id|nct_id|result_group_id|ctgov_group_code|title|period|description|count|milestone_description|count_units
48071115|NCT00825682|100497948|FG000|STARTED|Overall Study||47||
48071116|NCT00825682|100497949|FG001|STARTED|Overall Study||25||
48071117|NCT00825682|100497948|FG000|COMPLETED|Overall Study||34||
48071118|NCT00825682|100497949|FG001|COMPLETED|Overall Study||20||
48071119|NCT00825682|100497948|FG000|NOT COMPLETED|Overall Study||13||
48071120|NCT00825682|100497949|FG001|NOT COMPLETED|Overall Study||5||
48071121|NCT04021771|100497950|FG000|STARTED|Overall Study||55||
48071122|NCT04021771|100497951|FG001|STARTED|Overall Study||54||
48071123|NCT04021771|100497950|FG000|COMPLETED|Overall Study||55||
48071124|NCT04021771|100497951|FG001|COMPLETED|Overall Study||54||
48071125|NCT04021771|100497950|FG000|NOT COMPLETED|Overall Study||0||
48071126|NCT04021771|100497951|FG001|NOT COMPLETED|Overall Study||0||
48071127|NCT02850601|100497952|FG000|STARTED|Overall Study||12||
48071128|NCT02850601|100497953|FG001|STARTED|Overall Study||12||
48071129|NCT02850601|100497952|FG000|COMPLETED|Overall Study||12||
48071130|NCT02850601|100497953|FG001|COMPLETED|Overall Study||12||
48520155|NCT02994355|101607830|FG000|STARTED|Overall Study||0||12
48520156|NCT02994355|101607831|FG001|STARTED|Overall Study||0||12
48520157|NCT02994355|101607830|FG000|COMPLETED|Overall Study||0||11
48520158|NCT02994355|101607831|FG001|COMPLETED|Overall Study||0||11
48520159|NCT02994355|101607830|FG000|NOT COMPLETED|Overall Study||0||1
48520160|NCT02994355|101607831|FG001|NOT COMPLETED|Overall Study||0||1
48071131|NCT02850601|100497952|FG000|NOT COMPLETED|Overall Study||0||
48071132|NCT02850601|100497953|FG001|NOT COMPLETED|Overall Study||0||
48071133|NCT00828412|100497954|FG000|STARTED|Overall Study||50||
48071134|NCT00828412|100497955|FG001|STARTED|Overall Study||50||
48071135|NCT00828412|100497954|FG000|COMPLETED|Overall Study||41||
48071136|NCT00828412|100497955|FG001|COMPLETED|Overall Study||48||
48071137|NCT00828412|100497954|FG000|NOT COMPLETED|Overall Study||9||
48071138|NCT00828412|100497955|FG001|NOT COMPLETED|Overall Study||2||
48071139|NCT00675948|100497956|FG000|STARTED|Overall Study||39||
48071140|NCT00675948|100497957|FG001|STARTED|Overall Study||4||
48071141|NCT00675948|100497956|FG000|COMPLETED|Overall Study||0||
48520161|NCT01352182|101607832|FG000|STARTED|Overall Study||8||
48520162|NCT01352182|101607833|FG001|STARTED|Overall Study||4||
48520163|NCT01352182|101607832|FG000|COMPLETED|Overall Study||8||
48520164|NCT01352182|101607833|FG001|COMPLETED|Overall Study||4||
48071142|NCT00675948|100497957|FG001|COMPLETED|Overall Study||1||
48071143|NCT00675948|100497956|FG000|NOT COMPLETED|Overall Study||39||
48071144|NCT00675948|100497957|FG001|NOT COMPLETED|Overall Study||3||
48071145|NCT00094172|100497958|FG000|STARTED|Overall Study||50||
48071146|NCT00094172|100497959|FG001|STARTED|Overall Study||32||
48071147|NCT00094172|100497958|FG000|COMPLETED|Overall Study||36||
48071148|NCT00094172|100497959|FG001|COMPLETED|Overall Study||25||
48071149|NCT00094172|100497958|FG000|NOT COMPLETED|Overall Study||14||
48071150|NCT00094172|100497959|FG001|NOT COMPLETED|Overall Study||7||
48071151|NCT00968201|100497960|FG000|STARTED|Base Study - (Period II)||228||
48071152|NCT00968201|100497961|FG001|STARTED|Base Study - (Period II)||0||
48071153|NCT00968201|100497962|FG002|STARTED|Base Study - (Period II)||461||
48071154|NCT00968201|100497960|FG000|COMPLETED|Base Study - (Period II)||202||
48071155|NCT00968201|100497961|FG001|COMPLETED|Base Study - (Period II)||0||
48071156|NCT00968201|100497962|FG002|COMPLETED|Base Study - (Period II)||416||
48071157|NCT00968201|100497960|FG000|NOT COMPLETED|Base Study - (Period II)||26||
48071158|NCT00968201|100497961|FG001|NOT COMPLETED|Base Study - (Period II)||0||
48071159|NCT00968201|100497962|FG002|NOT COMPLETED|Base Study - (Period II)||45||
48071160|NCT00968201|100497960|FG000|STARTED|Extension Study - (Period III)||0||
48071161|NCT00968201|100497961|FG001|STARTED|Extension Study - (Period III)||157||
48071162|NCT00968201|100497962|FG002|STARTED|Extension Study - (Period III)||364||
48071163|NCT00968201|100497960|FG000|COMPLETED|Extension Study - (Period III)||0||
48071164|NCT00968201|100497961|FG001|COMPLETED|Extension Study - (Period III)||33||
48071165|NCT00968201|100497962|FG002|COMPLETED|Extension Study - (Period III)||84||
48071166|NCT00968201|100497960|FG000|NOT COMPLETED|Extension Study - (Period III)||0||
48071167|NCT00968201|100497961|FG001|NOT COMPLETED|Extension Study - (Period III)||124||
48071168|NCT00968201|100497962|FG002|NOT COMPLETED|Extension Study - (Period III)||280||
48071169|NCT00474760|100497963|FG000|STARTED|Overall Study||3||
48071170|NCT00474760|100497964|FG001|STARTED|Overall Study||3||
48071171|NCT00474760|100497965|FG002|STARTED|Overall Study||3||
48071172|NCT00474760|100497966|FG003|STARTED|Overall Study||3||
48071173|NCT00474760|100497967|FG004|STARTED|Overall Study||13||
48071174|NCT00474760|100497968|FG005|STARTED|Overall Study||29||
48071175|NCT00474760|100497969|FG006|STARTED|Overall Study||11||
48071176|NCT00474760|100497963|FG000|COMPLETED|Overall Study||0||
48071177|NCT00474760|100497964|FG001|COMPLETED|Overall Study||0||
48071178|NCT00474760|100497965|FG002|COMPLETED|Overall Study||0||
48071179|NCT00474760|100497966|FG003|COMPLETED|Overall Study||0||
48071180|NCT00474760|100497967|FG004|COMPLETED|Overall Study||1||
48071181|NCT00474760|100497968|FG005|COMPLETED|Overall Study||0||
48071182|NCT00474760|100497969|FG006|COMPLETED|Overall Study||1||
48071183|NCT00474760|100497963|FG000|NOT COMPLETED|Overall Study||3||
48071184|NCT00474760|100497964|FG001|NOT COMPLETED|Overall Study||3||
48071185|NCT00474760|100497965|FG002|NOT COMPLETED|Overall Study||3||
48071186|NCT00474760|100497966|FG003|NOT COMPLETED|Overall Study||3||
48071187|NCT00474760|100497967|FG004|NOT COMPLETED|Overall Study||12||
48071188|NCT00474760|100497968|FG005|NOT COMPLETED|Overall Study||29||
48071189|NCT00474760|100497969|FG006|NOT COMPLETED|Overall Study||10||
48071190|NCT00389597|100497970|FG000|STARTED|Overall Study||164||
48071191|NCT00389597|100497971|FG001|STARTED|Overall Study||81||
48071192|NCT00389597|100497972|FG002|STARTED|Overall Study||225||
48071193|NCT00389597|100497973|FG003|STARTED|Overall Study||105||
48071194|NCT00389597|100497970|FG000|24 mo|Overall Study||156||
48071195|NCT00389597|100497971|FG001|24 mo|Overall Study||75||
48071196|NCT00389597|100497972|FG002|24 mo|Overall Study||221||
48071197|NCT00389597|100497973|FG003|24 mo|Overall Study||99||
48071198|NCT00389597|100497970|FG000|COMPLETED|Overall Study||156||
48071199|NCT00389597|100497971|FG001|COMPLETED|Overall Study||75||
48071200|NCT00389597|100497972|FG002|COMPLETED|Overall Study||221||
48071201|NCT00389597|100497973|FG003|COMPLETED|Overall Study||99||
48071202|NCT00389597|100497970|FG000|NOT COMPLETED|Overall Study||8||
48071203|NCT00389597|100497971|FG001|NOT COMPLETED|Overall Study||6||
48071204|NCT00389597|100497972|FG002|NOT COMPLETED|Overall Study||4||
48071205|NCT00389597|100497973|FG003|NOT COMPLETED|Overall Study||6||
48071206|NCT05085730|100497974|FG000|STARTED|Overall Study||13||
48071207|NCT05085730|100497974|FG000|COMPLETED|Overall Study||8||
48071208|NCT05085730|100497974|FG000|NOT COMPLETED|Overall Study||5||
48071209|NCT02856035|100497975|FG000|STARTED|Overall Study||4||
48071210|NCT02856035|100497975|FG000|COMPLETED|Overall Study||4||
48071211|NCT02856035|100497975|FG000|NOT COMPLETED|Overall Study||0||
48071212|NCT01233258|100497976|FG000|STARTED|First Intervention (6 Months)||11||
48071213|NCT01233258|100497977|FG001|STARTED|First Intervention (6 Months)||10||
48071214|NCT01233258|100497978|FG002|STARTED|First Intervention (6 Months)||14||
48071215|NCT01233258|100497979|FG003|STARTED|First Intervention (6 Months)||16||
48071216|NCT01233258|100497980|FG004|STARTED|First Intervention (6 Months)||16||
48071217|NCT01233258|100497981|FG005|STARTED|First Intervention (6 Months)||16||
48071218|NCT01233258|100497976|FG000|Participants Received Treatment|First Intervention (6 Months)||11||
48071219|NCT01233258|100497977|FG001|Participants Received Treatment|First Intervention (6 Months)||10||
48071220|NCT01233258|100497978|FG002|Participants Received Treatment|First Intervention (6 Months)||13||
48071221|NCT01233258|100497979|FG003|Participants Received Treatment|First Intervention (6 Months)||15||
48071222|NCT01233258|100497980|FG004|Participants Received Treatment|First Intervention (6 Months)||16||
48071223|NCT01233258|100497981|FG005|Participants Received Treatment|First Intervention (6 Months)||15||
48071224|NCT01233258|100497976|FG000|COMPLETED|First Intervention (6 Months)||10||
48071225|NCT01233258|100497977|FG001|COMPLETED|First Intervention (6 Months)||10||
48071226|NCT01233258|100497978|FG002|COMPLETED|First Intervention (6 Months)||13||
48071227|NCT01233258|100497979|FG003|COMPLETED|First Intervention (6 Months)||15||
48071228|NCT01233258|100497980|FG004|COMPLETED|First Intervention (6 Months)||16||
48071229|NCT01233258|100497981|FG005|COMPLETED|First Intervention (6 Months)||15||
48071230|NCT01233258|100497976|FG000|NOT COMPLETED|First Intervention (6 Months)||1||
48071231|NCT01233258|100497977|FG001|NOT COMPLETED|First Intervention (6 Months)||0||
48071232|NCT01233258|100497978|FG002|NOT COMPLETED|First Intervention (6 Months)||1||
48071233|NCT01233258|100497979|FG003|NOT COMPLETED|First Intervention (6 Months)||1||
48071234|NCT01233258|100497980|FG004|NOT COMPLETED|First Intervention (6 Months)||0||
48071235|NCT01233258|100497981|FG005|NOT COMPLETED|First Intervention (6 Months)||1||
48071236|NCT01233258|100497976|FG000|STARTED|Washout (2-3 Days)||10||
48071237|NCT01233258|100497977|FG001|STARTED|Washout (2-3 Days)||10||
48071238|NCT01233258|100497978|FG002|STARTED|Washout (2-3 Days)||13||
48071239|NCT01233258|100497979|FG003|STARTED|Washout (2-3 Days)||15||
48071240|NCT01233258|100497980|FG004|STARTED|Washout (2-3 Days)||16||
48071241|NCT01233258|100497981|FG005|STARTED|Washout (2-3 Days)||15||
48071242|NCT01233258|100497976|FG000|COMPLETED|Washout (2-3 Days)||10||
48071243|NCT01233258|100497977|FG001|COMPLETED|Washout (2-3 Days)||10||
48071244|NCT01233258|100497978|FG002|COMPLETED|Washout (2-3 Days)||13||
48071245|NCT01233258|100497979|FG003|COMPLETED|Washout (2-3 Days)||15||
48071246|NCT01233258|100497980|FG004|COMPLETED|Washout (2-3 Days)||16||
48071247|NCT01233258|100497981|FG005|COMPLETED|Washout (2-3 Days)||15||
48520165|NCT01352182|101607832|FG000|NOT COMPLETED|Overall Study||0||
48520166|NCT01352182|101607833|FG001|NOT COMPLETED|Overall Study||0||
48520167|NCT02442271|101607834|FG000|STARTED|Overall Study||222||
48520168|NCT02442271|101607834|FG000|COMPLETED|Overall Study||218||
48520169|NCT02442271|101607834|FG000|NOT COMPLETED|Overall Study||4||
48520170|NCT00430950|101607835|FG000|STARTED|Overall Study||502||
48520171|NCT00430950|101607836|FG001|STARTED|Overall Study||508||
48071248|NCT01233258|100497976|FG000|NOT COMPLETED|Washout (2-3 Days)||0||
48071249|NCT01233258|100497977|FG001|NOT COMPLETED|Washout (2-3 Days)||0||
48071250|NCT01233258|100497978|FG002|NOT COMPLETED|Washout (2-3 Days)||0||
48071251|NCT01233258|100497979|FG003|NOT COMPLETED|Washout (2-3 Days)||0||
48071252|NCT01233258|100497980|FG004|NOT COMPLETED|Washout (2-3 Days)||0||
48071253|NCT01233258|100497981|FG005|NOT COMPLETED|Washout (2-3 Days)||0||
48071254|NCT01233258|100497976|FG000|STARTED|Second Intervention (6 Months)||10||
48071255|NCT01233258|100497977|FG001|STARTED|Second Intervention (6 Months)||10||
48071256|NCT01233258|100497978|FG002|STARTED|Second Intervention (6 Months)||13||
48071257|NCT01233258|100497979|FG003|STARTED|Second Intervention (6 Months)||15||
48071258|NCT01233258|100497980|FG004|STARTED|Second Intervention (6 Months)||16||
48520172|NCT00430950|101607835|FG000|COMPLETED|Overall Study||489||
48520173|NCT00430950|101607836|FG001|COMPLETED|Overall Study||495||
48520174|NCT00430950|101607835|FG000|NOT COMPLETED|Overall Study||13||
48520175|NCT00430950|101607836|FG001|NOT COMPLETED|Overall Study||13||
48520176|NCT00350402|101607837|FG000|STARTED|Overall Study||21||
48071259|NCT01233258|100497981|FG005|STARTED|Second Intervention (6 Months)||15||
48071260|NCT01233258|100497976|FG000|COMPLETED|Second Intervention (6 Months)||10||
48071261|NCT01233258|100497977|FG001|COMPLETED|Second Intervention (6 Months)||10||
48071262|NCT01233258|100497978|FG002|COMPLETED|Second Intervention (6 Months)||13||
48071263|NCT01233258|100497979|FG003|COMPLETED|Second Intervention (6 Months)||15||
48071264|NCT01233258|100497980|FG004|COMPLETED|Second Intervention (6 Months)||16||
48071265|NCT01233258|100497981|FG005|COMPLETED|Second Intervention (6 Months)||15||
48071266|NCT01233258|100497976|FG000|NOT COMPLETED|Second Intervention (6 Months)||0||
48071267|NCT01233258|100497977|FG001|NOT COMPLETED|Second Intervention (6 Months)||0||
48071268|NCT01233258|100497978|FG002|NOT COMPLETED|Second Intervention (6 Months)||0||
48071269|NCT01233258|100497979|FG003|NOT COMPLETED|Second Intervention (6 Months)||0||
48071270|NCT01233258|100497980|FG004|NOT COMPLETED|Second Intervention (6 Months)||0||
48071271|NCT01233258|100497981|FG005|NOT COMPLETED|Second Intervention (6 Months)||0||
48071272|NCT00781274|100497982|FG000|STARTED|Overall Study||32||
48071273|NCT00781274|100497982|FG000|COMPLETED|Overall Study||30||
48071274|NCT00781274|100497982|FG000|NOT COMPLETED|Overall Study||2||
48071275|NCT03750955|100497983|FG000|STARTED|Hygiene Phase of 2 Weeks||16||16
48071276|NCT03750955|100497984|FG001|STARTED|Hygiene Phase of 2 Weeks||16||16
48071277|NCT03750955|100497983|FG000|COMPLETED|Hygiene Phase of 2 Weeks||13||13
48071278|NCT03750955|100497984|FG001|COMPLETED|Hygiene Phase of 2 Weeks||13||13
48071279|NCT03750955|100497983|FG000|NOT COMPLETED|Hygiene Phase of 2 Weeks||3||3
48071280|NCT03750955|100497984|FG001|NOT COMPLETED|Hygiene Phase of 2 Weeks||3||3
48071281|NCT03750955|100497983|FG000|STARTED|Gingivitis Induction Phase of 2 Weeks||13||13
48071282|NCT03750955|100497984|FG001|STARTED|Gingivitis Induction Phase of 2 Weeks||13||13
48071283|NCT03750955|100497983|FG000|COMPLETED|Gingivitis Induction Phase of 2 Weeks||13||13
48071284|NCT03750955|100497984|FG001|COMPLETED|Gingivitis Induction Phase of 2 Weeks||13||13
48071285|NCT03750955|100497983|FG000|NOT COMPLETED|Gingivitis Induction Phase of 2 Weeks||0||0
48071286|NCT03750955|100497984|FG001|NOT COMPLETED|Gingivitis Induction Phase of 2 Weeks||0||0
48071287|NCT03750955|100497983|FG000|STARTED|Resolution Phase of 2 Weeks||13||13
48071288|NCT03750955|100497984|FG001|STARTED|Resolution Phase of 2 Weeks||13||13
48071289|NCT03750955|100497983|FG000|COMPLETED|Resolution Phase of 2 Weeks||13||13
48071290|NCT03750955|100497984|FG001|COMPLETED|Resolution Phase of 2 Weeks||13||13
48071291|NCT03750955|100497983|FG000|NOT COMPLETED|Resolution Phase of 2 Weeks||0||0
48071292|NCT03750955|100497984|FG001|NOT COMPLETED|Resolution Phase of 2 Weeks||0||0
48071293|NCT03407625|100497985|FG000|STARTED|Overall Study||1117||
48071294|NCT03407625|100497986|FG001|STARTED|Overall Study||1110||
48071295|NCT03407625|100497985|FG000|COMPLETED|Overall Study||1117||
48071296|NCT03407625|100497986|FG001|COMPLETED|Overall Study||1110||
48071297|NCT03407625|100497985|FG000|NOT COMPLETED|Overall Study||0||
48071298|NCT03407625|100497986|FG001|NOT COMPLETED|Overall Study||0||
48071299|NCT05047770|100497987|FG000|STARTED|Overall Study||272||
48071300|NCT05047770|100497988|FG001|STARTED|Overall Study||267||
48071301|NCT05047770|100497989|FG002|STARTED|Overall Study||497||
48520177|NCT00350402|101607838|FG001|STARTED|Overall Study||21||
48071302|NCT05047770|100497990|FG003|STARTED|Overall Study||498||
48071303|NCT05047770|100497987|FG000|COMPLETED|Overall Study||249||
48520178|NCT00350402|101607837|FG000|COMPLETED|Overall Study||20||
48071304|NCT05047770|100497988|FG001|COMPLETED|Overall Study||252||
48071305|NCT05047770|100497989|FG002|COMPLETED|Overall Study||478||
48520179|NCT00350402|101607838|FG001|COMPLETED|Overall Study||20||
48520180|NCT00350402|101607837|FG000|NOT COMPLETED|Overall Study||1||
48520181|NCT00350402|101607838|FG001|NOT COMPLETED|Overall Study||1||
48520182|NCT01680783|101607839|FG000|STARTED|Overall Study||39||
48520183|NCT01680783|101607840|FG001|STARTED|Overall Study||44||
48520184|NCT01680783|101607839|FG000|COMPLETED|Overall Study||39||
48520185|NCT01680783|101607840|FG001|COMPLETED|Overall Study||44||
48520186|NCT01680783|101607839|FG000|NOT COMPLETED|Overall Study||0||
48071306|NCT05047770|100497990|FG003|COMPLETED|Overall Study||473||
48222072|NCT00960141|100866674|FG000|STARTED|Overall Study||333||
48520187|NCT01680783|101607840|FG001|NOT COMPLETED|Overall Study||0||
48520188|NCT04588688|101607841|FG000|STARTED|Overall Study||3||
48520189|NCT04588688|101607841|FG000|COMPLETED|Overall Study||3||
48520190|NCT04588688|101607841|FG000|NOT COMPLETED|Overall Study||0||
48071307|NCT05047770|100497987|FG000|NOT COMPLETED|Overall Study||23||
48071308|NCT05047770|100497988|FG001|NOT COMPLETED|Overall Study||15||
48071309|NCT05047770|100497989|FG002|NOT COMPLETED|Overall Study||19||
48071310|NCT05047770|100497990|FG003|NOT COMPLETED|Overall Study||25||
48071311|NCT01441180|100497991|FG000|STARTED|Overall Study||10||
48071312|NCT01441180|100497992|FG001|STARTED|Overall Study||25||
48071313|NCT01441180|100497993|FG002|STARTED|Overall Study||25||
48071314|NCT01441180|100497991|FG000|COMPLETED|Overall Study||9||
48071315|NCT01441180|100497992|FG001|COMPLETED|Overall Study||24||
48520191|NCT00788593|101607842|FG000|STARTED|Placebo Run-in Phase||82||
48520192|NCT00788593|101607843|FG001|STARTED|Placebo Run-in Phase||0||
48520193|NCT00788593|101607844|FG002|STARTED|Placebo Run-in Phase||0||
48520194|NCT00788593|101607842|FG000|COMPLETED|Placebo Run-in Phase||76||
48222073|NCT00960141|100866675|FG001|STARTED|Overall Study||326||
48222074|NCT00960141|100866676|FG002|STARTED|Overall Study||170||
48222075|NCT00960141|100866674|FG000|COMPLETED|Overall Study||323||
48222076|NCT00960141|100866675|FG001|COMPLETED|Overall Study||309||
48222077|NCT00960141|100866676|FG002|COMPLETED|Overall Study||163||
48222078|NCT00960141|100866674|FG000|NOT COMPLETED|Overall Study||10||
48222079|NCT00960141|100866675|FG001|NOT COMPLETED|Overall Study||17||
48222080|NCT00960141|100866676|FG002|NOT COMPLETED|Overall Study||7||
48222081|NCT01968967|100866677|FG000|STARTED|Treatment Period||1071||
48222082|NCT01968967|100866678|FG001|STARTED|Treatment Period||1068||
48222083|NCT01968967|100866679|FG002|STARTED|Treatment Period||0||
48222084|NCT01968967|100866680|FG003|STARTED|Treatment Period||0||
48222085|NCT01968967|100866681|FG004|STARTED|Treatment Period||0||
48222086|NCT01968967|100866677|FG000|Treated|Treatment Period||1065||
48222087|NCT01968967|100866678|FG001|Treated|Treatment Period||1063||
48222088|NCT01968967|100866679|FG002|Treated|Treatment Period||0||
48222089|NCT01968967|100866680|FG003|Treated|Treatment Period||0||
48222090|NCT01968967|100866681|FG004|Treated|Treatment Period||0||
48222091|NCT01968967|100866677|FG000|COMPLETED|Treatment Period||925||
48222092|NCT01968967|100866678|FG001|COMPLETED|Treatment Period||934||
48222093|NCT01968967|100866679|FG002|COMPLETED|Treatment Period||0||
48222094|NCT01968967|100866680|FG003|COMPLETED|Treatment Period||0||
48222095|NCT01968967|100866681|FG004|COMPLETED|Treatment Period||0||
48520195|NCT00788593|101607843|FG001|COMPLETED|Placebo Run-in Phase||0||
48520196|NCT00788593|101607844|FG002|COMPLETED|Placebo Run-in Phase||0||
48520197|NCT00788593|101607842|FG000|NOT COMPLETED|Placebo Run-in Phase||6||
48520198|NCT00788593|101607843|FG001|NOT COMPLETED|Placebo Run-in Phase||0||
48222096|NCT01968967|100866677|FG000|NOT COMPLETED|Treatment Period||146||
48222097|NCT01968967|100866678|FG001|NOT COMPLETED|Treatment Period||134||
48222098|NCT01968967|100866679|FG002|NOT COMPLETED|Treatment Period||0||
48222099|NCT01968967|100866680|FG003|NOT COMPLETED|Treatment Period||0||
48222100|NCT01968967|100866681|FG004|NOT COMPLETED|Treatment Period||0||
48222101|NCT01968967|100866677|FG000|STARTED|Extension Period||0||
48222102|NCT01968967|100866678|FG001|STARTED|Extension Period||0||
48222103|NCT01968967|100866679|FG002|STARTED|Extension Period||47||
48222104|NCT01968967|100866680|FG003|STARTED|Extension Period||19||
48520199|NCT00788593|101607844|FG002|NOT COMPLETED|Placebo Run-in Phase||0||
48520200|NCT00788593|101607842|FG000|STARTED|First Intervention Period||0||
48520201|NCT00788593|101607843|FG001|STARTED|First Intervention Period||39||
48520202|NCT00788593|101607844|FG002|STARTED|First Intervention Period||37||
48520203|NCT00788593|101607842|FG000|COMPLETED|First Intervention Period||0||
48520204|NCT00788593|101607843|FG001|COMPLETED|First Intervention Period||38||
48520205|NCT00788593|101607844|FG002|COMPLETED|First Intervention Period||37||
48520206|NCT00788593|101607842|FG000|NOT COMPLETED|First Intervention Period||0||
48222105|NCT01968967|100866681|FG004|STARTED|Extension Period||39||
48222106|NCT01968967|100866677|FG000|COMPLETED|Extension Period||0||
48222107|NCT01968967|100866678|FG001|COMPLETED|Extension Period||0||
48222108|NCT01968967|100866679|FG002|COMPLETED|Extension Period||45||
48222109|NCT01968967|100866680|FG003|COMPLETED|Extension Period||19||
48222110|NCT01968967|100866681|FG004|COMPLETED|Extension Period||34||
48222111|NCT01968967|100866677|FG000|NOT COMPLETED|Extension Period||0||
48222112|NCT01968967|100866678|FG001|NOT COMPLETED|Extension Period||0||
48071316|NCT01441180|100497993|FG002|COMPLETED|Overall Study||22||
48071317|NCT01441180|100497991|FG000|NOT COMPLETED|Overall Study||1||
48071318|NCT01441180|100497992|FG001|NOT COMPLETED|Overall Study||1||
48071319|NCT01441180|100497993|FG002|NOT COMPLETED|Overall Study||3||
48071320|NCT03519178|100497994|FG000|STARTED|PF-06873600 Treatment||1||
48071321|NCT03519178|100497995|FG001|STARTED|PF-06873600 Treatment||2||
48520207|NCT00788593|101607843|FG001|NOT COMPLETED|First Intervention Period||1||
48520208|NCT00788593|101607844|FG002|NOT COMPLETED|First Intervention Period||0||
48520209|NCT00788593|101607842|FG000|STARTED|Second Intervention Period||0||
48520210|NCT00788593|101607843|FG001|STARTED|Second Intervention Period||38||
48520211|NCT00788593|101607844|FG002|STARTED|Second Intervention Period||37||
48222113|NCT01968967|100866679|FG002|NOT COMPLETED|Extension Period||2||
48222114|NCT01968967|100866680|FG003|NOT COMPLETED|Extension Period||0||
48222115|NCT01968967|100866681|FG004|NOT COMPLETED|Extension Period||5||
48222116|NCT00090519|100866682|FG000|STARTED|Overall Study||371||
48071322|NCT03519178|100497996|FG002|STARTED|PF-06873600 Treatment||2||
48071323|NCT03519178|100497997|FG003|STARTED|PF-06873600 Treatment||3||
48222117|NCT00090519|100866683|FG001|STARTED|Overall Study||360||
48222118|NCT00090519|100866682|FG000|COMPLETED|Overall Study||298||
48222119|NCT00090519|100866683|FG001|COMPLETED|Overall Study||285||
48222120|NCT00090519|100866682|FG000|NOT COMPLETED|Overall Study||73||
48222121|NCT00090519|100866683|FG001|NOT COMPLETED|Overall Study||75||
48222122|NCT00495677|100866684|FG000|STARTED|Stage 1 (25 Days)||2||
48222123|NCT00495677|100866685|FG001|STARTED|Stage 1 (25 Days)||6||
48222124|NCT00495677|100866686|FG002|STARTED|Stage 1 (25 Days)||6||
48222125|NCT00495677|100866687|FG003|STARTED|Stage 1 (25 Days)||6||
48520212|NCT00788593|101607842|FG000|COMPLETED|Second Intervention Period||0||
48592616|NCT01546168|101783148|FG000|NOT COMPLETED|Overall Study||4||
48071324|NCT03519178|100497998|FG004|STARTED|PF-06873600 Treatment||9||
48071325|NCT03519178|100497999|FG005|STARTED|PF-06873600 Treatment||7||
48222126|NCT00495677|100866688|FG004|STARTED|Stage 1 (25 Days)||0||
48071326|NCT03519178|100498000|FG006|STARTED|PF-06873600 Treatment||4||
48071327|NCT03519178|100498001|FG007|STARTED|PF-06873600 Treatment||13||
48520213|NCT00788593|101607843|FG001|COMPLETED|Second Intervention Period||37||
48520214|NCT00788593|101607844|FG002|COMPLETED|Second Intervention Period||36||
48520215|NCT00788593|101607842|FG000|NOT COMPLETED|Second Intervention Period||0||
48520216|NCT00788593|101607843|FG001|NOT COMPLETED|Second Intervention Period||1||
48520217|NCT00788593|101607844|FG002|NOT COMPLETED|Second Intervention Period||1||
48520218|NCT01564459|101607845|FG000|STARTED|Run-In||12||
48520219|NCT01564459|101607846|FG001|STARTED|Run-In||87||
48520220|NCT01564459|101607847|FG002|STARTED|Run-In||83||
48520221|NCT01564459|101607845|FG000|COMPLETED|Run-In||0||
48520222|NCT01564459|101607846|FG001|COMPLETED|Run-In||87||
48520223|NCT01564459|101607847|FG002|COMPLETED|Run-In||83||
48520224|NCT01564459|101607845|FG000|NOT COMPLETED|Run-In||12||
48520225|NCT01564459|101607846|FG001|NOT COMPLETED|Run-In||0||
48520226|NCT01564459|101607847|FG002|NOT COMPLETED|Run-In||0||
48520227|NCT01564459|101607845|FG000|STARTED|Double-blind Treatment||0||
48520228|NCT01564459|101607846|FG001|STARTED|Double-blind Treatment||87||
48520229|NCT01564459|101607847|FG002|STARTED|Double-blind Treatment||83||
48520230|NCT01564459|101607845|FG000|COMPLETED|Double-blind Treatment||0||
48520231|NCT01564459|101607846|FG001|COMPLETED|Double-blind Treatment||87||
48520232|NCT01564459|101607847|FG002|COMPLETED|Double-blind Treatment||82||
48520233|NCT01564459|101607845|FG000|NOT COMPLETED|Double-blind Treatment||0||
48520234|NCT01564459|101607846|FG001|NOT COMPLETED|Double-blind Treatment||0||
48520235|NCT01564459|101607847|FG002|NOT COMPLETED|Double-blind Treatment||1||
48520236|NCT00253981|101607848|FG000|STARTED|Overall Study||16||
48520237|NCT00253981|101607849|FG001|STARTED|Overall Study||14||
48071328|NCT03519178|100498002|FG008|STARTED|PF-06873600 Treatment||10||
48071329|NCT03519178|100498003|FG009|STARTED|PF-06873600 Treatment||9||
48071330|NCT03519178|100498004|FG010|STARTED|PF-06873600 Treatment||7||
48071331|NCT03519178|100498005|FG011|STARTED|PF-06873600 Treatment||5||
48071332|NCT03519178|100498006|FG012|STARTED|PF-06873600 Treatment||6||
48071333|NCT03519178|100498007|FG013|STARTED|PF-06873600 Treatment||45||
48071334|NCT03519178|100498008|FG014|STARTED|PF-06873600 Treatment||28||
48071335|NCT03519178|100497994|FG000|COMPLETED|PF-06873600 Treatment||0||
48071336|NCT03519178|100497995|FG001|COMPLETED|PF-06873600 Treatment||0||
48071337|NCT03519178|100497996|FG002|COMPLETED|PF-06873600 Treatment||0||
48071338|NCT03519178|100497997|FG003|COMPLETED|PF-06873600 Treatment||0||
48071339|NCT03519178|100497998|FG004|COMPLETED|PF-06873600 Treatment||0||
48071340|NCT03519178|100497999|FG005|COMPLETED|PF-06873600 Treatment||0||
48071341|NCT03519178|100498000|FG006|COMPLETED|PF-06873600 Treatment||0||
48071342|NCT03519178|100498001|FG007|COMPLETED|PF-06873600 Treatment||0||
48071343|NCT03519178|100498002|FG008|COMPLETED|PF-06873600 Treatment||0||
48071344|NCT03519178|100498003|FG009|COMPLETED|PF-06873600 Treatment||0||
48071345|NCT03519178|100498004|FG010|COMPLETED|PF-06873600 Treatment||0||
48071346|NCT03519178|100498005|FG011|COMPLETED|PF-06873600 Treatment||0||
48071347|NCT03519178|100498006|FG012|COMPLETED|PF-06873600 Treatment||0||
48071348|NCT03519178|100498007|FG013|COMPLETED|PF-06873600 Treatment||0||
48071349|NCT03519178|100498008|FG014|COMPLETED|PF-06873600 Treatment||0||
48071350|NCT03519178|100497994|FG000|NOT COMPLETED|PF-06873600 Treatment||1||
48071351|NCT03519178|100497995|FG001|NOT COMPLETED|PF-06873600 Treatment||2||
48071352|NCT03519178|100497996|FG002|NOT COMPLETED|PF-06873600 Treatment||2||
48071353|NCT03519178|100497997|FG003|NOT COMPLETED|PF-06873600 Treatment||3||
48071354|NCT03519178|100497998|FG004|NOT COMPLETED|PF-06873600 Treatment||9||
48071355|NCT03519178|100497999|FG005|NOT COMPLETED|PF-06873600 Treatment||7||
48071356|NCT03519178|100498000|FG006|NOT COMPLETED|PF-06873600 Treatment||4||
48071357|NCT03519178|100498001|FG007|NOT COMPLETED|PF-06873600 Treatment||13||
48071358|NCT03519178|100498002|FG008|NOT COMPLETED|PF-06873600 Treatment||10||
48071359|NCT03519178|100498003|FG009|NOT COMPLETED|PF-06873600 Treatment||9||
48071360|NCT03519178|100498004|FG010|NOT COMPLETED|PF-06873600 Treatment||7||
48071361|NCT03519178|100498005|FG011|NOT COMPLETED|PF-06873600 Treatment||5||
48071362|NCT03519178|100498006|FG012|NOT COMPLETED|PF-06873600 Treatment||6||
48071363|NCT03519178|100498007|FG013|NOT COMPLETED|PF-06873600 Treatment||45||
48071364|NCT03519178|100498008|FG014|NOT COMPLETED|PF-06873600 Treatment||28||
48071365|NCT03519178|100497994|FG000|STARTED|Disposition for Fluvestrant Treatment||0||
48071366|NCT03519178|100497995|FG001|STARTED|Disposition for Fluvestrant Treatment||0||
48071367|NCT03519178|100497996|FG002|STARTED|Disposition for Fluvestrant Treatment||0||
48071368|NCT03519178|100497997|FG003|STARTED|Disposition for Fluvestrant Treatment||0||
48071369|NCT03519178|100497998|FG004|STARTED|Disposition for Fluvestrant Treatment||0||
48071370|NCT03519178|100497999|FG005|STARTED|Disposition for Fluvestrant Treatment||0||
48071371|NCT03519178|100498000|FG006|STARTED|Disposition for Fluvestrant Treatment||0||
48071372|NCT03519178|100498001|FG007|STARTED|Disposition for Fluvestrant Treatment||0||
48071373|NCT03519178|100498002|FG008|STARTED|Disposition for Fluvestrant Treatment||0||
48071374|NCT03519178|100498003|FG009|STARTED|Disposition for Fluvestrant Treatment||9||
48520238|NCT00253981|101607848|FG000|COMPLETED|Overall Study||16||
48520239|NCT00253981|101607849|FG001|COMPLETED|Overall Study||14||
48520240|NCT00253981|101607848|FG000|NOT COMPLETED|Overall Study||0||
48071375|NCT03519178|100498004|FG010|STARTED|Disposition for Fluvestrant Treatment||0||
48520241|NCT00253981|101607849|FG001|NOT COMPLETED|Overall Study||0||
48071376|NCT03519178|100498005|FG011|STARTED|Disposition for Fluvestrant Treatment||0||
48071377|NCT03519178|100498006|FG012|STARTED|Disposition for Fluvestrant Treatment||0||
48071378|NCT03519178|100498007|FG013|STARTED|Disposition for Fluvestrant Treatment||45||
48071379|NCT03519178|100498008|FG014|STARTED|Disposition for Fluvestrant Treatment||28||
48071380|NCT03519178|100497994|FG000|COMPLETED|Disposition for Fluvestrant Treatment||0||
48071381|NCT03519178|100497995|FG001|COMPLETED|Disposition for Fluvestrant Treatment||0||
48071382|NCT03519178|100497996|FG002|COMPLETED|Disposition for Fluvestrant Treatment||0||
48071383|NCT03519178|100497997|FG003|COMPLETED|Disposition for Fluvestrant Treatment||0||
48071384|NCT03519178|100497998|FG004|COMPLETED|Disposition for Fluvestrant Treatment||0||
48071385|NCT03519178|100497999|FG005|COMPLETED|Disposition for Fluvestrant Treatment||0||
48071386|NCT03519178|100498000|FG006|COMPLETED|Disposition for Fluvestrant Treatment||0||
48071387|NCT03519178|100498001|FG007|COMPLETED|Disposition for Fluvestrant Treatment||0||
48071388|NCT03519178|100498002|FG008|COMPLETED|Disposition for Fluvestrant Treatment||0||
48071389|NCT03519178|100498003|FG009|COMPLETED|Disposition for Fluvestrant Treatment||0||
48520242|NCT01733147|101607850|FG000|STARTED|Overall Study||30||
48520243|NCT01733147|101607851|FG001|STARTED|Overall Study||30||
48520244|NCT01733147|101607850|FG000|COMPLETED|Overall Study||30||
48520245|NCT01733147|101607851|FG001|COMPLETED|Overall Study||30||
48520246|NCT01733147|101607850|FG000|NOT COMPLETED|Overall Study||0||
48520247|NCT01733147|101607851|FG001|NOT COMPLETED|Overall Study||0||
48520248|NCT00654654|101607852|FG000|STARTED|Overall Study||50||
48071390|NCT03519178|100498004|FG010|COMPLETED|Disposition for Fluvestrant Treatment||0||
48071391|NCT03519178|100498005|FG011|COMPLETED|Disposition for Fluvestrant Treatment||0||
48071392|NCT03519178|100498006|FG012|COMPLETED|Disposition for Fluvestrant Treatment||0||
48071393|NCT03519178|100498007|FG013|COMPLETED|Disposition for Fluvestrant Treatment||0||
48071394|NCT03519178|100498008|FG014|COMPLETED|Disposition for Fluvestrant Treatment||0||
48071395|NCT03519178|100497994|FG000|NOT COMPLETED|Disposition for Fluvestrant Treatment||0||
48071396|NCT03519178|100497995|FG001|NOT COMPLETED|Disposition for Fluvestrant Treatment||0||
48071397|NCT03519178|100497996|FG002|NOT COMPLETED|Disposition for Fluvestrant Treatment||0||
48071398|NCT03519178|100497997|FG003|NOT COMPLETED|Disposition for Fluvestrant Treatment||0||
48071399|NCT03519178|100497998|FG004|NOT COMPLETED|Disposition for Fluvestrant Treatment||0||
48071400|NCT03519178|100497999|FG005|NOT COMPLETED|Disposition for Fluvestrant Treatment||0||
48520249|NCT00654654|101607852|FG000|COMPLETED|Overall Study||43||
48520250|NCT00654654|101607852|FG000|NOT COMPLETED|Overall Study||7||
48520251|NCT01333072|101607853|FG000|STARTED|Overall Study||30||
48520252|NCT01333072|101607854|FG001|STARTED|Overall Study||31||
48520253|NCT01333072|101607853|FG000|COMPLETED|Overall Study||24||
48520254|NCT01333072|101607854|FG001|COMPLETED|Overall Study||27||
48520255|NCT01333072|101607853|FG000|NOT COMPLETED|Overall Study||6||
48520256|NCT01333072|101607854|FG001|NOT COMPLETED|Overall Study||4||
48520257|NCT01005706|101607855|FG000|STARTED|Overall Study||23||
48520258|NCT01005706|101607856|FG001|STARTED|Overall Study||17||
48520259|NCT01005706|101607855|FG000|COMPLETED|Overall Study||23||
48222127|NCT00495677|100866689|FG005|STARTED|Stage 1 (25 Days)||0||
48222128|NCT00495677|100866690|FG006|STARTED|Stage 1 (25 Days)||0||
48520260|NCT01005706|101607856|FG001|COMPLETED|Overall Study||17||
48520261|NCT01005706|101607855|FG000|NOT COMPLETED|Overall Study||0||
48520262|NCT01005706|101607856|FG001|NOT COMPLETED|Overall Study||0||
48520263|NCT02854059|101607857|FG000|STARTED|Overall Study||2||
48520264|NCT02854059|101607858|FG001|STARTED|Overall Study||0||
48520265|NCT02854059|101607857|FG000|COMPLETED|Overall Study||2||
48520266|NCT02854059|101607858|FG001|COMPLETED|Overall Study||0||
48520267|NCT02854059|101607857|FG000|NOT COMPLETED|Overall Study||0||
48520268|NCT02854059|101607858|FG001|NOT COMPLETED|Overall Study||0||
48520269|NCT02389101|101607859|FG000|STARTED|Overall Study||21||
48520270|NCT02389101|101607859|FG000|COMPLETED|Overall Study||21||
48520271|NCT02389101|101607859|FG000|NOT COMPLETED|Overall Study||0||
48520272|NCT00775606|101607860|FG000|STARTED|Overall Study||8||
48670539|NCT02573493|101978194|FG000|STARTED|Overall Study||40||
48222129|NCT00495677|100866684|FG000|COMPLETED|Stage 1 (25 Days)||2||
48071401|NCT03519178|100498000|FG006|NOT COMPLETED|Disposition for Fluvestrant Treatment||0||
48071402|NCT03519178|100498001|FG007|NOT COMPLETED|Disposition for Fluvestrant Treatment||0||
48071403|NCT03519178|100498002|FG008|NOT COMPLETED|Disposition for Fluvestrant Treatment||0||
48071404|NCT03519178|100498003|FG009|NOT COMPLETED|Disposition for Fluvestrant Treatment||9||
48071405|NCT03519178|100498004|FG010|NOT COMPLETED|Disposition for Fluvestrant Treatment||0||
48071406|NCT03519178|100498005|FG011|NOT COMPLETED|Disposition for Fluvestrant Treatment||0||
48222130|NCT00495677|100866685|FG001|COMPLETED|Stage 1 (25 Days)||6||
48071407|NCT03519178|100498006|FG012|NOT COMPLETED|Disposition for Fluvestrant Treatment||0||
48071408|NCT03519178|100498007|FG013|NOT COMPLETED|Disposition for Fluvestrant Treatment||45||
48071409|NCT03519178|100498008|FG014|NOT COMPLETED|Disposition for Fluvestrant Treatment||28||
48071410|NCT03519178|100497994|FG000|STARTED|Disposition for Letrozole Treatment||0||
48071411|NCT03519178|100497995|FG001|STARTED|Disposition for Letrozole Treatment||0||
48222131|NCT00495677|100866686|FG002|COMPLETED|Stage 1 (25 Days)||5||
48222132|NCT00495677|100866687|FG003|COMPLETED|Stage 1 (25 Days)||6||
48520273|NCT00775606|101607861|FG001|STARTED|Overall Study||5||
48520274|NCT00775606|101607860|FG000|COMPLETED|Overall Study||5||
48520275|NCT00775606|101607861|FG001|COMPLETED|Overall Study||5||
48520276|NCT00775606|101607860|FG000|NOT COMPLETED|Overall Study||3||
48520277|NCT00775606|101607861|FG001|NOT COMPLETED|Overall Study||0||
48520278|NCT05069155|101607862|FG000|STARTED|Overall Study||50||
48071412|NCT03519178|100497996|FG002|STARTED|Disposition for Letrozole Treatment||0||
48071413|NCT03519178|100497997|FG003|STARTED|Disposition for Letrozole Treatment||0||
48071414|NCT03519178|100497998|FG004|STARTED|Disposition for Letrozole Treatment||0||
48071415|NCT03519178|100497999|FG005|STARTED|Disposition for Letrozole Treatment||0||
48071416|NCT03519178|100498000|FG006|STARTED|Disposition for Letrozole Treatment||0||
48071417|NCT03519178|100498001|FG007|STARTED|Disposition for Letrozole Treatment||0||
48071418|NCT03519178|100498002|FG008|STARTED|Disposition for Letrozole Treatment||0||
48071419|NCT03519178|100498003|FG009|STARTED|Disposition for Letrozole Treatment||0||
48071420|NCT03519178|100498004|FG010|STARTED|Disposition for Letrozole Treatment||7||
48071421|NCT03519178|100498005|FG011|STARTED|Disposition for Letrozole Treatment||0||
48071422|NCT03519178|100498006|FG012|STARTED|Disposition for Letrozole Treatment||0||
48071423|NCT03519178|100498007|FG013|STARTED|Disposition for Letrozole Treatment||0||
48071424|NCT03519178|100498008|FG014|STARTED|Disposition for Letrozole Treatment||0||
48071425|NCT03519178|100497994|FG000|COMPLETED|Disposition for Letrozole Treatment||0||
48071426|NCT03519178|100497995|FG001|COMPLETED|Disposition for Letrozole Treatment||0||
48071427|NCT03519178|100497996|FG002|COMPLETED|Disposition for Letrozole Treatment||0||
48071428|NCT03519178|100497997|FG003|COMPLETED|Disposition for Letrozole Treatment||0||
48071429|NCT03519178|100497998|FG004|COMPLETED|Disposition for Letrozole Treatment||0||
48071430|NCT03519178|100497999|FG005|COMPLETED|Disposition for Letrozole Treatment||0||
48071431|NCT03519178|100498000|FG006|COMPLETED|Disposition for Letrozole Treatment||0||
48071432|NCT03519178|100498001|FG007|COMPLETED|Disposition for Letrozole Treatment||0||
48071433|NCT03519178|100498002|FG008|COMPLETED|Disposition for Letrozole Treatment||0||
48222133|NCT00495677|100866688|FG004|COMPLETED|Stage 1 (25 Days)||0||
48222134|NCT00495677|100866689|FG005|COMPLETED|Stage 1 (25 Days)||0||
48222135|NCT00495677|100866690|FG006|COMPLETED|Stage 1 (25 Days)||0||
48222136|NCT00495677|100866684|FG000|NOT COMPLETED|Stage 1 (25 Days)||0||
48222137|NCT00495677|100866685|FG001|NOT COMPLETED|Stage 1 (25 Days)||0||
48222138|NCT00495677|100866686|FG002|NOT COMPLETED|Stage 1 (25 Days)||1||
48222139|NCT00495677|100866687|FG003|NOT COMPLETED|Stage 1 (25 Days)||0||
48222140|NCT00495677|100866688|FG004|NOT COMPLETED|Stage 1 (25 Days)||0||
48222141|NCT00495677|100866689|FG005|NOT COMPLETED|Stage 1 (25 Days)||0||
48222142|NCT00495677|100866690|FG006|NOT COMPLETED|Stage 1 (25 Days)||0||
48222143|NCT00495677|100866684|FG000|STARTED|Stage 2 (25 Days)||0||
48222144|NCT00495677|100866685|FG001|STARTED|Stage 2 (25 Days)||0||
48222145|NCT00495677|100866686|FG002|STARTED|Stage 2 (25 Days)||0||
48222146|NCT00495677|100866687|FG003|STARTED|Stage 2 (25 Days)||0||
48222147|NCT00495677|100866688|FG004|STARTED|Stage 2 (25 Days)||8||
48222148|NCT00495677|100866689|FG005|STARTED|Stage 2 (25 Days)||8||
48222149|NCT00495677|100866690|FG006|STARTED|Stage 2 (25 Days)||7||
48520279|NCT05069155|101607863|FG001|STARTED|Overall Study||44||
48520280|NCT05069155|101607862|FG000|COMPLETED|Overall Study||49||
48520281|NCT05069155|101607863|FG001|COMPLETED|Overall Study||41||
48520282|NCT05069155|101607862|FG000|NOT COMPLETED|Overall Study||1||
48520283|NCT05069155|101607863|FG001|NOT COMPLETED|Overall Study||3||
48520284|NCT02477774|101607864|FG000|STARTED|Overall Study||29||
48071434|NCT03519178|100498003|FG009|COMPLETED|Disposition for Letrozole Treatment||0||
48071435|NCT03519178|100498004|FG010|COMPLETED|Disposition for Letrozole Treatment||0||
48222150|NCT00495677|100866684|FG000|COMPLETED|Stage 2 (25 Days)||0||
48222151|NCT00495677|100866685|FG001|COMPLETED|Stage 2 (25 Days)||0||
48222152|NCT00495677|100866686|FG002|COMPLETED|Stage 2 (25 Days)||0||
48222153|NCT00495677|100866687|FG003|COMPLETED|Stage 2 (25 Days)||0||
48222154|NCT00495677|100866688|FG004|COMPLETED|Stage 2 (25 Days)||8||
48222155|NCT00495677|100866689|FG005|COMPLETED|Stage 2 (25 Days)||8||
48222156|NCT00495677|100866690|FG006|COMPLETED|Stage 2 (25 Days)||7||
48222157|NCT00495677|100866684|FG000|NOT COMPLETED|Stage 2 (25 Days)||0||
48222158|NCT00495677|100866685|FG001|NOT COMPLETED|Stage 2 (25 Days)||0||
48222159|NCT00495677|100866686|FG002|NOT COMPLETED|Stage 2 (25 Days)||0||
48222160|NCT00495677|100866687|FG003|NOT COMPLETED|Stage 2 (25 Days)||0||
48222161|NCT00495677|100866688|FG004|NOT COMPLETED|Stage 2 (25 Days)||0||
48222162|NCT00495677|100866689|FG005|NOT COMPLETED|Stage 2 (25 Days)||0||
48222163|NCT00495677|100866690|FG006|NOT COMPLETED|Stage 2 (25 Days)||0||
48222164|NCT01046136|100866691|FG000|STARTED|Overall Study||188||
48071436|NCT03519178|100498005|FG011|COMPLETED|Disposition for Letrozole Treatment||0||
48071437|NCT03519178|100498006|FG012|COMPLETED|Disposition for Letrozole Treatment||0||
48071438|NCT03519178|100498007|FG013|COMPLETED|Disposition for Letrozole Treatment||0||
48222165|NCT01046136|100866692|FG001|STARTED|Overall Study||190||
48222166|NCT01046136|100866691|FG000|COMPLETED|Overall Study||184||
48222167|NCT01046136|100866692|FG001|COMPLETED|Overall Study||182||
48222168|NCT01046136|100866691|FG000|NOT COMPLETED|Overall Study||4||
48222169|NCT01046136|100866692|FG001|NOT COMPLETED|Overall Study||8||
48222170|NCT00372775|100866693|FG000|STARTED|Overall Study||66||
48520285|NCT02477774|101607865|FG001|STARTED|Overall Study||26||
48520286|NCT02477774|101607864|FG000|COMPLETED|Overall Study||29||
48520287|NCT02477774|101607865|FG001|COMPLETED|Overall Study||26||
48520288|NCT02477774|101607864|FG000|NOT COMPLETED|Overall Study||0||
48071439|NCT03519178|100498008|FG014|COMPLETED|Disposition for Letrozole Treatment||0||
48071440|NCT03519178|100497994|FG000|NOT COMPLETED|Disposition for Letrozole Treatment||0||
48071441|NCT03519178|100497995|FG001|NOT COMPLETED|Disposition for Letrozole Treatment||0||
48222171|NCT00372775|100866693|FG000|Received Treatment|Overall Study||64||
48222172|NCT00372775|100866693|FG000|COMPLETED|Overall Study||3||
48222173|NCT00372775|100866693|FG000|NOT COMPLETED|Overall Study||63||
48222174|NCT01000805|100866694|FG000|STARTED|Overall Study||262||
48222175|NCT01000805|100866695|FG001|STARTED|Overall Study||266||
48222176|NCT01000805|100866694|FG000|COMPLETED|Overall Study||192||
48071442|NCT03519178|100497996|FG002|NOT COMPLETED|Disposition for Letrozole Treatment||0||
48071443|NCT03519178|100497997|FG003|NOT COMPLETED|Disposition for Letrozole Treatment||0||
48071444|NCT03519178|100497998|FG004|NOT COMPLETED|Disposition for Letrozole Treatment||0||
48071445|NCT03519178|100497999|FG005|NOT COMPLETED|Disposition for Letrozole Treatment||0||
48071446|NCT03519178|100498000|FG006|NOT COMPLETED|Disposition for Letrozole Treatment||0||
48222177|NCT01000805|100866695|FG001|COMPLETED|Overall Study||204||
48222178|NCT01000805|100866694|FG000|NOT COMPLETED|Overall Study||70||
48222179|NCT01000805|100866695|FG001|NOT COMPLETED|Overall Study||62||
48222180|NCT04679675|100866696|FG000|STARTED|Overall Study||12709||
48222181|NCT04679675|100866697|FG001|STARTED|Overall Study||9279||
48222182|NCT04679675|100866698|FG002|STARTED|Overall Study||2974||
48222183|NCT04679675|100866699|FG003|STARTED|Overall Study||7809||
48222184|NCT04679675|100866696|FG000|COMPLETED|Overall Study||12142||
48222185|NCT04679675|100866697|FG001|COMPLETED|Overall Study||8854||
48222186|NCT04679675|100866698|FG002|COMPLETED|Overall Study||2897||
48222187|NCT04679675|100866699|FG003|COMPLETED|Overall Study||7462||
48222188|NCT04679675|100866696|FG000|NOT COMPLETED|Overall Study||567||
48222189|NCT04679675|100866697|FG001|NOT COMPLETED|Overall Study||425||
48222190|NCT04679675|100866698|FG002|NOT COMPLETED|Overall Study||77||
48071447|NCT03519178|100498001|FG007|NOT COMPLETED|Disposition for Letrozole Treatment||0||
48071448|NCT03519178|100498002|FG008|NOT COMPLETED|Disposition for Letrozole Treatment||0||
48071449|NCT03519178|100498003|FG009|NOT COMPLETED|Disposition for Letrozole Treatment||0||
48071450|NCT03519178|100498004|FG010|NOT COMPLETED|Disposition for Letrozole Treatment||7||
48071451|NCT03519178|100498005|FG011|NOT COMPLETED|Disposition for Letrozole Treatment||0||
48071452|NCT03519178|100498006|FG012|NOT COMPLETED|Disposition for Letrozole Treatment||0||
48071453|NCT03519178|100498007|FG013|NOT COMPLETED|Disposition for Letrozole Treatment||0||
48071454|NCT03519178|100498008|FG014|NOT COMPLETED|Disposition for Letrozole Treatment||0||
48071455|NCT03519178|100497994|FG000|STARTED|Follow-Up||1||
48071456|NCT03519178|100497995|FG001|STARTED|Follow-Up||2||
48071457|NCT03519178|100497996|FG002|STARTED|Follow-Up||3||
48071458|NCT03519178|100497997|FG003|STARTED|Follow-Up||3||
48071459|NCT03519178|100497998|FG004|STARTED|Follow-Up||10||
48071460|NCT03519178|100497999|FG005|STARTED|Follow-Up||7||
48071461|NCT03519178|100498000|FG006|STARTED|Follow-Up||4||
48071462|NCT03519178|100498001|FG007|STARTED|Follow-Up||13||
48071463|NCT03519178|100498002|FG008|STARTED|Follow-Up||10||
48071464|NCT03519178|100498003|FG009|STARTED|Follow-Up||9||
48071465|NCT03519178|100498004|FG010|STARTED|Follow-Up||7||
48071466|NCT03519178|100498005|FG011|STARTED|Follow-Up||5||
48071467|NCT03519178|100498006|FG012|STARTED|Follow-Up||6||
48071468|NCT03519178|100498007|FG013|STARTED|Follow-Up||0||
48071469|NCT03519178|100498008|FG014|STARTED|Follow-Up||0||
48071470|NCT03519178|100497994|FG000|COMPLETED|Follow-Up||0||
48071471|NCT03519178|100497995|FG001|COMPLETED|Follow-Up||0||
48071472|NCT03519178|100497996|FG002|COMPLETED|Follow-Up||0||
48071473|NCT03519178|100497997|FG003|COMPLETED|Follow-Up||0||
48071474|NCT03519178|100497998|FG004|COMPLETED|Follow-Up||5||
48071475|NCT03519178|100497999|FG005|COMPLETED|Follow-Up||3||
48071476|NCT03519178|100498000|FG006|COMPLETED|Follow-Up||1||
48071477|NCT03519178|100498001|FG007|COMPLETED|Follow-Up||2||
48071478|NCT03519178|100498002|FG008|COMPLETED|Follow-Up||1||
48071479|NCT03519178|100498003|FG009|COMPLETED|Follow-Up||6||
48071480|NCT03519178|100498004|FG010|COMPLETED|Follow-Up||4||
48071481|NCT03519178|100498005|FG011|COMPLETED|Follow-Up||0||
48071482|NCT03519178|100498006|FG012|COMPLETED|Follow-Up||2||
48071483|NCT03519178|100498007|FG013|COMPLETED|Follow-Up||0||
48071484|NCT03519178|100498008|FG014|COMPLETED|Follow-Up||0||
48071485|NCT03519178|100497994|FG000|NOT COMPLETED|Follow-Up||1||
48071486|NCT03519178|100497995|FG001|NOT COMPLETED|Follow-Up||2||
48071487|NCT03519178|100497996|FG002|NOT COMPLETED|Follow-Up||3||
48071488|NCT03519178|100497997|FG003|NOT COMPLETED|Follow-Up||3||
48071489|NCT03519178|100497998|FG004|NOT COMPLETED|Follow-Up||5||
48071490|NCT03519178|100497999|FG005|NOT COMPLETED|Follow-Up||4||
48071491|NCT03519178|100498000|FG006|NOT COMPLETED|Follow-Up||3||
48071492|NCT03519178|100498001|FG007|NOT COMPLETED|Follow-Up||11||
48071493|NCT03519178|100498002|FG008|NOT COMPLETED|Follow-Up||9||
48222191|NCT04679675|100866699|FG003|NOT COMPLETED|Overall Study||347||
48071494|NCT03519178|100498003|FG009|NOT COMPLETED|Follow-Up||3||
48071495|NCT03519178|100498004|FG010|NOT COMPLETED|Follow-Up||3||
48071496|NCT03519178|100498005|FG011|NOT COMPLETED|Follow-Up||5||
48222192|NCT02336958|100866700|FG000|STARTED|Overall Study||20||
48071497|NCT03519178|100498006|FG012|NOT COMPLETED|Follow-Up||4||
48071498|NCT03519178|100498007|FG013|NOT COMPLETED|Follow-Up||0||
48071499|NCT03519178|100498008|FG014|NOT COMPLETED|Follow-Up||0||
48071500|NCT03519178|100497994|FG000|STARTED|Long-term Follow-up||0||
48222193|NCT02336958|100866701|FG001|STARTED|Overall Study||20||
48071501|NCT03519178|100497995|FG001|STARTED|Long-term Follow-up||0||
48071502|NCT03519178|100497996|FG002|STARTED|Long-term Follow-up||0||
48071503|NCT03519178|100497997|FG003|STARTED|Long-term Follow-up||0||
48071504|NCT03519178|100497998|FG004|STARTED|Long-term Follow-up||0||
48071505|NCT03519178|100497999|FG005|STARTED|Long-term Follow-up||0||
48520289|NCT02477774|101607865|FG001|NOT COMPLETED|Overall Study||0||
48520290|NCT00868296|101607866|FG000|STARTED|Overall Study||12||
48071506|NCT03519178|100498000|FG006|STARTED|Long-term Follow-up||0||
48520291|NCT00868296|101607867|FG001|STARTED|Overall Study||46||
48071507|NCT03519178|100498001|FG007|STARTED|Long-term Follow-up||0||
48520292|NCT00868296|101607866|FG000|COMPLETED|Overall Study||12||
48071508|NCT03519178|100498002|FG008|STARTED|Long-term Follow-up||0||
48071509|NCT03519178|100498003|FG009|STARTED|Long-term Follow-up||0||
48071510|NCT03519178|100498004|FG010|STARTED|Long-term Follow-up||0||
48071511|NCT03519178|100498005|FG011|STARTED|Long-term Follow-up||0||
48071512|NCT03519178|100498006|FG012|STARTED|Long-term Follow-up||0||
48071513|NCT03519178|100498007|FG013|STARTED|Long-term Follow-up||44||
48071514|NCT03519178|100498008|FG014|STARTED|Long-term Follow-up||22||
48071515|NCT03519178|100497994|FG000|COMPLETED|Long-term Follow-up||0||
48071516|NCT03519178|100497995|FG001|COMPLETED|Long-term Follow-up||0||
48071517|NCT03519178|100497996|FG002|COMPLETED|Long-term Follow-up||0||
48071518|NCT03519178|100497997|FG003|COMPLETED|Long-term Follow-up||0||
48071519|NCT03519178|100497998|FG004|COMPLETED|Long-term Follow-up||0||
48071520|NCT03519178|100497999|FG005|COMPLETED|Long-term Follow-up||0||
48520293|NCT00868296|101607867|FG001|COMPLETED|Overall Study||43||
48520294|NCT00868296|101607866|FG000|NOT COMPLETED|Overall Study||0||
48520295|NCT00868296|101607867|FG001|NOT COMPLETED|Overall Study||3||
48071521|NCT03519178|100498000|FG006|COMPLETED|Long-term Follow-up||0||
48071522|NCT03519178|100498001|FG007|COMPLETED|Long-term Follow-up||0||
48071523|NCT03519178|100498002|FG008|COMPLETED|Long-term Follow-up||0||
48071524|NCT03519178|100498003|FG009|COMPLETED|Long-term Follow-up||0||
48071525|NCT03519178|100498004|FG010|COMPLETED|Long-term Follow-up||0||
48071526|NCT03519178|100498005|FG011|COMPLETED|Long-term Follow-up||0||
48071527|NCT03519178|100498006|FG012|COMPLETED|Long-term Follow-up||0||
48071528|NCT03519178|100498007|FG013|COMPLETED|Long-term Follow-up||0||
48071529|NCT03519178|100498008|FG014|COMPLETED|Long-term Follow-up||0||
48071530|NCT03519178|100497994|FG000|NOT COMPLETED|Long-term Follow-up||0||
48071531|NCT03519178|100497995|FG001|NOT COMPLETED|Long-term Follow-up||0||
48071532|NCT03519178|100497996|FG002|NOT COMPLETED|Long-term Follow-up||0||
48071533|NCT03519178|100497997|FG003|NOT COMPLETED|Long-term Follow-up||0||
48071534|NCT03519178|100497998|FG004|NOT COMPLETED|Long-term Follow-up||0||
48071535|NCT03519178|100497999|FG005|NOT COMPLETED|Long-term Follow-up||0||
48071536|NCT03519178|100498000|FG006|NOT COMPLETED|Long-term Follow-up||0||
48071537|NCT03519178|100498001|FG007|NOT COMPLETED|Long-term Follow-up||0||
48071538|NCT03519178|100498002|FG008|NOT COMPLETED|Long-term Follow-up||0||
48071539|NCT03519178|100498003|FG009|NOT COMPLETED|Long-term Follow-up||0||
48071540|NCT03519178|100498004|FG010|NOT COMPLETED|Long-term Follow-up||0||
48071541|NCT03519178|100498005|FG011|NOT COMPLETED|Long-term Follow-up||0||
48071542|NCT03519178|100498006|FG012|NOT COMPLETED|Long-term Follow-up||0||
48071543|NCT03519178|100498007|FG013|NOT COMPLETED|Long-term Follow-up||44||
48071544|NCT03519178|100498008|FG014|NOT COMPLETED|Long-term Follow-up||22||
48071545|NCT01090492|100498009|FG000|STARTED|First Intervention Period (4 Weeks)||27||
48071546|NCT01090492|100498010|FG001|STARTED|First Intervention Period (4 Weeks)||29||
48071547|NCT01090492|100498011|FG002|STARTED|First Intervention Period (4 Weeks)||29||
48071548|NCT01090492|100498012|FG003|STARTED|First Intervention Period (4 Weeks)||28||
48071549|NCT01090492|100498013|FG004|STARTED|First Intervention Period (4 Weeks)||33||
48071550|NCT01090492|100498014|FG005|STARTED|First Intervention Period (4 Weeks)||32||
48071551|NCT01090492|100498015|FG006|STARTED|First Intervention Period (4 Weeks)||32||
48071552|NCT01090492|100498016|FG007|STARTED|First Intervention Period (4 Weeks)||33||
48071553|NCT01090492|100498009|FG000|COMPLETED|First Intervention Period (4 Weeks)||26||
48071554|NCT01090492|100498010|FG001|COMPLETED|First Intervention Period (4 Weeks)||24||
48071555|NCT01090492|100498011|FG002|COMPLETED|First Intervention Period (4 Weeks)||26||
48071556|NCT01090492|100498012|FG003|COMPLETED|First Intervention Period (4 Weeks)||22||
48071557|NCT01090492|100498013|FG004|COMPLETED|First Intervention Period (4 Weeks)||29||
48071558|NCT01090492|100498014|FG005|COMPLETED|First Intervention Period (4 Weeks)||30||
48071559|NCT01090492|100498015|FG006|COMPLETED|First Intervention Period (4 Weeks)||31||
48071560|NCT01090492|100498016|FG007|COMPLETED|First Intervention Period (4 Weeks)||27||
48071561|NCT01090492|100498009|FG000|NOT COMPLETED|First Intervention Period (4 Weeks)||1||
48520296|NCT03499119|101607868|FG000|STARTED|Initial Treatment Phase||4||
48520297|NCT03499119|101607869|FG001|STARTED|Initial Treatment Phase||9||
48071562|NCT01090492|100498010|FG001|NOT COMPLETED|First Intervention Period (4 Weeks)||5||
48071563|NCT01090492|100498011|FG002|NOT COMPLETED|First Intervention Period (4 Weeks)||3||
48071564|NCT01090492|100498012|FG003|NOT COMPLETED|First Intervention Period (4 Weeks)||6||
48071565|NCT01090492|100498013|FG004|NOT COMPLETED|First Intervention Period (4 Weeks)||4||
48071566|NCT01090492|100498014|FG005|NOT COMPLETED|First Intervention Period (4 Weeks)||2||
48071567|NCT01090492|100498015|FG006|NOT COMPLETED|First Intervention Period (4 Weeks)||1||
48520298|NCT03499119|101607870|FG002|STARTED|Initial Treatment Phase||8||
48520299|NCT03499119|101607871|FG003|STARTED|Initial Treatment Phase||32||
48071568|NCT01090492|100498016|FG007|NOT COMPLETED|First Intervention Period (4 Weeks)||6||
48071569|NCT01090492|100498009|FG000|STARTED|Placebo Washout Period ( 2 Weeks)||26||
48071570|NCT01090492|100498010|FG001|STARTED|Placebo Washout Period ( 2 Weeks)||24||
48071571|NCT01090492|100498011|FG002|STARTED|Placebo Washout Period ( 2 Weeks)||26||
48071572|NCT01090492|100498012|FG003|STARTED|Placebo Washout Period ( 2 Weeks)||22||
48071573|NCT01090492|100498013|FG004|STARTED|Placebo Washout Period ( 2 Weeks)||29||
48071574|NCT01090492|100498014|FG005|STARTED|Placebo Washout Period ( 2 Weeks)||30||
48071575|NCT01090492|100498015|FG006|STARTED|Placebo Washout Period ( 2 Weeks)||31||
48071576|NCT01090492|100498016|FG007|STARTED|Placebo Washout Period ( 2 Weeks)||27||
48071577|NCT01090492|100498009|FG000|COMPLETED|Placebo Washout Period ( 2 Weeks)||26||
48071578|NCT01090492|100498010|FG001|COMPLETED|Placebo Washout Period ( 2 Weeks)||24||
48071579|NCT01090492|100498011|FG002|COMPLETED|Placebo Washout Period ( 2 Weeks)||26||
48071580|NCT01090492|100498012|FG003|COMPLETED|Placebo Washout Period ( 2 Weeks)||22||
48520300|NCT03499119|101607868|FG000|COMPLETED|Initial Treatment Phase||3||
48520301|NCT03499119|101607869|FG001|COMPLETED|Initial Treatment Phase||9||
48520302|NCT03499119|101607870|FG002|COMPLETED|Initial Treatment Phase||7||
48520303|NCT03499119|101607871|FG003|COMPLETED|Initial Treatment Phase||29||
48520304|NCT03499119|101607868|FG000|NOT COMPLETED|Initial Treatment Phase||1||
48520305|NCT03499119|101607869|FG001|NOT COMPLETED|Initial Treatment Phase||0||
48520306|NCT03499119|101607870|FG002|NOT COMPLETED|Initial Treatment Phase||1||
48520307|NCT03499119|101607871|FG003|NOT COMPLETED|Initial Treatment Phase||3||
48071581|NCT01090492|100498013|FG004|COMPLETED|Placebo Washout Period ( 2 Weeks)||29||
48071582|NCT01090492|100498014|FG005|COMPLETED|Placebo Washout Period ( 2 Weeks)||30||
48071583|NCT01090492|100498015|FG006|COMPLETED|Placebo Washout Period ( 2 Weeks)||31||
48071584|NCT01090492|100498016|FG007|COMPLETED|Placebo Washout Period ( 2 Weeks)||27||
48071585|NCT01090492|100498009|FG000|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0||
48520308|NCT03499119|101607868|FG000|STARTED|Optional Extension Phase||1|Enrollment into the extension phase was optional.|
48520309|NCT03499119|101607869|FG001|STARTED|Optional Extension Phase||3|Enrollment into the extension phase was optional.|
48520310|NCT03499119|101607870|FG002|STARTED|Optional Extension Phase||5|Enrollment into the extension phase was optional.|
48520311|NCT03499119|101607871|FG003|STARTED|Optional Extension Phase||27|Enrollment into the extension phase was optional.|
48520312|NCT03499119|101607868|FG000|COMPLETED|Optional Extension Phase||1||
48071586|NCT01090492|100498010|FG001|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0||
48071587|NCT01090492|100498011|FG002|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0||
48071588|NCT01090492|100498012|FG003|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0||
48071589|NCT01090492|100498013|FG004|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0||
48071590|NCT01090492|100498014|FG005|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0||
48071591|NCT01090492|100498015|FG006|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0||
48071592|NCT01090492|100498016|FG007|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0||
48071593|NCT01090492|100498009|FG000|STARTED|Second Intervention Period (4 Weeks)||26||
48071594|NCT01090492|100498010|FG001|STARTED|Second Intervention Period (4 Weeks)||24||
48071595|NCT01090492|100498011|FG002|STARTED|Second Intervention Period (4 Weeks)||26||
48071596|NCT01090492|100498012|FG003|STARTED|Second Intervention Period (4 Weeks)||22||
48071597|NCT01090492|100498013|FG004|STARTED|Second Intervention Period (4 Weeks)||29||
48071598|NCT01090492|100498014|FG005|STARTED|Second Intervention Period (4 Weeks)||30||
48071599|NCT01090492|100498015|FG006|STARTED|Second Intervention Period (4 Weeks)||31||
48071600|NCT01090492|100498016|FG007|STARTED|Second Intervention Period (4 Weeks)||27||
48071601|NCT01090492|100498009|FG000|COMPLETED|Second Intervention Period (4 Weeks)||25||
48071602|NCT01090492|100498010|FG001|COMPLETED|Second Intervention Period (4 Weeks)||22||
48071603|NCT01090492|100498011|FG002|COMPLETED|Second Intervention Period (4 Weeks)||24||
48071604|NCT01090492|100498012|FG003|COMPLETED|Second Intervention Period (4 Weeks)||22||
48071605|NCT01090492|100498013|FG004|COMPLETED|Second Intervention Period (4 Weeks)||27||
48520313|NCT03499119|101607869|FG001|COMPLETED|Optional Extension Phase||2||
48520314|NCT03499119|101607870|FG002|COMPLETED|Optional Extension Phase||5||
48520315|NCT03499119|101607871|FG003|COMPLETED|Optional Extension Phase||21||
48520316|NCT03499119|101607868|FG000|NOT COMPLETED|Optional Extension Phase||0||
48520317|NCT03499119|101607869|FG001|NOT COMPLETED|Optional Extension Phase||1||
48520318|NCT03499119|101607870|FG002|NOT COMPLETED|Optional Extension Phase||0||
48520319|NCT03499119|101607871|FG003|NOT COMPLETED|Optional Extension Phase||6||
48520320|NCT00140413|101607872|FG000|STARTED|Overall Study||13||
48520321|NCT00140413|101607873|FG001|STARTED|Overall Study||7||
48520322|NCT00140413|101607872|FG000|Received at Least One Dose of GH|Overall Study||13||
48520323|NCT00140413|101607873|FG001|Received at Least One Dose of GH|Overall Study||3||
48520324|NCT00140413|101607872|FG000|COMPLETED|Overall Study||10||
48520325|NCT00140413|101607873|FG001|COMPLETED|Overall Study||7||
48520326|NCT00140413|101607872|FG000|NOT COMPLETED|Overall Study||3||
48520327|NCT00140413|101607873|FG001|NOT COMPLETED|Overall Study||0||
48520328|NCT02973321|101607874|FG000|STARTED|Overall Study||33||
48520329|NCT02973321|101607875|FG001|STARTED|Overall Study||66||
48520330|NCT02973321|101607876|FG002|STARTED|Overall Study||66||
48520331|NCT02973321|101607877|FG003|STARTED|Overall Study||64||
48520332|NCT02973321|101607878|FG004|STARTED|Overall Study||67||
48520333|NCT02973321|101607874|FG000|COMPLETED|Overall Study||32||
48520334|NCT02973321|101607875|FG001|COMPLETED|Overall Study||51||
48071606|NCT01090492|100498014|FG005|COMPLETED|Second Intervention Period (4 Weeks)||29||
48071607|NCT01090492|100498015|FG006|COMPLETED|Second Intervention Period (4 Weeks)||22||
48071608|NCT01090492|100498016|FG007|COMPLETED|Second Intervention Period (4 Weeks)||25||
48071609|NCT01090492|100498009|FG000|NOT COMPLETED|Second Intervention Period (4 Weeks)||1||
48071610|NCT01090492|100498010|FG001|NOT COMPLETED|Second Intervention Period (4 Weeks)||2||
48520335|NCT02973321|101607876|FG002|COMPLETED|Overall Study||52||
48520336|NCT02973321|101607877|FG003|COMPLETED|Overall Study||48||
48520337|NCT02973321|101607878|FG004|COMPLETED|Overall Study||62||
48071611|NCT01090492|100498011|FG002|NOT COMPLETED|Second Intervention Period (4 Weeks)||2||
48071612|NCT01090492|100498012|FG003|NOT COMPLETED|Second Intervention Period (4 Weeks)||0||
48071613|NCT01090492|100498013|FG004|NOT COMPLETED|Second Intervention Period (4 Weeks)||2||
48071614|NCT01090492|100498014|FG005|NOT COMPLETED|Second Intervention Period (4 Weeks)||1||
48071615|NCT01090492|100498015|FG006|NOT COMPLETED|Second Intervention Period (4 Weeks)||9||
48071616|NCT01090492|100498016|FG007|NOT COMPLETED|Second Intervention Period (4 Weeks)||2||
48071617|NCT01126801|100498017|FG000|STARTED|Overall Study||1||
48071618|NCT01126801|100498018|FG001|STARTED|Overall Study||1||
48071619|NCT01126801|100498017|FG000|COMPLETED|Overall Study||1||
48071620|NCT01126801|100498018|FG001|COMPLETED|Overall Study||1||
48071621|NCT01126801|100498017|FG000|NOT COMPLETED|Overall Study||0||
48071622|NCT01126801|100498018|FG001|NOT COMPLETED|Overall Study||0||
48071623|NCT03334630|100498019|FG000|STARTED|Overall Study||239||
48071624|NCT03334630|100498020|FG001|STARTED|Overall Study||243||
48071625|NCT03334630|100498019|FG000|COMPLETED|Overall Study||225||
48071626|NCT03334630|100498020|FG001|COMPLETED|Overall Study||230||
48071627|NCT03334630|100498019|FG000|NOT COMPLETED|Overall Study||14||
48670540|NCT02573493|101978195|FG001|STARTED|Overall Study||40||
48670541|NCT02573493|101978196|FG002|STARTED|Overall Study||15||
48670542|NCT02573493|101978197|FG003|STARTED|Overall Study||1||
48670543|NCT02573493|101978194|FG000|COMPLETED|Overall Study||40||
48670544|NCT02573493|101978195|FG001|COMPLETED|Overall Study||40||
48670545|NCT02573493|101978196|FG002|COMPLETED|Overall Study||15||
48670546|NCT02573493|101978197|FG003|COMPLETED|Overall Study||0||
48670547|NCT02573493|101978194|FG000|NOT COMPLETED|Overall Study||0||
48670548|NCT02573493|101978195|FG001|NOT COMPLETED|Overall Study||0||
48670549|NCT02573493|101978196|FG002|NOT COMPLETED|Overall Study||0||
48520338|NCT02973321|101607874|FG000|NOT COMPLETED|Overall Study||1||
48520339|NCT02973321|101607875|FG001|NOT COMPLETED|Overall Study||15||
48520340|NCT02973321|101607876|FG002|NOT COMPLETED|Overall Study||14||
48670550|NCT02573493|101978197|FG003|NOT COMPLETED|Overall Study||1||
48670551|NCT06193070|101978198|FG000|STARTED|Overall Study||45||
48670552|NCT06193070|101978198|FG000|COMPLETED|Overall Study||43||
48670553|NCT06193070|101978198|FG000|NOT COMPLETED|Overall Study||2||
48670554|NCT05601544|101978199|FG000|STARTED|Phase 1 Period 1||5||
48071628|NCT03334630|100498020|FG001|NOT COMPLETED|Overall Study||13||
48071629|NCT05213481|100498021|FG000|STARTED|Overall Study||18||
48071630|NCT05213481|100498021|FG000|COMPLETED|Overall Study||14||
48071631|NCT05213481|100498021|FG000|NOT COMPLETED|Overall Study||4||
48071632|NCT01577108|100498022|FG000|STARTED|Overall Study||54||
48071633|NCT01577108|100498023|FG001|STARTED|Overall Study||56||
48670555|NCT05601544|101978200|FG001|STARTED|Phase 1 Period 1||6||
48670556|NCT05601544|101978201|FG002|STARTED|Phase 1 Period 1||5||
48670557|NCT05601544|101978202|FG003|STARTED|Phase 1 Period 1||5||
48670558|NCT05601544|101978203|FG004|STARTED|Phase 1 Period 1||0||
48670559|NCT05601544|101978204|FG005|STARTED|Phase 1 Period 1||0||
48670560|NCT05601544|101978199|FG000|COMPLETED|Phase 1 Period 1||5||
48670561|NCT05601544|101978200|FG001|COMPLETED|Phase 1 Period 1||6||
48670562|NCT05601544|101978201|FG002|COMPLETED|Phase 1 Period 1||5||
48670563|NCT05601544|101978202|FG003|COMPLETED|Phase 1 Period 1||5||
48670564|NCT05601544|101978203|FG004|COMPLETED|Phase 1 Period 1||0||
48670565|NCT05601544|101978204|FG005|COMPLETED|Phase 1 Period 1||0||
48670566|NCT05601544|101978199|FG000|NOT COMPLETED|Phase 1 Period 1||0||
48670567|NCT05601544|101978200|FG001|NOT COMPLETED|Phase 1 Period 1||0||
48670568|NCT05601544|101978201|FG002|NOT COMPLETED|Phase 1 Period 1||0||
48670569|NCT05601544|101978202|FG003|NOT COMPLETED|Phase 1 Period 1||0||
48670570|NCT05601544|101978203|FG004|NOT COMPLETED|Phase 1 Period 1||0||
48670571|NCT05601544|101978204|FG005|NOT COMPLETED|Phase 1 Period 1||0||
48670572|NCT05601544|101978199|FG000|STARTED|Phase 1 Period 2||5||
48071634|NCT01577108|100498022|FG000|COMPLETED|Overall Study||49||
48222194|NCT02336958|100866700|FG000|COMPLETED|Overall Study||20||
48071635|NCT01577108|100498023|FG001|COMPLETED|Overall Study||50||
48071636|NCT01577108|100498022|FG000|NOT COMPLETED|Overall Study||5||
48071637|NCT01577108|100498023|FG001|NOT COMPLETED|Overall Study||6||
48071638|NCT02657915|100498024|FG000|STARTED|Overall Study||24||
48520341|NCT02973321|101607877|FG003|NOT COMPLETED|Overall Study||16||
48520342|NCT02973321|101607878|FG004|NOT COMPLETED|Overall Study||5||
48520343|NCT03465748|101607879|FG000|STARTED|Overall Study||27||
48520344|NCT03465748|101607880|FG001|STARTED|Overall Study||18||
48520345|NCT03465748|101607879|FG000|COMPLETED|Overall Study||15||
48520346|NCT03465748|101607880|FG001|COMPLETED|Overall Study||7||
48520347|NCT03465748|101607879|FG000|NOT COMPLETED|Overall Study||12||
48670573|NCT05601544|101978200|FG001|STARTED|Phase 1 Period 2||6||
48071639|NCT02657915|100498025|FG001|STARTED|Overall Study||28||
48071640|NCT02657915|100498024|FG000|Intent-to Treat (ITT) Population|Overall Study||24||
48071641|NCT02657915|100498025|FG001|Intent-to Treat (ITT) Population|Overall Study||28||
48071642|NCT02657915|100498024|FG000|Per-protocol Population|Overall Study||23||
48071643|NCT02657915|100498025|FG001|Per-protocol Population|Overall Study||24||
48071644|NCT02657915|100498024|FG000|COMPLETED|Overall Study||24||
48071645|NCT02657915|100498025|FG001|COMPLETED|Overall Study||28||
48071646|NCT02657915|100498024|FG000|NOT COMPLETED|Overall Study||0||
48071647|NCT02657915|100498025|FG001|NOT COMPLETED|Overall Study||0||
48071648|NCT00560105|100498026|FG000|STARTED|Overall Study||20||
48071649|NCT00560105|100498027|FG001|STARTED|Overall Study||20||
48670574|NCT05601544|101978201|FG002|STARTED|Phase 1 Period 2||5||
48670575|NCT05601544|101978202|FG003|STARTED|Phase 1 Period 2||5||
48670576|NCT05601544|101978203|FG004|STARTED|Phase 1 Period 2||0||
48670577|NCT05601544|101978204|FG005|STARTED|Phase 1 Period 2||0||
48670578|NCT05601544|101978199|FG000|COMPLETED|Phase 1 Period 2||5||
48071650|NCT00560105|100498026|FG000|COMPLETED|Overall Study||19||
48071651|NCT00560105|100498027|FG001|COMPLETED|Overall Study||18||
48071652|NCT00560105|100498026|FG000|NOT COMPLETED|Overall Study||1||
48071653|NCT00560105|100498027|FG001|NOT COMPLETED|Overall Study||2||
48071654|NCT00622284|100498028|FG000|STARTED|Overall Study||776||
48071655|NCT00622284|100498029|FG001|STARTED|Overall Study||775||
48071656|NCT00622284|100498028|FG000|COMPLETED|Overall Study||587||
48071657|NCT00622284|100498029|FG001|COMPLETED|Overall Study||604||
48071658|NCT00622284|100498028|FG000|NOT COMPLETED|Overall Study||189||
48071659|NCT00622284|100498029|FG001|NOT COMPLETED|Overall Study||171||
48071660|NCT00493025|100498030|FG000|STARTED|Overall Study||19||
48071661|NCT00493025|100498030|FG000|COMPLETED|Overall Study||0||
48071662|NCT00493025|100498030|FG000|NOT COMPLETED|Overall Study||19||
48071663|NCT01216761|100498031|FG000|STARTED|Overall Study||1421||
48071664|NCT01216761|100498032|FG001|STARTED|Overall Study||1410||
48071665|NCT01216761|100498033|FG002|STARTED|Overall Study||1379||
48071666|NCT01216761|100498031|FG000|COMPLETED|Overall Study||1421||
48071667|NCT01216761|100498032|FG001|COMPLETED|Overall Study||1410||
48071668|NCT01216761|100498033|FG002|COMPLETED|Overall Study||1379||
48071669|NCT01216761|100498031|FG000|NOT COMPLETED|Overall Study||0||
48071670|NCT01216761|100498032|FG001|NOT COMPLETED|Overall Study||0||
48071671|NCT01216761|100498033|FG002|NOT COMPLETED|Overall Study||0||
48071672|NCT02051686|100498034|FG000|STARTED|Overall Study||42||
48071673|NCT02051686|100498035|FG001|STARTED|Overall Study||46||
48071674|NCT02051686|100498034|FG000|COMPLETED|Overall Study||42||
48071675|NCT02051686|100498035|FG001|COMPLETED|Overall Study||46||
48071676|NCT02051686|100498034|FG000|NOT COMPLETED|Overall Study||0||
48071677|NCT02051686|100498035|FG001|NOT COMPLETED|Overall Study||0||
48071678|NCT00446251|100498036|FG000|STARTED|Overall Study||14||
48071679|NCT00446251|100498036|FG000|COMPLETED|Overall Study||9||
48071680|NCT00446251|100498036|FG000|NOT COMPLETED|Overall Study||5||
48071681|NCT00187200|100498037|FG000|STARTED|Overall Study||49||
48071682|NCT00187200|100498038|FG001|STARTED|Overall Study||44||
48071683|NCT00187200|100498037|FG000|COMPLETED|Overall Study||31||
48071684|NCT00187200|100498038|FG001|COMPLETED|Overall Study||26||
48071685|NCT00187200|100498037|FG000|NOT COMPLETED|Overall Study||18||
48071686|NCT00187200|100498038|FG001|NOT COMPLETED|Overall Study||18||
48071687|NCT00515411|100498039|FG000|STARTED|Overall Study||54||
48071688|NCT00515411|100498040|FG001|STARTED|Overall Study||31||
48071689|NCT00515411|100498041|FG002|STARTED|Overall Study||26||
48071690|NCT00515411|100498039|FG000|COMPLETED|Overall Study||54||
48071691|NCT00515411|100498040|FG001|COMPLETED|Overall Study||31||
48071692|NCT00515411|100498041|FG002|COMPLETED|Overall Study||26||
48071693|NCT00515411|100498039|FG000|NOT COMPLETED|Overall Study||0||
48071694|NCT00515411|100498040|FG001|NOT COMPLETED|Overall Study||0||
48071695|NCT00515411|100498041|FG002|NOT COMPLETED|Overall Study||0||
48071696|NCT03953820|100498042|FG000|STARTED|Two-Sequence, Two-Way Crossover||15||
48071697|NCT03953820|100498043|FG001|STARTED|Two-Sequence, Two-Way Crossover||16||
48071698|NCT03953820|100498044|FG002|STARTED|Two-Sequence, Two-Way Crossover||0||
48071699|NCT03953820|100498042|FG000|COMPLETED|Two-Sequence, Two-Way Crossover||13||
48071700|NCT03953820|100498043|FG001|COMPLETED|Two-Sequence, Two-Way Crossover||16||
48071701|NCT03953820|100498044|FG002|COMPLETED|Two-Sequence, Two-Way Crossover||0||
48071702|NCT03953820|100498042|FG000|NOT COMPLETED|Two-Sequence, Two-Way Crossover||2||
48071703|NCT03953820|100498043|FG001|NOT COMPLETED|Two-Sequence, Two-Way Crossover||0||
48071704|NCT03953820|100498044|FG002|NOT COMPLETED|Two-Sequence, Two-Way Crossover||0||
48071705|NCT03953820|100498042|FG000|STARTED|DBF Following High-Fat Meal||0||
48071706|NCT03953820|100498043|FG001|STARTED|DBF Following High-Fat Meal||0||
48071707|NCT03953820|100498044|FG002|STARTED|DBF Following High-Fat Meal||10||
48071708|NCT03953820|100498042|FG000|COMPLETED|DBF Following High-Fat Meal||0||
48071709|NCT03953820|100498043|FG001|COMPLETED|DBF Following High-Fat Meal||0||
48071710|NCT03953820|100498044|FG002|COMPLETED|DBF Following High-Fat Meal||10||
48071711|NCT03953820|100498042|FG000|NOT COMPLETED|DBF Following High-Fat Meal||0||
48071712|NCT03953820|100498043|FG001|NOT COMPLETED|DBF Following High-Fat Meal||0||
48071713|NCT03953820|100498044|FG002|NOT COMPLETED|DBF Following High-Fat Meal||0||
48071714|NCT01488370|100498045|FG000|STARTED|Overall Study||22||
48071715|NCT01488370|100498046|FG001|STARTED|Overall Study||23||
48071716|NCT01488370|100498047|FG002|STARTED|Overall Study||20||
48071717|NCT01488370|100498045|FG000|COMPLETED|Overall Study||22||
48071718|NCT01488370|100498046|FG001|COMPLETED|Overall Study||22||
48071719|NCT01488370|100498047|FG002|COMPLETED|Overall Study||19||
48071720|NCT01488370|100498045|FG000|NOT COMPLETED|Overall Study||0||
48670579|NCT05601544|101978200|FG001|COMPLETED|Phase 1 Period 2||6||
48670580|NCT05601544|101978201|FG002|COMPLETED|Phase 1 Period 2||5||
48670581|NCT05601544|101978202|FG003|COMPLETED|Phase 1 Period 2||5||
48670582|NCT05601544|101978203|FG004|COMPLETED|Phase 1 Period 2||0||
48670583|NCT05601544|101978204|FG005|COMPLETED|Phase 1 Period 2||0||
48670584|NCT05601544|101978199|FG000|NOT COMPLETED|Phase 1 Period 2||0||
48670585|NCT05601544|101978200|FG001|NOT COMPLETED|Phase 1 Period 2||0||
48670586|NCT05601544|101978201|FG002|NOT COMPLETED|Phase 1 Period 2||0||
48670587|NCT05601544|101978202|FG003|NOT COMPLETED|Phase 1 Period 2||0||
48670588|NCT05601544|101978203|FG004|NOT COMPLETED|Phase 1 Period 2||0||
48670589|NCT05601544|101978204|FG005|NOT COMPLETED|Phase 1 Period 2||0||
48670590|NCT05601544|101978199|FG000|STARTED|Phase 2 Period 1||20||
48670591|NCT05601544|101978200|FG001|STARTED|Phase 2 Period 1||21||
48670592|NCT05601544|101978201|FG002|STARTED|Phase 2 Period 1||20||
48670593|NCT05601544|101978202|FG003|STARTED|Phase 2 Period 1||20||
48670594|NCT05601544|101978203|FG004|STARTED|Phase 2 Period 1||20||
48670595|NCT05601544|101978204|FG005|STARTED|Phase 2 Period 1||20||
48670596|NCT05601544|101978199|FG000|COMPLETED|Phase 2 Period 1||20||
48670597|NCT05601544|101978200|FG001|COMPLETED|Phase 2 Period 1||20||
48670598|NCT05601544|101978201|FG002|COMPLETED|Phase 2 Period 1||20||
48670599|NCT05601544|101978202|FG003|COMPLETED|Phase 2 Period 1||20||
48670600|NCT05601544|101978203|FG004|COMPLETED|Phase 2 Period 1||20||
48670601|NCT05601544|101978204|FG005|COMPLETED|Phase 2 Period 1||20||
48670602|NCT05601544|101978199|FG000|NOT COMPLETED|Phase 2 Period 1||0||
48670603|NCT05601544|101978200|FG001|NOT COMPLETED|Phase 2 Period 1||1||
48670604|NCT05601544|101978201|FG002|NOT COMPLETED|Phase 2 Period 1||0||
48670605|NCT05601544|101978202|FG003|NOT COMPLETED|Phase 2 Period 1||0||
48670606|NCT05601544|101978203|FG004|NOT COMPLETED|Phase 2 Period 1||0||
48670607|NCT05601544|101978204|FG005|NOT COMPLETED|Phase 2 Period 1||0||
48670608|NCT05601544|101978199|FG000|STARTED|Phase 2 Period 2||20||
48670609|NCT05601544|101978200|FG001|STARTED|Phase 2 Period 2||20||
48670610|NCT05601544|101978201|FG002|STARTED|Phase 2 Period 2||20||
48670611|NCT05601544|101978202|FG003|STARTED|Phase 2 Period 2||20||
48670612|NCT05601544|101978203|FG004|STARTED|Phase 2 Period 2||20||
48670613|NCT05601544|101978204|FG005|STARTED|Phase 2 Period 2||20||
48670614|NCT05601544|101978199|FG000|COMPLETED|Phase 2 Period 2||20||
48670615|NCT05601544|101978200|FG001|COMPLETED|Phase 2 Period 2||20||
48670616|NCT05601544|101978201|FG002|COMPLETED|Phase 2 Period 2||20||
48670617|NCT05601544|101978202|FG003|COMPLETED|Phase 2 Period 2||20||
48670618|NCT05601544|101978203|FG004|COMPLETED|Phase 2 Period 2||20||
48670619|NCT05601544|101978204|FG005|COMPLETED|Phase 2 Period 2||20||
48670620|NCT05601544|101978199|FG000|NOT COMPLETED|Phase 2 Period 2||0||
48670621|NCT05601544|101978200|FG001|NOT COMPLETED|Phase 2 Period 2||0||
48071721|NCT01488370|100498046|FG001|NOT COMPLETED|Overall Study||1||
48222195|NCT02336958|100866701|FG001|COMPLETED|Overall Study||20||
48520348|NCT03465748|101607880|FG001|NOT COMPLETED|Overall Study||11||
48520349|NCT04965389|101607881|FG000|STARTED|Overall Study||4|Started = Randomized|
48520350|NCT04965389|101607882|FG001|STARTED|Overall Study||5|Started = Randomized|
48520351|NCT04965389|101607883|FG002|STARTED|Overall Study||4|Started = Randomized|
48520352|NCT04965389|101607884|FG003|STARTED|Overall Study||4|Started = Randomized|
48520353|NCT04965389|101607881|FG000|Participants Completed Treatment Period 1|Overall Study||4||
48520354|NCT04965389|101607882|FG001|Participants Completed Treatment Period 1|Overall Study||5||
48520355|NCT04965389|101607883|FG002|Participants Completed Treatment Period 1|Overall Study||4||
48520356|NCT04965389|101607884|FG003|Participants Completed Treatment Period 1|Overall Study||4||
48520357|NCT04965389|101607881|FG000|Participants Completed Treatment Period 2|Overall Study||4||
48520358|NCT04965389|101607882|FG001|Participants Completed Treatment Period 2|Overall Study||4||
48520359|NCT04965389|101607883|FG002|Participants Completed Treatment Period 2|Overall Study||4||
48520360|NCT04965389|101607884|FG003|Participants Completed Treatment Period 2|Overall Study||4||
48520361|NCT04965389|101607881|FG000|Participants Completed Treatment Period 3|Overall Study||3||
48520362|NCT04965389|101607882|FG001|Participants Completed Treatment Period 3|Overall Study||4||
48520363|NCT04965389|101607883|FG002|Participants Completed Treatment Period 3|Overall Study||4||
48670622|NCT05601544|101978201|FG002|NOT COMPLETED|Phase 2 Period 2||0||
48592617|NCT01546168|101783149|FG001|NOT COMPLETED|Overall Study||0||
48670623|NCT05601544|101978202|FG003|NOT COMPLETED|Phase 2 Period 2||0||
48670624|NCT05601544|101978203|FG004|NOT COMPLETED|Phase 2 Period 2||0||
48670625|NCT05601544|101978204|FG005|NOT COMPLETED|Phase 2 Period 2||0||
48670626|NCT05646355|101978205|FG000|STARTED|Overall Study||59||
48670627|NCT05646355|101978206|FG001|STARTED|Overall Study||50||
48670628|NCT05646355|101978205|FG000|COMPLETED|Overall Study||50||
48670629|NCT05646355|101978206|FG001|COMPLETED|Overall Study||50||
48071722|NCT01488370|100498047|FG002|NOT COMPLETED|Overall Study||1||
48670630|NCT05646355|101978205|FG000|NOT COMPLETED|Overall Study||9||
48670631|NCT05646355|101978206|FG001|NOT COMPLETED|Overall Study||0||
48670632|NCT02867592|101978207|FG000|STARTED|Overall Study||15||
48071723|NCT01681472|100498048|FG000|STARTED|Overall Study||8||
48520364|NCT04965389|101607884|FG003|Participants Completed Treatment Period 3|Overall Study||4||
48520365|NCT04965389|101607881|FG000|Participants Completed Treatment Period 4|Overall Study||3||
48520366|NCT04965389|101607882|FG001|Participants Completed Treatment Period 4|Overall Study||3||
48520367|NCT04965389|101607883|FG002|Participants Completed Treatment Period 4|Overall Study||4||
48520368|NCT04965389|101607884|FG003|Participants Completed Treatment Period 4|Overall Study||4||
48520369|NCT04965389|101607881|FG000|Participants Completed Treatment Period 5|Overall Study||3||
48520370|NCT04965389|101607882|FG001|Participants Completed Treatment Period 5|Overall Study||3||
48520371|NCT04965389|101607883|FG002|Participants Completed Treatment Period 5|Overall Study||4||
48520372|NCT04965389|101607884|FG003|Participants Completed Treatment Period 5|Overall Study||4||
48520373|NCT04965389|101607881|FG000|COMPLETED|Overall Study||3|Completed=completed the study|
48520374|NCT04965389|101607882|FG001|COMPLETED|Overall Study||3|Completed=completed the study|
48520375|NCT04965389|101607883|FG002|COMPLETED|Overall Study||4|Completed=completed the study|
48520376|NCT04965389|101607884|FG003|COMPLETED|Overall Study||4|Completed=completed the study|
48520377|NCT04965389|101607881|FG000|NOT COMPLETED|Overall Study||1||
48520378|NCT04965389|101607882|FG001|NOT COMPLETED|Overall Study||2||
48670633|NCT02867592|101978208|FG001|STARTED|Overall Study||14||
48670634|NCT02867592|101978209|FG002|STARTED|Overall Study||13||
48670635|NCT02867592|101978210|FG003|STARTED|Overall Study||13||
48670636|NCT02867592|101978211|FG004|STARTED|Overall Study||25||
48670637|NCT02867592|101978212|FG005|STARTED|Overall Study||29||
48670638|NCT02867592|101978207|FG000|COMPLETED|Overall Study||0||
48670639|NCT02867592|101978208|FG001|COMPLETED|Overall Study||0||
48670640|NCT02867592|101978209|FG002|COMPLETED|Overall Study||0||
48670641|NCT02867592|101978210|FG003|COMPLETED|Overall Study||0||
48670642|NCT02867592|101978211|FG004|COMPLETED|Overall Study||0||
48670643|NCT02867592|101978212|FG005|COMPLETED|Overall Study||0||
48670644|NCT02867592|101978207|FG000|NOT COMPLETED|Overall Study||15||
48670645|NCT02867592|101978208|FG001|NOT COMPLETED|Overall Study||14||
48670646|NCT02867592|101978209|FG002|NOT COMPLETED|Overall Study||13||
48670647|NCT02867592|101978210|FG003|NOT COMPLETED|Overall Study||13||
48670648|NCT02867592|101978211|FG004|NOT COMPLETED|Overall Study||25||
48670649|NCT02867592|101978212|FG005|NOT COMPLETED|Overall Study||29||
48520379|NCT04965389|101607883|FG002|NOT COMPLETED|Overall Study||0||
48520380|NCT04965389|101607884|FG003|NOT COMPLETED|Overall Study||0||
48520381|NCT01615263|101607885|FG000|STARTED|Overall Study||20||
48520382|NCT01615263|101607886|FG001|STARTED|Overall Study||20||
48520383|NCT01615263|101607885|FG000|COMPLETED|Overall Study||20||
48520384|NCT01615263|101607886|FG001|COMPLETED|Overall Study||18||
48520385|NCT01615263|101607885|FG000|NOT COMPLETED|Overall Study||0||
48520386|NCT01615263|101607886|FG001|NOT COMPLETED|Overall Study||2||
48520387|NCT01000610|101607887|FG000|STARTED|Overall Study||18||
48520388|NCT01000610|101607887|FG000|COMPLETED|Overall Study||12||
48520389|NCT01000610|101607887|FG000|NOT COMPLETED|Overall Study||6||
48520390|NCT00876018|101607888|FG000|STARTED|Overall Study||100||
48520391|NCT00876018|101607889|FG001|STARTED|Overall Study||100||
48520392|NCT00876018|101607890|FG002|STARTED|Overall Study||100||
48520393|NCT00876018|101607888|FG000|COMPLETED|Overall Study||95||
48520394|NCT00876018|101607889|FG001|COMPLETED|Overall Study||95||
48520395|NCT00876018|101607890|FG002|COMPLETED|Overall Study||97||
48520396|NCT00876018|101607888|FG000|NOT COMPLETED|Overall Study||5||
48520397|NCT00876018|101607889|FG001|NOT COMPLETED|Overall Study||5||
48520398|NCT00876018|101607890|FG002|NOT COMPLETED|Overall Study||3||
48520399|NCT03554603|101607891|FG000|STARTED|Overall Study||51||
48520400|NCT03554603|101607892|FG001|STARTED|Overall Study||49||
48520401|NCT03554603|101607891|FG000|COMPLETED|Overall Study||49||
48520402|NCT03554603|101607892|FG001|COMPLETED|Overall Study||49||
48520403|NCT03554603|101607891|FG000|NOT COMPLETED|Overall Study||2||
48520404|NCT03554603|101607892|FG001|NOT COMPLETED|Overall Study||0||
48520405|NCT02537873|101607893|FG000|STARTED|Overall Study||17||
48520406|NCT02537873|101607894|FG001|STARTED|Overall Study||8||
48520407|NCT02537873|101607893|FG000|COMPLETED|Overall Study||9||
48520408|NCT02537873|101607894|FG001|COMPLETED|Overall Study||4||
48520409|NCT02537873|101607893|FG000|NOT COMPLETED|Overall Study||8||
48520410|NCT02537873|101607894|FG001|NOT COMPLETED|Overall Study||4||
48520411|NCT00983918|101607895|FG000|STARTED|Overall Study||20||
48520412|NCT00983918|101607896|FG001|STARTED|Overall Study||20||
48670650|NCT03478956|101978213|FG000|STARTED|Randomized Treatment Period||12|Enrolled in Randomized Treatment Phase|
48520413|NCT00983918|101607897|FG002|STARTED|Overall Study||20||
48520414|NCT00983918|101607898|FG003|STARTED|Overall Study||20||
48520415|NCT00983918|101607895|FG000|COMPLETED|Overall Study||20||
48520416|NCT00983918|101607896|FG001|COMPLETED|Overall Study||18||
48520417|NCT00983918|101607897|FG002|COMPLETED|Overall Study||18||
48520418|NCT00983918|101607898|FG003|COMPLETED|Overall Study||18||
48520419|NCT00983918|101607895|FG000|NOT COMPLETED|Overall Study||0||
48520420|NCT00983918|101607896|FG001|NOT COMPLETED|Overall Study||2||
48520421|NCT00983918|101607897|FG002|NOT COMPLETED|Overall Study||2||
48520422|NCT00983918|101607898|FG003|NOT COMPLETED|Overall Study||2||
48670651|NCT03478956|101978214|FG001|STARTED|Randomized Treatment Period||12|Enrolled in Randomized Treatment Phase|
48670652|NCT03478956|101978215|FG002|STARTED|Randomized Treatment Period||0|Enrolled in Randomized Treatment Phase|
48520423|NCT04317313|101607899|FG000|STARTED|Overall Study||100||
48520424|NCT04317313|101607900|FG001|STARTED|Overall Study||52||
48520425|NCT04317313|101607899|FG000|COMPLETED|Overall Study||100||
48520426|NCT04317313|101607900|FG001|COMPLETED|Overall Study||52||
48520427|NCT04317313|101607899|FG000|NOT COMPLETED|Overall Study||0||
48520428|NCT04317313|101607900|FG001|NOT COMPLETED|Overall Study||0||
48520429|NCT02206620|101607901|FG000|STARTED|Phase I - First Intervention (6 Weeks)||22||
48520430|NCT02206620|101607902|FG001|STARTED|Phase I - First Intervention (6 Weeks)||27||
48520431|NCT02206620|101607901|FG000|COMPLETED|Phase I - First Intervention (6 Weeks)||21||
48520432|NCT02206620|101607902|FG001|COMPLETED|Phase I - First Intervention (6 Weeks)||26||
48520433|NCT02206620|101607901|FG000|NOT COMPLETED|Phase I - First Intervention (6 Weeks)||1||
48520434|NCT02206620|101607902|FG001|NOT COMPLETED|Phase I - First Intervention (6 Weeks)||1||
48670653|NCT03478956|101978216|FG003|STARTED|Randomized Treatment Period||0|Enrolled in Randomized Treatment Phase|
48670654|NCT03478956|101978213|FG000|Received at Least One Dose of Study Drug|Randomized Treatment Period||12||
48670655|NCT03478956|101978214|FG001|Received at Least One Dose of Study Drug|Randomized Treatment Period||12||
48670656|NCT03478956|101978215|FG002|Received at Least One Dose of Study Drug|Randomized Treatment Period||0||
48670657|NCT03478956|101978216|FG003|Received at Least One Dose of Study Drug|Randomized Treatment Period||0||
48071724|NCT01681472|100498049|FG001|STARTED|Overall Study||8||
48071725|NCT01681472|100498050|FG002|STARTED|Overall Study||8||
48520435|NCT02206620|101607901|FG000|STARTED|Washout (6 Weeks)||21||
48520436|NCT02206620|101607902|FG001|STARTED|Washout (6 Weeks)||26||
48520437|NCT02206620|101607901|FG000|COMPLETED|Washout (6 Weeks)||21||
48520438|NCT02206620|101607902|FG001|COMPLETED|Washout (6 Weeks)||26||
48520439|NCT02206620|101607901|FG000|NOT COMPLETED|Washout (6 Weeks)||0||
48520440|NCT02206620|101607902|FG001|NOT COMPLETED|Washout (6 Weeks)||0||
48520441|NCT02206620|101607901|FG000|STARTED|Phase II - Second Intervention (6 Weeks)||21||
48520442|NCT02206620|101607902|FG001|STARTED|Phase II - Second Intervention (6 Weeks)||26||
48520443|NCT02206620|101607901|FG000|COMPLETED|Phase II - Second Intervention (6 Weeks)||21||
48520444|NCT02206620|101607902|FG001|COMPLETED|Phase II - Second Intervention (6 Weeks)||24||
48520445|NCT02206620|101607901|FG000|NOT COMPLETED|Phase II - Second Intervention (6 Weeks)||0||
48520446|NCT02206620|101607902|FG001|NOT COMPLETED|Phase II - Second Intervention (6 Weeks)||2||
48520447|NCT02903238|101607903|FG000|STARTED|Overall Study||21||
48520448|NCT02903238|101607903|FG000|COMPLETED|Overall Study||17||
48520449|NCT02903238|101607903|FG000|NOT COMPLETED|Overall Study||4||
48520450|NCT01011075|101607904|FG000|STARTED|Overall Study||34||
48520451|NCT01011075|101607904|FG000|COMPLETED|Overall Study||34||
48520452|NCT01011075|101607904|FG000|NOT COMPLETED|Overall Study||0||
48520453|NCT03433755|101607905|FG000|STARTED|Overall Study||42||
48520454|NCT03433755|101607906|FG001|STARTED|Overall Study||41||
48520455|NCT03433755|101607907|FG002|STARTED|Overall Study||79||
48520456|NCT03433755|101607908|FG003|STARTED|Overall Study||80||
48520457|NCT03433755|101607905|FG000|Randomized and Treated|Overall Study||41||
48520458|NCT03433755|101607906|FG001|Randomized and Treated|Overall Study||41||
48520459|NCT03433755|101607907|FG002|Randomized and Treated|Overall Study||79||
48520460|NCT03433755|101607908|FG003|Randomized and Treated|Overall Study||80||
48520461|NCT03433755|101607905|FG000|COMPLETED|Overall Study||40||
48520462|NCT03433755|101607906|FG001|COMPLETED|Overall Study||41||
48520463|NCT03433755|101607907|FG002|COMPLETED|Overall Study||79||
48520464|NCT03433755|101607908|FG003|COMPLETED|Overall Study||80||
48520465|NCT03433755|101607905|FG000|NOT COMPLETED|Overall Study||2||
48520466|NCT03433755|101607906|FG001|NOT COMPLETED|Overall Study||0||
48520467|NCT03433755|101607907|FG002|NOT COMPLETED|Overall Study||0||
48520468|NCT03433755|101607908|FG003|NOT COMPLETED|Overall Study||0||
48520469|NCT03097588|101607909|FG000|STARTED|Overall Study||43||
48520470|NCT03097588|101607909|FG000|COMPLETED|Overall Study||42||
48520471|NCT03097588|101607909|FG000|NOT COMPLETED|Overall Study||1||
48520472|NCT00686582|101607910|FG000|STARTED|Overall Study||92|Blood Draw for Antibody Persistence 2 yrs after study POX-MVA-005|
48520473|NCT00686582|101607911|FG001|STARTED|Overall Study||91|Blood Draw for Antibody Persistence 2 yrs after study POX-MVA-005|
48520474|NCT00686582|101607912|FG002|STARTED|Overall Study||121|Blood Draw for Antibody Persistence 2 yrs after study POX-MVA-005|
48520475|NCT00686582|101607910|FG000|Booster Vaccination|Overall Study||75||
48520476|NCT00686582|101607911|FG001|Booster Vaccination|Overall Study||77||
48520477|NCT00686582|101607912|FG002|Booster Vaccination|Overall Study||0||
48520478|NCT00686582|101607910|FG000|COMPLETED|Overall Study||74|Active trial phase|
48520479|NCT00686582|101607911|FG001|COMPLETED|Overall Study||77|Active trial phase|
48520480|NCT00686582|101607912|FG002|COMPLETED|Overall Study||121|Active trial phase|
48520481|NCT00686582|101607910|FG000|NOT COMPLETED|Overall Study||18||
48520482|NCT00686582|101607911|FG001|NOT COMPLETED|Overall Study||14||
48520483|NCT00686582|101607912|FG002|NOT COMPLETED|Overall Study||0||
48520484|NCT00195013|101607913|FG000|STARTED|Overall Study||14||
48520485|NCT00195013|101607914|FG001|STARTED|Overall Study||16||
48520486|NCT00195013|101607913|FG000|COMPLETED|Overall Study||12||
48520487|NCT00195013|101607914|FG001|COMPLETED|Overall Study||15||
48670658|NCT03478956|101978213|FG000|Completed Treatment|Randomized Treatment Period||11||
48670659|NCT03478956|101978214|FG001|Completed Treatment|Randomized Treatment Period||10||
48670660|NCT03478956|101978215|FG002|Completed Treatment|Randomized Treatment Period||0||
48520488|NCT00195013|101607913|FG000|NOT COMPLETED|Overall Study||2||
48670661|NCT03478956|101978216|FG003|Completed Treatment|Randomized Treatment Period||0||
48670662|NCT03478956|101978213|FG000|COMPLETED|Randomized Treatment Period||11||
48670663|NCT03478956|101978214|FG001|COMPLETED|Randomized Treatment Period||11||
48670664|NCT03478956|101978215|FG002|COMPLETED|Randomized Treatment Period||0||
48520489|NCT00195013|101607914|FG001|NOT COMPLETED|Overall Study||1||
48520490|NCT03060759|101607915|FG000|STARTED|Overall Study||20||
48520491|NCT03060759|101607916|FG001|STARTED|Overall Study||15||
48520492|NCT03060759|101607915|FG000|COMPLETED|Overall Study||15||
48520493|NCT03060759|101607916|FG001|COMPLETED|Overall Study||12||
48520494|NCT03060759|101607915|FG000|NOT COMPLETED|Overall Study||5||
48520495|NCT03060759|101607916|FG001|NOT COMPLETED|Overall Study||3||
48520496|NCT00109837|101607917|FG000|STARTED|Overall Study||79||
48520497|NCT00109837|101607917|FG000|Eligible|Overall Study||78||
48520498|NCT00109837|101607917|FG000|Eligible and Ph-|Overall Study||61||
48520499|NCT00109837|101607917|FG000|Eligible and Ph- and Treated|Overall Study||60||
48520500|NCT00109837|101607917|FG000|COMPLETED|Overall Study||56||
48520501|NCT00109837|101607917|FG000|NOT COMPLETED|Overall Study||23||
48520502|NCT00892281|101607918|FG000|STARTED|Overall Study||1197||
48520503|NCT00892281|101607919|FG001|STARTED|Overall Study||224||
48520504|NCT00892281|101607918|FG000|COMPLETED|Overall Study||930||
48520505|NCT00892281|101607919|FG001|COMPLETED|Overall Study||187||
48520506|NCT00892281|101607918|FG000|NOT COMPLETED|Overall Study||267||
48520507|NCT00892281|101607919|FG001|NOT COMPLETED|Overall Study||37||
48520508|NCT01524302|101607920|FG000|STARTED|Overall Study||6||
48520509|NCT01524302|101607921|FG001|STARTED|Overall Study||6||
48520510|NCT01524302|101607920|FG000|COMPLETED|Overall Study||6||
48520511|NCT01524302|101607921|FG001|COMPLETED|Overall Study||6||
48520512|NCT01524302|101607920|FG000|NOT COMPLETED|Overall Study||0||
48520513|NCT01524302|101607921|FG001|NOT COMPLETED|Overall Study||0||
48520514|NCT02463799|101607922|FG000|STARTED|Overall Study||16||
48520515|NCT02463799|101607923|FG001|STARTED|Overall Study||16||
48520516|NCT02463799|101607922|FG000|COMPLETED|Overall Study||16||
48520517|NCT02463799|101607923|FG001|COMPLETED|Overall Study||16||
48520518|NCT02463799|101607922|FG000|NOT COMPLETED|Overall Study||0||
48520519|NCT02463799|101607923|FG001|NOT COMPLETED|Overall Study||0||
48520520|NCT00489281|101607924|FG000|STARTED|Overall Study||29||
48520521|NCT00489281|101607925|FG001|STARTED|Overall Study||13||
48520522|NCT00489281|101607924|FG000|COMPLETED|Overall Study||29||
48520523|NCT00489281|101607925|FG001|COMPLETED|Overall Study||13||
48520524|NCT00489281|101607924|FG000|NOT COMPLETED|Overall Study||0||
48520525|NCT00489281|101607925|FG001|NOT COMPLETED|Overall Study||0||
48520526|NCT00958126|101607926|FG000|STARTED|Overall Study||49||
48520527|NCT00958126|101607927|FG001|STARTED|Overall Study||205||
48520528|NCT00958126|101607928|FG002|STARTED|Overall Study||201||
48520529|NCT00958126|101607929|FG003|STARTED|Overall Study||203||
48520530|NCT00958126|101607930|FG004|STARTED|Overall Study||50||
48520531|NCT00958126|101607931|FG005|STARTED|Overall Study||203||
48520532|NCT00958126|101607932|FG006|STARTED|Overall Study||200||
48520533|NCT00958126|101607933|FG007|STARTED|Overall Study||202||
48520534|NCT00958126|101607926|FG000|COMPLETED|Overall Study||48||
48520535|NCT00958126|101607927|FG001|COMPLETED|Overall Study||196||
48520536|NCT00958126|101607928|FG002|COMPLETED|Overall Study||191||
48520537|NCT00958126|101607929|FG003|COMPLETED|Overall Study||192||
48520538|NCT00958126|101607930|FG004|COMPLETED|Overall Study||50||
48520539|NCT00958126|101607931|FG005|COMPLETED|Overall Study||202||
48520540|NCT00958126|101607932|FG006|COMPLETED|Overall Study||199||
48520541|NCT00958126|101607933|FG007|COMPLETED|Overall Study||202||
48520542|NCT00958126|101607926|FG000|NOT COMPLETED|Overall Study||1||
48520543|NCT00958126|101607927|FG001|NOT COMPLETED|Overall Study||9||
48520544|NCT00958126|101607928|FG002|NOT COMPLETED|Overall Study||10||
48520545|NCT00958126|101607929|FG003|NOT COMPLETED|Overall Study||11||
48520546|NCT00958126|101607930|FG004|NOT COMPLETED|Overall Study||0||
48520547|NCT00958126|101607931|FG005|NOT COMPLETED|Overall Study||1||
48520548|NCT00958126|101607932|FG006|NOT COMPLETED|Overall Study||1||
48520549|NCT00958126|101607933|FG007|NOT COMPLETED|Overall Study||0||
48520550|NCT00112294|101607934|FG000|STARTED|Overall Study||325||
48520551|NCT00112294|101607935|FG001|STARTED|Overall Study||320||
48520552|NCT00112294|101607934|FG000|Never Treated|Overall Study||13||
48520553|NCT00112294|101607935|FG001|Never Treated|Overall Study||18||
48520554|NCT00112294|101607934|FG000|COMPLETED|Overall Study||320||
48520555|NCT00112294|101607935|FG001|COMPLETED|Overall Study||320||
48520556|NCT00112294|101607934|FG000|NOT COMPLETED|Overall Study||5||
48520557|NCT00112294|101607935|FG001|NOT COMPLETED|Overall Study||0||
48520558|NCT03329079|101607936|FG000|STARTED|Overall Study||40||
48520559|NCT03329079|101607937|FG001|STARTED|Overall Study||40||
48520560|NCT03329079|101607936|FG000|COMPLETED|Overall Study||36||
48520561|NCT03329079|101607937|FG001|COMPLETED|Overall Study||38||
48520562|NCT03329079|101607936|FG000|NOT COMPLETED|Overall Study||4||
48520563|NCT03329079|101607937|FG001|NOT COMPLETED|Overall Study||2||
48670665|NCT03478956|101978216|FG003|COMPLETED|Randomized Treatment Period||0||
48670666|NCT03478956|101978213|FG000|NOT COMPLETED|Randomized Treatment Period||1||
48670667|NCT03478956|101978214|FG001|NOT COMPLETED|Randomized Treatment Period||1||
48520564|NCT03856593|101607938|FG000|STARTED|Overall Study||284||
48520565|NCT03856593|101607939|FG001|STARTED|Overall Study||257||
48520566|NCT03856593|101607938|FG000|COMPLETED|Overall Study||269||
48520567|NCT03856593|101607939|FG001|COMPLETED|Overall Study||241||
48520568|NCT03856593|101607938|FG000|NOT COMPLETED|Overall Study||15||
48520569|NCT03856593|101607939|FG001|NOT COMPLETED|Overall Study||16||
48520570|NCT01481740|101607940|FG000|STARTED|Overall Study||90||
48520571|NCT01481740|101607941|FG001|STARTED|Overall Study||88||
48520572|NCT01481740|101607940|FG000|COMPLETED|Overall Study||79||
48520573|NCT01481740|101607941|FG001|COMPLETED|Overall Study||81||
48520574|NCT01481740|101607940|FG000|NOT COMPLETED|Overall Study||11||
48520575|NCT01481740|101607941|FG001|NOT COMPLETED|Overall Study||7||
48520576|NCT02324673|101607942|FG000|STARTED|Overall Study||20||
48520577|NCT02324673|101607943|FG001|STARTED|Overall Study||20||
48520578|NCT02324673|101607944|FG002|STARTED|Overall Study||21||
48520579|NCT02324673|101607942|FG000|COMPLETED|Overall Study||20||
48520580|NCT02324673|101607943|FG001|COMPLETED|Overall Study||20||
48520581|NCT02324673|101607944|FG002|COMPLETED|Overall Study||21||
48670668|NCT03478956|101978215|FG002|NOT COMPLETED|Randomized Treatment Period||0||
48670669|NCT03478956|101978216|FG003|NOT COMPLETED|Randomized Treatment Period||0||
48670670|NCT03478956|101978213|FG000|STARTED|Open Label Extension Period||0||
48520582|NCT02324673|101607942|FG000|NOT COMPLETED|Overall Study||0||
48520583|NCT02324673|101607943|FG001|NOT COMPLETED|Overall Study||0||
48520584|NCT02324673|101607944|FG002|NOT COMPLETED|Overall Study||0||
48520585|NCT02447926|101607945|FG000|STARTED|Overall Study||1||
48520586|NCT02447926|101607945|FG000|COMPLETED|Overall Study||1||
48520587|NCT02447926|101607945|FG000|NOT COMPLETED|Overall Study||0||
48520588|NCT02065713|101607946|FG000|STARTED|Overall Study||23||
48520589|NCT02065713|101607947|FG001|STARTED|Overall Study||21||
48520590|NCT02065713|101607946|FG000|COMPLETED|Overall Study||22||
48520591|NCT02065713|101607947|FG001|COMPLETED|Overall Study||20||
48520592|NCT02065713|101607946|FG000|NOT COMPLETED|Overall Study||1||
48520593|NCT02065713|101607947|FG001|NOT COMPLETED|Overall Study||1||
48520594|NCT00603291|101607948|FG000|STARTED|Overall Study||95||
48520595|NCT00603291|101607949|FG001|STARTED|Overall Study||256||
48520596|NCT00603291|101607950|FG002|STARTED|Overall Study||253||
48520597|NCT00603291|101607948|FG000|COMPLETED|Overall Study||75||
48520598|NCT00603291|101607949|FG001|COMPLETED|Overall Study||169||
48520599|NCT00603291|101607950|FG002|COMPLETED|Overall Study||157||
48520600|NCT00603291|101607948|FG000|NOT COMPLETED|Overall Study||20||
48520601|NCT00603291|101607949|FG001|NOT COMPLETED|Overall Study||87||
48520602|NCT00603291|101607950|FG002|NOT COMPLETED|Overall Study||96||
48520603|NCT00279955|101607951|FG000|STARTED|Overall Study||157||
48520604|NCT00279955|101607952|FG001|STARTED|Overall Study||486||
48520605|NCT00279955|101607953|FG002|STARTED|Overall Study||358||
48520606|NCT00279955|101607951|FG000|COMPLETED|Overall Study||157||
48520607|NCT00279955|101607952|FG001|COMPLETED|Overall Study||486||
48520608|NCT00279955|101607953|FG002|COMPLETED|Overall Study||358||
48520609|NCT00279955|101607951|FG000|NOT COMPLETED|Overall Study||0||
48520610|NCT00279955|101607952|FG001|NOT COMPLETED|Overall Study||0||
48520611|NCT00279955|101607953|FG002|NOT COMPLETED|Overall Study||0||
48520612|NCT00842530|101607954|FG000|STARTED|Overall Study||2669||
48520613|NCT00842530|101607955|FG001|STARTED|Overall Study||1333||
48520614|NCT00842530|101607954|FG000|Received Vaccination 1|Overall Study||2666||
48520615|NCT00842530|101607955|FG001|Received Vaccination 1|Overall Study||1331||
48520616|NCT00842530|101607954|FG000|Received Vaccination 2|Overall Study||2584||
48520617|NCT00842530|101607955|FG001|Received Vaccination 2|Overall Study||1300||
48520618|NCT00842530|101607954|FG000|Received Vaccination 3|Overall Study||2557||
48520619|NCT00842530|101607955|FG001|Received Vaccination 3|Overall Study||1282||
48520620|NCT00842530|101607954|FG000|COMPLETED|Overall Study||2552||
48520621|NCT00842530|101607955|FG001|COMPLETED|Overall Study||1276||
48520622|NCT00842530|101607954|FG000|NOT COMPLETED|Overall Study||117||
48520623|NCT00842530|101607955|FG001|NOT COMPLETED|Overall Study||57||
48520624|NCT02201290|101607956|FG000|STARTED|Overall Study||9||
48520625|NCT02201290|101607956|FG000|COMPLETED|Overall Study||4||
48520626|NCT02201290|101607956|FG000|NOT COMPLETED|Overall Study||5||
48520627|NCT02129647|101607957|FG000|STARTED|Overall Study||13||
48520628|NCT02129647|101607957|FG000|COMPLETED|Overall Study||10||
48520629|NCT02129647|101607957|FG000|NOT COMPLETED|Overall Study||3||
48520630|NCT02214420|101607958|FG000|STARTED|Overall Study||14||
48520631|NCT02214420|101607959|FG001|STARTED|Overall Study||10||
48520632|NCT02214420|101607958|FG000|COMPLETED|Overall Study||13||
48520633|NCT02214420|101607959|FG001|COMPLETED|Overall Study||10||
48520634|NCT02214420|101607958|FG000|NOT COMPLETED|Overall Study||1||
48520635|NCT02214420|101607959|FG001|NOT COMPLETED|Overall Study||0||
48520636|NCT04647383|101607960|FG000|STARTED|Treatment Period 1 (8 Days)||16||
48520637|NCT04647383|101607961|FG001|STARTED|Treatment Period 1 (8 Days)||17||
48520638|NCT04647383|101607962|FG002|STARTED|Treatment Period 1 (8 Days)||14||
48520639|NCT04647383|101607963|FG003|STARTED|Treatment Period 1 (8 Days)||16||
48520640|NCT04647383|101607960|FG000|COMPLETED|Treatment Period 1 (8 Days)||16||
48670671|NCT03478956|101978214|FG001|STARTED|Open Label Extension Period||0||
48670672|NCT03478956|101978215|FG002|STARTED|Open Label Extension Period||21||
48520641|NCT04647383|101607961|FG001|COMPLETED|Treatment Period 1 (8 Days)||17||
48520642|NCT04647383|101607962|FG002|COMPLETED|Treatment Period 1 (8 Days)||14||
48520643|NCT04647383|101607963|FG003|COMPLETED|Treatment Period 1 (8 Days)||16||
48520644|NCT04647383|101607960|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
48520645|NCT04647383|101607961|FG001|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
48520646|NCT04647383|101607962|FG002|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
48520647|NCT04647383|101607963|FG003|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
48520648|NCT04647383|101607960|FG000|STARTED|Washout Period (14 Days)||16||
48520649|NCT04647383|101607961|FG001|STARTED|Washout Period (14 Days)||17||
48520650|NCT04647383|101607962|FG002|STARTED|Washout Period (14 Days)||14||
48520651|NCT04647383|101607963|FG003|STARTED|Washout Period (14 Days)||16||
48520652|NCT04647383|101607960|FG000|COMPLETED|Washout Period (14 Days)||16||
48520653|NCT04647383|101607961|FG001|COMPLETED|Washout Period (14 Days)||17||
48520654|NCT04647383|101607962|FG002|COMPLETED|Washout Period (14 Days)||14||
48520655|NCT04647383|101607963|FG003|COMPLETED|Washout Period (14 Days)||16||
48520656|NCT04647383|101607960|FG000|NOT COMPLETED|Washout Period (14 Days)||0||
48520657|NCT04647383|101607961|FG001|NOT COMPLETED|Washout Period (14 Days)||0||
48520658|NCT04647383|101607962|FG002|NOT COMPLETED|Washout Period (14 Days)||0||
48520659|NCT04647383|101607963|FG003|NOT COMPLETED|Washout Period (14 Days)||0||
48520660|NCT04647383|101607960|FG000|STARTED|Treatment Period 2 (8 Days)||16||
48520661|NCT04647383|101607961|FG001|STARTED|Treatment Period 2 (8 Days)||17||
48520662|NCT04647383|101607962|FG002|STARTED|Treatment Period 2 (8 Days)||14||
48520663|NCT04647383|101607963|FG003|STARTED|Treatment Period 2 (8 Days)||16||
48520664|NCT04647383|101607960|FG000|COMPLETED|Treatment Period 2 (8 Days)||16||
48520665|NCT04647383|101607961|FG001|COMPLETED|Treatment Period 2 (8 Days)||16||
48520666|NCT04647383|101607962|FG002|COMPLETED|Treatment Period 2 (8 Days)||14||
48520667|NCT04647383|101607963|FG003|COMPLETED|Treatment Period 2 (8 Days)||16||
48520668|NCT04647383|101607960|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
48520669|NCT04647383|101607961|FG001|NOT COMPLETED|Treatment Period 2 (8 Days)||1||
48520670|NCT04647383|101607962|FG002|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
48520671|NCT04647383|101607963|FG003|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
48520672|NCT01343095|101607964|FG000|STARTED|Overall Study||2||
48520673|NCT01343095|101607965|FG001|STARTED|Overall Study||3||
48520674|NCT01343095|101607966|FG002|STARTED|Overall Study||3||
48520675|NCT01343095|101607964|FG000|COMPLETED|Overall Study||2||
48520676|NCT01343095|101607965|FG001|COMPLETED|Overall Study||3||
48520677|NCT01343095|101607966|FG002|COMPLETED|Overall Study||3||
48520678|NCT01343095|101607964|FG000|NOT COMPLETED|Overall Study||0||
48520679|NCT01343095|101607965|FG001|NOT COMPLETED|Overall Study||0||
48520680|NCT01343095|101607966|FG002|NOT COMPLETED|Overall Study||0||
48520681|NCT02631837|101607967|FG000|STARTED|Overall Study||35||
48520682|NCT02631837|101607968|FG001|STARTED|Overall Study||35||
48520683|NCT02631837|101607967|FG000|COMPLETED|Overall Study||35||
48520684|NCT02631837|101607968|FG001|COMPLETED|Overall Study||35||
48520685|NCT02631837|101607967|FG000|NOT COMPLETED|Overall Study||0||
48520686|NCT02631837|101607968|FG001|NOT COMPLETED|Overall Study||0||
48520687|NCT01312181|101607969|FG000|STARTED|Overall Study||80||
48520688|NCT01312181|101607970|FG001|STARTED|Overall Study||77||
48520689|NCT01312181|101607971|FG002|STARTED|Overall Study||83||
48520690|NCT01312181|101607969|FG000|COMPLETED|Overall Study||78||
48520691|NCT01312181|101607970|FG001|COMPLETED|Overall Study||71||
48520692|NCT01312181|101607971|FG002|COMPLETED|Overall Study||75||
48520693|NCT01312181|101607969|FG000|NOT COMPLETED|Overall Study||2||
48520694|NCT01312181|101607970|FG001|NOT COMPLETED|Overall Study||6||
48520695|NCT01312181|101607971|FG002|NOT COMPLETED|Overall Study||8||
48520696|NCT02459665|101607972|FG000|STARTED|Overall Study||17|Enrollment visit|
48520697|NCT02459665|101607973|FG001|STARTED|Overall Study||17|Enrollment visit|
48520698|NCT02459665|101607974|FG002|STARTED|Overall Study||17|Enrollment visit|
48520699|NCT02459665|101607975|FG003|STARTED|Overall Study||17|Enrollment visit|
48520700|NCT02459665|101607972|FG000|Day 7 Visit|Overall Study||17||
48520701|NCT02459665|101607973|FG001|Day 7 Visit|Overall Study||17||
48520702|NCT02459665|101607974|FG002|Day 7 Visit|Overall Study||17||
48520703|NCT02459665|101607975|FG003|Day 7 Visit|Overall Study||16||
48520704|NCT02459665|101607972|FG000|Month 1 Visit|Overall Study||17||
48520705|NCT02459665|101607973|FG001|Month 1 Visit|Overall Study||17||
48520706|NCT02459665|101607974|FG002|Month 1 Visit|Overall Study||17||
48520707|NCT02459665|101607975|FG003|Month 1 Visit|Overall Study||16||
48520708|NCT02459665|101607972|FG000|Month 2 Visit|Overall Study||17|Cessation of interventions|
48520709|NCT02459665|101607973|FG001|Month 2 Visit|Overall Study||16|Cessation of interventions|
48520710|NCT02459665|101607974|FG002|Month 2 Visit|Overall Study||17|Cessation of interventions|
48520711|NCT02459665|101607975|FG003|Month 2 Visit|Overall Study||16|Cessation of interventions|
48520712|NCT02459665|101607972|FG000|Month 6 Visit|Overall Study||17|Final study visit|
48520713|NCT02459665|101607973|FG001|Month 6 Visit|Overall Study||16|Final study visit|
48520714|NCT02459665|101607974|FG002|Month 6 Visit|Overall Study||16|Final study visit|
48520715|NCT02459665|101607975|FG003|Month 6 Visit|Overall Study||15|Final study visit|
48520716|NCT02459665|101607972|FG000|COMPLETED|Overall Study||17|Month 6|
48520717|NCT02459665|101607973|FG001|COMPLETED|Overall Study||16|Month 6|
48520718|NCT02459665|101607974|FG002|COMPLETED|Overall Study||16|Month 6|
48520719|NCT02459665|101607975|FG003|COMPLETED|Overall Study||15|Month 6|
48520720|NCT02459665|101607972|FG000|NOT COMPLETED|Overall Study||0||
48520721|NCT02459665|101607973|FG001|NOT COMPLETED|Overall Study||1||
48520722|NCT02459665|101607974|FG002|NOT COMPLETED|Overall Study||1||
48520723|NCT02459665|101607975|FG003|NOT COMPLETED|Overall Study||2||
48520724|NCT01930175|101607976|FG000|STARTED|Core Study||7||
48520725|NCT01930175|101607977|FG001|STARTED|Core Study||2||
48520726|NCT01930175|101607978|FG002|STARTED|Core Study||4||
48520727|NCT01930175|101607976|FG000|Safety Analysis Set|Core Study||7|Patients that received study drug|
48520728|NCT01930175|101607977|FG001|Safety Analysis Set|Core Study||2|Patients that received study drug|
48520729|NCT01930175|101607978|FG002|Safety Analysis Set|Core Study||4|Patients that received study drug|
48520730|NCT01930175|101607976|FG000|Pharmacokinetics (PK) Analysis Set|Core Study||7|Patients with at least one PK measurement and no major protocol deviations affecting PK|
48520731|NCT01930175|101607977|FG001|Pharmacokinetics (PK) Analysis Set|Core Study||2|Patients with at least one PK measurement and no major protocol deviations affecting PK|
48520732|NCT01930175|101607978|FG002|Pharmacokinetics (PK) Analysis Set|Core Study||0|Patients with at least one PK measurement and no major protocol deviations affecting PK|
48670673|NCT03478956|101978216|FG003|STARTED|Open Label Extension Period||0||
48670674|NCT03478956|101978213|FG000|COMPLETED|Open Label Extension Period||0||
48520733|NCT01930175|101607976|FG000|COMPLETED|Core Study||7||
48520734|NCT01930175|101607977|FG001|COMPLETED|Core Study||1||
48520735|NCT01930175|101607978|FG002|COMPLETED|Core Study||3||
48520736|NCT01930175|101607976|FG000|NOT COMPLETED|Core Study||0||
48520737|NCT01930175|101607977|FG001|NOT COMPLETED|Core Study||1||
48520738|NCT01930175|101607978|FG002|NOT COMPLETED|Core Study||1||
48520739|NCT01930175|101607976|FG000|STARTED|Open Label VAY736 10 mg/kg at Week 24||0||
48520740|NCT01930175|101607977|FG001|STARTED|Open Label VAY736 10 mg/kg at Week 24||0||
48520741|NCT01930175|101607978|FG002|STARTED|Open Label VAY736 10 mg/kg at Week 24||3||
48520742|NCT01930175|101607976|FG000|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0||
48520743|NCT01930175|101607977|FG001|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0||
48520744|NCT01930175|101607978|FG002|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||3||
48520745|NCT01930175|101607976|FG000|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0||
48520746|NCT01930175|101607977|FG001|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0||
48520747|NCT01930175|101607978|FG002|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0||
48520748|NCT00589849|101607979|FG000|STARTED|Overall Study||32||
48520749|NCT00589849|101607979|FG000|COMPLETED|Overall Study||32||
48520750|NCT00589849|101607979|FG000|NOT COMPLETED|Overall Study||0||
48520751|NCT03407118|101607980|FG000|STARTED|Period 1||14||
48520752|NCT03407118|101607981|FG001|STARTED|Period 1||17||
48520753|NCT03407118|101607980|FG000|Received at Least 1 Dose of Study Drug|Period 1||14||
48520754|NCT03407118|101607981|FG001|Received at Least 1 Dose of Study Drug|Period 1||17||
48520755|NCT03407118|101607980|FG000|COMPLETED|Period 1||14||
48520756|NCT03407118|101607981|FG001|COMPLETED|Period 1||17||
48520757|NCT03407118|101607980|FG000|NOT COMPLETED|Period 1||0||
48520758|NCT03407118|101607981|FG001|NOT COMPLETED|Period 1||0||
48520759|NCT03407118|101607980|FG000|STARTED|Period 2||14||
48520760|NCT03407118|101607981|FG001|STARTED|Period 2||17||
48520761|NCT03407118|101607980|FG000|Received at Least 1 Dose of Study Drug|Period 2||13||
48520762|NCT03407118|101607981|FG001|Received at Least 1 Dose of Study Drug|Period 2||17||
48520763|NCT03407118|101607980|FG000|COMPLETED|Period 2||13||
48520764|NCT03407118|101607981|FG001|COMPLETED|Period 2||17||
48520765|NCT03407118|101607980|FG000|NOT COMPLETED|Period 2||1||
48520766|NCT03407118|101607981|FG001|NOT COMPLETED|Period 2||0||
48520767|NCT01366443|101607982|FG000|STARTED|Overall Study||288||
48520768|NCT01366443|101607982|FG000|COMPLETED|Overall Study||285||
48520769|NCT01366443|101607982|FG000|NOT COMPLETED|Overall Study||3||
48520770|NCT00865514|101607983|FG000|STARTED|Overall Study||2||
48520771|NCT00865514|101607983|FG000|COMPLETED|Overall Study||0||
48520772|NCT00865514|101607983|FG000|NOT COMPLETED|Overall Study||2||
48520773|NCT00613834|101607984|FG000|STARTED|Overall Study||29||
48520774|NCT00613834|101607985|FG001|STARTED|Overall Study||29||
48520775|NCT00613834|101607984|FG000|COMPLETED|Overall Study||29||
48520776|NCT00613834|101607985|FG001|COMPLETED|Overall Study||26||
48520777|NCT00613834|101607984|FG000|NOT COMPLETED|Overall Study||0||
48520778|NCT00613834|101607985|FG001|NOT COMPLETED|Overall Study||3||
48520779|NCT01615887|101607986|FG000|STARTED|Overall Study||41||
48520780|NCT01615887|101607987|FG001|STARTED|Overall Study||22||
48520781|NCT01615887|101607986|FG000|COMPLETED|Overall Study||29||
48520782|NCT01615887|101607987|FG001|COMPLETED|Overall Study||19||
48520783|NCT01615887|101607986|FG000|NOT COMPLETED|Overall Study||12||
48520784|NCT01615887|101607987|FG001|NOT COMPLETED|Overall Study||3||
48520785|NCT01791153|101607988|FG000|STARTED|Part 1: Blinded Period||100||
48520786|NCT01791153|101607989|FG001|STARTED|Part 1: Blinded Period||49||
48520787|NCT01791153|101607990|FG002|STARTED|Part 1: Blinded Period||50||
48520788|NCT01791153|101607991|FG003|STARTED|Part 1: Blinded Period||51||
48520789|NCT01791153|101607992|FG004|STARTED|Part 1: Blinded Period||0||
48520790|NCT01791153|101607993|FG005|STARTED|Part 1: Blinded Period||0||
48520791|NCT01791153|101607994|FG006|STARTED|Part 1: Blinded Period||0||
48520792|NCT01791153|101607995|FG007|STARTED|Part 1: Blinded Period||0||
48670675|NCT03478956|101978214|FG001|COMPLETED|Open Label Extension Period||0||
48710632|NCT00383643|102077978|FG002|COMPLETED|Overall Study||13||
48520793|NCT01791153|101607988|FG000|COMPLETED|Part 1: Blinded Period||85||
48520794|NCT01791153|101607989|FG001|COMPLETED|Part 1: Blinded Period||41||
48520795|NCT01791153|101607990|FG002|COMPLETED|Part 1: Blinded Period||44||
48520796|NCT01791153|101607991|FG003|COMPLETED|Part 1: Blinded Period||46||
48520797|NCT01791153|101607992|FG004|COMPLETED|Part 1: Blinded Period||0||
48520798|NCT01791153|101607993|FG005|COMPLETED|Part 1: Blinded Period||0||
48520799|NCT01791153|101607994|FG006|COMPLETED|Part 1: Blinded Period||0||
48520800|NCT01791153|101607995|FG007|COMPLETED|Part 1: Blinded Period||0||
48520801|NCT01791153|101607988|FG000|NOT COMPLETED|Part 1: Blinded Period||15||
48670676|NCT03478956|101978215|FG002|COMPLETED|Open Label Extension Period||0||
48670677|NCT03478956|101978216|FG003|COMPLETED|Open Label Extension Period||0||
48520802|NCT01791153|101607989|FG001|NOT COMPLETED|Part 1: Blinded Period||8||
48520803|NCT01791153|101607990|FG002|NOT COMPLETED|Part 1: Blinded Period||6||
48520804|NCT01791153|101607991|FG003|NOT COMPLETED|Part 1: Blinded Period||5||
48520805|NCT01791153|101607992|FG004|NOT COMPLETED|Part 1: Blinded Period||0||
48520806|NCT01791153|101607993|FG005|NOT COMPLETED|Part 1: Blinded Period||0||
48520807|NCT01791153|101607994|FG006|NOT COMPLETED|Part 1: Blinded Period||0||
48520808|NCT01791153|101607995|FG007|NOT COMPLETED|Part 1: Blinded Period||0||
48520809|NCT01791153|101607988|FG000|STARTED|Part 2: Open-label Period||0||
48520810|NCT01791153|101607989|FG001|STARTED|Part 2: Open-label Period||0||
48520811|NCT01791153|101607990|FG002|STARTED|Part 2: Open-label Period||0||
48520812|NCT01791153|101607991|FG003|STARTED|Part 2: Open-label Period||0||
48520813|NCT01791153|101607992|FG004|STARTED|Part 2: Open-label Period||40||
48520814|NCT01791153|101607993|FG005|STARTED|Part 2: Open-label Period||58||
48520815|NCT01791153|101607994|FG006|STARTED|Part 2: Open-label Period||50||
48520816|NCT01791153|101607995|FG007|STARTED|Part 2: Open-label Period||67||
48520817|NCT01791153|101607988|FG000|COMPLETED|Part 2: Open-label Period||0||
48520818|NCT01791153|101607989|FG001|COMPLETED|Part 2: Open-label Period||0||
48520819|NCT01791153|101607990|FG002|COMPLETED|Part 2: Open-label Period||0||
48520820|NCT01791153|101607991|FG003|COMPLETED|Part 2: Open-label Period||0||
48520821|NCT01791153|101607992|FG004|COMPLETED|Part 2: Open-label Period||38||
48520822|NCT01791153|101607993|FG005|COMPLETED|Part 2: Open-label Period||54||
48520823|NCT01791153|101607994|FG006|COMPLETED|Part 2: Open-label Period||44||
48520824|NCT01791153|101607995|FG007|COMPLETED|Part 2: Open-label Period||61||
48520825|NCT01791153|101607988|FG000|NOT COMPLETED|Part 2: Open-label Period||0||
48520826|NCT01791153|101607989|FG001|NOT COMPLETED|Part 2: Open-label Period||0||
48520827|NCT01791153|101607990|FG002|NOT COMPLETED|Part 2: Open-label Period||0||
48520828|NCT01791153|101607991|FG003|NOT COMPLETED|Part 2: Open-label Period||0||
48520829|NCT01791153|101607992|FG004|NOT COMPLETED|Part 2: Open-label Period||2||
48520830|NCT01791153|101607993|FG005|NOT COMPLETED|Part 2: Open-label Period||4||
48520831|NCT01791153|101607994|FG006|NOT COMPLETED|Part 2: Open-label Period||6||
48520832|NCT01791153|101607995|FG007|NOT COMPLETED|Part 2: Open-label Period||6||
48520833|NCT03078582|101607996|FG000|STARTED|Overall Study||10||
48520834|NCT03078582|101607997|FG001|STARTED|Overall Study||16||
48520835|NCT03078582|101607996|FG000|COMPLETED|Overall Study||10||
48520836|NCT03078582|101607997|FG001|COMPLETED|Overall Study||8||
48520837|NCT03078582|101607996|FG000|NOT COMPLETED|Overall Study||0||
48520838|NCT03078582|101607997|FG001|NOT COMPLETED|Overall Study||8||
48520839|NCT01782482|101607998|FG000|STARTED|Overall Study||281||
48520840|NCT01782482|101607999|FG001|STARTED|Overall Study||280||
48520841|NCT01782482|101607998|FG000|COMPLETED|Overall Study||271||
48520842|NCT01782482|101607999|FG001|COMPLETED|Overall Study||270||
48520843|NCT01782482|101607998|FG000|NOT COMPLETED|Overall Study||10||
48520844|NCT01782482|101607999|FG001|NOT COMPLETED|Overall Study||10||
48520845|NCT01557842|101608000|FG000|STARTED|Overall Study||9||
48520846|NCT01557842|101608001|FG001|STARTED|Overall Study||6||
48520847|NCT01557842|101608000|FG000|COMPLETED|Overall Study||0||
48520848|NCT01557842|101608001|FG001|COMPLETED|Overall Study||0||
48670678|NCT03478956|101978213|FG000|NOT COMPLETED|Open Label Extension Period||0||
48670679|NCT03478956|101978214|FG001|NOT COMPLETED|Open Label Extension Period||0||
48520849|NCT01557842|101608000|FG000|NOT COMPLETED|Overall Study||9||
48520850|NCT01557842|101608001|FG001|NOT COMPLETED|Overall Study||6||
48520851|NCT03923699|101608002|FG000|STARTED|Overall Study||39750||17907
48520852|NCT03923699|101608003|FG001|STARTED|Overall Study||39810||18091
48520853|NCT03923699|101608002|FG000|COMPLETED|Overall Study||39750||17907
48520854|NCT03923699|101608003|FG001|COMPLETED|Overall Study||39810||18091
48520855|NCT03923699|101608002|FG000|NOT COMPLETED|Overall Study||0||0
48520856|NCT03923699|101608003|FG001|NOT COMPLETED|Overall Study||0||0
48520857|NCT00767338|101608004|FG000|STARTED|Overall Study||1||
48520858|NCT00767338|101608005|FG001|STARTED|Overall Study||2||
48520859|NCT00767338|101608006|FG002|STARTED|Overall Study||0||
48520860|NCT00767338|101608007|FG003|STARTED|Overall Study||0||
48520861|NCT00767338|101608004|FG000|COMPLETED|Overall Study||0||
48520862|NCT00767338|101608005|FG001|COMPLETED|Overall Study||0||
48520863|NCT00767338|101608006|FG002|COMPLETED|Overall Study||0||
48520864|NCT00767338|101608007|FG003|COMPLETED|Overall Study||0||
48520865|NCT00767338|101608004|FG000|NOT COMPLETED|Overall Study||1||
48670680|NCT03478956|101978215|FG002|NOT COMPLETED|Open Label Extension Period||21||
48670681|NCT03478956|101978216|FG003|NOT COMPLETED|Open Label Extension Period||0||
48670682|NCT03478956|101978213|FG000|STARTED|PML Safety Monitoring Period||0||
48520866|NCT00767338|101608005|FG001|NOT COMPLETED|Overall Study||2||
48520867|NCT00767338|101608006|FG002|NOT COMPLETED|Overall Study||0||
48520868|NCT00767338|101608007|FG003|NOT COMPLETED|Overall Study||0||
48520869|NCT01019707|101608008|FG000|STARTED|First Phase||3||
48520870|NCT01019707|101608009|FG001|STARTED|First Phase||3||
48520871|NCT01019707|101608008|FG000|COMPLETED|First Phase||3||
48520872|NCT01019707|101608009|FG001|COMPLETED|First Phase||3||
48520873|NCT01019707|101608008|FG000|NOT COMPLETED|First Phase||0||
48520874|NCT01019707|101608009|FG001|NOT COMPLETED|First Phase||0||
48520875|NCT01019707|101608008|FG000|STARTED|Washout||3||
48520876|NCT01019707|101608009|FG001|STARTED|Washout||3||
48520877|NCT01019707|101608008|FG000|COMPLETED|Washout||3||
48520878|NCT01019707|101608009|FG001|COMPLETED|Washout||1||
48520879|NCT01019707|101608008|FG000|NOT COMPLETED|Washout||0||
48520880|NCT01019707|101608009|FG001|NOT COMPLETED|Washout||2||
48670683|NCT03478956|101978214|FG001|STARTED|PML Safety Monitoring Period||0||
48520881|NCT01019707|101608008|FG000|STARTED|Second Phase||3||
48520882|NCT01019707|101608009|FG001|STARTED|Second Phase||1||
48520883|NCT01019707|101608008|FG000|COMPLETED|Second Phase||3||
48520884|NCT01019707|101608009|FG001|COMPLETED|Second Phase||1||
48520885|NCT01019707|101608008|FG000|NOT COMPLETED|Second Phase||0||
48520886|NCT01019707|101608009|FG001|NOT COMPLETED|Second Phase||0||
48520887|NCT00118378|101608010|FG000|STARTED|Overall Study||62||
48520888|NCT00118378|101608011|FG001|STARTED|Overall Study||53||
48520889|NCT00118378|101608010|FG000|COMPLETED|Overall Study||60||
48520890|NCT00118378|101608011|FG001|COMPLETED|Overall Study||45||
48520891|NCT00118378|101608010|FG000|NOT COMPLETED|Overall Study||2||
48520892|NCT00118378|101608011|FG001|NOT COMPLETED|Overall Study||8||
48520893|NCT01435031|101608012|FG000|STARTED|ITT at 1 Month||222||
48520894|NCT01435031|101608012|FG000|COMPLETED|ITT at 1 Month||216||
48520895|NCT01435031|101608012|FG000|NOT COMPLETED|ITT at 1 Month||6||
48520896|NCT01435031|101608012|FG000|STARTED|ITT at 6 Months||216||
48520897|NCT01435031|101608012|FG000|COMPLETED|ITT at 6 Months||211||
48520898|NCT01435031|101608012|FG000|NOT COMPLETED|ITT at 6 Months||5||
48520899|NCT01435031|101608012|FG000|STARTED|ITT at 1 Year||211||
48520900|NCT01435031|101608012|FG000|COMPLETED|ITT at 1 Year||202||
48520901|NCT01435031|101608012|FG000|NOT COMPLETED|ITT at 1 Year||9||
48520902|NCT01435031|101608012|FG000|STARTED|ITT at 2 Years||202||
48520903|NCT01435031|101608012|FG000|COMPLETED|ITT at 2 Years||189||
48520904|NCT01435031|101608012|FG000|NOT COMPLETED|ITT at 2 Years||13||
48520905|NCT01435031|101608012|FG000|STARTED|ITT at 3 Years||189||
48520906|NCT01435031|101608012|FG000|COMPLETED|ITT at 3 Years||178||
48520907|NCT01435031|101608012|FG000|NOT COMPLETED|ITT at 3 Years||11||
48520908|NCT01435031|101608012|FG000|STARTED|ITT at 4 Years||178||
48520909|NCT01435031|101608012|FG000|COMPLETED|ITT at 4 Years||171||
48520910|NCT01435031|101608012|FG000|NOT COMPLETED|ITT at 4 Years||7||
48520911|NCT01770431|101608013|FG000|STARTED|Overall Study||696||
48520912|NCT01770431|101608014|FG001|STARTED|Overall Study||348||
48520913|NCT01770431|101608013|FG000|COMPLETED|Overall Study||686||
48520914|NCT01770431|101608014|FG001|COMPLETED|Overall Study||316||
48520915|NCT01770431|101608013|FG000|NOT COMPLETED|Overall Study||10||
48520916|NCT01770431|101608014|FG001|NOT COMPLETED|Overall Study||32||
48520917|NCT00359632|101608015|FG000|STARTED|Overall Study||24||
48520918|NCT00359632|101608016|FG001|STARTED|Overall Study||9||
48520919|NCT00359632|101608015|FG000|COMPLETED|Overall Study||20||
48520920|NCT00359632|101608016|FG001|COMPLETED|Overall Study||9||
48520921|NCT00359632|101608015|FG000|NOT COMPLETED|Overall Study||4||
48071726|NCT01681472|100498051|FG003|STARTED|Overall Study||8||
48520922|NCT00359632|101608016|FG001|NOT COMPLETED|Overall Study||0||
48520923|NCT00969124|101608017|FG000|STARTED|Overall Study||328||
48520924|NCT00969124|101608017|FG000|COMPLETED|Overall Study||298||
48520925|NCT00969124|101608017|FG000|NOT COMPLETED|Overall Study||30||
48520926|NCT03978091|101608018|FG000|STARTED|Overall Study||8||
48520927|NCT03978091|101608019|FG001|STARTED|Overall Study||8||
48520928|NCT03978091|101608020|FG002|STARTED|Overall Study||8||
48520929|NCT03978091|101608021|FG003|STARTED|Overall Study||8||
48520930|NCT03978091|101608022|FG004|STARTED|Overall Study||8||
48520931|NCT03978091|101608023|FG005|STARTED|Overall Study||8||
48520932|NCT03978091|101608018|FG000|COMPLETED|Overall Study||8||
48520933|NCT03978091|101608019|FG001|COMPLETED|Overall Study||8||
48520934|NCT03978091|101608020|FG002|COMPLETED|Overall Study||7||
48520935|NCT03978091|101608021|FG003|COMPLETED|Overall Study||7||
48520936|NCT03978091|101608022|FG004|COMPLETED|Overall Study||7||
48520937|NCT03978091|101608023|FG005|COMPLETED|Overall Study||8||
48520938|NCT03978091|101608018|FG000|NOT COMPLETED|Overall Study||0||
48520939|NCT03978091|101608019|FG001|NOT COMPLETED|Overall Study||0||
48520940|NCT03978091|101608020|FG002|NOT COMPLETED|Overall Study||1||
48520941|NCT03978091|101608021|FG003|NOT COMPLETED|Overall Study||1||
48670684|NCT03478956|101978215|FG002|STARTED|PML Safety Monitoring Period||0||
48520942|NCT03978091|101608022|FG004|NOT COMPLETED|Overall Study||1||
48520943|NCT03978091|101608023|FG005|NOT COMPLETED|Overall Study||0||
48520944|NCT03903159|101608024|FG000|STARTED|Overall Study||15||
48520945|NCT03903159|101608024|FG000|COMPLETED|Overall Study||10||
48520946|NCT03903159|101608024|FG000|NOT COMPLETED|Overall Study||5||
48520947|NCT00252174|101608025|FG000|STARTED|Overall Study||0||
48670685|NCT03478956|101978216|FG003|STARTED|PML Safety Monitoring Period||13||
48520948|NCT00252174|101608026|FG001|STARTED|Overall Study||2||
48520949|NCT00252174|101608027|FG002|STARTED|Overall Study||0||
48520950|NCT00252174|101608025|FG000|COMPLETED|Overall Study||0||
48520951|NCT00252174|101608026|FG001|COMPLETED|Overall Study||1||
48520952|NCT00252174|101608027|FG002|COMPLETED|Overall Study||0||
48520953|NCT00252174|101608025|FG000|NOT COMPLETED|Overall Study||0||
48520954|NCT00252174|101608026|FG001|NOT COMPLETED|Overall Study||1||
48520955|NCT00252174|101608027|FG002|NOT COMPLETED|Overall Study||0||
48520956|NCT02960438|101608028|FG000|STARTED|Treatment Phase (Double-blind): 24 Weeks||56||
48520957|NCT02960438|101608029|FG001|STARTED|Treatment Phase (Double-blind): 24 Weeks||29||
48520958|NCT02960438|101608030|FG002|STARTED|Treatment Phase (Double-blind): 24 Weeks||54||
48520959|NCT02960438|101608031|FG003|STARTED|Treatment Phase (Double-blind): 24 Weeks||55||
48520960|NCT02960438|101608028|FG000|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||54||
48520961|NCT02960438|101608029|FG001|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||28||
48520962|NCT02960438|101608030|FG002|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||54||
48520963|NCT02960438|101608031|FG003|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||54||
48520964|NCT02960438|101608028|FG000|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||47||
48520965|NCT02960438|101608029|FG001|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||26||
48670686|NCT03478956|101978213|FG000|COMPLETED|PML Safety Monitoring Period||0||
48520966|NCT02960438|101608030|FG002|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||50||
48520967|NCT02960438|101608031|FG003|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||46||
48520968|NCT02960438|101608028|FG000|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||9||
48520969|NCT02960438|101608029|FG001|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||3||
48520970|NCT02960438|101608030|FG002|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||4||
48520971|NCT02960438|101608031|FG003|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||9||
48520972|NCT02960438|101608028|FG000|STARTED|Extension Phase (Open-label): 80 Weeks||47||
48520973|NCT02960438|101608029|FG001|STARTED|Extension Phase (Open-label): 80 Weeks||26||
48520974|NCT02960438|101608030|FG002|STARTED|Extension Phase (Open-label): 80 Weeks||50||
48520975|NCT02960438|101608031|FG003|STARTED|Extension Phase (Open-label): 80 Weeks||46||
48520976|NCT02960438|101608028|FG000|COMPLETED|Extension Phase (Open-label): 80 Weeks||36||
48520977|NCT02960438|101608029|FG001|COMPLETED|Extension Phase (Open-label): 80 Weeks||17||
48520978|NCT02960438|101608030|FG002|COMPLETED|Extension Phase (Open-label): 80 Weeks||36||
48520979|NCT02960438|101608031|FG003|COMPLETED|Extension Phase (Open-label): 80 Weeks||35||
48520980|NCT02960438|101608028|FG000|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||11||
48520981|NCT02960438|101608029|FG001|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||9||
48520982|NCT02960438|101608030|FG002|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||14||
48520983|NCT02960438|101608031|FG003|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||11||
48520984|NCT02692482|101608032|FG000|STARTED|Overall Study||177||
48520985|NCT02692482|101608033|FG001|STARTED|Overall Study||182||
48520986|NCT02692482|101608032|FG000|COMPLETED|Overall Study||174||
48520987|NCT02692482|101608033|FG001|COMPLETED|Overall Study||178||
48520988|NCT02692482|101608032|FG000|NOT COMPLETED|Overall Study||3||
48520989|NCT02692482|101608033|FG001|NOT COMPLETED|Overall Study||4||
48520990|NCT01202877|101608034|FG000|STARTED|Overall Study||6||
48520991|NCT01202877|101608035|FG001|STARTED|Overall Study||8||
48520992|NCT01202877|101608036|FG002|STARTED|Overall Study||40||
48520993|NCT01202877|101608034|FG000|COMPLETED|Overall Study||6||
48520994|NCT01202877|101608035|FG001|COMPLETED|Overall Study||7||
48520995|NCT01202877|101608036|FG002|COMPLETED|Overall Study||34||
48520996|NCT01202877|101608034|FG000|NOT COMPLETED|Overall Study||0||
48520997|NCT01202877|101608035|FG001|NOT COMPLETED|Overall Study||1||
48520998|NCT01202877|101608036|FG002|NOT COMPLETED|Overall Study||6||
48520999|NCT00156715|101608037|FG000|STARTED|Overall Study||23||
48521000|NCT00156715|101608037|FG000|COMPLETED|Overall Study||16||
48521001|NCT00156715|101608037|FG000|NOT COMPLETED|Overall Study||7||
48521002|NCT01673698|101608038|FG000|STARTED|Overall Study||187||
48521003|NCT01673698|101608039|FG001|STARTED|Overall Study||139||
48521004|NCT01673698|101608038|FG000|COMPLETED|Overall Study||136||
48521005|NCT01673698|101608039|FG001|COMPLETED|Overall Study||126||
48521006|NCT01673698|101608038|FG000|NOT COMPLETED|Overall Study||51||
48521007|NCT01673698|101608039|FG001|NOT COMPLETED|Overall Study||13||
48521008|NCT01010126|101608040|FG000|STARTED|Overall Study||27||
48521009|NCT01010126|101608041|FG001|STARTED|Overall Study||58||
48521010|NCT01010126|101608042|FG002|STARTED|Overall Study||28||
48521011|NCT01010126|101608043|FG003|STARTED|Overall Study||57||
48521012|NCT01010126|101608044|FG004|STARTED|Overall Study||58||
48521013|NCT01010126|101608045|FG005|STARTED|Overall Study||24||
48670687|NCT03478956|101978214|FG001|COMPLETED|PML Safety Monitoring Period||0||
48521014|NCT01010126|101608040|FG000|COMPLETED|Overall Study||26||
48521015|NCT01010126|101608041|FG001|COMPLETED|Overall Study||58||
48521016|NCT01010126|101608042|FG002|COMPLETED|Overall Study||27||
48521017|NCT01010126|101608043|FG003|COMPLETED|Overall Study||57||
48521018|NCT01010126|101608044|FG004|COMPLETED|Overall Study||55||
48521019|NCT01010126|101608045|FG005|COMPLETED|Overall Study||24||
48521020|NCT01010126|101608040|FG000|NOT COMPLETED|Overall Study||1||
48521021|NCT01010126|101608041|FG001|NOT COMPLETED|Overall Study||0||
48670688|NCT03478956|101978215|FG002|COMPLETED|PML Safety Monitoring Period||0||
48710633|NCT00383643|102077976|FG000|NOT COMPLETED|Overall Study||1||
48521022|NCT01010126|101608042|FG002|NOT COMPLETED|Overall Study||1||
48521023|NCT01010126|101608043|FG003|NOT COMPLETED|Overall Study||0||
48521024|NCT01010126|101608044|FG004|NOT COMPLETED|Overall Study||3||
48521025|NCT01010126|101608045|FG005|NOT COMPLETED|Overall Study||0||
48521026|NCT00317642|101608046|FG000|STARTED|Overall Study||163||
48521027|NCT00317642|101608047|FG001|STARTED|Overall Study||163||
48521028|NCT00317642|101608046|FG000|Full Analysis Set|Overall Study||162||
48521029|NCT00317642|101608047|FG001|Full Analysis Set|Overall Study||158||
48521030|NCT00317642|101608046|FG000|Received >= 1 Study Drug (Safety Set)|Overall Study||161||
48521031|NCT00317642|101608047|FG001|Received >= 1 Study Drug (Safety Set)|Overall Study||155||
48521032|NCT00317642|101608046|FG000|COMPLETED|Overall Study||41||
48521033|NCT00317642|101608047|FG001|COMPLETED|Overall Study||28||
48521034|NCT00317642|101608046|FG000|NOT COMPLETED|Overall Study||122||
48521035|NCT00317642|101608047|FG001|NOT COMPLETED|Overall Study||135||
48521036|NCT00731549|101608048|FG000|STARTED|Overall Study||1081||
48521037|NCT00731549|101608048|FG000|COMPLETED|Overall Study||858||
48521038|NCT00731549|101608048|FG000|NOT COMPLETED|Overall Study||223||
48521039|NCT03832738|101608049|FG000|STARTED|Overall Study||51||
48521040|NCT03832738|101608050|FG001|STARTED|Overall Study||50||
48521041|NCT03832738|101608051|FG002|STARTED|Overall Study||51||
48521042|NCT03832738|101608049|FG000|COMPLETED|Overall Study||43||
48521043|NCT03832738|101608050|FG001|COMPLETED|Overall Study||38||
48521044|NCT03832738|101608051|FG002|COMPLETED|Overall Study||32||
48521045|NCT03832738|101608049|FG000|NOT COMPLETED|Overall Study||8||
48521046|NCT03832738|101608050|FG001|NOT COMPLETED|Overall Study||12||
48521047|NCT03832738|101608051|FG002|NOT COMPLETED|Overall Study||19||
48521048|NCT02265341|101608052|FG000|STARTED|Overall Study||12||
48521049|NCT02265341|101608052|FG000|COMPLETED|Overall Study||12||
48521050|NCT02265341|101608052|FG000|NOT COMPLETED|Overall Study||0||
48521051|NCT02732691|101608053|FG000|STARTED|Overall Study||68||
48521052|NCT02732691|101608053|FG000|COMPLETED|Overall Study||68||
48521053|NCT02732691|101608053|FG000|NOT COMPLETED|Overall Study||0||
48521054|NCT04925713|101608054|FG000|STARTED|Overall Study||5||
48521055|NCT04925713|101608054|FG000|COMPLETED|Overall Study||5||
48521056|NCT04925713|101608054|FG000|NOT COMPLETED|Overall Study||0||
48521057|NCT02470091|101608055|FG000|STARTED|Overall Study||16||
48222196|NCT02336958|100866700|FG000|NOT COMPLETED|Overall Study||0||
48222197|NCT02336958|100866701|FG001|NOT COMPLETED|Overall Study||0||
48222198|NCT04187573|100866702|FG000|STARTED|Overall Study||38||
48222199|NCT04187573|100866702|FG000|COMPLETED|Overall Study||32||
48222200|NCT04187573|100866702|FG000|NOT COMPLETED|Overall Study||6||
48222201|NCT02831816|100866703|FG000|STARTED|Overall Study||640||640
48222202|NCT02831816|100866703|FG000|ZP|Overall Study||589||589
48222203|NCT02831816|100866703|FG000|CP|Overall Study||590||590
48222204|NCT02831816|100866703|FG000|Vehicle|Overall Study||131||131
48521058|NCT02470091|101608056|FG001|STARTED|Overall Study||40||
48521059|NCT02470091|101608055|FG000|Follow-up Report|Overall Study||1||
48521060|NCT02470091|101608056|FG001|Follow-up Report|Overall Study||10||
48521061|NCT02470091|101608055|FG000|COMPLETED|Overall Study||15||
48521062|NCT02470091|101608056|FG001|COMPLETED|Overall Study||38||
48521063|NCT02470091|101608055|FG000|NOT COMPLETED|Overall Study||1||
48521064|NCT02470091|101608056|FG001|NOT COMPLETED|Overall Study||2||
48521065|NCT00684567|101608057|FG000|STARTED|Concomitant Radiotherapy Period||30||
48521066|NCT00684567|101608057|FG000|COMPLETED|Concomitant Radiotherapy Period||28||
48521067|NCT00684567|101608057|FG000|NOT COMPLETED|Concomitant Radiotherapy Period||2||
48521068|NCT00684567|101608057|FG000|STARTED|Monotherapy Period||23||
48521069|NCT00684567|101608057|FG000|COMPLETED|Monotherapy Period||9||
48521070|NCT00684567|101608057|FG000|NOT COMPLETED|Monotherapy Period||14||
48521071|NCT00126126|101608058|FG000|STARTED|Overall Study||9||
48521072|NCT00126126|101608059|FG001|STARTED|Overall Study||9||
48521073|NCT00126126|101608058|FG000|COMPLETED|Overall Study||9||
48521074|NCT00126126|101608059|FG001|COMPLETED|Overall Study||7||
48521075|NCT00126126|101608058|FG000|NOT COMPLETED|Overall Study||0||
48521076|NCT00126126|101608059|FG001|NOT COMPLETED|Overall Study||2||
48521077|NCT01185028|101608060|FG000|STARTED|Overall Study||8||
48521078|NCT01185028|101608060|FG000|COMPLETED|Overall Study||4||
48521079|NCT01185028|101608060|FG000|NOT COMPLETED|Overall Study||4||
48521080|NCT00614926|101608061|FG000|STARTED|Overall Study||25||
48521081|NCT00614926|101608062|FG001|STARTED|Overall Study||7||
48521082|NCT00614926|101608061|FG000|COMPLETED|Overall Study||21||
48521083|NCT00614926|101608062|FG001|COMPLETED|Overall Study||7||
48521084|NCT00614926|101608061|FG000|NOT COMPLETED|Overall Study||4||
48521085|NCT00614926|101608062|FG001|NOT COMPLETED|Overall Study||0||
48521086|NCT00834899|101608063|FG000|STARTED|Overall Study||9||
48521087|NCT00834899|101608064|FG001|STARTED|Overall Study||4||
48521088|NCT00834899|101608063|FG000|COMPLETED|Overall Study||8||
48521089|NCT00834899|101608064|FG001|COMPLETED|Overall Study||3||
48222205|NCT02831816|100866703|FG000|COMPLETED|Overall Study||640||640
48222206|NCT02831816|100866703|FG000|NOT COMPLETED|Overall Study||0||0
48521090|NCT00834899|101608063|FG000|NOT COMPLETED|Overall Study||1||
48521091|NCT00834899|101608064|FG001|NOT COMPLETED|Overall Study||1||
48521092|NCT05571267|101608065|FG000|STARTED|Overall Study||1||
48521093|NCT05571267|101608066|FG001|STARTED|Overall Study||0||
48521094|NCT05571267|101608067|FG002|STARTED|Overall Study||0||
48521095|NCT05571267|101608065|FG000|COMPLETED|Overall Study||1||
48521096|NCT05571267|101608066|FG001|COMPLETED|Overall Study||0||
48521097|NCT05571267|101608067|FG002|COMPLETED|Overall Study||0||
48521098|NCT05571267|101608065|FG000|NOT COMPLETED|Overall Study||0||
48521099|NCT05571267|101608066|FG001|NOT COMPLETED|Overall Study||0||
48521100|NCT05571267|101608067|FG002|NOT COMPLETED|Overall Study||0||
48521101|NCT02519621|101608068|FG000|STARTED|Overall Study||30||
48521102|NCT02519621|101608069|FG001|STARTED|Overall Study||30||
48521103|NCT02519621|101608070|FG002|STARTED|Overall Study||30||
48521104|NCT02519621|101608068|FG000|COMPLETED|Overall Study||30||
48521105|NCT02519621|101608069|FG001|COMPLETED|Overall Study||30||
48521106|NCT02519621|101608070|FG002|COMPLETED|Overall Study||30||
48521107|NCT02519621|101608068|FG000|NOT COMPLETED|Overall Study||0||
48521108|NCT02519621|101608069|FG001|NOT COMPLETED|Overall Study||0||
48521109|NCT02519621|101608070|FG002|NOT COMPLETED|Overall Study||0||
48521110|NCT04844021|101608071|FG000|STARTED|Overall Study||24989||15
48521111|NCT04844021|101608072|FG001|STARTED|Overall Study||22318||15
48521112|NCT04844021|101608071|FG000|COMPLETED|Overall Study||24989||15
48521113|NCT04844021|101608072|FG001|COMPLETED|Overall Study||22318||14
48521114|NCT04844021|101608071|FG000|NOT COMPLETED|Overall Study||0||0
48521115|NCT04844021|101608072|FG001|NOT COMPLETED|Overall Study||0||1
48521116|NCT00369382|101608073|FG000|STARTED|Overall Study||59||
48521117|NCT00369382|101608074|FG001|STARTED|Overall Study||57||
48521118|NCT00369382|101608073|FG000|Received Treatment|Overall Study||57||
48521119|NCT00369382|101608074|FG001|Received Treatment|Overall Study||57||
48521120|NCT00369382|101608073|FG000|Completed Assigned Treatment Regimen|Overall Study||48||
48521121|NCT00369382|101608074|FG001|Completed Assigned Treatment Regimen|Overall Study||33||
48521122|NCT00369382|101608073|FG000|COMPLETED|Overall Study||49||
48521123|NCT00369382|101608074|FG001|COMPLETED|Overall Study||54||
48521124|NCT00369382|101608073|FG000|NOT COMPLETED|Overall Study||10||
48521125|NCT00369382|101608074|FG001|NOT COMPLETED|Overall Study||3||
48521126|NCT01763918|101608075|FG000|STARTED|Overall Study||55||
48521127|NCT01763918|101608076|FG001|STARTED|Overall Study||55||
48521128|NCT01763918|101608077|FG002|STARTED|Overall Study||111||
48521129|NCT01763918|101608078|FG003|STARTED|Overall Study||110||
48521130|NCT01763918|101608075|FG000|Received Treatment|Overall Study||54||
48521131|NCT01763918|101608076|FG001|Received Treatment|Overall Study||55||
48521132|NCT01763918|101608077|FG002|Received Treatment|Overall Study||110||
48521133|NCT01763918|101608078|FG003|Received Treatment|Overall Study||110||
48521134|NCT01763918|101608075|FG000|COMPLETED|Overall Study||49||
48521135|NCT01763918|101608076|FG001|COMPLETED|Overall Study||54||
48521136|NCT01763918|101608077|FG002|COMPLETED|Overall Study||101||
48521137|NCT01763918|101608078|FG003|COMPLETED|Overall Study||108||
48521138|NCT01763918|101608075|FG000|NOT COMPLETED|Overall Study||6||
48521139|NCT01763918|101608076|FG001|NOT COMPLETED|Overall Study||1||
48521140|NCT01763918|101608077|FG002|NOT COMPLETED|Overall Study||10||
48521141|NCT01763918|101608078|FG003|NOT COMPLETED|Overall Study||2||
48521142|NCT03420768|101608079|FG000|STARTED|Overall Study||18||
48521143|NCT03420768|101608080|FG001|STARTED|Overall Study||28||
48521144|NCT03420768|101608081|FG002|STARTED|Overall Study||15||
48521145|NCT03420768|101608079|FG000|COMPLETED|Overall Study||18||
48521146|NCT03420768|101608080|FG001|COMPLETED|Overall Study||28||
48521147|NCT03420768|101608081|FG002|COMPLETED|Overall Study||15||
48521148|NCT03420768|101608079|FG000|NOT COMPLETED|Overall Study||0||
48521149|NCT03420768|101608080|FG001|NOT COMPLETED|Overall Study||0||
48521150|NCT03420768|101608081|FG002|NOT COMPLETED|Overall Study||0||
48521151|NCT02777918|101608082|FG000|STARTED|Overall Study||53||
48521152|NCT02777918|101608083|FG001|STARTED|Overall Study||47||
48521153|NCT02777918|101608082|FG000|COMPLETED|Overall Study||50||
48521154|NCT02777918|101608083|FG001|COMPLETED|Overall Study||43||
48521155|NCT02777918|101608082|FG000|NOT COMPLETED|Overall Study||3||
48521156|NCT02777918|101608083|FG001|NOT COMPLETED|Overall Study||4||
48521157|NCT05855616|101608084|FG000|STARTED|Overall Study||26||
48521158|NCT05855616|101608085|FG001|STARTED|Overall Study||27||
48521159|NCT05855616|101608084|FG000|COMPLETED|Overall Study||25||
48521160|NCT05855616|101608085|FG001|COMPLETED|Overall Study||25||
48521161|NCT05855616|101608084|FG000|NOT COMPLETED|Overall Study||1||
48521162|NCT05855616|101608085|FG001|NOT COMPLETED|Overall Study||2||
48521163|NCT02315066|101608086|FG000|STARTED|Overall Study||2||
48521164|NCT02315066|101608087|FG001|STARTED|Overall Study||10||
48521165|NCT02315066|101608088|FG002|STARTED|Overall Study||11||
48521166|NCT02315066|101608089|FG003|STARTED|Overall Study||12||
48521167|NCT02315066|101608090|FG004|STARTED|Overall Study||13||
48521168|NCT02315066|101608091|FG005|STARTED|Overall Study||4||
48521169|NCT02315066|101608092|FG006|STARTED|Overall Study||16||
48521170|NCT02315066|101608093|FG007|STARTED|Overall Study||19||
48521171|NCT02315066|101608094|FG008|STARTED|Overall Study||11||
48521172|NCT02315066|101608095|FG009|STARTED|Overall Study||12||
48521173|NCT02315066|101608096|FG010|STARTED|Overall Study||12||
48521174|NCT02315066|101608097|FG011|STARTED|Overall Study||11||
48521175|NCT02315066|101608098|FG012|STARTED|Overall Study||11||
48521176|NCT02315066|101608099|FG013|STARTED|Overall Study||30||
48521177|NCT02315066|101608086|FG000|COMPLETED|Overall Study||0||
48521178|NCT02315066|101608087|FG001|COMPLETED|Overall Study||0||
48521179|NCT02315066|101608088|FG002|COMPLETED|Overall Study||2||
48521180|NCT02315066|101608089|FG003|COMPLETED|Overall Study||1||
48521181|NCT02315066|101608090|FG004|COMPLETED|Overall Study||2||
48521182|NCT02315066|101608091|FG005|COMPLETED|Overall Study||1||
48521183|NCT02315066|101608092|FG006|COMPLETED|Overall Study||3||
48521184|NCT02315066|101608093|FG007|COMPLETED|Overall Study||5||
48521185|NCT02315066|101608094|FG008|COMPLETED|Overall Study||0||
48521186|NCT02315066|101608095|FG009|COMPLETED|Overall Study||1||
48521187|NCT02315066|101608096|FG010|COMPLETED|Overall Study||0||
48521188|NCT02315066|101608097|FG011|COMPLETED|Overall Study||0||
48521189|NCT02315066|101608098|FG012|COMPLETED|Overall Study||1||
48521190|NCT02315066|101608099|FG013|COMPLETED|Overall Study||0||
48521191|NCT02315066|101608086|FG000|NOT COMPLETED|Overall Study||2||
48521192|NCT02315066|101608087|FG001|NOT COMPLETED|Overall Study||10||
48521193|NCT02315066|101608088|FG002|NOT COMPLETED|Overall Study||9||
48521194|NCT02315066|101608089|FG003|NOT COMPLETED|Overall Study||11||
48521195|NCT02315066|101608090|FG004|NOT COMPLETED|Overall Study||11||
48521196|NCT02315066|101608091|FG005|NOT COMPLETED|Overall Study||3||
48521197|NCT02315066|101608092|FG006|NOT COMPLETED|Overall Study||13||
48521198|NCT02315066|101608093|FG007|NOT COMPLETED|Overall Study||14||
48521199|NCT02315066|101608094|FG008|NOT COMPLETED|Overall Study||11||
48521200|NCT02315066|101608095|FG009|NOT COMPLETED|Overall Study||11||
48521201|NCT02315066|101608096|FG010|NOT COMPLETED|Overall Study||12||
48521202|NCT02315066|101608097|FG011|NOT COMPLETED|Overall Study||11||
48521203|NCT02315066|101608098|FG012|NOT COMPLETED|Overall Study||10||
48521204|NCT02315066|101608099|FG013|NOT COMPLETED|Overall Study||30||
48521205|NCT01045421|101608100|FG000|STARTED|Phase 1||1||
48521206|NCT01045421|101608101|FG001|STARTED|Phase 1||3||
48521207|NCT01045421|101608102|FG002|STARTED|Phase 1||4||
48521208|NCT01045421|101608103|FG003|STARTED|Phase 1||12||
48521209|NCT01045421|101608104|FG004|STARTED|Phase 1||3||
48521210|NCT01045421|101608105|FG005|STARTED|Phase 1||1||
48521211|NCT01045421|101608106|FG006|STARTED|Phase 1||0||
48521212|NCT01045421|101608107|FG007|STARTED|Phase 1||0||
48521213|NCT01045421|101608108|FG008|STARTED|Phase 1||0||
48521214|NCT01045421|101608109|FG009|STARTED|Phase 1||0||
48521215|NCT01045421|101608110|FG010|STARTED|Phase 1||0||
48521216|NCT01045421|101608100|FG000|COMPLETED|Phase 1||1||
48521217|NCT01045421|101608101|FG001|COMPLETED|Phase 1||3||
48521218|NCT01045421|101608102|FG002|COMPLETED|Phase 1||4||
48521219|NCT01045421|101608103|FG003|COMPLETED|Phase 1||11||
48521220|NCT01045421|101608104|FG004|COMPLETED|Phase 1||2||
48521221|NCT01045421|101608105|FG005|COMPLETED|Phase 1||1||
48521222|NCT01045421|101608106|FG006|COMPLETED|Phase 1||0||
48521223|NCT01045421|101608107|FG007|COMPLETED|Phase 1||0||
48521224|NCT01045421|101608108|FG008|COMPLETED|Phase 1||0||
48521225|NCT01045421|101608109|FG009|COMPLETED|Phase 1||0||
48521226|NCT01045421|101608110|FG010|COMPLETED|Phase 1||0||
48521227|NCT01045421|101608100|FG000|NOT COMPLETED|Phase 1||0||
48521228|NCT01045421|101608101|FG001|NOT COMPLETED|Phase 1||0||
48521229|NCT01045421|101608102|FG002|NOT COMPLETED|Phase 1||0||
48521230|NCT01045421|101608103|FG003|NOT COMPLETED|Phase 1||1||
48521231|NCT01045421|101608104|FG004|NOT COMPLETED|Phase 1||1||
48521232|NCT01045421|101608105|FG005|NOT COMPLETED|Phase 1||0||
48521233|NCT01045421|101608106|FG006|NOT COMPLETED|Phase 1||0||
48670689|NCT03478956|101978216|FG003|COMPLETED|PML Safety Monitoring Period||4||
48521234|NCT01045421|101608107|FG007|NOT COMPLETED|Phase 1||0||
48521235|NCT01045421|101608108|FG008|NOT COMPLETED|Phase 1||0||
48521236|NCT01045421|101608109|FG009|NOT COMPLETED|Phase 1||0||
48521237|NCT01045421|101608110|FG010|NOT COMPLETED|Phase 1||0||
48521238|NCT01045421|101608100|FG000|STARTED|Phase 2||0||
48521239|NCT01045421|101608101|FG001|STARTED|Phase 2||0||
48521240|NCT01045421|101608102|FG002|STARTED|Phase 2||0||
48521241|NCT01045421|101608103|FG003|STARTED|Phase 2||0||
48071727|NCT01681472|100498048|FG000|COMPLETED|Overall Study||8||
48071728|NCT01681472|100498049|FG001|COMPLETED|Overall Study||7||
48071729|NCT01681472|100498050|FG002|COMPLETED|Overall Study||8||
48521242|NCT01045421|101608104|FG004|STARTED|Phase 2||0||
48521243|NCT01045421|101608105|FG005|STARTED|Phase 2||0||
48521244|NCT01045421|101608106|FG006|STARTED|Phase 2||53||
48521245|NCT01045421|101608107|FG007|STARTED|Phase 2||55||
48521246|NCT01045421|101608108|FG008|STARTED|Phase 2||55||
48521247|NCT01045421|101608109|FG009|STARTED|Phase 2||26||
48521248|NCT01045421|101608110|FG010|STARTED|Phase 2||60||
48521249|NCT01045421|101608100|FG000|COMPLETED|Phase 2||0||
48521250|NCT01045421|101608101|FG001|COMPLETED|Phase 2||0||
48521251|NCT01045421|101608102|FG002|COMPLETED|Phase 2||0||
48521252|NCT01045421|101608103|FG003|COMPLETED|Phase 2||0||
48521253|NCT01045421|101608104|FG004|COMPLETED|Phase 2||0||
48521254|NCT01045421|101608105|FG005|COMPLETED|Phase 2||0||
48521255|NCT01045421|101608106|FG006|COMPLETED|Phase 2||53||
48521256|NCT01045421|101608107|FG007|COMPLETED|Phase 2||50||
48521257|NCT01045421|101608108|FG008|COMPLETED|Phase 2||53||
48521258|NCT01045421|101608109|FG009|COMPLETED|Phase 2||23||
48521259|NCT01045421|101608110|FG010|COMPLETED|Phase 2||58||
48521260|NCT01045421|101608100|FG000|NOT COMPLETED|Phase 2||0||
48521261|NCT01045421|101608101|FG001|NOT COMPLETED|Phase 2||0||
48521262|NCT01045421|101608102|FG002|NOT COMPLETED|Phase 2||0||
48521263|NCT01045421|101608103|FG003|NOT COMPLETED|Phase 2||0||
48710634|NCT00383643|102077977|FG001|NOT COMPLETED|Overall Study||1||
48521264|NCT01045421|101608104|FG004|NOT COMPLETED|Phase 2||0||
48521265|NCT01045421|101608105|FG005|NOT COMPLETED|Phase 2||0||
48521266|NCT01045421|101608106|FG006|NOT COMPLETED|Phase 2||0||
48521267|NCT01045421|101608107|FG007|NOT COMPLETED|Phase 2||5||
48521268|NCT01045421|101608108|FG008|NOT COMPLETED|Phase 2||2||
48521269|NCT01045421|101608109|FG009|NOT COMPLETED|Phase 2||3||
48521270|NCT01045421|101608110|FG010|NOT COMPLETED|Phase 2||2||
48521271|NCT00412737|101608111|FG000|STARTED|Overall Study||237||
48521272|NCT00412737|101608112|FG001|STARTED|Overall Study||238||
48521273|NCT00412737|101608111|FG000|COMPLETED|Overall Study||221||
48521274|NCT00412737|101608112|FG001|COMPLETED|Overall Study||232||
48521275|NCT00412737|101608111|FG000|NOT COMPLETED|Overall Study||16||
48521276|NCT00412737|101608112|FG001|NOT COMPLETED|Overall Study||6||
48521277|NCT03864042|101608113|FG000|STARTED|DDI Phase||29||
48521278|NCT03864042|101608114|FG001|STARTED|DDI Phase||12||
48521279|NCT03864042|101608115|FG002|STARTED|DDI Phase||15||
48521280|NCT03864042|101608113|FG000|COMPLETED|DDI Phase||25||
48521281|NCT03864042|101608114|FG001|COMPLETED|DDI Phase||12||
48521282|NCT03864042|101608115|FG002|COMPLETED|DDI Phase||15||
48521283|NCT03864042|101608113|FG000|NOT COMPLETED|DDI Phase||4||
48521284|NCT03864042|101608114|FG001|NOT COMPLETED|DDI Phase||0||
48521285|NCT03864042|101608115|FG002|NOT COMPLETED|DDI Phase||0||
48521286|NCT03864042|101608113|FG000|STARTED|Post-DDI Phase||25||
48521287|NCT03864042|101608114|FG001|STARTED|Post-DDI Phase||12||
48521288|NCT03864042|101608115|FG002|STARTED|Post-DDI Phase||15||
48521289|NCT03864042|101608113|FG000|COMPLETED|Post-DDI Phase||0||
48521290|NCT03864042|101608114|FG001|COMPLETED|Post-DDI Phase||0||
48521291|NCT03864042|101608115|FG002|COMPLETED|Post-DDI Phase||0||
48670690|NCT03478956|101978213|FG000|NOT COMPLETED|PML Safety Monitoring Period||0||
48670691|NCT03478956|101978214|FG001|NOT COMPLETED|PML Safety Monitoring Period||0||
48222207|NCT02397096|100866704|FG000|STARTED|Day 1 to Week 24||450||
48521292|NCT03864042|101608113|FG000|NOT COMPLETED|Post-DDI Phase||25||
48521293|NCT03864042|101608114|FG001|NOT COMPLETED|Post-DDI Phase||12||
48521294|NCT03864042|101608115|FG002|NOT COMPLETED|Post-DDI Phase||15||
48521295|NCT04440449|101608116|FG000|STARTED|Overall Study||20||
48521296|NCT04440449|101608117|FG001|STARTED|Overall Study||0||
48521297|NCT04440449|101608116|FG000|COMPLETED|Overall Study||18||
48521298|NCT04440449|101608117|FG001|COMPLETED|Overall Study||0||
48521299|NCT04440449|101608116|FG000|NOT COMPLETED|Overall Study||2||
48521300|NCT04440449|101608117|FG001|NOT COMPLETED|Overall Study||0||
48521301|NCT00655850|101608118|FG000|STARTED|Overall Study||39||
48521302|NCT00655850|101608118|FG000|COMPLETED|Overall Study||36||
48521303|NCT00655850|101608118|FG000|NOT COMPLETED|Overall Study||3||
48521304|NCT02786719|101608119|FG000|STARTED|Overall Study||13||
48521305|NCT02786719|101608119|FG000|COMPLETED|Overall Study||12||
48521306|NCT02786719|101608119|FG000|NOT COMPLETED|Overall Study||1||
48521307|NCT00971737|101608120|FG000|STARTED|Overall Study||30||
48521308|NCT00971737|101608121|FG001|STARTED|Overall Study||30||
48521309|NCT00971737|101608120|FG000|COMPLETED|Overall Study||30||
48521310|NCT00971737|101608121|FG001|COMPLETED|Overall Study||30||
48521311|NCT00971737|101608120|FG000|NOT COMPLETED|Overall Study||0||
48521312|NCT00971737|101608121|FG001|NOT COMPLETED|Overall Study||0||
48521313|NCT03093272|101608122|FG000|STARTED|Overall Study||9||
48521314|NCT03093272|101608122|FG000|COMPLETED|Overall Study||9||
48521315|NCT03093272|101608122|FG000|NOT COMPLETED|Overall Study||0||
48521316|NCT01091103|101608123|FG000|STARTED|Overall Study||60||
48521317|NCT01091103|101608123|FG000|COMPLETED|Overall Study||56||
48521318|NCT01091103|101608123|FG000|NOT COMPLETED|Overall Study||4||
48521319|NCT01360866|101608124|FG000|STARTED|Overall Study||516||
48521320|NCT01360866|101608125|FG001|STARTED|Overall Study||707||
48521321|NCT01360866|101608126|FG002|STARTED|Overall Study||1645||
48521322|NCT01360866|101608127|FG003|STARTED|Overall Study||76||
48521323|NCT01360866|101608124|FG000|COMPLETED|Overall Study||295||
48521324|NCT01360866|101608125|FG001|COMPLETED|Overall Study||420||
48521325|NCT01360866|101608126|FG002|COMPLETED|Overall Study||1126||
48222208|NCT02397096|100866705|FG001|STARTED|Day 1 to Week 24||223||
48222209|NCT02397096|100866704|FG000|Treated|Day 1 to Week 24||447||
48521326|NCT01360866|101608127|FG003|COMPLETED|Overall Study||54||
48521327|NCT01360866|101608124|FG000|NOT COMPLETED|Overall Study||221||
48521328|NCT01360866|101608125|FG001|NOT COMPLETED|Overall Study||287||
48521329|NCT01360866|101608126|FG002|NOT COMPLETED|Overall Study||519||
48521330|NCT01360866|101608127|FG003|NOT COMPLETED|Overall Study||22||
48521331|NCT01491035|101608128|FG000|STARTED|Overall Study||6||
48521332|NCT01491035|101608129|FG001|STARTED|Overall Study||6||
48521333|NCT01491035|101608130|FG002|STARTED|Overall Study||6||
48521334|NCT01491035|101608131|FG003|STARTED|Overall Study||6||
48521335|NCT01491035|101608132|FG004|STARTED|Overall Study||6||
48521336|NCT01491035|101608133|FG005|STARTED|Overall Study||6||
48521337|NCT01491035|101608134|FG006|STARTED|Overall Study||6||
48521338|NCT01491035|101608135|FG007|STARTED|Overall Study||6||
48521339|NCT01491035|101608128|FG000|COMPLETED|Overall Study||6||
48521340|NCT01491035|101608129|FG001|COMPLETED|Overall Study||6||
48521341|NCT01491035|101608130|FG002|COMPLETED|Overall Study||6||
48521342|NCT01491035|101608131|FG003|COMPLETED|Overall Study||6||
48670692|NCT03478956|101978215|FG002|NOT COMPLETED|PML Safety Monitoring Period||0||
48521343|NCT01491035|101608132|FG004|COMPLETED|Overall Study||5||
48521344|NCT01491035|101608133|FG005|COMPLETED|Overall Study||6||
48670693|NCT03478956|101978216|FG003|NOT COMPLETED|PML Safety Monitoring Period||9||
48670694|NCT03926130|101978217|FG000|STARTED|Overall Study||212||
48222210|NCT02397096|100866705|FG001|Treated|Day 1 to Week 24||223||
48222211|NCT02397096|100866704|FG000|COMPLETED|Day 1 to Week 24||427||
48222212|NCT02397096|100866705|FG001|COMPLETED|Day 1 to Week 24||209||
48222213|NCT02397096|100866704|FG000|NOT COMPLETED|Day 1 to Week 24||23||
48222214|NCT02397096|100866705|FG001|NOT COMPLETED|Day 1 to Week 24||14||
48222215|NCT02397096|100866704|FG000|STARTED|Week 24 to Week 48||427||
48521345|NCT01491035|101608134|FG006|COMPLETED|Overall Study||6||
48521346|NCT01491035|101608135|FG007|COMPLETED|Overall Study||6||
48521347|NCT01491035|101608128|FG000|NOT COMPLETED|Overall Study||0||
48521348|NCT01491035|101608129|FG001|NOT COMPLETED|Overall Study||0||
48521349|NCT01491035|101608130|FG002|NOT COMPLETED|Overall Study||0||
48521350|NCT01491035|101608131|FG003|NOT COMPLETED|Overall Study||0||
48521351|NCT01491035|101608132|FG004|NOT COMPLETED|Overall Study||1||
48521352|NCT01491035|101608133|FG005|NOT COMPLETED|Overall Study||0||
48521353|NCT01491035|101608134|FG006|NOT COMPLETED|Overall Study||0||
48521354|NCT01491035|101608135|FG007|NOT COMPLETED|Overall Study||0||
48521355|NCT01606852|101608136|FG000|STARTED|Overall Study||7||
48521356|NCT01606852|101608137|FG001|STARTED|Overall Study||8||
48521357|NCT01606852|101608136|FG000|COMPLETED|Overall Study||7||
48521358|NCT01606852|101608137|FG001|COMPLETED|Overall Study||8||
48521359|NCT01606852|101608136|FG000|NOT COMPLETED|Overall Study||0||
48521360|NCT01606852|101608137|FG001|NOT COMPLETED|Overall Study||0||
48521361|NCT01351350|101608138|FG000|STARTED|Overall Study||8|Here, started indicates the participants who were enrolled.|
48521362|NCT01351350|101608139|FG001|STARTED|Overall Study||29|Here, started indicates the participants who were enrolled.|
48521363|NCT01351350|101608140|FG002|STARTED|Overall Study||11|Here, started indicates the participants who were enrolled.|
48521364|NCT01351350|101608141|FG003|STARTED|Overall Study||13|Here, started indicates the participants who were enrolled.|
48521365|NCT01351350|101608142|FG004|STARTED|Overall Study||7|Here, started indicates the participants who were enrolled.|
48521366|NCT01351350|101608138|FG000|Treated|Overall Study||8||
48521367|NCT01351350|101608139|FG001|Treated|Overall Study||29||
48521368|NCT01351350|101608140|FG002|Treated|Overall Study||10||
48521369|NCT01351350|101608141|FG003|Treated|Overall Study||13||
48521370|NCT01351350|101608142|FG004|Treated|Overall Study||7||
48521371|NCT01351350|101608138|FG000|Dose-escalation Evaluable|Overall Study||7||
48521372|NCT01351350|101608139|FG001|Dose-escalation Evaluable|Overall Study||23||
48521373|NCT01351350|101608140|FG002|Dose-escalation Evaluable|Overall Study||10||
48521374|NCT01351350|101608141|FG003|Dose-escalation Evaluable|Overall Study||0||
48521375|NCT01351350|101608142|FG004|Dose-escalation Evaluable|Overall Study||0||
48521376|NCT01351350|101608138|FG000|COMPLETED|Overall Study||0||
48521377|NCT01351350|101608139|FG001|COMPLETED|Overall Study||0||
48521378|NCT01351350|101608140|FG002|COMPLETED|Overall Study||0||
48521379|NCT01351350|101608141|FG003|COMPLETED|Overall Study||0||
48521380|NCT01351350|101608142|FG004|COMPLETED|Overall Study||0||
48521381|NCT01351350|101608138|FG000|NOT COMPLETED|Overall Study||8||
48521382|NCT01351350|101608139|FG001|NOT COMPLETED|Overall Study||29||
48521383|NCT01351350|101608140|FG002|NOT COMPLETED|Overall Study||11||
48521384|NCT01351350|101608141|FG003|NOT COMPLETED|Overall Study||13||
48521385|NCT01351350|101608142|FG004|NOT COMPLETED|Overall Study||7||
48521386|NCT01490866|101608143|FG000|STARTED|FOLFOX/Bevacizumab Treatment||70||
48521387|NCT01490866|101608143|FG000|COMPLETED|FOLFOX/Bevacizumab Treatment||49||
48521388|NCT01490866|101608143|FG000|NOT COMPLETED|FOLFOX/Bevacizumab Treatment||21||
48521389|NCT01490866|101608143|FG000|STARTED|Axitinib Maintenance Therapy||49||
48521390|NCT01490866|101608143|FG000|COMPLETED|Axitinib Maintenance Therapy||0||
48521391|NCT01490866|101608143|FG000|NOT COMPLETED|Axitinib Maintenance Therapy||49||
48521392|NCT03307564|101608144|FG000|STARTED|Overall Study||6||
48521393|NCT03307564|101608144|FG000|COMPLETED|Overall Study||6||
48521394|NCT03307564|101608144|FG000|NOT COMPLETED|Overall Study||0||
48521395|NCT00062751|101608145|FG000|STARTED|Overall Study||33||
48521396|NCT00062751|101608146|FG001|STARTED|Overall Study||30||
48521397|NCT00062751|101608147|FG002|STARTED|Overall Study||33||
48521398|NCT00062751|101608148|FG003|STARTED|Overall Study||6||
48521399|NCT00062751|101608149|FG004|STARTED|Overall Study||6||
48521400|NCT00062751|101608145|FG000|COMPLETED|Overall Study||0||
48521401|NCT00062751|101608146|FG001|COMPLETED|Overall Study||0||
48521402|NCT00062751|101608147|FG002|COMPLETED|Overall Study||3||
48521403|NCT00062751|101608148|FG003|COMPLETED|Overall Study||1||
48521404|NCT00062751|101608149|FG004|COMPLETED|Overall Study||0||
48521405|NCT00062751|101608145|FG000|NOT COMPLETED|Overall Study||33||
48521406|NCT00062751|101608146|FG001|NOT COMPLETED|Overall Study||30||
48521407|NCT00062751|101608147|FG002|NOT COMPLETED|Overall Study||30||
48521408|NCT00062751|101608148|FG003|NOT COMPLETED|Overall Study||5||
48521409|NCT00062751|101608149|FG004|NOT COMPLETED|Overall Study||6||
48521410|NCT02370914|101608150|FG000|STARTED|Overall Study||84||
48521411|NCT02370914|101608150|FG000|COMPLETED|Overall Study||82||
48670695|NCT03926130|101978218|FG001|STARTED|Overall Study||631||
48670696|NCT03926130|101978219|FG002|STARTED|Overall Study||309||
48670697|NCT03926130|101978220|FG003|STARTED|Overall Study||6||
48710635|NCT00383643|102077978|FG002|NOT COMPLETED|Overall Study||1||
48521412|NCT02370914|101608150|FG000|NOT COMPLETED|Overall Study||2||
48521413|NCT02225665|101608151|FG000|STARTED|Overall Study||3||
48521414|NCT02225665|101608152|FG001|STARTED|Overall Study||5||
48521415|NCT02225665|101608151|FG000|COMPLETED|Overall Study||2||
48521416|NCT02225665|101608152|FG001|COMPLETED|Overall Study||4||
48670698|NCT03926130|101978217|FG000|Received at Least One Dose of Study Drug|Overall Study||211||
48670699|NCT03926130|101978218|FG001|Received at Least One Dose of Study Drug|Overall Study||630||
48071730|NCT01681472|100498051|FG003|COMPLETED|Overall Study||8||
48071731|NCT01681472|100498048|FG000|NOT COMPLETED|Overall Study||0||
48521417|NCT02225665|101608151|FG000|NOT COMPLETED|Overall Study||1||
48521418|NCT02225665|101608152|FG001|NOT COMPLETED|Overall Study||1||
48521419|NCT03508687|101608153|FG000|STARTED|Overall Study||2||
48521420|NCT03508687|101608154|FG001|STARTED|Overall Study||3||
48521421|NCT03508687|101608153|FG000|COMPLETED|Overall Study||2||
48521422|NCT03508687|101608154|FG001|COMPLETED|Overall Study||3||
48521423|NCT03508687|101608153|FG000|NOT COMPLETED|Overall Study||0||
48521424|NCT03508687|101608154|FG001|NOT COMPLETED|Overall Study||0||
48521425|NCT02549573|101608155|FG000|STARTED|Overall Study||6||
48521426|NCT02549573|101608156|FG001|STARTED|Overall Study||7||
48521427|NCT02549573|101608155|FG000|COMPLETED|Overall Study||6||
48521428|NCT02549573|101608156|FG001|COMPLETED|Overall Study||4||
48521429|NCT02549573|101608155|FG000|NOT COMPLETED|Overall Study||0||
48521430|NCT02549573|101608156|FG001|NOT COMPLETED|Overall Study||3||
48521431|NCT04975321|101608157|FG000|STARTED|Overall Study||25||70
48521432|NCT04975321|101608158|FG001|STARTED|Overall Study||26||80
48521433|NCT04975321|101608159|FG002|STARTED|Overall Study||25||70
48521434|NCT04975321|101608157|FG000|COMPLETED|Overall Study||15||40
48521435|NCT04975321|101608158|FG001|COMPLETED|Overall Study||15||47
48521436|NCT04975321|101608159|FG002|COMPLETED|Overall Study||17||48
48521437|NCT04975321|101608157|FG000|NOT COMPLETED|Overall Study||10||30
48521438|NCT04975321|101608158|FG001|NOT COMPLETED|Overall Study||11||33
48521439|NCT04975321|101608159|FG002|NOT COMPLETED|Overall Study||8||22
48521440|NCT02760264|101608160|FG000|STARTED|0.25 mg/kg/Day||12||
48521441|NCT02760264|101608161|FG001|STARTED|0.25 mg/kg/Day||0||
48521442|NCT02760264|101608162|FG002|STARTED|0.25 mg/kg/Day||0||
48521443|NCT02760264|101608163|FG003|STARTED|0.25 mg/kg/Day||0||
48521444|NCT02760264|101608160|FG000|COMPLETED|0.25 mg/kg/Day||12||
48521445|NCT02760264|101608161|FG001|COMPLETED|0.25 mg/kg/Day||0||
48521446|NCT02760264|101608162|FG002|COMPLETED|0.25 mg/kg/Day||0||
48521447|NCT02760264|101608163|FG003|COMPLETED|0.25 mg/kg/Day||0||
48521448|NCT02760264|101608160|FG000|NOT COMPLETED|0.25 mg/kg/Day||0||
48521449|NCT02760264|101608161|FG001|NOT COMPLETED|0.25 mg/kg/Day||0||
48521450|NCT02760264|101608162|FG002|NOT COMPLETED|0.25 mg/kg/Day||0||
48521451|NCT02760264|101608163|FG003|NOT COMPLETED|0.25 mg/kg/Day||0||
48521452|NCT02760264|101608160|FG000|STARTED|0.75 mg/kg/Day||0||
48521453|NCT02760264|101608161|FG001|STARTED|0.75 mg/kg/Day||12||
48521454|NCT02760264|101608162|FG002|STARTED|0.75 mg/kg/Day||0||
48521455|NCT02760264|101608163|FG003|STARTED|0.75 mg/kg/Day||0||
48071732|NCT01681472|100498049|FG001|NOT COMPLETED|Overall Study||1||
48521456|NCT02760264|101608160|FG000|COMPLETED|0.75 mg/kg/Day||0||
48521457|NCT02760264|101608161|FG001|COMPLETED|0.75 mg/kg/Day||12||
48521458|NCT02760264|101608162|FG002|COMPLETED|0.75 mg/kg/Day||0||
48071733|NCT01681472|100498050|FG002|NOT COMPLETED|Overall Study||0||
48071734|NCT01681472|100498051|FG003|NOT COMPLETED|Overall Study||0||
48071735|NCT00736944|100498052|FG000|STARTED|Induction||30||
48521459|NCT02760264|101608163|FG003|COMPLETED|0.75 mg/kg/Day||0||
48521460|NCT02760264|101608160|FG000|NOT COMPLETED|0.75 mg/kg/Day||0||
48521461|NCT02760264|101608161|FG001|NOT COMPLETED|0.75 mg/kg/Day||0||
48521462|NCT02760264|101608162|FG002|NOT COMPLETED|0.75 mg/kg/Day||0||
48521463|NCT02760264|101608163|FG003|NOT COMPLETED|0.75 mg/kg/Day||0||
48521464|NCT02760264|101608160|FG000|STARTED|2.0 mg/kg/Day||0||
48521465|NCT02760264|101608161|FG001|STARTED|2.0 mg/kg/Day||0||
48521466|NCT02760264|101608162|FG002|STARTED|2.0 mg/kg/Day||12||
48521467|NCT02760264|101608163|FG003|STARTED|2.0 mg/kg/Day||0||
48521468|NCT02760264|101608160|FG000|COMPLETED|2.0 mg/kg/Day||0||
48521469|NCT02760264|101608161|FG001|COMPLETED|2.0 mg/kg/Day||0||
48521470|NCT02760264|101608162|FG002|COMPLETED|2.0 mg/kg/Day||12||
48071736|NCT00736944|100498052|FG000|COMPLETED|Induction||29||
48071737|NCT00736944|100498052|FG000|NOT COMPLETED|Induction||1||
48521471|NCT02760264|101608163|FG003|COMPLETED|2.0 mg/kg/Day||0||
48521472|NCT02760264|101608160|FG000|NOT COMPLETED|2.0 mg/kg/Day||0||
48521473|NCT02760264|101608161|FG001|NOT COMPLETED|2.0 mg/kg/Day||0||
48521474|NCT02760264|101608162|FG002|NOT COMPLETED|2.0 mg/kg/Day||0||
48521475|NCT02760264|101608163|FG003|NOT COMPLETED|2.0 mg/kg/Day||0||
48521476|NCT02760264|101608160|FG000|STARTED|6.0 mg/kg/Day||0||
48521477|NCT02760264|101608161|FG001|STARTED|6.0 mg/kg/Day||0||
48521478|NCT02760264|101608162|FG002|STARTED|6.0 mg/kg/Day||0||
48521479|NCT02760264|101608163|FG003|STARTED|6.0 mg/kg/Day||12||
48521480|NCT02760264|101608160|FG000|COMPLETED|6.0 mg/kg/Day||0||
48521481|NCT02760264|101608161|FG001|COMPLETED|6.0 mg/kg/Day||0||
48521482|NCT02760264|101608162|FG002|COMPLETED|6.0 mg/kg/Day||0||
48521483|NCT02760264|101608163|FG003|COMPLETED|6.0 mg/kg/Day||12||
48521484|NCT02760264|101608160|FG000|NOT COMPLETED|6.0 mg/kg/Day||0||
48521485|NCT02760264|101608161|FG001|NOT COMPLETED|6.0 mg/kg/Day||0||
48670700|NCT03926130|101978219|FG002|Received at Least One Dose of Study Drug|Overall Study||309||
48071738|NCT00736944|100498052|FG000|STARTED|Definitive Treatment||29||
48071739|NCT00736944|100498052|FG000|COMPLETED|Definitive Treatment||28||
48071740|NCT00736944|100498052|FG000|NOT COMPLETED|Definitive Treatment||1||
48071741|NCT00566995|100498053|FG000|STARTED|Overall Study||37||
48071742|NCT00566995|100498053|FG000|COMPLETED|Overall Study||30||
48071743|NCT00566995|100498053|FG000|NOT COMPLETED|Overall Study||7||
48071744|NCT01330030|100498054|FG000|STARTED|Overall Study||121||
48521486|NCT02760264|101608162|FG002|NOT COMPLETED|6.0 mg/kg/Day||0||
48521487|NCT02760264|101608163|FG003|NOT COMPLETED|6.0 mg/kg/Day||0||
48521488|NCT03465436|101608164|FG000|STARTED|Period 1||14||
48521489|NCT03465436|101608165|FG001|STARTED|Period 1||14||
48521490|NCT03465436|101608166|FG002|STARTED|Period 1||14||
48521491|NCT03465436|101608167|FG003|STARTED|Period 1||14||
48521492|NCT03465436|101608164|FG000|Received at Least 1 Dose of Study Drug|Period 1||14||
48521493|NCT03465436|101608165|FG001|Received at Least 1 Dose of Study Drug|Period 1||14||
48521494|NCT03465436|101608166|FG002|Received at Least 1 Dose of Study Drug|Period 1||14||
48521495|NCT03465436|101608167|FG003|Received at Least 1 Dose of Study Drug|Period 1||14||
48521496|NCT03465436|101608164|FG000|COMPLETED|Period 1||14||
48521497|NCT03465436|101608165|FG001|COMPLETED|Period 1||14||
48521498|NCT03465436|101608166|FG002|COMPLETED|Period 1||13||
48521499|NCT03465436|101608167|FG003|COMPLETED|Period 1||14||
48521500|NCT03465436|101608164|FG000|NOT COMPLETED|Period 1||0||
48521501|NCT03465436|101608165|FG001|NOT COMPLETED|Period 1||0||
48521502|NCT03465436|101608166|FG002|NOT COMPLETED|Period 1||1||
48521503|NCT03465436|101608167|FG003|NOT COMPLETED|Period 1||0||
48521504|NCT03465436|101608164|FG000|STARTED|Period 2||14||
48071745|NCT01330030|100498055|FG001|STARTED|Overall Study||122||
48071746|NCT01330030|100498054|FG000|COMPLETED|Overall Study||105||
48071747|NCT01330030|100498055|FG001|COMPLETED|Overall Study||105||
48071748|NCT01330030|100498054|FG000|NOT COMPLETED|Overall Study||16||
48071749|NCT01330030|100498055|FG001|NOT COMPLETED|Overall Study||17||
48071750|NCT01945281|100498056|FG000|STARTED|Overall Study||34||
48071751|NCT01945281|100498057|FG001|STARTED|Overall Study||17||
48071752|NCT01945281|100498056|FG000|Treated|Overall Study||33||
48071753|NCT01945281|100498057|FG001|Treated|Overall Study||16||
48071754|NCT01945281|100498056|FG000|COMPLETED|Overall Study||28||
48071755|NCT01945281|100498057|FG001|COMPLETED|Overall Study||13||
48071756|NCT01945281|100498056|FG000|NOT COMPLETED|Overall Study||6||
48071757|NCT01945281|100498057|FG001|NOT COMPLETED|Overall Study||4||
48071758|NCT02012283|100498058|FG000|STARTED|First Intervention||10||
48071759|NCT02012283|100498059|FG001|STARTED|First Intervention||10||
48071760|NCT02012283|100498058|FG000|COMPLETED|First Intervention||10||
48071761|NCT02012283|100498059|FG001|COMPLETED|First Intervention||10||
48071762|NCT02012283|100498058|FG000|NOT COMPLETED|First Intervention||0||
48071763|NCT02012283|100498059|FG001|NOT COMPLETED|First Intervention||0||
48071764|NCT02012283|100498058|FG000|STARTED|Second Intervention||10||
48071765|NCT02012283|100498059|FG001|STARTED|Second Intervention||10||
48071766|NCT02012283|100498058|FG000|COMPLETED|Second Intervention||10||
48071767|NCT02012283|100498059|FG001|COMPLETED|Second Intervention||10||
48071768|NCT02012283|100498058|FG000|NOT COMPLETED|Second Intervention||0||
48071769|NCT02012283|100498059|FG001|NOT COMPLETED|Second Intervention||0||
48071770|NCT02012283|100498058|FG000|STARTED|Third Intervention||10||
48071771|NCT02012283|100498059|FG001|STARTED|Third Intervention||10||
48071772|NCT02012283|100498058|FG000|COMPLETED|Third Intervention||10||
48071773|NCT02012283|100498059|FG001|COMPLETED|Third Intervention||10||
48071774|NCT02012283|100498058|FG000|NOT COMPLETED|Third Intervention||0||
48071775|NCT02012283|100498059|FG001|NOT COMPLETED|Third Intervention||0||
48071776|NCT03345914|100498060|FG000|STARTED|Overall Study||123||
48071777|NCT03345914|100498061|FG001|STARTED|Overall Study||122||
48071778|NCT03345914|100498062|FG002|STARTED|Overall Study||122||
48071779|NCT03345914|100498060|FG000|Completed Week 16 Study Treatment|Overall Study||114||
48521505|NCT03465436|101608165|FG001|STARTED|Period 2||14||
48521506|NCT03465436|101608166|FG002|STARTED|Period 2||13||
48521507|NCT03465436|101608167|FG003|STARTED|Period 2||14||
48521508|NCT03465436|101608164|FG000|Received at Least 1 Dose of Study Drug|Period 2||14||
48521509|NCT03465436|101608165|FG001|Received at Least 1 Dose of Study Drug|Period 2||13||
48071780|NCT03345914|100498061|FG001|Completed Week 16 Study Treatment|Overall Study||118||
48071781|NCT03345914|100498062|FG002|Completed Week 16 Study Treatment|Overall Study||119||
48071782|NCT03345914|100498060|FG000|Completed Week 28 End of Study|Overall Study||0||
48071783|NCT03345914|100498061|FG001|Completed Week 28 End of Study|Overall Study||0||
48071784|NCT03345914|100498062|FG002|Completed Week 28 End of Study|Overall Study||0||
48071785|NCT03345914|100498060|FG000|COMPLETED|Overall Study||0||
48071786|NCT03345914|100498061|FG001|COMPLETED|Overall Study||0||
48071787|NCT03345914|100498062|FG002|COMPLETED|Overall Study||0||
48071788|NCT03345914|100498060|FG000|NOT COMPLETED|Overall Study||123||
48521510|NCT03465436|101608166|FG002|Received at Least 1 Dose of Study Drug|Period 2||13||
48521511|NCT03465436|101608167|FG003|Received at Least 1 Dose of Study Drug|Period 2||14||
48521512|NCT03465436|101608164|FG000|COMPLETED|Period 2||14||
48521513|NCT03465436|101608165|FG001|COMPLETED|Period 2||13||
48071789|NCT03345914|100498061|FG001|NOT COMPLETED|Overall Study||122||
48071790|NCT03345914|100498062|FG002|NOT COMPLETED|Overall Study||122||
48071791|NCT01289080|100498063|FG000|STARTED|Overall Study||9||
48521514|NCT03465436|101608166|FG002|COMPLETED|Period 2||13||
48521515|NCT03465436|101608167|FG003|COMPLETED|Period 2||14||
48521516|NCT03465436|101608164|FG000|NOT COMPLETED|Period 2||0||
48222216|NCT02397096|100866705|FG001|STARTED|Week 24 to Week 48||209||
48222217|NCT02397096|100866704|FG000|COMPLETED|Week 24 to Week 48||407||
48222218|NCT02397096|100866705|FG001|COMPLETED|Week 24 to Week 48||202||
48222219|NCT02397096|100866704|FG000|NOT COMPLETED|Week 24 to Week 48||20||
48222220|NCT02397096|100866705|FG001|NOT COMPLETED|Week 24 to Week 48||7||
48222221|NCT02397096|100866704|FG000|STARTED|Study Extension 1||398||
48222222|NCT02397096|100866705|FG001|STARTED|Study Extension 1||202||
48222223|NCT02397096|100866704|FG000|COMPLETED|Study Extension 1||357||
48222224|NCT02397096|100866705|FG001|COMPLETED|Study Extension 1||179||
48521517|NCT03465436|101608165|FG001|NOT COMPLETED|Period 2||1||
48670701|NCT03926130|101978220|FG003|Received at Least One Dose of Study Drug|Overall Study||6||
48071792|NCT01289080|100498064|FG001|STARTED|Overall Study||10||
48071793|NCT01289080|100498063|FG000|COMPLETED|Overall Study||9||
48071794|NCT01289080|100498064|FG001|COMPLETED|Overall Study||10||
48071795|NCT01289080|100498063|FG000|NOT COMPLETED|Overall Study||0||
48071796|NCT01289080|100498064|FG001|NOT COMPLETED|Overall Study||0||
48071797|NCT05451225|100498065|FG000|STARTED|Baseline||200||
48222225|NCT02397096|100866704|FG000|NOT COMPLETED|Study Extension 1||41||
48222226|NCT02397096|100866705|FG001|NOT COMPLETED|Study Extension 1||23||
48222227|NCT02397096|100866704|FG000|STARTED|Study Extension 2||303||
48222228|NCT02397096|100866705|FG001|STARTED|Study Extension 2||154||
48521518|NCT03465436|101608166|FG002|NOT COMPLETED|Period 2||0||
48071798|NCT05451225|100498065|FG000|COMPLETED|Baseline||200||
48071799|NCT05451225|100498065|FG000|NOT COMPLETED|Baseline||0||
48071800|NCT05451225|100498065|FG000|STARTED|6 Months||123||
48071801|NCT05451225|100498065|FG000|COMPLETED|6 Months||123||
48071802|NCT05451225|100498065|FG000|NOT COMPLETED|6 Months||0||
48071803|NCT05451225|100498065|FG000|STARTED|12 Months||128||
48071804|NCT05451225|100498065|FG000|COMPLETED|12 Months||128||
48521519|NCT03465436|101608167|FG003|NOT COMPLETED|Period 2||0||
48521520|NCT03465436|101608164|FG000|STARTED|Period 3||14||
48521521|NCT03465436|101608165|FG001|STARTED|Period 3||13||
48521522|NCT03465436|101608166|FG002|STARTED|Period 3||13||
48071805|NCT05451225|100498065|FG000|NOT COMPLETED|12 Months||0||
48071806|NCT02021773|100498066|FG000|STARTED|Overall Study||89|All randomized participants|
48071807|NCT02021773|100498067|FG001|STARTED|Overall Study||88|All randomized participants|
48071808|NCT02021773|100498068|FG002|STARTED|Overall Study||87|All randomized participants|
48071809|NCT02021773|100498066|FG000|Safety Analysis Set|Overall Study||89|Safety set: all participants who received at least one dose of study drug|
48071810|NCT02021773|100498067|FG001|Safety Analysis Set|Overall Study||88|Safety set: all participants who received at least one dose of study drug|
48071811|NCT02021773|100498068|FG002|Safety Analysis Set|Overall Study||86|Safety set: all participants who received at least one dose of study drug|
48071812|NCT02021773|100498066|FG000|Intent-to-treat (ITT)|Overall Study||89|All participants evaluable for efficacy|
48521523|NCT03465436|101608167|FG003|STARTED|Period 3||14||
48521524|NCT03465436|101608164|FG000|Received at Least One Dose of Study Drug|Period 3||13||
48521525|NCT03465436|101608165|FG001|Received at Least One Dose of Study Drug|Period 3||12||
48521526|NCT03465436|101608166|FG002|Received at Least One Dose of Study Drug|Period 3||13||
48521527|NCT03465436|101608167|FG003|Received at Least One Dose of Study Drug|Period 3||14||
48071813|NCT02021773|100498067|FG001|Intent-to-treat (ITT)|Overall Study||87|All participants evaluable for efficacy|
48071814|NCT02021773|100498068|FG002|Intent-to-treat (ITT)|Overall Study||85|All participants evaluable for efficacy|
48521528|NCT03465436|101608164|FG000|COMPLETED|Period 3||13||
48521529|NCT03465436|101608165|FG001|COMPLETED|Period 3||12||
48521530|NCT03465436|101608166|FG002|COMPLETED|Period 3||13||
48222229|NCT02397096|100866704|FG000|COMPLETED|Study Extension 2||129||
48521531|NCT03465436|101608167|FG003|COMPLETED|Period 3||14||
48521532|NCT03465436|101608164|FG000|NOT COMPLETED|Period 3||1||
48521533|NCT03465436|101608165|FG001|NOT COMPLETED|Period 3||1||
48521534|NCT03465436|101608166|FG002|NOT COMPLETED|Period 3||0||
48521535|NCT03465436|101608167|FG003|NOT COMPLETED|Period 3||0||
48521536|NCT03465436|101608164|FG000|STARTED|Period 4||13||
48521537|NCT03465436|101608165|FG001|STARTED|Period 4||12||
48521538|NCT03465436|101608166|FG002|STARTED|Period 4||13||
48521539|NCT03465436|101608167|FG003|STARTED|Period 4||14||
48521540|NCT03465436|101608164|FG000|Received at Least 1 Dose of Study Drug|Period 4||13||
48521541|NCT03465436|101608165|FG001|Received at Least 1 Dose of Study Drug|Period 4||12||
48521542|NCT03465436|101608166|FG002|Received at Least 1 Dose of Study Drug|Period 4||13||
48521543|NCT03465436|101608167|FG003|Received at Least 1 Dose of Study Drug|Period 4||14||
48521544|NCT03465436|101608164|FG000|COMPLETED|Period 4||13||
48521545|NCT03465436|101608165|FG001|COMPLETED|Period 4||12||
48521546|NCT03465436|101608166|FG002|COMPLETED|Period 4||12||
48521547|NCT03465436|101608167|FG003|COMPLETED|Period 4||14||
48222230|NCT02397096|100866705|FG001|COMPLETED|Study Extension 2||78||
48521548|NCT03465436|101608164|FG000|NOT COMPLETED|Period 4||0||
48521549|NCT03465436|101608165|FG001|NOT COMPLETED|Period 4||0||
48521550|NCT03465436|101608166|FG002|NOT COMPLETED|Period 4||1||
48521551|NCT03465436|101608167|FG003|NOT COMPLETED|Period 4||0||
48521552|NCT00680186|101608168|FG000|STARTED|Overall Study||1280||
48521553|NCT00680186|101608169|FG001|STARTED|Overall Study||1288||
48521554|NCT00680186|101608168|FG000|COMPLETED|Overall Study||1155||
48521555|NCT00680186|101608169|FG001|COMPLETED|Overall Study||1172||
48670702|NCT03926130|101978217|FG000|Placebo Non-Responder at Week 12|Overall Study||85||
48670703|NCT03926130|101978218|FG001|Placebo Non-Responder at Week 12|Overall Study||0||
48670704|NCT03926130|101978219|FG002|Placebo Non-Responder at Week 12|Overall Study||0||
48071815|NCT02021773|100498066|FG000|COMPLETED|Overall Study||77||
48670705|NCT03926130|101978220|FG003|Placebo Non-Responder at Week 12|Overall Study||0||
48670706|NCT03926130|101978217|FG000|COMPLETED|Overall Study||159||
48670707|NCT03926130|101978218|FG001|COMPLETED|Overall Study||561||
48670708|NCT03926130|101978219|FG002|COMPLETED|Overall Study||271||
48670709|NCT03926130|101978220|FG003|COMPLETED|Overall Study||4||
48670710|NCT03926130|101978217|FG000|NOT COMPLETED|Overall Study||53||
48670711|NCT03926130|101978218|FG001|NOT COMPLETED|Overall Study||70||
48071816|NCT02021773|100498067|FG001|COMPLETED|Overall Study||72||
48071817|NCT02021773|100498068|FG002|COMPLETED|Overall Study||76||
48071818|NCT02021773|100498066|FG000|NOT COMPLETED|Overall Study||12||
48071819|NCT02021773|100498067|FG001|NOT COMPLETED|Overall Study||16||
48071820|NCT02021773|100498068|FG002|NOT COMPLETED|Overall Study||11||
48071821|NCT00633750|100498069|FG000|STARTED|Overall Study||47||
48071822|NCT00633750|100498069|FG000|COMPLETED|Overall Study||42||
48071823|NCT00633750|100498069|FG000|NOT COMPLETED|Overall Study||5||
48071824|NCT02527161|100498070|FG000|STARTED|Overall Study||205||
48071825|NCT02527161|100498070|FG000|COMPLETED|Overall Study||73||
48071826|NCT02527161|100498070|FG000|NOT COMPLETED|Overall Study||132||
48071827|NCT00727636|100498071|FG000|STARTED|Overall Study||37||
48071828|NCT00727636|100498072|FG001|STARTED|Overall Study||15||
48071829|NCT00727636|100498071|FG000|COMPLETED|Overall Study||33||
48071830|NCT00727636|100498072|FG001|COMPLETED|Overall Study||15||
48071831|NCT00727636|100498071|FG000|NOT COMPLETED|Overall Study||4||
48670712|NCT03926130|101978219|FG002|NOT COMPLETED|Overall Study||38||
48670713|NCT03926130|101978220|FG003|NOT COMPLETED|Overall Study||2||
48670714|NCT04089865|101978221|FG000|STARTED|Overall Study||100||
48670715|NCT04089865|101978222|FG001|STARTED|Overall Study||100||
48670716|NCT04089865|101978223|FG002|STARTED|Overall Study||100||
48670717|NCT04089865|101978224|FG003|STARTED|Overall Study||100||
48670718|NCT04089865|101978221|FG000|COMPLETED|Overall Study||98||
48670719|NCT04089865|101978222|FG001|COMPLETED|Overall Study||98||
48670720|NCT04089865|101978223|FG002|COMPLETED|Overall Study||93||
48670721|NCT04089865|101978224|FG003|COMPLETED|Overall Study||98||
48670722|NCT04089865|101978221|FG000|NOT COMPLETED|Overall Study||2||
48670723|NCT04089865|101978222|FG001|NOT COMPLETED|Overall Study||2||
48670724|NCT04089865|101978223|FG002|NOT COMPLETED|Overall Study||7||
48670725|NCT04089865|101978224|FG003|NOT COMPLETED|Overall Study||2||
48670726|NCT04660539|101978225|FG000|STARTED|Overall Study||166||
48670727|NCT04660539|101978225|FG000|COMPLETED|Overall Study||106||
48670728|NCT04660539|101978225|FG000|NOT COMPLETED|Overall Study||60||
48670729|NCT04025554|101978226|FG000|STARTED|Overall Study||8||
48670730|NCT04025554|101978226|FG000|COMPLETED|Overall Study||5||
48670731|NCT04025554|101978226|FG000|NOT COMPLETED|Overall Study||3||
48670732|NCT04500613|101978227|FG000|STARTED|Overall Study||12||
48071832|NCT00727636|100498072|FG001|NOT COMPLETED|Overall Study||0||
48071833|NCT00915278|100498073|FG000|STARTED|Overall Study||8||
48071834|NCT00915278|100498074|FG001|STARTED|Overall Study||5||
48071835|NCT00915278|100498075|FG002|STARTED|Overall Study||3||
48071836|NCT00915278|100498076|FG003|STARTED|Overall Study||5||
48670733|NCT04500613|101978228|FG001|STARTED|Overall Study||12||
48670734|NCT04500613|101978227|FG000|COMPLETED|Overall Study||9||
48670735|NCT04500613|101978228|FG001|COMPLETED|Overall Study||12||
48670736|NCT04500613|101978227|FG000|NOT COMPLETED|Overall Study||3||
48670737|NCT04500613|101978228|FG001|NOT COMPLETED|Overall Study||0||
48670738|NCT03299049|101978229|FG000|STARTED|Overall Study||522||
48670739|NCT03299049|101978230|FG001|STARTED|Overall Study||523||
48670740|NCT03299049|101978229|FG000|COMPLETED|Overall Study||0||
48670741|NCT03299049|101978230|FG001|COMPLETED|Overall Study||0||
48670742|NCT03299049|101978229|FG000|NOT COMPLETED|Overall Study||522||
48670743|NCT03299049|101978230|FG001|NOT COMPLETED|Overall Study||523||
48670744|NCT00980538|101978231|FG000|STARTED|Overall Study||180||
48670745|NCT00980538|101978231|FG000|COMPLETED|Overall Study||0||
48670746|NCT00980538|101978231|FG000|NOT COMPLETED|Overall Study||180||
48670747|NCT02625428|101978232|FG000|STARTED|Overall Study||20||
48670748|NCT02625428|101978233|FG001|STARTED|Overall Study||20||
48670749|NCT02625428|101978232|FG000|COMPLETED|Overall Study||20||
48670750|NCT02625428|101978233|FG001|COMPLETED|Overall Study||20||
48670751|NCT02625428|101978232|FG000|NOT COMPLETED|Overall Study||0||
48670752|NCT02625428|101978233|FG001|NOT COMPLETED|Overall Study||0||
48670753|NCT02958865|101978234|FG000|STARTED|Induction Period (Day 1 to Week 8)||25||
48670754|NCT02958865|101978235|FG001|STARTED|Induction Period (Day 1 to Week 8)||51||
48670755|NCT02958865|101978236|FG002|STARTED|Induction Period (Day 1 to Week 8)||49||
48670756|NCT02958865|101978237|FG003|STARTED|Induction Period (Day 1 to Week 8)||50||
48670757|NCT02958865|101978238|FG004|STARTED|Induction Period (Day 1 to Week 8)||48||
48670758|NCT02958865|101978239|FG005|STARTED|Induction Period (Day 1 to Week 8)||47||
48670759|NCT02958865|101978240|FG006|STARTED|Induction Period (Day 1 to Week 8)||47||
48670760|NCT02958865|101978241|FG007|STARTED|Induction Period (Day 1 to Week 8)||0||
48670761|NCT02958865|101978242|FG008|STARTED|Induction Period (Day 1 to Week 8)||0||
48670762|NCT02958865|101978243|FG009|STARTED|Induction Period (Day 1 to Week 8)||0||
48670763|NCT02958865|101978244|FG010|STARTED|Induction Period (Day 1 to Week 8)||0||
48670764|NCT02958865|101978245|FG011|STARTED|Induction Period (Day 1 to Week 8)||0||
48071837|NCT00915278|100498077|FG004|STARTED|Overall Study||3||
48071838|NCT00915278|100498078|FG005|STARTED|Overall Study||9||
48071839|NCT00915278|100498073|FG000|COMPLETED|Overall Study||3||
48670765|NCT02958865|101978246|FG012|STARTED|Induction Period (Day 1 to Week 8)||0||
48670766|NCT02958865|101978247|FG013|STARTED|Induction Period (Day 1 to Week 8)||0||
48670767|NCT02958865|101978248|FG014|STARTED|Induction Period (Day 1 to Week 8)||0||
48670768|NCT02958865|101978249|FG015|STARTED|Induction Period (Day 1 to Week 8)||0||
48670769|NCT02958865|101978234|FG000|COMPLETED|Induction Period (Day 1 to Week 8)||21||
48670770|NCT02958865|101978235|FG001|COMPLETED|Induction Period (Day 1 to Week 8)||44||
48670771|NCT02958865|101978236|FG002|COMPLETED|Induction Period (Day 1 to Week 8)||43||
48670772|NCT02958865|101978237|FG003|COMPLETED|Induction Period (Day 1 to Week 8)||41||
48670773|NCT02958865|101978238|FG004|COMPLETED|Induction Period (Day 1 to Week 8)||45||
48670774|NCT02958865|101978239|FG005|COMPLETED|Induction Period (Day 1 to Week 8)||43||
48670775|NCT02958865|101978240|FG006|COMPLETED|Induction Period (Day 1 to Week 8)||44||
48670776|NCT02958865|101978241|FG007|COMPLETED|Induction Period (Day 1 to Week 8)||0||
48670777|NCT02958865|101978242|FG008|COMPLETED|Induction Period (Day 1 to Week 8)||0||
48670778|NCT02958865|101978243|FG009|COMPLETED|Induction Period (Day 1 to Week 8)||0||
48670779|NCT02958865|101978244|FG010|COMPLETED|Induction Period (Day 1 to Week 8)||0||
48071840|NCT00915278|100498074|FG001|COMPLETED|Overall Study||2||
48071841|NCT00915278|100498075|FG002|COMPLETED|Overall Study||2||
48071842|NCT00915278|100498076|FG003|COMPLETED|Overall Study||2||
48071843|NCT00915278|100498077|FG004|COMPLETED|Overall Study||1||
48071844|NCT00915278|100498078|FG005|COMPLETED|Overall Study||1||
48071845|NCT00915278|100498073|FG000|NOT COMPLETED|Overall Study||5||
48071846|NCT00915278|100498074|FG001|NOT COMPLETED|Overall Study||3||
48071847|NCT00915278|100498075|FG002|NOT COMPLETED|Overall Study||1||
48071848|NCT00915278|100498076|FG003|NOT COMPLETED|Overall Study||3||
48071849|NCT00915278|100498077|FG004|NOT COMPLETED|Overall Study||2||
48071850|NCT00915278|100498078|FG005|NOT COMPLETED|Overall Study||8||
48071851|NCT04094883|100498079|FG000|STARTED|Overall Study||11||
48071852|NCT04094883|100498079|FG000|COMPLETED|Overall Study||10||
48071853|NCT04094883|100498079|FG000|NOT COMPLETED|Overall Study||1||
48071854|NCT01194466|100498080|FG000|STARTED|Overall Study||14||
48071855|NCT01194466|100498081|FG001|STARTED|Overall Study||14||
48071856|NCT01194466|100498082|FG002|STARTED|Overall Study||13||
48071857|NCT01194466|100498080|FG000|COMPLETED|Overall Study||14||
48071858|NCT01194466|100498081|FG001|COMPLETED|Overall Study||14||
48670780|NCT02958865|101978245|FG011|COMPLETED|Induction Period (Day 1 to Week 8)||0||
48670781|NCT02958865|101978246|FG012|COMPLETED|Induction Period (Day 1 to Week 8)||0||
48670782|NCT02958865|101978247|FG013|COMPLETED|Induction Period (Day 1 to Week 8)||0||
48670783|NCT02958865|101978248|FG014|COMPLETED|Induction Period (Day 1 to Week 8)||0||
48670784|NCT02958865|101978249|FG015|COMPLETED|Induction Period (Day 1 to Week 8)||0||
48670785|NCT02958865|101978234|FG000|NOT COMPLETED|Induction Period (Day 1 to Week 8)||4||
48670786|NCT02958865|101978235|FG001|NOT COMPLETED|Induction Period (Day 1 to Week 8)||7||
48670787|NCT02958865|101978236|FG002|NOT COMPLETED|Induction Period (Day 1 to Week 8)||6||
48670788|NCT02958865|101978237|FG003|NOT COMPLETED|Induction Period (Day 1 to Week 8)||9||
48670789|NCT02958865|101978238|FG004|NOT COMPLETED|Induction Period (Day 1 to Week 8)||3||
48670790|NCT02958865|101978239|FG005|NOT COMPLETED|Induction Period (Day 1 to Week 8)||4||
48670791|NCT02958865|101978240|FG006|NOT COMPLETED|Induction Period (Day 1 to Week 8)||3||
48670792|NCT02958865|101978241|FG007|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0||
48670793|NCT02958865|101978242|FG008|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0||
48670794|NCT02958865|101978243|FG009|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0||
48670795|NCT02958865|101978244|FG010|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0||
48670796|NCT02958865|101978245|FG011|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0||
48670797|NCT02958865|101978246|FG012|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0||
48670798|NCT02958865|101978247|FG013|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0||
48670799|NCT02958865|101978248|FG014|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0||
48670800|NCT02958865|101978249|FG015|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0||
48071859|NCT01194466|100498082|FG002|COMPLETED|Overall Study||13||
48071860|NCT01194466|100498080|FG000|NOT COMPLETED|Overall Study||0||
48071861|NCT01194466|100498081|FG001|NOT COMPLETED|Overall Study||0||
48071862|NCT01194466|100498082|FG002|NOT COMPLETED|Overall Study||0||
48071863|NCT01854658|100498083|FG000|STARTED|Overall Study||439||
48071864|NCT01854658|100498084|FG001|STARTED|Overall Study||440||
48670801|NCT02958865|101978234|FG000|STARTED|Chronic Period (Week 8 to Week 32)||0||
48670802|NCT02958865|101978235|FG001|STARTED|Chronic Period (Week 8 to Week 32)||0||
48670803|NCT02958865|101978236|FG002|STARTED|Chronic Period (Week 8 to Week 32)||0||
48670804|NCT02958865|101978237|FG003|STARTED|Chronic Period (Week 8 to Week 32)||0||
48670805|NCT02958865|101978238|FG004|STARTED|Chronic Period (Week 8 to Week 32)||0||
48670806|NCT02958865|101978239|FG005|STARTED|Chronic Period (Week 8 to Week 32)||0||
48670807|NCT02958865|101978240|FG006|STARTED|Chronic Period (Week 8 to Week 32)||0||
48670808|NCT02958865|101978241|FG007|STARTED|Chronic Period (Week 8 to Week 32)||35||
48071865|NCT01854658|100498085|FG002|STARTED|Overall Study||512||
48071866|NCT01854658|100498086|FG003|STARTED|Overall Study||224||
48071867|NCT01854658|100498083|FG000|COMPLETED|Overall Study||346||
48071868|NCT01854658|100498084|FG001|COMPLETED|Overall Study||365||
48071869|NCT01854658|100498085|FG002|COMPLETED|Overall Study||432||
48071870|NCT01854658|100498086|FG003|COMPLETED|Overall Study||165||
48071871|NCT01854658|100498083|FG000|NOT COMPLETED|Overall Study||93||
48071872|NCT01854658|100498084|FG001|NOT COMPLETED|Overall Study||75||
48670809|NCT02958865|101978242|FG008|STARTED|Chronic Period (Week 8 to Week 32)||36||
48670810|NCT02958865|101978243|FG009|STARTED|Chronic Period (Week 8 to Week 32)||39||
48670811|NCT02958865|101978244|FG010|STARTED|Chronic Period (Week 8 to Week 32)||10||
48670812|NCT02958865|101978245|FG011|STARTED|Chronic Period (Week 8 to Week 32)||38||
48670813|NCT02958865|101978246|FG012|STARTED|Chronic Period (Week 8 to Week 32)||37||
48670814|NCT02958865|101978247|FG013|STARTED|Chronic Period (Week 8 to Week 32)||39||
48670815|NCT02958865|101978248|FG014|STARTED|Chronic Period (Week 8 to Week 32)||9||
48670816|NCT02958865|101978249|FG015|STARTED|Chronic Period (Week 8 to Week 32)||37||
48670817|NCT02958865|101978234|FG000|COMPLETED|Chronic Period (Week 8 to Week 32)||0||
48670818|NCT02958865|101978235|FG001|COMPLETED|Chronic Period (Week 8 to Week 32)||0||
48670819|NCT02958865|101978236|FG002|COMPLETED|Chronic Period (Week 8 to Week 32)||0||
48670820|NCT02958865|101978237|FG003|COMPLETED|Chronic Period (Week 8 to Week 32)||0||
48670821|NCT02958865|101978238|FG004|COMPLETED|Chronic Period (Week 8 to Week 32)||0||
48670822|NCT02958865|101978239|FG005|COMPLETED|Chronic Period (Week 8 to Week 32)||0||
48670823|NCT02958865|101978240|FG006|COMPLETED|Chronic Period (Week 8 to Week 32)||0||
48670824|NCT02958865|101978241|FG007|COMPLETED|Chronic Period (Week 8 to Week 32)||33||
48670825|NCT02958865|101978242|FG008|COMPLETED|Chronic Period (Week 8 to Week 32)||33||
48670826|NCT02958865|101978243|FG009|COMPLETED|Chronic Period (Week 8 to Week 32)||33||
48670827|NCT02958865|101978244|FG010|COMPLETED|Chronic Period (Week 8 to Week 32)||10||
48670828|NCT02958865|101978245|FG011|COMPLETED|Chronic Period (Week 8 to Week 32)||31||
48670829|NCT02958865|101978246|FG012|COMPLETED|Chronic Period (Week 8 to Week 32)||26||
48670830|NCT02958865|101978247|FG013|COMPLETED|Chronic Period (Week 8 to Week 32)||31||
48670831|NCT02958865|101978248|FG014|COMPLETED|Chronic Period (Week 8 to Week 32)||5||
48670832|NCT02958865|101978249|FG015|COMPLETED|Chronic Period (Week 8 to Week 32)||20||
48670833|NCT02958865|101978234|FG000|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||0||
48670834|NCT02958865|101978235|FG001|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||0||
48670835|NCT02958865|101978236|FG002|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||0||
48670836|NCT02958865|101978237|FG003|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||0||
48670837|NCT02958865|101978238|FG004|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||0||
48670838|NCT02958865|101978239|FG005|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||0||
48670839|NCT02958865|101978240|FG006|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||0||
48670840|NCT02958865|101978241|FG007|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||2||
48670841|NCT02958865|101978242|FG008|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||3||
48670842|NCT02958865|101978243|FG009|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||6||
48670843|NCT02958865|101978244|FG010|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||0||
48670844|NCT02958865|101978245|FG011|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||7||
48670845|NCT02958865|101978246|FG012|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||11||
48670846|NCT02958865|101978247|FG013|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||8||
48670847|NCT02958865|101978248|FG014|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||4||
48670848|NCT02958865|101978249|FG015|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||17||
48670849|NCT02415556|101978250|FG000|STARTED|Overall Study||57||
48670850|NCT02415556|101978251|FG001|STARTED|Overall Study||58||
48670851|NCT02415556|101978252|FG002|STARTED|Overall Study||65||
48670852|NCT02415556|101978253|FG003|STARTED|Overall Study||64||
48670853|NCT02415556|101978250|FG000|COMPLETED|Overall Study||32||
48670854|NCT02415556|101978251|FG001|COMPLETED|Overall Study||37||
48670855|NCT02415556|101978252|FG002|COMPLETED|Overall Study||43||
48670856|NCT02415556|101978253|FG003|COMPLETED|Overall Study||44||
48670857|NCT02415556|101978250|FG000|NOT COMPLETED|Overall Study||25||
48670858|NCT02415556|101978251|FG001|NOT COMPLETED|Overall Study||21||
48071873|NCT01854658|100498085|FG002|NOT COMPLETED|Overall Study||80||
48071874|NCT01854658|100498086|FG003|NOT COMPLETED|Overall Study||59||
48670859|NCT02415556|101978252|FG002|NOT COMPLETED|Overall Study||22||
48670860|NCT02415556|101978253|FG003|NOT COMPLETED|Overall Study||20||
48670861|NCT00856557|101978254|FG000|STARTED|Overall Study||62||
48670862|NCT00856557|101978255|FG001|STARTED|Overall Study||76||
48670863|NCT00856557|101978254|FG000|Received Intervention/Control|Overall Study||62||
48670864|NCT00856557|101978255|FG001|Received Intervention/Control|Overall Study||76||
48670865|NCT00856557|101978254|FG000|Tested With Standardized Patients|Overall Study||62||
48670866|NCT00856557|101978255|FG001|Tested With Standardized Patients|Overall Study||76||
48670867|NCT00856557|101978254|FG000|With Patients With Contextual Flags|Overall Study||50||
48670868|NCT00856557|101978255|FG001|With Patients With Contextual Flags|Overall Study||60||
48670869|NCT00856557|101978254|FG000|COMPLETED|Overall Study||50||
48670870|NCT00856557|101978255|FG001|COMPLETED|Overall Study||60||
48670871|NCT00856557|101978254|FG000|NOT COMPLETED|Overall Study||12||
48670872|NCT00856557|101978255|FG001|NOT COMPLETED|Overall Study||16||
48670873|NCT02216526|101978256|FG000|STARTED|Overall Study||45||
48670874|NCT02216526|101978257|FG001|STARTED|Overall Study||44||
48670875|NCT02216526|101978258|FG002|STARTED|Overall Study||44||
48670876|NCT02216526|101978256|FG000|COMPLETED|Overall Study||40||
48670877|NCT02216526|101978257|FG001|COMPLETED|Overall Study||41||
48670878|NCT02216526|101978258|FG002|COMPLETED|Overall Study||36||
48670879|NCT02216526|101978256|FG000|NOT COMPLETED|Overall Study||5||
48670880|NCT02216526|101978257|FG001|NOT COMPLETED|Overall Study||3||
48670881|NCT02216526|101978258|FG002|NOT COMPLETED|Overall Study||8||
48670882|NCT04547556|101978259|FG000|STARTED|Overall Study||92||
48670883|NCT04547556|101978260|FG001|STARTED|Overall Study||93||
48670884|NCT04547556|101978259|FG000|COMPLETED|Overall Study||92||
48670885|NCT04547556|101978260|FG001|COMPLETED|Overall Study||93||
48670886|NCT04547556|101978259|FG000|NOT COMPLETED|Overall Study||0||
48670887|NCT04547556|101978260|FG001|NOT COMPLETED|Overall Study||0||
48670888|NCT01722669|101978261|FG000|STARTED|Overall Study||5||
48670889|NCT01722669|101978262|FG001|STARTED|Overall Study||5||
48670890|NCT01722669|101978263|FG002|STARTED|Overall Study||5||
48670891|NCT01722669|101978264|FG003|STARTED|Overall Study||5||
48670892|NCT01722669|101978265|FG004|STARTED|Overall Study||10||
48670893|NCT01722669|101978266|FG005|STARTED|Overall Study||8||
48670894|NCT01722669|101978261|FG000|COMPLETED|Overall Study||5||
48670895|NCT01722669|101978262|FG001|COMPLETED|Overall Study||5||
48670896|NCT01722669|101978263|FG002|COMPLETED|Overall Study||5||
48670897|NCT01722669|101978264|FG003|COMPLETED|Overall Study||5||
48670898|NCT01722669|101978265|FG004|COMPLETED|Overall Study||10||
48670899|NCT01722669|101978266|FG005|COMPLETED|Overall Study||6||
48670900|NCT01722669|101978261|FG000|NOT COMPLETED|Overall Study||0||
48670901|NCT01722669|101978262|FG001|NOT COMPLETED|Overall Study||0||
48670902|NCT01722669|101978263|FG002|NOT COMPLETED|Overall Study||0||
48670903|NCT01722669|101978264|FG003|NOT COMPLETED|Overall Study||0||
48670904|NCT01722669|101978265|FG004|NOT COMPLETED|Overall Study||0||
48670905|NCT01722669|101978266|FG005|NOT COMPLETED|Overall Study||2||
48670906|NCT00538850|101978267|FG000|STARTED|Titration Period||130||
48670907|NCT00538850|101978268|FG001|STARTED|Titration Period||0||
48670908|NCT00538850|101978269|FG002|STARTED|Titration Period||0||
48670909|NCT00538850|101978267|FG000|COMPLETED|Titration Period||98||
48670910|NCT00538850|101978268|FG001|COMPLETED|Titration Period||0||
48670911|NCT00538850|101978269|FG002|COMPLETED|Titration Period||0||
48670912|NCT00538850|101978267|FG000|NOT COMPLETED|Titration Period||32||
48670913|NCT00538850|101978268|FG001|NOT COMPLETED|Titration Period||0||
48670914|NCT00538850|101978269|FG002|NOT COMPLETED|Titration Period||0||
48670915|NCT00538850|101978267|FG000|STARTED|Fentanyl Sublingual Spray - Double-blind||0||
48670916|NCT00538850|101978268|FG001|STARTED|Fentanyl Sublingual Spray - Double-blind||98||
48670917|NCT00538850|101978269|FG002|STARTED|Fentanyl Sublingual Spray - Double-blind||0||
48670918|NCT00538850|101978267|FG000|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0||
48670919|NCT00538850|101978268|FG001|COMPLETED|Fentanyl Sublingual Spray - Double-blind||95||
48670920|NCT00538850|101978269|FG002|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0||
48670921|NCT00538850|101978267|FG000|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0||
48670922|NCT00538850|101978268|FG001|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||3||
48670923|NCT00538850|101978269|FG002|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0||
48670924|NCT00538850|101978267|FG000|STARTED|Placebo - Double-blind||0||
48670925|NCT00538850|101978268|FG001|STARTED|Placebo - Double-blind||0||
48670926|NCT00538850|101978269|FG002|STARTED|Placebo - Double-blind||98||
48670927|NCT00538850|101978267|FG000|COMPLETED|Placebo - Double-blind||0||
48670928|NCT00538850|101978268|FG001|COMPLETED|Placebo - Double-blind||0||
48670929|NCT00538850|101978269|FG002|COMPLETED|Placebo - Double-blind||95||
48670930|NCT00538850|101978267|FG000|NOT COMPLETED|Placebo - Double-blind||0||
48670931|NCT00538850|101978268|FG001|NOT COMPLETED|Placebo - Double-blind||0||
48670932|NCT00538850|101978269|FG002|NOT COMPLETED|Placebo - Double-blind||3||
48670933|NCT03485157|101978270|FG000|STARTED|Double Blind Phase||223||
48670934|NCT03485157|101978271|FG001|STARTED|Double Blind Phase||224||
48670935|NCT03485157|101978270|FG000|COMPLETED|Double Blind Phase||208||
48670936|NCT03485157|101978271|FG001|COMPLETED|Double Blind Phase||203||
48670937|NCT03485157|101978270|FG000|NOT COMPLETED|Double Blind Phase||15||
48670938|NCT03485157|101978271|FG001|NOT COMPLETED|Double Blind Phase||21||
48670939|NCT03485157|101978270|FG000|STARTED|Open Label Phase||108||
48670940|NCT03485157|101978271|FG001|STARTED|Open Label Phase||109||
48670941|NCT03485157|101978270|FG000|COMPLETED|Open Label Phase||104||
48670942|NCT03485157|101978271|FG001|COMPLETED|Open Label Phase||104||
48670943|NCT03485157|101978270|FG000|NOT COMPLETED|Open Label Phase||4||
48670944|NCT03485157|101978271|FG001|NOT COMPLETED|Open Label Phase||5||
48670945|NCT00622726|101978272|FG000|STARTED|March, 2008 to August, 2010||75||
48670946|NCT00622726|101978273|FG001|STARTED|March, 2008 to August, 2010||75||
48670947|NCT00622726|101978272|FG000|COMPLETED|March, 2008 to August, 2010||70||
48670948|NCT00622726|101978273|FG001|COMPLETED|March, 2008 to August, 2010||73||
48670949|NCT00622726|101978272|FG000|NOT COMPLETED|March, 2008 to August, 2010||5||
48670950|NCT00622726|101978273|FG001|NOT COMPLETED|March, 2008 to August, 2010||2||
48670951|NCT00622726|101978272|FG000|STARTED|August, 2010 to April, 2013||70||
48670952|NCT00622726|101978273|FG001|STARTED|August, 2010 to April, 2013||73||
48670953|NCT00622726|101978272|FG000|COMPLETED|August, 2010 to April, 2013||69||
48670954|NCT00622726|101978273|FG001|COMPLETED|August, 2010 to April, 2013||68||
48670955|NCT00622726|101978272|FG000|NOT COMPLETED|August, 2010 to April, 2013||1||
48670956|NCT00622726|101978273|FG001|NOT COMPLETED|August, 2010 to April, 2013||5||
48670957|NCT00862940|101978274|FG000|STARTED|Overall Study||133||
48670958|NCT00862940|101978275|FG001|STARTED|Overall Study||144||
48670959|NCT00862940|101978274|FG000|COMPLETED|Overall Study||103||
48670960|NCT00862940|101978275|FG001|COMPLETED|Overall Study||114||
48670961|NCT00862940|101978274|FG000|NOT COMPLETED|Overall Study||30||
48670962|NCT00862940|101978275|FG001|NOT COMPLETED|Overall Study||30||
48670963|NCT00934921|101978276|FG000|STARTED|First Intervention||12||
48670964|NCT00934921|101978277|FG001|STARTED|First Intervention||12||
48670965|NCT00934921|101978276|FG000|COMPLETED|First Intervention||12||
48670966|NCT00934921|101978277|FG001|COMPLETED|First Intervention||12||
48670967|NCT00934921|101978276|FG000|NOT COMPLETED|First Intervention||0||
48670968|NCT00934921|101978277|FG001|NOT COMPLETED|First Intervention||0||
48670969|NCT00934921|101978276|FG000|STARTED|Second Intervention||12||
48670970|NCT00934921|101978277|FG001|STARTED|Second Intervention||12||
48670971|NCT00934921|101978276|FG000|COMPLETED|Second Intervention||12||
48670972|NCT00934921|101978277|FG001|COMPLETED|Second Intervention||12||
48670973|NCT00934921|101978276|FG000|NOT COMPLETED|Second Intervention||0||
48670974|NCT00934921|101978277|FG001|NOT COMPLETED|Second Intervention||0||
48670975|NCT03386773|101978278|FG000|STARTED|Overall Study||150||
48670976|NCT03386773|101978279|FG001|STARTED|Overall Study||150||
48670977|NCT03386773|101978278|FG000|COMPLETED|Overall Study||123||
48670978|NCT03386773|101978279|FG001|COMPLETED|Overall Study||115||
48670979|NCT03386773|101978278|FG000|NOT COMPLETED|Overall Study||27||
48670980|NCT03386773|101978279|FG001|NOT COMPLETED|Overall Study||35||
48670981|NCT00498628|101978280|FG000|STARTED|Overall Study||105||
48670982|NCT00498628|101978281|FG001|STARTED|Overall Study||113||
48670983|NCT00498628|101978280|FG000|COMPLETED|Overall Study||90||
48670984|NCT00498628|101978281|FG001|COMPLETED|Overall Study||92||
48670985|NCT00498628|101978280|FG000|NOT COMPLETED|Overall Study||15||
48670986|NCT00498628|101978281|FG001|NOT COMPLETED|Overall Study||21||
48670987|NCT01180127|101978282|FG000|STARTED|Overall Study||10||
48670988|NCT01180127|101978283|FG001|STARTED|Overall Study||11||
48670989|NCT01180127|101978284|FG002|STARTED|Overall Study||10||
48670990|NCT01180127|101978285|FG003|STARTED|Overall Study||10||
48670991|NCT01180127|101978282|FG000|COMPLETED|Overall Study||8||
48670992|NCT01180127|101978283|FG001|COMPLETED|Overall Study||11||
48670993|NCT01180127|101978284|FG002|COMPLETED|Overall Study||9||
48670994|NCT01180127|101978285|FG003|COMPLETED|Overall Study||9||
48670995|NCT01180127|101978282|FG000|NOT COMPLETED|Overall Study||2||
48670996|NCT01180127|101978283|FG001|NOT COMPLETED|Overall Study||0||
48670997|NCT01180127|101978284|FG002|NOT COMPLETED|Overall Study||1||
48670998|NCT01180127|101978285|FG003|NOT COMPLETED|Overall Study||1||
48670999|NCT00304161|101978286|FG000|STARTED|Overall Study||28||
48671000|NCT00304161|101978287|FG001|STARTED|Overall Study||27||
48671001|NCT00304161|101978286|FG000|COMPLETED|Overall Study||22||
48671002|NCT00304161|101978287|FG001|COMPLETED|Overall Study||21||
48671003|NCT00304161|101978286|FG000|NOT COMPLETED|Overall Study||6||
48671004|NCT00304161|101978287|FG001|NOT COMPLETED|Overall Study||6||
48671005|NCT05538728|101978288|FG000|STARTED|Overall Study||16||
48671006|NCT05538728|101978289|FG001|STARTED|Overall Study||14||
48671007|NCT05538728|101978288|FG000|COMPLETED|Overall Study||15||
48671008|NCT05538728|101978289|FG001|COMPLETED|Overall Study||13||
48671009|NCT05538728|101978288|FG000|NOT COMPLETED|Overall Study||1||
48671010|NCT05538728|101978289|FG001|NOT COMPLETED|Overall Study||1||
48671011|NCT02448381|101978290|FG000|STARTED|Overall Study||118||
48671012|NCT02448381|101978291|FG001|STARTED|Overall Study||51||
48671013|NCT02448381|101978290|FG000|Randomized, Not Treated|Overall Study||2||
48671014|NCT02448381|101978291|FG001|Randomized, Not Treated|Overall Study||1||
48671015|NCT02448381|101978290|FG000|Cycle 1|Overall Study||116||
48671016|NCT02448381|101978291|FG001|Cycle 1|Overall Study||50||
48671017|NCT02448381|101978290|FG000|Cycle 2|Overall Study||110||
48671018|NCT02448381|101978291|FG001|Cycle 2|Overall Study||45||
48671019|NCT02448381|101978290|FG000|Cycle 3|Overall Study||78||
48671020|NCT02448381|101978291|FG001|Cycle 3|Overall Study||32||
48671021|NCT02448381|101978290|FG000|Follow-up Period|Overall Study||98||
48671022|NCT02448381|101978291|FG001|Follow-up Period|Overall Study||39||
48671023|NCT02448381|101978290|FG000|COMPLETED|Overall Study||83||
48671024|NCT02448381|101978291|FG001|COMPLETED|Overall Study||32||
48671025|NCT02448381|101978290|FG000|NOT COMPLETED|Overall Study||35||
48671026|NCT02448381|101978291|FG001|NOT COMPLETED|Overall Study||19||
48671027|NCT04537650|101978292|FG000|STARTED|Overall Study||8||
48671028|NCT04537650|101978293|FG001|STARTED|Overall Study||36||
48671029|NCT04537650|101978292|FG000|COMPLETED|Overall Study||8||
48671030|NCT04537650|101978293|FG001|COMPLETED|Overall Study||36||
48671031|NCT04537650|101978292|FG000|NOT COMPLETED|Overall Study||0||
48671032|NCT04537650|101978293|FG001|NOT COMPLETED|Overall Study||0||
48671033|NCT04123704|101978294|FG000|STARTED|Overall Study||3||
48671034|NCT04123704|101978294|FG000|COMPLETED|Overall Study||1||
48671035|NCT04123704|101978294|FG000|NOT COMPLETED|Overall Study||2||
48671036|NCT04336826|101978295|FG000|STARTED|Overall Study||6||
48671037|NCT04336826|101978295|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
48671038|NCT04336826|101978295|FG000|COMPLETED|Overall Study||6||
48671039|NCT04336826|101978295|FG000|NOT COMPLETED|Overall Study||0||
48671040|NCT00666263|101978296|FG000|STARTED|Study Part 1 (Stabilization Phase 1)||22||
48671041|NCT00666263|101978297|FG001|STARTED|Study Part 1 (Stabilization Phase 1)||22||
48671042|NCT00666263|101978296|FG000|COMPLETED|Study Part 1 (Stabilization Phase 1)||22||
48671043|NCT00666263|101978297|FG001|COMPLETED|Study Part 1 (Stabilization Phase 1)||21||
48671044|NCT00666263|101978296|FG000|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||0||
48671045|NCT00666263|101978297|FG001|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||1||
48671046|NCT00666263|101978296|FG000|STARTED|Study Part 2 (Cross-over Period 1)||22||
48671047|NCT00666263|101978297|FG001|STARTED|Study Part 2 (Cross-over Period 1)||21||
48671048|NCT00666263|101978296|FG000|COMPLETED|Study Part 2 (Cross-over Period 1)||22||
48671049|NCT00666263|101978297|FG001|COMPLETED|Study Part 2 (Cross-over Period 1)||21||
48671050|NCT00666263|101978296|FG000|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0||
48671051|NCT00666263|101978297|FG001|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0||
48671052|NCT00666263|101978296|FG000|STARTED|Study Part 3 (Stabilization Phase 2)||22||
48671053|NCT00666263|101978297|FG001|STARTED|Study Part 3 (Stabilization Phase 2)||21||
48671054|NCT00666263|101978296|FG000|COMPLETED|Study Part 3 (Stabilization Phase 2)||22||
48671055|NCT00666263|101978297|FG001|COMPLETED|Study Part 3 (Stabilization Phase 2)||21||
48671056|NCT00666263|101978296|FG000|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0||
48671057|NCT00666263|101978297|FG001|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0||
48671058|NCT00666263|101978296|FG000|STARTED|Study Part 4 (Cross-over Period 2)||22||
48671059|NCT00666263|101978297|FG001|STARTED|Study Part 4 (Cross-over Period 2)||21||
48671060|NCT00666263|101978296|FG000|COMPLETED|Study Part 4 (Cross-over Period 2)||21||
48671061|NCT00666263|101978297|FG001|COMPLETED|Study Part 4 (Cross-over Period 2)||21||
48671062|NCT00666263|101978296|FG000|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||1||
48671063|NCT00666263|101978297|FG001|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||0||
48671064|NCT00666263|101978296|FG000|STARTED|Study Part 5 (Stabilization Phase 3)||21||
48671065|NCT00666263|101978297|FG001|STARTED|Study Part 5 (Stabilization Phase 3)||21||
48671066|NCT00666263|101978296|FG000|COMPLETED|Study Part 5 (Stabilization Phase 3)||21||
48671067|NCT00666263|101978297|FG001|COMPLETED|Study Part 5 (Stabilization Phase 3)||20||
48671068|NCT00666263|101978296|FG000|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||0||
48671069|NCT00666263|101978297|FG001|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||1||
48671070|NCT00666263|101978296|FG000|STARTED|End of Study Visit||22||
48671071|NCT00666263|101978297|FG001|STARTED|End of Study Visit||22||
48671072|NCT00666263|101978296|FG000|COMPLETED|End of Study Visit||22||
48671073|NCT00666263|101978297|FG001|COMPLETED|End of Study Visit||22||
48671074|NCT00666263|101978296|FG000|NOT COMPLETED|End of Study Visit||0||
48671075|NCT00666263|101978297|FG001|NOT COMPLETED|End of Study Visit||0||
48671076|NCT00954447|101978298|FG000|STARTED|Overall Study||630||
48671077|NCT00954447|101978299|FG001|STARTED|Overall Study||631||
48671078|NCT00954447|101978298|FG000|COMPLETED|Overall Study||520||
48671079|NCT00954447|101978299|FG001|COMPLETED|Overall Study||543||
48671080|NCT00954447|101978298|FG000|NOT COMPLETED|Overall Study||110||
48671081|NCT00954447|101978299|FG001|NOT COMPLETED|Overall Study||88||
48671082|NCT01259011|101978300|FG000|STARTED|Main Study Period||101||
48671083|NCT01259011|101978301|FG001|STARTED|Main Study Period||109||
48671084|NCT01259011|101978300|FG000|COMPLETED|Main Study Period||101||
48671085|NCT01259011|101978301|FG001|COMPLETED|Main Study Period||109||
48671086|NCT01259011|101978300|FG000|NOT COMPLETED|Main Study Period||0||
48671087|NCT01259011|101978301|FG001|NOT COMPLETED|Main Study Period||0||
48671088|NCT01259011|101978300|FG000|STARTED|After Patient Death||17||
48671089|NCT01259011|101978301|FG001|STARTED|After Patient Death||28||
48671090|NCT01259011|101978300|FG000|COMPLETED|After Patient Death||17||
48671091|NCT01259011|101978301|FG001|COMPLETED|After Patient Death||28||
48671092|NCT01259011|101978300|FG000|NOT COMPLETED|After Patient Death||0||
48671093|NCT01259011|101978301|FG001|NOT COMPLETED|After Patient Death||0||
48671094|NCT01696643|101978302|FG000|STARTED|Overall Study||703||
48671095|NCT01696643|101978303|FG001|STARTED|Overall Study||704||
48671096|NCT01696643|101978302|FG000|Received at Least 1 Dose of Study Drug|Overall Study||701||
48671097|NCT01696643|101978303|FG001|Received at Least 1 Dose of Study Drug|Overall Study||702||
48671098|NCT01696643|101978302|FG000|COMPLETED|Overall Study||174||
48671099|NCT01696643|101978303|FG001|COMPLETED|Overall Study||169||
48671100|NCT01696643|101978302|FG000|NOT COMPLETED|Overall Study||529||
48671101|NCT01696643|101978303|FG001|NOT COMPLETED|Overall Study||535||
48071875|NCT02903355|100498087|FG000|STARTED|Overall Study||186||
48671102|NCT00518180|101978304|FG000|STARTED|Overall Study||540||
48671103|NCT00518180|101978305|FG001|STARTED|Overall Study||541||
48671104|NCT00518180|101978306|FG002|STARTED|Overall Study||539||
48671105|NCT00518180|101978304|FG000|COMPLETED|Overall Study||475||
48671106|NCT00518180|101978305|FG001|COMPLETED|Overall Study||472||
48671107|NCT00518180|101978306|FG002|COMPLETED|Overall Study||457||
48671108|NCT00518180|101978304|FG000|NOT COMPLETED|Overall Study||65||
48671109|NCT00518180|101978305|FG001|NOT COMPLETED|Overall Study||69||
48671110|NCT00518180|101978306|FG002|NOT COMPLETED|Overall Study||82||
48671111|NCT00690339|101978307|FG000|STARTED|Overall Study||492||
48671112|NCT00690339|101978308|FG001|STARTED|Overall Study||225||
48671113|NCT00690339|101978309|FG002|STARTED|Overall Study||156||
48671114|NCT00690339|101978310|FG003|STARTED|Overall Study||68||
48671115|NCT00690339|101978307|FG000|COMPLETED|Overall Study||375||
48671116|NCT00690339|101978308|FG001|COMPLETED|Overall Study||144||
48671117|NCT00690339|101978309|FG002|COMPLETED|Overall Study||99||
48671118|NCT00690339|101978310|FG003|COMPLETED|Overall Study||43||
48671119|NCT00690339|101978307|FG000|NOT COMPLETED|Overall Study||117||
48671120|NCT00690339|101978308|FG001|NOT COMPLETED|Overall Study||81||
48671121|NCT00690339|101978309|FG002|NOT COMPLETED|Overall Study||57||
48671122|NCT00690339|101978310|FG003|NOT COMPLETED|Overall Study||25||
48671123|NCT00833690|101978311|FG000|STARTED|Overall Study||25||
48671124|NCT00833690|101978312|FG001|STARTED|Overall Study||24||
48671125|NCT00833690|101978313|FG002|STARTED|Overall Study||26||
48671126|NCT00833690|101978311|FG000|COMPLETED|Overall Study||21||
48671127|NCT00833690|101978312|FG001|COMPLETED|Overall Study||22||
48671128|NCT00833690|101978313|FG002|COMPLETED|Overall Study||26||
48671129|NCT00833690|101978311|FG000|NOT COMPLETED|Overall Study||4||
48671130|NCT00833690|101978312|FG001|NOT COMPLETED|Overall Study||2||
48671131|NCT00833690|101978313|FG002|NOT COMPLETED|Overall Study||0||
48671132|NCT01939145|101978314|FG000|STARTED|Overall Study||49||
48671133|NCT01939145|101978315|FG001|STARTED|Overall Study||51||
48671134|NCT01939145|101978314|FG000|COMPLETED|Overall Study||47||
48671135|NCT01939145|101978315|FG001|COMPLETED|Overall Study||44||
48671136|NCT01939145|101978314|FG000|NOT COMPLETED|Overall Study||2||
48671137|NCT01939145|101978315|FG001|NOT COMPLETED|Overall Study||7||
48671138|NCT01342666|101978316|FG000|STARTED|Overall Study||26||
48671139|NCT01342666|101978317|FG001|STARTED|Overall Study||24||
48671140|NCT01342666|101978316|FG000|COMPLETED|Overall Study||26||
48671141|NCT01342666|101978317|FG001|COMPLETED|Overall Study||24||
48671142|NCT01342666|101978316|FG000|NOT COMPLETED|Overall Study||0||
48671143|NCT01342666|101978317|FG001|NOT COMPLETED|Overall Study||0||
48671144|NCT02735200|101978318|FG000|STARTED|Overall Study||200||
48671145|NCT02735200|101978319|FG001|STARTED|Overall Study||350||
48671146|NCT02735200|101978318|FG000|COMPLETED|Overall Study||192||
48671147|NCT02735200|101978319|FG001|COMPLETED|Overall Study||345||
48671148|NCT02735200|101978318|FG000|NOT COMPLETED|Overall Study||8||
48671149|NCT02735200|101978319|FG001|NOT COMPLETED|Overall Study||5||
48671150|NCT00557440|101978320|FG000|STARTED|Treatment Period 1||12||
48671151|NCT00557440|101978321|FG001|STARTED|Treatment Period 1||12||
48671152|NCT00557440|101978322|FG002|STARTED|Treatment Period 1||13||
48071876|NCT02903355|100498088|FG001|STARTED|Overall Study||165||
48071877|NCT02903355|100498087|FG000|COMPLETED|Overall Study||142||
48071878|NCT02903355|100498088|FG001|COMPLETED|Overall Study||124||
48071879|NCT02903355|100498087|FG000|NOT COMPLETED|Overall Study||44||
48071880|NCT02903355|100498088|FG001|NOT COMPLETED|Overall Study||41||
48071881|NCT00072566|100498089|FG000|STARTED|Overall Study||70||
48071882|NCT00072566|100498089|FG000|COMPLETED|Overall Study||70||
48071883|NCT00072566|100498089|FG000|NOT COMPLETED|Overall Study||0||
48071884|NCT03817879|100498090|FG000|STARTED|Overall Study||35||
48071885|NCT03817879|100498091|FG001|STARTED|Overall Study||35||
48071886|NCT03817879|100498090|FG000|COMPLETED|Overall Study||30||
48071887|NCT03817879|100498091|FG001|COMPLETED|Overall Study||22||
48071888|NCT03817879|100498090|FG000|NOT COMPLETED|Overall Study||5||
48071889|NCT03817879|100498091|FG001|NOT COMPLETED|Overall Study||13||
48071890|NCT01197560|100498092|FG000|STARTED|Overall Study||54||
48071891|NCT01197560|100498093|FG001|STARTED|Overall Study||57||
48071892|NCT01197560|100498092|FG000|Received ≥ One Dose Study Drug|Overall Study||54||
48071893|NCT01197560|100498093|FG001|Received ≥ One Dose Study Drug|Overall Study||55||
48071894|NCT01197560|100498092|FG000|Lenalidomide Crossover|Overall Study||0||
48071895|NCT01197560|100498093|FG001|Lenalidomide Crossover|Overall Study||29||
48071896|NCT01197560|100498092|FG000|Discontinued Treatment After ≥ 6 Cycles|Overall Study||14||
48071897|NCT01197560|100498093|FG001|Discontinued Treatment After ≥ 6 Cycles|Overall Study||0||
48071898|NCT01197560|100498092|FG000|COMPLETED|Overall Study||0|Completed indicates the participates who completed core treatment.|
48071899|NCT01197560|100498093|FG001|COMPLETED|Overall Study||4|Completed indicates the participates who completed core treatment.|
48071900|NCT01197560|100498092|FG000|NOT COMPLETED|Overall Study||54||
48071901|NCT01197560|100498093|FG001|NOT COMPLETED|Overall Study||53||
48071902|NCT01189604|100498094|FG000|STARTED|Overall Study||21||
48071903|NCT01189604|100498095|FG001|STARTED|Overall Study||21||
48071904|NCT01189604|100498096|FG002|STARTED|Overall Study||20||
48671153|NCT00557440|101978320|FG000|COMPLETED|Treatment Period 1||12||
48671154|NCT00557440|101978321|FG001|COMPLETED|Treatment Period 1||12||
48671155|NCT00557440|101978322|FG002|COMPLETED|Treatment Period 1||12||
48671156|NCT00557440|101978320|FG000|NOT COMPLETED|Treatment Period 1||0||
48671157|NCT00557440|101978321|FG001|NOT COMPLETED|Treatment Period 1||0||
48671158|NCT00557440|101978322|FG002|NOT COMPLETED|Treatment Period 1||1||
48671159|NCT00557440|101978320|FG000|STARTED|Treatment Period 2||12||
48671160|NCT00557440|101978321|FG001|STARTED|Treatment Period 2||12||
48671161|NCT00557440|101978322|FG002|STARTED|Treatment Period 2||12||
48671162|NCT00557440|101978320|FG000|COMPLETED|Treatment Period 2||12||
48671163|NCT00557440|101978321|FG001|COMPLETED|Treatment Period 2||12||
48671164|NCT00557440|101978322|FG002|COMPLETED|Treatment Period 2||12||
48071905|NCT01189604|100498097|FG003|STARTED|Overall Study||20||
48071906|NCT01189604|100498098|FG004|STARTED|Overall Study||20||
48671165|NCT00557440|101978320|FG000|NOT COMPLETED|Treatment Period 2||0||
48671166|NCT00557440|101978321|FG001|NOT COMPLETED|Treatment Period 2||0||
48671167|NCT00557440|101978322|FG002|NOT COMPLETED|Treatment Period 2||0||
48671168|NCT00557440|101978320|FG000|STARTED|Treatment Period 3||12||
48671169|NCT00557440|101978321|FG001|STARTED|Treatment Period 3||12||
48671170|NCT00557440|101978322|FG002|STARTED|Treatment Period 3||12||
48671171|NCT00557440|101978320|FG000|COMPLETED|Treatment Period 3||12||
48671172|NCT00557440|101978321|FG001|COMPLETED|Treatment Period 3||12||
48671173|NCT00557440|101978322|FG002|COMPLETED|Treatment Period 3||12||
48671174|NCT00557440|101978320|FG000|NOT COMPLETED|Treatment Period 3||0||
48671175|NCT00557440|101978321|FG001|NOT COMPLETED|Treatment Period 3||0||
48671176|NCT00557440|101978322|FG002|NOT COMPLETED|Treatment Period 3||0||
48671177|NCT01602484|101978323|FG000|STARTED|Overall Study||25||
48671178|NCT01602484|101978324|FG001|STARTED|Overall Study||25||
48671179|NCT01602484|101978323|FG000|COMPLETED|Overall Study||25||
48671180|NCT01602484|101978324|FG001|COMPLETED|Overall Study||24||
48671181|NCT01602484|101978323|FG000|NOT COMPLETED|Overall Study||0||
48671182|NCT01602484|101978324|FG001|NOT COMPLETED|Overall Study||1||
48671183|NCT00688740|101978325|FG000|STARTED|Overall Study||745||
48671184|NCT00688740|101978326|FG001|STARTED|Overall Study||746||
48671185|NCT00688740|101978325|FG000|COMPLETED|Overall Study||679||
48671186|NCT00688740|101978326|FG001|COMPLETED|Overall Study||711||
48671187|NCT00688740|101978325|FG000|NOT COMPLETED|Overall Study||66||
48671188|NCT00688740|101978326|FG001|NOT COMPLETED|Overall Study||35||
48671189|NCT03094052|101978327|FG000|STARTED|Overall Study||11||
48671190|NCT03094052|101978327|FG000|COMPLETED|Overall Study||11||
48671191|NCT03094052|101978327|FG000|NOT COMPLETED|Overall Study||0||
48671192|NCT03682965|101978328|FG000|STARTED|Overall Study||11||
48671193|NCT03682965|101978329|FG001|STARTED|Overall Study||10||
48671194|NCT03682965|101978328|FG000|COMPLETED|Overall Study||11||
48671195|NCT03682965|101978329|FG001|COMPLETED|Overall Study||10||
48671196|NCT03682965|101978328|FG000|NOT COMPLETED|Overall Study||0||
48671197|NCT03682965|101978329|FG001|NOT COMPLETED|Overall Study||0||
48521556|NCT00680186|101608168|FG000|NOT COMPLETED|Overall Study||125||
48521557|NCT00680186|101608169|FG001|NOT COMPLETED|Overall Study||116||
48521558|NCT04209335|101608170|FG000|STARTED|Overall Study||48||
48521559|NCT04209335|101608170|FG000|COMPLETED|Overall Study||48||
48521560|NCT04209335|101608170|FG000|NOT COMPLETED|Overall Study||0||
48521561|NCT01056640|101608171|FG000|STARTED|Overall Study||102||
48521562|NCT01056640|101608172|FG001|STARTED|Overall Study||103||
48521563|NCT01056640|101608171|FG000|COMPLETED|Overall Study||76||
48521564|NCT01056640|101608172|FG001|COMPLETED|Overall Study||91||
48521565|NCT01056640|101608171|FG000|NOT COMPLETED|Overall Study||26||
48521566|NCT01056640|101608172|FG001|NOT COMPLETED|Overall Study||12||
48521567|NCT01334710|101608173|FG000|STARTED|Overall Study||3||
48521568|NCT01334710|101608173|FG000|COMPLETED|Overall Study||0||
48521569|NCT01334710|101608173|FG000|NOT COMPLETED|Overall Study||3||
48521570|NCT03165955|101608174|FG000|STARTED|Screening/Baseline||31||
48521571|NCT03165955|101608174|FG000|COMPLETED|Screening/Baseline||28||
48521572|NCT03165955|101608174|FG000|NOT COMPLETED|Screening/Baseline||3||
48521573|NCT03165955|101608174|FG000|STARTED|Treatment||28||
48521574|NCT03165955|101608174|FG000|COMPLETED|Treatment||20||
48521575|NCT03165955|101608174|FG000|NOT COMPLETED|Treatment||8||
48521576|NCT02164734|101611632|FG000|STARTED|Overall Study||42||
48521577|NCT02164734|101611633|FG001|STARTED|Overall Study||51||
48521578|NCT02164734|101611632|FG000|COMPLETED|Overall Study||42|Intention-to-treat analysis|
48521579|NCT02164734|101611633|FG001|COMPLETED|Overall Study||51|Intention-to-treat analysis|
48521580|NCT02164734|101611632|FG000|NOT COMPLETED|Overall Study||0||
48521581|NCT02164734|101611633|FG001|NOT COMPLETED|Overall Study||0||
48521582|NCT01064531|101611634|FG000|STARTED|Overall Study||21||21
48521583|NCT01064531|101611635|FG001|STARTED|Overall Study||20||20
48521584|NCT01064531|101611634|FG000|COMPLETED|Overall Study||18||18
48521585|NCT01064531|101611635|FG001|COMPLETED|Overall Study||13||13
48521586|NCT01064531|101611634|FG000|NOT COMPLETED|Overall Study||3||3
48521587|NCT01064531|101611635|FG001|NOT COMPLETED|Overall Study||7||7
48521588|NCT02046525|101611636|FG000|STARTED|Overall Study||5||
48521589|NCT02046525|101611637|FG001|STARTED|Overall Study||5||
48521590|NCT02046525|101611636|FG000|COMPLETED|Overall Study||5||
48521591|NCT02046525|101611637|FG001|COMPLETED|Overall Study||5||
48521592|NCT02046525|101611636|FG000|NOT COMPLETED|Overall Study||0||
48521593|NCT02046525|101611637|FG001|NOT COMPLETED|Overall Study||0||
48521594|NCT00493246|101611638|FG000|STARTED|Overall Study||2||
48521595|NCT00493246|101611639|FG001|STARTED|Overall Study||1||
48521596|NCT00493246|101611640|FG002|STARTED|Overall Study||12||
48521597|NCT00493246|101611641|FG003|STARTED|Overall Study||13||
48521598|NCT00493246|101611642|FG004|STARTED|Overall Study||9||
48521599|NCT00493246|101611643|FG005|STARTED|Overall Study||16||
48521600|NCT00493246|101611644|FG006|STARTED|Overall Study||12||
48521601|NCT00493246|101611645|FG007|STARTED|Overall Study||10||
48521602|NCT00493246|101611638|FG000|COMPLETED|Overall Study||2||
48521603|NCT00493246|101611639|FG001|COMPLETED|Overall Study||1||
48521604|NCT00493246|101611640|FG002|COMPLETED|Overall Study||12||
48521605|NCT00493246|101611641|FG003|COMPLETED|Overall Study||13||
48671198|NCT03058952|101978330|FG000|STARTED|Overall Study||123||
48671199|NCT03058952|101978331|FG001|STARTED|Overall Study||122||
48521606|NCT00493246|101611642|FG004|COMPLETED|Overall Study||8||
48521607|NCT00493246|101611643|FG005|COMPLETED|Overall Study||15||
48521608|NCT00493246|101611644|FG006|COMPLETED|Overall Study||11||
48521609|NCT00493246|101611645|FG007|COMPLETED|Overall Study||10||
48521610|NCT00493246|101611638|FG000|NOT COMPLETED|Overall Study||0||
48521611|NCT00493246|101611639|FG001|NOT COMPLETED|Overall Study||0||
48521612|NCT00493246|101611640|FG002|NOT COMPLETED|Overall Study||0||
48521613|NCT00493246|101611641|FG003|NOT COMPLETED|Overall Study||0||
48521614|NCT00493246|101611642|FG004|NOT COMPLETED|Overall Study||1||
48521615|NCT00493246|101611643|FG005|NOT COMPLETED|Overall Study||1||
48521616|NCT00493246|101611644|FG006|NOT COMPLETED|Overall Study||1||
48521617|NCT00493246|101611645|FG007|NOT COMPLETED|Overall Study||0||
48521618|NCT01045031|101611646|FG000|STARTED|Overall Study||58||
48521619|NCT01045031|101611647|FG001|STARTED|Overall Study||56||
48521620|NCT01045031|101611646|FG000|COMPLETED|Overall Study||49||
48521621|NCT01045031|101611647|FG001|COMPLETED|Overall Study||50||
48521622|NCT01045031|101611646|FG000|NOT COMPLETED|Overall Study||9||
48521623|NCT01045031|101611647|FG001|NOT COMPLETED|Overall Study||6||
48521624|NCT00571194|101611648|FG000|STARTED|Overall Study||7||
48521625|NCT00571194|101611648|FG000|COMPLETED|Overall Study||7||
48521626|NCT00571194|101611648|FG000|NOT COMPLETED|Overall Study||0||
48521627|NCT00986570|101611649|FG000|STARTED|Overall Study||121||
48521628|NCT00986570|101611649|FG000|COMPLETED|Overall Study||114||
48521629|NCT00986570|101611649|FG000|NOT COMPLETED|Overall Study||7||
48521630|NCT05020249|101611650|FG000|STARTED|Overall Study||15||
48521631|NCT05020249|101611651|FG001|STARTED|Overall Study||32||
48521632|NCT05020249|101611650|FG000|COMPLETED|Overall Study||14||
48521633|NCT05020249|101611651|FG001|COMPLETED|Overall Study||32||
48222231|NCT02397096|100866704|FG000|NOT COMPLETED|Study Extension 2||174||
48222232|NCT02397096|100866705|FG001|NOT COMPLETED|Study Extension 2||76||
48222233|NCT02397096|100866704|FG000|STARTED|Study Extension 3||84||
48222234|NCT02397096|100866705|FG001|STARTED|Study Extension 3||43||
48222235|NCT02397096|100866704|FG000|COMPLETED|Study Extension 3||69||
48222236|NCT02397096|100866705|FG001|COMPLETED|Study Extension 3||39||
48222237|NCT02397096|100866704|FG000|NOT COMPLETED|Study Extension 3||15||
48222238|NCT02397096|100866705|FG001|NOT COMPLETED|Study Extension 3||4||
48222239|NCT01836445|100866706|FG000|STARTED|Intervention Modules||445||
48222240|NCT01836445|100866707|FG001|STARTED|Intervention Modules||456||
48222241|NCT01836445|100866706|FG000|COMPLETED|Intervention Modules||375||
48222242|NCT01836445|100866707|FG001|COMPLETED|Intervention Modules||434||
48222243|NCT01836445|100866706|FG000|NOT COMPLETED|Intervention Modules||70||
48222244|NCT01836445|100866707|FG001|NOT COMPLETED|Intervention Modules||22||
48222245|NCT01836445|100866706|FG000|STARTED|3 Month Follow-up Assessment||445||
48222246|NCT01836445|100866707|FG001|STARTED|3 Month Follow-up Assessment||456||
48222247|NCT01836445|100866706|FG000|COMPLETED|3 Month Follow-up Assessment||348||
48222248|NCT01836445|100866707|FG001|COMPLETED|3 Month Follow-up Assessment||409||
48222249|NCT01836445|100866706|FG000|NOT COMPLETED|3 Month Follow-up Assessment||97||
48222250|NCT01836445|100866707|FG001|NOT COMPLETED|3 Month Follow-up Assessment||47||
48222251|NCT01836445|100866706|FG000|STARTED|6 Month Follow-up Assessment||445||
48222252|NCT01836445|100866707|FG001|STARTED|6 Month Follow-up Assessment||455||
48222253|NCT01836445|100866706|FG000|COMPLETED|6 Month Follow-up Assessment||342||
48222254|NCT01836445|100866707|FG001|COMPLETED|6 Month Follow-up Assessment||380||
48222255|NCT01836445|100866706|FG000|NOT COMPLETED|6 Month Follow-up Assessment||103||
48222256|NCT01836445|100866707|FG001|NOT COMPLETED|6 Month Follow-up Assessment||75||
48222257|NCT01836445|100866706|FG000|STARTED|12 Month Follow-up Assessment||445||
48521634|NCT05020249|101611650|FG000|NOT COMPLETED|Overall Study||1||
48521635|NCT05020249|101611651|FG001|NOT COMPLETED|Overall Study||0||
48521636|NCT00845975|101611652|FG000|STARTED|Overall Study||9||
48521637|NCT00845975|101611653|FG001|STARTED|Overall Study||9||
48521638|NCT00845975|101611652|FG000|COMPLETED|Overall Study||9||
48521639|NCT00845975|101611653|FG001|COMPLETED|Overall Study||9||
48521640|NCT00845975|101611652|FG000|NOT COMPLETED|Overall Study||0||
48521641|NCT00845975|101611653|FG001|NOT COMPLETED|Overall Study||0||
48521642|NCT03201211|101611654|FG000|STARTED|Overall Study||27||
48521643|NCT03201211|101611655|FG001|STARTED|Overall Study||26||
48521644|NCT03201211|101611656|FG002|STARTED|Overall Study||28||
48521645|NCT03201211|101611654|FG000|COMPLETED|Overall Study||25||
48521646|NCT03201211|101611655|FG001|COMPLETED|Overall Study||25||
48521647|NCT03201211|101611656|FG002|COMPLETED|Overall Study||27||
48521648|NCT03201211|101611654|FG000|NOT COMPLETED|Overall Study||2||
48521649|NCT03201211|101611655|FG001|NOT COMPLETED|Overall Study||1||
48521650|NCT03201211|101611656|FG002|NOT COMPLETED|Overall Study||1||
48521651|NCT04317599|101611657|FG000|STARTED|Overall Study||274||
48521652|NCT04317599|101611657|FG000|COMPLETED|Overall Study||255||
48521653|NCT04317599|101611657|FG000|NOT COMPLETED|Overall Study||19||
48521654|NCT02277704|101611658|FG000|STARTED|Overall Study||94||
48521655|NCT02277704|101611659|FG001|STARTED|Overall Study||101||
48521656|NCT02277704|101611660|FG002|STARTED|Overall Study||50||
48521657|NCT02277704|101611658|FG000|COMPLETED|Overall Study||67||
48521658|NCT02277704|101611659|FG001|COMPLETED|Overall Study||71||
48521659|NCT02277704|101611660|FG002|COMPLETED|Overall Study||41||
48521660|NCT02277704|101611658|FG000|NOT COMPLETED|Overall Study||27||
48521661|NCT02277704|101611659|FG001|NOT COMPLETED|Overall Study||30||
48521662|NCT02277704|101611660|FG002|NOT COMPLETED|Overall Study||9||
48521663|NCT00770692|101611661|FG000|STARTED|Overall Study||81||
48521664|NCT00770692|101611662|FG001|STARTED|Overall Study||83||
48521665|NCT00770692|101611663|FG002|STARTED|Overall Study||84||
48521666|NCT00770692|101611664|FG003|STARTED|Overall Study||77||
48521667|NCT00770692|101611661|FG000|COMPLETED|Overall Study||69||
48521668|NCT00770692|101611662|FG001|COMPLETED|Overall Study||74||
48521669|NCT00770692|101611663|FG002|COMPLETED|Overall Study||70||
48521670|NCT00770692|101611664|FG003|COMPLETED|Overall Study||66||
48521671|NCT00770692|101611661|FG000|NOT COMPLETED|Overall Study||12||
48521672|NCT00770692|101611662|FG001|NOT COMPLETED|Overall Study||9||
48521673|NCT00770692|101611663|FG002|NOT COMPLETED|Overall Study||14||
48521674|NCT00770692|101611664|FG003|NOT COMPLETED|Overall Study||11||
48521675|NCT01715896|101611665|FG000|STARTED|Overall Study||68||
48521676|NCT01715896|101611666|FG001|STARTED|Overall Study||70||
48521677|NCT01715896|101611665|FG000|COMPLETED|Overall Study||65||
48521678|NCT01715896|101611666|FG001|COMPLETED|Overall Study||59||
48521679|NCT01715896|101611665|FG000|NOT COMPLETED|Overall Study||3||
48521680|NCT01715896|101611666|FG001|NOT COMPLETED|Overall Study||11||
48521681|NCT01300923|101611667|FG000|STARTED|Overall Study||12||
48521682|NCT01300923|101611668|FG001|STARTED|Overall Study||2||
48521683|NCT01300923|101611667|FG000|COMPLETED|Overall Study||12||
48521684|NCT01300923|101611668|FG001|COMPLETED|Overall Study||0||
48521685|NCT01300923|101611667|FG000|NOT COMPLETED|Overall Study||0||
48521686|NCT01300923|101611668|FG001|NOT COMPLETED|Overall Study||2||
48521687|NCT01004042|101611669|FG000|STARTED|Overall Study||25||
48521688|NCT01004042|101611670|FG001|STARTED|Overall Study||25||
48521689|NCT01004042|101611669|FG000|COMPLETED|Overall Study||21||
48521690|NCT01004042|101611670|FG001|COMPLETED|Overall Study||25||
48521691|NCT01004042|101611669|FG000|NOT COMPLETED|Overall Study||4||
48521692|NCT01004042|101611670|FG001|NOT COMPLETED|Overall Study||0||
48521693|NCT03604341|101611671|FG000|STARTED|Overall Study||35||
48521694|NCT03604341|101611672|FG001|STARTED|Overall Study||35||
48521695|NCT03604341|101611671|FG000|COMPLETED|Overall Study||33||
48521696|NCT03604341|101611672|FG001|COMPLETED|Overall Study||33||
48521697|NCT03604341|101611671|FG000|NOT COMPLETED|Overall Study||2||
48521698|NCT03604341|101611672|FG001|NOT COMPLETED|Overall Study||2||
48521699|NCT03676751|101611673|FG000|STARTED|Overall Study||230||
48521700|NCT03676751|101611674|FG001|STARTED|Overall Study||220||
48521701|NCT03676751|101611673|FG000|Received Allocated Treatment|Overall Study||227||
48521702|NCT03676751|101611674|FG001|Received Allocated Treatment|Overall Study||214||
48521703|NCT03676751|101611673|FG000|Week 14 Follow up|Overall Study||218||
48521704|NCT03676751|101611674|FG001|Week 14 Follow up|Overall Study||203||
48521705|NCT03676751|101611673|FG000|COMPLETED|Overall Study||200|Month 6|
48521706|NCT03676751|101611674|FG001|COMPLETED|Overall Study||189|Month 6|
48521707|NCT03676751|101611673|FG000|NOT COMPLETED|Overall Study||30||
48521708|NCT03676751|101611674|FG001|NOT COMPLETED|Overall Study||31||
48521709|NCT00635830|101611675|FG000|STARTED|Overall Study||20||
48521710|NCT00635830|101611676|FG001|STARTED|Overall Study||20||
48521711|NCT00635830|101611675|FG000|COMPLETED|Overall Study||20||
48521712|NCT00635830|101611676|FG001|COMPLETED|Overall Study||20||
48521713|NCT00635830|101611675|FG000|NOT COMPLETED|Overall Study||0||
48521714|NCT00635830|101611676|FG001|NOT COMPLETED|Overall Study||0||
48521715|NCT03921151|101611677|FG000|STARTED|Overall Study||46||
48521716|NCT03921151|101611678|FG001|STARTED|Overall Study||44||
48521717|NCT03921151|101611677|FG000|COMPLETED|Overall Study||35||
48521718|NCT03921151|101611678|FG001|COMPLETED|Overall Study||28||
48521719|NCT03921151|101611677|FG000|NOT COMPLETED|Overall Study||11||
48521720|NCT03921151|101611678|FG001|NOT COMPLETED|Overall Study||16||
48521721|NCT02691741|101611679|FG000|STARTED|Overall Study||94|Randomized subjects|
48521722|NCT02691741|101611680|FG001|STARTED|Overall Study||94|Randomized subjects|
48521723|NCT02691741|101611679|FG000|All-Implanted Analysis Set|Overall Study||93|All subjects with successful test or control article bilateral implantation|
48521724|NCT02691741|101611680|FG001|All-Implanted Analysis Set|Overall Study||89|All subjects with successful test or control article bilateral implantation|
48521725|NCT02691741|101611679|FG000|Best-Case Analysis Set|Overall Study||86|All subjects successfully implanted, at least 1 post-op visit, no mac. degen., no major deviations|
48521726|NCT02691741|101611680|FG001|Best-Case Analysis Set|Overall Study||85|All subjects successfully implanted, at least 1 post-op visit, no mac. degen., no major deviations|
48521727|NCT02691741|101611679|FG000|Safety Analysis Set|Overall Study||93|All subjects with attempted implantation (successful or aborted after contact with the eye)|
48521728|NCT02691741|101611680|FG001|Safety Analysis Set|Overall Study||89|All subjects with attempted implantation (successful or aborted after contact with the eye)|
48521729|NCT02691741|101611679|FG000|COMPLETED|Overall Study||93||
48521730|NCT02691741|101611680|FG001|COMPLETED|Overall Study||87||
48521731|NCT02691741|101611679|FG000|NOT COMPLETED|Overall Study||1||
48521732|NCT02691741|101611680|FG001|NOT COMPLETED|Overall Study||7||
48521733|NCT03657108|101611681|FG000|STARTED|First Dose 60 Gy (90 Days Post EBRT)||1||
48521734|NCT03657108|101611682|FG001|STARTED|First Dose 60 Gy (90 Days Post EBRT)||0||
48521735|NCT03657108|101611681|FG000|COMPLETED|First Dose 60 Gy (90 Days Post EBRT)||1||
48521736|NCT03657108|101611682|FG001|COMPLETED|First Dose 60 Gy (90 Days Post EBRT)||0||
48521737|NCT03657108|101611681|FG000|NOT COMPLETED|First Dose 60 Gy (90 Days Post EBRT)||0||
48521738|NCT03657108|101611682|FG001|NOT COMPLETED|First Dose 60 Gy (90 Days Post EBRT)||0||
48521739|NCT03657108|101611681|FG000|STARTED|Next 2 Dose 60 Gy||2||
48521740|NCT03657108|101611682|FG001|STARTED|Next 2 Dose 60 Gy||0||
48521741|NCT03657108|101611681|FG000|COMPLETED|Next 2 Dose 60 Gy||2||
48521742|NCT03657108|101611682|FG001|COMPLETED|Next 2 Dose 60 Gy||0||
48521743|NCT03657108|101611681|FG000|NOT COMPLETED|Next 2 Dose 60 Gy||0||
48521744|NCT03657108|101611682|FG001|NOT COMPLETED|Next 2 Dose 60 Gy||0||
48521745|NCT03657108|101611681|FG000|STARTED|First Dose 75 Gy (90 Days Post EBRT)||0||
48521746|NCT03657108|101611682|FG001|STARTED|First Dose 75 Gy (90 Days Post EBRT)||1||
48521747|NCT03657108|101611681|FG000|COMPLETED|First Dose 75 Gy (90 Days Post EBRT)||0||
48521748|NCT03657108|101611682|FG001|COMPLETED|First Dose 75 Gy (90 Days Post EBRT)||0||
48521749|NCT03657108|101611681|FG000|NOT COMPLETED|First Dose 75 Gy (90 Days Post EBRT)||0||
48521750|NCT03657108|101611682|FG001|NOT COMPLETED|First Dose 75 Gy (90 Days Post EBRT)||1||
48521751|NCT03657108|101611681|FG000|STARTED|Next 2 Dose 75 Gy||0||
48521752|NCT03657108|101611682|FG001|STARTED|Next 2 Dose 75 Gy||2||
48521753|NCT03657108|101611681|FG000|COMPLETED|Next 2 Dose 75 Gy||0||
48521754|NCT03657108|101611682|FG001|COMPLETED|Next 2 Dose 75 Gy||2||
48521755|NCT03657108|101611681|FG000|NOT COMPLETED|Next 2 Dose 75 Gy||0||
48521756|NCT03657108|101611682|FG001|NOT COMPLETED|Next 2 Dose 75 Gy||0||
48521757|NCT02709486|101611683|FG000|STARTED|Overall Study||282||
48521758|NCT02709486|101611684|FG001|STARTED|Overall Study||283||
48521759|NCT02709486|101611685|FG002|STARTED|Overall Study||284||
48521760|NCT02709486|101611683|FG000|COMPLETED|Overall Study||238||
48521761|NCT02709486|101611684|FG001|COMPLETED|Overall Study||249||
48521762|NCT02709486|101611685|FG002|COMPLETED|Overall Study||239||
48521763|NCT02709486|101611683|FG000|NOT COMPLETED|Overall Study||44||
48521764|NCT02709486|101611684|FG001|NOT COMPLETED|Overall Study||34||
48521765|NCT02709486|101611685|FG002|NOT COMPLETED|Overall Study||45||
48521766|NCT00507546|101611686|FG000|STARTED|Overall Study||4||
48521767|NCT00507546|101611687|FG001|STARTED|Overall Study||4||
48521768|NCT00507546|101611686|FG000|COMPLETED|Overall Study||2||
48521769|NCT00507546|101611687|FG001|COMPLETED|Overall Study||3||
48521770|NCT00507546|101611686|FG000|NOT COMPLETED|Overall Study||2||
48521771|NCT00507546|101611687|FG001|NOT COMPLETED|Overall Study||1||
48521772|NCT01510652|101611688|FG000|STARTED|Overall Study||719||
48521773|NCT01510652|101611689|FG001|STARTED|Overall Study||355||
48521774|NCT01510652|101611688|FG000|Baseline|Overall Study||718||
48521775|NCT01510652|101611689|FG001|Baseline|Overall Study||348||
48521776|NCT01510652|101611688|FG000|COMPLETED|Overall Study||627||
48521777|NCT01510652|101611689|FG001|COMPLETED|Overall Study||288||
48521778|NCT01510652|101611688|FG000|NOT COMPLETED|Overall Study||92||
48521779|NCT01510652|101611689|FG001|NOT COMPLETED|Overall Study||67||
48521780|NCT05506358|101611690|FG000|STARTED|Overall Study||33||
48521781|NCT05506358|101611691|FG001|STARTED|Overall Study||45||
48521782|NCT05506358|101611692|FG002|STARTED|Overall Study||11||
48521783|NCT05506358|101611693|FG003|STARTED|Overall Study||26||
48521784|NCT05506358|101611694|FG004|STARTED|Overall Study||30||
48521785|NCT05506358|101611690|FG000|COMPLETED|Overall Study||29||
48521786|NCT05506358|101611691|FG001|COMPLETED|Overall Study||45||
48521787|NCT05506358|101611692|FG002|COMPLETED|Overall Study||11||
48521788|NCT05506358|101611693|FG003|COMPLETED|Overall Study||23||
48521789|NCT05506358|101611694|FG004|COMPLETED|Overall Study||30||
48521790|NCT05506358|101611690|FG000|NOT COMPLETED|Overall Study||4||
48521791|NCT05506358|101611691|FG001|NOT COMPLETED|Overall Study||0||
48521792|NCT05506358|101611692|FG002|NOT COMPLETED|Overall Study||0||
48521793|NCT05506358|101611693|FG003|NOT COMPLETED|Overall Study||3||
48521794|NCT05506358|101611694|FG004|NOT COMPLETED|Overall Study||0||
48521795|NCT00257920|101611695|FG000|STARTED|Period: First Intervention||21||
48521796|NCT00257920|101611696|FG001|STARTED|Period: First Intervention||20||
48521797|NCT00257920|101611695|FG000|COMPLETED|Period: First Intervention||21||
48521798|NCT00257920|101611696|FG001|COMPLETED|Period: First Intervention||20||
48521799|NCT00257920|101611695|FG000|NOT COMPLETED|Period: First Intervention||0||
48521800|NCT00257920|101611696|FG001|NOT COMPLETED|Period: First Intervention||0||
48521801|NCT00257920|101611695|FG000|STARTED|Period: Washout Period of Two Weeks||21||
48521802|NCT00257920|101611696|FG001|STARTED|Period: Washout Period of Two Weeks||20||
48521803|NCT00257920|101611695|FG000|COMPLETED|Period: Washout Period of Two Weeks||21||
48521804|NCT00257920|101611696|FG001|COMPLETED|Period: Washout Period of Two Weeks||19||
48521805|NCT00257920|101611695|FG000|NOT COMPLETED|Period: Washout Period of Two Weeks||0||
48521806|NCT00257920|101611696|FG001|NOT COMPLETED|Period: Washout Period of Two Weeks||1||
48521807|NCT00257920|101611695|FG000|STARTED|Period: Second Intervention||21||
48521808|NCT00257920|101611696|FG001|STARTED|Period: Second Intervention||19||
48521809|NCT00257920|101611695|FG000|COMPLETED|Period: Second Intervention||19||
48521810|NCT00257920|101611696|FG001|COMPLETED|Period: Second Intervention||18||
48521811|NCT00257920|101611695|FG000|NOT COMPLETED|Period: Second Intervention||2||
48521812|NCT00257920|101611696|FG001|NOT COMPLETED|Period: Second Intervention||1||
48521813|NCT00359788|101611697|FG000|STARTED|Overall Study||173||
48521814|NCT00359788|101611698|FG001|STARTED|Overall Study||176||
48521815|NCT00359788|101611697|FG000|COMPLETED|Overall Study||150||
48521816|NCT00359788|101611698|FG001|COMPLETED|Overall Study||159||
48521817|NCT00359788|101611697|FG000|NOT COMPLETED|Overall Study||23||
48521818|NCT00359788|101611698|FG001|NOT COMPLETED|Overall Study||17||
48521819|NCT01674647|101611699|FG000|STARTED|Treatment Period||1002||
48521820|NCT01674647|101611700|FG001|STARTED|Treatment Period||502||
48521821|NCT01674647|101611699|FG000|Subjects Received Treatment|Treatment Period||988||
48521822|NCT01674647|101611700|FG001|Subjects Received Treatment|Treatment Period||499||
48521823|NCT01674647|101611699|FG000|COMPLETED|Treatment Period||846||
48521824|NCT01674647|101611700|FG001|COMPLETED|Treatment Period||400||
48521825|NCT01674647|101611699|FG000|NOT COMPLETED|Treatment Period||156||
48521826|NCT01674647|101611700|FG001|NOT COMPLETED|Treatment Period||102||
48521827|NCT01674647|101611699|FG000|STARTED|30-day Safety Follow-up Period||982||
48521828|NCT01674647|101611700|FG001|STARTED|30-day Safety Follow-up Period||487||
48521829|NCT01674647|101611699|FG000|COMPLETED|30-day Safety Follow-up Period||924||
48521830|NCT01674647|101611700|FG001|COMPLETED|30-day Safety Follow-up Period||446||
48521831|NCT01674647|101611699|FG000|NOT COMPLETED|30-day Safety Follow-up Period||58||
48521832|NCT01674647|101611700|FG001|NOT COMPLETED|30-day Safety Follow-up Period||41||
48521833|NCT00952276|101611701|FG000|STARTED|Overall Study||127||
48521834|NCT00952276|101611702|FG001|STARTED|Overall Study||115||
48521835|NCT00952276|101611703|FG002|STARTED|Overall Study||122||
48521836|NCT00952276|101611704|FG003|STARTED|Overall Study||121||
48671200|NCT03058952|101978330|FG000|Completed Intervention|Overall Study||65|Completed 6 or more sessions of intervention|
48671201|NCT03058952|101978331|FG001|Completed Intervention|Overall Study||65|Completed 6 or more sessions of intervention|
48671202|NCT03058952|101978330|FG000|Completed Immediate Post-assessment|Overall Study||99||
48671203|NCT03058952|101978331|FG001|Completed Immediate Post-assessment|Overall Study||96||
48671204|NCT03058952|101978330|FG000|Completed 3-month Post-intervention Assessment|Overall Study||97||
48671205|NCT03058952|101978331|FG001|Completed 3-month Post-intervention Assessment|Overall Study||89||
48671206|NCT03058952|101978330|FG000|COMPLETED|Overall Study||100||
48671207|NCT03058952|101978331|FG001|COMPLETED|Overall Study||96||
48671208|NCT03058952|101978330|FG000|NOT COMPLETED|Overall Study||23||
48671209|NCT03058952|101978331|FG001|NOT COMPLETED|Overall Study||26||
48521837|NCT00952276|101611705|FG004|STARTED|Overall Study||63||
48521838|NCT00952276|101611701|FG000|COMPLETED|Overall Study||126||
48521839|NCT00952276|101611702|FG001|COMPLETED|Overall Study||115||
48671210|NCT03817580|101978332|FG000|STARTED|Overall Study||57||
48671211|NCT03817580|101978333|FG001|STARTED|Overall Study||56||
48671212|NCT03817580|101978334|FG002|STARTED|Overall Study||57||
48671213|NCT03817580|101978332|FG000|COMPLETED|Overall Study||57||
48671214|NCT03817580|101978333|FG001|COMPLETED|Overall Study||56||
48671215|NCT03817580|101978334|FG002|COMPLETED|Overall Study||57||
48671216|NCT03817580|101978332|FG000|NOT COMPLETED|Overall Study||0||
48671217|NCT03817580|101978333|FG001|NOT COMPLETED|Overall Study||0||
48671218|NCT03817580|101978334|FG002|NOT COMPLETED|Overall Study||0||
48671219|NCT01972659|101978335|FG000|STARTED|Overall Study||40||
48671220|NCT01972659|101978336|FG001|STARTED|Overall Study||40||
48671221|NCT01972659|101978335|FG000|COMPLETED|Overall Study||36||
48671222|NCT01972659|101978336|FG001|COMPLETED|Overall Study||37||
48671223|NCT01972659|101978335|FG000|NOT COMPLETED|Overall Study||4||
48671224|NCT01972659|101978336|FG001|NOT COMPLETED|Overall Study||3||
48671225|NCT05006495|101978337|FG000|STARTED|Overall Study||61||
48671226|NCT05006495|101978338|FG001|STARTED|Overall Study||61||
48671227|NCT05006495|101978337|FG000|COMPLETED|Overall Study||51||
48671228|NCT05006495|101978338|FG001|COMPLETED|Overall Study||58||
48671229|NCT05006495|101978337|FG000|NOT COMPLETED|Overall Study||10||
48671230|NCT05006495|101978338|FG001|NOT COMPLETED|Overall Study||3||
48671231|NCT03895372|101978339|FG000|STARTED|Investigational Treatment Period||23||
48671232|NCT03895372|101978340|FG001|STARTED|Investigational Treatment Period||22||
48671233|NCT03895372|101978341|FG002|STARTED|Investigational Treatment Period||11||
48671234|NCT03895372|101978342|FG003|STARTED|Investigational Treatment Period||11||
48671235|NCT03895372|101978343|FG004|STARTED|Investigational Treatment Period||12||
48671236|NCT03895372|101978344|FG005|STARTED|Investigational Treatment Period||11||
48671237|NCT03895372|101978345|FG006|STARTED|Investigational Treatment Period||45||
48671238|NCT03895372|101978346|FG007|STARTED|Investigational Treatment Period||43||
48671239|NCT03895372|101978339|FG000|COMPLETED|Investigational Treatment Period||19||
48671240|NCT03895372|101978340|FG001|COMPLETED|Investigational Treatment Period||19||
48671241|NCT03895372|101978341|FG002|COMPLETED|Investigational Treatment Period||10||
48671242|NCT03895372|101978342|FG003|COMPLETED|Investigational Treatment Period||9||
48671243|NCT03895372|101978343|FG004|COMPLETED|Investigational Treatment Period||12||
48671244|NCT03895372|101978344|FG005|COMPLETED|Investigational Treatment Period||9||
48671245|NCT03895372|101978345|FG006|COMPLETED|Investigational Treatment Period||37||
48671246|NCT03895372|101978346|FG007|COMPLETED|Investigational Treatment Period||38||
48671247|NCT03895372|101978339|FG000|NOT COMPLETED|Investigational Treatment Period||4||
48671248|NCT03895372|101978340|FG001|NOT COMPLETED|Investigational Treatment Period||3||
48671249|NCT03895372|101978341|FG002|NOT COMPLETED|Investigational Treatment Period||1||
48671250|NCT03895372|101978342|FG003|NOT COMPLETED|Investigational Treatment Period||2||
48671251|NCT03895372|101978343|FG004|NOT COMPLETED|Investigational Treatment Period||0||
48671252|NCT03895372|101978344|FG005|NOT COMPLETED|Investigational Treatment Period||2||
48671253|NCT03895372|101978345|FG006|NOT COMPLETED|Investigational Treatment Period||8||
48671254|NCT03895372|101978346|FG007|NOT COMPLETED|Investigational Treatment Period||5||
48671255|NCT03895372|101978339|FG000|STARTED|Extension Treatment Period||19||
48521840|NCT00952276|101611703|FG002|COMPLETED|Overall Study||122||
48671256|NCT03895372|101978340|FG001|STARTED|Extension Treatment Period||19||
48671257|NCT03895372|101978341|FG002|STARTED|Extension Treatment Period||10||
48671258|NCT03895372|101978342|FG003|STARTED|Extension Treatment Period||9||
48671259|NCT03895372|101978343|FG004|STARTED|Extension Treatment Period||12||
48671260|NCT03895372|101978344|FG005|STARTED|Extension Treatment Period||9||
48671261|NCT03895372|101978345|FG006|STARTED|Extension Treatment Period||37||
48671262|NCT03895372|101978346|FG007|STARTED|Extension Treatment Period||38||
48671263|NCT03895372|101978339|FG000|COMPLETED|Extension Treatment Period||16||
48671264|NCT03895372|101978340|FG001|COMPLETED|Extension Treatment Period||14||
48671265|NCT03895372|101978341|FG002|COMPLETED|Extension Treatment Period||10||
48671266|NCT03895372|101978342|FG003|COMPLETED|Extension Treatment Period||8||
48671267|NCT03895372|101978343|FG004|COMPLETED|Extension Treatment Period||9||
48671268|NCT03895372|101978344|FG005|COMPLETED|Extension Treatment Period||8||
48671269|NCT03895372|101978345|FG006|COMPLETED|Extension Treatment Period||33||
48671270|NCT03895372|101978346|FG007|COMPLETED|Extension Treatment Period||32||
48671271|NCT03895372|101978339|FG000|NOT COMPLETED|Extension Treatment Period||3||
48671272|NCT03895372|101978340|FG001|NOT COMPLETED|Extension Treatment Period||5||
48671273|NCT03895372|101978341|FG002|NOT COMPLETED|Extension Treatment Period||0||
48671274|NCT03895372|101978342|FG003|NOT COMPLETED|Extension Treatment Period||1||
48671275|NCT03895372|101978343|FG004|NOT COMPLETED|Extension Treatment Period||3||
48671276|NCT03895372|101978344|FG005|NOT COMPLETED|Extension Treatment Period||1||
48671277|NCT03895372|101978345|FG006|NOT COMPLETED|Extension Treatment Period||4||
48671278|NCT03895372|101978346|FG007|NOT COMPLETED|Extension Treatment Period||6||
48671279|NCT03369158|101978347|FG000|STARTED|Overall Study||14||
48671280|NCT03369158|101978348|FG001|STARTED|Overall Study||15||
48671281|NCT03369158|101978347|FG000|COMPLETED|Overall Study||14||
48671282|NCT03369158|101978348|FG001|COMPLETED|Overall Study||15||
48671283|NCT03369158|101978347|FG000|NOT COMPLETED|Overall Study||0||
48671284|NCT03369158|101978348|FG001|NOT COMPLETED|Overall Study||0||
48671285|NCT04604431|101978349|FG000|STARTED|Overall Study||9476|Total number of clinicians and infants observed as part of the trial.|16
48671286|NCT04604431|101978350|FG001|STARTED|Overall Study||9294|Total number of clinicians and infants observed as part of the trial.|14
48671287|NCT04604431|101978349|FG000|Clinicians Observed|Overall Study||186||16
48671288|NCT04604431|101978350|FG001|Clinicians Observed|Overall Study||104||14
48671289|NCT04604431|101978349|FG000|Infants Observed|Overall Study||9290||16
48671290|NCT04604431|101978350|FG001|Infants Observed|Overall Study||9190||14
48671291|NCT04604431|101978349|FG000|COMPLETED|Overall Study||9476|Total number of clinicians and infants observed as part of the trial.|16
48671292|NCT04604431|101978350|FG001|COMPLETED|Overall Study||9294|Total number of clinicians and infants observed as part of the trial.|14
48671293|NCT04604431|101978349|FG000|NOT COMPLETED|Overall Study||0||0
48671294|NCT04604431|101978350|FG001|NOT COMPLETED|Overall Study||0||0
48671295|NCT01121757|101978351|FG000|STARTED|First Drug||6||
48671296|NCT01121757|101978352|FG001|STARTED|First Drug||3||
48671297|NCT01121757|101978351|FG000|COMPLETED|First Drug||5||
48671298|NCT01121757|101978352|FG001|COMPLETED|First Drug||1||
48671299|NCT01121757|101978351|FG000|NOT COMPLETED|First Drug||1||
48671300|NCT01121757|101978352|FG001|NOT COMPLETED|First Drug||2||
48671301|NCT01121757|101978351|FG000|STARTED|Second Drug||4||
48671302|NCT01121757|101978352|FG001|STARTED|Second Drug||1||
48671303|NCT01121757|101978351|FG000|COMPLETED|Second Drug||4||
48671304|NCT01121757|101978352|FG001|COMPLETED|Second Drug||1||
48671305|NCT01121757|101978351|FG000|NOT COMPLETED|Second Drug||0||
48671306|NCT01121757|101978352|FG001|NOT COMPLETED|Second Drug||0||
48671307|NCT01121757|101978351|FG000|STARTED|Combination||2||
48671308|NCT01121757|101978352|FG001|STARTED|Combination||1||
48671309|NCT01121757|101978351|FG000|COMPLETED|Combination||0||
48671310|NCT01121757|101978352|FG001|COMPLETED|Combination||0||
48671311|NCT01121757|101978351|FG000|NOT COMPLETED|Combination||2||
48671312|NCT01121757|101978352|FG001|NOT COMPLETED|Combination||1||
48671313|NCT01262105|101978353|FG000|STARTED|Overall Study||13||
48671314|NCT01262105|101978354|FG001|STARTED|Overall Study||10||
48671315|NCT01262105|101978353|FG000|COMPLETED|Overall Study||13||
48671316|NCT01262105|101978354|FG001|COMPLETED|Overall Study||10||
48671317|NCT01262105|101978353|FG000|NOT COMPLETED|Overall Study||0||
48671318|NCT01262105|101978354|FG001|NOT COMPLETED|Overall Study||0||
48671319|NCT00895921|101978355|FG000|STARTED|Overall Study||15||
48671320|NCT00895921|101978356|FG001|STARTED|Overall Study||15||
48671321|NCT00895921|101978355|FG000|COMPLETED|Overall Study||15||
48671322|NCT00895921|101978356|FG001|COMPLETED|Overall Study||15||
48671323|NCT00895921|101978355|FG000|NOT COMPLETED|Overall Study||0||
48671324|NCT00895921|101978356|FG001|NOT COMPLETED|Overall Study||0||
48671325|NCT02037529|101978357|FG000|STARTED|Overall Study||101||
48671326|NCT02037529|101978358|FG001|STARTED|Overall Study||100||
48671327|NCT02037529|101978357|FG000|COMPLETED|Overall Study||100||
48671328|NCT02037529|101978358|FG001|COMPLETED|Overall Study||96||
48671329|NCT02037529|101978357|FG000|NOT COMPLETED|Overall Study||1||
48671330|NCT02037529|101978358|FG001|NOT COMPLETED|Overall Study||4||
48671331|NCT01936831|101978359|FG000|STARTED|Step 1: Group Identification||110||
48671332|NCT01936831|101978360|FG001|STARTED|Step 1: Group Identification||85||
48671333|NCT01936831|101978361|FG002|STARTED|Step 1: Group Identification||87||
48671334|NCT01936831|101978362|FG003|STARTED|Step 1: Group Identification||0||
48671335|NCT01936831|101978363|FG004|STARTED|Step 1: Group Identification||0||
48671336|NCT01936831|101978364|FG005|STARTED|Step 1: Group Identification||0||
48671337|NCT01936831|101978365|FG006|STARTED|Step 1: Group Identification||0||
48671338|NCT01936831|101978366|FG007|STARTED|Step 1: Group Identification||0||
48671339|NCT01936831|101978367|FG008|STARTED|Step 1: Group Identification||0||
48671340|NCT01936831|101978359|FG000|COMPLETED|Step 1: Group Identification||110||
48671341|NCT01936831|101978360|FG001|COMPLETED|Step 1: Group Identification||85||
48671342|NCT01936831|101978361|FG002|COMPLETED|Step 1: Group Identification||87||
48671343|NCT01936831|101978362|FG003|COMPLETED|Step 1: Group Identification||0||
48671344|NCT01936831|101978363|FG004|COMPLETED|Step 1: Group Identification||0||
48671345|NCT01936831|101978364|FG005|COMPLETED|Step 1: Group Identification||0||
48671346|NCT01936831|101978365|FG006|COMPLETED|Step 1: Group Identification||0||
48671347|NCT01936831|101978366|FG007|COMPLETED|Step 1: Group Identification||0||
48671348|NCT01936831|101978367|FG008|COMPLETED|Step 1: Group Identification||0||
48671349|NCT01936831|101978359|FG000|NOT COMPLETED|Step 1: Group Identification||0||
48671350|NCT01936831|101978360|FG001|NOT COMPLETED|Step 1: Group Identification||0||
48671351|NCT01936831|101978361|FG002|NOT COMPLETED|Step 1: Group Identification||0||
48671352|NCT01936831|101978362|FG003|NOT COMPLETED|Step 1: Group Identification||0||
48671353|NCT01936831|101978363|FG004|NOT COMPLETED|Step 1: Group Identification||0||
48671354|NCT01936831|101978364|FG005|NOT COMPLETED|Step 1: Group Identification||0||
48671355|NCT01936831|101978365|FG006|NOT COMPLETED|Step 1: Group Identification||0||
48671356|NCT01936831|101978366|FG007|NOT COMPLETED|Step 1: Group Identification||0||
48671357|NCT01936831|101978367|FG008|NOT COMPLETED|Step 1: Group Identification||0||
48671358|NCT01936831|101978359|FG000|STARTED|Step 2: Arm Randomization||0||
48671359|NCT01936831|101978360|FG001|STARTED|Step 2: Arm Randomization||0||
48671360|NCT01936831|101978361|FG002|STARTED|Step 2: Arm Randomization||0||
48671361|NCT01936831|101978362|FG003|STARTED|Step 2: Arm Randomization||13||
48671362|NCT01936831|101978363|FG004|STARTED|Step 2: Arm Randomization||14||
48671363|NCT01936831|101978364|FG005|STARTED|Step 2: Arm Randomization||16||
48671364|NCT01936831|101978365|FG006|STARTED|Step 2: Arm Randomization||16||
48671365|NCT01936831|101978366|FG007|STARTED|Step 2: Arm Randomization||11||
48671366|NCT01936831|101978367|FG008|STARTED|Step 2: Arm Randomization||10||
48671367|NCT01936831|101978359|FG000|COMPLETED|Step 2: Arm Randomization||0||
48671368|NCT01936831|101978360|FG001|COMPLETED|Step 2: Arm Randomization||0||
48671369|NCT01936831|101978361|FG002|COMPLETED|Step 2: Arm Randomization||0||
48671370|NCT01936831|101978362|FG003|COMPLETED|Step 2: Arm Randomization||13||
48671371|NCT01936831|101978363|FG004|COMPLETED|Step 2: Arm Randomization||14||
48671372|NCT01936831|101978364|FG005|COMPLETED|Step 2: Arm Randomization||15||
48671373|NCT01936831|101978365|FG006|COMPLETED|Step 2: Arm Randomization||16||
48671374|NCT01936831|101978366|FG007|COMPLETED|Step 2: Arm Randomization||11||
48671375|NCT01936831|101978367|FG008|COMPLETED|Step 2: Arm Randomization||10||
48671376|NCT01936831|101978359|FG000|NOT COMPLETED|Step 2: Arm Randomization||0||
48671377|NCT01936831|101978360|FG001|NOT COMPLETED|Step 2: Arm Randomization||0||
48671378|NCT01936831|101978361|FG002|NOT COMPLETED|Step 2: Arm Randomization||0||
48671379|NCT01936831|101978362|FG003|NOT COMPLETED|Step 2: Arm Randomization||0||
48671380|NCT01936831|101978363|FG004|NOT COMPLETED|Step 2: Arm Randomization||0||
48671381|NCT01936831|101978364|FG005|NOT COMPLETED|Step 2: Arm Randomization||1||
48671382|NCT01936831|101978365|FG006|NOT COMPLETED|Step 2: Arm Randomization||0||
48671383|NCT01936831|101978366|FG007|NOT COMPLETED|Step 2: Arm Randomization||0||
48671384|NCT01936831|101978367|FG008|NOT COMPLETED|Step 2: Arm Randomization||0||
48671385|NCT04466891|101978368|FG000|STARTED|Overall Study||80||
48671386|NCT04466891|101978369|FG001|STARTED|Overall Study||7||
48671387|NCT04466891|101978368|FG000|COMPLETED|Overall Study||20|Participants entered as completed are participants that are still on study follow up.|
48671388|NCT04466891|101978369|FG001|COMPLETED|Overall Study||1|Participants entered as completed are participants that are still on study follow up.|
48671389|NCT04466891|101978368|FG000|NOT COMPLETED|Overall Study||60||
48671390|NCT04466891|101978369|FG001|NOT COMPLETED|Overall Study||6||
48671391|NCT04388826|101978370|FG000|STARTED|Overall Study||19||
48671392|NCT04388826|101978371|FG001|STARTED|Overall Study||20||
48671393|NCT04388826|101978370|FG000|COMPLETED|Overall Study||15||
48671394|NCT04388826|101978371|FG001|COMPLETED|Overall Study||18||
48671395|NCT04388826|101978370|FG000|NOT COMPLETED|Overall Study||4||
48671396|NCT04388826|101978371|FG001|NOT COMPLETED|Overall Study||2||
48671397|NCT01661283|101978372|FG000|STARTED|Overall Study||25||
48671398|NCT01661283|101978372|FG000|COMPLETED|Overall Study||25||
48671399|NCT01661283|101978372|FG000|NOT COMPLETED|Overall Study||0||
48671400|NCT02666560|101978373|FG000|STARTED|Condition 1 (1 Day)||8||
48671401|NCT02666560|101978374|FG001|STARTED|Condition 1 (1 Day)||11||
48671402|NCT02666560|101978373|FG000|COMPLETED|Condition 1 (1 Day)||8||
48671403|NCT02666560|101978374|FG001|COMPLETED|Condition 1 (1 Day)||11||
48671404|NCT02666560|101978373|FG000|NOT COMPLETED|Condition 1 (1 Day)||0||
48671405|NCT02666560|101978374|FG001|NOT COMPLETED|Condition 1 (1 Day)||0||
48671406|NCT02666560|101978373|FG000|STARTED|Condition 2 (1 Day)||8||
48671407|NCT02666560|101978374|FG001|STARTED|Condition 2 (1 Day)||11||
48671408|NCT02666560|101978373|FG000|COMPLETED|Condition 2 (1 Day)||8||
48671409|NCT02666560|101978374|FG001|COMPLETED|Condition 2 (1 Day)||11||
48671410|NCT02666560|101978373|FG000|NOT COMPLETED|Condition 2 (1 Day)||0||
48671411|NCT02666560|101978374|FG001|NOT COMPLETED|Condition 2 (1 Day)||0||
48671412|NCT01974284|101978375|FG000|STARTED|Overall Study||7||
48671413|NCT01974284|101978375|FG000|COMPLETED|Overall Study||0||
48671414|NCT01974284|101978375|FG000|NOT COMPLETED|Overall Study||7||
48671415|NCT01333436|101978376|FG000|STARTED|Overall Study||43||
48671416|NCT01333436|101978377|FG001|STARTED|Overall Study||50||
48671417|NCT01333436|101978376|FG000|COMPLETED|Overall Study||43||
48671418|NCT01333436|101978377|FG001|COMPLETED|Overall Study||50||
48671419|NCT01333436|101978376|FG000|NOT COMPLETED|Overall Study||0||
48671420|NCT01333436|101978377|FG001|NOT COMPLETED|Overall Study||0||
48671421|NCT01047540|101978378|FG000|STARTED|Overall Study||34||
48671422|NCT01047540|101978379|FG001|STARTED|Overall Study||32||
48671423|NCT01047540|101978380|FG002|STARTED|Overall Study||29||
48671424|NCT01047540|101978381|FG003|STARTED|Overall Study||31||
48671425|NCT01047540|101978382|FG004|STARTED|Overall Study||30||
48671426|NCT01047540|101978378|FG000|Full Analysis Set|Overall Study||33||
48671427|NCT01047540|101978379|FG001|Full Analysis Set|Overall Study||32||
48671428|NCT01047540|101978380|FG002|Full Analysis Set|Overall Study||29||
48671429|NCT01047540|101978381|FG003|Full Analysis Set|Overall Study||31||
48671430|NCT01047540|101978382|FG004|Full Analysis Set|Overall Study||30||
48671431|NCT01047540|101978378|FG000|COMPLETED|Overall Study||29||
48671432|NCT01047540|101978379|FG001|COMPLETED|Overall Study||32||
48671433|NCT01047540|101978380|FG002|COMPLETED|Overall Study||26||
48671434|NCT01047540|101978381|FG003|COMPLETED|Overall Study||31||
48671435|NCT01047540|101978382|FG004|COMPLETED|Overall Study||29||
48671436|NCT01047540|101978378|FG000|NOT COMPLETED|Overall Study||5||
48671437|NCT01047540|101978379|FG001|NOT COMPLETED|Overall Study||0||
48671438|NCT01047540|101978380|FG002|NOT COMPLETED|Overall Study||3||
48671439|NCT01047540|101978381|FG003|NOT COMPLETED|Overall Study||0||
48671440|NCT01047540|101978382|FG004|NOT COMPLETED|Overall Study||1||
48671441|NCT02743962|101978383|FG000|STARTED|Overall Study||5||
48671442|NCT02743962|101978384|FG001|STARTED|Overall Study||5||
48671443|NCT02743962|101978383|FG000|COMPLETED|Overall Study||4||
48671444|NCT02743962|101978384|FG001|COMPLETED|Overall Study||5||
48671445|NCT02743962|101978383|FG000|NOT COMPLETED|Overall Study||1||
48671446|NCT02743962|101978384|FG001|NOT COMPLETED|Overall Study||0||
48671447|NCT00833521|101978385|FG000|STARTED|First Intervention||19||
48671448|NCT00833521|101978386|FG001|STARTED|First Intervention||19||
48671449|NCT00833521|101978385|FG000|COMPLETED|First Intervention||19||
48671450|NCT00833521|101978386|FG001|COMPLETED|First Intervention||19||
48671451|NCT00833521|101978385|FG000|NOT COMPLETED|First Intervention||0||
48671452|NCT00833521|101978386|FG001|NOT COMPLETED|First Intervention||0||
48671453|NCT00833521|101978385|FG000|STARTED|Second Intervention||19||
48671454|NCT00833521|101978386|FG001|STARTED|Second Intervention||19||
48671455|NCT00833521|101978385|FG000|COMPLETED|Second Intervention||19||
48671456|NCT00833521|101978386|FG001|COMPLETED|Second Intervention||19||
48671457|NCT00833521|101978385|FG000|NOT COMPLETED|Second Intervention||0||
48671458|NCT00833521|101978386|FG001|NOT COMPLETED|Second Intervention||0||
48671459|NCT01998477|101978387|FG000|STARTED|Overall Study||282||
48671460|NCT01998477|101978388|FG001|STARTED|Overall Study||148||
48671461|NCT01998477|101978387|FG000|COMPLETED|Overall Study||272||
48671462|NCT01998477|101978388|FG001|COMPLETED|Overall Study||143||
48671463|NCT01998477|101978387|FG000|NOT COMPLETED|Overall Study||10||
48671464|NCT01998477|101978388|FG001|NOT COMPLETED|Overall Study||5||
48671465|NCT01404234|101978389|FG000|STARTED|Overall Study||61||
48671466|NCT01404234|101978389|FG000|COMPLETED|Overall Study||59||
48671467|NCT01404234|101978389|FG000|NOT COMPLETED|Overall Study||2||
48671468|NCT00851084|101978390|FG000|STARTED|Overall Study||117||
48671469|NCT00851084|101978391|FG001|STARTED|Overall Study||119||
48671470|NCT00851084|101978390|FG000|COMPLETED|Overall Study||0||
48671471|NCT00851084|101978391|FG001|COMPLETED|Overall Study||0||
48671472|NCT00851084|101978390|FG000|NOT COMPLETED|Overall Study||117||
48671473|NCT00851084|101978391|FG001|NOT COMPLETED|Overall Study||119||
48671474|NCT03674281|101978392|FG000|STARTED|Overall Study||18||
48671475|NCT03674281|101978393|FG001|STARTED|Overall Study||16||
48671476|NCT03674281|101978394|FG002|STARTED|Overall Study||16||
48671477|NCT03674281|101978392|FG000|COMPLETED|Overall Study||15||
48671478|NCT03674281|101978393|FG001|COMPLETED|Overall Study||13||
48671479|NCT03674281|101978394|FG002|COMPLETED|Overall Study||13||
48671480|NCT03674281|101978392|FG000|NOT COMPLETED|Overall Study||3||
48671481|NCT03674281|101978393|FG001|NOT COMPLETED|Overall Study||3||
48671482|NCT03674281|101978394|FG002|NOT COMPLETED|Overall Study||3||
48671483|NCT00567580|101978395|FG000|STARTED|Overall Study||592||
48671484|NCT00567580|101978396|FG001|STARTED|Overall Study||602||
48671485|NCT00567580|101978397|FG002|STARTED|Overall Study||598||
48671486|NCT00567580|101978395|FG000|Eligible|Overall Study||564||
48671487|NCT00567580|101978396|FG001|Eligible|Overall Study||578||
48671488|NCT00567580|101978397|FG002|Eligible|Overall Study||574||
48671489|NCT00567580|101978395|FG000|Eligible, Started Study Treatment, and Have Adverse Event Data|Overall Study||547||
48671490|NCT00567580|101978396|FG001|Eligible, Started Study Treatment, and Have Adverse Event Data|Overall Study||563||
48671491|NCT00567580|101978397|FG002|Eligible, Started Study Treatment, and Have Adverse Event Data|Overall Study||563||
48671492|NCT00567580|101978395|FG000|COMPLETED|Overall Study||564|Participants contributing data to analysis are considered to have completed the study.|
48671493|NCT00567580|101978396|FG001|COMPLETED|Overall Study||578|Participants contributing data to analysis are considered to have completed the study.|
48671494|NCT00567580|101978397|FG002|COMPLETED|Overall Study||574|Participants contributing data to analysis are considered to have completed the study.|
48671495|NCT00567580|101978395|FG000|NOT COMPLETED|Overall Study||28||
48671496|NCT00567580|101978396|FG001|NOT COMPLETED|Overall Study||24||
48671497|NCT00567580|101978397|FG002|NOT COMPLETED|Overall Study||24||
48671498|NCT02467270|101978398|FG000|STARTED|Overall Study||94||
48671499|NCT02467270|101978399|FG001|STARTED|Overall Study||95||
48671500|NCT02467270|101978400|FG002|STARTED|Overall Study||94||
48671501|NCT02467270|101978398|FG000|Treated (Safety Population)|Overall Study||94|Included all participants who received at least one dose of study drug.|
48671502|NCT02467270|101978399|FG001|Treated (Safety Population)|Overall Study||94|Included all participants who received at least one dose of study drug.|
48671503|NCT02467270|101978400|FG002|Treated (Safety Population)|Overall Study||94|Included all participants who received at least one dose of study drug.|
48671504|NCT02467270|101978398|FG000|COMPLETED|Overall Study||0||
48671505|NCT02467270|101978399|FG001|COMPLETED|Overall Study||0||
48671506|NCT02467270|101978400|FG002|COMPLETED|Overall Study||0||
48671507|NCT02467270|101978398|FG000|NOT COMPLETED|Overall Study||94||
48671508|NCT02467270|101978399|FG001|NOT COMPLETED|Overall Study||95||
48671509|NCT02467270|101978400|FG002|NOT COMPLETED|Overall Study||94||
48671510|NCT03663582|101978401|FG000|STARTED|Overall Study||7||
48671511|NCT03663582|101978401|FG000|COMPLETED|Overall Study||6||
48671512|NCT03663582|101978401|FG000|NOT COMPLETED|Overall Study||1||
48671513|NCT02106832|101978402|FG000|STARTED|Overall Study||171||
48671514|NCT02106832|101978403|FG001|STARTED|Overall Study||176||
48671515|NCT02106832|101978404|FG002|STARTED|Overall Study||86||
48671516|NCT02106832|101978405|FG003|STARTED|Overall Study||88||
48671517|NCT02106832|101978402|FG000|Participants Received Treatment|Overall Study||171||
48671518|NCT02106832|101978403|FG001|Participants Received Treatment|Overall Study||174||
48710636|NCT03777709|102077979|FG000|STARTED|Overall Study||41||8
48671519|NCT02106832|101978404|FG002|Participants Received Treatment|Overall Study||86||
48671520|NCT02106832|101978405|FG003|Participants Received Treatment|Overall Study||88||
48671521|NCT02106832|101978402|FG000|COMPLETED|Overall Study||148||
48671522|NCT02106832|101978403|FG001|COMPLETED|Overall Study||151||
48671523|NCT02106832|101978404|FG002|COMPLETED|Overall Study||70||
48671524|NCT02106832|101978405|FG003|COMPLETED|Overall Study||73||
48671525|NCT02106832|101978402|FG000|NOT COMPLETED|Overall Study||23||
48671526|NCT02106832|101978403|FG001|NOT COMPLETED|Overall Study||25||
48671527|NCT02106832|101978404|FG002|NOT COMPLETED|Overall Study||16||
48671528|NCT02106832|101978405|FG003|NOT COMPLETED|Overall Study||15||
48671529|NCT04380142|101978406|FG000|STARTED|LD/CD Stabilization Period||174||
48671530|NCT04380142|101978407|FG001|STARTED|LD/CD Stabilization Period||0||
48671531|NCT04380142|101978408|FG002|STARTED|LD/CD Stabilization Period||0||
48671532|NCT04380142|101978406|FG000|COMPLETED|LD/CD Stabilization Period||145||
48671533|NCT04380142|101978407|FG001|COMPLETED|LD/CD Stabilization Period||0||
48671534|NCT04380142|101978408|FG002|COMPLETED|LD/CD Stabilization Period||0||
48671535|NCT04380142|101978406|FG000|NOT COMPLETED|LD/CD Stabilization Period||29||
48671536|NCT04380142|101978407|FG001|NOT COMPLETED|LD/CD Stabilization Period||0||
48671537|NCT04380142|101978408|FG002|NOT COMPLETED|LD/CD Stabilization Period||0||
48671538|NCT04380142|101978406|FG000|STARTED|Double-Blind Treatment Period||0|Number Randomized|
48671539|NCT04380142|101978407|FG001|STARTED|Double-Blind Treatment Period||69|Number Randomized|
48671540|NCT04380142|101978408|FG002|STARTED|Double-Blind Treatment Period||76|Number Randomized|
48671541|NCT04380142|101978406|FG000|Randomized and Treated|Double-Blind Treatment Period||0||
48671542|NCT04380142|101978407|FG001|Randomized and Treated|Double-Blind Treatment Period||67||
48671543|NCT04380142|101978408|FG002|Randomized and Treated|Double-Blind Treatment Period||74||
48671544|NCT04380142|101978406|FG000|COMPLETED|Double-Blind Treatment Period||0||
48671545|NCT04380142|101978407|FG001|COMPLETED|Double-Blind Treatment Period||62||
48671546|NCT04380142|101978408|FG002|COMPLETED|Double-Blind Treatment Period||48||
48671547|NCT04380142|101978406|FG000|NOT COMPLETED|Double-Blind Treatment Period||0||
48671548|NCT04380142|101978407|FG001|NOT COMPLETED|Double-Blind Treatment Period||7||
48671549|NCT04380142|101978408|FG002|NOT COMPLETED|Double-Blind Treatment Period||28||
48671550|NCT00793520|101978409|FG000|STARTED|Milnacipran Crossover to Placebo||1||
48671551|NCT00793520|101978410|FG001|STARTED|Milnacipran Crossover to Placebo||0||
48671552|NCT00793520|101978409|FG000|COMPLETED|Milnacipran Crossover to Placebo||0||
48671553|NCT00793520|101978410|FG001|COMPLETED|Milnacipran Crossover to Placebo||0||
48671554|NCT00793520|101978409|FG000|NOT COMPLETED|Milnacipran Crossover to Placebo||1||
48671555|NCT00793520|101978410|FG001|NOT COMPLETED|Milnacipran Crossover to Placebo||0||
48671556|NCT00793520|101978409|FG000|STARTED|Placebo Crossover to Milnacipran||0||
48671557|NCT00793520|101978410|FG001|STARTED|Placebo Crossover to Milnacipran||1||
48671558|NCT00793520|101978409|FG000|COMPLETED|Placebo Crossover to Milnacipran||0||
48671559|NCT00793520|101978410|FG001|COMPLETED|Placebo Crossover to Milnacipran||0||
48671560|NCT00793520|101978409|FG000|NOT COMPLETED|Placebo Crossover to Milnacipran||0||
48671561|NCT00793520|101978410|FG001|NOT COMPLETED|Placebo Crossover to Milnacipran||1||
48671562|NCT02421757|101978411|FG000|STARTED|Overall Study||11||
48671563|NCT02421757|101978412|FG001|STARTED|Overall Study||9||
48671564|NCT02421757|101978411|FG000|COMPLETED|Overall Study||11||
48671565|NCT02421757|101978412|FG001|COMPLETED|Overall Study||9||
48671566|NCT02421757|101978411|FG000|NOT COMPLETED|Overall Study||0||
48671567|NCT02421757|101978412|FG001|NOT COMPLETED|Overall Study||0||
48671568|NCT04312022|101978413|FG000|STARTED|First Intervention (1 Day)||9||
48671569|NCT04312022|101978414|FG001|STARTED|First Intervention (1 Day)||9||
48671570|NCT04312022|101978413|FG000|COMPLETED|First Intervention (1 Day)||9||
48671571|NCT04312022|101978414|FG001|COMPLETED|First Intervention (1 Day)||9||
48671572|NCT04312022|101978413|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48671573|NCT04312022|101978414|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48671574|NCT04312022|101978413|FG000|STARTED|Washout (2 Weeks)||9||
48671575|NCT04312022|101978414|FG001|STARTED|Washout (2 Weeks)||9||
48671576|NCT04312022|101978413|FG000|COMPLETED|Washout (2 Weeks)||9||
48671577|NCT04312022|101978414|FG001|COMPLETED|Washout (2 Weeks)||9||
48671578|NCT04312022|101978413|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
48671579|NCT04312022|101978414|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
48671580|NCT04312022|101978413|FG000|STARTED|Second Intervention (1 Day)||9||
48671581|NCT04312022|101978414|FG001|STARTED|Second Intervention (1 Day)||9||
48671582|NCT04312022|101978413|FG000|COMPLETED|Second Intervention (1 Day)||9||
48671583|NCT04312022|101978414|FG001|COMPLETED|Second Intervention (1 Day)||9||
48671584|NCT04312022|101978413|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48671585|NCT04312022|101978414|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48671586|NCT01959932|101978415|FG000|STARTED|Overall Study||80||
48671587|NCT01959932|101978416|FG001|STARTED|Overall Study||41||
48671588|NCT01959932|101978417|FG002|STARTED|Overall Study||39||
48671589|NCT01959932|101978415|FG000|COMPLETED|Overall Study||79||
48671590|NCT01959932|101978416|FG001|COMPLETED|Overall Study||41||
48671591|NCT01959932|101978417|FG002|COMPLETED|Overall Study||39||
48671592|NCT01959932|101978415|FG000|NOT COMPLETED|Overall Study||1||
48671593|NCT01959932|101978416|FG001|NOT COMPLETED|Overall Study||0||
48671594|NCT01959932|101978417|FG002|NOT COMPLETED|Overall Study||0||
48671595|NCT04164277|101978418|FG000|STARTED|Preschoolers||53|53 preschoolers in 5 intervention daycare centers and 42 preschoolers in 5 control intervention dyads|5
48671596|NCT04164277|101978419|FG001|STARTED|Preschoolers||42|53 preschoolers in 5 intervention daycare centers and 42 preschoolers in 5 control intervention dyads|5
48671597|NCT04164277|101978418|FG000|COMPLETED|Preschoolers||47|47 preschoolers in 5 intervention daycare centers and 36 preschoolers in 5 control intervention dyads|5
48671598|NCT04164277|101978419|FG001|COMPLETED|Preschoolers||36|47 preschoolers in 5 intervention daycare centers and 36 preschoolers in 5 control intervention dyads|5
48671599|NCT04164277|101978418|FG000|NOT COMPLETED|Preschoolers||6||0
48671600|NCT04164277|101978419|FG001|NOT COMPLETED|Preschoolers||6||0
48671601|NCT04164277|101978418|FG000|STARTED|Caregivers||53||5
48671602|NCT04164277|101978419|FG001|STARTED|Caregivers||42||5
48671603|NCT04164277|101978418|FG000|COMPLETED|Caregivers||47||5
48671604|NCT04164277|101978419|FG001|COMPLETED|Caregivers||36||5
48671605|NCT04164277|101978418|FG000|NOT COMPLETED|Caregivers||6||0
48671606|NCT04164277|101978419|FG001|NOT COMPLETED|Caregivers||6||0
48671607|NCT01567722|101978420|FG000|STARTED|Overall Study||93||
48671608|NCT01567722|101978421|FG001|STARTED|Overall Study||19||
48671609|NCT01567722|101978422|FG002|STARTED|Overall Study||2||
48671610|NCT01567722|101978420|FG000|COMPLETED|Overall Study||87||
48671611|NCT01567722|101978421|FG001|COMPLETED|Overall Study||19||
48671612|NCT01567722|101978422|FG002|COMPLETED|Overall Study||2||
48671613|NCT01567722|101978420|FG000|NOT COMPLETED|Overall Study||6||
48671614|NCT01567722|101978421|FG001|NOT COMPLETED|Overall Study||0||
48671615|NCT01567722|101978422|FG002|NOT COMPLETED|Overall Study||0||
48671616|NCT01636284|101978423|FG000|STARTED|Overall Study||16||
48671617|NCT01636284|101978423|FG000|COMPLETED|Overall Study||16||
48671618|NCT01636284|101978423|FG000|NOT COMPLETED|Overall Study||0||
48671619|NCT02757430|101978424|FG000|STARTED|Overall Study||515||
48671620|NCT02757430|101978424|FG000|Baseline Visits|Overall Study||503||
48671621|NCT02757430|101978424|FG000|EP Mapping/Ablation Procedure|Overall Study||503||
48671622|NCT02757430|101978424|FG000|COMPLETED|Overall Study||503||
48671623|NCT02757430|101978424|FG000|NOT COMPLETED|Overall Study||12||
48671624|NCT04581811|101978425|FG000|STARTED|Overall Study||26||
48671625|NCT04581811|101978426|FG001|STARTED|Overall Study||26||
48671626|NCT04581811|101978425|FG000|COMPLETED|Overall Study||26||
48671627|NCT04581811|101978426|FG001|COMPLETED|Overall Study||26||
48671628|NCT04581811|101978425|FG000|NOT COMPLETED|Overall Study||0||
48671629|NCT04581811|101978426|FG001|NOT COMPLETED|Overall Study||0||
48671630|NCT01474109|101978427|FG000|STARTED|Period 1: Baseline to Week 16||95||
48671631|NCT01474109|101978428|FG001|STARTED|Period 1: Baseline to Week 16||97||
48671632|NCT01474109|101978429|FG002|STARTED|Period 1: Baseline to Week 16||97||
48671633|NCT01474109|101978427|FG000|COMPLETED|Period 1: Baseline to Week 16||88||
48671634|NCT01474109|101978428|FG001|COMPLETED|Period 1: Baseline to Week 16||91||
48671635|NCT01474109|101978429|FG002|COMPLETED|Period 1: Baseline to Week 16||95||
48671636|NCT01474109|101978427|FG000|NOT COMPLETED|Period 1: Baseline to Week 16||7||
48671637|NCT01474109|101978428|FG001|NOT COMPLETED|Period 1: Baseline to Week 16||6||
48671638|NCT01474109|101978429|FG002|NOT COMPLETED|Period 1: Baseline to Week 16||2||
48671639|NCT01474109|101978427|FG000|STARTED|Period 2: Week 16 to End of Study||88||
48671640|NCT01474109|101978428|FG001|STARTED|Period 2: Week 16 to End of Study||91||
48671641|NCT01474109|101978429|FG002|STARTED|Period 2: Week 16 to End of Study||95||
48671642|NCT01474109|101978427|FG000|COMPLETED|Period 2: Week 16 to End of Study||70||
48671643|NCT01474109|101978428|FG001|COMPLETED|Period 2: Week 16 to End of Study||73||
48671644|NCT01474109|101978429|FG002|COMPLETED|Period 2: Week 16 to End of Study||83||
48671645|NCT01474109|101978427|FG000|NOT COMPLETED|Period 2: Week 16 to End of Study||18||
48671646|NCT01474109|101978428|FG001|NOT COMPLETED|Period 2: Week 16 to End of Study||18||
48671647|NCT01474109|101978429|FG002|NOT COMPLETED|Period 2: Week 16 to End of Study||12||
48671648|NCT00062764|101978430|FG000|STARTED|Overall Study||18||
48671649|NCT00062764|101978430|FG000|COMPLETED|Overall Study||18||
48671650|NCT00062764|101978430|FG000|NOT COMPLETED|Overall Study||0||
48671651|NCT03207347|101978431|FG000|STARTED|Overall Study||23||
48671652|NCT03207347|101978432|FG001|STARTED|Overall Study||14||
48671653|NCT03207347|101978431|FG000|COMPLETED|Overall Study||23||
48671654|NCT03207347|101978432|FG001|COMPLETED|Overall Study||14||
48671655|NCT03207347|101978431|FG000|NOT COMPLETED|Overall Study||0||
48671656|NCT03207347|101978432|FG001|NOT COMPLETED|Overall Study||0||
48671657|NCT00789555|101978433|FG000|STARTED|Overall Study||421||
48671658|NCT00789555|101978434|FG001|STARTED|Overall Study||417||
48671659|NCT00789555|101978435|FG002|STARTED|Overall Study||422||
48671660|NCT00789555|101978433|FG000|COMPLETED|Overall Study||262||
48671661|NCT00789555|101978434|FG001|COMPLETED|Overall Study||278||
48671662|NCT00789555|101978435|FG002|COMPLETED|Overall Study||263||
48671663|NCT00789555|101978433|FG000|NOT COMPLETED|Overall Study||159||
48671664|NCT00789555|101978434|FG001|NOT COMPLETED|Overall Study||139||
48671665|NCT00789555|101978435|FG002|NOT COMPLETED|Overall Study||159||
48671666|NCT02552225|101978436|FG000|STARTED|Overall Study||3||
48671667|NCT02552225|101978437|FG001|STARTED|Overall Study||3||
48671668|NCT02552225|101978436|FG000|COMPLETED|Overall Study||2||
48671669|NCT02552225|101978437|FG001|COMPLETED|Overall Study||3||
48671670|NCT02552225|101978436|FG000|NOT COMPLETED|Overall Study||1||
48671671|NCT02552225|101978437|FG001|NOT COMPLETED|Overall Study||0||
48671672|NCT02724839|101978438|FG000|STARTED|Overall Study||13||
48671673|NCT02724839|101978439|FG001|STARTED|Overall Study||12||
48671674|NCT02724839|101978440|FG002|STARTED|Overall Study||11||
48671675|NCT02724839|101978438|FG000|COMPLETED|Overall Study||12||
48671676|NCT02724839|101978439|FG001|COMPLETED|Overall Study||8||
48671677|NCT02724839|101978440|FG002|COMPLETED|Overall Study||6||
48671678|NCT02724839|101978438|FG000|NOT COMPLETED|Overall Study||1||
48671679|NCT02724839|101978439|FG001|NOT COMPLETED|Overall Study||4||
48671680|NCT02724839|101978440|FG002|NOT COMPLETED|Overall Study||5||
48671681|NCT03707821|101978441|FG000|STARTED|Overall Study||125||
48671682|NCT03707821|101978442|FG001|STARTED|Overall Study||126||
48671683|NCT03707821|101978441|FG000|COMPLETED|Overall Study||123||
48671684|NCT03707821|101978442|FG001|COMPLETED|Overall Study||125||
48671685|NCT03707821|101978441|FG000|NOT COMPLETED|Overall Study||2||
48671686|NCT03707821|101978442|FG001|NOT COMPLETED|Overall Study||1||
48671687|NCT03342560|101978443|FG000|STARTED|Overall Study||30||
48671688|NCT03342560|101978443|FG000|COMPLETED|Overall Study||28||
48671689|NCT03342560|101978443|FG000|NOT COMPLETED|Overall Study||2||
48671690|NCT02437318|101978444|FG000|STARTED|Overall Study||284||
48671691|NCT02437318|101978445|FG001|STARTED|Overall Study||288||
48671692|NCT02437318|101978444|FG000|End of Treatment (Didn't Complete)|Overall Study||229||
48671693|NCT02437318|101978445|FG001|End of Treatment (Didn't Complete)|Overall Study||241||
48671694|NCT02437318|101978444|FG000|Untreated (Protocol Deviation)|Overall Study||0||
48671695|NCT02437318|101978445|FG001|Untreated (Protocol Deviation)|Overall Study||1||
48671696|NCT02437318|101978444|FG000|COMPLETED|Overall Study||55|Completed = Subjects ongoing at the time of data cut-off: 12-Jun-2018|
48671697|NCT02437318|101978445|FG001|COMPLETED|Overall Study||46|Completed = Subjects ongoing at the time of data cut-off: 12-Jun-2018|
48671698|NCT02437318|101978444|FG000|NOT COMPLETED|Overall Study||229||
48671699|NCT02437318|101978445|FG001|NOT COMPLETED|Overall Study||242||
48671700|NCT00928668|101978446|FG000|STARTED|Overall Study||7||
48671701|NCT00928668|101978447|FG001|STARTED|Overall Study||7||
48671702|NCT00928668|101978448|FG002|STARTED|Overall Study||7||
48671703|NCT00928668|101978449|FG003|STARTED|Overall Study||4||
48671704|NCT00928668|101978450|FG004|STARTED|Overall Study||6||
48671705|NCT00928668|101978446|FG000|COMPLETED|Overall Study||6||
48671706|NCT00928668|101978447|FG001|COMPLETED|Overall Study||6||
48671707|NCT00928668|101978448|FG002|COMPLETED|Overall Study||6||
48671708|NCT00928668|101978449|FG003|COMPLETED|Overall Study||3||
48671709|NCT00928668|101978450|FG004|COMPLETED|Overall Study||5||
48671710|NCT00928668|101978446|FG000|NOT COMPLETED|Overall Study||1||
48671711|NCT00928668|101978447|FG001|NOT COMPLETED|Overall Study||1||
48671712|NCT00928668|101978448|FG002|NOT COMPLETED|Overall Study||1||
48671713|NCT00928668|101978449|FG003|NOT COMPLETED|Overall Study||1||
48671714|NCT00928668|101978450|FG004|NOT COMPLETED|Overall Study||1||
48671715|NCT01731782|101978451|FG000|STARTED|Overall Study||41||
48671716|NCT01731782|101978452|FG001|STARTED|Overall Study||38||
48671717|NCT01731782|101978451|FG000|COMPLETED|Overall Study||41||
48671718|NCT01731782|101978452|FG001|COMPLETED|Overall Study||38||
48671719|NCT01731782|101978451|FG000|NOT COMPLETED|Overall Study||0||
48671720|NCT01731782|101978452|FG001|NOT COMPLETED|Overall Study||0||
48671721|NCT00415636|101978453|FG000|STARTED|Overall Study||3||
48671722|NCT00415636|101978454|FG001|STARTED|Overall Study||3||
48671723|NCT00415636|101978455|FG002|STARTED|Overall Study||3||
48671724|NCT00415636|101978456|FG003|STARTED|Overall Study||13||
48671725|NCT00415636|101978457|FG004|STARTED|Overall Study||6||
48671726|NCT00415636|101978458|FG005|STARTED|Overall Study||3||
48671727|NCT00415636|101978453|FG000|COMPLETED|Overall Study||2||
48671728|NCT00415636|101978454|FG001|COMPLETED|Overall Study||3||
48671729|NCT00415636|101978455|FG002|COMPLETED|Overall Study||2||
48671730|NCT00415636|101978456|FG003|COMPLETED|Overall Study||7||
48671731|NCT00415636|101978457|FG004|COMPLETED|Overall Study||4||
48671732|NCT00415636|101978458|FG005|COMPLETED|Overall Study||1||
48671733|NCT00415636|101978453|FG000|NOT COMPLETED|Overall Study||1||
48671734|NCT00415636|101978454|FG001|NOT COMPLETED|Overall Study||0||
48671735|NCT00415636|101978455|FG002|NOT COMPLETED|Overall Study||1||
48671736|NCT00415636|101978456|FG003|NOT COMPLETED|Overall Study||6||
48671737|NCT00415636|101978457|FG004|NOT COMPLETED|Overall Study||2||
48671738|NCT00415636|101978458|FG005|NOT COMPLETED|Overall Study||2||
48671739|NCT00419744|101978459|FG000|STARTED|Overall Study||407||
48671740|NCT00419744|101978460|FG001|STARTED|Overall Study||408||
48671741|NCT00419744|101978461|FG002|STARTED|Overall Study||404||
48671742|NCT00419744|101978459|FG000|COMPLETED|Overall Study||290||
48671743|NCT00419744|101978460|FG001|COMPLETED|Overall Study||290||
48671744|NCT00419744|101978461|FG002|COMPLETED|Overall Study||271||
48671745|NCT00419744|101978459|FG000|NOT COMPLETED|Overall Study||117||
48671746|NCT00419744|101978460|FG001|NOT COMPLETED|Overall Study||118||
48671747|NCT00419744|101978461|FG002|NOT COMPLETED|Overall Study||133||
48671748|NCT04064905|101978462|FG000|STARTED|Overall Study||24||
48671749|NCT04064905|101978463|FG001|STARTED|Overall Study||24||
48671750|NCT04064905|101978464|FG002|STARTED|Overall Study||24||
48671751|NCT04064905|101978465|FG003|STARTED|Overall Study||24||
48671752|NCT04064905|101978466|FG004|STARTED|Overall Study||24||
48671753|NCT04064905|101978462|FG000|Received First Vaccination|Overall Study||24||
48671754|NCT04064905|101978463|FG001|Received First Vaccination|Overall Study||24||
48671755|NCT04064905|101978464|FG002|Received First Vaccination|Overall Study||24||
48671756|NCT04064905|101978465|FG003|Received First Vaccination|Overall Study||24||
48671757|NCT04064905|101978466|FG004|Received First Vaccination|Overall Study||24||
48671758|NCT04064905|101978462|FG000|Received Second Vaccination|Overall Study||24||
48671759|NCT04064905|101978463|FG001|Received Second Vaccination|Overall Study||23||
48671760|NCT04064905|101978464|FG002|Received Second Vaccination|Overall Study||23||
48671761|NCT04064905|101978465|FG003|Received Second Vaccination|Overall Study||24||
48671762|NCT04064905|101978466|FG004|Received Second Vaccination|Overall Study||24||
48671763|NCT04064905|101978462|FG000|COMPLETED|Overall Study||24||
48671764|NCT04064905|101978463|FG001|COMPLETED|Overall Study||21||
48671765|NCT04064905|101978464|FG002|COMPLETED|Overall Study||23||
48671766|NCT04064905|101978465|FG003|COMPLETED|Overall Study||20||
48671767|NCT04064905|101978466|FG004|COMPLETED|Overall Study||22||
48671768|NCT04064905|101978462|FG000|NOT COMPLETED|Overall Study||0||
48671769|NCT04064905|101978463|FG001|NOT COMPLETED|Overall Study||3||
48671770|NCT04064905|101978464|FG002|NOT COMPLETED|Overall Study||1||
48671771|NCT04064905|101978465|FG003|NOT COMPLETED|Overall Study||4||
48671772|NCT04064905|101978466|FG004|NOT COMPLETED|Overall Study||2||
48671773|NCT01463033|101978467|FG000|STARTED|Overall Study||66||
48671774|NCT01463033|101978468|FG001|STARTED|Overall Study||60||
48671775|NCT01463033|101978467|FG000|COMPLETED|Overall Study||59||
48671776|NCT01463033|101978468|FG001|COMPLETED|Overall Study||54||
48671777|NCT01463033|101978467|FG000|NOT COMPLETED|Overall Study||7||
48671778|NCT01463033|101978468|FG001|NOT COMPLETED|Overall Study||6||
48671779|NCT01153516|101978469|FG000|STARTED|Overall Study||12||
48671780|NCT01153516|101978470|FG001|STARTED|Overall Study||10||
48671781|NCT01153516|101978469|FG000|COMPLETED|Overall Study||10||
48671782|NCT01153516|101978470|FG001|COMPLETED|Overall Study||10||
48671783|NCT01153516|101978469|FG000|NOT COMPLETED|Overall Study||2||
48671784|NCT01153516|101978470|FG001|NOT COMPLETED|Overall Study||0||
48671785|NCT02327169|101978471|FG000|STARTED|Overall Study||4||
48671786|NCT02327169|101978472|FG001|STARTED|Overall Study||3||
48671787|NCT02327169|101978473|FG002|STARTED|Overall Study||7||
48671788|NCT02327169|101978474|FG003|STARTED|Overall Study||3||
48671789|NCT02327169|101978475|FG004|STARTED|Overall Study||8||
48671790|NCT02327169|101978476|FG005|STARTED|Overall Study||4||
48671791|NCT02327169|101978477|FG006|STARTED|Overall Study||3||
48671792|NCT02327169|101978478|FG007|STARTED|Overall Study||4||
48671793|NCT02327169|101978479|FG008|STARTED|Overall Study||6||
48671794|NCT02327169|101978480|FG009|STARTED|Overall Study||8||
48671795|NCT02327169|101978481|FG010|STARTED|Overall Study||6||
48671796|NCT02327169|101978482|FG011|STARTED|Overall Study||7||
48671797|NCT02327169|101978483|FG012|STARTED|Overall Study||1||
48671798|NCT02327169|101978484|FG013|STARTED|Overall Study||7||
48671799|NCT02327169|101978485|FG014|STARTED|Overall Study||10||
48671800|NCT02327169|101978471|FG000|COMPLETED|Overall Study||0||
48671801|NCT02327169|101978472|FG001|COMPLETED|Overall Study||0||
48671802|NCT02327169|101978473|FG002|COMPLETED|Overall Study||0||
48671803|NCT02327169|101978474|FG003|COMPLETED|Overall Study||0||
48671804|NCT02327169|101978475|FG004|COMPLETED|Overall Study||0||
48671805|NCT02327169|101978476|FG005|COMPLETED|Overall Study||0||
48671806|NCT02327169|101978477|FG006|COMPLETED|Overall Study||0||
48671807|NCT02327169|101978478|FG007|COMPLETED|Overall Study||0||
48671808|NCT02327169|101978479|FG008|COMPLETED|Overall Study||0||
48671809|NCT02327169|101978480|FG009|COMPLETED|Overall Study||0||
48671810|NCT02327169|101978481|FG010|COMPLETED|Overall Study||0||
48671811|NCT02327169|101978482|FG011|COMPLETED|Overall Study||0||
48671812|NCT02327169|101978483|FG012|COMPLETED|Overall Study||0||
48671813|NCT02327169|101978484|FG013|COMPLETED|Overall Study||0||
48671814|NCT02327169|101978485|FG014|COMPLETED|Overall Study||0||
48671815|NCT02327169|101978471|FG000|NOT COMPLETED|Overall Study||4||
48671816|NCT02327169|101978472|FG001|NOT COMPLETED|Overall Study||3||
48671817|NCT02327169|101978473|FG002|NOT COMPLETED|Overall Study||7||
48671818|NCT02327169|101978474|FG003|NOT COMPLETED|Overall Study||3||
48671819|NCT02327169|101978475|FG004|NOT COMPLETED|Overall Study||8||
48671820|NCT02327169|101978476|FG005|NOT COMPLETED|Overall Study||4||
48671821|NCT02327169|101978477|FG006|NOT COMPLETED|Overall Study||3||
48671822|NCT02327169|101978478|FG007|NOT COMPLETED|Overall Study||4||
48671823|NCT02327169|101978479|FG008|NOT COMPLETED|Overall Study||6||
48671824|NCT02327169|101978480|FG009|NOT COMPLETED|Overall Study||8||
48671825|NCT02327169|101978481|FG010|NOT COMPLETED|Overall Study||6||
48671826|NCT02327169|101978482|FG011|NOT COMPLETED|Overall Study||7||
48671827|NCT02327169|101978483|FG012|NOT COMPLETED|Overall Study||1||
48671828|NCT02327169|101978484|FG013|NOT COMPLETED|Overall Study||7||
48671829|NCT02327169|101978485|FG014|NOT COMPLETED|Overall Study||10||
48671830|NCT00600340|101978486|FG000|STARTED|Overall Study||285||
48671831|NCT00600340|101978487|FG001|STARTED|Overall Study||279||
48671832|NCT00600340|101978486|FG000|COMPLETED|Overall Study||285||
48671833|NCT00600340|101978487|FG001|COMPLETED|Overall Study||279||
48671834|NCT00600340|101978486|FG000|NOT COMPLETED|Overall Study||0||
48671835|NCT00600340|101978487|FG001|NOT COMPLETED|Overall Study||0||
48671836|NCT03680521|101978488|FG000|STARTED|Overall Study||7||
48671837|NCT03680521|101978489|FG001|STARTED|Overall Study||13||
48671838|NCT03680521|101978488|FG000|COMPLETED|Overall Study||7||
48671839|NCT03680521|101978489|FG001|COMPLETED|Overall Study||13||
48671840|NCT03680521|101978488|FG000|NOT COMPLETED|Overall Study||0||
48671841|NCT03680521|101978489|FG001|NOT COMPLETED|Overall Study||0||
48671842|NCT02006927|101978490|FG000|STARTED|Overall Study||3||
48671843|NCT02006927|101978490|FG000|COMPLETED|Overall Study||0||
48671844|NCT02006927|101978490|FG000|NOT COMPLETED|Overall Study||3||
48671845|NCT01969214|101978491|FG000|STARTED|Overall Study||101||
48671846|NCT01969214|101978491|FG000|COMPLETED|Overall Study||86||
48671847|NCT01969214|101978491|FG000|NOT COMPLETED|Overall Study||15||
48671848|NCT01155050|101978492|FG000|STARTED|Overall Study||50||
48671849|NCT01155050|101978493|FG001|STARTED|Overall Study||51||
48671850|NCT01155050|101978494|FG002|STARTED|Overall Study||52||
48671851|NCT01155050|101978495|FG003|STARTED|Overall Study||49||
48671852|NCT01155050|101978492|FG000|COMPLETED|Overall Study||35||
48671853|NCT01155050|101978493|FG001|COMPLETED|Overall Study||31||
48671854|NCT01155050|101978494|FG002|COMPLETED|Overall Study||33||
48671855|NCT01155050|101978495|FG003|COMPLETED|Overall Study||27||
48671856|NCT01155050|101978492|FG000|NOT COMPLETED|Overall Study||15||
48671857|NCT01155050|101978493|FG001|NOT COMPLETED|Overall Study||20||
48671858|NCT01155050|101978494|FG002|NOT COMPLETED|Overall Study||19||
48671859|NCT01155050|101978495|FG003|NOT COMPLETED|Overall Study||22||
48671860|NCT04436744|101982492|FG000|STARTED|Overall Study||112||
48671861|NCT04436744|101982493|FG001|STARTED|Overall Study||109||
48671862|NCT04436744|101982492|FG000|COMPLETED|Overall Study||108||
48671863|NCT04436744|101982493|FG001|COMPLETED|Overall Study||98||
48671864|NCT04436744|101982492|FG000|NOT COMPLETED|Overall Study||4||
48671865|NCT04436744|101982493|FG001|NOT COMPLETED|Overall Study||11||
48671866|NCT02578901|101982494|FG000|STARTED|Overall Study||165||
48671867|NCT02578901|101982495|FG001|STARTED|Overall Study||165||
48671868|NCT02578901|101982494|FG000|COMPLETED|Overall Study||145||
48671869|NCT02578901|101982495|FG001|COMPLETED|Overall Study||144||
48671870|NCT02578901|101982494|FG000|NOT COMPLETED|Overall Study||20||
48671871|NCT02578901|101982495|FG001|NOT COMPLETED|Overall Study||21||
48671872|NCT02133573|101982496|FG000|STARTED|Overall Study||52||
48671873|NCT02133573|101982497|FG001|STARTED|Overall Study||50||
48671874|NCT02133573|101982496|FG000|Dyads Allocated to Intervention|Overall Study||52||
48671875|NCT02133573|101982497|FG001|Dyads Allocated to Intervention|Overall Study||49||
48671876|NCT02133573|101982496|FG000|Number of Toddlers That Returned for 18 Month Follow Up Visit|Overall Study||45||
48671877|NCT02133573|101982497|FG001|Number of Toddlers That Returned for 18 Month Follow Up Visit|Overall Study||43||
48671878|NCT02133573|101982496|FG000|Number of Toddlers With Analyzed Primary Endpoint|Overall Study||43||
48671879|NCT02133573|101982497|FG001|Number of Toddlers With Analyzed Primary Endpoint|Overall Study||42||
48671880|NCT02133573|101982496|FG000|COMPLETED|Overall Study||43||
48671881|NCT02133573|101982497|FG001|COMPLETED|Overall Study||42||
48671882|NCT02133573|101982496|FG000|NOT COMPLETED|Overall Study||9||
48671883|NCT02133573|101982497|FG001|NOT COMPLETED|Overall Study||8||
48671884|NCT03229538|101982498|FG000|STARTED|Overall Study||599||
48671885|NCT03229538|101982499|FG001|STARTED|Overall Study||601||
48671886|NCT03229538|101982498|FG000|COMPLETED|Overall Study||599||
48671887|NCT03229538|101982499|FG001|COMPLETED|Overall Study||601||
48671888|NCT03229538|101982498|FG000|NOT COMPLETED|Overall Study||0||
48671889|NCT03229538|101982499|FG001|NOT COMPLETED|Overall Study||0||
48671890|NCT01693367|101982500|FG000|STARTED|Overall Study||2||
48671891|NCT01693367|101982501|FG001|STARTED|Overall Study||3||
48671892|NCT01693367|101982500|FG000|COMPLETED|Overall Study||1||
48671893|NCT01693367|101982501|FG001|COMPLETED|Overall Study||1||
48671894|NCT01693367|101982500|FG000|NOT COMPLETED|Overall Study||1||
48671895|NCT01693367|101982501|FG001|NOT COMPLETED|Overall Study||2||
48671896|NCT02878382|101982502|FG000|STARTED|Overall Study||20||20
48671897|NCT02878382|101982503|FG001|STARTED|Overall Study||20||20
48671898|NCT02878382|101982502|FG000|COMPLETED|Overall Study||20||20
48671899|NCT02878382|101982503|FG001|COMPLETED|Overall Study||20||20
48671900|NCT02878382|101982502|FG000|NOT COMPLETED|Overall Study||0||0
48671901|NCT02878382|101982503|FG001|NOT COMPLETED|Overall Study||0||0
48671902|NCT01150357|101982504|FG000|STARTED|Dose Response Phase (Phase 1)||108||
48671903|NCT01150357|101982505|FG001|STARTED|Dose Response Phase (Phase 1)||54||
48671904|NCT01150357|101982506|FG002|STARTED|Dose Response Phase (Phase 1)||105||
48671905|NCT01150357|101982504|FG000|COMPLETED|Dose Response Phase (Phase 1)||107||
48671906|NCT01150357|101982505|FG001|COMPLETED|Dose Response Phase (Phase 1)||51||
48671907|NCT01150357|101982506|FG002|COMPLETED|Dose Response Phase (Phase 1)||102||
48671908|NCT01150357|101982504|FG000|NOT COMPLETED|Dose Response Phase (Phase 1)||1||
48671909|NCT01150357|101982505|FG001|NOT COMPLETED|Dose Response Phase (Phase 1)||3||
48671910|NCT01150357|101982506|FG002|NOT COMPLETED|Dose Response Phase (Phase 1)||3||
48671911|NCT01150357|101982504|FG000|STARTED|Placebo-controlled Withdrawal (Phase 2)||107||
48671912|NCT01150357|101982505|FG001|STARTED|Placebo-controlled Withdrawal (Phase 2)||51||
48671913|NCT01150357|101982506|FG002|STARTED|Placebo-controlled Withdrawal (Phase 2)||102||
48671914|NCT01150357|101982504|FG000|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50||
48671915|NCT01150357|101982505|FG001|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30||
48671916|NCT01150357|101982506|FG002|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50||
48671917|NCT01150357|101982504|FG000|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50||
48671918|NCT01150357|101982505|FG001|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30||
48710637|NCT03777709|102077980|FG001|STARTED|Overall Study||44||8
48671919|NCT01150357|101982506|FG002|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||49||
48671920|NCT01150357|101982504|FG000|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||57||
48671921|NCT01150357|101982505|FG001|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||21||
48671922|NCT01150357|101982506|FG002|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||52||
48671923|NCT01150357|101982504|FG000|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||54||
48671924|NCT01150357|101982505|FG001|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||21||
48671925|NCT01150357|101982506|FG002|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||51||
48671926|NCT01150357|101982504|FG000|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||104||
48671927|NCT01150357|101982505|FG001|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||51||
48671928|NCT01150357|101982506|FG002|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||100||
48671929|NCT01150357|101982504|FG000|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||3||
48671930|NCT01150357|101982505|FG001|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||0||
48671931|NCT01150357|101982506|FG002|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||2||
48671932|NCT01170663|101982507|FG000|STARTED|Overall Study||330|One participant randomized to placebo/paclitaxel arm but received ramucirumab (IMC-1121B) in error.|
48671933|NCT01170663|101982508|FG001|STARTED|Overall Study||335|One participant randomized to placebo/paclitaxel arm but received ramucirumab (IMC-1121B) in error.|
48671934|NCT01170663|101982507|FG000|Received Any Treatment (Safety Pop)|Overall Study||327||
48671935|NCT01170663|101982508|FG001|Received Any Treatment (Safety Pop)|Overall Study||329||
48671936|NCT01170663|101982507|FG000|COMPLETED|Overall Study||316||
48671937|NCT01170663|101982508|FG001|COMPLETED|Overall Study||315||
48671938|NCT01170663|101982507|FG000|NOT COMPLETED|Overall Study||14||
48671939|NCT01170663|101982508|FG001|NOT COMPLETED|Overall Study||20||
48671940|NCT04103450|101982509|FG000|STARTED|Overall Study||142||
48671941|NCT04103450|101982510|FG001|STARTED|Overall Study||134||
48671942|NCT04103450|101982509|FG000|COMPLETED|Overall Study||126||
48671943|NCT04103450|101982510|FG001|COMPLETED|Overall Study||124||
48071907|NCT01189604|100498099|FG005|STARTED|Overall Study||11||
48071908|NCT01189604|100498100|FG006|STARTED|Overall Study||10||
48071909|NCT01189604|100498094|FG000|Administered Study Drug|Overall Study||20||
48671944|NCT04103450|101982509|FG000|NOT COMPLETED|Overall Study||16||
48671945|NCT04103450|101982510|FG001|NOT COMPLETED|Overall Study||10||
48671946|NCT01270529|101982511|FG000|STARTED|Overall Study||12||
48671947|NCT01270529|101982512|FG001|STARTED|Overall Study||7||
48671948|NCT01270529|101982513|FG002|STARTED|Overall Study||25||
48671949|NCT01270529|101982511|FG000|COMPLETED|Overall Study||12||
48671950|NCT01270529|101982512|FG001|COMPLETED|Overall Study||7||
48671951|NCT01270529|101982513|FG002|COMPLETED|Overall Study||25||
48671952|NCT01270529|101982511|FG000|NOT COMPLETED|Overall Study||0||
48671953|NCT01270529|101982512|FG001|NOT COMPLETED|Overall Study||0||
48671954|NCT01270529|101982513|FG002|NOT COMPLETED|Overall Study||0||
48671955|NCT01055028|101982514|FG000|STARTED|Screening||9||
48671956|NCT01055028|101982515|FG001|STARTED|Screening||9||
48671957|NCT01055028|101982514|FG000|COMPLETED|Screening||8||
48671958|NCT01055028|101982515|FG001|COMPLETED|Screening||8||
48671959|NCT01055028|101982514|FG000|NOT COMPLETED|Screening||1||
48671960|NCT01055028|101982515|FG001|NOT COMPLETED|Screening||1||
48671961|NCT01055028|101982514|FG000|STARTED|Treatment Cycles 1 to 3||8||
48671962|NCT01055028|101982515|FG001|STARTED|Treatment Cycles 1 to 3||8||
48671963|NCT01055028|101982514|FG000|COMPLETED|Treatment Cycles 1 to 3||6||
48671964|NCT01055028|101982515|FG001|COMPLETED|Treatment Cycles 1 to 3||5||
48671965|NCT01055028|101982514|FG000|NOT COMPLETED|Treatment Cycles 1 to 3||2||
48671966|NCT01055028|101982515|FG001|NOT COMPLETED|Treatment Cycles 1 to 3||3||
48671967|NCT01055028|101982514|FG000|STARTED|Inter-treatment Period||6||
48671968|NCT01055028|101982515|FG001|STARTED|Inter-treatment Period||5||
48671969|NCT01055028|101982514|FG000|COMPLETED|Inter-treatment Period||6||
48671970|NCT01055028|101982515|FG001|COMPLETED|Inter-treatment Period||2||
48671971|NCT01055028|101982514|FG000|NOT COMPLETED|Inter-treatment Period||0||
48671972|NCT01055028|101982515|FG001|NOT COMPLETED|Inter-treatment Period||3||
48671973|NCT01055028|101982514|FG000|STARTED|Treatment Cycles 4 to 6||6||
48671974|NCT01055028|101982515|FG001|STARTED|Treatment Cycles 4 to 6||2||
48671975|NCT01055028|101982514|FG000|COMPLETED|Treatment Cycles 4 to 6||6||
48671976|NCT01055028|101982515|FG001|COMPLETED|Treatment Cycles 4 to 6||2||
48671977|NCT01055028|101982514|FG000|NOT COMPLETED|Treatment Cycles 4 to 6||0||
48671978|NCT01055028|101982515|FG001|NOT COMPLETED|Treatment Cycles 4 to 6||0||
48671979|NCT03896633|101982516|FG000|STARTED|Overall Study||321||
48671980|NCT03896633|101982517|FG001|STARTED|Overall Study||316||
48671981|NCT03896633|101982516|FG000|COMPLETED|Overall Study||312||
48671982|NCT03896633|101982517|FG001|COMPLETED|Overall Study||306||
48671983|NCT03896633|101982516|FG000|NOT COMPLETED|Overall Study||9||
48671984|NCT03896633|101982517|FG001|NOT COMPLETED|Overall Study||10||
48671985|NCT03556891|101982518|FG000|STARTED|Overall Study||133||
48671986|NCT03556891|101982518|FG000|COMPLETED|Overall Study||120||
48671987|NCT03556891|101982518|FG000|NOT COMPLETED|Overall Study||13||
48671988|NCT00687076|101982519|FG000|STARTED|Overall Study||51||
48671989|NCT00687076|101982520|FG001|STARTED|Overall Study||51||
48671990|NCT00687076|101982519|FG000|COMPLETED|Overall Study||19||
48671991|NCT00687076|101982520|FG001|COMPLETED|Overall Study||21||
48671992|NCT00687076|101982519|FG000|NOT COMPLETED|Overall Study||32||
48671993|NCT00687076|101982520|FG001|NOT COMPLETED|Overall Study||30||
48671994|NCT00760552|101982521|FG000|STARTED|Overall Study||61||
48671995|NCT00760552|101982522|FG001|STARTED|Overall Study||62||
48671996|NCT00760552|101982521|FG000|COMPLETED|Overall Study||48||
48671997|NCT00760552|101982522|FG001|COMPLETED|Overall Study||52||
48671998|NCT00760552|101982521|FG000|NOT COMPLETED|Overall Study||13||
48671999|NCT00760552|101982522|FG001|NOT COMPLETED|Overall Study||10||
48672000|NCT00730327|101982523|FG000|STARTED|Overall Study||125||
48672001|NCT00730327|101982524|FG001|STARTED|Overall Study||130||
48672002|NCT00730327|101982523|FG000|Completed Week 26|Overall Study||125||
48672003|NCT00730327|101982524|FG001|Completed Week 26|Overall Study||99||
48672004|NCT00730327|101982523|FG000|COMPLETED|Overall Study||98||
48672005|NCT00730327|101982524|FG001|COMPLETED|Overall Study||93||
48672006|NCT00730327|101982523|FG000|NOT COMPLETED|Overall Study||27||
48672007|NCT00730327|101982524|FG001|NOT COMPLETED|Overall Study||37||
48672008|NCT02733757|101982525|FG000|STARTED|Overall Study||20||
48672009|NCT02733757|101982526|FG001|STARTED|Overall Study||20||
48672010|NCT02733757|101982527|FG002|STARTED|Overall Study||20||
48672011|NCT02733757|101982528|FG003|STARTED|Overall Study||20||
48672012|NCT02733757|101982525|FG000|COMPLETED|Overall Study||20||
48672013|NCT02733757|101982526|FG001|COMPLETED|Overall Study||20||
48672014|NCT02733757|101982527|FG002|COMPLETED|Overall Study||20||
48672015|NCT02733757|101982528|FG003|COMPLETED|Overall Study||20||
48672016|NCT02733757|101982525|FG000|NOT COMPLETED|Overall Study||0||
48672017|NCT02733757|101982526|FG001|NOT COMPLETED|Overall Study||0||
48672018|NCT02733757|101982527|FG002|NOT COMPLETED|Overall Study||0||
48672019|NCT02733757|101982528|FG003|NOT COMPLETED|Overall Study||0||
48672020|NCT04476784|101982529|FG000|STARTED|First Wear Period (30 Days ± 2 Days)||31||62
48672021|NCT04476784|101982530|FG001|STARTED|First Wear Period (30 Days ± 2 Days)||35||70
48071910|NCT01189604|100498095|FG001|Administered Study Drug|Overall Study||20||
48071911|NCT01189604|100498096|FG002|Administered Study Drug|Overall Study||20||
48071912|NCT01189604|100498097|FG003|Administered Study Drug|Overall Study||20||
48071913|NCT01189604|100498098|FG004|Administered Study Drug|Overall Study||20||
48071914|NCT01189604|100498099|FG005|Administered Study Drug|Overall Study||10||
48071915|NCT01189604|100498100|FG006|Administered Study Drug|Overall Study||10||
48071916|NCT01189604|100498094|FG000|COMPLETED|Overall Study||20||
48071917|NCT01189604|100498095|FG001|COMPLETED|Overall Study||20||
48071918|NCT01189604|100498096|FG002|COMPLETED|Overall Study||20||
48071919|NCT01189604|100498097|FG003|COMPLETED|Overall Study||20||
48071920|NCT01189604|100498098|FG004|COMPLETED|Overall Study||18||
48071921|NCT01189604|100498099|FG005|COMPLETED|Overall Study||10||
48071922|NCT01189604|100498100|FG006|COMPLETED|Overall Study||9||
48071923|NCT01189604|100498094|FG000|NOT COMPLETED|Overall Study||1||
48071924|NCT01189604|100498095|FG001|NOT COMPLETED|Overall Study||1||
48071925|NCT01189604|100498096|FG002|NOT COMPLETED|Overall Study||0||
48071926|NCT01189604|100498097|FG003|NOT COMPLETED|Overall Study||0||
48071927|NCT01189604|100498098|FG004|NOT COMPLETED|Overall Study||2||
48071928|NCT01189604|100498099|FG005|NOT COMPLETED|Overall Study||1||
48071929|NCT01189604|100498100|FG006|NOT COMPLETED|Overall Study||1||
48071930|NCT01365052|100498101|FG000|STARTED|Overall Study||217||
48071931|NCT01365052|100498102|FG001|STARTED|Overall Study||109||
48071932|NCT01365052|100498101|FG000|COMPLETED|Overall Study||213||
48071933|NCT01365052|100498102|FG001|COMPLETED|Overall Study||105||
48071934|NCT01365052|100498101|FG000|NOT COMPLETED|Overall Study||4||
48071935|NCT01365052|100498102|FG001|NOT COMPLETED|Overall Study||4||
48071936|NCT03988088|100498103|FG000|STARTED|Single-Dose Pharmacokinetic Study||11||
48071937|NCT03988088|100498104|FG001|STARTED|Single-Dose Pharmacokinetic Study||7||
48071938|NCT03988088|100498105|FG002|STARTED|Single-Dose Pharmacokinetic Study||0||
48071939|NCT03988088|100498106|FG003|STARTED|Single-Dose Pharmacokinetic Study||0||
48071940|NCT03988088|100498103|FG000|COMPLETED|Single-Dose Pharmacokinetic Study||11||
48071941|NCT03988088|100498104|FG001|COMPLETED|Single-Dose Pharmacokinetic Study||6||
48071942|NCT03988088|100498105|FG002|COMPLETED|Single-Dose Pharmacokinetic Study||0||
48071943|NCT03988088|100498106|FG003|COMPLETED|Single-Dose Pharmacokinetic Study||0||
48071944|NCT03988088|100498103|FG000|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0||
48071945|NCT03988088|100498104|FG001|NOT COMPLETED|Single-Dose Pharmacokinetic Study||1||
48071946|NCT03988088|100498105|FG002|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0||
48071947|NCT03988088|100498106|FG003|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0||
48071948|NCT03988088|100498103|FG000|STARTED|Open-Label Addendum||0||
48071949|NCT03988088|100498104|FG001|STARTED|Open-Label Addendum||0||
48071950|NCT03988088|100498105|FG002|STARTED|Open-Label Addendum||2||
48071951|NCT03988088|100498106|FG003|STARTED|Open-Label Addendum||2||
48071952|NCT03988088|100498103|FG000|COMPLETED|Open-Label Addendum||0||
48071953|NCT03988088|100498104|FG001|COMPLETED|Open-Label Addendum||0||
48071954|NCT03988088|100498105|FG002|COMPLETED|Open-Label Addendum||1||
48071955|NCT03988088|100498106|FG003|COMPLETED|Open-Label Addendum||2||
48071956|NCT03988088|100498103|FG000|NOT COMPLETED|Open-Label Addendum||0||
48071957|NCT03988088|100498104|FG001|NOT COMPLETED|Open-Label Addendum||0||
48071958|NCT03988088|100498105|FG002|NOT COMPLETED|Open-Label Addendum||1||
48071959|NCT03988088|100498106|FG003|NOT COMPLETED|Open-Label Addendum||0||
48071960|NCT02243696|100498107|FG000|STARTED|Overall Study||1694||
48672022|NCT04476784|101982529|FG000|COMPLETED|First Wear Period (30 Days ± 2 Days)||30||60
48071961|NCT02243696|100498107|FG000|COMPLETED|Overall Study||0||
48071962|NCT02243696|100498107|FG000|NOT COMPLETED|Overall Study||1694||
48071963|NCT03273270|100498108|FG000|STARTED|Overall Study||12||
48071964|NCT03273270|100498109|FG001|STARTED|Overall Study||8||
48071965|NCT03273270|100498108|FG000|COMPLETED|Overall Study||12||
48071966|NCT03273270|100498109|FG001|COMPLETED|Overall Study||8||
48071967|NCT03273270|100498108|FG000|NOT COMPLETED|Overall Study||0||
48071968|NCT03273270|100498109|FG001|NOT COMPLETED|Overall Study||0||
48071969|NCT00113022|100498110|FG000|STARTED|Overall Study||5||
48071970|NCT00113022|100498111|FG001|STARTED|Overall Study||4||
48071971|NCT00113022|100498110|FG000|COMPLETED|Overall Study||2||
48071972|NCT00113022|100498111|FG001|COMPLETED|Overall Study||2||
48071973|NCT00113022|100498110|FG000|NOT COMPLETED|Overall Study||3||
48071974|NCT00113022|100498111|FG001|NOT COMPLETED|Overall Study||2||
48071975|NCT02028754|100498112|FG000|STARTED|Overall Study||90||
48071976|NCT02028754|100498113|FG001|STARTED|Overall Study||90||
48071977|NCT02028754|100498112|FG000|COMPLETED|Overall Study||83||
48071978|NCT02028754|100498113|FG001|COMPLETED|Overall Study||82||
48071979|NCT02028754|100498112|FG000|NOT COMPLETED|Overall Study||7||
48071980|NCT02028754|100498113|FG001|NOT COMPLETED|Overall Study||8||
48071981|NCT00289133|100498114|FG000|STARTED|Overall Study||461||
48071982|NCT00289133|100498115|FG001|STARTED|Overall Study||477||
48071983|NCT00289133|100498114|FG000|COMPLETED|Overall Study||189||
48071984|NCT00289133|100498115|FG001|COMPLETED|Overall Study||179||
48071985|NCT00289133|100498114|FG000|NOT COMPLETED|Overall Study||272||
48071986|NCT00289133|100498115|FG001|NOT COMPLETED|Overall Study||298||
48071987|NCT01146665|100498116|FG000|STARTED|Overall Study||18||
48071988|NCT01146665|100498117|FG001|STARTED|Overall Study||26||
48071989|NCT01146665|100498116|FG000|1-month Post-ED Discharge (Follow-up)|Overall Study||9||
48071990|NCT01146665|100498117|FG001|1-month Post-ED Discharge (Follow-up)|Overall Study||12||
48071991|NCT01146665|100498116|FG000|3-month Post-ED Discharge (Follow-up)|Overall Study||8||
48071992|NCT01146665|100498117|FG001|3-month Post-ED Discharge (Follow-up)|Overall Study||10||
48071993|NCT01146665|100498116|FG000|COMPLETED|Overall Study||8||
48071994|NCT01146665|100498117|FG001|COMPLETED|Overall Study||10||
48071995|NCT01146665|100498116|FG000|NOT COMPLETED|Overall Study||10||
48071996|NCT01146665|100498117|FG001|NOT COMPLETED|Overall Study||16||
48071997|NCT03329508|100498118|FG000|STARTED|Overall Study||157||
48071998|NCT03329508|100498119|FG001|STARTED|Overall Study||154||
48071999|NCT03329508|100498120|FG002|STARTED|Overall Study||156||
48072000|NCT03329508|100498121|FG003|STARTED|Overall Study||77||
48072001|NCT03329508|100498118|FG000|COMPLETED|Overall Study||137||
48072002|NCT03329508|100498119|FG001|COMPLETED|Overall Study||134||
48072003|NCT03329508|100498120|FG002|COMPLETED|Overall Study||137||
48072004|NCT03329508|100498121|FG003|COMPLETED|Overall Study||67||
48072005|NCT03329508|100498118|FG000|NOT COMPLETED|Overall Study||20||
48072006|NCT03329508|100498119|FG001|NOT COMPLETED|Overall Study||20||
48072007|NCT03329508|100498120|FG002|NOT COMPLETED|Overall Study||19||
48072008|NCT03329508|100498121|FG003|NOT COMPLETED|Overall Study||10||
48072009|NCT01431989|100498122|FG000|STARTED|Period 1||14||
48072010|NCT01431989|100498123|FG001|STARTED|Period 1||14||
48072011|NCT01431989|100498122|FG000|COMPLETED|Period 1||14||
48072012|NCT01431989|100498123|FG001|COMPLETED|Period 1||14||
48072013|NCT01431989|100498122|FG000|NOT COMPLETED|Period 1||0||
48072014|NCT01431989|100498123|FG001|NOT COMPLETED|Period 1||0||
48072015|NCT01431989|100498122|FG000|STARTED|14-Day Washout Period||14||
48072016|NCT01431989|100498123|FG001|STARTED|14-Day Washout Period||14||
48072017|NCT01431989|100498122|FG000|COMPLETED|14-Day Washout Period||14||
48072018|NCT01431989|100498123|FG001|COMPLETED|14-Day Washout Period||14||
48072019|NCT01431989|100498122|FG000|NOT COMPLETED|14-Day Washout Period||0||
48072020|NCT01431989|100498123|FG001|NOT COMPLETED|14-Day Washout Period||0||
48072021|NCT01431989|100498122|FG000|STARTED|Period 2||14||
48072022|NCT01431989|100498123|FG001|STARTED|Period 2||14||
48072023|NCT01431989|100498122|FG000|COMPLETED|Period 2||14||
48072024|NCT01431989|100498123|FG001|COMPLETED|Period 2||14||
48072025|NCT01431989|100498122|FG000|NOT COMPLETED|Period 2||0||
48072026|NCT01431989|100498123|FG001|NOT COMPLETED|Period 2||0||
48072027|NCT03643796|100498124|FG000|STARTED|Overall Study||15||
48072028|NCT03643796|100498125|FG001|STARTED|Overall Study||17||
48072029|NCT03643796|100498124|FG000|COMPLETED|Overall Study||15||
48072030|NCT03643796|100498125|FG001|COMPLETED|Overall Study||17||
48072031|NCT03643796|100498124|FG000|NOT COMPLETED|Overall Study||0||
48072032|NCT03643796|100498125|FG001|NOT COMPLETED|Overall Study||0||
48072033|NCT01112358|100498126|FG000|STARTED|Overall Study||25||
48072034|NCT01112358|100498127|FG001|STARTED|Overall Study||33||
48072035|NCT01112358|100498126|FG000|COMPLETED|Overall Study||25||
48072036|NCT01112358|100498127|FG001|COMPLETED|Overall Study||33||
48072037|NCT01112358|100498126|FG000|NOT COMPLETED|Overall Study||0||
48072038|NCT01112358|100498127|FG001|NOT COMPLETED|Overall Study||0||
48072039|NCT02933606|100498128|FG000|STARTED|Overall Study||49||
48072040|NCT02933606|100498129|FG001|STARTED|Overall Study||48||
48072041|NCT02933606|100498130|FG002|STARTED|Overall Study||47||
48072042|NCT02933606|100498131|FG003|STARTED|Overall Study||49||
48072043|NCT02933606|100498128|FG000|COMPLETED|Overall Study||33||
48072044|NCT02933606|100498129|FG001|COMPLETED|Overall Study||39||
48072045|NCT02933606|100498130|FG002|COMPLETED|Overall Study||33||
48072046|NCT02933606|100498131|FG003|COMPLETED|Overall Study||30||
48072047|NCT02933606|100498128|FG000|NOT COMPLETED|Overall Study||16||
48072048|NCT02933606|100498129|FG001|NOT COMPLETED|Overall Study||9||
48072049|NCT02933606|100498130|FG002|NOT COMPLETED|Overall Study||14||
48072050|NCT02933606|100498131|FG003|NOT COMPLETED|Overall Study||19||
48072051|NCT04930965|100498132|FG000|STARTED|Overall Study||27||
48072052|NCT04930965|100498133|FG001|STARTED|Overall Study||29||
48072053|NCT04930965|100498132|FG000|COMPLETED|Overall Study||20||
48072054|NCT04930965|100498133|FG001|COMPLETED|Overall Study||24||
48072055|NCT04930965|100498132|FG000|NOT COMPLETED|Overall Study||7||
48072056|NCT04930965|100498133|FG001|NOT COMPLETED|Overall Study||5||
48072057|NCT00223262|100498134|FG000|STARTED|Overall Study||16||
48072058|NCT00223262|100498135|FG001|STARTED|Overall Study||12||
48072059|NCT00223262|100498134|FG000|COMPLETED|Overall Study||8||
48072060|NCT00223262|100498135|FG001|COMPLETED|Overall Study||11||
48072061|NCT00223262|100498134|FG000|NOT COMPLETED|Overall Study||8||
48072062|NCT00223262|100498135|FG001|NOT COMPLETED|Overall Study||1||
48072063|NCT05350410|100498136|FG000|STARTED|Overall Study||20||
48072064|NCT05350410|100498136|FG000|COMPLETED|Overall Study||19||
48072065|NCT05350410|100498136|FG000|NOT COMPLETED|Overall Study||1||
48072066|NCT00567307|100498137|FG000|STARTED|Overall Study||111||
48072067|NCT00567307|100498138|FG001|STARTED|Overall Study||105||
48072068|NCT00567307|100498137|FG000|COMPLETED|Overall Study||99||
48072069|NCT00567307|100498138|FG001|COMPLETED|Overall Study||104||
48072070|NCT00567307|100498137|FG000|NOT COMPLETED|Overall Study||12||
48072071|NCT00567307|100498138|FG001|NOT COMPLETED|Overall Study||1||
48072072|NCT03068455|100498139|FG000|STARTED|Pre-treatment Period||920|Started = Randomized|
48072073|NCT03068455|100498140|FG001|STARTED|Pre-treatment Period||924|Started = Randomized|
48072074|NCT03068455|100498139|FG000|COMPLETED|Pre-treatment Period||916|Completed = Treated|
48072075|NCT03068455|100498140|FG001|COMPLETED|Pre-treatment Period||917|Completed = Treated|
48072076|NCT03068455|100498139|FG000|NOT COMPLETED|Pre-treatment Period||4||
48072077|NCT03068455|100498140|FG001|NOT COMPLETED|Pre-treatment Period||7||
48072078|NCT03068455|100498139|FG000|STARTED|Treatment Period||916|Started = Treated|
48072079|NCT03068455|100498140|FG001|STARTED|Treatment Period||917|Started = Treated|
48072080|NCT03068455|100498139|FG000|COMPLETED|Treatment Period||364|Completed = Finished treatment period|
48072081|NCT03068455|100498140|FG001|COMPLETED|Treatment Period||561|Completed = Finished treatment period|
48072082|NCT03068455|100498139|FG000|NOT COMPLETED|Treatment Period||552||
48072083|NCT03068455|100498140|FG001|NOT COMPLETED|Treatment Period||356||
48072084|NCT04203797|100498141|FG000|STARTED|Overall Study||20||
48072085|NCT04203797|100498142|FG001|STARTED|Overall Study||20||
48072086|NCT04203797|100498141|FG000|COMPLETED|Overall Study||18||
48072087|NCT04203797|100498142|FG001|COMPLETED|Overall Study||20||
48072088|NCT04203797|100498141|FG000|NOT COMPLETED|Overall Study||2||
48072089|NCT04203797|100498142|FG001|NOT COMPLETED|Overall Study||0||
48072090|NCT02015754|100498143|FG000|STARTED|Overall Study||14||
48072091|NCT02015754|100498143|FG000|Completed First TACE|Overall Study||14|Number of patients who completed the first treatment on protocol and included in analysis.|
48072092|NCT02015754|100498143|FG000|Completed First Clinical and Imaging|Overall Study||13|Participants completing this milestone will be analyzed for image response outcomes|
48072093|NCT02015754|100498143|FG000|COMPLETED|Overall Study||3|Participants who have completed all 24 weeks of treatment on trial|
48072094|NCT02015754|100498143|FG000|NOT COMPLETED|Overall Study||11||
48072095|NCT02000583|100498144|FG000|STARTED|Overall Study||78||
48072096|NCT02000583|100498145|FG001|STARTED|Overall Study||39||
48072097|NCT02000583|100498144|FG000|COMPLETED|Overall Study||75||
48072098|NCT02000583|100498145|FG001|COMPLETED|Overall Study||34||
48072099|NCT02000583|100498144|FG000|NOT COMPLETED|Overall Study||3||
48072100|NCT02000583|100498145|FG001|NOT COMPLETED|Overall Study||5||
48072101|NCT03719612|100498146|FG000|STARTED|Overall Study||160||
48072102|NCT03719612|100498146|FG000|COMPLETED|Overall Study||148||
48072103|NCT03719612|100498146|FG000|NOT COMPLETED|Overall Study||12||
48072104|NCT02747875|100498147|FG000|STARTED|Overall Study||12||
48072105|NCT02747875|100498148|FG001|STARTED|Overall Study||14||
48072106|NCT02747875|100498147|FG000|COMPLETED|Overall Study||11||
48072107|NCT02747875|100498148|FG001|COMPLETED|Overall Study||13||
48072108|NCT02747875|100498147|FG000|NOT COMPLETED|Overall Study||1||
48072109|NCT02747875|100498148|FG001|NOT COMPLETED|Overall Study||1||
48072110|NCT04502433|100498149|FG000|STARTED|Overall Study||8||
48072111|NCT04502433|100498150|FG001|STARTED|Overall Study||14||
48072112|NCT04502433|100498149|FG000|COMPLETED|Overall Study||5||
48072113|NCT04502433|100498150|FG001|COMPLETED|Overall Study||9||
48072114|NCT04502433|100498149|FG000|NOT COMPLETED|Overall Study||3||
48072115|NCT04502433|100498150|FG001|NOT COMPLETED|Overall Study||5||
48072116|NCT00983437|100498151|FG000|STARTED|Overall Study||47||
48072117|NCT00983437|100498151|FG000|Safety Analysis Set (SAS)|Overall Study||47||
48072118|NCT00983437|100498151|FG000|Full Analysis Set (FAS)|Overall Study||45||
48072119|NCT00983437|100498151|FG000|COMPLETED|Overall Study||0||
48072120|NCT00983437|100498151|FG000|NOT COMPLETED|Overall Study||47||
48072121|NCT01896050|100498152|FG000|STARTED|Overall Study||93||
48072122|NCT01896050|100498153|FG001|STARTED|Overall Study||22||
48072123|NCT01896050|100498152|FG000|COMPLETED|Overall Study||55||
48072124|NCT01896050|100498153|FG001|COMPLETED|Overall Study||20||
48072125|NCT01896050|100498152|FG000|NOT COMPLETED|Overall Study||38||
48072126|NCT01896050|100498153|FG001|NOT COMPLETED|Overall Study||2||
48072127|NCT02130297|100498154|FG000|STARTED|Overall Study||30||
48072128|NCT02130297|100498154|FG000|COMPLETED|Overall Study||26||
48072129|NCT02130297|100498154|FG000|NOT COMPLETED|Overall Study||4||
48072130|NCT05306977|100498155|FG000|STARTED|Overall Study||5||
48072131|NCT05306977|100498155|FG000|COMPLETED|Overall Study||4||
48072132|NCT05306977|100498155|FG000|NOT COMPLETED|Overall Study||1||
48072133|NCT01213329|100498156|FG000|STARTED|Screening||25||
48072134|NCT01213329|100498157|FG001|STARTED|Screening||25||
48072135|NCT01213329|100498156|FG000|COMPLETED|Screening||25||
48072136|NCT01213329|100498157|FG001|COMPLETED|Screening||25||
48072137|NCT01213329|100498156|FG000|NOT COMPLETED|Screening||0||
48072138|NCT01213329|100498157|FG001|NOT COMPLETED|Screening||0||
48072139|NCT01213329|100498156|FG000|STARTED|Phase 2||0||
48072140|NCT01213329|100498157|FG001|STARTED|Phase 2||0||
48072141|NCT01213329|100498156|FG000|COMPLETED|Phase 2||0||
48072142|NCT01213329|100498157|FG001|COMPLETED|Phase 2||0||
48072143|NCT01213329|100498156|FG000|NOT COMPLETED|Phase 2||0||
48072144|NCT01213329|100498157|FG001|NOT COMPLETED|Phase 2||0||
48072145|NCT00392015|100498158|FG000|STARTED|Overall Study||6||
48072146|NCT00392015|100498159|FG001|STARTED|Overall Study||6||
48072147|NCT00392015|100498160|FG002|STARTED|Overall Study||20||
48072148|NCT00392015|100498161|FG003|STARTED|Overall Study||6||
48072149|NCT00392015|100498162|FG004|STARTED|Overall Study||15||
48072150|NCT00392015|100498163|FG005|STARTED|Overall Study||6||
48072151|NCT00392015|100498158|FG000|COMPLETED|Overall Study||4||
48072152|NCT00392015|100498159|FG001|COMPLETED|Overall Study||6||
48072153|NCT00392015|100498160|FG002|COMPLETED|Overall Study||16||
48072154|NCT00392015|100498161|FG003|COMPLETED|Overall Study||5||
48072155|NCT00392015|100498162|FG004|COMPLETED|Overall Study||12||
48072156|NCT00392015|100498163|FG005|COMPLETED|Overall Study||6||
48072157|NCT00392015|100498158|FG000|NOT COMPLETED|Overall Study||2||
48072158|NCT00392015|100498159|FG001|NOT COMPLETED|Overall Study||0||
48072159|NCT00392015|100498160|FG002|NOT COMPLETED|Overall Study||4||
48072160|NCT00392015|100498161|FG003|NOT COMPLETED|Overall Study||1||
48072161|NCT00392015|100498162|FG004|NOT COMPLETED|Overall Study||3||
48072162|NCT00392015|100498163|FG005|NOT COMPLETED|Overall Study||0||
48072163|NCT02846714|100498164|FG000|STARTED|Overall Study||42||
48072164|NCT02846714|100498164|FG000|COMPLETED|Overall Study||36||
48072165|NCT02846714|100498164|FG000|NOT COMPLETED|Overall Study||6||
48072166|NCT01267045|100498165|FG000|STARTED|2-month Outcomes||26||
48072167|NCT01267045|100498166|FG001|STARTED|2-month Outcomes||29||
48072168|NCT01267045|100498165|FG000|COMPLETED|2-month Outcomes||22||
48072169|NCT01267045|100498166|FG001|COMPLETED|2-month Outcomes||26||
48072170|NCT01267045|100498165|FG000|NOT COMPLETED|2-month Outcomes||4||
48072171|NCT01267045|100498166|FG001|NOT COMPLETED|2-month Outcomes||3||
48072172|NCT01267045|100498165|FG000|STARTED|6-month Outcome||22||
48072173|NCT01267045|100498166|FG001|STARTED|6-month Outcome||26||
48072174|NCT01267045|100498165|FG000|COMPLETED|6-month Outcome||22||
48072175|NCT01267045|100498166|FG001|COMPLETED|6-month Outcome||23||
48072176|NCT01267045|100498165|FG000|NOT COMPLETED|6-month Outcome||0||
48072177|NCT01267045|100498166|FG001|NOT COMPLETED|6-month Outcome||3||
48072178|NCT01768286|100498167|FG000|STARTED|Overall Study||109||
48072179|NCT01768286|100498168|FG001|STARTED|Overall Study||111||
48072180|NCT01768286|100498169|FG002|STARTED|Overall Study||110||
48072181|NCT01768286|100498170|FG003|STARTED|Overall Study||111||
48072182|NCT01768286|100498167|FG000|COMPLETED|Overall Study||102||
48072183|NCT01768286|100498168|FG001|COMPLETED|Overall Study||107||
48072184|NCT01768286|100498169|FG002|COMPLETED|Overall Study||108||
48072185|NCT01768286|100498170|FG003|COMPLETED|Overall Study||110||
48072186|NCT01768286|100498167|FG000|NOT COMPLETED|Overall Study||7||
48072187|NCT01768286|100498168|FG001|NOT COMPLETED|Overall Study||4||
48072188|NCT01768286|100498169|FG002|NOT COMPLETED|Overall Study||2||
48072189|NCT01768286|100498170|FG003|NOT COMPLETED|Overall Study||1||
48072190|NCT01337700|100498171|FG000|STARTED|Overall Study||5||
48072191|NCT01337700|100498172|FG001|STARTED|Overall Study||5||
48072192|NCT01337700|100498171|FG000|COMPLETED|Overall Study||5||
48072193|NCT01337700|100498172|FG001|COMPLETED|Overall Study||5||
48072194|NCT01337700|100498171|FG000|NOT COMPLETED|Overall Study||0||
48072195|NCT01337700|100498172|FG001|NOT COMPLETED|Overall Study||0||
48072196|NCT03572972|100498173|FG000|STARTED|Overall Study||10548||
48072197|NCT03572972|100498174|FG001|STARTED|Overall Study||11414||
48072198|NCT03572972|100498175|FG002|STARTED|Overall Study||17779||
48072199|NCT03572972|100498176|FG003|STARTED|Overall Study||8648||
48072200|NCT03572972|100498177|FG004|STARTED|Overall Study||16295||
48072201|NCT03572972|100498173|FG000|COMPLETED|Overall Study||10548||
48072202|NCT03572972|100498174|FG001|COMPLETED|Overall Study||11414||
48072203|NCT03572972|100498175|FG002|COMPLETED|Overall Study||17779||
48072204|NCT03572972|100498176|FG003|COMPLETED|Overall Study||8648||
48072205|NCT03572972|100498177|FG004|COMPLETED|Overall Study||16295||
48072206|NCT03572972|100498173|FG000|NOT COMPLETED|Overall Study||0||
48072207|NCT03572972|100498174|FG001|NOT COMPLETED|Overall Study||0||
48072208|NCT03572972|100498175|FG002|NOT COMPLETED|Overall Study||0||
48072209|NCT03572972|100498176|FG003|NOT COMPLETED|Overall Study||0||
48072210|NCT03572972|100498177|FG004|NOT COMPLETED|Overall Study||0||
48072211|NCT01253408|100498178|FG000|STARTED|Overall Study||10||
48072212|NCT01253408|100498179|FG001|STARTED|Overall Study||13||
48072213|NCT01253408|100498180|FG002|STARTED|Overall Study||13||
48072214|NCT01253408|100498178|FG000|COMPLETED|Overall Study||10||
48072215|NCT01253408|100498179|FG001|COMPLETED|Overall Study||12||
48072216|NCT01253408|100498180|FG002|COMPLETED|Overall Study||13||
48072217|NCT01253408|100498178|FG000|NOT COMPLETED|Overall Study||0||
48072218|NCT01253408|100498179|FG001|NOT COMPLETED|Overall Study||1||
48072219|NCT01253408|100498180|FG002|NOT COMPLETED|Overall Study||0||
48072220|NCT03840174|100498181|FG000|STARTED|Overall Study||6||
48072221|NCT03840174|100498182|FG001|STARTED|Overall Study||6||
48072222|NCT03840174|100498183|FG002|STARTED|Overall Study||3||
48072223|NCT03840174|100498184|FG003|STARTED|Overall Study||3||
48072224|NCT03840174|100498181|FG000|Vaccination 1|Overall Study||6||
48072225|NCT03840174|100498182|FG001|Vaccination 1|Overall Study||6||
48072226|NCT03840174|100498183|FG002|Vaccination 1|Overall Study||3||
48072227|NCT03840174|100498184|FG003|Vaccination 1|Overall Study||3||
48072228|NCT03840174|100498181|FG000|Vaccination 2|Overall Study||5||
48072229|NCT03840174|100498182|FG001|Vaccination 2|Overall Study||6||
48072230|NCT03840174|100498183|FG002|Vaccination 2|Overall Study||3||
48072231|NCT03840174|100498184|FG003|Vaccination 2|Overall Study||3||
48072232|NCT03840174|100498181|FG000|Vaccination 3|Overall Study||5||
48072233|NCT03840174|100498182|FG001|Vaccination 3|Overall Study||6||
48072234|NCT03840174|100498183|FG002|Vaccination 3|Overall Study||3||
48072235|NCT03840174|100498184|FG003|Vaccination 3|Overall Study||3||
48072236|NCT03840174|100498181|FG000|COMPLETED|Overall Study||5||
48072237|NCT03840174|100498182|FG001|COMPLETED|Overall Study||6||
48072238|NCT03840174|100498183|FG002|COMPLETED|Overall Study||3||
48072239|NCT03840174|100498184|FG003|COMPLETED|Overall Study||3||
48072240|NCT03840174|100498181|FG000|NOT COMPLETED|Overall Study||1||
48072241|NCT03840174|100498182|FG001|NOT COMPLETED|Overall Study||0||
48072242|NCT03840174|100498183|FG002|NOT COMPLETED|Overall Study||0||
48072243|NCT03840174|100498184|FG003|NOT COMPLETED|Overall Study||0||
48072244|NCT01397890|100498185|FG000|STARTED|Overall Study||287||
48072245|NCT01397890|100498186|FG001|STARTED|Overall Study||291||
48072246|NCT01397890|100498185|FG000|Post-baseline Efficacy Data Collected|Overall Study||287||
48072247|NCT01397890|100498186|FG001|Post-baseline Efficacy Data Collected|Overall Study||290||
48072248|NCT01397890|100498185|FG000|Received Correct Randomized Treatment|Overall Study||286||
48072249|NCT01397890|100498186|FG001|Received Correct Randomized Treatment|Overall Study||287||
48072250|NCT01397890|100498185|FG000|COMPLETED|Overall Study||264||
48072251|NCT01397890|100498186|FG001|COMPLETED|Overall Study||260||
48072252|NCT01397890|100498185|FG000|NOT COMPLETED|Overall Study||23||
48072253|NCT01397890|100498186|FG001|NOT COMPLETED|Overall Study||31||
48072254|NCT03228433|100498187|FG000|STARTED|Overall Study||10||
48072255|NCT03228433|100498188|FG001|STARTED|Overall Study||6||
48072256|NCT03228433|100498189|FG002|STARTED|Overall Study||6||
48072257|NCT03228433|100498190|FG003|STARTED|Overall Study||6||
48072258|NCT03228433|100498191|FG004|STARTED|Overall Study||6||
48072259|NCT03228433|100498192|FG005|STARTED|Overall Study||6||
48072260|NCT03228433|100498187|FG000|COMPLETED|Overall Study||9||
48072261|NCT03228433|100498188|FG001|COMPLETED|Overall Study||6||
48072262|NCT03228433|100498189|FG002|COMPLETED|Overall Study||6||
48072263|NCT03228433|100498190|FG003|COMPLETED|Overall Study||5||
48072264|NCT03228433|100498191|FG004|COMPLETED|Overall Study||6||
48072265|NCT03228433|100498192|FG005|COMPLETED|Overall Study||6||
48072266|NCT03228433|100498187|FG000|NOT COMPLETED|Overall Study||1||
48072267|NCT03228433|100498188|FG001|NOT COMPLETED|Overall Study||0||
48072268|NCT03228433|100498189|FG002|NOT COMPLETED|Overall Study||0||
48672023|NCT04476784|101982530|FG001|COMPLETED|First Wear Period (30 Days ± 2 Days)||35||70
48672024|NCT04476784|101982529|FG000|NOT COMPLETED|First Wear Period (30 Days ± 2 Days)||1||2
48672025|NCT04476784|101982530|FG001|NOT COMPLETED|First Wear Period (30 Days ± 2 Days)||0||0
48672026|NCT04476784|101982529|FG000|STARTED|Second Wear Period (30 Days ± 2 Days)||30||60
48672027|NCT04476784|101982530|FG001|STARTED|Second Wear Period (30 Days ± 2 Days)||35||70
48672028|NCT04476784|101982529|FG000|COMPLETED|Second Wear Period (30 Days ± 2 Days)||30||60
48672029|NCT04476784|101982530|FG001|COMPLETED|Second Wear Period (30 Days ± 2 Days)||35||70
48672030|NCT04476784|101982529|FG000|NOT COMPLETED|Second Wear Period (30 Days ± 2 Days)||0||0
48672031|NCT04476784|101982530|FG001|NOT COMPLETED|Second Wear Period (30 Days ± 2 Days)||0||0
48672032|NCT01605097|101982531|FG000|STARTED|Overall Study||26||
48672033|NCT01605097|101982531|FG000|COMPLETED|Overall Study||25||
48672034|NCT01605097|101982531|FG000|NOT COMPLETED|Overall Study||1||
48672035|NCT01397253|101982532|FG000|STARTED|Overall Study||443||
48672036|NCT01397253|101982533|FG001|STARTED|Overall Study||392||
48672037|NCT01397253|101982532|FG000|COMPLETED|Overall Study||317||
48672038|NCT01397253|101982533|FG001|COMPLETED|Overall Study||243||
48672039|NCT01397253|101982532|FG000|NOT COMPLETED|Overall Study||126||
48672040|NCT01397253|101982533|FG001|NOT COMPLETED|Overall Study||149||
48672041|NCT03283241|101982534|FG000|STARTED|Overall Study||32||57
48072269|NCT03228433|100498190|FG003|NOT COMPLETED|Overall Study||1||
48072270|NCT03228433|100498191|FG004|NOT COMPLETED|Overall Study||0||
48072271|NCT03228433|100498192|FG005|NOT COMPLETED|Overall Study||0||
48072272|NCT01373242|100498193|FG000|STARTED|Overall Study||54||
48672042|NCT03283241|101982535|FG001|STARTED|Overall Study||30||49
48672043|NCT03283241|101982534|FG000|Completed 12 Weeks|Overall Study||29||50
48672044|NCT03283241|101982535|FG001|Completed 12 Weeks|Overall Study||29||48
48672045|NCT03283241|101982534|FG000|COMPLETED|Overall Study||28||44
48672046|NCT03283241|101982535|FG001|COMPLETED|Overall Study||27||47
48672047|NCT03283241|101982534|FG000|NOT COMPLETED|Overall Study||4||13
48672048|NCT03283241|101982535|FG001|NOT COMPLETED|Overall Study||3||2
48672049|NCT03958331|101982536|FG000|STARTED|Overall Study||21||
48672050|NCT03958331|101982537|FG001|STARTED|Overall Study||19||
48672051|NCT03958331|101982538|FG002|STARTED|Overall Study||64||
48672052|NCT03958331|101982536|FG000|COMPLETED|Overall Study||14||
48672053|NCT03958331|101982537|FG001|COMPLETED|Overall Study||17||
48672054|NCT03958331|101982538|FG002|COMPLETED|Overall Study||47||
48672055|NCT03958331|101982536|FG000|NOT COMPLETED|Overall Study||7||
48672056|NCT03958331|101982537|FG001|NOT COMPLETED|Overall Study||2||
48672057|NCT03958331|101982538|FG002|NOT COMPLETED|Overall Study||17||
48672058|NCT00457626|101982539|FG000|STARTED|Overall Study||66||
48672059|NCT00457626|101982539|FG000|COMPLETED|Overall Study||60||
48672060|NCT00457626|101982539|FG000|NOT COMPLETED|Overall Study||6||
48672061|NCT01734902|101982540|FG000|STARTED|Overall Study||14||
48672062|NCT01734902|101982541|FG001|STARTED|Overall Study||16||
48672063|NCT01734902|101982540|FG000|COMPLETED|Overall Study||14||
48672064|NCT01734902|101982541|FG001|COMPLETED|Overall Study||14||
48672065|NCT01734902|101982540|FG000|NOT COMPLETED|Overall Study||0||
48672066|NCT01734902|101982541|FG001|NOT COMPLETED|Overall Study||2||
48672067|NCT00841815|101982542|FG000|STARTED|Period 1||14||
48672068|NCT00841815|101982543|FG001|STARTED|Period 1||14||
48672069|NCT00841815|101982542|FG000|COMPLETED|Period 1||14||
48672070|NCT00841815|101982543|FG001|COMPLETED|Period 1||14||
48672071|NCT00841815|101982542|FG000|NOT COMPLETED|Period 1||0||
48672072|NCT00841815|101982543|FG001|NOT COMPLETED|Period 1||0||
48672073|NCT00841815|101982542|FG000|STARTED|Washout||14||
48672074|NCT00841815|101982543|FG001|STARTED|Washout||14||
48672075|NCT00841815|101982542|FG000|COMPLETED|Washout||14||
48672076|NCT00841815|101982543|FG001|COMPLETED|Washout||13||
48672077|NCT00841815|101982542|FG000|NOT COMPLETED|Washout||0||
48672078|NCT00841815|101982543|FG001|NOT COMPLETED|Washout||1||
48672079|NCT00841815|101982542|FG000|STARTED|Period 2||14||
48672080|NCT00841815|101982543|FG001|STARTED|Period 2||13||
48672081|NCT00841815|101982542|FG000|COMPLETED|Period 2||14||
48672082|NCT00841815|101982543|FG001|COMPLETED|Period 2||13||
48672083|NCT00841815|101982542|FG000|NOT COMPLETED|Period 2||0||
48672084|NCT00841815|101982543|FG001|NOT COMPLETED|Period 2||0||
48672085|NCT03498716|101982544|FG000|STARTED|Overall Study||1098||
48672086|NCT03498716|101982545|FG001|STARTED|Overall Study||1101||
48672087|NCT03498716|101982544|FG000|Safety Evaluable Population|Overall Study||1084|Safety Evaluable Population included all participants who received any amount of any study drug.|
48672088|NCT03498716|101982545|FG001|Safety Evaluable Population|Overall Study||1093|Safety Evaluable Population included all participants who received any amount of any study drug.|
48672089|NCT03498716|101982544|FG000|COMPLETED|Overall Study||0||
48672090|NCT03498716|101982545|FG001|COMPLETED|Overall Study||0||
48672091|NCT03498716|101982544|FG000|NOT COMPLETED|Overall Study||1098||
48672092|NCT03498716|101982545|FG001|NOT COMPLETED|Overall Study||1101||
48672093|NCT03612570|101982546|FG000|STARTED|Overall Study||72||226
48672094|NCT03612570|101982546|FG000|COMPLETED|Overall Study||71||222
48672095|NCT03612570|101982546|FG000|NOT COMPLETED|Overall Study||1||4
48672096|NCT03950856|101982547|FG000|STARTED|Overall Study||702|Randomized|
48672097|NCT03950856|101982548|FG001|STARTED|Overall Study||704|Randomized|
48672098|NCT03950856|101982549|FG002|STARTED|Overall Study||701|Randomized|
48072273|NCT01373242|100498193|FG000|COMPLETED|Overall Study||38||
48222258|NCT01836445|100866707|FG001|STARTED|12 Month Follow-up Assessment||455||
48222259|NCT01836445|100866706|FG000|COMPLETED|12 Month Follow-up Assessment||370||
48222260|NCT01836445|100866707|FG001|COMPLETED|12 Month Follow-up Assessment||391||
48222261|NCT01836445|100866706|FG000|NOT COMPLETED|12 Month Follow-up Assessment||75||
48222262|NCT01836445|100866707|FG001|NOT COMPLETED|12 Month Follow-up Assessment||64||
48072274|NCT01373242|100498193|FG000|NOT COMPLETED|Overall Study||16||
48072275|NCT00259610|100498194|FG000|STARTED|Overall Study||244||
48072276|NCT00259610|100498195|FG001|STARTED|Overall Study||132||
48072277|NCT00259610|100498196|FG002|STARTED|Overall Study||255||
48072278|NCT00259610|100498197|FG003|STARTED|Overall Study||124||
48072279|NCT00259610|100498194|FG000|COMPLETED|Overall Study||168||
48072280|NCT00259610|100498195|FG001|COMPLETED|Overall Study||86||
48072281|NCT00259610|100498196|FG002|COMPLETED|Overall Study||182||
48072282|NCT00259610|100498197|FG003|COMPLETED|Overall Study||81||
48072283|NCT00259610|100498194|FG000|NOT COMPLETED|Overall Study||76||
48072284|NCT00259610|100498195|FG001|NOT COMPLETED|Overall Study||46||
48072285|NCT00259610|100498196|FG002|NOT COMPLETED|Overall Study||73||
48072286|NCT00259610|100498197|FG003|NOT COMPLETED|Overall Study||43||
48072287|NCT01466153|100498198|FG000|STARTED|Overall Study||62||
48072288|NCT01466153|100498199|FG001|STARTED|Overall Study||36||
48672099|NCT03950856|101982550|FG003|STARTED|Overall Study||233|Randomized|
48672100|NCT03950856|101982547|FG000|Vaccinated|Overall Study||698||
48672101|NCT03950856|101982548|FG001|Vaccinated|Overall Study||704||
48672102|NCT03950856|101982549|FG002|Vaccinated|Overall Study||700||
48672103|NCT03950856|101982550|FG003|Vaccinated|Overall Study||231||
48072289|NCT01466153|100498200|FG002|STARTED|Overall Study||61||
48072290|NCT01466153|100498198|FG000|COMPLETED|Overall Study||33||
48072291|NCT01466153|100498199|FG001|COMPLETED|Overall Study||12||
48072292|NCT01466153|100498200|FG002|COMPLETED|Overall Study||36||
48072293|NCT01466153|100498198|FG000|NOT COMPLETED|Overall Study||29||
48072294|NCT01466153|100498199|FG001|NOT COMPLETED|Overall Study||24||
48072295|NCT01466153|100498200|FG002|NOT COMPLETED|Overall Study||25||
48072296|NCT01235689|100498201|FG000|STARTED|Overall Study||122||
48072297|NCT01235689|100498202|FG001|STARTED|Overall Study||122||
48072298|NCT01235689|100498201|FG000|Early Randomized (Baseline to Week 9)|Overall Study||63||
48072299|NCT01235689|100498202|FG001|Early Randomized (Baseline to Week 9)|Overall Study||69||
48072300|NCT01235689|100498201|FG000|Randomized at Week 9|Overall Study||59||
48072301|NCT01235689|100498202|FG001|Randomized at Week 9|Overall Study||53||
48072302|NCT01235689|100498201|FG000|COMPLETED|Overall Study||93||
48072303|NCT01235689|100498202|FG001|COMPLETED|Overall Study||90||
48072304|NCT01235689|100498201|FG000|NOT COMPLETED|Overall Study||29||
48072305|NCT01235689|100498202|FG001|NOT COMPLETED|Overall Study||32||
48072306|NCT02403986|100498203|FG000|STARTED|Overall Study||26||
48072307|NCT02403986|100498204|FG001|STARTED|Overall Study||27||
48072308|NCT02403986|100498203|FG000|COMPLETED|Overall Study||21||
48072309|NCT02403986|100498204|FG001|COMPLETED|Overall Study||23||
48072310|NCT02403986|100498203|FG000|NOT COMPLETED|Overall Study||5||
48072311|NCT02403986|100498204|FG001|NOT COMPLETED|Overall Study||4||
48072312|NCT03386448|100498205|FG000|STARTED|Overall Study||6||
48072313|NCT03386448|100498206|FG001|STARTED|Overall Study||8||
48072314|NCT03386448|100498205|FG000|COMPLETED|Overall Study||6||
48072315|NCT03386448|100498206|FG001|COMPLETED|Overall Study||6||
48072316|NCT03386448|100498205|FG000|NOT COMPLETED|Overall Study||0||
48072317|NCT03386448|100498206|FG001|NOT COMPLETED|Overall Study||2||
48072318|NCT00303901|100498207|FG000|STARTED|Overall Study||40||
48072319|NCT00303901|100498207|FG000|COMPLETED|Overall Study||40||
48072320|NCT00303901|100498207|FG000|NOT COMPLETED|Overall Study||0||
48072321|NCT01895062|100498208|FG000|STARTED|Overall Study||30||
48072322|NCT01895062|100498209|FG001|STARTED|Overall Study||24||
48072323|NCT01895062|100498208|FG000|COMPLETED|Overall Study||30||
48072324|NCT01895062|100498209|FG001|COMPLETED|Overall Study||24||
48072325|NCT01895062|100498208|FG000|NOT COMPLETED|Overall Study||0||
48072326|NCT01895062|100498209|FG001|NOT COMPLETED|Overall Study||0||
48072327|NCT01533077|100498210|FG000|STARTED|Overall Study||5||
48072328|NCT01533077|100498211|FG001|STARTED|Overall Study||5||
48072329|NCT01533077|100498212|FG002|STARTED|Overall Study||4||
48072330|NCT01533077|100498213|FG003|STARTED|Overall Study||4||
48072331|NCT01533077|100498210|FG000|BIA 9-1067 50 mg|Overall Study||5||
48072332|NCT01533077|100498211|FG001|BIA 9-1067 50 mg|Overall Study||5||
48072333|NCT01533077|100498212|FG002|BIA 9-1067 50 mg|Overall Study||4||
48072334|NCT01533077|100498213|FG003|BIA 9-1067 50 mg|Overall Study||4||
48072335|NCT01533077|100498210|FG000|Sinemet® 100/25|Overall Study||4||
48072336|NCT01533077|100498211|FG001|Sinemet® 100/25|Overall Study||5||
48072337|NCT01533077|100498212|FG002|Sinemet® 100/25|Overall Study||4||
48072338|NCT01533077|100498213|FG003|Sinemet® 100/25|Overall Study||4||
48072339|NCT01533077|100498210|FG000|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4||
48072340|NCT01533077|100498211|FG001|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4||
48072341|NCT01533077|100498212|FG002|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4||
48072342|NCT01533077|100498213|FG003|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4||
48072343|NCT01533077|100498210|FG000|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5||
48072344|NCT01533077|100498211|FG001|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5||
48072345|NCT01533077|100498212|FG002|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4||
48072346|NCT01533077|100498213|FG003|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4||
48072347|NCT01533077|100498210|FG000|COMPLETED|Overall Study||4||
48072348|NCT01533077|100498211|FG001|COMPLETED|Overall Study||4||
48072349|NCT01533077|100498212|FG002|COMPLETED|Overall Study||4||
48072350|NCT01533077|100498213|FG003|COMPLETED|Overall Study||4||
48072351|NCT01533077|100498210|FG000|NOT COMPLETED|Overall Study||1||
48072352|NCT01533077|100498211|FG001|NOT COMPLETED|Overall Study||1||
48072353|NCT01533077|100498212|FG002|NOT COMPLETED|Overall Study||0||
48072354|NCT01533077|100498213|FG003|NOT COMPLETED|Overall Study||0||
48072355|NCT01064310|100498214|FG000|STARTED|Period 1||82||
48072356|NCT01064310|100498215|FG001|STARTED|Period 1||86||
48072357|NCT01064310|100498216|FG002|STARTED|Period 1||0||
48072358|NCT01064310|100498214|FG000|COMPLETED|Period 1||68||
48072359|NCT01064310|100498215|FG001|COMPLETED|Period 1||68||
48072360|NCT01064310|100498216|FG002|COMPLETED|Period 1||0||
48072361|NCT01064310|100498214|FG000|NOT COMPLETED|Period 1||14||
48072362|NCT01064310|100498215|FG001|NOT COMPLETED|Period 1||18||
48072363|NCT01064310|100498216|FG002|NOT COMPLETED|Period 1||0||
48072364|NCT01064310|100498214|FG000|STARTED|Period 2||68||
48072365|NCT01064310|100498215|FG001|STARTED|Period 2||68||
48072366|NCT01064310|100498216|FG002|STARTED|Period 2||0||
48072367|NCT01064310|100498214|FG000|COMPLETED|Period 2||64||
48072368|NCT01064310|100498215|FG001|COMPLETED|Period 2||62||
48072369|NCT01064310|100498216|FG002|COMPLETED|Period 2||0||
48072370|NCT01064310|100498214|FG000|NOT COMPLETED|Period 2||4||
48072371|NCT01064310|100498215|FG001|NOT COMPLETED|Period 2||6||
48672104|NCT03950856|101982547|FG000|COMPLETED|Overall Study||683||
48672105|NCT03950856|101982548|FG001|COMPLETED|Overall Study||689||
48672106|NCT03950856|101982549|FG002|COMPLETED|Overall Study||683||
48672107|NCT03950856|101982550|FG003|COMPLETED|Overall Study||227||
48672108|NCT03950856|101982547|FG000|NOT COMPLETED|Overall Study||19||
48672109|NCT03950856|101982548|FG001|NOT COMPLETED|Overall Study||15||
48672110|NCT03950856|101982549|FG002|NOT COMPLETED|Overall Study||18||
48672111|NCT03950856|101982550|FG003|NOT COMPLETED|Overall Study||6||
48672112|NCT03014635|101982551|FG000|STARTED|Overall Study||204||
48672113|NCT03014635|101982552|FG001|STARTED|Overall Study||102||
48072372|NCT01064310|100498216|FG002|NOT COMPLETED|Period 2||0||
48072373|NCT01064310|100498214|FG000|STARTED|Open Label Pazopinib||0||
48072374|NCT01064310|100498215|FG001|STARTED|Open Label Pazopinib||0||
48072375|NCT01064310|100498216|FG002|STARTED|Open Label Pazopinib||84||
48072376|NCT01064310|100498214|FG000|COMPLETED|Open Label Pazopinib||0||
48072377|NCT01064310|100498215|FG001|COMPLETED|Open Label Pazopinib||0||
48072378|NCT01064310|100498216|FG002|COMPLETED|Open Label Pazopinib||0||
48072379|NCT01064310|100498214|FG000|NOT COMPLETED|Open Label Pazopinib||0||
48072380|NCT01064310|100498215|FG001|NOT COMPLETED|Open Label Pazopinib||0||
48072381|NCT01064310|100498216|FG002|NOT COMPLETED|Open Label Pazopinib||84||
48072382|NCT03423641|100498217|FG000|STARTED|Overall Study||15524||
48072383|NCT03423641|100498218|FG001|STARTED|Overall Study||18284||
48072384|NCT03423641|100498217|FG000|COMPLETED|Overall Study||15193||
48072385|NCT03423641|100498218|FG001|COMPLETED|Overall Study||10210||
48072386|NCT03423641|100498217|FG000|NOT COMPLETED|Overall Study||331||
48072387|NCT03423641|100498218|FG001|NOT COMPLETED|Overall Study||8074||
48072388|NCT01146834|100498219|FG000|STARTED|Overall Study||20||
48072389|NCT01146834|100498220|FG001|STARTED|Overall Study||4||
48072390|NCT01146834|100498221|FG002|STARTED|Overall Study||23||
48072391|NCT01146834|100498222|FG003|STARTED|Overall Study||0||
48072392|NCT01146834|100498223|FG004|STARTED|Overall Study||0||
48072393|NCT01146834|100498219|FG000|COMPLETED|Overall Study||17||
48072394|NCT01146834|100498220|FG001|COMPLETED|Overall Study||4||
48072395|NCT01146834|100498221|FG002|COMPLETED|Overall Study||21||
48072396|NCT01146834|100498222|FG003|COMPLETED|Overall Study||0||
48072397|NCT01146834|100498223|FG004|COMPLETED|Overall Study||0||
48072398|NCT01146834|100498219|FG000|NOT COMPLETED|Overall Study||3||
48072399|NCT01146834|100498220|FG001|NOT COMPLETED|Overall Study||0||
48072400|NCT01146834|100498221|FG002|NOT COMPLETED|Overall Study||2||
48072401|NCT01146834|100498222|FG003|NOT COMPLETED|Overall Study||0||
48072402|NCT01146834|100498223|FG004|NOT COMPLETED|Overall Study||0||
48072403|NCT04010695|100498224|FG000|STARTED|Overall Study||250||
48072404|NCT04010695|100498224|FG000|COMPLETED|Overall Study||250||
48072405|NCT04010695|100498224|FG000|NOT COMPLETED|Overall Study||0||
48072406|NCT02136810|100498225|FG000|STARTED|Overall Study||200|A convenience sample of 200 participants were enrolled.|
48072407|NCT02136810|100498225|FG000|COMPLETED|Overall Study||200||
48072408|NCT02136810|100498225|FG000|NOT COMPLETED|Overall Study||0||
48072409|NCT02509481|100498226|FG000|STARTED|Overall Study||1265||
48072410|NCT02509481|100498227|FG001|STARTED|Overall Study||1447||
48072411|NCT02509481|100498226|FG000|COMPLETED|Overall Study||1265||
48072412|NCT02509481|100498227|FG001|COMPLETED|Overall Study||1447||
48072413|NCT02509481|100498226|FG000|NOT COMPLETED|Overall Study||0||
48072414|NCT02509481|100498227|FG001|NOT COMPLETED|Overall Study||0||
48072415|NCT00316719|100498228|FG000|STARTED|Overall Study||52||
48072416|NCT00316719|100498229|FG001|STARTED|Overall Study||53||
48072417|NCT00316719|100498228|FG000|COMPLETED|Overall Study||50||
48072418|NCT00316719|100498229|FG001|COMPLETED|Overall Study||47||
48072419|NCT00316719|100498228|FG000|NOT COMPLETED|Overall Study||2||
48072420|NCT00316719|100498229|FG001|NOT COMPLETED|Overall Study||6||
48072421|NCT00282412|100498230|FG000|STARTED|Overall Study||4||
48072422|NCT00282412|100498230|FG000|COMPLETED|Overall Study||2||
48072423|NCT00282412|100498230|FG000|NOT COMPLETED|Overall Study||2||
48072424|NCT03225573|100498231|FG000|STARTED|Overall Study||60||198
48072425|NCT03225573|100498231|FG000|COMPLETED|Overall Study||60||198
48072426|NCT03225573|100498231|FG000|NOT COMPLETED|Overall Study||0||0
48072427|NCT00533897|100498232|FG000|STARTED|Lead-in (LI) Period 1||167||
48072428|NCT00533897|100498233|FG001|STARTED|Lead-in (LI) Period 1||0||
48072429|NCT00533897|100498234|FG002|STARTED|Lead-in (LI) Period 1||0||
48072430|NCT00533897|100498235|FG003|STARTED|Lead-in (LI) Period 1||0||
48072431|NCT00533897|100498236|FG004|STARTED|Lead-in (LI) Period 1||0||
48072432|NCT00533897|100498237|FG005|STARTED|Lead-in (LI) Period 1||0||
48072433|NCT00533897|100498238|FG006|STARTED|Lead-in (LI) Period 1||0||
48072434|NCT00533897|100498239|FG007|STARTED|Lead-in (LI) Period 1||0||
48072435|NCT00533897|100498232|FG000|COMPLETED|Lead-in (LI) Period 1||157||
48072436|NCT00533897|100498233|FG001|COMPLETED|Lead-in (LI) Period 1||0||
48072437|NCT00533897|100498234|FG002|COMPLETED|Lead-in (LI) Period 1||0||
48072438|NCT00533897|100498235|FG003|COMPLETED|Lead-in (LI) Period 1||0||
48072439|NCT00533897|100498236|FG004|COMPLETED|Lead-in (LI) Period 1||0||
48072440|NCT00533897|100498237|FG005|COMPLETED|Lead-in (LI) Period 1||0||
48072441|NCT00533897|100498238|FG006|COMPLETED|Lead-in (LI) Period 1||0||
48072442|NCT00533897|100498239|FG007|COMPLETED|Lead-in (LI) Period 1||0||
48672114|NCT03014635|101982551|FG000|COMPLETED|Overall Study||191||
48672115|NCT03014635|101982552|FG001|COMPLETED|Overall Study||93||
48072443|NCT00533897|100498232|FG000|NOT COMPLETED|Lead-in (LI) Period 1||10||
48072444|NCT00533897|100498233|FG001|NOT COMPLETED|Lead-in (LI) Period 1||0||
48072445|NCT00533897|100498234|FG002|NOT COMPLETED|Lead-in (LI) Period 1||0||
48072446|NCT00533897|100498235|FG003|NOT COMPLETED|Lead-in (LI) Period 1||0||
48072447|NCT00533897|100498236|FG004|NOT COMPLETED|Lead-in (LI) Period 1||0||
48072448|NCT00533897|100498237|FG005|NOT COMPLETED|Lead-in (LI) Period 1||0||
48072449|NCT00533897|100498238|FG006|NOT COMPLETED|Lead-in (LI) Period 1||0||
48072450|NCT00533897|100498239|FG007|NOT COMPLETED|Lead-in (LI) Period 1||0||
48072451|NCT00533897|100498232|FG000|STARTED|Double-blind Withdrawal (DBW) Period 2||0||
48072452|NCT00533897|100498233|FG001|STARTED|Double-blind Withdrawal (DBW) Period 2||40||
48072453|NCT00533897|100498234|FG002|STARTED|Double-blind Withdrawal (DBW) Period 2||80||
48072454|NCT00533897|100498235|FG003|STARTED|Double-blind Withdrawal (DBW) Period 2||0||
48072455|NCT00533897|100498236|FG004|STARTED|Double-blind Withdrawal (DBW) Period 2||0||
48072456|NCT00533897|100498237|FG005|STARTED|Double-blind Withdrawal (DBW) Period 2||0||
48072457|NCT00533897|100498238|FG006|STARTED|Double-blind Withdrawal (DBW) Period 2||0||
48072458|NCT00533897|100498239|FG007|STARTED|Double-blind Withdrawal (DBW) Period 2||0||
48072459|NCT00533897|100498232|FG000|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0||
48072460|NCT00533897|100498233|FG001|COMPLETED|Double-blind Withdrawal (DBW) Period 2||39||
48072461|NCT00533897|100498234|FG002|COMPLETED|Double-blind Withdrawal (DBW) Period 2||77||
48072462|NCT00533897|100498235|FG003|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0||
48072463|NCT00533897|100498236|FG004|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0||
48072464|NCT00533897|100498237|FG005|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0||
48072465|NCT00533897|100498238|FG006|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0||
48072466|NCT00533897|100498239|FG007|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0||
48072467|NCT00533897|100498232|FG000|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0||
48072468|NCT00533897|100498233|FG001|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||1||
48072469|NCT00533897|100498234|FG002|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||3||
48072470|NCT00533897|100498235|FG003|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0||
48072471|NCT00533897|100498236|FG004|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0||
48072472|NCT00533897|100498237|FG005|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0||
48072473|NCT00533897|100498238|FG006|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0||
48072474|NCT00533897|100498239|FG007|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0||
48072475|NCT00533897|100498232|FG000|STARTED|Re-introduction (RI) Period 3||0||
48072476|NCT00533897|100498233|FG001|STARTED|Re-introduction (RI) Period 3||0||
48072477|NCT00533897|100498234|FG002|STARTED|Re-introduction (RI) Period 3||0||
48072478|NCT00533897|100498235|FG003|STARTED|Re-introduction (RI) Period 3||40||
48072479|NCT00533897|100498236|FG004|STARTED|Re-introduction (RI) Period 3||35||
48072480|NCT00533897|100498237|FG005|STARTED|Re-introduction (RI) Period 3||44||
48072481|NCT00533897|100498238|FG006|STARTED|Re-introduction (RI) Period 3||0||
48072482|NCT00533897|100498239|FG007|STARTED|Re-introduction (RI) Period 3||0||
48072483|NCT00533897|100498232|FG000|COMPLETED|Re-introduction (RI) Period 3||0||
48072484|NCT00533897|100498233|FG001|COMPLETED|Re-introduction (RI) Period 3||0||
48072485|NCT00533897|100498234|FG002|COMPLETED|Re-introduction (RI) Period 3||0||
48072486|NCT00533897|100498235|FG003|COMPLETED|Re-introduction (RI) Period 3||40||
48072487|NCT00533897|100498236|FG004|COMPLETED|Re-introduction (RI) Period 3||35||
48072488|NCT00533897|100498237|FG005|COMPLETED|Re-introduction (RI) Period 3||42||
48072489|NCT00533897|100498238|FG006|COMPLETED|Re-introduction (RI) Period 3||0||
48072490|NCT00533897|100498239|FG007|COMPLETED|Re-introduction (RI) Period 3||0||
48072491|NCT00533897|100498232|FG000|NOT COMPLETED|Re-introduction (RI) Period 3||0||
48072492|NCT00533897|100498233|FG001|NOT COMPLETED|Re-introduction (RI) Period 3||0||
48072493|NCT00533897|100498234|FG002|NOT COMPLETED|Re-introduction (RI) Period 3||0||
48072494|NCT00533897|100498235|FG003|NOT COMPLETED|Re-introduction (RI) Period 3||0||
48072495|NCT00533897|100498236|FG004|NOT COMPLETED|Re-introduction (RI) Period 3||0||
48072496|NCT00533897|100498237|FG005|NOT COMPLETED|Re-introduction (RI) Period 3||2||
48072497|NCT00533897|100498238|FG006|NOT COMPLETED|Re-introduction (RI) Period 3||0||
48072498|NCT00533897|100498239|FG007|NOT COMPLETED|Re-introduction (RI) Period 3||0||
48072499|NCT00533897|100498232|FG000|STARTED|Long Term Extension (LTE)||0||
48072500|NCT00533897|100498233|FG001|STARTED|Long Term Extension (LTE)||0||
48072501|NCT00533897|100498234|FG002|STARTED|Long Term Extension (LTE)||0||
48072502|NCT00533897|100498235|FG003|STARTED|Long Term Extension (LTE)||0||
48072503|NCT00533897|100498236|FG004|STARTED|Long Term Extension (LTE)||0||
48072504|NCT00533897|100498237|FG005|STARTED|Long Term Extension (LTE)||0||
48072505|NCT00533897|100498238|FG006|STARTED|Long Term Extension (LTE)||37||
48072506|NCT00533897|100498239|FG007|STARTED|Long Term Extension (LTE)||113||
48072507|NCT00533897|100498232|FG000|COMPLETED|Long Term Extension (LTE)||0||
48072508|NCT00533897|100498233|FG001|COMPLETED|Long Term Extension (LTE)||0||
48072509|NCT00533897|100498234|FG002|COMPLETED|Long Term Extension (LTE)||0||
48072510|NCT00533897|100498235|FG003|COMPLETED|Long Term Extension (LTE)||0||
48072511|NCT00533897|100498236|FG004|COMPLETED|Long Term Extension (LTE)||0||
48072512|NCT00533897|100498237|FG005|COMPLETED|Long Term Extension (LTE)||0||
48072513|NCT00533897|100498238|FG006|COMPLETED|Long Term Extension (LTE)||24||
48072514|NCT00533897|100498239|FG007|COMPLETED|Long Term Extension (LTE)||88||
48072515|NCT00533897|100498232|FG000|NOT COMPLETED|Long Term Extension (LTE)||0||
48072516|NCT00533897|100498233|FG001|NOT COMPLETED|Long Term Extension (LTE)||0||
48072517|NCT00533897|100498234|FG002|NOT COMPLETED|Long Term Extension (LTE)||0||
48072518|NCT00533897|100498235|FG003|NOT COMPLETED|Long Term Extension (LTE)||0||
48072519|NCT00533897|100498236|FG004|NOT COMPLETED|Long Term Extension (LTE)||0||
48072520|NCT00533897|100498237|FG005|NOT COMPLETED|Long Term Extension (LTE)||0||
48072521|NCT00533897|100498238|FG006|NOT COMPLETED|Long Term Extension (LTE)||13||
48072522|NCT00533897|100498239|FG007|NOT COMPLETED|Long Term Extension (LTE)||25||
48072523|NCT01479478|100498240|FG000|STARTED|Overall Study||125||
48072524|NCT01479478|100498241|FG001|STARTED|Overall Study||126||
48072525|NCT01479478|100498240|FG000|COMPLETED|Overall Study||125||
48072526|NCT01479478|100498241|FG001|COMPLETED|Overall Study||126||
48072527|NCT01479478|100498240|FG000|NOT COMPLETED|Overall Study||0||
48072528|NCT01479478|100498241|FG001|NOT COMPLETED|Overall Study||0||
48072529|NCT01708161|100498242|FG000|STARTED|Overall Study||4||
48072530|NCT01708161|100498243|FG001|STARTED|Overall Study||10||
48072531|NCT01708161|100498244|FG002|STARTED|Overall Study||10||
48072532|NCT01708161|100498245|FG003|STARTED|Overall Study||16||
48072533|NCT01708161|100498246|FG004|STARTED|Overall Study||6||
48072534|NCT01708161|100498247|FG005|STARTED|Overall Study||1||
48072535|NCT01708161|100498242|FG000|COMPLETED|Overall Study||0||
48072536|NCT01708161|100498243|FG001|COMPLETED|Overall Study||0||
48072537|NCT01708161|100498244|FG002|COMPLETED|Overall Study||0||
48072538|NCT01708161|100498245|FG003|COMPLETED|Overall Study||0||
48072539|NCT01708161|100498246|FG004|COMPLETED|Overall Study||0||
48072540|NCT01708161|100498247|FG005|COMPLETED|Overall Study||0||
48072541|NCT01708161|100498242|FG000|NOT COMPLETED|Overall Study||4||
48072542|NCT01708161|100498243|FG001|NOT COMPLETED|Overall Study||10||
48072543|NCT01708161|100498244|FG002|NOT COMPLETED|Overall Study||10||
48072544|NCT01708161|100498245|FG003|NOT COMPLETED|Overall Study||16||
48072545|NCT01708161|100498246|FG004|NOT COMPLETED|Overall Study||6||
48072546|NCT01708161|100498247|FG005|NOT COMPLETED|Overall Study||1||
48072547|NCT02989545|100498248|FG000|STARTED|Control Period - no Intervention||20||
48072548|NCT02989545|100498248|FG000|COMPLETED|Control Period - no Intervention||20||
48072549|NCT02989545|100498248|FG000|NOT COMPLETED|Control Period - no Intervention||0||
48072550|NCT02989545|100498248|FG000|STARTED|Treatment Period - Anal Tape Provided||20||
48072551|NCT02989545|100498248|FG000|COMPLETED|Treatment Period - Anal Tape Provided||20||
48072552|NCT02989545|100498248|FG000|NOT COMPLETED|Treatment Period - Anal Tape Provided||0||
48072553|NCT02296320|100498249|FG000|STARTED|Overall Study||102||
48072554|NCT02296320|100498250|FG001|STARTED|Overall Study||15||
48072555|NCT02296320|100498251|FG002|STARTED|Overall Study||96||
48072556|NCT02296320|100498249|FG000|Treated|Overall Study||100||
48072557|NCT02296320|100498250|FG001|Treated|Overall Study||15||
48072558|NCT02296320|100498251|FG002|Treated|Overall Study||96||
48072559|NCT02296320|100498249|FG000|COMPLETED|Overall Study||67||
48072560|NCT02296320|100498250|FG001|COMPLETED|Overall Study||10||
48072561|NCT02296320|100498251|FG002|COMPLETED|Overall Study||59||
48072562|NCT02296320|100498249|FG000|NOT COMPLETED|Overall Study||35||
48072563|NCT02296320|100498250|FG001|NOT COMPLETED|Overall Study||5||
48072564|NCT02296320|100498251|FG002|NOT COMPLETED|Overall Study||37||
48072565|NCT01999114|100498252|FG000|STARTED|Overall Study||66||
48072566|NCT01999114|100498253|FG001|STARTED|Overall Study||66||
48222263|NCT01836445|100866706|FG000|STARTED|12 Month STI Testing||445||
48072567|NCT01999114|100498254|FG002|STARTED|Overall Study||66||
48072568|NCT01999114|100498255|FG003|STARTED|Overall Study||65||
48072569|NCT01999114|100498256|FG004|STARTED|Overall Study||65||
48072570|NCT01999114|100498252|FG000|COMPLETED|Overall Study||58||
48072571|NCT01999114|100498253|FG001|COMPLETED|Overall Study||59||
48072572|NCT01999114|100498254|FG002|COMPLETED|Overall Study||61||
48072573|NCT01999114|100498255|FG003|COMPLETED|Overall Study||62||
48072574|NCT01999114|100498256|FG004|COMPLETED|Overall Study||61||
48072575|NCT01999114|100498252|FG000|NOT COMPLETED|Overall Study||8||
48072576|NCT01999114|100498253|FG001|NOT COMPLETED|Overall Study||7||
48072577|NCT01999114|100498254|FG002|NOT COMPLETED|Overall Study||5||
48072578|NCT01999114|100498255|FG003|NOT COMPLETED|Overall Study||3||
48072579|NCT01999114|100498256|FG004|NOT COMPLETED|Overall Study||4||
48072580|NCT00880997|100498257|FG000|STARTED|Overall Study||9||
48072581|NCT00880997|100498258|FG001|STARTED|Overall Study||8||
48072582|NCT00880997|100498259|FG002|STARTED|Overall Study||13||
48072583|NCT00880997|100498257|FG000|COMPLETED|Overall Study||6||
48072584|NCT00880997|100498258|FG001|COMPLETED|Overall Study||6||
48072585|NCT00880997|100498259|FG002|COMPLETED|Overall Study||5||
48072586|NCT00880997|100498257|FG000|NOT COMPLETED|Overall Study||3||
48072587|NCT00880997|100498258|FG001|NOT COMPLETED|Overall Study||2||
48072588|NCT00880997|100498259|FG002|NOT COMPLETED|Overall Study||8||
48072589|NCT01158157|100500800|FG000|STARTED|Overall Study||25||
48072590|NCT01158157|100500800|FG000|COMPLETED|Overall Study||25||
48072591|NCT01158157|100500800|FG000|NOT COMPLETED|Overall Study||0||
48072592|NCT02557555|100500801|FG000|STARTED|Overall Study||100||
48072593|NCT02557555|100500801|FG000|COMPLETED|Overall Study||100||
48072594|NCT02557555|100500801|FG000|NOT COMPLETED|Overall Study||0||
48072595|NCT03478657|100500802|FG000|STARTED|Overall Study||88||
48072596|NCT03478657|100500803|FG001|STARTED|Overall Study||134||
48072597|NCT03478657|100500802|FG000|COMPLETED|Overall Study||88||
48072598|NCT03478657|100500803|FG001|COMPLETED|Overall Study||133||
48072599|NCT03478657|100500802|FG000|NOT COMPLETED|Overall Study||0||
48072600|NCT03478657|100500803|FG001|NOT COMPLETED|Overall Study||1||
48072601|NCT01513343|100500804|FG000|STARTED|Group Allocation||136|Numbers reported reflect parent/child dyads; there are 2 unique participants within each dyad.|
48072602|NCT01513343|100500805|FG001|STARTED|Group Allocation||119|Numbers reported reflect parent/child dyads; there are 2 unique participants within each dyad.|
48072603|NCT01513343|100500804|FG000|COMPLETED|Group Allocation||128|Numbers reported reflect parent/child dyads; there are 2 unique participants within each dyad.|
48072604|NCT01513343|100500805|FG001|COMPLETED|Group Allocation||119|Numbers reported reflect parent/child dyads; there are 2 unique participants within each dyad.|
48072605|NCT01513343|100500804|FG000|NOT COMPLETED|Group Allocation||8||
48072606|NCT01513343|100500805|FG001|NOT COMPLETED|Group Allocation||0||
48072607|NCT01513343|100500804|FG000|STARTED|Post Data Collection||136|Numbers reported reflect parent/child dyads; there are 2 unique participants within each dyad.|
48072608|NCT01513343|100500805|FG001|STARTED|Post Data Collection||119|Numbers reported reflect parent/child dyads; there are 2 unique participants within each dyad.|
48072609|NCT01513343|100500804|FG000|COMPLETED|Post Data Collection||119|Numbers reported reflect parent/child dyads; there are 2 unique participants within each dyad.|
48072610|NCT01513343|100500805|FG001|COMPLETED|Post Data Collection||95|Numbers reported reflect parent/child dyads; there are 2 unique participants within each dyad.|
48072611|NCT01513343|100500804|FG000|NOT COMPLETED|Post Data Collection||17||
48072612|NCT01513343|100500805|FG001|NOT COMPLETED|Post Data Collection||24||
48072613|NCT01513343|100500804|FG000|STARTED|6-month Follow-up||119|Numbers reported reflect parent/child dyads; there are 2 unique participants within each dyad.|
48072614|NCT01513343|100500805|FG001|STARTED|6-month Follow-up||95|Numbers reported reflect parent/child dyads; there are 2 unique participants within each dyad.|
48072615|NCT01513343|100500804|FG000|COMPLETED|6-month Follow-up||91|Numbers reported reflect parent/child dyads; there are 2 unique participants within each dyad.|
48072616|NCT01513343|100500805|FG001|COMPLETED|6-month Follow-up||78|Numbers reported reflect parent/child dyads; there are 2 unique participants within each dyad.|
48072617|NCT01513343|100500804|FG000|NOT COMPLETED|6-month Follow-up||28||
48072618|NCT01513343|100500805|FG001|NOT COMPLETED|6-month Follow-up||17||
48072619|NCT01513343|100500804|FG000|STARTED|12-month Follow-up||91|Numbers reported reflect parent/child dyads; there are 2 unique participants within each dyad.|
48072620|NCT01513343|100500805|FG001|STARTED|12-month Follow-up||78|Numbers reported reflect parent/child dyads; there are 2 unique participants within each dyad.|
48072621|NCT01513343|100500804|FG000|COMPLETED|12-month Follow-up||81|Numbers reported reflect parent/child dyads; there are 2 unique participants within each dyad.|
48072622|NCT01513343|100500805|FG001|COMPLETED|12-month Follow-up||75|Numbers reported reflect parent/child dyads; there are 2 unique participants within each dyad.|
48072623|NCT01513343|100500804|FG000|NOT COMPLETED|12-month Follow-up||10||
48072624|NCT01513343|100500805|FG001|NOT COMPLETED|12-month Follow-up||3||
48072625|NCT03307967|100500806|FG000|STARTED|Overall Study||40||
48072626|NCT03307967|100500806|FG000|COMPLETED|Overall Study||36||
48072627|NCT03307967|100500806|FG000|NOT COMPLETED|Overall Study||4||
48072628|NCT05853185|100500807|FG000|STARTED|Overall Study||32||
48072629|NCT05853185|100500808|FG001|STARTED|Overall Study||32||
48072630|NCT05853185|100500807|FG000|COMPLETED|Overall Study||32||
48072631|NCT05853185|100500808|FG001|COMPLETED|Overall Study||32||
48072632|NCT05853185|100500807|FG000|NOT COMPLETED|Overall Study||0||
48072633|NCT05853185|100500808|FG001|NOT COMPLETED|Overall Study||0||
48072634|NCT00977860|100500809|FG000|STARTED|Overall Study||163||
48072635|NCT00977860|100500809|FG000|COMPLETED|Overall Study||163||
48072636|NCT00977860|100500809|FG000|NOT COMPLETED|Overall Study||0||
48072637|NCT01972568|100500810|FG000|STARTED|Overall Study||102||
48072638|NCT01972568|100500811|FG001|STARTED|Overall Study||104||
48072639|NCT01972568|100500812|FG002|STARTED|Overall Study||100||
48072640|NCT01972568|100500810|FG000|COMPLETED|Overall Study||86||
48072641|NCT01972568|100500811|FG001|COMPLETED|Overall Study||92||
48072642|NCT01972568|100500812|FG002|COMPLETED|Overall Study||84||
48072643|NCT01972568|100500810|FG000|NOT COMPLETED|Overall Study||16||
48072644|NCT01972568|100500811|FG001|NOT COMPLETED|Overall Study||12||
48072645|NCT01972568|100500812|FG002|NOT COMPLETED|Overall Study||16||
48072646|NCT01449539|100500813|FG000|STARTED|Overall Study||8||
48072647|NCT01449539|100500813|FG000|COMPLETED|Overall Study||4||
48072648|NCT01449539|100500813|FG000|NOT COMPLETED|Overall Study||4||
48072649|NCT00705289|100500814|FG000|STARTED|Overall Study||728||
48072650|NCT00705289|100500814|FG000|COMPLETED|Overall Study||597||
48072651|NCT00705289|100500814|FG000|NOT COMPLETED|Overall Study||131||
48072652|NCT03385564|100500815|FG000|STARTED|Overall Study||7||
48072653|NCT03385564|100500816|FG001|STARTED|Overall Study||15||
48072654|NCT03385564|100500817|FG002|STARTED|Overall Study||21||
48072655|NCT03385564|100500818|FG003|STARTED|Overall Study||26||
48072656|NCT03385564|100500815|FG000|Intent to Treat Set|Overall Study||7||
48072657|NCT03385564|100500816|FG001|Intent to Treat Set|Overall Study||15||
48072658|NCT03385564|100500817|FG002|Intent to Treat Set|Overall Study||21||
48072659|NCT03385564|100500818|FG003|Intent to Treat Set|Overall Study||26||
48072660|NCT03385564|100500815|FG000|COMPLETED|Overall Study||7|Completed trial medication|
48072661|NCT03385564|100500816|FG001|COMPLETED|Overall Study||14|Completed trial medication|
48072662|NCT03385564|100500817|FG002|COMPLETED|Overall Study||16|Completed trial medication|
48072663|NCT03385564|100500818|FG003|COMPLETED|Overall Study||17|Completed trial medication|
48072664|NCT03385564|100500815|FG000|NOT COMPLETED|Overall Study||0||
48072665|NCT03385564|100500816|FG001|NOT COMPLETED|Overall Study||1||
48072666|NCT03385564|100500817|FG002|NOT COMPLETED|Overall Study||5||
48072667|NCT03385564|100500818|FG003|NOT COMPLETED|Overall Study||9||
48072668|NCT02019693|100500819|FG000|STARTED|Overall Study||20||
48072669|NCT02019693|100500819|FG000|COMPLETED|Overall Study||20||
48072670|NCT02019693|100500819|FG000|NOT COMPLETED|Overall Study||0||
48072671|NCT00036270|100500820|FG000|STARTED|Randomized to Study Treatment||4904||
48072672|NCT00036270|100500821|FG001|STARTED|Randomized to Study Treatment||4875||
48072673|NCT00036270|100500820|FG000|COMPLETED|Randomized to Study Treatment||4898||
48072674|NCT00036270|100500821|FG001|COMPLETED|Randomized to Study Treatment||4868||
48072675|NCT00036270|100500820|FG000|NOT COMPLETED|Randomized to Study Treatment||6||
48072676|NCT00036270|100500821|FG001|NOT COMPLETED|Randomized to Study Treatment||7||
48072677|NCT00036270|100500820|FG000|STARTED|Study Treatment to 5 Year Report||4898||
48072678|NCT00036270|100500821|FG001|STARTED|Study Treatment to 5 Year Report||4868||
48072679|NCT00036270|100500820|FG000|Treated|Study Treatment to 5 Year Report||4852||
48072680|NCT00036270|100500821|FG001|Treated|Study Treatment to 5 Year Report||4814||
48072681|NCT00036270|100500820|FG000|COMPLETED|Study Treatment to 5 Year Report||2333||
48072682|NCT00036270|100500821|FG001|COMPLETED|Study Treatment to 5 Year Report||1380||
48072683|NCT00036270|100500820|FG000|NOT COMPLETED|Study Treatment to 5 Year Report||2565||
48072684|NCT00036270|100500821|FG001|NOT COMPLETED|Study Treatment to 5 Year Report||3488||
48072685|NCT01781975|100500822|FG000|STARTED|Overall Study||45||
48072686|NCT01781975|100500823|FG001|STARTED|Overall Study||22||
48072687|NCT01781975|100500822|FG000|Treatment Period|Overall Study||44||
48072688|NCT01781975|100500823|FG001|Treatment Period|Overall Study||22||
48072689|NCT01781975|100500822|FG000|Follow-Up Period|Overall Study||43||
48072690|NCT01781975|100500823|FG001|Follow-Up Period|Overall Study||21||
48072691|NCT01781975|100500822|FG000|COMPLETED|Overall Study||43||
48072692|NCT01781975|100500823|FG001|COMPLETED|Overall Study||21||
48072693|NCT01781975|100500822|FG000|NOT COMPLETED|Overall Study||2||
48072694|NCT01781975|100500823|FG001|NOT COMPLETED|Overall Study||1||
48072695|NCT01999868|100500824|FG000|STARTED|Lead-in Phase (Week 0 - 12)||45||
48072696|NCT01999868|100500825|FG001|STARTED|Lead-in Phase (Week 0 - 12)||46||
48072697|NCT01999868|100500826|FG002|STARTED|Lead-in Phase (Week 0 - 12)||17||
48072698|NCT01999868|100500824|FG000|COMPLETED|Lead-in Phase (Week 0 - 12)||45||
48072699|NCT01999868|100500825|FG001|COMPLETED|Lead-in Phase (Week 0 - 12)||46||
48072700|NCT01999868|100500826|FG002|COMPLETED|Lead-in Phase (Week 0 - 12)||12||
48072701|NCT01999868|100500824|FG000|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||0||
48072702|NCT01999868|100500825|FG001|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||0||
48072703|NCT01999868|100500826|FG002|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||5||
48072704|NCT01999868|100500824|FG000|STARTED|Blinded Treatment Phase (Week 12 - 40)||45||
48072705|NCT01999868|100500825|FG001|STARTED|Blinded Treatment Phase (Week 12 - 40)||46||
48072706|NCT01999868|100500826|FG002|STARTED|Blinded Treatment Phase (Week 12 - 40)||0||
48072707|NCT01999868|100500824|FG000|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||27||
48072708|NCT01999868|100500825|FG001|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||35||
48072709|NCT01999868|100500826|FG002|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||0||
48072710|NCT01999868|100500824|FG000|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||18||
48072711|NCT01999868|100500825|FG001|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||11||
48072712|NCT01999868|100500826|FG002|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||0||
48072713|NCT01999868|100500824|FG000|STARTED|Blinded Observation Phase (Week 40 - 88)||27||
48072714|NCT01999868|100500825|FG001|STARTED|Blinded Observation Phase (Week 40 - 88)||35||
48072715|NCT01999868|100500826|FG002|STARTED|Blinded Observation Phase (Week 40 - 88)||0||
48072716|NCT01999868|100500824|FG000|COMPLETED|Blinded Observation Phase (Week 40 - 88)||4||
48072717|NCT01999868|100500825|FG001|COMPLETED|Blinded Observation Phase (Week 40 - 88)||6||
48072718|NCT01999868|100500826|FG002|COMPLETED|Blinded Observation Phase (Week 40 - 88)||0||
48072719|NCT01999868|100500824|FG000|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||23||
48072720|NCT01999868|100500825|FG001|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||29||
48072721|NCT01999868|100500826|FG002|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||0||
48072722|NCT01034631|100500827|FG000|STARTED|Phase I||15||
48072723|NCT01034631|100500828|FG001|STARTED|Phase I||0||
48072724|NCT01034631|100500829|FG002|STARTED|Phase I||0||
48072725|NCT01034631|100500827|FG000|COMPLETED|Phase I||12||
48072726|NCT01034631|100500828|FG001|COMPLETED|Phase I||0||
48072727|NCT01034631|100500829|FG002|COMPLETED|Phase I||0||
48072728|NCT01034631|100500827|FG000|NOT COMPLETED|Phase I||3||
48072729|NCT01034631|100500828|FG001|NOT COMPLETED|Phase I||0||
48072730|NCT01034631|100500829|FG002|NOT COMPLETED|Phase I||0||
48072731|NCT01034631|100500827|FG000|STARTED|Phase II||0||
48072732|NCT01034631|100500828|FG001|STARTED|Phase II||70||
48072733|NCT01034631|100500829|FG002|STARTED|Phase II||69||
48072734|NCT01034631|100500827|FG000|COMPLETED|Phase II||0||
48072735|NCT01034631|100500828|FG001|COMPLETED|Phase II||69||
48072736|NCT01034631|100500829|FG002|COMPLETED|Phase II||67||
48072737|NCT01034631|100500827|FG000|NOT COMPLETED|Phase II||0||
48072738|NCT01034631|100500828|FG001|NOT COMPLETED|Phase II||1||
48072739|NCT01034631|100500829|FG002|NOT COMPLETED|Phase II||2||
48072740|NCT03289858|100500830|FG000|STARTED|Overall Study||27||
48072741|NCT03289858|100500831|FG001|STARTED|Overall Study||28||
48072742|NCT03289858|100500830|FG000|COMPLETED|Overall Study||25||
48072743|NCT03289858|100500831|FG001|COMPLETED|Overall Study||28||
48072744|NCT03289858|100500830|FG000|NOT COMPLETED|Overall Study||2||
48072745|NCT03289858|100500831|FG001|NOT COMPLETED|Overall Study||0||
48072746|NCT00868608|100500832|FG000|STARTED|Overall Study||72||
48072747|NCT00868608|100500833|FG001|STARTED|Overall Study||4||
48072748|NCT00868608|100500834|FG002|STARTED|Overall Study||5||
48072749|NCT00868608|100500832|FG000|COMPLETED|Overall Study||49||
48072750|NCT00868608|100500833|FG001|COMPLETED|Overall Study||1||
48072751|NCT00868608|100500834|FG002|COMPLETED|Overall Study||0||
48072752|NCT00868608|100500832|FG000|NOT COMPLETED|Overall Study||23||
48072753|NCT00868608|100500833|FG001|NOT COMPLETED|Overall Study||3||
48072754|NCT00868608|100500834|FG002|NOT COMPLETED|Overall Study||5||
48072755|NCT01849783|100500835|FG000|STARTED|Overall Study||41||
48072756|NCT01849783|100500835|FG000|COMPLETED|Overall Study||19||
48072757|NCT01849783|100500835|FG000|NOT COMPLETED|Overall Study||22||
48072758|NCT00622401|100500836|FG000|STARTED|Overall Study||6||
48072759|NCT00622401|100500837|FG001|STARTED|Overall Study||2||
48072760|NCT00622401|100500838|FG002|STARTED|Overall Study||0||
48072761|NCT00622401|100500836|FG000|COMPLETED|Overall Study||3||
48072762|NCT00622401|100500837|FG001|COMPLETED|Overall Study||0||
48072763|NCT00622401|100500838|FG002|COMPLETED|Overall Study||0||
48072764|NCT00622401|100500836|FG000|NOT COMPLETED|Overall Study||3||
48072765|NCT00622401|100500837|FG001|NOT COMPLETED|Overall Study||2||
48072766|NCT00622401|100500838|FG002|NOT COMPLETED|Overall Study||0||
48072767|NCT00003487|100500839|FG000|STARTED|Overall Study||8||
48072768|NCT00003487|100500839|FG000|COMPLETED|Overall Study||6||
48072769|NCT00003487|100500839|FG000|NOT COMPLETED|Overall Study||2||
48072770|NCT04424888|100500840|FG000|STARTED|First Intervention||3||
48072771|NCT04424888|100500841|FG001|STARTED|First Intervention||3||
48072772|NCT04424888|100500840|FG000|COMPLETED|First Intervention||3||
48072773|NCT04424888|100500841|FG001|COMPLETED|First Intervention||3||
48072774|NCT04424888|100500840|FG000|NOT COMPLETED|First Intervention||0||
48072775|NCT04424888|100500841|FG001|NOT COMPLETED|First Intervention||0||
48072776|NCT04424888|100500840|FG000|STARTED|Washout||3||
48072777|NCT04424888|100500841|FG001|STARTED|Washout||3||
48072778|NCT04424888|100500840|FG000|COMPLETED|Washout||3||
48072779|NCT04424888|100500841|FG001|COMPLETED|Washout||3||
48072780|NCT04424888|100500840|FG000|NOT COMPLETED|Washout||0||
48072781|NCT04424888|100500841|FG001|NOT COMPLETED|Washout||0||
48072782|NCT04424888|100500840|FG000|STARTED|Second Intervention||3||
48072783|NCT04424888|100500841|FG001|STARTED|Second Intervention||3||
48072784|NCT04424888|100500840|FG000|COMPLETED|Second Intervention||3||
48072785|NCT04424888|100500841|FG001|COMPLETED|Second Intervention||3||
48072786|NCT04424888|100500840|FG000|NOT COMPLETED|Second Intervention||0||
48072787|NCT04424888|100500841|FG001|NOT COMPLETED|Second Intervention||0||
48072788|NCT04755790|100500842|FG000|STARTED|No Prosthesis (Day 0)||13||
48072789|NCT04755790|100500842|FG000|COMPLETED|No Prosthesis (Day 0)||13||
48072790|NCT04755790|100500842|FG000|NOT COMPLETED|No Prosthesis (Day 0)||0||
48072791|NCT04755790|100500842|FG000|STARTED|Prosthesis (Day 0)||13||
48072792|NCT04755790|100500842|FG000|COMPLETED|Prosthesis (Day 0)||13||
48072793|NCT04755790|100500842|FG000|NOT COMPLETED|Prosthesis (Day 0)||0||
48072794|NCT04755790|100500842|FG000|STARTED|Prosthesis (Day 30)||13||
48072795|NCT04755790|100500842|FG000|COMPLETED|Prosthesis (Day 30)||11||
48072796|NCT04755790|100500842|FG000|NOT COMPLETED|Prosthesis (Day 30)||2||
48072797|NCT04755790|100500842|FG000|STARTED|Prosthesis (Day 60)||11||
48072798|NCT04755790|100500842|FG000|COMPLETED|Prosthesis (Day 60)||11||
48072799|NCT04755790|100500842|FG000|NOT COMPLETED|Prosthesis (Day 60)||0||
48072800|NCT00769392|100500843|FG000|STARTED|Overall Study||28||
48072801|NCT00769392|100500843|FG000|COMPLETED|Overall Study||24||
48072802|NCT00769392|100500843|FG000|NOT COMPLETED|Overall Study||4||
48072803|NCT00469274|100500844|FG000|STARTED|Overall Study||44||
48072804|NCT00469274|100500845|FG001|STARTED|Overall Study||42||
48072805|NCT00469274|100500844|FG000|COMPLETED|Overall Study||44||
48072806|NCT00469274|100500845|FG001|COMPLETED|Overall Study||42||
48072807|NCT00469274|100500844|FG000|NOT COMPLETED|Overall Study||0||
48072808|NCT00469274|100500845|FG001|NOT COMPLETED|Overall Study||0||
48072809|NCT01552694|100500846|FG000|STARTED|Overall Study||18||
48072810|NCT01552694|100500847|FG001|STARTED|Overall Study||20||
48072811|NCT01552694|100500846|FG000|COMPLETED|Overall Study||18||
48072812|NCT01552694|100500847|FG001|COMPLETED|Overall Study||18||
48072813|NCT01552694|100500846|FG000|NOT COMPLETED|Overall Study||0||
48072814|NCT01552694|100500847|FG001|NOT COMPLETED|Overall Study||2||
48072815|NCT00762385|100500848|FG000|STARTED|First Intervention||51||
48072816|NCT00762385|100500849|FG001|STARTED|First Intervention||46||
48072817|NCT00762385|100500848|FG000|COMPLETED|First Intervention||49||
48072818|NCT00762385|100500849|FG001|COMPLETED|First Intervention||42||
48072819|NCT00762385|100500848|FG000|NOT COMPLETED|First Intervention||2||
48072820|NCT00762385|100500849|FG001|NOT COMPLETED|First Intervention||4||
48072821|NCT00762385|100500848|FG000|STARTED|Second Intervention||49||
48072822|NCT00762385|100500849|FG001|STARTED|Second Intervention||42||
48072823|NCT00762385|100500848|FG000|COMPLETED|Second Intervention||46||
48072824|NCT00762385|100500849|FG001|COMPLETED|Second Intervention||39||
48072825|NCT00762385|100500848|FG000|NOT COMPLETED|Second Intervention||3||
48072826|NCT00762385|100500849|FG001|NOT COMPLETED|Second Intervention||3||
48072827|NCT01702961|100500850|FG000|STARTED|Overall Study||75||
48072828|NCT01702961|100500850|FG000|COMPLETED|Overall Study||28||
48072829|NCT01702961|100500850|FG000|NOT COMPLETED|Overall Study||47||
48072830|NCT00668707|100500851|FG000|STARTED|Overall Study||356||
48072831|NCT00668707|100500852|FG001|STARTED|Overall Study||353||
48072832|NCT00668707|100500851|FG000|COMPLETED|Overall Study||157||
48072833|NCT00668707|100500852|FG001|COMPLETED|Overall Study||173||
48072834|NCT00668707|100500851|FG000|NOT COMPLETED|Overall Study||199||
48072835|NCT00668707|100500852|FG001|NOT COMPLETED|Overall Study||180||
48072836|NCT00986830|100500853|FG000|STARTED|Overall Study||74||
48072837|NCT00986830|100500853|FG000|Treated|Overall Study||69||
48072838|NCT00986830|100500853|FG000|COMPLETED|Overall Study||66||
48072839|NCT00986830|100500853|FG000|NOT COMPLETED|Overall Study||8||
48072840|NCT01610570|100500854|FG000|STARTED|Ph I >/= 12 mo. Children & Adolescents||0||
48072841|NCT01610570|100500855|FG001|STARTED|Ph I >/= 12 mo. Children & Adolescents||2||
48072842|NCT01610570|100500856|FG002|STARTED|Ph I >/= 12 mo. Children & Adolescents||0||
48072843|NCT01610570|100500857|FG003|STARTED|Ph I >/= 12 mo. Children & Adolescents||0||
48072844|NCT01610570|100500854|FG000|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0||
48072845|NCT01610570|100500855|FG001|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||2||
48072846|NCT01610570|100500856|FG002|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0||
48072847|NCT01610570|100500857|FG003|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0||
48072848|NCT01610570|100500854|FG000|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0||
48072849|NCT01610570|100500855|FG001|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0||
48072850|NCT01610570|100500856|FG002|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0||
48072851|NCT01610570|100500857|FG003|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0||
48072852|NCT01610570|100500854|FG000|STARTED|Ph II >/= 18yrs of Age at Enrollment||0||
48072853|NCT01610570|100500855|FG001|STARTED|Ph II >/= 18yrs of Age at Enrollment||0||
48072854|NCT01610570|100500856|FG002|STARTED|Ph II >/= 18yrs of Age at Enrollment||0||
48072855|NCT01610570|100500857|FG003|STARTED|Ph II >/= 18yrs of Age at Enrollment||6||
48072856|NCT01610570|100500854|FG000|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0||
48072857|NCT01610570|100500855|FG001|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0||
48072858|NCT01610570|100500856|FG002|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0||
48072859|NCT01610570|100500857|FG003|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||6||
48072860|NCT01610570|100500854|FG000|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0||
48072861|NCT01610570|100500855|FG001|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0||
48072862|NCT01610570|100500856|FG002|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0||
48072863|NCT01610570|100500857|FG003|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0||
48072864|NCT01610570|100500854|FG000|STARTED|Ph II >/= 12 mo. & </=17yrs||0||
48072865|NCT01610570|100500855|FG001|STARTED|Ph II >/= 12 mo. & </=17yrs||0||
48072866|NCT01610570|100500856|FG002|STARTED|Ph II >/= 12 mo. & </=17yrs||0||
48072867|NCT01610570|100500857|FG003|STARTED|Ph II >/= 12 mo. & </=17yrs||0||
48072868|NCT01610570|100500854|FG000|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0||
48072869|NCT01610570|100500855|FG001|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0||
48072870|NCT01610570|100500856|FG002|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0||
48072871|NCT01610570|100500857|FG003|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0||
48072872|NCT01610570|100500854|FG000|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0||
48072873|NCT01610570|100500855|FG001|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0||
48072874|NCT01610570|100500856|FG002|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0||
48072875|NCT01610570|100500857|FG003|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0||
48072876|NCT02657369|100500858|FG000|STARTED|Overall Study||34||
48072877|NCT02657369|100500858|FG000|COMPLETED|Overall Study||0||
48072878|NCT02657369|100500858|FG000|NOT COMPLETED|Overall Study||34||
48072879|NCT00300274|100500859|FG000|STARTED|Overall Study||282||
48072880|NCT00300274|100500860|FG001|STARTED|Overall Study||168||
48072881|NCT00300274|100500861|FG002|STARTED|Overall Study||271||
48072882|NCT00300274|100500859|FG000|Completed 12 Month|Overall Study||250||
48072883|NCT00300274|100500860|FG001|Completed 12 Month|Overall Study||149||
48072884|NCT00300274|100500861|FG002|Completed 12 Month|Overall Study||248||
48072885|NCT00300274|100500859|FG000|COMPLETED|Overall Study||236||
48072886|NCT00300274|100500860|FG001|COMPLETED|Overall Study||141||
48072887|NCT00300274|100500861|FG002|COMPLETED|Overall Study||226||
48072888|NCT00300274|100500859|FG000|NOT COMPLETED|Overall Study||46||
48072889|NCT00300274|100500860|FG001|NOT COMPLETED|Overall Study||27||
48072890|NCT00300274|100500861|FG002|NOT COMPLETED|Overall Study||45||
48072891|NCT02718157|100500862|FG000|STARTED|Overall Study||771||
48072892|NCT02718157|100500862|FG000|COMPLETED|Overall Study||609||
48072893|NCT02718157|100500862|FG000|NOT COMPLETED|Overall Study||162||
48072894|NCT01352546|100500863|FG000|STARTED|Overall Study||31||
48072895|NCT01352546|100500863|FG000|COMPLETED|Overall Study||31||
48072896|NCT01352546|100500863|FG000|NOT COMPLETED|Overall Study||0||
48072897|NCT03372096|100500864|FG000|STARTED|Overall Study||18||
48072898|NCT03372096|100500864|FG000|Received Intervention|Overall Study||10||
48072899|NCT03372096|100500864|FG000|COMPLETED|Overall Study||10||
48072900|NCT03372096|100500864|FG000|NOT COMPLETED|Overall Study||8||
48072901|NCT01270516|100500865|FG000|STARTED|Overall Study||20||
48072902|NCT01270516|100500866|FG001|STARTED|Overall Study||17||
48072903|NCT01270516|100500867|FG002|STARTED|Overall Study||18||
48072904|NCT01270516|100500868|FG003|STARTED|Overall Study||18||
48072905|NCT01270516|100500865|FG000|COMPLETED|Overall Study||17||
48072906|NCT01270516|100500866|FG001|COMPLETED|Overall Study||13||
48072907|NCT01270516|100500867|FG002|COMPLETED|Overall Study||13||
48072908|NCT01270516|100500868|FG003|COMPLETED|Overall Study||13||
48072909|NCT01270516|100500865|FG000|NOT COMPLETED|Overall Study||3||
48072910|NCT01270516|100500866|FG001|NOT COMPLETED|Overall Study||4||
48072911|NCT01270516|100500867|FG002|NOT COMPLETED|Overall Study||5||
48072912|NCT01270516|100500868|FG003|NOT COMPLETED|Overall Study||5||
48072913|NCT03128411|100500869|FG000|STARTED|Treatment Phase||60||
48072914|NCT03128411|100500869|FG000|Received Treatment|Treatment Phase||60||
48072915|NCT03128411|100500869|FG000|COMPLETED|Treatment Phase||36||
48072916|NCT03128411|100500869|FG000|NOT COMPLETED|Treatment Phase||24||
48072917|NCT03128411|100500869|FG000|STARTED|Long Term Follow-up Phase||24||
48072918|NCT03128411|100500869|FG000|COMPLETED|Long Term Follow-up Phase||22||
48072919|NCT03128411|100500869|FG000|NOT COMPLETED|Long Term Follow-up Phase||2||
48072920|NCT02605824|100500870|FG000|STARTED|Overall Study||1||
48072921|NCT02605824|100500871|FG001|STARTED|Overall Study||0||
48072922|NCT02605824|100500870|FG000|COMPLETED|Overall Study||0||
48072923|NCT02605824|100500871|FG001|COMPLETED|Overall Study||0||
48072924|NCT02605824|100500870|FG000|NOT COMPLETED|Overall Study||1||
48072925|NCT02605824|100500871|FG001|NOT COMPLETED|Overall Study||0||
48072926|NCT01112865|100500872|FG000|STARTED|First Intervention||59||
48222264|NCT01836445|100866707|FG001|STARTED|12 Month STI Testing||455||
48222265|NCT01836445|100866706|FG000|COMPLETED|12 Month STI Testing||365||
48222266|NCT01836445|100866707|FG001|COMPLETED|12 Month STI Testing||378||
48222267|NCT01836445|100866706|FG000|NOT COMPLETED|12 Month STI Testing||80||
48222268|NCT01836445|100866707|FG001|NOT COMPLETED|12 Month STI Testing||77||
48222269|NCT02144597|100866708|FG000|STARTED|Overall Study||10||
48222270|NCT02144597|100866709|FG001|STARTED|Overall Study||10||
48222271|NCT02144597|100866710|FG002|STARTED|Overall Study||10||
48222272|NCT02144597|100866708|FG000|COMPLETED|Overall Study||4||
48222273|NCT02144597|100866709|FG001|COMPLETED|Overall Study||6||
48222274|NCT02144597|100866710|FG002|COMPLETED|Overall Study||6||
48222275|NCT02144597|100866708|FG000|NOT COMPLETED|Overall Study||6||
48222276|NCT02144597|100866709|FG001|NOT COMPLETED|Overall Study||4||
48222277|NCT02144597|100866710|FG002|NOT COMPLETED|Overall Study||4||
48222278|NCT03220724|100866711|FG000|STARTED|Overall Study||12||
48222279|NCT03220724|100866712|FG001|STARTED|Overall Study||12||
48222280|NCT03220724|100866713|FG002|STARTED|Overall Study||12||
48222281|NCT03220724|100866714|FG003|STARTED|Overall Study||6||
48222282|NCT03220724|100866715|FG004|STARTED|Overall Study||20||
48222283|NCT03220724|100866716|FG005|STARTED|Overall Study||20||
48222284|NCT03220724|100866717|FG006|STARTED|Overall Study||20||
48222285|NCT03220724|100866718|FG007|STARTED|Overall Study||5||
48222286|NCT03220724|100866719|FG008|STARTED|Overall Study||10||
48222287|NCT03220724|100866711|FG000|Month 4.5 Immunogenicity Cohort|Overall Study||11||
48222288|NCT03220724|100866712|FG001|Month 4.5 Immunogenicity Cohort|Overall Study||12||
48072927|NCT01112865|100500873|FG001|STARTED|First Intervention||61||
48072928|NCT01112865|100500872|FG000|COMPLETED|First Intervention||59||
48072929|NCT01112865|100500873|FG001|COMPLETED|First Intervention||61||
48072930|NCT01112865|100500872|FG000|NOT COMPLETED|First Intervention||0||
48072931|NCT01112865|100500873|FG001|NOT COMPLETED|First Intervention||0||
48072932|NCT01112865|100500872|FG000|STARTED|Second Intervention||59||
48072933|NCT01112865|100500873|FG001|STARTED|Second Intervention||61||
48072934|NCT01112865|100500872|FG000|COMPLETED|Second Intervention||59||
48072935|NCT01112865|100500873|FG001|COMPLETED|Second Intervention||61||
48072936|NCT01112865|100500872|FG000|NOT COMPLETED|Second Intervention||0||
48072937|NCT01112865|100500873|FG001|NOT COMPLETED|Second Intervention||0||
48072938|NCT00672646|100500874|FG000|STARTED|Overall Study||40||
48072939|NCT00672646|100500875|FG001|STARTED|Overall Study||23||
48072940|NCT00672646|100500876|FG002|STARTED|Overall Study||40||
48072941|NCT00672646|100500874|FG000|COMPLETED|Overall Study||40||
48072942|NCT00672646|100500875|FG001|COMPLETED|Overall Study||22||
48072943|NCT00672646|100500876|FG002|COMPLETED|Overall Study||37||
48072944|NCT00672646|100500874|FG000|NOT COMPLETED|Overall Study||0||
48072945|NCT00672646|100500875|FG001|NOT COMPLETED|Overall Study||1||
48072946|NCT00672646|100500876|FG002|NOT COMPLETED|Overall Study||3||
48072947|NCT01397162|100500877|FG000|STARTED|Overall Study||8||
48072948|NCT01397162|100500878|FG001|STARTED|Overall Study||5||
48072949|NCT01397162|100500879|FG002|STARTED|Overall Study||4||
48072950|NCT01397162|100500880|FG003|STARTED|Overall Study||6||
48072951|NCT01397162|100500881|FG004|STARTED|Overall Study||6||
48072952|NCT01397162|100500877|FG000|COMPLETED|Overall Study||1||
48072953|NCT01397162|100500878|FG001|COMPLETED|Overall Study||1||
48072954|NCT01397162|100500879|FG002|COMPLETED|Overall Study||1||
48072955|NCT01397162|100500880|FG003|COMPLETED|Overall Study||1||
48072956|NCT01397162|100500881|FG004|COMPLETED|Overall Study||3||
48072957|NCT01397162|100500877|FG000|NOT COMPLETED|Overall Study||7||
48072958|NCT01397162|100500878|FG001|NOT COMPLETED|Overall Study||4||
48072959|NCT01397162|100500879|FG002|NOT COMPLETED|Overall Study||3||
48222289|NCT03220724|100866713|FG002|Month 4.5 Immunogenicity Cohort|Overall Study||12||
48072960|NCT01397162|100500880|FG003|NOT COMPLETED|Overall Study||5||
48072961|NCT01397162|100500881|FG004|NOT COMPLETED|Overall Study||3||
48072962|NCT03129178|100500882|FG000|STARTED|Overall Study||13||
48370765|NCT04967599|101236526|FG000|STARTED|Overall Study||120||
48072963|NCT03129178|100500883|FG001|STARTED|Overall Study||13||
48072964|NCT03129178|100500882|FG000|COMPLETED|Overall Study||12||
48072965|NCT03129178|100500883|FG001|COMPLETED|Overall Study||11||
48072966|NCT03129178|100500882|FG000|NOT COMPLETED|Overall Study||1||
48072967|NCT03129178|100500883|FG001|NOT COMPLETED|Overall Study||2||
48072968|NCT00000371|100500884|FG000|STARTED|Overall Study||27||
48072969|NCT00000371|100500885|FG001|STARTED|Overall Study||28||
48072970|NCT00000371|100500884|FG000|COMPLETED|Overall Study||14||
48072971|NCT00000371|100500885|FG001|COMPLETED|Overall Study||12||
48072972|NCT00000371|100500884|FG000|NOT COMPLETED|Overall Study||13||
48072973|NCT00000371|100500885|FG001|NOT COMPLETED|Overall Study||16||
48072974|NCT01259596|100500886|FG000|STARTED|Overall Study||70||
48072975|NCT01259596|100500887|FG001|STARTED|Overall Study||71||
48072976|NCT01259596|100500886|FG000|COMPLETED|Overall Study||66||
48072977|NCT01259596|100500887|FG001|COMPLETED|Overall Study||65||
48072978|NCT01259596|100500886|FG000|NOT COMPLETED|Overall Study||4||
48072979|NCT01259596|100500887|FG001|NOT COMPLETED|Overall Study||6||
48072980|NCT00087607|100500888|FG000|STARTED|Overall Study||192||
48072981|NCT00087607|100500889|FG001|STARTED|Overall Study||193||
48072982|NCT00087607|100500888|FG000|COMPLETED|Overall Study||70||
48072983|NCT00087607|100500889|FG001|COMPLETED|Overall Study||71||
48072984|NCT00087607|100500888|FG000|NOT COMPLETED|Overall Study||122||
48072985|NCT00087607|100500889|FG001|NOT COMPLETED|Overall Study||122||
48072986|NCT02925923|100500890|FG000|STARTED|Overall Study||50||
48072987|NCT02925923|100500891|FG001|STARTED|Overall Study||50||
48072988|NCT02925923|100500890|FG000|COMPLETED|Overall Study||50||
48072989|NCT02925923|100500891|FG001|COMPLETED|Overall Study||48||
48072990|NCT02925923|100500890|FG000|NOT COMPLETED|Overall Study||0||
48072991|NCT02925923|100500891|FG001|NOT COMPLETED|Overall Study||2||
48072992|NCT01348165|100500892|FG000|STARTED|Overall Study||10||
48072993|NCT01348165|100500893|FG001|STARTED|Overall Study||5||
48072994|NCT01348165|100500894|FG002|STARTED|Overall Study||6||
48072995|NCT01348165|100500895|FG003|STARTED|Overall Study||6||
48072996|NCT01348165|100500896|FG004|STARTED|Overall Study||6||
48072997|NCT01348165|100500897|FG005|STARTED|Overall Study||1||
48072998|NCT01348165|100500898|FG006|STARTED|Overall Study||6||
48072999|NCT01348165|100500892|FG000|COMPLETED|Overall Study||10||
48073000|NCT01348165|100500893|FG001|COMPLETED|Overall Study||5||
48073001|NCT01348165|100500894|FG002|COMPLETED|Overall Study||6||
48073002|NCT01348165|100500895|FG003|COMPLETED|Overall Study||6||
48073003|NCT01348165|100500896|FG004|COMPLETED|Overall Study||6||
48073004|NCT01348165|100500897|FG005|COMPLETED|Overall Study||1||
48073005|NCT01348165|100500898|FG006|COMPLETED|Overall Study||5||
48073006|NCT01348165|100500892|FG000|NOT COMPLETED|Overall Study||0||
48073007|NCT01348165|100500893|FG001|NOT COMPLETED|Overall Study||0||
48073008|NCT01348165|100500894|FG002|NOT COMPLETED|Overall Study||0||
48073009|NCT01348165|100500895|FG003|NOT COMPLETED|Overall Study||0||
48073010|NCT01348165|100500896|FG004|NOT COMPLETED|Overall Study||0||
48073011|NCT01348165|100500897|FG005|NOT COMPLETED|Overall Study||0||
48073012|NCT01348165|100500898|FG006|NOT COMPLETED|Overall Study||1||
48073013|NCT02793921|100500899|FG000|STARTED|Overall Study||77||
48073014|NCT02793921|100500900|FG001|STARTED|Overall Study||76||
48073015|NCT02793921|100500899|FG000|COMPLETED|Overall Study||77||
48073016|NCT02793921|100500900|FG001|COMPLETED|Overall Study||76||
48073017|NCT02793921|100500899|FG000|NOT COMPLETED|Overall Study||0||
48073018|NCT02793921|100500900|FG001|NOT COMPLETED|Overall Study||0||
48073019|NCT01188421|100500901|FG000|STARTED|Overall Study||31||
48073020|NCT01188421|100500902|FG001|STARTED|Overall Study||36||
48073021|NCT01188421|100500903|FG002|STARTED|Overall Study||36||
48073022|NCT01188421|100500901|FG000|COMPLETED|Overall Study||28||
48073023|NCT01188421|100500902|FG001|COMPLETED|Overall Study||26||
48073024|NCT01188421|100500903|FG002|COMPLETED|Overall Study||22||
48073025|NCT01188421|100500901|FG000|NOT COMPLETED|Overall Study||3||
48073026|NCT01188421|100500902|FG001|NOT COMPLETED|Overall Study||10||
48073027|NCT01188421|100500903|FG002|NOT COMPLETED|Overall Study||14||
48073028|NCT03928353|100500904|FG000|STARTED|Overall Study||6||
48073029|NCT03928353|100500905|FG001|STARTED|Overall Study||5||
48073030|NCT03928353|100500906|FG002|STARTED|Overall Study||4||
48073031|NCT03928353|100500907|FG003|STARTED|Overall Study||6||
48073032|NCT03928353|100500908|FG004|STARTED|Overall Study||2||
48073033|NCT03928353|100500904|FG000|COMPLETED|Overall Study||6||
48073034|NCT03928353|100500905|FG001|COMPLETED|Overall Study||5||
48073035|NCT03928353|100500906|FG002|COMPLETED|Overall Study||4||
48073036|NCT03928353|100500907|FG003|COMPLETED|Overall Study||6||
48073037|NCT03928353|100500908|FG004|COMPLETED|Overall Study||2||
48073038|NCT03928353|100500904|FG000|NOT COMPLETED|Overall Study||0||
48073039|NCT03928353|100500905|FG001|NOT COMPLETED|Overall Study||0||
48073040|NCT03928353|100500906|FG002|NOT COMPLETED|Overall Study||0||
48073041|NCT03928353|100500907|FG003|NOT COMPLETED|Overall Study||0||
48073042|NCT03928353|100500908|FG004|NOT COMPLETED|Overall Study||0||
48073043|NCT00751933|100500909|FG000|STARTED|Overall Study||0||
48073044|NCT00751933|100500910|FG001|STARTED|Overall Study||1||
48073045|NCT00751933|100500911|FG002|STARTED|Overall Study||1||
48073046|NCT00751933|100500912|FG003|STARTED|Overall Study||1||
48073047|NCT00751933|100500909|FG000|COMPLETED|Overall Study||0||
48073048|NCT00751933|100500910|FG001|COMPLETED|Overall Study||0||
48073049|NCT00751933|100500911|FG002|COMPLETED|Overall Study||0||
48073050|NCT00751933|100500912|FG003|COMPLETED|Overall Study||0||
48073051|NCT00751933|100500909|FG000|NOT COMPLETED|Overall Study||0||
48073052|NCT00751933|100500910|FG001|NOT COMPLETED|Overall Study||1||
48073053|NCT00751933|100500911|FG002|NOT COMPLETED|Overall Study||1||
48073054|NCT00751933|100500912|FG003|NOT COMPLETED|Overall Study||1||
48073055|NCT03087643|100500913|FG000|STARTED|Overall Study||26||
48073056|NCT03087643|100500914|FG001|STARTED|Overall Study||25||
48073057|NCT03087643|100500913|FG000|COMPLETED|Overall Study||22||
48073058|NCT03087643|100500914|FG001|COMPLETED|Overall Study||19||
48073059|NCT03087643|100500913|FG000|NOT COMPLETED|Overall Study||4||
48073060|NCT03087643|100500914|FG001|NOT COMPLETED|Overall Study||6||
48073061|NCT01402011|100500915|FG000|STARTED|Delayed Treatment Period||29||
48073062|NCT01402011|100500916|FG001|STARTED|Delayed Treatment Period||23||
48073063|NCT01402011|100500917|FG002|STARTED|Delayed Treatment Period||26||
48073064|NCT01402011|100500915|FG000|COMPLETED|Delayed Treatment Period||28||
48073065|NCT01402011|100500916|FG001|COMPLETED|Delayed Treatment Period||23||
48073066|NCT01402011|100500917|FG002|COMPLETED|Delayed Treatment Period||26||
48073067|NCT01402011|100500915|FG000|NOT COMPLETED|Delayed Treatment Period||1||
48073068|NCT01402011|100500916|FG001|NOT COMPLETED|Delayed Treatment Period||0||
48073069|NCT01402011|100500917|FG002|NOT COMPLETED|Delayed Treatment Period||0||
48073070|NCT01402011|100500915|FG000|STARTED|Active Treatment Period||28||
48073071|NCT01402011|100500916|FG001|STARTED|Active Treatment Period||23||
48073072|NCT01402011|100500917|FG002|STARTED|Active Treatment Period||26||
48073073|NCT01402011|100500915|FG000|COMPLETED|Active Treatment Period||27|Patients who quit the study did so because they found the injections too painful.|
48073074|NCT01402011|100500916|FG001|COMPLETED|Active Treatment Period||20|Patients who quit the study did so because they found the injections too painful.|
48073075|NCT01402011|100500917|FG002|COMPLETED|Active Treatment Period||26|Patients who quit the study did so because they found the injections too painful.|
48073076|NCT01402011|100500915|FG000|NOT COMPLETED|Active Treatment Period||1||
48073077|NCT01402011|100500916|FG001|NOT COMPLETED|Active Treatment Period||3||
48073078|NCT01402011|100500917|FG002|NOT COMPLETED|Active Treatment Period||0||
48073079|NCT01402011|100500915|FG000|STARTED|Nine Month Follow-up||27||
48073080|NCT01402011|100500916|FG001|STARTED|Nine Month Follow-up||20||
48073081|NCT01402011|100500917|FG002|STARTED|Nine Month Follow-up||26||
48073082|NCT01402011|100500915|FG000|COMPLETED|Nine Month Follow-up||27||
48073083|NCT01402011|100500916|FG001|COMPLETED|Nine Month Follow-up||19||
48073084|NCT01402011|100500917|FG002|COMPLETED|Nine Month Follow-up||26||
48073085|NCT01402011|100500915|FG000|NOT COMPLETED|Nine Month Follow-up||0||
48073086|NCT01402011|100500916|FG001|NOT COMPLETED|Nine Month Follow-up||1||
48073087|NCT01402011|100500917|FG002|NOT COMPLETED|Nine Month Follow-up||0||
48073088|NCT01218243|100500918|FG000|STARTED|Overall Study||50||
48073089|NCT01218243|100500919|FG001|STARTED|Overall Study||50||
48073090|NCT01218243|100500918|FG000|Treatment Completed|Overall Study||45||
48073091|NCT01218243|100500919|FG001|Treatment Completed|Overall Study||42||
48073092|NCT01218243|100500918|FG000|COMPLETED|Overall Study||41||
48073093|NCT01218243|100500919|FG001|COMPLETED|Overall Study||36||
48073094|NCT01218243|100500918|FG000|NOT COMPLETED|Overall Study||9||
48073095|NCT01218243|100500919|FG001|NOT COMPLETED|Overall Study||14||
48073096|NCT05399641|100500920|FG000|STARTED|Overall Study||27||
48073097|NCT05399641|100500921|FG001|STARTED|Overall Study||62||
48073098|NCT05399641|100500922|FG002|STARTED|Overall Study||61||
48073099|NCT05399641|100500920|FG000|COMPLETED|Overall Study||18||
48073100|NCT05399641|100500921|FG001|COMPLETED|Overall Study||40||
48073101|NCT05399641|100500922|FG002|COMPLETED|Overall Study||42||
48073102|NCT05399641|100500920|FG000|NOT COMPLETED|Overall Study||9||
48073103|NCT05399641|100500921|FG001|NOT COMPLETED|Overall Study||22||
48073104|NCT05399641|100500922|FG002|NOT COMPLETED|Overall Study||19||
48073105|NCT03724032|100500923|FG000|STARTED|Overall Study||6||
48073106|NCT03724032|100500924|FG001|STARTED|Overall Study||6||
48073107|NCT03724032|100500925|FG002|STARTED|Overall Study||15||
48073108|NCT03724032|100500923|FG000|COMPLETED|Overall Study||3||
48073109|NCT03724032|100500924|FG001|COMPLETED|Overall Study||4||
48073110|NCT03724032|100500925|FG002|COMPLETED|Overall Study||14||
48073111|NCT03724032|100500923|FG000|NOT COMPLETED|Overall Study||3||
48073112|NCT03724032|100500924|FG001|NOT COMPLETED|Overall Study||2||
48073113|NCT03724032|100500925|FG002|NOT COMPLETED|Overall Study||1||
48073114|NCT01133522|100500926|FG000|STARTED|Overall Study||10||
48073115|NCT01133522|100500927|FG001|STARTED|Overall Study||7||
48073116|NCT01133522|100500928|FG002|STARTED|Overall Study||6||
48073117|NCT01133522|100500929|FG003|STARTED|Overall Study||7||
48073118|NCT01133522|100500930|FG004|STARTED|Overall Study||7||
48073119|NCT01133522|100500931|FG005|STARTED|Overall Study||6||
48073120|NCT01133522|100500932|FG006|STARTED|Overall Study||2||
48073121|NCT01133522|100500933|FG007|STARTED|Overall Study||9||
48073122|NCT01133522|100500934|FG008|STARTED|Overall Study||2||
48073123|NCT01133522|100500935|FG009|STARTED|Overall Study||4||
48073124|NCT01133522|100500926|FG000|Received Treatment|Overall Study||10||
48073125|NCT01133522|100500927|FG001|Received Treatment|Overall Study||6||
48073126|NCT01133522|100500928|FG002|Received Treatment|Overall Study||6||
48073127|NCT01133522|100500929|FG003|Received Treatment|Overall Study||6||
48222290|NCT03220724|100866714|FG003|Month 4.5 Immunogenicity Cohort|Overall Study||3||
48073128|NCT01133522|100500930|FG004|Received Treatment|Overall Study||6||
48073129|NCT01133522|100500931|FG005|Received Treatment|Overall Study||6||
48073130|NCT01133522|100500932|FG006|Received Treatment|Overall Study||2||
48073131|NCT01133522|100500933|FG007|Received Treatment|Overall Study||9||
48073132|NCT01133522|100500934|FG008|Received Treatment|Overall Study||2||
48073133|NCT01133522|100500935|FG009|Received Treatment|Overall Study||4||
48073134|NCT01133522|100500926|FG000|COMPLETED|Overall Study||10||
48073135|NCT01133522|100500927|FG001|COMPLETED|Overall Study||6||
48073136|NCT01133522|100500928|FG002|COMPLETED|Overall Study||6||
48073137|NCT01133522|100500929|FG003|COMPLETED|Overall Study||6||
48073138|NCT01133522|100500930|FG004|COMPLETED|Overall Study||6||
48073139|NCT01133522|100500931|FG005|COMPLETED|Overall Study||6||
48073140|NCT01133522|100500932|FG006|COMPLETED|Overall Study||2||
48073141|NCT01133522|100500933|FG007|COMPLETED|Overall Study||9||
48073142|NCT01133522|100500934|FG008|COMPLETED|Overall Study||2||
48073143|NCT01133522|100500935|FG009|COMPLETED|Overall Study||4||
48073144|NCT01133522|100500926|FG000|NOT COMPLETED|Overall Study||0||
48073145|NCT01133522|100500927|FG001|NOT COMPLETED|Overall Study||1||
48073146|NCT01133522|100500928|FG002|NOT COMPLETED|Overall Study||0||
48073147|NCT01133522|100500929|FG003|NOT COMPLETED|Overall Study||1||
48073148|NCT01133522|100500930|FG004|NOT COMPLETED|Overall Study||1||
48073149|NCT01133522|100500931|FG005|NOT COMPLETED|Overall Study||0||
48073150|NCT01133522|100500932|FG006|NOT COMPLETED|Overall Study||0||
48073151|NCT01133522|100500933|FG007|NOT COMPLETED|Overall Study||0||
48073152|NCT01133522|100500934|FG008|NOT COMPLETED|Overall Study||0||
48073153|NCT01133522|100500935|FG009|NOT COMPLETED|Overall Study||0||
48073154|NCT00705484|100500936|FG000|STARTED|Overall Study||1059||
48073155|NCT00705484|100500937|FG001|STARTED|Overall Study||1180||
48073156|NCT00705484|100500936|FG000|Follow-up Period|Overall Study||1059||
48073157|NCT00705484|100500937|FG001|Follow-up Period|Overall Study||296||
48073158|NCT00705484|100500936|FG000|COMPLETED|Overall Study||677||
48073159|NCT00705484|100500937|FG001|COMPLETED|Overall Study||772||
48073160|NCT00705484|100500936|FG000|NOT COMPLETED|Overall Study||382||
48073161|NCT00705484|100500937|FG001|NOT COMPLETED|Overall Study||408||
48073162|NCT01646762|100500938|FG000|STARTED|Overall Study||13||
48073163|NCT01646762|100500938|FG000|COMPLETED|Overall Study||13||
48073164|NCT01646762|100500938|FG000|NOT COMPLETED|Overall Study||0||
48073165|NCT00084383|100500939|FG000|STARTED|Overall Study||60||
48073166|NCT00084383|100500939|FG000|COMPLETED|Overall Study||13||
48073167|NCT00084383|100500939|FG000|NOT COMPLETED|Overall Study||47||
48073168|NCT00565045|100500940|FG000|STARTED|Overall Study||10||
48073169|NCT00565045|100500941|FG001|STARTED|Overall Study||11||
48073170|NCT00565045|100500940|FG000|COMPLETED|Overall Study||9||
48073171|NCT00565045|100500941|FG001|COMPLETED|Overall Study||8||
48073172|NCT00565045|100500940|FG000|NOT COMPLETED|Overall Study||1||
48073173|NCT00565045|100500941|FG001|NOT COMPLETED|Overall Study||3||
48073174|NCT00702923|100500942|FG000|STARTED|Overall Study||12||
48073175|NCT00702923|100500942|FG000|COMPLETED|Overall Study||11||
48073176|NCT00702923|100500942|FG000|NOT COMPLETED|Overall Study||1||
48073177|NCT02053051|100500943|FG000|STARTED|Overall Study||13||
48073178|NCT02053051|100500944|FG001|STARTED|Overall Study||12||
48073179|NCT02053051|100500943|FG000|COMPLETED|Overall Study||13||
48073180|NCT02053051|100500944|FG001|COMPLETED|Overall Study||12||
48073181|NCT02053051|100500943|FG000|NOT COMPLETED|Overall Study||0||
48073182|NCT02053051|100500944|FG001|NOT COMPLETED|Overall Study||0||
48073183|NCT02352974|100500945|FG000|STARTED|Main Study||12||
48073184|NCT02352974|100500945|FG000|COMPLETED|Main Study||12||
48073185|NCT02352974|100500945|FG000|NOT COMPLETED|Main Study||0||
48073186|NCT02352974|100500945|FG000|STARTED|Extension||3||
48073187|NCT02352974|100500945|FG000|COMPLETED|Extension||3||
48073188|NCT02352974|100500945|FG000|NOT COMPLETED|Extension||0||
48073189|NCT02044393|100500946|FG000|STARTED|Period 1||10||
48073190|NCT02044393|100500947|FG001|STARTED|Period 1||10||
48073191|NCT02044393|100500946|FG000|COMPLETED|Period 1||10||
48073192|NCT02044393|100500947|FG001|COMPLETED|Period 1||10||
48073193|NCT02044393|100500946|FG000|NOT COMPLETED|Period 1||0||
48073194|NCT02044393|100500947|FG001|NOT COMPLETED|Period 1||0||
48073195|NCT02044393|100500946|FG000|STARTED|Period 2||10||
48073196|NCT02044393|100500947|FG001|STARTED|Period 2||10||
48073197|NCT02044393|100500946|FG000|COMPLETED|Period 2||10||
48073198|NCT02044393|100500947|FG001|COMPLETED|Period 2||10||
48073199|NCT02044393|100500946|FG000|NOT COMPLETED|Period 2||0||
48073200|NCT02044393|100500947|FG001|NOT COMPLETED|Period 2||0||
48073201|NCT02450591|100500948|FG000|STARTED|Overall Study||4||
48073202|NCT02450591|100500948|FG000|COMPLETED|Overall Study||4||
48073203|NCT02450591|100500948|FG000|NOT COMPLETED|Overall Study||0||
48073204|NCT00679432|100500949|FG000|STARTED|Overall Study||126||
48073205|NCT00679432|100500950|FG001|STARTED|Overall Study||127||
48073206|NCT00679432|100500951|FG002|STARTED|Overall Study||129||
48073207|NCT00679432|100500952|FG003|STARTED|Overall Study||127||
48073208|NCT00679432|100500949|FG000|COMPLETED|Overall Study||89||
48073209|NCT00679432|100500950|FG001|COMPLETED|Overall Study||89||
48073210|NCT00679432|100500951|FG002|COMPLETED|Overall Study||76||
48073211|NCT00679432|100500952|FG003|COMPLETED|Overall Study||95||
48073212|NCT00679432|100500949|FG000|NOT COMPLETED|Overall Study||37||
48073213|NCT00679432|100500950|FG001|NOT COMPLETED|Overall Study||38||
48073214|NCT00679432|100500951|FG002|NOT COMPLETED|Overall Study||53||
48073215|NCT00679432|100500952|FG003|NOT COMPLETED|Overall Study||32||
48073216|NCT03493607|100500953|FG000|STARTED|Overall Study||6||
48073217|NCT03493607|100500953|FG000|COMPLETED|Overall Study||6||
48073218|NCT03493607|100500953|FG000|NOT COMPLETED|Overall Study||0||
48073219|NCT04431453|100500954|FG000|STARTED|Overall Study||12||
48073220|NCT04431453|100500955|FG001|STARTED|Overall Study||12||
48073221|NCT04431453|100500956|FG002|STARTED|Overall Study||12||
48073222|NCT04431453|100500957|FG003|STARTED|Overall Study||12||
48073223|NCT04431453|100500958|FG004|STARTED|Overall Study||4||
48073224|NCT04431453|100500959|FG005|STARTED|Overall Study||1||
48073225|NCT04431453|100500960|FG006|STARTED|Overall Study||1||
48073226|NCT04431453|100500961|FG007|STARTED|Overall Study||5||
48073227|NCT04431453|100500954|FG000|COMPLETED|Overall Study||11||
48073228|NCT04431453|100500955|FG001|COMPLETED|Overall Study||11||
48073229|NCT04431453|100500956|FG002|COMPLETED|Overall Study||11||
48073230|NCT04431453|100500957|FG003|COMPLETED|Overall Study||9||
48073231|NCT04431453|100500958|FG004|COMPLETED|Overall Study||3||
48073232|NCT04431453|100500959|FG005|COMPLETED|Overall Study||1||
48073233|NCT04431453|100500960|FG006|COMPLETED|Overall Study||1||
48073234|NCT04431453|100500961|FG007|COMPLETED|Overall Study||4||
48073235|NCT04431453|100500954|FG000|NOT COMPLETED|Overall Study||1||
48073236|NCT04431453|100500955|FG001|NOT COMPLETED|Overall Study||1||
48073237|NCT04431453|100500956|FG002|NOT COMPLETED|Overall Study||1||
48073238|NCT04431453|100500957|FG003|NOT COMPLETED|Overall Study||3||
48073239|NCT04431453|100500958|FG004|NOT COMPLETED|Overall Study||1||
48073240|NCT04431453|100500959|FG005|NOT COMPLETED|Overall Study||0||
48073241|NCT04431453|100500960|FG006|NOT COMPLETED|Overall Study||0||
48073242|NCT04431453|100500961|FG007|NOT COMPLETED|Overall Study||1||
48073243|NCT01216631|100500962|FG000|STARTED|Overall Study||0||
48073244|NCT01216631|100500963|FG001|STARTED|Overall Study||0||
48073245|NCT01216631|100500964|FG002|STARTED|Overall Study||1||
48073246|NCT01216631|100500962|FG000|COMPLETED|Overall Study||0||
48073247|NCT01216631|100500963|FG001|COMPLETED|Overall Study||0||
48073248|NCT01216631|100500964|FG002|COMPLETED|Overall Study||1||
48073249|NCT01216631|100500962|FG000|NOT COMPLETED|Overall Study||0||
48073250|NCT01216631|100500963|FG001|NOT COMPLETED|Overall Study||0||
48073251|NCT01216631|100500964|FG002|NOT COMPLETED|Overall Study||0||
48073252|NCT00621582|100500965|FG000|STARTED|Overall Study||4918||
48073253|NCT00621582|100500965|FG000|COMPLETED|Overall Study||4812||
48073254|NCT00621582|100500965|FG000|NOT COMPLETED|Overall Study||106||
48073255|NCT00144391|100500966|FG000|STARTED|Overall Study||11||
48073256|NCT00144391|100500967|FG001|STARTED|Overall Study||9||
48073257|NCT00144391|100500966|FG000|COMPLETED|Overall Study||11||
48073258|NCT00144391|100500967|FG001|COMPLETED|Overall Study||9||
48073259|NCT00144391|100500966|FG000|NOT COMPLETED|Overall Study||0||
48073260|NCT00144391|100500967|FG001|NOT COMPLETED|Overall Study||0||
48073261|NCT02572401|100500968|FG000|STARTED|Overall Study||97||
48073262|NCT02572401|100500969|FG001|STARTED|Overall Study||98||
48073263|NCT02572401|100500970|FG002|STARTED|Overall Study||98||
48073264|NCT02572401|100500971|FG003|STARTED|Overall Study||98||
48073265|NCT02572401|100500968|FG000|COMPLETED|Overall Study||92||
48073266|NCT02572401|100500969|FG001|COMPLETED|Overall Study||90||
48073267|NCT02572401|100500970|FG002|COMPLETED|Overall Study||89||
48073268|NCT02572401|100500971|FG003|COMPLETED|Overall Study||88||
48073269|NCT02572401|100500968|FG000|NOT COMPLETED|Overall Study||5||
48073270|NCT02572401|100500969|FG001|NOT COMPLETED|Overall Study||8||
48073271|NCT02572401|100500970|FG002|NOT COMPLETED|Overall Study||9||
48073272|NCT02572401|100500971|FG003|NOT COMPLETED|Overall Study||10||
48073273|NCT00845858|100500972|FG000|STARTED|Overall Study||96||
48073274|NCT00845858|100500973|FG001|STARTED|Overall Study||96||
48073275|NCT00845858|100500974|FG002|STARTED|Overall Study||95||
48073276|NCT00845858|100500972|FG000|COMPLETED|Overall Study||88||
48073277|NCT00845858|100500973|FG001|COMPLETED|Overall Study||84||
48073278|NCT00845858|100500974|FG002|COMPLETED|Overall Study||87||
48073279|NCT00845858|100500972|FG000|NOT COMPLETED|Overall Study||8||
48073280|NCT00845858|100500973|FG001|NOT COMPLETED|Overall Study||12||
48073281|NCT00845858|100500974|FG002|NOT COMPLETED|Overall Study||8||
48073282|NCT03243071|100500975|FG000|STARTED|Overall Study||59||
48073283|NCT03243071|100500976|FG001|STARTED|Overall Study||53||
48073284|NCT03243071|100500975|FG000|COMPLETED|Overall Study||59||
48073285|NCT03243071|100500976|FG001|COMPLETED|Overall Study||53||
48073286|NCT03243071|100500975|FG000|NOT COMPLETED|Overall Study||0||
48073287|NCT03243071|100500976|FG001|NOT COMPLETED|Overall Study||0||
48073288|NCT00727220|100500977|FG000|STARTED|Overall Study||21||
48073289|NCT00727220|100500978|FG001|STARTED|Overall Study||21||
48073290|NCT00727220|100500977|FG000|COMPLETED|Overall Study||20||
48073291|NCT00727220|100500978|FG001|COMPLETED|Overall Study||17||
48073292|NCT00727220|100500977|FG000|NOT COMPLETED|Overall Study||1||
48073293|NCT00727220|100500978|FG001|NOT COMPLETED|Overall Study||4||
48073294|NCT03173313|100500979|FG000|STARTED|Overall Study||58||
48073295|NCT03173313|100500980|FG001|STARTED|Overall Study||53||
48073296|NCT03173313|100500979|FG000|Informed Consent Signed|Overall Study||58||
48073297|NCT03173313|100500980|FG001|Informed Consent Signed|Overall Study||53||
48073298|NCT03173313|100500979|FG000|Randomized|Overall Study||58||
48073299|NCT03173313|100500980|FG001|Randomized|Overall Study||53||
48073300|NCT03173313|100500979|FG000|Cooled|Overall Study||54||
48073301|NCT03173313|100500980|FG001|Cooled|Overall Study||0||
48073302|NCT03173313|100500979|FG000|4-6 Day Follow-up|Overall Study||57||
48073303|NCT03173313|100500980|FG001|4-6 Day Follow-up|Overall Study||53||
48073304|NCT03173313|100500979|FG000|30-day Follow-up|Overall Study||52||
48073305|NCT03173313|100500980|FG001|30-day Follow-up|Overall Study||51||
48073306|NCT03173313|100500979|FG000|12-month Follow-up|Overall Study||49||
48073307|NCT03173313|100500980|FG001|12-month Follow-up|Overall Study||48||
48073308|NCT03173313|100500979|FG000|COMPLETED|Overall Study||49||
48073309|NCT03173313|100500980|FG001|COMPLETED|Overall Study||48||
48073310|NCT03173313|100500979|FG000|NOT COMPLETED|Overall Study||9||
48073311|NCT03173313|100500980|FG001|NOT COMPLETED|Overall Study||5||
48073312|NCT01809106|100500981|FG000|STARTED|Overall Study||130||
48073313|NCT01809106|100500982|FG001|STARTED|Overall Study||130||
48073314|NCT01809106|100500983|FG002|STARTED|Overall Study||130||
48073315|NCT01809106|100500984|FG003|STARTED|Overall Study||128||
48073316|NCT01809106|100500981|FG000|COMPLETED|Overall Study||122||
48073317|NCT01809106|100500982|FG001|COMPLETED|Overall Study||125||
48073318|NCT01809106|100500983|FG002|COMPLETED|Overall Study||127||
48073319|NCT01809106|100500984|FG003|COMPLETED|Overall Study||124||
48073320|NCT01809106|100500981|FG000|NOT COMPLETED|Overall Study||8||
48073321|NCT01809106|100500982|FG001|NOT COMPLETED|Overall Study||5||
48073322|NCT01809106|100500983|FG002|NOT COMPLETED|Overall Study||3||
48073323|NCT01809106|100500984|FG003|NOT COMPLETED|Overall Study||4||
48073324|NCT01273597|100500985|FG000|STARTED|Overall Study||60||
48073325|NCT01273597|100500985|FG000|COMPLETED|Overall Study||52||
48073326|NCT01273597|100500985|FG000|NOT COMPLETED|Overall Study||8||
48073327|NCT03019783|100500986|FG000|STARTED|Overall Study||29||
48073328|NCT03019783|100500987|FG001|STARTED|Overall Study||31||
48073329|NCT03019783|100500986|FG000|COMPLETED|Overall Study||29||
48073330|NCT03019783|100500987|FG001|COMPLETED|Overall Study||31||
48073331|NCT03019783|100500986|FG000|NOT COMPLETED|Overall Study||0||
48073332|NCT03019783|100500987|FG001|NOT COMPLETED|Overall Study||0||
48073333|NCT03351933|100500988|FG000|STARTED|Overall Study||28||
48073334|NCT03351933|100500988|FG000|COMPLETED|Overall Study||26||
48073335|NCT03351933|100500988|FG000|NOT COMPLETED|Overall Study||2||
48073336|NCT02339584|100500989|FG000|STARTED|Overall Study||188||
48073337|NCT02339584|100500990|FG001|STARTED|Overall Study||191||
48073338|NCT02339584|100500989|FG000|COMPLETED|Overall Study||173||
48073339|NCT02339584|100500990|FG001|COMPLETED|Overall Study||176||
48073340|NCT02339584|100500989|FG000|NOT COMPLETED|Overall Study||15||
48073341|NCT02339584|100500990|FG001|NOT COMPLETED|Overall Study||15||
48073342|NCT01786668|100500991|FG000|STARTED|Overall Study||52||
48073343|NCT01786668|100500992|FG001|STARTED|Overall Study||52||
48073344|NCT01786668|100500993|FG002|STARTED|Overall Study||52||
48073345|NCT01786668|100500994|FG003|STARTED|Overall Study||51||
48073346|NCT01786668|100500991|FG000|COMPLETED|Overall Study||51||
48073347|NCT01786668|100500992|FG001|COMPLETED|Overall Study||51||
48073348|NCT01786668|100500993|FG002|COMPLETED|Overall Study||47||
48073349|NCT01786668|100500994|FG003|COMPLETED|Overall Study||47||
48073350|NCT01786668|100500991|FG000|NOT COMPLETED|Overall Study||1||
48073351|NCT01786668|100500992|FG001|NOT COMPLETED|Overall Study||1||
48073352|NCT01786668|100500993|FG002|NOT COMPLETED|Overall Study||5||
48073353|NCT01786668|100500994|FG003|NOT COMPLETED|Overall Study||4||
48073354|NCT03338010|100500995|FG000|STARTED|Overall Study||359||
48073355|NCT03338010|100500996|FG001|STARTED|Overall Study||177||
48073356|NCT03338010|100500995|FG000|Received at Least One Dose of Study Drug|Overall Study||359||
48073357|NCT03338010|100500996|FG001|Received at Least One Dose of Study Drug|Overall Study||177||
48073358|NCT03338010|100500995|FG000|COMPLETED|Overall Study||336||
48073359|NCT03338010|100500996|FG001|COMPLETED|Overall Study||159||
48073360|NCT03338010|100500995|FG000|NOT COMPLETED|Overall Study||23||
48073361|NCT03338010|100500996|FG001|NOT COMPLETED|Overall Study||18||
48073362|NCT00115739|100500997|FG000|STARTED|Overall Study||11||
48073363|NCT00115739|100500997|FG000|COMPLETED|Overall Study||8||
48073364|NCT00115739|100500997|FG000|NOT COMPLETED|Overall Study||3||
48073365|NCT00538291|100500998|FG000|STARTED|Overall Study||13||
48073366|NCT00538291|100500998|FG000|COMPLETED|Overall Study||10||
48073367|NCT00538291|100500998|FG000|NOT COMPLETED|Overall Study||3||
48073368|NCT03741062|100500999|FG000|STARTED|Overall Study||5||
48073369|NCT03741062|100501000|FG001|STARTED|Overall Study||6||
48073370|NCT03741062|100500999|FG000|COMPLETED|Overall Study||4||
48073371|NCT03741062|100501000|FG001|COMPLETED|Overall Study||6||
48073372|NCT03741062|100500999|FG000|NOT COMPLETED|Overall Study||1||
48073373|NCT03741062|100501000|FG001|NOT COMPLETED|Overall Study||0||
48073374|NCT00080470|100501001|FG000|STARTED|Overall Study||45||
48073375|NCT00080470|100501002|FG001|STARTED|Overall Study||42||
48073376|NCT00080470|100501001|FG000|COMPLETED|Overall Study||11||
48073377|NCT00080470|100501002|FG001|COMPLETED|Overall Study||14||
48073378|NCT00080470|100501001|FG000|NOT COMPLETED|Overall Study||34||
48073379|NCT00080470|100501002|FG001|NOT COMPLETED|Overall Study||28||
48073380|NCT02556554|100501003|FG000|STARTED|Overall Study||8||
48073381|NCT02556554|100501004|FG001|STARTED|Overall Study||14||
48073382|NCT02556554|100501005|FG002|STARTED|Overall Study||19||
48073383|NCT02556554|100501006|FG003|STARTED|Overall Study||12||
48073384|NCT02556554|100501007|FG004|STARTED|Overall Study||14||
48073385|NCT02556554|100501003|FG000|COMPLETED|Overall Study||8||
48073386|NCT02556554|100501004|FG001|COMPLETED|Overall Study||13||
48073387|NCT02556554|100501005|FG002|COMPLETED|Overall Study||15||
48073388|NCT02556554|100501006|FG003|COMPLETED|Overall Study||12||
48073389|NCT02556554|100501007|FG004|COMPLETED|Overall Study||14||
48073390|NCT02556554|100501003|FG000|NOT COMPLETED|Overall Study||0||
48073391|NCT02556554|100501004|FG001|NOT COMPLETED|Overall Study||1||
48073392|NCT02556554|100501005|FG002|NOT COMPLETED|Overall Study||4||
48073393|NCT02556554|100501006|FG003|NOT COMPLETED|Overall Study||0||
48073394|NCT02556554|100501007|FG004|NOT COMPLETED|Overall Study||0||
48073395|NCT02320669|100501008|FG000|STARTED|Overall Study||110||
48073396|NCT02320669|100501009|FG001|STARTED|Overall Study||110||
48073397|NCT02320669|100501008|FG000|COMPLETED|Overall Study||104||
48073398|NCT02320669|100501009|FG001|COMPLETED|Overall Study||107||
48073399|NCT02320669|100501008|FG000|NOT COMPLETED|Overall Study||6||
48073400|NCT02320669|100501009|FG001|NOT COMPLETED|Overall Study||3||
48073401|NCT01259128|100501010|FG000|STARTED|Overall Study||15||
48073402|NCT01259128|100501011|FG001|STARTED|Overall Study||17||
48073403|NCT01259128|100501010|FG000|COMPLETED|Overall Study||15||
48073404|NCT01259128|100501011|FG001|COMPLETED|Overall Study||15||
48073405|NCT01259128|100501010|FG000|NOT COMPLETED|Overall Study||0||
48073406|NCT01259128|100501011|FG001|NOT COMPLETED|Overall Study||2||
48073407|NCT04066023|100501012|FG000|STARTED|Overall Study||12||
48073408|NCT04066023|100501013|FG001|STARTED|Overall Study||17||
48073409|NCT04066023|100501014|FG002|STARTED|Overall Study||13||
48073410|NCT04066023|100501012|FG000|COMPLETED|Overall Study||9||
48073411|NCT04066023|100501013|FG001|COMPLETED|Overall Study||9||
48073412|NCT04066023|100501014|FG002|COMPLETED|Overall Study||7||
48073413|NCT04066023|100501012|FG000|NOT COMPLETED|Overall Study||3||
48073414|NCT04066023|100501013|FG001|NOT COMPLETED|Overall Study||8||
48073415|NCT04066023|100501014|FG002|NOT COMPLETED|Overall Study||6||
48073416|NCT00378378|100501015|FG000|STARTED|Overall Study||51||
48073417|NCT00378378|100501016|FG001|STARTED|Overall Study||50||
48073418|NCT00378378|100501017|FG002|STARTED|Overall Study||26||
48073419|NCT00378378|100501015|FG000|COMPLETED|Overall Study||51||
48073420|NCT00378378|100501016|FG001|COMPLETED|Overall Study||49||
48073421|NCT00378378|100501017|FG002|COMPLETED|Overall Study||24||
48073422|NCT00378378|100501015|FG000|NOT COMPLETED|Overall Study||0||
48073423|NCT00378378|100501016|FG001|NOT COMPLETED|Overall Study||1||
48073424|NCT00378378|100501017|FG002|NOT COMPLETED|Overall Study||2||
48073425|NCT00453063|100501018|FG000|STARTED|Overall Study||211||
48073426|NCT00453063|100501019|FG001|STARTED|Overall Study||215||
48073427|NCT00453063|100501018|FG000|COMPLETED|Overall Study||208||
48073428|NCT00453063|100501019|FG001|COMPLETED|Overall Study||212||
48073429|NCT00453063|100501018|FG000|NOT COMPLETED|Overall Study||3||
48073430|NCT00453063|100501019|FG001|NOT COMPLETED|Overall Study||3||
48073431|NCT02192359|100501020|FG000|STARTED|Overall Study||4||
48073432|NCT02192359|100501021|FG001|STARTED|Overall Study||3||
48073433|NCT02192359|100501022|FG002|STARTED|Overall Study||4||
48073434|NCT02192359|100501023|FG003|STARTED|Overall Study||7||
48073435|NCT02192359|100501020|FG000|COMPLETED|Overall Study||3||
48073436|NCT02192359|100501021|FG001|COMPLETED|Overall Study||3||
48073437|NCT02192359|100501022|FG002|COMPLETED|Overall Study||3||
48073438|NCT02192359|100501023|FG003|COMPLETED|Overall Study||6||
48073439|NCT02192359|100501020|FG000|NOT COMPLETED|Overall Study||1||
48073440|NCT02192359|100501021|FG001|NOT COMPLETED|Overall Study||0||
48073441|NCT02192359|100501022|FG002|NOT COMPLETED|Overall Study||1||
48073442|NCT02192359|100501023|FG003|NOT COMPLETED|Overall Study||1||
48073443|NCT02569658|100501024|FG000|STARTED|Overall Study||53||
48073444|NCT02569658|100501025|FG001|STARTED|Overall Study||57||
48073445|NCT02569658|100501024|FG000|COMPLETED|Overall Study||52||
48073446|NCT02569658|100501025|FG001|COMPLETED|Overall Study||56||
48073447|NCT02569658|100501024|FG000|NOT COMPLETED|Overall Study||1||
48073448|NCT02569658|100501025|FG001|NOT COMPLETED|Overall Study||1||
48073449|NCT01550731|100501026|FG000|STARTED|Overall Study||205||
48073450|NCT01550731|100501027|FG001|STARTED|Overall Study||209||
48073451|NCT01550731|100501026|FG000|COMPLETED|Overall Study||205||
48073452|NCT01550731|100501027|FG001|COMPLETED|Overall Study||209||
48073453|NCT01550731|100501026|FG000|NOT COMPLETED|Overall Study||0||
48073454|NCT01550731|100501027|FG001|NOT COMPLETED|Overall Study||0||
48073455|NCT01771952|100501028|FG000|STARTED|Overall Study||45||
48073456|NCT01771952|100501029|FG001|STARTED|Overall Study||41||
48073457|NCT01771952|100501028|FG000|COMPLETED|Overall Study||42||
48073458|NCT01771952|100501029|FG001|COMPLETED|Overall Study||38||
48073459|NCT01771952|100501028|FG000|NOT COMPLETED|Overall Study||3||
48073460|NCT01771952|100501029|FG001|NOT COMPLETED|Overall Study||3||
48073461|NCT03104543|100501030|FG000|STARTED|Overall Study||175||
48073462|NCT03104543|100501031|FG001|STARTED|Overall Study||172||
48073463|NCT03104543|100501030|FG000|COMPLETED|Overall Study||126||
48073464|NCT03104543|100501031|FG001|COMPLETED|Overall Study||138||
48073465|NCT03104543|100501030|FG000|NOT COMPLETED|Overall Study||49||
48073466|NCT03104543|100501031|FG001|NOT COMPLETED|Overall Study||34||
48073467|NCT02577549|100501032|FG000|STARTED|Overall Study||414||
48073468|NCT02577549|100501033|FG001|STARTED|Overall Study||409||
48073469|NCT02577549|100501032|FG000|COMPLETED|Overall Study||336||
48073470|NCT02577549|100501033|FG001|COMPLETED|Overall Study||332||
48073471|NCT02577549|100501032|FG000|NOT COMPLETED|Overall Study||78||
48073472|NCT02577549|100501033|FG001|NOT COMPLETED|Overall Study||77||
48073473|NCT00717093|100501034|FG000|STARTED|Overall Study||214||
48222291|NCT03220724|100866715|FG004|Month 4.5 Immunogenicity Cohort|Overall Study||19||
48222292|NCT03220724|100866716|FG005|Month 4.5 Immunogenicity Cohort|Overall Study||20||
48222293|NCT03220724|100866717|FG006|Month 4.5 Immunogenicity Cohort|Overall Study||19||
48222294|NCT03220724|100866718|FG007|Month 4.5 Immunogenicity Cohort|Overall Study||4||
48222295|NCT03220724|100866719|FG008|Month 4.5 Immunogenicity Cohort|Overall Study||9||
48222296|NCT03220724|100866711|FG000|COMPLETED|Overall Study||9||
48073474|NCT00717093|100501035|FG001|STARTED|Overall Study||218||
48073475|NCT00717093|100501034|FG000|Received Treatment|Overall Study||213||
48073476|NCT00717093|100501035|FG001|Received Treatment|Overall Study||218||
48073477|NCT00717093|100501034|FG000|COMPLETED|Overall Study||170||
48073478|NCT00717093|100501035|FG001|COMPLETED|Overall Study||170||
48073479|NCT00717093|100501034|FG000|NOT COMPLETED|Overall Study||44||
48073480|NCT00717093|100501035|FG001|NOT COMPLETED|Overall Study||48||
48073481|NCT01262131|100501036|FG000|STARTED|Overall Study||5||
48073482|NCT01262131|100501037|FG001|STARTED|Overall Study||4||
48073483|NCT01262131|100501038|FG002|STARTED|Overall Study||4||
48073484|NCT01262131|100501036|FG000|COMPLETED|Overall Study||5||
48073485|NCT01262131|100501037|FG001|COMPLETED|Overall Study||4||
48073486|NCT01262131|100501038|FG002|COMPLETED|Overall Study||4||
48073487|NCT01262131|100501036|FG000|NOT COMPLETED|Overall Study||0||
48073488|NCT01262131|100501037|FG001|NOT COMPLETED|Overall Study||0||
48073489|NCT01262131|100501038|FG002|NOT COMPLETED|Overall Study||0||
48073490|NCT03725852|100501039|FG000|STARTED|Overall Study||45||
48073491|NCT03725852|100501040|FG001|STARTED|Overall Study||23||
48073492|NCT03725852|100501039|FG000|COMPLETED|Overall Study||41||
48073493|NCT03725852|100501040|FG001|COMPLETED|Overall Study||23||
48073494|NCT03725852|100501039|FG000|NOT COMPLETED|Overall Study||4||
48073495|NCT03725852|100501040|FG001|NOT COMPLETED|Overall Study||0||
48073496|NCT00332163|100501041|FG000|STARTED|Overall Study||48||
48073497|NCT00332163|100501042|FG001|STARTED|Overall Study||47||
48073498|NCT00332163|100501041|FG000|Received Treatment|Overall Study||48||
48073499|NCT00332163|100501042|FG001|Received Treatment|Overall Study||47||
48073500|NCT00332163|100501041|FG000|COMPLETED|Overall Study||48||
48073501|NCT00332163|100501042|FG001|COMPLETED|Overall Study||47||
48073502|NCT00332163|100501041|FG000|NOT COMPLETED|Overall Study||0||
48073503|NCT00332163|100501042|FG001|NOT COMPLETED|Overall Study||0||
48073504|NCT01300650|100501043|FG000|STARTED|Overall Study||8||
48073505|NCT01300650|100501043|FG000|COMPLETED|Overall Study||7||
48073506|NCT01300650|100501043|FG000|NOT COMPLETED|Overall Study||1||
48073507|NCT00183677|100501044|FG000|STARTED|Overall Study||97||
48073508|NCT00183677|100501044|FG000|COMPLETED|Overall Study||53||
48073509|NCT00183677|100501044|FG000|NOT COMPLETED|Overall Study||44||
48073510|NCT00129272|100501045|FG000|STARTED|Overall Study||71||
48073511|NCT00129272|100501046|FG001|STARTED|Overall Study||73||
48073512|NCT00129272|100501045|FG000|COMPLETED|Overall Study||54||
48073513|NCT00129272|100501046|FG001|COMPLETED|Overall Study||51||
48073514|NCT00129272|100501045|FG000|NOT COMPLETED|Overall Study||17||
48073515|NCT00129272|100501046|FG001|NOT COMPLETED|Overall Study||22||
48073516|NCT00934089|100501047|FG000|STARTED|First Intervention Period (14 Days)||15||
48073517|NCT00934089|100501048|FG001|STARTED|First Intervention Period (14 Days)||16||
48073518|NCT00934089|100501047|FG000|Treated|First Intervention Period (14 Days)||14||
48073519|NCT00934089|100501048|FG001|Treated|First Intervention Period (14 Days)||16||
48073520|NCT00934089|100501047|FG000|COMPLETED|First Intervention Period (14 Days)||13||
48073521|NCT00934089|100501048|FG001|COMPLETED|First Intervention Period (14 Days)||16||
48141157|NCT02366338|100670353|FG002|STARTED|Overall Study||36||
48222297|NCT03220724|100866712|FG001|COMPLETED|Overall Study||10||
48222298|NCT03220724|100866713|FG002|COMPLETED|Overall Study||11||
48222299|NCT03220724|100866714|FG003|COMPLETED|Overall Study||3||
48222300|NCT03220724|100866715|FG004|COMPLETED|Overall Study||19||
48222301|NCT03220724|100866716|FG005|COMPLETED|Overall Study||20||
48222302|NCT03220724|100866717|FG006|COMPLETED|Overall Study||18||
48222303|NCT03220724|100866718|FG007|COMPLETED|Overall Study||4||
48222304|NCT03220724|100866719|FG008|COMPLETED|Overall Study||10||
48222305|NCT03220724|100866711|FG000|NOT COMPLETED|Overall Study||3||
48222306|NCT03220724|100866712|FG001|NOT COMPLETED|Overall Study||2||
48222307|NCT03220724|100866713|FG002|NOT COMPLETED|Overall Study||1||
48222308|NCT03220724|100866714|FG003|NOT COMPLETED|Overall Study||3||
48222309|NCT03220724|100866715|FG004|NOT COMPLETED|Overall Study||1||
48222310|NCT03220724|100866716|FG005|NOT COMPLETED|Overall Study||0||
48222311|NCT03220724|100866717|FG006|NOT COMPLETED|Overall Study||2||
48222312|NCT03220724|100866718|FG007|NOT COMPLETED|Overall Study||1||
48222313|NCT03220724|100866719|FG008|NOT COMPLETED|Overall Study||0||
48222314|NCT04053270|100866720|FG000|STARTED|Overall Study||49||
48222315|NCT04053270|100866721|FG001|STARTED|Overall Study||51||
48222316|NCT04053270|100866720|FG000|COMPLETED|Overall Study||47||
48222317|NCT04053270|100866721|FG001|COMPLETED|Overall Study||46||
48222318|NCT04053270|100866720|FG000|NOT COMPLETED|Overall Study||2||
48222319|NCT04053270|100866721|FG001|NOT COMPLETED|Overall Study||5||
48222320|NCT04004325|100866722|FG000|STARTED|Overall Study||9||
48222321|NCT04004325|100866723|FG001|STARTED|Overall Study||5||
48222322|NCT04004325|100866722|FG000|COMPLETED|Overall Study||9||
48222323|NCT04004325|100866723|FG001|COMPLETED|Overall Study||5||
48222324|NCT04004325|100866722|FG000|NOT COMPLETED|Overall Study||0||
48222325|NCT04004325|100866723|FG001|NOT COMPLETED|Overall Study||0||
48222326|NCT04033315|100866724|FG000|STARTED|Overall Study||130||
48222327|NCT04033315|100866724|FG000|COMPLETED|Overall Study||129||
48222328|NCT04033315|100866724|FG000|NOT COMPLETED|Overall Study||1||
48222329|NCT01664741|100866725|FG000|STARTED|Overall Study||6||
48222330|NCT01664741|100866726|FG001|STARTED|Overall Study||6||
48222331|NCT01664741|100866727|FG002|STARTED|Overall Study||13||
48222332|NCT01664741|100866725|FG000|COMPLETED|Overall Study||6||
48222333|NCT01664741|100866726|FG001|COMPLETED|Overall Study||6||
48222334|NCT01664741|100866727|FG002|COMPLETED|Overall Study||13||
48222335|NCT01664741|100866725|FG000|NOT COMPLETED|Overall Study||0||
48222336|NCT01664741|100866726|FG001|NOT COMPLETED|Overall Study||0||
48222337|NCT01664741|100866727|FG002|NOT COMPLETED|Overall Study||0||
48222338|NCT01212744|100866728|FG000|STARTED|Overall Study||16||
48222339|NCT01212744|100866728|FG000|COMPLETED|Overall Study||15||
48222340|NCT01212744|100866728|FG000|NOT COMPLETED|Overall Study||1||
48222341|NCT01741363|100866729|FG000|STARTED|Overall Study||9076||
48222342|NCT01741363|100866730|FG001|STARTED|Overall Study||8987||
48222343|NCT01741363|100866731|FG002|STARTED|Overall Study||9032||
48222344|NCT01741363|100866732|FG003|STARTED|Overall Study||8945||
48222345|NCT01741363|100866733|FG004|STARTED|Overall Study||31497||
48222346|NCT01741363|100866734|FG005|STARTED|Overall Study||31777||
48222347|NCT01741363|100866729|FG000|COMPLETED|Overall Study||9076||
48222348|NCT01741363|100866730|FG001|COMPLETED|Overall Study||8987||
48222349|NCT01741363|100866731|FG002|COMPLETED|Overall Study||9032||
48222350|NCT01741363|100866732|FG003|COMPLETED|Overall Study||8945||
48222351|NCT01741363|100866733|FG004|COMPLETED|Overall Study||31497||
48222352|NCT01741363|100866734|FG005|COMPLETED|Overall Study||31777||
48222353|NCT01741363|100866729|FG000|NOT COMPLETED|Overall Study||0||
48222354|NCT01741363|100866730|FG001|NOT COMPLETED|Overall Study||0||
48222355|NCT01741363|100866731|FG002|NOT COMPLETED|Overall Study||0||
48222356|NCT01741363|100866732|FG003|NOT COMPLETED|Overall Study||0||
48222357|NCT01741363|100866733|FG004|NOT COMPLETED|Overall Study||0||
48222358|NCT01741363|100866734|FG005|NOT COMPLETED|Overall Study||0||
48222359|NCT04207736|100866735|FG000|STARTED|Overall Study||48||
48222360|NCT04207736|100866736|FG001|STARTED|Overall Study||47||
48222361|NCT04207736|100866735|FG000|COMPLETED|Overall Study||46||
48222362|NCT04207736|100866736|FG001|COMPLETED|Overall Study||43||
48222363|NCT04207736|100866735|FG000|NOT COMPLETED|Overall Study||2||
48222364|NCT04207736|100866736|FG001|NOT COMPLETED|Overall Study||4||
48222365|NCT03802994|100866737|FG000|STARTED|Overall Study||9||9
48222366|NCT03802994|100866738|FG001|STARTED|Overall Study||12||12
48222367|NCT03802994|100866739|FG002|STARTED|Overall Study||15||15
48222368|NCT03802994|100866740|FG003|STARTED|Overall Study||11||11
48222369|NCT03802994|100866741|FG004|STARTED|Overall Study||10||10
48222370|NCT03802994|100866737|FG000|COMPLETED|Overall Study||9||9
48222371|NCT03802994|100866738|FG001|COMPLETED|Overall Study||10||10
48222372|NCT03802994|100866739|FG002|COMPLETED|Overall Study||12||12
48222373|NCT03802994|100866740|FG003|COMPLETED|Overall Study||9||9
48222374|NCT03802994|100866741|FG004|COMPLETED|Overall Study||8||8
48222375|NCT03802994|100866737|FG000|NOT COMPLETED|Overall Study||0||0
48222376|NCT03802994|100866738|FG001|NOT COMPLETED|Overall Study||2||2
48222377|NCT03802994|100866739|FG002|NOT COMPLETED|Overall Study||3||3
48222378|NCT03802994|100866740|FG003|NOT COMPLETED|Overall Study||2||2
48222379|NCT03802994|100866741|FG004|NOT COMPLETED|Overall Study||2||2
48222380|NCT05747014|100866742|FG000|STARTED|Enrollment||86|86 subjects consented to participate|
48222381|NCT05747014|100866742|FG000|COMPLETED|Enrollment||77|77 subjects received Novapak implant|
48222382|NCT05747014|100866742|FG000|NOT COMPLETED|Enrollment||9||
48222383|NCT05747014|100866742|FG000|STARTED|14-Day Follow-up||77||
48222384|NCT05747014|100866742|FG000|COMPLETED|14-Day Follow-up||76||
48222385|NCT05747014|100866742|FG000|NOT COMPLETED|14-Day Follow-up||1||
48222386|NCT05747014|100866742|FG000|STARTED|30-Day Follow-up||76||
48222387|NCT05747014|100866742|FG000|COMPLETED|30-Day Follow-up||74||
48222388|NCT05747014|100866742|FG000|NOT COMPLETED|30-Day Follow-up||2||
48222389|NCT01854385|100866743|FG000|STARTED|Pre-Treatment||40||
48222390|NCT01854385|100866743|FG000|COMPLETED|Pre-Treatment||17||
48222391|NCT01854385|100866743|FG000|NOT COMPLETED|Pre-Treatment||23||
48222392|NCT01854385|100866743|FG000|STARTED|Treatment||17||
48222393|NCT01854385|100866743|FG000|COMPLETED|Treatment||16||
48222394|NCT01854385|100866743|FG000|NOT COMPLETED|Treatment||1||
48222395|NCT02409680|100866744|FG000|STARTED|Overall Study||5990||
48222396|NCT02409680|100866745|FG001|STARTED|Overall Study||5986||
48222397|NCT02409680|100866744|FG000|Treated|Overall Study||5943||
48222398|NCT02409680|100866745|FG001|Treated|Overall Study||5936||
48222399|NCT02409680|100866744|FG000|Included in mITT Analysis|Overall Study||5787|A modified intention-to-treat (mITT) analysis was planned a priori for the primary and secondary outcomes to include only women who delivered at or after 20 weeks and were determined to be eligible after randomization. Numbers reported in the Outcomes section reflect available data and therefore do not always reflect the total population defined in the mITT.|
48294126|NCT02527343|101047536|FG000|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0||
48294127|NCT02527343|101047537|FG001|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0||
48222400|NCT02409680|100866745|FG001|Included in mITT Analysis|Overall Study||5771|A modified intention-to-treat (mITT) analysis was planned a priori for the primary and secondary outcomes to include only women who delivered at or after 20 weeks and were determined to be eligible after randomization. Numbers reported in the Outcomes section reflect available data and therefore do not always reflect the total population defined in the mITT.|
48222401|NCT02409680|100866744|FG000|COMPLETED|Overall Study||5975||
48222402|NCT02409680|100866745|FG001|COMPLETED|Overall Study||5956||
48222403|NCT02409680|100866744|FG000|NOT COMPLETED|Overall Study||15||
48222404|NCT02409680|100866745|FG001|NOT COMPLETED|Overall Study||30||
48222405|NCT04503681|100866746|FG000|STARTED|Overall Study||188||
48222406|NCT04503681|100866747|FG001|STARTED|Overall Study||186||
48222407|NCT04503681|100866746|FG000|COMPLETED|Overall Study||183||
48222408|NCT04503681|100866747|FG001|COMPLETED|Overall Study||179||
48222409|NCT04503681|100866746|FG000|NOT COMPLETED|Overall Study||5||
48222410|NCT04503681|100866747|FG001|NOT COMPLETED|Overall Study||7||
48222411|NCT03739866|100866748|FG000|STARTED|Overall Study||6||
48222412|NCT03739866|100866749|FG001|STARTED|Overall Study||6||
48222413|NCT03739866|100866750|FG002|STARTED|Overall Study||7||
48222414|NCT03739866|100866751|FG003|STARTED|Overall Study||6||
48222415|NCT03739866|100866752|FG004|STARTED|Overall Study||6||
48222416|NCT03739866|100866753|FG005|STARTED|Overall Study||10||
48222417|NCT03739866|100866754|FG006|STARTED|Overall Study||7||
48222418|NCT03739866|100866755|FG007|STARTED|Overall Study||5||
48222419|NCT03739866|100866748|FG000|COMPLETED|Overall Study||6||
48222420|NCT03739866|100866749|FG001|COMPLETED|Overall Study||6||
48222421|NCT03739866|100866750|FG002|COMPLETED|Overall Study||6||
48222422|NCT03739866|100866751|FG003|COMPLETED|Overall Study||5||
48222423|NCT03739866|100866752|FG004|COMPLETED|Overall Study||5||
48222424|NCT03739866|100866753|FG005|COMPLETED|Overall Study||10||
48222425|NCT03739866|100866754|FG006|COMPLETED|Overall Study||7||
48222426|NCT03739866|100866755|FG007|COMPLETED|Overall Study||5||
48222427|NCT03739866|100866748|FG000|NOT COMPLETED|Overall Study||0||
48222428|NCT03739866|100866749|FG001|NOT COMPLETED|Overall Study||0||
48222429|NCT03739866|100866750|FG002|NOT COMPLETED|Overall Study||1||
48222430|NCT03739866|100866751|FG003|NOT COMPLETED|Overall Study||1||
48222431|NCT03739866|100866752|FG004|NOT COMPLETED|Overall Study||1||
48222432|NCT03739866|100866753|FG005|NOT COMPLETED|Overall Study||0||
48222433|NCT03739866|100866754|FG006|NOT COMPLETED|Overall Study||0||
48222434|NCT03739866|100866755|FG007|NOT COMPLETED|Overall Study||0||
48222435|NCT04023175|100866756|FG000|STARTED|Overall Study||59||
48222436|NCT04023175|100866757|FG001|STARTED|Overall Study||59||
48222437|NCT04023175|100866756|FG000|COMPLETED|Overall Study||53||
48222438|NCT04023175|100866757|FG001|COMPLETED|Overall Study||48||
48222439|NCT04023175|100866756|FG000|NOT COMPLETED|Overall Study||6||
48222440|NCT04023175|100866757|FG001|NOT COMPLETED|Overall Study||11||
48222441|NCT00258830|100866758|FG000|STARTED|Overall Study||60||
48222442|NCT00258830|100866759|FG001|STARTED|Overall Study||60||
48222443|NCT00258830|100866758|FG000|COMPLETED|Overall Study||60||
48222444|NCT00258830|100866759|FG001|COMPLETED|Overall Study||60||
48222445|NCT00258830|100866758|FG000|NOT COMPLETED|Overall Study||0||
48222446|NCT00258830|100866759|FG001|NOT COMPLETED|Overall Study||0||
48222447|NCT03355573|100866760|FG000|STARTED|Overall Study||255||
48222448|NCT03355573|100866760|FG000|COMPLETED|Overall Study||202||
48222449|NCT03355573|100866760|FG000|NOT COMPLETED|Overall Study||53||
48222450|NCT01447706|100866761|FG000|STARTED|Overall Study||140||
48222451|NCT01447706|100866762|FG001|STARTED|Overall Study||83||
48222452|NCT01447706|100866761|FG000|COMPLETED|Overall Study||140||
48222453|NCT01447706|100866762|FG001|COMPLETED|Overall Study||80||
48222454|NCT01447706|100866761|FG000|NOT COMPLETED|Overall Study||0||
48222455|NCT01447706|100866762|FG001|NOT COMPLETED|Overall Study||3||
48222456|NCT03779984|100866763|FG000|STARTED|Overall Study||56||
48222457|NCT03779984|100866764|FG001|STARTED|Overall Study||56||
48222458|NCT03779984|100866763|FG000|COMPLETED|Overall Study||56||
48222459|NCT03779984|100866764|FG001|COMPLETED|Overall Study||56||
48222460|NCT03779984|100866763|FG000|NOT COMPLETED|Overall Study||0||
48222461|NCT03779984|100866764|FG001|NOT COMPLETED|Overall Study||0||
48222462|NCT01567605|100866765|FG000|STARTED|Overall Study||7||
48222463|NCT01567605|100866766|FG001|STARTED|Overall Study||6||
48222464|NCT01567605|100866765|FG000|COMPLETED|Overall Study||7||
48222465|NCT01567605|100866766|FG001|COMPLETED|Overall Study||6||
48222466|NCT01567605|100866765|FG000|NOT COMPLETED|Overall Study||0||
48222467|NCT01567605|100866766|FG001|NOT COMPLETED|Overall Study||0||
48222468|NCT02189252|100866767|FG000|STARTED|Period 1 (Visit 4b, Week 4)||4||
48222469|NCT02189252|100866768|FG001|STARTED|Period 1 (Visit 4b, Week 4)||4||
48222470|NCT02189252|100866769|FG002|STARTED|Period 1 (Visit 4b, Week 4)||3||
48222471|NCT02189252|100866770|FG003|STARTED|Period 1 (Visit 4b, Week 4)||4||
48222472|NCT02189252|100866767|FG000|COMPLETED|Period 1 (Visit 4b, Week 4)||4||
48222473|NCT02189252|100866768|FG001|COMPLETED|Period 1 (Visit 4b, Week 4)||2||
48222474|NCT02189252|100866769|FG002|COMPLETED|Period 1 (Visit 4b, Week 4)||3||
48222475|NCT02189252|100866770|FG003|COMPLETED|Period 1 (Visit 4b, Week 4)||4||
48222476|NCT02189252|100866767|FG000|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0||
48222477|NCT02189252|100866768|FG001|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||2||
48222478|NCT02189252|100866769|FG002|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0||
48222479|NCT02189252|100866770|FG003|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0||
48222480|NCT02189252|100866767|FG000|STARTED|Period 2 (Visit6b, Week 12)||4||
48222481|NCT02189252|100866768|FG001|STARTED|Period 2 (Visit6b, Week 12)||2||
48222482|NCT02189252|100866769|FG002|STARTED|Period 2 (Visit6b, Week 12)||3||
48222483|NCT02189252|100866770|FG003|STARTED|Period 2 (Visit6b, Week 12)||4||
48222484|NCT02189252|100866767|FG000|COMPLETED|Period 2 (Visit6b, Week 12)||4||
48222485|NCT02189252|100866768|FG001|COMPLETED|Period 2 (Visit6b, Week 12)||2||
48222486|NCT02189252|100866769|FG002|COMPLETED|Period 2 (Visit6b, Week 12)||3||
48222487|NCT02189252|100866770|FG003|COMPLETED|Period 2 (Visit6b, Week 12)||4||
48222488|NCT02189252|100866767|FG000|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0||
48222489|NCT02189252|100866768|FG001|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0||
48222490|NCT02189252|100866769|FG002|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0||
48222491|NCT02189252|100866770|FG003|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0||
48222492|NCT00176202|100866771|FG000|STARTED|Overall Study||32||
48222493|NCT00176202|100866772|FG001|STARTED|Overall Study||33||
48222494|NCT00176202|100866771|FG000|COMPLETED|Overall Study||27||
48222495|NCT00176202|100866772|FG001|COMPLETED|Overall Study||17||
48222496|NCT00176202|100866771|FG000|NOT COMPLETED|Overall Study||5||
48222497|NCT00176202|100866772|FG001|NOT COMPLETED|Overall Study||16||
48222498|NCT02787005|100866773|FG000|STARTED|Overall Study||133||
48222499|NCT02787005|100866774|FG001|STARTED|Overall Study||69||
48222500|NCT02787005|100866775|FG002|STARTED|Overall Study||58||
48222501|NCT02787005|100866776|FG003|STARTED|Overall Study||81||
48222502|NCT02787005|100866777|FG004|STARTED|Overall Study||47||
48222503|NCT02787005|100866773|FG000|Treated|Overall Study||133||
48222504|NCT02787005|100866774|FG001|Treated|Overall Study||67||
48222505|NCT02787005|100866775|FG002|Treated|Overall Study||58||
48222506|NCT02787005|100866776|FG003|Treated|Overall Study||81||
48222507|NCT02787005|100866777|FG004|Treated|Overall Study||45||
48222508|NCT02787005|100866773|FG000|Received 2nd Course|Overall Study||1||
48222509|NCT02787005|100866774|FG001|Received 2nd Course|Overall Study||0||
48222510|NCT02787005|100866775|FG002|Received 2nd Course|Overall Study||0||
48222511|NCT02787005|100866776|FG003|Received 2nd Course|Overall Study||0||
48222512|NCT02787005|100866777|FG004|Received 2nd Course|Overall Study||0||
48222513|NCT02787005|100866773|FG000|COMPLETED|Overall Study||0||
48222514|NCT02787005|100866774|FG001|COMPLETED|Overall Study||0||
48222515|NCT02787005|100866775|FG002|COMPLETED|Overall Study||0||
48222516|NCT02787005|100866776|FG003|COMPLETED|Overall Study||0||
48222517|NCT02787005|100866777|FG004|COMPLETED|Overall Study||0||
48222518|NCT02787005|100866773|FG000|NOT COMPLETED|Overall Study||133||
48222519|NCT02787005|100866774|FG001|NOT COMPLETED|Overall Study||69||
48222520|NCT02787005|100866775|FG002|NOT COMPLETED|Overall Study||58||
48222521|NCT02787005|100866776|FG003|NOT COMPLETED|Overall Study||81||
48222522|NCT02787005|100866777|FG004|NOT COMPLETED|Overall Study||47||
48222523|NCT01664806|100866778|FG000|STARTED|Overall Study||20||
48222524|NCT01664806|100866779|FG001|STARTED|Overall Study||20||
48222525|NCT01664806|100866778|FG000|COMPLETED|Overall Study||20||
48222526|NCT01664806|100866779|FG001|COMPLETED|Overall Study||20||
48222527|NCT01664806|100866778|FG000|NOT COMPLETED|Overall Study||0||
48222528|NCT01664806|100866779|FG001|NOT COMPLETED|Overall Study||0||
48222529|NCT02844439|100866780|FG000|STARTED|Overall Study||40||
48222530|NCT02844439|100866780|FG000|Subpopulation A (EGFR Gene Amplified Glioblastoma)|Overall Study||24||
48222531|NCT02844439|100866780|FG000|Subpopulation B (EGFRvIII^Pos Glioblastoma)|Overall Study||11||
48222532|NCT02844439|100866780|FG000|COMPLETED|Overall Study||0||
48222533|NCT02844439|100866780|FG000|NOT COMPLETED|Overall Study||40||
48222534|NCT01185600|100866781|FG000|STARTED|Overall Study||73||
48222535|NCT01185600|100866782|FG001|STARTED|Overall Study||104||
48222536|NCT01185600|100866781|FG000|COMPLETED|Overall Study||41||
48222537|NCT01185600|100866782|FG001|COMPLETED|Overall Study||59||
48222538|NCT01185600|100866781|FG000|NOT COMPLETED|Overall Study||32||
48222539|NCT01185600|100866782|FG001|NOT COMPLETED|Overall Study||45||
48222540|NCT01970007|100866783|FG000|STARTED|Overall Study||243||
48222541|NCT01970007|100866783|FG000|COMPLETED|Overall Study||188||
48222542|NCT01970007|100866783|FG000|NOT COMPLETED|Overall Study||55||
48222543|NCT04989816|100866784|FG000|STARTED|Overall Study||95|Enrolled|
48222544|NCT04989816|100866784|FG000|Received Treatment|Overall Study||95||
48222545|NCT04989816|100866784|FG000|COMPLETED|Overall Study||15||
48222546|NCT04989816|100866784|FG000|NOT COMPLETED|Overall Study||80||
48222547|NCT01091168|100866785|FG000|STARTED|Overall Study||298||
48222548|NCT01091168|100866786|FG001|STARTED|Overall Study||296||
48222549|NCT01091168|100866785|FG000|COMPLETED|Overall Study||0||
48222550|NCT01091168|100866786|FG001|COMPLETED|Overall Study||0||
48222551|NCT01091168|100866785|FG000|NOT COMPLETED|Overall Study||298||
48222552|NCT01091168|100866786|FG001|NOT COMPLETED|Overall Study||296||
48222553|NCT02502461|100866787|FG000|STARTED|Overall Study||46||
48222554|NCT02502461|100866788|FG001|STARTED|Overall Study||44||
48222555|NCT02502461|100866787|FG000|COMPLETED|Overall Study||46||
48222556|NCT02502461|100866788|FG001|COMPLETED|Overall Study||44||
48222557|NCT02502461|100866787|FG000|NOT COMPLETED|Overall Study||0||
48222558|NCT02502461|100866788|FG001|NOT COMPLETED|Overall Study||0||
48222559|NCT02823574|100866789|FG000|STARTED|Randomization||159||
48222560|NCT02823574|100866790|FG001|STARTED|Randomization||82||
48222561|NCT02823574|100866791|FG002|STARTED|Randomization||123||
48222562|NCT02823574|100866792|FG003|STARTED|Randomization||61||
48222563|NCT02823574|100866789|FG000|COMPLETED|Randomization||158|Continuing to Treatment Period|
48222564|NCT02823574|100866790|FG001|COMPLETED|Randomization||82|Continuing to Treatment Period|
48222565|NCT02823574|100866791|FG002|COMPLETED|Randomization||122|Continuing to Treatment Period|
48222566|NCT02823574|100866792|FG003|COMPLETED|Randomization||61|Continuing to Treatment Period|
48222567|NCT02823574|100866789|FG000|NOT COMPLETED|Randomization||1||
48222568|NCT02823574|100866790|FG001|NOT COMPLETED|Randomization||0||
48222569|NCT02823574|100866791|FG002|NOT COMPLETED|Randomization||1||
48222570|NCT02823574|100866792|FG003|NOT COMPLETED|Randomization||0||
48222571|NCT02823574|100866789|FG000|STARTED|Treatment Period||158||
48222572|NCT02823574|100866790|FG001|STARTED|Treatment Period||82||
48222573|NCT02823574|100866791|FG002|STARTED|Treatment Period||122||
48222574|NCT02823574|100866792|FG003|STARTED|Treatment Period||61||
48222575|NCT02823574|100866789|FG000|COMPLETED|Treatment Period||0|Completed = Continuing in the Treatment Period|
48222576|NCT02823574|100866790|FG001|COMPLETED|Treatment Period||0|Completed = Continuing in the Treatment Period|
48222577|NCT02823574|100866791|FG002|COMPLETED|Treatment Period||0|Completed = Continuing in the Treatment Period|
48222578|NCT02823574|100866792|FG003|COMPLETED|Treatment Period||0|Completed = Continuing in the Treatment Period|
48222579|NCT02823574|100866789|FG000|NOT COMPLETED|Treatment Period||158||
48222580|NCT02823574|100866790|FG001|NOT COMPLETED|Treatment Period||82||
48222581|NCT02823574|100866791|FG002|NOT COMPLETED|Treatment Period||122||
48222582|NCT02823574|100866792|FG003|NOT COMPLETED|Treatment Period||61||
48222583|NCT00003459|100866793|FG000|STARTED|Overall Study||40||
48222584|NCT00003459|100866793|FG000|COMPLETED|Overall Study||31||
48222585|NCT00003459|100866793|FG000|NOT COMPLETED|Overall Study||9||
48222586|NCT04041219|100866794|FG000|STARTED|Overall Study||10||
48222587|NCT04041219|100866794|FG000|COMPLETED|Overall Study||10||
48222588|NCT04041219|100866794|FG000|NOT COMPLETED|Overall Study||0||
48222589|NCT03459846|100866795|FG000|STARTED|Overall Study||78||
48222590|NCT03459846|100866796|FG001|STARTED|Overall Study||76||
48222591|NCT03459846|100866795|FG000|COMPLETED|Overall Study||0||
48222592|NCT03459846|100866796|FG001|COMPLETED|Overall Study||0||
48222593|NCT03459846|100866795|FG000|NOT COMPLETED|Overall Study||78||
48222594|NCT03459846|100866796|FG001|NOT COMPLETED|Overall Study||76||
48222595|NCT00943917|100866797|FG000|STARTED|Stage I||51||
48222596|NCT00943917|100866798|FG001|STARTED|Stage I||51||
48222597|NCT00943917|100866799|FG002|STARTED|Stage I||53||
48222598|NCT00943917|100866800|FG003|STARTED|Stage I||0||
48222599|NCT00943917|100866801|FG004|STARTED|Stage I||0||
48222600|NCT00943917|100866802|FG005|STARTED|Stage I||0||
48222601|NCT00943917|100866803|FG006|STARTED|Stage I||0||
48222602|NCT00943917|100866804|FG007|STARTED|Stage I||0||
48222603|NCT00943917|100866805|FG008|STARTED|Stage I||0||
48222604|NCT00943917|100866806|FG009|STARTED|Stage I||0||
48222605|NCT00943917|100866807|FG010|STARTED|Stage I||0||
48222606|NCT00943917|100866808|FG011|STARTED|Stage I||0||
48222607|NCT00943917|100866809|FG012|STARTED|Stage I||0||
48222608|NCT00943917|100866810|FG013|STARTED|Stage I||0||
48222609|NCT00943917|100866811|FG014|STARTED|Stage I||0||
48222610|NCT00943917|100866797|FG000|COMPLETED|Stage I||47||
48222611|NCT00943917|100866798|FG001|COMPLETED|Stage I||48||
48222612|NCT00943917|100866799|FG002|COMPLETED|Stage I||47||
48222613|NCT00943917|100866800|FG003|COMPLETED|Stage I||0||
48222614|NCT00943917|100866801|FG004|COMPLETED|Stage I||0||
48222615|NCT00943917|100866802|FG005|COMPLETED|Stage I||0||
48222616|NCT00943917|100866803|FG006|COMPLETED|Stage I||0||
48222617|NCT00943917|100866804|FG007|COMPLETED|Stage I||0||
48222618|NCT00943917|100866805|FG008|COMPLETED|Stage I||0||
48222619|NCT00943917|100866806|FG009|COMPLETED|Stage I||0||
48222620|NCT00943917|100866807|FG010|COMPLETED|Stage I||0||
48222621|NCT00943917|100866808|FG011|COMPLETED|Stage I||0||
48222622|NCT00943917|100866809|FG012|COMPLETED|Stage I||0||
48222623|NCT00943917|100866810|FG013|COMPLETED|Stage I||0||
48222624|NCT00943917|100866811|FG014|COMPLETED|Stage I||0||
48222625|NCT00943917|100866797|FG000|NOT COMPLETED|Stage I||4||
48222626|NCT00943917|100866798|FG001|NOT COMPLETED|Stage I||3||
48222627|NCT00943917|100866799|FG002|NOT COMPLETED|Stage I||6||
48222628|NCT00943917|100866800|FG003|NOT COMPLETED|Stage I||0||
48222629|NCT00943917|100866801|FG004|NOT COMPLETED|Stage I||0||
48222630|NCT00943917|100866802|FG005|NOT COMPLETED|Stage I||0||
48222631|NCT00943917|100866803|FG006|NOT COMPLETED|Stage I||0||
48222632|NCT00943917|100866804|FG007|NOT COMPLETED|Stage I||0||
48222633|NCT00943917|100866805|FG008|NOT COMPLETED|Stage I||0||
48222634|NCT00943917|100866806|FG009|NOT COMPLETED|Stage I||0||
48222635|NCT00943917|100866807|FG010|NOT COMPLETED|Stage I||0||
48222636|NCT00943917|100866808|FG011|NOT COMPLETED|Stage I||0||
48222637|NCT00943917|100866809|FG012|NOT COMPLETED|Stage I||0||
48222638|NCT00943917|100866810|FG013|NOT COMPLETED|Stage I||0||
48222639|NCT00943917|100866811|FG014|NOT COMPLETED|Stage I||0||
48222640|NCT00943917|100866797|FG000|STARTED|Stage II||0||
48222641|NCT00943917|100866798|FG001|STARTED|Stage II||0||
48222642|NCT00943917|100866799|FG002|STARTED|Stage II||0||
48222643|NCT00943917|100866800|FG003|STARTED|Stage II||20||
48222644|NCT00943917|100866801|FG004|STARTED|Stage II||21||
48222645|NCT00943917|100866802|FG005|STARTED|Stage II||23||
48222646|NCT00943917|100866803|FG006|STARTED|Stage II||23||
48222647|NCT00943917|100866804|FG007|STARTED|Stage II||23||
48222648|NCT00943917|100866805|FG008|STARTED|Stage II||21||
48222649|NCT00943917|100866806|FG009|STARTED|Stage II||0||
48222650|NCT00943917|100866807|FG010|STARTED|Stage II||0||
48222651|NCT00943917|100866808|FG011|STARTED|Stage II||0||
48222652|NCT00943917|100866809|FG012|STARTED|Stage II||0||
48222653|NCT00943917|100866810|FG013|STARTED|Stage II||0||
48222654|NCT00943917|100866811|FG014|STARTED|Stage II||0||
48222655|NCT00943917|100866797|FG000|COMPLETED|Stage II||0||
48222656|NCT00943917|100866798|FG001|COMPLETED|Stage II||0||
48222657|NCT00943917|100866799|FG002|COMPLETED|Stage II||0||
48222658|NCT00943917|100866800|FG003|COMPLETED|Stage II||20||
48222659|NCT00943917|100866801|FG004|COMPLETED|Stage II||21||
48222660|NCT00943917|100866802|FG005|COMPLETED|Stage II||20||
48222661|NCT00943917|100866803|FG006|COMPLETED|Stage II||20||
48222662|NCT00943917|100866804|FG007|COMPLETED|Stage II||23||
48222663|NCT00943917|100866805|FG008|COMPLETED|Stage II||20||
48222664|NCT00943917|100866806|FG009|COMPLETED|Stage II||0||
48222665|NCT00943917|100866807|FG010|COMPLETED|Stage II||0||
48222666|NCT00943917|100866808|FG011|COMPLETED|Stage II||0||
48222667|NCT00943917|100866809|FG012|COMPLETED|Stage II||0||
48222668|NCT00943917|100866810|FG013|COMPLETED|Stage II||0||
48222669|NCT00943917|100866811|FG014|COMPLETED|Stage II||0||
48222670|NCT00943917|100866797|FG000|NOT COMPLETED|Stage II||0||
48222671|NCT00943917|100866798|FG001|NOT COMPLETED|Stage II||0||
48222672|NCT00943917|100866799|FG002|NOT COMPLETED|Stage II||0||
48222673|NCT00943917|100866800|FG003|NOT COMPLETED|Stage II||0||
48222674|NCT00943917|100866801|FG004|NOT COMPLETED|Stage II||0||
48222675|NCT00943917|100866802|FG005|NOT COMPLETED|Stage II||3||
48222676|NCT00943917|100866803|FG006|NOT COMPLETED|Stage II||3||
48222677|NCT00943917|100866804|FG007|NOT COMPLETED|Stage II||0||
48222678|NCT00943917|100866805|FG008|NOT COMPLETED|Stage II||1||
48222679|NCT00943917|100866806|FG009|NOT COMPLETED|Stage II||0||
48222680|NCT00943917|100866807|FG010|NOT COMPLETED|Stage II||0||
48222681|NCT00943917|100866808|FG011|NOT COMPLETED|Stage II||0||
48222682|NCT00943917|100866809|FG012|NOT COMPLETED|Stage II||0||
48222683|NCT00943917|100866810|FG013|NOT COMPLETED|Stage II||0||
48222684|NCT00943917|100866811|FG014|NOT COMPLETED|Stage II||0||
48222685|NCT00943917|100866797|FG000|STARTED|Stage II Continuation||0||
48222686|NCT00943917|100866798|FG001|STARTED|Stage II Continuation||0||
48222687|NCT00943917|100866799|FG002|STARTED|Stage II Continuation||0||
48222688|NCT00943917|100866800|FG003|STARTED|Stage II Continuation||0||
48222689|NCT00943917|100866801|FG004|STARTED|Stage II Continuation||0||
48222690|NCT00943917|100866802|FG005|STARTED|Stage II Continuation||0||
48222691|NCT00943917|100866803|FG006|STARTED|Stage II Continuation||0||
48222692|NCT00943917|100866804|FG007|STARTED|Stage II Continuation||0||
48222693|NCT00943917|100866805|FG008|STARTED|Stage II Continuation||0||
48222694|NCT00943917|100866806|FG009|STARTED|Stage II Continuation||15||
48222695|NCT00943917|100866807|FG010|STARTED|Stage II Continuation||15||
48222696|NCT00943917|100866808|FG011|STARTED|Stage II Continuation||13||
48222697|NCT00943917|100866809|FG012|STARTED|Stage II Continuation||16||
48222698|NCT00943917|100866810|FG013|STARTED|Stage II Continuation||15||
48222699|NCT00943917|100866811|FG014|STARTED|Stage II Continuation||12||
48222700|NCT00943917|100866797|FG000|COMPLETED|Stage II Continuation||0||
48222701|NCT00943917|100866798|FG001|COMPLETED|Stage II Continuation||0||
48222702|NCT00943917|100866799|FG002|COMPLETED|Stage II Continuation||0||
48222703|NCT00943917|100866800|FG003|COMPLETED|Stage II Continuation||0||
48222704|NCT00943917|100866801|FG004|COMPLETED|Stage II Continuation||0||
48222705|NCT00943917|100866802|FG005|COMPLETED|Stage II Continuation||0||
48222706|NCT00943917|100866803|FG006|COMPLETED|Stage II Continuation||0||
48222707|NCT00943917|100866804|FG007|COMPLETED|Stage II Continuation||0||
48222708|NCT00943917|100866805|FG008|COMPLETED|Stage II Continuation||0||
48222709|NCT00943917|100866806|FG009|COMPLETED|Stage II Continuation||14||
48222710|NCT00943917|100866807|FG010|COMPLETED|Stage II Continuation||15||
48222711|NCT00943917|100866808|FG011|COMPLETED|Stage II Continuation||11||
48222712|NCT00943917|100866809|FG012|COMPLETED|Stage II Continuation||13||
48222713|NCT00943917|100866810|FG013|COMPLETED|Stage II Continuation||12||
48222714|NCT00943917|100866811|FG014|COMPLETED|Stage II Continuation||8||
48222715|NCT00943917|100866797|FG000|NOT COMPLETED|Stage II Continuation||0||
48222716|NCT00943917|100866798|FG001|NOT COMPLETED|Stage II Continuation||0||
48222717|NCT00943917|100866799|FG002|NOT COMPLETED|Stage II Continuation||0||
48222718|NCT00943917|100866800|FG003|NOT COMPLETED|Stage II Continuation||0||
48222719|NCT00943917|100866801|FG004|NOT COMPLETED|Stage II Continuation||0||
48222720|NCT00943917|100866802|FG005|NOT COMPLETED|Stage II Continuation||0||
48222721|NCT00943917|100866803|FG006|NOT COMPLETED|Stage II Continuation||0||
48222722|NCT00943917|100866804|FG007|NOT COMPLETED|Stage II Continuation||0||
48222723|NCT00943917|100866805|FG008|NOT COMPLETED|Stage II Continuation||0||
48222724|NCT00943917|100866806|FG009|NOT COMPLETED|Stage II Continuation||1||
48222725|NCT00943917|100866807|FG010|NOT COMPLETED|Stage II Continuation||0||
48222726|NCT00943917|100866808|FG011|NOT COMPLETED|Stage II Continuation||2||
48222727|NCT00943917|100866809|FG012|NOT COMPLETED|Stage II Continuation||3||
48222728|NCT00943917|100866810|FG013|NOT COMPLETED|Stage II Continuation||3||
48222729|NCT00943917|100866811|FG014|NOT COMPLETED|Stage II Continuation||4||
48222730|NCT03500549|100866812|FG000|STARTED|Run-in Period (Day -28 to ≤Day 1)||41||
48222731|NCT03500549|100866813|FG001|STARTED|Run-in Period (Day -28 to ≤Day 1)||39||
48222732|NCT03500549|100866812|FG000|COMPLETED|Run-in Period (Day -28 to ≤Day 1)||41||
48222733|NCT03500549|100866813|FG001|COMPLETED|Run-in Period (Day -28 to ≤Day 1)||39||
48222734|NCT03500549|100866812|FG000|NOT COMPLETED|Run-in Period (Day -28 to ≤Day 1)||0||
48222735|NCT03500549|100866813|FG001|NOT COMPLETED|Run-in Period (Day -28 to ≤Day 1)||0||
48222736|NCT03500549|100866812|FG000|STARTED|RCP (Day 1 - Week 16)||41||
48222737|NCT03500549|100866813|FG001|STARTED|RCP (Day 1 - Week 16)||39||
48222738|NCT03500549|100866812|FG000|COMPLETED|RCP (Day 1 - Week 16)||38|Completed treatment at Week 16 analysis.|
48222739|NCT03500549|100866813|FG001|COMPLETED|RCP (Day 1 - Week 16)||39|Completed treatment at Week 16 analysis.|
48222740|NCT03500549|100866812|FG000|NOT COMPLETED|RCP (Day 1 - Week 16)||3||
48222741|NCT03500549|100866813|FG001|NOT COMPLETED|RCP (Day 1 - Week 16)||0||
48222742|NCT03500549|100866812|FG000|STARTED|Open-label Period (Week 17 to Week 48)||38||
48222743|NCT03500549|100866813|FG001|STARTED|Open-label Period (Week 17 to Week 48)||39||
48222744|NCT03500549|100866812|FG000|COMPLETED|Open-label Period (Week 17 to Week 48)||35|Completed treatment at Week 48 analysis.|
48222745|NCT03500549|100866813|FG001|COMPLETED|Open-label Period (Week 17 to Week 48)||32|Completed treatment at Week 48 analysis.|
48222746|NCT03500549|100866812|FG000|NOT COMPLETED|Open-label Period (Week 17 to Week 48)||3||
48222747|NCT03500549|100866813|FG001|NOT COMPLETED|Open-label Period (Week 17 to Week 48)||7||
48222748|NCT01177670|100866814|FG000|STARTED|Overall Study||169||
48222749|NCT01177670|100866814|FG000|COMPLETED|Overall Study||0||
48222750|NCT01177670|100866814|FG000|NOT COMPLETED|Overall Study||169||
48222751|NCT01736475|100866815|FG000|STARTED|Overall Study||121||
48222752|NCT01736475|100866816|FG001|STARTED|Overall Study||17||
48222753|NCT01736475|100866815|FG000|COMPLETED|Overall Study||109||
48222754|NCT01736475|100866816|FG001|COMPLETED|Overall Study||17||
48222755|NCT01736475|100866815|FG000|NOT COMPLETED|Overall Study||12||
48222756|NCT01736475|100866816|FG001|NOT COMPLETED|Overall Study||0||
48222757|NCT02788019|100866817|FG000|STARTED|Overall Study||27||
48222758|NCT02788019|100866818|FG001|STARTED|Overall Study||25||
48222759|NCT02788019|100866817|FG000|COMPLETED|Overall Study||23||
48222760|NCT02788019|100866818|FG001|COMPLETED|Overall Study||20||
48222761|NCT02788019|100866817|FG000|NOT COMPLETED|Overall Study||4||
48222762|NCT02788019|100866818|FG001|NOT COMPLETED|Overall Study||5||
48222763|NCT01296815|100866819|FG000|STARTED|Overall Study||7||
48222764|NCT01296815|100866820|FG001|STARTED|Overall Study||7||
48222765|NCT01296815|100866819|FG000|COMPLETED|Overall Study||7||
48222766|NCT01296815|100866820|FG001|COMPLETED|Overall Study||7||
48222767|NCT01296815|100866819|FG000|NOT COMPLETED|Overall Study||0||
48222768|NCT01296815|100866820|FG001|NOT COMPLETED|Overall Study||0||
48222769|NCT01970410|100866821|FG000|STARTED|Main Study||55||
48222770|NCT01970410|100866821|FG000|Baseline Procedures|Main Study||55||
48222771|NCT01970410|100866821|FG000|COMPLETED|Main Study||28||
48222772|NCT01970410|100866821|FG000|NOT COMPLETED|Main Study||27||
48222773|NCT01970410|100866821|FG000|STARTED|Sub-Study||41||
48222774|NCT01970410|100866821|FG000|COMPLETED|Sub-Study||36||
48222775|NCT01970410|100866821|FG000|NOT COMPLETED|Sub-Study||5||
48222776|NCT00945321|100866822|FG000|STARTED|Period 1||7||
48222777|NCT00945321|100866823|FG001|STARTED|Period 1||7||
48222778|NCT00945321|100866824|FG002|STARTED|Period 1||7||
48222779|NCT00945321|100866825|FG003|STARTED|Period 1||7||
48222780|NCT00945321|100866826|FG004|STARTED|Period 1||7||
48222781|NCT00945321|100866827|FG005|STARTED|Period 1||7||
48222782|NCT00945321|100866822|FG000|COMPLETED|Period 1||7||
48222783|NCT00945321|100866823|FG001|COMPLETED|Period 1||7||
48222784|NCT00945321|100866824|FG002|COMPLETED|Period 1||7||
48222785|NCT00945321|100866825|FG003|COMPLETED|Period 1||7||
48222786|NCT00945321|100866826|FG004|COMPLETED|Period 1||6||
48222787|NCT00945321|100866827|FG005|COMPLETED|Period 1||7||
48222788|NCT00945321|100866822|FG000|NOT COMPLETED|Period 1||0||
48222789|NCT00945321|100866823|FG001|NOT COMPLETED|Period 1||0||
48222790|NCT00945321|100866824|FG002|NOT COMPLETED|Period 1||0||
48222791|NCT00945321|100866825|FG003|NOT COMPLETED|Period 1||0||
48222792|NCT00945321|100866826|FG004|NOT COMPLETED|Period 1||1||
48222793|NCT00945321|100866827|FG005|NOT COMPLETED|Period 1||0||
48222794|NCT00945321|100866822|FG000|STARTED|Period 2||7||
48222795|NCT00945321|100866823|FG001|STARTED|Period 2||7||
48222796|NCT00945321|100866824|FG002|STARTED|Period 2||7||
48222797|NCT00945321|100866825|FG003|STARTED|Period 2||7||
48222798|NCT00945321|100866826|FG004|STARTED|Period 2||6||
48222799|NCT00945321|100866827|FG005|STARTED|Period 2||7||
48222800|NCT00945321|100866822|FG000|COMPLETED|Period 2||7||
48222801|NCT00945321|100866823|FG001|COMPLETED|Period 2||7||
48222802|NCT00945321|100866824|FG002|COMPLETED|Period 2||7||
48222803|NCT00945321|100866825|FG003|COMPLETED|Period 2||7||
48222804|NCT00945321|100866826|FG004|COMPLETED|Period 2||6||
48222805|NCT00945321|100866827|FG005|COMPLETED|Period 2||7||
48222806|NCT00945321|100866822|FG000|NOT COMPLETED|Period 2||0||
48222807|NCT00945321|100866823|FG001|NOT COMPLETED|Period 2||0||
48222808|NCT00945321|100866824|FG002|NOT COMPLETED|Period 2||0||
48222809|NCT00945321|100866825|FG003|NOT COMPLETED|Period 2||0||
48222810|NCT00945321|100866826|FG004|NOT COMPLETED|Period 2||0||
48222811|NCT00945321|100866827|FG005|NOT COMPLETED|Period 2||0||
48222812|NCT00945321|100866822|FG000|STARTED|Period 3||7||
48222813|NCT00945321|100866823|FG001|STARTED|Period 3||7||
48222814|NCT00945321|100866824|FG002|STARTED|Period 3||7||
48222815|NCT00945321|100866825|FG003|STARTED|Period 3||7||
48222816|NCT00945321|100866826|FG004|STARTED|Period 3||6||
48222817|NCT00945321|100866827|FG005|STARTED|Period 3||7||
48222818|NCT00945321|100866822|FG000|COMPLETED|Period 3||7||
48222819|NCT00945321|100866823|FG001|COMPLETED|Period 3||7||
48222820|NCT00945321|100866824|FG002|COMPLETED|Period 3||7||
48222821|NCT00945321|100866825|FG003|COMPLETED|Period 3||7||
48222822|NCT00945321|100866826|FG004|COMPLETED|Period 3||6||
48222823|NCT00945321|100866827|FG005|COMPLETED|Period 3||7||
48222824|NCT00945321|100866822|FG000|NOT COMPLETED|Period 3||0||
48222825|NCT00945321|100866823|FG001|NOT COMPLETED|Period 3||0||
48222826|NCT00945321|100866824|FG002|NOT COMPLETED|Period 3||0||
48222827|NCT00945321|100866825|FG003|NOT COMPLETED|Period 3||0||
48222828|NCT00945321|100866826|FG004|NOT COMPLETED|Period 3||0||
48222829|NCT00945321|100866827|FG005|NOT COMPLETED|Period 3||0||
48222830|NCT00945321|100866822|FG000|STARTED|Period 4||7||
48222831|NCT00945321|100866823|FG001|STARTED|Period 4||7||
48222832|NCT00945321|100866824|FG002|STARTED|Period 4||7||
48222833|NCT00945321|100866825|FG003|STARTED|Period 4||7||
48222834|NCT00945321|100866826|FG004|STARTED|Period 4||6||
48222835|NCT00945321|100866827|FG005|STARTED|Period 4||7||
48222836|NCT00945321|100866822|FG000|COMPLETED|Period 4||7||
48222837|NCT00945321|100866823|FG001|COMPLETED|Period 4||7||
48222838|NCT00945321|100866824|FG002|COMPLETED|Period 4||7||
48222839|NCT00945321|100866825|FG003|COMPLETED|Period 4||7||
48222840|NCT00945321|100866826|FG004|COMPLETED|Period 4||6||
48222841|NCT00945321|100866827|FG005|COMPLETED|Period 4||6||
48222842|NCT00945321|100866822|FG000|NOT COMPLETED|Period 4||0||
48222843|NCT00945321|100866823|FG001|NOT COMPLETED|Period 4||0||
48222844|NCT00945321|100866824|FG002|NOT COMPLETED|Period 4||0||
48222845|NCT00945321|100866825|FG003|NOT COMPLETED|Period 4||0||
48222846|NCT00945321|100866826|FG004|NOT COMPLETED|Period 4||0||
48222847|NCT00945321|100866827|FG005|NOT COMPLETED|Period 4||1||
48222848|NCT01979276|100866828|FG000|STARTED|Overall Study||2||
48222849|NCT01979276|100866828|FG000|COMPLETED|Overall Study||2|Completion defined as those removed from treatment due to disease progression (per protocol)|
48222850|NCT01979276|100866828|FG000|NOT COMPLETED|Overall Study||0||
48222851|NCT00371345|100866829|FG000|STARTED|Overall Study||24||
48222852|NCT00371345|100866830|FG001|STARTED|Overall Study||46||
48222853|NCT00371345|100866829|FG000|COMPLETED|Overall Study||0||
48222854|NCT00371345|100866830|FG001|COMPLETED|Overall Study||0||
48222855|NCT00371345|100866829|FG000|NOT COMPLETED|Overall Study||24||
48222856|NCT00371345|100866830|FG001|NOT COMPLETED|Overall Study||46||
48222857|NCT01340066|100866831|FG000|STARTED|Placebo Run in Period||94||
48222858|NCT01340066|100866832|FG001|STARTED|Placebo Run in Period||0||
48222859|NCT01340066|100866833|FG002|STARTED|Placebo Run in Period||0||
48222860|NCT01340066|100866831|FG000|COMPLETED|Placebo Run in Period||67||
48222861|NCT01340066|100866832|FG001|COMPLETED|Placebo Run in Period||0||
48222862|NCT01340066|100866833|FG002|COMPLETED|Placebo Run in Period||0||
48073522|NCT00934089|100501047|FG000|NOT COMPLETED|First Intervention Period (14 Days)||2||
48073523|NCT00934089|100501048|FG001|NOT COMPLETED|First Intervention Period (14 Days)||0||
48073524|NCT00934089|100501047|FG000|STARTED|Washout Period (28 Days)||13||
48073525|NCT00934089|100501048|FG001|STARTED|Washout Period (28 Days)||16||
48073526|NCT00934089|100501047|FG000|COMPLETED|Washout Period (28 Days)||13||
48073527|NCT00934089|100501048|FG001|COMPLETED|Washout Period (28 Days)||16||
48073528|NCT00934089|100501047|FG000|NOT COMPLETED|Washout Period (28 Days)||0||
48073529|NCT00934089|100501048|FG001|NOT COMPLETED|Washout Period (28 Days)||0||
48141158|NCT02366338|100670351|FG000|COMPLETED|Overall Study||73||
48141159|NCT02366338|100670352|FG001|COMPLETED|Overall Study||39||
48141160|NCT02366338|100670353|FG002|COMPLETED|Overall Study||36||
48141161|NCT02366338|100670351|FG000|NOT COMPLETED|Overall Study||0||
48141162|NCT02366338|100670352|FG001|NOT COMPLETED|Overall Study||0||
48141163|NCT02366338|100670353|FG002|NOT COMPLETED|Overall Study||0||
48141164|NCT00833638|100670354|FG000|STARTED|Phase 2: Double-blind Treatment Phase||121||
48141165|NCT00833638|100670355|FG001|STARTED|Phase 2: Double-blind Treatment Phase||118||
48141166|NCT00833638|100670356|FG002|STARTED|Phase 2: Double-blind Treatment Phase||133||
48141167|NCT00833638|100670354|FG000|COMPLETED|Phase 2: Double-blind Treatment Phase||111||
48141168|NCT00833638|100670355|FG001|COMPLETED|Phase 2: Double-blind Treatment Phase||108||
48141169|NCT00833638|100670356|FG002|COMPLETED|Phase 2: Double-blind Treatment Phase||124||
48141170|NCT00833638|100670354|FG000|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10||
48141171|NCT00833638|100670355|FG001|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10||
48141172|NCT00833638|100670356|FG002|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||9||
48141173|NCT00833638|100670354|FG000|STARTED|Phase 3: Open-label Extension Phase||111||
48141174|NCT00833638|100670355|FG001|STARTED|Phase 3: Open-label Extension Phase||108||
48141175|NCT00833638|100670356|FG002|STARTED|Phase 3: Open-label Extension Phase||124||
48141176|NCT00833638|100670354|FG000|COMPLETED|Phase 3: Open-label Extension Phase||110||
48141177|NCT00833638|100670355|FG001|COMPLETED|Phase 3: Open-label Extension Phase||105||
48141178|NCT00833638|100670356|FG002|COMPLETED|Phase 3: Open-label Extension Phase||122||
48141179|NCT00833638|100670354|FG000|NOT COMPLETED|Phase 3: Open-label Extension Phase||1||
48141180|NCT00833638|100670355|FG001|NOT COMPLETED|Phase 3: Open-label Extension Phase||3||
48141181|NCT00833638|100670356|FG002|NOT COMPLETED|Phase 3: Open-label Extension Phase||2||
48141182|NCT00487162|100670357|FG000|STARTED|Overall Study||30||
48073530|NCT00934089|100501047|FG000|STARTED|Second Intervention Period (14 Days)||13||
48073531|NCT00934089|100501048|FG001|STARTED|Second Intervention Period (14 Days)||16||
48073532|NCT00934089|100501047|FG000|COMPLETED|Second Intervention Period (14 Days)||13||
48073533|NCT00934089|100501048|FG001|COMPLETED|Second Intervention Period (14 Days)||16||
48073534|NCT00934089|100501047|FG000|NOT COMPLETED|Second Intervention Period (14 Days)||0||
48073535|NCT00934089|100501048|FG001|NOT COMPLETED|Second Intervention Period (14 Days)||0||
48073536|NCT03789474|100501049|FG000|STARTED|Overall Study||30||
48073537|NCT03789474|100501050|FG001|STARTED|Overall Study||30||
48073538|NCT03789474|100501049|FG000|COMPLETED|Overall Study||30||
48073539|NCT03789474|100501050|FG001|COMPLETED|Overall Study||30||
48073540|NCT03789474|100501049|FG000|NOT COMPLETED|Overall Study||0||
48073541|NCT03789474|100501050|FG001|NOT COMPLETED|Overall Study||0||
48073542|NCT00191139|100501051|FG000|STARTED|Overall Study||32||
48073543|NCT00191139|100501052|FG001|STARTED|Overall Study||32||
48073544|NCT00191139|100501051|FG000|COMPLETED|Overall Study||27||
48073545|NCT00191139|100501052|FG001|COMPLETED|Overall Study||20||
48073546|NCT00191139|100501051|FG000|NOT COMPLETED|Overall Study||5||
48073547|NCT00191139|100501052|FG001|NOT COMPLETED|Overall Study||12||
48073548|NCT01525563|100501053|FG000|STARTED|Overall Study||1000||
48073549|NCT01525563|100501053|FG000|End of Treatment|Overall Study||910||
48073550|NCT01525563|100501053|FG000|3 Months Follow-up|Overall Study||838||
48073551|NCT01525563|100501053|FG000|COMPLETED|Overall Study||788||
48073552|NCT01525563|100501053|FG000|NOT COMPLETED|Overall Study||212||
48073553|NCT00873015|100501054|FG000|STARTED|Overall Study||9||
48073554|NCT00873015|100501055|FG001|STARTED|Overall Study||4||
48073555|NCT00873015|100501056|FG002|STARTED|Overall Study||3||
48073556|NCT00873015|100501057|FG003|STARTED|Overall Study||3||
48073557|NCT00873015|100501054|FG000|COMPLETED|Overall Study||9||
48073558|NCT00873015|100501055|FG001|COMPLETED|Overall Study||3||
48073559|NCT00873015|100501056|FG002|COMPLETED|Overall Study||3||
48073560|NCT00873015|100501057|FG003|COMPLETED|Overall Study||3||
48073561|NCT00873015|100501054|FG000|NOT COMPLETED|Overall Study||0||
48073562|NCT00873015|100501055|FG001|NOT COMPLETED|Overall Study||1||
48073563|NCT00873015|100501056|FG002|NOT COMPLETED|Overall Study||0||
48073564|NCT00873015|100501057|FG003|NOT COMPLETED|Overall Study||0||
48073565|NCT02761252|100501058|FG000|STARTED|Overall Study||143||
48073566|NCT02761252|100501059|FG001|STARTED|Overall Study||140||
48073567|NCT02761252|100501060|FG002|STARTED|Overall Study||137||
48073568|NCT02761252|100501058|FG000|COMPLETED|Overall Study||133||
48073569|NCT02761252|100501059|FG001|COMPLETED|Overall Study||132||
48073570|NCT02761252|100501060|FG002|COMPLETED|Overall Study||123||
48073571|NCT02761252|100501058|FG000|NOT COMPLETED|Overall Study||10||
48073572|NCT02761252|100501059|FG001|NOT COMPLETED|Overall Study||8||
48073573|NCT02761252|100501060|FG002|NOT COMPLETED|Overall Study||14||
48073574|NCT01517074|100501061|FG000|STARTED|Overall Study||5||
48073575|NCT01517074|100501061|FG000|COMPLETED|Overall Study||5||
48073576|NCT01517074|100501061|FG000|NOT COMPLETED|Overall Study||0||
48073577|NCT02050841|100501062|FG000|STARTED|Overall Study||50||
48073578|NCT02050841|100501062|FG000|COMPLETED|Overall Study||49||
48073579|NCT02050841|100501062|FG000|NOT COMPLETED|Overall Study||1||
48073580|NCT02334358|100501063|FG000|STARTED|Overall Study||503||
48073581|NCT02334358|100501063|FG000|COMPLETED|Overall Study||494||
48073582|NCT02334358|100501063|FG000|NOT COMPLETED|Overall Study||9||
48073583|NCT02151110|100501064|FG000|STARTED|Overall Study||12||
48073584|NCT02151110|100501065|FG001|STARTED|Overall Study||2||
48073585|NCT02151110|100501066|FG002|STARTED|Overall Study||2||
48073586|NCT02151110|100501067|FG003|STARTED|Overall Study||8||
48073587|NCT02151110|100501068|FG004|STARTED|Overall Study||8||
48073588|NCT02151110|100501069|FG005|STARTED|Overall Study||8||
48073589|NCT02151110|100501070|FG006|STARTED|Overall Study||8||
48073590|NCT02151110|100501071|FG007|STARTED|Overall Study||8||
48073591|NCT02151110|100501064|FG000|COMPLETED|Overall Study||12||
48073592|NCT02151110|100501065|FG001|COMPLETED|Overall Study||2||
48073593|NCT02151110|100501066|FG002|COMPLETED|Overall Study||2||
48222863|NCT01340066|100866831|FG000|NOT COMPLETED|Placebo Run in Period||27||
48222864|NCT01340066|100866832|FG001|NOT COMPLETED|Placebo Run in Period||0||
48222865|NCT01340066|100866833|FG002|NOT COMPLETED|Placebo Run in Period||0||
48222866|NCT01340066|100866831|FG000|STARTED|5 Week Double Blind Randomization Period||0||
48222867|NCT01340066|100866832|FG001|STARTED|5 Week Double Blind Randomization Period||33||
48222868|NCT01340066|100866833|FG002|STARTED|5 Week Double Blind Randomization Period||34||
48222869|NCT01340066|100866831|FG000|COMPLETED|5 Week Double Blind Randomization Period||0||
48222870|NCT01340066|100866832|FG001|COMPLETED|5 Week Double Blind Randomization Period||28||
48222871|NCT01340066|100866833|FG002|COMPLETED|5 Week Double Blind Randomization Period||31||
48222872|NCT01340066|100866831|FG000|NOT COMPLETED|5 Week Double Blind Randomization Period||0||
48222873|NCT01340066|100866832|FG001|NOT COMPLETED|5 Week Double Blind Randomization Period||5||
48222874|NCT01340066|100866833|FG002|NOT COMPLETED|5 Week Double Blind Randomization Period||3||
48222875|NCT01084694|100866834|FG000|STARTED|Overall Study||50||
48222876|NCT01084694|100866835|FG001|STARTED|Overall Study||50||
48222877|NCT01084694|100866834|FG000|COMPLETED|Overall Study||44||
48222878|NCT01084694|100866835|FG001|COMPLETED|Overall Study||30||
48073594|NCT02151110|100501067|FG003|COMPLETED|Overall Study||8||
48073595|NCT02151110|100501068|FG004|COMPLETED|Overall Study||8||
48222879|NCT01084694|100866834|FG000|NOT COMPLETED|Overall Study||6||
48222880|NCT01084694|100866835|FG001|NOT COMPLETED|Overall Study||20||
48222881|NCT01318694|100866836|FG000|STARTED|Overall Study||275||
48222882|NCT01318694|100866837|FG001|STARTED|Overall Study||270||
48222883|NCT01318694|100866838|FG002|STARTED|Overall Study||268||
48222884|NCT01318694|100866839|FG003|STARTED|Overall Study||268||
48222885|NCT01318694|100866836|FG000|Full Analysis Set|Overall Study||274||
48222886|NCT01318694|100866837|FG001|Full Analysis Set|Overall Study||270||
48222887|NCT01318694|100866838|FG002|Full Analysis Set|Overall Study||265||
48222888|NCT01318694|100866839|FG003|Full Analysis Set|Overall Study||268||
48222889|NCT01318694|100866836|FG000|Safety Set|Overall Study||273||
48222890|NCT01318694|100866837|FG001|Safety Set|Overall Study||268||
48222891|NCT01318694|100866838|FG002|Safety Set|Overall Study||265||
48222892|NCT01318694|100866839|FG003|Safety Set|Overall Study||265||
48222893|NCT01318694|100866836|FG000|COMPLETED|Overall Study||223||
48222894|NCT01318694|100866837|FG001|COMPLETED|Overall Study||212||
48222895|NCT01318694|100866838|FG002|COMPLETED|Overall Study||225||
48222896|NCT01318694|100866839|FG003|COMPLETED|Overall Study||200||
48222897|NCT01318694|100866836|FG000|NOT COMPLETED|Overall Study||52||
48222898|NCT01318694|100866837|FG001|NOT COMPLETED|Overall Study||58||
48222899|NCT01318694|100866838|FG002|NOT COMPLETED|Overall Study||43||
48222900|NCT01318694|100866839|FG003|NOT COMPLETED|Overall Study||68||
48222901|NCT04098575|100866840|FG000|STARTED|Overall Study||505||
48222902|NCT04098575|100866841|FG001|STARTED|Overall Study||2961||
48222903|NCT04098575|100866842|FG002|STARTED|Overall Study||6105||
48222904|NCT04098575|100866840|FG000|COMPLETED|Overall Study||505||
48222905|NCT04098575|100866841|FG001|COMPLETED|Overall Study||2961||
48222906|NCT04098575|100866842|FG002|COMPLETED|Overall Study||6105||
48222907|NCT04098575|100866840|FG000|NOT COMPLETED|Overall Study||0||
48222908|NCT04098575|100866841|FG001|NOT COMPLETED|Overall Study||0||
48222909|NCT04098575|100866842|FG002|NOT COMPLETED|Overall Study||0||
48222910|NCT02406092|100866843|FG000|STARTED|Overall Study||105||
48222911|NCT02406092|100866844|FG001|STARTED|Overall Study||34||
48222912|NCT02406092|100866843|FG000|COMPLETED|Overall Study||67||
48222913|NCT02406092|100866844|FG001|COMPLETED|Overall Study||21||
48222914|NCT02406092|100866843|FG000|NOT COMPLETED|Overall Study||38||
48222915|NCT02406092|100866844|FG001|NOT COMPLETED|Overall Study||13||
48222916|NCT00797212|100866845|FG000|STARTED|Overall Study||50||
48222917|NCT00797212|100866845|FG000|COMPLETED|Overall Study||50||
48222918|NCT00797212|100866845|FG000|NOT COMPLETED|Overall Study||0||
48222919|NCT02513667|100866846|FG000|STARTED|Overall Study||8||
48222920|NCT02513667|100866847|FG001|STARTED|Overall Study||6||
48222921|NCT02513667|100866846|FG000|COMPLETED|Overall Study||8||
48222922|NCT02513667|100866847|FG001|COMPLETED|Overall Study||5||
48222923|NCT02513667|100866846|FG000|NOT COMPLETED|Overall Study||0||
48222924|NCT02513667|100866847|FG001|NOT COMPLETED|Overall Study||1||
48222925|NCT03890289|100866848|FG000|STARTED|Overall Study||5||
48222926|NCT03890289|100866848|FG000|COMPLETED|Overall Study||1||
48222927|NCT03890289|100866848|FG000|NOT COMPLETED|Overall Study||4||
48222928|NCT01593020|100866849|FG000|STARTED|Overall Study||28||
48222929|NCT01593020|100866850|FG001|STARTED|Overall Study||23||
48222930|NCT01593020|100866849|FG000|COMPLETED|Overall Study||26||
48222931|NCT01593020|100866850|FG001|COMPLETED|Overall Study||21||
48222932|NCT01593020|100866849|FG000|NOT COMPLETED|Overall Study||2||
48222933|NCT01593020|100866850|FG001|NOT COMPLETED|Overall Study||2||
48222934|NCT01759862|100866851|FG000|STARTED|Overall Study||23||
48222935|NCT01759862|100866852|FG001|STARTED|Overall Study||27||
48222936|NCT01759862|100866851|FG000|COMPLETED|Overall Study||20||
48222937|NCT01759862|100866852|FG001|COMPLETED|Overall Study||25||
48222938|NCT01759862|100866851|FG000|NOT COMPLETED|Overall Study||3||
48222939|NCT01759862|100866852|FG001|NOT COMPLETED|Overall Study||2||
48222940|NCT03664011|100866853|FG000|STARTED|Overall Study||6|Started are treated|
48222941|NCT03664011|100866853|FG000|COMPLETED|Overall Study||6||
48222942|NCT03664011|100866853|FG000|NOT COMPLETED|Overall Study||0||
48222943|NCT05048186|100866854|FG000|STARTED|Overall Study||252||
48222944|NCT05048186|100866855|FG001|STARTED|Overall Study||260||
48222945|NCT05048186|100866854|FG000|COMPLETED|Overall Study||242||
48222946|NCT05048186|100866855|FG001|COMPLETED|Overall Study||256||
48222947|NCT05048186|100866854|FG000|NOT COMPLETED|Overall Study||10||
48222948|NCT05048186|100866855|FG001|NOT COMPLETED|Overall Study||4||
48222949|NCT02717611|100866856|FG000|STARTED|Overall Study||60||
48222950|NCT02717611|100866856|FG000|COMPLETED|Overall Study||0||
48222951|NCT02717611|100866856|FG000|NOT COMPLETED|Overall Study||60||
48222952|NCT04839185|100866857|FG000|STARTED|Overall Study||3||
48222953|NCT04839185|100866857|FG000|COMPLETED|Overall Study||3||
48222954|NCT04839185|100866857|FG000|NOT COMPLETED|Overall Study||0||
48222955|NCT02964741|100866858|FG000|STARTED|Overall Study||15||
48222956|NCT02964741|100866859|FG001|STARTED|Overall Study||13||
48222957|NCT02964741|100866860|FG002|STARTED|Overall Study||12||
48222958|NCT02964741|100866858|FG000|COMPLETED|Overall Study||13||
48222959|NCT02964741|100866859|FG001|COMPLETED|Overall Study||12||
48222960|NCT02964741|100866860|FG002|COMPLETED|Overall Study||12||
48222961|NCT02964741|100866858|FG000|NOT COMPLETED|Overall Study||2||
48222962|NCT02964741|100866859|FG001|NOT COMPLETED|Overall Study||1||
48222963|NCT02964741|100866860|FG002|NOT COMPLETED|Overall Study||0||
48222964|NCT01437319|100866861|FG000|STARTED|Phase I||282||
48222965|NCT01437319|100866862|FG001|STARTED|Phase I||0||
48222966|NCT01437319|100866863|FG002|STARTED|Phase I||0||
48222967|NCT01437319|100866861|FG000|COMPLETED|Phase I||227||
48222968|NCT01437319|100866862|FG001|COMPLETED|Phase I||0||
48222969|NCT01437319|100866863|FG002|COMPLETED|Phase I||0||
48222970|NCT01437319|100866861|FG000|NOT COMPLETED|Phase I||55||
48222971|NCT01437319|100866862|FG001|NOT COMPLETED|Phase I||0||
48222972|NCT01437319|100866863|FG002|NOT COMPLETED|Phase I||0||
48222973|NCT01437319|100866861|FG000|STARTED|Phase II||0||
48222974|NCT01437319|100866862|FG001|STARTED|Phase II||115||
48222975|NCT01437319|100866863|FG002|STARTED|Phase II||112||
48222976|NCT01437319|100866861|FG000|COMPLETED|Phase II||0||
48222977|NCT01437319|100866862|FG001|COMPLETED|Phase II||71||
48222978|NCT01437319|100866863|FG002|COMPLETED|Phase II||75||
48222979|NCT01437319|100866861|FG000|NOT COMPLETED|Phase II||0||
48222980|NCT01437319|100866862|FG001|NOT COMPLETED|Phase II||44||
48222981|NCT01437319|100866863|FG002|NOT COMPLETED|Phase II||37||
48222982|NCT01303510|100866864|FG000|STARTED|Overall Study||55||
48222983|NCT01303510|100866865|FG001|STARTED|Overall Study||56||
48222984|NCT01303510|100866864|FG000|COMPLETED|Overall Study||54||
48222985|NCT01303510|100866865|FG001|COMPLETED|Overall Study||56||
48222986|NCT01303510|100866864|FG000|NOT COMPLETED|Overall Study||1||
48222987|NCT01303510|100866865|FG001|NOT COMPLETED|Overall Study||0||
48222988|NCT03614663|100866866|FG000|STARTED|Overall Study||110||
48222989|NCT03614663|100866867|FG001|STARTED|Overall Study||102||
48222990|NCT03614663|100866866|FG000|COMPLETED|Overall Study||106||
48222991|NCT03614663|100866867|FG001|COMPLETED|Overall Study||99||
48222992|NCT03614663|100866866|FG000|NOT COMPLETED|Overall Study||4||
48222993|NCT03614663|100866867|FG001|NOT COMPLETED|Overall Study||3||
48222994|NCT01773993|100866868|FG000|STARTED|Overall Study||534||
48222995|NCT01773993|100866868|FG000|COMPLETED|Overall Study||499||
48222996|NCT01773993|100866868|FG000|NOT COMPLETED|Overall Study||35||
48222997|NCT04474496|100866869|FG000|STARTED|Overall Study||120||
48222998|NCT04474496|100866869|FG000|COMPLETED|Overall Study||120||
48222999|NCT04474496|100866869|FG000|NOT COMPLETED|Overall Study||0||
48223000|NCT02940249|100866870|FG000|STARTED|Overall Study||34||
48223001|NCT02940249|100866870|FG000|COMPLETED|Overall Study||30||
48223002|NCT02940249|100866870|FG000|NOT COMPLETED|Overall Study||4||
48223003|NCT02284113|100866871|FG000|STARTED|Overall Study||74||
48223004|NCT02284113|100866872|FG001|STARTED|Overall Study||76||
48223005|NCT02284113|100866871|FG000|COMPLETED|Overall Study||71||
48223006|NCT02284113|100866872|FG001|COMPLETED|Overall Study||73||
48223007|NCT02284113|100866871|FG000|NOT COMPLETED|Overall Study||3||
48223008|NCT02284113|100866872|FG001|NOT COMPLETED|Overall Study||3||
48223009|NCT00351299|100866873|FG000|STARTED|Overall Study||25||
48223010|NCT00351299|100866874|FG001|STARTED|Overall Study||28||
48223011|NCT00351299|100866873|FG000|COMPLETED|Overall Study||25||
48223012|NCT00351299|100866874|FG001|COMPLETED|Overall Study||28||
48223013|NCT00351299|100866873|FG000|NOT COMPLETED|Overall Study||0||
48223014|NCT00351299|100866874|FG001|NOT COMPLETED|Overall Study||0||
48223015|NCT02524769|100866875|FG000|STARTED|Overall Study||27||
48223016|NCT02524769|100866875|FG000|COMPLETED|Overall Study||17||
48223017|NCT02524769|100866875|FG000|NOT COMPLETED|Overall Study||10||
48223018|NCT03709706|100866876|FG000|STARTED|Overall Study||20||
48223019|NCT03709706|100866877|FG001|STARTED|Overall Study||14||
48223020|NCT03709706|100866876|FG000|Intent-to-Treat (ITT) Population|Overall Study||20|Intent-to-Treat population includes all participants who started the leukapheresis procedure.|
48223021|NCT03709706|100866877|FG001|Intent-to-Treat (ITT) Population|Overall Study||14|Intent-to-Treat population includes all participants who started the leukapheresis procedure.|
48223022|NCT03709706|100866876|FG000|Modified - Intent to Treat Population|Overall Study||7|Includes all participants in ITT population who received Lete-cel infusion.|
48223023|NCT03709706|100866877|FG001|Modified - Intent to Treat Population|Overall Study||6|Includes all participants in ITT population who received Lete-cel infusion.|
48223024|NCT03709706|100866876|FG000|No Treatment|Overall Study||13|Participants who underwent leukapheresis but did not go on to receive lymphodepletion chemotherapy or Lete-cell infusion.|
48223025|NCT03709706|100866877|FG001|No Treatment|Overall Study||8|Participants who underwent leukapheresis but did not go on to receive lymphodepletion chemotherapy or Lete-cell infusion.|
48223026|NCT03709706|100866876|FG000|COMPLETED|Overall Study||3|Participants who received Lete-cel infusion and were followed-up in this study until death or for 15 years after infusion, or until transfer to a separate long-term follow-up (LTFU) study and participants who completed the treatment but did not transfer to LTFU study because Protocol amendment 06 was not in place to allow the transfer, are considered to have completed the study.|
48223027|NCT03709706|100866877|FG001|COMPLETED|Overall Study||3|Participants who received Lete-cel infusion and were followed-up in this study until death or for 15 years after infusion, or until transfer to a separate long-term follow-up (LTFU) study and participants who completed the treatment but did not transfer to LTFU study because Protocol amendment 06 was not in place to allow the transfer, are considered to have completed the study.|
48223028|NCT03709706|100866876|FG000|NOT COMPLETED|Overall Study||17||
48223029|NCT03709706|100866877|FG001|NOT COMPLETED|Overall Study||11||
48223030|NCT02157116|100866878|FG000|STARTED|Overall Study||13||
48223031|NCT02157116|100866878|FG000|COMPLETED|Overall Study||4||
48223032|NCT02157116|100866878|FG000|NOT COMPLETED|Overall Study||9||
48223033|NCT00571649|100866879|FG000|STARTED|Treatment Period||4050||
48223034|NCT00571649|100866880|FG001|STARTED|Treatment Period||4051||
48223035|NCT00571649|100866879|FG000|Participants Received Treatment|Treatment Period||3997||
48223036|NCT00571649|100866880|FG001|Participants Received Treatment|Treatment Period||4001||
48223037|NCT00571649|100866879|FG000|Day 10|Treatment Period||3454||
48223038|NCT00571649|100866880|FG001|Day 10|Treatment Period||3499||
48223039|NCT00571649|100866879|FG000|Day 35|Treatment Period||3033||
48223040|NCT00571649|100866880|FG001|Day 35|Treatment Period||3115||
48223041|NCT00571649|100866879|FG000|COMPLETED|Treatment Period||2958||
48223042|NCT00571649|100866880|FG001|COMPLETED|Treatment Period||3047||
48223043|NCT00571649|100866879|FG000|NOT COMPLETED|Treatment Period||1092||
48223044|NCT00571649|100866880|FG001|NOT COMPLETED|Treatment Period||1004||
48223045|NCT00571649|100866879|FG000|STARTED|Follow-up Period||3583||
48223046|NCT00571649|100866880|FG001|STARTED|Follow-up Period||3635||
48223047|NCT00571649|100866879|FG000|COMPLETED|Follow-up Period||3038||
48223048|NCT00571649|100866880|FG001|COMPLETED|Follow-up Period||3107||
48223049|NCT00571649|100866879|FG000|NOT COMPLETED|Follow-up Period||545||
48223050|NCT00571649|100866880|FG001|NOT COMPLETED|Follow-up Period||528||
48223051|NCT00475241|100866881|FG000|STARTED|Overall Study||18||
48223052|NCT00475241|100866882|FG001|STARTED|Overall Study||18||
48223053|NCT00475241|100866881|FG000|COMPLETED|Overall Study||11||
48223054|NCT00475241|100866882|FG001|COMPLETED|Overall Study||15||
48223055|NCT00475241|100866881|FG000|NOT COMPLETED|Overall Study||7||
48223056|NCT00475241|100866882|FG001|NOT COMPLETED|Overall Study||3||
48223057|NCT01471691|100866883|FG000|STARTED|Overall Study||8||
48223058|NCT01471691|100866884|FG001|STARTED|Overall Study||6||
48223059|NCT01471691|100866883|FG000|COMPLETED|Overall Study||8||
48223060|NCT01471691|100866884|FG001|COMPLETED|Overall Study||5||
48223061|NCT01471691|100866883|FG000|NOT COMPLETED|Overall Study||0||
48223062|NCT01471691|100866884|FG001|NOT COMPLETED|Overall Study||1||
48223063|NCT04029090|100866885|FG000|STARTED|Overall Study||9||
48223064|NCT04029090|100866886|FG001|STARTED|Overall Study||9||
48223065|NCT04029090|100866887|FG002|STARTED|Overall Study||9||
48223066|NCT04029090|100866885|FG000|COMPLETED|Overall Study||8||
48223067|NCT04029090|100866886|FG001|COMPLETED|Overall Study||8||
48223068|NCT04029090|100866887|FG002|COMPLETED|Overall Study||9||
48223069|NCT04029090|100866885|FG000|NOT COMPLETED|Overall Study||1||
48223070|NCT04029090|100866886|FG001|NOT COMPLETED|Overall Study||1||
48223071|NCT04029090|100866887|FG002|NOT COMPLETED|Overall Study||0||
48223072|NCT02432274|100866888|FG000|STARTED|Overall Study||3|The Participants Flow module (including deaths in reasons for not completed) presentation is based on full analysis set. (Full analysis set included all enrolled participants who did not fail study screening).|
48223073|NCT02432274|100866889|FG001|STARTED|Overall Study||9|The Participants Flow module (including deaths in reasons for not completed) presentation is based on full analysis set. (Full analysis set included all enrolled participants who did not fail study screening).|
48223074|NCT02432274|100866890|FG002|STARTED|Overall Study||11|The Participants Flow module (including deaths in reasons for not completed) presentation is based on full analysis set. (Full analysis set included all enrolled participants who did not fail study screening).|
48223075|NCT02432274|100866891|FG003|STARTED|Overall Study||1|The Participants Flow module (including deaths in reasons for not completed) presentation is based on full analysis set. (Full analysis set included all enrolled participants who did not fail study screening).|
48223076|NCT02432274|100866892|FG004|STARTED|Overall Study||31|The Participants Flow module (including deaths in reasons for not completed) presentation is based on full analysis set. (Full analysis set included all enrolled participants who did not fail study screening).|
48223077|NCT02432274|100866893|FG005|STARTED|Overall Study||7|The Participants Flow module (including deaths in reasons for not completed) presentation is based on full analysis set. (Full analysis set included all enrolled participants who did not fail study screening).|
48223078|NCT02432274|100866894|FG006|STARTED|Overall Study||15|The Participants Flow module (including deaths in reasons for not completed) presentation is based on full analysis set. (Full analysis set included all enrolled participants who did not fail study screening).|
48223079|NCT02432274|100866895|FG007|STARTED|Overall Study||20|The Participants Flow module (including deaths in reasons for not completed) presentation is based on full analysis set. (Full analysis set included all enrolled participants who did not fail study screening).|
48223080|NCT02432274|100866888|FG000|Underwent Run-in Period|Overall Study||1||
48223081|NCT02432274|100866889|FG001|Underwent Run-in Period|Overall Study||1||
48223082|NCT02432274|100866890|FG002|Underwent Run-in Period|Overall Study||0||
48223083|NCT02432274|100866891|FG003|Underwent Run-in Period|Overall Study||0||
48223084|NCT02432274|100866892|FG004|Underwent Run-in Period|Overall Study||0||
48223085|NCT02432274|100866893|FG005|Underwent Run-in Period|Overall Study||0||
48223086|NCT02432274|100866894|FG006|Underwent Run-in Period|Overall Study||0||
48223087|NCT02432274|100866895|FG007|Underwent Run-in Period|Overall Study||0||
48223088|NCT02432274|100866888|FG000|Treated (Safety Population)|Overall Study||5||
48223089|NCT02432274|100866889|FG001|Treated (Safety Population)|Overall Study||11||
48223090|NCT02432274|100866890|FG002|Treated (Safety Population)|Overall Study||7||
48223091|NCT02432274|100866891|FG003|Treated (Safety Population)|Overall Study||1||
48223092|NCT02432274|100866892|FG004|Treated (Safety Population)|Overall Study||31||
48223093|NCT02432274|100866893|FG005|Treated (Safety Population)|Overall Study||11||
48223094|NCT02432274|100866894|FG006|Treated (Safety Population)|Overall Study||11||
48223095|NCT02432274|100866895|FG007|Treated (Safety Population)|Overall Study||20||
48223096|NCT02432274|100866888|FG000|COMPLETED|Overall Study||1||
48223097|NCT02432274|100866889|FG001|COMPLETED|Overall Study||3||
48223098|NCT02432274|100866890|FG002|COMPLETED|Overall Study||4||
48223099|NCT02432274|100866891|FG003|COMPLETED|Overall Study||1||
48223100|NCT02432274|100866892|FG004|COMPLETED|Overall Study||2||
48223101|NCT02432274|100866893|FG005|COMPLETED|Overall Study||0||
48223102|NCT02432274|100866894|FG006|COMPLETED|Overall Study||5||
48223103|NCT02432274|100866895|FG007|COMPLETED|Overall Study||4||
48223104|NCT02432274|100866888|FG000|NOT COMPLETED|Overall Study||2||
48223105|NCT02432274|100866889|FG001|NOT COMPLETED|Overall Study||6||
48223106|NCT02432274|100866890|FG002|NOT COMPLETED|Overall Study||7||
48223107|NCT02432274|100866891|FG003|NOT COMPLETED|Overall Study||0||
48223108|NCT02432274|100866892|FG004|NOT COMPLETED|Overall Study||29||
48223109|NCT02432274|100866893|FG005|NOT COMPLETED|Overall Study||7||
48223110|NCT02432274|100866894|FG006|NOT COMPLETED|Overall Study||10||
48223111|NCT02432274|100866895|FG007|NOT COMPLETED|Overall Study||16||
48223112|NCT03936660|100866896|FG000|STARTED|Overall Study||459||25
48223113|NCT03936660|100866897|FG001|STARTED|Overall Study||590||24
48223114|NCT03936660|100866896|FG000|COMPLETED|Overall Study||457||20
48223115|NCT03936660|100866897|FG001|COMPLETED|Overall Study||588||23
48223116|NCT03936660|100866896|FG000|NOT COMPLETED|Overall Study||2||5
48223117|NCT03936660|100866897|FG001|NOT COMPLETED|Overall Study||2||1
48223118|NCT00293397|100866898|FG000|STARTED|Overall Study||20||
48223119|NCT00293397|100866898|FG000|Received First DEB-TACE|Overall Study||19||
48223120|NCT00293397|100866898|FG000|COMPLETED|Overall Study||18||
48223121|NCT00293397|100866898|FG000|NOT COMPLETED|Overall Study||2||
48223122|NCT01467934|100866899|FG000|STARTED|Overall Study||208||
48223123|NCT01467934|100866900|FG001|STARTED|Overall Study||212||
48223124|NCT01467934|100866901|FG002|STARTED|Overall Study||110||
48223125|NCT01467934|100866899|FG000|COMPLETED|Overall Study||208||
48223126|NCT01467934|100866900|FG001|COMPLETED|Overall Study||212||
48223127|NCT01467934|100866901|FG002|COMPLETED|Overall Study||110||
48223128|NCT01467934|100866899|FG000|NOT COMPLETED|Overall Study||0||
48223129|NCT01467934|100866900|FG001|NOT COMPLETED|Overall Study||0||
48223130|NCT01467934|100866901|FG002|NOT COMPLETED|Overall Study||0||
48223131|NCT01750684|100866902|FG000|STARTED|Overall Study||6||
48223132|NCT01750684|100866903|FG001|STARTED|Overall Study||7||
48223133|NCT01750684|100866902|FG000|COMPLETED|Overall Study||4||
48223134|NCT01750684|100866903|FG001|COMPLETED|Overall Study||5||
48223135|NCT01750684|100866902|FG000|NOT COMPLETED|Overall Study||2||
48223136|NCT01750684|100866903|FG001|NOT COMPLETED|Overall Study||2||
48223137|NCT02972359|100866904|FG000|STARTED|Overall Study||318||
48223138|NCT02972359|100866904|FG000|COMPLETED|Overall Study||247||
48223139|NCT02972359|100866904|FG000|NOT COMPLETED|Overall Study||71||
48223140|NCT04724759|100866905|FG000|STARTED|Overall Study||30||
48223141|NCT04724759|100866906|FG001|STARTED|Overall Study||30||
48223142|NCT04724759|100866905|FG000|COMPLETED|Overall Study||30||
48223143|NCT04724759|100866906|FG001|COMPLETED|Overall Study||30||
48223144|NCT04724759|100866905|FG000|NOT COMPLETED|Overall Study||0||
48223145|NCT04724759|100866906|FG001|NOT COMPLETED|Overall Study||0||
48223146|NCT00556478|100866907|FG000|STARTED|Double-blind Phase||171||
48223147|NCT00556478|100866908|FG001|STARTED|Double-blind Phase||85||
48223148|NCT00556478|100866907|FG000|ITT|Double-blind Phase||167||
48223149|NCT00556478|100866908|FG001|ITT|Double-blind Phase||82||
48223150|NCT00556478|100866907|FG000|COMPLETED|Double-blind Phase||150||
48223151|NCT00556478|100866908|FG001|COMPLETED|Double-blind Phase||77||
48223152|NCT00556478|100866907|FG000|NOT COMPLETED|Double-blind Phase||21||
48223153|NCT00556478|100866908|FG001|NOT COMPLETED|Double-blind Phase||8||
48223154|NCT00556478|100866907|FG000|STARTED|Open-Label Phase||146||
48223155|NCT00556478|100866908|FG001|STARTED|Open-Label Phase||77||
48223156|NCT00556478|100866907|FG000|Treated in Open-label|Open-Label Phase||142||
48223157|NCT00556478|100866908|FG001|Treated in Open-label|Open-Label Phase||71||
48223158|NCT00556478|100866907|FG000|COMPLETED|Open-Label Phase||132||
48223159|NCT00556478|100866908|FG001|COMPLETED|Open-Label Phase||67||
48223160|NCT00556478|100866907|FG000|NOT COMPLETED|Open-Label Phase||14||
48223161|NCT00556478|100866908|FG001|NOT COMPLETED|Open-Label Phase||10||
48223162|NCT01693822|100866909|FG000|STARTED|Overall Study||65||
48223163|NCT01693822|100866909|FG000|COMPLETED|Overall Study||65||
48223164|NCT01693822|100866909|FG000|NOT COMPLETED|Overall Study||0||
48223165|NCT01583868|100866910|FG000|STARTED|Overall Study||108||
48223166|NCT01583868|100866911|FG001|STARTED|Overall Study||108||
48223167|NCT01583868|100866910|FG000|COMPLETED|Overall Study||104||
48223168|NCT01583868|100866911|FG001|COMPLETED|Overall Study||104||
48223169|NCT01583868|100866910|FG000|NOT COMPLETED|Overall Study||4||
48223170|NCT01583868|100866911|FG001|NOT COMPLETED|Overall Study||4||
48223171|NCT00808405|100866912|FG000|STARTED|Overall Study||61||
48223172|NCT00808405|100866913|FG001|STARTED|Overall Study||27||
48223173|NCT00808405|100866912|FG000|COMPLETED|Overall Study||61||
48223174|NCT00808405|100866913|FG001|COMPLETED|Overall Study||27||
48223175|NCT00808405|100866912|FG000|NOT COMPLETED|Overall Study||0||
48223176|NCT00808405|100866913|FG001|NOT COMPLETED|Overall Study||0||
48223177|NCT02534285|100866914|FG000|STARTED|Overall Study||50||
48223178|NCT02534285|100866915|FG001|STARTED|Overall Study||50||
48223179|NCT02534285|100866914|FG000|COMPLETED|Overall Study||50||
48223180|NCT02534285|100866915|FG001|COMPLETED|Overall Study||50||
48223181|NCT02534285|100866914|FG000|NOT COMPLETED|Overall Study||0||
48223182|NCT02534285|100866915|FG001|NOT COMPLETED|Overall Study||0||
48223183|NCT00309166|100866916|FG000|STARTED|Overall Study||181||
48223184|NCT00309166|100866917|FG001|STARTED|Overall Study||89||
48223185|NCT00309166|100866916|FG000|COMPLETED|Overall Study||176||
48223186|NCT00309166|100866917|FG001|COMPLETED|Overall Study||86||
48223187|NCT00309166|100866916|FG000|NOT COMPLETED|Overall Study||5||
48223188|NCT00309166|100866917|FG001|NOT COMPLETED|Overall Study||3||
48223189|NCT05274321|100866918|FG000|STARTED|Overall Study||50||50
48223190|NCT05274321|100866919|FG001|STARTED|Overall Study||50||50
48223191|NCT05274321|100866918|FG000|COMPLETED|Overall Study||50||50
48223192|NCT05274321|100866919|FG001|COMPLETED|Overall Study||50||50
48223193|NCT05274321|100866918|FG000|NOT COMPLETED|Overall Study||0||0
48223194|NCT05274321|100866919|FG001|NOT COMPLETED|Overall Study||0||0
48223195|NCT01285999|100866920|FG000|STARTED|Overall Study||373||
48223196|NCT01285999|100866921|FG001|STARTED|Overall Study||127||
48223197|NCT01285999|100866920|FG000|COMPLETED|Overall Study||373||
48223198|NCT01285999|100866921|FG001|COMPLETED|Overall Study||127||
48223199|NCT01285999|100866920|FG000|NOT COMPLETED|Overall Study||0||
48223200|NCT01285999|100866921|FG001|NOT COMPLETED|Overall Study||0||
48223201|NCT02285270|100866922|FG000|STARTED|Overall Study||10||
48223202|NCT02285270|100866922|FG000|COMPLETED|Overall Study||5||
48223203|NCT02285270|100866922|FG000|NOT COMPLETED|Overall Study||5||
48223204|NCT01860079|100866923|FG000|STARTED|Overall Study||384||
48223205|NCT01860079|100866924|FG001|STARTED|Overall Study||385||
48223206|NCT01860079|100866923|FG000|COMPLETED|Overall Study||370||
48223207|NCT01860079|100866924|FG001|COMPLETED|Overall Study||363||
48223208|NCT01860079|100866923|FG000|NOT COMPLETED|Overall Study||14||
48223209|NCT01860079|100866924|FG001|NOT COMPLETED|Overall Study||22||
48223210|NCT00912964|100866925|FG000|STARTED|Overall Study||433||
48223211|NCT00912964|100866926|FG001|STARTED|Overall Study||433||
48223212|NCT00912964|100866927|FG002|STARTED|Overall Study||440||
48223213|NCT00912964|100866925|FG000|Safety Analysis Set (SAF)|Overall Study||433||
48223214|NCT00912964|100866926|FG001|Safety Analysis Set (SAF)|Overall Study||432||
48223215|NCT00912964|100866927|FG002|Safety Analysis Set (SAF)|Overall Study||440||
48223216|NCT00912964|100866925|FG000|Full Analysis Set (FAS)|Overall Study||415||
48223217|NCT00912964|100866926|FG001|Full Analysis Set (FAS)|Overall Study||410||
48223218|NCT00912964|100866927|FG002|Full Analysis Set (FAS)|Overall Study||426||
48223219|NCT00912964|100866925|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study||262||
48223220|NCT00912964|100866926|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study||254||
48223221|NCT00912964|100866927|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study||257||
48223222|NCT00912964|100866925|FG000|COMPLETED|Overall Study||367||
48223223|NCT00912964|100866926|FG001|COMPLETED|Overall Study||387||
48223224|NCT00912964|100866927|FG002|COMPLETED|Overall Study||386||
48223225|NCT00912964|100866925|FG000|NOT COMPLETED|Overall Study||66||
48223226|NCT00912964|100866926|FG001|NOT COMPLETED|Overall Study||46||
48223227|NCT00912964|100866927|FG002|NOT COMPLETED|Overall Study||54||
48223228|NCT01160354|100866928|FG000|STARTED|Overall Study||3||
48223229|NCT01160354|100866929|FG001|STARTED|Overall Study||4||
48223230|NCT01160354|100866930|FG002|STARTED|Overall Study||15||
48223231|NCT01160354|100866928|FG000|COMPLETED|Overall Study||3||
48223232|NCT01160354|100866929|FG001|COMPLETED|Overall Study||3||
48223233|NCT01160354|100866930|FG002|COMPLETED|Overall Study||14||
48223234|NCT01160354|100866928|FG000|NOT COMPLETED|Overall Study||0||
48223235|NCT01160354|100866929|FG001|NOT COMPLETED|Overall Study||1||
48223236|NCT01160354|100866930|FG002|NOT COMPLETED|Overall Study||1||
48223237|NCT05484661|100866931|FG000|STARTED|Overall Study||10||
48223238|NCT05484661|100866932|FG001|STARTED|Overall Study||10||
48223239|NCT05484661|100866931|FG000|COMPLETED|Overall Study||9||
48223240|NCT05484661|100866932|FG001|COMPLETED|Overall Study||10||
48223241|NCT05484661|100866931|FG000|NOT COMPLETED|Overall Study||1||
48223242|NCT05484661|100866932|FG001|NOT COMPLETED|Overall Study||0||
48223243|NCT02347332|100866933|FG000|STARTED|Overall Study||230||
48223244|NCT02347332|100866934|FG001|STARTED|Overall Study||229||
48223245|NCT02347332|100866933|FG000|COMPLETED|Overall Study||0|Were considered as discontinued the 12 patients dead due to various or unknown reasons.|
48223246|NCT02347332|100866934|FG001|COMPLETED|Overall Study||0|Were considered as discontinued the 12 patients dead due to various or unknown reasons.|
48223247|NCT02347332|100866933|FG000|NOT COMPLETED|Overall Study||230||
48223248|NCT02347332|100866934|FG001|NOT COMPLETED|Overall Study||229||
48223249|NCT03861052|100870025|FG000|STARTED|Overall Study||159||
48223250|NCT03861052|100870026|FG001|STARTED|Overall Study||158||
48223251|NCT03861052|100870027|FG002|STARTED|Overall Study||160||
48223252|NCT03861052|100870028|FG003|STARTED|Overall Study||159||
48223253|NCT03861052|100870025|FG000|Received at Least One Dose of Study Drug|Overall Study||159||
48223254|NCT03861052|100870026|FG001|Received at Least One Dose of Study Drug|Overall Study||158||
48223255|NCT03861052|100870027|FG002|Received at Least One Dose of Study Drug|Overall Study||160||
48223256|NCT03861052|100870028|FG003|Received at Least One Dose of Study Drug|Overall Study||159||
48223257|NCT03861052|100870025|FG000|COMPLETED|Overall Study||155||
48223258|NCT03861052|100870026|FG001|COMPLETED|Overall Study||151||
48223259|NCT03861052|100870027|FG002|COMPLETED|Overall Study||155||
48223260|NCT03861052|100870028|FG003|COMPLETED|Overall Study||154||
48223261|NCT03861052|100870025|FG000|NOT COMPLETED|Overall Study||4||
48223262|NCT03861052|100870026|FG001|NOT COMPLETED|Overall Study||7||
48223263|NCT03861052|100870027|FG002|NOT COMPLETED|Overall Study||5||
48223264|NCT03861052|100870028|FG003|NOT COMPLETED|Overall Study||5||
48223265|NCT02148705|100870029|FG000|STARTED|Overall Study||75||
48223266|NCT02148705|100870030|FG001|STARTED|Overall Study||25||
48223267|NCT02148705|100870031|FG002|STARTED|Overall Study||75||
48223268|NCT02148705|100870029|FG000|Treated|Overall Study||77||
48223269|NCT02148705|100870030|FG001|Treated|Overall Study||24||
48223270|NCT02148705|100870031|FG002|Treated|Overall Study||68||
48223271|NCT02148705|100870029|FG000|Completed Acute Phase|Overall Study||67||
48223272|NCT02148705|100870030|FG001|Completed Acute Phase|Overall Study||23||
48223273|NCT02148705|100870031|FG002|Completed Acute Phase|Overall Study||63||
48223274|NCT02148705|100870029|FG000|Completed 12M FU Period|Overall Study||57||
48223275|NCT02148705|100870030|FG001|Completed 12M FU Period|Overall Study||20||
48223276|NCT02148705|100870031|FG002|Completed 12M FU Period|Overall Study||58||
48223277|NCT02148705|100870029|FG000|COMPLETED|Overall Study||57||
48223278|NCT02148705|100870030|FG001|COMPLETED|Overall Study||20||
48223279|NCT02148705|100870031|FG002|COMPLETED|Overall Study||58||
48223280|NCT02148705|100870029|FG000|NOT COMPLETED|Overall Study||18||
48223281|NCT02148705|100870030|FG001|NOT COMPLETED|Overall Study||5||
48223282|NCT02148705|100870031|FG002|NOT COMPLETED|Overall Study||17||
48223283|NCT00918333|100870032|FG000|STARTED|Overall Study||26||
48223284|NCT00918333|100870033|FG001|STARTED|Overall Study||98||
48223285|NCT00918333|100870032|FG000|COMPLETED|Overall Study||23||
48223286|NCT00918333|100870033|FG001|COMPLETED|Overall Study||93||
48223287|NCT00918333|100870032|FG000|NOT COMPLETED|Overall Study||3||
48223288|NCT00918333|100870033|FG001|NOT COMPLETED|Overall Study||5||
48223289|NCT00640159|100870034|FG000|STARTED|Overall Study||48||
48223290|NCT00640159|100870034|FG000|Patients Who Preferred Zydis Selegiline|Overall Study||25||
48223291|NCT00640159|100870034|FG000|Patients Who Preferred Oral Selegiline|Overall Study||13||
48223292|NCT00640159|100870034|FG000|Patients Who Had no Specific Preferred Medication|Overall Study||10||
48223293|NCT00640159|100870034|FG000|COMPLETED|Overall Study||46||
48223294|NCT00640159|100870034|FG000|NOT COMPLETED|Overall Study||2||
48223295|NCT00523419|100870035|FG000|STARTED|Overall Study||32||
48223296|NCT00523419|100870035|FG000|COMPLETED|Overall Study||0||
48223297|NCT00523419|100870035|FG000|NOT COMPLETED|Overall Study||32||
48223298|NCT00702884|100870036|FG000|STARTED|Overall Study||25||
48223299|NCT00702884|100870036|FG000|COMPLETED|Overall Study||25||
48223300|NCT00702884|100870036|FG000|NOT COMPLETED|Overall Study||0||
48223301|NCT04566861|100870037|FG000|STARTED|Overall Study||26||
48223302|NCT04566861|100870038|FG001|STARTED|Overall Study||31||
48223303|NCT04566861|100870039|FG002|STARTED|Overall Study||60||
48223304|NCT04566861|100870037|FG000|COMPLETED|Overall Study||17||
48223305|NCT04566861|100870038|FG001|COMPLETED|Overall Study||19||
48223306|NCT04566861|100870039|FG002|COMPLETED|Overall Study||42||
48223307|NCT04566861|100870037|FG000|NOT COMPLETED|Overall Study||9||
48223308|NCT04566861|100870038|FG001|NOT COMPLETED|Overall Study||12||
48223309|NCT04566861|100870039|FG002|NOT COMPLETED|Overall Study||18||
48223310|NCT02613403|100870040|FG000|STARTED|Overall Study||36||
48223311|NCT02613403|100870041|FG001|STARTED|Overall Study||36||
48223312|NCT02613403|100870042|FG002|STARTED|Overall Study||9||
48223313|NCT02613403|100870043|FG003|STARTED|Overall Study||13||
48223314|NCT02613403|100870044|FG004|STARTED|Overall Study||0||
48223315|NCT02613403|100870040|FG000|Treated|Overall Study||35||
48223316|NCT02613403|100870041|FG001|Treated|Overall Study||36||
48223317|NCT02613403|100870042|FG002|Treated|Overall Study||9||
48223318|NCT02613403|100870043|FG003|Treated|Overall Study||13||
48223319|NCT02613403|100870044|FG004|Treated|Overall Study||0||
48223320|NCT02613403|100870040|FG000|COMPLETED|Overall Study||34||
48223321|NCT02613403|100870041|FG001|COMPLETED|Overall Study||35||
48223322|NCT02613403|100870042|FG002|COMPLETED|Overall Study||9||
48223323|NCT02613403|100870043|FG003|COMPLETED|Overall Study||13||
48223324|NCT02613403|100870044|FG004|COMPLETED|Overall Study||0||
48223325|NCT02613403|100870040|FG000|NOT COMPLETED|Overall Study||2||
48223326|NCT02613403|100870041|FG001|NOT COMPLETED|Overall Study||1||
48223327|NCT02613403|100870042|FG002|NOT COMPLETED|Overall Study||0||
48223328|NCT02613403|100870043|FG003|NOT COMPLETED|Overall Study||0||
48223329|NCT02613403|100870044|FG004|NOT COMPLETED|Overall Study||0||
48223330|NCT00613405|100870045|FG000|STARTED|Overall Study||45||
48223331|NCT00613405|100870046|FG001|STARTED|Overall Study||42||
48223332|NCT00613405|100870045|FG000|COMPLETED|Overall Study||45||
48223333|NCT00613405|100870046|FG001|COMPLETED|Overall Study||42||
48223334|NCT00613405|100870045|FG000|NOT COMPLETED|Overall Study||0||
48223335|NCT00613405|100870046|FG001|NOT COMPLETED|Overall Study||0||
48223336|NCT00290537|100870047|FG000|STARTED|Overall Study||4||
48223337|NCT00290537|100870048|FG001|STARTED|Overall Study||0||
48223338|NCT00290537|100870047|FG000|COMPLETED|Overall Study||4||
48223339|NCT00290537|100870048|FG001|COMPLETED|Overall Study||0||
48223340|NCT00290537|100870047|FG000|NOT COMPLETED|Overall Study||0||
48223341|NCT00290537|100870048|FG001|NOT COMPLETED|Overall Study||0||
48223342|NCT01094106|100870049|FG000|STARTED|Overall Study||33||
48223343|NCT01094106|100870050|FG001|STARTED|Overall Study||34||
48223344|NCT01094106|100870049|FG000|COMPLETED|Overall Study||33||
48223345|NCT01094106|100870050|FG001|COMPLETED|Overall Study||34||
48223346|NCT01094106|100870049|FG000|NOT COMPLETED|Overall Study||0||
48223347|NCT01094106|100870050|FG001|NOT COMPLETED|Overall Study||0||
48223348|NCT02502526|100870051|FG000|STARTED|Overall Study||62|All randomized subjects|
48223349|NCT02502526|100870052|FG001|STARTED|Overall Study||59|All randomized subjects|
48223350|NCT02502526|100870053|FG002|STARTED|Overall Study||61|All randomized subjects|
48223351|NCT02502526|100870051|FG000|Intent-to-Treat (ITT)|Overall Study||57|All randomized subjects who completed a procedure|
48223352|NCT02502526|100870052|FG001|Intent-to-Treat (ITT)|Overall Study||57|All randomized subjects who completed a procedure|
48223353|NCT02502526|100870053|FG002|Intent-to-Treat (ITT)|Overall Study||59|All randomized subjects who completed a procedure|
48223354|NCT02502526|100870051|FG000|COMPLETED|Overall Study||56|All subjects who completed the study|
48223355|NCT02502526|100870052|FG001|COMPLETED|Overall Study||55|All subjects who completed the study|
48223356|NCT02502526|100870053|FG002|COMPLETED|Overall Study||55|All subjects who completed the study|
48223357|NCT02502526|100870051|FG000|NOT COMPLETED|Overall Study||6||
48223358|NCT02502526|100870052|FG001|NOT COMPLETED|Overall Study||4||
48223359|NCT02502526|100870053|FG002|NOT COMPLETED|Overall Study||6||
48223360|NCT06260670|100870054|FG000|STARTED|Overall Study||10||
48223361|NCT06260670|100870054|FG000|COMPLETED|Overall Study||10||
48223362|NCT06260670|100870054|FG000|NOT COMPLETED|Overall Study||0||
48223363|NCT00442104|100870055|FG000|STARTED|Overall Study||54||
48223364|NCT00442104|100870055|FG000|COMPLETED|Overall Study||7||
48223365|NCT00442104|100870055|FG000|NOT COMPLETED|Overall Study||47||
48223366|NCT00680771|100870056|FG000|STARTED|Overall Study||15||
48223367|NCT00680771|100870057|FG001|STARTED|Overall Study||13||
48223368|NCT00680771|100870056|FG000|COMPLETED|Overall Study||9||
48223369|NCT00680771|100870057|FG001|COMPLETED|Overall Study||11||
48223370|NCT00680771|100870056|FG000|NOT COMPLETED|Overall Study||6||
48223371|NCT00680771|100870057|FG001|NOT COMPLETED|Overall Study||2||
48223372|NCT03975400|100870058|FG000|STARTED|Baseline: Pre-Campaign Activation||65|6-month baseline period where all regions were in the control condition (no campaign).|2
48223373|NCT03975400|100870059|FG001|STARTED|Baseline: Pre-Campaign Activation||84|6-month baseline period where all regions were in the control condition (no campaign).|2
48223374|NCT03975400|100870060|FG002|STARTED|Baseline: Pre-Campaign Activation||42|6-month baseline period where all regions were in the control condition (no campaign).|2
48223375|NCT03975400|100870058|FG000|COMPLETED|Baseline: Pre-Campaign Activation||65||2
48223376|NCT03975400|100870059|FG001|COMPLETED|Baseline: Pre-Campaign Activation||84||2
48223377|NCT03975400|100870060|FG002|COMPLETED|Baseline: Pre-Campaign Activation||42||2
48223378|NCT03975400|100870058|FG000|NOT COMPLETED|Baseline: Pre-Campaign Activation||0||0
48223379|NCT03975400|100870059|FG001|NOT COMPLETED|Baseline: Pre-Campaign Activation||0||0
48223380|NCT03975400|100870060|FG002|NOT COMPLETED|Baseline: Pre-Campaign Activation||0||0
48223381|NCT03975400|100870058|FG000|STARTED|Phase 1 (Active in 2 Regions)||62|Campaign activated in Manhattan and Queens|2
48223382|NCT03975400|100870059|FG001|STARTED|Phase 1 (Active in 2 Regions)||79|Campaign activated in Manhattan and Queens|2
48223383|NCT03975400|100870060|FG002|STARTED|Phase 1 (Active in 2 Regions)||42|Campaign activated in Manhattan and Queens|2
48223384|NCT03975400|100870058|FG000|COMPLETED|Phase 1 (Active in 2 Regions)||62||2
48223385|NCT03975400|100870059|FG001|COMPLETED|Phase 1 (Active in 2 Regions)||79||2
48223386|NCT03975400|100870060|FG002|COMPLETED|Phase 1 (Active in 2 Regions)||42||2
48223387|NCT03975400|100870058|FG000|NOT COMPLETED|Phase 1 (Active in 2 Regions)||0||0
48223388|NCT03975400|100870059|FG001|NOT COMPLETED|Phase 1 (Active in 2 Regions)||0||0
48223389|NCT03975400|100870060|FG002|NOT COMPLETED|Phase 1 (Active in 2 Regions)||0||0
48223390|NCT03975400|100870058|FG000|STARTED|Phase 2 (Active in 4 Regions)||54|Campaign expanded to Brooklyn and Hudson Valley/Central NY/Westchester/Middleton|2
48223391|NCT03975400|100870059|FG001|STARTED|Phase 2 (Active in 4 Regions)||78|Campaign expanded to Brooklyn and Hudson Valley/Central NY/Westchester/Middleton|2
48223392|NCT03975400|100870060|FG002|STARTED|Phase 2 (Active in 4 Regions)||44|Campaign expanded to Brooklyn and Hudson Valley/Central NY/Westchester/Middleton|2
48223393|NCT03975400|100870058|FG000|COMPLETED|Phase 2 (Active in 4 Regions)||54||2
48223394|NCT03975400|100870059|FG001|COMPLETED|Phase 2 (Active in 4 Regions)||78||2
48223395|NCT03975400|100870060|FG002|COMPLETED|Phase 2 (Active in 4 Regions)||44||2
48223396|NCT03975400|100870058|FG000|NOT COMPLETED|Phase 2 (Active in 4 Regions)||0||0
48223397|NCT03975400|100870059|FG001|NOT COMPLETED|Phase 2 (Active in 4 Regions)||0||0
48223398|NCT03975400|100870060|FG002|NOT COMPLETED|Phase 2 (Active in 4 Regions)||0||0
48223399|NCT03975400|100870058|FG000|STARTED|Phase 3 (Active in All 6 Regions)||55|Campaign expanded to Bronx and Staten Island/Long Island/Western NY|2
48223400|NCT03975400|100870059|FG001|STARTED|Phase 3 (Active in All 6 Regions)||52|Campaign expanded to Bronx and Staten Island/Long Island/Western NY|2
48223401|NCT03975400|100870060|FG002|STARTED|Phase 3 (Active in All 6 Regions)||41|Campaign expanded to Bronx and Staten Island/Long Island/Western NY|2
48223402|NCT03975400|100870058|FG000|COMPLETED|Phase 3 (Active in All 6 Regions)||55||2
48223403|NCT03975400|100870059|FG001|COMPLETED|Phase 3 (Active in All 6 Regions)||52||2
48223404|NCT03975400|100870060|FG002|COMPLETED|Phase 3 (Active in All 6 Regions)||41||2
48223405|NCT03975400|100870058|FG000|NOT COMPLETED|Phase 3 (Active in All 6 Regions)||0||0
48223406|NCT03975400|100870059|FG001|NOT COMPLETED|Phase 3 (Active in All 6 Regions)||0||0
48223407|NCT03975400|100870060|FG002|NOT COMPLETED|Phase 3 (Active in All 6 Regions)||0||0
48223408|NCT02414633|100870061|FG000|STARTED|Overall Study||148||
48223409|NCT02414633|100870061|FG000|COMPLETED|Overall Study||148||
48223410|NCT02414633|100870061|FG000|NOT COMPLETED|Overall Study||0||
48223411|NCT02386098|100870062|FG000|STARTED|Stage 1 (96 Weeks)||43||
48223412|NCT02386098|100870063|FG001|STARTED|Stage 1 (96 Weeks)||43||
48223413|NCT02386098|100870064|FG002|STARTED|Stage 1 (96 Weeks)||0||
48223414|NCT02386098|100870065|FG003|STARTED|Stage 1 (96 Weeks)||0||
48223415|NCT02386098|100870066|FG004|STARTED|Stage 1 (96 Weeks)||0||
48223416|NCT02386098|100870062|FG000|COMPLETED|Stage 1 (96 Weeks)||0||
48223417|NCT02386098|100870063|FG001|COMPLETED|Stage 1 (96 Weeks)||0||
48223418|NCT02386098|100870064|FG002|COMPLETED|Stage 1 (96 Weeks)||0||
48223419|NCT02386098|100870065|FG003|COMPLETED|Stage 1 (96 Weeks)||0||
48223420|NCT02386098|100870066|FG004|COMPLETED|Stage 1 (96 Weeks)||0||
48223421|NCT02386098|100870062|FG000|NOT COMPLETED|Stage 1 (96 Weeks)||43||
48223422|NCT02386098|100870063|FG001|NOT COMPLETED|Stage 1 (96 Weeks)||43||
48223423|NCT02386098|100870064|FG002|NOT COMPLETED|Stage 1 (96 Weeks)||0||
48223424|NCT02386098|100870065|FG003|NOT COMPLETED|Stage 1 (96 Weeks)||0||
48223425|NCT02386098|100870066|FG004|NOT COMPLETED|Stage 1 (96 Weeks)||0||
48223426|NCT02386098|100870062|FG000|STARTED|Stage 2 (96 Weeks)||0||
48223427|NCT02386098|100870063|FG001|STARTED|Stage 2 (96 Weeks)||0||
48223428|NCT02386098|100870064|FG002|STARTED|Stage 2 (96 Weeks)||0||
48223429|NCT02386098|100870065|FG003|STARTED|Stage 2 (96 Weeks)||0||
48223430|NCT02386098|100870066|FG004|STARTED|Stage 2 (96 Weeks)||0||
48223431|NCT02386098|100870062|FG000|COMPLETED|Stage 2 (96 Weeks)||0||
48223432|NCT02386098|100870063|FG001|COMPLETED|Stage 2 (96 Weeks)||0||
48223433|NCT02386098|100870064|FG002|COMPLETED|Stage 2 (96 Weeks)||0||
48223434|NCT02386098|100870065|FG003|COMPLETED|Stage 2 (96 Weeks)||0||
48223435|NCT02386098|100870066|FG004|COMPLETED|Stage 2 (96 Weeks)||0||
48223436|NCT02386098|100870062|FG000|NOT COMPLETED|Stage 2 (96 Weeks)||0||
48223437|NCT02386098|100870063|FG001|NOT COMPLETED|Stage 2 (96 Weeks)||0||
48223438|NCT02386098|100870064|FG002|NOT COMPLETED|Stage 2 (96 Weeks)||0||
48223439|NCT02386098|100870065|FG003|NOT COMPLETED|Stage 2 (96 Weeks)||0||
48223440|NCT02386098|100870066|FG004|NOT COMPLETED|Stage 2 (96 Weeks)||0||
48223441|NCT01078909|100870067|FG000|STARTED|Overall Study||25||
48223442|NCT01078909|100870068|FG001|STARTED|Overall Study||25||
48223443|NCT01078909|100870069|FG002|STARTED|Overall Study||25||
48223444|NCT01078909|100870070|FG003|STARTED|Overall Study||25||
48223445|NCT01078909|100870071|FG004|STARTED|Overall Study||25||
48223446|NCT01078909|100870067|FG000|COMPLETED|Overall Study||23||
48223447|NCT01078909|100870068|FG001|COMPLETED|Overall Study||21||
48223448|NCT01078909|100870069|FG002|COMPLETED|Overall Study||24||
48223449|NCT01078909|100870070|FG003|COMPLETED|Overall Study||24||
48223450|NCT01078909|100870071|FG004|COMPLETED|Overall Study||23||
48223451|NCT01078909|100870067|FG000|NOT COMPLETED|Overall Study||2||
48223452|NCT01078909|100870068|FG001|NOT COMPLETED|Overall Study||4||
48223453|NCT01078909|100870069|FG002|NOT COMPLETED|Overall Study||1||
48223454|NCT01078909|100870070|FG003|NOT COMPLETED|Overall Study||1||
48223455|NCT01078909|100870071|FG004|NOT COMPLETED|Overall Study||2||
48223456|NCT01303796|100870072|FG000|STARTED|Lead In Phase||21||
48223457|NCT01303796|100870073|FG001|STARTED|Lead In Phase||0||
48223458|NCT01303796|100870074|FG002|STARTED|Lead In Phase||0||
48223459|NCT01303796|100870072|FG000|COMPLETED|Lead In Phase||21||
48223460|NCT01303796|100870073|FG001|COMPLETED|Lead In Phase||0||
48223461|NCT01303796|100870074|FG002|COMPLETED|Lead In Phase||0||
48223462|NCT01303796|100870072|FG000|NOT COMPLETED|Lead In Phase||0||
48223463|NCT01303796|100870073|FG001|NOT COMPLETED|Lead In Phase||0||
48223464|NCT01303796|100870074|FG002|NOT COMPLETED|Lead In Phase||0||
48223465|NCT01303796|100870072|FG000|STARTED|Randomized Phase III||0||
48223466|NCT01303796|100870073|FG001|STARTED|Randomized Phase III||241||
48223467|NCT01303796|100870074|FG002|STARTED|Randomized Phase III||241||
48223468|NCT01303796|100870072|FG000|COMPLETED|Randomized Phase III||0||
48223469|NCT01303796|100870073|FG001|COMPLETED|Randomized Phase III||241||
48223470|NCT01303796|100870074|FG002|COMPLETED|Randomized Phase III||241||
48223471|NCT01303796|100870072|FG000|NOT COMPLETED|Randomized Phase III||0||
48223472|NCT01303796|100870073|FG001|NOT COMPLETED|Randomized Phase III||0||
48223473|NCT01303796|100870074|FG002|NOT COMPLETED|Randomized Phase III||0||
48223474|NCT02707198|100870075|FG000|STARTED|Overall Study||2||
48223475|NCT02707198|100870076|FG001|STARTED|Overall Study||0||
48223476|NCT02707198|100870077|FG002|STARTED|Overall Study||0||
48223477|NCT02707198|100870075|FG000|COMPLETED|Overall Study||2||
48223478|NCT02707198|100870076|FG001|COMPLETED|Overall Study||0||
48223479|NCT02707198|100870077|FG002|COMPLETED|Overall Study||0||
48223480|NCT02707198|100870075|FG000|NOT COMPLETED|Overall Study||0||
48223481|NCT02707198|100870076|FG001|NOT COMPLETED|Overall Study||0||
48223482|NCT02707198|100870077|FG002|NOT COMPLETED|Overall Study||0||
48223483|NCT03066609|100870078|FG000|STARTED|INDUCTION||136||
48223484|NCT03066609|100870079|FG001|STARTED|INDUCTION||272||
48223485|NCT03066609|100870080|FG002|STARTED|INDUCTION||135||
48223486|NCT03066609|100870081|FG003|STARTED|INDUCTION||0||
48223487|NCT03066609|100870078|FG000|COMPLETED|INDUCTION||134||
48223488|NCT03066609|100870079|FG001|COMPLETED|INDUCTION||270||
48223489|NCT03066609|100870080|FG002|COMPLETED|INDUCTION||133||
48223490|NCT03066609|100870081|FG003|COMPLETED|INDUCTION||0||
48223491|NCT03066609|100870078|FG000|NOT COMPLETED|INDUCTION||2||
48223492|NCT03066609|100870079|FG001|NOT COMPLETED|INDUCTION||2||
48223493|NCT03066609|100870080|FG002|NOT COMPLETED|INDUCTION||2||
48223494|NCT03066609|100870081|FG003|NOT COMPLETED|INDUCTION||0||
48223495|NCT03066609|100870078|FG000|STARTED|MAINTENANCE||134||
48223496|NCT03066609|100870079|FG001|STARTED|MAINTENANCE||270||
48223497|NCT03066609|100870080|FG002|STARTED|MAINTENANCE||4||
48223498|NCT03066609|100870081|FG003|STARTED|MAINTENANCE||129||
48223499|NCT03066609|100870078|FG000|COMPLETED|MAINTENANCE||127||
48223500|NCT03066609|100870079|FG001|COMPLETED|MAINTENANCE||266||
48223501|NCT03066609|100870080|FG002|COMPLETED|MAINTENANCE||2||
48223502|NCT03066609|100870081|FG003|COMPLETED|MAINTENANCE||126||
48223503|NCT03066609|100870078|FG000|NOT COMPLETED|MAINTENANCE||7||
48223504|NCT03066609|100870079|FG001|NOT COMPLETED|MAINTENANCE||4||
48223505|NCT03066609|100870080|FG002|NOT COMPLETED|MAINTENANCE||2||
48223506|NCT03066609|100870081|FG003|NOT COMPLETED|MAINTENANCE||3||
48223507|NCT03066609|100870078|FG000|STARTED|OVERALL STUDY||136||
48223508|NCT03066609|100870079|FG001|STARTED|OVERALL STUDY||272||
48223509|NCT03066609|100870080|FG002|STARTED|OVERALL STUDY||6||
48223510|NCT03066609|100870081|FG003|STARTED|OVERALL STUDY||129||
48223511|NCT03066609|100870078|FG000|COMPLETED|OVERALL STUDY||126||
48223512|NCT03066609|100870079|FG001|COMPLETED|OVERALL STUDY||264||
48223513|NCT03066609|100870080|FG002|COMPLETED|OVERALL STUDY||2||
48223514|NCT03066609|100870081|FG003|COMPLETED|OVERALL STUDY||124||
48223515|NCT03066609|100870078|FG000|NOT COMPLETED|OVERALL STUDY||10||
48223516|NCT03066609|100870079|FG001|NOT COMPLETED|OVERALL STUDY||8||
48223517|NCT03066609|100870080|FG002|NOT COMPLETED|OVERALL STUDY||4||
48223518|NCT03066609|100870081|FG003|NOT COMPLETED|OVERALL STUDY||5||
48223519|NCT00758550|100870082|FG000|STARTED|Overall Study||30||
48223520|NCT00758550|100870083|FG001|STARTED|Overall Study||30||
48223521|NCT00758550|100870082|FG000|COMPLETED|Overall Study||30||
48223522|NCT00758550|100870083|FG001|COMPLETED|Overall Study||30||
48223523|NCT00758550|100870082|FG000|NOT COMPLETED|Overall Study||0||
48223524|NCT00758550|100870083|FG001|NOT COMPLETED|Overall Study||0||
48223525|NCT01357512|100870084|FG000|STARTED|Overall Study||65||
48223526|NCT01357512|100870085|FG001|STARTED|Overall Study||65||
48223527|NCT01357512|100870084|FG000|COMPLETED|Overall Study||53||
48223528|NCT01357512|100870085|FG001|COMPLETED|Overall Study||60||
48223529|NCT01357512|100870084|FG000|NOT COMPLETED|Overall Study||12||
48223530|NCT01357512|100870085|FG001|NOT COMPLETED|Overall Study||5||
48223531|NCT02698475|100870086|FG000|STARTED|Main Study Period||44||
48223532|NCT02698475|100870086|FG000|COMPLETED|Main Study Period||41||
48223533|NCT02698475|100870086|FG000|NOT COMPLETED|Main Study Period||3||
48223534|NCT02698475|100870086|FG000|STARTED|Long-Term Extension Period||28||
48223535|NCT02698475|100870086|FG000|COMPLETED|Long-Term Extension Period||0||
48223536|NCT02698475|100870086|FG000|NOT COMPLETED|Long-Term Extension Period||28||
48223537|NCT01324310|100870087|FG000|STARTED|Overall Study||15||
48223538|NCT01324310|100870087|FG000|COMPLETED|Overall Study||13||
48223539|NCT01324310|100870087|FG000|NOT COMPLETED|Overall Study||2||
48223540|NCT00683800|100870088|FG000|STARTED|Overall Study||1101||
48223541|NCT00683800|100870089|FG001|STARTED|Overall Study||1085||
48223542|NCT00683800|100870088|FG000|Treated|Overall Study||1066||
48223543|NCT00683800|100870089|FG001|Treated|Overall Study||1052||
48223544|NCT00683800|100870088|FG000|COMPLETED|Overall Study||669||
48223545|NCT00683800|100870089|FG001|COMPLETED|Overall Study||719||
48223546|NCT00683800|100870088|FG000|NOT COMPLETED|Overall Study||432||
48223547|NCT00683800|100870089|FG001|NOT COMPLETED|Overall Study||366||
48223548|NCT03345095|100870090|FG000|STARTED|Overall Study||374||
48223549|NCT03345095|100870091|FG001|STARTED|Overall Study||375||
48223550|NCT03345095|100870090|FG000|COMPLETED|Overall Study||125||
48223551|NCT03345095|100870091|FG001|COMPLETED|Overall Study||8||
48223552|NCT03345095|100870090|FG000|NOT COMPLETED|Overall Study||249||
48223553|NCT03345095|100870091|FG001|NOT COMPLETED|Overall Study||367||
48223554|NCT00756574|100870092|FG000|STARTED|Overall Study||225||
48223555|NCT00756574|100870093|FG001|STARTED|Overall Study||221||
48223556|NCT00756574|100870092|FG000|COMPLETED|Overall Study||212||
48223557|NCT00756574|100870093|FG001|COMPLETED|Overall Study||210||
48223558|NCT00756574|100870092|FG000|NOT COMPLETED|Overall Study||13||
48223559|NCT00756574|100870093|FG001|NOT COMPLETED|Overall Study||11||
48223560|NCT04447287|100870094|FG000|STARTED|Period 1: Run-in Period||23||
48223561|NCT04447287|100870095|FG001|STARTED|Period 1: Run-in Period||0||
48223562|NCT04447287|100870096|FG002|STARTED|Period 1: Run-in Period||0||
48223563|NCT04447287|100870094|FG000|COMPLETED|Period 1: Run-in Period||19||
48223564|NCT04447287|100870095|FG001|COMPLETED|Period 1: Run-in Period||0||
48223565|NCT04447287|100870096|FG002|COMPLETED|Period 1: Run-in Period||0||
48223566|NCT04447287|100870094|FG000|NOT COMPLETED|Period 1: Run-in Period||4||
48223567|NCT04447287|100870095|FG001|NOT COMPLETED|Period 1: Run-in Period||0||
48223568|NCT04447287|100870096|FG002|NOT COMPLETED|Period 1: Run-in Period||0||
48223569|NCT04447287|100870094|FG000|STARTED|Period 2: Investigational Period||1||
48223570|NCT04447287|100870095|FG001|STARTED|Period 2: Investigational Period||12||
48223571|NCT04447287|100870096|FG002|STARTED|Period 2: Investigational Period||6||
48223572|NCT04447287|100870094|FG000|COMPLETED|Period 2: Investigational Period||0||
48223573|NCT04447287|100870095|FG001|COMPLETED|Period 2: Investigational Period||12||
48223574|NCT04447287|100870096|FG002|COMPLETED|Period 2: Investigational Period||6||
48223575|NCT04447287|100870094|FG000|NOT COMPLETED|Period 2: Investigational Period||1||
48223576|NCT04447287|100870095|FG001|NOT COMPLETED|Period 2: Investigational Period||0||
48223577|NCT04447287|100870096|FG002|NOT COMPLETED|Period 2: Investigational Period||0||
48223578|NCT04447287|100870094|FG000|STARTED|Period 3: Down-Titration Period||0||
48223579|NCT04447287|100870095|FG001|STARTED|Period 3: Down-Titration Period||12||
48223580|NCT04447287|100870096|FG002|STARTED|Period 3: Down-Titration Period||6||
48370766|NCT04967599|101236527|FG001|STARTED|Overall Study||120||
48223581|NCT04447287|100870094|FG000|COMPLETED|Period 3: Down-Titration Period||0||
48223582|NCT04447287|100870095|FG001|COMPLETED|Period 3: Down-Titration Period||12||
48223583|NCT04447287|100870096|FG002|COMPLETED|Period 3: Down-Titration Period||6||
48223584|NCT04447287|100870094|FG000|NOT COMPLETED|Period 3: Down-Titration Period||0||
48223585|NCT04447287|100870095|FG001|NOT COMPLETED|Period 3: Down-Titration Period||0||
48223586|NCT04447287|100870096|FG002|NOT COMPLETED|Period 3: Down-Titration Period||0||
48223587|NCT01588951|100870097|FG000|STARTED|Overall Study||2||
48223588|NCT01588951|100870098|FG001|STARTED|Overall Study||2||
48223589|NCT01588951|100870099|FG002|STARTED|Overall Study||6||
48223590|NCT01588951|100870097|FG000|COMPLETED|Overall Study||2||
48223591|NCT01588951|100870098|FG001|COMPLETED|Overall Study||2||
48223592|NCT01588951|100870099|FG002|COMPLETED|Overall Study||5||
48223593|NCT01588951|100870097|FG000|NOT COMPLETED|Overall Study||0||
48223594|NCT01588951|100870098|FG001|NOT COMPLETED|Overall Study||0||
48223595|NCT01588951|100870099|FG002|NOT COMPLETED|Overall Study||1||
48223596|NCT03205566|100870100|FG000|STARTED|Phase 1||19||
48223597|NCT03205566|100870101|FG001|STARTED|Phase 1||19||
48223598|NCT03205566|100870100|FG000|COMPLETED|Phase 1||18||
48223599|NCT03205566|100870101|FG001|COMPLETED|Phase 1||18||
48223600|NCT03205566|100870100|FG000|NOT COMPLETED|Phase 1||1||
48223601|NCT03205566|100870101|FG001|NOT COMPLETED|Phase 1||1||
48223602|NCT03205566|100870100|FG000|STARTED|Phase 2||18||
48223603|NCT03205566|100870101|FG001|STARTED|Phase 2||18||
48223604|NCT03205566|100870100|FG000|COMPLETED|Phase 2||18||
48223605|NCT03205566|100870101|FG001|COMPLETED|Phase 2||18||
48223606|NCT03205566|100870100|FG000|NOT COMPLETED|Phase 2||0||
48223607|NCT03205566|100870101|FG001|NOT COMPLETED|Phase 2||0||
48223608|NCT02597920|100870102|FG000|STARTED|Overall Study||585||
48223609|NCT02597920|100870103|FG001|STARTED|Overall Study||1159||
48223610|NCT02597920|100870104|FG002|STARTED|Overall Study||78||
48223611|NCT02597920|100870102|FG000|COMPLETED|Overall Study||544||
48223612|NCT02597920|100870103|FG001|COMPLETED|Overall Study||1075||
48223613|NCT02597920|100870104|FG002|COMPLETED|Overall Study||72||
48223614|NCT02597920|100870102|FG000|NOT COMPLETED|Overall Study||41||
48223615|NCT02597920|100870103|FG001|NOT COMPLETED|Overall Study||84||
48223616|NCT02597920|100870104|FG002|NOT COMPLETED|Overall Study||6||
48223617|NCT02022670|100870105|FG000|STARTED|Overall Study||11||
48223618|NCT02022670|100870106|FG001|STARTED|Overall Study||10||
48223619|NCT02022670|100870107|FG002|STARTED|Overall Study||12||
48223620|NCT02022670|100870105|FG000|COMPLETED|Overall Study||10||
48223621|NCT02022670|100870106|FG001|COMPLETED|Overall Study||10||
48223622|NCT02022670|100870107|FG002|COMPLETED|Overall Study||11||
48223623|NCT02022670|100870105|FG000|NOT COMPLETED|Overall Study||1||
48223624|NCT02022670|100870106|FG001|NOT COMPLETED|Overall Study||0||
48223625|NCT02022670|100870107|FG002|NOT COMPLETED|Overall Study||1||
48223626|NCT04617574|100870108|FG000|STARTED|Overall Study||30||
48223627|NCT04617574|100870109|FG001|STARTED|Overall Study||30||
48223628|NCT04617574|100870108|FG000|COMPLETED|Overall Study||30||
48223629|NCT04617574|100870109|FG001|COMPLETED|Overall Study||30||
48223630|NCT04617574|100870108|FG000|NOT COMPLETED|Overall Study||0||
48223631|NCT04617574|100870109|FG001|NOT COMPLETED|Overall Study||0||
48223632|NCT02189759|100870110|FG000|STARTED|Overall Study||102||
48223633|NCT02189759|100870111|FG001|STARTED|Overall Study||101||
48223634|NCT02189759|100870112|FG002|STARTED|Overall Study||83||
48223635|NCT02189759|100870113|FG003|STARTED|Overall Study||89||
48223636|NCT02189759|100870110|FG000|COMPLETED|Overall Study||102||
48223637|NCT02189759|100870111|FG001|COMPLETED|Overall Study||101||
48223638|NCT02189759|100870112|FG002|COMPLETED|Overall Study||81||
48223639|NCT02189759|100870113|FG003|COMPLETED|Overall Study||84||
48223640|NCT02189759|100870110|FG000|NOT COMPLETED|Overall Study||0||
48223641|NCT02189759|100870111|FG001|NOT COMPLETED|Overall Study||0||
48223642|NCT02189759|100870112|FG002|NOT COMPLETED|Overall Study||2||
48223643|NCT02189759|100870113|FG003|NOT COMPLETED|Overall Study||5||
48223644|NCT01662505|100870114|FG000|STARTED|Overall Study||7||
48223645|NCT01662505|100870115|FG001|STARTED|Overall Study||4||
48223646|NCT01662505|100870116|FG002|STARTED|Overall Study||8||
48223647|NCT01662505|100870114|FG000|COMPLETED|Overall Study||0||
48223648|NCT01662505|100870115|FG001|COMPLETED|Overall Study||0||
48223649|NCT01662505|100870116|FG002|COMPLETED|Overall Study||0||
48223650|NCT01662505|100870114|FG000|NOT COMPLETED|Overall Study||7||
48223651|NCT01662505|100870115|FG001|NOT COMPLETED|Overall Study||4||
48223652|NCT01662505|100870116|FG002|NOT COMPLETED|Overall Study||8||
48223653|NCT03433794|100870117|FG000|STARTED|Baseline||183||
48223654|NCT03433794|100870118|FG001|STARTED|Baseline||173||
48223655|NCT03433794|100870119|FG002|STARTED|Baseline||181||
48223656|NCT03433794|100870117|FG000|COMPLETED|Baseline||183||
48223657|NCT03433794|100870118|FG001|COMPLETED|Baseline||173||
48223658|NCT03433794|100870119|FG002|COMPLETED|Baseline||181||
48223659|NCT03433794|100870117|FG000|NOT COMPLETED|Baseline||0||
48223660|NCT03433794|100870118|FG001|NOT COMPLETED|Baseline||0||
48223661|NCT03433794|100870119|FG002|NOT COMPLETED|Baseline||0||
48223662|NCT03433794|100870117|FG000|STARTED|2-Week Assessment||183||
48223663|NCT03433794|100870118|FG001|STARTED|2-Week Assessment||173||
48223664|NCT03433794|100870119|FG002|STARTED|2-Week Assessment||181||
48223665|NCT03433794|100870117|FG000|COMPLETED|2-Week Assessment||117||
48223666|NCT03433794|100870118|FG001|COMPLETED|2-Week Assessment||112||
48223667|NCT03433794|100870119|FG002|COMPLETED|2-Week Assessment||109||
48223668|NCT03433794|100870117|FG000|NOT COMPLETED|2-Week Assessment||66||
48223669|NCT03433794|100870118|FG001|NOT COMPLETED|2-Week Assessment||61||
48223670|NCT03433794|100870119|FG002|NOT COMPLETED|2-Week Assessment||72||
48223671|NCT03433794|100870117|FG000|STARTED|4-Week Assessment||183||
48223672|NCT03433794|100870118|FG001|STARTED|4-Week Assessment||173||
48223673|NCT03433794|100870119|FG002|STARTED|4-Week Assessment||181||
48223674|NCT03433794|100870117|FG000|COMPLETED|4-Week Assessment||98||
48223675|NCT03433794|100870118|FG001|COMPLETED|4-Week Assessment||95||
48223676|NCT03433794|100870119|FG002|COMPLETED|4-Week Assessment||91||
48223677|NCT03433794|100870117|FG000|NOT COMPLETED|4-Week Assessment||85||
48223678|NCT03433794|100870118|FG001|NOT COMPLETED|4-Week Assessment||78||
48223679|NCT03433794|100870119|FG002|NOT COMPLETED|4-Week Assessment||90||
48223680|NCT03433794|100870117|FG000|STARTED|6-Week Assessment||183||
48223681|NCT03433794|100870118|FG001|STARTED|6-Week Assessment||173||
48223682|NCT03433794|100870119|FG002|STARTED|6-Week Assessment||181||
48223683|NCT03433794|100870117|FG000|COMPLETED|6-Week Assessment||94||
48223684|NCT03433794|100870118|FG001|COMPLETED|6-Week Assessment||85||
48223685|NCT03433794|100870119|FG002|COMPLETED|6-Week Assessment||80||
48223686|NCT03433794|100870117|FG000|NOT COMPLETED|6-Week Assessment||89||
48223687|NCT03433794|100870118|FG001|NOT COMPLETED|6-Week Assessment||88||
48223688|NCT03433794|100870119|FG002|NOT COMPLETED|6-Week Assessment||101||
48223689|NCT03433794|100870117|FG000|STARTED|3-Month Assessment||183||
48223690|NCT03433794|100870118|FG001|STARTED|3-Month Assessment||173||
48223691|NCT03433794|100870119|FG002|STARTED|3-Month Assessment||181||
48223692|NCT03433794|100870117|FG000|COMPLETED|3-Month Assessment||69||
48223693|NCT03433794|100870118|FG001|COMPLETED|3-Month Assessment||73||
48223694|NCT03433794|100870119|FG002|COMPLETED|3-Month Assessment||71||
48223695|NCT03433794|100870117|FG000|NOT COMPLETED|3-Month Assessment||114||
48223696|NCT03433794|100870118|FG001|NOT COMPLETED|3-Month Assessment||100||
48223697|NCT03433794|100870119|FG002|NOT COMPLETED|3-Month Assessment||110||
48223698|NCT03433794|100870117|FG000|STARTED|6-Month Assessment||183||
48223699|NCT03433794|100870118|FG001|STARTED|6-Month Assessment||173||
48223700|NCT03433794|100870119|FG002|STARTED|6-Month Assessment||181||
48223701|NCT03433794|100870117|FG000|COMPLETED|6-Month Assessment||65||
48223702|NCT03433794|100870118|FG001|COMPLETED|6-Month Assessment||58||
48223703|NCT03433794|100870119|FG002|COMPLETED|6-Month Assessment||50||
48223704|NCT03433794|100870117|FG000|NOT COMPLETED|6-Month Assessment||118||
48223705|NCT03433794|100870118|FG001|NOT COMPLETED|6-Month Assessment||115||
48223706|NCT03433794|100870119|FG002|NOT COMPLETED|6-Month Assessment||131||
48223707|NCT03433794|100870117|FG000|STARTED|9-Month Assessment||183||
48223708|NCT03433794|100870118|FG001|STARTED|9-Month Assessment||173||
48223709|NCT03433794|100870119|FG002|STARTED|9-Month Assessment||181||
48223710|NCT03433794|100870117|FG000|COMPLETED|9-Month Assessment||49||
48223711|NCT03433794|100870118|FG001|COMPLETED|9-Month Assessment||52||
48223712|NCT03433794|100870119|FG002|COMPLETED|9-Month Assessment||39||
48223713|NCT03433794|100870117|FG000|NOT COMPLETED|9-Month Assessment||134||
48223714|NCT03433794|100870118|FG001|NOT COMPLETED|9-Month Assessment||121||
48223715|NCT03433794|100870119|FG002|NOT COMPLETED|9-Month Assessment||142||
48223716|NCT03938337|100870120|FG000|STARTED|Overall Study||1||
48223717|NCT03938337|100870121|FG001|STARTED|Overall Study||0||
48223718|NCT03938337|100870120|FG000|COMPLETED|Overall Study||1||
48223719|NCT03938337|100870121|FG001|COMPLETED|Overall Study||0||
48223720|NCT03938337|100870120|FG000|NOT COMPLETED|Overall Study||0||
48223721|NCT03938337|100870121|FG001|NOT COMPLETED|Overall Study||0||
48223722|NCT01170208|100870122|FG000|STARTED|Overall Study||20||
48223723|NCT01170208|100870123|FG001|STARTED|Overall Study||20||
48223724|NCT01170208|100870124|FG002|STARTED|Overall Study||6||
48223725|NCT01170208|100870122|FG000|COMPLETED|Overall Study||14||
48223726|NCT01170208|100870123|FG001|COMPLETED|Overall Study||20||
48223727|NCT01170208|100870124|FG002|COMPLETED|Overall Study||4||
48223728|NCT01170208|100870122|FG000|NOT COMPLETED|Overall Study||6||
48223729|NCT01170208|100870123|FG001|NOT COMPLETED|Overall Study||0||
48223730|NCT01170208|100870124|FG002|NOT COMPLETED|Overall Study||2||
48223731|NCT00686595|100870125|FG000|STARTED|Overall Study||38||
48223732|NCT00686595|100870125|FG000|COMPLETED|Overall Study||31||
48223733|NCT00686595|100870125|FG000|NOT COMPLETED|Overall Study||7||
48223734|NCT03552276|100870126|FG000|STARTED|Overall Study||5||
48223735|NCT03552276|100870127|FG001|STARTED|Overall Study||22||
48223736|NCT03552276|100870128|FG002|STARTED|Overall Study||49||
48223737|NCT03552276|100870129|FG003|STARTED|Overall Study||54||
48223738|NCT03552276|100870130|FG004|STARTED|Overall Study||151||
48223739|NCT03552276|100870126|FG000|COMPLETED|Overall Study||0||
48223740|NCT03552276|100870127|FG001|COMPLETED|Overall Study||0||
48223741|NCT03552276|100870128|FG002|COMPLETED|Overall Study||33||
48223742|NCT03552276|100870129|FG003|COMPLETED|Overall Study||46||
48223743|NCT03552276|100870130|FG004|COMPLETED|Overall Study||126||
48223744|NCT03552276|100870126|FG000|NOT COMPLETED|Overall Study||5||
48223745|NCT03552276|100870127|FG001|NOT COMPLETED|Overall Study||22||
48223746|NCT03552276|100870128|FG002|NOT COMPLETED|Overall Study||16||
48223747|NCT03552276|100870129|FG003|NOT COMPLETED|Overall Study||8||
48223748|NCT03552276|100870130|FG004|NOT COMPLETED|Overall Study||25||
48223749|NCT00186446|100870131|FG000|STARTED|Overall Study||20||
48223750|NCT00186446|100870131|FG000|COMPLETED|Overall Study||11||
48223751|NCT00186446|100870131|FG000|NOT COMPLETED|Overall Study||9||
48223752|NCT02972034|100870132|FG000|STARTED|Overall Study||14||
48223753|NCT02972034|100870133|FG001|STARTED|Overall Study||1||
48223754|NCT02972034|100870134|FG002|STARTED|Overall Study||3||
48223755|NCT02972034|100870135|FG003|STARTED|Overall Study||4||
48223756|NCT02972034|100870136|FG004|STARTED|Overall Study||4||
48223757|NCT02972034|100870137|FG005|STARTED|Overall Study||3||
48223758|NCT02972034|100870138|FG006|STARTED|Overall Study||4||
48223759|NCT02972034|100870139|FG007|STARTED|Overall Study||7||
48223760|NCT02972034|100870140|FG008|STARTED|Overall Study||10||
48223761|NCT02972034|100870141|FG009|STARTED|Overall Study||14||
48223762|NCT02972034|100870142|FG010|STARTED|Overall Study||8||
48223763|NCT02972034|100870143|FG011|STARTED|Overall Study||3||
48223764|NCT02972034|100870144|FG012|STARTED|Overall Study||14||
48223765|NCT02972034|100870145|FG013|STARTED|Overall Study||11||
48223766|NCT02972034|100870146|FG014|STARTED|Overall Study||11||
48223767|NCT02972034|100870132|FG000|Treated|Overall Study||14||
48223768|NCT02972034|100870133|FG001|Treated|Overall Study||1||
48223769|NCT02972034|100870134|FG002|Treated|Overall Study||3||
48223770|NCT02972034|100870135|FG003|Treated|Overall Study||4||
48223771|NCT02972034|100870136|FG004|Treated|Overall Study||4||
48223772|NCT02972034|100870137|FG005|Treated|Overall Study||3||
48223773|NCT02972034|100870138|FG006|Treated|Overall Study||4||
48223774|NCT02972034|100870139|FG007|Treated|Overall Study||7||
48223775|NCT02972034|100870140|FG008|Treated|Overall Study||10||
48223776|NCT02972034|100870141|FG009|Treated|Overall Study||14||
48223777|NCT02972034|100870142|FG010|Treated|Overall Study||8||
48223778|NCT02972034|100870143|FG011|Treated|Overall Study||3||
48223779|NCT02972034|100870144|FG012|Treated|Overall Study||13||
48223780|NCT02972034|100870145|FG013|Treated|Overall Study||11||
48223781|NCT02972034|100870146|FG014|Treated|Overall Study||11||
48223782|NCT02972034|100870132|FG000|COMPLETED|Overall Study||0||
48223783|NCT02972034|100870133|FG001|COMPLETED|Overall Study||0||
48223784|NCT02972034|100870134|FG002|COMPLETED|Overall Study||0||
48223785|NCT02972034|100870135|FG003|COMPLETED|Overall Study||0||
48223786|NCT02972034|100870136|FG004|COMPLETED|Overall Study||0||
48223787|NCT02972034|100870137|FG005|COMPLETED|Overall Study||0||
48223788|NCT02972034|100870138|FG006|COMPLETED|Overall Study||0||
48223789|NCT02972034|100870139|FG007|COMPLETED|Overall Study||0||
48223790|NCT02972034|100870140|FG008|COMPLETED|Overall Study||0||
48223791|NCT02972034|100870141|FG009|COMPLETED|Overall Study||0||
48223792|NCT02972034|100870142|FG010|COMPLETED|Overall Study||0||
48223793|NCT02972034|100870143|FG011|COMPLETED|Overall Study||0||
48223794|NCT02972034|100870144|FG012|COMPLETED|Overall Study||0||
48223795|NCT02972034|100870145|FG013|COMPLETED|Overall Study||0||
48223796|NCT02972034|100870146|FG014|COMPLETED|Overall Study||0||
48223797|NCT02972034|100870132|FG000|NOT COMPLETED|Overall Study||14||
48223798|NCT02972034|100870133|FG001|NOT COMPLETED|Overall Study||1||
48223799|NCT02972034|100870134|FG002|NOT COMPLETED|Overall Study||3||
48223800|NCT02972034|100870135|FG003|NOT COMPLETED|Overall Study||4||
48223801|NCT02972034|100870136|FG004|NOT COMPLETED|Overall Study||4||
48223802|NCT02972034|100870137|FG005|NOT COMPLETED|Overall Study||3||
48223803|NCT02972034|100870138|FG006|NOT COMPLETED|Overall Study||4||
48223804|NCT02972034|100870139|FG007|NOT COMPLETED|Overall Study||7||
48223805|NCT02972034|100870140|FG008|NOT COMPLETED|Overall Study||10||
48223806|NCT02972034|100870141|FG009|NOT COMPLETED|Overall Study||14||
48223807|NCT02972034|100870142|FG010|NOT COMPLETED|Overall Study||8||
48223808|NCT02972034|100870143|FG011|NOT COMPLETED|Overall Study||3||
48223809|NCT02972034|100870144|FG012|NOT COMPLETED|Overall Study||14||
48223810|NCT02972034|100870145|FG013|NOT COMPLETED|Overall Study||11||
48223811|NCT02972034|100870146|FG014|NOT COMPLETED|Overall Study||11||
48223812|NCT04984889|100870147|FG000|STARTED|PK Part||5||
48223813|NCT04984889|100870147|FG000|COMPLETED|PK Part||5||
48223814|NCT04984889|100870147|FG000|NOT COMPLETED|PK Part||0||
48223815|NCT04984889|100870147|FG000|STARTED|Extension Part||5||
48223816|NCT04984889|100870147|FG000|COMPLETED|Extension Part||0||
48223817|NCT04984889|100870147|FG000|NOT COMPLETED|Extension Part||5||
48223818|NCT02052440|100870148|FG000|STARTED|Overall Study||50||
48223819|NCT02052440|100870149|FG001|STARTED|Overall Study||52||
48223820|NCT02052440|100870148|FG000|COMPLETED|Overall Study||50||
48223821|NCT02052440|100870149|FG001|COMPLETED|Overall Study||51||
48223822|NCT02052440|100870148|FG000|NOT COMPLETED|Overall Study||0||
48223823|NCT02052440|100870149|FG001|NOT COMPLETED|Overall Study||1||
48223824|NCT01505166|100870150|FG000|STARTED|Overall Study||3||
48223825|NCT01505166|100870151|FG001|STARTED|Overall Study||0||
48223826|NCT01505166|100870152|FG002|STARTED|Overall Study||0||
48223827|NCT01505166|100870150|FG000|COMPLETED|Overall Study||3||
48223828|NCT01505166|100870151|FG001|COMPLETED|Overall Study||0||
48223829|NCT01505166|100870152|FG002|COMPLETED|Overall Study||0||
48223830|NCT01505166|100870150|FG000|NOT COMPLETED|Overall Study||0||
48223831|NCT01505166|100870151|FG001|NOT COMPLETED|Overall Study||0||
48223832|NCT01505166|100870152|FG002|NOT COMPLETED|Overall Study||0||
48223833|NCT03150875|100870153|FG000|STARTED|Overall Study||145||
48223834|NCT03150875|100870154|FG001|STARTED|Overall Study||145||
48223835|NCT03150875|100870153|FG000|Treated|Overall Study||144||
48223836|NCT03150875|100870154|FG001|Treated|Overall Study||130||
48223837|NCT03150875|100870153|FG000|Crossover to Certain Treatment|Overall Study||0||
48223838|NCT03150875|100870154|FG001|Crossover to Certain Treatment|Overall Study||0||
48223839|NCT03150875|100870153|FG000|COMPLETED|Overall Study||0||
48223840|NCT03150875|100870154|FG001|COMPLETED|Overall Study||0||
48223841|NCT03150875|100870153|FG000|NOT COMPLETED|Overall Study||145||
48223842|NCT03150875|100870154|FG001|NOT COMPLETED|Overall Study||145||
48223843|NCT03284359|100870155|FG000|STARTED|Overall Study||93||
48223844|NCT03284359|100870156|FG001|STARTED|Overall Study||89||
48223845|NCT03284359|100870155|FG000|COMPLETED|Overall Study||93||
48223846|NCT03284359|100870156|FG001|COMPLETED|Overall Study||89||
48223847|NCT03284359|100870155|FG000|NOT COMPLETED|Overall Study||0||
48223848|NCT03284359|100870156|FG001|NOT COMPLETED|Overall Study||0||
48223849|NCT01235936|100870157|FG000|STARTED|Overall Study||10||
48223850|NCT01235936|100870157|FG000|COMPLETED|Overall Study||10||
48223851|NCT01235936|100870157|FG000|NOT COMPLETED|Overall Study||0||
48223852|NCT03903692|100870158|FG000|STARTED|Overall Study||23||
48223853|NCT03903692|100870159|FG001|STARTED|Overall Study||20||
48223854|NCT03903692|100870158|FG000|COMPLETED|Overall Study||23||
48223855|NCT03903692|100870159|FG001|COMPLETED|Overall Study||20||
48223856|NCT03903692|100870158|FG000|NOT COMPLETED|Overall Study||0||
48223857|NCT03903692|100870159|FG001|NOT COMPLETED|Overall Study||0||
48223858|NCT03699163|100870160|FG000|STARTED|Overall Study||1487||
48223859|NCT03699163|100870161|FG001|STARTED|Overall Study||368||
48223860|NCT03699163|100870160|FG000|COMPLETED|Overall Study||1270||
48223861|NCT03699163|100870161|FG001|COMPLETED|Overall Study||162||
48223862|NCT03699163|100870160|FG000|NOT COMPLETED|Overall Study||217||
48223863|NCT03699163|100870161|FG001|NOT COMPLETED|Overall Study||206||
48223864|NCT02408887|100870162|FG000|STARTED|Overall Study||8||
48223865|NCT02408887|100870163|FG001|STARTED|Overall Study||6||
48223866|NCT02408887|100870162|FG000|COMPLETED|Overall Study||7||
48223867|NCT02408887|100870163|FG001|COMPLETED|Overall Study||5||
48223868|NCT02408887|100870162|FG000|NOT COMPLETED|Overall Study||1||
48223869|NCT02408887|100870163|FG001|NOT COMPLETED|Overall Study||1||
48223870|NCT04759833|100870164|FG000|STARTED|PartA:Placebo-controlled Period(12Weeks)||56||
48223871|NCT04759833|100870165|FG001|STARTED|PartA:Placebo-controlled Period(12Weeks)||60||
48223872|NCT04759833|100870166|FG002|STARTED|PartA:Placebo-controlled Period(12Weeks)||59||
48223873|NCT04759833|100870167|FG003|STARTED|PartA:Placebo-controlled Period(12Weeks)||0||
48223874|NCT04759833|100870168|FG004|STARTED|PartA:Placebo-controlled Period(12Weeks)||0||
48223875|NCT04759833|100870164|FG000|COMPLETED|PartA:Placebo-controlled Period(12Weeks)||46||
48223876|NCT04759833|100870165|FG001|COMPLETED|PartA:Placebo-controlled Period(12Weeks)||49||
48223877|NCT04759833|100870166|FG002|COMPLETED|PartA:Placebo-controlled Period(12Weeks)||39||
48223878|NCT04759833|100870167|FG003|COMPLETED|PartA:Placebo-controlled Period(12Weeks)||0||
48223879|NCT04759833|100870168|FG004|COMPLETED|PartA:Placebo-controlled Period(12Weeks)||0||
48223880|NCT04759833|100870164|FG000|NOT COMPLETED|PartA:Placebo-controlled Period(12Weeks)||10||
48223881|NCT04759833|100870165|FG001|NOT COMPLETED|PartA:Placebo-controlled Period(12Weeks)||11||
48223882|NCT04759833|100870166|FG002|NOT COMPLETED|PartA:Placebo-controlled Period(12Weeks)||20||
48223883|NCT04759833|100870167|FG003|NOT COMPLETED|PartA:Placebo-controlled Period(12Weeks)||0||
48223884|NCT04759833|100870168|FG004|NOT COMPLETED|PartA:Placebo-controlled Period(12Weeks)||0||
48223885|NCT04759833|100870164|FG000|STARTED|Part B:Safety Extension Period(40 Weeks)||0||
48223886|NCT04759833|100870165|FG001|STARTED|Part B:Safety Extension Period(40 Weeks)||0||
48223887|NCT04759833|100870166|FG002|STARTED|Part B:Safety Extension Period(40 Weeks)||0||
48223888|NCT04759833|100870167|FG003|STARTED|Part B:Safety Extension Period(40 Weeks)||72||
48223889|NCT04759833|100870168|FG004|STARTED|Part B:Safety Extension Period(40 Weeks)||62||
48223890|NCT04759833|100870164|FG000|COMPLETED|Part B:Safety Extension Period(40 Weeks)||0||
48223891|NCT04759833|100870165|FG001|COMPLETED|Part B:Safety Extension Period(40 Weeks)||0||
48223892|NCT04759833|100870166|FG002|COMPLETED|Part B:Safety Extension Period(40 Weeks)||0||
48223893|NCT04759833|100870167|FG003|COMPLETED|Part B:Safety Extension Period(40 Weeks)||37||
48223894|NCT04759833|100870168|FG004|COMPLETED|Part B:Safety Extension Period(40 Weeks)||28||
48223895|NCT04759833|100870164|FG000|NOT COMPLETED|Part B:Safety Extension Period(40 Weeks)||0||
48223896|NCT04759833|100870165|FG001|NOT COMPLETED|Part B:Safety Extension Period(40 Weeks)||0||
48223897|NCT04759833|100870166|FG002|NOT COMPLETED|Part B:Safety Extension Period(40 Weeks)||0||
48223898|NCT04759833|100870167|FG003|NOT COMPLETED|Part B:Safety Extension Period(40 Weeks)||35||
48223899|NCT04759833|100870168|FG004|NOT COMPLETED|Part B:Safety Extension Period(40 Weeks)||34||
48223900|NCT04060212|100870169|FG000|STARTED|Overall Study||36||
48223901|NCT04060212|100870169|FG000|COMPLETED|Overall Study||29||
48223902|NCT04060212|100870169|FG000|NOT COMPLETED|Overall Study||7||
48223903|NCT02927249|100870170|FG000|STARTED|Overall Study||1511||
48223904|NCT02927249|100870171|FG001|STARTED|Overall Study||1510||
48223905|NCT02927249|100870170|FG000|COMPLETED|Overall Study||1511||
48223906|NCT02927249|100870171|FG001|COMPLETED|Overall Study||1510||
48223907|NCT02927249|100870170|FG000|NOT COMPLETED|Overall Study||0||
48223908|NCT02927249|100870171|FG001|NOT COMPLETED|Overall Study||0||
48223909|NCT05011292|100870172|FG000|STARTED|Overall Study||116||
48223910|NCT05011292|100870173|FG001|STARTED|Overall Study||267||
48223911|NCT05011292|100870174|FG002|STARTED|Overall Study||5||
48223912|NCT05011292|100870172|FG000|COMPLETED|Overall Study||116||
48223913|NCT05011292|100870173|FG001|COMPLETED|Overall Study||56||
48223914|NCT05011292|100870174|FG002|COMPLETED|Overall Study||5||
48223915|NCT05011292|100870172|FG000|NOT COMPLETED|Overall Study||0||
48223916|NCT05011292|100870173|FG001|NOT COMPLETED|Overall Study||211||
48223917|NCT05011292|100870174|FG002|NOT COMPLETED|Overall Study||0||
48223918|NCT02383043|100870175|FG000|STARTED|Overall Study||9||
48223919|NCT02383043|100870176|FG001|STARTED|Overall Study||5||
48223920|NCT02383043|100870177|FG002|STARTED|Overall Study||4||
48223921|NCT02383043|100870175|FG000|COMPLETED|Overall Study||7||
48223922|NCT02383043|100870176|FG001|COMPLETED|Overall Study||5||
48223923|NCT02383043|100870177|FG002|COMPLETED|Overall Study||4||
48223924|NCT02383043|100870175|FG000|NOT COMPLETED|Overall Study||2||
48223925|NCT02383043|100870176|FG001|NOT COMPLETED|Overall Study||0||
48223926|NCT02383043|100870177|FG002|NOT COMPLETED|Overall Study||0||
48223927|NCT03861234|100870178|FG000|STARTED|Overall Study||3||
48223928|NCT03861234|100870179|FG001|STARTED|Overall Study||3||
48223929|NCT03861234|100870180|FG002|STARTED|Overall Study||3||
48223930|NCT03861234|100870181|FG003|STARTED|Overall Study||3||
48223931|NCT03861234|100870182|FG004|STARTED|Overall Study||3||
48223932|NCT03861234|100870183|FG005|STARTED|Overall Study||11||
48223933|NCT03861234|100870184|FG006|STARTED|Overall Study||4||
48223934|NCT03861234|100870185|FG007|STARTED|Overall Study||13||
48223935|NCT03861234|100870178|FG000|Treated|Overall Study||3||
48223936|NCT03861234|100870179|FG001|Treated|Overall Study||3||
48223937|NCT03861234|100870180|FG002|Treated|Overall Study||3||
48223938|NCT03861234|100870181|FG003|Treated|Overall Study||3||
48223939|NCT03861234|100870182|FG004|Treated|Overall Study||3||
48223940|NCT03861234|100870183|FG005|Treated|Overall Study||10||
48223941|NCT03861234|100870184|FG006|Treated|Overall Study||4||
48223942|NCT03861234|100870185|FG007|Treated|Overall Study||13||
48223943|NCT03861234|100870178|FG000|COMPLETED|Overall Study||3|Completed trial mediation|
48223944|NCT03861234|100870179|FG001|COMPLETED|Overall Study||3|Completed trial mediation|
48223945|NCT03861234|100870180|FG002|COMPLETED|Overall Study||3|Completed trial mediation|
48223946|NCT03861234|100870181|FG003|COMPLETED|Overall Study||3|Completed trial mediation|
48223947|NCT03861234|100870182|FG004|COMPLETED|Overall Study||3|Completed trial mediation|
48370767|NCT04967599|101236528|FG002|STARTED|Overall Study||120||
48370768|NCT04967599|101236526|FG000|COMPLETED|Overall Study||85||
48370769|NCT04967599|101236527|FG001|COMPLETED|Overall Study||101||
48370770|NCT04967599|101236528|FG002|COMPLETED|Overall Study||97||
48370771|NCT04967599|101236526|FG000|NOT COMPLETED|Overall Study||35||
48370772|NCT04967599|101236527|FG001|NOT COMPLETED|Overall Study||19||
48223948|NCT03861234|100870183|FG005|COMPLETED|Overall Study||8|Completed trial mediation|
48223949|NCT03861234|100870184|FG006|COMPLETED|Overall Study||1|Completed trial mediation|
48223950|NCT03861234|100870185|FG007|COMPLETED|Overall Study||13|Completed trial mediation|
48223951|NCT03861234|100870178|FG000|NOT COMPLETED|Overall Study||0||
48223952|NCT03861234|100870179|FG001|NOT COMPLETED|Overall Study||0||
48223953|NCT03861234|100870180|FG002|NOT COMPLETED|Overall Study||0||
48223954|NCT03861234|100870181|FG003|NOT COMPLETED|Overall Study||0||
48223955|NCT03861234|100870182|FG004|NOT COMPLETED|Overall Study||0||
48223956|NCT03861234|100870183|FG005|NOT COMPLETED|Overall Study||3||
48370773|NCT04967599|101236528|FG002|NOT COMPLETED|Overall Study||23||
48370774|NCT02809443|101236529|FG000|STARTED|Overall Study||20||
48370775|NCT02809443|101236530|FG001|STARTED|Overall Study||20||
48370776|NCT02809443|101236529|FG000|COMPLETED|Overall Study||17||
48223957|NCT03861234|100870184|FG006|NOT COMPLETED|Overall Study||3||
48223958|NCT03861234|100870185|FG007|NOT COMPLETED|Overall Study||0||
48223959|NCT01034306|100870186|FG000|STARTED|Overall Study||42||
48223960|NCT01034306|100870187|FG001|STARTED|Overall Study||37||
48223961|NCT01034306|100870186|FG000|COMPLETED|Overall Study||37||
48223962|NCT01034306|100870187|FG001|COMPLETED|Overall Study||34||
48223963|NCT01034306|100870186|FG000|NOT COMPLETED|Overall Study||5||
48223964|NCT01034306|100870187|FG001|NOT COMPLETED|Overall Study||3||
48223965|NCT02298842|100870188|FG000|STARTED|First Platelet Donation (Day 0)||44||
48223966|NCT02298842|100870189|FG001|STARTED|First Platelet Donation (Day 0)||41||
48223967|NCT02298842|100870188|FG000|COMPLETED|First Platelet Donation (Day 0)||38||
48223968|NCT02298842|100870189|FG001|COMPLETED|First Platelet Donation (Day 0)||36||
48223969|NCT02298842|100870188|FG000|NOT COMPLETED|First Platelet Donation (Day 0)||6||
48223970|NCT02298842|100870189|FG001|NOT COMPLETED|First Platelet Donation (Day 0)||5||
48223971|NCT02298842|100870188|FG000|STARTED|Second Platelet Donation (Day 6-8)||38||
48223972|NCT02298842|100870189|FG001|STARTED|Second Platelet Donation (Day 6-8)||36||
48223973|NCT02298842|100870188|FG000|COMPLETED|Second Platelet Donation (Day 6-8)||30||
48223974|NCT02298842|100870189|FG001|COMPLETED|Second Platelet Donation (Day 6-8)||30||
48223975|NCT02298842|100870188|FG000|NOT COMPLETED|Second Platelet Donation (Day 6-8)||8||
48223976|NCT02298842|100870189|FG001|NOT COMPLETED|Second Platelet Donation (Day 6-8)||6||
48223977|NCT02063659|100870190|FG000|STARTED|Double-Blind Treatment Period||26||
48223978|NCT02063659|100870191|FG001|STARTED|Double-Blind Treatment Period||25||
48223979|NCT02063659|100870192|FG002|STARTED|Double-Blind Treatment Period||25||
48223980|NCT02063659|100870193|FG003|STARTED|Double-Blind Treatment Period||0||
48223981|NCT02063659|100870190|FG000|COMPLETED|Double-Blind Treatment Period||24||
48223982|NCT02063659|100870191|FG001|COMPLETED|Double-Blind Treatment Period||22||
48223983|NCT02063659|100870192|FG002|COMPLETED|Double-Blind Treatment Period||22||
48223984|NCT02063659|100870193|FG003|COMPLETED|Double-Blind Treatment Period||0||
48223985|NCT02063659|100870190|FG000|NOT COMPLETED|Double-Blind Treatment Period||2||
48223986|NCT02063659|100870191|FG001|NOT COMPLETED|Double-Blind Treatment Period||3||
48223987|NCT02063659|100870192|FG002|NOT COMPLETED|Double-Blind Treatment Period||3||
48223988|NCT02063659|100870193|FG003|NOT COMPLETED|Double-Blind Treatment Period||0||
48223989|NCT02063659|100870190|FG000|STARTED|Open-Label Extension Period (OLE)||0||
48223990|NCT02063659|100870191|FG001|STARTED|Open-Label Extension Period (OLE)||0||
48223991|NCT02063659|100870192|FG002|STARTED|Open-Label Extension Period (OLE)||0||
48223992|NCT02063659|100870193|FG003|STARTED|Open-Label Extension Period (OLE)||67||
48223993|NCT02063659|100870190|FG000|COMPLETED|Open-Label Extension Period (OLE)||0||
48223994|NCT02063659|100870191|FG001|COMPLETED|Open-Label Extension Period (OLE)||0||
48223995|NCT02063659|100870192|FG002|COMPLETED|Open-Label Extension Period (OLE)||0||
48223996|NCT02063659|100870193|FG003|COMPLETED|Open-Label Extension Period (OLE)||47||
48223997|NCT02063659|100870190|FG000|NOT COMPLETED|Open-Label Extension Period (OLE)||0||
48370777|NCT02809443|101236530|FG001|COMPLETED|Overall Study||19||
48370778|NCT02809443|101236529|FG000|NOT COMPLETED|Overall Study||3||
48370779|NCT02809443|101236530|FG001|NOT COMPLETED|Overall Study||1||
48370780|NCT05319600|101236531|FG000|STARTED|Overall Study||17||
48370781|NCT05319600|101236532|FG001|STARTED|Overall Study||14||
48370782|NCT05319600|101236531|FG000|COMPLETED|Overall Study||16||
48370783|NCT05319600|101236532|FG001|COMPLETED|Overall Study||10||
48370784|NCT05319600|101236531|FG000|NOT COMPLETED|Overall Study||1||
48370785|NCT05319600|101236532|FG001|NOT COMPLETED|Overall Study||4||
48370786|NCT04600323|101236533|FG000|STARTED|Overall Study||16||
48370787|NCT04600323|101236534|FG001|STARTED|Overall Study||18||
48370788|NCT04600323|101236533|FG000|COMPLETED|Overall Study||16||
48370789|NCT04600323|101236534|FG001|COMPLETED|Overall Study||17||
48370790|NCT04600323|101236533|FG000|NOT COMPLETED|Overall Study||0||
48370791|NCT04600323|101236534|FG001|NOT COMPLETED|Overall Study||1||
48370792|NCT04549168|101236535|FG000|STARTED|Prerandomization Phase||194||
48370793|NCT04549168|101236536|FG001|STARTED|Prerandomization Phase||0||
48370794|NCT04549168|101236537|FG002|STARTED|Prerandomization Phase||0||
48370795|NCT04549168|101236535|FG000|COMPLETED|Prerandomization Phase||194||
48370796|NCT04549168|101236536|FG001|COMPLETED|Prerandomization Phase||0||
48370797|NCT04549168|101236537|FG002|COMPLETED|Prerandomization Phase||0||
48370798|NCT04549168|101236535|FG000|NOT COMPLETED|Prerandomization Phase||0||
48370799|NCT04549168|101236536|FG001|NOT COMPLETED|Prerandomization Phase||0||
48370800|NCT04549168|101236537|FG002|NOT COMPLETED|Prerandomization Phase||0||
48370801|NCT04549168|101236535|FG000|STARTED|Randomization Phase||0||
48370802|NCT04549168|101236536|FG001|STARTED|Randomization Phase||100||
48370803|NCT04549168|101236537|FG002|STARTED|Randomization Phase||94||
48370804|NCT04549168|101236535|FG000|Full Analysis Set (FAS)|Randomization Phase||0|The FAS was the group of randomized participants who received at least 1 dose of randomized study drug and had at least 1 postdose primary efficacy measurement.|
48370805|NCT04549168|101236536|FG001|Full Analysis Set (FAS)|Randomization Phase||100|The FAS was the group of randomized participants who received at least 1 dose of randomized study drug and had at least 1 postdose primary efficacy measurement.|
48370806|NCT04549168|101236537|FG002|Full Analysis Set (FAS)|Randomization Phase||93|The FAS was the group of randomized participants who received at least 1 dose of randomized study drug and had at least 1 postdose primary efficacy measurement.|
48370807|NCT04549168|101236535|FG000|COMPLETED|Randomization Phase||0||
48370808|NCT04549168|101236536|FG001|COMPLETED|Randomization Phase||96||
48370809|NCT04549168|101236537|FG002|COMPLETED|Randomization Phase||92||
48370810|NCT04549168|101236535|FG000|NOT COMPLETED|Randomization Phase||0||
48370811|NCT04549168|101236536|FG001|NOT COMPLETED|Randomization Phase||4||
48370812|NCT04549168|101236537|FG002|NOT COMPLETED|Randomization Phase||2||
48370813|NCT04353661|101236538|FG000|STARTED|Overall Study||3||
48370814|NCT04353661|101236539|FG001|STARTED|Overall Study||5||
48370815|NCT04353661|101236540|FG002|STARTED|Overall Study||4||
48370816|NCT04353661|101236538|FG000|COMPLETED|Overall Study||2||
48370817|NCT04353661|101236539|FG001|COMPLETED|Overall Study||4||
48370818|NCT04353661|101236540|FG002|COMPLETED|Overall Study||2||
48370819|NCT04353661|101236538|FG000|NOT COMPLETED|Overall Study||1||
48370820|NCT04353661|101236539|FG001|NOT COMPLETED|Overall Study||1||
48370821|NCT04353661|101236540|FG002|NOT COMPLETED|Overall Study||2||
48370822|NCT04314778|101236541|FG000|STARTED|Overall Study||30||
48370823|NCT04314778|101236542|FG001|STARTED|Overall Study||31||
48370824|NCT04314778|101236541|FG000|COMPLETED|Overall Study||25||
48370825|NCT04314778|101236542|FG001|COMPLETED|Overall Study||28||
48370826|NCT04314778|101236541|FG000|NOT COMPLETED|Overall Study||5||
48370827|NCT04314778|101236542|FG001|NOT COMPLETED|Overall Study||3||
48370828|NCT03692052|101236543|FG000|STARTED|Core Period (Day 1 to Week 24)||20||
48370829|NCT03692052|101236543|FG000|COMPLETED|Core Period (Day 1 to Week 24)||19||
48370830|NCT03692052|101236543|FG000|NOT COMPLETED|Core Period (Day 1 to Week 24)||1||
48370831|NCT03692052|101236543|FG000|STARTED|Extension Period (Week 25 to 10 Years)||19||
48370832|NCT03692052|101236543|FG000|COMPLETED|Extension Period (Week 25 to 10 Years)||0||
48370833|NCT03692052|101236543|FG000|NOT COMPLETED|Extension Period (Week 25 to 10 Years)||19||
48370834|NCT00291525|101236544|FG000|STARTED|Overall Study||99||
48370835|NCT00291525|101236545|FG001|STARTED|Overall Study||102||
48223998|NCT02063659|100870191|FG001|NOT COMPLETED|Open-Label Extension Period (OLE)||0||
48370836|NCT00291525|101236546|FG002|STARTED|Overall Study||185||
48370837|NCT00291525|101236547|FG003|STARTED|Overall Study||190||
48370838|NCT00291525|101236548|FG004|STARTED|Overall Study||201||
48370839|NCT00291525|101236549|FG005|STARTED|Overall Study||200||
48370840|NCT00291525|101236544|FG000|COMPLETED|Overall Study||19||
48370841|NCT00291525|101236545|FG001|COMPLETED|Overall Study||74||
48370842|NCT00291525|101236546|FG002|COMPLETED|Overall Study||81||
48370843|NCT00291525|101236547|FG003|COMPLETED|Overall Study||112||
48370844|NCT00291525|101236548|FG004|COMPLETED|Overall Study||132||
48370845|NCT00291525|101236549|FG005|COMPLETED|Overall Study||120||
48370846|NCT00291525|101236544|FG000|NOT COMPLETED|Overall Study||80||
48370847|NCT00291525|101236545|FG001|NOT COMPLETED|Overall Study||28||
48370848|NCT00291525|101236546|FG002|NOT COMPLETED|Overall Study||104||
48223999|NCT02063659|100870192|FG002|NOT COMPLETED|Open-Label Extension Period (OLE)||0||
48224000|NCT02063659|100870193|FG003|NOT COMPLETED|Open-Label Extension Period (OLE)||20||
48224001|NCT02111096|100870194|FG000|STARTED|Overall Study||65||
48224002|NCT02111096|100870195|FG001|STARTED|Overall Study||41||
48224003|NCT02111096|100870196|FG002|STARTED|Overall Study||68||
48224004|NCT02111096|100870194|FG000|Received at Least 1 Dose of Study Drug|Overall Study||65||
48224005|NCT02111096|100870195|FG001|Received at Least 1 Dose of Study Drug|Overall Study||41||
48224006|NCT02111096|100870196|FG002|Received at Least 1 Dose of Study Drug|Overall Study||68||
48224007|NCT02111096|100870194|FG000|COMPLETED|Overall Study||1||
48224008|NCT02111096|100870195|FG001|COMPLETED|Overall Study||0||
48224009|NCT02111096|100870196|FG002|COMPLETED|Overall Study||2||
48224010|NCT02111096|100870194|FG000|NOT COMPLETED|Overall Study||64||
48224011|NCT02111096|100870195|FG001|NOT COMPLETED|Overall Study||41||
48224012|NCT02111096|100870196|FG002|NOT COMPLETED|Overall Study||66||
48224013|NCT02091752|100870197|FG000|STARTED|Overall Study||3||
48224014|NCT02091752|100870197|FG000|COMPLETED|Overall Study||0||
48224015|NCT02091752|100870197|FG000|NOT COMPLETED|Overall Study||3||
48224016|NCT02235298|100870198|FG000|STARTED|Overall Study||50||
48224017|NCT02235298|100870199|FG001|STARTED|Overall Study||50||
48224018|NCT02235298|100870198|FG000|COMPLETED|Overall Study||42||
48224019|NCT02235298|100870199|FG001|COMPLETED|Overall Study||42||
48224020|NCT02235298|100870198|FG000|NOT COMPLETED|Overall Study||8||
48224021|NCT02235298|100870199|FG001|NOT COMPLETED|Overall Study||8||
48224022|NCT02739100|100870200|FG000|STARTED|Overall Study||13||
48224023|NCT02739100|100870200|FG000|Triferic 2 Micromolar Via Hemodialysate|Overall Study||13||
48224024|NCT02739100|100870200|FG000|Triferic 6.6 mg IV Predialyzer|Overall Study||13||
48224025|NCT02739100|100870200|FG000|Triferic 6.6. mg IV Post-dialyzer|Overall Study||13||
48224026|NCT02739100|100870200|FG000|COMPLETED|Overall Study||13||
48224027|NCT02739100|100870200|FG000|NOT COMPLETED|Overall Study||0||
48224028|NCT00743574|100870201|FG000|STARTED|Overall Study||36||
48224029|NCT00743574|100870201|FG000|Dropped Out Before Eligibility Testing|Overall Study||13||
48224030|NCT00743574|100870201|FG000|Further Exclusions|Overall Study||8||
48224031|NCT00743574|100870201|FG000|Dropped Out After Initiating Trial|Overall Study||3||
48224032|NCT00743574|100870201|FG000|COMPLETED|Overall Study||12||
48224033|NCT00743574|100870201|FG000|NOT COMPLETED|Overall Study||24||
48224034|NCT03478969|100870202|FG000|STARTED|Overall Study||62|Full Analysis Set|
48224035|NCT03478969|100870203|FG001|STARTED|Overall Study||61|Full Analysis Set|
48224036|NCT03478969|100870204|FG002|STARTED|Overall Study||58|Full Analysis Set|
48224037|NCT03478969|100870202|FG000|Participants at End of Parallel Phase|Overall Study||55|Week 26|
48224038|NCT03478969|100870203|FG001|Participants at End of Parallel Phase|Overall Study||58|Week 26|
48224039|NCT03478969|100870204|FG002|Participants at End of Parallel Phase|Overall Study||52|Week 26|
48224040|NCT03478969|100870202|FG000|COMPLETED|Overall Study||53|Week 39 (End of Solo Phase)|
48224041|NCT03478969|100870203|FG001|COMPLETED|Overall Study||49|Week 39 (End of Solo Phase)|
48224042|NCT03478969|100870204|FG002|COMPLETED|Overall Study||40|Week 39 (End of Solo Phase)|
48224043|NCT03478969|100870202|FG000|NOT COMPLETED|Overall Study||9||
48224044|NCT03478969|100870203|FG001|NOT COMPLETED|Overall Study||12||
48224045|NCT03478969|100870204|FG002|NOT COMPLETED|Overall Study||18||
48224046|NCT03542305|100870205|FG000|STARTED|Overall Study||8||
48224047|NCT03542305|100870206|FG001|STARTED|Overall Study||8||
48224048|NCT03542305|100870207|FG002|STARTED|Overall Study||8||
48224049|NCT03542305|100870208|FG003|STARTED|Overall Study||5||
48224050|NCT03542305|100870205|FG000|COMPLETED|Overall Study||8||
48224051|NCT03542305|100870206|FG001|COMPLETED|Overall Study||8||
48224052|NCT03542305|100870207|FG002|COMPLETED|Overall Study||8||
48224053|NCT03542305|100870208|FG003|COMPLETED|Overall Study||5||
48224054|NCT03542305|100870205|FG000|NOT COMPLETED|Overall Study||0||
48370849|NCT00291525|101236547|FG003|NOT COMPLETED|Overall Study||78||
48370850|NCT00291525|101236548|FG004|NOT COMPLETED|Overall Study||69||
48370851|NCT00291525|101236549|FG005|NOT COMPLETED|Overall Study||80||
48370852|NCT05395351|101236550|FG000|STARTED|Overall Study||3332||
48370853|NCT05395351|101236551|FG001|STARTED|Overall Study||28086||
48370854|NCT05395351|101236552|FG002|STARTED|Overall Study||12533||
48224055|NCT03542305|100870206|FG001|NOT COMPLETED|Overall Study||0||
48224056|NCT03542305|100870207|FG002|NOT COMPLETED|Overall Study||0||
48224057|NCT03542305|100870208|FG003|NOT COMPLETED|Overall Study||0||
48224058|NCT01898754|100870209|FG000|STARTED|Overall Study||494||
48224059|NCT01898754|100870210|FG001|STARTED|Overall Study||497||
48370855|NCT05395351|101236553|FG003|STARTED|Overall Study||69084||
48370856|NCT05395351|101236550|FG000|COMPLETED|Overall Study||3332||
48370857|NCT05395351|101236551|FG001|COMPLETED|Overall Study||28086||
48672116|NCT03014635|101982551|FG000|NOT COMPLETED|Overall Study||13||
48672117|NCT03014635|101982552|FG001|NOT COMPLETED|Overall Study||9||
48672118|NCT02950259|101982553|FG000|STARTED|Overall Study||16||
48224060|NCT01898754|100870209|FG000|COMPLETED|Overall Study||400||
48224061|NCT01898754|100870210|FG001|COMPLETED|Overall Study||403||
48224062|NCT01898754|100870209|FG000|NOT COMPLETED|Overall Study||94||
48224063|NCT01898754|100870210|FG001|NOT COMPLETED|Overall Study||94||
48224064|NCT00933270|100870211|FG000|STARTED|Overall Study||264||
48224065|NCT00933270|100870211|FG000|COMPLETED|Overall Study||177||
48224066|NCT00933270|100870211|FG000|NOT COMPLETED|Overall Study||87||
48224067|NCT03489369|100870212|FG000|STARTED|Overall Study||3||
48224068|NCT03489369|100870213|FG001|STARTED|Overall Study||3||
48224069|NCT03489369|100870214|FG002|STARTED|Overall Study||3||
48224070|NCT03489369|100870215|FG003|STARTED|Overall Study||6||
48224071|NCT03489369|100870212|FG000|COMPLETED|Overall Study||0||
48224072|NCT03489369|100870213|FG001|COMPLETED|Overall Study||0||
48224073|NCT03489369|100870214|FG002|COMPLETED|Overall Study||0||
48224074|NCT03489369|100870215|FG003|COMPLETED|Overall Study||0||
48224075|NCT03489369|100870212|FG000|NOT COMPLETED|Overall Study||3||
48224076|NCT03489369|100870213|FG001|NOT COMPLETED|Overall Study||3||
48224077|NCT03489369|100870214|FG002|NOT COMPLETED|Overall Study||3||
48224078|NCT03489369|100870215|FG003|NOT COMPLETED|Overall Study||6||
48224079|NCT00210106|100870216|FG000|STARTED|Overall Study||52||
48224080|NCT00210106|100870216|FG000|Safety Population|Overall Study||49|safety population is defined as patients who received IRFA treatment with our without resection.|
48224081|NCT00210106|100870216|FG000|COMPLETED|Overall Study||38|Patients eligible (without major protocol deviation) who received the treatment (IRFA +/- surgery) and for whom 2 scans (2 months and 3 months) were available.|
48224082|NCT00210106|100870216|FG000|NOT COMPLETED|Overall Study||14||
48224083|NCT03683576|100870217|FG000|STARTED|Overall Study||120|Randomized and treated. One participant randomized to GB001 40 mg was never treated and was therefore excluded from the Intent-to-Treat (ITT) and Safety Analysis Populations.|
48224084|NCT03683576|100870218|FG001|STARTED|Overall Study||120|Randomized and treated. One participant randomized to GB001 40 mg was never treated and was therefore excluded from the Intent-to-Treat (ITT) and Safety Analysis Populations.|
48224085|NCT03683576|100870219|FG002|STARTED|Overall Study||118|Randomized and treated. One participant randomized to GB001 40 mg was never treated and was therefore excluded from the Intent-to-Treat (ITT) and Safety Analysis Populations.|
48224086|NCT03683576|100870220|FG003|STARTED|Overall Study||122|Randomized and treated. One participant randomized to GB001 40 mg was never treated and was therefore excluded from the Intent-to-Treat (ITT) and Safety Analysis Populations.|
48224087|NCT03683576|100870217|FG000|COMPLETED|Overall Study||114||
48224088|NCT03683576|100870218|FG001|COMPLETED|Overall Study||116||
48224089|NCT03683576|100870219|FG002|COMPLETED|Overall Study||106||
48224090|NCT03683576|100870220|FG003|COMPLETED|Overall Study||114||
48224091|NCT03683576|100870217|FG000|NOT COMPLETED|Overall Study||6||
48224092|NCT03683576|100870218|FG001|NOT COMPLETED|Overall Study||4||
48224093|NCT03683576|100870219|FG002|NOT COMPLETED|Overall Study||12||
48224094|NCT03683576|100870220|FG003|NOT COMPLETED|Overall Study||8||
48224095|NCT01371994|100870221|FG000|STARTED|Overall Study||320||
48224096|NCT01371994|100870222|FG001|STARTED|Overall Study||320||
48224097|NCT01371994|100870221|FG000|Received Treatment|Overall Study||310||
48224098|NCT01371994|100870222|FG001|Received Treatment|Overall Study||313||
48224099|NCT01371994|100870221|FG000|COMPLETED|Overall Study||263||
48224100|NCT01371994|100870222|FG001|COMPLETED|Overall Study||278||
48224101|NCT01371994|100870221|FG000|NOT COMPLETED|Overall Study||57||
48224102|NCT01371994|100870222|FG001|NOT COMPLETED|Overall Study||42||
48224103|NCT03876457|100870223|FG000|STARTED|Overall Study||178||
48224104|NCT03876457|100870224|FG001|STARTED|Overall Study||174||
48224105|NCT03876457|100870223|FG000|COMPLETED|Overall Study||177||
48224106|NCT03876457|100870224|FG001|COMPLETED|Overall Study||171||
48224107|NCT03876457|100870223|FG000|NOT COMPLETED|Overall Study||1||
48224108|NCT03876457|100870224|FG001|NOT COMPLETED|Overall Study||3||
48224109|NCT01410409|100870225|FG000|STARTED|Overall Study||50||
48224110|NCT01410409|100870226|FG001|STARTED|Overall Study||50||
48224111|NCT01410409|100870225|FG000|COMPLETED|Overall Study||49||
48224112|NCT01410409|100870226|FG001|COMPLETED|Overall Study||46||
48224113|NCT01410409|100870225|FG000|NOT COMPLETED|Overall Study||1||
48224114|NCT01410409|100870226|FG001|NOT COMPLETED|Overall Study||4||
48224115|NCT02628106|100870227|FG000|STARTED|Overall Study||21||
48224116|NCT02628106|100870227|FG000|COMPLETED|Overall Study||21||
48224117|NCT02628106|100870227|FG000|NOT COMPLETED|Overall Study||0||
48224118|NCT00822120|100870228|FG000|STARTED|Initial Registration||358||
48224119|NCT00822120|100870229|FG001|STARTED|Initial Registration||13||
48224120|NCT00822120|100870230|FG002|STARTED|Initial Registration||0||
48224121|NCT00822120|100870231|FG003|STARTED|Initial Registration||0||
48224122|NCT00822120|100870232|FG004|STARTED|Initial Registration||0||
48224123|NCT00822120|100870233|FG005|STARTED|Initial Registration||0||
48224124|NCT00822120|100870228|FG000|Eligible and Evaluable Patients|Initial Registration||336||
48224125|NCT00822120|100870229|FG001|Eligible and Evaluable Patients|Initial Registration||12||
48224126|NCT00822120|100870230|FG002|Eligible and Evaluable Patients|Initial Registration||0||
48224127|NCT00822120|100870231|FG003|Eligible and Evaluable Patients|Initial Registration||0||
48224128|NCT00822120|100870232|FG004|Eligible and Evaluable Patients|Initial Registration||0||
48224129|NCT00822120|100870233|FG005|Eligible and Evaluable Patients|Initial Registration||0||
48224130|NCT00822120|100870228|FG000|COMPLETED|Initial Registration||332||
48224131|NCT00822120|100870229|FG001|COMPLETED|Initial Registration||12||
48224132|NCT00822120|100870230|FG002|COMPLETED|Initial Registration||0||
48224133|NCT00822120|100870231|FG003|COMPLETED|Initial Registration||0||
48224134|NCT00822120|100870232|FG004|COMPLETED|Initial Registration||0||
48224135|NCT00822120|100870233|FG005|COMPLETED|Initial Registration||0||
48224136|NCT00822120|100870228|FG000|NOT COMPLETED|Initial Registration||26||
48224137|NCT00822120|100870229|FG001|NOT COMPLETED|Initial Registration||1||
48224138|NCT00822120|100870230|FG002|NOT COMPLETED|Initial Registration||0||
48224139|NCT00822120|100870231|FG003|NOT COMPLETED|Initial Registration||0||
48224140|NCT00822120|100870232|FG004|NOT COMPLETED|Initial Registration||0||
48224141|NCT00822120|100870233|FG005|NOT COMPLETED|Initial Registration||0||
48224142|NCT00822120|100870228|FG000|STARTED|PET-directed Therapy||0||
48224143|NCT00822120|100870229|FG001|STARTED|PET-directed Therapy||0||
48224144|NCT00822120|100870230|FG002|STARTED|PET-directed Therapy||270||
48224145|NCT00822120|100870231|FG003|STARTED|PET-directed Therapy||55||
48224146|NCT00822120|100870232|FG004|STARTED|PET-directed Therapy||10||
48224147|NCT00822120|100870233|FG005|STARTED|PET-directed Therapy||1||
48224148|NCT00822120|100870228|FG000|Eligibile and Evaluable Patients|PET-directed Therapy||0||
48224149|NCT00822120|100870229|FG001|Eligibile and Evaluable Patients|PET-directed Therapy||0||
48224150|NCT00822120|100870230|FG002|Eligibile and Evaluable Patients|PET-directed Therapy||270||
48224151|NCT00822120|100870231|FG003|Eligibile and Evaluable Patients|PET-directed Therapy||55||
48224152|NCT00822120|100870232|FG004|Eligibile and Evaluable Patients|PET-directed Therapy||10||
48224153|NCT00822120|100870233|FG005|Eligibile and Evaluable Patients|PET-directed Therapy||1||
48224154|NCT00822120|100870228|FG000|COMPLETED|PET-directed Therapy||0||
48224155|NCT00822120|100870229|FG001|COMPLETED|PET-directed Therapy||0||
48224156|NCT00822120|100870230|FG002|COMPLETED|PET-directed Therapy||270||
48224157|NCT00822120|100870231|FG003|COMPLETED|PET-directed Therapy||45||
48224158|NCT00822120|100870232|FG004|COMPLETED|PET-directed Therapy||10||
48224159|NCT00822120|100870233|FG005|COMPLETED|PET-directed Therapy||1||
48224160|NCT00822120|100870228|FG000|NOT COMPLETED|PET-directed Therapy||0||
48224161|NCT00822120|100870229|FG001|NOT COMPLETED|PET-directed Therapy||0||
48224162|NCT00822120|100870230|FG002|NOT COMPLETED|PET-directed Therapy||0||
48224163|NCT00822120|100870231|FG003|NOT COMPLETED|PET-directed Therapy||10||
48224164|NCT00822120|100870232|FG004|NOT COMPLETED|PET-directed Therapy||0||
48224165|NCT00822120|100870233|FG005|NOT COMPLETED|PET-directed Therapy||0||
48224166|NCT02330588|100870234|FG000|STARTED|Overall Study||44||
48224167|NCT02330588|100870235|FG001|STARTED|Overall Study||43||
48224168|NCT02330588|100870236|FG002|STARTED|Overall Study||46||
48224169|NCT02330588|100870237|FG003|STARTED|Overall Study||46||
48224170|NCT02330588|100870238|FG004|STARTED|Overall Study||47||
48224171|NCT02330588|100870234|FG000|COMPLETED|Overall Study||28||
48224172|NCT02330588|100870235|FG001|COMPLETED|Overall Study||25||
48224173|NCT02330588|100870236|FG002|COMPLETED|Overall Study||31||
48224174|NCT02330588|100870237|FG003|COMPLETED|Overall Study||24||
48224175|NCT02330588|100870238|FG004|COMPLETED|Overall Study||28||
48224176|NCT02330588|100870234|FG000|NOT COMPLETED|Overall Study||16||
48224177|NCT02330588|100870235|FG001|NOT COMPLETED|Overall Study||18||
48224178|NCT02330588|100870236|FG002|NOT COMPLETED|Overall Study||15||
48224179|NCT02330588|100870237|FG003|NOT COMPLETED|Overall Study||22||
48224180|NCT02330588|100870238|FG004|NOT COMPLETED|Overall Study||19||
48224181|NCT01141075|100870239|FG000|STARTED|Cycle 1||11||
48224182|NCT01141075|100870239|FG000|Received at Least 1 Dose of Study Drug|Cycle 1||11||
48224183|NCT01141075|100870239|FG000|COMPLETED|Cycle 1||11||
48224184|NCT01141075|100870239|FG000|NOT COMPLETED|Cycle 1||0||
48224185|NCT01141075|100870239|FG000|STARTED|Cycle 2||11||
48224186|NCT01141075|100870239|FG000|Received at Least 1 Dose of Study Drug|Cycle 2||11||
48224187|NCT01141075|100870239|FG000|COMPLETED|Cycle 2||11||
48224188|NCT01141075|100870239|FG000|NOT COMPLETED|Cycle 2||0||
48224189|NCT00345046|100870240|FG000|STARTED|Overall Study||18||
48224190|NCT00345046|100870241|FG001|STARTED|Overall Study||22||
48224191|NCT00345046|100870242|FG002|STARTED|Overall Study||16||
48224192|NCT00345046|100870240|FG000|COMPLETED|Overall Study||17||
48224193|NCT00345046|100870241|FG001|COMPLETED|Overall Study||21||
48224194|NCT00345046|100870242|FG002|COMPLETED|Overall Study||14||
48224195|NCT00345046|100870240|FG000|NOT COMPLETED|Overall Study||1||
48224196|NCT00345046|100870241|FG001|NOT COMPLETED|Overall Study||1||
48224197|NCT00345046|100870242|FG002|NOT COMPLETED|Overall Study||2||
48224198|NCT00070317|100870243|FG000|STARTED|Overall Study||102||
48224199|NCT00070317|100870243|FG000|COMPLETED|Overall Study||89||
48224200|NCT00070317|100870243|FG000|NOT COMPLETED|Overall Study||13||
48224201|NCT04860505|100870244|FG000|STARTED|Overall Study||20||
48224202|NCT04860505|100870244|FG000|Attended 24 Hours Post-dose Visit|Overall Study||20||
48224203|NCT04860505|100870244|FG000|COMPLETED|Overall Study||18|Completed 7 days post-dose visit|
48224204|NCT04860505|100870244|FG000|NOT COMPLETED|Overall Study||2||
48224205|NCT01227421|100870245|FG000|STARTED|Overall Study||201||
48224206|NCT01227421|100870246|FG001|STARTED|Overall Study||212||
48224207|NCT01227421|100870247|FG002|STARTED|Overall Study||211||
48224208|NCT01227421|100870245|FG000|COMPLETED|Overall Study||190||
48224209|NCT01227421|100870246|FG001|COMPLETED|Overall Study||194||
48224210|NCT01227421|100870247|FG002|COMPLETED|Overall Study||201||
48224211|NCT01227421|100870245|FG000|NOT COMPLETED|Overall Study||11||
48224212|NCT01227421|100870246|FG001|NOT COMPLETED|Overall Study||18||
48224213|NCT01227421|100870247|FG002|NOT COMPLETED|Overall Study||10||
48224214|NCT00312208|100870248|FG000|STARTED|Overall Study||1649||
48224215|NCT00312208|100870249|FG001|STARTED|Overall Study||1649||
48224216|NCT00312208|100870248|FG000|COMPLETED|Overall Study||1477||
48224217|NCT00312208|100870249|FG001|COMPLETED|Overall Study||1526||
48224218|NCT00312208|100870248|FG000|NOT COMPLETED|Overall Study||172||
48224219|NCT00312208|100870249|FG001|NOT COMPLETED|Overall Study||123||
48224220|NCT01988402|100870250|FG000|STARTED|Overall Study||16||
48224221|NCT01988402|100870251|FG001|STARTED|Overall Study||19||
48224222|NCT01988402|100870250|FG000|COMPLETED|Overall Study||14||
48224223|NCT01988402|100870251|FG001|COMPLETED|Overall Study||17||
48224224|NCT01988402|100870250|FG000|NOT COMPLETED|Overall Study||2||
48224225|NCT01988402|100870251|FG001|NOT COMPLETED|Overall Study||2||
48224226|NCT01898299|100870252|FG000|STARTED|Post Treatment (One Week)||47||
48224227|NCT01898299|100870253|FG001|STARTED|Post Treatment (One Week)||42||
48224228|NCT01898299|100870252|FG000|COMPLETED|Post Treatment (One Week)||47||
48224229|NCT01898299|100870253|FG001|COMPLETED|Post Treatment (One Week)||42||
48224230|NCT01898299|100870252|FG000|NOT COMPLETED|Post Treatment (One Week)||0||
48224231|NCT01898299|100870253|FG001|NOT COMPLETED|Post Treatment (One Week)||0||
48224232|NCT01898299|100870252|FG000|STARTED|Post Treatment (One Month)||47||
48224233|NCT01898299|100870253|FG001|STARTED|Post Treatment (One Month)||42||
48224234|NCT01898299|100870252|FG000|COMPLETED|Post Treatment (One Month)||44||
48224235|NCT01898299|100870253|FG001|COMPLETED|Post Treatment (One Month)||38||
48224236|NCT01898299|100870252|FG000|NOT COMPLETED|Post Treatment (One Month)||3||
48224237|NCT01898299|100870253|FG001|NOT COMPLETED|Post Treatment (One Month)||4||
48224238|NCT02147093|100870254|FG000|STARTED|Period 1||20||
48224239|NCT02147093|100870255|FG001|STARTED|Period 1||20||
48224240|NCT02147093|100870254|FG000|COMPLETED|Period 1||20||
48224241|NCT02147093|100870255|FG001|COMPLETED|Period 1||19||
48224242|NCT02147093|100870254|FG000|NOT COMPLETED|Period 1||0||
48224243|NCT02147093|100870255|FG001|NOT COMPLETED|Period 1||1||
48224244|NCT02147093|100870254|FG000|STARTED|Period 2||20||
48224245|NCT02147093|100870255|FG001|STARTED|Period 2||19||
48224246|NCT02147093|100870254|FG000|COMPLETED|Period 2||18||
48224247|NCT02147093|100870255|FG001|COMPLETED|Period 2||19||
48224248|NCT02147093|100870254|FG000|NOT COMPLETED|Period 2||2||
48224249|NCT02147093|100870255|FG001|NOT COMPLETED|Period 2||0||
48224250|NCT00452452|100870256|FG000|STARTED|Overall Study||90||
48224251|NCT00452452|100870257|FG001|STARTED|Overall Study||112||
48224252|NCT00452452|100870258|FG002|STARTED|Overall Study||153||
48224253|NCT00452452|100870256|FG000|Vaccinated Dose 1|Overall Study||90||
48224254|NCT00452452|100870257|FG001|Vaccinated Dose 1|Overall Study||112||
48224255|NCT00452452|100870258|FG002|Vaccinated Dose 1|Overall Study||152||
48224256|NCT00452452|100870256|FG000|Vaccinated Dose 2|Overall Study||90||
48224257|NCT00452452|100870257|FG001|Vaccinated Dose 2|Overall Study||112||
48224258|NCT00452452|100870258|FG002|Vaccinated Dose 2|Overall Study||0||
48224259|NCT00452452|100870256|FG000|Vaccinated Dose 3|Overall Study||89||
48224260|NCT00452452|100870257|FG001|Vaccinated Dose 3|Overall Study||0||
48224261|NCT00452452|100870258|FG002|Vaccinated Dose 3|Overall Study||0||
48224262|NCT00452452|100870256|FG000|COMPLETED|Overall Study||88||
48224263|NCT00452452|100870257|FG001|COMPLETED|Overall Study||112||
48224264|NCT00452452|100870258|FG002|COMPLETED|Overall Study||152||
48224265|NCT00452452|100870256|FG000|NOT COMPLETED|Overall Study||2||
48224266|NCT00452452|100870257|FG001|NOT COMPLETED|Overall Study||0||
48224267|NCT00452452|100870258|FG002|NOT COMPLETED|Overall Study||1||
48224268|NCT00273052|100870259|FG000|STARTED|Overall Study||290||
48224269|NCT00273052|100870260|FG001|STARTED|Overall Study||278||
48224270|NCT00273052|100870259|FG000|COMPLETED|Overall Study||221||
48224271|NCT00273052|100870260|FG001|COMPLETED|Overall Study||190||
48224272|NCT00273052|100870259|FG000|NOT COMPLETED|Overall Study||69||
48224273|NCT00273052|100870260|FG001|NOT COMPLETED|Overall Study||88||
48224274|NCT00734578|100870261|FG000|STARTED|Overall Study||154||
48224275|NCT00734578|100870262|FG001|STARTED|Overall Study||153||
48224276|NCT00734578|100870263|FG002|STARTED|Overall Study||154||
48224277|NCT00734578|100870261|FG000|COMPLETED|Overall Study||121||
48224278|NCT00734578|100870262|FG001|COMPLETED|Overall Study||128||
48224279|NCT00734578|100870263|FG002|COMPLETED|Overall Study||129||
48224280|NCT00734578|100870261|FG000|NOT COMPLETED|Overall Study||33||
48224281|NCT00734578|100870262|FG001|NOT COMPLETED|Overall Study||25||
48224282|NCT00734578|100870263|FG002|NOT COMPLETED|Overall Study||25||
48224283|NCT02094534|100870264|FG000|STARTED|Overall Study||15||
48224284|NCT02094534|100870265|FG001|STARTED|Overall Study||10||
48224285|NCT02094534|100870264|FG000|COMPLETED|Overall Study||15||
48224286|NCT02094534|100870265|FG001|COMPLETED|Overall Study||10||
48224287|NCT02094534|100870264|FG000|NOT COMPLETED|Overall Study||0||
48224288|NCT02094534|100870265|FG001|NOT COMPLETED|Overall Study||0||
48224289|NCT03274076|100870266|FG000|STARTED|24 Weeks Double Blind||10||
48224290|NCT03274076|100870267|FG001|STARTED|24 Weeks Double Blind||5||
48224291|NCT03274076|100870268|FG002|STARTED|24 Weeks Double Blind||0||
48224292|NCT03274076|100870269|FG003|STARTED|24 Weeks Double Blind||0||
48224293|NCT03274076|100870266|FG000|COMPLETED|24 Weeks Double Blind||10||
48224294|NCT03274076|100870267|FG001|COMPLETED|24 Weeks Double Blind||4||
48224295|NCT03274076|100870268|FG002|COMPLETED|24 Weeks Double Blind||0||
48224296|NCT03274076|100870269|FG003|COMPLETED|24 Weeks Double Blind||0||
48224297|NCT03274076|100870266|FG000|NOT COMPLETED|24 Weeks Double Blind||0||
48224298|NCT03274076|100870267|FG001|NOT COMPLETED|24 Weeks Double Blind||1||
48224299|NCT03274076|100870268|FG002|NOT COMPLETED|24 Weeks Double Blind||0||
48224300|NCT03274076|100870269|FG003|NOT COMPLETED|24 Weeks Double Blind||0||
48224301|NCT03274076|100870266|FG000|STARTED|24 Weeks Open Label||0||
48224302|NCT03274076|100870267|FG001|STARTED|24 Weeks Open Label||0||
48224303|NCT03274076|100870268|FG002|STARTED|24 Weeks Open Label||10||
48224304|NCT03274076|100870269|FG003|STARTED|24 Weeks Open Label||4||
48224305|NCT03274076|100870266|FG000|COMPLETED|24 Weeks Open Label||0||
48224306|NCT03274076|100870267|FG001|COMPLETED|24 Weeks Open Label||0||
48224307|NCT03274076|100870268|FG002|COMPLETED|24 Weeks Open Label||8||
48224308|NCT03274076|100870269|FG003|COMPLETED|24 Weeks Open Label||3||
48224309|NCT03274076|100870266|FG000|NOT COMPLETED|24 Weeks Open Label||0||
48224310|NCT03274076|100870267|FG001|NOT COMPLETED|24 Weeks Open Label||0||
48224311|NCT03274076|100870268|FG002|NOT COMPLETED|24 Weeks Open Label||2||
48224312|NCT03274076|100870269|FG003|NOT COMPLETED|24 Weeks Open Label||1||
48224313|NCT01732120|100870270|FG000|STARTED|Overall Study||40||
48224314|NCT01732120|100870271|FG001|STARTED|Overall Study||40||
48224315|NCT01732120|100870270|FG000|COMPLETED|Overall Study||40||
48224316|NCT01732120|100870271|FG001|COMPLETED|Overall Study||40||
48224317|NCT01732120|100870270|FG000|NOT COMPLETED|Overall Study||0||
48224318|NCT01732120|100870271|FG001|NOT COMPLETED|Overall Study||0||
48224319|NCT02377700|100870272|FG000|STARTED|Overall Study||5||
48224320|NCT02377700|100870272|FG000|COMPLETED|Overall Study||5||
48224321|NCT02377700|100870272|FG000|NOT COMPLETED|Overall Study||0||
48224322|NCT01972776|100870273|FG000|STARTED|Part 1||6||
48224323|NCT01972776|100870274|FG001|STARTED|Part 1||6||
48224324|NCT01972776|100870275|FG002|STARTED|Part 1||8||
48224325|NCT01972776|100870276|FG003|STARTED|Part 1||7||
48224326|NCT01972776|100870277|FG004|STARTED|Part 1||0||
48224327|NCT01972776|100870278|FG005|STARTED|Part 1||0||
48224328|NCT01972776|100870273|FG000|COMPLETED|Part 1||6||
48224329|NCT01972776|100870274|FG001|COMPLETED|Part 1||6||
48224330|NCT01972776|100870275|FG002|COMPLETED|Part 1||6||
48224331|NCT01972776|100870276|FG003|COMPLETED|Part 1||6||
48224332|NCT01972776|100870277|FG004|COMPLETED|Part 1||0||
48224333|NCT01972776|100870278|FG005|COMPLETED|Part 1||0||
48224334|NCT01972776|100870273|FG000|NOT COMPLETED|Part 1||0||
48224335|NCT01972776|100870274|FG001|NOT COMPLETED|Part 1||0||
48224336|NCT01972776|100870275|FG002|NOT COMPLETED|Part 1||2||
48224337|NCT01972776|100870276|FG003|NOT COMPLETED|Part 1||1||
48224338|NCT01972776|100870277|FG004|NOT COMPLETED|Part 1||0||
48224339|NCT01972776|100870278|FG005|NOT COMPLETED|Part 1||0||
48224340|NCT01972776|100870273|FG000|STARTED|Part 2||0||
48224341|NCT01972776|100870274|FG001|STARTED|Part 2||0||
48224342|NCT01972776|100870275|FG002|STARTED|Part 2||0||
48224343|NCT01972776|100870276|FG003|STARTED|Part 2||0||
48224344|NCT01972776|100870277|FG004|STARTED|Part 2||14||
48224345|NCT01972776|100870278|FG005|STARTED|Part 2||7||
48224346|NCT01972776|100870273|FG000|COMPLETED|Part 2||0||
48224347|NCT01972776|100870274|FG001|COMPLETED|Part 2||0||
48224348|NCT01972776|100870275|FG002|COMPLETED|Part 2||0||
48224349|NCT01972776|100870276|FG003|COMPLETED|Part 2||0||
48224350|NCT01972776|100870277|FG004|COMPLETED|Part 2||1||
48224351|NCT01972776|100870278|FG005|COMPLETED|Part 2||0||
48224352|NCT01972776|100870273|FG000|NOT COMPLETED|Part 2||0||
48224353|NCT01972776|100870274|FG001|NOT COMPLETED|Part 2||0||
48224354|NCT01972776|100870275|FG002|NOT COMPLETED|Part 2||0||
48224355|NCT01972776|100870276|FG003|NOT COMPLETED|Part 2||0||
48224356|NCT01972776|100870277|FG004|NOT COMPLETED|Part 2||13||
48224357|NCT01972776|100870278|FG005|NOT COMPLETED|Part 2||7||
48224358|NCT01143142|100870279|FG000|STARTED|Overall Study||36||
48224359|NCT01143142|100870280|FG001|STARTED|Overall Study||34||
48224360|NCT01143142|100870279|FG000|COMPLETED|Overall Study||36||
48224361|NCT01143142|100870280|FG001|COMPLETED|Overall Study||34||
48224362|NCT01143142|100870279|FG000|NOT COMPLETED|Overall Study||0||
48224363|NCT01143142|100870280|FG001|NOT COMPLETED|Overall Study||0||
48224364|NCT02803749|100870281|FG000|STARTED|Overall Study||17||
48224365|NCT02803749|100870282|FG001|STARTED|Overall Study||4||
48224366|NCT02803749|100870281|FG000|COMPLETED|Overall Study||12||
48224367|NCT02803749|100870282|FG001|COMPLETED|Overall Study||4||
48224368|NCT02803749|100870281|FG000|NOT COMPLETED|Overall Study||5||
48224369|NCT02803749|100870282|FG001|NOT COMPLETED|Overall Study||0||
48224370|NCT01640951|100870283|FG000|STARTED|Overall Study||77|All randomized patients (Full Analysis Set and Safety Set)|
48224371|NCT01640951|100870284|FG001|STARTED|Overall Study||75|All randomized patients (Full Analysis Set and Safety Set)|
48224372|NCT01640951|100870285|FG002|STARTED|Overall Study||168|All randomized patients (Full Analysis Set and Safety Set)|
48224373|NCT01640951|100870286|FG003|STARTED|Overall Study||55|All randomized patients (Full Analysis Set and Safety Set)|
48224374|NCT01640951|100870287|FG004|STARTED|Overall Study||95|All randomized patients (Full Analysis Set and Safety Set)|
48224375|NCT01640951|100870288|FG005|STARTED|Overall Study||60|All randomized patients (Full Analysis Set and Safety Set)|
48224376|NCT01640951|100870289|FG006|STARTED|Overall Study||112|All randomized patients (Full Analysis Set and Safety Set)|
48224377|NCT01640951|100870290|FG007|STARTED|Overall Study||33|All randomized patients (Full Analysis Set and Safety Set)|
48224378|NCT01640951|100870283|FG000|COMPLETED|Overall Study||31||
48224379|NCT01640951|100870284|FG001|COMPLETED|Overall Study||60||
48224380|NCT01640951|100870285|FG002|COMPLETED|Overall Study||126||
48224381|NCT01640951|100870286|FG003|COMPLETED|Overall Study||10||
48224382|NCT01640951|100870287|FG004|COMPLETED|Overall Study||82||
48224383|NCT01640951|100870288|FG005|COMPLETED|Overall Study||13||
48224384|NCT01640951|100870289|FG006|COMPLETED|Overall Study||94||
48224385|NCT01640951|100870290|FG007|COMPLETED|Overall Study||17||
48224386|NCT01640951|100870283|FG000|NOT COMPLETED|Overall Study||46||
48224387|NCT01640951|100870284|FG001|NOT COMPLETED|Overall Study||15||
48224388|NCT01640951|100870285|FG002|NOT COMPLETED|Overall Study||42||
48224389|NCT01640951|100870286|FG003|NOT COMPLETED|Overall Study||45||
48224390|NCT01640951|100870287|FG004|NOT COMPLETED|Overall Study||13||
48224391|NCT01640951|100870288|FG005|NOT COMPLETED|Overall Study||47||
48224392|NCT01640951|100870289|FG006|NOT COMPLETED|Overall Study||18||
48224393|NCT01640951|100870290|FG007|NOT COMPLETED|Overall Study||16||
48224394|NCT04492475|100870291|FG000|STARTED|Overall Study||487||
48224395|NCT04492475|100870292|FG001|STARTED|Overall Study||482||
48224396|NCT04492475|100870291|FG000|ITT and Modified ITT Population|Overall Study||487||
48224397|NCT04492475|100870292|FG001|ITT and Modified ITT Population|Overall Study||482||
48224398|NCT04492475|100870291|FG000|As Treated Population|Overall Study||477||
48224399|NCT04492475|100870292|FG001|As Treated Population|Overall Study||468||
48224400|NCT04492475|100870291|FG000|COMPLETED|Overall Study||473||
48224401|NCT04492475|100870292|FG001|COMPLETED|Overall Study||474||
48224402|NCT04492475|100870291|FG000|NOT COMPLETED|Overall Study||14||
48224403|NCT04492475|100870292|FG001|NOT COMPLETED|Overall Study||8||
48224404|NCT02180724|100870293|FG000|STARTED|Overall Study||92||
48224405|NCT02180724|100870294|FG001|STARTED|Overall Study||14||
48224406|NCT02180724|100870293|FG000|200 mg QD|Overall Study||7|In the original protocol, previously treated subjects were planned to be randomized 1:1 into 2 cohorts: Cohort 1 to receive Acala 100 mg BID for 28 days and Cohort 2 to receive Acala 200 mg once daily (QD) for 28 days. After enrollment started, the dose regimen was amended. The 200 mg QD dose was eliminated, and subjects who were enrolled under the original protocol and received treatment with 200 mg QD were switched to 100 mg BID. Results are combined.|
48224407|NCT02180724|100870294|FG001|200 mg QD|Overall Study||1|In the original protocol, previously treated subjects were planned to be randomized 1:1 into 2 cohorts: Cohort 1 to receive Acala 100 mg BID for 28 days and Cohort 2 to receive Acala 200 mg once daily (QD) for 28 days. After enrollment started, the dose regimen was amended. The 200 mg QD dose was eliminated, and subjects who were enrolled under the original protocol and received treatment with 200 mg QD were switched to 100 mg BID. Results are combined.|
48224408|NCT02180724|100870293|FG000|100 mg BID|Overall Study||85|In the original protocol, previously treated subjects were planned to be randomized 1:1 into 2 cohorts: Cohort 1 to receive Acala 100 mg BID for 28 days and Cohort 2 to receive Acala 200 mg once daily (QD) for 28 days. After enrollment started, the dose regimen was amended. The 200 mg QD dose was eliminated, and subjects who were enrolled under the original protocol and received treatment with 200 mg QD were switched to 100 mg BID. Results are combined.|
48224409|NCT02180724|100870294|FG001|100 mg BID|Overall Study||13|In the original protocol, previously treated subjects were planned to be randomized 1:1 into 2 cohorts: Cohort 1 to receive Acala 100 mg BID for 28 days and Cohort 2 to receive Acala 200 mg once daily (QD) for 28 days. After enrollment started, the dose regimen was amended. The 200 mg QD dose was eliminated, and subjects who were enrolled under the original protocol and received treatment with 200 mg QD were switched to 100 mg BID. Results are combined.|
48224410|NCT02180724|100870293|FG000|COMPLETED|Overall Study||0||
48224411|NCT02180724|100870294|FG001|COMPLETED|Overall Study||0||
48224412|NCT02180724|100870293|FG000|NOT COMPLETED|Overall Study||92||
48224413|NCT02180724|100870294|FG001|NOT COMPLETED|Overall Study||14||
48224414|NCT00982072|100870295|FG000|STARTED|Overall Study||25||
48224415|NCT00982072|100870296|FG001|STARTED|Overall Study||27||
48224416|NCT00982072|100870295|FG000|COMPLETED|Overall Study||25||
48224417|NCT00982072|100870296|FG001|COMPLETED|Overall Study||25||
48224418|NCT00982072|100870295|FG000|NOT COMPLETED|Overall Study||0||
48224419|NCT00982072|100870296|FG001|NOT COMPLETED|Overall Study||2||
48224420|NCT02824198|100870297|FG000|STARTED|Overall Study||89||
48224421|NCT02824198|100870298|FG001|STARTED|Overall Study||29||
48224422|NCT02824198|100870297|FG000|COMPLETED|Overall Study||74||
48224423|NCT02824198|100870298|FG001|COMPLETED|Overall Study||26||
48224424|NCT02824198|100870297|FG000|NOT COMPLETED|Overall Study||15||
48224425|NCT02824198|100870298|FG001|NOT COMPLETED|Overall Study||3||
48224426|NCT02404441|100870299|FG000|STARTED|Phase 1 Part||16||
48224427|NCT02404441|100870300|FG001|STARTED|Phase 1 Part||15||
48224428|NCT02404441|100870301|FG002|STARTED|Phase 1 Part||11||
48224429|NCT02404441|100870302|FG003|STARTED|Phase 1 Part||6||
48224430|NCT02404441|100870303|FG004|STARTED|Phase 1 Part||10||
48224431|NCT02404441|100870304|FG005|STARTED|Phase 1 Part||0||
48224432|NCT02404441|100870305|FG006|STARTED|Phase 1 Part||0||
48224433|NCT02404441|100870306|FG007|STARTED|Phase 1 Part||0||
48224434|NCT02404441|100870307|FG008|STARTED|Phase 1 Part||0||
48224435|NCT02404441|100870308|FG009|STARTED|Phase 1 Part||0||
48224436|NCT02404441|100870299|FG000|COMPLETED|Phase 1 Part||0|Completed = Treatment Discontinued|
48224437|NCT02404441|100870300|FG001|COMPLETED|Phase 1 Part||0|Completed = Treatment Discontinued|
48224438|NCT02404441|100870301|FG002|COMPLETED|Phase 1 Part||0|Completed = Treatment Discontinued|
48224439|NCT02404441|100870302|FG003|COMPLETED|Phase 1 Part||0|Completed = Treatment Discontinued|
48224440|NCT02404441|100870303|FG004|COMPLETED|Phase 1 Part||0|Completed = Treatment Discontinued|
48224441|NCT02404441|100870304|FG005|COMPLETED|Phase 1 Part||0|Completed = Treatment Discontinued|
48224442|NCT02404441|100870305|FG006|COMPLETED|Phase 1 Part||0|Completed = Treatment Discontinued|
48224443|NCT02404441|100870306|FG007|COMPLETED|Phase 1 Part||0|Completed = Treatment Discontinued|
48224444|NCT02404441|100870307|FG008|COMPLETED|Phase 1 Part||0|Completed = Treatment Discontinued|
48224445|NCT02404441|100870308|FG009|COMPLETED|Phase 1 Part||0|Completed = Treatment Discontinued|
48224446|NCT02404441|100870299|FG000|NOT COMPLETED|Phase 1 Part||16||
48224447|NCT02404441|100870300|FG001|NOT COMPLETED|Phase 1 Part||15||
48224448|NCT02404441|100870301|FG002|NOT COMPLETED|Phase 1 Part||11||
48224449|NCT02404441|100870302|FG003|NOT COMPLETED|Phase 1 Part||6||
48224450|NCT02404441|100870303|FG004|NOT COMPLETED|Phase 1 Part||10||
48224451|NCT02404441|100870304|FG005|NOT COMPLETED|Phase 1 Part||0||
48224452|NCT02404441|100870305|FG006|NOT COMPLETED|Phase 1 Part||0||
48224453|NCT02404441|100870306|FG007|NOT COMPLETED|Phase 1 Part||0||
48224454|NCT02404441|100870307|FG008|NOT COMPLETED|Phase 1 Part||0||
48224455|NCT02404441|100870308|FG009|NOT COMPLETED|Phase 1 Part||0||
48224456|NCT02404441|100870299|FG000|STARTED|Phase 2 Part||0||
48224457|NCT02404441|100870300|FG001|STARTED|Phase 2 Part||0||
48224458|NCT02404441|100870301|FG002|STARTED|Phase 2 Part||0||
48224459|NCT02404441|100870302|FG003|STARTED|Phase 2 Part||0||
48224460|NCT02404441|100870303|FG004|STARTED|Phase 2 Part||0||
48224461|NCT02404441|100870304|FG005|STARTED|Phase 2 Part||59||
48224462|NCT02404441|100870305|FG006|STARTED|Phase 2 Part||61||
48224463|NCT02404441|100870306|FG007|STARTED|Phase 2 Part||40||
48224464|NCT02404441|100870307|FG008|STARTED|Phase 2 Part||59||
48224465|NCT02404441|100870308|FG009|STARTED|Phase 2 Part||42||
48224466|NCT02404441|100870299|FG000|Entered Post-treatment Follow-up|Phase 2 Part||0||
48224467|NCT02404441|100870300|FG001|Entered Post-treatment Follow-up|Phase 2 Part||0||
48224468|NCT02404441|100870301|FG002|Entered Post-treatment Follow-up|Phase 2 Part||0||
48224469|NCT02404441|100870302|FG003|Entered Post-treatment Follow-up|Phase 2 Part||0||
48224470|NCT02404441|100870303|FG004|Entered Post-treatment Follow-up|Phase 2 Part||0||
48224471|NCT02404441|100870304|FG005|Entered Post-treatment Follow-up|Phase 2 Part||2||
48224472|NCT02404441|100870305|FG006|Entered Post-treatment Follow-up|Phase 2 Part||6||
48224473|NCT02404441|100870306|FG007|Entered Post-treatment Follow-up|Phase 2 Part||1||
48224474|NCT02404441|100870307|FG008|Entered Post-treatment Follow-up|Phase 2 Part||6||
48224475|NCT02404441|100870308|FG009|Entered Post-treatment Follow-up|Phase 2 Part||1||
48224476|NCT02404441|100870299|FG000|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0||
48224477|NCT02404441|100870300|FG001|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0||
48224478|NCT02404441|100870301|FG002|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0||
48224479|NCT02404441|100870302|FG003|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0||
48224480|NCT02404441|100870303|FG004|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0||
48224481|NCT02404441|100870304|FG005|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||2||
48224482|NCT02404441|100870305|FG006|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||6||
48224483|NCT02404441|100870306|FG007|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||1||
48224484|NCT02404441|100870307|FG008|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||6||
48224485|NCT02404441|100870308|FG009|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||1||
48224486|NCT02404441|100870299|FG000|Entered Survival Follow-up|Phase 2 Part||0||
48224487|NCT02404441|100870300|FG001|Entered Survival Follow-up|Phase 2 Part||0||
48224488|NCT02404441|100870301|FG002|Entered Survival Follow-up|Phase 2 Part||0||
48224489|NCT02404441|100870302|FG003|Entered Survival Follow-up|Phase 2 Part||0||
48224490|NCT02404441|100870303|FG004|Entered Survival Follow-up|Phase 2 Part||0||
48224491|NCT02404441|100870304|FG005|Entered Survival Follow-up|Phase 2 Part||38||
48224492|NCT02404441|100870305|FG006|Entered Survival Follow-up|Phase 2 Part||34||
48224493|NCT02404441|100870306|FG007|Entered Survival Follow-up|Phase 2 Part||26||
48224494|NCT02404441|100870307|FG008|Entered Survival Follow-up|Phase 2 Part||35||
48224495|NCT02404441|100870308|FG009|Entered Survival Follow-up|Phase 2 Part||25||
48224496|NCT02404441|100870299|FG000|COMPLETED|Phase 2 Part||0|Completed = Treatment Discontinued|
48224497|NCT02404441|100870300|FG001|COMPLETED|Phase 2 Part||0|Completed = Treatment Discontinued|
48224498|NCT02404441|100870301|FG002|COMPLETED|Phase 2 Part||0|Completed = Treatment Discontinued|
48224499|NCT02404441|100870302|FG003|COMPLETED|Phase 2 Part||0|Completed = Treatment Discontinued|
48224500|NCT02404441|100870303|FG004|COMPLETED|Phase 2 Part||0|Completed = Treatment Discontinued|
48224501|NCT02404441|100870304|FG005|COMPLETED|Phase 2 Part||0|Completed = Treatment Discontinued|
48224502|NCT02404441|100870305|FG006|COMPLETED|Phase 2 Part||0|Completed = Treatment Discontinued|
48224503|NCT02404441|100870306|FG007|COMPLETED|Phase 2 Part||0|Completed = Treatment Discontinued|
48224504|NCT02404441|100870307|FG008|COMPLETED|Phase 2 Part||0|Completed = Treatment Discontinued|
48224505|NCT02404441|100870308|FG009|COMPLETED|Phase 2 Part||0|Completed = Treatment Discontinued|
48224506|NCT02404441|100870299|FG000|NOT COMPLETED|Phase 2 Part||0||
48224507|NCT02404441|100870300|FG001|NOT COMPLETED|Phase 2 Part||0||
48224508|NCT02404441|100870301|FG002|NOT COMPLETED|Phase 2 Part||0||
48224509|NCT02404441|100870302|FG003|NOT COMPLETED|Phase 2 Part||0||
48224510|NCT02404441|100870303|FG004|NOT COMPLETED|Phase 2 Part||0||
48224511|NCT02404441|100870304|FG005|NOT COMPLETED|Phase 2 Part||59||
48224512|NCT02404441|100870305|FG006|NOT COMPLETED|Phase 2 Part||61||
48224513|NCT02404441|100870306|FG007|NOT COMPLETED|Phase 2 Part||40||
48224514|NCT02404441|100870307|FG008|NOT COMPLETED|Phase 2 Part||59||
48224515|NCT02404441|100870308|FG009|NOT COMPLETED|Phase 2 Part||42||
48224516|NCT00463229|100870309|FG000|STARTED|Overall Study||52||
48224517|NCT00463229|100870310|FG001|STARTED|Overall Study||49||
48224518|NCT00463229|100870309|FG000|COMPLETED|Overall Study||43||
48224519|NCT00463229|100870310|FG001|COMPLETED|Overall Study||39||
48224520|NCT00463229|100870309|FG000|NOT COMPLETED|Overall Study||9||
48224521|NCT00463229|100870310|FG001|NOT COMPLETED|Overall Study||10||
48224522|NCT02371395|100870311|FG000|STARTED|Overall Study||1000||
48224523|NCT02371395|100870311|FG000|COMPLETED|Overall Study||1000||
48224524|NCT02371395|100870311|FG000|NOT COMPLETED|Overall Study||0||
48224525|NCT04334317|100870312|FG000|STARTED|Overall Study||26||
48224526|NCT04334317|100870313|FG001|STARTED|Overall Study||28||
48224527|NCT04334317|100870314|FG002|STARTED|Overall Study||2||
48224528|NCT04334317|100870315|FG003|STARTED|Overall Study||8||
48224529|NCT04334317|100870312|FG000|COMPLETED|Overall Study||23||
48224530|NCT04334317|100870313|FG001|COMPLETED|Overall Study||23||
48224531|NCT04334317|100870314|FG002|COMPLETED|Overall Study||2||
48224532|NCT04334317|100870315|FG003|COMPLETED|Overall Study||8||
48224533|NCT04334317|100870312|FG000|NOT COMPLETED|Overall Study||3||
48224534|NCT04334317|100870313|FG001|NOT COMPLETED|Overall Study||5||
48224535|NCT04334317|100870314|FG002|NOT COMPLETED|Overall Study||0||
48224536|NCT04334317|100870315|FG003|NOT COMPLETED|Overall Study||0||
48224537|NCT03567616|100870316|FG000|STARTED|Overall Study||8||
48224538|NCT03567616|100870316|FG000|COMPLETED|Overall Study||0||
48224539|NCT03567616|100870316|FG000|NOT COMPLETED|Overall Study||8||
48224540|NCT02628626|100870317|FG000|STARTED|Overall Study||32||
48224541|NCT02628626|100870318|FG001|STARTED|Overall Study||24||
48224542|NCT02628626|100870317|FG000|COMPLETED|Overall Study||30||
48224543|NCT02628626|100870318|FG001|COMPLETED|Overall Study||22||
48224544|NCT02628626|100870317|FG000|NOT COMPLETED|Overall Study||2||
48224545|NCT02628626|100870318|FG001|NOT COMPLETED|Overall Study||2||
48224546|NCT01617369|100870319|FG000|STARTED|Overall Study||12||
48224547|NCT01617369|100870319|FG000|COMPLETED|Overall Study||12||
48224548|NCT01617369|100870319|FG000|NOT COMPLETED|Overall Study||0||
48224549|NCT01767467|100870320|FG000|STARTED|Vaccination Phase (up to Month 2)||283||
48224550|NCT01767467|100870321|FG001|STARTED|Vaccination Phase (up to Month 2)||279||
48224551|NCT01767467|100870320|FG000|COMPLETED|Vaccination Phase (up to Month 2)||266||
48224552|NCT01767467|100870321|FG001|COMPLETED|Vaccination Phase (up to Month 2)||259||
48224553|NCT01767467|100870320|FG000|NOT COMPLETED|Vaccination Phase (up to Month 2)||17||
48224554|NCT01767467|100870321|FG001|NOT COMPLETED|Vaccination Phase (up to Month 2)||20||
48224555|NCT01767467|100870320|FG000|STARTED|End of Study Phase (up to Month 13)||283||
48224556|NCT01767467|100870321|FG001|STARTED|End of Study Phase (up to Month 13)||279||
48224557|NCT01767467|100870320|FG000|COMPLETED|End of Study Phase (up to Month 13)||236||
48224558|NCT01767467|100870321|FG001|COMPLETED|End of Study Phase (up to Month 13)||216||
48224559|NCT01767467|100870320|FG000|NOT COMPLETED|End of Study Phase (up to Month 13)||47||
48224560|NCT01767467|100870321|FG001|NOT COMPLETED|End of Study Phase (up to Month 13)||63||
48224561|NCT02568215|100870322|FG000|STARTED|Overall Study||637|Enrollment is concurrent with receiving the first infusion (safety analyses)|
48224562|NCT02568215|100870323|FG001|STARTED|Overall Study||642|Enrollment is concurrent with receiving the first infusion (safety analyses)|
48224563|NCT02568215|100870324|FG002|STARTED|Overall Study||645|Enrollment is concurrent with receiving the first infusion (safety analyses)|
48224564|NCT02568215|100870322|FG000|Modified Intent-to-treat Population|Overall Study||637|Participants excluded from MITT if HIV positive at enrollment or randomized/enrolled more than once (efficacy analyses)|
48224565|NCT02568215|100870323|FG001|Modified Intent-to-treat Population|Overall Study||642|Participants excluded from MITT if HIV positive at enrollment or randomized/enrolled more than once (efficacy analyses)|
48224566|NCT02568215|100870324|FG002|Modified Intent-to-treat Population|Overall Study||645|Participants excluded from MITT if HIV positive at enrollment or randomized/enrolled more than once (efficacy analyses)|
48224567|NCT02568215|100870322|FG000|COMPLETED|Overall Study||558||
48224568|NCT02568215|100870323|FG001|COMPLETED|Overall Study||562||
48224569|NCT02568215|100870324|FG002|COMPLETED|Overall Study||555||
48224570|NCT02568215|100870322|FG000|NOT COMPLETED|Overall Study||79||
48224571|NCT02568215|100870323|FG001|NOT COMPLETED|Overall Study||80||
48224572|NCT02568215|100870324|FG002|NOT COMPLETED|Overall Study||90||
48224573|NCT03212638|100870325|FG000|STARTED|Period 1||8||
48224574|NCT03212638|100870326|FG001|STARTED|Period 1||8||
48224575|NCT03212638|100870327|FG002|STARTED|Period 1||8||
48224576|NCT03212638|100870328|FG003|STARTED|Period 1||0||
48224577|NCT03212638|100870329|FG004|STARTED|Period 1||0||
48224578|NCT03212638|100870325|FG000|Received at Least 1 Dose of Study Drug|Period 1||8||
48224579|NCT03212638|100870326|FG001|Received at Least 1 Dose of Study Drug|Period 1||8||
48224580|NCT03212638|100870327|FG002|Received at Least 1 Dose of Study Drug|Period 1||8||
48224581|NCT03212638|100870328|FG003|Received at Least 1 Dose of Study Drug|Period 1||0||
48224582|NCT03212638|100870329|FG004|Received at Least 1 Dose of Study Drug|Period 1||0||
48224583|NCT03212638|100870325|FG000|COMPLETED|Period 1||8||
48224584|NCT03212638|100870326|FG001|COMPLETED|Period 1||8||
48224585|NCT03212638|100870327|FG002|COMPLETED|Period 1||8||
48224586|NCT03212638|100870328|FG003|COMPLETED|Period 1||0||
48224587|NCT03212638|100870329|FG004|COMPLETED|Period 1||0||
48224588|NCT03212638|100870325|FG000|NOT COMPLETED|Period 1||0||
48224589|NCT03212638|100870326|FG001|NOT COMPLETED|Period 1||0||
48224590|NCT03212638|100870327|FG002|NOT COMPLETED|Period 1||0||
48224591|NCT03212638|100870328|FG003|NOT COMPLETED|Period 1||0||
48224592|NCT03212638|100870329|FG004|NOT COMPLETED|Period 1||0||
48224593|NCT03212638|100870325|FG000|STARTED|Period 2||8||
48224594|NCT03212638|100870326|FG001|STARTED|Period 2||8||
48224595|NCT03212638|100870327|FG002|STARTED|Period 2||8||
48224596|NCT03212638|100870328|FG003|STARTED|Period 2||0||
48224597|NCT03212638|100870329|FG004|STARTED|Period 2||0||
48224598|NCT03212638|100870325|FG000|Received at Least 1 Dose of Study Drug|Period 2||8||
48224599|NCT03212638|100870326|FG001|Received at Least 1 Dose of Study Drug|Period 2||8||
48224600|NCT03212638|100870327|FG002|Received at Least 1 Dose of Study Drug|Period 2||8||
48224601|NCT03212638|100870328|FG003|Received at Least 1 Dose of Study Drug|Period 2||0||
48224602|NCT03212638|100870329|FG004|Received at Least 1 Dose of Study Drug|Period 2||0||
48224603|NCT03212638|100870325|FG000|COMPLETED|Period 2||8||
48224604|NCT03212638|100870326|FG001|COMPLETED|Period 2||8||
48224605|NCT03212638|100870327|FG002|COMPLETED|Period 2||8||
48224606|NCT03212638|100870328|FG003|COMPLETED|Period 2||0||
48224607|NCT03212638|100870329|FG004|COMPLETED|Period 2||0||
48224608|NCT03212638|100870325|FG000|NOT COMPLETED|Period 2||0||
48224609|NCT03212638|100870326|FG001|NOT COMPLETED|Period 2||0||
48224610|NCT03212638|100870327|FG002|NOT COMPLETED|Period 2||0||
48224611|NCT03212638|100870328|FG003|NOT COMPLETED|Period 2||0||
48224612|NCT03212638|100870329|FG004|NOT COMPLETED|Period 2||0||
48224613|NCT03212638|100870325|FG000|STARTED|Period 3||8||
48224614|NCT03212638|100870326|FG001|STARTED|Period 3||8||
48224615|NCT03212638|100870327|FG002|STARTED|Period 3||8||
48224616|NCT03212638|100870328|FG003|STARTED|Period 3||0||
48224617|NCT03212638|100870329|FG004|STARTED|Period 3||0||
48224618|NCT03212638|100870325|FG000|Received at Least 1 Dose of Study Drug|Period 3||8||
48224619|NCT03212638|100870326|FG001|Received at Least 1 Dose of Study Drug|Period 3||8||
48224620|NCT03212638|100870327|FG002|Received at Least 1 Dose of Study Drug|Period 3||8||
48224621|NCT03212638|100870328|FG003|Received at Least 1 Dose of Study Drug|Period 3||0||
48224622|NCT03212638|100870329|FG004|Received at Least 1 Dose of Study Drug|Period 3||0||
48224623|NCT03212638|100870325|FG000|COMPLETED|Period 3||8||
48224624|NCT03212638|100870326|FG001|COMPLETED|Period 3||8||
48224625|NCT03212638|100870327|FG002|COMPLETED|Period 3||8||
48224626|NCT03212638|100870328|FG003|COMPLETED|Period 3||0||
48224627|NCT03212638|100870329|FG004|COMPLETED|Period 3||0||
48224628|NCT03212638|100870325|FG000|NOT COMPLETED|Period 3||0||
48224629|NCT03212638|100870326|FG001|NOT COMPLETED|Period 3||0||
48224630|NCT03212638|100870327|FG002|NOT COMPLETED|Period 3||0||
48224631|NCT03212638|100870328|FG003|NOT COMPLETED|Period 3||0||
48224632|NCT03212638|100870329|FG004|NOT COMPLETED|Period 3||0||
48224633|NCT03212638|100870325|FG000|STARTED|Period 4||0||
48224634|NCT03212638|100870326|FG001|STARTED|Period 4||0||
48224635|NCT03212638|100870327|FG002|STARTED|Period 4||0||
48224636|NCT03212638|100870328|FG003|STARTED|Period 4||9||
48224637|NCT03212638|100870329|FG004|STARTED|Period 4||9||
48224638|NCT03212638|100870325|FG000|Received at Least 1 Dose of Study Drug|Period 4||0||
48224639|NCT03212638|100870326|FG001|Received at Least 1 Dose of Study Drug|Period 4||0||
48224640|NCT03212638|100870327|FG002|Received at Least 1 Dose of Study Drug|Period 4||0||
48224641|NCT03212638|100870328|FG003|Received at Least 1 Dose of Study Drug|Period 4||9||
48224642|NCT03212638|100870329|FG004|Received at Least 1 Dose of Study Drug|Period 4||9||
48224643|NCT03212638|100870325|FG000|COMPLETED|Period 4||0||
48224644|NCT03212638|100870326|FG001|COMPLETED|Period 4||0||
48224645|NCT03212638|100870327|FG002|COMPLETED|Period 4||0||
48224646|NCT03212638|100870328|FG003|COMPLETED|Period 4||9||
48224647|NCT03212638|100870329|FG004|COMPLETED|Period 4||9||
48224648|NCT03212638|100870325|FG000|NOT COMPLETED|Period 4||0||
48224649|NCT03212638|100870326|FG001|NOT COMPLETED|Period 4||0||
48224650|NCT03212638|100870327|FG002|NOT COMPLETED|Period 4||0||
48224651|NCT03212638|100870328|FG003|NOT COMPLETED|Period 4||0||
48224652|NCT03212638|100870329|FG004|NOT COMPLETED|Period 4||0||
48224653|NCT03212638|100870325|FG000|STARTED|Period 5||0||
48224654|NCT03212638|100870326|FG001|STARTED|Period 5||0||
48224655|NCT03212638|100870327|FG002|STARTED|Period 5||0||
48224656|NCT03212638|100870328|FG003|STARTED|Period 5||9||
48224657|NCT03212638|100870329|FG004|STARTED|Period 5||9||
48224658|NCT03212638|100870325|FG000|Received at Least 1 Dose of Study Drug|Period 5||0||
48224659|NCT03212638|100870326|FG001|Received at Least 1 Dose of Study Drug|Period 5||0||
48224660|NCT03212638|100870327|FG002|Received at Least 1 Dose of Study Drug|Period 5||0||
48224661|NCT03212638|100870328|FG003|Received at Least 1 Dose of Study Drug|Period 5||9||
48224662|NCT03212638|100870329|FG004|Received at Least 1 Dose of Study Drug|Period 5||9||
48224663|NCT03212638|100870325|FG000|COMPLETED|Period 5||0||
48224664|NCT03212638|100870326|FG001|COMPLETED|Period 5||0||
48224665|NCT03212638|100870327|FG002|COMPLETED|Period 5||0||
48224666|NCT03212638|100870328|FG003|COMPLETED|Period 5||9||
48224667|NCT03212638|100870329|FG004|COMPLETED|Period 5||9||
48224668|NCT03212638|100870325|FG000|NOT COMPLETED|Period 5||0||
48224669|NCT03212638|100870326|FG001|NOT COMPLETED|Period 5||0||
48224670|NCT03212638|100870327|FG002|NOT COMPLETED|Period 5||0||
48224671|NCT03212638|100870328|FG003|NOT COMPLETED|Period 5||0||
48224672|NCT03212638|100870329|FG004|NOT COMPLETED|Period 5||0||
48224673|NCT00779194|100870330|FG000|STARTED|Overall Study||43||
48224674|NCT00779194|100870331|FG001|STARTED|Overall Study||56||
48224675|NCT00779194|100870330|FG000|COMPLETED|Overall Study||29||
48224676|NCT00779194|100870331|FG001|COMPLETED|Overall Study||56||
48224677|NCT00779194|100870330|FG000|NOT COMPLETED|Overall Study||14||
48224678|NCT00779194|100870331|FG001|NOT COMPLETED|Overall Study||0||
48224679|NCT01532999|100870332|FG000|STARTED|Overall Study||96||
48224680|NCT01532999|100870333|FG001|STARTED|Overall Study||95||
48224681|NCT01532999|100870332|FG000|COMPLETED|Overall Study||65||
48224682|NCT01532999|100870333|FG001|COMPLETED|Overall Study||77||
48224683|NCT01532999|100870332|FG000|NOT COMPLETED|Overall Study||31||
48224684|NCT01532999|100870333|FG001|NOT COMPLETED|Overall Study||18||
48224685|NCT05184062|100873657|FG000|STARTED|Overall Study||202||
48224686|NCT05184062|100873658|FG001|STARTED|Overall Study||70||
48224687|NCT05184062|100873657|FG000|COMPLETED|Overall Study||196||
48224688|NCT05184062|100873658|FG001|COMPLETED|Overall Study||69||
48224689|NCT05184062|100873657|FG000|NOT COMPLETED|Overall Study||6||
48224690|NCT05184062|100873658|FG001|NOT COMPLETED|Overall Study||1||
48224691|NCT01478594|100873659|FG000|STARTED|Overall Study||177||
48224692|NCT01478594|100873660|FG001|STARTED|Overall Study||88||
48224693|NCT01478594|100873659|FG000|Treated|Overall Study||177||
48224694|NCT01478594|100873660|FG001|Treated|Overall Study||87||
48224695|NCT01478594|100873659|FG000|COMPLETED|Overall Study||112||
48224696|NCT01478594|100873660|FG001|COMPLETED|Overall Study||60||
48224697|NCT01478594|100873659|FG000|NOT COMPLETED|Overall Study||65||
48224698|NCT01478594|100873660|FG001|NOT COMPLETED|Overall Study||28||
48224699|NCT02561195|100873661|FG000|STARTED|Vaccination 1 to 3||183||
48224700|NCT02561195|100873662|FG001|STARTED|Vaccination 1 to 3||184||
48224701|NCT02561195|100873663|FG002|STARTED|Vaccination 1 to 3||61||
48224702|NCT02561195|100873664|FG003|STARTED|Vaccination 1 to 3||183||
48224703|NCT02561195|100873665|FG004|STARTED|Vaccination 1 to 3||183||
48224704|NCT02561195|100873666|FG005|STARTED|Vaccination 1 to 3||61||
48224705|NCT02561195|100873667|FG006|STARTED|Vaccination 1 to 3||0||
48224706|NCT02561195|100873668|FG007|STARTED|Vaccination 1 to 3||0||
48224707|NCT02561195|100873669|FG008|STARTED|Vaccination 1 to 3||0||
48224708|NCT02561195|100873670|FG009|STARTED|Vaccination 1 to 3||0||
48224709|NCT02561195|100873671|FG010|STARTED|Vaccination 1 to 3||0||
48224710|NCT02561195|100873672|FG011|STARTED|Vaccination 1 to 3||0||
48224711|NCT02561195|100873673|FG012|STARTED|Vaccination 1 to 3||0||
48224712|NCT02561195|100873674|FG013|STARTED|Vaccination 1 to 3||0||
48224713|NCT02561195|100873661|FG000|Treated|Vaccination 1 to 3||182||
48224714|NCT02561195|100873662|FG001|Treated|Vaccination 1 to 3||184||
48224715|NCT02561195|100873663|FG002|Treated|Vaccination 1 to 3||61||
48224716|NCT02561195|100873664|FG003|Treated|Vaccination 1 to 3||183||
48224717|NCT02561195|100873665|FG004|Treated|Vaccination 1 to 3||183||
48224718|NCT02561195|100873666|FG005|Treated|Vaccination 1 to 3||61||
48224719|NCT02561195|100873667|FG006|Treated|Vaccination 1 to 3||0||
48224720|NCT02561195|100873668|FG007|Treated|Vaccination 1 to 3||0||
48224721|NCT02561195|100873669|FG008|Treated|Vaccination 1 to 3||0||
48224722|NCT02561195|100873670|FG009|Treated|Vaccination 1 to 3||0||
48224723|NCT02561195|100873671|FG010|Treated|Vaccination 1 to 3||0||
48224724|NCT02561195|100873672|FG011|Treated|Vaccination 1 to 3||0||
48224725|NCT02561195|100873673|FG012|Treated|Vaccination 1 to 3||0||
48224726|NCT02561195|100873674|FG013|Treated|Vaccination 1 to 3||0||
48224727|NCT02561195|100873661|FG000|COMPLETED|Vaccination 1 to 3||160||
48224728|NCT02561195|100873662|FG001|COMPLETED|Vaccination 1 to 3||162||
48224729|NCT02561195|100873663|FG002|COMPLETED|Vaccination 1 to 3||55||
48224730|NCT02561195|100873664|FG003|COMPLETED|Vaccination 1 to 3||157||
48224731|NCT02561195|100873665|FG004|COMPLETED|Vaccination 1 to 3||155||
48224732|NCT02561195|100873666|FG005|COMPLETED|Vaccination 1 to 3||51||
48224733|NCT02561195|100873667|FG006|COMPLETED|Vaccination 1 to 3||0||
48224734|NCT02561195|100873668|FG007|COMPLETED|Vaccination 1 to 3||0||
48224735|NCT02561195|100873669|FG008|COMPLETED|Vaccination 1 to 3||0||
48224736|NCT02561195|100873670|FG009|COMPLETED|Vaccination 1 to 3||0||
48224737|NCT02561195|100873671|FG010|COMPLETED|Vaccination 1 to 3||0||
48224738|NCT02561195|100873672|FG011|COMPLETED|Vaccination 1 to 3||0||
48224739|NCT02561195|100873673|FG012|COMPLETED|Vaccination 1 to 3||0||
48224740|NCT02561195|100873674|FG013|COMPLETED|Vaccination 1 to 3||0||
48224741|NCT02561195|100873661|FG000|NOT COMPLETED|Vaccination 1 to 3||23||
48224742|NCT02561195|100873662|FG001|NOT COMPLETED|Vaccination 1 to 3||22||
48224743|NCT02561195|100873663|FG002|NOT COMPLETED|Vaccination 1 to 3||6||
48224744|NCT02561195|100873664|FG003|NOT COMPLETED|Vaccination 1 to 3||26||
48224745|NCT02561195|100873665|FG004|NOT COMPLETED|Vaccination 1 to 3||28||
48224746|NCT02561195|100873666|FG005|NOT COMPLETED|Vaccination 1 to 3||10||
48224747|NCT02561195|100873667|FG006|NOT COMPLETED|Vaccination 1 to 3||0||
48224748|NCT02561195|100873668|FG007|NOT COMPLETED|Vaccination 1 to 3||0||
48224749|NCT02561195|100873669|FG008|NOT COMPLETED|Vaccination 1 to 3||0||
48224750|NCT02561195|100873670|FG009|NOT COMPLETED|Vaccination 1 to 3||0||
48224751|NCT02561195|100873671|FG010|NOT COMPLETED|Vaccination 1 to 3||0||
48224752|NCT02561195|100873672|FG011|NOT COMPLETED|Vaccination 1 to 3||0||
48224753|NCT02561195|100873673|FG012|NOT COMPLETED|Vaccination 1 to 3||0||
48224754|NCT02561195|100873674|FG013|NOT COMPLETED|Vaccination 1 to 3||0||
48224755|NCT02561195|100873661|FG000|STARTED|Extension Stage (Vaccination 4)||0||
48224756|NCT02561195|100873662|FG001|STARTED|Extension Stage (Vaccination 4)||0||
48224757|NCT02561195|100873663|FG002|STARTED|Extension Stage (Vaccination 4)||0||
48224758|NCT02561195|100873664|FG003|STARTED|Extension Stage (Vaccination 4)||0||
48224759|NCT02561195|100873665|FG004|STARTED|Extension Stage (Vaccination 4)||0||
48224760|NCT02561195|100873666|FG005|STARTED|Extension Stage (Vaccination 4)||0||
48224761|NCT02561195|100873667|FG006|STARTED|Extension Stage (Vaccination 4)||16||
48224762|NCT02561195|100873668|FG007|STARTED|Extension Stage (Vaccination 4)||18||
48224763|NCT02561195|100873669|FG008|STARTED|Extension Stage (Vaccination 4)||24||
48224764|NCT02561195|100873670|FG009|STARTED|Extension Stage (Vaccination 4)||22||
48224765|NCT02561195|100873671|FG010|STARTED|Extension Stage (Vaccination 4)||51||
48224766|NCT02561195|100873672|FG011|STARTED|Extension Stage (Vaccination 4)||52||
48224767|NCT02561195|100873673|FG012|STARTED|Extension Stage (Vaccination 4)||58||
48224768|NCT02561195|100873674|FG013|STARTED|Extension Stage (Vaccination 4)||59||
48224769|NCT02561195|100873661|FG000|COMPLETED|Extension Stage (Vaccination 4)||0||
48224770|NCT02561195|100873662|FG001|COMPLETED|Extension Stage (Vaccination 4)||0||
48224771|NCT02561195|100873663|FG002|COMPLETED|Extension Stage (Vaccination 4)||0||
48224772|NCT02561195|100873664|FG003|COMPLETED|Extension Stage (Vaccination 4)||0||
48224773|NCT02561195|100873665|FG004|COMPLETED|Extension Stage (Vaccination 4)||0||
48224774|NCT02561195|100873666|FG005|COMPLETED|Extension Stage (Vaccination 4)||0||
48224775|NCT02561195|100873667|FG006|COMPLETED|Extension Stage (Vaccination 4)||14||
48224776|NCT02561195|100873668|FG007|COMPLETED|Extension Stage (Vaccination 4)||17||
48224777|NCT02561195|100873669|FG008|COMPLETED|Extension Stage (Vaccination 4)||21||
48224778|NCT02561195|100873670|FG009|COMPLETED|Extension Stage (Vaccination 4)||20||
48224779|NCT02561195|100873671|FG010|COMPLETED|Extension Stage (Vaccination 4)||43||
48224780|NCT02561195|100873672|FG011|COMPLETED|Extension Stage (Vaccination 4)||45||
48224781|NCT02561195|100873673|FG012|COMPLETED|Extension Stage (Vaccination 4)||51||
48224782|NCT02561195|100873674|FG013|COMPLETED|Extension Stage (Vaccination 4)||54||
48224783|NCT02561195|100873661|FG000|NOT COMPLETED|Extension Stage (Vaccination 4)||0||
48224784|NCT02561195|100873662|FG001|NOT COMPLETED|Extension Stage (Vaccination 4)||0||
48224785|NCT02561195|100873663|FG002|NOT COMPLETED|Extension Stage (Vaccination 4)||0||
48224786|NCT02561195|100873664|FG003|NOT COMPLETED|Extension Stage (Vaccination 4)||0||
48224787|NCT02561195|100873665|FG004|NOT COMPLETED|Extension Stage (Vaccination 4)||0||
48224788|NCT02561195|100873666|FG005|NOT COMPLETED|Extension Stage (Vaccination 4)||0||
48224789|NCT02561195|100873667|FG006|NOT COMPLETED|Extension Stage (Vaccination 4)||2||
48224790|NCT02561195|100873668|FG007|NOT COMPLETED|Extension Stage (Vaccination 4)||1||
48224791|NCT02561195|100873669|FG008|NOT COMPLETED|Extension Stage (Vaccination 4)||3||
48224792|NCT02561195|100873670|FG009|NOT COMPLETED|Extension Stage (Vaccination 4)||2||
48224793|NCT02561195|100873671|FG010|NOT COMPLETED|Extension Stage (Vaccination 4)||8||
48224794|NCT02561195|100873672|FG011|NOT COMPLETED|Extension Stage (Vaccination 4)||7||
48224795|NCT02561195|100873673|FG012|NOT COMPLETED|Extension Stage (Vaccination 4)||7||
48224796|NCT02561195|100873674|FG013|NOT COMPLETED|Extension Stage (Vaccination 4)||5||
48224797|NCT02195232|100873675|FG000|STARTED|Overall Study||32||
48224798|NCT02195232|100873676|FG001|STARTED|Overall Study||32||
48224799|NCT02195232|100873675|FG000|COMPLETED|Overall Study||28||
48224800|NCT02195232|100873676|FG001|COMPLETED|Overall Study||29||
48224801|NCT02195232|100873675|FG000|NOT COMPLETED|Overall Study||4||
48224802|NCT02195232|100873676|FG001|NOT COMPLETED|Overall Study||3||
48224803|NCT03041233|100873677|FG000|STARTED|Overall Study||833||
48224804|NCT03041233|100873677|FG000|Procedure|Overall Study||829||
48224805|NCT03041233|100873677|FG000|6-month Follow-up|Overall Study||803||
48224806|NCT03041233|100873677|FG000|12-month Follow-up|Overall Study||705||
48224807|NCT03041233|100873677|FG000|COMPLETED|Overall Study||801||
48224808|NCT03041233|100873677|FG000|NOT COMPLETED|Overall Study||32||
48224809|NCT00739934|100873678|FG000|STARTED|Voriconazole IV||40||
48224810|NCT00739934|100873678|FG000|COMPLETED|Voriconazole IV||34||
48224811|NCT00739934|100873678|FG000|NOT COMPLETED|Voriconazole IV||6||
48224812|NCT00739934|100873678|FG000|STARTED|Voriconazole Oral||34||
48224813|NCT00739934|100873678|FG000|COMPLETED|Voriconazole Oral||31||
48224814|NCT00739934|100873678|FG000|NOT COMPLETED|Voriconazole Oral||3||
48224815|NCT04456413|100873679|FG000|STARTED|Overall Study||10||
48224816|NCT04456413|100873680|FG001|STARTED|Overall Study||11||
48224817|NCT04456413|100873679|FG000|COMPLETED|Overall Study||10||
48224818|NCT04456413|100873680|FG001|COMPLETED|Overall Study||11||
48672119|NCT02950259|101982554|FG001|STARTED|Overall Study||0||
48224819|NCT04456413|100873679|FG000|NOT COMPLETED|Overall Study||0||
48224820|NCT04456413|100873680|FG001|NOT COMPLETED|Overall Study||0||
48224821|NCT01214759|100873681|FG000|STARTED|Overall Study||103||
48224822|NCT01214759|100873681|FG000|28 Days nPEP Completion|Overall Study||85||
48672120|NCT02950259|101982553|FG000|COMPLETED|Overall Study||16||
48224823|NCT01214759|100873681|FG000|COMPLETED|Overall Study||55||
48224824|NCT01214759|100873681|FG000|NOT COMPLETED|Overall Study||48||
48224825|NCT00326196|100873682|FG000|STARTED|Overall Study||101||
48224826|NCT00326196|100873683|FG001|STARTED|Overall Study||97||
48224827|NCT00326196|100873682|FG000|COMPLETED|Overall Study||101||
48224828|NCT00326196|100873683|FG001|COMPLETED|Overall Study||97||
48224829|NCT00326196|100873682|FG000|NOT COMPLETED|Overall Study||0||
48224830|NCT00326196|100873683|FG001|NOT COMPLETED|Overall Study||0||
48224831|NCT01915914|100873684|FG000|STARTED|Acute Phase||123||
48224832|NCT01915914|100873685|FG001|STARTED|Acute Phase||0||
48224833|NCT01915914|100873686|FG002|STARTED|Acute Phase||0||
48224834|NCT01915914|100873687|FG003|STARTED|Acute Phase||0||
48224835|NCT01915914|100873684|FG000|Completed-Not Entered Maintenance Phase|Acute Phase||4||
48224836|NCT01915914|100873685|FG001|Completed-Not Entered Maintenance Phase|Acute Phase||0||
48224837|NCT01915914|100873686|FG002|Completed-Not Entered Maintenance Phase|Acute Phase||0||
48224838|NCT01915914|100873687|FG003|Completed-Not Entered Maintenance Phase|Acute Phase||0||
48224839|NCT01915914|100873684|FG000|COMPLETED|Acute Phase||111||
48224840|NCT01915914|100873685|FG001|COMPLETED|Acute Phase||0||
48224841|NCT01915914|100873686|FG002|COMPLETED|Acute Phase||0||
48224842|NCT01915914|100873687|FG003|COMPLETED|Acute Phase||0||
48224843|NCT01915914|100873684|FG000|NOT COMPLETED|Acute Phase||12||
48224844|NCT01915914|100873685|FG001|NOT COMPLETED|Acute Phase||0||
48224845|NCT01915914|100873686|FG002|NOT COMPLETED|Acute Phase||0||
48224846|NCT01915914|100873687|FG003|NOT COMPLETED|Acute Phase||0||
48224847|NCT01915914|100873684|FG000|STARTED|Maintenance Phase||0||
48224848|NCT01915914|100873685|FG001|STARTED|Maintenance Phase||54||
48224849|NCT01915914|100873686|FG002|STARTED|Maintenance Phase||53||
48224850|NCT01915914|100873687|FG003|STARTED|Maintenance Phase||0||
48224851|NCT01915914|100873684|FG000|COMPLETED|Maintenance Phase||0||
48224852|NCT01915914|100873685|FG001|COMPLETED|Maintenance Phase||48||
48224853|NCT01915914|100873686|FG002|COMPLETED|Maintenance Phase||51||
48224854|NCT01915914|100873687|FG003|COMPLETED|Maintenance Phase||0||
48224855|NCT01915914|100873684|FG000|NOT COMPLETED|Maintenance Phase||0||
48224856|NCT01915914|100873685|FG001|NOT COMPLETED|Maintenance Phase||6||
48224857|NCT01915914|100873686|FG002|NOT COMPLETED|Maintenance Phase||2||
48224858|NCT01915914|100873687|FG003|NOT COMPLETED|Maintenance Phase||0||
48224859|NCT01915914|100873684|FG000|STARTED|Follow-up Phase||0||
48224860|NCT01915914|100873685|FG001|STARTED|Follow-up Phase||0||
48224861|NCT01915914|100873686|FG002|STARTED|Follow-up Phase||0||
48224862|NCT01915914|100873687|FG003|STARTED|Follow-up Phase||66||
48224863|NCT01915914|100873684|FG000|COMPLETED|Follow-up Phase||0||
48224864|NCT01915914|100873685|FG001|COMPLETED|Follow-up Phase||0||
48224865|NCT01915914|100873686|FG002|COMPLETED|Follow-up Phase||0||
48224866|NCT01915914|100873687|FG003|COMPLETED|Follow-up Phase||64||
48224867|NCT01915914|100873684|FG000|NOT COMPLETED|Follow-up Phase||0||
48224868|NCT01915914|100873685|FG001|NOT COMPLETED|Follow-up Phase||0||
48224869|NCT01915914|100873686|FG002|NOT COMPLETED|Follow-up Phase||0||
48224870|NCT01915914|100873687|FG003|NOT COMPLETED|Follow-up Phase||2||
48224871|NCT00753545|100873688|FG000|STARTED|Overall Study||136||
48224872|NCT00753545|100873689|FG001|STARTED|Overall Study||129||
48224873|NCT00753545|100873688|FG000|COMPLETED|Overall Study||28||
48224874|NCT00753545|100873689|FG001|COMPLETED|Overall Study||11||
48224875|NCT00753545|100873688|FG000|NOT COMPLETED|Overall Study||108||
48224876|NCT00753545|100873689|FG001|NOT COMPLETED|Overall Study||118||
48224877|NCT02397707|100873690|FG000|STARTED|Overall Study||14||
48224878|NCT02397707|100873691|FG001|STARTED|Overall Study||10||
48224879|NCT02397707|100873692|FG002|STARTED|Overall Study||9||
48224880|NCT02397707|100873690|FG000|COMPLETED|Overall Study||14||
48224881|NCT02397707|100873691|FG001|COMPLETED|Overall Study||10||
48224882|NCT02397707|100873692|FG002|COMPLETED|Overall Study||9||
48224883|NCT02397707|100873690|FG000|NOT COMPLETED|Overall Study||0||
48224884|NCT02397707|100873691|FG001|NOT COMPLETED|Overall Study||0||
48224885|NCT02397707|100873692|FG002|NOT COMPLETED|Overall Study||0||
48224886|NCT04250636|100873693|FG000|STARTED|Overall Study||6||
48224887|NCT04250636|100873693|FG000|COMPLETED|Overall Study||4||
48224888|NCT04250636|100873693|FG000|NOT COMPLETED|Overall Study||2||
48224889|NCT04097535|100873694|FG000|STARTED|Overall Study||11||
48224890|NCT04097535|100873694|FG000|COMPLETED|Overall Study||10||
48224891|NCT04097535|100873694|FG000|NOT COMPLETED|Overall Study||1||
48224892|NCT03451422|100873695|FG000|STARTED|Overall Study||10||
48224893|NCT03451422|100873696|FG001|STARTED|Overall Study||5||
48224894|NCT03451422|100873697|FG002|STARTED|Overall Study||5||
48224895|NCT03451422|100873698|FG003|STARTED|Overall Study||7||
48224896|NCT03451422|100873699|FG004|STARTED|Overall Study||4||
48224897|NCT03451422|100873700|FG005|STARTED|Overall Study||4||
48224898|NCT03451422|100873695|FG000|COMPLETED|Overall Study||9||
48224899|NCT03451422|100873696|FG001|COMPLETED|Overall Study||5||
48224900|NCT03451422|100873697|FG002|COMPLETED|Overall Study||2||
48224901|NCT03451422|100873698|FG003|COMPLETED|Overall Study||4||
48224902|NCT03451422|100873699|FG004|COMPLETED|Overall Study||2||
48224903|NCT03451422|100873700|FG005|COMPLETED|Overall Study||2||
48224904|NCT03451422|100873695|FG000|NOT COMPLETED|Overall Study||1||
48224905|NCT03451422|100873696|FG001|NOT COMPLETED|Overall Study||0||
48224906|NCT03451422|100873697|FG002|NOT COMPLETED|Overall Study||3||
48224907|NCT03451422|100873698|FG003|NOT COMPLETED|Overall Study||3||
48224908|NCT03451422|100873699|FG004|NOT COMPLETED|Overall Study||2||
48224909|NCT03451422|100873700|FG005|NOT COMPLETED|Overall Study||2||
48224910|NCT02079649|100873701|FG000|STARTED|Overall Study||42||
48224911|NCT02079649|100873702|FG001|STARTED|Overall Study||41||
48224912|NCT02079649|100873703|FG002|STARTED|Overall Study||41||
48224913|NCT02079649|100873704|FG003|STARTED|Overall Study||40||
48224914|NCT02079649|100873701|FG000|Treated|Overall Study||41||
48224915|NCT02079649|100873702|FG001|Treated|Overall Study||41||
48224916|NCT02079649|100873703|FG002|Treated|Overall Study||40||
48224917|NCT02079649|100873704|FG003|Treated|Overall Study||40||
48224918|NCT02079649|100873701|FG000|COMPLETED|Overall Study||41||
48224919|NCT02079649|100873702|FG001|COMPLETED|Overall Study||41||
48224920|NCT02079649|100873703|FG002|COMPLETED|Overall Study||40||
48224921|NCT02079649|100873704|FG003|COMPLETED|Overall Study||38||
48224922|NCT02079649|100873701|FG000|NOT COMPLETED|Overall Study||1||
48224923|NCT02079649|100873702|FG001|NOT COMPLETED|Overall Study||0||
48224924|NCT02079649|100873703|FG002|NOT COMPLETED|Overall Study||1||
48224925|NCT02079649|100873704|FG003|NOT COMPLETED|Overall Study||2||
48224926|NCT03875313|100873705|FG000|STARTED|Overall Study||3||
48224927|NCT03875313|100873706|FG001|STARTED|Overall Study||16||
48224928|NCT03875313|100873707|FG002|STARTED|Overall Study||6||
48224929|NCT03875313|100873708|FG003|STARTED|Overall Study||4||
48224930|NCT03875313|100873709|FG004|STARTED|Overall Study||4||
48224931|NCT03875313|100873705|FG000|COMPLETED|Overall Study||0|"All participants discontinued the study, and none entered survival follow up. Reason Not Completed presents the reasons for study discontinuation."|
48224932|NCT03875313|100873706|FG001|COMPLETED|Overall Study||0|"All participants discontinued the study, and none entered survival follow up. Reason Not Completed presents the reasons for study discontinuation."|
48224933|NCT03875313|100873707|FG002|COMPLETED|Overall Study||0|"All participants discontinued the study, and none entered survival follow up. Reason Not Completed presents the reasons for study discontinuation."|
48224934|NCT03875313|100873708|FG003|COMPLETED|Overall Study||0|"All participants discontinued the study, and none entered survival follow up. Reason Not Completed presents the reasons for study discontinuation."|
48224935|NCT03875313|100873709|FG004|COMPLETED|Overall Study||0|"All participants discontinued the study, and none entered survival follow up. Reason Not Completed presents the reasons for study discontinuation."|
48224936|NCT03875313|100873705|FG000|NOT COMPLETED|Overall Study||3||
48224937|NCT03875313|100873706|FG001|NOT COMPLETED|Overall Study||16||
48224938|NCT03875313|100873707|FG002|NOT COMPLETED|Overall Study||6||
48224939|NCT03875313|100873708|FG003|NOT COMPLETED|Overall Study||4||
48224940|NCT03875313|100873709|FG004|NOT COMPLETED|Overall Study||4||
48224941|NCT01566890|100873710|FG000|STARTED|Overall Study||32||
48224942|NCT01566890|100873711|FG001|STARTED|Overall Study||10||
48224943|NCT01566890|100873712|FG002|STARTED|Overall Study||21||
48224944|NCT01566890|100873713|FG003|STARTED|Overall Study||21||
48224945|NCT01566890|100873714|FG004|STARTED|Overall Study||7||
48224946|NCT01566890|100873710|FG000|COMPLETED|Overall Study||21||
48224947|NCT01566890|100873711|FG001|COMPLETED|Overall Study||6||
48224948|NCT01566890|100873712|FG002|COMPLETED|Overall Study||10||
48224949|NCT01566890|100873713|FG003|COMPLETED|Overall Study||7||
48224950|NCT01566890|100873714|FG004|COMPLETED|Overall Study||0||
48224951|NCT01566890|100873710|FG000|NOT COMPLETED|Overall Study||11||
48224952|NCT01566890|100873711|FG001|NOT COMPLETED|Overall Study||4||
48224953|NCT01566890|100873712|FG002|NOT COMPLETED|Overall Study||11||
48224954|NCT01566890|100873713|FG003|NOT COMPLETED|Overall Study||14||
48224955|NCT01566890|100873714|FG004|NOT COMPLETED|Overall Study||7||
48224956|NCT01500200|100873715|FG000|STARTED|Stage 1||98||
48224957|NCT01500200|100873716|FG001|STARTED|Stage 1||24||
48224958|NCT01500200|100873717|FG002|STARTED|Stage 1||19||
48224959|NCT01500200|100873718|FG003|STARTED|Stage 1||0||
48224960|NCT01500200|100873719|FG004|STARTED|Stage 1||0||
48224961|NCT01500200|100873720|FG005|STARTED|Stage 1||0||
48224962|NCT01500200|100873715|FG000|COMPLETED|Stage 1||90||
48224963|NCT01500200|100873716|FG001|COMPLETED|Stage 1||18||
48224964|NCT01500200|100873717|FG002|COMPLETED|Stage 1||13||
48224965|NCT01500200|100873718|FG003|COMPLETED|Stage 1||0||
48224966|NCT01500200|100873719|FG004|COMPLETED|Stage 1||0||
48224967|NCT01500200|100873720|FG005|COMPLETED|Stage 1||0||
48224968|NCT01500200|100873715|FG000|NOT COMPLETED|Stage 1||8||
48224969|NCT01500200|100873716|FG001|NOT COMPLETED|Stage 1||6||
48224970|NCT01500200|100873717|FG002|NOT COMPLETED|Stage 1||6||
48224971|NCT01500200|100873718|FG003|NOT COMPLETED|Stage 1||0||
48224972|NCT01500200|100873719|FG004|NOT COMPLETED|Stage 1||0||
48224973|NCT01500200|100873720|FG005|NOT COMPLETED|Stage 1||0||
48224974|NCT01500200|100873715|FG000|STARTED|Stage 2||0|Subjects in Stage 2 are a subset of those randomized to placebo in Stage 1.|
48224975|NCT01500200|100873716|FG001|STARTED|Stage 2||0|Subjects in Stage 2 are a subset of those randomized to placebo in Stage 1.|
48224976|NCT01500200|100873717|FG002|STARTED|Stage 2||0|Subjects in Stage 2 are a subset of those randomized to placebo in Stage 1.|
48224977|NCT01500200|100873718|FG003|STARTED|Stage 2||20|Subjects in Stage 2 are a subset of those randomized to placebo in Stage 1.|
48224978|NCT01500200|100873719|FG004|STARTED|Stage 2||23|Subjects in Stage 2 are a subset of those randomized to placebo in Stage 1.|
48224979|NCT01500200|100873720|FG005|STARTED|Stage 2||22|Subjects in Stage 2 are a subset of those randomized to placebo in Stage 1.|
48224980|NCT01500200|100873715|FG000|COMPLETED|Stage 2||0||
48224981|NCT01500200|100873716|FG001|COMPLETED|Stage 2||0||
48224982|NCT01500200|100873717|FG002|COMPLETED|Stage 2||0||
48224983|NCT01500200|100873718|FG003|COMPLETED|Stage 2||20||
48672121|NCT02950259|101982554|FG001|COMPLETED|Overall Study||0||
48224984|NCT01500200|100873719|FG004|COMPLETED|Stage 2||18||
48224985|NCT01500200|100873720|FG005|COMPLETED|Stage 2||18||
48224986|NCT01500200|100873715|FG000|NOT COMPLETED|Stage 2||0||
48224987|NCT01500200|100873716|FG001|NOT COMPLETED|Stage 2||0||
48224988|NCT01500200|100873717|FG002|NOT COMPLETED|Stage 2||0||
48224989|NCT01500200|100873718|FG003|NOT COMPLETED|Stage 2||0||
48224990|NCT01500200|100873719|FG004|NOT COMPLETED|Stage 2||5||
48224991|NCT01500200|100873720|FG005|NOT COMPLETED|Stage 2||4||
48224992|NCT02310581|100873721|FG000|STARTED|Overall Study||9||
48224993|NCT02310581|100873722|FG001|STARTED|Overall Study||11||
48224994|NCT02310581|100873723|FG002|STARTED|Overall Study||10||
48224995|NCT02310581|100873724|FG003|STARTED|Overall Study||10||
48224996|NCT02310581|100873721|FG000|COMPLETED|Overall Study||6||
48224997|NCT02310581|100873722|FG001|COMPLETED|Overall Study||9||
48224998|NCT02310581|100873723|FG002|COMPLETED|Overall Study||9||
48224999|NCT02310581|100873724|FG003|COMPLETED|Overall Study||9||
48225000|NCT02310581|100873721|FG000|NOT COMPLETED|Overall Study||3||
48225001|NCT02310581|100873722|FG001|NOT COMPLETED|Overall Study||2||
48225002|NCT02310581|100873723|FG002|NOT COMPLETED|Overall Study||1||
48225003|NCT02310581|100873724|FG003|NOT COMPLETED|Overall Study||1||
48225004|NCT00738400|100873725|FG000|STARTED|Overall Study||76||
48225005|NCT00738400|100873726|FG001|STARTED|Overall Study||74||
48225006|NCT00738400|100873725|FG000|Received Treatment, Safety Population|Overall Study||75||
48225007|NCT00738400|100873726|FG001|Received Treatment, Safety Population|Overall Study||72||
48225008|NCT00738400|100873725|FG000|ITT (Intent To Treatment) Population|Overall Study||75||
48225009|NCT00738400|100873726|FG001|ITT (Intent To Treatment) Population|Overall Study||70||
48225010|NCT00738400|100873725|FG000|COMPLETED|Overall Study||72||
48225011|NCT00738400|100873726|FG001|COMPLETED|Overall Study||67||
48225012|NCT00738400|100873725|FG000|NOT COMPLETED|Overall Study||4||
48225013|NCT00738400|100873726|FG001|NOT COMPLETED|Overall Study||7||
48225014|NCT00759798|100873727|FG000|STARTED|Overall Study||289||
48225015|NCT00759798|100873727|FG000|COMPLETED|Overall Study||289||
48225016|NCT00759798|100873727|FG000|NOT COMPLETED|Overall Study||0||
48225017|NCT03601715|100873728|FG000|STARTED|First Intervention||7||
48225018|NCT03601715|100873729|FG001|STARTED|First Intervention||7||
48225019|NCT03601715|100873730|FG002|STARTED|First Intervention||6||
48225020|NCT03601715|100873728|FG000|COMPLETED|First Intervention||7||
48225021|NCT03601715|100873729|FG001|COMPLETED|First Intervention||7||
48225022|NCT03601715|100873730|FG002|COMPLETED|First Intervention||6||
48225023|NCT03601715|100873728|FG000|NOT COMPLETED|First Intervention||0||
48225024|NCT03601715|100873729|FG001|NOT COMPLETED|First Intervention||0||
48225025|NCT03601715|100873730|FG002|NOT COMPLETED|First Intervention||0||
48225026|NCT03601715|100873728|FG000|STARTED|Washout 1 (at Least 24 Hours)||7||
48225027|NCT03601715|100873729|FG001|STARTED|Washout 1 (at Least 24 Hours)||7||
48225028|NCT03601715|100873730|FG002|STARTED|Washout 1 (at Least 24 Hours)||6||
48225029|NCT03601715|100873728|FG000|COMPLETED|Washout 1 (at Least 24 Hours)||7||
48225030|NCT03601715|100873729|FG001|COMPLETED|Washout 1 (at Least 24 Hours)||7||
48225031|NCT03601715|100873730|FG002|COMPLETED|Washout 1 (at Least 24 Hours)||6||
48225032|NCT03601715|100873728|FG000|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0||
48225033|NCT03601715|100873729|FG001|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0||
48225034|NCT03601715|100873730|FG002|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0||
48225035|NCT03601715|100873728|FG000|STARTED|Second Intervention||7||
48225036|NCT03601715|100873729|FG001|STARTED|Second Intervention||7||
48225037|NCT03601715|100873730|FG002|STARTED|Second Intervention||6||
48225038|NCT03601715|100873728|FG000|COMPLETED|Second Intervention||6||
48225039|NCT03601715|100873729|FG001|COMPLETED|Second Intervention||6||
48225040|NCT03601715|100873730|FG002|COMPLETED|Second Intervention||6||
48225041|NCT03601715|100873728|FG000|NOT COMPLETED|Second Intervention||1||
48225042|NCT03601715|100873729|FG001|NOT COMPLETED|Second Intervention||1||
48225043|NCT03601715|100873730|FG002|NOT COMPLETED|Second Intervention||0||
48225044|NCT03601715|100873728|FG000|STARTED|Wash Out 2 (at Least 24 Hours)||6||
48225045|NCT03601715|100873729|FG001|STARTED|Wash Out 2 (at Least 24 Hours)||6||
48225046|NCT03601715|100873730|FG002|STARTED|Wash Out 2 (at Least 24 Hours)||6||
48225047|NCT03601715|100873728|FG000|COMPLETED|Wash Out 2 (at Least 24 Hours)||6||
48225048|NCT03601715|100873729|FG001|COMPLETED|Wash Out 2 (at Least 24 Hours)||6||
48225049|NCT03601715|100873730|FG002|COMPLETED|Wash Out 2 (at Least 24 Hours)||6||
48225050|NCT03601715|100873728|FG000|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0||
48225051|NCT03601715|100873729|FG001|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0||
48225052|NCT03601715|100873730|FG002|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0||
48225053|NCT03601715|100873728|FG000|STARTED|Third Intervention||6||
48225054|NCT03601715|100873729|FG001|STARTED|Third Intervention||6||
48225055|NCT03601715|100873730|FG002|STARTED|Third Intervention||6||
48225056|NCT03601715|100873728|FG000|COMPLETED|Third Intervention||6||
48225057|NCT03601715|100873729|FG001|COMPLETED|Third Intervention||6||
48225058|NCT03601715|100873730|FG002|COMPLETED|Third Intervention||6||
48225059|NCT03601715|100873728|FG000|NOT COMPLETED|Third Intervention||0||
48225060|NCT03601715|100873729|FG001|NOT COMPLETED|Third Intervention||0||
48225061|NCT03601715|100873730|FG002|NOT COMPLETED|Third Intervention||0||
48225062|NCT03398798|100873731|FG000|STARTED|Overall Study||9||
48225063|NCT03398798|100873732|FG001|STARTED|Overall Study||9||
48225064|NCT03398798|100873733|FG002|STARTED|Overall Study||9||
48225065|NCT03398798|100873734|FG003|STARTED|Overall Study||9||
48225066|NCT03398798|100873731|FG000|COMPLETED|Overall Study||9||
48225067|NCT03398798|100873732|FG001|COMPLETED|Overall Study||9||
48225068|NCT03398798|100873733|FG002|COMPLETED|Overall Study||9||
48225069|NCT03398798|100873734|FG003|COMPLETED|Overall Study||9||
48225070|NCT03398798|100873731|FG000|NOT COMPLETED|Overall Study||0||
48225071|NCT03398798|100873732|FG001|NOT COMPLETED|Overall Study||0||
48225072|NCT03398798|100873733|FG002|NOT COMPLETED|Overall Study||0||
48225073|NCT03398798|100873734|FG003|NOT COMPLETED|Overall Study||0||
48225074|NCT00776009|100873735|FG000|STARTED|Period 1: First Intervention||26||
48225075|NCT00776009|100873736|FG001|STARTED|Period 1: First Intervention||28||
48225076|NCT00776009|100873737|FG002|STARTED|Period 1: First Intervention||29||
48225077|NCT00776009|100873738|FG003|STARTED|Period 1: First Intervention||27||
48225078|NCT00776009|100873739|FG004|STARTED|Period 1: First Intervention||28||
48225079|NCT00776009|100873740|FG005|STARTED|Period 1: First Intervention||27||
48225080|NCT00776009|100873735|FG000|COMPLETED|Period 1: First Intervention||26||
48225081|NCT00776009|100873736|FG001|COMPLETED|Period 1: First Intervention||27||
48225082|NCT00776009|100873737|FG002|COMPLETED|Period 1: First Intervention||28||
48225083|NCT00776009|100873738|FG003|COMPLETED|Period 1: First Intervention||27||
48225084|NCT00776009|100873739|FG004|COMPLETED|Period 1: First Intervention||26||
48225085|NCT00776009|100873740|FG005|COMPLETED|Period 1: First Intervention||27||
48225086|NCT00776009|100873735|FG000|NOT COMPLETED|Period 1: First Intervention||0||
48225087|NCT00776009|100873736|FG001|NOT COMPLETED|Period 1: First Intervention||1||
48225088|NCT00776009|100873737|FG002|NOT COMPLETED|Period 1: First Intervention||1||
48225089|NCT00776009|100873738|FG003|NOT COMPLETED|Period 1: First Intervention||0||
48225090|NCT00776009|100873739|FG004|NOT COMPLETED|Period 1: First Intervention||2||
48225091|NCT00776009|100873740|FG005|NOT COMPLETED|Period 1: First Intervention||0||
48225092|NCT00776009|100873735|FG000|STARTED|Period 2: Second Intervention||26||
48225093|NCT00776009|100873736|FG001|STARTED|Period 2: Second Intervention||27||
48225094|NCT00776009|100873737|FG002|STARTED|Period 2: Second Intervention||28||
48225095|NCT00776009|100873738|FG003|STARTED|Period 2: Second Intervention||27||
48225096|NCT00776009|100873739|FG004|STARTED|Period 2: Second Intervention||26||
48225097|NCT00776009|100873740|FG005|STARTED|Period 2: Second Intervention||27||
48225098|NCT00776009|100873735|FG000|COMPLETED|Period 2: Second Intervention||25||
48225099|NCT00776009|100873736|FG001|COMPLETED|Period 2: Second Intervention||27||
48225100|NCT00776009|100873737|FG002|COMPLETED|Period 2: Second Intervention||27||
48225101|NCT00776009|100873738|FG003|COMPLETED|Period 2: Second Intervention||27||
48225102|NCT00776009|100873739|FG004|COMPLETED|Period 2: Second Intervention||26||
48225103|NCT00776009|100873740|FG005|COMPLETED|Period 2: Second Intervention||26||
48225104|NCT00776009|100873735|FG000|NOT COMPLETED|Period 2: Second Intervention||1||
48225105|NCT00776009|100873736|FG001|NOT COMPLETED|Period 2: Second Intervention||0||
48225106|NCT00776009|100873737|FG002|NOT COMPLETED|Period 2: Second Intervention||1||
48225107|NCT00776009|100873738|FG003|NOT COMPLETED|Period 2: Second Intervention||0||
48225108|NCT00776009|100873739|FG004|NOT COMPLETED|Period 2: Second Intervention||0||
48225109|NCT00776009|100873740|FG005|NOT COMPLETED|Period 2: Second Intervention||1||
48225110|NCT00776009|100873735|FG000|STARTED|Period 3: Third Intervention||25||
48225111|NCT00776009|100873736|FG001|STARTED|Period 3: Third Intervention||27||
48225112|NCT00776009|100873737|FG002|STARTED|Period 3: Third Intervention||27||
48225113|NCT00776009|100873738|FG003|STARTED|Period 3: Third Intervention||27||
48225114|NCT00776009|100873739|FG004|STARTED|Period 3: Third Intervention||26||
48225115|NCT00776009|100873740|FG005|STARTED|Period 3: Third Intervention||26||
48225116|NCT00776009|100873735|FG000|COMPLETED|Period 3: Third Intervention||24||
48225117|NCT00776009|100873736|FG001|COMPLETED|Period 3: Third Intervention||27||
48225118|NCT00776009|100873737|FG002|COMPLETED|Period 3: Third Intervention||27||
48225119|NCT00776009|100873738|FG003|COMPLETED|Period 3: Third Intervention||27||
48225120|NCT00776009|100873739|FG004|COMPLETED|Period 3: Third Intervention||26||
48225121|NCT00776009|100873740|FG005|COMPLETED|Period 3: Third Intervention||26||
48225122|NCT00776009|100873735|FG000|NOT COMPLETED|Period 3: Third Intervention||1||
48225123|NCT00776009|100873736|FG001|NOT COMPLETED|Period 3: Third Intervention||0||
48225124|NCT00776009|100873737|FG002|NOT COMPLETED|Period 3: Third Intervention||0||
48225125|NCT00776009|100873738|FG003|NOT COMPLETED|Period 3: Third Intervention||0||
48225126|NCT00776009|100873739|FG004|NOT COMPLETED|Period 3: Third Intervention||0||
48225127|NCT00776009|100873740|FG005|NOT COMPLETED|Period 3: Third Intervention||0||
48225128|NCT01561300|100873741|FG000|STARTED|Run in on Placebo||15||
48225129|NCT01561300|100873742|FG001|STARTED|Run in on Placebo||15||
48225130|NCT01561300|100873741|FG000|COMPLETED|Run in on Placebo||14||
48225131|NCT01561300|100873742|FG001|COMPLETED|Run in on Placebo||15||
48225132|NCT01561300|100873741|FG000|NOT COMPLETED|Run in on Placebo||1||
48225133|NCT01561300|100873742|FG001|NOT COMPLETED|Run in on Placebo||0||
48225134|NCT01561300|100873741|FG000|STARTED|First Intervention||14||
48225135|NCT01561300|100873742|FG001|STARTED|First Intervention||15||
48225136|NCT01561300|100873741|FG000|COMPLETED|First Intervention||14||
48225137|NCT01561300|100873742|FG001|COMPLETED|First Intervention||15||
48225138|NCT01561300|100873741|FG000|NOT COMPLETED|First Intervention||0||
48370858|NCT05395351|101236552|FG002|COMPLETED|Overall Study||12533||
48225139|NCT01561300|100873742|FG001|NOT COMPLETED|First Intervention||0||
48225140|NCT01561300|100873741|FG000|STARTED|Washout on Placebo||14||
48225141|NCT01561300|100873742|FG001|STARTED|Washout on Placebo||15||
48225142|NCT01561300|100873741|FG000|COMPLETED|Washout on Placebo||14||
48225143|NCT01561300|100873742|FG001|COMPLETED|Washout on Placebo||15||
48225144|NCT01561300|100873741|FG000|NOT COMPLETED|Washout on Placebo||0||
48225145|NCT01561300|100873742|FG001|NOT COMPLETED|Washout on Placebo||0||
48672122|NCT02950259|101982553|FG000|NOT COMPLETED|Overall Study||0||
48225146|NCT01561300|100873741|FG000|STARTED|Second Intervention||14||
48225147|NCT01561300|100873742|FG001|STARTED|Second Intervention||15||
48225148|NCT01561300|100873741|FG000|COMPLETED|Second Intervention||14||
48225149|NCT01561300|100873742|FG001|COMPLETED|Second Intervention||15||
48225150|NCT01561300|100873741|FG000|NOT COMPLETED|Second Intervention||0||
48225151|NCT01561300|100873742|FG001|NOT COMPLETED|Second Intervention||0||
48225152|NCT00562094|100873743|FG000|STARTED|Overall Study||8616||
48225153|NCT00562094|100873743|FG000|COMPLETED|Overall Study||8554||
48225154|NCT00562094|100873743|FG000|NOT COMPLETED|Overall Study||62||
48225155|NCT02029443|100873744|FG000|STARTED|Overall Study||134||
48225156|NCT02029443|100873745|FG001|STARTED|Overall Study||99||
48225157|NCT02029443|100873746|FG002|STARTED|Overall Study||33||
48225158|NCT02029443|100873747|FG003|STARTED|Overall Study||29||
48225159|NCT02029443|100873748|FG004|STARTED|Overall Study||6||
48225160|NCT02029443|100873744|FG000|COMPLETED|Overall Study||41||
48225161|NCT02029443|100873745|FG001|COMPLETED|Overall Study||70||
48225162|NCT02029443|100873746|FG002|COMPLETED|Overall Study||6||
48225163|NCT02029443|100873747|FG003|COMPLETED|Overall Study||3||
48225164|NCT02029443|100873748|FG004|COMPLETED|Overall Study||0||
48225165|NCT02029443|100873744|FG000|NOT COMPLETED|Overall Study||93||
48225166|NCT02029443|100873745|FG001|NOT COMPLETED|Overall Study||29||
48225167|NCT02029443|100873746|FG002|NOT COMPLETED|Overall Study||27||
48225168|NCT02029443|100873747|FG003|NOT COMPLETED|Overall Study||26||
48225169|NCT02029443|100873748|FG004|NOT COMPLETED|Overall Study||6||
48225170|NCT00745875|100873749|FG000|STARTED|Overall Study||36||
48225171|NCT00745875|100873750|FG001|STARTED|Overall Study||30||
48225172|NCT00745875|100873749|FG000|COMPLETED|Overall Study||32||
48225173|NCT00745875|100873750|FG001|COMPLETED|Overall Study||26||
48225174|NCT00745875|100873749|FG000|NOT COMPLETED|Overall Study||4||
48225175|NCT00745875|100873750|FG001|NOT COMPLETED|Overall Study||4||
48225176|NCT03530631|100873751|FG000|STARTED|Adderall/Truth||4||
48225177|NCT03530631|100873751|FG000|COMPLETED|Adderall/Truth||4||
48225178|NCT03530631|100873751|FG000|NOT COMPLETED|Adderall/Truth||0||
48225179|NCT03530631|100873751|FG000|STARTED|Placebo/Truth||4||
48225180|NCT03530631|100873751|FG000|COMPLETED|Placebo/Truth||4||
48225181|NCT03530631|100873751|FG000|NOT COMPLETED|Placebo/Truth||0||
48225182|NCT03530631|100873751|FG000|STARTED|Adderall/Deception||4||
48225183|NCT03530631|100873751|FG000|COMPLETED|Adderall/Deception||4||
48225184|NCT03530631|100873751|FG000|NOT COMPLETED|Adderall/Deception||0||
48225185|NCT03530631|100873751|FG000|STARTED|Placebo/Deception||4||
48225186|NCT03530631|100873751|FG000|COMPLETED|Placebo/Deception||4||
48225187|NCT03530631|100873751|FG000|NOT COMPLETED|Placebo/Deception||0||
48225188|NCT00949117|100873752|FG000|STARTED|Overall Study||4||
48225189|NCT00949117|100873753|FG001|STARTED|Overall Study||5||
48225190|NCT00949117|100873752|FG000|COMPLETED|Overall Study||1||
48225191|NCT00949117|100873753|FG001|COMPLETED|Overall Study||0||
48225192|NCT00949117|100873752|FG000|NOT COMPLETED|Overall Study||3||
48225193|NCT00949117|100873753|FG001|NOT COMPLETED|Overall Study||5||
48225194|NCT02816398|100873754|FG000|STARTED|Overall Study||26||
48225195|NCT02816398|100873754|FG000|COMPLETED|Overall Study||12||
48225196|NCT02816398|100873754|FG000|NOT COMPLETED|Overall Study||14||
48225197|NCT01218659|100873755|FG000|STARTED|18-Month Randomized Period||36||
48225198|NCT01218659|100873756|FG001|STARTED|18-Month Randomized Period||24||
48225199|NCT01218659|100873757|FG002|STARTED|18-Month Randomized Period||0||
48225200|NCT01218659|100873755|FG000|Safety Population|18-Month Randomized Period||36|Safety: received at least 1 dose of migalastat or ERT.|
48225201|NCT01218659|100873756|FG001|Safety Population|18-Month Randomized Period||21|Safety: received at least 1 dose of migalastat or ERT.|
48225202|NCT01218659|100873757|FG002|Safety Population|18-Month Randomized Period||0|Safety: received at least 1 dose of migalastat or ERT.|
48225203|NCT01218659|100873755|FG000|COMPLETED|18-Month Randomized Period||34||
48225204|NCT01218659|100873756|FG001|COMPLETED|18-Month Randomized Period||18||
48225205|NCT01218659|100873757|FG002|COMPLETED|18-Month Randomized Period||0||
48225206|NCT01218659|100873755|FG000|NOT COMPLETED|18-Month Randomized Period||2||
48225207|NCT01218659|100873756|FG001|NOT COMPLETED|18-Month Randomized Period||6||
48225208|NCT01218659|100873757|FG002|NOT COMPLETED|18-Month Randomized Period||0||
48225209|NCT01218659|100873755|FG000|STARTED|12-Month OLE||0||
48225210|NCT01218659|100873756|FG001|STARTED|12-Month OLE||0||
48225211|NCT01218659|100873757|FG002|STARTED|12-Month OLE||52||
48225212|NCT01218659|100873755|FG000|Safety Population|12-Month OLE||0|Safety: ITT pop. who received ≥1 dose of study drug during the 18-mo randomized treatment period.|
48225213|NCT01218659|100873756|FG001|Safety Population|12-Month OLE||0|Safety: ITT pop. who received ≥1 dose of study drug during the 18-mo randomized treatment period.|
48225214|NCT01218659|100873757|FG002|Safety Population|12-Month OLE||51|Safety: ITT pop. who received ≥1 dose of study drug during the 18-mo randomized treatment period.|
48225215|NCT01218659|100873755|FG000|Modified Intent-to-Treat (mITT)|12-Month OLE||0|mITT: Eligibility based on Good Laboratory Practice (GLP) human embryonic kidney cell (HEK) assay.|
48225216|NCT01218659|100873756|FG001|Modified Intent-to-Treat (mITT)|12-Month OLE||0|mITT: Eligibility based on Good Laboratory Practice (GLP) human embryonic kidney cell (HEK) assay.|
48225217|NCT01218659|100873757|FG002|Modified Intent-to-Treat (mITT)|12-Month OLE||46|mITT: Eligibility based on Good Laboratory Practice (GLP) human embryonic kidney cell (HEK) assay.|
48225218|NCT01218659|100873755|FG000|COMPLETED|12-Month OLE||0||
48225219|NCT01218659|100873756|FG001|COMPLETED|12-Month OLE||0||
48225220|NCT01218659|100873757|FG002|COMPLETED|12-Month OLE||42||
48225221|NCT01218659|100873755|FG000|NOT COMPLETED|12-Month OLE||0||
48225222|NCT01218659|100873756|FG001|NOT COMPLETED|12-Month OLE||0||
48225223|NCT01218659|100873757|FG002|NOT COMPLETED|12-Month OLE||10||
48225224|NCT03520036|100873758|FG000|STARTED|Overall Study||33||
48225225|NCT03520036|100873759|FG001|STARTED|Overall Study||34||
48225226|NCT03520036|100873760|FG002|STARTED|Overall Study||35||
48225227|NCT03520036|100873758|FG000|COMPLETED|Overall Study||31||
48225228|NCT03520036|100873759|FG001|COMPLETED|Overall Study||30||
48225229|NCT03520036|100873760|FG002|COMPLETED|Overall Study||31||
48225230|NCT03520036|100873758|FG000|NOT COMPLETED|Overall Study||2||
48225231|NCT03520036|100873759|FG001|NOT COMPLETED|Overall Study||4||
48225232|NCT03520036|100873760|FG002|NOT COMPLETED|Overall Study||4||
48225233|NCT00123409|100873761|FG000|STARTED|Overall Study||72||
48225234|NCT00123409|100873762|FG001|STARTED|Overall Study||74||
48225235|NCT00123409|100873761|FG000|COMPLETED|Overall Study||68||
48225236|NCT00123409|100873762|FG001|COMPLETED|Overall Study||71||
48225237|NCT00123409|100873761|FG000|NOT COMPLETED|Overall Study||4||
48225238|NCT00123409|100873762|FG001|NOT COMPLETED|Overall Study||3||
48225239|NCT02470806|100873763|FG000|STARTED|Overall Study||80||
48225240|NCT02470806|100873764|FG001|STARTED|Overall Study||84||
48225241|NCT02470806|100873763|FG000|COMPLETED|Overall Study||62||
48225242|NCT02470806|100873764|FG001|COMPLETED|Overall Study||42||
48225243|NCT02470806|100873763|FG000|NOT COMPLETED|Overall Study||18||
48225244|NCT02470806|100873764|FG001|NOT COMPLETED|Overall Study||42||
48225245|NCT02334215|100873765|FG000|STARTED|Overall Study||75||
48225246|NCT02334215|100873766|FG001|STARTED|Overall Study||74||
48225247|NCT02334215|100873767|FG002|STARTED|Overall Study||76||
48225248|NCT02334215|100873765|FG000|COMPLETED|Overall Study||68|Number of participants that had at least one urine test conducted|
48225249|NCT02334215|100873766|FG001|COMPLETED|Overall Study||68|Number of participants that had at least one urine test conducted|
48225250|NCT02334215|100873767|FG002|COMPLETED|Overall Study||61|Number of participants that had at least one urine test conducted|
48225251|NCT02334215|100873765|FG000|NOT COMPLETED|Overall Study||7||
48225252|NCT02334215|100873766|FG001|NOT COMPLETED|Overall Study||6||
48225253|NCT02334215|100873767|FG002|NOT COMPLETED|Overall Study||15||
48225254|NCT01307800|100873768|FG000|STARTED|Overall Study||111||
48225255|NCT01307800|100873769|FG001|STARTED|Overall Study||110||
48225256|NCT01307800|100873770|FG002|STARTED|Overall Study||118||
48225257|NCT01307800|100873771|FG003|STARTED|Overall Study||228||
48225258|NCT01307800|100873768|FG000|Received Treatment (Rec'd Tx)|Overall Study||111||
48225259|NCT01307800|100873769|FG001|Received Treatment (Rec'd Tx)|Overall Study||110||
48225260|NCT01307800|100873770|FG002|Received Treatment (Rec'd Tx)|Overall Study||118||
48225261|NCT01307800|100873771|FG003|Received Treatment (Rec'd Tx)|Overall Study||228||
48225262|NCT01307800|100873768|FG000|Rec'd Tx, Not a Placebo (PL) Responder|Overall Study||102||
48225263|NCT01307800|100873769|FG001|Rec'd Tx, Not a Placebo (PL) Responder|Overall Study||103||
48225264|NCT01307800|100873770|FG002|Rec'd Tx, Not a Placebo (PL) Responder|Overall Study||112||
48225265|NCT01307800|100873771|FG003|Rec'd Tx, Not a Placebo (PL) Responder|Overall Study||217||
48225266|NCT01307800|100873768|FG000|COMPLETED|Overall Study||57||
48225267|NCT01307800|100873769|FG001|COMPLETED|Overall Study||45||
48225268|NCT01307800|100873770|FG002|COMPLETED|Overall Study||60||
48225269|NCT01307800|100873771|FG003|COMPLETED|Overall Study||118||
48225270|NCT01307800|100873768|FG000|NOT COMPLETED|Overall Study||54||
48225271|NCT01307800|100873769|FG001|NOT COMPLETED|Overall Study||65||
48225272|NCT01307800|100873770|FG002|NOT COMPLETED|Overall Study||58||
48225273|NCT01307800|100873771|FG003|NOT COMPLETED|Overall Study||110||
48225274|NCT02892019|100873772|FG000|STARTED|Overall Study||41||
48225275|NCT02892019|100873773|FG001|STARTED|Overall Study||39||
48225276|NCT02892019|100873772|FG000|COMPLETED|Overall Study||40||
48225277|NCT02892019|100873773|FG001|COMPLETED|Overall Study||36||
48225278|NCT02892019|100873772|FG000|NOT COMPLETED|Overall Study||1||
48225279|NCT02892019|100873773|FG001|NOT COMPLETED|Overall Study||3||
48225280|NCT03347396|100873774|FG000|STARTED|Part A (26 Weeks)||17||
48225281|NCT03347396|100873775|FG001|STARTED|Part A (26 Weeks)||7||
48225282|NCT03347396|100873774|FG000|COMPLETED|Part A (26 Weeks)||16||
48225283|NCT03347396|100873775|FG001|COMPLETED|Part A (26 Weeks)||6||
48225284|NCT03347396|100873774|FG000|NOT COMPLETED|Part A (26 Weeks)||1||
48225285|NCT03347396|100873775|FG001|NOT COMPLETED|Part A (26 Weeks)||1||
48225286|NCT03347396|100873774|FG000|STARTED|Part B (149 Weeks)||16||
48225287|NCT03347396|100873775|FG001|STARTED|Part B (149 Weeks)||6||
48225288|NCT03347396|100873774|FG000|COMPLETED|Part B (149 Weeks)||14||
48225289|NCT03347396|100873775|FG001|COMPLETED|Part B (149 Weeks)||5||
48225290|NCT03347396|100873774|FG000|NOT COMPLETED|Part B (149 Weeks)||2||
48225291|NCT03347396|100873775|FG001|NOT COMPLETED|Part B (149 Weeks)||1||
48225292|NCT00887224|100873776|FG000|STARTED|Open-label Response (OLR) Phase||874||
48225293|NCT00887224|100873777|FG001|STARTED|Open-label Response (OLR) Phase||0||
48225294|NCT00887224|100873778|FG002|STARTED|Open-label Response (OLR) Phase||0||
48225295|NCT00887224|100873776|FG000|COMPLETED|Open-label Response (OLR) Phase||752||
48225296|NCT00887224|100873777|FG001|COMPLETED|Open-label Response (OLR) Phase||0||
48225297|NCT00887224|100873778|FG002|COMPLETED|Open-label Response (OLR) Phase||0||
48225298|NCT00887224|100873776|FG000|NOT COMPLETED|Open-label Response (OLR) Phase||122||
48225299|NCT00887224|100873777|FG001|NOT COMPLETED|Open-label Response (OLR) Phase||0||
48225300|NCT00887224|100873778|FG002|NOT COMPLETED|Open-label Response (OLR) Phase||0||
48225301|NCT00887224|100873776|FG000|STARTED|Between OLR and OLS Phases||752||
48225302|NCT00887224|100873777|FG001|STARTED|Between OLR and OLS Phases||0||
48225303|NCT00887224|100873778|FG002|STARTED|Between OLR and OLS Phases||0||
48225304|NCT00887224|100873776|FG000|COMPLETED|Between OLR and OLS Phases||659||
48225305|NCT00887224|100873777|FG001|COMPLETED|Between OLR and OLS Phases||0||
48225306|NCT00887224|100873778|FG002|COMPLETED|Between OLR and OLS Phases||0||
48225307|NCT00887224|100873776|FG000|NOT COMPLETED|Between OLR and OLS Phases||93||
48225308|NCT00887224|100873777|FG001|NOT COMPLETED|Between OLR and OLS Phases||0||
48225309|NCT00887224|100873778|FG002|NOT COMPLETED|Between OLR and OLS Phases||0||
48225310|NCT00887224|100873776|FG000|STARTED|Open-label Stability (OLS) Phase||659||
48225311|NCT00887224|100873777|FG001|STARTED|Open-label Stability (OLS) Phase||0||
48225312|NCT00887224|100873778|FG002|STARTED|Open-label Stability (OLS) Phase||0||
48225313|NCT00887224|100873776|FG000|COMPLETED|Open-label Stability (OLS) Phase||576||
48225314|NCT00887224|100873777|FG001|COMPLETED|Open-label Stability (OLS) Phase||0||
48225315|NCT00887224|100873778|FG002|COMPLETED|Open-label Stability (OLS) Phase||0||
48225316|NCT00887224|100873776|FG000|NOT COMPLETED|Open-label Stability (OLS) Phase||83||
48225317|NCT00887224|100873777|FG001|NOT COMPLETED|Open-label Stability (OLS) Phase||0||
48225318|NCT00887224|100873778|FG002|NOT COMPLETED|Open-label Stability (OLS) Phase||0||
48225319|NCT00887224|100873776|FG000|STARTED|Between OLS and DB Phases||576||
48225320|NCT00887224|100873777|FG001|STARTED|Between OLS and DB Phases||0||
48225321|NCT00887224|100873778|FG002|STARTED|Between OLS and DB Phases||0||
48225322|NCT00887224|100873776|FG000|COMPLETED|Between OLS and DB Phases||548||
48225323|NCT00887224|100873777|FG001|COMPLETED|Between OLS and DB Phases||0||
48225324|NCT00887224|100873778|FG002|COMPLETED|Between OLS and DB Phases||0||
48225325|NCT00887224|100873776|FG000|NOT COMPLETED|Between OLS and DB Phases||28||
48225326|NCT00887224|100873777|FG001|NOT COMPLETED|Between OLS and DB Phases||0||
48225327|NCT00887224|100873778|FG002|NOT COMPLETED|Between OLS and DB Phases||0||
48225328|NCT00887224|100873776|FG000|STARTED|OL Taper Phase / OL Follow Up||307||
48225329|NCT00887224|100873777|FG001|STARTED|OL Taper Phase / OL Follow Up||0||
48225330|NCT00887224|100873778|FG002|STARTED|OL Taper Phase / OL Follow Up||0||
48225331|NCT00887224|100873776|FG000|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||144||
48225332|NCT00887224|100873777|FG001|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0||
48225333|NCT00887224|100873778|FG002|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0||
48225334|NCT00887224|100873776|FG000|COMPLETED|OL Taper Phase / OL Follow Up||163||
48225335|NCT00887224|100873777|FG001|COMPLETED|OL Taper Phase / OL Follow Up||0||
48225336|NCT00887224|100873778|FG002|COMPLETED|OL Taper Phase / OL Follow Up||0||
48225337|NCT00887224|100873776|FG000|NOT COMPLETED|OL Taper Phase / OL Follow Up||144||
48225338|NCT00887224|100873777|FG001|NOT COMPLETED|OL Taper Phase / OL Follow Up||0||
48225339|NCT00887224|100873778|FG002|NOT COMPLETED|OL Taper Phase / OL Follow Up||0||
48225340|NCT00887224|100873776|FG000|STARTED|Double-blind (DB) Phase||0||
48225341|NCT00887224|100873777|FG001|STARTED|Double-blind (DB) Phase||276||
48225342|NCT00887224|100873778|FG002|STARTED|Double-blind (DB) Phase||272||
48225343|NCT00887224|100873776|FG000|COMPLETED|Double-blind (DB) Phase||0||
48225344|NCT00887224|100873777|FG001|COMPLETED|Double-blind (DB) Phase||176||
48225345|NCT00887224|100873778|FG002|COMPLETED|Double-blind (DB) Phase||210||
48225346|NCT00887224|100873776|FG000|NOT COMPLETED|Double-blind (DB) Phase||0||
48225347|NCT00887224|100873777|FG001|NOT COMPLETED|Double-blind (DB) Phase||100||
48225348|NCT00887224|100873778|FG002|NOT COMPLETED|Double-blind (DB) Phase||62||
48225349|NCT00887224|100873776|FG000|STARTED|DB Taper Phase / Post Study Follow Up||0||
48225350|NCT00887224|100873777|FG001|STARTED|DB Taper Phase / Post Study Follow Up||267||
48225351|NCT00887224|100873778|FG002|STARTED|DB Taper Phase / Post Study Follow Up||265||
48225352|NCT00887224|100873776|FG000|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||0||
48225353|NCT00887224|100873777|FG001|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||9||
48225354|NCT00887224|100873778|FG002|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||7||
48225355|NCT00887224|100873776|FG000|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||0||
48225356|NCT00887224|100873777|FG001|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||41||
48225357|NCT00887224|100873778|FG002|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||30||
48225358|NCT00887224|100873776|FG000|COMPLETED|DB Taper Phase / Post Study Follow Up||0||
48225359|NCT00887224|100873777|FG001|COMPLETED|DB Taper Phase / Post Study Follow Up||226||
48225360|NCT00887224|100873778|FG002|COMPLETED|DB Taper Phase / Post Study Follow Up||235||
48225361|NCT00887224|100873776|FG000|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||0||
48225362|NCT00887224|100873777|FG001|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||41||
48225363|NCT00887224|100873778|FG002|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||30||
48225364|NCT01779050|100873779|FG000|STARTED|Overall Study||4||
48225365|NCT01779050|100873780|FG001|STARTED|Overall Study||3||
48225366|NCT01779050|100873779|FG000|COMPLETED|Overall Study||3||
48370859|NCT05395351|101236553|FG003|COMPLETED|Overall Study||69084||
48225367|NCT01779050|100873780|FG001|COMPLETED|Overall Study||3||
48225368|NCT01779050|100873779|FG000|NOT COMPLETED|Overall Study||1||
48225369|NCT01779050|100873780|FG001|NOT COMPLETED|Overall Study||0||
48225370|NCT00452114|100873781|FG000|STARTED|Overall Study||15||
48225371|NCT00452114|100873782|FG001|STARTED|Overall Study||13||
48225372|NCT00452114|100873781|FG000|COMPLETED|Overall Study||12||
48225373|NCT00452114|100873782|FG001|COMPLETED|Overall Study||10||
48225374|NCT00452114|100873781|FG000|NOT COMPLETED|Overall Study||3||
48225375|NCT00452114|100873782|FG001|NOT COMPLETED|Overall Study||3||
48225376|NCT00195403|100873783|FG000|STARTED|Overall Study||1014||
48225377|NCT00195403|100873783|FG000|COMPLETED|Overall Study||1014||
48225378|NCT00195403|100873783|FG000|NOT COMPLETED|Overall Study||0||
48225379|NCT01600482|100873784|FG000|STARTED|Overall Study||148||
48225380|NCT01600482|100873785|FG001|STARTED|Overall Study||59||
48225381|NCT01600482|100873784|FG000|COMPLETED|Overall Study||148||
48225382|NCT01600482|100873785|FG001|COMPLETED|Overall Study||59||
48225383|NCT01600482|100873784|FG000|NOT COMPLETED|Overall Study||0||
48225384|NCT01600482|100873785|FG001|NOT COMPLETED|Overall Study||0||
48225385|NCT02605174|100873786|FG000|STARTED|Overall Study||501||
48225386|NCT02605174|100873787|FG001|STARTED|Overall Study||249||
48225387|NCT02605174|100873788|FG002|STARTED|Overall Study||502||
48225388|NCT02605174|100873789|FG003|STARTED|Overall Study||252||
48225389|NCT02605174|100873790|FG004|STARTED|Overall Study||501||
48225390|NCT02605174|100873791|FG005|STARTED|Overall Study||249||
48225391|NCT02605174|100873792|FG006|STARTED|Overall Study||751||
48225392|NCT02605174|100873786|FG000|Received at Least 1 Dose of Study Drug|Overall Study||429||
48225393|NCT02605174|100873787|FG001|Received at Least 1 Dose of Study Drug|Overall Study||225||
48225394|NCT02605174|100873788|FG002|Received at Least 1 Dose of Study Drug|Overall Study||423||
48225395|NCT02605174|100873789|FG003|Received at Least 1 Dose of Study Drug|Overall Study||212||
48225396|NCT02605174|100873790|FG004|Received at Least 1 Dose of Study Drug|Overall Study||434||
48225397|NCT02605174|100873791|FG005|Received at Least 1 Dose of Study Drug|Overall Study||215||
48225398|NCT02605174|100873792|FG006|Received at Least 1 Dose of Study Drug|Overall Study||645||
48225399|NCT02605174|100873786|FG000|Received Optional 2nd Dose|Overall Study||206||
48225400|NCT02605174|100873787|FG001|Received Optional 2nd Dose|Overall Study||96||
48225401|NCT02605174|100873788|FG002|Received Optional 2nd Dose|Overall Study||177||
48225402|NCT02605174|100873789|FG003|Received Optional 2nd Dose|Overall Study||83||
48225403|NCT02605174|100873790|FG004|Received Optional 2nd Dose|Overall Study||144||
48225404|NCT02605174|100873791|FG005|Received Optional 2nd Dose|Overall Study||74||
48225405|NCT02605174|100873792|FG006|Received Optional 2nd Dose|Overall Study||361||
48225406|NCT02605174|100873786|FG000|COMPLETED|Overall Study||437|One site was burned down and several participants have incomplete data.|
48225407|NCT02605174|100873787|FG001|COMPLETED|Overall Study||226|One site was burned down and several participants have incomplete data.|
48225408|NCT02605174|100873788|FG002|COMPLETED|Overall Study||426|One site was burned down and several participants have incomplete data.|
48225409|NCT02605174|100873789|FG003|COMPLETED|Overall Study||216|One site was burned down and several participants have incomplete data.|
48225410|NCT02605174|100873790|FG004|COMPLETED|Overall Study||448|One site was burned down and several participants have incomplete data.|
48225411|NCT02605174|100873791|FG005|COMPLETED|Overall Study||217|One site was burned down and several participants have incomplete data.|
48225412|NCT02605174|100873792|FG006|COMPLETED|Overall Study||662|One site was burned down and several participants have incomplete data.|
48225413|NCT02605174|100873786|FG000|NOT COMPLETED|Overall Study||64||
48225414|NCT02605174|100873787|FG001|NOT COMPLETED|Overall Study||23||
48225415|NCT02605174|100873788|FG002|NOT COMPLETED|Overall Study||76||
48225416|NCT02605174|100873789|FG003|NOT COMPLETED|Overall Study||36||
48225417|NCT02605174|100873790|FG004|NOT COMPLETED|Overall Study||53||
48225418|NCT02605174|100873791|FG005|NOT COMPLETED|Overall Study||32||
48225419|NCT02605174|100873792|FG006|NOT COMPLETED|Overall Study||89||
48225420|NCT01074242|100873793|FG000|STARTED|Overall Study||3798||
48225421|NCT01074242|100873793|FG000|Received at Least 1 Dose of Vaccine|Overall Study||3395||
48225422|NCT01074242|100873793|FG000|COMPLETED|Overall Study||3395||
48225423|NCT01074242|100873793|FG000|NOT COMPLETED|Overall Study||403||
48225424|NCT01105975|100873794|FG000|STARTED|Overall Study||40||
48225425|NCT01105975|100873795|FG001|STARTED|Overall Study||39||
48225426|NCT01105975|100873796|FG002|STARTED|Overall Study||42||
48225427|NCT01105975|100873797|FG003|STARTED|Overall Study||38||
48225428|NCT01105975|100873798|FG004|STARTED|Overall Study||41||
48225429|NCT01105975|100873799|FG005|STARTED|Overall Study||35||
48225430|NCT01105975|100873800|FG006|STARTED|Overall Study||42||
48225431|NCT01105975|100873801|FG007|STARTED|Overall Study||40||
48225432|NCT01105975|100873802|FG008|STARTED|Overall Study||40||
48225433|NCT01105975|100873803|FG009|STARTED|Overall Study||41||
48225434|NCT01105975|100873794|FG000|Took at Least One Dose of Study Drug|Overall Study||40||
48225435|NCT01105975|100873795|FG001|Took at Least One Dose of Study Drug|Overall Study||38||
48225436|NCT01105975|100873796|FG002|Took at Least One Dose of Study Drug|Overall Study||40||
48225437|NCT01105975|100873797|FG003|Took at Least One Dose of Study Drug|Overall Study||38||
48225438|NCT01105975|100873798|FG004|Took at Least One Dose of Study Drug|Overall Study||41||
48225439|NCT01105975|100873799|FG005|Took at Least One Dose of Study Drug|Overall Study||35||
48225440|NCT01105975|100873800|FG006|Took at Least One Dose of Study Drug|Overall Study||41||
48225441|NCT01105975|100873801|FG007|Took at Least One Dose of Study Drug|Overall Study||40||
48370860|NCT05395351|101236550|FG000|NOT COMPLETED|Overall Study||0||
48225442|NCT01105975|100873802|FG008|Took at Least One Dose of Study Drug|Overall Study||39||
48225443|NCT01105975|100873803|FG009|Took at Least One Dose of Study Drug|Overall Study||41||
48225444|NCT01105975|100873794|FG000|COMPLETED|Overall Study||35||
48225445|NCT01105975|100873795|FG001|COMPLETED|Overall Study||34||
48225446|NCT01105975|100873796|FG002|COMPLETED|Overall Study||32||
48225447|NCT01105975|100873797|FG003|COMPLETED|Overall Study||36||
48225448|NCT01105975|100873798|FG004|COMPLETED|Overall Study||35||
48225449|NCT01105975|100873799|FG005|COMPLETED|Overall Study||30||
48225450|NCT01105975|100873800|FG006|COMPLETED|Overall Study||34||
48225451|NCT01105975|100873801|FG007|COMPLETED|Overall Study||33||
48225452|NCT01105975|100873802|FG008|COMPLETED|Overall Study||34||
48225453|NCT01105975|100873803|FG009|COMPLETED|Overall Study||32||
48225454|NCT01105975|100873794|FG000|NOT COMPLETED|Overall Study||5||
48225455|NCT01105975|100873795|FG001|NOT COMPLETED|Overall Study||5||
48225456|NCT01105975|100873796|FG002|NOT COMPLETED|Overall Study||10||
48225457|NCT01105975|100873797|FG003|NOT COMPLETED|Overall Study||2||
48225458|NCT01105975|100873798|FG004|NOT COMPLETED|Overall Study||6||
48225459|NCT01105975|100873799|FG005|NOT COMPLETED|Overall Study||5||
48225460|NCT01105975|100873800|FG006|NOT COMPLETED|Overall Study||8||
48225461|NCT01105975|100873801|FG007|NOT COMPLETED|Overall Study||7||
48225462|NCT01105975|100873802|FG008|NOT COMPLETED|Overall Study||6||
48225463|NCT01105975|100873803|FG009|NOT COMPLETED|Overall Study||9||
48225464|NCT00309751|100873804|FG000|STARTED|Overall Study||279||
48225465|NCT00309751|100873805|FG001|STARTED|Overall Study||139||
48225466|NCT00309751|100873804|FG000|Safety Population|Overall Study||275||
48225467|NCT00309751|100873805|FG001|Safety Population|Overall Study||137||
48225468|NCT00309751|100873804|FG000|COMPLETED|Overall Study||248||
48225469|NCT00309751|100873805|FG001|COMPLETED|Overall Study||124||
48225470|NCT00309751|100873804|FG000|NOT COMPLETED|Overall Study||31||
48225471|NCT00309751|100873805|FG001|NOT COMPLETED|Overall Study||15||
48225472|NCT03088800|100873806|FG000|STARTED|Overall Study||30||
48225473|NCT03088800|100873807|FG001|STARTED|Overall Study||30||
48225474|NCT03088800|100873808|FG002|STARTED|Overall Study||30||
48225475|NCT03088800|100873806|FG000|COMPLETED|Overall Study||30||
48225476|NCT03088800|100873807|FG001|COMPLETED|Overall Study||30||
48225477|NCT03088800|100873808|FG002|COMPLETED|Overall Study||30||
48225478|NCT03088800|100873806|FG000|NOT COMPLETED|Overall Study||0||
48225479|NCT03088800|100873807|FG001|NOT COMPLETED|Overall Study||0||
48225480|NCT03088800|100873808|FG002|NOT COMPLETED|Overall Study||0||
48225481|NCT02746107|100873809|FG000|STARTED|Overall Study||968||
48225482|NCT02746107|100873809|FG000|2 Diagrams DA|Overall Study||482||
48225483|NCT02746107|100873809|FG000|1 Diagram DA|Overall Study||486||
48225484|NCT02746107|100873809|FG000|1year Risk Estimate|Overall Study||483||
48225485|NCT02746107|100873809|FG000|5year Risk Estimate|Overall Study||485||
48225486|NCT02746107|100873809|FG000|Target=Patient|Overall Study||486||
48225487|NCT02746107|100873809|FG000|Target=Physician|Overall Study||482||
48225488|NCT02746107|100873809|FG000|CHA2DS2-VASC Score = 1|Overall Study||195||
48225489|NCT02746107|100873809|FG000|CHA2DS2-VASC Score = 2|Overall Study||189||
48225490|NCT02746107|100873809|FG000|CHA2DS2-VASC Score = 3|Overall Study||195||
48225491|NCT02746107|100873809|FG000|CHA2DS2-VASC Score = 4|Overall Study||197||
48225492|NCT02746107|100873809|FG000|CHA2DS2-VASC Score = 5|Overall Study||192||
48225493|NCT02746107|100873809|FG000|COMPLETED|Overall Study||968||
48225494|NCT02746107|100873809|FG000|NOT COMPLETED|Overall Study||0||
48225495|NCT01641900|100873810|FG000|STARTED|Overall Study||28||
48225496|NCT01641900|100873811|FG001|STARTED|Overall Study||31||
48225497|NCT01641900|100873810|FG000|Completed Placebo Intervention|Overall Study||27||
48225498|NCT01641900|100873811|FG001|Completed Placebo Intervention|Overall Study||29||
48225499|NCT01641900|100873810|FG000|Completed Drug Intervention|Overall Study||26||
48225500|NCT01641900|100873811|FG001|Completed Drug Intervention|Overall Study||29||
48225501|NCT01641900|100873810|FG000|COMPLETED|Overall Study||26||
48225502|NCT01641900|100873811|FG001|COMPLETED|Overall Study||29||
48225503|NCT01641900|100873810|FG000|NOT COMPLETED|Overall Study||2||
48225504|NCT01641900|100873811|FG001|NOT COMPLETED|Overall Study||2||
48225505|NCT02132520|100873812|FG000|STARTED|Overall Study||0||
48225506|NCT02132520|100873813|FG001|STARTED|Overall Study||1||
48225507|NCT02132520|100873814|FG002|STARTED|Overall Study||2||
48225508|NCT02132520|100873812|FG000|COMPLETED|Overall Study||0||
48225509|NCT02132520|100873813|FG001|COMPLETED|Overall Study||1||
48225510|NCT02132520|100873814|FG002|COMPLETED|Overall Study||2||
48225511|NCT02132520|100873812|FG000|NOT COMPLETED|Overall Study||0||
48225512|NCT02132520|100873813|FG001|NOT COMPLETED|Overall Study||0||
48225513|NCT02132520|100873814|FG002|NOT COMPLETED|Overall Study||0||
48225514|NCT03113409|100873815|FG000|STARTED|Overall Study||10||
48225515|NCT03113409|100873816|FG001|STARTED|Overall Study||0||
48225516|NCT03113409|100873817|FG002|STARTED|Overall Study||0||
48225517|NCT03113409|100873815|FG000|COMPLETED|Overall Study||5||
48225518|NCT03113409|100873816|FG001|COMPLETED|Overall Study||0||
48225519|NCT03113409|100873817|FG002|COMPLETED|Overall Study||0||
48225520|NCT03113409|100873815|FG000|NOT COMPLETED|Overall Study||5||
48225521|NCT03113409|100873816|FG001|NOT COMPLETED|Overall Study||0||
48225522|NCT03113409|100873817|FG002|NOT COMPLETED|Overall Study||0||
48225523|NCT01766206|100873818|FG000|STARTED|Overall Study||3939|Among 3939 subjects, 15 are in the ≥ 56 age category (outside the range defined as per the protocol)|
48225524|NCT01766206|100873818|FG000|COMPLETED|Overall Study||3888||
48225525|NCT01766206|100873818|FG000|NOT COMPLETED|Overall Study||51||
48225526|NCT00609869|100873819|FG000|STARTED|Overall Study||29||
48225527|NCT00609869|100873819|FG000|COMPLETED|Overall Study||18||
48225528|NCT00609869|100873819|FG000|NOT COMPLETED|Overall Study||11||
48225529|NCT00663819|100873820|FG000|STARTED|Overall Study||123||
48225530|NCT00663819|100873821|FG001|STARTED|Overall Study||135||
48225531|NCT00663819|100873820|FG000|COMPLETED|Overall Study||123||
48225532|NCT00663819|100873821|FG001|COMPLETED|Overall Study||135||
48225533|NCT00663819|100873820|FG000|NOT COMPLETED|Overall Study||0||
48225534|NCT00663819|100873821|FG001|NOT COMPLETED|Overall Study||0||
48225535|NCT01006538|100873822|FG000|STARTED|Overall Study||244||
48225536|NCT01006538|100873823|FG001|STARTED|Overall Study||119||
48225537|NCT01006538|100873822|FG000|COMPLETED|Overall Study||233||
48225538|NCT01006538|100873823|FG001|COMPLETED|Overall Study||115||
48225539|NCT01006538|100873822|FG000|NOT COMPLETED|Overall Study||11||
48225540|NCT01006538|100873823|FG001|NOT COMPLETED|Overall Study||4||
48225541|NCT00512252|100873824|FG000|STARTED|Overall Study||3||
48225542|NCT00512252|100873825|FG001|STARTED|Overall Study||3||
48225543|NCT00512252|100873826|FG002|STARTED|Overall Study||46||
48225544|NCT00512252|100873824|FG000|COMPLETED|Overall Study||3||
48225545|NCT00512252|100873825|FG001|COMPLETED|Overall Study||3||
48225546|NCT00512252|100873826|FG002|COMPLETED|Overall Study||43||
48225547|NCT00512252|100873824|FG000|NOT COMPLETED|Overall Study||0||
48225548|NCT00512252|100873825|FG001|NOT COMPLETED|Overall Study||0||
48225549|NCT00512252|100873826|FG002|NOT COMPLETED|Overall Study||3||
48225550|NCT01499849|100873827|FG000|STARTED|Overall Study||266||
48225551|NCT01499849|100873828|FG001|STARTED|Overall Study||266||
48225552|NCT01499849|100873827|FG000|COMPLETED|Overall Study||42||
48225553|NCT01499849|100873828|FG001|COMPLETED|Overall Study||40||
48225554|NCT01499849|100873827|FG000|NOT COMPLETED|Overall Study||224||
48225555|NCT01499849|100873828|FG001|NOT COMPLETED|Overall Study||226||
48225556|NCT00698867|100873829|FG000|STARTED|Overall Study||118||118
48225557|NCT00698867|100873829|FG000|Subjects With 1 Year Data|Overall Study||68||68
48225558|NCT00698867|100873829|FG000|Subjects With 2 Year Data|Overall Study||55||55
48225559|NCT00698867|100873829|FG000|Subjects With 3 Year Data|Overall Study||35||35
48225560|NCT00698867|100873829|FG000|Subjects With 4 Year Data|Overall Study||34||34
48225561|NCT00698867|100873829|FG000|COMPLETED|Overall Study||27||27
48225562|NCT00698867|100873829|FG000|NOT COMPLETED|Overall Study||91||91
48225563|NCT00836498|100873830|FG000|STARTED|Overall Study||44||
48225564|NCT00836498|100873831|FG001|STARTED|Overall Study||22||
48225565|NCT00836498|100873830|FG000|COMPLETED|Overall Study||40||
48225566|NCT00836498|100873831|FG001|COMPLETED|Overall Study||21||
48225567|NCT00836498|100873830|FG000|NOT COMPLETED|Overall Study||4||
48225568|NCT00836498|100873831|FG001|NOT COMPLETED|Overall Study||1||
48225569|NCT01823224|100873832|FG000|STARTED|Overall Study||34||
48225570|NCT01823224|100873833|FG001|STARTED|Overall Study||33||
48225571|NCT01823224|100873832|FG000|COMPLETED|Overall Study||28||
48225572|NCT01823224|100873833|FG001|COMPLETED|Overall Study||22||
48225573|NCT01823224|100873832|FG000|NOT COMPLETED|Overall Study||6||
48225574|NCT01823224|100873833|FG001|NOT COMPLETED|Overall Study||11||
48225575|NCT02722434|100873834|FG000|STARTED|Overall Study||25|Registered/Randomized|
48225576|NCT02722434|100873835|FG001|STARTED|Overall Study||25|Registered/Randomized|
48225577|NCT02722434|100873834|FG000|Started Treatment|Overall Study||24||
48225578|NCT02722434|100873835|FG001|Started Treatment|Overall Study||25||
48225579|NCT02722434|100873834|FG000|COMPLETED|Overall Study||24|Completed Treatment|
48225580|NCT02722434|100873835|FG001|COMPLETED|Overall Study||22|Completed Treatment|
48225581|NCT02722434|100873834|FG000|NOT COMPLETED|Overall Study||1||
48225582|NCT02722434|100873835|FG001|NOT COMPLETED|Overall Study||3||
48225583|NCT00518206|100873836|FG000|STARTED|Overall Study||27||
48225584|NCT00518206|100873837|FG001|STARTED|Overall Study||19||
48225585|NCT00518206|100873836|FG000|COMPLETED|Overall Study||16||
48225586|NCT00518206|100873837|FG001|COMPLETED|Overall Study||13||
48225587|NCT00518206|100873836|FG000|NOT COMPLETED|Overall Study||11||
48225588|NCT00518206|100873837|FG001|NOT COMPLETED|Overall Study||6||
48225589|NCT00605306|100873838|FG000|STARTED|Overall Study||14||
48225590|NCT00605306|100873839|FG001|STARTED|Overall Study||14||
48225591|NCT00605306|100873838|FG000|COMPLETED|Overall Study||14||
48225592|NCT00605306|100873839|FG001|COMPLETED|Overall Study||13||
48225593|NCT00605306|100873838|FG000|NOT COMPLETED|Overall Study||0||
48225594|NCT00605306|100873839|FG001|NOT COMPLETED|Overall Study||1||
48225595|NCT00557284|100873840|FG000|STARTED|Overall Study||9||
48225596|NCT00557284|100873841|FG001|STARTED|Overall Study||11||
48225597|NCT00557284|100873840|FG000|COMPLETED|Overall Study||9||
48225598|NCT00557284|100873841|FG001|COMPLETED|Overall Study||11||
48225599|NCT00557284|100873840|FG000|NOT COMPLETED|Overall Study||0||
48225600|NCT00557284|100873841|FG001|NOT COMPLETED|Overall Study||0||
48225601|NCT04990388|100873842|FG000|STARTED|Overall Study||4||
48225602|NCT04990388|100873843|FG001|STARTED|Overall Study||4||
48225603|NCT04990388|100873842|FG000|COMPLETED|Overall Study||4||
48225604|NCT04990388|100873843|FG001|COMPLETED|Overall Study||4||
48225605|NCT04990388|100873842|FG000|NOT COMPLETED|Overall Study||0||
48225606|NCT04990388|100873843|FG001|NOT COMPLETED|Overall Study||0||
48225607|NCT03697603|100873844|FG000|STARTED|Overall Study||250||
48225608|NCT03697603|100873845|FG001|STARTED|Overall Study||246||
48225609|NCT03697603|100873846|FG002|STARTED|Overall Study||244||
48225610|NCT03697603|100873844|FG000|COMPLETED|Overall Study||238||
48225611|NCT03697603|100873845|FG001|COMPLETED|Overall Study||219||
48225612|NCT03697603|100873846|FG002|COMPLETED|Overall Study||232||
48225613|NCT03697603|100873844|FG000|NOT COMPLETED|Overall Study||12||
48225614|NCT03697603|100873845|FG001|NOT COMPLETED|Overall Study||27||
48225615|NCT03697603|100873846|FG002|NOT COMPLETED|Overall Study||12||
48225616|NCT02555306|100873847|FG000|STARTED|Overall Study||3||
48225617|NCT02555306|100873848|FG001|STARTED|Overall Study||3||
48225618|NCT02555306|100873849|FG002|STARTED|Overall Study||3||
48225619|NCT02555306|100873850|FG003|STARTED|Overall Study||3||
48225620|NCT02555306|100873847|FG000|COMPLETED|Overall Study||3||
48225621|NCT02555306|100873848|FG001|COMPLETED|Overall Study||3||
48225622|NCT02555306|100873849|FG002|COMPLETED|Overall Study||3||
48225623|NCT02555306|100873850|FG003|COMPLETED|Overall Study||3||
48225624|NCT02555306|100873847|FG000|NOT COMPLETED|Overall Study||0||
48225625|NCT02555306|100873848|FG001|NOT COMPLETED|Overall Study||0||
48225626|NCT02555306|100873849|FG002|NOT COMPLETED|Overall Study||0||
48225627|NCT02555306|100873850|FG003|NOT COMPLETED|Overall Study||0||
48225628|NCT02432300|100873851|FG000|STARTED|Overall Study||17||
48225629|NCT02432300|100873851|FG000|COMPLETED|Overall Study||13||
48225630|NCT02432300|100873851|FG000|NOT COMPLETED|Overall Study||4||
48225631|NCT00843050|100873852|FG000|STARTED|Overall Study||13||
48225632|NCT00843050|100873852|FG000|COMPLETED|Overall Study||0||
48225633|NCT00843050|100873852|FG000|NOT COMPLETED|Overall Study||13||
48225634|NCT00960206|100873853|FG000|STARTED|Overall Study||190||
48225635|NCT00960206|100873854|FG001|STARTED|Overall Study||185||
48225636|NCT00960206|100873855|FG002|STARTED|Overall Study||89||
48225637|NCT00960206|100873853|FG000|COMPLETED|Overall Study||150||
48225638|NCT00960206|100873854|FG001|COMPLETED|Overall Study||158||
48225639|NCT00960206|100873855|FG002|COMPLETED|Overall Study||77||
48225640|NCT00960206|100873853|FG000|NOT COMPLETED|Overall Study||40||
48225641|NCT00960206|100873854|FG001|NOT COMPLETED|Overall Study||27||
48225642|NCT00960206|100873855|FG002|NOT COMPLETED|Overall Study||12||
48225643|NCT02909959|100873856|FG000|STARTED|Overall Study||24||
48225644|NCT02909959|100873857|FG001|STARTED|Overall Study||24||
48225645|NCT02909959|100873856|FG000|COMPLETED|Overall Study||24||
48225646|NCT02909959|100873857|FG001|COMPLETED|Overall Study||24||
48225647|NCT02909959|100873856|FG000|NOT COMPLETED|Overall Study||0||
48225648|NCT02909959|100873857|FG001|NOT COMPLETED|Overall Study||0||
48225649|NCT01579318|100873858|FG000|STARTED|Overall Study||2||
48225650|NCT01579318|100873858|FG000|COMPLETED|Overall Study||1||
48225651|NCT01579318|100873858|FG000|NOT COMPLETED|Overall Study||1||
48225652|NCT01738698|100873859|FG000|STARTED|Overall Study||0||
48225653|NCT01738698|100873860|FG001|STARTED|Overall Study||0||
48225654|NCT01738698|100873861|FG002|STARTED|Overall Study||0||
48225655|NCT01738698|100873862|FG003|STARTED|Overall Study||0||
48225656|NCT01738698|100873859|FG000|COMPLETED|Overall Study||0||
48225657|NCT01738698|100873860|FG001|COMPLETED|Overall Study||0||
48225658|NCT01738698|100873861|FG002|COMPLETED|Overall Study||0||
48225659|NCT01738698|100873862|FG003|COMPLETED|Overall Study||0||
48225660|NCT01738698|100873859|FG000|NOT COMPLETED|Overall Study||0||
48225661|NCT01738698|100873860|FG001|NOT COMPLETED|Overall Study||0||
48225662|NCT01738698|100873861|FG002|NOT COMPLETED|Overall Study||0||
48225663|NCT01738698|100873862|FG003|NOT COMPLETED|Overall Study||0||
48225664|NCT03293238|100873863|FG000|STARTED|Overall Study||19||
48225665|NCT03293238|100873864|FG001|STARTED|Overall Study||16||
48225666|NCT03293238|100873865|FG002|STARTED|Overall Study||14||
48225667|NCT03293238|100873866|FG003|STARTED|Overall Study||14||
48225668|NCT03293238|100873863|FG000|COMPLETED|Overall Study||19||
48225669|NCT03293238|100873864|FG001|COMPLETED|Overall Study||16||
48225670|NCT03293238|100873865|FG002|COMPLETED|Overall Study||14||
48225671|NCT03293238|100873866|FG003|COMPLETED|Overall Study||14||
48225672|NCT03293238|100873863|FG000|NOT COMPLETED|Overall Study||0||
48225673|NCT03293238|100873864|FG001|NOT COMPLETED|Overall Study||0||
48225674|NCT03293238|100873865|FG002|NOT COMPLETED|Overall Study||0||
48225675|NCT03293238|100873866|FG003|NOT COMPLETED|Overall Study||0||
48225676|NCT02168309|100873867|FG000|STARTED|Overall Study||25||
48225677|NCT02168309|100873868|FG001|STARTED|Overall Study||25||
48225678|NCT02168309|100873867|FG000|COMPLETED|Overall Study||25||
48225679|NCT02168309|100873868|FG001|COMPLETED|Overall Study||25||
48225680|NCT02168309|100873867|FG000|NOT COMPLETED|Overall Study||0||
48225681|NCT02168309|100873868|FG001|NOT COMPLETED|Overall Study||0||
48225682|NCT00824408|100873869|FG000|STARTED|Run-in Phase||6||
48225683|NCT00824408|100873870|FG001|STARTED|Run-in Phase||6||
48225684|NCT00824408|100873871|FG002|STARTED|Run-in Phase||0||
48225685|NCT00824408|100873872|FG003|STARTED|Run-in Phase||0||
48225686|NCT00824408|100873873|FG004|STARTED|Run-in Phase||0||
48225687|NCT00824408|100873869|FG000|COMPLETED|Run-in Phase||0||
48225688|NCT00824408|100873870|FG001|COMPLETED|Run-in Phase||0||
48225689|NCT00824408|100873871|FG002|COMPLETED|Run-in Phase||0||
48225690|NCT00824408|100873872|FG003|COMPLETED|Run-in Phase||0||
48225691|NCT00824408|100873873|FG004|COMPLETED|Run-in Phase||0||
48225692|NCT00824408|100873869|FG000|NOT COMPLETED|Run-in Phase||6||
48225693|NCT00824408|100873870|FG001|NOT COMPLETED|Run-in Phase||6||
48225694|NCT00824408|100873871|FG002|NOT COMPLETED|Run-in Phase||0||
48225695|NCT00824408|100873872|FG003|NOT COMPLETED|Run-in Phase||0||
48225696|NCT00824408|100873873|FG004|NOT COMPLETED|Run-in Phase||0||
48225697|NCT00824408|100873869|FG000|STARTED|Randomized Phase||0||
48225698|NCT00824408|100873870|FG001|STARTED|Randomized Phase||0||
48225699|NCT00824408|100873871|FG002|STARTED|Randomized Phase||37||
48225700|NCT00824408|100873872|FG003|STARTED|Randomized Phase||47||
48225701|NCT00824408|100873873|FG004|STARTED|Randomized Phase||47||
48225702|NCT00824408|100873869|FG000|COMPLETED|Randomized Phase||0||
48225703|NCT00824408|100873870|FG001|COMPLETED|Randomized Phase||0||
48225704|NCT00824408|100873871|FG002|COMPLETED|Randomized Phase||1||
48225705|NCT00824408|100873872|FG003|COMPLETED|Randomized Phase||1||
48225706|NCT00824408|100873873|FG004|COMPLETED|Randomized Phase||1||
48225707|NCT00824408|100873869|FG000|NOT COMPLETED|Randomized Phase||0||
48225708|NCT00824408|100873870|FG001|NOT COMPLETED|Randomized Phase||0||
48225709|NCT00824408|100873871|FG002|NOT COMPLETED|Randomized Phase||36||
48225710|NCT00824408|100873872|FG003|NOT COMPLETED|Randomized Phase||46||
48225711|NCT00824408|100873873|FG004|NOT COMPLETED|Randomized Phase||46||
48225712|NCT02551224|100873874|FG000|STARTED|First Intervention||50||
48225713|NCT02551224|100873875|FG001|STARTED|First Intervention||50||
48225714|NCT02551224|100873874|FG000|COMPLETED|First Intervention||50||
48225715|NCT02551224|100873875|FG001|COMPLETED|First Intervention||50||
48225716|NCT02551224|100873874|FG000|NOT COMPLETED|First Intervention||0||
48225717|NCT02551224|100873875|FG001|NOT COMPLETED|First Intervention||0||
48225718|NCT02551224|100873874|FG000|STARTED|Second Intervention (5 Min After First )||50||
48225719|NCT02551224|100873875|FG001|STARTED|Second Intervention (5 Min After First )||50||
48225720|NCT02551224|100873874|FG000|COMPLETED|Second Intervention (5 Min After First )||50||
48225721|NCT02551224|100873875|FG001|COMPLETED|Second Intervention (5 Min After First )||50||
48225722|NCT02551224|100873874|FG000|NOT COMPLETED|Second Intervention (5 Min After First )||0||
48225723|NCT02551224|100873875|FG001|NOT COMPLETED|Second Intervention (5 Min After First )||0||
48225724|NCT01536093|100873876|FG000|STARTED|Overall Study||24||
48225725|NCT01536093|100873877|FG001|STARTED|Overall Study||24||
48225726|NCT01536093|100873876|FG000|COMPLETED|Overall Study||21||
48225727|NCT01536093|100873877|FG001|COMPLETED|Overall Study||21||
48225728|NCT01536093|100873876|FG000|NOT COMPLETED|Overall Study||3||
48225729|NCT01536093|100873877|FG001|NOT COMPLETED|Overall Study||3||
48225730|NCT03392194|100873878|FG000|STARTED|Overall Study||16||
48225731|NCT03392194|100873879|FG001|STARTED|Overall Study||17||
48225732|NCT03392194|100873878|FG000|COMPLETED|Overall Study||14||
48225733|NCT03392194|100873879|FG001|COMPLETED|Overall Study||15||
48225734|NCT03392194|100873878|FG000|NOT COMPLETED|Overall Study||2||
48225735|NCT03392194|100873879|FG001|NOT COMPLETED|Overall Study||2||
48225736|NCT02132676|100873880|FG000|STARTED|Overall Study||727||
48225737|NCT02132676|100873881|FG001|STARTED|Overall Study||809||
48225738|NCT02132676|100873880|FG000|COMPLETED|Overall Study||727||
48225739|NCT02132676|100873881|FG001|COMPLETED|Overall Study||809||
48225740|NCT02132676|100873880|FG000|NOT COMPLETED|Overall Study||0||
48225741|NCT02132676|100873881|FG001|NOT COMPLETED|Overall Study||0||
48225742|NCT02227706|100873882|FG000|STARTED|Overall Study||20||
48225743|NCT02227706|100873883|FG001|STARTED|Overall Study||20||
48225744|NCT02227706|100873882|FG000|COMPLETED|Overall Study||20||
48225745|NCT02227706|100873883|FG001|COMPLETED|Overall Study||20||
48225746|NCT02227706|100873882|FG000|NOT COMPLETED|Overall Study||0||
48225747|NCT02227706|100873883|FG001|NOT COMPLETED|Overall Study||0||
48225748|NCT00229970|100873884|FG000|STARTED|Overall Study||78||
48225749|NCT00229970|100873885|FG001|STARTED|Overall Study||72||
48225750|NCT00229970|100873886|FG002|STARTED|Overall Study||75||
48225751|NCT00229970|100873884|FG000|COMPLETED|Overall Study||78||
48225752|NCT00229970|100873885|FG001|COMPLETED|Overall Study||72||
48225753|NCT00229970|100873886|FG002|COMPLETED|Overall Study||75||
48225754|NCT00229970|100873884|FG000|NOT COMPLETED|Overall Study||0||
48225755|NCT00229970|100873885|FG001|NOT COMPLETED|Overall Study||0||
48225756|NCT00229970|100873886|FG002|NOT COMPLETED|Overall Study||0||
48225757|NCT01827839|100873887|FG000|STARTED|Overall Study||96||
48225758|NCT01827839|100873887|FG000|COMPLETED|Overall Study||93||
48225759|NCT01827839|100873887|FG000|NOT COMPLETED|Overall Study||3||
48672123|NCT02950259|101982554|FG001|NOT COMPLETED|Overall Study||0||
48672124|NCT01968980|101982555|FG000|STARTED|Overall Study||185||
48225760|NCT00146172|100873888|FG000|STARTED|Overall Study||3||
48225761|NCT00146172|100873889|FG001|STARTED|Overall Study||4||
48225762|NCT00146172|100873890|FG002|STARTED|Overall Study||4||
48225763|NCT00146172|100873891|FG003|STARTED|Overall Study||6||
48225764|NCT00146172|100873892|FG004|STARTED|Overall Study||3||
48225765|NCT00146172|100873893|FG005|STARTED|Overall Study||7||
48225766|NCT00146172|100873894|FG006|STARTED|Overall Study||6||
48225767|NCT00146172|100873895|FG007|STARTED|Overall Study||40||
48225768|NCT00146172|100873888|FG000|Received Drug|Overall Study||3||
48225769|NCT00146172|100873889|FG001|Received Drug|Overall Study||4||
48225770|NCT00146172|100873890|FG002|Received Drug|Overall Study||4||
48225771|NCT00146172|100873891|FG003|Received Drug|Overall Study||6||
48225772|NCT00146172|100873892|FG004|Received Drug|Overall Study||3||
48225773|NCT00146172|100873893|FG005|Received Drug|Overall Study||7||
48225774|NCT00146172|100873894|FG006|Received Drug|Overall Study||6||
48225775|NCT00146172|100873895|FG007|Received Drug|Overall Study||39||
48225776|NCT00146172|100873888|FG000|COMPLETED|Overall Study||0||
48225777|NCT00146172|100873889|FG001|COMPLETED|Overall Study||0||
48225778|NCT00146172|100873890|FG002|COMPLETED|Overall Study||0||
48225779|NCT00146172|100873891|FG003|COMPLETED|Overall Study||0||
48225780|NCT00146172|100873892|FG004|COMPLETED|Overall Study||0||
48225781|NCT00146172|100873893|FG005|COMPLETED|Overall Study||0||
48225782|NCT00146172|100873894|FG006|COMPLETED|Overall Study||0||
48225783|NCT00146172|100873895|FG007|COMPLETED|Overall Study||0||
48225784|NCT00146172|100873888|FG000|NOT COMPLETED|Overall Study||3||
48225785|NCT00146172|100873889|FG001|NOT COMPLETED|Overall Study||4||
48225786|NCT00146172|100873890|FG002|NOT COMPLETED|Overall Study||4||
48225787|NCT00146172|100873891|FG003|NOT COMPLETED|Overall Study||6||
48225788|NCT00146172|100873892|FG004|NOT COMPLETED|Overall Study||3||
48225789|NCT00146172|100873893|FG005|NOT COMPLETED|Overall Study||7||
48225790|NCT00146172|100873894|FG006|NOT COMPLETED|Overall Study||6||
48225791|NCT00146172|100873895|FG007|NOT COMPLETED|Overall Study||40||
48225792|NCT04604652|100873896|FG000|STARTED|Overall Study||24||
48225793|NCT04604652|100873896|FG000|COMPLETED|Overall Study||24||
48225794|NCT04604652|100873896|FG000|NOT COMPLETED|Overall Study||0||
48225795|NCT02734355|100873897|FG000|STARTED|Overall Study||34||
48225796|NCT02734355|100873898|FG001|STARTED|Overall Study||30||
48225797|NCT02734355|100873897|FG000|COMPLETED|Overall Study||34||
48225798|NCT02734355|100873898|FG001|COMPLETED|Overall Study||30||
48225799|NCT02734355|100873897|FG000|NOT COMPLETED|Overall Study||0||
48225800|NCT02734355|100873898|FG001|NOT COMPLETED|Overall Study||0||
48225801|NCT00724126|100873899|FG000|STARTED|Overall Study||321||
48225802|NCT00724126|100873900|FG001|STARTED|Overall Study||316||
48225803|NCT00724126|100873899|FG000|COMPLETED|Overall Study||302||
48225804|NCT00724126|100873900|FG001|COMPLETED|Overall Study||301||
48225805|NCT00724126|100873899|FG000|NOT COMPLETED|Overall Study||19||
48225806|NCT00724126|100873900|FG001|NOT COMPLETED|Overall Study||15||
48225807|NCT04205669|100873901|FG000|STARTED|Overall Study||47||
48225808|NCT04205669|100873902|FG001|STARTED|Overall Study||57||
48225809|NCT04205669|100873901|FG000|COMPLETED|Overall Study||34||
48225810|NCT04205669|100873902|FG001|COMPLETED|Overall Study||45||
48225811|NCT04205669|100873901|FG000|NOT COMPLETED|Overall Study||13||
48225812|NCT04205669|100873902|FG001|NOT COMPLETED|Overall Study||12||
48225813|NCT03897699|100873903|FG000|STARTED|Overall Study||21||
48225814|NCT03897699|100873904|FG001|STARTED|Overall Study||22||
48225815|NCT03897699|100873903|FG000|COMPLETED|Overall Study||16||
48225816|NCT03897699|100873904|FG001|COMPLETED|Overall Study||20||
48225817|NCT03897699|100873903|FG000|NOT COMPLETED|Overall Study||5||
48225818|NCT03897699|100873904|FG001|NOT COMPLETED|Overall Study||2||
48225819|NCT00845520|100873905|FG000|STARTED|Overall Study||25||25
48225820|NCT00845520|100873906|FG001|STARTED|Overall Study||25||25
48225821|NCT00845520|100873907|FG002|STARTED|Overall Study||24||24
48225822|NCT00845520|100873905|FG000|COMPLETED|Overall Study||23||23
48225823|NCT00845520|100873906|FG001|COMPLETED|Overall Study||23||23
48225824|NCT00845520|100873907|FG002|COMPLETED|Overall Study||23||23
48225825|NCT00845520|100873905|FG000|NOT COMPLETED|Overall Study||2||2
48225826|NCT00845520|100873906|FG001|NOT COMPLETED|Overall Study||2||2
48225827|NCT00845520|100873907|FG002|NOT COMPLETED|Overall Study||1||1
48225828|NCT04230941|100873908|FG000|STARTED|Overall Study||4||
48225829|NCT04230941|100873909|FG001|STARTED|Overall Study||1||
48225830|NCT04230941|100873908|FG000|COMPLETED|Overall Study||4||
48225831|NCT04230941|100873909|FG001|COMPLETED|Overall Study||1||
48225832|NCT04230941|100873908|FG000|NOT COMPLETED|Overall Study||0||
48225833|NCT04230941|100873909|FG001|NOT COMPLETED|Overall Study||0||
48225834|NCT02106884|100873910|FG000|STARTED|Overall Study||72||
48225835|NCT02106884|100873911|FG001|STARTED|Overall Study||74||
48225836|NCT02106884|100873910|FG000|COMPLETED|Overall Study||72||
48225837|NCT02106884|100873911|FG001|COMPLETED|Overall Study||73||
48225838|NCT02106884|100873910|FG000|NOT COMPLETED|Overall Study||0||
48225839|NCT02106884|100873911|FG001|NOT COMPLETED|Overall Study||1||
48225840|NCT03132298|100873912|FG000|STARTED|Overall Study||48||
48225841|NCT03132298|100873913|FG001|STARTED|Overall Study||48||
48225842|NCT03132298|100873912|FG000|COMPLETED|Overall Study||36||
48225843|NCT03132298|100873913|FG001|COMPLETED|Overall Study||35||
48225844|NCT03132298|100873912|FG000|NOT COMPLETED|Overall Study||12||
48225845|NCT03132298|100873913|FG001|NOT COMPLETED|Overall Study||13||
48225846|NCT01969916|100873914|FG000|STARTED|Overall Study||150||
48225847|NCT01969916|100873914|FG000|COMPLETED|Overall Study||105||
48225848|NCT01969916|100873914|FG000|NOT COMPLETED|Overall Study||45||
48225849|NCT03559205|100873915|FG000|STARTED|Overall Study||177||
48225850|NCT03559205|100873916|FG001|STARTED|Overall Study||144||
48225851|NCT03559205|100873915|FG000|Baseline Data|Overall Study||141||
48225852|NCT03559205|100873916|FG001|Baseline Data|Overall Study||132||
48225853|NCT03559205|100873915|FG000|COMPLETED|Overall Study||65||
48225854|NCT03559205|100873916|FG001|COMPLETED|Overall Study||57||
48225855|NCT03559205|100873915|FG000|NOT COMPLETED|Overall Study||112||
48225856|NCT03559205|100873916|FG001|NOT COMPLETED|Overall Study||87||
48225857|NCT01335867|100873917|FG000|STARTED|Overall Study||16||
48225858|NCT01335867|100873918|FG001|STARTED|Overall Study||16||
48225859|NCT01335867|100873917|FG000|COMPLETED|Overall Study||9||
48225860|NCT01335867|100873918|FG001|COMPLETED|Overall Study||12||
48225861|NCT01335867|100873917|FG000|NOT COMPLETED|Overall Study||7||
48225862|NCT01335867|100873918|FG001|NOT COMPLETED|Overall Study||4||
48225863|NCT02159352|100873919|FG000|STARTED|Overall Study||14||
48225864|NCT02159352|100873920|FG001|STARTED|Overall Study||14||
48225865|NCT02159352|100873919|FG000|Phase 1 (Day 1- 4)|Overall Study||14||
48225866|NCT02159352|100873920|FG001|Phase 1 (Day 1- 4)|Overall Study||14||
48225867|NCT02159352|100873919|FG000|Phase 2 (Day 5-14)|Overall Study||11||
48225868|NCT02159352|100873920|FG001|Phase 2 (Day 5-14)|Overall Study||12||
48225869|NCT02159352|100873919|FG000|COMPLETED|Overall Study||11||
48225870|NCT02159352|100873920|FG001|COMPLETED|Overall Study||12||
48225871|NCT02159352|100873919|FG000|NOT COMPLETED|Overall Study||3||
48225872|NCT02159352|100873920|FG001|NOT COMPLETED|Overall Study||2||
48225873|NCT02807857|100873921|FG000|STARTED|Enrolled Set||1415||
48225874|NCT02807857|100873921|FG000|COMPLETED|Enrolled Set||864||
48225875|NCT02807857|100873921|FG000|NOT COMPLETED|Enrolled Set||551||
48225876|NCT02807857|100873921|FG000|STARTED|Follow-Up Set||864||
48225877|NCT02807857|100873921|FG000|COMPLETED|Follow-Up Set||680||
48225878|NCT02807857|100873921|FG000|NOT COMPLETED|Follow-Up Set||184||
48225879|NCT01833455|100873922|FG000|STARTED|Overall Study||4||
48225880|NCT01833455|100873923|FG001|STARTED|Overall Study||4||
48225881|NCT01833455|100873922|FG000|Completed 1st Baseline|Overall Study||4||
48225882|NCT01833455|100873923|FG001|Completed 1st Baseline|Overall Study||4||
48225883|NCT01833455|100873922|FG000|Completed 1st Intervention|Overall Study||3||
48225884|NCT01833455|100873923|FG001|Completed 1st Intervention|Overall Study||4||
48225885|NCT01833455|100873922|FG000|Completed 2nd Baseline (Washout)|Overall Study||3||
48225886|NCT01833455|100873923|FG001|Completed 2nd Baseline (Washout)|Overall Study||4||
48225887|NCT01833455|100873922|FG000|COMPLETED|Overall Study||3||
48225888|NCT01833455|100873923|FG001|COMPLETED|Overall Study||4||
48225889|NCT01833455|100873922|FG000|NOT COMPLETED|Overall Study||1||
48225890|NCT01833455|100873923|FG001|NOT COMPLETED|Overall Study||0||
48225891|NCT02241785|100873924|FG000|STARTED|Overall Study||47||
48225892|NCT02241785|100873924|FG000|COMPLETED|Overall Study||0||
48225893|NCT02241785|100873924|FG000|NOT COMPLETED|Overall Study||47||
48225894|NCT01613417|100873925|FG000|STARTED|First Injection||113||
48225895|NCT01613417|100873926|FG001|STARTED|First Injection||116||
48225896|NCT01613417|100873925|FG000|COMPLETED|First Injection||113||
48225897|NCT01613417|100873926|FG001|COMPLETED|First Injection||116||
48225898|NCT01613417|100873925|FG000|NOT COMPLETED|First Injection||0||
48225899|NCT01613417|100873926|FG001|NOT COMPLETED|First Injection||0||
48225900|NCT01613417|100873925|FG000|STARTED|Washout (no Second Injection/MRI)||113||
48225901|NCT01613417|100873926|FG001|STARTED|Washout (no Second Injection/MRI)||116||
48225902|NCT01613417|100873925|FG000|COMPLETED|Washout (no Second Injection/MRI)||100||
48225903|NCT01613417|100873926|FG001|COMPLETED|Washout (no Second Injection/MRI)||109||
48225904|NCT01613417|100873925|FG000|NOT COMPLETED|Washout (no Second Injection/MRI)||13||
48225905|NCT01613417|100873926|FG001|NOT COMPLETED|Washout (no Second Injection/MRI)||7||
48225906|NCT01613417|100873925|FG000|STARTED|Second Injection||100||
48225907|NCT01613417|100873926|FG001|STARTED|Second Injection||109||
48225908|NCT01613417|100873925|FG000|COMPLETED|Second Injection||100||
48225909|NCT01613417|100873926|FG001|COMPLETED|Second Injection||109||
48225910|NCT01613417|100873925|FG000|NOT COMPLETED|Second Injection||0||
48225911|NCT01613417|100873926|FG001|NOT COMPLETED|Second Injection||0||
48225912|NCT02429115|100873927|FG000|STARTED|Overall Study||52|Includes patient participants and caregiver participants|
48225913|NCT02429115|100873928|FG001|STARTED|Overall Study||52|Includes patient participants and caregiver participants|
48225914|NCT02429115|100873929|FG002|STARTED|Overall Study||51|Includes patient participants and caregiver participants|
48225915|NCT02429115|100873930|FG003|STARTED|Overall Study||29|Includes patient participants and caregiver participants|
48225916|NCT02429115|100873931|FG004|STARTED|Overall Study||29|Includes patient participants and caregiver participants|
48225917|NCT02429115|100873932|FG005|STARTED|Overall Study||28|Includes patient participants and caregiver participants|
48225918|NCT02429115|100873927|FG000|COMPLETED|Overall Study||40||
48225919|NCT02429115|100873928|FG001|COMPLETED|Overall Study||42||
48225920|NCT02429115|100873929|FG002|COMPLETED|Overall Study||35||
48225921|NCT02429115|100873930|FG003|COMPLETED|Overall Study||21||
48225922|NCT02429115|100873931|FG004|COMPLETED|Overall Study||22||
48225923|NCT02429115|100873932|FG005|COMPLETED|Overall Study||27||
48225924|NCT02429115|100873927|FG000|NOT COMPLETED|Overall Study||12||
48225925|NCT02429115|100873928|FG001|NOT COMPLETED|Overall Study||10||
48370861|NCT05395351|101236551|FG001|NOT COMPLETED|Overall Study||0||
48225926|NCT02429115|100873929|FG002|NOT COMPLETED|Overall Study||16||
48225927|NCT02429115|100873930|FG003|NOT COMPLETED|Overall Study||8||
48225928|NCT02429115|100873931|FG004|NOT COMPLETED|Overall Study||7||
48225929|NCT02429115|100873932|FG005|NOT COMPLETED|Overall Study||1||
48225930|NCT03926026|100873933|FG000|STARTED|Overall Study||10||
48225931|NCT03926026|100873934|FG001|STARTED|Overall Study||5||
48225932|NCT03926026|100873935|FG002|STARTED|Overall Study||10||
48225933|NCT03926026|100873936|FG003|STARTED|Overall Study||11||
48225934|NCT03926026|100873933|FG000|COMPLETED|Overall Study||10||
48225935|NCT03926026|100873934|FG001|COMPLETED|Overall Study||5||
48225936|NCT03926026|100873935|FG002|COMPLETED|Overall Study||10||
48225937|NCT03926026|100873936|FG003|COMPLETED|Overall Study||11||
48225938|NCT03926026|100873933|FG000|NOT COMPLETED|Overall Study||0||
48225939|NCT03926026|100873934|FG001|NOT COMPLETED|Overall Study||0||
48225940|NCT03926026|100873935|FG002|NOT COMPLETED|Overall Study||0||
48225941|NCT03926026|100873936|FG003|NOT COMPLETED|Overall Study||0||
48225942|NCT01212822|100873937|FG000|STARTED|Overall Study||20||
48225943|NCT01212822|100873937|FG000|COMPLETED|Overall Study||20||
48225944|NCT01212822|100873937|FG000|NOT COMPLETED|Overall Study||0||
48225945|NCT02219659|100873938|FG000|STARTED|Overall Study||29||
48225946|NCT02219659|100873939|FG001|STARTED|Overall Study||30||
48225947|NCT02219659|100873940|FG002|STARTED|Overall Study||31||
48225948|NCT02219659|100873938|FG000|COMPLETED|Overall Study||27||
48225949|NCT02219659|100873939|FG001|COMPLETED|Overall Study||28||
48225950|NCT02219659|100873940|FG002|COMPLETED|Overall Study||31||
48225951|NCT02219659|100873938|FG000|NOT COMPLETED|Overall Study||2||
48225952|NCT02219659|100873939|FG001|NOT COMPLETED|Overall Study||2||
48225953|NCT02219659|100873940|FG002|NOT COMPLETED|Overall Study||0||
48225954|NCT01379651|100873941|FG000|STARTED|Overall Study||10||
48225955|NCT01379651|100873942|FG001|STARTED|Overall Study||10||
48225956|NCT01379651|100873941|FG000|COMPLETED|Overall Study||10||
48225957|NCT01379651|100873942|FG001|COMPLETED|Overall Study||10||
48225958|NCT01379651|100873941|FG000|NOT COMPLETED|Overall Study||0||
48225959|NCT01379651|100873942|FG001|NOT COMPLETED|Overall Study||0||
48225960|NCT04433091|100873943|FG000|STARTED|Overall Study||46||
48225961|NCT04433091|100873944|FG001|STARTED|Overall Study||43||
48225962|NCT04433091|100873943|FG000|COMPLETED|Overall Study||43||
48225963|NCT04433091|100873944|FG001|COMPLETED|Overall Study||39||
48225964|NCT04433091|100873943|FG000|NOT COMPLETED|Overall Study||3||
48225965|NCT04433091|100873944|FG001|NOT COMPLETED|Overall Study||4||
48225966|NCT01218009|100873945|FG000|STARTED|Overall Study||166||
48225967|NCT01218009|100873946|FG001|STARTED|Overall Study||165||
48225968|NCT01218009|100873945|FG000|COMPLETED|Overall Study||0||
48225969|NCT01218009|100873946|FG001|COMPLETED|Overall Study||0||
48225970|NCT01218009|100873945|FG000|NOT COMPLETED|Overall Study||166||
48225971|NCT01218009|100873946|FG001|NOT COMPLETED|Overall Study||165||
48225972|NCT00485693|100873947|FG000|STARTED|Overall Study||34||
48225973|NCT00485693|100873948|FG001|STARTED|Overall Study||104||
48225974|NCT00485693|100873947|FG000|COMPLETED|Overall Study||34||
48225975|NCT00485693|100873948|FG001|COMPLETED|Overall Study||104||
48225976|NCT00485693|100873947|FG000|NOT COMPLETED|Overall Study||0||
48225977|NCT00485693|100873948|FG001|NOT COMPLETED|Overall Study||0||
48225978|NCT03244800|100873949|FG000|STARTED|Overall Study||13||
48225979|NCT03244800|100873950|FG001|STARTED|Overall Study||26||
48225980|NCT03244800|100873951|FG002|STARTED|Overall Study||6||
48672125|NCT01968980|101982556|FG001|STARTED|Overall Study||185||
48672126|NCT01968980|101982555|FG000|COMPLETED|Overall Study||169||
48672127|NCT01968980|101982556|FG001|COMPLETED|Overall Study||171||
48672128|NCT01968980|101982555|FG000|NOT COMPLETED|Overall Study||16||
48672129|NCT01968980|101982556|FG001|NOT COMPLETED|Overall Study||14||
48672130|NCT03243084|101982557|FG000|STARTED|Session 1||11||
48672131|NCT03243084|101982558|FG001|STARTED|Session 1||10||
48672132|NCT03243084|101982557|FG000|COMPLETED|Session 1||11||
48672133|NCT03243084|101982558|FG001|COMPLETED|Session 1||10||
48672134|NCT03243084|101982557|FG000|NOT COMPLETED|Session 1||0||
48672135|NCT03243084|101982558|FG001|NOT COMPLETED|Session 1||0||
48672136|NCT03243084|101982557|FG000|STARTED|Washout (1-3 Weeks)||11||
48672137|NCT03243084|101982558|FG001|STARTED|Washout (1-3 Weeks)||10||
48672138|NCT03243084|101982557|FG000|COMPLETED|Washout (1-3 Weeks)||10||
48672139|NCT03243084|101982558|FG001|COMPLETED|Washout (1-3 Weeks)||10||
48672140|NCT03243084|101982557|FG000|NOT COMPLETED|Washout (1-3 Weeks)||1||
48672141|NCT03243084|101982558|FG001|NOT COMPLETED|Washout (1-3 Weeks)||0||
48672142|NCT03243084|101982557|FG000|STARTED|Session 2||10||
48672143|NCT03243084|101982558|FG001|STARTED|Session 2||10||
48672144|NCT03243084|101982557|FG000|COMPLETED|Session 2||10||
48672145|NCT03243084|101982558|FG001|COMPLETED|Session 2||10||
48672146|NCT03243084|101982557|FG000|NOT COMPLETED|Session 2||0||
48225981|NCT03244800|100873952|FG003|STARTED|Overall Study||20||
48225982|NCT03244800|100873949|FG000|COMPLETED|Overall Study||13||
48225983|NCT03244800|100873950|FG001|COMPLETED|Overall Study||25||
48225984|NCT03244800|100873951|FG002|COMPLETED|Overall Study||6||
48225985|NCT03244800|100873952|FG003|COMPLETED|Overall Study||18||
48225986|NCT03244800|100873949|FG000|NOT COMPLETED|Overall Study||0||
48672147|NCT03243084|101982558|FG001|NOT COMPLETED|Session 2||0||
48672148|NCT01378195|101982559|FG000|STARTED|Overall Study||75||
48225987|NCT03244800|100873950|FG001|NOT COMPLETED|Overall Study||1||
48225988|NCT03244800|100873951|FG002|NOT COMPLETED|Overall Study||0||
48225989|NCT03244800|100873952|FG003|NOT COMPLETED|Overall Study||2||
48225990|NCT00526994|100873953|FG000|STARTED|Overall Study||909||
48225991|NCT00526994|100873954|FG001|STARTED|Overall Study||893||
48225992|NCT00526994|100873955|FG002|STARTED|Overall Study||898||
48225993|NCT00526994|100873953|FG000|COMPLETED|Overall Study||801||
48225994|NCT00526994|100873954|FG001|COMPLETED|Overall Study||772||
48225995|NCT00526994|100873955|FG002|COMPLETED|Overall Study||791||
48225996|NCT00526994|100873953|FG000|NOT COMPLETED|Overall Study||108||
48225997|NCT00526994|100873954|FG001|NOT COMPLETED|Overall Study||121||
48225998|NCT00526994|100873955|FG002|NOT COMPLETED|Overall Study||107||
48672149|NCT01378195|101982560|FG001|STARTED|Overall Study||75||
48672150|NCT01378195|101982559|FG000|COMPLETED|Overall Study||46||
48225999|NCT01786876|100873956|FG000|STARTED|Overall Study||6||
48226000|NCT01786876|100873956|FG000|COMPLETED|Overall Study||6||
48226001|NCT01786876|100873956|FG000|NOT COMPLETED|Overall Study||0||
48226002|NCT02466958|100873957|FG000|STARTED|Overall Study||17||
48226003|NCT02466958|100873958|FG001|STARTED|Overall Study||12||
48226004|NCT02466958|100873957|FG000|COMPLETED|Overall Study||7||
48226005|NCT02466958|100873958|FG001|COMPLETED|Overall Study||9||
48226006|NCT02466958|100873957|FG000|NOT COMPLETED|Overall Study||10||
48226007|NCT02466958|100873958|FG001|NOT COMPLETED|Overall Study||3||
48226008|NCT02304757|100873959|FG000|STARTED|Overall Study||70||
48226009|NCT02304757|100873960|FG001|STARTED|Overall Study||72||
48226010|NCT02304757|100873959|FG000|COMPLETED|Overall Study||70||
48226011|NCT02304757|100873960|FG001|COMPLETED|Overall Study||72||
48226012|NCT02304757|100873959|FG000|NOT COMPLETED|Overall Study||0||
48226013|NCT02304757|100873960|FG001|NOT COMPLETED|Overall Study||0||
48226014|NCT00087022|100873961|FG000|STARTED|Overall Study||433|ITT Population|
48226015|NCT00087022|100873962|FG001|STARTED|Overall Study||431|ITT Population|
48226016|NCT00087022|100873961|FG000|Treated (Safety Population)|Overall Study||431||
48226017|NCT00087022|100873962|FG001|Treated (Safety Population)|Overall Study||424||
48226018|NCT00087022|100873961|FG000|COMPLETED|Overall Study||379||
48226019|NCT00087022|100873962|FG001|COMPLETED|Overall Study||376||
48226020|NCT00087022|100873961|FG000|NOT COMPLETED|Overall Study||54||
48226021|NCT00087022|100873962|FG001|NOT COMPLETED|Overall Study||55||
48226022|NCT02579915|100873963|FG000|STARTED|Overall Study||19||
48226023|NCT02579915|100873964|FG001|STARTED|Overall Study||21||
48226024|NCT02579915|100873963|FG000|COMPLETED|Overall Study||9||
48226025|NCT02579915|100873964|FG001|COMPLETED|Overall Study||16||
48226026|NCT02579915|100873963|FG000|NOT COMPLETED|Overall Study||10||
48226027|NCT02579915|100873964|FG001|NOT COMPLETED|Overall Study||5||
48226028|NCT01530334|100873965|FG000|STARTED|Overall Study||61||
48226029|NCT01530334|100873965|FG000|COMPLETED|Overall Study||10||
48226030|NCT01530334|100873965|FG000|NOT COMPLETED|Overall Study||51||
48226031|NCT02022657|100873966|FG000|STARTED|Overall Study||10||
48226032|NCT02022657|100873967|FG001|STARTED|Overall Study||8||
48226033|NCT02022657|100873968|FG002|STARTED|Overall Study||9||
48226034|NCT02022657|100873969|FG003|STARTED|Overall Study||8||
48226035|NCT02022657|100873970|FG004|STARTED|Overall Study||8||
48226036|NCT02022657|100873971|FG005|STARTED|Overall Study||9||
48226037|NCT02022657|100873966|FG000|COMPLETED|Overall Study||8||
48226038|NCT02022657|100873967|FG001|COMPLETED|Overall Study||8||
48226039|NCT02022657|100873968|FG002|COMPLETED|Overall Study||8||
48226040|NCT02022657|100873969|FG003|COMPLETED|Overall Study||8||
48226041|NCT02022657|100873970|FG004|COMPLETED|Overall Study||8||
48226042|NCT02022657|100873971|FG005|COMPLETED|Overall Study||8||
48226043|NCT02022657|100873966|FG000|NOT COMPLETED|Overall Study||2||
48226044|NCT02022657|100873967|FG001|NOT COMPLETED|Overall Study||0||
48226045|NCT02022657|100873968|FG002|NOT COMPLETED|Overall Study||1||
48226046|NCT02022657|100873969|FG003|NOT COMPLETED|Overall Study||0||
48226047|NCT02022657|100873970|FG004|NOT COMPLETED|Overall Study||0||
48226048|NCT02022657|100873971|FG005|NOT COMPLETED|Overall Study||1||
48226049|NCT00822900|100873972|FG000|STARTED|Overall Study||442||
48226050|NCT00822900|100873973|FG001|STARTED|Overall Study||440||
48226051|NCT00822900|100873972|FG000|COMPLETED|Overall Study||334||
48226052|NCT00822900|100873973|FG001|COMPLETED|Overall Study||347||
48226053|NCT00822900|100873972|FG000|NOT COMPLETED|Overall Study||108||
48226054|NCT00822900|100873973|FG001|NOT COMPLETED|Overall Study||93||
48226055|NCT01083732|100873974|FG000|STARTED|Overall Study||6||
48226056|NCT01083732|100873975|FG001|STARTED|Overall Study||9||
48226057|NCT01083732|100873976|FG002|STARTED|Overall Study||3||
48226058|NCT01083732|100873974|FG000|COMPLETED|Overall Study||6||
48226059|NCT01083732|100873975|FG001|COMPLETED|Overall Study||9||
48226060|NCT01083732|100873976|FG002|COMPLETED|Overall Study||3||
48226061|NCT01083732|100873974|FG000|NOT COMPLETED|Overall Study||0||
48226062|NCT01083732|100873975|FG001|NOT COMPLETED|Overall Study||0||
48226063|NCT01083732|100873976|FG002|NOT COMPLETED|Overall Study||0||
48226064|NCT01128595|100873977|FG000|STARTED|Treatment Period 1||7||
48226065|NCT01128595|100873978|FG001|STARTED|Treatment Period 1||6||
48226066|NCT01128595|100873979|FG002|STARTED|Treatment Period 1||7||
48226067|NCT01128595|100873980|FG003|STARTED|Treatment Period 1||7||
48226068|NCT01128595|100873977|FG000|COMPLETED|Treatment Period 1||7||
48226069|NCT01128595|100873978|FG001|COMPLETED|Treatment Period 1||6||
48226070|NCT01128595|100873979|FG002|COMPLETED|Treatment Period 1||7||
48226071|NCT01128595|100873980|FG003|COMPLETED|Treatment Period 1||7||
48226072|NCT01128595|100873977|FG000|NOT COMPLETED|Treatment Period 1||0||
48226073|NCT01128595|100873978|FG001|NOT COMPLETED|Treatment Period 1||0||
48226074|NCT01128595|100873979|FG002|NOT COMPLETED|Treatment Period 1||0||
48226075|NCT01128595|100873980|FG003|NOT COMPLETED|Treatment Period 1||0||
48226076|NCT01128595|100873977|FG000|STARTED|Washout Period 1||7||
48226077|NCT01128595|100873978|FG001|STARTED|Washout Period 1||6||
48226078|NCT01128595|100873979|FG002|STARTED|Washout Period 1||7||
48226079|NCT01128595|100873980|FG003|STARTED|Washout Period 1||7||
48226080|NCT01128595|100873977|FG000|COMPLETED|Washout Period 1||7||
48226081|NCT01128595|100873978|FG001|COMPLETED|Washout Period 1||6||
48226082|NCT01128595|100873979|FG002|COMPLETED|Washout Period 1||7||
48226083|NCT01128595|100873980|FG003|COMPLETED|Washout Period 1||7||
48226084|NCT01128595|100873977|FG000|NOT COMPLETED|Washout Period 1||0||
48226085|NCT01128595|100873978|FG001|NOT COMPLETED|Washout Period 1||0||
48226086|NCT01128595|100873979|FG002|NOT COMPLETED|Washout Period 1||0||
48226087|NCT01128595|100873980|FG003|NOT COMPLETED|Washout Period 1||0||
48226088|NCT01128595|100873977|FG000|STARTED|Treatment Period 2||7||
48226089|NCT01128595|100873978|FG001|STARTED|Treatment Period 2||6||
48226090|NCT01128595|100873979|FG002|STARTED|Treatment Period 2||7||
48226091|NCT01128595|100873980|FG003|STARTED|Treatment Period 2||7||
48226092|NCT01128595|100873977|FG000|COMPLETED|Treatment Period 2||7||
48226093|NCT01128595|100873978|FG001|COMPLETED|Treatment Period 2||6||
48226094|NCT01128595|100873979|FG002|COMPLETED|Treatment Period 2||7||
48226095|NCT01128595|100873980|FG003|COMPLETED|Treatment Period 2||7||
48226096|NCT01128595|100873977|FG000|NOT COMPLETED|Treatment Period 2||0||
48226097|NCT01128595|100873978|FG001|NOT COMPLETED|Treatment Period 2||0||
48226098|NCT01128595|100873979|FG002|NOT COMPLETED|Treatment Period 2||0||
48226099|NCT01128595|100873980|FG003|NOT COMPLETED|Treatment Period 2||0||
48226100|NCT01128595|100873977|FG000|STARTED|Washout Period 2||7||
48226101|NCT01128595|100873978|FG001|STARTED|Washout Period 2||6||
48226102|NCT01128595|100873979|FG002|STARTED|Washout Period 2||7||
48226103|NCT01128595|100873980|FG003|STARTED|Washout Period 2||7||
48226104|NCT01128595|100873977|FG000|COMPLETED|Washout Period 2||7||
48226105|NCT01128595|100873978|FG001|COMPLETED|Washout Period 2||6||
48226106|NCT01128595|100873979|FG002|COMPLETED|Washout Period 2||7||
48226107|NCT01128595|100873980|FG003|COMPLETED|Washout Period 2||7||
48226108|NCT01128595|100873977|FG000|NOT COMPLETED|Washout Period 2||0||
48226109|NCT01128595|100873978|FG001|NOT COMPLETED|Washout Period 2||0||
48226110|NCT01128595|100873979|FG002|NOT COMPLETED|Washout Period 2||0||
48226111|NCT01128595|100873980|FG003|NOT COMPLETED|Washout Period 2||0||
48226112|NCT01128595|100873977|FG000|STARTED|Treatment Period 3||7||
48226113|NCT01128595|100873978|FG001|STARTED|Treatment Period 3||6||
48226114|NCT01128595|100873979|FG002|STARTED|Treatment Period 3||7||
48226115|NCT01128595|100873980|FG003|STARTED|Treatment Period 3||7||
48226116|NCT01128595|100873977|FG000|COMPLETED|Treatment Period 3||7||
48226117|NCT01128595|100873978|FG001|COMPLETED|Treatment Period 3||5||
48226118|NCT01128595|100873979|FG002|COMPLETED|Treatment Period 3||7||
48226119|NCT01128595|100873980|FG003|COMPLETED|Treatment Period 3||7||
48226120|NCT01128595|100873977|FG000|NOT COMPLETED|Treatment Period 3||0||
48226121|NCT01128595|100873978|FG001|NOT COMPLETED|Treatment Period 3||1||
48226122|NCT01128595|100873979|FG002|NOT COMPLETED|Treatment Period 3||0||
48226123|NCT01128595|100873980|FG003|NOT COMPLETED|Treatment Period 3||0||
48226124|NCT01128595|100873977|FG000|STARTED|Washout Period 3||7||
48226125|NCT01128595|100873978|FG001|STARTED|Washout Period 3||5||
48226126|NCT01128595|100873979|FG002|STARTED|Washout Period 3||7||
48226127|NCT01128595|100873980|FG003|STARTED|Washout Period 3||7||
48226128|NCT01128595|100873977|FG000|COMPLETED|Washout Period 3||7||
48226129|NCT01128595|100873978|FG001|COMPLETED|Washout Period 3||5||
48226130|NCT01128595|100873979|FG002|COMPLETED|Washout Period 3||7||
48226131|NCT01128595|100873980|FG003|COMPLETED|Washout Period 3||7||
48226132|NCT01128595|100873977|FG000|NOT COMPLETED|Washout Period 3||0||
48226133|NCT01128595|100873978|FG001|NOT COMPLETED|Washout Period 3||0||
48226134|NCT01128595|100873979|FG002|NOT COMPLETED|Washout Period 3||0||
48226135|NCT01128595|100873980|FG003|NOT COMPLETED|Washout Period 3||0||
48226136|NCT01128595|100873977|FG000|STARTED|Treatment Period 4||7||
48226137|NCT01128595|100873978|FG001|STARTED|Treatment Period 4||5||
48226138|NCT01128595|100873979|FG002|STARTED|Treatment Period 4||7||
48226139|NCT01128595|100873980|FG003|STARTED|Treatment Period 4||7||
48226140|NCT01128595|100873977|FG000|COMPLETED|Treatment Period 4||7||
48226141|NCT01128595|100873978|FG001|COMPLETED|Treatment Period 4||5||
48226142|NCT01128595|100873979|FG002|COMPLETED|Treatment Period 4||7||
48226143|NCT01128595|100873980|FG003|COMPLETED|Treatment Period 4||7||
48226144|NCT01128595|100873977|FG000|NOT COMPLETED|Treatment Period 4||0||
48226145|NCT01128595|100873978|FG001|NOT COMPLETED|Treatment Period 4||0||
48226146|NCT01128595|100873979|FG002|NOT COMPLETED|Treatment Period 4||0||
48226147|NCT01128595|100873980|FG003|NOT COMPLETED|Treatment Period 4||0||
48226148|NCT00705406|100873981|FG000|STARTED|Overall Study||203||
48226149|NCT00705406|100873982|FG001|STARTED|Overall Study||202||
48226150|NCT00705406|100873981|FG000|COMPLETED|Overall Study||199||
48226151|NCT00705406|100873982|FG001|COMPLETED|Overall Study||197||
48226152|NCT00705406|100873981|FG000|NOT COMPLETED|Overall Study||4||
48226153|NCT00705406|100873982|FG001|NOT COMPLETED|Overall Study||5||
48226154|NCT04263714|100873983|FG000|STARTED|Overall Study||16||
48226155|NCT04263714|100873983|FG000|COMPLETED|Overall Study||16||
48226156|NCT04263714|100873983|FG000|NOT COMPLETED|Overall Study||0||
48226157|NCT01351376|100873984|FG000|STARTED|Overall Study||10||
48226158|NCT01351376|100873985|FG001|STARTED|Overall Study||11||
48226159|NCT01351376|100873984|FG000|COMPLETED|Overall Study||10||
48226160|NCT01351376|100873985|FG001|COMPLETED|Overall Study||11||
48226161|NCT01351376|100873984|FG000|NOT COMPLETED|Overall Study||0||
48226162|NCT01351376|100873985|FG001|NOT COMPLETED|Overall Study||0||
48226163|NCT02683174|100873986|FG000|STARTED|Overall Study||86||
48226164|NCT02683174|100873986|FG000|COMPLETED|Overall Study||86||
48226165|NCT02683174|100873986|FG000|NOT COMPLETED|Overall Study||0||
48226166|NCT02117310|100873987|FG000|STARTED|Overall Study||5||
48226167|NCT02117310|100873987|FG000|COMPLETED|Overall Study||5||
48226168|NCT02117310|100873987|FG000|NOT COMPLETED|Overall Study||0||
48226169|NCT00692913|100873988|FG000|STARTED|Overall Study||257||
48226170|NCT00692913|100873989|FG001|STARTED|Overall Study||258||
48226171|NCT00692913|100873988|FG000|COMPLETED|Overall Study||228||
48226172|NCT00692913|100873989|FG001|COMPLETED|Overall Study||228||
48226173|NCT00692913|100873988|FG000|NOT COMPLETED|Overall Study||29||
48226174|NCT00692913|100873989|FG001|NOT COMPLETED|Overall Study||30||
48226175|NCT01856569|100873990|FG000|STARTED|Overall Study||152||
48226176|NCT01856569|100873990|FG000|Full Analysis Set|Overall Study||144||
48226177|NCT01856569|100873990|FG000|COMPLETED|Overall Study||139||
48226178|NCT01856569|100873990|FG000|NOT COMPLETED|Overall Study||13||
48226179|NCT01683409|100873991|FG000|STARTED|Treatment Period (Weeks 1-24)||27||
48226180|NCT01683409|100873992|FG001|STARTED|Treatment Period (Weeks 1-24)||25||
48226181|NCT01683409|100873993|FG002|STARTED|Treatment Period (Weeks 1-24)||27||
48226182|NCT01683409|100873994|FG003|STARTED|Treatment Period (Weeks 1-24)||26||
48226183|NCT01683409|100873995|FG004|STARTED|Treatment Period (Weeks 1-24)||25||
48226184|NCT01683409|100873991|FG000|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||27||
48226185|NCT01683409|100873992|FG001|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25||
48226186|NCT01683409|100873993|FG002|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26||
48226187|NCT01683409|100873994|FG003|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26||
48226188|NCT01683409|100873995|FG004|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25||
48226189|NCT01683409|100873991|FG000|COMPLETED|Treatment Period (Weeks 1-24)||27||
48226190|NCT01683409|100873992|FG001|COMPLETED|Treatment Period (Weeks 1-24)||21||
48226191|NCT01683409|100873993|FG002|COMPLETED|Treatment Period (Weeks 1-24)||26||
48226192|NCT01683409|100873994|FG003|COMPLETED|Treatment Period (Weeks 1-24)||24||
48226193|NCT01683409|100873995|FG004|COMPLETED|Treatment Period (Weeks 1-24)||23||
48226194|NCT01683409|100873991|FG000|NOT COMPLETED|Treatment Period (Weeks 1-24)||0||
48226195|NCT01683409|100873992|FG001|NOT COMPLETED|Treatment Period (Weeks 1-24)||4||
48226196|NCT01683409|100873993|FG002|NOT COMPLETED|Treatment Period (Weeks 1-24)||1||
48226197|NCT01683409|100873994|FG003|NOT COMPLETED|Treatment Period (Weeks 1-24)||2||
48226198|NCT01683409|100873995|FG004|NOT COMPLETED|Treatment Period (Weeks 1-24)||2||
48226199|NCT01683409|100873991|FG000|STARTED|Washout Period 1 (Weeks 25-28)||27||
48226200|NCT01683409|100873992|FG001|STARTED|Washout Period 1 (Weeks 25-28)||21||
48226201|NCT01683409|100873993|FG002|STARTED|Washout Period 1 (Weeks 25-28)||26||
48226202|NCT01683409|100873994|FG003|STARTED|Washout Period 1 (Weeks 25-28)||24||
48226203|NCT01683409|100873995|FG004|STARTED|Washout Period 1 (Weeks 25-28)||23||
48226204|NCT01683409|100873991|FG000|COMPLETED|Washout Period 1 (Weeks 25-28)||24||
48226205|NCT01683409|100873992|FG001|COMPLETED|Washout Period 1 (Weeks 25-28)||17||
48226206|NCT01683409|100873993|FG002|COMPLETED|Washout Period 1 (Weeks 25-28)||25||
48226207|NCT01683409|100873994|FG003|COMPLETED|Washout Period 1 (Weeks 25-28)||22||
48226208|NCT01683409|100873995|FG004|COMPLETED|Washout Period 1 (Weeks 25-28)||20||
48226209|NCT01683409|100873991|FG000|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3||
48226210|NCT01683409|100873992|FG001|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||4||
48226211|NCT01683409|100873993|FG002|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||1||
48226212|NCT01683409|100873994|FG003|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||2||
48226213|NCT01683409|100873995|FG004|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3||
48226214|NCT01683409|100873991|FG000|STARTED|Washout Period 2 (Weeks 29-32)||6||
48226215|NCT01683409|100873992|FG001|STARTED|Washout Period 2 (Weeks 29-32)||6||
48226216|NCT01683409|100873993|FG002|STARTED|Washout Period 2 (Weeks 29-32)||8||
48226217|NCT01683409|100873994|FG003|STARTED|Washout Period 2 (Weeks 29-32)||6||
48226218|NCT01683409|100873995|FG004|STARTED|Washout Period 2 (Weeks 29-32)||12||
48226219|NCT01683409|100873991|FG000|COMPLETED|Washout Period 2 (Weeks 29-32)||6||
48226220|NCT01683409|100873992|FG001|COMPLETED|Washout Period 2 (Weeks 29-32)||6||
48226221|NCT01683409|100873993|FG002|COMPLETED|Washout Period 2 (Weeks 29-32)||7||
48226222|NCT01683409|100873994|FG003|COMPLETED|Washout Period 2 (Weeks 29-32)||6||
48226223|NCT01683409|100873995|FG004|COMPLETED|Washout Period 2 (Weeks 29-32)||9||
48226224|NCT01683409|100873991|FG000|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0||
48226225|NCT01683409|100873992|FG001|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0||
48226226|NCT01683409|100873993|FG002|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||1||
48226227|NCT01683409|100873994|FG003|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0||
48226228|NCT01683409|100873995|FG004|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||3||
48226229|NCT02701296|100873996|FG000|STARTED|Overall Study||42||
48226230|NCT02701296|100873997|FG001|STARTED|Overall Study||38||
48226231|NCT02701296|100873996|FG000|COMPLETED|Overall Study||42||
48226232|NCT02701296|100873997|FG001|COMPLETED|Overall Study||36||
48226233|NCT02701296|100873996|FG000|NOT COMPLETED|Overall Study||0||
48226234|NCT02701296|100873997|FG001|NOT COMPLETED|Overall Study||2||
48226235|NCT02203032|100873998|FG000|STARTED|Open Label Run-in (Week 0 to Week 16)||872||
48226236|NCT02203032|100873999|FG001|STARTED|Open Label Run-in (Week 0 to Week 16)||0||
48226237|NCT02203032|100874000|FG002|STARTED|Open Label Run-in (Week 0 to Week 16)||0||
48226238|NCT02203032|100874001|FG003|STARTED|Open Label Run-in (Week 0 to Week 16)||0||
48226239|NCT02203032|100873998|FG000|Treated|Open Label Run-in (Week 0 to Week 16)||871||
48370862|NCT05395351|101236552|FG002|NOT COMPLETED|Overall Study||0||
48226240|NCT02203032|100873999|FG001|Treated|Open Label Run-in (Week 0 to Week 16)||0||
48226241|NCT02203032|100874000|FG002|Treated|Open Label Run-in (Week 0 to Week 16)||0||
48226242|NCT02203032|100874001|FG003|Treated|Open Label Run-in (Week 0 to Week 16)||0||
48226243|NCT02203032|100873998|FG000|COMPLETED|Open Label Run-in (Week 0 to Week 16)||853||
48226244|NCT02203032|100873999|FG001|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0||
48226245|NCT02203032|100874000|FG002|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0||
48226246|NCT02203032|100874001|FG003|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0||
48226247|NCT02203032|100873998|FG000|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||19||
48226248|NCT02203032|100873999|FG001|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0||
48226249|NCT02203032|100874000|FG002|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0||
48226250|NCT02203032|100874001|FG003|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0||
48226251|NCT02203032|100873998|FG000|STARTED|Blinded Phase (Week 16 to Week 44)||0||
48226252|NCT02203032|100873999|FG001|STARTED|Blinded Phase (Week 16 to Week 44)||135||
48226253|NCT02203032|100874000|FG002|STARTED|Blinded Phase (Week 16 to Week 44)||133||
48226254|NCT02203032|100874001|FG003|STARTED|Blinded Phase (Week 16 to Week 44)||585||
48226255|NCT02203032|100873998|FG000|COMPLETED|Blinded Phase (Week 16 to Week 44)||0||
48226256|NCT02203032|100873999|FG001|COMPLETED|Blinded Phase (Week 16 to Week 44)||120||
48226257|NCT02203032|100874000|FG002|COMPLETED|Blinded Phase (Week 16 to Week 44)||107||
48226258|NCT02203032|100874001|FG003|COMPLETED|Blinded Phase (Week 16 to Week 44)||539||
48226259|NCT02203032|100873998|FG000|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||0||
48226260|NCT02203032|100873999|FG001|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||15||
48226261|NCT02203032|100874000|FG002|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||26||
48226262|NCT02203032|100874001|FG003|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||46||
48226263|NCT05062343|100874002|FG000|STARTED|Overall Study||40||
48226264|NCT05062343|100874003|FG001|STARTED|Overall Study||40||
48226265|NCT05062343|100874002|FG000|COMPLETED|Overall Study||40||
48226266|NCT05062343|100874003|FG001|COMPLETED|Overall Study||40||
48226267|NCT05062343|100874002|FG000|NOT COMPLETED|Overall Study||0||
48226268|NCT05062343|100874003|FG001|NOT COMPLETED|Overall Study||0||
48226269|NCT03577106|100874004|FG000|STARTED|Overall Study||24||
48226270|NCT03577106|100874004|FG000|COMPLETED|Overall Study||21||
48226271|NCT03577106|100874004|FG000|NOT COMPLETED|Overall Study||3||
48226272|NCT01550952|100874005|FG000|STARTED|Overall Study||10||
48226273|NCT01550952|100874005|FG000|COMPLETED|Overall Study||10||
48226274|NCT01550952|100874005|FG000|NOT COMPLETED|Overall Study||0||
48226275|NCT01201772|100874006|FG000|STARTED|Overall Study||23||
48226276|NCT01201772|100874007|FG001|STARTED|Overall Study||21||
48226277|NCT01201772|100874008|FG002|STARTED|Overall Study||21||
48226278|NCT01201772|100874006|FG000|COMPLETED|Overall Study||22||
48226279|NCT01201772|100874007|FG001|COMPLETED|Overall Study||21||
48226280|NCT01201772|100874008|FG002|COMPLETED|Overall Study||21||
48226281|NCT01201772|100874006|FG000|NOT COMPLETED|Overall Study||1||
48226282|NCT01201772|100874007|FG001|NOT COMPLETED|Overall Study||0||
48226283|NCT01201772|100874008|FG002|NOT COMPLETED|Overall Study||0||
48226284|NCT01673594|100874009|FG000|STARTED|Overall Study||18||
48226285|NCT01673594|100874010|FG001|STARTED|Overall Study||19||
48226286|NCT01673594|100874009|FG000|COMPLETED|Overall Study||12||
48226287|NCT01673594|100874010|FG001|COMPLETED|Overall Study||13||
48226288|NCT01673594|100874009|FG000|NOT COMPLETED|Overall Study||6||
48226289|NCT01673594|100874010|FG001|NOT COMPLETED|Overall Study||6||
48226290|NCT00065182|100874011|FG000|STARTED|Overall Study||202||
48226291|NCT00065182|100874012|FG001|STARTED|Overall Study||197||
48226292|NCT00065182|100874011|FG000|COMPLETED|Overall Study||154||
48226293|NCT00065182|100874012|FG001|COMPLETED|Overall Study||160||
48226294|NCT00065182|100874011|FG000|NOT COMPLETED|Overall Study||48||
48226295|NCT00065182|100874012|FG001|NOT COMPLETED|Overall Study||37||
48226296|NCT01353274|100874013|FG000|STARTED|Overall Study||1157||
48226297|NCT01353274|100874013|FG000|COMPLETED|Overall Study||1129||
48226298|NCT01353274|100874013|FG000|NOT COMPLETED|Overall Study||28||
48226299|NCT03805672|100874014|FG000|STARTED|Overall Study||2||
48226300|NCT03805672|100874015|FG001|STARTED|Overall Study||2||
48226301|NCT03805672|100874014|FG000|COMPLETED|Overall Study||2||
48226302|NCT03805672|100874015|FG001|COMPLETED|Overall Study||2||
48226303|NCT03805672|100874014|FG000|NOT COMPLETED|Overall Study||0||
48226304|NCT03805672|100874015|FG001|NOT COMPLETED|Overall Study||0||
48226305|NCT01822756|100877762|FG000|STARTED|Overall Study||16||
48226306|NCT01822756|100877763|FG001|STARTED|Overall Study||4||
48226307|NCT01822756|100877764|FG002|STARTED|Overall Study||10||
48226308|NCT01822756|100877765|FG003|STARTED|Overall Study||4||
48226309|NCT01822756|100877766|FG004|STARTED|Overall Study||8||
48226310|NCT01822756|100877762|FG000|Discontinued From the Study|Overall Study||16||
48226311|NCT01822756|100877763|FG001|Discontinued From the Study|Overall Study||4||
48226312|NCT01822756|100877764|FG002|Discontinued From the Study|Overall Study||10||
48226313|NCT01822756|100877765|FG003|Discontinued From the Study|Overall Study||4||
48226314|NCT01822756|100877766|FG004|Discontinued From the Study|Overall Study||7||
48226315|NCT01822756|100877762|FG000|COMPLETED|Overall Study||0||
48226316|NCT01822756|100877763|FG001|COMPLETED|Overall Study||0||
48226317|NCT01822756|100877764|FG002|COMPLETED|Overall Study||0||
48226318|NCT01822756|100877765|FG003|COMPLETED|Overall Study||0||
48226319|NCT01822756|100877766|FG004|COMPLETED|Overall Study||1||
48226320|NCT01822756|100877762|FG000|NOT COMPLETED|Overall Study||16||
48226321|NCT01822756|100877763|FG001|NOT COMPLETED|Overall Study||4||
48226322|NCT01822756|100877764|FG002|NOT COMPLETED|Overall Study||10||
48226323|NCT01822756|100877765|FG003|NOT COMPLETED|Overall Study||4||
48226324|NCT01822756|100877766|FG004|NOT COMPLETED|Overall Study||7||
48226325|NCT00999596|100877767|FG000|STARTED|Overall Study||107||
48226326|NCT00999596|100877767|FG000|New FDA Guideline Released|Overall Study||6||
48226327|NCT00999596|100877767|FG000|COMPLETED|Overall Study||6||
48226328|NCT00999596|100877767|FG000|NOT COMPLETED|Overall Study||101||
48226329|NCT02260154|100877768|FG000|STARTED|Overall Study||220||
48226330|NCT02260154|100877768|FG000|COMPLETED|Overall Study||218||
48226331|NCT02260154|100877768|FG000|NOT COMPLETED|Overall Study||2||
48226332|NCT03653364|100877769|FG000|STARTED|Overall Study||49||
48226333|NCT03653364|100877769|FG000|COMPLETED|Overall Study||46||
48226334|NCT03653364|100877769|FG000|NOT COMPLETED|Overall Study||3||
48226335|NCT00145145|100877770|FG000|STARTED|Overall Study||1||
48226336|NCT00145145|100877770|FG000|COMPLETED|Overall Study||1||
48226337|NCT00145145|100877770|FG000|NOT COMPLETED|Overall Study||0||
48226338|NCT01920932|100877771|FG000|STARTED|Overall Study||77||
48226339|NCT01920932|100877771|FG000|COMPLETED|Overall Study||75||
48226340|NCT01920932|100877771|FG000|NOT COMPLETED|Overall Study||2||
48226341|NCT00145587|100877772|FG000|STARTED|Overall Study||5||
48226342|NCT00145587|100877773|FG001|STARTED|Overall Study||1||
48226343|NCT00145587|100877772|FG000|COMPLETED|Overall Study||5||
48226344|NCT00145587|100877773|FG001|COMPLETED|Overall Study||1||
48226345|NCT00145587|100877772|FG000|NOT COMPLETED|Overall Study||0||
48226346|NCT00145587|100877773|FG001|NOT COMPLETED|Overall Study||0||
48226347|NCT02684435|100877774|FG000|STARTED|Overall Study||63||64
48226348|NCT02684435|100877774|FG000|COMPLETED|Overall Study||63||64
48226349|NCT02684435|100877774|FG000|NOT COMPLETED|Overall Study||0||0
48226350|NCT01263496|100877775|FG000|STARTED|Enrolled - Long-Term Extension Study||72||
48226351|NCT01263496|100877776|FG001|STARTED|Enrolled - Long-Term Extension Study||75||
48226352|NCT01263496|100877777|FG002|STARTED|Enrolled - Long-Term Extension Study||72||
48226353|NCT01263496|100877778|FG003|STARTED|Enrolled - Long-Term Extension Study||75||
48226354|NCT01263496|100877779|FG004|STARTED|Enrolled - Long-Term Extension Study||74||
48226355|NCT01263496|100877780|FG005|STARTED|Enrolled - Long-Term Extension Study||17||
48226356|NCT01263496|100877781|FG006|STARTED|Enrolled - Long-Term Extension Study||17||
48226357|NCT01263496|100877782|FG007|STARTED|Enrolled - Long-Term Extension Study||18||
48226358|NCT01263496|100877783|FG008|STARTED|Enrolled - Long-Term Extension Study||18||
48226359|NCT01263496|100877775|FG000|COMPLETED|Enrolled - Long-Term Extension Study||71||
48226360|NCT01263496|100877776|FG001|COMPLETED|Enrolled - Long-Term Extension Study||75||
48226361|NCT01263496|100877777|FG002|COMPLETED|Enrolled - Long-Term Extension Study||72||
48226362|NCT01263496|100877778|FG003|COMPLETED|Enrolled - Long-Term Extension Study||74||
48226363|NCT01263496|100877779|FG004|COMPLETED|Enrolled - Long-Term Extension Study||72||
48226364|NCT01263496|100877780|FG005|COMPLETED|Enrolled - Long-Term Extension Study||17||
48226365|NCT01263496|100877781|FG006|COMPLETED|Enrolled - Long-Term Extension Study||17||
48226366|NCT01263496|100877782|FG007|COMPLETED|Enrolled - Long-Term Extension Study||18||
48226367|NCT01263496|100877783|FG008|COMPLETED|Enrolled - Long-Term Extension Study||18||
48226368|NCT01263496|100877775|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||1||
48226369|NCT01263496|100877776|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
48226370|NCT01263496|100877777|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
48226371|NCT01263496|100877778|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||1||
48226372|NCT01263496|100877779|FG004|NOT COMPLETED|Enrolled - Long-Term Extension Study||2||
48226373|NCT01263496|100877780|FG005|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
48226374|NCT01263496|100877781|FG006|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
48226375|NCT01263496|100877782|FG007|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
48226376|NCT01263496|100877783|FG008|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
48226377|NCT01263496|100877775|FG000|STARTED|Entered - Long-Term Extension Study||71||
48226378|NCT01263496|100877776|FG001|STARTED|Entered - Long-Term Extension Study||72||
48226379|NCT01263496|100877777|FG002|STARTED|Entered - Long-Term Extension Study||72||
48226380|NCT01263496|100877778|FG003|STARTED|Entered - Long-Term Extension Study||74||
48226381|NCT01263496|100877779|FG004|STARTED|Entered - Long-Term Extension Study||71||
48226382|NCT01263496|100877780|FG005|STARTED|Entered - Long-Term Extension Study||17||
48226383|NCT01263496|100877781|FG006|STARTED|Entered - Long-Term Extension Study||17||
48226384|NCT01263496|100877782|FG007|STARTED|Entered - Long-Term Extension Study||17||
48226385|NCT01263496|100877783|FG008|STARTED|Entered - Long-Term Extension Study||18||
48226386|NCT01263496|100877775|FG000|COMPLETED|Entered - Long-Term Extension Study||62||
48226387|NCT01263496|100877776|FG001|COMPLETED|Entered - Long-Term Extension Study||59||
48226388|NCT01263496|100877777|FG002|COMPLETED|Entered - Long-Term Extension Study||62||
48226389|NCT01263496|100877778|FG003|COMPLETED|Entered - Long-Term Extension Study||68||
48226390|NCT01263496|100877779|FG004|COMPLETED|Entered - Long-Term Extension Study||61||
48226391|NCT01263496|100877780|FG005|COMPLETED|Entered - Long-Term Extension Study||16||
48226392|NCT01263496|100877781|FG006|COMPLETED|Entered - Long-Term Extension Study||16||
48226393|NCT01263496|100877782|FG007|COMPLETED|Entered - Long-Term Extension Study||16||
48370863|NCT05395351|101236553|FG003|NOT COMPLETED|Overall Study||0||
48226394|NCT01263496|100877783|FG008|COMPLETED|Entered - Long-Term Extension Study||15||
48226395|NCT01263496|100877775|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||9||
48226396|NCT01263496|100877776|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||13||
48226397|NCT01263496|100877777|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||10||
48226398|NCT01263496|100877778|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||6||
48226399|NCT01263496|100877779|FG004|NOT COMPLETED|Entered - Long-Term Extension Study||10||
48226400|NCT01263496|100877780|FG005|NOT COMPLETED|Entered - Long-Term Extension Study||1||
48226401|NCT01263496|100877781|FG006|NOT COMPLETED|Entered - Long-Term Extension Study||1||
48226402|NCT01263496|100877782|FG007|NOT COMPLETED|Entered - Long-Term Extension Study||1||
48226403|NCT01263496|100877783|FG008|NOT COMPLETED|Entered - Long-Term Extension Study||3||
48226404|NCT02575365|100877784|FG000|STARTED|Overall Study||4||
48226405|NCT02575365|100877784|FG000|COMPLETED|Overall Study||0||
48226406|NCT02575365|100877784|FG000|NOT COMPLETED|Overall Study||4||
48226407|NCT02841449|100877785|FG000|STARTED|Overall Study||7||
48226408|NCT02841449|100877786|FG001|STARTED|Overall Study||9||
48226409|NCT02841449|100877785|FG000|COMPLETED|Overall Study||7||
48226410|NCT02841449|100877786|FG001|COMPLETED|Overall Study||9||
48226411|NCT02841449|100877785|FG000|NOT COMPLETED|Overall Study||0||
48226412|NCT02841449|100877786|FG001|NOT COMPLETED|Overall Study||0||
48226413|NCT01502813|100877787|FG000|STARTED|Overall Study||40||
48226414|NCT01502813|100877787|FG000|COMPLETED|Overall Study||40||
48226415|NCT01502813|100877787|FG000|NOT COMPLETED|Overall Study||0||
48226416|NCT03732807|100877788|FG000|STARTED|Treatment Period (up to Week 24)||132||
48226417|NCT03732807|100877789|FG001|STARTED|Treatment Period (up to Week 24)||130||
48226418|NCT03732807|100877790|FG002|STARTED|Treatment Period (up to Week 24)||130||
48226419|NCT03732807|100877791|FG003|STARTED|Treatment Period (up to Week 24)||132||
48226420|NCT03732807|100877792|FG004|STARTED|Treatment Period (up to Week 24)||63||
48226421|NCT03732807|100877793|FG005|STARTED|Treatment Period (up to Week 24)||65||
48226422|NCT03732807|100877794|FG006|STARTED|Treatment Period (up to Week 24)||66||
48226423|NCT03732807|100877788|FG000|COMPLETED|Treatment Period (up to Week 24)||122||
48226424|NCT03732807|100877789|FG001|COMPLETED|Treatment Period (up to Week 24)||124||
48226425|NCT03732807|100877790|FG002|COMPLETED|Treatment Period (up to Week 24)||121||
48226426|NCT03732807|100877791|FG003|COMPLETED|Treatment Period (up to Week 24)||117||
48226427|NCT03732807|100877792|FG004|COMPLETED|Treatment Period (up to Week 24)||58||
48226428|NCT03732807|100877793|FG005|COMPLETED|Treatment Period (up to Week 24)||63||
48226429|NCT03732807|100877794|FG006|COMPLETED|Treatment Period (up to Week 24)||61||
48226430|NCT03732807|100877788|FG000|NOT COMPLETED|Treatment Period (up to Week 24)||10||
48226431|NCT03732807|100877789|FG001|NOT COMPLETED|Treatment Period (up to Week 24)||6||
48226432|NCT03732807|100877790|FG002|NOT COMPLETED|Treatment Period (up to Week 24)||9||
48226433|NCT03732807|100877791|FG003|NOT COMPLETED|Treatment Period (up to Week 24)||15||
48226434|NCT03732807|100877792|FG004|NOT COMPLETED|Treatment Period (up to Week 24)||5||
48226435|NCT03732807|100877793|FG005|NOT COMPLETED|Treatment Period (up to Week 24)||2||
48226436|NCT03732807|100877794|FG006|NOT COMPLETED|Treatment Period (up to Week 24)||5||
48226437|NCT03732807|100877788|FG000|STARTED|Treatment Extension (Week 25 up to 48)||113||
48226438|NCT03732807|100877789|FG001|STARTED|Treatment Extension (Week 25 up to 48)||111||
48226439|NCT03732807|100877790|FG002|STARTED|Treatment Extension (Week 25 up to 48)||108||
48226440|NCT03732807|100877791|FG003|STARTED|Treatment Extension (Week 25 up to 48)||106||
48226441|NCT03732807|100877792|FG004|STARTED|Treatment Extension (Week 25 up to 48)||49||
48226442|NCT03732807|100877793|FG005|STARTED|Treatment Extension (Week 25 up to 48)||59||
48226443|NCT03732807|100877794|FG006|STARTED|Treatment Extension (Week 25 up to 48)||57||
48226444|NCT03732807|100877788|FG000|COMPLETED|Treatment Extension (Week 25 up to 48)||107||
48226445|NCT03732807|100877789|FG001|COMPLETED|Treatment Extension (Week 25 up to 48)||100||
48226446|NCT03732807|100877790|FG002|COMPLETED|Treatment Extension (Week 25 up to 48)||103||
48226447|NCT03732807|100877791|FG003|COMPLETED|Treatment Extension (Week 25 up to 48)||97||
48226448|NCT03732807|100877792|FG004|COMPLETED|Treatment Extension (Week 25 up to 48)||44||
48226449|NCT03732807|100877793|FG005|COMPLETED|Treatment Extension (Week 25 up to 48)||56||
48226450|NCT03732807|100877794|FG006|COMPLETED|Treatment Extension (Week 25 up to 48)||53||
48226451|NCT03732807|100877788|FG000|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||6||
48226452|NCT03732807|100877789|FG001|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||11||
48226453|NCT03732807|100877790|FG002|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||5||
48226454|NCT03732807|100877791|FG003|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||9||
48226455|NCT03732807|100877792|FG004|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||5||
48226456|NCT03732807|100877793|FG005|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||3||
48226457|NCT03732807|100877794|FG006|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||4||
48226458|NCT00263757|100877795|FG000|STARTED|Overall Study||12||
48226459|NCT00263757|100877796|FG001|STARTED|Overall Study||13||
48226460|NCT00263757|100877795|FG000|COMPLETED|Overall Study||4||
48226461|NCT00263757|100877796|FG001|COMPLETED|Overall Study||5||
48226462|NCT00263757|100877795|FG000|NOT COMPLETED|Overall Study||8||
48226463|NCT00263757|100877796|FG001|NOT COMPLETED|Overall Study||8||
48226464|NCT01394276|100877797|FG000|STARTED|Overall Study||322||
48226465|NCT01394276|100877797|FG000|COMPLETED|Overall Study||260||
48226466|NCT01394276|100877797|FG000|NOT COMPLETED|Overall Study||62||
48226467|NCT05445557|100877798|FG000|STARTED|Double Blind Part||12|RZL-012|24
48226468|NCT05445557|100877798|FG000|Flanks Treated With RZL-012|Double Blind Part||12||12
48226469|NCT05445557|100877798|FG000|Flanks Treated With Placebo|Double Blind Part||12||12
48226470|NCT05445557|100877798|FG000|COMPLETED|Double Blind Part||11||22
48226471|NCT05445557|100877798|FG000|NOT COMPLETED|Double Blind Part||1||2
48226472|NCT05445557|100877798|FG000|STARTED|Open Label - Active Only||9||9
48226473|NCT05445557|100877798|FG000|COMPLETED|Open Label - Active Only||9||9
48226474|NCT05445557|100877798|FG000|NOT COMPLETED|Open Label - Active Only||0||0
48226475|NCT02234141|100877799|FG000|STARTED|Treatment Period (24 Weeks)||39||
48226476|NCT02234141|100877800|FG001|STARTED|Treatment Period (24 Weeks)||38||
48226477|NCT02234141|100877801|FG002|STARTED|Treatment Period (24 Weeks)||37||
48226478|NCT02234141|100877802|FG003|STARTED|Treatment Period (24 Weeks)||37||
48226479|NCT02234141|100877803|FG004|STARTED|Treatment Period (24 Weeks)||0||
48226480|NCT02234141|100877804|FG005|STARTED|Treatment Period (24 Weeks)||0||
48226481|NCT02234141|100877805|FG006|STARTED|Treatment Period (24 Weeks)||0||
48226482|NCT02234141|100877799|FG000|COMPLETED|Treatment Period (24 Weeks)||35||
48226483|NCT02234141|100877800|FG001|COMPLETED|Treatment Period (24 Weeks)||32||
48226484|NCT02234141|100877801|FG002|COMPLETED|Treatment Period (24 Weeks)||35||
48226485|NCT02234141|100877802|FG003|COMPLETED|Treatment Period (24 Weeks)||32||
48226486|NCT02234141|100877803|FG004|COMPLETED|Treatment Period (24 Weeks)||0||
48226487|NCT02234141|100877804|FG005|COMPLETED|Treatment Period (24 Weeks)||0||
48226488|NCT02234141|100877805|FG006|COMPLETED|Treatment Period (24 Weeks)||0||
48226489|NCT02234141|100877799|FG000|NOT COMPLETED|Treatment Period (24 Weeks)||4||
48226490|NCT02234141|100877800|FG001|NOT COMPLETED|Treatment Period (24 Weeks)||6||
48226491|NCT02234141|100877801|FG002|NOT COMPLETED|Treatment Period (24 Weeks)||2||
48226492|NCT02234141|100877802|FG003|NOT COMPLETED|Treatment Period (24 Weeks)||5||
48226493|NCT02234141|100877803|FG004|NOT COMPLETED|Treatment Period (24 Weeks)||0||
48226494|NCT02234141|100877804|FG005|NOT COMPLETED|Treatment Period (24 Weeks)||0||
48226495|NCT02234141|100877805|FG006|NOT COMPLETED|Treatment Period (24 Weeks)||0||
48226496|NCT02234141|100877799|FG000|STARTED|Long-Term Treatment Period||33||
48226497|NCT02234141|100877800|FG001|STARTED|Long-Term Treatment Period||31||
48226498|NCT02234141|100877801|FG002|STARTED|Long-Term Treatment Period||33||
48226499|NCT02234141|100877802|FG003|STARTED|Long-Term Treatment Period||0||
48226500|NCT02234141|100877803|FG004|STARTED|Long-Term Treatment Period||10||
48226501|NCT02234141|100877804|FG005|STARTED|Long-Term Treatment Period||12||
48226502|NCT02234141|100877805|FG006|STARTED|Long-Term Treatment Period||10||
48226503|NCT02234141|100877799|FG000|COMPLETED|Long-Term Treatment Period||0||
48226504|NCT02234141|100877800|FG001|COMPLETED|Long-Term Treatment Period||0||
48226505|NCT02234141|100877801|FG002|COMPLETED|Long-Term Treatment Period||0||
48226506|NCT02234141|100877802|FG003|COMPLETED|Long-Term Treatment Period||0||
48226507|NCT02234141|100877803|FG004|COMPLETED|Long-Term Treatment Period||0||
48226508|NCT02234141|100877804|FG005|COMPLETED|Long-Term Treatment Period||0||
48226509|NCT02234141|100877805|FG006|COMPLETED|Long-Term Treatment Period||0||
48226510|NCT02234141|100877799|FG000|NOT COMPLETED|Long-Term Treatment Period||33||
48226511|NCT02234141|100877800|FG001|NOT COMPLETED|Long-Term Treatment Period||31||
48226512|NCT02234141|100877801|FG002|NOT COMPLETED|Long-Term Treatment Period||33||
48226513|NCT02234141|100877802|FG003|NOT COMPLETED|Long-Term Treatment Period||0||
48226514|NCT02234141|100877803|FG004|NOT COMPLETED|Long-Term Treatment Period||10||
48226515|NCT02234141|100877804|FG005|NOT COMPLETED|Long-Term Treatment Period||12||
48226516|NCT02234141|100877805|FG006|NOT COMPLETED|Long-Term Treatment Period||10||
48226517|NCT01580306|100877806|FG000|STARTED|Overall Study||8||
48226518|NCT01580306|100877807|FG001|STARTED|Overall Study||8||
48226519|NCT01580306|100877808|FG002|STARTED|Overall Study||8||
48226520|NCT01580306|100877809|FG003|STARTED|Overall Study||8||
48226521|NCT01580306|100877806|FG000|COMPLETED|Overall Study||8||
48226522|NCT01580306|100877807|FG001|COMPLETED|Overall Study||8||
48226523|NCT01580306|100877808|FG002|COMPLETED|Overall Study||8||
48226524|NCT01580306|100877809|FG003|COMPLETED|Overall Study||8||
48226525|NCT01580306|100877806|FG000|NOT COMPLETED|Overall Study||0||
48226526|NCT01580306|100877807|FG001|NOT COMPLETED|Overall Study||0||
48226527|NCT01580306|100877808|FG002|NOT COMPLETED|Overall Study||0||
48226528|NCT01580306|100877809|FG003|NOT COMPLETED|Overall Study||0||
48226529|NCT03589768|100877810|FG000|STARTED|Overall Study||134||
48226530|NCT03589768|100877811|FG001|STARTED|Overall Study||67||
48226531|NCT03589768|100877812|FG002|STARTED|Overall Study||131||
48226532|NCT03589768|100877813|FG003|STARTED|Overall Study||67||
48226533|NCT03589768|100877810|FG000|COMPLETED|Overall Study||130||
48226534|NCT03589768|100877811|FG001|COMPLETED|Overall Study||67||
48226535|NCT03589768|100877812|FG002|COMPLETED|Overall Study||123||
48226536|NCT03589768|100877813|FG003|COMPLETED|Overall Study||64||
48226537|NCT03589768|100877810|FG000|NOT COMPLETED|Overall Study||4||
48226538|NCT03589768|100877811|FG001|NOT COMPLETED|Overall Study||0||
48226539|NCT03589768|100877812|FG002|NOT COMPLETED|Overall Study||8||
48226540|NCT03589768|100877813|FG003|NOT COMPLETED|Overall Study||3||
48226541|NCT03987074|100877814|FG000|STARTED|Overall Study||21||
48226542|NCT03987074|100877815|FG001|STARTED|Overall Study||22||
48226543|NCT03987074|100877816|FG002|STARTED|Overall Study||22||
48226544|NCT03987074|100877817|FG003|STARTED|Overall Study||22||
48226545|NCT03987074|100877818|FG004|STARTED|Overall Study||21||
48226546|NCT03987074|100877814|FG000|COMPLETED|Overall Study||18||
48226547|NCT03987074|100877815|FG001|COMPLETED|Overall Study||20||
48226548|NCT03987074|100877816|FG002|COMPLETED|Overall Study||21||
48226549|NCT03987074|100877817|FG003|COMPLETED|Overall Study||18||
48226550|NCT03987074|100877818|FG004|COMPLETED|Overall Study||19||
48226551|NCT03987074|100877814|FG000|NOT COMPLETED|Overall Study||3||
48226552|NCT03987074|100877815|FG001|NOT COMPLETED|Overall Study||2||
48226553|NCT03987074|100877816|FG002|NOT COMPLETED|Overall Study||1||
48226554|NCT03987074|100877817|FG003|NOT COMPLETED|Overall Study||4||
48226555|NCT03987074|100877818|FG004|NOT COMPLETED|Overall Study||2||
48226556|NCT03184987|100877819|FG000|STARTED|Overall Study||47||
48226557|NCT03184987|100877820|FG001|STARTED|Overall Study||9||
48226558|NCT03184987|100877821|FG002|STARTED|Overall Study||55||
48226559|NCT03184987|100877819|FG000|COMPLETED|Overall Study||46||
48226560|NCT03184987|100877820|FG001|COMPLETED|Overall Study||8||
48226561|NCT03184987|100877821|FG002|COMPLETED|Overall Study||51||
48226562|NCT03184987|100877819|FG000|NOT COMPLETED|Overall Study||1||
48226563|NCT03184987|100877820|FG001|NOT COMPLETED|Overall Study||1||
48226564|NCT03184987|100877821|FG002|NOT COMPLETED|Overall Study||4||
48226565|NCT00291694|100877822|FG000|STARTED|Overall Study||24||
48226566|NCT00291694|100877823|FG001|STARTED|Overall Study||48||
48226567|NCT00291694|100877822|FG000|COMPLETED|Overall Study||21||
48226568|NCT00291694|100877823|FG001|COMPLETED|Overall Study||43||
48226569|NCT00291694|100877822|FG000|NOT COMPLETED|Overall Study||3||
48226570|NCT00291694|100877823|FG001|NOT COMPLETED|Overall Study||5||
48226571|NCT03905642|100877824|FG000|STARTED|Overall Study||49||
48226572|NCT03905642|100877824|FG000|COMPLETED|Overall Study||41||
48226573|NCT03905642|100877824|FG000|NOT COMPLETED|Overall Study||8||
48226574|NCT00786864|100877825|FG000|STARTED|Overall Study||39||
48226575|NCT00786864|100877826|FG001|STARTED|Overall Study||33||
48226576|NCT00786864|100877825|FG000|COMPLETED|Overall Study||38||
48226577|NCT00786864|100877826|FG001|COMPLETED|Overall Study||32||
48226578|NCT00786864|100877825|FG000|NOT COMPLETED|Overall Study||1||
48226579|NCT00786864|100877826|FG001|NOT COMPLETED|Overall Study||1||
48226580|NCT04000399|100877827|FG000|STARTED|Overall Study||38||
48226581|NCT04000399|100877828|FG001|STARTED|Overall Study||5||
48226582|NCT04000399|100877827|FG000|COMPLETED|Overall Study||38||
48226583|NCT04000399|100877828|FG001|COMPLETED|Overall Study||5||
48226584|NCT04000399|100877827|FG000|NOT COMPLETED|Overall Study||0||
48226585|NCT04000399|100877828|FG001|NOT COMPLETED|Overall Study||0||
48226586|NCT02351791|100877829|FG000|STARTED|Overall Study||12||
48226587|NCT02351791|100877830|FG001|STARTED|Overall Study||10||
48226588|NCT02351791|100877829|FG000|COMPLETED|Overall Study||12||
48226589|NCT02351791|100877830|FG001|COMPLETED|Overall Study||10||
48226590|NCT02351791|100877829|FG000|NOT COMPLETED|Overall Study||0||
48226591|NCT02351791|100877830|FG001|NOT COMPLETED|Overall Study||0||
48226592|NCT02170532|100877831|FG000|STARTED|Overall Study||10||
48226593|NCT02170532|100877831|FG000|COMPLETED|Overall Study||10||
48226594|NCT02170532|100877831|FG000|NOT COMPLETED|Overall Study||0||
48226595|NCT02646618|100877832|FG000|STARTED|Overall Study||167||
48226596|NCT02646618|100877833|FG001|STARTED|Overall Study||162||
48226597|NCT02646618|100877832|FG000|6 Month Follow-up|Overall Study||152||
48226598|NCT02646618|100877833|FG001|6 Month Follow-up|Overall Study||150||
48226599|NCT02646618|100877832|FG000|COMPLETED|Overall Study||157||
48226600|NCT02646618|100877833|FG001|COMPLETED|Overall Study||148||
48226601|NCT02646618|100877832|FG000|NOT COMPLETED|Overall Study||10||
48226602|NCT02646618|100877833|FG001|NOT COMPLETED|Overall Study||14||
48226603|NCT01372085|100877834|FG000|STARTED|First Intervention (Period 1)||8||
48226604|NCT01372085|100877835|FG001|STARTED|First Intervention (Period 1)||2||
48226605|NCT01372085|100877836|FG002|STARTED|First Intervention (Period 1)||2||
48226606|NCT01372085|100877837|FG003|STARTED|First Intervention (Period 1)||1||
48226607|NCT01372085|100877838|FG004|STARTED|First Intervention (Period 1)||3||
48226608|NCT01372085|100877839|FG005|STARTED|First Intervention (Period 1)||5||
48226609|NCT01372085|100877840|FG006|STARTED|First Intervention (Period 1)||3||
48226610|NCT01372085|100877841|FG007|STARTED|First Intervention (Period 1)||1||
48226611|NCT01372085|100877842|FG008|STARTED|First Intervention (Period 1)||1||
48226612|NCT01372085|100877843|FG009|STARTED|First Intervention (Period 1)||0||
48226613|NCT01372085|100877834|FG000|COMPLETED|First Intervention (Period 1)||8||
48226614|NCT01372085|100877835|FG001|COMPLETED|First Intervention (Period 1)||2||
48226615|NCT01372085|100877836|FG002|COMPLETED|First Intervention (Period 1)||2||
48226616|NCT01372085|100877837|FG003|COMPLETED|First Intervention (Period 1)||1||
48226617|NCT01372085|100877838|FG004|COMPLETED|First Intervention (Period 1)||3||
48226618|NCT01372085|100877839|FG005|COMPLETED|First Intervention (Period 1)||5||
48226619|NCT01372085|100877840|FG006|COMPLETED|First Intervention (Period 1)||3||
48226620|NCT01372085|100877841|FG007|COMPLETED|First Intervention (Period 1)||1||
48226621|NCT01372085|100877842|FG008|COMPLETED|First Intervention (Period 1)||1||
48226622|NCT01372085|100877843|FG009|COMPLETED|First Intervention (Period 1)||0||
48226623|NCT01372085|100877834|FG000|NOT COMPLETED|First Intervention (Period 1)||0||
48226624|NCT01372085|100877835|FG001|NOT COMPLETED|First Intervention (Period 1)||0||
48226625|NCT01372085|100877836|FG002|NOT COMPLETED|First Intervention (Period 1)||0||
48226626|NCT01372085|100877837|FG003|NOT COMPLETED|First Intervention (Period 1)||0||
48226627|NCT01372085|100877838|FG004|NOT COMPLETED|First Intervention (Period 1)||0||
48370864|NCT01897441|101236554|FG000|STARTED|Overall Study||1||
48226628|NCT01372085|100877839|FG005|NOT COMPLETED|First Intervention (Period 1)||0||
48226629|NCT01372085|100877840|FG006|NOT COMPLETED|First Intervention (Period 1)||0||
48226630|NCT01372085|100877841|FG007|NOT COMPLETED|First Intervention (Period 1)||0||
48226631|NCT01372085|100877842|FG008|NOT COMPLETED|First Intervention (Period 1)||0||
48226632|NCT01372085|100877843|FG009|NOT COMPLETED|First Intervention (Period 1)||0||
48226633|NCT01372085|100877834|FG000|STARTED|Washout Period 1||0||
48226634|NCT01372085|100877835|FG001|STARTED|Washout Period 1||0||
48226635|NCT01372085|100877836|FG002|STARTED|Washout Period 1||2||
48226636|NCT01372085|100877837|FG003|STARTED|Washout Period 1||1||
48226637|NCT01372085|100877838|FG004|STARTED|Washout Period 1||3||
48226638|NCT01372085|100877839|FG005|STARTED|Washout Period 1||5||
48226639|NCT01372085|100877840|FG006|STARTED|Washout Period 1||3||
48226640|NCT01372085|100877841|FG007|STARTED|Washout Period 1||1||
48226641|NCT01372085|100877842|FG008|STARTED|Washout Period 1||1||
48226642|NCT01372085|100877843|FG009|STARTED|Washout Period 1||0||
48226643|NCT01372085|100877834|FG000|COMPLETED|Washout Period 1||0||
48226644|NCT01372085|100877835|FG001|COMPLETED|Washout Period 1||0||
48226645|NCT01372085|100877836|FG002|COMPLETED|Washout Period 1||2||
48226646|NCT01372085|100877837|FG003|COMPLETED|Washout Period 1||1||
48226647|NCT01372085|100877838|FG004|COMPLETED|Washout Period 1||3||
48226648|NCT01372085|100877839|FG005|COMPLETED|Washout Period 1||5||
48226649|NCT01372085|100877840|FG006|COMPLETED|Washout Period 1||3||
48226650|NCT01372085|100877841|FG007|COMPLETED|Washout Period 1||1||
48226651|NCT01372085|100877842|FG008|COMPLETED|Washout Period 1||1||
48226652|NCT01372085|100877843|FG009|COMPLETED|Washout Period 1||0||
48226653|NCT01372085|100877834|FG000|NOT COMPLETED|Washout Period 1||0||
48226654|NCT01372085|100877835|FG001|NOT COMPLETED|Washout Period 1||0||
48226655|NCT01372085|100877836|FG002|NOT COMPLETED|Washout Period 1||0||
48226656|NCT01372085|100877837|FG003|NOT COMPLETED|Washout Period 1||0||
48226657|NCT01372085|100877838|FG004|NOT COMPLETED|Washout Period 1||0||
48226658|NCT01372085|100877839|FG005|NOT COMPLETED|Washout Period 1||0||
48226659|NCT01372085|100877840|FG006|NOT COMPLETED|Washout Period 1||0||
48226660|NCT01372085|100877841|FG007|NOT COMPLETED|Washout Period 1||0||
48226661|NCT01372085|100877842|FG008|NOT COMPLETED|Washout Period 1||0||
48226662|NCT01372085|100877843|FG009|NOT COMPLETED|Washout Period 1||0||
48226663|NCT01372085|100877834|FG000|STARTED|Second Intervention (Period 2)||0||
48226664|NCT01372085|100877835|FG001|STARTED|Second Intervention (Period 2)||0||
48226665|NCT01372085|100877836|FG002|STARTED|Second Intervention (Period 2)||2||
48226666|NCT01372085|100877837|FG003|STARTED|Second Intervention (Period 2)||1||
48226667|NCT01372085|100877838|FG004|STARTED|Second Intervention (Period 2)||3||
48226668|NCT01372085|100877839|FG005|STARTED|Second Intervention (Period 2)||5||
48226669|NCT01372085|100877840|FG006|STARTED|Second Intervention (Period 2)||3||
48226670|NCT01372085|100877841|FG007|STARTED|Second Intervention (Period 2)||1||
48226671|NCT01372085|100877842|FG008|STARTED|Second Intervention (Period 2)||1||
48226672|NCT01372085|100877843|FG009|STARTED|Second Intervention (Period 2)||0||
48226673|NCT01372085|100877834|FG000|COMPLETED|Second Intervention (Period 2)||0||
48226674|NCT01372085|100877835|FG001|COMPLETED|Second Intervention (Period 2)||0||
48226675|NCT01372085|100877836|FG002|COMPLETED|Second Intervention (Period 2)||2||
48226676|NCT01372085|100877837|FG003|COMPLETED|Second Intervention (Period 2)||1||
48226677|NCT01372085|100877838|FG004|COMPLETED|Second Intervention (Period 2)||3||
48226678|NCT01372085|100877839|FG005|COMPLETED|Second Intervention (Period 2)||5||
48226679|NCT01372085|100877840|FG006|COMPLETED|Second Intervention (Period 2)||3||
48226680|NCT01372085|100877841|FG007|COMPLETED|Second Intervention (Period 2)||1||
48226681|NCT01372085|100877842|FG008|COMPLETED|Second Intervention (Period 2)||1||
48226682|NCT01372085|100877843|FG009|COMPLETED|Second Intervention (Period 2)||0||
48226683|NCT01372085|100877834|FG000|NOT COMPLETED|Second Intervention (Period 2)||0||
48226684|NCT01372085|100877835|FG001|NOT COMPLETED|Second Intervention (Period 2)||0||
48226685|NCT01372085|100877836|FG002|NOT COMPLETED|Second Intervention (Period 2)||0||
48226686|NCT01372085|100877837|FG003|NOT COMPLETED|Second Intervention (Period 2)||0||
48226687|NCT01372085|100877838|FG004|NOT COMPLETED|Second Intervention (Period 2)||0||
48226688|NCT01372085|100877839|FG005|NOT COMPLETED|Second Intervention (Period 2)||0||
48226689|NCT01372085|100877840|FG006|NOT COMPLETED|Second Intervention (Period 2)||0||
48226690|NCT01372085|100877841|FG007|NOT COMPLETED|Second Intervention (Period 2)||0||
48226691|NCT01372085|100877842|FG008|NOT COMPLETED|Second Intervention (Period 2)||0||
48226692|NCT01372085|100877843|FG009|NOT COMPLETED|Second Intervention (Period 2)||0||
48226693|NCT01372085|100877834|FG000|STARTED|Washout Period 2||0||
48226694|NCT01372085|100877835|FG001|STARTED|Washout Period 2||0||
48226695|NCT01372085|100877836|FG002|STARTED|Washout Period 2||2||
48226696|NCT01372085|100877837|FG003|STARTED|Washout Period 2||1||
48226697|NCT01372085|100877838|FG004|STARTED|Washout Period 2||3||
48226698|NCT01372085|100877839|FG005|STARTED|Washout Period 2||5||
48226699|NCT01372085|100877840|FG006|STARTED|Washout Period 2||3||
48226700|NCT01372085|100877841|FG007|STARTED|Washout Period 2||1||
48226701|NCT01372085|100877842|FG008|STARTED|Washout Period 2||1||
48226702|NCT01372085|100877843|FG009|STARTED|Washout Period 2||0||
48226703|NCT01372085|100877834|FG000|COMPLETED|Washout Period 2||0||
48226704|NCT01372085|100877835|FG001|COMPLETED|Washout Period 2||0||
48226705|NCT01372085|100877836|FG002|COMPLETED|Washout Period 2||2||
48226706|NCT01372085|100877837|FG003|COMPLETED|Washout Period 2||1||
48226707|NCT01372085|100877838|FG004|COMPLETED|Washout Period 2||2||
48226708|NCT01372085|100877839|FG005|COMPLETED|Washout Period 2||5||
48226709|NCT01372085|100877840|FG006|COMPLETED|Washout Period 2||3||
48226710|NCT01372085|100877841|FG007|COMPLETED|Washout Period 2||1||
48226711|NCT01372085|100877842|FG008|COMPLETED|Washout Period 2||1||
48226712|NCT01372085|100877843|FG009|COMPLETED|Washout Period 2||0||
48226713|NCT01372085|100877834|FG000|NOT COMPLETED|Washout Period 2||0||
48226714|NCT01372085|100877835|FG001|NOT COMPLETED|Washout Period 2||0||
48226715|NCT01372085|100877836|FG002|NOT COMPLETED|Washout Period 2||0||
48226716|NCT01372085|100877837|FG003|NOT COMPLETED|Washout Period 2||0||
48226717|NCT01372085|100877838|FG004|NOT COMPLETED|Washout Period 2||1||
48226718|NCT01372085|100877839|FG005|NOT COMPLETED|Washout Period 2||0||
48226719|NCT01372085|100877840|FG006|NOT COMPLETED|Washout Period 2||0||
48226720|NCT01372085|100877841|FG007|NOT COMPLETED|Washout Period 2||0||
48226721|NCT01372085|100877842|FG008|NOT COMPLETED|Washout Period 2||0||
48226722|NCT01372085|100877843|FG009|NOT COMPLETED|Washout Period 2||0||
48226723|NCT01372085|100877834|FG000|STARTED|Third Intervention (Period 3)||0||
48226724|NCT01372085|100877835|FG001|STARTED|Third Intervention (Period 3)||0||
48226725|NCT01372085|100877836|FG002|STARTED|Third Intervention (Period 3)||2||
48226726|NCT01372085|100877837|FG003|STARTED|Third Intervention (Period 3)||1||
48226727|NCT01372085|100877838|FG004|STARTED|Third Intervention (Period 3)||2||
48226728|NCT01372085|100877839|FG005|STARTED|Third Intervention (Period 3)||7||
48226729|NCT01372085|100877840|FG006|STARTED|Third Intervention (Period 3)||3||
48226730|NCT01372085|100877841|FG007|STARTED|Third Intervention (Period 3)||1||
48226731|NCT01372085|100877842|FG008|STARTED|Third Intervention (Period 3)||1||
48226732|NCT01372085|100877843|FG009|STARTED|Third Intervention (Period 3)||0||
48226733|NCT01372085|100877834|FG000|COMPLETED|Third Intervention (Period 3)||0||
48226734|NCT01372085|100877835|FG001|COMPLETED|Third Intervention (Period 3)||0||
48226735|NCT01372085|100877836|FG002|COMPLETED|Third Intervention (Period 3)||2||
48226736|NCT01372085|100877837|FG003|COMPLETED|Third Intervention (Period 3)||1||
48226737|NCT01372085|100877838|FG004|COMPLETED|Third Intervention (Period 3)||2||
48226738|NCT01372085|100877839|FG005|COMPLETED|Third Intervention (Period 3)||7||
48226739|NCT01372085|100877840|FG006|COMPLETED|Third Intervention (Period 3)||3||
48226740|NCT01372085|100877841|FG007|COMPLETED|Third Intervention (Period 3)||1||
48226741|NCT01372085|100877842|FG008|COMPLETED|Third Intervention (Period 3)||1||
48226742|NCT01372085|100877843|FG009|COMPLETED|Third Intervention (Period 3)||0||
48226743|NCT01372085|100877834|FG000|NOT COMPLETED|Third Intervention (Period 3)||0||
48226744|NCT01372085|100877835|FG001|NOT COMPLETED|Third Intervention (Period 3)||0||
48226745|NCT01372085|100877836|FG002|NOT COMPLETED|Third Intervention (Period 3)||0||
48226746|NCT01372085|100877837|FG003|NOT COMPLETED|Third Intervention (Period 3)||0||
48226747|NCT01372085|100877838|FG004|NOT COMPLETED|Third Intervention (Period 3)||0||
48226748|NCT01372085|100877839|FG005|NOT COMPLETED|Third Intervention (Period 3)||0||
48226749|NCT01372085|100877840|FG006|NOT COMPLETED|Third Intervention (Period 3)||0||
48226750|NCT01372085|100877841|FG007|NOT COMPLETED|Third Intervention (Period 3)||0||
48226751|NCT01372085|100877842|FG008|NOT COMPLETED|Third Intervention (Period 3)||0||
48226752|NCT01372085|100877843|FG009|NOT COMPLETED|Third Intervention (Period 3)||0||
48226753|NCT01372085|100877834|FG000|STARTED|Washout Period 3||0||
48226754|NCT01372085|100877835|FG001|STARTED|Washout Period 3||0||
48226755|NCT01372085|100877836|FG002|STARTED|Washout Period 3||2||
48226756|NCT01372085|100877837|FG003|STARTED|Washout Period 3||1||
48226757|NCT01372085|100877838|FG004|STARTED|Washout Period 3||2||
48226758|NCT01372085|100877839|FG005|STARTED|Washout Period 3||7||
48226759|NCT01372085|100877840|FG006|STARTED|Washout Period 3||3||
48226760|NCT01372085|100877841|FG007|STARTED|Washout Period 3||1||
48226761|NCT01372085|100877842|FG008|STARTED|Washout Period 3||1||
48226762|NCT01372085|100877843|FG009|STARTED|Washout Period 3||0||
48226763|NCT01372085|100877834|FG000|COMPLETED|Washout Period 3||0||
48226764|NCT01372085|100877835|FG001|COMPLETED|Washout Period 3||0||
48226765|NCT01372085|100877836|FG002|COMPLETED|Washout Period 3||2||
48226766|NCT01372085|100877837|FG003|COMPLETED|Washout Period 3||1||
48226767|NCT01372085|100877838|FG004|COMPLETED|Washout Period 3||2||
48226768|NCT01372085|100877839|FG005|COMPLETED|Washout Period 3||5||
48226769|NCT01372085|100877840|FG006|COMPLETED|Washout Period 3||3||
48226770|NCT01372085|100877841|FG007|COMPLETED|Washout Period 3||1||
48226771|NCT01372085|100877842|FG008|COMPLETED|Washout Period 3||1||
48226772|NCT01372085|100877843|FG009|COMPLETED|Washout Period 3||0||
48226773|NCT01372085|100877834|FG000|NOT COMPLETED|Washout Period 3||0||
48226774|NCT01372085|100877835|FG001|NOT COMPLETED|Washout Period 3||0||
48226775|NCT01372085|100877836|FG002|NOT COMPLETED|Washout Period 3||0||
48226776|NCT01372085|100877837|FG003|NOT COMPLETED|Washout Period 3||0||
48226777|NCT01372085|100877838|FG004|NOT COMPLETED|Washout Period 3||0||
48226778|NCT01372085|100877839|FG005|NOT COMPLETED|Washout Period 3||2||
48226779|NCT01372085|100877840|FG006|NOT COMPLETED|Washout Period 3||0||
48226780|NCT01372085|100877841|FG007|NOT COMPLETED|Washout Period 3||0||
48226781|NCT01372085|100877842|FG008|NOT COMPLETED|Washout Period 3||0||
48226782|NCT01372085|100877843|FG009|NOT COMPLETED|Washout Period 3||0||
48226783|NCT01372085|100877834|FG000|STARTED|Forth Intervention (Period 4a/4b)||0||
48226784|NCT01372085|100877835|FG001|STARTED|Forth Intervention (Period 4a/4b)||0||
48226785|NCT01372085|100877836|FG002|STARTED|Forth Intervention (Period 4a/4b)||2||
48226786|NCT01372085|100877837|FG003|STARTED|Forth Intervention (Period 4a/4b)||1||
48226787|NCT01372085|100877838|FG004|STARTED|Forth Intervention (Period 4a/4b)||2||
48226788|NCT01372085|100877839|FG005|STARTED|Forth Intervention (Period 4a/4b)||5||
48226789|NCT01372085|100877840|FG006|STARTED|Forth Intervention (Period 4a/4b)||3||
48226790|NCT01372085|100877841|FG007|STARTED|Forth Intervention (Period 4a/4b)||1||
48226791|NCT01372085|100877842|FG008|STARTED|Forth Intervention (Period 4a/4b)||1||
48226792|NCT01372085|100877843|FG009|STARTED|Forth Intervention (Period 4a/4b)||1||
48226793|NCT01372085|100877834|FG000|COMPLETED|Forth Intervention (Period 4a/4b)||0||
48226794|NCT01372085|100877835|FG001|COMPLETED|Forth Intervention (Period 4a/4b)||0||
48226795|NCT01372085|100877836|FG002|COMPLETED|Forth Intervention (Period 4a/4b)||2||
48226796|NCT01372085|100877837|FG003|COMPLETED|Forth Intervention (Period 4a/4b)||1||
48226797|NCT01372085|100877838|FG004|COMPLETED|Forth Intervention (Period 4a/4b)||2||
48226798|NCT01372085|100877839|FG005|COMPLETED|Forth Intervention (Period 4a/4b)||5||
48226799|NCT01372085|100877840|FG006|COMPLETED|Forth Intervention (Period 4a/4b)||3||
48226800|NCT01372085|100877841|FG007|COMPLETED|Forth Intervention (Period 4a/4b)||1||
48226801|NCT01372085|100877842|FG008|COMPLETED|Forth Intervention (Period 4a/4b)||1||
48226802|NCT01372085|100877843|FG009|COMPLETED|Forth Intervention (Period 4a/4b)||1||
48226803|NCT01372085|100877834|FG000|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0||
48226804|NCT01372085|100877835|FG001|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0||
48226805|NCT01372085|100877836|FG002|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0||
48226806|NCT01372085|100877837|FG003|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0||
48226807|NCT01372085|100877838|FG004|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0||
48226808|NCT01372085|100877839|FG005|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0||
48226809|NCT01372085|100877840|FG006|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0||
48226810|NCT01372085|100877841|FG007|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0||
48226811|NCT01372085|100877842|FG008|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0||
48226812|NCT01372085|100877843|FG009|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0||
48226813|NCT00610558|100877844|FG000|STARTED|Overall Study||20||
48226814|NCT00610558|100877845|FG001|STARTED|Overall Study||20||
48226815|NCT00610558|100877846|FG002|STARTED|Overall Study||20||
48226816|NCT00610558|100877844|FG000|COMPLETED|Overall Study||15||
48226817|NCT00610558|100877845|FG001|COMPLETED|Overall Study||14||
48226818|NCT00610558|100877846|FG002|COMPLETED|Overall Study||14||
48226819|NCT00610558|100877844|FG000|NOT COMPLETED|Overall Study||5||
48226820|NCT00610558|100877845|FG001|NOT COMPLETED|Overall Study||6||
48226821|NCT00610558|100877846|FG002|NOT COMPLETED|Overall Study||6||
48226822|NCT02934932|100877847|FG000|STARTED|Overall Study||9||
48226823|NCT02934932|100877847|FG000|COMPLETED|Overall Study||6||
48226824|NCT02934932|100877847|FG000|NOT COMPLETED|Overall Study||3||
48226825|NCT03490032|100877848|FG000|STARTED|Overall Study||6|All enrolled patients were included in the Full Analysis Set (FAS)|
48226826|NCT03490032|100877849|FG001|STARTED|Overall Study||12|All enrolled patients were included in the Full Analysis Set (FAS)|
48226827|NCT03490032|100877850|FG002|STARTED|Overall Study||12|All enrolled patients were included in the Full Analysis Set (FAS)|
48226828|NCT03490032|100877848|FG000|COMPLETED|Overall Study||5||
48226829|NCT03490032|100877849|FG001|COMPLETED|Overall Study||12||
48226830|NCT03490032|100877850|FG002|COMPLETED|Overall Study||12||
48226831|NCT03490032|100877848|FG000|NOT COMPLETED|Overall Study||1||
48226832|NCT03490032|100877849|FG001|NOT COMPLETED|Overall Study||0||
48226833|NCT03490032|100877850|FG002|NOT COMPLETED|Overall Study||0||
48226834|NCT01354145|100877851|FG000|STARTED|Overall Study||97||
48226835|NCT01354145|100877852|FG001|STARTED|Overall Study||97||
48226836|NCT01354145|100877851|FG000|COMPLETED|Overall Study||58||
48226837|NCT01354145|100877852|FG001|COMPLETED|Overall Study||63||
48226838|NCT01354145|100877851|FG000|NOT COMPLETED|Overall Study||39||
48226839|NCT01354145|100877852|FG001|NOT COMPLETED|Overall Study||34||
48672151|NCT01378195|101982560|FG001|COMPLETED|Overall Study||57||
48672152|NCT01378195|101982559|FG000|NOT COMPLETED|Overall Study||29||
48672153|NCT01378195|101982560|FG001|NOT COMPLETED|Overall Study||18||
48672154|NCT02660229|101982561|FG000|STARTED|Overall Study||34||
48672155|NCT02660229|101982562|FG001|STARTED|Overall Study||32||
48672156|NCT02660229|101982561|FG000|Safety Analysis Set|Overall Study||34||
48672157|NCT02660229|101982562|FG001|Safety Analysis Set|Overall Study||32||
48672158|NCT02660229|101982561|FG000|FAS Set|Overall Study||33||
48672159|NCT02660229|101982562|FG001|FAS Set|Overall Study||32||
48672160|NCT02660229|101982561|FG000|Per Protocol Set|Overall Study||28||
48226840|NCT01555138|100877853|FG000|STARTED|Overall Study||293||
48226841|NCT01555138|100877854|FG001|STARTED|Overall Study||288||
48226842|NCT01555138|100877853|FG000|COMPLETED|Overall Study||246||
48226843|NCT01555138|100877854|FG001|COMPLETED|Overall Study||250||
48226844|NCT01555138|100877853|FG000|NOT COMPLETED|Overall Study||47||
48226845|NCT01555138|100877854|FG001|NOT COMPLETED|Overall Study||38||
48226846|NCT01812759|100877855|FG000|STARTED|Overall Study||1||
48226847|NCT01812759|100877856|FG001|STARTED|Overall Study||1||
48226848|NCT01812759|100877857|FG002|STARTED|Overall Study||1||
48226849|NCT01812759|100877855|FG000|COMPLETED|Overall Study||1||
48226850|NCT01812759|100877856|FG001|COMPLETED|Overall Study||1||
48226851|NCT01812759|100877857|FG002|COMPLETED|Overall Study||0||
48672161|NCT02660229|101982562|FG001|Per Protocol Set|Overall Study||29||
48672162|NCT02660229|101982561|FG000|COMPLETED|Overall Study||32||
48226852|NCT01812759|100877855|FG000|NOT COMPLETED|Overall Study||0||
48226853|NCT01812759|100877856|FG001|NOT COMPLETED|Overall Study||0||
48226854|NCT01812759|100877857|FG002|NOT COMPLETED|Overall Study||1||
48226855|NCT03890484|100877858|FG000|STARTED|Overall Study||5||
48226856|NCT03890484|100877859|FG001|STARTED|Overall Study||8||
48226857|NCT03890484|100877858|FG000|Completed Alcohol Admin Session|Overall Study||5||
48226858|NCT03890484|100877859|FG001|Completed Alcohol Admin Session|Overall Study||8||
48226859|NCT03890484|100877858|FG000|COMPLETED|Overall Study||4||
48226860|NCT03890484|100877859|FG001|COMPLETED|Overall Study||7||
48226861|NCT03890484|100877858|FG000|NOT COMPLETED|Overall Study||1||
48226862|NCT03890484|100877859|FG001|NOT COMPLETED|Overall Study||1||
48226863|NCT02110381|100877860|FG000|STARTED|Single Modality||9||
48226864|NCT02110381|100877861|FG001|STARTED|Single Modality||9||
48226865|NCT02110381|100877860|FG000|COMPLETED|Single Modality||7||
48226866|NCT02110381|100877861|FG001|COMPLETED|Single Modality||8||
48226867|NCT02110381|100877860|FG000|NOT COMPLETED|Single Modality||2||
48226868|NCT02110381|100877861|FG001|NOT COMPLETED|Single Modality||1||
48226869|NCT02110381|100877860|FG000|STARTED|Dual Modality||7||
48226870|NCT02110381|100877861|FG001|STARTED|Dual Modality||8||
48226871|NCT02110381|100877860|FG000|Began Active Treatment|Dual Modality||7||
48226872|NCT02110381|100877861|FG001|Began Active Treatment|Dual Modality||7||
48226873|NCT02110381|100877860|FG000|COMPLETED|Dual Modality||5||
48226874|NCT02110381|100877861|FG001|COMPLETED|Dual Modality||7||
48226875|NCT02110381|100877860|FG000|NOT COMPLETED|Dual Modality||2||
48226876|NCT02110381|100877861|FG001|NOT COMPLETED|Dual Modality||1||
48226877|NCT03057600|100877862|FG000|STARTED|Overall Study||9||
48226878|NCT03057600|100877863|FG001|STARTED|Overall Study||10||
48226879|NCT03057600|100877864|FG002|STARTED|Overall Study||20||
48226880|NCT03057600|100877865|FG003|STARTED|Overall Study||13||
48226881|NCT03057600|100877862|FG000|COMPLETED|Overall Study||0||
48226882|NCT03057600|100877863|FG001|COMPLETED|Overall Study||0||
48226883|NCT03057600|100877864|FG002|COMPLETED|Overall Study||0||
48226884|NCT03057600|100877865|FG003|COMPLETED|Overall Study||0||
48226885|NCT03057600|100877862|FG000|NOT COMPLETED|Overall Study||9||
48226886|NCT03057600|100877863|FG001|NOT COMPLETED|Overall Study||10||
48226887|NCT03057600|100877864|FG002|NOT COMPLETED|Overall Study||20||
48226888|NCT03057600|100877865|FG003|NOT COMPLETED|Overall Study||13||
48672163|NCT02660229|101982562|FG001|COMPLETED|Overall Study||31||
48672164|NCT02660229|101982561|FG000|NOT COMPLETED|Overall Study||2||
48672165|NCT02660229|101982562|FG001|NOT COMPLETED|Overall Study||1||
48672166|NCT03801525|101982563|FG000|STARTED|Overall Study||165||
48672167|NCT03801525|101982564|FG001|STARTED|Overall Study||56||
48672168|NCT03801525|101982565|FG002|STARTED|Overall Study||56||
48672169|NCT03801525|101982563|FG000|Intent-To-Treat (ITT) Population|Overall Study||149|In Phase 2, ITT population consisted of all participants who received at least one dose of each study drug (ublituximab, umbralisib, and venetoclax); and in Phase 3, ITT population consisted of all participants who were randomized.|
48672170|NCT03801525|101982564|FG001|Intent-To-Treat (ITT) Population|Overall Study||56|In Phase 2, ITT population consisted of all participants who received at least one dose of each study drug (ublituximab, umbralisib, and venetoclax); and in Phase 3, ITT population consisted of all participants who were randomized.|
48672171|NCT03801525|101982565|FG002|Intent-To-Treat (ITT) Population|Overall Study||56|In Phase 2, ITT population consisted of all participants who received at least one dose of each study drug (ublituximab, umbralisib, and venetoclax); and in Phase 3, ITT population consisted of all participants who were randomized.|
48672172|NCT03801525|101982563|FG000|COMPLETED|Overall Study||11||
48672173|NCT03801525|101982564|FG001|COMPLETED|Overall Study||0||
48672174|NCT03801525|101982565|FG002|COMPLETED|Overall Study||0||
48672175|NCT03801525|101982563|FG000|NOT COMPLETED|Overall Study||154||
48672176|NCT03801525|101982564|FG001|NOT COMPLETED|Overall Study||56||
48672177|NCT03801525|101982565|FG002|NOT COMPLETED|Overall Study||56||
48672178|NCT01987414|101982566|FG000|STARTED|Overall Study||10||
48672179|NCT01987414|101982567|FG001|STARTED|Overall Study||8||
48672180|NCT01987414|101982566|FG000|COMPLETED|Overall Study||8||
48672181|NCT01987414|101982567|FG001|COMPLETED|Overall Study||6||
48672182|NCT01987414|101982566|FG000|NOT COMPLETED|Overall Study||2||
48672183|NCT01987414|101982567|FG001|NOT COMPLETED|Overall Study||2||
48672184|NCT00163189|101982568|FG000|STARTED|Overall Study||98||
48672185|NCT00163189|101982568|FG000|COMPLETED|Overall Study||35||
48226889|NCT01957163|100877866|FG000|STARTED|Overall Study||206||
48226890|NCT01957163|100877867|FG001|STARTED|Overall Study||206||
48226891|NCT01957163|100877868|FG002|STARTED|Overall Study||207||
48226892|NCT01957163|100877866|FG000|COMPLETED|Overall Study||191||
48226893|NCT01957163|100877867|FG001|COMPLETED|Overall Study||195||
48226894|NCT01957163|100877868|FG002|COMPLETED|Overall Study||189||
48226895|NCT01957163|100877866|FG000|NOT COMPLETED|Overall Study||15||
48226896|NCT01957163|100877867|FG001|NOT COMPLETED|Overall Study||11||
48226897|NCT01957163|100877868|FG002|NOT COMPLETED|Overall Study||18||
48226898|NCT01989689|100877869|FG000|STARTED|Baseline||11||
48226899|NCT01989689|100877870|FG001|STARTED|Baseline||13||
48226900|NCT01989689|100877869|FG000|COMPLETED|Baseline||11||
48226901|NCT01989689|100877870|FG001|COMPLETED|Baseline||13||
48226902|NCT01989689|100877869|FG000|NOT COMPLETED|Baseline||0||
48226903|NCT01989689|100877870|FG001|NOT COMPLETED|Baseline||0||
48226904|NCT01989689|100877869|FG000|STARTED|Treatment Period 1 ( 3 Months)||11||
48226905|NCT01989689|100877870|FG001|STARTED|Treatment Period 1 ( 3 Months)||13||
48226906|NCT01989689|100877869|FG000|COMPLETED|Treatment Period 1 ( 3 Months)||11||
48226907|NCT01989689|100877870|FG001|COMPLETED|Treatment Period 1 ( 3 Months)||10||
48226908|NCT01989689|100877869|FG000|NOT COMPLETED|Treatment Period 1 ( 3 Months)||0||
48226909|NCT01989689|100877870|FG001|NOT COMPLETED|Treatment Period 1 ( 3 Months)||3||
48226910|NCT01989689|100877869|FG000|STARTED|Treatment Period ( 3 Months)||11||
48226911|NCT01989689|100877870|FG001|STARTED|Treatment Period ( 3 Months)||10||
48226912|NCT01989689|100877869|FG000|COMPLETED|Treatment Period ( 3 Months)||11||
48226913|NCT01989689|100877870|FG001|COMPLETED|Treatment Period ( 3 Months)||10||
48226914|NCT01989689|100877869|FG000|NOT COMPLETED|Treatment Period ( 3 Months)||0||
48226915|NCT01989689|100877870|FG001|NOT COMPLETED|Treatment Period ( 3 Months)||0||
48226916|NCT00780494|100877871|FG000|STARTED|Overall Study||35||
48226917|NCT00780494|100877871|FG000|COMPLETED|Overall Study||35||
48226918|NCT00780494|100877871|FG000|NOT COMPLETED|Overall Study||0||
48226919|NCT04248868|100877872|FG000|STARTED|Overall Study||109||
48226920|NCT04248868|100877872|FG000|COMPLETED|Overall Study||103||
48226921|NCT04248868|100877872|FG000|NOT COMPLETED|Overall Study||6||
48226922|NCT01479010|100877873|FG000|STARTED|Overall Study||2||
48226923|NCT01479010|100877873|FG000|COMPLETED|Overall Study||1||
48226924|NCT01479010|100877873|FG000|NOT COMPLETED|Overall Study||1||
48226925|NCT02630966|100877874|FG000|STARTED|Overall Study||16||
48672186|NCT00163189|101982568|FG000|NOT COMPLETED|Overall Study||63||
48672187|NCT00940602|101982569|FG000|STARTED|Overall Study||149|All patients to whom study treatment had been assigned by randomization (Full Analysis Set).|
48672188|NCT00940602|101982570|FG001|STARTED|Overall Study||76|All patients to whom study treatment had been assigned by randomization (Full Analysis Set).|
48672189|NCT00940602|101982569|FG000|Safety Analysis Set|Overall Study||148|All randomized patients who received at least one dose of study medication|
48672190|NCT00940602|101982570|FG001|Safety Analysis Set|Overall Study||76|All randomized patients who received at least one dose of study medication|
48672191|NCT00940602|101982569|FG000|Full Analysis Set|Overall Study||149|All patients to whom study treatment had been assigned by randomization|
48672192|NCT00940602|101982570|FG001|Full Analysis Set|Overall Study||76|All patients to whom study treatment had been assigned by randomization|
48672193|NCT00940602|101982569|FG000|Treated|Overall Study||148|Treated = Received study drug|
48672194|NCT00940602|101982570|FG001|Treated|Overall Study||76|Treated = Received study drug|
48672195|NCT00940602|101982569|FG000|Untreated|Overall Study||1|Untreated = Did not receive study drug|
48226926|NCT02630966|100877875|FG001|STARTED|Overall Study||18||
48226927|NCT02630966|100877874|FG000|COMPLETED|Overall Study||14|Completed here refers to participants who completed study drug.|
48226928|NCT02630966|100877875|FG001|COMPLETED|Overall Study||10|Completed here refers to participants who completed study drug.|
48226929|NCT02630966|100877874|FG000|NOT COMPLETED|Overall Study||2||
48226930|NCT02630966|100877875|FG001|NOT COMPLETED|Overall Study||8||
48226931|NCT01619059|100877876|FG000|STARTED|Short-Term (ST) Treatment Period||162||
48226932|NCT01619059|100877877|FG001|STARTED|Short-Term (ST) Treatment Period||153||
48226933|NCT01619059|100877876|FG000|COMPLETED|Short-Term (ST) Treatment Period||156||
48226934|NCT01619059|100877877|FG001|COMPLETED|Short-Term (ST) Treatment Period||142||
48226935|NCT01619059|100877876|FG000|NOT COMPLETED|Short-Term (ST) Treatment Period||6||
48226936|NCT01619059|100877877|FG001|NOT COMPLETED|Short-Term (ST) Treatment Period||11||
48226937|NCT01619059|100877876|FG000|STARTED|Long-Term (LT) Treatment Period||155||
48226938|NCT01619059|100877877|FG001|STARTED|Long-Term (LT) Treatment Period||142||
48226939|NCT01619059|100877876|FG000|COMPLETED|Long-Term (LT) Treatment Period||147||
48226940|NCT01619059|100877877|FG001|COMPLETED|Long-Term (LT) Treatment Period||133||
48226941|NCT01619059|100877876|FG000|NOT COMPLETED|Long-Term (LT) Treatment Period||8||
48226942|NCT01619059|100877877|FG001|NOT COMPLETED|Long-Term (LT) Treatment Period||9||
48226943|NCT03418545|100877878|FG000|STARTED|Overall Study||35||
48226944|NCT03418545|100877879|FG001|STARTED|Overall Study||105||
48226945|NCT03418545|100877878|FG000|Safety Population|Overall Study||34|Safety Population included participants who were randomized to study treatment (JUVÉDERM® VOLBELLA™ XC treatment group) and received at least 1 study device treatment and participants who were randomized to the control group.|
48226946|NCT03418545|100877879|FG001|Safety Population|Overall Study||105|Safety Population included participants who were randomized to study treatment (JUVÉDERM® VOLBELLA™ XC treatment group) and received at least 1 study device treatment and participants who were randomized to the control group.|
48226947|NCT03418545|100877878|FG000|Received Optional or Repeat Treatment|Overall Study||29|Participants randomized to the No-treatment Control group who received optional treatment with JUVÉDERM® VOLBELLA™ XC injectable gel after Month 3 and participants randomized to the JUVÉDERM® VOLBELLA™ XC arm who received repeat treatment with JUVÉDERM® VOLBELLA™ XC injectable gel 12 months after the initial treatment.|
48226948|NCT03418545|100877879|FG001|Received Optional or Repeat Treatment|Overall Study||37|Participants randomized to the No-treatment Control group who received optional treatment with JUVÉDERM® VOLBELLA™ XC injectable gel after Month 3 and participants randomized to the JUVÉDERM® VOLBELLA™ XC arm who received repeat treatment with JUVÉDERM® VOLBELLA™ XC injectable gel 12 months after the initial treatment.|
48226949|NCT03418545|100877878|FG000|COMPLETED|Overall Study||30||
48226950|NCT03418545|100877879|FG001|COMPLETED|Overall Study||94||
48226951|NCT03418545|100877878|FG000|NOT COMPLETED|Overall Study||5||
48226952|NCT03418545|100877879|FG001|NOT COMPLETED|Overall Study||11||
48226953|NCT01450007|100877880|FG000|STARTED|Overall Study||44||
48226954|NCT01450007|100877881|FG001|STARTED|Overall Study||42||
48226955|NCT01450007|100877882|FG002|STARTED|Overall Study||44||
48226956|NCT01450007|100877880|FG000|COMPLETED|Overall Study||42||
48226957|NCT01450007|100877881|FG001|COMPLETED|Overall Study||37||
48226958|NCT01450007|100877882|FG002|COMPLETED|Overall Study||41||
48370865|NCT01897441|101236555|FG001|STARTED|Overall Study||8||
48370866|NCT01897441|101236556|FG002|STARTED|Overall Study||9||
48370867|NCT01897441|101236557|FG003|STARTED|Overall Study||5||
48370868|NCT01897441|101236558|FG004|STARTED|Overall Study||6||
48370869|NCT01897441|101236559|FG005|STARTED|Overall Study||1||
48370870|NCT01897441|101236554|FG000|COMPLETED|Overall Study||1||
48370871|NCT01897441|101236555|FG001|COMPLETED|Overall Study||6||
48370872|NCT01897441|101236556|FG002|COMPLETED|Overall Study||8||
48370873|NCT01897441|101236557|FG003|COMPLETED|Overall Study||5||
48370874|NCT01897441|101236558|FG004|COMPLETED|Overall Study||5||
48370875|NCT01897441|101236559|FG005|COMPLETED|Overall Study||1||
48370876|NCT01897441|101236554|FG000|NOT COMPLETED|Overall Study||0||
48370877|NCT01897441|101236555|FG001|NOT COMPLETED|Overall Study||2||
48370878|NCT01897441|101236556|FG002|NOT COMPLETED|Overall Study||1||
48370879|NCT01897441|101236557|FG003|NOT COMPLETED|Overall Study||0||
48370880|NCT01897441|101236558|FG004|NOT COMPLETED|Overall Study||1||
48370881|NCT01897441|101236559|FG005|NOT COMPLETED|Overall Study||0||
48370882|NCT01909453|101236560|FG000|STARTED|Overall Study||192||
48370883|NCT01909453|101236561|FG001|STARTED|Overall Study||194||
48370884|NCT01909453|101236562|FG002|STARTED|Overall Study||191||
48370885|NCT01909453|101236563|FG003|STARTED|Overall Study||258||
48370886|NCT01909453|101236564|FG004|STARTED|Overall Study||86||
48370887|NCT01909453|101236560|FG000|COMPLETED|Overall Study||0||
48672196|NCT00940602|101982570|FG001|Untreated|Overall Study||0|Untreated = Did not receive study drug|
48672197|NCT00940602|101982569|FG000|COMPLETED|Overall Study||0||
48672198|NCT00940602|101982570|FG001|COMPLETED|Overall Study||0||
48672199|NCT00940602|101982569|FG000|NOT COMPLETED|Overall Study||149||
48672200|NCT00940602|101982570|FG001|NOT COMPLETED|Overall Study||76||
48370888|NCT01909453|101236561|FG001|COMPLETED|Overall Study||0||
48370889|NCT01909453|101236562|FG002|COMPLETED|Overall Study||0||
48370890|NCT01909453|101236563|FG003|COMPLETED|Overall Study||0||
48370891|NCT01909453|101236564|FG004|COMPLETED|Overall Study||0||
48370892|NCT01909453|101236560|FG000|NOT COMPLETED|Overall Study||192||
48370893|NCT01909453|101236561|FG001|NOT COMPLETED|Overall Study||194||
48370894|NCT01909453|101236562|FG002|NOT COMPLETED|Overall Study||191||
48370895|NCT01909453|101236563|FG003|NOT COMPLETED|Overall Study||258||
48370896|NCT01909453|101236564|FG004|NOT COMPLETED|Overall Study||86||
48370897|NCT04386746|101236565|FG000|STARTED|Overall Study||26||
48370898|NCT04386746|101236565|FG000|COMPLETED|Overall Study||4||
48370899|NCT04386746|101236565|FG000|NOT COMPLETED|Overall Study||22||
48370900|NCT03215706|101236566|FG000|STARTED|Randomization||361|= Participants Randomized|
48370901|NCT03215706|101236567|FG001|STARTED|Randomization||358|= Participants Randomized|
48370902|NCT03215706|101236566|FG000|COMPLETED|Randomization||358|= Participants treated|
48370903|NCT03215706|101236567|FG001|COMPLETED|Randomization||349|= Participants treated|
48370904|NCT03215706|101236566|FG000|NOT COMPLETED|Randomization||3||
48370905|NCT03215706|101236567|FG001|NOT COMPLETED|Randomization||9||
48370906|NCT03215706|101236566|FG000|STARTED|Treatment Period||358|= Participants treated|
48370907|NCT03215706|101236567|FG001|STARTED|Treatment Period||349|= Participants treated|
48370908|NCT03215706|101236566|FG000|COMPLETED|Treatment Period||16|= completing treatment|
48370909|NCT03215706|101236567|FG001|COMPLETED|Treatment Period||103|= completing treatment|
48370910|NCT03215706|101236566|FG000|NOT COMPLETED|Treatment Period||342||
48370911|NCT03215706|101236567|FG001|NOT COMPLETED|Treatment Period||246||
48370912|NCT03759379|101236568|FG000|STARTED|Treatment Period||122||
48370913|NCT03759379|101236569|FG001|STARTED|Treatment Period||42||
48370914|NCT03759379|101236568|FG000|COMPLETED|Treatment Period||0||
48370915|NCT03759379|101236569|FG001|COMPLETED|Treatment Period||0||
48370916|NCT03759379|101236568|FG000|NOT COMPLETED|Treatment Period||122||
48370917|NCT03759379|101236569|FG001|NOT COMPLETED|Treatment Period||42||
48370918|NCT03759379|101236568|FG000|STARTED|Randomized Treatment Extension Period||0||
48370919|NCT03759379|101236569|FG001|STARTED|Randomized Treatment Extension Period||0||
48370920|NCT03759379|101236568|FG000|COMPLETED|Randomized Treatment Extension Period||0||
48370921|NCT03759379|101236569|FG001|COMPLETED|Randomized Treatment Extension Period||0||
48370922|NCT03759379|101236568|FG000|NOT COMPLETED|Randomized Treatment Extension Period||0||
48370923|NCT03759379|101236569|FG001|NOT COMPLETED|Randomized Treatment Extension Period||0||
48370924|NCT05349838|101236570|FG000|STARTED|Overall Study||95||
48370925|NCT05349838|101236571|FG001|STARTED|Overall Study||45||
48370926|NCT05349838|101236570|FG000|Per-protocol Population at Week 48|Overall Study||87||
48370927|NCT05349838|101236571|FG001|Per-protocol Population at Week 48|Overall Study||40||
48370928|NCT05349838|101236570|FG000|COMPLETED|Overall Study||83||
48370929|NCT05349838|101236571|FG001|COMPLETED|Overall Study||36||
48370930|NCT05349838|101236570|FG000|NOT COMPLETED|Overall Study||12||
48370931|NCT05349838|101236571|FG001|NOT COMPLETED|Overall Study||9||
48370932|NCT05165485|101236572|FG000|STARTED|Overall Study||191|A total of 23 enrolled participants from 2 sites are excluded from the Participant Flow table and all analysis populations due to data integrity concerns.|
48370933|NCT05165485|101236573|FG001|STARTED|Overall Study||190|A total of 23 enrolled participants from 2 sites are excluded from the Participant Flow table and all analysis populations due to data integrity concerns.|
48370934|NCT05165485|101236572|FG000|COMPLETED|Overall Study||156||
48370935|NCT05165485|101236573|FG001|COMPLETED|Overall Study||147||
48370936|NCT05165485|101236572|FG000|NOT COMPLETED|Overall Study||35||
48370937|NCT05165485|101236573|FG001|NOT COMPLETED|Overall Study||43||
48370938|NCT01931462|101236574|FG000|STARTED|Overall Study||2||
48370939|NCT01931462|101236574|FG000|COMPLETED|Overall Study||1||
48370940|NCT01931462|101236574|FG000|NOT COMPLETED|Overall Study||1||
48370941|NCT03276936|101236575|FG000|STARTED|Overall Study||332||
48370942|NCT03276936|101236576|FG001|STARTED|Overall Study||172||
48370943|NCT03276936|101236575|FG000|COMPLETED|Overall Study||276||
48370944|NCT03276936|101236576|FG001|COMPLETED|Overall Study||134||
48370945|NCT03276936|101236575|FG000|NOT COMPLETED|Overall Study||56||
48370946|NCT03276936|101236576|FG001|NOT COMPLETED|Overall Study||38||
48370947|NCT03097328|101236577|FG000|STARTED|Overall Study||39||
48370948|NCT03097328|101236577|FG000|Treated|Overall Study||38||
48370949|NCT03097328|101236577|FG000|COMPLETED|Overall Study||0||
48370950|NCT03097328|101236577|FG000|NOT COMPLETED|Overall Study||39||
48370951|NCT03100942|101236578|FG000|STARTED|Randomized Treatment Period||38||
48370952|NCT03100942|101236579|FG001|STARTED|Randomized Treatment Period||38||
48370953|NCT03100942|101236580|FG002|STARTED|Randomized Treatment Period||39||
48370954|NCT03100942|101236581|FG003|STARTED|Randomized Treatment Period||37||
48370955|NCT03100942|101236582|FG004|STARTED|Randomized Treatment Period||0||
48370956|NCT03100942|101236583|FG005|STARTED|Randomized Treatment Period||0||
48370957|NCT03100942|101236584|FG006|STARTED|Randomized Treatment Period||0||
48370958|NCT03100942|101236578|FG000|COMPLETED|Randomized Treatment Period||26||
48370959|NCT03100942|101236579|FG001|COMPLETED|Randomized Treatment Period||29||
48370960|NCT03100942|101236580|FG002|COMPLETED|Randomized Treatment Period||33||
48370961|NCT03100942|101236581|FG003|COMPLETED|Randomized Treatment Period||32||
48370962|NCT03100942|101236582|FG004|COMPLETED|Randomized Treatment Period||0||
48370963|NCT03100942|101236583|FG005|COMPLETED|Randomized Treatment Period||0||
48672201|NCT02468583|101982571|FG000|STARTED|Overall Study||3||
48370964|NCT03100942|101236584|FG006|COMPLETED|Randomized Treatment Period||0||
48370965|NCT03100942|101236578|FG000|NOT COMPLETED|Randomized Treatment Period||12||
48370966|NCT03100942|101236579|FG001|NOT COMPLETED|Randomized Treatment Period||9||
48370967|NCT03100942|101236580|FG002|NOT COMPLETED|Randomized Treatment Period||6||
48370968|NCT03100942|101236581|FG003|NOT COMPLETED|Randomized Treatment Period||5||
48370969|NCT03100942|101236582|FG004|NOT COMPLETED|Randomized Treatment Period||0||
48370970|NCT03100942|101236583|FG005|NOT COMPLETED|Randomized Treatment Period||0||
48370971|NCT03100942|101236584|FG006|NOT COMPLETED|Randomized Treatment Period||0||
48370972|NCT03100942|101236578|FG000|STARTED|Placebo Arm Re-Randomized||0||
48672202|NCT02468583|101982572|FG001|STARTED|Overall Study||3||
48672203|NCT02468583|101982571|FG000|COMPLETED|Overall Study||3||
48672204|NCT02468583|101982572|FG001|COMPLETED|Overall Study||3||
48672205|NCT02468583|101982571|FG000|NOT COMPLETED|Overall Study||0||
48672206|NCT02468583|101982572|FG001|NOT COMPLETED|Overall Study||0||
48672207|NCT00718315|101982573|FG000|STARTED|Overall Study||67||
48672208|NCT00718315|101982574|FG001|STARTED|Overall Study||67||
48672209|NCT00718315|101982575|FG002|STARTED|Overall Study||67||
48672210|NCT00718315|101982573|FG000|COMPLETED|Overall Study||48||
48672211|NCT00718315|101982574|FG001|COMPLETED|Overall Study||45||
48672212|NCT00718315|101982575|FG002|COMPLETED|Overall Study||46||
48672213|NCT00718315|101982573|FG000|NOT COMPLETED|Overall Study||19||
48370973|NCT03100942|101236579|FG001|STARTED|Placebo Arm Re-Randomized||0||
48370974|NCT03100942|101236580|FG002|STARTED|Placebo Arm Re-Randomized||0||
48370975|NCT03100942|101236581|FG003|STARTED|Placebo Arm Re-Randomized||0||
48672214|NCT00718315|101982574|FG001|NOT COMPLETED|Overall Study||22||
48672215|NCT00718315|101982575|FG002|NOT COMPLETED|Overall Study||21||
48672216|NCT02347605|101982576|FG000|STARTED|Overall Study||10||
48672217|NCT02347605|101982577|FG001|STARTED|Overall Study||10||
48672218|NCT02347605|101982578|FG002|STARTED|Overall Study||8||
48672219|NCT02347605|101982579|FG003|STARTED|Overall Study||10||
48672220|NCT02347605|101982580|FG004|STARTED|Overall Study||9||
48672221|NCT02347605|101982581|FG005|STARTED|Overall Study||9||
48672222|NCT02347605|101982576|FG000|Completed Lab 1|Overall Study||10||
48672223|NCT02347605|101982577|FG001|Completed Lab 1|Overall Study||10||
48672224|NCT02347605|101982578|FG002|Completed Lab 1|Overall Study||8||
48672225|NCT02347605|101982579|FG003|Completed Lab 1|Overall Study||10||
48672226|NCT02347605|101982580|FG004|Completed Lab 1|Overall Study||8||
48370976|NCT03100942|101236582|FG004|STARTED|Placebo Arm Re-Randomized||10||
48370977|NCT03100942|101236583|FG005|STARTED|Placebo Arm Re-Randomized||12||
48370978|NCT03100942|101236584|FG006|STARTED|Placebo Arm Re-Randomized||10||
48370979|NCT03100942|101236578|FG000|COMPLETED|Placebo Arm Re-Randomized||0||
48370980|NCT03100942|101236579|FG001|COMPLETED|Placebo Arm Re-Randomized||0||
48370981|NCT03100942|101236580|FG002|COMPLETED|Placebo Arm Re-Randomized||0||
48370982|NCT03100942|101236581|FG003|COMPLETED|Placebo Arm Re-Randomized||0||
48370983|NCT03100942|101236582|FG004|COMPLETED|Placebo Arm Re-Randomized||10||
48370984|NCT03100942|101236583|FG005|COMPLETED|Placebo Arm Re-Randomized||12||
48370985|NCT03100942|101236584|FG006|COMPLETED|Placebo Arm Re-Randomized||9||
48370986|NCT03100942|101236578|FG000|NOT COMPLETED|Placebo Arm Re-Randomized||0||
48370987|NCT03100942|101236579|FG001|NOT COMPLETED|Placebo Arm Re-Randomized||0||
48370988|NCT03100942|101236580|FG002|NOT COMPLETED|Placebo Arm Re-Randomized||0||
48370989|NCT03100942|101236581|FG003|NOT COMPLETED|Placebo Arm Re-Randomized||0||
48370990|NCT03100942|101236582|FG004|NOT COMPLETED|Placebo Arm Re-Randomized||0||
48370991|NCT03100942|101236583|FG005|NOT COMPLETED|Placebo Arm Re-Randomized||0||
48370992|NCT03100942|101236584|FG006|NOT COMPLETED|Placebo Arm Re-Randomized||1||
48370993|NCT01199263|101236585|FG000|STARTED|Overall Study||54||
48370994|NCT01199263|101236586|FG001|STARTED|Overall Study||54||
48370995|NCT01199263|101236585|FG000|COMPLETED|Overall Study||48||
48370996|NCT01199263|101236586|FG001|COMPLETED|Overall Study||52||
48370997|NCT01199263|101236585|FG000|NOT COMPLETED|Overall Study||6||
48370998|NCT01199263|101236586|FG001|NOT COMPLETED|Overall Study||2||
48370999|NCT03259334|101236587|FG000|STARTED|Overall Study||76||
48371000|NCT03259334|101236588|FG001|STARTED|Overall Study||153||
48371001|NCT03259334|101236589|FG002|STARTED|Overall Study||151||
48371002|NCT03259334|101236587|FG000|Treated|Overall Study||76||
48371003|NCT03259334|101236588|FG001|Treated|Overall Study||151||
48371004|NCT03259334|101236589|FG002|Treated|Overall Study||151||
48371005|NCT03259334|101236587|FG000|COMPLETED|Overall Study||66||
48371006|NCT03259334|101236588|FG001|COMPLETED|Overall Study||136||
48371007|NCT03259334|101236589|FG002|COMPLETED|Overall Study||138||
48371008|NCT03259334|101236587|FG000|NOT COMPLETED|Overall Study||10||
48371009|NCT03259334|101236588|FG001|NOT COMPLETED|Overall Study||17||
48371010|NCT03259334|101236589|FG002|NOT COMPLETED|Overall Study||13||
48371011|NCT03220048|101236590|FG000|STARTED|Overall Study||11||
48371012|NCT03220048|101236591|FG001|STARTED|Overall Study||27||
48371013|NCT03220048|101236592|FG002|STARTED|Overall Study||28||
48371014|NCT03220048|101236590|FG000|COMPLETED|Overall Study||11||
48371015|NCT03220048|101236591|FG001|COMPLETED|Overall Study||25||
48371016|NCT03220048|101236592|FG002|COMPLETED|Overall Study||27||
48073596|NCT02151110|100501069|FG005|COMPLETED|Overall Study||8||
48073597|NCT02151110|100501070|FG006|COMPLETED|Overall Study||8||
48073598|NCT02151110|100501071|FG007|COMPLETED|Overall Study||5||
48073599|NCT02151110|100501064|FG000|NOT COMPLETED|Overall Study||0||
48073600|NCT02151110|100501065|FG001|NOT COMPLETED|Overall Study||0||
48371017|NCT03220048|101236590|FG000|NOT COMPLETED|Overall Study||0||
48371018|NCT03220048|101236591|FG001|NOT COMPLETED|Overall Study||2||
48371019|NCT03220048|101236592|FG002|NOT COMPLETED|Overall Study||1||
48371020|NCT02344628|101236593|FG000|STARTED|Overall Study||291||
48371021|NCT02344628|101236594|FG001|STARTED|Overall Study||292||
48371022|NCT02344628|101236593|FG000|COMPLETED|Overall Study||200||
48371023|NCT02344628|101236594|FG001|COMPLETED|Overall Study||206||
48371024|NCT02344628|101236593|FG000|NOT COMPLETED|Overall Study||91||
48371025|NCT02344628|101236594|FG001|NOT COMPLETED|Overall Study||86||
48371026|NCT03484923|101236595|FG000|STARTED|Overall Study||45||
48371027|NCT03484923|101236596|FG001|STARTED|Overall Study||43||
48371028|NCT03484923|101236597|FG002|STARTED|Overall Study||43||
48371029|NCT03484923|101236598|FG003|STARTED|Overall Study||44||
48371030|NCT03484923|101236599|FG004|STARTED|Overall Study||21||
48371031|NCT03484923|101236595|FG000|Treated|Overall Study||45||
48371032|NCT03484923|101236596|FG001|Treated|Overall Study||43||
48371033|NCT03484923|101236597|FG002|Treated|Overall Study||42||
48371034|NCT03484923|101236598|FG003|Treated|Overall Study||44||
48371035|NCT03484923|101236599|FG004|Treated|Overall Study||21||
48371036|NCT03484923|101236595|FG000|COMPLETED|Overall Study||0||
48371037|NCT03484923|101236596|FG001|COMPLETED|Overall Study||0||
48371038|NCT03484923|101236597|FG002|COMPLETED|Overall Study||0||
48371039|NCT03484923|101236598|FG003|COMPLETED|Overall Study||0||
48371040|NCT03484923|101236599|FG004|COMPLETED|Overall Study||0||
48371041|NCT03484923|101236595|FG000|NOT COMPLETED|Overall Study||45||
48371042|NCT03484923|101236596|FG001|NOT COMPLETED|Overall Study||43||
48371043|NCT03484923|101236597|FG002|NOT COMPLETED|Overall Study||43||
48371044|NCT03484923|101236598|FG003|NOT COMPLETED|Overall Study||44||
48371045|NCT03484923|101236599|FG004|NOT COMPLETED|Overall Study||21||
48371046|NCT02042404|101236600|FG000|STARTED|Overall Study||43||
48371047|NCT02042404|101236601|FG001|STARTED|Overall Study||5||
48371048|NCT02042404|101236600|FG000|COMPLETED|Overall Study||38||
48371049|NCT02042404|101236601|FG001|COMPLETED|Overall Study||5||
48371050|NCT02042404|101236600|FG000|NOT COMPLETED|Overall Study||5||
48371051|NCT02042404|101236601|FG001|NOT COMPLETED|Overall Study||0||
48371052|NCT01328158|101236602|FG000|STARTED|Overall Study||220||
48371053|NCT01328158|101236602|FG000|COMPLETED|Overall Study||220||
48371054|NCT01328158|101236602|FG000|NOT COMPLETED|Overall Study||0||
48371055|NCT01355068|101236603|FG000|STARTED|First Intervention Period||13||
48371056|NCT01355068|101236604|FG001|STARTED|First Intervention Period||13||
48371057|NCT01355068|101236603|FG000|COMPLETED|First Intervention Period||13||
48371058|NCT01355068|101236604|FG001|COMPLETED|First Intervention Period||11||
48371059|NCT01355068|101236603|FG000|NOT COMPLETED|First Intervention Period||0||
48371060|NCT01355068|101236604|FG001|NOT COMPLETED|First Intervention Period||2||
48371061|NCT01355068|101236603|FG000|STARTED|Washout Period (at Least 7 Days)||13||
48371062|NCT01355068|101236604|FG001|STARTED|Washout Period (at Least 7 Days)||11||
48371063|NCT01355068|101236603|FG000|COMPLETED|Washout Period (at Least 7 Days)||13||
48371064|NCT01355068|101236604|FG001|COMPLETED|Washout Period (at Least 7 Days)||11||
48371065|NCT01355068|101236603|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48371066|NCT01355068|101236604|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48371067|NCT01355068|101236603|FG000|STARTED|Second Intervention Period||13||
48371068|NCT01355068|101236604|FG001|STARTED|Second Intervention Period||11||
48371069|NCT01355068|101236603|FG000|COMPLETED|Second Intervention Period||13||
48371070|NCT01355068|101236604|FG001|COMPLETED|Second Intervention Period||11||
48371071|NCT01355068|101236603|FG000|NOT COMPLETED|Second Intervention Period||0||
48371072|NCT01355068|101236604|FG001|NOT COMPLETED|Second Intervention Period||0||
48371073|NCT01270581|101236605|FG000|STARTED|Overall Study||4||
48371074|NCT01270581|101236606|FG001|STARTED|Overall Study||3||
48371075|NCT01270581|101236605|FG000|COMPLETED|Overall Study||3||
48371076|NCT01270581|101236606|FG001|COMPLETED|Overall Study||3||
48371077|NCT01270581|101236605|FG000|NOT COMPLETED|Overall Study||1||
48371078|NCT01270581|101236606|FG001|NOT COMPLETED|Overall Study||0||
48371079|NCT02409784|101236607|FG000|STARTED|Overall Study||10||
48371080|NCT02409784|101236607|FG000|COMPLETED|Overall Study||10||
48371081|NCT02409784|101236607|FG000|NOT COMPLETED|Overall Study||0||
48371082|NCT02214186|101236608|FG000|STARTED|Overall Study||23||
48371083|NCT02214186|101236609|FG001|STARTED|Overall Study||23||
48371084|NCT02214186|101236608|FG000|COMPLETED|Overall Study||21||
48371085|NCT02214186|101236609|FG001|COMPLETED|Overall Study||21||
48371086|NCT02214186|101236608|FG000|NOT COMPLETED|Overall Study||2||
48371087|NCT02214186|101236609|FG001|NOT COMPLETED|Overall Study||2||
48371088|NCT05460871|101236610|FG000|STARTED|Overall Study||1||
48371089|NCT05460871|101236611|FG001|STARTED|Overall Study||2||
48371090|NCT05460871|101236610|FG000|COMPLETED|Overall Study||0||
48371091|NCT05460871|101236611|FG001|COMPLETED|Overall Study||0||
48371092|NCT05460871|101236610|FG000|NOT COMPLETED|Overall Study||1||
48371093|NCT05460871|101236611|FG001|NOT COMPLETED|Overall Study||2||
48371094|NCT01543490|101236612|FG000|STARTED|Overall Study||368||
48371095|NCT01543490|101236613|FG001|STARTED|Overall Study||190||
48371096|NCT01543490|101236612|FG000|COMPLETED|Overall Study||352||
48371097|NCT01543490|101236613|FG001|COMPLETED|Overall Study||185||
48371098|NCT01543490|101236612|FG000|NOT COMPLETED|Overall Study||16||
48371099|NCT01543490|101236613|FG001|NOT COMPLETED|Overall Study||5||
48371100|NCT00748540|101236614|FG000|STARTED|Overall Study||50||
48371101|NCT00748540|101236614|FG000|COMPLETED|Overall Study||49||
48371102|NCT00748540|101236614|FG000|NOT COMPLETED|Overall Study||1||
48371103|NCT04146272|101236615|FG000|STARTED|First Intervention||11||
48371104|NCT04146272|101236616|FG001|STARTED|First Intervention||11||
48371105|NCT04146272|101236617|FG002|STARTED|First Intervention||6||
48371106|NCT04146272|101236618|FG003|STARTED|First Intervention||5||
48371107|NCT04146272|101236615|FG000|COMPLETED|First Intervention||11||
48371108|NCT04146272|101236616|FG001|COMPLETED|First Intervention||11||
48371109|NCT04146272|101236617|FG002|COMPLETED|First Intervention||6||
48371110|NCT04146272|101236618|FG003|COMPLETED|First Intervention||5||
48371111|NCT04146272|101236615|FG000|NOT COMPLETED|First Intervention||0||
48371112|NCT04146272|101236616|FG001|NOT COMPLETED|First Intervention||0||
48371113|NCT04146272|101236617|FG002|NOT COMPLETED|First Intervention||0||
48371114|NCT04146272|101236618|FG003|NOT COMPLETED|First Intervention||0||
48371115|NCT04146272|101236615|FG000|STARTED|Second Intervention||11||
48371116|NCT04146272|101236616|FG001|STARTED|Second Intervention||11||
48371117|NCT04146272|101236617|FG002|STARTED|Second Intervention||6||
48371118|NCT04146272|101236618|FG003|STARTED|Second Intervention||5||
48371119|NCT04146272|101236615|FG000|COMPLETED|Second Intervention||11||
48371120|NCT04146272|101236616|FG001|COMPLETED|Second Intervention||11||
48371121|NCT04146272|101236617|FG002|COMPLETED|Second Intervention||6||
48371122|NCT04146272|101236618|FG003|COMPLETED|Second Intervention||5||
48371123|NCT04146272|101236615|FG000|NOT COMPLETED|Second Intervention||0||
48371124|NCT04146272|101236616|FG001|NOT COMPLETED|Second Intervention||0||
48371125|NCT04146272|101236617|FG002|NOT COMPLETED|Second Intervention||0||
48371126|NCT04146272|101236618|FG003|NOT COMPLETED|Second Intervention||0||
48371127|NCT03493685|101236619|FG000|STARTED|Overall Study||184||
48371128|NCT03493685|101236620|FG001|STARTED|Overall Study||187||
48371129|NCT03493685|101236619|FG000|COMPLETED|Overall Study||168|The participant flow presented is based on the primary analysis (double-blind period of the study).|
48371130|NCT03493685|101236620|FG001|COMPLETED|Overall Study||171|The participant flow presented is based on the primary analysis (double-blind period of the study).|
48371131|NCT03493685|101236619|FG000|NOT COMPLETED|Overall Study||16||
48371132|NCT03493685|101236620|FG001|NOT COMPLETED|Overall Study||16||
48371133|NCT03011840|101236621|FG000|STARTED|Overall Study||232||
48371134|NCT03011840|101236622|FG001|STARTED|Overall Study||217||
48371135|NCT03011840|101236621|FG000|COMPLETED|Overall Study||232||
48371136|NCT03011840|101236622|FG001|COMPLETED|Overall Study||196||
48371137|NCT03011840|101236621|FG000|NOT COMPLETED|Overall Study||0||
48371138|NCT03011840|101236622|FG001|NOT COMPLETED|Overall Study||21||
48371139|NCT04929262|101236623|FG000|STARTED|Pre-Presentation Questionnaires||152||14
48371140|NCT04929262|101236624|FG001|STARTED|Pre-Presentation Questionnaires||131||13
48371141|NCT04929262|101236623|FG000|COMPLETED|Pre-Presentation Questionnaires||112||13
48371142|NCT04929262|101236624|FG001|COMPLETED|Pre-Presentation Questionnaires||97||12
48371143|NCT04929262|101236623|FG000|NOT COMPLETED|Pre-Presentation Questionnaires||40||1
48371144|NCT04929262|101236624|FG001|NOT COMPLETED|Pre-Presentation Questionnaires||34||1
48371145|NCT04929262|101236623|FG000|STARTED|Attended Presentation||112||13
48371146|NCT04929262|101236624|FG001|STARTED|Attended Presentation||97||12
48371147|NCT04929262|101236623|FG000|COMPLETED|Attended Presentation||57||13
48371148|NCT04929262|101236624|FG001|COMPLETED|Attended Presentation||52||12
48371149|NCT04929262|101236623|FG000|NOT COMPLETED|Attended Presentation||55||0
48371150|NCT04929262|101236624|FG001|NOT COMPLETED|Attended Presentation||45||0
48371151|NCT04929262|101236623|FG000|STARTED|Post-Presentation Questionnaires||57||13
48371152|NCT04929262|101236624|FG001|STARTED|Post-Presentation Questionnaires||52||12
48371153|NCT04929262|101236623|FG000|COMPLETED|Post-Presentation Questionnaires||49||13
48371154|NCT04929262|101236624|FG001|COMPLETED|Post-Presentation Questionnaires||47||12
48371155|NCT04929262|101236623|FG000|NOT COMPLETED|Post-Presentation Questionnaires||8||0
48371156|NCT04929262|101236624|FG001|NOT COMPLETED|Post-Presentation Questionnaires||5||0
48371157|NCT04929262|101236623|FG000|STARTED|3 Month Follow-Up Questionnaires||57||13
48371158|NCT04929262|101236624|FG001|STARTED|3 Month Follow-Up Questionnaires||52||12
48371159|NCT04929262|101236623|FG000|COMPLETED|3 Month Follow-Up Questionnaires||39||13
48371160|NCT04929262|101236624|FG001|COMPLETED|3 Month Follow-Up Questionnaires||36||12
48371161|NCT04929262|101236623|FG000|NOT COMPLETED|3 Month Follow-Up Questionnaires||18||0
48371162|NCT04929262|101236624|FG001|NOT COMPLETED|3 Month Follow-Up Questionnaires||16||0
48371163|NCT02626819|101236625|FG000|STARTED|Overall Study||22||
48371164|NCT02626819|101236626|FG001|STARTED|Overall Study||23||
48371165|NCT02626819|101236625|FG000|COMPLETED|Overall Study||18||
48371166|NCT02626819|101236626|FG001|COMPLETED|Overall Study||20||
48371167|NCT02626819|101236625|FG000|NOT COMPLETED|Overall Study||4||
48371168|NCT02626819|101236626|FG001|NOT COMPLETED|Overall Study||3||
48371169|NCT03827473|101236627|FG000|STARTED|Overall Study||1||
48371170|NCT03827473|101236628|FG001|STARTED|Overall Study||0||
48371171|NCT03827473|101236627|FG000|COMPLETED|Overall Study||0||
48371172|NCT03827473|101236628|FG001|COMPLETED|Overall Study||0||
48371173|NCT03827473|101236627|FG000|NOT COMPLETED|Overall Study||1||
48371174|NCT03827473|101236628|FG001|NOT COMPLETED|Overall Study||0||
48672227|NCT02347605|101982581|FG005|Completed Lab 1|Overall Study||9||
48672228|NCT02347605|101982576|FG000|Completed Lab 2|Overall Study||7||
48672229|NCT02347605|101982577|FG001|Completed Lab 2|Overall Study||7||
48371175|NCT02680847|101236629|FG000|STARTED|Overall Study||16||
48371176|NCT02680847|101236630|FG001|STARTED|Overall Study||9||
48371177|NCT02680847|101236631|FG002|STARTED|Overall Study||7||
48371178|NCT02680847|101236629|FG000|COMPLETED|Overall Study||11||
48371179|NCT02680847|101236630|FG001|COMPLETED|Overall Study||6||
48371180|NCT02680847|101236631|FG002|COMPLETED|Overall Study||4||
48371181|NCT02680847|101236629|FG000|NOT COMPLETED|Overall Study||5||
48371182|NCT02680847|101236630|FG001|NOT COMPLETED|Overall Study||3||
48371183|NCT02680847|101236631|FG002|NOT COMPLETED|Overall Study||3||
48371184|NCT01596842|101236632|FG000|STARTED|Overall Study||10||
48371185|NCT01596842|101236633|FG001|STARTED|Overall Study||7||
48371186|NCT01596842|101236632|FG000|COMPLETED|Overall Study||8||
48371187|NCT01596842|101236633|FG001|COMPLETED|Overall Study||7||
48371188|NCT01596842|101236632|FG000|NOT COMPLETED|Overall Study||2||
48371189|NCT01596842|101236633|FG001|NOT COMPLETED|Overall Study||0||
48371190|NCT02531035|101236634|FG000|STARTED|Overall Study||705||
48371191|NCT02531035|101236635|FG001|STARTED|Overall Study||700||
48371192|NCT02531035|101236634|FG000|Treated|Overall Study||703||
48371193|NCT02531035|101236635|FG001|Treated|Overall Study||699||
48371194|NCT02531035|101236634|FG000|COMPLETED|Overall Study||624||
48371195|NCT02531035|101236635|FG001|COMPLETED|Overall Study||605||
48371196|NCT02531035|101236634|FG000|NOT COMPLETED|Overall Study||81||
48371197|NCT02531035|101236635|FG001|NOT COMPLETED|Overall Study||95||
48371198|NCT03885726|101236636|FG000|STARTED|Overall Study||32||
48672230|NCT02347605|101982578|FG002|Completed Lab 2|Overall Study||7||
48371199|NCT03885726|101236636|FG000|COMPLETED|Overall Study||28||
48371200|NCT03885726|101236636|FG000|NOT COMPLETED|Overall Study||4||
48371201|NCT02759146|101236637|FG000|STARTED|Week 1-4||57|"150 reflexology dyads, 150 mediative practice dyads, and 47 control dyads were randomized. Between the randomization and response to weekly calls, 24 reflexology dyads, 44 meditative practice dyads and 3 control dyads attrited from the study totaling n=71 attrited dyad between the start of participant flow.~In the analysis of repeated measures, participants with at least one non-missing post-baseline value were included."|
48404002|NCT00544466|101321753|FG000|COMPLETED|Overall Study||62||
48404003|NCT00544466|101321753|FG000|NOT COMPLETED|Overall Study||0||
48672231|NCT02347605|101982579|FG003|Completed Lab 2|Overall Study||7||
48371202|NCT02759146|101236638|FG001|STARTED|Week 1-4||36|"150 reflexology dyads, 150 mediative practice dyads, and 47 control dyads were randomized. Between the randomization and response to weekly calls, 24 reflexology dyads, 44 meditative practice dyads and 3 control dyads attrited from the study totaling n=71 attrited dyad between the start of participant flow.~In the analysis of repeated measures, participants with at least one non-missing post-baseline value were included."|
48371203|NCT02759146|101236639|FG002|STARTED|Week 1-4||33|"150 reflexology dyads, 150 mediative practice dyads, and 47 control dyads were randomized. Between the randomization and response to weekly calls, 24 reflexology dyads, 44 meditative practice dyads and 3 control dyads attrited from the study totaling n=71 attrited dyad between the start of participant flow.~In the analysis of repeated measures, participants with at least one non-missing post-baseline value were included."|
48371204|NCT02759146|101236640|FG003|STARTED|Week 1-4||44|"150 reflexology dyads, 150 mediative practice dyads, and 47 control dyads were randomized. Between the randomization and response to weekly calls, 24 reflexology dyads, 44 meditative practice dyads and 3 control dyads attrited from the study totaling n=71 attrited dyad between the start of participant flow.~In the analysis of repeated measures, participants with at least one non-missing post-baseline value were included."|
48371205|NCT02759146|101236641|FG004|STARTED|Week 1-4||49|"150 reflexology dyads, 150 mediative practice dyads, and 47 control dyads were randomized. Between the randomization and response to weekly calls, 24 reflexology dyads, 44 meditative practice dyads and 3 control dyads attrited from the study totaling n=71 attrited dyad between the start of participant flow.~In the analysis of repeated measures, participants with at least one non-missing post-baseline value were included."|
48371206|NCT02759146|101236642|FG005|STARTED|Week 1-4||30|"150 reflexology dyads, 150 mediative practice dyads, and 47 control dyads were randomized. Between the randomization and response to weekly calls, 24 reflexology dyads, 44 meditative practice dyads and 3 control dyads attrited from the study totaling n=71 attrited dyad between the start of participant flow.~In the analysis of repeated measures, participants with at least one non-missing post-baseline value were included."|
48371207|NCT02759146|101236643|FG006|STARTED|Week 1-4||27|"150 reflexology dyads, 150 mediative practice dyads, and 47 control dyads were randomized. Between the randomization and response to weekly calls, 24 reflexology dyads, 44 meditative practice dyads and 3 control dyads attrited from the study totaling n=71 attrited dyad between the start of participant flow.~In the analysis of repeated measures, participants with at least one non-missing post-baseline value were included."|
48371208|NCT02759146|101236637|FG000|COMPLETED|Week 1-4||56||
48371209|NCT02759146|101236638|FG001|COMPLETED|Week 1-4||34||
48371210|NCT02759146|101236639|FG002|COMPLETED|Week 1-4||32||
48371211|NCT02759146|101236640|FG003|COMPLETED|Week 1-4||44||
48371212|NCT02759146|101236641|FG004|COMPLETED|Week 1-4||49||
48371213|NCT02759146|101236642|FG005|COMPLETED|Week 1-4||29||
48672232|NCT02347605|101982580|FG004|Completed Lab 2|Overall Study||6||
48371214|NCT02759146|101236643|FG006|COMPLETED|Week 1-4||26||
48371215|NCT02759146|101236637|FG000|NOT COMPLETED|Week 1-4||1||
48371216|NCT02759146|101236638|FG001|NOT COMPLETED|Week 1-4||2||
48371217|NCT02759146|101236639|FG002|NOT COMPLETED|Week 1-4||1||
48672233|NCT02347605|101982581|FG005|Completed Lab 2|Overall Study||8||
48672234|NCT02347605|101982576|FG000|COMPLETED|Overall Study||7|Completed lab 3 (and therefore the entire study)|
48371218|NCT02759146|101236640|FG003|NOT COMPLETED|Week 1-4||0||
48371219|NCT02759146|101236641|FG004|NOT COMPLETED|Week 1-4||0||
48371220|NCT02759146|101236642|FG005|NOT COMPLETED|Week 1-4||1||
48371221|NCT02759146|101236643|FG006|NOT COMPLETED|Week 1-4||1||
48371222|NCT02759146|101236637|FG000|STARTED|Week 5-8||56|In the analysis of repeated measures, participants with at least one non-missing post-baseline value were included. For example, if a participant dropped out before week 5 but completed one of the weeks 1-4, their data were included in the analysis of weeks 1-4 under the missing at random assumption. Same applies to the analysis of longitudinal data for weeks 5-12.|
48371223|NCT02759146|101236638|FG001|STARTED|Week 5-8||34|In the analysis of repeated measures, participants with at least one non-missing post-baseline value were included. For example, if a participant dropped out before week 5 but completed one of the weeks 1-4, their data were included in the analysis of weeks 1-4 under the missing at random assumption. Same applies to the analysis of longitudinal data for weeks 5-12.|
48371224|NCT02759146|101236639|FG002|STARTED|Week 5-8||32|In the analysis of repeated measures, participants with at least one non-missing post-baseline value were included. For example, if a participant dropped out before week 5 but completed one of the weeks 1-4, their data were included in the analysis of weeks 1-4 under the missing at random assumption. Same applies to the analysis of longitudinal data for weeks 5-12.|
48672235|NCT02347605|101982577|FG001|COMPLETED|Overall Study||7|Completed lab 3 (and therefore the entire study)|
48672236|NCT02347605|101982578|FG002|COMPLETED|Overall Study||7|Completed lab 3 (and therefore the entire study)|
48672237|NCT02347605|101982579|FG003|COMPLETED|Overall Study||6|Completed lab 3 (and therefore the entire study)|
48073601|NCT02151110|100501066|FG002|NOT COMPLETED|Overall Study||0||
48371225|NCT02759146|101236640|FG003|STARTED|Week 5-8||44|In the analysis of repeated measures, participants with at least one non-missing post-baseline value were included. For example, if a participant dropped out before week 5 but completed one of the weeks 1-4, their data were included in the analysis of weeks 1-4 under the missing at random assumption. Same applies to the analysis of longitudinal data for weeks 5-12.|
48371226|NCT02759146|101236641|FG004|STARTED|Week 5-8||49|In the analysis of repeated measures, participants with at least one non-missing post-baseline value were included. For example, if a participant dropped out before week 5 but completed one of the weeks 1-4, their data were included in the analysis of weeks 1-4 under the missing at random assumption. Same applies to the analysis of longitudinal data for weeks 5-12.|
48404004|NCT03417505|101321754|FG000|STARTED|First Lens Type (30 Days)||9||
48672238|NCT02347605|101982580|FG004|COMPLETED|Overall Study||6|Completed lab 3 (and therefore the entire study)|
48073602|NCT02151110|100501067|FG003|NOT COMPLETED|Overall Study||0||
48371227|NCT02759146|101236642|FG005|STARTED|Week 5-8||29|In the analysis of repeated measures, participants with at least one non-missing post-baseline value were included. For example, if a participant dropped out before week 5 but completed one of the weeks 1-4, their data were included in the analysis of weeks 1-4 under the missing at random assumption. Same applies to the analysis of longitudinal data for weeks 5-12.|
48371228|NCT02759146|101236643|FG006|STARTED|Week 5-8||26|In the analysis of repeated measures, participants with at least one non-missing post-baseline value were included. For example, if a participant dropped out before week 5 but completed one of the weeks 1-4, their data were included in the analysis of weeks 1-4 under the missing at random assumption. Same applies to the analysis of longitudinal data for weeks 5-12.|
48371229|NCT02759146|101236637|FG000|COMPLETED|Week 5-8||46|In the reflexology and meditative practices groups created by the first randomization, one participant could not continue without the other at week 5 unless the patient was a responder and dyad was not re-randomized.|
48371230|NCT02759146|101236638|FG001|COMPLETED|Week 5-8||29|In the reflexology and meditative practices groups created by the first randomization, one participant could not continue without the other at week 5 unless the patient was a responder and dyad was not re-randomized.|
48371231|NCT02759146|101236639|FG002|COMPLETED|Week 5-8||22|In the reflexology and meditative practices groups created by the first randomization, one participant could not continue without the other at week 5 unless the patient was a responder and dyad was not re-randomized.|
48371232|NCT02759146|101236640|FG003|COMPLETED|Week 5-8||37|In the reflexology and meditative practices groups created by the first randomization, one participant could not continue without the other at week 5 unless the patient was a responder and dyad was not re-randomized.|
48371233|NCT02759146|101236641|FG004|COMPLETED|Week 5-8||44|In the reflexology and meditative practices groups created by the first randomization, one participant could not continue without the other at week 5 unless the patient was a responder and dyad was not re-randomized.|
48371234|NCT02759146|101236642|FG005|COMPLETED|Week 5-8||23|In the reflexology and meditative practices groups created by the first randomization, one participant could not continue without the other at week 5 unless the patient was a responder and dyad was not re-randomized.|
48371235|NCT02759146|101236643|FG006|COMPLETED|Week 5-8||20|In the reflexology and meditative practices groups created by the first randomization, one participant could not continue without the other at week 5 unless the patient was a responder and dyad was not re-randomized.|
48371236|NCT02759146|101236637|FG000|NOT COMPLETED|Week 5-8||10||
48371237|NCT02759146|101236638|FG001|NOT COMPLETED|Week 5-8||5||
48371238|NCT02759146|101236639|FG002|NOT COMPLETED|Week 5-8||10||
48371239|NCT02759146|101236640|FG003|NOT COMPLETED|Week 5-8||7||
48371240|NCT02759146|101236641|FG004|NOT COMPLETED|Week 5-8||5||
48371241|NCT02759146|101236642|FG005|NOT COMPLETED|Week 5-8||6||
48371242|NCT02759146|101236643|FG006|NOT COMPLETED|Week 5-8||6||
48371243|NCT03488472|101236644|FG000|STARTED|Overall Study||1||
48371244|NCT03488472|101236644|FG000|COMPLETED|Overall Study||0||
48371245|NCT03488472|101236644|FG000|NOT COMPLETED|Overall Study||1||
48371246|NCT01028651|101236645|FG000|STARTED|Overall Study||13||
48371247|NCT01028651|101236645|FG000|COMPLETED|Overall Study||10||
48371248|NCT01028651|101236645|FG000|NOT COMPLETED|Overall Study||3||
48371249|NCT03158688|101236646|FG000|STARTED|Overall Study||154||
48371250|NCT03158688|101236647|FG001|STARTED|Overall Study||312||
48371251|NCT03158688|101236646|FG000|Treated|Overall Study||153||
48371252|NCT03158688|101236647|FG001|Treated|Overall Study||308||
48371253|NCT03158688|101236646|FG000|COMPLETED|Overall Study||49||
48371254|NCT03158688|101236647|FG001|COMPLETED|Overall Study||102||
48371255|NCT03158688|101236646|FG000|NOT COMPLETED|Overall Study||105||
48371256|NCT03158688|101236647|FG001|NOT COMPLETED|Overall Study||210||
48371257|NCT01998581|101236648|FG000|STARTED|Overall Study||169||
48371258|NCT01998581|101236649|FG001|STARTED|Overall Study||56||
48371259|NCT01998581|101236648|FG000|COMPLETED|Overall Study||123||
48371260|NCT01998581|101236649|FG001|COMPLETED|Overall Study||44||
48371261|NCT01998581|101236648|FG000|NOT COMPLETED|Overall Study||46||
48371262|NCT01998581|101236649|FG001|NOT COMPLETED|Overall Study||12||
48371263|NCT00392171|101236650|FG000|STARTED|Overall Study||120||
48371264|NCT00392171|101236650|FG000|COMPLETED|Overall Study||15||
48371265|NCT00392171|101236650|FG000|NOT COMPLETED|Overall Study||105||
48371266|NCT03637842|101236651|FG000|STARTED|Overall Study||2||
48371267|NCT03637842|101236652|FG001|STARTED|Overall Study||2||
48371268|NCT03637842|101236651|FG000|COMPLETED|Overall Study||2||
48371269|NCT03637842|101236652|FG001|COMPLETED|Overall Study||2||
48371270|NCT03637842|101236651|FG000|NOT COMPLETED|Overall Study||0||
48371271|NCT03637842|101236652|FG001|NOT COMPLETED|Overall Study||0||
48371272|NCT01058369|101236653|FG000|STARTED|Overall Study||2||
48371273|NCT01058369|101236653|FG000|COMPLETED|Overall Study||0||
48371274|NCT01058369|101236653|FG000|NOT COMPLETED|Overall Study||2||
48371275|NCT02916498|101236654|FG000|STARTED|First Intervention, 21 Days||2||
48371276|NCT02916498|101236655|FG001|STARTED|First Intervention, 21 Days||4||
48371277|NCT02916498|101236654|FG000|COMPLETED|First Intervention, 21 Days||2||
48371278|NCT02916498|101236655|FG001|COMPLETED|First Intervention, 21 Days||4||
48371279|NCT02916498|101236654|FG000|NOT COMPLETED|First Intervention, 21 Days||0||
48371280|NCT02916498|101236655|FG001|NOT COMPLETED|First Intervention, 21 Days||0||
48371281|NCT02916498|101236654|FG000|STARTED|Second Intervention, 21 Days||2||
48371282|NCT02916498|101236655|FG001|STARTED|Second Intervention, 21 Days||4||
48371283|NCT02916498|101236654|FG000|COMPLETED|Second Intervention, 21 Days||2||
48371284|NCT02916498|101236655|FG001|COMPLETED|Second Intervention, 21 Days||4||
48371285|NCT02916498|101236654|FG000|NOT COMPLETED|Second Intervention, 21 Days||0||
48371286|NCT02916498|101236655|FG001|NOT COMPLETED|Second Intervention, 21 Days||0||
48371287|NCT03000309|101236656|FG000|STARTED|Overall Study||20||
48371288|NCT03000309|101236656|FG000|COMPLETED|Overall Study||19||
48371289|NCT03000309|101236656|FG000|NOT COMPLETED|Overall Study||1||
48371290|NCT02834052|101236657|FG000|STARTED|Overall Study||8||
48371291|NCT02834052|101236658|FG001|STARTED|Overall Study||10||
48371292|NCT02834052|101236659|FG002|STARTED|Overall Study||24||
48371293|NCT02834052|101236657|FG000|COMPLETED|Overall Study||0||
48371294|NCT02834052|101236658|FG001|COMPLETED|Overall Study||0||
48371295|NCT02834052|101236659|FG002|COMPLETED|Overall Study||0||
48371296|NCT02834052|101236657|FG000|NOT COMPLETED|Overall Study||8||
48371297|NCT02834052|101236658|FG001|NOT COMPLETED|Overall Study||10||
48371298|NCT02834052|101236659|FG002|NOT COMPLETED|Overall Study||24||
48371299|NCT00589888|101236660|FG000|STARTED|Normal Saline @ 40cc/Hour||13||
48371300|NCT00589888|101236661|FG001|STARTED|Normal Saline @ 40cc/Hour||0||
48371301|NCT00589888|101236662|FG002|STARTED|Normal Saline @ 40cc/Hour||0||
48371302|NCT00589888|101236663|FG003|STARTED|Normal Saline @ 40cc/Hour||0||
48371303|NCT00589888|101236664|FG004|STARTED|Normal Saline @ 40cc/Hour||0||
48371304|NCT00589888|101236660|FG000|COMPLETED|Normal Saline @ 40cc/Hour||13||
48371305|NCT00589888|101236661|FG001|COMPLETED|Normal Saline @ 40cc/Hour||0||
48371306|NCT00589888|101236662|FG002|COMPLETED|Normal Saline @ 40cc/Hour||0||
48371307|NCT00589888|101236663|FG003|COMPLETED|Normal Saline @ 40cc/Hour||0||
48371308|NCT00589888|101236664|FG004|COMPLETED|Normal Saline @ 40cc/Hour||0||
48371309|NCT00589888|101236660|FG000|NOT COMPLETED|Normal Saline @ 40cc/Hour||0||
48672239|NCT02347605|101982581|FG005|COMPLETED|Overall Study||7|Completed lab 3 (and therefore the entire study)|
48672240|NCT02347605|101982576|FG000|NOT COMPLETED|Overall Study||3||
48371310|NCT00589888|101236661|FG001|NOT COMPLETED|Normal Saline @ 40cc/Hour||0||
48371311|NCT00589888|101236662|FG002|NOT COMPLETED|Normal Saline @ 40cc/Hour||0||
48371312|NCT00589888|101236663|FG003|NOT COMPLETED|Normal Saline @ 40cc/Hour||0||
48371313|NCT00589888|101236664|FG004|NOT COMPLETED|Normal Saline @ 40cc/Hour||0||
48371314|NCT00589888|101236660|FG000|STARTED|Intralipid 20% @ 20cc/hr||0||
48371315|NCT00589888|101236661|FG001|STARTED|Intralipid 20% @ 20cc/hr||13||
48371316|NCT00589888|101236662|FG002|STARTED|Intralipid 20% @ 20cc/hr||0||
48371317|NCT00589888|101236663|FG003|STARTED|Intralipid 20% @ 20cc/hr||0||
48371318|NCT00589888|101236664|FG004|STARTED|Intralipid 20% @ 20cc/hr||0||
48672241|NCT02347605|101982577|FG001|NOT COMPLETED|Overall Study||3||
48672242|NCT02347605|101982578|FG002|NOT COMPLETED|Overall Study||1||
48371319|NCT00589888|101236660|FG000|COMPLETED|Intralipid 20% @ 20cc/hr||0||
48371320|NCT00589888|101236661|FG001|COMPLETED|Intralipid 20% @ 20cc/hr||13||
48371321|NCT00589888|101236662|FG002|COMPLETED|Intralipid 20% @ 20cc/hr||0||
48371322|NCT00589888|101236663|FG003|COMPLETED|Intralipid 20% @ 20cc/hr||0||
48371323|NCT00589888|101236664|FG004|COMPLETED|Intralipid 20% @ 20cc/hr||0||
48371324|NCT00589888|101236660|FG000|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0||
48371325|NCT00589888|101236661|FG001|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0||
48371326|NCT00589888|101236662|FG002|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0||
48371327|NCT00589888|101236663|FG003|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0||
48371328|NCT00589888|101236664|FG004|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0||
48371329|NCT00589888|101236660|FG000|STARTED|Intralipid 20% @ 40cc/Hour||0||
48371330|NCT00589888|101236661|FG001|STARTED|Intralipid 20% @ 40cc/Hour||0||
48371331|NCT00589888|101236662|FG002|STARTED|Intralipid 20% @ 40cc/Hour||13||
48371332|NCT00589888|101236663|FG003|STARTED|Intralipid 20% @ 40cc/Hour||0||
48371333|NCT00589888|101236664|FG004|STARTED|Intralipid 20% @ 40cc/Hour||0||
48371334|NCT00589888|101236660|FG000|COMPLETED|Intralipid 20% @ 40cc/Hour||0||
48371335|NCT00589888|101236661|FG001|COMPLETED|Intralipid 20% @ 40cc/Hour||0||
48371336|NCT00589888|101236662|FG002|COMPLETED|Intralipid 20% @ 40cc/Hour||13||
48371337|NCT00589888|101236663|FG003|COMPLETED|Intralipid 20% @ 40cc/Hour||0||
48371338|NCT00589888|101236664|FG004|COMPLETED|Intralipid 20% @ 40cc/Hour||0||
48371339|NCT00589888|101236660|FG000|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0||
48371340|NCT00589888|101236661|FG001|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0||
48371341|NCT00589888|101236662|FG002|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0||
48371342|NCT00589888|101236663|FG003|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0||
48371343|NCT00589888|101236664|FG004|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0||
48371344|NCT00589888|101236660|FG000|STARTED|32-gram Oral Fat Load||0||
48371345|NCT00589888|101236661|FG001|STARTED|32-gram Oral Fat Load||0||
48371346|NCT00589888|101236662|FG002|STARTED|32-gram Oral Fat Load||0||
48371347|NCT00589888|101236663|FG003|STARTED|32-gram Oral Fat Load||13||
48371348|NCT00589888|101236664|FG004|STARTED|32-gram Oral Fat Load||0||
48371349|NCT00589888|101236660|FG000|COMPLETED|32-gram Oral Fat Load||0||
48371350|NCT00589888|101236661|FG001|COMPLETED|32-gram Oral Fat Load||0||
48672243|NCT02347605|101982579|FG003|NOT COMPLETED|Overall Study||4||
48371351|NCT00589888|101236662|FG002|COMPLETED|32-gram Oral Fat Load||0||
48371352|NCT00589888|101236663|FG003|COMPLETED|32-gram Oral Fat Load||13||
48371353|NCT00589888|101236664|FG004|COMPLETED|32-gram Oral Fat Load||0||
48371354|NCT00589888|101236660|FG000|NOT COMPLETED|32-gram Oral Fat Load||0||
48371355|NCT00589888|101236661|FG001|NOT COMPLETED|32-gram Oral Fat Load||0||
48371356|NCT00589888|101236662|FG002|NOT COMPLETED|32-gram Oral Fat Load||0||
48371357|NCT00589888|101236663|FG003|NOT COMPLETED|32-gram Oral Fat Load||0||
48371358|NCT00589888|101236664|FG004|NOT COMPLETED|32-gram Oral Fat Load||0||
48371359|NCT00589888|101236660|FG000|STARTED|64-gram Oral Fat Load||0||
48371360|NCT00589888|101236661|FG001|STARTED|64-gram Oral Fat Load||0||
48371361|NCT00589888|101236662|FG002|STARTED|64-gram Oral Fat Load||0||
48371362|NCT00589888|101236663|FG003|STARTED|64-gram Oral Fat Load||0||
48371363|NCT00589888|101236664|FG004|STARTED|64-gram Oral Fat Load||13||
48371364|NCT00589888|101236660|FG000|COMPLETED|64-gram Oral Fat Load||0||
48371365|NCT00589888|101236661|FG001|COMPLETED|64-gram Oral Fat Load||0||
48371366|NCT00589888|101236662|FG002|COMPLETED|64-gram Oral Fat Load||0||
48672244|NCT02347605|101982580|FG004|NOT COMPLETED|Overall Study||3||
48672245|NCT02347605|101982581|FG005|NOT COMPLETED|Overall Study||2||
48672246|NCT02300545|101982582|FG000|STARTED|Overall Study||56||
48672247|NCT02300545|101982582|FG000|COMPLETED|Overall Study||56||
48672248|NCT02300545|101982582|FG000|NOT COMPLETED|Overall Study||0||
48672249|NCT02538614|101982583|FG000|STARTED|Overall Study||2||
48371367|NCT00589888|101236663|FG003|COMPLETED|64-gram Oral Fat Load||0||
48371368|NCT00589888|101236664|FG004|COMPLETED|64-gram Oral Fat Load||13||
48371369|NCT00589888|101236660|FG000|NOT COMPLETED|64-gram Oral Fat Load||0||
48371370|NCT00589888|101236661|FG001|NOT COMPLETED|64-gram Oral Fat Load||0||
48371371|NCT00589888|101236662|FG002|NOT COMPLETED|64-gram Oral Fat Load||0||
48371372|NCT00589888|101236663|FG003|NOT COMPLETED|64-gram Oral Fat Load||0||
48371373|NCT00589888|101236664|FG004|NOT COMPLETED|64-gram Oral Fat Load||0||
48371374|NCT01814800|101236665|FG000|STARTED|Overall Study||59||
48371375|NCT01814800|101236665|FG000|COMPLETED|Overall Study||54||
48371376|NCT01814800|101236665|FG000|NOT COMPLETED|Overall Study||5||
48371377|NCT02688842|101236666|FG000|STARTED|Overall Study||38||
48371378|NCT02688842|101236666|FG000|COMPLETED|Overall Study||38||
48371379|NCT02688842|101236666|FG000|NOT COMPLETED|Overall Study||0||
48371380|NCT03041116|101236667|FG000|STARTED|Double-blind||41||
48371381|NCT03041116|101236668|FG001|STARTED|Double-blind||43||
48371382|NCT03041116|101236667|FG000|Received at Least 1 Dose of Study Drug|Double-blind||41||
48371383|NCT03041116|101236668|FG001|Received at Least 1 Dose of Study Drug|Double-blind||43||
48371384|NCT03041116|101236667|FG000|COMPLETED|Double-blind||41||
48371385|NCT03041116|101236668|FG001|COMPLETED|Double-blind||37||
48371386|NCT03041116|101236667|FG000|NOT COMPLETED|Double-blind||0||
48371387|NCT03041116|101236668|FG001|NOT COMPLETED|Double-blind||6||
48371388|NCT03041116|101236667|FG000|STARTED|Open-label||41||
48371389|NCT03041116|101236668|FG001|STARTED|Open-label||37||
48371390|NCT03041116|101236667|FG000|Received At Least 1 Dose of Study Drug|Open-label||41||
48371391|NCT03041116|101236668|FG001|Received At Least 1 Dose of Study Drug|Open-label||37||
48371392|NCT03041116|101236667|FG000|COMPLETED|Open-label||0||
48371393|NCT03041116|101236668|FG001|COMPLETED|Open-label||0||
48371394|NCT03041116|101236667|FG000|NOT COMPLETED|Open-label||41||
48371395|NCT03041116|101236668|FG001|NOT COMPLETED|Open-label||37||
48371396|NCT04346628|101236669|FG000|STARTED|Overall Study||74||
48371397|NCT04346628|101236670|FG001|STARTED|Overall Study||75||
48371398|NCT04346628|101236669|FG000|Intention-to-treat (ITT) Analysis Set|Overall Study||74||
48371399|NCT04346628|101236670|FG001|Intention-to-treat (ITT) Analysis Set|Overall Study||75||
48672250|NCT02538614|101982583|FG000|COMPLETED|Overall Study||0||
48672251|NCT02538614|101982583|FG000|NOT COMPLETED|Overall Study||2||
48073603|NCT02151110|100501068|FG004|NOT COMPLETED|Overall Study||0||
48371400|NCT04346628|101236669|FG000|Symptomatic Modified ITT (smITT) Analysis Set|Overall Study||70|Participant reported at least one symptom other than mild cough, mild fatigue, or decreased taste/smell at baseline.|
48371401|NCT04346628|101236670|FG001|Symptomatic Modified ITT (smITT) Analysis Set|Overall Study||65|Participant reported at least one symptom other than mild cough, mild fatigue, or decreased taste/smell at baseline.|
48371402|NCT04346628|101236669|FG000|Modified ITT (mITT) Analysis|Overall Study||57|Participant was symptomatic with positive RT-PCR result at baseline.|
48371403|NCT04346628|101236670|FG001|Modified ITT (mITT) Analysis|Overall Study||59|Participant was symptomatic with positive RT-PCR result at baseline.|
48371404|NCT04346628|101236669|FG000|COMPLETED|Overall Study||68||
48371405|NCT04346628|101236670|FG001|COMPLETED|Overall Study||62||
48371406|NCT04346628|101236669|FG000|NOT COMPLETED|Overall Study||6||
48371407|NCT04346628|101236670|FG001|NOT COMPLETED|Overall Study||13||
48371408|NCT01379534|101236671|FG000|STARTED|Treatment Phase||22||
48371409|NCT01379534|101236672|FG001|STARTED|Treatment Phase||31||
48371410|NCT01379534|101236671|FG000|COMPLETED|Treatment Phase||0||
48371411|NCT01379534|101236672|FG001|COMPLETED|Treatment Phase||0||
48371412|NCT01379534|101236671|FG000|NOT COMPLETED|Treatment Phase||22||
48371413|NCT01379534|101236672|FG001|NOT COMPLETED|Treatment Phase||31||
48371414|NCT01379534|101236671|FG000|STARTED|Tumor Assessment Follow-up (f/u) Phase||4||
48371415|NCT01379534|101236672|FG001|STARTED|Tumor Assessment Follow-up (f/u) Phase||2||
48672252|NCT02621892|101982584|FG000|STARTED|Treatment Period||307||
48672253|NCT02621892|101982585|FG001|STARTED|Treatment Period||299||
48672254|NCT02621892|101982584|FG000|COMPLETED|Treatment Period||261||
48672255|NCT02621892|101982585|FG001|COMPLETED|Treatment Period||272||
48672256|NCT02621892|101982584|FG000|NOT COMPLETED|Treatment Period||46||
48371416|NCT01379534|101236671|FG000|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0||
48371417|NCT01379534|101236672|FG001|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0||
48371418|NCT01379534|101236671|FG000|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||4||
48371419|NCT01379534|101236672|FG001|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||2||
48371420|NCT02293954|101236673|FG000|STARTED|Overall Study||20||
48371421|NCT02293954|101236673|FG000|COMPLETED|Overall Study||20||
48371422|NCT02293954|101236673|FG000|NOT COMPLETED|Overall Study||0||
48371423|NCT00740779|101236674|FG000|STARTED|Overall Study||52||
48371424|NCT00740779|101236675|FG001|STARTED|Overall Study||45||
48371425|NCT00740779|101236676|FG002|STARTED|Overall Study||54||
48371426|NCT00740779|101236674|FG000|COMPLETED|Overall Study||43||
48371427|NCT00740779|101236675|FG001|COMPLETED|Overall Study||31||
48371428|NCT00740779|101236676|FG002|COMPLETED|Overall Study||41||
48371429|NCT00740779|101236674|FG000|NOT COMPLETED|Overall Study||9||
48371430|NCT00740779|101236675|FG001|NOT COMPLETED|Overall Study||14||
48371431|NCT00740779|101236676|FG002|NOT COMPLETED|Overall Study||13||
48371432|NCT04095286|101236677|FG000|STARTED|Period 1 (4 Days) + Washout (7days)||4||
48371433|NCT04095286|101236678|FG001|STARTED|Period 1 (4 Days) + Washout (7days)||5||
48371434|NCT04095286|101236679|FG002|STARTED|Period 1 (4 Days) + Washout (7days)||5||
48371435|NCT04095286|101236680|FG003|STARTED|Period 1 (4 Days) + Washout (7days)||5||
48371436|NCT04095286|101236681|FG004|STARTED|Period 1 (4 Days) + Washout (7days)||5||
48371437|NCT04095286|101236682|FG005|STARTED|Period 1 (4 Days) + Washout (7days)||5||
48371438|NCT04095286|101236677|FG000|COMPLETED|Period 1 (4 Days) + Washout (7days)||3||
48371439|NCT04095286|101236678|FG001|COMPLETED|Period 1 (4 Days) + Washout (7days)||4||
48371440|NCT04095286|101236679|FG002|COMPLETED|Period 1 (4 Days) + Washout (7days)||4||
48371441|NCT04095286|101236680|FG003|COMPLETED|Period 1 (4 Days) + Washout (7days)||5||
48371442|NCT04095286|101236681|FG004|COMPLETED|Period 1 (4 Days) + Washout (7days)||5||
48371443|NCT04095286|101236682|FG005|COMPLETED|Period 1 (4 Days) + Washout (7days)||5||
48371444|NCT04095286|101236677|FG000|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1||
48371445|NCT04095286|101236678|FG001|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1||
48371446|NCT04095286|101236679|FG002|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1||
48371447|NCT04095286|101236680|FG003|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0||
48371448|NCT04095286|101236681|FG004|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0||
48371449|NCT04095286|101236682|FG005|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0||
48371450|NCT04095286|101236677|FG000|STARTED|Period 2 (4 Days) + Washout (7days)||3||
48371451|NCT04095286|101236678|FG001|STARTED|Period 2 (4 Days) + Washout (7days)||4||
48371452|NCT04095286|101236679|FG002|STARTED|Period 2 (4 Days) + Washout (7days)||4||
48371453|NCT04095286|101236680|FG003|STARTED|Period 2 (4 Days) + Washout (7days)||5||
48371454|NCT04095286|101236681|FG004|STARTED|Period 2 (4 Days) + Washout (7days)||5||
48371455|NCT04095286|101236682|FG005|STARTED|Period 2 (4 Days) + Washout (7days)||5||
48371456|NCT04095286|101236677|FG000|COMPLETED|Period 2 (4 Days) + Washout (7days)||3||
48371457|NCT04095286|101236678|FG001|COMPLETED|Period 2 (4 Days) + Washout (7days)||4||
48371458|NCT04095286|101236679|FG002|COMPLETED|Period 2 (4 Days) + Washout (7days)||2||
48371459|NCT04095286|101236680|FG003|COMPLETED|Period 2 (4 Days) + Washout (7days)||5||
48371460|NCT04095286|101236681|FG004|COMPLETED|Period 2 (4 Days) + Washout (7days)||4||
48371461|NCT04095286|101236682|FG005|COMPLETED|Period 2 (4 Days) + Washout (7days)||5||
48371462|NCT04095286|101236677|FG000|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0||
48371463|NCT04095286|101236678|FG001|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0||
48371464|NCT04095286|101236679|FG002|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||2||
48371465|NCT04095286|101236680|FG003|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0||
48672257|NCT02621892|101982585|FG001|NOT COMPLETED|Treatment Period||27||
48672258|NCT02621892|101982584|FG000|STARTED|Randomized Withdrawal Period||261||
48073604|NCT02151110|100501069|FG005|NOT COMPLETED|Overall Study||0||
48371466|NCT04095286|101236681|FG004|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||1||
48371467|NCT04095286|101236682|FG005|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0||
48371468|NCT04095286|101236677|FG000|STARTED|Period 3 (4 Days) + Follow up (14 Days)||3||
48371469|NCT04095286|101236678|FG001|STARTED|Period 3 (4 Days) + Follow up (14 Days)||4||
48371470|NCT04095286|101236679|FG002|STARTED|Period 3 (4 Days) + Follow up (14 Days)||2||
48371471|NCT04095286|101236680|FG003|STARTED|Period 3 (4 Days) + Follow up (14 Days)||5||
48371472|NCT04095286|101236681|FG004|STARTED|Period 3 (4 Days) + Follow up (14 Days)||4||
48371473|NCT04095286|101236682|FG005|STARTED|Period 3 (4 Days) + Follow up (14 Days)||5||
48371474|NCT04095286|101236677|FG000|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||3||
48371475|NCT04095286|101236678|FG001|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||4||
48371476|NCT04095286|101236679|FG002|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||2||
48371477|NCT04095286|101236680|FG003|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||5||
48371478|NCT04095286|101236681|FG004|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||4||
48371479|NCT04095286|101236682|FG005|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||5||
48371480|NCT04095286|101236677|FG000|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0||
48371481|NCT04095286|101236678|FG001|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0||
48371482|NCT04095286|101236679|FG002|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0||
48371483|NCT04095286|101236680|FG003|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0||
48371484|NCT04095286|101236681|FG004|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0||
48521841|NCT00952276|101611704|FG003|COMPLETED|Overall Study||120||
48672259|NCT02621892|101982585|FG001|STARTED|Randomized Withdrawal Period||272||
48672260|NCT02621892|101982584|FG000|COMPLETED|Randomized Withdrawal Period||250||
48371485|NCT04095286|101236682|FG005|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0||
48371486|NCT02026908|101236683|FG000|STARTED|Overall Study||45||
48371487|NCT02026908|101236683|FG000|COMPLETED|Overall Study||45||
48371488|NCT02026908|101236683|FG000|NOT COMPLETED|Overall Study||0||
48371489|NCT01087528|101236684|FG000|STARTED|Overall Study||51||
48371490|NCT01087528|101236684|FG000|COMPLETED|Overall Study||44||
48371491|NCT01087528|101236684|FG000|NOT COMPLETED|Overall Study||7||
48371492|NCT01554956|101236685|FG000|STARTED|Part 1 (Segment 1 and Segment 2)||4||8
48371493|NCT01554956|101236686|FG001|STARTED|Part 1 (Segment 1 and Segment 2)||7||14
48371494|NCT01554956|101236687|FG002|STARTED|Part 1 (Segment 1 and Segment 2)||0||0
48672261|NCT02621892|101982585|FG001|COMPLETED|Randomized Withdrawal Period||260||
48672262|NCT02621892|101982584|FG000|NOT COMPLETED|Randomized Withdrawal Period||11||
48371495|NCT01554956|101236685|FG000|COMPLETED|Part 1 (Segment 1 and Segment 2)||4||8
48371496|NCT01554956|101236686|FG001|COMPLETED|Part 1 (Segment 1 and Segment 2)||6||12
48371497|NCT01554956|101236687|FG002|COMPLETED|Part 1 (Segment 1 and Segment 2)||0||0
48371498|NCT01554956|101236685|FG000|NOT COMPLETED|Part 1 (Segment 1 and Segment 2)||0||0
48371499|NCT01554956|101236686|FG001|NOT COMPLETED|Part 1 (Segment 1 and Segment 2)||1||2
48371500|NCT01554956|101236687|FG002|NOT COMPLETED|Part 1 (Segment 1 and Segment 2)||0||0
48371501|NCT01554956|101236685|FG000|STARTED|Part 2 (Continuation Segment)||4||8
48371502|NCT01554956|101236686|FG001|STARTED|Part 2 (Continuation Segment)||6||12
48371503|NCT01554956|101236687|FG002|STARTED|Part 2 (Continuation Segment)||1||2
48371504|NCT01554956|101236685|FG000|COMPLETED|Part 2 (Continuation Segment)||2||4
48371505|NCT01554956|101236686|FG001|COMPLETED|Part 2 (Continuation Segment)||1||2
48371506|NCT01554956|101236687|FG002|COMPLETED|Part 2 (Continuation Segment)||0||0
48371507|NCT01554956|101236685|FG000|NOT COMPLETED|Part 2 (Continuation Segment)||2||4
48371508|NCT01554956|101236686|FG001|NOT COMPLETED|Part 2 (Continuation Segment)||5||10
48371509|NCT01554956|101236687|FG002|NOT COMPLETED|Part 2 (Continuation Segment)||1||2
48371510|NCT00883558|101236688|FG000|STARTED|Titration Period (Weeks 0 to 4)||48||
48371511|NCT00883558|101236689|FG001|STARTED|Titration Period (Weeks 0 to 4)||0||
48371512|NCT00883558|101236690|FG002|STARTED|Titration Period (Weeks 0 to 4)||0||
48371513|NCT00883558|101236688|FG000|COMPLETED|Titration Period (Weeks 0 to 4)||46||
48371514|NCT00883558|101236689|FG001|COMPLETED|Titration Period (Weeks 0 to 4)||0||
48371515|NCT00883558|101236690|FG002|COMPLETED|Titration Period (Weeks 0 to 4)||0||
48371516|NCT00883558|101236688|FG000|NOT COMPLETED|Titration Period (Weeks 0 to 4)||2||
48371517|NCT00883558|101236689|FG001|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0||
48371518|NCT00883558|101236690|FG002|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0||
48672263|NCT02621892|101982585|FG001|NOT COMPLETED|Randomized Withdrawal Period||12||
48672264|NCT00049543|101982586|FG000|STARTED|Overall Study||251||
48672265|NCT00049543|101982587|FG001|STARTED|Overall Study||252||
48672266|NCT00049543|101982586|FG000|COMPLETED|Overall Study||249||
48672267|NCT00049543|101982587|FG001|COMPLETED|Overall Study||243||
48672268|NCT00049543|101982586|FG000|NOT COMPLETED|Overall Study||2||
48672269|NCT00049543|101982587|FG001|NOT COMPLETED|Overall Study||9||
48672270|NCT04290624|101982588|FG000|STARTED|Overall Study||24||
48672271|NCT04290624|101982589|FG001|STARTED|Overall Study||25||
48672272|NCT04290624|101982588|FG000|COMPLETED|Overall Study||23||
48672273|NCT04290624|101982589|FG001|COMPLETED|Overall Study||25||
48672274|NCT04290624|101982588|FG000|NOT COMPLETED|Overall Study||1||
48672275|NCT04290624|101982589|FG001|NOT COMPLETED|Overall Study||0||
48672276|NCT01103414|101982590|FG000|STARTED|Overall Study||72||
48672277|NCT01103414|101982591|FG001|STARTED|Overall Study||71||
48672278|NCT01103414|101982592|FG002|STARTED|Overall Study||71||
48672279|NCT01103414|101982593|FG003|STARTED|Overall Study||71||
48672280|NCT01103414|101982594|FG004|STARTED|Overall Study||71||
48672281|NCT01103414|101982590|FG000|COMPLETED|Overall Study||59||
48672282|NCT01103414|101982591|FG001|COMPLETED|Overall Study||62||
48672283|NCT01103414|101982592|FG002|COMPLETED|Overall Study||56||
48672284|NCT01103414|101982593|FG003|COMPLETED|Overall Study||64||
48672285|NCT01103414|101982594|FG004|COMPLETED|Overall Study||56||
48672286|NCT01103414|101982590|FG000|NOT COMPLETED|Overall Study||13||
48672287|NCT01103414|101982591|FG001|NOT COMPLETED|Overall Study||9||
48672288|NCT01103414|101982592|FG002|NOT COMPLETED|Overall Study||15||
48672289|NCT01103414|101982593|FG003|NOT COMPLETED|Overall Study||7||
48073605|NCT02151110|100501070|FG006|NOT COMPLETED|Overall Study||0||
48371519|NCT00883558|101236688|FG000|STARTED|First Treatment Cycle (Weeks 4 to 16)||0||
48371520|NCT00883558|101236689|FG001|STARTED|First Treatment Cycle (Weeks 4 to 16)||22||
48371521|NCT00883558|101236690|FG002|STARTED|First Treatment Cycle (Weeks 4 to 16)||24||
48371522|NCT00883558|101236688|FG000|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||0||
48371523|NCT00883558|101236689|FG001|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||22||
48371524|NCT00883558|101236690|FG002|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||24||
48371525|NCT00883558|101236688|FG000|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0||
48672290|NCT01103414|101982594|FG004|NOT COMPLETED|Overall Study||15||
48672291|NCT02684461|101982595|FG000|STARTED|Overall Study||7||
48073606|NCT02151110|100501071|FG007|NOT COMPLETED|Overall Study||3||
48371526|NCT00883558|101236689|FG001|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||19||
48371527|NCT00883558|101236690|FG002|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||23||
48672292|NCT02684461|101982596|FG001|STARTED|Overall Study||7||
48672293|NCT02684461|101982597|FG002|STARTED|Overall Study||6||
48371528|NCT00883558|101236688|FG000|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0||
48371529|NCT00883558|101236689|FG001|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||3||
48371530|NCT00883558|101236690|FG002|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||1||
48371531|NCT00883558|101236688|FG000|STARTED|Second Treatment Cycle (Weeks 16 to 28)||0||
48371532|NCT00883558|101236689|FG001|STARTED|Second Treatment Cycle (Weeks 16 to 28)||19||
48371533|NCT00883558|101236690|FG002|STARTED|Second Treatment Cycle (Weeks 16 to 28)||23||
48371534|NCT00883558|101236688|FG000|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||0||
48371535|NCT00883558|101236689|FG001|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||19||
48371536|NCT00883558|101236690|FG002|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||23||
48371537|NCT00883558|101236688|FG000|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0||
48371538|NCT00883558|101236689|FG001|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||19||
48371539|NCT00883558|101236690|FG002|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||22||
48371540|NCT00883558|101236688|FG000|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0||
48371541|NCT00883558|101236689|FG001|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0||
48371542|NCT00883558|101236690|FG002|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||1||
48371543|NCT03382899|101236691|FG000|STARTED|Overall Study||51||
48371544|NCT03382899|101236692|FG001|STARTED|Overall Study||50||
48371545|NCT03382899|101236691|FG000|Received at Least 1 Dose of Study Drug|Overall Study||50||
48371546|NCT03382899|101236692|FG001|Received at Least 1 Dose of Study Drug|Overall Study||48||
48371547|NCT03382899|101236691|FG000|COMPLETED|Overall Study||20||
48371548|NCT03382899|101236692|FG001|COMPLETED|Overall Study||15||
48371549|NCT03382899|101236691|FG000|NOT COMPLETED|Overall Study||31||
48371550|NCT03382899|101236692|FG001|NOT COMPLETED|Overall Study||35||
48371551|NCT04552535|101236693|FG000|STARTED|Overall Study||99||
48371552|NCT04552535|101236694|FG001|STARTED|Overall Study||101||
48371553|NCT04552535|101236693|FG000|COMPLETED|Overall Study||99||
48371554|NCT04552535|101236694|FG001|COMPLETED|Overall Study||101||
48371555|NCT04552535|101236693|FG000|NOT COMPLETED|Overall Study||0||
48371556|NCT04552535|101236694|FG001|NOT COMPLETED|Overall Study||0||
48371557|NCT03705962|101239765|FG000|STARTED|Overall Study||8||
48371558|NCT03705962|101239766|FG001|STARTED|Overall Study||3||
48371559|NCT03705962|101239765|FG000|COMPLETED|Overall Study||8||
48371560|NCT03705962|101239766|FG001|COMPLETED|Overall Study||3||
48371561|NCT03705962|101239765|FG000|NOT COMPLETED|Overall Study||0||
48371562|NCT03705962|101239766|FG001|NOT COMPLETED|Overall Study||0||
48371563|NCT00584220|101239767|FG000|STARTED|First Period||48||
48371564|NCT00584220|101239768|FG001|STARTED|First Period||39||
48371565|NCT00584220|101239767|FG000|COMPLETED|First Period||48||
48371566|NCT00584220|101239768|FG001|COMPLETED|First Period||39||
48371567|NCT00584220|101239767|FG000|NOT COMPLETED|First Period||0||
48371568|NCT00584220|101239768|FG001|NOT COMPLETED|First Period||0||
48371569|NCT00584220|101239767|FG000|STARTED|Second Period||48||
48371570|NCT00584220|101239768|FG001|STARTED|Second Period||39||
48371571|NCT00584220|101239767|FG000|COMPLETED|Second Period||48||
48371572|NCT00584220|101239768|FG001|COMPLETED|Second Period||39||
48371573|NCT00584220|101239767|FG000|NOT COMPLETED|Second Period||0||
48371574|NCT00584220|101239768|FG001|NOT COMPLETED|Second Period||0||
48371575|NCT01507584|101239769|FG000|STARTED|Overall Study||0||
48371576|NCT01507584|101239769|FG000|COMPLETED|Overall Study||0||
48371577|NCT01507584|101239769|FG000|NOT COMPLETED|Overall Study||0||
48371578|NCT01850563|101239770|FG000|STARTED|Overall Study||22||
48371579|NCT01850563|101239771|FG001|STARTED|Overall Study||19||
48371580|NCT01850563|101239770|FG000|HBO Treatment Completed|Overall Study||19||
48371581|NCT01850563|101239771|FG001|HBO Treatment Completed|Overall Study||0||
48371582|NCT01850563|101239770|FG000|COMPLETED|Overall Study||19|SRS treatment completed|
48371583|NCT01850563|101239771|FG001|COMPLETED|Overall Study||19|SRS treatment completed|
48371584|NCT01850563|101239770|FG000|NOT COMPLETED|Overall Study||3||
48371585|NCT01850563|101239771|FG001|NOT COMPLETED|Overall Study||0||
48371586|NCT01689207|101239772|FG000|STARTED|Overall Study||4||
48371587|NCT01689207|101239773|FG001|STARTED|Overall Study||8||
48371588|NCT01689207|101239774|FG002|STARTED|Overall Study||16||
48371589|NCT01689207|101239775|FG003|STARTED|Overall Study||8||
48371590|NCT01689207|101239776|FG004|STARTED|Overall Study||4||
48521842|NCT00952276|101611705|FG004|COMPLETED|Overall Study||63||
48672294|NCT02684461|101982595|FG000|COMPLETED|Overall Study||5||
48371591|NCT01689207|101239777|FG005|STARTED|Overall Study||8||
48371592|NCT01689207|101239778|FG006|STARTED|Overall Study||10||
48371593|NCT01689207|101239779|FG007|STARTED|Overall Study||10||
48371594|NCT01689207|101239780|FG008|STARTED|Overall Study||6||
48371595|NCT01689207|101239781|FG009|STARTED|Overall Study||10||
48371596|NCT01689207|101239782|FG010|STARTED|Overall Study||8||
48371597|NCT01689207|101239772|FG000|COMPLETED|Overall Study||4||
48371598|NCT01689207|101239773|FG001|COMPLETED|Overall Study||7||
48371599|NCT01689207|101239774|FG002|COMPLETED|Overall Study||16||
48371600|NCT01689207|101239775|FG003|COMPLETED|Overall Study||8||
48371601|NCT01689207|101239776|FG004|COMPLETED|Overall Study||2||
48371602|NCT01689207|101239777|FG005|COMPLETED|Overall Study||7||
48371603|NCT01689207|101239778|FG006|COMPLETED|Overall Study||10||
48371604|NCT01689207|101239779|FG007|COMPLETED|Overall Study||10||
48371605|NCT01689207|101239780|FG008|COMPLETED|Overall Study||5||
48371606|NCT01689207|101239781|FG009|COMPLETED|Overall Study||10||
48371607|NCT01689207|101239782|FG010|COMPLETED|Overall Study||8||
48371608|NCT01689207|101239772|FG000|NOT COMPLETED|Overall Study||0||
48371609|NCT01689207|101239773|FG001|NOT COMPLETED|Overall Study||1||
48371610|NCT01689207|101239774|FG002|NOT COMPLETED|Overall Study||0||
48371611|NCT01689207|101239775|FG003|NOT COMPLETED|Overall Study||0||
48371612|NCT01689207|101239776|FG004|NOT COMPLETED|Overall Study||2||
48371613|NCT01689207|101239777|FG005|NOT COMPLETED|Overall Study||1||
48371614|NCT01689207|101239778|FG006|NOT COMPLETED|Overall Study||0||
48371615|NCT01689207|101239779|FG007|NOT COMPLETED|Overall Study||0||
48371616|NCT01689207|101239780|FG008|NOT COMPLETED|Overall Study||1||
48371617|NCT01689207|101239781|FG009|NOT COMPLETED|Overall Study||0||
48371618|NCT01689207|101239782|FG010|NOT COMPLETED|Overall Study||0||
48371619|NCT00086957|101239783|FG000|STARTED|Overall Study||2||
48371620|NCT00086957|101239784|FG001|STARTED|Overall Study||7||
48371621|NCT00086957|101239785|FG002|STARTED|Overall Study||22||
48371622|NCT00086957|101239783|FG000|COMPLETED|Overall Study||2||
48371623|NCT00086957|101239784|FG001|COMPLETED|Overall Study||7||
48371624|NCT00086957|101239785|FG002|COMPLETED|Overall Study||22||
48371625|NCT00086957|101239783|FG000|NOT COMPLETED|Overall Study||0||
48371626|NCT00086957|101239784|FG001|NOT COMPLETED|Overall Study||0||
48371627|NCT00086957|101239785|FG002|NOT COMPLETED|Overall Study||0||
48371628|NCT00488033|101239786|FG000|STARTED|Overall Study||448||
48371629|NCT00488033|101239787|FG001|STARTED|Overall Study||452||
48371630|NCT00488033|101239786|FG000|COMPLETED|Overall Study||447||
48371631|NCT00488033|101239787|FG001|COMPLETED|Overall Study||452||
48371632|NCT00488033|101239786|FG000|NOT COMPLETED|Overall Study||1||
48371633|NCT00488033|101239787|FG001|NOT COMPLETED|Overall Study||0||
48371634|NCT00257192|101239788|FG000|STARTED|Overall Study||193||
48371635|NCT00257192|101239789|FG001|STARTED|Overall Study||91||
48371636|NCT00257192|101239788|FG000|Received Study Treatment|Overall Study||193||
48371637|NCT00257192|101239789|FG001|Received Study Treatment|Overall Study||90||
48371638|NCT00257192|101239788|FG000|COMPLETED|Overall Study||135||
48371639|NCT00257192|101239789|FG001|COMPLETED|Overall Study||52||
48371640|NCT00257192|101239788|FG000|NOT COMPLETED|Overall Study||58||
48371641|NCT00257192|101239789|FG001|NOT COMPLETED|Overall Study||39||
48371642|NCT01989546|101239790|FG000|STARTED|Overall Study||9||
48371643|NCT01989546|101239790|FG000|COMPLETED|Overall Study||0||
48371644|NCT01989546|101239790|FG000|NOT COMPLETED|Overall Study||9||
48371645|NCT01100307|101239791|FG000|STARTED|Double Masked Phase (Up to Week 24)||123||
48371646|NCT01100307|101239792|FG001|STARTED|Double Masked Phase (Up to Week 24)||120||
48371647|NCT01100307|101239791|FG000|COMPLETED|Double Masked Phase (Up to Week 24)||117||
48371648|NCT01100307|101239792|FG001|COMPLETED|Double Masked Phase (Up to Week 24)||116||
48371649|NCT01100307|101239791|FG000|NOT COMPLETED|Double Masked Phase (Up to Week 24)||6||
48371650|NCT01100307|101239792|FG001|NOT COMPLETED|Double Masked Phase (Up to Week 24)||4||
48371651|NCT01100307|101239791|FG000|STARTED|Open Phase (Week 24 up to Week 54)||116||
48371652|NCT01100307|101239792|FG001|STARTED|Open Phase (Week 24 up to Week 54)||112||
48371653|NCT01100307|101239791|FG000|COMPLETED|Open Phase (Week 24 up to Week 54)||110||
48371654|NCT01100307|101239792|FG001|COMPLETED|Open Phase (Week 24 up to Week 54)||99||
48371655|NCT01100307|101239791|FG000|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||6||
48371656|NCT01100307|101239792|FG001|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||13||
48371657|NCT01215734|101239793|FG000|STARTED|Overall Study||29||
48371658|NCT01215734|101239794|FG001|STARTED|Overall Study||15||
48371659|NCT01215734|101239793|FG000|COMPLETED|Overall Study||29||
48371660|NCT01215734|101239794|FG001|COMPLETED|Overall Study||14||
48371661|NCT01215734|101239793|FG000|NOT COMPLETED|Overall Study||0||
48371662|NCT01215734|101239794|FG001|NOT COMPLETED|Overall Study||1||
48371663|NCT04357379|101239795|FG000|STARTED|Overall Study||10||
48371664|NCT04357379|101239795|FG000|COMPLETED|Overall Study||10||
48371665|NCT04357379|101239795|FG000|NOT COMPLETED|Overall Study||0||
48371666|NCT01585961|101239796|FG000|STARTED|Overall Study||511||
48371667|NCT01585961|101239796|FG000|Safety|Overall Study||508||
48371668|NCT01585961|101239796|FG000|COMPLETED|Overall Study||478||
48371669|NCT01585961|101239796|FG000|NOT COMPLETED|Overall Study||33||
48371670|NCT04158908|101239797|FG000|STARTED|Overall Study||11||
48371671|NCT04158908|101239798|FG001|STARTED|Overall Study||9||
48371672|NCT04158908|101239797|FG000|COMPLETED|Overall Study||10||
48371673|NCT04158908|101239798|FG001|COMPLETED|Overall Study||8||
48371674|NCT04158908|101239797|FG000|NOT COMPLETED|Overall Study||1||
48371675|NCT04158908|101239798|FG001|NOT COMPLETED|Overall Study||1||
48371676|NCT03987620|101239799|FG000|STARTED|Overall Study||303||
48371677|NCT03987620|101239800|FG001|STARTED|Overall Study||152||
48371678|NCT03987620|101239799|FG000|Withdrawn Before Treatment|Overall Study||5||
48371679|NCT03987620|101239800|FG001|Withdrawn Before Treatment|Overall Study||1||
48371680|NCT03987620|101239799|FG000|Withdrawn Before TOC|Overall Study||48||
48371681|NCT03987620|101239800|FG001|Withdrawn Before TOC|Overall Study||45||
48371682|NCT03987620|101239799|FG000|Completed the TOC Visit|Overall Study||250||
48371683|NCT03987620|101239800|FG001|Completed the TOC Visit|Overall Study||106||
48371684|NCT03987620|101239799|FG000|Withdrawn At or After the TOC Visit|Overall Study||4||
48371685|NCT03987620|101239800|FG001|Withdrawn At or After the TOC Visit|Overall Study||4||
48371686|NCT03987620|101239799|FG000|COMPLETED|Overall Study||246||
48371687|NCT03987620|101239800|FG001|COMPLETED|Overall Study||102||
48371688|NCT03987620|101239799|FG000|NOT COMPLETED|Overall Study||57||
48371689|NCT03987620|101239800|FG001|NOT COMPLETED|Overall Study||50||
48371690|NCT00237796|101239801|FG000|STARTED|Overall Study||41||
48371691|NCT00237796|101239802|FG001|STARTED|Overall Study||38||
48371692|NCT00237796|101239801|FG000|COMPLETED|Overall Study||31||
48371693|NCT00237796|101239802|FG001|COMPLETED|Overall Study||33||
48371694|NCT00237796|101239801|FG000|NOT COMPLETED|Overall Study||10||
48371695|NCT00237796|101239802|FG001|NOT COMPLETED|Overall Study||5||
48371696|NCT01452126|101239803|FG000|STARTED|Overall Study||49||
48371697|NCT01452126|101239803|FG000|COMPLETED|Overall Study||49||
48371698|NCT01452126|101239803|FG000|NOT COMPLETED|Overall Study||0||
48371699|NCT05896761|101239804|FG000|STARTED|Thigh Injection Phase (Up to Week 16)||54||
48371700|NCT05896761|101239805|FG001|STARTED|Thigh Injection Phase (Up to Week 16)||64||
48371701|NCT05896761|101239804|FG000|COMPLETED|Thigh Injection Phase (Up to Week 16)||51||
48371702|NCT05896761|101239805|FG001|COMPLETED|Thigh Injection Phase (Up to Week 16)||61||
48371703|NCT05896761|101239804|FG000|NOT COMPLETED|Thigh Injection Phase (Up to Week 16)||3||
48371704|NCT05896761|101239805|FG001|NOT COMPLETED|Thigh Injection Phase (Up to Week 16)||3||
48371705|NCT05896761|101239804|FG000|STARTED|Return to Glu Inj Phase (Weeks 16 to 24)||51||
48371706|NCT05896761|101239805|FG001|STARTED|Return to Glu Inj Phase (Weeks 16 to 24)||61||
48371707|NCT05896761|101239804|FG000|COMPLETED|Return to Glu Inj Phase (Weeks 16 to 24)||51||
48371708|NCT05896761|101239805|FG001|COMPLETED|Return to Glu Inj Phase (Weeks 16 to 24)||61||
48371709|NCT05896761|101239804|FG000|NOT COMPLETED|Return to Glu Inj Phase (Weeks 16 to 24)||0||
48371710|NCT05896761|101239805|FG001|NOT COMPLETED|Return to Glu Inj Phase (Weeks 16 to 24)||0||
48371711|NCT00668434|101239806|FG000|STARTED|Primary Outcome Time Point (3 Weeks)||181||
48371712|NCT00668434|101239807|FG001|STARTED|Primary Outcome Time Point (3 Weeks)||88||
48371713|NCT00668434|101239806|FG000|COMPLETED|Primary Outcome Time Point (3 Weeks)||179||
48371714|NCT00668434|101239807|FG001|COMPLETED|Primary Outcome Time Point (3 Weeks)||88||
48371715|NCT00668434|101239806|FG000|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||2||
48371716|NCT00668434|101239807|FG001|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||0||
48371717|NCT00668434|101239806|FG000|STARTED|Secondary Outcome Time Point (52 Weeks)||179||
48371718|NCT00668434|101239807|FG001|STARTED|Secondary Outcome Time Point (52 Weeks)||88||
48371719|NCT00668434|101239806|FG000|COMPLETED|Secondary Outcome Time Point (52 Weeks)||157||
48371720|NCT00668434|101239807|FG001|COMPLETED|Secondary Outcome Time Point (52 Weeks)||77||
48371721|NCT00668434|101239806|FG000|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||22||
48371722|NCT00668434|101239807|FG001|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||11||
48371723|NCT02433288|101239808|FG000|STARTED|Overall Study||443||
48371724|NCT02433288|101239809|FG001|STARTED|Overall Study||442||
48371725|NCT02433288|101239808|FG000|COMPLETED|Overall Study||320||
48371726|NCT02433288|101239809|FG001|COMPLETED|Overall Study||316||
48371727|NCT02433288|101239808|FG000|NOT COMPLETED|Overall Study||123||
48371728|NCT02433288|101239809|FG001|NOT COMPLETED|Overall Study||126||
48371729|NCT01231633|101239810|FG000|STARTED|Overall Study||14||
48371730|NCT01231633|101239811|FG001|STARTED|Overall Study||13||
48371731|NCT01231633|101239810|FG000|COMPLETED|Overall Study||14||
48371732|NCT01231633|101239811|FG001|COMPLETED|Overall Study||13||
48371733|NCT01231633|101239810|FG000|NOT COMPLETED|Overall Study||0||
48371734|NCT01231633|101239811|FG001|NOT COMPLETED|Overall Study||0||
48371735|NCT01641835|101239812|FG000|STARTED|Overall Study||303||
48371736|NCT01641835|101239812|FG000|COMPLETED|Overall Study||303||
48371737|NCT01641835|101239812|FG000|NOT COMPLETED|Overall Study||0||
48371738|NCT01576016|101239813|FG000|STARTED|Lead Safety||920||
48371739|NCT01576016|101239814|FG001|STARTED|Lead Safety||0||
48371740|NCT01576016|101239813|FG000|COMPLETED|Lead Safety||647||
48371741|NCT01576016|101239814|FG001|COMPLETED|Lead Safety||0||
48371742|NCT01576016|101239813|FG000|NOT COMPLETED|Lead Safety||273||
48371743|NCT01576016|101239814|FG001|NOT COMPLETED|Lead Safety||0||
48371744|NCT01576016|101239813|FG000|STARTED|MRI Safety||0||
48371745|NCT01576016|101239814|FG001|STARTED|MRI Safety||255||
48371746|NCT01576016|101239813|FG000|COMPLETED|MRI Safety||0||
48371747|NCT01576016|101239814|FG001|COMPLETED|MRI Safety||181||
48371748|NCT01576016|101239813|FG000|NOT COMPLETED|MRI Safety||0||
48371749|NCT01576016|101239814|FG001|NOT COMPLETED|MRI Safety||74||
48371750|NCT05515601|101239815|FG000|STARTED|Overall Study||63||
48371751|NCT05515601|101239816|FG001|STARTED|Overall Study||69||
48371752|NCT05515601|101239817|FG002|STARTED|Overall Study||67||
48371753|NCT05515601|101239818|FG003|STARTED|Overall Study||66||
48371754|NCT05515601|101239819|FG004|STARTED|Overall Study||66||
48371755|NCT05515601|101239820|FG005|STARTED|Overall Study||65||
48371756|NCT05515601|101239815|FG000|Received at Least 1 Dose of Study Drug|Overall Study||63||
48371757|NCT05515601|101239816|FG001|Received at Least 1 Dose of Study Drug|Overall Study||69||
48371758|NCT05515601|101239817|FG002|Received at Least 1 Dose of Study Drug|Overall Study||67||
48371759|NCT05515601|101239818|FG003|Received at Least 1 Dose of Study Drug|Overall Study||66||
48371760|NCT05515601|101239819|FG004|Received at Least 1 Dose of Study Drug|Overall Study||66||
48371761|NCT05515601|101239820|FG005|Received at Least 1 Dose of Study Drug|Overall Study||65||
48371762|NCT05515601|101239815|FG000|COMPLETED|Overall Study||62||
48371763|NCT05515601|101239816|FG001|COMPLETED|Overall Study||66||
48371764|NCT05515601|101239817|FG002|COMPLETED|Overall Study||65||
48371765|NCT05515601|101239818|FG003|COMPLETED|Overall Study||65||
48371766|NCT05515601|101239819|FG004|COMPLETED|Overall Study||64||
48371767|NCT05515601|101239820|FG005|COMPLETED|Overall Study||64||
48371768|NCT05515601|101239815|FG000|NOT COMPLETED|Overall Study||1||
48371769|NCT05515601|101239816|FG001|NOT COMPLETED|Overall Study||3||
48371770|NCT05515601|101239817|FG002|NOT COMPLETED|Overall Study||2||
48371771|NCT05515601|101239818|FG003|NOT COMPLETED|Overall Study||1||
48371772|NCT05515601|101239819|FG004|NOT COMPLETED|Overall Study||2||
48371773|NCT05515601|101239820|FG005|NOT COMPLETED|Overall Study||1||
48371774|NCT00431847|101239821|FG000|STARTED|Overall Study||132||
48371775|NCT00431847|101239822|FG001|STARTED|Overall Study||45||
48371776|NCT00431847|101239823|FG002|STARTED|Overall Study||24||
48371777|NCT00431847|101239824|FG003|STARTED|Overall Study||184||
48371778|NCT00431847|101239825|FG004|STARTED|Overall Study||1||
48371779|NCT00431847|101239821|FG000|COMPLETED|Overall Study||126||
48371780|NCT00431847|101239822|FG001|COMPLETED|Overall Study||42||
48371781|NCT00431847|101239823|FG002|COMPLETED|Overall Study||20||
48371782|NCT00431847|101239824|FG003|COMPLETED|Overall Study||170||
48371783|NCT00431847|101239825|FG004|COMPLETED|Overall Study||0||
48371784|NCT00431847|101239821|FG000|NOT COMPLETED|Overall Study||6||
48371785|NCT00431847|101239822|FG001|NOT COMPLETED|Overall Study||3||
48371786|NCT00431847|101239823|FG002|NOT COMPLETED|Overall Study||4||
48371787|NCT00431847|101239824|FG003|NOT COMPLETED|Overall Study||14||
48371788|NCT00431847|101239825|FG004|NOT COMPLETED|Overall Study||1||
48371789|NCT01434472|101239826|FG000|STARTED|Overall Study||20||
48371790|NCT01434472|101239826|FG000|COMPLETED|Overall Study||20||
48371791|NCT01434472|101239826|FG000|NOT COMPLETED|Overall Study||0||
48371792|NCT00088634|101239827|FG000|STARTED|Overall Study||90||
48371793|NCT00088634|101239828|FG001|STARTED|Overall Study||90||
48371794|NCT00088634|101239827|FG000|COMPLETED|Overall Study||52||
48371795|NCT00088634|101239828|FG001|COMPLETED|Overall Study||47||
48371796|NCT00088634|101239827|FG000|NOT COMPLETED|Overall Study||38||
48371797|NCT00088634|101239828|FG001|NOT COMPLETED|Overall Study||43||
48371798|NCT03744676|101239829|FG000|STARTED|Pre-Treatment Phase||104|Participants who underwent leukapheresis|
48371799|NCT03744676|101239829|FG000|COMPLETED|Pre-Treatment Phase||83|Participants who completed leukapheresis and continued to lymphodepleting chemotherapy (LDC) treatment period and JCAR017|
48371800|NCT03744676|101239829|FG000|NOT COMPLETED|Pre-Treatment Phase||21||
48371801|NCT03744676|101239829|FG000|STARTED|Treatment Phase||82|Participants who underwent lymphodepleting chemotherapy (LDC) treatment with conforming JCAR017|
48371802|NCT03744676|101239829|FG000|Participants Who Received LDC and Non Conforming Product|Treatment Phase||1||
48371803|NCT03744676|101239829|FG000|COMPLETED|Treatment Phase||19|Completed study|
48371804|NCT03744676|101239829|FG000|NOT COMPLETED|Treatment Phase||63||
48371805|NCT01597622|101239830|FG000|STARTED|Overall Study||142||
48371806|NCT01597622|101239830|FG000|COMPLETED|Overall Study||104||
48371807|NCT01597622|101239830|FG000|NOT COMPLETED|Overall Study||38||
48371808|NCT01958606|101239831|FG000|STARTED|Overall Study||13||
48371809|NCT01958606|101239832|FG001|STARTED|Overall Study||5||
48371810|NCT01958606|101239831|FG000|COMPLETED|Overall Study||11||
48371811|NCT01958606|101239832|FG001|COMPLETED|Overall Study||5||
48371812|NCT01958606|101239831|FG000|NOT COMPLETED|Overall Study||2||
48371813|NCT01958606|101239832|FG001|NOT COMPLETED|Overall Study||0||
48371814|NCT01125176|101239833|FG000|STARTED|Treatment Phase||14||
48371815|NCT01125176|101239833|FG000|COMPLETED|Treatment Phase||13||
48371816|NCT01125176|101239833|FG000|NOT COMPLETED|Treatment Phase||1||
48371817|NCT01125176|101239833|FG000|STARTED|Post-treatment Follow-up Phase||13||
48371818|NCT01125176|101239833|FG000|COMPLETED|Post-treatment Follow-up Phase||2||
48371819|NCT01125176|101239833|FG000|NOT COMPLETED|Post-treatment Follow-up Phase||11||
48371820|NCT04429503|101239834|FG000|STARTED|Overall Study||167|Randomized|
48371821|NCT04429503|101239835|FG001|STARTED|Overall Study||329|Randomized|
48371822|NCT04429503|101239836|FG002|STARTED|Overall Study||164|Randomized|
48371823|NCT04429503|101239834|FG000|Treated|Overall Study||167|All randomized participants who received at least 1 dose of study drug (Full Analysis Set)|
48371824|NCT04429503|101239835|FG001|Treated|Overall Study||328|All randomized participants who received at least 1 dose of study drug (Full Analysis Set)|
48371825|NCT04429503|101239836|FG002|Treated|Overall Study||163|All randomized participants who received at least 1 dose of study drug (Full Analysis Set)|
48371826|NCT04429503|101239834|FG000|Completed Week 60|Overall Study||155||
48371827|NCT04429503|101239835|FG001|Completed Week 60|Overall Study||289||
48371828|NCT04429503|101239836|FG002|Completed Week 60|Overall Study||152||
48371829|NCT04429503|101239834|FG000|COMPLETED|Overall Study||139|Completed Week 96|
48371830|NCT04429503|101239835|FG001|COMPLETED|Overall Study||256|Completed Week 96|
48371831|NCT04429503|101239836|FG002|COMPLETED|Overall Study||139|Completed Week 96|
48371832|NCT04429503|101239834|FG000|NOT COMPLETED|Overall Study||28||
48371833|NCT04429503|101239835|FG001|NOT COMPLETED|Overall Study||73||
48371834|NCT04429503|101239836|FG002|NOT COMPLETED|Overall Study||25||
48371835|NCT03569293|101239837|FG000|STARTED|Overall Study||241|Randomized into study|
48371836|NCT03569293|101239838|FG001|STARTED|Overall Study||239|Randomized into study|
48371837|NCT03569293|101239839|FG002|STARTED|Overall Study||243|Randomized into study|
48371838|NCT03569293|101239840|FG003|STARTED|Overall Study||61|Randomized into study|
48371839|NCT03569293|101239841|FG004|STARTED|Overall Study||64|Randomized into study|
48371840|NCT03569293|101239842|FG005|STARTED|Overall Study||64|Randomized into study|
48371841|NCT03569293|101239837|FG000|Received Study Drug|Overall Study||241||
48371842|NCT03569293|101239838|FG001|Received Study Drug|Overall Study||239||
48371843|NCT03569293|101239839|FG002|Received Study Drug|Overall Study||243||
48672295|NCT02684461|101982596|FG001|COMPLETED|Overall Study||5||
48672296|NCT02684461|101982597|FG002|COMPLETED|Overall Study||6||
48672297|NCT02684461|101982595|FG000|NOT COMPLETED|Overall Study||2||
48672298|NCT02684461|101982596|FG001|NOT COMPLETED|Overall Study||2||
48672299|NCT02684461|101982597|FG002|NOT COMPLETED|Overall Study||0||
48672300|NCT01014871|101982598|FG000|STARTED|Overall Study||30||
48672301|NCT01014871|101982598|FG000|COMPLETED|Overall Study||30||
48672302|NCT01014871|101982598|FG000|NOT COMPLETED|Overall Study||0||
48672303|NCT04606927|101982599|FG000|STARTED|Overall Study||150||
48672304|NCT04606927|101982600|FG001|STARTED|Overall Study||160||
48672305|NCT04606927|101982599|FG000|COMPLETED|Overall Study||150||
48672306|NCT04606927|101982600|FG001|COMPLETED|Overall Study||160||
48672307|NCT04606927|101982599|FG000|NOT COMPLETED|Overall Study||0||
48672308|NCT04606927|101982600|FG001|NOT COMPLETED|Overall Study||0||
48672309|NCT01409096|101982601|FG000|STARTED|Overall Study||40||
48672310|NCT01409096|101982602|FG001|STARTED|Overall Study||40||
48672311|NCT01409096|101982601|FG000|COMPLETED|Overall Study||38||
48672312|NCT01409096|101982602|FG001|COMPLETED|Overall Study||35||
48672313|NCT01409096|101982601|FG000|NOT COMPLETED|Overall Study||2||
48672314|NCT01409096|101982602|FG001|NOT COMPLETED|Overall Study||5||
48672315|NCT04573972|101982603|FG000|STARTED|Overall Study||88||
48672316|NCT04573972|101982604|FG001|STARTED|Overall Study||84||
48672317|NCT04573972|101982603|FG000|COMPLETED|Overall Study||56||
48672318|NCT04573972|101982604|FG001|COMPLETED|Overall Study||70||
48672319|NCT04573972|101982603|FG000|NOT COMPLETED|Overall Study||32||
48371844|NCT03569293|101239840|FG003|Received Study Drug|Overall Study||61||
48371845|NCT03569293|101239841|FG004|Received Study Drug|Overall Study||64||
48371846|NCT03569293|101239842|FG005|Received Study Drug|Overall Study||64||
48371847|NCT03569293|101239837|FG000|COMPLETED|Overall Study||204|Completed Week 16|
48371848|NCT03569293|101239838|FG001|COMPLETED|Overall Study||230|Completed Week 16|
48371849|NCT03569293|101239839|FG002|COMPLETED|Overall Study||229|Completed Week 16|
48371850|NCT03569293|101239840|FG003|COMPLETED|Overall Study||57|Completed Week 16|
48371851|NCT03569293|101239841|FG004|COMPLETED|Overall Study||64|Completed Week 16|
48371852|NCT03569293|101239842|FG005|COMPLETED|Overall Study||64|Completed Week 16|
48371853|NCT03569293|101239837|FG000|NOT COMPLETED|Overall Study||37||
48371854|NCT03569293|101239838|FG001|NOT COMPLETED|Overall Study||9||
48371855|NCT03569293|101239839|FG002|NOT COMPLETED|Overall Study||14||
48371856|NCT03569293|101239840|FG003|NOT COMPLETED|Overall Study||4||
48371857|NCT03569293|101239841|FG004|NOT COMPLETED|Overall Study||0||
48371858|NCT03569293|101239842|FG005|NOT COMPLETED|Overall Study||0||
48371859|NCT01831934|101239843|FG000|STARTED|Overall Study||12||
48371860|NCT01831934|101239844|FG001|STARTED|Overall Study||10||
48371861|NCT01831934|101239843|FG000|COMPLETED|Overall Study||11||
48371862|NCT01831934|101239844|FG001|COMPLETED|Overall Study||10||
48371863|NCT01831934|101239843|FG000|NOT COMPLETED|Overall Study||1||
48371864|NCT01831934|101239844|FG001|NOT COMPLETED|Overall Study||0||
48371865|NCT00843310|101239845|FG000|STARTED|Overall Study||8||
48371866|NCT00843310|101239845|FG000|COMPLETED|Overall Study||1||
48371867|NCT00843310|101239845|FG000|NOT COMPLETED|Overall Study||7||
48371868|NCT01096446|101239846|FG000|STARTED|Overall Study||12||
48371869|NCT01096446|101239847|FG001|STARTED|Overall Study||10||
48371870|NCT01096446|101239846|FG000|COMPLETED|Overall Study||9||
48371871|NCT01096446|101239847|FG001|COMPLETED|Overall Study||10||
48371872|NCT01096446|101239846|FG000|NOT COMPLETED|Overall Study||3||
48371873|NCT01096446|101239847|FG001|NOT COMPLETED|Overall Study||0||
48371874|NCT03403504|101239848|FG000|STARTED|Period 1||12||
48371875|NCT03403504|101239849|FG001|STARTED|Period 1||12||
48371876|NCT03403504|101239848|FG000|COMPLETED|Period 1||12||
48371877|NCT03403504|101239849|FG001|COMPLETED|Period 1||11||
48371878|NCT03403504|101239848|FG000|NOT COMPLETED|Period 1||0||
48371879|NCT03403504|101239849|FG001|NOT COMPLETED|Period 1||1||
48371880|NCT03403504|101239848|FG000|STARTED|Period 2||12||
48371881|NCT03403504|101239849|FG001|STARTED|Period 2||11||
48371882|NCT03403504|101239848|FG000|COMPLETED|Period 2||12||
48371883|NCT03403504|101239849|FG001|COMPLETED|Period 2||11||
48371884|NCT03403504|101239848|FG000|NOT COMPLETED|Period 2||0||
48371885|NCT03403504|101239849|FG001|NOT COMPLETED|Period 2||0||
48371886|NCT01242020|101239850|FG000|STARTED|Overall Study||6||
48371887|NCT01242020|101239851|FG001|STARTED|Overall Study||0||
48371888|NCT01242020|101239850|FG000|COMPLETED|Overall Study||3||
48371889|NCT01242020|101239851|FG001|COMPLETED|Overall Study||0||
48371890|NCT01242020|101239850|FG000|NOT COMPLETED|Overall Study||3||
48371891|NCT01242020|101239851|FG001|NOT COMPLETED|Overall Study||0||
48371892|NCT00041717|101239852|FG000|STARTED|Overall Study||114||
48371893|NCT00041717|101239853|FG001|STARTED|Overall Study||98||
48371894|NCT00041717|101239852|FG000|COMPLETED|Overall Study||81||
48371895|NCT00041717|101239853|FG001|COMPLETED|Overall Study||86||
48371896|NCT00041717|101239852|FG000|NOT COMPLETED|Overall Study||33||
48371897|NCT00041717|101239853|FG001|NOT COMPLETED|Overall Study||12||
48371898|NCT02330627|101239854|FG000|STARTED|Overall Study||16||
48371899|NCT02330627|101239855|FG001|STARTED|Overall Study||13||
48371900|NCT02330627|101239854|FG000|COMPLETED|Overall Study||15||
48371901|NCT02330627|101239855|FG001|COMPLETED|Overall Study||12||
48371902|NCT02330627|101239854|FG000|NOT COMPLETED|Overall Study||1||
48371903|NCT02330627|101239855|FG001|NOT COMPLETED|Overall Study||1||
48371904|NCT02179515|101239856|FG000|STARTED|Overall Study||3||
48371905|NCT02179515|101239857|FG001|STARTED|Overall Study||17||
48371906|NCT02179515|101239858|FG002|STARTED|Overall Study||18||
48371907|NCT02179515|101239856|FG000|COMPLETED|Overall Study||1||
48371908|NCT02179515|101239857|FG001|COMPLETED|Overall Study||1||
48371909|NCT02179515|101239858|FG002|COMPLETED|Overall Study||4||
48371910|NCT02179515|101239856|FG000|NOT COMPLETED|Overall Study||2||
48371911|NCT02179515|101239857|FG001|NOT COMPLETED|Overall Study||16||
48371912|NCT02179515|101239858|FG002|NOT COMPLETED|Overall Study||14||
48371913|NCT03709810|101239859|FG000|STARTED|Treatment Period 1 (Visit 2)||24||
48371914|NCT03709810|101239860|FG001|STARTED|Treatment Period 1 (Visit 2)||24||
48371915|NCT03709810|101239859|FG000|COMPLETED|Treatment Period 1 (Visit 2)||24||
48371916|NCT03709810|101239860|FG001|COMPLETED|Treatment Period 1 (Visit 2)||24||
48371917|NCT03709810|101239859|FG000|NOT COMPLETED|Treatment Period 1 (Visit 2)||0||
48371918|NCT03709810|101239860|FG001|NOT COMPLETED|Treatment Period 1 (Visit 2)||0||
48371919|NCT03709810|101239859|FG000|STARTED|Treatment Period 2 (Visit 3)||24||
48371920|NCT03709810|101239860|FG001|STARTED|Treatment Period 2 (Visit 3)||24||
48371921|NCT03709810|101239859|FG000|COMPLETED|Treatment Period 2 (Visit 3)||24||
48371922|NCT03709810|101239860|FG001|COMPLETED|Treatment Period 2 (Visit 3)||24||
48371923|NCT03709810|101239859|FG000|NOT COMPLETED|Treatment Period 2 (Visit 3)||0||
48371924|NCT03709810|101239860|FG001|NOT COMPLETED|Treatment Period 2 (Visit 3)||0||
48371925|NCT02739594|101239861|FG000|STARTED|Overall Study||46||
48371926|NCT02739594|101239862|FG001|STARTED|Overall Study||43||
48371927|NCT02739594|101239861|FG000|Completed at Week 44|Overall Study||11||
48371928|NCT02739594|101239862|FG001|Completed at Week 44|Overall Study||5||
48371929|NCT02739594|101239861|FG000|Completed at Week 96|Overall Study||10||
48371930|NCT02739594|101239862|FG001|Completed at Week 96|Overall Study||10||
48371931|NCT02739594|101239861|FG000|COMPLETED|Overall Study||21||
48371932|NCT02739594|101239862|FG001|COMPLETED|Overall Study||15||
48371933|NCT02739594|101239861|FG000|NOT COMPLETED|Overall Study||25||
48371934|NCT02739594|101239862|FG001|NOT COMPLETED|Overall Study||28||
48371935|NCT00972244|101239863|FG000|STARTED|Overall Study||59||
48371936|NCT00972244|101239864|FG001|STARTED|Overall Study||56||
48371937|NCT00972244|101239865|FG002|STARTED|Overall Study||58||
48371938|NCT00972244|101239866|FG003|STARTED|Overall Study||52||
48371939|NCT00972244|101239867|FG004|STARTED|Overall Study||54||
48371940|NCT00972244|101239863|FG000|COMPLETED|Overall Study||54||
48371941|NCT00972244|101239864|FG001|COMPLETED|Overall Study||51||
48371942|NCT00972244|101239865|FG002|COMPLETED|Overall Study||56||
48371943|NCT00972244|101239866|FG003|COMPLETED|Overall Study||52||
48371944|NCT00972244|101239867|FG004|COMPLETED|Overall Study||45||
48371945|NCT00972244|101239863|FG000|NOT COMPLETED|Overall Study||5||
48371946|NCT00972244|101239864|FG001|NOT COMPLETED|Overall Study||5||
48371947|NCT00972244|101239865|FG002|NOT COMPLETED|Overall Study||2||
48371948|NCT00972244|101239866|FG003|NOT COMPLETED|Overall Study||0||
48371949|NCT00972244|101239867|FG004|NOT COMPLETED|Overall Study||9||
48371950|NCT04285346|101239868|FG000|STARTED|Treatment Period (Up to 12 Weeks)||23||
48371951|NCT04285346|101239869|FG001|STARTED|Treatment Period (Up to 12 Weeks)||0||
48371952|NCT04285346|101239868|FG000|COMPLETED|Treatment Period (Up to 12 Weeks)||17||
48371953|NCT04285346|101239869|FG001|COMPLETED|Treatment Period (Up to 12 Weeks)||0||
48371954|NCT04285346|101239868|FG000|NOT COMPLETED|Treatment Period (Up to 12 Weeks)||6||
48371955|NCT04285346|101239869|FG001|NOT COMPLETED|Treatment Period (Up to 12 Weeks)||0||
48371956|NCT04285346|101239868|FG000|STARTED|Open Label Period (Week 12 to 38)||0||
48371957|NCT04285346|101239869|FG001|STARTED|Open Label Period (Week 12 to 38)||9||
48371958|NCT04285346|101239868|FG000|COMPLETED|Open Label Period (Week 12 to 38)||0||
48371959|NCT04285346|101239869|FG001|COMPLETED|Open Label Period (Week 12 to 38)||9||
48371960|NCT04285346|101239868|FG000|NOT COMPLETED|Open Label Period (Week 12 to 38)||0||
48371961|NCT04285346|101239869|FG001|NOT COMPLETED|Open Label Period (Week 12 to 38)||0||
48371962|NCT03329937|101239870|FG000|STARTED|Overall Study||21||
48371963|NCT03329937|101239870|FG000|COMPLETED|Overall Study||21||
48371964|NCT03329937|101239870|FG000|NOT COMPLETED|Overall Study||0||
48371965|NCT03569111|101239871|FG000|STARTED|Overall Study||30||
48371966|NCT03569111|101239871|FG000|Procedure|Overall Study||30||
48371967|NCT03569111|101239871|FG000|1-Month|Overall Study||30||
48371968|NCT03569111|101239871|FG000|COMPLETED|Overall Study||30||
48371969|NCT03569111|101239871|FG000|NOT COMPLETED|Overall Study||0||
48371970|NCT02401555|101239872|FG000|STARTED|Overall Study||87||
48371971|NCT02401555|101239873|FG001|STARTED|Overall Study||212||
48371972|NCT02401555|101239874|FG002|STARTED|Overall Study||120||
48371973|NCT02401555|101239872|FG000|COMPLETED|Overall Study||87||
48371974|NCT02401555|101239873|FG001|COMPLETED|Overall Study||212||
48371975|NCT02401555|101239874|FG002|COMPLETED|Overall Study||120||
48371976|NCT02401555|101239872|FG000|NOT COMPLETED|Overall Study||0||
48371977|NCT02401555|101239873|FG001|NOT COMPLETED|Overall Study||0||
48371978|NCT02401555|101239874|FG002|NOT COMPLETED|Overall Study||0||
48371979|NCT01793051|101239875|FG000|STARTED|Overall Study||43||
48371980|NCT01793051|101239876|FG001|STARTED|Overall Study||44||
48371981|NCT01793051|101239875|FG000|COMPLETED|Overall Study||33||
48371982|NCT01793051|101239876|FG001|COMPLETED|Overall Study||36||
48371983|NCT01793051|101239875|FG000|NOT COMPLETED|Overall Study||10||
48371984|NCT01793051|101239876|FG001|NOT COMPLETED|Overall Study||8||
48371985|NCT01728584|101239877|FG000|STARTED|Overall Study||36||
48371986|NCT01728584|101239878|FG001|STARTED|Overall Study||30||
48672320|NCT04573972|101982604|FG001|NOT COMPLETED|Overall Study||14||
48371987|NCT01728584|101239879|FG002|STARTED|Overall Study||31||
48371988|NCT01728584|101239880|FG003|STARTED|Overall Study||30||
48371989|NCT01728584|101239877|FG000|COMPLETED|Overall Study||28||
48371990|NCT01728584|101239878|FG001|COMPLETED|Overall Study||30||
48371991|NCT01728584|101239879|FG002|COMPLETED|Overall Study||30||
48371992|NCT01728584|101239880|FG003|COMPLETED|Overall Study||29||
48672321|NCT04507763|101982605|FG000|STARTED|Overall Study||763||
48672322|NCT04507763|101982605|FG000|COMPLETED|Overall Study||562||
48672323|NCT04507763|101982605|FG000|NOT COMPLETED|Overall Study||201||
48672324|NCT01209767|101982606|FG000|STARTED|Overall Study||22||
48672325|NCT01209767|101982606|FG000|COMPLETED|Overall Study||18||
48672326|NCT01209767|101982606|FG000|NOT COMPLETED|Overall Study||4||
48672327|NCT00107575|101982607|FG000|STARTED|Overall Study||119||
48672328|NCT00107575|101982608|FG001|STARTED|Overall Study||117||
48672329|NCT00107575|101982607|FG000|COMPLETED|Overall Study||108||
48672330|NCT00107575|101982608|FG001|COMPLETED|Overall Study||107||
48672331|NCT00107575|101982607|FG000|NOT COMPLETED|Overall Study||11||
48672332|NCT00107575|101982608|FG001|NOT COMPLETED|Overall Study||10||
48672333|NCT00907621|101982609|FG000|STARTED|Overall Study||45||
48672334|NCT00907621|101982610|FG001|STARTED|Overall Study||45||
48672335|NCT00907621|101982609|FG000|COMPLETED|Overall Study||38||
48371993|NCT01728584|101239877|FG000|NOT COMPLETED|Overall Study||8||
48371994|NCT01728584|101239878|FG001|NOT COMPLETED|Overall Study||0||
48371995|NCT01728584|101239879|FG002|NOT COMPLETED|Overall Study||1||
48371996|NCT01728584|101239880|FG003|NOT COMPLETED|Overall Study||1||
48371997|NCT01035606|101239881|FG000|STARTED|Overall Study||19||
48371998|NCT01035606|101239882|FG001|STARTED|Overall Study||19||
48371999|NCT01035606|101239883|FG002|STARTED|Overall Study||11||
48372000|NCT01035606|101239881|FG000|COMPLETED|Overall Study||16||
48372001|NCT01035606|101239882|FG001|COMPLETED|Overall Study||16||
48372002|NCT01035606|101239883|FG002|COMPLETED|Overall Study||7||
48372003|NCT01035606|101239881|FG000|NOT COMPLETED|Overall Study||3||
48372004|NCT01035606|101239882|FG001|NOT COMPLETED|Overall Study||3||
48372005|NCT01035606|101239883|FG002|NOT COMPLETED|Overall Study||4||
48372006|NCT01675531|101239884|FG000|STARTED|Overall Study||66||
48372007|NCT01675531|101239884|FG000|COMPLETED|Overall Study||41||
48372008|NCT01675531|101239884|FG000|NOT COMPLETED|Overall Study||25||
48372009|NCT04160468|101239885|FG000|STARTED|Overall Study||173||
48372010|NCT04160468|101239886|FG001|STARTED|Overall Study||86||
48372011|NCT04160468|101239885|FG000|COMPLETED|Overall Study||142||
48372012|NCT04160468|101239886|FG001|COMPLETED|Overall Study||81||
48372013|NCT04160468|101239885|FG000|NOT COMPLETED|Overall Study||31||
48372014|NCT04160468|101239886|FG001|NOT COMPLETED|Overall Study||5||
48372015|NCT04436822|101239887|FG000|STARTED|Overall Study||172||
48372016|NCT04436822|101239888|FG001|STARTED|Overall Study||138||
48372017|NCT04436822|101239887|FG000|COMPLETED|Overall Study||160||
48372018|NCT04436822|101239888|FG001|COMPLETED|Overall Study||132||
48372019|NCT04436822|101239887|FG000|NOT COMPLETED|Overall Study||12||
48372020|NCT04436822|101239888|FG001|NOT COMPLETED|Overall Study||6||
48672336|NCT00907621|101982610|FG001|COMPLETED|Overall Study||41||
48372021|NCT01798134|101239889|FG000|STARTED|Overall Study||25||
48372022|NCT01798134|101239889|FG000|COMPLETED|Overall Study||9||
48372023|NCT01798134|101239889|FG000|NOT COMPLETED|Overall Study||16||
48372024|NCT03161678|101239890|FG000|STARTED|Intervention 1 (8 Days)||17||
48372025|NCT03161678|101239891|FG001|STARTED|Intervention 1 (8 Days)||19||
48372026|NCT03161678|101239892|FG002|STARTED|Intervention 1 (8 Days)||10||
48372027|NCT03161678|101239893|FG003|STARTED|Intervention 1 (8 Days)||12||
48372028|NCT03161678|101239894|FG004|STARTED|Intervention 1 (8 Days)||23||
48372029|NCT03161678|101239895|FG005|STARTED|Intervention 1 (8 Days)||19||
48372030|NCT03161678|101239890|FG000|COMPLETED|Intervention 1 (8 Days)||16||
48372031|NCT03161678|101239891|FG001|COMPLETED|Intervention 1 (8 Days)||18||
48372032|NCT03161678|101239892|FG002|COMPLETED|Intervention 1 (8 Days)||10||
48372033|NCT03161678|101239893|FG003|COMPLETED|Intervention 1 (8 Days)||9||
48372034|NCT03161678|101239894|FG004|COMPLETED|Intervention 1 (8 Days)||22||
48372035|NCT03161678|101239895|FG005|COMPLETED|Intervention 1 (8 Days)||19||
48372036|NCT03161678|101239890|FG000|NOT COMPLETED|Intervention 1 (8 Days)||1||
48372037|NCT03161678|101239891|FG001|NOT COMPLETED|Intervention 1 (8 Days)||1||
48372038|NCT03161678|101239892|FG002|NOT COMPLETED|Intervention 1 (8 Days)||0||
48372039|NCT03161678|101239893|FG003|NOT COMPLETED|Intervention 1 (8 Days)||3||
48672337|NCT00907621|101982609|FG000|NOT COMPLETED|Overall Study||7||
48672338|NCT00907621|101982610|FG001|NOT COMPLETED|Overall Study||4||
48672339|NCT01138514|101982611|FG000|STARTED|Overall Study||522||
48372040|NCT03161678|101239894|FG004|NOT COMPLETED|Intervention 1 (8 Days)||1||
48372041|NCT03161678|101239895|FG005|NOT COMPLETED|Intervention 1 (8 Days)||0||
48372042|NCT03161678|101239890|FG000|STARTED|Washout (14 Days)||16||
48372043|NCT03161678|101239891|FG001|STARTED|Washout (14 Days)||18||
48372044|NCT03161678|101239892|FG002|STARTED|Washout (14 Days)||10||
48372045|NCT03161678|101239893|FG003|STARTED|Washout (14 Days)||9||
48372046|NCT03161678|101239894|FG004|STARTED|Washout (14 Days)||22||
48372047|NCT03161678|101239895|FG005|STARTED|Washout (14 Days)||19||
48372048|NCT03161678|101239890|FG000|COMPLETED|Washout (14 Days)||16||
48672340|NCT01138514|101982612|FG001|STARTED|Overall Study||516||
48672341|NCT01138514|101982613|FG002|STARTED|Overall Study||517||
48672342|NCT01138514|101982611|FG000|COMPLETED|Overall Study||474||
48672343|NCT01138514|101982612|FG001|COMPLETED|Overall Study||463||
48672344|NCT01138514|101982613|FG002|COMPLETED|Overall Study||424||
48672345|NCT01138514|101982611|FG000|NOT COMPLETED|Overall Study||48||
48672346|NCT01138514|101982612|FG001|NOT COMPLETED|Overall Study||53||
48372049|NCT03161678|101239891|FG001|COMPLETED|Washout (14 Days)||18||
48372050|NCT03161678|101239892|FG002|COMPLETED|Washout (14 Days)||9||
48372051|NCT03161678|101239893|FG003|COMPLETED|Washout (14 Days)||9||
48372052|NCT03161678|101239894|FG004|COMPLETED|Washout (14 Days)||20||
48372053|NCT03161678|101239895|FG005|COMPLETED|Washout (14 Days)||18||
48372054|NCT03161678|101239890|FG000|NOT COMPLETED|Washout (14 Days)||0||
48372055|NCT03161678|101239891|FG001|NOT COMPLETED|Washout (14 Days)||0||
48372056|NCT03161678|101239892|FG002|NOT COMPLETED|Washout (14 Days)||1||
48372057|NCT03161678|101239893|FG003|NOT COMPLETED|Washout (14 Days)||0||
48372058|NCT03161678|101239894|FG004|NOT COMPLETED|Washout (14 Days)||2||
48372059|NCT03161678|101239895|FG005|NOT COMPLETED|Washout (14 Days)||1||
48372060|NCT03161678|101239890|FG000|STARTED|Intervention 2 (8 Days)||16||
48372061|NCT03161678|101239891|FG001|STARTED|Intervention 2 (8 Days)||18||
48372062|NCT03161678|101239892|FG002|STARTED|Intervention 2 (8 Days)||9||
48372063|NCT03161678|101239893|FG003|STARTED|Intervention 2 (8 Days)||9||
48372064|NCT03161678|101239894|FG004|STARTED|Intervention 2 (8 Days)||20||
48372065|NCT03161678|101239895|FG005|STARTED|Intervention 2 (8 Days)||18||
48372066|NCT03161678|101239890|FG000|COMPLETED|Intervention 2 (8 Days)||16||
48372067|NCT03161678|101239891|FG001|COMPLETED|Intervention 2 (8 Days)||18||
48372068|NCT03161678|101239892|FG002|COMPLETED|Intervention 2 (8 Days)||9||
48372069|NCT03161678|101239893|FG003|COMPLETED|Intervention 2 (8 Days)||8||
48372070|NCT03161678|101239894|FG004|COMPLETED|Intervention 2 (8 Days)||20||
48372071|NCT03161678|101239895|FG005|COMPLETED|Intervention 2 (8 Days)||18||
48372072|NCT03161678|101239890|FG000|NOT COMPLETED|Intervention 2 (8 Days)||0||
48372073|NCT03161678|101239891|FG001|NOT COMPLETED|Intervention 2 (8 Days)||0||
48372074|NCT03161678|101239892|FG002|NOT COMPLETED|Intervention 2 (8 Days)||0||
48372075|NCT03161678|101239893|FG003|NOT COMPLETED|Intervention 2 (8 Days)||1||
48372076|NCT03161678|101239894|FG004|NOT COMPLETED|Intervention 2 (8 Days)||0||
48372077|NCT03161678|101239895|FG005|NOT COMPLETED|Intervention 2 (8 Days)||0||
48372078|NCT03807739|101239896|FG000|STARTED|Overall Study||9||
48372079|NCT03807739|101239897|FG001|STARTED|Overall Study||10||
48372080|NCT03807739|101239898|FG002|STARTED|Overall Study||9||
48372081|NCT03807739|101239899|FG003|STARTED|Overall Study||10||
48372082|NCT03807739|101239896|FG000|COMPLETED|Overall Study||7||
48521843|NCT00952276|101611701|FG000|NOT COMPLETED|Overall Study||1||
48372083|NCT03807739|101239897|FG001|COMPLETED|Overall Study||10||
48372084|NCT03807739|101239898|FG002|COMPLETED|Overall Study||9||
48372085|NCT03807739|101239899|FG003|COMPLETED|Overall Study||10||
48372086|NCT03807739|101239896|FG000|NOT COMPLETED|Overall Study||2||
48372087|NCT03807739|101239897|FG001|NOT COMPLETED|Overall Study||0||
48372088|NCT03807739|101239898|FG002|NOT COMPLETED|Overall Study||0||
48372089|NCT03807739|101239899|FG003|NOT COMPLETED|Overall Study||0||
48372090|NCT02322320|101239900|FG000|STARTED|Overall Study||98||
48372091|NCT02322320|101239901|FG001|STARTED|Overall Study||86||
48372092|NCT02322320|101239902|FG002|STARTED|Overall Study||89||
48372093|NCT02322320|101239900|FG000|COMPLETED|Overall Study||98||
48372094|NCT02322320|101239901|FG001|COMPLETED|Overall Study||86||
48372095|NCT02322320|101239902|FG002|COMPLETED|Overall Study||89||
48372096|NCT02322320|101239900|FG000|NOT COMPLETED|Overall Study||0||
48372097|NCT02322320|101239901|FG001|NOT COMPLETED|Overall Study||0||
48372098|NCT02322320|101239902|FG002|NOT COMPLETED|Overall Study||0||
48372099|NCT04111276|101239903|FG000|STARTED|Overall Study||23||
48372100|NCT04111276|101239903|FG000|COMPLETED|Overall Study||20||
48372101|NCT04111276|101239903|FG000|NOT COMPLETED|Overall Study||3||
48372102|NCT04593940|101239904|FG000|STARTED|Overall Study||531||
48372103|NCT04593940|101239905|FG001|STARTED|Overall Study||524||
48372104|NCT04593940|101239906|FG002|STARTED|Overall Study||360||
48372105|NCT04593940|101239907|FG003|STARTED|Overall Study||556||
48372106|NCT04593940|101239904|FG000|COMPLETED|Overall Study||425||
48372107|NCT04593940|101239905|FG001|COMPLETED|Overall Study||394||
48372108|NCT04593940|101239906|FG002|COMPLETED|Overall Study||263||
48372109|NCT04593940|101239907|FG003|COMPLETED|Overall Study||419||
48372110|NCT04593940|101239904|FG000|NOT COMPLETED|Overall Study||106||
48372111|NCT04593940|101239905|FG001|NOT COMPLETED|Overall Study||130||
48372112|NCT04593940|101239906|FG002|NOT COMPLETED|Overall Study||97||
48372113|NCT04593940|101239907|FG003|NOT COMPLETED|Overall Study||137||
48372114|NCT03123354|101239908|FG000|STARTED|Overall Study||44||
48372115|NCT03123354|101239908|FG000|COMPLETED|Overall Study||38||
48372116|NCT03123354|101239908|FG000|NOT COMPLETED|Overall Study||6||
48372117|NCT04045613|101239909|FG000|STARTED|Overall Study||32||
48372118|NCT04045613|101239910|FG001|STARTED|Overall Study||14||
48372119|NCT04045613|101239911|FG002|STARTED|Overall Study||12||
48372120|NCT04045613|101239912|FG003|STARTED|Overall Study||2||
48372121|NCT04045613|101239913|FG004|STARTED|Overall Study||8||
48372122|NCT04045613|101239914|FG005|STARTED|Overall Study||10||
48372123|NCT04045613|101239915|FG006|STARTED|Overall Study||17||
48372124|NCT04045613|101239909|FG000|COMPLETED|Overall Study||0||
48372125|NCT04045613|101239910|FG001|COMPLETED|Overall Study||0||
48372126|NCT04045613|101239911|FG002|COMPLETED|Overall Study||0||
48372127|NCT04045613|101239912|FG003|COMPLETED|Overall Study||0||
48372128|NCT04045613|101239913|FG004|COMPLETED|Overall Study||0||
48372129|NCT04045613|101239914|FG005|COMPLETED|Overall Study||0||
48372130|NCT04045613|101239915|FG006|COMPLETED|Overall Study||0||
48372131|NCT04045613|101239909|FG000|NOT COMPLETED|Overall Study||32||
48372132|NCT04045613|101239910|FG001|NOT COMPLETED|Overall Study||14||
48372133|NCT04045613|101239911|FG002|NOT COMPLETED|Overall Study||12||
48372134|NCT04045613|101239912|FG003|NOT COMPLETED|Overall Study||2||
48372135|NCT04045613|101239913|FG004|NOT COMPLETED|Overall Study||8||
48372136|NCT04045613|101239914|FG005|NOT COMPLETED|Overall Study||10||
48372137|NCT04045613|101239915|FG006|NOT COMPLETED|Overall Study||17||
48372138|NCT01552928|101239916|FG000|STARTED|Period 1||14||
48372139|NCT01552928|101239917|FG001|STARTED|Period 1||15||
48372140|NCT01552928|101239918|FG002|STARTED|Period 1||15||
48372141|NCT01552928|101239919|FG003|STARTED|Period 1||16||
48372142|NCT01552928|101239916|FG000|COMPLETED|Period 1||14||
48372143|NCT01552928|101239917|FG001|COMPLETED|Period 1||15||
48372144|NCT01552928|101239918|FG002|COMPLETED|Period 1||15||
48372145|NCT01552928|101239919|FG003|COMPLETED|Period 1||16||
48372146|NCT01552928|101239916|FG000|NOT COMPLETED|Period 1||0||
48372147|NCT01552928|101239917|FG001|NOT COMPLETED|Period 1||0||
48372148|NCT01552928|101239918|FG002|NOT COMPLETED|Period 1||0||
48372149|NCT01552928|101239919|FG003|NOT COMPLETED|Period 1||0||
48372150|NCT01552928|101239916|FG000|STARTED|Period 2||14||
48372151|NCT01552928|101239917|FG001|STARTED|Period 2||15||
48372152|NCT01552928|101239918|FG002|STARTED|Period 2||15||
48372153|NCT01552928|101239919|FG003|STARTED|Period 2||16||
48372154|NCT01552928|101239916|FG000|COMPLETED|Period 2||14||
48372155|NCT01552928|101239917|FG001|COMPLETED|Period 2||15||
48372156|NCT01552928|101239918|FG002|COMPLETED|Period 2||15||
48372157|NCT01552928|101239919|FG003|COMPLETED|Period 2||16||
48372158|NCT01552928|101239916|FG000|NOT COMPLETED|Period 2||0||
48372159|NCT01552928|101239917|FG001|NOT COMPLETED|Period 2||0||
48521844|NCT00952276|101611702|FG001|NOT COMPLETED|Overall Study||0||
48672347|NCT01138514|101982613|FG002|NOT COMPLETED|Overall Study||93||
48672348|NCT03983421|101982614|FG000|STARTED|Overall Study||25||
48672349|NCT03983421|101982614|FG000|COMPLETED|Overall Study||24||
48672350|NCT03983421|101982614|FG000|NOT COMPLETED|Overall Study||1||
48672351|NCT01133847|101982615|FG000|STARTED|Active Treatment Phase (Weeks 1-16)||78||
48672352|NCT01133847|101982616|FG001|STARTED|Active Treatment Phase (Weeks 1-16)||74||
48372160|NCT01552928|101239918|FG002|NOT COMPLETED|Period 2||0||
48372161|NCT01552928|101239919|FG003|NOT COMPLETED|Period 2||0||
48372162|NCT01552928|101239916|FG000|STARTED|Period 3||14||
48372163|NCT01552928|101239917|FG001|STARTED|Period 3||15||
48372164|NCT01552928|101239918|FG002|STARTED|Period 3||15||
48372165|NCT01552928|101239919|FG003|STARTED|Period 3||16||
48372166|NCT01552928|101239916|FG000|COMPLETED|Period 3||14||
48672353|NCT01133847|101982617|FG002|STARTED|Active Treatment Phase (Weeks 1-16)||70||
48672354|NCT01133847|101982615|FG000|COMPLETED|Active Treatment Phase (Weeks 1-16)||73||
48672355|NCT01133847|101982616|FG001|COMPLETED|Active Treatment Phase (Weeks 1-16)||73||
48672356|NCT01133847|101982617|FG002|COMPLETED|Active Treatment Phase (Weeks 1-16)||67||
48672357|NCT01133847|101982615|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||5||
48672358|NCT01133847|101982616|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||1||
48672359|NCT01133847|101982617|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||3||
48672360|NCT01133847|101982615|FG000|STARTED|Follow-Up Phase||73||
48672361|NCT01133847|101982616|FG001|STARTED|Follow-Up Phase||73||
48672362|NCT01133847|101982617|FG002|STARTED|Follow-Up Phase||67||
48672363|NCT01133847|101982615|FG000|COMPLETED|Follow-Up Phase||72||
48672364|NCT01133847|101982616|FG001|COMPLETED|Follow-Up Phase||70||
48672365|NCT01133847|101982617|FG002|COMPLETED|Follow-Up Phase||60||
48672366|NCT01133847|101982615|FG000|NOT COMPLETED|Follow-Up Phase||1||
48672367|NCT01133847|101982616|FG001|NOT COMPLETED|Follow-Up Phase||3||
48672368|NCT01133847|101982617|FG002|NOT COMPLETED|Follow-Up Phase||7||
48672369|NCT00725985|101982618|FG000|STARTED|ITP- Treatment Disposition||205||
48672370|NCT00725985|101982619|FG001|STARTED|ITP- Treatment Disposition||206||
48672371|NCT00725985|101982620|FG002|STARTED|ITP- Treatment Disposition||206||
48672372|NCT00725985|101982621|FG003|STARTED|ITP- Treatment Disposition||0||
48672373|NCT00725985|101982622|FG004|STARTED|ITP- Treatment Disposition||0||
48672374|NCT00725985|101982623|FG005|STARTED|ITP- Treatment Disposition||0||
48672375|NCT00725985|101982624|FG006|STARTED|ITP- Treatment Disposition||0||
48672376|NCT00725985|101982625|FG007|STARTED|ITP- Treatment Disposition||0||
48672377|NCT00725985|101982626|FG008|STARTED|ITP- Treatment Disposition||0||
48672378|NCT00725985|101982627|FG009|STARTED|ITP- Treatment Disposition||0||
48672379|NCT00725985|101982628|FG010|STARTED|ITP- Treatment Disposition||0||
48672380|NCT00725985|101982629|FG011|STARTED|ITP- Treatment Disposition||0||
48672381|NCT00725985|101982618|FG000|Treated|ITP- Treatment Disposition||204||
48672382|NCT00725985|101982619|FG001|Treated|ITP- Treatment Disposition||206||
48672383|NCT00725985|101982620|FG002|Treated|ITP- Treatment Disposition||206||
48672384|NCT00725985|101982621|FG003|Treated|ITP- Treatment Disposition||0||
48672385|NCT00725985|101982622|FG004|Treated|ITP- Treatment Disposition||0||
48672386|NCT00725985|101982623|FG005|Treated|ITP- Treatment Disposition||0||
48672387|NCT00725985|101982624|FG006|Treated|ITP- Treatment Disposition||0||
48710638|NCT03777709|102077979|FG000|COMPLETED|Overall Study||34||8
48672388|NCT00725985|101982625|FG007|Treated|ITP- Treatment Disposition||0||
48672389|NCT00725985|101982626|FG008|Treated|ITP- Treatment Disposition||0||
48672390|NCT00725985|101982627|FG009|Treated|ITP- Treatment Disposition||0||
48672391|NCT00725985|101982628|FG010|Treated|ITP- Treatment Disposition||0||
48672392|NCT00725985|101982629|FG011|Treated|ITP- Treatment Disposition||0||
48672393|NCT00725985|101982618|FG000|COMPLETED|ITP- Treatment Disposition||104||
48672394|NCT00725985|101982619|FG001|COMPLETED|ITP- Treatment Disposition||131||
48672395|NCT00725985|101982620|FG002|COMPLETED|ITP- Treatment Disposition||104||
48672396|NCT00725985|101982621|FG003|COMPLETED|ITP- Treatment Disposition||0||
48672397|NCT00725985|101982622|FG004|COMPLETED|ITP- Treatment Disposition||0||
48672398|NCT00725985|101982623|FG005|COMPLETED|ITP- Treatment Disposition||0||
48672399|NCT00725985|101982624|FG006|COMPLETED|ITP- Treatment Disposition||0||
48672400|NCT00725985|101982625|FG007|COMPLETED|ITP- Treatment Disposition||0||
48672401|NCT00725985|101982626|FG008|COMPLETED|ITP- Treatment Disposition||0||
48672402|NCT00725985|101982627|FG009|COMPLETED|ITP- Treatment Disposition||0||
48672403|NCT00725985|101982628|FG010|COMPLETED|ITP- Treatment Disposition||0||
48672404|NCT00725985|101982629|FG011|COMPLETED|ITP- Treatment Disposition||0||
48672405|NCT00725985|101982618|FG000|NOT COMPLETED|ITP- Treatment Disposition||101||
48672406|NCT00725985|101982619|FG001|NOT COMPLETED|ITP- Treatment Disposition||75||
48672407|NCT00725985|101982620|FG002|NOT COMPLETED|ITP- Treatment Disposition||102||
48672408|NCT00725985|101982621|FG003|NOT COMPLETED|ITP- Treatment Disposition||0||
48672409|NCT00725985|101982622|FG004|NOT COMPLETED|ITP- Treatment Disposition||0||
48672410|NCT00725985|101982623|FG005|NOT COMPLETED|ITP- Treatment Disposition||0||
48672411|NCT00725985|101982624|FG006|NOT COMPLETED|ITP- Treatment Disposition||0||
48672412|NCT00725985|101982625|FG007|NOT COMPLETED|ITP- Treatment Disposition||0||
48672413|NCT00725985|101982626|FG008|NOT COMPLETED|ITP- Treatment Disposition||0||
48672414|NCT00725985|101982627|FG009|NOT COMPLETED|ITP- Treatment Disposition||0||
48672415|NCT00725985|101982628|FG010|NOT COMPLETED|ITP- Treatment Disposition||0||
48672416|NCT00725985|101982629|FG011|NOT COMPLETED|ITP- Treatment Disposition||0||
48672417|NCT00725985|101982618|FG000|STARTED|OLMP (Up to 96 Weeks)||0||
48672418|NCT00725985|101982619|FG001|STARTED|OLMP (Up to 96 Weeks)||0||
48672419|NCT00725985|101982620|FG002|STARTED|OLMP (Up to 96 Weeks)||0||
48672420|NCT00725985|101982621|FG003|STARTED|OLMP (Up to 96 Weeks)||24||
48672421|NCT00725985|101982622|FG004|STARTED|OLMP (Up to 96 Weeks)||25||
48672422|NCT00725985|101982623|FG005|STARTED|OLMP (Up to 96 Weeks)||60||
48672423|NCT00725985|101982624|FG006|STARTED|OLMP (Up to 96 Weeks)||0||
48672424|NCT00725985|101982625|FG007|STARTED|OLMP (Up to 96 Weeks)||0||
48672425|NCT00725985|101982626|FG008|STARTED|OLMP (Up to 96 Weeks)||0||
48672426|NCT00725985|101982627|FG009|STARTED|OLMP (Up to 96 Weeks)||0||
48672427|NCT00725985|101982628|FG010|STARTED|OLMP (Up to 96 Weeks)||0||
48672428|NCT00725985|101982629|FG011|STARTED|OLMP (Up to 96 Weeks)||0||
48672429|NCT00725985|101982618|FG000|COMPLETED|OLMP (Up to 96 Weeks)||0||
48672430|NCT00725985|101982619|FG001|COMPLETED|OLMP (Up to 96 Weeks)||0||
48672431|NCT00725985|101982620|FG002|COMPLETED|OLMP (Up to 96 Weeks)||0||
48672432|NCT00725985|101982621|FG003|COMPLETED|OLMP (Up to 96 Weeks)||6||
48672433|NCT00725985|101982622|FG004|COMPLETED|OLMP (Up to 96 Weeks)||2||
48672434|NCT00725985|101982623|FG005|COMPLETED|OLMP (Up to 96 Weeks)||7||
48672435|NCT00725985|101982624|FG006|COMPLETED|OLMP (Up to 96 Weeks)||0||
48672436|NCT00725985|101982625|FG007|COMPLETED|OLMP (Up to 96 Weeks)||0||
48672437|NCT00725985|101982626|FG008|COMPLETED|OLMP (Up to 96 Weeks)||0||
48672438|NCT00725985|101982627|FG009|COMPLETED|OLMP (Up to 96 Weeks)||0||
48672439|NCT00725985|101982628|FG010|COMPLETED|OLMP (Up to 96 Weeks)||0||
48672440|NCT00725985|101982629|FG011|COMPLETED|OLMP (Up to 96 Weeks)||0||
48672441|NCT00725985|101982618|FG000|NOT COMPLETED|OLMP (Up to 96 Weeks)||0||
48672442|NCT00725985|101982619|FG001|NOT COMPLETED|OLMP (Up to 96 Weeks)||0||
48672443|NCT00725985|101982620|FG002|NOT COMPLETED|OLMP (Up to 96 Weeks)||0||
48672444|NCT00725985|101982621|FG003|NOT COMPLETED|OLMP (Up to 96 Weeks)||18||
48672445|NCT00725985|101982622|FG004|NOT COMPLETED|OLMP (Up to 96 Weeks)||23||
48672446|NCT00725985|101982623|FG005|NOT COMPLETED|OLMP (Up to 96 Weeks)||53||
48672447|NCT00725985|101982624|FG006|NOT COMPLETED|OLMP (Up to 96 Weeks)||0||
48672448|NCT00725985|101982625|FG007|NOT COMPLETED|OLMP (Up to 96 Weeks)||0||
48672449|NCT00725985|101982626|FG008|NOT COMPLETED|OLMP (Up to 96 Weeks)||0||
48672450|NCT00725985|101982627|FG009|NOT COMPLETED|OLMP (Up to 96 Weeks)||0||
48672451|NCT00725985|101982628|FG010|NOT COMPLETED|OLMP (Up to 96 Weeks)||0||
48672452|NCT00725985|101982629|FG011|NOT COMPLETED|OLMP (Up to 96 Weeks)||0||
48672453|NCT00725985|101982618|FG000|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0||
48672454|NCT00725985|101982619|FG001|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0||
48672455|NCT00725985|101982620|FG002|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0||
48672456|NCT00725985|101982621|FG003|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0||
48672457|NCT00725985|101982622|FG004|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0||
48672458|NCT00725985|101982623|FG005|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0||
48672459|NCT00725985|101982624|FG006|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||9||
48672460|NCT00725985|101982625|FG007|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||9||
48672461|NCT00725985|101982626|FG008|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||17||
48672462|NCT00725985|101982627|FG009|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0||
48672463|NCT00725985|101982628|FG010|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0||
48672464|NCT00725985|101982629|FG011|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0||
48672465|NCT00725985|101982618|FG000|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
48672466|NCT00725985|101982619|FG001|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
48672467|NCT00725985|101982620|FG002|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
48672468|NCT00725985|101982621|FG003|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
48672469|NCT00725985|101982622|FG004|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
48672470|NCT00725985|101982623|FG005|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
48672471|NCT00725985|101982624|FG006|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
48672472|NCT00725985|101982625|FG007|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
48672473|NCT00725985|101982626|FG008|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
48672474|NCT00725985|101982627|FG009|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
48672475|NCT00725985|101982628|FG010|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
48672476|NCT00725985|101982629|FG011|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
48672477|NCT00725985|101982618|FG000|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
48672478|NCT00725985|101982619|FG001|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
48672479|NCT00725985|101982620|FG002|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
48672480|NCT00725985|101982621|FG003|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
48672481|NCT00725985|101982622|FG004|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
48672482|NCT00725985|101982623|FG005|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
48672483|NCT00725985|101982624|FG006|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||9||
48672484|NCT00725985|101982625|FG007|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||9||
48672485|NCT00725985|101982626|FG008|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||17||
48672486|NCT00725985|101982627|FG009|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
48672487|NCT00725985|101982628|FG010|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
48672488|NCT00725985|101982629|FG011|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
48672489|NCT00725985|101982618|FG000|STARTED|LTFU (No Cladribine) (48 Weeks)||0||
48672490|NCT00725985|101982619|FG001|STARTED|LTFU (No Cladribine) (48 Weeks)||0||
48672491|NCT00725985|101982620|FG002|STARTED|LTFU (No Cladribine) (48 Weeks)||0||
48672492|NCT00725985|101982621|FG003|STARTED|LTFU (No Cladribine) (48 Weeks)||0||
48672493|NCT00725985|101982622|FG004|STARTED|LTFU (No Cladribine) (48 Weeks)||0||
48672494|NCT00725985|101982623|FG005|STARTED|LTFU (No Cladribine) (48 Weeks)||0||
48672495|NCT00725985|101982624|FG006|STARTED|LTFU (No Cladribine) (48 Weeks)||0||
48672496|NCT00725985|101982625|FG007|STARTED|LTFU (No Cladribine) (48 Weeks)||0||
48672497|NCT00725985|101982626|FG008|STARTED|LTFU (No Cladribine) (48 Weeks)||0||
48672498|NCT00725985|101982627|FG009|STARTED|LTFU (No Cladribine) (48 Weeks)||34||
48672499|NCT00725985|101982628|FG010|STARTED|LTFU (No Cladribine) (48 Weeks)||36||
48672500|NCT00725985|101982629|FG011|STARTED|LTFU (No Cladribine) (48 Weeks)||14||
48672501|NCT00725985|101982618|FG000|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
48672502|NCT00725985|101982619|FG001|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
48672503|NCT00725985|101982620|FG002|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
48672504|NCT00725985|101982621|FG003|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
48672505|NCT00725985|101982622|FG004|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
48672506|NCT00725985|101982623|FG005|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
48672507|NCT00725985|101982624|FG006|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
48672508|NCT00725985|101982625|FG007|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
48672509|NCT00725985|101982626|FG008|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
48672510|NCT00725985|101982627|FG009|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
48672511|NCT00725985|101982628|FG010|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
48672512|NCT00725985|101982629|FG011|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
48672513|NCT00725985|101982618|FG000|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
48672514|NCT00725985|101982619|FG001|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
48672515|NCT00725985|101982620|FG002|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
48672516|NCT00725985|101982621|FG003|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
48672517|NCT00725985|101982622|FG004|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
48672518|NCT00725985|101982623|FG005|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
48672519|NCT00725985|101982624|FG006|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
48672520|NCT00725985|101982625|FG007|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
48672521|NCT00725985|101982626|FG008|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
48672522|NCT00725985|101982627|FG009|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||34||
48672523|NCT00725985|101982628|FG010|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||36||
48672524|NCT00725985|101982629|FG011|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||14||
48672525|NCT00543985|101982630|FG000|STARTED|Overall Study||36||
48672526|NCT00543985|101982630|FG000|COMPLETED|Overall Study||32||
48672527|NCT00543985|101982630|FG000|NOT COMPLETED|Overall Study||4||
48672528|NCT01994876|101982631|FG000|STARTED|Baseline - Own Product||9||
48672529|NCT01994876|101982632|FG001|STARTED|Baseline - Own Product||9||
48672530|NCT01994876|101982631|FG000|COMPLETED|Baseline - Own Product||9||
48672531|NCT01994876|101982632|FG001|COMPLETED|Baseline - Own Product||9||
48672532|NCT01994876|101982631|FG000|NOT COMPLETED|Baseline - Own Product||0||
48672533|NCT01994876|101982632|FG001|NOT COMPLETED|Baseline - Own Product||0||
48672534|NCT01994876|101982631|FG000|STARTED|Test Period 1||9||
48672535|NCT01994876|101982632|FG001|STARTED|Test Period 1||9||
48672536|NCT01994876|101982631|FG000|COMPLETED|Test Period 1||9||
48672537|NCT01994876|101982632|FG001|COMPLETED|Test Period 1||7||
48672538|NCT01994876|101982631|FG000|NOT COMPLETED|Test Period 1||0||
48672539|NCT01994876|101982632|FG001|NOT COMPLETED|Test Period 1||2||
48672540|NCT01994876|101982631|FG000|STARTED|Test Period 2||9||
48672541|NCT01994876|101982632|FG001|STARTED|Test Period 2||7||
48672542|NCT01994876|101982631|FG000|COMPLETED|Test Period 2||8||
48672543|NCT01994876|101982632|FG001|COMPLETED|Test Period 2||6||
48672544|NCT01994876|101982631|FG000|NOT COMPLETED|Test Period 2||1||
48073607|NCT02383498|100501072|FG000|STARTED|Overall Study||11||
48073608|NCT02383498|100501073|FG001|STARTED|Overall Study||13||
48073609|NCT02383498|100501072|FG000|COMPLETED|Overall Study||11||
48372167|NCT01552928|101239917|FG001|COMPLETED|Period 3||15||
48372168|NCT01552928|101239918|FG002|COMPLETED|Period 3||14||
48372169|NCT01552928|101239919|FG003|COMPLETED|Period 3||16||
48372170|NCT01552928|101239916|FG000|NOT COMPLETED|Period 3||0||
48372171|NCT01552928|101239917|FG001|NOT COMPLETED|Period 3||0||
48372172|NCT01552928|101239918|FG002|NOT COMPLETED|Period 3||1||
48372173|NCT01552928|101239919|FG003|NOT COMPLETED|Period 3||0||
48372174|NCT01552928|101239916|FG000|STARTED|Period 4||14||
48372175|NCT01552928|101239917|FG001|STARTED|Period 4||15||
48372176|NCT01552928|101239918|FG002|STARTED|Period 4||14||
48372177|NCT01552928|101239919|FG003|STARTED|Period 4||16||
48372178|NCT01552928|101239916|FG000|COMPLETED|Period 4||14||
48372179|NCT01552928|101239917|FG001|COMPLETED|Period 4||15||
48372180|NCT01552928|101239918|FG002|COMPLETED|Period 4||14||
48372181|NCT01552928|101239919|FG003|COMPLETED|Period 4||16||
48372182|NCT01552928|101239916|FG000|NOT COMPLETED|Period 4||0||
48372183|NCT01552928|101239917|FG001|NOT COMPLETED|Period 4||0||
48372184|NCT01552928|101239918|FG002|NOT COMPLETED|Period 4||0||
48372185|NCT01552928|101239919|FG003|NOT COMPLETED|Period 4||0||
48372186|NCT04286412|101239920|FG000|STARTED|Overall Study||25||
48372187|NCT04286412|101239920|FG000|COMPLETED|Overall Study||25||
48372188|NCT04286412|101239920|FG000|NOT COMPLETED|Overall Study||0||
48372189|NCT00771407|101239921|FG000|STARTED|Overall Study||60||
48372190|NCT00771407|101239922|FG001|STARTED|Overall Study||60||
48372191|NCT00771407|101239921|FG000|COMPLETED|Overall Study||40||
48372192|NCT00771407|101239922|FG001|COMPLETED|Overall Study||35||
48372193|NCT00771407|101239921|FG000|NOT COMPLETED|Overall Study||20||
48372194|NCT00771407|101239922|FG001|NOT COMPLETED|Overall Study||25||
48372195|NCT01701583|101239923|FG000|STARTED|Overall Study||7||
48372196|NCT01701583|101239924|FG001|STARTED|Overall Study||3||
48372197|NCT01701583|101239923|FG000|COMPLETED|Overall Study||5||
48372198|NCT01701583|101239924|FG001|COMPLETED|Overall Study||3||
48372199|NCT01701583|101239923|FG000|NOT COMPLETED|Overall Study||2||
48372200|NCT01701583|101239924|FG001|NOT COMPLETED|Overall Study||0||
48672545|NCT01994876|101982632|FG001|NOT COMPLETED|Test Period 2||1||
48372201|NCT02631135|101239925|FG000|STARTED|Overall Study||21||
48372202|NCT02631135|101239926|FG001|STARTED|Overall Study||20||
48372203|NCT02631135|101239925|FG000|COMPLETED|Overall Study||20||
48372204|NCT02631135|101239926|FG001|COMPLETED|Overall Study||20||
48372205|NCT02631135|101239925|FG000|NOT COMPLETED|Overall Study||1||
48372206|NCT02631135|101239926|FG001|NOT COMPLETED|Overall Study||0||
48372207|NCT00722553|101239927|FG000|STARTED|Overall Study||30||
48372208|NCT00722553|101239927|FG000|COMPLETED|Overall Study||30||
48372209|NCT00722553|101239927|FG000|NOT COMPLETED|Overall Study||0||
48372210|NCT02338076|101239928|FG000|STARTED|Overall Study||20||
48372211|NCT02338076|101239928|FG000|COMPLETED|Overall Study||20||
48372212|NCT02338076|101239928|FG000|NOT COMPLETED|Overall Study||0||
48372213|NCT05092971|101239929|FG000|STARTED|Overall Study||20||
48372214|NCT05092971|101239930|FG001|STARTED|Overall Study||31||
48372215|NCT05092971|101239929|FG000|COMPLETED|Overall Study||20||
48372216|NCT05092971|101239930|FG001|COMPLETED|Overall Study||31||
48372217|NCT05092971|101239929|FG000|NOT COMPLETED|Overall Study||0||
48372218|NCT05092971|101239930|FG001|NOT COMPLETED|Overall Study||0||
48372219|NCT01975272|101239931|FG000|STARTED|Overall Study||9||
48372220|NCT01975272|101239932|FG001|STARTED|Overall Study||10||
48372221|NCT01975272|101239933|FG002|STARTED|Overall Study||8||
48372222|NCT01975272|101239931|FG000|COMPLETED|Overall Study||8||
48372223|NCT01975272|101239932|FG001|COMPLETED|Overall Study||9||
48073610|NCT02383498|100501073|FG001|COMPLETED|Overall Study||13||
48372224|NCT01975272|101239933|FG002|COMPLETED|Overall Study||6||
48073611|NCT02383498|100501072|FG000|NOT COMPLETED|Overall Study||0||
48073612|NCT02383498|100501073|FG001|NOT COMPLETED|Overall Study||0||
48073613|NCT01976338|100504287|FG000|STARTED|Overall Study||190||
48073614|NCT01976338|100504288|FG001|STARTED|Overall Study||93||
48073615|NCT01976338|100504287|FG000|Completed 6 Months|Overall Study||185||
48073616|NCT01976338|100504288|FG001|Completed 6 Months|Overall Study||91||
48073617|NCT01976338|100504287|FG000|Discontinued Study Prior to 6 Months|Overall Study||5||
48073618|NCT01976338|100504288|FG001|Discontinued Study Prior to 6 Months|Overall Study||2||
48073619|NCT01976338|100504287|FG000|COMPLETED|Overall Study||177||
48073620|NCT01976338|100504288|FG001|COMPLETED|Overall Study||89||
48073621|NCT01976338|100504287|FG000|NOT COMPLETED|Overall Study||13||
48073622|NCT01976338|100504288|FG001|NOT COMPLETED|Overall Study||4||
48073623|NCT01667029|100504289|FG000|STARTED|Overall Study||4||
48073624|NCT01667029|100504290|FG001|STARTED|Overall Study||4||
48073625|NCT01667029|100504289|FG000|COMPLETED|Overall Study||3||
48073626|NCT01667029|100504290|FG001|COMPLETED|Overall Study||3||
48073627|NCT01667029|100504289|FG000|NOT COMPLETED|Overall Study||1||
48073628|NCT01667029|100504290|FG001|NOT COMPLETED|Overall Study||1||
48073629|NCT01091974|100504291|FG000|STARTED|Overall Study||24||
48073630|NCT01091974|100504292|FG001|STARTED|Overall Study||23||
48073631|NCT01091974|100504293|FG002|STARTED|Overall Study||25||
48073632|NCT01091974|100504294|FG003|STARTED|Overall Study||24||
48073633|NCT01091974|100504291|FG000|COMPLETED|Overall Study||19||
48073634|NCT01091974|100504292|FG001|COMPLETED|Overall Study||18||
48073635|NCT01091974|100504293|FG002|COMPLETED|Overall Study||19||
48073636|NCT01091974|100504294|FG003|COMPLETED|Overall Study||17||
48073637|NCT01091974|100504291|FG000|NOT COMPLETED|Overall Study||5||
48073638|NCT01091974|100504292|FG001|NOT COMPLETED|Overall Study||5||
48073639|NCT01091974|100504293|FG002|NOT COMPLETED|Overall Study||6||
48073640|NCT01091974|100504294|FG003|NOT COMPLETED|Overall Study||7||
48073641|NCT01921387|100504295|FG000|STARTED|Overall Study||20||
48073642|NCT01921387|100504295|FG000|COMPLETED|Overall Study||19||
48073643|NCT01921387|100504295|FG000|NOT COMPLETED|Overall Study||1||
48073644|NCT01471171|100504296|FG000|STARTED|Treatment Period 1||57||
48073645|NCT01471171|100504297|FG001|STARTED|Treatment Period 1||55||
48073646|NCT01471171|100504296|FG000|COMPLETED|Treatment Period 1||53||
48073647|NCT01471171|100504297|FG001|COMPLETED|Treatment Period 1||54||
48073648|NCT01471171|100504296|FG000|NOT COMPLETED|Treatment Period 1||4||
48073649|NCT01471171|100504297|FG001|NOT COMPLETED|Treatment Period 1||1||
48073650|NCT01471171|100504296|FG000|STARTED|Treatment Period 2||53||
48073651|NCT01471171|100504297|FG001|STARTED|Treatment Period 2||54||
48073652|NCT01471171|100504296|FG000|COMPLETED|Treatment Period 2||52||
48073653|NCT01471171|100504297|FG001|COMPLETED|Treatment Period 2||54||
48073654|NCT01471171|100504296|FG000|NOT COMPLETED|Treatment Period 2||1||
48073655|NCT01471171|100504297|FG001|NOT COMPLETED|Treatment Period 2||0||
48073656|NCT01218113|100504298|FG000|STARTED|Overall Study||62||
48073657|NCT01218113|100504299|FG001|STARTED|Overall Study||64||
48073658|NCT01218113|100504300|FG002|STARTED|Overall Study||64||
48073659|NCT01218113|100504298|FG000|COMPLETED|Overall Study||57||
48073660|NCT01218113|100504299|FG001|COMPLETED|Overall Study||63||
48073661|NCT01218113|100504300|FG002|COMPLETED|Overall Study||58||
48073662|NCT01218113|100504298|FG000|NOT COMPLETED|Overall Study||5||
48073663|NCT01218113|100504299|FG001|NOT COMPLETED|Overall Study||1||
48073664|NCT01218113|100504300|FG002|NOT COMPLETED|Overall Study||6||
48073665|NCT03302234|100504301|FG000|STARTED|Overall Study||284||
48073666|NCT03302234|100504302|FG001|STARTED|Overall Study||284||
48073667|NCT03302234|100504301|FG000|COMPLETED|Overall Study||0||
48073668|NCT03302234|100504302|FG001|COMPLETED|Overall Study||0||
48073669|NCT03302234|100504301|FG000|NOT COMPLETED|Overall Study||284||
48073670|NCT03302234|100504302|FG001|NOT COMPLETED|Overall Study||284||
48073671|NCT02579239|100504303|FG000|STARTED|Overall Study||4||
48073672|NCT02579239|100504304|FG001|STARTED|Overall Study||14||
48073673|NCT02579239|100504303|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4||
48073674|NCT02579239|100504304|FG001|Received at Least 1 Dose of Study Drug|Overall Study||14||
48073675|NCT02579239|100504303|FG000|COMPLETED|Overall Study||4||
48073676|NCT02579239|100504304|FG001|COMPLETED|Overall Study||14||
48073677|NCT02579239|100504303|FG000|NOT COMPLETED|Overall Study||0||
48073678|NCT02579239|100504304|FG001|NOT COMPLETED|Overall Study||0||
48073679|NCT03834441|100504305|FG000|STARTED|Allocation||115||
48073680|NCT03834441|100504306|FG001|STARTED|Allocation||121||
48073681|NCT03834441|100504305|FG000|COMPLETED|Allocation||112||
48073682|NCT03834441|100504306|FG001|COMPLETED|Allocation||116||
48073683|NCT03834441|100504305|FG000|NOT COMPLETED|Allocation||3||
48073684|NCT03834441|100504306|FG001|NOT COMPLETED|Allocation||5||
48073685|NCT03834441|100504305|FG000|STARTED|Analysis||112||
48073686|NCT03834441|100504306|FG001|STARTED|Analysis||116||
48073687|NCT03834441|100504305|FG000|COMPLETED|Analysis||105||
48073688|NCT03834441|100504306|FG001|COMPLETED|Analysis||109||
48073689|NCT03834441|100504305|FG000|NOT COMPLETED|Analysis||7||
48073690|NCT03834441|100504306|FG001|NOT COMPLETED|Analysis||7||
48073691|NCT01086033|100504307|FG000|STARTED|Overall Study||566||
48073692|NCT01086033|100504307|FG000|COMPLETED|Overall Study||262||
48073693|NCT01086033|100504307|FG000|NOT COMPLETED|Overall Study||304||
48073694|NCT02218320|100504308|FG000|STARTED|Overall Study||10||
48073695|NCT02218320|100504309|FG001|STARTED|Overall Study||10||
48073696|NCT02218320|100504308|FG000|COMPLETED|Overall Study||10||
48073697|NCT02218320|100504309|FG001|COMPLETED|Overall Study||10||
48073698|NCT02218320|100504308|FG000|NOT COMPLETED|Overall Study||0||
48073699|NCT02218320|100504309|FG001|NOT COMPLETED|Overall Study||0||
48073700|NCT02915016|100504310|FG000|STARTED|Overall Study||30||
48073701|NCT02915016|100504311|FG001|STARTED|Overall Study||50||
48073702|NCT02915016|100504312|FG002|STARTED|Overall Study||50||
48073703|NCT02915016|100504313|FG003|STARTED|Overall Study||30||
48073704|NCT02915016|100504314|FG004|STARTED|Overall Study||50||
48073705|NCT02915016|100504315|FG005|STARTED|Overall Study||50||
48073706|NCT02915016|100504316|FG006|STARTED|Overall Study||50||
48073707|NCT02915016|100504317|FG007|STARTED|Overall Study||24||
48073708|NCT02915016|100504310|FG000|Month 6.5 Immunogenicity Timepoint|Overall Study||23|HIV uninfected at Month 6.5 and specimen available for assays|
48073709|NCT02915016|100504311|FG001|Month 6.5 Immunogenicity Timepoint|Overall Study||49|HIV uninfected at Month 6.5 and specimen available for assays|
48073710|NCT02915016|100504312|FG002|Month 6.5 Immunogenicity Timepoint|Overall Study||46|HIV uninfected at Month 6.5 and specimen available for assays|
48073711|NCT02915016|100504313|FG003|Month 6.5 Immunogenicity Timepoint|Overall Study||26|HIV uninfected at Month 6.5 and specimen available for assays|
48073712|NCT02915016|100504314|FG004|Month 6.5 Immunogenicity Timepoint|Overall Study||43|HIV uninfected at Month 6.5 and specimen available for assays|
48073713|NCT02915016|100504315|FG005|Month 6.5 Immunogenicity Timepoint|Overall Study||42|HIV uninfected at Month 6.5 and specimen available for assays|
48073714|NCT02915016|100504316|FG006|Month 6.5 Immunogenicity Timepoint|Overall Study||42|HIV uninfected at Month 6.5 and specimen available for assays|
48073715|NCT02915016|100504317|FG007|Month 6.5 Immunogenicity Timepoint|Overall Study||21|HIV uninfected at Month 6.5 and specimen available for assays|
48073716|NCT02915016|100504310|FG000|COMPLETED|Overall Study||23||
48073717|NCT02915016|100504311|FG001|COMPLETED|Overall Study||47||
48073718|NCT02915016|100504312|FG002|COMPLETED|Overall Study||42||
48073719|NCT02915016|100504313|FG003|COMPLETED|Overall Study||26||
48073720|NCT02915016|100504314|FG004|COMPLETED|Overall Study||43||
48073721|NCT02915016|100504315|FG005|COMPLETED|Overall Study||44||
48073722|NCT02915016|100504316|FG006|COMPLETED|Overall Study||38||
48073723|NCT02915016|100504317|FG007|COMPLETED|Overall Study||20||
48073724|NCT02915016|100504310|FG000|NOT COMPLETED|Overall Study||7||
48073725|NCT02915016|100504311|FG001|NOT COMPLETED|Overall Study||3||
48073726|NCT02915016|100504312|FG002|NOT COMPLETED|Overall Study||8||
48073727|NCT02915016|100504313|FG003|NOT COMPLETED|Overall Study||4||
48073728|NCT02915016|100504314|FG004|NOT COMPLETED|Overall Study||7||
48073729|NCT02915016|100504315|FG005|NOT COMPLETED|Overall Study||6||
48073730|NCT02915016|100504316|FG006|NOT COMPLETED|Overall Study||12||
48073731|NCT02915016|100504317|FG007|NOT COMPLETED|Overall Study||4||
48073732|NCT04159571|100504318|FG000|STARTED|Overall Study||26||
48073733|NCT04159571|100504319|FG001|STARTED|Overall Study||14||
48073734|NCT04159571|100504318|FG000|COMPLETED|Overall Study||15||
48073735|NCT04159571|100504319|FG001|COMPLETED|Overall Study||8||
48073736|NCT04159571|100504318|FG000|NOT COMPLETED|Overall Study||11||
48073737|NCT04159571|100504319|FG001|NOT COMPLETED|Overall Study||6||
48073738|NCT00799383|100504320|FG000|STARTED|Overall Study||23||
48073739|NCT00799383|100504321|FG001|STARTED|Overall Study||24||
48073740|NCT00799383|100504320|FG000|COMPLETED|Overall Study||20||
48073741|NCT00799383|100504321|FG001|COMPLETED|Overall Study||18||
48073742|NCT00799383|100504320|FG000|NOT COMPLETED|Overall Study||3||
48073743|NCT00799383|100504321|FG001|NOT COMPLETED|Overall Study||6||
48073744|NCT00334958|100504322|FG000|STARTED|Overall Study||176||
48073745|NCT00334958|100504323|FG001|STARTED|Overall Study||180||
48073746|NCT00334958|100504322|FG000|COMPLETED|Overall Study||139||
48073747|NCT00334958|100504323|FG001|COMPLETED|Overall Study||156||
48073748|NCT00334958|100504322|FG000|NOT COMPLETED|Overall Study||37||
48073749|NCT00334958|100504323|FG001|NOT COMPLETED|Overall Study||24||
48073750|NCT00674362|100504324|FG000|STARTED|Double Blind||96||
48073751|NCT00674362|100504325|FG001|STARTED|Double Blind||98||
48073752|NCT00674362|100504324|FG000|COMPLETED|Double Blind||84||
48073753|NCT00674362|100504325|FG001|COMPLETED|Double Blind||80||
48073754|NCT00674362|100504324|FG000|NOT COMPLETED|Double Blind||12||
48073755|NCT00674362|100504325|FG001|NOT COMPLETED|Double Blind||18||
48073756|NCT00674362|100504324|FG000|STARTED|Open Label||20||
48073757|NCT00674362|100504325|FG001|STARTED|Open Label||7||
48073758|NCT00674362|100504324|FG000|COMPLETED|Open Label||18||
48073759|NCT00674362|100504325|FG001|COMPLETED|Open Label||7||
48073760|NCT00674362|100504324|FG000|NOT COMPLETED|Open Label||2||
48073761|NCT00674362|100504325|FG001|NOT COMPLETED|Open Label||0||
48073762|NCT04401423|100504326|FG000|STARTED|Overall Study||11||
48073763|NCT04401423|100504327|FG001|STARTED|Overall Study||11||
48073764|NCT04401423|100504326|FG000|COMPLETED|Overall Study||6||
48073765|NCT04401423|100504327|FG001|COMPLETED|Overall Study||9||
48073766|NCT04401423|100504326|FG000|NOT COMPLETED|Overall Study||5||
48073767|NCT04401423|100504327|FG001|NOT COMPLETED|Overall Study||2||
48073768|NCT03758066|100504328|FG000|STARTED|Overall Study||65||
48073769|NCT03758066|100504328|FG000|COMPLETED|Overall Study||51||
48073770|NCT03758066|100504328|FG000|NOT COMPLETED|Overall Study||14||
48073771|NCT02027883|100504329|FG000|STARTED|Overall Study||50||
48073772|NCT02027883|100504330|FG001|STARTED|Overall Study||50||
48073773|NCT02027883|100504329|FG000|COMPLETED|Overall Study||50||
48073774|NCT02027883|100504330|FG001|COMPLETED|Overall Study||50||
48073775|NCT02027883|100504329|FG000|NOT COMPLETED|Overall Study||0||
48073776|NCT02027883|100504330|FG001|NOT COMPLETED|Overall Study||0||
48073777|NCT00816595|100504331|FG000|STARTED|Overall Study||35||
48073778|NCT00816595|100504332|FG001|STARTED|Overall Study||33||
48073779|NCT00816595|100504331|FG000|COMPLETED|Overall Study||33||
48073780|NCT00816595|100504332|FG001|COMPLETED|Overall Study||33||
48073781|NCT00816595|100504331|FG000|NOT COMPLETED|Overall Study||2||
48073782|NCT00816595|100504332|FG001|NOT COMPLETED|Overall Study||0||
48073783|NCT01960400|100504333|FG000|STARTED|Overall Study||11||
48073784|NCT01960400|100504334|FG001|STARTED|Overall Study||11||
48073785|NCT01960400|100504333|FG000|COMPLETED|Overall Study||11||
48073786|NCT01960400|100504334|FG001|COMPLETED|Overall Study||11||
48073787|NCT01960400|100504333|FG000|NOT COMPLETED|Overall Study||0||
48073788|NCT01960400|100504334|FG001|NOT COMPLETED|Overall Study||0||
48073789|NCT01529502|100504335|FG000|STARTED|Overall Study||2||
48073790|NCT01529502|100504336|FG001|STARTED|Overall Study||3||
48073791|NCT01529502|100504337|FG002|STARTED|Overall Study||2||
48073792|NCT01529502|100504338|FG003|STARTED|Overall Study||3||
48073793|NCT01529502|100504339|FG004|STARTED|Overall Study||2||
48073794|NCT01529502|100504340|FG005|STARTED|Overall Study||2||
48073795|NCT01529502|100504335|FG000|COMPLETED|Overall Study||2||
48073796|NCT01529502|100504336|FG001|COMPLETED|Overall Study||3||
48073797|NCT01529502|100504337|FG002|COMPLETED|Overall Study||2||
48073798|NCT01529502|100504338|FG003|COMPLETED|Overall Study||1||
48073799|NCT01529502|100504339|FG004|COMPLETED|Overall Study||2||
48073800|NCT01529502|100504340|FG005|COMPLETED|Overall Study||2||
48073801|NCT01529502|100504335|FG000|NOT COMPLETED|Overall Study||0||
48073802|NCT01529502|100504336|FG001|NOT COMPLETED|Overall Study||0||
48073803|NCT01529502|100504337|FG002|NOT COMPLETED|Overall Study||0||
48073804|NCT01529502|100504338|FG003|NOT COMPLETED|Overall Study||2||
48073805|NCT01529502|100504339|FG004|NOT COMPLETED|Overall Study||0||
48073806|NCT01529502|100504340|FG005|NOT COMPLETED|Overall Study||0||
48073807|NCT03159624|100504341|FG000|STARTED|Overall Study||21||
48073808|NCT03159624|100504342|FG001|STARTED|Overall Study||26||
48073809|NCT03159624|100504341|FG000|COMPLETED|Overall Study||21||
48073810|NCT03159624|100504342|FG001|COMPLETED|Overall Study||25||
48073811|NCT03159624|100504341|FG000|NOT COMPLETED|Overall Study||0||
48073812|NCT03159624|100504342|FG001|NOT COMPLETED|Overall Study||1||
48073813|NCT00544830|100504343|FG000|STARTED|Overall Study||29||
48073814|NCT00544830|100504343|FG000|COMPLETED|Overall Study||29||
48073815|NCT00544830|100504343|FG000|NOT COMPLETED|Overall Study||0||
48073816|NCT02639065|100504344|FG000|STARTED|Study Treatment||39||
48073817|NCT02639065|100504344|FG000|COMPLETED|Study Treatment||16||
48073818|NCT02639065|100504344|FG000|NOT COMPLETED|Study Treatment||23||
48073819|NCT02639065|100504344|FG000|STARTED|Follow up||39||
48073820|NCT02639065|100504344|FG000|COMPLETED|Follow up||30||
48073821|NCT02639065|100504344|FG000|NOT COMPLETED|Follow up||9||
48073822|NCT00945893|100504345|FG000|STARTED|Overall Study||60||
48073823|NCT00945893|100504346|FG001|STARTED|Overall Study||240||
48073824|NCT00945893|100504345|FG000|Day 15 Post Dose 1|Overall Study||60||
48073825|NCT00945893|100504346|FG001|Day 15 Post Dose 1|Overall Study||238||
48073826|NCT00945893|100504345|FG000|Day 15 Post Dose 2|Overall Study||54||
48073827|NCT00945893|100504346|FG001|Day 15 Post Dose 2|Overall Study||226||
48073828|NCT00945893|100504345|FG000|COMPLETED|Overall Study||57||
48073829|NCT00945893|100504346|FG001|COMPLETED|Overall Study||230||
48073830|NCT00945893|100504345|FG000|NOT COMPLETED|Overall Study||3||
48073831|NCT00945893|100504346|FG001|NOT COMPLETED|Overall Study||10||
48073832|NCT00385762|100504347|FG000|STARTED|Overall Study||35||
48073833|NCT00385762|100504347|FG000|COMPLETED|Overall Study||33||
48073834|NCT00385762|100504347|FG000|NOT COMPLETED|Overall Study||2||
48073835|NCT02202980|100504348|FG000|STARTED|Overall Study||14||
48073836|NCT02202980|100504349|FG001|STARTED|Overall Study||26||
48073837|NCT02202980|100504350|FG002|STARTED|Overall Study||27||
48073838|NCT02202980|100504351|FG003|STARTED|Overall Study||32||
48073839|NCT02202980|100504352|FG004|STARTED|Overall Study||13||
48073840|NCT02202980|100504353|FG005|STARTED|Overall Study||15||
48073841|NCT02202980|100504354|FG006|STARTED|Overall Study||15||
48073842|NCT02202980|100504355|FG007|STARTED|Overall Study||15||
48073843|NCT02202980|100504356|FG008|STARTED|Overall Study||18||
48073844|NCT02202980|100504357|FG009|STARTED|Overall Study||17||
48073845|NCT02202980|100504358|FG010|STARTED|Overall Study||19||
48073846|NCT02202980|100504359|FG011|STARTED|Overall Study||28||
48372225|NCT01975272|101239931|FG000|NOT COMPLETED|Overall Study||1||
48073847|NCT02202980|100504360|FG012|STARTED|Overall Study||30||
48073848|NCT02202980|100504361|FG013|STARTED|Overall Study||4||
48073849|NCT02202980|100504348|FG000|COMPLETED|Overall Study||13||
48073850|NCT02202980|100504349|FG001|COMPLETED|Overall Study||24||
48073851|NCT02202980|100504350|FG002|COMPLETED|Overall Study||17||
48073852|NCT02202980|100504351|FG003|COMPLETED|Overall Study||28||
48073853|NCT02202980|100504352|FG004|COMPLETED|Overall Study||7||
48073854|NCT02202980|100504353|FG005|COMPLETED|Overall Study||14||
48073855|NCT02202980|100504354|FG006|COMPLETED|Overall Study||4||
48073856|NCT02202980|100504355|FG007|COMPLETED|Overall Study||12||
48073857|NCT02202980|100504356|FG008|COMPLETED|Overall Study||14||
48073858|NCT02202980|100504357|FG009|COMPLETED|Overall Study||17||
48073859|NCT02202980|100504358|FG010|COMPLETED|Overall Study||19||
48073860|NCT02202980|100504359|FG011|COMPLETED|Overall Study||25||
48073861|NCT02202980|100504360|FG012|COMPLETED|Overall Study||19||
48073862|NCT02202980|100504361|FG013|COMPLETED|Overall Study||4||
48073863|NCT02202980|100504348|FG000|NOT COMPLETED|Overall Study||1||
48073864|NCT02202980|100504349|FG001|NOT COMPLETED|Overall Study||2||
48073865|NCT02202980|100504350|FG002|NOT COMPLETED|Overall Study||10||
48073866|NCT02202980|100504351|FG003|NOT COMPLETED|Overall Study||4||
48073867|NCT02202980|100504352|FG004|NOT COMPLETED|Overall Study||6||
48073868|NCT02202980|100504353|FG005|NOT COMPLETED|Overall Study||1||
48073869|NCT02202980|100504354|FG006|NOT COMPLETED|Overall Study||11||
48073870|NCT02202980|100504355|FG007|NOT COMPLETED|Overall Study||3||
48073871|NCT02202980|100504356|FG008|NOT COMPLETED|Overall Study||4||
48372226|NCT01975272|101239932|FG001|NOT COMPLETED|Overall Study||1||
48073872|NCT02202980|100504357|FG009|NOT COMPLETED|Overall Study||0||
48073873|NCT02202980|100504358|FG010|NOT COMPLETED|Overall Study||0||
48073874|NCT02202980|100504359|FG011|NOT COMPLETED|Overall Study||3||
48073875|NCT02202980|100504360|FG012|NOT COMPLETED|Overall Study||11||
48073876|NCT02202980|100504361|FG013|NOT COMPLETED|Overall Study||0||
48073877|NCT01926015|100504362|FG000|STARTED|Overall Study||96||
48073878|NCT01926015|100504363|FG001|STARTED|Overall Study||96||
48073879|NCT01926015|100504362|FG000|Received >=1 Vaccination|Overall Study||94||
48073880|NCT01926015|100504363|FG001|Received >=1 Vaccination|Overall Study||96||
48073881|NCT01926015|100504362|FG000|COMPLETED|Overall Study||94||
48073882|NCT01926015|100504363|FG001|COMPLETED|Overall Study||95||
48073883|NCT01926015|100504362|FG000|NOT COMPLETED|Overall Study||2||
48073884|NCT01926015|100504363|FG001|NOT COMPLETED|Overall Study||1||
48073885|NCT03569618|100504364|FG000|STARTED|Overall Study||23||
48073886|NCT03569618|100504365|FG001|STARTED|Overall Study||21||
48073887|NCT03569618|100504364|FG000|COMPLETED|Overall Study||20||
48073888|NCT03569618|100504365|FG001|COMPLETED|Overall Study||20||
48073889|NCT03569618|100504364|FG000|NOT COMPLETED|Overall Study||3||
48073890|NCT03569618|100504365|FG001|NOT COMPLETED|Overall Study||1||
48073891|NCT01216748|100504366|FG000|STARTED|Overall Study||10||
48073892|NCT01216748|100504366|FG000|Quiet Breathing|Overall Study||10||
48073893|NCT01216748|100504366|FG000|Hypocapnic Hyperventilation|Overall Study||10||
48073894|NCT01216748|100504366|FG000|Hypercapnic Hyperventilation|Overall Study||10||
48073895|NCT01216748|100504366|FG000|Eucapnic Hyperventilation|Overall Study||10||
48073896|NCT01216748|100504366|FG000|COMPLETED|Overall Study||10||
48073897|NCT01216748|100504366|FG000|NOT COMPLETED|Overall Study||0||
48073898|NCT04138810|100504367|FG000|STARTED|Overall Study||27||
48073899|NCT04138810|100504368|FG001|STARTED|Overall Study||27||
48073900|NCT04138810|100504367|FG000|COMPLETED|Overall Study||26||
48073901|NCT04138810|100504368|FG001|COMPLETED|Overall Study||26||
48073902|NCT04138810|100504367|FG000|NOT COMPLETED|Overall Study||1||
48073903|NCT04138810|100504368|FG001|NOT COMPLETED|Overall Study||1||
48073904|NCT05229406|100504369|FG000|STARTED|Overall Study||46||
48073905|NCT05229406|100504370|FG001|STARTED|Overall Study||46||
48073906|NCT05229406|100504369|FG000|COMPLETED|Overall Study||45||
48073907|NCT05229406|100504370|FG001|COMPLETED|Overall Study||44||
48073908|NCT05229406|100504369|FG000|NOT COMPLETED|Overall Study||1||
48073909|NCT05229406|100504370|FG001|NOT COMPLETED|Overall Study||2||
48073910|NCT02767843|100504371|FG000|STARTED|Overall Study||4||
48372227|NCT01975272|101239933|FG002|NOT COMPLETED|Overall Study||2||
48521845|NCT00952276|101611703|FG002|NOT COMPLETED|Overall Study||0||
48073911|NCT02767843|100504371|FG000|COMPLETED|Overall Study||4||
48073912|NCT02767843|100504371|FG000|NOT COMPLETED|Overall Study||0||
48073913|NCT00903396|100504372|FG000|STARTED|Overall Study||2||
48073914|NCT00903396|100504373|FG001|STARTED|Overall Study||1||
48073915|NCT00903396|100504374|FG002|STARTED|Overall Study||3||
48073916|NCT00903396|100504375|FG003|STARTED|Overall Study||1||
48073917|NCT00903396|100504372|FG000|COMPLETED|Overall Study||2||
48073918|NCT00903396|100504373|FG001|COMPLETED|Overall Study||1||
48073919|NCT00903396|100504374|FG002|COMPLETED|Overall Study||3||
48073920|NCT00903396|100504375|FG003|COMPLETED|Overall Study||1||
48073921|NCT00903396|100504372|FG000|NOT COMPLETED|Overall Study||0||
48073922|NCT00903396|100504373|FG001|NOT COMPLETED|Overall Study||0||
48073923|NCT00903396|100504374|FG002|NOT COMPLETED|Overall Study||0||
48073924|NCT00903396|100504375|FG003|NOT COMPLETED|Overall Study||0||
48073925|NCT00923156|100504376|FG000|STARTED|Overall Study||40||
48073926|NCT00923156|100504377|FG001|STARTED|Overall Study||42||
48073927|NCT00923156|100504378|FG002|STARTED|Overall Study||41||
48073928|NCT00923156|100504376|FG000|COMPLETED|Overall Study||40||
48073929|NCT00923156|100504377|FG001|COMPLETED|Overall Study||38||
48073930|NCT00923156|100504378|FG002|COMPLETED|Overall Study||38||
48073931|NCT00923156|100504376|FG000|NOT COMPLETED|Overall Study||0||
48073932|NCT00923156|100504377|FG001|NOT COMPLETED|Overall Study||4||
48073933|NCT00923156|100504378|FG002|NOT COMPLETED|Overall Study||3||
48073934|NCT01970397|100504379|FG000|STARTED|Overall Study||69||
48073935|NCT01970397|100504380|FG001|STARTED|Overall Study||69||
48073936|NCT01970397|100504379|FG000|COMPLETED|Overall Study||67||
48073937|NCT01970397|100504380|FG001|COMPLETED|Overall Study||64||
48372228|NCT01987986|101239934|FG000|STARTED|Overall Study||43||
48372229|NCT01987986|101239935|FG001|STARTED|Overall Study||43||
48073938|NCT01970397|100504379|FG000|NOT COMPLETED|Overall Study||2||
48073939|NCT01970397|100504380|FG001|NOT COMPLETED|Overall Study||5||
48073940|NCT00221403|100504381|FG000|STARTED|Overall Study||18||
48073941|NCT00221403|100504382|FG001|STARTED|Overall Study||21||
48073942|NCT00221403|100504383|FG002|STARTED|Overall Study||7||
48073943|NCT00221403|100504381|FG000|COMPLETED|Overall Study||16||
48073944|NCT00221403|100504382|FG001|COMPLETED|Overall Study||16||
48073945|NCT00221403|100504383|FG002|COMPLETED|Overall Study||7||
48073946|NCT00221403|100504381|FG000|NOT COMPLETED|Overall Study||2||
48073947|NCT00221403|100504382|FG001|NOT COMPLETED|Overall Study||5||
48073948|NCT00221403|100504383|FG002|NOT COMPLETED|Overall Study||0||
48073949|NCT02590003|100504384|FG000|STARTED|Overall Study||1||
48073950|NCT02590003|100504385|FG001|STARTED|Overall Study||2||
48073951|NCT02590003|100504384|FG000|COMPLETED|Overall Study||0||
48073952|NCT02590003|100504385|FG001|COMPLETED|Overall Study||0||
48073953|NCT02590003|100504384|FG000|NOT COMPLETED|Overall Study||1||
48073954|NCT02590003|100504385|FG001|NOT COMPLETED|Overall Study||2||
48073955|NCT01180985|100504386|FG000|STARTED|Period 1 (7 +/- Days)||27||
48372230|NCT01987986|101239936|FG002|STARTED|Overall Study||40||
48073956|NCT01180985|100504387|FG001|STARTED|Period 1 (7 +/- Days)||26||
48073957|NCT01180985|100504386|FG000|COMPLETED|Period 1 (7 +/- Days)||27||
48073958|NCT01180985|100504387|FG001|COMPLETED|Period 1 (7 +/- Days)||26||
48073959|NCT01180985|100504386|FG000|NOT COMPLETED|Period 1 (7 +/- Days)||0||
48073960|NCT01180985|100504387|FG001|NOT COMPLETED|Period 1 (7 +/- Days)||0||
48073961|NCT01180985|100504386|FG000|STARTED|Period 2 (7 +/- 1 Days)||27||
48073962|NCT01180985|100504387|FG001|STARTED|Period 2 (7 +/- 1 Days)||26||
48073963|NCT01180985|100504386|FG000|COMPLETED|Period 2 (7 +/- 1 Days)||26||
48073964|NCT01180985|100504387|FG001|COMPLETED|Period 2 (7 +/- 1 Days)||26||
48073965|NCT01180985|100504386|FG000|NOT COMPLETED|Period 2 (7 +/- 1 Days)||1||
48073966|NCT01180985|100504387|FG001|NOT COMPLETED|Period 2 (7 +/- 1 Days)||0||
48073967|NCT02349061|100504388|FG000|STARTED|Main Study: PCP (Up to Week 24)||42||
48073968|NCT02349061|100504389|FG001|STARTED|Main Study: PCP (Up to Week 24)||60||
48073969|NCT02349061|100504390|FG002|STARTED|Main Study: PCP (Up to Week 24)||0||
48073970|NCT02349061|100504388|FG000|COMPLETED|Main Study: PCP (Up to Week 24)||33||
48073971|NCT02349061|100504389|FG001|COMPLETED|Main Study: PCP (Up to Week 24)||56||
48073972|NCT02349061|100504390|FG002|COMPLETED|Main Study: PCP (Up to Week 24)||0||
48073973|NCT02349061|100504388|FG000|NOT COMPLETED|Main Study: PCP (Up to Week 24)||9||
48073974|NCT02349061|100504389|FG001|NOT COMPLETED|Main Study: PCP (Up to Week 24)||4||
48073975|NCT02349061|100504390|FG002|NOT COMPLETED|Main Study: PCP (Up to Week 24)||0||
48073976|NCT02349061|100504388|FG000|STARTED|Main Study: Week 24 to 56||0||
48073977|NCT02349061|100504389|FG001|STARTED|Main Study: Week 24 to 56||56||
48073978|NCT02349061|100504390|FG002|STARTED|Main Study: Week 24 to 56||33||
48073979|NCT02349061|100504388|FG000|COMPLETED|Main Study: Week 24 to 56||0||
48073980|NCT02349061|100504389|FG001|COMPLETED|Main Study: Week 24 to 56||53||
48073981|NCT02349061|100504390|FG002|COMPLETED|Main Study: Week 24 to 56||30||
48073982|NCT02349061|100504388|FG000|NOT COMPLETED|Main Study: Week 24 to 56||0||
48073983|NCT02349061|100504389|FG001|NOT COMPLETED|Main Study: Week 24 to 56||3||
48073984|NCT02349061|100504390|FG002|NOT COMPLETED|Main Study: Week 24 to 56||3||
48073985|NCT02349061|100504388|FG000|STARTED|Study Extension (Week 56 to Week 120)||0||
48073986|NCT02349061|100504389|FG001|STARTED|Study Extension (Week 56 to Week 120)||29||
48073987|NCT02349061|100504390|FG002|STARTED|Study Extension (Week 56 to Week 120)||17||
48073988|NCT02349061|100504388|FG000|COMPLETED|Study Extension (Week 56 to Week 120)||0||
48372231|NCT01987986|101239937|FG003|STARTED|Overall Study||24||
48372232|NCT01987986|101239934|FG000|COMPLETED|Overall Study||41||
48073989|NCT02349061|100504389|FG001|COMPLETED|Study Extension (Week 56 to Week 120)||24||
48073990|NCT02349061|100504390|FG002|COMPLETED|Study Extension (Week 56 to Week 120)||14||
48073991|NCT02349061|100504388|FG000|NOT COMPLETED|Study Extension (Week 56 to Week 120)||0||
48073992|NCT02349061|100504389|FG001|NOT COMPLETED|Study Extension (Week 56 to Week 120)||5||
48073993|NCT02349061|100504390|FG002|NOT COMPLETED|Study Extension (Week 56 to Week 120)||3||
48073994|NCT02577978|100504391|FG000|STARTED|Overall Study||32||
48073995|NCT02577978|100504392|FG001|STARTED|Overall Study||29||
48073996|NCT02577978|100504391|FG000|COMPLETED|Overall Study||25||
48073997|NCT02577978|100504392|FG001|COMPLETED|Overall Study||25||
48073998|NCT02577978|100504391|FG000|NOT COMPLETED|Overall Study||7||
48372233|NCT01987986|101239935|FG001|COMPLETED|Overall Study||43||
48372234|NCT01987986|101239936|FG002|COMPLETED|Overall Study||38||
48372235|NCT01987986|101239937|FG003|COMPLETED|Overall Study||24||
48372236|NCT01987986|101239934|FG000|NOT COMPLETED|Overall Study||2||
48372237|NCT01987986|101239935|FG001|NOT COMPLETED|Overall Study||0||
48372238|NCT01987986|101239936|FG002|NOT COMPLETED|Overall Study||2||
48372239|NCT01987986|101239937|FG003|NOT COMPLETED|Overall Study||0||
48372240|NCT00610935|101239938|FG000|STARTED|Overall Study||25||
48372241|NCT00610935|101239939|FG001|STARTED|Overall Study||57||
48372242|NCT00610935|101239938|FG000|ITTI Population|Overall Study||25|Intent to treat - infected (ITTI) population included all subjects who were randomized, received at least one injection of study drug, and had proven influenza infection by at least one of the following assessments performed on a Screening/Baseline sample: positive PCR assay or positive viral culture for Influenza A or B.|
48372243|NCT00610935|101239939|FG001|ITTI Population|Overall Study||55|Intent to treat - infected (ITTI) population included all subjects who were randomized, received at least one injection of study drug, and had proven influenza infection by at least one of the following assessments performed on a Screening/Baseline sample: positive PCR assay or positive viral culture for Influenza A or B.|
48372244|NCT00610935|101239938|FG000|ITT Population|Overall Study||25|Intent to treat (ITT) population included all randomized subjects for whom data were analyzed in the respective randomized treatment groups. The ITT population = Safety Population|
48372245|NCT00610935|101239939|FG001|ITT Population|Overall Study||57|Intent to treat (ITT) population included all randomized subjects for whom data were analyzed in the respective randomized treatment groups. The ITT population = Safety Population|
48372246|NCT00610935|101239938|FG000|COMPLETED|Overall Study||24||
48073999|NCT02577978|100504392|FG001|NOT COMPLETED|Overall Study||4||
48074000|NCT02021331|100504393|FG000|STARTED|Overall Study||2||
48074001|NCT02021331|100504394|FG001|STARTED|Overall Study||3||
48074002|NCT02021331|100504393|FG000|COMPLETED|Overall Study||2||
48074003|NCT02021331|100504394|FG001|COMPLETED|Overall Study||1||
48074004|NCT02021331|100504393|FG000|NOT COMPLETED|Overall Study||0||
48074005|NCT02021331|100504394|FG001|NOT COMPLETED|Overall Study||2||
48074006|NCT04523220|100504395|FG000|STARTED|Main Treatment Period||234|Randomized|
48074007|NCT04523220|100504396|FG001|STARTED|Main Treatment Period||235|Randomized|
48372247|NCT00610935|101239939|FG001|COMPLETED|Overall Study||54||
48372248|NCT00610935|101239938|FG000|NOT COMPLETED|Overall Study||1||
48372249|NCT00610935|101239939|FG001|NOT COMPLETED|Overall Study||3||
48372250|NCT02689219|101239940|FG000|STARTED|Overall Study||11||
48372251|NCT02689219|101239941|FG001|STARTED|Overall Study||7||
48372252|NCT02689219|101239940|FG000|COMPLETED|Overall Study||0||
48372253|NCT02689219|101239941|FG001|COMPLETED|Overall Study||0||
48372254|NCT02689219|101239940|FG000|NOT COMPLETED|Overall Study||11||
48372255|NCT02689219|101239941|FG001|NOT COMPLETED|Overall Study||7||
48074008|NCT04523220|100504397|FG002|STARTED|Main Treatment Period||235|Randomized|
48074009|NCT04523220|100504395|FG000|Treated|Main Treatment Period||224||
48074010|NCT04523220|100504396|FG001|Treated|Main Treatment Period||232||
48074011|NCT04523220|100504397|FG002|Treated|Main Treatment Period||230||
48074012|NCT04523220|100504395|FG000|COMPLETED|Main Treatment Period||194||
48226959|NCT01450007|100877880|FG000|NOT COMPLETED|Overall Study||2||
48226960|NCT01450007|100877881|FG001|NOT COMPLETED|Overall Study||5||
48226961|NCT01450007|100877882|FG002|NOT COMPLETED|Overall Study||3||
48226962|NCT03510195|100877883|FG000|STARTED|Overall Study||267||
48226963|NCT03510195|100877883|FG000|COMPLETED|Overall Study||101||
48226964|NCT03510195|100877883|FG000|NOT COMPLETED|Overall Study||166||
48074013|NCT04523220|100504396|FG001|COMPLETED|Main Treatment Period||199||
48074014|NCT04523220|100504397|FG002|COMPLETED|Main Treatment Period||206||
48074015|NCT04523220|100504395|FG000|NOT COMPLETED|Main Treatment Period||40||
48074016|NCT04523220|100504396|FG001|NOT COMPLETED|Main Treatment Period||36||
48074017|NCT04523220|100504397|FG002|NOT COMPLETED|Main Treatment Period||29||
48074018|NCT04523220|100504395|FG000|STARTED|Extension Treatment Period||194||
48074019|NCT04523220|100504396|FG001|STARTED|Extension Treatment Period||199||
48074020|NCT04523220|100504397|FG002|STARTED|Extension Treatment Period||206||
48074021|NCT04523220|100504395|FG000|COMPLETED|Extension Treatment Period||174||
48074022|NCT04523220|100504396|FG001|COMPLETED|Extension Treatment Period||178||
48074023|NCT04523220|100504397|FG002|COMPLETED|Extension Treatment Period||176||
48074024|NCT04523220|100504395|FG000|NOT COMPLETED|Extension Treatment Period||20||
48074025|NCT04523220|100504396|FG001|NOT COMPLETED|Extension Treatment Period||21||
48074026|NCT04523220|100504397|FG002|NOT COMPLETED|Extension Treatment Period||30||
48074027|NCT04453722|100504398|FG000|STARTED|Overall Study||24||
48074028|NCT04453722|100504399|FG001|STARTED|Overall Study||25||
48074029|NCT04453722|100504398|FG000|COMPLETED|Overall Study||23||
48074030|NCT04453722|100504399|FG001|COMPLETED|Overall Study||24||
48074031|NCT04453722|100504398|FG000|NOT COMPLETED|Overall Study||1||
48074032|NCT04453722|100504399|FG001|NOT COMPLETED|Overall Study||1||
48074033|NCT02267083|100504400|FG000|STARTED|Overall Study||22||
48074034|NCT02267083|100504400|FG000|COMPLETED|Overall Study||3||
48074035|NCT02267083|100504400|FG000|NOT COMPLETED|Overall Study||19||
48074036|NCT00261807|100504401|FG000|STARTED|Overall Study||25||
48074037|NCT00261807|100504401|FG000|COMPLETED|Overall Study||18||
48074038|NCT00261807|100504401|FG000|NOT COMPLETED|Overall Study||7||
48074039|NCT00363883|100504402|FG000|STARTED|Overall Study||14||
48074040|NCT00363883|100504402|FG000|COMPLETED|Overall Study||14||
48074041|NCT00363883|100504402|FG000|NOT COMPLETED|Overall Study||0||
48074042|NCT03642457|100504403|FG000|STARTED|Overall Study||35||
48074043|NCT03642457|100504404|FG001|STARTED|Overall Study||30||
48074044|NCT03642457|100504403|FG000|COMPLETED|Overall Study||35||
48074045|NCT03642457|100504404|FG001|COMPLETED|Overall Study||30||
48074046|NCT03642457|100504403|FG000|NOT COMPLETED|Overall Study||0||
48074047|NCT03642457|100504404|FG001|NOT COMPLETED|Overall Study||0||
48074048|NCT00060008|100504405|FG000|STARTED|Overall Study||18||
48074049|NCT00060008|100504405|FG000|COMPLETED|Overall Study||18||
48074050|NCT00060008|100504405|FG000|NOT COMPLETED|Overall Study||0||
48074051|NCT00941005|100504406|FG000|STARTED|Overall Study||61||
48074052|NCT00941005|100504407|FG001|STARTED|Overall Study||61||
48074053|NCT00941005|100504406|FG000|COMPLETED|Overall Study||61||
48074054|NCT00941005|100504407|FG001|COMPLETED|Overall Study||61||
48074055|NCT00941005|100504406|FG000|NOT COMPLETED|Overall Study||0||
48074056|NCT00941005|100504407|FG001|NOT COMPLETED|Overall Study||0||
48074057|NCT02975336|100504408|FG000|STARTED|DBPC (52 Weeks)||117||
48226965|NCT03082313|100877884|FG000|STARTED|Overall Study||12||
48226966|NCT03082313|100877884|FG000|COMPLETED|Overall Study||12||
48226967|NCT03082313|100877884|FG000|NOT COMPLETED|Overall Study||0||
48226968|NCT02644122|100877885|FG000|STARTED|Overall Study||1||
48226969|NCT02644122|100877885|FG000|COMPLETED|Overall Study||0||
48226970|NCT02644122|100877885|FG000|NOT COMPLETED|Overall Study||1||
48226971|NCT05270460|100877886|FG000|STARTED|Overall Study||9||
48226972|NCT05270460|100877887|FG001|STARTED|Overall Study||8||
48226973|NCT05270460|100877888|FG002|STARTED|Overall Study||8||
48226974|NCT05270460|100877886|FG000|COMPLETED|Overall Study||9||
48226975|NCT05270460|100877887|FG001|COMPLETED|Overall Study||6||
48226976|NCT05270460|100877888|FG002|COMPLETED|Overall Study||8||
48226977|NCT05270460|100877886|FG000|NOT COMPLETED|Overall Study||0||
48226978|NCT05270460|100877887|FG001|NOT COMPLETED|Overall Study||2||
48074058|NCT02975336|100504409|FG001|STARTED|DBPC (52 Weeks)||118||
48074059|NCT02975336|100504410|FG002|STARTED|DBPC (52 Weeks)||117||
48074060|NCT02975336|100504411|FG003|STARTED|DBPC (52 Weeks)||117||
48372256|NCT02856581|101239942|FG000|STARTED|Overall Study||12||
48372257|NCT02856581|101239943|FG001|STARTED|Overall Study||11||
48074061|NCT02975336|100504412|FG004|STARTED|DBPC (52 Weeks)||0||
48074062|NCT02975336|100504413|FG005|STARTED|DBPC (52 Weeks)||0||
48074063|NCT02975336|100504414|FG006|STARTED|DBPC (52 Weeks)||0||
48074064|NCT02975336|100504415|FG007|STARTED|DBPC (52 Weeks)||0||
48074065|NCT02975336|100504408|FG000|COMPLETED|DBPC (52 Weeks)||85||
48074066|NCT02975336|100504409|FG001|COMPLETED|DBPC (52 Weeks)||89||
48074067|NCT02975336|100504410|FG002|COMPLETED|DBPC (52 Weeks)||90||
48372258|NCT02856581|101239942|FG000|COMPLETED|Overall Study||12||
48372259|NCT02856581|101239943|FG001|COMPLETED|Overall Study||11||
48372260|NCT02856581|101239942|FG000|NOT COMPLETED|Overall Study||0||
48372261|NCT02856581|101239943|FG001|NOT COMPLETED|Overall Study||0||
48372262|NCT01532700|101239944|FG000|STARTED|Overall Study||28||
48372263|NCT01532700|101239944|FG000|COMPLETED|Overall Study||28||
48372264|NCT01532700|101239944|FG000|NOT COMPLETED|Overall Study||0||
48372265|NCT03047993|101239945|FG000|STARTED|Overall Study||28||
48372266|NCT03047993|101239945|FG000|COMPLETED|Overall Study||28||
48074068|NCT02975336|100504411|FG003|COMPLETED|DBPC (52 Weeks)||84||
48074069|NCT02975336|100504412|FG004|COMPLETED|DBPC (52 Weeks)||0||
48074070|NCT02975336|100504413|FG005|COMPLETED|DBPC (52 Weeks)||0||
48372267|NCT03047993|101239945|FG000|NOT COMPLETED|Overall Study||0||
48372268|NCT00601523|101239946|FG000|STARTED|Overall Study||368||
48372269|NCT00601523|101239947|FG001|STARTED|Overall Study||143||
48372270|NCT00601523|101239946|FG000|COMPLETED|Overall Study||291||
48372271|NCT00601523|101239947|FG001|COMPLETED|Overall Study||117||
48372272|NCT00601523|101239946|FG000|NOT COMPLETED|Overall Study||77||
48372273|NCT00601523|101239947|FG001|NOT COMPLETED|Overall Study||26||
48372274|NCT04072146|101239948|FG000|STARTED|Overall Study||11||
48372275|NCT04072146|101239949|FG001|STARTED|Overall Study||11||
48372276|NCT04072146|101239948|FG000|COMPLETED|Overall Study||11||
48372277|NCT04072146|101239949|FG001|COMPLETED|Overall Study||10||
48372278|NCT04072146|101239948|FG000|NOT COMPLETED|Overall Study||0||
48372279|NCT04072146|101239949|FG001|NOT COMPLETED|Overall Study||1||
48372280|NCT00367640|101239950|FG000|STARTED|Overall Study||157||
48372281|NCT00367640|101239951|FG001|STARTED|Overall Study||155||
48372282|NCT00367640|101239952|FG002|STARTED|Overall Study||160||
48372283|NCT00367640|101239953|FG003|STARTED|Overall Study||156||
48372284|NCT00367640|101239950|FG000|COMPLETED|Overall Study||139||
48372285|NCT00367640|101239951|FG001|COMPLETED|Overall Study||133||
48372286|NCT00367640|101239952|FG002|COMPLETED|Overall Study||141||
48372287|NCT00367640|101239953|FG003|COMPLETED|Overall Study||146||
48372288|NCT00367640|101239950|FG000|NOT COMPLETED|Overall Study||18||
48372289|NCT00367640|101239951|FG001|NOT COMPLETED|Overall Study||22||
48372290|NCT00367640|101239952|FG002|NOT COMPLETED|Overall Study||19||
48372291|NCT00367640|101239953|FG003|NOT COMPLETED|Overall Study||10||
48372292|NCT00875017|101239954|FG000|STARTED|First Intervention||5||
48372293|NCT00875017|101239955|FG001|STARTED|First Intervention||5||
48372294|NCT00875017|101239956|FG002|STARTED|First Intervention||5||
48372295|NCT00875017|101239957|FG003|STARTED|First Intervention||6||
48372296|NCT00875017|101239958|FG004|STARTED|First Intervention||5||
48372297|NCT00875017|101239959|FG005|STARTED|First Intervention||5||
48372298|NCT00875017|101239954|FG000|COMPLETED|First Intervention||3||
48372299|NCT00875017|101239955|FG001|COMPLETED|First Intervention||5||
48372300|NCT00875017|101239956|FG002|COMPLETED|First Intervention||4||
48372301|NCT00875017|101239957|FG003|COMPLETED|First Intervention||5||
48372302|NCT00875017|101239958|FG004|COMPLETED|First Intervention||4||
48372303|NCT00875017|101239959|FG005|COMPLETED|First Intervention||5||
48074071|NCT02975336|100504414|FG006|COMPLETED|DBPC (52 Weeks)||0||
48074072|NCT02975336|100504415|FG007|COMPLETED|DBPC (52 Weeks)||0||
48074073|NCT02975336|100504408|FG000|NOT COMPLETED|DBPC (52 Weeks)||32||
48074074|NCT02975336|100504409|FG001|NOT COMPLETED|DBPC (52 Weeks)||29||
48074075|NCT02975336|100504410|FG002|NOT COMPLETED|DBPC (52 Weeks)||27||
48074076|NCT02975336|100504411|FG003|NOT COMPLETED|DBPC (52 Weeks)||33||
48074077|NCT02975336|100504412|FG004|NOT COMPLETED|DBPC (52 Weeks)||0||
48074078|NCT02975336|100504413|FG005|NOT COMPLETED|DBPC (52 Weeks)||0||
48074079|NCT02975336|100504414|FG006|NOT COMPLETED|DBPC (52 Weeks)||0||
48074080|NCT02975336|100504415|FG007|NOT COMPLETED|DBPC (52 Weeks)||0||
48074081|NCT02975336|100504408|FG000|STARTED|LTE (104 Weeks)||0||
48074082|NCT02975336|100504409|FG001|STARTED|LTE (104 Weeks)||0||
48074083|NCT02975336|100504410|FG002|STARTED|LTE (104 Weeks)||0||
48074084|NCT02975336|100504411|FG003|STARTED|LTE (104 Weeks)||0||
48372304|NCT00875017|101239954|FG000|NOT COMPLETED|First Intervention||2||
48372305|NCT00875017|101239955|FG001|NOT COMPLETED|First Intervention||0||
48372306|NCT00875017|101239956|FG002|NOT COMPLETED|First Intervention||1||
48372307|NCT00875017|101239957|FG003|NOT COMPLETED|First Intervention||1||
48074085|NCT02975336|100504412|FG004|STARTED|LTE (104 Weeks)||62||
48074086|NCT02975336|100504413|FG005|STARTED|LTE (104 Weeks)||69||
48074087|NCT02975336|100504414|FG006|STARTED|LTE (104 Weeks)||80||
48074088|NCT02975336|100504415|FG007|STARTED|LTE (104 Weeks)||72||
48074089|NCT02975336|100504408|FG000|COMPLETED|LTE (104 Weeks)||0||
48074090|NCT02975336|100504409|FG001|COMPLETED|LTE (104 Weeks)||0||
48074091|NCT02975336|100504410|FG002|COMPLETED|LTE (104 Weeks)||0||
48372308|NCT00875017|101239958|FG004|NOT COMPLETED|First Intervention||1||
48372309|NCT00875017|101239959|FG005|NOT COMPLETED|First Intervention||0||
48372310|NCT00875017|101239954|FG000|STARTED|Washout||3||
48372311|NCT00875017|101239955|FG001|STARTED|Washout||5||
48074092|NCT02975336|100504411|FG003|COMPLETED|LTE (104 Weeks)||0||
48074093|NCT02975336|100504412|FG004|COMPLETED|LTE (104 Weeks)||0||
48074094|NCT02975336|100504413|FG005|COMPLETED|LTE (104 Weeks)||0||
48074095|NCT02975336|100504414|FG006|COMPLETED|LTE (104 Weeks)||0||
48074096|NCT02975336|100504415|FG007|COMPLETED|LTE (104 Weeks)||0||
48074097|NCT02975336|100504408|FG000|NOT COMPLETED|LTE (104 Weeks)||0||
48074098|NCT02975336|100504409|FG001|NOT COMPLETED|LTE (104 Weeks)||0||
48074099|NCT02975336|100504410|FG002|NOT COMPLETED|LTE (104 Weeks)||0||
48074100|NCT02975336|100504411|FG003|NOT COMPLETED|LTE (104 Weeks)||0||
48074101|NCT02975336|100504412|FG004|NOT COMPLETED|LTE (104 Weeks)||62||
48074102|NCT02975336|100504413|FG005|NOT COMPLETED|LTE (104 Weeks)||69||
48074103|NCT02975336|100504414|FG006|NOT COMPLETED|LTE (104 Weeks)||80||
48074104|NCT02975336|100504415|FG007|NOT COMPLETED|LTE (104 Weeks)||72||
48074105|NCT00672932|100504416|FG000|STARTED|Overall Study||9||
48074106|NCT00672932|100504417|FG001|STARTED|Overall Study||9||
48074107|NCT00672932|100504416|FG000|Completed Initial 12-week Assignment|Overall Study||9||
48074108|NCT00672932|100504417|FG001|Completed Initial 12-week Assignment|Overall Study||9||
48074109|NCT00672932|100504416|FG000|Provided Analyzable Blood and CSF Sample|Overall Study||8||
48074110|NCT00672932|100504417|FG001|Provided Analyzable Blood and CSF Sample|Overall Study||9||
48074111|NCT00672932|100504416|FG000|Rolled Over to Raltegravir|Overall Study||0||
48074112|NCT00672932|100504417|FG001|Rolled Over to Raltegravir|Overall Study||6||
48074113|NCT00672932|100504416|FG000|COMPLETED|Overall Study||9||
48074114|NCT00672932|100504417|FG001|COMPLETED|Overall Study||9||
48074115|NCT00672932|100504416|FG000|NOT COMPLETED|Overall Study||0||
48074116|NCT00672932|100504417|FG001|NOT COMPLETED|Overall Study||0||
48074117|NCT02763462|100504418|FG000|STARTED|Overall Study||1492||
48074118|NCT02763462|100504418|FG000|COMPLETED|Overall Study||1486||
48074119|NCT02763462|100504418|FG000|NOT COMPLETED|Overall Study||6||
48074120|NCT01696084|100504419|FG000|STARTED|Overall Study||153||
48074121|NCT01696084|100504420|FG001|STARTED|Overall Study||156||
48074122|NCT01696084|100504419|FG000|COMPLETED|Overall Study||22||
48074123|NCT01696084|100504420|FG001|COMPLETED|Overall Study||10||
48074124|NCT01696084|100504419|FG000|NOT COMPLETED|Overall Study||131||
48074125|NCT01696084|100504420|FG001|NOT COMPLETED|Overall Study||146||
48074126|NCT02207244|100504421|FG000|STARTED|Placebo Controlled Period: Week 0-16||248||
48074127|NCT02207244|100504422|FG001|STARTED|Placebo Controlled Period: Week 0-16||496||
48074128|NCT02207244|100504423|FG002|STARTED|Placebo Controlled Period: Week 0-16||248||
48074129|NCT02207244|100504424|FG003|STARTED|Placebo Controlled Period: Week 0-16||0||
48074130|NCT02207244|100504425|FG004|STARTED|Placebo Controlled Period: Week 0-16||0||
48074131|NCT02207244|100504426|FG005|STARTED|Placebo Controlled Period: Week 0-16||0||
48074132|NCT02207244|100504427|FG006|STARTED|Placebo Controlled Period: Week 0-16||0||
48074133|NCT02207244|100504428|FG007|STARTED|Placebo Controlled Period: Week 0-16||0||
48074134|NCT02207244|100504429|FG008|STARTED|Placebo Controlled Period: Week 0-16||0||
48074135|NCT02207244|100504430|FG009|STARTED|Placebo Controlled Period: Week 0-16||0||
48074136|NCT02207244|100504431|FG010|STARTED|Placebo Controlled Period: Week 0-16||0||
48074137|NCT02207244|100504421|FG000|Treated|Placebo Controlled Period: Week 0-16||248||
48074138|NCT02207244|100504422|FG001|Treated|Placebo Controlled Period: Week 0-16||494||
48074139|NCT02207244|100504423|FG002|Treated|Placebo Controlled Period: Week 0-16||248||
48074140|NCT02207244|100504424|FG003|Treated|Placebo Controlled Period: Week 0-16||0||
48074141|NCT02207244|100504425|FG004|Treated|Placebo Controlled Period: Week 0-16||0||
48074142|NCT02207244|100504426|FG005|Treated|Placebo Controlled Period: Week 0-16||0||
48074143|NCT02207244|100504427|FG006|Treated|Placebo Controlled Period: Week 0-16||0||
48074144|NCT02207244|100504428|FG007|Treated|Placebo Controlled Period: Week 0-16||0||
48074145|NCT02207244|100504429|FG008|Treated|Placebo Controlled Period: Week 0-16||0||
48074146|NCT02207244|100504430|FG009|Treated|Placebo Controlled Period: Week 0-16||0||
48074147|NCT02207244|100504431|FG010|Treated|Placebo Controlled Period: Week 0-16||0||
48074148|NCT02207244|100504421|FG000|COMPLETED|Placebo Controlled Period: Week 0-16||233||
48074149|NCT02207244|100504422|FG001|COMPLETED|Placebo Controlled Period: Week 0-16||478||
48074150|NCT02207244|100504423|FG002|COMPLETED|Placebo Controlled Period: Week 0-16||237||
48074151|NCT02207244|100504424|FG003|COMPLETED|Placebo Controlled Period: Week 0-16||0||
48074152|NCT02207244|100504425|FG004|COMPLETED|Placebo Controlled Period: Week 0-16||0||
48074153|NCT02207244|100504426|FG005|COMPLETED|Placebo Controlled Period: Week 0-16||0||
48074154|NCT02207244|100504427|FG006|COMPLETED|Placebo Controlled Period: Week 0-16||0||
48074155|NCT02207244|100504428|FG007|COMPLETED|Placebo Controlled Period: Week 0-16||0||
48074156|NCT02207244|100504429|FG008|COMPLETED|Placebo Controlled Period: Week 0-16||0||
48074157|NCT02207244|100504430|FG009|COMPLETED|Placebo Controlled Period: Week 0-16||0||
48074158|NCT02207244|100504431|FG010|COMPLETED|Placebo Controlled Period: Week 0-16||0||
48074159|NCT02207244|100504421|FG000|NOT COMPLETED|Placebo Controlled Period: Week 0-16||15||
48074160|NCT02207244|100504422|FG001|NOT COMPLETED|Placebo Controlled Period: Week 0-16||18||
48074161|NCT02207244|100504423|FG002|NOT COMPLETED|Placebo Controlled Period: Week 0-16||11||
48074162|NCT02207244|100504424|FG003|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0||
48074163|NCT02207244|100504425|FG004|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0||
48074164|NCT02207244|100504426|FG005|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0||
48074165|NCT02207244|100504427|FG006|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0||
48074166|NCT02207244|100504428|FG007|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0||
48074167|NCT02207244|100504429|FG008|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0||
48074168|NCT02207244|100504430|FG009|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0||
48074169|NCT02207244|100504431|FG010|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0||
48074170|NCT02207244|100504421|FG000|STARTED|Placebo Crossover and ACP: Week 16-28||0||
48074171|NCT02207244|100504422|FG001|STARTED|Placebo Crossover and ACP: Week 16-28||0||
48074172|NCT02207244|100504423|FG002|STARTED|Placebo Crossover and ACP: Week 16-28||0||
48074173|NCT02207244|100504424|FG003|STARTED|Placebo Crossover and ACP: Week 16-28||233||
48074174|NCT02207244|100504425|FG004|STARTED|Placebo Crossover and ACP: Week 16-28||478||
48074175|NCT02207244|100504426|FG005|STARTED|Placebo Crossover and ACP: Week 16-28||237||
48074176|NCT02207244|100504427|FG006|STARTED|Placebo Crossover and ACP: Week 16-28||0||
48074177|NCT02207244|100504428|FG007|STARTED|Placebo Crossover and ACP: Week 16-28||0||
48074178|NCT02207244|100504429|FG008|STARTED|Placebo Crossover and ACP: Week 16-28||0||
48074179|NCT02207244|100504430|FG009|STARTED|Placebo Crossover and ACP: Week 16-28||0||
48074180|NCT02207244|100504431|FG010|STARTED|Placebo Crossover and ACP: Week 16-28||0||
48074181|NCT02207244|100504421|FG000|COMPLETED|Placebo Crossover and ACP: Week 16-28||0||
48074182|NCT02207244|100504422|FG001|COMPLETED|Placebo Crossover and ACP: Week 16-28||0||
48074183|NCT02207244|100504423|FG002|COMPLETED|Placebo Crossover and ACP: Week 16-28||0||
48074184|NCT02207244|100504424|FG003|COMPLETED|Placebo Crossover and ACP: Week 16-28||227||
48074185|NCT02207244|100504425|FG004|COMPLETED|Placebo Crossover and ACP: Week 16-28||470||
48074186|NCT02207244|100504426|FG005|COMPLETED|Placebo Crossover and ACP: Week 16-28||228||
48074187|NCT02207244|100504427|FG006|COMPLETED|Placebo Crossover and ACP: Week 16-28||0||
48074188|NCT02207244|100504428|FG007|COMPLETED|Placebo Crossover and ACP: Week 16-28||0||
48074189|NCT02207244|100504429|FG008|COMPLETED|Placebo Crossover and ACP: Week 16-28||0||
48074190|NCT02207244|100504430|FG009|COMPLETED|Placebo Crossover and ACP: Week 16-28||0||
48074191|NCT02207244|100504431|FG010|COMPLETED|Placebo Crossover and ACP: Week 16-28||0||
48074192|NCT02207244|100504421|FG000|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0||
48074193|NCT02207244|100504422|FG001|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0||
48074194|NCT02207244|100504423|FG002|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0||
48074195|NCT02207244|100504424|FG003|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||6||
48074196|NCT02207244|100504425|FG004|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||8||
48074197|NCT02207244|100504426|FG005|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||9||
48074198|NCT02207244|100504427|FG006|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0||
48074199|NCT02207244|100504428|FG007|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0||
48074200|NCT02207244|100504429|FG008|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0||
48074201|NCT02207244|100504430|FG009|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0||
48074202|NCT02207244|100504431|FG010|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0||
48074203|NCT02207244|100504421|FG000|STARTED|Withdrawal and Re-treatment: Week 28-72||0||
48074204|NCT02207244|100504422|FG001|STARTED|Withdrawal and Re-treatment: Week 28-72||0||
48074205|NCT02207244|100504423|FG002|STARTED|Withdrawal and Re-treatment: Week 28-72||0||
48074206|NCT02207244|100504424|FG003|STARTED|Withdrawal and Re-treatment: Week 28-72||0||
48074207|NCT02207244|100504425|FG004|STARTED|Withdrawal and Re-treatment: Week 28-72||0||
48372312|NCT00875017|101239956|FG002|STARTED|Washout||4||
48372313|NCT00875017|101239957|FG003|STARTED|Washout||5||
48372314|NCT00875017|101239958|FG004|STARTED|Washout||4||
48372315|NCT00875017|101239959|FG005|STARTED|Washout||5||
48372316|NCT00875017|101239954|FG000|COMPLETED|Washout||3||
48372317|NCT00875017|101239955|FG001|COMPLETED|Washout||5||
48372318|NCT00875017|101239956|FG002|COMPLETED|Washout||3||
48372319|NCT00875017|101239957|FG003|COMPLETED|Washout||5||
48372320|NCT00875017|101239958|FG004|COMPLETED|Washout||4||
48372321|NCT00875017|101239959|FG005|COMPLETED|Washout||5||
48372322|NCT00875017|101239954|FG000|NOT COMPLETED|Washout||0||
48372323|NCT00875017|101239955|FG001|NOT COMPLETED|Washout||0||
48372324|NCT00875017|101239956|FG002|NOT COMPLETED|Washout||1||
48372325|NCT00875017|101239957|FG003|NOT COMPLETED|Washout||0||
48372326|NCT00875017|101239958|FG004|NOT COMPLETED|Washout||0||
48372327|NCT00875017|101239959|FG005|NOT COMPLETED|Washout||0||
48372328|NCT00875017|101239954|FG000|STARTED|Second Intervention||3||
48372329|NCT00875017|101239955|FG001|STARTED|Second Intervention||5||
48372330|NCT00875017|101239956|FG002|STARTED|Second Intervention||3||
48372331|NCT00875017|101239957|FG003|STARTED|Second Intervention||5||
48372332|NCT00875017|101239958|FG004|STARTED|Second Intervention||4||
48372333|NCT00875017|101239959|FG005|STARTED|Second Intervention||5||
48372334|NCT00875017|101239954|FG000|COMPLETED|Second Intervention||3||
48372335|NCT00875017|101239955|FG001|COMPLETED|Second Intervention||5||
48372336|NCT00875017|101239956|FG002|COMPLETED|Second Intervention||3||
48372337|NCT00875017|101239957|FG003|COMPLETED|Second Intervention||4||
48372338|NCT00875017|101239958|FG004|COMPLETED|Second Intervention||4||
48074208|NCT02207244|100504426|FG005|STARTED|Withdrawal and Re-treatment: Week 28-72||0||
48372339|NCT00875017|101239959|FG005|COMPLETED|Second Intervention||5||
48372340|NCT00875017|101239954|FG000|NOT COMPLETED|Second Intervention||0||
48372341|NCT00875017|101239955|FG001|NOT COMPLETED|Second Intervention||0||
48372342|NCT00875017|101239956|FG002|NOT COMPLETED|Second Intervention||0||
48372343|NCT00875017|101239957|FG003|NOT COMPLETED|Second Intervention||1||
48074209|NCT02207244|100504427|FG006|STARTED|Withdrawal and Re-treatment: Week 28-72||227||
48074210|NCT02207244|100504428|FG007|STARTED|Withdrawal and Re-treatment: Week 28-72||470||
48074211|NCT02207244|100504429|FG008|STARTED|Withdrawal and Re-treatment: Week 28-72||220||
48074212|NCT02207244|100504430|FG009|STARTED|Withdrawal and Re-treatment: Week 28-72||8||
48074213|NCT02207244|100504431|FG010|STARTED|Withdrawal and Re-treatment: Week 28-72||0||
48074214|NCT02207244|100504421|FG000|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0||
48074215|NCT02207244|100504422|FG001|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0||
48074216|NCT02207244|100504423|FG002|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0||
48074217|NCT02207244|100504424|FG003|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0||
48074218|NCT02207244|100504425|FG004|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0||
48074219|NCT02207244|100504426|FG005|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0||
48074220|NCT02207244|100504427|FG006|Nonresponders|Withdrawal and Re-treatment: Week 28-72||80||
48074221|NCT02207244|100504428|FG007|Nonresponders|Withdrawal and Re-treatment: Week 28-72||95||
48074222|NCT02207244|100504429|FG008|Nonresponders|Withdrawal and Re-treatment: Week 28-72||112||
48074223|NCT02207244|100504430|FG009|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0||
48074224|NCT02207244|100504431|FG010|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0||
48074225|NCT02207244|100504421|FG000|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0||
48074226|NCT02207244|100504422|FG001|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0||
48074227|NCT02207244|100504423|FG002|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0||
48074228|NCT02207244|100504424|FG003|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0||
48074229|NCT02207244|100504425|FG004|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0||
48372344|NCT00875017|101239958|FG004|NOT COMPLETED|Second Intervention||0||
48372345|NCT00875017|101239959|FG005|NOT COMPLETED|Second Intervention||0||
48372346|NCT00875017|101239954|FG000|STARTED|Washout||3||
48372347|NCT00875017|101239955|FG001|STARTED|Washout||5||
48372348|NCT00875017|101239956|FG002|STARTED|Washout||3||
48372349|NCT00875017|101239957|FG003|STARTED|Washout||4||
48372350|NCT00875017|101239958|FG004|STARTED|Washout||4||
48372351|NCT00875017|101239959|FG005|STARTED|Washout||5||
48372352|NCT00875017|101239954|FG000|COMPLETED|Washout||3||
48372353|NCT00875017|101239955|FG001|COMPLETED|Washout||4||
48372354|NCT00875017|101239956|FG002|COMPLETED|Washout||3||
48372355|NCT00875017|101239957|FG003|COMPLETED|Washout||4||
48372356|NCT00875017|101239958|FG004|COMPLETED|Washout||4||
48372357|NCT00875017|101239959|FG005|COMPLETED|Washout||5||
48372358|NCT00875017|101239954|FG000|NOT COMPLETED|Washout||0||
48372359|NCT00875017|101239955|FG001|NOT COMPLETED|Washout||1||
48372360|NCT00875017|101239956|FG002|NOT COMPLETED|Washout||0||
48372361|NCT00875017|101239957|FG003|NOT COMPLETED|Washout||0||
48372362|NCT00875017|101239958|FG004|NOT COMPLETED|Washout||0||
48372363|NCT00875017|101239959|FG005|NOT COMPLETED|Washout||0||
48372364|NCT00875017|101239954|FG000|STARTED|Third Intervention||3||
48372365|NCT00875017|101239955|FG001|STARTED|Third Intervention||4||
48372366|NCT00875017|101239956|FG002|STARTED|Third Intervention||3||
48372367|NCT00875017|101239957|FG003|STARTED|Third Intervention||4||
48372368|NCT00875017|101239958|FG004|STARTED|Third Intervention||4||
48372369|NCT00875017|101239959|FG005|STARTED|Third Intervention||5||
48372370|NCT00875017|101239954|FG000|COMPLETED|Third Intervention||3||
48372371|NCT00875017|101239955|FG001|COMPLETED|Third Intervention||3||
48372372|NCT00875017|101239956|FG002|COMPLETED|Third Intervention||2||
48074230|NCT02207244|100504426|FG005|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0||
48074231|NCT02207244|100504427|FG006|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0||
48074232|NCT02207244|100504428|FG007|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||375||
48141183|NCT00487162|100670358|FG001|STARTED|Overall Study||26||
48141184|NCT00487162|100670357|FG000|COMPLETED|Overall Study||28||
48141185|NCT00487162|100670358|FG001|COMPLETED|Overall Study||21||
48141186|NCT00487162|100670357|FG000|NOT COMPLETED|Overall Study||2||
48141187|NCT00487162|100670358|FG001|NOT COMPLETED|Overall Study||5||
48226979|NCT05270460|100877888|FG002|NOT COMPLETED|Overall Study||0||
48226980|NCT01079806|100877889|FG000|STARTED|Day 1 to Week 96||120||
48372373|NCT00875017|101239957|FG003|COMPLETED|Third Intervention||4||
48372374|NCT00875017|101239958|FG004|COMPLETED|Third Intervention||4||
48372375|NCT00875017|101239959|FG005|COMPLETED|Third Intervention||5||
48372376|NCT00875017|101239954|FG000|NOT COMPLETED|Third Intervention||0||
48372377|NCT00875017|101239955|FG001|NOT COMPLETED|Third Intervention||1||
48372378|NCT00875017|101239956|FG002|NOT COMPLETED|Third Intervention||1||
48372379|NCT00875017|101239957|FG003|NOT COMPLETED|Third Intervention||0||
48372380|NCT00875017|101239958|FG004|NOT COMPLETED|Third Intervention||0||
48372381|NCT00875017|101239959|FG005|NOT COMPLETED|Third Intervention||0||
48372382|NCT00875017|101239954|FG000|STARTED|Washout||3||
48372383|NCT00875017|101239955|FG001|STARTED|Washout||3||
48372384|NCT00875017|101239956|FG002|STARTED|Washout||2||
48141188|NCT01031810|100670359|FG000|STARTED|Overall Study||13||
48141189|NCT01031810|100670359|FG000|COMPLETED|Overall Study||9||
48141190|NCT01031810|100670359|FG000|NOT COMPLETED|Overall Study||4||
48372385|NCT00875017|101239957|FG003|STARTED|Washout||4||
48372386|NCT00875017|101239958|FG004|STARTED|Washout||4||
48372387|NCT00875017|101239959|FG005|STARTED|Washout||5||
48141191|NCT03581305|100670360|FG000|STARTED|Dopaminergic Study||23||
48372388|NCT00875017|101239954|FG000|COMPLETED|Washout||3||
48372389|NCT00875017|101239955|FG001|COMPLETED|Washout||3||
48372390|NCT00875017|101239956|FG002|COMPLETED|Washout||2||
48074233|NCT02207244|100504429|FG008|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0||
48074234|NCT02207244|100504430|FG009|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0||
48074235|NCT02207244|100504431|FG010|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0||
48074236|NCT02207244|100504421|FG000|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0|These participants were re-treated with guselkumab at or before Week 72.|
48372391|NCT00875017|101239957|FG003|COMPLETED|Washout||4||
48372392|NCT00875017|101239958|FG004|COMPLETED|Washout||3||
48074237|NCT02207244|100504422|FG001|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0|These participants were re-treated with guselkumab at or before Week 72.|
48074238|NCT02207244|100504423|FG002|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0|These participants were re-treated with guselkumab at or before Week 72.|
48074239|NCT02207244|100504424|FG003|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0|These participants were re-treated with guselkumab at or before Week 72.|
48074240|NCT02207244|100504425|FG004|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0|These participants were re-treated with guselkumab at or before Week 72.|
48074241|NCT02207244|100504426|FG005|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0|These participants were re-treated with guselkumab at or before Week 72.|
48074242|NCT02207244|100504427|FG006|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||147|These participants were re-treated with guselkumab at or before Week 72.|
48074243|NCT02207244|100504428|FG007|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0|These participants were re-treated with guselkumab at or before Week 72.|
48074244|NCT02207244|100504429|FG008|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||108|These participants were re-treated with guselkumab at or before Week 72.|
48074245|NCT02207244|100504430|FG009|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0|These participants were re-treated with guselkumab at or before Week 72.|
48074246|NCT02207244|100504431|FG010|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0|These participants were re-treated with guselkumab at or before Week 72.|
48074247|NCT02207244|100504421|FG000|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0||
48074248|NCT02207244|100504422|FG001|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0||
48074249|NCT02207244|100504423|FG002|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0||
48372393|NCT00875017|101239959|FG005|COMPLETED|Washout||5||
48372394|NCT00875017|101239954|FG000|NOT COMPLETED|Washout||0||
48372395|NCT00875017|101239955|FG001|NOT COMPLETED|Washout||0||
48372396|NCT00875017|101239956|FG002|NOT COMPLETED|Washout||0||
48372397|NCT00875017|101239957|FG003|NOT COMPLETED|Washout||0||
48372398|NCT00875017|101239958|FG004|NOT COMPLETED|Washout||1||
48372399|NCT00875017|101239959|FG005|NOT COMPLETED|Washout||0||
48372400|NCT00875017|101239954|FG000|STARTED|Fourth Intervention||3||
48372401|NCT00875017|101239955|FG001|STARTED|Fourth Intervention||3||
48372402|NCT00875017|101239956|FG002|STARTED|Fourth Intervention||2||
48372403|NCT00875017|101239957|FG003|STARTED|Fourth Intervention||4||
48372404|NCT00875017|101239958|FG004|STARTED|Fourth Intervention||3||
48372405|NCT00875017|101239959|FG005|STARTED|Fourth Intervention||5||
48372406|NCT00875017|101239954|FG000|COMPLETED|Fourth Intervention||3||
48372407|NCT00875017|101239955|FG001|COMPLETED|Fourth Intervention||3||
48372408|NCT00875017|101239956|FG002|COMPLETED|Fourth Intervention||2||
48372409|NCT00875017|101239957|FG003|COMPLETED|Fourth Intervention||4||
48372410|NCT00875017|101239958|FG004|COMPLETED|Fourth Intervention||3||
48372411|NCT00875017|101239959|FG005|COMPLETED|Fourth Intervention||4||
48372412|NCT00875017|101239954|FG000|NOT COMPLETED|Fourth Intervention||0||
48372413|NCT00875017|101239955|FG001|NOT COMPLETED|Fourth Intervention||0||
48372414|NCT00875017|101239956|FG002|NOT COMPLETED|Fourth Intervention||0||
48372415|NCT00875017|101239957|FG003|NOT COMPLETED|Fourth Intervention||0||
48372416|NCT00875017|101239958|FG004|NOT COMPLETED|Fourth Intervention||0||
48372417|NCT00875017|101239959|FG005|NOT COMPLETED|Fourth Intervention||1||
48372418|NCT03229759|101239960|FG000|STARTED|Overall Study||99|Participants consented and enrolled.|
48372419|NCT03229759|101239960|FG000|Participants Treated|Overall Study||69||
48372420|NCT03229759|101239960|FG000|Treated With Investigational Product|Overall Study||45|Participants were treated with 2 of 3 study products.|
48372421|NCT03229759|101239960|FG000|Treated With Vehicle Control|Overall Study||47|Participants were treated with 2 of 3 study products.|
48372422|NCT03229759|101239960|FG000|Treated With Saline Control|Overall Study||46|Participants were treated with 2 of 3 study products.|
48372423|NCT03229759|101239960|FG000|COMPLETED|Overall Study||69||
48372424|NCT03229759|101239960|FG000|NOT COMPLETED|Overall Study||30||
48372425|NCT02100748|101239961|FG000|STARTED|Overall Study||25||
48372426|NCT02100748|101239962|FG001|STARTED|Overall Study||24||
48372427|NCT02100748|101239963|FG002|STARTED|Overall Study||22||
48372428|NCT02100748|101239964|FG003|STARTED|Overall Study||22||
48372429|NCT02100748|101239965|FG004|STARTED|Overall Study||25||
48372430|NCT02100748|101239966|FG005|STARTED|Overall Study||23||
48372431|NCT02100748|101239967|FG006|STARTED|Overall Study||20||
48372432|NCT02100748|101239968|FG007|STARTED|Overall Study||38||
48372433|NCT02100748|101239969|FG008|STARTED|Overall Study||36||
48372434|NCT02100748|101239970|FG009|STARTED|Overall Study||31||
48372435|NCT02100748|101239971|FG010|STARTED|Overall Study||28||
48372436|NCT02100748|101239972|FG011|STARTED|Overall Study||39||
48372437|NCT02100748|101239961|FG000|COMPLETED|Overall Study||23||
48074250|NCT02207244|100504424|FG003|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0||
48074251|NCT02207244|100504425|FG004|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0||
48074252|NCT02207244|100504426|FG005|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0||
48074253|NCT02207244|100504427|FG006|COMPLETED|Withdrawal and Re-treatment: Week 28-72||213||
48074254|NCT02207244|100504428|FG007|COMPLETED|Withdrawal and Re-treatment: Week 28-72||443||
48074255|NCT02207244|100504429|FG008|COMPLETED|Withdrawal and Re-treatment: Week 28-72||211||
48372438|NCT02100748|101239962|FG001|COMPLETED|Overall Study||23||
48372439|NCT02100748|101239963|FG002|COMPLETED|Overall Study||21||
48372440|NCT02100748|101239964|FG003|COMPLETED|Overall Study||21||
48372441|NCT02100748|101239965|FG004|COMPLETED|Overall Study||23||
48372442|NCT02100748|101239966|FG005|COMPLETED|Overall Study||23||
48372443|NCT02100748|101239967|FG006|COMPLETED|Overall Study||18||
48372444|NCT02100748|101239968|FG007|COMPLETED|Overall Study||34||
48372445|NCT02100748|101239969|FG008|COMPLETED|Overall Study||33||
48372446|NCT02100748|101239970|FG009|COMPLETED|Overall Study||29||
48372447|NCT02100748|101239971|FG010|COMPLETED|Overall Study||26||
48372448|NCT02100748|101239972|FG011|COMPLETED|Overall Study||39||
48372449|NCT02100748|101239961|FG000|NOT COMPLETED|Overall Study||2||
48372450|NCT02100748|101239962|FG001|NOT COMPLETED|Overall Study||1||
48372451|NCT02100748|101239963|FG002|NOT COMPLETED|Overall Study||1||
48372452|NCT02100748|101239964|FG003|NOT COMPLETED|Overall Study||1||
48372453|NCT02100748|101239965|FG004|NOT COMPLETED|Overall Study||2||
48372454|NCT02100748|101239966|FG005|NOT COMPLETED|Overall Study||0||
48372455|NCT02100748|101239967|FG006|NOT COMPLETED|Overall Study||2||
48372456|NCT02100748|101239968|FG007|NOT COMPLETED|Overall Study||4||
48372457|NCT02100748|101239969|FG008|NOT COMPLETED|Overall Study||3||
48372458|NCT02100748|101239970|FG009|NOT COMPLETED|Overall Study||2||
48372459|NCT02100748|101239971|FG010|NOT COMPLETED|Overall Study||2||
48372460|NCT02100748|101239972|FG011|NOT COMPLETED|Overall Study||0||
48074256|NCT02207244|100504430|FG009|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0||
48074257|NCT02207244|100504431|FG010|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0||
48074258|NCT02207244|100504421|FG000|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0||
48074259|NCT02207244|100504422|FG001|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0||
48074260|NCT02207244|100504423|FG002|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0||
48074261|NCT02207244|100504424|FG003|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0||
48074262|NCT02207244|100504425|FG004|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0||
48074263|NCT02207244|100504426|FG005|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0||
48074264|NCT02207244|100504427|FG006|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||14||
48074265|NCT02207244|100504428|FG007|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||27||
48074266|NCT02207244|100504429|FG008|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||9||
48074267|NCT02207244|100504430|FG009|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||8||
48074268|NCT02207244|100504431|FG010|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0||
48074269|NCT02207244|100504421|FG000|STARTED|Open-label Guselkumab: Week 72-264||0||
48074270|NCT02207244|100504422|FG001|STARTED|Open-label Guselkumab: Week 72-264||0||
48074271|NCT02207244|100504423|FG002|STARTED|Open-label Guselkumab: Week 72-264||0||
48074272|NCT02207244|100504424|FG003|STARTED|Open-label Guselkumab: Week 72-264||0||
48074273|NCT02207244|100504425|FG004|STARTED|Open-label Guselkumab: Week 72-264||0||
48074274|NCT02207244|100504426|FG005|STARTED|Open-label Guselkumab: Week 72-264||0||
48074275|NCT02207244|100504427|FG006|STARTED|Open-label Guselkumab: Week 72-264||0||
48074276|NCT02207244|100504428|FG007|STARTED|Open-label Guselkumab: Week 72-264||0||
48074277|NCT02207244|100504429|FG008|STARTED|Open-label Guselkumab: Week 72-264||211||
48074278|NCT02207244|100504430|FG009|STARTED|Open-label Guselkumab: Week 72-264||0||
48074279|NCT02207244|100504431|FG010|STARTED|Open-label Guselkumab: Week 72-264||656||
48074280|NCT02207244|100504421|FG000|COMPLETED|Open-label Guselkumab: Week 72-264||0||
48074281|NCT02207244|100504422|FG001|COMPLETED|Open-label Guselkumab: Week 72-264||0||
48074282|NCT02207244|100504423|FG002|COMPLETED|Open-label Guselkumab: Week 72-264||0||
48074283|NCT02207244|100504424|FG003|COMPLETED|Open-label Guselkumab: Week 72-264||0||
48074284|NCT02207244|100504425|FG004|COMPLETED|Open-label Guselkumab: Week 72-264||0||
48074285|NCT02207244|100504426|FG005|COMPLETED|Open-label Guselkumab: Week 72-264||0||
48074286|NCT02207244|100504427|FG006|COMPLETED|Open-label Guselkumab: Week 72-264||0||
48074287|NCT02207244|100504428|FG007|COMPLETED|Open-label Guselkumab: Week 72-264||0||
48074288|NCT02207244|100504429|FG008|COMPLETED|Open-label Guselkumab: Week 72-264||173||
48074289|NCT02207244|100504430|FG009|COMPLETED|Open-label Guselkumab: Week 72-264||0||
48074290|NCT02207244|100504431|FG010|COMPLETED|Open-label Guselkumab: Week 72-264||554||
48074291|NCT02207244|100504421|FG000|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0||
48074292|NCT02207244|100504422|FG001|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0||
48074293|NCT02207244|100504423|FG002|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0||
48074294|NCT02207244|100504424|FG003|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0||
48074295|NCT02207244|100504425|FG004|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0||
48372461|NCT01425190|101239973|FG000|STARTED|Overall Study||16||
48372462|NCT01425190|101239974|FG001|STARTED|Overall Study||0||
48372463|NCT01425190|101239975|FG002|STARTED|Overall Study||0||
48074296|NCT02207244|100504426|FG005|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0||
48074297|NCT02207244|100504427|FG006|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0||
48074298|NCT02207244|100504428|FG007|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0||
48074299|NCT02207244|100504429|FG008|NOT COMPLETED|Open-label Guselkumab: Week 72-264||38||
48074300|NCT02207244|100504430|FG009|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0||
48074301|NCT02207244|100504431|FG010|NOT COMPLETED|Open-label Guselkumab: Week 72-264||102||
48074302|NCT01964430|100504432|FG000|STARTED|Pre-Treatment (Randomization) Period||432||
48074303|NCT01964430|100504433|FG001|STARTED|Pre-Treatment (Randomization) Period||434||
48074304|NCT01964430|100504432|FG000|COMPLETED|Pre-Treatment (Randomization) Period||429|Participants continuing to Treatment|
48074305|NCT01964430|100504433|FG001|COMPLETED|Pre-Treatment (Randomization) Period||423|Participants continuing to Treatment|
48074306|NCT01964430|100504432|FG000|NOT COMPLETED|Pre-Treatment (Randomization) Period||3||
48372464|NCT01425190|101239973|FG000|COMPLETED|Overall Study||15||
48372465|NCT01425190|101239974|FG001|COMPLETED|Overall Study||0||
48372466|NCT01425190|101239975|FG002|COMPLETED|Overall Study||0||
48372467|NCT01425190|101239973|FG000|NOT COMPLETED|Overall Study||1||
48372468|NCT01425190|101239974|FG001|NOT COMPLETED|Overall Study||0||
48372469|NCT01425190|101239975|FG002|NOT COMPLETED|Overall Study||0||
48372470|NCT04009096|101239976|FG000|STARTED|Overall Study||3||
48372471|NCT04009096|101239977|FG001|STARTED|Overall Study||10||
48372472|NCT04009096|101239978|FG002|STARTED|Overall Study||3||
48372473|NCT04009096|101239976|FG000|COMPLETED|Overall Study||3||
48372474|NCT04009096|101239977|FG001|COMPLETED|Overall Study||2||
48372475|NCT04009096|101239978|FG002|COMPLETED|Overall Study||3||
48372476|NCT04009096|101239976|FG000|NOT COMPLETED|Overall Study||0||
48372477|NCT04009096|101239977|FG001|NOT COMPLETED|Overall Study||8||
48372478|NCT04009096|101239978|FG002|NOT COMPLETED|Overall Study||0||
48074307|NCT01964430|100504433|FG001|NOT COMPLETED|Pre-Treatment (Randomization) Period||11||
48074308|NCT01964430|100504432|FG000|STARTED|Treatment Period||429||
48074309|NCT01964430|100504433|FG001|STARTED|Treatment Period||423||
48074310|NCT01964430|100504432|FG000|COMPLETED|Treatment Period||287||
48074311|NCT01964430|100504433|FG001|COMPLETED|Treatment Period||310||
48372479|NCT03648476|101239979|FG000|STARTED|Overall Study||10||
48372480|NCT03648476|101239980|FG001|STARTED|Overall Study||14||
48372481|NCT03648476|101239979|FG000|COMPLETED|Overall Study||8||
48372482|NCT03648476|101239980|FG001|COMPLETED|Overall Study||13||
48372483|NCT03648476|101239979|FG000|NOT COMPLETED|Overall Study||2||
48372484|NCT03648476|101239980|FG001|NOT COMPLETED|Overall Study||1||
48372485|NCT01295112|101239981|FG000|STARTED|Overall Study||35||
48372486|NCT01295112|101239982|FG001|STARTED|Overall Study||33||
48372487|NCT01295112|101239981|FG000|COMPLETED|Overall Study||35||
48372488|NCT01295112|101239982|FG001|COMPLETED|Overall Study||33||
48372489|NCT01295112|101239981|FG000|NOT COMPLETED|Overall Study||0||
48372490|NCT01295112|101239982|FG001|NOT COMPLETED|Overall Study||0||
48372491|NCT01397071|101239983|FG000|STARTED|Consumption of Beef Patty Alone||11||
48372492|NCT01397071|101239983|FG000|COMPLETED|Consumption of Beef Patty Alone||11||
48074312|NCT01964430|100504432|FG000|NOT COMPLETED|Treatment Period||142||
48074313|NCT01964430|100504433|FG001|NOT COMPLETED|Treatment Period||113||
48074314|NCT03792191|100504434|FG000|STARTED|Overall Study||140||
48074315|NCT03792191|100504435|FG001|STARTED|Overall Study||140||
48074316|NCT03792191|100504434|FG000|COMPLETED|Overall Study||140||
48074317|NCT03792191|100504435|FG001|COMPLETED|Overall Study||140||
48074318|NCT03792191|100504434|FG000|NOT COMPLETED|Overall Study||0||
48074319|NCT03792191|100504435|FG001|NOT COMPLETED|Overall Study||0||
48074320|NCT00939770|100504436|FG000|STARTED|Overall Study||6||
48074321|NCT00939770|100504437|FG001|STARTED|Overall Study||8||
48074322|NCT00939770|100504438|FG002|STARTED|Overall Study||23||
48074323|NCT00939770|100504439|FG003|STARTED|Overall Study||12||
48074324|NCT00939770|100504440|FG004|STARTED|Overall Study||38||
48074325|NCT00939770|100504441|FG005|STARTED|Overall Study||11||
48074326|NCT00939770|100504442|FG006|STARTED|Overall Study||14||
48074327|NCT00939770|100504443|FG007|STARTED|Overall Study||10||
48074328|NCT00939770|100504436|FG000|COMPLETED|Overall Study||1||
48074329|NCT00939770|100504437|FG001|COMPLETED|Overall Study||0||
48074330|NCT00939770|100504438|FG002|COMPLETED|Overall Study||3||
48074331|NCT00939770|100504439|FG003|COMPLETED|Overall Study||1||
48074332|NCT00939770|100504440|FG004|COMPLETED|Overall Study||1||
48074333|NCT00939770|100504441|FG005|COMPLETED|Overall Study||0||
48074334|NCT00939770|100504442|FG006|COMPLETED|Overall Study||0||
48074335|NCT00939770|100504443|FG007|COMPLETED|Overall Study||0||
48074336|NCT00939770|100504436|FG000|NOT COMPLETED|Overall Study||5||
48074337|NCT00939770|100504437|FG001|NOT COMPLETED|Overall Study||8||
48372493|NCT01397071|101239983|FG000|NOT COMPLETED|Consumption of Beef Patty Alone||0||
48074338|NCT00939770|100504438|FG002|NOT COMPLETED|Overall Study||20||
48074339|NCT00939770|100504439|FG003|NOT COMPLETED|Overall Study||11||
48074340|NCT00939770|100504440|FG004|NOT COMPLETED|Overall Study||37||
48074341|NCT00939770|100504441|FG005|NOT COMPLETED|Overall Study||11||
48074342|NCT00939770|100504442|FG006|NOT COMPLETED|Overall Study||14||
48074343|NCT00939770|100504443|FG007|NOT COMPLETED|Overall Study||10||
48372494|NCT01397071|101239983|FG000|STARTED|Consumption of Beef Patty With Avocado||11||
48372495|NCT01397071|101239983|FG000|COMPLETED|Consumption of Beef Patty With Avocado||11||
48372496|NCT01397071|101239983|FG000|NOT COMPLETED|Consumption of Beef Patty With Avocado||0||
48074344|NCT02983825|100504444|FG000|STARTED|Overall Study||12||
48074345|NCT02983825|100504444|FG000|COMPLETED|Overall Study||9||
48074346|NCT02983825|100504444|FG000|NOT COMPLETED|Overall Study||3||
48372497|NCT00532883|101239984|FG000|STARTED|Overall Study||11||
48372498|NCT00532883|101239985|FG001|STARTED|Overall Study||12||
48074347|NCT03693300|100504445|FG000|STARTED|Overall Study||114||
48372499|NCT00532883|101239986|FG002|STARTED|Overall Study||10||
48372500|NCT00532883|101239987|FG003|STARTED|Overall Study||11||
48372501|NCT00532883|101239984|FG000|COMPLETED|Overall Study||5||
48372502|NCT00532883|101239985|FG001|COMPLETED|Overall Study||5||
48372503|NCT00532883|101239986|FG002|COMPLETED|Overall Study||6||
48372504|NCT00532883|101239987|FG003|COMPLETED|Overall Study||6||
48372505|NCT00532883|101239984|FG000|NOT COMPLETED|Overall Study||6||
48372506|NCT00532883|101239985|FG001|NOT COMPLETED|Overall Study||7||
48372507|NCT00532883|101239986|FG002|NOT COMPLETED|Overall Study||4||
48372508|NCT00532883|101239987|FG003|NOT COMPLETED|Overall Study||5||
48372509|NCT01958671|101239988|FG000|STARTED|Overall Study||156||
48372510|NCT01958671|101239989|FG001|STARTED|Overall Study||152||
48074348|NCT03693300|100504446|FG001|STARTED|Overall Study||3||
48074349|NCT03693300|100504445|FG000|COMPLETED|Overall Study||56||
48074350|NCT03693300|100504446|FG001|COMPLETED|Overall Study||1||
48074351|NCT03693300|100504445|FG000|NOT COMPLETED|Overall Study||58||
48074352|NCT03693300|100504446|FG001|NOT COMPLETED|Overall Study||2||
48074353|NCT00282984|100504447|FG000|STARTED|Overall Study||353||
48074354|NCT00282984|100504448|FG001|STARTED|Overall Study||350||
48074355|NCT00282984|100504447|FG000|COMPLETED|Overall Study||302||
48074356|NCT00282984|100504448|FG001|COMPLETED|Overall Study||289||
48074357|NCT00282984|100504447|FG000|NOT COMPLETED|Overall Study||51||
48074358|NCT00282984|100504448|FG001|NOT COMPLETED|Overall Study||61||
48074359|NCT02400333|100504449|FG000|STARTED|Overall Study||9||
48074360|NCT02400333|100504450|FG001|STARTED|Overall Study||9||
48074361|NCT02400333|100504451|FG002|STARTED|Overall Study||9||
48074362|NCT02400333|100504452|FG003|STARTED|Overall Study||9||
48074363|NCT02400333|100504449|FG000|COMPLETED|Overall Study||8||
48074364|NCT02400333|100504450|FG001|COMPLETED|Overall Study||8||
48074365|NCT02400333|100504451|FG002|COMPLETED|Overall Study||7||
48074366|NCT02400333|100504452|FG003|COMPLETED|Overall Study||7||
48074367|NCT02400333|100504449|FG000|NOT COMPLETED|Overall Study||1||
48074368|NCT02400333|100504450|FG001|NOT COMPLETED|Overall Study||1||
48074369|NCT02400333|100504451|FG002|NOT COMPLETED|Overall Study||2||
48074370|NCT02400333|100504452|FG003|NOT COMPLETED|Overall Study||2||
48074371|NCT01084083|100504453|FG000|STARTED|Overall Study||90||
48074372|NCT01084083|100504453|FG000|Treated|Overall Study||89||
48074373|NCT01084083|100504453|FG000|Eligible|Overall Study||81||
48074374|NCT01084083|100504453|FG000|Eligible and Treated|Overall Study||80||
48074375|NCT01084083|100504453|FG000|CR to Induction Therapy|Overall Study||56||
48074376|NCT01084083|100504453|FG000|CR and Treated With 5400 cGy IMRT|Overall Study||44||
48074377|NCT01084083|100504453|FG000|COMPLETED|Overall Study||78||
48074378|NCT01084083|100504453|FG000|NOT COMPLETED|Overall Study||12||
48074379|NCT00594659|100504454|FG000|STARTED|Overall Study||29||
48074380|NCT00594659|100504455|FG001|STARTED|Overall Study||30||
48074381|NCT00594659|100504456|FG002|STARTED|Overall Study||16||
48074382|NCT00594659|100504454|FG000|COMPLETED|Overall Study||16||
48074383|NCT00594659|100504455|FG001|COMPLETED|Overall Study||21||
48074384|NCT00594659|100504456|FG002|COMPLETED|Overall Study||9||
48074385|NCT00594659|100504454|FG000|NOT COMPLETED|Overall Study||13||
48074386|NCT00594659|100504455|FG001|NOT COMPLETED|Overall Study||9||
48074387|NCT00594659|100504456|FG002|NOT COMPLETED|Overall Study||7||
48074388|NCT00730132|100504457|FG000|STARTED|Overall Study||712||
48074389|NCT00730132|100504457|FG000|COMPLETED|Overall Study||557||
48074390|NCT00730132|100504457|FG000|NOT COMPLETED|Overall Study||155||
48074391|NCT01211730|100504458|FG000|STARTED|Overall Study||82||
48074392|NCT01211730|100504459|FG001|STARTED|Overall Study||82||
48074393|NCT01211730|100504458|FG000|COMPLETED|Overall Study||82||
48074394|NCT01211730|100504459|FG001|COMPLETED|Overall Study||82||
48074395|NCT01211730|100504458|FG000|NOT COMPLETED|Overall Study||0||
48074396|NCT01211730|100504459|FG001|NOT COMPLETED|Overall Study||0||
48074397|NCT04456959|100504460|FG000|STARTED|Overall Study||28||
48074398|NCT04456959|100504460|FG000|COMPLETED|Overall Study||28||
48372511|NCT01958671|101239990|FG002|STARTED|Overall Study||153||
48074399|NCT04456959|100504460|FG000|NOT COMPLETED|Overall Study||0||
48074400|NCT02030041|100504461|FG000|STARTED|Overall Study||11||
48074401|NCT02030041|100504462|FG001|STARTED|Overall Study||11||
48074402|NCT02030041|100504463|FG002|STARTED|Overall Study||11||
48074403|NCT02030041|100504461|FG000|COMPLETED|Overall Study||9||
48074404|NCT02030041|100504462|FG001|COMPLETED|Overall Study||9||
48074405|NCT02030041|100504463|FG002|COMPLETED|Overall Study||10||
48074406|NCT02030041|100504461|FG000|NOT COMPLETED|Overall Study||2||
48074407|NCT02030041|100504462|FG001|NOT COMPLETED|Overall Study||2||
48074408|NCT02030041|100504463|FG002|NOT COMPLETED|Overall Study||1||
48074409|NCT01317030|100504464|FG000|STARTED|Overall Study||12||
48074410|NCT01317030|100504465|FG001|STARTED|Overall Study||13||
48074411|NCT01317030|100504464|FG000|COMPLETED|Overall Study||12||
48074412|NCT01317030|100504465|FG001|COMPLETED|Overall Study||13||
48074413|NCT01317030|100504464|FG000|NOT COMPLETED|Overall Study||0||
48372512|NCT01958671|101239988|FG000|COMPLETED|Overall Study||137||
48074414|NCT01317030|100504465|FG001|NOT COMPLETED|Overall Study||0||
48074415|NCT02993757|100504466|FG000|STARTED|Overall Study||266||
48074416|NCT02993757|100504467|FG001|STARTED|Overall Study||262||
48074417|NCT02993757|100504466|FG000|Safety Analysis Set (SafAS)|Overall Study||263|SafAS was defined as participants who had received at least 1 dose of study vaccines.|
48074418|NCT02993757|100504467|FG001|Safety Analysis Set (SafAS)|Overall Study||260|SafAS was defined as participants who had received at least 1 dose of study vaccines.|
48074419|NCT02993757|100504466|FG000|COMPLETED|Overall Study||102||
48074420|NCT02993757|100504467|FG001|COMPLETED|Overall Study||84||
48074421|NCT02993757|100504466|FG000|NOT COMPLETED|Overall Study||164||
48074422|NCT02993757|100504467|FG001|NOT COMPLETED|Overall Study||178||
48074423|NCT02158273|100504468|FG000|STARTED|Overall Study||25||
48074424|NCT02158273|100504469|FG001|STARTED|Overall Study||25||
48074425|NCT02158273|100504468|FG000|COMPLETED|Overall Study||22||
48074426|NCT02158273|100504469|FG001|COMPLETED|Overall Study||22||
48074427|NCT02158273|100504468|FG000|NOT COMPLETED|Overall Study||3||
48074428|NCT02158273|100504469|FG001|NOT COMPLETED|Overall Study||3||
48074429|NCT02516046|100504470|FG000|STARTED|Overall Study||156||
48074430|NCT02516046|100504470|FG000|Died While on Study|Overall Study||73||
48074431|NCT02516046|100504470|FG000|Valid Autopsy Results and PET Scan|Overall Study||67||
48074432|NCT02516046|100504470|FG000|COMPLETED|Overall Study||64||
48074433|NCT02516046|100504470|FG000|NOT COMPLETED|Overall Study||92||
48074434|NCT00401531|100504471|FG000|STARTED|Overall Study||206||
48074435|NCT00401531|100504472|FG001|STARTED|Overall Study||206||
48074436|NCT00401531|100504471|FG000|COMPLETED|Overall Study||197||
48074437|NCT00401531|100504472|FG001|COMPLETED|Overall Study||196||
48074438|NCT00401531|100504471|FG000|NOT COMPLETED|Overall Study||9||
48074439|NCT00401531|100504472|FG001|NOT COMPLETED|Overall Study||10||
48074440|NCT00873912|100504473|FG000|STARTED|Overall Study||240||
48074441|NCT00873912|100504474|FG001|STARTED|Overall Study||60||
48074442|NCT00873912|100504473|FG000|COMPLETED|Overall Study||237||
48074443|NCT00873912|100504474|FG001|COMPLETED|Overall Study||60||
48074444|NCT00873912|100504473|FG000|NOT COMPLETED|Overall Study||3||
48074445|NCT00873912|100504474|FG001|NOT COMPLETED|Overall Study||0||
48074446|NCT02610725|100504475|FG000|STARTED|Overall Study||281||
48074447|NCT02610725|100504475|FG000|COMPLETED|Overall Study||75||
48074448|NCT02610725|100504475|FG000|NOT COMPLETED|Overall Study||206||
48074449|NCT01637935|100504476|FG000|STARTED|Overall Study||34181||
48074450|NCT01637935|100504477|FG001|STARTED|Overall Study||158918||
48074451|NCT01637935|100504476|FG000|COMPLETED|Overall Study||34181||
48074452|NCT01637935|100504477|FG001|COMPLETED|Overall Study||158918||
48074453|NCT01637935|100504476|FG000|NOT COMPLETED|Overall Study||0||
48226981|NCT01079806|100877890|FG001|STARTED|Day 1 to Week 96||60||
48226982|NCT01079806|100877889|FG000|Received Treatment|Day 1 to Week 96||120||
48226983|NCT01079806|100877890|FG001|Received Treatment|Day 1 to Week 96||60||
48226984|NCT01079806|100877889|FG000|Primary Endpoint Cohort|Day 1 to Week 96||82||
48226985|NCT01079806|100877890|FG001|Primary Endpoint Cohort|Day 1 to Week 96||41||
48372513|NCT01958671|101239989|FG001|COMPLETED|Overall Study||128||
48372514|NCT01958671|101239990|FG002|COMPLETED|Overall Study||121||
48372515|NCT01958671|101239988|FG000|NOT COMPLETED|Overall Study||19||
48372516|NCT01958671|101239989|FG001|NOT COMPLETED|Overall Study||24||
48372517|NCT01958671|101239990|FG002|NOT COMPLETED|Overall Study||32||
48372518|NCT01469013|101239991|FG000|STARTED|Part A (Treatment Period)||24||
48372519|NCT01469013|101239992|FG001|STARTED|Part A (Treatment Period)||24||
48372520|NCT01469013|101239993|FG002|STARTED|Part A (Treatment Period)||24||
48372521|NCT01469013|101239994|FG003|STARTED|Part A (Treatment Period)||24||
48372522|NCT01469013|101239995|FG004|STARTED|Part A (Treatment Period)||49||
48372523|NCT01469013|101239996|FG005|STARTED|Part A (Treatment Period)||0||
48372524|NCT01469013|101239997|FG006|STARTED|Part A (Treatment Period)||0||
48372525|NCT01469013|101239998|FG007|STARTED|Part A (Treatment Period)||0||
48372526|NCT01469013|101239999|FG008|STARTED|Part A (Treatment Period)||0||
48372527|NCT01469013|101240000|FG009|STARTED|Part A (Treatment Period)||0||
48372528|NCT01469013|101240001|FG010|STARTED|Part A (Treatment Period)||0||
48372529|NCT01469013|101240002|FG011|STARTED|Part A (Treatment Period)||0||
48372530|NCT01469013|101240003|FG012|STARTED|Part A (Treatment Period)||0||
48372531|NCT01469013|101239991|FG000|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24||
48372532|NCT01469013|101239992|FG001|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24||
48074454|NCT01637935|100504477|FG001|NOT COMPLETED|Overall Study||0||
48074455|NCT01534962|100504478|FG000|STARTED|Overall Study||67||
48074456|NCT01534962|100504479|FG001|STARTED|Overall Study||60||
48074457|NCT01534962|100504480|FG002|STARTED|Overall Study||58||
48074458|NCT01534962|100504481|FG003|STARTED|Overall Study||56||
48074459|NCT01534962|100504478|FG000|COMPLETED|Overall Study||30||
48226986|NCT01079806|100877889|FG000|COMPLETED|Day 1 to Week 96||113||
48226987|NCT01079806|100877890|FG001|COMPLETED|Day 1 to Week 96||53||
48226988|NCT01079806|100877889|FG000|NOT COMPLETED|Day 1 to Week 96||7||
48226989|NCT01079806|100877890|FG001|NOT COMPLETED|Day 1 to Week 96||7||
48226990|NCT01079806|100877889|FG000|STARTED|Long-term Follow-up: Day 1-End of Study||111|Entered from start to end of long-term follow-up|
48226991|NCT01079806|100877890|FG001|STARTED|Long-term Follow-up: Day 1-End of Study||58|Entered from start to end of long-term follow-up|
48226992|NCT01079806|100877889|FG000|COMPLETED|Long-term Follow-up: Day 1-End of Study||92||
48372533|NCT01469013|101239993|FG002|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24||
48372534|NCT01469013|101239994|FG003|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24||
48372535|NCT01469013|101239995|FG004|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||49||
48372536|NCT01469013|101239996|FG005|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0||
48372537|NCT01469013|101239997|FG006|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0||
48372538|NCT01469013|101239998|FG007|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0||
48372539|NCT01469013|101239999|FG008|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0||
48372540|NCT01469013|101240000|FG009|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0||
48372541|NCT01469013|101240001|FG010|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0||
48372542|NCT01469013|101240002|FG011|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0||
48372543|NCT01469013|101240003|FG012|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0||
48226993|NCT01079806|100877890|FG001|COMPLETED|Long-term Follow-up: Day 1-End of Study||43||
48226994|NCT01079806|100877889|FG000|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||19||
48226995|NCT01079806|100877890|FG001|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||15||
48226996|NCT01888484|100877891|FG000|STARTED|Overall Study||12||
48226997|NCT01888484|100877892|FG001|STARTED|Overall Study||14||
48226998|NCT01888484|100877893|FG002|STARTED|Overall Study||12||
48226999|NCT01888484|100877894|FG003|STARTED|Overall Study||37||
48227000|NCT01888484|100877891|FG000|COMPLETED|Overall Study||12||
48372544|NCT01469013|101239991|FG000|COMPLETED|Part A (Treatment Period)||23||
48372545|NCT01469013|101239992|FG001|COMPLETED|Part A (Treatment Period)||24||
48372546|NCT01469013|101239993|FG002|COMPLETED|Part A (Treatment Period)||23||
48372547|NCT01469013|101239994|FG003|COMPLETED|Part A (Treatment Period)||24||
48372548|NCT01469013|101239995|FG004|COMPLETED|Part A (Treatment Period)||48||
48372549|NCT01469013|101239996|FG005|COMPLETED|Part A (Treatment Period)||0||
48372550|NCT01469013|101239997|FG006|COMPLETED|Part A (Treatment Period)||0||
48372551|NCT01469013|101239998|FG007|COMPLETED|Part A (Treatment Period)||0||
48372552|NCT01469013|101239999|FG008|COMPLETED|Part A (Treatment Period)||0||
48372553|NCT01469013|101240000|FG009|COMPLETED|Part A (Treatment Period)||0||
48372554|NCT01469013|101240001|FG010|COMPLETED|Part A (Treatment Period)||0||
48372555|NCT01469013|101240002|FG011|COMPLETED|Part A (Treatment Period)||0||
48372556|NCT01469013|101240003|FG012|COMPLETED|Part A (Treatment Period)||0||
48372557|NCT01469013|101239991|FG000|NOT COMPLETED|Part A (Treatment Period)||1||
48372558|NCT01469013|101239992|FG001|NOT COMPLETED|Part A (Treatment Period)||0||
48372559|NCT01469013|101239993|FG002|NOT COMPLETED|Part A (Treatment Period)||1||
48372560|NCT01469013|101239994|FG003|NOT COMPLETED|Part A (Treatment Period)||0||
48372561|NCT01469013|101239995|FG004|NOT COMPLETED|Part A (Treatment Period)||1||
48372562|NCT01469013|101239996|FG005|NOT COMPLETED|Part A (Treatment Period)||0||
48372563|NCT01469013|101239997|FG006|NOT COMPLETED|Part A (Treatment Period)||0||
48372564|NCT01469013|101239998|FG007|NOT COMPLETED|Part A (Treatment Period)||0||
48372565|NCT01469013|101239999|FG008|NOT COMPLETED|Part A (Treatment Period)||0||
48372566|NCT01469013|101240000|FG009|NOT COMPLETED|Part A (Treatment Period)||0||
48372567|NCT01469013|101240001|FG010|NOT COMPLETED|Part A (Treatment Period)||0||
48372568|NCT01469013|101240002|FG011|NOT COMPLETED|Part A (Treatment Period)||0||
48372569|NCT01469013|101240003|FG012|NOT COMPLETED|Part A (Treatment Period)||0||
48372570|NCT01469013|101239991|FG000|STARTED|Part B (Extension Period)||0||
48372571|NCT01469013|101239992|FG001|STARTED|Part B (Extension Period)||0||
48372572|NCT01469013|101239993|FG002|STARTED|Part B (Extension Period)||0||
48227001|NCT01888484|100877892|FG001|COMPLETED|Overall Study||14||
48227002|NCT01888484|100877893|FG002|COMPLETED|Overall Study||8||
48227003|NCT01888484|100877894|FG003|COMPLETED|Overall Study||34||
48227004|NCT01888484|100877891|FG000|NOT COMPLETED|Overall Study||0||
48227005|NCT01888484|100877892|FG001|NOT COMPLETED|Overall Study||0||
48227006|NCT01888484|100877893|FG002|NOT COMPLETED|Overall Study||4||
48227007|NCT01888484|100877894|FG003|NOT COMPLETED|Overall Study||3||
48227008|NCT00890591|100877895|FG000|STARTED|Overall Study||144||
48227009|NCT00890591|100877895|FG000|COMPLETED|Overall Study||124||
48227010|NCT00890591|100877895|FG000|NOT COMPLETED|Overall Study||20||
48227011|NCT02067819|100877896|FG000|STARTED|Overall Study||11||
48227012|NCT02067819|100877897|FG001|STARTED|Overall Study||10||
48227013|NCT02067819|100877896|FG000|COMPLETED|Overall Study||6||
48227014|NCT02067819|100877897|FG001|COMPLETED|Overall Study||7||
48227015|NCT02067819|100877896|FG000|NOT COMPLETED|Overall Study||5||
48227016|NCT02067819|100877897|FG001|NOT COMPLETED|Overall Study||3||
48227017|NCT02760654|100877898|FG000|STARTED|Overall Study||30|Randomized|
48227018|NCT02760654|100877899|FG001|STARTED|Overall Study||30|Randomized|
48227019|NCT02760654|100877898|FG000|COMPLETED|Overall Study||23||
48372573|NCT01469013|101239994|FG003|STARTED|Part B (Extension Period)||0||
48372574|NCT01469013|101239995|FG004|STARTED|Part B (Extension Period)||0||
48372575|NCT01469013|101239996|FG005|STARTED|Part B (Extension Period)||12||
48372576|NCT01469013|101239997|FG006|STARTED|Part B (Extension Period)||12||
48372577|NCT01469013|101239998|FG007|STARTED|Part B (Extension Period)||23||
48372578|NCT01469013|101239999|FG008|STARTED|Part B (Extension Period)||24||
48372579|NCT01469013|101240000|FG009|STARTED|Part B (Extension Period)||11||
48372580|NCT01469013|101240001|FG010|STARTED|Part B (Extension Period)||12||
48227020|NCT02760654|100877899|FG001|COMPLETED|Overall Study||24||
48227021|NCT02760654|100877898|FG000|NOT COMPLETED|Overall Study||7||
48227022|NCT02760654|100877899|FG001|NOT COMPLETED|Overall Study||6||
48227023|NCT02410278|100877900|FG000|STARTED|Run-in Period||102||
48227024|NCT02410278|100877901|FG001|STARTED|Run-in Period||0||
48227025|NCT02410278|100877902|FG002|STARTED|Run-in Period||0||
48372581|NCT01469013|101240002|FG011|STARTED|Part B (Extension Period)||24||
48372582|NCT01469013|101240003|FG012|STARTED|Part B (Extension Period)||24||
48372583|NCT01469013|101239991|FG000|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0||
48372584|NCT01469013|101239992|FG001|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0||
48372585|NCT01469013|101239993|FG002|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0||
48372586|NCT01469013|101239994|FG003|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0||
48372587|NCT01469013|101239995|FG004|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0||
48372588|NCT01469013|101239996|FG005|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12||
48372589|NCT01469013|101239997|FG006|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12||
48227026|NCT02410278|100877900|FG000|Received at Least 1 Dose of DMF|Run-in Period||98||
48227027|NCT02410278|100877901|FG001|Received at Least 1 Dose of DMF|Run-in Period||0||
48227028|NCT02410278|100877902|FG002|Received at Least 1 Dose of DMF|Run-in Period||0||
48227029|NCT02410278|100877900|FG000|COMPLETED|Run-in Period||64||
48227030|NCT02410278|100877901|FG001|COMPLETED|Run-in Period||0||
48227031|NCT02410278|100877902|FG002|COMPLETED|Run-in Period||0||
48227032|NCT02410278|100877900|FG000|NOT COMPLETED|Run-in Period||38||
48227033|NCT02410278|100877901|FG001|NOT COMPLETED|Run-in Period||0||
48227034|NCT02410278|100877902|FG002|NOT COMPLETED|Run-in Period||0||
48227035|NCT02410278|100877900|FG000|STARTED|Study Treatment Period||0||
48227036|NCT02410278|100877901|FG001|STARTED|Study Treatment Period||31||
48227037|NCT02410278|100877902|FG002|STARTED|Study Treatment Period||33||
48227038|NCT02410278|100877900|FG000|Modified Intent-to Treat(mITT)Population|Study Treatment Period||0||
48227039|NCT02410278|100877901|FG001|Modified Intent-to Treat(mITT)Population|Study Treatment Period||30||
48227040|NCT02410278|100877902|FG002|Modified Intent-to Treat(mITT)Population|Study Treatment Period||33||
48227041|NCT02410278|100877900|FG000|Completed Randomized Study Treatment|Study Treatment Period||0||
48227042|NCT02410278|100877901|FG001|Completed Randomized Study Treatment|Study Treatment Period||20||
48227043|NCT02410278|100877902|FG002|Completed Randomized Study Treatment|Study Treatment Period||29||
48372590|NCT01469013|101239998|FG007|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||23||
48372591|NCT01469013|101239999|FG008|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||24||
48372592|NCT01469013|101240000|FG009|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||11||
48372593|NCT01469013|101240001|FG010|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12||
48372594|NCT01469013|101240002|FG011|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||24||
48372595|NCT01469013|101240003|FG012|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||23||
48372596|NCT01469013|101239991|FG000|COMPLETED|Part B (Extension Period)||0||
48372597|NCT01469013|101239992|FG001|COMPLETED|Part B (Extension Period)||0||
48372598|NCT01469013|101239993|FG002|COMPLETED|Part B (Extension Period)||0||
48372599|NCT01469013|101239994|FG003|COMPLETED|Part B (Extension Period)||0||
48372600|NCT01469013|101239995|FG004|COMPLETED|Part B (Extension Period)||0||
48372601|NCT01469013|101239996|FG005|COMPLETED|Part B (Extension Period)||10||
48372602|NCT01469013|101239997|FG006|COMPLETED|Part B (Extension Period)||7||
48372603|NCT01469013|101239998|FG007|COMPLETED|Part B (Extension Period)||18||
48372604|NCT01469013|101239999|FG008|COMPLETED|Part B (Extension Period)||20||
48372605|NCT01469013|101240000|FG009|COMPLETED|Part B (Extension Period)||8||
48372606|NCT01469013|101240001|FG010|COMPLETED|Part B (Extension Period)||10||
48372607|NCT01469013|101240002|FG011|COMPLETED|Part B (Extension Period)||18||
48372608|NCT01469013|101240003|FG012|COMPLETED|Part B (Extension Period)||18||
48372609|NCT01469013|101239991|FG000|NOT COMPLETED|Part B (Extension Period)||0||
48372610|NCT01469013|101239992|FG001|NOT COMPLETED|Part B (Extension Period)||0||
48372611|NCT01469013|101239993|FG002|NOT COMPLETED|Part B (Extension Period)||0||
48372612|NCT01469013|101239994|FG003|NOT COMPLETED|Part B (Extension Period)||0||
48372613|NCT01469013|101239995|FG004|NOT COMPLETED|Part B (Extension Period)||0||
48227044|NCT02410278|100877900|FG000|COMPLETED|Study Treatment Period||0||
48227045|NCT02410278|100877901|FG001|COMPLETED|Study Treatment Period||20||
48227046|NCT02410278|100877902|FG002|COMPLETED|Study Treatment Period||29||
48227047|NCT02410278|100877900|FG000|NOT COMPLETED|Study Treatment Period||0||
48227048|NCT02410278|100877901|FG001|NOT COMPLETED|Study Treatment Period||11||
48227049|NCT02410278|100877902|FG002|NOT COMPLETED|Study Treatment Period||4||
48227050|NCT00695188|100877903|FG000|STARTED|Overall Study||10||
48227051|NCT00695188|100877904|FG001|STARTED|Overall Study||9||
48227052|NCT00695188|100877903|FG000|COMPLETED|Overall Study||10||
48227053|NCT00695188|100877904|FG001|COMPLETED|Overall Study||9||
48227054|NCT00695188|100877903|FG000|NOT COMPLETED|Overall Study||0||
48227055|NCT00695188|100877904|FG001|NOT COMPLETED|Overall Study||0||
48227056|NCT00713596|100877905|FG000|STARTED|Overall Study||9||
48227057|NCT00713596|100877906|FG001|STARTED|Overall Study||8||
48372614|NCT01469013|101239996|FG005|NOT COMPLETED|Part B (Extension Period)||2||
48372615|NCT01469013|101239997|FG006|NOT COMPLETED|Part B (Extension Period)||5||
48372616|NCT01469013|101239998|FG007|NOT COMPLETED|Part B (Extension Period)||5||
48372617|NCT01469013|101239999|FG008|NOT COMPLETED|Part B (Extension Period)||4||
48372618|NCT01469013|101240000|FG009|NOT COMPLETED|Part B (Extension Period)||3||
48227058|NCT00713596|100877907|FG002|STARTED|Overall Study||8||
48227059|NCT00713596|100877905|FG000|COMPLETED|Overall Study||7||
48227060|NCT00713596|100877906|FG001|COMPLETED|Overall Study||5||
48227061|NCT00713596|100877907|FG002|COMPLETED|Overall Study||6||
48227062|NCT00713596|100877905|FG000|NOT COMPLETED|Overall Study||2||
48227063|NCT00713596|100877906|FG001|NOT COMPLETED|Overall Study||3||
48227064|NCT00713596|100877907|FG002|NOT COMPLETED|Overall Study||2||
48227065|NCT00747006|100877908|FG000|STARTED|Overall Study||7||
48372619|NCT01469013|101240001|FG010|NOT COMPLETED|Part B (Extension Period)||2||
48372620|NCT01469013|101240002|FG011|NOT COMPLETED|Part B (Extension Period)||6||
48372621|NCT01469013|101240003|FG012|NOT COMPLETED|Part B (Extension Period)||6||
48227066|NCT00747006|100877909|FG001|STARTED|Overall Study||8||
48227067|NCT00747006|100877910|FG002|STARTED|Overall Study||3||
48227068|NCT00747006|100877908|FG000|COMPLETED|Overall Study||4||
48227069|NCT00747006|100877909|FG001|COMPLETED|Overall Study||7||
48227070|NCT00747006|100877910|FG002|COMPLETED|Overall Study||2||
48227071|NCT00747006|100877908|FG000|NOT COMPLETED|Overall Study||3||
48227072|NCT00747006|100877909|FG001|NOT COMPLETED|Overall Study||1||
48227073|NCT00747006|100877910|FG002|NOT COMPLETED|Overall Study||1||
48227074|NCT05741450|100877911|FG000|STARTED|Period 1: Lens 1, 15 Minutes||45||
48227075|NCT05741450|100877912|FG001|STARTED|Period 1: Lens 1, 15 Minutes||0||
48227076|NCT05741450|100877911|FG000|COMPLETED|Period 1: Lens 1, 15 Minutes||45||
48227077|NCT05741450|100877912|FG001|COMPLETED|Period 1: Lens 1, 15 Minutes||0||
48227078|NCT05741450|100877911|FG000|NOT COMPLETED|Period 1: Lens 1, 15 Minutes||0||
48227079|NCT05741450|100877912|FG001|NOT COMPLETED|Period 1: Lens 1, 15 Minutes||0||
48227080|NCT05741450|100877911|FG000|STARTED|Period 2: Lens 2, 15 Minutes||0||
48227081|NCT05741450|100877912|FG001|STARTED|Period 2: Lens 2, 15 Minutes||45||
48227082|NCT05741450|100877911|FG000|COMPLETED|Period 2: Lens 2, 15 Minutes||0||
48227083|NCT05741450|100877912|FG001|COMPLETED|Period 2: Lens 2, 15 Minutes||45||
48227084|NCT05741450|100877911|FG000|NOT COMPLETED|Period 2: Lens 2, 15 Minutes||0||
48227085|NCT05741450|100877912|FG001|NOT COMPLETED|Period 2: Lens 2, 15 Minutes||0||
48227086|NCT01536366|100877913|FG000|STARTED|Overall Study||14||
48227087|NCT01536366|100877914|FG001|STARTED|Overall Study||13||
48227088|NCT01536366|100877913|FG000|BIA 9-1067 + Repaglinide|Overall Study||14||
48227089|NCT01536366|100877914|FG001|BIA 9-1067 + Repaglinide|Overall Study||10||
48227090|NCT01536366|100877913|FG000|Repaglinide|Overall Study||14||
48227091|NCT01536366|100877914|FG001|Repaglinide|Overall Study||13||
48227092|NCT01536366|100877913|FG000|Follow-up|Overall Study||13||
48227093|NCT01536366|100877914|FG001|Follow-up|Overall Study||9||
48227094|NCT01536366|100877913|FG000|COMPLETED|Overall Study||1||
48227095|NCT01536366|100877914|FG001|COMPLETED|Overall Study||9||
48227096|NCT01536366|100877913|FG000|NOT COMPLETED|Overall Study||13||
48227097|NCT01536366|100877914|FG001|NOT COMPLETED|Overall Study||4||
48227098|NCT01209195|100877915|FG000|STARTED|Overall Study||7||
48227099|NCT01209195|100877916|FG001|STARTED|Overall Study||3||
48227100|NCT01209195|100877917|FG002|STARTED|Overall Study||6||
48227101|NCT01209195|100877918|FG003|STARTED|Overall Study||6||
48227102|NCT01209195|100877919|FG004|STARTED|Overall Study||6||
48227103|NCT01209195|100877920|FG005|STARTED|Overall Study||13||
48227104|NCT01209195|100877915|FG000|COMPLETED|Overall Study||7||
48227105|NCT01209195|100877916|FG001|COMPLETED|Overall Study||3||
48227106|NCT01209195|100877917|FG002|COMPLETED|Overall Study||6||
48227107|NCT01209195|100877918|FG003|COMPLETED|Overall Study||6||
48227108|NCT01209195|100877919|FG004|COMPLETED|Overall Study||6||
48227109|NCT01209195|100877920|FG005|COMPLETED|Overall Study||13||
48227110|NCT01209195|100877915|FG000|NOT COMPLETED|Overall Study||0||
48227111|NCT01209195|100877916|FG001|NOT COMPLETED|Overall Study||0||
48227112|NCT01209195|100877917|FG002|NOT COMPLETED|Overall Study||0||
48227113|NCT01209195|100877918|FG003|NOT COMPLETED|Overall Study||0||
48227114|NCT01209195|100877919|FG004|NOT COMPLETED|Overall Study||0||
48227115|NCT01209195|100877920|FG005|NOT COMPLETED|Overall Study||0||
48227116|NCT00022672|100877921|FG000|STARTED|Main Phase: 24 Months||103||
48227117|NCT00022672|100877922|FG001|STARTED|Main Phase: 24 Months||104||
48227118|NCT00022672|100877921|FG000|Safety Set: Received Study Drug|Main Phase: 24 Months||103||
48227119|NCT00022672|100877922|FG001|Safety Set: Received Study Drug|Main Phase: 24 Months||104||
48227120|NCT00022672|100877921|FG000|COMPLETED|Main Phase: 24 Months||16||
48227121|NCT00022672|100877922|FG001|COMPLETED|Main Phase: 24 Months||4||
48227122|NCT00022672|100877921|FG000|NOT COMPLETED|Main Phase: 24 Months||87||
48227123|NCT00022672|100877922|FG001|NOT COMPLETED|Main Phase: 24 Months||100||
48227124|NCT00022672|100877921|FG000|STARTED|Extension Phase||14||
48227125|NCT00022672|100877922|FG001|STARTED|Extension Phase||58||
48227126|NCT00022672|100877921|FG000|Safety Set: Received Study Drug|Extension Phase||14||
48227127|NCT00022672|100877922|FG001|Safety Set: Received Study Drug|Extension Phase||58||
48227128|NCT00022672|100877921|FG000|COMPLETED|Extension Phase||11||
48227129|NCT00022672|100877922|FG001|COMPLETED|Extension Phase||7||
48227130|NCT00022672|100877921|FG000|NOT COMPLETED|Extension Phase||3||
48227131|NCT00022672|100877922|FG001|NOT COMPLETED|Extension Phase||51||
48372622|NCT00807846|101240004|FG000|STARTED|Overall Study||100||
48227132|NCT02261805|100877923|FG000|STARTED|Overall Study||3||
48227133|NCT02261805|100877924|FG001|STARTED|Overall Study||6||
48227134|NCT02261805|100877925|FG002|STARTED|Overall Study||2||
48372623|NCT00807846|101240005|FG001|STARTED|Overall Study||98||
48227135|NCT02261805|100877923|FG000|COMPLETED|Overall Study||3||
48227136|NCT02261805|100877924|FG001|COMPLETED|Overall Study||6||
48227137|NCT02261805|100877925|FG002|COMPLETED|Overall Study||2||
48227138|NCT02261805|100877923|FG000|NOT COMPLETED|Overall Study||0||
48227139|NCT02261805|100877924|FG001|NOT COMPLETED|Overall Study||0||
48227140|NCT02261805|100877925|FG002|NOT COMPLETED|Overall Study||0||
48227141|NCT05313412|100877926|FG000|STARTED|Overall Study||19||
48227142|NCT05313412|100877927|FG001|STARTED|Overall Study||19||
48227143|NCT05313412|100877926|FG000|COMPLETED|Overall Study||19||
48227144|NCT05313412|100877927|FG001|COMPLETED|Overall Study||19||
48227145|NCT05313412|100877926|FG000|NOT COMPLETED|Overall Study||0||
48227146|NCT05313412|100877927|FG001|NOT COMPLETED|Overall Study||0||
48227147|NCT03960957|100877928|FG000|STARTED|Overall Study||224||
48227148|NCT03960957|100877929|FG001|STARTED|Overall Study||77||
48227149|NCT03960957|100877928|FG000|COMPLETED|Overall Study||216||
48227150|NCT03960957|100877929|FG001|COMPLETED|Overall Study||71||
48227151|NCT03960957|100877928|FG000|NOT COMPLETED|Overall Study||8||
48227152|NCT03960957|100877929|FG001|NOT COMPLETED|Overall Study||6||
48227153|NCT01184885|100877930|FG000|STARTED|Overall Study||7||
48227154|NCT01184885|100877930|FG000|COMPLETED|Overall Study||7||
48227155|NCT01184885|100877930|FG000|NOT COMPLETED|Overall Study||0||
48227156|NCT00853580|100877931|FG000|STARTED|Overall Study||74||
48227157|NCT00853580|100877932|FG001|STARTED|Overall Study||72||
48227158|NCT00853580|100877931|FG000|COMPLETED|Overall Study||67||
48372624|NCT00807846|101240004|FG000|COMPLETED|Overall Study||88||
48372625|NCT00807846|101240005|FG001|COMPLETED|Overall Study||94||
48372626|NCT00807846|101240004|FG000|NOT COMPLETED|Overall Study||12||
48372627|NCT00807846|101240005|FG001|NOT COMPLETED|Overall Study||4||
48372628|NCT01428063|101240006|FG000|STARTED|Overall Study||99||
48372629|NCT01428063|101240007|FG001|STARTED|Overall Study||122||
48372630|NCT01428063|101240008|FG002|STARTED|Overall Study||6||
48372631|NCT01428063|101240006|FG000|COMPLETED|Overall Study||89||
48372632|NCT01428063|101240007|FG001|COMPLETED|Overall Study||112||
48372633|NCT01428063|101240008|FG002|COMPLETED|Overall Study||5||
48372634|NCT01428063|101240006|FG000|NOT COMPLETED|Overall Study||10||
48372635|NCT01428063|101240007|FG001|NOT COMPLETED|Overall Study||10||
48372636|NCT01428063|101240008|FG002|NOT COMPLETED|Overall Study||1||
48372637|NCT00255684|101240009|FG000|STARTED|Overall Study||16||
48372638|NCT00255684|101240009|FG000|COMPLETED|Overall Study||16||
48372639|NCT00255684|101240009|FG000|NOT COMPLETED|Overall Study||0||
48372640|NCT05161351|101240010|FG000|STARTED|Overall Study||3||
48372641|NCT05161351|101240011|FG001|STARTED|Overall Study||4||
48372642|NCT05161351|101240012|FG002|STARTED|Overall Study||5||
48372643|NCT05161351|101240013|FG003|STARTED|Overall Study||4||
48372644|NCT05161351|101240010|FG000|COMPLETED|Overall Study||3||
48372645|NCT05161351|101240011|FG001|COMPLETED|Overall Study||4||
48372646|NCT05161351|101240012|FG002|COMPLETED|Overall Study||5||
48372647|NCT05161351|101240013|FG003|COMPLETED|Overall Study||4||
48372648|NCT05161351|101240010|FG000|NOT COMPLETED|Overall Study||0||
48372649|NCT05161351|101240011|FG001|NOT COMPLETED|Overall Study||0||
48372650|NCT05161351|101240012|FG002|NOT COMPLETED|Overall Study||0||
48372651|NCT05161351|101240013|FG003|NOT COMPLETED|Overall Study||0||
48372652|NCT00527111|101240014|FG000|STARTED|Overall Study||70||
48372653|NCT00527111|101240015|FG001|STARTED|Overall Study||69||
48372654|NCT00527111|101240014|FG000|COMPLETED|Overall Study||50||
48372655|NCT00527111|101240015|FG001|COMPLETED|Overall Study||47||
48372656|NCT00527111|101240014|FG000|NOT COMPLETED|Overall Study||20||
48372657|NCT00527111|101240015|FG001|NOT COMPLETED|Overall Study||22||
48372658|NCT01879618|101240016|FG000|STARTED|Overall Study||152||
48372659|NCT01879618|101240016|FG000|COMPLETED|Overall Study||131||
48372660|NCT01879618|101240016|FG000|NOT COMPLETED|Overall Study||21||
48372661|NCT03342469|101240017|FG000|STARTED|Overall Study||9||
48372662|NCT03342469|101240018|FG001|STARTED|Overall Study||9||
48372663|NCT03342469|101240019|FG002|STARTED|Overall Study||3||
48372664|NCT03342469|101240020|FG003|STARTED|Overall Study||8||
48372665|NCT03342469|101240017|FG000|COMPLETED|Overall Study||9||
48372666|NCT03342469|101240018|FG001|COMPLETED|Overall Study||8||
48372667|NCT03342469|101240019|FG002|COMPLETED|Overall Study||3||
48372668|NCT03342469|101240020|FG003|COMPLETED|Overall Study||8||
48372669|NCT03342469|101240017|FG000|NOT COMPLETED|Overall Study||0||
48372670|NCT03342469|101240018|FG001|NOT COMPLETED|Overall Study||1||
48372671|NCT03342469|101240019|FG002|NOT COMPLETED|Overall Study||0||
48372672|NCT03342469|101240020|FG003|NOT COMPLETED|Overall Study||0||
48372673|NCT01351077|101240021|FG000|STARTED|Overall Study||180||
48227159|NCT00853580|100877932|FG001|COMPLETED|Overall Study||56||
48227160|NCT00853580|100877931|FG000|NOT COMPLETED|Overall Study||7||
48227161|NCT00853580|100877932|FG001|NOT COMPLETED|Overall Study||16||
48074460|NCT01534962|100504479|FG001|COMPLETED|Overall Study||34||
48372674|NCT01351077|101240022|FG001|STARTED|Overall Study||180||
48227162|NCT02797132|100877933|FG000|STARTED|Part A (15 Days)||12||
48227163|NCT02797132|100877933|FG000|Part A (<14 kg Weight)|Part A (15 Days)||4||
48227164|NCT02797132|100877933|FG000|Part A (>=14 kg Weight)|Part A (15 Days)||8||
48372675|NCT01351077|101240021|FG000|COMPLETED|Overall Study||180||
48372676|NCT01351077|101240022|FG001|COMPLETED|Overall Study||180||
48372677|NCT01351077|101240021|FG000|NOT COMPLETED|Overall Study||0||
48372678|NCT01351077|101240022|FG001|NOT COMPLETED|Overall Study||0||
48372679|NCT02713230|101240023|FG000|STARTED|Overall Study||69||
48372680|NCT02713230|101240024|FG001|STARTED|Overall Study||15||
48372681|NCT02713230|101240025|FG002|STARTED|Overall Study||71||
48372682|NCT02713230|101240023|FG000|COMPLETED|Overall Study||68||
48372683|NCT02713230|101240024|FG001|COMPLETED|Overall Study||15||
48372684|NCT02713230|101240025|FG002|COMPLETED|Overall Study||71||
48372685|NCT02713230|101240023|FG000|NOT COMPLETED|Overall Study||1||
48372686|NCT02713230|101240024|FG001|NOT COMPLETED|Overall Study||0||
48372687|NCT02713230|101240025|FG002|NOT COMPLETED|Overall Study||0||
48372688|NCT01240122|101240026|FG000|STARTED|Overall Study||29||
48372689|NCT01240122|101240026|FG000|COMPLETED|Overall Study||29||
48372690|NCT01240122|101240026|FG000|NOT COMPLETED|Overall Study||0||
48372691|NCT01926041|101240027|FG000|STARTED|Overall Study||279||
48372692|NCT01926041|101240028|FG001|STARTED|Overall Study||310||
48372693|NCT01926041|101240027|FG000|COMPLETED|Overall Study||270||
48372694|NCT01926041|101240028|FG001|COMPLETED|Overall Study||262||
48372695|NCT01926041|101240027|FG000|NOT COMPLETED|Overall Study||9||
48372696|NCT01926041|101240028|FG001|NOT COMPLETED|Overall Study||48||
48074461|NCT01534962|100504480|FG002|COMPLETED|Overall Study||34||
48074462|NCT01534962|100504481|FG003|COMPLETED|Overall Study||24||
48074463|NCT01534962|100504478|FG000|NOT COMPLETED|Overall Study||37||
48074464|NCT01534962|100504479|FG001|NOT COMPLETED|Overall Study||26||
48074465|NCT01534962|100504480|FG002|NOT COMPLETED|Overall Study||24||
48227165|NCT02797132|100877933|FG000|COMPLETED|Part A (15 Days)||11||
48227166|NCT02797132|100877933|FG000|NOT COMPLETED|Part A (15 Days)||1||
48074466|NCT01534962|100504481|FG003|NOT COMPLETED|Overall Study||32||
48074467|NCT00304746|100504482|FG000|STARTED|Overall Study||50||
48074468|NCT00304746|100504483|FG001|STARTED|Overall Study||50||
48074469|NCT00304746|100504482|FG000|COMPLETED|Overall Study||50||
48372697|NCT01839188|101240029|FG000|STARTED|Overall Study||385||
48372698|NCT01839188|101240029|FG000|Treated|Overall Study||385||
48372699|NCT01839188|101240029|FG000|COMPLETED|Overall Study||384||
48372700|NCT01839188|101240029|FG000|NOT COMPLETED|Overall Study||1||
48372701|NCT02588248|101240030|FG000|STARTED|Overall Study||42||
48372702|NCT02588248|101240031|FG001|STARTED|Overall Study||40||
48372703|NCT02588248|101240030|FG000|COMPLETED|Overall Study||38||
48372704|NCT02588248|101240031|FG001|COMPLETED|Overall Study||37||
48372705|NCT02588248|101240030|FG000|NOT COMPLETED|Overall Study||4||
48372706|NCT02588248|101240031|FG001|NOT COMPLETED|Overall Study||3||
48372707|NCT03196505|101240032|FG000|STARTED|Overall Study||115||
48372708|NCT03196505|101240033|FG001|STARTED|Overall Study||116||
48372709|NCT03196505|101240032|FG000|COMPLETED|Overall Study||89||
48372710|NCT03196505|101240033|FG001|COMPLETED|Overall Study||90||
48372711|NCT03196505|101240032|FG000|NOT COMPLETED|Overall Study||26||
48372712|NCT03196505|101240033|FG001|NOT COMPLETED|Overall Study||26||
48372713|NCT00718419|101240034|FG000|STARTED|Overall Study||14||
48372714|NCT00718419|101240035|FG001|STARTED|Overall Study||42||
48372715|NCT00718419|101240034|FG000|Received at Least One Dose of Study Drug|Overall Study||14||
48372716|NCT00718419|101240035|FG001|Received at Least One Dose of Study Drug|Overall Study||42||
48372717|NCT00718419|101240034|FG000|COMPLETED|Overall Study||1||
48372718|NCT00718419|101240035|FG001|COMPLETED|Overall Study||3||
48372719|NCT00718419|101240034|FG000|NOT COMPLETED|Overall Study||13||
48372720|NCT00718419|101240035|FG001|NOT COMPLETED|Overall Study||39||
48372721|NCT05117229|101240036|FG000|STARTED|Overall Study||40||
48372722|NCT05117229|101240036|FG000|COMPLETED|Overall Study||40||
48372723|NCT05117229|101240036|FG000|NOT COMPLETED|Overall Study||0||
48372724|NCT01247220|101240037|FG000|STARTED|Overall Study||6||
48372725|NCT01247220|101240038|FG001|STARTED|Overall Study||6||
48372726|NCT01247220|101240037|FG000|COMPLETED|Overall Study||6||
48372727|NCT01247220|101240038|FG001|COMPLETED|Overall Study||6||
48372728|NCT01247220|101240037|FG000|NOT COMPLETED|Overall Study||0||
48372729|NCT01247220|101240038|FG001|NOT COMPLETED|Overall Study||0||
48372730|NCT04594239|101240039|FG000|STARTED|Overall Study||49||
48372731|NCT04594239|101240040|FG001|STARTED|Overall Study||48||
48372732|NCT04594239|101240041|FG002|STARTED|Overall Study||27||
48372733|NCT04594239|101240042|FG003|STARTED|Overall Study||26||
48372734|NCT04594239|101240039|FG000|Safety Population|Overall Study||49||
48372735|NCT04594239|101240040|FG001|Safety Population|Overall Study||48||
48372736|NCT04594239|101240041|FG002|Safety Population|Overall Study||26||
48372737|NCT04594239|101240042|FG003|Safety Population|Overall Study||21||
48372738|NCT04594239|101240039|FG000|COMPLETED|Overall Study||38||
48372739|NCT04594239|101240040|FG001|COMPLETED|Overall Study||39||
48372740|NCT04594239|101240041|FG002|COMPLETED|Overall Study||21||
48372741|NCT04594239|101240042|FG003|COMPLETED|Overall Study||15||
48074470|NCT00304746|100504483|FG001|COMPLETED|Overall Study||50||
48074471|NCT00304746|100504482|FG000|NOT COMPLETED|Overall Study||0||
48074472|NCT00304746|100504483|FG001|NOT COMPLETED|Overall Study||0||
48372742|NCT04594239|101240039|FG000|NOT COMPLETED|Overall Study||11||
48372743|NCT04594239|101240040|FG001|NOT COMPLETED|Overall Study||9||
48372744|NCT04594239|101240041|FG002|NOT COMPLETED|Overall Study||6||
48372745|NCT04594239|101240042|FG003|NOT COMPLETED|Overall Study||11||
48372746|NCT01441440|101240043|FG000|STARTED|Overall Study||183||
48372747|NCT01441440|101240044|FG001|STARTED|Overall Study||174||
48372748|NCT01441440|101240045|FG002|STARTED|Overall Study||180||
48372749|NCT01441440|101240043|FG000|COMPLETED|Overall Study||166||
48372750|NCT01441440|101240044|FG001|COMPLETED|Overall Study||151||
48372751|NCT01441440|101240045|FG002|COMPLETED|Overall Study||158||
48372752|NCT01441440|101240043|FG000|NOT COMPLETED|Overall Study||17||
48372753|NCT01441440|101240044|FG001|NOT COMPLETED|Overall Study||23||
48372754|NCT01441440|101240045|FG002|NOT COMPLETED|Overall Study||22||
48372755|NCT00830037|101240046|FG000|STARTED|Overall Study||67||
48372756|NCT00830037|101240047|FG001|STARTED|Overall Study||69||
48372757|NCT00830037|101240046|FG000|COMPLETED|Overall Study||49||
48372758|NCT00830037|101240047|FG001|COMPLETED|Overall Study||50||
48372759|NCT00830037|101240046|FG000|NOT COMPLETED|Overall Study||18||
48372760|NCT00830037|101240047|FG001|NOT COMPLETED|Overall Study||19||
48372761|NCT05058664|101240048|FG000|STARTED|Overall Study||37|Participant numbers shown represent dyads of one adolescent and one caregiver.|
48372762|NCT05058664|101240049|FG001|STARTED|Overall Study||42|Participant numbers shown represent dyads of one adolescent and one caregiver.|
48372763|NCT05058664|101240050|FG002|STARTED|Overall Study||41|Participant numbers shown represent dyads of one adolescent and one caregiver.|
48372764|NCT05058664|101240048|FG000|COMPLETED|Overall Study||33||
48372765|NCT05058664|101240049|FG001|COMPLETED|Overall Study||42||
48372766|NCT05058664|101240050|FG002|COMPLETED|Overall Study||38||
48372767|NCT05058664|101240048|FG000|NOT COMPLETED|Overall Study||4||
48372768|NCT05058664|101240049|FG001|NOT COMPLETED|Overall Study||0||
48372769|NCT05058664|101240050|FG002|NOT COMPLETED|Overall Study||3||
48372770|NCT02742077|101240051|FG000|STARTED|Overall Study||20||
48372771|NCT02742077|101240051|FG000|COMPLETED|Overall Study||20||
48372772|NCT02742077|101240051|FG000|NOT COMPLETED|Overall Study||0||
48372773|NCT01081223|101240052|FG000|STARTED|Overall Study||12||
48372774|NCT01081223|101240052|FG000|COMPLETED|Overall Study||12||
48372775|NCT01081223|101240052|FG000|NOT COMPLETED|Overall Study||0||
48372776|NCT05118386|101240053|FG000|STARTED|Dose Escalation Phase (Day 1 to Day 151)||6||
48372777|NCT05118386|101240054|FG001|STARTED|Dose Escalation Phase (Day 1 to Day 151)||6||
48372778|NCT05118386|101240055|FG002|STARTED|Dose Escalation Phase (Day 1 to Day 151)||6||
48372779|NCT05118386|101240056|FG003|STARTED|Dose Escalation Phase (Day 1 to Day 151)||6||
48372780|NCT05118386|101240057|FG004|STARTED|Dose Escalation Phase (Day 1 to Day 151)||0||
48372781|NCT05118386|101240058|FG005|STARTED|Dose Escalation Phase (Day 1 to Day 151)||4||
48372782|NCT05118386|101240053|FG000|COMPLETED|Dose Escalation Phase (Day 1 to Day 151)||6||
48372783|NCT05118386|101240054|FG001|COMPLETED|Dose Escalation Phase (Day 1 to Day 151)||6||
48372784|NCT05118386|101240055|FG002|COMPLETED|Dose Escalation Phase (Day 1 to Day 151)||6||
48372785|NCT05118386|101240056|FG003|COMPLETED|Dose Escalation Phase (Day 1 to Day 151)||4||
48372786|NCT05118386|101240057|FG004|COMPLETED|Dose Escalation Phase (Day 1 to Day 151)||0||
48372787|NCT05118386|101240058|FG005|COMPLETED|Dose Escalation Phase (Day 1 to Day 151)||4||
48372788|NCT05118386|101240053|FG000|NOT COMPLETED|Dose Escalation Phase (Day 1 to Day 151)||0||
48372789|NCT05118386|101240054|FG001|NOT COMPLETED|Dose Escalation Phase (Day 1 to Day 151)||0||
48372790|NCT05118386|101240055|FG002|NOT COMPLETED|Dose Escalation Phase (Day 1 to Day 151)||0||
48372791|NCT05118386|101240056|FG003|NOT COMPLETED|Dose Escalation Phase (Day 1 to Day 151)||2||
48372792|NCT05118386|101240057|FG004|NOT COMPLETED|Dose Escalation Phase (Day 1 to Day 151)||0||
48372793|NCT05118386|101240058|FG005|NOT COMPLETED|Dose Escalation Phase (Day 1 to Day 151)||0||
48372794|NCT05118386|101240053|FG000|STARTED|Dose Expansion Phase (Day 1 to Day 151)||0||
48372795|NCT05118386|101240054|FG001|STARTED|Dose Expansion Phase (Day 1 to Day 151)||0||
48372796|NCT05118386|101240055|FG002|STARTED|Dose Expansion Phase (Day 1 to Day 151)||0||
48372797|NCT05118386|101240056|FG003|STARTED|Dose Expansion Phase (Day 1 to Day 151)||0||
48372798|NCT05118386|101240057|FG004|STARTED|Dose Expansion Phase (Day 1 to Day 151)||24||
48372799|NCT05118386|101240058|FG005|STARTED|Dose Expansion Phase (Day 1 to Day 151)||4||
48372800|NCT05118386|101240053|FG000|COMPLETED|Dose Expansion Phase (Day 1 to Day 151)||0||
48372801|NCT05118386|101240054|FG001|COMPLETED|Dose Expansion Phase (Day 1 to Day 151)||0||
48372802|NCT05118386|101240055|FG002|COMPLETED|Dose Expansion Phase (Day 1 to Day 151)||0||
48372803|NCT05118386|101240056|FG003|COMPLETED|Dose Expansion Phase (Day 1 to Day 151)||0||
48372804|NCT05118386|101240057|FG004|COMPLETED|Dose Expansion Phase (Day 1 to Day 151)||23||
48372805|NCT05118386|101240058|FG005|COMPLETED|Dose Expansion Phase (Day 1 to Day 151)||4||
48372806|NCT05118386|101240053|FG000|NOT COMPLETED|Dose Expansion Phase (Day 1 to Day 151)||0||
48372807|NCT05118386|101240054|FG001|NOT COMPLETED|Dose Expansion Phase (Day 1 to Day 151)||0||
48372808|NCT05118386|101240055|FG002|NOT COMPLETED|Dose Expansion Phase (Day 1 to Day 151)||0||
48372809|NCT05118386|101240056|FG003|NOT COMPLETED|Dose Expansion Phase (Day 1 to Day 151)||0||
48372810|NCT05118386|101240057|FG004|NOT COMPLETED|Dose Expansion Phase (Day 1 to Day 151)||1||
48372811|NCT05118386|101240058|FG005|NOT COMPLETED|Dose Expansion Phase (Day 1 to Day 151)||0||
48372812|NCT03375112|101240059|FG000|STARTED|Overall Study||62||
48372813|NCT03375112|101240060|FG001|STARTED|Overall Study||60||
48372814|NCT03375112|101240059|FG000|COMPLETED|Overall Study||59||
48372815|NCT03375112|101240060|FG001|COMPLETED|Overall Study||60||
48372816|NCT03375112|101240059|FG000|NOT COMPLETED|Overall Study||3||
48372817|NCT03375112|101240060|FG001|NOT COMPLETED|Overall Study||0||
48372818|NCT01597557|101240061|FG000|STARTED|Overall Study||132||
48372819|NCT01597557|101240062|FG001|STARTED|Overall Study||129||
48372820|NCT01597557|101240061|FG000|COMPLETED|Overall Study||128||
48372821|NCT01597557|101240062|FG001|COMPLETED|Overall Study||126||
48372822|NCT01597557|101240061|FG000|NOT COMPLETED|Overall Study||4||
48372823|NCT01597557|101240062|FG001|NOT COMPLETED|Overall Study||3||
48372824|NCT01703286|101240063|FG000|STARTED|Period 1 Including Washout||7||
48372825|NCT01703286|101240064|FG001|STARTED|Period 1 Including Washout||7||
48372826|NCT01703286|101240065|FG002|STARTED|Period 1 Including Washout||7||
48372827|NCT01703286|101240066|FG003|STARTED|Period 1 Including Washout||7||
48372828|NCT01703286|101240067|FG004|STARTED|Period 1 Including Washout||7||
48372829|NCT01703286|101240068|FG005|STARTED|Period 1 Including Washout||7||
48372830|NCT01703286|101240063|FG000|COMPLETED|Period 1 Including Washout||7||
48372831|NCT01703286|101240064|FG001|COMPLETED|Period 1 Including Washout||7||
48372832|NCT01703286|101240065|FG002|COMPLETED|Period 1 Including Washout||7||
48372833|NCT01703286|101240066|FG003|COMPLETED|Period 1 Including Washout||6||
48372834|NCT01703286|101240067|FG004|COMPLETED|Period 1 Including Washout||7||
48372835|NCT01703286|101240068|FG005|COMPLETED|Period 1 Including Washout||6||
48372836|NCT01703286|101240063|FG000|NOT COMPLETED|Period 1 Including Washout||0||
48372837|NCT01703286|101240064|FG001|NOT COMPLETED|Period 1 Including Washout||0||
48372838|NCT01703286|101240065|FG002|NOT COMPLETED|Period 1 Including Washout||0||
48372839|NCT01703286|101240066|FG003|NOT COMPLETED|Period 1 Including Washout||1||
48372840|NCT01703286|101240067|FG004|NOT COMPLETED|Period 1 Including Washout||0||
48372841|NCT01703286|101240068|FG005|NOT COMPLETED|Period 1 Including Washout||1||
48372842|NCT01703286|101240063|FG000|STARTED|Period 2 Including Washout||7||
48372843|NCT01703286|101240064|FG001|STARTED|Period 2 Including Washout||7||
48372844|NCT01703286|101240065|FG002|STARTED|Period 2 Including Washout||7||
48372845|NCT01703286|101240066|FG003|STARTED|Period 2 Including Washout||6||
48372846|NCT01703286|101240067|FG004|STARTED|Period 2 Including Washout||7||
48372847|NCT01703286|101240068|FG005|STARTED|Period 2 Including Washout||6||
48372848|NCT01703286|101240063|FG000|COMPLETED|Period 2 Including Washout||7||
48372849|NCT01703286|101240064|FG001|COMPLETED|Period 2 Including Washout||7||
48372850|NCT01703286|101240065|FG002|COMPLETED|Period 2 Including Washout||7||
48372851|NCT01703286|101240066|FG003|COMPLETED|Period 2 Including Washout||5||
48372852|NCT01703286|101240067|FG004|COMPLETED|Period 2 Including Washout||7||
48372853|NCT01703286|101240068|FG005|COMPLETED|Period 2 Including Washout||6||
48372854|NCT01703286|101240063|FG000|NOT COMPLETED|Period 2 Including Washout||0||
48372855|NCT01703286|101240064|FG001|NOT COMPLETED|Period 2 Including Washout||0||
48372856|NCT01703286|101240065|FG002|NOT COMPLETED|Period 2 Including Washout||0||
48372857|NCT01703286|101240066|FG003|NOT COMPLETED|Period 2 Including Washout||1||
48372858|NCT01703286|101240067|FG004|NOT COMPLETED|Period 2 Including Washout||0||
48372859|NCT01703286|101240068|FG005|NOT COMPLETED|Period 2 Including Washout||0||
48372860|NCT01703286|101240063|FG000|STARTED|Period 3 Including Washout||7||
48372861|NCT01703286|101240064|FG001|STARTED|Period 3 Including Washout||7||
48372862|NCT01703286|101240065|FG002|STARTED|Period 3 Including Washout||7||
48372863|NCT01703286|101240066|FG003|STARTED|Period 3 Including Washout||5||
48372864|NCT01703286|101240067|FG004|STARTED|Period 3 Including Washout||7||
48372865|NCT01703286|101240068|FG005|STARTED|Period 3 Including Washout||6||
48372866|NCT01703286|101240063|FG000|COMPLETED|Period 3 Including Washout||7||
48372867|NCT01703286|101240064|FG001|COMPLETED|Period 3 Including Washout||7||
48372868|NCT01703286|101240065|FG002|COMPLETED|Period 3 Including Washout||7||
48372869|NCT01703286|101240066|FG003|COMPLETED|Period 3 Including Washout||5||
48372870|NCT01703286|101240067|FG004|COMPLETED|Period 3 Including Washout||7||
48372871|NCT01703286|101240068|FG005|COMPLETED|Period 3 Including Washout||6||
48372872|NCT01703286|101240063|FG000|NOT COMPLETED|Period 3 Including Washout||0||
48372873|NCT01703286|101240064|FG001|NOT COMPLETED|Period 3 Including Washout||0||
48372874|NCT01703286|101240065|FG002|NOT COMPLETED|Period 3 Including Washout||0||
48372875|NCT01703286|101240066|FG003|NOT COMPLETED|Period 3 Including Washout||0||
48372876|NCT01703286|101240067|FG004|NOT COMPLETED|Period 3 Including Washout||0||
48372877|NCT01703286|101240068|FG005|NOT COMPLETED|Period 3 Including Washout||0||
48372878|NCT02245568|101240069|FG000|STARTED|Overall Study||913||
48372879|NCT02245568|101240069|FG000|COMPLETED|Overall Study||60||
48372880|NCT02245568|101240069|FG000|NOT COMPLETED|Overall Study||853||
48372881|NCT01301742|101240070|FG000|STARTED|First Intervention||9||
48372882|NCT01301742|101240071|FG001|STARTED|First Intervention||9||
48372883|NCT01301742|101240070|FG000|COMPLETED|First Intervention||9||
48372884|NCT01301742|101240071|FG001|COMPLETED|First Intervention||9||
48372885|NCT01301742|101240070|FG000|NOT COMPLETED|First Intervention||0||
48372886|NCT01301742|101240071|FG001|NOT COMPLETED|First Intervention||0||
48372887|NCT01301742|101240070|FG000|STARTED|Washout Period of at Least 7 Days||9||
48372888|NCT01301742|101240071|FG001|STARTED|Washout Period of at Least 7 Days||9||
48372889|NCT01301742|101240070|FG000|COMPLETED|Washout Period of at Least 7 Days||9||
48372890|NCT01301742|101240071|FG001|COMPLETED|Washout Period of at Least 7 Days||9||
48372891|NCT01301742|101240070|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||0||
48372892|NCT01301742|101240071|FG001|NOT COMPLETED|Washout Period of at Least 7 Days||0||
48372893|NCT01301742|101240070|FG000|STARTED|Second Intervention||9||
48372894|NCT01301742|101240071|FG001|STARTED|Second Intervention||9||
48372895|NCT01301742|101240070|FG000|COMPLETED|Second Intervention||9||
48372896|NCT01301742|101240071|FG001|COMPLETED|Second Intervention||9||
48372897|NCT01301742|101240070|FG000|NOT COMPLETED|Second Intervention||0||
48521846|NCT00952276|101611704|FG003|NOT COMPLETED|Overall Study||1||
48372898|NCT01301742|101240071|FG001|NOT COMPLETED|Second Intervention||0||
48372899|NCT01463072|101240072|FG000|STARTED|Overall Study||40||
48372900|NCT01463072|101240072|FG000|COMPLETED|Overall Study||40||
48372901|NCT01463072|101240072|FG000|NOT COMPLETED|Overall Study||0||
48372902|NCT01577160|101240073|FG000|STARTED|Overall Study||353||
48372903|NCT01577160|101240073|FG000|COMPLETED|Overall Study||255||
48372904|NCT01577160|101240073|FG000|NOT COMPLETED|Overall Study||98||
48372905|NCT02342561|101240074|FG000|STARTED|Overall Study||20||
48372906|NCT02342561|101240074|FG000|COMPLETED|Overall Study||20||
48372907|NCT02342561|101240074|FG000|NOT COMPLETED|Overall Study||0||
48372908|NCT01081873|101240075|FG000|STARTED|Overall Study||2714||
48372909|NCT01081873|101240075|FG000|COMPLETED|Overall Study||2416||
48372910|NCT01081873|101240075|FG000|NOT COMPLETED|Overall Study||298||
48372911|NCT03633227|101240076|FG000|STARTED|Double Blind (DB), up to Week 48||12||
48372912|NCT03633227|101240077|FG001|STARTED|Double Blind (DB), up to Week 48||10||
48372913|NCT03633227|101240076|FG000|COMPLETED|Double Blind (DB), up to Week 48||4||
48372914|NCT03633227|101240077|FG001|COMPLETED|Double Blind (DB), up to Week 48||6||
48372915|NCT03633227|101240076|FG000|NOT COMPLETED|Double Blind (DB), up to Week 48||8||
48372916|NCT03633227|101240077|FG001|NOT COMPLETED|Double Blind (DB), up to Week 48||4||
48372917|NCT03633227|101240076|FG000|STARTED|DB Extension, Week 48 up to 3 Years||4||
48372918|NCT03633227|101240077|FG001|STARTED|DB Extension, Week 48 up to 3 Years||6||
48372919|NCT03633227|101240076|FG000|COMPLETED|DB Extension, Week 48 up to 3 Years||0||
48372920|NCT03633227|101240077|FG001|COMPLETED|DB Extension, Week 48 up to 3 Years||0||
48372921|NCT03633227|101240076|FG000|NOT COMPLETED|DB Extension, Week 48 up to 3 Years||4||
48372922|NCT03633227|101240077|FG001|NOT COMPLETED|DB Extension, Week 48 up to 3 Years||6||
48372923|NCT02411201|101240078|FG000|STARTED|Overall Study||51||
48372924|NCT02411201|101240078|FG000|COMPLETED|Overall Study||45||
48372925|NCT02411201|101240078|FG000|NOT COMPLETED|Overall Study||6||
48372926|NCT01120093|101240079|FG000|STARTED|Treatment Period 1||18||
48372927|NCT01120093|101240080|FG001|STARTED|Treatment Period 1||14||
48372928|NCT01120093|101240081|FG002|STARTED|Treatment Period 1||17||
48372929|NCT01120093|101240082|FG003|STARTED|Treatment Period 1||14||
48372930|NCT01120093|101240083|FG004|STARTED|Treatment Period 1||16||
48372931|NCT01120093|101240079|FG000|COMPLETED|Treatment Period 1||18||
48372932|NCT01120093|101240080|FG001|COMPLETED|Treatment Period 1||13||
48372933|NCT01120093|101240081|FG002|COMPLETED|Treatment Period 1||16||
48372934|NCT01120093|101240082|FG003|COMPLETED|Treatment Period 1||14||
48372935|NCT01120093|101240083|FG004|COMPLETED|Treatment Period 1||15||
48372936|NCT01120093|101240079|FG000|NOT COMPLETED|Treatment Period 1||0||
48372937|NCT01120093|101240080|FG001|NOT COMPLETED|Treatment Period 1||1||
48372938|NCT01120093|101240081|FG002|NOT COMPLETED|Treatment Period 1||1||
48372939|NCT01120093|101240082|FG003|NOT COMPLETED|Treatment Period 1||0||
48372940|NCT01120093|101240083|FG004|NOT COMPLETED|Treatment Period 1||1||
48372941|NCT01120093|101240079|FG000|STARTED|Treatment Period 2||18||
48372942|NCT01120093|101240080|FG001|STARTED|Treatment Period 2||13||
48372943|NCT01120093|101240081|FG002|STARTED|Treatment Period 2||16||
48372944|NCT01120093|101240082|FG003|STARTED|Treatment Period 2||14||
48372945|NCT01120093|101240083|FG004|STARTED|Treatment Period 2||15||
48372946|NCT01120093|101240079|FG000|COMPLETED|Treatment Period 2||18||
48372947|NCT01120093|101240080|FG001|COMPLETED|Treatment Period 2||13||
48372948|NCT01120093|101240081|FG002|COMPLETED|Treatment Period 2||16||
48372949|NCT01120093|101240082|FG003|COMPLETED|Treatment Period 2||13||
48372950|NCT01120093|101240083|FG004|COMPLETED|Treatment Period 2||14||
48372951|NCT01120093|101240079|FG000|NOT COMPLETED|Treatment Period 2||0||
48372952|NCT01120093|101240080|FG001|NOT COMPLETED|Treatment Period 2||0||
48372953|NCT01120093|101240081|FG002|NOT COMPLETED|Treatment Period 2||0||
48372954|NCT01120093|101240082|FG003|NOT COMPLETED|Treatment Period 2||1||
48372955|NCT01120093|101240083|FG004|NOT COMPLETED|Treatment Period 2||1||
48372956|NCT01120093|101240079|FG000|STARTED|Treatment Period 3||18||
48372957|NCT01120093|101240080|FG001|STARTED|Treatment Period 3||13||
48372958|NCT01120093|101240081|FG002|STARTED|Treatment Period 3||16||
48372959|NCT01120093|101240082|FG003|STARTED|Treatment Period 3||13||
48372960|NCT01120093|101240083|FG004|STARTED|Treatment Period 3||14||
48372961|NCT01120093|101240079|FG000|COMPLETED|Treatment Period 3||18||
48372962|NCT01120093|101240080|FG001|COMPLETED|Treatment Period 3||13||
48372963|NCT01120093|101240081|FG002|COMPLETED|Treatment Period 3||15||
48372964|NCT01120093|101240082|FG003|COMPLETED|Treatment Period 3||12||
48372965|NCT01120093|101240083|FG004|COMPLETED|Treatment Period 3||13||
48372966|NCT01120093|101240079|FG000|NOT COMPLETED|Treatment Period 3||0||
48372967|NCT01120093|101240080|FG001|NOT COMPLETED|Treatment Period 3||0||
48372968|NCT01120093|101240081|FG002|NOT COMPLETED|Treatment Period 3||1||
48372969|NCT01120093|101240082|FG003|NOT COMPLETED|Treatment Period 3||1||
48372970|NCT01120093|101240083|FG004|NOT COMPLETED|Treatment Period 3||1||
48372971|NCT01120093|101240079|FG000|STARTED|Treatment Period 4||18||
48372972|NCT01120093|101240080|FG001|STARTED|Treatment Period 4||13||
48372973|NCT01120093|101240081|FG002|STARTED|Treatment Period 4||15||
48372974|NCT01120093|101240082|FG003|STARTED|Treatment Period 4||12||
48372975|NCT01120093|101240083|FG004|STARTED|Treatment Period 4||13||
48372976|NCT01120093|101240079|FG000|COMPLETED|Treatment Period 4||17||
48372977|NCT01120093|101240080|FG001|COMPLETED|Treatment Period 4||13||
48372978|NCT01120093|101240081|FG002|COMPLETED|Treatment Period 4||15||
48372979|NCT01120093|101240082|FG003|COMPLETED|Treatment Period 4||12||
48372980|NCT01120093|101240083|FG004|COMPLETED|Treatment Period 4||13||
48372981|NCT01120093|101240079|FG000|NOT COMPLETED|Treatment Period 4||1||
48372982|NCT01120093|101240080|FG001|NOT COMPLETED|Treatment Period 4||0||
48372983|NCT01120093|101240081|FG002|NOT COMPLETED|Treatment Period 4||0||
48372984|NCT01120093|101240082|FG003|NOT COMPLETED|Treatment Period 4||0||
48372985|NCT01120093|101240083|FG004|NOT COMPLETED|Treatment Period 4||0||
48372986|NCT01120093|101240079|FG000|STARTED|Treatment Period 5||17||
48372987|NCT01120093|101240080|FG001|STARTED|Treatment Period 5||13||
48372988|NCT01120093|101240081|FG002|STARTED|Treatment Period 5||15||
48372989|NCT01120093|101240082|FG003|STARTED|Treatment Period 5||12||
48372990|NCT01120093|101240083|FG004|STARTED|Treatment Period 5||13||
48372991|NCT01120093|101240079|FG000|COMPLETED|Treatment Period 5||17||
48372992|NCT01120093|101240080|FG001|COMPLETED|Treatment Period 5||12||
48372993|NCT01120093|101240081|FG002|COMPLETED|Treatment Period 5||15||
48372994|NCT01120093|101240082|FG003|COMPLETED|Treatment Period 5||11||
48372995|NCT01120093|101240083|FG004|COMPLETED|Treatment Period 5||13||
48372996|NCT01120093|101240079|FG000|NOT COMPLETED|Treatment Period 5||0||
48372997|NCT01120093|101240080|FG001|NOT COMPLETED|Treatment Period 5||1||
48372998|NCT01120093|101240081|FG002|NOT COMPLETED|Treatment Period 5||0||
48372999|NCT01120093|101240082|FG003|NOT COMPLETED|Treatment Period 5||1||
48373000|NCT01120093|101240083|FG004|NOT COMPLETED|Treatment Period 5||0||
48373001|NCT00337467|101240084|FG000|STARTED|Overall Study||61||
48373002|NCT00337467|101240084|FG000|Discontinued Prior to Week 96|Overall Study||10||
48373003|NCT00337467|101240084|FG000|COMPLETED|Overall Study||51||
48373004|NCT00337467|101240084|FG000|NOT COMPLETED|Overall Study||10||
48373005|NCT00850460|101240085|FG000|STARTED|Overall Study||7||
48373006|NCT00850460|101240086|FG001|STARTED|Overall Study||7||
48373007|NCT00850460|101240085|FG000|Started - Week 0|Overall Study||7||
48373008|NCT00850460|101240086|FG001|Started - Week 0|Overall Study||7||
48373009|NCT00850460|101240085|FG000|Completion - Week 8|Overall Study||3||
48373010|NCT00850460|101240086|FG001|Completion - Week 8|Overall Study||3||
48373011|NCT00850460|101240085|FG000|COMPLETED|Overall Study||3||
48373012|NCT00850460|101240086|FG001|COMPLETED|Overall Study||3||
48373013|NCT00850460|101240085|FG000|NOT COMPLETED|Overall Study||4||
48373014|NCT00850460|101240086|FG001|NOT COMPLETED|Overall Study||4||
48373015|NCT02404155|101240087|FG000|STARTED|Overall Study||274||
48373016|NCT02404155|101240087|FG000|COMPLETED|Overall Study||227||
48373017|NCT02404155|101240087|FG000|NOT COMPLETED|Overall Study||47||
48373018|NCT00907881|101240088|FG000|STARTED|Overall Study||1069||
48373019|NCT00907881|101240088|FG000|COMPLETED|Overall Study||984||
48373020|NCT00907881|101240088|FG000|NOT COMPLETED|Overall Study||85||
48373021|NCT01519245|101240089|FG000|STARTED|Overall Study||24||
48373022|NCT01519245|101240090|FG001|STARTED|Overall Study||20||
48373023|NCT01519245|101240089|FG000|Received Pre-pump IV TXA|Overall Study||21||
48373024|NCT01519245|101240090|FG001|Received Pre-pump IV TXA|Overall Study||18||
48373025|NCT01519245|101240089|FG000|Received Post-pump IV TXA|Overall Study||6||
48373026|NCT01519245|101240090|FG001|Received Post-pump IV TXA|Overall Study||2||
48373027|NCT01519245|101240089|FG000|COMPLETED|Overall Study||23||
48373028|NCT01519245|101240090|FG001|COMPLETED|Overall Study||18||
48373029|NCT01519245|101240089|FG000|NOT COMPLETED|Overall Study||1||
48373030|NCT01519245|101240090|FG001|NOT COMPLETED|Overall Study||2||
48373031|NCT00631488|101240091|FG000|STARTED|Overall Study||48||
48373032|NCT00631488|101240092|FG001|STARTED|Overall Study||49||
48373033|NCT00631488|101240093|FG002|STARTED|Overall Study||49||
48373034|NCT00631488|101240091|FG000|Completed Post-Treatment Period|Overall Study||44||
48373035|NCT00631488|101240092|FG001|Completed Post-Treatment Period|Overall Study||47||
48373036|NCT00631488|101240093|FG002|Completed Post-Treatment Period|Overall Study||47||
48373037|NCT00631488|101240091|FG000|COMPLETED|Overall Study||44||
48373038|NCT00631488|101240092|FG001|COMPLETED|Overall Study||47||
48373039|NCT00631488|101240093|FG002|COMPLETED|Overall Study||47||
48373040|NCT00631488|101240091|FG000|NOT COMPLETED|Overall Study||4||
48373041|NCT00631488|101240092|FG001|NOT COMPLETED|Overall Study||2||
48373042|NCT00631488|101240093|FG002|NOT COMPLETED|Overall Study||2||
48373043|NCT00002663|101240094|FG000|STARTED|Overall Study||11||
48373044|NCT00002663|101240095|FG001|STARTED|Overall Study||4||
48373045|NCT00002663|101240096|FG002|STARTED|Overall Study||2||
48373046|NCT00002663|101240097|FG003|STARTED|Overall Study||5||
48373047|NCT00002663|101240098|FG004|STARTED|Overall Study||1||
48373048|NCT00002663|101240099|FG005|STARTED|Overall Study||23||
48373049|NCT00002663|101240100|FG006|STARTED|Overall Study||2||
48373050|NCT00002663|101240101|FG007|STARTED|Overall Study||6||
48373051|NCT00002663|101240102|FG008|STARTED|Overall Study||2||
48373052|NCT00002663|101240103|FG009|STARTED|Overall Study||2||
48521847|NCT00952276|101611705|FG004|NOT COMPLETED|Overall Study||0||
48373053|NCT00002663|101240094|FG000|COMPLETED|Overall Study||4||
48373054|NCT00002663|101240095|FG001|COMPLETED|Overall Study||2||
48373055|NCT00002663|101240096|FG002|COMPLETED|Overall Study||1||
48373056|NCT00002663|101240097|FG003|COMPLETED|Overall Study||3||
48373057|NCT00002663|101240098|FG004|COMPLETED|Overall Study||0||
48373058|NCT00002663|101240099|FG005|COMPLETED|Overall Study||8||
48373059|NCT00002663|101240100|FG006|COMPLETED|Overall Study||1||
48373060|NCT00002663|101240101|FG007|COMPLETED|Overall Study||4||
48373061|NCT00002663|101240102|FG008|COMPLETED|Overall Study||0||
48373062|NCT00002663|101240103|FG009|COMPLETED|Overall Study||0||
48373063|NCT00002663|101240094|FG000|NOT COMPLETED|Overall Study||7||
48373064|NCT00002663|101240095|FG001|NOT COMPLETED|Overall Study||2||
48373065|NCT00002663|101240096|FG002|NOT COMPLETED|Overall Study||1||
48373066|NCT00002663|101240097|FG003|NOT COMPLETED|Overall Study||2||
48373067|NCT00002663|101240098|FG004|NOT COMPLETED|Overall Study||1||
48373068|NCT00002663|101240099|FG005|NOT COMPLETED|Overall Study||15||
48373069|NCT00002663|101240100|FG006|NOT COMPLETED|Overall Study||1||
48373070|NCT00002663|101240101|FG007|NOT COMPLETED|Overall Study||2||
48373071|NCT00002663|101240102|FG008|NOT COMPLETED|Overall Study||2||
48373072|NCT00002663|101240103|FG009|NOT COMPLETED|Overall Study||2||
48373073|NCT02575079|101240104|FG000|STARTED|Overall Study||48||
48373074|NCT02575079|101240105|FG001|STARTED|Overall Study||71||
48373075|NCT02575079|101240104|FG000|COMPLETED|Overall Study||42||
48373076|NCT02575079|101240105|FG001|COMPLETED|Overall Study||71||
48373077|NCT02575079|101240104|FG000|NOT COMPLETED|Overall Study||6||
48373078|NCT02575079|101240105|FG001|NOT COMPLETED|Overall Study||0||
48404005|NCT03417505|101321755|FG001|STARTED|First Lens Type (30 Days)||12||
48404006|NCT03417505|101321754|FG000|COMPLETED|First Lens Type (30 Days)||8||
48404007|NCT03417505|101321755|FG001|COMPLETED|First Lens Type (30 Days)||11||
48404008|NCT03417505|101321754|FG000|NOT COMPLETED|First Lens Type (30 Days)||1||
48404009|NCT03417505|101321755|FG001|NOT COMPLETED|First Lens Type (30 Days)||1||
48404010|NCT03417505|101321754|FG000|STARTED|Washout Period (7 Days)||8||
48404011|NCT03417505|101321755|FG001|STARTED|Washout Period (7 Days)||11||
48404012|NCT03417505|101321754|FG000|COMPLETED|Washout Period (7 Days)||8||
48404013|NCT03417505|101321755|FG001|COMPLETED|Washout Period (7 Days)||11||
48404014|NCT03417505|101321754|FG000|NOT COMPLETED|Washout Period (7 Days)||0||
48404015|NCT03417505|101321755|FG001|NOT COMPLETED|Washout Period (7 Days)||0||
48404016|NCT03417505|101321754|FG000|STARTED|Second Lens Type (30 Days)||8||
48404017|NCT03417505|101321755|FG001|STARTED|Second Lens Type (30 Days)||11||
48404018|NCT03417505|101321754|FG000|COMPLETED|Second Lens Type (30 Days)||8||
48404019|NCT03417505|101321755|FG001|COMPLETED|Second Lens Type (30 Days)||11||
48404020|NCT03417505|101321754|FG000|NOT COMPLETED|Second Lens Type (30 Days)||0||
48404021|NCT03417505|101321755|FG001|NOT COMPLETED|Second Lens Type (30 Days)||0||
48404022|NCT04319445|101321756|FG000|STARTED|Overall Study||144||
48404023|NCT04319445|101321756|FG000|COMPLETED|Overall Study||144||
48404024|NCT04319445|101321756|FG000|NOT COMPLETED|Overall Study||0||
48404025|NCT02027272|101321757|FG000|STARTED|Overall Study||0||
48404026|NCT02027272|101321758|FG001|STARTED|Overall Study||1||
48404027|NCT02027272|101321757|FG000|COMPLETED|Overall Study||0||
48404028|NCT02027272|101321758|FG001|COMPLETED|Overall Study||0||
48404029|NCT02027272|101321757|FG000|NOT COMPLETED|Overall Study||0||
48404030|NCT02027272|101321758|FG001|NOT COMPLETED|Overall Study||1||
48404031|NCT04363944|101321759|FG000|STARTED|Overall Study||18||
48404032|NCT04363944|101321760|FG001|STARTED|Overall Study||1||
48404033|NCT04363944|101321759|FG000|COMPLETED|Overall Study||16||
48404034|NCT04363944|101321760|FG001|COMPLETED|Overall Study||1||
48404035|NCT04363944|101321759|FG000|NOT COMPLETED|Overall Study||2||
48404036|NCT04363944|101321760|FG001|NOT COMPLETED|Overall Study||0||
48404037|NCT02007252|101321761|FG000|STARTED|Overall Study||31||
48404038|NCT02007252|101321762|FG001|STARTED|Overall Study||33||
48404039|NCT02007252|101321761|FG000|Safety Analysis Set|Overall Study||31||
48404040|NCT02007252|101321762|FG001|Safety Analysis Set|Overall Study||33||
48404041|NCT02007252|101321761|FG000|Pharmacodynamic Analysis Set|Overall Study||31||
48404042|NCT02007252|101321762|FG001|Pharmacodynamic Analysis Set|Overall Study||33||
48404043|NCT02007252|101321761|FG000|COMPLETED|Overall Study||20||
48404044|NCT02007252|101321762|FG001|COMPLETED|Overall Study||22||
48404045|NCT02007252|101321761|FG000|NOT COMPLETED|Overall Study||11||
48404046|NCT02007252|101321762|FG001|NOT COMPLETED|Overall Study||11||
48404047|NCT04884945|101321763|FG000|STARTED|Overall Study||5||
48404048|NCT04884945|101321764|FG001|STARTED|Overall Study||6||
48404049|NCT04884945|101321763|FG000|1 Week Post op|Overall Study||5||
48404050|NCT04884945|101321764|FG001|1 Week Post op|Overall Study||6||
48404051|NCT04884945|101321763|FG000|2 Week Post op|Overall Study||4||
48404052|NCT04884945|101321764|FG001|2 Week Post op|Overall Study||6||
48404053|NCT04884945|101321763|FG000|6 Week Post op|Overall Study||4||
48404054|NCT04884945|101321764|FG001|6 Week Post op|Overall Study||6||
48404055|NCT04884945|101321763|FG000|3 Month Follow up|Overall Study||4|Timing is 3 months after the 6 week post op visit|
48404056|NCT04884945|101321764|FG001|3 Month Follow up|Overall Study||5|Timing is 3 months after the 6 week post op visit|
48404057|NCT04884945|101321763|FG000|COMPLETED|Overall Study||4||
48404058|NCT04884945|101321764|FG001|COMPLETED|Overall Study||5||
48404059|NCT04884945|101321763|FG000|NOT COMPLETED|Overall Study||1||
48404060|NCT04884945|101321764|FG001|NOT COMPLETED|Overall Study||1||
48404061|NCT02768103|101321765|FG000|STARTED|Overall Study||5||
48404062|NCT02768103|101321765|FG000|COMPLETED|Overall Study||4||
48404063|NCT02768103|101321765|FG000|NOT COMPLETED|Overall Study||1||
48404064|NCT03689972|101321766|FG000|STARTED|Part 1 (Day 1 up to Week 72)||248||
48404065|NCT03689972|101321767|FG001|STARTED|Part 1 (Day 1 up to Week 72)||251||
48404066|NCT03689972|101321768|FG002|STARTED|Part 1 (Day 1 up to Week 72)||0||
48373079|NCT00968253|101243422|FG000|STARTED|Overall Study||3||
48373080|NCT00968253|101243423|FG001|STARTED|Overall Study||9||
48373081|NCT00968253|101243424|FG002|STARTED|Overall Study||12||
48373082|NCT00968253|101243422|FG000|COMPLETED|Overall Study||3||
48373083|NCT00968253|101243423|FG001|COMPLETED|Overall Study||6||
48373084|NCT00968253|101243424|FG002|COMPLETED|Overall Study||5||
48373085|NCT00968253|101243422|FG000|NOT COMPLETED|Overall Study||0||
48373086|NCT00968253|101243423|FG001|NOT COMPLETED|Overall Study||3||
48373087|NCT00968253|101243424|FG002|NOT COMPLETED|Overall Study||7||
48373088|NCT02928406|101243425|FG000|STARTED|Overall Study||1004||
48373089|NCT02928406|101243425|FG000|Did Not Receive Study Drug|Overall Study||7||
48373090|NCT02928406|101243425|FG000|COMPLETED|Overall Study||0||
48373091|NCT02928406|101243425|FG000|NOT COMPLETED|Overall Study||1004||
48373092|NCT01912768|101243426|FG000|STARTED|Overall Study||239||
48373093|NCT01912768|101243427|FG001|STARTED|Overall Study||113||
48373094|NCT01912768|101243426|FG000|COMPLETED|Overall Study||229||
48373095|NCT01912768|101243427|FG001|COMPLETED|Overall Study||109||
48373096|NCT01912768|101243426|FG000|NOT COMPLETED|Overall Study||10||
48373097|NCT01912768|101243427|FG001|NOT COMPLETED|Overall Study||4||
48373098|NCT03132805|101243428|FG000|STARTED|Overall Study||1629|Students and teachers enrolled within participating schools|16
48373099|NCT03132805|101243429|FG001|STARTED|Overall Study||1792|Students and teachers enrolled within participating schools|16
48373100|NCT03132805|101243430|FG002|STARTED|Overall Study||1812|Students and teachers enrolled within participating schools|16
48373101|NCT03132805|101243428|FG000|Students|Overall Study||1527||16
48373102|NCT03132805|101243429|FG001|Students|Overall Study||1694||16
48373103|NCT03132805|101243430|FG002|Students|Overall Study||1702||16
48373104|NCT03132805|101243428|FG000|Teachers|Overall Study||102||16
48373105|NCT03132805|101243429|FG001|Teachers|Overall Study||98||16
48373106|NCT03132805|101243430|FG002|Teachers|Overall Study||110||16
48373107|NCT03132805|101243428|FG000|Baseline Data Collection (Students)|Overall Study||1442||16
48373108|NCT03132805|101243429|FG001|Baseline Data Collection (Students)|Overall Study||1603||16
48373109|NCT03132805|101243430|FG002|Baseline Data Collection (Students)|Overall Study||1617||16
48373110|NCT03132805|101243428|FG000|Post-test Data Collection (Students)|Overall Study||1395||16
48373111|NCT03132805|101243429|FG001|Post-test Data Collection (Students)|Overall Study||1564||16
48373112|NCT03132805|101243430|FG002|Post-test Data Collection (Students)|Overall Study||1609||16
48373113|NCT03132805|101243428|FG000|Baseline Data Collection (Teachers)|Overall Study||102||16
48373114|NCT03132805|101243429|FG001|Baseline Data Collection (Teachers)|Overall Study||91||16
48373115|NCT03132805|101243430|FG002|Baseline Data Collection (Teachers)|Overall Study||99||16
48373116|NCT03132805|101243428|FG000|Post-test Data Collection (Teachers)|Overall Study||92||16
48373117|NCT03132805|101243429|FG001|Post-test Data Collection (Teachers)|Overall Study||87||16
48373118|NCT03132805|101243430|FG002|Post-test Data Collection (Teachers)|Overall Study||90||16
48373119|NCT03132805|101243428|FG000|COMPLETED|Overall Study||1487|Students and teachers enrolled within participating schools who were assessed at post-test|16
48373120|NCT03132805|101243429|FG001|COMPLETED|Overall Study||1651|Students and teachers enrolled within participating schools who were assessed at post-test|16
48373121|NCT03132805|101243430|FG002|COMPLETED|Overall Study||1699|Students and teachers enrolled within participating schools who were assessed at post-test|16
48373122|NCT03132805|101243428|FG000|NOT COMPLETED|Overall Study||142||0
48373123|NCT03132805|101243429|FG001|NOT COMPLETED|Overall Study||141||0
48373124|NCT03132805|101243430|FG002|NOT COMPLETED|Overall Study||113||0
48373125|NCT03977727|101243431|FG000|STARTED|First Treatment||20||
48373126|NCT03977727|101243432|FG001|STARTED|First Treatment||20||
48373127|NCT03977727|101243431|FG000|Received Treatment|First Treatment||20||
48373128|NCT03977727|101243432|FG001|Received Treatment|First Treatment||20||
48373129|NCT03977727|101243431|FG000|COMPLETED|First Treatment||20||
48373130|NCT03977727|101243432|FG001|COMPLETED|First Treatment||20||
48373131|NCT03977727|101243431|FG000|NOT COMPLETED|First Treatment||0||
48373132|NCT03977727|101243432|FG001|NOT COMPLETED|First Treatment||0||
48373133|NCT03977727|101243431|FG000|STARTED|Second Treatment||20||
48373134|NCT03977727|101243432|FG001|STARTED|Second Treatment||20||
48373135|NCT03977727|101243431|FG000|COMPLETED|Second Treatment||20||
48373136|NCT03977727|101243432|FG001|COMPLETED|Second Treatment||17||
48373137|NCT03977727|101243431|FG000|NOT COMPLETED|Second Treatment||0||
48373138|NCT03977727|101243432|FG001|NOT COMPLETED|Second Treatment||3||
48373139|NCT03492463|101243433|FG000|STARTED|Overall Study||37||
48373140|NCT03492463|101243434|FG001|STARTED|Overall Study||33||
48373141|NCT03492463|101243435|FG002|STARTED|Overall Study||11||
48373142|NCT03492463|101243436|FG003|STARTED|Overall Study||13||
48373143|NCT03492463|101243433|FG000|COMPLETED|Overall Study||26||
48373144|NCT03492463|101243434|FG001|COMPLETED|Overall Study||19||
48373145|NCT03492463|101243435|FG002|COMPLETED|Overall Study||7||
48373146|NCT03492463|101243436|FG003|COMPLETED|Overall Study||10||
48373147|NCT03492463|101243433|FG000|NOT COMPLETED|Overall Study||11||
48373148|NCT03492463|101243434|FG001|NOT COMPLETED|Overall Study||14||
48373149|NCT03492463|101243435|FG002|NOT COMPLETED|Overall Study||4||
48373150|NCT03492463|101243436|FG003|NOT COMPLETED|Overall Study||3||
48373151|NCT02963714|101243437|FG000|STARTED|Overall Study||176||
48373152|NCT02963714|101243438|FG001|STARTED|Overall Study||176||
48373153|NCT02963714|101243437|FG000|COMPLETED|Overall Study||126||
48373154|NCT02963714|101243438|FG001|COMPLETED|Overall Study||126||
48373155|NCT02963714|101243437|FG000|NOT COMPLETED|Overall Study||50||
48373156|NCT02963714|101243438|FG001|NOT COMPLETED|Overall Study||50||
48373157|NCT00421343|101243439|FG000|STARTED|Overall Study||29||
48373158|NCT00421343|101243439|FG000|COMPLETED|Overall Study||23||
48373159|NCT00421343|101243439|FG000|NOT COMPLETED|Overall Study||6||
48373160|NCT00894413|101243440|FG000|STARTED|Overall Study||15||
48373161|NCT00894413|101243441|FG001|STARTED|Overall Study||25||
48373162|NCT00894413|101243440|FG000|COMPLETED|Overall Study||15||
48373163|NCT00894413|101243441|FG001|COMPLETED|Overall Study||17||
48373164|NCT00894413|101243440|FG000|NOT COMPLETED|Overall Study||0||
48373165|NCT00894413|101243441|FG001|NOT COMPLETED|Overall Study||8||
48373166|NCT04360187|101243442|FG000|STARTED|Double-Blind Treatment||131||
48373167|NCT04360187|101243443|FG001|STARTED|Double-Blind Treatment||260||
48373168|NCT04360187|101243442|FG000|COMPLETED|Double-Blind Treatment||108||
48373169|NCT04360187|101243443|FG001|COMPLETED|Double-Blind Treatment||245||
48373170|NCT04360187|101243442|FG000|NOT COMPLETED|Double-Blind Treatment||23||
48373171|NCT04360187|101243443|FG001|NOT COMPLETED|Double-Blind Treatment||15||
48373172|NCT04360187|101243442|FG000|STARTED|Follow-Up||114||
48373173|NCT04360187|101243443|FG001|STARTED|Follow-Up||232||
48373174|NCT04360187|101243442|FG000|COMPLETED|Follow-Up||113||
48373175|NCT04360187|101243443|FG001|COMPLETED|Follow-Up||232||
48373176|NCT04360187|101243442|FG000|NOT COMPLETED|Follow-Up||1||
48373177|NCT04360187|101243443|FG001|NOT COMPLETED|Follow-Up||0||
48373178|NCT01580592|101243444|FG000|STARTED|Overall Study||10||
48373179|NCT01580592|101243445|FG001|STARTED|Overall Study||9||
48373180|NCT01580592|101243446|FG002|STARTED|Overall Study||12||
48373181|NCT01580592|101243444|FG000|COMPLETED|Overall Study||10||
48373182|NCT01580592|101243445|FG001|COMPLETED|Overall Study||9||
48373183|NCT01580592|101243446|FG002|COMPLETED|Overall Study||12||
48373184|NCT01580592|101243444|FG000|NOT COMPLETED|Overall Study||0||
48373185|NCT01580592|101243445|FG001|NOT COMPLETED|Overall Study||0||
48373186|NCT01580592|101243446|FG002|NOT COMPLETED|Overall Study||0||
48373187|NCT00553059|101243447|FG000|STARTED|Overall Study||31||
48373188|NCT00553059|101243448|FG001|STARTED|Overall Study||31||
48373189|NCT00553059|101243447|FG000|COMPLETED|Overall Study||30||
48373190|NCT00553059|101243448|FG001|COMPLETED|Overall Study||29||
48373191|NCT00553059|101243447|FG000|NOT COMPLETED|Overall Study||1||
48373192|NCT00553059|101243448|FG001|NOT COMPLETED|Overall Study||2||
48521848|NCT03431974|101611706|FG000|STARTED|Overall Study||11||
48521849|NCT03431974|101611707|FG001|STARTED|Overall Study||8||
48373193|NCT00363805|101243449|FG000|STARTED|Overall Study||42||
48373194|NCT00363805|101243450|FG001|STARTED|Overall Study||63||
48373195|NCT00363805|101243451|FG002|STARTED|Overall Study||73||
48373196|NCT00363805|101243449|FG000|COMPLETED|Overall Study||38||
48373197|NCT00363805|101243450|FG001|COMPLETED|Overall Study||57||
48373198|NCT00363805|101243451|FG002|COMPLETED|Overall Study||70||
48373199|NCT00363805|101243449|FG000|NOT COMPLETED|Overall Study||4||
48373200|NCT00363805|101243450|FG001|NOT COMPLETED|Overall Study||6||
48373201|NCT00363805|101243451|FG002|NOT COMPLETED|Overall Study||3||
48373202|NCT02868216|101243452|FG000|STARTED|Overall Study||43||
48373203|NCT02868216|101243453|FG001|STARTED|Overall Study||47||
48373204|NCT02868216|101243452|FG000|COMPLETED|Overall Study||35||
48373205|NCT02868216|101243453|FG001|COMPLETED|Overall Study||41||
48373206|NCT02868216|101243452|FG000|NOT COMPLETED|Overall Study||8||
48373207|NCT02868216|101243453|FG001|NOT COMPLETED|Overall Study||6||
48373208|NCT01109004|101243454|FG000|STARTED|Overall Study||247||
48373209|NCT01109004|101243455|FG001|STARTED|Overall Study||254||
48373210|NCT01109004|101243456|FG002|STARTED|Overall Study||257||
48373211|NCT01109004|101243454|FG000|COMPLETED|Overall Study||247||
48373212|NCT01109004|101243455|FG001|COMPLETED|Overall Study||254||
48373213|NCT01109004|101243456|FG002|COMPLETED|Overall Study||257||
48373214|NCT01109004|101243454|FG000|NOT COMPLETED|Overall Study||0||
48373215|NCT01109004|101243455|FG001|NOT COMPLETED|Overall Study||0||
48373216|NCT01109004|101243456|FG002|NOT COMPLETED|Overall Study||0||
48373217|NCT03235544|101243457|FG000|STARTED|Overall Study||12||
48373218|NCT03235544|101243458|FG001|STARTED|Overall Study||41||
48373219|NCT03235544|101243459|FG002|STARTED|Overall Study||31||
48373220|NCT03235544|101243460|FG003|STARTED|Overall Study||77||
48373221|NCT03235544|101243457|FG000|COMPLETED|Overall Study||0||
48373222|NCT03235544|101243458|FG001|COMPLETED|Overall Study||0||
48373223|NCT03235544|101243459|FG002|COMPLETED|Overall Study||0||
48373224|NCT03235544|101243460|FG003|COMPLETED|Overall Study||0||
48373225|NCT03235544|101243457|FG000|NOT COMPLETED|Overall Study||12||
48373226|NCT03235544|101243458|FG001|NOT COMPLETED|Overall Study||41||
48373227|NCT03235544|101243459|FG002|NOT COMPLETED|Overall Study||31||
48373228|NCT03235544|101243460|FG003|NOT COMPLETED|Overall Study||77||
48373229|NCT01380106|101243461|FG000|STARTED|Overall Study||16||
48373230|NCT01380106|101243462|FG001|STARTED|Overall Study||17||
48373231|NCT01380106|101243461|FG000|COMPLETED|Overall Study||16||
48373232|NCT01380106|101243462|FG001|COMPLETED|Overall Study||17||
48373233|NCT01380106|101243461|FG000|NOT COMPLETED|Overall Study||0||
48373234|NCT01380106|101243462|FG001|NOT COMPLETED|Overall Study||0||
48373235|NCT01153763|101243463|FG000|STARTED|Overall Study||92||
48373236|NCT01153763|101243463|FG000|COMPLETED|Overall Study||71||
48373237|NCT01153763|101243463|FG000|NOT COMPLETED|Overall Study||21||
48373238|NCT00488618|101243464|FG000|STARTED|Overall Study||120||
48373239|NCT00488618|101243465|FG001|STARTED|Overall Study||118||
48373240|NCT00488618|101243464|FG000|Safety Population: Received Study Drug|Overall Study||118||
48373241|NCT00488618|101243465|FG001|Safety Population: Received Study Drug|Overall Study||118||
48373242|NCT00488618|101243464|FG000|COMPLETED|Overall Study||73||
48373243|NCT00488618|101243465|FG001|COMPLETED|Overall Study||75||
48373244|NCT00488618|101243464|FG000|NOT COMPLETED|Overall Study||47||
48373245|NCT00488618|101243465|FG001|NOT COMPLETED|Overall Study||43||
48373246|NCT00365716|101243466|FG000|STARTED|Base Study (Day 1 to Month 7)||290||
48373247|NCT00365716|101243467|FG001|STARTED|Base Study (Day 1 to Month 7)||284||
48373248|NCT00365716|101243468|FG002|STARTED|Base Study (Day 1 to Month 7)||292||
48373249|NCT00365716|101243469|FG003|STARTED|Base Study (Day 1 to Month 7)||146||
48373250|NCT00365716|101243470|FG004|STARTED|Base Study (Day 1 to Month 7)||146||
48373251|NCT00365716|101243471|FG005|STARTED|Base Study (Day 1 to Month 7)||0||
48373252|NCT00365716|101243472|FG006|STARTED|Base Study (Day 1 to Month 7)||0||
48373253|NCT00365716|101243466|FG000|COMPLETED|Base Study (Day 1 to Month 7)||269||
48373254|NCT00365716|101243467|FG001|COMPLETED|Base Study (Day 1 to Month 7)||260||
48373255|NCT00365716|101243468|FG002|COMPLETED|Base Study (Day 1 to Month 7)||271||
48373256|NCT00365716|101243469|FG003|COMPLETED|Base Study (Day 1 to Month 7)||136||
48373257|NCT00365716|101243470|FG004|COMPLETED|Base Study (Day 1 to Month 7)||139||
48373258|NCT00365716|101243471|FG005|COMPLETED|Base Study (Day 1 to Month 7)||0||
48373259|NCT00365716|101243472|FG006|COMPLETED|Base Study (Day 1 to Month 7)||0||
48373260|NCT00365716|101243466|FG000|NOT COMPLETED|Base Study (Day 1 to Month 7)||21||
48373261|NCT00365716|101243467|FG001|NOT COMPLETED|Base Study (Day 1 to Month 7)||24||
48373262|NCT00365716|101243468|FG002|NOT COMPLETED|Base Study (Day 1 to Month 7)||21||
48373263|NCT00365716|101243469|FG003|NOT COMPLETED|Base Study (Day 1 to Month 7)||10||
48373264|NCT00365716|101243470|FG004|NOT COMPLETED|Base Study (Day 1 to Month 7)||7||
48373265|NCT00365716|101243471|FG005|NOT COMPLETED|Base Study (Day 1 to Month 7)||0||
48373266|NCT00365716|101243472|FG006|NOT COMPLETED|Base Study (Day 1 to Month 7)||0||
48373267|NCT00365716|101243466|FG000|STARTED|Long Term Follow-up (Month 7 toMonth 36)||269||
48373268|NCT00365716|101243467|FG001|STARTED|Long Term Follow-up (Month 7 toMonth 36)||260||
48373269|NCT00365716|101243468|FG002|STARTED|Long Term Follow-up (Month 7 toMonth 36)||271||
48373270|NCT00365716|101243469|FG003|STARTED|Long Term Follow-up (Month 7 toMonth 36)||136||
48373271|NCT00365716|101243470|FG004|STARTED|Long Term Follow-up (Month 7 toMonth 36)||139||
48373272|NCT00365716|101243471|FG005|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0||
48373273|NCT00365716|101243472|FG006|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0||
48373274|NCT00365716|101243466|FG000|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||137||
48373275|NCT00365716|101243467|FG001|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||245||
48373276|NCT00365716|101243468|FG002|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||251||
48373277|NCT00365716|101243469|FG003|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57||
48373278|NCT00365716|101243470|FG004|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57||
48373279|NCT00365716|101243471|FG005|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0||
48373280|NCT00365716|101243472|FG006|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0||
48373281|NCT00365716|101243466|FG000|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||132||
48373282|NCT00365716|101243467|FG001|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||15||
48373283|NCT00365716|101243468|FG002|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||20||
48373284|NCT00365716|101243469|FG003|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||79||
48373285|NCT00365716|101243470|FG004|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||82||
48373286|NCT00365716|101243471|FG005|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0||
48373287|NCT00365716|101243472|FG006|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0||
48373288|NCT00365716|101243466|FG000|STARTED|Extension 1||0||
48373289|NCT00365716|101243467|FG001|STARTED|Extension 1||0||
48373290|NCT00365716|101243468|FG002|STARTED|Extension 1||0||
48373291|NCT00365716|101243469|FG003|STARTED|Extension 1||0||
48373292|NCT00365716|101243470|FG004|STARTED|Extension 1||0||
48373293|NCT00365716|101243471|FG005|STARTED|Extension 1||241||
48373294|NCT00365716|101243472|FG006|STARTED|Extension 1||0||
48373295|NCT00365716|101243466|FG000|COMPLETED|Extension 1||0||
48373296|NCT00365716|101243467|FG001|COMPLETED|Extension 1||0||
48373297|NCT00365716|101243468|FG002|COMPLETED|Extension 1||0||
48373298|NCT00365716|101243469|FG003|COMPLETED|Extension 1||0||
48373299|NCT00365716|101243470|FG004|COMPLETED|Extension 1||0||
48373300|NCT00365716|101243471|FG005|COMPLETED|Extension 1||219||
48373301|NCT00365716|101243472|FG006|COMPLETED|Extension 1||0||
48373302|NCT00365716|101243466|FG000|NOT COMPLETED|Extension 1||0||
48373303|NCT00365716|101243467|FG001|NOT COMPLETED|Extension 1||0||
48373304|NCT00365716|101243468|FG002|NOT COMPLETED|Extension 1||0||
48373305|NCT00365716|101243469|FG003|NOT COMPLETED|Extension 1||0||
48373306|NCT00365716|101243470|FG004|NOT COMPLETED|Extension 1||0||
48373307|NCT00365716|101243471|FG005|NOT COMPLETED|Extension 1||22||
48373308|NCT00365716|101243472|FG006|NOT COMPLETED|Extension 1||0||
48373309|NCT00365716|101243466|FG000|STARTED|Extension 2||0||
48373310|NCT00365716|101243467|FG001|STARTED|Extension 2||0||
48373311|NCT00365716|101243468|FG002|STARTED|Extension 2||0||
48373312|NCT00365716|101243469|FG003|STARTED|Extension 2||0||
48373313|NCT00365716|101243470|FG004|STARTED|Extension 2||0||
48373314|NCT00365716|101243471|FG005|STARTED|Extension 2||0||
48373315|NCT00365716|101243472|FG006|STARTED|Extension 2||17||
48373316|NCT00365716|101243466|FG000|COMPLETED|Extension 2||0||
48373317|NCT00365716|101243467|FG001|COMPLETED|Extension 2||0||
48373318|NCT00365716|101243468|FG002|COMPLETED|Extension 2||0||
48373319|NCT00365716|101243469|FG003|COMPLETED|Extension 2||0||
48373320|NCT00365716|101243470|FG004|COMPLETED|Extension 2||0||
48373321|NCT00365716|101243471|FG005|COMPLETED|Extension 2||0||
48373322|NCT00365716|101243472|FG006|COMPLETED|Extension 2||7||
48373323|NCT00365716|101243466|FG000|NOT COMPLETED|Extension 2||0||
48373324|NCT00365716|101243467|FG001|NOT COMPLETED|Extension 2||0||
48373325|NCT00365716|101243468|FG002|NOT COMPLETED|Extension 2||0||
48373326|NCT00365716|101243469|FG003|NOT COMPLETED|Extension 2||0||
48373327|NCT00365716|101243470|FG004|NOT COMPLETED|Extension 2||0||
48373328|NCT00365716|101243471|FG005|NOT COMPLETED|Extension 2||0||
48373329|NCT00365716|101243472|FG006|NOT COMPLETED|Extension 2||10||
48373330|NCT03072719|101243473|FG000|STARTED|Overall Study||60||
48373331|NCT03072719|101243474|FG001|STARTED|Overall Study||60||
48373332|NCT03072719|101243473|FG000|COMPLETED|Overall Study||59||
48373333|NCT03072719|101243474|FG001|COMPLETED|Overall Study||59||
48373334|NCT03072719|101243473|FG000|NOT COMPLETED|Overall Study||1||
48373335|NCT03072719|101243474|FG001|NOT COMPLETED|Overall Study||1||
48373336|NCT02335216|101243475|FG000|STARTED|Overall Study||22||
48373337|NCT02335216|101243475|FG000|Received Trial System|Overall Study||16||
48373338|NCT02335216|101243475|FG000|Received Permanent System|Overall Study||13||
48373339|NCT02335216|101243475|FG000|COMPLETED|Overall Study||9||
48373340|NCT02335216|101243475|FG000|NOT COMPLETED|Overall Study||13||
48373341|NCT03352414|101243476|FG000|STARTED|Overall Study||42|Is the Randomized population meeting preoperative eligibility criteria (also called the Safety Population)|
48373342|NCT03352414|101243477|FG001|STARTED|Overall Study||42|Is the Randomized population meeting preoperative eligibility criteria (also called the Safety Population)|
48373343|NCT03352414|101243476|FG000|Allocated|Overall Study||30|Eligible by operative criteria (received additional postoperative study drug)|
48373344|NCT03352414|101243477|FG001|Allocated|Overall Study||32|Eligible by operative criteria (received additional postoperative study drug)|
48373345|NCT03352414|101243476|FG000|COMPLETED|Overall Study||30||
48373346|NCT03352414|101243477|FG001|COMPLETED|Overall Study||32||
48373347|NCT03352414|101243476|FG000|NOT COMPLETED|Overall Study||12||
48373348|NCT03352414|101243477|FG001|NOT COMPLETED|Overall Study||10||
48373349|NCT02488551|101243478|FG000|STARTED|Overall Study||86||
48373350|NCT02488551|101243479|FG001|STARTED|Overall Study||49||
48373351|NCT02488551|101243480|FG002|STARTED|Overall Study||17||
48373352|NCT02488551|101243481|FG003|STARTED|Overall Study||15||
48373353|NCT02488551|101243478|FG000|COMPLETED|Overall Study||81||
48373354|NCT02488551|101243479|FG001|COMPLETED|Overall Study||41||
48373355|NCT02488551|101243480|FG002|COMPLETED|Overall Study||17||
48373356|NCT02488551|101243481|FG003|COMPLETED|Overall Study||15||
48373357|NCT02488551|101243478|FG000|NOT COMPLETED|Overall Study||5||
48373358|NCT02488551|101243479|FG001|NOT COMPLETED|Overall Study||8||
48373359|NCT02488551|101243480|FG002|NOT COMPLETED|Overall Study||0||
48373360|NCT02488551|101243481|FG003|NOT COMPLETED|Overall Study||0||
48373361|NCT01921257|101243482|FG000|STARTED|Overall Study||16||
48373362|NCT01921257|101243482|FG000|Placebo run-in|Overall Study||16||
48373363|NCT01921257|101243482|FG000|Active Treatment|Overall Study||13||
48373364|NCT01921257|101243482|FG000|COMPLETED|Overall Study||13||
48373365|NCT01921257|101243482|FG000|NOT COMPLETED|Overall Study||3||
48373366|NCT00536978|101243483|FG000|STARTED|Overall Study||22||
48373367|NCT00536978|101243483|FG000|COMPLETED|Overall Study||0||
48373368|NCT00536978|101243483|FG000|NOT COMPLETED|Overall Study||22||
48373369|NCT00540436|101243484|FG000|STARTED|First 12-Week Treatment Period||25||
48373370|NCT00540436|101243484|FG000|COMPLETED|First 12-Week Treatment Period||22||
48373371|NCT00540436|101243484|FG000|NOT COMPLETED|First 12-Week Treatment Period||3||
48373372|NCT00540436|101243484|FG000|STARTED|Second 12-Week Treatment Period||22||
48373373|NCT00540436|101243484|FG000|COMPLETED|Second 12-Week Treatment Period||21||
48373374|NCT00540436|101243484|FG000|NOT COMPLETED|Second 12-Week Treatment Period||1||
48373375|NCT01599754|101243485|FG000|STARTED|Overall Study||363||
48373376|NCT01599754|101243486|FG001|STARTED|Overall Study||361||
48373377|NCT01599754|101243485|FG000|Treated|Overall Study||360||
48373378|NCT01599754|101243486|FG001|Treated|Overall Study||360||
48373379|NCT01599754|101243485|FG000|COMPLETED|Overall Study||0||
48373380|NCT01599754|101243486|FG001|COMPLETED|Overall Study||1||
48373381|NCT01599754|101243485|FG000|NOT COMPLETED|Overall Study||363||
48373382|NCT01599754|101243486|FG001|NOT COMPLETED|Overall Study||360||
48373383|NCT01876732|101243487|FG000|STARTED|Overall Study||132||
48373384|NCT01876732|101243487|FG000|COMPLETED|Overall Study||57||
48373385|NCT01876732|101243487|FG000|NOT COMPLETED|Overall Study||75||
48373386|NCT03929588|101243488|FG000|STARTED|Overall Study||230||
48373387|NCT03929588|101243488|FG000|COMPLETED|Overall Study||143||
48373388|NCT03929588|101243488|FG000|NOT COMPLETED|Overall Study||87||
48373389|NCT04332640|101243489|FG000|STARTED|Overall Study||79||115
48373390|NCT04332640|101243489|FG000|COMPLETED|Overall Study||79||115
48373391|NCT04332640|101243489|FG000|NOT COMPLETED|Overall Study||0||0
48373392|NCT00369668|101243490|FG000|STARTED|Overall Study||10||
48373393|NCT00369668|101243491|FG001|STARTED|Overall Study||10||
48373394|NCT00369668|101243492|FG002|STARTED|Overall Study||10||
48373395|NCT00369668|101243490|FG000|COMPLETED|Overall Study||6||
48373396|NCT00369668|101243491|FG001|COMPLETED|Overall Study||5||
48373397|NCT00369668|101243492|FG002|COMPLETED|Overall Study||3||
48373398|NCT00369668|101243490|FG000|NOT COMPLETED|Overall Study||4||
48373399|NCT00369668|101243491|FG001|NOT COMPLETED|Overall Study||5||
48373400|NCT00369668|101243492|FG002|NOT COMPLETED|Overall Study||7||
48373401|NCT02618928|101243493|FG000|STARTED|Overall Study||735||
48373402|NCT02618928|101243493|FG000|Received Treatment|Overall Study||728||
48373403|NCT02618928|101243493|FG000|COMPLETED|Overall Study||677|HCV ribonucleic acid (RNA) treatment assessment performed at least 10 weeks post-treatment|
48373404|NCT02618928|101243493|FG000|NOT COMPLETED|Overall Study||58||
48373405|NCT01614769|101243494|FG000|STARTED|Period 1||2||
48373406|NCT01614769|101243495|FG001|STARTED|Period 1||1||
48373407|NCT01614769|101243496|FG002|STARTED|Period 1||2||
48373408|NCT01614769|101243497|FG003|STARTED|Period 1||2||
48373409|NCT01614769|101243498|FG004|STARTED|Period 1||1||
48373410|NCT01614769|101243499|FG005|STARTED|Period 1||2||
48373411|NCT01614769|101243494|FG000|COMPLETED|Period 1||1||
48373412|NCT01614769|101243495|FG001|COMPLETED|Period 1||1||
48373413|NCT01614769|101243496|FG002|COMPLETED|Period 1||2||
48373414|NCT01614769|101243497|FG003|COMPLETED|Period 1||0||
48373415|NCT01614769|101243498|FG004|COMPLETED|Period 1||1||
48373416|NCT01614769|101243499|FG005|COMPLETED|Period 1||1||
48373417|NCT01614769|101243494|FG000|NOT COMPLETED|Period 1||1||
48373418|NCT01614769|101243495|FG001|NOT COMPLETED|Period 1||0||
48373419|NCT01614769|101243496|FG002|NOT COMPLETED|Period 1||0||
48373420|NCT01614769|101243497|FG003|NOT COMPLETED|Period 1||2||
48373421|NCT01614769|101243498|FG004|NOT COMPLETED|Period 1||0||
48373422|NCT01614769|101243499|FG005|NOT COMPLETED|Period 1||1||
48373423|NCT01614769|101243494|FG000|STARTED|7-Day Washout||1||
48373424|NCT01614769|101243495|FG001|STARTED|7-Day Washout||1||
48373425|NCT01614769|101243496|FG002|STARTED|7-Day Washout||2||
48373426|NCT01614769|101243497|FG003|STARTED|7-Day Washout||0||
48373427|NCT01614769|101243498|FG004|STARTED|7-Day Washout||1||
48373428|NCT01614769|101243499|FG005|STARTED|7-Day Washout||1||
48373429|NCT01614769|101243494|FG000|COMPLETED|7-Day Washout||1||
48373430|NCT01614769|101243495|FG001|COMPLETED|7-Day Washout||1||
48373431|NCT01614769|101243496|FG002|COMPLETED|7-Day Washout||2||
48373432|NCT01614769|101243497|FG003|COMPLETED|7-Day Washout||0||
48373433|NCT01614769|101243498|FG004|COMPLETED|7-Day Washout||1||
48373434|NCT01614769|101243499|FG005|COMPLETED|7-Day Washout||1||
48373435|NCT01614769|101243494|FG000|NOT COMPLETED|7-Day Washout||0||
48373436|NCT01614769|101243495|FG001|NOT COMPLETED|7-Day Washout||0||
48373437|NCT01614769|101243496|FG002|NOT COMPLETED|7-Day Washout||0||
48373438|NCT01614769|101243497|FG003|NOT COMPLETED|7-Day Washout||0||
48373439|NCT01614769|101243498|FG004|NOT COMPLETED|7-Day Washout||0||
48373440|NCT01614769|101243499|FG005|NOT COMPLETED|7-Day Washout||0||
48373441|NCT01614769|101243494|FG000|STARTED|Period 2||1||
48373442|NCT01614769|101243495|FG001|STARTED|Period 2||1||
48373443|NCT01614769|101243496|FG002|STARTED|Period 2||2||
48373444|NCT01614769|101243497|FG003|STARTED|Period 2||0||
48373445|NCT01614769|101243498|FG004|STARTED|Period 2||1||
48373446|NCT01614769|101243499|FG005|STARTED|Period 2||1||
48373447|NCT01614769|101243494|FG000|COMPLETED|Period 2||1||
48373448|NCT01614769|101243495|FG001|COMPLETED|Period 2||1||
48373449|NCT01614769|101243496|FG002|COMPLETED|Period 2||2||
48373450|NCT01614769|101243497|FG003|COMPLETED|Period 2||0||
48373451|NCT01614769|101243498|FG004|COMPLETED|Period 2||1||
48373452|NCT01614769|101243499|FG005|COMPLETED|Period 2||1||
48373453|NCT01614769|101243494|FG000|NOT COMPLETED|Period 2||0||
48373454|NCT01614769|101243495|FG001|NOT COMPLETED|Period 2||0||
48373455|NCT01614769|101243496|FG002|NOT COMPLETED|Period 2||0||
48373456|NCT01614769|101243497|FG003|NOT COMPLETED|Period 2||0||
48373457|NCT01614769|101243498|FG004|NOT COMPLETED|Period 2||0||
48373458|NCT01614769|101243499|FG005|NOT COMPLETED|Period 2||0||
48373459|NCT01614769|101243494|FG000|STARTED|7-Day Washout||1||
48373460|NCT01614769|101243495|FG001|STARTED|7-Day Washout||1||
48373461|NCT01614769|101243496|FG002|STARTED|7-Day Washout||2||
48373462|NCT01614769|101243497|FG003|STARTED|7-Day Washout||0||
48373463|NCT01614769|101243498|FG004|STARTED|7-Day Washout||1||
48373464|NCT01614769|101243499|FG005|STARTED|7-Day Washout||1||
48373465|NCT01614769|101243494|FG000|COMPLETED|7-Day Washout||1||
48373466|NCT01614769|101243495|FG001|COMPLETED|7-Day Washout||1||
48373467|NCT01614769|101243496|FG002|COMPLETED|7-Day Washout||2||
48373468|NCT01614769|101243497|FG003|COMPLETED|7-Day Washout||0||
48373469|NCT01614769|101243498|FG004|COMPLETED|7-Day Washout||1||
48373470|NCT01614769|101243499|FG005|COMPLETED|7-Day Washout||1||
48373471|NCT01614769|101243494|FG000|NOT COMPLETED|7-Day Washout||0||
48373472|NCT01614769|101243495|FG001|NOT COMPLETED|7-Day Washout||0||
48373473|NCT01614769|101243496|FG002|NOT COMPLETED|7-Day Washout||0||
48373474|NCT01614769|101243497|FG003|NOT COMPLETED|7-Day Washout||0||
48373475|NCT01614769|101243498|FG004|NOT COMPLETED|7-Day Washout||0||
48373476|NCT01614769|101243499|FG005|NOT COMPLETED|7-Day Washout||0||
48373477|NCT01614769|101243494|FG000|STARTED|Period 3||1||
48373478|NCT01614769|101243495|FG001|STARTED|Period 3||1||
48373479|NCT01614769|101243496|FG002|STARTED|Period 3||2||
48373480|NCT01614769|101243497|FG003|STARTED|Period 3||0||
48373481|NCT01614769|101243498|FG004|STARTED|Period 3||1||
48373482|NCT01614769|101243499|FG005|STARTED|Period 3||1||
48373483|NCT01614769|101243494|FG000|COMPLETED|Period 3||1||
48373484|NCT01614769|101243495|FG001|COMPLETED|Period 3||1||
48373485|NCT01614769|101243496|FG002|COMPLETED|Period 3||1||
48373486|NCT01614769|101243497|FG003|COMPLETED|Period 3||0||
48373487|NCT01614769|101243498|FG004|COMPLETED|Period 3||1||
48373488|NCT01614769|101243499|FG005|COMPLETED|Period 3||1||
48373489|NCT01614769|101243494|FG000|NOT COMPLETED|Period 3||0||
48373490|NCT01614769|101243495|FG001|NOT COMPLETED|Period 3||0||
48373491|NCT01614769|101243496|FG002|NOT COMPLETED|Period 3||1||
48373492|NCT01614769|101243497|FG003|NOT COMPLETED|Period 3||0||
48373493|NCT01614769|101243498|FG004|NOT COMPLETED|Period 3||0||
48373494|NCT01614769|101243499|FG005|NOT COMPLETED|Period 3||0||
48373495|NCT01912729|101243500|FG000|STARTED|Overall Study||20||
48373496|NCT01912729|101243501|FG001|STARTED|Overall Study||20||
48373497|NCT01912729|101243500|FG000|COMPLETED|Overall Study||20||
48373498|NCT01912729|101243501|FG001|COMPLETED|Overall Study||19||
48373499|NCT01912729|101243500|FG000|NOT COMPLETED|Overall Study||0||
48373500|NCT01912729|101243501|FG001|NOT COMPLETED|Overall Study||1||
48373501|NCT01721408|101243502|FG000|STARTED|Overall Study||232||
48373502|NCT01721408|101243503|FG001|STARTED|Overall Study||231||
48373503|NCT01721408|101243502|FG000|COMPLETED|Overall Study||196||
48373504|NCT01721408|101243503|FG001|COMPLETED|Overall Study||207||
48373505|NCT01721408|101243502|FG000|NOT COMPLETED|Overall Study||36||
48373506|NCT01721408|101243503|FG001|NOT COMPLETED|Overall Study||24||
48373507|NCT01662297|101243504|FG000|STARTED|Overall Study||0||
48373508|NCT01662297|101243505|FG001|STARTED|Overall Study||1||
48373509|NCT01662297|101243504|FG000|COMPLETED|Overall Study||0||
48373510|NCT01662297|101243505|FG001|COMPLETED|Overall Study||1||
48373511|NCT01662297|101243504|FG000|NOT COMPLETED|Overall Study||0||
48373512|NCT01662297|101243505|FG001|NOT COMPLETED|Overall Study||0||
48373513|NCT03213626|101243506|FG000|STARTED|Overall Study||7||
48373514|NCT03213626|101243506|FG000|COMPLETED|Overall Study||0||
48373515|NCT03213626|101243506|FG000|NOT COMPLETED|Overall Study||7||
48373516|NCT01835496|101243507|FG000|STARTED|Overall Study||8||
48373517|NCT01835496|101243507|FG000|COMPLETED|Overall Study||8||
48373518|NCT01835496|101243507|FG000|NOT COMPLETED|Overall Study||0||
48373519|NCT00940342|101243508|FG000|STARTED|Overall Study||50||
48373520|NCT00940342|101243509|FG001|STARTED|Overall Study||40||
48373521|NCT00940342|101243510|FG002|STARTED|Overall Study||40||
48373522|NCT00940342|101243508|FG000|COMPLETED|Overall Study||50||
48373523|NCT00940342|101243509|FG001|COMPLETED|Overall Study||38||
48373524|NCT00940342|101243510|FG002|COMPLETED|Overall Study||39||
48373525|NCT00940342|101243508|FG000|NOT COMPLETED|Overall Study||0||
48373526|NCT00940342|101243509|FG001|NOT COMPLETED|Overall Study||2||
48373527|NCT00940342|101243510|FG002|NOT COMPLETED|Overall Study||1||
48373528|NCT04341675|101243511|FG000|STARTED|Overall Study||18||
48373529|NCT04341675|101243512|FG001|STARTED|Overall Study||10||
48373530|NCT04341675|101243511|FG000|COMPLETED|Overall Study||18||
48373531|NCT04341675|101243512|FG001|COMPLETED|Overall Study||10||
48373532|NCT04341675|101243511|FG000|NOT COMPLETED|Overall Study||0||
48373533|NCT04341675|101243512|FG001|NOT COMPLETED|Overall Study||0||
48373534|NCT00506077|101243513|FG000|STARTED|Treatment Period 1||28||
48373535|NCT00506077|101243514|FG001|STARTED|Treatment Period 1||27||
48373536|NCT00506077|101243513|FG000|COMPLETED|Treatment Period 1||24||
48373537|NCT00506077|101243514|FG001|COMPLETED|Treatment Period 1||24||
48373538|NCT00506077|101243513|FG000|NOT COMPLETED|Treatment Period 1||4||
48373539|NCT00506077|101243514|FG001|NOT COMPLETED|Treatment Period 1||3||
48373540|NCT00506077|101243513|FG000|STARTED|Washout||24||
48373541|NCT00506077|101243514|FG001|STARTED|Washout||24||
48373542|NCT00506077|101243513|FG000|COMPLETED|Washout||24||
48373543|NCT00506077|101243514|FG001|COMPLETED|Washout||24||
48373544|NCT00506077|101243513|FG000|NOT COMPLETED|Washout||0||
48373545|NCT00506077|101243514|FG001|NOT COMPLETED|Washout||0||
48373546|NCT00506077|101243513|FG000|STARTED|Treatment Period 2||24||
48373547|NCT00506077|101243514|FG001|STARTED|Treatment Period 2||24||
48373548|NCT00506077|101243513|FG000|COMPLETED|Treatment Period 2||23||
48373549|NCT00506077|101243514|FG001|COMPLETED|Treatment Period 2||23||
48373550|NCT00506077|101243513|FG000|NOT COMPLETED|Treatment Period 2||1||
48373551|NCT00506077|101243514|FG001|NOT COMPLETED|Treatment Period 2||1||
48373552|NCT01815333|101243515|FG000|STARTED|Overall Study||10||
48373553|NCT01815333|101243515|FG000|COMPLETED|Overall Study||10||
48373554|NCT01815333|101243515|FG000|NOT COMPLETED|Overall Study||0||
48373555|NCT02426658|101243516|FG000|STARTED|Overall Study||16||
48373556|NCT02426658|101243516|FG000|COMPLETED|Overall Study||13||
48373557|NCT02426658|101243516|FG000|NOT COMPLETED|Overall Study||3||
48373558|NCT00988559|101243517|FG000|STARTED|Overall Study||10||
48373559|NCT00988559|101243518|FG001|STARTED|Overall Study||11||
48373560|NCT00988559|101243519|FG002|STARTED|Overall Study||11||
48373561|NCT00988559|101243520|FG003|STARTED|Overall Study||7||
48373562|NCT00988559|101243517|FG000|COMPLETED|Overall Study||9||
48373563|NCT00988559|101243518|FG001|COMPLETED|Overall Study||9||
48373564|NCT00988559|101243519|FG002|COMPLETED|Overall Study||9||
48373565|NCT00988559|101243520|FG003|COMPLETED|Overall Study||6||
48373566|NCT00988559|101243517|FG000|NOT COMPLETED|Overall Study||1||
48373567|NCT00988559|101243518|FG001|NOT COMPLETED|Overall Study||2||
48373568|NCT00988559|101243519|FG002|NOT COMPLETED|Overall Study||2||
48373569|NCT00988559|101243520|FG003|NOT COMPLETED|Overall Study||1||
48373570|NCT01655823|101243521|FG000|STARTED|Overall Study||25||
48373571|NCT01655823|101243522|FG001|STARTED|Overall Study||25||
48373572|NCT01655823|101243523|FG002|STARTED|Overall Study||24||
48373573|NCT01655823|101243524|FG003|STARTED|Overall Study||25||
48373574|NCT01655823|101243525|FG004|STARTED|Overall Study||26||
48373575|NCT01655823|101243521|FG000|COMPLETED|Overall Study||25||
48373576|NCT01655823|101243522|FG001|COMPLETED|Overall Study||23||
48373577|NCT01655823|101243523|FG002|COMPLETED|Overall Study||24||
48373578|NCT01655823|101243524|FG003|COMPLETED|Overall Study||24||
48373579|NCT01655823|101243525|FG004|COMPLETED|Overall Study||25||
48373580|NCT01655823|101243521|FG000|NOT COMPLETED|Overall Study||0||
48373581|NCT01655823|101243522|FG001|NOT COMPLETED|Overall Study||2||
48373582|NCT01655823|101243523|FG002|NOT COMPLETED|Overall Study||0||
48373583|NCT01655823|101243524|FG003|NOT COMPLETED|Overall Study||1||
48373584|NCT01655823|101243525|FG004|NOT COMPLETED|Overall Study||1||
48373585|NCT01402284|101243526|FG000|STARTED|Overall Study||45||
48373586|NCT01402284|101243526|FG000|COMPLETED|Overall Study||31||
48373587|NCT01402284|101243526|FG000|NOT COMPLETED|Overall Study||14||
48373588|NCT02932475|101243527|FG000|STARTED|Overall Study||416||
48373589|NCT02932475|101243528|FG001|STARTED|Overall Study||415||
48373590|NCT02932475|101243527|FG000|Randomized|Overall Study||416||
48373591|NCT02932475|101243528|FG001|Randomized|Overall Study||415||
48373592|NCT02932475|101243527|FG000|Received Intervention|Overall Study||397||
48373593|NCT02932475|101243528|FG001|Received Intervention|Overall Study||397||
48373594|NCT02932475|101243527|FG000|Liveborn Infants During Study|Overall Study||376||
48373595|NCT02932475|101243528|FG001|Liveborn Infants During Study|Overall Study||370||
48373596|NCT02932475|101243527|FG000|COMPLETED|Overall Study||386||
48373597|NCT02932475|101243528|FG001|COMPLETED|Overall Study||382||
48373598|NCT02932475|101243527|FG000|NOT COMPLETED|Overall Study||30||
48373599|NCT02932475|101243528|FG001|NOT COMPLETED|Overall Study||33||
48373600|NCT03302793|101243529|FG000|STARTED|Overall Study||6||
48373601|NCT03302793|101243530|FG001|STARTED|Overall Study||6||
48373602|NCT03302793|101243529|FG000|COMPLETED|Overall Study||6||
48373603|NCT03302793|101243530|FG001|COMPLETED|Overall Study||4||
48373604|NCT03302793|101243529|FG000|NOT COMPLETED|Overall Study||0||
48373605|NCT03302793|101243530|FG001|NOT COMPLETED|Overall Study||2||
48373606|NCT03215264|101243531|FG000|STARTED|Dose Level 1||6||
48373607|NCT03215264|101243532|FG001|STARTED|Dose Level 1||0||
48373608|NCT03215264|101243533|FG002|STARTED|Dose Level 1||0||
48373609|NCT03215264|101243531|FG000|COMPLETED|Dose Level 1||6||
48373610|NCT03215264|101243532|FG001|COMPLETED|Dose Level 1||0||
48373611|NCT03215264|101243533|FG002|COMPLETED|Dose Level 1||0||
48373612|NCT03215264|101243531|FG000|NOT COMPLETED|Dose Level 1||0||
48373613|NCT03215264|101243532|FG001|NOT COMPLETED|Dose Level 1||0||
48373614|NCT03215264|101243533|FG002|NOT COMPLETED|Dose Level 1||0||
48373615|NCT03215264|101243531|FG000|STARTED|Dose Level 2||0||
48373616|NCT03215264|101243532|FG001|STARTED|Dose Level 2||7||
48373617|NCT03215264|101243533|FG002|STARTED|Dose Level 2||0||
48373618|NCT03215264|101243531|FG000|COMPLETED|Dose Level 2||0||
48373619|NCT03215264|101243532|FG001|COMPLETED|Dose Level 2||6||
48373620|NCT03215264|101243533|FG002|COMPLETED|Dose Level 2||0||
48373621|NCT03215264|101243531|FG000|NOT COMPLETED|Dose Level 2||0||
48373622|NCT03215264|101243532|FG001|NOT COMPLETED|Dose Level 2||1||
48373623|NCT03215264|101243533|FG002|NOT COMPLETED|Dose Level 2||0||
48373624|NCT03215264|101243531|FG000|STARTED|Dose Level 3||0||
48373625|NCT03215264|101243532|FG001|STARTED|Dose Level 3||0||
48373626|NCT03215264|101243533|FG002|STARTED|Dose Level 3||7||
48373627|NCT03215264|101243531|FG000|COMPLETED|Dose Level 3||0||
48373628|NCT03215264|101243532|FG001|COMPLETED|Dose Level 3||0||
48373629|NCT03215264|101243533|FG002|COMPLETED|Dose Level 3||6||
48373630|NCT03215264|101243531|FG000|NOT COMPLETED|Dose Level 3||0||
48373631|NCT03215264|101243532|FG001|NOT COMPLETED|Dose Level 3||0||
48373632|NCT03215264|101243533|FG002|NOT COMPLETED|Dose Level 3||1||
48373633|NCT00719576|101243534|FG000|STARTED|Overall Study||72||
48373634|NCT00719576|101243535|FG001|STARTED|Overall Study||72||
48373635|NCT00719576|101243534|FG000|COMPLETED|Overall Study||70||
48373636|NCT00719576|101243535|FG001|COMPLETED|Overall Study||67||
48373637|NCT00719576|101243534|FG000|NOT COMPLETED|Overall Study||2||
48373638|NCT00719576|101243535|FG001|NOT COMPLETED|Overall Study||5||
48373639|NCT00243230|101243536|FG000|STARTED|Double-Blind Period||39||
48373640|NCT00243230|101243537|FG001|STARTED|Double-Blind Period||40||
48373641|NCT00243230|101243538|FG002|STARTED|Double-Blind Period||37||
48373642|NCT00243230|101243539|FG003|STARTED|Double-Blind Period||0||
48373643|NCT00243230|101243536|FG000|Treated|Double-Blind Period||39||
48373644|NCT00243230|101243537|FG001|Treated|Double-Blind Period||40||
48373645|NCT00243230|101243538|FG002|Treated|Double-Blind Period||35||
48373646|NCT00243230|101243539|FG003|Treated|Double-Blind Period||0||
48373647|NCT00243230|101243536|FG000|COMPLETED|Double-Blind Period||33||
48373648|NCT00243230|101243537|FG001|COMPLETED|Double-Blind Period||35||
48373649|NCT00243230|101243538|FG002|COMPLETED|Double-Blind Period||18||
48373650|NCT00243230|101243539|FG003|COMPLETED|Double-Blind Period||0||
48373651|NCT00243230|101243536|FG000|NOT COMPLETED|Double-Blind Period||6||
48373652|NCT00243230|101243537|FG001|NOT COMPLETED|Double-Blind Period||5||
48373653|NCT00243230|101243538|FG002|NOT COMPLETED|Double-Blind Period||19||
48373654|NCT00243230|101243539|FG003|NOT COMPLETED|Double-Blind Period||0||
48373655|NCT00243230|101243536|FG000|STARTED|Open Label Period||0||
48373656|NCT00243230|101243537|FG001|STARTED|Open Label Period||0||
48373657|NCT00243230|101243538|FG002|STARTED|Open Label Period||0||
48373658|NCT00243230|101243539|FG003|STARTED|Open Label Period||85||
48373659|NCT00243230|101243536|FG000|COMPLETED|Open Label Period||0||
48373660|NCT00243230|101243537|FG001|COMPLETED|Open Label Period||0||
48373661|NCT00243230|101243538|FG002|COMPLETED|Open Label Period||0||
48373662|NCT00243230|101243539|FG003|COMPLETED|Open Label Period||0||
48373663|NCT00243230|101243536|FG000|NOT COMPLETED|Open Label Period||0||
48373664|NCT00243230|101243537|FG001|NOT COMPLETED|Open Label Period||0||
48373665|NCT00243230|101243538|FG002|NOT COMPLETED|Open Label Period||0||
48373666|NCT00243230|101243539|FG003|NOT COMPLETED|Open Label Period||85||
48373667|NCT00634244|101243540|FG000|STARTED|Overall Study||35||
48373668|NCT00634244|101243541|FG001|STARTED|Overall Study||37||
48373669|NCT00634244|101243542|FG002|STARTED|Overall Study||20||
48373670|NCT00634244|101243540|FG000|Eligible and Treated|Overall Study||35||
48373671|NCT00634244|101243541|FG001|Eligible and Treated|Overall Study||36||
48373672|NCT00634244|101243542|FG002|Eligible and Treated|Overall Study||20||
48373673|NCT00634244|101243540|FG000|COMPLETED|Overall Study||34||
48373674|NCT00634244|101243541|FG001|COMPLETED|Overall Study||24||
48373675|NCT00634244|101243542|FG002|COMPLETED|Overall Study||20||
48373676|NCT00634244|101243540|FG000|NOT COMPLETED|Overall Study||1||
48373677|NCT00634244|101243541|FG001|NOT COMPLETED|Overall Study||13||
48373678|NCT00634244|101243542|FG002|NOT COMPLETED|Overall Study||0||
48373679|NCT02145299|101243543|FG000|STARTED|Overall Study||6||
48373680|NCT02145299|101243544|FG001|STARTED|Overall Study||2||
48373681|NCT02145299|101243543|FG000|COMPLETED|Overall Study||6||
48373682|NCT02145299|101243544|FG001|COMPLETED|Overall Study||2||
48373683|NCT02145299|101243543|FG000|NOT COMPLETED|Overall Study||0||
48373684|NCT02145299|101243544|FG001|NOT COMPLETED|Overall Study||0||
48373685|NCT03152136|101243545|FG000|STARTED|Overall Study||32||
48373686|NCT03152136|101243546|FG001|STARTED|Overall Study||15||
48373687|NCT03152136|101243547|FG002|STARTED|Overall Study||15||
48373688|NCT03152136|101243545|FG000|COMPLETED|Overall Study||29||
48373689|NCT03152136|101243546|FG001|COMPLETED|Overall Study||15||
48373690|NCT03152136|101243547|FG002|COMPLETED|Overall Study||14||
48373691|NCT03152136|101243545|FG000|NOT COMPLETED|Overall Study||3||
48373692|NCT03152136|101243546|FG001|NOT COMPLETED|Overall Study||0||
48373693|NCT03152136|101243547|FG002|NOT COMPLETED|Overall Study||1||
48373694|NCT02432287|101243548|FG000|STARTED|First Intervention||8||
48373695|NCT02432287|101243549|FG001|STARTED|First Intervention||8||
48373696|NCT02432287|101243548|FG000|COMPLETED|First Intervention||8||
48373697|NCT02432287|101243549|FG001|COMPLETED|First Intervention||7||
48373698|NCT02432287|101243548|FG000|NOT COMPLETED|First Intervention||0||
48373699|NCT02432287|101243549|FG001|NOT COMPLETED|First Intervention||1||
48373700|NCT02432287|101243548|FG000|STARTED|Washout Period||7||
48373701|NCT02432287|101243549|FG001|STARTED|Washout Period||7||
48373702|NCT02432287|101243548|FG000|COMPLETED|Washout Period||7||
48373703|NCT02432287|101243549|FG001|COMPLETED|Washout Period||7||
48373704|NCT02432287|101243548|FG000|NOT COMPLETED|Washout Period||0||
48373705|NCT02432287|101243549|FG001|NOT COMPLETED|Washout Period||0||
48373706|NCT02432287|101243548|FG000|STARTED|Second Intervention||7||
48373707|NCT02432287|101243549|FG001|STARTED|Second Intervention||7||
48373708|NCT02432287|101243548|FG000|COMPLETED|Second Intervention||7||
48373709|NCT02432287|101243549|FG001|COMPLETED|Second Intervention||7||
48373710|NCT02432287|101243548|FG000|NOT COMPLETED|Second Intervention||0||
48373711|NCT02432287|101243549|FG001|NOT COMPLETED|Second Intervention||0||
48373712|NCT05131451|101243550|FG000|STARTED|Overall Study||83||
48373713|NCT05131451|101243551|FG001|STARTED|Overall Study||81||
48373714|NCT05131451|101243550|FG000|COMPLETED|Overall Study||82||
48373715|NCT05131451|101243551|FG001|COMPLETED|Overall Study||81||
48373716|NCT05131451|101243550|FG000|NOT COMPLETED|Overall Study||1||
48373717|NCT05131451|101243551|FG001|NOT COMPLETED|Overall Study||0||
48373718|NCT04019093|101243552|FG000|STARTED|Overall Study||9||
48373719|NCT04019093|101243553|FG001|STARTED|Overall Study||16||
48373720|NCT04019093|101243554|FG002|STARTED|Overall Study||10||
48373721|NCT04019093|101243555|FG003|STARTED|Overall Study||13||
48373722|NCT04019093|101243552|FG000|COMPLETED|Overall Study||9||
48373723|NCT04019093|101243553|FG001|COMPLETED|Overall Study||16||
48373724|NCT04019093|101243554|FG002|COMPLETED|Overall Study||10||
48373725|NCT04019093|101243555|FG003|COMPLETED|Overall Study||13||
48373726|NCT04019093|101243552|FG000|NOT COMPLETED|Overall Study||0||
48373727|NCT04019093|101243553|FG001|NOT COMPLETED|Overall Study||0||
48373728|NCT04019093|101243554|FG002|NOT COMPLETED|Overall Study||0||
48373729|NCT04019093|101243555|FG003|NOT COMPLETED|Overall Study||0||
48373730|NCT00837512|101243556|FG000|STARTED|First Intervention (6hrs) - RANDOMIZED||8||
48373731|NCT00837512|101243557|FG001|STARTED|First Intervention (6hrs) - RANDOMIZED||8||
48373732|NCT00837512|101243556|FG000|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8||
48373733|NCT00837512|101243557|FG001|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8||
48373734|NCT00837512|101243556|FG000|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0||
48373735|NCT00837512|101243557|FG001|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0||
48373736|NCT00837512|101243556|FG000|STARTED|Both Arms: Washout (7-28 Days)||8||
48373737|NCT00837512|101243557|FG001|STARTED|Both Arms: Washout (7-28 Days)||8||
48373738|NCT00837512|101243556|FG000|COMPLETED|Both Arms: Washout (7-28 Days)||8||
48373739|NCT00837512|101243557|FG001|COMPLETED|Both Arms: Washout (7-28 Days)||8||
48373740|NCT00837512|101243556|FG000|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0||
48373741|NCT00837512|101243557|FG001|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0||
48373742|NCT00837512|101243556|FG000|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8||
48373743|NCT00837512|101243557|FG001|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8||
48373744|NCT00837512|101243556|FG000|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8||
48373745|NCT00837512|101243557|FG001|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8||
48373746|NCT00837512|101243556|FG000|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0||
48373747|NCT00837512|101243557|FG001|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0||
48373748|NCT05047640|101243558|FG000|STARTED|Overall Study||30||
48373749|NCT05047640|101243559|FG001|STARTED|Overall Study||28||
48373750|NCT05047640|101243558|FG000|COMPLETED|Overall Study||30||
48373751|NCT05047640|101243559|FG001|COMPLETED|Overall Study||28||
48373752|NCT05047640|101243558|FG000|NOT COMPLETED|Overall Study||0||
48373753|NCT05047640|101243559|FG001|NOT COMPLETED|Overall Study||0||
48373754|NCT02774226|101243560|FG000|STARTED|Overall Study||8||
48373755|NCT02774226|101243561|FG001|STARTED|Overall Study||7||
48373756|NCT02774226|101243560|FG000|COMPLETED|Overall Study||8||
48373757|NCT02774226|101243561|FG001|COMPLETED|Overall Study||7||
48373758|NCT02774226|101243560|FG000|NOT COMPLETED|Overall Study||0||
48373759|NCT02774226|101243561|FG001|NOT COMPLETED|Overall Study||0||
48373760|NCT01741272|101243562|FG000|STARTED|Overall Study||92||
48373761|NCT01741272|101243563|FG001|STARTED|Overall Study||97||
48373762|NCT01741272|101243562|FG000|COMPLETED|Overall Study||92||
48373763|NCT01741272|101243563|FG001|COMPLETED|Overall Study||97||
48373764|NCT01741272|101243562|FG000|NOT COMPLETED|Overall Study||0||
48373765|NCT01741272|101243563|FG001|NOT COMPLETED|Overall Study||0||
48373766|NCT00441558|101243564|FG000|STARTED|Overall Study||1723||
48373767|NCT00441558|101243564|FG000|COMPLETED|Overall Study||667||
48373768|NCT00441558|101243564|FG000|NOT COMPLETED|Overall Study||1056||
48373769|NCT01766336|101243565|FG000|STARTED|Overall Study||150||
48373770|NCT01766336|101243566|FG001|STARTED|Overall Study||146||
48373771|NCT01766336|101243565|FG000|COMPLETED|Overall Study||60||
48373772|NCT01766336|101243566|FG001|COMPLETED|Overall Study||71||
48373773|NCT01766336|101243565|FG000|NOT COMPLETED|Overall Study||90||
48373774|NCT01766336|101243566|FG001|NOT COMPLETED|Overall Study||75||
48373775|NCT01754922|101243567|FG000|STARTED|Overall Study||32||
48373776|NCT01754922|101243568|FG001|STARTED|Overall Study||18||
48373777|NCT01754922|101243567|FG000|COMPLETED|Overall Study||32||
48373778|NCT01754922|101243568|FG001|COMPLETED|Overall Study||17||
48373779|NCT01754922|101243567|FG000|NOT COMPLETED|Overall Study||0||
48373780|NCT01754922|101243568|FG001|NOT COMPLETED|Overall Study||1||
48373781|NCT00586924|101243569|FG000|STARTED|Overall Study||3||
48373782|NCT00586924|101243570|FG001|STARTED|Overall Study||3||
48373783|NCT00586924|101243571|FG002|STARTED|Overall Study||3||
48373784|NCT00586924|101243572|FG003|STARTED|Overall Study||3||
48373785|NCT00586924|101243573|FG004|STARTED|Overall Study||4||
48373786|NCT00586924|101243574|FG005|STARTED|Overall Study||33||
48373787|NCT00586924|101243569|FG000|COMPLETED|Overall Study||0||
48373788|NCT00586924|101243570|FG001|COMPLETED|Overall Study||0||
48373789|NCT00586924|101243571|FG002|COMPLETED|Overall Study||0||
48373790|NCT00586924|101243572|FG003|COMPLETED|Overall Study||0||
48373791|NCT00586924|101243573|FG004|COMPLETED|Overall Study||0||
48373792|NCT00586924|101243574|FG005|COMPLETED|Overall Study||0||
48373793|NCT00586924|101243569|FG000|NOT COMPLETED|Overall Study||3||
48373794|NCT00586924|101243570|FG001|NOT COMPLETED|Overall Study||3||
48373795|NCT00586924|101243571|FG002|NOT COMPLETED|Overall Study||3||
48373796|NCT00586924|101243572|FG003|NOT COMPLETED|Overall Study||3||
48373797|NCT00586924|101243573|FG004|NOT COMPLETED|Overall Study||4||
48373798|NCT00586924|101243574|FG005|NOT COMPLETED|Overall Study||33||
48373799|NCT03960138|101243575|FG000|STARTED|Second TBS||20||
48373800|NCT03960138|101243576|FG001|STARTED|Second TBS||21||
48373801|NCT03960138|101243575|FG000|COMPLETED|Second TBS||16||
48373802|NCT03960138|101243576|FG001|COMPLETED|Second TBS||21||
48373803|NCT03960138|101243575|FG000|NOT COMPLETED|Second TBS||4||
48373804|NCT03960138|101243576|FG001|NOT COMPLETED|Second TBS||0||
48373805|NCT03960138|101243575|FG000|STARTED|First TBS||20||
48373806|NCT03960138|101243576|FG001|STARTED|First TBS||21||
48373807|NCT03960138|101243575|FG000|COMPLETED|First TBS||16||
48373808|NCT03960138|101243576|FG001|COMPLETED|First TBS||21||
48373809|NCT03960138|101243575|FG000|NOT COMPLETED|First TBS||4||
48373810|NCT03960138|101243576|FG001|NOT COMPLETED|First TBS||0||
48373811|NCT03201198|101243577|FG000|STARTED|Overall Study||92||
48373812|NCT03201198|101243578|FG001|STARTED|Overall Study||90||
48373813|NCT03201198|101243577|FG000|COMPLETED|Overall Study||55||
48373814|NCT03201198|101243578|FG001|COMPLETED|Overall Study||50||
48373815|NCT03201198|101243577|FG000|NOT COMPLETED|Overall Study||37||
48373816|NCT03201198|101243578|FG001|NOT COMPLETED|Overall Study||40||
48373817|NCT02417870|101243579|FG000|STARTED|Overall Study||2||
48373818|NCT02417870|101243579|FG000|COMPLETED|Overall Study||0||
48373819|NCT02417870|101243579|FG000|NOT COMPLETED|Overall Study||2||
48373820|NCT05142332|101243580|FG000|STARTED|Overall Study||166|Participant came in on the day site was randomized to this condition and participant was consented|
48373821|NCT05142332|101243581|FG001|STARTED|Overall Study||27|Participant came in on the day site was randomized to this condition and participant was consented|
48373822|NCT05142332|101243582|FG002|STARTED|Overall Study||110|Participant came in on the day site was randomized to this condition and participant was consented|
48373823|NCT05142332|101243583|FG003|STARTED|Overall Study||97|Participant came in on the day site was randomized to this condition and participant was consented|
48373824|NCT05142332|101243584|FG004|STARTED|Overall Study||12|Participant came in on the day site was randomized to this condition and participant was consented|
48373825|NCT05142332|101243585|FG005|STARTED|Overall Study||12|Participant came in on the day site was randomized to this condition and participant was consented|
48373826|NCT05142332|101243586|FG006|STARTED|Overall Study||117|Participant came in on the day site was randomized to this condition and participant was consented|
48373827|NCT05142332|101243580|FG000|Received PROCOVAXED Intervention|Overall Study||82||
48373828|NCT05142332|101243581|FG001|Received PROCOVAXED Intervention|Overall Study||8||
48373829|NCT05142332|101243582|FG002|Received PROCOVAXED Intervention|Overall Study||49||
48373830|NCT05142332|101243583|FG003|Received PROCOVAXED Intervention|Overall Study||27||
48373831|NCT05142332|101243584|FG004|Received PROCOVAXED Intervention|Overall Study||2||
48373832|NCT05142332|101243585|FG005|Received PROCOVAXED Intervention|Overall Study||3||
48373833|NCT05142332|101243586|FG006|Received PROCOVAXED Intervention|Overall Study||50||
48373834|NCT05142332|101243580|FG000|C C Control|Overall Study||79||
48373835|NCT05142332|101243581|FG001|C C Control|Overall Study||18||
48373836|NCT05142332|101243582|FG002|C C Control|Overall Study||52||
48373837|NCT05142332|101243583|FG003|C C Control|Overall Study||61||
48373838|NCT05142332|101243584|FG004|C C Control|Overall Study||9||
48373839|NCT05142332|101243585|FG005|C C Control|Overall Study||4||
48373840|NCT05142332|101243586|FG006|C C Control|Overall Study||52||
48373841|NCT05142332|101243580|FG000|COMPLETED|Overall Study||161||
48373842|NCT05142332|101243581|FG001|COMPLETED|Overall Study||26||
48373843|NCT05142332|101243582|FG002|COMPLETED|Overall Study||101||
48373844|NCT05142332|101243583|FG003|COMPLETED|Overall Study||88||
48373845|NCT05142332|101243584|FG004|COMPLETED|Overall Study||11||
48373846|NCT05142332|101243585|FG005|COMPLETED|Overall Study||7||
48373847|NCT05142332|101243586|FG006|COMPLETED|Overall Study||102||
48373848|NCT05142332|101243580|FG000|NOT COMPLETED|Overall Study||5||
48373849|NCT05142332|101243581|FG001|NOT COMPLETED|Overall Study||1||
48373850|NCT05142332|101243582|FG002|NOT COMPLETED|Overall Study||9||
48373851|NCT05142332|101243583|FG003|NOT COMPLETED|Overall Study||9||
48373852|NCT05142332|101243584|FG004|NOT COMPLETED|Overall Study||1||
48373853|NCT05142332|101243585|FG005|NOT COMPLETED|Overall Study||5||
48373854|NCT05142332|101243586|FG006|NOT COMPLETED|Overall Study||15||
48373855|NCT00218036|101243587|FG000|STARTED|Overall Study||11||
48373856|NCT00218036|101243588|FG001|STARTED|Overall Study||6||
48373857|NCT00218036|101243589|FG002|STARTED|Overall Study||13||
48373858|NCT00218036|101243590|FG003|STARTED|Overall Study||12||
48373859|NCT00218036|101243591|FG004|STARTED|Overall Study||9||
48373860|NCT00218036|101243587|FG000|COMPLETED|Overall Study||6||
48373861|NCT00218036|101243588|FG001|COMPLETED|Overall Study||3||
48373862|NCT00218036|101243589|FG002|COMPLETED|Overall Study||5||
48373863|NCT00218036|101243590|FG003|COMPLETED|Overall Study||6||
48373864|NCT00218036|101243591|FG004|COMPLETED|Overall Study||3||
48373865|NCT00218036|101243587|FG000|NOT COMPLETED|Overall Study||5||
48373866|NCT00218036|101243588|FG001|NOT COMPLETED|Overall Study||3||
48373867|NCT00218036|101243589|FG002|NOT COMPLETED|Overall Study||8||
48373868|NCT00218036|101243590|FG003|NOT COMPLETED|Overall Study||6||
48373869|NCT00218036|101243591|FG004|NOT COMPLETED|Overall Study||6||
48373870|NCT00524316|101243592|FG000|STARTED|Overall Study||16||
48373871|NCT00524316|101243592|FG000|COMPLETED|Overall Study||0||
48373872|NCT00524316|101243592|FG000|NOT COMPLETED|Overall Study||16||
48373873|NCT03904446|101243593|FG000|STARTED|Overall Study||80||
48373874|NCT03904446|101243594|FG001|STARTED|Overall Study||80||
48373875|NCT03904446|101243593|FG000|COMPLETED|Overall Study||80||
48373876|NCT03904446|101243594|FG001|COMPLETED|Overall Study||80||
48373877|NCT03904446|101243593|FG000|NOT COMPLETED|Overall Study||0||
48373878|NCT03904446|101243594|FG001|NOT COMPLETED|Overall Study||0||
48373879|NCT00303108|101243595|FG000|STARTED|Overall Study||43||
48373880|NCT00303108|101243596|FG001|STARTED|Overall Study||46||
48373881|NCT00303108|101243597|FG002|STARTED|Overall Study||47||
48373882|NCT00303108|101243595|FG000|COMPLETED|Overall Study||31||
48373883|NCT00303108|101243596|FG001|COMPLETED|Overall Study||37||
48373884|NCT00303108|101243597|FG002|COMPLETED|Overall Study||31||
48373885|NCT00303108|101243595|FG000|NOT COMPLETED|Overall Study||12||
48373886|NCT00303108|101243596|FG001|NOT COMPLETED|Overall Study||9||
48373887|NCT00303108|101243597|FG002|NOT COMPLETED|Overall Study||16||
48373888|NCT02184143|101243598|FG000|STARTED|Overall Study||124||
48373889|NCT02184143|101243599|FG001|STARTED|Overall Study||124||
48373890|NCT02184143|101243598|FG000|COMPLETED|Overall Study||114||
48373891|NCT02184143|101243599|FG001|COMPLETED|Overall Study||117||
48373892|NCT02184143|101243598|FG000|NOT COMPLETED|Overall Study||10||
48373893|NCT02184143|101243599|FG001|NOT COMPLETED|Overall Study||7||
48373894|NCT03539458|101243600|FG000|STARTED|Overall Study||11||
48373895|NCT03539458|101243600|FG000|COMPLETED|Overall Study||10||
48373896|NCT03539458|101243600|FG000|NOT COMPLETED|Overall Study||1||
48373897|NCT00952289|101243601|FG000|STARTED|All Participants||155||
48373898|NCT00952289|101243602|FG001|STARTED|All Participants||154||
48373899|NCT00952289|101243601|FG000|Safety Population|All Participants||155||
48373900|NCT00952289|101243602|FG001|Safety Population|All Participants||151||
48373901|NCT00952289|101243601|FG000|COMPLETED|All Participants||134||
48373902|NCT00952289|101243602|FG001|COMPLETED|All Participants||114||
48373903|NCT00952289|101243601|FG000|NOT COMPLETED|All Participants||21||
48373904|NCT00952289|101243602|FG001|NOT COMPLETED|All Participants||40||
48373905|NCT00952289|101243601|FG000|STARTED|Patients Who Crossed Over to Ruxolitinib||0||
48373906|NCT00952289|101243602|FG001|STARTED|Patients Who Crossed Over to Ruxolitinib||111||
48373907|NCT00952289|101243601|FG000|COMPLETED|Patients Who Crossed Over to Ruxolitinib||0||
48373908|NCT00952289|101243602|FG001|COMPLETED|Patients Who Crossed Over to Ruxolitinib||57||
48373909|NCT00952289|101243601|FG000|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||0||
48373910|NCT00952289|101243602|FG001|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||54||
48373911|NCT00786838|101243603|FG000|STARTED|Overall Study||75||
48373912|NCT00786838|101243603|FG000|COMPLETED|Overall Study||26||
48373913|NCT00786838|101243603|FG000|NOT COMPLETED|Overall Study||49||
48373914|NCT01429987|101243604|FG000|STARTED|Overall Study||238||
48373915|NCT01429987|101243605|FG001|STARTED|Overall Study||238||
48373916|NCT01429987|101243606|FG002|STARTED|Overall Study||238||
48373917|NCT01429987|101243607|FG003|STARTED|Overall Study||237||
48373918|NCT01429987|101243604|FG000|COMPLETED|Overall Study||189||
48373919|NCT01429987|101243605|FG001|COMPLETED|Overall Study||176||
48373920|NCT01429987|101243606|FG002|COMPLETED|Overall Study||202||
48373921|NCT01429987|101243607|FG003|COMPLETED|Overall Study||171||
48373922|NCT01429987|101243604|FG000|NOT COMPLETED|Overall Study||49||
48373923|NCT01429987|101243605|FG001|NOT COMPLETED|Overall Study||62||
48373924|NCT01429987|101243606|FG002|NOT COMPLETED|Overall Study||36||
48373925|NCT01429987|101243607|FG003|NOT COMPLETED|Overall Study||66||
48373926|NCT02336594|101243608|FG000|STARTED|Overall Study||3||
48373927|NCT02336594|101243609|FG001|STARTED|Overall Study||4||
48373928|NCT02336594|101243610|FG002|STARTED|Overall Study||4||
48373929|NCT02336594|101243611|FG003|STARTED|Overall Study||4||
48373930|NCT02336594|101243608|FG000|COMPLETED|Overall Study||3||
48373931|NCT02336594|101243609|FG001|COMPLETED|Overall Study||4||
48373932|NCT02336594|101243610|FG002|COMPLETED|Overall Study||4||
48373933|NCT02336594|101243611|FG003|COMPLETED|Overall Study||4||
48373934|NCT02336594|101243608|FG000|NOT COMPLETED|Overall Study||0||
48373935|NCT02336594|101243609|FG001|NOT COMPLETED|Overall Study||0||
48373936|NCT02336594|101243610|FG002|NOT COMPLETED|Overall Study||0||
48373937|NCT02336594|101243611|FG003|NOT COMPLETED|Overall Study||0||
48373938|NCT01193348|101243612|FG000|STARTED|Screening Period||27||
48373939|NCT01193348|101243612|FG000|COMPLETED|Screening Period||22||
48373940|NCT01193348|101243612|FG000|NOT COMPLETED|Screening Period||5||
48373941|NCT01193348|101243612|FG000|STARTED|Treatment Period (26 Weeks)||22||
48373942|NCT01193348|101243612|FG000|COMPLETED|Treatment Period (26 Weeks)||19||
48373943|NCT01193348|101243612|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||3||
48373944|NCT01193348|101243612|FG000|STARTED|Extension Treatment Period||17||
48373945|NCT01193348|101243612|FG000|COMPLETED|Extension Treatment Period||16||
48373946|NCT01193348|101243612|FG000|NOT COMPLETED|Extension Treatment Period||1||
48373947|NCT01193348|101243612|FG000|STARTED|Post Treatment Period (Patients Who Disc||10||
48373948|NCT01193348|101243612|FG000|COMPLETED|Post Treatment Period (Patients Who Disc||8||
48373949|NCT01193348|101243612|FG000|NOT COMPLETED|Post Treatment Period (Patients Who Disc||2||
48373950|NCT02566525|101243613|FG000|STARTED|Overall Study||23||
48373951|NCT02566525|101243614|FG001|STARTED|Overall Study||23||
48373952|NCT02566525|101243613|FG000|COMPLETED|Overall Study||20||
48373953|NCT02566525|101243614|FG001|COMPLETED|Overall Study||18||
48373954|NCT02566525|101243613|FG000|NOT COMPLETED|Overall Study||3||
48521850|NCT03431974|101611706|FG000|COMPLETED|Overall Study||8||
48521851|NCT03431974|101611707|FG001|COMPLETED|Overall Study||6||
48521852|NCT03431974|101611706|FG000|NOT COMPLETED|Overall Study||3||
48521853|NCT03431974|101611707|FG001|NOT COMPLETED|Overall Study||2||
48521854|NCT03250299|101611708|FG000|STARTED|BAL101553 4 mg Cohort||5||
48521855|NCT03250299|101611709|FG001|STARTED|BAL101553 4 mg Cohort||0||
48521856|NCT03250299|101611710|FG002|STARTED|BAL101553 4 mg Cohort||0||
48521857|NCT03250299|101611711|FG003|STARTED|BAL101553 4 mg Cohort||0||
48521858|NCT03250299|101611712|FG004|STARTED|BAL101553 4 mg Cohort||0||
48521859|NCT03250299|101611708|FG000|COMPLETED|BAL101553 4 mg Cohort||5||
48521860|NCT03250299|101611709|FG001|COMPLETED|BAL101553 4 mg Cohort||0||
48521861|NCT03250299|101611710|FG002|COMPLETED|BAL101553 4 mg Cohort||0||
48521862|NCT03250299|101611711|FG003|COMPLETED|BAL101553 4 mg Cohort||0||
48521863|NCT03250299|101611712|FG004|COMPLETED|BAL101553 4 mg Cohort||0||
48521864|NCT03250299|101611708|FG000|NOT COMPLETED|BAL101553 4 mg Cohort||0||
48521865|NCT03250299|101611709|FG001|NOT COMPLETED|BAL101553 4 mg Cohort||0||
48521866|NCT03250299|101611710|FG002|NOT COMPLETED|BAL101553 4 mg Cohort||0||
48521867|NCT03250299|101611711|FG003|NOT COMPLETED|BAL101553 4 mg Cohort||0||
48521868|NCT03250299|101611712|FG004|NOT COMPLETED|BAL101553 4 mg Cohort||0||
48521869|NCT03250299|101611708|FG000|STARTED|BAL101553 6 mg Cohort||0||
48521870|NCT03250299|101611709|FG001|STARTED|BAL101553 6 mg Cohort||5||
48521871|NCT03250299|101611710|FG002|STARTED|BAL101553 6 mg Cohort||0||
48521872|NCT03250299|101611711|FG003|STARTED|BAL101553 6 mg Cohort||0||
48521873|NCT03250299|101611712|FG004|STARTED|BAL101553 6 mg Cohort||0||
48521874|NCT03250299|101611708|FG000|COMPLETED|BAL101553 6 mg Cohort||0||
48521875|NCT03250299|101611709|FG001|COMPLETED|BAL101553 6 mg Cohort||4||
48521876|NCT03250299|101611710|FG002|COMPLETED|BAL101553 6 mg Cohort||0||
48521877|NCT03250299|101611711|FG003|COMPLETED|BAL101553 6 mg Cohort||0||
48521878|NCT03250299|101611712|FG004|COMPLETED|BAL101553 6 mg Cohort||0||
48521879|NCT03250299|101611708|FG000|NOT COMPLETED|BAL101553 6 mg Cohort||0||
48521880|NCT03250299|101611709|FG001|NOT COMPLETED|BAL101553 6 mg Cohort||1||
48521881|NCT03250299|101611710|FG002|NOT COMPLETED|BAL101553 6 mg Cohort||0||
48521882|NCT03250299|101611711|FG003|NOT COMPLETED|BAL101553 6 mg Cohort||0||
48521883|NCT03250299|101611712|FG004|NOT COMPLETED|BAL101553 6 mg Cohort||0||
48521884|NCT03250299|101611708|FG000|STARTED|BAL101553 8 mg Cohort||0||
48521885|NCT03250299|101611709|FG001|STARTED|BAL101553 8 mg Cohort||0||
48521886|NCT03250299|101611710|FG002|STARTED|BAL101553 8 mg Cohort||7||
48521887|NCT03250299|101611711|FG003|STARTED|BAL101553 8 mg Cohort||0||
48521888|NCT03250299|101611712|FG004|STARTED|BAL101553 8 mg Cohort||0||
48521889|NCT03250299|101611708|FG000|COMPLETED|BAL101553 8 mg Cohort||0||
48521890|NCT03250299|101611709|FG001|COMPLETED|BAL101553 8 mg Cohort||0||
48521891|NCT03250299|101611710|FG002|COMPLETED|BAL101553 8 mg Cohort||5||
48521892|NCT03250299|101611711|FG003|COMPLETED|BAL101553 8 mg Cohort||0||
48521893|NCT03250299|101611712|FG004|COMPLETED|BAL101553 8 mg Cohort||0||
48521894|NCT03250299|101611708|FG000|NOT COMPLETED|BAL101553 8 mg Cohort||0||
48521895|NCT03250299|101611709|FG001|NOT COMPLETED|BAL101553 8 mg Cohort||0||
48521896|NCT03250299|101611710|FG002|NOT COMPLETED|BAL101553 8 mg Cohort||2||
48521897|NCT03250299|101611711|FG003|NOT COMPLETED|BAL101553 8 mg Cohort||0||
48373955|NCT02566525|101243614|FG001|NOT COMPLETED|Overall Study||5||
48373956|NCT01249872|101243615|FG000|STARTED|Overall Study||16||
48373957|NCT01249872|101243616|FG001|STARTED|Overall Study||16||
48373958|NCT01249872|101243617|FG002|STARTED|Overall Study||16||
48373959|NCT01249872|101243618|FG003|STARTED|Overall Study||16||
48373960|NCT01249872|101243619|FG004|STARTED|Overall Study||16||
48373961|NCT01249872|101243620|FG005|STARTED|Overall Study||16||
48373962|NCT01249872|101243615|FG000|COMPLETED|Overall Study||16||
48373963|NCT01249872|101243616|FG001|COMPLETED|Overall Study||16||
48373964|NCT01249872|101243617|FG002|COMPLETED|Overall Study||16||
48373965|NCT01249872|101243618|FG003|COMPLETED|Overall Study||16||
48373966|NCT01249872|101243619|FG004|COMPLETED|Overall Study||16||
48373967|NCT01249872|101243620|FG005|COMPLETED|Overall Study||16||
48373968|NCT01249872|101243615|FG000|NOT COMPLETED|Overall Study||0||
48373969|NCT01249872|101243616|FG001|NOT COMPLETED|Overall Study||0||
48373970|NCT01249872|101243617|FG002|NOT COMPLETED|Overall Study||0||
48373971|NCT01249872|101243618|FG003|NOT COMPLETED|Overall Study||0||
48373972|NCT01249872|101243619|FG004|NOT COMPLETED|Overall Study||0||
48373973|NCT01249872|101243620|FG005|NOT COMPLETED|Overall Study||0||
48373974|NCT01079962|101243621|FG000|STARTED|Overall Study||105||
48373975|NCT01079962|101243622|FG001|STARTED|Overall Study||104||
48373976|NCT01079962|101243621|FG000|COMPLETED|Overall Study||90||
48373977|NCT01079962|101243622|FG001|COMPLETED|Overall Study||89||
48373978|NCT01079962|101243621|FG000|NOT COMPLETED|Overall Study||15||
48373979|NCT01079962|101243622|FG001|NOT COMPLETED|Overall Study||15||
48373980|NCT00868959|101243623|FG000|STARTED|Overall Study||817||
48373981|NCT00868959|101243623|FG000|COMPLETED|Overall Study||559||
48373982|NCT00868959|101243623|FG000|NOT COMPLETED|Overall Study||258||
48373983|NCT00603980|101243624|FG000|STARTED|Study Qualification||31||
48373984|NCT00603980|101243624|FG000|COMPLETED|Study Qualification||15||
48373985|NCT00603980|101243624|FG000|NOT COMPLETED|Study Qualification||16||
48373986|NCT00603980|101243624|FG000|STARTED|Main Study||15||
48373987|NCT00603980|101243624|FG000|COMPLETED|Main Study||14||
48373988|NCT00603980|101243624|FG000|NOT COMPLETED|Main Study||1||
48373989|NCT02242994|101243625|FG000|STARTED|Overall Study||5||
48373990|NCT02242994|101243625|FG000|COMPLETED|Overall Study||5||
48373991|NCT02242994|101243625|FG000|NOT COMPLETED|Overall Study||0||
48373992|NCT00958308|101243626|FG000|STARTED|Overall Study||84||
48373993|NCT00958308|101243627|FG001|STARTED|Overall Study||85||
48373994|NCT00958308|101243628|FG002|STARTED|Overall Study||86||
48373995|NCT00958308|101243626|FG000|COMPLETED|Overall Study||84||
48373996|NCT00958308|101243627|FG001|COMPLETED|Overall Study||85||
48373997|NCT00958308|101243628|FG002|COMPLETED|Overall Study||86||
48373998|NCT00958308|101243626|FG000|NOT COMPLETED|Overall Study||0||
48373999|NCT00958308|101243627|FG001|NOT COMPLETED|Overall Study||0||
48374000|NCT00958308|101243628|FG002|NOT COMPLETED|Overall Study||0||
48374001|NCT01952834|101243629|FG000|STARTED|Overall Study||21||
48374002|NCT01952834|101243629|FG000|COMPLETED|Overall Study||20||
48374003|NCT01952834|101243629|FG000|NOT COMPLETED|Overall Study||1||
48374004|NCT02427477|101243630|FG000|STARTED|Period 1||60||
48374005|NCT02427477|101243631|FG001|STARTED|Period 1||60||
48374006|NCT02427477|101243630|FG000|COMPLETED|Period 1||59||
48374007|NCT02427477|101243631|FG001|COMPLETED|Period 1||60||
48374008|NCT02427477|101243630|FG000|NOT COMPLETED|Period 1||1||
48374009|NCT02427477|101243631|FG001|NOT COMPLETED|Period 1||0||
48374010|NCT02427477|101243630|FG000|STARTED|Period 2||59||
48374011|NCT02427477|101243631|FG001|STARTED|Period 2||60||
48374012|NCT02427477|101243630|FG000|COMPLETED|Period 2||59||
48374013|NCT02427477|101243631|FG001|COMPLETED|Period 2||60||
48374014|NCT02427477|101243630|FG000|NOT COMPLETED|Period 2||0||
48374015|NCT02427477|101243631|FG001|NOT COMPLETED|Period 2||0||
48374016|NCT02427477|101243630|FG000|STARTED|Period 3||59||
48374017|NCT02427477|101243631|FG001|STARTED|Period 3||60||
48374018|NCT02427477|101243630|FG000|COMPLETED|Period 3||59||
48374019|NCT02427477|101243631|FG001|COMPLETED|Period 3||60||
48374020|NCT02427477|101243630|FG000|NOT COMPLETED|Period 3||0||
48374021|NCT02427477|101243631|FG001|NOT COMPLETED|Period 3||0||
48374022|NCT02724774|101243632|FG000|STARTED|Overall Study||127||
48374023|NCT02724774|101243633|FG001|STARTED|Overall Study||125||
48374024|NCT02724774|101243632|FG000|Infant 6 Months|Overall Study||122||
48374025|NCT02724774|101243633|FG001|Infant 6 Months|Overall Study||122||
48374026|NCT02724774|101243632|FG000|Infant 12 Months|Overall Study||120||
48374027|NCT02724774|101243633|FG001|Infant 12 Months|Overall Study||123||
48374028|NCT02724774|101243632|FG000|COMPLETED|Overall Study||120||
48374029|NCT02724774|101243633|FG001|COMPLETED|Overall Study||123||
48374030|NCT02724774|101243632|FG000|NOT COMPLETED|Overall Study||7||
48374031|NCT02724774|101243633|FG001|NOT COMPLETED|Overall Study||2||
48374032|NCT01258348|101243634|FG000|STARTED|Overall Study||1||
48374033|NCT01258348|101243635|FG001|STARTED|Overall Study||5||
48374034|NCT01258348|101243636|FG002|STARTED|Overall Study||3||
48374035|NCT01258348|101243637|FG003|STARTED|Overall Study||6||
48374036|NCT01258348|101243638|FG004|STARTED|Overall Study||6||
48374037|NCT01258348|101243634|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1||
48374038|NCT01258348|101243635|FG001|Received at Least 1 Dose of Study Drug|Overall Study||5||
48374039|NCT01258348|101243636|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
48374040|NCT01258348|101243637|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6||
48374041|NCT01258348|101243638|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6||
48374042|NCT01258348|101243634|FG000|COMPLETED|Overall Study||0||
48374043|NCT01258348|101243635|FG001|COMPLETED|Overall Study||0||
48374044|NCT01258348|101243636|FG002|COMPLETED|Overall Study||0||
48374045|NCT01258348|101243637|FG003|COMPLETED|Overall Study||0||
48374046|NCT01258348|101243638|FG004|COMPLETED|Overall Study||0||
48374047|NCT01258348|101243634|FG000|NOT COMPLETED|Overall Study||1||
48374048|NCT01258348|101243635|FG001|NOT COMPLETED|Overall Study||5||
48374049|NCT01258348|101243636|FG002|NOT COMPLETED|Overall Study||3||
48374050|NCT01258348|101243637|FG003|NOT COMPLETED|Overall Study||6||
48374051|NCT01258348|101243638|FG004|NOT COMPLETED|Overall Study||6||
48374052|NCT02417233|101243639|FG000|STARTED|Overall Study||169||
48374053|NCT02417233|101243640|FG001|STARTED|Overall Study||289||
48374054|NCT02417233|101243641|FG002|STARTED|Overall Study||298||
48374055|NCT02417233|101243639|FG000|COMPLETED|Overall Study||133||
48374056|NCT02417233|101243640|FG001|COMPLETED|Overall Study||238||
48374057|NCT02417233|101243641|FG002|COMPLETED|Overall Study||239||
48374058|NCT02417233|101243639|FG000|NOT COMPLETED|Overall Study||36||
48374059|NCT02417233|101243640|FG001|NOT COMPLETED|Overall Study||51||
48374060|NCT02417233|101243641|FG002|NOT COMPLETED|Overall Study||59||
48374061|NCT01834144|101243642|FG000|STARTED|Overall Study||1||
48374062|NCT01834144|101243643|FG001|STARTED|Overall Study||3||
48374063|NCT01834144|101243642|FG000|COMPLETED|Overall Study||1||
48374064|NCT01834144|101243643|FG001|COMPLETED|Overall Study||2||
48374065|NCT01834144|101243642|FG000|NOT COMPLETED|Overall Study||0||
48374066|NCT01834144|101243643|FG001|NOT COMPLETED|Overall Study||1||
48374067|NCT03599141|101243644|FG000|STARTED|Overall Study||8||
48374068|NCT03599141|101243645|FG001|STARTED|Overall Study||8||
48374069|NCT03599141|101243644|FG000|3 Months Post Baseline|Overall Study||8||
48374070|NCT03599141|101243645|FG001|3 Months Post Baseline|Overall Study||8||
48374071|NCT03599141|101243644|FG000|6 Months Post Baseline|Overall Study||5||
48374072|NCT03599141|101243645|FG001|6 Months Post Baseline|Overall Study||7||
48374073|NCT03599141|101243644|FG000|COMPLETED|Overall Study||5||
48374074|NCT03599141|101243645|FG001|COMPLETED|Overall Study||7||
48374075|NCT03599141|101243644|FG000|NOT COMPLETED|Overall Study||3||
48374076|NCT03599141|101243645|FG001|NOT COMPLETED|Overall Study||1||
48374077|NCT03860311|101243646|FG000|STARTED|Overall Study||22||
48374078|NCT03860311|101243647|FG001|STARTED|Overall Study||23||
48374079|NCT03860311|101243646|FG000|COMPLETED|Overall Study||22||
48374080|NCT03860311|101243647|FG001|COMPLETED|Overall Study||23||
48374081|NCT03860311|101243646|FG000|NOT COMPLETED|Overall Study||0||
48374082|NCT03860311|101243647|FG001|NOT COMPLETED|Overall Study||0||
48374083|NCT02439281|101243648|FG000|STARTED|Overall Study||24||
48374084|NCT02439281|101243649|FG001|STARTED|Overall Study||26||
48374085|NCT02439281|101243648|FG000|COMPLETED|Overall Study||24||
48374086|NCT02439281|101243649|FG001|COMPLETED|Overall Study||26||
48374087|NCT02439281|101243648|FG000|NOT COMPLETED|Overall Study||0||
48374088|NCT02439281|101243649|FG001|NOT COMPLETED|Overall Study||0||
48374089|NCT05373706|101243650|FG000|STARTED|Overall Study||48||
48374090|NCT05373706|101243651|FG001|STARTED|Overall Study||51||
48374091|NCT05373706|101243650|FG000|COMPLETED|Overall Study||46||
48374092|NCT05373706|101243651|FG001|COMPLETED|Overall Study||49||
48374093|NCT05373706|101243650|FG000|NOT COMPLETED|Overall Study||2||
48374094|NCT05373706|101243651|FG001|NOT COMPLETED|Overall Study||2||
48374095|NCT01468909|101243652|FG000|STARTED|Overall Study||52||
48374096|NCT01468909|101243653|FG001|STARTED|Overall Study||54||
48374097|NCT01468909|101243652|FG000|COMPLETED|Overall Study||50||
48374098|NCT01468909|101243653|FG001|COMPLETED|Overall Study||52||
48374099|NCT01468909|101243652|FG000|NOT COMPLETED|Overall Study||2||
48374100|NCT01468909|101243653|FG001|NOT COMPLETED|Overall Study||2||
48374101|NCT01187901|101243654|FG000|STARTED|Overall Study||46||
48374102|NCT01187901|101243655|FG001|STARTED|Overall Study||46||
48374103|NCT01187901|101243654|FG000|COMPLETED|Overall Study||37||
48374104|NCT01187901|101243655|FG001|COMPLETED|Overall Study||36||
48374105|NCT01187901|101243654|FG000|NOT COMPLETED|Overall Study||9||
48374106|NCT01187901|101243655|FG001|NOT COMPLETED|Overall Study||10||
48374107|NCT01165021|101243656|FG000|STARTED|Overall Study||19||
48374108|NCT01165021|101243656|FG000|≥1 Dose Chemo|Overall Study||19||
48374109|NCT01165021|101243656|FG000|≥1 Dose Chemo, Baseline, Cy 3 Assessment|Overall Study||17||
48374110|NCT01165021|101243656|FG000|3 Cycles of Chemo, Then Surgery|Overall Study||15||
48374111|NCT01165021|101243656|FG000|COMPLETED|Overall Study||18||
48374112|NCT01165021|101243656|FG000|NOT COMPLETED|Overall Study||1||
48374113|NCT01094717|101243657|FG000|STARTED|Overall Study||3||
48374114|NCT01094717|101243658|FG001|STARTED|Overall Study||10||
48374115|NCT01094717|101243657|FG000|COMPLETED|Overall Study||3||
48374116|NCT01094717|101243658|FG001|COMPLETED|Overall Study||10||
48374117|NCT01094717|101243657|FG000|NOT COMPLETED|Overall Study||0||
48374118|NCT01094717|101243658|FG001|NOT COMPLETED|Overall Study||0||
48374119|NCT02519244|101243659|FG000|STARTED|Overall Study||10||
48374120|NCT02519244|101243659|FG000|COMPLETED|Overall Study||10||
48374121|NCT02519244|101243659|FG000|NOT COMPLETED|Overall Study||0||
48374122|NCT00430521|101243660|FG000|STARTED|Overall Study||63||
48374123|NCT00430521|101243661|FG001|STARTED|Overall Study||66||
48374124|NCT00430521|101243662|FG002|STARTED|Overall Study||64||
48374125|NCT00430521|101243663|FG003|STARTED|Overall Study||63||
48374126|NCT00430521|101243664|FG004|STARTED|Overall Study||64||
48374127|NCT00430521|101243665|FG005|STARTED|Overall Study||64||
48374128|NCT00430521|101243666|FG006|STARTED|Overall Study||65||
48374129|NCT00430521|101243667|FG007|STARTED|Overall Study||63||
48374130|NCT00430521|101243660|FG000|COMPLETED|Overall Study||52||
48374131|NCT00430521|101243661|FG001|COMPLETED|Overall Study||57||
48374132|NCT00430521|101243662|FG002|COMPLETED|Overall Study||61||
48374133|NCT00430521|101243663|FG003|COMPLETED|Overall Study||55||
48374134|NCT00430521|101243664|FG004|COMPLETED|Overall Study||59||
48374135|NCT00430521|101243665|FG005|COMPLETED|Overall Study||59||
48374136|NCT00430521|101243666|FG006|COMPLETED|Overall Study||55||
48374137|NCT00430521|101243667|FG007|COMPLETED|Overall Study||51||
48374138|NCT00430521|101243660|FG000|NOT COMPLETED|Overall Study||11||
48374139|NCT00430521|101243661|FG001|NOT COMPLETED|Overall Study||9||
48374140|NCT00430521|101243662|FG002|NOT COMPLETED|Overall Study||3||
48374141|NCT00430521|101243663|FG003|NOT COMPLETED|Overall Study||8||
48374142|NCT00430521|101243664|FG004|NOT COMPLETED|Overall Study||5||
48374143|NCT00430521|101243665|FG005|NOT COMPLETED|Overall Study||5||
48374144|NCT00430521|101243666|FG006|NOT COMPLETED|Overall Study||10||
48374145|NCT00430521|101243667|FG007|NOT COMPLETED|Overall Study||12||
48374146|NCT03116399|101243668|FG000|STARTED|Overall Study||128||
48374147|NCT03116399|101243669|FG001|STARTED|Overall Study||120||
48374148|NCT03116399|101243668|FG000|6-month|Overall Study||98||
48374149|NCT03116399|101243669|FG001|6-month|Overall Study||108||
48374150|NCT03116399|101243668|FG000|9-month|Overall Study||91||
48374151|NCT03116399|101243669|FG001|9-month|Overall Study||101||
48374152|NCT03116399|101243668|FG000|COMPLETED|Overall Study||88||
48374153|NCT03116399|101243669|FG001|COMPLETED|Overall Study||96||
48374154|NCT03116399|101243668|FG000|NOT COMPLETED|Overall Study||40||
48374155|NCT03116399|101243669|FG001|NOT COMPLETED|Overall Study||24||
48374156|NCT01457118|101243670|FG000|STARTED|Overall Study||20||
48374157|NCT01457118|101243671|FG001|STARTED|Overall Study||4||
48374158|NCT01457118|101243672|FG002|STARTED|Overall Study||1||
48374159|NCT01457118|101243673|FG003|STARTED|Overall Study||2||
48374160|NCT01457118|101243670|FG000|COMPLETED|Overall Study||0||
48374161|NCT01457118|101243671|FG001|COMPLETED|Overall Study||0||
48374162|NCT01457118|101243672|FG002|COMPLETED|Overall Study||0||
48374163|NCT01457118|101243673|FG003|COMPLETED|Overall Study||0||
48374164|NCT01457118|101243670|FG000|NOT COMPLETED|Overall Study||20||
48374165|NCT01457118|101243671|FG001|NOT COMPLETED|Overall Study||4||
48374166|NCT01457118|101243672|FG002|NOT COMPLETED|Overall Study||1||
48374167|NCT01457118|101243673|FG003|NOT COMPLETED|Overall Study||2||
48374168|NCT03645408|101243674|FG000|STARTED|Overall Study||1||
48374169|NCT03645408|101243675|FG001|STARTED|Overall Study||2||
48374170|NCT03645408|101243674|FG000|COMPLETED|Overall Study||1||
48374171|NCT03645408|101243675|FG001|COMPLETED|Overall Study||2||
48374172|NCT03645408|101243674|FG000|NOT COMPLETED|Overall Study||0||
48374173|NCT03645408|101243675|FG001|NOT COMPLETED|Overall Study||0||
48374174|NCT00915005|101243676|FG000|STARTED|Overall Study||105||
48374175|NCT00915005|101243677|FG001|STARTED|Overall Study||76||
48374176|NCT00915005|101243676|FG000|COMPLETED|Overall Study||92||
48374177|NCT00915005|101243677|FG001|COMPLETED|Overall Study||57||
48374178|NCT00915005|101243676|FG000|NOT COMPLETED|Overall Study||13||
48374179|NCT00915005|101243677|FG001|NOT COMPLETED|Overall Study||19||
48374180|NCT03260205|101243678|FG000|STARTED|Overall Study||46||
48374181|NCT03260205|101243679|FG001|STARTED|Overall Study||40||
48374182|NCT03260205|101243680|FG002|STARTED|Overall Study||37||
48374183|NCT03260205|101243681|FG003|STARTED|Overall Study||37||
48374184|NCT03260205|101243682|FG004|STARTED|Overall Study||39||
48374185|NCT03260205|101243678|FG000|Received Treatment|Overall Study||45||
48374186|NCT03260205|101243679|FG001|Received Treatment|Overall Study||39||
48374187|NCT03260205|101243680|FG002|Received Treatment|Overall Study||35||
48374188|NCT03260205|101243681|FG003|Received Treatment|Overall Study||34||
48374189|NCT03260205|101243682|FG004|Received Treatment|Overall Study||38||
48374190|NCT03260205|101243678|FG000|COMPLETED|Overall Study||37||
48374191|NCT03260205|101243679|FG001|COMPLETED|Overall Study||32||
48374192|NCT03260205|101243680|FG002|COMPLETED|Overall Study||26||
48374193|NCT03260205|101243681|FG003|COMPLETED|Overall Study||30||
48374194|NCT03260205|101243682|FG004|COMPLETED|Overall Study||25||
48374195|NCT03260205|101243678|FG000|NOT COMPLETED|Overall Study||9||
48374196|NCT03260205|101243679|FG001|NOT COMPLETED|Overall Study||8||
48374197|NCT03260205|101243680|FG002|NOT COMPLETED|Overall Study||11||
48374198|NCT03260205|101243681|FG003|NOT COMPLETED|Overall Study||7||
48374199|NCT03260205|101243682|FG004|NOT COMPLETED|Overall Study||14||
48374200|NCT00118482|101243683|FG000|STARTED|Overall Study||105||
48374201|NCT00118482|101243684|FG001|STARTED|Overall Study||105||
48374202|NCT00118482|101243683|FG000|COMPLETED|Overall Study||75||
48374203|NCT00118482|101243684|FG001|COMPLETED|Overall Study||76||
48374204|NCT00118482|101243683|FG000|NOT COMPLETED|Overall Study||30||
48374205|NCT00118482|101243684|FG001|NOT COMPLETED|Overall Study||29||
48374206|NCT01856595|101243685|FG000|STARTED|Overall Study||18||
48374207|NCT01856595|101243686|FG001|STARTED|Overall Study||12||
48374208|NCT01856595|101243687|FG002|STARTED|Overall Study||12||
48374209|NCT01856595|101243688|FG003|STARTED|Overall Study||12||
48374210|NCT01856595|101243689|FG004|STARTED|Overall Study||14||
48374211|NCT01856595|101243690|FG005|STARTED|Overall Study||12||
48374212|NCT01856595|101243691|FG006|STARTED|Overall Study||13||
48374213|NCT01856595|101243692|FG007|STARTED|Overall Study||10||
48374214|NCT01856595|101243693|FG008|STARTED|Overall Study||14||
48374215|NCT01856595|101243685|FG000|COMPLETED|Overall Study||18||
48374216|NCT01856595|101243686|FG001|COMPLETED|Overall Study||11||
48374217|NCT01856595|101243687|FG002|COMPLETED|Overall Study||12||
48374218|NCT01856595|101243688|FG003|COMPLETED|Overall Study||12||
48374219|NCT01856595|101243689|FG004|COMPLETED|Overall Study||14||
48374220|NCT01856595|101243690|FG005|COMPLETED|Overall Study||12||
48374221|NCT01856595|101243691|FG006|COMPLETED|Overall Study||12||
48374222|NCT01856595|101243692|FG007|COMPLETED|Overall Study||10||
48374223|NCT01856595|101243693|FG008|COMPLETED|Overall Study||14||
48374224|NCT01856595|101243685|FG000|NOT COMPLETED|Overall Study||0||
48374225|NCT01856595|101243686|FG001|NOT COMPLETED|Overall Study||1||
48374226|NCT01856595|101243687|FG002|NOT COMPLETED|Overall Study||0||
48374227|NCT01856595|101243688|FG003|NOT COMPLETED|Overall Study||0||
48374228|NCT01856595|101243689|FG004|NOT COMPLETED|Overall Study||0||
48374229|NCT01856595|101243690|FG005|NOT COMPLETED|Overall Study||0||
48374230|NCT01856595|101243691|FG006|NOT COMPLETED|Overall Study||1||
48374231|NCT01856595|101243692|FG007|NOT COMPLETED|Overall Study||0||
48374232|NCT01856595|101243693|FG008|NOT COMPLETED|Overall Study||0||
48374233|NCT02196038|101243694|FG000|STARTED|Overall Study||174||
48374234|NCT02196038|101243695|FG001|STARTED|Overall Study||175||
48374235|NCT02196038|101243694|FG000|COMPLETED|Overall Study||157||
48374236|NCT02196038|101243695|FG001|COMPLETED|Overall Study||153||
48374237|NCT02196038|101243694|FG000|NOT COMPLETED|Overall Study||17||
48374238|NCT02196038|101243695|FG001|NOT COMPLETED|Overall Study||22||
48374239|NCT03255291|101243696|FG000|STARTED|Overall Study||93||
48374240|NCT03255291|101243697|FG001|STARTED|Overall Study||90||
48374241|NCT03255291|101243698|FG002|STARTED|Overall Study||91||
48374242|NCT03255291|101243699|FG003|STARTED|Overall Study||90||
48374243|NCT03255291|101243700|FG004|STARTED|Overall Study||95||
48374244|NCT03255291|101243701|FG005|STARTED|Overall Study||95||
48374245|NCT03255291|101243696|FG000|COMPLETED|Overall Study||80||
48374246|NCT03255291|101243697|FG001|COMPLETED|Overall Study||78||
48374247|NCT03255291|101243698|FG002|COMPLETED|Overall Study||85||
48374248|NCT03255291|101243699|FG003|COMPLETED|Overall Study||84||
48374249|NCT03255291|101243700|FG004|COMPLETED|Overall Study||88||
48374250|NCT03255291|101243701|FG005|COMPLETED|Overall Study||85||
48374251|NCT03255291|101243696|FG000|NOT COMPLETED|Overall Study||13||
48374252|NCT03255291|101243697|FG001|NOT COMPLETED|Overall Study||12||
48374253|NCT03255291|101243698|FG002|NOT COMPLETED|Overall Study||6||
48374254|NCT03255291|101243699|FG003|NOT COMPLETED|Overall Study||6||
48374255|NCT03255291|101243700|FG004|NOT COMPLETED|Overall Study||7||
48374256|NCT03255291|101243701|FG005|NOT COMPLETED|Overall Study||10||
48374257|NCT02202031|101243702|FG000|STARTED|Overall Study||82||
48374258|NCT02202031|101243703|FG001|STARTED|Overall Study||79||
48374259|NCT02202031|101243702|FG000|COMPLETED|Overall Study||77||
48374260|NCT02202031|101243703|FG001|COMPLETED|Overall Study||74||
48374261|NCT02202031|101243702|FG000|NOT COMPLETED|Overall Study||5||
48374262|NCT02202031|101243703|FG001|NOT COMPLETED|Overall Study||5||
48374263|NCT02849990|101243704|FG000|STARTED|Overall Study||22||
48374264|NCT02849990|101243704|FG000|COMPLETED|Overall Study||20||
48374265|NCT02849990|101243704|FG000|NOT COMPLETED|Overall Study||2||
48374266|NCT00069576|101243705|FG000|STARTED|Original Trial||485||
48374267|NCT00069576|101243706|FG001|STARTED|Original Trial||473||
48374268|NCT00069576|101243705|FG000|COMPLETED|Original Trial||460||
48374269|NCT00069576|101243706|FG001|COMPLETED|Original Trial||440||
48374270|NCT00069576|101243705|FG000|NOT COMPLETED|Original Trial||25||
48374271|NCT00069576|101243706|FG001|NOT COMPLETED|Original Trial||33||
48374272|NCT00069576|101243705|FG000|STARTED|Follow-up Study at 5-10 Years||460||
48374273|NCT00069576|101243706|FG001|STARTED|Follow-up Study at 5-10 Years||440||
48374274|NCT00069576|101243705|FG000|COMPLETED|Follow-up Study at 5-10 Years||264||
48374275|NCT00069576|101243706|FG001|COMPLETED|Follow-up Study at 5-10 Years||236||
48374276|NCT00069576|101243705|FG000|NOT COMPLETED|Follow-up Study at 5-10 Years||196||
48592618|NCT01877382|101783150|FG000|STARTED|Dose Escalation||3||
48374277|NCT00069576|101243706|FG001|NOT COMPLETED|Follow-up Study at 5-10 Years||204||
48374278|NCT00316303|101243707|FG000|STARTED|Overall Study||118||
48374279|NCT00316303|101243708|FG001|STARTED|Overall Study||118||
48374280|NCT00316303|101243707|FG000|COMPLETED|Overall Study||107||
48374281|NCT00316303|101243708|FG001|COMPLETED|Overall Study||102||
48374282|NCT00316303|101243707|FG000|NOT COMPLETED|Overall Study||11||
48374283|NCT00316303|101243708|FG001|NOT COMPLETED|Overall Study||16||
48374284|NCT01290484|101243709|FG000|STARTED|Overall Study||7||
48374285|NCT01290484|101243709|FG000|COMPLETED|Overall Study||7||
48374286|NCT01290484|101243709|FG000|NOT COMPLETED|Overall Study||0||
48374287|NCT01029002|101243710|FG000|STARTED|Overall Study||36||
48374288|NCT01029002|101243711|FG001|STARTED|Overall Study||38||
48374289|NCT01029002|101243710|FG000|COMPLETED|Overall Study||34||
48374290|NCT01029002|101243711|FG001|COMPLETED|Overall Study||34||
48374291|NCT01029002|101243710|FG000|NOT COMPLETED|Overall Study||2||
48374292|NCT01029002|101243711|FG001|NOT COMPLETED|Overall Study||4||
48374293|NCT00439673|101243712|FG000|STARTED|Overall Study||62||
48374294|NCT00439673|101243712|FG000|COMPLETED|Overall Study||26||
48374295|NCT00439673|101243712|FG000|NOT COMPLETED|Overall Study||36||
48374296|NCT02361762|101243713|FG000|STARTED|Overall Study||35||
48374297|NCT02361762|101243714|FG001|STARTED|Overall Study||35||
48374298|NCT02361762|101243713|FG000|COMPLETED|Overall Study||35||
48374299|NCT02361762|101243714|FG001|COMPLETED|Overall Study||33||
48374300|NCT02361762|101243713|FG000|NOT COMPLETED|Overall Study||0||
48374301|NCT02361762|101243714|FG001|NOT COMPLETED|Overall Study||2||
48374302|NCT01419665|101243715|FG000|STARTED|Combination Treatment||312||
48374303|NCT01419665|101243716|FG001|STARTED|Combination Treatment||315||
48374304|NCT01419665|101243715|FG000|COMPLETED|Combination Treatment||274|completed treatment at week 24|
48374305|NCT01419665|101243716|FG001|COMPLETED|Combination Treatment||274|completed treatment at week 24|
48374306|NCT01419665|101243715|FG000|NOT COMPLETED|Combination Treatment||38||
48374307|NCT01419665|101243716|FG001|NOT COMPLETED|Combination Treatment||41||
48374308|NCT01419665|101243715|FG000|STARTED|Maintenance Treatment and/or Follow up||254||
48374309|NCT01419665|101243716|FG001|STARTED|Maintenance Treatment and/or Follow up||252||
48374310|NCT01419665|101243715|FG000|COMPLETED|Maintenance Treatment and/or Follow up||132||
48374311|NCT01419665|101243716|FG001|COMPLETED|Maintenance Treatment and/or Follow up||150||
48374312|NCT01419665|101243715|FG000|NOT COMPLETED|Maintenance Treatment and/or Follow up||122||
48374313|NCT01419665|101243716|FG001|NOT COMPLETED|Maintenance Treatment and/or Follow up||102||
48374314|NCT01419665|101243715|FG000|STARTED|Open Label Phase||44||
48374315|NCT01419665|101243716|FG001|STARTED|Open Label Phase||39||
48374316|NCT01419665|101243715|FG000|COMPLETED|Open Label Phase||43||
48374317|NCT01419665|101243716|FG001|COMPLETED|Open Label Phase||38||
48374318|NCT01419665|101243715|FG000|NOT COMPLETED|Open Label Phase||1||
48374319|NCT01419665|101243716|FG001|NOT COMPLETED|Open Label Phase||1||
48374320|NCT01487668|101243717|FG000|STARTED|Overall Study||146||
48374321|NCT01487668|101243718|FG001|STARTED|Overall Study||141||
48374322|NCT01487668|101243717|FG000|COMPLETED|Overall Study||121||
48374323|NCT01487668|101243718|FG001|COMPLETED|Overall Study||124||
48374324|NCT01487668|101243717|FG000|NOT COMPLETED|Overall Study||25||
48374325|NCT01487668|101243718|FG001|NOT COMPLETED|Overall Study||17||
48374326|NCT00943319|101243719|FG000|STARTED|Overall Study||50||
48374327|NCT00943319|101243719|FG000|COMPLETED|Overall Study||49||
48374328|NCT00943319|101243719|FG000|NOT COMPLETED|Overall Study||1||
48374329|NCT03696758|101243720|FG000|STARTED|First Intervention||3||
48374330|NCT03696758|101243721|FG001|STARTED|First Intervention||6||
48374331|NCT03696758|101243720|FG000|COMPLETED|First Intervention||3||
48374332|NCT03696758|101243721|FG001|COMPLETED|First Intervention||6||
48374333|NCT03696758|101243720|FG000|NOT COMPLETED|First Intervention||0||
48374334|NCT03696758|101243721|FG001|NOT COMPLETED|First Intervention||0||
48374335|NCT03696758|101243720|FG000|STARTED|Wash Out>12 Hours||3||
48374336|NCT03696758|101243721|FG001|STARTED|Wash Out>12 Hours||6||
48374337|NCT03696758|101243720|FG000|COMPLETED|Wash Out>12 Hours||3||
48374338|NCT03696758|101243721|FG001|COMPLETED|Wash Out>12 Hours||6||
48374339|NCT03696758|101243720|FG000|NOT COMPLETED|Wash Out>12 Hours||0||
48374340|NCT03696758|101243721|FG001|NOT COMPLETED|Wash Out>12 Hours||0||
48374341|NCT03696758|101243720|FG000|STARTED|Second Intervention||3||
48374342|NCT03696758|101243721|FG001|STARTED|Second Intervention||6||
48374343|NCT03696758|101243720|FG000|COMPLETED|Second Intervention||3||
48374344|NCT03696758|101243721|FG001|COMPLETED|Second Intervention||6||
48374345|NCT03696758|101243720|FG000|NOT COMPLETED|Second Intervention||0||
48374346|NCT03696758|101243721|FG001|NOT COMPLETED|Second Intervention||0||
48374347|NCT00436969|101243722|FG000|STARTED|Overall Study||88||
48374348|NCT00436969|101243723|FG001|STARTED|Overall Study||186||
48374349|NCT00436969|101243722|FG000|Randomized But Not Treated|Overall Study||1||
48374350|NCT00436969|101243723|FG001|Randomized But Not Treated|Overall Study||3||
48374351|NCT00436969|101243722|FG000|COMPLETED|Overall Study||66||
48374352|NCT00436969|101243723|FG001|COMPLETED|Overall Study||134||
48374353|NCT00436969|101243722|FG000|NOT COMPLETED|Overall Study||22||
48374354|NCT00436969|101243723|FG001|NOT COMPLETED|Overall Study||52||
48374355|NCT02046265|101243724|FG000|STARTED|Overall Study||17||
48374356|NCT02046265|101243725|FG001|STARTED|Overall Study||17||
48374357|NCT02046265|101243726|FG002|STARTED|Overall Study||12||
48374358|NCT02046265|101243727|FG003|STARTED|Overall Study||14||
48374359|NCT02046265|101243724|FG000|COMPLETED|Overall Study||16||
48374360|NCT02046265|101243725|FG001|COMPLETED|Overall Study||15||
48374361|NCT02046265|101243726|FG002|COMPLETED|Overall Study||10||
48374362|NCT02046265|101243727|FG003|COMPLETED|Overall Study||12||
48374363|NCT02046265|101243724|FG000|NOT COMPLETED|Overall Study||1||
48374364|NCT02046265|101243725|FG001|NOT COMPLETED|Overall Study||2||
48374365|NCT02046265|101243726|FG002|NOT COMPLETED|Overall Study||2||
48374366|NCT02046265|101243727|FG003|NOT COMPLETED|Overall Study||2||
48374367|NCT04369430|101243728|FG000|STARTED|Overall Study||55||
48374368|NCT04369430|101243729|FG001|STARTED|Overall Study||55||
48374369|NCT04369430|101243728|FG000|COMPLETED|Overall Study||46||
48374370|NCT04369430|101243729|FG001|COMPLETED|Overall Study||47||
48374371|NCT04369430|101243728|FG000|NOT COMPLETED|Overall Study||9||
48374372|NCT04369430|101243729|FG001|NOT COMPLETED|Overall Study||8||
48374373|NCT03333057|101243730|FG000|STARTED|Overall Study||111||
48374374|NCT03333057|101243731|FG001|STARTED|Overall Study||114||
48374375|NCT03333057|101243732|FG002|STARTED|Overall Study||111||
48374376|NCT03333057|101243730|FG000|COMPLETED|Overall Study||105||
48374377|NCT03333057|101243731|FG001|COMPLETED|Overall Study||110||
48374378|NCT03333057|101243732|FG002|COMPLETED|Overall Study||108||
48374379|NCT03333057|101243730|FG000|NOT COMPLETED|Overall Study||6||
48374380|NCT03333057|101243731|FG001|NOT COMPLETED|Overall Study||4||
48374381|NCT03333057|101243732|FG002|NOT COMPLETED|Overall Study||3||
48374382|NCT01474746|101243733|FG000|STARTED|Overall Study||30||
48374383|NCT01474746|101243734|FG001|STARTED|Overall Study||27||
48374384|NCT01474746|101243733|FG000|COMPLETED|Overall Study||27||
48374385|NCT01474746|101243734|FG001|COMPLETED|Overall Study||25||
48374386|NCT01474746|101243733|FG000|NOT COMPLETED|Overall Study||3||
48374387|NCT01474746|101243734|FG001|NOT COMPLETED|Overall Study||2||
48374388|NCT00913978|101243735|FG000|STARTED|Overall Study||26||
48374389|NCT00913978|101243736|FG001|STARTED|Overall Study||24||
48374390|NCT00913978|101243735|FG000|COMPLETED|Overall Study||25||
48374391|NCT00913978|101243736|FG001|COMPLETED|Overall Study||21||
48374392|NCT00913978|101243735|FG000|NOT COMPLETED|Overall Study||1||
48374393|NCT00913978|101243736|FG001|NOT COMPLETED|Overall Study||3||
48374394|NCT02678741|101243737|FG000|STARTED|Overall Study||26||
48374395|NCT02678741|101243737|FG000|No Clinical Response|Overall Study||3||
48374396|NCT02678741|101243737|FG000|Stable Disease|Overall Study||2||
48374397|NCT02678741|101243737|FG000|Progressive Disease|Overall Study||10||
48374398|NCT02678741|101243737|FG000|COMPLETED|Overall Study||6||
48374399|NCT02678741|101243737|FG000|NOT COMPLETED|Overall Study||20||
48374400|NCT00372190|101243738|FG000|STARTED|Overall Study||93||
48374401|NCT00372190|101243739|FG001|STARTED|Overall Study||97||
48374402|NCT00372190|101243738|FG000|COMPLETED|Overall Study||90||
48374403|NCT00372190|101243739|FG001|COMPLETED|Overall Study||96||
48374404|NCT00372190|101243738|FG000|NOT COMPLETED|Overall Study||3||
48374405|NCT00372190|101243739|FG001|NOT COMPLETED|Overall Study||1||
48374406|NCT02998554|101243740|FG000|STARTED|Overall Study||79||
48374407|NCT02998554|101243741|FG001|STARTED|Overall Study||77||
48374408|NCT02998554|101243740|FG000|COMPLETED|Overall Study||68||
48374409|NCT02998554|101243741|FG001|COMPLETED|Overall Study||66||
48374410|NCT02998554|101243740|FG000|NOT COMPLETED|Overall Study||11||
48374411|NCT02998554|101243741|FG001|NOT COMPLETED|Overall Study||11||
48374412|NCT03090620|101243742|FG000|STARTED|Overall Study||9||
48374413|NCT03090620|101243743|FG001|STARTED|Overall Study||10||
48374414|NCT03090620|101243742|FG000|COMPLETED|Overall Study||9||
48374415|NCT03090620|101243743|FG001|COMPLETED|Overall Study||10||
48374416|NCT03090620|101243742|FG000|NOT COMPLETED|Overall Study||0||
48374417|NCT03090620|101243743|FG001|NOT COMPLETED|Overall Study||0||
48374418|NCT02467387|101243744|FG000|STARTED|First Intervention||11||
48374419|NCT02467387|101243745|FG001|STARTED|First Intervention||12||
48374420|NCT02467387|101243744|FG000|Received Treatment as Randomized|First Intervention||10||
48374421|NCT02467387|101243745|FG001|Received Treatment as Randomized|First Intervention||12||
48374422|NCT02467387|101243744|FG000|COMPLETED|First Intervention||10||
48374423|NCT02467387|101243745|FG001|COMPLETED|First Intervention||12||
48374424|NCT02467387|101243744|FG000|NOT COMPLETED|First Intervention||1||
48374425|NCT02467387|101243745|FG001|NOT COMPLETED|First Intervention||0||
48374426|NCT02467387|101243744|FG000|STARTED|Second Intervention||10||
48374427|NCT02467387|101243745|FG001|STARTED|Second Intervention||12||
48374428|NCT02467387|101243744|FG000|COMPLETED|Second Intervention||7||
48374429|NCT02467387|101243745|FG001|COMPLETED|Second Intervention||12||
48374430|NCT02467387|101243744|FG000|NOT COMPLETED|Second Intervention||3||
48374431|NCT02467387|101243745|FG001|NOT COMPLETED|Second Intervention||0||
48374432|NCT01930799|101243746|FG000|STARTED|Overall Study||120||
48374433|NCT01930799|101243746|FG000|COMPLETED|Overall Study||112||
48374434|NCT01930799|101243746|FG000|NOT COMPLETED|Overall Study||8||
48374435|NCT02772965|101243747|FG000|STARTED|Overall Study||162||
48374436|NCT02772965|101243748|FG001|STARTED|Overall Study||144||
48374437|NCT02772965|101243747|FG000|Randomized|Overall Study||162||
48374438|NCT02772965|101243748|FG001|Randomized|Overall Study||144||
48374439|NCT02772965|101243747|FG000|Withdrew Before Receiving Drug|Overall Study||6||
48374440|NCT02772965|101243748|FG001|Withdrew Before Receiving Drug|Overall Study||3||
48374441|NCT02772965|101243747|FG000|Modified Intent to Treat|Overall Study||156||
48374442|NCT02772965|101243748|FG001|Modified Intent to Treat|Overall Study||141||
48374443|NCT02772965|101243747|FG000|COMPLETED|Overall Study||140||
48374444|NCT02772965|101243748|FG001|COMPLETED|Overall Study||126||
48374445|NCT02772965|101243747|FG000|NOT COMPLETED|Overall Study||22||
48374446|NCT02772965|101243748|FG001|NOT COMPLETED|Overall Study||18||
48374447|NCT01228071|101243749|FG000|STARTED|Overall Study||34||
48374448|NCT01228071|101243749|FG000|COMPLETED|Overall Study||32||
48374449|NCT01228071|101243749|FG000|NOT COMPLETED|Overall Study||2||
48374450|NCT03099369|101243750|FG000|STARTED|Overall Study||11||
48374451|NCT03099369|101243751|FG001|STARTED|Overall Study||9||
48374452|NCT03099369|101243750|FG000|COMPLETED|Overall Study||5||
48374453|NCT03099369|101243751|FG001|COMPLETED|Overall Study||5||
48374454|NCT03099369|101243750|FG000|NOT COMPLETED|Overall Study||6||
48374455|NCT03099369|101243751|FG001|NOT COMPLETED|Overall Study||4||
48374456|NCT02238028|101243752|FG000|STARTED|Overall Study||14||
48374457|NCT02238028|101243753|FG001|STARTED|Overall Study||14||
48374458|NCT02238028|101243752|FG000|COMPLETED|Overall Study||12||
48374459|NCT02238028|101243753|FG001|COMPLETED|Overall Study||12||
48374460|NCT02238028|101243752|FG000|NOT COMPLETED|Overall Study||2||
48374461|NCT02238028|101243753|FG001|NOT COMPLETED|Overall Study||2||
48374462|NCT02435277|101243754|FG000|STARTED|Overall Study||12||
48374463|NCT02435277|101243755|FG001|STARTED|Overall Study||16||
48374464|NCT02435277|101243756|FG002|STARTED|Overall Study||11||
48374465|NCT02435277|101243757|FG003|STARTED|Overall Study||11||
48374466|NCT02435277|101243754|FG000|COMPLETED|Overall Study||10||
48374467|NCT02435277|101243755|FG001|COMPLETED|Overall Study||15||
48374468|NCT02435277|101243756|FG002|COMPLETED|Overall Study||11||
48374469|NCT02435277|101243757|FG003|COMPLETED|Overall Study||11||
48374470|NCT02435277|101243754|FG000|NOT COMPLETED|Overall Study||2||
48374471|NCT02435277|101243755|FG001|NOT COMPLETED|Overall Study||1||
48374472|NCT02435277|101243756|FG002|NOT COMPLETED|Overall Study||0||
48374473|NCT02435277|101243757|FG003|NOT COMPLETED|Overall Study||0||
48374474|NCT00654511|101243758|FG000|STARTED|Overall Study||26||
48521898|NCT03250299|101611712|FG004|NOT COMPLETED|BAL101553 8 mg Cohort||0||
48521899|NCT03250299|101611708|FG000|STARTED|BAL101553 12 mg Cohort||0||
48521900|NCT03250299|101611709|FG001|STARTED|BAL101553 12 mg Cohort||0||
48521901|NCT03250299|101611710|FG002|STARTED|BAL101553 12 mg Cohort||0||
48521902|NCT03250299|101611711|FG003|STARTED|BAL101553 12 mg Cohort||5||
48521903|NCT03250299|101611712|FG004|STARTED|BAL101553 12 mg Cohort||0||
48521904|NCT03250299|101611708|FG000|COMPLETED|BAL101553 12 mg Cohort||0||
48521905|NCT03250299|101611709|FG001|COMPLETED|BAL101553 12 mg Cohort||0||
48521906|NCT03250299|101611710|FG002|COMPLETED|BAL101553 12 mg Cohort||0||
48521907|NCT03250299|101611711|FG003|COMPLETED|BAL101553 12 mg Cohort||3||
48521908|NCT03250299|101611712|FG004|COMPLETED|BAL101553 12 mg Cohort||0||
48521909|NCT03250299|101611708|FG000|NOT COMPLETED|BAL101553 12 mg Cohort||0||
48521910|NCT03250299|101611709|FG001|NOT COMPLETED|BAL101553 12 mg Cohort||0||
48521911|NCT03250299|101611710|FG002|NOT COMPLETED|BAL101553 12 mg Cohort||0||
48521912|NCT03250299|101611711|FG003|NOT COMPLETED|BAL101553 12 mg Cohort||2||
48521913|NCT03250299|101611712|FG004|NOT COMPLETED|BAL101553 12 mg Cohort||0||
48521914|NCT03250299|101611708|FG000|STARTED|BAL101553 15 mg Cohort||0||
48521915|NCT03250299|101611709|FG001|STARTED|BAL101553 15 mg Cohort||0||
48521916|NCT03250299|101611710|FG002|STARTED|BAL101553 15 mg Cohort||0||
48521917|NCT03250299|101611711|FG003|STARTED|BAL101553 15 mg Cohort||0||
48521918|NCT03250299|101611712|FG004|STARTED|BAL101553 15 mg Cohort||4||
48521919|NCT03250299|101611708|FG000|COMPLETED|BAL101553 15 mg Cohort||0||
48521920|NCT03250299|101611709|FG001|COMPLETED|BAL101553 15 mg Cohort||0||
48521921|NCT03250299|101611710|FG002|COMPLETED|BAL101553 15 mg Cohort||0||
48521922|NCT03250299|101611711|FG003|COMPLETED|BAL101553 15 mg Cohort||0||
48521923|NCT03250299|101611712|FG004|COMPLETED|BAL101553 15 mg Cohort||4||
48521924|NCT03250299|101611708|FG000|NOT COMPLETED|BAL101553 15 mg Cohort||0||
48521925|NCT03250299|101611709|FG001|NOT COMPLETED|BAL101553 15 mg Cohort||0||
48521926|NCT03250299|101611710|FG002|NOT COMPLETED|BAL101553 15 mg Cohort||0||
48521927|NCT03250299|101611711|FG003|NOT COMPLETED|BAL101553 15 mg Cohort||0||
48521928|NCT03250299|101611712|FG004|NOT COMPLETED|BAL101553 15 mg Cohort||0||
48521929|NCT00466726|101611713|FG000|STARTED|Overall Study||57||
48521930|NCT00466726|101611713|FG000|COMPLETED|Overall Study||43||
48521931|NCT00466726|101611713|FG000|NOT COMPLETED|Overall Study||14||
48521932|NCT02037165|101611714|FG000|STARTED|Period 1 (2 Days)||5||
48521933|NCT02037165|101611715|FG001|STARTED|Period 1 (2 Days)||5||
48521934|NCT02037165|101611716|FG002|STARTED|Period 1 (2 Days)||5||
48521935|NCT02037165|101611717|FG003|STARTED|Period 1 (2 Days)||5||
48521936|NCT02037165|101611718|FG004|STARTED|Period 1 (2 Days)||5||
48521937|NCT02037165|101611714|FG000|COMPLETED|Period 1 (2 Days)||5||
48521938|NCT02037165|101611715|FG001|COMPLETED|Period 1 (2 Days)||5||
48521939|NCT02037165|101611716|FG002|COMPLETED|Period 1 (2 Days)||5||
48521940|NCT02037165|101611717|FG003|COMPLETED|Period 1 (2 Days)||5||
48521941|NCT02037165|101611718|FG004|COMPLETED|Period 1 (2 Days)||5||
48521942|NCT02037165|101611714|FG000|NOT COMPLETED|Period 1 (2 Days)||0||
48521943|NCT02037165|101611715|FG001|NOT COMPLETED|Period 1 (2 Days)||0||
48521944|NCT02037165|101611716|FG002|NOT COMPLETED|Period 1 (2 Days)||0||
48521945|NCT02037165|101611717|FG003|NOT COMPLETED|Period 1 (2 Days)||0||
48521946|NCT02037165|101611718|FG004|NOT COMPLETED|Period 1 (2 Days)||0||
48521947|NCT02037165|101611714|FG000|STARTED|Washout Period 1 (6 Days)||5||
48521948|NCT02037165|101611715|FG001|STARTED|Washout Period 1 (6 Days)||5||
48521949|NCT02037165|101611716|FG002|STARTED|Washout Period 1 (6 Days)||5||
48521950|NCT02037165|101611717|FG003|STARTED|Washout Period 1 (6 Days)||5||
48521951|NCT02037165|101611718|FG004|STARTED|Washout Period 1 (6 Days)||5||
48521952|NCT02037165|101611714|FG000|COMPLETED|Washout Period 1 (6 Days)||5||
48521953|NCT02037165|101611715|FG001|COMPLETED|Washout Period 1 (6 Days)||5||
48374475|NCT00654511|101243759|FG001|STARTED|Overall Study||25||
48374476|NCT00654511|101243760|FG002|STARTED|Overall Study||25||
48374477|NCT00654511|101243761|FG003|STARTED|Overall Study||25||
48374478|NCT00654511|101243758|FG000|COMPLETED|Overall Study||26||
48374479|NCT00654511|101243759|FG001|COMPLETED|Overall Study||25||
48374480|NCT00654511|101243760|FG002|COMPLETED|Overall Study||25||
48374481|NCT00654511|101243761|FG003|COMPLETED|Overall Study||25||
48374482|NCT00654511|101243758|FG000|NOT COMPLETED|Overall Study||0||
48521954|NCT02037165|101611716|FG002|COMPLETED|Washout Period 1 (6 Days)||5||
48521955|NCT02037165|101611717|FG003|COMPLETED|Washout Period 1 (6 Days)||5||
48521956|NCT02037165|101611718|FG004|COMPLETED|Washout Period 1 (6 Days)||5||
48521957|NCT02037165|101611714|FG000|NOT COMPLETED|Washout Period 1 (6 Days)||0||
48521958|NCT02037165|101611715|FG001|NOT COMPLETED|Washout Period 1 (6 Days)||0||
48521959|NCT02037165|101611716|FG002|NOT COMPLETED|Washout Period 1 (6 Days)||0||
48521960|NCT02037165|101611717|FG003|NOT COMPLETED|Washout Period 1 (6 Days)||0||
48521961|NCT02037165|101611718|FG004|NOT COMPLETED|Washout Period 1 (6 Days)||0||
48521962|NCT02037165|101611714|FG000|STARTED|Period 2 (2 Days)||5||
48521963|NCT02037165|101611715|FG001|STARTED|Period 2 (2 Days)||5||
48521964|NCT02037165|101611716|FG002|STARTED|Period 2 (2 Days)||5||
48521965|NCT02037165|101611717|FG003|STARTED|Period 2 (2 Days)||5||
48521966|NCT02037165|101611718|FG004|STARTED|Period 2 (2 Days)||5||
48521967|NCT02037165|101611714|FG000|COMPLETED|Period 2 (2 Days)||5||
48521968|NCT02037165|101611715|FG001|COMPLETED|Period 2 (2 Days)||5||
48521969|NCT02037165|101611716|FG002|COMPLETED|Period 2 (2 Days)||5||
48521970|NCT02037165|101611717|FG003|COMPLETED|Period 2 (2 Days)||5||
48521971|NCT02037165|101611718|FG004|COMPLETED|Period 2 (2 Days)||5||
48521972|NCT02037165|101611714|FG000|NOT COMPLETED|Period 2 (2 Days)||0||
48521973|NCT02037165|101611715|FG001|NOT COMPLETED|Period 2 (2 Days)||0||
48521974|NCT02037165|101611716|FG002|NOT COMPLETED|Period 2 (2 Days)||0||
48521975|NCT02037165|101611717|FG003|NOT COMPLETED|Period 2 (2 Days)||0||
48521976|NCT02037165|101611718|FG004|NOT COMPLETED|Period 2 (2 Days)||0||
48521977|NCT02037165|101611714|FG000|STARTED|Washout Period 2 (6 Days)||5||
48521978|NCT02037165|101611715|FG001|STARTED|Washout Period 2 (6 Days)||5||
48521979|NCT02037165|101611716|FG002|STARTED|Washout Period 2 (6 Days)||5||
48521980|NCT02037165|101611717|FG003|STARTED|Washout Period 2 (6 Days)||5||
48521981|NCT02037165|101611718|FG004|STARTED|Washout Period 2 (6 Days)||5||
48521982|NCT02037165|101611714|FG000|COMPLETED|Washout Period 2 (6 Days)||5||
48521983|NCT02037165|101611715|FG001|COMPLETED|Washout Period 2 (6 Days)||5||
48521984|NCT02037165|101611716|FG002|COMPLETED|Washout Period 2 (6 Days)||5||
48521985|NCT02037165|101611717|FG003|COMPLETED|Washout Period 2 (6 Days)||5||
48521986|NCT02037165|101611718|FG004|COMPLETED|Washout Period 2 (6 Days)||5||
48521987|NCT02037165|101611714|FG000|NOT COMPLETED|Washout Period 2 (6 Days)||0||
48521988|NCT02037165|101611715|FG001|NOT COMPLETED|Washout Period 2 (6 Days)||0||
48521989|NCT02037165|101611716|FG002|NOT COMPLETED|Washout Period 2 (6 Days)||0||
48521990|NCT02037165|101611717|FG003|NOT COMPLETED|Washout Period 2 (6 Days)||0||
48521991|NCT02037165|101611718|FG004|NOT COMPLETED|Washout Period 2 (6 Days)||0||
48521992|NCT02037165|101611714|FG000|STARTED|Period 3 (2 Days)||5||
48521993|NCT02037165|101611715|FG001|STARTED|Period 3 (2 Days)||5||
48521994|NCT02037165|101611716|FG002|STARTED|Period 3 (2 Days)||5||
48521995|NCT02037165|101611717|FG003|STARTED|Period 3 (2 Days)||5||
48521996|NCT02037165|101611718|FG004|STARTED|Period 3 (2 Days)||5||
48521997|NCT02037165|101611714|FG000|COMPLETED|Period 3 (2 Days)||5||
48521998|NCT02037165|101611715|FG001|COMPLETED|Period 3 (2 Days)||5||
48521999|NCT02037165|101611716|FG002|COMPLETED|Period 3 (2 Days)||5||
48522000|NCT02037165|101611717|FG003|COMPLETED|Period 3 (2 Days)||5||
48522001|NCT02037165|101611718|FG004|COMPLETED|Period 3 (2 Days)||5||
48522002|NCT02037165|101611714|FG000|NOT COMPLETED|Period 3 (2 Days)||0||
48522003|NCT02037165|101611715|FG001|NOT COMPLETED|Period 3 (2 Days)||0||
48522004|NCT02037165|101611716|FG002|NOT COMPLETED|Period 3 (2 Days)||0||
48522005|NCT02037165|101611717|FG003|NOT COMPLETED|Period 3 (2 Days)||0||
48522006|NCT02037165|101611718|FG004|NOT COMPLETED|Period 3 (2 Days)||0||
48522007|NCT02037165|101611714|FG000|STARTED|Washout Period 3 (6 Days)||5||
48522008|NCT02037165|101611715|FG001|STARTED|Washout Period 3 (6 Days)||5||
48522009|NCT02037165|101611716|FG002|STARTED|Washout Period 3 (6 Days)||5||
48522010|NCT02037165|101611717|FG003|STARTED|Washout Period 3 (6 Days)||5||
48522011|NCT02037165|101611718|FG004|STARTED|Washout Period 3 (6 Days)||5||
48522012|NCT02037165|101611714|FG000|COMPLETED|Washout Period 3 (6 Days)||5||
48522013|NCT02037165|101611715|FG001|COMPLETED|Washout Period 3 (6 Days)||5||
48522014|NCT02037165|101611716|FG002|COMPLETED|Washout Period 3 (6 Days)||5||
48522015|NCT02037165|101611717|FG003|COMPLETED|Washout Period 3 (6 Days)||5||
48522016|NCT02037165|101611718|FG004|COMPLETED|Washout Period 3 (6 Days)||5||
48522017|NCT02037165|101611714|FG000|NOT COMPLETED|Washout Period 3 (6 Days)||0||
48522018|NCT02037165|101611715|FG001|NOT COMPLETED|Washout Period 3 (6 Days)||0||
48522019|NCT02037165|101611716|FG002|NOT COMPLETED|Washout Period 3 (6 Days)||0||
48522020|NCT02037165|101611717|FG003|NOT COMPLETED|Washout Period 3 (6 Days)||0||
48522021|NCT02037165|101611718|FG004|NOT COMPLETED|Washout Period 3 (6 Days)||0||
48522022|NCT02037165|101611714|FG000|STARTED|Period 4 (2 Days)||5||
48522023|NCT02037165|101611715|FG001|STARTED|Period 4 (2 Days)||5||
48522024|NCT02037165|101611716|FG002|STARTED|Period 4 (2 Days)||5||
48522025|NCT02037165|101611717|FG003|STARTED|Period 4 (2 Days)||5||
48522026|NCT02037165|101611718|FG004|STARTED|Period 4 (2 Days)||5||
48522027|NCT02037165|101611714|FG000|COMPLETED|Period 4 (2 Days)||5||
48522028|NCT02037165|101611715|FG001|COMPLETED|Period 4 (2 Days)||5||
48522029|NCT02037165|101611716|FG002|COMPLETED|Period 4 (2 Days)||5||
48522030|NCT02037165|101611717|FG003|COMPLETED|Period 4 (2 Days)||5||
48522031|NCT02037165|101611718|FG004|COMPLETED|Period 4 (2 Days)||5||
48522032|NCT02037165|101611714|FG000|NOT COMPLETED|Period 4 (2 Days)||0||
48522033|NCT02037165|101611715|FG001|NOT COMPLETED|Period 4 (2 Days)||0||
48522034|NCT02037165|101611716|FG002|NOT COMPLETED|Period 4 (2 Days)||0||
48522035|NCT02037165|101611717|FG003|NOT COMPLETED|Period 4 (2 Days)||0||
48522036|NCT02037165|101611718|FG004|NOT COMPLETED|Period 4 (2 Days)||0||
48522037|NCT02037165|101611714|FG000|STARTED|Washout Period 4 (6 Days)||5||
48522038|NCT02037165|101611715|FG001|STARTED|Washout Period 4 (6 Days)||5||
48522039|NCT02037165|101611716|FG002|STARTED|Washout Period 4 (6 Days)||5||
48522040|NCT02037165|101611717|FG003|STARTED|Washout Period 4 (6 Days)||5||
48522041|NCT02037165|101611718|FG004|STARTED|Washout Period 4 (6 Days)||5||
48522042|NCT02037165|101611714|FG000|COMPLETED|Washout Period 4 (6 Days)||5||
48522043|NCT02037165|101611715|FG001|COMPLETED|Washout Period 4 (6 Days)||5||
48522044|NCT02037165|101611716|FG002|COMPLETED|Washout Period 4 (6 Days)||5||
48522045|NCT02037165|101611717|FG003|COMPLETED|Washout Period 4 (6 Days)||5||
48522046|NCT02037165|101611718|FG004|COMPLETED|Washout Period 4 (6 Days)||4||
48522047|NCT02037165|101611714|FG000|NOT COMPLETED|Washout Period 4 (6 Days)||0||
48522048|NCT02037165|101611715|FG001|NOT COMPLETED|Washout Period 4 (6 Days)||0||
48522049|NCT02037165|101611716|FG002|NOT COMPLETED|Washout Period 4 (6 Days)||0||
48522050|NCT02037165|101611717|FG003|NOT COMPLETED|Washout Period 4 (6 Days)||0||
48522051|NCT02037165|101611718|FG004|NOT COMPLETED|Washout Period 4 (6 Days)||1||
48522052|NCT02037165|101611714|FG000|STARTED|Period 5 (2 Days)||5||
48522053|NCT02037165|101611715|FG001|STARTED|Period 5 (2 Days)||5||
48522054|NCT02037165|101611716|FG002|STARTED|Period 5 (2 Days)||5||
48522055|NCT02037165|101611717|FG003|STARTED|Period 5 (2 Days)||5||
48522056|NCT02037165|101611718|FG004|STARTED|Period 5 (2 Days)||4||
48522057|NCT02037165|101611714|FG000|COMPLETED|Period 5 (2 Days)||5||
48522058|NCT02037165|101611715|FG001|COMPLETED|Period 5 (2 Days)||5||
48522059|NCT02037165|101611716|FG002|COMPLETED|Period 5 (2 Days)||5||
48522060|NCT02037165|101611717|FG003|COMPLETED|Period 5 (2 Days)||5||
48522061|NCT02037165|101611718|FG004|COMPLETED|Period 5 (2 Days)||4||
48522062|NCT02037165|101611714|FG000|NOT COMPLETED|Period 5 (2 Days)||0||
48522063|NCT02037165|101611715|FG001|NOT COMPLETED|Period 5 (2 Days)||0||
48522064|NCT02037165|101611716|FG002|NOT COMPLETED|Period 5 (2 Days)||0||
48522065|NCT02037165|101611717|FG003|NOT COMPLETED|Period 5 (2 Days)||0||
48522066|NCT02037165|101611718|FG004|NOT COMPLETED|Period 5 (2 Days)||0||
48522067|NCT00916136|101611719|FG000|STARTED|Overall Study||37||
48522068|NCT00916136|101611720|FG001|STARTED|Overall Study||29||
48522069|NCT00916136|101611719|FG000|COMPLETED|Overall Study||37||
48522070|NCT00916136|101611720|FG001|COMPLETED|Overall Study||29||
48522071|NCT00916136|101611719|FG000|NOT COMPLETED|Overall Study||0||
48522072|NCT00916136|101611720|FG001|NOT COMPLETED|Overall Study||0||
48522073|NCT02547766|101611721|FG000|STARTED|Overall Study||10||
48522074|NCT02547766|101611721|FG000|COMPLETED|Overall Study||9||
48522075|NCT02547766|101611721|FG000|NOT COMPLETED|Overall Study||1||
48522076|NCT04032158|101611722|FG000|STARTED|Overall Study||2||
48522077|NCT04032158|101611723|FG001|STARTED|Overall Study||1||
48522078|NCT04032158|101611722|FG000|COMPLETED|Overall Study||0||
48522079|NCT04032158|101611723|FG001|COMPLETED|Overall Study||0||
48522080|NCT04032158|101611722|FG000|NOT COMPLETED|Overall Study||2||
48522081|NCT04032158|101611723|FG001|NOT COMPLETED|Overall Study||1||
48522082|NCT02813421|101611724|FG000|STARTED|Overall Study||5||
48522083|NCT02813421|101611725|FG001|STARTED|Overall Study||6||
48522084|NCT02813421|101611724|FG000|COMPLETED|Overall Study||3||
48522085|NCT02813421|101611725|FG001|COMPLETED|Overall Study||3||
48522086|NCT02813421|101611724|FG000|NOT COMPLETED|Overall Study||2||
48522087|NCT02813421|101611725|FG001|NOT COMPLETED|Overall Study||3||
48522088|NCT00804141|101611726|FG000|STARTED|Overall Study||1040||
48522089|NCT00804141|101611726|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1034||
48522090|NCT00804141|101611726|FG000|COMPLETED|Overall Study||477||
48522091|NCT00804141|101611726|FG000|NOT COMPLETED|Overall Study||563||
48522092|NCT02332980|101611727|FG000|STARTED|Initial Study Phase||25||
48522093|NCT02332980|101611728|FG001|STARTED|Initial Study Phase||23||
48522094|NCT02332980|101611729|FG002|STARTED|Initial Study Phase||17||
48522095|NCT02332980|101611727|FG000|COMPLETED|Initial Study Phase||25||
48522096|NCT02332980|101611728|FG001|COMPLETED|Initial Study Phase||23||
48522097|NCT02332980|101611729|FG002|COMPLETED|Initial Study Phase||17||
48522098|NCT02332980|101611727|FG000|NOT COMPLETED|Initial Study Phase||0||
48522099|NCT02332980|101611728|FG001|NOT COMPLETED|Initial Study Phase||0||
48522100|NCT02332980|101611729|FG002|NOT COMPLETED|Initial Study Phase||0||
48522101|NCT02332980|101611727|FG000|STARTED|Continuation Phase||5||
48522102|NCT02332980|101611728|FG001|STARTED|Continuation Phase||0||
48522103|NCT02332980|101611729|FG002|STARTED|Continuation Phase||13||
48522104|NCT02332980|101611727|FG000|COMPLETED|Continuation Phase||5||
48522105|NCT02332980|101611728|FG001|COMPLETED|Continuation Phase||0||
48522106|NCT02332980|101611729|FG002|COMPLETED|Continuation Phase||13||
48522107|NCT02332980|101611727|FG000|NOT COMPLETED|Continuation Phase||0||
48522108|NCT02332980|101611728|FG001|NOT COMPLETED|Continuation Phase||0||
48522109|NCT02332980|101611729|FG002|NOT COMPLETED|Continuation Phase||0||
48522110|NCT00775684|101611730|FG000|STARTED|Overall Study||17||
48522111|NCT00775684|101611731|FG001|STARTED|Overall Study||13||
48522112|NCT00775684|101611732|FG002|STARTED|Overall Study||17||
48522113|NCT00775684|101611730|FG000|COMPLETED|Overall Study||14||
48522114|NCT00775684|101611731|FG001|COMPLETED|Overall Study||12||
48522115|NCT00775684|101611732|FG002|COMPLETED|Overall Study||14||
48374483|NCT00654511|101243759|FG001|NOT COMPLETED|Overall Study||0||
48374484|NCT00654511|101243760|FG002|NOT COMPLETED|Overall Study||0||
48374485|NCT00654511|101243761|FG003|NOT COMPLETED|Overall Study||0||
48374486|NCT02491437|101243762|FG000|STARTED|Overall Study||520||
48374487|NCT02491437|101243763|FG001|STARTED|Overall Study||514||
48374488|NCT02491437|101243762|FG000|Safety Sample|Overall Study||518||
48374489|NCT02491437|101243763|FG001|Safety Sample|Overall Study||512||
48374490|NCT02491437|101243762|FG000|Full Analysis Sample|Overall Study||494||
48374491|NCT02491437|101243763|FG001|Full Analysis Sample|Overall Study||489||
48374492|NCT02491437|101243762|FG000|COMPLETED|Overall Study||168||
48374493|NCT02491437|101243763|FG001|COMPLETED|Overall Study||157||
48374494|NCT02491437|101243762|FG000|NOT COMPLETED|Overall Study||352||
48374495|NCT02491437|101243763|FG001|NOT COMPLETED|Overall Study||357||
48374496|NCT00089843|101243764|FG000|STARTED|Overall Study||19||
48374497|NCT00089843|101243765|FG001|STARTED|Overall Study||20||
48374498|NCT00089843|101243766|FG002|STARTED|Overall Study||20||
48374499|NCT00089843|101243767|FG003|STARTED|Overall Study||18||
48374500|NCT00089843|101243764|FG000|COMPLETED|Overall Study||17||
48374501|NCT00089843|101243765|FG001|COMPLETED|Overall Study||16||
48374502|NCT00089843|101243766|FG002|COMPLETED|Overall Study||15||
48374503|NCT00089843|101243767|FG003|COMPLETED|Overall Study||11||
48374504|NCT00089843|101243764|FG000|NOT COMPLETED|Overall Study||2||
48374505|NCT00089843|101243765|FG001|NOT COMPLETED|Overall Study||4||
48374506|NCT00089843|101243766|FG002|NOT COMPLETED|Overall Study||5||
48374507|NCT00089843|101243767|FG003|NOT COMPLETED|Overall Study||7||
48374508|NCT04964063|101243768|FG000|STARTED|Overall Study||655||
48374509|NCT04964063|101243768|FG000|COMPLETED|Overall Study||557||
48374510|NCT04964063|101243768|FG000|NOT COMPLETED|Overall Study||98||
48374511|NCT00853333|101243769|FG000|STARTED|Overall Study||28||
48374512|NCT00853333|101243770|FG001|STARTED|Overall Study||27||
48374513|NCT00853333|101243771|FG002|STARTED|Overall Study||31||
48374514|NCT00853333|101243769|FG000|COMPLETED|Overall Study||28||
48374515|NCT00853333|101243770|FG001|COMPLETED|Overall Study||27||
48374516|NCT00853333|101243771|FG002|COMPLETED|Overall Study||31||
48374517|NCT00853333|101243769|FG000|NOT COMPLETED|Overall Study||0||
48374518|NCT00853333|101243770|FG001|NOT COMPLETED|Overall Study||0||
48374519|NCT00853333|101243771|FG002|NOT COMPLETED|Overall Study||0||
48374520|NCT04192448|101243772|FG000|STARTED|Overall Study||1||
48374521|NCT04192448|101243773|FG001|STARTED|Overall Study||1||
48374522|NCT04192448|101243774|FG002|STARTED|Overall Study||0||
48374523|NCT04192448|101243775|FG003|STARTED|Overall Study||1||
48374524|NCT04192448|101243772|FG000|COMPLETED|Overall Study||1||
48374525|NCT04192448|101243773|FG001|COMPLETED|Overall Study||1||
48374526|NCT04192448|101243774|FG002|COMPLETED|Overall Study||0||
48374527|NCT04192448|101243775|FG003|COMPLETED|Overall Study||1||
48374528|NCT04192448|101243772|FG000|NOT COMPLETED|Overall Study||0||
48374529|NCT04192448|101243773|FG001|NOT COMPLETED|Overall Study||0||
48374530|NCT04192448|101243774|FG002|NOT COMPLETED|Overall Study||0||
48374531|NCT04192448|101243775|FG003|NOT COMPLETED|Overall Study||0||
48374532|NCT01883440|101243776|FG000|STARTED|Overall Study||45||
48374533|NCT01883440|101243777|FG001|STARTED|Overall Study||45||
48374534|NCT01883440|101243776|FG000|COMPLETED|Overall Study||42||
48374535|NCT01883440|101243777|FG001|COMPLETED|Overall Study||45||
48374536|NCT01883440|101243776|FG000|NOT COMPLETED|Overall Study||3||
48374537|NCT01883440|101243777|FG001|NOT COMPLETED|Overall Study||0||
48374538|NCT04544709|101247424|FG000|STARTED|Overall Study||3||
48374539|NCT04544709|101247424|FG000|COMPLETED|Overall Study||0||
48374540|NCT04544709|101247424|FG000|NOT COMPLETED|Overall Study||3||
48374541|NCT02531373|101247425|FG000|STARTED|Overall Study||20||
48374542|NCT02531373|101247426|FG001|STARTED|Overall Study||20||
48374543|NCT02531373|101247427|FG002|STARTED|Overall Study||20||
48374544|NCT02531373|101247428|FG003|STARTED|Overall Study||20||
48374545|NCT02531373|101247429|FG004|STARTED|Overall Study||51||
48374546|NCT02531373|101247430|FG005|STARTED|Overall Study||51||
48374547|NCT02531373|101247431|FG006|STARTED|Overall Study||52||
48374548|NCT02531373|101247432|FG007|STARTED|Overall Study||52||
48374549|NCT02531373|101247433|FG008|STARTED|Overall Study||52||
48374550|NCT02531373|101247425|FG000|Vaccination 1|Overall Study||20||
48374551|NCT02531373|101247426|FG001|Vaccination 1|Overall Study||20||
48374552|NCT02531373|101247427|FG002|Vaccination 1|Overall Study||20||
48374553|NCT02531373|101247428|FG003|Vaccination 1|Overall Study||20||
48374554|NCT02531373|101247429|FG004|Vaccination 1|Overall Study||50||
48374555|NCT02531373|101247430|FG005|Vaccination 1|Overall Study||50||
48374556|NCT02531373|101247431|FG006|Vaccination 1|Overall Study||52||
48374557|NCT02531373|101247432|FG007|Vaccination 1|Overall Study||52||
48374558|NCT02531373|101247433|FG008|Vaccination 1|Overall Study||52||
48374559|NCT02531373|101247425|FG000|Vaccination 2|Overall Study||0||
48374560|NCT02531373|101247426|FG001|Vaccination 2|Overall Study||0||
48374561|NCT02531373|101247427|FG002|Vaccination 2|Overall Study||0||
48374562|NCT02531373|101247428|FG003|Vaccination 2|Overall Study||0||
48374563|NCT02531373|101247429|FG004|Vaccination 2|Overall Study||49||
48374564|NCT02531373|101247430|FG005|Vaccination 2|Overall Study||48||
48374565|NCT02531373|101247431|FG006|Vaccination 2|Overall Study||50||
48374566|NCT02531373|101247432|FG007|Vaccination 2|Overall Study||51||
48522116|NCT00775684|101611730|FG000|NOT COMPLETED|Overall Study||3||
48522117|NCT00775684|101611731|FG001|NOT COMPLETED|Overall Study||1||
48522118|NCT00775684|101611732|FG002|NOT COMPLETED|Overall Study||3||
48522119|NCT03036839|101611733|FG000|STARTED|Overall Study||45||
48522120|NCT03036839|101611734|FG001|STARTED|Overall Study||31||
48522121|NCT03036839|101611735|FG002|STARTED|Overall Study||19||
48522122|NCT03036839|101611733|FG000|COMPLETED|Overall Study||42||
48522123|NCT03036839|101611734|FG001|COMPLETED|Overall Study||31||
48522124|NCT03036839|101611735|FG002|COMPLETED|Overall Study||14||
48522125|NCT03036839|101611733|FG000|NOT COMPLETED|Overall Study||3||
48522126|NCT03036839|101611734|FG001|NOT COMPLETED|Overall Study||0||
48522127|NCT03036839|101611735|FG002|NOT COMPLETED|Overall Study||5||
48522128|NCT01635062|101611736|FG000|STARTED|Overall Study||9||
48522129|NCT01635062|101611737|FG001|STARTED|Overall Study||9||
48522130|NCT01635062|101611736|FG000|Sodium Restriction Baseline Visit|Overall Study||9|The first study visit was a pre-randomization assessment while sodium restricted (Baseline)|
48522131|NCT01635062|101611737|FG001|Sodium Restriction Baseline Visit|Overall Study||9|The first study visit was a pre-randomization assessment while sodium restricted (Baseline)|
48522132|NCT01635062|101611736|FG000|Sodium Loading Baseline Visit|Overall Study||9|The second study visit was a pre-randomization assessment while sodium loaded (Baseline)|
48522133|NCT01635062|101611737|FG001|Sodium Loading Baseline Visit|Overall Study||9|The second study visit was a pre-randomization assessment while sodium loaded (Baseline)|
48522134|NCT01635062|101611736|FG000|Post-randomization Sodium Restriction|Overall Study||9|This visit was an assessment while sodium restricted and following 3 weeks of study medication|
48522135|NCT01635062|101611737|FG001|Post-randomization Sodium Restriction|Overall Study||9|This visit was an assessment while sodium restricted and following 3 weeks of study medication|
48522136|NCT01635062|101611736|FG000|Post-Randomization Sodium Loaded|Overall Study||9|This visit was an assessment while sodium loaded and following 3 weeks of study medication|
48522137|NCT01635062|101611737|FG001|Post-Randomization Sodium Loaded|Overall Study||9|This visit was an assessment while sodium loaded and following 3 weeks of study medication|
48522138|NCT01635062|101611736|FG000|COMPLETED|Overall Study||9||
48522139|NCT01635062|101611737|FG001|COMPLETED|Overall Study||9||
48522140|NCT01635062|101611736|FG000|NOT COMPLETED|Overall Study||0||
48522141|NCT01635062|101611737|FG001|NOT COMPLETED|Overall Study||0||
48522142|NCT02443545|101611738|FG000|STARTED|Overall Study||89||
48522143|NCT02443545|101611739|FG001|STARTED|Overall Study||45||
48522144|NCT02443545|101611738|FG000|COMPLETED|Overall Study||50||
48522145|NCT02443545|101611739|FG001|COMPLETED|Overall Study||26||
48522146|NCT02443545|101611738|FG000|NOT COMPLETED|Overall Study||39||
48522147|NCT02443545|101611739|FG001|NOT COMPLETED|Overall Study||19||
48522148|NCT03394755|101611740|FG000|STARTED|Overall Study||8||
48522149|NCT03394755|101611741|FG001|STARTED|Overall Study||8||
48522150|NCT03394755|101611742|FG002|STARTED|Overall Study||8||
48522151|NCT03394755|101611740|FG000|COMPLETED|Overall Study||8||
48522152|NCT03394755|101611741|FG001|COMPLETED|Overall Study||8||
48522153|NCT03394755|101611742|FG002|COMPLETED|Overall Study||8||
48522154|NCT03394755|101611740|FG000|NOT COMPLETED|Overall Study||0||
48522155|NCT03394755|101611741|FG001|NOT COMPLETED|Overall Study||0||
48522156|NCT03394755|101611742|FG002|NOT COMPLETED|Overall Study||0||
48522157|NCT04943159|101611743|FG000|STARTED|Overall Study||3||
48522158|NCT04943159|101611743|FG000|COMPLETED|Overall Study||3||
48522159|NCT04943159|101611743|FG000|NOT COMPLETED|Overall Study||0||
48522160|NCT02133001|101611744|FG000|STARTED|Double Blind (Day 1-25)||32||
48522161|NCT02133001|101611745|FG001|STARTED|Double Blind (Day 1-25)||36||
48522162|NCT02133001|101611744|FG000|Safety|Double Blind (Day 1-25)||31||
48522163|NCT02133001|101611745|FG001|Safety|Double Blind (Day 1-25)||35||
48522164|NCT02133001|101611744|FG000|COMPLETED|Double Blind (Day 1-25)||22||
48522165|NCT02133001|101611745|FG001|COMPLETED|Double Blind (Day 1-25)||27||
48522166|NCT02133001|101611744|FG000|NOT COMPLETED|Double Blind (Day 1-25)||10||
48522167|NCT02133001|101611745|FG001|NOT COMPLETED|Double Blind (Day 1-25)||9||
48522168|NCT02133001|101611744|FG000|STARTED|Follow-Up Phase (Day 26-81)||22||
48522169|NCT02133001|101611745|FG001|STARTED|Follow-Up Phase (Day 26-81)||27||
48522170|NCT02133001|101611744|FG000|COMPLETED|Follow-Up Phase (Day 26-81)||20||
48522171|NCT02133001|101611745|FG001|COMPLETED|Follow-Up Phase (Day 26-81)||24||
48522172|NCT02133001|101611744|FG000|NOT COMPLETED|Follow-Up Phase (Day 26-81)||2||
48522173|NCT02133001|101611745|FG001|NOT COMPLETED|Follow-Up Phase (Day 26-81)||3||
48522174|NCT05016622|101611746|FG000|STARTED|1st Booster: 4 Week Follow up Visit||106||
48522175|NCT05016622|101611746|FG000|COMPLETED|1st Booster: 4 Week Follow up Visit||106||
48522176|NCT05016622|101611746|FG000|NOT COMPLETED|1st Booster: 4 Week Follow up Visit||0||
48522177|NCT05016622|101611746|FG000|STARTED|1st Booster: 4-6 Month Follow up Visit||106||
48522178|NCT05016622|101611746|FG000|COMPLETED|1st Booster: 4-6 Month Follow up Visit||47||
48522179|NCT05016622|101611746|FG000|NOT COMPLETED|1st Booster: 4-6 Month Follow up Visit||59||
48522180|NCT05016622|101611746|FG000|STARTED|2nd Booster: 4 Week Follow up Visit||20|Twenty participants received a second booster dose but only 18 were enrolled. As demonstrated in the table, two patients who had received the second booster dose declined to participate.|
48522181|NCT05016622|101611746|FG000|COMPLETED|2nd Booster: 4 Week Follow up Visit||18||
48522182|NCT05016622|101611746|FG000|NOT COMPLETED|2nd Booster: 4 Week Follow up Visit||2||
48522183|NCT05016622|101611746|FG000|STARTED|2nd Booster: 4-6 Month Follow up Visit||18||
48592619|NCT01877382|101783151|FG001|STARTED|Dose Escalation||1||
48592620|NCT01877382|101783152|FG002|STARTED|Dose Escalation||1||
48522184|NCT05016622|101611746|FG000|COMPLETED|2nd Booster: 4-6 Month Follow up Visit||0|Due to lack of patient participation and lack of funding the study was terminated prior to any Cohort 2 patients having reached the 4-6 month collection timepoint|
48522185|NCT05016622|101611746|FG000|NOT COMPLETED|2nd Booster: 4-6 Month Follow up Visit||18||
48522186|NCT02972502|101611747|FG000|STARTED|Overall Study||35||
48522187|NCT02972502|101611748|FG001|STARTED|Overall Study||31||
48522188|NCT02972502|101611747|FG000|COMPLETED|Overall Study||31||
48522189|NCT02972502|101611748|FG001|COMPLETED|Overall Study||29||
48522190|NCT02972502|101611747|FG000|NOT COMPLETED|Overall Study||4||
48522191|NCT02972502|101611748|FG001|NOT COMPLETED|Overall Study||2||
48522192|NCT02416011|101611749|FG000|STARTED|Overall Study||575||
48522193|NCT02416011|101611750|FG001|STARTED|Overall Study||1154||
48522194|NCT02416011|101611751|FG002|STARTED|Overall Study||1167||
48522195|NCT02416011|101611749|FG000|COMPLETED|Overall Study||561||
48522196|NCT02416011|101611750|FG001|COMPLETED|Overall Study||1101||
48522197|NCT02416011|101611751|FG002|COMPLETED|Overall Study||1114||
48522198|NCT02416011|101611749|FG000|NOT COMPLETED|Overall Study||14||
48522199|NCT02416011|101611750|FG001|NOT COMPLETED|Overall Study||53||
48522200|NCT02416011|101611751|FG002|NOT COMPLETED|Overall Study||53||
48522201|NCT02919826|101611752|FG000|STARTED|Overall Study||10||
48522202|NCT02919826|101611753|FG001|STARTED|Overall Study||10||
48522203|NCT02919826|101611752|FG000|COMPLETED|Overall Study||10||
48522204|NCT02919826|101611753|FG001|COMPLETED|Overall Study||8||
48522205|NCT02919826|101611752|FG000|NOT COMPLETED|Overall Study||0||
48522206|NCT02919826|101611753|FG001|NOT COMPLETED|Overall Study||2||
48522207|NCT01588236|101611754|FG000|STARTED|Overall Study||92||
48522208|NCT01588236|101611755|FG001|STARTED|Overall Study||94||
48522209|NCT01588236|101611756|FG002|STARTED|Overall Study||94||
48522210|NCT01588236|101611754|FG000|COMPLETED|Overall Study||76||
48522211|NCT01588236|101611755|FG001|COMPLETED|Overall Study||66||
48522212|NCT01588236|101611756|FG002|COMPLETED|Overall Study||69||
48522213|NCT01588236|101611754|FG000|NOT COMPLETED|Overall Study||16||
48522214|NCT01588236|101611755|FG001|NOT COMPLETED|Overall Study||28||
48522215|NCT01588236|101611756|FG002|NOT COMPLETED|Overall Study||25||
48522216|NCT00594646|101611757|FG000|STARTED|Overall Study||100||
48522217|NCT00594646|101611757|FG000|COMPLETED|Overall Study||84||
48522218|NCT00594646|101611757|FG000|NOT COMPLETED|Overall Study||16||
48522219|NCT00572117|101611758|FG000|STARTED|Overall Study||5||
48522220|NCT00572117|101611759|FG001|STARTED|Overall Study||7||
48522221|NCT00572117|101611758|FG000|COMPLETED|Overall Study||3||
48522222|NCT00572117|101611759|FG001|COMPLETED|Overall Study||5||
48522223|NCT00572117|101611758|FG000|NOT COMPLETED|Overall Study||2||
48522224|NCT00572117|101611759|FG001|NOT COMPLETED|Overall Study||2||
48522225|NCT00679913|101611760|FG000|STARTED|Overall Study||101||
48522226|NCT00679913|101611761|FG001|STARTED|Overall Study||99||
48522227|NCT00679913|101611760|FG000|COMPLETED|Overall Study||83||
48522228|NCT00679913|101611761|FG001|COMPLETED|Overall Study||86||
48522229|NCT00679913|101611760|FG000|NOT COMPLETED|Overall Study||18||
48522230|NCT00679913|101611761|FG001|NOT COMPLETED|Overall Study||13||
48522231|NCT01568866|101611762|FG000|STARTED|Overall Study||465||
48522232|NCT01568866|101611763|FG001|STARTED|Overall Study||464||
48522233|NCT01568866|101611762|FG000|Received Treatment|Overall Study||456||
48522234|NCT01568866|101611763|FG001|Received Treatment|Overall Study||463||
48522235|NCT01568866|101611762|FG000|COMPLETED|Overall Study||27||
48522236|NCT01568866|101611763|FG001|COMPLETED|Overall Study||48||
48522237|NCT01568866|101611762|FG000|NOT COMPLETED|Overall Study||438||
48522238|NCT01568866|101611763|FG001|NOT COMPLETED|Overall Study||416||
48522239|NCT03476343|101611764|FG000|STARTED|Overall Study||386||
48522240|NCT03476343|101611764|FG000|COMPLETED|Overall Study||374||
48522241|NCT03476343|101611764|FG000|NOT COMPLETED|Overall Study||12||
48522242|NCT01421342|101611765|FG000|STARTED|Acute Treatment Phase (12 Weeks)||511||
48522243|NCT01421342|101611766|FG001|STARTED|Acute Treatment Phase (12 Weeks)||506||
48522244|NCT01421342|101611767|FG002|STARTED|Acute Treatment Phase (12 Weeks)||505||
48522245|NCT01421342|101611765|FG000|COMPLETED|Acute Treatment Phase (12 Weeks)||353||
48522246|NCT01421342|101611766|FG001|COMPLETED|Acute Treatment Phase (12 Weeks)||378||
48522247|NCT01421342|101611767|FG002|COMPLETED|Acute Treatment Phase (12 Weeks)||406||
48522248|NCT01421342|101611765|FG000|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||158||
48522249|NCT01421342|101611766|FG001|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||128||
48522250|NCT01421342|101611767|FG002|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||99||
48522251|NCT01421342|101611765|FG000|STARTED|Completed to Week 12 But Then Withdrawn||353||
48522252|NCT01421342|101611766|FG001|STARTED|Completed to Week 12 But Then Withdrawn||378||
48522253|NCT01421342|101611767|FG002|STARTED|Completed to Week 12 But Then Withdrawn||406||
48522254|NCT01421342|101611765|FG000|COMPLETED|Completed to Week 12 But Then Withdrawn||204||
48522255|NCT01421342|101611766|FG001|COMPLETED|Completed to Week 12 But Then Withdrawn||253||
48522256|NCT01421342|101611767|FG002|COMPLETED|Completed to Week 12 But Then Withdrawn||268||
48522257|NCT01421342|101611765|FG000|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||149||
48522258|NCT01421342|101611766|FG001|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||125||
48522259|NCT01421342|101611767|FG002|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||138||
48522260|NCT01421342|101611765|FG000|STARTED|Continuation of Treatment (Week 12 - 36)||204||
48522261|NCT01421342|101611766|FG001|STARTED|Continuation of Treatment (Week 12 - 36)||253||
48522262|NCT01421342|101611767|FG002|STARTED|Continuation of Treatment (Week 12 - 36)||268||
48522263|NCT01421342|101611765|FG000|COMPLETED|Continuation of Treatment (Week 12 - 36)||152||
48522264|NCT01421342|101611766|FG001|COMPLETED|Continuation of Treatment (Week 12 - 36)||194||
48522265|NCT01421342|101611767|FG002|COMPLETED|Continuation of Treatment (Week 12 - 36)||203||
48522266|NCT01421342|101611765|FG000|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||52||
48522267|NCT01421342|101611766|FG001|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||59||
48522268|NCT01421342|101611767|FG002|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||65||
48522269|NCT02780167|101611768|FG000|STARTED|Overall Study||56||
48522270|NCT02780167|101611769|FG001|STARTED|Overall Study||49||
48522271|NCT02780167|101611770|FG002|STARTED|Overall Study||51||
48522272|NCT02780167|101611771|FG003|STARTED|Overall Study||56||
48522273|NCT02780167|101611772|FG004|STARTED|Overall Study||55||
48522274|NCT02780167|101611768|FG000|COMPLETED|Overall Study||28||
48522275|NCT02780167|101611769|FG001|COMPLETED|Overall Study||27||
48522276|NCT02780167|101611770|FG002|COMPLETED|Overall Study||27||
48522277|NCT02780167|101611771|FG003|COMPLETED|Overall Study||37||
48522278|NCT02780167|101611772|FG004|COMPLETED|Overall Study||38||
48522279|NCT02780167|101611768|FG000|NOT COMPLETED|Overall Study||28||
48522280|NCT02780167|101611769|FG001|NOT COMPLETED|Overall Study||22||
48522281|NCT02780167|101611770|FG002|NOT COMPLETED|Overall Study||24||
48522282|NCT02780167|101611771|FG003|NOT COMPLETED|Overall Study||19||
48522283|NCT02780167|101611772|FG004|NOT COMPLETED|Overall Study||17||
48522284|NCT00703508|101611773|FG000|STARTED|Overall Study||26||
48522285|NCT00703508|101611773|FG000|COMPLETED|Overall Study||26||
48522286|NCT00703508|101611773|FG000|NOT COMPLETED|Overall Study||0||
48522287|NCT03197558|101611774|FG000|STARTED|Overall Study||30||
48522288|NCT03197558|101611774|FG000|COMPLETED|Overall Study||29|Participants undergoing iontophoresis with adequate anesthesia for tube placement.|
48522289|NCT03197558|101611774|FG000|NOT COMPLETED|Overall Study||1||
48522290|NCT02072824|101611775|FG000|STARTED|Overall Study||71||
48522291|NCT02072824|101611776|FG001|STARTED|Overall Study||34||
48522292|NCT02072824|101611777|FG002|STARTED|Overall Study||70||
48522293|NCT02072824|101611775|FG000|COMPLETED|Overall Study||69||
48522294|NCT02072824|101611776|FG001|COMPLETED|Overall Study||33||
48522295|NCT02072824|101611777|FG002|COMPLETED|Overall Study||67||
48522296|NCT02072824|101611775|FG000|NOT COMPLETED|Overall Study||2||
48522297|NCT02072824|101611776|FG001|NOT COMPLETED|Overall Study||1||
48522298|NCT02072824|101611777|FG002|NOT COMPLETED|Overall Study||3||
48522299|NCT02596321|101611778|FG000|STARTED|Overall Study||56||
48522300|NCT02596321|101611779|FG001|STARTED|Overall Study||56||
48522301|NCT02596321|101611778|FG000|COMPLETED|Overall Study||53||
48522302|NCT02596321|101611779|FG001|COMPLETED|Overall Study||56||
48522303|NCT02596321|101611778|FG000|NOT COMPLETED|Overall Study||3||
48522304|NCT02596321|101611779|FG001|NOT COMPLETED|Overall Study||0||
48522305|NCT01641133|101611780|FG000|STARTED|Overall Study||97||
48522306|NCT01641133|101611781|FG001|STARTED|Overall Study||99||
48522307|NCT01641133|101611782|FG002|STARTED|Overall Study||98||
48522308|NCT01641133|101611780|FG000|COMPLETED|Overall Study||87||
48522309|NCT01641133|101611781|FG001|COMPLETED|Overall Study||90||
48522310|NCT01641133|101611782|FG002|COMPLETED|Overall Study||90||
48522311|NCT01641133|101611780|FG000|NOT COMPLETED|Overall Study||10||
48522312|NCT01641133|101611781|FG001|NOT COMPLETED|Overall Study||9||
48522313|NCT01641133|101611782|FG002|NOT COMPLETED|Overall Study||8||
48522314|NCT03399318|101611783|FG000|STARTED|Overall Study||128||
48522315|NCT03399318|101611784|FG001|STARTED|Overall Study||128||
48522316|NCT03399318|101611783|FG000|COMPLETED|Overall Study||128||
48522317|NCT03399318|101611784|FG001|COMPLETED|Overall Study||128||
48522318|NCT03399318|101611783|FG000|NOT COMPLETED|Overall Study||0||
48522319|NCT03399318|101611784|FG001|NOT COMPLETED|Overall Study||0||
48522320|NCT00925301|101611785|FG000|STARTED|6-Month Double-blind (Stage 1)||34||
48522321|NCT00925301|101611786|FG001|STARTED|6-Month Double-blind (Stage 1)||33||
48522322|NCT00925301|101611787|FG002|STARTED|6-Month Double-blind (Stage 1)||0||
48522323|NCT00925301|101611788|FG003|STARTED|6-Month Double-blind (Stage 1)||0||
48522324|NCT00925301|101611785|FG000|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||34||
48522325|NCT00925301|101611786|FG001|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||33||
48522326|NCT00925301|101611787|FG002|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||0||
48522327|NCT00925301|101611788|FG003|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||0||
48522328|NCT00925301|101611785|FG000|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||34|All randomized participants regardless of their participation in the study beyond Randomization.|
48522329|NCT00925301|101611786|FG001|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||33|All randomized participants regardless of their participation in the study beyond Randomization.|
48522330|NCT00925301|101611787|FG002|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||0|All randomized participants regardless of their participation in the study beyond Randomization.|
48522331|NCT00925301|101611788|FG003|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||0|All randomized participants regardless of their participation in the study beyond Randomization.|
48522332|NCT00925301|101611785|FG000|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||30|Participants with Baseline and Month 6 biopsy results.|
48522333|NCT00925301|101611786|FG001|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||30|Participants with Baseline and Month 6 biopsy results.|
48522334|NCT00925301|101611787|FG002|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||0|Participants with Baseline and Month 6 biopsy results.|
48522335|NCT00925301|101611788|FG003|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||0|Participants with Baseline and Month 6 biopsy results.|
48522336|NCT00925301|101611785|FG000|COMPLETED|6-Month Double-blind (Stage 1)||34||
48522337|NCT00925301|101611786|FG001|COMPLETED|6-Month Double-blind (Stage 1)||30||
48522338|NCT00925301|101611787|FG002|COMPLETED|6-Month Double-blind (Stage 1)||0||
48522339|NCT00925301|101611788|FG003|COMPLETED|6-Month Double-blind (Stage 1)||0||
48522340|NCT00925301|101611785|FG000|NOT COMPLETED|6-Month Double-blind (Stage 1)||0||
48522341|NCT00925301|101611786|FG001|NOT COMPLETED|6-Month Double-blind (Stage 1)||3||
48522342|NCT00925301|101611787|FG002|NOT COMPLETED|6-Month Double-blind (Stage 1)||0||
48522343|NCT00925301|101611788|FG003|NOT COMPLETED|6-Month Double-blind (Stage 1)||0||
48522344|NCT00925301|101611785|FG000|STARTED|6-Month Open-label (Stage 2)||0||
48522345|NCT00925301|101611786|FG001|STARTED|6-Month Open-label (Stage 2)||0||
48522346|NCT00925301|101611787|FG002|STARTED|6-Month Open-label (Stage 2)||63||
48522347|NCT00925301|101611788|FG003|STARTED|6-Month Open-label (Stage 2)||0||
48522348|NCT00925301|101611785|FG000|ITT-amenable|6-Month Open-label (Stage 2)||0|Amenable mutations based on Good Laboratory Practice (GLP) Human Embryonic Kidney (HEK) assay.|
48522349|NCT00925301|101611786|FG001|ITT-amenable|6-Month Open-label (Stage 2)||0|Amenable mutations based on Good Laboratory Practice (GLP) Human Embryonic Kidney (HEK) assay.|
48522350|NCT00925301|101611787|FG002|ITT-amenable|6-Month Open-label (Stage 2)||47|Amenable mutations based on Good Laboratory Practice (GLP) Human Embryonic Kidney (HEK) assay.|
48522351|NCT00925301|101611788|FG003|ITT-amenable|6-Month Open-label (Stage 2)||0|Amenable mutations based on Good Laboratory Practice (GLP) Human Embryonic Kidney (HEK) assay.|
48522352|NCT00925301|101611785|FG000|COMPLETED|6-Month Open-label (Stage 2)||0||
48522353|NCT00925301|101611786|FG001|COMPLETED|6-Month Open-label (Stage 2)||0||
48522354|NCT00925301|101611787|FG002|COMPLETED|6-Month Open-label (Stage 2)||60||
48522355|NCT00925301|101611788|FG003|COMPLETED|6-Month Open-label (Stage 2)||0||
48522356|NCT00925301|101611785|FG000|NOT COMPLETED|6-Month Open-label (Stage 2)||0||
48522357|NCT00925301|101611786|FG001|NOT COMPLETED|6-Month Open-label (Stage 2)||0||
48522358|NCT00925301|101611787|FG002|NOT COMPLETED|6-Month Open-label (Stage 2)||3||
48522359|NCT00925301|101611788|FG003|NOT COMPLETED|6-Month Open-label (Stage 2)||0||
48522360|NCT00925301|101611785|FG000|STARTED|12-Month Open-label Extension (Optional)||0||
48522361|NCT00925301|101611786|FG001|STARTED|12-Month Open-label Extension (Optional)||0||
48522362|NCT00925301|101611787|FG002|STARTED|12-Month Open-label Extension (Optional)||0||
48522363|NCT00925301|101611788|FG003|STARTED|12-Month Open-label Extension (Optional)||57||
48522364|NCT00925301|101611785|FG000|ITT-amenable|12-Month Open-label Extension (Optional)||0|Amenable mutations based on GLP HEK assay.|
48522365|NCT00925301|101611786|FG001|ITT-amenable|12-Month Open-label Extension (Optional)||0|Amenable mutations based on GLP HEK assay.|
48522366|NCT00925301|101611787|FG002|ITT-amenable|12-Month Open-label Extension (Optional)||0|Amenable mutations based on GLP HEK assay.|
48522367|NCT00925301|101611788|FG003|ITT-amenable|12-Month Open-label Extension (Optional)||42|Amenable mutations based on GLP HEK assay.|
48522368|NCT00925301|101611785|FG000|COMPLETED|12-Month Open-label Extension (Optional)||0||
48522369|NCT00925301|101611786|FG001|COMPLETED|12-Month Open-label Extension (Optional)||0||
48522370|NCT00925301|101611787|FG002|COMPLETED|12-Month Open-label Extension (Optional)||0||
48522371|NCT00925301|101611788|FG003|COMPLETED|12-Month Open-label Extension (Optional)||54||
48522372|NCT00925301|101611785|FG000|NOT COMPLETED|12-Month Open-label Extension (Optional)||0||
48522373|NCT00925301|101611786|FG001|NOT COMPLETED|12-Month Open-label Extension (Optional)||0||
48522374|NCT00925301|101611787|FG002|NOT COMPLETED|12-Month Open-label Extension (Optional)||0||
48522375|NCT00925301|101611788|FG003|NOT COMPLETED|12-Month Open-label Extension (Optional)||3||
48522376|NCT01227655|101611789|FG000|STARTED|Overall Study||129||
48522377|NCT01227655|101611790|FG001|STARTED|Overall Study||154||
48522378|NCT01227655|101611791|FG002|STARTED|Overall Study||144||
48522379|NCT01227655|101611789|FG000|Safety Set|Overall Study||125||
48522380|NCT01227655|101611790|FG001|Safety Set|Overall Study||150||
48522381|NCT01227655|101611791|FG002|Safety Set|Overall Study||136||
48522382|NCT01227655|101611789|FG000|Full Analysis Set|Overall Study||125||
48522383|NCT01227655|101611790|FG001|Full Analysis Set|Overall Study||147||
48522384|NCT01227655|101611791|FG002|Full Analysis Set|Overall Study||135||
48522385|NCT01227655|101611789|FG000|COMPLETED|Overall Study||118||
48522386|NCT01227655|101611790|FG001|COMPLETED|Overall Study||128||
48522387|NCT01227655|101611791|FG002|COMPLETED|Overall Study||130||
48522388|NCT01227655|101611789|FG000|NOT COMPLETED|Overall Study||11||
48522389|NCT01227655|101611790|FG001|NOT COMPLETED|Overall Study||26||
48522390|NCT01227655|101611791|FG002|NOT COMPLETED|Overall Study||14||
48522391|NCT01370213|101611792|FG000|STARTED|Overall Study||7||
48522392|NCT01370213|101611793|FG001|STARTED|Overall Study||17||
48522393|NCT01370213|101611794|FG002|STARTED|Overall Study||1||
48522394|NCT01370213|101611792|FG000|COMPLETED|Overall Study||6||
48522395|NCT01370213|101611793|FG001|COMPLETED|Overall Study||15||
48522396|NCT01370213|101611794|FG002|COMPLETED|Overall Study||1||
48522397|NCT01370213|101611792|FG000|NOT COMPLETED|Overall Study||1||
48522398|NCT01370213|101611793|FG001|NOT COMPLETED|Overall Study||2||
48522399|NCT01370213|101611794|FG002|NOT COMPLETED|Overall Study||0||
48522400|NCT00586482|101611795|FG000|STARTED|Overall Study||22||
48522401|NCT00586482|101611796|FG001|STARTED|Overall Study||24||
48522402|NCT00586482|101611795|FG000|COMPLETED|Overall Study||22||
48522403|NCT00586482|101611796|FG001|COMPLETED|Overall Study||24||
48522404|NCT00586482|101611795|FG000|NOT COMPLETED|Overall Study||0||
48522405|NCT00586482|101611796|FG001|NOT COMPLETED|Overall Study||0||
48522406|NCT00355472|101611797|FG000|STARTED|Overall Study||16||
48522407|NCT00355472|101611797|FG000|COMPLETED|Overall Study||15||
48522408|NCT00355472|101611797|FG000|NOT COMPLETED|Overall Study||1||
48522409|NCT03545191|101611798|FG000|STARTED|Overall Study||310||
48522410|NCT03545191|101611799|FG001|STARTED|Overall Study||310||
48522411|NCT03545191|101611800|FG002|STARTED|Overall Study||310||
48522412|NCT03545191|101611798|FG000|COMPLETED|Overall Study||288||
48522413|NCT03545191|101611799|FG001|COMPLETED|Overall Study||285||
48522414|NCT03545191|101611800|FG002|COMPLETED|Overall Study||280||
48522415|NCT03545191|101611798|FG000|NOT COMPLETED|Overall Study||22||
48522416|NCT03545191|101611799|FG001|NOT COMPLETED|Overall Study||25||
48522417|NCT03545191|101611800|FG002|NOT COMPLETED|Overall Study||30||
48522418|NCT00594620|101611801|FG000|STARTED|Overall Study||0||
48522419|NCT00594620|101611802|FG001|STARTED|Overall Study||0||
48522420|NCT00594620|101611801|FG000|COMPLETED|Overall Study||0||
48522421|NCT00594620|101611802|FG001|COMPLETED|Overall Study||0||
48522422|NCT00594620|101611801|FG000|NOT COMPLETED|Overall Study||0||
48522423|NCT00594620|101611802|FG001|NOT COMPLETED|Overall Study||0||
48522424|NCT00912093|101611803|FG000|STARTED|The Controlled Phase||43||
48522425|NCT00912093|101611804|FG001|STARTED|The Controlled Phase||45||
48522426|NCT00912093|101611805|FG002|STARTED|The Controlled Phase||3||
48522427|NCT00912093|101611806|FG003|STARTED|The Controlled Phase||2||
48522428|NCT00912093|101611807|FG004|STARTED|The Controlled Phase||5||
48522429|NCT00912093|101611803|FG000|COMPLETED|The Controlled Phase||43||
48522430|NCT00912093|101611804|FG001|COMPLETED|The Controlled Phase||43||
48522431|NCT00912093|101611805|FG002|COMPLETED|The Controlled Phase||3||
48522432|NCT00912093|101611806|FG003|COMPLETED|The Controlled Phase||2||
48522433|NCT00912093|101611807|FG004|COMPLETED|The Controlled Phase||4||
48522434|NCT00912093|101611803|FG000|NOT COMPLETED|The Controlled Phase||0||
48522435|NCT00912093|101611804|FG001|NOT COMPLETED|The Controlled Phase||2||
48522436|NCT00912093|101611805|FG002|NOT COMPLETED|The Controlled Phase||0||
48522437|NCT00912093|101611806|FG003|NOT COMPLETED|The Controlled Phase||0||
48522438|NCT00912093|101611807|FG004|NOT COMPLETED|The Controlled Phase||1||
48522439|NCT00912093|101611803|FG000|STARTED|The Open Label Extension (OLE) Phase||38||
48522440|NCT00912093|101611804|FG001|STARTED|The Open Label Extension (OLE) Phase||35||
48522441|NCT00912093|101611805|FG002|STARTED|The Open Label Extension (OLE) Phase||3||
48522442|NCT00912093|101611806|FG003|STARTED|The Open Label Extension (OLE) Phase||2||
48522443|NCT00912093|101611807|FG004|STARTED|The Open Label Extension (OLE) Phase||4||
48522444|NCT00912093|101611803|FG000|COMPLETED|The Open Label Extension (OLE) Phase||38||
48522445|NCT00912093|101611804|FG001|COMPLETED|The Open Label Extension (OLE) Phase||35||
48522446|NCT00912093|101611805|FG002|COMPLETED|The Open Label Extension (OLE) Phase||3||
48522447|NCT00912093|101611806|FG003|COMPLETED|The Open Label Extension (OLE) Phase||2||
48522448|NCT00912093|101611807|FG004|COMPLETED|The Open Label Extension (OLE) Phase||4||
48522449|NCT00912093|101611803|FG000|NOT COMPLETED|The Open Label Extension (OLE) Phase||0||
48522450|NCT00912093|101611804|FG001|NOT COMPLETED|The Open Label Extension (OLE) Phase||0||
48522451|NCT00912093|101611805|FG002|NOT COMPLETED|The Open Label Extension (OLE) Phase||0||
48522452|NCT00912093|101611806|FG003|NOT COMPLETED|The Open Label Extension (OLE) Phase||0||
48522453|NCT00912093|101611807|FG004|NOT COMPLETED|The Open Label Extension (OLE) Phase||0||
48522454|NCT00059787|101611808|FG000|STARTED|Overall Study||56||
48522455|NCT00059787|101611808|FG000|COMPLETED|Overall Study||36||
48522456|NCT00059787|101611808|FG000|NOT COMPLETED|Overall Study||20||
48522457|NCT03656874|101611809|FG000|STARTED|Overall Study||13|Patient Participants|4
48522458|NCT03656874|101611810|FG001|STARTED|Overall Study||43|Patient Participants|6
48522459|NCT03656874|101611809|FG000|COMPLETED|Overall Study||10|Patient participants|2
48522460|NCT03656874|101611810|FG001|COMPLETED|Overall Study||26|Patient participants|5
48522461|NCT03656874|101611809|FG000|NOT COMPLETED|Overall Study||3||2
48522462|NCT03656874|101611810|FG001|NOT COMPLETED|Overall Study||17||1
48522463|NCT02407171|101611811|FG000|STARTED|Phase 1 Dose Escalation||10||
48522464|NCT02407171|101611812|FG001|STARTED|Phase 1 Dose Escalation||3||
48522465|NCT02407171|101611813|FG002|STARTED|Phase 1 Dose Escalation||5||
48522466|NCT02407171|101611814|FG003|STARTED|Phase 1 Dose Escalation||6||
48522467|NCT02407171|101611815|FG004|STARTED|Phase 1 Dose Escalation||0||
48522468|NCT02407171|101611816|FG005|STARTED|Phase 1 Dose Escalation||0||
48522469|NCT02407171|101611811|FG000|Dose Escalation 30 GY3|Phase 1 Dose Escalation||3||
48522470|NCT02407171|101611812|FG001|Dose Escalation 30 GY3|Phase 1 Dose Escalation||3||
48522471|NCT02407171|101611813|FG002|Dose Escalation 30 GY3|Phase 1 Dose Escalation||4||
48522472|NCT02407171|101611814|FG003|Dose Escalation 30 GY3|Phase 1 Dose Escalation||3||
48522473|NCT02407171|101611815|FG004|Dose Escalation 30 GY3|Phase 1 Dose Escalation||0||
48522474|NCT02407171|101611816|FG005|Dose Escalation 30 GY3|Phase 1 Dose Escalation||0||
48522475|NCT02407171|101611811|FG000|Dose Escalation 30 GY5|Phase 1 Dose Escalation||7||
48522476|NCT02407171|101611812|FG001|Dose Escalation 30 GY5|Phase 1 Dose Escalation||0||
48522477|NCT02407171|101611813|FG002|Dose Escalation 30 GY5|Phase 1 Dose Escalation||1||
48522478|NCT02407171|101611814|FG003|Dose Escalation 30 GY5|Phase 1 Dose Escalation||3||
48522479|NCT02407171|101611815|FG004|Dose Escalation 30 GY5|Phase 1 Dose Escalation||0||
48592621|NCT01877382|101783153|FG003|STARTED|Dose Escalation||13||
48522480|NCT02407171|101611816|FG005|Dose Escalation 30 GY5|Phase 1 Dose Escalation||0||
48522481|NCT02407171|101611811|FG000|COMPLETED|Phase 1 Dose Escalation||10||
48522482|NCT02407171|101611812|FG001|COMPLETED|Phase 1 Dose Escalation||3||
48522483|NCT02407171|101611813|FG002|COMPLETED|Phase 1 Dose Escalation||5||
48522484|NCT02407171|101611814|FG003|COMPLETED|Phase 1 Dose Escalation||6||
48522485|NCT02407171|101611815|FG004|COMPLETED|Phase 1 Dose Escalation||0||
48522486|NCT02407171|101611816|FG005|COMPLETED|Phase 1 Dose Escalation||0||
48522487|NCT02407171|101611811|FG000|NOT COMPLETED|Phase 1 Dose Escalation||0||
48522488|NCT02407171|101611812|FG001|NOT COMPLETED|Phase 1 Dose Escalation||0||
48522489|NCT02407171|101611813|FG002|NOT COMPLETED|Phase 1 Dose Escalation||0||
48522490|NCT02407171|101611814|FG003|NOT COMPLETED|Phase 1 Dose Escalation||0||
48522491|NCT02407171|101611815|FG004|NOT COMPLETED|Phase 1 Dose Escalation||0||
48522492|NCT02407171|101611816|FG005|NOT COMPLETED|Phase 1 Dose Escalation||0||
48522493|NCT02407171|101611811|FG000|STARTED|Phase 2 Treatment||10||
48522494|NCT02407171|101611812|FG001|STARTED|Phase 2 Treatment||3||
48522495|NCT02407171|101611813|FG002|STARTED|Phase 2 Treatment||5||
48522496|NCT02407171|101611814|FG003|STARTED|Phase 2 Treatment||6||
48522497|NCT02407171|101611815|FG004|STARTED|Phase 2 Treatment||35||
48522498|NCT02407171|101611816|FG005|STARTED|Phase 2 Treatment||2||
48522499|NCT02407171|101611811|FG000|Received SBRT|Phase 2 Treatment||10||
48522500|NCT02407171|101611812|FG001|Received SBRT|Phase 2 Treatment||3||
48522501|NCT02407171|101611813|FG002|Received SBRT|Phase 2 Treatment||5||
48522502|NCT02407171|101611814|FG003|Received SBRT|Phase 2 Treatment||6||
48522503|NCT02407171|101611815|FG004|Received SBRT|Phase 2 Treatment||0||
48522504|NCT02407171|101611816|FG005|Received SBRT|Phase 2 Treatment||2||
48522505|NCT02407171|101611811|FG000|COMPLETED|Phase 2 Treatment||10||
48522506|NCT02407171|101611812|FG001|COMPLETED|Phase 2 Treatment||3||
48522507|NCT02407171|101611813|FG002|COMPLETED|Phase 2 Treatment||5||
48522508|NCT02407171|101611814|FG003|COMPLETED|Phase 2 Treatment||6||
48522509|NCT02407171|101611815|FG004|COMPLETED|Phase 2 Treatment||35||
48522510|NCT02407171|101611816|FG005|COMPLETED|Phase 2 Treatment||2||
48522511|NCT02407171|101611811|FG000|NOT COMPLETED|Phase 2 Treatment||0||
48522512|NCT02407171|101611812|FG001|NOT COMPLETED|Phase 2 Treatment||0||
48522513|NCT02407171|101611813|FG002|NOT COMPLETED|Phase 2 Treatment||0||
48522514|NCT02407171|101611814|FG003|NOT COMPLETED|Phase 2 Treatment||0||
48522515|NCT02407171|101611815|FG004|NOT COMPLETED|Phase 2 Treatment||0||
48522516|NCT02407171|101611816|FG005|NOT COMPLETED|Phase 2 Treatment||0||
48522517|NCT01795105|101611817|FG000|STARTED|Overall Study||692||
48522518|NCT01795105|101611817|FG000|COMPLETED|Overall Study||648||
48522519|NCT01795105|101611817|FG000|NOT COMPLETED|Overall Study||44||
48522520|NCT03487848|101611818|FG000|STARTED|Overall Study||5||
48522521|NCT03487848|101611818|FG000|COMPLETED|Overall Study||4||
48522522|NCT03487848|101611818|FG000|NOT COMPLETED|Overall Study||1||
48522523|NCT03438227|101611819|FG000|STARTED|Overall Study||20||
48522524|NCT03438227|101611820|FG001|STARTED|Overall Study||18||
48522525|NCT03438227|101611819|FG000|COMPLETED|Overall Study||10||
48522526|NCT03438227|101611820|FG001|COMPLETED|Overall Study||13||
48522527|NCT03438227|101611819|FG000|NOT COMPLETED|Overall Study||10||
48522528|NCT03438227|101611820|FG001|NOT COMPLETED|Overall Study||5||
48522529|NCT01701037|101611821|FG000|STARTED|Overall Study||13||
48522530|NCT01701037|101611821|FG000|COMPLETED|Overall Study||13||
48522531|NCT01701037|101611821|FG000|NOT COMPLETED|Overall Study||0||
48522532|NCT01901874|101611822|FG000|STARTED|Procedure||312||
48522533|NCT01901874|101611822|FG000|COMPLETED|Procedure||312||
48522534|NCT01901874|101611822|FG000|NOT COMPLETED|Procedure||0||
48522535|NCT01901874|101611822|FG000|STARTED|Screening Committee Retrospective Review||312||
48522536|NCT01901874|101611822|FG000|COMPLETED|Screening Committee Retrospective Review||265||
48522537|NCT01901874|101611822|FG000|NOT COMPLETED|Screening Committee Retrospective Review||47||
48522538|NCT01901874|101611822|FG000|STARTED|30-Day MAE Evaluation||265||
48522539|NCT01901874|101611822|FG000|COMPLETED|30-Day MAE Evaluation||264||
48522540|NCT01901874|101611822|FG000|NOT COMPLETED|30-Day MAE Evaluation||1||
48522541|NCT01901874|101611822|FG000|STARTED|1-Year (365-Day) MAE Evaluation||264||
48522542|NCT01901874|101611822|FG000|COMPLETED|1-Year (365-Day) MAE Evaluation||244||
48522543|NCT01901874|101611822|FG000|NOT COMPLETED|1-Year (365-Day) MAE Evaluation||20||
48522544|NCT01194973|101611823|FG000|STARTED|Screening Period||44||
48522545|NCT01194973|101611823|FG000|COMPLETED|Screening Period||41||
48522546|NCT01194973|101611823|FG000|NOT COMPLETED|Screening Period||3||
48522547|NCT01194973|101611823|FG000|STARTED|26 Week Treatment Period||41||
48522548|NCT01194973|101611823|FG000|COMPLETED|26 Week Treatment Period||38||
48522549|NCT01194973|101611823|FG000|NOT COMPLETED|26 Week Treatment Period||3||
48522550|NCT01534637|101611824|FG000|STARTED|Overall Study||22||
48522551|NCT01534637|101611824|FG000|COMPLETED|Overall Study||13||
48522552|NCT01534637|101611824|FG000|NOT COMPLETED|Overall Study||9||
48522553|NCT02100319|101611825|FG000|STARTED|Overall Study||387||
48522554|NCT02100319|101611825|FG000|COMPLETED|Overall Study||371||
48522555|NCT02100319|101611825|FG000|NOT COMPLETED|Overall Study||16||
48522556|NCT00446199|101611826|FG000|STARTED|Overall Study||183||
48522557|NCT00446199|101611827|FG001|STARTED|Overall Study||184||
48522558|NCT00446199|101611828|FG002|STARTED|Overall Study||185||
48522559|NCT00446199|101611829|FG003|STARTED|Overall Study||183||
48522560|NCT00446199|101611826|FG000|Participants Received Treatment|Overall Study||181||
48592622|NCT01877382|101783154|FG004|STARTED|Dose Escalation||2||
48522561|NCT00446199|101611827|FG001|Participants Received Treatment|Overall Study||183||
48522562|NCT00446199|101611828|FG002|Participants Received Treatment|Overall Study||182||
48522563|NCT00446199|101611829|FG003|Participants Received Treatment|Overall Study||180||
48522564|NCT00446199|101611826|FG000|Baseline and Postdose VMS Data Available|Overall Study||178||
48522565|NCT00446199|101611827|FG001|Baseline and Postdose VMS Data Available|Overall Study||177||
48522566|NCT00446199|101611828|FG002|Baseline and Postdose VMS Data Available|Overall Study||179||
48522567|NCT00446199|101611829|FG003|Baseline and Postdose VMS Data Available|Overall Study||176||
48522568|NCT00446199|101611826|FG000|COMPLETED|Overall Study||160||
48522569|NCT00446199|101611827|FG001|COMPLETED|Overall Study||164||
48522570|NCT00446199|101611828|FG002|COMPLETED|Overall Study||158||
48522571|NCT00446199|101611829|FG003|COMPLETED|Overall Study||153||
48522572|NCT00446199|101611826|FG000|NOT COMPLETED|Overall Study||23||
48522573|NCT00446199|101611827|FG001|NOT COMPLETED|Overall Study||20||
48522574|NCT00446199|101611828|FG002|NOT COMPLETED|Overall Study||27||
48522575|NCT00446199|101611829|FG003|NOT COMPLETED|Overall Study||30||
48522576|NCT03227224|101611830|FG000|STARTED|Double-blind Treatment Period (6 Weeks)||138||
48522577|NCT03227224|101611831|FG001|STARTED|Double-blind Treatment Period (6 Weeks)||33||
48522578|NCT03227224|101611832|FG002|STARTED|Double-blind Treatment Period (6 Weeks)||63||
48522579|NCT03227224|101611833|FG003|STARTED|Double-blind Treatment Period (6 Weeks)||53||
48522580|NCT03227224|101611830|FG000|Treated|Double-blind Treatment Period (6 Weeks)||137||
48522581|NCT03227224|101611831|FG001|Treated|Double-blind Treatment Period (6 Weeks)||33||
48522582|NCT03227224|101611832|FG002|Treated|Double-blind Treatment Period (6 Weeks)||61||
48522583|NCT03227224|101611833|FG003|Treated|Double-blind Treatment Period (6 Weeks)||52||
48522584|NCT03227224|101611830|FG000|COMPLETED|Double-blind Treatment Period (6 Weeks)||123||
48522585|NCT03227224|101611831|FG001|COMPLETED|Double-blind Treatment Period (6 Weeks)||27||
48522586|NCT03227224|101611832|FG002|COMPLETED|Double-blind Treatment Period (6 Weeks)||55||
48522587|NCT03227224|101611833|FG003|COMPLETED|Double-blind Treatment Period (6 Weeks)||46||
48522588|NCT03227224|101611830|FG000|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||15||
48522589|NCT03227224|101611831|FG001|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||6||
48522590|NCT03227224|101611832|FG002|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||8||
48522591|NCT03227224|101611833|FG003|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||7||
48522592|NCT03227224|101611830|FG000|STARTED|Follow-up Phase (2 Weeks)||138||
48522593|NCT03227224|101611831|FG001|STARTED|Follow-up Phase (2 Weeks)||33||
48522594|NCT03227224|101611832|FG002|STARTED|Follow-up Phase (2 Weeks)||63||
48522595|NCT03227224|101611833|FG003|STARTED|Follow-up Phase (2 Weeks)||53||
48522596|NCT03227224|101611830|FG000|COMPLETED|Follow-up Phase (2 Weeks)||134||
48522597|NCT03227224|101611831|FG001|COMPLETED|Follow-up Phase (2 Weeks)||29||
48522598|NCT03227224|101611832|FG002|COMPLETED|Follow-up Phase (2 Weeks)||57||
48522599|NCT03227224|101611833|FG003|COMPLETED|Follow-up Phase (2 Weeks)||50||
48522600|NCT03227224|101611830|FG000|NOT COMPLETED|Follow-up Phase (2 Weeks)||4||
48522601|NCT03227224|101611831|FG001|NOT COMPLETED|Follow-up Phase (2 Weeks)||4||
48522602|NCT03227224|101611832|FG002|NOT COMPLETED|Follow-up Phase (2 Weeks)||6||
48522603|NCT03227224|101611833|FG003|NOT COMPLETED|Follow-up Phase (2 Weeks)||3||
48522604|NCT03064438|101611834|FG000|STARTED|Overall Study||27||
48522605|NCT03064438|101611835|FG001|STARTED|Overall Study||13||
48522606|NCT03064438|101611834|FG000|COMPLETED|Overall Study||26||
48522607|NCT03064438|101611835|FG001|COMPLETED|Overall Study||12||
48522608|NCT03064438|101611834|FG000|NOT COMPLETED|Overall Study||1||
48522609|NCT03064438|101611835|FG001|NOT COMPLETED|Overall Study||1||
48522610|NCT01475253|101611836|FG000|STARTED|Randomized, Blinded Study||47||
48522611|NCT01475253|101611837|FG001|STARTED|Randomized, Blinded Study||46||
48522612|NCT01475253|101611838|FG002|STARTED|Randomized, Blinded Study||11||
48522613|NCT01475253|101611839|FG003|STARTED|Randomized, Blinded Study||0||
48522614|NCT01475253|101611836|FG000|COMPLETED|Randomized, Blinded Study||45||
48522615|NCT01475253|101611837|FG001|COMPLETED|Randomized, Blinded Study||45||
48522616|NCT01475253|101611838|FG002|COMPLETED|Randomized, Blinded Study||11||
48522617|NCT01475253|101611839|FG003|COMPLETED|Randomized, Blinded Study||0||
48522618|NCT01475253|101611836|FG000|NOT COMPLETED|Randomized, Blinded Study||2||
48522619|NCT01475253|101611837|FG001|NOT COMPLETED|Randomized, Blinded Study||1||
48522620|NCT01475253|101611838|FG002|NOT COMPLETED|Randomized, Blinded Study||0||
48522621|NCT01475253|101611839|FG003|NOT COMPLETED|Randomized, Blinded Study||0||
48522622|NCT01475253|101611836|FG000|STARTED|Open Label Extension||0||
48522623|NCT01475253|101611837|FG001|STARTED|Open Label Extension||0||
48522624|NCT01475253|101611838|FG002|STARTED|Open Label Extension||0||
48522625|NCT01475253|101611839|FG003|STARTED|Open Label Extension||56||
48522626|NCT01475253|101611836|FG000|COMPLETED|Open Label Extension||0||
48522627|NCT01475253|101611837|FG001|COMPLETED|Open Label Extension||0||
48522628|NCT01475253|101611838|FG002|COMPLETED|Open Label Extension||0||
48522629|NCT01475253|101611839|FG003|COMPLETED|Open Label Extension||56||
48522630|NCT01475253|101611836|FG000|NOT COMPLETED|Open Label Extension||0||
48522631|NCT01475253|101611837|FG001|NOT COMPLETED|Open Label Extension||0||
48522632|NCT01475253|101611838|FG002|NOT COMPLETED|Open Label Extension||0||
48522633|NCT01475253|101611839|FG003|NOT COMPLETED|Open Label Extension||0||
48522634|NCT01843348|101611840|FG000|STARTED|Overall Study||205||
48522635|NCT01843348|101611841|FG001|STARTED|Overall Study||208||
48522636|NCT01843348|101611842|FG002|STARTED|Overall Study||199||
48522637|NCT01843348|101611840|FG000|Safety Analysis Set (SAS)|Overall Study||204||
48522638|NCT01843348|101611841|FG001|Safety Analysis Set (SAS)|Overall Study||210||
48522639|NCT01843348|101611842|FG002|Safety Analysis Set (SAS)|Overall Study||198||
48522640|NCT01843348|101611840|FG000|Full Analysis Set (FAS)|Overall Study||205||
48522641|NCT01843348|101611841|FG001|Full Analysis Set (FAS)|Overall Study||208||
48522642|NCT01843348|101611842|FG002|Full Analysis Set (FAS)|Overall Study||199||
48522643|NCT01843348|101611840|FG000|Per Protocol Set (PPS)|Overall Study||147||
48522644|NCT01843348|101611841|FG001|Per Protocol Set (PPS)|Overall Study||111||
48522645|NCT01843348|101611842|FG002|Per Protocol Set (PPS)|Overall Study||80||
48522646|NCT01843348|101611840|FG000|COMPLETED|Overall Study||182||
48522647|NCT01843348|101611841|FG001|COMPLETED|Overall Study||168||
48522648|NCT01843348|101611842|FG002|COMPLETED|Overall Study||158||
48522649|NCT01843348|101611840|FG000|NOT COMPLETED|Overall Study||23||
48522650|NCT01843348|101611841|FG001|NOT COMPLETED|Overall Study||40||
48522651|NCT01843348|101611842|FG002|NOT COMPLETED|Overall Study||41||
48522652|NCT00106938|101611843|FG000|STARTED|Overall Study||1089||
48522653|NCT00106938|101611844|FG001|STARTED|Overall Study||364||
48522654|NCT00106938|101611843|FG000|COMPLETED|Overall Study||913||
48522655|NCT00106938|101611844|FG001|COMPLETED|Overall Study||293||
48522656|NCT00106938|101611843|FG000|NOT COMPLETED|Overall Study||176||
48522657|NCT00106938|101611844|FG001|NOT COMPLETED|Overall Study||71||
48522658|NCT04400760|101611845|FG000|STARTED|Overall Study||40||
48522659|NCT04400760|101611845|FG000|COMPLETED|Overall Study||27||
48522660|NCT04400760|101611845|FG000|NOT COMPLETED|Overall Study||13||
48522661|NCT00784524|101611846|FG000|STARTED|Overall Study||14||
48522662|NCT00784524|101611846|FG000|COMPLETED|Overall Study||14||
48522663|NCT00784524|101611846|FG000|NOT COMPLETED|Overall Study||0||
48522664|NCT01393457|101611847|FG000|STARTED|Overall Study||26||
48522665|NCT01393457|101611848|FG001|STARTED|Overall Study||26||
48522666|NCT01393457|101611849|FG002|STARTED|Overall Study||31||
48522667|NCT01393457|101611850|FG003|STARTED|Overall Study||27||
48522668|NCT01393457|101611847|FG000|COMPLETED|Overall Study||14||
48522669|NCT01393457|101611848|FG001|COMPLETED|Overall Study||14||
48522670|NCT01393457|101611849|FG002|COMPLETED|Overall Study||16||
48522671|NCT01393457|101611850|FG003|COMPLETED|Overall Study||15||
48522672|NCT01393457|101611847|FG000|NOT COMPLETED|Overall Study||12||
48522673|NCT01393457|101611848|FG001|NOT COMPLETED|Overall Study||12||
48522674|NCT01393457|101611849|FG002|NOT COMPLETED|Overall Study||15||
48522675|NCT01393457|101611850|FG003|NOT COMPLETED|Overall Study||12||
48522676|NCT00293202|101611851|FG000|STARTED|Overall Study||5||
48522677|NCT00293202|101611852|FG001|STARTED|Overall Study||5||
48522678|NCT00293202|101611851|FG000|COMPLETED|Overall Study||2||
48522679|NCT00293202|101611852|FG001|COMPLETED|Overall Study||3||
48522680|NCT00293202|101611851|FG000|NOT COMPLETED|Overall Study||3||
48522681|NCT00293202|101611852|FG001|NOT COMPLETED|Overall Study||2||
48522682|NCT01453413|101611853|FG000|STARTED|Overall Study||297||
48522683|NCT01453413|101611853|FG000|COMPLETED|Overall Study||297||
48522684|NCT01453413|101611853|FG000|NOT COMPLETED|Overall Study||0||
48522685|NCT01079832|101611854|FG000|STARTED|Overall Study||50||
48522686|NCT01079832|101611854|FG000|COMPLETED|Overall Study||49||
48522687|NCT01079832|101611854|FG000|NOT COMPLETED|Overall Study||1||
48522688|NCT02480582|101611855|FG000|STARTED|Overall Study||7||
48522689|NCT02480582|101611856|FG001|STARTED|Overall Study||7||
48522690|NCT02480582|101611857|FG002|STARTED|Overall Study||7||
48522691|NCT02480582|101611858|FG003|STARTED|Overall Study||7||
48522692|NCT02480582|101611859|FG004|STARTED|Overall Study||7||
48522693|NCT02480582|101611860|FG005|STARTED|Overall Study||7||
48522694|NCT02480582|101611855|FG000|COMPLETED|Overall Study||7||
48522695|NCT02480582|101611856|FG001|COMPLETED|Overall Study||7||
48522696|NCT02480582|101611857|FG002|COMPLETED|Overall Study||7||
48522697|NCT02480582|101611858|FG003|COMPLETED|Overall Study||7||
48522698|NCT02480582|101611859|FG004|COMPLETED|Overall Study||7||
48522699|NCT02480582|101611860|FG005|COMPLETED|Overall Study||7||
48522700|NCT02480582|101611855|FG000|NOT COMPLETED|Overall Study||0||
48522701|NCT02480582|101611856|FG001|NOT COMPLETED|Overall Study||0||
48522702|NCT02480582|101611857|FG002|NOT COMPLETED|Overall Study||0||
48522703|NCT02480582|101611858|FG003|NOT COMPLETED|Overall Study||0||
48522704|NCT02480582|101611859|FG004|NOT COMPLETED|Overall Study||0||
48522705|NCT02480582|101611860|FG005|NOT COMPLETED|Overall Study||0||
48522706|NCT01382251|101611861|FG000|STARTED|Overall Study||123||
48522707|NCT01382251|101611862|FG001|STARTED|Overall Study||123||
48522708|NCT01382251|101611861|FG000|COMPLETED|Overall Study||102||
48522709|NCT01382251|101611862|FG001|COMPLETED|Overall Study||102||
48522710|NCT01382251|101611861|FG000|NOT COMPLETED|Overall Study||21||
48522711|NCT01382251|101611862|FG001|NOT COMPLETED|Overall Study||21||
48522712|NCT01846273|101611863|FG000|STARTED|Overall Study||168|Full Analysis Set|
48522713|NCT01846273|101611864|FG001|STARTED|Overall Study||113|Full Analysis Set|
48522714|NCT01846273|101611865|FG002|STARTED|Overall Study||41|Full Analysis Set|
48522715|NCT01846273|101611863|FG000|Safety Analysis Set|Overall Study||172||
48522716|NCT01846273|101611864|FG001|Safety Analysis Set|Overall Study||135||
48522717|NCT01846273|101611865|FG002|Safety Analysis Set|Overall Study||14||
48522718|NCT01846273|101611863|FG000|COMPLETED|Overall Study||146||
48522719|NCT01846273|101611864|FG001|COMPLETED|Overall Study||87||
48522720|NCT01846273|101611865|FG002|COMPLETED|Overall Study||41||
48522721|NCT01846273|101611863|FG000|NOT COMPLETED|Overall Study||22||
48522722|NCT01846273|101611864|FG001|NOT COMPLETED|Overall Study||26||
48522723|NCT01846273|101611865|FG002|NOT COMPLETED|Overall Study||0||
48522724|NCT01157897|101611866|FG000|STARTED|Overall Study||10||
48522725|NCT01157897|101611867|FG001|STARTED|Overall Study||10||
48522726|NCT01157897|101611868|FG002|STARTED|Overall Study||10||
48522727|NCT01157897|101611869|FG003|STARTED|Overall Study||6||
48522728|NCT01157897|101611866|FG000|COMPLETED|Overall Study||8||
48522729|NCT01157897|101611867|FG001|COMPLETED|Overall Study||8||
48522730|NCT01157897|101611868|FG002|COMPLETED|Overall Study||10||
48522731|NCT01157897|101611869|FG003|COMPLETED|Overall Study||5||
48522732|NCT01157897|101611866|FG000|NOT COMPLETED|Overall Study||2||
48522733|NCT01157897|101611867|FG001|NOT COMPLETED|Overall Study||2||
48522734|NCT01157897|101611868|FG002|NOT COMPLETED|Overall Study||0||
48522735|NCT01157897|101611869|FG003|NOT COMPLETED|Overall Study||1||
48522736|NCT00534794|101611870|FG000|STARTED|Overall Study||40||
48522737|NCT00534794|101611871|FG001|STARTED|Overall Study||39||
48522738|NCT00534794|101611870|FG000|COMPLETED|Overall Study||40||
48522739|NCT00534794|101611871|FG001|COMPLETED|Overall Study||39||
48522740|NCT00534794|101611870|FG000|NOT COMPLETED|Overall Study||0||
48522741|NCT00534794|101611871|FG001|NOT COMPLETED|Overall Study||0||
48522742|NCT03827564|101611872|FG000|STARTED|Overall Study||9||
48522743|NCT03827564|101611873|FG001|STARTED|Overall Study||5||
48522744|NCT03827564|101611872|FG000|COMPLETED|Overall Study||8||
48522745|NCT03827564|101611873|FG001|COMPLETED|Overall Study||5||
48522746|NCT03827564|101611872|FG000|NOT COMPLETED|Overall Study||1||
48522747|NCT03827564|101611873|FG001|NOT COMPLETED|Overall Study||0||
48522748|NCT00753220|101611874|FG000|STARTED|Overall Study||7||
48522749|NCT00753220|101611874|FG000|COMPLETED|Overall Study||2||
48522750|NCT00753220|101611874|FG000|NOT COMPLETED|Overall Study||5||
48522751|NCT01301508|101611875|FG000|STARTED|Overall Study||21||
48522752|NCT01301508|101611876|FG001|STARTED|Overall Study||25||
48522753|NCT01301508|101611875|FG000|COMPLETED|Overall Study||20||
48522754|NCT01301508|101611876|FG001|COMPLETED|Overall Study||22||
48522755|NCT01301508|101611875|FG000|NOT COMPLETED|Overall Study||1||
48522756|NCT01301508|101611876|FG001|NOT COMPLETED|Overall Study||3||
48522757|NCT00472797|101611877|FG000|STARTED|Overall Study||119||
48522758|NCT00472797|101611878|FG001|STARTED|Overall Study||113||
48522759|NCT00472797|101611877|FG000|COMPLETED|Overall Study||115||
48522760|NCT00472797|101611878|FG001|COMPLETED|Overall Study||112||
48522761|NCT00472797|101611877|FG000|NOT COMPLETED|Overall Study||4||
48522762|NCT00472797|101611878|FG001|NOT COMPLETED|Overall Study||1||
48522763|NCT02865395|101611879|FG000|STARTED|Overall Study||6||
48522764|NCT02865395|101611880|FG001|STARTED|Overall Study||10||
48522765|NCT02865395|101611881|FG002|STARTED|Overall Study||7||
48522766|NCT02865395|101611879|FG000|COMPLETED|Overall Study||0||
48522767|NCT02865395|101611880|FG001|COMPLETED|Overall Study||0||
48522768|NCT02865395|101611881|FG002|COMPLETED|Overall Study||0||
48522769|NCT02865395|101611879|FG000|NOT COMPLETED|Overall Study||6||
48522770|NCT02865395|101611880|FG001|NOT COMPLETED|Overall Study||10||
48522771|NCT02865395|101611881|FG002|NOT COMPLETED|Overall Study||7||
48522772|NCT02646449|101611882|FG000|STARTED|Overall Study||4||
48522773|NCT02646449|101611883|FG001|STARTED|Overall Study||3||
48522774|NCT02646449|101611882|FG000|COMPLETED|Overall Study||4||
48522775|NCT02646449|101611883|FG001|COMPLETED|Overall Study||3||
48522776|NCT02646449|101611882|FG000|NOT COMPLETED|Overall Study||0||
48522777|NCT02646449|101611883|FG001|NOT COMPLETED|Overall Study||0||
48522778|NCT02224573|101611884|FG000|STARTED|Treatment Phase||315||
48522779|NCT02224573|101611885|FG001|STARTED|Treatment Phase||366||
48522780|NCT02224573|101611884|FG000|COMPLETED|Treatment Phase||170||
48522781|NCT02224573|101611885|FG001|COMPLETED|Treatment Phase||243||
48522782|NCT02224573|101611884|FG000|NOT COMPLETED|Treatment Phase||145||
48522783|NCT02224573|101611885|FG001|NOT COMPLETED|Treatment Phase||123||
48522784|NCT02224573|101611884|FG000|STARTED|Taper Phase||79||
48522785|NCT02224573|101611885|FG001|STARTED|Taper Phase||71||
48522786|NCT02224573|101611884|FG000|COMPLETED|Taper Phase||76||
48522787|NCT02224573|101611885|FG001|COMPLETED|Taper Phase||67||
48522788|NCT02224573|101611884|FG000|NOT COMPLETED|Taper Phase||3||
48522789|NCT02224573|101611885|FG001|NOT COMPLETED|Taper Phase||4||
48522790|NCT01000493|101611886|FG000|STARTED|Overall Study||60||
48522791|NCT01000493|101611887|FG001|STARTED|Overall Study||69||
48522792|NCT01000493|101611886|FG000|COMPLETED|Overall Study||21||
48522793|NCT01000493|101611887|FG001|COMPLETED|Overall Study||14||
48522794|NCT01000493|101611886|FG000|NOT COMPLETED|Overall Study||39||
48522795|NCT01000493|101611887|FG001|NOT COMPLETED|Overall Study||55||
48522796|NCT01299805|101611888|FG000|STARTED|Overall Study||12||
48522797|NCT01299805|101611889|FG001|STARTED|Overall Study||5||
48522798|NCT01299805|101611888|FG000|COMPLETED|Overall Study||10||
48522799|NCT01299805|101611889|FG001|COMPLETED|Overall Study||5||
48522800|NCT01299805|101611888|FG000|NOT COMPLETED|Overall Study||2||
48522801|NCT01299805|101611889|FG001|NOT COMPLETED|Overall Study||0||
48522802|NCT04051684|101611890|FG000|STARTED|Overall Study||12||
48522803|NCT04051684|101611891|FG001|STARTED|Overall Study||11||
48522804|NCT04051684|101611890|FG000|COMPLETED|Overall Study||12||
48522805|NCT04051684|101611891|FG001|COMPLETED|Overall Study||11||
48522806|NCT04051684|101611890|FG000|NOT COMPLETED|Overall Study||0||
48522807|NCT04051684|101611891|FG001|NOT COMPLETED|Overall Study||0||
48522808|NCT01117337|101611892|FG000|STARTED|Overall Study||52||
48522809|NCT01117337|101611893|FG001|STARTED|Overall Study||52||
48522810|NCT01117337|101611892|FG000|Underwent Surgery|Overall Study||52||
48522811|NCT01117337|101611893|FG001|Underwent Surgery|Overall Study||52||
48522812|NCT01117337|101611892|FG000|COMPLETED|Overall Study||48||
48522813|NCT01117337|101611893|FG001|COMPLETED|Overall Study||52||
48522814|NCT01117337|101611892|FG000|NOT COMPLETED|Overall Study||4||
48522815|NCT01117337|101611893|FG001|NOT COMPLETED|Overall Study||0||
48522816|NCT00306163|101611894|FG000|STARTED|Overall Study||19||
48522817|NCT00306163|101611895|FG001|STARTED|Overall Study||18||
48522818|NCT00306163|101611894|FG000|COMPLETED|Overall Study||19||
48522819|NCT00306163|101611895|FG001|COMPLETED|Overall Study||18||
48522820|NCT00306163|101611894|FG000|NOT COMPLETED|Overall Study||0||
48522821|NCT00306163|101611895|FG001|NOT COMPLETED|Overall Study||0||
48374567|NCT02531373|101247433|FG008|Vaccination 2|Overall Study||51||
48374568|NCT02531373|101247425|FG000|Vaccination 3|Overall Study||0||
48374569|NCT02531373|101247426|FG001|Vaccination 3|Overall Study||0||
48374570|NCT02531373|101247427|FG002|Vaccination 3|Overall Study||0||
48374571|NCT02531373|101247428|FG003|Vaccination 3|Overall Study||0||
48374572|NCT02531373|101247429|FG004|Vaccination 3|Overall Study||48||
48374573|NCT02531373|101247430|FG005|Vaccination 3|Overall Study||47||
48374574|NCT02531373|101247431|FG006|Vaccination 3|Overall Study||49||
48374575|NCT02531373|101247432|FG007|Vaccination 3|Overall Study||51||
48374576|NCT02531373|101247433|FG008|Vaccination 3|Overall Study||49||
48374577|NCT02531373|101247425|FG000|Vaccination 4|Overall Study||0||
48374578|NCT02531373|101247426|FG001|Vaccination 4|Overall Study||0||
48374579|NCT02531373|101247427|FG002|Vaccination 4|Overall Study||0||
48374580|NCT02531373|101247428|FG003|Vaccination 4|Overall Study||0||
48374581|NCT02531373|101247429|FG004|Vaccination 4|Overall Study||44||
48374582|NCT02531373|101247430|FG005|Vaccination 4|Overall Study||43||
48374583|NCT02531373|101247431|FG006|Vaccination 4|Overall Study||43||
48374584|NCT02531373|101247432|FG007|Vaccination 4|Overall Study||43||
48374585|NCT02531373|101247433|FG008|Vaccination 4|Overall Study||43||
48374586|NCT02531373|101247425|FG000|COMPLETED|Overall Study||20||
48374587|NCT02531373|101247426|FG001|COMPLETED|Overall Study||20||
48374588|NCT02531373|101247427|FG002|COMPLETED|Overall Study||20||
48374589|NCT02531373|101247428|FG003|COMPLETED|Overall Study||20||
48374590|NCT02531373|101247429|FG004|COMPLETED|Overall Study||43||
48374591|NCT02531373|101247430|FG005|COMPLETED|Overall Study||42||
48374592|NCT02531373|101247431|FG006|COMPLETED|Overall Study||41||
48374593|NCT02531373|101247432|FG007|COMPLETED|Overall Study||43||
48374594|NCT02531373|101247433|FG008|COMPLETED|Overall Study||43||
48374595|NCT02531373|101247425|FG000|NOT COMPLETED|Overall Study||0||
48374596|NCT02531373|101247426|FG001|NOT COMPLETED|Overall Study||0||
48374597|NCT02531373|101247427|FG002|NOT COMPLETED|Overall Study||0||
48374598|NCT02531373|101247428|FG003|NOT COMPLETED|Overall Study||0||
48374599|NCT02531373|101247429|FG004|NOT COMPLETED|Overall Study||8||
48522822|NCT00995085|101611896|FG000|STARTED|Overall Study||43||
48522823|NCT00995085|101611896|FG000|COMPLETED|Overall Study||38||
48522824|NCT00995085|101611896|FG000|NOT COMPLETED|Overall Study||5||
48522825|NCT01218984|101611897|FG000|STARTED|Overall Study||9||
48522826|NCT01218984|101611898|FG001|STARTED|Overall Study||8||
48522827|NCT01218984|101611899|FG002|STARTED|Overall Study||10||
48522828|NCT01218984|101611897|FG000|COMPLETED|Overall Study||8||
48522829|NCT01218984|101611898|FG001|COMPLETED|Overall Study||6||
48522830|NCT01218984|101611899|FG002|COMPLETED|Overall Study||7||
48522831|NCT01218984|101611897|FG000|NOT COMPLETED|Overall Study||1||
48522832|NCT01218984|101611898|FG001|NOT COMPLETED|Overall Study||2||
48522833|NCT01218984|101611899|FG002|NOT COMPLETED|Overall Study||3||
48522834|NCT00016718|101611900|FG000|STARTED|Overall Study||6||
48522835|NCT00016718|101611901|FG001|STARTED|Overall Study||21||
48074473|NCT01487200|100504484|FG000|STARTED|Overall Study||5||
48522836|NCT00016718|101611902|FG002|STARTED|Overall Study||16||
48522837|NCT00016718|101611900|FG000|COMPLETED|Overall Study||6||
48522838|NCT00016718|101611901|FG001|COMPLETED|Overall Study||21||
48522839|NCT00016718|101611902|FG002|COMPLETED|Overall Study||16||
48522840|NCT00016718|101611900|FG000|NOT COMPLETED|Overall Study||0||
48374600|NCT02531373|101247430|FG005|NOT COMPLETED|Overall Study||9||
48374601|NCT02531373|101247431|FG006|NOT COMPLETED|Overall Study||11||
48374602|NCT02531373|101247432|FG007|NOT COMPLETED|Overall Study||9||
48374603|NCT02531373|101247433|FG008|NOT COMPLETED|Overall Study||9||
48522841|NCT00016718|101611901|FG001|NOT COMPLETED|Overall Study||0||
48522842|NCT00016718|101611902|FG002|NOT COMPLETED|Overall Study||0||
48522843|NCT00754013|101611903|FG000|STARTED|Overall Study||4||
48522844|NCT00754013|101611904|FG001|STARTED|Overall Study||5||
48522845|NCT00754013|101611903|FG000|COMPLETED|Overall Study||0||
48522846|NCT00754013|101611904|FG001|COMPLETED|Overall Study||0||
48522847|NCT00754013|101611903|FG000|NOT COMPLETED|Overall Study||4||
48522848|NCT00754013|101611904|FG001|NOT COMPLETED|Overall Study||5||
48522849|NCT01124695|101611905|FG000|STARTED|Overall Study||124||
48522850|NCT01124695|101611905|FG000|Treated|Overall Study||122||
48522851|NCT01124695|101611905|FG000|Eligible and Treated|Overall Study||113||
48522852|NCT01124695|101611905|FG000|Eligible and Treated and Had CYP2D6 Score|Overall Study||85||
48522853|NCT01124695|101611905|FG000|Eligible and Treated and Had Cycle 3 Edoxifen Evaluation|Overall Study||63||
48522854|NCT01124695|101611905|FG000|Eligible and Treated Patients With 3-month Endoxifen and Were Progression-free and Alive at 3 Months|Overall Study||43||
48522855|NCT01124695|101611905|FG000|COMPLETED|Overall Study||1||
48522856|NCT01124695|101611905|FG000|NOT COMPLETED|Overall Study||123||
48522857|NCT02039414|101611906|FG000|STARTED|Overall Study||22||
48522858|NCT02039414|101611907|FG001|STARTED|Overall Study||18||
48522859|NCT02039414|101611906|FG000|COMPLETED|Overall Study||16||
48522860|NCT02039414|101611907|FG001|COMPLETED|Overall Study||16||
48522861|NCT02039414|101611906|FG000|NOT COMPLETED|Overall Study||6||
48522862|NCT02039414|101611907|FG001|NOT COMPLETED|Overall Study||2||
48522863|NCT00831623|101611908|FG000|STARTED|Overall Study||167||
48522864|NCT00831623|101611908|FG000|Treated Per Protocol|Overall Study||158||
48522865|NCT00831623|101611908|FG000|At Least 2 Years Since Completing Treatment|Overall Study||146||
48522866|NCT00831623|101611908|FG000|COMPLETED|Overall Study||145|At least two years since completing treatment|
48522867|NCT00831623|101611908|FG000|NOT COMPLETED|Overall Study||22||
48522868|NCT01829919|101611909|FG000|STARTED|Overall Study||24||
48522869|NCT01829919|101611909|FG000|COMPLETED|Overall Study||24||
48522870|NCT01829919|101611909|FG000|NOT COMPLETED|Overall Study||0||
48522871|NCT01408563|101611910|FG000|STARTED|Overall Study||33||
48522872|NCT01408563|101611910|FG000|Received Transplant|Overall Study||31||
48522873|NCT01408563|101611910|FG000|COMPLETED|Overall Study||31||
48522874|NCT01408563|101611910|FG000|NOT COMPLETED|Overall Study||2||
48522875|NCT01231750|101611911|FG000|STARTED|Overall Study||3||
48522876|NCT01231750|101611912|FG001|STARTED|Overall Study||4||
48522877|NCT01231750|101611911|FG000|COMPLETED|Overall Study||3||
48522878|NCT01231750|101611912|FG001|COMPLETED|Overall Study||4||
48522879|NCT01231750|101611911|FG000|NOT COMPLETED|Overall Study||0||
48522880|NCT01231750|101611912|FG001|NOT COMPLETED|Overall Study||0||
48522881|NCT04969861|101611913|FG000|STARTED|Overall Study||1||
48522882|NCT04969861|101611914|FG001|STARTED|Overall Study||0||
48522883|NCT04969861|101611913|FG000|COMPLETED|Overall Study||0||
48522884|NCT04969861|101611914|FG001|COMPLETED|Overall Study||0||
48522885|NCT04969861|101611913|FG000|NOT COMPLETED|Overall Study||1||
48522886|NCT04969861|101611914|FG001|NOT COMPLETED|Overall Study||0||
48522887|NCT02522403|101611915|FG000|STARTED|Overall Study||17||
48522888|NCT02522403|101611916|FG001|STARTED|Overall Study||19||
48522889|NCT02522403|101611915|FG000|COMPLETED|Overall Study||13||
48522890|NCT02522403|101611916|FG001|COMPLETED|Overall Study||13||
48522891|NCT02522403|101611915|FG000|NOT COMPLETED|Overall Study||4||
48522892|NCT02522403|101611916|FG001|NOT COMPLETED|Overall Study||6||
48522893|NCT02931045|101611917|FG000|STARTED|Overall Study||30||
48522894|NCT02931045|101611918|FG001|STARTED|Overall Study||30||
48522895|NCT02931045|101611917|FG000|COMPLETED|Overall Study||27||
48522896|NCT02931045|101611918|FG001|COMPLETED|Overall Study||28||
48522897|NCT02931045|101611917|FG000|NOT COMPLETED|Overall Study||3||
48522898|NCT02931045|101611918|FG001|NOT COMPLETED|Overall Study||2||
48522899|NCT02080832|101611919|FG000|STARTED|Overall Study||15||
48522900|NCT02080832|101611920|FG001|STARTED|Overall Study||17||
48522901|NCT02080832|101611921|FG002|STARTED|Overall Study||22||
48522902|NCT02080832|101611919|FG000|COMPLETED|Overall Study||6||
48522903|NCT02080832|101611920|FG001|COMPLETED|Overall Study||5||
48522904|NCT02080832|101611921|FG002|COMPLETED|Overall Study||6||
48522905|NCT02080832|101611919|FG000|NOT COMPLETED|Overall Study||9||
48522906|NCT02080832|101611920|FG001|NOT COMPLETED|Overall Study||12||
48522907|NCT02080832|101611921|FG002|NOT COMPLETED|Overall Study||16||
48522908|NCT02041091|101611922|FG000|STARTED|Treatment||112||
48522909|NCT02041091|101611923|FG001|STARTED|Treatment||114||
48522910|NCT02041091|101611922|FG000|Received At Least One Dose of Study Drug|Treatment||112||
48522911|NCT02041091|101611923|FG001|Received At Least One Dose of Study Drug|Treatment||114||
48522912|NCT02041091|101611922|FG000|Participated in Follow Up|Treatment||106||
48522913|NCT02041091|101611923|FG001|Participated in Follow Up|Treatment||96||
48074474|NCT01487200|100504485|FG001|STARTED|Overall Study||7||
48074475|NCT01487200|100504486|FG002|STARTED|Overall Study||7||
48522914|NCT02041091|101611922|FG000|COMPLETED|Treatment||90||
48522915|NCT02041091|101611923|FG001|COMPLETED|Treatment||91||
48522916|NCT02041091|101611922|FG000|NOT COMPLETED|Treatment||22||
48522917|NCT02041091|101611923|FG001|NOT COMPLETED|Treatment||23||
48522918|NCT02041091|101611922|FG000|STARTED|Optional Safety Extension Period||85||
48522919|NCT02041091|101611923|FG001|STARTED|Optional Safety Extension Period||82||
48522920|NCT02041091|101611922|FG000|COMPLETED|Optional Safety Extension Period||0||
48522921|NCT02041091|101611923|FG001|COMPLETED|Optional Safety Extension Period||0||
48522922|NCT02041091|101611922|FG000|NOT COMPLETED|Optional Safety Extension Period||85||
48522923|NCT02041091|101611923|FG001|NOT COMPLETED|Optional Safety Extension Period||82||
48522924|NCT04556552|101611924|FG000|STARTED|Overall Study||12||
48522925|NCT04556552|101611925|FG001|STARTED|Overall Study||8||
48522926|NCT04556552|101611924|FG000|COMPLETED|Overall Study||11||
48522927|NCT04556552|101611925|FG001|COMPLETED|Overall Study||6||
48522928|NCT04556552|101611924|FG000|NOT COMPLETED|Overall Study||1||
48522929|NCT04556552|101611925|FG001|NOT COMPLETED|Overall Study||2||
48522930|NCT03716076|101611926|FG000|STARTED|Overall Study||25||
48522931|NCT03716076|101611927|FG001|STARTED|Overall Study||25||
48522932|NCT03716076|101611926|FG000|COMPLETED|Overall Study||22||
48522933|NCT03716076|101611927|FG001|COMPLETED|Overall Study||19||
48522934|NCT03716076|101611926|FG000|NOT COMPLETED|Overall Study||3||
48522935|NCT03716076|101611927|FG001|NOT COMPLETED|Overall Study||6||
48522936|NCT03050918|101611928|FG000|STARTED|Overall Study||1534||
48522937|NCT03050918|101611929|FG001|STARTED|Overall Study||1520||
48522938|NCT03050918|101611928|FG000|COMPLETED|Overall Study||1534||
48522939|NCT03050918|101611929|FG001|COMPLETED|Overall Study||1520||
48522940|NCT03050918|101611928|FG000|NOT COMPLETED|Overall Study||0||
48522941|NCT03050918|101611929|FG001|NOT COMPLETED|Overall Study||0||
48522942|NCT00673933|101611930|FG000|STARTED|Overall Study||20||
48522943|NCT00673933|101611930|FG000|COMPLETED|Overall Study||17||
48522944|NCT00673933|101611930|FG000|NOT COMPLETED|Overall Study||3||
48522945|NCT02357342|101611931|FG000|STARTED|First 6 Months||20|15 subjects were still in study when it was extended; 13 subjects qualified for extension.|
48672546|NCT02095106|101982633|FG000|STARTED|First Intervention (14 Days)||14||
48672547|NCT02095106|101982634|FG001|STARTED|First Intervention (14 Days)||13||
48672548|NCT02095106|101982633|FG000|COMPLETED|First Intervention (14 Days)||14||
48672549|NCT02095106|101982634|FG001|COMPLETED|First Intervention (14 Days)||13||
48672550|NCT02095106|101982633|FG000|NOT COMPLETED|First Intervention (14 Days)||0||
48672551|NCT02095106|101982634|FG001|NOT COMPLETED|First Intervention (14 Days)||0||
48672552|NCT02095106|101982633|FG000|STARTED|Second Intervention (14 Days)||14||
48672553|NCT02095106|101982634|FG001|STARTED|Second Intervention (14 Days)||13||
48672554|NCT02095106|101982633|FG000|COMPLETED|Second Intervention (14 Days)||14||
48672555|NCT02095106|101982634|FG001|COMPLETED|Second Intervention (14 Days)||12||
48672556|NCT02095106|101982633|FG000|NOT COMPLETED|Second Intervention (14 Days)||0||
48672557|NCT02095106|101982634|FG001|NOT COMPLETED|Second Intervention (14 Days)||1||
48672558|NCT00492557|101982635|FG000|STARTED|Overall Study||580||
48672559|NCT00492557|101982636|FG001|STARTED|Overall Study||580||
48672560|NCT00492557|101982635|FG000|Vaccinated Dose 1|Overall Study||577||
48672561|NCT00492557|101982636|FG001|Vaccinated Dose 1|Overall Study||575||
48672562|NCT00492557|101982635|FG000|Vaccinated Dose 2|Overall Study||560||
48672563|NCT00492557|101982636|FG001|Vaccinated Dose 2|Overall Study||558||
48672564|NCT00492557|101982635|FG000|COMPLETED|Overall Study||556||
48672565|NCT00492557|101982636|FG001|COMPLETED|Overall Study||557||
48672566|NCT00492557|101982635|FG000|NOT COMPLETED|Overall Study||24||
48672567|NCT00492557|101982636|FG001|NOT COMPLETED|Overall Study||23||
48672568|NCT02164864|101982637|FG000|STARTED|Overall Study||981||
48672569|NCT02164864|101982638|FG001|STARTED|Overall Study||763||
48672570|NCT02164864|101982639|FG002|STARTED|Overall Study||981||
48672571|NCT02164864|101982637|FG000|COMPLETED|Overall Study||886||
48672572|NCT02164864|101982638|FG001|COMPLETED|Overall Study||703||
48672573|NCT02164864|101982639|FG002|COMPLETED|Overall Study||849||
48672574|NCT02164864|101982637|FG000|NOT COMPLETED|Overall Study||95||
48672575|NCT02164864|101982638|FG001|NOT COMPLETED|Overall Study||60||
48672576|NCT02164864|101982639|FG002|NOT COMPLETED|Overall Study||132||
48672577|NCT01822925|101982640|FG000|STARTED|Overall Study||32||
48672578|NCT01822925|101982641|FG001|STARTED|Overall Study||32||
48672579|NCT01822925|101982642|FG002|STARTED|Overall Study||32||
48672580|NCT01822925|101982643|FG003|STARTED|Overall Study||32||
48672581|NCT01822925|101982640|FG000|COMPLETED|Overall Study||26||
48672582|NCT01822925|101982641|FG001|COMPLETED|Overall Study||30||
48672583|NCT01822925|101982642|FG002|COMPLETED|Overall Study||29||
48672584|NCT01822925|101982643|FG003|COMPLETED|Overall Study||27||
48672585|NCT01822925|101982640|FG000|NOT COMPLETED|Overall Study||6||
48672586|NCT01822925|101982641|FG001|NOT COMPLETED|Overall Study||2||
48672587|NCT01822925|101982642|FG002|NOT COMPLETED|Overall Study||3||
48672588|NCT01822925|101982643|FG003|NOT COMPLETED|Overall Study||5||
48672589|NCT02665260|101982644|FG000|STARTED|Overall Study||24||
48672590|NCT02665260|101982645|FG001|STARTED|Overall Study||23||
48672591|NCT02665260|101982646|FG002|STARTED|Overall Study||25||
48672592|NCT02665260|101982647|FG003|STARTED|Overall Study||22||
48672593|NCT02665260|101982644|FG000|COMPLETED|Overall Study||22||
48672594|NCT02665260|101982645|FG001|COMPLETED|Overall Study||22||
48672595|NCT02665260|101982646|FG002|COMPLETED|Overall Study||21||
48672596|NCT02665260|101982647|FG003|COMPLETED|Overall Study||21||
48672597|NCT02665260|101982644|FG000|NOT COMPLETED|Overall Study||2||
48672598|NCT02665260|101982645|FG001|NOT COMPLETED|Overall Study||1||
48672599|NCT02665260|101982646|FG002|NOT COMPLETED|Overall Study||4||
48672600|NCT02665260|101982647|FG003|NOT COMPLETED|Overall Study||1||
48672601|NCT00656370|101982648|FG000|STARTED|Overall Study||25||
48672602|NCT00656370|101982648|FG000|COMPLETED|Overall Study||15||
48672603|NCT00656370|101982648|FG000|NOT COMPLETED|Overall Study||10||
48672604|NCT04194450|101982649|FG000|STARTED|Overall Study||9||
48672605|NCT04194450|101982650|FG001|STARTED|Overall Study||10||
48672606|NCT04194450|101982649|FG000|COMPLETED|Overall Study||8||
48672607|NCT04194450|101982650|FG001|COMPLETED|Overall Study||10||
48672608|NCT04194450|101982649|FG000|NOT COMPLETED|Overall Study||1||
48672609|NCT04194450|101982650|FG001|NOT COMPLETED|Overall Study||0||
48672610|NCT03235050|101982651|FG000|STARTED|Overall Study||112||
48672611|NCT03235050|101982652|FG001|STARTED|Overall Study||110||
48672612|NCT03235050|101982653|FG002|STARTED|Overall Study||100||
48672613|NCT03235050|101982654|FG003|STARTED|Overall Study||256||
48672614|NCT03235050|101982655|FG004|STARTED|Overall Study||256||
48672615|NCT03235050|101982651|FG000|COMPLETED|Overall Study||108||
48672616|NCT03235050|101982652|FG001|COMPLETED|Overall Study||105||
48672617|NCT03235050|101982653|FG002|COMPLETED|Overall Study||96||
48672618|NCT03235050|101982654|FG003|COMPLETED|Overall Study||242||
48672619|NCT03235050|101982655|FG004|COMPLETED|Overall Study||245||
48672620|NCT03235050|101982651|FG000|NOT COMPLETED|Overall Study||4||
48672621|NCT03235050|101982652|FG001|NOT COMPLETED|Overall Study||5||
48672622|NCT03235050|101982653|FG002|NOT COMPLETED|Overall Study||4||
48672623|NCT03235050|101982654|FG003|NOT COMPLETED|Overall Study||14||
48672624|NCT03235050|101982655|FG004|NOT COMPLETED|Overall Study||11||
48672625|NCT01394159|101982656|FG000|STARTED|Overall Study||28||
48672626|NCT01394159|101982657|FG001|STARTED|Overall Study||28||
48672627|NCT01394159|101982656|FG000|COMPLETED|Overall Study||28||
48672628|NCT01394159|101982657|FG001|COMPLETED|Overall Study||28||
48672629|NCT01394159|101982656|FG000|NOT COMPLETED|Overall Study||0||
48672630|NCT01394159|101982657|FG001|NOT COMPLETED|Overall Study||0||
48672631|NCT01347060|101982658|FG000|STARTED|Overall Study||9868||
48672632|NCT01347060|101982659|FG001|STARTED|Overall Study||7580||
48672633|NCT01347060|101982658|FG000|COMPLETED|Overall Study||9868||
48672634|NCT01347060|101982659|FG001|COMPLETED|Overall Study||7580||
48672635|NCT01347060|101982658|FG000|NOT COMPLETED|Overall Study||0||
48672636|NCT01347060|101982659|FG001|NOT COMPLETED|Overall Study||0||
48672637|NCT01197547|101982660|FG000|STARTED|Overall Study||1014||
48672638|NCT01197547|101982660|FG000|COMPLETED|Overall Study||992||
48672639|NCT01197547|101982660|FG000|NOT COMPLETED|Overall Study||22||
48672640|NCT00400686|101982661|FG000|STARTED|Overall Study||31||
48672641|NCT00400686|101982661|FG000|COMPLETED|Overall Study||31||
48672642|NCT00400686|101982661|FG000|NOT COMPLETED|Overall Study||0||
48672643|NCT00127439|101982662|FG000|STARTED|Overall Study||9||
48672644|NCT00127439|101982663|FG001|STARTED|Overall Study||10||
48672645|NCT00127439|101982662|FG000|COMPLETED|Overall Study||9||
48672646|NCT00127439|101982663|FG001|COMPLETED|Overall Study||10||
48672647|NCT00127439|101982662|FG000|NOT COMPLETED|Overall Study||0||
48672648|NCT00127439|101982663|FG001|NOT COMPLETED|Overall Study||0||
48672649|NCT00746811|101982664|FG000|STARTED|First Intervention (6 Weeks)||16||
48672650|NCT00746811|101982665|FG001|STARTED|First Intervention (6 Weeks)||16||
48672651|NCT00746811|101982664|FG000|COMPLETED|First Intervention (6 Weeks)||15||
48672652|NCT00746811|101982665|FG001|COMPLETED|First Intervention (6 Weeks)||16||
48672653|NCT00746811|101982664|FG000|NOT COMPLETED|First Intervention (6 Weeks)||1||
48672654|NCT00746811|101982665|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0||
48672655|NCT00746811|101982664|FG000|STARTED|Second Intervention (6 Weeks)||15||
48672656|NCT00746811|101982665|FG001|STARTED|Second Intervention (6 Weeks)||16||
48672657|NCT00746811|101982664|FG000|COMPLETED|Second Intervention (6 Weeks)||15||
48672658|NCT00746811|101982665|FG001|COMPLETED|Second Intervention (6 Weeks)||16||
48672659|NCT00746811|101982664|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0||
48672660|NCT00746811|101982665|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0||
48672661|NCT00980044|101982666|FG000|STARTED|Overall Study||17||
48672662|NCT00980044|101982667|FG001|STARTED|Overall Study||19||
48672663|NCT00980044|101982668|FG002|STARTED|Overall Study||17||
48672664|NCT00980044|101982666|FG000|COMPLETED|Overall Study||12||
48672665|NCT00980044|101982667|FG001|COMPLETED|Overall Study||12||
48672666|NCT00980044|101982668|FG002|COMPLETED|Overall Study||12||
48672667|NCT00980044|101982666|FG000|NOT COMPLETED|Overall Study||5||
48672668|NCT00980044|101982667|FG001|NOT COMPLETED|Overall Study||7||
48672669|NCT00980044|101982668|FG002|NOT COMPLETED|Overall Study||5||
48672670|NCT02746809|101982669|FG000|STARTED|Enrollment||72||
48672671|NCT02746809|101982669|FG000|COMPLETED|Enrollment||60||
48672672|NCT02746809|101982669|FG000|NOT COMPLETED|Enrollment||12||
48672673|NCT02746809|101982669|FG000|STARTED|Procedure||60||
48672674|NCT02746809|101982669|FG000|COMPLETED|Procedure||59||
48672675|NCT02746809|101982669|FG000|NOT COMPLETED|Procedure||1||
48672676|NCT02746809|101982669|FG000|STARTED|1-Month||59||
48672677|NCT02746809|101982669|FG000|COMPLETED|1-Month||54||
48672678|NCT02746809|101982669|FG000|NOT COMPLETED|1-Month||5||
48672679|NCT02746809|101982669|FG000|STARTED|6-Month||54||
48672680|NCT02746809|101982669|FG000|COMPLETED|6-Month||51||
48672681|NCT02746809|101982669|FG000|NOT COMPLETED|6-Month||3||
48672682|NCT02746809|101982669|FG000|STARTED|12-Month||51||
48672683|NCT02746809|101982669|FG000|COMPLETED|12-Month||46||
48672684|NCT02746809|101982669|FG000|NOT COMPLETED|12-Month||5||
48672685|NCT02746809|101982669|FG000|STARTED|24-Month||46||
48672686|NCT02746809|101982669|FG000|COMPLETED|24-Month||44||
48672687|NCT02746809|101982669|FG000|NOT COMPLETED|24-Month||2||
48672688|NCT02746809|101982669|FG000|STARTED|36-Month||44||
48672689|NCT02746809|101982669|FG000|COMPLETED|36-Month||35||
48672690|NCT02746809|101982669|FG000|NOT COMPLETED|36-Month||9||
48672691|NCT02746809|101982669|FG000|STARTED|48-Month||35||
48672692|NCT02746809|101982669|FG000|COMPLETED|48-Month||27||
48672693|NCT02746809|101982669|FG000|NOT COMPLETED|48-Month||8||
48672694|NCT02746809|101982669|FG000|STARTED|60-Month||27||
48672695|NCT02746809|101982669|FG000|COMPLETED|60-Month||24||
48672696|NCT02746809|101982669|FG000|NOT COMPLETED|60-Month||3||
48672697|NCT02134184|101982670|FG000|STARTED|Overall Study||33||
48672698|NCT02134184|101982671|FG001|STARTED|Overall Study||37||
48672699|NCT02134184|101982672|FG002|STARTED|Overall Study||8||
48672700|NCT02134184|101982670|FG000|COMPLETED|Overall Study||33||
48672701|NCT02134184|101982671|FG001|COMPLETED|Overall Study||37||
48672702|NCT02134184|101982672|FG002|COMPLETED|Overall Study||8||
48672703|NCT02134184|101982670|FG000|NOT COMPLETED|Overall Study||0||
48672704|NCT02134184|101982671|FG001|NOT COMPLETED|Overall Study||0||
48672705|NCT02134184|101982672|FG002|NOT COMPLETED|Overall Study||0||
48672706|NCT03837509|101982673|FG000|STARTED|Phase 1||6||
48672707|NCT03837509|101982674|FG001|STARTED|Phase 1||4||
48672708|NCT03837509|101982675|FG002|STARTED|Phase 1||0||
48672709|NCT03837509|101982676|FG003|STARTED|Phase 1||0||
48672710|NCT03837509|101982677|FG004|STARTED|Phase 1||0||
48672711|NCT03837509|101982673|FG000|COMPLETED|Phase 1||1||
48672712|NCT03837509|101982674|FG001|COMPLETED|Phase 1||2||
48672713|NCT03837509|101982675|FG002|COMPLETED|Phase 1||0||
48672714|NCT03837509|101982676|FG003|COMPLETED|Phase 1||0||
48672715|NCT03837509|101982677|FG004|COMPLETED|Phase 1||0||
48672716|NCT03837509|101982673|FG000|NOT COMPLETED|Phase 1||5||
48672717|NCT03837509|101982674|FG001|NOT COMPLETED|Phase 1||2||
48672718|NCT03837509|101982675|FG002|NOT COMPLETED|Phase 1||0||
48672719|NCT03837509|101982676|FG003|NOT COMPLETED|Phase 1||0||
48672720|NCT03837509|101982677|FG004|NOT COMPLETED|Phase 1||0||
48672721|NCT03837509|101982673|FG000|STARTED|Phase 2||0||
48672722|NCT03837509|101982674|FG001|STARTED|Phase 2||0||
48672723|NCT03837509|101982675|FG002|STARTED|Phase 2||2||
48672724|NCT03837509|101982676|FG003|STARTED|Phase 2||1||
48672725|NCT03837509|101982677|FG004|STARTED|Phase 2||2||
48672726|NCT03837509|101982673|FG000|Disease Progression in Part 1|Phase 2||0||
48672727|NCT03837509|101982674|FG001|Disease Progression in Part 1|Phase 2||0||
48672728|NCT03837509|101982675|FG002|Disease Progression in Part 1|Phase 2||0||
48672729|NCT03837509|101982676|FG003|Disease Progression in Part 1|Phase 2||1||
48672730|NCT03837509|101982677|FG004|Disease Progression in Part 1|Phase 2||2||
48672731|NCT03837509|101982673|FG000|COMPLETED|Phase 2||0||
48672732|NCT03837509|101982674|FG001|COMPLETED|Phase 2||0||
48672733|NCT03837509|101982675|FG002|COMPLETED|Phase 2||2||
48672734|NCT03837509|101982676|FG003|COMPLETED|Phase 2||0||
48672735|NCT03837509|101982677|FG004|COMPLETED|Phase 2||1||
48672736|NCT03837509|101982673|FG000|NOT COMPLETED|Phase 2||0||
48672737|NCT03837509|101982674|FG001|NOT COMPLETED|Phase 2||0||
48672738|NCT03837509|101982675|FG002|NOT COMPLETED|Phase 2||0||
48672739|NCT03837509|101982676|FG003|NOT COMPLETED|Phase 2||1||
48672740|NCT03837509|101982677|FG004|NOT COMPLETED|Phase 2||1||
48672741|NCT03715790|101982678|FG000|STARTED|3-months||1491||
48672742|NCT03715790|101982678|FG000|COMPLETED|3-months||1170||
48672743|NCT03715790|101982678|FG000|NOT COMPLETED|3-months||321||
48672744|NCT03715790|101982678|FG000|STARTED|6-months||1170||
48672745|NCT03715790|101982678|FG000|COMPLETED|6-months||916||
48672746|NCT03715790|101982678|FG000|NOT COMPLETED|6-months||254||
48672747|NCT03715790|101982678|FG000|STARTED|12-months||916||
48672748|NCT03715790|101982678|FG000|COMPLETED|12-months||887||
48672749|NCT03715790|101982678|FG000|NOT COMPLETED|12-months||29||
48672750|NCT02891226|101982679|FG000|STARTED|Period 1 (Weeks 0 to 12)||64||
48672751|NCT02891226|101982680|FG001|STARTED|Period 1 (Weeks 0 to 12)||31||
48672752|NCT02891226|101982681|FG002|STARTED|Period 1 (Weeks 0 to 12)||32||
48672753|NCT02891226|101982682|FG003|STARTED|Period 1 (Weeks 0 to 12)||64||
48672754|NCT02891226|101982683|FG004|STARTED|Period 1 (Weeks 0 to 12)||0||
48672755|NCT02891226|101982684|FG005|STARTED|Period 1 (Weeks 0 to 12)||0||
48672756|NCT02891226|101982685|FG006|STARTED|Period 1 (Weeks 0 to 12)||0||
48672757|NCT02891226|101982686|FG007|STARTED|Period 1 (Weeks 0 to 12)||0||
48672758|NCT02891226|101982687|FG008|STARTED|Period 1 (Weeks 0 to 12)||0||
48672759|NCT02891226|101982688|FG009|STARTED|Period 1 (Weeks 0 to 12)||0||
48672760|NCT02891226|101982689|FG010|STARTED|Period 1 (Weeks 0 to 12)||0||
48672761|NCT02891226|101982690|FG011|STARTED|Period 1 (Weeks 0 to 12)||0||
48672762|NCT02891226|101982691|FG012|STARTED|Period 1 (Weeks 0 to 12)||0||
48672763|NCT02891226|101982692|FG013|STARTED|Period 1 (Weeks 0 to 12)||0||
48672764|NCT02891226|101982693|FG014|STARTED|Period 1 (Weeks 0 to 12)||0||
48672765|NCT02891226|101982694|FG015|STARTED|Period 1 (Weeks 0 to 12)||0||
48672766|NCT02891226|101982679|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||64||
48672767|NCT02891226|101982680|FG001|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||31||
48672768|NCT02891226|101982681|FG002|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||32||
48672769|NCT02891226|101982682|FG003|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||64||
48672770|NCT02891226|101982683|FG004|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0||
48672771|NCT02891226|101982684|FG005|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0||
48672772|NCT02891226|101982685|FG006|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0||
48672773|NCT02891226|101982686|FG007|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0||
48672774|NCT02891226|101982687|FG008|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0||
48672775|NCT02891226|101982688|FG009|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0||
48672776|NCT02891226|101982689|FG010|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0||
48672777|NCT02891226|101982690|FG011|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0||
48672778|NCT02891226|101982691|FG012|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0||
48672779|NCT02891226|101982692|FG013|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0||
48672780|NCT02891226|101982693|FG014|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0||
48672781|NCT02891226|101982694|FG015|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0||
48672782|NCT02891226|101982679|FG000|COMPLETED|Period 1 (Weeks 0 to 12)||59||
48672783|NCT02891226|101982680|FG001|COMPLETED|Period 1 (Weeks 0 to 12)||29||
48672784|NCT02891226|101982681|FG002|COMPLETED|Period 1 (Weeks 0 to 12)||28||
48672785|NCT02891226|101982682|FG003|COMPLETED|Period 1 (Weeks 0 to 12)||60||
48672786|NCT02891226|101982683|FG004|COMPLETED|Period 1 (Weeks 0 to 12)||0||
48672787|NCT02891226|101982684|FG005|COMPLETED|Period 1 (Weeks 0 to 12)||0||
48672788|NCT02891226|101982685|FG006|COMPLETED|Period 1 (Weeks 0 to 12)||0||
48672789|NCT02891226|101982686|FG007|COMPLETED|Period 1 (Weeks 0 to 12)||0||
48672790|NCT02891226|101982687|FG008|COMPLETED|Period 1 (Weeks 0 to 12)||0||
48672791|NCT02891226|101982688|FG009|COMPLETED|Period 1 (Weeks 0 to 12)||0||
48672792|NCT02891226|101982689|FG010|COMPLETED|Period 1 (Weeks 0 to 12)||0||
48672793|NCT02891226|101982690|FG011|COMPLETED|Period 1 (Weeks 0 to 12)||0||
48672794|NCT02891226|101982691|FG012|COMPLETED|Period 1 (Weeks 0 to 12)||0||
48672795|NCT02891226|101982692|FG013|COMPLETED|Period 1 (Weeks 0 to 12)||0||
48672796|NCT02891226|101982693|FG014|COMPLETED|Period 1 (Weeks 0 to 12)||0||
48672797|NCT02891226|101982694|FG015|COMPLETED|Period 1 (Weeks 0 to 12)||0||
48672798|NCT02891226|101982679|FG000|NOT COMPLETED|Period 1 (Weeks 0 to 12)||5||
48672799|NCT02891226|101982680|FG001|NOT COMPLETED|Period 1 (Weeks 0 to 12)||2||
48672800|NCT02891226|101982681|FG002|NOT COMPLETED|Period 1 (Weeks 0 to 12)||4||
48672801|NCT02891226|101982682|FG003|NOT COMPLETED|Period 1 (Weeks 0 to 12)||4||
48672802|NCT02891226|101982683|FG004|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0||
48672803|NCT02891226|101982684|FG005|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0||
48672804|NCT02891226|101982685|FG006|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0||
48672805|NCT02891226|101982686|FG007|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0||
48672806|NCT02891226|101982687|FG008|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0||
48672807|NCT02891226|101982688|FG009|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0||
48672808|NCT02891226|101982689|FG010|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0||
48672809|NCT02891226|101982690|FG011|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0||
48672810|NCT02891226|101982691|FG012|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0||
48672811|NCT02891226|101982692|FG013|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0||
48672812|NCT02891226|101982693|FG014|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0||
48672813|NCT02891226|101982694|FG015|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0||
48672814|NCT02891226|101982679|FG000|STARTED|Period 2 (Weeks 12 to 52)||0||
48672815|NCT02891226|101982680|FG001|STARTED|Period 2 (Weeks 12 to 52)||0||
48672816|NCT02891226|101982681|FG002|STARTED|Period 2 (Weeks 12 to 52)||0||
48672817|NCT02891226|101982682|FG003|STARTED|Period 2 (Weeks 12 to 52)||0||
48672818|NCT02891226|101982683|FG004|STARTED|Period 2 (Weeks 12 to 52)||9||
48672819|NCT02891226|101982684|FG005|STARTED|Period 2 (Weeks 12 to 52)||9||
48672820|NCT02891226|101982685|FG006|STARTED|Period 2 (Weeks 12 to 52)||23||
48672821|NCT02891226|101982686|FG007|STARTED|Period 2 (Weeks 12 to 52)||46||
48672822|NCT02891226|101982687|FG008|STARTED|Period 2 (Weeks 12 to 52)||30||
48672823|NCT02891226|101982688|FG009|STARTED|Period 2 (Weeks 12 to 52)||59||
48672824|NCT02891226|101982689|FG010|STARTED|Period 2 (Weeks 12 to 52)||0||
48672825|NCT02891226|101982690|FG011|STARTED|Period 2 (Weeks 12 to 52)||0||
48672826|NCT02891226|101982691|FG012|STARTED|Period 2 (Weeks 12 to 52)||0||
48672827|NCT02891226|101982692|FG013|STARTED|Period 2 (Weeks 12 to 52)||0||
48672828|NCT02891226|101982693|FG014|STARTED|Period 2 (Weeks 12 to 52)||0||
48672829|NCT02891226|101982694|FG015|STARTED|Period 2 (Weeks 12 to 52)||0||
48672830|NCT02891226|101982679|FG000|COMPLETED|Period 2 (Weeks 12 to 52)||0||
48672831|NCT02891226|101982680|FG001|COMPLETED|Period 2 (Weeks 12 to 52)||0||
48672832|NCT02891226|101982681|FG002|COMPLETED|Period 2 (Weeks 12 to 52)||0||
48672833|NCT02891226|101982682|FG003|COMPLETED|Period 2 (Weeks 12 to 52)||0||
48672834|NCT02891226|101982683|FG004|COMPLETED|Period 2 (Weeks 12 to 52)||8||
48672835|NCT02891226|101982684|FG005|COMPLETED|Period 2 (Weeks 12 to 52)||8||
48672836|NCT02891226|101982685|FG006|COMPLETED|Period 2 (Weeks 12 to 52)||20||
48672837|NCT02891226|101982686|FG007|COMPLETED|Period 2 (Weeks 12 to 52)||41||
48672838|NCT02891226|101982687|FG008|COMPLETED|Period 2 (Weeks 12 to 52)||24||
48672839|NCT02891226|101982688|FG009|COMPLETED|Period 2 (Weeks 12 to 52)||42||
48672840|NCT02891226|101982689|FG010|COMPLETED|Period 2 (Weeks 12 to 52)||0||
48672841|NCT02891226|101982690|FG011|COMPLETED|Period 2 (Weeks 12 to 52)||0||
48672842|NCT02891226|101982691|FG012|COMPLETED|Period 2 (Weeks 12 to 52)||0||
48672843|NCT02891226|101982692|FG013|COMPLETED|Period 2 (Weeks 12 to 52)||0||
48672844|NCT02891226|101982693|FG014|COMPLETED|Period 2 (Weeks 12 to 52)||0||
48672845|NCT02891226|101982694|FG015|COMPLETED|Period 2 (Weeks 12 to 52)||0||
48672846|NCT02891226|101982679|FG000|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0||
48672847|NCT02891226|101982680|FG001|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0||
48672848|NCT02891226|101982681|FG002|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0||
48672849|NCT02891226|101982682|FG003|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0||
48672850|NCT02891226|101982683|FG004|NOT COMPLETED|Period 2 (Weeks 12 to 52)||1||
48672851|NCT02891226|101982684|FG005|NOT COMPLETED|Period 2 (Weeks 12 to 52)||1||
48672852|NCT02891226|101982685|FG006|NOT COMPLETED|Period 2 (Weeks 12 to 52)||3||
48672853|NCT02891226|101982686|FG007|NOT COMPLETED|Period 2 (Weeks 12 to 52)||5||
48672854|NCT02891226|101982687|FG008|NOT COMPLETED|Period 2 (Weeks 12 to 52)||6||
48672855|NCT02891226|101982688|FG009|NOT COMPLETED|Period 2 (Weeks 12 to 52)||17||
48672856|NCT02891226|101982689|FG010|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0||
48672857|NCT02891226|101982690|FG011|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0||
48672858|NCT02891226|101982691|FG012|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0||
48672859|NCT02891226|101982692|FG013|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0||
48672860|NCT02891226|101982693|FG014|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0||
48672861|NCT02891226|101982694|FG015|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0||
48672862|NCT02891226|101982679|FG000|STARTED|Period 3 (Weeks 52 to 208)||0||
48672863|NCT02891226|101982680|FG001|STARTED|Period 3 (Weeks 52 to 208)||0||
48672864|NCT02891226|101982681|FG002|STARTED|Period 3 (Weeks 52 to 208)||0||
48672865|NCT02891226|101982682|FG003|STARTED|Period 3 (Weeks 52 to 208)||0||
48672866|NCT02891226|101982683|FG004|STARTED|Period 3 (Weeks 52 to 208)||0||
48672867|NCT02891226|101982684|FG005|STARTED|Period 3 (Weeks 52 to 208)||0||
48672868|NCT02891226|101982685|FG006|STARTED|Period 3 (Weeks 52 to 208)||0||
48672869|NCT02891226|101982686|FG007|STARTED|Period 3 (Weeks 52 to 208)||0||
48672870|NCT02891226|101982687|FG008|STARTED|Period 3 (Weeks 52 to 208)||0||
48672871|NCT02891226|101982688|FG009|STARTED|Period 3 (Weeks 52 to 208)||0||
48672872|NCT02891226|101982689|FG010|STARTED|Period 3 (Weeks 52 to 208)||137||
48672873|NCT02891226|101982690|FG011|STARTED|Period 3 (Weeks 52 to 208)||0||
48672874|NCT02891226|101982691|FG012|STARTED|Period 3 (Weeks 52 to 208)||0||
48672875|NCT02891226|101982692|FG013|STARTED|Period 3 (Weeks 52 to 208)||0||
48672876|NCT02891226|101982693|FG014|STARTED|Period 3 (Weeks 52 to 208)||0||
48672877|NCT02891226|101982694|FG015|STARTED|Period 3 (Weeks 52 to 208)||0||
48672878|NCT02891226|101982679|FG000|COMPLETED|Period 3 (Weeks 52 to 208)||0||
48672879|NCT02891226|101982680|FG001|COMPLETED|Period 3 (Weeks 52 to 208)||0||
48672880|NCT02891226|101982681|FG002|COMPLETED|Period 3 (Weeks 52 to 208)||0||
48672881|NCT02891226|101982682|FG003|COMPLETED|Period 3 (Weeks 52 to 208)||0||
48672882|NCT02891226|101982683|FG004|COMPLETED|Period 3 (Weeks 52 to 208)||0||
48672883|NCT02891226|101982684|FG005|COMPLETED|Period 3 (Weeks 52 to 208)||0||
48672884|NCT02891226|101982685|FG006|COMPLETED|Period 3 (Weeks 52 to 208)||0||
48672885|NCT02891226|101982686|FG007|COMPLETED|Period 3 (Weeks 52 to 208)||0||
48672886|NCT02891226|101982687|FG008|COMPLETED|Period 3 (Weeks 52 to 208)||0||
48672887|NCT02891226|101982688|FG009|COMPLETED|Period 3 (Weeks 52 to 208)||0||
48672888|NCT02891226|101982689|FG010|COMPLETED|Period 3 (Weeks 52 to 208)||0||
48672889|NCT02891226|101982690|FG011|COMPLETED|Period 3 (Weeks 52 to 208)||0||
48672890|NCT02891226|101982691|FG012|COMPLETED|Period 3 (Weeks 52 to 208)||0||
48672891|NCT02891226|101982692|FG013|COMPLETED|Period 3 (Weeks 52 to 208)||0||
48672892|NCT02891226|101982693|FG014|COMPLETED|Period 3 (Weeks 52 to 208)||0||
48672893|NCT02891226|101982694|FG015|COMPLETED|Period 3 (Weeks 52 to 208)||0||
48672894|NCT02891226|101982679|FG000|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0||
48672895|NCT02891226|101982680|FG001|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0||
48672896|NCT02891226|101982681|FG002|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0||
48672897|NCT02891226|101982682|FG003|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0||
48672898|NCT02891226|101982683|FG004|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0||
48672899|NCT02891226|101982684|FG005|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0||
48672900|NCT02891226|101982685|FG006|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0||
48672901|NCT02891226|101982686|FG007|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0||
48672902|NCT02891226|101982687|FG008|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0||
48672903|NCT02891226|101982688|FG009|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0||
48672904|NCT02891226|101982689|FG010|NOT COMPLETED|Period 3 (Weeks 52 to 208)||137||
48672905|NCT02891226|101982690|FG011|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0||
48672906|NCT02891226|101982691|FG012|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0||
48672907|NCT02891226|101982692|FG013|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0||
48672908|NCT02891226|101982693|FG014|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0||
48672909|NCT02891226|101982694|FG015|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0||
48672910|NCT02891226|101982679|FG000|STARTED|Follow-up Period||0||
48672911|NCT02891226|101982680|FG001|STARTED|Follow-up Period||0||
48672912|NCT02891226|101982681|FG002|STARTED|Follow-up Period||0||
48672913|NCT02891226|101982682|FG003|STARTED|Follow-up Period||0||
48672914|NCT02891226|101982683|FG004|STARTED|Follow-up Period||0||
48672915|NCT02891226|101982684|FG005|STARTED|Follow-up Period||0||
48672916|NCT02891226|101982685|FG006|STARTED|Follow-up Period||0||
48672917|NCT02891226|101982686|FG007|STARTED|Follow-up Period||0||
48672918|NCT02891226|101982687|FG008|STARTED|Follow-up Period||0||
48672919|NCT02891226|101982688|FG009|STARTED|Follow-up Period||0||
48672920|NCT02891226|101982689|FG010|STARTED|Follow-up Period||0||
48672921|NCT02891226|101982690|FG011|STARTED|Follow-up Period||1||
48672922|NCT02891226|101982691|FG012|STARTED|Follow-up Period||2||
48672923|NCT02891226|101982692|FG013|STARTED|Follow-up Period||1||
48672924|NCT02891226|101982693|FG014|STARTED|Follow-up Period||1||
48672925|NCT02891226|101982694|FG015|STARTED|Follow-up Period||3||
48672926|NCT02891226|101982679|FG000|COMPLETED|Follow-up Period||0||
48672927|NCT02891226|101982680|FG001|COMPLETED|Follow-up Period||0||
48672928|NCT02891226|101982681|FG002|COMPLETED|Follow-up Period||0||
48672929|NCT02891226|101982682|FG003|COMPLETED|Follow-up Period||0||
48672930|NCT02891226|101982683|FG004|COMPLETED|Follow-up Period||0||
48672931|NCT02891226|101982684|FG005|COMPLETED|Follow-up Period||0||
48672932|NCT02891226|101982685|FG006|COMPLETED|Follow-up Period||0||
48672933|NCT02891226|101982686|FG007|COMPLETED|Follow-up Period||0||
48672934|NCT02891226|101982687|FG008|COMPLETED|Follow-up Period||0||
48672935|NCT02891226|101982688|FG009|COMPLETED|Follow-up Period||0||
48672936|NCT02891226|101982689|FG010|COMPLETED|Follow-up Period||0||
48672937|NCT02891226|101982690|FG011|COMPLETED|Follow-up Period||0||
48672938|NCT02891226|101982691|FG012|COMPLETED|Follow-up Period||2||
48672939|NCT02891226|101982692|FG013|COMPLETED|Follow-up Period||1||
48672940|NCT02891226|101982693|FG014|COMPLETED|Follow-up Period||0||
48672941|NCT02891226|101982694|FG015|COMPLETED|Follow-up Period||2||
48672942|NCT02891226|101982679|FG000|NOT COMPLETED|Follow-up Period||0||
48672943|NCT02891226|101982680|FG001|NOT COMPLETED|Follow-up Period||0||
48672944|NCT02891226|101982681|FG002|NOT COMPLETED|Follow-up Period||0||
48672945|NCT02891226|101982682|FG003|NOT COMPLETED|Follow-up Period||0||
48672946|NCT02891226|101982683|FG004|NOT COMPLETED|Follow-up Period||0||
48672947|NCT02891226|101982684|FG005|NOT COMPLETED|Follow-up Period||0||
48672948|NCT02891226|101982685|FG006|NOT COMPLETED|Follow-up Period||0||
48672949|NCT02891226|101982686|FG007|NOT COMPLETED|Follow-up Period||0||
48672950|NCT02891226|101982687|FG008|NOT COMPLETED|Follow-up Period||0||
48672951|NCT02891226|101982688|FG009|NOT COMPLETED|Follow-up Period||0||
48672952|NCT02891226|101982689|FG010|NOT COMPLETED|Follow-up Period||0||
48672953|NCT02891226|101982690|FG011|NOT COMPLETED|Follow-up Period||1||
48672954|NCT02891226|101982691|FG012|NOT COMPLETED|Follow-up Period||0||
48672955|NCT02891226|101982692|FG013|NOT COMPLETED|Follow-up Period||0||
48672956|NCT02891226|101982693|FG014|NOT COMPLETED|Follow-up Period||1||
48672957|NCT02891226|101982694|FG015|NOT COMPLETED|Follow-up Period||1||
48672958|NCT00189423|101982695|FG000|STARTED|Overall Study||813||
48672959|NCT00189423|101982696|FG001|STARTED|Overall Study||840||
48672960|NCT00189423|101982695|FG000|COMPLETED|Overall Study||48||
48672961|NCT00189423|101982696|FG001|COMPLETED|Overall Study||74||
48672962|NCT00189423|101982695|FG000|NOT COMPLETED|Overall Study||765||
48672963|NCT00189423|101982696|FG001|NOT COMPLETED|Overall Study||766||
48672964|NCT02196922|101982697|FG000|STARTED|Overall Study||58||
48672965|NCT02196922|101982698|FG001|STARTED|Overall Study||46||
48672966|NCT02196922|101982697|FG000|COMPLETED|Overall Study||58||
48672967|NCT02196922|101982698|FG001|COMPLETED|Overall Study||46||
48672968|NCT02196922|101982697|FG000|NOT COMPLETED|Overall Study||0||
48672969|NCT02196922|101982698|FG001|NOT COMPLETED|Overall Study||0||
48672970|NCT00590317|101982699|FG000|STARTED|Overall Study||32||
48672971|NCT00590317|101982700|FG001|STARTED|Overall Study||32||
48672972|NCT00590317|101982699|FG000|COMPLETED|Overall Study||31||
48672973|NCT00590317|101982700|FG001|COMPLETED|Overall Study||27||
48672974|NCT00590317|101982699|FG000|NOT COMPLETED|Overall Study||1||
48672975|NCT00590317|101982700|FG001|NOT COMPLETED|Overall Study||5||
48672976|NCT01736917|101982701|FG000|STARTED|Overall Study||65||
48672977|NCT01736917|101982701|FG000|COMPLETED|Overall Study||54||
48672978|NCT01736917|101982701|FG000|NOT COMPLETED|Overall Study||11||
48672979|NCT01493414|101982702|FG000|STARTED|Overall Study||2233||
48672980|NCT01493414|101982702|FG000|COMPLETED|Overall Study||1283||
48672981|NCT01493414|101982702|FG000|NOT COMPLETED|Overall Study||950||
48672982|NCT01428635|101982703|FG000|STARTED|Overall Study||15||
48672983|NCT01428635|101982704|FG001|STARTED|Overall Study||6||
48672984|NCT01428635|101982703|FG000|COMPLETED|Overall Study||15||
48672985|NCT01428635|101982704|FG001|COMPLETED|Overall Study||6||
48672986|NCT01428635|101982703|FG000|NOT COMPLETED|Overall Study||0||
48672987|NCT01428635|101982704|FG001|NOT COMPLETED|Overall Study||0||
48672988|NCT01368614|101982705|FG000|STARTED|Screening Period||90||
48672989|NCT01368614|101982706|FG001|STARTED|Screening Period||0||
48672990|NCT01368614|101982707|FG002|STARTED|Screening Period||0||
48672991|NCT01368614|101982708|FG003|STARTED|Screening Period||0||
48672992|NCT01368614|101982705|FG000|COMPLETED|Screening Period||32||
48672993|NCT01368614|101982706|FG001|COMPLETED|Screening Period||0||
48672994|NCT01368614|101982707|FG002|COMPLETED|Screening Period||0||
48672995|NCT01368614|101982708|FG003|COMPLETED|Screening Period||0||
48672996|NCT01368614|101982705|FG000|NOT COMPLETED|Screening Period||58||
48672997|NCT01368614|101982706|FG001|NOT COMPLETED|Screening Period||0||
48672998|NCT01368614|101982707|FG002|NOT COMPLETED|Screening Period||0||
48672999|NCT01368614|101982708|FG003|NOT COMPLETED|Screening Period||0||
48673000|NCT01368614|101982705|FG000|STARTED|Study Period||0||
48673001|NCT01368614|101982706|FG001|STARTED|Study Period||11||
48673002|NCT01368614|101982707|FG002|STARTED|Study Period||10||
48673003|NCT01368614|101982708|FG003|STARTED|Study Period||11||
48673004|NCT01368614|101982705|FG000|COMPLETED|Study Period||0||
48673005|NCT01368614|101982706|FG001|COMPLETED|Study Period||10||
48673006|NCT01368614|101982707|FG002|COMPLETED|Study Period||8||
48673007|NCT01368614|101982708|FG003|COMPLETED|Study Period||8||
48673008|NCT01368614|101982705|FG000|NOT COMPLETED|Study Period||0||
48673009|NCT01368614|101982706|FG001|NOT COMPLETED|Study Period||1||
48673010|NCT01368614|101982707|FG002|NOT COMPLETED|Study Period||2||
48673011|NCT01368614|101982708|FG003|NOT COMPLETED|Study Period||3||
48673012|NCT04987372|101982709|FG000|STARTED|Overall Study||50||
48673013|NCT04987372|101982710|FG001|STARTED|Overall Study||50||
48673014|NCT04987372|101982709|FG000|COMPLETED|Overall Study||50||
48673015|NCT04987372|101982710|FG001|COMPLETED|Overall Study||46||
48673016|NCT04987372|101982709|FG000|NOT COMPLETED|Overall Study||0||
48673017|NCT04987372|101982710|FG001|NOT COMPLETED|Overall Study||4||
48673018|NCT03435380|101982711|FG000|STARTED|Overall Study||90||
48673019|NCT03435380|101982712|FG001|STARTED|Overall Study||91||
48673020|NCT03435380|101982713|FG002|STARTED|Overall Study||90||
48673021|NCT03435380|101982711|FG000|COMPLETED|Overall Study||76||
48673022|NCT03435380|101982712|FG001|COMPLETED|Overall Study||79||
48673023|NCT03435380|101982713|FG002|COMPLETED|Overall Study||81||
48673024|NCT03435380|101982711|FG000|NOT COMPLETED|Overall Study||14||
48673025|NCT03435380|101982712|FG001|NOT COMPLETED|Overall Study||12||
48673026|NCT03435380|101982713|FG002|NOT COMPLETED|Overall Study||9||
48673027|NCT01650402|101982714|FG000|STARTED|Overall Study||99||
48673028|NCT01650402|101982715|FG001|STARTED|Overall Study||100||
48673029|NCT01650402|101982714|FG000|COMPLETED|Overall Study||79||
48673030|NCT01650402|101982715|FG001|COMPLETED|Overall Study||86||
48673031|NCT01650402|101982714|FG000|NOT COMPLETED|Overall Study||20||
48673032|NCT01650402|101982715|FG001|NOT COMPLETED|Overall Study||14||
48673033|NCT01959685|101982716|FG000|STARTED|Overall Study||9||
48673034|NCT01959685|101982716|FG000|COMPLETED|Overall Study||9||
48673035|NCT01959685|101982716|FG000|NOT COMPLETED|Overall Study||0||
48673036|NCT05201807|101982717|FG000|STARTED|Overall Study||80||
48673037|NCT05201807|101982717|FG000|COMPLETED|Overall Study||78||
48673038|NCT05201807|101982717|FG000|NOT COMPLETED|Overall Study||2||
48673039|NCT00427700|101982718|FG000|STARTED|Overall Study||40||
48673040|NCT00427700|101982719|FG001|STARTED|Overall Study||42||
48673041|NCT00427700|101982718|FG000|COMPLETED|Overall Study||37||
48673042|NCT00427700|101982719|FG001|COMPLETED|Overall Study||31||
48673043|NCT00427700|101982718|FG000|NOT COMPLETED|Overall Study||3||
48673044|NCT00427700|101982719|FG001|NOT COMPLETED|Overall Study||11||
48673045|NCT04881760|101982720|FG000|STARTED|Overall Study||70||
48673046|NCT04881760|101982721|FG001|STARTED|Overall Study||69||
48673047|NCT04881760|101982722|FG002|STARTED|Overall Study||33||
48673048|NCT04881760|101982723|FG003|STARTED|Overall Study||34||
48673049|NCT04881760|101982724|FG004|STARTED|Overall Study||35||
48673050|NCT04881760|101982725|FG005|STARTED|Overall Study||35||
48673051|NCT04881760|101982726|FG006|STARTED|Overall Study||62||
48673052|NCT04881760|101982720|FG000|Received at Least One Dose of Study Drug|Overall Study||70||
48673053|NCT04881760|101982721|FG001|Received at Least One Dose of Study Drug|Overall Study||69||
48673054|NCT04881760|101982722|FG002|Received at Least One Dose of Study Drug|Overall Study||33||
48673055|NCT04881760|101982723|FG003|Received at Least One Dose of Study Drug|Overall Study||33||
48673056|NCT04881760|101982724|FG004|Received at Least One Dose of Study Drug|Overall Study||35||
48673057|NCT04881760|101982725|FG005|Received at Least One Dose of Study Drug|Overall Study||35||
48673058|NCT04881760|101982726|FG006|Received at Least One Dose of Study Drug|Overall Study||62||
48673059|NCT04881760|101982720|FG000|COMPLETED|Overall Study||50||
48673060|NCT04881760|101982721|FG001|COMPLETED|Overall Study||60||
48673061|NCT04881760|101982722|FG002|COMPLETED|Overall Study||26||
48673062|NCT04881760|101982723|FG003|COMPLETED|Overall Study||26||
48673063|NCT04881760|101982724|FG004|COMPLETED|Overall Study||30||
48673064|NCT04881760|101982725|FG005|COMPLETED|Overall Study||29||
48673065|NCT04881760|101982726|FG006|COMPLETED|Overall Study||54||
48673066|NCT04881760|101982720|FG000|NOT COMPLETED|Overall Study||20||
48673067|NCT04881760|101982721|FG001|NOT COMPLETED|Overall Study||9||
48673068|NCT04881760|101982722|FG002|NOT COMPLETED|Overall Study||7||
48673069|NCT04881760|101982723|FG003|NOT COMPLETED|Overall Study||8||
48673070|NCT04881760|101982724|FG004|NOT COMPLETED|Overall Study||5||
48673071|NCT04881760|101982725|FG005|NOT COMPLETED|Overall Study||6||
48673072|NCT04881760|101982726|FG006|NOT COMPLETED|Overall Study||8||
48673073|NCT02604511|101982727|FG000|STARTED|Overall Study||31||
48673074|NCT02604511|101982727|FG000|COMPLETED|Overall Study||19||
48673075|NCT02604511|101982727|FG000|NOT COMPLETED|Overall Study||12||
48673076|NCT02317627|101982728|FG000|STARTED|Overall Study||13||
48673077|NCT02317627|101982729|FG001|STARTED|Overall Study||13||
48673078|NCT02317627|101982730|FG002|STARTED|Overall Study||12||
48673079|NCT02317627|101982728|FG000|COMPLETED|Overall Study||11||
48673080|NCT02317627|101982729|FG001|COMPLETED|Overall Study||8||
48673081|NCT02317627|101982730|FG002|COMPLETED|Overall Study||8||
48673082|NCT02317627|101982728|FG000|NOT COMPLETED|Overall Study||2||
48673083|NCT02317627|101982729|FG001|NOT COMPLETED|Overall Study||5||
48673084|NCT02317627|101982730|FG002|NOT COMPLETED|Overall Study||4||
48673085|NCT00791648|101982731|FG000|STARTED|Overall Study||308||
48673086|NCT00791648|101982732|FG001|STARTED|Overall Study||309||
48673087|NCT00791648|101982731|FG000|COMPLETED|Overall Study||308||
48673088|NCT00791648|101982732|FG001|COMPLETED|Overall Study||307||
48673089|NCT00791648|101982731|FG000|NOT COMPLETED|Overall Study||0||
48673090|NCT00791648|101982732|FG001|NOT COMPLETED|Overall Study||2||
48673091|NCT04549454|101982733|FG000|STARTED|T1 to T2||134|Note that the participant flow reported here reflects the period between the student baseline (July 2021 \[T1\]) and first follow-up (October 2021 \[T2\]) surveys. Thus, the number of participants reported during this period reflects the number of students who completed the surveys between T1 and T2. Students, not parents, are the ones who reported on outcomes. Parent data was not collected and therefore we could not include them in the Participant Flow.|
48710639|NCT03777709|102077980|FG001|COMPLETED|Overall Study||42||8
48673092|NCT04549454|101982734|FG001|STARTED|T1 to T2||132|Note that the participant flow reported here reflects the period between the student baseline (July 2021 \[T1\]) and first follow-up (October 2021 \[T2\]) surveys. Thus, the number of participants reported during this period reflects the number of students who completed the surveys between T1 and T2. Students, not parents, are the ones who reported on outcomes. Parent data was not collected and therefore we could not include them in the Participant Flow.|
48673093|NCT04549454|101982733|FG000|COMPLETED|T1 to T2||112||
48673094|NCT04549454|101982734|FG001|COMPLETED|T1 to T2||106||
48673095|NCT04549454|101982733|FG000|NOT COMPLETED|T1 to T2||22||
48673096|NCT04549454|101982734|FG001|NOT COMPLETED|T1 to T2||26||
48673097|NCT04549454|101982733|FG000|STARTED|T1 to T3||134|Note that the participant flow reported here reflects the period between the student baseline (July 2021 \[T1\]) and second follow-up (February 2022 \[T3\]) surveys. Thus, the number of participants reported during this period reflects the number of students who completed the surveys between T1 and T3. Students, not parents, are the ones who reported on outcomes. Parent data was not collected and therefore we could not include them in the Participant Flow.|
48673098|NCT04549454|101982734|FG001|STARTED|T1 to T3||132|Note that the participant flow reported here reflects the period between the student baseline (July 2021 \[T1\]) and second follow-up (February 2022 \[T3\]) surveys. Thus, the number of participants reported during this period reflects the number of students who completed the surveys between T1 and T3. Students, not parents, are the ones who reported on outcomes. Parent data was not collected and therefore we could not include them in the Participant Flow.|
48673099|NCT04549454|101982733|FG000|COMPLETED|T1 to T3||103||
48673100|NCT04549454|101982734|FG001|COMPLETED|T1 to T3||96||
48673101|NCT04549454|101982733|FG000|NOT COMPLETED|T1 to T3||31||
48673102|NCT04549454|101982734|FG001|NOT COMPLETED|T1 to T3||36||
48673103|NCT01195597|101982735|FG000|STARTED|Overall Study||40||
48673104|NCT01195597|101982735|FG000|COMPLETED|Overall Study||27||
48673105|NCT01195597|101982735|FG000|NOT COMPLETED|Overall Study||13||
48673106|NCT04614324|101982736|FG000|STARTED|Overall Study||129||
48673107|NCT04614324|101982736|FG000|3Month|Overall Study||128||
48673108|NCT04614324|101982736|FG000|6 Month|Overall Study||123||
48673109|NCT04614324|101982736|FG000|COMPLETED|Overall Study||0|Subjects still in follow up|
48673110|NCT04614324|101982736|FG000|NOT COMPLETED|Overall Study||129||
48673111|NCT01441960|101982737|FG000|STARTED|First Neuromuscular Blocking Agent:||26||
48673112|NCT01441960|101982738|FG001|STARTED|First Neuromuscular Blocking Agent:||19||
48673113|NCT01441960|101982737|FG000|COMPLETED|First Neuromuscular Blocking Agent:||18||
48673114|NCT01441960|101982738|FG001|COMPLETED|First Neuromuscular Blocking Agent:||13||
48673115|NCT01441960|101982737|FG000|NOT COMPLETED|First Neuromuscular Blocking Agent:||8||
48673116|NCT01441960|101982738|FG001|NOT COMPLETED|First Neuromuscular Blocking Agent:||6||
48673117|NCT01441960|101982737|FG000|STARTED|Second Neuromuscular Blocking Agent||18||
48673118|NCT01441960|101982738|FG001|STARTED|Second Neuromuscular Blocking Agent||13||
48673119|NCT01441960|101982737|FG000|COMPLETED|Second Neuromuscular Blocking Agent||18||
48673120|NCT01441960|101982738|FG001|COMPLETED|Second Neuromuscular Blocking Agent||13||
48673121|NCT01441960|101982737|FG000|NOT COMPLETED|Second Neuromuscular Blocking Agent||0||
48673122|NCT01441960|101982738|FG001|NOT COMPLETED|Second Neuromuscular Blocking Agent||0||
48673123|NCT02561962|101982739|FG000|STARTED|Overall Study||3||
48673124|NCT02561962|101982740|FG001|STARTED|Overall Study||3||
48673125|NCT02561962|101982741|FG002|STARTED|Overall Study||3||
48673126|NCT02561962|101982742|FG003|STARTED|Overall Study||3||
48673127|NCT02561962|101982743|FG004|STARTED|Overall Study||6||
48673128|NCT02561962|101982744|FG005|STARTED|Overall Study||6||
48673129|NCT02561962|101982745|FG006|STARTED|Overall Study||5||
48673130|NCT02561962|101982746|FG007|STARTED|Overall Study||11||
48673131|NCT02561962|101982747|FG008|STARTED|Overall Study||2||
48673132|NCT02561962|101982739|FG000|Received Treatment|Overall Study||3||
48673133|NCT02561962|101982740|FG001|Received Treatment|Overall Study||3||
48673134|NCT02561962|101982741|FG002|Received Treatment|Overall Study||3||
48673135|NCT02561962|101982742|FG003|Received Treatment|Overall Study||3||
48673136|NCT02561962|101982743|FG004|Received Treatment|Overall Study||6||
48673137|NCT02561962|101982744|FG005|Received Treatment|Overall Study||6||
48673138|NCT02561962|101982745|FG006|Received Treatment|Overall Study||5||
48673139|NCT02561962|101982746|FG007|Received Treatment|Overall Study||9||
48673140|NCT02561962|101982747|FG008|Received Treatment|Overall Study||2||
48673141|NCT02561962|101982739|FG000|COMPLETED|Overall Study||2||
48673142|NCT02561962|101982740|FG001|COMPLETED|Overall Study||3||
48673143|NCT02561962|101982741|FG002|COMPLETED|Overall Study||3||
48074476|NCT01487200|100504487|FG003|STARTED|Overall Study||5||
48074477|NCT01487200|100504484|FG000|COMPLETED|Overall Study||5||
48673144|NCT02561962|101982742|FG003|COMPLETED|Overall Study||3||
48673145|NCT02561962|101982743|FG004|COMPLETED|Overall Study||4||
48673146|NCT02561962|101982744|FG005|COMPLETED|Overall Study||3||
48673147|NCT02561962|101982745|FG006|COMPLETED|Overall Study||3||
48673148|NCT02561962|101982746|FG007|COMPLETED|Overall Study||7||
48673149|NCT02561962|101982747|FG008|COMPLETED|Overall Study||2||
48673150|NCT02561962|101982739|FG000|NOT COMPLETED|Overall Study||1||
48673151|NCT02561962|101982740|FG001|NOT COMPLETED|Overall Study||0||
48673152|NCT02561962|101982741|FG002|NOT COMPLETED|Overall Study||0||
48673153|NCT02561962|101982742|FG003|NOT COMPLETED|Overall Study||0||
48673154|NCT02561962|101982743|FG004|NOT COMPLETED|Overall Study||2||
48673155|NCT02561962|101982744|FG005|NOT COMPLETED|Overall Study||3||
48673156|NCT02561962|101982745|FG006|NOT COMPLETED|Overall Study||2||
48673157|NCT02561962|101982746|FG007|NOT COMPLETED|Overall Study||4||
48673158|NCT02561962|101982747|FG008|NOT COMPLETED|Overall Study||0||
48673159|NCT01634152|101982748|FG000|STARTED|Overall Study||134||
48673160|NCT01634152|101982749|FG001|STARTED|Overall Study||137||
48673161|NCT01634152|101982750|FG002|STARTED|Overall Study||130||
48673162|NCT01634152|101982748|FG000|COMPLETED|Overall Study||130||
48673163|NCT01634152|101982749|FG001|COMPLETED|Overall Study||136||
48673164|NCT01634152|101982750|FG002|COMPLETED|Overall Study||126||
48673165|NCT01634152|101982748|FG000|NOT COMPLETED|Overall Study||4||
48673166|NCT01634152|101982749|FG001|NOT COMPLETED|Overall Study||1||
48673167|NCT01634152|101982750|FG002|NOT COMPLETED|Overall Study||4||
48673168|NCT00949533|101982751|FG000|STARTED|Overall Study||19||
48673169|NCT00949533|101982752|FG001|STARTED|Overall Study||18||
48673170|NCT00949533|101982751|FG000|COMPLETED|Overall Study||19||
48673171|NCT00949533|101982752|FG001|COMPLETED|Overall Study||17||
48673172|NCT00949533|101982751|FG000|NOT COMPLETED|Overall Study||0||
48673173|NCT00949533|101982752|FG001|NOT COMPLETED|Overall Study||1||
48673174|NCT02347410|101982753|FG000|STARTED|Overall Study||102||
48673175|NCT02347410|101982753|FG000|COMPLETED|Overall Study||98||
48673176|NCT02347410|101982753|FG000|NOT COMPLETED|Overall Study||4||
48673177|NCT01646827|101982754|FG000|STARTED|Overall Study||18||
48673178|NCT01646827|101982755|FG001|STARTED|Overall Study||19||
48673179|NCT01646827|101982754|FG000|COMPLETED|Overall Study||16||
48673180|NCT01646827|101982755|FG001|COMPLETED|Overall Study||14||
48673181|NCT01646827|101982754|FG000|NOT COMPLETED|Overall Study||2||
48673182|NCT01646827|101982755|FG001|NOT COMPLETED|Overall Study||5||
48673183|NCT02157909|101982756|FG000|STARTED|Overall Study||66||
48673184|NCT02157909|101982757|FG001|STARTED|Overall Study||66||
48673185|NCT02157909|101982756|FG000|COMPLETED|Overall Study||66||
48673186|NCT02157909|101982757|FG001|COMPLETED|Overall Study||66||
48673187|NCT02157909|101982756|FG000|NOT COMPLETED|Overall Study||0||
48673188|NCT02157909|101982757|FG001|NOT COMPLETED|Overall Study||0||
48673189|NCT02154061|101982758|FG000|STARTED|Overall Study||16||
48673190|NCT02154061|101982759|FG001|STARTED|Overall Study||17||
48673191|NCT02154061|101982758|FG000|COMPLETED|Overall Study||14||
48673192|NCT02154061|101982759|FG001|COMPLETED|Overall Study||17||
48673193|NCT02154061|101982758|FG000|NOT COMPLETED|Overall Study||2||
48673194|NCT02154061|101982759|FG001|NOT COMPLETED|Overall Study||0||
48673195|NCT02297516|101982760|FG000|STARTED|Single Treatment Phase (6 Months)||32||
48673196|NCT02297516|101982761|FG001|STARTED|Single Treatment Phase (6 Months)||33||
48673197|NCT02297516|101982760|FG000|COMPLETED|Single Treatment Phase (6 Months)||31||
48673198|NCT02297516|101982761|FG001|COMPLETED|Single Treatment Phase (6 Months)||31||
48673199|NCT02297516|101982760|FG000|NOT COMPLETED|Single Treatment Phase (6 Months)||1||
48673200|NCT02297516|101982761|FG001|NOT COMPLETED|Single Treatment Phase (6 Months)||2||
48673201|NCT02297516|101982760|FG000|STARTED|Combination Treatment Phase (up to 18 m)||31||
48673202|NCT02297516|101982761|FG001|STARTED|Combination Treatment Phase (up to 18 m)||31||
48673203|NCT02297516|101982760|FG000|COMPLETED|Combination Treatment Phase (up to 18 m)||31||
48673204|NCT02297516|101982761|FG001|COMPLETED|Combination Treatment Phase (up to 18 m)||30||
48673205|NCT02297516|101982760|FG000|NOT COMPLETED|Combination Treatment Phase (up to 18 m)||0||
48673206|NCT02297516|101982761|FG001|NOT COMPLETED|Combination Treatment Phase (up to 18 m)||1||
48673207|NCT02546323|101982762|FG000|STARTED|Overall Study||272|Randomized patients|
48673208|NCT02546323|101982763|FG001|STARTED|Overall Study||271|Randomized patients|
48673209|NCT02546323|101982762|FG000|Received Treatment|Overall Study||272||
48673210|NCT02546323|101982763|FG001|Received Treatment|Overall Study||268||
48673211|NCT02546323|101982762|FG000|COMPLETED|Overall Study||212||
48673212|NCT02546323|101982763|FG001|COMPLETED|Overall Study||205||
48673213|NCT02546323|101982762|FG000|NOT COMPLETED|Overall Study||60||
48673214|NCT02546323|101982763|FG001|NOT COMPLETED|Overall Study||66||
48673215|NCT00261833|101982764|FG000|STARTED|Overall Study||93||
48673216|NCT00261833|101982765|FG001|STARTED|Overall Study||87||
48673217|NCT00261833|101982764|FG000|COMPLETED|Overall Study||84||
48673218|NCT00261833|101982765|FG001|COMPLETED|Overall Study||69||
48673219|NCT00261833|101982764|FG000|NOT COMPLETED|Overall Study||9||
48673220|NCT00261833|101982765|FG001|NOT COMPLETED|Overall Study||18||
48673221|NCT00557193|101982766|FG000|STARTED|Induction||218||
48673222|NCT00557193|101982767|FG001|STARTED|Induction||0||
48673223|NCT00557193|101982768|FG002|STARTED|Induction||0||
48673224|NCT00557193|101982769|FG003|STARTED|Induction||0||
48673225|NCT00557193|101982770|FG004|STARTED|Induction||0||
48673226|NCT00557193|101982771|FG005|STARTED|Induction||0||
48673227|NCT00557193|101982766|FG000|COMPLETED|Induction||192||
48673228|NCT00557193|101982767|FG001|COMPLETED|Induction||0||
48673229|NCT00557193|101982768|FG002|COMPLETED|Induction||0||
48673230|NCT00557193|101982769|FG003|COMPLETED|Induction||0||
48673231|NCT00557193|101982770|FG004|COMPLETED|Induction||0||
48673232|NCT00557193|101982771|FG005|COMPLETED|Induction||0||
48673233|NCT00557193|101982766|FG000|NOT COMPLETED|Induction||26||
48673234|NCT00557193|101982767|FG001|NOT COMPLETED|Induction||0||
48673235|NCT00557193|101982768|FG002|NOT COMPLETED|Induction||0||
48673236|NCT00557193|101982769|FG003|NOT COMPLETED|Induction||0||
48673237|NCT00557193|101982770|FG004|NOT COMPLETED|Induction||0||
48673238|NCT00557193|101982771|FG005|NOT COMPLETED|Induction||0||
48673239|NCT00557193|101982766|FG000|STARTED|Post Induction Therapy by Tx Assignment||0||
48673240|NCT00557193|101982767|FG001|STARTED|Post Induction Therapy by Tx Assignment||60||
48673241|NCT00557193|101982768|FG002|STARTED|Post Induction Therapy by Tx Assignment||54||
48673242|NCT00557193|101982769|FG003|STARTED|Post Induction Therapy by Tx Assignment||11||
48673243|NCT00557193|101982770|FG004|STARTED|Post Induction Therapy by Tx Assignment||11||
48673244|NCT00557193|101982771|FG005|STARTED|Post Induction Therapy by Tx Assignment||56||
48673245|NCT00557193|101982766|FG000|COMPLETED|Post Induction Therapy by Tx Assignment||0||
48673246|NCT00557193|101982767|FG001|COMPLETED|Post Induction Therapy by Tx Assignment||50||
48673247|NCT00557193|101982768|FG002|COMPLETED|Post Induction Therapy by Tx Assignment||22||
48673248|NCT00557193|101982769|FG003|COMPLETED|Post Induction Therapy by Tx Assignment||4||
48673249|NCT00557193|101982770|FG004|COMPLETED|Post Induction Therapy by Tx Assignment||4||
48673250|NCT00557193|101982771|FG005|COMPLETED|Post Induction Therapy by Tx Assignment||19||
48673251|NCT00557193|101982766|FG000|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0||
48673252|NCT00557193|101982767|FG001|NOT COMPLETED|Post Induction Therapy by Tx Assignment||10||
48673253|NCT00557193|101982768|FG002|NOT COMPLETED|Post Induction Therapy by Tx Assignment||32||
48673254|NCT00557193|101982769|FG003|NOT COMPLETED|Post Induction Therapy by Tx Assignment||7||
48673255|NCT00557193|101982770|FG004|NOT COMPLETED|Post Induction Therapy by Tx Assignment||7||
48673256|NCT00557193|101982771|FG005|NOT COMPLETED|Post Induction Therapy by Tx Assignment||37||
48673257|NCT00584857|101982772|FG000|STARTED|Overall Study||30||
48673258|NCT00584857|101982772|FG000|COMPLETED|Overall Study||30||
48673259|NCT00584857|101982772|FG000|NOT COMPLETED|Overall Study||0||
48673260|NCT01752049|101982773|FG000|STARTED|Overall Study||5||15
48673261|NCT01752049|101982774|FG001|STARTED|Overall Study||5||5
48673262|NCT01752049|101982773|FG000|COMPLETED|Overall Study||5||15
48673263|NCT01752049|101982774|FG001|COMPLETED|Overall Study||5||5
48673264|NCT01752049|101982773|FG000|NOT COMPLETED|Overall Study||0||0
48673265|NCT01752049|101982774|FG001|NOT COMPLETED|Overall Study||0||0
48673266|NCT00814255|101982775|FG000|STARTED|Overall Study||8||
48673267|NCT00814255|101982776|FG001|STARTED|Overall Study||7||
48673268|NCT00814255|101982777|FG002|STARTED|Overall Study||8||
48673269|NCT00814255|101982775|FG000|COMPLETED|Overall Study||7||
48673270|NCT00814255|101982776|FG001|COMPLETED|Overall Study||7||
48673271|NCT00814255|101982777|FG002|COMPLETED|Overall Study||7||
48673272|NCT00814255|101982775|FG000|NOT COMPLETED|Overall Study||1||
48673273|NCT00814255|101982776|FG001|NOT COMPLETED|Overall Study||0||
48673274|NCT00814255|101982777|FG002|NOT COMPLETED|Overall Study||1||
48673275|NCT02185183|101982778|FG000|STARTED|Overall Study||14||
48673276|NCT02185183|101982778|FG000|COMPLETED|Overall Study||14||
48673277|NCT02185183|101982778|FG000|NOT COMPLETED|Overall Study||0||
48673278|NCT00787150|101982779|FG000|STARTED|Overall Study||75||
48673279|NCT00787150|101982780|FG001|STARTED|Overall Study||72||
48673280|NCT00787150|101982781|FG002|STARTED|Overall Study||71||
48673281|NCT00787150|101982779|FG000|COMPLETED|Overall Study||66||
48673282|NCT00787150|101982780|FG001|COMPLETED|Overall Study||65||
48673283|NCT00787150|101982781|FG002|COMPLETED|Overall Study||66||
48673284|NCT00787150|101982779|FG000|NOT COMPLETED|Overall Study||9||
48673285|NCT00787150|101982780|FG001|NOT COMPLETED|Overall Study||7||
48673286|NCT00787150|101982781|FG002|NOT COMPLETED|Overall Study||5||
48673287|NCT01482715|101982782|FG000|STARTED|Overall Study||6||
48673288|NCT01482715|101982783|FG001|STARTED|Overall Study||3||
48673289|NCT01482715|101982784|FG002|STARTED|Overall Study||4||
48673290|NCT01482715|101982785|FG003|STARTED|Overall Study||9||
48673291|NCT01482715|101982786|FG004|STARTED|Overall Study||4||
48673292|NCT01482715|101982787|FG005|STARTED|Overall Study||3||
48673293|NCT01482715|101982788|FG006|STARTED|Overall Study||8||
48673294|NCT01482715|101982789|FG007|STARTED|Overall Study||9||
48673295|NCT01482715|101982790|FG008|STARTED|Overall Study||7||
48673296|NCT01482715|101982791|FG009|STARTED|Overall Study||3||
48673297|NCT01482715|101982792|FG010|STARTED|Overall Study||42||
48673298|NCT01482715|101982793|FG011|STARTED|Overall Study||12||
48673299|NCT01482715|101982794|FG012|STARTED|Overall Study||26||
48673300|NCT01482715|101982782|FG000|COMPLETED|Overall Study||6||
48673301|NCT01482715|101982783|FG001|COMPLETED|Overall Study||3||
48673302|NCT01482715|101982784|FG002|COMPLETED|Overall Study||4||
48673303|NCT01482715|101982785|FG003|COMPLETED|Overall Study||9||
48673304|NCT01482715|101982786|FG004|COMPLETED|Overall Study||4||
48673305|NCT01482715|101982787|FG005|COMPLETED|Overall Study||3||
48673306|NCT01482715|101982788|FG006|COMPLETED|Overall Study||8||
48673307|NCT01482715|101982789|FG007|COMPLETED|Overall Study||9||
48673308|NCT01482715|101982790|FG008|COMPLETED|Overall Study||7||
48673309|NCT01482715|101982791|FG009|COMPLETED|Overall Study||3||
48673310|NCT01482715|101982792|FG010|COMPLETED|Overall Study||42||
48673311|NCT01482715|101982793|FG011|COMPLETED|Overall Study||12||
48673312|NCT01482715|101982794|FG012|COMPLETED|Overall Study||26||
48673313|NCT01482715|101982782|FG000|NOT COMPLETED|Overall Study||0||
48673314|NCT01482715|101982783|FG001|NOT COMPLETED|Overall Study||0||
48673315|NCT01482715|101982784|FG002|NOT COMPLETED|Overall Study||0||
48673316|NCT01482715|101982785|FG003|NOT COMPLETED|Overall Study||0||
48673317|NCT01482715|101982786|FG004|NOT COMPLETED|Overall Study||0||
48673318|NCT01482715|101982787|FG005|NOT COMPLETED|Overall Study||0||
48673319|NCT01482715|101982788|FG006|NOT COMPLETED|Overall Study||0||
48673320|NCT01482715|101982789|FG007|NOT COMPLETED|Overall Study||0||
48673321|NCT01482715|101982790|FG008|NOT COMPLETED|Overall Study||0||
48673322|NCT01482715|101982791|FG009|NOT COMPLETED|Overall Study||0||
48673323|NCT01482715|101982792|FG010|NOT COMPLETED|Overall Study||0||
48673324|NCT01482715|101982793|FG011|NOT COMPLETED|Overall Study||0||
48673325|NCT01482715|101982794|FG012|NOT COMPLETED|Overall Study||0||
48673326|NCT01168596|101982795|FG000|STARTED|Overall Study||16||
48673327|NCT01168596|101982796|FG001|STARTED|Overall Study||14||
48673328|NCT01168596|101982795|FG000|COMPLETED|Overall Study||13||
48673329|NCT01168596|101982796|FG001|COMPLETED|Overall Study||13||
48673330|NCT01168596|101982795|FG000|NOT COMPLETED|Overall Study||3||
48673331|NCT01168596|101982796|FG001|NOT COMPLETED|Overall Study||1||
48673332|NCT00399529|101982797|FG000|STARTED|Overall Study||22||
48673333|NCT00399529|101982797|FG000|COMPLETED|Overall Study||20||
48673334|NCT00399529|101982797|FG000|NOT COMPLETED|Overall Study||2||
48673335|NCT02458235|101982798|FG000|STARTED|Overall Study||17||
48673336|NCT02458235|101982798|FG000|COMPLETED|Overall Study||17||
48673337|NCT02458235|101982798|FG000|NOT COMPLETED|Overall Study||0||
48673338|NCT04079738|101982799|FG000|STARTED|Study Treatment||8||
48673339|NCT04079738|101982800|FG001|STARTED|Study Treatment||0||
48673340|NCT04079738|101982801|FG002|STARTED|Study Treatment||0||
48673341|NCT04079738|101982802|FG003|STARTED|Study Treatment||0||
48673342|NCT04079738|101982799|FG000|COMPLETED|Study Treatment||0||
48673343|NCT04079738|101982800|FG001|COMPLETED|Study Treatment||0||
48673344|NCT04079738|101982801|FG002|COMPLETED|Study Treatment||0||
48673345|NCT04079738|101982802|FG003|COMPLETED|Study Treatment||0||
48673346|NCT04079738|101982799|FG000|NOT COMPLETED|Study Treatment||8||
48673347|NCT04079738|101982800|FG001|NOT COMPLETED|Study Treatment||0||
48673348|NCT04079738|101982801|FG002|NOT COMPLETED|Study Treatment||0||
48673349|NCT04079738|101982802|FG003|NOT COMPLETED|Study Treatment||0||
48673350|NCT04079738|101982799|FG000|STARTED|Follow up||8||
48673351|NCT04079738|101982800|FG001|STARTED|Follow up||0||
48673352|NCT04079738|101982801|FG002|STARTED|Follow up||0||
48673353|NCT04079738|101982802|FG003|STARTED|Follow up||0||
48673354|NCT04079738|101982799|FG000|COMPLETED|Follow up||0||
48673355|NCT04079738|101982800|FG001|COMPLETED|Follow up||0||
48673356|NCT04079738|101982801|FG002|COMPLETED|Follow up||0||
48673357|NCT04079738|101982802|FG003|COMPLETED|Follow up||0||
48673358|NCT04079738|101982799|FG000|NOT COMPLETED|Follow up||8||
48673359|NCT04079738|101982800|FG001|NOT COMPLETED|Follow up||0||
48673360|NCT04079738|101982801|FG002|NOT COMPLETED|Follow up||0||
48673361|NCT04079738|101982802|FG003|NOT COMPLETED|Follow up||0||
48673362|NCT02271880|101982803|FG000|STARTED|Overall Study||3||
48673363|NCT02271880|101982804|FG001|STARTED|Overall Study||4||
48673364|NCT02271880|101982803|FG000|COMPLETED|Overall Study||0|This study was prematurely discontinued due to low enrollment.|
48673365|NCT02271880|101982804|FG001|COMPLETED|Overall Study||0|This study was prematurely discontinued due to low enrollment.|
48673366|NCT02271880|101982803|FG000|NOT COMPLETED|Overall Study||3||
48673367|NCT02271880|101982804|FG001|NOT COMPLETED|Overall Study||4||
48673368|NCT01528592|101982805|FG000|STARTED|Overall Study||18||
48673369|NCT01528592|101982805|FG000|COMPLETED|Overall Study||18||
48673370|NCT01528592|101982805|FG000|NOT COMPLETED|Overall Study||0||
48673371|NCT02965781|101982806|FG000|STARTED|Overall Study||46||
48673372|NCT02965781|101982807|FG001|STARTED|Overall Study||46||
48673373|NCT02965781|101982808|FG002|STARTED|Overall Study||47||
48673374|NCT02965781|101982806|FG000|COMPLETED|Overall Study||46||
48673375|NCT02965781|101982807|FG001|COMPLETED|Overall Study||46||
48673376|NCT02965781|101982808|FG002|COMPLETED|Overall Study||47||
48673377|NCT02965781|101982806|FG000|NOT COMPLETED|Overall Study||0||
48673378|NCT02965781|101982807|FG001|NOT COMPLETED|Overall Study||0||
48673379|NCT02965781|101982808|FG002|NOT COMPLETED|Overall Study||0||
48673380|NCT02958345|101982809|FG000|STARTED|Overall Study||14||
48673381|NCT02958345|101982810|FG001|STARTED|Overall Study||14||
48673382|NCT02958345|101982809|FG000|COMPLETED|Overall Study||13||
48673383|NCT02958345|101982810|FG001|COMPLETED|Overall Study||13||
48673384|NCT02958345|101982809|FG000|NOT COMPLETED|Overall Study||1||
48673385|NCT02958345|101982810|FG001|NOT COMPLETED|Overall Study||1||
48673386|NCT04189484|101982811|FG000|STARTED|Overall Study||8||
48673387|NCT04189484|101982812|FG001|STARTED|Overall Study||8||
48673388|NCT04189484|101982813|FG002|STARTED|Overall Study||8||
48673389|NCT04189484|101982814|FG003|STARTED|Overall Study||8||
48673390|NCT04189484|101982815|FG004|STARTED|Overall Study||8||
48673391|NCT04189484|101982816|FG005|STARTED|Overall Study||8||
48673392|NCT04189484|101982817|FG006|STARTED|Overall Study||8||
48673393|NCT04189484|101982818|FG007|STARTED|Overall Study||8||
48673394|NCT04189484|101982819|FG008|STARTED|Overall Study||8||
48673395|NCT04189484|101982811|FG000|COMPLETED|Overall Study||7||
48673396|NCT04189484|101982812|FG001|COMPLETED|Overall Study||8||
48673397|NCT04189484|101982813|FG002|COMPLETED|Overall Study||8||
48673398|NCT04189484|101982814|FG003|COMPLETED|Overall Study||8||
48673399|NCT04189484|101982815|FG004|COMPLETED|Overall Study||8||
48673400|NCT04189484|101982816|FG005|COMPLETED|Overall Study||8||
48673401|NCT04189484|101982817|FG006|COMPLETED|Overall Study||7||
48673402|NCT04189484|101982818|FG007|COMPLETED|Overall Study||7||
48673403|NCT04189484|101982819|FG008|COMPLETED|Overall Study||7||
48673404|NCT04189484|101982811|FG000|NOT COMPLETED|Overall Study||1||
48673405|NCT04189484|101982812|FG001|NOT COMPLETED|Overall Study||0||
48673406|NCT04189484|101982813|FG002|NOT COMPLETED|Overall Study||0||
48673407|NCT04189484|101982814|FG003|NOT COMPLETED|Overall Study||0||
48673408|NCT04189484|101982815|FG004|NOT COMPLETED|Overall Study||0||
48673409|NCT04189484|101982816|FG005|NOT COMPLETED|Overall Study||0||
48673410|NCT04189484|101982817|FG006|NOT COMPLETED|Overall Study||1||
48673411|NCT04189484|101982818|FG007|NOT COMPLETED|Overall Study||1||
48673412|NCT04189484|101982819|FG008|NOT COMPLETED|Overall Study||1||
48673413|NCT03069716|101982820|FG000|STARTED|Run-in Period (2 Weeks)||49||
48673414|NCT03069716|101982821|FG001|STARTED|Run-in Period (2 Weeks)||0||
48673415|NCT03069716|101982822|FG002|STARTED|Run-in Period (2 Weeks)||0||
48673416|NCT03069716|101982820|FG000|COMPLETED|Run-in Period (2 Weeks)||42||
48673417|NCT03069716|101982821|FG001|COMPLETED|Run-in Period (2 Weeks)||0||
48673418|NCT03069716|101982822|FG002|COMPLETED|Run-in Period (2 Weeks)||0||
48673419|NCT03069716|101982820|FG000|NOT COMPLETED|Run-in Period (2 Weeks)||7||
48673420|NCT03069716|101982821|FG001|NOT COMPLETED|Run-in Period (2 Weeks)||0||
48673421|NCT03069716|101982822|FG002|NOT COMPLETED|Run-in Period (2 Weeks)||0||
48673422|NCT03069716|101982820|FG000|STARTED|Randomized Treatment||0||
48673423|NCT03069716|101982821|FG001|STARTED|Randomized Treatment||20||
48673424|NCT03069716|101982822|FG002|STARTED|Randomized Treatment||22||
48673425|NCT03069716|101982820|FG000|COMPLETED|Randomized Treatment||0||
48673426|NCT03069716|101982821|FG001|COMPLETED|Randomized Treatment||18||
48673427|NCT03069716|101982822|FG002|COMPLETED|Randomized Treatment||22||
48673428|NCT03069716|101982820|FG000|NOT COMPLETED|Randomized Treatment||0||
48673429|NCT03069716|101982821|FG001|NOT COMPLETED|Randomized Treatment||2||
48673430|NCT03069716|101982822|FG002|NOT COMPLETED|Randomized Treatment||0||
48673431|NCT02369536|101982823|FG000|STARTED|Overall Study||62||
48673432|NCT02369536|101982824|FG001|STARTED|Overall Study||64||
48673433|NCT02369536|101982823|FG000|COMPLETED|Overall Study||55||
48673434|NCT02369536|101982824|FG001|COMPLETED|Overall Study||58||
48673435|NCT02369536|101982823|FG000|NOT COMPLETED|Overall Study||7||
48673436|NCT02369536|101982824|FG001|NOT COMPLETED|Overall Study||6||
48673437|NCT00265798|101982825|FG000|STARTED|Overall Study||38||
48673438|NCT00265798|101982825|FG000|COMPLETED|Overall Study||38||
48673439|NCT00265798|101982825|FG000|NOT COMPLETED|Overall Study||0||
48673440|NCT04116684|101982826|FG000|STARTED|Overall Study||3||
48673441|NCT04116684|101982827|FG001|STARTED|Overall Study||1||
48673442|NCT04116684|101982826|FG000|COMPLETED|Overall Study||1||
48673443|NCT04116684|101982827|FG001|COMPLETED|Overall Study||1||
48673444|NCT04116684|101982826|FG000|NOT COMPLETED|Overall Study||2||
48673445|NCT04116684|101982827|FG001|NOT COMPLETED|Overall Study||0||
48673446|NCT01983111|101982828|FG000|STARTED|Overall Study||70||
48673447|NCT01983111|101982829|FG001|STARTED|Overall Study||66||
48673448|NCT01983111|101982828|FG000|COMPLETED|Overall Study||58||
48673449|NCT01983111|101982829|FG001|COMPLETED|Overall Study||59||
48673450|NCT01983111|101982828|FG000|NOT COMPLETED|Overall Study||12||
48673451|NCT01983111|101982829|FG001|NOT COMPLETED|Overall Study||7||
48673452|NCT01280968|101982830|FG000|STARTED|Overall Study||45||
48673453|NCT01280968|101982831|FG001|STARTED|Overall Study||7||
48673454|NCT01280968|101982830|FG000|COMPLETED|Overall Study||27||
48673455|NCT01280968|101982831|FG001|COMPLETED|Overall Study||4||
48673456|NCT01280968|101982830|FG000|NOT COMPLETED|Overall Study||18||
48673457|NCT01280968|101982831|FG001|NOT COMPLETED|Overall Study||3||
48673458|NCT02378480|101982832|FG000|STARTED|Overall Study||329||
48673459|NCT02378480|101982833|FG001|STARTED|Overall Study||326||
48673460|NCT02378480|101982832|FG000|COMPLETED|Overall Study||301||
48673461|NCT02378480|101982833|FG001|COMPLETED|Overall Study||294||
48673462|NCT02378480|101982832|FG000|NOT COMPLETED|Overall Study||28||
48673463|NCT02378480|101982833|FG001|NOT COMPLETED|Overall Study||32||
48673464|NCT02499887|101982834|FG000|STARTED|Overall Study||3||
48673465|NCT02499887|101982835|FG001|STARTED|Overall Study||3||
48673466|NCT02499887|101982834|FG000|COMPLETED|Overall Study||3||
48673467|NCT02499887|101982835|FG001|COMPLETED|Overall Study||3||
48673468|NCT02499887|101982834|FG000|NOT COMPLETED|Overall Study||0||
48673469|NCT02499887|101982835|FG001|NOT COMPLETED|Overall Study||0||
48673470|NCT02874092|101982836|FG000|STARTED|Overall Study||7||
48673471|NCT02874092|101982837|FG001|STARTED|Overall Study||2||
48673472|NCT02874092|101982836|FG000|COMPLETED|Overall Study||7||
48673473|NCT02874092|101982837|FG001|COMPLETED|Overall Study||2||
48673474|NCT02874092|101982836|FG000|NOT COMPLETED|Overall Study||0||
48673475|NCT02874092|101982837|FG001|NOT COMPLETED|Overall Study||0||
48673476|NCT04570384|101982838|FG000|STARTED|Overall Study||33||
48673477|NCT04570384|101982839|FG001|STARTED|Overall Study||32||
48673478|NCT04570384|101982838|FG000|COMPLETED|Overall Study||22||
48673479|NCT04570384|101982839|FG001|COMPLETED|Overall Study||23||
48673480|NCT04570384|101982838|FG000|NOT COMPLETED|Overall Study||11||
48673481|NCT04570384|101982839|FG001|NOT COMPLETED|Overall Study||9||
48673482|NCT04856527|101982840|FG000|STARTED|Overall Study||13||26
48673483|NCT04856527|101982841|FG001|STARTED|Overall Study||12||24
48673484|NCT04856527|101982840|FG000|COMPLETED|Overall Study||11||22
48673485|NCT04856527|101982841|FG001|COMPLETED|Overall Study||12||24
48673486|NCT04856527|101982840|FG000|NOT COMPLETED|Overall Study||2||4
48673487|NCT04856527|101982841|FG001|NOT COMPLETED|Overall Study||0||0
48673488|NCT01365455|101982842|FG000|STARTED|Induction Period||245||
48673489|NCT01365455|101982843|FG001|STARTED|Induction Period||245||
48673490|NCT01365455|101982844|FG002|STARTED|Induction Period||248||
48673491|NCT01365455|101982845|FG003|STARTED|Induction Period||0||
48673492|NCT01365455|101982846|FG004|STARTED|Induction Period||0||
48673493|NCT01365455|101982842|FG000|COMPLETED|Induction Period||230||
48673494|NCT01365455|101982843|FG001|COMPLETED|Induction Period||238||
48673495|NCT01365455|101982844|FG002|COMPLETED|Induction Period||232||
48673496|NCT01365455|101982845|FG003|COMPLETED|Induction Period||0||
48673497|NCT01365455|101982846|FG004|COMPLETED|Induction Period||0||
48673498|NCT01365455|101982842|FG000|NOT COMPLETED|Induction Period||15||
48673499|NCT01365455|101982843|FG001|NOT COMPLETED|Induction Period||7||
48673500|NCT01365455|101982844|FG002|NOT COMPLETED|Induction Period||16||
48673501|NCT01365455|101982845|FG003|NOT COMPLETED|Induction Period||0||
48673502|NCT01365455|101982846|FG004|NOT COMPLETED|Induction Period||0||
48673503|NCT01365455|101982842|FG000|STARTED|Maintenance Period||230||
48673504|NCT01365455|101982843|FG001|STARTED|Maintenance Period||238||
48673505|NCT01365455|101982844|FG002|STARTED|Maintenance Period||18||
48673506|NCT01365455|101982845|FG003|STARTED|Maintenance Period||109||
48673507|NCT01365455|101982846|FG004|STARTED|Maintenance Period||105||
48673508|NCT01365455|101982842|FG000|COMPLETED|Maintenance Period||201||
48673509|NCT01365455|101982843|FG001|COMPLETED|Maintenance Period||215||
48673510|NCT01365455|101982844|FG002|COMPLETED|Maintenance Period||15||
48673511|NCT01365455|101982845|FG003|COMPLETED|Maintenance Period||100||
48673512|NCT01365455|101982846|FG004|COMPLETED|Maintenance Period||92||
48673513|NCT01365455|101982842|FG000|NOT COMPLETED|Maintenance Period||29||
48673514|NCT01365455|101982843|FG001|NOT COMPLETED|Maintenance Period||23||
48673515|NCT01365455|101982844|FG002|NOT COMPLETED|Maintenance Period||3||
48673516|NCT01365455|101982845|FG003|NOT COMPLETED|Maintenance Period||9||
48673517|NCT01365455|101982846|FG004|NOT COMPLETED|Maintenance Period||13||
48673518|NCT01365455|101982842|FG000|STARTED|Follow-up Period||58||
48673519|NCT01365455|101982843|FG001|STARTED|Follow-up Period||47||
48673520|NCT01365455|101982844|FG002|STARTED|Follow-up Period||18||
48673521|NCT01365455|101982845|FG003|STARTED|Follow-up Period||0||
48673522|NCT01365455|101982846|FG004|STARTED|Follow-up Period||0||
48673523|NCT01365455|101982842|FG000|COMPLETED|Follow-up Period||58||
48673524|NCT01365455|101982843|FG001|COMPLETED|Follow-up Period||47||
48673525|NCT01365455|101982844|FG002|COMPLETED|Follow-up Period||18||
48673526|NCT01365455|101982845|FG003|COMPLETED|Follow-up Period||0||
48673527|NCT01365455|101982846|FG004|COMPLETED|Follow-up Period||0||
48673528|NCT01365455|101982842|FG000|NOT COMPLETED|Follow-up Period||0||
48673529|NCT01365455|101982843|FG001|NOT COMPLETED|Follow-up Period||0||
48673530|NCT01365455|101982844|FG002|NOT COMPLETED|Follow-up Period||0||
48673531|NCT01365455|101982845|FG003|NOT COMPLETED|Follow-up Period||0||
48673532|NCT01365455|101982846|FG004|NOT COMPLETED|Follow-up Period||0||
48673533|NCT02390076|101982847|FG000|STARTED|Overall Study||18||
48673534|NCT02390076|101982848|FG001|STARTED|Overall Study||18||
48673535|NCT02390076|101982849|FG002|STARTED|Overall Study||15||
48673536|NCT02390076|101982847|FG000|COMPLETED|Overall Study||16||
48673537|NCT02390076|101982848|FG001|COMPLETED|Overall Study||17||
48673538|NCT02390076|101982849|FG002|COMPLETED|Overall Study||11||
48673539|NCT02390076|101982847|FG000|NOT COMPLETED|Overall Study||2||
48673540|NCT02390076|101982848|FG001|NOT COMPLETED|Overall Study||1||
48673541|NCT02390076|101982849|FG002|NOT COMPLETED|Overall Study||4||
48673542|NCT03402841|101982850|FG000|STARTED|Overall Study||279||
48673543|NCT03402841|101982850|FG000|COMPLETED|Overall Study||128||
48673544|NCT03402841|101982850|FG000|NOT COMPLETED|Overall Study||151||
48673545|NCT04622592|101982851|FG000|STARTED|Overall Study||19||
48673546|NCT04622592|101982852|FG001|STARTED|Overall Study||9||
48673547|NCT04622592|101982853|FG002|STARTED|Overall Study||42||
48673548|NCT04622592|101982854|FG003|STARTED|Overall Study||19||
48673549|NCT04622592|101982855|FG004|STARTED|Overall Study||23||
48673550|NCT04622592|101982856|FG005|STARTED|Overall Study||13||
48673551|NCT04622592|101982857|FG006|STARTED|Overall Study||41||
48673552|NCT04622592|101982858|FG007|STARTED|Overall Study||43||
48673553|NCT04622592|101982851|FG000|Vaccinated|Overall Study||19||
48673554|NCT04622592|101982852|FG001|Vaccinated|Overall Study||9||
48673555|NCT04622592|101982853|FG002|Vaccinated|Overall Study||42||
48673556|NCT04622592|101982854|FG003|Vaccinated|Overall Study||19||
48673557|NCT04622592|101982855|FG004|Vaccinated|Overall Study||23||
48673558|NCT04622592|101982856|FG005|Vaccinated|Overall Study||13||
48673559|NCT04622592|101982857|FG006|Vaccinated|Overall Study||41||
48673560|NCT04622592|101982858|FG007|Vaccinated|Overall Study||43||
48673561|NCT04622592|101982851|FG000|COMPLETED|Overall Study||18||
48673562|NCT04622592|101982852|FG001|COMPLETED|Overall Study||9||
48673563|NCT04622592|101982853|FG002|COMPLETED|Overall Study||38||
48673564|NCT04622592|101982854|FG003|COMPLETED|Overall Study||16||
48673565|NCT04622592|101982855|FG004|COMPLETED|Overall Study||21||
48673566|NCT04622592|101982856|FG005|COMPLETED|Overall Study||13||
48673567|NCT04622592|101982857|FG006|COMPLETED|Overall Study||38||
48673568|NCT04622592|101982858|FG007|COMPLETED|Overall Study||36||
48673569|NCT04622592|101982851|FG000|NOT COMPLETED|Overall Study||1||
48673570|NCT04622592|101982852|FG001|NOT COMPLETED|Overall Study||0||
48673571|NCT04622592|101982853|FG002|NOT COMPLETED|Overall Study||4||
48673572|NCT04622592|101982854|FG003|NOT COMPLETED|Overall Study||3||
48673573|NCT04622592|101982855|FG004|NOT COMPLETED|Overall Study||2||
48673574|NCT04622592|101982856|FG005|NOT COMPLETED|Overall Study||0||
48673575|NCT04622592|101982857|FG006|NOT COMPLETED|Overall Study||3||
48673576|NCT04622592|101982858|FG007|NOT COMPLETED|Overall Study||7||
48673577|NCT00485173|101982859|FG000|STARTED|Overall Study||224||
48673578|NCT00485173|101982860|FG001|STARTED|Overall Study||486||
48673579|NCT00485173|101982859|FG000|COMPLETED|Overall Study||188||
48673580|NCT00485173|101982860|FG001|COMPLETED|Overall Study||422||
48673581|NCT00485173|101982859|FG000|NOT COMPLETED|Overall Study||36||
48673582|NCT00485173|101982860|FG001|NOT COMPLETED|Overall Study||64||
48673583|NCT01098422|101982861|FG000|STARTED|Overall Study||10||
48673584|NCT01098422|101982861|FG000|COMPLETED|Overall Study||9||
48673585|NCT01098422|101982861|FG000|NOT COMPLETED|Overall Study||1||
48673586|NCT01600287|101982862|FG000|STARTED|Overall Study||20||
48673587|NCT01600287|101982863|FG001|STARTED|Overall Study||20||
48673588|NCT01600287|101982862|FG000|COMPLETED|Overall Study||20||
48673589|NCT01600287|101982863|FG001|COMPLETED|Overall Study||20||
48673590|NCT01600287|101982862|FG000|NOT COMPLETED|Overall Study||0||
48673591|NCT01600287|101982863|FG001|NOT COMPLETED|Overall Study||0||
48673592|NCT01728246|101982864|FG000|STARTED|Overall Study||242||
48673593|NCT01728246|101982865|FG001|STARTED|Overall Study||231||
48673594|NCT01728246|101982864|FG000|COMPLETED|Overall Study||206||
48673595|NCT01728246|101982865|FG001|COMPLETED|Overall Study||195||
48673596|NCT01728246|101982864|FG000|NOT COMPLETED|Overall Study||36||
48673597|NCT01728246|101982865|FG001|NOT COMPLETED|Overall Study||36||
48673598|NCT03840967|101982866|FG000|STARTED|Overall Study||14||
48673599|NCT03840967|101982866|FG000|COMPLETED|Overall Study||14||
48673600|NCT03840967|101982866|FG000|NOT COMPLETED|Overall Study||0||
48710640|NCT03777709|102077979|FG000|NOT COMPLETED|Overall Study||7||0
48710641|NCT03777709|102077980|FG001|NOT COMPLETED|Overall Study||2||0
48710642|NCT01477463|102077981|FG000|STARTED|Overall Study||18||
48710643|NCT01477463|102077982|FG001|STARTED|Overall Study||6||
48710644|NCT01477463|102077981|FG000|COMPLETED|Overall Study||18||
48710645|NCT01477463|102077982|FG001|COMPLETED|Overall Study||6||
48673601|NCT04442269|101985830|FG000|STARTED|Overall Study||27||
48673602|NCT04442269|101985831|FG001|STARTED|Overall Study||35||
48673603|NCT04442269|101985830|FG000|COMPLETED|Overall Study||20||
48673604|NCT04442269|101985831|FG001|COMPLETED|Overall Study||29||
48673605|NCT04442269|101985830|FG000|NOT COMPLETED|Overall Study||7||
48673606|NCT04442269|101985831|FG001|NOT COMPLETED|Overall Study||6||
48673607|NCT01448616|101985832|FG000|STARTED|Lead-In (Observational Phase)||73||
48673608|NCT01448616|101985833|FG001|STARTED|Lead-In (Observational Phase)||0||
48673609|NCT01448616|101985834|FG002|STARTED|Lead-In (Observational Phase)||0||
48673610|NCT01448616|101985835|FG003|STARTED|Lead-In (Observational Phase)||0||
48673611|NCT01448616|101985832|FG000|COMPLETED|Lead-In (Observational Phase)||64||
48673612|NCT01448616|101985833|FG001|COMPLETED|Lead-In (Observational Phase)||0||
48673613|NCT01448616|101985834|FG002|COMPLETED|Lead-In (Observational Phase)||0||
48673614|NCT01448616|101985835|FG003|COMPLETED|Lead-In (Observational Phase)||0||
48673615|NCT01448616|101985832|FG000|NOT COMPLETED|Lead-In (Observational Phase)||9||
48673616|NCT01448616|101985833|FG001|NOT COMPLETED|Lead-In (Observational Phase)||0||
48673617|NCT01448616|101985834|FG002|NOT COMPLETED|Lead-In (Observational Phase)||0||
48673618|NCT01448616|101985835|FG003|NOT COMPLETED|Lead-In (Observational Phase)||0||
48673619|NCT01448616|101985832|FG000|STARTED|Study Drug (Treatment Phase)||0||
48673620|NCT01448616|101985833|FG001|STARTED|Study Drug (Treatment Phase)||24||
48673621|NCT01448616|101985834|FG002|STARTED|Study Drug (Treatment Phase)||27||
48673622|NCT01448616|101985835|FG003|STARTED|Study Drug (Treatment Phase)||13||
48673623|NCT01448616|101985832|FG000|COMPLETED|Study Drug (Treatment Phase)||0||
48673624|NCT01448616|101985833|FG001|COMPLETED|Study Drug (Treatment Phase)||22||
48673625|NCT01448616|101985834|FG002|COMPLETED|Study Drug (Treatment Phase)||23||
48673626|NCT01448616|101985835|FG003|COMPLETED|Study Drug (Treatment Phase)||9||
48673627|NCT01448616|101985832|FG000|NOT COMPLETED|Study Drug (Treatment Phase)||0||
48673628|NCT01448616|101985833|FG001|NOT COMPLETED|Study Drug (Treatment Phase)||2||
48673629|NCT01448616|101985834|FG002|NOT COMPLETED|Study Drug (Treatment Phase)||4||
48673630|NCT01448616|101985835|FG003|NOT COMPLETED|Study Drug (Treatment Phase)||4||
48673631|NCT01664624|101985836|FG000|STARTED|Overall Study||10||
48673632|NCT01664624|101985837|FG001|STARTED|Overall Study||11||
48673633|NCT01664624|101985838|FG002|STARTED|Overall Study||10||
48673634|NCT01664624|101985839|FG003|STARTED|Overall Study||9||
48673635|NCT01664624|101985836|FG000|COMPLETED|Overall Study||10||
48673636|NCT01664624|101985837|FG001|COMPLETED|Overall Study||10||
48673637|NCT01664624|101985838|FG002|COMPLETED|Overall Study||10||
48673638|NCT01664624|101985839|FG003|COMPLETED|Overall Study||9||
48673639|NCT01664624|101985836|FG000|NOT COMPLETED|Overall Study||0||
48673640|NCT01664624|101985837|FG001|NOT COMPLETED|Overall Study||1||
48673641|NCT01664624|101985838|FG002|NOT COMPLETED|Overall Study||0||
48673642|NCT01664624|101985839|FG003|NOT COMPLETED|Overall Study||0||
48673643|NCT03673176|101985840|FG000|STARTED|Overall Study||9||
48673644|NCT03673176|101985840|FG000|Received SABR Treatment|Overall Study||8||
48673645|NCT03673176|101985840|FG000|COMPLETED|Overall Study||4||
48673646|NCT03673176|101985840|FG000|NOT COMPLETED|Overall Study||5||
48673647|NCT03373435|101985841|FG000|STARTED|Treatment Period 1 (14 Days)||8||
48673648|NCT03373435|101985842|FG001|STARTED|Treatment Period 1 (14 Days)||10||
48673649|NCT03373435|101985841|FG000|COMPLETED|Treatment Period 1 (14 Days)||8||
48522946|NCT02357342|101611932|FG001|STARTED|First 6 Months||20|15 subjects were still in study when it was extended; 13 subjects qualified for extension.|
48522947|NCT02357342|101611931|FG000|COMPLETED|First 6 Months||18||
48522948|NCT02357342|101611932|FG001|COMPLETED|First 6 Months||20||
48522949|NCT02357342|101611931|FG000|NOT COMPLETED|First 6 Months||2||
48522950|NCT02357342|101611932|FG001|NOT COMPLETED|First 6 Months||0||
48522951|NCT02357342|101611931|FG000|STARTED|Extension Study||4||
48673650|NCT03373435|101985842|FG001|COMPLETED|Treatment Period 1 (14 Days)||10||
48673651|NCT03373435|101985841|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||0||
48522952|NCT02357342|101611932|FG001|STARTED|Extension Study||9||
48522953|NCT02357342|101611931|FG000|COMPLETED|Extension Study||4||
48522954|NCT02357342|101611932|FG001|COMPLETED|Extension Study||9||
48522955|NCT02357342|101611931|FG000|NOT COMPLETED|Extension Study||0||
48522956|NCT02357342|101611932|FG001|NOT COMPLETED|Extension Study||0||
48592623|NCT01877382|101783155|FG005|STARTED|Dose Escalation||5||
48592624|NCT01877382|101783156|FG006|STARTED|Dose Escalation||9||
48592625|NCT01877382|101783157|FG007|STARTED|Dose Escalation||15||
48592626|NCT01877382|101783158|FG008|STARTED|Dose Escalation||6||
48592627|NCT01877382|101783159|FG009|STARTED|Dose Escalation||3||
48592628|NCT01877382|101783160|FG010|STARTED|Dose Escalation||3||
48592629|NCT01877382|101783161|FG011|STARTED|Dose Escalation||3||
48592630|NCT01877382|101783162|FG012|STARTED|Dose Escalation||20||
48592631|NCT01877382|101783163|FG013|STARTED|Dose Escalation||3||
48592632|NCT01877382|101783164|FG014|STARTED|Dose Escalation||0||
48592633|NCT01877382|101783150|FG000|COMPLETED|Dose Escalation||0||
48592634|NCT01877382|101783151|FG001|COMPLETED|Dose Escalation||0||
48592635|NCT01877382|101783152|FG002|COMPLETED|Dose Escalation||0||
48592636|NCT01877382|101783153|FG003|COMPLETED|Dose Escalation||0||
48592637|NCT01877382|101783154|FG004|COMPLETED|Dose Escalation||0||
48592638|NCT01877382|101783155|FG005|COMPLETED|Dose Escalation||0||
48592639|NCT01877382|101783156|FG006|COMPLETED|Dose Escalation||0||
48592640|NCT01877382|101783157|FG007|COMPLETED|Dose Escalation||0||
48522957|NCT00038649|101616008|FG000|STARTED|Overall Study||114||
48522958|NCT00038649|101616008|FG000|COMPLETED|Overall Study||105||
48522959|NCT00038649|101616008|FG000|NOT COMPLETED|Overall Study||9||
48522960|NCT02595008|101616009|FG000|STARTED|Overall Study||20||
48522961|NCT02595008|101616010|FG001|STARTED|Overall Study||4||
48522962|NCT02595008|101616009|FG000|COMPLETED|Overall Study||19||
48522963|NCT02595008|101616010|FG001|COMPLETED|Overall Study||4||
48522964|NCT02595008|101616009|FG000|NOT COMPLETED|Overall Study||1||
48522965|NCT02595008|101616010|FG001|NOT COMPLETED|Overall Study||0||
48522966|NCT01425723|101616011|FG000|STARTED|Overall Study||27||
48522967|NCT01425723|101616012|FG001|STARTED|Overall Study||93||
48522968|NCT01425723|101616011|FG000|Weekly Prophylaxis|Overall Study||23||
48522969|NCT01425723|101616012|FG001|Weekly Prophylaxis|Overall Study||51||
48522970|NCT01425723|101616011|FG000|Individualized Prophylaxis|Overall Study||5||
48522971|NCT01425723|101616012|FG001|Individualized Prophylaxis|Overall Study||31||
48522972|NCT01425723|101616011|FG000|Personalized Prophylaxis|Overall Study||2||
48522973|NCT01425723|101616012|FG001|Personalized Prophylaxis|Overall Study||17||
48522974|NCT01425723|101616011|FG000|Episodic|Overall Study||0||
48522975|NCT01425723|101616012|FG001|Episodic|Overall Study||15||
48522976|NCT01425723|101616011|FG000|Surgery Subgroup|Overall Study||1|Participants who have undergone major surgery or have major surgical/rehabilitation period in study.|
48522977|NCT01425723|101616012|FG001|Surgery Subgroup|Overall Study||15|Participants who have undergone major surgery or have major surgical/rehabilitation period in study.|
48522978|NCT01425723|101616011|FG000|COMPLETED|Overall Study||23||
48522979|NCT01425723|101616012|FG001|COMPLETED|Overall Study||75||
48522980|NCT01425723|101616011|FG000|NOT COMPLETED|Overall Study||4||
48522981|NCT01425723|101616012|FG001|NOT COMPLETED|Overall Study||18||
48522982|NCT01524913|101616013|FG000|STARTED|Overall Study||35||
48522983|NCT01524913|101616014|FG001|STARTED|Overall Study||36||
48522984|NCT01524913|101616015|FG002|STARTED|Overall Study||31||
48522985|NCT01524913|101616013|FG000|COMPLETED|Overall Study||31||
48074478|NCT01487200|100504485|FG001|COMPLETED|Overall Study||6||
48522986|NCT01524913|101616014|FG001|COMPLETED|Overall Study||36||
48522987|NCT01524913|101616015|FG002|COMPLETED|Overall Study||31||
48522988|NCT01524913|101616013|FG000|NOT COMPLETED|Overall Study||4||
48522989|NCT01524913|101616014|FG001|NOT COMPLETED|Overall Study||0||
48522990|NCT01524913|101616015|FG002|NOT COMPLETED|Overall Study||0||
48522991|NCT03345394|101616016|FG000|STARTED|Overall Study||48||
48522992|NCT03345394|101616017|FG001|STARTED|Overall Study||50||
48522993|NCT03345394|101616016|FG000|COMPLETED|Overall Study||48||
48522994|NCT03345394|101616017|FG001|COMPLETED|Overall Study||50||
48522995|NCT03345394|101616016|FG000|NOT COMPLETED|Overall Study||0||
48522996|NCT03345394|101616017|FG001|NOT COMPLETED|Overall Study||0||
48074479|NCT01487200|100504486|FG002|COMPLETED|Overall Study||7||
48074480|NCT01487200|100504487|FG003|COMPLETED|Overall Study||5||
48074481|NCT01487200|100504484|FG000|NOT COMPLETED|Overall Study||0||
48227167|NCT02797132|100877933|FG000|STARTED|Part B (24 Weeks)||60||
48227168|NCT02797132|100877933|FG000|Part B (<14 kg Weight)|Part B (24 Weeks)||19||
48227169|NCT02797132|100877933|FG000|Part B (>=14 kg Weight)|Part B (24 Weeks)||41||
48227170|NCT02797132|100877933|FG000|COMPLETED|Part B (24 Weeks)||57||
48227171|NCT02797132|100877933|FG000|NOT COMPLETED|Part B (24 Weeks)||3||
48227172|NCT01323790|100877934|FG000|STARTED|Overall Study||233||
48227173|NCT01323790|100877935|FG001|STARTED|Overall Study||234||
48227174|NCT01323790|100877936|FG002|STARTED|Overall Study||233||
48227175|NCT01323790|100877934|FG000|COMPLETED|Overall Study||178||
48374604|NCT03738566|101247434|FG000|STARTED|Initial Study Phase||6||
48374605|NCT03738566|101247435|FG001|STARTED|Initial Study Phase||6||
48374606|NCT03738566|101247436|FG002|STARTED|Initial Study Phase||14||
48374607|NCT03738566|101247437|FG003|STARTED|Initial Study Phase||0||
48227176|NCT01323790|100877935|FG001|COMPLETED|Overall Study||174||
48227177|NCT01323790|100877936|FG002|COMPLETED|Overall Study||188||
48227178|NCT01323790|100877934|FG000|NOT COMPLETED|Overall Study||55||
48374608|NCT03738566|101247434|FG000|COMPLETED|Initial Study Phase||0||
48374609|NCT03738566|101247435|FG001|COMPLETED|Initial Study Phase||4||
48374610|NCT03738566|101247436|FG002|COMPLETED|Initial Study Phase||12||
48074482|NCT01487200|100504485|FG001|NOT COMPLETED|Overall Study||1||
48074483|NCT01487200|100504486|FG002|NOT COMPLETED|Overall Study||0||
48074484|NCT01487200|100504487|FG003|NOT COMPLETED|Overall Study||0||
48074485|NCT00415168|100504488|FG000|STARTED|Overall Study||53||
48074486|NCT00415168|100504488|FG000|Completed Treatment|Overall Study||15||
48074487|NCT00415168|100504488|FG000|COMPLETED|Overall Study||1||
48074488|NCT00415168|100504488|FG000|NOT COMPLETED|Overall Study||52||
48074489|NCT04377620|100504489|FG000|STARTED|Overall Study||77||
48074490|NCT04377620|100504490|FG001|STARTED|Overall Study||87||
48074491|NCT04377620|100504491|FG002|STARTED|Overall Study||47||
48074492|NCT04377620|100504489|FG000|COMPLETED|Overall Study||35||
48074493|NCT04377620|100504490|FG001|COMPLETED|Overall Study||37||
48074494|NCT04377620|100504491|FG002|COMPLETED|Overall Study||11||
48074495|NCT04377620|100504489|FG000|NOT COMPLETED|Overall Study||42||
48074496|NCT04377620|100504490|FG001|NOT COMPLETED|Overall Study||50||
48074497|NCT04377620|100504491|FG002|NOT COMPLETED|Overall Study||36||
48074498|NCT04338074|100504492|FG000|STARTED|Overall Study||3||
48074499|NCT04338074|100504493|FG001|STARTED|Overall Study||2||
48074500|NCT04338074|100504492|FG000|COMPLETED|Overall Study||3||
48074501|NCT04338074|100504493|FG001|COMPLETED|Overall Study||2||
48074502|NCT04338074|100504492|FG000|NOT COMPLETED|Overall Study||0||
48074503|NCT04338074|100504493|FG001|NOT COMPLETED|Overall Study||0||
48074504|NCT02587234|100504494|FG000|STARTED|Overall Study||11||
48074505|NCT02587234|100504495|FG001|STARTED|Overall Study||10||
48074506|NCT02587234|100504494|FG000|COMPLETED|Overall Study||10||
48074507|NCT02587234|100504495|FG001|COMPLETED|Overall Study||7||
48074508|NCT02587234|100504494|FG000|NOT COMPLETED|Overall Study||1||
48074509|NCT02587234|100504495|FG001|NOT COMPLETED|Overall Study||3||
48074510|NCT03298867|100504496|FG000|STARTED|Double-Masked 24-Week Treatment Period||42||
48074511|NCT03298867|100504497|FG001|STARTED|Double-Masked 24-Week Treatment Period||41||
48074512|NCT03298867|100504496|FG000|COMPLETED|Double-Masked 24-Week Treatment Period||40||
48074513|NCT03298867|100504497|FG001|COMPLETED|Double-Masked 24-Week Treatment Period||39||
48074514|NCT03298867|100504496|FG000|NOT COMPLETED|Double-Masked 24-Week Treatment Period||2||
48074515|NCT03298867|100504497|FG001|NOT COMPLETED|Double-Masked 24-Week Treatment Period||2||
48074516|NCT03298867|100504496|FG000|STARTED|48-Week Follow-Up Period (Weeks 24-72)||4||
48074517|NCT03298867|100504497|FG001|STARTED|48-Week Follow-Up Period (Weeks 24-72)||36||
48074518|NCT03298867|100504496|FG000|COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||3||
48074519|NCT03298867|100504497|FG001|COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||20||
48074520|NCT03298867|100504496|FG000|NOT COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||1||
48074521|NCT03298867|100504497|FG001|NOT COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||16||
48074522|NCT03298867|100504496|FG000|STARTED|48-Week Follow-Up Contact (Weeks 96-120)||3||
48074523|NCT03298867|100504497|FG001|STARTED|48-Week Follow-Up Contact (Weeks 96-120)||20||
48074524|NCT03298867|100504496|FG000|COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||3||
48074525|NCT03298867|100504497|FG001|COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||19||
48074526|NCT03298867|100504496|FG000|NOT COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||0||
48074527|NCT03298867|100504497|FG001|NOT COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||1||
48074528|NCT00190671|100504498|FG000|STARTED|Overall Study||42||
48074529|NCT00190671|100504499|FG001|STARTED|Overall Study||61||
48074530|NCT00190671|100504498|FG000|COMPLETED|Overall Study||15||
48074531|NCT00190671|100504499|FG001|COMPLETED|Overall Study||19||
48074532|NCT00190671|100504498|FG000|NOT COMPLETED|Overall Study||27||
48074533|NCT00190671|100504499|FG001|NOT COMPLETED|Overall Study||42||
48074534|NCT02728596|100504500|FG000|STARTED|Overall Study||707||
48074535|NCT02728596|100504501|FG001|STARTED|Overall Study||644||
48074536|NCT02728596|100504502|FG002|STARTED|Overall Study||1281||
48074537|NCT02728596|100504503|FG003|STARTED|Overall Study||973||
48074538|NCT02728596|100504500|FG000|Treatment Completed|Overall Study||665||
48074539|NCT02728596|100504501|FG001|Treatment Completed|Overall Study||602||
48074540|NCT02728596|100504502|FG002|Treatment Completed|Overall Study||1158||
48074541|NCT02728596|100504503|FG003|Treatment Completed|Overall Study||905||
48074542|NCT02728596|100504500|FG000|COMPLETED|Overall Study||660||
48074543|NCT02728596|100504501|FG001|COMPLETED|Overall Study||596||
48074544|NCT02728596|100504502|FG002|COMPLETED|Overall Study||1151||
48074545|NCT02728596|100504503|FG003|COMPLETED|Overall Study||898||
48074546|NCT02728596|100504500|FG000|NOT COMPLETED|Overall Study||47||
48074547|NCT02728596|100504501|FG001|NOT COMPLETED|Overall Study||48||
48074548|NCT02728596|100504502|FG002|NOT COMPLETED|Overall Study||130||
48074549|NCT02728596|100504503|FG003|NOT COMPLETED|Overall Study||75||
48074550|NCT02509767|100504504|FG000|STARTED|Overall Study||201||
48074551|NCT02509767|100504505|FG001|STARTED|Overall Study||200||
48074552|NCT02509767|100504504|FG000|COMPLETED|Overall Study||157||
48074553|NCT02509767|100504505|FG001|COMPLETED|Overall Study||159||
48074554|NCT02509767|100504504|FG000|NOT COMPLETED|Overall Study||44||
48074555|NCT02509767|100504505|FG001|NOT COMPLETED|Overall Study||41||
48074556|NCT03822078|100504506|FG000|STARTED|Overall Study||12||
48074557|NCT03822078|100504507|FG001|STARTED|Overall Study||6||
48074558|NCT03822078|100504508|FG002|STARTED|Overall Study||6||
48074559|NCT03822078|100504509|FG003|STARTED|Overall Study||8||
48074560|NCT03822078|100504510|FG004|STARTED|Overall Study||7||
48074561|NCT03822078|100504511|FG005|STARTED|Overall Study||6||
48074562|NCT03822078|100504506|FG000|Received Study Drug|Overall Study||10||
48074563|NCT03822078|100504507|FG001|Received Study Drug|Overall Study||6||
48074564|NCT03822078|100504508|FG002|Received Study Drug|Overall Study||6||
48074565|NCT03822078|100504509|FG003|Received Study Drug|Overall Study||6||
48074566|NCT03822078|100504510|FG004|Received Study Drug|Overall Study||6||
48074567|NCT03822078|100504511|FG005|Received Study Drug|Overall Study||6||
48074568|NCT03822078|100504506|FG000|COMPLETED|Overall Study||10||
48074569|NCT03822078|100504507|FG001|COMPLETED|Overall Study||6||
48074570|NCT03822078|100504508|FG002|COMPLETED|Overall Study||6||
48074571|NCT03822078|100504509|FG003|COMPLETED|Overall Study||6||
48074572|NCT03822078|100504510|FG004|COMPLETED|Overall Study||6||
48074573|NCT03822078|100504511|FG005|COMPLETED|Overall Study||6||
48074574|NCT03822078|100504506|FG000|NOT COMPLETED|Overall Study||2||
48074575|NCT03822078|100504507|FG001|NOT COMPLETED|Overall Study||0||
48074576|NCT03822078|100504508|FG002|NOT COMPLETED|Overall Study||0||
48074577|NCT03822078|100504509|FG003|NOT COMPLETED|Overall Study||2||
48074578|NCT03822078|100504510|FG004|NOT COMPLETED|Overall Study||1||
48074579|NCT03822078|100504511|FG005|NOT COMPLETED|Overall Study||0||
48074580|NCT00393029|100504512|FG000|STARTED|Overall Study||2||
48074581|NCT00393029|100504513|FG001|STARTED|Overall Study||10||
48074582|NCT00393029|100504512|FG000|COMPLETED|Overall Study||2||
48074583|NCT00393029|100504513|FG001|COMPLETED|Overall Study||9||
48074584|NCT00393029|100504512|FG000|NOT COMPLETED|Overall Study||0||
48074585|NCT00393029|100504513|FG001|NOT COMPLETED|Overall Study||1||
48074586|NCT03675477|100504514|FG000|STARTED|Treatment Phase||41||
48074587|NCT03675477|100504515|FG001|STARTED|Treatment Phase||41||
48074588|NCT03675477|100504516|FG002|STARTED|Treatment Phase||41||
48074589|NCT03675477|100504517|FG003|STARTED|Treatment Phase||41||
48074590|NCT03675477|100504514|FG000|COMPLETED|Treatment Phase||41||
48074591|NCT03675477|100504515|FG001|COMPLETED|Treatment Phase||41||
48074592|NCT03675477|100504516|FG002|COMPLETED|Treatment Phase||41||
48074593|NCT03675477|100504517|FG003|COMPLETED|Treatment Phase||41||
48074594|NCT03675477|100504514|FG000|NOT COMPLETED|Treatment Phase||0||
48074595|NCT03675477|100504515|FG001|NOT COMPLETED|Treatment Phase||0||
48074596|NCT03675477|100504516|FG002|NOT COMPLETED|Treatment Phase||0||
48074597|NCT03675477|100504517|FG003|NOT COMPLETED|Treatment Phase||0||
48074598|NCT03675477|100504514|FG000|STARTED|Extension Phase||47||
48074599|NCT03675477|100504515|FG001|STARTED|Extension Phase||49||
48074600|NCT03675477|100504516|FG002|STARTED|Extension Phase||48||
48074601|NCT03675477|100504517|FG003|STARTED|Extension Phase||0||
48074602|NCT03675477|100504514|FG000|COMPLETED|Extension Phase||47||
48074603|NCT03675477|100504515|FG001|COMPLETED|Extension Phase||49||
48074604|NCT03675477|100504516|FG002|COMPLETED|Extension Phase||48||
48074605|NCT03675477|100504517|FG003|COMPLETED|Extension Phase||0||
48074606|NCT03675477|100504514|FG000|NOT COMPLETED|Extension Phase||0||
48074607|NCT03675477|100504515|FG001|NOT COMPLETED|Extension Phase||0||
48074608|NCT03675477|100504516|FG002|NOT COMPLETED|Extension Phase||0||
48074609|NCT03675477|100504517|FG003|NOT COMPLETED|Extension Phase||0||
48074610|NCT01999179|100504518|FG000|STARTED|Overall Study||27||
48074611|NCT01999179|100504518|FG000|COMPLETED|Overall Study||20||
48074612|NCT01999179|100504518|FG000|NOT COMPLETED|Overall Study||7||
48074613|NCT01546883|100504519|FG000|STARTED|Overall Study||14||
48074614|NCT01546883|100504519|FG000|COMPLETED|Overall Study||2||
48074615|NCT01546883|100504519|FG000|NOT COMPLETED|Overall Study||12||
48074616|NCT01203098|100504520|FG000|STARTED|Overall Study||89||
48074617|NCT01203098|100504521|FG001|STARTED|Overall Study||86||
48074618|NCT01203098|100504522|FG002|STARTED|Overall Study||89||
48074619|NCT01203098|100504520|FG000|Safety Analysis Dataset|Overall Study||89||
48074620|NCT01203098|100504521|FG001|Safety Analysis Dataset|Overall Study||85||
48074621|NCT01203098|100504522|FG002|Safety Analysis Dataset|Overall Study||87||
48074622|NCT01203098|100504520|FG000|COMPLETED|Overall Study||83||
48074623|NCT01203098|100504521|FG001|COMPLETED|Overall Study||82||
48074624|NCT01203098|100504522|FG002|COMPLETED|Overall Study||78||
48074625|NCT01203098|100504520|FG000|NOT COMPLETED|Overall Study||6||
48074626|NCT01203098|100504521|FG001|NOT COMPLETED|Overall Study||4||
48074627|NCT01203098|100504522|FG002|NOT COMPLETED|Overall Study||11||
48074628|NCT01387932|100504523|FG000|STARTED|Randomized and Treated||118||
48074629|NCT01387932|100504524|FG001|STARTED|Randomized and Treated||117||
48074630|NCT01387932|100504523|FG000|COMPLETED|Randomized and Treated||111||
48074631|NCT01387932|100504524|FG001|COMPLETED|Randomized and Treated||113||
48074632|NCT01387932|100504523|FG000|NOT COMPLETED|Randomized and Treated||7||
48074633|NCT01387932|100504524|FG001|NOT COMPLETED|Randomized and Treated||4||
48074634|NCT01387932|100504523|FG000|STARTED|Completion of TACE Cycle||111||
48074635|NCT01387932|100504524|FG001|STARTED|Completion of TACE Cycle||113||
48074636|NCT01387932|100504523|FG000|COMPLETED|Completion of TACE Cycle||111|One hundred percent of the hqTACE arm and 100% of the cTACE arm received their first TACE Cycle.|
48074637|NCT01387932|100504524|FG001|COMPLETED|Completion of TACE Cycle||113|One hundred percent of the hqTACE arm and 100% of the cTACE arm received their first TACE Cycle.|
48074638|NCT01387932|100504523|FG000|NOT COMPLETED|Completion of TACE Cycle||0||
48074639|NCT01387932|100504524|FG001|NOT COMPLETED|Completion of TACE Cycle||0||
48522997|NCT02939014|101616018|FG000|STARTED|Overall Study||30||
48522998|NCT02939014|101616019|FG001|STARTED|Overall Study||9||
48522999|NCT02939014|101616018|FG000|COMPLETED|Overall Study||25|Completed included participants who completed 16 cycles of treatment with brentuximab vedotin and 18-months post-treatment follow-up.|
48523000|NCT02939014|101616019|FG001|COMPLETED|Overall Study||6|Completed included participants who completed 16 cycles of treatment with brentuximab vedotin and 18-months post-treatment follow-up.|
48523001|NCT02939014|101616018|FG000|NOT COMPLETED|Overall Study||5||
48074640|NCT01387932|100504523|FG000|STARTED|Survival Follow-up||111|All subjects that completed at least one TACE cycle were eligible for long-term survival follow-up.|
48074641|NCT01387932|100504524|FG001|STARTED|Survival Follow-up||113|All subjects that completed at least one TACE cycle were eligible for long-term survival follow-up.|
48074642|NCT01387932|100504523|FG000|COMPLETED|Survival Follow-up||27||
48074643|NCT01387932|100504524|FG001|COMPLETED|Survival Follow-up||23||
48074644|NCT01387932|100504523|FG000|NOT COMPLETED|Survival Follow-up||84||
48074645|NCT01387932|100504524|FG001|NOT COMPLETED|Survival Follow-up||90||
48074646|NCT03685968|100504525|FG000|STARTED|Overall Study||75||
48074647|NCT03685968|100504526|FG001|STARTED|Overall Study||75||
48074648|NCT03685968|100504527|FG002|STARTED|Overall Study||75||
48074649|NCT03685968|100504525|FG000|COMPLETED|Overall Study||75||
48074650|NCT03685968|100504526|FG001|COMPLETED|Overall Study||75||
48074651|NCT03685968|100504527|FG002|COMPLETED|Overall Study||75||
48074652|NCT03685968|100504525|FG000|NOT COMPLETED|Overall Study||0||
48074653|NCT03685968|100504526|FG001|NOT COMPLETED|Overall Study||0||
48074654|NCT03685968|100504527|FG002|NOT COMPLETED|Overall Study||0||
48074655|NCT03673046|100504528|FG000|STARTED|Overall Study||40||
48074656|NCT03673046|100504529|FG001|STARTED|Overall Study||40||
48074657|NCT03673046|100504528|FG000|COMPLETED|Overall Study||31||
48074658|NCT03673046|100504529|FG001|COMPLETED|Overall Study||37||
48074659|NCT03673046|100504528|FG000|NOT COMPLETED|Overall Study||9||
48074660|NCT03673046|100504529|FG001|NOT COMPLETED|Overall Study||3||
48074661|NCT01072331|100504530|FG000|STARTED|Overall Study||34||
48074662|NCT01072331|100504531|FG001|STARTED|Overall Study||33||
48074663|NCT01072331|100504532|FG002|STARTED|Overall Study||32||
48074664|NCT01072331|100504530|FG000|COMPLETED|Overall Study||34||
48074665|NCT01072331|100504531|FG001|COMPLETED|Overall Study||33||
48074666|NCT01072331|100504532|FG002|COMPLETED|Overall Study||32||
48074667|NCT01072331|100504530|FG000|NOT COMPLETED|Overall Study||0||
48074668|NCT01072331|100504531|FG001|NOT COMPLETED|Overall Study||0||
48074669|NCT01072331|100504532|FG002|NOT COMPLETED|Overall Study||0||
48074670|NCT00003473|100504533|FG000|STARTED|Overall Study||20||
48074671|NCT00003473|100504533|FG000|COMPLETED|Overall Study||17||
48074672|NCT00003473|100504533|FG000|NOT COMPLETED|Overall Study||3||
48074673|NCT03600818|100504534|FG000|STARTED|Overall Study||58||
48074674|NCT03600818|100504535|FG001|STARTED|Overall Study||60||
48074675|NCT03600818|100504534|FG000|Safety Population|Overall Study||58|All randomized participants who received at least one dose or part of a dose of the study medication (IMP) analyzed according to the treatment they actually received.|
48074676|NCT03600818|100504535|FG001|Safety Population|Overall Study||59|All randomized participants who received at least one dose or part of a dose of the study medication (IMP) analyzed according to the treatment they actually received.|
48074677|NCT03600818|100504534|FG000|COMPLETED|Overall Study||36||
48074678|NCT03600818|100504535|FG001|COMPLETED|Overall Study||42||
48074679|NCT03600818|100504534|FG000|NOT COMPLETED|Overall Study||22||
48074680|NCT03600818|100504535|FG001|NOT COMPLETED|Overall Study||18||
48074681|NCT03733470|100504536|FG000|STARTED|Overall Study||8||
48074682|NCT03733470|100504537|FG001|STARTED|Overall Study||11||
48074683|NCT03733470|100504536|FG000|COMPLETED|Overall Study||7||
48074684|NCT03733470|100504537|FG001|COMPLETED|Overall Study||10||
48074685|NCT03733470|100504536|FG000|NOT COMPLETED|Overall Study||1||
48074686|NCT03733470|100504537|FG001|NOT COMPLETED|Overall Study||1||
48074687|NCT01626456|100504538|FG000|STARTED|Overall Study||110||
48074688|NCT01626456|100504539|FG001|STARTED|Overall Study||368||
48074689|NCT01626456|100504538|FG000|COMPLETED|Overall Study||75||
48074690|NCT01626456|100504539|FG001|COMPLETED|Overall Study||251||
48074691|NCT01626456|100504538|FG000|NOT COMPLETED|Overall Study||35||
48074692|NCT01626456|100504539|FG001|NOT COMPLETED|Overall Study||117||
48074693|NCT02959307|100504540|FG000|STARTED|Phase 1||18||
48074694|NCT02959307|100504541|FG001|STARTED|Phase 1||31||
48074695|NCT02959307|100504540|FG000|COMPLETED|Phase 1||15||
48074696|NCT02959307|100504541|FG001|COMPLETED|Phase 1||23||
48074697|NCT02959307|100504540|FG000|NOT COMPLETED|Phase 1||3||
48074698|NCT02959307|100504541|FG001|NOT COMPLETED|Phase 1||8||
48074699|NCT02959307|100504540|FG000|STARTED|Phase 2||28||
48074700|NCT02959307|100504541|FG001|STARTED|Phase 2||10||
48074701|NCT02959307|100504540|FG000|COMPLETED|Phase 2||26||
48074702|NCT02959307|100504541|FG001|COMPLETED|Phase 2||10||
48074703|NCT02959307|100504540|FG000|NOT COMPLETED|Phase 2||2||
48074704|NCT02959307|100504541|FG001|NOT COMPLETED|Phase 2||0||
48074705|NCT01434667|100504542|FG000|STARTED|Overall Study||39||
48074706|NCT01434667|100504543|FG001|STARTED|Overall Study||75||
48074707|NCT01434667|100504542|FG000|COMPLETED|Overall Study||34||
48074708|NCT01434667|100504543|FG001|COMPLETED|Overall Study||65||
48074709|NCT01434667|100504542|FG000|NOT COMPLETED|Overall Study||5||
48074710|NCT01434667|100504543|FG001|NOT COMPLETED|Overall Study||10||
48074711|NCT00353795|100504544|FG000|STARTED|Overall Study||179||
48074712|NCT00353795|100504544|FG000|COMPLETED|Overall Study||179||
48074713|NCT00353795|100504544|FG000|NOT COMPLETED|Overall Study||0||
48074714|NCT01785069|100504545|FG000|STARTED|Overall Study||107||
48074715|NCT01785069|100504546|FG001|STARTED|Overall Study||76||
48074716|NCT01785069|100504547|FG002|STARTED|Overall Study||104||
48074717|NCT01785069|100504548|FG003|STARTED|Overall Study||68||
48074718|NCT01785069|100504545|FG000|COMPLETED|Overall Study||95||
48074719|NCT01785069|100504546|FG001|COMPLETED|Overall Study||64||
48074720|NCT01785069|100504547|FG002|COMPLETED|Overall Study||91||
48074721|NCT01785069|100504548|FG003|COMPLETED|Overall Study||54||
48074722|NCT01785069|100504545|FG000|NOT COMPLETED|Overall Study||12||
48074723|NCT01785069|100504546|FG001|NOT COMPLETED|Overall Study||12||
48074724|NCT01785069|100504547|FG002|NOT COMPLETED|Overall Study||13||
48074725|NCT01785069|100504548|FG003|NOT COMPLETED|Overall Study||14||
48074726|NCT01392443|100504549|FG000|STARTED|Overall Study||120||
48074727|NCT01392443|100504549|FG000|COMPLETED|Overall Study||52|Completed = End of Treatment|
48074728|NCT01392443|100504549|FG000|NOT COMPLETED|Overall Study||68||
48074729|NCT02362269|100504550|FG000|STARTED|Overall Study||83||
48074730|NCT02362269|100504551|FG001|STARTED|Overall Study||86||
48074731|NCT02362269|100504550|FG000|COMPLETED|Overall Study||82||
48074732|NCT02362269|100504551|FG001|COMPLETED|Overall Study||80||
48074733|NCT02362269|100504550|FG000|NOT COMPLETED|Overall Study||1||
48074734|NCT02362269|100504551|FG001|NOT COMPLETED|Overall Study||6||
48074735|NCT00824720|100504552|FG000|STARTED|Overall Study||19||
48074736|NCT00824720|100504553|FG001|STARTED|Overall Study||16||
48074737|NCT00824720|100504554|FG002|STARTED|Overall Study||20||
48074738|NCT00824720|100504552|FG000|COMPLETED|Overall Study||16||
48074739|NCT00824720|100504553|FG001|COMPLETED|Overall Study||15||
48074740|NCT00824720|100504554|FG002|COMPLETED|Overall Study||19||
48074741|NCT00824720|100504552|FG000|NOT COMPLETED|Overall Study||3||
48074742|NCT00824720|100504553|FG001|NOT COMPLETED|Overall Study||1||
48074743|NCT00824720|100504554|FG002|NOT COMPLETED|Overall Study||1||
48074744|NCT04444895|100504555|FG000|STARTED|Overall Study||73||
48074745|NCT04444895|100504555|FG000|Reduced-dose Safety AnalysisSet(RD-SFAS)|Overall Study||2|The RD-SFAS Set was a subset of the Safety Analysis Set (SFAS) and included participants who switched from lanadelumab 300 mg Q2W to a lanadelumab 300 mg Q4W dosing regimen as recorded on the Dose Frequency Modification electronic case report form.|
48074746|NCT04444895|100504555|FG000|COMPLETED|Overall Study||64||
48074747|NCT04444895|100504555|FG000|NOT COMPLETED|Overall Study||9||
48074748|NCT05544734|100504556|FG000|STARTED|Overall Study||10||
48074749|NCT05544734|100504557|FG001|STARTED|Overall Study||10||
48074750|NCT05544734|100504556|FG000|COMPLETED|Overall Study||10||
48074751|NCT05544734|100504557|FG001|COMPLETED|Overall Study||10||
48074752|NCT05544734|100504556|FG000|NOT COMPLETED|Overall Study||0||
48074753|NCT05544734|100504557|FG001|NOT COMPLETED|Overall Study||0||
48074754|NCT01564914|100504558|FG000|STARTED|Overall Study||16||
48074755|NCT01564914|100504559|FG001|STARTED|Overall Study||6||
48074756|NCT01564914|100504558|FG000|COMPLETED|Overall Study||16||
48074757|NCT01564914|100504559|FG001|COMPLETED|Overall Study||6||
48074758|NCT01564914|100504558|FG000|NOT COMPLETED|Overall Study||0||
48074759|NCT01564914|100504559|FG001|NOT COMPLETED|Overall Study||0||
48074760|NCT02166905|100504560|FG000|STARTED|Overall Study||7||
48074761|NCT02166905|100504561|FG001|STARTED|Overall Study||16||
48074762|NCT02166905|100504562|FG002|STARTED|Overall Study||15||
48074763|NCT02166905|100504563|FG003|STARTED|Overall Study||2||
48074764|NCT02166905|100504560|FG000|COMPLETED|Overall Study||6||
48074765|NCT02166905|100504561|FG001|COMPLETED|Overall Study||16||
48074766|NCT02166905|100504562|FG002|COMPLETED|Overall Study||15||
48074767|NCT02166905|100504563|FG003|COMPLETED|Overall Study||2||
48074768|NCT02166905|100504560|FG000|NOT COMPLETED|Overall Study||1||
48074769|NCT02166905|100504561|FG001|NOT COMPLETED|Overall Study||0||
48074770|NCT02166905|100504562|FG002|NOT COMPLETED|Overall Study||0||
48074771|NCT02166905|100504563|FG003|NOT COMPLETED|Overall Study||0||
48074772|NCT03978832|100504564|FG000|STARTED|Overall Study||69||
48074773|NCT03978832|100504564|FG000|Stabilization Period|Overall Study||25||
48074774|NCT03978832|100504564|FG000|Treatment Period|Overall Study||23||
48074775|NCT03978832|100504564|FG000|COMPLETED|Overall Study||15||
48227179|NCT01323790|100877935|FG001|NOT COMPLETED|Overall Study||60||
48074776|NCT03978832|100504564|FG000|NOT COMPLETED|Overall Study||54||
48074777|NCT01744574|100504565|FG000|STARTED|Overall Study||57||
48074778|NCT01744574|100504566|FG001|STARTED|Overall Study||56||
48074779|NCT01744574|100504567|FG002|STARTED|Overall Study||52||
48074780|NCT01744574|100504568|FG003|STARTED|Overall Study||51||
48074781|NCT01744574|100504565|FG000|COMPLETED|Overall Study||33||
48074782|NCT01744574|100504566|FG001|COMPLETED|Overall Study||31||
48074783|NCT01744574|100504567|FG002|COMPLETED|Overall Study||32||
48074784|NCT01744574|100504568|FG003|COMPLETED|Overall Study||40||
48074785|NCT01744574|100504565|FG000|NOT COMPLETED|Overall Study||24||
48074786|NCT01744574|100504566|FG001|NOT COMPLETED|Overall Study||25||
48074787|NCT01744574|100504567|FG002|NOT COMPLETED|Overall Study||20||
48074788|NCT01744574|100504568|FG003|NOT COMPLETED|Overall Study||11||
48074789|NCT05209360|100504569|FG000|STARTED|Overall Study||5||
48074790|NCT05209360|100504570|FG001|STARTED|Overall Study||3||
48074791|NCT05209360|100504571|FG002|STARTED|Overall Study||3||
48074792|NCT05209360|100504572|FG003|STARTED|Overall Study||5||
48074793|NCT05209360|100504573|FG004|STARTED|Overall Study||2||
48074794|NCT05209360|100504574|FG005|STARTED|Overall Study||2||
48074795|NCT05209360|100504569|FG000|COMPLETED|Overall Study||5||
48074796|NCT05209360|100504570|FG001|COMPLETED|Overall Study||3||
48074797|NCT05209360|100504571|FG002|COMPLETED|Overall Study||2||
48074798|NCT05209360|100504572|FG003|COMPLETED|Overall Study||5||
48074799|NCT05209360|100504573|FG004|COMPLETED|Overall Study||2||
48074800|NCT05209360|100504574|FG005|COMPLETED|Overall Study||2||
48074801|NCT05209360|100504569|FG000|NOT COMPLETED|Overall Study||0||
48074802|NCT05209360|100504570|FG001|NOT COMPLETED|Overall Study||0||
48074803|NCT05209360|100504571|FG002|NOT COMPLETED|Overall Study||1||
48074804|NCT05209360|100504572|FG003|NOT COMPLETED|Overall Study||0||
48074805|NCT05209360|100504573|FG004|NOT COMPLETED|Overall Study||0||
48074806|NCT05209360|100504574|FG005|NOT COMPLETED|Overall Study||0||
48074807|NCT04600375|100504575|FG000|STARTED|Overall Study||12||
48074808|NCT04600375|100504576|FG001|STARTED|Overall Study||10||
48074809|NCT04600375|100504575|FG000|COMPLETED|Overall Study||12||
48074810|NCT04600375|100504576|FG001|COMPLETED|Overall Study||10||
48074811|NCT04600375|100504575|FG000|NOT COMPLETED|Overall Study||0||
48074812|NCT04600375|100504576|FG001|NOT COMPLETED|Overall Study||0||
48074813|NCT00134082|100504577|FG000|STARTED|Overall Study||30||
48074814|NCT00134082|100504577|FG000|COMPLETED|Overall Study||27||
48074815|NCT00134082|100504577|FG000|NOT COMPLETED|Overall Study||3||
48074816|NCT00899574|100504578|FG000|STARTED|Overall Study||10||
48074817|NCT00899574|100504578|FG000|COMPLETED|Overall Study||10||
48074818|NCT00899574|100504578|FG000|NOT COMPLETED|Overall Study||0||
48074819|NCT02914119|100504579|FG000|STARTED|Overall Study||30430||
48074820|NCT02914119|100504579|FG000|COMPLETED|Overall Study||30430||
48074821|NCT02914119|100504579|FG000|NOT COMPLETED|Overall Study||0||
48074822|NCT04706091|100504580|FG000|STARTED|Treatment 1||18||
48074823|NCT04706091|100504581|FG001|STARTED|Treatment 1||16||
48074824|NCT04706091|100504580|FG000|COMPLETED|Treatment 1||18||
48074825|NCT04706091|100504581|FG001|COMPLETED|Treatment 1||16||
48074826|NCT04706091|100504580|FG000|NOT COMPLETED|Treatment 1||0||
48074827|NCT04706091|100504581|FG001|NOT COMPLETED|Treatment 1||0||
48074828|NCT04706091|100504580|FG000|STARTED|Treatment 2||17|One participant in the Treatment --\> Placebo group withdrew before treatment period 2 due to starting CBT.|
48074829|NCT04706091|100504581|FG001|STARTED|Treatment 2||16|One participant in the Treatment --\> Placebo group withdrew before treatment period 2 due to starting CBT.|
48074830|NCT04706091|100504580|FG000|COMPLETED|Treatment 2||16||
48074831|NCT04706091|100504581|FG001|COMPLETED|Treatment 2||16||
48074832|NCT04706091|100504580|FG000|NOT COMPLETED|Treatment 2||1||
48074833|NCT04706091|100504581|FG001|NOT COMPLETED|Treatment 2||0||
48074834|NCT00443261|100504582|FG000|STARTED|Overall Study||1||
48074835|NCT00443261|100504582|FG000|Accrual in 10 Months|Overall Study||1||
48074836|NCT00443261|100504582|FG000|COMPLETED|Overall Study||0||
48074837|NCT00443261|100504582|FG000|NOT COMPLETED|Overall Study||1||
48074838|NCT02124083|100504583|FG000|STARTED|Overall Study||12||
48074839|NCT02124083|100504583|FG000|COMPLETED|Overall Study||11||
48074840|NCT02124083|100504583|FG000|NOT COMPLETED|Overall Study||1||
48074841|NCT03123913|100504584|FG000|STARTED|Overall Study||20||
48074842|NCT03123913|100504584|FG000|COMPLETED|Overall Study||19||
48074843|NCT03123913|100504584|FG000|NOT COMPLETED|Overall Study||1||
48074844|NCT00709761|100504585|FG000|STARTED|Overall Study||60||
48074845|NCT00709761|100504585|FG000|COMPLETED|Overall Study||33||
48074846|NCT00709761|100504585|FG000|NOT COMPLETED|Overall Study||27||
48074847|NCT03282682|100504586|FG000|STARTED|Overall Study||6||
48074848|NCT03282682|100504587|FG001|STARTED|Overall Study||8||
48074849|NCT03282682|100504588|FG002|STARTED|Overall Study||8||
48074850|NCT03282682|100504586|FG000|COMPLETED|Overall Study||6||
48074851|NCT03282682|100504587|FG001|COMPLETED|Overall Study||8||
48074852|NCT03282682|100504588|FG002|COMPLETED|Overall Study||8||
48074853|NCT03282682|100504586|FG000|NOT COMPLETED|Overall Study||0||
48074854|NCT03282682|100504587|FG001|NOT COMPLETED|Overall Study||0||
48074855|NCT03282682|100504588|FG002|NOT COMPLETED|Overall Study||0||
48074856|NCT00926328|100504589|FG000|STARTED|Overall Study||60||
48074857|NCT00926328|100504590|FG001|STARTED|Overall Study||60||
48074858|NCT00926328|100504589|FG000|COMPLETED|Overall Study||48||
48074859|NCT00926328|100504590|FG001|COMPLETED|Overall Study||46||
48074860|NCT00926328|100504589|FG000|NOT COMPLETED|Overall Study||12||
48074861|NCT00926328|100504590|FG001|NOT COMPLETED|Overall Study||14||
48074862|NCT01935791|100504591|FG000|STARTED|Period 1||4||
48074863|NCT01935791|100504592|FG001|STARTED|Period 1||4||
48074864|NCT01935791|100504593|FG002|STARTED|Period 1||3||
48074865|NCT01935791|100504594|FG003|STARTED|Period 1||0||
48074866|NCT01935791|100504595|FG004|STARTED|Period 1||0||
48074867|NCT01935791|100504596|FG005|STARTED|Period 1||0||
48074868|NCT01935791|100504597|FG006|STARTED|Period 1||0||
48074869|NCT01935791|100504598|FG007|STARTED|Period 1||0||
48074870|NCT01935791|100504599|FG008|STARTED|Period 1||0||
48074871|NCT01935791|100504591|FG000|COMPLETED|Period 1||4||
48074872|NCT01935791|100504592|FG001|COMPLETED|Period 1||4||
48074873|NCT01935791|100504593|FG002|COMPLETED|Period 1||3||
48074874|NCT01935791|100504594|FG003|COMPLETED|Period 1||0||
48074875|NCT01935791|100504595|FG004|COMPLETED|Period 1||0||
48074876|NCT01935791|100504596|FG005|COMPLETED|Period 1||0||
48074877|NCT01935791|100504597|FG006|COMPLETED|Period 1||0||
48074878|NCT01935791|100504598|FG007|COMPLETED|Period 1||0||
48074879|NCT01935791|100504599|FG008|COMPLETED|Period 1||0||
48074880|NCT01935791|100504591|FG000|NOT COMPLETED|Period 1||0||
48074881|NCT01935791|100504592|FG001|NOT COMPLETED|Period 1||0||
48074882|NCT01935791|100504593|FG002|NOT COMPLETED|Period 1||0||
48074883|NCT01935791|100504594|FG003|NOT COMPLETED|Period 1||0||
48074884|NCT01935791|100504595|FG004|NOT COMPLETED|Period 1||0||
48074885|NCT01935791|100504596|FG005|NOT COMPLETED|Period 1||0||
48074886|NCT01935791|100504597|FG006|NOT COMPLETED|Period 1||0||
48074887|NCT01935791|100504598|FG007|NOT COMPLETED|Period 1||0||
48074888|NCT01935791|100504599|FG008|NOT COMPLETED|Period 1||0||
48074889|NCT01935791|100504591|FG000|STARTED|Period 2||0||
48074890|NCT01935791|100504592|FG001|STARTED|Period 2||0||
48074891|NCT01935791|100504593|FG002|STARTED|Period 2||0||
48074892|NCT01935791|100504594|FG003|STARTED|Period 2||2||
48074893|NCT01935791|100504595|FG004|STARTED|Period 2||3||
48074894|NCT01935791|100504596|FG005|STARTED|Period 2||1||
48074895|NCT01935791|100504597|FG006|STARTED|Period 2||1||
48074896|NCT01935791|100504598|FG007|STARTED|Period 2||3||
48074897|NCT01935791|100504599|FG008|STARTED|Period 2||1||
48074898|NCT01935791|100504591|FG000|COMPLETED|Period 2||0||
48074899|NCT01935791|100504592|FG001|COMPLETED|Period 2||0||
48074900|NCT01935791|100504593|FG002|COMPLETED|Period 2||0||
48074901|NCT01935791|100504594|FG003|COMPLETED|Period 2||2||
48074902|NCT01935791|100504595|FG004|COMPLETED|Period 2||3||
48074903|NCT01935791|100504596|FG005|COMPLETED|Period 2||1||
48074904|NCT01935791|100504597|FG006|COMPLETED|Period 2||1||
48074905|NCT01935791|100504598|FG007|COMPLETED|Period 2||3||
48074906|NCT01935791|100504599|FG008|COMPLETED|Period 2||1||
48074907|NCT01935791|100504591|FG000|NOT COMPLETED|Period 2||0||
48074908|NCT01935791|100504592|FG001|NOT COMPLETED|Period 2||0||
48074909|NCT01935791|100504593|FG002|NOT COMPLETED|Period 2||0||
48074910|NCT01935791|100504594|FG003|NOT COMPLETED|Period 2||0||
48074911|NCT01935791|100504595|FG004|NOT COMPLETED|Period 2||0||
48074912|NCT01935791|100504596|FG005|NOT COMPLETED|Period 2||0||
48074913|NCT01935791|100504597|FG006|NOT COMPLETED|Period 2||0||
48074914|NCT01935791|100504598|FG007|NOT COMPLETED|Period 2||0||
48074915|NCT01935791|100504599|FG008|NOT COMPLETED|Period 2||0||
48074916|NCT03513328|100504600|FG000|STARTED|Overall Study||6||
48074917|NCT03513328|100504601|FG001|STARTED|Overall Study||0||
48074918|NCT03513328|100504602|FG002|STARTED|Overall Study||0||
48074919|NCT03513328|100504603|FG003|STARTED|Overall Study||0||
48074920|NCT03513328|100504600|FG000|COMPLETED|Overall Study||6||
48074921|NCT03513328|100504601|FG001|COMPLETED|Overall Study||0||
48074922|NCT03513328|100504602|FG002|COMPLETED|Overall Study||0||
48074923|NCT03513328|100504603|FG003|COMPLETED|Overall Study||0||
48074924|NCT03513328|100504600|FG000|NOT COMPLETED|Overall Study||0||
48074925|NCT03513328|100504601|FG001|NOT COMPLETED|Overall Study||0||
48074926|NCT03513328|100504602|FG002|NOT COMPLETED|Overall Study||0||
48074927|NCT03513328|100504603|FG003|NOT COMPLETED|Overall Study||0||
48074928|NCT03706079|100504604|FG000|STARTED|Predecessor Study||529||
48074929|NCT03706079|100504605|FG001|STARTED|Predecessor Study||532||
48074930|NCT03706079|100504606|FG002|STARTED|Predecessor Study||0||
48074931|NCT03706079|100504607|FG003|STARTED|Predecessor Study||74||
48074932|NCT03706079|100504608|FG004|STARTED|Predecessor Study||76||
48074933|NCT03706079|100504609|FG005|STARTED|Predecessor Study||0||
48074934|NCT03706079|100504604|FG000|Received Treatment|Predecessor Study||528||
48074935|NCT03706079|100504605|FG001|Received Treatment|Predecessor Study||531||
48074936|NCT03706079|100504606|FG002|Received Treatment|Predecessor Study||0||
48074937|NCT03706079|100504607|FG003|Received Treatment|Predecessor Study||74||
48074938|NCT03706079|100504608|FG004|Received Treatment|Predecessor Study||76||
48074939|NCT03706079|100504609|FG005|Received Treatment|Predecessor Study||0||
48074940|NCT03706079|100504604|FG000|COMPLETED|Predecessor Study||513||
48074941|NCT03706079|100504605|FG001|COMPLETED|Predecessor Study||509||
48074942|NCT03706079|100504606|FG002|COMPLETED|Predecessor Study||0||
48074943|NCT03706079|100504607|FG003|COMPLETED|Predecessor Study||68||
48074944|NCT03706079|100504608|FG004|COMPLETED|Predecessor Study||73||
48074945|NCT03706079|100504609|FG005|COMPLETED|Predecessor Study||0||
48074946|NCT03706079|100504604|FG000|NOT COMPLETED|Predecessor Study||16||
48074947|NCT03706079|100504605|FG001|NOT COMPLETED|Predecessor Study||23||
48074948|NCT03706079|100504606|FG002|NOT COMPLETED|Predecessor Study||0||
48074949|NCT03706079|100504607|FG003|NOT COMPLETED|Predecessor Study||6||
48074950|NCT03706079|100504608|FG004|NOT COMPLETED|Predecessor Study||3||
48074951|NCT03706079|100504609|FG005|NOT COMPLETED|Predecessor Study||0||
48074952|NCT03706079|100504604|FG000|STARTED|Long Term Extension (DESTINATION)||415||
48074953|NCT03706079|100504605|FG001|STARTED|Long Term Extension (DESTINATION)||206||
48074954|NCT03706079|100504606|FG002|STARTED|Long Term Extension (DESTINATION)||206||
48074955|NCT03706079|100504607|FG003|STARTED|Long Term Extension (DESTINATION)||60||
48074956|NCT03706079|100504608|FG004|STARTED|Long Term Extension (DESTINATION)||32||
48074957|NCT03706079|100504609|FG005|STARTED|Long Term Extension (DESTINATION)||32||
48074958|NCT03706079|100504604|FG000|Received Treatment|Long Term Extension (DESTINATION)||415||
48074959|NCT03706079|100504605|FG001|Received Treatment|Long Term Extension (DESTINATION)||206||
48074960|NCT03706079|100504606|FG002|Received Treatment|Long Term Extension (DESTINATION)||205||
48074961|NCT03706079|100504607|FG003|Received Treatment|Long Term Extension (DESTINATION)||60||
48074962|NCT03706079|100504608|FG004|Received Treatment|Long Term Extension (DESTINATION)||32||
48074963|NCT03706079|100504609|FG005|Received Treatment|Long Term Extension (DESTINATION)||32||
48074964|NCT03706079|100504604|FG000|COMPLETED|Long Term Extension (DESTINATION)||400||
48074965|NCT03706079|100504605|FG001|COMPLETED|Long Term Extension (DESTINATION)||200||
48074966|NCT03706079|100504606|FG002|COMPLETED|Long Term Extension (DESTINATION)||198||
48074967|NCT03706079|100504607|FG003|COMPLETED|Long Term Extension (DESTINATION)||58||
48074968|NCT03706079|100504608|FG004|COMPLETED|Long Term Extension (DESTINATION)||28||
48074969|NCT03706079|100504609|FG005|COMPLETED|Long Term Extension (DESTINATION)||31||
48074970|NCT03706079|100504604|FG000|NOT COMPLETED|Long Term Extension (DESTINATION)||15||
48074971|NCT03706079|100504605|FG001|NOT COMPLETED|Long Term Extension (DESTINATION)||6||
48074972|NCT03706079|100504606|FG002|NOT COMPLETED|Long Term Extension (DESTINATION)||8||
48074973|NCT03706079|100504607|FG003|NOT COMPLETED|Long Term Extension (DESTINATION)||2||
48074974|NCT03706079|100504608|FG004|NOT COMPLETED|Long Term Extension (DESTINATION)||4||
48074975|NCT03706079|100504609|FG005|NOT COMPLETED|Long Term Extension (DESTINATION)||1||
48074976|NCT01540838|100504610|FG000|STARTED|Overall Study||188||
48074977|NCT01540838|100504611|FG001|STARTED|Overall Study||187||
48074978|NCT01540838|100504610|FG000|COMPLETED|Overall Study||166||
48074979|NCT01540838|100504611|FG001|COMPLETED|Overall Study||164||
48074980|NCT01540838|100504610|FG000|NOT COMPLETED|Overall Study||22||
48074981|NCT01540838|100504611|FG001|NOT COMPLETED|Overall Study||23||
48074982|NCT02571075|100504612|FG000|STARTED|Overall Study||45||
48074983|NCT02571075|100504613|FG001|STARTED|Overall Study||50||
48074984|NCT02571075|100504612|FG000|COMPLETED|Overall Study||25||
48074985|NCT02571075|100504613|FG001|COMPLETED|Overall Study||26||
48074986|NCT02571075|100504612|FG000|NOT COMPLETED|Overall Study||20||
48074987|NCT02571075|100504613|FG001|NOT COMPLETED|Overall Study||24||
48074988|NCT00244010|100504614|FG000|STARTED|Overall Study||2||
48074989|NCT00244010|100504615|FG001|STARTED|Overall Study||2||
48074990|NCT00244010|100504614|FG000|COMPLETED|Overall Study||2||
48074991|NCT00244010|100504615|FG001|COMPLETED|Overall Study||2||
48074992|NCT00244010|100504614|FG000|NOT COMPLETED|Overall Study||0||
48074993|NCT00244010|100504615|FG001|NOT COMPLETED|Overall Study||0||
48074994|NCT02478775|100504616|FG000|STARTED|Overall Study||6||
48074995|NCT02478775|100504617|FG001|STARTED|Overall Study||27||
48074996|NCT02478775|100504618|FG002|STARTED|Overall Study||27||
48074997|NCT02478775|100504616|FG000|COMPLETED|Overall Study||6||
48074998|NCT02478775|100504617|FG001|COMPLETED|Overall Study||27||
48074999|NCT02478775|100504618|FG002|COMPLETED|Overall Study||27||
48075000|NCT02478775|100504616|FG000|NOT COMPLETED|Overall Study||0||
48075001|NCT02478775|100504617|FG001|NOT COMPLETED|Overall Study||0||
48075002|NCT02478775|100504618|FG002|NOT COMPLETED|Overall Study||0||
48075003|NCT00667875|100504619|FG000|STARTED|Overall Study||23||
48075004|NCT00667875|100504620|FG001|STARTED|Overall Study||21||
48075005|NCT00667875|100504621|FG002|STARTED|Overall Study||21||
48075006|NCT00667875|100504619|FG000|Subjects Included in Analysisd|Overall Study||20||
48075007|NCT00667875|100504620|FG001|Subjects Included in Analysisd|Overall Study||21||
48075008|NCT00667875|100504621|FG002|Subjects Included in Analysisd|Overall Study||19||
48075009|NCT00667875|100504619|FG000|COMPLETED|Overall Study||13||
48075010|NCT00667875|100504620|FG001|COMPLETED|Overall Study||10||
48075011|NCT00667875|100504621|FG002|COMPLETED|Overall Study||8||
48075012|NCT00667875|100504619|FG000|NOT COMPLETED|Overall Study||10||
48075013|NCT00667875|100504620|FG001|NOT COMPLETED|Overall Study||11||
48075014|NCT00667875|100504621|FG002|NOT COMPLETED|Overall Study||13||
48075015|NCT03166735|100504622|FG000|STARTED|Overall Study||33||
48075016|NCT03166735|100504623|FG001|STARTED|Overall Study||16||
48075017|NCT03166735|100504624|FG002|STARTED|Overall Study||16||
48075018|NCT03166735|100504625|FG003|STARTED|Overall Study||17||
48075019|NCT03166735|100504626|FG004|STARTED|Overall Study||32||
48075020|NCT03166735|100504622|FG000|Treated|Overall Study||32||
48075021|NCT03166735|100504623|FG001|Treated|Overall Study||16||
48075022|NCT03166735|100504624|FG002|Treated|Overall Study||16||
48075023|NCT03166735|100504625|FG003|Treated|Overall Study||17||
48075024|NCT03166735|100504626|FG004|Treated|Overall Study||32||
48075025|NCT03166735|100504622|FG000|COMPLETED|Overall Study||32||
48075026|NCT03166735|100504623|FG001|COMPLETED|Overall Study||13||
48075027|NCT03166735|100504624|FG002|COMPLETED|Overall Study||13||
48075028|NCT03166735|100504625|FG003|COMPLETED|Overall Study||16||
48075029|NCT03166735|100504626|FG004|COMPLETED|Overall Study||28||
48075030|NCT03166735|100504622|FG000|NOT COMPLETED|Overall Study||1||
48075031|NCT03166735|100504623|FG001|NOT COMPLETED|Overall Study||3||
48075032|NCT03166735|100504624|FG002|NOT COMPLETED|Overall Study||3||
48075033|NCT03166735|100504625|FG003|NOT COMPLETED|Overall Study||1||
48075034|NCT03166735|100504626|FG004|NOT COMPLETED|Overall Study||4||
48075035|NCT02570074|100504627|FG000|STARTED|Period 1 (First Dosing Regimen)||9||
48075036|NCT02570074|100504628|FG001|STARTED|Period 1 (First Dosing Regimen)||10||
48075037|NCT02570074|100504627|FG000|COMPLETED|Period 1 (First Dosing Regimen)||9||
48075038|NCT02570074|100504628|FG001|COMPLETED|Period 1 (First Dosing Regimen)||10||
48075039|NCT02570074|100504627|FG000|NOT COMPLETED|Period 1 (First Dosing Regimen)||0||
48075040|NCT02570074|100504628|FG001|NOT COMPLETED|Period 1 (First Dosing Regimen)||0||
48075041|NCT02570074|100504627|FG000|STARTED|Period 2 (Second Dosing Regimen)||9||
48075042|NCT02570074|100504628|FG001|STARTED|Period 2 (Second Dosing Regimen)||10||
48075043|NCT02570074|100504627|FG000|COMPLETED|Period 2 (Second Dosing Regimen)||8||
48075044|NCT02570074|100504628|FG001|COMPLETED|Period 2 (Second Dosing Regimen)||10||
48075045|NCT02570074|100504627|FG000|NOT COMPLETED|Period 2 (Second Dosing Regimen)||1||
48075046|NCT02570074|100504628|FG001|NOT COMPLETED|Period 2 (Second Dosing Regimen)||0||
48075047|NCT03727230|100504629|FG000|STARTED|Overall Study||54||
48075048|NCT03727230|100504629|FG000|COMPLETED|Overall Study||42||
48075049|NCT03727230|100504629|FG000|NOT COMPLETED|Overall Study||12||
48075050|NCT01135420|100508016|FG000|STARTED|Overall Study||199||
48075051|NCT01135420|100508017|FG001|STARTED|Overall Study||207||
48075052|NCT01135420|100508016|FG000|COMPLETED|Overall Study||155||
48075053|NCT01135420|100508017|FG001|COMPLETED|Overall Study||175||
48075054|NCT01135420|100508016|FG000|NOT COMPLETED|Overall Study||44||
48075055|NCT01135420|100508017|FG001|NOT COMPLETED|Overall Study||32||
48075056|NCT00619177|100508018|FG000|STARTED|Overall Study||3569||
48075057|NCT00619177|100508018|FG000|COMPLETED|Overall Study||3061||
48075058|NCT00619177|100508018|FG000|NOT COMPLETED|Overall Study||508||
48075059|NCT01578187|100508019|FG000|STARTED|Label Comprehension Phase||63||
48075060|NCT01578187|100508019|FG000|COMPLETED|Label Comprehension Phase||63||
48075061|NCT01578187|100508019|FG000|NOT COMPLETED|Label Comprehension Phase||0||
48075062|NCT01578187|100508019|FG000|STARTED|Usability Phase||48||
48075063|NCT01578187|100508019|FG000|COMPLETED|Usability Phase||47||
48075064|NCT01578187|100508019|FG000|NOT COMPLETED|Usability Phase||1||
48075065|NCT02571777|100508020|FG000|STARTED|Overall Study||619|All patients who were assigned a randomization number|
48075066|NCT02571777|100508021|FG001|STARTED|Overall Study||620|All patients who were assigned a randomization number|
48075067|NCT02571777|100508022|FG002|STARTED|Overall Study||618|All patients who were assigned a randomization number|
48075068|NCT02571777|100508023|FG003|STARTED|Overall Study||617|All patients who were assigned a randomization number|
48075069|NCT02571777|100508024|FG004|STARTED|Overall Study||618|All patients who were assigned a randomization number|
48075070|NCT02571777|100508020|FG000|Full Analysis Set (FAS)|Overall Study||615|All patients in the randomization set who received at least one dose of study medication|
48075071|NCT02571777|100508021|FG001|Full Analysis Set (FAS)|Overall Study||616|All patients in the randomization set who received at least one dose of study medication|
48075072|NCT02571777|100508022|FG002|Full Analysis Set (FAS)|Overall Study||611|All patients in the randomization set who received at least one dose of study medication|
48075073|NCT02571777|100508023|FG003|Full Analysis Set (FAS)|Overall Study||607|All patients in the randomization set who received at least one dose of study medication|
48075074|NCT02571777|100508024|FG004|Full Analysis Set (FAS)|Overall Study||612|All patients in the randomization set who received at least one dose of study medication|
48075075|NCT02571777|100508020|FG000|Safety Set (SAF)|Overall Study||616|All patients who received at least one dose of study medication whether or not being randomized|
48075076|NCT02571777|100508021|FG001|Safety Set (SAF)|Overall Study||617|All patients who received at least one dose of study medication whether or not being randomized|
48075077|NCT02571777|100508022|FG002|Safety Set (SAF)|Overall Study||613|All patients who received at least one dose of study medication whether or not being randomized|
48075078|NCT02571777|100508023|FG003|Safety Set (SAF)|Overall Study||608|All patients who received at least one dose of study medication whether or not being randomized|
48075079|NCT02571777|100508024|FG004|Safety Set (SAF)|Overall Study||618|All patients who received at least one dose of study medication whether or not being randomized|
48075080|NCT02571777|100508020|FG000|COMPLETED|Overall Study||580||
48075081|NCT02571777|100508021|FG001|COMPLETED|Overall Study||582||
48075082|NCT02571777|100508022|FG002|COMPLETED|Overall Study||577||
48075083|NCT02571777|100508023|FG003|COMPLETED|Overall Study||580||
48075084|NCT02571777|100508024|FG004|COMPLETED|Overall Study||582||
48075085|NCT02571777|100508020|FG000|NOT COMPLETED|Overall Study||39||
48075086|NCT02571777|100508021|FG001|NOT COMPLETED|Overall Study||38||
48075087|NCT02571777|100508022|FG002|NOT COMPLETED|Overall Study||41||
48075088|NCT02571777|100508023|FG003|NOT COMPLETED|Overall Study||37||
48075089|NCT02571777|100508024|FG004|NOT COMPLETED|Overall Study||36||
48075090|NCT02619175|100508025|FG000|STARTED|Overall Study||18||
48075091|NCT02619175|100508026|FG001|STARTED|Overall Study||16||
48075092|NCT02619175|100508025|FG000|COMPLETED|Overall Study||16||
48075093|NCT02619175|100508026|FG001|COMPLETED|Overall Study||16||
48075094|NCT02619175|100508025|FG000|NOT COMPLETED|Overall Study||2||
48075095|NCT02619175|100508026|FG001|NOT COMPLETED|Overall Study||0||
48075096|NCT00957580|100508027|FG000|STARTED|Overall Study||33||
48075097|NCT00957580|100508028|FG001|STARTED|Overall Study||33||
48075098|NCT00957580|100508029|FG002|STARTED|Overall Study||15||
48075099|NCT00957580|100508027|FG000|Treated|Overall Study||33||
48075100|NCT00957580|100508028|FG001|Treated|Overall Study||32||
48075101|NCT00957580|100508029|FG002|Treated|Overall Study||15||
48075102|NCT00957580|100508027|FG000|COMPLETED|Overall Study||33||
48075103|NCT00957580|100508028|FG001|COMPLETED|Overall Study||31||
48075104|NCT00957580|100508029|FG002|COMPLETED|Overall Study||15||
48075105|NCT00957580|100508027|FG000|NOT COMPLETED|Overall Study||0||
48075106|NCT00957580|100508028|FG001|NOT COMPLETED|Overall Study||2||
48075107|NCT00957580|100508029|FG002|NOT COMPLETED|Overall Study||0||
48075108|NCT01519271|100508030|FG000|STARTED|Phase 1||14||
48075109|NCT01519271|100508031|FG001|STARTED|Phase 1||14||
48075110|NCT01519271|100508030|FG000|COMPLETED|Phase 1||14||
48075111|NCT01519271|100508031|FG001|COMPLETED|Phase 1||13||
48075112|NCT01519271|100508030|FG000|NOT COMPLETED|Phase 1||0||
48075113|NCT01519271|100508031|FG001|NOT COMPLETED|Phase 1||1||
48075114|NCT01519271|100508030|FG000|STARTED|Phase 2||12||
48075115|NCT01519271|100508031|FG001|STARTED|Phase 2||14||
48075116|NCT01519271|100508030|FG000|COMPLETED|Phase 2||12||
48075117|NCT01519271|100508031|FG001|COMPLETED|Phase 2||14||
48075118|NCT01519271|100508030|FG000|NOT COMPLETED|Phase 2||0||
48075119|NCT01519271|100508031|FG001|NOT COMPLETED|Phase 2||0||
48075120|NCT01281865|100508032|FG000|STARTED|Overall Study||12||
48075121|NCT01281865|100508033|FG001|STARTED|Overall Study||2||
48075122|NCT01281865|100508032|FG000|COMPLETED|Overall Study||9||
48075123|NCT01281865|100508033|FG001|COMPLETED|Overall Study||1||
48075124|NCT01281865|100508032|FG000|NOT COMPLETED|Overall Study||3||
48075125|NCT01281865|100508033|FG001|NOT COMPLETED|Overall Study||1||
48075126|NCT00726986|100508034|FG000|STARTED|Induction Phase||18||
48075127|NCT00726986|100508034|FG000|Maintance|Induction Phase||3||
48075128|NCT00726986|100508034|FG000|COMPLETED|Induction Phase||3||
48075129|NCT00726986|100508034|FG000|NOT COMPLETED|Induction Phase||15||
48075130|NCT00726986|100508034|FG000|STARTED|Maintenance Phase||3||
48075131|NCT00726986|100508034|FG000|COMPLETED|Maintenance Phase||0||
48075132|NCT00726986|100508034|FG000|NOT COMPLETED|Maintenance Phase||3||
48075133|NCT04746963|100508035|FG000|STARTED|Overall Study||3||
48075134|NCT04746963|100508036|FG001|STARTED|Overall Study||0||
48075135|NCT04746963|100508037|FG002|STARTED|Overall Study||0||
48075136|NCT04746963|100508035|FG000|COMPLETED|Overall Study||3||
48075137|NCT04746963|100508036|FG001|COMPLETED|Overall Study||0||
48075138|NCT04746963|100508037|FG002|COMPLETED|Overall Study||0||
48075139|NCT04746963|100508035|FG000|NOT COMPLETED|Overall Study||0||
48075140|NCT04746963|100508036|FG001|NOT COMPLETED|Overall Study||0||
48075141|NCT04746963|100508037|FG002|NOT COMPLETED|Overall Study||0||
48075142|NCT01201850|100508038|FG000|STARTED|Overall Study||7||
48075143|NCT01201850|100508038|FG000|COMPLETED|Overall Study||3||
48075144|NCT01201850|100508038|FG000|NOT COMPLETED|Overall Study||4||
48075145|NCT01876420|100508039|FG000|STARTED|Overall Study||60||
48075146|NCT01876420|100508039|FG000|COMPLETED|Overall Study||59||
48075147|NCT01876420|100508039|FG000|NOT COMPLETED|Overall Study||1||
48075148|NCT02929667|100508040|FG000|STARTED|Overall Study||11||
48075149|NCT02929667|100508041|FG001|STARTED|Overall Study||11||
48075150|NCT02929667|100508040|FG000|COMPLETED|Overall Study||11||
48075151|NCT02929667|100508041|FG001|COMPLETED|Overall Study||11||
48075152|NCT02929667|100508040|FG000|NOT COMPLETED|Overall Study||0||
48075153|NCT02929667|100508041|FG001|NOT COMPLETED|Overall Study||0||
48075154|NCT00270790|100508042|FG000|STARTED|Overall Study||21||
48075155|NCT00270790|100508042|FG000|COMPLETED|Overall Study||16||
48075156|NCT00270790|100508042|FG000|NOT COMPLETED|Overall Study||5||
48075157|NCT02742441|100508043|FG000|STARTED|Overall Study||205||
48075158|NCT02742441|100508044|FG001|STARTED|Overall Study||204||
48075159|NCT02742441|100508043|FG000|COMPLETED|Overall Study||199||
48075160|NCT02742441|100508044|FG001|COMPLETED|Overall Study||196||
48075161|NCT02742441|100508043|FG000|NOT COMPLETED|Overall Study||6||
48075162|NCT02742441|100508044|FG001|NOT COMPLETED|Overall Study||8||
48075163|NCT00481078|100508045|FG000|STARTED|Overall Study||62||
48075164|NCT00481078|100508046|FG001|STARTED|Overall Study||32||
48075165|NCT00481078|100508045|FG000|COMPLETED|Overall Study||20||
48075166|NCT00481078|100508046|FG001|COMPLETED|Overall Study||12||
48075167|NCT00481078|100508045|FG000|NOT COMPLETED|Overall Study||42||
48075168|NCT00481078|100508046|FG001|NOT COMPLETED|Overall Study||20||
48075169|NCT01496248|100508047|FG000|STARTED|Overall Study||35||
48075170|NCT01496248|100508047|FG000|COMPLETED|Overall Study||25||
48075171|NCT01496248|100508047|FG000|NOT COMPLETED|Overall Study||10||
48075172|NCT01744197|100508048|FG000|STARTED|Overall Study||32||
48075173|NCT01744197|100508049|FG001|STARTED|Overall Study||29||
48075174|NCT01744197|100508048|FG000|COMPLETED|Overall Study||28||
48075175|NCT01744197|100508049|FG001|COMPLETED|Overall Study||26||
48075176|NCT01744197|100508048|FG000|NOT COMPLETED|Overall Study||4||
48075177|NCT01744197|100508049|FG001|NOT COMPLETED|Overall Study||3||
48075178|NCT01539538|100508050|FG000|STARTED|Overall Study||177||
48075179|NCT01539538|100508051|FG001|STARTED|Overall Study||180||
48075180|NCT01539538|100508050|FG000|COMPLETED|Overall Study||146||
48075181|NCT01539538|100508051|FG001|COMPLETED|Overall Study||136||
48075182|NCT01539538|100508050|FG000|NOT COMPLETED|Overall Study||31||
48075183|NCT01539538|100508051|FG001|NOT COMPLETED|Overall Study||44||
48075184|NCT03322631|100508052|FG000|STARTED|Overall Study||9||
48075185|NCT03322631|100508053|FG001|STARTED|Overall Study||12||
48075186|NCT03322631|100508054|FG002|STARTED|Overall Study||16||
48075187|NCT03322631|100508055|FG003|STARTED|Overall Study||11||
48075188|NCT03322631|100508052|FG000|Received at Least 1 Dose of Study Drug|Overall Study||9||
48075189|NCT03322631|100508053|FG001|Received at Least 1 Dose of Study Drug|Overall Study||12||
48075190|NCT03322631|100508054|FG002|Received at Least 1 Dose of Study Drug|Overall Study||16||
48075191|NCT03322631|100508055|FG003|Received at Least 1 Dose of Study Drug|Overall Study||11||
48075192|NCT03322631|100508052|FG000|COMPLETED|Overall Study||9||
48075193|NCT03322631|100508053|FG001|COMPLETED|Overall Study||11||
48075194|NCT03322631|100508054|FG002|COMPLETED|Overall Study||15||
48075195|NCT03322631|100508055|FG003|COMPLETED|Overall Study||11||
48075196|NCT03322631|100508052|FG000|NOT COMPLETED|Overall Study||0||
48075197|NCT03322631|100508053|FG001|NOT COMPLETED|Overall Study||1||
48075198|NCT03322631|100508054|FG002|NOT COMPLETED|Overall Study||1||
48075199|NCT03322631|100508055|FG003|NOT COMPLETED|Overall Study||0||
48075200|NCT02969369|100508056|FG000|STARTED|Study||14||
48075201|NCT02969369|100508057|FG001|STARTED|Study||25||
48075202|NCT02969369|100508056|FG000|Modified Intent-to-Treat Population|Study||14||
48075203|NCT02969369|100508057|FG001|Modified Intent-to-Treat Population|Study||24||
48075204|NCT02969369|100508056|FG000|COMPLETED|Study||10||
48075205|NCT02969369|100508057|FG001|COMPLETED|Study||11||
48075206|NCT02969369|100508056|FG000|NOT COMPLETED|Study||4||
48075207|NCT02969369|100508057|FG001|NOT COMPLETED|Study||14||
48075208|NCT02969369|100508056|FG000|STARTED|Double-blind Period||14||
48075209|NCT02969369|100508057|FG001|STARTED|Double-blind Period||25||
48075210|NCT02969369|100508056|FG000|Modified Intent-to-Treat Population|Double-blind Period||14||
48075211|NCT02969369|100508057|FG001|Modified Intent-to-Treat Population|Double-blind Period||24||
48075212|NCT02969369|100508056|FG000|COMPLETED|Double-blind Period||11||
48075213|NCT02969369|100508057|FG001|COMPLETED|Double-blind Period||15||
48075214|NCT02969369|100508056|FG000|NOT COMPLETED|Double-blind Period||3||
48523002|NCT02939014|101616019|FG001|NOT COMPLETED|Overall Study||3||
48523003|NCT02546362|101616020|FG000|STARTED|4-week Treatment Period||50||
48523004|NCT02546362|101616020|FG000|COMPLETED|4-week Treatment Period||47||
48523005|NCT02546362|101616020|FG000|NOT COMPLETED|4-week Treatment Period||3||
48523006|NCT02546362|101616020|FG000|STARTED|12-week Treatment Period||47||
48523007|NCT02546362|101616020|FG000|COMPLETED|12-week Treatment Period||38||
48523008|NCT02546362|101616020|FG000|NOT COMPLETED|12-week Treatment Period||9||
48523009|NCT02381626|101616021|FG000|STARTED|Overall Study||17||
48523010|NCT02381626|101616022|FG001|STARTED|Overall Study||16||
48523011|NCT02381626|101616023|FG002|STARTED|Overall Study||6||
48523012|NCT02381626|101616021|FG000|COMPLETED|Overall Study||17||
48523013|NCT02381626|101616022|FG001|COMPLETED|Overall Study||16||
48523014|NCT02381626|101616023|FG002|COMPLETED|Overall Study||6||
48523015|NCT02381626|101616021|FG000|NOT COMPLETED|Overall Study||0||
48523016|NCT02381626|101616022|FG001|NOT COMPLETED|Overall Study||0||
48523017|NCT02381626|101616023|FG002|NOT COMPLETED|Overall Study||0||
48523018|NCT01970865|101616024|FG000|STARTED|Overall Study||3||
48523019|NCT01970865|101616025|FG001|STARTED|Overall Study||3||
48523020|NCT01970865|101616026|FG002|STARTED|Overall Study||3||
48523021|NCT01970865|101616027|FG003|STARTED|Overall Study||12||
48523022|NCT01970865|101616028|FG004|STARTED|Overall Study||17||
48523023|NCT01970865|101616029|FG005|STARTED|Overall Study||3||
48523024|NCT01970865|101616030|FG006|STARTED|Overall Study||3||
48523025|NCT01970865|101616031|FG007|STARTED|Overall Study||3||
48523026|NCT01970865|101616032|FG008|STARTED|Overall Study||3||
48523027|NCT01970865|101616033|FG009|STARTED|Overall Study||4||
48523028|NCT01970865|101616034|FG010|STARTED|Overall Study||30||
48523029|NCT01970865|101616035|FG011|STARTED|Overall Study||27||
48523030|NCT01970865|101616036|FG012|STARTED|Overall Study||60||
48523031|NCT01970865|101616037|FG013|STARTED|Overall Study||65||
48523032|NCT01970865|101616038|FG014|STARTED|Overall Study||46||
48523033|NCT01970865|101616039|FG015|STARTED|Overall Study||47||
48523034|NCT01970865|101616040|FG016|STARTED|Overall Study||3||
48523035|NCT01970865|101616041|FG017|STARTED|Overall Study||32||
48523036|NCT01970865|101616024|FG000|COMPLETED|Overall Study||0||
48523037|NCT01970865|101616025|FG001|COMPLETED|Overall Study||0||
48523038|NCT01970865|101616026|FG002|COMPLETED|Overall Study||0||
48523039|NCT01970865|101616027|FG003|COMPLETED|Overall Study||2||
48523040|NCT01970865|101616028|FG004|COMPLETED|Overall Study||3||
48523041|NCT01970865|101616029|FG005|COMPLETED|Overall Study||0||
48523042|NCT01970865|101616030|FG006|COMPLETED|Overall Study||0||
48523043|NCT01970865|101616031|FG007|COMPLETED|Overall Study||0||
48523044|NCT01970865|101616032|FG008|COMPLETED|Overall Study||1||
48523045|NCT01970865|101616033|FG009|COMPLETED|Overall Study||2||
48075215|NCT02969369|100508057|FG001|NOT COMPLETED|Double-blind Period||10||
48523046|NCT01970865|101616034|FG010|COMPLETED|Overall Study||18||
48523047|NCT01970865|101616035|FG011|COMPLETED|Overall Study||7||
48075216|NCT02969369|100508056|FG000|STARTED|Open-label SEP-363856 Period||7||
48075217|NCT02969369|100508057|FG001|STARTED|Open-label SEP-363856 Period||9||
48075218|NCT02969369|100508056|FG000|COMPLETED|Open-label SEP-363856 Period||6||
48075219|NCT02969369|100508057|FG001|COMPLETED|Open-label SEP-363856 Period||5||
48075220|NCT02969369|100508056|FG000|NOT COMPLETED|Open-label SEP-363856 Period||1||
48075221|NCT02969369|100508057|FG001|NOT COMPLETED|Open-label SEP-363856 Period||4||
48075222|NCT01427972|100508058|FG000|STARTED|Treatment Period 1 (21 Days)||3||
48075223|NCT01427972|100508059|FG001|STARTED|Treatment Period 1 (21 Days)||4||
48075224|NCT01427972|100508060|FG002|STARTED|Treatment Period 1 (21 Days)||4||
48075225|NCT01427972|100508061|FG003|STARTED|Treatment Period 1 (21 Days)||3||
48075226|NCT01427972|100508062|FG004|STARTED|Treatment Period 1 (21 Days)||4||
48075227|NCT01427972|100508063|FG005|STARTED|Treatment Period 1 (21 Days)||3||
48075228|NCT01427972|100508064|FG006|STARTED|Treatment Period 1 (21 Days)||3||
48075229|NCT01427972|100508065|FG007|STARTED|Treatment Period 1 (21 Days)||5||
48075230|NCT01427972|100508066|FG008|STARTED|Treatment Period 1 (21 Days)||3||
48075231|NCT01427972|100508067|FG009|STARTED|Treatment Period 1 (21 Days)||3||
48075232|NCT01427972|100508068|FG010|STARTED|Treatment Period 1 (21 Days)||3||
48075233|NCT01427972|100508069|FG011|STARTED|Treatment Period 1 (21 Days)||4||
48075234|NCT01427972|100508058|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3||
48075235|NCT01427972|100508059|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4||
48075236|NCT01427972|100508060|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4||
48075237|NCT01427972|100508061|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3||
48075238|NCT01427972|100508062|FG004|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4||
48075239|NCT01427972|100508063|FG005|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3||
48075240|NCT01427972|100508064|FG006|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3||
48075241|NCT01427972|100508065|FG007|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||5||
48075242|NCT01427972|100508066|FG008|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3||
48075243|NCT01427972|100508067|FG009|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3||
48075244|NCT01427972|100508068|FG010|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3||
48075245|NCT01427972|100508069|FG011|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4||
48075246|NCT01427972|100508058|FG000|COMPLETED|Treatment Period 1 (21 Days)||3||
48075247|NCT01427972|100508059|FG001|COMPLETED|Treatment Period 1 (21 Days)||4||
48075248|NCT01427972|100508060|FG002|COMPLETED|Treatment Period 1 (21 Days)||4||
48075249|NCT01427972|100508061|FG003|COMPLETED|Treatment Period 1 (21 Days)||3||
48075250|NCT01427972|100508062|FG004|COMPLETED|Treatment Period 1 (21 Days)||4||
48075251|NCT01427972|100508063|FG005|COMPLETED|Treatment Period 1 (21 Days)||3||
48075252|NCT01427972|100508064|FG006|COMPLETED|Treatment Period 1 (21 Days)||3||
48075253|NCT01427972|100508065|FG007|COMPLETED|Treatment Period 1 (21 Days)||4||
48075254|NCT01427972|100508066|FG008|COMPLETED|Treatment Period 1 (21 Days)||3||
48075255|NCT01427972|100508067|FG009|COMPLETED|Treatment Period 1 (21 Days)||3||
48075256|NCT01427972|100508068|FG010|COMPLETED|Treatment Period 1 (21 Days)||3||
48075257|NCT01427972|100508069|FG011|COMPLETED|Treatment Period 1 (21 Days)||4||
48075258|NCT01427972|100508058|FG000|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
48075259|NCT01427972|100508059|FG001|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
48075260|NCT01427972|100508060|FG002|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
48075261|NCT01427972|100508061|FG003|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
48075262|NCT01427972|100508062|FG004|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
48075263|NCT01427972|100508063|FG005|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
48075264|NCT01427972|100508064|FG006|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
48075265|NCT01427972|100508065|FG007|NOT COMPLETED|Treatment Period 1 (21 Days)||1||
48075266|NCT01427972|100508066|FG008|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
48075267|NCT01427972|100508067|FG009|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
48075268|NCT01427972|100508068|FG010|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
48075269|NCT01427972|100508069|FG011|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
48075270|NCT01427972|100508058|FG000|STARTED|Washout (at Least 28 Days)||3||
48075271|NCT01427972|100508059|FG001|STARTED|Washout (at Least 28 Days)||4||
48075272|NCT01427972|100508060|FG002|STARTED|Washout (at Least 28 Days)||4||
48075273|NCT01427972|100508061|FG003|STARTED|Washout (at Least 28 Days)||3||
48075274|NCT01427972|100508062|FG004|STARTED|Washout (at Least 28 Days)||4||
48075275|NCT01427972|100508063|FG005|STARTED|Washout (at Least 28 Days)||3||
48075276|NCT01427972|100508064|FG006|STARTED|Washout (at Least 28 Days)||3||
48075277|NCT01427972|100508065|FG007|STARTED|Washout (at Least 28 Days)||4||
48075278|NCT01427972|100508066|FG008|STARTED|Washout (at Least 28 Days)||3||
48075279|NCT01427972|100508067|FG009|STARTED|Washout (at Least 28 Days)||3||
48075280|NCT01427972|100508068|FG010|STARTED|Washout (at Least 28 Days)||3||
48075281|NCT01427972|100508069|FG011|STARTED|Washout (at Least 28 Days)||4||
48075282|NCT01427972|100508058|FG000|COMPLETED|Washout (at Least 28 Days)||3||
48075283|NCT01427972|100508059|FG001|COMPLETED|Washout (at Least 28 Days)||4||
48075284|NCT01427972|100508060|FG002|COMPLETED|Washout (at Least 28 Days)||4||
48075285|NCT01427972|100508061|FG003|COMPLETED|Washout (at Least 28 Days)||3||
48075286|NCT01427972|100508062|FG004|COMPLETED|Washout (at Least 28 Days)||4||
48075287|NCT01427972|100508063|FG005|COMPLETED|Washout (at Least 28 Days)||1||
48075288|NCT01427972|100508064|FG006|COMPLETED|Washout (at Least 28 Days)||3||
48075289|NCT01427972|100508065|FG007|COMPLETED|Washout (at Least 28 Days)||4||
48075290|NCT01427972|100508066|FG008|COMPLETED|Washout (at Least 28 Days)||3||
48075291|NCT01427972|100508067|FG009|COMPLETED|Washout (at Least 28 Days)||3||
48075292|NCT01427972|100508068|FG010|COMPLETED|Washout (at Least 28 Days)||3||
48075293|NCT01427972|100508069|FG011|COMPLETED|Washout (at Least 28 Days)||4||
48075294|NCT01427972|100508058|FG000|NOT COMPLETED|Washout (at Least 28 Days)||0||
48075295|NCT01427972|100508059|FG001|NOT COMPLETED|Washout (at Least 28 Days)||0||
48075296|NCT01427972|100508060|FG002|NOT COMPLETED|Washout (at Least 28 Days)||0||
48075297|NCT01427972|100508061|FG003|NOT COMPLETED|Washout (at Least 28 Days)||0||
48075298|NCT01427972|100508062|FG004|NOT COMPLETED|Washout (at Least 28 Days)||0||
48075299|NCT01427972|100508063|FG005|NOT COMPLETED|Washout (at Least 28 Days)||2||
48075300|NCT01427972|100508064|FG006|NOT COMPLETED|Washout (at Least 28 Days)||0||
48075301|NCT01427972|100508065|FG007|NOT COMPLETED|Washout (at Least 28 Days)||0||
48075302|NCT01427972|100508066|FG008|NOT COMPLETED|Washout (at Least 28 Days)||0||
48075303|NCT01427972|100508067|FG009|NOT COMPLETED|Washout (at Least 28 Days)||0||
48075304|NCT01427972|100508068|FG010|NOT COMPLETED|Washout (at Least 28 Days)||0||
48075305|NCT01427972|100508069|FG011|NOT COMPLETED|Washout (at Least 28 Days)||0||
48075306|NCT01427972|100508058|FG000|STARTED|Treatment Period 2 (21 Days)||3||
48075307|NCT01427972|100508059|FG001|STARTED|Treatment Period 2 (21 Days)||4||
48075308|NCT01427972|100508060|FG002|STARTED|Treatment Period 2 (21 Days)||4||
48075309|NCT01427972|100508061|FG003|STARTED|Treatment Period 2 (21 Days)||3||
48075310|NCT01427972|100508062|FG004|STARTED|Treatment Period 2 (21 Days)||4||
48075311|NCT01427972|100508063|FG005|STARTED|Treatment Period 2 (21 Days)||1||
48075312|NCT01427972|100508064|FG006|STARTED|Treatment Period 2 (21 Days)||3||
48075313|NCT01427972|100508065|FG007|STARTED|Treatment Period 2 (21 Days)||4||
48075314|NCT01427972|100508066|FG008|STARTED|Treatment Period 2 (21 Days)||3||
48075315|NCT01427972|100508067|FG009|STARTED|Treatment Period 2 (21 Days)||3||
48075316|NCT01427972|100508068|FG010|STARTED|Treatment Period 2 (21 Days)||3||
48075317|NCT01427972|100508069|FG011|STARTED|Treatment Period 2 (21 Days)||4||
48075318|NCT01427972|100508058|FG000|COMPLETED|Treatment Period 2 (21 Days)||3||
48075319|NCT01427972|100508059|FG001|COMPLETED|Treatment Period 2 (21 Days)||3||
48075320|NCT01427972|100508060|FG002|COMPLETED|Treatment Period 2 (21 Days)||4||
48075321|NCT01427972|100508061|FG003|COMPLETED|Treatment Period 2 (21 Days)||3||
48075322|NCT01427972|100508062|FG004|COMPLETED|Treatment Period 2 (21 Days)||4||
48075323|NCT01427972|100508063|FG005|COMPLETED|Treatment Period 2 (21 Days)||1||
48075324|NCT01427972|100508064|FG006|COMPLETED|Treatment Period 2 (21 Days)||3||
48075325|NCT01427972|100508065|FG007|COMPLETED|Treatment Period 2 (21 Days)||4||
48075326|NCT01427972|100508066|FG008|COMPLETED|Treatment Period 2 (21 Days)||3||
48075327|NCT01427972|100508067|FG009|COMPLETED|Treatment Period 2 (21 Days)||3||
48075328|NCT01427972|100508068|FG010|COMPLETED|Treatment Period 2 (21 Days)||3||
48075329|NCT01427972|100508069|FG011|COMPLETED|Treatment Period 2 (21 Days)||4||
48075330|NCT01427972|100508058|FG000|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
48227180|NCT01323790|100877936|FG002|NOT COMPLETED|Overall Study||45||
48227181|NCT04867382|100877937|FG000|STARTED|Overall Study||48||
48227182|NCT04867382|100877938|FG001|STARTED|Overall Study||40||
48075331|NCT01427972|100508059|FG001|NOT COMPLETED|Treatment Period 2 (21 Days)||1||
48075332|NCT01427972|100508060|FG002|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
48075333|NCT01427972|100508061|FG003|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
48075334|NCT01427972|100508062|FG004|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
48075335|NCT01427972|100508063|FG005|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
48075336|NCT01427972|100508064|FG006|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
48075337|NCT01427972|100508065|FG007|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
48075338|NCT01427972|100508066|FG008|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
48075339|NCT01427972|100508067|FG009|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
48075340|NCT01427972|100508068|FG010|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
48075341|NCT01427972|100508069|FG011|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
48075342|NCT00508716|100508070|FG000|STARTED|Overall Study||61||
48075343|NCT00508716|100508071|FG001|STARTED|Overall Study||63||
48075344|NCT00508716|100508070|FG000|COMPLETED|Overall Study||61||
48075345|NCT00508716|100508071|FG001|COMPLETED|Overall Study||63||
48075346|NCT00508716|100508070|FG000|NOT COMPLETED|Overall Study||0||
48075347|NCT00508716|100508071|FG001|NOT COMPLETED|Overall Study||0||
48075348|NCT01325584|100508072|FG000|STARTED|Overall Study||12||
48075349|NCT01325584|100508072|FG000|COMPLETED|Overall Study||11||
48075350|NCT01325584|100508072|FG000|NOT COMPLETED|Overall Study||1||
48075351|NCT01845831|100508073|FG000|STARTED|Inpatient Phase||140||
48075352|NCT01845831|100508074|FG001|STARTED|Inpatient Phase||139||
48075353|NCT01845831|100508075|FG002|STARTED|Inpatient Phase||0||
48075354|NCT01845831|100508076|FG003|STARTED|Inpatient Phase||0||
48075355|NCT01845831|100508077|FG004|STARTED|Inpatient Phase||0||
48075356|NCT01845831|100508073|FG000|COMPLETED|Inpatient Phase||139||
48075357|NCT01845831|100508074|FG001|COMPLETED|Inpatient Phase||138||
48075358|NCT01845831|100508075|FG002|COMPLETED|Inpatient Phase||0||
48075359|NCT01845831|100508076|FG003|COMPLETED|Inpatient Phase||0||
48075360|NCT01845831|100508077|FG004|COMPLETED|Inpatient Phase||0||
48075361|NCT01845831|100508073|FG000|NOT COMPLETED|Inpatient Phase||1||
48075362|NCT01845831|100508074|FG001|NOT COMPLETED|Inpatient Phase||1||
48075363|NCT01845831|100508075|FG002|NOT COMPLETED|Inpatient Phase||0||
48075364|NCT01845831|100508076|FG003|NOT COMPLETED|Inpatient Phase||0||
48075365|NCT01845831|100508077|FG004|NOT COMPLETED|Inpatient Phase||0||
48075366|NCT01845831|100508073|FG000|STARTED|Outpatient Phase||0||
48075367|NCT01845831|100508074|FG001|STARTED|Outpatient Phase||0||
48075368|NCT01845831|100508075|FG002|STARTED|Outpatient Phase||68||
48075369|NCT01845831|100508076|FG003|STARTED|Outpatient Phase||98||
48075370|NCT01845831|100508077|FG004|STARTED|Outpatient Phase||87||
48075371|NCT01845831|100508073|FG000|COMPLETED|Outpatient Phase||0||
48075372|NCT01845831|100508074|FG001|COMPLETED|Outpatient Phase||0||
48075373|NCT01845831|100508075|FG002|COMPLETED|Outpatient Phase||68||
48075374|NCT01845831|100508076|FG003|COMPLETED|Outpatient Phase||98||
48075375|NCT01845831|100508077|FG004|COMPLETED|Outpatient Phase||87||
48075376|NCT01845831|100508073|FG000|NOT COMPLETED|Outpatient Phase||0||
48075377|NCT01845831|100508074|FG001|NOT COMPLETED|Outpatient Phase||0||
48075378|NCT01845831|100508075|FG002|NOT COMPLETED|Outpatient Phase||0||
48075379|NCT01845831|100508076|FG003|NOT COMPLETED|Outpatient Phase||0||
48075380|NCT01845831|100508077|FG004|NOT COMPLETED|Outpatient Phase||0||
48075381|NCT04545060|100508078|FG000|STARTED|Overall Study||528||
48075382|NCT04545060|100508079|FG001|STARTED|Overall Study||529||
48075383|NCT04545060|100508078|FG000|COMPLETED|Overall Study||498||
48075384|NCT04545060|100508079|FG001|COMPLETED|Overall Study||488||
48075385|NCT04545060|100508078|FG000|NOT COMPLETED|Overall Study||30||
48075386|NCT04545060|100508079|FG001|NOT COMPLETED|Overall Study||41||
48075387|NCT00695409|100508080|FG000|STARTED|Overall Study||122||
48075388|NCT00695409|100508080|FG000|COMPLETED|Overall Study||122||
48075389|NCT00695409|100508080|FG000|NOT COMPLETED|Overall Study||0||
48075390|NCT02160535|100508081|FG000|STARTED|Overall Study||13||
48075391|NCT02160535|100508081|FG000|COMPLETED|Overall Study||10||
48075392|NCT02160535|100508081|FG000|NOT COMPLETED|Overall Study||3||
48075393|NCT03329573|100508082|FG000|STARTED|Treatment Period 1 (Up to 5 Days)||23||
48075394|NCT03329573|100508083|FG001|STARTED|Treatment Period 1 (Up to 5 Days)||24||
48075395|NCT03329573|100508084|FG002|STARTED|Treatment Period 1 (Up to 5 Days)||19||
48075396|NCT03329573|100508085|FG003|STARTED|Treatment Period 1 (Up to 5 Days)||19||
48075397|NCT03329573|100508082|FG000|COMPLETED|Treatment Period 1 (Up to 5 Days)||22||
48075398|NCT03329573|100508083|FG001|COMPLETED|Treatment Period 1 (Up to 5 Days)||21||
48075399|NCT03329573|100508084|FG002|COMPLETED|Treatment Period 1 (Up to 5 Days)||19||
48075400|NCT03329573|100508085|FG003|COMPLETED|Treatment Period 1 (Up to 5 Days)||19||
48075401|NCT03329573|100508082|FG000|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||1||
48075402|NCT03329573|100508083|FG001|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||3||
48075403|NCT03329573|100508084|FG002|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||0||
48075404|NCT03329573|100508085|FG003|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||0||
48075405|NCT03329573|100508082|FG000|STARTED|Washout Period (Day 6 to Day 11)||22||
48075406|NCT03329573|100508083|FG001|STARTED|Washout Period (Day 6 to Day 11)||21||
48075407|NCT03329573|100508084|FG002|STARTED|Washout Period (Day 6 to Day 11)||19||
48075408|NCT03329573|100508085|FG003|STARTED|Washout Period (Day 6 to Day 11)||19||
48075409|NCT03329573|100508082|FG000|COMPLETED|Washout Period (Day 6 to Day 11)||22||
48075410|NCT03329573|100508083|FG001|COMPLETED|Washout Period (Day 6 to Day 11)||21||
48075411|NCT03329573|100508084|FG002|COMPLETED|Washout Period (Day 6 to Day 11)||19||
48075412|NCT03329573|100508085|FG003|COMPLETED|Washout Period (Day 6 to Day 11)||19||
48075413|NCT03329573|100508082|FG000|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0||
48075414|NCT03329573|100508083|FG001|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0||
48075415|NCT03329573|100508084|FG002|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0||
48075416|NCT03329573|100508085|FG003|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0||
48075417|NCT03329573|100508082|FG000|STARTED|Treatment Period 2 (Day 12 to Day 26)||22||
48075418|NCT03329573|100508083|FG001|STARTED|Treatment Period 2 (Day 12 to Day 26)||21||
48075419|NCT03329573|100508084|FG002|STARTED|Treatment Period 2 (Day 12 to Day 26)||19||
48075420|NCT03329573|100508085|FG003|STARTED|Treatment Period 2 (Day 12 to Day 26)||19||
48075421|NCT03329573|100508082|FG000|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||21||
48075422|NCT03329573|100508083|FG001|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||20||
48075423|NCT03329573|100508084|FG002|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||19||
48075424|NCT03329573|100508085|FG003|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||19||
48075425|NCT03329573|100508082|FG000|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||1||
48075426|NCT03329573|100508083|FG001|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||1||
48075427|NCT03329573|100508084|FG002|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||0||
48075428|NCT03329573|100508085|FG003|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||0||
48075429|NCT00690274|100508086|FG000|STARTED|Overall Study||29||
48075430|NCT00690274|100508087|FG001|STARTED|Overall Study||23||
48075431|NCT00690274|100508086|FG000|COMPLETED|Overall Study||23||
48075432|NCT00690274|100508087|FG001|COMPLETED|Overall Study||15||
48075433|NCT00690274|100508086|FG000|NOT COMPLETED|Overall Study||6||
48075434|NCT00690274|100508087|FG001|NOT COMPLETED|Overall Study||8||
48075435|NCT02985957|100508088|FG000|STARTED|Pre-Treatment Period||2||
48075436|NCT02985957|100508089|FG001|STARTED|Pre-Treatment Period||45||
48075437|NCT02985957|100508090|FG002|STARTED|Pre-Treatment Period||45||
48075438|NCT02985957|100508091|FG003|STARTED|Pre-Treatment Period||73||
48075439|NCT02985957|100508092|FG004|STARTED|Pre-Treatment Period||74||
48075440|NCT02985957|100508093|FG005|STARTED|Pre-Treatment Period||38||
48075441|NCT02985957|100508094|FG006|STARTED|Pre-Treatment Period||74||
48075442|NCT02985957|100508088|FG000|COMPLETED|Pre-Treatment Period||2||
48075443|NCT02985957|100508089|FG001|COMPLETED|Pre-Treatment Period||45||
48075444|NCT02985957|100508090|FG002|COMPLETED|Pre-Treatment Period||45||
48075445|NCT02985957|100508091|FG003|COMPLETED|Pre-Treatment Period||73||
48075446|NCT02985957|100508092|FG004|COMPLETED|Pre-Treatment Period||73||
48075447|NCT02985957|100508093|FG005|COMPLETED|Pre-Treatment Period||38||
48075448|NCT02985957|100508094|FG006|COMPLETED|Pre-Treatment Period||72||
48075449|NCT02985957|100508088|FG000|NOT COMPLETED|Pre-Treatment Period||0||
48075450|NCT02985957|100508089|FG001|NOT COMPLETED|Pre-Treatment Period||0||
48075451|NCT02985957|100508090|FG002|NOT COMPLETED|Pre-Treatment Period||0||
48075452|NCT02985957|100508091|FG003|NOT COMPLETED|Pre-Treatment Period||0||
48075453|NCT02985957|100508092|FG004|NOT COMPLETED|Pre-Treatment Period||1||
48075454|NCT02985957|100508093|FG005|NOT COMPLETED|Pre-Treatment Period||0||
48075455|NCT02985957|100508094|FG006|NOT COMPLETED|Pre-Treatment Period||2||
48075456|NCT02985957|100508088|FG000|STARTED|Treatment Period||2|Started Treatment|
48075457|NCT02985957|100508089|FG001|STARTED|Treatment Period||45|Started Treatment|
48075458|NCT02985957|100508090|FG002|STARTED|Treatment Period||45|Started Treatment|
48075459|NCT02985957|100508091|FG003|STARTED|Treatment Period||73|Started Treatment|
48075460|NCT02985957|100508092|FG004|STARTED|Treatment Period||73|Started Treatment|
48075461|NCT02985957|100508093|FG005|STARTED|Treatment Period||38|Started Treatment|
48075462|NCT02985957|100508094|FG006|STARTED|Treatment Period||72|Started Treatment|
48075463|NCT02985957|100508088|FG000|Eligible Participants Who Progressed and Received Nivolumab 3 mg/kg + Ipilimumab 1 mg/kg|Treatment Period||0||
48075464|NCT02985957|100508089|FG001|Eligible Participants Who Progressed and Received Nivolumab 3 mg/kg + Ipilimumab 1 mg/kg|Treatment Period||0||
48075465|NCT02985957|100508090|FG002|Eligible Participants Who Progressed and Received Nivolumab 3 mg/kg + Ipilimumab 1 mg/kg|Treatment Period||0||
48075466|NCT02985957|100508091|FG003|Eligible Participants Who Progressed and Received Nivolumab 3 mg/kg + Ipilimumab 1 mg/kg|Treatment Period||0||
48075467|NCT02985957|100508092|FG004|Eligible Participants Who Progressed and Received Nivolumab 3 mg/kg + Ipilimumab 1 mg/kg|Treatment Period||0||
48075468|NCT02985957|100508093|FG005|Eligible Participants Who Progressed and Received Nivolumab 3 mg/kg + Ipilimumab 1 mg/kg|Treatment Period||12||
48075469|NCT02985957|100508094|FG006|Eligible Participants Who Progressed and Received Nivolumab 3 mg/kg + Ipilimumab 1 mg/kg|Treatment Period||25||
48075470|NCT02985957|100508088|FG000|COMPLETED|Treatment Period||0||
48075471|NCT02985957|100508089|FG001|COMPLETED|Treatment Period||0||
48075472|NCT02985957|100508090|FG002|COMPLETED|Treatment Period||0||
48075473|NCT02985957|100508091|FG003|COMPLETED|Treatment Period||2||
48075474|NCT02985957|100508092|FG004|COMPLETED|Treatment Period||0||
48075475|NCT02985957|100508093|FG005|COMPLETED|Treatment Period||19||
48075476|NCT02985957|100508094|FG006|COMPLETED|Treatment Period||25||
48075477|NCT02985957|100508088|FG000|NOT COMPLETED|Treatment Period||2||
48075478|NCT02985957|100508089|FG001|NOT COMPLETED|Treatment Period||45||
48075479|NCT02985957|100508090|FG002|NOT COMPLETED|Treatment Period||45||
48075480|NCT02985957|100508091|FG003|NOT COMPLETED|Treatment Period||71||
48075481|NCT02985957|100508092|FG004|NOT COMPLETED|Treatment Period||73||
48075482|NCT02985957|100508093|FG005|NOT COMPLETED|Treatment Period||19||
48075483|NCT02985957|100508094|FG006|NOT COMPLETED|Treatment Period||47||
48075484|NCT01919606|100508095|FG000|STARTED|Overall Study||1||
48075485|NCT01919606|100508096|FG001|STARTED|Overall Study||0||
48075486|NCT01919606|100508095|FG000|COMPLETED|Overall Study||1||
48075487|NCT01919606|100508096|FG001|COMPLETED|Overall Study||0||
48075488|NCT01919606|100508095|FG000|NOT COMPLETED|Overall Study||0||
48075489|NCT01919606|100508096|FG001|NOT COMPLETED|Overall Study||0||
48075490|NCT01056653|100508097|FG000|STARTED|Overall Study||46||
48075491|NCT01056653|100508098|FG001|STARTED|Overall Study||23||
48075492|NCT01056653|100508099|FG002|STARTED|Overall Study||44||
48075493|NCT01056653|100508097|FG000|COMPLETED|Overall Study||46||
48075494|NCT01056653|100508098|FG001|COMPLETED|Overall Study||23||
48075495|NCT01056653|100508099|FG002|COMPLETED|Overall Study||42||
48075496|NCT01056653|100508097|FG000|NOT COMPLETED|Overall Study||0||
48075497|NCT01056653|100508098|FG001|NOT COMPLETED|Overall Study||0||
48075498|NCT01056653|100508099|FG002|NOT COMPLETED|Overall Study||2||
48075499|NCT03483740|100508100|FG000|STARTED|Overall Study||6||
48075500|NCT03483740|100508101|FG001|STARTED|Overall Study||6||
48075501|NCT03483740|100508100|FG000|COMPLETED|Overall Study||5||
48075502|NCT03483740|100508101|FG001|COMPLETED|Overall Study||5||
48075503|NCT03483740|100508100|FG000|NOT COMPLETED|Overall Study||1||
48075504|NCT03483740|100508101|FG001|NOT COMPLETED|Overall Study||1||
48075505|NCT00365508|100508102|FG000|STARTED|Overall Study||321||
48075506|NCT00365508|100508103|FG001|STARTED|Overall Study||321||
48075507|NCT00365508|100508102|FG000|COMPLETED|Overall Study||182||
48075508|NCT00365508|100508103|FG001|COMPLETED|Overall Study||167||
48075509|NCT00365508|100508102|FG000|NOT COMPLETED|Overall Study||139||
48075510|NCT00365508|100508103|FG001|NOT COMPLETED|Overall Study||154||
48075511|NCT02412618|100508104|FG000|STARTED|Overall Study||50||
48075512|NCT02412618|100508105|FG001|STARTED|Overall Study||50||
48075513|NCT02412618|100508104|FG000|COMPLETED|Overall Study||48||
48075514|NCT02412618|100508105|FG001|COMPLETED|Overall Study||48||
48075515|NCT02412618|100508104|FG000|NOT COMPLETED|Overall Study||2||
48075516|NCT02412618|100508105|FG001|NOT COMPLETED|Overall Study||2||
48075517|NCT05673889|100508106|FG000|STARTED|Period 1 (4 Days)||24||
48075518|NCT05673889|100508106|FG000|COMPLETED|Period 1 (4 Days)||24||
48075519|NCT05673889|100508106|FG000|NOT COMPLETED|Period 1 (4 Days)||0||
48075520|NCT05673889|100508106|FG000|STARTED|Period 2 (3 Days)||24||
48075521|NCT05673889|100508106|FG000|COMPLETED|Period 2 (3 Days)||24||
48075522|NCT05673889|100508106|FG000|NOT COMPLETED|Period 2 (3 Days)||0||
48075523|NCT01101880|100508107|FG000|STARTED|Overall Study||50||
48075524|NCT01101880|100508107|FG000|COMPLETED|Overall Study||50||
48075525|NCT01101880|100508107|FG000|NOT COMPLETED|Overall Study||0||
48075526|NCT03334539|100508108|FG000|STARTED|Overall Study||50||
48075527|NCT03334539|100508109|FG001|STARTED|Overall Study||50||
48075528|NCT03334539|100508110|FG002|STARTED|Overall Study||50||
48075529|NCT03334539|100508108|FG000|COMPLETED|Overall Study||46||
48075530|NCT03334539|100508109|FG001|COMPLETED|Overall Study||43||
48075531|NCT03334539|100508110|FG002|COMPLETED|Overall Study||49||
48075532|NCT03334539|100508108|FG000|NOT COMPLETED|Overall Study||4||
48075533|NCT03334539|100508109|FG001|NOT COMPLETED|Overall Study||7||
48075534|NCT03334539|100508110|FG002|NOT COMPLETED|Overall Study||1||
48075535|NCT02543437|100508111|FG000|STARTED|Overall Study||117||
48075536|NCT02543437|100508111|FG000|COMPLETED|Overall Study||117||
48075537|NCT02543437|100508111|FG000|NOT COMPLETED|Overall Study||0||
48075538|NCT00518284|100508112|FG000|STARTED|Overall Study||0||
48075539|NCT00518284|100508113|FG001|STARTED|Overall Study||3||
48075540|NCT00518284|100508114|FG002|STARTED|Overall Study||1||
48075541|NCT00518284|100508115|FG003|STARTED|Overall Study||2||
48075542|NCT00518284|100508112|FG000|COMPLETED|Overall Study||0||
48075543|NCT00518284|100508113|FG001|COMPLETED|Overall Study||0||
48075544|NCT00518284|100508114|FG002|COMPLETED|Overall Study||0||
48075545|NCT00518284|100508115|FG003|COMPLETED|Overall Study||0||
48075546|NCT00518284|100508112|FG000|NOT COMPLETED|Overall Study||0||
48075547|NCT00518284|100508113|FG001|NOT COMPLETED|Overall Study||3||
48075548|NCT00518284|100508114|FG002|NOT COMPLETED|Overall Study||1||
48075549|NCT00518284|100508115|FG003|NOT COMPLETED|Overall Study||2||
48075550|NCT00635167|100508116|FG000|STARTED|Overall Study||1||
48075551|NCT00635167|100508116|FG000|COMPLETED|Overall Study||1||
48075552|NCT00635167|100508116|FG000|NOT COMPLETED|Overall Study||0||
48075553|NCT01929343|100508117|FG000|STARTED|Overall Study||12||
48075554|NCT01929343|100508118|FG001|STARTED|Overall Study||9||
48075555|NCT01929343|100508119|FG002|STARTED|Overall Study||12||
48075556|NCT01929343|100508117|FG000|COMPLETED|Overall Study||11||
48227183|NCT04867382|100877937|FG000|Completed Stigma Reduction (Intervention) or Attention-control (Comparison) Training|Overall Study||48||
48075557|NCT01929343|100508118|FG001|COMPLETED|Overall Study||7||
48075558|NCT01929343|100508119|FG002|COMPLETED|Overall Study||12||
48075559|NCT01929343|100508117|FG000|NOT COMPLETED|Overall Study||1||
48075560|NCT01929343|100508118|FG001|NOT COMPLETED|Overall Study||2||
48075561|NCT01929343|100508119|FG002|NOT COMPLETED|Overall Study||0||
48075562|NCT01847274|100508120|FG000|STARTED|Main Study (Upto 7years 7months 6 Days)||138||
48075563|NCT01847274|100508121|FG001|STARTED|Main Study (Upto 7years 7months 6 Days)||65||
48075564|NCT01847274|100508122|FG002|STARTED|Main Study (Upto 7years 7months 6 Days)||234||
48075565|NCT01847274|100508123|FG003|STARTED|Main Study (Upto 7years 7months 6 Days)||116||
48075566|NCT01847274|100508124|FG004|STARTED|Main Study (Upto 7years 7months 6 Days)||0||
48075567|NCT01847274|100508125|FG005|STARTED|Main Study (Upto 7years 7months 6 Days)||0||
48075568|NCT01847274|100508126|FG006|STARTED|Main Study (Upto 7years 7months 6 Days)||0||
48075569|NCT01847274|100508127|FG007|STARTED|Main Study (Upto 7years 7months 6 Days)||0||
48075570|NCT01847274|100508128|FG008|STARTED|Main Study (Upto 7years 7months 6 Days)||0||
48075571|NCT01847274|100508129|FG009|STARTED|Main Study (Upto 7years 7months 6 Days)||0||
48075572|NCT01847274|100508130|FG010|STARTED|Main Study (Upto 7years 7months 6 Days)||0||
48075573|NCT01847274|100508120|FG000|COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
48075574|NCT01847274|100508121|FG001|COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
48075575|NCT01847274|100508122|FG002|COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
48075576|NCT01847274|100508123|FG003|COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
48075577|NCT01847274|100508124|FG004|COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
48075578|NCT01847274|100508125|FG005|COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
48075579|NCT01847274|100508126|FG006|COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
48075580|NCT01847274|100508127|FG007|COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
48075581|NCT01847274|100508128|FG008|COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
48075582|NCT01847274|100508129|FG009|COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
48075583|NCT01847274|100508130|FG010|COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
48075584|NCT01847274|100508120|FG000|NOT COMPLETED|Main Study (Upto 7years 7months 6 Days)||138||
48075585|NCT01847274|100508121|FG001|NOT COMPLETED|Main Study (Upto 7years 7months 6 Days)||65||
48075586|NCT01847274|100508122|FG002|NOT COMPLETED|Main Study (Upto 7years 7months 6 Days)||234||
48075587|NCT01847274|100508123|FG003|NOT COMPLETED|Main Study (Upto 7years 7months 6 Days)||116||
48075588|NCT01847274|100508124|FG004|NOT COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
48075589|NCT01847274|100508125|FG005|NOT COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
48141192|NCT03581305|100670361|FG001|STARTED|Dopaminergic Study||23||
48075590|NCT01847274|100508126|FG006|NOT COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
48075591|NCT01847274|100508127|FG007|NOT COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
48075592|NCT01847274|100508128|FG008|NOT COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
48075593|NCT01847274|100508129|FG009|NOT COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
48075594|NCT01847274|100508130|FG010|NOT COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
48075595|NCT01847274|100508120|FG000|STARTED|FE Sub-study, Period1 (Day1)||0||
48075596|NCT01847274|100508121|FG001|STARTED|FE Sub-study, Period1 (Day1)||0||
48075597|NCT01847274|100508122|FG002|STARTED|FE Sub-study, Period1 (Day1)||0||
48075598|NCT01847274|100508123|FG003|STARTED|FE Sub-study, Period1 (Day1)||0||
48075599|NCT01847274|100508124|FG004|STARTED|FE Sub-study, Period1 (Day1)||8||
48075600|NCT01847274|100508125|FG005|STARTED|FE Sub-study, Period1 (Day1)||9||
48075601|NCT01847274|100508126|FG006|STARTED|FE Sub-study, Period1 (Day1)||0||
48075602|NCT01847274|100508127|FG007|STARTED|FE Sub-study, Period1 (Day1)||0||
48075603|NCT01847274|100508128|FG008|STARTED|FE Sub-study, Period1 (Day1)||0||
48075604|NCT01847274|100508129|FG009|STARTED|FE Sub-study, Period1 (Day1)||0||
48075605|NCT01847274|100508130|FG010|STARTED|FE Sub-study, Period1 (Day1)||0||
48075606|NCT01847274|100508120|FG000|COMPLETED|FE Sub-study, Period1 (Day1)||0||
48075607|NCT01847274|100508121|FG001|COMPLETED|FE Sub-study, Period1 (Day1)||0||
48075608|NCT01847274|100508122|FG002|COMPLETED|FE Sub-study, Period1 (Day1)||0||
48075609|NCT01847274|100508123|FG003|COMPLETED|FE Sub-study, Period1 (Day1)||0||
48075610|NCT01847274|100508124|FG004|COMPLETED|FE Sub-study, Period1 (Day1)||8||
48075611|NCT01847274|100508125|FG005|COMPLETED|FE Sub-study, Period1 (Day1)||8||
48075612|NCT01847274|100508126|FG006|COMPLETED|FE Sub-study, Period1 (Day1)||0||
48075613|NCT01847274|100508127|FG007|COMPLETED|FE Sub-study, Period1 (Day1)||0||
48075614|NCT01847274|100508128|FG008|COMPLETED|FE Sub-study, Period1 (Day1)||0||
48075615|NCT01847274|100508129|FG009|COMPLETED|FE Sub-study, Period1 (Day1)||0||
48075616|NCT01847274|100508130|FG010|COMPLETED|FE Sub-study, Period1 (Day1)||0||
48075617|NCT01847274|100508120|FG000|NOT COMPLETED|FE Sub-study, Period1 (Day1)||0||
48075618|NCT01847274|100508121|FG001|NOT COMPLETED|FE Sub-study, Period1 (Day1)||0||
48075619|NCT01847274|100508122|FG002|NOT COMPLETED|FE Sub-study, Period1 (Day1)||0||
48075620|NCT01847274|100508123|FG003|NOT COMPLETED|FE Sub-study, Period1 (Day1)||0||
48075621|NCT01847274|100508124|FG004|NOT COMPLETED|FE Sub-study, Period1 (Day1)||0||
48075622|NCT01847274|100508125|FG005|NOT COMPLETED|FE Sub-study, Period1 (Day1)||1||
48075623|NCT01847274|100508126|FG006|NOT COMPLETED|FE Sub-study, Period1 (Day1)||0||
48075624|NCT01847274|100508127|FG007|NOT COMPLETED|FE Sub-study, Period1 (Day1)||0||
48075625|NCT01847274|100508128|FG008|NOT COMPLETED|FE Sub-study, Period1 (Day1)||0||
48227184|NCT04867382|100877938|FG001|Completed Stigma Reduction (Intervention) or Attention-control (Comparison) Training|Overall Study||40||
48075626|NCT01847274|100508129|FG009|NOT COMPLETED|FE Sub-study, Period1 (Day1)||0||
48075627|NCT01847274|100508130|FG010|NOT COMPLETED|FE Sub-study, Period1 (Day1)||0||
48075628|NCT01847274|100508120|FG000|STARTED|FE Sub-study, Washout 1 (Up to Day 7)||0||
48075629|NCT01847274|100508121|FG001|STARTED|FE Sub-study, Washout 1 (Up to Day 7)||0||
48075630|NCT01847274|100508122|FG002|STARTED|FE Sub-study, Washout 1 (Up to Day 7)||0||
48075631|NCT01847274|100508123|FG003|STARTED|FE Sub-study, Washout 1 (Up to Day 7)||0||
48075632|NCT01847274|100508124|FG004|STARTED|FE Sub-study, Washout 1 (Up to Day 7)||8||
48075633|NCT01847274|100508125|FG005|STARTED|FE Sub-study, Washout 1 (Up to Day 7)||8||
48075634|NCT01847274|100508126|FG006|STARTED|FE Sub-study, Washout 1 (Up to Day 7)||0||
48075635|NCT01847274|100508127|FG007|STARTED|FE Sub-study, Washout 1 (Up to Day 7)||0||
48075636|NCT01847274|100508128|FG008|STARTED|FE Sub-study, Washout 1 (Up to Day 7)||0||
48075637|NCT01847274|100508129|FG009|STARTED|FE Sub-study, Washout 1 (Up to Day 7)||0||
48075638|NCT01847274|100508130|FG010|STARTED|FE Sub-study, Washout 1 (Up to Day 7)||0||
48075639|NCT01847274|100508120|FG000|COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
48075640|NCT01847274|100508121|FG001|COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
48075641|NCT01847274|100508122|FG002|COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
48075642|NCT01847274|100508123|FG003|COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
48075643|NCT01847274|100508124|FG004|COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||7||
48075644|NCT01847274|100508125|FG005|COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||8||
48075645|NCT01847274|100508126|FG006|COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
48075646|NCT01847274|100508127|FG007|COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
48075647|NCT01847274|100508128|FG008|COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
48075648|NCT01847274|100508129|FG009|COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
48075649|NCT01847274|100508130|FG010|COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
48075650|NCT01847274|100508120|FG000|NOT COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
48075651|NCT01847274|100508121|FG001|NOT COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
48075652|NCT01847274|100508122|FG002|NOT COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
48075653|NCT01847274|100508123|FG003|NOT COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
48075654|NCT01847274|100508124|FG004|NOT COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||1||
48075655|NCT01847274|100508125|FG005|NOT COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
48075656|NCT01847274|100508126|FG006|NOT COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
48075657|NCT01847274|100508127|FG007|NOT COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
48075658|NCT01847274|100508128|FG008|NOT COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
48075659|NCT01847274|100508129|FG009|NOT COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
48075660|NCT01847274|100508130|FG010|NOT COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
48075661|NCT01847274|100508120|FG000|STARTED|FE Sub-study, Period 2 (Day 1)||0||
48075662|NCT01847274|100508121|FG001|STARTED|FE Sub-study, Period 2 (Day 1)||0||
48075663|NCT01847274|100508122|FG002|STARTED|FE Sub-study, Period 2 (Day 1)||0||
48075664|NCT01847274|100508123|FG003|STARTED|FE Sub-study, Period 2 (Day 1)||0||
48075665|NCT01847274|100508124|FG004|STARTED|FE Sub-study, Period 2 (Day 1)||7||
48075666|NCT01847274|100508125|FG005|STARTED|FE Sub-study, Period 2 (Day 1)||8||
48075667|NCT01847274|100508126|FG006|STARTED|FE Sub-study, Period 2 (Day 1)||0||
48075668|NCT01847274|100508127|FG007|STARTED|FE Sub-study, Period 2 (Day 1)||0||
48075669|NCT01847274|100508128|FG008|STARTED|FE Sub-study, Period 2 (Day 1)||0||
48075670|NCT01847274|100508129|FG009|STARTED|FE Sub-study, Period 2 (Day 1)||0||
48075671|NCT01847274|100508130|FG010|STARTED|FE Sub-study, Period 2 (Day 1)||0||
48075672|NCT01847274|100508120|FG000|COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
48075673|NCT01847274|100508121|FG001|COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
48075674|NCT01847274|100508122|FG002|COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
48075675|NCT01847274|100508123|FG003|COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
48075676|NCT01847274|100508124|FG004|COMPLETED|FE Sub-study, Period 2 (Day 1)||7||
48075677|NCT01847274|100508125|FG005|COMPLETED|FE Sub-study, Period 2 (Day 1)||8||
48075678|NCT01847274|100508126|FG006|COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
48075679|NCT01847274|100508127|FG007|COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
48075680|NCT01847274|100508128|FG008|COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
48075681|NCT01847274|100508129|FG009|COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
48075682|NCT01847274|100508130|FG010|COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
48075683|NCT01847274|100508120|FG000|NOT COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
48075684|NCT01847274|100508121|FG001|NOT COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
48075685|NCT01847274|100508122|FG002|NOT COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
48075686|NCT01847274|100508123|FG003|NOT COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
48075687|NCT01847274|100508124|FG004|NOT COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
48075688|NCT01847274|100508125|FG005|NOT COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
48075689|NCT01847274|100508126|FG006|NOT COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
48075690|NCT01847274|100508127|FG007|NOT COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
48075691|NCT01847274|100508128|FG008|NOT COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
48075692|NCT01847274|100508129|FG009|NOT COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
48075693|NCT01847274|100508130|FG010|NOT COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
48075694|NCT01847274|100508120|FG000|STARTED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
48075695|NCT01847274|100508121|FG001|STARTED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
48075696|NCT01847274|100508122|FG002|STARTED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
48075697|NCT01847274|100508123|FG003|STARTED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
48075698|NCT01847274|100508124|FG004|STARTED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
48075699|NCT01847274|100508125|FG005|STARTED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
48075700|NCT01847274|100508126|FG006|STARTED|QTcSub-study(Upto 5 Year,10 Month,22day)||26||
48075701|NCT01847274|100508127|FG007|STARTED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
48075702|NCT01847274|100508128|FG008|STARTED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
48075703|NCT01847274|100508129|FG009|STARTED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
48075704|NCT01847274|100508130|FG010|STARTED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
48075705|NCT01847274|100508120|FG000|COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
48075706|NCT01847274|100508121|FG001|COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
48075707|NCT01847274|100508122|FG002|COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
48075708|NCT01847274|100508123|FG003|COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
48075709|NCT01847274|100508124|FG004|COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
48075710|NCT01847274|100508125|FG005|COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
48075711|NCT01847274|100508126|FG006|COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
48075712|NCT01847274|100508127|FG007|COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
48075713|NCT01847274|100508128|FG008|COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
48075714|NCT01847274|100508129|FG009|COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
48075715|NCT01847274|100508130|FG010|COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
48075716|NCT01847274|100508120|FG000|NOT COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
48075717|NCT01847274|100508121|FG001|NOT COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
48075718|NCT01847274|100508122|FG002|NOT COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
48075719|NCT01847274|100508123|FG003|NOT COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
48075720|NCT01847274|100508124|FG004|NOT COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
48075721|NCT01847274|100508125|FG005|NOT COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
48075722|NCT01847274|100508126|FG006|NOT COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||26||
48075723|NCT01847274|100508127|FG007|NOT COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
48075724|NCT01847274|100508128|FG008|NOT COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
48075725|NCT01847274|100508129|FG009|NOT COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
48075726|NCT01847274|100508130|FG010|NOT COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
48075727|NCT01847274|100508120|FG000|STARTED|Main Study PSU (Up to 8months, 26days)||0||
48075728|NCT01847274|100508121|FG001|STARTED|Main Study PSU (Up to 8months, 26days)||0||
48075729|NCT01847274|100508122|FG002|STARTED|Main Study PSU (Up to 8months, 26days)||0||
48075730|NCT01847274|100508123|FG003|STARTED|Main Study PSU (Up to 8months, 26days)||0||
48075731|NCT01847274|100508124|FG004|STARTED|Main Study PSU (Up to 8months, 26days)||0||
48075732|NCT01847274|100508125|FG005|STARTED|Main Study PSU (Up to 8months, 26days)||0||
48075733|NCT01847274|100508126|FG006|STARTED|Main Study PSU (Up to 8months, 26days)||0||
48075734|NCT01847274|100508127|FG007|STARTED|Main Study PSU (Up to 8months, 26days)||22||
48075735|NCT01847274|100508128|FG008|STARTED|Main Study PSU (Up to 8months, 26days)||8||
48075736|NCT01847274|100508129|FG009|STARTED|Main Study PSU (Up to 8months, 26days)||31||
48075737|NCT01847274|100508130|FG010|STARTED|Main Study PSU (Up to 8months, 26days)||13||
48075738|NCT01847274|100508120|FG000|COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
48075739|NCT01847274|100508121|FG001|COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
48075740|NCT01847274|100508122|FG002|COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
48075741|NCT01847274|100508123|FG003|COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
48075742|NCT01847274|100508124|FG004|COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
48075743|NCT01847274|100508125|FG005|COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
48075744|NCT01847274|100508126|FG006|COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
48075745|NCT01847274|100508127|FG007|COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
48075746|NCT01847274|100508128|FG008|COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
48075747|NCT01847274|100508129|FG009|COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
48075748|NCT01847274|100508130|FG010|COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
48075749|NCT01847274|100508120|FG000|NOT COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
48075750|NCT01847274|100508121|FG001|NOT COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
48075751|NCT01847274|100508122|FG002|NOT COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
48075752|NCT01847274|100508123|FG003|NOT COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
48075753|NCT01847274|100508124|FG004|NOT COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
48075754|NCT01847274|100508125|FG005|NOT COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
48075755|NCT01847274|100508126|FG006|NOT COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
48075756|NCT01847274|100508127|FG007|NOT COMPLETED|Main Study PSU (Up to 8months, 26days)||22||
48075757|NCT01847274|100508128|FG008|NOT COMPLETED|Main Study PSU (Up to 8months, 26days)||8||
48075758|NCT01847274|100508129|FG009|NOT COMPLETED|Main Study PSU (Up to 8months, 26days)||31||
48075759|NCT01847274|100508130|FG010|NOT COMPLETED|Main Study PSU (Up to 8months, 26days)||13||
48075760|NCT01191333|100508131|FG000|STARTED|Overall Study||81||
48075761|NCT01191333|100508132|FG001|STARTED|Overall Study||83||
48075762|NCT01191333|100508131|FG000|COMPLETED|Overall Study||60||
48075763|NCT01191333|100508132|FG001|COMPLETED|Overall Study||65||
48075764|NCT01191333|100508131|FG000|NOT COMPLETED|Overall Study||21||
48075765|NCT01191333|100508132|FG001|NOT COMPLETED|Overall Study||18||
48075766|NCT03355820|100508133|FG000|STARTED|Overall Study||227||
48075767|NCT03355820|100508133|FG000|COMPLETED|Overall Study||227||
48075768|NCT03355820|100508133|FG000|NOT COMPLETED|Overall Study||0||
48075769|NCT04538430|100508134|FG000|STARTED|Overall Study||7||
48075770|NCT04538430|100508134|FG000|COMPLETED|Overall Study||7||
48075771|NCT04538430|100508134|FG000|NOT COMPLETED|Overall Study||0||
48075772|NCT03100500|100508135|FG000|STARTED|Overall Study||51||
48075773|NCT03100500|100508135|FG000|COMPLETED|Overall Study||51||
48075774|NCT03100500|100508135|FG000|NOT COMPLETED|Overall Study||0||
48075775|NCT03416946|100508136|FG000|STARTED|Overall Study||25||
48075776|NCT03416946|100508137|FG001|STARTED|Overall Study||29||
48075777|NCT03416946|100508136|FG000|COMPLETED|Overall Study||25||
48075778|NCT03416946|100508137|FG001|COMPLETED|Overall Study||29||
48075779|NCT03416946|100508136|FG000|NOT COMPLETED|Overall Study||0||
48075780|NCT03416946|100508137|FG001|NOT COMPLETED|Overall Study||0||
48075781|NCT02701400|100508138|FG000|STARTED|Overall Study||9||
48075782|NCT02701400|100508139|FG001|STARTED|Overall Study||9||
48075783|NCT02701400|100508138|FG000|COMPLETED|Overall Study||9||
48075784|NCT02701400|100508139|FG001|COMPLETED|Overall Study||9||
48075785|NCT02701400|100508138|FG000|NOT COMPLETED|Overall Study||0||
48075786|NCT02701400|100508139|FG001|NOT COMPLETED|Overall Study||0||
48075787|NCT02989714|100508140|FG000|STARTED|Overall Study||13|Started Interleukin-2|
48075788|NCT02989714|100508140|FG000|Started Nivolumab|Overall Study||12||
48075789|NCT02989714|100508140|FG000|COMPLETED|Overall Study||12||
48075790|NCT02989714|100508140|FG000|NOT COMPLETED|Overall Study||1||
48075791|NCT00329238|100508141|FG000|STARTED|Overall Study||1430||
48075792|NCT00329238|100508142|FG001|STARTED|Overall Study||1426||
48075793|NCT00329238|100508141|FG000|COMPLETED|Overall Study||1154||
48075794|NCT00329238|100508142|FG001|COMPLETED|Overall Study||1145||
48075795|NCT00329238|100508141|FG000|NOT COMPLETED|Overall Study||276||
48075796|NCT00329238|100508142|FG001|NOT COMPLETED|Overall Study||281||
48075797|NCT02784431|100508143|FG000|STARTED|Overall Study||20||
48075798|NCT02784431|100508143|FG000|COMPLETED|Overall Study||0||
48075799|NCT02784431|100508143|FG000|NOT COMPLETED|Overall Study||20||
48075800|NCT02356575|100508144|FG000|STARTED|Overall Study||80||
48075801|NCT02356575|100508145|FG001|STARTED|Overall Study||80||
48075802|NCT02356575|100508144|FG000|COMPLETED|Overall Study||80||
48075803|NCT02356575|100508145|FG001|COMPLETED|Overall Study||80||
48075804|NCT02356575|100508144|FG000|NOT COMPLETED|Overall Study||0||
48075805|NCT02356575|100508145|FG001|NOT COMPLETED|Overall Study||0||
48075806|NCT00867568|100508146|FG000|STARTED|Overall Study||18||
48075807|NCT00867568|100508146|FG000|COMPLETED|Overall Study||3||
48075808|NCT00867568|100508146|FG000|NOT COMPLETED|Overall Study||15||
48075809|NCT01703039|100508147|FG000|STARTED|Overall Study||9||
48075810|NCT01703039|100508148|FG001|STARTED|Overall Study||12||
48075811|NCT01703039|100508147|FG000|COMPLETED|Overall Study||6||
48075812|NCT01703039|100508148|FG001|COMPLETED|Overall Study||7||
48075813|NCT01703039|100508147|FG000|NOT COMPLETED|Overall Study||3||
48075814|NCT01703039|100508148|FG001|NOT COMPLETED|Overall Study||5||
48075815|NCT02958293|100508149|FG000|STARTED|Overall Study||19872||
48075816|NCT02958293|100508149|FG000|COMPLETED|Overall Study||19872||
48075817|NCT02958293|100508149|FG000|NOT COMPLETED|Overall Study||0||
48075818|NCT01134276|100508150|FG000|STARTED|Overall Study||104||
48075819|NCT01134276|100508151|FG001|STARTED|Overall Study||107||
48075820|NCT01134276|100508150|FG000|COMPLETED|Overall Study||104||
48075821|NCT01134276|100508151|FG001|COMPLETED|Overall Study||107||
48075822|NCT01134276|100508150|FG000|NOT COMPLETED|Overall Study||0||
48075823|NCT01134276|100508151|FG001|NOT COMPLETED|Overall Study||0||
48075824|NCT03739593|100508152|FG000|STARTED|Overall Study||5||
48075825|NCT03739593|100508153|FG001|STARTED|Overall Study||22||
48075826|NCT03739593|100508154|FG002|STARTED|Overall Study||22||
48075827|NCT03739593|100508152|FG000|COMPLETED|Overall Study||2||
48075828|NCT03739593|100508153|FG001|COMPLETED|Overall Study||16||
48075829|NCT03739593|100508154|FG002|COMPLETED|Overall Study||14||
48075830|NCT03739593|100508152|FG000|NOT COMPLETED|Overall Study||3||
48075831|NCT03739593|100508153|FG001|NOT COMPLETED|Overall Study||6||
48075832|NCT03739593|100508154|FG002|NOT COMPLETED|Overall Study||8||
48075833|NCT01858389|100508155|FG000|STARTED|Overall Study||16||
48075834|NCT01858389|100508156|FG001|STARTED|Overall Study||25||
48075835|NCT01858389|100508155|FG000|Received Treatment|Overall Study||16||
48075836|NCT01858389|100508156|FG001|Received Treatment|Overall Study||22||
48075837|NCT01858389|100508155|FG000|COMPLETED|Overall Study||0||
48075838|NCT01858389|100508156|FG001|COMPLETED|Overall Study||0||
48075839|NCT01858389|100508155|FG000|NOT COMPLETED|Overall Study||16||
48075840|NCT01858389|100508156|FG001|NOT COMPLETED|Overall Study||25||
48075841|NCT02217878|100508157|FG000|STARTED|Overall Study||37||
48075842|NCT02217878|100508158|FG001|STARTED|Overall Study||37||
48075843|NCT02217878|100508157|FG000|COMPLETED|Overall Study||35||
48075844|NCT02217878|100508158|FG001|COMPLETED|Overall Study||35||
48075845|NCT02217878|100508157|FG000|NOT COMPLETED|Overall Study||2||
48075846|NCT02217878|100508158|FG001|NOT COMPLETED|Overall Study||2||
48075847|NCT02468674|100508159|FG000|STARTED|Overall Study||5|All randomized patients were included in the Full Analysis (FAS) and Safety Set|
48075848|NCT02468674|100508160|FG001|STARTED|Overall Study||5|All randomized patients were included in the Full Analysis (FAS) and Safety Set|
48075849|NCT02468674|100508161|FG002|STARTED|Overall Study||5|All randomized patients were included in the Full Analysis (FAS) and Safety Set|
48075850|NCT02468674|100508162|FG003|STARTED|Overall Study||4|All randomized patients were included in the Full Analysis (FAS) and Safety Set|
48075851|NCT02468674|100508163|FG004|STARTED|Overall Study||7|All randomized patients were included in the Full Analysis (FAS) and Safety Set|
48075852|NCT02468674|100508164|FG005|STARTED|Overall Study||7|All randomized patients were included in the Full Analysis (FAS) and Safety Set|
48075853|NCT02468674|100508165|FG006|STARTED|Overall Study||15|All randomized patients were included in the Full Analysis (FAS) and Safety Set|
48075854|NCT02468674|100508166|FG007|STARTED|Overall Study||69|All randomized patients were included in the Full Analysis (FAS) and Safety Set|
48075855|NCT02468674|100508167|FG008|STARTED|Overall Study||43|All randomized patients were included in the Full Analysis (FAS) and Safety Set|
48075856|NCT02468674|100508159|FG000|COMPLETED|Overall Study||4||
48075857|NCT02468674|100508160|FG001|COMPLETED|Overall Study||5||
48075858|NCT02468674|100508161|FG002|COMPLETED|Overall Study||5||
48075859|NCT02468674|100508162|FG003|COMPLETED|Overall Study||3||
48075860|NCT02468674|100508163|FG004|COMPLETED|Overall Study||6||
48075861|NCT02468674|100508164|FG005|COMPLETED|Overall Study||6||
48075862|NCT02468674|100508165|FG006|COMPLETED|Overall Study||14||
48075863|NCT02468674|100508166|FG007|COMPLETED|Overall Study||65||
48075864|NCT02468674|100508167|FG008|COMPLETED|Overall Study||40||
48075865|NCT02468674|100508159|FG000|NOT COMPLETED|Overall Study||1||
48075866|NCT02468674|100508160|FG001|NOT COMPLETED|Overall Study||0||
48075867|NCT02468674|100508161|FG002|NOT COMPLETED|Overall Study||0||
48075868|NCT02468674|100508162|FG003|NOT COMPLETED|Overall Study||1||
48075869|NCT02468674|100508163|FG004|NOT COMPLETED|Overall Study||1||
48075870|NCT02468674|100508164|FG005|NOT COMPLETED|Overall Study||1||
48075871|NCT02468674|100508165|FG006|NOT COMPLETED|Overall Study||1||
48075872|NCT02468674|100508166|FG007|NOT COMPLETED|Overall Study||4||
48075873|NCT02468674|100508167|FG008|NOT COMPLETED|Overall Study||3||
48075874|NCT01637272|100508168|FG000|STARTED|Overall Study||43||
48075875|NCT01637272|100508168|FG000|Completed sc Phase|Overall Study||33||
48075876|NCT01637272|100508168|FG000|Completed Core Phase (sc + LAR)|Overall Study||31||
48075877|NCT01637272|100508168|FG000|Entered Extension Phase|Overall Study||27||
48075878|NCT01637272|100508168|FG000|Completed Core But Did no Enter Ext..|Overall Study||4||
48075879|NCT01637272|100508168|FG000|COMPLETED|Overall Study||23||
48075880|NCT01637272|100508168|FG000|NOT COMPLETED|Overall Study||20||
48075881|NCT01862874|100508169|FG000|STARTED|Overall Study||562||
48075882|NCT01862874|100508170|FG001|STARTED|Overall Study||562||
48075883|NCT01862874|100508169|FG000|Vaccination 1|Overall Study||561||
48075884|NCT01862874|100508170|FG001|Vaccination 1|Overall Study||562||
48075885|NCT01862874|100508169|FG000|Vaccination 2|Overall Study||539||
48075886|NCT01862874|100508170|FG001|Vaccination 2|Overall Study||542||
48075887|NCT01862874|100508169|FG000|Vaccination 3|Overall Study||530||
48075888|NCT01862874|100508170|FG001|Vaccination 3|Overall Study||532||
48075889|NCT01862874|100508169|FG000|COMPLETED|Overall Study||483||
48075890|NCT01862874|100508170|FG001|COMPLETED|Overall Study||485||
48075891|NCT01862874|100508169|FG000|NOT COMPLETED|Overall Study||79||
48075892|NCT01862874|100508170|FG001|NOT COMPLETED|Overall Study||77||
48075893|NCT02582983|100508171|FG000|STARTED|Overall Study||23||
48075894|NCT02582983|100508171|FG000|COMPLETED|Overall Study||17||
48075895|NCT02582983|100508171|FG000|NOT COMPLETED|Overall Study||6||
48075896|NCT01826604|100508172|FG000|STARTED|Overall Study||144||
48075897|NCT01826604|100508173|FG001|STARTED|Overall Study||157||
48075898|NCT01826604|100508172|FG000|COMPLETED|Overall Study||136||
48075899|NCT01826604|100508173|FG001|COMPLETED|Overall Study||148||
48075900|NCT01826604|100508172|FG000|NOT COMPLETED|Overall Study||8||
48075901|NCT01826604|100508173|FG001|NOT COMPLETED|Overall Study||9||
48075902|NCT00040365|100508174|FG000|STARTED|Overall Study||30||
48075903|NCT00040365|100508174|FG000|Completed Follow Up Phase|Overall Study||19||
48075904|NCT00040365|100508174|FG000|COMPLETED|Overall Study||19||
48075905|NCT00040365|100508174|FG000|NOT COMPLETED|Overall Study||11||
48075906|NCT00211510|100508175|FG000|STARTED|Overall Study||72||
48075907|NCT00211510|100508176|FG001|STARTED|Overall Study||74||
48075908|NCT00211510|100508175|FG000|COMPLETED|Overall Study||66||
48075909|NCT00211510|100508176|FG001|COMPLETED|Overall Study||72||
48075910|NCT00211510|100508175|FG000|NOT COMPLETED|Overall Study||6||
48075911|NCT00211510|100508176|FG001|NOT COMPLETED|Overall Study||2||
48075912|NCT01909674|100508177|FG000|STARTED|Overall Study||12||
48075913|NCT01909674|100508178|FG001|STARTED|Overall Study||9||
48075914|NCT01909674|100508177|FG000|COMPLETED|Overall Study||7||
48075915|NCT01909674|100508178|FG001|COMPLETED|Overall Study||7||
48075916|NCT01909674|100508177|FG000|NOT COMPLETED|Overall Study||5||
48075917|NCT01909674|100508178|FG001|NOT COMPLETED|Overall Study||2||
48075918|NCT00758836|100508179|FG000|STARTED|Overall Study||171||
48075919|NCT00758836|100508180|FG001|STARTED|Overall Study||171||
48075920|NCT00758836|100508181|FG002|STARTED|Overall Study||171||
48075921|NCT00758836|100508182|FG003|STARTED|Overall Study||170||
48075922|NCT00758836|100508179|FG000|Treated|Overall Study||147||
48075923|NCT00758836|100508180|FG001|Treated|Overall Study||145||
48075924|NCT00758836|100508181|FG002|Treated|Overall Study||133||
48075925|NCT00758836|100508182|FG003|Treated|Overall Study||138||
48075926|NCT00758836|100508179|FG000|COMPLETED|Overall Study||147||
48075927|NCT00758836|100508180|FG001|COMPLETED|Overall Study||145||
48075928|NCT00758836|100508181|FG002|COMPLETED|Overall Study||133||
48075929|NCT00758836|100508182|FG003|COMPLETED|Overall Study||138||
48075930|NCT00758836|100508179|FG000|NOT COMPLETED|Overall Study||24||
48075931|NCT00758836|100508180|FG001|NOT COMPLETED|Overall Study||26||
48075932|NCT00758836|100508181|FG002|NOT COMPLETED|Overall Study||38||
48075933|NCT00758836|100508182|FG003|NOT COMPLETED|Overall Study||32||
48075934|NCT01930123|100508183|FG000|STARTED|Overall Study||81||
48075935|NCT01930123|100508184|FG001|STARTED|Overall Study||37||
48075936|NCT01930123|100508183|FG000|COMPLETED|Overall Study||58||
48075937|NCT01930123|100508184|FG001|COMPLETED|Overall Study||29||
48075938|NCT01930123|100508183|FG000|NOT COMPLETED|Overall Study||23||
48075939|NCT01930123|100508184|FG001|NOT COMPLETED|Overall Study||8||
48075940|NCT01416272|100508185|FG000|STARTED|Overall Study||12||
48075941|NCT01416272|100508185|FG000|COMPLETED|Overall Study||8||
48075942|NCT01416272|100508185|FG000|NOT COMPLETED|Overall Study||4||
48075943|NCT01893632|100508186|FG000|STARTED|Overall Study||1||
48075944|NCT01893632|100508187|FG001|STARTED|Overall Study||1||
48075945|NCT01893632|100508186|FG000|COMPLETED|Overall Study||1||
48075946|NCT01893632|100508187|FG001|COMPLETED|Overall Study||1||
48075947|NCT01893632|100508186|FG000|NOT COMPLETED|Overall Study||0||
48075948|NCT01893632|100508187|FG001|NOT COMPLETED|Overall Study||0||
48075949|NCT03408483|100508188|FG000|STARTED|Overall Study||42||
48075950|NCT03408483|100508189|FG001|STARTED|Overall Study||38||
48075951|NCT03408483|100508188|FG000|COMPLETED|Overall Study||36||
48075952|NCT03408483|100508189|FG001|COMPLETED|Overall Study||35||
48075953|NCT03408483|100508188|FG000|NOT COMPLETED|Overall Study||6||
48075954|NCT03408483|100508189|FG001|NOT COMPLETED|Overall Study||3||
48075955|NCT01364649|100508190|FG000|STARTED|Overall Study||225||
48075956|NCT01364649|100508191|FG001|STARTED|Overall Study||222||
48075957|NCT01364649|100508190|FG000|COMPLETED|Overall Study||169||
48075958|NCT01364649|100508191|FG001|COMPLETED|Overall Study||179||
48075959|NCT01364649|100508190|FG000|NOT COMPLETED|Overall Study||56||
48075960|NCT01364649|100508191|FG001|NOT COMPLETED|Overall Study||43||
48075961|NCT01405456|100508192|FG000|STARTED|Overall Study||25||
48075962|NCT01405456|100508193|FG001|STARTED|Overall Study||21||
48075963|NCT01405456|100508192|FG000|COMPLETED|Overall Study||22||
48075964|NCT01405456|100508193|FG001|COMPLETED|Overall Study||20||
48075965|NCT01405456|100508192|FG000|NOT COMPLETED|Overall Study||3||
48075966|NCT01405456|100508193|FG001|NOT COMPLETED|Overall Study||1||
48075967|NCT01774968|100508194|FG000|STARTED|Overall Study||162||
48075968|NCT01774968|100508195|FG001|STARTED|Overall Study||163||
48075969|NCT01774968|100508194|FG000|Received at Least 1 Dose of Study Drug|Overall Study||162||
48075970|NCT01774968|100508195|FG001|Received at Least 1 Dose of Study Drug|Overall Study||161||
48075971|NCT01774968|100508194|FG000|COMPLETED|Overall Study||132||
48075972|NCT01774968|100508195|FG001|COMPLETED|Overall Study||128||
48075973|NCT01774968|100508194|FG000|NOT COMPLETED|Overall Study||30||
48075974|NCT01774968|100508195|FG001|NOT COMPLETED|Overall Study||35||
48075975|NCT01517711|100508196|FG000|STARTED|Overall Study||22||
48227185|NCT04867382|100877937|FG000|COMPLETED|Overall Study||46|Primary analysis conducted with data from those who completed survey immediately following the online training.|
48075976|NCT01517711|100508197|FG001|STARTED|Overall Study||18||
48075977|NCT01517711|100508196|FG000|COMPLETED|Overall Study||20||
48075978|NCT01517711|100508197|FG001|COMPLETED|Overall Study||15||
48075979|NCT01517711|100508196|FG000|NOT COMPLETED|Overall Study||2||
48075980|NCT01517711|100508197|FG001|NOT COMPLETED|Overall Study||3||
48075981|NCT01702805|100508198|FG000|STARTED|Overall Study||911||
48075982|NCT01702805|100508199|FG001|STARTED|Overall Study||913||
48075983|NCT01702805|100508198|FG000|Completed Assessment for Neurodevelopmental Impairment|Overall Study||699||
48075984|NCT01702805|100508199|FG001|Completed Assessment for Neurodevelopmental Impairment|Overall Study||712||
48075985|NCT01702805|100508198|FG000|Died After Discharge|Overall Study||19||
48075986|NCT01702805|100508199|FG001|Died After Discharge|Overall Study||10||
48075987|NCT01702805|100508198|FG000|Died Before Discharge|Overall Study||127||
48075988|NCT01702805|100508199|FG001|Died Before Discharge|Overall Study||125||
48075989|NCT01702805|100508198|FG000|Survived to Discharge|Overall Study||781||
48075990|NCT01702805|100508199|FG001|Survived to Discharge|Overall Study||781||
48075991|NCT01702805|100508198|FG000|COMPLETED|Overall Study||845|Complete data for Primary Outcome, Death or Neurodevelopmental Impairment|
48075992|NCT01702805|100508199|FG001|COMPLETED|Overall Study||847|Complete data for Primary Outcome, Death or Neurodevelopmental Impairment|
48075993|NCT01702805|100508198|FG000|NOT COMPLETED|Overall Study||66||
48075994|NCT01702805|100508199|FG001|NOT COMPLETED|Overall Study||66||
48075995|NCT01651039|100508200|FG000|STARTED|Overall Study||32||
48075996|NCT01651039|100508200|FG000|COMPLETED|Overall Study||2||
48075997|NCT01651039|100508200|FG000|NOT COMPLETED|Overall Study||30||
48075998|NCT01146418|100508201|FG000|STARTED|Base Study P06029 (NCT01144416)||694||
48075999|NCT01146418|100508202|FG001|STARTED|Base Study P06029 (NCT01144416)||696||
48294128|NCT02527343|101047538|FG002|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||6||
48374611|NCT03738566|101247437|FG003|COMPLETED|Initial Study Phase||0||
48076000|NCT01146418|100508203|FG002|STARTED|Base Study P06029 (NCT01144416)||0||
48076001|NCT01146418|100508204|FG003|STARTED|Base Study P06029 (NCT01144416)||0||
48076002|NCT01146418|100508201|FG000|COMPLETED|Base Study P06029 (NCT01144416)||632||
48076003|NCT01146418|100508202|FG001|COMPLETED|Base Study P06029 (NCT01144416)||647||
48076004|NCT01146418|100508203|FG002|COMPLETED|Base Study P06029 (NCT01144416)||0||
48076005|NCT01146418|100508204|FG003|COMPLETED|Base Study P06029 (NCT01144416)||0||
48076006|NCT01146418|100508201|FG000|NOT COMPLETED|Base Study P06029 (NCT01144416)||62||
48374612|NCT03738566|101247434|FG000|NOT COMPLETED|Initial Study Phase||6||
48076007|NCT01146418|100508202|FG001|NOT COMPLETED|Base Study P06029 (NCT01144416)||49||
48076008|NCT01146418|100508203|FG002|NOT COMPLETED|Base Study P06029 (NCT01144416)||0||
48076009|NCT01146418|100508204|FG003|NOT COMPLETED|Base Study P06029 (NCT01144416)||0||
48076010|NCT01146418|100508201|FG000|STARTED|Women/Expectant Mother Follow Up||157||
48076011|NCT01146418|100508202|FG001|STARTED|Women/Expectant Mother Follow Up||150||
48076012|NCT01146418|100508203|FG002|STARTED|Women/Expectant Mother Follow Up||0||
48076013|NCT01146418|100508204|FG003|STARTED|Women/Expectant Mother Follow Up||0||
48076014|NCT01146418|100508201|FG000|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||151||
48076015|NCT01146418|100508202|FG001|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||147||
48076016|NCT01146418|100508203|FG002|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0||
48076017|NCT01146418|100508204|FG003|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0||
48076018|NCT01146418|100508201|FG000|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||52||
48076019|NCT01146418|100508202|FG001|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||50||
48076020|NCT01146418|100508203|FG002|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0||
48076021|NCT01146418|100508204|FG003|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0||
48076022|NCT01146418|100508201|FG000|COMPLETED|Women/Expectant Mother Follow Up||113||
48076023|NCT01146418|100508202|FG001|COMPLETED|Women/Expectant Mother Follow Up||110||
48076024|NCT01146418|100508203|FG002|COMPLETED|Women/Expectant Mother Follow Up||0||
48076025|NCT01146418|100508204|FG003|COMPLETED|Women/Expectant Mother Follow Up||0||
48076026|NCT01146418|100508201|FG000|NOT COMPLETED|Women/Expectant Mother Follow Up||44||
48076027|NCT01146418|100508202|FG001|NOT COMPLETED|Women/Expectant Mother Follow Up||40||
48076028|NCT01146418|100508203|FG002|NOT COMPLETED|Women/Expectant Mother Follow Up||0||
48076029|NCT01146418|100508204|FG003|NOT COMPLETED|Women/Expectant Mother Follow Up||0||
48076030|NCT01146418|100508201|FG000|STARTED|Live-Born Infant Follow Up||0||
48076031|NCT01146418|100508202|FG001|STARTED|Live-Born Infant Follow Up||0||
48076032|NCT01146418|100508203|FG002|STARTED|Live-Born Infant Follow Up||61||
48374613|NCT03738566|101247435|FG001|NOT COMPLETED|Initial Study Phase||2||
48374614|NCT03738566|101247436|FG002|NOT COMPLETED|Initial Study Phase||2||
48374615|NCT03738566|101247437|FG003|NOT COMPLETED|Initial Study Phase||0||
48076033|NCT01146418|100508204|FG003|STARTED|Live-Born Infant Follow Up||56||
48076034|NCT01146418|100508201|FG000|COMPLETED|Live-Born Infant Follow Up||0||
48076035|NCT01146418|100508202|FG001|COMPLETED|Live-Born Infant Follow Up||0||
48076036|NCT01146418|100508203|FG002|COMPLETED|Live-Born Infant Follow Up||55||
48076037|NCT01146418|100508204|FG003|COMPLETED|Live-Born Infant Follow Up||51||
48076038|NCT01146418|100508201|FG000|NOT COMPLETED|Live-Born Infant Follow Up||0||
48076039|NCT01146418|100508202|FG001|NOT COMPLETED|Live-Born Infant Follow Up||0||
48076040|NCT01146418|100508203|FG002|NOT COMPLETED|Live-Born Infant Follow Up||6||
48076041|NCT01146418|100508204|FG003|NOT COMPLETED|Live-Born Infant Follow Up||5||
48076042|NCT03715530|100508205|FG000|STARTED|Overall Study||33||
48076043|NCT03715530|100508206|FG001|STARTED|Overall Study||42||
48076044|NCT03715530|100508207|FG002|STARTED|Overall Study||87||
48076045|NCT03715530|100508205|FG000|COMPLETED|Overall Study||30||
48076046|NCT03715530|100508206|FG001|COMPLETED|Overall Study||41||
48374616|NCT03738566|101247434|FG000|STARTED|Cross-over for Treatment Failure||0||
48076047|NCT03715530|100508207|FG002|COMPLETED|Overall Study||85||
48076048|NCT03715530|100508205|FG000|NOT COMPLETED|Overall Study||3||
48076049|NCT03715530|100508206|FG001|NOT COMPLETED|Overall Study||1||
48076050|NCT03715530|100508207|FG002|NOT COMPLETED|Overall Study||2||
48076051|NCT00256750|100508208|FG000|STARTED|Transplanted Pre-Treatment||221||
48076052|NCT00256750|100508209|FG001|STARTED|Transplanted Pre-Treatment||226||
48076053|NCT00256750|100508210|FG002|STARTED|Transplanted Pre-Treatment||219||
48076054|NCT00256750|100508208|FG000|COMPLETED|Transplanted Pre-Treatment||215||
48076055|NCT00256750|100508209|FG001|COMPLETED|Transplanted Pre-Treatment||226||
48076056|NCT00256750|100508210|FG002|COMPLETED|Transplanted Pre-Treatment||219||
48076057|NCT00256750|100508208|FG000|NOT COMPLETED|Transplanted Pre-Treatment||6||
48076058|NCT00256750|100508209|FG001|NOT COMPLETED|Transplanted Pre-Treatment||0||
48076059|NCT00256750|100508210|FG002|NOT COMPLETED|Transplanted Pre-Treatment||0||
48076060|NCT00256750|100508208|FG000|STARTED|Post-Transplant Treated (12 Months)||215||
48076061|NCT00256750|100508209|FG001|STARTED|Post-Transplant Treated (12 Months)||226||
48076062|NCT00256750|100508210|FG002|STARTED|Post-Transplant Treated (12 Months)||219||
48076063|NCT00256750|100508208|FG000|COMPLETED|Post-Transplant Treated (12 Months)||174||
48076064|NCT00256750|100508209|FG001|COMPLETED|Post-Transplant Treated (12 Months)||183||
48076065|NCT00256750|100508210|FG002|COMPLETED|Post-Transplant Treated (12 Months)||173||
48076066|NCT00256750|100508208|FG000|NOT COMPLETED|Post-Transplant Treated (12 Months)||41||
48076067|NCT00256750|100508209|FG001|NOT COMPLETED|Post-Transplant Treated (12 Months)||43||
48076068|NCT00256750|100508210|FG002|NOT COMPLETED|Post-Transplant Treated (12 Months)||46||
48076069|NCT00256750|100508208|FG000|STARTED|Post-Transplant Treated (24 Months)||174||
48374617|NCT03738566|101247435|FG001|STARTED|Cross-over for Treatment Failure||0||
48076070|NCT00256750|100508209|FG001|STARTED|Post-Transplant Treated (24 Months)||183||
48076071|NCT00256750|100508210|FG002|STARTED|Post-Transplant Treated (24 Months)||173||
48076072|NCT00256750|100508208|FG000|COMPLETED|Post-Transplant Treated (24 Months)||153||
48076073|NCT00256750|100508209|FG001|COMPLETED|Post-Transplant Treated (24 Months)||176||
48076074|NCT00256750|100508210|FG002|COMPLETED|Post-Transplant Treated (24 Months)||164||
48076075|NCT00256750|100508208|FG000|NOT COMPLETED|Post-Transplant Treated (24 Months)||21||
48076076|NCT00256750|100508209|FG001|NOT COMPLETED|Post-Transplant Treated (24 Months)||7||
48076077|NCT00256750|100508210|FG002|NOT COMPLETED|Post-Transplant Treated (24 Months)||9||
48076078|NCT00256750|100508208|FG000|STARTED|Post-Transplant Treated (36 Months)||153||
48076079|NCT00256750|100508209|FG001|STARTED|Post-Transplant Treated (36 Months)||176||
48076080|NCT00256750|100508210|FG002|STARTED|Post-Transplant Treated (36 Months)||164||
48076081|NCT00256750|100508208|FG000|COMPLETED|Post-Transplant Treated (36 Months)||143||
48076082|NCT00256750|100508209|FG001|COMPLETED|Post-Transplant Treated (36 Months)||170||
48076083|NCT00256750|100508210|FG002|COMPLETED|Post-Transplant Treated (36 Months)||158||
48076084|NCT00256750|100508208|FG000|NOT COMPLETED|Post-Transplant Treated (36 Months)||10||
48076085|NCT00256750|100508209|FG001|NOT COMPLETED|Post-Transplant Treated (36 Months)||6||
48076086|NCT00256750|100508210|FG002|NOT COMPLETED|Post-Transplant Treated (36 Months)||6||
48076087|NCT00256750|100508208|FG000|STARTED|Long Term Extension (LTE; 84 Months)||136||
48076088|NCT00256750|100508209|FG001|STARTED|Long Term Extension (LTE; 84 Months)||166||
48076089|NCT00256750|100508210|FG002|STARTED|Long Term Extension (LTE; 84 Months)||155||
48076090|NCT00256750|100508208|FG000|COMPLETED|Long Term Extension (LTE; 84 Months)||89||
48076091|NCT00256750|100508209|FG001|COMPLETED|Long Term Extension (LTE; 84 Months)||136||
48076092|NCT00256750|100508210|FG002|COMPLETED|Long Term Extension (LTE; 84 Months)||127||
48076093|NCT00256750|100508208|FG000|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||47||
48076094|NCT00256750|100508209|FG001|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||30||
48076095|NCT00256750|100508210|FG002|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||28||
48076096|NCT02100514|100508211|FG000|STARTED|Treatment Period||247||
48076097|NCT02100514|100508212|FG001|STARTED|Treatment Period||499||
48076098|NCT02100514|100508213|FG002|STARTED|Treatment Period||0||
48076099|NCT02100514|100508214|FG003|STARTED|Treatment Period||0||
48076100|NCT02100514|100508215|FG004|STARTED|Treatment Period||0||
48076101|NCT02100514|100508211|FG000|COMPLETED|Treatment Period||218||
48076102|NCT02100514|100508212|FG001|COMPLETED|Treatment Period||425||
48076103|NCT02100514|100508213|FG002|COMPLETED|Treatment Period||0||
48374618|NCT03738566|101247436|FG002|STARTED|Cross-over for Treatment Failure||0||
48076104|NCT02100514|100508214|FG003|COMPLETED|Treatment Period||0||
48076105|NCT02100514|100508215|FG004|COMPLETED|Treatment Period||0||
48076106|NCT02100514|100508211|FG000|NOT COMPLETED|Treatment Period||29||
48076107|NCT02100514|100508212|FG001|NOT COMPLETED|Treatment Period||74||
48076108|NCT02100514|100508213|FG002|NOT COMPLETED|Treatment Period||0||
48076109|NCT02100514|100508214|FG003|NOT COMPLETED|Treatment Period||0||
48076110|NCT02100514|100508215|FG004|NOT COMPLETED|Treatment Period||0||
48076111|NCT02100514|100508211|FG000|STARTED|Extension Period||0||
48076112|NCT02100514|100508212|FG001|STARTED|Extension Period||0||
48076113|NCT02100514|100508213|FG002|STARTED|Extension Period||44||
48076114|NCT02100514|100508214|FG003|STARTED|Extension Period||33||
48076115|NCT02100514|100508215|FG004|STARTED|Extension Period||56||
48076116|NCT02100514|100508211|FG000|COMPLETED|Extension Period||0||
48076117|NCT02100514|100508212|FG001|COMPLETED|Extension Period||0||
48076118|NCT02100514|100508213|FG002|COMPLETED|Extension Period||42||
48076119|NCT02100514|100508214|FG003|COMPLETED|Extension Period||33||
48076120|NCT02100514|100508215|FG004|COMPLETED|Extension Period||56||
48076121|NCT02100514|100508211|FG000|NOT COMPLETED|Extension Period||0||
48076122|NCT02100514|100508212|FG001|NOT COMPLETED|Extension Period||0||
48076123|NCT02100514|100508213|FG002|NOT COMPLETED|Extension Period||2||
48076124|NCT02100514|100508214|FG003|NOT COMPLETED|Extension Period||0||
48076125|NCT02100514|100508215|FG004|NOT COMPLETED|Extension Period||0||
48076126|NCT00288054|100508216|FG000|STARTED|Overall Study||24||
48076127|NCT00288054|100508216|FG000|COMPLETED|Overall Study||0||
48076128|NCT00288054|100508216|FG000|NOT COMPLETED|Overall Study||24||
48076129|NCT01550289|100508217|FG000|STARTED|Overall Study||128||
48076130|NCT01550289|100508218|FG001|STARTED|Overall Study||61||
48076131|NCT01550289|100508217|FG000|COMPLETED|Overall Study||115||
48076132|NCT01550289|100508218|FG001|COMPLETED|Overall Study||57||
48076133|NCT01550289|100508217|FG000|NOT COMPLETED|Overall Study||13||
48076134|NCT01550289|100508218|FG001|NOT COMPLETED|Overall Study||4||
48076135|NCT02059395|100508219|FG000|STARTED|Overall Study||22||
48076136|NCT02059395|100508220|FG001|STARTED|Overall Study||27||
48076137|NCT02059395|100508219|FG000|COMPLETED|Overall Study||20||
48076138|NCT02059395|100508220|FG001|COMPLETED|Overall Study||23||
48076139|NCT02059395|100508219|FG000|NOT COMPLETED|Overall Study||2||
48076140|NCT02059395|100508220|FG001|NOT COMPLETED|Overall Study||4||
48076141|NCT01507298|100508221|FG000|STARTED|Overall Study||1||
48076142|NCT01507298|100508222|FG001|STARTED|Overall Study||20||
48076143|NCT01507298|100508221|FG000|COMPLETED|Overall Study||1||
48076144|NCT01507298|100508222|FG001|COMPLETED|Overall Study||14||
48076145|NCT01507298|100508221|FG000|NOT COMPLETED|Overall Study||0||
48076146|NCT01507298|100508222|FG001|NOT COMPLETED|Overall Study||6||
48076147|NCT03292562|100508223|FG000|STARTED|Overall Study||35||
48076148|NCT03292562|100508224|FG001|STARTED|Overall Study||31||
48076149|NCT03292562|100508223|FG000|COMPLETED|Overall Study||29||
48076150|NCT03292562|100508224|FG001|COMPLETED|Overall Study||30||
48076151|NCT03292562|100508223|FG000|NOT COMPLETED|Overall Study||6||
48076152|NCT03292562|100508224|FG001|NOT COMPLETED|Overall Study||1||
48076153|NCT00842608|100508225|FG000|STARTED|Overall Study||174||
48076154|NCT00842608|100508226|FG001|STARTED|Overall Study||177||
48076155|NCT00842608|100508227|FG002|STARTED|Overall Study||99||
48076156|NCT00842608|100508228|FG003|STARTED|Overall Study||101||
48076157|NCT00842608|100508225|FG000|COMPLETED|Overall Study||170||
48076158|NCT00842608|100508226|FG001|COMPLETED|Overall Study||176||
48076159|NCT00842608|100508227|FG002|COMPLETED|Overall Study||99||
48076160|NCT00842608|100508228|FG003|COMPLETED|Overall Study||100||
48076161|NCT00842608|100508225|FG000|NOT COMPLETED|Overall Study||4||
48076162|NCT00842608|100508226|FG001|NOT COMPLETED|Overall Study||1||
48076163|NCT00842608|100508227|FG002|NOT COMPLETED|Overall Study||0||
48076164|NCT00842608|100508228|FG003|NOT COMPLETED|Overall Study||1||
48076165|NCT02862171|100508229|FG000|STARTED|Overall Study||941||
48076166|NCT02862171|100508229|FG000|COMPLETED|Overall Study||848||
48076167|NCT02862171|100508229|FG000|NOT COMPLETED|Overall Study||93||
48076168|NCT00228384|100508230|FG000|STARTED|Overall Study||72||
48076169|NCT00228384|100508231|FG001|STARTED|Overall Study||76||
48076170|NCT00228384|100508230|FG000|Baseline|Overall Study||72||
48076171|NCT00228384|100508231|FG001|Baseline|Overall Study||76||
48076172|NCT00228384|100508230|FG000|30-Day Follow-up (Safety Outcome)|Overall Study||69||
48076173|NCT00228384|100508231|FG001|30-Day Follow-up (Safety Outcome)|Overall Study||72||
48076174|NCT00228384|100508230|FG000|Three Year Follow-up (Final)|Overall Study||43||
48076175|NCT00228384|100508231|FG001|Three Year Follow-up (Final)|Overall Study||47||
48076176|NCT00228384|100508230|FG000|COMPLETED|Overall Study||43||
48076177|NCT00228384|100508231|FG001|COMPLETED|Overall Study||47||
48076178|NCT00228384|100508230|FG000|NOT COMPLETED|Overall Study||29||
48076179|NCT00228384|100508231|FG001|NOT COMPLETED|Overall Study||29||
48076180|NCT02468232|100508232|FG000|STARTED|Core Part of Study||112|Started = Enrolled in Core|
48076181|NCT02468232|100508233|FG001|STARTED|Core Part of Study||113|Started = Enrolled in Core|
48076182|NCT02468232|100508234|FG002|STARTED|Core Part of Study||0|Started = Enrolled in Core|
48076183|NCT02468232|100508235|FG003|STARTED|Core Part of Study||0|Started = Enrolled in Core|
48076184|NCT02468232|100508232|FG000|Randomized Patients|Core Part of Study||112||
48076185|NCT02468232|100508233|FG001|Randomized Patients|Core Part of Study||113||
48523048|NCT01970865|101616036|FG012|COMPLETED|Overall Study||18||
48076186|NCT02468232|100508234|FG002|Randomized Patients|Core Part of Study||0||
48374619|NCT03738566|101247437|FG003|STARTED|Cross-over for Treatment Failure||5||
48374620|NCT03738566|101247434|FG000|COMPLETED|Cross-over for Treatment Failure||0||
48374621|NCT03738566|101247435|FG001|COMPLETED|Cross-over for Treatment Failure||0||
48374622|NCT03738566|101247436|FG002|COMPLETED|Cross-over for Treatment Failure||0||
48374623|NCT03738566|101247437|FG003|COMPLETED|Cross-over for Treatment Failure||4||
48374624|NCT03738566|101247434|FG000|NOT COMPLETED|Cross-over for Treatment Failure||0||
48374625|NCT03738566|101247435|FG001|NOT COMPLETED|Cross-over for Treatment Failure||0||
48374626|NCT03738566|101247436|FG002|NOT COMPLETED|Cross-over for Treatment Failure||0||
48374627|NCT03738566|101247437|FG003|NOT COMPLETED|Cross-over for Treatment Failure||1||
48374628|NCT01253421|101247438|FG000|STARTED|Assessment and Scheduling||159|Enrolled for screening visit|
48076187|NCT02468232|100508235|FG003|Randomized Patients|Core Part of Study||0||
48076188|NCT02468232|100508232|FG000|Mis-randomized Patients|Core Part of Study||1||
48076189|NCT02468232|100508233|FG001|Mis-randomized Patients|Core Part of Study||1||
48076190|NCT02468232|100508234|FG002|Mis-randomized Patients|Core Part of Study||0||
48076191|NCT02468232|100508235|FG003|Mis-randomized Patients|Core Part of Study||0||
48076192|NCT02468232|100508232|FG000|Discont. From Randomized Treatment (Rand. Set)|Core Part of Study||21||
48076193|NCT02468232|100508233|FG001|Discont. From Randomized Treatment (Rand. Set)|Core Part of Study||19||
48076194|NCT02468232|100508234|FG002|Discont. From Randomized Treatment (Rand. Set)|Core Part of Study||0||
48076195|NCT02468232|100508235|FG003|Discont. From Randomized Treatment (Rand. Set)|Core Part of Study||0||
48076196|NCT02468232|100508232|FG000|Discont. From Rand. Treatment (Full Analysis Set)|Core Part of Study||20||
48076197|NCT02468232|100508233|FG001|Discont. From Rand. Treatment (Full Analysis Set)|Core Part of Study||18||
48076198|NCT02468232|100508234|FG002|Discont. From Rand. Treatment (Full Analysis Set)|Core Part of Study||0||
48076199|NCT02468232|100508235|FG003|Discont. From Rand. Treatment (Full Analysis Set)|Core Part of Study||0||
48076200|NCT02468232|100508232|FG000|COMPLETED|Core Part of Study||91|Completed = Completed Core|
48076201|NCT02468232|100508233|FG001|COMPLETED|Core Part of Study||94|Completed = Completed Core|
48076202|NCT02468232|100508234|FG002|COMPLETED|Core Part of Study||0|Completed = Completed Core|
48076203|NCT02468232|100508235|FG003|COMPLETED|Core Part of Study||0|Completed = Completed Core|
48076204|NCT02468232|100508232|FG000|NOT COMPLETED|Core Part of Study||21||
48076205|NCT02468232|100508233|FG001|NOT COMPLETED|Core Part of Study||19||
48076206|NCT02468232|100508234|FG002|NOT COMPLETED|Core Part of Study||0||
48076207|NCT02468232|100508235|FG003|NOT COMPLETED|Core Part of Study||0||
48076208|NCT02468232|100508232|FG000|STARTED|OLE Part of Study||0||
48076209|NCT02468232|100508233|FG001|STARTED|OLE Part of Study||0||
48076210|NCT02468232|100508234|FG002|STARTED|OLE Part of Study||79||
48076211|NCT02468232|100508235|FG003|STARTED|OLE Part of Study||71||
48076212|NCT02468232|100508232|FG000|COMPLETED|OLE Part of Study||0||
48076213|NCT02468232|100508233|FG001|COMPLETED|OLE Part of Study||0||
48076214|NCT02468232|100508234|FG002|COMPLETED|OLE Part of Study||65||
48076215|NCT02468232|100508235|FG003|COMPLETED|OLE Part of Study||59||
48076216|NCT02468232|100508232|FG000|NOT COMPLETED|OLE Part of Study||0||
48076217|NCT02468232|100508233|FG001|NOT COMPLETED|OLE Part of Study||0||
48076218|NCT02468232|100508234|FG002|NOT COMPLETED|OLE Part of Study||14||
48076219|NCT02468232|100508235|FG003|NOT COMPLETED|OLE Part of Study||12||
48076220|NCT04092582|100508236|FG000|STARTED|Overall Study||69||
48076221|NCT04092582|100508237|FG001|STARTED|Overall Study||66||
48076222|NCT04092582|100508236|FG000|Safety Population|Overall Study||69|The safety analysis population included all randomized participants who received at least one dose of study drug during the 48-week double-blind treatment period.|
48076223|NCT04092582|100508237|FG001|Safety Population|Overall Study||65|The safety analysis population included all randomized participants who received at least one dose of study drug during the 48-week double-blind treatment period.|
48076224|NCT04092582|100508236|FG000|COMPLETED|Overall Study||64||
48076225|NCT04092582|100508237|FG001|COMPLETED|Overall Study||63||
48076226|NCT04092582|100508236|FG000|NOT COMPLETED|Overall Study||5||
48076227|NCT04092582|100508237|FG001|NOT COMPLETED|Overall Study||3||
48076228|NCT02200211|100508238|FG000|STARTED|Overall Study||190||
48076229|NCT02200211|100508239|FG001|STARTED|Overall Study||195||
48076230|NCT02200211|100508240|FG002|STARTED|Overall Study||40||
48076231|NCT02200211|100508241|FG003|STARTED|Overall Study||60||
48076232|NCT02200211|100508238|FG000|Included in 16-week Primary Analysis|Overall Study||177|16-week visits completed within pre-specified analysis window (148-196 days after randomization)|
48374629|NCT01253421|101247439|FG001|STARTED|Assessment and Scheduling||0|Enrolled for screening visit|
48076233|NCT02200211|100508239|FG001|Included in 16-week Primary Analysis|Overall Study||186|16-week visits completed within pre-specified analysis window (148-196 days after randomization)|
48076234|NCT02200211|100508240|FG002|Included in 16-week Primary Analysis|Overall Study||39|16-week visits completed within pre-specified analysis window (148-196 days after randomization)|
48076235|NCT02200211|100508241|FG003|Included in 16-week Primary Analysis|Overall Study||56|16-week visits completed within pre-specified analysis window (148-196 days after randomization)|
48076236|NCT02200211|100508238|FG000|COMPLETED|Overall Study||182|Completed 16-week study|
48076237|NCT02200211|100508239|FG001|COMPLETED|Overall Study||188|Completed 16-week study|
48076238|NCT02200211|100508240|FG002|COMPLETED|Overall Study||39|Completed 16-week study|
48076239|NCT02200211|100508241|FG003|COMPLETED|Overall Study||58|Completed 16-week study|
48076240|NCT02200211|100508238|FG000|NOT COMPLETED|Overall Study||8||
48523049|NCT01970865|101616037|FG013|COMPLETED|Overall Study||8||
48076241|NCT02200211|100508239|FG001|NOT COMPLETED|Overall Study||7||
48076242|NCT02200211|100508240|FG002|NOT COMPLETED|Overall Study||1||
48374630|NCT01253421|101247440|FG002|STARTED|Assessment and Scheduling||0|Enrolled for screening visit|
48374631|NCT01253421|101247441|FG003|STARTED|Assessment and Scheduling||0|Enrolled for screening visit|
48374632|NCT01253421|101247442|FG004|STARTED|Assessment and Scheduling||0|Enrolled for screening visit|
48374633|NCT01253421|101247438|FG000|Eligible After Screening Visit|Assessment and Scheduling||85||
48374634|NCT01253421|101247439|FG001|Eligible After Screening Visit|Assessment and Scheduling||0||
48374635|NCT01253421|101247440|FG002|Eligible After Screening Visit|Assessment and Scheduling||0||
48374636|NCT01253421|101247441|FG003|Eligible After Screening Visit|Assessment and Scheduling||0||
48374637|NCT01253421|101247442|FG004|Eligible After Screening Visit|Assessment and Scheduling||0||
48374638|NCT01253421|101247438|FG000|Returned for Drug+Scanning Visit|Assessment and Scheduling||60|This milestone accounts for participants who were lost to follow up or withdrew for other reasons.|
48374639|NCT01253421|101247439|FG001|Returned for Drug+Scanning Visit|Assessment and Scheduling||0|This milestone accounts for participants who were lost to follow up or withdrew for other reasons.|
48374640|NCT01253421|101247440|FG002|Returned for Drug+Scanning Visit|Assessment and Scheduling||0|This milestone accounts for participants who were lost to follow up or withdrew for other reasons.|
48374641|NCT01253421|101247441|FG003|Returned for Drug+Scanning Visit|Assessment and Scheduling||0|This milestone accounts for participants who were lost to follow up or withdrew for other reasons.|
48404067|NCT03689972|101321769|FG003|STARTED|Part 1 (Day 1 up to Week 72)||0||
48404068|NCT03689972|101321770|FG004|STARTED|Part 1 (Day 1 up to Week 72)||0||
48523050|NCT01970865|101616038|FG014|COMPLETED|Overall Study||3||
48523051|NCT01970865|101616039|FG015|COMPLETED|Overall Study||7||
48523052|NCT01970865|101616040|FG016|COMPLETED|Overall Study||2||
48523053|NCT01970865|101616041|FG017|COMPLETED|Overall Study||6||
48523054|NCT01970865|101616024|FG000|NOT COMPLETED|Overall Study||3||
48523055|NCT01970865|101616025|FG001|NOT COMPLETED|Overall Study||3||
48523056|NCT01970865|101616026|FG002|NOT COMPLETED|Overall Study||3||
48523057|NCT01970865|101616027|FG003|NOT COMPLETED|Overall Study||10||
48076243|NCT02200211|100508241|FG003|NOT COMPLETED|Overall Study||2||
48076244|NCT00530946|100508242|FG000|STARTED|Overall Study||43||
48076245|NCT00530946|100508243|FG001|STARTED|Overall Study||41||
48076246|NCT00530946|100508244|FG002|STARTED|Overall Study||41||
48076247|NCT00530946|100508245|FG003|STARTED|Overall Study||40||
48076248|NCT00530946|100508242|FG000|COMPLETED|Overall Study||41||
48076249|NCT00530946|100508243|FG001|COMPLETED|Overall Study||39||
48076250|NCT00530946|100508244|FG002|COMPLETED|Overall Study||40||
48076251|NCT00530946|100508245|FG003|COMPLETED|Overall Study||38||
48523058|NCT01970865|101616028|FG004|NOT COMPLETED|Overall Study||14||
48076252|NCT00530946|100508242|FG000|NOT COMPLETED|Overall Study||2||
48076253|NCT00530946|100508243|FG001|NOT COMPLETED|Overall Study||2||
48076254|NCT00530946|100508244|FG002|NOT COMPLETED|Overall Study||1||
48076255|NCT00530946|100508245|FG003|NOT COMPLETED|Overall Study||2||
48076256|NCT00283400|100508246|FG000|STARTED|Overall Study||20||
48076257|NCT00283400|100508247|FG001|STARTED|Overall Study||20||
48076258|NCT00283400|100508248|FG002|STARTED|Overall Study||7||
48076259|NCT00283400|100508249|FG003|STARTED|Overall Study||0||
48076260|NCT00283400|100508246|FG000|COMPLETED|Overall Study||18||
48076261|NCT00283400|100508247|FG001|COMPLETED|Overall Study||19||
48076262|NCT00283400|100508248|FG002|COMPLETED|Overall Study||6||
48076263|NCT00283400|100508249|FG003|COMPLETED|Overall Study||0||
48076264|NCT00283400|100508246|FG000|NOT COMPLETED|Overall Study||2||
48076265|NCT00283400|100508247|FG001|NOT COMPLETED|Overall Study||1||
48076266|NCT00283400|100508248|FG002|NOT COMPLETED|Overall Study||1||
48076267|NCT00283400|100508249|FG003|NOT COMPLETED|Overall Study||0||
48076268|NCT01805154|100508250|FG000|STARTED|Overall Study||1529||
48076269|NCT01805154|100508250|FG000|COMPLETED|Overall Study||1175||
48076270|NCT01805154|100508250|FG000|NOT COMPLETED|Overall Study||354||
48076271|NCT02256631|100508251|FG000|STARTED|Overall Study||13||
48076272|NCT02256631|100508252|FG001|STARTED|Overall Study||14||
48076273|NCT02256631|100508253|FG002|STARTED|Overall Study||13||
48076274|NCT02256631|100508254|FG003|STARTED|Overall Study||10||
48076275|NCT02256631|100508255|FG004|STARTED|Overall Study||11||
48076276|NCT02256631|100508256|FG005|STARTED|Overall Study||11||
48076277|NCT02256631|100508257|FG006|STARTED|Overall Study||11||
48076278|NCT02256631|100508251|FG000|COMPLETED|Overall Study||12||
48076279|NCT02256631|100508252|FG001|COMPLETED|Overall Study||11||
48076280|NCT02256631|100508253|FG002|COMPLETED|Overall Study||13||
48076281|NCT02256631|100508254|FG003|COMPLETED|Overall Study||6||
48076282|NCT02256631|100508255|FG004|COMPLETED|Overall Study||10||
48076283|NCT02256631|100508256|FG005|COMPLETED|Overall Study||6||
48076284|NCT02256631|100508257|FG006|COMPLETED|Overall Study||7||
48076285|NCT02256631|100508251|FG000|NOT COMPLETED|Overall Study||1||
48076286|NCT02256631|100508252|FG001|NOT COMPLETED|Overall Study||3||
48076287|NCT02256631|100508253|FG002|NOT COMPLETED|Overall Study||0||
48076288|NCT02256631|100508254|FG003|NOT COMPLETED|Overall Study||4||
48076289|NCT02256631|100508255|FG004|NOT COMPLETED|Overall Study||1||
48076290|NCT02256631|100508256|FG005|NOT COMPLETED|Overall Study||5||
48076291|NCT02256631|100508257|FG006|NOT COMPLETED|Overall Study||4||
48076292|NCT04353271|100508258|FG000|STARTED|Overall Study||1||
48076293|NCT04353271|100508259|FG001|STARTED|Overall Study||2||
48374642|NCT01253421|101247442|FG004|Returned for Drug+Scanning Visit|Assessment and Scheduling||0|This milestone accounts for participants who were lost to follow up or withdrew for other reasons.|
48374643|NCT01253421|101247438|FG000|COMPLETED|Assessment and Scheduling||60|These 60 participants enter Period 2.|
48076294|NCT04353271|100508258|FG000|COMPLETED|Overall Study||1||
48076295|NCT04353271|100508259|FG001|COMPLETED|Overall Study||1||
48076296|NCT04353271|100508258|FG000|NOT COMPLETED|Overall Study||0||
48076297|NCT04353271|100508259|FG001|NOT COMPLETED|Overall Study||1||
48076298|NCT02280304|100508260|FG000|STARTED|Overall Study||19||
48076299|NCT02280304|100508261|FG001|STARTED|Overall Study||18||
48076300|NCT02280304|100508260|FG000|COMPLETED|Overall Study||12||
48076301|NCT02280304|100508261|FG001|COMPLETED|Overall Study||10||
48374644|NCT01253421|101247439|FG001|COMPLETED|Assessment and Scheduling||0|These 60 participants enter Period 2.|
48523059|NCT01970865|101616029|FG005|NOT COMPLETED|Overall Study||3||
48523060|NCT01970865|101616030|FG006|NOT COMPLETED|Overall Study||3||
48523061|NCT01970865|101616031|FG007|NOT COMPLETED|Overall Study||3||
48523062|NCT01970865|101616032|FG008|NOT COMPLETED|Overall Study||2||
48076302|NCT02280304|100508260|FG000|NOT COMPLETED|Overall Study||7||
48076303|NCT02280304|100508261|FG001|NOT COMPLETED|Overall Study||8||
48227186|NCT04867382|100877938|FG001|COMPLETED|Overall Study||39|Primary analysis conducted with data from those who completed survey immediately following the online training.|
48227187|NCT04867382|100877937|FG000|NOT COMPLETED|Overall Study||2||
48227188|NCT04867382|100877938|FG001|NOT COMPLETED|Overall Study||1||
48227189|NCT00979459|100877939|FG000|STARTED|First Intervention||6||
48227190|NCT00979459|100877940|FG001|STARTED|First Intervention||6||
48227191|NCT00979459|100877939|FG000|COMPLETED|First Intervention||6||
48227192|NCT00979459|100877940|FG001|COMPLETED|First Intervention||6||
48227193|NCT00979459|100877939|FG000|NOT COMPLETED|First Intervention||0||
48227194|NCT00979459|100877940|FG001|NOT COMPLETED|First Intervention||0||
48227195|NCT00979459|100877939|FG000|STARTED|7-day Washout Period||6||
48076304|NCT02099708|100508262|FG000|STARTED|Overall Study||3502||
48076305|NCT02099708|100508262|FG000|Safety Analysis Set (SAS)|Overall Study||3302||
48076306|NCT02099708|100508262|FG000|COMPLETED|Overall Study||3302||
48076307|NCT02099708|100508262|FG000|NOT COMPLETED|Overall Study||200||
48076308|NCT04805541|100508263|FG000|STARTED|Overall Study||900||
48076309|NCT04805541|100508263|FG000|COMPLETED|Overall Study||865||
48076310|NCT04805541|100508263|FG000|NOT COMPLETED|Overall Study||35||
48076311|NCT03845985|100508264|FG000|STARTED|Overall Study||9||
48076312|NCT03845985|100508265|FG001|STARTED|Overall Study||7||
48076313|NCT03845985|100508264|FG000|COMPLETED|Overall Study||2||
48076314|NCT03845985|100508265|FG001|COMPLETED|Overall Study||5||
48076315|NCT03845985|100508264|FG000|NOT COMPLETED|Overall Study||7||
48076316|NCT03845985|100508265|FG001|NOT COMPLETED|Overall Study||2||
48076317|NCT00361569|100508266|FG000|STARTED|Overall Study||150||
48076318|NCT00361569|100508267|FG001|STARTED|Overall Study||161||
48076319|NCT00361569|100508268|FG002|STARTED|Overall Study||155||
48076320|NCT00361569|100508269|FG003|STARTED|Overall Study||156||
48076321|NCT00361569|100508266|FG000|COMPLETED|Overall Study||138||
48076322|NCT00361569|100508267|FG001|COMPLETED|Overall Study||150||
48076323|NCT00361569|100508268|FG002|COMPLETED|Overall Study||137||
48076324|NCT00361569|100508269|FG003|COMPLETED|Overall Study||135||
48076325|NCT00361569|100508266|FG000|NOT COMPLETED|Overall Study||12||
48076326|NCT00361569|100508267|FG001|NOT COMPLETED|Overall Study||11||
48076327|NCT00361569|100508268|FG002|NOT COMPLETED|Overall Study||18||
48076328|NCT00361569|100508269|FG003|NOT COMPLETED|Overall Study||21||
48076329|NCT01258582|100508270|FG000|STARTED|Overall Study||830||
48076330|NCT01258582|100508271|FG001|STARTED|Overall Study||821||
48076331|NCT01258582|100508270|FG000|COMPLETED|Overall Study||548||
48076332|NCT01258582|100508271|FG001|COMPLETED|Overall Study||563||
48076333|NCT01258582|100508270|FG000|NOT COMPLETED|Overall Study||282||
48076334|NCT01258582|100508271|FG001|NOT COMPLETED|Overall Study||258||
48076335|NCT00743483|100508272|FG000|STARTED|Baseline Period||15||
48076336|NCT00743483|100508272|FG000|COMPLETED|Baseline Period||14||
48076337|NCT00743483|100508272|FG000|NOT COMPLETED|Baseline Period||1||
48076338|NCT00743483|100508272|FG000|STARTED|Treatment Period||14||
48076339|NCT00743483|100508272|FG000|COMPLETED|Treatment Period||13||
48076340|NCT00743483|100508272|FG000|NOT COMPLETED|Treatment Period||1||
48076341|NCT02614092|100508273|FG000|STARTED|Overall Study||101||
48227196|NCT00979459|100877940|FG001|STARTED|7-day Washout Period||6||
48227197|NCT00979459|100877939|FG000|COMPLETED|7-day Washout Period||6||
48523063|NCT01970865|101616033|FG009|NOT COMPLETED|Overall Study||2||
48076342|NCT02614092|100508273|FG000|Met All Eligibility Criteria|Overall Study||31||
48076343|NCT02614092|100508273|FG000|COMPLETED|Overall Study||21||
48076344|NCT02614092|100508273|FG000|NOT COMPLETED|Overall Study||80||
48076345|NCT03572062|100508274|FG000|STARTED|Overall Study||32||
48076346|NCT03572062|100508275|FG001|STARTED|Overall Study||32||
48076347|NCT03572062|100508276|FG002|STARTED|Overall Study||32||
48076348|NCT03572062|100508277|FG003|STARTED|Overall Study||31||
48076349|NCT03572062|100508278|FG004|STARTED|Overall Study||32||
48076350|NCT03572062|100508279|FG005|STARTED|Overall Study||32||
48076351|NCT03572062|100508280|FG006|STARTED|Overall Study||32||
48076352|NCT03572062|100508281|FG007|STARTED|Overall Study||31||
48076353|NCT03572062|100508282|FG008|STARTED|Overall Study||32||
48076354|NCT03572062|100508283|FG009|STARTED|Overall Study||31||
48076355|NCT03572062|100508274|FG000|Treated|Overall Study||32||
48076356|NCT03572062|100508275|FG001|Treated|Overall Study||32||
48076357|NCT03572062|100508276|FG002|Treated|Overall Study||32||
48076358|NCT03572062|100508277|FG003|Treated|Overall Study||31||
48076359|NCT03572062|100508278|FG004|Treated|Overall Study||31||
48076360|NCT03572062|100508279|FG005|Treated|Overall Study||30||
48076361|NCT03572062|100508280|FG006|Treated|Overall Study||32||
48076362|NCT03572062|100508281|FG007|Treated|Overall Study||30||
48076363|NCT03572062|100508282|FG008|Treated|Overall Study||32||
48076364|NCT03572062|100508283|FG009|Treated|Overall Study||31||
48076365|NCT03572062|100508274|FG000|COMPLETED|Overall Study||32||
48076366|NCT03572062|100508275|FG001|COMPLETED|Overall Study||32||
48227198|NCT00979459|100877940|FG001|COMPLETED|7-day Washout Period||6||
48227199|NCT00979459|100877939|FG000|NOT COMPLETED|7-day Washout Period||0||
48076367|NCT03572062|100508276|FG002|COMPLETED|Overall Study||32||
48076368|NCT03572062|100508277|FG003|COMPLETED|Overall Study||31||
48076369|NCT03572062|100508278|FG004|COMPLETED|Overall Study||31||
48076370|NCT03572062|100508279|FG005|COMPLETED|Overall Study||28||
48076371|NCT03572062|100508280|FG006|COMPLETED|Overall Study||31||
48076372|NCT03572062|100508281|FG007|COMPLETED|Overall Study||30||
48076373|NCT03572062|100508282|FG008|COMPLETED|Overall Study||0||
48076374|NCT03572062|100508283|FG009|COMPLETED|Overall Study||0||
48076375|NCT03572062|100508274|FG000|NOT COMPLETED|Overall Study||0||
48076376|NCT03572062|100508275|FG001|NOT COMPLETED|Overall Study||0||
48076377|NCT03572062|100508276|FG002|NOT COMPLETED|Overall Study||0||
48076378|NCT03572062|100508277|FG003|NOT COMPLETED|Overall Study||0||
48076379|NCT03572062|100508278|FG004|NOT COMPLETED|Overall Study||1||
48076380|NCT03572062|100508279|FG005|NOT COMPLETED|Overall Study||4||
48076381|NCT03572062|100508280|FG006|NOT COMPLETED|Overall Study||1||
48076382|NCT03572062|100508281|FG007|NOT COMPLETED|Overall Study||1||
48076383|NCT03572062|100508282|FG008|NOT COMPLETED|Overall Study||32||
48076384|NCT03572062|100508283|FG009|NOT COMPLETED|Overall Study||31||
48076385|NCT00826943|100508284|FG000|STARTED|Overall Study||6||
48076386|NCT00826943|100508285|FG001|STARTED|Overall Study||6||
48076387|NCT00826943|100508286|FG002|STARTED|Overall Study||4||
48076388|NCT00826943|100508287|FG003|STARTED|Overall Study||5||
48076389|NCT00826943|100508288|FG004|STARTED|Overall Study||7||
48076390|NCT00826943|100508289|FG005|STARTED|Overall Study||2||
48076391|NCT00826943|100508284|FG000|COMPLETED|Overall Study||6||
48076392|NCT00826943|100508285|FG001|COMPLETED|Overall Study||6||
48076393|NCT00826943|100508286|FG002|COMPLETED|Overall Study||4||
48076394|NCT00826943|100508287|FG003|COMPLETED|Overall Study||5||
48076395|NCT00826943|100508288|FG004|COMPLETED|Overall Study||6||
48076396|NCT00826943|100508289|FG005|COMPLETED|Overall Study||2||
48076397|NCT00826943|100508284|FG000|NOT COMPLETED|Overall Study||0||
48076398|NCT00826943|100508285|FG001|NOT COMPLETED|Overall Study||0||
48076399|NCT00826943|100508286|FG002|NOT COMPLETED|Overall Study||0||
48076400|NCT00826943|100508287|FG003|NOT COMPLETED|Overall Study||0||
48076401|NCT00826943|100508288|FG004|NOT COMPLETED|Overall Study||1||
48076402|NCT00826943|100508289|FG005|NOT COMPLETED|Overall Study||0||
48076403|NCT00750815|100508290|FG000|STARTED|Overall Study||12||
48076404|NCT00750815|100508291|FG001|STARTED|Overall Study||46||
48076405|NCT00750815|100508290|FG000|COMPLETED|Overall Study||12||
48076406|NCT00750815|100508291|FG001|COMPLETED|Overall Study||46||
48076407|NCT00750815|100508290|FG000|NOT COMPLETED|Overall Study||0||
48076408|NCT00750815|100508291|FG001|NOT COMPLETED|Overall Study||0||
48076409|NCT02795832|100508292|FG000|STARTED|Overall Study||8||
48076410|NCT02795832|100508293|FG001|STARTED|Overall Study||4||
48076411|NCT02795832|100508294|FG002|STARTED|Overall Study||8||
48076412|NCT02795832|100508295|FG003|STARTED|Overall Study||3||
48076413|NCT02795832|100508296|FG004|STARTED|Overall Study||20||
48076414|NCT02795832|100508297|FG005|STARTED|Overall Study||10||
48076415|NCT02795832|100508292|FG000|COMPLETED|Overall Study||8||
48076416|NCT02795832|100508293|FG001|COMPLETED|Overall Study||4||
48076417|NCT02795832|100508294|FG002|COMPLETED|Overall Study||8||
48227200|NCT00979459|100877940|FG001|NOT COMPLETED|7-day Washout Period||0||
48076418|NCT02795832|100508295|FG003|COMPLETED|Overall Study||3||
48076419|NCT02795832|100508296|FG004|COMPLETED|Overall Study||20||
48076420|NCT02795832|100508297|FG005|COMPLETED|Overall Study||7||
48076421|NCT02795832|100508292|FG000|NOT COMPLETED|Overall Study||0||
48076422|NCT02795832|100508293|FG001|NOT COMPLETED|Overall Study||0||
48076423|NCT02795832|100508294|FG002|NOT COMPLETED|Overall Study||0||
48076424|NCT02795832|100508295|FG003|NOT COMPLETED|Overall Study||0||
48076425|NCT02795832|100508296|FG004|NOT COMPLETED|Overall Study||0||
48076426|NCT02795832|100508297|FG005|NOT COMPLETED|Overall Study||3||
48076427|NCT00418457|100508298|FG000|STARTED|Overall Study||1065||
48076428|NCT00418457|100508299|FG001|STARTED|Overall Study||1043||
48076429|NCT00418457|100508298|FG000|COMPLETED|Overall Study||1065||
48076430|NCT00418457|100508299|FG001|COMPLETED|Overall Study||1043||
48076431|NCT00418457|100508298|FG000|NOT COMPLETED|Overall Study||0||
48076432|NCT00418457|100508299|FG001|NOT COMPLETED|Overall Study||0||
48076433|NCT02955602|100508300|FG000|STARTED|Overall Study||11||
48076434|NCT02955602|100508301|FG001|STARTED|Overall Study||53||
48076435|NCT02955602|100508302|FG002|STARTED|Overall Study||55||
48076436|NCT02955602|100508300|FG000|COMPLETED|Overall Study||10||
48076437|NCT02955602|100508301|FG001|COMPLETED|Overall Study||46||
48076438|NCT02955602|100508302|FG002|COMPLETED|Overall Study||49||
48076439|NCT02955602|100508300|FG000|NOT COMPLETED|Overall Study||1||
48076440|NCT02955602|100508301|FG001|NOT COMPLETED|Overall Study||7||
48076441|NCT02955602|100508302|FG002|NOT COMPLETED|Overall Study||6||
48076442|NCT00713323|100508303|FG000|STARTED|Overall Study||380||
48076443|NCT00713323|100508303|FG000|COMPLETED|Overall Study||234||
48076444|NCT00713323|100508303|FG000|NOT COMPLETED|Overall Study||146||
48076445|NCT02151383|100508304|FG000|STARTED|Overall Study||8||
48076446|NCT02151383|100508305|FG001|STARTED|Overall Study||3||
48076447|NCT02151383|100508306|FG002|STARTED|Overall Study||1||
48076448|NCT02151383|100508304|FG000|Low-dose|Overall Study||2||
48076449|NCT02151383|100508305|FG001|Low-dose|Overall Study||3||
48076450|NCT02151383|100508306|FG002|Low-dose|Overall Study||1||
48076451|NCT02151383|100508304|FG000|High-dose|Overall Study||6||
48076452|NCT02151383|100508305|FG001|High-dose|Overall Study||0||
48076453|NCT02151383|100508306|FG002|High-dose|Overall Study||0||
48076454|NCT02151383|100508304|FG000|COMPLETED|Overall Study||8||
48076455|NCT02151383|100508305|FG001|COMPLETED|Overall Study||3||
48076456|NCT02151383|100508306|FG002|COMPLETED|Overall Study||1||
48076457|NCT02151383|100508304|FG000|NOT COMPLETED|Overall Study||0||
48076458|NCT02151383|100508305|FG001|NOT COMPLETED|Overall Study||0||
48076459|NCT02151383|100508306|FG002|NOT COMPLETED|Overall Study||0||
48076460|NCT02378961|100508307|FG000|STARTED|Overall Study||33||
48076461|NCT02378961|100508308|FG001|STARTED|Overall Study||30||
48076462|NCT02378961|100508309|FG002|STARTED|Overall Study||36||
48076463|NCT02378961|100508310|FG003|STARTED|Overall Study||29||
48076464|NCT02378961|100508307|FG000|COMPLETED|Overall Study||29||
48076465|NCT02378961|100508308|FG001|COMPLETED|Overall Study||28||
48076466|NCT02378961|100508309|FG002|COMPLETED|Overall Study||35||
48076467|NCT02378961|100508310|FG003|COMPLETED|Overall Study||28||
48076468|NCT02378961|100508307|FG000|NOT COMPLETED|Overall Study||4||
48076469|NCT02378961|100508308|FG001|NOT COMPLETED|Overall Study||2||
48076470|NCT02378961|100508309|FG002|NOT COMPLETED|Overall Study||1||
48076471|NCT02378961|100508310|FG003|NOT COMPLETED|Overall Study||1||
48076472|NCT04003012|100508311|FG000|STARTED|Overall Study||5||
48076473|NCT04003012|100508312|FG001|STARTED|Overall Study||5||
48076474|NCT04003012|100508311|FG000|COMPLETED|Overall Study||5||
48076475|NCT04003012|100508312|FG001|COMPLETED|Overall Study||5||
48076476|NCT04003012|100508311|FG000|NOT COMPLETED|Overall Study||0||
48076477|NCT04003012|100508312|FG001|NOT COMPLETED|Overall Study||0||
48076478|NCT00885846|100508313|FG000|STARTED|Overall Study||11||
48076479|NCT00885846|100508314|FG001|STARTED|Overall Study||11||
48076480|NCT00885846|100508315|FG002|STARTED|Overall Study||10||
48076481|NCT00885846|100508313|FG000|COMPLETED|Overall Study||9||
48076482|NCT00885846|100508314|FG001|COMPLETED|Overall Study||6||
48076483|NCT00885846|100508315|FG002|COMPLETED|Overall Study||8||
48076484|NCT00885846|100508313|FG000|NOT COMPLETED|Overall Study||2||
48076485|NCT00885846|100508314|FG001|NOT COMPLETED|Overall Study||5||
48076486|NCT00885846|100508315|FG002|NOT COMPLETED|Overall Study||2||
48076487|NCT00545662|100508316|FG000|STARTED|Overall Study||606||
48076488|NCT00545662|100508317|FG001|STARTED|Overall Study||607||
48076489|NCT00545662|100508316|FG000|COMPLETED|Overall Study||521||
48076490|NCT00545662|100508317|FG001|COMPLETED|Overall Study||528||
48076491|NCT00545662|100508316|FG000|NOT COMPLETED|Overall Study||85||
48076492|NCT00545662|100508317|FG001|NOT COMPLETED|Overall Study||79||
48076493|NCT01606800|100508318|FG000|STARTED|Overall Study||22||
48076494|NCT01606800|100508319|FG001|STARTED|Overall Study||23||
48076495|NCT01606800|100508318|FG000|Treated|Overall Study||22||
48076496|NCT01606800|100508319|FG001|Treated|Overall Study||23||
48076497|NCT01606800|100508318|FG000|COMPLETED|Overall Study||17||
48076498|NCT01606800|100508319|FG001|COMPLETED|Overall Study||21||
48076499|NCT01606800|100508318|FG000|NOT COMPLETED|Overall Study||5||
48076500|NCT01606800|100508319|FG001|NOT COMPLETED|Overall Study||2||
48076501|NCT01256008|100508320|FG000|STARTED|Overall Study||98||
48076502|NCT01256008|100508321|FG001|STARTED|Overall Study||98||
48076503|NCT01256008|100508322|FG002|STARTED|Overall Study||196||
48076504|NCT01256008|100508320|FG000|COMPLETED|Overall Study||90||
48076505|NCT01256008|100508321|FG001|COMPLETED|Overall Study||91||
48076506|NCT01256008|100508322|FG002|COMPLETED|Overall Study||175||
48076507|NCT01256008|100508320|FG000|NOT COMPLETED|Overall Study||8||
48076508|NCT01256008|100508321|FG001|NOT COMPLETED|Overall Study||7||
48076509|NCT01256008|100508322|FG002|NOT COMPLETED|Overall Study||21||
48076510|NCT00717197|100508323|FG000|STARTED|Overall Study||30||
48076511|NCT00717197|100508323|FG000|COMPLETED|Overall Study||23||
48076512|NCT00717197|100508323|FG000|NOT COMPLETED|Overall Study||7||
48076513|NCT00006237|100508324|FG000|STARTED|Overall Study||212||
48076514|NCT00006237|100508325|FG001|STARTED|Overall Study||220||
48076515|NCT00006237|100508324|FG000|Eligible|Overall Study||203||
48076516|NCT00006237|100508325|FG001|Eligible|Overall Study||200||
48076517|NCT00006237|100508324|FG000|Eligible and Treated|Overall Study||203||
48076518|NCT00006237|100508325|FG001|Eligible and Treated|Overall Study||199||
48076519|NCT00006237|100508324|FG000|COMPLETED|Overall Study||87||
48076520|NCT00006237|100508325|FG001|COMPLETED|Overall Study||159||
48076521|NCT00006237|100508324|FG000|NOT COMPLETED|Overall Study||125||
48076522|NCT00006237|100508325|FG001|NOT COMPLETED|Overall Study||61||
48076523|NCT00528788|100508326|FG000|STARTED|Overall Study||24||
48076524|NCT00528788|100508326|FG000|COMPLETED|Overall Study||20||
48076525|NCT00528788|100508326|FG000|NOT COMPLETED|Overall Study||4||
48076526|NCT04213079|100508327|FG000|STARTED|Overall Study||24||
48076527|NCT04213079|100508328|FG001|STARTED|Overall Study||23||
48076528|NCT04213079|100508327|FG000|COMPLETED|Overall Study||24||
48076529|NCT04213079|100508328|FG001|COMPLETED|Overall Study||21||
48076530|NCT04213079|100508327|FG000|NOT COMPLETED|Overall Study||0||
48076531|NCT04213079|100508328|FG001|NOT COMPLETED|Overall Study||2||
48076532|NCT03806790|100511140|FG000|STARTED|Overall Study||87||
48076533|NCT03806790|100511141|FG001|STARTED|Overall Study||95||
48076534|NCT03806790|100511140|FG000|COMPLETED|Overall Study||87||
48076535|NCT03806790|100511141|FG001|COMPLETED|Overall Study||95||
48076536|NCT03806790|100511140|FG000|NOT COMPLETED|Overall Study||0||
48076537|NCT03806790|100511141|FG001|NOT COMPLETED|Overall Study||0||
48076538|NCT03648983|100511142|FG000|STARTED|Overall Study||95||
48076539|NCT03648983|100511142|FG000|COMPLETED|Overall Study||0||
48076540|NCT03648983|100511142|FG000|NOT COMPLETED|Overall Study||95||
48076541|NCT02988843|100511143|FG000|STARTED|Overall Study||1||
48076542|NCT02988843|100511143|FG000|COMPLETED|Overall Study||1||
48076543|NCT02988843|100511143|FG000|NOT COMPLETED|Overall Study||0||
48076544|NCT00291577|100511144|FG000|STARTED|Overall Study||22||
48076545|NCT00291577|100511144|FG000|COMPLETED|Overall Study||1||
48076546|NCT00291577|100511144|FG000|NOT COMPLETED|Overall Study||21||
48076547|NCT00319553|100511145|FG000|STARTED|Overall Study||323||
48076548|NCT00319553|100511146|FG001|STARTED|Overall Study||321||
48076549|NCT00319553|100511145|FG000|COMPLETED|Overall Study||319||
48076550|NCT00319553|100511146|FG001|COMPLETED|Overall Study||317||
48076551|NCT00319553|100511145|FG000|NOT COMPLETED|Overall Study||4||
48076552|NCT00319553|100511146|FG001|NOT COMPLETED|Overall Study||4||
48076553|NCT03178903|100511147|FG000|STARTED|Overall Study||25||
48076554|NCT03178903|100511148|FG001|STARTED|Overall Study||26||
48076555|NCT03178903|100511147|FG000|COMPLETED|Overall Study||25||
48076556|NCT03178903|100511148|FG001|COMPLETED|Overall Study||26||
48076557|NCT03178903|100511147|FG000|NOT COMPLETED|Overall Study||0||
48076558|NCT03178903|100511148|FG001|NOT COMPLETED|Overall Study||0||
48076559|NCT00259649|100511149|FG000|STARTED|Overall Study||71||
48076560|NCT00259649|100511149|FG000|COMPLETED|Overall Study||61||
48076561|NCT00259649|100511149|FG000|NOT COMPLETED|Overall Study||10||
48076562|NCT03261973|100511150|FG000|STARTED|Overall Study||47||
48076563|NCT03261973|100511150|FG000|COMPLETED|Overall Study||43||
48076564|NCT03261973|100511150|FG000|NOT COMPLETED|Overall Study||4||
48076565|NCT03943147|100511151|FG000|STARTED|Open-Label MMF Run-in (Part A)||16||
48076566|NCT03943147|100511152|FG001|STARTED|Open-Label MMF Run-in (Part A)||0||
48076567|NCT03943147|100511151|FG000|COMPLETED|Open-Label MMF Run-in (Part A)||6||
48076568|NCT03943147|100511152|FG001|COMPLETED|Open-Label MMF Run-in (Part A)||0||
48227201|NCT00979459|100877939|FG000|STARTED|Second Intervention||6||
48227202|NCT00979459|100877940|FG001|STARTED|Second Intervention||6||
48227203|NCT00979459|100877939|FG000|COMPLETED|Second Intervention||6||
48227204|NCT00979459|100877940|FG001|COMPLETED|Second Intervention||6||
48227205|NCT00979459|100877939|FG000|NOT COMPLETED|Second Intervention||0||
48227206|NCT00979459|100877940|FG001|NOT COMPLETED|Second Intervention||0||
48227207|NCT02972424|100877941|FG000|STARTED|3 Month Endpoints- Blinded Portion||18||
48523064|NCT01970865|101616034|FG010|NOT COMPLETED|Overall Study||12||
48374645|NCT01253421|101247440|FG002|COMPLETED|Assessment and Scheduling||0|These 60 participants enter Period 2.|
48076569|NCT03943147|100511151|FG000|NOT COMPLETED|Open-Label MMF Run-in (Part A)||10||
48076570|NCT03943147|100511152|FG001|NOT COMPLETED|Open-Label MMF Run-in (Part A)||0||
48076571|NCT03943147|100511151|FG000|STARTED|Blinded Treatment (Part B)||5||
48076572|NCT03943147|100511152|FG001|STARTED|Blinded Treatment (Part B)||1||
48076573|NCT03943147|100511151|FG000|COMPLETED|Blinded Treatment (Part B)||2||
48076574|NCT03943147|100511152|FG001|COMPLETED|Blinded Treatment (Part B)||1||
48076575|NCT03943147|100511151|FG000|NOT COMPLETED|Blinded Treatment (Part B)||3||
48076576|NCT03943147|100511152|FG001|NOT COMPLETED|Blinded Treatment (Part B)||0||
48076577|NCT03811028|100511153|FG000|STARTED|Overall Study||3||
48076578|NCT03811028|100511154|FG001|STARTED|Overall Study||3||
48076579|NCT03811028|100511153|FG000|COMPLETED|Overall Study||3||
48076580|NCT03811028|100511154|FG001|COMPLETED|Overall Study||3||
48076581|NCT03811028|100511153|FG000|NOT COMPLETED|Overall Study||0||
48076582|NCT03811028|100511154|FG001|NOT COMPLETED|Overall Study||0||
48076583|NCT02515825|100511155|FG000|STARTED|Overall Study||70||
48076584|NCT02515825|100511156|FG001|STARTED|Overall Study||31||
48076585|NCT02515825|100511155|FG000|COMPLETED|Overall Study||70||
48076586|NCT02515825|100511156|FG001|COMPLETED|Overall Study||31||
48076587|NCT02515825|100511155|FG000|NOT COMPLETED|Overall Study||0||
48076588|NCT02515825|100511156|FG001|NOT COMPLETED|Overall Study||0||
48076589|NCT02096731|100511157|FG000|STARTED|Overall Study||26442||
48076590|NCT02096731|100511158|FG001|STARTED|Overall Study||88955||
48076591|NCT02096731|100511157|FG000|COMPLETED|Overall Study||26442||
48076592|NCT02096731|100511158|FG001|COMPLETED|Overall Study||88955||
48076593|NCT02096731|100511157|FG000|NOT COMPLETED|Overall Study||0||
48227208|NCT02972424|100877942|FG001|STARTED|3 Month Endpoints- Blinded Portion||17||
48227209|NCT02972424|100877941|FG000|COMPLETED|3 Month Endpoints- Blinded Portion||17||
48076594|NCT02096731|100511158|FG001|NOT COMPLETED|Overall Study||0||
48076595|NCT01292746|100511159|FG000|STARTED|Overall Study||14||
48076596|NCT01292746|100511159|FG000|COMPLETED|Overall Study||14||
48076597|NCT01292746|100511159|FG000|NOT COMPLETED|Overall Study||0||
48076598|NCT03478930|100511160|FG000|STARTED|Overall Study||126||
48076599|NCT03478930|100511161|FG001|STARTED|Overall Study||123||
48076600|NCT03478930|100511160|FG000|COMPLETED|Overall Study||117||
48076601|NCT03478930|100511161|FG001|COMPLETED|Overall Study||114||
48076602|NCT03478930|100511160|FG000|NOT COMPLETED|Overall Study||9||
48076603|NCT03478930|100511161|FG001|NOT COMPLETED|Overall Study||9||
48076604|NCT02756013|100511162|FG000|STARTED|Overall Study||3||
48076605|NCT02756013|100511162|FG000|COMPLETED|Overall Study||1||
48076606|NCT02756013|100511162|FG000|NOT COMPLETED|Overall Study||2||
48076607|NCT00496470|100511163|FG000|STARTED|Overall Study||329||
48076608|NCT00496470|100511164|FG001|STARTED|Overall Study||331||
48076609|NCT00496470|100511163|FG000|Received Study Medication|Overall Study||329||
48076610|NCT00496470|100511164|FG001|Received Study Medication|Overall Study||330||
48076611|NCT00496470|100511163|FG000|COMPLETED|Overall Study||303||
48076612|NCT00496470|100511164|FG001|COMPLETED|Overall Study||302||
48076613|NCT00496470|100511163|FG000|NOT COMPLETED|Overall Study||26||
48076614|NCT00496470|100511164|FG001|NOT COMPLETED|Overall Study||29||
48076615|NCT02197520|100511165|FG000|STARTED|Period 1||12||
48076616|NCT02197520|100511166|FG001|STARTED|Period 1||12||
48076617|NCT02197520|100511165|FG000|COMPLETED|Period 1||11||
48076618|NCT02197520|100511166|FG001|COMPLETED|Period 1||12||
48076619|NCT02197520|100511165|FG000|NOT COMPLETED|Period 1||1||
48076620|NCT02197520|100511166|FG001|NOT COMPLETED|Period 1||0||
48076621|NCT02197520|100511165|FG000|STARTED|Period 2||11||
48076622|NCT02197520|100511166|FG001|STARTED|Period 2||12||
48076623|NCT02197520|100511165|FG000|COMPLETED|Period 2||10||
48076624|NCT02197520|100511166|FG001|COMPLETED|Period 2||10||
48076625|NCT02197520|100511165|FG000|NOT COMPLETED|Period 2||1||
48076626|NCT02197520|100511166|FG001|NOT COMPLETED|Period 2||2||
48076627|NCT02221947|100511167|FG000|STARTED|Overall Study||6||
48076628|NCT02221947|100511168|FG001|STARTED|Overall Study||3||
48076629|NCT02221947|100511167|FG000|COMPLETED|Overall Study||6||
48076630|NCT02221947|100511168|FG001|COMPLETED|Overall Study||3||
48076631|NCT02221947|100511167|FG000|NOT COMPLETED|Overall Study||0||
48076632|NCT02221947|100511168|FG001|NOT COMPLETED|Overall Study||0||
48076633|NCT02837328|100511169|FG000|STARTED|Overall Study||29||
48076634|NCT02837328|100511170|FG001|STARTED|Overall Study||30||
48076635|NCT02837328|100511169|FG000|COMPLETED|Overall Study||29||
48076636|NCT02837328|100511170|FG001|COMPLETED|Overall Study||30||
48076637|NCT02837328|100511169|FG000|NOT COMPLETED|Overall Study||0||
48076638|NCT02837328|100511170|FG001|NOT COMPLETED|Overall Study||0||
48076639|NCT00571948|100511171|FG000|STARTED|Overall Study||66||
48076640|NCT00571948|100511172|FG001|STARTED|Overall Study||66||
48076641|NCT00571948|100511171|FG000|COMPLETED|Overall Study||55||
48076642|NCT00571948|100511172|FG001|COMPLETED|Overall Study||52||
48076643|NCT00571948|100511171|FG000|NOT COMPLETED|Overall Study||11||
48076644|NCT00571948|100511172|FG001|NOT COMPLETED|Overall Study||14||
48076645|NCT01925534|100511173|FG000|STARTED|Overall Study||23||
48076646|NCT01925534|100511174|FG001|STARTED|Overall Study||24||
48076647|NCT01925534|100511173|FG000|COMPLETED|Overall Study||23||
48076648|NCT01925534|100511174|FG001|COMPLETED|Overall Study||24||
48076649|NCT01925534|100511173|FG000|NOT COMPLETED|Overall Study||0||
48076650|NCT01925534|100511174|FG001|NOT COMPLETED|Overall Study||0||
48076651|NCT00541931|100511175|FG000|STARTED|Overall Study||22||
48076652|NCT00541931|100511176|FG001|STARTED|Overall Study||15||
48076653|NCT00541931|100511175|FG000|COMPLETED|Overall Study||17||
48076654|NCT00541931|100511176|FG001|COMPLETED|Overall Study||11||
48076655|NCT00541931|100511175|FG000|NOT COMPLETED|Overall Study||5||
48076656|NCT00541931|100511176|FG001|NOT COMPLETED|Overall Study||4||
48076657|NCT04786990|100511177|FG000|STARTED|Overall Study||56|"Number of subjects Started is based on the Safety Population (defined as subjects who signed an Informed Consent and took at least one dose of SPN-812)."|
48076658|NCT04786990|100511177|FG000|COMPLETED|Overall Study||48||
48076659|NCT04786990|100511177|FG000|NOT COMPLETED|Overall Study||8||
48076660|NCT01691339|100511178|FG000|STARTED|Overall Study||50||
48076661|NCT01691339|100511179|FG001|STARTED|Overall Study||50||
48076662|NCT01691339|100511180|FG002|STARTED|Overall Study||51||
48076663|NCT01691339|100511181|FG003|STARTED|Overall Study||49||
48076664|NCT01691339|100511178|FG000|COMPLETED|Overall Study||50||
48076665|NCT01691339|100511179|FG001|COMPLETED|Overall Study||50||
48076666|NCT01691339|100511180|FG002|COMPLETED|Overall Study||51||
48076667|NCT01691339|100511181|FG003|COMPLETED|Overall Study||49||
48076668|NCT01691339|100511178|FG000|NOT COMPLETED|Overall Study||0||
48076669|NCT01691339|100511179|FG001|NOT COMPLETED|Overall Study||0||
48076670|NCT01691339|100511180|FG002|NOT COMPLETED|Overall Study||0||
48076671|NCT01691339|100511181|FG003|NOT COMPLETED|Overall Study||0||
48076672|NCT00224042|100511182|FG000|STARTED|Overall Study||26||
48076673|NCT00224042|100511183|FG001|STARTED|Overall Study||26||
48076674|NCT00224042|100511182|FG000|COMPLETED|Overall Study||20||
48076675|NCT00224042|100511183|FG001|COMPLETED|Overall Study||20||
48076676|NCT00224042|100511182|FG000|NOT COMPLETED|Overall Study||6||
48076677|NCT00224042|100511183|FG001|NOT COMPLETED|Overall Study||6||
48076678|NCT03616600|100511184|FG000|STARTED|Overall Study||16||
48076679|NCT03616600|100511185|FG001|STARTED|Overall Study||15||
48076680|NCT03616600|100511184|FG000|COMPLETED|Overall Study||15||
48374646|NCT01253421|101247441|FG003|COMPLETED|Assessment and Scheduling||0|These 60 participants enter Period 2.|
48523065|NCT01970865|101616035|FG011|NOT COMPLETED|Overall Study||20||
48523066|NCT01970865|101616036|FG012|NOT COMPLETED|Overall Study||42||
48523067|NCT01970865|101616037|FG013|NOT COMPLETED|Overall Study||57||
48374647|NCT01253421|101247442|FG004|COMPLETED|Assessment and Scheduling||0|These 60 participants enter Period 2.|
48374648|NCT01253421|101247438|FG000|NOT COMPLETED|Assessment and Scheduling||99||
48523068|NCT01970865|101616038|FG014|NOT COMPLETED|Overall Study||43||
48076681|NCT03616600|100511185|FG001|COMPLETED|Overall Study||15||
48076682|NCT03616600|100511184|FG000|NOT COMPLETED|Overall Study||1||
48227210|NCT02972424|100877942|FG001|COMPLETED|3 Month Endpoints- Blinded Portion||12||
48227211|NCT02972424|100877941|FG000|NOT COMPLETED|3 Month Endpoints- Blinded Portion||1||
48227212|NCT02972424|100877942|FG001|NOT COMPLETED|3 Month Endpoints- Blinded Portion||5||
48227213|NCT02972424|100877941|FG000|STARTED|Open Label Extension 3 to 12 Months||17||
48227214|NCT02972424|100877942|FG001|STARTED|Open Label Extension 3 to 12 Months||12||
48227215|NCT02972424|100877941|FG000|COMPLETED|Open Label Extension 3 to 12 Months||12||
48227216|NCT02972424|100877942|FG001|COMPLETED|Open Label Extension 3 to 12 Months||9||
48076683|NCT03616600|100511185|FG001|NOT COMPLETED|Overall Study||0||
48076684|NCT02794883|100511186|FG000|STARTED|Pre-Surgical Treatment||12||
48227217|NCT02972424|100877941|FG000|NOT COMPLETED|Open Label Extension 3 to 12 Months||5||
48076685|NCT02794883|100511187|FG001|STARTED|Pre-Surgical Treatment||12||
48076686|NCT02794883|100511188|FG002|STARTED|Pre-Surgical Treatment||12||
48076687|NCT02794883|100511186|FG000|Registered for Study|Pre-Surgical Treatment||12||
48076688|NCT02794883|100511187|FG001|Registered for Study|Pre-Surgical Treatment||12||
48076689|NCT02794883|100511188|FG002|Registered for Study|Pre-Surgical Treatment||12||
48076690|NCT02794883|100511186|FG000|Received First Dose (Pre-surgical Dose) of Study Drug|Pre-Surgical Treatment||12||
48076691|NCT02794883|100511187|FG001|Received First Dose (Pre-surgical Dose) of Study Drug|Pre-Surgical Treatment||11||
48076692|NCT02794883|100511188|FG002|Received First Dose (Pre-surgical Dose) of Study Drug|Pre-Surgical Treatment||11||
48076693|NCT02794883|100511186|FG000|COMPLETED|Pre-Surgical Treatment||12||
48076694|NCT02794883|100511187|FG001|COMPLETED|Pre-Surgical Treatment||11||
48076695|NCT02794883|100511188|FG002|COMPLETED|Pre-Surgical Treatment||11||
48076696|NCT02794883|100511186|FG000|NOT COMPLETED|Pre-Surgical Treatment||0||
48076697|NCT02794883|100511187|FG001|NOT COMPLETED|Pre-Surgical Treatment||1||
48076698|NCT02794883|100511188|FG002|NOT COMPLETED|Pre-Surgical Treatment||1||
48076699|NCT02794883|100511186|FG000|STARTED|Post-Surgery Treatment (Adjuvant)||12||
48076700|NCT02794883|100511187|FG001|STARTED|Post-Surgery Treatment (Adjuvant)||11||
48076701|NCT02794883|100511188|FG002|STARTED|Post-Surgery Treatment (Adjuvant)||11||
48076702|NCT02794883|100511186|FG000|Started Cycle 1|Post-Surgery Treatment (Adjuvant)||11||
48076703|NCT02794883|100511187|FG001|Started Cycle 1|Post-Surgery Treatment (Adjuvant)||8||
48076704|NCT02794883|100511188|FG002|Started Cycle 1|Post-Surgery Treatment (Adjuvant)||11||
48076705|NCT02794883|100511186|FG000|Started Cycle 2|Post-Surgery Treatment (Adjuvant)||7||
48076706|NCT02794883|100511187|FG001|Started Cycle 2|Post-Surgery Treatment (Adjuvant)||8||
48076707|NCT02794883|100511188|FG002|Started Cycle 2|Post-Surgery Treatment (Adjuvant)||11||
48076708|NCT02794883|100511186|FG000|Started Cycle 3|Post-Surgery Treatment (Adjuvant)||3||
48076709|NCT02794883|100511187|FG001|Started Cycle 3|Post-Surgery Treatment (Adjuvant)||7||
48076710|NCT02794883|100511188|FG002|Started Cycle 3|Post-Surgery Treatment (Adjuvant)||4||
48076711|NCT02794883|100511186|FG000|Started Cycle 4|Post-Surgery Treatment (Adjuvant)||2||
48076712|NCT02794883|100511187|FG001|Started Cycle 4|Post-Surgery Treatment (Adjuvant)||5||
48076713|NCT02794883|100511188|FG002|Started Cycle 4|Post-Surgery Treatment (Adjuvant)||2||
48076714|NCT02794883|100511186|FG000|Started Cycle 5|Post-Surgery Treatment (Adjuvant)||2||
48076715|NCT02794883|100511187|FG001|Started Cycle 5|Post-Surgery Treatment (Adjuvant)||3||
48076716|NCT02794883|100511188|FG002|Started Cycle 5|Post-Surgery Treatment (Adjuvant)||2||
48076717|NCT02794883|100511186|FG000|Started Cycle 6|Post-Surgery Treatment (Adjuvant)||0||
48076718|NCT02794883|100511187|FG001|Started Cycle 6|Post-Surgery Treatment (Adjuvant)||3||
48076719|NCT02794883|100511188|FG002|Started Cycle 6|Post-Surgery Treatment (Adjuvant)||2||
48076720|NCT02794883|100511186|FG000|Started Cycle 7|Post-Surgery Treatment (Adjuvant)||0||
48076721|NCT02794883|100511187|FG001|Started Cycle 7|Post-Surgery Treatment (Adjuvant)||3||
48076722|NCT02794883|100511188|FG002|Started Cycle 7|Post-Surgery Treatment (Adjuvant)||1||
48076723|NCT02794883|100511186|FG000|Started Cycle 8|Post-Surgery Treatment (Adjuvant)||0||
48076724|NCT02794883|100511187|FG001|Started Cycle 8|Post-Surgery Treatment (Adjuvant)||3||
48076725|NCT02794883|100511188|FG002|Started Cycle 8|Post-Surgery Treatment (Adjuvant)||1||
48076726|NCT02794883|100511186|FG000|Started Cycle 9|Post-Surgery Treatment (Adjuvant)||0||
48076727|NCT02794883|100511187|FG001|Started Cycle 9|Post-Surgery Treatment (Adjuvant)||3||
48076728|NCT02794883|100511188|FG002|Started Cycle 9|Post-Surgery Treatment (Adjuvant)||1||
48076729|NCT02794883|100511186|FG000|Started Cycle 10|Post-Surgery Treatment (Adjuvant)||0||
48076730|NCT02794883|100511187|FG001|Started Cycle 10|Post-Surgery Treatment (Adjuvant)||2||
48076731|NCT02794883|100511188|FG002|Started Cycle 10|Post-Surgery Treatment (Adjuvant)||1||
48076732|NCT02794883|100511186|FG000|Started Cycle 11|Post-Surgery Treatment (Adjuvant)||0||
48227218|NCT02972424|100877942|FG001|NOT COMPLETED|Open Label Extension 3 to 12 Months||3||
48076733|NCT02794883|100511187|FG001|Started Cycle 11|Post-Surgery Treatment (Adjuvant)||2||
48076734|NCT02794883|100511188|FG002|Started Cycle 11|Post-Surgery Treatment (Adjuvant)||1||
48076735|NCT02794883|100511186|FG000|Started Cycle 12|Post-Surgery Treatment (Adjuvant)||0||
48076736|NCT02794883|100511187|FG001|Started Cycle 12|Post-Surgery Treatment (Adjuvant)||1||
48076737|NCT02794883|100511188|FG002|Started Cycle 12|Post-Surgery Treatment (Adjuvant)||1||
48076738|NCT02794883|100511186|FG000|Started Cycle 13|Post-Surgery Treatment (Adjuvant)||0||
48076739|NCT02794883|100511187|FG001|Started Cycle 13|Post-Surgery Treatment (Adjuvant)||1||
48076740|NCT02794883|100511188|FG002|Started Cycle 13|Post-Surgery Treatment (Adjuvant)||1||
48076741|NCT02794883|100511186|FG000|Started Cycle 14|Post-Surgery Treatment (Adjuvant)||0||
48076742|NCT02794883|100511187|FG001|Started Cycle 14|Post-Surgery Treatment (Adjuvant)||1||
48076743|NCT02794883|100511188|FG002|Started Cycle 14|Post-Surgery Treatment (Adjuvant)||1||
48076744|NCT02794883|100511186|FG000|Started Cycle 15|Post-Surgery Treatment (Adjuvant)||0||
48076745|NCT02794883|100511187|FG001|Started Cycle 15|Post-Surgery Treatment (Adjuvant)||0||
48076746|NCT02794883|100511188|FG002|Started Cycle 15|Post-Surgery Treatment (Adjuvant)||1||
48076747|NCT02794883|100511186|FG000|Started Cycle 16|Post-Surgery Treatment (Adjuvant)||0||
48076748|NCT02794883|100511187|FG001|Started Cycle 16|Post-Surgery Treatment (Adjuvant)||0||
48076749|NCT02794883|100511188|FG002|Started Cycle 16|Post-Surgery Treatment (Adjuvant)||1||
48076750|NCT02794883|100511186|FG000|Started Cycle 17|Post-Surgery Treatment (Adjuvant)||0||
48076751|NCT02794883|100511187|FG001|Started Cycle 17|Post-Surgery Treatment (Adjuvant)||0||
48076752|NCT02794883|100511188|FG002|Started Cycle 17|Post-Surgery Treatment (Adjuvant)||0||
48076753|NCT02794883|100511186|FG000|COMPLETED|Post-Surgery Treatment (Adjuvant)||0||
48076754|NCT02794883|100511187|FG001|COMPLETED|Post-Surgery Treatment (Adjuvant)||0||
48076755|NCT02794883|100511188|FG002|COMPLETED|Post-Surgery Treatment (Adjuvant)||0||
48076756|NCT02794883|100511186|FG000|NOT COMPLETED|Post-Surgery Treatment (Adjuvant)||12||
48076757|NCT02794883|100511187|FG001|NOT COMPLETED|Post-Surgery Treatment (Adjuvant)||11||
48076758|NCT02794883|100511188|FG002|NOT COMPLETED|Post-Surgery Treatment (Adjuvant)||11||
48076759|NCT02794883|100511186|FG000|STARTED|Follow-up Period (up to 2 Years)||12|All patients who receive at least 1 dose of study drug go into follow-up.|
48076760|NCT02794883|100511187|FG001|STARTED|Follow-up Period (up to 2 Years)||11|All patients who receive at least 1 dose of study drug go into follow-up.|
48076761|NCT02794883|100511188|FG002|STARTED|Follow-up Period (up to 2 Years)||11|All patients who receive at least 1 dose of study drug go into follow-up.|
48076762|NCT02794883|100511186|FG000|COMPLETED|Follow-up Period (up to 2 Years)||0||
48076763|NCT02794883|100511187|FG001|COMPLETED|Follow-up Period (up to 2 Years)||1||
48076764|NCT02794883|100511188|FG002|COMPLETED|Follow-up Period (up to 2 Years)||1||
48076765|NCT02794883|100511186|FG000|NOT COMPLETED|Follow-up Period (up to 2 Years)||12||
48076766|NCT02794883|100511187|FG001|NOT COMPLETED|Follow-up Period (up to 2 Years)||10||
48076767|NCT02794883|100511188|FG002|NOT COMPLETED|Follow-up Period (up to 2 Years)||10||
48076768|NCT03284398|100511189|FG000|STARTED|Overall Study||2753||
48076769|NCT03284398|100511190|FG001|STARTED|Overall Study||970||
48076770|NCT03284398|100511189|FG000|COMPLETED|Overall Study||2753|Retrospective data collection: all patients under study intervention during the predefined period|
48076771|NCT03284398|100511190|FG001|COMPLETED|Overall Study||970|Retrospective data collection: all patients under study intervention during the predefined period|
48076772|NCT03284398|100511189|FG000|NOT COMPLETED|Overall Study||0||
48076773|NCT03284398|100511190|FG001|NOT COMPLETED|Overall Study||0||
48076774|NCT01687998|100511191|FG000|STARTED|Overall Study||6038||
48076775|NCT01687998|100511192|FG001|STARTED|Overall Study||6054||
48076776|NCT01687998|100511191|FG000|Received at Least One Dose of Study Drug|Overall Study||6036||
48076777|NCT01687998|100511192|FG001|Received at Least One Dose of Study Drug|Overall Study||6052||
48076778|NCT01687998|100511191|FG000|COMPLETED|Overall Study||5926||
48076779|NCT01687998|100511192|FG001|COMPLETED|Overall Study||5934||
48076780|NCT01687998|100511191|FG000|NOT COMPLETED|Overall Study||112||
48076781|NCT01687998|100511192|FG001|NOT COMPLETED|Overall Study||120||
48076782|NCT00299104|100511193|FG000|STARTED|Treatment Period||251||
48076783|NCT00299104|100511194|FG001|STARTED|Treatment Period||252||
48076784|NCT00299104|100511195|FG002|STARTED|Treatment Period||252||
48076785|NCT00299104|100511193|FG000|Safety/ITT: Received Study Drug|Treatment Period||249||
48076786|NCT00299104|100511194|FG001|Safety/ITT: Received Study Drug|Treatment Period||249||
48076787|NCT00299104|100511195|FG002|Safety/ITT: Received Study Drug|Treatment Period||250||
48076788|NCT00299104|100511193|FG000|Completed Week 24|Treatment Period||227||
48076789|NCT00299104|100511194|FG001|Completed Week 24|Treatment Period||240||
48076790|NCT00299104|100511195|FG002|Completed Week 24|Treatment Period||241||
48076791|NCT00299104|100511193|FG000|Completed Week 52|Treatment Period||213||
48076792|NCT00299104|100511194|FG001|Completed Week 52|Treatment Period||227||
48076793|NCT00299104|100511195|FG002|Completed Week 52|Treatment Period||232||
48076794|NCT00299104|100511193|FG000|Completed Week 104|Treatment Period||178||
48076795|NCT00299104|100511194|FG001|Completed Week 104|Treatment Period||213||
48076796|NCT00299104|100511195|FG002|Completed Week 104|Treatment Period||216||
48076797|NCT00299104|100511193|FG000|COMPLETED|Treatment Period||62||
48076798|NCT00299104|100511194|FG001|COMPLETED|Treatment Period||77||
48076799|NCT00299104|100511195|FG002|COMPLETED|Treatment Period||80||
48076800|NCT00299104|100511193|FG000|NOT COMPLETED|Treatment Period||189||
48076801|NCT00299104|100511194|FG001|NOT COMPLETED|Treatment Period||175||
48076802|NCT00299104|100511195|FG002|NOT COMPLETED|Treatment Period||172||
48076803|NCT00299104|100511193|FG000|STARTED|Safety Follow-Up (SFU) Period||184||
48076804|NCT00299104|100511194|FG001|STARTED|Safety Follow-Up (SFU) Period||212||
48076805|NCT00299104|100511195|FG002|STARTED|Safety Follow-Up (SFU) Period||213||
48076806|NCT00299104|100511193|FG000|COMPLETED|Safety Follow-Up (SFU) Period||129||
48076807|NCT00299104|100511194|FG001|COMPLETED|Safety Follow-Up (SFU) Period||171||
48076808|NCT00299104|100511195|FG002|COMPLETED|Safety Follow-Up (SFU) Period||176||
48076809|NCT00299104|100511193|FG000|NOT COMPLETED|Safety Follow-Up (SFU) Period||55||
48076810|NCT00299104|100511194|FG001|NOT COMPLETED|Safety Follow-Up (SFU) Period||41||
48076811|NCT00299104|100511195|FG002|NOT COMPLETED|Safety Follow-Up (SFU) Period||37||
48076812|NCT00299104|100511193|FG000|STARTED|Extended Safety Follow-Up (ESFU) Period||34||
48076813|NCT00299104|100511194|FG001|STARTED|Extended Safety Follow-Up (ESFU) Period||40||
48076814|NCT00299104|100511195|FG002|STARTED|Extended Safety Follow-Up (ESFU) Period||51||
48076815|NCT00299104|100511193|FG000|COMPLETED|Extended Safety Follow-Up (ESFU) Period||29||
48076816|NCT00299104|100511194|FG001|COMPLETED|Extended Safety Follow-Up (ESFU) Period||31||
48076817|NCT00299104|100511195|FG002|COMPLETED|Extended Safety Follow-Up (ESFU) Period||39||
48076818|NCT00299104|100511193|FG000|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||5||
48076819|NCT00299104|100511194|FG001|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||9||
48076820|NCT00299104|100511195|FG002|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||12||
48076821|NCT02494297|100511196|FG000|STARTED|Overall Study||1597|1,698 patients were recruited 101 patients were excluded due to protocol violations.|
48076822|NCT02494297|100511196|FG000|COMPLETED|Overall Study||1597||
48076823|NCT02494297|100511196|FG000|NOT COMPLETED|Overall Study||0||
48076824|NCT01966159|100511197|FG000|STARTED|Overall Study||205||
48076825|NCT01966159|100511198|FG001|STARTED|Overall Study||207||
48076826|NCT01966159|100511197|FG000|COMPLETED|Overall Study||205||
48076827|NCT01966159|100511198|FG001|COMPLETED|Overall Study||207||
48076828|NCT01966159|100511197|FG000|NOT COMPLETED|Overall Study||0||
48076829|NCT01966159|100511198|FG001|NOT COMPLETED|Overall Study||0||
48076830|NCT02801396|100511199|FG000|STARTED|Period 1||17||
48076831|NCT02801396|100511200|FG001|STARTED|Period 1||17||
48076832|NCT02801396|100511201|FG002|STARTED|Period 1||17||
48076833|NCT02801396|100511202|FG003|STARTED|Period 1||16||
48076834|NCT02801396|100511203|FG004|STARTED|Period 1||17||
48076835|NCT02801396|100511204|FG005|STARTED|Period 1||17||
48076836|NCT02801396|100511199|FG000|COMPLETED|Period 1||17||
48076837|NCT02801396|100511200|FG001|COMPLETED|Period 1||17||
48076838|NCT02801396|100511201|FG002|COMPLETED|Period 1||17||
48076839|NCT02801396|100511202|FG003|COMPLETED|Period 1||16||
48076840|NCT02801396|100511203|FG004|COMPLETED|Period 1||16||
48076841|NCT02801396|100511204|FG005|COMPLETED|Period 1||17||
48076842|NCT02801396|100511199|FG000|NOT COMPLETED|Period 1||0||
48076843|NCT02801396|100511200|FG001|NOT COMPLETED|Period 1||0||
48076844|NCT02801396|100511201|FG002|NOT COMPLETED|Period 1||0||
48076845|NCT02801396|100511202|FG003|NOT COMPLETED|Period 1||0||
48076846|NCT02801396|100511203|FG004|NOT COMPLETED|Period 1||1||
48076847|NCT02801396|100511204|FG005|NOT COMPLETED|Period 1||0||
48076848|NCT02801396|100511199|FG000|STARTED|Period 2||17||
48076849|NCT02801396|100511200|FG001|STARTED|Period 2||17||
48076850|NCT02801396|100511201|FG002|STARTED|Period 2||17||
48076851|NCT02801396|100511202|FG003|STARTED|Period 2||16||
48076852|NCT02801396|100511203|FG004|STARTED|Period 2||16||
48076853|NCT02801396|100511204|FG005|STARTED|Period 2||17||
48076854|NCT02801396|100511199|FG000|COMPLETED|Period 2||17||
48076855|NCT02801396|100511200|FG001|COMPLETED|Period 2||17||
48076856|NCT02801396|100511201|FG002|COMPLETED|Period 2||17||
48076857|NCT02801396|100511202|FG003|COMPLETED|Period 2||16||
48076858|NCT02801396|100511203|FG004|COMPLETED|Period 2||16||
48076859|NCT02801396|100511204|FG005|COMPLETED|Period 2||17||
48076860|NCT02801396|100511199|FG000|NOT COMPLETED|Period 2||0||
48076861|NCT02801396|100511200|FG001|NOT COMPLETED|Period 2||0||
48076862|NCT02801396|100511201|FG002|NOT COMPLETED|Period 2||0||
48076863|NCT02801396|100511202|FG003|NOT COMPLETED|Period 2||0||
48076864|NCT02801396|100511203|FG004|NOT COMPLETED|Period 2||0||
48076865|NCT02801396|100511204|FG005|NOT COMPLETED|Period 2||0||
48076866|NCT02801396|100511199|FG000|STARTED|Period 3||17||
48076867|NCT02801396|100511200|FG001|STARTED|Period 3||17||
48076868|NCT02801396|100511201|FG002|STARTED|Period 3||17||
48076869|NCT02801396|100511202|FG003|STARTED|Period 3||16||
48076870|NCT02801396|100511203|FG004|STARTED|Period 3||16||
48076871|NCT02801396|100511204|FG005|STARTED|Period 3||17||
48076872|NCT02801396|100511199|FG000|COMPLETED|Period 3||17||
48076873|NCT02801396|100511200|FG001|COMPLETED|Period 3||17||
48076874|NCT02801396|100511201|FG002|COMPLETED|Period 3||17||
48076875|NCT02801396|100511202|FG003|COMPLETED|Period 3||16||
48076876|NCT02801396|100511203|FG004|COMPLETED|Period 3||16||
48076877|NCT02801396|100511204|FG005|COMPLETED|Period 3||17||
48076878|NCT02801396|100511199|FG000|NOT COMPLETED|Period 3||0||
48076879|NCT02801396|100511200|FG001|NOT COMPLETED|Period 3||0||
48076880|NCT02801396|100511201|FG002|NOT COMPLETED|Period 3||0||
48076881|NCT02801396|100511202|FG003|NOT COMPLETED|Period 3||0||
48076882|NCT02801396|100511203|FG004|NOT COMPLETED|Period 3||0||
48076883|NCT02801396|100511204|FG005|NOT COMPLETED|Period 3||0||
48076884|NCT01947582|100511205|FG000|STARTED|Overall Study||2||
48076885|NCT01947582|100511205|FG000|COMPLETED|Overall Study||1||
48076886|NCT01947582|100511205|FG000|NOT COMPLETED|Overall Study||1||
48076887|NCT02555683|100511206|FG000|STARTED|Overall Study||301||
48076888|NCT02555683|100511207|FG001|STARTED|Overall Study||295||
48076889|NCT02555683|100511208|FG002|STARTED|Overall Study||298||
48076890|NCT02555683|100511206|FG000|FAS/SAF: High Eosinophil Subpopulation|Overall Study||200|Full analysis set/safety set. All patients who received study drug and had high eosinophils count|
48076891|NCT02555683|100511207|FG001|FAS/SAF: High Eosinophil Subpopulation|Overall Study||201|Full analysis set/safety set. All patients who received study drug and had high eosinophils count|
48076892|NCT02555683|100511208|FG002|FAS/SAF: High Eosinophil Subpopulation|Overall Study||201|Full analysis set/safety set. All patients who received study drug and had high eosinophils count|
48076893|NCT02555683|100511206|FG000|FAS/SAF: Overall Population|Overall Study||299|Full analysis set/safety set. All patients who received study drug|
48076894|NCT02555683|100511207|FG001|FAS/SAF: Overall Population|Overall Study||293|Full analysis set/safety set. All patients who received study drug|
48076895|NCT02555683|100511208|FG002|FAS/SAF: Overall Population|Overall Study||298|Full analysis set/safety set. All patients who received study drug|
48076896|NCT02555683|100511206|FG000|COMPLETED|Overall Study||282||
48076897|NCT02555683|100511207|FG001|COMPLETED|Overall Study||278||
48076898|NCT02555683|100511208|FG002|COMPLETED|Overall Study||269||
48076899|NCT02555683|100511206|FG000|NOT COMPLETED|Overall Study||19||
48076900|NCT02555683|100511207|FG001|NOT COMPLETED|Overall Study||17||
48076901|NCT02555683|100511208|FG002|NOT COMPLETED|Overall Study||29||
48076902|NCT00039130|100511209|FG000|STARTED|Overall Study||105||
48076903|NCT00039130|100511209|FG000|COMPLETED|Overall Study||75||
48076904|NCT00039130|100511209|FG000|NOT COMPLETED|Overall Study||30||
48076905|NCT03791489|100511210|FG000|STARTED|30 Days||30||
48076906|NCT03791489|100511210|FG000|COMPLETED|30 Days||30||
48076907|NCT03791489|100511210|FG000|NOT COMPLETED|30 Days||0||
48076908|NCT03791489|100511210|FG000|STARTED|90 Days (Primary Endpoint)||30||
48076909|NCT03791489|100511210|FG000|COMPLETED|90 Days (Primary Endpoint)||30||
48076910|NCT03791489|100511210|FG000|NOT COMPLETED|90 Days (Primary Endpoint)||0||
48076911|NCT00126191|100511211|FG000|STARTED|Overall Study||2||
48076912|NCT00126191|100511212|FG001|STARTED|Overall Study||8||
48076913|NCT00126191|100511211|FG000|COMPLETED|Overall Study||2||
48076914|NCT00126191|100511212|FG001|COMPLETED|Overall Study||6||
48076915|NCT00126191|100511211|FG000|NOT COMPLETED|Overall Study||0||
48076916|NCT00126191|100511212|FG001|NOT COMPLETED|Overall Study||2||
48076917|NCT00827502|100511213|FG000|STARTED|Overall Study||421||
48076918|NCT00827502|100511213|FG000|Received Treatment (Number Treated)|Overall Study||410||
48076919|NCT00827502|100511213|FG000|COMPLETED|Overall Study||400||
48076920|NCT00827502|100511213|FG000|NOT COMPLETED|Overall Study||21||
48076921|NCT00520936|100511214|FG000|STARTED|Overall Study||10||
48076922|NCT00520936|100511215|FG001|STARTED|Overall Study||11||
48076923|NCT00520936|100511216|FG002|STARTED|Overall Study||9||
48076924|NCT00520936|100511217|FG003|STARTED|Overall Study||5||
48076925|NCT00520936|100511218|FG004|STARTED|Overall Study||6||
48076926|NCT00520936|100511219|FG005|STARTED|Overall Study||10||
48076927|NCT00520936|100511220|FG006|STARTED|Overall Study||11||
48076928|NCT00520936|100511221|FG007|STARTED|Overall Study||10||
48076929|NCT00520936|100511214|FG000|COMPLETED|Overall Study||10||
48076930|NCT00520936|100511215|FG001|COMPLETED|Overall Study||7||
48076931|NCT00520936|100511216|FG002|COMPLETED|Overall Study||7||
48076932|NCT00520936|100511217|FG003|COMPLETED|Overall Study||5||
48076933|NCT00520936|100511218|FG004|COMPLETED|Overall Study||5||
48076934|NCT00520936|100511219|FG005|COMPLETED|Overall Study||10||
48076935|NCT00520936|100511220|FG006|COMPLETED|Overall Study||7||
48076936|NCT00520936|100511221|FG007|COMPLETED|Overall Study||9||
48076937|NCT00520936|100511214|FG000|NOT COMPLETED|Overall Study||0||
48076938|NCT00520936|100511215|FG001|NOT COMPLETED|Overall Study||4||
48076939|NCT00520936|100511216|FG002|NOT COMPLETED|Overall Study||2||
48076940|NCT00520936|100511217|FG003|NOT COMPLETED|Overall Study||0||
48076941|NCT00520936|100511218|FG004|NOT COMPLETED|Overall Study||1||
48076942|NCT00520936|100511219|FG005|NOT COMPLETED|Overall Study||0||
48076943|NCT00520936|100511220|FG006|NOT COMPLETED|Overall Study||4||
48076944|NCT00520936|100511221|FG007|NOT COMPLETED|Overall Study||1||
48076945|NCT00289991|100511222|FG000|STARTED|Overall Study||234||
48076946|NCT00289991|100511223|FG001|STARTED|Overall Study||255||
48076947|NCT00289991|100511222|FG000|COMPLETED|Overall Study||176||
48076948|NCT00289991|100511223|FG001|COMPLETED|Overall Study||175||
48076949|NCT00289991|100511222|FG000|NOT COMPLETED|Overall Study||58||
48076950|NCT00289991|100511223|FG001|NOT COMPLETED|Overall Study||80||
48076951|NCT03680105|100511224|FG000|STARTED|Overall Study||8||
48076952|NCT03680105|100511225|FG001|STARTED|Overall Study||8||
48076953|NCT03680105|100511226|FG002|STARTED|Overall Study||8||
48076954|NCT03680105|100511227|FG003|STARTED|Overall Study||8||
48076955|NCT03680105|100511228|FG004|STARTED|Overall Study||8||
48076956|NCT03680105|100511229|FG005|STARTED|Overall Study||12||
48076957|NCT03680105|100511230|FG006|STARTED|Overall Study||8||
48076958|NCT03680105|100511231|FG007|STARTED|Overall Study||8||
48076959|NCT03680105|100511232|FG008|STARTED|Overall Study||8||
48076960|NCT03680105|100511224|FG000|COMPLETED|Overall Study||8||
48076961|NCT03680105|100511225|FG001|COMPLETED|Overall Study||8||
48076962|NCT03680105|100511226|FG002|COMPLETED|Overall Study||8||
48076963|NCT03680105|100511227|FG003|COMPLETED|Overall Study||8||
48076964|NCT03680105|100511228|FG004|COMPLETED|Overall Study||8||
48076965|NCT03680105|100511229|FG005|COMPLETED|Overall Study||12||
48076966|NCT03680105|100511230|FG006|COMPLETED|Overall Study||8||
48076967|NCT03680105|100511231|FG007|COMPLETED|Overall Study||8||
48076968|NCT03680105|100511232|FG008|COMPLETED|Overall Study||8||
48076969|NCT03680105|100511224|FG000|NOT COMPLETED|Overall Study||0||
48076970|NCT03680105|100511225|FG001|NOT COMPLETED|Overall Study||0||
48076971|NCT03680105|100511226|FG002|NOT COMPLETED|Overall Study||0||
48076972|NCT03680105|100511227|FG003|NOT COMPLETED|Overall Study||0||
48076973|NCT03680105|100511228|FG004|NOT COMPLETED|Overall Study||0||
48076974|NCT03680105|100511229|FG005|NOT COMPLETED|Overall Study||0||
48076975|NCT03680105|100511230|FG006|NOT COMPLETED|Overall Study||0||
48076976|NCT03680105|100511231|FG007|NOT COMPLETED|Overall Study||0||
48076977|NCT03680105|100511232|FG008|NOT COMPLETED|Overall Study||0||
48076978|NCT02165215|100511233|FG000|STARTED|Induction Phase||359||
48076979|NCT02165215|100511234|FG001|STARTED|Induction Phase||0||
48076980|NCT02165215|100511235|FG002|STARTED|Induction Phase||0||
48076981|NCT02165215|100511233|FG000|Dosed|Induction Phase||358||
48076982|NCT02165215|100511234|FG001|Dosed|Induction Phase||0||
48076983|NCT02165215|100511235|FG002|Dosed|Induction Phase||0||
48076984|NCT02165215|100511233|FG000|COMPLETED|Induction Phase||336||
48076985|NCT02165215|100511234|FG001|COMPLETED|Induction Phase||0||
48076986|NCT02165215|100511235|FG002|COMPLETED|Induction Phase||0||
48076987|NCT02165215|100511233|FG000|NOT COMPLETED|Induction Phase||23||
48076988|NCT02165215|100511234|FG001|NOT COMPLETED|Induction Phase||0||
48076989|NCT02165215|100511235|FG002|NOT COMPLETED|Induction Phase||0||
48076990|NCT02165215|100511233|FG000|STARTED|Maintenance Phase||0||
48076991|NCT02165215|100511234|FG001|STARTED|Maintenance Phase||108||
48076992|NCT02165215|100511235|FG002|STARTED|Maintenance Phase||106||
48076993|NCT02165215|100511233|FG000|Dosed|Maintenance Phase||0||
48076994|NCT02165215|100511234|FG001|Dosed|Maintenance Phase||108||
48076995|NCT02165215|100511235|FG002|Dosed|Maintenance Phase||102||
48076996|NCT02165215|100511233|FG000|COMPLETED|Maintenance Phase||0||
48076997|NCT02165215|100511234|FG001|COMPLETED|Maintenance Phase||96||
48076998|NCT02165215|100511235|FG002|COMPLETED|Maintenance Phase||101||
48076999|NCT02165215|100511233|FG000|NOT COMPLETED|Maintenance Phase||0||
48077000|NCT02165215|100511234|FG001|NOT COMPLETED|Maintenance Phase||12||
48077001|NCT02165215|100511235|FG002|NOT COMPLETED|Maintenance Phase||5||
48077002|NCT03019575|100511236|FG000|STARTED|Overall Study||17||
48077003|NCT03019575|100511236|FG000|COMPLETED|Overall Study||17||
48077004|NCT03019575|100511236|FG000|NOT COMPLETED|Overall Study||0||
48077005|NCT01382212|100511237|FG000|STARTED|Overall Study||13||
48077006|NCT01382212|100511237|FG000|COMPLETED|Overall Study||11||
48077007|NCT01382212|100511237|FG000|NOT COMPLETED|Overall Study||2||
48077008|NCT01372462|100511238|FG000|STARTED|NIOV - Room Air||15||
48077009|NCT01372462|100511238|FG000|COMPLETED|NIOV - Room Air||15||
48077010|NCT01372462|100511238|FG000|NOT COMPLETED|NIOV - Room Air||0||
48077011|NCT01372462|100511238|FG000|STARTED|NIOV - Oxygen||15||
48077012|NCT01372462|100511238|FG000|COMPLETED|NIOV - Oxygen||15||
48077013|NCT01372462|100511238|FG000|NOT COMPLETED|NIOV - Oxygen||0||
48077014|NCT01372462|100511238|FG000|STARTED|Oxygen Nasal Cannula||15||
48077015|NCT01372462|100511238|FG000|COMPLETED|Oxygen Nasal Cannula||15||
48077016|NCT01372462|100511238|FG000|NOT COMPLETED|Oxygen Nasal Cannula||0||
48077017|NCT01372462|100511238|FG000|STARTED|No Treatment Control||15||
48077018|NCT01372462|100511238|FG000|COMPLETED|No Treatment Control||15||
48077019|NCT01372462|100511238|FG000|NOT COMPLETED|No Treatment Control||0||
48077020|NCT00444912|100511239|FG000|STARTED|Overall Study||15||
48227219|NCT03455985|100877943|FG000|STARTED|Overall Study||82||
48077021|NCT00444912|100511240|FG001|STARTED|Overall Study||15||
48077022|NCT00444912|100511239|FG000|Received Plerixafor|Overall Study||15||
48077023|NCT00444912|100511240|FG001|Received Plerixafor|Overall Study||15||
48077024|NCT00444912|100511239|FG000|Received Transplant|Overall Study||14||
48077025|NCT00444912|100511240|FG001|Received Transplant|Overall Study||14||
48077026|NCT00444912|100511239|FG000|COMPLETED|Overall Study||12||
48077027|NCT00444912|100511240|FG001|COMPLETED|Overall Study||13||
48077028|NCT00444912|100511239|FG000|NOT COMPLETED|Overall Study||3||
48077029|NCT00444912|100511240|FG001|NOT COMPLETED|Overall Study||2||
48077030|NCT04950998|100511241|FG000|STARTED|Overall Study||15||
48077031|NCT04950998|100511242|FG001|STARTED|Overall Study||6||
48077032|NCT04950998|100511241|FG000|COMPLETED|Overall Study||15||
48077033|NCT04950998|100511242|FG001|COMPLETED|Overall Study||6||
48227220|NCT03455985|100877944|FG001|STARTED|Overall Study||76||
48077034|NCT04950998|100511241|FG000|NOT COMPLETED|Overall Study||0||
48077035|NCT04950998|100511242|FG001|NOT COMPLETED|Overall Study||0||
48077036|NCT01600638|100511243|FG000|STARTED|Overall Study||25||
48077037|NCT01600638|100511243|FG000|COMPLETED|Overall Study||25||
48077038|NCT01600638|100511243|FG000|NOT COMPLETED|Overall Study||0||
48227221|NCT03455985|100877943|FG000|COMPLETED|Overall Study||44||
48077039|NCT00701675|100511244|FG000|STARTED|Overall Study||14||
48077040|NCT00701675|100511245|FG001|STARTED|Overall Study||14||
48077041|NCT00701675|100511246|FG002|STARTED|Overall Study||14||
48077042|NCT00701675|100511244|FG000|COMPLETED|Overall Study||10||
48077043|NCT00701675|100511245|FG001|COMPLETED|Overall Study||6||
48077044|NCT00701675|100511246|FG002|COMPLETED|Overall Study||7||
48077045|NCT00701675|100511244|FG000|NOT COMPLETED|Overall Study||4||
48077046|NCT00701675|100511245|FG001|NOT COMPLETED|Overall Study||8||
48077047|NCT00701675|100511246|FG002|NOT COMPLETED|Overall Study||7||
48077048|NCT02197247|100511247|FG000|STARTED|Part A: Day 1-28 (AZD9291 Alone)||41||
48077049|NCT02197247|100511247|FG000|COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||41||
48077050|NCT02197247|100511247|FG000|NOT COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||0||
48077051|NCT02197247|100511247|FG000|STARTED|Part A: Day 29-49 (AZD9291+Rifampicin)||41||
48077052|NCT02197247|100511247|FG000|COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||37||
48077053|NCT02197247|100511247|FG000|NOT COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||4||
48077054|NCT02197247|100511247|FG000|STARTED|Part A: Day 50-77 (AZD9291 Alone)||37||
48077055|NCT02197247|100511247|FG000|COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||32||
48077056|NCT02197247|100511247|FG000|NOT COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||5||
48077057|NCT02197247|100511247|FG000|STARTED|Part B: Day 78 to End Part B (AZD9291)||34||
48077058|NCT02197247|100511247|FG000|COMPLETED|Part B: Day 78 to End Part B (AZD9291)||19||
48077059|NCT02197247|100511247|FG000|NOT COMPLETED|Part B: Day 78 to End Part B (AZD9291)||15||
48077060|NCT03704467|100511248|FG000|STARTED|Overall Study||3||
48077061|NCT03704467|100511248|FG000|COMPLETED|Overall Study||3||
48077062|NCT03704467|100511248|FG000|NOT COMPLETED|Overall Study||0||
48077063|NCT02439138|100511249|FG000|STARTED|Overall Study||5||
48077064|NCT02439138|100511249|FG000|COMPLETED|Overall Study||2||
48077065|NCT02439138|100511249|FG000|NOT COMPLETED|Overall Study||3||
48077066|NCT03676010|100511250|FG000|STARTED|Overall Study||32||
48077067|NCT03676010|100511251|FG001|STARTED|Overall Study||35||
48077068|NCT03676010|100511252|FG002|STARTED|Overall Study||33||
48077069|NCT03676010|100511253|FG003|STARTED|Overall Study||36||
48077070|NCT03676010|100511254|FG004|STARTED|Overall Study||24||
48077071|NCT03676010|100511255|FG005|STARTED|Overall Study||36||
48077072|NCT03676010|100511250|FG000|COMPLETED|Overall Study||28||
48077073|NCT03676010|100511251|FG001|COMPLETED|Overall Study||31||
48077074|NCT03676010|100511252|FG002|COMPLETED|Overall Study||30||
48077075|NCT03676010|100511253|FG003|COMPLETED|Overall Study||31||
48077076|NCT03676010|100511254|FG004|COMPLETED|Overall Study||24||
48077077|NCT03676010|100511255|FG005|COMPLETED|Overall Study||24||
48077078|NCT03676010|100511250|FG000|NOT COMPLETED|Overall Study||4||
48077079|NCT03676010|100511251|FG001|NOT COMPLETED|Overall Study||4||
48077080|NCT03676010|100511252|FG002|NOT COMPLETED|Overall Study||3||
48077081|NCT03676010|100511253|FG003|NOT COMPLETED|Overall Study||5||
48077082|NCT03676010|100511254|FG004|NOT COMPLETED|Overall Study||0||
48077083|NCT03676010|100511255|FG005|NOT COMPLETED|Overall Study||12||
48077084|NCT00407797|100511256|FG000|STARTED|Overall Study||136||
48077085|NCT00407797|100511256|FG000|Full Analysis Set|Overall Study||135||
48077086|NCT00407797|100511256|FG000|COMPLETED|Overall Study||118||
48077087|NCT00407797|100511256|FG000|NOT COMPLETED|Overall Study||18||
48077088|NCT01774604|100511257|FG000|STARTED|Overall Study||223||
48077089|NCT01774604|100511258|FG001|STARTED|Overall Study||226||
48077090|NCT01774604|100511257|FG000|COMPLETED|Overall Study||223||
48077091|NCT01774604|100511258|FG001|COMPLETED|Overall Study||226||
48077092|NCT01774604|100511257|FG000|NOT COMPLETED|Overall Study||0||
48077093|NCT01774604|100511258|FG001|NOT COMPLETED|Overall Study||0||
48077094|NCT01746745|100511259|FG000|STARTED|Overall Study||6||
48077095|NCT01746745|100511259|FG000|Received Study Drug|Overall Study||6||
48077096|NCT01746745|100511259|FG000|COMPLETED|Overall Study||6||
48077097|NCT01746745|100511259|FG000|NOT COMPLETED|Overall Study||0||
48077098|NCT01257087|100511260|FG000|STARTED|Overall Study||18||
48077099|NCT01257087|100511261|FG001|STARTED|Overall Study||17||
48077100|NCT01257087|100511260|FG000|COMPLETED|Overall Study||18||
48077101|NCT01257087|100511261|FG001|COMPLETED|Overall Study||17||
48077102|NCT01257087|100511260|FG000|NOT COMPLETED|Overall Study||0||
48077103|NCT01257087|100511261|FG001|NOT COMPLETED|Overall Study||0||
48077104|NCT05091047|100511262|FG000|STARTED|Overall Study||8||
48077105|NCT05091047|100511262|FG000|COMPLETED|Overall Study||8||
48077106|NCT05091047|100511262|FG000|NOT COMPLETED|Overall Study||0||
48077107|NCT00843024|100511263|FG000|STARTED|Single-blind Placebo Run-In Phase||408||
48077108|NCT00843024|100511264|FG001|STARTED|Single-blind Placebo Run-In Phase||457||
48077109|NCT00843024|100511265|FG002|STARTED|Single-blind Placebo Run-In Phase||0||
48077110|NCT00843024|100511266|FG003|STARTED|Single-blind Placebo Run-In Phase||0||
48077111|NCT00843024|100511267|FG004|STARTED|Single-blind Placebo Run-In Phase||0||
48077112|NCT00843024|100511268|FG005|STARTED|Single-blind Placebo Run-In Phase||0||
48077113|NCT00843024|100511263|FG000|COMPLETED|Single-blind Placebo Run-In Phase||268||
48077114|NCT00843024|100511264|FG001|COMPLETED|Single-blind Placebo Run-In Phase||321||
48077115|NCT00843024|100511265|FG002|COMPLETED|Single-blind Placebo Run-In Phase||0||
48077116|NCT00843024|100511266|FG003|COMPLETED|Single-blind Placebo Run-In Phase||0||
48077117|NCT00843024|100511267|FG004|COMPLETED|Single-blind Placebo Run-In Phase||0||
48077118|NCT00843024|100511268|FG005|COMPLETED|Single-blind Placebo Run-In Phase||0||
48077119|NCT00843024|100511263|FG000|NOT COMPLETED|Single-blind Placebo Run-In Phase||140||
48077120|NCT00843024|100511264|FG001|NOT COMPLETED|Single-blind Placebo Run-In Phase||136||
48077121|NCT00843024|100511265|FG002|NOT COMPLETED|Single-blind Placebo Run-In Phase||0||
48077122|NCT00843024|100511266|FG003|NOT COMPLETED|Single-blind Placebo Run-In Phase||0||
48077123|NCT00843024|100511267|FG004|NOT COMPLETED|Single-blind Placebo Run-In Phase||0||
48077124|NCT00843024|100511268|FG005|NOT COMPLETED|Single-blind Placebo Run-In Phase||0||
48077125|NCT00843024|100511263|FG000|STARTED|Double-blind Treatment Phase||0||
48077126|NCT00843024|100511264|FG001|STARTED|Double-blind Treatment Phase||0||
48077127|NCT00843024|100511265|FG002|STARTED|Double-blind Treatment Phase||176||
48077128|NCT00843024|100511266|FG003|STARTED|Double-blind Treatment Phase||119||
48077129|NCT00843024|100511267|FG004|STARTED|Double-blind Treatment Phase||117||
48227222|NCT03455985|100877944|FG001|COMPLETED|Overall Study||45||
48077130|NCT00843024|100511268|FG005|STARTED|Double-blind Treatment Phase||177||
48077131|NCT00843024|100511263|FG000|COMPLETED|Double-blind Treatment Phase||0||
48077132|NCT00843024|100511264|FG001|COMPLETED|Double-blind Treatment Phase||0||
48077133|NCT00843024|100511265|FG002|COMPLETED|Double-blind Treatment Phase||145||
48077134|NCT00843024|100511266|FG003|COMPLETED|Double-blind Treatment Phase||96||
48077135|NCT00843024|100511267|FG004|COMPLETED|Double-blind Treatment Phase||97||
48077136|NCT00843024|100511268|FG005|COMPLETED|Double-blind Treatment Phase||152||
48077137|NCT00843024|100511263|FG000|NOT COMPLETED|Double-blind Treatment Phase||0||
48077138|NCT00843024|100511264|FG001|NOT COMPLETED|Double-blind Treatment Phase||0||
48077139|NCT00843024|100511265|FG002|NOT COMPLETED|Double-blind Treatment Phase||31||
48077140|NCT00843024|100511266|FG003|NOT COMPLETED|Double-blind Treatment Phase||23||
48077141|NCT00843024|100511267|FG004|NOT COMPLETED|Double-blind Treatment Phase||20||
48077142|NCT00843024|100511268|FG005|NOT COMPLETED|Double-blind Treatment Phase||25||
48077143|NCT00779285|100511269|FG000|STARTED|Overall Study||1||
48077144|NCT00779285|100511269|FG000|COMPLETED|Overall Study||1||
48077145|NCT00779285|100511269|FG000|NOT COMPLETED|Overall Study||0||
48077146|NCT01125605|100511270|FG000|STARTED|Overall Study||325||
48077147|NCT01125605|100511270|FG000|Safety|Overall Study||326||
48077148|NCT01125605|100511270|FG000|COMPLETED|Overall Study||325||
48077149|NCT01125605|100511270|FG000|NOT COMPLETED|Overall Study||0||
48077150|NCT00541593|100511271|FG000|STARTED|Overall Study||5||
48077151|NCT00541593|100511271|FG000|COMPLETED|Overall Study||5||
48077152|NCT00541593|100511271|FG000|NOT COMPLETED|Overall Study||0||
48077153|NCT02469298|100511272|FG000|STARTED|Overall Study||15||
48077154|NCT02469298|100511273|FG001|STARTED|Overall Study||7||
48077155|NCT02469298|100511274|FG002|STARTED|Overall Study||16||
48077156|NCT02469298|100511275|FG003|STARTED|Overall Study||7||
48077157|NCT02469298|100511272|FG000|COMPLETED|Overall Study||14||
48077158|NCT02469298|100511273|FG001|COMPLETED|Overall Study||6||
48077159|NCT02469298|100511274|FG002|COMPLETED|Overall Study||14||
48077160|NCT02469298|100511275|FG003|COMPLETED|Overall Study||5||
48077161|NCT02469298|100511272|FG000|NOT COMPLETED|Overall Study||1||
48077162|NCT02469298|100511273|FG001|NOT COMPLETED|Overall Study||1||
48077163|NCT02469298|100511274|FG002|NOT COMPLETED|Overall Study||2||
48077164|NCT02469298|100511275|FG003|NOT COMPLETED|Overall Study||2||
48077165|NCT02083783|100511276|FG000|STARTED|Overall Study||52|Open-Label Optimization|
48077166|NCT02083783|100511277|FG001|STARTED|Overall Study||48|Open-Label Optimization|
48077167|NCT02083783|100511276|FG000|COMPLETED|Overall Study||51||
48077168|NCT02083783|100511277|FG001|COMPLETED|Overall Study||48||
48077169|NCT02083783|100511276|FG000|NOT COMPLETED|Overall Study||1||
48077170|NCT02083783|100511277|FG001|NOT COMPLETED|Overall Study||0||
48077171|NCT03200860|100511278|FG000|STARTED|Overall Study||41||
48077172|NCT03200860|100511279|FG001|STARTED|Overall Study||39||
48077173|NCT03200860|100511278|FG000|COMPLETED|Overall Study||40||
48077174|NCT03200860|100511279|FG001|COMPLETED|Overall Study||39||
48077175|NCT03200860|100511278|FG000|NOT COMPLETED|Overall Study||1||
48077176|NCT03200860|100511279|FG001|NOT COMPLETED|Overall Study||0||
48077177|NCT03050554|100511280|FG000|STARTED|Overall Study||2||
48077178|NCT03050554|100511280|FG000|COMPLETED|Overall Study||2||
48077179|NCT03050554|100511280|FG000|NOT COMPLETED|Overall Study||0||
48077180|NCT00418015|100511281|FG000|STARTED|Overall Study||144||
48077181|NCT00418015|100511282|FG001|STARTED|Overall Study||46||
48077182|NCT00418015|100511283|FG002|STARTED|Overall Study||78||
48077183|NCT00418015|100511284|FG003|STARTED|Overall Study||25||
48077184|NCT00418015|100511281|FG000|COMPLETED|Overall Study||144||
48077185|NCT00418015|100511282|FG001|COMPLETED|Overall Study||46||
48077186|NCT00418015|100511283|FG002|COMPLETED|Overall Study||78||
48077187|NCT00418015|100511284|FG003|COMPLETED|Overall Study||25||
48077188|NCT00418015|100511281|FG000|NOT COMPLETED|Overall Study||0||
48077189|NCT00418015|100511282|FG001|NOT COMPLETED|Overall Study||0||
48077190|NCT00418015|100511283|FG002|NOT COMPLETED|Overall Study||0||
48077191|NCT00418015|100511284|FG003|NOT COMPLETED|Overall Study||0||
48077192|NCT00621153|100511285|FG000|STARTED|Overall Study||117||
48077193|NCT00621153|100511286|FG001|STARTED|Overall Study||116||
48077194|NCT00621153|100511285|FG000|Discontinued|Overall Study||20||
48077195|NCT00621153|100511286|FG001|Discontinued|Overall Study||15||
48077196|NCT00621153|100511285|FG000|COMPLETED|Overall Study||97||
48077197|NCT00621153|100511286|FG001|COMPLETED|Overall Study||101||
48077198|NCT00621153|100511285|FG000|NOT COMPLETED|Overall Study||20||
48077199|NCT00621153|100511286|FG001|NOT COMPLETED|Overall Study||15||
48077200|NCT00119106|100511287|FG000|STARTED|Overall Study||1204||
48077201|NCT00119106|100511288|FG001|STARTED|Overall Study||1209||
48077202|NCT00119106|100511287|FG000|COMPLETED|Overall Study||1025||
48077203|NCT00119106|100511288|FG001|COMPLETED|Overall Study||1031||
48077204|NCT00119106|100511287|FG000|NOT COMPLETED|Overall Study||179||
48077205|NCT00119106|100511288|FG001|NOT COMPLETED|Overall Study||178||
48077206|NCT03119831|100511289|FG000|STARTED|Overall Study||14||
48077207|NCT03119831|100511290|FG001|STARTED|Overall Study||14||
48077208|NCT03119831|100511291|FG002|STARTED|Overall Study||14||
48077209|NCT03119831|100511289|FG000|COMPLETED|Overall Study||14||
48077210|NCT03119831|100511290|FG001|COMPLETED|Overall Study||14||
48077211|NCT03119831|100511291|FG002|COMPLETED|Overall Study||14||
48077212|NCT03119831|100511289|FG000|NOT COMPLETED|Overall Study||0||
48077213|NCT03119831|100511290|FG001|NOT COMPLETED|Overall Study||0||
48077214|NCT03119831|100511291|FG002|NOT COMPLETED|Overall Study||0||
48077215|NCT03208244|100511292|FG000|STARTED|Overall Study||33||
48077216|NCT03208244|100511292|FG000|COMPLETED|Overall Study||32||
48077217|NCT03208244|100511292|FG000|NOT COMPLETED|Overall Study||1||
48077218|NCT00602797|100511293|FG000|STARTED|Overall Study||20||
48077219|NCT00602797|100511293|FG000|COMPLETED|Overall Study||19||
48077220|NCT00602797|100511293|FG000|NOT COMPLETED|Overall Study||1||
48077221|NCT00456014|100511294|FG000|STARTED|SSRI Phase||37||
48077222|NCT00456014|100511294|FG000|COMPLETED|SSRI Phase||28||
48077223|NCT00456014|100511294|FG000|NOT COMPLETED|SSRI Phase||9||
48077224|NCT00456014|100511294|FG000|STARTED|Tricyclic Phase||4||
48077225|NCT00456014|100511294|FG000|COMPLETED|Tricyclic Phase||1||
48077226|NCT00456014|100511294|FG000|NOT COMPLETED|Tricyclic Phase||3||
48077227|NCT01152697|100511295|FG000|STARTED|Overall Study||30||
48077228|NCT01152697|100511295|FG000|COMPLETED|Overall Study||11||
48077229|NCT01152697|100511295|FG000|NOT COMPLETED|Overall Study||19||
48077230|NCT00217620|100511296|FG000|STARTED|Overall Study||51||
48077231|NCT00217620|100511296|FG000|Eligible|Overall Study||38||
48077232|NCT00217620|100511296|FG000|Eligible and Began Protocol Therapy|Overall Study||37||
48077233|NCT00217620|100511296|FG000|COMPLETED|Overall Study||0||
48227223|NCT03455985|100877943|FG000|NOT COMPLETED|Overall Study||38||
48227224|NCT03455985|100877944|FG001|NOT COMPLETED|Overall Study||31||
48077234|NCT00217620|100511296|FG000|NOT COMPLETED|Overall Study||51||
48077235|NCT01644565|100511297|FG000|STARTED|Overall Study||5||
48077236|NCT01644565|100511298|FG001|STARTED|Overall Study||5||
48077237|NCT01644565|100511299|FG002|STARTED|Overall Study||5||
48077238|NCT01644565|100511300|FG003|STARTED|Overall Study||5||
48077239|NCT01644565|100511301|FG004|STARTED|Overall Study||5||
48077240|NCT01644565|100511302|FG005|STARTED|Overall Study||7||
48077241|NCT01644565|100511303|FG006|STARTED|Overall Study||7||
48077242|NCT01644565|100511304|FG007|STARTED|Overall Study||10||
48077243|NCT01644565|100511305|FG008|STARTED|Overall Study||8||
48077244|NCT01644565|100511297|FG000|COMPLETED|Overall Study||4||
48077245|NCT01644565|100511298|FG001|COMPLETED|Overall Study||5||
48077246|NCT01644565|100511299|FG002|COMPLETED|Overall Study||5||
48077247|NCT01644565|100511300|FG003|COMPLETED|Overall Study||4||
48077248|NCT01644565|100511301|FG004|COMPLETED|Overall Study||4||
48077249|NCT01644565|100511302|FG005|COMPLETED|Overall Study||7||
48077250|NCT01644565|100511303|FG006|COMPLETED|Overall Study||7||
48077251|NCT01644565|100511304|FG007|COMPLETED|Overall Study||8||
48077252|NCT01644565|100511305|FG008|COMPLETED|Overall Study||7||
48077253|NCT01644565|100511297|FG000|NOT COMPLETED|Overall Study||1||
48077254|NCT01644565|100511298|FG001|NOT COMPLETED|Overall Study||0||
48077255|NCT01644565|100511299|FG002|NOT COMPLETED|Overall Study||0||
48077256|NCT01644565|100511300|FG003|NOT COMPLETED|Overall Study||1||
48077257|NCT01644565|100511301|FG004|NOT COMPLETED|Overall Study||1||
48077258|NCT01644565|100511302|FG005|NOT COMPLETED|Overall Study||0||
48077259|NCT01644565|100511303|FG006|NOT COMPLETED|Overall Study||0||
48077260|NCT01644565|100511304|FG007|NOT COMPLETED|Overall Study||2||
48077261|NCT01644565|100511305|FG008|NOT COMPLETED|Overall Study||1||
48077262|NCT01866293|100511306|FG000|STARTED|Overall Study||11||
48077263|NCT01866293|100511306|FG000|COMPLETED|Overall Study||9||
48077264|NCT01866293|100511306|FG000|NOT COMPLETED|Overall Study||2||
48077265|NCT00345839|100511307|FG000|STARTED|Overall Study||1948||
48077266|NCT00345839|100511308|FG001|STARTED|Overall Study||1935||
48077267|NCT00345839|100511307|FG000|COMPLETED|Overall Study||1799||
48077268|NCT00345839|100511308|FG001|COMPLETED|Overall Study||1776||
48077269|NCT00345839|100511307|FG000|NOT COMPLETED|Overall Study||149||
48077270|NCT00345839|100511308|FG001|NOT COMPLETED|Overall Study||159||
48077271|NCT00279305|100511309|FG000|STARTED|Overall Study||57||
48077272|NCT00279305|100511310|FG001|STARTED|Overall Study||30||
48077273|NCT00279305|100511309|FG000|COMPLETED|Overall Study||49||
48077274|NCT00279305|100511310|FG001|COMPLETED|Overall Study||29||
48077275|NCT00279305|100511309|FG000|NOT COMPLETED|Overall Study||8||
48077276|NCT00279305|100511310|FG001|NOT COMPLETED|Overall Study||1||
48077277|NCT01081678|100511311|FG000|STARTED|Overall Study||89||
48077278|NCT01081678|100511312|FG001|STARTED|Overall Study||60||
48077279|NCT01081678|100511313|FG002|STARTED|Overall Study||93||
48077280|NCT01081678|100511314|FG003|STARTED|Overall Study||90||
48077281|NCT01081678|100511311|FG000|Received Study Drug|Overall Study||87||
48077282|NCT01081678|100511312|FG001|Received Study Drug|Overall Study||60||
48077283|NCT01081678|100511313|FG002|Received Study Drug|Overall Study||89||
48077284|NCT01081678|100511314|FG003|Received Study Drug|Overall Study||89||
48077285|NCT01081678|100511311|FG000|Completed 24 Weeks of Study|Overall Study||73||
48077286|NCT01081678|100511312|FG001|Completed 24 Weeks of Study|Overall Study||50||
48077287|NCT01081678|100511313|FG002|Completed 24 Weeks of Study|Overall Study||72||
48077288|NCT01081678|100511314|FG003|Completed 24 Weeks of Study|Overall Study||68||
48077289|NCT01081678|100511311|FG000|COMPLETED|Overall Study||62||
48077290|NCT01081678|100511312|FG001|COMPLETED|Overall Study||44||
48077291|NCT01081678|100511313|FG002|COMPLETED|Overall Study||62||
48077292|NCT01081678|100511314|FG003|COMPLETED|Overall Study||61||
48077293|NCT01081678|100511311|FG000|NOT COMPLETED|Overall Study||27||
48077294|NCT01081678|100511312|FG001|NOT COMPLETED|Overall Study||16||
48077295|NCT01081678|100511313|FG002|NOT COMPLETED|Overall Study||31||
48077296|NCT01081678|100511314|FG003|NOT COMPLETED|Overall Study||29||
48077297|NCT04774328|100511315|FG000|STARTED|Overall Study||10||
48077298|NCT04774328|100511316|FG001|STARTED|Overall Study||12||
48077299|NCT04774328|100511317|FG002|STARTED|Overall Study||12||
48077300|NCT04774328|100511315|FG000|Follow-up to 29 Days Post Surgery|Overall Study||10||
48077301|NCT04774328|100511316|FG001|Follow-up to 29 Days Post Surgery|Overall Study||12||
48077302|NCT04774328|100511317|FG002|Follow-up to 29 Days Post Surgery|Overall Study||12||
48077303|NCT04774328|100511315|FG000|COMPLETED|Overall Study||10||
48077304|NCT04774328|100511316|FG001|COMPLETED|Overall Study||12||
48077305|NCT04774328|100511317|FG002|COMPLETED|Overall Study||12||
48077306|NCT04774328|100511315|FG000|NOT COMPLETED|Overall Study||0||
48077307|NCT04774328|100511316|FG001|NOT COMPLETED|Overall Study||0||
48077308|NCT04774328|100511317|FG002|NOT COMPLETED|Overall Study||0||
48077309|NCT01115101|100511318|FG000|STARTED|Overall Study||113||
48077310|NCT01115101|100511319|FG001|STARTED|Overall Study||126||
48077311|NCT01115101|100511318|FG000|COMPLETED|Overall Study||113||
48077312|NCT01115101|100511319|FG001|COMPLETED|Overall Study||126||
48077313|NCT01115101|100511318|FG000|NOT COMPLETED|Overall Study||0||
48077314|NCT01115101|100511319|FG001|NOT COMPLETED|Overall Study||0||
48077315|NCT01758432|100511320|FG000|STARTED|Overall Study||18||
48077316|NCT01758432|100511321|FG001|STARTED|Overall Study||6||
48077317|NCT01758432|100511322|FG002|STARTED|Overall Study||6||
48077318|NCT01758432|100511323|FG003|STARTED|Overall Study||6||
48077319|NCT01758432|100511324|FG004|STARTED|Overall Study||6||
48077320|NCT01758432|100511325|FG005|STARTED|Overall Study||6||
48077321|NCT01758432|100511326|FG006|STARTED|Overall Study||6||
48077322|NCT01758432|100511320|FG000|COMPLETED|Overall Study||18||
48077323|NCT01758432|100511321|FG001|COMPLETED|Overall Study||6||
48077324|NCT01758432|100511322|FG002|COMPLETED|Overall Study||6||
48077325|NCT01758432|100511323|FG003|COMPLETED|Overall Study||6||
48077326|NCT01758432|100511324|FG004|COMPLETED|Overall Study||6||
48077327|NCT01758432|100511325|FG005|COMPLETED|Overall Study||6||
48077328|NCT01758432|100511326|FG006|COMPLETED|Overall Study||6||
48077329|NCT01758432|100511320|FG000|NOT COMPLETED|Overall Study||0||
48077330|NCT01758432|100511321|FG001|NOT COMPLETED|Overall Study||0||
48077331|NCT01758432|100511322|FG002|NOT COMPLETED|Overall Study||0||
48077332|NCT01758432|100511323|FG003|NOT COMPLETED|Overall Study||0||
48077333|NCT01758432|100511324|FG004|NOT COMPLETED|Overall Study||0||
48077334|NCT01758432|100511325|FG005|NOT COMPLETED|Overall Study||0||
48077335|NCT01758432|100511326|FG006|NOT COMPLETED|Overall Study||0||
48077336|NCT03722966|100511327|FG000|STARTED|Overall Study||2||
48077337|NCT03722966|100511328|FG001|STARTED|Overall Study||12||
48077338|NCT03722966|100511329|FG002|STARTED|Overall Study||11||
48077339|NCT03722966|100511330|FG003|STARTED|Overall Study||9||
48077340|NCT03722966|100511327|FG000|COMPLETED|Overall Study||1||
48077341|NCT03722966|100511328|FG001|COMPLETED|Overall Study||9||
48077342|NCT03722966|100511329|FG002|COMPLETED|Overall Study||7||
48077343|NCT03722966|100511330|FG003|COMPLETED|Overall Study||7||
48077344|NCT03722966|100511327|FG000|NOT COMPLETED|Overall Study||1||
48077345|NCT03722966|100511328|FG001|NOT COMPLETED|Overall Study||3||
48077346|NCT03722966|100511329|FG002|NOT COMPLETED|Overall Study||4||
48077347|NCT03722966|100511330|FG003|NOT COMPLETED|Overall Study||2||
48077348|NCT02123121|100511331|FG000|STARTED|Overall Study||20||
48077349|NCT02123121|100511332|FG001|STARTED|Overall Study||21||
48077350|NCT02123121|100511333|FG002|STARTED|Overall Study||19||
48077351|NCT02123121|100511331|FG000|COMPLETED|Overall Study||18||
48077352|NCT02123121|100511332|FG001|COMPLETED|Overall Study||20||
48077353|NCT02123121|100511333|FG002|COMPLETED|Overall Study||16||
48077354|NCT02123121|100511331|FG000|NOT COMPLETED|Overall Study||2||
48077355|NCT02123121|100511332|FG001|NOT COMPLETED|Overall Study||1||
48077356|NCT02123121|100511333|FG002|NOT COMPLETED|Overall Study||3||
48077357|NCT00844831|100511334|FG000|STARTED|Overall Study||25||
48077358|NCT00844831|100511334|FG000|COMPLETED|Overall Study||19||
48077359|NCT00844831|100511334|FG000|NOT COMPLETED|Overall Study||6||
48077360|NCT03965039|100511335|FG000|STARTED|Overall Study||30||
48077361|NCT03965039|100511336|FG001|STARTED|Overall Study||30||
48077362|NCT03965039|100511337|FG002|STARTED|Overall Study||30||
48077363|NCT03965039|100511338|FG003|STARTED|Overall Study||30||
48077364|NCT03965039|100511335|FG000|COMPLETED|Overall Study||30||
48077365|NCT03965039|100511336|FG001|COMPLETED|Overall Study||29||
48077366|NCT03965039|100511337|FG002|COMPLETED|Overall Study||30||
48077367|NCT03965039|100511338|FG003|COMPLETED|Overall Study||29||
48077368|NCT03965039|100511335|FG000|NOT COMPLETED|Overall Study||0||
48077369|NCT03965039|100511336|FG001|NOT COMPLETED|Overall Study||1||
48077370|NCT03965039|100511337|FG002|NOT COMPLETED|Overall Study||0||
48077371|NCT03965039|100511338|FG003|NOT COMPLETED|Overall Study||1||
48077372|NCT03338998|100511339|FG000|STARTED|Treatment Period||16||
48077373|NCT03338998|100511340|FG001|STARTED|Treatment Period||13||
48077374|NCT03338998|100511339|FG000|COMPLETED|Treatment Period||8||
48077375|NCT03338998|100511340|FG001|COMPLETED|Treatment Period||10||
48077376|NCT03338998|100511339|FG000|NOT COMPLETED|Treatment Period||8||
48077377|NCT03338998|100511340|FG001|NOT COMPLETED|Treatment Period||3||
48077378|NCT03338998|100511339|FG000|STARTED|Safety Follow-Up Period||16||
48077379|NCT03338998|100511340|FG001|STARTED|Safety Follow-Up Period||13||
48077380|NCT03338998|100511339|FG000|COMPLETED|Safety Follow-Up Period||14||
48077381|NCT03338998|100511340|FG001|COMPLETED|Safety Follow-Up Period||12||
48077382|NCT03338998|100511339|FG000|NOT COMPLETED|Safety Follow-Up Period||2||
48077383|NCT03338998|100511340|FG001|NOT COMPLETED|Safety Follow-Up Period||1||
48077384|NCT01335191|100511341|FG000|STARTED|Overall Study||16||
48077385|NCT01335191|100511342|FG001|STARTED|Overall Study||11||
48077386|NCT01335191|100511341|FG000|COMPLETED|Overall Study||16||
48077387|NCT01335191|100511342|FG001|COMPLETED|Overall Study||11||
48077388|NCT01335191|100511341|FG000|NOT COMPLETED|Overall Study||0||
48077389|NCT01335191|100511342|FG001|NOT COMPLETED|Overall Study||0||
48077390|NCT02578316|100511343|FG000|STARTED|Study Phase||6||
48077391|NCT02578316|100511343|FG000|COMPLETED|Study Phase||6||
48077392|NCT02578316|100511343|FG000|NOT COMPLETED|Study Phase||0||
48077393|NCT02578316|100511343|FG000|STARTED|Extension Phase||6||
48077394|NCT02578316|100511343|FG000|COMPLETED|Extension Phase||0||
48077395|NCT02578316|100511343|FG000|NOT COMPLETED|Extension Phase||6||
48077396|NCT00680017|100511344|FG000|STARTED|Overall Study||140||
48077397|NCT00680017|100511345|FG001|STARTED|Overall Study||140||
48077398|NCT00680017|100511344|FG000|COMPLETED|Overall Study||123||
48077399|NCT00680017|100511345|FG001|COMPLETED|Overall Study||128||
48077400|NCT00680017|100511344|FG000|NOT COMPLETED|Overall Study||17||
48077401|NCT00680017|100511345|FG001|NOT COMPLETED|Overall Study||12||
48077402|NCT03039283|100511346|FG000|STARTED|Overall Study||162||
48077403|NCT03039283|100511346|FG000|COMPLETED|Overall Study||160||
48077404|NCT03039283|100511346|FG000|NOT COMPLETED|Overall Study||2||
48077405|NCT02446483|100511347|FG000|STARTED|Period 1: Intervention Period 1||30||
48077406|NCT02446483|100511348|FG001|STARTED|Period 1: Intervention Period 1||30||
48077407|NCT02446483|100511347|FG000|COMPLETED|Period 1: Intervention Period 1||30||
48077408|NCT02446483|100511348|FG001|COMPLETED|Period 1: Intervention Period 1||30||
48077409|NCT02446483|100511347|FG000|NOT COMPLETED|Period 1: Intervention Period 1||0||
48077410|NCT02446483|100511348|FG001|NOT COMPLETED|Period 1: Intervention Period 1||0||
48077411|NCT02446483|100511347|FG000|STARTED|Period 2: Washout Period (7 Days)||30||
48077412|NCT02446483|100511348|FG001|STARTED|Period 2: Washout Period (7 Days)||30||
48077413|NCT02446483|100511347|FG000|COMPLETED|Period 2: Washout Period (7 Days)||30||
48077414|NCT02446483|100511348|FG001|COMPLETED|Period 2: Washout Period (7 Days)||30||
48077415|NCT02446483|100511347|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0||
48077416|NCT02446483|100511348|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||0||
48077417|NCT02446483|100511347|FG000|STARTED|Period 3: Intervention Period 2||30||
48077418|NCT02446483|100511348|FG001|STARTED|Period 3: Intervention Period 2||30||
48077419|NCT02446483|100511347|FG000|COMPLETED|Period 3: Intervention Period 2||30||
48077420|NCT02446483|100511348|FG001|COMPLETED|Period 3: Intervention Period 2||30||
48077421|NCT02446483|100511347|FG000|NOT COMPLETED|Period 3: Intervention Period 2||0||
48077422|NCT02446483|100511348|FG001|NOT COMPLETED|Period 3: Intervention Period 2||0||
48077423|NCT02650856|100511349|FG000|STARTED|Overall Study||19||
48077424|NCT02650856|100511350|FG001|STARTED|Overall Study||21||
48077425|NCT02650856|100511349|FG000|Baseline|Overall Study||19||
48077426|NCT02650856|100511350|FG001|Baseline|Overall Study||21||
48077427|NCT02650856|100511349|FG000|24 Hours|Overall Study||19||
48077428|NCT02650856|100511350|FG001|24 Hours|Overall Study||21||
48077429|NCT02650856|100511349|FG000|48 Hours|Overall Study||19||
48077430|NCT02650856|100511350|FG001|48 Hours|Overall Study||21||
48077431|NCT02650856|100511349|FG000|72 Hours|Overall Study||19||
48077432|NCT02650856|100511350|FG001|72 Hours|Overall Study||21||
48077433|NCT02650856|100511349|FG000|COMPLETED|Overall Study||19||
48077434|NCT02650856|100511350|FG001|COMPLETED|Overall Study||21||
48077435|NCT02650856|100511349|FG000|NOT COMPLETED|Overall Study||0||
48077436|NCT02650856|100511350|FG001|NOT COMPLETED|Overall Study||0||
48077437|NCT00681083|100511351|FG000|STARTED|Night 1||13||
48077438|NCT00681083|100511352|FG001|STARTED|Night 1||13||
48077439|NCT00681083|100511351|FG000|COMPLETED|Night 1||10||
48077440|NCT00681083|100511352|FG001|COMPLETED|Night 1||10||
48077441|NCT00681083|100511351|FG000|NOT COMPLETED|Night 1||3||
48077442|NCT00681083|100511352|FG001|NOT COMPLETED|Night 1||3||
48077443|NCT00681083|100511351|FG000|STARTED|Night 2 (Crossover of Night 1)||10||
48077444|NCT00681083|100511352|FG001|STARTED|Night 2 (Crossover of Night 1)||10||
48077445|NCT00681083|100511351|FG000|COMPLETED|Night 2 (Crossover of Night 1)||10||
48077446|NCT00681083|100511352|FG001|COMPLETED|Night 2 (Crossover of Night 1)||10||
48077447|NCT00681083|100511351|FG000|NOT COMPLETED|Night 2 (Crossover of Night 1)||0||
48077448|NCT00681083|100511352|FG001|NOT COMPLETED|Night 2 (Crossover of Night 1)||0||
48077449|NCT01509950|100511353|FG000|STARTED|Overall Study||7||
48077450|NCT01509950|100511354|FG001|STARTED|Overall Study||8||
48077451|NCT01509950|100511355|FG002|STARTED|Overall Study||0||
48077452|NCT01509950|100511353|FG000|COMPLETED|Overall Study||7||
48077453|NCT01509950|100511354|FG001|COMPLETED|Overall Study||8||
48077454|NCT01509950|100511355|FG002|COMPLETED|Overall Study||0||
48077455|NCT01509950|100511353|FG000|NOT COMPLETED|Overall Study||0||
48077456|NCT01509950|100511354|FG001|NOT COMPLETED|Overall Study||0||
48077457|NCT01509950|100511355|FG002|NOT COMPLETED|Overall Study||0||
48077458|NCT00555971|100511356|FG000|STARTED|Overall Study||5||
48077459|NCT00555971|100511357|FG001|STARTED|Overall Study||8||
48077460|NCT00555971|100511356|FG000|COMPLETED|Overall Study||4||
48077461|NCT00555971|100511357|FG001|COMPLETED|Overall Study||7||
48077462|NCT00555971|100511356|FG000|NOT COMPLETED|Overall Study||1||
48077463|NCT00555971|100511357|FG001|NOT COMPLETED|Overall Study||1||
48077464|NCT03748758|100511358|FG000|STARTED|Overall Study||12||
48077465|NCT03748758|100511359|FG001|STARTED|Overall Study||12||
48077466|NCT03748758|100511360|FG002|STARTED|Overall Study||6||
48077467|NCT03748758|100511358|FG000|COMPLETED|Overall Study||12||
48077468|NCT03748758|100511359|FG001|COMPLETED|Overall Study||12||
48077469|NCT03748758|100511360|FG002|COMPLETED|Overall Study||5||
48077470|NCT03748758|100511358|FG000|NOT COMPLETED|Overall Study||0||
48077471|NCT03748758|100511359|FG001|NOT COMPLETED|Overall Study||0||
48077472|NCT03748758|100511360|FG002|NOT COMPLETED|Overall Study||1||
48077473|NCT03719885|100511361|FG000|STARTED|Overall Study||55||
48077474|NCT03719885|100511361|FG000|COMPLETED|Overall Study||35||
48077475|NCT03719885|100511361|FG000|NOT COMPLETED|Overall Study||20||
48077476|NCT03681405|100511362|FG000|STARTED|Overall Study||14||
48077477|NCT03681405|100511363|FG001|STARTED|Overall Study||17||
48077478|NCT03681405|100511362|FG000|COMPLETED|Overall Study||13||
48077479|NCT03681405|100511363|FG001|COMPLETED|Overall Study||17||
48077480|NCT03681405|100511362|FG000|NOT COMPLETED|Overall Study||1||
48077481|NCT03681405|100511363|FG001|NOT COMPLETED|Overall Study||0||
48077482|NCT01996852|100511364|FG000|STARTED|Overall Study||0||
48077483|NCT01996852|100511365|FG001|STARTED|Overall Study||0||
48077484|NCT01996852|100511366|FG002|STARTED|Overall Study||0||
48077485|NCT01996852|100511364|FG000|COMPLETED|Overall Study||0||
48077486|NCT01996852|100511365|FG001|COMPLETED|Overall Study||0||
48077487|NCT01996852|100511366|FG002|COMPLETED|Overall Study||0||
48077488|NCT01996852|100511364|FG000|NOT COMPLETED|Overall Study||0||
48077489|NCT01996852|100511365|FG001|NOT COMPLETED|Overall Study||0||
48077490|NCT01996852|100511366|FG002|NOT COMPLETED|Overall Study||0||
48077491|NCT00823095|100511367|FG000|STARTED|Overall Study||7||
48077492|NCT00823095|100511367|FG000|COMPLETED|Overall Study||7||
48077493|NCT00823095|100511367|FG000|NOT COMPLETED|Overall Study||0||
48077494|NCT03547583|100511368|FG000|STARTED|Overall Study||263||
48077495|NCT03547583|100511369|FG001|STARTED|Overall Study||264||
48077496|NCT03547583|100511370|FG002|STARTED|Overall Study||262||
48077497|NCT03547583|100511368|FG000|Treated|Overall Study||262||
48077498|NCT03547583|100511369|FG001|Treated|Overall Study||264||
48077499|NCT03547583|100511370|FG002|Treated|Overall Study||262||
48077500|NCT03547583|100511368|FG000|COMPLETED|Overall Study||218||
48077501|NCT03547583|100511369|FG001|COMPLETED|Overall Study||224||
48077502|NCT03547583|100511370|FG002|COMPLETED|Overall Study||230||
48077503|NCT03547583|100511368|FG000|NOT COMPLETED|Overall Study||45||
48077504|NCT03547583|100511369|FG001|NOT COMPLETED|Overall Study||40||
48077505|NCT03547583|100511370|FG002|NOT COMPLETED|Overall Study||32||
48077506|NCT01032837|100511371|FG000|STARTED|Overall Study||26||
48077507|NCT01032837|100511372|FG001|STARTED|Overall Study||26||
48077508|NCT01032837|100511373|FG002|STARTED|Overall Study||25||
48077509|NCT01032837|100511374|FG003|STARTED|Overall Study||25||
48077510|NCT01032837|100511371|FG000|Intent-to-Treat|Overall Study||26||
48077511|NCT01032837|100511372|FG001|Intent-to-Treat|Overall Study||26||
48077512|NCT01032837|100511373|FG002|Intent-to-Treat|Overall Study||25||
48077513|NCT01032837|100511374|FG003|Intent-to-Treat|Overall Study||24||
48077514|NCT01032837|100511371|FG000|COMPLETED|Overall Study||26||
48077515|NCT01032837|100511372|FG001|COMPLETED|Overall Study||23||
48077516|NCT01032837|100511373|FG002|COMPLETED|Overall Study||24||
48077517|NCT01032837|100511374|FG003|COMPLETED|Overall Study||22||
48077518|NCT01032837|100511371|FG000|NOT COMPLETED|Overall Study||0||
48077519|NCT01032837|100511372|FG001|NOT COMPLETED|Overall Study||3||
48077520|NCT01032837|100511373|FG002|NOT COMPLETED|Overall Study||1||
48077521|NCT01032837|100511374|FG003|NOT COMPLETED|Overall Study||3||
48077522|NCT00847379|100511375|FG000|STARTED|Overall Study||59||
48077523|NCT00847379|100511376|FG001|STARTED|Overall Study||57||
48077524|NCT00847379|100511377|FG002|STARTED|Overall Study||57||
48077525|NCT00847379|100511375|FG000|As-treated Population|Overall Study||59|All participants who completed Study 007 and received ≥1 dose of ataluren in Study 007e.|
48077526|NCT00847379|100511376|FG001|As-treated Population|Overall Study||57|All participants who completed Study 007 and received ≥1 dose of ataluren in Study 007e.|
48077527|NCT00847379|100511377|FG002|As-treated Population|Overall Study||57|All participants who completed Study 007 and received ≥1 dose of ataluren in Study 007e.|
48077528|NCT00847379|100511375|FG000|COMPLETED|Overall Study||0||
48077529|NCT00847379|100511376|FG001|COMPLETED|Overall Study||0||
48077530|NCT00847379|100511377|FG002|COMPLETED|Overall Study||0||
48077531|NCT00847379|100511375|FG000|NOT COMPLETED|Overall Study||59||
48077532|NCT00847379|100511376|FG001|NOT COMPLETED|Overall Study||57||
48077533|NCT00847379|100511377|FG002|NOT COMPLETED|Overall Study||57||
48077534|NCT02673138|100511378|FG000|STARTED|Overall Study||10||
48077535|NCT02673138|100511378|FG000|Started Day 1|Overall Study||10||
48077536|NCT02673138|100511378|FG000|Ended Day 1|Overall Study||10||
48077537|NCT02673138|100511378|FG000|Started Day 2|Overall Study||10||
48077538|NCT02673138|100511378|FG000|Ended Day 2|Overall Study||10||
48077539|NCT02673138|100511378|FG000|COMPLETED|Overall Study||10||
48077540|NCT02673138|100511378|FG000|NOT COMPLETED|Overall Study||0||
48077541|NCT04974697|100511379|FG000|STARTED|Overall Study||86||
48077542|NCT04974697|100511379|FG000|COMPLETED|Overall Study||84||
48077543|NCT04974697|100511379|FG000|NOT COMPLETED|Overall Study||2||
48077544|NCT00844896|100511380|FG000|STARTED|Overall Study||29||
48077545|NCT00844896|100511381|FG001|STARTED|Overall Study||28||
48077546|NCT00844896|100511380|FG000|COMPLETED|Overall Study||17||
48077547|NCT00844896|100511381|FG001|COMPLETED|Overall Study||11||
48077548|NCT00844896|100511380|FG000|NOT COMPLETED|Overall Study||12||
48077549|NCT00844896|100511381|FG001|NOT COMPLETED|Overall Study||17||
48077550|NCT01962896|100511382|FG000|STARTED|Overall Study||4||
48077551|NCT01962896|100511382|FG000|COMPLETED|Overall Study||0||
48077552|NCT01962896|100511382|FG000|NOT COMPLETED|Overall Study||4||
48077553|NCT02710396|100511383|FG000|STARTED|Overall Study||14||
48077554|NCT02710396|100511384|FG001|STARTED|Overall Study||5||
48077555|NCT02710396|100511385|FG002|STARTED|Overall Study||0||
48077556|NCT02710396|100511383|FG000|COMPLETED|Overall Study||14||
48077557|NCT02710396|100511384|FG001|COMPLETED|Overall Study||5||
48077558|NCT02710396|100511385|FG002|COMPLETED|Overall Study||0||
48077559|NCT02710396|100511383|FG000|NOT COMPLETED|Overall Study||0||
48077560|NCT02710396|100511384|FG001|NOT COMPLETED|Overall Study||0||
48077561|NCT02710396|100511385|FG002|NOT COMPLETED|Overall Study||0||
48077562|NCT02695329|100511386|FG000|STARTED|Overall Study||50||
48077563|NCT02695329|100511387|FG001|STARTED|Overall Study||50||
48077564|NCT02695329|100511386|FG000|COMPLETED|Overall Study||45||
48077565|NCT02695329|100511387|FG001|COMPLETED|Overall Study||45||
48077566|NCT02695329|100511386|FG000|NOT COMPLETED|Overall Study||5||
48077567|NCT02695329|100511387|FG001|NOT COMPLETED|Overall Study||5||
48077568|NCT04678661|100511388|FG000|STARTED|Overall Study||60||
48077569|NCT04678661|100511389|FG001|STARTED|Overall Study||33||
48077570|NCT04678661|100511388|FG000|COMPLETED|Overall Study||36||
48077571|NCT04678661|100511389|FG001|COMPLETED|Overall Study||33||
48077572|NCT04678661|100511388|FG000|NOT COMPLETED|Overall Study||24||
48077573|NCT04678661|100511389|FG001|NOT COMPLETED|Overall Study||0||
48077574|NCT00814164|100511390|FG000|STARTED|Overall Study||21||
48077575|NCT00814164|100511390|FG000|COMPLETED|Overall Study||2||
48077576|NCT00814164|100511390|FG000|NOT COMPLETED|Overall Study||19||
48077577|NCT00993200|100511391|FG000|STARTED|Overall Study||13||
48077578|NCT00993200|100511392|FG001|STARTED|Overall Study||13||
48077579|NCT00993200|100511391|FG000|COMPLETED|Overall Study||13||
48077580|NCT00993200|100511392|FG001|COMPLETED|Overall Study||13||
48077581|NCT00993200|100511391|FG000|NOT COMPLETED|Overall Study||0||
48077582|NCT00993200|100511392|FG001|NOT COMPLETED|Overall Study||0||
48077583|NCT01304316|100511393|FG000|STARTED|Overall Study||12||
48077584|NCT01304316|100511393|FG000|COMPLETED|Overall Study||12||
48077585|NCT01304316|100511393|FG000|NOT COMPLETED|Overall Study||0||
48077586|NCT00519831|100511394|FG000|STARTED|Overall Study||16||
48077587|NCT00519831|100511394|FG000|COMPLETED|Overall Study||13||
48077588|NCT00519831|100511394|FG000|NOT COMPLETED|Overall Study||3||
48077589|NCT02499783|100511395|FG000|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||102||
48077590|NCT02499783|100511396|FG001|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||103||
48077591|NCT02499783|100511397|FG002|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||0||
48077592|NCT02499783|100511395|FG000|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||98||
48077593|NCT02499783|100511396|FG001|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||98||
48077594|NCT02499783|100511397|FG002|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||0||
48077595|NCT02499783|100511395|FG000|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||4||
48077596|NCT02499783|100511396|FG001|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||5||
48077597|NCT02499783|100511397|FG002|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||0||
48077598|NCT02499783|100511395|FG000|STARTED|DB Period: Weeks 0-8||102||
48077599|NCT02499783|100511396|FG001|STARTED|DB Period: Weeks 0-8||103||
48077600|NCT02499783|100511397|FG002|STARTED|DB Period: Weeks 0-8||0||
48077601|NCT02499783|100511395|FG000|COMPLETED|DB Period: Weeks 0-8||92||
48077602|NCT02499783|100511396|FG001|COMPLETED|DB Period: Weeks 0-8||96||
48077603|NCT02499783|100511397|FG002|COMPLETED|DB Period: Weeks 0-8||0||
48077604|NCT02499783|100511395|FG000|NOT COMPLETED|DB Period: Weeks 0-8||10||
48077605|NCT02499783|100511396|FG001|NOT COMPLETED|DB Period: Weeks 0-8||7||
48077606|NCT02499783|100511397|FG002|NOT COMPLETED|DB Period: Weeks 0-8||0||
48077607|NCT02499783|100511395|FG000|STARTED|Open Label Period: Weeks 8 to 26||0||
48077608|NCT02499783|100511396|FG001|STARTED|Open Label Period: Weeks 8 to 26||0||
48077609|NCT02499783|100511397|FG002|STARTED|Open Label Period: Weeks 8 to 26||188||
48077610|NCT02499783|100511395|FG000|COMPLETED|Open Label Period: Weeks 8 to 26||0||
48077611|NCT02499783|100511396|FG001|COMPLETED|Open Label Period: Weeks 8 to 26||0||
48077612|NCT02499783|100511397|FG002|COMPLETED|Open Label Period: Weeks 8 to 26||159||
48077613|NCT02499783|100511395|FG000|NOT COMPLETED|Open Label Period: Weeks 8 to 26||0||
48077614|NCT02499783|100511396|FG001|NOT COMPLETED|Open Label Period: Weeks 8 to 26||0||
48077615|NCT02499783|100511397|FG002|NOT COMPLETED|Open Label Period: Weeks 8 to 26||29||
48077616|NCT00956020|100511398|FG000|STARTED|Overall Study||4||
48077617|NCT00956020|100511398|FG000|COMPLETED|Overall Study||4||
48077618|NCT00956020|100511398|FG000|NOT COMPLETED|Overall Study||0||
48077619|NCT04112784|100511399|FG000|STARTED|Overall Study||38||
48077620|NCT04112784|100511399|FG000|COMPLETED|Overall Study||25||
48077621|NCT04112784|100511399|FG000|NOT COMPLETED|Overall Study||13||
48077622|NCT02197130|100511400|FG000|STARTED|Overall Study||95||
48077623|NCT02197130|100511401|FG001|STARTED|Overall Study||89||
48077624|NCT02197130|100511402|FG002|STARTED|Overall Study||88||
48077625|NCT02197130|100511400|FG000|Received Treatment|Overall Study||95||
48077626|NCT02197130|100511401|FG001|Received Treatment|Overall Study||88||
48077627|NCT02197130|100511402|FG002|Received Treatment|Overall Study||87||
48077628|NCT02197130|100511400|FG000|COMPLETED|Overall Study||79||
48077629|NCT02197130|100511401|FG001|COMPLETED|Overall Study||81||
48077630|NCT02197130|100511402|FG002|COMPLETED|Overall Study||56||
48077631|NCT02197130|100511400|FG000|NOT COMPLETED|Overall Study||16||
48077632|NCT02197130|100511401|FG001|NOT COMPLETED|Overall Study||8||
48077633|NCT02197130|100511402|FG002|NOT COMPLETED|Overall Study||32||
48077634|NCT01626391|100511403|FG000|STARTED|Overall Study||5||
48077635|NCT01626391|100511404|FG001|STARTED|Overall Study||4||
48077636|NCT01626391|100511403|FG000|COMPLETED|Overall Study||3||
48077637|NCT01626391|100511404|FG001|COMPLETED|Overall Study||4||
48077638|NCT01626391|100511403|FG000|NOT COMPLETED|Overall Study||2||
48077639|NCT01626391|100511404|FG001|NOT COMPLETED|Overall Study||0||
48077640|NCT00639678|100511405|FG000|STARTED|Overall Study||74||
48077641|NCT00639678|100511406|FG001|STARTED|Overall Study||6||
48077642|NCT00639678|100511407|FG002|STARTED|Overall Study||217||
48077643|NCT00639678|100511408|FG003|STARTED|Overall Study||23||
48077644|NCT00639678|100511405|FG000|COMPLETED|Overall Study||70||
48077645|NCT00639678|100511406|FG001|COMPLETED|Overall Study||5||
48077646|NCT00639678|100511407|FG002|COMPLETED|Overall Study||206||
48077647|NCT00639678|100511408|FG003|COMPLETED|Overall Study||23||
48077648|NCT00639678|100511405|FG000|NOT COMPLETED|Overall Study||4||
48077649|NCT00639678|100511406|FG001|NOT COMPLETED|Overall Study||1||
48077650|NCT00639678|100511407|FG002|NOT COMPLETED|Overall Study||11||
48077651|NCT00639678|100511408|FG003|NOT COMPLETED|Overall Study||0||
48077652|NCT03481907|100511409|FG000|STARTED|Overall Study||8||16
48077653|NCT03481907|100511409|FG000|Two Biopsies One on Each Thigh at Day 0 With Photo IHC and Histopathological Processing|Overall Study||8||16
48077654|NCT03481907|100511409|FG000|One Biopsy Wound Managed With Primary Closure|Overall Study||8||8
48077655|NCT03481907|100511409|FG000|Other One Biopsy Wound Managed With Topical Collagen Powder for 4 Weeks|Overall Study||8||8
48077656|NCT03481907|100511409|FG000|Photos of Both Wounds Were Taken at Week 46 With a Ruler in the Frame for Size Calibration|Overall Study||8||16
48077657|NCT03481907|100511409|FG000|Immunohistochemistry Done at 4 Weeks to Determine Collagen Content by Performing a Second Biopsy|Overall Study||8||16
48077658|NCT03481907|100511409|FG000|COMPLETED|Overall Study||8||16
48077659|NCT03481907|100511409|FG000|NOT COMPLETED|Overall Study||0||0
48077660|NCT01088997|100511410|FG000|STARTED|Overall Study||7||
48077661|NCT01088997|100511411|FG001|STARTED|Overall Study||5||
48077662|NCT01088997|100511410|FG000|COMPLETED|Overall Study||4||
48077663|NCT01088997|100511411|FG001|COMPLETED|Overall Study||2||
48077664|NCT01088997|100511410|FG000|NOT COMPLETED|Overall Study||3||
48077665|NCT01088997|100511411|FG001|NOT COMPLETED|Overall Study||3||
48077666|NCT04390191|100511412|FG000|STARTED|Overall Study||1||
48077667|NCT04390191|100511413|FG001|STARTED|Overall Study||3||
48077668|NCT04390191|100511412|FG000|COMPLETED|Overall Study||0||
48077669|NCT04390191|100511413|FG001|COMPLETED|Overall Study||3||
48077670|NCT04390191|100511412|FG000|NOT COMPLETED|Overall Study||1||
48077671|NCT04390191|100511413|FG001|NOT COMPLETED|Overall Study||0||
48077672|NCT01318993|100511414|FG000|STARTED|Overall Study||398||
48077673|NCT01318993|100511414|FG000|COMPLETED|Overall Study||0||
48077674|NCT01318993|100511414|FG000|NOT COMPLETED|Overall Study||398||
48077675|NCT02042183|100511415|FG000|STARTED|Overall Study||404||
48077676|NCT02042183|100511416|FG001|STARTED|Overall Study||202||
48077677|NCT02042183|100511415|FG000|Safety Population|Overall Study||400|All participants who took at least one dose of double-blinded study medication.|
48077678|NCT02042183|100511416|FG001|Safety Population|Overall Study||195|All participants who took at least one dose of double-blinded study medication.|
48077679|NCT02042183|100511415|FG000|Modified Intent-to-treat (mITT)|Overall Study||399|All participants in safety population who have at least one efficacy assessment.|
48077680|NCT02042183|100511416|FG001|Modified Intent-to-treat (mITT)|Overall Study||195|All participants in safety population who have at least one efficacy assessment.|
48077681|NCT02042183|100511415|FG000|COMPLETED|Overall Study||339||
48077682|NCT02042183|100511416|FG001|COMPLETED|Overall Study||166||
48077683|NCT02042183|100511415|FG000|NOT COMPLETED|Overall Study||65||
48077684|NCT02042183|100511416|FG001|NOT COMPLETED|Overall Study||36||
48077685|NCT02621060|100511417|FG000|STARTED|Overall Study||15||
48077686|NCT02621060|100511418|FG001|STARTED|Overall Study||15||
48077687|NCT02621060|100511417|FG000|COMPLETED|Overall Study||12||
48077688|NCT02621060|100511418|FG001|COMPLETED|Overall Study||14||
48077689|NCT02621060|100511417|FG000|NOT COMPLETED|Overall Study||3||
48077690|NCT02621060|100511418|FG001|NOT COMPLETED|Overall Study||1||
48077691|NCT01434030|100511419|FG000|STARTED|Overall Study||57||
48077692|NCT01434030|100511419|FG000|COMPLETED|Overall Study||56||
48077693|NCT01434030|100511419|FG000|NOT COMPLETED|Overall Study||1||
48077694|NCT01269463|100511420|FG000|STARTED|First Intervention||13||
48077695|NCT01269463|100511421|FG001|STARTED|First Intervention||13||
48077696|NCT01269463|100511420|FG000|COMPLETED|First Intervention||11||
48077697|NCT01269463|100511421|FG001|COMPLETED|First Intervention||11||
48077698|NCT01269463|100511420|FG000|NOT COMPLETED|First Intervention||2||
48077699|NCT01269463|100511421|FG001|NOT COMPLETED|First Intervention||2||
48077700|NCT01269463|100511420|FG000|STARTED|Second Intervention||11||
48077701|NCT01269463|100511421|FG001|STARTED|Second Intervention||11||
48077702|NCT01269463|100511420|FG000|COMPLETED|Second Intervention||11||
48077703|NCT01269463|100511421|FG001|COMPLETED|Second Intervention||11||
48077704|NCT01269463|100511420|FG000|NOT COMPLETED|Second Intervention||0||
48077705|NCT01269463|100511421|FG001|NOT COMPLETED|Second Intervention||0||
48077706|NCT01269463|100511420|FG000|STARTED|Third Intervention||11||
48077707|NCT01269463|100511421|FG001|STARTED|Third Intervention||11||
48077708|NCT01269463|100511420|FG000|COMPLETED|Third Intervention||11||
48077709|NCT01269463|100511421|FG001|COMPLETED|Third Intervention||11||
48077710|NCT01269463|100511420|FG000|NOT COMPLETED|Third Intervention||0||
48077711|NCT01269463|100511421|FG001|NOT COMPLETED|Third Intervention||0||
48077712|NCT00672243|100515018|FG000|STARTED|Overall Study||32||
48077713|NCT00672243|100515018|FG000|COMPLETED|Overall Study||32||
48077714|NCT00672243|100515018|FG000|NOT COMPLETED|Overall Study||0||
48077715|NCT00880009|100515019|FG000|STARTED|Overall Study||16||
48077716|NCT00880009|100515019|FG000|COMPLETED|Overall Study||0||
48077717|NCT00880009|100515019|FG000|NOT COMPLETED|Overall Study||16||
48077718|NCT02850965|100515020|FG000|STARTED|Overall Study||159|Randomized|
48077719|NCT02850965|100515021|FG001|STARTED|Overall Study||159|Randomized|
48227225|NCT03374254|100877945|FG000|STARTED|Overall Study||6||
48227226|NCT03374254|100877946|FG001|STARTED|Overall Study||16||
48227227|NCT03374254|100877947|FG002|STARTED|Overall Study||15||
48077720|NCT02850965|100515020|FG000|Treated|Overall Study||159||
48077721|NCT02850965|100515021|FG001|Treated|Overall Study||158||
48077722|NCT02850965|100515020|FG000|COMPLETED|Overall Study||141||
48077723|NCT02850965|100515021|FG001|COMPLETED|Overall Study||134||
48077724|NCT02850965|100515020|FG000|NOT COMPLETED|Overall Study||18||
48077725|NCT02850965|100515021|FG001|NOT COMPLETED|Overall Study||25||
48077726|NCT04160195|100515022|FG000|STARTED|Overall Study||2||
48077727|NCT04160195|100515023|FG001|STARTED|Overall Study||0||
48077728|NCT04160195|100515022|FG000|COMPLETED|Overall Study||1||
48077729|NCT04160195|100515023|FG001|COMPLETED|Overall Study||0||
48077730|NCT04160195|100515022|FG000|NOT COMPLETED|Overall Study||1||
48077731|NCT04160195|100515023|FG001|NOT COMPLETED|Overall Study||0||
48077732|NCT01370356|100515024|FG000|STARTED|Overall Study||751||
48077733|NCT01370356|100515025|FG001|STARTED|Overall Study||742||
48077734|NCT01370356|100515024|FG000|COMPLETED|Overall Study||559||
48077735|NCT01370356|100515025|FG001|COMPLETED|Overall Study||515||
48077736|NCT01370356|100515024|FG000|NOT COMPLETED|Overall Study||192||
48077737|NCT01370356|100515025|FG001|NOT COMPLETED|Overall Study||227||
48077738|NCT01425281|100515026|FG000|STARTED|At 30-day Clinical Follow-up||335||
48077739|NCT01425281|100515027|FG001|STARTED|At 30-day Clinical Follow-up||166||
48077740|NCT01425281|100515026|FG000|COMPLETED|At 30-day Clinical Follow-up||334||
48077741|NCT01425281|100515027|FG001|COMPLETED|At 30-day Clinical Follow-up||166||
48077742|NCT01425281|100515026|FG000|NOT COMPLETED|At 30-day Clinical Follow-up||1||
48077743|NCT01425281|100515027|FG001|NOT COMPLETED|At 30-day Clinical Follow-up||0||
48077744|NCT01425281|100515026|FG000|STARTED|At 180-day Clinical Follow-up||334||
48077745|NCT01425281|100515027|FG001|STARTED|At 180-day Clinical Follow-up||166||
48077746|NCT01425281|100515026|FG000|COMPLETED|At 180-day Clinical Follow-up||331||
48077747|NCT01425281|100515027|FG001|COMPLETED|At 180-day Clinical Follow-up||165||
48077748|NCT01425281|100515026|FG000|NOT COMPLETED|At 180-day Clinical Follow-up||3||
48077749|NCT01425281|100515027|FG001|NOT COMPLETED|At 180-day Clinical Follow-up||1||
48077750|NCT01425281|100515026|FG000|STARTED|At 1-year Clinical Follow-up||331||
48077751|NCT01425281|100515027|FG001|STARTED|At 1-year Clinical Follow-up||165||
48077752|NCT01425281|100515026|FG000|COMPLETED|At 1-year Clinical Follow-up||329||
48077753|NCT01425281|100515027|FG001|COMPLETED|At 1-year Clinical Follow-up||164||
48077754|NCT01425281|100515026|FG000|NOT COMPLETED|At 1-year Clinical Follow-up||2||
48077755|NCT01425281|100515027|FG001|NOT COMPLETED|At 1-year Clinical Follow-up||1||
48077756|NCT01425281|100515026|FG000|STARTED|At 2-year Clinical Follow-up||329||
48077757|NCT01425281|100515027|FG001|STARTED|At 2-year Clinical Follow-up||164||
48077758|NCT01425281|100515026|FG000|COMPLETED|At 2-year Clinical Follow-up||323||
48077759|NCT01425281|100515027|FG001|COMPLETED|At 2-year Clinical Follow-up||163||
48077760|NCT01425281|100515026|FG000|NOT COMPLETED|At 2-year Clinical Follow-up||6||
48077761|NCT01425281|100515027|FG001|NOT COMPLETED|At 2-year Clinical Follow-up||1||
48077762|NCT01425281|100515026|FG000|STARTED|At 3-year Clinical Follow-up||323||
48077763|NCT01425281|100515027|FG001|STARTED|At 3-year Clinical Follow-up||163||
48077764|NCT01425281|100515026|FG000|COMPLETED|At 3-year Clinical Follow-up||318||
48077765|NCT01425281|100515027|FG001|COMPLETED|At 3-year Clinical Follow-up||157||
48077766|NCT01425281|100515026|FG000|NOT COMPLETED|At 3-year Clinical Follow-up||5||
48077767|NCT01425281|100515027|FG001|NOT COMPLETED|At 3-year Clinical Follow-up||6||
48077768|NCT01425281|100515026|FG000|STARTED|At 4-year Clinical Follow-up||318||
48077769|NCT01425281|100515027|FG001|STARTED|At 4-year Clinical Follow-up||157||
48077770|NCT01425281|100515026|FG000|COMPLETED|At 4-year Clinical Follow-up||288||
48077771|NCT01425281|100515027|FG001|COMPLETED|At 4-year Clinical Follow-up||136||
48077772|NCT01425281|100515026|FG000|NOT COMPLETED|At 4-year Clinical Follow-up||30||
48077773|NCT01425281|100515027|FG001|NOT COMPLETED|At 4-year Clinical Follow-up||21||
48077774|NCT01425281|100515026|FG000|STARTED|At 5-year Clinical Follow-up||288||
48077775|NCT01425281|100515027|FG001|STARTED|At 5-year Clinical Follow-up||136||
48077776|NCT01425281|100515026|FG000|COMPLETED|At 5-year Clinical Follow-up||256||
48077777|NCT01425281|100515027|FG001|COMPLETED|At 5-year Clinical Follow-up||125||
48077778|NCT01425281|100515026|FG000|NOT COMPLETED|At 5-year Clinical Follow-up||32||
48077779|NCT01425281|100515027|FG001|NOT COMPLETED|At 5-year Clinical Follow-up||11||
48077780|NCT01727297|100515028|FG000|STARTED|Overall Study||395||
48077781|NCT01727297|100515029|FG001|STARTED|Overall Study||51||
48077782|NCT01727297|100515028|FG000|COMPLETED|Overall Study||293||
48077783|NCT01727297|100515029|FG001|COMPLETED|Overall Study||0||
48077784|NCT01727297|100515028|FG000|NOT COMPLETED|Overall Study||102||
48227228|NCT03374254|100877948|FG003|STARTED|Overall Study||16||
48227229|NCT03374254|100877949|FG004|STARTED|Overall Study||11||
48077785|NCT01727297|100515029|FG001|NOT COMPLETED|Overall Study||51||
48077786|NCT01003288|100515030|FG000|STARTED|Overall Study||255||
48077787|NCT01003288|100515030|FG000|COMPLETED|Overall Study||255||
48077788|NCT01003288|100515030|FG000|NOT COMPLETED|Overall Study||0||
48077789|NCT01683383|100515031|FG000|STARTED|Overall Study||50||
48077790|NCT01683383|100515032|FG001|STARTED|Overall Study||51||
48077791|NCT01683383|100515031|FG000|Transported and Treated|Overall Study||49||
48077792|NCT01683383|100515032|FG001|Transported and Treated|Overall Study||51||
48077793|NCT01683383|100515031|FG000|COMPLETED|Overall Study||49||
48077794|NCT01683383|100515032|FG001|COMPLETED|Overall Study||51||
48077795|NCT01683383|100515031|FG000|NOT COMPLETED|Overall Study||1||
48227230|NCT03374254|100877950|FG005|STARTED|Overall Study||16||
48077796|NCT01683383|100515032|FG001|NOT COMPLETED|Overall Study||0||
48077797|NCT01587001|100515033|FG000|STARTED|Overall Study||14||
48077798|NCT01587001|100515034|FG001|STARTED|Overall Study||3||
48077799|NCT01587001|100515033|FG000|COMPLETED|Overall Study||8||
48077800|NCT01587001|100515034|FG001|COMPLETED|Overall Study||2||
48077801|NCT01587001|100515033|FG000|NOT COMPLETED|Overall Study||6||
48077802|NCT01587001|100515034|FG001|NOT COMPLETED|Overall Study||1||
48077803|NCT01957930|100515035|FG000|STARTED|Overall Study||35||
48077804|NCT01957930|100515036|FG001|STARTED|Overall Study||37||
48077805|NCT01957930|100515037|FG002|STARTED|Overall Study||19||
48077806|NCT01957930|100515035|FG000|COMPLETED|Overall Study||35||
48077807|NCT01957930|100515036|FG001|COMPLETED|Overall Study||37||
48077808|NCT01957930|100515037|FG002|COMPLETED|Overall Study||19||
48077809|NCT01957930|100515035|FG000|NOT COMPLETED|Overall Study||0||
48077810|NCT01957930|100515036|FG001|NOT COMPLETED|Overall Study||0||
48077811|NCT01957930|100515037|FG002|NOT COMPLETED|Overall Study||0||
48077812|NCT00834171|100515038|FG000|STARTED|Overall Study||43||
48077813|NCT00834171|100515039|FG001|STARTED|Overall Study||7||
48077814|NCT00834171|100515038|FG000|COMPLETED|Overall Study||43||
48077815|NCT00834171|100515039|FG001|COMPLETED|Overall Study||7||
48077816|NCT00834171|100515038|FG000|NOT COMPLETED|Overall Study||0||
48077817|NCT00834171|100515039|FG001|NOT COMPLETED|Overall Study||0||
48077818|NCT03602482|100515040|FG000|STARTED|Overall Study||50||
48077819|NCT03602482|100515041|FG001|STARTED|Overall Study||50||
48077820|NCT03602482|100515042|FG002|STARTED|Overall Study||20||
48077821|NCT03602482|100515043|FG003|STARTED|Overall Study||19||
48077822|NCT03602482|100515040|FG000|COMPLETED|Overall Study||44||
48077823|NCT03602482|100515041|FG001|COMPLETED|Overall Study||43||
48077824|NCT03602482|100515042|FG002|COMPLETED|Overall Study||20||
48077825|NCT03602482|100515043|FG003|COMPLETED|Overall Study||19||
48077826|NCT03602482|100515040|FG000|NOT COMPLETED|Overall Study||6||
48077827|NCT03602482|100515041|FG001|NOT COMPLETED|Overall Study||7||
48077828|NCT03602482|100515042|FG002|NOT COMPLETED|Overall Study||0||
48077829|NCT03602482|100515043|FG003|NOT COMPLETED|Overall Study||0||
48077830|NCT02516163|100515044|FG000|STARTED|Overall Study||52||
48077831|NCT02516163|100515044|FG000|COMPLETED|Overall Study||24||
48077832|NCT02516163|100515044|FG000|NOT COMPLETED|Overall Study||28||
48077833|NCT01354990|100515045|FG000|STARTED|Overall Study||2974||
48077834|NCT01354990|100515045|FG000|COMPLETED|Overall Study||2974||
48077835|NCT01354990|100515045|FG000|NOT COMPLETED|Overall Study||0||
48077836|NCT01898806|100515046|FG000|STARTED|Overall Study||11||
48077837|NCT01898806|100515046|FG000|COMPLETED|Overall Study||8||
48077838|NCT01898806|100515046|FG000|NOT COMPLETED|Overall Study||3||
48077839|NCT02140372|100515047|FG000|STARTED|Overall Study||10||
48077840|NCT02140372|100515047|FG000|COMPLETED|Overall Study||10||
48077841|NCT02140372|100515047|FG000|NOT COMPLETED|Overall Study||0||
48077842|NCT03809052|100515048|FG000|STARTED|Overall Study||6||
48077843|NCT03809052|100515049|FG001|STARTED|Overall Study||6||
48077844|NCT03809052|100515050|FG002|STARTED|Overall Study||6||
48077845|NCT03809052|100515051|FG003|STARTED|Overall Study||6||
48077846|NCT03809052|100515052|FG004|STARTED|Overall Study||6||
48077847|NCT03809052|100515053|FG005|STARTED|Overall Study||6||
48077848|NCT03809052|100515054|FG006|STARTED|Overall Study||6||
48077849|NCT03809052|100515055|FG007|STARTED|Overall Study||14||
48077850|NCT03809052|100515056|FG008|STARTED|Overall Study||8||
48077851|NCT03809052|100515057|FG009|STARTED|Overall Study||8||
48077852|NCT03809052|100515058|FG010|STARTED|Overall Study||6||
48077853|NCT03809052|100515048|FG000|COMPLETED|Overall Study||6||
48077854|NCT03809052|100515049|FG001|COMPLETED|Overall Study||6||
48077855|NCT03809052|100515050|FG002|COMPLETED|Overall Study||6||
48077856|NCT03809052|100515051|FG003|COMPLETED|Overall Study||6||
48077857|NCT03809052|100515052|FG004|COMPLETED|Overall Study||6||
48077858|NCT03809052|100515053|FG005|COMPLETED|Overall Study||6||
48077859|NCT03809052|100515054|FG006|COMPLETED|Overall Study||6||
48077860|NCT03809052|100515055|FG007|COMPLETED|Overall Study||14||
48077861|NCT03809052|100515056|FG008|COMPLETED|Overall Study||8||
48077862|NCT03809052|100515057|FG009|COMPLETED|Overall Study||8||
48077863|NCT03809052|100515058|FG010|COMPLETED|Overall Study||6||
48077864|NCT03809052|100515048|FG000|NOT COMPLETED|Overall Study||0||
48077865|NCT03809052|100515049|FG001|NOT COMPLETED|Overall Study||0||
48077866|NCT03809052|100515050|FG002|NOT COMPLETED|Overall Study||0||
48077867|NCT03809052|100515051|FG003|NOT COMPLETED|Overall Study||0||
48077868|NCT03809052|100515052|FG004|NOT COMPLETED|Overall Study||0||
48077869|NCT03809052|100515053|FG005|NOT COMPLETED|Overall Study||0||
48077870|NCT03809052|100515054|FG006|NOT COMPLETED|Overall Study||0||
48077871|NCT03809052|100515055|FG007|NOT COMPLETED|Overall Study||0||
48077872|NCT03809052|100515056|FG008|NOT COMPLETED|Overall Study||0||
48077873|NCT03809052|100515057|FG009|NOT COMPLETED|Overall Study||0||
48077874|NCT03809052|100515058|FG010|NOT COMPLETED|Overall Study||0||
48077875|NCT02521870|100515059|FG000|STARTED|Phase 1: Dose Escalation||6||
48077876|NCT02521870|100515060|FG001|STARTED|Phase 1: Dose Escalation||5||
48077877|NCT02521870|100515061|FG002|STARTED|Phase 1: Dose Escalation||5||
48077878|NCT02521870|100515062|FG003|STARTED|Phase 1: Dose Escalation||6||
48077879|NCT02521870|100515063|FG004|STARTED|Phase 1: Dose Escalation||0||
48077880|NCT02521870|100515064|FG005|STARTED|Phase 1: Dose Escalation||0||
48077881|NCT02521870|100515065|FG006|STARTED|Phase 1: Dose Escalation||0||
48077882|NCT02521870|100515066|FG007|STARTED|Phase 1: Dose Escalation||0||
48077883|NCT02521870|100515067|FG008|STARTED|Phase 1: Dose Escalation||0||
48077884|NCT02521870|100515068|FG009|STARTED|Phase 1: Dose Escalation||0||
48077885|NCT02521870|100515069|FG010|STARTED|Phase 1: Dose Escalation||0||
48077886|NCT02521870|100515070|FG011|STARTED|Phase 1: Dose Escalation||0||
48077887|NCT02521870|100515059|FG000|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||3||
48077888|NCT02521870|100515060|FG001|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||3||
48077889|NCT02521870|100515061|FG002|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0||
48077890|NCT02521870|100515062|FG003|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||1||
48077891|NCT02521870|100515063|FG004|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0||
48077892|NCT02521870|100515064|FG005|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0||
48077893|NCT02521870|100515065|FG006|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0||
48077894|NCT02521870|100515066|FG007|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0||
48077895|NCT02521870|100515067|FG008|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0||
48077896|NCT02521870|100515068|FG009|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0||
48077897|NCT02521870|100515069|FG010|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0||
48077898|NCT02521870|100515070|FG011|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0||
48077899|NCT02521870|100515059|FG000|COMPLETED|Phase 1: Dose Escalation||1|Completed Pembrolizumab Treatment (up to 35 doses)|
48077900|NCT02521870|100515060|FG001|COMPLETED|Phase 1: Dose Escalation||1|Completed Pembrolizumab Treatment (up to 35 doses)|
48077901|NCT02521870|100515061|FG002|COMPLETED|Phase 1: Dose Escalation||1|Completed Pembrolizumab Treatment (up to 35 doses)|
48077902|NCT02521870|100515062|FG003|COMPLETED|Phase 1: Dose Escalation||0|Completed Pembrolizumab Treatment (up to 35 doses)|
48077903|NCT02521870|100515063|FG004|COMPLETED|Phase 1: Dose Escalation||0|Completed Pembrolizumab Treatment (up to 35 doses)|
48077904|NCT02521870|100515064|FG005|COMPLETED|Phase 1: Dose Escalation||0|Completed Pembrolizumab Treatment (up to 35 doses)|
48077905|NCT02521870|100515065|FG006|COMPLETED|Phase 1: Dose Escalation||0|Completed Pembrolizumab Treatment (up to 35 doses)|
48077906|NCT02521870|100515066|FG007|COMPLETED|Phase 1: Dose Escalation||0|Completed Pembrolizumab Treatment (up to 35 doses)|
48077907|NCT02521870|100515067|FG008|COMPLETED|Phase 1: Dose Escalation||0|Completed Pembrolizumab Treatment (up to 35 doses)|
48077908|NCT02521870|100515068|FG009|COMPLETED|Phase 1: Dose Escalation||0|Completed Pembrolizumab Treatment (up to 35 doses)|
48077909|NCT02521870|100515069|FG010|COMPLETED|Phase 1: Dose Escalation||0|Completed Pembrolizumab Treatment (up to 35 doses)|
48077910|NCT02521870|100515070|FG011|COMPLETED|Phase 1: Dose Escalation||0|Completed Pembrolizumab Treatment (up to 35 doses)|
48077911|NCT02521870|100515059|FG000|NOT COMPLETED|Phase 1: Dose Escalation||5||
48077912|NCT02521870|100515060|FG001|NOT COMPLETED|Phase 1: Dose Escalation||4||
48077913|NCT02521870|100515061|FG002|NOT COMPLETED|Phase 1: Dose Escalation||4||
48077914|NCT02521870|100515062|FG003|NOT COMPLETED|Phase 1: Dose Escalation||6||
48077915|NCT02521870|100515063|FG004|NOT COMPLETED|Phase 1: Dose Escalation||0||
48077916|NCT02521870|100515064|FG005|NOT COMPLETED|Phase 1: Dose Escalation||0||
48077917|NCT02521870|100515065|FG006|NOT COMPLETED|Phase 1: Dose Escalation||0||
48077918|NCT02521870|100515066|FG007|NOT COMPLETED|Phase 1: Dose Escalation||0||
48077919|NCT02521870|100515067|FG008|NOT COMPLETED|Phase 1: Dose Escalation||0||
48077920|NCT02521870|100515068|FG009|NOT COMPLETED|Phase 1: Dose Escalation||0||
48077921|NCT02521870|100515069|FG010|NOT COMPLETED|Phase 1: Dose Escalation||0||
48077922|NCT02521870|100515070|FG011|NOT COMPLETED|Phase 1: Dose Escalation||0||
48077923|NCT02521870|100515059|FG000|STARTED|Phase 2: Dose Expansion||0||
48077924|NCT02521870|100515060|FG001|STARTED|Phase 2: Dose Expansion||0||
48077925|NCT02521870|100515061|FG002|STARTED|Phase 2: Dose Expansion||0||
48077926|NCT02521870|100515062|FG003|STARTED|Phase 2: Dose Expansion||0||
48077927|NCT02521870|100515063|FG004|STARTED|Phase 2: Dose Expansion||57||
48077928|NCT02521870|100515064|FG005|STARTED|Phase 2: Dose Expansion||25||
48077929|NCT02521870|100515065|FG006|STARTED|Phase 2: Dose Expansion||23||
48077930|NCT02521870|100515066|FG007|STARTED|Phase 2: Dose Expansion||9||
48077931|NCT02521870|100515067|FG008|STARTED|Phase 2: Dose Expansion||24||
48077932|NCT02521870|100515068|FG009|STARTED|Phase 2: Dose Expansion||28||
48077933|NCT02521870|100515069|FG010|STARTED|Phase 2: Dose Expansion||23||
48077934|NCT02521870|100515070|FG011|STARTED|Phase 2: Dose Expansion||30||
48077935|NCT02521870|100515059|FG000|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0||
48077936|NCT02521870|100515060|FG001|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0||
48077937|NCT02521870|100515061|FG002|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0||
48077938|NCT02521870|100515062|FG003|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0||
48077939|NCT02521870|100515063|FG004|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||25||
48077940|NCT02521870|100515064|FG005|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||7||
48077941|NCT02521870|100515065|FG006|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||3||
48077942|NCT02521870|100515066|FG007|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||2||
48077943|NCT02521870|100515067|FG008|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||9||
48077944|NCT02521870|100515068|FG009|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||5||
48227231|NCT03374254|100877951|FG006|STARTED|Overall Study||16||
48077945|NCT02521870|100515069|FG010|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||1||
48077946|NCT02521870|100515070|FG011|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||11||
48077947|NCT02521870|100515059|FG000|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0||
48077948|NCT02521870|100515060|FG001|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0||
48227232|NCT03374254|100877952|FG007|STARTED|Overall Study||9||
48227233|NCT03374254|100877953|FG008|STARTED|Overall Study||11||
48227234|NCT03374254|100877945|FG000|Treated|Overall Study||6||
48227235|NCT03374254|100877946|FG001|Treated|Overall Study||14||
48227236|NCT03374254|100877947|FG002|Treated|Overall Study||15||
48227237|NCT03374254|100877948|FG003|Treated|Overall Study||16||
48227238|NCT03374254|100877949|FG004|Treated|Overall Study||11||
48227239|NCT03374254|100877950|FG005|Treated|Overall Study||16||
48227240|NCT03374254|100877951|FG006|Treated|Overall Study||16||
48227241|NCT03374254|100877952|FG007|Treated|Overall Study||9||
48227242|NCT03374254|100877953|FG008|Treated|Overall Study||11||
48227243|NCT03374254|100877945|FG000|COMPLETED|Overall Study||0||
48227244|NCT03374254|100877946|FG001|COMPLETED|Overall Study||0||
48227245|NCT03374254|100877947|FG002|COMPLETED|Overall Study||0||
48227246|NCT03374254|100877948|FG003|COMPLETED|Overall Study||0||
48227247|NCT03374254|100877949|FG004|COMPLETED|Overall Study||0||
48227248|NCT03374254|100877950|FG005|COMPLETED|Overall Study||0||
48227249|NCT03374254|100877951|FG006|COMPLETED|Overall Study||0||
48227250|NCT03374254|100877952|FG007|COMPLETED|Overall Study||0||
48227251|NCT03374254|100877953|FG008|COMPLETED|Overall Study||0||
48227252|NCT03374254|100877945|FG000|NOT COMPLETED|Overall Study||6||
48227253|NCT03374254|100877946|FG001|NOT COMPLETED|Overall Study||16||
48227254|NCT03374254|100877947|FG002|NOT COMPLETED|Overall Study||15||
48227255|NCT03374254|100877948|FG003|NOT COMPLETED|Overall Study||16||
48227256|NCT03374254|100877949|FG004|NOT COMPLETED|Overall Study||11||
48227257|NCT03374254|100877950|FG005|NOT COMPLETED|Overall Study||16||
48227258|NCT03374254|100877951|FG006|NOT COMPLETED|Overall Study||16||
48227259|NCT03374254|100877952|FG007|NOT COMPLETED|Overall Study||9||
48227260|NCT03374254|100877953|FG008|NOT COMPLETED|Overall Study||11||
48227261|NCT00390884|100877954|FG000|STARTED|Overall Study||116||
48227262|NCT00390884|100877955|FG001|STARTED|Overall Study||57||
48227263|NCT00390884|100877954|FG000|COMPLETED|Overall Study||114||
48227264|NCT00390884|100877955|FG001|COMPLETED|Overall Study||55||
48227265|NCT00390884|100877954|FG000|NOT COMPLETED|Overall Study||2||
48227266|NCT00390884|100877955|FG001|NOT COMPLETED|Overall Study||2||
48227267|NCT04017611|100877956|FG000|STARTED|Overall Study||13||
48227268|NCT04017611|100877956|FG000|COMPLETED|Overall Study||12||
48077949|NCT02521870|100515061|FG002|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0||
48077950|NCT02521870|100515062|FG003|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0||
48077951|NCT02521870|100515063|FG004|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||7||
48077952|NCT02521870|100515064|FG005|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||1||
48077953|NCT02521870|100515065|FG006|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0||
48077954|NCT02521870|100515066|FG007|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0||
48077955|NCT02521870|100515067|FG008|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0||
48077956|NCT02521870|100515068|FG009|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0||
48077957|NCT02521870|100515069|FG010|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0||
48077958|NCT02521870|100515070|FG011|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0||
48077959|NCT02521870|100515059|FG000|COMPLETED|Phase 2: Dose Expansion||0|Completed Pembrolizumab Treatment (up to 35 doses)|
48077960|NCT02521870|100515060|FG001|COMPLETED|Phase 2: Dose Expansion||0|Completed Pembrolizumab Treatment (up to 35 doses)|
48077961|NCT02521870|100515061|FG002|COMPLETED|Phase 2: Dose Expansion||0|Completed Pembrolizumab Treatment (up to 35 doses)|
48077962|NCT02521870|100515062|FG003|COMPLETED|Phase 2: Dose Expansion||0|Completed Pembrolizumab Treatment (up to 35 doses)|
48077963|NCT02521870|100515063|FG004|COMPLETED|Phase 2: Dose Expansion||5|Completed Pembrolizumab Treatment (up to 35 doses)|
48077964|NCT02521870|100515064|FG005|COMPLETED|Phase 2: Dose Expansion||0|Completed Pembrolizumab Treatment (up to 35 doses)|
48077965|NCT02521870|100515065|FG006|COMPLETED|Phase 2: Dose Expansion||0|Completed Pembrolizumab Treatment (up to 35 doses)|
48077966|NCT02521870|100515066|FG007|COMPLETED|Phase 2: Dose Expansion||0|Completed Pembrolizumab Treatment (up to 35 doses)|
48077967|NCT02521870|100515067|FG008|COMPLETED|Phase 2: Dose Expansion||2|Completed Pembrolizumab Treatment (up to 35 doses)|
48077968|NCT02521870|100515068|FG009|COMPLETED|Phase 2: Dose Expansion||0|Completed Pembrolizumab Treatment (up to 35 doses)|
48077969|NCT02521870|100515069|FG010|COMPLETED|Phase 2: Dose Expansion||0|Completed Pembrolizumab Treatment (up to 35 doses)|
48077970|NCT02521870|100515070|FG011|COMPLETED|Phase 2: Dose Expansion||0|Completed Pembrolizumab Treatment (up to 35 doses)|
48227269|NCT04017611|100877956|FG000|NOT COMPLETED|Overall Study||1||
48227270|NCT03376659|100877957|FG000|STARTED|Overall Study||4||
48227271|NCT03376659|100877958|FG001|STARTED|Overall Study||4||
48227272|NCT03376659|100877957|FG000|COMPLETED|Overall Study||4||
48227273|NCT03376659|100877958|FG001|COMPLETED|Overall Study||4||
48227274|NCT03376659|100877957|FG000|NOT COMPLETED|Overall Study||0||
48227275|NCT03376659|100877958|FG001|NOT COMPLETED|Overall Study||0||
48227276|NCT00808834|100877959|FG000|STARTED|Period 1||97||
48227277|NCT00808834|100877960|FG001|STARTED|Period 1||99||
48227278|NCT00808834|100877959|FG000|COMPLETED|Period 1||97||
48227279|NCT00808834|100877960|FG001|COMPLETED|Period 1||99||
48227280|NCT00808834|100877959|FG000|NOT COMPLETED|Period 1||0||
48227281|NCT00808834|100877960|FG001|NOT COMPLETED|Period 1||0||
48227282|NCT00808834|100877959|FG000|STARTED|Period 2||97||
48227283|NCT00808834|100877960|FG001|STARTED|Period 2||99||
48227284|NCT00808834|100877959|FG000|COMPLETED|Period 2||97||
48227285|NCT00808834|100877960|FG001|COMPLETED|Period 2||99||
48227286|NCT00808834|100877959|FG000|NOT COMPLETED|Period 2||0||
48227287|NCT00808834|100877960|FG001|NOT COMPLETED|Period 2||0||
48227288|NCT00783952|100877961|FG000|STARTED|Overall Study||8||
48227289|NCT00783952|100877961|FG000|COMPLETED|Overall Study||8||
48227290|NCT00783952|100877961|FG000|NOT COMPLETED|Overall Study||0||
48227291|NCT00790569|100877962|FG000|STARTED|End of Treatment (6 Month Interview)||137||
48227292|NCT00790569|100877963|FG001|STARTED|End of Treatment (6 Month Interview)||45||
48227293|NCT00790569|100877964|FG002|STARTED|End of Treatment (6 Month Interview)||133||
48227294|NCT00790569|100877962|FG000|COMPLETED|End of Treatment (6 Month Interview)||115||
48227295|NCT00790569|100877963|FG001|COMPLETED|End of Treatment (6 Month Interview)||35||
48227296|NCT00790569|100877964|FG002|COMPLETED|End of Treatment (6 Month Interview)||107||
48227297|NCT00790569|100877962|FG000|NOT COMPLETED|End of Treatment (6 Month Interview)||22||
48227298|NCT00790569|100877963|FG001|NOT COMPLETED|End of Treatment (6 Month Interview)||10||
48227299|NCT00790569|100877964|FG002|NOT COMPLETED|End of Treatment (6 Month Interview)||26||
48227300|NCT00790569|100877962|FG000|STARTED|End of Study (12 Month Interview)||137||
48227301|NCT00790569|100877963|FG001|STARTED|End of Study (12 Month Interview)||45||
48227302|NCT00790569|100877964|FG002|STARTED|End of Study (12 Month Interview)||133||
48227303|NCT00790569|100877962|FG000|COMPLETED|End of Study (12 Month Interview)||71||
48227304|NCT00790569|100877963|FG001|COMPLETED|End of Study (12 Month Interview)||26||
48227305|NCT00790569|100877964|FG002|COMPLETED|End of Study (12 Month Interview)||83||
48227306|NCT00790569|100877962|FG000|NOT COMPLETED|End of Study (12 Month Interview)||66||
48227307|NCT00790569|100877963|FG001|NOT COMPLETED|End of Study (12 Month Interview)||19||
48227308|NCT00790569|100877964|FG002|NOT COMPLETED|End of Study (12 Month Interview)||50||
48227309|NCT00705159|100877965|FG000|STARTED|Overall Study||34||
48227310|NCT00705159|100877966|FG001|STARTED|Overall Study||35||
48227311|NCT00705159|100877967|FG002|STARTED|Overall Study||34||
48227312|NCT00705159|100877968|FG003|STARTED|Overall Study||34||
48227313|NCT00705159|100877965|FG000|COMPLETED|Overall Study||34||
48227314|NCT00705159|100877966|FG001|COMPLETED|Overall Study||33||
48227315|NCT00705159|100877967|FG002|COMPLETED|Overall Study||29||
48227316|NCT00705159|100877968|FG003|COMPLETED|Overall Study||30||
48227317|NCT00705159|100877965|FG000|NOT COMPLETED|Overall Study||0||
48227318|NCT00705159|100877966|FG001|NOT COMPLETED|Overall Study||2||
48227319|NCT00705159|100877967|FG002|NOT COMPLETED|Overall Study||5||
48227320|NCT00705159|100877968|FG003|NOT COMPLETED|Overall Study||4||
48227321|NCT02157948|100877969|FG000|STARTED|Overall Study||197||
48227322|NCT02157948|100877970|FG001|STARTED|Overall Study||197||
48227323|NCT02157948|100877969|FG000|Received Treatment|Overall Study||196||
48227324|NCT02157948|100877970|FG001|Received Treatment|Overall Study||196||
48227325|NCT02157948|100877969|FG000|COMPLETED|Overall Study||188||
48227326|NCT02157948|100877970|FG001|COMPLETED|Overall Study||188||
48227327|NCT02157948|100877969|FG000|NOT COMPLETED|Overall Study||9||
48227328|NCT02157948|100877970|FG001|NOT COMPLETED|Overall Study||9||
48227329|NCT00326183|100877971|FG000|STARTED|Overall Study||1453||
48227330|NCT00326183|100877972|FG001|STARTED|Overall Study||347||
48227331|NCT00326183|100877971|FG000|Vaccination 1 + Safety Follow-up|Overall Study||1453||
48227332|NCT00326183|100877972|FG001|Vaccination 1 + Safety Follow-up|Overall Study||347||
48227333|NCT00326183|100877971|FG000|Postvaccination 1 Post-safety Follow-up|Overall Study||1393||
48227334|NCT00326183|100877972|FG001|Postvaccination 1 Post-safety Follow-up|Overall Study||325||
48227335|NCT00326183|100877971|FG000|Vaccination 2 + Safety Follow-up|Overall Study||1301||
48227336|NCT00326183|100877972|FG001|Vaccination 2 + Safety Follow-up|Overall Study||292||
48227337|NCT00326183|100877971|FG000|Postvaccination 2 Post-safety Follow-up|Overall Study||1265||
48227338|NCT00326183|100877972|FG001|Postvaccination 2 Post-safety Follow-up|Overall Study||271||
48227339|NCT00326183|100877971|FG000|COMPLETED|Overall Study||1253||
48374649|NCT01253421|101247439|FG001|NOT COMPLETED|Assessment and Scheduling||0||
48374650|NCT01253421|101247440|FG002|NOT COMPLETED|Assessment and Scheduling||0||
48523069|NCT01970865|101616039|FG015|NOT COMPLETED|Overall Study||40||
48523070|NCT01970865|101616040|FG016|NOT COMPLETED|Overall Study||1||
48523071|NCT01970865|101616041|FG017|NOT COMPLETED|Overall Study||26||
48523072|NCT03325972|101616042|FG000|STARTED|Overall Study||33||
48523073|NCT03325972|101616043|FG001|STARTED|Overall Study||31||
48523074|NCT03325972|101616042|FG000|COMPLETED|Overall Study||18||
48523075|NCT03325972|101616043|FG001|COMPLETED|Overall Study||13||
48523076|NCT03325972|101616042|FG000|NOT COMPLETED|Overall Study||15||
48523077|NCT03325972|101616043|FG001|NOT COMPLETED|Overall Study||18||
48227340|NCT00326183|100877972|FG001|COMPLETED|Overall Study||264||
48227341|NCT00326183|100877971|FG000|NOT COMPLETED|Overall Study||200||
48227342|NCT00326183|100877972|FG001|NOT COMPLETED|Overall Study||83||
48227343|NCT01436175|100877973|FG000|STARTED|Overall Study||1570||
48227344|NCT01436175|100877973|FG000|COMPLETED|Overall Study||300||
48523078|NCT04700280|101616044|FG000|STARTED|Overall Study||20||
48523079|NCT04700280|101616045|FG001|STARTED|Overall Study||11||
48523080|NCT04700280|101616044|FG000|COMPLETED|Overall Study||9||
48523081|NCT04700280|101616045|FG001|COMPLETED|Overall Study||8||
48523082|NCT04700280|101616044|FG000|NOT COMPLETED|Overall Study||11||
48523083|NCT04700280|101616045|FG001|NOT COMPLETED|Overall Study||3||
48523084|NCT02562482|101616046|FG000|STARTED|Overall Study||201||
48523085|NCT02562482|101616047|FG001|STARTED|Overall Study||199||
48523086|NCT02562482|101616046|FG000|Received 1st Injection|Overall Study||197||
48523087|NCT02562482|101616047|FG001|Received 1st Injection|Overall Study||199||
48523088|NCT02562482|101616046|FG000|Received 2nd Injection|Overall Study||192||
48523089|NCT02562482|101616047|FG001|Received 2nd Injection|Overall Study||192||
48523090|NCT02562482|101616046|FG000|COMPLETED|Overall Study||180||
48523091|NCT02562482|101616047|FG001|COMPLETED|Overall Study||183||
48523092|NCT02562482|101616046|FG000|NOT COMPLETED|Overall Study||21||
48523093|NCT02562482|101616047|FG001|NOT COMPLETED|Overall Study||16||
48523094|NCT00652028|101616048|FG000|STARTED|Overall Study||16||
48523095|NCT00652028|101616049|FG001|STARTED|Overall Study||14||
48077971|NCT02521870|100515059|FG000|NOT COMPLETED|Phase 2: Dose Expansion||0||
48077972|NCT02521870|100515060|FG001|NOT COMPLETED|Phase 2: Dose Expansion||0||
48077973|NCT02521870|100515061|FG002|NOT COMPLETED|Phase 2: Dose Expansion||0||
48077974|NCT02521870|100515062|FG003|NOT COMPLETED|Phase 2: Dose Expansion||0||
48227345|NCT01436175|100877973|FG000|NOT COMPLETED|Overall Study||1270||
48227346|NCT00866619|100877974|FG000|STARTED|Overall Study||5948||
48227347|NCT00866619|100877975|FG001|STARTED|Overall Study||4358||
48227348|NCT00866619|100877976|FG002|STARTED|Overall Study||2974||
48523096|NCT00652028|101616050|FG002|STARTED|Overall Study||15||
48523097|NCT00652028|101616051|FG003|STARTED|Overall Study||14||
48077975|NCT02521870|100515063|FG004|NOT COMPLETED|Phase 2: Dose Expansion||52||
48077976|NCT02521870|100515064|FG005|NOT COMPLETED|Phase 2: Dose Expansion||25||
48077977|NCT02521870|100515065|FG006|NOT COMPLETED|Phase 2: Dose Expansion||23||
48077978|NCT02521870|100515066|FG007|NOT COMPLETED|Phase 2: Dose Expansion||9||
48077979|NCT02521870|100515067|FG008|NOT COMPLETED|Phase 2: Dose Expansion||22||
48077980|NCT02521870|100515068|FG009|NOT COMPLETED|Phase 2: Dose Expansion||28||
48077981|NCT02521870|100515069|FG010|NOT COMPLETED|Phase 2: Dose Expansion||23||
48077982|NCT02521870|100515070|FG011|NOT COMPLETED|Phase 2: Dose Expansion||30||
48077983|NCT02644135|100515071|FG000|STARTED|Overall Study||50||
48077984|NCT02644135|100515072|FG001|STARTED|Overall Study||44||
48077985|NCT02644135|100515071|FG000|COMPLETED|Overall Study||50||
48077986|NCT02644135|100515072|FG001|COMPLETED|Overall Study||44||
48077987|NCT02644135|100515071|FG000|NOT COMPLETED|Overall Study||0||
48077988|NCT02644135|100515072|FG001|NOT COMPLETED|Overall Study||0||
48077989|NCT02849678|100515073|FG000|STARTED|Overall Study||20||
48077990|NCT02849678|100515074|FG001|STARTED|Overall Study||24||
48077991|NCT02849678|100515073|FG000|COMPLETED|Overall Study||17||
48077992|NCT02849678|100515074|FG001|COMPLETED|Overall Study||18||
48077993|NCT02849678|100515073|FG000|NOT COMPLETED|Overall Study||3||
48077994|NCT02849678|100515074|FG001|NOT COMPLETED|Overall Study||6||
48077995|NCT01405742|100515075|FG000|STARTED|Overall Study||2||
48077996|NCT01405742|100515076|FG001|STARTED|Overall Study||2||
48077997|NCT01405742|100515075|FG000|COMPLETED|Overall Study||1||
48077998|NCT01405742|100515076|FG001|COMPLETED|Overall Study||2||
48077999|NCT01405742|100515075|FG000|NOT COMPLETED|Overall Study||1||
48078000|NCT01405742|100515076|FG001|NOT COMPLETED|Overall Study||0||
48078001|NCT00176228|100515077|FG000|STARTED|Overall Study||48||
48078002|NCT00176228|100515077|FG000|COMPLETED|Overall Study||46||
48078003|NCT00176228|100515077|FG000|NOT COMPLETED|Overall Study||2||
48078004|NCT00640601|100515078|FG000|STARTED|Overall Study||295||
48078005|NCT00640601|100515078|FG000|COMPLETED|Overall Study||183||
48078006|NCT00640601|100515078|FG000|NOT COMPLETED|Overall Study||112||
48078007|NCT01496612|100515079|FG000|STARTED|1st Intervention||3||
48078008|NCT01496612|100515080|FG001|STARTED|1st Intervention||4||
48523098|NCT00652028|101616048|FG000|COMPLETED|Overall Study||15||
48523099|NCT00652028|101616049|FG001|COMPLETED|Overall Study||13||
48523100|NCT00652028|101616050|FG002|COMPLETED|Overall Study||14||
48523101|NCT00652028|101616051|FG003|COMPLETED|Overall Study||14||
48523102|NCT00652028|101616048|FG000|NOT COMPLETED|Overall Study||1||
48523103|NCT00652028|101616049|FG001|NOT COMPLETED|Overall Study||1||
48523104|NCT00652028|101616050|FG002|NOT COMPLETED|Overall Study||1||
48523105|NCT00652028|101616051|FG003|NOT COMPLETED|Overall Study||0||
48523106|NCT04722601|101616052|FG000|STARTED|Overall Study||2||
48523107|NCT04722601|101616052|FG000|COMPLETED|Overall Study||2||
48523108|NCT04722601|101616052|FG000|NOT COMPLETED|Overall Study||0||
48523109|NCT00653991|101616053|FG000|STARTED|3 Month Follow-up||444||
48523110|NCT00653991|101616054|FG001|STARTED|3 Month Follow-up||491||
48523111|NCT00653991|101616053|FG000|COMPLETED|3 Month Follow-up||294||
48523112|NCT00653991|101616054|FG001|COMPLETED|3 Month Follow-up||334||
48523113|NCT00653991|101616053|FG000|NOT COMPLETED|3 Month Follow-up||150||
48078009|NCT01496612|100515079|FG000|COMPLETED|1st Intervention||1||
48078010|NCT01496612|100515080|FG001|COMPLETED|1st Intervention||4||
48227349|NCT00866619|100877977|FG003|STARTED|Overall Study||2179||
48523114|NCT00653991|101616054|FG001|NOT COMPLETED|3 Month Follow-up||157||
48523115|NCT00653991|101616053|FG000|STARTED|6 Month Follow-up||444||
48078011|NCT01496612|100515079|FG000|NOT COMPLETED|1st Intervention||2||
48078012|NCT01496612|100515080|FG001|NOT COMPLETED|1st Intervention||0||
48078013|NCT01496612|100515079|FG000|STARTED|2nd Intervention||1||
48078014|NCT01496612|100515080|FG001|STARTED|2nd Intervention||4||
48078015|NCT01496612|100515079|FG000|COMPLETED|2nd Intervention||1||
48523116|NCT00653991|101616054|FG001|STARTED|6 Month Follow-up||491||
48523117|NCT00653991|101616053|FG000|COMPLETED|6 Month Follow-up||311||
48523118|NCT00653991|101616054|FG001|COMPLETED|6 Month Follow-up||350||
48523119|NCT00653991|101616053|FG000|NOT COMPLETED|6 Month Follow-up||133||
48523120|NCT00653991|101616054|FG001|NOT COMPLETED|6 Month Follow-up||141||
48523121|NCT03401450|101616055|FG000|STARTED|Overall Study||33||
48523122|NCT03401450|101616056|FG001|STARTED|Overall Study||36||
48523123|NCT03401450|101616055|FG000|COMPLETED|Overall Study||21||
48523124|NCT03401450|101616056|FG001|COMPLETED|Overall Study||23||
48523125|NCT03401450|101616055|FG000|NOT COMPLETED|Overall Study||12||
48523126|NCT03401450|101616056|FG001|NOT COMPLETED|Overall Study||13||
48523127|NCT00695435|101616057|FG000|STARTED|Overall Study||7||
48523128|NCT00695435|101616058|FG001|STARTED|Overall Study||7||
48523129|NCT00695435|101616059|FG002|STARTED|Overall Study||7||
48523130|NCT00695435|101616057|FG000|COMPLETED|Overall Study||7||
48523131|NCT00695435|101616058|FG001|COMPLETED|Overall Study||7||
48523132|NCT00695435|101616059|FG002|COMPLETED|Overall Study||7||
48523133|NCT00695435|101616057|FG000|NOT COMPLETED|Overall Study||0||
48523134|NCT00695435|101616058|FG001|NOT COMPLETED|Overall Study||0||
48523135|NCT00695435|101616059|FG002|NOT COMPLETED|Overall Study||0||
48078016|NCT01496612|100515080|FG001|COMPLETED|2nd Intervention||4||
48078017|NCT01496612|100515079|FG000|NOT COMPLETED|2nd Intervention||0||
48078018|NCT01496612|100515080|FG001|NOT COMPLETED|2nd Intervention||0||
48078019|NCT01619423|100515081|FG000|STARTED|Part 1 (Dose Escalation)||0||
48078020|NCT01619423|100515082|FG001|STARTED|Part 1 (Dose Escalation)||5||
48078021|NCT01619423|100515083|FG002|STARTED|Part 1 (Dose Escalation)||3||
48078022|NCT01619423|100515084|FG003|STARTED|Part 1 (Dose Escalation)||5||
48078023|NCT01619423|100515081|FG000|COMPLETED|Part 1 (Dose Escalation)||0||
48374651|NCT01253421|101247441|FG003|NOT COMPLETED|Assessment and Scheduling||0||
48374652|NCT01253421|101247442|FG004|NOT COMPLETED|Assessment and Scheduling||0||
48374653|NCT01253421|101247438|FG000|STARTED|Drug+Scanning Visit||0|At the start of this period, all 60 active participants are randomized to a drug-X-condition arm|
48374654|NCT01253421|101247439|FG001|STARTED|Drug+Scanning Visit||15|At the start of this period, all 60 active participants are randomized to a drug-X-condition arm|
48374655|NCT01253421|101247440|FG002|STARTED|Drug+Scanning Visit||14|At the start of this period, all 60 active participants are randomized to a drug-X-condition arm|
48374656|NCT01253421|101247441|FG003|STARTED|Drug+Scanning Visit||16|At the start of this period, all 60 active participants are randomized to a drug-X-condition arm|
48374657|NCT01253421|101247442|FG004|STARTED|Drug+Scanning Visit||15|At the start of this period, all 60 active participants are randomized to a drug-X-condition arm|
48374658|NCT01253421|101247438|FG000|Received Drug Challenge|Drug+Scanning Visit||0||
48374659|NCT01253421|101247439|FG001|Received Drug Challenge|Drug+Scanning Visit||15||
48374660|NCT01253421|101247440|FG002|Received Drug Challenge|Drug+Scanning Visit||14||
48374661|NCT01253421|101247441|FG003|Received Drug Challenge|Drug+Scanning Visit||16||
48374662|NCT01253421|101247442|FG004|Received Drug Challenge|Drug+Scanning Visit||15||
48374663|NCT01253421|101247438|FG000|COMPLETED|Drug+Scanning Visit||0||
48374664|NCT01253421|101247439|FG001|COMPLETED|Drug+Scanning Visit||15||
48374665|NCT01253421|101247440|FG002|COMPLETED|Drug+Scanning Visit||14||
48374666|NCT01253421|101247441|FG003|COMPLETED|Drug+Scanning Visit||16||
48374667|NCT01253421|101247442|FG004|COMPLETED|Drug+Scanning Visit||14||
48374668|NCT01253421|101247438|FG000|NOT COMPLETED|Drug+Scanning Visit||0||
48374669|NCT01253421|101247439|FG001|NOT COMPLETED|Drug+Scanning Visit||0||
48374670|NCT01253421|101247440|FG002|NOT COMPLETED|Drug+Scanning Visit||0||
48374671|NCT01253421|101247441|FG003|NOT COMPLETED|Drug+Scanning Visit||0||
48374672|NCT01253421|101247442|FG004|NOT COMPLETED|Drug+Scanning Visit||1||
48374673|NCT01005732|101247443|FG000|STARTED|Overall Study||54||
48374674|NCT01005732|101247443|FG000|COMPLETED|Overall Study||43||
48374675|NCT01005732|101247443|FG000|NOT COMPLETED|Overall Study||11||
48374676|NCT00626912|101247444|FG000|STARTED|Overall Study||222||
48374677|NCT00626912|101247445|FG001|STARTED|Overall Study||225||
48374678|NCT00626912|101247444|FG000|COMPLETED|Overall Study||220||
48374679|NCT00626912|101247445|FG001|COMPLETED|Overall Study||215||
48374680|NCT00626912|101247444|FG000|NOT COMPLETED|Overall Study||2||
48374681|NCT00626912|101247445|FG001|NOT COMPLETED|Overall Study||10||
48374682|NCT01240811|101247446|FG000|STARTED|Overall Study||8||
48374683|NCT01240811|101247447|FG001|STARTED|Overall Study||17||
48374684|NCT01240811|101247448|FG002|STARTED|Overall Study||17||
48374685|NCT01240811|101247446|FG000|COMPLETED|Overall Study||8||
48374686|NCT01240811|101247447|FG001|COMPLETED|Overall Study||16||
48523136|NCT01933464|101616060|FG000|STARTED|Overall Study||5||
48523137|NCT01933464|101616061|FG001|STARTED|Overall Study||5||
48078024|NCT01619423|100515082|FG001|COMPLETED|Part 1 (Dose Escalation)||3||
48078025|NCT01619423|100515083|FG002|COMPLETED|Part 1 (Dose Escalation)||3||
48078026|NCT01619423|100515084|FG003|COMPLETED|Part 1 (Dose Escalation)||5||
48078027|NCT01619423|100515081|FG000|NOT COMPLETED|Part 1 (Dose Escalation)||0||
48078028|NCT01619423|100515082|FG001|NOT COMPLETED|Part 1 (Dose Escalation)||2||
48523138|NCT01933464|101616060|FG000|COMPLETED|Overall Study||5||
48078029|NCT01619423|100515083|FG002|NOT COMPLETED|Part 1 (Dose Escalation)||0||
48078030|NCT01619423|100515084|FG003|NOT COMPLETED|Part 1 (Dose Escalation)||0||
48078031|NCT01619423|100515081|FG000|STARTED|Part 2a||15||
48078032|NCT01619423|100515082|FG001|STARTED|Part 2a||13||
48078033|NCT01619423|100515083|FG002|STARTED|Part 2a||0||
48078034|NCT01619423|100515084|FG003|STARTED|Part 2a||11||
48078035|NCT01619423|100515081|FG000|COMPLETED|Part 2a||15||
48078036|NCT01619423|100515082|FG001|COMPLETED|Part 2a||13||
48078037|NCT01619423|100515083|FG002|COMPLETED|Part 2a||0||
48078038|NCT01619423|100515084|FG003|COMPLETED|Part 2a||11||
48078039|NCT01619423|100515081|FG000|NOT COMPLETED|Part 2a||0||
48078040|NCT01619423|100515082|FG001|NOT COMPLETED|Part 2a||0||
48078041|NCT01619423|100515083|FG002|NOT COMPLETED|Part 2a||0||
48078042|NCT01619423|100515084|FG003|NOT COMPLETED|Part 2a||0||
48078043|NCT01619423|100515081|FG000|STARTED|Part 2b||45||
48078044|NCT01619423|100515082|FG001|STARTED|Part 2b||44||
48078045|NCT01619423|100515083|FG002|STARTED|Part 2b||45||
48523139|NCT01933464|101616061|FG001|COMPLETED|Overall Study||5||
48523140|NCT01933464|101616060|FG000|NOT COMPLETED|Overall Study||0||
48523141|NCT01933464|101616061|FG001|NOT COMPLETED|Overall Study||0||
48523142|NCT02771795|101616062|FG000|STARTED|Overall Study||271||
48523143|NCT02771795|101616063|FG001|STARTED|Overall Study||267||
48523144|NCT02771795|101616062|FG000|COMPLETED|Overall Study||56||
48523145|NCT02771795|101616063|FG001|COMPLETED|Overall Study||45||
48523146|NCT02771795|101616062|FG000|NOT COMPLETED|Overall Study||215||
48523147|NCT02771795|101616063|FG001|NOT COMPLETED|Overall Study||222||
48523148|NCT01174082|101616064|FG000|STARTED|Overall Study||1||
48523149|NCT01174082|101616065|FG001|STARTED|Overall Study||1||
48523150|NCT01174082|101616064|FG000|COMPLETED|Overall Study||1||
48523151|NCT01174082|101616065|FG001|COMPLETED|Overall Study||1||
48523152|NCT01174082|101616064|FG000|NOT COMPLETED|Overall Study||0||
48523153|NCT01174082|101616065|FG001|NOT COMPLETED|Overall Study||0||
48523154|NCT02221037|101616066|FG000|STARTED|Overall Study||5||
48523155|NCT02221037|101616067|FG001|STARTED|Overall Study||11||
48523156|NCT02221037|101616068|FG002|STARTED|Overall Study||8||
48523157|NCT02221037|101616069|FG003|STARTED|Overall Study||9||
48523158|NCT02221037|101616066|FG000|COMPLETED|Overall Study||5||
48523159|NCT02221037|101616067|FG001|COMPLETED|Overall Study||11||
48523160|NCT02221037|101616068|FG002|COMPLETED|Overall Study||7||
48523161|NCT02221037|101616069|FG003|COMPLETED|Overall Study||9||
48523162|NCT02221037|101616066|FG000|NOT COMPLETED|Overall Study||0||
48523163|NCT02221037|101616067|FG001|NOT COMPLETED|Overall Study||0||
48523164|NCT02221037|101616068|FG002|NOT COMPLETED|Overall Study||1||
48523165|NCT02221037|101616069|FG003|NOT COMPLETED|Overall Study||0||
48523166|NCT02071953|101616070|FG000|STARTED|Overall Study||35||53
48523167|NCT02071953|101616071|FG001|STARTED|Overall Study||35||54
48523168|NCT02071953|101616070|FG000|COMPLETED|Overall Study||18||30
48523169|NCT02071953|101616071|FG001|COMPLETED|Overall Study||21||34
48523170|NCT02071953|101616070|FG000|NOT COMPLETED|Overall Study||17||23
48523171|NCT02071953|101616071|FG001|NOT COMPLETED|Overall Study||14||20
48523172|NCT03334721|101616072|FG000|STARTED|Overall Study||12||
48523173|NCT03334721|101616073|FG001|STARTED|Overall Study||11||
48523174|NCT03334721|101616072|FG000|COMPLETED|Overall Study||10||
48523175|NCT03334721|101616073|FG001|COMPLETED|Overall Study||11||
48523176|NCT03334721|101616072|FG000|NOT COMPLETED|Overall Study||2||
48078046|NCT01619423|100515084|FG003|STARTED|Part 2b||0||
48078047|NCT01619423|100515081|FG000|COMPLETED|Part 2b||45||
48078048|NCT01619423|100515082|FG001|COMPLETED|Part 2b||44||
48078049|NCT01619423|100515083|FG002|COMPLETED|Part 2b||45||
48078050|NCT01619423|100515084|FG003|COMPLETED|Part 2b||0||
48078051|NCT01619423|100515081|FG000|NOT COMPLETED|Part 2b||0||
48078052|NCT01619423|100515082|FG001|NOT COMPLETED|Part 2b||0||
48078053|NCT01619423|100515083|FG002|NOT COMPLETED|Part 2b||0||
48078054|NCT01619423|100515084|FG003|NOT COMPLETED|Part 2b||0||
48078055|NCT00558558|100515085|FG000|STARTED|Overall Study||6||
48078056|NCT00558558|100515085|FG000|COMPLETED|Overall Study||0||
48078057|NCT00558558|100515085|FG000|NOT COMPLETED|Overall Study||6||
48078058|NCT00838578|100515086|FG000|STARTED|Overall Study||65||
48078059|NCT00838578|100515086|FG000|COMPLETED|Overall Study||63||
48078060|NCT00838578|100515086|FG000|NOT COMPLETED|Overall Study||2||
48078061|NCT00833794|100515087|FG000|STARTED|Open-label Phase||1028||
48078062|NCT00833794|100515088|FG001|STARTED|Open-label Phase||0||
48078063|NCT00833794|100515087|FG000|Entered run-in Period|Open-label Phase||1027||
48078064|NCT00833794|100515088|FG001|Entered run-in Period|Open-label Phase||0||
48078065|NCT00833794|100515087|FG000|Received Open-Label Treatment|Open-label Phase||1023||
48078066|NCT00833794|100515088|FG001|Received Open-Label Treatment|Open-label Phase||0||
48078067|NCT00833794|100515087|FG000|COMPLETED|Open-label Phase||646||
48078068|NCT00833794|100515088|FG001|COMPLETED|Open-label Phase||0||
48078069|NCT00833794|100515087|FG000|NOT COMPLETED|Open-label Phase||382||
48078070|NCT00833794|100515088|FG001|NOT COMPLETED|Open-label Phase||0||
48078071|NCT00833794|100515087|FG000|STARTED|Double-blind Phase||432||
48078072|NCT00833794|100515088|FG001|STARTED|Double-blind Phase||214||
48078073|NCT00833794|100515087|FG000|COMPLETED|Double-blind Phase||326||
48078074|NCT00833794|100515088|FG001|COMPLETED|Double-blind Phase||165||
48078075|NCT00833794|100515087|FG000|NOT COMPLETED|Double-blind Phase||106||
48523177|NCT03334721|101616073|FG001|NOT COMPLETED|Overall Study||0||
48078076|NCT00833794|100515088|FG001|NOT COMPLETED|Double-blind Phase||49||
48078077|NCT01227434|100515089|FG000|STARTED|Overall Study||6||
48078078|NCT01227434|100515090|FG001|STARTED|Overall Study||16||
48078079|NCT01227434|100515089|FG000|COMPLETED|Overall Study||6||
48078080|NCT01227434|100515090|FG001|COMPLETED|Overall Study||16||
48078081|NCT01227434|100515089|FG000|NOT COMPLETED|Overall Study||0||
48078082|NCT01227434|100515090|FG001|NOT COMPLETED|Overall Study||0||
48078083|NCT01169493|100515091|FG000|STARTED|Period 1 (6 Months)||2||
48078084|NCT01169493|100515092|FG001|STARTED|Period 1 (6 Months)||4||
48078085|NCT01169493|100515093|FG002|STARTED|Period 1 (6 Months)||5||
48078086|NCT01169493|100515094|FG003|STARTED|Period 1 (6 Months)||0||
48078087|NCT01169493|100515095|FG004|STARTED|Period 1 (6 Months)||0||
48078088|NCT01169493|100515096|FG005|STARTED|Period 1 (6 Months)||5||
48227350|NCT00866619|100877974|FG000|COMPLETED|Overall Study||4102||
48227351|NCT00866619|100877975|FG001|COMPLETED|Overall Study||3088||
48227352|NCT00866619|100877976|FG002|COMPLETED|Overall Study||2085||
48227353|NCT00866619|100877977|FG003|COMPLETED|Overall Study||1549||
48227354|NCT00866619|100877974|FG000|NOT COMPLETED|Overall Study||1846||
48227355|NCT00866619|100877975|FG001|NOT COMPLETED|Overall Study||1270||
48078089|NCT01169493|100515091|FG000|COMPLETED|Period 1 (6 Months)||2||
48078090|NCT01169493|100515092|FG001|COMPLETED|Period 1 (6 Months)||3||
48078091|NCT01169493|100515093|FG002|COMPLETED|Period 1 (6 Months)||3||
48078092|NCT01169493|100515094|FG003|COMPLETED|Period 1 (6 Months)||0||
48078093|NCT01169493|100515095|FG004|COMPLETED|Period 1 (6 Months)||0||
48078094|NCT01169493|100515096|FG005|COMPLETED|Period 1 (6 Months)||2||
48078095|NCT01169493|100515091|FG000|NOT COMPLETED|Period 1 (6 Months)||0||
48078096|NCT01169493|100515092|FG001|NOT COMPLETED|Period 1 (6 Months)||1||
48078097|NCT01169493|100515093|FG002|NOT COMPLETED|Period 1 (6 Months)||2||
48078098|NCT01169493|100515094|FG003|NOT COMPLETED|Period 1 (6 Months)||0||
48078099|NCT01169493|100515095|FG004|NOT COMPLETED|Period 1 (6 Months)||0||
48078100|NCT01169493|100515096|FG005|NOT COMPLETED|Period 1 (6 Months)||3||
48078101|NCT01169493|100515091|FG000|STARTED|Period 2 (6 Months)||2||
48078102|NCT01169493|100515092|FG001|STARTED|Period 2 (6 Months)||3||
48078103|NCT01169493|100515093|FG002|STARTED|Period 2 (6 Months)||3||
48078104|NCT01169493|100515094|FG003|STARTED|Period 2 (6 Months)||0||
48078105|NCT01169493|100515095|FG004|STARTED|Period 2 (6 Months)||0||
48078106|NCT01169493|100515096|FG005|STARTED|Period 2 (6 Months)||2||
48078107|NCT01169493|100515091|FG000|COMPLETED|Period 2 (6 Months)||2||
48078108|NCT01169493|100515092|FG001|COMPLETED|Period 2 (6 Months)||3||
48078109|NCT01169493|100515093|FG002|COMPLETED|Period 2 (6 Months)||3||
48523178|NCT01332578|101616074|FG000|STARTED|Period I||12||
48523179|NCT01332578|101616075|FG001|STARTED|Period I||13||
48523180|NCT01332578|101616074|FG000|COMPLETED|Period I||12||
48523181|NCT01332578|101616075|FG001|COMPLETED|Period I||13||
48523182|NCT01332578|101616074|FG000|NOT COMPLETED|Period I||0||
48523183|NCT01332578|101616075|FG001|NOT COMPLETED|Period I||0||
48078110|NCT01169493|100515094|FG003|COMPLETED|Period 2 (6 Months)||0||
48078111|NCT01169493|100515095|FG004|COMPLETED|Period 2 (6 Months)||0||
48078112|NCT01169493|100515096|FG005|COMPLETED|Period 2 (6 Months)||2||
48078113|NCT01169493|100515091|FG000|NOT COMPLETED|Period 2 (6 Months)||0||
48078114|NCT01169493|100515092|FG001|NOT COMPLETED|Period 2 (6 Months)||0||
48078115|NCT01169493|100515093|FG002|NOT COMPLETED|Period 2 (6 Months)||0||
48078116|NCT01169493|100515094|FG003|NOT COMPLETED|Period 2 (6 Months)||0||
48078117|NCT01169493|100515095|FG004|NOT COMPLETED|Period 2 (6 Months)||0||
48078118|NCT01169493|100515096|FG005|NOT COMPLETED|Period 2 (6 Months)||0||
48227356|NCT00866619|100877976|FG002|NOT COMPLETED|Overall Study||889||
48227357|NCT00866619|100877977|FG003|NOT COMPLETED|Overall Study||630||
48078119|NCT01169493|100515091|FG000|STARTED|Period 3 (6 Months)||2||
48078120|NCT01169493|100515092|FG001|STARTED|Period 3 (6 Months)||3||
48078121|NCT01169493|100515093|FG002|STARTED|Period 3 (6 Months)||3||
48078122|NCT01169493|100515094|FG003|STARTED|Period 3 (6 Months)||0||
48078123|NCT01169493|100515095|FG004|STARTED|Period 3 (6 Months)||0||
48078124|NCT01169493|100515096|FG005|STARTED|Period 3 (6 Months)||2||
48078125|NCT01169493|100515091|FG000|COMPLETED|Period 3 (6 Months)||2||
48078126|NCT01169493|100515092|FG001|COMPLETED|Period 3 (6 Months)||1||
48078127|NCT01169493|100515093|FG002|COMPLETED|Period 3 (6 Months)||2||
48078128|NCT01169493|100515094|FG003|COMPLETED|Period 3 (6 Months)||0||
48078129|NCT01169493|100515095|FG004|COMPLETED|Period 3 (6 Months)||0||
48227358|NCT02988713|100877978|FG000|STARTED|Overall Study||35||
48227359|NCT02988713|100877978|FG000|COMPLETED|Overall Study||32||
48227360|NCT02988713|100877978|FG000|NOT COMPLETED|Overall Study||3||
48227361|NCT03578965|100877979|FG000|STARTED|Overall Study||24||
48078130|NCT01169493|100515096|FG005|COMPLETED|Period 3 (6 Months)||2||
48078131|NCT01169493|100515091|FG000|NOT COMPLETED|Period 3 (6 Months)||0||
48078132|NCT01169493|100515092|FG001|NOT COMPLETED|Period 3 (6 Months)||2||
48078133|NCT01169493|100515093|FG002|NOT COMPLETED|Period 3 (6 Months)||1||
48078134|NCT01169493|100515094|FG003|NOT COMPLETED|Period 3 (6 Months)||0||
48078135|NCT01169493|100515095|FG004|NOT COMPLETED|Period 3 (6 Months)||0||
48078136|NCT01169493|100515096|FG005|NOT COMPLETED|Period 3 (6 Months)||0||
48078137|NCT03230097|100515097|FG000|STARTED|Overall Study||24||
48227362|NCT03578965|100877980|FG001|STARTED|Overall Study||26||
48227363|NCT03578965|100877979|FG000|COMPLETED|Overall Study||24||
48227364|NCT03578965|100877980|FG001|COMPLETED|Overall Study||26||
48078138|NCT03230097|100515098|FG001|STARTED|Overall Study||26||
48078139|NCT03230097|100515097|FG000|COMPLETED|Overall Study||9||
48078140|NCT03230097|100515098|FG001|COMPLETED|Overall Study||10||
48078141|NCT03230097|100515097|FG000|NOT COMPLETED|Overall Study||15||
48227365|NCT03578965|100877979|FG000|NOT COMPLETED|Overall Study||0||
48227366|NCT03578965|100877980|FG001|NOT COMPLETED|Overall Study||0||
48227367|NCT00507767|100877981|FG000|STARTED|Overall Study||15||
48078142|NCT03230097|100515098|FG001|NOT COMPLETED|Overall Study||16||
48078143|NCT00395304|100515099|FG000|STARTED|Treatment Period 1||31||
48078144|NCT00395304|100515100|FG001|STARTED|Treatment Period 1||30||
48078145|NCT00395304|100515101|FG002|STARTED|Treatment Period 1||30||
48078146|NCT00395304|100515102|FG003|STARTED|Treatment Period 1||31||
48078147|NCT00395304|100515103|FG004|STARTED|Treatment Period 1||28||
48078148|NCT00395304|100515104|FG005|STARTED|Treatment Period 1||32||
48078149|NCT00395304|100515099|FG000|COMPLETED|Treatment Period 1||30||
48078150|NCT00395304|100515100|FG001|COMPLETED|Treatment Period 1||26||
48078151|NCT00395304|100515101|FG002|COMPLETED|Treatment Period 1||30||
48078152|NCT00395304|100515102|FG003|COMPLETED|Treatment Period 1||28||
48078153|NCT00395304|100515103|FG004|COMPLETED|Treatment Period 1||27||
48078154|NCT00395304|100515104|FG005|COMPLETED|Treatment Period 1||30||
48078155|NCT00395304|100515099|FG000|NOT COMPLETED|Treatment Period 1||1||
48078156|NCT00395304|100515100|FG001|NOT COMPLETED|Treatment Period 1||4||
48078157|NCT00395304|100515101|FG002|NOT COMPLETED|Treatment Period 1||0||
48078158|NCT00395304|100515102|FG003|NOT COMPLETED|Treatment Period 1||3||
48078159|NCT00395304|100515103|FG004|NOT COMPLETED|Treatment Period 1||1||
48078160|NCT00395304|100515104|FG005|NOT COMPLETED|Treatment Period 1||2||
48078161|NCT00395304|100515099|FG000|STARTED|Treatment Period 2||30||
48078162|NCT00395304|100515100|FG001|STARTED|Treatment Period 2||26||
48078163|NCT00395304|100515101|FG002|STARTED|Treatment Period 2||30||
48078164|NCT00395304|100515102|FG003|STARTED|Treatment Period 2||28||
48078165|NCT00395304|100515103|FG004|STARTED|Treatment Period 2||27||
48078166|NCT00395304|100515104|FG005|STARTED|Treatment Period 2||30||
48078167|NCT00395304|100515099|FG000|COMPLETED|Treatment Period 2||30||
48078168|NCT00395304|100515100|FG001|COMPLETED|Treatment Period 2||22||
48078169|NCT00395304|100515101|FG002|COMPLETED|Treatment Period 2||29||
48078170|NCT00395304|100515102|FG003|COMPLETED|Treatment Period 2||27||
48078171|NCT00395304|100515103|FG004|COMPLETED|Treatment Period 2||27||
48078172|NCT00395304|100515104|FG005|COMPLETED|Treatment Period 2||28||
48078173|NCT00395304|100515099|FG000|NOT COMPLETED|Treatment Period 2||0||
48078174|NCT00395304|100515100|FG001|NOT COMPLETED|Treatment Period 2||4||
48078175|NCT00395304|100515101|FG002|NOT COMPLETED|Treatment Period 2||1||
48227368|NCT00507767|100877981|FG000|COMPLETED|Overall Study||15||
48227369|NCT00507767|100877981|FG000|NOT COMPLETED|Overall Study||0||
48227370|NCT01026805|100877982|FG000|STARTED|Overall Study||11||
48227371|NCT01026805|100877982|FG000|COMPLETED|Overall Study||11||
48227372|NCT01026805|100877982|FG000|NOT COMPLETED|Overall Study||0||
48227373|NCT03259568|100877983|FG000|STARTED|Overall Study||27||
48078176|NCT00395304|100515102|FG003|NOT COMPLETED|Treatment Period 2||1||
48078177|NCT00395304|100515103|FG004|NOT COMPLETED|Treatment Period 2||0||
48078178|NCT00395304|100515104|FG005|NOT COMPLETED|Treatment Period 2||2||
48078179|NCT00395304|100515099|FG000|STARTED|Treatment Period 3||30||
48078180|NCT00395304|100515100|FG001|STARTED|Treatment Period 3||22||
48078181|NCT00395304|100515101|FG002|STARTED|Treatment Period 3||29||
48078182|NCT00395304|100515102|FG003|STARTED|Treatment Period 3||27||
48078183|NCT00395304|100515103|FG004|STARTED|Treatment Period 3||27||
48078184|NCT00395304|100515104|FG005|STARTED|Treatment Period 3||28||
48078185|NCT00395304|100515099|FG000|COMPLETED|Treatment Period 3||29||
48078186|NCT00395304|100515100|FG001|COMPLETED|Treatment Period 3||20||
48078187|NCT00395304|100515101|FG002|COMPLETED|Treatment Period 3||29||
48078188|NCT00395304|100515102|FG003|COMPLETED|Treatment Period 3||25||
48078189|NCT00395304|100515103|FG004|COMPLETED|Treatment Period 3||27||
48078190|NCT00395304|100515104|FG005|COMPLETED|Treatment Period 3||27||
48078191|NCT00395304|100515099|FG000|NOT COMPLETED|Treatment Period 3||1||
48078192|NCT00395304|100515100|FG001|NOT COMPLETED|Treatment Period 3||2||
48078193|NCT00395304|100515101|FG002|NOT COMPLETED|Treatment Period 3||0||
48078194|NCT00395304|100515102|FG003|NOT COMPLETED|Treatment Period 3||2||
48078195|NCT00395304|100515103|FG004|NOT COMPLETED|Treatment Period 3||0||
48078196|NCT00395304|100515104|FG005|NOT COMPLETED|Treatment Period 3||1||
48078197|NCT03644212|100515105|FG000|STARTED|Overall Study||63||
48078198|NCT03644212|100515106|FG001|STARTED|Overall Study||16||
48078199|NCT03644212|100515105|FG000|COMPLETED|Overall Study||63||
48078200|NCT03644212|100515106|FG001|COMPLETED|Overall Study||16||
48078201|NCT03644212|100515105|FG000|NOT COMPLETED|Overall Study||0||
48078202|NCT03644212|100515106|FG001|NOT COMPLETED|Overall Study||0||
48227374|NCT03259568|100877983|FG000|COMPLETED|Overall Study||24||
48227375|NCT03259568|100877983|FG000|NOT COMPLETED|Overall Study||3||
48227376|NCT00875706|100877984|FG000|STARTED|Overall Study||8||
48227377|NCT00875706|100877985|FG001|STARTED|Overall Study||24||
48227378|NCT00875706|100877986|FG002|STARTED|Overall Study||13||
48227379|NCT00875706|100877984|FG000|COMPLETED|Overall Study||7||
48227380|NCT00875706|100877985|FG001|COMPLETED|Overall Study||24||
48227381|NCT00875706|100877986|FG002|COMPLETED|Overall Study||13||
48227382|NCT00875706|100877984|FG000|NOT COMPLETED|Overall Study||1||
48078203|NCT03486223|100515107|FG000|STARTED|Intervention 1||8||
48078204|NCT03486223|100515108|FG001|STARTED|Intervention 1||8||
48078205|NCT03486223|100515107|FG000|COMPLETED|Intervention 1||8||
48078206|NCT03486223|100515108|FG001|COMPLETED|Intervention 1||7||
48078207|NCT03486223|100515107|FG000|NOT COMPLETED|Intervention 1||0||
48078208|NCT03486223|100515108|FG001|NOT COMPLETED|Intervention 1||1||
48078209|NCT03486223|100515107|FG000|STARTED|Washout||8||
48078210|NCT03486223|100515108|FG001|STARTED|Washout||7||
48078211|NCT03486223|100515107|FG000|COMPLETED|Washout||8||
48078212|NCT03486223|100515108|FG001|COMPLETED|Washout||7||
48227383|NCT00875706|100877985|FG001|NOT COMPLETED|Overall Study||0||
48227384|NCT00875706|100877986|FG002|NOT COMPLETED|Overall Study||0||
48227385|NCT01092416|100877987|FG000|STARTED|Enrollment||443||
48078213|NCT03486223|100515107|FG000|NOT COMPLETED|Washout||0||
48078214|NCT03486223|100515108|FG001|NOT COMPLETED|Washout||0||
48078215|NCT03486223|100515107|FG000|STARTED|Intervention 2||8||
48078216|NCT03486223|100515108|FG001|STARTED|Intervention 2||7||
48078217|NCT03486223|100515107|FG000|COMPLETED|Intervention 2||8||
48078218|NCT03486223|100515108|FG001|COMPLETED|Intervention 2||7||
48078219|NCT03486223|100515107|FG000|NOT COMPLETED|Intervention 2||0||
48078220|NCT03486223|100515108|FG001|NOT COMPLETED|Intervention 2||0||
48078221|NCT00687323|100515109|FG000|STARTED|Overall Study||195||
48078222|NCT00687323|100515109|FG000|Received Treatment|Overall Study||47||
48078223|NCT00687323|100515109|FG000|COMPLETED|Overall Study||15||
48078224|NCT00687323|100515109|FG000|NOT COMPLETED|Overall Study||180||
48078225|NCT02643381|100515110|FG000|STARTED|Overall Study||400||
48078226|NCT02643381|100515111|FG001|STARTED|Overall Study||401||
48078227|NCT02643381|100515110|FG000|COMPLETED|Overall Study||396||
48078228|NCT02643381|100515111|FG001|COMPLETED|Overall Study||395||
48078229|NCT02643381|100515110|FG000|NOT COMPLETED|Overall Study||4||
48078230|NCT02643381|100515111|FG001|NOT COMPLETED|Overall Study||6||
48078231|NCT01782222|100515112|FG000|STARTED|Overall Study||40||
48078232|NCT01782222|100515113|FG001|STARTED|Overall Study||41||
48227386|NCT01092416|100877987|FG000|COMPLETED|Enrollment||440||
48227387|NCT01092416|100877987|FG000|NOT COMPLETED|Enrollment||3||
48227388|NCT01092416|100877987|FG000|STARTED|30-Day Follow-up||440||
48227389|NCT01092416|100877987|FG000|COMPLETED|30-Day Follow-up||430||
48227390|NCT01092416|100877987|FG000|NOT COMPLETED|30-Day Follow-up||10||
48227391|NCT01092416|100877987|FG000|STARTED|12-Month Follow-up||438||
48227392|NCT01092416|100877987|FG000|COMPLETED|12-Month Follow-up||413||
48227393|NCT01092416|100877987|FG000|NOT COMPLETED|12-Month Follow-up||25||
48227394|NCT04009291|100877988|FG000|STARTED|Blinded Period (Weeks 0 to 4)||14||
48227395|NCT04009291|100877989|FG001|STARTED|Blinded Period (Weeks 0 to 4)||15||
48227396|NCT04009291|100877990|FG002|STARTED|Blinded Period (Weeks 0 to 4)||15||
48227397|NCT04009291|100877991|FG003|STARTED|Blinded Period (Weeks 0 to 4)||15||
48227398|NCT04009291|100877992|FG004|STARTED|Blinded Period (Weeks 0 to 4)||0||
48227399|NCT04009291|100877988|FG000|COMPLETED|Blinded Period (Weeks 0 to 4)||14||
48227400|NCT04009291|100877989|FG001|COMPLETED|Blinded Period (Weeks 0 to 4)||15||
48227401|NCT04009291|100877990|FG002|COMPLETED|Blinded Period (Weeks 0 to 4)||15||
48227402|NCT04009291|100877991|FG003|COMPLETED|Blinded Period (Weeks 0 to 4)||15||
48227403|NCT04009291|100877992|FG004|COMPLETED|Blinded Period (Weeks 0 to 4)||0||
48227404|NCT04009291|100877988|FG000|NOT COMPLETED|Blinded Period (Weeks 0 to 4)||0||
48227405|NCT04009291|100877989|FG001|NOT COMPLETED|Blinded Period (Weeks 0 to 4)||0||
48227406|NCT04009291|100877990|FG002|NOT COMPLETED|Blinded Period (Weeks 0 to 4)||0||
48227407|NCT04009291|100877991|FG003|NOT COMPLETED|Blinded Period (Weeks 0 to 4)||0||
48227408|NCT04009291|100877992|FG004|NOT COMPLETED|Blinded Period (Weeks 0 to 4)||0||
48227409|NCT04009291|100877988|FG000|STARTED|Open-Label Period (Weeks 4 to 266)||0||
48227410|NCT04009291|100877989|FG001|STARTED|Open-Label Period (Weeks 4 to 266)||0||
48227411|NCT04009291|100877990|FG002|STARTED|Open-Label Period (Weeks 4 to 266)||0||
48227412|NCT04009291|100877991|FG003|STARTED|Open-Label Period (Weeks 4 to 266)||0||
48227413|NCT04009291|100877992|FG004|STARTED|Open-Label Period (Weeks 4 to 266)||59||
48227414|NCT04009291|100877988|FG000|COMPLETED|Open-Label Period (Weeks 4 to 266)||0||
48227415|NCT04009291|100877989|FG001|COMPLETED|Open-Label Period (Weeks 4 to 266)||0||
48227416|NCT04009291|100877990|FG002|COMPLETED|Open-Label Period (Weeks 4 to 266)||0||
48227417|NCT04009291|100877991|FG003|COMPLETED|Open-Label Period (Weeks 4 to 266)||0||
48227418|NCT04009291|100877992|FG004|COMPLETED|Open-Label Period (Weeks 4 to 266)||0||
48523184|NCT01332578|101616074|FG000|STARTED|Washout Period||12||
48227419|NCT04009291|100877988|FG000|NOT COMPLETED|Open-Label Period (Weeks 4 to 266)||0||
48227420|NCT04009291|100877989|FG001|NOT COMPLETED|Open-Label Period (Weeks 4 to 266)||0||
48227421|NCT04009291|100877990|FG002|NOT COMPLETED|Open-Label Period (Weeks 4 to 266)||0||
48078233|NCT01782222|100515114|FG002|STARTED|Overall Study||41||
48078234|NCT01782222|100515112|FG000|COMPLETED|Overall Study||32||
48227422|NCT04009291|100877991|FG003|NOT COMPLETED|Open-Label Period (Weeks 4 to 266)||0||
48227423|NCT04009291|100877992|FG004|NOT COMPLETED|Open-Label Period (Weeks 4 to 266)||59||
48227424|NCT02208843|100877993|FG000|STARTED|Overall Study||60|Patients entered the study and all received at least 1 dose of afatinib|
48227425|NCT02208843|100877993|FG000|COMPLETED|Overall Study||0||
48227426|NCT02208843|100877993|FG000|NOT COMPLETED|Overall Study||60||
48227427|NCT04748341|100877994|FG000|STARTED|Overall Study||31||
48227428|NCT04748341|100877995|FG001|STARTED|Overall Study||31||
48227429|NCT04748341|100877994|FG000|COMPLETED|Overall Study||30||
48227430|NCT04748341|100877995|FG001|COMPLETED|Overall Study||30||
48227431|NCT04748341|100877994|FG000|NOT COMPLETED|Overall Study||1||
48227432|NCT04748341|100877995|FG001|NOT COMPLETED|Overall Study||1||
48227433|NCT02185794|100877996|FG000|STARTED|Overall Study||9||
48227434|NCT02185794|100877997|FG001|STARTED|Overall Study||20||
48227435|NCT02185794|100877998|FG002|STARTED|Overall Study||33||
48227436|NCT02185794|100877999|FG003|STARTED|Overall Study||16||
48078235|NCT01782222|100515113|FG001|COMPLETED|Overall Study||30||
48078236|NCT01782222|100515114|FG002|COMPLETED|Overall Study||37||
48078237|NCT01782222|100515112|FG000|NOT COMPLETED|Overall Study||8||
48078238|NCT01782222|100515113|FG001|NOT COMPLETED|Overall Study||11||
48078239|NCT01782222|100515114|FG002|NOT COMPLETED|Overall Study||4||
48078240|NCT03310775|100515115|FG000|STARTED|Overall Study||19||
48078241|NCT03310775|100515116|FG001|STARTED|Overall Study||18||
48078242|NCT03310775|100515115|FG000|COMPLETED|Overall Study||17||
48078243|NCT03310775|100515116|FG001|COMPLETED|Overall Study||14||
48078244|NCT03310775|100515115|FG000|NOT COMPLETED|Overall Study||2||
48078245|NCT03310775|100515116|FG001|NOT COMPLETED|Overall Study||4||
48078246|NCT00680706|100515117|FG000|STARTED|Overall Study||70||
48078247|NCT00680706|100515118|FG001|STARTED|Overall Study||60||
48078248|NCT00680706|100515117|FG000|COMPLETED|Overall Study||63||
48078249|NCT00680706|100515118|FG001|COMPLETED|Overall Study||55||
48227437|NCT02185794|100878000|FG004|STARTED|Overall Study||7||
48227438|NCT02185794|100878001|FG005|STARTED|Overall Study||16||
48227439|NCT02185794|100877996|FG000|COMPLETED|Overall Study||4||
48227440|NCT02185794|100877997|FG001|COMPLETED|Overall Study||7||
48227441|NCT02185794|100877998|FG002|COMPLETED|Overall Study||17||
48227442|NCT02185794|100877999|FG003|COMPLETED|Overall Study||8||
48227443|NCT02185794|100878000|FG004|COMPLETED|Overall Study||4||
48078250|NCT00680706|100515117|FG000|NOT COMPLETED|Overall Study||7||
48078251|NCT00680706|100515118|FG001|NOT COMPLETED|Overall Study||5||
48078252|NCT00586001|100515119|FG000|STARTED|Overall Study||26||
48078253|NCT00586001|100515120|FG001|STARTED|Overall Study||11||
48078254|NCT00586001|100515119|FG000|COMPLETED|Overall Study||22||
48078255|NCT00586001|100515120|FG001|COMPLETED|Overall Study||10||
48078256|NCT00586001|100515119|FG000|NOT COMPLETED|Overall Study||4||
48078257|NCT00586001|100515120|FG001|NOT COMPLETED|Overall Study||1||
48078258|NCT01023620|100515121|FG000|STARTED|Overall Study||0||
48078259|NCT01023620|100515122|FG001|STARTED|Overall Study||0||
48078260|NCT01023620|100515121|FG000|COMPLETED|Overall Study||0||
48078261|NCT01023620|100515122|FG001|COMPLETED|Overall Study||0||
48078262|NCT01023620|100515121|FG000|NOT COMPLETED|Overall Study||0||
48078263|NCT01023620|100515122|FG001|NOT COMPLETED|Overall Study||0||
48078264|NCT05012683|100515123|FG000|STARTED|No Prosthesis (Day 0)||11||
48078265|NCT05012683|100515123|FG000|COMPLETED|No Prosthesis (Day 0)||11||
48078266|NCT05012683|100515123|FG000|NOT COMPLETED|No Prosthesis (Day 0)||0||
48078267|NCT05012683|100515123|FG000|STARTED|Prosthesis (Day 0)||11||
48078268|NCT05012683|100515123|FG000|COMPLETED|Prosthesis (Day 0)||11||
48078269|NCT05012683|100515123|FG000|NOT COMPLETED|Prosthesis (Day 0)||0||
48078270|NCT05012683|100515123|FG000|STARTED|Prosthesis (Day 30)||11||
48078271|NCT05012683|100515123|FG000|COMPLETED|Prosthesis (Day 30)||11||
48078272|NCT05012683|100515123|FG000|NOT COMPLETED|Prosthesis (Day 30)||0||
48078273|NCT05012683|100515123|FG000|STARTED|Prosthesis (Day 60)||11||
48078274|NCT05012683|100515123|FG000|COMPLETED|Prosthesis (Day 60)||11||
48078275|NCT05012683|100515123|FG000|NOT COMPLETED|Prosthesis (Day 60)||0||
48078276|NCT00844714|100515124|FG000|STARTED|Overall Study||20||
48078277|NCT00844714|100515124|FG000|COMPLETED|Overall Study||20||
48078278|NCT00844714|100515124|FG000|NOT COMPLETED|Overall Study||0||
48078279|NCT01209260|100515125|FG000|STARTED|Overall Study||36||
48078280|NCT01209260|100515126|FG001|STARTED|Overall Study||36||
48078281|NCT01209260|100515125|FG000|COMPLETED|Overall Study||36||
48078282|NCT01209260|100515126|FG001|COMPLETED|Overall Study||36||
48078283|NCT01209260|100515125|FG000|NOT COMPLETED|Overall Study||0||
48078284|NCT01209260|100515126|FG001|NOT COMPLETED|Overall Study||0||
48078285|NCT02321800|100515127|FG000|STARTED|Overall Study||303||
48078286|NCT02321800|100515128|FG001|STARTED|Overall Study||149||
48078287|NCT02321800|100515127|FG000|Received Study Drug|Overall Study||300||
48078288|NCT02321800|100515128|FG001|Received Study Drug|Overall Study||148||
48227444|NCT02185794|100878001|FG005|COMPLETED|Overall Study||0||
48227445|NCT02185794|100877996|FG000|NOT COMPLETED|Overall Study||5||
48227446|NCT02185794|100877997|FG001|NOT COMPLETED|Overall Study||13||
48227447|NCT02185794|100877998|FG002|NOT COMPLETED|Overall Study||16||
48227448|NCT02185794|100877999|FG003|NOT COMPLETED|Overall Study||8||
48227449|NCT02185794|100878000|FG004|NOT COMPLETED|Overall Study||3||
48227450|NCT02185794|100878001|FG005|NOT COMPLETED|Overall Study||16||
48227451|NCT03485287|100878002|FG000|STARTED|Overall Study||4||
48227452|NCT03485287|100878002|FG000|COMPLETED|Overall Study||4||
48227453|NCT03485287|100878002|FG000|NOT COMPLETED|Overall Study||0||
48227454|NCT00703391|100878003|FG000|STARTED|Overall Study||12||
48227455|NCT00703391|100878004|FG001|STARTED|Overall Study||6||
48227456|NCT00703391|100878003|FG000|COMPLETED|Overall Study||12||
48227457|NCT00703391|100878004|FG001|COMPLETED|Overall Study||6||
48227458|NCT00703391|100878003|FG000|NOT COMPLETED|Overall Study||0||
48227459|NCT00703391|100878004|FG001|NOT COMPLETED|Overall Study||0||
48227460|NCT02915783|100878005|FG000|STARTED|Overall Study||31||
48227461|NCT02915783|100878005|FG000|COMPLETED|Overall Study||7||
48227462|NCT02915783|100878005|FG000|NOT COMPLETED|Overall Study||24||
48227463|NCT02158806|100878006|FG000|STARTED|Overall Study||125||
48227464|NCT02158806|100878007|FG001|STARTED|Overall Study||126||
48227465|NCT02158806|100878006|FG000|COMPLETED|Overall Study||121||
48227466|NCT02158806|100878007|FG001|COMPLETED|Overall Study||121||
48227467|NCT02158806|100878006|FG000|NOT COMPLETED|Overall Study||4||
48227468|NCT02158806|100878007|FG001|NOT COMPLETED|Overall Study||5||
48227469|NCT02634307|100878008|FG000|STARTED|Overall Study||593||
48227470|NCT02634307|100878009|FG001|STARTED|Overall Study||239||
48227471|NCT02634307|100878010|FG002|STARTED|Overall Study||225||
48227472|NCT02634307|100878008|FG000|Safety Population|Overall Study||593||
48227473|NCT02634307|100878009|FG001|Safety Population|Overall Study||239||
48227474|NCT02634307|100878010|FG002|Safety Population|Overall Study||225||
48227475|NCT02634307|100878008|FG000|Full Analysis Set (FAS) Population|Overall Study||582||
48227476|NCT02634307|100878009|FG001|Full Analysis Set (FAS) Population|Overall Study||235||
48227477|NCT02634307|100878010|FG002|Full Analysis Set (FAS) Population|Overall Study||224||
48227478|NCT02634307|100878008|FG000|COMPLETED|Overall Study||468||
48227479|NCT02634307|100878009|FG001|COMPLETED|Overall Study||168||
48227480|NCT02634307|100878010|FG002|COMPLETED|Overall Study||164||
48227481|NCT02634307|100878008|FG000|NOT COMPLETED|Overall Study||125||
48227482|NCT02634307|100878009|FG001|NOT COMPLETED|Overall Study||71||
48227483|NCT02634307|100878010|FG002|NOT COMPLETED|Overall Study||61||
48227484|NCT03065400|100878011|FG000|STARTED|Overall Study||10||
48227485|NCT03065400|100878011|FG000|COMPLETED|Overall Study||0||
48227486|NCT03065400|100878011|FG000|NOT COMPLETED|Overall Study||10||
48227487|NCT02040870|100878012|FG000|STARTED|Overall Study||103|Treatment Phase|
48227488|NCT02040870|100878012|FG000|Entered Post-treatment Follow-up|Overall Study||2||
48227489|NCT02040870|100878012|FG000|Entered Survival Follow-up|Overall Study||75||
48227490|NCT02040870|100878012|FG000|Discontinue From Study|Overall Study||26||
48227491|NCT02040870|100878012|FG000|COMPLETED|Overall Study||0||
48227492|NCT02040870|100878012|FG000|NOT COMPLETED|Overall Study||103||
48227493|NCT02325466|100878013|FG000|STARTED|Period 1 Timeframe - Baseline to Week 4||23||
48227494|NCT02325466|100878014|FG001|STARTED|Period 1 Timeframe - Baseline to Week 4||23||
48227495|NCT02325466|100878015|FG002|STARTED|Period 1 Timeframe - Baseline to Week 4||24||
48227496|NCT02325466|100878013|FG000|COMPLETED|Period 1 Timeframe - Baseline to Week 4||22||
48227497|NCT02325466|100878014|FG001|COMPLETED|Period 1 Timeframe - Baseline to Week 4||21||
48227498|NCT02325466|100878015|FG002|COMPLETED|Period 1 Timeframe - Baseline to Week 4||21||
48227499|NCT02325466|100878013|FG000|NOT COMPLETED|Period 1 Timeframe - Baseline to Week 4||1||
48227500|NCT02325466|100878014|FG001|NOT COMPLETED|Period 1 Timeframe - Baseline to Week 4||2||
48227501|NCT02325466|100878015|FG002|NOT COMPLETED|Period 1 Timeframe - Baseline to Week 4||3||
48227502|NCT02325466|100878013|FG000|STARTED|Period 2 - Timeframe Week 4 to Week 10||22||
48227503|NCT02325466|100878014|FG001|STARTED|Period 2 - Timeframe Week 4 to Week 10||21||
48227504|NCT02325466|100878015|FG002|STARTED|Period 2 - Timeframe Week 4 to Week 10||21||
48227505|NCT02325466|100878013|FG000|COMPLETED|Period 2 - Timeframe Week 4 to Week 10||19||
48227506|NCT02325466|100878014|FG001|COMPLETED|Period 2 - Timeframe Week 4 to Week 10||20||
48227507|NCT02325466|100878015|FG002|COMPLETED|Period 2 - Timeframe Week 4 to Week 10||21||
48227508|NCT02325466|100878013|FG000|NOT COMPLETED|Period 2 - Timeframe Week 4 to Week 10||3||
48227509|NCT02325466|100878014|FG001|NOT COMPLETED|Period 2 - Timeframe Week 4 to Week 10||1||
48227510|NCT02325466|100878015|FG002|NOT COMPLETED|Period 2 - Timeframe Week 4 to Week 10||0||
48227511|NCT02325466|100878013|FG000|STARTED|3rd Crossover - Week 10 to Week 16||19||
48227512|NCT02325466|100878014|FG001|STARTED|3rd Crossover - Week 10 to Week 16||20||
48227513|NCT02325466|100878015|FG002|STARTED|3rd Crossover - Week 10 to Week 16||21||
48227514|NCT02325466|100878013|FG000|COMPLETED|3rd Crossover - Week 10 to Week 16||18||
48227515|NCT02325466|100878014|FG001|COMPLETED|3rd Crossover - Week 10 to Week 16||18||
48227516|NCT02325466|100878015|FG002|COMPLETED|3rd Crossover - Week 10 to Week 16||21||
48227517|NCT02325466|100878013|FG000|NOT COMPLETED|3rd Crossover - Week 10 to Week 16||1||
48227518|NCT02325466|100878014|FG001|NOT COMPLETED|3rd Crossover - Week 10 to Week 16||2||
48227519|NCT02325466|100878015|FG002|NOT COMPLETED|3rd Crossover - Week 10 to Week 16||0||
48227520|NCT02785159|100878016|FG000|STARTED|Overall Study||62||
48227521|NCT02785159|100878017|FG001|STARTED|Overall Study||58||
48227522|NCT02785159|100878018|FG002|STARTED|Overall Study||15||
48227523|NCT02785159|100878019|FG003|STARTED|Overall Study||17||
48227524|NCT02785159|100878016|FG000|COMPLETED|Overall Study||51||
48227525|NCT02785159|100878017|FG001|COMPLETED|Overall Study||45||
48227526|NCT02785159|100878018|FG002|COMPLETED|Overall Study||12||
48227527|NCT02785159|100878019|FG003|COMPLETED|Overall Study||14||
48227528|NCT02785159|100878016|FG000|NOT COMPLETED|Overall Study||11||
48227529|NCT02785159|100878017|FG001|NOT COMPLETED|Overall Study||13||
48227530|NCT02785159|100878018|FG002|NOT COMPLETED|Overall Study||3||
48227531|NCT02785159|100878019|FG003|NOT COMPLETED|Overall Study||3||
48227532|NCT03879538|100878020|FG000|STARTED|Overall Study||20||
48227533|NCT03879538|100878021|FG001|STARTED|Overall Study||24||
48227534|NCT03879538|100878020|FG000|COMPLETED|Overall Study||20||
48078289|NCT02321800|100515127|FG000|COMPLETED|Overall Study||283||
48078290|NCT02321800|100515128|FG001|COMPLETED|Overall Study||138||
48078291|NCT02321800|100515127|FG000|NOT COMPLETED|Overall Study||20||
48078292|NCT02321800|100515128|FG001|NOT COMPLETED|Overall Study||11||
48078293|NCT04404361|100515129|FG000|STARTED|Overall Study||99||
48078294|NCT04404361|100515130|FG001|STARTED|Overall Study||101||
48227535|NCT03879538|100878021|FG001|COMPLETED|Overall Study||24||
48227536|NCT03879538|100878020|FG000|NOT COMPLETED|Overall Study||0||
48227537|NCT03879538|100878021|FG001|NOT COMPLETED|Overall Study||0||
48227538|NCT01971255|100878022|FG000|STARTED|Overall Study||32||
48227539|NCT01971255|100878023|FG001|STARTED|Overall Study||42||
48227540|NCT01971255|100878022|FG000|COMPLETED|Overall Study||31||
48227541|NCT01971255|100878023|FG001|COMPLETED|Overall Study||40||
48227542|NCT01971255|100878022|FG000|NOT COMPLETED|Overall Study||1||
48227543|NCT01971255|100878023|FG001|NOT COMPLETED|Overall Study||2||
48227544|NCT03292692|100878024|FG000|STARTED|Overall Study||302||
48227545|NCT03292692|100878025|FG001|STARTED|Overall Study||298||
48227546|NCT03292692|100878024|FG000|COMPLETED|Overall Study||264||
48227547|NCT03292692|100878025|FG001|COMPLETED|Overall Study||260||
48227548|NCT03292692|100878024|FG000|NOT COMPLETED|Overall Study||38||
48227549|NCT03292692|100878025|FG001|NOT COMPLETED|Overall Study||38||
48227550|NCT03032198|100878026|FG000|STARTED|Overall Study||37||
48227551|NCT03032198|100878026|FG000|COMPLETED|Overall Study||36|Trial was terminated early due to change in corporate strategy|
48227552|NCT03032198|100878026|FG000|NOT COMPLETED|Overall Study||1||
48227553|NCT00689351|100878027|FG000|STARTED|Infant Series of Dosing||91||
48227554|NCT00689351|100878028|FG001|STARTED|Infant Series of Dosing||89||
48227555|NCT00689351|100878027|FG000|Vaccinated Dose 1|Infant Series of Dosing||88||
48227556|NCT00689351|100878028|FG001|Vaccinated Dose 1|Infant Series of Dosing||89||
48227557|NCT00689351|100878027|FG000|Vaccinated Dose 2|Infant Series of Dosing||86||
48227558|NCT00689351|100878028|FG001|Vaccinated Dose 2|Infant Series of Dosing||88||
48227559|NCT00689351|100878027|FG000|Vaccinated Dose 3|Infant Series of Dosing||85||
48227560|NCT00689351|100878028|FG001|Vaccinated Dose 3|Infant Series of Dosing||88||
48227561|NCT00689351|100878027|FG000|COMPLETED|Infant Series of Dosing||85||
48227562|NCT00689351|100878028|FG001|COMPLETED|Infant Series of Dosing||88||
48227563|NCT00689351|100878027|FG000|NOT COMPLETED|Infant Series of Dosing||6||
48227564|NCT00689351|100878028|FG001|NOT COMPLETED|Infant Series of Dosing||1||
48227565|NCT00689351|100878027|FG000|STARTED|After Infant Series||85||
48227566|NCT00689351|100878028|FG001|STARTED|After Infant Series||88||
48227567|NCT00689351|100878027|FG000|COMPLETED|After Infant Series||84||
48227568|NCT00689351|100878028|FG001|COMPLETED|After Infant Series||88||
48227569|NCT00689351|100878027|FG000|NOT COMPLETED|After Infant Series||1||
48227570|NCT00689351|100878028|FG001|NOT COMPLETED|After Infant Series||0||
48227571|NCT00689351|100878027|FG000|STARTED|Toddler Dose||84||
48227572|NCT00689351|100878028|FG001|STARTED|Toddler Dose||88||
48227573|NCT00689351|100878027|FG000|COMPLETED|Toddler Dose||84||
48227574|NCT00689351|100878028|FG001|COMPLETED|Toddler Dose||88||
48078295|NCT04404361|100515129|FG000|COMPLETED|Overall Study||68||
48078296|NCT04404361|100515130|FG001|COMPLETED|Overall Study||80||
48078297|NCT04404361|100515129|FG000|NOT COMPLETED|Overall Study||31||
48078298|NCT04404361|100515130|FG001|NOT COMPLETED|Overall Study||21||
48078299|NCT04659161|100515131|FG000|STARTED|Overall Study||126||
48078300|NCT04659161|100515132|FG001|STARTED|Overall Study||126||
48078301|NCT04659161|100515131|FG000|COMPLETED|Overall Study||94||
48078302|NCT04659161|100515132|FG001|COMPLETED|Overall Study||100||
48227575|NCT00689351|100878027|FG000|NOT COMPLETED|Toddler Dose||0||
48227576|NCT00689351|100878028|FG001|NOT COMPLETED|Toddler Dose||0||
48227577|NCT03611556|100878029|FG000|STARTED|Overall Study||7||
48227578|NCT03611556|100878030|FG001|STARTED|Overall Study||7||
48078303|NCT04659161|100515131|FG000|NOT COMPLETED|Overall Study||32||
48078304|NCT04659161|100515132|FG001|NOT COMPLETED|Overall Study||26||
48078305|NCT05074667|100515133|FG000|STARTED|Overall Study||30||
48078306|NCT05074667|100515133|FG000|COMPLETED|Overall Study||15||
48078307|NCT05074667|100515133|FG000|NOT COMPLETED|Overall Study||15||
48078308|NCT02591290|100515134|FG000|STARTED|Overall Study||60||
48227579|NCT03611556|100878031|FG002|STARTED|Overall Study||3||
48227580|NCT03611556|100878032|FG003|STARTED|Overall Study||8||
48227581|NCT03611556|100878033|FG004|STARTED|Overall Study||62||
48227582|NCT03611556|100878034|FG005|STARTED|Overall Study||38||
48227583|NCT03611556|100878035|FG006|STARTED|Overall Study||70||
48374687|NCT01240811|101247448|FG002|COMPLETED|Overall Study||16||
48374688|NCT01240811|101247446|FG000|NOT COMPLETED|Overall Study||0||
48374689|NCT01240811|101247447|FG001|NOT COMPLETED|Overall Study||1||
48374690|NCT01240811|101247448|FG002|NOT COMPLETED|Overall Study||1||
48374691|NCT00414310|101247449|FG000|STARTED|Overall Study||71||
48374692|NCT00414310|101247450|FG001|STARTED|Overall Study||79||
48374693|NCT00414310|101247449|FG000|COMPLETED|Overall Study||70||
48374694|NCT00414310|101247450|FG001|COMPLETED|Overall Study||79||
48374695|NCT00414310|101247449|FG000|NOT COMPLETED|Overall Study||1||
48374696|NCT00414310|101247450|FG001|NOT COMPLETED|Overall Study||0||
48374697|NCT00103194|101247451|FG000|STARTED|Overall Study||49||
48374698|NCT00103194|101247451|FG000|Treated|Overall Study||49||
48374699|NCT00103194|101247451|FG000|Eligible|Overall Study||35||
48078309|NCT02591290|100515134|FG000|Vaccinated Dose 1|Overall Study||60||
48078310|NCT02591290|100515134|FG000|Vaccinated Dose 2|Overall Study||58||
48078311|NCT02591290|100515134|FG000|COMPLETED|Overall Study||58||
48078312|NCT02591290|100515134|FG000|NOT COMPLETED|Overall Study||2||
48078313|NCT04661839|100515135|FG000|STARTED|Overall Study||8||
48078314|NCT04661839|100515136|FG001|STARTED|Overall Study||8||
48078315|NCT04661839|100515137|FG002|STARTED|Overall Study||8||
48078316|NCT04661839|100515138|FG003|STARTED|Overall Study||4||
48374700|NCT00103194|101247451|FG000|Eligible and Treated|Overall Study||35||
48374701|NCT00103194|101247451|FG000|COMPLETED|Overall Study||18||
48374702|NCT00103194|101247451|FG000|NOT COMPLETED|Overall Study||31||
48374703|NCT02020031|101247452|FG000|STARTED|Overall Study||11||
48374704|NCT02020031|101247453|FG001|STARTED|Overall Study||11||
48374705|NCT02020031|101247452|FG000|COMPLETED|Overall Study||10||
48374706|NCT02020031|101247453|FG001|COMPLETED|Overall Study||10||
48374707|NCT02020031|101247452|FG000|NOT COMPLETED|Overall Study||1||
48374708|NCT02020031|101247453|FG001|NOT COMPLETED|Overall Study||1||
48374709|NCT02118610|101247454|FG000|STARTED|Overall Study||30||
48374710|NCT02118610|101247455|FG001|STARTED|Overall Study||33||
48374711|NCT02118610|101247454|FG000|COMPLETED|Overall Study||29||
48374712|NCT02118610|101247455|FG001|COMPLETED|Overall Study||32||
48374713|NCT02118610|101247454|FG000|NOT COMPLETED|Overall Study||1||
48374714|NCT02118610|101247455|FG001|NOT COMPLETED|Overall Study||1||
48374715|NCT02164513|101247456|FG000|STARTED|Overall Study||4151||
48374716|NCT02164513|101247457|FG001|STARTED|Overall Study||4134||
48374717|NCT02164513|101247458|FG002|STARTED|Overall Study||2070||
48374718|NCT02164513|101247456|FG000|Completed Investigational Product (IP)|Overall Study||3393||
48374719|NCT02164513|101247457|FG001|Completed Investigational Product (IP)|Overall Study||3094||
48374720|NCT02164513|101247458|FG002|Completed Investigational Product (IP)|Overall Study||1504||
48374721|NCT02164513|101247456|FG000|Not Completed IP|Overall Study||758||
48523185|NCT01332578|101616075|FG001|STARTED|Washout Period||13||
48078317|NCT04661839|100515135|FG000|Safety Population|Overall Study||8||
48078318|NCT04661839|100515136|FG001|Safety Population|Overall Study||8||
48078319|NCT04661839|100515137|FG002|Safety Population|Overall Study||7||
48078320|NCT04661839|100515138|FG003|Safety Population|Overall Study||4||
48078321|NCT04661839|100515135|FG000|COMPLETED|Overall Study||7||
48078322|NCT04661839|100515136|FG001|COMPLETED|Overall Study||8||
48078323|NCT04661839|100515137|FG002|COMPLETED|Overall Study||7||
48078324|NCT04661839|100515138|FG003|COMPLETED|Overall Study||3||
48078325|NCT04661839|100515135|FG000|NOT COMPLETED|Overall Study||1||
48078326|NCT04661839|100515136|FG001|NOT COMPLETED|Overall Study||0||
48078327|NCT04661839|100515137|FG002|NOT COMPLETED|Overall Study||1||
48078328|NCT04661839|100515138|FG003|NOT COMPLETED|Overall Study||1||
48078329|NCT02195583|100515139|FG000|STARTED|Overall Study||62||
48078330|NCT02195583|100515139|FG000|Sodium Fluoride (1150 Ppm)|Overall Study||57||
48078331|NCT02195583|100515139|FG000|Sodium Fluoride (0 Ppm)|Overall Study||59||
48078332|NCT02195583|100515139|FG000|Sodium Fluoride (1426 Ppm) + Zinc Base A|Overall Study||58||
48078333|NCT02195583|100515139|FG000|Sodium Fluoride (250 Ppm)|Overall Study||55||
48078334|NCT02195583|100515139|FG000|Sodium Fluoride (1426 Ppm)|Overall Study||59||
48078335|NCT02195583|100515139|FG000|Sodium Fluoride (1426 Ppm) + Zinc Base B|Overall Study||60||
48078336|NCT02195583|100515139|FG000|COMPLETED|Overall Study||53||
48078337|NCT02195583|100515139|FG000|NOT COMPLETED|Overall Study||9||
48078338|NCT02114216|100515140|FG000|STARTED|Overall Study||16||
48078339|NCT02114216|100515141|FG001|STARTED|Overall Study||45||
48227584|NCT03611556|100878029|FG000|COMPLETED|Overall Study||0||
48227585|NCT03611556|100878030|FG001|COMPLETED|Overall Study||0||
48227586|NCT03611556|100878031|FG002|COMPLETED|Overall Study||0||
48227587|NCT03611556|100878032|FG003|COMPLETED|Overall Study||0||
48374722|NCT02164513|101247457|FG001|Not Completed IP|Overall Study||1040||
48374723|NCT02164513|101247458|FG002|Not Completed IP|Overall Study||566||
48374724|NCT02164513|101247456|FG000|Withdrew IP (WIP): Adverse Event|Overall Study||249||
48374725|NCT02164513|101247457|FG001|Withdrew IP (WIP): Adverse Event|Overall Study||325||
48374726|NCT02164513|101247458|FG002|Withdrew IP (WIP): Adverse Event|Overall Study||186||
48374727|NCT02164513|101247456|FG000|WIP: Lack of Efficacy|Overall Study||163||
48523186|NCT01332578|101616074|FG000|COMPLETED|Washout Period||12||
48374728|NCT02164513|101247457|FG001|WIP: Lack of Efficacy|Overall Study||313||
48374729|NCT02164513|101247458|FG002|WIP: Lack of Efficacy|Overall Study||172||
48374730|NCT02164513|101247456|FG000|Withdrew IP: Protocol Deviation|Overall Study||32||
48374731|NCT02164513|101247457|FG001|Withdrew IP: Protocol Deviation|Overall Study||41||
48374732|NCT02164513|101247458|FG002|Withdrew IP: Protocol Deviation|Overall Study||19||
48374733|NCT02164513|101247456|FG000|WIP (Other): Stopping Criteria Reached|Overall Study||4||
48227588|NCT03611556|100878033|FG004|COMPLETED|Overall Study||0||
48227589|NCT03611556|100878034|FG005|COMPLETED|Overall Study||0||
48227590|NCT03611556|100878035|FG006|COMPLETED|Overall Study||0||
48227591|NCT03611556|100878029|FG000|NOT COMPLETED|Overall Study||7||
48227592|NCT03611556|100878030|FG001|NOT COMPLETED|Overall Study||7||
48227593|NCT03611556|100878031|FG002|NOT COMPLETED|Overall Study||3||
48227594|NCT03611556|100878032|FG003|NOT COMPLETED|Overall Study||8||
48227595|NCT03611556|100878033|FG004|NOT COMPLETED|Overall Study||62||
48227596|NCT03611556|100878034|FG005|NOT COMPLETED|Overall Study||38||
48227597|NCT03611556|100878035|FG006|NOT COMPLETED|Overall Study||70||
48227598|NCT02399449|100878036|FG000|STARTED|Overall Study||25||
48227599|NCT02399449|100878037|FG001|STARTED|Overall Study||32||
48227600|NCT02399449|100878036|FG000|COMPLETED|Overall Study||22||
48227601|NCT02399449|100878037|FG001|COMPLETED|Overall Study||22||
48227602|NCT02399449|100878036|FG000|NOT COMPLETED|Overall Study||3||
48227603|NCT02399449|100878037|FG001|NOT COMPLETED|Overall Study||10||
48227604|NCT04652869|100878038|FG000|STARTED|Overall Study||20|Started intervention|
48227605|NCT04652869|100878039|FG001|STARTED|Overall Study||21|Started intervention|
48227606|NCT04652869|100878040|FG002|STARTED|Overall Study||20|Started intervention|
48227607|NCT04652869|100878038|FG000|COMPLETED|Overall Study||20||
48227608|NCT04652869|100878039|FG001|COMPLETED|Overall Study||19||
48227609|NCT04652869|100878040|FG002|COMPLETED|Overall Study||20||
48227610|NCT04652869|100878038|FG000|NOT COMPLETED|Overall Study||0||
48227611|NCT04652869|100878039|FG001|NOT COMPLETED|Overall Study||2||
48227612|NCT04652869|100878040|FG002|NOT COMPLETED|Overall Study||0||
48227613|NCT04559698|100878041|FG000|STARTED|Overall Study||61||
48227614|NCT04559698|100878042|FG001|STARTED|Overall Study||60||
48227615|NCT04559698|100878041|FG000|Four-month Pre-intervention|Overall Study||0||
48227616|NCT04559698|100878042|FG001|Four-month Pre-intervention|Overall Study||60||
48227617|NCT04559698|100878041|FG000|Immediate Pre-intervention|Overall Study||61||
48227618|NCT04559698|100878042|FG001|Immediate Pre-intervention|Overall Study||55||
48227619|NCT04559698|100878041|FG000|Immediate Post-intervention|Overall Study||52||
48227620|NCT04559698|100878042|FG001|Immediate Post-intervention|Overall Study||44||
48227621|NCT04559698|100878041|FG000|Four-month Post-intervention|Overall Study||47||
48227622|NCT04559698|100878042|FG001|Four-month Post-intervention|Overall Study||0||
48227623|NCT04559698|100878041|FG000|COMPLETED|Overall Study||47||
48227624|NCT04559698|100878042|FG001|COMPLETED|Overall Study||44||
48227625|NCT04559698|100878041|FG000|NOT COMPLETED|Overall Study||14||
48227626|NCT04559698|100878042|FG001|NOT COMPLETED|Overall Study||16||
48227627|NCT00600353|100878043|FG000|STARTED|Overall Study||10||
48227628|NCT00600353|100878044|FG001|STARTED|Overall Study||10||
48227629|NCT00600353|100878043|FG000|COMPLETED|Overall Study||9||
48227630|NCT00600353|100878044|FG001|COMPLETED|Overall Study||9||
48227631|NCT00600353|100878043|FG000|NOT COMPLETED|Overall Study||1||
48227632|NCT00600353|100878044|FG001|NOT COMPLETED|Overall Study||1||
48227633|NCT00336505|100878045|FG000|STARTED|Overall Study||291||
48227634|NCT00336505|100878046|FG001|STARTED|Overall Study||291||
48227635|NCT00336505|100878045|FG000|COMPLETED|Overall Study||254||
48227636|NCT00336505|100878046|FG001|COMPLETED|Overall Study||264||
48227637|NCT00336505|100878045|FG000|NOT COMPLETED|Overall Study||37||
48227638|NCT00336505|100878046|FG001|NOT COMPLETED|Overall Study||27||
48227639|NCT03340415|100878047|FG000|STARTED|Overall Study||29||
48227640|NCT03340415|100878048|FG001|STARTED|Overall Study||24||
48227641|NCT03340415|100878047|FG000|COMPLETED|Overall Study||29||
48523187|NCT01332578|101616075|FG001|COMPLETED|Washout Period||13||
48227642|NCT03340415|100878048|FG001|COMPLETED|Overall Study||21||
48227643|NCT03340415|100878047|FG000|NOT COMPLETED|Overall Study||0||
48227644|NCT03340415|100878048|FG001|NOT COMPLETED|Overall Study||3||
48227645|NCT03905512|100878049|FG000|STARTED|Overall Study||83||
48227646|NCT03905512|100878050|FG001|STARTED|Overall Study||87||
48227647|NCT03905512|100878049|FG000|Received At Least 1 Dose of Study Drug|Overall Study||83||
48227648|NCT03905512|100878050|FG001|Received At Least 1 Dose of Study Drug|Overall Study||87||
48227649|NCT03905512|100878049|FG000|COMPLETED|Overall Study||62||
48227650|NCT03905512|100878050|FG001|COMPLETED|Overall Study||70||
48227651|NCT03905512|100878049|FG000|NOT COMPLETED|Overall Study||21||
48227652|NCT03905512|100878050|FG001|NOT COMPLETED|Overall Study||17||
48227653|NCT02161458|100878051|FG000|STARTED|Overall Study||22||
48227654|NCT02161458|100878052|FG001|STARTED|Overall Study||35||
48227655|NCT02161458|100878053|FG002|STARTED|Overall Study||33||
48227656|NCT02161458|100878054|FG003|STARTED|Overall Study||8||
48227657|NCT02161458|100878051|FG000|COMPLETED|Overall Study||22||
48227658|NCT02161458|100878052|FG001|COMPLETED|Overall Study||29||
48374734|NCT02164513|101247457|FG001|WIP (Other): Stopping Criteria Reached|Overall Study||1||
48523188|NCT01332578|101616074|FG000|NOT COMPLETED|Washout Period||0||
48227659|NCT02161458|100878053|FG002|COMPLETED|Overall Study||28||
48374735|NCT02164513|101247458|FG002|WIP (Other): Stopping Criteria Reached|Overall Study||2||
48374736|NCT02164513|101247456|FG000|WIP: Study Closed/Terminated|Overall Study||5||
48374737|NCT02164513|101247457|FG001|WIP: Study Closed/Terminated|Overall Study||2||
48374738|NCT02164513|101247458|FG002|WIP: Study Closed/Terminated|Overall Study||5||
48374739|NCT02164513|101247456|FG000|WIP: Lost to Follow-up|Overall Study||21||
48374740|NCT02164513|101247457|FG001|WIP: Lost to Follow-up|Overall Study||25||
48374741|NCT02164513|101247458|FG002|WIP: Lost to Follow-up|Overall Study||14||
48374742|NCT02164513|101247456|FG000|WIP: Investigator Discretion|Overall Study||33||
48374743|NCT02164513|101247457|FG001|WIP: Investigator Discretion|Overall Study||36||
48374744|NCT02164513|101247458|FG002|WIP: Investigator Discretion|Overall Study||15||
48374745|NCT02164513|101247456|FG000|WIP: Withdrawal by Participant|Overall Study||250||
48374746|NCT02164513|101247457|FG001|WIP: Withdrawal by Participant|Overall Study||296||
48374747|NCT02164513|101247458|FG002|WIP: Withdrawal by Participant|Overall Study||153||
48374748|NCT02164513|101247456|FG000|WIP :Did Not Complete Study Treatment|Overall Study||1||
48374749|NCT02164513|101247457|FG001|WIP :Did Not Complete Study Treatment|Overall Study||1||
48374750|NCT02164513|101247458|FG002|WIP :Did Not Complete Study Treatment|Overall Study||0||
48374751|NCT02164513|101247456|FG000|COMPLETED|Overall Study||3714||
48374752|NCT02164513|101247457|FG001|COMPLETED|Overall Study||3598||
48374753|NCT02164513|101247458|FG002|COMPLETED|Overall Study||1775||
48374754|NCT02164513|101247456|FG000|NOT COMPLETED|Overall Study||437||
48374755|NCT02164513|101247457|FG001|NOT COMPLETED|Overall Study||536||
48374756|NCT02164513|101247458|FG002|NOT COMPLETED|Overall Study||295||
48374757|NCT01746732|101247459|FG000|STARTED|Lead-In Period||23||
48374758|NCT01746732|101247460|FG001|STARTED|Lead-In Period||0||
48374759|NCT01746732|101247461|FG002|STARTED|Lead-In Period||0||
48374760|NCT01746732|101247459|FG000|Participants Received at Least 1 Dose|Lead-In Period||22||
48374761|NCT01746732|101247460|FG001|Participants Received at Least 1 Dose|Lead-In Period||0||
48374762|NCT01746732|101247461|FG002|Participants Received at Least 1 Dose|Lead-In Period||0||
48374763|NCT01746732|101247459|FG000|COMPLETED|Lead-In Period||22||
48374764|NCT01746732|101247460|FG001|COMPLETED|Lead-In Period||0||
48374765|NCT01746732|101247461|FG002|COMPLETED|Lead-In Period||0||
48374766|NCT01746732|101247459|FG000|NOT COMPLETED|Lead-In Period||1||
48374767|NCT01746732|101247460|FG001|NOT COMPLETED|Lead-In Period||0||
48374768|NCT01746732|101247461|FG002|NOT COMPLETED|Lead-In Period||0||
48374769|NCT01746732|101247459|FG000|STARTED|Period 1||0||
48374770|NCT01746732|101247460|FG001|STARTED|Period 1||11||
48374771|NCT01746732|101247461|FG002|STARTED|Period 1||11||
48374772|NCT01746732|101247459|FG000|COMPLETED|Period 1||0||
48374773|NCT01746732|101247460|FG001|COMPLETED|Period 1||10||
48374774|NCT01746732|101247461|FG002|COMPLETED|Period 1||11||
48374775|NCT01746732|101247459|FG000|NOT COMPLETED|Period 1||0||
48374776|NCT01746732|101247460|FG001|NOT COMPLETED|Period 1||1||
48374777|NCT01746732|101247461|FG002|NOT COMPLETED|Period 1||0||
48374778|NCT01746732|101247459|FG000|STARTED|Period 2||0||
48374779|NCT01746732|101247460|FG001|STARTED|Period 2||10||
48374780|NCT01746732|101247461|FG002|STARTED|Period 2||11||
48374781|NCT01746732|101247459|FG000|COMPLETED|Period 2||0||
48078340|NCT02114216|100515142|FG002|STARTED|Overall Study||14||
48078341|NCT02114216|100515140|FG000|COMPLETED|Overall Study||16||
48078342|NCT02114216|100515141|FG001|COMPLETED|Overall Study||45||
48078343|NCT02114216|100515142|FG002|COMPLETED|Overall Study||14||
48078344|NCT02114216|100515140|FG000|NOT COMPLETED|Overall Study||0||
48078345|NCT02114216|100515141|FG001|NOT COMPLETED|Overall Study||0||
48078346|NCT02114216|100515142|FG002|NOT COMPLETED|Overall Study||0||
48078347|NCT00458211|100515143|FG000|STARTED|Overall Study||40||
48078348|NCT00458211|100515143|FG000|COMPLETED|Overall Study||24||
48078349|NCT00458211|100515143|FG000|NOT COMPLETED|Overall Study||16||
48078350|NCT00858130|100515144|FG000|STARTED|Overall Study||12||
48374782|NCT01746732|101247460|FG001|COMPLETED|Period 2||10||
48374783|NCT01746732|101247461|FG002|COMPLETED|Period 2||7||
48374784|NCT01746732|101247459|FG000|NOT COMPLETED|Period 2||0||
48374785|NCT01746732|101247460|FG001|NOT COMPLETED|Period 2||0||
48374786|NCT01746732|101247461|FG002|NOT COMPLETED|Period 2||4||
48374787|NCT03314519|101247462|FG000|STARTED|Overall Study||100||
48374788|NCT03314519|101247463|FG001|STARTED|Overall Study||100||
48374789|NCT03314519|101247462|FG000|COMPLETED|Overall Study||97||
48374790|NCT03314519|101247463|FG001|COMPLETED|Overall Study||98||
48374791|NCT03314519|101247462|FG000|NOT COMPLETED|Overall Study||3||
48374792|NCT03314519|101247463|FG001|NOT COMPLETED|Overall Study||2||
48374793|NCT03554005|101247464|FG000|STARTED|Overall Study||1||
48374794|NCT03554005|101247465|FG001|STARTED|Overall Study||2||
48374795|NCT03554005|101247466|FG002|STARTED|Overall Study||2||
48374796|NCT03554005|101247467|FG003|STARTED|Overall Study||2||
48374797|NCT03554005|101247468|FG004|STARTED|Overall Study||11||
48374798|NCT03554005|101247469|FG005|STARTED|Overall Study||11||
48374799|NCT03554005|101247464|FG000|COMPLETED|Overall Study||0||
48374800|NCT03554005|101247465|FG001|COMPLETED|Overall Study||1||
48374801|NCT03554005|101247466|FG002|COMPLETED|Overall Study||1||
48374802|NCT03554005|101247467|FG003|COMPLETED|Overall Study||1||
48374803|NCT03554005|101247468|FG004|COMPLETED|Overall Study||5||
48374804|NCT03554005|101247469|FG005|COMPLETED|Overall Study||0||
48523189|NCT01332578|101616075|FG001|NOT COMPLETED|Washout Period||0||
48078351|NCT00858130|100515144|FG000|COMPLETED|Overall Study||12||
48078352|NCT00858130|100515144|FG000|NOT COMPLETED|Overall Study||0||
48078353|NCT03889444|100515145|FG000|STARTED|Overall Study||141||
48374805|NCT03554005|101247464|FG000|NOT COMPLETED|Overall Study||1||
48374806|NCT03554005|101247465|FG001|NOT COMPLETED|Overall Study||1||
48374807|NCT03554005|101247466|FG002|NOT COMPLETED|Overall Study||1||
48523190|NCT01332578|101616074|FG000|STARTED|Period II||12||
48523191|NCT01332578|101616075|FG001|STARTED|Period II||13||
48227660|NCT02161458|100878054|FG003|COMPLETED|Overall Study||8||
48227661|NCT02161458|100878051|FG000|NOT COMPLETED|Overall Study||0||
48227662|NCT02161458|100878052|FG001|NOT COMPLETED|Overall Study||6||
48227663|NCT02161458|100878053|FG002|NOT COMPLETED|Overall Study||5||
48227664|NCT02161458|100878054|FG003|NOT COMPLETED|Overall Study||0||
48227665|NCT02167451|100878055|FG000|STARTED|Overall Study||31||
48227666|NCT02167451|100878055|FG000|COMPLETED|Overall Study||30||
48227667|NCT02167451|100878055|FG000|NOT COMPLETED|Overall Study||1||
48227668|NCT02108171|100878056|FG000|STARTED|Overall Study||40||
48227669|NCT02108171|100878057|FG001|STARTED|Overall Study||41||
48227670|NCT02108171|100878056|FG000|COMPLETED|Overall Study||40||
48227671|NCT02108171|100878057|FG001|COMPLETED|Overall Study||41||
48227672|NCT02108171|100878056|FG000|NOT COMPLETED|Overall Study||0||
48227673|NCT02108171|100878057|FG001|NOT COMPLETED|Overall Study||0||
48227674|NCT01263132|100878058|FG000|STARTED|Overall Study||38||
48227675|NCT01263132|100878059|FG001|STARTED|Overall Study||37||
48227676|NCT01263132|100878058|FG000|COMPLETED|Overall Study||38||
48227677|NCT01263132|100878059|FG001|COMPLETED|Overall Study||37||
48523192|NCT01332578|101616074|FG000|COMPLETED|Period II||12||
48523193|NCT01332578|101616075|FG001|COMPLETED|Period II||13||
48523194|NCT01332578|101616074|FG000|NOT COMPLETED|Period II||0||
48523195|NCT01332578|101616075|FG001|NOT COMPLETED|Period II||0||
48523196|NCT01570348|101616076|FG000|STARTED|Overall Study||2||
48523197|NCT01570348|101616076|FG000|COMPLETED|Overall Study||2||
48523198|NCT01570348|101616076|FG000|NOT COMPLETED|Overall Study||0||
48523199|NCT00292188|101616077|FG000|STARTED|Single-Blind||368||
48523200|NCT00292188|101616078|FG001|STARTED|Single-Blind||0||
48523201|NCT00292188|101616079|FG002|STARTED|Single-Blind||0||
48523202|NCT00292188|101616077|FG000|Received Treatment|Single-Blind||367||
48523203|NCT00292188|101616078|FG001|Received Treatment|Single-Blind||0||
48078354|NCT03889444|100515145|FG000|COMPLETED|Overall Study||141||
48078355|NCT03889444|100515145|FG000|NOT COMPLETED|Overall Study||0||
48078356|NCT03053960|100515146|FG000|STARTED|Overall Study||8||
48078357|NCT03053960|100515146|FG000|COMPLETED|Overall Study||8||
48078358|NCT03053960|100515146|FG000|NOT COMPLETED|Overall Study||0||
48078359|NCT00297830|100515147|FG000|STARTED|Baseline||41||
48078360|NCT00297830|100515148|FG001|STARTED|Baseline||43||
48523204|NCT00292188|101616079|FG002|Received Treatment|Single-Blind||0||
48523205|NCT00292188|101616077|FG000|COMPLETED|Single-Blind||254||
48523206|NCT00292188|101616078|FG001|COMPLETED|Single-Blind||0||
48523207|NCT00292188|101616079|FG002|COMPLETED|Single-Blind||0||
48523208|NCT00292188|101616077|FG000|NOT COMPLETED|Single-Blind||114||
48523209|NCT00292188|101616078|FG001|NOT COMPLETED|Single-Blind||0||
48523210|NCT00292188|101616079|FG002|NOT COMPLETED|Single-Blind||0||
48523211|NCT00292188|101616077|FG000|STARTED|Double-Blind||0||
48523212|NCT00292188|101616078|FG001|STARTED|Double-Blind||127||
48523213|NCT00292188|101616079|FG002|STARTED|Double-Blind||127||
48523214|NCT00292188|101616077|FG000|COMPLETED|Double-Blind||0||
48523215|NCT00292188|101616078|FG001|COMPLETED|Double-Blind||96||
48523216|NCT00292188|101616079|FG002|COMPLETED|Double-Blind||98||
48078361|NCT00297830|100515149|FG002|STARTED|Baseline||27||
48078362|NCT00297830|100515147|FG000|COMPLETED|Baseline||41||
48078363|NCT00297830|100515148|FG001|COMPLETED|Baseline||43||
48078364|NCT00297830|100515149|FG002|COMPLETED|Baseline||27||
48078365|NCT00297830|100515147|FG000|NOT COMPLETED|Baseline||0||
48078366|NCT00297830|100515148|FG001|NOT COMPLETED|Baseline||0||
48078367|NCT00297830|100515149|FG002|NOT COMPLETED|Baseline||0||
48078368|NCT00297830|100515147|FG000|STARTED|6 Month Visit||41||
48078369|NCT00297830|100515148|FG001|STARTED|6 Month Visit||43||
48078370|NCT00297830|100515149|FG002|STARTED|6 Month Visit||27||
48078371|NCT00297830|100515147|FG000|COMPLETED|6 Month Visit||38||
48078372|NCT00297830|100515148|FG001|COMPLETED|6 Month Visit||41||
48227678|NCT01263132|100878058|FG000|NOT COMPLETED|Overall Study||0||
48227679|NCT01263132|100878059|FG001|NOT COMPLETED|Overall Study||0||
48227680|NCT04806100|100878060|FG000|STARTED|Overall Study||5||
48523217|NCT00292188|101616077|FG000|NOT COMPLETED|Double-Blind||0||
48078373|NCT00297830|100515149|FG002|COMPLETED|6 Month Visit||24||
48078374|NCT00297830|100515147|FG000|NOT COMPLETED|6 Month Visit||3||
48078375|NCT00297830|100515148|FG001|NOT COMPLETED|6 Month Visit||2||
48078376|NCT00297830|100515149|FG002|NOT COMPLETED|6 Month Visit||3||
48227681|NCT04806100|100878061|FG001|STARTED|Overall Study||5||
48227682|NCT04806100|100878062|FG002|STARTED|Overall Study||3||
48227683|NCT04806100|100878063|FG003|STARTED|Overall Study||2||
48374808|NCT03554005|101247467|FG003|NOT COMPLETED|Overall Study||1||
48523218|NCT00292188|101616078|FG001|NOT COMPLETED|Double-Blind||31||
48523219|NCT00292188|101616079|FG002|NOT COMPLETED|Double-Blind||29||
48523220|NCT01769274|101616080|FG000|STARTED|Part A||5||
48523221|NCT01769274|101616081|FG001|STARTED|Part A||0||
48523222|NCT01769274|101616082|FG002|STARTED|Part A||0||
48523223|NCT01769274|101616080|FG000|COMPLETED|Part A||5||
48523224|NCT01769274|101616081|FG001|COMPLETED|Part A||0||
48523225|NCT01769274|101616082|FG002|COMPLETED|Part A||0||
48523226|NCT01769274|101616080|FG000|NOT COMPLETED|Part A||0||
48523227|NCT01769274|101616081|FG001|NOT COMPLETED|Part A||0||
48523228|NCT01769274|101616082|FG002|NOT COMPLETED|Part A||0||
48523229|NCT01769274|101616080|FG000|STARTED|Part B:Treatment Session1-Period1||0||
48523230|NCT01769274|101616081|FG001|STARTED|Part B:Treatment Session1-Period1||2||
48523231|NCT01769274|101616082|FG002|STARTED|Part B:Treatment Session1-Period1||3||
48523232|NCT01769274|101616080|FG000|COMPLETED|Part B:Treatment Session1-Period1||0||
48523233|NCT01769274|101616081|FG001|COMPLETED|Part B:Treatment Session1-Period1||2||
48523234|NCT01769274|101616082|FG002|COMPLETED|Part B:Treatment Session1-Period1||3||
48523235|NCT01769274|101616080|FG000|NOT COMPLETED|Part B:Treatment Session1-Period1||0||
48523236|NCT01769274|101616081|FG001|NOT COMPLETED|Part B:Treatment Session1-Period1||0||
48523237|NCT01769274|101616082|FG002|NOT COMPLETED|Part B:Treatment Session1-Period1||0||
48523238|NCT01769274|101616080|FG000|STARTED|Washout Period||0||
48523239|NCT01769274|101616081|FG001|STARTED|Washout Period||2||
48523240|NCT01769274|101616082|FG002|STARTED|Washout Period||3||
48523241|NCT01769274|101616080|FG000|COMPLETED|Washout Period||0||
48523242|NCT01769274|101616081|FG001|COMPLETED|Washout Period||2||
48523243|NCT01769274|101616082|FG002|COMPLETED|Washout Period||3||
48523244|NCT01769274|101616080|FG000|NOT COMPLETED|Washout Period||0||
48523245|NCT01769274|101616081|FG001|NOT COMPLETED|Washout Period||0||
48523246|NCT01769274|101616082|FG002|NOT COMPLETED|Washout Period||0||
48523247|NCT01769274|101616080|FG000|STARTED|Part B:Treatment Session1-Period2||0||
48523248|NCT01769274|101616081|FG001|STARTED|Part B:Treatment Session1-Period2||2||
48523249|NCT01769274|101616082|FG002|STARTED|Part B:Treatment Session1-Period2||3||
48523250|NCT01769274|101616080|FG000|COMPLETED|Part B:Treatment Session1-Period2||0||
48523251|NCT01769274|101616081|FG001|COMPLETED|Part B:Treatment Session1-Period2||2||
48592641|NCT01877382|101783158|FG008|COMPLETED|Dose Escalation||0||
48374809|NCT03554005|101247468|FG004|NOT COMPLETED|Overall Study||6||
48374810|NCT03554005|101247469|FG005|NOT COMPLETED|Overall Study||11||
48374811|NCT01934192|101247470|FG000|STARTED|Overall Study||40||
48374812|NCT01934192|101247471|FG001|STARTED|Overall Study||44||
48374813|NCT01934192|101247472|FG002|STARTED|Overall Study||4||
48374814|NCT01934192|101247473|FG003|STARTED|Overall Study||4||
48374815|NCT01934192|101247470|FG000|COMPLETED|Overall Study||31||
48374816|NCT01934192|101247471|FG001|COMPLETED|Overall Study||37||
48374817|NCT01934192|101247472|FG002|COMPLETED|Overall Study||3||
48374818|NCT01934192|101247473|FG003|COMPLETED|Overall Study||3||
48374819|NCT01934192|101247470|FG000|NOT COMPLETED|Overall Study||9||
48374820|NCT01934192|101247471|FG001|NOT COMPLETED|Overall Study||7||
48374821|NCT01934192|101247472|FG002|NOT COMPLETED|Overall Study||1||
48374822|NCT01934192|101247473|FG003|NOT COMPLETED|Overall Study||1||
48374823|NCT00417976|101247474|FG000|STARTED|Overall Study||42||
48374824|NCT00417976|101247474|FG000|COMPLETED|Overall Study||39||
48374825|NCT00417976|101247474|FG000|NOT COMPLETED|Overall Study||3||
48374826|NCT00339183|101247475|FG000|STARTED|Overall Study||591||
48374827|NCT00339183|101247476|FG001|STARTED|Overall Study||595||
48374828|NCT00339183|101247475|FG000|Received Study Drug|Overall Study||588||
48374829|NCT00339183|101247476|FG001|Received Study Drug|Overall Study||593||
48374830|NCT00339183|101247475|FG000|COMPLETED|Overall Study||470||
48374831|NCT00339183|101247476|FG001|COMPLETED|Overall Study||490||
48374832|NCT00339183|101247475|FG000|NOT COMPLETED|Overall Study||121||
48374833|NCT00339183|101247476|FG001|NOT COMPLETED|Overall Study||105||
48374834|NCT00411788|101247477|FG000|STARTED|Overall Study||11||
48374835|NCT00411788|101247477|FG000|COMPLETED|Overall Study||9||
48374836|NCT00411788|101247477|FG000|NOT COMPLETED|Overall Study||2||
48374837|NCT01808118|101247478|FG000|STARTED|Period 1||673||
48374838|NCT01808118|101247479|FG001|STARTED|Period 1||0||
48374839|NCT01808118|101247480|FG002|STARTED|Period 1||0||
48374840|NCT01808118|101247478|FG000|COMPLETED|Period 1||305||
48374841|NCT01808118|101247479|FG001|COMPLETED|Period 1||0||
48374842|NCT01808118|101247480|FG002|COMPLETED|Period 1||0||
48374843|NCT01808118|101247478|FG000|NOT COMPLETED|Period 1||368||
48374844|NCT01808118|101247479|FG001|NOT COMPLETED|Period 1||0||
48374845|NCT01808118|101247480|FG002|NOT COMPLETED|Period 1||0||
48374846|NCT01808118|101247478|FG000|STARTED|Period 2||0||
48374847|NCT01808118|101247479|FG001|STARTED|Period 2||153||
48374848|NCT01808118|101247480|FG002|STARTED|Period 2||152||
48374849|NCT01808118|101247478|FG000|COMPLETED|Period 2||0||
48374850|NCT01808118|101247479|FG001|COMPLETED|Period 2||140||
48374851|NCT01808118|101247480|FG002|COMPLETED|Period 2||144||
48374852|NCT01808118|101247478|FG000|NOT COMPLETED|Period 2||0||
48374853|NCT01808118|101247479|FG001|NOT COMPLETED|Period 2||13||
48374854|NCT01808118|101247480|FG002|NOT COMPLETED|Period 2||8||
48374855|NCT01763905|101247481|FG000|STARTED|Overall Study||51||
48374856|NCT01763905|101247482|FG001|STARTED|Overall Study||51||
48374857|NCT01763905|101247483|FG002|STARTED|Overall Study||103||
48374858|NCT01763905|101247484|FG003|STARTED|Overall Study||102||
48374859|NCT01763905|101247481|FG000|COMPLETED|Overall Study||45||
48374860|NCT01763905|101247482|FG001|COMPLETED|Overall Study||50||
48374861|NCT01763905|101247483|FG002|COMPLETED|Overall Study||94||
48374862|NCT01763905|101247484|FG003|COMPLETED|Overall Study||101||
48374863|NCT01763905|101247481|FG000|NOT COMPLETED|Overall Study||6||
48374864|NCT01763905|101247482|FG001|NOT COMPLETED|Overall Study||1||
48374865|NCT01763905|101247483|FG002|NOT COMPLETED|Overall Study||9||
48374866|NCT01763905|101247484|FG003|NOT COMPLETED|Overall Study||1||
48374867|NCT01863849|101247485|FG000|STARTED|Overall Study||60||
48374868|NCT01863849|101247486|FG001|STARTED|Overall Study||60||
48374869|NCT01863849|101247485|FG000|COMPLETED|Overall Study||59||
48374870|NCT01863849|101247486|FG001|COMPLETED|Overall Study||60||
48374871|NCT01863849|101247485|FG000|NOT COMPLETED|Overall Study||1||
48374872|NCT01863849|101247486|FG001|NOT COMPLETED|Overall Study||0||
48374873|NCT00076219|101247487|FG000|STARTED|Overall Study||563||
48374874|NCT00076219|101247488|FG001|STARTED|Overall Study||561||
48374875|NCT00076219|101247487|FG000|COMPLETED|Overall Study||545||
48374876|NCT00076219|101247488|FG001|COMPLETED|Overall Study||550||
48374877|NCT00076219|101247487|FG000|NOT COMPLETED|Overall Study||18||
48374878|NCT00076219|101247488|FG001|NOT COMPLETED|Overall Study||11||
48374879|NCT01387295|101247489|FG000|STARTED|Overall Study||38||
48374880|NCT01387295|101247489|FG000|COMPLETED|Overall Study||38||
48374881|NCT01387295|101247489|FG000|NOT COMPLETED|Overall Study||0||
48374882|NCT00142519|101247490|FG000|STARTED|Overall Study||25||
48374883|NCT00142519|101247491|FG001|STARTED|Overall Study||25||
48374884|NCT00142519|101247490|FG000|COMPLETED|Overall Study||7||
48374885|NCT00142519|101247491|FG001|COMPLETED|Overall Study||9||
48374886|NCT00142519|101247490|FG000|NOT COMPLETED|Overall Study||18||
48374887|NCT00142519|101247491|FG001|NOT COMPLETED|Overall Study||16||
48078377|NCT00297830|100515147|FG000|STARTED|12 Month Visit||38||
48374888|NCT02819310|101247492|FG000|STARTED|Overall Study||330||
48374889|NCT02819310|101247492|FG000|COMPLETED|Overall Study||221||
48374890|NCT02819310|101247492|FG000|NOT COMPLETED|Overall Study||109||
48374891|NCT04439838|101247493|FG000|STARTED|Overall Study||16||
48374892|NCT04439838|101247494|FG001|STARTED|Overall Study||6||
48374893|NCT04439838|101247495|FG002|STARTED|Overall Study||6||
48374894|NCT04439838|101247496|FG003|STARTED|Overall Study||6||
48374895|NCT04439838|101247497|FG004|STARTED|Overall Study||6||
48374896|NCT04439838|101247498|FG005|STARTED|Overall Study||6||
48374897|NCT04439838|101247499|FG006|STARTED|Overall Study||6||
48374898|NCT04439838|101247500|FG007|STARTED|Overall Study||6||
48374899|NCT04439838|101247501|FG008|STARTED|Overall Study||6||
48374900|NCT04439838|101247493|FG000|COMPLETED|Overall Study||16|planned observation time|
48374901|NCT04439838|101247494|FG001|COMPLETED|Overall Study||6|planned observation time|
48374902|NCT04439838|101247495|FG002|COMPLETED|Overall Study||6|planned observation time|
48374903|NCT04439838|101247496|FG003|COMPLETED|Overall Study||6|planned observation time|
48374904|NCT04439838|101247497|FG004|COMPLETED|Overall Study||6|planned observation time|
48374905|NCT04439838|101247498|FG005|COMPLETED|Overall Study||6|planned observation time|
48374906|NCT04439838|101247499|FG006|COMPLETED|Overall Study||6|planned observation time|
48374907|NCT04439838|101247500|FG007|COMPLETED|Overall Study||6|planned observation time|
48374908|NCT04439838|101247501|FG008|COMPLETED|Overall Study||5|planned observation time|
48374909|NCT04439838|101247493|FG000|NOT COMPLETED|Overall Study||0||
48374910|NCT04439838|101247494|FG001|NOT COMPLETED|Overall Study||0||
48374911|NCT04439838|101247495|FG002|NOT COMPLETED|Overall Study||0||
48374912|NCT04439838|101247496|FG003|NOT COMPLETED|Overall Study||0||
48374913|NCT04439838|101247497|FG004|NOT COMPLETED|Overall Study||0||
48374914|NCT04439838|101247498|FG005|NOT COMPLETED|Overall Study||0||
48374915|NCT04439838|101247499|FG006|NOT COMPLETED|Overall Study||0||
48374916|NCT04439838|101247500|FG007|NOT COMPLETED|Overall Study||0||
48374917|NCT04439838|101247501|FG008|NOT COMPLETED|Overall Study||1||
48374918|NCT02116660|101247502|FG000|STARTED|Overall Study||6||
48374919|NCT02116660|101247503|FG001|STARTED|Overall Study||5||
48374920|NCT02116660|101247502|FG000|COMPLETED|Overall Study||4||
48374921|NCT02116660|101247503|FG001|COMPLETED|Overall Study||1||
48374922|NCT02116660|101247502|FG000|NOT COMPLETED|Overall Study||2||
48374923|NCT02116660|101247503|FG001|NOT COMPLETED|Overall Study||4||
48374924|NCT01345123|101247504|FG000|STARTED|Overall Study||3323||
48078378|NCT00297830|100515148|FG001|STARTED|12 Month Visit||41||
48374925|NCT01345123|101247505|FG001|STARTED|Overall Study||3311||
48374926|NCT01345123|101247506|FG002|STARTED|Overall Study||3291||
48374927|NCT01345123|101247504|FG000|COMPLETED|Overall Study||3244||
48078379|NCT00297830|100515149|FG002|STARTED|12 Month Visit||24||
48078380|NCT00297830|100515147|FG000|COMPLETED|12 Month Visit||37||
48078381|NCT00297830|100515148|FG001|COMPLETED|12 Month Visit||35||
48374928|NCT01345123|101247505|FG001|COMPLETED|Overall Study||3226||
48374929|NCT01345123|101247506|FG002|COMPLETED|Overall Study||3203||
48374930|NCT01345123|101247504|FG000|NOT COMPLETED|Overall Study||79||
48374931|NCT01345123|101247505|FG001|NOT COMPLETED|Overall Study||85||
48374932|NCT01345123|101247506|FG002|NOT COMPLETED|Overall Study||88||
48374933|NCT02367170|101247507|FG000|STARTED|Overall Study||1||
48374934|NCT02367170|101247508|FG001|STARTED|Overall Study||0||
48374935|NCT02367170|101247507|FG000|COMPLETED|Overall Study||1||
48374936|NCT02367170|101247508|FG001|COMPLETED|Overall Study||0||
48374937|NCT02367170|101247507|FG000|NOT COMPLETED|Overall Study||0||
48374938|NCT02367170|101247508|FG001|NOT COMPLETED|Overall Study||0||
48374939|NCT02145156|101247509|FG000|STARTED|Overall Study||430||
48374940|NCT02145156|101247510|FG001|STARTED|Overall Study||425||
48374941|NCT02145156|101247511|FG002|STARTED|Overall Study||439||
48374942|NCT02145156|101247509|FG000|COMPLETED|Overall Study||370||
48374943|NCT02145156|101247510|FG001|COMPLETED|Overall Study||373||
48374944|NCT02145156|101247511|FG002|COMPLETED|Overall Study||398||
48374945|NCT02145156|101247509|FG000|NOT COMPLETED|Overall Study||60||
48374946|NCT02145156|101247510|FG001|NOT COMPLETED|Overall Study||52||
48374947|NCT02145156|101247511|FG002|NOT COMPLETED|Overall Study||41||
48374948|NCT03546413|101247512|FG000|STARTED|Overall Study||253||
48374949|NCT03546413|101247513|FG001|STARTED|Overall Study||255||
48374950|NCT03546413|101247514|FG002|STARTED|Overall Study||193||
48374951|NCT03546413|101247515|FG003|STARTED|Overall Study||191||
48374952|NCT03546413|101247516|FG004|STARTED|Overall Study||76||
48374953|NCT03546413|101247517|FG005|STARTED|Overall Study||91||
48374954|NCT03546413|101247518|FG006|STARTED|Overall Study||400||
48374955|NCT03546413|101247519|FG007|STARTED|Overall Study||409||
48374956|NCT03546413|101247512|FG000|COMPLETED|Overall Study||253||
48374957|NCT03546413|101247513|FG001|COMPLETED|Overall Study||255||
48078382|NCT00297830|100515149|FG002|COMPLETED|12 Month Visit||24||
48078383|NCT00297830|100515147|FG000|NOT COMPLETED|12 Month Visit||1||
48078384|NCT00297830|100515148|FG001|NOT COMPLETED|12 Month Visit||6||
48374958|NCT03546413|101247514|FG002|COMPLETED|Overall Study||193||
48374959|NCT03546413|101247515|FG003|COMPLETED|Overall Study||191||
48374960|NCT03546413|101247516|FG004|COMPLETED|Overall Study||76||
48374961|NCT03546413|101247517|FG005|COMPLETED|Overall Study||91||
48374962|NCT03546413|101247518|FG006|COMPLETED|Overall Study||400||
48374963|NCT03546413|101247519|FG007|COMPLETED|Overall Study||409||
48374964|NCT03546413|101247512|FG000|NOT COMPLETED|Overall Study||0||
48374965|NCT03546413|101247513|FG001|NOT COMPLETED|Overall Study||0||
48374966|NCT03546413|101247514|FG002|NOT COMPLETED|Overall Study||0||
48374967|NCT03546413|101247515|FG003|NOT COMPLETED|Overall Study||0||
48374968|NCT03546413|101247516|FG004|NOT COMPLETED|Overall Study||0||
48374969|NCT03546413|101247517|FG005|NOT COMPLETED|Overall Study||0||
48374970|NCT03546413|101247518|FG006|NOT COMPLETED|Overall Study||0||
48374971|NCT03546413|101247519|FG007|NOT COMPLETED|Overall Study||0||
48374972|NCT02592629|101247520|FG000|STARTED|Overall Study||5||
48078385|NCT00297830|100515149|FG002|NOT COMPLETED|12 Month Visit||0||
48078386|NCT01896102|100515150|FG000|STARTED|Overall Study||32||
48374973|NCT02592629|101247521|FG001|STARTED|Overall Study||9||
48523252|NCT01769274|101616082|FG002|COMPLETED|Part B:Treatment Session1-Period2||3||
48523253|NCT01769274|101616080|FG000|NOT COMPLETED|Part B:Treatment Session1-Period2||0||
48523254|NCT01769274|101616081|FG001|NOT COMPLETED|Part B:Treatment Session1-Period2||0||
48078387|NCT01896102|100515150|FG000|COMPLETED|Overall Study||29||
48374974|NCT02592629|101247522|FG002|STARTED|Overall Study||5||
48374975|NCT02592629|101247520|FG000|COMPLETED|Overall Study||5||
48374976|NCT02592629|101247521|FG001|COMPLETED|Overall Study||9||
48374977|NCT02592629|101247522|FG002|COMPLETED|Overall Study||5||
48374978|NCT02592629|101247520|FG000|NOT COMPLETED|Overall Study||0||
48374979|NCT02592629|101247521|FG001|NOT COMPLETED|Overall Study||0||
48374980|NCT02592629|101247522|FG002|NOT COMPLETED|Overall Study||0||
48374981|NCT00818324|101247523|FG000|STARTED|Overall Study||154||
48374982|NCT00818324|101247523|FG000|COMPLETED|Overall Study||127||
48374983|NCT00818324|101247523|FG000|NOT COMPLETED|Overall Study||27||
48078388|NCT01896102|100515150|FG000|NOT COMPLETED|Overall Study||3||
48374984|NCT00752609|101247524|FG000|STARTED|Overall Study||53||
48374985|NCT00752609|101247525|FG001|STARTED|Overall Study||49||
48374986|NCT00752609|101247524|FG000|Full Analysis Set|Overall Study||52||
48374987|NCT00752609|101247525|FG001|Full Analysis Set|Overall Study||49||
48374988|NCT00752609|101247524|FG000|COMPLETED|Overall Study||44||
48374989|NCT00752609|101247525|FG001|COMPLETED|Overall Study||47||
48374990|NCT00752609|101247524|FG000|NOT COMPLETED|Overall Study||9||
48374991|NCT00752609|101247525|FG001|NOT COMPLETED|Overall Study||2||
48374992|NCT00905021|101247526|FG000|STARTED|Overall Study||4||
48374993|NCT00905021|101247526|FG000|COMPLETED|Overall Study||2||
48374994|NCT00905021|101247526|FG000|NOT COMPLETED|Overall Study||2||
48374995|NCT03992768|101247527|FG000|STARTED|Overall Study||540||540
48374996|NCT03992768|101247527|FG000|COMPLETED|Overall Study||540||540
48374997|NCT03992768|101247527|FG000|NOT COMPLETED|Overall Study||0||0
48078389|NCT01537393|100515151|FG000|STARTED|Overall Study||707|1046 eyes from 1151 participants randomized|707
48078390|NCT01537393|100515152|FG001|STARTED|Overall Study||698|1046 eyes from 1151 participants randomized|699
48078391|NCT01537393|100515151|FG000|COMPLETED|Overall Study||553|Study eyes with 3-year visit completed|553
48374998|NCT03439748|101247528|FG000|STARTED|Overall Study||42||
48374999|NCT03439748|101247529|FG001|STARTED|Overall Study||43||
48375000|NCT03439748|101247528|FG000|Week 5 Assessment|Overall Study||36||
48078392|NCT01537393|100515152|FG001|COMPLETED|Overall Study||507|Study eyes with 3-year visit completed|508
48375001|NCT03439748|101247529|FG001|Week 5 Assessment|Overall Study||37||
48375002|NCT03439748|101247528|FG000|Week 10 Assessment|Overall Study||32||
48375003|NCT03439748|101247529|FG001|Week 10 Assessment|Overall Study||29||
48375004|NCT03439748|101247528|FG000|COMPLETED|Overall Study||31||
48375005|NCT03439748|101247529|FG001|COMPLETED|Overall Study||26||
48375006|NCT03439748|101247528|FG000|NOT COMPLETED|Overall Study||11||
48375007|NCT03439748|101247529|FG001|NOT COMPLETED|Overall Study||17||
48375008|NCT04985799|101247530|FG000|STARTED|Overall Study||73||
48375009|NCT04985799|101247531|FG001|STARTED|Overall Study||74||
48078393|NCT01537393|100515151|FG000|NOT COMPLETED|Overall Study||154||154
48078394|NCT01537393|100515152|FG001|NOT COMPLETED|Overall Study||191||191
48078395|NCT00721500|100515153|FG000|STARTED|Period One||6||
48078396|NCT00721500|100515154|FG001|STARTED|Period One||7||
48078397|NCT00721500|100515155|FG002|STARTED|Period One||6||
48078398|NCT00721500|100515156|FG003|STARTED|Period One||6||
48078399|NCT00721500|100515153|FG000|COMPLETED|Period One||6||
48078400|NCT00721500|100515154|FG001|COMPLETED|Period One||7||
48375010|NCT04985799|101247530|FG000|COMPLETED|Overall Study||73||
48375011|NCT04985799|101247531|FG001|COMPLETED|Overall Study||74||
48375012|NCT04985799|101247530|FG000|NOT COMPLETED|Overall Study||0||
48375013|NCT04985799|101247531|FG001|NOT COMPLETED|Overall Study||0||
48375014|NCT02876055|101247532|FG000|STARTED|Overall Study||42||
48375015|NCT02876055|101247533|FG001|STARTED|Overall Study||41||
48375016|NCT02876055|101247534|FG002|STARTED|Overall Study||42||
48375017|NCT02876055|101247532|FG000|COMPLETED|Overall Study||42||
48375018|NCT02876055|101247533|FG001|COMPLETED|Overall Study||41||
48078401|NCT00721500|100515155|FG002|COMPLETED|Period One||6||
48078402|NCT00721500|100515156|FG003|COMPLETED|Period One||6||
48078403|NCT00721500|100515153|FG000|NOT COMPLETED|Period One||0||
48078404|NCT00721500|100515154|FG001|NOT COMPLETED|Period One||0||
48078405|NCT00721500|100515155|FG002|NOT COMPLETED|Period One||0||
48078406|NCT00721500|100515156|FG003|NOT COMPLETED|Period One||0||
48375019|NCT02876055|101247534|FG002|COMPLETED|Overall Study||42||
48375020|NCT02876055|101247532|FG000|NOT COMPLETED|Overall Study||0||
48375021|NCT02876055|101247533|FG001|NOT COMPLETED|Overall Study||0||
48375022|NCT02876055|101247534|FG002|NOT COMPLETED|Overall Study||0||
48375023|NCT00789477|101247535|FG000|STARTED|Overall Study||44||
48375024|NCT00789477|101247536|FG001|STARTED|Overall Study||44||
48375025|NCT00789477|101247537|FG002|STARTED|Overall Study||44||
48375026|NCT00789477|101247538|FG003|STARTED|Overall Study||44||
48375027|NCT00789477|101247539|FG004|STARTED|Overall Study||45||
48375028|NCT00789477|101247535|FG000|Participants Received Treatment|Overall Study||44||
48078407|NCT00721500|100515153|FG000|STARTED|Period Two||6||
48078408|NCT00721500|100515154|FG001|STARTED|Period Two||7||
48078409|NCT00721500|100515155|FG002|STARTED|Period Two||6||
48078410|NCT00721500|100515156|FG003|STARTED|Period Two||6||
48078411|NCT00721500|100515153|FG000|COMPLETED|Period Two||6||
48078412|NCT00721500|100515154|FG001|COMPLETED|Period Two||7||
48078413|NCT00721500|100515155|FG002|COMPLETED|Period Two||6||
48078414|NCT00721500|100515156|FG003|COMPLETED|Period Two||6||
48078415|NCT00721500|100515153|FG000|NOT COMPLETED|Period Two||0||
48078416|NCT00721500|100515154|FG001|NOT COMPLETED|Period Two||0||
48078417|NCT00721500|100515155|FG002|NOT COMPLETED|Period Two||0||
48078418|NCT00721500|100515156|FG003|NOT COMPLETED|Period Two||0||
48078419|NCT00721500|100515153|FG000|STARTED|Period Three||6||
48078420|NCT00721500|100515154|FG001|STARTED|Period Three||7||
48078421|NCT00721500|100515155|FG002|STARTED|Period Three||6||
48078422|NCT00721500|100515156|FG003|STARTED|Period Three||6||
48078423|NCT00721500|100515153|FG000|COMPLETED|Period Three||6||
48078424|NCT00721500|100515154|FG001|COMPLETED|Period Three||7||
48078425|NCT00721500|100515155|FG002|COMPLETED|Period Three||6||
48078426|NCT00721500|100515156|FG003|COMPLETED|Period Three||6||
48078427|NCT00721500|100515153|FG000|NOT COMPLETED|Period Three||0||
48078428|NCT00721500|100515154|FG001|NOT COMPLETED|Period Three||0||
48375029|NCT00789477|101247536|FG001|Participants Received Treatment|Overall Study||44||
48375030|NCT00789477|101247537|FG002|Participants Received Treatment|Overall Study||44||
48375031|NCT00789477|101247538|FG003|Participants Received Treatment|Overall Study||42||
48375032|NCT00789477|101247539|FG004|Participants Received Treatment|Overall Study||45||
48078429|NCT00721500|100515155|FG002|NOT COMPLETED|Period Three||0||
48078430|NCT00721500|100515156|FG003|NOT COMPLETED|Period Three||0||
48078431|NCT03130257|100515157|FG000|STARTED|Overall Study||172||
48078432|NCT03130257|100515158|FG001|STARTED|Overall Study||170||
48078433|NCT03130257|100515159|FG002|STARTED|Overall Study||168||
48078434|NCT03130257|100515157|FG000|COMPLETED|Overall Study||171||
48078435|NCT03130257|100515158|FG001|COMPLETED|Overall Study||170||
48078436|NCT03130257|100515159|FG002|COMPLETED|Overall Study||166||
48078437|NCT03130257|100515157|FG000|NOT COMPLETED|Overall Study||1||
48078438|NCT03130257|100515158|FG001|NOT COMPLETED|Overall Study||0||
48078439|NCT03130257|100515159|FG002|NOT COMPLETED|Overall Study||2||
48078440|NCT01516437|100515160|FG000|STARTED|Overall Study||24||
48375033|NCT00789477|101247535|FG000|COMPLETED|Overall Study||33||
48375034|NCT00789477|101247536|FG001|COMPLETED|Overall Study||38||
48375035|NCT00789477|101247537|FG002|COMPLETED|Overall Study||33||
48375036|NCT00789477|101247538|FG003|COMPLETED|Overall Study||34||
48078441|NCT01516437|100515161|FG001|STARTED|Overall Study||24||
48078442|NCT01516437|100515162|FG002|STARTED|Overall Study||15||
48078443|NCT01516437|100515163|FG003|STARTED|Overall Study||7||
48078444|NCT01516437|100515160|FG000|COMPLETED|Overall Study||24||
48078445|NCT01516437|100515161|FG001|COMPLETED|Overall Study||24||
48375037|NCT00789477|101247539|FG004|COMPLETED|Overall Study||38||
48375038|NCT00789477|101247535|FG000|NOT COMPLETED|Overall Study||11||
48375039|NCT00789477|101247536|FG001|NOT COMPLETED|Overall Study||6||
48375040|NCT00789477|101247537|FG002|NOT COMPLETED|Overall Study||11||
48375041|NCT00789477|101247538|FG003|NOT COMPLETED|Overall Study||10||
48375042|NCT00789477|101247539|FG004|NOT COMPLETED|Overall Study||7||
48375043|NCT01716533|101247540|FG000|STARTED|Overall Study||7||
48375044|NCT01716533|101247541|FG001|STARTED|Overall Study||25||
48375045|NCT01716533|101247542|FG002|STARTED|Overall Study||5||
48375046|NCT01716533|101247543|FG003|STARTED|Overall Study||9||
48078446|NCT01516437|100515162|FG002|COMPLETED|Overall Study||14||
48078447|NCT01516437|100515163|FG003|COMPLETED|Overall Study||6||
48078448|NCT01516437|100515160|FG000|NOT COMPLETED|Overall Study||0||
48078449|NCT01516437|100515161|FG001|NOT COMPLETED|Overall Study||0||
48078450|NCT01516437|100515162|FG002|NOT COMPLETED|Overall Study||1||
48375047|NCT01716533|101247540|FG000|COMPLETED|Overall Study||7||
48375048|NCT01716533|101247541|FG001|COMPLETED|Overall Study||25||
48375049|NCT01716533|101247542|FG002|COMPLETED|Overall Study||0||
48523255|NCT01769274|101616082|FG002|NOT COMPLETED|Part B:Treatment Session1-Period2||0||
48523256|NCT01769274|101616080|FG000|STARTED|Washout Period||0||
48523257|NCT01769274|101616081|FG001|STARTED|Washout Period||2||
48523258|NCT01769274|101616082|FG002|STARTED|Washout Period||3||
48523259|NCT01769274|101616080|FG000|COMPLETED|Washout Period||0||
48523260|NCT01769274|101616081|FG001|COMPLETED|Washout Period||2||
48523261|NCT01769274|101616082|FG002|COMPLETED|Washout Period||3||
48523262|NCT01769274|101616080|FG000|NOT COMPLETED|Washout Period||0||
48523263|NCT01769274|101616081|FG001|NOT COMPLETED|Washout Period||0||
48523264|NCT01769274|101616082|FG002|NOT COMPLETED|Washout Period||0||
48523265|NCT01769274|101616080|FG000|STARTED|Part B:Treatment Session2-Period3||0||
48523266|NCT01769274|101616081|FG001|STARTED|Part B:Treatment Session2-Period3||2||
48523267|NCT01769274|101616082|FG002|STARTED|Part B:Treatment Session2-Period3||3||
48523268|NCT01769274|101616080|FG000|COMPLETED|Part B:Treatment Session2-Period3||0||
48523269|NCT01769274|101616081|FG001|COMPLETED|Part B:Treatment Session2-Period3||2||
48375050|NCT01716533|101247543|FG003|COMPLETED|Overall Study||1||
48375051|NCT01716533|101247540|FG000|NOT COMPLETED|Overall Study||0||
48375052|NCT01716533|101247541|FG001|NOT COMPLETED|Overall Study||0||
48523270|NCT01769274|101616082|FG002|COMPLETED|Part B:Treatment Session2-Period3||3||
48523271|NCT01769274|101616080|FG000|NOT COMPLETED|Part B:Treatment Session2-Period3||0||
48523272|NCT01769274|101616081|FG001|NOT COMPLETED|Part B:Treatment Session2-Period3||0||
48523273|NCT01769274|101616082|FG002|NOT COMPLETED|Part B:Treatment Session2-Period3||0||
48523274|NCT01769274|101616080|FG000|STARTED|Washout Period||0||
48523275|NCT01769274|101616081|FG001|STARTED|Washout Period||2||
48523276|NCT01769274|101616082|FG002|STARTED|Washout Period||3||
48523277|NCT01769274|101616080|FG000|COMPLETED|Washout Period||0||
48523278|NCT01769274|101616081|FG001|COMPLETED|Washout Period||2||
48523279|NCT01769274|101616082|FG002|COMPLETED|Washout Period||3||
48523280|NCT01769274|101616080|FG000|NOT COMPLETED|Washout Period||0||
48523281|NCT01769274|101616081|FG001|NOT COMPLETED|Washout Period||0||
48375053|NCT01716533|101247542|FG002|NOT COMPLETED|Overall Study||5||
48375054|NCT01716533|101247543|FG003|NOT COMPLETED|Overall Study||8||
48375055|NCT00321984|101247544|FG000|STARTED|Overall Study||317||
48375056|NCT00321984|101247545|FG001|STARTED|Overall Study||315||
48375057|NCT00321984|101247546|FG002|STARTED|Overall Study||315||
48375058|NCT00321984|101247544|FG000|COMPLETED|Overall Study||290||
48375059|NCT00321984|101247545|FG001|COMPLETED|Overall Study||294||
48375060|NCT00321984|101247546|FG002|COMPLETED|Overall Study||289||
48375061|NCT00321984|101247544|FG000|NOT COMPLETED|Overall Study||27||
48375062|NCT00321984|101247545|FG001|NOT COMPLETED|Overall Study||21||
48375063|NCT00321984|101247546|FG002|NOT COMPLETED|Overall Study||26||
48375064|NCT02632110|101247547|FG000|STARTED|Overall Study||25||25
48375065|NCT02632110|101247548|FG001|STARTED|Overall Study||25||25
48375066|NCT02632110|101247549|FG002|STARTED|Overall Study||27||27
48375067|NCT02632110|101247550|FG003|STARTED|Overall Study||27||27
48375068|NCT02632110|101247551|FG004|STARTED|Overall Study||29||29
48375069|NCT02632110|101247552|FG005|STARTED|Overall Study||29||29
48375070|NCT02632110|101247553|FG006|STARTED|Overall Study||26||26
48375071|NCT02632110|101247554|FG007|STARTED|Overall Study||26||26
48375072|NCT02632110|101247555|FG008|STARTED|Overall Study||30||30
48375073|NCT02632110|101247556|FG009|STARTED|Overall Study||30||30
48078451|NCT01516437|100515163|FG003|NOT COMPLETED|Overall Study||1||
48078452|NCT03470441|100515164|FG000|STARTED|Overall Study||29||
48078453|NCT03470441|100515165|FG001|STARTED|Overall Study||31||
48078454|NCT03470441|100515166|FG002|STARTED|Overall Study||31||
48078455|NCT03470441|100515167|FG003|STARTED|Overall Study||29||
48078456|NCT03470441|100515164|FG000|COMPLETED|Overall Study||28||
48078457|NCT03470441|100515165|FG001|COMPLETED|Overall Study||26||
48078458|NCT03470441|100515166|FG002|COMPLETED|Overall Study||29||
48078459|NCT03470441|100515167|FG003|COMPLETED|Overall Study||25||
48078460|NCT03470441|100515164|FG000|NOT COMPLETED|Overall Study||1||
48078461|NCT03470441|100515165|FG001|NOT COMPLETED|Overall Study||5||
48078462|NCT03470441|100515166|FG002|NOT COMPLETED|Overall Study||2||
48078463|NCT03470441|100515167|FG003|NOT COMPLETED|Overall Study||4||
48078464|NCT01737697|100515168|FG000|STARTED|Acute Phase-Initial 48 Hours||158||
48078465|NCT01737697|100515169|FG001|STARTED|Acute Phase-Initial 48 Hours||154||
48078466|NCT01737697|100515170|FG002|STARTED|Acute Phase-Initial 48 Hours||141||
48375074|NCT02632110|101247547|FG000|COMPLETED|Overall Study||24||24
48375075|NCT02632110|101247548|FG001|COMPLETED|Overall Study||24||24
48523282|NCT01769274|101616082|FG002|NOT COMPLETED|Washout Period||0||
48375076|NCT02632110|101247549|FG002|COMPLETED|Overall Study||27||27
48375077|NCT02632110|101247550|FG003|COMPLETED|Overall Study||27||27
48375078|NCT02632110|101247551|FG004|COMPLETED|Overall Study||28||28
48375079|NCT02632110|101247552|FG005|COMPLETED|Overall Study||28||28
48375080|NCT02632110|101247553|FG006|COMPLETED|Overall Study||23||23
48375081|NCT02632110|101247554|FG007|COMPLETED|Overall Study||23||23
48375082|NCT02632110|101247555|FG008|COMPLETED|Overall Study||29||29
48375083|NCT02632110|101247556|FG009|COMPLETED|Overall Study||29||29
48375084|NCT02632110|101247547|FG000|NOT COMPLETED|Overall Study||1||1
48375085|NCT02632110|101247548|FG001|NOT COMPLETED|Overall Study||1||1
48375086|NCT02632110|101247549|FG002|NOT COMPLETED|Overall Study||0||0
48375087|NCT02632110|101247550|FG003|NOT COMPLETED|Overall Study||0||0
48375088|NCT02632110|101247551|FG004|NOT COMPLETED|Overall Study||1||1
48375089|NCT02632110|101247552|FG005|NOT COMPLETED|Overall Study||1||1
48375090|NCT02632110|101247553|FG006|NOT COMPLETED|Overall Study||3||3
48375091|NCT02632110|101247554|FG007|NOT COMPLETED|Overall Study||3||3
48375092|NCT02632110|101247555|FG008|NOT COMPLETED|Overall Study||1||1
48375093|NCT02632110|101247556|FG009|NOT COMPLETED|Overall Study||1||1
48375094|NCT02596711|101247557|FG000|STARTED|Overall Study||9||
48375095|NCT02596711|101247558|FG001|STARTED|Overall Study||8||
48375096|NCT02596711|101247559|FG002|STARTED|Overall Study||8||
48375097|NCT02596711|101247557|FG000|Visit 2|Overall Study||9||
48375098|NCT02596711|101247558|FG001|Visit 2|Overall Study||7||
48375099|NCT02596711|101247559|FG002|Visit 2|Overall Study||6||
48375100|NCT02596711|101247557|FG000|Visit 3|Overall Study||7||
48375101|NCT02596711|101247558|FG001|Visit 3|Overall Study||8||
48375102|NCT02596711|101247559|FG002|Visit 3|Overall Study||6||
48375103|NCT02596711|101247557|FG000|3 Month Follow-up|Overall Study||8||
48375104|NCT02596711|101247558|FG001|3 Month Follow-up|Overall Study||6||
48375105|NCT02596711|101247559|FG002|3 Month Follow-up|Overall Study||6||
48375106|NCT02596711|101247557|FG000|6 Month Follow-up|Overall Study||8||
48375107|NCT02596711|101247558|FG001|6 Month Follow-up|Overall Study||6||
48375108|NCT02596711|101247559|FG002|6 Month Follow-up|Overall Study||5||
48375109|NCT02596711|101247557|FG000|COMPLETED|Overall Study||8||
48375110|NCT02596711|101247558|FG001|COMPLETED|Overall Study||6||
48375111|NCT02596711|101247559|FG002|COMPLETED|Overall Study||5||
48375112|NCT02596711|101247557|FG000|NOT COMPLETED|Overall Study||1||
48375113|NCT02596711|101247558|FG001|NOT COMPLETED|Overall Study||2||
48375114|NCT02596711|101247559|FG002|NOT COMPLETED|Overall Study||3||
48375115|NCT00408421|101247560|FG000|STARTED|Treatment Initial Randomization||120||
48375116|NCT00408421|101247561|FG001|STARTED|Treatment Initial Randomization||111||
48078467|NCT01737697|100515171|FG003|STARTED|Acute Phase-Initial 48 Hours||158||
48375117|NCT00408421|101247562|FG002|STARTED|Treatment Initial Randomization||0||
48375118|NCT00408421|101247560|FG000|COMPLETED|Treatment Initial Randomization||103||
48375119|NCT00408421|101247561|FG001|COMPLETED|Treatment Initial Randomization||89||
48375120|NCT00408421|101247562|FG002|COMPLETED|Treatment Initial Randomization||0||
48375121|NCT00408421|101247560|FG000|NOT COMPLETED|Treatment Initial Randomization||17||
48375122|NCT00408421|101247561|FG001|NOT COMPLETED|Treatment Initial Randomization||22||
48375123|NCT00408421|101247562|FG002|NOT COMPLETED|Treatment Initial Randomization||0||
48375124|NCT00408421|101247560|FG000|STARTED|Treatment Re-Randomization||103||
48375125|NCT00408421|101247561|FG001|STARTED|Treatment Re-Randomization||46||
48375126|NCT00408421|101247562|FG002|STARTED|Treatment Re-Randomization||43||
48375127|NCT00408421|101247560|FG000|COMPLETED|Treatment Re-Randomization||96||
48375128|NCT00408421|101247561|FG001|COMPLETED|Treatment Re-Randomization||39||
48375129|NCT00408421|101247562|FG002|COMPLETED|Treatment Re-Randomization||38||
48375130|NCT00408421|101247560|FG000|NOT COMPLETED|Treatment Re-Randomization||7||
48375131|NCT00408421|101247561|FG001|NOT COMPLETED|Treatment Re-Randomization||7||
48375132|NCT00408421|101247562|FG002|NOT COMPLETED|Treatment Re-Randomization||5||
48375133|NCT00312884|101247563|FG000|STARTED|Overall Study||91||
48375134|NCT00312884|101247564|FG001|STARTED|Overall Study||91||
48375135|NCT00312884|101247563|FG000|COMPLETED|Overall Study||74||
48375136|NCT00312884|101247564|FG001|COMPLETED|Overall Study||79||
48375137|NCT00312884|101247563|FG000|NOT COMPLETED|Overall Study||17||
48375138|NCT00312884|101247564|FG001|NOT COMPLETED|Overall Study||12||
48375139|NCT02322892|101247565|FG000|STARTED|Overall Study||35||
48375140|NCT02322892|101247566|FG001|STARTED|Overall Study||34||
48375141|NCT02322892|101247565|FG000|COMPLETED|Overall Study||33||
48375142|NCT02322892|101247566|FG001|COMPLETED|Overall Study||31||
48375143|NCT02322892|101247565|FG000|NOT COMPLETED|Overall Study||2||
48375144|NCT02322892|101247566|FG001|NOT COMPLETED|Overall Study||3||
48375145|NCT00138151|101247567|FG000|STARTED|Overall Study||33||
48375146|NCT00138151|101247567|FG000|COMPLETED|Overall Study||29||
48375147|NCT00138151|101247567|FG000|NOT COMPLETED|Overall Study||4||
48375148|NCT01115569|101247568|FG000|STARTED|Conversion/Titration Phase||638||
48375149|NCT01115569|101247569|FG001|STARTED|Conversion/Titration Phase||0||
48078468|NCT01737697|100515172|FG004|STARTED|Acute Phase-Initial 48 Hours||143||
48375150|NCT01115569|101247568|FG000|COMPLETED|Conversion/Titration Phase||424||
48078469|NCT01737697|100515173|FG005|STARTED|Acute Phase-Initial 48 Hours||0||
48375151|NCT01115569|101247569|FG001|COMPLETED|Conversion/Titration Phase||0||
48375152|NCT01115569|101247568|FG000|NOT COMPLETED|Conversion/Titration Phase||214||
48375153|NCT01115569|101247569|FG001|NOT COMPLETED|Conversion/Titration Phase||0||
48375154|NCT01115569|101247568|FG000|STARTED|Maintenance Phase||0||
48375155|NCT01115569|101247569|FG001|STARTED|Maintenance Phase||424||
48375156|NCT01115569|101247568|FG000|COMPLETED|Maintenance Phase||0||
48523283|NCT01769274|101616080|FG000|STARTED|Part B:Treatment Session2-Period4||0||
48523284|NCT01769274|101616081|FG001|STARTED|Part B:Treatment Session2-Period4||2||
48523285|NCT01769274|101616082|FG002|STARTED|Part B:Treatment Session2-Period4||3||
48523286|NCT01769274|101616080|FG000|COMPLETED|Part B:Treatment Session2-Period4||0||
48523287|NCT01769274|101616081|FG001|COMPLETED|Part B:Treatment Session2-Period4||2||
48523288|NCT01769274|101616082|FG002|COMPLETED|Part B:Treatment Session2-Period4||3||
48523289|NCT01769274|101616080|FG000|NOT COMPLETED|Part B:Treatment Session2-Period4||0||
48523290|NCT01769274|101616081|FG001|NOT COMPLETED|Part B:Treatment Session2-Period4||0||
48523291|NCT01769274|101616082|FG002|NOT COMPLETED|Part B:Treatment Session2-Period4||0||
48523292|NCT00441350|101616083|FG000|STARTED|Phase A: Randomization to Week 8||285||
48523293|NCT00441350|101616084|FG001|STARTED|Phase A: Randomization to Week 8||561||
48523294|NCT00441350|101616085|FG002|STARTED|Phase A: Randomization to Week 8||0||
48523295|NCT00441350|101616086|FG003|STARTED|Phase A: Randomization to Week 8||0||
48523296|NCT00441350|101616087|FG004|STARTED|Phase A: Randomization to Week 8||0||
48523297|NCT00441350|101616088|FG005|STARTED|Phase A: Randomization to Week 8||0||
48592642|NCT01877382|101783159|FG009|COMPLETED|Dose Escalation||0||
48375157|NCT01115569|101247569|FG001|COMPLETED|Maintenance Phase||285||
48375158|NCT01115569|101247568|FG000|NOT COMPLETED|Maintenance Phase||0||
48375159|NCT01115569|101247569|FG001|NOT COMPLETED|Maintenance Phase||139||
48375160|NCT02536170|101247570|FG000|STARTED|Overall Study||36||
48375161|NCT02536170|101247571|FG001|STARTED|Overall Study||36||
48375162|NCT02536170|101247572|FG002|STARTED|Overall Study||36||
48375163|NCT02536170|101247570|FG000|COMPLETED|Overall Study||36||
48375164|NCT02536170|101247571|FG001|COMPLETED|Overall Study||36||
48375165|NCT02536170|101247572|FG002|COMPLETED|Overall Study||36||
48375166|NCT02536170|101247570|FG000|NOT COMPLETED|Overall Study||0||
48375167|NCT02536170|101247571|FG001|NOT COMPLETED|Overall Study||0||
48375168|NCT02536170|101247572|FG002|NOT COMPLETED|Overall Study||0||
48375169|NCT02773238|101247573|FG000|STARTED|Overall Study||51||
48375170|NCT02773238|101247573|FG000|COMPLETED|Overall Study||47||
48375171|NCT02773238|101247573|FG000|NOT COMPLETED|Overall Study||4||
48375172|NCT00115349|101247574|FG000|STARTED|Overall Study||11||
48375173|NCT00115349|101247575|FG001|STARTED|Overall Study||9||
48375174|NCT00115349|101247574|FG000|COMPLETED|Overall Study||0||
48375175|NCT00115349|101247575|FG001|COMPLETED|Overall Study||0||
48375176|NCT00115349|101247574|FG000|NOT COMPLETED|Overall Study||11||
48375177|NCT00115349|101247575|FG001|NOT COMPLETED|Overall Study||9||
48375178|NCT02399813|101247576|FG000|STARTED|Overall Study||36||
48375179|NCT02399813|101247576|FG000|COMPLETED|Overall Study||0||
48375180|NCT02399813|101247576|FG000|NOT COMPLETED|Overall Study||36||
48375181|NCT03638947|101247577|FG000|STARTED|Overall Study||130||
48375182|NCT03638947|101247578|FG001|STARTED|Overall Study||106||
48375183|NCT03638947|101247577|FG000|COMPLETED|Overall Study||130||
48375184|NCT03638947|101247578|FG001|COMPLETED|Overall Study||106||
48375185|NCT03638947|101247577|FG000|NOT COMPLETED|Overall Study||0||
48375186|NCT03638947|101247578|FG001|NOT COMPLETED|Overall Study||0||
48375187|NCT01008995|101247579|FG000|STARTED|Controlled Period||162||
48375188|NCT01008995|101247580|FG001|STARTED|Controlled Period||160||
48375189|NCT01008995|101247581|FG002|STARTED|Controlled Period||0||
48375190|NCT01008995|101247582|FG003|STARTED|Controlled Period||0||
48375191|NCT01008995|101247579|FG000|COMPLETED|Controlled Period||159||
48375192|NCT01008995|101247580|FG001|COMPLETED|Controlled Period||157||
48375193|NCT01008995|101247581|FG002|COMPLETED|Controlled Period||0||
48375194|NCT01008995|101247582|FG003|COMPLETED|Controlled Period||0||
48375195|NCT01008995|101247579|FG000|NOT COMPLETED|Controlled Period||3||
48375196|NCT01008995|101247580|FG001|NOT COMPLETED|Controlled Period||3||
48375197|NCT01008995|101247581|FG002|NOT COMPLETED|Controlled Period||0||
48375198|NCT01008995|101247582|FG003|NOT COMPLETED|Controlled Period||0||
48375199|NCT01008995|101247579|FG000|STARTED|After Controlled Period||0||
48375200|NCT01008995|101247580|FG001|STARTED|After Controlled Period||0||
48375201|NCT01008995|101247581|FG002|STARTED|After Controlled Period||158||
48375202|NCT01008995|101247582|FG003|STARTED|After Controlled Period||157||
48375203|NCT01008995|101247579|FG000|COMPLETED|After Controlled Period||0||
48375204|NCT01008995|101247580|FG001|COMPLETED|After Controlled Period||0||
48375205|NCT01008995|101247581|FG002|COMPLETED|After Controlled Period||156||
48375206|NCT01008995|101247582|FG003|COMPLETED|After Controlled Period||156||
48375207|NCT01008995|101247579|FG000|NOT COMPLETED|After Controlled Period||0||
48375208|NCT01008995|101247580|FG001|NOT COMPLETED|After Controlled Period||0||
48375209|NCT01008995|101247581|FG002|NOT COMPLETED|After Controlled Period||2||
48375210|NCT01008995|101247582|FG003|NOT COMPLETED|After Controlled Period||1||
48375211|NCT01514188|101247583|FG000|STARTED|Overall Study||40||
48375212|NCT01514188|101247584|FG001|STARTED|Overall Study||83||
48375213|NCT01514188|101247583|FG000|COMPLETED|Overall Study||17||
48375214|NCT01514188|101247584|FG001|COMPLETED|Overall Study||50||
48375215|NCT01514188|101247583|FG000|NOT COMPLETED|Overall Study||23||
48375216|NCT01514188|101247584|FG001|NOT COMPLETED|Overall Study||33||
48375217|NCT00926796|101247585|FG000|STARTED|Overall Study||309||
48375218|NCT00926796|101247586|FG001|STARTED|Overall Study||305||
48375219|NCT00926796|101247585|FG000|COMPLETED|Overall Study||202||
48375220|NCT00926796|101247586|FG001|COMPLETED|Overall Study||199||
48375221|NCT00926796|101247585|FG000|NOT COMPLETED|Overall Study||107||
48375222|NCT00926796|101247586|FG001|NOT COMPLETED|Overall Study||106||
48375223|NCT03126539|101247587|FG000|STARTED|Overall Study||9||9
48375224|NCT03126539|101247588|FG001|STARTED|Overall Study||9||9
48375225|NCT03126539|101247589|FG002|STARTED|Overall Study||9||27
48375226|NCT03126539|101247590|FG003|STARTED|Overall Study||0||0
48375227|NCT03126539|101247591|FG004|STARTED|Overall Study||0||0
48375228|NCT03126539|101247587|FG000|COMPLETED|Overall Study||8||8
48375229|NCT03126539|101247588|FG001|COMPLETED|Overall Study||8||8
48375230|NCT03126539|101247589|FG002|COMPLETED|Overall Study||8||24
48375231|NCT03126539|101247590|FG003|COMPLETED|Overall Study||0||0
48375232|NCT03126539|101247591|FG004|COMPLETED|Overall Study||0||0
48375233|NCT03126539|101247587|FG000|NOT COMPLETED|Overall Study||1||1
48375234|NCT03126539|101247588|FG001|NOT COMPLETED|Overall Study||1||1
48375235|NCT03126539|101247589|FG002|NOT COMPLETED|Overall Study||1||3
48078470|NCT01737697|100515174|FG006|STARTED|Acute Phase-Initial 48 Hours||0||
48078471|NCT01737697|100515175|FG007|STARTED|Acute Phase-Initial 48 Hours||0||
48078472|NCT01737697|100515176|FG008|STARTED|Acute Phase-Initial 48 Hours||0||
48375236|NCT03126539|101247590|FG003|NOT COMPLETED|Overall Study||0||0
48375237|NCT03126539|101247591|FG004|NOT COMPLETED|Overall Study||0||0
48375238|NCT00300469|101247592|FG000|STARTED|Overall Study||110||
48375239|NCT00300469|101247593|FG001|STARTED|Overall Study||110||
48375240|NCT00300469|101247594|FG002|STARTED|Overall Study||112||
48375241|NCT00300469|101247595|FG003|STARTED|Overall Study||113||
48375242|NCT00300469|101247596|FG004|STARTED|Overall Study||109||
48375243|NCT00300469|101247597|FG005|STARTED|Overall Study||55||
48375244|NCT00300469|101247592|FG000|COMPLETED|Overall Study||89||
48375245|NCT00300469|101247593|FG001|COMPLETED|Overall Study||89||
48375246|NCT00300469|101247594|FG002|COMPLETED|Overall Study||95||
48375247|NCT00300469|101247595|FG003|COMPLETED|Overall Study||104||
48375248|NCT00300469|101247596|FG004|COMPLETED|Overall Study||95||
48375249|NCT00300469|101247597|FG005|COMPLETED|Overall Study||46||
48375250|NCT00300469|101247592|FG000|NOT COMPLETED|Overall Study||21||
48375251|NCT00300469|101247593|FG001|NOT COMPLETED|Overall Study||21||
48375252|NCT00300469|101247594|FG002|NOT COMPLETED|Overall Study||17||
48375253|NCT00300469|101247595|FG003|NOT COMPLETED|Overall Study||9||
48375254|NCT00300469|101247596|FG004|NOT COMPLETED|Overall Study||14||
48375255|NCT00300469|101247597|FG005|NOT COMPLETED|Overall Study||9||
48375256|NCT02128763|101247598|FG000|STARTED|Overall Study||349||
48375257|NCT02128763|101247599|FG001|STARTED|Overall Study||186||
48375258|NCT02128763|101247598|FG000|COMPLETED|Overall Study||329||
48375259|NCT02128763|101247599|FG001|COMPLETED|Overall Study||170||
48078473|NCT01737697|100515177|FG009|STARTED|Acute Phase-Initial 48 Hours||0||
48078474|NCT01737697|100515178|FG010|STARTED|Acute Phase-Initial 48 Hours||0||
48078475|NCT01737697|100515179|FG011|STARTED|Acute Phase-Initial 48 Hours||0||
48078476|NCT01737697|100515180|FG012|STARTED|Acute Phase-Initial 48 Hours||0||
48078477|NCT01737697|100515181|FG013|STARTED|Acute Phase-Initial 48 Hours||0||
48078478|NCT01737697|100515182|FG014|STARTED|Acute Phase-Initial 48 Hours||0||
48078479|NCT01737697|100515168|FG000|COMPLETED|Acute Phase-Initial 48 Hours||157||
48078480|NCT01737697|100515169|FG001|COMPLETED|Acute Phase-Initial 48 Hours||150||
48078481|NCT01737697|100515170|FG002|COMPLETED|Acute Phase-Initial 48 Hours||137||
48078482|NCT01737697|100515171|FG003|COMPLETED|Acute Phase-Initial 48 Hours||152||
48078483|NCT01737697|100515172|FG004|COMPLETED|Acute Phase-Initial 48 Hours||140||
48078484|NCT01737697|100515173|FG005|COMPLETED|Acute Phase-Initial 48 Hours||0||
48078485|NCT01737697|100515174|FG006|COMPLETED|Acute Phase-Initial 48 Hours||0||
48078486|NCT01737697|100515175|FG007|COMPLETED|Acute Phase-Initial 48 Hours||0||
48078487|NCT01737697|100515176|FG008|COMPLETED|Acute Phase-Initial 48 Hours||0||
48078488|NCT01737697|100515177|FG009|COMPLETED|Acute Phase-Initial 48 Hours||0||
48078489|NCT01737697|100515178|FG010|COMPLETED|Acute Phase-Initial 48 Hours||0||
48078490|NCT01737697|100515179|FG011|COMPLETED|Acute Phase-Initial 48 Hours||0||
48078491|NCT01737697|100515180|FG012|COMPLETED|Acute Phase-Initial 48 Hours||0||
48078492|NCT01737697|100515181|FG013|COMPLETED|Acute Phase-Initial 48 Hours||0||
48078493|NCT01737697|100515182|FG014|COMPLETED|Acute Phase-Initial 48 Hours||0||
48078494|NCT01737697|100515168|FG000|NOT COMPLETED|Acute Phase-Initial 48 Hours||1||
48078495|NCT01737697|100515169|FG001|NOT COMPLETED|Acute Phase-Initial 48 Hours||4||
48078496|NCT01737697|100515170|FG002|NOT COMPLETED|Acute Phase-Initial 48 Hours||4||
48078497|NCT01737697|100515171|FG003|NOT COMPLETED|Acute Phase-Initial 48 Hours||6||
48078498|NCT01737697|100515172|FG004|NOT COMPLETED|Acute Phase-Initial 48 Hours||3||
48078499|NCT01737697|100515173|FG005|NOT COMPLETED|Acute Phase-Initial 48 Hours||0||
48078500|NCT01737697|100515174|FG006|NOT COMPLETED|Acute Phase-Initial 48 Hours||0||
48078501|NCT01737697|100515175|FG007|NOT COMPLETED|Acute Phase-Initial 48 Hours||0||
48078502|NCT01737697|100515176|FG008|NOT COMPLETED|Acute Phase-Initial 48 Hours||0||
48375260|NCT02128763|101247598|FG000|NOT COMPLETED|Overall Study||20||
48375261|NCT02128763|101247599|FG001|NOT COMPLETED|Overall Study||16||
48375262|NCT00632463|101247600|FG000|STARTED|Overall Study||7||
48375263|NCT00632463|101247601|FG001|STARTED|Overall Study||7||
48375264|NCT00632463|101247602|FG002|STARTED|Overall Study||7||
48375265|NCT00632463|101247600|FG000|COMPLETED|Overall Study||7||
48375266|NCT00632463|101247601|FG001|COMPLETED|Overall Study||6||
48078503|NCT01737697|100515177|FG009|NOT COMPLETED|Acute Phase-Initial 48 Hours||0||
48078504|NCT01737697|100515178|FG010|NOT COMPLETED|Acute Phase-Initial 48 Hours||0||
48375267|NCT00632463|101247602|FG002|COMPLETED|Overall Study||7||
48375268|NCT00632463|101247600|FG000|NOT COMPLETED|Overall Study||0||
48375269|NCT00632463|101247601|FG001|NOT COMPLETED|Overall Study||1||
48375270|NCT00632463|101247602|FG002|NOT COMPLETED|Overall Study||0||
48375271|NCT03855137|101247603|FG000|STARTED|DB Treatment Period (Day 1 to Week 12)||259||
48375272|NCT03855137|101247604|FG001|STARTED|DB Treatment Period (Day 1 to Week 12)||257||
48375273|NCT03855137|101247605|FG002|STARTED|DB Treatment Period (Day 1 to Week 12)||262||
48375274|NCT03855137|101247603|FG000|Safety Population|DB Treatment Period (Day 1 to Week 12)||255|Safety population included all participants who received at least 1 dose of study intervention.|
48375275|NCT03855137|101247604|FG001|Safety Population|DB Treatment Period (Day 1 to Week 12)||257|Safety population included all participants who received at least 1 dose of study intervention.|
48375276|NCT03855137|101247605|FG002|Safety Population|DB Treatment Period (Day 1 to Week 12)||261|Safety population included all participants who received at least 1 dose of study intervention.|
48375277|NCT03855137|101247603|FG000|Modified Intent-to-Treat (mITT) Population|DB Treatment Period (Day 1 to Week 12)||246|mITT population included all randomized participants who received at least 1 dose of study intervention, had an evaluable baseline period of eDiary data, and had at least 1 evaluable post-baseline 4-week period (Weeks 1 to 4, 5 to 8, and 9 to 12) of eDiary data during the double-blind treatment period.|
48375278|NCT03855137|101247604|FG001|Modified Intent-to-Treat (mITT) Population|DB Treatment Period (Day 1 to Week 12)||253|mITT population included all randomized participants who received at least 1 dose of study intervention, had an evaluable baseline period of eDiary data, and had at least 1 evaluable post-baseline 4-week period (Weeks 1 to 4, 5 to 8, and 9 to 12) of eDiary data during the double-blind treatment period.|
48375279|NCT03855137|101247605|FG002|Modified Intent-to-Treat (mITT) Population|DB Treatment Period (Day 1 to Week 12)||256|mITT population included all randomized participants who received at least 1 dose of study intervention, had an evaluable baseline period of eDiary data, and had at least 1 evaluable post-baseline 4-week period (Weeks 1 to 4, 5 to 8, and 9 to 12) of eDiary data during the double-blind treatment period.|
48375280|NCT03855137|101247603|FG000|Off-treatment Hypothetical Estimand Population|DB Treatment Period (Day 1 to Week 12)||249|Off-treatment hypothetical estimand population included all randomized participants who received ≥ 1 dose of study intervention, had an evaluable baseline period of eDiary data and had ≥ 1 evaluable postbaseline 4-week period (Weeks 1 to 4, 5 to 8, 9 to 12) of eDiary data during the study, regardless of whether on study treatment or off study treatment.|
48375281|NCT03855137|101247604|FG001|Off-treatment Hypothetical Estimand Population|DB Treatment Period (Day 1 to Week 12)||254|Off-treatment hypothetical estimand population included all randomized participants who received ≥ 1 dose of study intervention, had an evaluable baseline period of eDiary data and had ≥ 1 evaluable postbaseline 4-week period (Weeks 1 to 4, 5 to 8, 9 to 12) of eDiary data during the study, regardless of whether on study treatment or off study treatment.|
48375282|NCT03855137|101247605|FG002|Off-treatment Hypothetical Estimand Population|DB Treatment Period (Day 1 to Week 12)||257|Off-treatment hypothetical estimand population included all randomized participants who received ≥ 1 dose of study intervention, had an evaluable baseline period of eDiary data and had ≥ 1 evaluable postbaseline 4-week period (Weeks 1 to 4, 5 to 8, 9 to 12) of eDiary data during the study, regardless of whether on study treatment or off study treatment.|
48375283|NCT03855137|101247603|FG000|COMPLETED|DB Treatment Period (Day 1 to Week 12)||230||
48078505|NCT01737697|100515179|FG011|NOT COMPLETED|Acute Phase-Initial 48 Hours||0||
48078506|NCT01737697|100515180|FG012|NOT COMPLETED|Acute Phase-Initial 48 Hours||0||
48078507|NCT01737697|100515181|FG013|NOT COMPLETED|Acute Phase-Initial 48 Hours||0||
48078508|NCT01737697|100515182|FG014|NOT COMPLETED|Acute Phase-Initial 48 Hours||0||
48078509|NCT01737697|100515168|FG000|STARTED|Subacute Phase||0||
48375284|NCT03855137|101247604|FG001|COMPLETED|DB Treatment Period (Day 1 to Week 12)||231||
48375285|NCT03855137|101247605|FG002|COMPLETED|DB Treatment Period (Day 1 to Week 12)||233||
48375286|NCT03855137|101247603|FG000|NOT COMPLETED|DB Treatment Period (Day 1 to Week 12)||29||
48375287|NCT03855137|101247604|FG001|NOT COMPLETED|DB Treatment Period (Day 1 to Week 12)||26||
48375288|NCT03855137|101247605|FG002|NOT COMPLETED|DB Treatment Period (Day 1 to Week 12)||29||
48375289|NCT03855137|101247603|FG000|STARTED|FU Period (Week 12 to Week 16)||169|Out of 694 participants who completed the DB treatment period, only 517 participants continued the follow-up period.|
48375290|NCT03855137|101247604|FG001|STARTED|FU Period (Week 12 to Week 16)||179|Out of 694 participants who completed the DB treatment period, only 517 participants continued the follow-up period.|
48375291|NCT03855137|101247605|FG002|STARTED|FU Period (Week 12 to Week 16)||169|Out of 694 participants who completed the DB treatment period, only 517 participants continued the follow-up period.|
48375292|NCT03855137|101247603|FG000|COMPLETED|FU Period (Week 12 to Week 16)||161|Participants who completed the DB treatment period and rolled-over to other extension studies 3101-312-002 (NCT04686136), 3101-306-002 (NCT04437433),and 3101-311-002 (NCT04829747) were not required to enter the follow-up period.|
48375293|NCT03855137|101247604|FG001|COMPLETED|FU Period (Week 12 to Week 16)||170|Participants who completed the DB treatment period and rolled-over to other extension studies 3101-312-002 (NCT04686136), 3101-306-002 (NCT04437433),and 3101-311-002 (NCT04829747) were not required to enter the follow-up period.|
48404084|NCT03689972|101321766|FG000|COMPLETED|Part 2:Run-in Period (Week73uptoWeek107)||0||
48078510|NCT01737697|100515169|FG001|STARTED|Subacute Phase||0||
48078511|NCT01737697|100515170|FG002|STARTED|Subacute Phase||0||
48078512|NCT01737697|100515171|FG003|STARTED|Subacute Phase||0||
48078513|NCT01737697|100515172|FG004|STARTED|Subacute Phase||0||
48078514|NCT01737697|100515173|FG005|STARTED|Subacute Phase||41||
48078515|NCT01737697|100515174|FG006|STARTED|Subacute Phase||49||
48078516|NCT01737697|100515175|FG007|STARTED|Subacute Phase||46||
48078517|NCT01737697|100515176|FG008|STARTED|Subacute Phase||54||
48375294|NCT03855137|101247605|FG002|COMPLETED|FU Period (Week 12 to Week 16)||165|Participants who completed the DB treatment period and rolled-over to other extension studies 3101-312-002 (NCT04686136), 3101-306-002 (NCT04437433),and 3101-311-002 (NCT04829747) were not required to enter the follow-up period.|
48375295|NCT03855137|101247603|FG000|NOT COMPLETED|FU Period (Week 12 to Week 16)||8||
48375296|NCT03855137|101247604|FG001|NOT COMPLETED|FU Period (Week 12 to Week 16)||9||
48375297|NCT03855137|101247605|FG002|NOT COMPLETED|FU Period (Week 12 to Week 16)||4||
48375298|NCT05836818|101247606|FG000|STARTED|Overall Study||245||270
48375299|NCT05836818|101247607|FG001|STARTED|Overall Study||214||270
48078518|NCT01737697|100515177|FG009|STARTED|Subacute Phase||68||
48078519|NCT01737697|100515178|FG010|STARTED|Subacute Phase||65||
48375300|NCT05836818|101247608|FG002|STARTED|Overall Study||317||270
48375301|NCT05836818|101247606|FG000|COMPLETED|Overall Study||244||270
48375302|NCT05836818|101247607|FG001|COMPLETED|Overall Study||210||270
48375303|NCT05836818|101247608|FG002|COMPLETED|Overall Study||313||270
48375304|NCT05836818|101247606|FG000|NOT COMPLETED|Overall Study||1||0
48375305|NCT05836818|101247607|FG001|NOT COMPLETED|Overall Study||4||0
48375306|NCT05836818|101247608|FG002|NOT COMPLETED|Overall Study||4||0
48375307|NCT04688346|101247609|FG000|STARTED|Overall Study||6||6
48375308|NCT04688346|101247610|FG001|STARTED|Overall Study||7||7
48375309|NCT04688346|101247609|FG000|First Intervention|Overall Study||6||6
48375310|NCT04688346|101247610|FG001|First Intervention|Overall Study||7||7
48375311|NCT04688346|101247609|FG000|Second Intervention|Overall Study||6||6
48375312|NCT04688346|101247610|FG001|Second Intervention|Overall Study||7||7
48375313|NCT04688346|101247609|FG000|COMPLETED|Overall Study||6||6
48375314|NCT04688346|101247610|FG001|COMPLETED|Overall Study||7||7
48375315|NCT04688346|101247609|FG000|NOT COMPLETED|Overall Study||0||0
48375316|NCT04688346|101247610|FG001|NOT COMPLETED|Overall Study||0||0
48375317|NCT02993224|101247611|FG000|STARTED|Core Phase - Period 1||148||
48375318|NCT02993224|101247611|FG000|COMPLETED|Core Phase - Period 1||140||
48375319|NCT02993224|101247611|FG000|NOT COMPLETED|Core Phase - Period 1||8||
48375320|NCT02993224|101247611|FG000|STARTED|Core Phase- Period 2||140||
48375321|NCT02993224|101247611|FG000|COMPLETED|Core Phase- Period 2||136||
48375322|NCT02993224|101247611|FG000|NOT COMPLETED|Core Phase- Period 2||4||
48375323|NCT02993224|101247611|FG000|STARTED|Extension Phase||116|Participation in the extension phase was optional|
48375324|NCT02993224|101247611|FG000|COMPLETED|Extension Phase||80||
48375325|NCT02993224|101247611|FG000|NOT COMPLETED|Extension Phase||36||
48375326|NCT00702052|101247612|FG000|STARTED|Overall Study||58||
48375327|NCT00702052|101247612|FG000|COMPLETED|Overall Study||0||
48375328|NCT00702052|101247612|FG000|NOT COMPLETED|Overall Study||58||
48375329|NCT00597935|101247613|FG000|STARTED|Randomized to Surgical and BPMT Arms||95||
48375330|NCT00597935|101247614|FG001|STARTED|Randomized to Surgical and BPMT Arms||91||
48375331|NCT00597935|101247615|FG002|STARTED|Randomized to Surgical and BPMT Arms||91||
48375332|NCT00597935|101247616|FG003|STARTED|Randomized to Surgical and BPMT Arms||97||
48375333|NCT00597935|101247613|FG000|COMPLETED|Randomized to Surgical and BPMT Arms||95||
48375334|NCT00597935|101247614|FG001|COMPLETED|Randomized to Surgical and BPMT Arms||91||
48375335|NCT00597935|101247615|FG002|COMPLETED|Randomized to Surgical and BPMT Arms||91||
48375336|NCT00597935|101247616|FG003|COMPLETED|Randomized to Surgical and BPMT Arms||97||
48375337|NCT00597935|101247613|FG000|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0||
48375338|NCT00597935|101247614|FG001|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0||
48078520|NCT01737697|100515179|FG011|STARTED|Subacute Phase||61||
48078521|NCT01737697|100515180|FG012|STARTED|Subacute Phase||63||
48375339|NCT00597935|101247615|FG002|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0||
48375340|NCT00597935|101247616|FG003|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0||
48375341|NCT00597935|101247613|FG000|STARTED|Baseline to 6-Months||95||
48375342|NCT00597935|101247614|FG001|STARTED|Baseline to 6-Months||91||
48375343|NCT00597935|101247615|FG002|STARTED|Baseline to 6-Months||91||
48375344|NCT00597935|101247616|FG003|STARTED|Baseline to 6-Months||97||
48375345|NCT00597935|101247613|FG000|COMPLETED|Baseline to 6-Months||93||
48375346|NCT00597935|101247614|FG001|COMPLETED|Baseline to 6-Months||87||
48375347|NCT00597935|101247615|FG002|COMPLETED|Baseline to 6-Months||87||
48375348|NCT00597935|101247616|FG003|COMPLETED|Baseline to 6-Months||93||
48375349|NCT00597935|101247613|FG000|NOT COMPLETED|Baseline to 6-Months||2||
48375350|NCT00597935|101247614|FG001|NOT COMPLETED|Baseline to 6-Months||4||
48375351|NCT00597935|101247615|FG002|NOT COMPLETED|Baseline to 6-Months||4||
48375352|NCT00597935|101247616|FG003|NOT COMPLETED|Baseline to 6-Months||4||
48375353|NCT00597935|101247613|FG000|STARTED|6-Months to 24-Months||93||
48375354|NCT00597935|101247614|FG001|STARTED|6-Months to 24-Months||87||
48375355|NCT00597935|101247615|FG002|STARTED|6-Months to 24-Months||87||
48375356|NCT00597935|101247616|FG003|STARTED|6-Months to 24-Months||93||
48375357|NCT00597935|101247613|FG000|COMPLETED|6-Months to 24-Months||76||
48375358|NCT00597935|101247614|FG001|COMPLETED|6-Months to 24-Months||79||
48375359|NCT00597935|101247615|FG002|COMPLETED|6-Months to 24-Months||77||
48375360|NCT00597935|101247616|FG003|COMPLETED|6-Months to 24-Months||85||
48375361|NCT00597935|101247613|FG000|NOT COMPLETED|6-Months to 24-Months||17||
48375362|NCT00597935|101247614|FG001|NOT COMPLETED|6-Months to 24-Months||8||
48375363|NCT00597935|101247615|FG002|NOT COMPLETED|6-Months to 24-Months||10||
48375364|NCT00597935|101247616|FG003|NOT COMPLETED|6-Months to 24-Months||8||
48375365|NCT04087343|101247617|FG000|STARTED|Overall Study||4||
48375366|NCT04087343|101247618|FG001|STARTED|Overall Study||5||
48375367|NCT04087343|101247617|FG000|COMPLETED|Overall Study||4||
48375368|NCT04087343|101247618|FG001|COMPLETED|Overall Study||5||
48375369|NCT04087343|101247617|FG000|NOT COMPLETED|Overall Study||0||
48375370|NCT04087343|101247618|FG001|NOT COMPLETED|Overall Study||0||
48375371|NCT00816907|101247619|FG000|STARTED|Overall Study||71||
48078522|NCT01737697|100515181|FG013|STARTED|Subacute Phase||46||
48078523|NCT01737697|100515182|FG014|STARTED|Subacute Phase||50||
48078524|NCT01737697|100515168|FG000|COMPLETED|Subacute Phase||0||
48078525|NCT01737697|100515169|FG001|COMPLETED|Subacute Phase||0||
48078526|NCT01737697|100515170|FG002|COMPLETED|Subacute Phase||0||
48078527|NCT01737697|100515171|FG003|COMPLETED|Subacute Phase||0||
48078528|NCT01737697|100515172|FG004|COMPLETED|Subacute Phase||0||
48078529|NCT01737697|100515173|FG005|COMPLETED|Subacute Phase||38||
48078530|NCT01737697|100515174|FG006|COMPLETED|Subacute Phase||48||
48078531|NCT01737697|100515175|FG007|COMPLETED|Subacute Phase||43||
48078532|NCT01737697|100515176|FG008|COMPLETED|Subacute Phase||52||
48078533|NCT01737697|100515177|FG009|COMPLETED|Subacute Phase||66||
48078534|NCT01737697|100515178|FG010|COMPLETED|Subacute Phase||59||
48078535|NCT01737697|100515179|FG011|COMPLETED|Subacute Phase||58||
48078536|NCT01737697|100515180|FG012|COMPLETED|Subacute Phase||61||
48078537|NCT01737697|100515181|FG013|COMPLETED|Subacute Phase||44||
48078538|NCT01737697|100515182|FG014|COMPLETED|Subacute Phase||49||
48078539|NCT01737697|100515168|FG000|NOT COMPLETED|Subacute Phase||0||
48078540|NCT01737697|100515169|FG001|NOT COMPLETED|Subacute Phase||0||
48078541|NCT01737697|100515170|FG002|NOT COMPLETED|Subacute Phase||0||
48078542|NCT01737697|100515171|FG003|NOT COMPLETED|Subacute Phase||0||
48078543|NCT01737697|100515172|FG004|NOT COMPLETED|Subacute Phase||0||
48078544|NCT01737697|100515173|FG005|NOT COMPLETED|Subacute Phase||3||
48078545|NCT01737697|100515174|FG006|NOT COMPLETED|Subacute Phase||1||
48078546|NCT01737697|100515175|FG007|NOT COMPLETED|Subacute Phase||3||
48078547|NCT01737697|100515176|FG008|NOT COMPLETED|Subacute Phase||2||
48375372|NCT00816907|101247620|FG001|STARTED|Overall Study||75||
48375373|NCT00816907|101247619|FG000|COMPLETED|Overall Study||58||
48375374|NCT00816907|101247620|FG001|COMPLETED|Overall Study||58||
48375375|NCT00816907|101247619|FG000|NOT COMPLETED|Overall Study||13||
48375376|NCT00816907|101247620|FG001|NOT COMPLETED|Overall Study||17||
48375377|NCT03670641|101247621|FG000|STARTED|Overall Study||10||
48375378|NCT03670641|101247621|FG000|COMPLETED|Overall Study||7||
48375379|NCT03670641|101247621|FG000|NOT COMPLETED|Overall Study||3||
48375380|NCT03011034|101247622|FG000|STARTED|Overall Study||1||
48375381|NCT03011034|101247623|FG001|STARTED|Overall Study||33||
48375382|NCT03011034|101247622|FG000|COMPLETED|Overall Study||0||
48375383|NCT03011034|101247623|FG001|COMPLETED|Overall Study||33||
48375384|NCT03011034|101247622|FG000|NOT COMPLETED|Overall Study||1||
48375385|NCT03011034|101247623|FG001|NOT COMPLETED|Overall Study||0||
48375386|NCT00564954|101247624|FG000|STARTED|Period 1- 1 Week||44||
48375387|NCT00564954|101247625|FG001|STARTED|Period 1- 1 Week||42||
48375388|NCT00564954|101247624|FG000|COMPLETED|Period 1- 1 Week||44||
48375389|NCT00564954|101247625|FG001|COMPLETED|Period 1- 1 Week||42||
48375390|NCT00564954|101247624|FG000|NOT COMPLETED|Period 1- 1 Week||0||
48375391|NCT00564954|101247625|FG001|NOT COMPLETED|Period 1- 1 Week||0||
48375392|NCT00564954|101247624|FG000|STARTED|Period 2- 1 Week||44||
48375393|NCT00564954|101247625|FG001|STARTED|Period 2- 1 Week||42||
48375394|NCT00564954|101247624|FG000|COMPLETED|Period 2- 1 Week||44||
48375395|NCT00564954|101247625|FG001|COMPLETED|Period 2- 1 Week||42||
48375396|NCT00564954|101247624|FG000|NOT COMPLETED|Period 2- 1 Week||0||
48375397|NCT00564954|101247625|FG001|NOT COMPLETED|Period 2- 1 Week||0||
48375398|NCT01716468|101247626|FG000|STARTED|Overall Study||17||
48375399|NCT01716468|101247626|FG000|COMPLETED|Overall Study||11||
48375400|NCT01716468|101247626|FG000|NOT COMPLETED|Overall Study||6||
48375401|NCT02340819|101247627|FG000|STARTED|Overall Study||11||
48375402|NCT02340819|101247627|FG000|Started Stage 2|Overall Study||11||
48375403|NCT02340819|101247627|FG000|Completed Stage 2|Overall Study||9||
48375404|NCT02340819|101247627|FG000|Started Stage 3|Overall Study||8||
48375405|NCT02340819|101247627|FG000|Completed Stage 3|Overall Study||7||
48375406|NCT02340819|101247627|FG000|Started Stage 4|Overall Study||7||
48375407|NCT02340819|101247627|FG000|Completed Stage 4|Overall Study||7||
48375408|NCT02340819|101247627|FG000|COMPLETED|Overall Study||7||
48375409|NCT02340819|101247627|FG000|NOT COMPLETED|Overall Study||4||
48375410|NCT05080179|101247628|FG000|STARTED|Overall Study||4232||
48375411|NCT05080179|101247629|FG001|STARTED|Overall Study||4246||
48375412|NCT05080179|101247630|FG002|STARTED|Overall Study||4211||
48375413|NCT05080179|101247631|FG003|STARTED|Overall Study||4214||
48375414|NCT05080179|101247628|FG000|COMPLETED|Overall Study||353||
48375415|NCT05080179|101247629|FG001|COMPLETED|Overall Study||380||
48375416|NCT05080179|101247630|FG002|COMPLETED|Overall Study||355||
48375417|NCT05080179|101247631|FG003|COMPLETED|Overall Study||744||
48375418|NCT05080179|101247628|FG000|NOT COMPLETED|Overall Study||3879||
48375419|NCT05080179|101247629|FG001|NOT COMPLETED|Overall Study||3866||
48375420|NCT05080179|101247630|FG002|NOT COMPLETED|Overall Study||3856||
48375421|NCT05080179|101247631|FG003|NOT COMPLETED|Overall Study||3470||
48375422|NCT03480282|101247632|FG000|STARTED|Overall Study||90||
48375423|NCT03480282|101247632|FG000|COMPLETED|Overall Study||90||
48375424|NCT03480282|101247632|FG000|NOT COMPLETED|Overall Study||0||
48078548|NCT01737697|100515177|FG009|NOT COMPLETED|Subacute Phase||2||
48078549|NCT01737697|100515178|FG010|NOT COMPLETED|Subacute Phase||6||
48375425|NCT02389816|101247633|FG000|STARTED|Overall Study||164||
48375426|NCT02389816|101247634|FG001|STARTED|Overall Study||165||
48375427|NCT02389816|101247635|FG002|STARTED|Overall Study||164||
48375428|NCT02389816|101247633|FG000|COMPLETED|Overall Study||149||
48523298|NCT00441350|101616083|FG000|COMPLETED|Phase A: Randomization to Week 8||268||
48523299|NCT00441350|101616084|FG001|COMPLETED|Phase A: Randomization to Week 8||524||
48523300|NCT00441350|101616085|FG002|COMPLETED|Phase A: Randomization to Week 8||0||
48523301|NCT00441350|101616086|FG003|COMPLETED|Phase A: Randomization to Week 8||0||
48523302|NCT00441350|101616087|FG004|COMPLETED|Phase A: Randomization to Week 8||0||
48523303|NCT00441350|101616088|FG005|COMPLETED|Phase A: Randomization to Week 8||0||
48523304|NCT00441350|101616083|FG000|NOT COMPLETED|Phase A: Randomization to Week 8||17||
48375429|NCT02389816|101247634|FG001|COMPLETED|Overall Study||152||
48375430|NCT02389816|101247635|FG002|COMPLETED|Overall Study||152||
48375431|NCT02389816|101247633|FG000|NOT COMPLETED|Overall Study||15||
48375432|NCT02389816|101247634|FG001|NOT COMPLETED|Overall Study||13||
48375433|NCT02389816|101247635|FG002|NOT COMPLETED|Overall Study||12||
48375434|NCT02108600|101247636|FG000|STARTED|Overall Study||17||
48375435|NCT02108600|101247637|FG001|STARTED|Overall Study||16||
48375436|NCT02108600|101247636|FG000|COMPLETED|Overall Study||14||
48375437|NCT02108600|101247637|FG001|COMPLETED|Overall Study||15||
48375438|NCT02108600|101247636|FG000|NOT COMPLETED|Overall Study||3||
48375439|NCT02108600|101247637|FG001|NOT COMPLETED|Overall Study||1||
48375440|NCT00986258|101247638|FG000|STARTED|Observation Period||136||
48375441|NCT00986258|101247638|FG000|COMPLETED|Observation Period||125||
48375442|NCT00986258|101247638|FG000|NOT COMPLETED|Observation Period||11||
48375443|NCT00986258|101247638|FG000|STARTED|Titration and Optimal Dose Period||125||
48375444|NCT00986258|101247638|FG000|COMPLETED|Titration and Optimal Dose Period||102||
48375445|NCT00986258|101247638|FG000|NOT COMPLETED|Titration and Optimal Dose Period||23||
48375446|NCT00986258|101247638|FG000|STARTED|Maintenance Period||102||
48375447|NCT00986258|101247638|FG000|COMPLETED|Maintenance Period||93||
48375448|NCT00986258|101247638|FG000|NOT COMPLETED|Maintenance Period||9||
48375449|NCT00922194|101247639|FG000|STARTED|Metformin in Maximum Tolerated Dose||102||
48375450|NCT00922194|101247639|FG000|COMPLETED|Metformin in Maximum Tolerated Dose||102||
48375451|NCT00922194|101247639|FG000|NOT COMPLETED|Metformin in Maximum Tolerated Dose||0||
48375452|NCT00922194|101247639|FG000|STARTED|Metformin for 12 Months or More||102||
48375453|NCT00922194|101247639|FG000|COMPLETED|Metformin for 12 Months or More||102||
48375454|NCT00922194|101247639|FG000|NOT COMPLETED|Metformin for 12 Months or More||0||
48375455|NCT00516269|101247640|FG000|STARTED|Overall Study||19||
48375456|NCT00516269|101247641|FG001|STARTED|Overall Study||19||
48375457|NCT00516269|101247640|FG000|COMPLETED|Overall Study||17||
48375458|NCT00516269|101247641|FG001|COMPLETED|Overall Study||16||
48375459|NCT00516269|101247640|FG000|NOT COMPLETED|Overall Study||2||
48375460|NCT00516269|101247641|FG001|NOT COMPLETED|Overall Study||3||
48375461|NCT03744780|101247642|FG000|STARTED|Overall Study||32||
48375462|NCT03744780|101247642|FG000|COMPLETED|Overall Study||32||
48375463|NCT03744780|101247642|FG000|NOT COMPLETED|Overall Study||0||
48375464|NCT05818527|101247643|FG000|STARTED|Overall Study||16||
48375465|NCT05818527|101247644|FG001|STARTED|Overall Study||16||
48375466|NCT05818527|101247643|FG000|COMPLETED|Overall Study||16||
48375467|NCT05818527|101247644|FG001|COMPLETED|Overall Study||16||
48375468|NCT05818527|101247643|FG000|NOT COMPLETED|Overall Study||0||
48375469|NCT05818527|101247644|FG001|NOT COMPLETED|Overall Study||0||
48375470|NCT01426425|101247645|FG000|STARTED|Overall Study||572||
48375471|NCT01426425|101247645|FG000|EP Study|Overall Study||550||
48375472|NCT01426425|101247645|FG000|Intent to Treat|Overall Study||399||
48375473|NCT01426425|101247645|FG000|COMPLETED|Overall Study||397||
48375474|NCT01426425|101247645|FG000|NOT COMPLETED|Overall Study||175||
48375475|NCT03459131|101247646|FG000|STARTED|Period 1, First 7 Days of Wear||7||
48375476|NCT03459131|101247647|FG001|STARTED|Period 1, First 7 Days of Wear||8||
48523305|NCT00441350|101616084|FG001|NOT COMPLETED|Phase A: Randomization to Week 8||37||
48375477|NCT03459131|101247646|FG000|COMPLETED|Period 1, First 7 Days of Wear||7||
48375478|NCT03459131|101247647|FG001|COMPLETED|Period 1, First 7 Days of Wear||8||
48375479|NCT03459131|101247646|FG000|NOT COMPLETED|Period 1, First 7 Days of Wear||0||
48523306|NCT00441350|101616085|FG002|NOT COMPLETED|Phase A: Randomization to Week 8||0||
48523307|NCT00441350|101616086|FG003|NOT COMPLETED|Phase A: Randomization to Week 8||0||
48523308|NCT00441350|101616087|FG004|NOT COMPLETED|Phase A: Randomization to Week 8||0||
48523309|NCT00441350|101616088|FG005|NOT COMPLETED|Phase A: Randomization to Week 8||0||
48078550|NCT01737697|100515179|FG011|NOT COMPLETED|Subacute Phase||3||
48078551|NCT01737697|100515180|FG012|NOT COMPLETED|Subacute Phase||2||
48078552|NCT01737697|100515181|FG013|NOT COMPLETED|Subacute Phase||2||
48078553|NCT01737697|100515182|FG014|NOT COMPLETED|Subacute Phase||1||
48078554|NCT00394147|100515183|FG000|STARTED|Overall Study||17||
48078555|NCT00394147|100515183|FG000|COMPLETED|Overall Study||17||
48078556|NCT00394147|100515183|FG000|NOT COMPLETED|Overall Study||0||
48078557|NCT00289783|100515184|FG000|STARTED|Primary Phase||3136||
48523310|NCT00441350|101616083|FG000|STARTED|Phase B: Week 8 to Week 16||0||
48523311|NCT00441350|101616084|FG001|STARTED|Phase B: Week 8 to Week 16||0||
48375480|NCT03459131|101247647|FG001|NOT COMPLETED|Period 1, First 7 Days of Wear||0||
48375481|NCT03459131|101247646|FG000|STARTED|Period 2, Second 7 Days of Wear||7||
48523312|NCT00441350|101616085|FG002|STARTED|Phase B: Week 8 to Week 16||129||
48523313|NCT00441350|101616086|FG003|STARTED|Phase B: Week 8 to Week 16||139||
48523314|NCT00441350|101616087|FG004|STARTED|Phase B: Week 8 to Week 16||336||
48523315|NCT00441350|101616088|FG005|STARTED|Phase B: Week 8 to Week 16||188||
48523316|NCT00441350|101616083|FG000|COMPLETED|Phase B: Week 8 to Week 16||0||
48523317|NCT00441350|101616084|FG001|COMPLETED|Phase B: Week 8 to Week 16||0||
48523318|NCT00441350|101616085|FG002|COMPLETED|Phase B: Week 8 to Week 16||128||
48523319|NCT00441350|101616086|FG003|COMPLETED|Phase B: Week 8 to Week 16||137||
48523320|NCT00441350|101616087|FG004|COMPLETED|Phase B: Week 8 to Week 16||333||
48523321|NCT00441350|101616088|FG005|COMPLETED|Phase B: Week 8 to Week 16||186||
48523322|NCT00441350|101616083|FG000|NOT COMPLETED|Phase B: Week 8 to Week 16||0||
48523323|NCT00441350|101616084|FG001|NOT COMPLETED|Phase B: Week 8 to Week 16||0||
48523324|NCT00441350|101616085|FG002|NOT COMPLETED|Phase B: Week 8 to Week 16||1||
48523325|NCT00441350|101616086|FG003|NOT COMPLETED|Phase B: Week 8 to Week 16||2||
48523326|NCT00441350|101616087|FG004|NOT COMPLETED|Phase B: Week 8 to Week 16||3||
48523327|NCT00441350|101616088|FG005|NOT COMPLETED|Phase B: Week 8 to Week 16||2||
48523328|NCT02834806|101616089|FG000|STARTED|Overall Study||58||
48523329|NCT02834806|101616089|FG000|COMPLETED|Overall Study||58||
48523330|NCT02834806|101616089|FG000|NOT COMPLETED|Overall Study||0||
48523331|NCT02013375|101616090|FG000|STARTED|Overall Study||2||
48523332|NCT02013375|101616090|FG000|COMPLETED|Overall Study||0|Both subjects did not engraft|
48523333|NCT02013375|101616090|FG000|NOT COMPLETED|Overall Study||2||
48523334|NCT01660334|101616091|FG000|STARTED|Overall Study||13||
48523335|NCT01660334|101616091|FG000|COMPLETED|Overall Study||12||
48523336|NCT01660334|101616091|FG000|NOT COMPLETED|Overall Study||1||
48523337|NCT01222390|101616092|FG000|STARTED|Overall Study||12||
48523338|NCT01222390|101616092|FG000|COMPLETED|Overall Study||12||
48523339|NCT01222390|101616092|FG000|NOT COMPLETED|Overall Study||0||
48523340|NCT03955471|101616093|FG000|STARTED|Overall Study||41||
48523341|NCT03955471|101616093|FG000|COMPLETED|Overall Study||1||
48078558|NCT00289783|100515185|FG001|STARTED|Primary Phase||1044||
48523342|NCT03955471|101616093|FG000|NOT COMPLETED|Overall Study||40||
48078559|NCT00289783|100515184|FG000|COMPLETED|Primary Phase||2888||
48078560|NCT00289783|100515185|FG001|COMPLETED|Primary Phase||961||
48078561|NCT00289783|100515184|FG000|NOT COMPLETED|Primary Phase||248||
48523343|NCT01083810|101616094|FG000|STARTED|Overall Study||137||
48523344|NCT01083810|101616095|FG001|STARTED|Overall Study||92||
48523345|NCT01083810|101616096|FG002|STARTED|Overall Study||55||
48523346|NCT01083810|101616094|FG000|COMPLETED|Overall Study||72||
48523347|NCT01083810|101616095|FG001|COMPLETED|Overall Study||47||
48523348|NCT01083810|101616096|FG002|COMPLETED|Overall Study||35||
48523349|NCT01083810|101616094|FG000|NOT COMPLETED|Overall Study||65||
48523350|NCT01083810|101616095|FG001|NOT COMPLETED|Overall Study||45||
48523351|NCT01083810|101616096|FG002|NOT COMPLETED|Overall Study||20||
48523352|NCT01432574|101616097|FG000|STARTED|Overall Study||150||
48523353|NCT01432574|101616097|FG000|COMPLETED|Overall Study||147||
48523354|NCT01432574|101616097|FG000|NOT COMPLETED|Overall Study||3||
48523355|NCT00161382|101616098|FG000|STARTED|Overall Study||598||
48523356|NCT00161382|101616099|FG001|STARTED|Overall Study||847||
48523357|NCT00161382|101616098|FG000|COMPLETED|Overall Study||349||
48523358|NCT00161382|101616099|FG001|COMPLETED|Overall Study||558||
48523359|NCT00161382|101616098|FG000|NOT COMPLETED|Overall Study||249||
48523360|NCT00161382|101616099|FG001|NOT COMPLETED|Overall Study||289||
48523361|NCT01311557|101616100|FG000|STARTED|Overall Study||651||
48523362|NCT01311557|101616101|FG001|STARTED|Overall Study||651||
48523363|NCT01311557|101616100|FG000|COMPLETED|Overall Study||646||
48523364|NCT01311557|101616101|FG001|COMPLETED|Overall Study||645||
48523365|NCT01311557|101616100|FG000|NOT COMPLETED|Overall Study||5||
48523366|NCT01311557|101616101|FG001|NOT COMPLETED|Overall Study||6||
48523367|NCT04154150|101616102|FG000|STARTED|Overall Study||7||
48523368|NCT04154150|101616103|FG001|STARTED|Overall Study||9||
48523369|NCT04154150|101616102|FG000|COMPLETED|Overall Study||7||
48523370|NCT04154150|101616103|FG001|COMPLETED|Overall Study||9||
48523371|NCT04154150|101616102|FG000|NOT COMPLETED|Overall Study||0||
48523372|NCT04154150|101616103|FG001|NOT COMPLETED|Overall Study||0||
48523373|NCT05212883|101616104|FG000|STARTED|Overall Study||2778||
48523374|NCT05212883|101616104|FG000|COMPLETED|Overall Study||2653||
48523375|NCT05212883|101616104|FG000|NOT COMPLETED|Overall Study||125||
48523376|NCT03977701|101616105|FG000|STARTED|Overall Study||0||
48523377|NCT03977701|101616106|FG001|STARTED|Overall Study||0||
48523378|NCT03977701|101616107|FG002|STARTED|Overall Study||7||
48523379|NCT03977701|101616108|FG003|STARTED|Overall Study||0||
48523380|NCT03977701|101616109|FG004|STARTED|Overall Study||0||
48523381|NCT03977701|101616110|FG005|STARTED|Overall Study||1||
48523382|NCT03977701|101616111|FG006|STARTED|Overall Study||10||
48523383|NCT03977701|101616112|FG007|STARTED|Overall Study||1||
48523384|NCT03977701|101616113|FG008|STARTED|Overall Study||0||
48523385|NCT03977701|101616114|FG009|STARTED|Overall Study||0||
48523386|NCT03977701|101616105|FG000|COMPLETED|Overall Study||0||
48523387|NCT03977701|101616106|FG001|COMPLETED|Overall Study||0||
48523388|NCT03977701|101616107|FG002|COMPLETED|Overall Study||7||
48078562|NCT00289783|100515185|FG001|NOT COMPLETED|Primary Phase||83||
48523389|NCT03977701|101616108|FG003|COMPLETED|Overall Study||0||
48523390|NCT03977701|101616109|FG004|COMPLETED|Overall Study||0||
48523391|NCT03977701|101616110|FG005|COMPLETED|Overall Study||0||
48523392|NCT03977701|101616111|FG006|COMPLETED|Overall Study||10||
48523393|NCT03977701|101616112|FG007|COMPLETED|Overall Study||0||
48523394|NCT03977701|101616113|FG008|COMPLETED|Overall Study||0||
48523395|NCT03977701|101616114|FG009|COMPLETED|Overall Study||0||
48523396|NCT03977701|101616105|FG000|NOT COMPLETED|Overall Study||0||
48523397|NCT03977701|101616106|FG001|NOT COMPLETED|Overall Study||0||
48523398|NCT03977701|101616107|FG002|NOT COMPLETED|Overall Study||0||
48523399|NCT03977701|101616108|FG003|NOT COMPLETED|Overall Study||0||
48523400|NCT03977701|101616109|FG004|NOT COMPLETED|Overall Study||0||
48523401|NCT03977701|101616110|FG005|NOT COMPLETED|Overall Study||1||
48523402|NCT03977701|101616111|FG006|NOT COMPLETED|Overall Study||0||
48523403|NCT03977701|101616112|FG007|NOT COMPLETED|Overall Study||1||
48523404|NCT03977701|101616113|FG008|NOT COMPLETED|Overall Study||0||
48523405|NCT03977701|101616114|FG009|NOT COMPLETED|Overall Study||0||
48523406|NCT03575871|101616115|FG000|STARTED|Overall Study||158||
48523407|NCT03575871|101616116|FG001|STARTED|Overall Study||155||
48078563|NCT00289783|100515184|FG000|STARTED|Fourth Dose Phase||2769||
48523408|NCT03575871|101616117|FG002|STARTED|Overall Study||78||
48523409|NCT03575871|101616115|FG000|COMPLETED|Overall Study||137||
48523410|NCT03575871|101616116|FG001|COMPLETED|Overall Study||141||
48523411|NCT03575871|101616117|FG002|COMPLETED|Overall Study||52||
48523412|NCT03575871|101616115|FG000|NOT COMPLETED|Overall Study||21||
48523413|NCT03575871|101616116|FG001|NOT COMPLETED|Overall Study||14||
48523414|NCT03575871|101616117|FG002|NOT COMPLETED|Overall Study||26||
48523415|NCT00855803|101616118|FG000|STARTED|Overall Study||35||
48523416|NCT00855803|101616118|FG000|COMPLETED|Overall Study||21||
48078564|NCT00289783|100515185|FG001|STARTED|Fourth Dose Phase||923||
48523417|NCT00855803|101616118|FG000|NOT COMPLETED|Overall Study||14||
48523418|NCT02192164|101616119|FG000|STARTED|Overall Study||126||
48523419|NCT02192164|101616119|FG000|Etanercept Treated Population|Overall Study||112||
48523420|NCT02192164|101616119|FG000|COMPLETED|Overall Study||112||
48523421|NCT02192164|101616119|FG000|NOT COMPLETED|Overall Study||14||
48078565|NCT00289783|100515184|FG000|COMPLETED|Fourth Dose Phase||2682||
48078566|NCT00289783|100515185|FG001|COMPLETED|Fourth Dose Phase||899||
48078567|NCT00289783|100515184|FG000|NOT COMPLETED|Fourth Dose Phase||87||
48078568|NCT00289783|100515185|FG001|NOT COMPLETED|Fourth Dose Phase||24||
48078569|NCT00851747|100515186|FG000|STARTED|Overall Study||6||
48078570|NCT00851747|100515187|FG001|STARTED|Overall Study||6||
48078571|NCT00851747|100515188|FG002|STARTED|Overall Study||6||
48078572|NCT00851747|100515186|FG000|COMPLETED|Overall Study||0||
48523422|NCT02296684|101616120|FG000|STARTED|Overall Study||36||
48523423|NCT02296684|101616121|FG001|STARTED|Overall Study||30||
48523424|NCT02296684|101616122|FG002|STARTED|Overall Study||1||
48523425|NCT02296684|101616120|FG000|COMPLETED|Overall Study||34||
48523426|NCT02296684|101616121|FG001|COMPLETED|Overall Study||29||
48523427|NCT02296684|101616122|FG002|COMPLETED|Overall Study||0||
48523428|NCT02296684|101616120|FG000|NOT COMPLETED|Overall Study||2||
48523429|NCT02296684|101616121|FG001|NOT COMPLETED|Overall Study||1||
48523430|NCT02296684|101616122|FG002|NOT COMPLETED|Overall Study||1||
48078573|NCT00851747|100515187|FG001|COMPLETED|Overall Study||0||
48078574|NCT00851747|100515188|FG002|COMPLETED|Overall Study||0||
48078575|NCT00851747|100515186|FG000|NOT COMPLETED|Overall Study||6||
48078576|NCT00851747|100515187|FG001|NOT COMPLETED|Overall Study||6||
48078577|NCT00851747|100515188|FG002|NOT COMPLETED|Overall Study||6||
48078578|NCT02094677|100515189|FG000|STARTED|Overall Study||43||
48078579|NCT02094677|100515190|FG001|STARTED|Overall Study||31||
48523431|NCT02939950|101616123|FG000|STARTED|Overall Study||406||812
48523432|NCT02939950|101616124|FG001|STARTED|Overall Study||410||820
48523433|NCT02939950|101616123|FG000|Dispensed the Assigned Lenses|Overall Study||405||810
48523434|NCT02939950|101616124|FG001|Dispensed the Assigned Lenses|Overall Study||410||820
48523435|NCT02939950|101616123|FG000|Eligible at Baseline|Overall Study||403||806
48523436|NCT02939950|101616124|FG001|Eligible at Baseline|Overall Study||402||804
48523437|NCT02939950|101616123|FG000|COMPLETED|Overall Study||340||680
48523438|NCT02939950|101616124|FG001|COMPLETED|Overall Study||329||658
48523439|NCT02939950|101616123|FG000|NOT COMPLETED|Overall Study||66||132
48523440|NCT02939950|101616124|FG001|NOT COMPLETED|Overall Study||81||162
48523441|NCT00103038|101616125|FG000|STARTED|Overall Study||155||
48523442|NCT00103038|101616125|FG000|COMPLETED|Overall Study||142||
48523443|NCT00103038|101616125|FG000|NOT COMPLETED|Overall Study||13||
48523444|NCT02243293|101616126|FG000|STARTED|Overall Study||25||
48523445|NCT02243293|101616127|FG001|STARTED|Overall Study||24||
48523446|NCT02243293|101616128|FG002|STARTED|Overall Study||25||
48523447|NCT02243293|101616129|FG003|STARTED|Overall Study||30||
48523448|NCT02243293|101616130|FG004|STARTED|Overall Study||31||
48523449|NCT02243293|101616131|FG005|STARTED|Overall Study||31||
48523450|NCT02243293|101616132|FG006|STARTED|Overall Study||30||
48523451|NCT02243293|101616133|FG007|STARTED|Overall Study||0||
48523452|NCT02243293|101616134|FG008|STARTED|Overall Study||0||
48523453|NCT02243293|101616135|FG009|STARTED|Overall Study||55||
48523454|NCT02243293|101616136|FG010|STARTED|Overall Study||0||
48523455|NCT02243293|101616137|FG011|STARTED|Overall Study||53||
48523456|NCT02243293|101616138|FG012|STARTED|Overall Study||0||
48523457|NCT02243293|101616139|FG013|STARTED|Overall Study||0||
48523458|NCT02243293|101616140|FG014|STARTED|Overall Study||28||
48523459|NCT02243293|101616141|FG015|STARTED|Overall Study||27||
48078580|NCT02094677|100515189|FG000|COMPLETED|Overall Study||40||
48078581|NCT02094677|100515190|FG001|COMPLETED|Overall Study||30||
48078582|NCT02094677|100515189|FG000|NOT COMPLETED|Overall Study||3||
48078583|NCT02094677|100515190|FG001|NOT COMPLETED|Overall Study||1||
48078584|NCT02871297|100515191|FG000|STARTED|Overall Study||662||
48078585|NCT02871297|100515191|FG000|Received at Least 1 Dose of Study Drug|Overall Study||662||
48078586|NCT02871297|100515191|FG000|COMPLETED|Overall Study||526||
48523460|NCT02243293|101616142|FG016|STARTED|Overall Study||40||
48523461|NCT02243293|101616143|FG017|STARTED|Overall Study||22||
48523462|NCT02243293|101616144|FG018|STARTED|Overall Study||22||
48523463|NCT02243293|101616145|FG019|STARTED|Overall Study||48||
48523464|NCT02243293|101616146|FG020|STARTED|Overall Study||145||
48523465|NCT02243293|101616147|FG021|STARTED|Overall Study||58||
48523466|NCT02243293|101616126|FG000|COMPLETED|Overall Study||23||
48523467|NCT02243293|101616127|FG001|COMPLETED|Overall Study||23||
48523468|NCT02243293|101616128|FG002|COMPLETED|Overall Study||24||
48523469|NCT02243293|101616129|FG003|COMPLETED|Overall Study||29||
48523470|NCT02243293|101616130|FG004|COMPLETED|Overall Study||30||
48523471|NCT02243293|101616131|FG005|COMPLETED|Overall Study||31||
48523472|NCT02243293|101616132|FG006|COMPLETED|Overall Study||27||
48523473|NCT02243293|101616133|FG007|COMPLETED|Overall Study||0||
48523474|NCT02243293|101616134|FG008|COMPLETED|Overall Study||0||
48523475|NCT02243293|101616135|FG009|COMPLETED|Overall Study||53||
48523476|NCT02243293|101616136|FG010|COMPLETED|Overall Study||0||
48523477|NCT02243293|101616137|FG011|COMPLETED|Overall Study||50||
48523478|NCT02243293|101616138|FG012|COMPLETED|Overall Study||0||
48523479|NCT02243293|101616139|FG013|COMPLETED|Overall Study||0||
48523480|NCT02243293|101616140|FG014|COMPLETED|Overall Study||27||
48523481|NCT02243293|101616141|FG015|COMPLETED|Overall Study||26||
48523482|NCT02243293|101616142|FG016|COMPLETED|Overall Study||37||
48523483|NCT02243293|101616143|FG017|COMPLETED|Overall Study||21||
48523484|NCT02243293|101616144|FG018|COMPLETED|Overall Study||22||
48523485|NCT02243293|101616145|FG019|COMPLETED|Overall Study||47||
48523486|NCT02243293|101616146|FG020|COMPLETED|Overall Study||143||
48523487|NCT02243293|101616147|FG021|COMPLETED|Overall Study||55||
48523488|NCT02243293|101616126|FG000|NOT COMPLETED|Overall Study||2||
48523489|NCT02243293|101616127|FG001|NOT COMPLETED|Overall Study||1||
48523490|NCT02243293|101616128|FG002|NOT COMPLETED|Overall Study||1||
48523491|NCT02243293|101616129|FG003|NOT COMPLETED|Overall Study||1||
48523492|NCT02243293|101616130|FG004|NOT COMPLETED|Overall Study||1||
48523493|NCT02243293|101616131|FG005|NOT COMPLETED|Overall Study||0||
48523494|NCT02243293|101616132|FG006|NOT COMPLETED|Overall Study||3||
48523495|NCT02243293|101616133|FG007|NOT COMPLETED|Overall Study||0||
48523496|NCT02243293|101616134|FG008|NOT COMPLETED|Overall Study||0||
48523497|NCT02243293|101616135|FG009|NOT COMPLETED|Overall Study||2||
48523498|NCT02243293|101616136|FG010|NOT COMPLETED|Overall Study||0||
48523499|NCT02243293|101616137|FG011|NOT COMPLETED|Overall Study||3||
48523500|NCT02243293|101616138|FG012|NOT COMPLETED|Overall Study||0||
48523501|NCT02243293|101616139|FG013|NOT COMPLETED|Overall Study||0||
48523502|NCT02243293|101616140|FG014|NOT COMPLETED|Overall Study||1||
48523503|NCT02243293|101616141|FG015|NOT COMPLETED|Overall Study||1||
48523504|NCT02243293|101616142|FG016|NOT COMPLETED|Overall Study||3||
48523505|NCT02243293|101616143|FG017|NOT COMPLETED|Overall Study||1||
48523506|NCT02243293|101616144|FG018|NOT COMPLETED|Overall Study||0||
48523507|NCT02243293|101616145|FG019|NOT COMPLETED|Overall Study||1||
48523508|NCT02243293|101616146|FG020|NOT COMPLETED|Overall Study||2||
48078587|NCT02871297|100515191|FG000|NOT COMPLETED|Overall Study||136||
48078588|NCT02549937|100515192|FG000|STARTED|Overall Study||3||
48078589|NCT02549937|100515193|FG001|STARTED|Overall Study||7||
48078590|NCT02549937|100515194|FG002|STARTED|Overall Study||3||
48078591|NCT02549937|100515195|FG003|STARTED|Overall Study||9||
48078592|NCT02549937|100515196|FG004|STARTED|Overall Study||13||
48078593|NCT02549937|100515197|FG005|STARTED|Overall Study||30||
48078594|NCT02549937|100515198|FG006|STARTED|Overall Study||16||
48078595|NCT02549937|100515199|FG007|STARTED|Overall Study||16||
48078596|NCT02549937|100515200|FG008|STARTED|Overall Study||33||
48523509|NCT02243293|101616147|FG021|NOT COMPLETED|Overall Study||3||
48523510|NCT02749292|101616148|FG000|STARTED|Overall Study||58||
48523511|NCT02749292|101616149|FG001|STARTED|Overall Study||57||
48523512|NCT02749292|101616148|FG000|COMPLETED|Overall Study||36|Subjects who were not withdrawn from the study and reached to common close out of the study.|
48523513|NCT02749292|101616149|FG001|COMPLETED|Overall Study||31|Subjects who were not withdrawn from the study and reached to common close out of the study.|
48523514|NCT02749292|101616148|FG000|NOT COMPLETED|Overall Study||22||
48523515|NCT02749292|101616149|FG001|NOT COMPLETED|Overall Study||26||
48523516|NCT01277718|101616150|FG000|STARTED|Period 1 - First Intervention||10||
48523517|NCT01277718|101616151|FG001|STARTED|Period 1 - First Intervention||10||
48523518|NCT01277718|101616150|FG000|COMPLETED|Period 1 - First Intervention||10||
48523519|NCT01277718|101616151|FG001|COMPLETED|Period 1 - First Intervention||10||
48523520|NCT01277718|101616150|FG000|NOT COMPLETED|Period 1 - First Intervention||0||
48523521|NCT01277718|101616151|FG001|NOT COMPLETED|Period 1 - First Intervention||0||
48523522|NCT01277718|101616150|FG000|STARTED|Washout Period of 13 Days||10||
48523523|NCT01277718|101616151|FG001|STARTED|Washout Period of 13 Days||10||
48523524|NCT01277718|101616150|FG000|COMPLETED|Washout Period of 13 Days||10||
48523525|NCT01277718|101616151|FG001|COMPLETED|Washout Period of 13 Days||10||
48523526|NCT01277718|101616150|FG000|NOT COMPLETED|Washout Period of 13 Days||0||
48523527|NCT01277718|101616151|FG001|NOT COMPLETED|Washout Period of 13 Days||0||
48523528|NCT01277718|101616150|FG000|STARTED|Period 2 - Second Intervention||10||
48523529|NCT01277718|101616151|FG001|STARTED|Period 2 - Second Intervention||10||
48523530|NCT01277718|101616150|FG000|COMPLETED|Period 2 - Second Intervention||10||
48523531|NCT01277718|101616151|FG001|COMPLETED|Period 2 - Second Intervention||7||
48523532|NCT01277718|101616150|FG000|NOT COMPLETED|Period 2 - Second Intervention||0||
48523533|NCT01277718|101616151|FG001|NOT COMPLETED|Period 2 - Second Intervention||3||
48523534|NCT01277718|101616150|FG000|STARTED|Washout Period of 13 Days||10||
48523535|NCT01277718|101616151|FG001|STARTED|Washout Period of 13 Days||7||
48523536|NCT01277718|101616150|FG000|COMPLETED|Washout Period of 13 Days||10||
48523537|NCT01277718|101616151|FG001|COMPLETED|Washout Period of 13 Days||7||
48523538|NCT01277718|101616150|FG000|NOT COMPLETED|Washout Period of 13 Days||0||
48523539|NCT01277718|101616151|FG001|NOT COMPLETED|Washout Period of 13 Days||0||
48523540|NCT01277718|101616150|FG000|STARTED|Period 3 - Third Intervention||10||
48523541|NCT01277718|101616151|FG001|STARTED|Period 3 - Third Intervention||7||
48523542|NCT01277718|101616150|FG000|COMPLETED|Period 3 - Third Intervention||10||
48523543|NCT01277718|101616151|FG001|COMPLETED|Period 3 - Third Intervention||7||
48523544|NCT01277718|101616150|FG000|NOT COMPLETED|Period 3 - Third Intervention||0||
48592643|NCT01877382|101783160|FG010|COMPLETED|Dose Escalation||0||
48078597|NCT02549937|100515192|FG000|COMPLETED|Overall Study||0||
48078598|NCT02549937|100515193|FG001|COMPLETED|Overall Study||0||
48523545|NCT01277718|101616151|FG001|NOT COMPLETED|Period 3 - Third Intervention||0||
48523546|NCT02916693|101616152|FG000|STARTED|Overall Study||20||
48523547|NCT02916693|101616152|FG000|COMPLETED|Overall Study||13||
48523548|NCT02916693|101616152|FG000|NOT COMPLETED|Overall Study||7||
48523549|NCT02621034|101616153|FG000|STARTED|Overall Study||53||
48523550|NCT02621034|101616154|FG001|STARTED|Overall Study||52||
48523551|NCT02621034|101616155|FG002|STARTED|Overall Study||55||
48523552|NCT02621034|101616153|FG000|COMPLETED|Overall Study||50||
48523553|NCT02621034|101616154|FG001|COMPLETED|Overall Study||50||
48523554|NCT02621034|101616155|FG002|COMPLETED|Overall Study||50||
48523555|NCT02621034|101616153|FG000|NOT COMPLETED|Overall Study||3||
48523556|NCT02621034|101616154|FG001|NOT COMPLETED|Overall Study||2||
48523557|NCT02621034|101616155|FG002|NOT COMPLETED|Overall Study||5||
48523558|NCT01138111|101616156|FG000|STARTED|Overall Study||45||
48523559|NCT01138111|101616156|FG000|COMPLETED|Overall Study||36||
48523560|NCT01138111|101616156|FG000|NOT COMPLETED|Overall Study||9||
48523561|NCT03715998|101616157|FG000|STARTED|Overall Study||98||
48523562|NCT03715998|101616158|FG001|STARTED|Overall Study||99||
48523563|NCT03715998|101616159|FG002|STARTED|Overall Study||98||
48523564|NCT03715998|101616157|FG000|COMPLETED|Overall Study||81||
48523565|NCT03715998|101616158|FG001|COMPLETED|Overall Study||80||
48523566|NCT03715998|101616159|FG002|COMPLETED|Overall Study||88||
48523567|NCT03715998|101616157|FG000|NOT COMPLETED|Overall Study||17||
48523568|NCT03715998|101616158|FG001|NOT COMPLETED|Overall Study||19||
48523569|NCT03715998|101616159|FG002|NOT COMPLETED|Overall Study||10||
48523570|NCT03176459|101616160|FG000|STARTED|Overall Study||96|Subject 263-0203 was randomized to bupivacaine HCl but received EXPAREL 266 mg. Subject 263-0203 is included in the IR bupivacaine group in this table.|
48523571|NCT03176459|101616161|FG001|STARTED|Overall Study||90|Subject 263-0203 was randomized to bupivacaine HCl but received EXPAREL 266 mg. Subject 263-0203 is included in the IR bupivacaine group in this table.|
48523572|NCT03176459|101616160|FG000|COMPLETED|Overall Study||91||
48523573|NCT03176459|101616161|FG001|COMPLETED|Overall Study||83||
48523574|NCT03176459|101616160|FG000|NOT COMPLETED|Overall Study||5||
48523575|NCT03176459|101616161|FG001|NOT COMPLETED|Overall Study||7||
48523576|NCT01583218|101616162|FG000|STARTED|Overall Study||3759||
48523577|NCT01583218|101616163|FG001|STARTED|Overall Study||3754||
48523578|NCT01583218|101616162|FG000|COMPLETED|Overall Study||3470||
48523579|NCT01583218|101616163|FG001|COMPLETED|Overall Study||3471||
48523580|NCT01583218|101616162|FG000|NOT COMPLETED|Overall Study||289||
48523581|NCT01583218|101616163|FG001|NOT COMPLETED|Overall Study||283||
48523582|NCT01030341|101616164|FG000|STARTED|Overall Study||45||
48523583|NCT01030341|101616164|FG000|COMPLETED|Overall Study||42||
48523584|NCT01030341|101616164|FG000|NOT COMPLETED|Overall Study||3||
48523585|NCT01672970|101616165|FG000|STARTED|Overall Study||291||
48523586|NCT01672970|101616165|FG000|Treated|Overall Study||290||
48523587|NCT01672970|101616165|FG000|COMPLETED|Overall Study||244||
48523588|NCT01672970|101616165|FG000|NOT COMPLETED|Overall Study||47||
48523589|NCT01237353|101616166|FG000|STARTED|Overall Study||6||
48523590|NCT01237353|101616166|FG000|COMPLETED|Overall Study||6||
48523591|NCT01237353|101616166|FG000|NOT COMPLETED|Overall Study||0||
48523592|NCT02071849|101616167|FG000|STARTED|6-month Primary Endpoint||20||
48523593|NCT02071849|101616167|FG000|COMPLETED|6-month Primary Endpoint||15||
48523594|NCT02071849|101616167|FG000|NOT COMPLETED|6-month Primary Endpoint||5||
48523595|NCT02071849|101616167|FG000|STARTED|2-year Extended Follow-up||15||
48523596|NCT02071849|101616167|FG000|COMPLETED|2-year Extended Follow-up||14||
48523597|NCT02071849|101616167|FG000|NOT COMPLETED|2-year Extended Follow-up||1||
48523598|NCT02701413|101616168|FG000|STARTED|Overall Study||33||
48523599|NCT02701413|101616169|FG001|STARTED|Overall Study||33||
48523600|NCT02701413|101616168|FG000|COMPLETED|Overall Study||26||
48523601|NCT02701413|101616169|FG001|COMPLETED|Overall Study||22||
48523602|NCT02701413|101616168|FG000|NOT COMPLETED|Overall Study||7||
48523603|NCT02701413|101616169|FG001|NOT COMPLETED|Overall Study||11||
48523604|NCT03322384|101616170|FG000|STARTED|Overall Study||20||
48523605|NCT03322384|101616170|FG000|COMPLETED|Overall Study||14||
48523606|NCT03322384|101616170|FG000|NOT COMPLETED|Overall Study||6||
48523607|NCT02149121|101616171|FG000|STARTED|Main Study Period||161||
48523608|NCT02149121|101616172|FG001|STARTED|Main Study Period||151||
48523609|NCT02149121|101616173|FG002|STARTED|Main Study Period||60||
48523610|NCT02149121|101616174|FG003|STARTED|Main Study Period||0||
48523611|NCT02149121|101616175|FG004|STARTED|Main Study Period||0||
48523612|NCT02149121|101616176|FG005|STARTED|Main Study Period||0||
48523613|NCT02149121|101616177|FG006|STARTED|Main Study Period||0||
48523614|NCT02149121|101616171|FG000|COMPLETED|Main Study Period||140||
48523615|NCT02149121|101616172|FG001|COMPLETED|Main Study Period||134||
48523616|NCT02149121|101616173|FG002|COMPLETED|Main Study Period||56||
48523617|NCT02149121|101616174|FG003|COMPLETED|Main Study Period||0||
48523618|NCT02149121|101616175|FG004|COMPLETED|Main Study Period||0||
48523619|NCT02149121|101616176|FG005|COMPLETED|Main Study Period||0||
48523620|NCT02149121|101616177|FG006|COMPLETED|Main Study Period||0||
48523621|NCT02149121|101616171|FG000|NOT COMPLETED|Main Study Period||21||
48523622|NCT02149121|101616172|FG001|NOT COMPLETED|Main Study Period||17||
48523623|NCT02149121|101616173|FG002|NOT COMPLETED|Main Study Period||4||
48523624|NCT02149121|101616174|FG003|NOT COMPLETED|Main Study Period||0||
48523625|NCT02149121|101616175|FG004|NOT COMPLETED|Main Study Period||0||
48523626|NCT02149121|101616176|FG005|NOT COMPLETED|Main Study Period||0||
48523627|NCT02149121|101616177|FG006|NOT COMPLETED|Main Study Period||0||
48523628|NCT02149121|101616171|FG000|STARTED|Extension Study Period||0||
48523629|NCT02149121|101616172|FG001|STARTED|Extension Study Period||0||
48523630|NCT02149121|101616173|FG002|STARTED|Extension Study Period||0||
48523631|NCT02149121|101616174|FG003|STARTED|Extension Study Period||122||
48523632|NCT02149121|101616175|FG004|STARTED|Extension Study Period||64||
48523633|NCT02149121|101616176|FG005|STARTED|Extension Study Period||62||
48523634|NCT02149121|101616177|FG006|STARTED|Extension Study Period||47||
48523635|NCT02149121|101616171|FG000|COMPLETED|Extension Study Period||0||
48523636|NCT02149121|101616172|FG001|COMPLETED|Extension Study Period||0||
48523637|NCT02149121|101616173|FG002|COMPLETED|Extension Study Period||0||
48523638|NCT02149121|101616174|FG003|COMPLETED|Extension Study Period||121||
48523639|NCT02149121|101616175|FG004|COMPLETED|Extension Study Period||64||
48078599|NCT02549937|100515194|FG002|COMPLETED|Overall Study||0||
48078600|NCT02549937|100515195|FG003|COMPLETED|Overall Study||0||
48078601|NCT02549937|100515196|FG004|COMPLETED|Overall Study||0||
48078602|NCT02549937|100515197|FG005|COMPLETED|Overall Study||0||
48078603|NCT02549937|100515198|FG006|COMPLETED|Overall Study||0||
48078604|NCT02549937|100515199|FG007|COMPLETED|Overall Study||0||
48078605|NCT02549937|100515200|FG008|COMPLETED|Overall Study||0||
48078606|NCT02549937|100515192|FG000|NOT COMPLETED|Overall Study||3||
48078607|NCT02549937|100515193|FG001|NOT COMPLETED|Overall Study||7||
48078608|NCT02549937|100515194|FG002|NOT COMPLETED|Overall Study||3||
48078609|NCT02549937|100515195|FG003|NOT COMPLETED|Overall Study||9||
48078610|NCT02549937|100515196|FG004|NOT COMPLETED|Overall Study||13||
48078611|NCT02549937|100515197|FG005|NOT COMPLETED|Overall Study||30||
48078612|NCT02549937|100515198|FG006|NOT COMPLETED|Overall Study||16||
48078613|NCT02549937|100515199|FG007|NOT COMPLETED|Overall Study||16||
48078614|NCT02549937|100515200|FG008|NOT COMPLETED|Overall Study||33||
48078615|NCT03728790|100515201|FG000|STARTED|Overall Study||112||
48078616|NCT03728790|100515202|FG001|STARTED|Overall Study||101||
48078617|NCT03728790|100515201|FG000|COMPLETED|Overall Study||112||
48078618|NCT03728790|100515202|FG001|COMPLETED|Overall Study||101||
48078619|NCT03728790|100515201|FG000|NOT COMPLETED|Overall Study||0||
48078620|NCT03728790|100515202|FG001|NOT COMPLETED|Overall Study||0||
48078621|NCT01979445|100515203|FG000|STARTED|Overall Study||3||
48078622|NCT01979445|100515204|FG001|STARTED|Overall Study||3||
48078623|NCT01979445|100515205|FG002|STARTED|Overall Study||6||
48078624|NCT01979445|100515206|FG003|STARTED|Overall Study||3||
48078625|NCT01979445|100515203|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3|Safety Population included all participants who received at least 1 dose of study drug.|
48523640|NCT02149121|101616176|FG005|COMPLETED|Extension Study Period||60||
48523641|NCT02149121|101616177|FG006|COMPLETED|Extension Study Period||47||
48523642|NCT02149121|101616171|FG000|NOT COMPLETED|Extension Study Period||0||
48523643|NCT02149121|101616172|FG001|NOT COMPLETED|Extension Study Period||0||
48078626|NCT01979445|100515204|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3|Safety Population included all participants who received at least 1 dose of study drug.|
48523644|NCT02149121|101616173|FG002|NOT COMPLETED|Extension Study Period||0||
48523645|NCT02149121|101616174|FG003|NOT COMPLETED|Extension Study Period||1||
48523646|NCT02149121|101616175|FG004|NOT COMPLETED|Extension Study Period||0||
48523647|NCT02149121|101616176|FG005|NOT COMPLETED|Extension Study Period||2||
48523648|NCT02149121|101616177|FG006|NOT COMPLETED|Extension Study Period||0||
48523649|NCT04135196|101616178|FG000|STARTED|Overall Study||21||
48523650|NCT04135196|101616179|FG001|STARTED|Overall Study||24||
48523651|NCT04135196|101616180|FG002|STARTED|Overall Study||21||
48523652|NCT04135196|101616181|FG003|STARTED|Overall Study||20||
48523653|NCT04135196|101616182|FG004|STARTED|Overall Study||16||
48523654|NCT04135196|101616178|FG000|COMPLETED|Overall Study||13||
48523655|NCT04135196|101616179|FG001|COMPLETED|Overall Study||17||
48078627|NCT01979445|100515205|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6|Safety Population included all participants who received at least 1 dose of study drug.|
48078628|NCT01979445|100515206|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3|Safety Population included all participants who received at least 1 dose of study drug.|
48078629|NCT01979445|100515203|FG000|ITT Population|Overall Study||3|Intent to treat (ITT) Population included all enrolled participants in the study.|
48523656|NCT04135196|101616180|FG002|COMPLETED|Overall Study||12||
48523657|NCT04135196|101616181|FG003|COMPLETED|Overall Study||11||
48523658|NCT04135196|101616182|FG004|COMPLETED|Overall Study||14||
48523659|NCT04135196|101616178|FG000|NOT COMPLETED|Overall Study||8||
48523660|NCT04135196|101616179|FG001|NOT COMPLETED|Overall Study||7||
48078630|NCT01979445|100515204|FG001|ITT Population|Overall Study||3|Intent to treat (ITT) Population included all enrolled participants in the study.|
48078631|NCT01979445|100515205|FG002|ITT Population|Overall Study||6|Intent to treat (ITT) Population included all enrolled participants in the study.|
48078632|NCT01979445|100515206|FG003|ITT Population|Overall Study||3|Intent to treat (ITT) Population included all enrolled participants in the study.|
48523661|NCT04135196|101616180|FG002|NOT COMPLETED|Overall Study||9||
48523662|NCT04135196|101616181|FG003|NOT COMPLETED|Overall Study||9||
48523663|NCT04135196|101616182|FG004|NOT COMPLETED|Overall Study||2||
48523664|NCT02132754|101616183|FG000|STARTED|Overall Study||1||
48523665|NCT02132754|101616184|FG001|STARTED|Overall Study||1||
48523666|NCT02132754|101616185|FG002|STARTED|Overall Study||1||
48078633|NCT01979445|100515203|FG000|COMPLETED|Overall Study||3||
48078634|NCT01979445|100515204|FG001|COMPLETED|Overall Study||3||
48078635|NCT01979445|100515205|FG002|COMPLETED|Overall Study||6||
48078636|NCT01979445|100515206|FG003|COMPLETED|Overall Study||3||
48078637|NCT01979445|100515203|FG000|NOT COMPLETED|Overall Study||0||
48523667|NCT02132754|101616186|FG003|STARTED|Overall Study||1||
48523668|NCT02132754|101616187|FG004|STARTED|Overall Study||1||
48523669|NCT02132754|101616188|FG005|STARTED|Overall Study||1||
48523670|NCT02132754|101616189|FG006|STARTED|Overall Study||1||
48523671|NCT02132754|101616190|FG007|STARTED|Overall Study||1||
48523672|NCT02132754|101616191|FG008|STARTED|Overall Study||1||
48523673|NCT02132754|101616192|FG009|STARTED|Overall Study||6||
48523674|NCT02132754|101616193|FG010|STARTED|Overall Study||3||
48523675|NCT02132754|101616194|FG011|STARTED|Overall Study||3||
48523676|NCT02132754|101616195|FG012|STARTED|Overall Study||4||
48523677|NCT02132754|101616196|FG013|STARTED|Overall Study||3||
48523678|NCT02132754|101616197|FG014|STARTED|Overall Study||3||
48523679|NCT02132754|101616198|FG015|STARTED|Overall Study||5||
48523680|NCT02132754|101616199|FG016|STARTED|Overall Study||4||
48523681|NCT02132754|101616200|FG017|STARTED|Overall Study||3||
48523682|NCT02132754|101616201|FG018|STARTED|Overall Study||3||
48523683|NCT02132754|101616202|FG019|STARTED|Overall Study||4||
48523684|NCT02132754|101616203|FG020|STARTED|Overall Study||3||
48523685|NCT02132754|101616204|FG021|STARTED|Overall Study||5||
48523686|NCT02132754|101616205|FG022|STARTED|Overall Study||3||
48523687|NCT02132754|101616206|FG023|STARTED|Overall Study||3||
48523688|NCT02132754|101616207|FG024|STARTED|Overall Study||3||
48523689|NCT02132754|101616208|FG025|STARTED|Overall Study||3||
48523690|NCT02132754|101616209|FG026|STARTED|Overall Study||4||
48523691|NCT02132754|101616210|FG027|STARTED|Overall Study||3||
48523692|NCT02132754|101616211|FG028|STARTED|Overall Study||3||
48523693|NCT02132754|101616212|FG029|STARTED|Overall Study||3||
48523694|NCT02132754|101616213|FG030|STARTED|Overall Study||3||
48523695|NCT02132754|101616214|FG031|STARTED|Overall Study||3||
48523696|NCT02132754|101616215|FG032|STARTED|Overall Study||4||
48523697|NCT02132754|101616216|FG033|STARTED|Overall Study||23||
48523698|NCT02132754|101616183|FG000|Treated|Overall Study||1||
48523699|NCT02132754|101616184|FG001|Treated|Overall Study||1||
48523700|NCT02132754|101616185|FG002|Treated|Overall Study||1||
48523701|NCT02132754|101616186|FG003|Treated|Overall Study||1||
48523702|NCT02132754|101616187|FG004|Treated|Overall Study||1||
48523703|NCT02132754|101616188|FG005|Treated|Overall Study||1||
48523704|NCT02132754|101616189|FG006|Treated|Overall Study||1||
48523705|NCT02132754|101616190|FG007|Treated|Overall Study||1||
48523706|NCT02132754|101616191|FG008|Treated|Overall Study||1||
48523707|NCT02132754|101616192|FG009|Treated|Overall Study||6||
48523708|NCT02132754|101616193|FG010|Treated|Overall Study||3||
48523709|NCT02132754|101616194|FG011|Treated|Overall Study||3||
48523710|NCT02132754|101616195|FG012|Treated|Overall Study||3||
48523711|NCT02132754|101616196|FG013|Treated|Overall Study||3||
48523712|NCT02132754|101616197|FG014|Treated|Overall Study||3||
48523713|NCT02132754|101616198|FG015|Treated|Overall Study||5||
48523714|NCT02132754|101616199|FG016|Treated|Overall Study||4||
48523715|NCT02132754|101616200|FG017|Treated|Overall Study||3||
48523716|NCT02132754|101616201|FG018|Treated|Overall Study||3||
48523717|NCT02132754|101616202|FG019|Treated|Overall Study||3||
48523718|NCT02132754|101616203|FG020|Treated|Overall Study||3||
48523719|NCT02132754|101616204|FG021|Treated|Overall Study||4||
48523720|NCT02132754|101616205|FG022|Treated|Overall Study||3||
48523721|NCT02132754|101616206|FG023|Treated|Overall Study||3||
48523722|NCT02132754|101616207|FG024|Treated|Overall Study||3||
48523723|NCT02132754|101616208|FG025|Treated|Overall Study||3||
48523724|NCT02132754|101616209|FG026|Treated|Overall Study||4||
48523725|NCT02132754|101616210|FG027|Treated|Overall Study||3||
48523726|NCT02132754|101616211|FG028|Treated|Overall Study||3||
48078638|NCT01979445|100515204|FG001|NOT COMPLETED|Overall Study||0||
48078639|NCT01979445|100515205|FG002|NOT COMPLETED|Overall Study||0||
48078640|NCT01979445|100515206|FG003|NOT COMPLETED|Overall Study||0||
48078641|NCT01448486|100515207|FG000|STARTED|Overall Study||3||
48078642|NCT01448486|100515208|FG001|STARTED|Overall Study||3||
48078643|NCT01448486|100515207|FG000|COMPLETED|Overall Study||3||
48523727|NCT02132754|101616212|FG029|Treated|Overall Study||3||
48523728|NCT02132754|101616213|FG030|Treated|Overall Study||3||
48523729|NCT02132754|101616214|FG031|Treated|Overall Study||3||
48523730|NCT02132754|101616215|FG032|Treated|Overall Study||4||
48523731|NCT02132754|101616216|FG033|Treated|Overall Study||23||
48078644|NCT01448486|100515208|FG001|COMPLETED|Overall Study||3||
48523732|NCT02132754|101616183|FG000|COMPLETED|Overall Study||0||
48523733|NCT02132754|101616184|FG001|COMPLETED|Overall Study||0||
48523734|NCT02132754|101616185|FG002|COMPLETED|Overall Study||0||
48523735|NCT02132754|101616186|FG003|COMPLETED|Overall Study||0||
48523736|NCT02132754|101616187|FG004|COMPLETED|Overall Study||0||
48523737|NCT02132754|101616188|FG005|COMPLETED|Overall Study||0||
48523738|NCT02132754|101616189|FG006|COMPLETED|Overall Study||0||
48523739|NCT02132754|101616190|FG007|COMPLETED|Overall Study||0||
48523740|NCT02132754|101616191|FG008|COMPLETED|Overall Study||0||
48523741|NCT02132754|101616192|FG009|COMPLETED|Overall Study||0||
48523742|NCT02132754|101616193|FG010|COMPLETED|Overall Study||0||
48523743|NCT02132754|101616194|FG011|COMPLETED|Overall Study||0||
48523744|NCT02132754|101616195|FG012|COMPLETED|Overall Study||0||
48523745|NCT02132754|101616196|FG013|COMPLETED|Overall Study||0||
48523746|NCT02132754|101616197|FG014|COMPLETED|Overall Study||0||
48523747|NCT02132754|101616198|FG015|COMPLETED|Overall Study||0||
48523748|NCT02132754|101616199|FG016|COMPLETED|Overall Study||0||
48523749|NCT02132754|101616200|FG017|COMPLETED|Overall Study||0||
48523750|NCT02132754|101616201|FG018|COMPLETED|Overall Study||0||
48523751|NCT02132754|101616202|FG019|COMPLETED|Overall Study||0||
48523752|NCT02132754|101616203|FG020|COMPLETED|Overall Study||0||
48523753|NCT02132754|101616204|FG021|COMPLETED|Overall Study||0||
48523754|NCT02132754|101616205|FG022|COMPLETED|Overall Study||0||
48523755|NCT02132754|101616206|FG023|COMPLETED|Overall Study||0||
48523756|NCT02132754|101616207|FG024|COMPLETED|Overall Study||0||
48523757|NCT02132754|101616208|FG025|COMPLETED|Overall Study||0||
48523758|NCT02132754|101616209|FG026|COMPLETED|Overall Study||0||
48523759|NCT02132754|101616210|FG027|COMPLETED|Overall Study||0||
48078645|NCT01448486|100515207|FG000|NOT COMPLETED|Overall Study||0||
48078646|NCT01448486|100515208|FG001|NOT COMPLETED|Overall Study||0||
48523760|NCT02132754|101616211|FG028|COMPLETED|Overall Study||0||
48523761|NCT02132754|101616212|FG029|COMPLETED|Overall Study||0||
48523762|NCT02132754|101616213|FG030|COMPLETED|Overall Study||0||
48523763|NCT02132754|101616214|FG031|COMPLETED|Overall Study||0||
48523764|NCT02132754|101616215|FG032|COMPLETED|Overall Study||0||
48523765|NCT02132754|101616216|FG033|COMPLETED|Overall Study||0||
48523766|NCT02132754|101616183|FG000|NOT COMPLETED|Overall Study||1||
48523767|NCT02132754|101616184|FG001|NOT COMPLETED|Overall Study||1||
48523768|NCT02132754|101616185|FG002|NOT COMPLETED|Overall Study||1||
48523769|NCT02132754|101616186|FG003|NOT COMPLETED|Overall Study||1||
48523770|NCT02132754|101616187|FG004|NOT COMPLETED|Overall Study||1||
48523771|NCT02132754|101616188|FG005|NOT COMPLETED|Overall Study||1||
48523772|NCT02132754|101616189|FG006|NOT COMPLETED|Overall Study||1||
48523773|NCT02132754|101616190|FG007|NOT COMPLETED|Overall Study||1||
48523774|NCT02132754|101616191|FG008|NOT COMPLETED|Overall Study||1||
48523775|NCT02132754|101616192|FG009|NOT COMPLETED|Overall Study||6||
48523776|NCT02132754|101616193|FG010|NOT COMPLETED|Overall Study||3||
48523777|NCT02132754|101616194|FG011|NOT COMPLETED|Overall Study||3||
48078647|NCT02216591|100515209|FG000|STARTED|Overall Study||11||
48078648|NCT02216591|100515210|FG001|STARTED|Overall Study||10||
48078649|NCT02216591|100515209|FG000|COMPLETED|Overall Study||11||
48078650|NCT02216591|100515210|FG001|COMPLETED|Overall Study||9||
48078651|NCT02216591|100515209|FG000|NOT COMPLETED|Overall Study||0||
48078652|NCT02216591|100515210|FG001|NOT COMPLETED|Overall Study||1||
48078653|NCT01481376|100515211|FG000|STARTED|Overall Study||200||
48078654|NCT01481376|100515211|FG000|COMPLETED|Overall Study||169||
48078655|NCT01481376|100515211|FG000|NOT COMPLETED|Overall Study||31||
48078656|NCT03288129|100515212|FG000|STARTED|Overall Study||54||
48078657|NCT03288129|100515212|FG000|COMPLETED|Overall Study||32||
48078658|NCT03288129|100515212|FG000|NOT COMPLETED|Overall Study||22||
48078659|NCT00492583|100515213|FG000|STARTED|Overall Study||95||
48078660|NCT00492583|100515214|FG001|STARTED|Overall Study||87||
48078661|NCT00492583|100515213|FG000|COMPLETED|Overall Study||95||
48078662|NCT00492583|100515214|FG001|COMPLETED|Overall Study||87||
48078663|NCT00492583|100515213|FG000|NOT COMPLETED|Overall Study||0||
48078664|NCT00492583|100515214|FG001|NOT COMPLETED|Overall Study||0||
48523778|NCT02132754|101616195|FG012|NOT COMPLETED|Overall Study||4||
48523779|NCT02132754|101616196|FG013|NOT COMPLETED|Overall Study||3||
48523780|NCT02132754|101616197|FG014|NOT COMPLETED|Overall Study||3||
48523781|NCT02132754|101616198|FG015|NOT COMPLETED|Overall Study||5||
48523782|NCT02132754|101616199|FG016|NOT COMPLETED|Overall Study||4||
48523783|NCT02132754|101616200|FG017|NOT COMPLETED|Overall Study||3||
48523784|NCT02132754|101616201|FG018|NOT COMPLETED|Overall Study||3||
48523785|NCT02132754|101616202|FG019|NOT COMPLETED|Overall Study||4||
48523786|NCT02132754|101616203|FG020|NOT COMPLETED|Overall Study||3||
48523787|NCT02132754|101616204|FG021|NOT COMPLETED|Overall Study||5||
48523788|NCT02132754|101616205|FG022|NOT COMPLETED|Overall Study||3||
48078665|NCT01182675|100515215|FG000|STARTED|Overall Study||7||
48078666|NCT01182675|100515216|FG001|STARTED|Overall Study||0||
48078667|NCT01182675|100515215|FG000|COMPLETED|Overall Study||7||
48078668|NCT01182675|100515216|FG001|COMPLETED|Overall Study||0||
48078669|NCT01182675|100515215|FG000|NOT COMPLETED|Overall Study||0||
48078670|NCT01182675|100515216|FG001|NOT COMPLETED|Overall Study||0||
48078671|NCT02249585|100515217|FG000|STARTED|Overall Study||43||
48078672|NCT02249585|100515218|FG001|STARTED|Overall Study||44||
48078673|NCT02249585|100515219|FG002|STARTED|Overall Study||44||
48078674|NCT02249585|100515217|FG000|COMPLETED|Overall Study||43||
48078675|NCT02249585|100515218|FG001|COMPLETED|Overall Study||44||
48523789|NCT02132754|101616206|FG023|NOT COMPLETED|Overall Study||3||
48523790|NCT02132754|101616207|FG024|NOT COMPLETED|Overall Study||3||
48523791|NCT02132754|101616208|FG025|NOT COMPLETED|Overall Study||3||
48523792|NCT02132754|101616209|FG026|NOT COMPLETED|Overall Study||4||
48523793|NCT02132754|101616210|FG027|NOT COMPLETED|Overall Study||3||
48523794|NCT02132754|101616211|FG028|NOT COMPLETED|Overall Study||3||
48523795|NCT02132754|101616212|FG029|NOT COMPLETED|Overall Study||3||
48523796|NCT02132754|101616213|FG030|NOT COMPLETED|Overall Study||3||
48078676|NCT02249585|100515219|FG002|COMPLETED|Overall Study||44||
48078677|NCT02249585|100515217|FG000|NOT COMPLETED|Overall Study||0||
48078678|NCT02249585|100515218|FG001|NOT COMPLETED|Overall Study||0||
48078679|NCT02249585|100515219|FG002|NOT COMPLETED|Overall Study||0||
48078680|NCT01606007|100515220|FG000|STARTED|Overall Study||176||
48078681|NCT01606007|100515221|FG001|STARTED|Overall Study||179||
48078682|NCT01606007|100515222|FG002|STARTED|Overall Study||179||
48078683|NCT01606007|100515220|FG000|COMPLETED|Overall Study||161||
48078684|NCT01606007|100515221|FG001|COMPLETED|Overall Study||160||
48078685|NCT01606007|100515222|FG002|COMPLETED|Overall Study||169||
48078686|NCT01606007|100515220|FG000|NOT COMPLETED|Overall Study||15||
48078687|NCT01606007|100515221|FG001|NOT COMPLETED|Overall Study||19||
48078688|NCT01606007|100515222|FG002|NOT COMPLETED|Overall Study||10||
48078689|NCT03569033|100515223|FG000|STARTED|Overall Study||23||
48523797|NCT02132754|101616214|FG031|NOT COMPLETED|Overall Study||3||
48523798|NCT02132754|101616215|FG032|NOT COMPLETED|Overall Study||4||
48523799|NCT02132754|101616216|FG033|NOT COMPLETED|Overall Study||23||
48523800|NCT03510182|101616217|FG000|STARTED|Overall Study||25||
48523801|NCT03510182|101616217|FG000|COMPLETED|Overall Study||23||
48523802|NCT03510182|101616217|FG000|NOT COMPLETED|Overall Study||2||
48523803|NCT01936519|101616218|FG000|STARTED|Overall Study||12||
48523804|NCT01936519|101616219|FG001|STARTED|Overall Study||12||
48523805|NCT01936519|101616218|FG000|COMPLETED|Overall Study||11||
48523806|NCT01936519|101616219|FG001|COMPLETED|Overall Study||8||
48523807|NCT01936519|101616218|FG000|NOT COMPLETED|Overall Study||1||
48523808|NCT01936519|101616219|FG001|NOT COMPLETED|Overall Study||4||
48523809|NCT04079127|101616220|FG000|STARTED|Overall Study||150||
48523810|NCT04079127|101616220|FG000|COMPLETED|Overall Study||89||
48523811|NCT04079127|101616220|FG000|NOT COMPLETED|Overall Study||61||
48523812|NCT03852459|101616221|FG000|STARTED|Overall Study||126||
48523813|NCT03852459|101616222|FG001|STARTED|Overall Study||125||
48523814|NCT03852459|101616221|FG000|COMPLETED|Overall Study||123||
48523815|NCT03852459|101616222|FG001|COMPLETED|Overall Study||122||
48523816|NCT03852459|101616221|FG000|NOT COMPLETED|Overall Study||3||
48523817|NCT03852459|101616222|FG001|NOT COMPLETED|Overall Study||3||
48078690|NCT03569033|100515224|FG001|STARTED|Overall Study||23||
48078691|NCT03569033|100515223|FG000|COMPLETED|Overall Study||23||
48078692|NCT03569033|100515224|FG001|COMPLETED|Overall Study||23||
48078693|NCT03569033|100515223|FG000|NOT COMPLETED|Overall Study||0||
48078694|NCT03569033|100515224|FG001|NOT COMPLETED|Overall Study||0||
48078695|NCT04394286|100515225|FG000|STARTED|Overall Study||0||
48078696|NCT04394286|100515226|FG001|STARTED|Overall Study||0||
48078697|NCT04394286|100515227|FG002|STARTED|Overall Study||0||
48078698|NCT04394286|100515225|FG000|COMPLETED|Overall Study||0||
48078699|NCT04394286|100515226|FG001|COMPLETED|Overall Study||0||
48078700|NCT04394286|100515227|FG002|COMPLETED|Overall Study||0||
48078701|NCT04394286|100515225|FG000|NOT COMPLETED|Overall Study||0||
48078702|NCT04394286|100515226|FG001|NOT COMPLETED|Overall Study||0||
48078703|NCT04394286|100515227|FG002|NOT COMPLETED|Overall Study||0||
48078704|NCT04015336|100515228|FG000|STARTED|Overall Study||1||
48078705|NCT04015336|100515228|FG000|COMPLETED|Overall Study||0||
48523818|NCT01197417|101616223|FG000|STARTED|Overall Study||104||
48523819|NCT01197417|101616224|FG001|STARTED|Overall Study||104||
48523820|NCT01197417|101616223|FG000|Received Study Drug|Overall Study||101||
48523821|NCT01197417|101616224|FG001|Received Study Drug|Overall Study||103||
48523822|NCT01197417|101616223|FG000|COMPLETED|Overall Study||96||
48078706|NCT04015336|100515228|FG000|NOT COMPLETED|Overall Study||1||
48078707|NCT01546207|100515229|FG000|STARTED|Overall Study||4||
48078708|NCT01546207|100515229|FG000|COMPLETED|Overall Study||3||
48078709|NCT01546207|100515229|FG000|NOT COMPLETED|Overall Study||1||
48078710|NCT02784275|100515230|FG000|STARTED|Overall Study||16||
48078711|NCT02784275|100515231|FG001|STARTED|Overall Study||16||
48078712|NCT02784275|100515232|FG002|STARTED|Overall Study||17||
48523823|NCT01197417|101616224|FG001|COMPLETED|Overall Study||86||
48523824|NCT01197417|101616223|FG000|NOT COMPLETED|Overall Study||8||
48523825|NCT01197417|101616224|FG001|NOT COMPLETED|Overall Study||18||
48523826|NCT01057381|101616225|FG000|STARTED|Overall Study||26||
48078713|NCT02784275|100515233|FG003|STARTED|Overall Study||15||
48078714|NCT02784275|100515230|FG000|COMPLETED|Overall Study||15||
48078715|NCT02784275|100515231|FG001|COMPLETED|Overall Study||16||
48078716|NCT02784275|100515232|FG002|COMPLETED|Overall Study||16||
48078717|NCT02784275|100515233|FG003|COMPLETED|Overall Study||14||
48078718|NCT02784275|100515230|FG000|NOT COMPLETED|Overall Study||1||
48078719|NCT02784275|100515231|FG001|NOT COMPLETED|Overall Study||0||
48078720|NCT02784275|100515232|FG002|NOT COMPLETED|Overall Study||1||
48078721|NCT02784275|100515233|FG003|NOT COMPLETED|Overall Study||1||
48078722|NCT01666782|100515234|FG000|STARTED|Overall Study||54||
48078723|NCT01666782|100515235|FG001|STARTED|Overall Study||51||
48078724|NCT01666782|100515234|FG000|COMPLETED|Overall Study||50||
48078725|NCT01666782|100515235|FG001|COMPLETED|Overall Study||50||
48078726|NCT01666782|100515234|FG000|NOT COMPLETED|Overall Study||4||
48078727|NCT01666782|100515235|FG001|NOT COMPLETED|Overall Study||1||
48078728|NCT02289417|100515236|FG000|STARTED|Placebo-Controlled Phase Weeks 0-12||58||
48078729|NCT02289417|100515237|FG001|STARTED|Placebo-Controlled Phase Weeks 0-12||57||
48523827|NCT01057381|101616226|FG001|STARTED|Overall Study||27||
48523828|NCT01057381|101616227|FG002|STARTED|Overall Study||30||
48523829|NCT01057381|101616228|FG003|STARTED|Overall Study||26||
48523830|NCT01057381|101616225|FG000|COMPLETED|Overall Study||26||
48523831|NCT01057381|101616226|FG001|COMPLETED|Overall Study||27||
48523832|NCT01057381|101616227|FG002|COMPLETED|Overall Study||30||
48523833|NCT01057381|101616228|FG003|COMPLETED|Overall Study||26||
48078730|NCT02289417|100515238|FG002|STARTED|Placebo-Controlled Phase Weeks 0-12||55||
48078731|NCT02289417|100515239|FG003|STARTED|Placebo-Controlled Phase Weeks 0-12||0||
48078732|NCT02289417|100515240|FG004|STARTED|Placebo-Controlled Phase Weeks 0-12||0||
48523834|NCT01057381|101616225|FG000|NOT COMPLETED|Overall Study||0||
48523835|NCT01057381|101616226|FG001|NOT COMPLETED|Overall Study||0||
48523836|NCT01057381|101616227|FG002|NOT COMPLETED|Overall Study||0||
48523837|NCT01057381|101616228|FG003|NOT COMPLETED|Overall Study||0||
48523838|NCT03828448|101616229|FG000|STARTED|Overall Study||34||
48523839|NCT03828448|101616229|FG000|COMPLETED|Overall Study||0||
48523840|NCT03828448|101616229|FG000|NOT COMPLETED|Overall Study||34||
48523841|NCT00560937|101616230|FG000|STARTED|Overall Study||10||
48523842|NCT00560937|101616231|FG001|STARTED|Overall Study||11||
48523843|NCT00560937|101616230|FG000|COMPLETED|Overall Study||9||
48523844|NCT00560937|101616231|FG001|COMPLETED|Overall Study||9||
48523845|NCT00560937|101616230|FG000|NOT COMPLETED|Overall Study||1||
48523846|NCT00560937|101616231|FG001|NOT COMPLETED|Overall Study||2||
48523847|NCT03314662|101616232|FG000|STARTED|Overall Study||889||
48523848|NCT03314662|101616233|FG001|STARTED|Overall Study||445||
48078733|NCT02289417|100515241|FG005|STARTED|Placebo-Controlled Phase Weeks 0-12||0||
48078734|NCT02289417|100515242|FG006|STARTED|Placebo-Controlled Phase Weeks 0-12||0||
48078735|NCT02289417|100515243|FG007|STARTED|Placebo-Controlled Phase Weeks 0-12||0||
48078736|NCT02289417|100515244|FG008|STARTED|Placebo-Controlled Phase Weeks 0-12||0||
48078737|NCT02289417|100515236|FG000|COMPLETED|Placebo-Controlled Phase Weeks 0-12||51||
48078738|NCT02289417|100515237|FG001|COMPLETED|Placebo-Controlled Phase Weeks 0-12||53||
48078739|NCT02289417|100515238|FG002|COMPLETED|Placebo-Controlled Phase Weeks 0-12||52||
48523849|NCT03314662|101616234|FG002|STARTED|Overall Study||444||
48523850|NCT03314662|101616232|FG000|Treated|Overall Study||888||
48523851|NCT03314662|101616233|FG001|Treated|Overall Study||444||
48523852|NCT03314662|101616234|FG002|Treated|Overall Study||444||
48523853|NCT03314662|101616232|FG000|COMPLETED|Overall Study||881||
48523854|NCT03314662|101616233|FG001|COMPLETED|Overall Study||440||
48523855|NCT03314662|101616234|FG002|COMPLETED|Overall Study||439||
48523856|NCT03314662|101616232|FG000|NOT COMPLETED|Overall Study||8||
48523857|NCT03314662|101616233|FG001|NOT COMPLETED|Overall Study||5||
48523858|NCT03314662|101616234|FG002|NOT COMPLETED|Overall Study||5||
48523859|NCT03212521|101616235|FG000|STARTED|Overall Study||230||
48523860|NCT03212521|101616235|FG000|COMPLETED|Overall Study||223||
48523861|NCT03212521|101616235|FG000|NOT COMPLETED|Overall Study||7||
48523862|NCT01797484|101616236|FG000|STARTED|Overall Study||10||
48523863|NCT01797484|101616237|FG001|STARTED|Overall Study||10||
48523864|NCT01797484|101616236|FG000|COMPLETED|Overall Study||10||
48523865|NCT01797484|101616237|FG001|COMPLETED|Overall Study||10||
48078740|NCT02289417|100515239|FG003|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0||
48078741|NCT02289417|100515240|FG004|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0||
48078742|NCT02289417|100515241|FG005|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0||
48078743|NCT02289417|100515242|FG006|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0||
48078744|NCT02289417|100515243|FG007|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0||
48078745|NCT02289417|100515244|FG008|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0||
48078746|NCT02289417|100515236|FG000|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||7||
48078747|NCT02289417|100515237|FG001|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||4||
48078748|NCT02289417|100515238|FG002|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||3||
48078749|NCT02289417|100515239|FG003|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0||
48078750|NCT02289417|100515240|FG004|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0||
48078751|NCT02289417|100515241|FG005|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0||
48078752|NCT02289417|100515242|FG006|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0||
48078753|NCT02289417|100515243|FG007|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0||
48078754|NCT02289417|100515244|FG008|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0||
48078755|NCT02289417|100515236|FG000|STARTED|Active Treatment Phase Weeks 12-52||0||
48078756|NCT02289417|100515237|FG001|STARTED|Active Treatment Phase Weeks 12-52||41||
48078757|NCT02289417|100515238|FG002|STARTED|Active Treatment Phase Weeks 12-52||42||
48078758|NCT02289417|100515239|FG003|STARTED|Active Treatment Phase Weeks 12-52||26||
48078759|NCT02289417|100515240|FG004|STARTED|Active Treatment Phase Weeks 12-52||25||
48078760|NCT02289417|100515241|FG005|STARTED|Active Treatment Phase Weeks 12-52||12||
48523866|NCT01797484|101616236|FG000|NOT COMPLETED|Overall Study||0||
48523867|NCT01797484|101616237|FG001|NOT COMPLETED|Overall Study||0||
48523868|NCT02510014|101616238|FG000|STARTED|Run-In Period (Days -14 to Day -1)||508|Received at least one dose of SUBOXONE sublingual film.|
48523869|NCT02510014|101616239|FG001|STARTED|Run-In Period (Days -14 to Day -1)||267|Received at least one dose of SUBOXONE sublingual film.|
48078761|NCT02289417|100515242|FG006|STARTED|Active Treatment Phase Weeks 12-52||7||
48523870|NCT02510014|101616238|FG000|COMPLETED|Run-In Period (Days -14 to Day -1)||412||
48523871|NCT02510014|101616239|FG001|COMPLETED|Run-In Period (Days -14 to Day -1)||257||
48078762|NCT02289417|100515243|FG007|STARTED|Active Treatment Phase Weeks 12-52||0||
48078763|NCT02289417|100515244|FG008|STARTED|Active Treatment Phase Weeks 12-52||0||
48078764|NCT02289417|100515236|FG000|COMPLETED|Active Treatment Phase Weeks 12-52||0||
48078765|NCT02289417|100515237|FG001|COMPLETED|Active Treatment Phase Weeks 12-52||39||
48078766|NCT02289417|100515238|FG002|COMPLETED|Active Treatment Phase Weeks 12-52||32||
48078767|NCT02289417|100515239|FG003|COMPLETED|Active Treatment Phase Weeks 12-52||17||
48078768|NCT02289417|100515240|FG004|COMPLETED|Active Treatment Phase Weeks 12-52||20||
48078769|NCT02289417|100515241|FG005|COMPLETED|Active Treatment Phase Weeks 12-52||7||
48078770|NCT02289417|100515242|FG006|COMPLETED|Active Treatment Phase Weeks 12-52||5||
48078771|NCT02289417|100515243|FG007|COMPLETED|Active Treatment Phase Weeks 12-52||0||
48078772|NCT02289417|100515244|FG008|COMPLETED|Active Treatment Phase Weeks 12-52||0||
48078773|NCT02289417|100515236|FG000|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0||
48078774|NCT02289417|100515237|FG001|NOT COMPLETED|Active Treatment Phase Weeks 12-52||2||
48078775|NCT02289417|100515238|FG002|NOT COMPLETED|Active Treatment Phase Weeks 12-52||10||
48078776|NCT02289417|100515239|FG003|NOT COMPLETED|Active Treatment Phase Weeks 12-52||9||
48078777|NCT02289417|100515240|FG004|NOT COMPLETED|Active Treatment Phase Weeks 12-52||5||
48078778|NCT02289417|100515241|FG005|NOT COMPLETED|Active Treatment Phase Weeks 12-52||5||
48078779|NCT02289417|100515242|FG006|NOT COMPLETED|Active Treatment Phase Weeks 12-52||2||
48078780|NCT02289417|100515243|FG007|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0||
48078781|NCT02289417|100515244|FG008|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0||
48078782|NCT02289417|100515236|FG000|STARTED|Extension Phase Weeks 52-104||0||
48078783|NCT02289417|100515237|FG001|STARTED|Extension Phase Weeks 52-104||0||
48078784|NCT02289417|100515238|FG002|STARTED|Extension Phase Weeks 52-104||0||
48078785|NCT02289417|100515239|FG003|STARTED|Extension Phase Weeks 52-104||0||
48078786|NCT02289417|100515240|FG004|STARTED|Extension Phase Weeks 52-104||0||
48078787|NCT02289417|100515241|FG005|STARTED|Extension Phase Weeks 52-104||0||
48078788|NCT02289417|100515242|FG006|STARTED|Extension Phase Weeks 52-104||0||
48078789|NCT02289417|100515243|FG007|STARTED|Extension Phase Weeks 52-104||45||
48078790|NCT02289417|100515244|FG008|STARTED|Extension Phase Weeks 52-104||54||
48078791|NCT02289417|100515236|FG000|COMPLETED|Extension Phase Weeks 52-104||0||
48078792|NCT02289417|100515237|FG001|COMPLETED|Extension Phase Weeks 52-104||0||
48078793|NCT02289417|100515238|FG002|COMPLETED|Extension Phase Weeks 52-104||0||
48078794|NCT02289417|100515239|FG003|COMPLETED|Extension Phase Weeks 52-104||0||
48078795|NCT02289417|100515240|FG004|COMPLETED|Extension Phase Weeks 52-104||0||
48078796|NCT02289417|100515241|FG005|COMPLETED|Extension Phase Weeks 52-104||0||
48078797|NCT02289417|100515242|FG006|COMPLETED|Extension Phase Weeks 52-104||0||
48078798|NCT02289417|100515243|FG007|COMPLETED|Extension Phase Weeks 52-104||38||
48078799|NCT02289417|100515244|FG008|COMPLETED|Extension Phase Weeks 52-104||48||
48523872|NCT02510014|101616238|FG000|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||96||
48523873|NCT02510014|101616239|FG001|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||10||
48523874|NCT02510014|101616238|FG000|STARTED|Treatment Period||412||
48523875|NCT02510014|101616239|FG001|STARTED|Treatment Period||257||
48523876|NCT02510014|101616238|FG000|COMPLETED|Treatment Period||206||
48523877|NCT02510014|101616239|FG001|COMPLETED|Treatment Period||200||
48523878|NCT02510014|101616238|FG000|NOT COMPLETED|Treatment Period||206||
48523879|NCT02510014|101616239|FG001|NOT COMPLETED|Treatment Period||57||
48523880|NCT04718194|101616240|FG000|STARTED|Overall Study||60||
48078800|NCT02289417|100515236|FG000|NOT COMPLETED|Extension Phase Weeks 52-104||0||
48078801|NCT02289417|100515237|FG001|NOT COMPLETED|Extension Phase Weeks 52-104||0||
48078802|NCT02289417|100515238|FG002|NOT COMPLETED|Extension Phase Weeks 52-104||0||
48078803|NCT02289417|100515239|FG003|NOT COMPLETED|Extension Phase Weeks 52-104||0||
48078804|NCT02289417|100515240|FG004|NOT COMPLETED|Extension Phase Weeks 52-104||0||
48078805|NCT02289417|100515241|FG005|NOT COMPLETED|Extension Phase Weeks 52-104||0||
48078806|NCT02289417|100515242|FG006|NOT COMPLETED|Extension Phase Weeks 52-104||0||
48078807|NCT02289417|100515243|FG007|NOT COMPLETED|Extension Phase Weeks 52-104||7||
48078808|NCT02289417|100515244|FG008|NOT COMPLETED|Extension Phase Weeks 52-104||6||
48078809|NCT01051323|100515245|FG000|STARTED|Overall Study||1580||
48078810|NCT01051323|100515245|FG000|Received at Least One Dose|Overall Study||1547||
48078811|NCT01051323|100515245|FG000|COMPLETED|Overall Study||1041||
48078812|NCT01051323|100515245|FG000|NOT COMPLETED|Overall Study||539||
48078813|NCT05570500|100515246|FG000|STARTED|Overall Study||319||8
48078814|NCT05570500|100515247|FG001|STARTED|Overall Study||317||8
48078815|NCT05570500|100515246|FG000|Classroom 1 in Each Study Group|Overall Study||42||1
48078816|NCT05570500|100515247|FG001|Classroom 1 in Each Study Group|Overall Study||40||1
48078817|NCT05570500|100515246|FG000|Classroom 2 in Each Study Group|Overall Study||38||1
48078818|NCT05570500|100515247|FG001|Classroom 2 in Each Study Group|Overall Study||39||1
48078819|NCT05570500|100515246|FG000|Classroom 3 in Each Study Group|Overall Study||39||1
48078820|NCT05570500|100515247|FG001|Classroom 3 in Each Study Group|Overall Study||41||1
48078821|NCT05570500|100515246|FG000|Classroom 4 in Each Study Group|Overall Study||36||1
48078822|NCT05570500|100515247|FG001|Classroom 4 in Each Study Group|Overall Study||42||1
48078823|NCT05570500|100515246|FG000|Classroom 5 in Each Study Group|Overall Study||41||1
48078824|NCT05570500|100515247|FG001|Classroom 5 in Each Study Group|Overall Study||37||1
48227684|NCT04806100|100878064|FG004|STARTED|Overall Study||4||
48523881|NCT04718194|101616241|FG001|STARTED|Overall Study||60||
48078825|NCT05570500|100515246|FG000|Classroom 6 in Each Study Group|Overall Study||40||1
48078826|NCT05570500|100515247|FG001|Classroom 6 in Each Study Group|Overall Study||39||1
48078827|NCT05570500|100515246|FG000|Classroom 7 in Each Study Group|Overall Study||43||1
48078828|NCT05570500|100515247|FG001|Classroom 7 in Each Study Group|Overall Study||41||1
48078829|NCT05570500|100515246|FG000|Classroom 8 in Each Study Group|Overall Study||40||1
48078830|NCT05570500|100515247|FG001|Classroom 8 in Each Study Group|Overall Study||38||1
48078831|NCT05570500|100515246|FG000|COMPLETED|Overall Study||312||8
48078832|NCT05570500|100515247|FG001|COMPLETED|Overall Study||312||8
48078833|NCT05570500|100515246|FG000|NOT COMPLETED|Overall Study||7||0
48078834|NCT05570500|100515247|FG001|NOT COMPLETED|Overall Study||5||0
48078835|NCT02854631|100515248|FG000|STARTED|Overall Study||52||
48078836|NCT02854631|100515249|FG001|STARTED|Overall Study||52||
48078837|NCT02854631|100515248|FG000|COMPLETED|Overall Study||26||
48078838|NCT02854631|100515249|FG001|COMPLETED|Overall Study||37||
48523882|NCT04718194|101616240|FG000|Completed ≥ 1 Module of the Intervention|Overall Study||58||
48523883|NCT04718194|101616241|FG001|Completed ≥ 1 Module of the Intervention|Overall Study||60||
48523884|NCT04718194|101616240|FG000|Completed 4-month Follow-up|Overall Study||54||
48523885|NCT04718194|101616241|FG001|Completed 4-month Follow-up|Overall Study||60||
48523886|NCT04718194|101616240|FG000|Completed 8-month Follow-up|Overall Study||54||
48523887|NCT04718194|101616241|FG001|Completed 8-month Follow-up|Overall Study||60||
48078839|NCT02854631|100515248|FG000|NOT COMPLETED|Overall Study||26||
48078840|NCT02854631|100515249|FG001|NOT COMPLETED|Overall Study||15||
48078841|NCT05166824|100515250|FG000|STARTED|Overall Study||1||
48078842|NCT05166824|100515251|FG001|STARTED|Overall Study||10||
48078843|NCT05166824|100515252|FG002|STARTED|Overall Study||68||
48523888|NCT04718194|101616240|FG000|COMPLETED|Overall Study||54||
48078844|NCT05166824|100515253|FG003|STARTED|Overall Study||10||
48078845|NCT05166824|100515250|FG000|COMPLETED|Overall Study||1||
48078846|NCT05166824|100515251|FG001|COMPLETED|Overall Study||10||
48078847|NCT05166824|100515252|FG002|COMPLETED|Overall Study||59||
48078848|NCT05166824|100515253|FG003|COMPLETED|Overall Study||10||
48078849|NCT05166824|100515250|FG000|NOT COMPLETED|Overall Study||0||
48078850|NCT05166824|100515251|FG001|NOT COMPLETED|Overall Study||0||
48078851|NCT05166824|100515252|FG002|NOT COMPLETED|Overall Study||9||
48078852|NCT05166824|100515253|FG003|NOT COMPLETED|Overall Study||0||
48078853|NCT01977794|100515254|FG000|STARTED|Overall Study||100||
48078854|NCT01977794|100515255|FG001|STARTED|Overall Study||100||
48078855|NCT01977794|100515254|FG000|COMPLETED|Overall Study||92||
48078856|NCT01977794|100515255|FG001|COMPLETED|Overall Study||94||
48078857|NCT01977794|100515254|FG000|NOT COMPLETED|Overall Study||8||
48078858|NCT01977794|100515255|FG001|NOT COMPLETED|Overall Study||6||
48078859|NCT01446289|100515256|FG000|STARTED|Overall Study||51||
48078860|NCT01446289|100515257|FG001|STARTED|Overall Study||35||
48078861|NCT01446289|100515258|FG002|STARTED|Overall Study||51||
48078862|NCT01446289|100515259|FG003|STARTED|Overall Study||35||
48078863|NCT01446289|100515256|FG000|COMPLETED|Overall Study||50||
48078864|NCT01446289|100515257|FG001|COMPLETED|Overall Study||35||
48078865|NCT01446289|100515258|FG002|COMPLETED|Overall Study||50||
48078866|NCT01446289|100515259|FG003|COMPLETED|Overall Study||35||
48078867|NCT01446289|100515256|FG000|NOT COMPLETED|Overall Study||1||
48078868|NCT01446289|100515257|FG001|NOT COMPLETED|Overall Study||0||
48078869|NCT01446289|100515258|FG002|NOT COMPLETED|Overall Study||1||
48078870|NCT01446289|100515259|FG003|NOT COMPLETED|Overall Study||0||
48078871|NCT01819831|100515260|FG000|STARTED|Overall Study||7||
48078872|NCT01819831|100515260|FG000|COMPLETED|Overall Study||6||
48078873|NCT01819831|100515260|FG000|NOT COMPLETED|Overall Study||1||
48078874|NCT01350492|100515261|FG000|STARTED|Intervention||28||
48078875|NCT01350492|100515262|FG001|STARTED|Intervention||26||
48078876|NCT01350492|100515261|FG000|6-week MRI Scan|Intervention||24||
48078877|NCT01350492|100515262|FG001|6-week MRI Scan|Intervention||22||
48078878|NCT01350492|100515261|FG000|11-week MRI Scan|Intervention||23||
48078879|NCT01350492|100515262|FG001|11-week MRI Scan|Intervention||21||
48078880|NCT01350492|100515261|FG000|COMPLETED|Intervention||23||
48078881|NCT01350492|100515262|FG001|COMPLETED|Intervention||20||
48078882|NCT01350492|100515261|FG000|NOT COMPLETED|Intervention||5||
48078883|NCT01350492|100515262|FG001|NOT COMPLETED|Intervention||6||
48078884|NCT01350492|100515261|FG000|STARTED|Post Intervention Follow-Up||23||
48078885|NCT01350492|100515262|FG001|STARTED|Post Intervention Follow-Up||20||
48523889|NCT04718194|101616241|FG001|COMPLETED|Overall Study||60||
48523890|NCT04718194|101616240|FG000|NOT COMPLETED|Overall Study||6||
48523891|NCT04718194|101616241|FG001|NOT COMPLETED|Overall Study||0||
48523892|NCT00841906|101616242|FG000|STARTED|Overall Study||18||
48078886|NCT01350492|100515261|FG000|6-month MRI Scan|Post Intervention Follow-Up||20||
48078887|NCT01350492|100515262|FG001|6-month MRI Scan|Post Intervention Follow-Up||20||
48078888|NCT01350492|100515261|FG000|COMPLETED|Post Intervention Follow-Up||17||
48078889|NCT01350492|100515262|FG001|COMPLETED|Post Intervention Follow-Up||18||
48078890|NCT01350492|100515261|FG000|NOT COMPLETED|Post Intervention Follow-Up||6||
48078891|NCT01350492|100515262|FG001|NOT COMPLETED|Post Intervention Follow-Up||2||
48078892|NCT01496807|100515263|FG000|STARTED|Overall Study||31||
48523893|NCT00841906|101616243|FG001|STARTED|Overall Study||14||
48523894|NCT00841906|101616242|FG000|COMPLETED|Overall Study||16||
48523895|NCT00841906|101616243|FG001|COMPLETED|Overall Study||14||
48078893|NCT01496807|100515263|FG000|COMPLETED|Overall Study||1||
48078894|NCT01496807|100515263|FG000|NOT COMPLETED|Overall Study||30||
48078895|NCT01391559|100515264|FG000|STARTED|First Intervention||10||
48078896|NCT01391559|100515265|FG001|STARTED|First Intervention||10||
48078897|NCT01391559|100515264|FG000|COMPLETED|First Intervention||10||
48078898|NCT01391559|100515265|FG001|COMPLETED|First Intervention||10||
48078899|NCT01391559|100515264|FG000|NOT COMPLETED|First Intervention||0||
48078900|NCT01391559|100515265|FG001|NOT COMPLETED|First Intervention||0||
48523896|NCT00841906|101616242|FG000|NOT COMPLETED|Overall Study||2||
48523897|NCT00841906|101616243|FG001|NOT COMPLETED|Overall Study||0||
48523898|NCT01385306|101616244|FG000|STARTED|Overall Study||6||
48523899|NCT01385306|101616244|FG000|COMPLETED|Overall Study||6||
48523900|NCT01385306|101616244|FG000|NOT COMPLETED|Overall Study||0||
48523901|NCT00965055|101616245|FG000|STARTED|Overall Study||2||
48078901|NCT01391559|100515264|FG000|STARTED|Second Intervention||10||
48078902|NCT01391559|100515265|FG001|STARTED|Second Intervention||10||
48078903|NCT01391559|100515264|FG000|COMPLETED|Second Intervention||10||
48078904|NCT01391559|100515265|FG001|COMPLETED|Second Intervention||10||
48078905|NCT01391559|100515264|FG000|NOT COMPLETED|Second Intervention||0||
48078906|NCT01391559|100515265|FG001|NOT COMPLETED|Second Intervention||0||
48078907|NCT02130570|100515266|FG000|STARTED|Overall Study||987||
48078908|NCT02130570|100515267|FG001|STARTED|Overall Study||692||
48078909|NCT02130570|100515266|FG000|COMPLETED|Overall Study||978||
48078910|NCT02130570|100515267|FG001|COMPLETED|Overall Study||679||
48078911|NCT02130570|100515266|FG000|NOT COMPLETED|Overall Study||9||
48078912|NCT02130570|100515267|FG001|NOT COMPLETED|Overall Study||13||
48078913|NCT01866930|100515268|FG000|STARTED|Treatment Period||104||
48078914|NCT01866930|100515269|FG001|STARTED|Treatment Period||196||
48078915|NCT01866930|100515268|FG000|COMPLETED|Treatment Period||95||
48078916|NCT01866930|100515269|FG001|COMPLETED|Treatment Period||161||
48078917|NCT01866930|100515268|FG000|NOT COMPLETED|Treatment Period||9||
48523902|NCT00965055|101616245|FG000|COMPLETED|Overall Study||2||
48523903|NCT00965055|101616245|FG000|NOT COMPLETED|Overall Study||0||
48523904|NCT03276780|101616246|FG000|STARTED|Overall Study||41||
48523905|NCT03276780|101616247|FG001|STARTED|Overall Study||39||
48523906|NCT03276780|101616246|FG000|COMPLETED|Overall Study||23||
48523907|NCT03276780|101616247|FG001|COMPLETED|Overall Study||29||
48523908|NCT03276780|101616246|FG000|NOT COMPLETED|Overall Study||18||
48523909|NCT03276780|101616247|FG001|NOT COMPLETED|Overall Study||10||
48523910|NCT03082664|101616248|FG000|STARTED|Overall Study||75||
48523911|NCT03082664|101616249|FG001|STARTED|Overall Study||79||
48523912|NCT03082664|101616248|FG000|COMPLETED|Overall Study||75||
48523913|NCT03082664|101616249|FG001|COMPLETED|Overall Study||79||
48523914|NCT03082664|101616248|FG000|NOT COMPLETED|Overall Study||0||
48523915|NCT03082664|101616249|FG001|NOT COMPLETED|Overall Study||0||
48523916|NCT01458106|101616250|FG000|STARTED|Overall Study||36||
48523917|NCT01458106|101616251|FG001|STARTED|Overall Study||35||
48523918|NCT01458106|101616250|FG000|PK Subgroup|Overall Study||25||
48523919|NCT01458106|101616251|FG001|PK Subgroup|Overall Study||35||
48523920|NCT01458106|101616250|FG000|Non-PK Subgroup|Overall Study||11||
48523921|NCT01458106|101616251|FG001|Non-PK Subgroup|Overall Study||0||
48523922|NCT01458106|101616250|FG000|COMPLETED|Overall Study||33||
48523923|NCT01458106|101616251|FG001|COMPLETED|Overall Study||34||
48523924|NCT01458106|101616250|FG000|NOT COMPLETED|Overall Study||3||
48523925|NCT01458106|101616251|FG001|NOT COMPLETED|Overall Study||1||
48523926|NCT01855048|101616252|FG000|STARTED|Overall Study||9||
48523927|NCT01855048|101616253|FG001|STARTED|Overall Study||3||
48523928|NCT01855048|101616254|FG002|STARTED|Overall Study||6||
48523929|NCT01855048|101616255|FG003|STARTED|Overall Study||6||
48523930|NCT01855048|101616256|FG004|STARTED|Overall Study||6||
48523931|NCT01855048|101616257|FG005|STARTED|Overall Study||6||
48523932|NCT01855048|101616252|FG000|COMPLETED|Overall Study||9||
48523933|NCT01855048|101616253|FG001|COMPLETED|Overall Study||2||
48523934|NCT01855048|101616254|FG002|COMPLETED|Overall Study||6||
48523935|NCT01855048|101616255|FG003|COMPLETED|Overall Study||6||
48523936|NCT01855048|101616256|FG004|COMPLETED|Overall Study||5||
48523937|NCT01855048|101616257|FG005|COMPLETED|Overall Study||6||
48523938|NCT01855048|101616252|FG000|NOT COMPLETED|Overall Study||0||
48078918|NCT01866930|100515269|FG001|NOT COMPLETED|Treatment Period||35||
48078919|NCT01866930|100515268|FG000|STARTED|Follow-up Period||102||
48078920|NCT01866930|100515269|FG001|STARTED|Follow-up Period||185||
48078921|NCT01866930|100515268|FG000|COMPLETED|Follow-up Period||96||
48523939|NCT01855048|101616253|FG001|NOT COMPLETED|Overall Study||1||
48523940|NCT01855048|101616254|FG002|NOT COMPLETED|Overall Study||0||
48523941|NCT01855048|101616255|FG003|NOT COMPLETED|Overall Study||0||
48523942|NCT01855048|101616256|FG004|NOT COMPLETED|Overall Study||1||
48523943|NCT01855048|101616257|FG005|NOT COMPLETED|Overall Study||0||
48078922|NCT01866930|100515269|FG001|COMPLETED|Follow-up Period||176||
48078923|NCT01866930|100515268|FG000|NOT COMPLETED|Follow-up Period||6||
48523944|NCT03043560|101616258|FG000|STARTED|Overall Study||21||
48523945|NCT03043560|101616259|FG001|STARTED|Overall Study||24||
48523946|NCT03043560|101616258|FG000|COMPLETED|Overall Study||20||
48078924|NCT01866930|100515269|FG001|NOT COMPLETED|Follow-up Period||9||
48523947|NCT03043560|101616259|FG001|COMPLETED|Overall Study||21||
48523948|NCT03043560|101616258|FG000|NOT COMPLETED|Overall Study||1||
48523949|NCT03043560|101616259|FG001|NOT COMPLETED|Overall Study||3||
48523950|NCT04527328|101616260|FG000|STARTED|Overall Study||5||
48523951|NCT04527328|101616261|FG001|STARTED|Overall Study||5||
48523952|NCT04527328|101616260|FG000|AKST1210 S-15 or Control|Overall Study||5||
48523953|NCT04527328|101616261|FG001|AKST1210 S-15 or Control|Overall Study||5||
48523954|NCT04527328|101616260|FG000|AKST1210 S-25 or Control|Overall Study||5||
48523955|NCT04527328|101616261|FG001|AKST1210 S-25 or Control|Overall Study||5||
48523956|NCT04527328|101616260|FG000|AKST1210 S-35 or Control|Overall Study||4||
48523957|NCT04527328|101616261|FG001|AKST1210 S-35 or Control|Overall Study||5||
48523958|NCT04527328|101616260|FG000|COMPLETED|Overall Study||3|Subjects who completed the End of Study (follow-up) visit|
48523959|NCT04527328|101616261|FG001|COMPLETED|Overall Study||5|Subjects who completed the End of Study (follow-up) visit|
48523960|NCT04527328|101616260|FG000|NOT COMPLETED|Overall Study||2||
48523961|NCT04527328|101616261|FG001|NOT COMPLETED|Overall Study||0||
48523962|NCT04322149|101616262|FG000|STARTED|Overall Study||9||
48523963|NCT04322149|101616263|FG001|STARTED|Overall Study||9||
48523964|NCT04322149|101616264|FG002|STARTED|Overall Study||18||
48523965|NCT04322149|101616265|FG003|STARTED|Overall Study||18||
48523966|NCT04322149|101616262|FG000|COMPLETED|Overall Study||8||
48523967|NCT04322149|101616263|FG001|COMPLETED|Overall Study||7||
48523968|NCT04322149|101616264|FG002|COMPLETED|Overall Study||18||
48523969|NCT04322149|101616265|FG003|COMPLETED|Overall Study||16||
48523970|NCT04322149|101616262|FG000|NOT COMPLETED|Overall Study||1||
48523971|NCT04322149|101616263|FG001|NOT COMPLETED|Overall Study||2||
48523972|NCT04322149|101616264|FG002|NOT COMPLETED|Overall Study||0||
48523973|NCT04322149|101616265|FG003|NOT COMPLETED|Overall Study||2||
48523974|NCT04551911|101616266|FG000|STARTED|Overall Study||85||
48523975|NCT04551911|101616267|FG001|STARTED|Overall Study||86||
48523976|NCT04551911|101616266|FG000|COMPLETED|Overall Study||70||
48523977|NCT04551911|101616267|FG001|COMPLETED|Overall Study||71||
48523978|NCT04551911|101616266|FG000|NOT COMPLETED|Overall Study||15||
48523979|NCT04551911|101616267|FG001|NOT COMPLETED|Overall Study||15||
48523980|NCT00922987|101616268|FG000|STARTED|Overall Study||281||
48523981|NCT00922987|101616268|FG000|COMPLETED|Overall Study||277||
48523982|NCT00922987|101616268|FG000|NOT COMPLETED|Overall Study||4||
48523983|NCT00313443|101616269|FG000|STARTED|Overall Study||30||
48523984|NCT00313443|101616269|FG000|COMPLETED|Overall Study||30||
48523985|NCT00313443|101616269|FG000|NOT COMPLETED|Overall Study||0||
48523986|NCT03188718|101616270|FG000|STARTED|Overall Study||45||
48523987|NCT03188718|101616270|FG000|COMPLETED|Overall Study||37||
48523988|NCT03188718|101616270|FG000|NOT COMPLETED|Overall Study||8||
48523989|NCT00869024|101616271|FG000|STARTED|Overall Study||16||
48523990|NCT00869024|101616272|FG001|STARTED|Overall Study||9||
48523991|NCT00869024|101616271|FG000|COMPLETED|Overall Study||14||
48523992|NCT00869024|101616272|FG001|COMPLETED|Overall Study||4||
48523993|NCT00869024|101616271|FG000|NOT COMPLETED|Overall Study||2||
48523994|NCT00869024|101616272|FG001|NOT COMPLETED|Overall Study||5||
48523995|NCT01698775|101616273|FG000|STARTED|Phase A||107||
48523996|NCT01698775|101616274|FG001|STARTED|Phase A||106||
48523997|NCT01698775|101616273|FG000|COMPLETED|Phase A||98||
48523998|NCT01698775|101616274|FG001|COMPLETED|Phase A||97||
48523999|NCT01698775|101616273|FG000|NOT COMPLETED|Phase A||9||
48524000|NCT01698775|101616274|FG001|NOT COMPLETED|Phase A||9||
48524001|NCT01698775|101616273|FG000|STARTED|Phase B||98||
48524002|NCT01698775|101616274|FG001|STARTED|Phase B||97||
48078925|NCT03797014|100515270|FG000|STARTED|Overall Study||28||
48078926|NCT03797014|100515270|FG000|COMPLETED|Overall Study||25||
48524003|NCT01698775|101616273|FG000|COMPLETED|Phase B||84||
48524004|NCT01698775|101616274|FG001|COMPLETED|Phase B||86||
48524005|NCT01698775|101616273|FG000|NOT COMPLETED|Phase B||14||
48524006|NCT01698775|101616274|FG001|NOT COMPLETED|Phase B||11||
48524007|NCT02919813|101616275|FG000|STARTED|Overall Study||14||
48524008|NCT02919813|101616276|FG001|STARTED|Overall Study||17||
48524009|NCT02919813|101616275|FG000|COMPLETED|Overall Study||14||
48078927|NCT03797014|100515270|FG000|NOT COMPLETED|Overall Study||3||
48078928|NCT04092439|100515271|FG000|STARTED|Overall Study||10||
48078929|NCT04092439|100515272|FG001|STARTED|Overall Study||8||
48078930|NCT04092439|100515271|FG000|COMPLETED|Overall Study||10||
48078931|NCT04092439|100515272|FG001|COMPLETED|Overall Study||7||
48078932|NCT04092439|100515271|FG000|NOT COMPLETED|Overall Study||0||
48078933|NCT04092439|100515272|FG001|NOT COMPLETED|Overall Study||1||
48078934|NCT03936985|100515273|FG000|STARTED|Overall Study||1464||
48078935|NCT03936985|100515273|FG000|COMPLETED|Overall Study||1464||
48078936|NCT03936985|100515273|FG000|NOT COMPLETED|Overall Study||0||
48524010|NCT02919813|101616276|FG001|COMPLETED|Overall Study||17||
48524011|NCT02919813|101616275|FG000|NOT COMPLETED|Overall Study||0||
48524012|NCT02919813|101616276|FG001|NOT COMPLETED|Overall Study||0||
48524013|NCT00513682|101616277|FG000|STARTED|Screening Phase||9||
48524014|NCT00513682|101616277|FG000|COMPLETED|Screening Phase||9||
48524015|NCT00513682|101616277|FG000|NOT COMPLETED|Screening Phase||0||
48524016|NCT00513682|101616277|FG000|STARTED|Washout Phase||9||
48524017|NCT00513682|101616277|FG000|COMPLETED|Washout Phase||7||
48524018|NCT00513682|101616277|FG000|NOT COMPLETED|Washout Phase||2||
48524019|NCT00513682|101616277|FG000|STARTED|Treatment Phase||7||
48524020|NCT00513682|101616277|FG000|COMPLETED|Treatment Phase||7||
48524021|NCT00513682|101616277|FG000|NOT COMPLETED|Treatment Phase||0||
48078937|NCT00582166|100515274|FG000|STARTED|Overall Study||18||
48078938|NCT00582166|100515274|FG000|COMPLETED|Overall Study||16||
48078939|NCT00582166|100515274|FG000|NOT COMPLETED|Overall Study||2||
48078940|NCT02706691|100515275|FG000|STARTED|Overall Study||1||
48078941|NCT02706691|100515275|FG000|COMPLETED|Overall Study||0||
48078942|NCT02706691|100515275|FG000|NOT COMPLETED|Overall Study||1||
48078943|NCT00967668|100515276|FG000|STARTED|Overall Study||162||
48078944|NCT00967668|100515277|FG001|STARTED|Overall Study||160||
48078945|NCT00967668|100515278|FG002|STARTED|Overall Study||159||
48078946|NCT00967668|100515276|FG000|3-mo Assessment|Overall Study||131||
48078947|NCT00967668|100515277|FG001|3-mo Assessment|Overall Study||127||
48078948|NCT00967668|100515278|FG002|3-mo Assessment|Overall Study||115||
48078949|NCT00967668|100515276|FG000|Completed Year 1 - 12-mo Assessment|Overall Study||120||
48078950|NCT00967668|100515277|FG001|Completed Year 1 - 12-mo Assessment|Overall Study||122||
48078951|NCT00967668|100515278|FG002|Completed Year 1 - 12-mo Assessment|Overall Study||119||
48078952|NCT00967668|100515276|FG000|18-mo Assessment|Overall Study||95||
48078953|NCT00967668|100515277|FG001|18-mo Assessment|Overall Study||102||
48078954|NCT00967668|100515278|FG002|18-mo Assessment|Overall Study||92||
48078955|NCT00967668|100515276|FG000|COMPLETED|Overall Study||91||
48078956|NCT00967668|100515277|FG001|COMPLETED|Overall Study||104||
48078957|NCT00967668|100515278|FG002|COMPLETED|Overall Study||90||
48078958|NCT00967668|100515276|FG000|NOT COMPLETED|Overall Study||71||
48078959|NCT00967668|100515277|FG001|NOT COMPLETED|Overall Study||56||
48078960|NCT00967668|100515278|FG002|NOT COMPLETED|Overall Study||69||
48524022|NCT02615171|101616278|FG000|STARTED|Overall Study||32||
48524023|NCT02615171|101616279|FG001|STARTED|Overall Study||32||
48524024|NCT02615171|101616278|FG000|COMPLETED|Overall Study||30||
48524025|NCT02615171|101616279|FG001|COMPLETED|Overall Study||31||
48524026|NCT02615171|101616278|FG000|NOT COMPLETED|Overall Study||2||
48524027|NCT02615171|101616279|FG001|NOT COMPLETED|Overall Study||1||
48524028|NCT02566993|101616280|FG000|STARTED|Overall Study||307||
48524029|NCT02566993|101616281|FG001|STARTED|Overall Study||306||
48524030|NCT02566993|101616280|FG000|COMPLETED|Overall Study||0||
48524031|NCT02566993|101616281|FG001|COMPLETED|Overall Study||0||
48524032|NCT02566993|101616280|FG000|NOT COMPLETED|Overall Study||307||
48524033|NCT02566993|101616281|FG001|NOT COMPLETED|Overall Study||306||
48524034|NCT04988152|101616282|FG000|STARTED|Part 1 (Up to Week 18)||3||
48524035|NCT04988152|101616283|FG001|STARTED|Part 1 (Up to Week 18)||3||
48524036|NCT04988152|101616284|FG002|STARTED|Part 1 (Up to Week 18)||9||
48524037|NCT04988152|101616285|FG003|STARTED|Part 1 (Up to Week 18)||9||
48524038|NCT04988152|101616286|FG004|STARTED|Part 1 (Up to Week 18)||0||
48524039|NCT04988152|101616287|FG005|STARTED|Part 1 (Up to Week 18)||0||
48524040|NCT04988152|101616288|FG006|STARTED|Part 1 (Up to Week 18)||0||
48524041|NCT04988152|101616289|FG007|STARTED|Part 1 (Up to Week 18)||0||
48524042|NCT04988152|101616282|FG000|COMPLETED|Part 1 (Up to Week 18)||3||
48524043|NCT04988152|101616283|FG001|COMPLETED|Part 1 (Up to Week 18)||3||
48524044|NCT04988152|101616284|FG002|COMPLETED|Part 1 (Up to Week 18)||9||
48524045|NCT04988152|101616285|FG003|COMPLETED|Part 1 (Up to Week 18)||9||
48524046|NCT04988152|101616286|FG004|COMPLETED|Part 1 (Up to Week 18)||0||
48524047|NCT04988152|101616287|FG005|COMPLETED|Part 1 (Up to Week 18)||0||
48524048|NCT04988152|101616288|FG006|COMPLETED|Part 1 (Up to Week 18)||0||
48524049|NCT04988152|101616289|FG007|COMPLETED|Part 1 (Up to Week 18)||0||
48524050|NCT04988152|101616282|FG000|NOT COMPLETED|Part 1 (Up to Week 18)||0||
48524051|NCT04988152|101616283|FG001|NOT COMPLETED|Part 1 (Up to Week 18)||0||
48524052|NCT04988152|101616284|FG002|NOT COMPLETED|Part 1 (Up to Week 18)||0||
48524053|NCT04988152|101616285|FG003|NOT COMPLETED|Part 1 (Up to Week 18)||0||
48524054|NCT04988152|101616286|FG004|NOT COMPLETED|Part 1 (Up to Week 18)||0||
48524055|NCT04988152|101616287|FG005|NOT COMPLETED|Part 1 (Up to Week 18)||0||
48524056|NCT04988152|101616288|FG006|NOT COMPLETED|Part 1 (Up to Week 18)||0||
48524057|NCT04988152|101616289|FG007|NOT COMPLETED|Part 1 (Up to Week 18)||0||
48524058|NCT04988152|101616282|FG000|STARTED|Part 2 (Up to Week 18)||0||
48524059|NCT04988152|101616283|FG001|STARTED|Part 2 (Up to Week 18)||0||
48524060|NCT04988152|101616284|FG002|STARTED|Part 2 (Up to Week 18)||0||
48524061|NCT04988152|101616285|FG003|STARTED|Part 2 (Up to Week 18)||0||
48078961|NCT01306942|100515279|FG000|STARTED|Phase I||6||
48078962|NCT01306942|100515280|FG001|STARTED|Phase I||4||
48078963|NCT01306942|100515281|FG002|STARTED|Phase I||0||
48078964|NCT01306942|100515282|FG003|STARTED|Phase I||0||
48078965|NCT01306942|100515279|FG000|COMPLETED|Phase I||1||
48078966|NCT01306942|100515280|FG001|COMPLETED|Phase I||1||
48524062|NCT04988152|101616286|FG004|STARTED|Part 2 (Up to Week 18)||2||
48524063|NCT04988152|101616287|FG005|STARTED|Part 2 (Up to Week 18)||2||
48524064|NCT04988152|101616288|FG006|STARTED|Part 2 (Up to Week 18)||10||
48524065|NCT04988152|101616289|FG007|STARTED|Part 2 (Up to Week 18)||10||
48524066|NCT04988152|101616282|FG000|COMPLETED|Part 2 (Up to Week 18)||0||
48524067|NCT04988152|101616283|FG001|COMPLETED|Part 2 (Up to Week 18)||0||
48524068|NCT04988152|101616284|FG002|COMPLETED|Part 2 (Up to Week 18)||0||
48078967|NCT01306942|100515281|FG002|COMPLETED|Phase I||0||
48078968|NCT01306942|100515282|FG003|COMPLETED|Phase I||0||
48078969|NCT01306942|100515279|FG000|NOT COMPLETED|Phase I||5||
48524069|NCT04988152|101616285|FG003|COMPLETED|Part 2 (Up to Week 18)||0||
48524070|NCT04988152|101616286|FG004|COMPLETED|Part 2 (Up to Week 18)||2||
48524071|NCT04988152|101616287|FG005|COMPLETED|Part 2 (Up to Week 18)||2||
48524072|NCT04988152|101616288|FG006|COMPLETED|Part 2 (Up to Week 18)||10||
48524073|NCT04988152|101616289|FG007|COMPLETED|Part 2 (Up to Week 18)||10||
48524074|NCT04988152|101616282|FG000|NOT COMPLETED|Part 2 (Up to Week 18)||0||
48524075|NCT04988152|101616283|FG001|NOT COMPLETED|Part 2 (Up to Week 18)||0||
48524076|NCT04988152|101616284|FG002|NOT COMPLETED|Part 2 (Up to Week 18)||0||
48524077|NCT04988152|101616285|FG003|NOT COMPLETED|Part 2 (Up to Week 18)||0||
48524078|NCT04988152|101616286|FG004|NOT COMPLETED|Part 2 (Up to Week 18)||0||
48524079|NCT04988152|101616287|FG005|NOT COMPLETED|Part 2 (Up to Week 18)||0||
48524080|NCT04988152|101616288|FG006|NOT COMPLETED|Part 2 (Up to Week 18)||0||
48524081|NCT04988152|101616289|FG007|NOT COMPLETED|Part 2 (Up to Week 18)||0||
48524082|NCT00444457|101616290|FG000|STARTED|Infant Series||489||
48524083|NCT00444457|101616291|FG001|STARTED|Infant Series||488||
48524084|NCT00444457|101616292|FG002|STARTED|Infant Series||489||
48524085|NCT00444457|101616293|FG003|STARTED|Infant Series||246||
48524086|NCT00444457|101616290|FG000|Vaccinated Dose 1|Infant Series||486||
48524087|NCT00444457|101616291|FG001|Vaccinated Dose 1|Infant Series||484||
48524088|NCT00444457|101616292|FG002|Vaccinated Dose 1|Infant Series||485||
48524089|NCT00444457|101616293|FG003|Vaccinated Dose 1|Infant Series||244||
48524090|NCT00444457|101616290|FG000|Vaccinated Dose 2|Infant Series||455||
48524091|NCT00444457|101616291|FG001|Vaccinated Dose 2|Infant Series||447||
48524092|NCT00444457|101616292|FG002|Vaccinated Dose 2|Infant Series||455||
48524093|NCT00444457|101616293|FG003|Vaccinated Dose 2|Infant Series||228||
48524094|NCT00444457|101616290|FG000|Vaccinated Dose 3|Infant Series||442||
48524095|NCT00444457|101616291|FG001|Vaccinated Dose 3|Infant Series||435||
48524096|NCT00444457|101616292|FG002|Vaccinated Dose 3|Infant Series||438||
48524097|NCT00444457|101616293|FG003|Vaccinated Dose 3|Infant Series||225||
48524098|NCT00444457|101616290|FG000|COMPLETED|Infant Series||435||
48524099|NCT00444457|101616291|FG001|COMPLETED|Infant Series||427||
48524100|NCT00444457|101616292|FG002|COMPLETED|Infant Series||428||
48524101|NCT00444457|101616293|FG003|COMPLETED|Infant Series||218||
48524102|NCT00444457|101616290|FG000|NOT COMPLETED|Infant Series||54||
48524103|NCT00444457|101616291|FG001|NOT COMPLETED|Infant Series||61||
48524104|NCT00444457|101616292|FG002|NOT COMPLETED|Infant Series||61||
48524105|NCT00444457|101616293|FG003|NOT COMPLETED|Infant Series||28||
48524106|NCT00444457|101616290|FG000|STARTED|After Infant Series||435||
48524107|NCT00444457|101616291|FG001|STARTED|After Infant Series||427||
48524108|NCT00444457|101616292|FG002|STARTED|After Infant Series||427||
48524109|NCT00444457|101616293|FG003|STARTED|After Infant Series||218||
48524110|NCT00444457|101616290|FG000|COMPLETED|After Infant Series||415||
48524111|NCT00444457|101616291|FG001|COMPLETED|After Infant Series||397||
48524112|NCT00444457|101616292|FG002|COMPLETED|After Infant Series||408||
48524113|NCT00444457|101616293|FG003|COMPLETED|After Infant Series||208||
48524114|NCT00444457|101616290|FG000|NOT COMPLETED|After Infant Series||20||
48524115|NCT00444457|101616291|FG001|NOT COMPLETED|After Infant Series||30||
48524116|NCT00444457|101616292|FG002|NOT COMPLETED|After Infant Series||19||
48524117|NCT00444457|101616293|FG003|NOT COMPLETED|After Infant Series||10||
48524118|NCT00444457|101616290|FG000|STARTED|Toddler Dose||415||
48524119|NCT00444457|101616291|FG001|STARTED|Toddler Dose||397||
48524120|NCT00444457|101616292|FG002|STARTED|Toddler Dose||408||
48524121|NCT00444457|101616293|FG003|STARTED|Toddler Dose||208||
48524122|NCT00444457|101616290|FG000|COMPLETED|Toddler Dose||408||
48524123|NCT00444457|101616291|FG001|COMPLETED|Toddler Dose||391||
48524124|NCT00444457|101616292|FG002|COMPLETED|Toddler Dose||404||
48524125|NCT00444457|101616293|FG003|COMPLETED|Toddler Dose||200||
48524126|NCT00444457|101616290|FG000|NOT COMPLETED|Toddler Dose||7||
48524127|NCT00444457|101616291|FG001|NOT COMPLETED|Toddler Dose||6||
48524128|NCT00444457|101616292|FG002|NOT COMPLETED|Toddler Dose||4||
48524129|NCT00444457|101616293|FG003|NOT COMPLETED|Toddler Dose||8||
48524130|NCT00997139|101616294|FG000|STARTED|Overall Study||216||
48524131|NCT00997139|101616294|FG000|Treated for Positive Baseline Culture|Overall Study||30||
48524132|NCT00997139|101616294|FG000|COMPLETED|Overall Study||30||
48524133|NCT00997139|101616294|FG000|NOT COMPLETED|Overall Study||186||
48524134|NCT05012865|101616295|FG000|STARTED|Overall Study||48||
48524135|NCT05012865|101616295|FG000|COMPLETED|Overall Study||48||
48524136|NCT05012865|101616295|FG000|NOT COMPLETED|Overall Study||0||
48524137|NCT00073021|101616296|FG000|STARTED|Overall Study||139||
48524138|NCT00073021|101616297|FG001|STARTED|Overall Study||129||
48524139|NCT00073021|101616296|FG000|COMPLETED|Overall Study||113||
48524140|NCT00073021|101616297|FG001|COMPLETED|Overall Study||113||
48524141|NCT00073021|101616296|FG000|NOT COMPLETED|Overall Study||26||
48524142|NCT00073021|101616297|FG001|NOT COMPLETED|Overall Study||16||
48524143|NCT01144364|101616298|FG000|STARTED|Induction Phase||234||
48524144|NCT01144364|101616299|FG001|STARTED|Induction Phase||0||
48524145|NCT01144364|101616300|FG002|STARTED|Induction Phase||0||
48524146|NCT01144364|101616298|FG000|COMPLETED|Induction Phase||202||
48524147|NCT01144364|101616299|FG001|COMPLETED|Induction Phase||0||
48524148|NCT01144364|101616300|FG002|COMPLETED|Induction Phase||0||
48524149|NCT01144364|101616298|FG000|NOT COMPLETED|Induction Phase||32||
48524150|NCT01144364|101616299|FG001|NOT COMPLETED|Induction Phase||0||
48524151|NCT01144364|101616300|FG002|NOT COMPLETED|Induction Phase||0||
48524152|NCT01144364|101616298|FG000|STARTED|Follow-Up/Maintenance Phase||0||
48524153|NCT01144364|101616299|FG001|STARTED|Follow-Up/Maintenance Phase||101||
48524154|NCT01144364|101616300|FG002|STARTED|Follow-Up/Maintenance Phase||101||
48524155|NCT01144364|101616298|FG000|COMPLETED|Follow-Up/Maintenance Phase||0||
48524156|NCT01144364|101616299|FG001|COMPLETED|Follow-Up/Maintenance Phase||66||
48524157|NCT01144364|101616300|FG002|COMPLETED|Follow-Up/Maintenance Phase||60||
48524158|NCT01144364|101616298|FG000|NOT COMPLETED|Follow-Up/Maintenance Phase||0||
48524159|NCT01144364|101616299|FG001|NOT COMPLETED|Follow-Up/Maintenance Phase||35||
48524160|NCT01144364|101616300|FG002|NOT COMPLETED|Follow-Up/Maintenance Phase||41||
48524161|NCT03647046|101616301|FG000|STARTED|Overall Study||12||
48524162|NCT03647046|101616301|FG000|COMPLETED|Overall Study||8||
48524163|NCT03647046|101616301|FG000|NOT COMPLETED|Overall Study||4||
48524164|NCT00809159|101616302|FG000|STARTED|Part 1||24||
48524165|NCT00809159|101616303|FG001|STARTED|Part 1||6||
48524166|NCT00809159|101616304|FG002|STARTED|Part 1||0||
48524167|NCT00809159|101616305|FG003|STARTED|Part 1||0||
48524168|NCT00809159|101616306|FG004|STARTED|Part 1||0||
48524169|NCT00809159|101616307|FG005|STARTED|Part 1||0||
48524170|NCT00809159|101616302|FG000|PK Analysis Set|Part 1||24||
48524171|NCT00809159|101616303|FG001|PK Analysis Set|Part 1||6||
48524172|NCT00809159|101616304|FG002|PK Analysis Set|Part 1||0||
48524173|NCT00809159|101616305|FG003|PK Analysis Set|Part 1||0||
48524174|NCT00809159|101616306|FG004|PK Analysis Set|Part 1||0||
48524175|NCT00809159|101616307|FG005|PK Analysis Set|Part 1||0||
48524176|NCT00809159|101616302|FG000|PD Analysis Set|Part 1||23||
48524177|NCT00809159|101616303|FG001|PD Analysis Set|Part 1||6||
48524178|NCT00809159|101616304|FG002|PD Analysis Set|Part 1||0||
48524179|NCT00809159|101616305|FG003|PD Analysis Set|Part 1||0||
48524180|NCT00809159|101616306|FG004|PD Analysis Set|Part 1||0||
48524181|NCT00809159|101616307|FG005|PD Analysis Set|Part 1||0||
48524182|NCT00809159|101616302|FG000|COMPLETED|Part 1||16||
48524183|NCT00809159|101616303|FG001|COMPLETED|Part 1||3||
48524184|NCT00809159|101616304|FG002|COMPLETED|Part 1||0||
48524185|NCT00809159|101616305|FG003|COMPLETED|Part 1||0||
48524186|NCT00809159|101616306|FG004|COMPLETED|Part 1||0||
48524187|NCT00809159|101616307|FG005|COMPLETED|Part 1||0||
48524188|NCT00809159|101616302|FG000|NOT COMPLETED|Part 1||8||
48524189|NCT00809159|101616303|FG001|NOT COMPLETED|Part 1||3||
48524190|NCT00809159|101616304|FG002|NOT COMPLETED|Part 1||0||
48524191|NCT00809159|101616305|FG003|NOT COMPLETED|Part 1||0||
48524192|NCT00809159|101616306|FG004|NOT COMPLETED|Part 1||0||
48524193|NCT00809159|101616307|FG005|NOT COMPLETED|Part 1||0||
48524194|NCT00809159|101616302|FG000|STARTED|Part 1 and 2||0||
48524195|NCT00809159|101616303|FG001|STARTED|Part 1 and 2||0||
48524196|NCT00809159|101616304|FG002|STARTED|Part 1 and 2||30||
48524197|NCT00809159|101616305|FG003|STARTED|Part 1 and 2||12||
48524198|NCT00809159|101616306|FG004|STARTED|Part 1 and 2||12||
48524199|NCT00809159|101616307|FG005|STARTED|Part 1 and 2||6||
48524200|NCT00809159|101616302|FG000|PK Analysis Set|Part 1 and 2||0||
48524201|NCT00809159|101616303|FG001|PK Analysis Set|Part 1 and 2||0||
48524202|NCT00809159|101616304|FG002|PK Analysis Set|Part 1 and 2||30||
48524203|NCT00809159|101616305|FG003|PK Analysis Set|Part 1 and 2||12||
48524204|NCT00809159|101616306|FG004|PK Analysis Set|Part 1 and 2||12||
48524205|NCT00809159|101616307|FG005|PK Analysis Set|Part 1 and 2||6||
48524206|NCT00809159|101616302|FG000|PD Analysis Set|Part 1 and 2||0||
48524207|NCT00809159|101616303|FG001|PD Analysis Set|Part 1 and 2||0||
48524208|NCT00809159|101616304|FG002|PD Analysis Set|Part 1 and 2||28||
48524209|NCT00809159|101616305|FG003|PD Analysis Set|Part 1 and 2||12||
48524210|NCT00809159|101616306|FG004|PD Analysis Set|Part 1 and 2||12||
48524211|NCT00809159|101616307|FG005|PD Analysis Set|Part 1 and 2||6||
48524212|NCT00809159|101616302|FG000|COMPLETED|Part 1 and 2||0||
48524213|NCT00809159|101616303|FG001|COMPLETED|Part 1 and 2||0||
48524214|NCT00809159|101616304|FG002|COMPLETED|Part 1 and 2||20||
48524215|NCT00809159|101616305|FG003|COMPLETED|Part 1 and 2||7||
48524216|NCT00809159|101616306|FG004|COMPLETED|Part 1 and 2||6||
48524217|NCT00809159|101616307|FG005|COMPLETED|Part 1 and 2||3||
48524218|NCT00809159|101616302|FG000|NOT COMPLETED|Part 1 and 2||0||
48524219|NCT00809159|101616303|FG001|NOT COMPLETED|Part 1 and 2||0||
48524220|NCT00809159|101616304|FG002|NOT COMPLETED|Part 1 and 2||10||
48524221|NCT00809159|101616305|FG003|NOT COMPLETED|Part 1 and 2||5||
48524222|NCT00809159|101616306|FG004|NOT COMPLETED|Part 1 and 2||6||
48524223|NCT00809159|101616307|FG005|NOT COMPLETED|Part 1 and 2||3||
48524224|NCT02003911|101616308|FG000|STARTED|Overall Study||80||
48524225|NCT02003911|101616309|FG001|STARTED|Overall Study||79||
48524226|NCT02003911|101616308|FG000|COMPLETED|Overall Study||78||
48524227|NCT02003911|101616309|FG001|COMPLETED|Overall Study||72||
48524228|NCT02003911|101616308|FG000|NOT COMPLETED|Overall Study||2||
48524229|NCT02003911|101616309|FG001|NOT COMPLETED|Overall Study||7||
48524230|NCT00911807|101616310|FG000|STARTED|Overall Study||72||
48524231|NCT00911807|101616311|FG001|STARTED|Overall Study||70||
48524232|NCT00911807|101616312|FG002|STARTED|Overall Study||75||
48524233|NCT00911807|101616310|FG000|COMPLETED|Overall Study||55||
48524234|NCT00911807|101616311|FG001|COMPLETED|Overall Study||52||
48524235|NCT00911807|101616312|FG002|COMPLETED|Overall Study||52||
48524236|NCT00911807|101616310|FG000|NOT COMPLETED|Overall Study||17||
48524237|NCT00911807|101616311|FG001|NOT COMPLETED|Overall Study||18||
48524238|NCT00911807|101616312|FG002|NOT COMPLETED|Overall Study||23||
48524239|NCT00389831|101616313|FG000|STARTED|Overall Study||10||
48524240|NCT00389831|101616314|FG001|STARTED|Overall Study||34||
48524241|NCT00389831|101616313|FG000|COMPLETED|Overall Study||10||
48524242|NCT00389831|101616314|FG001|COMPLETED|Overall Study||27||
48524243|NCT00389831|101616313|FG000|NOT COMPLETED|Overall Study||0||
48524244|NCT00389831|101616314|FG001|NOT COMPLETED|Overall Study||7||
48524245|NCT03316378|101616315|FG000|STARTED|Overall Study||23||
48524246|NCT03316378|101616316|FG001|STARTED|Overall Study||23||
48524247|NCT03316378|101616315|FG000|COMPLETED|Overall Study||23||
48524248|NCT03316378|101616316|FG001|COMPLETED|Overall Study||23||
48524249|NCT03316378|101616315|FG000|NOT COMPLETED|Overall Study||0||
48524250|NCT03316378|101616316|FG001|NOT COMPLETED|Overall Study||0||
48524251|NCT02280226|101616317|FG000|STARTED|Overall Study||17||
48524252|NCT02280226|101616317|FG000|COMPLETED|Overall Study||17||
48524253|NCT02280226|101616317|FG000|NOT COMPLETED|Overall Study||0||
48524254|NCT02516410|101616318|FG000|STARTED|Overall Study||85||
48524255|NCT02516410|101616319|FG001|STARTED|Overall Study||83||
48524256|NCT02516410|101616318|FG000|COMPLETED|Overall Study||85||
48524257|NCT02516410|101616319|FG001|COMPLETED|Overall Study||81||
48524258|NCT02516410|101616318|FG000|NOT COMPLETED|Overall Study||0||
48524259|NCT02516410|101616319|FG001|NOT COMPLETED|Overall Study||2||
48524260|NCT01138826|101616320|FG000|STARTED|First Intervention Period||3||
48524261|NCT01138826|101616321|FG001|STARTED|First Intervention Period||3||
48524262|NCT01138826|101616322|FG002|STARTED|First Intervention Period||3||
48524263|NCT01138826|101616323|FG003|STARTED|First Intervention Period||3||
48524264|NCT01138826|101616324|FG004|STARTED|First Intervention Period||3||
48524265|NCT01138826|101616325|FG005|STARTED|First Intervention Period||3||
48524266|NCT01138826|101616320|FG000|COMPLETED|First Intervention Period||3||
48524267|NCT01138826|101616321|FG001|COMPLETED|First Intervention Period||3||
48524268|NCT01138826|101616322|FG002|COMPLETED|First Intervention Period||3||
48524269|NCT01138826|101616323|FG003|COMPLETED|First Intervention Period||3||
48524270|NCT01138826|101616324|FG004|COMPLETED|First Intervention Period||3||
48524271|NCT01138826|101616325|FG005|COMPLETED|First Intervention Period||3||
48524272|NCT01138826|101616320|FG000|NOT COMPLETED|First Intervention Period||0||
48524273|NCT01138826|101616321|FG001|NOT COMPLETED|First Intervention Period||0||
48524274|NCT01138826|101616322|FG002|NOT COMPLETED|First Intervention Period||0||
48524275|NCT01138826|101616323|FG003|NOT COMPLETED|First Intervention Period||0||
48524276|NCT01138826|101616324|FG004|NOT COMPLETED|First Intervention Period||0||
48524277|NCT01138826|101616325|FG005|NOT COMPLETED|First Intervention Period||0||
48524278|NCT01138826|101616320|FG000|STARTED|Washout Period I (of 16 Days)||3||
48524279|NCT01138826|101616321|FG001|STARTED|Washout Period I (of 16 Days)||3||
48524280|NCT01138826|101616322|FG002|STARTED|Washout Period I (of 16 Days)||3||
48524281|NCT01138826|101616323|FG003|STARTED|Washout Period I (of 16 Days)||3||
48524282|NCT01138826|101616324|FG004|STARTED|Washout Period I (of 16 Days)||3||
48524283|NCT01138826|101616325|FG005|STARTED|Washout Period I (of 16 Days)||3||
48524284|NCT01138826|101616320|FG000|COMPLETED|Washout Period I (of 16 Days)||2||
48524285|NCT01138826|101616321|FG001|COMPLETED|Washout Period I (of 16 Days)||2||
48524286|NCT01138826|101616322|FG002|COMPLETED|Washout Period I (of 16 Days)||3||
48524287|NCT01138826|101616323|FG003|COMPLETED|Washout Period I (of 16 Days)||3||
48524288|NCT01138826|101616324|FG004|COMPLETED|Washout Period I (of 16 Days)||2||
48524289|NCT01138826|101616325|FG005|COMPLETED|Washout Period I (of 16 Days)||3||
48524290|NCT01138826|101616320|FG000|NOT COMPLETED|Washout Period I (of 16 Days)||1||
48524291|NCT01138826|101616321|FG001|NOT COMPLETED|Washout Period I (of 16 Days)||1||
48524292|NCT01138826|101616322|FG002|NOT COMPLETED|Washout Period I (of 16 Days)||0||
48524293|NCT01138826|101616323|FG003|NOT COMPLETED|Washout Period I (of 16 Days)||0||
48524294|NCT01138826|101616324|FG004|NOT COMPLETED|Washout Period I (of 16 Days)||1||
48524295|NCT01138826|101616325|FG005|NOT COMPLETED|Washout Period I (of 16 Days)||0||
48524296|NCT01138826|101616320|FG000|STARTED|Second Intervention Period||2||
48524297|NCT01138826|101616321|FG001|STARTED|Second Intervention Period||2||
48524298|NCT01138826|101616322|FG002|STARTED|Second Intervention Period||3||
48524299|NCT01138826|101616323|FG003|STARTED|Second Intervention Period||3||
48524300|NCT01138826|101616324|FG004|STARTED|Second Intervention Period||2||
48524301|NCT01138826|101616325|FG005|STARTED|Second Intervention Period||3||
48524302|NCT01138826|101616320|FG000|COMPLETED|Second Intervention Period||2||
48524303|NCT01138826|101616321|FG001|COMPLETED|Second Intervention Period||2||
48524304|NCT01138826|101616322|FG002|COMPLETED|Second Intervention Period||3||
48524305|NCT01138826|101616323|FG003|COMPLETED|Second Intervention Period||3||
48524306|NCT01138826|101616324|FG004|COMPLETED|Second Intervention Period||2||
48524307|NCT01138826|101616325|FG005|COMPLETED|Second Intervention Period||3||
48524308|NCT01138826|101616320|FG000|NOT COMPLETED|Second Intervention Period||0||
48524309|NCT01138826|101616321|FG001|NOT COMPLETED|Second Intervention Period||0||
48524310|NCT01138826|101616322|FG002|NOT COMPLETED|Second Intervention Period||0||
48524311|NCT01138826|101616323|FG003|NOT COMPLETED|Second Intervention Period||0||
48524312|NCT01138826|101616324|FG004|NOT COMPLETED|Second Intervention Period||0||
48524313|NCT01138826|101616325|FG005|NOT COMPLETED|Second Intervention Period||0||
48524314|NCT01138826|101616320|FG000|STARTED|Washout Period II (of 16 Days)||2||
48524315|NCT01138826|101616321|FG001|STARTED|Washout Period II (of 16 Days)||2||
48524316|NCT01138826|101616322|FG002|STARTED|Washout Period II (of 16 Days)||3||
48524317|NCT01138826|101616323|FG003|STARTED|Washout Period II (of 16 Days)||3||
48524318|NCT01138826|101616324|FG004|STARTED|Washout Period II (of 16 Days)||2||
48524319|NCT01138826|101616325|FG005|STARTED|Washout Period II (of 16 Days)||3||
48524320|NCT01138826|101616320|FG000|COMPLETED|Washout Period II (of 16 Days)||2||
48524321|NCT01138826|101616321|FG001|COMPLETED|Washout Period II (of 16 Days)||2||
48524322|NCT01138826|101616322|FG002|COMPLETED|Washout Period II (of 16 Days)||3||
48524323|NCT01138826|101616323|FG003|COMPLETED|Washout Period II (of 16 Days)||3||
48524324|NCT01138826|101616324|FG004|COMPLETED|Washout Period II (of 16 Days)||2||
48524325|NCT01138826|101616325|FG005|COMPLETED|Washout Period II (of 16 Days)||3||
48524326|NCT01138826|101616320|FG000|NOT COMPLETED|Washout Period II (of 16 Days)||0||
48524327|NCT01138826|101616321|FG001|NOT COMPLETED|Washout Period II (of 16 Days)||0||
48524328|NCT01138826|101616322|FG002|NOT COMPLETED|Washout Period II (of 16 Days)||0||
48524329|NCT01138826|101616323|FG003|NOT COMPLETED|Washout Period II (of 16 Days)||0||
48524330|NCT01138826|101616324|FG004|NOT COMPLETED|Washout Period II (of 16 Days)||0||
48524331|NCT01138826|101616325|FG005|NOT COMPLETED|Washout Period II (of 16 Days)||0||
48524332|NCT01138826|101616320|FG000|STARTED|Third Intervention Period||2||
48524333|NCT01138826|101616321|FG001|STARTED|Third Intervention Period||2||
48524334|NCT01138826|101616322|FG002|STARTED|Third Intervention Period||3||
48524335|NCT01138826|101616323|FG003|STARTED|Third Intervention Period||3||
48524336|NCT01138826|101616324|FG004|STARTED|Third Intervention Period||2||
48524337|NCT01138826|101616325|FG005|STARTED|Third Intervention Period||3||
48524338|NCT01138826|101616320|FG000|COMPLETED|Third Intervention Period||2||
48524339|NCT01138826|101616321|FG001|COMPLETED|Third Intervention Period||2||
48524340|NCT01138826|101616322|FG002|COMPLETED|Third Intervention Period||3||
48524341|NCT01138826|101616323|FG003|COMPLETED|Third Intervention Period||3||
48524342|NCT01138826|101616324|FG004|COMPLETED|Third Intervention Period||2||
48524343|NCT01138826|101616325|FG005|COMPLETED|Third Intervention Period||3||
48524344|NCT01138826|101616320|FG000|NOT COMPLETED|Third Intervention Period||0||
48524345|NCT01138826|101616321|FG001|NOT COMPLETED|Third Intervention Period||0||
48524346|NCT01138826|101616322|FG002|NOT COMPLETED|Third Intervention Period||0||
48524347|NCT01138826|101616323|FG003|NOT COMPLETED|Third Intervention Period||0||
48524348|NCT01138826|101616324|FG004|NOT COMPLETED|Third Intervention Period||0||
48524349|NCT01138826|101616325|FG005|NOT COMPLETED|Third Intervention Period||0||
48524350|NCT01829113|101616326|FG000|STARTED|Overall Study||77||
48524351|NCT01829113|101616327|FG001|STARTED|Overall Study||78||
48524352|NCT01829113|101616326|FG000|COMPLETED|Overall Study||0||
48524353|NCT01829113|101616327|FG001|COMPLETED|Overall Study||0||
48524354|NCT01829113|101616326|FG000|NOT COMPLETED|Overall Study||77||
48524355|NCT01829113|101616327|FG001|NOT COMPLETED|Overall Study||78||
48524356|NCT00407758|101616328|FG000|STARTED|Overall Study||28||
48524357|NCT00407758|101616328|FG000|COMPLETED|Overall Study||27|Eligible and treated patients.|
48524358|NCT00407758|101616328|FG000|NOT COMPLETED|Overall Study||1||
48524359|NCT02914236|101616329|FG000|STARTED|Overall Study||50|Underwent procedure|
48524360|NCT02914236|101616329|FG000|4-week Follow-up Visit|Overall Study||50||
48524361|NCT02914236|101616329|FG000|12-week Follow-up Visit|Overall Study||50||
48524362|NCT02914236|101616329|FG000|26-week Follow-up Visit|Overall Study||49||
48524363|NCT02914236|101616329|FG000|COMPLETED|Overall Study||49||
48524364|NCT02914236|101616329|FG000|NOT COMPLETED|Overall Study||1||
48524365|NCT00851643|101616330|FG000|STARTED|Base Study (Up to 12 Months)||15||
48524366|NCT00851643|101616331|FG001|STARTED|Base Study (Up to 12 Months)||30||
48524367|NCT00851643|101616332|FG002|STARTED|Base Study (Up to 12 Months)||30||
48524368|NCT00851643|101616333|FG003|STARTED|Base Study (Up to 12 Months)||15||
48524369|NCT00851643|101616334|FG004|STARTED|Base Study (Up to 12 Months)||30||
48524370|NCT00851643|101616335|FG005|STARTED|Base Study (Up to 12 Months)||30||
48524371|NCT00851643|101616330|FG000|COMPLETED|Base Study (Up to 12 Months)||14||
48524372|NCT00851643|101616331|FG001|COMPLETED|Base Study (Up to 12 Months)||30||
48524373|NCT00851643|101616332|FG002|COMPLETED|Base Study (Up to 12 Months)||30||
48524374|NCT00851643|101616333|FG003|COMPLETED|Base Study (Up to 12 Months)||15||
48524375|NCT00851643|101616334|FG004|COMPLETED|Base Study (Up to 12 Months)||30||
48524376|NCT00851643|101616335|FG005|COMPLETED|Base Study (Up to 12 Months)||29||
48524377|NCT00851643|101616330|FG000|NOT COMPLETED|Base Study (Up to 12 Months)||1||
48524378|NCT00851643|101616331|FG001|NOT COMPLETED|Base Study (Up to 12 Months)||0||
48524379|NCT00851643|101616332|FG002|NOT COMPLETED|Base Study (Up to 12 Months)||0||
48524380|NCT00851643|101616333|FG003|NOT COMPLETED|Base Study (Up to 12 Months)||0||
48524381|NCT00851643|101616334|FG004|NOT COMPLETED|Base Study (Up to 12 Months)||0||
48524382|NCT00851643|101616335|FG005|NOT COMPLETED|Base Study (Up to 12 Months)||1||
48524383|NCT00851643|101616330|FG000|STARTED|Extension Study (Up to 36 Months)||10||
48524384|NCT00851643|101616331|FG001|STARTED|Extension Study (Up to 36 Months)||19||
48524385|NCT00851643|101616332|FG002|STARTED|Extension Study (Up to 36 Months)||19||
48524386|NCT00851643|101616333|FG003|STARTED|Extension Study (Up to 36 Months)||7||
48524387|NCT00851643|101616334|FG004|STARTED|Extension Study (Up to 36 Months)||21||
48524388|NCT00851643|101616335|FG005|STARTED|Extension Study (Up to 36 Months)||15||
48524389|NCT00851643|101616330|FG000|COMPLETED|Extension Study (Up to 36 Months)||6||
48524390|NCT00851643|101616331|FG001|COMPLETED|Extension Study (Up to 36 Months)||15||
48524391|NCT00851643|101616332|FG002|COMPLETED|Extension Study (Up to 36 Months)||14||
48524392|NCT00851643|101616333|FG003|COMPLETED|Extension Study (Up to 36 Months)||5||
48524393|NCT00851643|101616334|FG004|COMPLETED|Extension Study (Up to 36 Months)||19||
48524394|NCT00851643|101616335|FG005|COMPLETED|Extension Study (Up to 36 Months)||14||
48524395|NCT00851643|101616330|FG000|NOT COMPLETED|Extension Study (Up to 36 Months)||4||
48524396|NCT00851643|101616331|FG001|NOT COMPLETED|Extension Study (Up to 36 Months)||4||
48524397|NCT00851643|101616332|FG002|NOT COMPLETED|Extension Study (Up to 36 Months)||5||
48524398|NCT00851643|101616333|FG003|NOT COMPLETED|Extension Study (Up to 36 Months)||2||
48524399|NCT00851643|101616334|FG004|NOT COMPLETED|Extension Study (Up to 36 Months)||2||
48524400|NCT00851643|101616335|FG005|NOT COMPLETED|Extension Study (Up to 36 Months)||1||
48524401|NCT01940497|101616336|FG000|STARTED|Overall Study||121||
48524402|NCT01940497|101616337|FG001|STARTED|Overall Study||119||
48524403|NCT01940497|101616336|FG000|Treated|Overall Study||115||
48078970|NCT01306942|100515280|FG001|NOT COMPLETED|Phase I||3||
48524404|NCT01940497|101616337|FG001|Treated|Overall Study||113||
48524405|NCT01940497|101616336|FG000|Treated: Adjuvant|Overall Study||95||
48524406|NCT01940497|101616337|FG001|Treated: Adjuvant|Overall Study||92||
48524407|NCT01940497|101616336|FG000|Treated: Neoadjuvant|Overall Study||20||
48524408|NCT01940497|101616337|FG001|Treated: Neoadjuvant|Overall Study||21||
48524409|NCT01940497|101616336|FG000|COMPLETED|Overall Study||100|Completed Treatment Period|
48524410|NCT01940497|101616337|FG001|COMPLETED|Overall Study||101|Completed Treatment Period|
48524411|NCT01940497|101616336|FG000|NOT COMPLETED|Overall Study||21||
48524412|NCT01940497|101616337|FG001|NOT COMPLETED|Overall Study||18||
48524413|NCT01929031|101616338|FG000|STARTED|Overall Study||213||
48524414|NCT01929031|101616339|FG001|STARTED|Overall Study||209||
48524415|NCT01929031|101616340|FG002|STARTED|Overall Study||35||
48524416|NCT01929031|101616341|FG003|STARTED|Overall Study||35||
48524417|NCT01929031|101616342|FG004|STARTED|Overall Study||34||
48524418|NCT01929031|101616343|FG005|STARTED|Overall Study||36||
48524419|NCT01929031|101616338|FG000|COMPLETED|Overall Study||209||
48524420|NCT01929031|101616339|FG001|COMPLETED|Overall Study||207||
48524421|NCT01929031|101616340|FG002|COMPLETED|Overall Study||34||
48524422|NCT01929031|101616341|FG003|COMPLETED|Overall Study||35||
48524423|NCT01929031|101616342|FG004|COMPLETED|Overall Study||33||
48524424|NCT01929031|101616343|FG005|COMPLETED|Overall Study||35||
48524425|NCT01929031|101616338|FG000|NOT COMPLETED|Overall Study||4||
48524426|NCT01929031|101616339|FG001|NOT COMPLETED|Overall Study||2||
48524427|NCT01929031|101616340|FG002|NOT COMPLETED|Overall Study||1||
48524428|NCT01929031|101616341|FG003|NOT COMPLETED|Overall Study||0||
48524429|NCT01929031|101616342|FG004|NOT COMPLETED|Overall Study||1||
48524430|NCT01929031|101616343|FG005|NOT COMPLETED|Overall Study||1||
48524431|NCT03544879|101616344|FG000|STARTED|Overall Study||22||
48524432|NCT03544879|101616345|FG001|STARTED|Overall Study||24||
48524433|NCT03544879|101616344|FG000|Completed Follow-up Physical Assessment|Overall Study||20||
48524434|NCT03544879|101616345|FG001|Completed Follow-up Physical Assessment|Overall Study||21||
48524435|NCT03544879|101616344|FG000|COMPLETED|Overall Study||22|refers to completing follow-up self-report questionnaires|
48524436|NCT03544879|101616345|FG001|COMPLETED|Overall Study||23|refers to completing follow-up self-report questionnaires|
48524437|NCT03544879|101616344|FG000|NOT COMPLETED|Overall Study||0||
48524438|NCT03544879|101616345|FG001|NOT COMPLETED|Overall Study||1||
48524439|NCT00836017|101616346|FG000|STARTED|Overall Study||1046||
48524440|NCT00836017|101616346|FG000|COMPLETED|Overall Study||502||
48524441|NCT00836017|101616346|FG000|NOT COMPLETED|Overall Study||544||
48524442|NCT02707861|101616347|FG000|STARTED|Overall Study||41||
48524443|NCT02707861|101616348|FG001|STARTED|Overall Study||38||
48524444|NCT02707861|101616347|FG000|COMPLETED|Overall Study||0||
48524445|NCT02707861|101616348|FG001|COMPLETED|Overall Study||0||
48524446|NCT02707861|101616347|FG000|NOT COMPLETED|Overall Study||41||
48524447|NCT02707861|101616348|FG001|NOT COMPLETED|Overall Study||38||
48524448|NCT02072148|101620745|FG000|STARTED|Overall Study||54||
48524449|NCT02072148|101620746|FG001|STARTED|Overall Study||29||
48524450|NCT02072148|101620747|FG002|STARTED|Overall Study||29||
48524451|NCT02072148|101620745|FG000|COMPLETED|Overall Study||31||
48524452|NCT02072148|101620746|FG001|COMPLETED|Overall Study||16||
48524453|NCT02072148|101620747|FG002|COMPLETED|Overall Study||16||
48524454|NCT02072148|101620745|FG000|NOT COMPLETED|Overall Study||23||
48524455|NCT02072148|101620746|FG001|NOT COMPLETED|Overall Study||13||
48524456|NCT02072148|101620747|FG002|NOT COMPLETED|Overall Study||13||
48524457|NCT05017974|101620748|FG000|STARTED|Overall Study||26||
48524458|NCT05017974|101620749|FG001|STARTED|Overall Study||26||
48524459|NCT05017974|101620748|FG000|COMPLETED|Overall Study||24||
48078971|NCT01306942|100515281|FG002|NOT COMPLETED|Phase I||0||
48524460|NCT05017974|101620749|FG001|COMPLETED|Overall Study||24||
48524461|NCT05017974|101620748|FG000|NOT COMPLETED|Overall Study||2||
48524462|NCT05017974|101620749|FG001|NOT COMPLETED|Overall Study||2||
48524463|NCT02523196|101620750|FG000|STARTED|Overall Study||20||
48524464|NCT02523196|101620750|FG000|Received HVPG|Overall Study||20||
48524465|NCT02523196|101620750|FG000|Received HQ Shunt|Overall Study||20||
48524466|NCT02523196|101620750|FG000|COMPLETED|Overall Study||20||
48524467|NCT02523196|101620750|FG000|NOT COMPLETED|Overall Study||0||
48524468|NCT01684436|101620751|FG000|STARTED|Overall Study||30||
48524469|NCT01684436|101620751|FG000|COMPLETED|Overall Study||29||
48524470|NCT01684436|101620751|FG000|NOT COMPLETED|Overall Study||1||
48524471|NCT01869478|101620752|FG000|STARTED|Overall Study||0||
48524472|NCT01869478|101620753|FG001|STARTED|Overall Study||1||
48524473|NCT01869478|101620752|FG000|COMPLETED|Overall Study||0||
48524474|NCT01869478|101620753|FG001|COMPLETED|Overall Study||1||
48524475|NCT01869478|101620752|FG000|NOT COMPLETED|Overall Study||0||
48524476|NCT01869478|101620753|FG001|NOT COMPLETED|Overall Study||0||
48524477|NCT01251978|101620754|FG000|STARTED|Overall Study||5||
48078972|NCT01306942|100515282|FG003|NOT COMPLETED|Phase I||0||
48524478|NCT01251978|101620755|FG001|STARTED|Overall Study||3||
48524479|NCT01251978|101620754|FG000|COMPLETED|Overall Study||5||
48524480|NCT01251978|101620755|FG001|COMPLETED|Overall Study||3||
48524481|NCT01251978|101620754|FG000|NOT COMPLETED|Overall Study||0||
48524482|NCT01251978|101620755|FG001|NOT COMPLETED|Overall Study||0||
48524483|NCT00762931|101620756|FG000|STARTED|Overall Study||25||
48524484|NCT00762931|101620756|FG000|COMPLETED|Overall Study||23||
48524485|NCT00762931|101620756|FG000|NOT COMPLETED|Overall Study||2||
48524486|NCT00973765|101620757|FG000|STARTED|Overall Study||96||
48524487|NCT00973765|101620758|FG001|STARTED|Overall Study||116||
48524488|NCT00973765|101620757|FG000|COMPLETED|Overall Study||88||
48524489|NCT00973765|101620758|FG001|COMPLETED|Overall Study||102||
48524490|NCT00973765|101620757|FG000|NOT COMPLETED|Overall Study||8||
48524491|NCT00973765|101620758|FG001|NOT COMPLETED|Overall Study||14||
48524492|NCT02287493|101620759|FG000|STARTED|Overall Study||19||
48524493|NCT02287493|101620760|FG001|STARTED|Overall Study||16||
48524494|NCT02287493|101620759|FG000|COMPLETED|Overall Study||19||
48524495|NCT02287493|101620760|FG001|COMPLETED|Overall Study||16||
48524496|NCT02287493|101620759|FG000|NOT COMPLETED|Overall Study||0||
48524497|NCT02287493|101620760|FG001|NOT COMPLETED|Overall Study||0||
48524498|NCT02667288|101620761|FG000|STARTED|Overall Study||147||
48524499|NCT02667288|101620761|FG000|COMPLETED|Overall Study||134||
48524500|NCT02667288|101620761|FG000|NOT COMPLETED|Overall Study||13||
48524501|NCT02697773|101620762|FG000|STARTED|Overall Study||233||
48524502|NCT02697773|101620763|FG001|STARTED|Overall Study||232||
48524503|NCT02697773|101620764|FG002|STARTED|Overall Study||233||
48524504|NCT02697773|101620762|FG000|Treated|Overall Study||232||
48524505|NCT02697773|101620763|FG001|Treated|Overall Study||231||
48524506|NCT02697773|101620764|FG002|Treated|Overall Study||233||
48524507|NCT02697773|101620762|FG000|COMPLETED|Overall Study||195||
48524508|NCT02697773|101620763|FG001|COMPLETED|Overall Study||194||
48524509|NCT02697773|101620764|FG002|COMPLETED|Overall Study||193||
48524510|NCT02697773|101620762|FG000|NOT COMPLETED|Overall Study||38||
48524511|NCT02697773|101620763|FG001|NOT COMPLETED|Overall Study||38||
48524512|NCT02697773|101620764|FG002|NOT COMPLETED|Overall Study||40||
48524513|NCT02312713|101620765|FG000|STARTED|Overall Study||140||
48524514|NCT02312713|101620766|FG001|STARTED|Overall Study||142||
48524515|NCT02312713|101620767|FG002|STARTED|Overall Study||68||
48524516|NCT02312713|101620765|FG000|COMPLETED|Overall Study||129||
48524517|NCT02312713|101620766|FG001|COMPLETED|Overall Study||112||
48524518|NCT02312713|101620767|FG002|COMPLETED|Overall Study||63||
48524519|NCT02312713|101620765|FG000|NOT COMPLETED|Overall Study||11||
48524520|NCT02312713|101620766|FG001|NOT COMPLETED|Overall Study||30||
48524521|NCT02312713|101620767|FG002|NOT COMPLETED|Overall Study||5||
48524522|NCT01797835|101620768|FG000|STARTED|Overall Study||153||
48078973|NCT01306942|100515279|FG000|STARTED|Phase II||2||
48078974|NCT01306942|100515280|FG001|STARTED|Phase II||0||
48078975|NCT01306942|100515281|FG002|STARTED|Phase II||0||
48078976|NCT01306942|100515282|FG003|STARTED|Phase II||27||
48078977|NCT01306942|100515279|FG000|COMPLETED|Phase II||0||
48078978|NCT01306942|100515280|FG001|COMPLETED|Phase II||0||
48078979|NCT01306942|100515281|FG002|COMPLETED|Phase II||0||
48524523|NCT01797835|101620769|FG001|STARTED|Overall Study||141||
48524524|NCT01797835|101620768|FG000|COMPLETED|Overall Study||122||
48524525|NCT01797835|101620769|FG001|COMPLETED|Overall Study||114||
48524526|NCT01797835|101620768|FG000|NOT COMPLETED|Overall Study||31||
48524527|NCT01797835|101620769|FG001|NOT COMPLETED|Overall Study||27||
48524528|NCT02963311|101620770|FG000|STARTED|Overall Study||9||
48524529|NCT02963311|101620770|FG000|COMPLETED|Overall Study||4||
48078980|NCT01306942|100515282|FG003|COMPLETED|Phase II||11||
48078981|NCT01306942|100515279|FG000|NOT COMPLETED|Phase II||2||
48078982|NCT01306942|100515280|FG001|NOT COMPLETED|Phase II||0||
48524530|NCT02963311|101620770|FG000|NOT COMPLETED|Overall Study||5||
48524531|NCT03110601|101620771|FG000|STARTED|Conventional SCS Parameters||25||
48524532|NCT03110601|101620771|FG000|COMPLETED|Conventional SCS Parameters||24||
48524533|NCT03110601|101620771|FG000|NOT COMPLETED|Conventional SCS Parameters||1||
48524534|NCT03110601|101620771|FG000|STARTED|Washout Period||24||
48524535|NCT03110601|101620771|FG000|COMPLETED|Washout Period||23||
48524536|NCT03110601|101620771|FG000|NOT COMPLETED|Washout Period||1||
48524537|NCT03110601|101620771|FG000|STARTED|Stimgenics SCS Parameters||23||
48524538|NCT03110601|101620771|FG000|COMPLETED|Stimgenics SCS Parameters||20||
48524539|NCT03110601|101620771|FG000|NOT COMPLETED|Stimgenics SCS Parameters||3||
48078983|NCT01306942|100515281|FG002|NOT COMPLETED|Phase II||0||
48078984|NCT01306942|100515282|FG003|NOT COMPLETED|Phase II||16||
48078985|NCT01312272|100515283|FG000|STARTED|Overall Study||12||
48078986|NCT01312272|100515284|FG001|STARTED|Overall Study||12||
48078987|NCT01312272|100515283|FG000|COMPLETED|Overall Study||12||
48524540|NCT01784666|101620772|FG000|STARTED|Overall Study||1||
48078988|NCT01312272|100515284|FG001|COMPLETED|Overall Study||11||
48078989|NCT01312272|100515283|FG000|NOT COMPLETED|Overall Study||0||
48078990|NCT01312272|100515284|FG001|NOT COMPLETED|Overall Study||1||
48078991|NCT02505867|100515285|FG000|STARTED|Overall Study||6||
48078992|NCT02505867|100515286|FG001|STARTED|Overall Study||6||
48078993|NCT02505867|100515285|FG000|COMPLETED|Overall Study||0||
48078994|NCT02505867|100515286|FG001|COMPLETED|Overall Study||0||
48078995|NCT02505867|100515285|FG000|NOT COMPLETED|Overall Study||6||
48524541|NCT01784666|101620773|FG001|STARTED|Overall Study||0||
48524542|NCT01784666|101620774|FG002|STARTED|Overall Study||1||
48524543|NCT01784666|101620772|FG000|COMPLETED|Overall Study||1||
48524544|NCT01784666|101620773|FG001|COMPLETED|Overall Study||0||
48524545|NCT01784666|101620774|FG002|COMPLETED|Overall Study||1||
48524546|NCT01784666|101620772|FG000|NOT COMPLETED|Overall Study||0||
48524547|NCT01784666|101620773|FG001|NOT COMPLETED|Overall Study||0||
48524548|NCT01784666|101620774|FG002|NOT COMPLETED|Overall Study||0||
48524549|NCT02811263|101620775|FG000|STARTED|Overall Study||257||
48524550|NCT02811263|101620776|FG001|STARTED|Overall Study||243||
48524551|NCT02811263|101620775|FG000|COMPLETED|Overall Study||240||
48524552|NCT02811263|101620776|FG001|COMPLETED|Overall Study||222||
48524553|NCT02811263|101620775|FG000|NOT COMPLETED|Overall Study||17||
48524554|NCT02811263|101620776|FG001|NOT COMPLETED|Overall Study||21||
48524555|NCT00899470|101620777|FG000|STARTED|First Therapy||6||
48524556|NCT00899470|101620778|FG001|STARTED|First Therapy||6||
48524557|NCT00899470|101620779|FG002|STARTED|First Therapy||6||
48524558|NCT00899470|101620780|FG003|STARTED|First Therapy||6||
48524559|NCT00899470|101620777|FG000|COMPLETED|First Therapy||6||
48524560|NCT00899470|101620778|FG001|COMPLETED|First Therapy||6||
48524561|NCT00899470|101620779|FG002|COMPLETED|First Therapy||6||
48524562|NCT00899470|101620780|FG003|COMPLETED|First Therapy||6||
48524563|NCT00899470|101620777|FG000|NOT COMPLETED|First Therapy||0||
48524564|NCT00899470|101620778|FG001|NOT COMPLETED|First Therapy||0||
48524565|NCT00899470|101620779|FG002|NOT COMPLETED|First Therapy||0||
48524566|NCT00899470|101620780|FG003|NOT COMPLETED|First Therapy||0||
48524567|NCT00899470|101620777|FG000|STARTED|First Washout Period||6||
48524568|NCT00899470|101620778|FG001|STARTED|First Washout Period||6||
48524569|NCT00899470|101620779|FG002|STARTED|First Washout Period||6||
48524570|NCT00899470|101620780|FG003|STARTED|First Washout Period||6||
48524571|NCT00899470|101620777|FG000|COMPLETED|First Washout Period||6||
48524572|NCT00899470|101620778|FG001|COMPLETED|First Washout Period||6||
48524573|NCT00899470|101620779|FG002|COMPLETED|First Washout Period||6||
48524574|NCT00899470|101620780|FG003|COMPLETED|First Washout Period||6||
48524575|NCT00899470|101620777|FG000|NOT COMPLETED|First Washout Period||0||
48524576|NCT00899470|101620778|FG001|NOT COMPLETED|First Washout Period||0||
48524577|NCT00899470|101620779|FG002|NOT COMPLETED|First Washout Period||0||
48524578|NCT00899470|101620780|FG003|NOT COMPLETED|First Washout Period||0||
48524579|NCT00899470|101620777|FG000|STARTED|Second Therapy||6||
48524580|NCT00899470|101620778|FG001|STARTED|Second Therapy||6||
48524581|NCT00899470|101620779|FG002|STARTED|Second Therapy||6||
48524582|NCT00899470|101620780|FG003|STARTED|Second Therapy||6||
48078996|NCT02505867|100515286|FG001|NOT COMPLETED|Overall Study||6||
48078997|NCT00753415|100515287|FG000|STARTED|Part A||3||
48524583|NCT00899470|101620777|FG000|COMPLETED|Second Therapy||6||
48524584|NCT00899470|101620778|FG001|COMPLETED|Second Therapy||6||
48524585|NCT00899470|101620779|FG002|COMPLETED|Second Therapy||6||
48524586|NCT00899470|101620780|FG003|COMPLETED|Second Therapy||6||
48524587|NCT00899470|101620777|FG000|NOT COMPLETED|Second Therapy||0||
48524588|NCT00899470|101620778|FG001|NOT COMPLETED|Second Therapy||0||
48524589|NCT00899470|101620779|FG002|NOT COMPLETED|Second Therapy||0||
48524590|NCT00899470|101620780|FG003|NOT COMPLETED|Second Therapy||0||
48524591|NCT00899470|101620777|FG000|STARTED|Second Washout||6||
48078998|NCT00753415|100515288|FG001|STARTED|Part A||3||
48524592|NCT00899470|101620778|FG001|STARTED|Second Washout||6||
48524593|NCT00899470|101620779|FG002|STARTED|Second Washout||6||
48524594|NCT00899470|101620780|FG003|STARTED|Second Washout||6||
48524595|NCT00899470|101620777|FG000|COMPLETED|Second Washout||6||
48524596|NCT00899470|101620778|FG001|COMPLETED|Second Washout||6||
48078999|NCT00753415|100515289|FG002|STARTED|Part A||10||
48079000|NCT00753415|100515290|FG003|STARTED|Part A||11||
48079001|NCT00753415|100515291|FG004|STARTED|Part A||10||
48524597|NCT00899470|101620779|FG002|COMPLETED|Second Washout||6||
48079002|NCT00753415|100515292|FG005|STARTED|Part A||0||
48079003|NCT00753415|100515293|FG006|STARTED|Part A||0||
48079004|NCT00753415|100515294|FG007|STARTED|Part A||0||
48524598|NCT00899470|101620780|FG003|COMPLETED|Second Washout||6||
48524599|NCT00899470|101620777|FG000|NOT COMPLETED|Second Washout||0||
48524600|NCT00899470|101620778|FG001|NOT COMPLETED|Second Washout||0||
48524601|NCT00899470|101620779|FG002|NOT COMPLETED|Second Washout||0||
48524602|NCT00899470|101620780|FG003|NOT COMPLETED|Second Washout||0||
48524603|NCT00899470|101620777|FG000|STARTED|Third Therapy||6||
48524604|NCT00899470|101620778|FG001|STARTED|Third Therapy||6||
48079005|NCT00753415|100515295|FG008|STARTED|Part A||0||
48079006|NCT00753415|100515296|FG009|STARTED|Part A||0||
48079007|NCT00753415|100515287|FG000|COMPLETED|Part A||2||
48079008|NCT00753415|100515288|FG001|COMPLETED|Part A||3||
48079009|NCT00753415|100515289|FG002|COMPLETED|Part A||8||
48524605|NCT00899470|101620779|FG002|STARTED|Third Therapy||6||
48524606|NCT00899470|101620780|FG003|STARTED|Third Therapy||6||
48524607|NCT00899470|101620777|FG000|COMPLETED|Third Therapy||6||
48524608|NCT00899470|101620778|FG001|COMPLETED|Third Therapy||6||
48524609|NCT00899470|101620779|FG002|COMPLETED|Third Therapy||6||
48524610|NCT00899470|101620780|FG003|COMPLETED|Third Therapy||6||
48524611|NCT00899470|101620777|FG000|NOT COMPLETED|Third Therapy||0||
48524612|NCT00899470|101620778|FG001|NOT COMPLETED|Third Therapy||0||
48524613|NCT00899470|101620779|FG002|NOT COMPLETED|Third Therapy||0||
48524614|NCT00899470|101620780|FG003|NOT COMPLETED|Third Therapy||0||
48524615|NCT00899470|101620777|FG000|STARTED|Third Washout||6||
48524616|NCT00899470|101620778|FG001|STARTED|Third Washout||6||
48524617|NCT00899470|101620779|FG002|STARTED|Third Washout||6||
48524618|NCT00899470|101620780|FG003|STARTED|Third Washout||6||
48524619|NCT00899470|101620777|FG000|COMPLETED|Third Washout||6||
48524620|NCT00899470|101620778|FG001|COMPLETED|Third Washout||6||
48524621|NCT00899470|101620779|FG002|COMPLETED|Third Washout||6||
48524622|NCT00899470|101620780|FG003|COMPLETED|Third Washout||6||
48524623|NCT00899470|101620777|FG000|NOT COMPLETED|Third Washout||0||
48524624|NCT00899470|101620778|FG001|NOT COMPLETED|Third Washout||0||
48524625|NCT00899470|101620779|FG002|NOT COMPLETED|Third Washout||0||
48524626|NCT00899470|101620780|FG003|NOT COMPLETED|Third Washout||0||
48524627|NCT00899470|101620777|FG000|STARTED|Fourth Therapy||6||
48524628|NCT00899470|101620778|FG001|STARTED|Fourth Therapy||6||
48524629|NCT00899470|101620779|FG002|STARTED|Fourth Therapy||6||
48524630|NCT00899470|101620780|FG003|STARTED|Fourth Therapy||6||
48524631|NCT00899470|101620777|FG000|COMPLETED|Fourth Therapy||6||
48524632|NCT00899470|101620778|FG001|COMPLETED|Fourth Therapy||6||
48524633|NCT00899470|101620779|FG002|COMPLETED|Fourth Therapy||6||
48524634|NCT00899470|101620780|FG003|COMPLETED|Fourth Therapy||6||
48524635|NCT00899470|101620777|FG000|NOT COMPLETED|Fourth Therapy||0||
48524636|NCT00899470|101620778|FG001|NOT COMPLETED|Fourth Therapy||0||
48524637|NCT00899470|101620779|FG002|NOT COMPLETED|Fourth Therapy||0||
48524638|NCT00899470|101620780|FG003|NOT COMPLETED|Fourth Therapy||0||
48524639|NCT00666848|101620781|FG000|STARTED|Overall Study||8||
48524640|NCT00666848|101620782|FG001|STARTED|Overall Study||9||
48524641|NCT00666848|101620783|FG002|STARTED|Overall Study||7||
48524642|NCT00666848|101620781|FG000|COMPLETED|Overall Study||8||
48524643|NCT00666848|101620782|FG001|COMPLETED|Overall Study||9||
48524644|NCT00666848|101620783|FG002|COMPLETED|Overall Study||7||
48524645|NCT00666848|101620781|FG000|NOT COMPLETED|Overall Study||0||
48524646|NCT00666848|101620782|FG001|NOT COMPLETED|Overall Study||0||
48524647|NCT00666848|101620783|FG002|NOT COMPLETED|Overall Study||0||
48524648|NCT02639052|101620784|FG000|STARTED|Overall Study||35||
48524649|NCT02639052|101620784|FG000|Visit 1 (Baseline)|Overall Study||35||
48524650|NCT02639052|101620784|FG000|Visit 2 (1-week Follow-up)|Overall Study||35||
48524651|NCT02639052|101620784|FG000|Visit 3 (1-month Follow-up)|Overall Study||35||
48524652|NCT02639052|101620784|FG000|Visit 4 (3-month Follow-up)|Overall Study||34||
48524653|NCT02639052|101620784|FG000|COMPLETED|Overall Study||34||
48524654|NCT02639052|101620784|FG000|NOT COMPLETED|Overall Study||1||
48524655|NCT04568031|101620785|FG000|STARTED|Overall Study||96||
48524656|NCT04568031|101620786|FG001|STARTED|Overall Study||32||
48524657|NCT04568031|101620787|FG002|STARTED|Overall Study||96||
48524658|NCT04568031|101620788|FG003|STARTED|Overall Study||32||
48524659|NCT04568031|101620785|FG000|Participants Received 1 Vaccination|Overall Study||96||
48524660|NCT04568031|101620786|FG001|Participants Received 1 Vaccination|Overall Study||32||
48524661|NCT04568031|101620787|FG002|Participants Received 1 Vaccination|Overall Study||96||
48524662|NCT04568031|101620788|FG003|Participants Received 1 Vaccination|Overall Study||32||
48524663|NCT04568031|101620785|FG000|Participants Received 2 Vaccinations|Overall Study||84||
48524664|NCT04568031|101620786|FG001|Participants Received 2 Vaccinations|Overall Study||30||
48524665|NCT04568031|101620787|FG002|Participants Received 2 Vaccinations|Overall Study||92||
48524666|NCT04568031|101620788|FG003|Participants Received 2 Vaccinations|Overall Study||31||
48524667|NCT04568031|101620785|FG000|COMPLETED|Overall Study||93||
48524668|NCT04568031|101620786|FG001|COMPLETED|Overall Study||32||
48524669|NCT04568031|101620787|FG002|COMPLETED|Overall Study||91||
48524670|NCT04568031|101620788|FG003|COMPLETED|Overall Study||31||
48524671|NCT04568031|101620785|FG000|NOT COMPLETED|Overall Study||3||
48524672|NCT04568031|101620786|FG001|NOT COMPLETED|Overall Study||0||
48524673|NCT04568031|101620787|FG002|NOT COMPLETED|Overall Study||5||
48524674|NCT04568031|101620788|FG003|NOT COMPLETED|Overall Study||1||
48524675|NCT00532935|101620789|FG000|STARTED|Overall Study||261||
48524676|NCT00532935|101620790|FG001|STARTED|Overall Study||256||
48524677|NCT00532935|101620789|FG000|COMPLETED|Overall Study||210||
48524678|NCT00532935|101620790|FG001|COMPLETED|Overall Study||204||
48524679|NCT00532935|101620789|FG000|NOT COMPLETED|Overall Study||51||
48524680|NCT00532935|101620790|FG001|NOT COMPLETED|Overall Study||52||
48524681|NCT01700049|101620791|FG000|STARTED|Overall Study||28||
48524682|NCT01700049|101620791|FG000|COMPLETED|Overall Study||27||
48524683|NCT01700049|101620791|FG000|NOT COMPLETED|Overall Study||1||
48524684|NCT02478320|101620792|FG000|STARTED|Overall Study||12||
48524685|NCT02478320|101620793|FG001|STARTED|Overall Study||0||
48524686|NCT02478320|101620792|FG000|COMPLETED|Overall Study||0||
48524687|NCT02478320|101620793|FG001|COMPLETED|Overall Study||0||
48524688|NCT02478320|101620792|FG000|NOT COMPLETED|Overall Study||12||
48524689|NCT02478320|101620793|FG001|NOT COMPLETED|Overall Study||0||
48524690|NCT03052322|101620794|FG000|STARTED|Overall Study||143||
48524691|NCT03052322|101620795|FG001|STARTED|Overall Study||145||
48524692|NCT03052322|101620794|FG000|COMPLETED|Overall Study||122||
48524693|NCT03052322|101620795|FG001|COMPLETED|Overall Study||113||
48524694|NCT03052322|101620794|FG000|NOT COMPLETED|Overall Study||21||
48524695|NCT03052322|101620795|FG001|NOT COMPLETED|Overall Study||32||
48524696|NCT02238626|101620796|FG000|STARTED|Overall Study||17||
48524697|NCT02238626|101620797|FG001|STARTED|Overall Study||34||
48524698|NCT02238626|101620798|FG002|STARTED|Overall Study||8||
48524699|NCT02238626|101620799|FG003|STARTED|Overall Study||11||
48524700|NCT02238626|101620796|FG000|COMPLETED|Overall Study||12||
48524701|NCT02238626|101620797|FG001|COMPLETED|Overall Study||20||
48524702|NCT02238626|101620798|FG002|COMPLETED|Overall Study||5||
48524703|NCT02238626|101620799|FG003|COMPLETED|Overall Study||4||
48524704|NCT02238626|101620796|FG000|NOT COMPLETED|Overall Study||5||
48524705|NCT02238626|101620797|FG001|NOT COMPLETED|Overall Study||14||
48524706|NCT02238626|101620798|FG002|NOT COMPLETED|Overall Study||3||
48524707|NCT02238626|101620799|FG003|NOT COMPLETED|Overall Study||7||
48524708|NCT03578237|101620800|FG000|STARTED|Postoperative Days 0-21||51||
48524709|NCT03578237|101620801|FG001|STARTED|Postoperative Days 0-21||48||
48524710|NCT03578237|101620800|FG000|COMPLETED|Postoperative Days 0-21||51||
48524711|NCT03578237|101620801|FG001|COMPLETED|Postoperative Days 0-21||48||
48524712|NCT03578237|101620800|FG000|NOT COMPLETED|Postoperative Days 0-21||0||
48524713|NCT03578237|101620801|FG001|NOT COMPLETED|Postoperative Days 0-21||0||
48524714|NCT03578237|101620800|FG000|STARTED|Postoperative Day 0 - Month 12||51||
48524715|NCT03578237|101620801|FG001|STARTED|Postoperative Day 0 - Month 12||48||
48524716|NCT03578237|101620800|FG000|COMPLETED|Postoperative Day 0 - Month 12||37||
48524717|NCT03578237|101620801|FG001|COMPLETED|Postoperative Day 0 - Month 12||32||
48524718|NCT03578237|101620800|FG000|NOT COMPLETED|Postoperative Day 0 - Month 12||14||
48524719|NCT03578237|101620801|FG001|NOT COMPLETED|Postoperative Day 0 - Month 12||16||
48524720|NCT01746264|101620802|FG000|STARTED|Overall Study||19||
48524721|NCT01746264|101620802|FG000|COMPLETED|Overall Study||19||
48524722|NCT01746264|101620802|FG000|NOT COMPLETED|Overall Study||0||
48524723|NCT00629265|101620803|FG000|STARTED|Overall Study||116||
48524724|NCT00629265|101620804|FG001|STARTED|Overall Study||54||
48524725|NCT00629265|101620803|FG000|COMPLETED|Overall Study||84||
48079010|NCT00753415|100515290|FG003|COMPLETED|Part A||9||
48079011|NCT00753415|100515291|FG004|COMPLETED|Part A||10||
48079012|NCT00753415|100515292|FG005|COMPLETED|Part A||0||
48079013|NCT00753415|100515293|FG006|COMPLETED|Part A||0||
48079014|NCT00753415|100515294|FG007|COMPLETED|Part A||0||
48079015|NCT00753415|100515295|FG008|COMPLETED|Part A||0||
48079016|NCT00753415|100515296|FG009|COMPLETED|Part A||0||
48079017|NCT00753415|100515287|FG000|NOT COMPLETED|Part A||1||
48079018|NCT00753415|100515288|FG001|NOT COMPLETED|Part A||0||
48079019|NCT00753415|100515289|FG002|NOT COMPLETED|Part A||2||
48079020|NCT00753415|100515290|FG003|NOT COMPLETED|Part A||2||
48079021|NCT00753415|100515291|FG004|NOT COMPLETED|Part A||0||
48079022|NCT00753415|100515292|FG005|NOT COMPLETED|Part A||0||
48079023|NCT00753415|100515293|FG006|NOT COMPLETED|Part A||0||
48079024|NCT00753415|100515294|FG007|NOT COMPLETED|Part A||0||
48079025|NCT00753415|100515295|FG008|NOT COMPLETED|Part A||0||
48079026|NCT00753415|100515296|FG009|NOT COMPLETED|Part A||0||
48079027|NCT00753415|100515287|FG000|STARTED|Part B||0||
48079028|NCT00753415|100515288|FG001|STARTED|Part B||0||
48079029|NCT00753415|100515289|FG002|STARTED|Part B||0||
48079030|NCT00753415|100515290|FG003|STARTED|Part B||0||
48524726|NCT00629265|101620804|FG001|COMPLETED|Overall Study||34||
48524727|NCT00629265|101620803|FG000|NOT COMPLETED|Overall Study||32||
48524728|NCT00629265|101620804|FG001|NOT COMPLETED|Overall Study||20||
48079031|NCT00753415|100515291|FG004|STARTED|Part B||0||
48079032|NCT00753415|100515292|FG005|STARTED|Part B||1||
48079033|NCT00753415|100515293|FG006|STARTED|Part B||2||
48079034|NCT00753415|100515294|FG007|STARTED|Part B||7||
48079035|NCT00753415|100515295|FG008|STARTED|Part B||9||
48079036|NCT00753415|100515296|FG009|STARTED|Part B||9||
48079037|NCT00753415|100515287|FG000|COMPLETED|Part B||0||
48524729|NCT02304991|101620805|FG000|STARTED|Overall Study||25||
48524730|NCT02304991|101620806|FG001|STARTED|Overall Study||25||
48524731|NCT02304991|101620805|FG000|COMPLETED|Overall Study||18||
48524732|NCT02304991|101620806|FG001|COMPLETED|Overall Study||15||
48524733|NCT02304991|101620805|FG000|NOT COMPLETED|Overall Study||7||
48524734|NCT02304991|101620806|FG001|NOT COMPLETED|Overall Study||10||
48524735|NCT00975286|101620807|FG000|STARTED|Overall Study||223||
48524736|NCT00975286|101620808|FG001|STARTED|Overall Study||223||
48524737|NCT00975286|101620807|FG000|Safety Population|Overall Study||223||
48079038|NCT00753415|100515288|FG001|COMPLETED|Part B||0||
48079039|NCT00753415|100515289|FG002|COMPLETED|Part B||0||
48079040|NCT00753415|100515290|FG003|COMPLETED|Part B||0||
48079041|NCT00753415|100515291|FG004|COMPLETED|Part B||0||
48079042|NCT00753415|100515292|FG005|COMPLETED|Part B||1||
48079043|NCT00753415|100515293|FG006|COMPLETED|Part B||2||
48079044|NCT00753415|100515294|FG007|COMPLETED|Part B||6||
48079045|NCT00753415|100515295|FG008|COMPLETED|Part B||6||
48079046|NCT00753415|100515296|FG009|COMPLETED|Part B||8||
48524738|NCT00975286|101620808|FG001|Safety Population|Overall Study||223||
48524739|NCT00975286|101620807|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study||223||
48079047|NCT00753415|100515287|FG000|NOT COMPLETED|Part B||0||
48079048|NCT00753415|100515288|FG001|NOT COMPLETED|Part B||0||
48079049|NCT00753415|100515289|FG002|NOT COMPLETED|Part B||0||
48079050|NCT00753415|100515290|FG003|NOT COMPLETED|Part B||0||
48079051|NCT00753415|100515291|FG004|NOT COMPLETED|Part B||0||
48079052|NCT00753415|100515292|FG005|NOT COMPLETED|Part B||0||
48079053|NCT00753415|100515293|FG006|NOT COMPLETED|Part B||0||
48079054|NCT00753415|100515294|FG007|NOT COMPLETED|Part B||1||
48079055|NCT00753415|100515295|FG008|NOT COMPLETED|Part B||3||
48079056|NCT00753415|100515296|FG009|NOT COMPLETED|Part B||1||
48079057|NCT01193868|100515297|FG000|STARTED|Overall Study||6||
48079058|NCT01193868|100515297|FG000|COMPLETED|Overall Study||6||
48079059|NCT01193868|100515297|FG000|NOT COMPLETED|Overall Study||0||
48079060|NCT03060629|100515298|FG000|STARTED|Overall Study||1313||
48079061|NCT03060629|100515299|FG001|STARTED|Overall Study||1323||
48079062|NCT03060629|100515298|FG000|COMPLETED|Overall Study||78||
48079063|NCT03060629|100515299|FG001|COMPLETED|Overall Study||88||
48079064|NCT03060629|100515298|FG000|NOT COMPLETED|Overall Study||1235||
48079065|NCT03060629|100515299|FG001|NOT COMPLETED|Overall Study||1235||
48079066|NCT00042289|100515300|FG000|STARTED|Overall Study||26||
48079067|NCT00042289|100515301|FG001|STARTED|Overall Study||30||
48079068|NCT00042289|100515302|FG002|STARTED|Overall Study||27||
48079069|NCT00042289|100515303|FG003|STARTED|Overall Study||33||
48079070|NCT00042289|100515304|FG004|STARTED|Overall Study||29||
48079071|NCT00042289|100515305|FG005|STARTED|Overall Study||31||
48079072|NCT00042289|100515306|FG006|STARTED|Overall Study||28||
48079073|NCT00042289|100515307|FG007|STARTED|Overall Study||12||
48079074|NCT00042289|100515308|FG008|STARTED|Overall Study||27||
48079075|NCT00042289|100515309|FG009|STARTED|Overall Study||24||
48079076|NCT00042289|100515310|FG010|STARTED|Overall Study||2||
48079077|NCT00042289|100515311|FG011|STARTED|Overall Study||27||
48079078|NCT00042289|100515312|FG012|STARTED|Overall Study||13||
48079079|NCT00042289|100515313|FG013|STARTED|Overall Study||2||
48079080|NCT00042289|100515314|FG014|STARTED|Overall Study||6||
48079081|NCT00042289|100515315|FG015|STARTED|Overall Study||29||
48079082|NCT00042289|100515316|FG016|STARTED|Overall Study||28||
48079083|NCT00042289|100515317|FG017|STARTED|Overall Study||12||
48079084|NCT00042289|100515318|FG018|STARTED|Overall Study||26||
48079085|NCT00042289|100515319|FG019|STARTED|Overall Study||17||
48079086|NCT00042289|100515320|FG020|STARTED|Overall Study||1||
48079087|NCT00042289|100515321|FG021|STARTED|Overall Study||30||
48079088|NCT00042289|100515322|FG022|STARTED|Overall Study||29||
48079089|NCT00042289|100515323|FG023|STARTED|Overall Study||22||
48079090|NCT00042289|100515324|FG024|STARTED|Overall Study||18||
48079091|NCT00042289|100515325|FG025|STARTED|Overall Study||21||
48079092|NCT00042289|100515326|FG026|STARTED|Overall Study||28||
48079093|NCT00042289|100515327|FG027|STARTED|Overall Study||25||
48079094|NCT00042289|100515328|FG028|STARTED|Overall Study||29||
48079095|NCT00042289|100515329|FG029|STARTED|Overall Study||25||
48079096|NCT00042289|100515330|FG030|STARTED|Overall Study||1||
48079097|NCT00042289|100515331|FG031|STARTED|Overall Study||35||
48079098|NCT00042289|100515332|FG032|STARTED|Overall Study||43||
48079099|NCT00042289|100515333|FG033|STARTED|Overall Study||16||
48079100|NCT00042289|100515334|FG034|STARTED|Overall Study||12||
48079101|NCT00042289|100515335|FG035|STARTED|Overall Study||32||
48079102|NCT00042289|100515336|FG036|STARTED|Overall Study||36||
48079103|NCT00042289|100515337|FG037|STARTED|Overall Study||38||
48079104|NCT00042289|100515338|FG038|STARTED|Overall Study||35||
48079105|NCT00042289|100515339|FG039|STARTED|Overall Study||18||
48079106|NCT00042289|100515340|FG040|STARTED|Overall Study||26||
48079107|NCT00042289|100515341|FG041|STARTED|Overall Study||25||
48079108|NCT00042289|100515342|FG042|STARTED|Overall Study||32||
48524740|NCT00975286|101620808|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||223||
48524741|NCT00975286|101620807|FG000|COMPLETED|Overall Study||211||
48524742|NCT00975286|101620808|FG001|COMPLETED|Overall Study||194||
48524743|NCT00975286|101620807|FG000|NOT COMPLETED|Overall Study||12||
48524744|NCT00975286|101620808|FG001|NOT COMPLETED|Overall Study||29||
48524745|NCT01366092|101620809|FG000|STARTED|Overall Study||35||
48079109|NCT00042289|100515343|FG043|STARTED|Overall Study||25||
48079110|NCT00042289|100515344|FG044|STARTED|Overall Study||27||
48524746|NCT01366092|101620809|FG000|COMPLETED|Overall Study||31||
48079111|NCT00042289|100515345|FG045|STARTED|Overall Study||27||
48079112|NCT00042289|100515346|FG046|STARTED|Overall Study||28||
48079113|NCT00042289|100515300|FG000|Infant Started|Overall Study||25||
48079114|NCT00042289|100515301|FG001|Infant Started|Overall Study||30||
48079115|NCT00042289|100515302|FG002|Infant Started|Overall Study||27||
48079116|NCT00042289|100515303|FG003|Infant Started|Overall Study||32||
48079117|NCT00042289|100515304|FG004|Infant Started|Overall Study||28||
48079118|NCT00042289|100515305|FG005|Infant Started|Overall Study||31||
48079119|NCT00042289|100515306|FG006|Infant Started|Overall Study||27||
48079120|NCT00042289|100515307|FG007|Infant Started|Overall Study||12||
48079121|NCT00042289|100515308|FG008|Infant Started|Overall Study||26||
48079122|NCT00042289|100515309|FG009|Infant Started|Overall Study||23||
48079123|NCT00042289|100515310|FG010|Infant Started|Overall Study||2||
48079124|NCT00042289|100515311|FG011|Infant Started|Overall Study||27||
48079125|NCT00042289|100515312|FG012|Infant Started|Overall Study||14||
48079126|NCT00042289|100515313|FG013|Infant Started|Overall Study||0||
48079127|NCT00042289|100515314|FG014|Infant Started|Overall Study||0||
48079128|NCT00042289|100515315|FG015|Infant Started|Overall Study||0||
48079129|NCT00042289|100515316|FG016|Infant Started|Overall Study||0||
48079130|NCT00042289|100515317|FG017|Infant Started|Overall Study||0||
48079131|NCT00042289|100515318|FG018|Infant Started|Overall Study||0||
48079132|NCT00042289|100515319|FG019|Infant Started|Overall Study||0||
48079133|NCT00042289|100515320|FG020|Infant Started|Overall Study||0||
48079134|NCT00042289|100515321|FG021|Infant Started|Overall Study||9||
48079135|NCT00042289|100515322|FG022|Infant Started|Overall Study||0||
48079136|NCT00042289|100515323|FG023|Infant Started|Overall Study||22||
48079137|NCT00042289|100515324|FG024|Infant Started|Overall Study||4||
48079138|NCT00042289|100515325|FG025|Infant Started|Overall Study||5||
48079139|NCT00042289|100515326|FG026|Infant Started|Overall Study||0||
48079140|NCT00042289|100515327|FG027|Infant Started|Overall Study||21||
48079141|NCT00042289|100515328|FG028|Infant Started|Overall Study||0||
48079142|NCT00042289|100515329|FG029|Infant Started|Overall Study||21||
48079143|NCT00042289|100515330|FG030|Infant Started|Overall Study||0||
48079144|NCT00042289|100515331|FG031|Infant Started|Overall Study||0||
48079145|NCT00042289|100515332|FG032|Infant Started|Overall Study||6||
48079146|NCT00042289|100515333|FG033|Infant Started|Overall Study||6||
48079147|NCT00042289|100515334|FG034|Infant Started|Overall Study||4||
48079148|NCT00042289|100515335|FG035|Infant Started|Overall Study||0||
48079149|NCT00042289|100515336|FG036|Infant Started|Overall Study||9||
48079150|NCT00042289|100515337|FG037|Infant Started|Overall Study||38||
48079151|NCT00042289|100515338|FG038|Infant Started|Overall Study||35||
48079152|NCT00042289|100515339|FG039|Infant Started|Overall Study||0||
48079153|NCT00042289|100515340|FG040|Infant Started|Overall Study||26||
48079154|NCT00042289|100515341|FG041|Infant Started|Overall Study||25||
48079155|NCT00042289|100515342|FG042|Infant Started|Overall Study||30||
48079156|NCT00042289|100515343|FG043|Infant Started|Overall Study||0||
48524747|NCT01366092|101620809|FG000|NOT COMPLETED|Overall Study||4||
48524748|NCT04796779|101620810|FG000|STARTED|Overall Study||68||
48524749|NCT04796779|101620811|FG001|STARTED|Overall Study||34||
48524750|NCT04796779|101620810|FG000|COMPLETED|Overall Study||67||
48524751|NCT04796779|101620811|FG001|COMPLETED|Overall Study||34||
48524752|NCT04796779|101620810|FG000|NOT COMPLETED|Overall Study||1||
48524753|NCT04796779|101620811|FG001|NOT COMPLETED|Overall Study||0||
48524754|NCT03161964|101620812|FG000|STARTED|Overall Study||1||
48524755|NCT03161964|101620813|FG001|STARTED|Overall Study||1||
48524756|NCT03161964|101620812|FG000|COMPLETED|Overall Study||1||
48524757|NCT03161964|101620813|FG001|COMPLETED|Overall Study||0||
48524758|NCT03161964|101620812|FG000|NOT COMPLETED|Overall Study||0||
48524759|NCT03161964|101620813|FG001|NOT COMPLETED|Overall Study||1||
48524760|NCT02244918|101620814|FG000|STARTED|Overall Study||185||
48524761|NCT02244918|101620815|FG001|STARTED|Overall Study||93||
48524762|NCT02244918|101620814|FG000|Week 12|Overall Study||160|End of Treatment|
48524763|NCT02244918|101620815|FG001|Week 12|Overall Study||83|End of Treatment|
48524764|NCT02244918|101620814|FG000|COMPLETED|Overall Study||185||
48524765|NCT02244918|101620815|FG001|COMPLETED|Overall Study||93||
48524766|NCT02244918|101620814|FG000|NOT COMPLETED|Overall Study||0||
48524767|NCT02244918|101620815|FG001|NOT COMPLETED|Overall Study||0||
48524768|NCT01576874|101620816|FG000|STARTED|Overall Study||72||
48524769|NCT01576874|101620817|FG001|STARTED|Overall Study||72||
48524770|NCT01576874|101620816|FG000|COMPLETED|Overall Study||72||
48524771|NCT01576874|101620817|FG001|COMPLETED|Overall Study||72||
48524772|NCT01576874|101620816|FG000|NOT COMPLETED|Overall Study||0||
48079157|NCT00042289|100515344|FG044|Infant Started|Overall Study||0||
48079158|NCT00042289|100515345|FG045|Infant Started|Overall Study||0||
48079159|NCT00042289|100515346|FG046|Infant Started|Overall Study||0||
48079160|NCT00042289|100515300|FG000|Infant Completed|Overall Study||21||
48079161|NCT00042289|100515301|FG001|Infant Completed|Overall Study||28||
48079162|NCT00042289|100515302|FG002|Infant Completed|Overall Study||27||
48079163|NCT00042289|100515303|FG003|Infant Completed|Overall Study||29||
48079164|NCT00042289|100515304|FG004|Infant Completed|Overall Study||26||
48079165|NCT00042289|100515305|FG005|Infant Completed|Overall Study||25||
48079166|NCT00042289|100515306|FG006|Infant Completed|Overall Study||26||
48079167|NCT00042289|100515307|FG007|Infant Completed|Overall Study||10||
48079168|NCT00042289|100515308|FG008|Infant Completed|Overall Study||25||
48079169|NCT00042289|100515309|FG009|Infant Completed|Overall Study||20||
48079170|NCT00042289|100515310|FG010|Infant Completed|Overall Study||2||
48079171|NCT00042289|100515311|FG011|Infant Completed|Overall Study||24||
48524773|NCT01576874|101620817|FG001|NOT COMPLETED|Overall Study||0||
48524774|NCT03667014|101620818|FG000|STARTED|Overall Study||34||
48524775|NCT03667014|101620818|FG000|COMPLETED|Overall Study||24||
48524776|NCT03667014|101620818|FG000|NOT COMPLETED|Overall Study||10||
48524777|NCT01252719|101620819|FG000|STARTED|Overall Study||483||
48524778|NCT01252719|101620820|FG001|STARTED|Overall Study||485||
48524779|NCT01252719|101620819|FG000|Modified Intent to Treat Population|Overall Study||475||
48524780|NCT01252719|101620820|FG001|Modified Intent to Treat Population|Overall Study||479||
48079172|NCT00042289|100515312|FG012|Infant Completed|Overall Study||11||
48524781|NCT01252719|101620819|FG000|COMPLETED|Overall Study||433||
48524782|NCT01252719|101620820|FG001|COMPLETED|Overall Study||423||
48524783|NCT01252719|101620819|FG000|NOT COMPLETED|Overall Study||50||
48524784|NCT01252719|101620820|FG001|NOT COMPLETED|Overall Study||62||
48524785|NCT04355663|101620821|FG000|STARTED|Overall Study||42||
48524786|NCT04355663|101620822|FG001|STARTED|Overall Study||29||
48524787|NCT04355663|101620823|FG002|STARTED|Overall Study||21||
48524788|NCT04355663|101620821|FG000|COMPLETED|Overall Study||40||
48524789|NCT04355663|101620822|FG001|COMPLETED|Overall Study||14||
48524790|NCT04355663|101620823|FG002|COMPLETED|Overall Study||17||
48524791|NCT04355663|101620821|FG000|NOT COMPLETED|Overall Study||2||
48524792|NCT04355663|101620822|FG001|NOT COMPLETED|Overall Study||15||
48079173|NCT00042289|100515313|FG013|Infant Completed|Overall Study||0||
48079174|NCT00042289|100515314|FG014|Infant Completed|Overall Study||0||
48079175|NCT00042289|100515315|FG015|Infant Completed|Overall Study||0||
48524793|NCT04355663|101620823|FG002|NOT COMPLETED|Overall Study||4||
48524794|NCT03001219|101620824|FG000|STARTED|Proof of Concept||37||
48524795|NCT03001219|101620825|FG001|STARTED|Proof of Concept||72||
48524796|NCT03001219|101620824|FG000|COMPLETED|Proof of Concept||35||
48524797|NCT03001219|101620825|FG001|COMPLETED|Proof of Concept||65||
48524798|NCT03001219|101620824|FG000|NOT COMPLETED|Proof of Concept||2||
48524799|NCT03001219|101620825|FG001|NOT COMPLETED|Proof of Concept||7||
48524800|NCT03001219|101620824|FG000|STARTED|Extension Period Analysis||9||
48524801|NCT03001219|101620825|FG001|STARTED|Extension Period Analysis||97||
48524802|NCT03001219|101620824|FG000|COMPLETED|Extension Period Analysis||4||
48524803|NCT03001219|101620825|FG001|COMPLETED|Extension Period Analysis||52||
48524804|NCT03001219|101620824|FG000|NOT COMPLETED|Extension Period Analysis||5||
48524805|NCT03001219|101620825|FG001|NOT COMPLETED|Extension Period Analysis||45||
48524806|NCT00511992|101620826|FG000|STARTED|Overall Study||20||
48524807|NCT00511992|101620826|FG000|COMPLETED|Overall Study||13||
48524808|NCT00511992|101620826|FG000|NOT COMPLETED|Overall Study||7||
48524809|NCT01699763|101620827|FG000|STARTED|Overall Study||112||
48524810|NCT01699763|101620827|FG000|COMPLETED|Overall Study||112||
48524811|NCT01699763|101620827|FG000|NOT COMPLETED|Overall Study||0||
48524812|NCT04146363|101620828|FG000|STARTED|Induction Period||141||
48524813|NCT04146363|101620829|FG001|STARTED|Induction Period||283||
48524814|NCT04146363|101620830|FG002|STARTED|Induction Period||0||
48524815|NCT04146363|101620831|FG003|STARTED|Induction Period||0||
48524816|NCT04146363|101620832|FG004|STARTED|Induction Period||0||
48524817|NCT04146363|101620833|FG005|STARTED|Induction Period||0||
48524818|NCT04146363|101620834|FG006|STARTED|Induction Period||0||
48524819|NCT04146363|101620835|FG007|STARTED|Induction Period||0||
48524820|NCT04146363|101620836|FG008|STARTED|Induction Period||0||
48524821|NCT04146363|101620837|FG009|STARTED|Induction Period||0||
48524822|NCT04146363|101620838|FG010|STARTED|Induction Period||0||
48524823|NCT04146363|101620828|FG000|Received at Least One Dose of Study Drug|Induction Period||141||
48524824|NCT04146363|101620829|FG001|Received at Least One Dose of Study Drug|Induction Period||282||
48524825|NCT04146363|101620830|FG002|Received at Least One Dose of Study Drug|Induction Period||0||
48524826|NCT04146363|101620831|FG003|Received at Least One Dose of Study Drug|Induction Period||0||
48524827|NCT04146363|101620832|FG004|Received at Least One Dose of Study Drug|Induction Period||0||
48524828|NCT04146363|101620833|FG005|Received at Least One Dose of Study Drug|Induction Period||0||
48079176|NCT00042289|100515316|FG016|Infant Completed|Overall Study||0||
48079177|NCT00042289|100515317|FG017|Infant Completed|Overall Study||0||
48079178|NCT00042289|100515318|FG018|Infant Completed|Overall Study||0||
48079179|NCT00042289|100515319|FG019|Infant Completed|Overall Study||0||
48079180|NCT00042289|100515320|FG020|Infant Completed|Overall Study||0||
48079181|NCT00042289|100515321|FG021|Infant Completed|Overall Study||9||
48079182|NCT00042289|100515322|FG022|Infant Completed|Overall Study||0||
48079183|NCT00042289|100515323|FG023|Infant Completed|Overall Study||20||
48079184|NCT00042289|100515324|FG024|Infant Completed|Overall Study||3||
48079185|NCT00042289|100515325|FG025|Infant Completed|Overall Study||5||
48079186|NCT00042289|100515326|FG026|Infant Completed|Overall Study||0||
48079187|NCT00042289|100515327|FG027|Infant Completed|Overall Study||20||
48079188|NCT00042289|100515328|FG028|Infant Completed|Overall Study||0||
48079189|NCT00042289|100515329|FG029|Infant Completed|Overall Study||21||
48079190|NCT00042289|100515330|FG030|Infant Completed|Overall Study||0||
48079191|NCT00042289|100515331|FG031|Infant Completed|Overall Study||0||
48079192|NCT00042289|100515332|FG032|Infant Completed|Overall Study||6||
48079193|NCT00042289|100515333|FG033|Infant Completed|Overall Study||4||
48079194|NCT00042289|100515334|FG034|Infant Completed|Overall Study||4||
48079195|NCT00042289|100515335|FG035|Infant Completed|Overall Study||0||
48524829|NCT04146363|101620834|FG006|Received at Least One Dose of Study Drug|Induction Period||0||
48524830|NCT04146363|101620835|FG007|Received at Least One Dose of Study Drug|Induction Period||0||
48524831|NCT04146363|101620836|FG008|Received at Least One Dose of Study Drug|Induction Period||0||
48524832|NCT04146363|101620837|FG009|Received at Least One Dose of Study Drug|Induction Period||0||
48524833|NCT04146363|101620838|FG010|Received at Least One Dose of Study Drug|Induction Period||0||
48524834|NCT04146363|101620828|FG000|COMPLETED|Induction Period||120||
48524835|NCT04146363|101620829|FG001|COMPLETED|Induction Period||263||
48524836|NCT04146363|101620830|FG002|COMPLETED|Induction Period||0||
48524837|NCT04146363|101620831|FG003|COMPLETED|Induction Period||0||
48524838|NCT04146363|101620832|FG004|COMPLETED|Induction Period||0||
48524839|NCT04146363|101620833|FG005|COMPLETED|Induction Period||0||
48524840|NCT04146363|101620834|FG006|COMPLETED|Induction Period||0||
48524841|NCT04146363|101620835|FG007|COMPLETED|Induction Period||0||
48524842|NCT04146363|101620836|FG008|COMPLETED|Induction Period||0||
48524843|NCT04146363|101620837|FG009|COMPLETED|Induction Period||0||
48524844|NCT04146363|101620838|FG010|COMPLETED|Induction Period||0||
48524845|NCT04146363|101620828|FG000|NOT COMPLETED|Induction Period||21||
48524846|NCT04146363|101620829|FG001|NOT COMPLETED|Induction Period||20||
48524847|NCT04146363|101620830|FG002|NOT COMPLETED|Induction Period||0||
48524848|NCT04146363|101620831|FG003|NOT COMPLETED|Induction Period||0||
48524849|NCT04146363|101620832|FG004|NOT COMPLETED|Induction Period||0||
48524850|NCT04146363|101620833|FG005|NOT COMPLETED|Induction Period||0||
48524851|NCT04146363|101620834|FG006|NOT COMPLETED|Induction Period||0||
48524852|NCT04146363|101620835|FG007|NOT COMPLETED|Induction Period||0||
48524853|NCT04146363|101620836|FG008|NOT COMPLETED|Induction Period||0||
48524854|NCT04146363|101620837|FG009|NOT COMPLETED|Induction Period||0||
48524855|NCT04146363|101620838|FG010|NOT COMPLETED|Induction Period||0||
48524856|NCT04146363|101620828|FG000|STARTED|Maintenance Blinded Treatment Period||0||
48079196|NCT00042289|100515336|FG036|Infant Completed|Overall Study||8||
48079197|NCT00042289|100515337|FG037|Infant Completed|Overall Study||35||
48524857|NCT04146363|101620829|FG001|STARTED|Maintenance Blinded Treatment Period||0||
48524858|NCT04146363|101620830|FG002|STARTED|Maintenance Blinded Treatment Period||4||
48524859|NCT04146363|101620831|FG003|STARTED|Maintenance Blinded Treatment Period||10||
48524860|NCT04146363|101620832|FG004|STARTED|Maintenance Blinded Treatment Period||10||
48079198|NCT00042289|100515338|FG038|Infant Completed|Overall Study||34||
48079199|NCT00042289|100515339|FG039|Infant Completed|Overall Study||0||
48524861|NCT04146363|101620833|FG005|STARTED|Maintenance Blinded Treatment Period||32||
48524862|NCT04146363|101620834|FG006|STARTED|Maintenance Blinded Treatment Period||63||
48524863|NCT04146363|101620835|FG007|STARTED|Maintenance Blinded Treatment Period||62||
48524864|NCT04146363|101620836|FG008|STARTED|Maintenance Blinded Treatment Period||0||
48524865|NCT04146363|101620837|FG009|STARTED|Maintenance Blinded Treatment Period||0||
48524866|NCT04146363|101620838|FG010|STARTED|Maintenance Blinded Treatment Period||0||
48524867|NCT04146363|101620828|FG000|COMPLETED|Maintenance Blinded Treatment Period||0||
48524868|NCT04146363|101620829|FG001|COMPLETED|Maintenance Blinded Treatment Period||0||
48524869|NCT04146363|101620830|FG002|COMPLETED|Maintenance Blinded Treatment Period||2||
48524870|NCT04146363|101620831|FG003|COMPLETED|Maintenance Blinded Treatment Period||10||
48524871|NCT04146363|101620832|FG004|COMPLETED|Maintenance Blinded Treatment Period||9||
48524872|NCT04146363|101620833|FG005|COMPLETED|Maintenance Blinded Treatment Period||22||
48524873|NCT04146363|101620834|FG006|COMPLETED|Maintenance Blinded Treatment Period||54||
48524874|NCT04146363|101620835|FG007|COMPLETED|Maintenance Blinded Treatment Period||48||
48524875|NCT04146363|101620836|FG008|COMPLETED|Maintenance Blinded Treatment Period||0||
48524876|NCT04146363|101620837|FG009|COMPLETED|Maintenance Blinded Treatment Period||0||
48524877|NCT04146363|101620838|FG010|COMPLETED|Maintenance Blinded Treatment Period||0||
48524878|NCT04146363|101620828|FG000|NOT COMPLETED|Maintenance Blinded Treatment Period||0||
48524879|NCT04146363|101620829|FG001|NOT COMPLETED|Maintenance Blinded Treatment Period||0||
48524880|NCT04146363|101620830|FG002|NOT COMPLETED|Maintenance Blinded Treatment Period||2||
48524881|NCT04146363|101620831|FG003|NOT COMPLETED|Maintenance Blinded Treatment Period||0||
48524882|NCT04146363|101620832|FG004|NOT COMPLETED|Maintenance Blinded Treatment Period||1||
48524883|NCT04146363|101620833|FG005|NOT COMPLETED|Maintenance Blinded Treatment Period||10||
48524884|NCT04146363|101620834|FG006|NOT COMPLETED|Maintenance Blinded Treatment Period||9||
48524885|NCT04146363|101620835|FG007|NOT COMPLETED|Maintenance Blinded Treatment Period||14||
48524886|NCT04146363|101620836|FG008|NOT COMPLETED|Maintenance Blinded Treatment Period||0||
48524887|NCT04146363|101620837|FG009|NOT COMPLETED|Maintenance Blinded Treatment Period||0||
48524888|NCT04146363|101620838|FG010|NOT COMPLETED|Maintenance Blinded Treatment Period||0||
48524889|NCT04146363|101620828|FG000|STARTED|Maintenance Open Label Escape Arm||0||
48524890|NCT04146363|101620829|FG001|STARTED|Maintenance Open Label Escape Arm||0||
48524891|NCT04146363|101620830|FG002|STARTED|Maintenance Open Label Escape Arm||0||
48524892|NCT04146363|101620831|FG003|STARTED|Maintenance Open Label Escape Arm||0||
48524893|NCT04146363|101620832|FG004|STARTED|Maintenance Open Label Escape Arm||0||
48079200|NCT00042289|100515340|FG040|Infant Completed|Overall Study||26||
48079201|NCT00042289|100515341|FG041|Infant Completed|Overall Study||21||
48079202|NCT00042289|100515342|FG042|Infant Completed|Overall Study||27||
48079203|NCT00042289|100515343|FG043|Infant Completed|Overall Study||0||
48079204|NCT00042289|100515344|FG044|Infant Completed|Overall Study||0||
48079205|NCT00042289|100515345|FG045|Infant Completed|Overall Study||0||
48079206|NCT00042289|100515346|FG046|Infant Completed|Overall Study||0||
48524894|NCT04146363|101620833|FG005|STARTED|Maintenance Open Label Escape Arm||0||
48524895|NCT04146363|101620834|FG006|STARTED|Maintenance Open Label Escape Arm||0||
48524896|NCT04146363|101620835|FG007|STARTED|Maintenance Open Label Escape Arm||0||
48079207|NCT00042289|100515300|FG000|COMPLETED|Overall Study||19||
48079208|NCT00042289|100515301|FG001|COMPLETED|Overall Study||29||
48079209|NCT00042289|100515302|FG002|COMPLETED|Overall Study||27||
48079210|NCT00042289|100515303|FG003|COMPLETED|Overall Study||25||
48079211|NCT00042289|100515304|FG004|COMPLETED|Overall Study||26||
48079212|NCT00042289|100515305|FG005|COMPLETED|Overall Study||25||
48079213|NCT00042289|100515306|FG006|COMPLETED|Overall Study||22||
48079214|NCT00042289|100515307|FG007|COMPLETED|Overall Study||10||
48079215|NCT00042289|100515308|FG008|COMPLETED|Overall Study||26||
48079216|NCT00042289|100515309|FG009|COMPLETED|Overall Study||23||
48079217|NCT00042289|100515310|FG010|COMPLETED|Overall Study||2||
48079218|NCT00042289|100515311|FG011|COMPLETED|Overall Study||27||
48079219|NCT00042289|100515312|FG012|COMPLETED|Overall Study||11||
48079220|NCT00042289|100515313|FG013|COMPLETED|Overall Study||2||
48524897|NCT04146363|101620836|FG008|STARTED|Maintenance Open Label Escape Arm||96||
48524898|NCT04146363|101620837|FG009|STARTED|Maintenance Open Label Escape Arm||106||
48524899|NCT04146363|101620838|FG010|STARTED|Maintenance Open Label Escape Arm||18||
48524900|NCT04146363|101620828|FG000|COMPLETED|Maintenance Open Label Escape Arm||0||
48524901|NCT04146363|101620829|FG001|COMPLETED|Maintenance Open Label Escape Arm||0||
48524902|NCT04146363|101620830|FG002|COMPLETED|Maintenance Open Label Escape Arm||0||
48524903|NCT04146363|101620831|FG003|COMPLETED|Maintenance Open Label Escape Arm||0||
48524904|NCT04146363|101620832|FG004|COMPLETED|Maintenance Open Label Escape Arm||0||
48524905|NCT04146363|101620833|FG005|COMPLETED|Maintenance Open Label Escape Arm||0||
48524906|NCT04146363|101620834|FG006|COMPLETED|Maintenance Open Label Escape Arm||0||
48079221|NCT00042289|100515314|FG014|COMPLETED|Overall Study||6||
48079222|NCT00042289|100515315|FG015|COMPLETED|Overall Study||28||
48079223|NCT00042289|100515316|FG016|COMPLETED|Overall Study||27||
48079224|NCT00042289|100515317|FG017|COMPLETED|Overall Study||12||
48079225|NCT00042289|100515318|FG018|COMPLETED|Overall Study||18||
48079226|NCT00042289|100515319|FG019|COMPLETED|Overall Study||13||
48079227|NCT00042289|100515320|FG020|COMPLETED|Overall Study||1||
48079228|NCT00042289|100515321|FG021|COMPLETED|Overall Study||26||
48079229|NCT00042289|100515322|FG022|COMPLETED|Overall Study||27||
48079230|NCT00042289|100515323|FG023|COMPLETED|Overall Study||17||
48079231|NCT00042289|100515324|FG024|COMPLETED|Overall Study||17||
48079232|NCT00042289|100515325|FG025|COMPLETED|Overall Study||20||
48079233|NCT00042289|100515326|FG026|COMPLETED|Overall Study||20||
48079234|NCT00042289|100515327|FG027|COMPLETED|Overall Study||22||
48079235|NCT00042289|100515328|FG028|COMPLETED|Overall Study||21||
48079236|NCT00042289|100515329|FG029|COMPLETED|Overall Study||25||
48079237|NCT00042289|100515330|FG030|COMPLETED|Overall Study||0||
48079238|NCT00042289|100515331|FG031|COMPLETED|Overall Study||26||
48079239|NCT00042289|100515332|FG032|COMPLETED|Overall Study||38||
48079240|NCT00042289|100515333|FG033|COMPLETED|Overall Study||10||
48079241|NCT00042289|100515334|FG034|COMPLETED|Overall Study||10||
48079242|NCT00042289|100515335|FG035|COMPLETED|Overall Study||27||
48079243|NCT00042289|100515336|FG036|COMPLETED|Overall Study||32||
48079244|NCT00042289|100515337|FG037|COMPLETED|Overall Study||36||
48079245|NCT00042289|100515338|FG038|COMPLETED|Overall Study||33||
48079246|NCT00042289|100515339|FG039|COMPLETED|Overall Study||13||
48079247|NCT00042289|100515340|FG040|COMPLETED|Overall Study||26||
48079248|NCT00042289|100515341|FG041|COMPLETED|Overall Study||22||
48079249|NCT00042289|100515342|FG042|COMPLETED|Overall Study||25||
48079250|NCT00042289|100515343|FG043|COMPLETED|Overall Study||22||
48079251|NCT00042289|100515344|FG044|COMPLETED|Overall Study||27||
48524907|NCT04146363|101620835|FG007|COMPLETED|Maintenance Open Label Escape Arm||0||
48524908|NCT04146363|101620836|FG008|COMPLETED|Maintenance Open Label Escape Arm||77||
48524909|NCT04146363|101620837|FG009|COMPLETED|Maintenance Open Label Escape Arm||77||
48524910|NCT04146363|101620838|FG010|COMPLETED|Maintenance Open Label Escape Arm||15||
48524911|NCT04146363|101620828|FG000|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
48524912|NCT04146363|101620829|FG001|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
48524913|NCT04146363|101620830|FG002|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
48524914|NCT04146363|101620831|FG003|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
48524915|NCT04146363|101620832|FG004|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
48524916|NCT04146363|101620833|FG005|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
48524917|NCT04146363|101620834|FG006|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
48524918|NCT04146363|101620835|FG007|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
48524919|NCT04146363|101620836|FG008|NOT COMPLETED|Maintenance Open Label Escape Arm||19||
48524920|NCT04146363|101620837|FG009|NOT COMPLETED|Maintenance Open Label Escape Arm||29||
48524921|NCT04146363|101620838|FG010|NOT COMPLETED|Maintenance Open Label Escape Arm||3||
48524922|NCT01408628|101620839|FG000|STARTED|Consented||51||
48524923|NCT01408628|101620839|FG000|COMPLETED|Consented||39||
48524924|NCT01408628|101620839|FG000|NOT COMPLETED|Consented||12||
48524925|NCT01408628|101620839|FG000|STARTED|Started Classes/Intervention||39||
48524926|NCT01408628|101620839|FG000|COMPLETED|Started Classes/Intervention||39||
48524927|NCT01408628|101620839|FG000|NOT COMPLETED|Started Classes/Intervention||0||
48524928|NCT01408628|101620839|FG000|STARTED|Completed 6 Month Follow-Up||39||
48524929|NCT01408628|101620839|FG000|COMPLETED|Completed 6 Month Follow-Up||25||
48524930|NCT01408628|101620839|FG000|NOT COMPLETED|Completed 6 Month Follow-Up||14||
48524931|NCT00262041|101620840|FG000|STARTED|Overall Study||164||
48524932|NCT00262041|101620841|FG001|STARTED|Overall Study||151||
48524933|NCT00262041|101620842|FG002|STARTED|Overall Study||209||
48524934|NCT00262041|101620840|FG000|COMPLETED|Overall Study||162||
48524935|NCT00262041|101620841|FG001|COMPLETED|Overall Study||147||
48524936|NCT00262041|101620842|FG002|COMPLETED|Overall Study||203||
48524937|NCT00262041|101620840|FG000|NOT COMPLETED|Overall Study||2||
48524938|NCT00262041|101620841|FG001|NOT COMPLETED|Overall Study||4||
48524939|NCT00262041|101620842|FG002|NOT COMPLETED|Overall Study||6||
48524940|NCT02548312|101620843|FG000|STARTED|Overall Study||133||
48524941|NCT02548312|101620844|FG001|STARTED|Overall Study||133||
48524942|NCT02548312|101620845|FG002|STARTED|Overall Study||134||
48524943|NCT02548312|101620846|FG003|STARTED|Overall Study||133||
48524944|NCT02548312|101620847|FG004|STARTED|Overall Study||133||
48524945|NCT02548312|101620848|FG005|STARTED|Overall Study||133||
48524946|NCT02548312|101620849|FG006|STARTED|Overall Study||133||
48524947|NCT02548312|101620850|FG007|STARTED|Overall Study||133||
48524948|NCT02548312|101620843|FG000|COMPLETED|Overall Study||100||
48524949|NCT02548312|101620844|FG001|COMPLETED|Overall Study||90||
48524950|NCT02548312|101620845|FG002|COMPLETED|Overall Study||96||
48524951|NCT02548312|101620846|FG003|COMPLETED|Overall Study||87||
48079252|NCT00042289|100515345|FG045|COMPLETED|Overall Study||26||
48079253|NCT00042289|100515346|FG046|COMPLETED|Overall Study||27||
48079254|NCT00042289|100515300|FG000|NOT COMPLETED|Overall Study||7||
48079255|NCT00042289|100515301|FG001|NOT COMPLETED|Overall Study||1||
48079256|NCT00042289|100515302|FG002|NOT COMPLETED|Overall Study||0||
48079257|NCT00042289|100515303|FG003|NOT COMPLETED|Overall Study||8||
48079258|NCT00042289|100515304|FG004|NOT COMPLETED|Overall Study||3||
48079259|NCT00042289|100515305|FG005|NOT COMPLETED|Overall Study||6||
48079260|NCT00042289|100515306|FG006|NOT COMPLETED|Overall Study||6||
48079261|NCT00042289|100515307|FG007|NOT COMPLETED|Overall Study||2||
48079262|NCT00042289|100515308|FG008|NOT COMPLETED|Overall Study||1||
48079263|NCT00042289|100515309|FG009|NOT COMPLETED|Overall Study||1||
48079264|NCT00042289|100515310|FG010|NOT COMPLETED|Overall Study||0||
48524952|NCT02548312|101620847|FG004|COMPLETED|Overall Study||99||
48079265|NCT00042289|100515311|FG011|NOT COMPLETED|Overall Study||0||
48079266|NCT00042289|100515312|FG012|NOT COMPLETED|Overall Study||2||
48524953|NCT02548312|101620848|FG005|COMPLETED|Overall Study||93||
48524954|NCT02548312|101620849|FG006|COMPLETED|Overall Study||93||
48524955|NCT02548312|101620850|FG007|COMPLETED|Overall Study||91||
48524956|NCT02548312|101620843|FG000|NOT COMPLETED|Overall Study||33||
48524957|NCT02548312|101620844|FG001|NOT COMPLETED|Overall Study||43||
48524958|NCT02548312|101620845|FG002|NOT COMPLETED|Overall Study||38||
48524959|NCT02548312|101620846|FG003|NOT COMPLETED|Overall Study||46||
48524960|NCT02548312|101620847|FG004|NOT COMPLETED|Overall Study||34||
48524961|NCT02548312|101620848|FG005|NOT COMPLETED|Overall Study||40||
48524962|NCT02548312|101620849|FG006|NOT COMPLETED|Overall Study||40||
48524963|NCT02548312|101620850|FG007|NOT COMPLETED|Overall Study||42||
48524964|NCT02070302|101620851|FG000|STARTED|Overall Study||5||
48524965|NCT02070302|101620852|FG001|STARTED|Overall Study||5||
48524966|NCT02070302|101620851|FG000|COMPLETED|Overall Study||5||
48524967|NCT02070302|101620852|FG001|COMPLETED|Overall Study||5||
48524968|NCT02070302|101620851|FG000|NOT COMPLETED|Overall Study||0||
48524969|NCT02070302|101620852|FG001|NOT COMPLETED|Overall Study||0||
48524970|NCT03096847|101620853|FG000|STARTED|Overall Study||319|participants who started treatment|
48524971|NCT03096847|101620854|FG001|STARTED|Overall Study||26|participants who started treatment|
48524972|NCT03096847|101620855|FG002|STARTED|Overall Study||157|participants who started treatment|
48524973|NCT03096847|101620853|FG000|Full Analysis Set|Overall Study||307||
48524974|NCT03096847|101620854|FG001|Full Analysis Set|Overall Study||26||
48079267|NCT00042289|100515313|FG013|NOT COMPLETED|Overall Study||0||
48079268|NCT00042289|100515314|FG014|NOT COMPLETED|Overall Study||0||
48079269|NCT00042289|100515315|FG015|NOT COMPLETED|Overall Study||1||
48079270|NCT00042289|100515316|FG016|NOT COMPLETED|Overall Study||1||
48079271|NCT00042289|100515317|FG017|NOT COMPLETED|Overall Study||0||
48079272|NCT00042289|100515318|FG018|NOT COMPLETED|Overall Study||8||
48079273|NCT00042289|100515319|FG019|NOT COMPLETED|Overall Study||4||
48079274|NCT00042289|100515320|FG020|NOT COMPLETED|Overall Study||0||
48079275|NCT00042289|100515321|FG021|NOT COMPLETED|Overall Study||4||
48079276|NCT00042289|100515322|FG022|NOT COMPLETED|Overall Study||2||
48079277|NCT00042289|100515323|FG023|NOT COMPLETED|Overall Study||5||
48524975|NCT03096847|101620855|FG002|Full Analysis Set|Overall Study||154||
48524976|NCT03096847|101620853|FG000|COMPLETED|Overall Study||100|Completed study|
48524977|NCT03096847|101620854|FG001|COMPLETED|Overall Study||6|Completed study|
48524978|NCT03096847|101620855|FG002|COMPLETED|Overall Study||19|Completed study|
48524979|NCT03096847|101620853|FG000|NOT COMPLETED|Overall Study||219||
48524980|NCT03096847|101620854|FG001|NOT COMPLETED|Overall Study||20||
48524981|NCT03096847|101620855|FG002|NOT COMPLETED|Overall Study||138||
48524982|NCT02138136|101620856|FG000|STARTED|Overall Study||419||
48524983|NCT02138136|101620856|FG000|Safety Analysis Set|Overall Study||419||
48524984|NCT02138136|101620856|FG000|Modified Intent to Treat (mITT)|Overall Study||418|One participant excluded for serious compliance issues with potential data integrity impact|
48524985|NCT02138136|101620856|FG000|COMPLETED|Overall Study||280||
48524986|NCT02138136|101620856|FG000|NOT COMPLETED|Overall Study||139||
48524987|NCT06141824|101620857|FG000|STARTED|Overall Study||1361||
48524988|NCT06141824|101620857|FG000|Evaluable COVID-19 Results|Overall Study||1229||
48524989|NCT06141824|101620857|FG000|Evaluable Flu A Results|Overall Study||1333||
48524990|NCT06141824|101620857|FG000|Evaluable Flu B Results|Overall Study||1332||
48524991|NCT06141824|101620857|FG000|COMPLETED|Overall Study||1361||
48524992|NCT06141824|101620857|FG000|NOT COMPLETED|Overall Study||0||
48524993|NCT02025751|101620858|FG000|STARTED|Overall Study||26||
48524994|NCT02025751|101620859|FG001|STARTED|Overall Study||27||
48524995|NCT02025751|101620858|FG000|COMPLETED|Overall Study||25||
48524996|NCT02025751|101620859|FG001|COMPLETED|Overall Study||24||
48524997|NCT02025751|101620858|FG000|NOT COMPLETED|Overall Study||1||
48524998|NCT02025751|101620859|FG001|NOT COMPLETED|Overall Study||3||
48524999|NCT01181271|101620860|FG000|STARTED|Autologous Transplant||42||
48525000|NCT01181271|101620860|FG000|COMPLETED|Autologous Transplant||42||
48079278|NCT00042289|100515324|FG024|NOT COMPLETED|Overall Study||1||
48079279|NCT00042289|100515325|FG025|NOT COMPLETED|Overall Study||1||
48079280|NCT00042289|100515326|FG026|NOT COMPLETED|Overall Study||8||
48079281|NCT00042289|100515327|FG027|NOT COMPLETED|Overall Study||3||
48079282|NCT00042289|100515328|FG028|NOT COMPLETED|Overall Study||8||
48079283|NCT00042289|100515329|FG029|NOT COMPLETED|Overall Study||0||
48079284|NCT00042289|100515330|FG030|NOT COMPLETED|Overall Study||1||
48079285|NCT00042289|100515331|FG031|NOT COMPLETED|Overall Study||9||
48079286|NCT00042289|100515332|FG032|NOT COMPLETED|Overall Study||5||
48079287|NCT00042289|100515333|FG033|NOT COMPLETED|Overall Study||6||
48079288|NCT00042289|100515334|FG034|NOT COMPLETED|Overall Study||2||
48079289|NCT00042289|100515335|FG035|NOT COMPLETED|Overall Study||5||
48079290|NCT00042289|100515336|FG036|NOT COMPLETED|Overall Study||4||
48079291|NCT00042289|100515337|FG037|NOT COMPLETED|Overall Study||2||
48525001|NCT01181271|101620860|FG000|NOT COMPLETED|Autologous Transplant||0||
48525002|NCT01181271|101620860|FG000|STARTED|Evaluation for Allogeneic Transplant||42||
48525003|NCT01181271|101620860|FG000|COMPLETED|Evaluation for Allogeneic Transplant||29||
48525004|NCT01181271|101620860|FG000|NOT COMPLETED|Evaluation for Allogeneic Transplant||13||
48525005|NCT01181271|101620860|FG000|STARTED|Allogeneic Transplant||29||
48525006|NCT01181271|101620860|FG000|COMPLETED|Allogeneic Transplant||29||
48592644|NCT01877382|101783161|FG011|COMPLETED|Dose Escalation||0||
48079292|NCT00042289|100515338|FG038|NOT COMPLETED|Overall Study||2||
48079293|NCT00042289|100515339|FG039|NOT COMPLETED|Overall Study||5||
48079294|NCT00042289|100515340|FG040|NOT COMPLETED|Overall Study||0||
48079295|NCT00042289|100515341|FG041|NOT COMPLETED|Overall Study||3||
48079296|NCT00042289|100515342|FG042|NOT COMPLETED|Overall Study||7||
48079297|NCT00042289|100515343|FG043|NOT COMPLETED|Overall Study||3||
48079298|NCT00042289|100515344|FG044|NOT COMPLETED|Overall Study||0||
48079299|NCT00042289|100515345|FG045|NOT COMPLETED|Overall Study||1||
48079300|NCT00042289|100515346|FG046|NOT COMPLETED|Overall Study||1||
48079301|NCT01594762|100515347|FG000|STARTED|Overall Study||97||
48525007|NCT01181271|101620860|FG000|NOT COMPLETED|Allogeneic Transplant||0||
48525008|NCT05713552|101620861|FG000|STARTED|Period 1||15||
48525009|NCT05713552|101620862|FG001|STARTED|Period 1||15||
48525010|NCT05713552|101620861|FG000|COMPLETED|Period 1||15||
48525011|NCT05713552|101620862|FG001|COMPLETED|Period 1||15||
48525012|NCT05713552|101620861|FG000|NOT COMPLETED|Period 1||0||
48525013|NCT05713552|101620862|FG001|NOT COMPLETED|Period 1||0||
48525014|NCT05713552|101620861|FG000|STARTED|Period 2||15||
48525015|NCT05713552|101620862|FG001|STARTED|Period 2||15||
48525016|NCT05713552|101620861|FG000|COMPLETED|Period 2||15||
48525017|NCT05713552|101620862|FG001|COMPLETED|Period 2||15||
48525018|NCT05713552|101620861|FG000|NOT COMPLETED|Period 2||0||
48525019|NCT05713552|101620862|FG001|NOT COMPLETED|Period 2||0||
48525020|NCT02792959|101620863|FG000|STARTED|Overall Study||11||
48525021|NCT02792959|101620863|FG000|COMPLETED|Overall Study||10||
48525022|NCT02792959|101620863|FG000|NOT COMPLETED|Overall Study||1||
48525023|NCT00996931|101620864|FG000|STARTED|Overall Study||6||
48525024|NCT00996931|101620864|FG000|COMPLETED|Overall Study||6||
48525025|NCT00996931|101620864|FG000|NOT COMPLETED|Overall Study||0||
48525026|NCT00608517|101620865|FG000|STARTED|Overall Study||2||
48525027|NCT00608517|101620866|FG001|STARTED|Overall Study||3||
48525028|NCT00608517|101620867|FG002|STARTED|Overall Study||1||
48525029|NCT00608517|101620865|FG000|COMPLETED|Overall Study||1||
48525030|NCT00608517|101620866|FG001|COMPLETED|Overall Study||3||
48525031|NCT00608517|101620867|FG002|COMPLETED|Overall Study||1||
48525032|NCT00608517|101620865|FG000|NOT COMPLETED|Overall Study||1||
48525033|NCT00608517|101620866|FG001|NOT COMPLETED|Overall Study||0||
48525034|NCT00608517|101620867|FG002|NOT COMPLETED|Overall Study||0||
48525035|NCT00321737|101620868|FG000|STARTED|Overall Study||147||
48525036|NCT00321737|101620869|FG001|STARTED|Overall Study||140||
48525037|NCT00321737|101620870|FG002|STARTED|Overall Study||158||
48525038|NCT00321737|101620868|FG000|COMPLETED|Overall Study||25||
48525039|NCT00321737|101620869|FG001|COMPLETED|Overall Study||92||
48525040|NCT00321737|101620870|FG002|COMPLETED|Overall Study||104||
48525041|NCT00321737|101620868|FG000|NOT COMPLETED|Overall Study||122||
48525042|NCT00321737|101620869|FG001|NOT COMPLETED|Overall Study||48||
48525043|NCT00321737|101620870|FG002|NOT COMPLETED|Overall Study||54||
48525044|NCT04397445|101620871|FG000|STARTED|Overall Study||5||
48525045|NCT04397445|101620872|FG001|STARTED|Overall Study||5||
48525046|NCT04397445|101620873|FG002|STARTED|Overall Study||4||
48525047|NCT04397445|101620874|FG003|STARTED|Overall Study||4||
48525048|NCT04397445|101620871|FG000|COMPLETED|Overall Study||4||
48525049|NCT04397445|101620872|FG001|COMPLETED|Overall Study||5||
48525050|NCT04397445|101620873|FG002|COMPLETED|Overall Study||4||
48525051|NCT04397445|101620874|FG003|COMPLETED|Overall Study||4||
48525052|NCT04397445|101620871|FG000|NOT COMPLETED|Overall Study||1||
48525053|NCT04397445|101620872|FG001|NOT COMPLETED|Overall Study||0||
48525054|NCT04397445|101620873|FG002|NOT COMPLETED|Overall Study||0||
48525055|NCT04397445|101620874|FG003|NOT COMPLETED|Overall Study||0||
48079302|NCT01594762|100515348|FG001|STARTED|Overall Study||103||
48079303|NCT01594762|100515347|FG000|COMPLETED|Overall Study||86||
48079304|NCT01594762|100515348|FG001|COMPLETED|Overall Study||93||
48079305|NCT01594762|100515347|FG000|NOT COMPLETED|Overall Study||11||
48079306|NCT01594762|100515348|FG001|NOT COMPLETED|Overall Study||10||
48079307|NCT03159195|100515349|FG000|STARTED|Overall Study||360||
48079308|NCT03159195|100515350|FG001|STARTED|Overall Study||292||
48079309|NCT03159195|100515349|FG000|COMPLETED|Overall Study||360||
48079310|NCT03159195|100515350|FG001|COMPLETED|Overall Study||292||
48525056|NCT03918109|101620875|FG000|STARTED|Overall Study||6||
48525057|NCT03918109|101620876|FG001|STARTED|Overall Study||2||
48525058|NCT03918109|101620877|FG002|STARTED|Overall Study||17||
48525059|NCT03918109|101620878|FG003|STARTED|Overall Study||18||
48525060|NCT03918109|101620875|FG000|COMPLETED|Overall Study||6||
48525061|NCT03918109|101620876|FG001|COMPLETED|Overall Study||2||
48525062|NCT03918109|101620877|FG002|COMPLETED|Overall Study||15||
48525063|NCT03918109|101620878|FG003|COMPLETED|Overall Study||16||
48525064|NCT03918109|101620875|FG000|NOT COMPLETED|Overall Study||0||
48525065|NCT03918109|101620876|FG001|NOT COMPLETED|Overall Study||0||
48525066|NCT03918109|101620877|FG002|NOT COMPLETED|Overall Study||2||
48525067|NCT03918109|101620878|FG003|NOT COMPLETED|Overall Study||2||
48525068|NCT03346070|101620879|FG000|STARTED|Overall Study||41||
48525069|NCT03346070|101620880|FG001|STARTED|Overall Study||41||
48525070|NCT03346070|101620881|FG002|STARTED|Overall Study||41||
48525071|NCT03346070|101620882|FG003|STARTED|Overall Study||42||
48525072|NCT03346070|101620883|FG004|STARTED|Overall Study||42||
48525073|NCT03346070|101620879|FG000|Treated|Overall Study||38||
48525074|NCT03346070|101620880|FG001|Treated|Overall Study||38||
48525075|NCT03346070|101620881|FG002|Treated|Overall Study||38||
48525076|NCT03346070|101620882|FG003|Treated|Overall Study||36||
48525077|NCT03346070|101620883|FG004|Treated|Overall Study||38||
48525078|NCT03346070|101620879|FG000|COMPLETED|Overall Study||38||
48525079|NCT03346070|101620880|FG001|COMPLETED|Overall Study||37||
48525080|NCT03346070|101620881|FG002|COMPLETED|Overall Study||37||
48525081|NCT03346070|101620882|FG003|COMPLETED|Overall Study||36||
48525082|NCT03346070|101620883|FG004|COMPLETED|Overall Study||37||
48525083|NCT03346070|101620879|FG000|NOT COMPLETED|Overall Study||3||
48525084|NCT03346070|101620880|FG001|NOT COMPLETED|Overall Study||4||
48525085|NCT03346070|101620881|FG002|NOT COMPLETED|Overall Study||4||
48525086|NCT03346070|101620882|FG003|NOT COMPLETED|Overall Study||6||
48525087|NCT03346070|101620883|FG004|NOT COMPLETED|Overall Study||5||
48525088|NCT01386684|101620884|FG000|STARTED|Overall Study||552||
48525089|NCT01386684|101620884|FG000|COMPLETED|Overall Study||259||
48525090|NCT01386684|101620884|FG000|NOT COMPLETED|Overall Study||293||
48525091|NCT00408564|101620885|FG000|STARTED|Overall Study||39||
48525092|NCT00408564|101620885|FG000|COMPLETED|Overall Study||39||
48525093|NCT00408564|101620885|FG000|NOT COMPLETED|Overall Study||0||
48525094|NCT03218163|101620886|FG000|STARTED|Overall Study||0||
48525095|NCT03218163|101620886|FG000|COMPLETED|Overall Study||0||
48525096|NCT03218163|101620886|FG000|NOT COMPLETED|Overall Study||0||
48525097|NCT03533374|101620887|FG000|STARTED|Overall Study||54||
48525098|NCT03533374|101620888|FG001|STARTED|Overall Study||46||
48525099|NCT03533374|101620887|FG000|COMPLETED|Overall Study||54||
48525100|NCT03533374|101620888|FG001|COMPLETED|Overall Study||46||
48525101|NCT03533374|101620887|FG000|NOT COMPLETED|Overall Study||0||
48525102|NCT03533374|101620888|FG001|NOT COMPLETED|Overall Study||0||
48525103|NCT03118570|101620889|FG000|STARTED|Overall Study||31||
48525104|NCT03118570|101620890|FG001|STARTED|Overall Study||29||
48525105|NCT03118570|101620891|FG002|STARTED|Overall Study||30||
48525106|NCT03118570|101620892|FG003|STARTED|Overall Study||2||
48525107|NCT03118570|101620893|FG004|STARTED|Overall Study||20||
48525108|NCT03118570|101620889|FG000|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||0||
48525109|NCT03118570|101620890|FG001|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||0||
48525110|NCT03118570|101620891|FG002|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||0||
48525111|NCT03118570|101620892|FG003|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||0||
48525112|NCT03118570|101620893|FG004|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||19||
48525113|NCT03118570|101620889|FG000|COMPLETED|Overall Study||26||
48525114|NCT03118570|101620890|FG001|COMPLETED|Overall Study||22||
48525115|NCT03118570|101620891|FG002|COMPLETED|Overall Study||25||
48525116|NCT03118570|101620892|FG003|COMPLETED|Overall Study||2||
48525117|NCT03118570|101620893|FG004|COMPLETED|Overall Study||15||
48525118|NCT03118570|101620889|FG000|NOT COMPLETED|Overall Study||5||
48525119|NCT03118570|101620890|FG001|NOT COMPLETED|Overall Study||7||
48525120|NCT03118570|101620891|FG002|NOT COMPLETED|Overall Study||5||
48525121|NCT03118570|101620892|FG003|NOT COMPLETED|Overall Study||0||
48525122|NCT03118570|101620893|FG004|NOT COMPLETED|Overall Study||5||
48525123|NCT03649412|101620894|FG000|STARTED|Part A, Period 1 (4 Days)||16||
48525124|NCT03649412|101620895|FG001|STARTED|Part A, Period 1 (4 Days)||0||
48525125|NCT03649412|101620894|FG000|COMPLETED|Part A, Period 1 (4 Days)||16||
48525126|NCT03649412|101620895|FG001|COMPLETED|Part A, Period 1 (4 Days)||0||
48525127|NCT03649412|101620894|FG000|NOT COMPLETED|Part A, Period 1 (4 Days)||0||
48525128|NCT03649412|101620895|FG001|NOT COMPLETED|Part A, Period 1 (4 Days)||0||
48525129|NCT03649412|101620894|FG000|STARTED|Part A, Washout Period 1 (7 Days)||16||
48525130|NCT03649412|101620895|FG001|STARTED|Part A, Washout Period 1 (7 Days)||0||
48525131|NCT03649412|101620894|FG000|COMPLETED|Part A, Washout Period 1 (7 Days)||15||
48525132|NCT03649412|101620895|FG001|COMPLETED|Part A, Washout Period 1 (7 Days)||0||
48525133|NCT03649412|101620894|FG000|NOT COMPLETED|Part A, Washout Period 1 (7 Days)||1||
48525134|NCT03649412|101620895|FG001|NOT COMPLETED|Part A, Washout Period 1 (7 Days)||0||
48525135|NCT03649412|101620894|FG000|STARTED|Part A, Period 2 (3 Days)||16||
48525136|NCT03649412|101620895|FG001|STARTED|Part A, Period 2 (3 Days)||0||
48525137|NCT03649412|101620894|FG000|COMPLETED|Part A, Period 2 (3 Days)||16||
48525138|NCT03649412|101620895|FG001|COMPLETED|Part A, Period 2 (3 Days)||0||
48525139|NCT03649412|101620894|FG000|NOT COMPLETED|Part A, Period 2 (3 Days)||0||
48525140|NCT03649412|101620895|FG001|NOT COMPLETED|Part A, Period 2 (3 Days)||0||
48525141|NCT03649412|101620894|FG000|STARTED|Part A, Washout Period 2 (7 Days)||16||
48525142|NCT03649412|101620895|FG001|STARTED|Part A, Washout Period 2 (7 Days)||0||
48525143|NCT03649412|101620894|FG000|COMPLETED|Part A, Washout Period 2 (7 Days)||16||
48525144|NCT03649412|101620895|FG001|COMPLETED|Part A, Washout Period 2 (7 Days)||0||
48525145|NCT03649412|101620894|FG000|NOT COMPLETED|Part A, Washout Period 2 (7 Days)||0||
48525146|NCT03649412|101620895|FG001|NOT COMPLETED|Part A, Washout Period 2 (7 Days)||0||
48525147|NCT03649412|101620894|FG000|STARTED|Part A, Period 3 (4 Days)||16||
48525148|NCT03649412|101620895|FG001|STARTED|Part A, Period 3 (4 Days)||0||
48525149|NCT03649412|101620894|FG000|COMPLETED|Part A, Period 3 (4 Days)||16||
48525150|NCT03649412|101620895|FG001|COMPLETED|Part A, Period 3 (4 Days)||0||
48525151|NCT03649412|101620894|FG000|NOT COMPLETED|Part A, Period 3 (4 Days)||0||
48525152|NCT03649412|101620895|FG001|NOT COMPLETED|Part A, Period 3 (4 Days)||0||
48525153|NCT03649412|101620894|FG000|STARTED|Part A, Washout Period 3 (7 Days)||16||
48525154|NCT03649412|101620895|FG001|STARTED|Part A, Washout Period 3 (7 Days)||0||
48525155|NCT03649412|101620894|FG000|COMPLETED|Part A, Washout Period 3 (7 Days)||16||
48525156|NCT03649412|101620895|FG001|COMPLETED|Part A, Washout Period 3 (7 Days)||0||
48525157|NCT03649412|101620894|FG000|NOT COMPLETED|Part A, Washout Period 3 (7 Days)||0||
48525158|NCT03649412|101620895|FG001|NOT COMPLETED|Part A, Washout Period 3 (7 Days)||0||
48525159|NCT03649412|101620894|FG000|STARTED|Part A, Period 4 (4 Days)||16||
48525160|NCT03649412|101620895|FG001|STARTED|Part A, Period 4 (4 Days)||0||
48525161|NCT03649412|101620894|FG000|COMPLETED|Part A, Period 4 (4 Days)||16||
48525162|NCT03649412|101620895|FG001|COMPLETED|Part A, Period 4 (4 Days)||0||
48525163|NCT03649412|101620894|FG000|NOT COMPLETED|Part A, Period 4 (4 Days)||0||
48525164|NCT03649412|101620895|FG001|NOT COMPLETED|Part A, Period 4 (4 Days)||0||
48525165|NCT03649412|101620894|FG000|STARTED|Part A, Washout Period 4 (7 Days)||16||
48525166|NCT03649412|101620895|FG001|STARTED|Part A, Washout Period 4 (7 Days)||0||
48525167|NCT03649412|101620894|FG000|COMPLETED|Part A, Washout Period 4 (7 Days)||14||
48525168|NCT03649412|101620895|FG001|COMPLETED|Part A, Washout Period 4 (7 Days)||0||
48525169|NCT03649412|101620894|FG000|NOT COMPLETED|Part A, Washout Period 4 (7 Days)||2||
48525170|NCT03649412|101620895|FG001|NOT COMPLETED|Part A, Washout Period 4 (7 Days)||0||
48525171|NCT03649412|101620894|FG000|STARTED|Part A, Period 5 (4 Days)||12||
48525172|NCT03649412|101620895|FG001|STARTED|Part A, Period 5 (4 Days)||0||
48525173|NCT03649412|101620894|FG000|COMPLETED|Part A, Period 5 (4 Days)||12||
48525174|NCT03649412|101620895|FG001|COMPLETED|Part A, Period 5 (4 Days)||0||
48525175|NCT03649412|101620894|FG000|NOT COMPLETED|Part A, Period 5 (4 Days)||0||
48525176|NCT03649412|101620895|FG001|NOT COMPLETED|Part A, Period 5 (4 Days)||0||
48525177|NCT03649412|101620894|FG000|STARTED|Part A, Washout Period 5 (7 Days)||12||
48525178|NCT03649412|101620895|FG001|STARTED|Part A, Washout Period 5 (7 Days)||0||
48525179|NCT03649412|101620894|FG000|COMPLETED|Part A, Washout Period 5 (7 Days)||11||
48525180|NCT03649412|101620895|FG001|COMPLETED|Part A, Washout Period 5 (7 Days)||0||
48525181|NCT03649412|101620894|FG000|NOT COMPLETED|Part A, Washout Period 5 (7 Days)||1||
48525182|NCT03649412|101620895|FG001|NOT COMPLETED|Part A, Washout Period 5 (7 Days)||0||
48525183|NCT03649412|101620894|FG000|STARTED|Part A, Period 6 (4 Days)||12||
48525184|NCT03649412|101620895|FG001|STARTED|Part A, Period 6 (4 Days)||0||
48525185|NCT03649412|101620894|FG000|COMPLETED|Part A, Period 6 (4 Days)||12||
48525186|NCT03649412|101620895|FG001|COMPLETED|Part A, Period 6 (4 Days)||0||
48525187|NCT03649412|101620894|FG000|NOT COMPLETED|Part A, Period 6 (4 Days)||0||
48525188|NCT03649412|101620895|FG001|NOT COMPLETED|Part A, Period 6 (4 Days)||0||
48525189|NCT03649412|101620894|FG000|STARTED|Part B, Period 1 (4 Days)||0||
48525190|NCT03649412|101620895|FG001|STARTED|Part B, Period 1 (4 Days)||16||
48525191|NCT03649412|101620894|FG000|COMPLETED|Part B, Period 1 (4 Days)||0||
48525192|NCT03649412|101620895|FG001|COMPLETED|Part B, Period 1 (4 Days)||16||
48525193|NCT03649412|101620894|FG000|NOT COMPLETED|Part B, Period 1 (4 Days)||0||
48525194|NCT03649412|101620895|FG001|NOT COMPLETED|Part B, Period 1 (4 Days)||0||
48525195|NCT03649412|101620894|FG000|STARTED|Part B, Washout Period 1 (7 Days)||0||
48525196|NCT03649412|101620895|FG001|STARTED|Part B, Washout Period 1 (7 Days)||16||
48525197|NCT03649412|101620894|FG000|COMPLETED|Part B, Washout Period 1 (7 Days)||0||
48525198|NCT03649412|101620895|FG001|COMPLETED|Part B, Washout Period 1 (7 Days)||15||
48525199|NCT03649412|101620894|FG000|NOT COMPLETED|Part B, Washout Period 1 (7 Days)||0||
48525200|NCT03649412|101620895|FG001|NOT COMPLETED|Part B, Washout Period 1 (7 Days)||1||
48525201|NCT03649412|101620894|FG000|STARTED|Part B, Period 2 (4 Days)||0||
48525202|NCT03649412|101620895|FG001|STARTED|Part B, Period 2 (4 Days)||15||
48525203|NCT03649412|101620894|FG000|COMPLETED|Part B, Period 2 (4 Days)||0||
48525204|NCT03649412|101620895|FG001|COMPLETED|Part B, Period 2 (4 Days)||15||
48525205|NCT03649412|101620894|FG000|NOT COMPLETED|Part B, Period 2 (4 Days)||0||
48525206|NCT03649412|101620895|FG001|NOT COMPLETED|Part B, Period 2 (4 Days)||0||
48525207|NCT03649412|101620894|FG000|STARTED|Part B, Washout Period 2 (7 Days)||0||
48525208|NCT03649412|101620895|FG001|STARTED|Part B, Washout Period 2 (7 Days)||15||
48525209|NCT03649412|101620894|FG000|COMPLETED|Part B, Washout Period 2 (7 Days)||0||
48525210|NCT03649412|101620895|FG001|COMPLETED|Part B, Washout Period 2 (7 Days)||15||
48525211|NCT03649412|101620894|FG000|NOT COMPLETED|Part B, Washout Period 2 (7 Days)||0||
48525212|NCT03649412|101620895|FG001|NOT COMPLETED|Part B, Washout Period 2 (7 Days)||0||
48525213|NCT03649412|101620894|FG000|STARTED|Part B, Period 3 (4 Days)||0||
48525214|NCT03649412|101620895|FG001|STARTED|Part B, Period 3 (4 Days)||15||
48525215|NCT03649412|101620894|FG000|COMPLETED|Part B, Period 3 (4 Days)||0||
48525216|NCT03649412|101620895|FG001|COMPLETED|Part B, Period 3 (4 Days)||15||
48525217|NCT03649412|101620894|FG000|NOT COMPLETED|Part B, Period 3 (4 Days)||0||
48525218|NCT03649412|101620895|FG001|NOT COMPLETED|Part B, Period 3 (4 Days)||0||
48525219|NCT03649412|101620894|FG000|STARTED|Part B, Washout Period 3 (7 Days)||0||
48525220|NCT03649412|101620895|FG001|STARTED|Part B, Washout Period 3 (7 Days)||15||
48525221|NCT03649412|101620894|FG000|COMPLETED|Part B, Washout Period 3 (7 Days)||0||
48525222|NCT03649412|101620895|FG001|COMPLETED|Part B, Washout Period 3 (7 Days)||15||
48525223|NCT03649412|101620894|FG000|NOT COMPLETED|Part B, Washout Period 3 (7 Days)||0||
48525224|NCT03649412|101620895|FG001|NOT COMPLETED|Part B, Washout Period 3 (7 Days)||0||
48079311|NCT03159195|100515349|FG000|NOT COMPLETED|Overall Study||0||
48525225|NCT03649412|101620894|FG000|STARTED|Part B, Period 4 (4 Days)||0||
48525226|NCT03649412|101620895|FG001|STARTED|Part B, Period 4 (4 Days)||15||
48525227|NCT03649412|101620894|FG000|COMPLETED|Part B, Period 4 (4 Days)||0||
48525228|NCT03649412|101620895|FG001|COMPLETED|Part B, Period 4 (4 Days)||15||
48525229|NCT03649412|101620894|FG000|NOT COMPLETED|Part B, Period 4 (4 Days)||0||
48525230|NCT03649412|101620895|FG001|NOT COMPLETED|Part B, Period 4 (4 Days)||0||
48525231|NCT03649412|101620894|FG000|STARTED|Part B, Washout Period 4 (7 Days)||0||
48525232|NCT03649412|101620895|FG001|STARTED|Part B, Washout Period 4 (7 Days)||15||
48525233|NCT03649412|101620894|FG000|COMPLETED|Part B, Washout Period 4 (7 Days)||0||
48525234|NCT03649412|101620895|FG001|COMPLETED|Part B, Washout Period 4 (7 Days)||15||
48525235|NCT03649412|101620894|FG000|NOT COMPLETED|Part B, Washout Period 4 (7 Days)||0||
48525236|NCT03649412|101620895|FG001|NOT COMPLETED|Part B, Washout Period 4 (7 Days)||0||
48525237|NCT03649412|101620894|FG000|STARTED|Part B, Period 5 (4 Days)||0||
48525238|NCT03649412|101620895|FG001|STARTED|Part B, Period 5 (4 Days)||14||
48525239|NCT03649412|101620894|FG000|COMPLETED|Part B, Period 5 (4 Days)||0||
48525240|NCT03649412|101620895|FG001|COMPLETED|Part B, Period 5 (4 Days)||14||
48525241|NCT03649412|101620894|FG000|NOT COMPLETED|Part B, Period 5 (4 Days)||0||
48525242|NCT03649412|101620895|FG001|NOT COMPLETED|Part B, Period 5 (4 Days)||0||
48525243|NCT03649412|101620894|FG000|STARTED|Part B, Washout Period 5 (7 Days)||0||
48525244|NCT03649412|101620895|FG001|STARTED|Part B, Washout Period 5 (7 Days)||14||
48525245|NCT03649412|101620894|FG000|COMPLETED|Part B, Washout Period 5 (7 Days)||0||
48525246|NCT03649412|101620895|FG001|COMPLETED|Part B, Washout Period 5 (7 Days)||13||
48525247|NCT03649412|101620894|FG000|NOT COMPLETED|Part B, Washout Period 5 (7 Days)||0||
48525248|NCT03649412|101620895|FG001|NOT COMPLETED|Part B, Washout Period 5 (7 Days)||1||
48525249|NCT03649412|101620894|FG000|STARTED|Part B, Period 6 (4days)||0||
48525250|NCT03649412|101620895|FG001|STARTED|Part B, Period 6 (4days)||14||
48525251|NCT03649412|101620894|FG000|COMPLETED|Part B, Period 6 (4days)||0||
48525252|NCT03649412|101620895|FG001|COMPLETED|Part B, Period 6 (4days)||14||
48525253|NCT03649412|101620894|FG000|NOT COMPLETED|Part B, Period 6 (4days)||0||
48079312|NCT03159195|100515350|FG001|NOT COMPLETED|Overall Study||0||
48079313|NCT02478632|100515351|FG000|STARTED|Early Switch Phase (Up to Week 52)||53||
48079314|NCT02478632|100515352|FG001|STARTED|Early Switch Phase (Up to Week 52)||49||
48079315|NCT02478632|100515351|FG000|COMPLETED|Early Switch Phase (Up to Week 52)||49||
48079316|NCT02478632|100515352|FG001|COMPLETED|Early Switch Phase (Up to Week 52)||44||
48079317|NCT02478632|100515351|FG000|NOT COMPLETED|Early Switch Phase (Up to Week 52)||4||
48079318|NCT02478632|100515352|FG001|NOT COMPLETED|Early Switch Phase (Up to Week 52)||5||
48079319|NCT02478632|100515351|FG000|STARTED|Late Switch Phase (Week 52 to Week 148)||49||
48079320|NCT02478632|100515352|FG001|STARTED|Late Switch Phase (Week 52 to Week 148)||44||
48079321|NCT02478632|100515351|FG000|COMPLETED|Late Switch Phase (Week 52 to Week 148)||42||
48079322|NCT02478632|100515352|FG001|COMPLETED|Late Switch Phase (Week 52 to Week 148)||40||
48079323|NCT02478632|100515351|FG000|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||7||
48079324|NCT02478632|100515352|FG001|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||4||
48079325|NCT05059600|100515353|FG000|STARTED|Overall Study||52||
48079326|NCT05059600|100515353|FG000|Treated|Overall Study||42||
48079327|NCT05059600|100515353|FG000|COMPLETED|Overall Study||42||
48079328|NCT05059600|100515353|FG000|NOT COMPLETED|Overall Study||10||
48079329|NCT03736447|100515354|FG000|STARTED|Overall Study||98||
48079330|NCT03736447|100515355|FG001|STARTED|Overall Study||48||
48079331|NCT03736447|100515354|FG000|COMPLETED|Overall Study||83||
48079332|NCT03736447|100515355|FG001|COMPLETED|Overall Study||45||
48079333|NCT03736447|100515354|FG000|NOT COMPLETED|Overall Study||15||
48079334|NCT03736447|100515355|FG001|NOT COMPLETED|Overall Study||3||
48525254|NCT03649412|101620895|FG001|NOT COMPLETED|Part B, Period 6 (4days)||0||
48525255|NCT04209205|101620896|FG000|STARTED|Overall Study||191||
48525256|NCT04209205|101620897|FG001|STARTED|Overall Study||190||
48525257|NCT04209205|101620896|FG000|COMPLETED|Overall Study||173||
48525258|NCT04209205|101620897|FG001|COMPLETED|Overall Study||167||
48525259|NCT04209205|101620896|FG000|NOT COMPLETED|Overall Study||18||
48525260|NCT04209205|101620897|FG001|NOT COMPLETED|Overall Study||23||
48525261|NCT01215513|101620898|FG000|STARTED|Overall Study||157||
48525262|NCT01215513|101620898|FG000|CS42 and CS42A Safety Analysis Set|Overall Study||156||
48525263|NCT01215513|101620898|FG000|CS42 and CS42A Full Analysis Set|Overall Study||155||
48525264|NCT01215513|101620898|FG000|CS42A Safety Analysis Set|Overall Study||127||
48525265|NCT01215513|101620898|FG000|COMPLETED|Overall Study||112||
48525266|NCT01215513|101620898|FG000|NOT COMPLETED|Overall Study||45||
48079335|NCT00612040|100515356|FG000|STARTED|Overall Study||60||
48079336|NCT00612040|100515357|FG001|STARTED|Overall Study||59||
48079337|NCT00612040|100515358|FG002|STARTED|Overall Study||59||
48079338|NCT00612040|100515356|FG000|Exposed|Overall Study||60||
48079339|NCT00612040|100515357|FG001|Exposed|Overall Study||59||
48079340|NCT00612040|100515358|FG002|Exposed|Overall Study||59||
48079341|NCT00612040|100515356|FG000|COMPLETED|Overall Study||55||
48079342|NCT00612040|100515357|FG001|COMPLETED|Overall Study||52||
48079343|NCT00612040|100515358|FG002|COMPLETED|Overall Study||52||
48079344|NCT00612040|100515356|FG000|NOT COMPLETED|Overall Study||5||
48079345|NCT00612040|100515357|FG001|NOT COMPLETED|Overall Study||7||
48525267|NCT05307887|101620899|FG000|STARTED|Overall Study||41||
48525268|NCT05307887|101620900|FG001|STARTED|Overall Study||42||
48525269|NCT05307887|101620899|FG000|COMPLETED|Overall Study||41||
48525270|NCT05307887|101620900|FG001|COMPLETED|Overall Study||42||
48525271|NCT05307887|101620899|FG000|NOT COMPLETED|Overall Study||0||
48525272|NCT05307887|101620900|FG001|NOT COMPLETED|Overall Study||0||
48525273|NCT03185013|101620901|FG000|STARTED|Overall Study||138||
48525274|NCT03185013|101620902|FG001|STARTED|Overall Study||63||
48525275|NCT03185013|101620901|FG000|Intent-to-Treat (ITT) Population|Overall Study||138|ITT population included all participants who were randomized.|
48525276|NCT03185013|101620902|FG001|Intent-to-Treat (ITT) Population|Overall Study||63|ITT population included all participants who were randomized.|
48525277|NCT03185013|101620901|FG000|Modified ITT (mITT) Population|Overall Study||134|mITT population included all participants who received at least one dose of clinical trial treatment and who had the analysis endpoint of interest.|
48525278|NCT03185013|101620902|FG001|Modified ITT (mITT) Population|Overall Study||63|mITT population included all participants who received at least one dose of clinical trial treatment and who had the analysis endpoint of interest.|
48525279|NCT03185013|101620901|FG000|Safety Population|Overall Study||136|Safety set included all participants who received at least one dose of clinical trial treatment.|
48525280|NCT03185013|101620902|FG001|Safety Population|Overall Study||63|Safety set included all participants who received at least one dose of clinical trial treatment.|
48525281|NCT03185013|101620901|FG000|COMPLETED|Overall Study||116||
48525282|NCT03185013|101620902|FG001|COMPLETED|Overall Study||56||
48525283|NCT03185013|101620901|FG000|NOT COMPLETED|Overall Study||22||
48525284|NCT03185013|101620902|FG001|NOT COMPLETED|Overall Study||7||
48525285|NCT03301532|101620903|FG000|STARTED|Overall Study||10||
48525286|NCT03301532|101620903|FG000|COMPLETED|Overall Study||10||
48525287|NCT03301532|101620903|FG000|NOT COMPLETED|Overall Study||0||
48525288|NCT03375294|101620904|FG000|STARTED|Overall Study||3||
48525289|NCT03375294|101620904|FG000|COMPLETED|Overall Study||3||
48525290|NCT03375294|101620904|FG000|NOT COMPLETED|Overall Study||0||
48525291|NCT00311311|101620905|FG000|STARTED|Overall Study||37||
48525292|NCT00311311|101620906|FG001|STARTED|Overall Study||35||
48525293|NCT00311311|101620905|FG000|COMPLETED|Overall Study||29||
48525294|NCT00311311|101620906|FG001|COMPLETED|Overall Study||26||
48525295|NCT00311311|101620905|FG000|NOT COMPLETED|Overall Study||8||
48525296|NCT00311311|101620906|FG001|NOT COMPLETED|Overall Study||9||
48525297|NCT01616953|101620907|FG000|STARTED|Overall Study||10||
48525298|NCT01616953|101620908|FG001|STARTED|Overall Study||8||
48525299|NCT01616953|101620907|FG000|Implant Placement Surgery|Overall Study||9||
48525300|NCT01616953|101620908|FG001|Implant Placement Surgery|Overall Study||8||
48525301|NCT01616953|101620907|FG000|Implant Uncovery|Overall Study||8||
48525302|NCT01616953|101620908|FG001|Implant Uncovery|Overall Study||8||
48525303|NCT01616953|101620907|FG000|6 Months Post-loading|Overall Study||8||
48525304|NCT01616953|101620908|FG001|6 Months Post-loading|Overall Study||8||
48525305|NCT01616953|101620907|FG000|COMPLETED|Overall Study||8||
48525306|NCT01616953|101620908|FG001|COMPLETED|Overall Study||8||
48525307|NCT01616953|101620907|FG000|NOT COMPLETED|Overall Study||2||
48525308|NCT01616953|101620908|FG001|NOT COMPLETED|Overall Study||0||
48525309|NCT01462318|101620909|FG000|STARTED|Main Study / TP-DI Study||113||
48525310|NCT01462318|101620910|FG001|STARTED|Main Study / TP-DI Study||20||
48525311|NCT01462318|101620911|FG002|STARTED|Main Study / TP-DI Study||0||
48525312|NCT01462318|101620909|FG000|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||26||
48525313|NCT01462318|101620910|FG001|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0||
48525314|NCT01462318|101620911|FG002|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0||
48525315|NCT01462318|101620909|FG000|COMPLETED|Main Study / TP-DI Study||105||
48525316|NCT01462318|101620910|FG001|COMPLETED|Main Study / TP-DI Study||20||
48525317|NCT01462318|101620911|FG002|COMPLETED|Main Study / TP-DI Study||0||
48525318|NCT01462318|101620909|FG000|NOT COMPLETED|Main Study / TP-DI Study||8||
48525319|NCT01462318|101620910|FG001|NOT COMPLETED|Main Study / TP-DI Study||0||
48525320|NCT01462318|101620911|FG002|NOT COMPLETED|Main Study / TP-DI Study||0||
48525321|NCT01462318|101620909|FG000|STARTED|Extension Phase||0||
48525322|NCT01462318|101620910|FG001|STARTED|Extension Phase||0||
48525323|NCT01462318|101620911|FG002|STARTED|Extension Phase||115||
48525324|NCT01462318|101620909|FG000|COMPLETED|Extension Phase||0||
48525325|NCT01462318|101620910|FG001|COMPLETED|Extension Phase||0||
48525326|NCT01462318|101620911|FG002|COMPLETED|Extension Phase||70||
48525327|NCT01462318|101620909|FG000|NOT COMPLETED|Extension Phase||0||
48525328|NCT01462318|101620910|FG001|NOT COMPLETED|Extension Phase||0||
48525329|NCT01462318|101620911|FG002|NOT COMPLETED|Extension Phase||45||
48525330|NCT00631852|101620912|FG000|STARTED|Overall Study||16||
48525331|NCT00631852|101620912|FG000|COMPLETED|Overall Study||16||
48525332|NCT00631852|101620912|FG000|NOT COMPLETED|Overall Study||0||
48525333|NCT01997229|101620913|FG000|STARTED|Overall Study||62||
48525334|NCT01997229|101620914|FG001|STARTED|Overall Study||63||
48525335|NCT01997229|101620913|FG000|COMPLETED|Overall Study||57||
48525336|NCT01997229|101620914|FG001|COMPLETED|Overall Study||61||
48525337|NCT01997229|101620913|FG000|NOT COMPLETED|Overall Study||5||
48525338|NCT01997229|101620914|FG001|NOT COMPLETED|Overall Study||2||
48525339|NCT03633448|101620915|FG000|STARTED|Period 1 (1 Day)||12||
48525340|NCT03633448|101620916|FG001|STARTED|Period 1 (1 Day)||12||
48525341|NCT03633448|101620915|FG000|COMPLETED|Period 1 (1 Day)||12||
48525342|NCT03633448|101620916|FG001|COMPLETED|Period 1 (1 Day)||12||
48525343|NCT03633448|101620915|FG000|NOT COMPLETED|Period 1 (1 Day)||0||
48525344|NCT03633448|101620916|FG001|NOT COMPLETED|Period 1 (1 Day)||0||
48525345|NCT03633448|101620915|FG000|STARTED|Washout (7 Days)||12||
48525346|NCT03633448|101620916|FG001|STARTED|Washout (7 Days)||12||
48525347|NCT03633448|101620915|FG000|COMPLETED|Washout (7 Days)||12||
48525348|NCT03633448|101620916|FG001|COMPLETED|Washout (7 Days)||12||
48525349|NCT03633448|101620915|FG000|NOT COMPLETED|Washout (7 Days)||0||
48525350|NCT03633448|101620916|FG001|NOT COMPLETED|Washout (7 Days)||0||
48525351|NCT03633448|101620915|FG000|STARTED|Period 2 (1 Day)||12||
48525352|NCT03633448|101620916|FG001|STARTED|Period 2 (1 Day)||12||
48525353|NCT03633448|101620915|FG000|COMPLETED|Period 2 (1 Day)||12||
48525354|NCT03633448|101620916|FG001|COMPLETED|Period 2 (1 Day)||12||
48525355|NCT03633448|101620915|FG000|NOT COMPLETED|Period 2 (1 Day)||0||
48525356|NCT03633448|101620916|FG001|NOT COMPLETED|Period 2 (1 Day)||0||
48525357|NCT03407430|101620917|FG000|STARTED|First Intervention||5||
48525358|NCT03407430|101620918|FG001|STARTED|First Intervention||3||
48525359|NCT03407430|101620917|FG000|COMPLETED|First Intervention||5||
48525360|NCT03407430|101620918|FG001|COMPLETED|First Intervention||3||
48525361|NCT03407430|101620917|FG000|NOT COMPLETED|First Intervention||0||
48525362|NCT03407430|101620918|FG001|NOT COMPLETED|First Intervention||0||
48525363|NCT03407430|101620917|FG000|STARTED|Washout||5||
48525364|NCT03407430|101620918|FG001|STARTED|Washout||3||
48525365|NCT03407430|101620917|FG000|COMPLETED|Washout||4||
48525366|NCT03407430|101620918|FG001|COMPLETED|Washout||3||
48525367|NCT03407430|101620917|FG000|NOT COMPLETED|Washout||1||
48525368|NCT03407430|101620918|FG001|NOT COMPLETED|Washout||0||
48525369|NCT03407430|101620917|FG000|STARTED|Second Intervention||4||
48525370|NCT03407430|101620918|FG001|STARTED|Second Intervention||3||
48525371|NCT03407430|101620917|FG000|COMPLETED|Second Intervention||4||
48525372|NCT03407430|101620918|FG001|COMPLETED|Second Intervention||3||
48525373|NCT03407430|101620917|FG000|NOT COMPLETED|Second Intervention||0||
48525374|NCT03407430|101620918|FG001|NOT COMPLETED|Second Intervention||0||
48525375|NCT03660241|101620919|FG000|STARTED|Overall Study||8||
48525376|NCT03660241|101620920|FG001|STARTED|Overall Study||7||
48525377|NCT03660241|101620921|FG002|STARTED|Overall Study||8||
48525378|NCT03660241|101620919|FG000|COMPLETED|Overall Study||8||
48525379|NCT03660241|101620920|FG001|COMPLETED|Overall Study||7||
48525380|NCT03660241|101620921|FG002|COMPLETED|Overall Study||8||
48525381|NCT03660241|101620919|FG000|NOT COMPLETED|Overall Study||0||
48525382|NCT03660241|101620920|FG001|NOT COMPLETED|Overall Study||0||
48525383|NCT03660241|101620921|FG002|NOT COMPLETED|Overall Study||0||
48525384|NCT02494817|101620922|FG000|STARTED|Overall Study||162||
48525385|NCT02494817|101620923|FG001|STARTED|Overall Study||136||
48525386|NCT02494817|101620922|FG000|3 Month Assessment|Overall Study||125||
48525387|NCT02494817|101620923|FG001|3 Month Assessment|Overall Study||92||
48525388|NCT02494817|101620922|FG000|6 Month Assessment|Overall Study||115||
48525389|NCT02494817|101620923|FG001|6 Month Assessment|Overall Study||98||
48525390|NCT02494817|101620922|FG000|COMPLETED|Overall Study||107||
48525391|NCT02494817|101620923|FG001|COMPLETED|Overall Study||87||
48525392|NCT02494817|101620922|FG000|NOT COMPLETED|Overall Study||55||
48525393|NCT02494817|101620923|FG001|NOT COMPLETED|Overall Study||49||
48525394|NCT01338987|101620924|FG000|STARTED|Overall Study||12||
48525395|NCT01338987|101620925|FG001|STARTED|Overall Study||9||
48525396|NCT01338987|101620926|FG002|STARTED|Overall Study||22||
48525397|NCT01338987|101620927|FG003|STARTED|Overall Study||31||
48525398|NCT01338987|101620928|FG004|STARTED|Overall Study||2||
48525399|NCT01338987|101620924|FG000|COMPLETED|Overall Study||10||
48525400|NCT01338987|101620925|FG001|COMPLETED|Overall Study||8||
48525401|NCT01338987|101620926|FG002|COMPLETED|Overall Study||20||
48525402|NCT01338987|101620927|FG003|COMPLETED|Overall Study||31||
48525403|NCT01338987|101620928|FG004|COMPLETED|Overall Study||2||
48525404|NCT01338987|101620924|FG000|NOT COMPLETED|Overall Study||2||
48525405|NCT01338987|101620925|FG001|NOT COMPLETED|Overall Study||1||
48525406|NCT01338987|101620926|FG002|NOT COMPLETED|Overall Study||2||
48525407|NCT01338987|101620927|FG003|NOT COMPLETED|Overall Study||0||
48525408|NCT01338987|101620928|FG004|NOT COMPLETED|Overall Study||0||
48525409|NCT03012672|101620929|FG000|STARTED|Overall Study||20||
48525410|NCT03012672|101620930|FG001|STARTED|Overall Study||30||
48525411|NCT03012672|101620929|FG000|COMPLETED|Overall Study||20||
48525412|NCT03012672|101620930|FG001|COMPLETED|Overall Study||30||
48525413|NCT03012672|101620929|FG000|NOT COMPLETED|Overall Study||0||
48525414|NCT03012672|101620930|FG001|NOT COMPLETED|Overall Study||0||
48525415|NCT02466230|101620931|FG000|STARTED|Overall Study||28||
48525416|NCT02466230|101620931|FG000|COMPLETED|Overall Study||28||
48525417|NCT02466230|101620931|FG000|NOT COMPLETED|Overall Study||0||
48525418|NCT01401257|101620932|FG000|STARTED|Overall Study||21||
48525419|NCT01401257|101620933|FG001|STARTED|Overall Study||21||
48525420|NCT01401257|101620934|FG002|STARTED|Overall Study||19||
48525421|NCT01401257|101620935|FG003|STARTED|Overall Study||19||
48525422|NCT01401257|101620932|FG000|COMPLETED|Overall Study||21||
48525423|NCT01401257|101620933|FG001|COMPLETED|Overall Study||19||
48525424|NCT01401257|101620934|FG002|COMPLETED|Overall Study||16||
48525425|NCT01401257|101620935|FG003|COMPLETED|Overall Study||17||
48525426|NCT01401257|101620932|FG000|NOT COMPLETED|Overall Study||0||
48525427|NCT01401257|101620933|FG001|NOT COMPLETED|Overall Study||2||
48525428|NCT01401257|101620934|FG002|NOT COMPLETED|Overall Study||3||
48525429|NCT01401257|101620935|FG003|NOT COMPLETED|Overall Study||2||
48525430|NCT00888459|101620936|FG000|STARTED|Overall Study||30||
48525431|NCT00888459|101620937|FG001|STARTED|Overall Study||30||
48525432|NCT00888459|101620936|FG000|COMPLETED|Overall Study||30||
48525433|NCT00888459|101620937|FG001|COMPLETED|Overall Study||30||
48525434|NCT00888459|101620936|FG000|NOT COMPLETED|Overall Study||0||
48525435|NCT00888459|101620937|FG001|NOT COMPLETED|Overall Study||0||
48525436|NCT01300052|101620938|FG000|STARTED|Overall Study||46||
48525437|NCT01300052|101620939|FG001|STARTED|Overall Study||22||
48525438|NCT01300052|101620938|FG000|COMPLETED|Overall Study||40||
48525439|NCT01300052|101620939|FG001|COMPLETED|Overall Study||19||
48525440|NCT01300052|101620938|FG000|NOT COMPLETED|Overall Study||6||
48525441|NCT01300052|101620939|FG001|NOT COMPLETED|Overall Study||3||
48525442|NCT02581163|101620940|FG000|STARTED|Overall Study||311||
48525443|NCT02581163|101620940|FG000|COMPLETED|Overall Study||282||
48525444|NCT02581163|101620940|FG000|NOT COMPLETED|Overall Study||29||
48525445|NCT01835379|101620941|FG000|STARTED|Overall Study||41||
48525446|NCT01835379|101620942|FG001|STARTED|Overall Study||41||
48525447|NCT01835379|101620941|FG000|COMPLETED|Overall Study||41||
48525448|NCT01835379|101620942|FG001|COMPLETED|Overall Study||41||
48525449|NCT01835379|101620941|FG000|NOT COMPLETED|Overall Study||0||
48525450|NCT01835379|101620942|FG001|NOT COMPLETED|Overall Study||0||
48525451|NCT01621191|101620943|FG000|STARTED|Overall Study||149||
48525452|NCT01621191|101620943|FG000|Received at Least 1 Dose of Study Drug|Overall Study||149||
48525453|NCT01621191|101620943|FG000|Had at Least 1 Post-Baseline Observation|Overall Study||148||
48525454|NCT01621191|101620943|FG000|COMPLETED|Overall Study||124||
48525455|NCT01621191|101620943|FG000|NOT COMPLETED|Overall Study||25||
48525456|NCT01825122|101620944|FG000|STARTED|Overall Study||77||
48525457|NCT01825122|101620945|FG001|STARTED|Overall Study||78||
48525458|NCT01825122|101620944|FG000|COMPLETED|Overall Study||67||
48525459|NCT01825122|101620945|FG001|COMPLETED|Overall Study||59||
48525460|NCT01825122|101620944|FG000|NOT COMPLETED|Overall Study||10||
48525461|NCT01825122|101620945|FG001|NOT COMPLETED|Overall Study||19||
48525462|NCT00857792|101620946|FG000|STARTED|Overall Study||120||
48525463|NCT00857792|101620946|FG000|COMPLETED|Overall Study||108||
48525464|NCT00857792|101620946|FG000|NOT COMPLETED|Overall Study||12||
48079346|NCT00612040|100515358|FG002|NOT COMPLETED|Overall Study||7||
48079347|NCT01516346|100515359|FG000|STARTED|Overall Study||13||
48525465|NCT02103270|101620947|FG000|STARTED|Overall Study||60||
48525466|NCT02103270|101620948|FG001|STARTED|Overall Study||35||
48525467|NCT02103270|101620949|FG002|STARTED|Overall Study||25||
48525468|NCT02103270|101620947|FG000|COMPLETED|Overall Study||51||
48525469|NCT02103270|101620948|FG001|COMPLETED|Overall Study||29||
48525470|NCT02103270|101620949|FG002|COMPLETED|Overall Study||1||
48525471|NCT02103270|101620947|FG000|NOT COMPLETED|Overall Study||9||
48525472|NCT02103270|101620948|FG001|NOT COMPLETED|Overall Study||6||
48525473|NCT02103270|101620949|FG002|NOT COMPLETED|Overall Study||24||
48525474|NCT04795908|101620950|FG000|STARTED|Overall Study||3||
48525475|NCT04795908|101620950|FG000|COMPLETED|Overall Study||3||
48525476|NCT04795908|101620950|FG000|NOT COMPLETED|Overall Study||0||
48525477|NCT00669071|101620951|FG000|STARTED|Overall Study||56||
48525478|NCT00669071|101620951|FG000|COMPLETED|Overall Study||52||
48525479|NCT00669071|101620951|FG000|NOT COMPLETED|Overall Study||4||
48525480|NCT01470612|101620952|FG000|STARTED|Overall Study||175||
48525481|NCT01470612|101620953|FG001|STARTED|Overall Study||769||
48525482|NCT01470612|101620952|FG000|COMPLETED|Overall Study||91||
48525483|NCT01470612|101620953|FG001|COMPLETED|Overall Study||104||
48525484|NCT01470612|101620952|FG000|NOT COMPLETED|Overall Study||84||
48525485|NCT01470612|101620953|FG001|NOT COMPLETED|Overall Study||665||
48525486|NCT00102687|101620954|FG000|STARTED|Initial Period||50||
48525487|NCT00102687|101620955|FG001|STARTED|Initial Period||50||
48525488|NCT00102687|101620956|FG002|STARTED|Initial Period||51||
48525489|NCT00102687|101620957|FG003|STARTED|Initial Period||0||
48525490|NCT00102687|101620958|FG004|STARTED|Initial Period||0||
48525491|NCT00102687|101620954|FG000|COMPLETED|Initial Period||32||
48525492|NCT00102687|101620955|FG001|COMPLETED|Initial Period||22||
48525493|NCT00102687|101620956|FG002|COMPLETED|Initial Period||25||
48525494|NCT00102687|101620957|FG003|COMPLETED|Initial Period||0||
48525495|NCT00102687|101620958|FG004|COMPLETED|Initial Period||0||
48525496|NCT00102687|101620954|FG000|NOT COMPLETED|Initial Period||18||
48525497|NCT00102687|101620955|FG001|NOT COMPLETED|Initial Period||28||
48525498|NCT00102687|101620956|FG002|NOT COMPLETED|Initial Period||26||
48525499|NCT00102687|101620957|FG003|NOT COMPLETED|Initial Period||0||
48525500|NCT00102687|101620958|FG004|NOT COMPLETED|Initial Period||0||
48525501|NCT00102687|101620954|FG000|STARTED|Maintenance Period||13||
48525502|NCT00102687|101620955|FG001|STARTED|Maintenance Period||6||
48525503|NCT00102687|101620956|FG002|STARTED|Maintenance Period||8||
48525504|NCT00102687|101620957|FG003|STARTED|Maintenance Period||22||
48525505|NCT00102687|101620958|FG004|STARTED|Maintenance Period||21||
48525506|NCT00102687|101620954|FG000|COMPLETED|Maintenance Period||6||
48525507|NCT00102687|101620955|FG001|COMPLETED|Maintenance Period||2||
48525508|NCT00102687|101620956|FG002|COMPLETED|Maintenance Period||2||
48525509|NCT00102687|101620957|FG003|COMPLETED|Maintenance Period||12||
48525510|NCT00102687|101620958|FG004|COMPLETED|Maintenance Period||8||
48525511|NCT00102687|101620954|FG000|NOT COMPLETED|Maintenance Period||7||
48525512|NCT00102687|101620955|FG001|NOT COMPLETED|Maintenance Period||4||
48525513|NCT00102687|101620956|FG002|NOT COMPLETED|Maintenance Period||6||
48525514|NCT00102687|101620957|FG003|NOT COMPLETED|Maintenance Period||10||
48525515|NCT00102687|101620958|FG004|NOT COMPLETED|Maintenance Period||13||
48525516|NCT01304693|101620959|FG000|STARTED|Overall Study||10||
48525517|NCT01304693|101620960|FG001|STARTED|Overall Study||35||
48079348|NCT01516346|100515360|FG001|STARTED|Overall Study||15||
48079349|NCT01516346|100515361|FG002|STARTED|Overall Study||16||
48079350|NCT01516346|100515359|FG000|COMPLETED|Overall Study||7||
48079351|NCT01516346|100515360|FG001|COMPLETED|Overall Study||9||
48079352|NCT01516346|100515361|FG002|COMPLETED|Overall Study||11||
48079353|NCT01516346|100515359|FG000|NOT COMPLETED|Overall Study||6||
48079354|NCT01516346|100515360|FG001|NOT COMPLETED|Overall Study||6||
48079355|NCT01516346|100515361|FG002|NOT COMPLETED|Overall Study||5||
48079356|NCT01061177|100515362|FG000|STARTED|Overall Study||1089||
48525518|NCT01304693|101620961|FG002|STARTED|Overall Study||48||
48525519|NCT01304693|101620962|FG003|STARTED|Overall Study||40||
48525520|NCT01304693|101620963|FG004|STARTED|Overall Study||61||
48525521|NCT01304693|101620959|FG000|COMPLETED|Overall Study||10||
48525522|NCT01304693|101620960|FG001|COMPLETED|Overall Study||35||
48525523|NCT01304693|101620961|FG002|COMPLETED|Overall Study||47||
48525524|NCT01304693|101620962|FG003|COMPLETED|Overall Study||39||
48525525|NCT01304693|101620963|FG004|COMPLETED|Overall Study||60||
48525526|NCT01304693|101620959|FG000|NOT COMPLETED|Overall Study||0||
48525527|NCT01304693|101620960|FG001|NOT COMPLETED|Overall Study||0||
48525528|NCT01304693|101620961|FG002|NOT COMPLETED|Overall Study||1||
48525529|NCT01304693|101620962|FG003|NOT COMPLETED|Overall Study||1||
48525530|NCT01304693|101620963|FG004|NOT COMPLETED|Overall Study||1||
48525531|NCT01064323|101620964|FG000|STARTED|Overall Study||10||
48525532|NCT01064323|101620964|FG000|COMPLETED|Overall Study||10||
48525533|NCT01064323|101620964|FG000|NOT COMPLETED|Overall Study||0||
48525534|NCT01222286|101620965|FG000|STARTED|Overall Study||16||
48525535|NCT01222286|101620966|FG001|STARTED|Overall Study||14||
48525536|NCT01222286|101620965|FG000|COMPLETED|Overall Study||16||
48525537|NCT01222286|101620966|FG001|COMPLETED|Overall Study||14||
48525538|NCT01222286|101620965|FG000|NOT COMPLETED|Overall Study||0||
48525539|NCT01222286|101620966|FG001|NOT COMPLETED|Overall Study||0||
48525540|NCT03970837|101620967|FG000|STARTED|Overall Study||545|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participant was randomized to.|
48525541|NCT03970837|101620968|FG001|STARTED|Overall Study||539|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participant was randomized to.|
48525542|NCT03970837|101620969|FG002|STARTED|Overall Study||271|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participant was randomized to.|
48525543|NCT03970837|101620970|FG003|STARTED|Overall Study||91|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participant was randomized to.|
48525544|NCT03970837|101620971|FG004|STARTED|Overall Study||89|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participant was randomized to.|
48525545|NCT03970837|101620972|FG005|STARTED|Overall Study||90|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participant was randomized to.|
48525546|NCT03970837|101620973|FG006|STARTED|Overall Study||47|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participant was randomized to.|
48525547|NCT03970837|101620974|FG007|STARTED|Overall Study||49|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participant was randomized to.|
48525548|NCT03970837|101620975|FG008|STARTED|Overall Study||19|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participant was randomized to.|
48525549|NCT03970837|101620976|FG009|STARTED|Overall Study||6|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participant was randomized to.|
48525550|NCT03970837|101620977|FG010|STARTED|Overall Study||8|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participant was randomized to.|
48525551|NCT03970837|101620978|FG011|STARTED|Overall Study||9|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participant was randomized to.|
48525552|NCT03970837|101620967|FG000|Safety Set|Overall Study||545|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participants actually received.|
48525553|NCT03970837|101620968|FG001|Safety Set|Overall Study||539|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participants actually received.|
48525554|NCT03970837|101620969|FG002|Safety Set|Overall Study||286|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participants actually received.|
48079357|NCT01061177|100515362|FG000|ITT_MR (b2a2 &/or b3a2 +ve Pts Only)|Overall Study||1056||
48079358|NCT01061177|100515362|FG000|ITT_CyR (Ph+ Patients Only)|Overall Study||983||
48079359|NCT01061177|100515362|FG000|COMPLETED|Overall Study||881||
48079360|NCT01061177|100515362|FG000|NOT COMPLETED|Overall Study||208||
48525555|NCT03970837|101620970|FG003|Safety Set|Overall Study||0|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participants actually received.|
48525556|NCT03970837|101620971|FG004|Safety Set|Overall Study||0|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participants actually received.|
48525557|NCT03970837|101620972|FG005|Safety Set|Overall Study||0|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participants actually received.|
48525558|NCT03970837|101620973|FG006|Safety Set|Overall Study||47|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participants actually received.|
48525559|NCT03970837|101620974|FG007|Safety Set|Overall Study||49|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participants actually received.|
48525560|NCT03970837|101620975|FG008|Safety Set|Overall Study||19|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participants actually received.|
48525561|NCT03970837|101620976|FG009|Safety Set|Overall Study||0|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participants actually received.|
48525562|NCT03970837|101620977|FG010|Safety Set|Overall Study||0|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participants actually received.|
48525563|NCT03970837|101620978|FG011|Safety Set|Overall Study||0|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participants actually received.|
48525564|NCT03970837|101620967|FG000|Safety Set-Placebo Switch|Overall Study||0|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment after Week 12.|
48079361|NCT01044771|100515363|FG000|STARTED|Overall Study||20||
48079362|NCT01044771|100515363|FG000|COMPLETED|Overall Study||20||
48079363|NCT01044771|100515363|FG000|NOT COMPLETED|Overall Study||0||
48079364|NCT03311724|100515364|FG000|STARTED|Overall Study||26||
48079365|NCT03311724|100515365|FG001|STARTED|Overall Study||29||
48079366|NCT03311724|100515366|FG002|STARTED|Overall Study||28||
48079367|NCT03311724|100515367|FG003|STARTED|Overall Study||28||
48079368|NCT03311724|100515364|FG000|Received At Least One Dose of Study Drug|Overall Study||26||
48079369|NCT03311724|100515365|FG001|Received At Least One Dose of Study Drug|Overall Study||29||
48079370|NCT03311724|100515366|FG002|Received At Least One Dose of Study Drug|Overall Study||28||
48079371|NCT03311724|100515367|FG003|Received At Least One Dose of Study Drug|Overall Study||28||
48079372|NCT03311724|100515364|FG000|Completed Treatment|Overall Study||20||
48079373|NCT03311724|100515365|FG001|Completed Treatment|Overall Study||27||
48079374|NCT03311724|100515366|FG002|Completed Treatment|Overall Study||22||
48079375|NCT03311724|100515367|FG003|Completed Treatment|Overall Study||26||
48079376|NCT03311724|100515364|FG000|COMPLETED|Overall Study||23||
48079377|NCT03311724|100515365|FG001|COMPLETED|Overall Study||28||
48079378|NCT03311724|100515366|FG002|COMPLETED|Overall Study||26||
48079379|NCT03311724|100515367|FG003|COMPLETED|Overall Study||27||
48079380|NCT03311724|100515364|FG000|NOT COMPLETED|Overall Study||3||
48079381|NCT03311724|100515365|FG001|NOT COMPLETED|Overall Study||1||
48079382|NCT03311724|100515366|FG002|NOT COMPLETED|Overall Study||2||
48079383|NCT03311724|100515367|FG003|NOT COMPLETED|Overall Study||1||
48079384|NCT02607033|100515368|FG000|STARTED|Overall Study||9||
48079385|NCT02607033|100515369|FG001|STARTED|Overall Study||9||
48079386|NCT02607033|100515368|FG000|COMPLETED|Overall Study||7||
48079387|NCT02607033|100515369|FG001|COMPLETED|Overall Study||2||
48525565|NCT03970837|101620968|FG001|Safety Set-Placebo Switch|Overall Study||0|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment after Week 12.|
48592645|NCT01877382|101783162|FG012|COMPLETED|Dose Escalation||0||
48592646|NCT01877382|101783163|FG013|COMPLETED|Dose Escalation||0||
48079388|NCT02607033|100515368|FG000|NOT COMPLETED|Overall Study||2||
48079389|NCT02607033|100515369|FG001|NOT COMPLETED|Overall Study||7||
48079390|NCT00764738|100515370|FG000|STARTED|Overall Study||24||
48079391|NCT00764738|100515371|FG001|STARTED|Overall Study||28||
48079392|NCT00764738|100515372|FG002|STARTED|Overall Study||15||
48079393|NCT00764738|100515373|FG003|STARTED|Overall Study||24||
48079394|NCT00764738|100515370|FG000|COMPLETED|Overall Study||22||
48079395|NCT00764738|100515371|FG001|COMPLETED|Overall Study||25||
48079396|NCT00764738|100515372|FG002|COMPLETED|Overall Study||12||
48079397|NCT00764738|100515373|FG003|COMPLETED|Overall Study||18||
48079398|NCT00764738|100515370|FG000|NOT COMPLETED|Overall Study||2||
48079399|NCT00764738|100515371|FG001|NOT COMPLETED|Overall Study||3||
48079400|NCT00764738|100515372|FG002|NOT COMPLETED|Overall Study||3||
48079401|NCT00764738|100515373|FG003|NOT COMPLETED|Overall Study||6||
48079402|NCT03167411|100515374|FG000|STARTED|Overall Study||10||
48079403|NCT03167411|100515375|FG001|STARTED|Overall Study||10||
48079404|NCT03167411|100515374|FG000|COMPLETED|Overall Study||10||
48079405|NCT03167411|100515375|FG001|COMPLETED|Overall Study||9||
48079406|NCT03167411|100515374|FG000|NOT COMPLETED|Overall Study||0||
48079407|NCT03167411|100515375|FG001|NOT COMPLETED|Overall Study||1||
48079408|NCT00629707|100515376|FG000|STARTED|Overall Study||10||
48079409|NCT00629707|100515377|FG001|STARTED|Overall Study||10||
48079410|NCT00629707|100515376|FG000|COMPLETED|Overall Study||10||
48525566|NCT03970837|101620969|FG002|Safety Set-Placebo Switch|Overall Study||0|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment after Week 12.|
48525567|NCT03970837|101620970|FG003|Safety Set-Placebo Switch|Overall Study||85|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment after Week 12.|
48525568|NCT03970837|101620971|FG004|Safety Set-Placebo Switch|Overall Study||80|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment after Week 12.|
48525569|NCT03970837|101620972|FG005|Safety Set-Placebo Switch|Overall Study||67|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment after Week 12.|
48525570|NCT03970837|101620973|FG006|Safety Set-Placebo Switch|Overall Study||0|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment after Week 12.|
48525571|NCT03970837|101620974|FG007|Safety Set-Placebo Switch|Overall Study||0|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment after Week 12.|
48525572|NCT03970837|101620975|FG008|Safety Set-Placebo Switch|Overall Study||0|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment after Week 12.|
48525573|NCT03970837|101620976|FG009|Safety Set-Placebo Switch|Overall Study||6|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment after Week 12.|
48525574|NCT03970837|101620977|FG010|Safety Set-Placebo Switch|Overall Study||8|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment after Week 12.|
48525575|NCT03970837|101620978|FG011|Safety Set-Placebo Switch|Overall Study||8|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment after Week 12.|
48525576|NCT03970837|101620967|FG000|COMPLETED|Overall Study||461||
48525577|NCT03970837|101620968|FG001|COMPLETED|Overall Study||447||
48525578|NCT03970837|101620969|FG002|COMPLETED|Overall Study||231||
48525579|NCT03970837|101620970|FG003|COMPLETED|Overall Study||73||
48525580|NCT03970837|101620971|FG004|COMPLETED|Overall Study||69||
48525581|NCT03970837|101620972|FG005|COMPLETED|Overall Study||68||
48525582|NCT03970837|101620973|FG006|COMPLETED|Overall Study||25||
48525583|NCT03970837|101620974|FG007|COMPLETED|Overall Study||23||
48525584|NCT03970837|101620975|FG008|COMPLETED|Overall Study||15||
48525585|NCT03970837|101620976|FG009|COMPLETED|Overall Study||4||
48525586|NCT03970837|101620977|FG010|COMPLETED|Overall Study||5||
48525587|NCT03970837|101620978|FG011|COMPLETED|Overall Study||4||
48525588|NCT03970837|101620967|FG000|NOT COMPLETED|Overall Study||84||
48525589|NCT03970837|101620968|FG001|NOT COMPLETED|Overall Study||92||
48525590|NCT03970837|101620969|FG002|NOT COMPLETED|Overall Study||40||
48525591|NCT03970837|101620970|FG003|NOT COMPLETED|Overall Study||18||
48525592|NCT03970837|101620971|FG004|NOT COMPLETED|Overall Study||20||
48525593|NCT03970837|101620972|FG005|NOT COMPLETED|Overall Study||22||
48525594|NCT03970837|101620973|FG006|NOT COMPLETED|Overall Study||22||
48525595|NCT03970837|101620974|FG007|NOT COMPLETED|Overall Study||26||
48525596|NCT03970837|101620975|FG008|NOT COMPLETED|Overall Study||4||
48525597|NCT03970837|101620976|FG009|NOT COMPLETED|Overall Study||2||
48525598|NCT03970837|101620977|FG010|NOT COMPLETED|Overall Study||3||
48525599|NCT03970837|101620978|FG011|NOT COMPLETED|Overall Study||5||
48525600|NCT00384176|101620979|FG000|STARTED|Overall Study||709||
48079411|NCT00629707|100515377|FG001|COMPLETED|Overall Study||8||
48079412|NCT00629707|100515376|FG000|NOT COMPLETED|Overall Study||0||
48079413|NCT00629707|100515377|FG001|NOT COMPLETED|Overall Study||2||
48079414|NCT02144012|100515378|FG000|STARTED|Overall Study||34||
48079415|NCT02144012|100515379|FG001|STARTED|Overall Study||15||
48079416|NCT02144012|100515378|FG000|COMPLETED|Overall Study||0||
48079417|NCT02144012|100515379|FG001|COMPLETED|Overall Study||0||
48079418|NCT02144012|100515378|FG000|NOT COMPLETED|Overall Study||34||
48079419|NCT02144012|100515379|FG001|NOT COMPLETED|Overall Study||15||
48079420|NCT01745133|100515380|FG000|STARTED|Overall Study||19||
48079421|NCT01745133|100515381|FG001|STARTED|Overall Study||20||
48079422|NCT01745133|100515382|FG002|STARTED|Overall Study||19||
48079423|NCT01745133|100515380|FG000|COMPLETED|Overall Study||13||
48079424|NCT01745133|100515381|FG001|COMPLETED|Overall Study||16||
48079425|NCT01745133|100515382|FG002|COMPLETED|Overall Study||15||
48079426|NCT01745133|100515380|FG000|NOT COMPLETED|Overall Study||6||
48079427|NCT01745133|100515381|FG001|NOT COMPLETED|Overall Study||4||
48079428|NCT01745133|100515382|FG002|NOT COMPLETED|Overall Study||4||
48079429|NCT00745823|100515383|FG000|STARTED|Overall Study||386||
48079430|NCT00745823|100515384|FG001|STARTED|Overall Study||389||
48079431|NCT00745823|100515383|FG000|TREATED Week 0 - 96|Overall Study||382||
48079432|NCT00745823|100515384|FG001|TREATED Week 0 - 96|Overall Study||388||
48079433|NCT00745823|100515383|FG000|COMPLETED|Overall Study||1||
48079434|NCT00745823|100515384|FG001|COMPLETED|Overall Study||3||
48079435|NCT00745823|100515383|FG000|NOT COMPLETED|Overall Study||385||
48079436|NCT00745823|100515384|FG001|NOT COMPLETED|Overall Study||386||
48079437|NCT02389361|100515385|FG000|STARTED|Overall Study||24||
48079438|NCT02389361|100515386|FG001|STARTED|Overall Study||27||
48079439|NCT02389361|100515385|FG000|COMPLETED|Overall Study||24||
48079440|NCT02389361|100515386|FG001|COMPLETED|Overall Study||27||
48079441|NCT02389361|100515385|FG000|NOT COMPLETED|Overall Study||0||
48079442|NCT02389361|100515386|FG001|NOT COMPLETED|Overall Study||0||
48079443|NCT00133952|100515387|FG000|STARTED|Overall Study||157||
48079444|NCT00133952|100515388|FG001|STARTED|Overall Study||152||
48079445|NCT00133952|100515387|FG000|Received at Least One Dose of Study Drug|Overall Study||153||
48079446|NCT00133952|100515388|FG001|Received at Least One Dose of Study Drug|Overall Study||149||
48079447|NCT00133952|100515387|FG000|COMPLETED|Overall Study||115||
48079448|NCT00133952|100515388|FG001|COMPLETED|Overall Study||124||
48079449|NCT00133952|100515387|FG000|NOT COMPLETED|Overall Study||42||
48079450|NCT00133952|100515388|FG001|NOT COMPLETED|Overall Study||28||
48079451|NCT03012165|100515389|FG000|STARTED|Overall Study||53||
48079452|NCT03012165|100515390|FG001|STARTED|Overall Study||51||
48079453|NCT03012165|100515391|FG002|STARTED|Overall Study||50||
48079454|NCT03012165|100515389|FG000|COMPLETED|Overall Study||51||
48079455|NCT03012165|100515390|FG001|COMPLETED|Overall Study||49||
48079456|NCT03012165|100515391|FG002|COMPLETED|Overall Study||49||
48079457|NCT03012165|100515389|FG000|NOT COMPLETED|Overall Study||2||
48079458|NCT03012165|100515390|FG001|NOT COMPLETED|Overall Study||2||
48079459|NCT03012165|100515391|FG002|NOT COMPLETED|Overall Study||1||
48079460|NCT04866225|100515392|FG000|STARTED|Overall Study||6||
48079461|NCT04866225|100515392|FG000|COMPLETED|Overall Study||6||
48079462|NCT04866225|100515392|FG000|NOT COMPLETED|Overall Study||0||
48525601|NCT00384176|101620980|FG001|STARTED|Overall Study||713||
48525602|NCT00384176|101620981|FG002|STARTED|Overall Study||192||
48525603|NCT00384176|101620979|FG000|COMPLETED|Overall Study||397||
48525604|NCT00384176|101620980|FG001|COMPLETED|Overall Study||394||
48525605|NCT00384176|101620981|FG002|COMPLETED|Overall Study||60||
48525606|NCT00384176|101620979|FG000|NOT COMPLETED|Overall Study||312||
48525607|NCT00384176|101620980|FG001|NOT COMPLETED|Overall Study||319||
48525608|NCT00384176|101620981|FG002|NOT COMPLETED|Overall Study||132||
48525609|NCT05161806|101620982|FG000|STARTED|Overall Study||30||
48525610|NCT05161806|101620982|FG000|Full Analysis Set (FAS)|Overall Study||30|FAS included all participants who received an injection of study treatment.|
48079463|NCT04189081|100515393|FG000|STARTED|Overall Study||46||
48079464|NCT04189081|100515394|FG001|STARTED|Overall Study||45||
48079465|NCT04189081|100515395|FG002|STARTED|Overall Study||46||
48079466|NCT04189081|100515393|FG000|COMPLETED|Overall Study||45||
48079467|NCT04189081|100515394|FG001|COMPLETED|Overall Study||45||
48079468|NCT04189081|100515395|FG002|COMPLETED|Overall Study||45||
48079469|NCT04189081|100515393|FG000|NOT COMPLETED|Overall Study||1||
48079470|NCT04189081|100515394|FG001|NOT COMPLETED|Overall Study||0||
48079471|NCT04189081|100515395|FG002|NOT COMPLETED|Overall Study||1||
48079472|NCT04380116|100515396|FG000|STARTED|Overall Study||48||
48079473|NCT04380116|100515397|FG001|STARTED|Overall Study||48||
48079474|NCT04380116|100515396|FG000|COMPLETED|Overall Study||43||
48079475|NCT04380116|100515397|FG001|COMPLETED|Overall Study||32||
48079476|NCT04380116|100515396|FG000|NOT COMPLETED|Overall Study||5||
48079477|NCT04380116|100515397|FG001|NOT COMPLETED|Overall Study||16||
48079478|NCT00980057|100515398|FG000|STARTED|Overall Study||318||
48079479|NCT00980057|100515399|FG001|STARTED|Overall Study||160||
48079480|NCT00980057|100515398|FG000|COMPLETED|Overall Study||299||
48079481|NCT00980057|100515399|FG001|COMPLETED|Overall Study||155||
48079482|NCT00980057|100515398|FG000|NOT COMPLETED|Overall Study||19||
48079483|NCT00980057|100515399|FG001|NOT COMPLETED|Overall Study||5||
48079484|NCT01731990|100515400|FG000|STARTED|Overall Study||18||
48079485|NCT01731990|100515401|FG001|STARTED|Overall Study||20||
48079486|NCT01731990|100515400|FG000|COMPLETED|Overall Study||14||
48525611|NCT05161806|101620982|FG000|COMPLETED|Overall Study||30||
48525612|NCT05161806|101620982|FG000|NOT COMPLETED|Overall Study||0||
48079487|NCT01731990|100515401|FG001|COMPLETED|Overall Study||12||
48079488|NCT01731990|100515400|FG000|NOT COMPLETED|Overall Study||4||
48079489|NCT01731990|100515401|FG001|NOT COMPLETED|Overall Study||8||
48079490|NCT03663816|100515402|FG000|STARTED|Overall Study||15||
48079491|NCT03663816|100515402|FG000|COMPLETED|Overall Study||15||
48079492|NCT03663816|100515402|FG000|NOT COMPLETED|Overall Study||0||
48525613|NCT00307034|101620983|FG000|STARTED|Overall Study||175||
48079493|NCT01558271|100515403|FG000|STARTED|Overall Study||281||
48079494|NCT01558271|100515404|FG001|STARTED|Overall Study||70||
48525614|NCT00307034|101620984|FG001|STARTED|Overall Study||176||
48525615|NCT00307034|101620983|FG000|COMPLETED|Overall Study||173||
48525616|NCT00307034|101620984|FG001|COMPLETED|Overall Study||169||
48525617|NCT00307034|101620983|FG000|NOT COMPLETED|Overall Study||2||
48079495|NCT01558271|100515405|FG002|STARTED|Overall Study||141||
48079496|NCT01558271|100515403|FG000|Received at Least 1 Dose of Study Drug|Overall Study||280||
48079497|NCT01558271|100515404|FG001|Received at Least 1 Dose of Study Drug|Overall Study||70||
48079498|NCT01558271|100515405|FG002|Received at Least 1 Dose of Study Drug|Overall Study||137||
48079499|NCT01558271|100515403|FG000|Completed 26 Weeks|Overall Study||271||
48079500|NCT01558271|100515404|FG001|Completed 26 Weeks|Overall Study||63||
48079501|NCT01558271|100515405|FG002|Completed 26 Weeks|Overall Study||128||
48079502|NCT01558271|100515403|FG000|COMPLETED|Overall Study||263||
48079503|NCT01558271|100515404|FG001|COMPLETED|Overall Study||59||
48079504|NCT01558271|100515405|FG002|COMPLETED|Overall Study||124||
48525618|NCT00307034|101620984|FG001|NOT COMPLETED|Overall Study||7||
48525619|NCT00759902|101620985|FG000|STARTED|Overall Study||18||
48525620|NCT00759902|101620986|FG001|STARTED|Overall Study||18||
48525621|NCT00759902|101620985|FG000|COMPLETED|Overall Study||18||
48525622|NCT00759902|101620986|FG001|COMPLETED|Overall Study||17||
48525623|NCT00759902|101620985|FG000|NOT COMPLETED|Overall Study||0||
48525624|NCT00759902|101620986|FG001|NOT COMPLETED|Overall Study||1||
48525625|NCT02377063|101620987|FG000|STARTED|Overall Study||25||
48525626|NCT02377063|101620987|FG000|COMPLETED|Overall Study||20||
48525627|NCT02377063|101620987|FG000|NOT COMPLETED|Overall Study||5||
48525628|NCT01359644|101620988|FG000|STARTED|Treatment Period||15||
48525629|NCT01359644|101620989|FG001|STARTED|Treatment Period||16||
48525630|NCT01359644|101620990|FG002|STARTED|Treatment Period||14||
48525631|NCT01359644|101620991|FG003|STARTED|Treatment Period||14||
48525632|NCT01359644|101620992|FG004|STARTED|Treatment Period||15||
48525633|NCT01359644|101620993|FG005|STARTED|Treatment Period||14||
48525634|NCT01359644|101620994|FG006|STARTED|Treatment Period||41||
48525635|NCT01359644|101620995|FG007|STARTED|Treatment Period||41||
48525636|NCT01359644|101620996|FG008|STARTED|Treatment Period||21||
48525637|NCT01359644|101620997|FG009|STARTED|Treatment Period||20||
48525638|NCT01359644|101620988|FG000|COMPLETED|Treatment Period||15||
48525639|NCT01359644|101620989|FG001|COMPLETED|Treatment Period||15||
48525640|NCT01359644|101620990|FG002|COMPLETED|Treatment Period||13||
48525641|NCT01359644|101620991|FG003|COMPLETED|Treatment Period||14||
48525642|NCT01359644|101620992|FG004|COMPLETED|Treatment Period||15||
48525643|NCT01359644|101620993|FG005|COMPLETED|Treatment Period||12||
48525644|NCT01359644|101620994|FG006|COMPLETED|Treatment Period||41||
48525645|NCT01359644|101620995|FG007|COMPLETED|Treatment Period||41||
48525646|NCT01359644|101620996|FG008|COMPLETED|Treatment Period||21||
48525647|NCT01359644|101620997|FG009|COMPLETED|Treatment Period||20||
48525648|NCT01359644|101620988|FG000|NOT COMPLETED|Treatment Period||0||
48525649|NCT01359644|101620989|FG001|NOT COMPLETED|Treatment Period||1||
48525650|NCT01359644|101620990|FG002|NOT COMPLETED|Treatment Period||1||
48525651|NCT01359644|101620991|FG003|NOT COMPLETED|Treatment Period||0||
48525652|NCT01359644|101620992|FG004|NOT COMPLETED|Treatment Period||0||
48525653|NCT01359644|101620993|FG005|NOT COMPLETED|Treatment Period||2||
48525654|NCT01359644|101620994|FG006|NOT COMPLETED|Treatment Period||0||
48525655|NCT01359644|101620995|FG007|NOT COMPLETED|Treatment Period||0||
48525656|NCT01359644|101620996|FG008|NOT COMPLETED|Treatment Period||0||
48079505|NCT01558271|100515403|FG000|NOT COMPLETED|Overall Study||18||
48079506|NCT01558271|100515404|FG001|NOT COMPLETED|Overall Study||11||
48079507|NCT01558271|100515405|FG002|NOT COMPLETED|Overall Study||17||
48079508|NCT02519036|100515406|FG000|STARTED|Overall Study||12||
48079509|NCT02519036|100515407|FG001|STARTED|Overall Study||3||
48079510|NCT02519036|100515408|FG002|STARTED|Overall Study||6||
48079511|NCT02519036|100515409|FG003|STARTED|Overall Study||6||
48079512|NCT02519036|100515410|FG004|STARTED|Overall Study||9||
48079513|NCT02519036|100515411|FG005|STARTED|Overall Study||10||
48525657|NCT01359644|101620997|FG009|NOT COMPLETED|Treatment Period||0||
48525658|NCT01359644|101620988|FG000|STARTED|Follow-up Period||15||
48525659|NCT01359644|101620989|FG001|STARTED|Follow-up Period||16||
48079514|NCT02519036|100515406|FG000|COMPLETED|Overall Study||12||
48079515|NCT02519036|100515407|FG001|COMPLETED|Overall Study||3||
48079516|NCT02519036|100515408|FG002|COMPLETED|Overall Study||6||
48079517|NCT02519036|100515409|FG003|COMPLETED|Overall Study||6||
48525660|NCT01359644|101620990|FG002|STARTED|Follow-up Period||14||
48525661|NCT01359644|101620991|FG003|STARTED|Follow-up Period||14||
48525662|NCT01359644|101620992|FG004|STARTED|Follow-up Period||15||
48525663|NCT01359644|101620993|FG005|STARTED|Follow-up Period||13||
48525664|NCT01359644|101620994|FG006|STARTED|Follow-up Period||41||
48525665|NCT01359644|101620995|FG007|STARTED|Follow-up Period||41||
48525666|NCT01359644|101620996|FG008|STARTED|Follow-up Period||21||
48525667|NCT01359644|101620997|FG009|STARTED|Follow-up Period||20||
48525668|NCT01359644|101620988|FG000|COMPLETED|Follow-up Period||15||
48525669|NCT01359644|101620989|FG001|COMPLETED|Follow-up Period||16||
48525670|NCT01359644|101620990|FG002|COMPLETED|Follow-up Period||14||
48525671|NCT01359644|101620991|FG003|COMPLETED|Follow-up Period||14||
48525672|NCT01359644|101620992|FG004|COMPLETED|Follow-up Period||15||
48525673|NCT01359644|101620993|FG005|COMPLETED|Follow-up Period||12||
48525674|NCT01359644|101620994|FG006|COMPLETED|Follow-up Period||40||
48525675|NCT01359644|101620995|FG007|COMPLETED|Follow-up Period||39||
48525676|NCT01359644|101620996|FG008|COMPLETED|Follow-up Period||21||
48525677|NCT01359644|101620997|FG009|COMPLETED|Follow-up Period||20||
48525678|NCT01359644|101620988|FG000|NOT COMPLETED|Follow-up Period||0||
48525679|NCT01359644|101620989|FG001|NOT COMPLETED|Follow-up Period||0||
48525680|NCT01359644|101620990|FG002|NOT COMPLETED|Follow-up Period||0||
48525681|NCT01359644|101620991|FG003|NOT COMPLETED|Follow-up Period||0||
48079518|NCT02519036|100515410|FG004|COMPLETED|Overall Study||9||
48079519|NCT02519036|100515411|FG005|COMPLETED|Overall Study||10||
48079520|NCT02519036|100515406|FG000|NOT COMPLETED|Overall Study||0||
48079521|NCT02519036|100515407|FG001|NOT COMPLETED|Overall Study||0||
48079522|NCT02519036|100515408|FG002|NOT COMPLETED|Overall Study||0||
48079523|NCT02519036|100515409|FG003|NOT COMPLETED|Overall Study||0||
48079524|NCT02519036|100515410|FG004|NOT COMPLETED|Overall Study||0||
48079525|NCT02519036|100515411|FG005|NOT COMPLETED|Overall Study||0||
48079526|NCT03851705|100515412|FG000|STARTED|Part 1: Double-Blind Period||37||
48079527|NCT03851705|100515413|FG001|STARTED|Part 1: Double-Blind Period||19||
48079528|NCT03851705|100515414|FG002|STARTED|Part 1: Double-Blind Period||0||
48079529|NCT03851705|100515415|FG003|STARTED|Part 1: Double-Blind Period||0||
48079530|NCT03851705|100515412|FG000|COMPLETED|Part 1: Double-Blind Period||34||
48079531|NCT03851705|100515413|FG001|COMPLETED|Part 1: Double-Blind Period||19||
48079532|NCT03851705|100515414|FG002|COMPLETED|Part 1: Double-Blind Period||0||
48079533|NCT03851705|100515415|FG003|COMPLETED|Part 1: Double-Blind Period||0||
48079534|NCT03851705|100515412|FG000|NOT COMPLETED|Part 1: Double-Blind Period||3||
48079535|NCT03851705|100515413|FG001|NOT COMPLETED|Part 1: Double-Blind Period||0||
48079536|NCT03851705|100515414|FG002|NOT COMPLETED|Part 1: Double-Blind Period||0||
48525682|NCT01359644|101620992|FG004|NOT COMPLETED|Follow-up Period||0||
48525683|NCT01359644|101620993|FG005|NOT COMPLETED|Follow-up Period||1||
48079537|NCT03851705|100515415|FG003|NOT COMPLETED|Part 1: Double-Blind Period||0||
48079538|NCT03851705|100515412|FG000|STARTED|Part 2: Open-Label Period||0||
48079539|NCT03851705|100515413|FG001|STARTED|Part 2: Open-Label Period||0||
48079540|NCT03851705|100515414|FG002|STARTED|Part 2: Open-Label Period||34||
48079541|NCT03851705|100515415|FG003|STARTED|Part 2: Open-Label Period||19||
48079542|NCT03851705|100515412|FG000|COMPLETED|Part 2: Open-Label Period||0||
48079543|NCT03851705|100515413|FG001|COMPLETED|Part 2: Open-Label Period||0||
48079544|NCT03851705|100515414|FG002|COMPLETED|Part 2: Open-Label Period||29||
48079545|NCT03851705|100515415|FG003|COMPLETED|Part 2: Open-Label Period||18||
48079546|NCT03851705|100515412|FG000|NOT COMPLETED|Part 2: Open-Label Period||0||
48079547|NCT03851705|100515413|FG001|NOT COMPLETED|Part 2: Open-Label Period||0||
48079548|NCT03851705|100515414|FG002|NOT COMPLETED|Part 2: Open-Label Period||5||
48079549|NCT03851705|100515415|FG003|NOT COMPLETED|Part 2: Open-Label Period||1||
48525684|NCT01359644|101620994|FG006|NOT COMPLETED|Follow-up Period||1||
48525685|NCT01359644|101620995|FG007|NOT COMPLETED|Follow-up Period||2||
48525686|NCT01359644|101620996|FG008|NOT COMPLETED|Follow-up Period||0||
48525687|NCT01359644|101620997|FG009|NOT COMPLETED|Follow-up Period||0||
48525688|NCT02429934|101620998|FG000|STARTED|Overall Study||15||
48525689|NCT02429934|101620999|FG001|STARTED|Overall Study||13||
48525690|NCT02429934|101620998|FG000|COMPLETED|Overall Study||11||
48525691|NCT02429934|101620999|FG001|COMPLETED|Overall Study||10||
48525692|NCT02429934|101620998|FG000|NOT COMPLETED|Overall Study||4||
48525693|NCT02429934|101620999|FG001|NOT COMPLETED|Overall Study||3||
48525694|NCT01946191|101621000|FG000|STARTED|Allocation||98||
48525695|NCT01946191|101621001|FG001|STARTED|Allocation||96||
48525696|NCT01946191|101621000|FG000|COMPLETED|Allocation||97||
48525697|NCT01946191|101621001|FG001|COMPLETED|Allocation||95||
48525698|NCT01946191|101621000|FG000|NOT COMPLETED|Allocation||1||
48525699|NCT01946191|101621001|FG001|NOT COMPLETED|Allocation||1||
48525700|NCT01946191|101621000|FG000|STARTED|Follow-Up, 24-mo Endpoint||97||
48525701|NCT01946191|101621001|FG001|STARTED|Follow-Up, 24-mo Endpoint||95||
48525702|NCT01946191|101621000|FG000|COMPLETED|Follow-Up, 24-mo Endpoint||80||
48525703|NCT01946191|101621001|FG001|COMPLETED|Follow-Up, 24-mo Endpoint||77||
48079550|NCT01408485|100515416|FG000|STARTED|Overall Study||200||
48079551|NCT01408485|100515416|FG000|COMPLETED|Overall Study||179||
48079552|NCT01408485|100515416|FG000|NOT COMPLETED|Overall Study||21||
48079553|NCT00963937|100515417|FG000|STARTED|Overall Study||89||
48525704|NCT01946191|101621000|FG000|NOT COMPLETED|Follow-Up, 24-mo Endpoint||17||
48525705|NCT01946191|101621001|FG001|NOT COMPLETED|Follow-Up, 24-mo Endpoint||18||
48525706|NCT01946191|101621000|FG000|STARTED|Primary Outcome Analysis||98||
48525707|NCT01946191|101621001|FG001|STARTED|Primary Outcome Analysis||95||
48079554|NCT00963937|100515418|FG001|STARTED|Overall Study||44||
48079555|NCT00963937|100515419|FG002|STARTED|Overall Study||45||
48525708|NCT01946191|101621000|FG000|COMPLETED|Primary Outcome Analysis||80||
48525709|NCT01946191|101621001|FG001|COMPLETED|Primary Outcome Analysis||77||
48079556|NCT00963937|100515417|FG000|COMPLETED|Overall Study||70||
48079557|NCT00963937|100515418|FG001|COMPLETED|Overall Study||33||
48079558|NCT00963937|100515419|FG002|COMPLETED|Overall Study||41||
48079559|NCT00963937|100515417|FG000|NOT COMPLETED|Overall Study||19||
48079560|NCT00963937|100515418|FG001|NOT COMPLETED|Overall Study||11||
48525710|NCT01946191|101621000|FG000|NOT COMPLETED|Primary Outcome Analysis||18||
48525711|NCT01946191|101621001|FG001|NOT COMPLETED|Primary Outcome Analysis||18||
48525712|NCT02689063|101621002|FG000|STARTED|Overall Study||75||
48525713|NCT02689063|101621003|FG001|STARTED|Overall Study||75||
48525714|NCT02689063|101621004|FG002|STARTED|Overall Study||76||
48525715|NCT02689063|101621005|FG003|STARTED|Overall Study||50||
48525716|NCT02689063|101621002|FG000|COMPLETED|Overall Study||75||
48525717|NCT02689063|101621003|FG001|COMPLETED|Overall Study||73||
48525718|NCT02689063|101621004|FG002|COMPLETED|Overall Study||73||
48525719|NCT02689063|101621005|FG003|COMPLETED|Overall Study||50||
48525720|NCT02689063|101621002|FG000|NOT COMPLETED|Overall Study||0||
48525721|NCT02689063|101621003|FG001|NOT COMPLETED|Overall Study||2||
48525722|NCT02689063|101621004|FG002|NOT COMPLETED|Overall Study||3||
48525723|NCT02689063|101621005|FG003|NOT COMPLETED|Overall Study||0||
48525724|NCT04920916|101621006|FG000|STARTED|Phase IIa 60 Day Study||19||
48525725|NCT04920916|101621007|FG001|STARTED|Phase IIa 60 Day Study||21||
48525726|NCT04920916|101621006|FG000|COMPLETED|Phase IIa 60 Day Study||17||
48525727|NCT04920916|101621007|FG001|COMPLETED|Phase IIa 60 Day Study||16||
48525728|NCT04920916|101621006|FG000|NOT COMPLETED|Phase IIa 60 Day Study||2||
48525729|NCT04920916|101621007|FG001|NOT COMPLETED|Phase IIa 60 Day Study||5||
48525730|NCT04920916|101621006|FG000|STARTED|1 Year Follow up (Phone Call)||17||
48525731|NCT04920916|101621007|FG001|STARTED|1 Year Follow up (Phone Call)||16||
48525732|NCT04920916|101621006|FG000|COMPLETED|1 Year Follow up (Phone Call)||16||
48525733|NCT04920916|101621007|FG001|COMPLETED|1 Year Follow up (Phone Call)||13||
48525734|NCT04920916|101621006|FG000|NOT COMPLETED|1 Year Follow up (Phone Call)||1||
48525735|NCT04920916|101621007|FG001|NOT COMPLETED|1 Year Follow up (Phone Call)||3||
48079561|NCT00963937|100515419|FG002|NOT COMPLETED|Overall Study||4||
48079562|NCT01389817|100515420|FG000|STARTED|Overall Study||4||
48079563|NCT01389817|100515421|FG001|STARTED|Overall Study||0||
48079564|NCT01389817|100515420|FG000|COMPLETED|Overall Study||0||
48079565|NCT01389817|100515421|FG001|COMPLETED|Overall Study||0||
48525736|NCT04920916|101621006|FG000|STARTED|1 Year Follow up Visits||16||
48525737|NCT04920916|101621007|FG001|STARTED|1 Year Follow up Visits||13||
48525738|NCT04920916|101621006|FG000|COMPLETED|1 Year Follow up Visits||10||
48525739|NCT04920916|101621007|FG001|COMPLETED|1 Year Follow up Visits||6||
48525740|NCT04920916|101621006|FG000|NOT COMPLETED|1 Year Follow up Visits||6||
48079566|NCT01389817|100515420|FG000|NOT COMPLETED|Overall Study||4||
48079567|NCT01389817|100515421|FG001|NOT COMPLETED|Overall Study||0||
48079568|NCT02957305|100515422|FG000|STARTED|Overall Study||106||
48079569|NCT02957305|100515423|FG001|STARTED|Overall Study||105||
48079570|NCT02957305|100515422|FG000|COMPLETED|Overall Study||106||
48079571|NCT02957305|100515423|FG001|COMPLETED|Overall Study||105||
48079572|NCT02957305|100515422|FG000|NOT COMPLETED|Overall Study||0||
48525741|NCT04920916|101621007|FG001|NOT COMPLETED|1 Year Follow up Visits||7||
48525742|NCT00391079|101621008|FG000|STARTED|Overall Study||167||
48525743|NCT00391079|101621009|FG001|STARTED|Overall Study||172||
48525744|NCT00391079|101621008|FG000|COMPLETED|Overall Study||141||
48525745|NCT00391079|101621009|FG001|COMPLETED|Overall Study||156||
48525746|NCT00391079|101621008|FG000|NOT COMPLETED|Overall Study||26||
48525747|NCT00391079|101621009|FG001|NOT COMPLETED|Overall Study||16||
48525748|NCT00750308|101621010|FG000|STARTED|First Treatment||2||
48525749|NCT00750308|101621011|FG001|STARTED|First Treatment||3||
48525750|NCT00750308|101621012|FG002|STARTED|First Treatment||2||
48525751|NCT00750308|101621013|FG003|STARTED|First Treatment||2||
48525752|NCT00750308|101621014|FG004|STARTED|First Treatment||2||
48525753|NCT00750308|101621015|FG005|STARTED|First Treatment||3||
48525754|NCT00750308|101621016|FG006|STARTED|First Treatment||2||
48525755|NCT00750308|101621017|FG007|STARTED|First Treatment||3||
48525756|NCT00750308|101621018|FG008|STARTED|First Treatment||2||
48525757|NCT00750308|101621019|FG009|STARTED|First Treatment||2||
48525758|NCT00750308|101621020|FG010|STARTED|First Treatment||2||
48525759|NCT00750308|101621021|FG011|STARTED|First Treatment||2||
48525760|NCT00750308|101621010|FG000|COMPLETED|First Treatment||2||
48525761|NCT00750308|101621011|FG001|COMPLETED|First Treatment||2||
48525762|NCT00750308|101621012|FG002|COMPLETED|First Treatment||2||
48525763|NCT00750308|101621013|FG003|COMPLETED|First Treatment||1||
48525764|NCT00750308|101621014|FG004|COMPLETED|First Treatment||2||
48079573|NCT02957305|100515423|FG001|NOT COMPLETED|Overall Study||0||
48525765|NCT00750308|101621015|FG005|COMPLETED|First Treatment||3||
48079574|NCT02430311|100515424|FG000|STARTED|Part A||20||
48079575|NCT02430311|100515425|FG001|STARTED|Part A||16||
48525766|NCT00750308|101621016|FG006|COMPLETED|First Treatment||2||
48525767|NCT00750308|101621017|FG007|COMPLETED|First Treatment||2||
48525768|NCT00750308|101621018|FG008|COMPLETED|First Treatment||2||
48525769|NCT00750308|101621019|FG009|COMPLETED|First Treatment||2||
48525770|NCT00750308|101621020|FG010|COMPLETED|First Treatment||1||
48079576|NCT02430311|100515424|FG000|Received Olaparib|Part A||20||
48079577|NCT02430311|100515425|FG001|Received Olaparib|Part A||16||
48079578|NCT02430311|100515424|FG000|Received Paclitaxel|Part A||0||
48079579|NCT02430311|100515425|FG001|Received Paclitaxel|Part A||16||
48079580|NCT02430311|100515424|FG000|COMPLETED|Part A||19||
48079581|NCT02430311|100515425|FG001|COMPLETED|Part A||15||
48079582|NCT02430311|100515424|FG000|NOT COMPLETED|Part A||1||
48079583|NCT02430311|100515425|FG001|NOT COMPLETED|Part A||1||
48079584|NCT02430311|100515424|FG000|STARTED|Part B||19||
48079585|NCT02430311|100515425|FG001|STARTED|Part B||15||
48079586|NCT02430311|100515424|FG000|Received Olaparib|Part B||19||
48079587|NCT02430311|100515425|FG001|Received Olaparib|Part B||15||
48079588|NCT02430311|100515424|FG000|Received Paclitaxel|Part B||0||
48079589|NCT02430311|100515425|FG001|Received Paclitaxel|Part B||14||
48079590|NCT02430311|100515424|FG000|COMPLETED|Part B||9||
48079591|NCT02430311|100515425|FG001|COMPLETED|Part B||7||
48079592|NCT02430311|100515424|FG000|NOT COMPLETED|Part B||10||
48079593|NCT02430311|100515425|FG001|NOT COMPLETED|Part B||8||
48079594|NCT01594281|100518598|FG000|STARTED|Interventional Core Phase||36|All randomized patients, including one patient who withdrew prior to the baseline visit|
48079595|NCT01594281|100518599|FG001|STARTED|Interventional Core Phase||36|All randomized patients, including one patient who withdrew prior to the baseline visit|
48079596|NCT01594281|100518600|FG002|STARTED|Interventional Core Phase||36|All randomized patients, including one patient who withdrew prior to the baseline visit|
48079597|NCT01594281|100518598|FG000|Full Analysis Set (FAS)|Interventional Core Phase||35|All randomized patients with at least one study treatment and one post-baseline assessment|
48079598|NCT01594281|100518599|FG001|Full Analysis Set (FAS)|Interventional Core Phase||35|All randomized patients with at least one study treatment and one post-baseline assessment|
48079599|NCT01594281|100518600|FG002|Full Analysis Set (FAS)|Interventional Core Phase||36|All randomized patients with at least one study treatment and one post-baseline assessment|
48079600|NCT01594281|100518598|FG000|COMPLETED|Interventional Core Phase||29|End of Core Study (EOCS), defined as the last visit under therapy, up to Month 12|
48079601|NCT01594281|100518599|FG001|COMPLETED|Interventional Core Phase||26|End of Core Study (EOCS), defined as the last visit under therapy, up to Month 12|
48079602|NCT01594281|100518600|FG002|COMPLETED|Interventional Core Phase||28|End of Core Study (EOCS), defined as the last visit under therapy, up to Month 12|
48079603|NCT01594281|100518598|FG000|NOT COMPLETED|Interventional Core Phase||7||
48525771|NCT00750308|101621021|FG011|COMPLETED|First Treatment||1||
48525772|NCT00750308|101621010|FG000|NOT COMPLETED|First Treatment||0||
48525773|NCT00750308|101621011|FG001|NOT COMPLETED|First Treatment||1||
48525774|NCT00750308|101621012|FG002|NOT COMPLETED|First Treatment||0||
48079604|NCT01594281|100518599|FG001|NOT COMPLETED|Interventional Core Phase||10||
48079605|NCT01594281|100518600|FG002|NOT COMPLETED|Interventional Core Phase||8||
48079606|NCT01594281|100518598|FG000|STARTED|Non-Interventional Follow Up Phase||28|All patients signing an Informed Consent, including one patient who withdrew without documented data|
48079607|NCT01594281|100518599|FG001|STARTED|Non-Interventional Follow Up Phase||21|All patients signing an Informed Consent, including one patient who withdrew without documented data|
48079608|NCT01594281|100518600|FG002|STARTED|Non-Interventional Follow Up Phase||25|All patients signing an Informed Consent, including one patient who withdrew without documented data|
48079609|NCT01594281|100518598|FG000|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||28|All patients with documented data in the follow up phase|
48079610|NCT01594281|100518599|FG001|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||20|All patients with documented data in the follow up phase|
48079611|NCT01594281|100518600|FG002|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||25|All patients with documented data in the follow up phase|
48079612|NCT01594281|100518598|FG000|COMPLETED|Non-Interventional Follow Up Phase||25||
48079613|NCT01594281|100518599|FG001|COMPLETED|Non-Interventional Follow Up Phase||19||
48079614|NCT01594281|100518600|FG002|COMPLETED|Non-Interventional Follow Up Phase||23||
48079615|NCT01594281|100518598|FG000|NOT COMPLETED|Non-Interventional Follow Up Phase||3||
48079616|NCT01594281|100518599|FG001|NOT COMPLETED|Non-Interventional Follow Up Phase||2||
48079617|NCT01594281|100518600|FG002|NOT COMPLETED|Non-Interventional Follow Up Phase||2||
48079618|NCT03521934|100518601|FG000|STARTED|Overall Study||608||
48079619|NCT03521934|100518602|FG001|STARTED|Overall Study||614||
48079620|NCT03521934|100518601|FG000|Randomized and Treated|Overall Study||605||
48079621|NCT03521934|100518602|FG001|Randomized and Treated|Overall Study||611||
48079622|NCT03521934|100518601|FG000|COMPLETED|Overall Study||0||
48079623|NCT03521934|100518602|FG001|COMPLETED|Overall Study||0||
48079624|NCT03521934|100518601|FG000|NOT COMPLETED|Overall Study||608||
48079625|NCT03521934|100518602|FG001|NOT COMPLETED|Overall Study||614||
48079626|NCT02859454|100518603|FG000|STARTED|Overall Study||13||
48079627|NCT02859454|100518603|FG000|COMPLETED|Overall Study||12||
48079628|NCT02859454|100518603|FG000|NOT COMPLETED|Overall Study||1||
48079629|NCT01650844|100518604|FG000|STARTED|Overall Study||200||
48079630|NCT01650844|100518605|FG001|STARTED|Overall Study||200||
48079631|NCT01650844|100518604|FG000|COMPLETED|Overall Study||199|'Completed' indicates all participants who had data to include in the primary analysis.|
48079632|NCT01650844|100518605|FG001|COMPLETED|Overall Study||196|'Completed' indicates all participants who had data to include in the primary analysis.|
48079633|NCT01650844|100518604|FG000|NOT COMPLETED|Overall Study||1||
48079634|NCT01650844|100518605|FG001|NOT COMPLETED|Overall Study||4||
48079635|NCT01161862|100518606|FG000|STARTED|Overall Study||12||
48079636|NCT01161862|100518607|FG001|STARTED|Overall Study||12||
48079637|NCT01161862|100518606|FG000|COMPLETED|Overall Study||12||
48079638|NCT01161862|100518607|FG001|COMPLETED|Overall Study||12||
48079639|NCT01161862|100518606|FG000|NOT COMPLETED|Overall Study||0||
48525775|NCT00750308|101621013|FG003|NOT COMPLETED|First Treatment||1||
48079640|NCT01161862|100518607|FG001|NOT COMPLETED|Overall Study||0||
48079641|NCT00496808|100518608|FG000|STARTED|Overall Study||69||
48079642|NCT00496808|100518608|FG000|COMPLETED|Overall Study||69||
48079643|NCT00496808|100518608|FG000|NOT COMPLETED|Overall Study||0||
48079644|NCT01756898|100518609|FG000|STARTED|Overall Study||92||
48079645|NCT01756898|100518610|FG001|STARTED|Overall Study||92||
48079646|NCT01756898|100518611|FG002|STARTED|Overall Study||93||
48079647|NCT01756898|100518612|FG003|STARTED|Overall Study||93||
48079648|NCT01756898|100518609|FG000|COMPLETED|Overall Study||73||
48525776|NCT00750308|101621014|FG004|NOT COMPLETED|First Treatment||0||
48525777|NCT00750308|101621015|FG005|NOT COMPLETED|First Treatment||0||
48525778|NCT00750308|101621016|FG006|NOT COMPLETED|First Treatment||0||
48525779|NCT00750308|101621017|FG007|NOT COMPLETED|First Treatment||1||
48525780|NCT00750308|101621018|FG008|NOT COMPLETED|First Treatment||0||
48525781|NCT00750308|101621019|FG009|NOT COMPLETED|First Treatment||0||
48525782|NCT00750308|101621020|FG010|NOT COMPLETED|First Treatment||1||
48525783|NCT00750308|101621021|FG011|NOT COMPLETED|First Treatment||1||
48079649|NCT01756898|100518610|FG001|COMPLETED|Overall Study||73||
48079650|NCT01756898|100518611|FG002|COMPLETED|Overall Study||76||
48079651|NCT01756898|100518612|FG003|COMPLETED|Overall Study||77||
48079652|NCT01756898|100518609|FG000|NOT COMPLETED|Overall Study||19||
48079653|NCT01756898|100518610|FG001|NOT COMPLETED|Overall Study||19||
48079654|NCT01756898|100518611|FG002|NOT COMPLETED|Overall Study||17||
48079655|NCT01756898|100518612|FG003|NOT COMPLETED|Overall Study||16||
48079656|NCT02161731|100518613|FG000|STARTED|Period 1 (Day -1 to Day 7 Predose)||24||
48079657|NCT02161731|100518614|FG001|STARTED|Period 1 (Day -1 to Day 7 Predose)||0||
48079658|NCT02161731|100518613|FG000|Received 1 Dose of Study Drug|Period 1 (Day -1 to Day 7 Predose)||24||
48079659|NCT02161731|100518614|FG001|Received 1 Dose of Study Drug|Period 1 (Day -1 to Day 7 Predose)||0||
48079660|NCT02161731|100518613|FG000|COMPLETED|Period 1 (Day -1 to Day 7 Predose)||24||
48079661|NCT02161731|100518614|FG001|COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0||
48079662|NCT02161731|100518613|FG000|NOT COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0||
48079663|NCT02161731|100518614|FG001|NOT COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0||
48079664|NCT02161731|100518613|FG000|STARTED|Period 2 (Day 7 Dosing to Day 23)||0||
48079665|NCT02161731|100518614|FG001|STARTED|Period 2 (Day 7 Dosing to Day 23)||24||
48079666|NCT02161731|100518613|FG000|Received 1 Dose of Study Drug|Period 2 (Day 7 Dosing to Day 23)||0||
48079667|NCT02161731|100518614|FG001|Received 1 Dose of Study Drug|Period 2 (Day 7 Dosing to Day 23)||24||
48079668|NCT02161731|100518613|FG000|COMPLETED|Period 2 (Day 7 Dosing to Day 23)||0||
48079669|NCT02161731|100518614|FG001|COMPLETED|Period 2 (Day 7 Dosing to Day 23)||22||
48079670|NCT02161731|100518613|FG000|NOT COMPLETED|Period 2 (Day 7 Dosing to Day 23)||0||
48079671|NCT02161731|100518614|FG001|NOT COMPLETED|Period 2 (Day 7 Dosing to Day 23)||2||
48079672|NCT01337739|100518615|FG000|STARTED|Overall Study||6||
48079673|NCT01337739|100518616|FG001|STARTED|Overall Study||4||
48079674|NCT01337739|100518615|FG000|COMPLETED|Overall Study||6||
48079675|NCT01337739|100518616|FG001|COMPLETED|Overall Study||4||
48079676|NCT01337739|100518615|FG000|NOT COMPLETED|Overall Study||0||
48079677|NCT01337739|100518616|FG001|NOT COMPLETED|Overall Study||0||
48079678|NCT01542125|100518617|FG000|STARTED|Overall Study||140||
48079679|NCT01542125|100518618|FG001|STARTED|Overall Study||141||
48079680|NCT01542125|100518617|FG000|COMPLETED|Overall Study||140||
48525784|NCT00750308|101621010|FG000|STARTED|Washout||2||
48525785|NCT00750308|101621011|FG001|STARTED|Washout||2||
48525786|NCT00750308|101621012|FG002|STARTED|Washout||2||
48079681|NCT01542125|100518618|FG001|COMPLETED|Overall Study||141||
48079682|NCT01542125|100518617|FG000|NOT COMPLETED|Overall Study||0||
48079683|NCT01542125|100518618|FG001|NOT COMPLETED|Overall Study||0||
48079684|NCT02423876|100518619|FG000|STARTED|Overall Study||52||
48079685|NCT02423876|100518620|FG001|STARTED|Overall Study||52||
48079686|NCT02423876|100518619|FG000|COMPLETED|Overall Study||52||
48079687|NCT02423876|100518620|FG001|COMPLETED|Overall Study||52||
48079688|NCT02423876|100518619|FG000|NOT COMPLETED|Overall Study||0||
48079689|NCT02423876|100518620|FG001|NOT COMPLETED|Overall Study||0||
48079690|NCT01340885|100518621|FG000|STARTED|Overall Study||0||
48079691|NCT01340885|100518622|FG001|STARTED|Overall Study||0||
48079692|NCT01340885|100518623|FG002|STARTED|Overall Study||0||
48079693|NCT01340885|100518621|FG000|COMPLETED|Overall Study||0||
48079694|NCT01340885|100518622|FG001|COMPLETED|Overall Study||0||
48079695|NCT01340885|100518623|FG002|COMPLETED|Overall Study||0||
48079696|NCT01340885|100518621|FG000|NOT COMPLETED|Overall Study||0||
48079697|NCT01340885|100518622|FG001|NOT COMPLETED|Overall Study||0||
48079698|NCT01340885|100518623|FG002|NOT COMPLETED|Overall Study||0||
48079699|NCT01603056|100518624|FG000|STARTED|Overall Study||413||
48079700|NCT01603056|100518625|FG001|STARTED|Overall Study||204||
48079701|NCT01603056|100518624|FG000|COMPLETED|Overall Study||379||
48525787|NCT00750308|101621013|FG003|STARTED|Washout||1||
48525788|NCT00750308|101621014|FG004|STARTED|Washout||2||
48525789|NCT00750308|101621015|FG005|STARTED|Washout||3||
48525790|NCT00750308|101621016|FG006|STARTED|Washout||2||
48525791|NCT00750308|101621017|FG007|STARTED|Washout||2||
48525792|NCT00750308|101621018|FG008|STARTED|Washout||2||
48525793|NCT00750308|101621019|FG009|STARTED|Washout||2||
48525794|NCT00750308|101621020|FG010|STARTED|Washout||1||
48079702|NCT01603056|100518625|FG001|COMPLETED|Overall Study||190||
48525795|NCT00750308|101621021|FG011|STARTED|Washout||1||
48079703|NCT01603056|100518624|FG000|NOT COMPLETED|Overall Study||34||
48079704|NCT01603056|100518625|FG001|NOT COMPLETED|Overall Study||14||
48525796|NCT00750308|101621010|FG000|COMPLETED|Washout||2||
48525797|NCT00750308|101621011|FG001|COMPLETED|Washout||2||
48079705|NCT00592943|100518626|FG000|STARTED|Overall Study||6||
48079706|NCT00592943|100518627|FG001|STARTED|Overall Study||6||
48079707|NCT00592943|100518626|FG000|COMPLETED|Overall Study||6||
48079708|NCT00592943|100518627|FG001|COMPLETED|Overall Study||6||
48079709|NCT00592943|100518626|FG000|NOT COMPLETED|Overall Study||0||
48079710|NCT00592943|100518627|FG001|NOT COMPLETED|Overall Study||0||
48079711|NCT01844518|100518628|FG000|STARTED|Overall Study||173||
48079712|NCT01844518|100518629|FG001|STARTED|Overall Study||46||
48079713|NCT01844518|100518628|FG000|COMPLETED|Overall Study||132||
48079714|NCT01844518|100518629|FG001|COMPLETED|Overall Study||39||
48079715|NCT01844518|100518628|FG000|NOT COMPLETED|Overall Study||41||
48079716|NCT01844518|100518629|FG001|NOT COMPLETED|Overall Study||7||
48079717|NCT00864383|100518630|FG000|STARTED|Per- Protocol||640||
48079718|NCT00864383|100518631|FG001|STARTED|Per- Protocol||655||
48079719|NCT00864383|100518632|FG002|STARTED|Per- Protocol||636||
48079720|NCT00864383|100518630|FG000|COMPLETED|Per- Protocol||510||
48079721|NCT00864383|100518631|FG001|COMPLETED|Per- Protocol||514||
48079722|NCT00864383|100518632|FG002|COMPLETED|Per- Protocol||524||
48079723|NCT00864383|100518630|FG000|NOT COMPLETED|Per- Protocol||130||
48079724|NCT00864383|100518631|FG001|NOT COMPLETED|Per- Protocol||141||
48525798|NCT00750308|101621012|FG002|COMPLETED|Washout||2||
48525799|NCT00750308|101621013|FG003|COMPLETED|Washout||1||
48525800|NCT00750308|101621014|FG004|COMPLETED|Washout||2||
48525801|NCT00750308|101621015|FG005|COMPLETED|Washout||3||
48525802|NCT00750308|101621016|FG006|COMPLETED|Washout||2||
48525803|NCT00750308|101621017|FG007|COMPLETED|Washout||2||
48525804|NCT00750308|101621018|FG008|COMPLETED|Washout||2||
48525805|NCT00750308|101621019|FG009|COMPLETED|Washout||2||
48525806|NCT00750308|101621020|FG010|COMPLETED|Washout||1||
48079725|NCT00864383|100518632|FG002|NOT COMPLETED|Per- Protocol||112||
48079726|NCT00864383|100518630|FG000|STARTED|Modified Intent to Treat||640||
48079727|NCT00864383|100518631|FG001|STARTED|Modified Intent to Treat||655||
48079728|NCT00864383|100518632|FG002|STARTED|Modified Intent to Treat||636||
48079729|NCT00864383|100518630|FG000|COMPLETED|Modified Intent to Treat||555||
48079730|NCT00864383|100518631|FG001|COMPLETED|Modified Intent to Treat||568||
48079731|NCT00864383|100518632|FG002|COMPLETED|Modified Intent to Treat||551||
48079732|NCT00864383|100518630|FG000|NOT COMPLETED|Modified Intent to Treat||85||
48079733|NCT00864383|100518631|FG001|NOT COMPLETED|Modified Intent to Treat||87||
48079734|NCT00864383|100518632|FG002|NOT COMPLETED|Modified Intent to Treat||85||
48079735|NCT01369758|100518633|FG000|STARTED|Overall Study||290||
48079736|NCT01369758|100518633|FG000|COMPLETED|Overall Study||290||
48079737|NCT01369758|100518633|FG000|NOT COMPLETED|Overall Study||0||
48079738|NCT02725710|100518634|FG000|STARTED|Overall Study||48||
48079739|NCT02725710|100518635|FG001|STARTED|Overall Study||47||
48079740|NCT02725710|100518634|FG000|COMPLETED|Overall Study||47||
48079741|NCT02725710|100518635|FG001|COMPLETED|Overall Study||47||
48079742|NCT02725710|100518634|FG000|NOT COMPLETED|Overall Study||1||
48079743|NCT02725710|100518635|FG001|NOT COMPLETED|Overall Study||0||
48079744|NCT00074152|100518636|FG000|STARTED|Overall Study||77||
48079745|NCT00074152|100518637|FG001|STARTED|Overall Study||85||
48079746|NCT00074152|100518636|FG000|COMPLETED|Overall Study||22||
48079747|NCT00074152|100518637|FG001|COMPLETED|Overall Study||52||
48079748|NCT00074152|100518636|FG000|NOT COMPLETED|Overall Study||55||
48227685|NCT04806100|100878065|FG005|STARTED|Overall Study||1||
48525807|NCT00750308|101621021|FG011|COMPLETED|Washout||1||
48525808|NCT00750308|101621010|FG000|NOT COMPLETED|Washout||0||
48525809|NCT00750308|101621011|FG001|NOT COMPLETED|Washout||0||
48525810|NCT00750308|101621012|FG002|NOT COMPLETED|Washout||0||
48525811|NCT00750308|101621013|FG003|NOT COMPLETED|Washout||0||
48525812|NCT00750308|101621014|FG004|NOT COMPLETED|Washout||0||
48525813|NCT00750308|101621015|FG005|NOT COMPLETED|Washout||0||
48525814|NCT00750308|101621016|FG006|NOT COMPLETED|Washout||0||
48525815|NCT00750308|101621017|FG007|NOT COMPLETED|Washout||0||
48525816|NCT00750308|101621018|FG008|NOT COMPLETED|Washout||0||
48525817|NCT00750308|101621019|FG009|NOT COMPLETED|Washout||0||
48525818|NCT00750308|101621020|FG010|NOT COMPLETED|Washout||0||
48525819|NCT00750308|101621021|FG011|NOT COMPLETED|Washout||0||
48525820|NCT00750308|101621010|FG000|STARTED|Second Treatment||2||
48079749|NCT00074152|100518637|FG001|NOT COMPLETED|Overall Study||33||
48079750|NCT01806298|100518638|FG000|STARTED|Overall Study||78||
48079751|NCT01806298|100518638|FG000|COMPLETED|Overall Study||68||
48079752|NCT01806298|100518638|FG000|NOT COMPLETED|Overall Study||10||
48525821|NCT00750308|101621011|FG001|STARTED|Second Treatment||2||
48079753|NCT00730405|100518639|FG000|STARTED|Overall Study-Treatment Phase||116||
48079754|NCT00730405|100518640|FG001|STARTED|Overall Study-Treatment Phase||117||
48079755|NCT00730405|100518641|FG002|STARTED|Overall Study-Treatment Phase||117||
48525822|NCT00750308|101621012|FG002|STARTED|Second Treatment||2||
48525823|NCT00750308|101621013|FG003|STARTED|Second Treatment||1||
48079756|NCT00730405|100518642|FG003|STARTED|Overall Study-Treatment Phase||117||
48079757|NCT00730405|100518643|FG004|STARTED|Overall Study-Treatment Phase||115||
48525824|NCT00750308|101621014|FG004|STARTED|Second Treatment||2||
48525825|NCT00750308|101621015|FG005|STARTED|Second Treatment||3||
48079758|NCT00730405|100518639|FG000|COMPLETED|Overall Study-Treatment Phase||97||
48079759|NCT00730405|100518640|FG001|COMPLETED|Overall Study-Treatment Phase||96||
48079760|NCT00730405|100518641|FG002|COMPLETED|Overall Study-Treatment Phase||96||
48079761|NCT00730405|100518642|FG003|COMPLETED|Overall Study-Treatment Phase||98||
48079762|NCT00730405|100518643|FG004|COMPLETED|Overall Study-Treatment Phase||95||
48079763|NCT00730405|100518639|FG000|NOT COMPLETED|Overall Study-Treatment Phase||19||
48079764|NCT00730405|100518640|FG001|NOT COMPLETED|Overall Study-Treatment Phase||21||
48525826|NCT00750308|101621016|FG006|STARTED|Second Treatment||2||
48525827|NCT00750308|101621017|FG007|STARTED|Second Treatment||2||
48525828|NCT00750308|101621018|FG008|STARTED|Second Treatment||2||
48525829|NCT00750308|101621019|FG009|STARTED|Second Treatment||2||
48525830|NCT00750308|101621020|FG010|STARTED|Second Treatment||1||
48525831|NCT00750308|101621021|FG011|STARTED|Second Treatment||1||
48525832|NCT00750308|101621010|FG000|COMPLETED|Second Treatment||2||
48525833|NCT00750308|101621011|FG001|COMPLETED|Second Treatment||2||
48079765|NCT00730405|100518641|FG002|NOT COMPLETED|Overall Study-Treatment Phase||21||
48079766|NCT00730405|100518642|FG003|NOT COMPLETED|Overall Study-Treatment Phase||19||
48079767|NCT00730405|100518643|FG004|NOT COMPLETED|Overall Study-Treatment Phase||20||
48079768|NCT00730405|100518639|FG000|STARTED|Overall Study-follow-up Phase||116||
48079769|NCT00730405|100518640|FG001|STARTED|Overall Study-follow-up Phase||117||
48525834|NCT00750308|101621012|FG002|COMPLETED|Second Treatment||2||
48525835|NCT00750308|101621013|FG003|COMPLETED|Second Treatment||1||
48079770|NCT00730405|100518641|FG002|STARTED|Overall Study-follow-up Phase||117||
48079771|NCT00730405|100518642|FG003|STARTED|Overall Study-follow-up Phase||117||
48079772|NCT00730405|100518643|FG004|STARTED|Overall Study-follow-up Phase||115||
48079773|NCT00730405|100518639|FG000|COMPLETED|Overall Study-follow-up Phase||95||
48079774|NCT00730405|100518640|FG001|COMPLETED|Overall Study-follow-up Phase||96||
48079775|NCT00730405|100518641|FG002|COMPLETED|Overall Study-follow-up Phase||94||
48079776|NCT00730405|100518642|FG003|COMPLETED|Overall Study-follow-up Phase||100||
48079777|NCT00730405|100518643|FG004|COMPLETED|Overall Study-follow-up Phase||93||
48079778|NCT00730405|100518639|FG000|NOT COMPLETED|Overall Study-follow-up Phase||21||
48079779|NCT00730405|100518640|FG001|NOT COMPLETED|Overall Study-follow-up Phase||21||
48079780|NCT00730405|100518641|FG002|NOT COMPLETED|Overall Study-follow-up Phase||23||
48079781|NCT00730405|100518642|FG003|NOT COMPLETED|Overall Study-follow-up Phase||17||
48079782|NCT00730405|100518643|FG004|NOT COMPLETED|Overall Study-follow-up Phase||22||
48079783|NCT00961233|100518644|FG000|STARTED|Overall Study||13||
48079784|NCT00961233|100518645|FG001|STARTED|Overall Study||12||
48079785|NCT00961233|100518644|FG000|COMPLETED|Overall Study||11||
48079786|NCT00961233|100518645|FG001|COMPLETED|Overall Study||11||
48079787|NCT00961233|100518644|FG000|NOT COMPLETED|Overall Study||2||
48079788|NCT00961233|100518645|FG001|NOT COMPLETED|Overall Study||1||
48079789|NCT01010061|100518646|FG000|STARTED|Overall Study||238||
48079790|NCT01010061|100518647|FG001|STARTED|Overall Study||118||
48079791|NCT01010061|100518646|FG000|Received Study Drug|Overall Study||236||
48079792|NCT01010061|100518647|FG001|Received Study Drug|Overall Study||116||
48079793|NCT01010061|100518646|FG000|COMPLETED|Overall Study||190||
48079794|NCT01010061|100518647|FG001|COMPLETED|Overall Study||78||
48079795|NCT01010061|100518646|FG000|NOT COMPLETED|Overall Study||48||
48079796|NCT01010061|100518647|FG001|NOT COMPLETED|Overall Study||40||
48079797|NCT02614586|100518648|FG000|STARTED|Overall Study||11||
48079798|NCT02614586|100518648|FG000|COMPLETED|Overall Study||11||
48079799|NCT02614586|100518648|FG000|NOT COMPLETED|Overall Study||0||
48079800|NCT03379168|100518649|FG000|STARTED|Overall Study||22||
48079801|NCT03379168|100518650|FG001|STARTED|Overall Study||23||
48079802|NCT03379168|100518651|FG002|STARTED|Overall Study||23||
48079803|NCT03379168|100518649|FG000|COMPLETED|Overall Study||18||
48079804|NCT03379168|100518650|FG001|COMPLETED|Overall Study||16||
48079805|NCT03379168|100518651|FG002|COMPLETED|Overall Study||18||
48227686|NCT04806100|100878060|FG000|COMPLETED|Overall Study||5||
48227687|NCT04806100|100878061|FG001|COMPLETED|Overall Study||5||
48525836|NCT00750308|101621014|FG004|COMPLETED|Second Treatment||1||
48525837|NCT00750308|101621015|FG005|COMPLETED|Second Treatment||2||
48525838|NCT00750308|101621016|FG006|COMPLETED|Second Treatment||2||
48525839|NCT00750308|101621017|FG007|COMPLETED|Second Treatment||2||
48525840|NCT00750308|101621018|FG008|COMPLETED|Second Treatment||1||
48525841|NCT00750308|101621019|FG009|COMPLETED|Second Treatment||2||
48525842|NCT00750308|101621020|FG010|COMPLETED|Second Treatment||1||
48525843|NCT00750308|101621021|FG011|COMPLETED|Second Treatment||1||
48525844|NCT00750308|101621010|FG000|NOT COMPLETED|Second Treatment||0||
48525845|NCT00750308|101621011|FG001|NOT COMPLETED|Second Treatment||0||
48079806|NCT03379168|100518649|FG000|NOT COMPLETED|Overall Study||4||
48079807|NCT03379168|100518650|FG001|NOT COMPLETED|Overall Study||7||
48525846|NCT00750308|101621012|FG002|NOT COMPLETED|Second Treatment||0||
48079808|NCT03379168|100518651|FG002|NOT COMPLETED|Overall Study||5||
48079809|NCT01918774|100518652|FG000|STARTED|Overall Study||57||
48525847|NCT00750308|101621013|FG003|NOT COMPLETED|Second Treatment||0||
48079810|NCT01918774|100518652|FG000|COMPLETED|Overall Study||52||
48079811|NCT01918774|100518652|FG000|NOT COMPLETED|Overall Study||5||
48079812|NCT02837783|100518653|FG000|STARTED|Overall Study||9||
48525848|NCT00750308|101621014|FG004|NOT COMPLETED|Second Treatment||1||
48525849|NCT00750308|101621015|FG005|NOT COMPLETED|Second Treatment||1||
48525850|NCT00750308|101621016|FG006|NOT COMPLETED|Second Treatment||0||
48525851|NCT00750308|101621017|FG007|NOT COMPLETED|Second Treatment||0||
48525852|NCT00750308|101621018|FG008|NOT COMPLETED|Second Treatment||1||
48525853|NCT00750308|101621019|FG009|NOT COMPLETED|Second Treatment||0||
48525854|NCT00750308|101621020|FG010|NOT COMPLETED|Second Treatment||0||
48525855|NCT00750308|101621021|FG011|NOT COMPLETED|Second Treatment||0||
48525856|NCT00750308|101621010|FG000|STARTED|Washout||2||
48525857|NCT00750308|101621011|FG001|STARTED|Washout||2||
48525858|NCT00750308|101621012|FG002|STARTED|Washout||2||
48079813|NCT02837783|100518654|FG001|STARTED|Overall Study||11||
48227688|NCT04806100|100878062|FG002|COMPLETED|Overall Study||3||
48525859|NCT00750308|101621013|FG003|STARTED|Washout||1||
48525860|NCT00750308|101621014|FG004|STARTED|Washout||1||
48525861|NCT00750308|101621015|FG005|STARTED|Washout||2||
48525862|NCT00750308|101621016|FG006|STARTED|Washout||2||
48525863|NCT00750308|101621017|FG007|STARTED|Washout||2||
48525864|NCT00750308|101621018|FG008|STARTED|Washout||1||
48525865|NCT00750308|101621019|FG009|STARTED|Washout||2||
48525866|NCT00750308|101621020|FG010|STARTED|Washout||1||
48525867|NCT00750308|101621021|FG011|STARTED|Washout||1||
48525868|NCT00750308|101621010|FG000|COMPLETED|Washout||2||
48525869|NCT00750308|101621011|FG001|COMPLETED|Washout||2||
48525870|NCT00750308|101621012|FG002|COMPLETED|Washout||2||
48525871|NCT00750308|101621013|FG003|COMPLETED|Washout||1||
48525872|NCT00750308|101621014|FG004|COMPLETED|Washout||1||
48525873|NCT00750308|101621015|FG005|COMPLETED|Washout||2||
48525874|NCT00750308|101621016|FG006|COMPLETED|Washout||2||
48525875|NCT00750308|101621017|FG007|COMPLETED|Washout||2||
48525876|NCT00750308|101621018|FG008|COMPLETED|Washout||1||
48525877|NCT00750308|101621019|FG009|COMPLETED|Washout||2||
48525878|NCT00750308|101621020|FG010|COMPLETED|Washout||1||
48525879|NCT00750308|101621021|FG011|COMPLETED|Washout||1||
48525880|NCT00750308|101621010|FG000|NOT COMPLETED|Washout||0||
48525881|NCT00750308|101621011|FG001|NOT COMPLETED|Washout||0||
48525882|NCT00750308|101621012|FG002|NOT COMPLETED|Washout||0||
48525883|NCT00750308|101621013|FG003|NOT COMPLETED|Washout||0||
48525884|NCT00750308|101621014|FG004|NOT COMPLETED|Washout||0||
48525885|NCT00750308|101621015|FG005|NOT COMPLETED|Washout||0||
48525886|NCT00750308|101621016|FG006|NOT COMPLETED|Washout||0||
48525887|NCT00750308|101621017|FG007|NOT COMPLETED|Washout||0||
48525888|NCT00750308|101621018|FG008|NOT COMPLETED|Washout||0||
48525889|NCT00750308|101621019|FG009|NOT COMPLETED|Washout||0||
48525890|NCT00750308|101621020|FG010|NOT COMPLETED|Washout||0||
48525891|NCT00750308|101621021|FG011|NOT COMPLETED|Washout||0||
48525892|NCT00750308|101621010|FG000|STARTED|Third Treatment||2||
48525893|NCT00750308|101621011|FG001|STARTED|Third Treatment||2||
48525894|NCT00750308|101621012|FG002|STARTED|Third Treatment||2||
48525895|NCT00750308|101621013|FG003|STARTED|Third Treatment||1||
48525896|NCT00750308|101621014|FG004|STARTED|Third Treatment||1||
48525897|NCT00750308|101621015|FG005|STARTED|Third Treatment||2||
48525898|NCT00750308|101621016|FG006|STARTED|Third Treatment||2||
48525899|NCT00750308|101621017|FG007|STARTED|Third Treatment||2||
48525900|NCT00750308|101621018|FG008|STARTED|Third Treatment||1||
48525901|NCT00750308|101621019|FG009|STARTED|Third Treatment||2||
48525902|NCT00750308|101621020|FG010|STARTED|Third Treatment||1||
48525903|NCT00750308|101621021|FG011|STARTED|Third Treatment||1||
48525904|NCT00750308|101621010|FG000|COMPLETED|Third Treatment||2||
48525905|NCT00750308|101621011|FG001|COMPLETED|Third Treatment||1||
48525906|NCT00750308|101621012|FG002|COMPLETED|Third Treatment||2||
48525907|NCT00750308|101621013|FG003|COMPLETED|Third Treatment||1||
48525908|NCT00750308|101621014|FG004|COMPLETED|Third Treatment||1||
48525909|NCT00750308|101621015|FG005|COMPLETED|Third Treatment||2||
48525910|NCT00750308|101621016|FG006|COMPLETED|Third Treatment||2||
48525911|NCT00750308|101621017|FG007|COMPLETED|Third Treatment||2||
48525912|NCT00750308|101621018|FG008|COMPLETED|Third Treatment||1||
48525913|NCT00750308|101621019|FG009|COMPLETED|Third Treatment||2||
48525914|NCT00750308|101621020|FG010|COMPLETED|Third Treatment||1||
48525915|NCT00750308|101621021|FG011|COMPLETED|Third Treatment||1||
48525916|NCT00750308|101621010|FG000|NOT COMPLETED|Third Treatment||0||
48525917|NCT00750308|101621011|FG001|NOT COMPLETED|Third Treatment||1||
48525918|NCT00750308|101621012|FG002|NOT COMPLETED|Third Treatment||0||
48525919|NCT00750308|101621013|FG003|NOT COMPLETED|Third Treatment||0||
48525920|NCT00750308|101621014|FG004|NOT COMPLETED|Third Treatment||0||
48525921|NCT00750308|101621015|FG005|NOT COMPLETED|Third Treatment||0||
48525922|NCT00750308|101621016|FG006|NOT COMPLETED|Third Treatment||0||
48525923|NCT00750308|101621017|FG007|NOT COMPLETED|Third Treatment||0||
48525924|NCT00750308|101621018|FG008|NOT COMPLETED|Third Treatment||0||
48525925|NCT00750308|101621019|FG009|NOT COMPLETED|Third Treatment||0||
48525926|NCT00750308|101621020|FG010|NOT COMPLETED|Third Treatment||0||
48525927|NCT00750308|101621021|FG011|NOT COMPLETED|Third Treatment||0||
48525928|NCT00750308|101621010|FG000|STARTED|Washout||2||
48525929|NCT00750308|101621011|FG001|STARTED|Washout||1||
48525930|NCT00750308|101621012|FG002|STARTED|Washout||2||
48525931|NCT00750308|101621013|FG003|STARTED|Washout||1||
48525932|NCT00750308|101621014|FG004|STARTED|Washout||1||
48525933|NCT00750308|101621015|FG005|STARTED|Washout||2||
48525934|NCT00750308|101621016|FG006|STARTED|Washout||2||
48525935|NCT00750308|101621017|FG007|STARTED|Washout||2||
48525936|NCT00750308|101621018|FG008|STARTED|Washout||1||
48525937|NCT00750308|101621019|FG009|STARTED|Washout||2||
48525938|NCT00750308|101621020|FG010|STARTED|Washout||1||
48525939|NCT00750308|101621021|FG011|STARTED|Washout||1||
48525940|NCT00750308|101621010|FG000|COMPLETED|Washout||2||
48525941|NCT00750308|101621011|FG001|COMPLETED|Washout||1||
48525942|NCT00750308|101621012|FG002|COMPLETED|Washout||2||
48079814|NCT02837783|100518653|FG000|Received >= 1 Dose of Study Drug|Overall Study||9||
48079815|NCT02837783|100518654|FG001|Received >= 1 Dose of Study Drug|Overall Study||10||
48079816|NCT02837783|100518653|FG000|COMPLETED|Overall Study||7||
48079817|NCT02837783|100518654|FG001|COMPLETED|Overall Study||9||
48079818|NCT02837783|100518653|FG000|NOT COMPLETED|Overall Study||2||
48079819|NCT02837783|100518654|FG001|NOT COMPLETED|Overall Study||2||
48079820|NCT03706456|100518655|FG000|STARTED|Overall Study||22||
48079821|NCT03706456|100518655|FG000|COMPLETED|Overall Study||19||
48079822|NCT03706456|100518655|FG000|NOT COMPLETED|Overall Study||3||
48079823|NCT00147446|100518656|FG000|STARTED|Overall Study||60||
48079824|NCT00147446|100518657|FG001|STARTED|Overall Study||61||
48079825|NCT00147446|100518656|FG000|COMPLETED|Overall Study||60||
48079826|NCT00147446|100518657|FG001|COMPLETED|Overall Study||61||
48079827|NCT00147446|100518656|FG000|NOT COMPLETED|Overall Study||0||
48525943|NCT00750308|101621013|FG003|COMPLETED|Washout||1||
48525944|NCT00750308|101621014|FG004|COMPLETED|Washout||1||
48525945|NCT00750308|101621015|FG005|COMPLETED|Washout||2||
48525946|NCT00750308|101621016|FG006|COMPLETED|Washout||2||
48525947|NCT00750308|101621017|FG007|COMPLETED|Washout||2||
48525948|NCT00750308|101621018|FG008|COMPLETED|Washout||1||
48079828|NCT00147446|100518657|FG001|NOT COMPLETED|Overall Study||0||
48079829|NCT02550106|100518658|FG000|STARTED|Overall Study||136||
48079830|NCT02550106|100518658|FG000|COMPLETED|Overall Study||124||
48079831|NCT02550106|100518658|FG000|NOT COMPLETED|Overall Study||12||
48079832|NCT01751178|100518659|FG000|STARTED|Overall Study||108||
48079833|NCT01751178|100518660|FG001|STARTED|Overall Study||109||
48079834|NCT01751178|100518661|FG002|STARTED|Overall Study||107||
48079835|NCT01751178|100518659|FG000|COMPLETED|Overall Study||105||
48079836|NCT01751178|100518660|FG001|COMPLETED|Overall Study||109||
48079837|NCT01751178|100518661|FG002|COMPLETED|Overall Study||105||
48079838|NCT01751178|100518659|FG000|NOT COMPLETED|Overall Study||3||
48079839|NCT01751178|100518660|FG001|NOT COMPLETED|Overall Study||0||
48079840|NCT01751178|100518661|FG002|NOT COMPLETED|Overall Study||2||
48079841|NCT02480114|100518662|FG000|STARTED|Overall Study||41||
48079842|NCT02480114|100518663|FG001|STARTED|Overall Study||38||
48079843|NCT02480114|100518662|FG000|COMPLETED|Overall Study||32||
48079844|NCT02480114|100518663|FG001|COMPLETED|Overall Study||30||
48079845|NCT02480114|100518662|FG000|NOT COMPLETED|Overall Study||9||
48079846|NCT02480114|100518663|FG001|NOT COMPLETED|Overall Study||8||
48525949|NCT00750308|101621019|FG009|COMPLETED|Washout||2||
48525950|NCT00750308|101621020|FG010|COMPLETED|Washout||1||
48525951|NCT00750308|101621021|FG011|COMPLETED|Washout||1||
48525952|NCT00750308|101621010|FG000|NOT COMPLETED|Washout||0||
48525953|NCT00750308|101621011|FG001|NOT COMPLETED|Washout||0||
48525954|NCT00750308|101621012|FG002|NOT COMPLETED|Washout||0||
48525955|NCT00750308|101621013|FG003|NOT COMPLETED|Washout||0||
48525956|NCT00750308|101621014|FG004|NOT COMPLETED|Washout||0||
48525957|NCT00750308|101621015|FG005|NOT COMPLETED|Washout||0||
48525958|NCT00750308|101621016|FG006|NOT COMPLETED|Washout||0||
48525959|NCT00750308|101621017|FG007|NOT COMPLETED|Washout||0||
48525960|NCT00750308|101621018|FG008|NOT COMPLETED|Washout||0||
48525961|NCT00750308|101621019|FG009|NOT COMPLETED|Washout||0||
48525962|NCT00750308|101621020|FG010|NOT COMPLETED|Washout||0||
48079847|NCT00370032|100518664|FG000|STARTED|Treatment Period 1||24||
48079848|NCT00370032|100518665|FG001|STARTED|Treatment Period 1||25||
48079849|NCT00370032|100518664|FG000|COMPLETED|Treatment Period 1||24||
48079850|NCT00370032|100518665|FG001|COMPLETED|Treatment Period 1||24||
48079851|NCT00370032|100518664|FG000|NOT COMPLETED|Treatment Period 1||0||
48079852|NCT00370032|100518665|FG001|NOT COMPLETED|Treatment Period 1||1||
48079853|NCT00370032|100518664|FG000|STARTED|Washout Period||24||
48079854|NCT00370032|100518665|FG001|STARTED|Washout Period||24||
48079855|NCT00370032|100518664|FG000|COMPLETED|Washout Period||23||
48525963|NCT00750308|101621021|FG011|NOT COMPLETED|Washout||0||
48525964|NCT00750308|101621010|FG000|STARTED|Fourth Treatment||2||
48525965|NCT00750308|101621011|FG001|STARTED|Fourth Treatment||1||
48079856|NCT00370032|100518665|FG001|COMPLETED|Washout Period||22||
48525966|NCT00750308|101621012|FG002|STARTED|Fourth Treatment||2||
48525967|NCT00750308|101621013|FG003|STARTED|Fourth Treatment||1||
48525968|NCT00750308|101621014|FG004|STARTED|Fourth Treatment||1||
48525969|NCT00750308|101621015|FG005|STARTED|Fourth Treatment||2||
48525970|NCT00750308|101621016|FG006|STARTED|Fourth Treatment||2||
48525971|NCT00750308|101621017|FG007|STARTED|Fourth Treatment||2||
48525972|NCT00750308|101621018|FG008|STARTED|Fourth Treatment||1||
48079857|NCT00370032|100518664|FG000|NOT COMPLETED|Washout Period||1||
48079858|NCT00370032|100518665|FG001|NOT COMPLETED|Washout Period||2||
48079859|NCT00370032|100518664|FG000|STARTED|Treatment Period 2||23||
48079860|NCT00370032|100518665|FG001|STARTED|Treatment Period 2||22||
48525973|NCT00750308|101621019|FG009|STARTED|Fourth Treatment||2||
48525974|NCT00750308|101621020|FG010|STARTED|Fourth Treatment||1||
48525975|NCT00750308|101621021|FG011|STARTED|Fourth Treatment||1||
48525976|NCT00750308|101621010|FG000|COMPLETED|Fourth Treatment||2||
48525977|NCT00750308|101621011|FG001|COMPLETED|Fourth Treatment||1||
48525978|NCT00750308|101621012|FG002|COMPLETED|Fourth Treatment||2||
48525979|NCT00750308|101621013|FG003|COMPLETED|Fourth Treatment||1||
48525980|NCT00750308|101621014|FG004|COMPLETED|Fourth Treatment||1||
48525981|NCT00750308|101621015|FG005|COMPLETED|Fourth Treatment||2||
48525982|NCT00750308|101621016|FG006|COMPLETED|Fourth Treatment||2||
48525983|NCT00750308|101621017|FG007|COMPLETED|Fourth Treatment||2||
48079861|NCT00370032|100518664|FG000|COMPLETED|Treatment Period 2||23||
48079862|NCT00370032|100518665|FG001|COMPLETED|Treatment Period 2||22||
48079863|NCT00370032|100518664|FG000|NOT COMPLETED|Treatment Period 2||0||
48079864|NCT00370032|100518665|FG001|NOT COMPLETED|Treatment Period 2||0||
48079865|NCT00370032|100518664|FG000|STARTED|Follow-up Period||23||
48079866|NCT00370032|100518665|FG001|STARTED|Follow-up Period||22||
48079867|NCT00370032|100518664|FG000|COMPLETED|Follow-up Period||22||
48079868|NCT00370032|100518665|FG001|COMPLETED|Follow-up Period||22||
48079869|NCT00370032|100518664|FG000|NOT COMPLETED|Follow-up Period||1||
48525984|NCT00750308|101621018|FG008|COMPLETED|Fourth Treatment||1||
48525985|NCT00750308|101621019|FG009|COMPLETED|Fourth Treatment||2||
48525986|NCT00750308|101621020|FG010|COMPLETED|Fourth Treatment||1||
48525987|NCT00750308|101621021|FG011|COMPLETED|Fourth Treatment||1||
48525988|NCT00750308|101621010|FG000|NOT COMPLETED|Fourth Treatment||0||
48079870|NCT00370032|100518665|FG001|NOT COMPLETED|Follow-up Period||0||
48079871|NCT02139228|100518666|FG000|STARTED|Overall Study||215||
48079872|NCT02139228|100518667|FG001|STARTED|Overall Study||211||
48079873|NCT02139228|100518666|FG000|COMPLETED|Overall Study||215||
48079874|NCT02139228|100518667|FG001|COMPLETED|Overall Study||211||
48079875|NCT02139228|100518666|FG000|NOT COMPLETED|Overall Study||0||
48079876|NCT02139228|100518667|FG001|NOT COMPLETED|Overall Study||0||
48079877|NCT00630396|100518668|FG000|STARTED|Overall Study||60||
48079878|NCT00630396|100518668|FG000|COMPLETED|Overall Study||53||
48079879|NCT00630396|100518668|FG000|NOT COMPLETED|Overall Study||7||
48525989|NCT00750308|101621011|FG001|NOT COMPLETED|Fourth Treatment||0||
48525990|NCT00750308|101621012|FG002|NOT COMPLETED|Fourth Treatment||0||
48525991|NCT00750308|101621013|FG003|NOT COMPLETED|Fourth Treatment||0||
48525992|NCT00750308|101621014|FG004|NOT COMPLETED|Fourth Treatment||0||
48079880|NCT00205881|100518669|FG000|STARTED|Overall Study||32||
48079881|NCT00205881|100518669|FG000|COMPLETED|Overall Study||16||
48525993|NCT00750308|101621015|FG005|NOT COMPLETED|Fourth Treatment||0||
48079882|NCT00205881|100518669|FG000|NOT COMPLETED|Overall Study||16||
48079883|NCT00779701|100518670|FG000|STARTED|Overall Study||27||
48525994|NCT00750308|101621016|FG006|NOT COMPLETED|Fourth Treatment||0||
48525995|NCT00750308|101621017|FG007|NOT COMPLETED|Fourth Treatment||0||
48525996|NCT00750308|101621018|FG008|NOT COMPLETED|Fourth Treatment||0||
48525997|NCT00750308|101621019|FG009|NOT COMPLETED|Fourth Treatment||0||
48525998|NCT00750308|101621020|FG010|NOT COMPLETED|Fourth Treatment||0||
48525999|NCT00750308|101621021|FG011|NOT COMPLETED|Fourth Treatment||0||
48526000|NCT03438396|101621022|FG000|STARTED|Overall Study||102||
48526001|NCT03438396|101621022|FG000|Treated|Overall Study||101||
48526002|NCT03438396|101621022|FG000|COMPLETED|Overall Study||0||
48526003|NCT03438396|101621022|FG000|NOT COMPLETED|Overall Study||102||
48526004|NCT02906241|101621023|FG000|STARTED|Overall Study||25||
48526005|NCT02906241|101621024|FG001|STARTED|Overall Study||29||
48526006|NCT02906241|101621025|FG002|STARTED|Overall Study||27||
48526007|NCT02906241|101621026|FG003|STARTED|Overall Study||235||
48526008|NCT02906241|101621023|FG000|COMPLETED|Overall Study||25||
48526009|NCT02906241|101621024|FG001|COMPLETED|Overall Study||29||
48526010|NCT02906241|101621025|FG002|COMPLETED|Overall Study||19||
48526011|NCT02906241|101621026|FG003|COMPLETED|Overall Study||235||
48526012|NCT02906241|101621023|FG000|NOT COMPLETED|Overall Study||0||
48526013|NCT02906241|101621024|FG001|NOT COMPLETED|Overall Study||0||
48526014|NCT02906241|101621025|FG002|NOT COMPLETED|Overall Study||8||
48526015|NCT02906241|101621026|FG003|NOT COMPLETED|Overall Study||0||
48526016|NCT01460901|101621027|FG000|STARTED|Overall Study||5||
48526017|NCT01460901|101621027|FG000|tV-CTL Infusion|Overall Study||3||
48526018|NCT01460901|101621027|FG000|COMPLETED|Overall Study||3||
48526019|NCT01460901|101621027|FG000|NOT COMPLETED|Overall Study||2||
48526020|NCT02017860|101621028|FG000|STARTED|Overall Study||4||
48526021|NCT02017860|101621028|FG000|COMPLETED|Overall Study||2||
48526022|NCT02017860|101621028|FG000|NOT COMPLETED|Overall Study||2||
48526023|NCT01330420|101621029|FG000|STARTED|Overall Study||28||
48079884|NCT00779701|100518670|FG000|COMPLETED|Overall Study||27||
48079885|NCT00779701|100518670|FG000|NOT COMPLETED|Overall Study||0||
48079886|NCT03334903|100518671|FG000|STARTED|Overall Study||39||
48079887|NCT03334903|100518672|FG001|STARTED|Overall Study||38||
48526024|NCT01330420|101621029|FG000|COMPLETED|Overall Study||24||
48526025|NCT01330420|101621029|FG000|NOT COMPLETED|Overall Study||4||
48526026|NCT02932228|101621030|FG000|STARTED|Overall Study||150||
48526027|NCT02932228|101621031|FG001|STARTED|Overall Study||433||
48526028|NCT02932228|101621030|FG000|COMPLETED|Overall Study||140||
48526029|NCT02932228|101621031|FG001|COMPLETED|Overall Study||405||
48526030|NCT02932228|101621030|FG000|NOT COMPLETED|Overall Study||10||
48526031|NCT02932228|101621031|FG001|NOT COMPLETED|Overall Study||28||
48526032|NCT01347866|101621032|FG000|STARTED|Overall Study||5||
48526033|NCT01347866|101621033|FG001|STARTED|Overall Study||1||
48526034|NCT01347866|101621034|FG002|STARTED|Overall Study||1||
48079888|NCT03334903|100518671|FG000|COMPLETED|Overall Study||35||
48079889|NCT03334903|100518672|FG001|COMPLETED|Overall Study||33||
48079890|NCT03334903|100518671|FG000|NOT COMPLETED|Overall Study||4||
48079891|NCT03334903|100518672|FG001|NOT COMPLETED|Overall Study||5||
48079892|NCT00787891|100518673|FG000|STARTED|Short-term Double-blind Phase (Part 1)||65||
48526035|NCT01347866|101621035|FG003|STARTED|Overall Study||7||
48526036|NCT01347866|101621036|FG004|STARTED|Overall Study||7||
48526037|NCT01347866|101621037|FG005|STARTED|Overall Study||3||
48526038|NCT01347866|101621038|FG006|STARTED|Overall Study||6||
48526039|NCT01347866|101621039|FG007|STARTED|Overall Study||4||
48526040|NCT01347866|101621040|FG008|STARTED|Overall Study||31||
48526041|NCT01347866|101621041|FG009|STARTED|Overall Study||7||
48526042|NCT01347866|101621042|FG010|STARTED|Overall Study||3||
48526043|NCT01347866|101621043|FG011|STARTED|Overall Study||4||
48526044|NCT01347866|101621044|FG012|STARTED|Overall Study||7||
48526045|NCT01347866|101621045|FG013|STARTED|Overall Study||7||
48526046|NCT01347866|101621046|FG014|STARTED|Overall Study||3||
48526047|NCT01347866|101621047|FG015|STARTED|Overall Study||4||
48526048|NCT01347866|101621048|FG016|STARTED|Overall Study||2||
48526049|NCT01347866|101621032|FG000|COMPLETED|Overall Study||0||
48526050|NCT01347866|101621033|FG001|COMPLETED|Overall Study||0||
48526051|NCT01347866|101621034|FG002|COMPLETED|Overall Study||0||
48526052|NCT01347866|101621035|FG003|COMPLETED|Overall Study||0||
48526053|NCT01347866|101621036|FG004|COMPLETED|Overall Study||0||
48079893|NCT00787891|100518674|FG001|STARTED|Short-term Double-blind Phase (Part 1)||62||
48079894|NCT00787891|100518673|FG000|COMPLETED|Short-term Double-blind Phase (Part 1)||55||
48079895|NCT00787891|100518674|FG001|COMPLETED|Short-term Double-blind Phase (Part 1)||53||
48079896|NCT00787891|100518673|FG000|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||10||
48079897|NCT00787891|100518674|FG001|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||9||
48526054|NCT01347866|101621037|FG005|COMPLETED|Overall Study||0||
48526055|NCT01347866|101621038|FG006|COMPLETED|Overall Study||0||
48526056|NCT01347866|101621039|FG007|COMPLETED|Overall Study||0||
48526057|NCT01347866|101621040|FG008|COMPLETED|Overall Study||0||
48526058|NCT01347866|101621041|FG009|COMPLETED|Overall Study||0||
48526059|NCT01347866|101621042|FG010|COMPLETED|Overall Study||0||
48526060|NCT01347866|101621043|FG011|COMPLETED|Overall Study||0||
48526061|NCT01347866|101621044|FG012|COMPLETED|Overall Study||0||
48526062|NCT01347866|101621045|FG013|COMPLETED|Overall Study||0||
48526063|NCT01347866|101621046|FG014|COMPLETED|Overall Study||0||
48526064|NCT01347866|101621047|FG015|COMPLETED|Overall Study||0||
48526065|NCT01347866|101621048|FG016|COMPLETED|Overall Study||0||
48526066|NCT01347866|101621032|FG000|NOT COMPLETED|Overall Study||5||
48526067|NCT01347866|101621033|FG001|NOT COMPLETED|Overall Study||1||
48526068|NCT01347866|101621034|FG002|NOT COMPLETED|Overall Study||1||
48526069|NCT01347866|101621035|FG003|NOT COMPLETED|Overall Study||7||
48526070|NCT01347866|101621036|FG004|NOT COMPLETED|Overall Study||7||
48526071|NCT01347866|101621037|FG005|NOT COMPLETED|Overall Study||3||
48526072|NCT01347866|101621038|FG006|NOT COMPLETED|Overall Study||6||
48526073|NCT01347866|101621039|FG007|NOT COMPLETED|Overall Study||4||
48526074|NCT01347866|101621040|FG008|NOT COMPLETED|Overall Study||31||
48526075|NCT01347866|101621041|FG009|NOT COMPLETED|Overall Study||7||
48526076|NCT01347866|101621042|FG010|NOT COMPLETED|Overall Study||3||
48526077|NCT01347866|101621043|FG011|NOT COMPLETED|Overall Study||4||
48526078|NCT01347866|101621044|FG012|NOT COMPLETED|Overall Study||7||
48079898|NCT00787891|100518673|FG000|STARTED|Maintenance Double-blind Phase (Part 2)||33||
48526079|NCT01347866|101621045|FG013|NOT COMPLETED|Overall Study||7||
48526080|NCT01347866|101621046|FG014|NOT COMPLETED|Overall Study||3||
48526081|NCT01347866|101621047|FG015|NOT COMPLETED|Overall Study||4||
48526082|NCT01347866|101621048|FG016|NOT COMPLETED|Overall Study||2||
48526083|NCT01833533|101621049|FG000|STARTED|Overall Study||100||
48526084|NCT01833533|101621050|FG001|STARTED|Overall Study||205||
48526085|NCT01833533|101621049|FG000|COMPLETED|Overall Study||94||
48526086|NCT01833533|101621050|FG001|COMPLETED|Overall Study||184||
48526087|NCT01833533|101621049|FG000|NOT COMPLETED|Overall Study||6||
48526088|NCT01833533|101621050|FG001|NOT COMPLETED|Overall Study||21||
48526089|NCT02145026|101621051|FG000|STARTED|Overall Study||100||
48526090|NCT02145026|101621051|FG000|COMPLETED|Overall Study||88||
48526091|NCT02145026|101621051|FG000|NOT COMPLETED|Overall Study||12||
48526092|NCT01045993|101621052|FG000|STARTED|Overall Study||26||
48526093|NCT01045993|101621053|FG001|STARTED|Overall Study||5||
48526094|NCT01045993|101621054|FG002|STARTED|Overall Study||5||
48526095|NCT01045993|101621055|FG003|STARTED|Overall Study||25||
48526096|NCT01045993|101621052|FG000|COMPLETED|Overall Study||26||
48526097|NCT01045993|101621053|FG001|COMPLETED|Overall Study||4||
48526098|NCT01045993|101621054|FG002|COMPLETED|Overall Study||5||
48526099|NCT01045993|101621055|FG003|COMPLETED|Overall Study||25||
48526100|NCT01045993|101621052|FG000|NOT COMPLETED|Overall Study||0||
48526101|NCT01045993|101621053|FG001|NOT COMPLETED|Overall Study||1||
48526102|NCT01045993|101621054|FG002|NOT COMPLETED|Overall Study||0||
48526103|NCT01045993|101621055|FG003|NOT COMPLETED|Overall Study||0||
48227689|NCT04806100|100878063|FG003|COMPLETED|Overall Study||2||
48526104|NCT01117766|101621056|FG000|STARTED|First Intervention||14||
48526105|NCT01117766|101621057|FG001|STARTED|First Intervention||17||
48526106|NCT01117766|101621056|FG000|Received Treatment|First Intervention||14||
48526107|NCT01117766|101621057|FG001|Received Treatment|First Intervention||17||
48526108|NCT01117766|101621056|FG000|COMPLETED|First Intervention||13||
48526109|NCT01117766|101621057|FG001|COMPLETED|First Intervention||16||
48526110|NCT01117766|101621056|FG000|NOT COMPLETED|First Intervention||1||
48526111|NCT01117766|101621057|FG001|NOT COMPLETED|First Intervention||1||
48526112|NCT01117766|101621056|FG000|STARTED|Washout Period||13||
48526113|NCT01117766|101621057|FG001|STARTED|Washout Period||16||
48526114|NCT01117766|101621056|FG000|COMPLETED|Washout Period||13||
48526115|NCT01117766|101621057|FG001|COMPLETED|Washout Period||14||
48526116|NCT01117766|101621056|FG000|NOT COMPLETED|Washout Period||0||
48526117|NCT01117766|101621057|FG001|NOT COMPLETED|Washout Period||2||
48526118|NCT01117766|101621056|FG000|STARTED|Second Intervention||13||
48526119|NCT01117766|101621057|FG001|STARTED|Second Intervention||14||
48526120|NCT01117766|101621056|FG000|COMPLETED|Second Intervention||11||
48526121|NCT01117766|101621057|FG001|COMPLETED|Second Intervention||9||
48526122|NCT01117766|101621056|FG000|NOT COMPLETED|Second Intervention||2||
48526123|NCT01117766|101621057|FG001|NOT COMPLETED|Second Intervention||5||
48526124|NCT00605865|101621058|FG000|STARTED|Overall Study||2272||
48526125|NCT00605865|101621058|FG000|COMPLETED|Overall Study||2157||
48079899|NCT00787891|100518674|FG001|STARTED|Maintenance Double-blind Phase (Part 2)||31||
48079900|NCT00787891|100518673|FG000|COMPLETED|Maintenance Double-blind Phase (Part 2)||26||
48526126|NCT00605865|101621058|FG000|NOT COMPLETED|Overall Study||115||
48526127|NCT03083821|101621059|FG000|STARTED|Overall Study||6||
48526128|NCT03083821|101621059|FG000|COMPLETED|Overall Study||6||
48526129|NCT03083821|101621059|FG000|NOT COMPLETED|Overall Study||0||
48526130|NCT00136318|101621060|FG000|STARTED|Overall Study||90||
48526131|NCT00136318|101621061|FG001|STARTED|Overall Study||91||
48526132|NCT00136318|101621060|FG000|COMPLETED|Overall Study||83||
48526133|NCT00136318|101621061|FG001|COMPLETED|Overall Study||84||
48526134|NCT00136318|101621060|FG000|NOT COMPLETED|Overall Study||7||
48079901|NCT00787891|100518674|FG001|COMPLETED|Maintenance Double-blind Phase (Part 2)||24||
48227690|NCT04806100|100878064|FG004|COMPLETED|Overall Study||4||
48227691|NCT04806100|100878065|FG005|COMPLETED|Overall Study||1||
48227692|NCT04806100|100878060|FG000|NOT COMPLETED|Overall Study||0||
48526135|NCT00136318|101621061|FG001|NOT COMPLETED|Overall Study||7||
48526136|NCT02310646|101621062|FG000|STARTED|First Intervention (Day 1 - Day 7)||109||
48526137|NCT02310646|101621063|FG001|STARTED|First Intervention (Day 1 - Day 7)||104||
48526138|NCT02310646|101621062|FG000|COMPLETED|First Intervention (Day 1 - Day 7)||107||
48526139|NCT02310646|101621063|FG001|COMPLETED|First Intervention (Day 1 - Day 7)||104||
48526140|NCT02310646|101621062|FG000|NOT COMPLETED|First Intervention (Day 1 - Day 7)||2||
48227693|NCT04806100|100878061|FG001|NOT COMPLETED|Overall Study||0||
48227694|NCT04806100|100878062|FG002|NOT COMPLETED|Overall Study||0||
48227695|NCT04806100|100878063|FG003|NOT COMPLETED|Overall Study||0||
48227696|NCT04806100|100878064|FG004|NOT COMPLETED|Overall Study||0||
48526141|NCT02310646|101621063|FG001|NOT COMPLETED|First Intervention (Day 1 - Day 7)||0||
48526142|NCT02310646|101621062|FG000|STARTED|Second Intervention (Day 8 - Day 14)||107||
48526143|NCT02310646|101621063|FG001|STARTED|Second Intervention (Day 8 - Day 14)||104||
48526144|NCT02310646|101621062|FG000|COMPLETED|Second Intervention (Day 8 - Day 14)||107||
48526145|NCT02310646|101621063|FG001|COMPLETED|Second Intervention (Day 8 - Day 14)||104||
48526146|NCT02310646|101621062|FG000|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0||
48526147|NCT02310646|101621063|FG001|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0||
48526148|NCT00588640|101621064|FG000|STARTED|Overall Study||10||
48526149|NCT00588640|101621064|FG000|COMPLETED|Overall Study||8||
48526150|NCT00588640|101621064|FG000|NOT COMPLETED|Overall Study||2||
48526151|NCT00725530|101621065|FG000|STARTED|First Intervention, 7 Days (+0/-1)||27||
48526152|NCT00725530|101621066|FG001|STARTED|First Intervention, 7 Days (+0/-1)||27||
48526153|NCT00725530|101621065|FG000|COMPLETED|First Intervention, 7 Days (+0/-1)||27||
48526154|NCT00725530|101621066|FG001|COMPLETED|First Intervention, 7 Days (+0/-1)||27||
48526155|NCT00725530|101621065|FG000|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0||
48526156|NCT00725530|101621066|FG001|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0||
48526157|NCT00725530|101621065|FG000|STARTED|Second Intervention, 7 Days (+0/-1)||27||
48526158|NCT00725530|101621066|FG001|STARTED|Second Intervention, 7 Days (+0/-1)||27||
48526159|NCT00725530|101621065|FG000|COMPLETED|Second Intervention, 7 Days (+0/-1)||27||
48526160|NCT00725530|101621066|FG001|COMPLETED|Second Intervention, 7 Days (+0/-1)||27||
48526161|NCT00725530|101621065|FG000|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0||
48526162|NCT00725530|101621066|FG001|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0||
48526163|NCT01753336|101621067|FG000|STARTED|Overall Study||112||
48526164|NCT01753336|101621067|FG000|Cycle 1|Overall Study||112||
48526165|NCT01753336|101621067|FG000|Cycle 2|Overall Study||98||
48526166|NCT01753336|101621067|FG000|Cycle 3|Overall Study||93||
48526167|NCT01753336|101621067|FG000|COMPLETED|Overall Study||92||
48526168|NCT01753336|101621067|FG000|NOT COMPLETED|Overall Study||20||
48526169|NCT04430855|101621068|FG000|STARTED|Period 1 (Weeks 1-12)||21||
48526170|NCT04430855|101621069|FG001|STARTED|Period 1 (Weeks 1-12)||47||
48526171|NCT04430855|101621068|FG000|Received Study Drug|Period 1 (Weeks 1-12)||21||
48526172|NCT04430855|101621069|FG001|Received Study Drug|Period 1 (Weeks 1-12)||47||
48526173|NCT04430855|101621068|FG000|COMPLETED|Period 1 (Weeks 1-12)||19||
48526174|NCT04430855|101621069|FG001|COMPLETED|Period 1 (Weeks 1-12)||41||
48079902|NCT00787891|100518673|FG000|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7||
48079903|NCT00787891|100518674|FG001|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7||
48079904|NCT02713347|100518675|FG000|STARTED|Baseline to 4 Months||154||
48079905|NCT02713347|100518676|FG001|STARTED|Baseline to 4 Months||152||
48526175|NCT04430855|101621068|FG000|NOT COMPLETED|Period 1 (Weeks 1-12)||2||
48526176|NCT04430855|101621069|FG001|NOT COMPLETED|Period 1 (Weeks 1-12)||6||
48526177|NCT04430855|101621068|FG000|STARTED|Period 2 (Weeks 12-48)||19||
48526178|NCT04430855|101621069|FG001|STARTED|Period 2 (Weeks 12-48)||41||
48526179|NCT04430855|101621068|FG000|COMPLETED|Period 2 (Weeks 12-48)||14||
48526180|NCT04430855|101621069|FG001|COMPLETED|Period 2 (Weeks 12-48)||31||
48526181|NCT04430855|101621068|FG000|NOT COMPLETED|Period 2 (Weeks 12-48)||5||
48526182|NCT04430855|101621069|FG001|NOT COMPLETED|Period 2 (Weeks 12-48)||10||
48526183|NCT02876926|101621070|FG000|STARTED|Overall Study||21||
48526184|NCT02876926|101621071|FG001|STARTED|Overall Study||22||
48526185|NCT02876926|101621072|FG002|STARTED|Overall Study||22||
48526186|NCT02876926|101621070|FG000|COMPLETED|Overall Study||3||
48526187|NCT02876926|101621071|FG001|COMPLETED|Overall Study||3||
48526188|NCT02876926|101621072|FG002|COMPLETED|Overall Study||2||
48526189|NCT02876926|101621070|FG000|NOT COMPLETED|Overall Study||18||
48526190|NCT02876926|101621071|FG001|NOT COMPLETED|Overall Study||19||
48526191|NCT02876926|101621072|FG002|NOT COMPLETED|Overall Study||20||
48526192|NCT02622113|101621073|FG000|STARTED|Overall Study||67||
48526193|NCT02622113|101621074|FG001|STARTED|Overall Study||76||
48526194|NCT02622113|101621073|FG000|COMPLETED|Overall Study||62||
48526195|NCT02622113|101621074|FG001|COMPLETED|Overall Study||66||
48526196|NCT02622113|101621073|FG000|NOT COMPLETED|Overall Study||5||
48526197|NCT02622113|101621074|FG001|NOT COMPLETED|Overall Study||10||
48526198|NCT00891371|101621075|FG000|STARTED|Pre-assignment||42||
48526199|NCT00891371|101621075|FG000|COMPLETED|Pre-assignment||36||
48526200|NCT00891371|101621075|FG000|NOT COMPLETED|Pre-assignment||6||
48526201|NCT00891371|101621075|FG000|STARTED|Treatment||36||
48526202|NCT00891371|101621075|FG000|COMPLETED|Treatment||27||
48526203|NCT00891371|101621075|FG000|NOT COMPLETED|Treatment||9||
48526204|NCT00946348|101621076|FG000|STARTED|Overall Study||6||
48526205|NCT00946348|101621077|FG001|STARTED|Overall Study||6||
48526206|NCT00946348|101621076|FG000|COMPLETED|Overall Study||6||
48526207|NCT00946348|101621077|FG001|COMPLETED|Overall Study||6||
48526208|NCT00946348|101621076|FG000|NOT COMPLETED|Overall Study||0||
48526209|NCT00946348|101621077|FG001|NOT COMPLETED|Overall Study||0||
48526210|NCT00546572|101621078|FG000|STARTED|Vax 1 / Year 0||464||
48079906|NCT02713347|100518675|FG000|COMPLETED|Baseline to 4 Months||120||
48079907|NCT02713347|100518676|FG001|COMPLETED|Baseline to 4 Months||129||
48079908|NCT02713347|100518675|FG000|NOT COMPLETED|Baseline to 4 Months||34||
48079909|NCT02713347|100518676|FG001|NOT COMPLETED|Baseline to 4 Months||23||
48079910|NCT02713347|100518675|FG000|STARTED|4 Months to 6 Months||148|The number eligible for follow-up at this time period was entered. The investigators allowed patients to miss a study time point and be eligible to complete surveys at subsequent time points. Participants who withdrew or deceased were not eligible for follow-up.|
48141193|NCT03581305|100670360|FG000|COMPLETED|Dopaminergic Study||20|this includes participants who finished the scan|
48141194|NCT03581305|100670361|FG001|COMPLETED|Dopaminergic Study||22|this includes participants who finished the scan|
48526211|NCT00546572|101621079|FG001|STARTED|Vax 1 / Year 0||474||
48526212|NCT00546572|101621078|FG000|Received Vax 1|Vax 1 / Year 0||463||
48526213|NCT00546572|101621079|FG001|Received Vax 1|Vax 1 / Year 0||473||
48526214|NCT00546572|101621078|FG000|COMPLETED|Vax 1 / Year 0||391||
48526215|NCT00546572|101621079|FG001|COMPLETED|Vax 1 / Year 0||404||
48526216|NCT00546572|101621078|FG000|NOT COMPLETED|Vax 1 / Year 0||73||
48526217|NCT00546572|101621079|FG001|NOT COMPLETED|Vax 1 / Year 0||70||
48526218|NCT00546572|101621078|FG000|STARTED|Vax 2 / Year 1||391||
48526219|NCT00546572|101621079|FG001|STARTED|Vax 2 / Year 1||404||
48526220|NCT00546572|101621078|FG000|Received Vax 2|Vax 2 / Year 1||391||
48526221|NCT00546572|101621079|FG001|Received Vax 2|Vax 2 / Year 1||404||
48526222|NCT00546572|101621078|FG000|COMPLETED|Vax 2 / Year 1||387||
48526223|NCT00546572|101621079|FG001|COMPLETED|Vax 2 / Year 1||402||
48526224|NCT00546572|101621078|FG000|NOT COMPLETED|Vax 2 / Year 1||4||
48526225|NCT00546572|101621079|FG001|NOT COMPLETED|Vax 2 / Year 1||2||
48526226|NCT03512262|101621080|FG000|STARTED|Overall Study||149||
48526227|NCT03512262|101621081|FG001|STARTED|Overall Study||79||
48526228|NCT03512262|101621080|FG000|Received at Least 1 Dose of Study Drug|Overall Study||149||
48526229|NCT03512262|101621081|FG001|Received at Least 1 Dose of Study Drug|Overall Study||79||
48526230|NCT03512262|101621080|FG000|COMPLETED|Overall Study||114||
48526231|NCT03512262|101621081|FG001|COMPLETED|Overall Study||64||
48526232|NCT03512262|101621080|FG000|NOT COMPLETED|Overall Study||35||
48526233|NCT03512262|101621081|FG001|NOT COMPLETED|Overall Study||15||
48526234|NCT00486018|101621082|FG000|STARTED|Overall Study||132||
48526235|NCT00486018|101621083|FG001|STARTED|Overall Study||134||
48526236|NCT00486018|101621084|FG002|STARTED|Overall Study||131||
48526237|NCT00486018|101621082|FG000|Received Drug (Safety Population)|Overall Study||131||
48526238|NCT00486018|101621083|FG001|Received Drug (Safety Population)|Overall Study||134||
48526239|NCT00486018|101621084|FG002|Received Drug (Safety Population)|Overall Study||130||
48526240|NCT00486018|101621082|FG000|COMPLETED|Overall Study||123||
48526241|NCT00486018|101621083|FG001|COMPLETED|Overall Study||128||
48526242|NCT00486018|101621084|FG002|COMPLETED|Overall Study||125||
48526243|NCT00486018|101621082|FG000|NOT COMPLETED|Overall Study||9||
48526244|NCT00486018|101621083|FG001|NOT COMPLETED|Overall Study||6||
48526245|NCT00486018|101621084|FG002|NOT COMPLETED|Overall Study||6||
48526246|NCT02296853|101621085|FG000|STARTED|Overall Study||10||
48526247|NCT02296853|101621086|FG001|STARTED|Overall Study||10||
48526248|NCT02296853|101621085|FG000|COMPLETED|Overall Study||10||
48526249|NCT02296853|101621086|FG001|COMPLETED|Overall Study||10||
48526250|NCT02296853|101621085|FG000|NOT COMPLETED|Overall Study||0||
48526251|NCT02296853|101621086|FG001|NOT COMPLETED|Overall Study||0||
48526252|NCT03923530|101621087|FG000|STARTED|Overall Study||12||
48526253|NCT03923530|101621087|FG000|COMPLETED|Overall Study||8||
48526254|NCT03923530|101621087|FG000|NOT COMPLETED|Overall Study||4||
48526255|NCT00871741|101621088|FG000|STARTED|Overall Study||9||
48526256|NCT00871741|101621089|FG001|STARTED|Overall Study||7||
48526257|NCT00871741|101621088|FG000|COMPLETED|Overall Study||0||
48526258|NCT00871741|101621089|FG001|COMPLETED|Overall Study||0||
48526259|NCT00871741|101621088|FG000|NOT COMPLETED|Overall Study||9||
48526260|NCT00871741|101621089|FG001|NOT COMPLETED|Overall Study||7||
48526261|NCT03734666|101623911|FG000|STARTED|Overall Study||35||
48526262|NCT03734666|101623912|FG001|STARTED|Overall Study||32||
48526263|NCT03734666|101623911|FG000|COMPLETED|Overall Study||16||
48526264|NCT03734666|101623912|FG001|COMPLETED|Overall Study||16||
48526265|NCT03734666|101623911|FG000|NOT COMPLETED|Overall Study||19||
48526266|NCT03734666|101623912|FG001|NOT COMPLETED|Overall Study||16||
48526267|NCT00468728|101623913|FG000|STARTED|Enrollment||264||
48526268|NCT00468728|101623914|FG001|STARTED|Enrollment||271||
48526269|NCT00468728|101623913|FG000|COMPLETED|Enrollment||260||
48526270|NCT00468728|101623914|FG001|COMPLETED|Enrollment||264||
48526271|NCT00468728|101623913|FG000|NOT COMPLETED|Enrollment||4||
48526272|NCT00468728|101623914|FG001|NOT COMPLETED|Enrollment||7||
48526273|NCT00468728|101623913|FG000|STARTED|Treatment||260||
48526274|NCT00468728|101623914|FG001|STARTED|Treatment||264||
48526275|NCT00468728|101623913|FG000|COMPLETED|Treatment||256||
48526276|NCT00468728|101623914|FG001|COMPLETED|Treatment||253||
48079911|NCT02713347|100518676|FG001|STARTED|4 Months to 6 Months||148|The number eligible for follow-up at this time period was entered. The investigators allowed patients to miss a study time point and be eligible to complete surveys at subsequent time points. Participants who withdrew or deceased were not eligible for follow-up.|
48079912|NCT02713347|100518675|FG000|COMPLETED|4 Months to 6 Months||122||
48079913|NCT02713347|100518676|FG001|COMPLETED|4 Months to 6 Months||122||
48526277|NCT00468728|101623913|FG000|NOT COMPLETED|Treatment||4||
48526278|NCT00468728|101623914|FG001|NOT COMPLETED|Treatment||11||
48526279|NCT00468728|101623913|FG000|STARTED|Follow-up||256||
48526280|NCT00468728|101623914|FG001|STARTED|Follow-up||253||
48526281|NCT00468728|101623913|FG000|COMPLETED|Follow-up||222||
48526282|NCT00468728|101623914|FG001|COMPLETED|Follow-up||222||
48526283|NCT00468728|101623913|FG000|NOT COMPLETED|Follow-up||34||
48526284|NCT00468728|101623914|FG001|NOT COMPLETED|Follow-up||31||
48079914|NCT02713347|100518675|FG000|NOT COMPLETED|4 Months to 6 Months||26||
48079915|NCT02713347|100518676|FG001|NOT COMPLETED|4 Months to 6 Months||26||
48079916|NCT02713347|100518675|FG000|STARTED|6 Months to 12 Months||146|The number eligible for follow-up at this time period was entered. We allowed patients to miss a study time point and be eligible to complete surveys at subsequent time points. Participants who withdrew or deceased were not eligible for follow-up.|
48079917|NCT02713347|100518676|FG001|STARTED|6 Months to 12 Months||143|The number eligible for follow-up at this time period was entered. We allowed patients to miss a study time point and be eligible to complete surveys at subsequent time points. Participants who withdrew or deceased were not eligible for follow-up.|
48079918|NCT02713347|100518675|FG000|COMPLETED|6 Months to 12 Months||107||
48079919|NCT02713347|100518676|FG001|COMPLETED|6 Months to 12 Months||111||
48079920|NCT02713347|100518675|FG000|NOT COMPLETED|6 Months to 12 Months||39||
48079921|NCT02713347|100518676|FG001|NOT COMPLETED|6 Months to 12 Months||32||
48079922|NCT01238471|100518677|FG000|STARTED|Overall Study||10||
48079923|NCT01238471|100518678|FG001|STARTED|Overall Study||10||
48079924|NCT01238471|100518677|FG000|COMPLETED|Overall Study||10||
48079925|NCT01238471|100518678|FG001|COMPLETED|Overall Study||10||
48079926|NCT01238471|100518677|FG000|NOT COMPLETED|Overall Study||0||
48079927|NCT01238471|100518678|FG001|NOT COMPLETED|Overall Study||0||
48526285|NCT03493542|101623915|FG000|STARTED|Overall Study||383||
48526286|NCT03493542|101623916|FG001|STARTED|Overall Study||383||
48526287|NCT03493542|101623915|FG000|Vaccination 1|Overall Study||383||
48526288|NCT03493542|101623916|FG001|Vaccination 1|Overall Study||383||
48526289|NCT03493542|101623915|FG000|Vaccination 2|Overall Study||379||
48526290|NCT03493542|101623916|FG001|Vaccination 2|Overall Study||378||
48526291|NCT03493542|101623915|FG000|Vaccination 3|Overall Study||376||
48526292|NCT03493542|101623916|FG001|Vaccination 3|Overall Study||374||
48526293|NCT03493542|101623915|FG000|COMPLETED|Overall Study||376||
48526294|NCT03493542|101623916|FG001|COMPLETED|Overall Study||374||
48526295|NCT03493542|101623915|FG000|NOT COMPLETED|Overall Study||7||
48526296|NCT03493542|101623916|FG001|NOT COMPLETED|Overall Study||9||
48526297|NCT02304458|101623917|FG000|STARTED|Overall Study||7||
48526298|NCT02304458|101623918|FG001|STARTED|Overall Study||6||
48526299|NCT02304458|101623919|FG002|STARTED|Overall Study||72||
48526300|NCT02304458|101623920|FG003|STARTED|Overall Study||6||
48526301|NCT02304458|101623921|FG004|STARTED|Overall Study||6||
48526302|NCT02304458|101623922|FG005|STARTED|Overall Study||6||
48526303|NCT02304458|101623923|FG006|STARTED|Overall Study||29||
48526304|NCT02304458|101623924|FG007|STARTED|Overall Study||8||
48526305|NCT02304458|101623917|FG000|COMPLETED|Overall Study||0||
48526306|NCT02304458|101623918|FG001|COMPLETED|Overall Study||0||
48526307|NCT02304458|101623919|FG002|COMPLETED|Overall Study||1||
48526308|NCT02304458|101623920|FG003|COMPLETED|Overall Study||0||
48526309|NCT02304458|101623921|FG004|COMPLETED|Overall Study||0||
48526310|NCT02304458|101623922|FG005|COMPLETED|Overall Study||0||
48526311|NCT02304458|101623923|FG006|COMPLETED|Overall Study||0||
48526312|NCT02304458|101623924|FG007|COMPLETED|Overall Study||0||
48526313|NCT02304458|101623917|FG000|NOT COMPLETED|Overall Study||7||
48526314|NCT02304458|101623918|FG001|NOT COMPLETED|Overall Study||6||
48526315|NCT02304458|101623919|FG002|NOT COMPLETED|Overall Study||71||
48526316|NCT02304458|101623920|FG003|NOT COMPLETED|Overall Study||6||
48526317|NCT02304458|101623921|FG004|NOT COMPLETED|Overall Study||6||
48526318|NCT02304458|101623922|FG005|NOT COMPLETED|Overall Study||6||
48526319|NCT02304458|101623923|FG006|NOT COMPLETED|Overall Study||29||
48526320|NCT02304458|101623924|FG007|NOT COMPLETED|Overall Study||8||
48526321|NCT03979820|101623925|FG000|STARTED|Overall Study||13||
48526322|NCT03979820|101623926|FG001|STARTED|Overall Study||14||
48526323|NCT03979820|101623927|FG002|STARTED|Overall Study||16||
48526324|NCT03979820|101623928|FG003|STARTED|Overall Study||10||
48526325|NCT03979820|101623925|FG000|COMPLETED|Overall Study||7||
48526326|NCT03979820|101623926|FG001|COMPLETED|Overall Study||14||
48526327|NCT03979820|101623927|FG002|COMPLETED|Overall Study||15||
48526328|NCT03979820|101623928|FG003|COMPLETED|Overall Study||0||
48526329|NCT03979820|101623925|FG000|NOT COMPLETED|Overall Study||6||
48526330|NCT03979820|101623926|FG001|NOT COMPLETED|Overall Study||0||
48526331|NCT03979820|101623927|FG002|NOT COMPLETED|Overall Study||1||
48526332|NCT03979820|101623928|FG003|NOT COMPLETED|Overall Study||10||
48526333|NCT02581007|101623929|FG000|STARTED|Overall Study||25||
48526334|NCT02581007|101623929|FG000|COMPLETED|Overall Study||25||
48526335|NCT02581007|101623929|FG000|NOT COMPLETED|Overall Study||0||
48526336|NCT01859130|101623930|FG000|STARTED|Overall Study||299||
48526337|NCT01859130|101623930|FG000|COMPLETED|Overall Study||192||
48526338|NCT01859130|101623930|FG000|NOT COMPLETED|Overall Study||107||
48526339|NCT02143583|101623931|FG000|STARTED|Overall Study||62||
48526340|NCT02143583|101623932|FG001|STARTED|Overall Study||66||
48526341|NCT02143583|101623933|FG002|STARTED|Overall Study||68||
48526342|NCT02143583|101623931|FG000|COMPLETED|Overall Study||61||
48526343|NCT02143583|101623932|FG001|COMPLETED|Overall Study||66||
48526344|NCT02143583|101623933|FG002|COMPLETED|Overall Study||66||
48526345|NCT02143583|101623931|FG000|NOT COMPLETED|Overall Study||1||
48526346|NCT02143583|101623932|FG001|NOT COMPLETED|Overall Study||0||
48526347|NCT02143583|101623933|FG002|NOT COMPLETED|Overall Study||2||
48526348|NCT02384941|101623934|FG000|STARTED|Overall Study||268||
48526349|NCT02384941|101623935|FG001|STARTED|Overall Study||263||
48526350|NCT02384941|101623936|FG002|STARTED|Overall Study||262||
48526351|NCT02384941|101623934|FG000|COMPLETED|Overall Study||218||
48526352|NCT02384941|101623935|FG001|COMPLETED|Overall Study||228||
48526353|NCT02384941|101623936|FG002|COMPLETED|Overall Study||221||
48526354|NCT02384941|101623934|FG000|NOT COMPLETED|Overall Study||50||
48526355|NCT02384941|101623935|FG001|NOT COMPLETED|Overall Study||35||
48526356|NCT02384941|101623936|FG002|NOT COMPLETED|Overall Study||41||
48526357|NCT01598350|101623937|FG000|STARTED|Overall Study||6||
48526358|NCT01598350|101623937|FG000|COMPLETED|Overall Study||6||
48526359|NCT01598350|101623937|FG000|NOT COMPLETED|Overall Study||0||
48526360|NCT02920918|101623938|FG000|STARTED|Overall Study||17||
48526361|NCT02920918|101623939|FG001|STARTED|Overall Study||19||
48526362|NCT02920918|101623938|FG000|COMPLETED|Overall Study||17||
48526363|NCT02920918|101623939|FG001|COMPLETED|Overall Study||19||
48526364|NCT02920918|101623938|FG000|NOT COMPLETED|Overall Study||0||
48526365|NCT02920918|101623939|FG001|NOT COMPLETED|Overall Study||0||
48526366|NCT03474432|101623940|FG000|STARTED|Overall Study||12||
48526367|NCT03474432|101623940|FG000|COMPLETED|Overall Study||6||
48526368|NCT03474432|101623940|FG000|NOT COMPLETED|Overall Study||6||
48526369|NCT02327741|101623941|FG000|STARTED|Overall Study||502||
48526370|NCT02327741|101623942|FG001|STARTED|Overall Study||508||
48526371|NCT02327741|101623941|FG000|COMPLETED|Overall Study||502||
48526372|NCT02327741|101623942|FG001|COMPLETED|Overall Study||508||
48526373|NCT02327741|101623941|FG000|NOT COMPLETED|Overall Study||0||
48526374|NCT02327741|101623942|FG001|NOT COMPLETED|Overall Study||0||
48526375|NCT03182582|101623943|FG000|STARTED|Treatment 1||12||
48526376|NCT03182582|101623944|FG001|STARTED|Treatment 1||10||
48526377|NCT03182582|101623943|FG000|COMPLETED|Treatment 1||12||
48526378|NCT03182582|101623944|FG001|COMPLETED|Treatment 1||10||
48526379|NCT03182582|101623943|FG000|NOT COMPLETED|Treatment 1||0||
48526380|NCT03182582|101623944|FG001|NOT COMPLETED|Treatment 1||0||
48526381|NCT03182582|101623943|FG000|STARTED|Treatment 2||12||
48526382|NCT03182582|101623944|FG001|STARTED|Treatment 2||10||
48526383|NCT03182582|101623943|FG000|COMPLETED|Treatment 2||12||
48526384|NCT03182582|101623944|FG001|COMPLETED|Treatment 2||10||
48526385|NCT03182582|101623943|FG000|NOT COMPLETED|Treatment 2||0||
48526386|NCT03182582|101623944|FG001|NOT COMPLETED|Treatment 2||0||
48526387|NCT01565616|101623945|FG000|STARTED|Overall Study||22||
48592647|NCT01877382|101783164|FG014|COMPLETED|Dose Escalation||0||
48079928|NCT04649060|100518679|FG000|STARTED|Arm A/Arm B Treatment||27||
48079929|NCT04649060|100518680|FG001|STARTED|Arm A/Arm B Treatment||27||
48079930|NCT04649060|100518679|FG000|Treated|Arm A/Arm B Treatment||22|There were 6 randomized patients (5 in Arm A and 1 in Arm B) who never received treatment due to failure to meet treatment initiation criteria and/or consent withdrawal.|
48079931|NCT04649060|100518680|FG001|Treated|Arm A/Arm B Treatment||26|There were 6 randomized patients (5 in Arm A and 1 in Arm B) who never received treatment due to failure to meet treatment initiation criteria and/or consent withdrawal.|
48079932|NCT04649060|100518679|FG000|COMPLETED|Arm A/Arm B Treatment||0||
48526388|NCT01565616|101623945|FG000|First Component: 5 Related Donors|Overall Study||5|The first component was restricted to patients having an HLA-identical sibling donor.|
48526389|NCT01565616|101623945|FG000|Second Component: Related or Unrelated|Overall Study||17|The second component included patients having a related or unrelated HLA matched donor.|
48526390|NCT01565616|101623945|FG000|COMPLETED|Overall Study||22||
48526391|NCT01565616|101623945|FG000|NOT COMPLETED|Overall Study||0||
48526392|NCT00448136|101623946|FG000|STARTED|Overall Study||34||
48526393|NCT00448136|101623947|FG001|STARTED|Overall Study||49||
48526394|NCT00448136|101623946|FG000|COMPLETED|Overall Study||30||
48526395|NCT00448136|101623947|FG001|COMPLETED|Overall Study||41||
48526396|NCT00448136|101623946|FG000|NOT COMPLETED|Overall Study||4||
48526397|NCT00448136|101623947|FG001|NOT COMPLETED|Overall Study||8||
48526398|NCT00289874|101623948|FG000|STARTED|Overall Study||203||
48526399|NCT00289874|101623949|FG001|STARTED|Overall Study||218||
48526400|NCT00289874|101623948|FG000|COMPLETED|Overall Study||197||
48526401|NCT00289874|101623949|FG001|COMPLETED|Overall Study||210||
48526402|NCT00289874|101623948|FG000|NOT COMPLETED|Overall Study||6||
48526403|NCT00289874|101623949|FG001|NOT COMPLETED|Overall Study||8||
48526404|NCT01481324|101623950|FG000|STARTED|Overall Study||21||
48079933|NCT04649060|100518680|FG001|COMPLETED|Arm A/Arm B Treatment||0||
48079934|NCT04649060|100518679|FG000|NOT COMPLETED|Arm A/Arm B Treatment||27||
48079935|NCT04649060|100518680|FG001|NOT COMPLETED|Arm A/Arm B Treatment||27||
48079936|NCT04649060|100518679|FG000|STARTED|Crossover (Arm B)||0||
48079937|NCT04649060|100518680|FG001|STARTED|Crossover (Arm B)||2||
48079938|NCT04649060|100518679|FG000|Treated|Crossover (Arm B)||0||
48079939|NCT04649060|100518680|FG001|Treated|Crossover (Arm B)||2||
48079940|NCT04649060|100518679|FG000|COMPLETED|Crossover (Arm B)||0||
48079941|NCT04649060|100518680|FG001|COMPLETED|Crossover (Arm B)||0||
48079942|NCT04649060|100518679|FG000|NOT COMPLETED|Crossover (Arm B)||0||
48079943|NCT04649060|100518680|FG001|NOT COMPLETED|Crossover (Arm B)||2||
48079944|NCT02006719|100518681|FG000|STARTED|Overall Study||237||
48079945|NCT02006719|100518682|FG001|STARTED|Overall Study||85||
48079946|NCT02006719|100518681|FG000|COMPLETED|Overall Study||219||
48079947|NCT02006719|100518682|FG001|COMPLETED|Overall Study||80||
48079948|NCT02006719|100518681|FG000|NOT COMPLETED|Overall Study||18||
48079949|NCT02006719|100518682|FG001|NOT COMPLETED|Overall Study||5||
48079950|NCT00317356|100518683|FG000|STARTED|Overall Study||11||
48079951|NCT00317356|100518684|FG001|STARTED|Overall Study||11||
48079952|NCT00317356|100518685|FG002|STARTED|Overall Study||10||
48079953|NCT00317356|100518686|FG003|STARTED|Overall Study||11||
48079954|NCT00317356|100518683|FG000|COMPLETED|Overall Study||10||
48079955|NCT00317356|100518684|FG001|COMPLETED|Overall Study||9||
48079956|NCT00317356|100518685|FG002|COMPLETED|Overall Study||9||
48079957|NCT00317356|100518686|FG003|COMPLETED|Overall Study||8||
48079958|NCT00317356|100518683|FG000|NOT COMPLETED|Overall Study||1||
48079959|NCT00317356|100518684|FG001|NOT COMPLETED|Overall Study||2||
48526405|NCT01481324|101623951|FG001|STARTED|Overall Study||24||
48526406|NCT01481324|101623952|FG002|STARTED|Overall Study||22||
48526407|NCT01481324|101623950|FG000|Month 1-Wear Rate Data|Overall Study||15||
48526408|NCT01481324|101623951|FG001|Month 1-Wear Rate Data|Overall Study||16||
48526409|NCT01481324|101623952|FG002|Month 1-Wear Rate Data|Overall Study||8||
48526410|NCT01481324|101623950|FG000|Month 2-Wear Rate Data|Overall Study||9||
48526411|NCT01481324|101623951|FG001|Month 2-Wear Rate Data|Overall Study||13||
48526412|NCT01481324|101623952|FG002|Month 2-Wear Rate Data|Overall Study||7||
48526413|NCT01481324|101623950|FG000|Month 3-Wear Rate Data|Overall Study||7||
48526414|NCT01481324|101623951|FG001|Month 3-Wear Rate Data|Overall Study||11||
48526415|NCT01481324|101623952|FG002|Month 3-Wear Rate Data|Overall Study||6||
48526416|NCT01481324|101623950|FG000|COMPLETED|Overall Study||21||
48526417|NCT01481324|101623951|FG001|COMPLETED|Overall Study||22||
48526418|NCT01481324|101623952|FG002|COMPLETED|Overall Study||20||
48526419|NCT01481324|101623950|FG000|NOT COMPLETED|Overall Study||0||
48526420|NCT01481324|101623951|FG001|NOT COMPLETED|Overall Study||2||
48526421|NCT01481324|101623952|FG002|NOT COMPLETED|Overall Study||2||
48526422|NCT01108666|101623953|FG000|STARTED|Overall Study||7||
48526423|NCT01108666|101623953|FG000|COMPLETED|Overall Study||7||
48079960|NCT00317356|100518685|FG002|NOT COMPLETED|Overall Study||1||
48079961|NCT00317356|100518686|FG003|NOT COMPLETED|Overall Study||3||
48227697|NCT04806100|100878065|FG005|NOT COMPLETED|Overall Study||0||
48227698|NCT04012970|100878066|FG000|STARTED|Intervention Session, 30 Minutes||26||
48227699|NCT04012970|100878067|FG001|STARTED|Intervention Session, 30 Minutes||14||
48227700|NCT04012970|100878066|FG000|COMPLETED|Intervention Session, 30 Minutes||26||
48526424|NCT01108666|101623953|FG000|NOT COMPLETED|Overall Study||0||
48526425|NCT01769339|101623954|FG000|STARTED|Overall Study||115||
48526426|NCT01769339|101623954|FG000|COMPLETED|Overall Study||72||
48526427|NCT01769339|101623954|FG000|NOT COMPLETED|Overall Study||43||
48526428|NCT01941940|101623955|FG000|STARTED|Overall Study||227||
48526429|NCT01941940|101623955|FG000|COMPLETED|Overall Study||194||
48526430|NCT01941940|101623955|FG000|NOT COMPLETED|Overall Study||33||
48526431|NCT01565850|101623956|FG000|STARTED|Overall Study||103||
48526432|NCT01565850|101623957|FG001|STARTED|Overall Study||50||
48526433|NCT01565850|101623956|FG000|COMPLETED|Overall Study||83||
48079962|NCT01179568|100518687|FG000|STARTED|Overall Study||101||
48079963|NCT01179568|100518688|FG001|STARTED|Overall Study||99||
48079964|NCT01179568|100518689|FG002|STARTED|Overall Study||99||
48079965|NCT01179568|100518690|FG003|STARTED|Overall Study||96||
48079966|NCT01179568|100518687|FG000|Completed Week 12 Assessment|Overall Study||69||
48079967|NCT01179568|100518688|FG001|Completed Week 12 Assessment|Overall Study||69||
48079968|NCT01179568|100518689|FG002|Completed Week 12 Assessment|Overall Study||76||
48079969|NCT01179568|100518690|FG003|Completed Week 12 Assessment|Overall Study||75||
48079970|NCT01179568|100518687|FG000|COMPLETED|Overall Study||73|Week 20 assessment|
48079971|NCT01179568|100518688|FG001|COMPLETED|Overall Study||61|Week 20 assessment|
48079972|NCT01179568|100518689|FG002|COMPLETED|Overall Study||76|Week 20 assessment|
48526434|NCT01565850|101623957|FG001|COMPLETED|Overall Study||42||
48526435|NCT01565850|101623956|FG000|NOT COMPLETED|Overall Study||20||
48526436|NCT01565850|101623957|FG001|NOT COMPLETED|Overall Study||8||
48526437|NCT00931268|101623958|FG000|STARTED|Overall Study||10||
48526438|NCT00931268|101623958|FG000|COMPLETED|Overall Study||4||
48526439|NCT00931268|101623958|FG000|NOT COMPLETED|Overall Study||6||
48526440|NCT01550744|101623959|FG000|STARTED|Open-Label||478||
48526441|NCT01550744|101623960|FG001|STARTED|Open-Label||0||
48526442|NCT01550744|101623961|FG002|STARTED|Open-Label||0||
48526443|NCT01550744|101623959|FG000|COMPLETED|Open-Label||378||
48526444|NCT01550744|101623960|FG001|COMPLETED|Open-Label||0||
48526445|NCT01550744|101623961|FG002|COMPLETED|Open-Label||0||
48526446|NCT01550744|101623959|FG000|NOT COMPLETED|Open-Label||100||
48526447|NCT01550744|101623960|FG001|NOT COMPLETED|Open-Label||0||
48526448|NCT01550744|101623961|FG002|NOT COMPLETED|Open-Label||0||
48526449|NCT01550744|101623959|FG000|STARTED|Double-Blind||0||
48227701|NCT04012970|100878067|FG001|COMPLETED|Intervention Session, 30 Minutes||14||
48227702|NCT04012970|100878066|FG000|NOT COMPLETED|Intervention Session, 30 Minutes||0||
48227703|NCT04012970|100878067|FG001|NOT COMPLETED|Intervention Session, 30 Minutes||0||
48227704|NCT04012970|100878066|FG000|STARTED|Control Session, 30 Minutes||26||
48227705|NCT04012970|100878067|FG001|STARTED|Control Session, 30 Minutes||14||
48227706|NCT04012970|100878066|FG000|COMPLETED|Control Session, 30 Minutes||26||
48526450|NCT01550744|101623960|FG001|STARTED|Double-Blind||76||
48526451|NCT01550744|101623961|FG002|STARTED|Double-Blind||302||
48526452|NCT01550744|101623959|FG000|COMPLETED|Double-Blind||0||
48526453|NCT01550744|101623960|FG001|COMPLETED|Double-Blind||59||
48526454|NCT01550744|101623961|FG002|COMPLETED|Double-Blind||235||
48526455|NCT01550744|101623959|FG000|NOT COMPLETED|Double-Blind||0||
48526456|NCT01550744|101623960|FG001|NOT COMPLETED|Double-Blind||17||
48526457|NCT01550744|101623961|FG002|NOT COMPLETED|Double-Blind||67||
48526458|NCT03736213|101623962|FG000|STARTED|Overall Study||7||10
48526459|NCT03736213|101623963|FG001|STARTED|Overall Study||7||10
48526460|NCT03736213|101623962|FG000|COMPLETED|Overall Study||7||10
48526461|NCT03736213|101623963|FG001|COMPLETED|Overall Study||7||10
48526462|NCT03736213|101623962|FG000|NOT COMPLETED|Overall Study||0||0
48526463|NCT03736213|101623963|FG001|NOT COMPLETED|Overall Study||0||0
48526464|NCT02246439|101623964|FG000|STARTED|Overall Study||192|ITT Population (treated)|
48526465|NCT02246439|101623965|FG001|STARTED|Overall Study||129|ITT Population (treated)|
48526466|NCT02246439|101623964|FG000|Randomized|Overall Study||198||
48526467|NCT02246439|101623965|FG001|Randomized|Overall Study||132||
48526468|NCT02246439|101623964|FG000|COMPLETED|Overall Study||180||
48526469|NCT02246439|101623965|FG001|COMPLETED|Overall Study||118||
48526470|NCT02246439|101623964|FG000|NOT COMPLETED|Overall Study||12||
48526471|NCT02246439|101623965|FG001|NOT COMPLETED|Overall Study||11||
48526472|NCT01892657|101623966|FG000|STARTED|Overall Study||128||
48526473|NCT01892657|101623966|FG000|COMPLETED|Overall Study||110||
48526474|NCT01892657|101623966|FG000|NOT COMPLETED|Overall Study||18||
48526475|NCT02666352|101623967|FG000|STARTED|Overall Study||8||
48526476|NCT02666352|101623968|FG001|STARTED|Overall Study||8||
48526477|NCT02666352|101623969|FG002|STARTED|Overall Study||8||
48526478|NCT02666352|101623967|FG000|COMPLETED|Overall Study||8||
48526479|NCT02666352|101623968|FG001|COMPLETED|Overall Study||8||
48526480|NCT02666352|101623969|FG002|COMPLETED|Overall Study||8||
48526481|NCT02666352|101623967|FG000|NOT COMPLETED|Overall Study||0||
48079973|NCT01179568|100518690|FG003|COMPLETED|Overall Study||76|Week 20 assessment|
48079974|NCT01179568|100518687|FG000|NOT COMPLETED|Overall Study||28||
48079975|NCT01179568|100518688|FG001|NOT COMPLETED|Overall Study||38||
48079976|NCT01179568|100518689|FG002|NOT COMPLETED|Overall Study||23||
48079977|NCT01179568|100518690|FG003|NOT COMPLETED|Overall Study||20||
48079978|NCT00390468|100518691|FG000|STARTED|Overall Study||18||
48079979|NCT00390468|100518691|FG000|COMPLETED|Overall Study||15||
48079980|NCT00390468|100518691|FG000|NOT COMPLETED|Overall Study||3||
48227707|NCT04012970|100878067|FG001|COMPLETED|Control Session, 30 Minutes||14||
48526482|NCT02666352|101623968|FG001|NOT COMPLETED|Overall Study||0||
48526483|NCT02666352|101623969|FG002|NOT COMPLETED|Overall Study||0||
48526484|NCT00622466|101623970|FG000|STARTED|Overall Study||20||
48526485|NCT00622466|101623970|FG000|COMPLETED|Overall Study||16||
48526486|NCT00622466|101623970|FG000|NOT COMPLETED|Overall Study||4||
48526487|NCT01383421|101623971|FG000|STARTED|Overall Study||1025||
48526488|NCT01383421|101623971|FG000|COMPLETED|Overall Study||679||
48526489|NCT01383421|101623971|FG000|NOT COMPLETED|Overall Study||346||
48526490|NCT01659736|101623972|FG000|STARTED|Treatment Period||14||
48526491|NCT01659736|101623973|FG001|STARTED|Treatment Period||12||
48526492|NCT01659736|101623972|FG000|COMPLETED|Treatment Period||9||
48526493|NCT01659736|101623973|FG001|COMPLETED|Treatment Period||10||
48526494|NCT01659736|101623972|FG000|NOT COMPLETED|Treatment Period||5||
48526495|NCT01659736|101623973|FG001|NOT COMPLETED|Treatment Period||2||
48526496|NCT01659736|101623972|FG000|STARTED|3-month Follow-up||9||
48526497|NCT01659736|101623973|FG001|STARTED|3-month Follow-up||10||
48526498|NCT01659736|101623972|FG000|COMPLETED|3-month Follow-up||9||
48526499|NCT01659736|101623973|FG001|COMPLETED|3-month Follow-up||9||
48526500|NCT01659736|101623972|FG000|NOT COMPLETED|3-month Follow-up||0||
48227708|NCT04012970|100878066|FG000|NOT COMPLETED|Control Session, 30 Minutes||0||
48227709|NCT04012970|100878067|FG001|NOT COMPLETED|Control Session, 30 Minutes||0||
48227710|NCT00570505|100878068|FG000|STARTED|Overall Study||149||
48526501|NCT01659736|101623973|FG001|NOT COMPLETED|3-month Follow-up||1||
48526502|NCT00944749|101623974|FG000|STARTED|Overall Study||23||
48526503|NCT00944749|101623974|FG000|COMPLETED|Overall Study||22||
48526504|NCT00944749|101623974|FG000|NOT COMPLETED|Overall Study||1||
48526505|NCT00115297|101623975|FG000|STARTED|Overall Study||30||
48526506|NCT00115297|101623976|FG001|STARTED|Overall Study||32||
48526507|NCT00115297|101623975|FG000|COMPLETED|Overall Study||30||
48526508|NCT00115297|101623976|FG001|COMPLETED|Overall Study||32||
48526509|NCT00115297|101623975|FG000|NOT COMPLETED|Overall Study||0||
48526510|NCT00115297|101623976|FG001|NOT COMPLETED|Overall Study||0||
48526511|NCT00557076|101623977|FG000|STARTED|Overall Study||8||
48526512|NCT00557076|101623978|FG001|STARTED|Overall Study||8||
48227711|NCT00570505|100878068|FG000|COMPLETED|Overall Study||108||
48227712|NCT00570505|100878068|FG000|NOT COMPLETED|Overall Study||41||
48526513|NCT00557076|101623977|FG000|COMPLETED|Overall Study||8||
48526514|NCT00557076|101623978|FG001|COMPLETED|Overall Study||7||
48526515|NCT00557076|101623977|FG000|NOT COMPLETED|Overall Study||0||
48526516|NCT00557076|101623978|FG001|NOT COMPLETED|Overall Study||1||
48526517|NCT00620659|101623979|FG000|STARTED|Treatment Period 1||21||
48526518|NCT00620659|101623980|FG001|STARTED|Treatment Period 1||21||
48526519|NCT00620659|101623981|FG002|STARTED|Treatment Period 1||21||
48526520|NCT00620659|101623982|FG003|STARTED|Treatment Period 1||21||
48526521|NCT00620659|101623983|FG004|STARTED|Treatment Period 1||21||
48526522|NCT00620659|101623984|FG005|STARTED|Treatment Period 1||20||
48526523|NCT00620659|101623979|FG000|COMPLETED|Treatment Period 1||18||
48526524|NCT00620659|101623980|FG001|COMPLETED|Treatment Period 1||21||
48526525|NCT00620659|101623981|FG002|COMPLETED|Treatment Period 1||20||
48526526|NCT00620659|101623982|FG003|COMPLETED|Treatment Period 1||18||
48526527|NCT00620659|101623983|FG004|COMPLETED|Treatment Period 1||20||
48526528|NCT00620659|101623984|FG005|COMPLETED|Treatment Period 1||20||
48526529|NCT00620659|101623979|FG000|NOT COMPLETED|Treatment Period 1||3||
48526530|NCT00620659|101623980|FG001|NOT COMPLETED|Treatment Period 1||0||
48526531|NCT00620659|101623981|FG002|NOT COMPLETED|Treatment Period 1||1||
48526532|NCT00620659|101623982|FG003|NOT COMPLETED|Treatment Period 1||3||
48526533|NCT00620659|101623983|FG004|NOT COMPLETED|Treatment Period 1||1||
48526534|NCT00620659|101623984|FG005|NOT COMPLETED|Treatment Period 1||0||
48526535|NCT00620659|101623979|FG000|STARTED|Placebo Washout Period 1||18||
48526536|NCT00620659|101623980|FG001|STARTED|Placebo Washout Period 1||21||
48526537|NCT00620659|101623981|FG002|STARTED|Placebo Washout Period 1||20||
48526538|NCT00620659|101623982|FG003|STARTED|Placebo Washout Period 1||19||
48526539|NCT00620659|101623983|FG004|STARTED|Placebo Washout Period 1||20||
48526540|NCT00620659|101623984|FG005|STARTED|Placebo Washout Period 1||20||
48526541|NCT00620659|101623979|FG000|COMPLETED|Placebo Washout Period 1||18||
48526542|NCT00620659|101623980|FG001|COMPLETED|Placebo Washout Period 1||21||
48526543|NCT00620659|101623981|FG002|COMPLETED|Placebo Washout Period 1||20||
48526544|NCT00620659|101623982|FG003|COMPLETED|Placebo Washout Period 1||18||
48526545|NCT00620659|101623983|FG004|COMPLETED|Placebo Washout Period 1||20||
48526546|NCT00620659|101623984|FG005|COMPLETED|Placebo Washout Period 1||20||
48526547|NCT00620659|101623979|FG000|NOT COMPLETED|Placebo Washout Period 1||0||
48526548|NCT00620659|101623980|FG001|NOT COMPLETED|Placebo Washout Period 1||0||
48526549|NCT00620659|101623981|FG002|NOT COMPLETED|Placebo Washout Period 1||0||
48526550|NCT00620659|101623982|FG003|NOT COMPLETED|Placebo Washout Period 1||1||
48526551|NCT00620659|101623983|FG004|NOT COMPLETED|Placebo Washout Period 1||0||
48526552|NCT00620659|101623984|FG005|NOT COMPLETED|Placebo Washout Period 1||0||
48526553|NCT00620659|101623979|FG000|STARTED|Treatment Period 2||18||
48526554|NCT00620659|101623980|FG001|STARTED|Treatment Period 2||21||
48526555|NCT00620659|101623981|FG002|STARTED|Treatment Period 2||20||
48227713|NCT03041090|100878069|FG000|STARTED|Overall Study||109||
48227714|NCT03041090|100878070|FG001|STARTED|Overall Study||24||
48227715|NCT03041090|100878069|FG000|COMPLETED|Overall Study||109||
48227716|NCT03041090|100878070|FG001|COMPLETED|Overall Study||21||
48526556|NCT00620659|101623982|FG003|STARTED|Treatment Period 2||18||
48526557|NCT00620659|101623983|FG004|STARTED|Treatment Period 2||20||
48526558|NCT00620659|101623984|FG005|STARTED|Treatment Period 2||20||
48526559|NCT00620659|101623979|FG000|COMPLETED|Treatment Period 2||18||
48526560|NCT00620659|101623980|FG001|COMPLETED|Treatment Period 2||18||
48526561|NCT00620659|101623981|FG002|COMPLETED|Treatment Period 2||19||
48526562|NCT00620659|101623982|FG003|COMPLETED|Treatment Period 2||18||
48526563|NCT00620659|101623983|FG004|COMPLETED|Treatment Period 2||15||
48526564|NCT00620659|101623984|FG005|COMPLETED|Treatment Period 2||20||
48526565|NCT00620659|101623979|FG000|NOT COMPLETED|Treatment Period 2||0||
48526566|NCT00620659|101623980|FG001|NOT COMPLETED|Treatment Period 2||3||
48526567|NCT00620659|101623981|FG002|NOT COMPLETED|Treatment Period 2||1||
48526568|NCT00620659|101623982|FG003|NOT COMPLETED|Treatment Period 2||0||
48526569|NCT00620659|101623983|FG004|NOT COMPLETED|Treatment Period 2||5||
48526570|NCT00620659|101623984|FG005|NOT COMPLETED|Treatment Period 2||0||
48526571|NCT00620659|101623979|FG000|STARTED|Placebo Washout Period 2||18||
48526572|NCT00620659|101623980|FG001|STARTED|Placebo Washout Period 2||18||
48526573|NCT00620659|101623981|FG002|STARTED|Placebo Washout Period 2||19||
48526574|NCT00620659|101623982|FG003|STARTED|Placebo Washout Period 2||18||
48526575|NCT00620659|101623983|FG004|STARTED|Placebo Washout Period 2||15||
48526576|NCT00620659|101623984|FG005|STARTED|Placebo Washout Period 2||20||
48526577|NCT00620659|101623979|FG000|COMPLETED|Placebo Washout Period 2||16||
48526578|NCT00620659|101623980|FG001|COMPLETED|Placebo Washout Period 2||18||
48526579|NCT00620659|101623981|FG002|COMPLETED|Placebo Washout Period 2||19||
48526580|NCT00620659|101623982|FG003|COMPLETED|Placebo Washout Period 2||18||
48526581|NCT00620659|101623983|FG004|COMPLETED|Placebo Washout Period 2||15||
48526582|NCT00620659|101623984|FG005|COMPLETED|Placebo Washout Period 2||20||
48526583|NCT00620659|101623979|FG000|NOT COMPLETED|Placebo Washout Period 2||2||
48526584|NCT00620659|101623980|FG001|NOT COMPLETED|Placebo Washout Period 2||0||
48526585|NCT00620659|101623981|FG002|NOT COMPLETED|Placebo Washout Period 2||0||
48526586|NCT00620659|101623982|FG003|NOT COMPLETED|Placebo Washout Period 2||0||
48526587|NCT00620659|101623983|FG004|NOT COMPLETED|Placebo Washout Period 2||0||
48526588|NCT00620659|101623984|FG005|NOT COMPLETED|Placebo Washout Period 2||0||
48526589|NCT00620659|101623979|FG000|STARTED|Treatment Period 3||16||
48526590|NCT00620659|101623980|FG001|STARTED|Treatment Period 3||18||
48526591|NCT00620659|101623981|FG002|STARTED|Treatment Period 3||19||
48526592|NCT00620659|101623982|FG003|STARTED|Treatment Period 3||18||
48526593|NCT00620659|101623983|FG004|STARTED|Treatment Period 3||15||
48526594|NCT00620659|101623984|FG005|STARTED|Treatment Period 3||20||
48526595|NCT00620659|101623979|FG000|COMPLETED|Treatment Period 3||16||
48526596|NCT00620659|101623980|FG001|COMPLETED|Treatment Period 3||16||
48526597|NCT00620659|101623981|FG002|COMPLETED|Treatment Period 3||19||
48526598|NCT00620659|101623982|FG003|COMPLETED|Treatment Period 3||17||
48526599|NCT00620659|101623983|FG004|COMPLETED|Treatment Period 3||15||
48526600|NCT00620659|101623984|FG005|COMPLETED|Treatment Period 3||20||
48526601|NCT00620659|101623979|FG000|NOT COMPLETED|Treatment Period 3||0||
48526602|NCT00620659|101623980|FG001|NOT COMPLETED|Treatment Period 3||2||
48526603|NCT00620659|101623981|FG002|NOT COMPLETED|Treatment Period 3||0||
48526604|NCT00620659|101623982|FG003|NOT COMPLETED|Treatment Period 3||1||
48526605|NCT00620659|101623983|FG004|NOT COMPLETED|Treatment Period 3||0||
48526606|NCT00620659|101623984|FG005|NOT COMPLETED|Treatment Period 3||0||
48526607|NCT02439749|101623985|FG000|STARTED|Overall Study||182||
48526608|NCT02439749|101623986|FG001|STARTED|Overall Study||184||
48526609|NCT02439749|101623985|FG000|COMPLETED|Overall Study||153||
48526610|NCT02439749|101623986|FG001|COMPLETED|Overall Study||147||
48526611|NCT02439749|101623985|FG000|NOT COMPLETED|Overall Study||29||
48526612|NCT02439749|101623986|FG001|NOT COMPLETED|Overall Study||37||
48526613|NCT04982874|101623987|FG000|STARTED|1st Intervention||12||
48526614|NCT04982874|101623988|FG001|STARTED|1st Intervention||12||
48526615|NCT04982874|101623987|FG000|COMPLETED|1st Intervention||12||
48526616|NCT04982874|101623988|FG001|COMPLETED|1st Intervention||12||
48526617|NCT04982874|101623987|FG000|NOT COMPLETED|1st Intervention||0||
48526618|NCT04982874|101623988|FG001|NOT COMPLETED|1st Intervention||0||
48526619|NCT04982874|101623987|FG000|STARTED|Washout Periods >= One Week||12||
48526620|NCT04982874|101623988|FG001|STARTED|Washout Periods >= One Week||12||
48526621|NCT04982874|101623987|FG000|COMPLETED|Washout Periods >= One Week||12||
48526622|NCT04982874|101623988|FG001|COMPLETED|Washout Periods >= One Week||12||
48526623|NCT04982874|101623987|FG000|NOT COMPLETED|Washout Periods >= One Week||0||
48526624|NCT04982874|101623988|FG001|NOT COMPLETED|Washout Periods >= One Week||0||
48526625|NCT04982874|101623987|FG000|STARTED|2nd Intervention||12||
48526626|NCT04982874|101623988|FG001|STARTED|2nd Intervention||12||
48526627|NCT04982874|101623987|FG000|COMPLETED|2nd Intervention||12||
48526628|NCT04982874|101623988|FG001|COMPLETED|2nd Intervention||12||
48526629|NCT04982874|101623987|FG000|NOT COMPLETED|2nd Intervention||0||
48526630|NCT04982874|101623988|FG001|NOT COMPLETED|2nd Intervention||0||
48526631|NCT01346774|101623989|FG000|STARTED|Overall Study||80||
48526632|NCT01346774|101623990|FG001|STARTED|Overall Study||80||
48526633|NCT01346774|101623989|FG000|COMPLETED|Overall Study||67||
48526634|NCT01346774|101623990|FG001|COMPLETED|Overall Study||63||
48526635|NCT01346774|101623989|FG000|NOT COMPLETED|Overall Study||13||
48526636|NCT01346774|101623990|FG001|NOT COMPLETED|Overall Study||17||
48526637|NCT04874636|101623991|FG000|STARTED|Overall Study||102||
48526638|NCT04874636|101623992|FG001|STARTED|Overall Study||51||
48526639|NCT04874636|101623991|FG000|Received at Least One Dose of Study Drug|Overall Study||102||
48526640|NCT04874636|101623992|FG001|Received at Least One Dose of Study Drug|Overall Study||50||
48526641|NCT04874636|101623991|FG000|COMPLETED|Overall Study||75||
48526642|NCT04874636|101623992|FG001|COMPLETED|Overall Study||39||
48526643|NCT04874636|101623991|FG000|NOT COMPLETED|Overall Study||27||
48227717|NCT03041090|100878069|FG000|NOT COMPLETED|Overall Study||0||
48526644|NCT04874636|101623992|FG001|NOT COMPLETED|Overall Study||12||
48526645|NCT04465630|101623993|FG000|STARTED|Overall Study||78||
48526646|NCT04465630|101623993|FG000|COMPLETED|Overall Study||0||
48526647|NCT04465630|101623993|FG000|NOT COMPLETED|Overall Study||78||
48526648|NCT01173471|101623994|FG000|STARTED|Overall Study||6||
48079981|NCT01332500|100518692|FG000|STARTED|Overall Study||13257||
48079982|NCT01332500|100518693|FG001|STARTED|Overall Study||39771||
48079983|NCT01332500|100518694|FG002|STARTED|Overall Study||2903||
48079984|NCT01332500|100518695|FG003|STARTED|Overall Study||5806||
48079985|NCT01332500|100518692|FG000|COMPLETED|Overall Study||13257||
48079986|NCT01332500|100518693|FG001|COMPLETED|Overall Study||39771||
48079987|NCT01332500|100518694|FG002|COMPLETED|Overall Study||2903||
48079988|NCT01332500|100518695|FG003|COMPLETED|Overall Study||5806||
48079989|NCT01332500|100518692|FG000|NOT COMPLETED|Overall Study||0||
48079990|NCT01332500|100518693|FG001|NOT COMPLETED|Overall Study||0||
48079991|NCT01332500|100518694|FG002|NOT COMPLETED|Overall Study||0||
48079992|NCT01332500|100518695|FG003|NOT COMPLETED|Overall Study||0||
48079993|NCT02288897|100518696|FG000|STARTED|Overall Study||12||
48079994|NCT02288897|100518697|FG001|STARTED|Overall Study||8||
48079995|NCT02288897|100518696|FG000|COMPLETED|Overall Study||12||
48079996|NCT02288897|100518697|FG001|COMPLETED|Overall Study||8||
48079997|NCT02288897|100518696|FG000|NOT COMPLETED|Overall Study||0||
48079998|NCT02288897|100518697|FG001|NOT COMPLETED|Overall Study||0||
48079999|NCT03727347|100518698|FG000|STARTED|Overall Study||50||
48080000|NCT03727347|100518698|FG000|2-week Evaluation|Overall Study||50||
48080001|NCT03727347|100518698|FG000|4-week Evaluation|Overall Study||50||
48080002|NCT03727347|100518698|FG000|12-week Primary Endpoint Evaluation|Overall Study||50||
48080003|NCT03727347|100518698|FG000|26-week Evaluation|Overall Study||48||
48080004|NCT03727347|100518698|FG000|52-week Evaluation|Overall Study||47||
48080005|NCT03727347|100518698|FG000|COMPLETED|Overall Study||47||
48080006|NCT03727347|100518698|FG000|NOT COMPLETED|Overall Study||3||
48080007|NCT02984709|100518699|FG000|STARTED|Overall Study||24||
48080008|NCT02984709|100518700|FG001|STARTED|Overall Study||24||
48080009|NCT02984709|100518699|FG000|COMPLETED|Overall Study||24||
48080010|NCT02984709|100518700|FG001|COMPLETED|Overall Study||24||
48080011|NCT02984709|100518699|FG000|NOT COMPLETED|Overall Study||0||
48080012|NCT02984709|100518700|FG001|NOT COMPLETED|Overall Study||0||
48080013|NCT01812174|100518701|FG000|STARTED|Overall Study||14||
48080014|NCT01812174|100518702|FG001|STARTED|Overall Study||6||
48080015|NCT01812174|100518701|FG000|COMPLETED|Overall Study||11||
48080016|NCT01812174|100518702|FG001|COMPLETED|Overall Study||6||
48526649|NCT01173471|101623995|FG001|STARTED|Overall Study||7||
48526650|NCT01173471|101623996|FG002|STARTED|Overall Study||18||
48526651|NCT01173471|101623997|FG003|STARTED|Overall Study||19||
48526652|NCT01173471|101623994|FG000|Received Treatment|Overall Study||6||
48526653|NCT01173471|101623995|FG001|Received Treatment|Overall Study||7||
48526654|NCT01173471|101623996|FG002|Received Treatment|Overall Study||18||
48526655|NCT01173471|101623997|FG003|Received Treatment|Overall Study||19||
48526656|NCT01173471|101623994|FG000|Completed Treatment|Overall Study||4||
48526657|NCT01173471|101623995|FG001|Completed Treatment|Overall Study||7||
48080017|NCT01812174|100518701|FG000|NOT COMPLETED|Overall Study||3||
48080018|NCT01812174|100518702|FG001|NOT COMPLETED|Overall Study||0||
48080019|NCT00960778|100518703|FG000|STARTED|Overall Study||17||
48080020|NCT00960778|100518704|FG001|STARTED|Overall Study||16||
48526658|NCT01173471|101623996|FG002|Completed Treatment|Overall Study||15||
48526659|NCT01173471|101623997|FG003|Completed Treatment|Overall Study||18||
48526660|NCT01173471|101623994|FG000|COMPLETED|Overall Study||4||
48526661|NCT01173471|101623995|FG001|COMPLETED|Overall Study||7||
48526662|NCT01173471|101623996|FG002|COMPLETED|Overall Study||15||
48080021|NCT00960778|100518703|FG000|COMPLETED|Overall Study||8||
48080022|NCT00960778|100518704|FG001|COMPLETED|Overall Study||13||
48080023|NCT00960778|100518703|FG000|NOT COMPLETED|Overall Study||9||
48080024|NCT00960778|100518704|FG001|NOT COMPLETED|Overall Study||3||
48080025|NCT03782792|100518705|FG000|STARTED|Overall Study||18||
48080026|NCT03782792|100518706|FG001|STARTED|Overall Study||35||
48080027|NCT03782792|100518705|FG000|Received Open Label Treatment With Spesolimab at Wk1/D8|Overall Study||15|In addition to the randomized treatment, patients received also an i.v. dose of 900 mg spesolimab at Wk1/D8.|
48141195|NCT03581305|100670360|FG000|NOT COMPLETED|Dopaminergic Study||3||
48141196|NCT03581305|100670361|FG001|NOT COMPLETED|Dopaminergic Study||1||
48141197|NCT03581305|100670360|FG000|STARTED|Serotonergic Study||23|this includes participants who finished the DASB scan.|
48141198|NCT03581305|100670361|FG001|STARTED|Serotonergic Study||23|this includes participants who finished the DASB scan.|
48141199|NCT03581305|100670360|FG000|COMPLETED|Serotonergic Study||18||
48141200|NCT03581305|100670361|FG001|COMPLETED|Serotonergic Study||22||
48141201|NCT03581305|100670360|FG000|NOT COMPLETED|Serotonergic Study||5||
48080028|NCT03782792|100518706|FG001|Received Open Label Treatment With Spesolimab at Wk1/D8|Overall Study||12|In addition to the randomized treatment, patients received also an i.v. dose of 900 mg spesolimab at Wk1/D8.|
48080029|NCT03782792|100518705|FG000|Received Rescue Treatment With Spesolimab After Wk1|Overall Study||2|In addition to the randomized treatment, Patients received also one single rescue i.v. dose of 900 mg spesolimab between Wk1 to Wk 12.|
48080030|NCT03782792|100518706|FG001|Received Rescue Treatment With Spesolimab After Wk1|Overall Study||4|In addition to the randomized treatment, Patients received also one single rescue i.v. dose of 900 mg spesolimab between Wk1 to Wk 12.|
48080031|NCT03782792|100518705|FG000|COMPLETED|Overall Study||17|Completed planned observation period.|
48080032|NCT03782792|100518706|FG001|COMPLETED|Overall Study||32|Completed planned observation period.|
48080033|NCT03782792|100518705|FG000|NOT COMPLETED|Overall Study||1||
48526663|NCT01173471|101623997|FG003|COMPLETED|Overall Study||18||
48526664|NCT01173471|101623994|FG000|NOT COMPLETED|Overall Study||2||
48526665|NCT01173471|101623995|FG001|NOT COMPLETED|Overall Study||0||
48526666|NCT01173471|101623996|FG002|NOT COMPLETED|Overall Study||3||
48526667|NCT01173471|101623997|FG003|NOT COMPLETED|Overall Study||1||
48526668|NCT01745211|101623998|FG000|STARTED|Overall Study||45||104
48526669|NCT01745211|101623998|FG000|COMPLETED|Overall Study||27||64
48526670|NCT01745211|101623998|FG000|NOT COMPLETED|Overall Study||18||40
48526671|NCT02551666|101623999|FG000|STARTED|Overall Study||16||
48080034|NCT03782792|100518706|FG001|NOT COMPLETED|Overall Study||3||
48080035|NCT05201703|100518707|FG000|STARTED|Overall Study||1||
48080036|NCT05201703|100518708|FG001|STARTED|Overall Study||3||
48526672|NCT02551666|101624000|FG001|STARTED|Overall Study||19||
48080037|NCT05201703|100518707|FG000|COMPLETED|Overall Study||1||
48080038|NCT05201703|100518708|FG001|COMPLETED|Overall Study||1||
48080039|NCT05201703|100518707|FG000|NOT COMPLETED|Overall Study||0||
48080040|NCT05201703|100518708|FG001|NOT COMPLETED|Overall Study||2||
48080041|NCT00506662|100518709|FG000|STARTED|Overall Study||38||
48080042|NCT00506662|100518710|FG001|STARTED|Overall Study||48||
48080043|NCT00506662|100518709|FG000|COMPLETED|Overall Study||21||
48080044|NCT00506662|100518710|FG001|COMPLETED|Overall Study||20||
48080045|NCT00506662|100518709|FG000|NOT COMPLETED|Overall Study||17||
48080046|NCT00506662|100518710|FG001|NOT COMPLETED|Overall Study||28||
48080047|NCT02627144|100518711|FG000|STARTED|Overall Study||365||
48080048|NCT02627144|100518711|FG000|Treated|Overall Study||359||
48080049|NCT02627144|100518711|FG000|COMPLETED|Overall Study||0||
48080050|NCT02627144|100518711|FG000|NOT COMPLETED|Overall Study||365||
48080051|NCT03066804|100518712|FG000|STARTED|Overall Study||1286||
48080052|NCT03066804|100518713|FG001|STARTED|Overall Study||1286||
48080053|NCT03066804|100518712|FG000|COMPLETED|Overall Study||1235||
48080054|NCT03066804|100518713|FG001|COMPLETED|Overall Study||1236||
48080055|NCT03066804|100518712|FG000|NOT COMPLETED|Overall Study||51||
48080056|NCT03066804|100518713|FG001|NOT COMPLETED|Overall Study||50||
48080057|NCT03031678|100518714|FG000|STARTED|Overall Study||50||
48080058|NCT03031678|100518714|FG000|EAS Test Condition Complete|Overall Study||39||
48080059|NCT03031678|100518714|FG000|CI Alone Test Condition Complete|Overall Study||10||
48080060|NCT03031678|100518714|FG000|COMPLETED|Overall Study||49||
48080061|NCT03031678|100518714|FG000|NOT COMPLETED|Overall Study||1||
48080062|NCT04672993|100518715|FG000|STARTED|Overall Study||20||
48080063|NCT04672993|100518715|FG000|COMPLETED|Overall Study||20||
48080064|NCT04672993|100518715|FG000|NOT COMPLETED|Overall Study||0||
48080065|NCT02154243|100518716|FG000|STARTED|Overall Study||5||
48526673|NCT02551666|101623999|FG000|COMPLETED|Overall Study||15||
48526674|NCT02551666|101624000|FG001|COMPLETED|Overall Study||16||
48526675|NCT02551666|101623999|FG000|NOT COMPLETED|Overall Study||1||
48526676|NCT02551666|101624000|FG001|NOT COMPLETED|Overall Study||3||
48526677|NCT00423319|101624001|FG000|STARTED|Overall Study||2708||
48526678|NCT00423319|101624002|FG001|STARTED|Overall Study||2699||
48526679|NCT00423319|101624001|FG000|Participants Who Received Treatment|Overall Study||2673||
48526680|NCT00423319|101624002|FG001|Participants Who Received Treatment|Overall Study||2659||
48526681|NCT00423319|101624001|FG000|COMPLETED|Overall Study||2484||
48526682|NCT00423319|101624002|FG001|COMPLETED|Overall Study||2447||
48526683|NCT00423319|101624001|FG000|NOT COMPLETED|Overall Study||224||
48526684|NCT00423319|101624002|FG001|NOT COMPLETED|Overall Study||252||
48526685|NCT00939120|101624003|FG000|STARTED|Overall Study||23||
48526686|NCT00939120|101624004|FG001|STARTED|Overall Study||23||
48526687|NCT00939120|101624003|FG000|COMPLETED|Overall Study||15||
48526688|NCT00939120|101624004|FG001|COMPLETED|Overall Study||18||
48526689|NCT00939120|101624003|FG000|NOT COMPLETED|Overall Study||8||
48526690|NCT00939120|101624004|FG001|NOT COMPLETED|Overall Study||5||
48080066|NCT02154243|100518717|FG001|STARTED|Overall Study||4||
48080067|NCT02154243|100518718|FG002|STARTED|Overall Study||4||
48080068|NCT02154243|100518716|FG000|COMPLETED|Overall Study||5||
48526691|NCT03733210|101624005|FG000|STARTED|Overall Study||7||
48526692|NCT03733210|101624006|FG001|STARTED|Overall Study||7||
48526693|NCT03733210|101624005|FG000|COMPLETED|Overall Study||3||
48526694|NCT03733210|101624006|FG001|COMPLETED|Overall Study||5||
48526695|NCT03733210|101624005|FG000|NOT COMPLETED|Overall Study||4||
48526696|NCT03733210|101624006|FG001|NOT COMPLETED|Overall Study||2||
48526697|NCT03179163|101624007|FG000|STARTED|Overall Study||10||
48526698|NCT03179163|101624007|FG000|COMPLETED|Overall Study||10||
48526699|NCT03179163|101624007|FG000|NOT COMPLETED|Overall Study||0||
48080069|NCT02154243|100518717|FG001|COMPLETED|Overall Study||4||
48080070|NCT02154243|100518718|FG002|COMPLETED|Overall Study||4||
48080071|NCT02154243|100518716|FG000|NOT COMPLETED|Overall Study||0||
48080072|NCT02154243|100518717|FG001|NOT COMPLETED|Overall Study||0||
48080073|NCT02154243|100518718|FG002|NOT COMPLETED|Overall Study||0||
48080074|NCT04096963|100518719|FG000|STARTED|Overall Study||50||
48080075|NCT04096963|100518719|FG000|COMPLETED|Overall Study||46||
48080076|NCT04096963|100518719|FG000|NOT COMPLETED|Overall Study||4||
48080077|NCT01709513|100518720|FG000|STARTED|Overall Study||63||
48080078|NCT01709513|100518721|FG001|STARTED|Overall Study||125||
48080079|NCT01709513|100518722|FG002|STARTED|Overall Study||126||
48080080|NCT01709513|100518720|FG000|Treated|Overall Study||63||
48080081|NCT01709513|100518721|FG001|Treated|Overall Study||124||
48080082|NCT01709513|100518722|FG002|Treated|Overall Study||126||
48080083|NCT01709513|100518720|FG000|COMPLETED|Overall Study||42||
48080084|NCT01709513|100518721|FG001|COMPLETED|Overall Study||82||
48080085|NCT01709513|100518722|FG002|COMPLETED|Overall Study||96||
48080086|NCT01709513|100518720|FG000|NOT COMPLETED|Overall Study||21||
48080087|NCT01709513|100518721|FG001|NOT COMPLETED|Overall Study||43||
48080088|NCT01709513|100518722|FG002|NOT COMPLETED|Overall Study||30||
48080089|NCT05228132|100518723|FG000|STARTED|Overall Study||7||
48080090|NCT05228132|100518723|FG000|1-Month Follow-up|Overall Study||2||
48080091|NCT05228132|100518723|FG000|3-Month Follow-up|Overall Study||0||
48080092|NCT05228132|100518723|FG000|6-Month Follow-up|Overall Study||0||
48080093|NCT05228132|100518723|FG000|12-Month Follow-up|Overall Study||0||
48080094|NCT05228132|100518723|FG000|COMPLETED|Overall Study||0||
48080095|NCT05228132|100518723|FG000|NOT COMPLETED|Overall Study||7||
48080096|NCT01877265|100518724|FG000|STARTED|Treatment Period 1||3||
48080097|NCT01877265|100518725|FG001|STARTED|Treatment Period 1||3||
48080098|NCT01877265|100518726|FG002|STARTED|Treatment Period 1||3||
48080099|NCT01877265|100518727|FG003|STARTED|Treatment Period 1||3||
48080100|NCT01877265|100518728|FG004|STARTED|Treatment Period 1||3||
48080101|NCT01877265|100518729|FG005|STARTED|Treatment Period 1||3||
48080102|NCT01877265|100518724|FG000|Received at Least One Dose of Study Drug|Treatment Period 1||3||
48080103|NCT01877265|100518725|FG001|Received at Least One Dose of Study Drug|Treatment Period 1||3||
48080104|NCT01877265|100518726|FG002|Received at Least One Dose of Study Drug|Treatment Period 1||3||
48080105|NCT01877265|100518727|FG003|Received at Least One Dose of Study Drug|Treatment Period 1||3||
48080106|NCT01877265|100518728|FG004|Received at Least One Dose of Study Drug|Treatment Period 1||3||
48080107|NCT01877265|100518729|FG005|Received at Least One Dose of Study Drug|Treatment Period 1||3||
48080108|NCT01877265|100518724|FG000|COMPLETED|Treatment Period 1||3||
48080109|NCT01877265|100518725|FG001|COMPLETED|Treatment Period 1||3||
48080110|NCT01877265|100518726|FG002|COMPLETED|Treatment Period 1||2||
48080111|NCT01877265|100518727|FG003|COMPLETED|Treatment Period 1||3||
48080112|NCT01877265|100518728|FG004|COMPLETED|Treatment Period 1||3||
48080113|NCT01877265|100518729|FG005|COMPLETED|Treatment Period 1||3||
48080114|NCT01877265|100518724|FG000|NOT COMPLETED|Treatment Period 1||0||
48080115|NCT01877265|100518725|FG001|NOT COMPLETED|Treatment Period 1||0||
48080116|NCT01877265|100518726|FG002|NOT COMPLETED|Treatment Period 1||1||
48080117|NCT01877265|100518727|FG003|NOT COMPLETED|Treatment Period 1||0||
48080118|NCT01877265|100518728|FG004|NOT COMPLETED|Treatment Period 1||0||
48080119|NCT01877265|100518729|FG005|NOT COMPLETED|Treatment Period 1||0||
48080120|NCT01877265|100518724|FG000|STARTED|Washout Period 1 (at Least 14 Days)||3||
48080121|NCT01877265|100518725|FG001|STARTED|Washout Period 1 (at Least 14 Days)||3||
48080122|NCT01877265|100518726|FG002|STARTED|Washout Period 1 (at Least 14 Days)||2||
48080123|NCT01877265|100518727|FG003|STARTED|Washout Period 1 (at Least 14 Days)||3||
48080124|NCT01877265|100518728|FG004|STARTED|Washout Period 1 (at Least 14 Days)||3||
48080125|NCT01877265|100518729|FG005|STARTED|Washout Period 1 (at Least 14 Days)||3||
48080126|NCT01877265|100518724|FG000|COMPLETED|Washout Period 1 (at Least 14 Days)||3||
48080127|NCT01877265|100518725|FG001|COMPLETED|Washout Period 1 (at Least 14 Days)||3||
48526700|NCT00168311|101624008|FG000|STARTED|Overall Study||12||
48526701|NCT00168311|101624009|FG001|STARTED|Overall Study||10||
48526702|NCT00168311|101624008|FG000|COMPLETED|Overall Study||12||
48080128|NCT01877265|100518726|FG002|COMPLETED|Washout Period 1 (at Least 14 Days)||2||
48080129|NCT01877265|100518727|FG003|COMPLETED|Washout Period 1 (at Least 14 Days)||3||
48080130|NCT01877265|100518728|FG004|COMPLETED|Washout Period 1 (at Least 14 Days)||3||
48080131|NCT01877265|100518729|FG005|COMPLETED|Washout Period 1 (at Least 14 Days)||3||
48080132|NCT01877265|100518724|FG000|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0||
48080133|NCT01877265|100518725|FG001|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0||
48080134|NCT01877265|100518726|FG002|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0||
48080135|NCT01877265|100518727|FG003|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0||
48080136|NCT01877265|100518728|FG004|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0||
48526703|NCT00168311|101624009|FG001|COMPLETED|Overall Study||8||
48526704|NCT00168311|101624008|FG000|NOT COMPLETED|Overall Study||0||
48526705|NCT00168311|101624009|FG001|NOT COMPLETED|Overall Study||2||
48526706|NCT02664363|101624010|FG000|STARTED|Overall Study||3||
48526707|NCT02664363|101624010|FG000|COMPLETED|Overall Study||3||
48526708|NCT02664363|101624010|FG000|NOT COMPLETED|Overall Study||0||
48526709|NCT02312063|101624011|FG000|STARTED|Overall Study||23||
48080137|NCT01877265|100518729|FG005|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0||
48080138|NCT01877265|100518724|FG000|STARTED|Treatment Period 2||3||
48080139|NCT01877265|100518725|FG001|STARTED|Treatment Period 2||3||
48080140|NCT01877265|100518726|FG002|STARTED|Treatment Period 2||2||
48080141|NCT01877265|100518727|FG003|STARTED|Treatment Period 2||3||
48080142|NCT01877265|100518728|FG004|STARTED|Treatment Period 2||3||
48080143|NCT01877265|100518729|FG005|STARTED|Treatment Period 2||3||
48080144|NCT01877265|100518724|FG000|Received at Least One Dose of Study Drug|Treatment Period 2||3||
48080145|NCT01877265|100518725|FG001|Received at Least One Dose of Study Drug|Treatment Period 2||3||
48080146|NCT01877265|100518726|FG002|Received at Least One Dose of Study Drug|Treatment Period 2||2||
48080147|NCT01877265|100518727|FG003|Received at Least One Dose of Study Drug|Treatment Period 2||3||
48080148|NCT01877265|100518728|FG004|Received at Least One Dose of Study Drug|Treatment Period 2||3||
48080149|NCT01877265|100518729|FG005|Received at Least One Dose of Study Drug|Treatment Period 2||3||
48080150|NCT01877265|100518724|FG000|COMPLETED|Treatment Period 2||3||
48080151|NCT01877265|100518725|FG001|COMPLETED|Treatment Period 2||3||
48080152|NCT01877265|100518726|FG002|COMPLETED|Treatment Period 2||2||
48080153|NCT01877265|100518727|FG003|COMPLETED|Treatment Period 2||3||
48080154|NCT01877265|100518728|FG004|COMPLETED|Treatment Period 2||3||
48080155|NCT01877265|100518729|FG005|COMPLETED|Treatment Period 2||3||
48080156|NCT01877265|100518724|FG000|NOT COMPLETED|Treatment Period 2||0||
48080157|NCT01877265|100518725|FG001|NOT COMPLETED|Treatment Period 2||0||
48080158|NCT01877265|100518726|FG002|NOT COMPLETED|Treatment Period 2||0||
48080159|NCT01877265|100518727|FG003|NOT COMPLETED|Treatment Period 2||0||
48080160|NCT01877265|100518728|FG004|NOT COMPLETED|Treatment Period 2||0||
48080161|NCT01877265|100518729|FG005|NOT COMPLETED|Treatment Period 2||0||
48080162|NCT01877265|100518724|FG000|STARTED|Washout Period 2 (at Least 14 Days)||3||
48080163|NCT01877265|100518725|FG001|STARTED|Washout Period 2 (at Least 14 Days)||3||
48080164|NCT01877265|100518726|FG002|STARTED|Washout Period 2 (at Least 14 Days)||2||
48080165|NCT01877265|100518727|FG003|STARTED|Washout Period 2 (at Least 14 Days)||3||
48080166|NCT01877265|100518728|FG004|STARTED|Washout Period 2 (at Least 14 Days)||3||
48080167|NCT01877265|100518729|FG005|STARTED|Washout Period 2 (at Least 14 Days)||3||
48080168|NCT01877265|100518724|FG000|COMPLETED|Washout Period 2 (at Least 14 Days)||3||
48080169|NCT01877265|100518725|FG001|COMPLETED|Washout Period 2 (at Least 14 Days)||3||
48080170|NCT01877265|100518726|FG002|COMPLETED|Washout Period 2 (at Least 14 Days)||2||
48080171|NCT01877265|100518727|FG003|COMPLETED|Washout Period 2 (at Least 14 Days)||3||
48080172|NCT01877265|100518728|FG004|COMPLETED|Washout Period 2 (at Least 14 Days)||3||
48080173|NCT01877265|100518729|FG005|COMPLETED|Washout Period 2 (at Least 14 Days)||2||
48080174|NCT01877265|100518724|FG000|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0||
48080175|NCT01877265|100518725|FG001|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0||
48080176|NCT01877265|100518726|FG002|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0||
48080177|NCT01877265|100518727|FG003|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0||
48080178|NCT01877265|100518728|FG004|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0||
48080179|NCT01877265|100518729|FG005|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||1||
48080180|NCT01877265|100518724|FG000|STARTED|Treatment Period 3||3||
48080181|NCT01877265|100518725|FG001|STARTED|Treatment Period 3||3||
48080182|NCT01877265|100518726|FG002|STARTED|Treatment Period 3||2||
48080183|NCT01877265|100518727|FG003|STARTED|Treatment Period 3||3||
48080184|NCT01877265|100518728|FG004|STARTED|Treatment Period 3||3||
48080185|NCT01877265|100518729|FG005|STARTED|Treatment Period 3||2||
48080186|NCT01877265|100518724|FG000|Received at Least One Dose of Study Drug|Treatment Period 3||3||
48080187|NCT01877265|100518725|FG001|Received at Least One Dose of Study Drug|Treatment Period 3||3||
48080188|NCT01877265|100518726|FG002|Received at Least One Dose of Study Drug|Treatment Period 3||2||
48080189|NCT01877265|100518727|FG003|Received at Least One Dose of Study Drug|Treatment Period 3||3||
48227718|NCT03041090|100878070|FG001|NOT COMPLETED|Overall Study||3||
48227719|NCT01925144|100878071|FG000|STARTED|Period 1 (Day 1 Through Predose Day 3)||30||
48227720|NCT01925144|100878071|FG000|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||30||
48227721|NCT01925144|100878071|FG000|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||30||
48227722|NCT01925144|100878071|FG000|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0||
48227723|NCT01925144|100878071|FG000|STARTED|Period 2 (At Dosing Day 3 Through Day12)||30||
48227724|NCT01925144|100878071|FG000|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day12)||30||
48227725|NCT01925144|100878071|FG000|Received 8 Doses of Omeprazole|Period 2 (At Dosing Day 3 Through Day12)||30||
48227726|NCT01925144|100878071|FG000|COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||30||
48080190|NCT01877265|100518728|FG004|Received at Least One Dose of Study Drug|Treatment Period 3||3||
48080191|NCT01877265|100518729|FG005|Received at Least One Dose of Study Drug|Treatment Period 3||2||
48080192|NCT01877265|100518724|FG000|COMPLETED|Treatment Period 3||2||
48080193|NCT01877265|100518725|FG001|COMPLETED|Treatment Period 3||3||
48080194|NCT01877265|100518726|FG002|COMPLETED|Treatment Period 3||2||
48080195|NCT01877265|100518727|FG003|COMPLETED|Treatment Period 3||3||
48080196|NCT01877265|100518728|FG004|COMPLETED|Treatment Period 3||3||
48080197|NCT01877265|100518729|FG005|COMPLETED|Treatment Period 3||2||
48080198|NCT01877265|100518724|FG000|NOT COMPLETED|Treatment Period 3||1||
48080199|NCT01877265|100518725|FG001|NOT COMPLETED|Treatment Period 3||0||
48080200|NCT01877265|100518726|FG002|NOT COMPLETED|Treatment Period 3||0||
48080201|NCT01877265|100518727|FG003|NOT COMPLETED|Treatment Period 3||0||
48080202|NCT01877265|100518728|FG004|NOT COMPLETED|Treatment Period 3||0||
48080203|NCT01877265|100518729|FG005|NOT COMPLETED|Treatment Period 3||0||
48080204|NCT00300391|100518730|FG000|STARTED|Overall Study||16||
48080205|NCT00300391|100518731|FG001|STARTED|Overall Study||14||
48080206|NCT00300391|100518730|FG000|COMPLETED|Overall Study||16||
48080207|NCT00300391|100518731|FG001|COMPLETED|Overall Study||14||
48080208|NCT00300391|100518730|FG000|NOT COMPLETED|Overall Study||0||
48080209|NCT00300391|100518731|FG001|NOT COMPLETED|Overall Study||0||
48080210|NCT01004705|100518732|FG000|STARTED|Run-In||44||
48080211|NCT01004705|100518733|FG001|STARTED|Run-In||0||
48080212|NCT01004705|100518734|FG002|STARTED|Run-In||0||
48080213|NCT01004705|100518732|FG000|COMPLETED|Run-In||36||
48080214|NCT01004705|100518733|FG001|COMPLETED|Run-In||0||
48080215|NCT01004705|100518734|FG002|COMPLETED|Run-In||0||
48080216|NCT01004705|100518732|FG000|NOT COMPLETED|Run-In||8||
48080217|NCT01004705|100518733|FG001|NOT COMPLETED|Run-In||0||
48080218|NCT01004705|100518734|FG002|NOT COMPLETED|Run-In||0||
48227727|NCT01925144|100878071|FG000|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||0||
48227728|NCT01278030|100878072|FG000|STARTED|Overall Study||43||
48227729|NCT01278030|100878073|FG001|STARTED|Overall Study||35||
48227730|NCT01278030|100878072|FG000|COMPLETED|Overall Study||35||
48227731|NCT01278030|100878073|FG001|COMPLETED|Overall Study||31||
48080219|NCT01004705|100518732|FG000|STARTED|Period 1 (12 Weeks)||0||
48080220|NCT01004705|100518733|FG001|STARTED|Period 1 (12 Weeks)||18||
48080221|NCT01004705|100518734|FG002|STARTED|Period 1 (12 Weeks)||18||
48080222|NCT01004705|100518732|FG000|COMPLETED|Period 1 (12 Weeks)||0||
48080223|NCT01004705|100518733|FG001|COMPLETED|Period 1 (12 Weeks)||13||
48080224|NCT01004705|100518734|FG002|COMPLETED|Period 1 (12 Weeks)||13||
48227732|NCT01278030|100878072|FG000|NOT COMPLETED|Overall Study||8||
48227733|NCT01278030|100878073|FG001|NOT COMPLETED|Overall Study||4||
48227734|NCT01596231|100878074|FG000|STARTED|Overall Study||10||
48227735|NCT01596231|100878075|FG001|STARTED|Overall Study||10||
48227736|NCT01596231|100878074|FG000|COMPLETED|Overall Study||10||
48227737|NCT01596231|100878075|FG001|COMPLETED|Overall Study||10||
48227738|NCT01596231|100878074|FG000|NOT COMPLETED|Overall Study||0||
48227739|NCT01596231|100878075|FG001|NOT COMPLETED|Overall Study||0||
48227740|NCT00360269|100878076|FG000|STARTED|Overall Study||19||
48227741|NCT00360269|100878077|FG001|STARTED|Overall Study||19||
48227742|NCT00360269|100878076|FG000|COMPLETED|Overall Study||9||
48227743|NCT00360269|100878077|FG001|COMPLETED|Overall Study||7||
48227744|NCT00360269|100878076|FG000|NOT COMPLETED|Overall Study||10||
48227745|NCT00360269|100878077|FG001|NOT COMPLETED|Overall Study||12||
48227746|NCT01529632|100878078|FG000|STARTED|Overall Study||90||
48227747|NCT01529632|100878079|FG001|STARTED|Overall Study||103||
48227748|NCT01529632|100878078|FG000|COMPLETED|Overall Study||87||
48227749|NCT01529632|100878079|FG001|COMPLETED|Overall Study||100||
48227750|NCT01529632|100878078|FG000|NOT COMPLETED|Overall Study||3||
48227751|NCT01529632|100878079|FG001|NOT COMPLETED|Overall Study||3||
48227752|NCT01961609|100878080|FG000|STARTED|Initiation||119||
48227753|NCT01961609|100878081|FG001|STARTED|Initiation||116||
48227754|NCT01961609|100878082|FG002|STARTED|Initiation||0||
48227755|NCT01961609|100878083|FG003|STARTED|Initiation||0||
48227756|NCT01961609|100878080|FG000|Safety Set|Initiation||118||
48227757|NCT01961609|100878081|FG001|Safety Set|Initiation||115||
48227758|NCT01961609|100878082|FG002|Safety Set|Initiation||0||
48227759|NCT01961609|100878083|FG003|Safety Set|Initiation||0||
48227760|NCT01961609|100878080|FG000|Full Analysis Set|Initiation||118||
48227761|NCT01961609|100878081|FG001|Full Analysis Set|Initiation||115||
48227762|NCT01961609|100878082|FG002|Full Analysis Set|Initiation||0||
48227763|NCT01961609|100878083|FG003|Full Analysis Set|Initiation||0||
48227764|NCT01961609|100878080|FG000|COMPLETED|Initiation||107||
48227765|NCT01961609|100878081|FG001|COMPLETED|Initiation||103||
48227766|NCT01961609|100878082|FG002|COMPLETED|Initiation||0||
48080225|NCT01004705|100518732|FG000|NOT COMPLETED|Period 1 (12 Weeks)||0||
48080226|NCT01004705|100518733|FG001|NOT COMPLETED|Period 1 (12 Weeks)||5||
48080227|NCT01004705|100518734|FG002|NOT COMPLETED|Period 1 (12 Weeks)||5||
48227767|NCT01961609|100878083|FG003|COMPLETED|Initiation||0||
48080228|NCT01004705|100518732|FG000|STARTED|Washout Period (6 Weeks)||0||
48227768|NCT01961609|100878080|FG000|NOT COMPLETED|Initiation||12||
48227769|NCT01961609|100878081|FG001|NOT COMPLETED|Initiation||13||
48227770|NCT01961609|100878082|FG002|NOT COMPLETED|Initiation||0||
48227771|NCT01961609|100878083|FG003|NOT COMPLETED|Initiation||0||
48227772|NCT01961609|100878080|FG000|STARTED|Maintenance 1 (Weeks 17 - 48)||107||
48227773|NCT01961609|100878081|FG001|STARTED|Maintenance 1 (Weeks 17 - 48)||66||
48227774|NCT01961609|100878082|FG002|STARTED|Maintenance 1 (Weeks 17 - 48)||37||
48227775|NCT01961609|100878083|FG003|STARTED|Maintenance 1 (Weeks 17 - 48)||0||
48227776|NCT01961609|100878080|FG000|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||107||
48080229|NCT01004705|100518733|FG001|STARTED|Washout Period (6 Weeks)||13||
48080230|NCT01004705|100518734|FG002|STARTED|Washout Period (6 Weeks)||13||
48080231|NCT01004705|100518732|FG000|COMPLETED|Washout Period (6 Weeks)||0||
48080232|NCT01004705|100518733|FG001|COMPLETED|Washout Period (6 Weeks)||13||
48080233|NCT01004705|100518734|FG002|COMPLETED|Washout Period (6 Weeks)||13||
48080234|NCT01004705|100518732|FG000|NOT COMPLETED|Washout Period (6 Weeks)||0||
48080235|NCT01004705|100518733|FG001|NOT COMPLETED|Washout Period (6 Weeks)||0||
48080236|NCT01004705|100518734|FG002|NOT COMPLETED|Washout Period (6 Weeks)||0||
48080237|NCT01004705|100518732|FG000|STARTED|Period 2 (12 Weeks)||0||
48080238|NCT01004705|100518733|FG001|STARTED|Period 2 (12 Weeks)||13||
48080239|NCT01004705|100518734|FG002|STARTED|Period 2 (12 Weeks)||13||
48080240|NCT01004705|100518732|FG000|COMPLETED|Period 2 (12 Weeks)||0||
48080241|NCT01004705|100518733|FG001|COMPLETED|Period 2 (12 Weeks)||13||
48080242|NCT01004705|100518734|FG002|COMPLETED|Period 2 (12 Weeks)||9||
48080243|NCT01004705|100518732|FG000|NOT COMPLETED|Period 2 (12 Weeks)||0||
48080244|NCT01004705|100518733|FG001|NOT COMPLETED|Period 2 (12 Weeks)||0||
48080245|NCT01004705|100518734|FG002|NOT COMPLETED|Period 2 (12 Weeks)||4||
48080246|NCT00585247|100518735|FG000|STARTED|Overall Study||14||
48080247|NCT00585247|100518736|FG001|STARTED|Overall Study||13||
48080248|NCT00585247|100518735|FG000|COMPLETED|Overall Study||14||
48080249|NCT00585247|100518736|FG001|COMPLETED|Overall Study||13||
48080250|NCT00585247|100518735|FG000|NOT COMPLETED|Overall Study||0||
48080251|NCT00585247|100518736|FG001|NOT COMPLETED|Overall Study||0||
48080252|NCT01897454|100518737|FG000|STARTED|Overall Study||23||
48080253|NCT01897454|100518737|FG000|COMPLETED|Overall Study||22||
48080254|NCT01897454|100518737|FG000|NOT COMPLETED|Overall Study||1||
48080255|NCT01950741|100518738|FG000|STARTED|Overall Study||48||
48080256|NCT01950741|100518738|FG000|COMPLETED|Overall Study||45||
48080257|NCT01950741|100518738|FG000|NOT COMPLETED|Overall Study||3||
48227777|NCT01961609|100878081|FG001|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||66||
48080258|NCT03003390|100518739|FG000|STARTED|Overall Study||27||
48080259|NCT03003390|100518740|FG001|STARTED|Overall Study||24||
48080260|NCT03003390|100518739|FG000|COMPLETED|Overall Study||23||
48080261|NCT03003390|100518740|FG001|COMPLETED|Overall Study||24||
48080262|NCT03003390|100518739|FG000|NOT COMPLETED|Overall Study||4||
48080263|NCT03003390|100518740|FG001|NOT COMPLETED|Overall Study||0||
48080264|NCT05280782|100518741|FG000|STARTED|Overall Study||8||
48080265|NCT05280782|100518741|FG000|COMPLETED|Overall Study||8||
48080266|NCT05280782|100518741|FG000|NOT COMPLETED|Overall Study||0||
48080267|NCT03930797|100518742|FG000|STARTED|Overall Study||122||
48080268|NCT03930797|100518743|FG001|STARTED|Overall Study||118||
48080269|NCT03930797|100518742|FG000|COMPLETED|Overall Study||119||
48080270|NCT03930797|100518743|FG001|COMPLETED|Overall Study||108||
48080271|NCT03930797|100518742|FG000|NOT COMPLETED|Overall Study||3||
48080272|NCT03930797|100518743|FG001|NOT COMPLETED|Overall Study||10||
48080273|NCT02864498|100518744|FG000|STARTED|Overall Study||105||
48080274|NCT02864498|100518745|FG001|STARTED|Overall Study||112||
48080275|NCT02864498|100518746|FG002|STARTED|Overall Study||104||
48080276|NCT02864498|100518744|FG000|COMPLETED|Overall Study||85||
48080277|NCT02864498|100518745|FG001|COMPLETED|Overall Study||87||
48080278|NCT02864498|100518746|FG002|COMPLETED|Overall Study||91||
48080279|NCT02864498|100518744|FG000|NOT COMPLETED|Overall Study||20||
48080280|NCT02864498|100518745|FG001|NOT COMPLETED|Overall Study||25||
48080281|NCT02864498|100518746|FG002|NOT COMPLETED|Overall Study||13||
48080282|NCT04502693|100518747|FG000|STARTED|Overall Study||897||
48080283|NCT04502693|100518748|FG001|STARTED|Overall Study||906||
48080284|NCT04502693|100518749|FG002|STARTED|Overall Study||1657||
48080285|NCT04502693|100518750|FG003|STARTED|Overall Study||178||
48080286|NCT04502693|100518747|FG000|ABCWY-1 Group|Overall Study||0||
48080287|NCT04502693|100518748|FG001|ABCWY-1 Group|Overall Study||0||
48080288|NCT04502693|100518749|FG002|ABCWY-1 Group|Overall Study||549||
48080289|NCT04502693|100518750|FG003|ABCWY-1 Group|Overall Study||0||
48080290|NCT04502693|100518747|FG000|ABCWY-2 Group|Overall Study||0||
48080291|NCT04502693|100518748|FG001|ABCWY-2 Group|Overall Study||0||
48080292|NCT04502693|100518749|FG002|ABCWY-2 Group|Overall Study||554||
48080293|NCT04502693|100518750|FG003|ABCWY-2 Group|Overall Study||0||
48080294|NCT04502693|100518747|FG000|ABCWY-3 Group|Overall Study||0||
48080295|NCT04502693|100518748|FG001|ABCWY-3 Group|Overall Study||0||
48080296|NCT04502693|100518749|FG002|ABCWY-3 Group|Overall Study||554||
48080297|NCT04502693|100518750|FG003|ABCWY-3 Group|Overall Study||0||
48080298|NCT04502693|100518747|FG000|COMPLETED|Overall Study||797||
48080299|NCT04502693|100518748|FG001|COMPLETED|Overall Study||811||
48080300|NCT04502693|100518749|FG002|COMPLETED|Overall Study||1497||
48080301|NCT04502693|100518750|FG003|COMPLETED|Overall Study||163||
48080302|NCT04502693|100518747|FG000|NOT COMPLETED|Overall Study||100||
48080303|NCT04502693|100518748|FG001|NOT COMPLETED|Overall Study||95||
48080304|NCT04502693|100518749|FG002|NOT COMPLETED|Overall Study||160||
48080305|NCT04502693|100518750|FG003|NOT COMPLETED|Overall Study||15||
48080306|NCT02853604|100518751|FG000|STARTED|Overall Study||37||
48080307|NCT02853604|100518752|FG001|STARTED|Overall Study||73||
48080308|NCT02853604|100518751|FG000|Treated|Overall Study||37||
48080309|NCT02853604|100518752|FG001|Treated|Overall Study||72||
48080310|NCT02853604|100518751|FG000|COMPLETED|Overall Study||9||
48080311|NCT02853604|100518752|FG001|COMPLETED|Overall Study||21||
48227778|NCT01961609|100878082|FG002|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||37||
48080312|NCT02853604|100518751|FG000|NOT COMPLETED|Overall Study||28||
48080313|NCT02853604|100518752|FG001|NOT COMPLETED|Overall Study||52||
48080314|NCT02244606|100518753|FG000|STARTED|Overall Study||7||
48080315|NCT02244606|100518754|FG001|STARTED|Overall Study||7||
48080316|NCT02244606|100518755|FG002|STARTED|Overall Study||7||
48080317|NCT02244606|100518756|FG003|STARTED|Overall Study||1||
48080318|NCT02244606|100518753|FG000|Did Not Receive Study Drug|Overall Study||1||
48227779|NCT01961609|100878083|FG003|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||0||
48227780|NCT01961609|100878080|FG000|Safety Set|Maintenance 1 (Weeks 17 - 48)||107||
48080319|NCT02244606|100518754|FG001|Did Not Receive Study Drug|Overall Study||0||
48080320|NCT02244606|100518755|FG002|Did Not Receive Study Drug|Overall Study||0||
48080321|NCT02244606|100518756|FG003|Did Not Receive Study Drug|Overall Study||0||
48080322|NCT02244606|100518753|FG000|Did Not Complete Randomized Study Drug|Overall Study||1||
48080323|NCT02244606|100518754|FG001|Did Not Complete Randomized Study Drug|Overall Study||1||
48080324|NCT02244606|100518755|FG002|Did Not Complete Randomized Study Drug|Overall Study||2||
48080325|NCT02244606|100518756|FG003|Did Not Complete Randomized Study Drug|Overall Study||0||
48080326|NCT02244606|100518753|FG000|COMPLETED|Overall Study||4||
48080327|NCT02244606|100518754|FG001|COMPLETED|Overall Study||2||
48080328|NCT02244606|100518755|FG002|COMPLETED|Overall Study||4||
48080329|NCT02244606|100518756|FG003|COMPLETED|Overall Study||0||
48080330|NCT02244606|100518753|FG000|NOT COMPLETED|Overall Study||3||
48080331|NCT02244606|100518754|FG001|NOT COMPLETED|Overall Study||5||
48080332|NCT02244606|100518755|FG002|NOT COMPLETED|Overall Study||3||
48080333|NCT02244606|100518756|FG003|NOT COMPLETED|Overall Study||1||
48080334|NCT01754623|100518757|FG000|STARTED|Overall Study||9||
48080335|NCT01754623|100518757|FG000|COMPLETED|Overall Study||9||
48080336|NCT01754623|100518757|FG000|NOT COMPLETED|Overall Study||0||
48080337|NCT05564429|100518758|FG000|STARTED|Phase 1||0||
48080338|NCT05564429|100518759|FG001|STARTED|Phase 1||0||
48080339|NCT05564429|100518760|FG002|STARTED|Phase 1||1||
48080340|NCT05564429|100518758|FG000|Whole Body PET Scan|Phase 1||0||
48080341|NCT05564429|100518759|FG001|Whole Body PET Scan|Phase 1||0||
48080342|NCT05564429|100518760|FG002|Whole Body PET Scan|Phase 1||1||
48080343|NCT05564429|100518758|FG000|COMPLETED|Phase 1||0||
48080344|NCT05564429|100518759|FG001|COMPLETED|Phase 1||0||
48080345|NCT05564429|100518760|FG002|COMPLETED|Phase 1||1||
48080346|NCT05564429|100518758|FG000|NOT COMPLETED|Phase 1||0||
48080347|NCT05564429|100518759|FG001|NOT COMPLETED|Phase 1||0||
48080348|NCT05564429|100518760|FG002|NOT COMPLETED|Phase 1||0||
48080349|NCT05564429|100518758|FG000|STARTED|Phase 2||3||
48080350|NCT05564429|100518759|FG001|STARTED|Phase 2||2||
48080351|NCT05564429|100518760|FG002|STARTED|Phase 2||3||
48080352|NCT05564429|100518758|FG000|Brain PET Scan|Phase 2||3||
48080353|NCT05564429|100518759|FG001|Brain PET Scan|Phase 2||2||
48080354|NCT05564429|100518760|FG002|Brain PET Scan|Phase 2||3||
48080355|NCT05564429|100518758|FG000|COMPLETED|Phase 2||3||
48080356|NCT05564429|100518759|FG001|COMPLETED|Phase 2||2||
48080357|NCT05564429|100518760|FG002|COMPLETED|Phase 2||3||
48080358|NCT05564429|100518758|FG000|NOT COMPLETED|Phase 2||0||
48080359|NCT05564429|100518759|FG001|NOT COMPLETED|Phase 2||0||
48080360|NCT05564429|100518760|FG002|NOT COMPLETED|Phase 2||0||
48227781|NCT01961609|100878081|FG001|Safety Set|Maintenance 1 (Weeks 17 - 48)||66||
48227782|NCT01961609|100878082|FG002|Safety Set|Maintenance 1 (Weeks 17 - 48)||37||
48227783|NCT01961609|100878083|FG003|Safety Set|Maintenance 1 (Weeks 17 - 48)||0||
48227784|NCT01961609|100878080|FG000|COMPLETED|Maintenance 1 (Weeks 17 - 48)||84||
48227785|NCT01961609|100878081|FG001|COMPLETED|Maintenance 1 (Weeks 17 - 48)||55||
48080361|NCT05564429|100518758|FG000|STARTED|Phase 3||1||
48080362|NCT05564429|100518759|FG001|STARTED|Phase 3||0||
48080363|NCT05564429|100518760|FG002|STARTED|Phase 3||0||
48080364|NCT05564429|100518758|FG000|Whole Body PET Scan|Phase 3||1||
48080365|NCT05564429|100518759|FG001|Whole Body PET Scan|Phase 3||0||
48080366|NCT05564429|100518760|FG002|Whole Body PET Scan|Phase 3||0||
48080367|NCT05564429|100518758|FG000|COMPLETED|Phase 3||1||
48080368|NCT05564429|100518759|FG001|COMPLETED|Phase 3||0||
48080369|NCT05564429|100518760|FG002|COMPLETED|Phase 3||0||
48080370|NCT05564429|100518758|FG000|NOT COMPLETED|Phase 3||0||
48080371|NCT05564429|100518759|FG001|NOT COMPLETED|Phase 3||0||
48080372|NCT05564429|100518760|FG002|NOT COMPLETED|Phase 3||0||
48080373|NCT00871260|100518761|FG000|STARTED|Overall Study||20||
48080374|NCT00871260|100518761|FG000|COMPLETED|Overall Study||20||
48080375|NCT00871260|100518761|FG000|NOT COMPLETED|Overall Study||0||
48080376|NCT02417831|100518762|FG000|STARTED|Period 1: Treatment Period 1 + Washout||17||
48080377|NCT02417831|100518763|FG001|STARTED|Period 1: Treatment Period 1 + Washout||17||
48080378|NCT02417831|100518762|FG000|COMPLETED|Period 1: Treatment Period 1 + Washout||17||
48080379|NCT02417831|100518763|FG001|COMPLETED|Period 1: Treatment Period 1 + Washout||17||
48080380|NCT02417831|100518762|FG000|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0||
48080381|NCT02417831|100518763|FG001|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0||
48080382|NCT02417831|100518762|FG000|STARTED|Period 2: Treatment Period 2 + Washout||17||
48080383|NCT02417831|100518763|FG001|STARTED|Period 2: Treatment Period 2 + Washout||17||
48080384|NCT02417831|100518762|FG000|COMPLETED|Period 2: Treatment Period 2 + Washout||17||
48080385|NCT02417831|100518763|FG001|COMPLETED|Period 2: Treatment Period 2 + Washout||17||
48080386|NCT02417831|100518762|FG000|NOT COMPLETED|Period 2: Treatment Period 2 + Washout||0||
48080387|NCT02417831|100518763|FG001|NOT COMPLETED|Period 2: Treatment Period 2 + Washout||0||
48080388|NCT00901316|100518764|FG000|STARTED|Overall Study||492||
48080389|NCT00901316|100518765|FG001|STARTED|Overall Study||495||
48080390|NCT00901316|100518764|FG000|COMPLETED|Overall Study||492||
48080391|NCT00901316|100518765|FG001|COMPLETED|Overall Study||495||
48080392|NCT00901316|100518764|FG000|NOT COMPLETED|Overall Study||0||
48526710|NCT02312063|101624012|FG001|STARTED|Overall Study||25||
48080393|NCT00901316|100518765|FG001|NOT COMPLETED|Overall Study||0||
48080394|NCT03542474|100518766|FG000|STARTED|Overall Study||8||
48080395|NCT03542474|100518766|FG000|COMPLETED|Overall Study||8||
48080396|NCT03542474|100518766|FG000|NOT COMPLETED|Overall Study||0||
48080397|NCT02432729|100518767|FG000|STARTED|Month 3 Visit||720||
48080398|NCT02432729|100518767|FG000|COMPLETED|Month 3 Visit||718||
48080399|NCT02432729|100518767|FG000|NOT COMPLETED|Month 3 Visit||2||
48080400|NCT02432729|100518767|FG000|STARTED|Month 6 Visit||718||
48080401|NCT02432729|100518767|FG000|COMPLETED|Month 6 Visit||632||
48080402|NCT02432729|100518767|FG000|NOT COMPLETED|Month 6 Visit||86||
48080403|NCT02432729|100518767|FG000|STARTED|Month 12 Visit||632||
48080404|NCT02432729|100518767|FG000|COMPLETED|Month 12 Visit||436||
48080405|NCT02432729|100518767|FG000|NOT COMPLETED|Month 12 Visit||196||
48526711|NCT02312063|101624011|FG000|COMPLETED|Overall Study||23||
48526712|NCT02312063|101624012|FG001|COMPLETED|Overall Study||24||
48080406|NCT01049308|100518768|FG000|STARTED|Evaluation of Cognitive Impairment||251||
48080407|NCT01049308|100518768|FG000|COMPLETED|Evaluation of Cognitive Impairment||251||
48080408|NCT01049308|100518768|FG000|NOT COMPLETED|Evaluation of Cognitive Impairment||0||
48080409|NCT01049308|100518768|FG000|STARTED|Pill Counts||251||
48080410|NCT01049308|100518768|FG000|COMPLETED|Pill Counts||168||
48080411|NCT01049308|100518768|FG000|NOT COMPLETED|Pill Counts||83||
48080412|NCT01738321|100518769|FG000|STARTED|Overall Study||33||
48080413|NCT01738321|100518770|FG001|STARTED|Overall Study||30||
48080414|NCT01738321|100518769|FG000|COMPLETED|Overall Study||33||
48080415|NCT01738321|100518770|FG001|COMPLETED|Overall Study||30||
48080416|NCT01738321|100518769|FG000|NOT COMPLETED|Overall Study||0||
48080417|NCT01738321|100518770|FG001|NOT COMPLETED|Overall Study||0||
48080418|NCT01811654|100518771|FG000|STARTED|Overall Study||14||
48080419|NCT01811654|100518772|FG001|STARTED|Overall Study||16||
48080420|NCT01811654|100518771|FG000|COMPLETED|Overall Study||14||
48080421|NCT01811654|100518772|FG001|COMPLETED|Overall Study||16||
48080422|NCT01811654|100518771|FG000|NOT COMPLETED|Overall Study||0||
48080423|NCT01811654|100518772|FG001|NOT COMPLETED|Overall Study||0||
48080424|NCT03434275|100518773|FG000|STARTED|Overall Study||98||
48080425|NCT03434275|100518774|FG001|STARTED|Overall Study||96||
48080426|NCT03434275|100518773|FG000|Treated|Overall Study||93||
48080427|NCT03434275|100518774|FG001|Treated|Overall Study||88||
48080428|NCT03434275|100518773|FG000|COMPLETED|Overall Study||93||
48080429|NCT03434275|100518774|FG001|COMPLETED|Overall Study||88||
48080430|NCT03434275|100518773|FG000|NOT COMPLETED|Overall Study||5||
48080431|NCT03434275|100518774|FG001|NOT COMPLETED|Overall Study||8||
48080432|NCT02885012|100518775|FG000|STARTED|Overall Study||1||
48080433|NCT02885012|100518776|FG001|STARTED|Overall Study||2||
48080434|NCT02885012|100518775|FG000|COMPLETED|Overall Study||1||
48080435|NCT02885012|100518776|FG001|COMPLETED|Overall Study||2||
48080436|NCT02885012|100518775|FG000|NOT COMPLETED|Overall Study||0||
48080437|NCT02885012|100518776|FG001|NOT COMPLETED|Overall Study||0||
48080438|NCT03064451|100518777|FG000|STARTED|Overall Study||60||
48080439|NCT03064451|100518777|FG000|Safety Population|Overall Study||52||
48080440|NCT03064451|100518777|FG000|COMPLETED|Overall Study||46||
48080441|NCT03064451|100518777|FG000|NOT COMPLETED|Overall Study||14||
48080442|NCT01663532|100518778|FG000|STARTED|Overall Study||168||
48080443|NCT01663532|100518779|FG001|STARTED|Overall Study||172||
48080444|NCT01663532|100518778|FG000|COMPLETED|Overall Study||94||
48080445|NCT01663532|100518779|FG001|COMPLETED|Overall Study||65||
48080446|NCT01663532|100518778|FG000|NOT COMPLETED|Overall Study||74||
48080447|NCT01663532|100518779|FG001|NOT COMPLETED|Overall Study||107||
48080448|NCT04115839|100518780|FG000|STARTED|Main Study (Up to 16 Weeks)||36||
48080449|NCT04115839|100518781|FG001|STARTED|Main Study (Up to 16 Weeks)||34||
48080450|NCT04115839|100518782|FG002|STARTED|Main Study (Up to 16 Weeks)||36||
48080451|NCT04115839|100518783|FG003|STARTED|Main Study (Up to 16 Weeks)||0||
48080452|NCT04115839|100518784|FG004|STARTED|Main Study (Up to 16 Weeks)||0||
48080453|NCT04115839|100518785|FG005|STARTED|Main Study (Up to 16 Weeks)||0||
48080454|NCT04115839|100518786|FG006|STARTED|Main Study (Up to 16 Weeks)||0||
48080455|NCT04115839|100518780|FG000|COMPLETED|Main Study (Up to 16 Weeks)||18||
48080456|NCT04115839|100518781|FG001|COMPLETED|Main Study (Up to 16 Weeks)||20||
48080457|NCT04115839|100518782|FG002|COMPLETED|Main Study (Up to 16 Weeks)||18||
48080458|NCT04115839|100518783|FG003|COMPLETED|Main Study (Up to 16 Weeks)||0||
48080459|NCT04115839|100518784|FG004|COMPLETED|Main Study (Up to 16 Weeks)||0||
48080460|NCT04115839|100518785|FG005|COMPLETED|Main Study (Up to 16 Weeks)||0||
48080461|NCT04115839|100518786|FG006|COMPLETED|Main Study (Up to 16 Weeks)||0||
48526713|NCT02312063|101624011|FG000|NOT COMPLETED|Overall Study||0||
48526714|NCT02312063|101624012|FG001|NOT COMPLETED|Overall Study||1||
48526715|NCT01362127|101624013|FG000|STARTED|Overall Study||90||
48526716|NCT01362127|101624014|FG001|STARTED|Overall Study||91||
48526717|NCT01362127|101624013|FG000|COMPLETED|Overall Study||90||
48526718|NCT01362127|101624014|FG001|COMPLETED|Overall Study||91||
48526719|NCT01362127|101624013|FG000|NOT COMPLETED|Overall Study||0||
48526720|NCT01362127|101624014|FG001|NOT COMPLETED|Overall Study||0||
48526721|NCT00367003|101624015|FG000|STARTED|Overall Study||37||
48080462|NCT04115839|100518780|FG000|NOT COMPLETED|Main Study (Up to 16 Weeks)||18||
48080463|NCT04115839|100518781|FG001|NOT COMPLETED|Main Study (Up to 16 Weeks)||14||
48080464|NCT04115839|100518782|FG002|NOT COMPLETED|Main Study (Up to 16 Weeks)||18||
48080465|NCT04115839|100518783|FG003|NOT COMPLETED|Main Study (Up to 16 Weeks)||0||
48080466|NCT04115839|100518784|FG004|NOT COMPLETED|Main Study (Up to 16 Weeks)||0||
48080467|NCT04115839|100518785|FG005|NOT COMPLETED|Main Study (Up to 16 Weeks)||0||
48080468|NCT04115839|100518786|FG006|NOT COMPLETED|Main Study (Up to 16 Weeks)||0||
48080469|NCT04115839|100518780|FG000|STARTED|LTE Phase (After Week 16 to Week 63)||0||
48080470|NCT04115839|100518781|FG001|STARTED|LTE Phase (After Week 16 to Week 63)||0||
48080471|NCT04115839|100518782|FG002|STARTED|LTE Phase (After Week 16 to Week 63)||0||
48080472|NCT04115839|100518783|FG003|STARTED|LTE Phase (After Week 16 to Week 63)||18||
48080473|NCT04115839|100518784|FG004|STARTED|LTE Phase (After Week 16 to Week 63)||20||
48080474|NCT04115839|100518785|FG005|STARTED|LTE Phase (After Week 16 to Week 63)||10||
48080475|NCT04115839|100518786|FG006|STARTED|LTE Phase (After Week 16 to Week 63)||8||
48080476|NCT04115839|100518780|FG000|COMPLETED|LTE Phase (After Week 16 to Week 63)||0||
48080477|NCT04115839|100518781|FG001|COMPLETED|LTE Phase (After Week 16 to Week 63)||0||
48080478|NCT04115839|100518782|FG002|COMPLETED|LTE Phase (After Week 16 to Week 63)||0||
48080479|NCT04115839|100518783|FG003|COMPLETED|LTE Phase (After Week 16 to Week 63)||0||
48227786|NCT01961609|100878082|FG002|COMPLETED|Maintenance 1 (Weeks 17 - 48)||18||
48227787|NCT01961609|100878083|FG003|COMPLETED|Maintenance 1 (Weeks 17 - 48)||0||
48227788|NCT01961609|100878080|FG000|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||23||
48227789|NCT01961609|100878081|FG001|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||11||
48227790|NCT01961609|100878082|FG002|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||19||
48227791|NCT01961609|100878083|FG003|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||0||
48227792|NCT01961609|100878080|FG000|STARTED|Maintanence 2 (Weeks 49 - 72)||83||
48227793|NCT01961609|100878081|FG001|STARTED|Maintanence 2 (Weeks 49 - 72)||31||
48227794|NCT01961609|100878082|FG002|STARTED|Maintanence 2 (Weeks 49 - 72)||16||
48227795|NCT01961609|100878083|FG003|STARTED|Maintanence 2 (Weeks 49 - 72)||24||
48227796|NCT01961609|100878080|FG000|Safety Set|Maintanence 2 (Weeks 49 - 72)||83||
48227797|NCT01961609|100878081|FG001|Safety Set|Maintanence 2 (Weeks 49 - 72)||31||
48227798|NCT01961609|100878082|FG002|Safety Set|Maintanence 2 (Weeks 49 - 72)||16||
48227799|NCT01961609|100878083|FG003|Safety Set|Maintanence 2 (Weeks 49 - 72)||24||
48227800|NCT01961609|100878080|FG000|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||83||
48227801|NCT01961609|100878081|FG001|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||31||
48227802|NCT01961609|100878082|FG002|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||16||
48227803|NCT01961609|100878083|FG003|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||24||
48227804|NCT01961609|100878080|FG000|COMPLETED|Maintanence 2 (Weeks 49 - 72)||71||
48227805|NCT01961609|100878081|FG001|COMPLETED|Maintanence 2 (Weeks 49 - 72)||25||
48227806|NCT01961609|100878082|FG002|COMPLETED|Maintanence 2 (Weeks 49 - 72)||12||
48227807|NCT01961609|100878083|FG003|COMPLETED|Maintanence 2 (Weeks 49 - 72)||17||
48526722|NCT00367003|101624015|FG000|COMPLETED|Overall Study||28||
48526723|NCT00367003|101624015|FG000|NOT COMPLETED|Overall Study||9||
48526724|NCT01553279|101624016|FG000|STARTED|Part 1 (Infant Vaccinations)||142|Number Randomized|
48526725|NCT01553279|101624017|FG001|STARTED|Part 1 (Infant Vaccinations)||142|Number Randomized|
48526726|NCT01553279|101624016|FG000|COMPLETED|Part 1 (Infant Vaccinations)||140||
48526727|NCT01553279|101624017|FG001|COMPLETED|Part 1 (Infant Vaccinations)||141||
48526728|NCT01553279|101624016|FG000|NOT COMPLETED|Part 1 (Infant Vaccinations)||2||
48526729|NCT01553279|101624017|FG001|NOT COMPLETED|Part 1 (Infant Vaccinations)||1||
48526730|NCT01553279|101624016|FG000|STARTED|Interim Period||140||
48526731|NCT01553279|101624017|FG001|STARTED|Interim Period||141||
48526732|NCT01553279|101624016|FG000|COMPLETED|Interim Period||137||
48526733|NCT01553279|101624017|FG001|COMPLETED|Interim Period||139||
48526734|NCT01553279|101624016|FG000|NOT COMPLETED|Interim Period||3||
48526735|NCT01553279|101624017|FG001|NOT COMPLETED|Interim Period||2||
48526736|NCT01553279|101624016|FG000|STARTED|Period 2: Toddler Vaccinations||137||
48526737|NCT01553279|101624017|FG001|STARTED|Period 2: Toddler Vaccinations||139||
48526738|NCT01553279|101624016|FG000|COMPLETED|Period 2: Toddler Vaccinations||134||
48080480|NCT04115839|100518784|FG004|COMPLETED|LTE Phase (After Week 16 to Week 63)||0||
48080481|NCT04115839|100518785|FG005|COMPLETED|LTE Phase (After Week 16 to Week 63)||0||
48080482|NCT04115839|100518786|FG006|COMPLETED|LTE Phase (After Week 16 to Week 63)||0||
48526739|NCT01553279|101624017|FG001|COMPLETED|Period 2: Toddler Vaccinations||132||
48526740|NCT01553279|101624016|FG000|NOT COMPLETED|Period 2: Toddler Vaccinations||3||
48526741|NCT01553279|101624017|FG001|NOT COMPLETED|Period 2: Toddler Vaccinations||7||
48526742|NCT02400671|101624018|FG000|STARTED|Overall Study||276||
48526743|NCT02400671|101624019|FG001|STARTED|Overall Study||271||
48526744|NCT02400671|101624020|FG002|STARTED|Overall Study||277||
48526745|NCT02400671|101624018|FG000|COMPLETED|Overall Study||249||
48526746|NCT02400671|101624019|FG001|COMPLETED|Overall Study||239||
48526747|NCT02400671|101624020|FG002|COMPLETED|Overall Study||249||
48526748|NCT02400671|101624018|FG000|NOT COMPLETED|Overall Study||27||
48526749|NCT02400671|101624019|FG001|NOT COMPLETED|Overall Study||32||
48526750|NCT02400671|101624020|FG002|NOT COMPLETED|Overall Study||28||
48526751|NCT01765582|101624021|FG000|STARTED|Overall Study||93||
48526752|NCT01765582|101624022|FG001|STARTED|Overall Study||92||
48526753|NCT01765582|101624023|FG002|STARTED|Overall Study||95||
48526754|NCT01765582|101624021|FG000|COMPLETED|Overall Study||0||
48227808|NCT01961609|100878080|FG000|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||12||
48227809|NCT01961609|100878081|FG001|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||6||
48227810|NCT01961609|100878082|FG002|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||4||
48227811|NCT01961609|100878083|FG003|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||7||
48227812|NCT00391170|100878084|FG000|STARTED|Overall Study||27||
48227813|NCT00391170|100878085|FG001|STARTED|Overall Study||27||
48227814|NCT00391170|100878084|FG000|COMPLETED|Overall Study||21||
48526755|NCT01765582|101624022|FG001|COMPLETED|Overall Study||0||
48080483|NCT04115839|100518780|FG000|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||0||
48080484|NCT04115839|100518781|FG001|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||0||
48080485|NCT04115839|100518782|FG002|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||0||
48526756|NCT01765582|101624023|FG002|COMPLETED|Overall Study||0||
48526757|NCT01765582|101624021|FG000|NOT COMPLETED|Overall Study||93||
48526758|NCT01765582|101624022|FG001|NOT COMPLETED|Overall Study||92||
48526759|NCT01765582|101624023|FG002|NOT COMPLETED|Overall Study||95||
48526760|NCT02006628|101624024|FG000|STARTED|Overall Study||43||
48526761|NCT02006628|101624025|FG001|STARTED|Overall Study||45||
48526762|NCT02006628|101624024|FG000|Received at Least 1 Dose of Study Drug|Overall Study||43|Safety analysis set|
48526763|NCT02006628|101624025|FG001|Received at Least 1 Dose of Study Drug|Overall Study||45|Safety analysis set|
48526764|NCT02006628|101624024|FG000|Intention to Treat (ITT) Analysis Set|Overall Study||42|Provided informed consent, randomized, took at least 1 dose of IMP, had post-baseline efficacy data|
48526765|NCT02006628|101624025|FG001|Intention to Treat (ITT) Analysis Set|Overall Study||44|Provided informed consent, randomized, took at least 1 dose of IMP, had post-baseline efficacy data|
48526766|NCT02006628|101624024|FG000|COMPLETED|Overall Study||40||
48526767|NCT02006628|101624025|FG001|COMPLETED|Overall Study||43||
48080486|NCT04115839|100518783|FG003|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||18||
48080487|NCT04115839|100518784|FG004|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||20||
48080488|NCT04115839|100518785|FG005|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||10||
48080489|NCT04115839|100518786|FG006|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||8||
48080490|NCT00662012|100518787|FG000|STARTED|Overall Study||414||
48526768|NCT02006628|101624024|FG000|NOT COMPLETED|Overall Study||3||
48526769|NCT02006628|101624025|FG001|NOT COMPLETED|Overall Study||2||
48526770|NCT01558297|101624026|FG000|STARTED|Overall Study||30||
48526771|NCT01558297|101624027|FG001|STARTED|Overall Study||29||
48526772|NCT01558297|101624028|FG002|STARTED|Overall Study||30||
48526773|NCT01558297|101624026|FG000|COMPLETED|Overall Study||28||
48526774|NCT01558297|101624027|FG001|COMPLETED|Overall Study||27||
48526775|NCT01558297|101624028|FG002|COMPLETED|Overall Study||29||
48526776|NCT01558297|101624026|FG000|NOT COMPLETED|Overall Study||2||
48526777|NCT01558297|101624027|FG001|NOT COMPLETED|Overall Study||2||
48526778|NCT01558297|101624028|FG002|NOT COMPLETED|Overall Study||1||
48526779|NCT03040323|101624029|FG000|STARTED|Overall Study||0||
48080491|NCT00662012|100518787|FG000|COMPLETED|Overall Study||327||
48080492|NCT00662012|100518787|FG000|NOT COMPLETED|Overall Study||87||
48080493|NCT03633695|100518788|FG000|STARTED|Overall Study||343||686
48080494|NCT03633695|100518789|FG001|STARTED|Overall Study||110||220
48080495|NCT03633695|100518788|FG000|Astigmatism Group 1 (IC-8™ IOL Group)|Overall Study||273||546
48080496|NCT03633695|100518789|FG001|Astigmatism Group 1 (IC-8™ IOL Group)|Overall Study||0||0
48080497|NCT03633695|100518788|FG000|Astigmatism Group 2 (IC-8™ IOL Group)|Overall Study||70||140
48080498|NCT03633695|100518789|FG001|Astigmatism Group 2 (IC-8™ IOL Group)|Overall Study||0||0
48080499|NCT03633695|100518788|FG000|Astigmatism Group 1 (Control Group)|Overall Study||0||0
48080500|NCT03633695|100518789|FG001|Astigmatism Group 1 (Control Group)|Overall Study||91||182
48080501|NCT03633695|100518788|FG000|Astigmatism Group 2 (Control Group)|Overall Study||0||0
48080502|NCT03633695|100518789|FG001|Astigmatism Group 2 (Control Group)|Overall Study||19||38
48080503|NCT03633695|100518788|FG000|COMPLETED|Overall Study||331||662
48080504|NCT03633695|100518789|FG001|COMPLETED|Overall Study||101||202
48080505|NCT03633695|100518788|FG000|NOT COMPLETED|Overall Study||12||24
48080506|NCT03633695|100518789|FG001|NOT COMPLETED|Overall Study||9||18
48080507|NCT00975650|100518790|FG000|STARTED|Period 1||13||
48080508|NCT00975650|100518791|FG001|STARTED|Period 1||16||
48080509|NCT00975650|100518792|FG002|STARTED|Period 1||14||
48080510|NCT00975650|100518793|FG003|STARTED|Period 1||14||
48080511|NCT00975650|100518790|FG000|COMPLETED|Period 1||13||
48080512|NCT00975650|100518791|FG001|COMPLETED|Period 1||16||
48080513|NCT00975650|100518792|FG002|COMPLETED|Period 1||14||
48080514|NCT00975650|100518793|FG003|COMPLETED|Period 1||14||
48080515|NCT00975650|100518790|FG000|NOT COMPLETED|Period 1||0||
48080516|NCT00975650|100518791|FG001|NOT COMPLETED|Period 1||0||
48080517|NCT00975650|100518792|FG002|NOT COMPLETED|Period 1||0||
48080518|NCT00975650|100518793|FG003|NOT COMPLETED|Period 1||0||
48080519|NCT00975650|100518790|FG000|STARTED|Period 2||13||
48080520|NCT00975650|100518791|FG001|STARTED|Period 2||16||
48080521|NCT00975650|100518792|FG002|STARTED|Period 2||14||
48080522|NCT00975650|100518793|FG003|STARTED|Period 2||14||
48080523|NCT00975650|100518790|FG000|COMPLETED|Period 2||12||
48080524|NCT00975650|100518791|FG001|COMPLETED|Period 2||14||
48080525|NCT00975650|100518792|FG002|COMPLETED|Period 2||14||
48080526|NCT00975650|100518793|FG003|COMPLETED|Period 2||14||
48080527|NCT00975650|100518790|FG000|NOT COMPLETED|Period 2||1||
48080528|NCT00975650|100518791|FG001|NOT COMPLETED|Period 2||2||
48080529|NCT00975650|100518792|FG002|NOT COMPLETED|Period 2||0||
48080530|NCT00975650|100518793|FG003|NOT COMPLETED|Period 2||0||
48080531|NCT00975650|100518790|FG000|STARTED|Period 3||12||
48080532|NCT00975650|100518791|FG001|STARTED|Period 3||14||
48526780|NCT03040323|101624030|FG001|STARTED|Overall Study||0||
48526781|NCT03040323|101624029|FG000|COMPLETED|Overall Study||0||
48526782|NCT03040323|101624030|FG001|COMPLETED|Overall Study||0||
48526783|NCT03040323|101624029|FG000|NOT COMPLETED|Overall Study||0||
48526784|NCT03040323|101624030|FG001|NOT COMPLETED|Overall Study||0||
48526785|NCT05304611|101624031|FG000|STARTED|Adult Dose-escalation: 300 mg L9LS||6||
48526786|NCT05304611|101624032|FG001|STARTED|Adult Dose-escalation: 300 mg L9LS||0||
48526787|NCT05304611|101624033|FG002|STARTED|Adult Dose-escalation: 300 mg L9LS||0||
48526788|NCT05304611|101624034|FG003|STARTED|Adult Dose-escalation: 300 mg L9LS||0||
48526789|NCT05304611|101624035|FG004|STARTED|Adult Dose-escalation: 300 mg L9LS||0||
48526790|NCT05304611|101624036|FG005|STARTED|Adult Dose-escalation: 300 mg L9LS||0||
48526791|NCT05304611|101624037|FG006|STARTED|Adult Dose-escalation: 300 mg L9LS||0||
48526792|NCT05304611|101624038|FG007|STARTED|Adult Dose-escalation: 300 mg L9LS||0||
48526793|NCT05304611|101624039|FG008|STARTED|Adult Dose-escalation: 300 mg L9LS||0||
48526794|NCT05304611|101624031|FG000|COMPLETED|Adult Dose-escalation: 300 mg L9LS||6||
48526795|NCT05304611|101624032|FG001|COMPLETED|Adult Dose-escalation: 300 mg L9LS||0||
48526796|NCT05304611|101624033|FG002|COMPLETED|Adult Dose-escalation: 300 mg L9LS||0||
48526797|NCT05304611|101624034|FG003|COMPLETED|Adult Dose-escalation: 300 mg L9LS||0||
48526798|NCT05304611|101624035|FG004|COMPLETED|Adult Dose-escalation: 300 mg L9LS||0||
48526799|NCT05304611|101624036|FG005|COMPLETED|Adult Dose-escalation: 300 mg L9LS||0||
48526800|NCT05304611|101624037|FG006|COMPLETED|Adult Dose-escalation: 300 mg L9LS||0||
48526801|NCT05304611|101624038|FG007|COMPLETED|Adult Dose-escalation: 300 mg L9LS||0||
48526802|NCT05304611|101624039|FG008|COMPLETED|Adult Dose-escalation: 300 mg L9LS||0||
48526803|NCT05304611|101624031|FG000|NOT COMPLETED|Adult Dose-escalation: 300 mg L9LS||0||
48526804|NCT05304611|101624032|FG001|NOT COMPLETED|Adult Dose-escalation: 300 mg L9LS||0||
48526805|NCT05304611|101624033|FG002|NOT COMPLETED|Adult Dose-escalation: 300 mg L9LS||0||
48526806|NCT05304611|101624034|FG003|NOT COMPLETED|Adult Dose-escalation: 300 mg L9LS||0||
48526807|NCT05304611|101624035|FG004|NOT COMPLETED|Adult Dose-escalation: 300 mg L9LS||0||
48526808|NCT05304611|101624036|FG005|NOT COMPLETED|Adult Dose-escalation: 300 mg L9LS||0||
48526809|NCT05304611|101624037|FG006|NOT COMPLETED|Adult Dose-escalation: 300 mg L9LS||0||
48526810|NCT05304611|101624038|FG007|NOT COMPLETED|Adult Dose-escalation: 300 mg L9LS||0||
48526811|NCT05304611|101624039|FG008|NOT COMPLETED|Adult Dose-escalation: 300 mg L9LS||0||
48526812|NCT05304611|101624031|FG000|STARTED|Adult Dose-escalation: 600 mg L9LS||0||
48526813|NCT05304611|101624032|FG001|STARTED|Adult Dose-escalation: 600 mg L9LS||6||
48526814|NCT05304611|101624033|FG002|STARTED|Adult Dose-escalation: 600 mg L9LS||0||
48526815|NCT05304611|101624034|FG003|STARTED|Adult Dose-escalation: 600 mg L9LS||0||
48526816|NCT05304611|101624035|FG004|STARTED|Adult Dose-escalation: 600 mg L9LS||0||
48526817|NCT05304611|101624036|FG005|STARTED|Adult Dose-escalation: 600 mg L9LS||0||
48526818|NCT05304611|101624037|FG006|STARTED|Adult Dose-escalation: 600 mg L9LS||0||
48526819|NCT05304611|101624038|FG007|STARTED|Adult Dose-escalation: 600 mg L9LS||0||
48526820|NCT05304611|101624039|FG008|STARTED|Adult Dose-escalation: 600 mg L9LS||0||
48526821|NCT05304611|101624031|FG000|COMPLETED|Adult Dose-escalation: 600 mg L9LS||0||
48526822|NCT05304611|101624032|FG001|COMPLETED|Adult Dose-escalation: 600 mg L9LS||6||
48526823|NCT05304611|101624033|FG002|COMPLETED|Adult Dose-escalation: 600 mg L9LS||0||
48526824|NCT05304611|101624034|FG003|COMPLETED|Adult Dose-escalation: 600 mg L9LS||0||
48526825|NCT05304611|101624035|FG004|COMPLETED|Adult Dose-escalation: 600 mg L9LS||0||
48526826|NCT05304611|101624036|FG005|COMPLETED|Adult Dose-escalation: 600 mg L9LS||0||
48526827|NCT05304611|101624037|FG006|COMPLETED|Adult Dose-escalation: 600 mg L9LS||0||
48526828|NCT05304611|101624038|FG007|COMPLETED|Adult Dose-escalation: 600 mg L9LS||0||
48526829|NCT05304611|101624039|FG008|COMPLETED|Adult Dose-escalation: 600 mg L9LS||0||
48526830|NCT05304611|101624031|FG000|NOT COMPLETED|Adult Dose-escalation: 600 mg L9LS||0||
48526831|NCT05304611|101624032|FG001|NOT COMPLETED|Adult Dose-escalation: 600 mg L9LS||0||
48526832|NCT05304611|101624033|FG002|NOT COMPLETED|Adult Dose-escalation: 600 mg L9LS||0||
48526833|NCT05304611|101624034|FG003|NOT COMPLETED|Adult Dose-escalation: 600 mg L9LS||0||
48526834|NCT05304611|101624035|FG004|NOT COMPLETED|Adult Dose-escalation: 600 mg L9LS||0||
48526835|NCT05304611|101624036|FG005|NOT COMPLETED|Adult Dose-escalation: 600 mg L9LS||0||
48526836|NCT05304611|101624037|FG006|NOT COMPLETED|Adult Dose-escalation: 600 mg L9LS||0||
48526837|NCT05304611|101624038|FG007|NOT COMPLETED|Adult Dose-escalation: 600 mg L9LS||0||
48526838|NCT05304611|101624039|FG008|NOT COMPLETED|Adult Dose-escalation: 600 mg L9LS||0||
48526839|NCT05304611|101624031|FG000|STARTED|Adult Dose-escalation: 20 mg/kg L9LS||0||
48526840|NCT05304611|101624032|FG001|STARTED|Adult Dose-escalation: 20 mg/kg L9LS||0||
48526841|NCT05304611|101624033|FG002|STARTED|Adult Dose-escalation: 20 mg/kg L9LS||6||
48526842|NCT05304611|101624034|FG003|STARTED|Adult Dose-escalation: 20 mg/kg L9LS||0||
48526843|NCT05304611|101624035|FG004|STARTED|Adult Dose-escalation: 20 mg/kg L9LS||0||
48526844|NCT05304611|101624036|FG005|STARTED|Adult Dose-escalation: 20 mg/kg L9LS||0||
48080533|NCT00975650|100518792|FG002|STARTED|Period 3||14||
48080534|NCT00975650|100518793|FG003|STARTED|Period 3||14||
48080535|NCT00975650|100518790|FG000|COMPLETED|Period 3||12||
48080536|NCT00975650|100518791|FG001|COMPLETED|Period 3||14||
48080537|NCT00975650|100518792|FG002|COMPLETED|Period 3||14||
48080538|NCT00975650|100518793|FG003|COMPLETED|Period 3||14||
48080539|NCT00975650|100518790|FG000|NOT COMPLETED|Period 3||0||
48080540|NCT00975650|100518791|FG001|NOT COMPLETED|Period 3||0||
48080541|NCT00975650|100518792|FG002|NOT COMPLETED|Period 3||0||
48080542|NCT00975650|100518793|FG003|NOT COMPLETED|Period 3||0||
48080543|NCT00975650|100518790|FG000|STARTED|Period 4||12||
48080544|NCT00975650|100518791|FG001|STARTED|Period 4||14||
48080545|NCT00975650|100518792|FG002|STARTED|Period 4||14||
48080546|NCT00975650|100518793|FG003|STARTED|Period 4||14||
48080547|NCT00975650|100518790|FG000|COMPLETED|Period 4||12||
48080548|NCT00975650|100518791|FG001|COMPLETED|Period 4||14||
48080549|NCT00975650|100518792|FG002|COMPLETED|Period 4||14||
48080550|NCT00975650|100518793|FG003|COMPLETED|Period 4||14||
48080551|NCT00975650|100518790|FG000|NOT COMPLETED|Period 4||0||
48080552|NCT00975650|100518791|FG001|NOT COMPLETED|Period 4||0||
48080553|NCT00975650|100518792|FG002|NOT COMPLETED|Period 4||0||
48080554|NCT00975650|100518793|FG003|NOT COMPLETED|Period 4||0||
48080555|NCT00982137|100518794|FG000|STARTED|Overall Study||36||
48080556|NCT00982137|100518795|FG001|STARTED|Overall Study||36||
48080557|NCT00982137|100518796|FG002|STARTED|Overall Study||18||
48080558|NCT00982137|100518797|FG003|STARTED|Overall Study||18||
48080559|NCT00982137|100518794|FG000|COMPLETED|Overall Study||36||
48080560|NCT00982137|100518795|FG001|COMPLETED|Overall Study||35||
48080561|NCT00982137|100518796|FG002|COMPLETED|Overall Study||18||
48080562|NCT00982137|100518797|FG003|COMPLETED|Overall Study||17||
48080563|NCT00982137|100518794|FG000|NOT COMPLETED|Overall Study||0||
48080564|NCT00982137|100518795|FG001|NOT COMPLETED|Overall Study||1||
48080565|NCT00982137|100518796|FG002|NOT COMPLETED|Overall Study||0||
48080566|NCT00982137|100518797|FG003|NOT COMPLETED|Overall Study||1||
48080567|NCT02206048|100518798|FG000|STARTED|Overall Study||9||
48526845|NCT05304611|101624037|FG006|STARTED|Adult Dose-escalation: 20 mg/kg L9LS||0||
48526846|NCT05304611|101624038|FG007|STARTED|Adult Dose-escalation: 20 mg/kg L9LS||0||
48526847|NCT05304611|101624039|FG008|STARTED|Adult Dose-escalation: 20 mg/kg L9LS||0||
48526848|NCT05304611|101624031|FG000|COMPLETED|Adult Dose-escalation: 20 mg/kg L9LS||0||
48526849|NCT05304611|101624032|FG001|COMPLETED|Adult Dose-escalation: 20 mg/kg L9LS||0||
48526850|NCT05304611|101624033|FG002|COMPLETED|Adult Dose-escalation: 20 mg/kg L9LS||6||
48526851|NCT05304611|101624034|FG003|COMPLETED|Adult Dose-escalation: 20 mg/kg L9LS||0||
48526852|NCT05304611|101624035|FG004|COMPLETED|Adult Dose-escalation: 20 mg/kg L9LS||0||
48526853|NCT05304611|101624036|FG005|COMPLETED|Adult Dose-escalation: 20 mg/kg L9LS||0||
48526854|NCT05304611|101624037|FG006|COMPLETED|Adult Dose-escalation: 20 mg/kg L9LS||0||
48526855|NCT05304611|101624038|FG007|COMPLETED|Adult Dose-escalation: 20 mg/kg L9LS||0||
48526856|NCT05304611|101624039|FG008|COMPLETED|Adult Dose-escalation: 20 mg/kg L9LS||0||
48526857|NCT05304611|101624031|FG000|NOT COMPLETED|Adult Dose-escalation: 20 mg/kg L9LS||0||
48080568|NCT02206048|100518798|FG000|COMPLETED|Overall Study||8||
48080569|NCT02206048|100518798|FG000|NOT COMPLETED|Overall Study||1||
48080570|NCT01633853|100518799|FG000|STARTED|Overall Study||104||
48080571|NCT01633853|100518800|FG001|STARTED|Overall Study||100||
48080572|NCT01633853|100518799|FG000|COMPLETED|Overall Study||104||
48080573|NCT01633853|100518800|FG001|COMPLETED|Overall Study||100||
48080574|NCT01633853|100518799|FG000|NOT COMPLETED|Overall Study||0||
48080575|NCT01633853|100518800|FG001|NOT COMPLETED|Overall Study||0||
48080576|NCT00003499|100518801|FG000|STARTED|Overall Study||31||
48080577|NCT00003499|100518801|FG000|COMPLETED|Overall Study||23||
48080578|NCT00003499|100518801|FG000|NOT COMPLETED|Overall Study||8||
48080579|NCT03305575|100518802|FG000|STARTED|Overall Study||5||
48080580|NCT03305575|100518803|FG001|STARTED|Overall Study||5||
48080581|NCT03305575|100518802|FG000|COMPLETED|Overall Study||4||
48080582|NCT03305575|100518803|FG001|COMPLETED|Overall Study||5||
48080583|NCT03305575|100518802|FG000|NOT COMPLETED|Overall Study||1||
48080584|NCT03305575|100518803|FG001|NOT COMPLETED|Overall Study||0||
48080585|NCT03473977|100518804|FG000|STARTED|Overall Study||13||
48080586|NCT03473977|100518805|FG001|STARTED|Overall Study||13||
48080587|NCT03473977|100518804|FG000|COMPLETED|Overall Study||13||
48080588|NCT03473977|100518805|FG001|COMPLETED|Overall Study||13||
48080589|NCT03473977|100518804|FG000|NOT COMPLETED|Overall Study||0||
48080590|NCT03473977|100518805|FG001|NOT COMPLETED|Overall Study||0||
48080591|NCT00887978|100518806|FG000|STARTED|Overall Study||157||
48080592|NCT00887978|100518807|FG001|STARTED|Overall Study||153||
48080593|NCT00887978|100518806|FG000|COMPLETED|Overall Study||132||
48080594|NCT00887978|100518807|FG001|COMPLETED|Overall Study||138||
48080595|NCT00887978|100518806|FG000|NOT COMPLETED|Overall Study||25||
48080596|NCT00887978|100518807|FG001|NOT COMPLETED|Overall Study||15||
48080597|NCT03539081|100518808|FG000|STARTED|Overall Study||5||
48080598|NCT03539081|100518809|FG001|STARTED|Overall Study||10||
48080599|NCT03539081|100518810|FG002|STARTED|Overall Study||0||
48080600|NCT03539081|100518808|FG000|COMPLETED|Overall Study||2||
48080601|NCT03539081|100518809|FG001|COMPLETED|Overall Study||7||
48080602|NCT03539081|100518810|FG002|COMPLETED|Overall Study||0||
48080603|NCT03539081|100518808|FG000|NOT COMPLETED|Overall Study||3||
48080604|NCT03539081|100518809|FG001|NOT COMPLETED|Overall Study||3||
48080605|NCT03539081|100518810|FG002|NOT COMPLETED|Overall Study||0||
48080606|NCT01243892|100518811|FG000|STARTED|Overall Study||15||
48526858|NCT05304611|101624032|FG001|NOT COMPLETED|Adult Dose-escalation: 20 mg/kg L9LS||0||
48526859|NCT05304611|101624033|FG002|NOT COMPLETED|Adult Dose-escalation: 20 mg/kg L9LS||0||
48526860|NCT05304611|101624034|FG003|NOT COMPLETED|Adult Dose-escalation: 20 mg/kg L9LS||0||
48526861|NCT05304611|101624035|FG004|NOT COMPLETED|Adult Dose-escalation: 20 mg/kg L9LS||0||
48526862|NCT05304611|101624036|FG005|NOT COMPLETED|Adult Dose-escalation: 20 mg/kg L9LS||0||
48526863|NCT05304611|101624037|FG006|NOT COMPLETED|Adult Dose-escalation: 20 mg/kg L9LS||0||
48526864|NCT05304611|101624038|FG007|NOT COMPLETED|Adult Dose-escalation: 20 mg/kg L9LS||0||
48526865|NCT05304611|101624039|FG008|NOT COMPLETED|Adult Dose-escalation: 20 mg/kg L9LS||0||
48526866|NCT05304611|101624031|FG000|STARTED|Ped Dose-escalation: 150mg L9LS/ Placebo||0||
48526867|NCT05304611|101624032|FG001|STARTED|Ped Dose-escalation: 150mg L9LS/ Placebo||0||
48526868|NCT05304611|101624033|FG002|STARTED|Ped Dose-escalation: 150mg L9LS/ Placebo||0||
48526869|NCT05304611|101624034|FG003|STARTED|Ped Dose-escalation: 150mg L9LS/ Placebo||9||
48526870|NCT05304611|101624035|FG004|STARTED|Ped Dose-escalation: 150mg L9LS/ Placebo||0||
48526871|NCT05304611|101624036|FG005|STARTED|Ped Dose-escalation: 150mg L9LS/ Placebo||9||
48526872|NCT05304611|101624037|FG006|STARTED|Ped Dose-escalation: 150mg L9LS/ Placebo||0||
48526873|NCT05304611|101624038|FG007|STARTED|Ped Dose-escalation: 150mg L9LS/ Placebo||0||
48526874|NCT05304611|101624039|FG008|STARTED|Ped Dose-escalation: 150mg L9LS/ Placebo||0||
48526875|NCT05304611|101624031|FG000|COMPLETED|Ped Dose-escalation: 150mg L9LS/ Placebo||0||
48526876|NCT05304611|101624032|FG001|COMPLETED|Ped Dose-escalation: 150mg L9LS/ Placebo||0||
48526877|NCT05304611|101624033|FG002|COMPLETED|Ped Dose-escalation: 150mg L9LS/ Placebo||0||
48526878|NCT05304611|101624034|FG003|COMPLETED|Ped Dose-escalation: 150mg L9LS/ Placebo||9||
48526879|NCT05304611|101624035|FG004|COMPLETED|Ped Dose-escalation: 150mg L9LS/ Placebo||0||
48526880|NCT05304611|101624036|FG005|COMPLETED|Ped Dose-escalation: 150mg L9LS/ Placebo||9||
48526881|NCT05304611|101624037|FG006|COMPLETED|Ped Dose-escalation: 150mg L9LS/ Placebo||0||
48526882|NCT05304611|101624038|FG007|COMPLETED|Ped Dose-escalation: 150mg L9LS/ Placebo||0||
48526883|NCT05304611|101624039|FG008|COMPLETED|Ped Dose-escalation: 150mg L9LS/ Placebo||0||
48526884|NCT05304611|101624031|FG000|NOT COMPLETED|Ped Dose-escalation: 150mg L9LS/ Placebo||0||
48526885|NCT05304611|101624032|FG001|NOT COMPLETED|Ped Dose-escalation: 150mg L9LS/ Placebo||0||
48526886|NCT05304611|101624033|FG002|NOT COMPLETED|Ped Dose-escalation: 150mg L9LS/ Placebo||0||
48526887|NCT05304611|101624034|FG003|NOT COMPLETED|Ped Dose-escalation: 150mg L9LS/ Placebo||0||
48526888|NCT05304611|101624035|FG004|NOT COMPLETED|Ped Dose-escalation: 150mg L9LS/ Placebo||0||
48526889|NCT05304611|101624036|FG005|NOT COMPLETED|Ped Dose-escalation: 150mg L9LS/ Placebo||0||
48080607|NCT01243892|100518812|FG001|STARTED|Overall Study||3||
48080608|NCT01243892|100518811|FG000|COMPLETED|Overall Study||13||
48080609|NCT01243892|100518812|FG001|COMPLETED|Overall Study||3||
48080610|NCT01243892|100518811|FG000|NOT COMPLETED|Overall Study||2||
48080611|NCT01243892|100518812|FG001|NOT COMPLETED|Overall Study||0||
48526890|NCT05304611|101624037|FG006|NOT COMPLETED|Ped Dose-escalation: 150mg L9LS/ Placebo||0||
48526891|NCT05304611|101624038|FG007|NOT COMPLETED|Ped Dose-escalation: 150mg L9LS/ Placebo||0||
48526892|NCT05304611|101624039|FG008|NOT COMPLETED|Ped Dose-escalation: 150mg L9LS/ Placebo||0||
48526893|NCT05304611|101624031|FG000|STARTED|Ped Dose-escalation: 300mg L9LS/ Placebo||0||
48526894|NCT05304611|101624032|FG001|STARTED|Ped Dose-escalation: 300mg L9LS/ Placebo||0||
48526895|NCT05304611|101624033|FG002|STARTED|Ped Dose-escalation: 300mg L9LS/ Placebo||0||
48526896|NCT05304611|101624034|FG003|STARTED|Ped Dose-escalation: 300mg L9LS/ Placebo||0||
48526897|NCT05304611|101624035|FG004|STARTED|Ped Dose-escalation: 300mg L9LS/ Placebo||9||
48526898|NCT05304611|101624036|FG005|STARTED|Ped Dose-escalation: 300mg L9LS/ Placebo||9||
48526899|NCT05304611|101624037|FG006|STARTED|Ped Dose-escalation: 300mg L9LS/ Placebo||0||
48526900|NCT05304611|101624038|FG007|STARTED|Ped Dose-escalation: 300mg L9LS/ Placebo||0||
48526901|NCT05304611|101624039|FG008|STARTED|Ped Dose-escalation: 300mg L9LS/ Placebo||0||
48526902|NCT05304611|101624031|FG000|COMPLETED|Ped Dose-escalation: 300mg L9LS/ Placebo||0||
48526903|NCT05304611|101624032|FG001|COMPLETED|Ped Dose-escalation: 300mg L9LS/ Placebo||0||
48526904|NCT05304611|101624033|FG002|COMPLETED|Ped Dose-escalation: 300mg L9LS/ Placebo||0||
48526905|NCT05304611|101624034|FG003|COMPLETED|Ped Dose-escalation: 300mg L9LS/ Placebo||0||
48526906|NCT05304611|101624035|FG004|COMPLETED|Ped Dose-escalation: 300mg L9LS/ Placebo||9||
48080612|NCT00814970|100518813|FG000|STARTED|Overall Study||196||
48080613|NCT00814970|100518813|FG000|COMPLETED|Overall Study||146||
48080614|NCT00814970|100518813|FG000|NOT COMPLETED|Overall Study||50||
48080615|NCT01154764|100518814|FG000|STARTED|Intervention 1 (5days)||14||
48526907|NCT05304611|101624036|FG005|COMPLETED|Ped Dose-escalation: 300mg L9LS/ Placebo||9||
48526908|NCT05304611|101624037|FG006|COMPLETED|Ped Dose-escalation: 300mg L9LS/ Placebo||0||
48526909|NCT05304611|101624038|FG007|COMPLETED|Ped Dose-escalation: 300mg L9LS/ Placebo||0||
48526910|NCT05304611|101624039|FG008|COMPLETED|Ped Dose-escalation: 300mg L9LS/ Placebo||0||
48526911|NCT05304611|101624031|FG000|NOT COMPLETED|Ped Dose-escalation: 300mg L9LS/ Placebo||0||
48526912|NCT05304611|101624032|FG001|NOT COMPLETED|Ped Dose-escalation: 300mg L9LS/ Placebo||0||
48080616|NCT01154764|100518815|FG001|STARTED|Intervention 1 (5days)||14||
48080617|NCT01154764|100518814|FG000|COMPLETED|Intervention 1 (5days)||14||
48080618|NCT01154764|100518815|FG001|COMPLETED|Intervention 1 (5days)||14||
48080619|NCT01154764|100518814|FG000|NOT COMPLETED|Intervention 1 (5days)||0||
48080620|NCT01154764|100518815|FG001|NOT COMPLETED|Intervention 1 (5days)||0||
48526913|NCT05304611|101624033|FG002|NOT COMPLETED|Ped Dose-escalation: 300mg L9LS/ Placebo||0||
48526914|NCT05304611|101624034|FG003|NOT COMPLETED|Ped Dose-escalation: 300mg L9LS/ Placebo||0||
48526915|NCT05304611|101624035|FG004|NOT COMPLETED|Ped Dose-escalation: 300mg L9LS/ Placebo||0||
48526916|NCT05304611|101624036|FG005|NOT COMPLETED|Ped Dose-escalation: 300mg L9LS/ Placebo||0||
48526917|NCT05304611|101624037|FG006|NOT COMPLETED|Ped Dose-escalation: 300mg L9LS/ Placebo||0||
48526918|NCT05304611|101624038|FG007|NOT COMPLETED|Ped Dose-escalation: 300mg L9LS/ Placebo||0||
48526919|NCT05304611|101624039|FG008|NOT COMPLETED|Ped Dose-escalation: 300mg L9LS/ Placebo||0||
48526920|NCT05304611|101624031|FG000|STARTED|Pediatric Efficacy Study||0||
48526921|NCT05304611|101624032|FG001|STARTED|Pediatric Efficacy Study||0||
48526922|NCT05304611|101624033|FG002|STARTED|Pediatric Efficacy Study||0||
48526923|NCT05304611|101624034|FG003|STARTED|Pediatric Efficacy Study||0||
48526924|NCT05304611|101624035|FG004|STARTED|Pediatric Efficacy Study||0||
48526925|NCT05304611|101624036|FG005|STARTED|Pediatric Efficacy Study||0||
48526926|NCT05304611|101624037|FG006|STARTED|Pediatric Efficacy Study||75||
48526927|NCT05304611|101624038|FG007|STARTED|Pediatric Efficacy Study||75||
48080621|NCT01154764|100518814|FG000|STARTED|Intervention 2 (5days)||14||
48080622|NCT01154764|100518815|FG001|STARTED|Intervention 2 (5days)||14||
48080623|NCT01154764|100518814|FG000|COMPLETED|Intervention 2 (5days)||13||
48080624|NCT01154764|100518815|FG001|COMPLETED|Intervention 2 (5days)||13||
48080625|NCT01154764|100518814|FG000|NOT COMPLETED|Intervention 2 (5days)||1||
48080626|NCT01154764|100518815|FG001|NOT COMPLETED|Intervention 2 (5days)||1||
48080627|NCT02220205|100518816|FG000|STARTED|Overall Study||30||
48080628|NCT02220205|100518817|FG001|STARTED|Overall Study||30||
48080629|NCT02220205|100518816|FG000|COMPLETED|Overall Study||29||
48080630|NCT02220205|100518817|FG001|COMPLETED|Overall Study||30||
48080631|NCT02220205|100518816|FG000|NOT COMPLETED|Overall Study||1||
48080632|NCT02220205|100518817|FG001|NOT COMPLETED|Overall Study||0||
48080633|NCT00064337|100518818|FG000|STARTED|PBSCC or Induction/PBSCC||93||
48526928|NCT05304611|101624039|FG008|STARTED|Pediatric Efficacy Study||75||
48080634|NCT00064337|100518818|FG000|COMPLETED|PBSCC or Induction/PBSCC||73||
48080635|NCT00064337|100518818|FG000|NOT COMPLETED|PBSCC or Induction/PBSCC||20||
48080636|NCT00064337|100518818|FG000|STARTED|Transplant||67||
48080637|NCT00064337|100518818|FG000|COMPLETED|Transplant||46||
48080638|NCT00064337|100518818|FG000|NOT COMPLETED|Transplant||21||
48080639|NCT00064337|100518818|FG000|STARTED|Maintenance||13||
48080640|NCT00064337|100518818|FG000|COMPLETED|Maintenance||3||
48080641|NCT00064337|100518818|FG000|NOT COMPLETED|Maintenance||10||
48080642|NCT01465997|100518819|FG000|STARTED|Overall Study||279||
48080643|NCT01465997|100518820|FG001|STARTED|Overall Study||269||
48080644|NCT01465997|100518819|FG000|COMPLETED|Overall Study||211||
48080645|NCT01465997|100518820|FG001|COMPLETED|Overall Study||180||
48080646|NCT01465997|100518819|FG000|NOT COMPLETED|Overall Study||68||
48080647|NCT01465997|100518820|FG001|NOT COMPLETED|Overall Study||89||
48080648|NCT00743340|100518821|FG000|STARTED|Overall Study||50||
48080649|NCT00743340|100518821|FG000|COMPLETED|Overall Study||9||
48080650|NCT00743340|100518821|FG000|NOT COMPLETED|Overall Study||41||
48080651|NCT01235351|100518822|FG000|STARTED|Initial Treatment With 75 mg and 150 mg||247||
48080652|NCT01235351|100518823|FG001|STARTED|Initial Treatment With 75 mg and 150 mg||86||
48080653|NCT01235351|100518822|FG000|COMPLETED|Initial Treatment With 75 mg and 150 mg||237||
48080654|NCT01235351|100518823|FG001|COMPLETED|Initial Treatment With 75 mg and 150 mg||82||
48080655|NCT01235351|100518822|FG000|NOT COMPLETED|Initial Treatment With 75 mg and 150 mg||10||
48080656|NCT01235351|100518823|FG001|NOT COMPLETED|Initial Treatment With 75 mg and 150 mg||4||
48080657|NCT01235351|100518822|FG000|STARTED|Treatment With Different Dose Sequences||233||
48080658|NCT01235351|100518823|FG001|STARTED|Treatment With Different Dose Sequences||82||
48080659|NCT01235351|100518822|FG000|75 mg First and Then 150 mg|Treatment With Different Dose Sequences||116||
48227815|NCT00391170|100878085|FG001|COMPLETED|Overall Study||23||
48227816|NCT00391170|100878084|FG000|NOT COMPLETED|Overall Study||6||
48227817|NCT00391170|100878085|FG001|NOT COMPLETED|Overall Study||4||
48227818|NCT01583166|100878086|FG000|STARTED|Overall Study||45||
48227819|NCT01583166|100878087|FG001|STARTED|Overall Study||45||
48227820|NCT01583166|100878086|FG000|COMPLETED|Overall Study||41||
48227821|NCT01583166|100878087|FG001|COMPLETED|Overall Study||39||
48227822|NCT01583166|100878086|FG000|NOT COMPLETED|Overall Study||4||
48227823|NCT01583166|100878087|FG001|NOT COMPLETED|Overall Study||6||
48227824|NCT02542943|100878088|FG000|STARTED|Overall Study||79||
48227825|NCT02542943|100878089|FG001|STARTED|Overall Study||80||
48227826|NCT02542943|100878090|FG002|STARTED|Overall Study||81||
48227827|NCT02542943|100878088|FG000|COMPLETED|Overall Study||78||
48227828|NCT02542943|100878089|FG001|COMPLETED|Overall Study||79||
48227829|NCT02542943|100878090|FG002|COMPLETED|Overall Study||81||
48227830|NCT02542943|100878088|FG000|NOT COMPLETED|Overall Study||1||
48227831|NCT02542943|100878089|FG001|NOT COMPLETED|Overall Study||1||
48227832|NCT02542943|100878090|FG002|NOT COMPLETED|Overall Study||0||
48227833|NCT03170882|100878091|FG000|STARTED|Overall Study||49||
48227834|NCT03170882|100878092|FG001|STARTED|Overall Study||73||
48227835|NCT03170882|100878091|FG000|Treated: Safety Population|Overall Study||47|Safety Population included all participants who received at least 1 dose of any study drug.|
48227836|NCT03170882|100878092|FG001|Treated: Safety Population|Overall Study||72|Safety Population included all participants who received at least 1 dose of any study drug.|
48526929|NCT05304611|101624031|FG000|COMPLETED|Pediatric Efficacy Study||0||
48227837|NCT03170882|100878091|FG000|ITT PRO Population|Overall Study||45|Intent-to-Treat Patient Reported Outcomes (ITT PRO) Population included participants with a measurement at study entry and at least one post study entry measurement for at least 1 subscale on all 3 questionnaires (EORTC QLQ-C30, EORTC QLQ-MY20 and EQ-5D-5L).|
48227838|NCT03170882|100878092|FG001|ITT PRO Population|Overall Study||70|Intent-to-Treat Patient Reported Outcomes (ITT PRO) Population included participants with a measurement at study entry and at least one post study entry measurement for at least 1 subscale on all 3 questionnaires (EORTC QLQ-C30, EORTC QLQ-MY20 and EQ-5D-5L).|
48227839|NCT03170882|100878091|FG000|COMPLETED|Overall Study||0||
48227840|NCT03170882|100878092|FG001|COMPLETED|Overall Study||0||
48227841|NCT03170882|100878091|FG000|NOT COMPLETED|Overall Study||49||
48227842|NCT03170882|100878092|FG001|NOT COMPLETED|Overall Study||73||
48227843|NCT00895245|100878093|FG000|STARTED|Overall Study||6||
48227844|NCT00895245|100878093|FG000|COMPLETED|Overall Study||0||
48227845|NCT00895245|100878093|FG000|NOT COMPLETED|Overall Study||6||
48227846|NCT03020498|100878094|FG000|STARTED|Overall Study||14||
48227847|NCT03020498|100878095|FG001|STARTED|Overall Study||41||
48227848|NCT03020498|100878096|FG002|STARTED|Overall Study||36||
48526930|NCT05304611|101624032|FG001|COMPLETED|Pediatric Efficacy Study||0||
48526931|NCT05304611|101624033|FG002|COMPLETED|Pediatric Efficacy Study||0||
48526932|NCT05304611|101624034|FG003|COMPLETED|Pediatric Efficacy Study||0||
48526933|NCT05304611|101624035|FG004|COMPLETED|Pediatric Efficacy Study||0||
48526934|NCT05304611|101624036|FG005|COMPLETED|Pediatric Efficacy Study||0||
48526935|NCT05304611|101624037|FG006|COMPLETED|Pediatric Efficacy Study||73||
48526936|NCT05304611|101624038|FG007|COMPLETED|Pediatric Efficacy Study||74||
48526937|NCT05304611|101624039|FG008|COMPLETED|Pediatric Efficacy Study||72||
48526938|NCT05304611|101624031|FG000|NOT COMPLETED|Pediatric Efficacy Study||0||
48526939|NCT05304611|101624032|FG001|NOT COMPLETED|Pediatric Efficacy Study||0||
48526940|NCT05304611|101624033|FG002|NOT COMPLETED|Pediatric Efficacy Study||0||
48526941|NCT05304611|101624034|FG003|NOT COMPLETED|Pediatric Efficacy Study||0||
48526942|NCT05304611|101624035|FG004|NOT COMPLETED|Pediatric Efficacy Study||0||
48526943|NCT05304611|101624036|FG005|NOT COMPLETED|Pediatric Efficacy Study||0||
48526944|NCT05304611|101624037|FG006|NOT COMPLETED|Pediatric Efficacy Study||2||
48526945|NCT05304611|101624038|FG007|NOT COMPLETED|Pediatric Efficacy Study||1||
48526946|NCT05304611|101624039|FG008|NOT COMPLETED|Pediatric Efficacy Study||3||
48526947|NCT01951885|101624040|FG000|STARTED|Overall Study||50||
48526948|NCT01951885|101624041|FG001|STARTED|Overall Study||51||
48526949|NCT01951885|101624040|FG000|COMPLETED|Overall Study||49||
48526950|NCT01951885|101624041|FG001|COMPLETED|Overall Study||47||
48526951|NCT01951885|101624040|FG000|NOT COMPLETED|Overall Study||1||
48526952|NCT01951885|101624041|FG001|NOT COMPLETED|Overall Study||4||
48526953|NCT02980874|101624042|FG000|STARTED|Overall Study||231||
48526954|NCT02980874|101624043|FG001|STARTED|Overall Study||229||
48526955|NCT02980874|101624042|FG000|COMPLETED|Overall Study||128||
48526956|NCT02980874|101624043|FG001|COMPLETED|Overall Study||127||
48526957|NCT02980874|101624042|FG000|NOT COMPLETED|Overall Study||103||
48526958|NCT02980874|101624043|FG001|NOT COMPLETED|Overall Study||102||
48227849|NCT03020498|100878094|FG000|COMPLETED|Overall Study||14||
48227850|NCT03020498|100878095|FG001|COMPLETED|Overall Study||38||
48227851|NCT03020498|100878096|FG002|COMPLETED|Overall Study||36||
48227852|NCT03020498|100878094|FG000|NOT COMPLETED|Overall Study||0||
48227853|NCT03020498|100878095|FG001|NOT COMPLETED|Overall Study||3||
48227854|NCT03020498|100878096|FG002|NOT COMPLETED|Overall Study||0||
48227855|NCT01711294|100880538|FG000|STARTED|Overall Study||121||
48227856|NCT01711294|100880539|FG001|STARTED|Overall Study||65||
48227857|NCT01711294|100880540|FG002|STARTED|Overall Study||64||
48227858|NCT01711294|100880538|FG000|COMPLETED|Overall Study||121||
48227859|NCT01711294|100880539|FG001|COMPLETED|Overall Study||65||
48227860|NCT01711294|100880540|FG002|COMPLETED|Overall Study||64||
48227861|NCT01711294|100880538|FG000|NOT COMPLETED|Overall Study||0||
48227862|NCT01711294|100880539|FG001|NOT COMPLETED|Overall Study||0||
48227863|NCT01711294|100880540|FG002|NOT COMPLETED|Overall Study||0||
48227864|NCT04809623|100880541|FG000|STARTED|Overall Study||2||
48227865|NCT04809623|100880542|FG001|STARTED|Overall Study||1||
48227866|NCT04809623|100880541|FG000|COMPLETED|Overall Study||1||
48227867|NCT04809623|100880542|FG001|COMPLETED|Overall Study||1||
48227868|NCT04809623|100880541|FG000|NOT COMPLETED|Overall Study||1||
48227869|NCT04809623|100880542|FG001|NOT COMPLETED|Overall Study||0||
48227870|NCT00595959|100880543|FG000|STARTED|Overall Study||65||
48227871|NCT00595959|100880543|FG000|COMPLETED|Overall Study||63||
48227872|NCT00595959|100880543|FG000|NOT COMPLETED|Overall Study||2||
48227873|NCT00536120|100880544|FG000|STARTED|Overall Study||30||
48227874|NCT00536120|100880545|FG001|STARTED|Overall Study||30||
48526959|NCT00474851|101624044|FG000|STARTED|Overall Study||26||
48526960|NCT00474851|101624045|FG001|STARTED|Overall Study||27||
48526961|NCT00474851|101624044|FG000|Completed Baseline|Overall Study||25||
48227875|NCT00536120|100880544|FG000|COMPLETED|Overall Study||24||
48227876|NCT00536120|100880545|FG001|COMPLETED|Overall Study||27||
48227877|NCT00536120|100880544|FG000|NOT COMPLETED|Overall Study||6||
48526962|NCT00474851|101624045|FG001|Completed Baseline|Overall Study||26||
48526963|NCT00474851|101624044|FG000|COMPLETED|Overall Study||18||
48526964|NCT00474851|101624045|FG001|COMPLETED|Overall Study||16||
48526965|NCT00474851|101624044|FG000|NOT COMPLETED|Overall Study||8||
48526966|NCT00474851|101624045|FG001|NOT COMPLETED|Overall Study||11||
48526967|NCT02685202|101624046|FG000|STARTED|Overall Study||9||
48526968|NCT02685202|101624046|FG000|COMPLETED|Overall Study||0||
48526969|NCT02685202|101624046|FG000|NOT COMPLETED|Overall Study||9||
48526970|NCT00535587|101624047|FG000|STARTED|Overall Study||53||
48227878|NCT00536120|100880545|FG001|NOT COMPLETED|Overall Study||3||
48227879|NCT00089791|100880546|FG000|STARTED|Overall Study||3906||
48227880|NCT00089791|100880547|FG001|STARTED|Overall Study||3902||
48227881|NCT00089791|100880546|FG000|Received Study Medication|Overall Study||3883||
48227882|NCT00089791|100880547|FG001|Received Study Medication|Overall Study||3879||
48227883|NCT00089791|100880546|FG000|Safety Analysis Set|Overall Study||3876||
48526971|NCT00535587|101624048|FG001|STARTED|Overall Study||53||
48526972|NCT00535587|101624049|FG002|STARTED|Overall Study||47||
48526973|NCT00535587|101624050|FG003|STARTED|Overall Study||54||
48526974|NCT00535587|101624047|FG000|COMPLETED|Overall Study||43||
48526975|NCT00535587|101624048|FG001|COMPLETED|Overall Study||42||
48526976|NCT00535587|101624049|FG002|COMPLETED|Overall Study||39||
48526977|NCT00535587|101624050|FG003|COMPLETED|Overall Study||41||
48526978|NCT00535587|101624047|FG000|NOT COMPLETED|Overall Study||10||
48526979|NCT00535587|101624048|FG001|NOT COMPLETED|Overall Study||11||
48526980|NCT00535587|101624049|FG002|NOT COMPLETED|Overall Study||8||
48526981|NCT00535587|101624050|FG003|NOT COMPLETED|Overall Study||13||
48526982|NCT02660528|101624051|FG000|STARTED|Overall Study||0||
48526983|NCT02660528|101624051|FG000|COMPLETED|Overall Study||0||
48526984|NCT02660528|101624051|FG000|NOT COMPLETED|Overall Study||0||
48526985|NCT00704730|101624052|FG000|STARTED|Overall Study||219||
48526986|NCT00704730|101624053|FG001|STARTED|Overall Study||111||
48526987|NCT00704730|101624052|FG000|COMPLETED|Overall Study||98||
48526988|NCT00704730|101624053|FG001|COMPLETED|Overall Study||15||
48526989|NCT00704730|101624052|FG000|NOT COMPLETED|Overall Study||121||
48526990|NCT00704730|101624053|FG001|NOT COMPLETED|Overall Study||96||
48526991|NCT00361335|101624054|FG000|STARTED|IV Period: Baseline to E0||129||
48526992|NCT00361335|101624055|FG001|STARTED|IV Period: Baseline to E0||128||
48526993|NCT00361335|101624056|FG002|STARTED|IV Period: Baseline to E0||128||
48526994|NCT00361335|101624057|FG003|STARTED|IV Period: Baseline to E0||129||
48526995|NCT00361335|101624058|FG004|STARTED|IV Period: Baseline to E0||129||
48526996|NCT00361335|101624059|FG005|STARTED|IV Period: Baseline to E0||0||
48526997|NCT00361335|101624060|FG006|STARTED|IV Period: Baseline to E0||0||
48526998|NCT00361335|101624054|FG000|COMPLETED|IV Period: Baseline to E0||109||
48526999|NCT00361335|101624055|FG001|COMPLETED|IV Period: Baseline to E0||99||
48527000|NCT00361335|101624056|FG002|COMPLETED|IV Period: Baseline to E0||107||
48527001|NCT00361335|101624057|FG003|COMPLETED|IV Period: Baseline to E0||102||
48227884|NCT00089791|100880547|FG001|Safety Analysis Set|Overall Study||3886||
48227885|NCT00089791|100880546|FG000|COMPLETED|Overall Study||3206||
48227886|NCT00089791|100880547|FG001|COMPLETED|Overall Study||3272||
48227887|NCT00089791|100880546|FG000|NOT COMPLETED|Overall Study||700||
48227888|NCT00089791|100880547|FG001|NOT COMPLETED|Overall Study||630||
48227889|NCT00647400|100880548|FG000|STARTED|Overall Study||89||
48527002|NCT00361335|101624058|FG004|COMPLETED|IV Period: Baseline to E0||105||
48527003|NCT00361335|101624059|FG005|COMPLETED|IV Period: Baseline to E0||0||
48227890|NCT00647400|100880549|FG001|STARTED|Overall Study||58||
48227891|NCT00647400|100880548|FG000|COMPLETED|Overall Study||67||
48227892|NCT00647400|100880549|FG001|COMPLETED|Overall Study||45||
48227893|NCT00647400|100880548|FG000|NOT COMPLETED|Overall Study||22||
48227894|NCT00647400|100880549|FG001|NOT COMPLETED|Overall Study||13||
48227895|NCT03035942|100880550|FG000|STARTED|Overall Study||45||
48227896|NCT03035942|100880551|FG001|STARTED|Overall Study||45||
48227897|NCT03035942|100880552|FG002|STARTED|Overall Study||45||
48227898|NCT03035942|100880550|FG000|COMPLETED|Overall Study||37||
48227899|NCT03035942|100880551|FG001|COMPLETED|Overall Study||41||
48227900|NCT03035942|100880552|FG002|COMPLETED|Overall Study||40||
48227901|NCT03035942|100880550|FG000|NOT COMPLETED|Overall Study||8||
48227902|NCT03035942|100880551|FG001|NOT COMPLETED|Overall Study||4||
48227903|NCT03035942|100880552|FG002|NOT COMPLETED|Overall Study||5||
48527004|NCT00361335|101624060|FG006|COMPLETED|IV Period: Baseline to E0||0||
48527005|NCT00361335|101624054|FG000|NOT COMPLETED|IV Period: Baseline to E0||20||
48527006|NCT00361335|101624055|FG001|NOT COMPLETED|IV Period: Baseline to E0||29||
48527007|NCT00361335|101624056|FG002|NOT COMPLETED|IV Period: Baseline to E0||21||
48227904|NCT00266656|100880553|FG000|STARTED|Overall Study||36||
48227905|NCT00266656|100880554|FG001|STARTED|Overall Study||33||
48227906|NCT00266656|100880553|FG000|COMPLETED|Overall Study||22||
48227907|NCT00266656|100880554|FG001|COMPLETED|Overall Study||20||
48527008|NCT00361335|101624057|FG003|NOT COMPLETED|IV Period: Baseline to E0||27||
48527009|NCT00361335|101624058|FG004|NOT COMPLETED|IV Period: Baseline to E0||24||
48527010|NCT00361335|101624059|FG005|NOT COMPLETED|IV Period: Baseline to E0||0||
48527011|NCT00361335|101624060|FG006|NOT COMPLETED|IV Period: Baseline to E0||0||
48527012|NCT00361335|101624054|FG000|STARTED|SC Period: Week E0 to Week E24||82||
48527013|NCT00361335|101624055|FG001|STARTED|SC Period: Week E0 to Week E24||59||
48527014|NCT00361335|101624056|FG002|STARTED|SC Period: Week E0 to Week E24||104||
48592648|NCT01877382|101783150|FG000|NOT COMPLETED|Dose Escalation||3||
48227908|NCT00266656|100880553|FG000|NOT COMPLETED|Overall Study||14||
48227909|NCT00266656|100880554|FG001|NOT COMPLETED|Overall Study||13||
48227910|NCT03400579|100880555|FG000|STARTED|Overall Study||10||
48227911|NCT03400579|100880555|FG000|COMPLETED|Overall Study||10||
48227912|NCT03400579|100880555|FG000|NOT COMPLETED|Overall Study||0||
48227913|NCT02725372|100880556|FG000|STARTED|Part 1: Blinded Tx (2 Week Run In)||78||
48227914|NCT02725372|100880557|FG001|STARTED|Part 1: Blinded Tx (2 Week Run In)||79||
48227915|NCT02725372|100880556|FG000|Participants That Actually Received Treatment|Part 1: Blinded Tx (2 Week Run In)||74|Following randomization, there were some participants that did not start treatment during this 2 week run in period that is used to determine ability to comply with using the drug/device combination treatment therapy before they are moved to the treatment dose (75 mcg/kg IBW/hr) at Week 2.|
48227916|NCT02725372|100880557|FG001|Participants That Actually Received Treatment|Part 1: Blinded Tx (2 Week Run In)||78|Following randomization, there were some participants that did not start treatment during this 2 week run in period that is used to determine ability to comply with using the drug/device combination treatment therapy before they are moved to the treatment dose (75 mcg/kg IBW/hr) at Week 2.|
48227917|NCT02725372|100880556|FG000|COMPLETED|Part 1: Blinded Tx (2 Week Run In)||52||
48227918|NCT02725372|100880557|FG001|COMPLETED|Part 1: Blinded Tx (2 Week Run In)||59||
48227919|NCT02725372|100880556|FG000|NOT COMPLETED|Part 1: Blinded Tx (2 Week Run In)||26||
48227920|NCT02725372|100880557|FG001|NOT COMPLETED|Part 1: Blinded Tx (2 Week Run In)||20||
48227921|NCT02725372|100880556|FG000|STARTED|Part 1: Blinded Tx (16 Weeks)||52||
48227922|NCT02725372|100880557|FG001|STARTED|Part 1: Blinded Tx (16 Weeks)||58||
48227923|NCT02725372|100880556|FG000|COMPLETED|Part 1: Blinded Tx (16 Weeks)||40||
48227924|NCT02725372|100880557|FG001|COMPLETED|Part 1: Blinded Tx (16 Weeks)||42||
48227925|NCT02725372|100880556|FG000|NOT COMPLETED|Part 1: Blinded Tx (16 Weeks)||12||
48227926|NCT02725372|100880557|FG001|NOT COMPLETED|Part 1: Blinded Tx (16 Weeks)||16||
48227927|NCT02725372|100880556|FG000|STARTED|Part 2: Open Label Extension Period||40||
48227928|NCT02725372|100880557|FG001|STARTED|Part 2: Open Label Extension Period||42||
48227929|NCT02725372|100880556|FG000|COMPLETED|Part 2: Open Label Extension Period||40|"Completed indicates the subjects that were in Part 2 (Open Label Extension) at the time of the Interim Analysis when the study was early terminated for futility."|
48227930|NCT02725372|100880557|FG001|COMPLETED|Part 2: Open Label Extension Period||42|"Completed indicates the subjects that were in Part 2 (Open Label Extension) at the time of the Interim Analysis when the study was early terminated for futility."|
48227931|NCT02725372|100880556|FG000|NOT COMPLETED|Part 2: Open Label Extension Period||0||
48227932|NCT02725372|100880557|FG001|NOT COMPLETED|Part 2: Open Label Extension Period||0||
48227933|NCT00770874|100880558|FG000|STARTED|Overall Study||188||
48227934|NCT00770874|100880559|FG001|STARTED|Overall Study||176||
48227935|NCT00770874|100880558|FG000|COMPLETED|Overall Study||188||
48227936|NCT00770874|100880559|FG001|COMPLETED|Overall Study||176||
48227937|NCT00770874|100880558|FG000|NOT COMPLETED|Overall Study||0||
48227938|NCT00770874|100880559|FG001|NOT COMPLETED|Overall Study||0||
48227939|NCT00849485|100880560|FG000|STARTED|First Intervention||11||
48227940|NCT00849485|100880561|FG001|STARTED|First Intervention||11||
48227941|NCT00849485|100880560|FG000|COMPLETED|First Intervention||11||
48227942|NCT00849485|100880561|FG001|COMPLETED|First Intervention||11||
48227943|NCT00849485|100880560|FG000|NOT COMPLETED|First Intervention||0||
48227944|NCT00849485|100880561|FG001|NOT COMPLETED|First Intervention||0||
48227945|NCT00849485|100880560|FG000|STARTED|Washout: 7 Days||11||
48227946|NCT00849485|100880561|FG001|STARTED|Washout: 7 Days||11||
48227947|NCT00849485|100880560|FG000|COMPLETED|Washout: 7 Days||11||
48227948|NCT00849485|100880561|FG001|COMPLETED|Washout: 7 Days||11||
48227949|NCT00849485|100880560|FG000|NOT COMPLETED|Washout: 7 Days||0||
48227950|NCT00849485|100880561|FG001|NOT COMPLETED|Washout: 7 Days||0||
48227951|NCT00849485|100880560|FG000|STARTED|Second Intervention||11||
48227952|NCT00849485|100880561|FG001|STARTED|Second Intervention||11||
48227953|NCT00849485|100880560|FG000|COMPLETED|Second Intervention||11||
48227954|NCT00849485|100880561|FG001|COMPLETED|Second Intervention||11||
48227955|NCT00849485|100880560|FG000|NOT COMPLETED|Second Intervention||0||
48227956|NCT00849485|100880561|FG001|NOT COMPLETED|Second Intervention||0||
48227957|NCT03442777|100880562|FG000|STARTED|Overall Study||542||
48227958|NCT03442777|100880563|FG001|STARTED|Overall Study||545||
48227959|NCT03442777|100880564|FG002|STARTED|Overall Study||546||
48227960|NCT03442777|100880562|FG000|COMPLETED|Overall Study||534|All participants completed the study however not all were included in the analysis.|
48227961|NCT03442777|100880563|FG001|COMPLETED|Overall Study||532|All participants completed the study however not all were included in the analysis.|
48227962|NCT03442777|100880564|FG002|COMPLETED|Overall Study||539|All participants completed the study however not all were included in the analysis.|
48227963|NCT03442777|100880562|FG000|NOT COMPLETED|Overall Study||8||
48227964|NCT03442777|100880563|FG001|NOT COMPLETED|Overall Study||13||
48227965|NCT03442777|100880564|FG002|NOT COMPLETED|Overall Study||7||
48227966|NCT04348357|100880565|FG000|STARTED|Overall Study||25||
48227967|NCT04348357|100880566|FG001|STARTED|Overall Study||28||
48227968|NCT04348357|100880565|FG000|COMPLETED|Overall Study||25||
48227969|NCT04348357|100880566|FG001|COMPLETED|Overall Study||16||
48227970|NCT04348357|100880565|FG000|NOT COMPLETED|Overall Study||0||
48227971|NCT04348357|100880566|FG001|NOT COMPLETED|Overall Study||12||
48227972|NCT01779700|100880567|FG000|STARTED|Overall Study||18||
48227973|NCT01779700|100880568|FG001|STARTED|Overall Study||22||
48227974|NCT01779700|100880567|FG000|COMPLETED|Overall Study||14||
48227975|NCT01779700|100880568|FG001|COMPLETED|Overall Study||17||
48227976|NCT01779700|100880567|FG000|NOT COMPLETED|Overall Study||4||
48227977|NCT01779700|100880568|FG001|NOT COMPLETED|Overall Study||5||
48227978|NCT02431741|100880569|FG000|STARTED|Overall Study||14||
48227979|NCT02431741|100880569|FG000|COMPLETED|Overall Study||14||
48527015|NCT00361335|101624057|FG003|STARTED|SC Period: Week E0 to Week E24||63||
48527016|NCT00361335|101624058|FG004|STARTED|SC Period: Week E0 to Week E24||3||
48527017|NCT00361335|101624059|FG005|STARTED|SC Period: Week E0 to Week E24||24||
48527018|NCT00361335|101624060|FG006|STARTED|SC Period: Week E0 to Week E24||173||
48527019|NCT00361335|101624054|FG000|COMPLETED|SC Period: Week E0 to Week E24||80||
48527020|NCT00361335|101624055|FG001|COMPLETED|SC Period: Week E0 to Week E24||56||
48527021|NCT00361335|101624056|FG002|COMPLETED|SC Period: Week E0 to Week E24||99||
48527022|NCT00361335|101624057|FG003|COMPLETED|SC Period: Week E0 to Week E24||59||
48527023|NCT00361335|101624058|FG004|COMPLETED|SC Period: Week E0 to Week E24||3||
48527024|NCT00361335|101624059|FG005|COMPLETED|SC Period: Week E0 to Week E24||23||
48527025|NCT00361335|101624060|FG006|COMPLETED|SC Period: Week E0 to Week E24||164||
48527026|NCT00361335|101624054|FG000|NOT COMPLETED|SC Period: Week E0 to Week E24||2||
48527027|NCT00361335|101624055|FG001|NOT COMPLETED|SC Period: Week E0 to Week E24||3||
48527028|NCT00361335|101624056|FG002|NOT COMPLETED|SC Period: Week E0 to Week E24||5||
48527029|NCT00361335|101624057|FG003|NOT COMPLETED|SC Period: Week E0 to Week E24||4||
48527030|NCT00361335|101624058|FG004|NOT COMPLETED|SC Period: Week E0 to Week E24||0||
48527031|NCT00361335|101624059|FG005|NOT COMPLETED|SC Period: Week E0 to Week E24||1||
48527032|NCT00361335|101624060|FG006|NOT COMPLETED|SC Period: Week E0 to Week E24||9||
48527033|NCT02989168|101624061|FG000|STARTED|Overall Study||11||
48527034|NCT02989168|101624062|FG001|STARTED|Overall Study||3||
48527035|NCT02989168|101624061|FG000|COMPLETED|Overall Study||7||
48527036|NCT02989168|101624062|FG001|COMPLETED|Overall Study||0||
48527037|NCT02989168|101624061|FG000|NOT COMPLETED|Overall Study||4||
48527038|NCT02989168|101624062|FG001|NOT COMPLETED|Overall Study||3||
48527039|NCT01031953|101624063|FG000|STARTED|Overall Study||11||
48527040|NCT01031953|101624063|FG000|COMPLETED|Overall Study||11||
48527041|NCT01031953|101624063|FG000|NOT COMPLETED|Overall Study||0||
48527042|NCT01429051|101624064|FG000|STARTED|Titration Phase||45||
48527043|NCT01429051|101624064|FG000|COMPLETED|Titration Phase||33||
48527044|NCT01429051|101624064|FG000|NOT COMPLETED|Titration Phase||12||
48527045|NCT01429051|101624064|FG000|STARTED|Efficacy Phase||15||
48527046|NCT01429051|101624064|FG000|COMPLETED|Efficacy Phase||13||
48527047|NCT01429051|101624064|FG000|NOT COMPLETED|Efficacy Phase||2||
48527048|NCT01429051|101624064|FG000|STARTED|Tolerability Phase||31||
48527049|NCT01429051|101624064|FG000|COMPLETED|Tolerability Phase||16||
48527050|NCT01429051|101624064|FG000|NOT COMPLETED|Tolerability Phase||15||
48527051|NCT00251719|101624065|FG000|STARTED|Overall Study||694||
48527052|NCT00251719|101624066|FG001|STARTED|Overall Study||687||
48527053|NCT00251719|101624067|FG002|STARTED|Overall Study||673||
48527054|NCT00251719|101624065|FG000|COMPLETED|Overall Study||641||
48527055|NCT00251719|101624066|FG001|COMPLETED|Overall Study||642||
48527056|NCT00251719|101624067|FG002|COMPLETED|Overall Study||643||
48527057|NCT00251719|101624065|FG000|NOT COMPLETED|Overall Study||53||
48527058|NCT00251719|101624066|FG001|NOT COMPLETED|Overall Study||45||
48527059|NCT00251719|101624067|FG002|NOT COMPLETED|Overall Study||30||
48527060|NCT01969448|101624068|FG000|STARTED|Overall Study||55||
48527061|NCT01969448|101624069|FG001|STARTED|Overall Study||24||
48527062|NCT01969448|101624070|FG002|STARTED|Overall Study||0||
48527063|NCT01969448|101624068|FG000|COMPLETED|Overall Study||55||
48227980|NCT02431741|100880569|FG000|NOT COMPLETED|Overall Study||0||
48227981|NCT01240785|100880570|FG000|STARTED|Overall Study||111||
48527064|NCT01969448|101624069|FG001|COMPLETED|Overall Study||24||
48527065|NCT01969448|101624070|FG002|COMPLETED|Overall Study||0||
48527066|NCT01969448|101624068|FG000|NOT COMPLETED|Overall Study||0||
48527067|NCT01969448|101624069|FG001|NOT COMPLETED|Overall Study||0||
48527068|NCT01969448|101624070|FG002|NOT COMPLETED|Overall Study||0||
48527069|NCT02139124|101624071|FG000|STARTED|Overall Study||78||
48527070|NCT02139124|101624072|FG001|STARTED|Overall Study||77||
48227982|NCT01240785|100880571|FG001|STARTED|Overall Study||110||
48527071|NCT02139124|101624073|FG002|STARTED|Overall Study||73||
48527072|NCT02139124|101624074|FG003|STARTED|Overall Study||73||
48527073|NCT02139124|101624075|FG004|STARTED|Overall Study||74||
48527074|NCT02139124|101624071|FG000|COMPLETED|Overall Study||69||
48527075|NCT02139124|101624072|FG001|COMPLETED|Overall Study||73||
48527076|NCT02139124|101624073|FG002|COMPLETED|Overall Study||69||
48527077|NCT02139124|101624074|FG003|COMPLETED|Overall Study||61||
48527078|NCT02139124|101624075|FG004|COMPLETED|Overall Study||61||
48527079|NCT02139124|101624071|FG000|NOT COMPLETED|Overall Study||9||
48527080|NCT02139124|101624072|FG001|NOT COMPLETED|Overall Study||4||
48527081|NCT02139124|101624073|FG002|NOT COMPLETED|Overall Study||4||
48527082|NCT02139124|101624074|FG003|NOT COMPLETED|Overall Study||12||
48227983|NCT01240785|100880570|FG000|COMPLETED|Overall Study||110||
48527083|NCT02139124|101624075|FG004|NOT COMPLETED|Overall Study||13||
48527084|NCT00186043|101624076|FG000|STARTED|Overall Study||30||
48527085|NCT00186043|101624077|FG001|STARTED|Overall Study||25||
48527086|NCT00186043|101624076|FG000|COMPLETED|Overall Study||15||
48527087|NCT00186043|101624077|FG001|COMPLETED|Overall Study||12||
48227984|NCT01240785|100880571|FG001|COMPLETED|Overall Study||107||
48527088|NCT00186043|101624076|FG000|NOT COMPLETED|Overall Study||15||
48227985|NCT01240785|100880570|FG000|NOT COMPLETED|Overall Study||1||
48527089|NCT00186043|101624077|FG001|NOT COMPLETED|Overall Study||13||
48527090|NCT01775865|101624078|FG000|STARTED|Overall Study||14||
48527091|NCT01775865|101624079|FG001|STARTED|Overall Study||14||
48527092|NCT01775865|101624080|FG002|STARTED|Overall Study||17||
48527093|NCT01775865|101624078|FG000|COMPLETED|Overall Study||11||
48527094|NCT01775865|101624079|FG001|COMPLETED|Overall Study||13||
48527095|NCT01775865|101624080|FG002|COMPLETED|Overall Study||17||
48527096|NCT01775865|101624078|FG000|NOT COMPLETED|Overall Study||3||
48527097|NCT01775865|101624079|FG001|NOT COMPLETED|Overall Study||1||
48527098|NCT01775865|101624080|FG002|NOT COMPLETED|Overall Study||0||
48527099|NCT02494102|101624081|FG000|STARTED|Overall Study||42||
48527100|NCT02494102|101624082|FG001|STARTED|Overall Study||47||
48527101|NCT02494102|101624081|FG000|COMPLETED|Overall Study||42||
48527102|NCT02494102|101624082|FG001|COMPLETED|Overall Study||47||
48527103|NCT02494102|101624081|FG000|NOT COMPLETED|Overall Study||0||
48227986|NCT01240785|100880571|FG001|NOT COMPLETED|Overall Study||3||
48227987|NCT01556594|100880572|FG000|STARTED|Overall Study||10||
48227988|NCT01556594|100880573|FG001|STARTED|Overall Study||2||
48227989|NCT01556594|100880574|FG002|STARTED|Overall Study||6||
48227990|NCT01556594|100880572|FG000|COMPLETED|Overall Study||10||
48227991|NCT01556594|100880573|FG001|COMPLETED|Overall Study||2||
48227992|NCT01556594|100880574|FG002|COMPLETED|Overall Study||6||
48227993|NCT01556594|100880572|FG000|NOT COMPLETED|Overall Study||0||
48227994|NCT01556594|100880573|FG001|NOT COMPLETED|Overall Study||0||
48227995|NCT01556594|100880574|FG002|NOT COMPLETED|Overall Study||0||
48227996|NCT00148122|100880575|FG000|STARTED|Overall Study||40||
48227997|NCT00148122|100880575|FG000|COMPLETED|Overall Study||38||
48227998|NCT00148122|100880575|FG000|NOT COMPLETED|Overall Study||2||
48227999|NCT03774849|100880576|FG000|STARTED|Overall Study||80||
48527104|NCT02494102|101624082|FG001|NOT COMPLETED|Overall Study||0||
48527105|NCT01691820|101624083|FG000|STARTED|Overall Study||210||
48527106|NCT01691820|101624084|FG001|STARTED|Overall Study||152||
48527107|NCT01691820|101624083|FG000|COMPLETED|Overall Study||184||
48527108|NCT01691820|101624084|FG001|COMPLETED|Overall Study||115||
48527109|NCT01691820|101624083|FG000|NOT COMPLETED|Overall Study||26||
48527110|NCT01691820|101624084|FG001|NOT COMPLETED|Overall Study||37||
48527111|NCT01195272|101624085|FG000|STARTED|Overall Study||21||
48527112|NCT01195272|101624085|FG000|COMPLETED|Overall Study||17||
48527113|NCT01195272|101624085|FG000|NOT COMPLETED|Overall Study||4||
48228000|NCT03774849|100880577|FG001|STARTED|Overall Study||31||
48228001|NCT03774849|100880578|FG002|STARTED|Overall Study||4||
48228002|NCT03774849|100880576|FG000|PicoWay 532nm|Overall Study||43||
48228003|NCT03774849|100880577|FG001|PicoWay 532nm|Overall Study||0||
48228004|NCT03774849|100880578|FG002|PicoWay 532nm|Overall Study||0||
48228005|NCT03774849|100880576|FG000|PicoWay 1064nm|Overall Study||1||
48228006|NCT03774849|100880577|FG001|PicoWay 1064nm|Overall Study||31||
48228007|NCT03774849|100880578|FG002|PicoWay 1064nm|Overall Study||0||
48228008|NCT03774849|100880576|FG000|PicoWay 730nm|Overall Study||22||
48228009|NCT03774849|100880577|FG001|PicoWay 730nm|Overall Study||0||
48228010|NCT03774849|100880578|FG002|PicoWay 730nm|Overall Study||0||
48228011|NCT03774849|100880576|FG000|PicoWay 532nm and 730nm|Overall Study||4||
48228012|NCT03774849|100880577|FG001|PicoWay 532nm and 730nm|Overall Study||0||
48228013|NCT03774849|100880578|FG002|PicoWay 532nm and 730nm|Overall Study||0||
48228014|NCT03774849|100880576|FG000|PicoWay 730nm and 1064nm|Overall Study||0||
48228015|NCT03774849|100880577|FG001|PicoWay 730nm and 1064nm|Overall Study||0||
48228016|NCT03774849|100880578|FG002|PicoWay 730nm and 1064nm|Overall Study||4||
48228017|NCT03774849|100880576|FG000|COMPLETED|Overall Study||70||
48228018|NCT03774849|100880577|FG001|COMPLETED|Overall Study||31||
48228019|NCT03774849|100880578|FG002|COMPLETED|Overall Study||4||
48228020|NCT03774849|100880576|FG000|NOT COMPLETED|Overall Study||10||
48228021|NCT03774849|100880577|FG001|NOT COMPLETED|Overall Study||0||
48228022|NCT03774849|100880578|FG002|NOT COMPLETED|Overall Study||0||
48228023|NCT01640340|100880579|FG000|STARTED|Overall Study||20||
48228024|NCT01640340|100880580|FG001|STARTED|Overall Study||20||
48228025|NCT01640340|100880579|FG000|Overall Complete Response Rate|Overall Study||20||
48228026|NCT01640340|100880580|FG001|Overall Complete Response Rate|Overall Study||20||
48228027|NCT01640340|100880579|FG000|COMPLETED|Overall Study||20||
48228028|NCT01640340|100880580|FG001|COMPLETED|Overall Study||20||
48228029|NCT01640340|100880579|FG000|NOT COMPLETED|Overall Study||0||
48228030|NCT01640340|100880580|FG001|NOT COMPLETED|Overall Study||0||
48228031|NCT02764970|100880581|FG000|STARTED|Overall Study||65||
48228032|NCT02764970|100880582|FG001|STARTED|Overall Study||47||
48228033|NCT02764970|100880581|FG000|COMPLETED|Overall Study||65||
48228034|NCT02764970|100880582|FG001|COMPLETED|Overall Study||47||
48228035|NCT02764970|100880581|FG000|NOT COMPLETED|Overall Study||0||
48228036|NCT02764970|100880582|FG001|NOT COMPLETED|Overall Study||0||
48228037|NCT00286325|100880583|FG000|STARTED|Overall Study||8||
48228038|NCT00286325|100880583|FG000|COMPLETED|Overall Study||8||
48228039|NCT00286325|100880583|FG000|NOT COMPLETED|Overall Study||0||
48228040|NCT00359203|100880584|FG000|STARTED|Overall Study||39||
48228041|NCT00359203|100880585|FG001|STARTED|Overall Study||38||
48527114|NCT02440568|101624086|FG000|STARTED|Overall Study||5||
48527115|NCT02440568|101624087|FG001|STARTED|Overall Study||4||
48527116|NCT02440568|101624088|FG002|STARTED|Overall Study||10||
48527117|NCT02440568|101624089|FG003|STARTED|Overall Study||3||
48527118|NCT02440568|101624086|FG000|COMPLETED|Overall Study||1||
48527119|NCT02440568|101624087|FG001|COMPLETED|Overall Study||1||
48527120|NCT02440568|101624088|FG002|COMPLETED|Overall Study||5||
48527121|NCT02440568|101624089|FG003|COMPLETED|Overall Study||1||
48527122|NCT02440568|101624086|FG000|NOT COMPLETED|Overall Study||4||
48527123|NCT02440568|101624087|FG001|NOT COMPLETED|Overall Study||3||
48527124|NCT02440568|101624088|FG002|NOT COMPLETED|Overall Study||5||
48527125|NCT02440568|101624089|FG003|NOT COMPLETED|Overall Study||2||
48527126|NCT01244061|101624090|FG000|STARTED|Overall Study||251||
48228042|NCT00359203|100880584|FG000|COMPLETED|Overall Study||39||
48228043|NCT00359203|100880585|FG001|COMPLETED|Overall Study||38||
48228044|NCT00359203|100880584|FG000|NOT COMPLETED|Overall Study||0||
48228045|NCT00359203|100880585|FG001|NOT COMPLETED|Overall Study||0||
48228046|NCT01661972|100880586|FG000|STARTED|Overall Study||13||
48228047|NCT01661972|100880587|FG001|STARTED|Overall Study||50||
48228048|NCT01661972|100880586|FG000|COMPLETED|Overall Study||11||
48228049|NCT01661972|100880587|FG001|COMPLETED|Overall Study||46||
48228050|NCT01661972|100880586|FG000|NOT COMPLETED|Overall Study||2||
48527127|NCT01244061|101624091|FG001|STARTED|Overall Study||247||
48527128|NCT01244061|101624090|FG000|COMPLETED|Overall Study||169||
48527129|NCT01244061|101624091|FG001|COMPLETED|Overall Study||144||
48527130|NCT01244061|101624090|FG000|NOT COMPLETED|Overall Study||82||
48527131|NCT01244061|101624091|FG001|NOT COMPLETED|Overall Study||103||
48527132|NCT03439852|101624092|FG000|STARTED|Baseline to 12 Weeks||12|baseline enrollment|
48527133|NCT03439852|101624093|FG001|STARTED|Baseline to 12 Weeks||23|baseline enrollment|
48527134|NCT03439852|101624092|FG000|COMPLETED|Baseline to 12 Weeks||8|Completed 12 wk survey|
48527135|NCT03439852|101624093|FG001|COMPLETED|Baseline to 12 Weeks||16|Completed 12 wk survey|
48527136|NCT03439852|101624092|FG000|NOT COMPLETED|Baseline to 12 Weeks||4||
48527137|NCT03439852|101624093|FG001|NOT COMPLETED|Baseline to 12 Weeks||7||
48527138|NCT03439852|101624092|FG000|STARTED|12weeks to 24weeks||8||
48527139|NCT03439852|101624093|FG001|STARTED|12weeks to 24weeks||16||
48527140|NCT03439852|101624092|FG000|COMPLETED|12weeks to 24weeks||6||
48527141|NCT03439852|101624093|FG001|COMPLETED|12weeks to 24weeks||16||
48527142|NCT03439852|101624092|FG000|NOT COMPLETED|12weeks to 24weeks||2||
48527143|NCT03439852|101624093|FG001|NOT COMPLETED|12weeks to 24weeks||0||
48527144|NCT03439852|101624092|FG000|STARTED|24 Weeks to 36 Weeks Follow up||6||
48527145|NCT03439852|101624093|FG001|STARTED|24 Weeks to 36 Weeks Follow up||16||
48527146|NCT03439852|101624092|FG000|COMPLETED|24 Weeks to 36 Weeks Follow up||5||
48527147|NCT03439852|101624093|FG001|COMPLETED|24 Weeks to 36 Weeks Follow up||16||
48527148|NCT03439852|101624092|FG000|NOT COMPLETED|24 Weeks to 36 Weeks Follow up||1||
48527149|NCT03439852|101624093|FG001|NOT COMPLETED|24 Weeks to 36 Weeks Follow up||0||
48527150|NCT02575976|101624094|FG000|STARTED|Overall Study||37||
48527151|NCT02575976|101624095|FG001|STARTED|Overall Study||39||
48527152|NCT02575976|101624096|FG002|STARTED|Overall Study||39||
48527153|NCT02575976|101624094|FG000|COMPLETED|Overall Study||32||
48527154|NCT02575976|101624095|FG001|COMPLETED|Overall Study||31||
48527155|NCT02575976|101624096|FG002|COMPLETED|Overall Study||30||
48527156|NCT02575976|101624094|FG000|NOT COMPLETED|Overall Study||5||
48527157|NCT02575976|101624095|FG001|NOT COMPLETED|Overall Study||8||
48527158|NCT02575976|101624096|FG002|NOT COMPLETED|Overall Study||9||
48527159|NCT00741936|101624097|FG000|STARTED|Overall Study||60||
48527160|NCT00741936|101624098|FG001|STARTED|Overall Study||60||
48527161|NCT00741936|101624097|FG000|COMPLETED|Overall Study||51||
48228051|NCT01661972|100880587|FG001|NOT COMPLETED|Overall Study||4||
48228052|NCT02226159|100880588|FG000|STARTED|Overall Study||33||
48527162|NCT00741936|101624098|FG001|COMPLETED|Overall Study||52||
48527163|NCT00741936|101624097|FG000|NOT COMPLETED|Overall Study||9||
48527164|NCT00741936|101624098|FG001|NOT COMPLETED|Overall Study||8||
48527165|NCT00914459|101624099|FG000|STARTED|Overall Study||18||
48527166|NCT00914459|101624100|FG001|STARTED|Overall Study||19||
48228053|NCT02226159|100880589|FG001|STARTED|Overall Study||32||
48228054|NCT02226159|100880588|FG000|COMPLETED|Overall Study||27||
48228055|NCT02226159|100880589|FG001|COMPLETED|Overall Study||26||
48228056|NCT02226159|100880588|FG000|NOT COMPLETED|Overall Study||6||
48228057|NCT02226159|100880589|FG001|NOT COMPLETED|Overall Study||6||
48228058|NCT00109031|100880590|FG000|STARTED|Overall Study||11||
48228059|NCT00109031|100880591|FG001|STARTED|Overall Study||10||
48228060|NCT00109031|100880592|FG002|STARTED|Overall Study||14||
48228061|NCT00109031|100880593|FG003|STARTED|Overall Study||12||
48228062|NCT00109031|100880590|FG000|COMPLETED|Overall Study||11||
48228063|NCT00109031|100880591|FG001|COMPLETED|Overall Study||8||
48228064|NCT00109031|100880592|FG002|COMPLETED|Overall Study||12||
48228065|NCT00109031|100880593|FG003|COMPLETED|Overall Study||12||
48228066|NCT00109031|100880590|FG000|NOT COMPLETED|Overall Study||0||
48228067|NCT00109031|100880591|FG001|NOT COMPLETED|Overall Study||2||
48228068|NCT00109031|100880592|FG002|NOT COMPLETED|Overall Study||2||
48228069|NCT00109031|100880593|FG003|NOT COMPLETED|Overall Study||0||
48228070|NCT02591056|100880594|FG000|STARTED|Overall Study||27||
48228071|NCT02591056|100880594|FG000|COMPLETED|Overall Study||27||
48228072|NCT02591056|100880594|FG000|NOT COMPLETED|Overall Study||0||
48527167|NCT00914459|101624099|FG000|COMPLETED|Overall Study||17||
48527168|NCT00914459|101624100|FG001|COMPLETED|Overall Study||18||
48527169|NCT00914459|101624099|FG000|NOT COMPLETED|Overall Study||1||
48228073|NCT03352713|100880595|FG000|STARTED|Overall Study||185||
48228074|NCT03352713|100880595|FG000|COMPLETED|Overall Study||159||
48228075|NCT03352713|100880595|FG000|NOT COMPLETED|Overall Study||26||
48228076|NCT01469585|100880596|FG000|STARTED|Overall Study||11||
48228077|NCT01469585|100880597|FG001|STARTED|Overall Study||9||
48228078|NCT01469585|100880596|FG000|COMPLETED|Overall Study||4||
48228079|NCT01469585|100880597|FG001|COMPLETED|Overall Study||6||
48228080|NCT01469585|100880596|FG000|NOT COMPLETED|Overall Study||7||
48228081|NCT01469585|100880597|FG001|NOT COMPLETED|Overall Study||3||
48228082|NCT03140670|100880598|FG000|STARTED|Overall Study||46||
48228083|NCT03140670|100880598|FG000|COMPLETED|Overall Study||42||
48228084|NCT03140670|100880598|FG000|NOT COMPLETED|Overall Study||4||
48228085|NCT01787032|100880599|FG000|STARTED|Overall Study||3||
48228086|NCT01787032|100880600|FG001|STARTED|Overall Study||3||
48228087|NCT01787032|100880601|FG002|STARTED|Overall Study||3||
48228088|NCT01787032|100880602|FG003|STARTED|Overall Study||3||
48228089|NCT01787032|100880603|FG004|STARTED|Overall Study||4||
48228090|NCT01787032|100880604|FG005|STARTED|Overall Study||4||
48228091|NCT01787032|100880599|FG000|Received R|Overall Study||3||
48228092|NCT01787032|100880600|FG001|Received R|Overall Study||3||
48228093|NCT01787032|100880601|FG002|Received R|Overall Study||3||
48228094|NCT01787032|100880602|FG003|Received R|Overall Study||3||
48527170|NCT00914459|101624100|FG001|NOT COMPLETED|Overall Study||1||
48527171|NCT02302859|101624101|FG000|STARTED|Overall Study||2||
48527172|NCT02302859|101624102|FG001|STARTED|Overall Study||6||
48527173|NCT02302859|101624101|FG000|COMPLETED|Overall Study||1||
48228095|NCT01787032|100880603|FG004|Received R|Overall Study||4||
48228096|NCT01787032|100880604|FG005|Received R|Overall Study||3||
48228097|NCT01787032|100880599|FG000|Received T1|Overall Study||3||
48228098|NCT01787032|100880600|FG001|Received T1|Overall Study||3||
48228099|NCT01787032|100880601|FG002|Received T1|Overall Study||3||
48228100|NCT01787032|100880602|FG003|Received T1|Overall Study||3||
48228101|NCT01787032|100880603|FG004|Received T1|Overall Study||3||
48228102|NCT01787032|100880604|FG005|Received T1|Overall Study||4||
48228103|NCT01787032|100880599|FG000|Received T2|Overall Study||3||
48228104|NCT01787032|100880600|FG001|Received T2|Overall Study||3||
48228105|NCT01787032|100880601|FG002|Received T2|Overall Study||3||
48228106|NCT01787032|100880602|FG003|Received T2|Overall Study||3||
48228107|NCT01787032|100880603|FG004|Received T2|Overall Study||4||
48228108|NCT01787032|100880604|FG005|Received T2|Overall Study||4||
48527174|NCT02302859|101624102|FG001|COMPLETED|Overall Study||4||
48527175|NCT02302859|101624101|FG000|NOT COMPLETED|Overall Study||1||
48527176|NCT02302859|101624102|FG001|NOT COMPLETED|Overall Study||2||
48527177|NCT01959035|101624103|FG000|STARTED|Overall Study||88||
48527178|NCT01959035|101624103|FG000|COMPLETED|Overall Study||77||
48527179|NCT01959035|101624103|FG000|NOT COMPLETED|Overall Study||11||
48527180|NCT00856973|101624104|FG000|STARTED|Overall Study||162||
48527181|NCT00856973|101624105|FG001|STARTED|Overall Study||163||
48527182|NCT00856973|101624106|FG002|STARTED|Overall Study||161||
48527183|NCT00856973|101624104|FG000|COMPLETED|Overall Study||126||
48527184|NCT00856973|101624105|FG001|COMPLETED|Overall Study||122||
48527185|NCT00856973|101624106|FG002|COMPLETED|Overall Study||123||
48527186|NCT00856973|101624104|FG000|NOT COMPLETED|Overall Study||36||
48228109|NCT01787032|100880599|FG000|COMPLETED|Overall Study||3||
48228110|NCT01787032|100880600|FG001|COMPLETED|Overall Study||3||
48228111|NCT01787032|100880601|FG002|COMPLETED|Overall Study||3||
48228112|NCT01787032|100880602|FG003|COMPLETED|Overall Study||3||
48228113|NCT01787032|100880603|FG004|COMPLETED|Overall Study||3||
48228114|NCT01787032|100880604|FG005|COMPLETED|Overall Study||3||
48228115|NCT01787032|100880599|FG000|NOT COMPLETED|Overall Study||0||
48228116|NCT01787032|100880600|FG001|NOT COMPLETED|Overall Study||0||
48228117|NCT01787032|100880601|FG002|NOT COMPLETED|Overall Study||0||
48228118|NCT01787032|100880602|FG003|NOT COMPLETED|Overall Study||0||
48228119|NCT01787032|100880603|FG004|NOT COMPLETED|Overall Study||1||
48527187|NCT00856973|101624105|FG001|NOT COMPLETED|Overall Study||41||
48527188|NCT00856973|101624106|FG002|NOT COMPLETED|Overall Study||38||
48527189|NCT01732484|101624107|FG000|STARTED|Overall Study||100||
48527190|NCT01732484|101624107|FG000|Randomized|Overall Study||100||
48527191|NCT01732484|101624107|FG000|Allocation|Overall Study||100||
48527192|NCT01732484|101624107|FG000|COMPLETED|Overall Study||74||
48527193|NCT01732484|101624107|FG000|NOT COMPLETED|Overall Study||26||
48527194|NCT02791893|101624108|FG000|STARTED|Blinded Phase||13||
48527195|NCT02791893|101624109|FG001|STARTED|Blinded Phase||14||
48527196|NCT02791893|101624108|FG000|COMPLETED|Blinded Phase||10||
48527197|NCT02791893|101624109|FG001|COMPLETED|Blinded Phase||10||
48527198|NCT02791893|101624108|FG000|NOT COMPLETED|Blinded Phase||3||
48527199|NCT02791893|101624109|FG001|NOT COMPLETED|Blinded Phase||4||
48527200|NCT02791893|101624108|FG000|STARTED|Open Label Phase||10||
48228120|NCT01787032|100880604|FG005|NOT COMPLETED|Overall Study||1||
48228121|NCT00780741|100880605|FG000|STARTED|Overall Study||82||
48228122|NCT00780741|100880606|FG001|STARTED|Overall Study||81||
48228123|NCT00780741|100880605|FG000|6-Month Visit|Overall Study||73||
48228124|NCT00780741|100880606|FG001|6-Month Visit|Overall Study||67||
48228125|NCT00780741|100880605|FG000|COMPLETED|Overall Study||75||
48228126|NCT00780741|100880606|FG001|COMPLETED|Overall Study||71||
48527201|NCT02791893|101624109|FG001|STARTED|Open Label Phase||10||
48527202|NCT02791893|101624108|FG000|COMPLETED|Open Label Phase||7||
48527203|NCT02791893|101624109|FG001|COMPLETED|Open Label Phase||8||
48228127|NCT00780741|100880605|FG000|NOT COMPLETED|Overall Study||7||
48228128|NCT00780741|100880606|FG001|NOT COMPLETED|Overall Study||10||
48228129|NCT03403036|100880607|FG000|STARTED|Overall Study||39||
48527204|NCT02791893|101624108|FG000|NOT COMPLETED|Open Label Phase||3||
48527205|NCT02791893|101624109|FG001|NOT COMPLETED|Open Label Phase||2||
48527206|NCT02093221|101624110|FG000|STARTED|Overall Study||15||
48527207|NCT02093221|101624111|FG001|STARTED|Overall Study||16||
48527208|NCT02093221|101624112|FG002|STARTED|Overall Study||15||
48527209|NCT02093221|101624113|FG003|STARTED|Overall Study||15||
48527210|NCT02093221|101624114|FG004|STARTED|Overall Study||15||
48527211|NCT02093221|101624110|FG000|COMPLETED|Overall Study||5||
48527212|NCT02093221|101624111|FG001|COMPLETED|Overall Study||8||
48527213|NCT02093221|101624112|FG002|COMPLETED|Overall Study||6||
48527214|NCT02093221|101624113|FG003|COMPLETED|Overall Study||7||
48527215|NCT02093221|101624114|FG004|COMPLETED|Overall Study||7||
48527216|NCT02093221|101624110|FG000|NOT COMPLETED|Overall Study||10||
48527217|NCT02093221|101624111|FG001|NOT COMPLETED|Overall Study||8||
48527218|NCT02093221|101624112|FG002|NOT COMPLETED|Overall Study||9||
48527219|NCT02093221|101624113|FG003|NOT COMPLETED|Overall Study||8||
48527220|NCT02093221|101624114|FG004|NOT COMPLETED|Overall Study||8||
48527221|NCT04049617|101624115|FG000|STARTED|Overall Study||3||
48527222|NCT04049617|101624116|FG001|STARTED|Overall Study||3||
48527223|NCT04049617|101624117|FG002|STARTED|Overall Study||6||
48527224|NCT04049617|101624118|FG003|STARTED|Overall Study||3||
48527225|NCT04049617|101624119|FG004|STARTED|Overall Study||2||
48527226|NCT04049617|101624120|FG005|STARTED|Overall Study||1||
48228130|NCT03403036|100880607|FG000|COMPLETED|Overall Study||34||
48228131|NCT03403036|100880607|FG000|NOT COMPLETED|Overall Study||5||
48228132|NCT01211106|100880608|FG000|STARTED|Overall Study||95||
48228133|NCT01211106|100880609|FG001|STARTED|Overall Study||88||
48228134|NCT01211106|100880608|FG000|COMPLETED|Overall Study||82||
48228135|NCT01211106|100880609|FG001|COMPLETED|Overall Study||77||
48228136|NCT01211106|100880608|FG000|NOT COMPLETED|Overall Study||13||
48527227|NCT04049617|101624115|FG000|COMPLETED|Overall Study||3||
48527228|NCT04049617|101624116|FG001|COMPLETED|Overall Study||3||
48527229|NCT04049617|101624117|FG002|COMPLETED|Overall Study||5||
48527230|NCT04049617|101624118|FG003|COMPLETED|Overall Study||1||
48527231|NCT04049617|101624119|FG004|COMPLETED|Overall Study||2||
48527232|NCT04049617|101624120|FG005|COMPLETED|Overall Study||0||
48527233|NCT04049617|101624115|FG000|NOT COMPLETED|Overall Study||0||
48527234|NCT04049617|101624116|FG001|NOT COMPLETED|Overall Study||0||
48527235|NCT04049617|101624117|FG002|NOT COMPLETED|Overall Study||1||
48527236|NCT04049617|101624118|FG003|NOT COMPLETED|Overall Study||2||
48527237|NCT04049617|101624119|FG004|NOT COMPLETED|Overall Study||0||
48527238|NCT04049617|101624120|FG005|NOT COMPLETED|Overall Study||1||
48527239|NCT00621049|101624121|FG000|STARTED|Adjuvant Treatment||55||
48527240|NCT00621049|101624122|FG001|STARTED|Adjuvant Treatment||57||
48527241|NCT00621049|101624121|FG000|COMPLETED|Adjuvant Treatment||52||
48527242|NCT00621049|101624122|FG001|COMPLETED|Adjuvant Treatment||47||
48527243|NCT00621049|101624121|FG000|NOT COMPLETED|Adjuvant Treatment||3||
48527244|NCT00621049|101624122|FG001|NOT COMPLETED|Adjuvant Treatment||10||
48527245|NCT00621049|101624121|FG000|STARTED|Maintenance Treatment||49||
48527246|NCT00621049|101624122|FG001|STARTED|Maintenance Treatment||0||
48527247|NCT00621049|101624121|FG000|COMPLETED|Maintenance Treatment||34||
48527248|NCT00621049|101624122|FG001|COMPLETED|Maintenance Treatment||0||
48527249|NCT00621049|101624121|FG000|NOT COMPLETED|Maintenance Treatment||15||
48527250|NCT00621049|101624122|FG001|NOT COMPLETED|Maintenance Treatment||0||
48527251|NCT02991430|101624123|FG000|STARTED|Treatment Period 1||14||
48527252|NCT02991430|101624124|FG001|STARTED|Treatment Period 1||15||
48527253|NCT02991430|101624125|FG002|STARTED|Treatment Period 1||16||
48527254|NCT02991430|101624123|FG000|COMPLETED|Treatment Period 1||13||
48527255|NCT02991430|101624124|FG001|COMPLETED|Treatment Period 1||11||
48527256|NCT02991430|101624125|FG002|COMPLETED|Treatment Period 1||14||
48527257|NCT02991430|101624123|FG000|NOT COMPLETED|Treatment Period 1||1||
48527258|NCT02991430|101624124|FG001|NOT COMPLETED|Treatment Period 1||4||
48527259|NCT02991430|101624125|FG002|NOT COMPLETED|Treatment Period 1||2||
48527260|NCT02991430|101624123|FG000|STARTED|Treatment Period 2||13||
48527261|NCT02991430|101624124|FG001|STARTED|Treatment Period 2||11||
48527262|NCT02991430|101624125|FG002|STARTED|Treatment Period 2||14||
48228137|NCT01211106|100880609|FG001|NOT COMPLETED|Overall Study||11||
48228138|NCT01326455|100880610|FG000|STARTED|Overall Study||25||
48527263|NCT02991430|101624123|FG000|COMPLETED|Treatment Period 2||7||
48527264|NCT02991430|101624124|FG001|COMPLETED|Treatment Period 2||8||
48228139|NCT01326455|100880611|FG001|STARTED|Overall Study||25||
48228140|NCT01326455|100880612|FG002|STARTED|Overall Study||25||
48228141|NCT01326455|100880610|FG000|COMPLETED|Overall Study||15||
48228142|NCT01326455|100880611|FG001|COMPLETED|Overall Study||20||
48228143|NCT01326455|100880612|FG002|COMPLETED|Overall Study||18||
48527265|NCT02991430|101624125|FG002|COMPLETED|Treatment Period 2||10||
48527266|NCT02991430|101624123|FG000|NOT COMPLETED|Treatment Period 2||6||
48527267|NCT02991430|101624124|FG001|NOT COMPLETED|Treatment Period 2||3||
48527268|NCT02991430|101624125|FG002|NOT COMPLETED|Treatment Period 2||4||
48527269|NCT02991430|101624123|FG000|STARTED|Post-treatment Observation Period||7||
48527270|NCT02991430|101624124|FG001|STARTED|Post-treatment Observation Period||8||
48228144|NCT01326455|100880610|FG000|NOT COMPLETED|Overall Study||10||
48228145|NCT01326455|100880611|FG001|NOT COMPLETED|Overall Study||5||
48228146|NCT01326455|100880612|FG002|NOT COMPLETED|Overall Study||7||
48228147|NCT02169414|100880613|FG000|STARTED|Overall Study||19||
48228148|NCT02169414|100880614|FG001|STARTED|Overall Study||19||
48228149|NCT02169414|100880615|FG002|STARTED|Overall Study||18||
48228150|NCT02169414|100880616|FG003|STARTED|Overall Study||18||
48228151|NCT02169414|100880613|FG000|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18||
48228152|NCT02169414|100880614|FG001|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||19||
48228153|NCT02169414|100880615|FG002|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18||
48228154|NCT02169414|100880616|FG003|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18||
48228155|NCT02169414|100880613|FG000|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18||
48228156|NCT02169414|100880614|FG001|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18||
48527271|NCT02991430|101624125|FG002|STARTED|Post-treatment Observation Period||10||
48527272|NCT02991430|101624123|FG000|COMPLETED|Post-treatment Observation Period||4||
48527273|NCT02991430|101624124|FG001|COMPLETED|Post-treatment Observation Period||2||
48527274|NCT02991430|101624125|FG002|COMPLETED|Post-treatment Observation Period||5||
48228157|NCT02169414|100880615|FG002|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18||
48228158|NCT02169414|100880616|FG003|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18||
48228159|NCT02169414|100880613|FG000|COMPLETED|Overall Study||18||
48228160|NCT02169414|100880614|FG001|COMPLETED|Overall Study||18||
48228161|NCT02169414|100880615|FG002|COMPLETED|Overall Study||18||
48228162|NCT02169414|100880616|FG003|COMPLETED|Overall Study||18||
48228163|NCT02169414|100880613|FG000|NOT COMPLETED|Overall Study||1||
48228164|NCT02169414|100880614|FG001|NOT COMPLETED|Overall Study||1||
48228165|NCT02169414|100880615|FG002|NOT COMPLETED|Overall Study||0||
48228166|NCT02169414|100880616|FG003|NOT COMPLETED|Overall Study||0||
48527275|NCT02991430|101624123|FG000|NOT COMPLETED|Post-treatment Observation Period||3||
48527276|NCT02991430|101624124|FG001|NOT COMPLETED|Post-treatment Observation Period||6||
48527277|NCT02991430|101624125|FG002|NOT COMPLETED|Post-treatment Observation Period||5||
48527278|NCT00197392|101624126|FG000|STARTED|Overall Study||214||
48527279|NCT00197392|101624127|FG001|STARTED|Overall Study||220||
48527280|NCT00197392|101624126|FG000|Safety Population|Overall Study||214||
48527281|NCT00197392|101624127|FG001|Safety Population|Overall Study||220||
48527282|NCT00197392|101624126|FG000|Modified Intent to Treat|Overall Study||209||
48527283|NCT00197392|101624127|FG001|Modified Intent to Treat|Overall Study||210||
48527284|NCT00197392|101624126|FG000|Evaluable|Overall Study||176||
48527285|NCT00197392|101624127|FG001|Evaluable|Overall Study||181||
48527286|NCT00197392|101624126|FG000|Per Protocol|Overall Study||126||
48527287|NCT00197392|101624127|FG001|Per Protocol|Overall Study||134||
48527288|NCT00197392|101624126|FG000|COMPLETED|Overall Study||126||
48228167|NCT01989104|100880617|FG000|STARTED|Overall Study||25||
48228168|NCT01989104|100880618|FG001|STARTED|Overall Study||25||
48228169|NCT01989104|100880619|FG002|STARTED|Overall Study||25||
48228170|NCT01989104|100880620|FG003|STARTED|Overall Study||24||
48527289|NCT00197392|101624127|FG001|COMPLETED|Overall Study||134||
48527290|NCT00197392|101624126|FG000|NOT COMPLETED|Overall Study||88||
48527291|NCT00197392|101624127|FG001|NOT COMPLETED|Overall Study||86||
48527292|NCT02579161|101624128|FG000|STARTED|Overall Study||49||
48527293|NCT02579161|101624129|FG001|STARTED|Overall Study||49||
48527294|NCT02579161|101624128|FG000|COMPLETED|Overall Study||49||
48527295|NCT02579161|101624129|FG001|COMPLETED|Overall Study||49||
48527296|NCT02579161|101624128|FG000|NOT COMPLETED|Overall Study||0||
48228171|NCT01989104|100880621|FG004|STARTED|Overall Study||24||
48228172|NCT01989104|100880617|FG000|COMPLETED|Overall Study||22||
48228173|NCT01989104|100880618|FG001|COMPLETED|Overall Study||25||
48228174|NCT01989104|100880619|FG002|COMPLETED|Overall Study||25||
48228175|NCT01989104|100880620|FG003|COMPLETED|Overall Study||24||
48228176|NCT01989104|100880621|FG004|COMPLETED|Overall Study||24||
48228177|NCT01989104|100880617|FG000|NOT COMPLETED|Overall Study||3||
48228178|NCT01989104|100880618|FG001|NOT COMPLETED|Overall Study||0||
48228179|NCT01989104|100880619|FG002|NOT COMPLETED|Overall Study||0||
48228180|NCT01989104|100880620|FG003|NOT COMPLETED|Overall Study||0||
48527297|NCT02579161|101624129|FG001|NOT COMPLETED|Overall Study||0||
48527298|NCT04053465|101624130|FG000|STARTED|Overall Study||22||
48527299|NCT04053465|101624131|FG001|STARTED|Overall Study||12||
48527300|NCT04053465|101624130|FG000|COMPLETED|Overall Study||18||
48527301|NCT04053465|101624131|FG001|COMPLETED|Overall Study||8||
48527302|NCT04053465|101624130|FG000|NOT COMPLETED|Overall Study||4||
48527303|NCT04053465|101624131|FG001|NOT COMPLETED|Overall Study||4||
48527304|NCT01629966|101624132|FG000|STARTED|Overall Study||221||
48527305|NCT01629966|101624133|FG001|STARTED|Overall Study||227||
48527306|NCT01629966|101624134|FG002|STARTED|Overall Study||225||
48527307|NCT01629966|101624132|FG000|COMPLETED|Overall Study||180||
48527308|NCT01629966|101624133|FG001|COMPLETED|Overall Study||175||
48527309|NCT01629966|101624134|FG002|COMPLETED|Overall Study||159||
48228181|NCT01989104|100880621|FG004|NOT COMPLETED|Overall Study||0||
48228182|NCT01855399|100880622|FG000|STARTED|6 Month||146||
48228183|NCT01855399|100880623|FG001|STARTED|6 Month||144||
48228184|NCT01855399|100880622|FG000|COMPLETED|6 Month||126||
48228185|NCT01855399|100880623|FG001|COMPLETED|6 Month||129||
48228186|NCT01855399|100880622|FG000|NOT COMPLETED|6 Month||20||
48228187|NCT01855399|100880623|FG001|NOT COMPLETED|6 Month||15||
48228188|NCT01855399|100880622|FG000|STARTED|12 Month||126||
48228189|NCT01855399|100880623|FG001|STARTED|12 Month||129||
48228190|NCT01855399|100880622|FG000|COMPLETED|12 Month||119||
48228191|NCT01855399|100880623|FG001|COMPLETED|12 Month||118||
48228192|NCT01855399|100880622|FG000|NOT COMPLETED|12 Month||7||
48228193|NCT01855399|100880623|FG001|NOT COMPLETED|12 Month||11||
48228194|NCT03128099|100880624|FG000|STARTED|Overall Study||21||
48228195|NCT03128099|100880625|FG001|STARTED|Overall Study||4||
48228196|NCT03128099|100880626|FG002|STARTED|Overall Study||22||
48228197|NCT03128099|100880624|FG000|Hour 1 (Low Dose) Started|Overall Study||21||
48228198|NCT03128099|100880625|FG001|Hour 1 (Low Dose) Started|Overall Study||4||
48228199|NCT03128099|100880626|FG002|Hour 1 (Low Dose) Started|Overall Study||22||
48228200|NCT03128099|100880624|FG000|Hour 1 (Low Dose) Completed|Overall Study||19||
48228201|NCT03128099|100880625|FG001|Hour 1 (Low Dose) Completed|Overall Study||4||
48228202|NCT03128099|100880626|FG002|Hour 1 (Low Dose) Completed|Overall Study||21||
48228203|NCT03128099|100880624|FG000|Hour 2 (High Dose)Started|Overall Study||0||
48228204|NCT03128099|100880625|FG001|Hour 2 (High Dose)Started|Overall Study||4||
48228205|NCT03128099|100880626|FG002|Hour 2 (High Dose)Started|Overall Study||0||
48228206|NCT03128099|100880624|FG000|Hour 2 (High Dose) Completed|Overall Study||0||
48228207|NCT03128099|100880625|FG001|Hour 2 (High Dose) Completed|Overall Study||0||
48228208|NCT03128099|100880626|FG002|Hour 2 (High Dose) Completed|Overall Study||0||
48228209|NCT03128099|100880624|FG000|COMPLETED|Overall Study||19||
48228210|NCT03128099|100880625|FG001|COMPLETED|Overall Study||0||
48228211|NCT03128099|100880626|FG002|COMPLETED|Overall Study||21||
48228212|NCT03128099|100880624|FG000|NOT COMPLETED|Overall Study||2||
48228213|NCT03128099|100880625|FG001|NOT COMPLETED|Overall Study||4||
48228214|NCT03128099|100880626|FG002|NOT COMPLETED|Overall Study||1||
48228215|NCT03547154|100880627|FG000|STARTED|Overall Study||173||
48228216|NCT03547154|100880628|FG001|STARTED|Overall Study||171||
48228217|NCT03547154|100880627|FG000|COMPLETED|Overall Study||50||
48527310|NCT01629966|101624132|FG000|NOT COMPLETED|Overall Study||41||
48527311|NCT01629966|101624133|FG001|NOT COMPLETED|Overall Study||52||
48527312|NCT01629966|101624134|FG002|NOT COMPLETED|Overall Study||66||
48527313|NCT03095118|101624135|FG000|STARTED|Overall Study||12||
48527314|NCT03095118|101624135|FG000|COMPLETED|Overall Study||10||
48527315|NCT03095118|101624135|FG000|NOT COMPLETED|Overall Study||2||
48527316|NCT01602965|101624136|FG000|STARTED|Overall Study||20||
48527317|NCT01602965|101624137|FG001|STARTED|Overall Study||20||
48527318|NCT01602965|101624136|FG000|COMPLETED|Overall Study||16||
48527319|NCT01602965|101624137|FG001|COMPLETED|Overall Study||18||
48527320|NCT01602965|101624136|FG000|NOT COMPLETED|Overall Study||4||
48527321|NCT01602965|101624137|FG001|NOT COMPLETED|Overall Study||2||
48527322|NCT02728752|101624138|FG000|STARTED|First Period||48||
48527323|NCT02728752|101624139|FG001|STARTED|First Period||47||
48527324|NCT02728752|101624138|FG000|COMPLETED|First Period||46||
48527325|NCT02728752|101624139|FG001|COMPLETED|First Period||45||
48527326|NCT02728752|101624138|FG000|NOT COMPLETED|First Period||2||
48527327|NCT02728752|101624139|FG001|NOT COMPLETED|First Period||2||
48527328|NCT02728752|101624138|FG000|STARTED|Extension Period||46||
48527329|NCT02728752|101624139|FG001|STARTED|Extension Period||45||
48527330|NCT02728752|101624138|FG000|COMPLETED|Extension Period||35||
48527331|NCT02728752|101624139|FG001|COMPLETED|Extension Period||34||
48527332|NCT02728752|101624138|FG000|NOT COMPLETED|Extension Period||11||
48527333|NCT02728752|101624139|FG001|NOT COMPLETED|Extension Period||11||
48527334|NCT00642694|101624140|FG000|STARTED|Overall Study||14||
48527335|NCT00642694|101624141|FG001|STARTED|Overall Study||15||
48527336|NCT00642694|101624140|FG000|COMPLETED|Overall Study||8||
48228218|NCT03547154|100880628|FG001|COMPLETED|Overall Study||55||
48228219|NCT03547154|100880627|FG000|NOT COMPLETED|Overall Study||123||
48527337|NCT00642694|101624141|FG001|COMPLETED|Overall Study||11||
48527338|NCT00642694|101624140|FG000|NOT COMPLETED|Overall Study||6||
48527339|NCT00642694|101624141|FG001|NOT COMPLETED|Overall Study||4||
48527340|NCT00816361|101624142|FG000|STARTED|Overall Study||4||
48527341|NCT00816361|101624143|FG001|STARTED|Overall Study||3||
48527342|NCT00816361|101624144|FG002|STARTED|Overall Study||4||
48527343|NCT00816361|101624145|FG003|STARTED|Overall Study||3||
48527344|NCT00816361|101624146|FG004|STARTED|Overall Study||3||
48228220|NCT03547154|100880628|FG001|NOT COMPLETED|Overall Study||116||
48527345|NCT00816361|101624147|FG005|STARTED|Overall Study||3||
48527346|NCT00816361|101624148|FG006|STARTED|Overall Study||3||
48527347|NCT00816361|101624149|FG007|STARTED|Overall Study||10||
48527348|NCT00816361|101624150|FG008|STARTED|Overall Study||10||
48527349|NCT00816361|101624142|FG000|COMPLETED|Overall Study||0||
48527350|NCT00816361|101624143|FG001|COMPLETED|Overall Study||0||
48527351|NCT00816361|101624144|FG002|COMPLETED|Overall Study||1||
48527352|NCT00816361|101624145|FG003|COMPLETED|Overall Study||0||
48527353|NCT00816361|101624146|FG004|COMPLETED|Overall Study||1||
48527354|NCT00816361|101624147|FG005|COMPLETED|Overall Study||0||
48527355|NCT00816361|101624148|FG006|COMPLETED|Overall Study||0||
48228221|NCT03735849|100880629|FG000|STARTED|Overall Study||11||
48228222|NCT03735849|100880630|FG001|STARTED|Overall Study||13||
48228223|NCT03735849|100880631|FG002|STARTED|Overall Study||4||
48228224|NCT03735849|100880629|FG000|Safety Population|Overall Study||11||
48527356|NCT00816361|101624149|FG007|COMPLETED|Overall Study||1||
48527357|NCT00816361|101624150|FG008|COMPLETED|Overall Study||0||
48527358|NCT00816361|101624142|FG000|NOT COMPLETED|Overall Study||4||
48527359|NCT00816361|101624143|FG001|NOT COMPLETED|Overall Study||3||
48527360|NCT00816361|101624144|FG002|NOT COMPLETED|Overall Study||3||
48527361|NCT00816361|101624145|FG003|NOT COMPLETED|Overall Study||3||
48527362|NCT00816361|101624146|FG004|NOT COMPLETED|Overall Study||2||
48527363|NCT00816361|101624147|FG005|NOT COMPLETED|Overall Study||3||
48527364|NCT00816361|101624148|FG006|NOT COMPLETED|Overall Study||3||
48527365|NCT00816361|101624149|FG007|NOT COMPLETED|Overall Study||9||
48228225|NCT03735849|100880630|FG001|Safety Population|Overall Study||13||
48527366|NCT00816361|101624150|FG008|NOT COMPLETED|Overall Study||10||
48527367|NCT01744093|101624151|FG000|STARTED|Overall Study||18||
48228226|NCT03735849|100880631|FG002|Safety Population|Overall Study||4||
48228227|NCT03735849|100880629|FG000|COMPLETED|Overall Study||9||
48228228|NCT03735849|100880630|FG001|COMPLETED|Overall Study||13||
48228229|NCT03735849|100880631|FG002|COMPLETED|Overall Study||0||
48228230|NCT03735849|100880629|FG000|NOT COMPLETED|Overall Study||2||
48228231|NCT03735849|100880630|FG001|NOT COMPLETED|Overall Study||0||
48228232|NCT03735849|100880631|FG002|NOT COMPLETED|Overall Study||4||
48228233|NCT01331408|100880632|FG000|STARTED|Overall Study||61||
48527368|NCT01744093|101624152|FG001|STARTED|Overall Study||9||
48527369|NCT01744093|101624151|FG000|Treated|Overall Study||16||
48527370|NCT01744093|101624152|FG001|Treated|Overall Study||8||
48527371|NCT01744093|101624151|FG000|COMPLETED|Overall Study||12||
48527372|NCT01744093|101624152|FG001|COMPLETED|Overall Study||8||
48527373|NCT01744093|101624151|FG000|NOT COMPLETED|Overall Study||6||
48527374|NCT01744093|101624152|FG001|NOT COMPLETED|Overall Study||1||
48527375|NCT00251225|101624153|FG000|STARTED|Overall Study||49||
48527376|NCT00251225|101624153|FG000|COMPLETED|Overall Study||49||
48527377|NCT00251225|101624153|FG000|NOT COMPLETED|Overall Study||0||
48527378|NCT01036490|101624154|FG000|STARTED|Overall Study||18||
48527379|NCT01036490|101624155|FG001|STARTED|Overall Study||18||
48527380|NCT01036490|101624154|FG000|COMPLETED|Overall Study||14||
48228234|NCT01331408|100880632|FG000|COMPLETED|Overall Study||50||
48228235|NCT01331408|100880632|FG000|NOT COMPLETED|Overall Study||11||
48228236|NCT02114515|100880633|FG000|STARTED|Overall Study||511||
48228237|NCT02114515|100880634|FG001|STARTED|Overall Study||518||
48228238|NCT02114515|100880633|FG000|COMPLETED|Overall Study||378||
48228239|NCT02114515|100880634|FG001|COMPLETED|Overall Study||368||
48228240|NCT02114515|100880633|FG000|NOT COMPLETED|Overall Study||133||
48228241|NCT02114515|100880634|FG001|NOT COMPLETED|Overall Study||150||
48228242|NCT02707952|100880635|FG000|STARTED|Overall Study||129|This milestone represents participants randomized.|
48228243|NCT02707952|100880636|FG001|STARTED|Overall Study||53|This milestone represents participants randomized.|
48527381|NCT01036490|101624155|FG001|COMPLETED|Overall Study||18||
48527382|NCT01036490|101624154|FG000|NOT COMPLETED|Overall Study||4||
48527383|NCT01036490|101624155|FG001|NOT COMPLETED|Overall Study||0||
48527384|NCT01398943|101624156|FG000|STARTED|First Intervention (1 Day)||15||
48527385|NCT01398943|101624157|FG001|STARTED|First Intervention (1 Day)||15||
48527386|NCT01398943|101624158|FG002|STARTED|First Intervention (1 Day)||15||
48527387|NCT01398943|101624159|FG003|STARTED|First Intervention (1 Day)||15||
48527388|NCT01398943|101624156|FG000|COMPLETED|First Intervention (1 Day)||15||
48527389|NCT01398943|101624157|FG001|COMPLETED|First Intervention (1 Day)||15||
48527390|NCT01398943|101624158|FG002|COMPLETED|First Intervention (1 Day)||15||
48527391|NCT01398943|101624159|FG003|COMPLETED|First Intervention (1 Day)||15||
48527392|NCT01398943|101624156|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48527393|NCT01398943|101624157|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48527394|NCT01398943|101624158|FG002|NOT COMPLETED|First Intervention (1 Day)||0||
48527395|NCT01398943|101624159|FG003|NOT COMPLETED|First Intervention (1 Day)||0||
48527396|NCT01398943|101624156|FG000|STARTED|Washout (2-7 Days)||15||
48527397|NCT01398943|101624157|FG001|STARTED|Washout (2-7 Days)||15||
48527398|NCT01398943|101624158|FG002|STARTED|Washout (2-7 Days)||15||
48228244|NCT02707952|100880637|FG002|STARTED|Overall Study||103|This milestone represents participants randomized.|
48228245|NCT02707952|100880638|FG003|STARTED|Overall Study||10|This milestone represents participants randomized.|
48228246|NCT02707952|100880635|FG000|Participants Who Received Study Drug|Overall Study||129||
48228247|NCT02707952|100880636|FG001|Participants Who Received Study Drug|Overall Study||52||
48228248|NCT02707952|100880637|FG002|Participants Who Received Study Drug|Overall Study||103||
48228249|NCT02707952|100880638|FG003|Participants Who Received Study Drug|Overall Study||10||
48228250|NCT02707952|100880635|FG000|COMPLETED|Overall Study||127||
48228251|NCT02707952|100880636|FG001|COMPLETED|Overall Study||52||
48228252|NCT02707952|100880637|FG002|COMPLETED|Overall Study||101||
48527399|NCT01398943|101624159|FG003|STARTED|Washout (2-7 Days)||15||
48527400|NCT01398943|101624156|FG000|COMPLETED|Washout (2-7 Days)||15||
48228253|NCT02707952|100880638|FG003|COMPLETED|Overall Study||10||
48228254|NCT02707952|100880635|FG000|NOT COMPLETED|Overall Study||2||
48527401|NCT01398943|101624157|FG001|COMPLETED|Washout (2-7 Days)||15||
48527402|NCT01398943|101624158|FG002|COMPLETED|Washout (2-7 Days)||15||
48527403|NCT01398943|101624159|FG003|COMPLETED|Washout (2-7 Days)||15||
48527404|NCT01398943|101624156|FG000|NOT COMPLETED|Washout (2-7 Days)||0||
48527405|NCT01398943|101624157|FG001|NOT COMPLETED|Washout (2-7 Days)||0||
48527406|NCT01398943|101624158|FG002|NOT COMPLETED|Washout (2-7 Days)||0||
48228255|NCT02707952|100880636|FG001|NOT COMPLETED|Overall Study||1||
48228256|NCT02707952|100880637|FG002|NOT COMPLETED|Overall Study||2||
48527407|NCT01398943|101624159|FG003|NOT COMPLETED|Washout (2-7 Days)||0||
48228257|NCT02707952|100880638|FG003|NOT COMPLETED|Overall Study||0||
48527408|NCT01398943|101624156|FG000|STARTED|Second Intervention (1 Day)||15||
48527409|NCT01398943|101624157|FG001|STARTED|Second Intervention (1 Day)||15||
48527410|NCT01398943|101624158|FG002|STARTED|Second Intervention (1 Day)||15||
48527411|NCT01398943|101624159|FG003|STARTED|Second Intervention (1 Day)||15||
48527412|NCT01398943|101624156|FG000|COMPLETED|Second Intervention (1 Day)||15||
48527413|NCT01398943|101624157|FG001|COMPLETED|Second Intervention (1 Day)||15||
48527414|NCT01398943|101624158|FG002|COMPLETED|Second Intervention (1 Day)||15||
48527415|NCT01398943|101624159|FG003|COMPLETED|Second Intervention (1 Day)||15||
48527416|NCT01398943|101624156|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48527417|NCT01398943|101624157|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48527418|NCT01398943|101624158|FG002|NOT COMPLETED|Second Intervention (1 Day)||0||
48527419|NCT01398943|101624159|FG003|NOT COMPLETED|Second Intervention (1 Day)||0||
48527420|NCT03340064|101624160|FG000|STARTED|First Period||32||
48527421|NCT03340064|101624161|FG001|STARTED|First Period||6||
48527422|NCT03340064|101624160|FG000|COMPLETED|First Period||27||
48527423|NCT03340064|101624161|FG001|COMPLETED|First Period||6||
48527424|NCT03340064|101624160|FG000|NOT COMPLETED|First Period||5||
48527425|NCT03340064|101624161|FG001|NOT COMPLETED|First Period||0||
48527426|NCT03340064|101624160|FG000|STARTED|Second Period||27||
48527427|NCT03340064|101624161|FG001|STARTED|Second Period||6||
48527428|NCT03340064|101624160|FG000|COMPLETED|Second Period||8||
48527429|NCT03340064|101624161|FG001|COMPLETED|Second Period||4||
48527430|NCT03340064|101624160|FG000|NOT COMPLETED|Second Period||19||
48527431|NCT03340064|101624161|FG001|NOT COMPLETED|Second Period||2||
48527432|NCT00735917|101624162|FG000|STARTED|Overall Study||19||
48527433|NCT00735917|101624162|FG000|COMPLETED|Overall Study||19||
48527434|NCT00735917|101624162|FG000|NOT COMPLETED|Overall Study||0||
48527435|NCT01649271|101624163|FG000|STARTED|Overall Study||6||
48527436|NCT01649271|101624164|FG001|STARTED|Overall Study||7||
48527437|NCT01649271|101624163|FG000|COMPLETED|Overall Study||0||
48527438|NCT01649271|101624164|FG001|COMPLETED|Overall Study||0||
48527439|NCT01649271|101624163|FG000|NOT COMPLETED|Overall Study||6||
48527440|NCT01649271|101624164|FG001|NOT COMPLETED|Overall Study||7||
48527441|NCT01388166|101624165|FG000|STARTED|Overall Study||1253||
48527442|NCT01388166|101624165|FG000|COMPLETED|Overall Study||1194||
48527443|NCT01388166|101624165|FG000|NOT COMPLETED|Overall Study||59||
48527444|NCT00062010|101624166|FG000|STARTED|Overall Study||37||
48527445|NCT00062010|101624166|FG000|Eligible and Treated|Overall Study||34||
48527446|NCT00062010|101624166|FG000|COMPLETED|Overall Study||34||
48527447|NCT00062010|101624166|FG000|NOT COMPLETED|Overall Study||3||
48527448|NCT01902628|101624167|FG000|STARTED|Overall Study||437||
48527449|NCT01902628|101624167|FG000|COMPLETED|Overall Study||354||
48527450|NCT01902628|101624167|FG000|NOT COMPLETED|Overall Study||83||
48527451|NCT00723645|101624168|FG000|STARTED|Visit 1 (≤4 Weeks Post-treatment)||258||
48527452|NCT00723645|101624168|FG000|COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||258||
48527453|NCT00723645|101624168|FG000|NOT COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||0||
48527454|NCT00723645|101624168|FG000|STARTED|Visit 2 (Week 24 Post-treatment)||248||
48527455|NCT00723645|101624168|FG000|COMPLETED|Visit 2 (Week 24 Post-treatment)||248||
48527456|NCT00723645|101624168|FG000|NOT COMPLETED|Visit 2 (Week 24 Post-treatment)||0||
48527457|NCT00723645|101624168|FG000|STARTED|Visit 3 (Week 72 Post-treatment)||187||
48527458|NCT00723645|101624168|FG000|COMPLETED|Visit 3 (Week 72 Post-treatment)||187||
48527459|NCT00723645|101624168|FG000|NOT COMPLETED|Visit 3 (Week 72 Post-treatment)||0||
48527460|NCT03687658|101624169|FG000|STARTED|Overall Study||67||
48527461|NCT03687658|101624170|FG001|STARTED|Overall Study||24||
48228258|NCT01767688|100880639|FG000|STARTED|Overall Study||8||
48228259|NCT01767688|100880640|FG001|STARTED|Overall Study||8||
48228260|NCT01767688|100880639|FG000|COMPLETED|Overall Study||8||
48228261|NCT01767688|100880640|FG001|COMPLETED|Overall Study||8||
48228262|NCT01767688|100880639|FG000|NOT COMPLETED|Overall Study||0||
48228263|NCT01767688|100880640|FG001|NOT COMPLETED|Overall Study||0||
48228264|NCT00388726|100880641|FG000|STARTED|Overall Study||508||
48228265|NCT00388726|100880642|FG001|STARTED|Overall Study||254||
48228266|NCT00388726|100880641|FG000|COMPLETED|Overall Study||24||
48527462|NCT03687658|101624169|FG000|Completed 1st Scan|Overall Study||52||
48527463|NCT03687658|101624170|FG001|Completed 1st Scan|Overall Study||20||
48527464|NCT03687658|101624169|FG000|Completed 2nd Scan|Overall Study||46||
48527465|NCT03687658|101624170|FG001|Completed 2nd Scan|Overall Study||10||
48527466|NCT03687658|101624169|FG000|COMPLETED|Overall Study||46||
48527467|NCT03687658|101624170|FG001|COMPLETED|Overall Study||10||
48527468|NCT03687658|101624169|FG000|NOT COMPLETED|Overall Study||21||
48527469|NCT03687658|101624170|FG001|NOT COMPLETED|Overall Study||14||
48527470|NCT03949244|101624171|FG000|STARTED|Overall Study||12||
48228267|NCT00388726|100880642|FG001|COMPLETED|Overall Study||10||
48527471|NCT03949244|101624172|FG001|STARTED|Overall Study||21||
48527472|NCT03949244|101624173|FG002|STARTED|Overall Study||14||
48527473|NCT03949244|101624171|FG000|COMPLETED|Overall Study||12||
48527474|NCT03949244|101624172|FG001|COMPLETED|Overall Study||21||
48527475|NCT03949244|101624173|FG002|COMPLETED|Overall Study||14||
48527476|NCT03949244|101624171|FG000|NOT COMPLETED|Overall Study||0||
48527477|NCT03949244|101624172|FG001|NOT COMPLETED|Overall Study||0||
48527478|NCT03949244|101624173|FG002|NOT COMPLETED|Overall Study||0||
48527479|NCT00430495|101624174|FG000|STARTED|Overall Study||64||
48527480|NCT00430495|101624175|FG001|STARTED|Overall Study||66||
48527481|NCT00430495|101624176|FG002|STARTED|Overall Study||62||
48527482|NCT00430495|101624177|FG003|STARTED|Overall Study||64||
48527483|NCT00430495|101624174|FG000|Treated|Overall Study||62||
48527484|NCT00430495|101624175|FG001|Treated|Overall Study||66||
48527485|NCT00430495|101624176|FG002|Treated|Overall Study||62||
48527486|NCT00430495|101624177|FG003|Treated|Overall Study||64||
48527487|NCT00430495|101624174|FG000|COMPLETED|Overall Study||50||
48527488|NCT00430495|101624175|FG001|COMPLETED|Overall Study||59||
48527489|NCT00430495|101624176|FG002|COMPLETED|Overall Study||49||
48527490|NCT00430495|101624177|FG003|COMPLETED|Overall Study||60||
48527491|NCT00430495|101624174|FG000|NOT COMPLETED|Overall Study||14||
48527492|NCT00430495|101624175|FG001|NOT COMPLETED|Overall Study||7||
48527493|NCT00430495|101624176|FG002|NOT COMPLETED|Overall Study||13||
48527494|NCT00430495|101624177|FG003|NOT COMPLETED|Overall Study||4||
48527495|NCT03835221|101624178|FG000|STARTED|Methafilcon A||43||
48527496|NCT03835221|101624178|FG000|COMPLETED|Methafilcon A||42||
48527497|NCT03835221|101624178|FG000|NOT COMPLETED|Methafilcon A||1||
48527498|NCT03835221|101624178|FG000|STARTED|Fanfilcon A||42||
48527499|NCT03835221|101624178|FG000|COMPLETED|Fanfilcon A||42||
48527500|NCT03835221|101624178|FG000|NOT COMPLETED|Fanfilcon A||0||
48527501|NCT04156620|101624179|FG000|STARTED|Overall Study||264||
48527502|NCT04156620|101624180|FG001|STARTED|Overall Study||262||
48527503|NCT04156620|101624179|FG000|Completed Period 1|Overall Study||255|Baseline up to Week 16|
48527504|NCT04156620|101624180|FG001|Completed Period 1|Overall Study||253|Baseline up to Week 16|
48527505|NCT04156620|101624179|FG000|Started Period 2|Overall Study||255|Week 16 up Week 52|
48527506|NCT04156620|101624180|FG001|Started Period 2|Overall Study||251|Week 16 up Week 52|
48527507|NCT04156620|101624179|FG000|Completed Period 2|Overall Study||233||
48527508|NCT04156620|101624180|FG001|Completed Period 2|Overall Study||235||
48527509|NCT04156620|101624179|FG000|COMPLETED|Overall Study||227|Completed up to Week 60 (follow-up)|
48527510|NCT04156620|101624180|FG001|COMPLETED|Overall Study||233|Completed up to Week 60 (follow-up)|
48527511|NCT04156620|101624179|FG000|NOT COMPLETED|Overall Study||37||
48527512|NCT04156620|101624180|FG001|NOT COMPLETED|Overall Study||29||
48527513|NCT02823652|101624181|FG000|STARTED|Step 1: On-line Genetic Education Study||293||
48527514|NCT02823652|101624182|FG001|STARTED|Step 1: On-line Genetic Education Study||301||
48527515|NCT02823652|101624183|FG002|STARTED|Step 1: On-line Genetic Education Study||7||
48527516|NCT02823652|101624181|FG000|Baseline Survey Completion|Step 1: On-line Genetic Education Study||235||
48527517|NCT02823652|101624182|FG001|Baseline Survey Completion|Step 1: On-line Genetic Education Study||237||
48527518|NCT02823652|101624183|FG002|Baseline Survey Completion|Step 1: On-line Genetic Education Study||0||
48527519|NCT02823652|101624181|FG000|COMPLETED|Step 1: On-line Genetic Education Study||235||
48527520|NCT02823652|101624182|FG001|COMPLETED|Step 1: On-line Genetic Education Study||237||
48527521|NCT02823652|101624183|FG002|COMPLETED|Step 1: On-line Genetic Education Study||0||
48527522|NCT02823652|101624181|FG000|NOT COMPLETED|Step 1: On-line Genetic Education Study||58||
48527523|NCT02823652|101624182|FG001|NOT COMPLETED|Step 1: On-line Genetic Education Study||64||
48527524|NCT02823652|101624183|FG002|NOT COMPLETED|Step 1: On-line Genetic Education Study||7||
48527525|NCT02823652|101624181|FG000|STARTED|Step 2: Genetic Counseling Substudy||9||
48527526|NCT02823652|101624182|FG001|STARTED|Step 2: Genetic Counseling Substudy||4||
48527527|NCT02823652|101624183|FG002|STARTED|Step 2: Genetic Counseling Substudy||7||
48527528|NCT02823652|101624181|FG000|Eligible Patients|Step 2: Genetic Counseling Substudy||7||
48527529|NCT02823652|101624182|FG001|Eligible Patients|Step 2: Genetic Counseling Substudy||4||
48527530|NCT02823652|101624183|FG002|Eligible Patients|Step 2: Genetic Counseling Substudy||7||
48527531|NCT02823652|101624181|FG000|COMPLETED|Step 2: Genetic Counseling Substudy||3||
48527532|NCT02823652|101624182|FG001|COMPLETED|Step 2: Genetic Counseling Substudy||2||
48527533|NCT02823652|101624183|FG002|COMPLETED|Step 2: Genetic Counseling Substudy||5||
48527534|NCT02823652|101624181|FG000|NOT COMPLETED|Step 2: Genetic Counseling Substudy||6||
48527535|NCT02823652|101624182|FG001|NOT COMPLETED|Step 2: Genetic Counseling Substudy||2||
48527536|NCT02823652|101624183|FG002|NOT COMPLETED|Step 2: Genetic Counseling Substudy||2||
48527537|NCT04048343|101624184|FG000|STARTED|Overall Study||65||
48080660|NCT01235351|100518823|FG001|75 mg First and Then 150 mg|Treatment With Different Dose Sequences||0||
48080661|NCT01235351|100518822|FG000|150 mg First Then 75 mg|Treatment With Different Dose Sequences||117||
48527538|NCT04048343|101624184|FG000|COMPLETED|Overall Study||65||
48527539|NCT04048343|101624184|FG000|NOT COMPLETED|Overall Study||0||
48527540|NCT03801382|101624185|FG000|STARTED|First Assessment||99||
48527541|NCT03801382|101624186|FG001|STARTED|First Assessment||101||
48527542|NCT03801382|101624187|FG002|STARTED|First Assessment||53||
48527543|NCT03801382|101624188|FG003|STARTED|First Assessment||49||
48527544|NCT03801382|101624189|FG004|STARTED|First Assessment||148||
48527545|NCT03801382|101624185|FG000|COMPLETED|First Assessment||99||
48527546|NCT03801382|101624186|FG001|COMPLETED|First Assessment||101||
48527547|NCT03801382|101624187|FG002|COMPLETED|First Assessment||53||
48527548|NCT03801382|101624188|FG003|COMPLETED|First Assessment||49||
48527549|NCT03801382|101624189|FG004|COMPLETED|First Assessment||148||
48527550|NCT03801382|101624185|FG000|NOT COMPLETED|First Assessment||0||
48527551|NCT03801382|101624186|FG001|NOT COMPLETED|First Assessment||0||
48527552|NCT03801382|101624187|FG002|NOT COMPLETED|First Assessment||0||
48527553|NCT03801382|101624188|FG003|NOT COMPLETED|First Assessment||0||
48527554|NCT03801382|101624189|FG004|NOT COMPLETED|First Assessment||0||
48527555|NCT03801382|101624185|FG000|STARTED|Second Assessment||99||
48527556|NCT03801382|101624186|FG001|STARTED|Second Assessment||101||
48527557|NCT03801382|101624187|FG002|STARTED|Second Assessment||53||
48527558|NCT03801382|101624188|FG003|STARTED|Second Assessment||49||
48527559|NCT03801382|101624189|FG004|STARTED|Second Assessment||0||
48527560|NCT03801382|101624185|FG000|COMPLETED|Second Assessment||99||
48527561|NCT03801382|101624186|FG001|COMPLETED|Second Assessment||101||
48527562|NCT03801382|101624187|FG002|COMPLETED|Second Assessment||53||
48527563|NCT03801382|101624188|FG003|COMPLETED|Second Assessment||49||
48527564|NCT03801382|101624189|FG004|COMPLETED|Second Assessment||0||
48527565|NCT03801382|101624185|FG000|NOT COMPLETED|Second Assessment||0||
48527566|NCT03801382|101624186|FG001|NOT COMPLETED|Second Assessment||0||
48527567|NCT03801382|101624187|FG002|NOT COMPLETED|Second Assessment||0||
48527568|NCT03801382|101624188|FG003|NOT COMPLETED|Second Assessment||0||
48527569|NCT03801382|101624189|FG004|NOT COMPLETED|Second Assessment||0||
48527570|NCT00834652|101624190|FG000|STARTED|Overall Study||104||
48527571|NCT00834652|101624191|FG001|STARTED|Overall Study||102||
48527572|NCT00834652|101624190|FG000|COMPLETED|Overall Study||66||
48527573|NCT00834652|101624191|FG001|COMPLETED|Overall Study||62||
48527574|NCT00834652|101624190|FG000|NOT COMPLETED|Overall Study||38||
48527575|NCT00834652|101624191|FG001|NOT COMPLETED|Overall Study||40||
48527576|NCT01055132|101624192|FG000|STARTED|Period 1 (5-9 Days)||36||
48527577|NCT01055132|101624193|FG001|STARTED|Period 1 (5-9 Days)||33||
48527578|NCT01055132|101624192|FG000|COMPLETED|Period 1 (5-9 Days)||35||
48527579|NCT01055132|101624193|FG001|COMPLETED|Period 1 (5-9 Days)||33||
48527580|NCT01055132|101624192|FG000|NOT COMPLETED|Period 1 (5-9 Days)||1||
48527581|NCT01055132|101624193|FG001|NOT COMPLETED|Period 1 (5-9 Days)||0||
48527582|NCT01055132|101624192|FG000|STARTED|Period 2 (5-9 Days)||35||
48527583|NCT01055132|101624193|FG001|STARTED|Period 2 (5-9 Days)||33||
48527584|NCT01055132|101624192|FG000|COMPLETED|Period 2 (5-9 Days)||35||
48527585|NCT01055132|101624193|FG001|COMPLETED|Period 2 (5-9 Days)||32||
48527586|NCT01055132|101624192|FG000|NOT COMPLETED|Period 2 (5-9 Days)||0||
48527587|NCT01055132|101624193|FG001|NOT COMPLETED|Period 2 (5-9 Days)||1||
48527588|NCT03805100|101624194|FG000|STARTED|Overall Study||292||
48527589|NCT03805100|101624195|FG001|STARTED|Overall Study||290||
48527590|NCT03805100|101624194|FG000|COMPLETED|Overall Study||245||
48527591|NCT03805100|101624195|FG001|COMPLETED|Overall Study||241||
48527592|NCT03805100|101624194|FG000|NOT COMPLETED|Overall Study||47||
48527593|NCT03805100|101624195|FG001|NOT COMPLETED|Overall Study||49||
48527594|NCT01568320|101624196|FG000|STARTED|Overall Study||73||
48527595|NCT01568320|101624196|FG000|5-Year|Overall Study||36||
48527596|NCT01568320|101624196|FG000|COMPLETED|Overall Study||32||
48527597|NCT01568320|101624196|FG000|NOT COMPLETED|Overall Study||41||
48527598|NCT01881113|101624197|FG000|STARTED|Overall Study||51||
48527599|NCT01881113|101624198|FG001|STARTED|Overall Study||50||
48527600|NCT01881113|101624197|FG000|COMPLETED|Overall Study||43||
48527601|NCT01881113|101624198|FG001|COMPLETED|Overall Study||44||
48527602|NCT01881113|101624197|FG000|NOT COMPLETED|Overall Study||8||
48527603|NCT01881113|101624198|FG001|NOT COMPLETED|Overall Study||6||
48527604|NCT00782821|101624199|FG000|STARTED|Overall Study||10||
48527605|NCT00782821|101624200|FG001|STARTED|Overall Study||10||
48527606|NCT00782821|101624201|FG002|STARTED|Overall Study||10||
48527607|NCT00782821|101624202|FG003|STARTED|Overall Study||10||
48527608|NCT00782821|101624199|FG000|COMPLETED|Overall Study||10||
48527609|NCT00782821|101624200|FG001|COMPLETED|Overall Study||10||
48527610|NCT00782821|101624201|FG002|COMPLETED|Overall Study||9||
48527611|NCT00782821|101624202|FG003|COMPLETED|Overall Study||8||
48527612|NCT00782821|101624199|FG000|NOT COMPLETED|Overall Study||0||
48527613|NCT00782821|101624200|FG001|NOT COMPLETED|Overall Study||0||
48527614|NCT00782821|101624201|FG002|NOT COMPLETED|Overall Study||1||
48527615|NCT00782821|101624202|FG003|NOT COMPLETED|Overall Study||2||
48527616|NCT00861198|101624203|FG000|STARTED|Overall Study||75||
48527617|NCT00861198|101624203|FG000|COMPLETED|Overall Study||70||
48527618|NCT00861198|101624203|FG000|NOT COMPLETED|Overall Study||5||
48527619|NCT02075671|101624204|FG000|STARTED|Overall Study||10||
48527620|NCT02075671|101624205|FG001|STARTED|Overall Study||10||
48527621|NCT02075671|101624206|FG002|STARTED|Overall Study||10||
48527622|NCT02075671|101624204|FG000|COMPLETED|Overall Study||8||
48527623|NCT02075671|101624205|FG001|COMPLETED|Overall Study||10||
48527624|NCT02075671|101624206|FG002|COMPLETED|Overall Study||6||
48527625|NCT02075671|101624204|FG000|NOT COMPLETED|Overall Study||2||
48527626|NCT02075671|101624205|FG001|NOT COMPLETED|Overall Study||0||
48527627|NCT02075671|101624206|FG002|NOT COMPLETED|Overall Study||4||
48527628|NCT00127036|101624207|FG000|STARTED|Overall Study||34||
48527629|NCT00127036|101624208|FG001|STARTED|Overall Study||31||
48527630|NCT00127036|101624207|FG000|COMPLETED|Overall Study||26||
48527631|NCT00127036|101624208|FG001|COMPLETED|Overall Study||20||
48527632|NCT00127036|101624207|FG000|NOT COMPLETED|Overall Study||8||
48527633|NCT00127036|101624208|FG001|NOT COMPLETED|Overall Study||11||
48228268|NCT00388726|100880641|FG000|NOT COMPLETED|Overall Study||484||
48228269|NCT00388726|100880642|FG001|NOT COMPLETED|Overall Study||244||
48228270|NCT02699099|100880643|FG000|STARTED|Overall Study||231||
48228271|NCT02699099|100880644|FG001|STARTED|Overall Study||236||
48228272|NCT02699099|100880645|FG002|STARTED|Overall Study||232||
48228273|NCT02699099|100880643|FG000|COMPLETED|Overall Study||223||
48228274|NCT02699099|100880644|FG001|COMPLETED|Overall Study||233||
48228275|NCT02699099|100880645|FG002|COMPLETED|Overall Study||226||
48228276|NCT02699099|100880643|FG000|NOT COMPLETED|Overall Study||8||
48228277|NCT02699099|100880644|FG001|NOT COMPLETED|Overall Study||3||
48228278|NCT02699099|100880645|FG002|NOT COMPLETED|Overall Study||6||
48228279|NCT02113449|100880646|FG000|STARTED|Overall Study||147||
48228280|NCT02113449|100880646|FG000|COMPLETED|Overall Study||143||
48228281|NCT02113449|100880646|FG000|NOT COMPLETED|Overall Study||4||
48228282|NCT00718120|100880647|FG000|STARTED|Overall Study||55||
48228283|NCT00718120|100880648|FG001|STARTED|Overall Study||55||
48228284|NCT00718120|100880647|FG000|COMPLETED|Overall Study||55||
48228285|NCT00718120|100880648|FG001|COMPLETED|Overall Study||55||
48228286|NCT00718120|100880647|FG000|NOT COMPLETED|Overall Study||0||
48228287|NCT00718120|100880648|FG001|NOT COMPLETED|Overall Study||0||
48228288|NCT02326220|100880649|FG000|STARTED|Double-blind Treatment Period||21||
48228289|NCT02326220|100880650|FG001|STARTED|Double-blind Treatment Period||41||
48228290|NCT02326220|100880651|FG002|STARTED|Double-blind Treatment Period||0||
48228291|NCT02326220|100880649|FG000|COMPLETED|Double-blind Treatment Period||20||
48527634|NCT01121666|101624209|FG000|STARTED|Overall Study||249||
48527635|NCT01121666|101624210|FG001|STARTED|Overall Study||123||
48527636|NCT01121666|101624209|FG000|COMPLETED|Overall Study||220||
48527637|NCT01121666|101624210|FG001|COMPLETED|Overall Study||113||
48527638|NCT01121666|101624209|FG000|NOT COMPLETED|Overall Study||29||
48527639|NCT01121666|101624210|FG001|NOT COMPLETED|Overall Study||10||
48527640|NCT01150890|101628206|FG000|STARTED|Overall Study||32||
48527641|NCT01150890|101628207|FG001|STARTED|Overall Study||32||
48527642|NCT01150890|101628208|FG002|STARTED|Overall Study||33||
48527643|NCT01150890|101628209|FG003|STARTED|Overall Study||33||
48527644|NCT01150890|101628206|FG000|Received Study Drug|Overall Study||32||
48527645|NCT01150890|101628207|FG001|Received Study Drug|Overall Study||31||
48527646|NCT01150890|101628208|FG002|Received Study Drug|Overall Study||32||
48527647|NCT01150890|101628209|FG003|Received Study Drug|Overall Study||33||
48527648|NCT01150890|101628206|FG000|COMPLETED|Overall Study||28|Completing the study is defined as completing 12 weeks of study evaluations|
48527649|NCT01150890|101628207|FG001|COMPLETED|Overall Study||19|Completing the study is defined as completing 12 weeks of study evaluations|
48527650|NCT01150890|101628208|FG002|COMPLETED|Overall Study||21|Completing the study is defined as completing 12 weeks of study evaluations|
48527651|NCT01150890|101628209|FG003|COMPLETED|Overall Study||16|Completing the study is defined as completing 12 weeks of study evaluations|
48527652|NCT01150890|101628206|FG000|NOT COMPLETED|Overall Study||4||
48527653|NCT01150890|101628207|FG001|NOT COMPLETED|Overall Study||13||
48228292|NCT02326220|100880650|FG001|COMPLETED|Double-blind Treatment Period||37||
48228293|NCT02326220|100880651|FG002|COMPLETED|Double-blind Treatment Period||0||
48228294|NCT02326220|100880649|FG000|NOT COMPLETED|Double-blind Treatment Period||1||
48228295|NCT02326220|100880650|FG001|NOT COMPLETED|Double-blind Treatment Period||4||
48228296|NCT02326220|100880651|FG002|NOT COMPLETED|Double-blind Treatment Period||0||
48228297|NCT02326220|100880649|FG000|STARTED|Open-label Treatment Period||0|Open-label available to participants in a country in which alirocumab was not commercially available|
48228298|NCT02326220|100880650|FG001|STARTED|Open-label Treatment Period||0|Open-label available to participants in a country in which alirocumab was not commercially available|
48228299|NCT02326220|100880651|FG002|STARTED|Open-label Treatment Period||29|Open-label available to participants in a country in which alirocumab was not commercially available|
48228300|NCT02326220|100880649|FG000|COMPLETED|Open-label Treatment Period||0||
48228301|NCT02326220|100880650|FG001|COMPLETED|Open-label Treatment Period||0||
48228302|NCT02326220|100880651|FG002|COMPLETED|Open-label Treatment Period||27||
48228303|NCT02326220|100880649|FG000|NOT COMPLETED|Open-label Treatment Period||0||
48228304|NCT02326220|100880650|FG001|NOT COMPLETED|Open-label Treatment Period||0||
48527654|NCT01150890|101628208|FG002|NOT COMPLETED|Overall Study||12||
48527655|NCT01150890|101628209|FG003|NOT COMPLETED|Overall Study||17||
48527656|NCT00787020|101628210|FG000|STARTED|Overall Study||24||
48527657|NCT00787020|101628211|FG001|STARTED|Overall Study||13||
48527658|NCT00787020|101628210|FG000|COMPLETED|Overall Study||24||
48527659|NCT00787020|101628211|FG001|COMPLETED|Overall Study||13||
48527660|NCT00787020|101628210|FG000|NOT COMPLETED|Overall Study||0||
48527661|NCT00787020|101628211|FG001|NOT COMPLETED|Overall Study||0||
48527662|NCT00974974|101628212|FG000|STARTED|IR CD-LD Dose Adjustment||0||
48527663|NCT00974974|101628213|FG001|STARTED|IR CD-LD Dose Adjustment||471||
48527664|NCT00974974|101628212|FG000|COMPLETED|IR CD-LD Dose Adjustment||0||
48527665|NCT00974974|101628213|FG001|COMPLETED|IR CD-LD Dose Adjustment||450||
48527666|NCT00974974|101628212|FG000|NOT COMPLETED|IR CD-LD Dose Adjustment||0||
48527667|NCT00974974|101628213|FG001|NOT COMPLETED|IR CD-LD Dose Adjustment||21||
48527668|NCT00974974|101628212|FG000|STARTED|IPX066 Dose Conversion||450||
48527669|NCT00974974|101628213|FG001|STARTED|IPX066 Dose Conversion||0||
48527670|NCT00974974|101628212|FG000|COMPLETED|IPX066 Dose Conversion||393||
48527671|NCT00974974|101628213|FG001|COMPLETED|IPX066 Dose Conversion||0||
48527672|NCT00974974|101628212|FG000|NOT COMPLETED|IPX066 Dose Conversion||57||
48527673|NCT00974974|101628213|FG001|NOT COMPLETED|IPX066 Dose Conversion||0||
48527674|NCT00974974|101628212|FG000|STARTED|Maintenance - Double Blind Treatment||201||
48527675|NCT00974974|101628213|FG001|STARTED|Maintenance - Double Blind Treatment||192||
48527676|NCT00974974|101628212|FG000|COMPLETED|Maintenance - Double Blind Treatment||186||
48527677|NCT00974974|101628213|FG001|COMPLETED|Maintenance - Double Blind Treatment||182||
48527678|NCT00974974|101628212|FG000|NOT COMPLETED|Maintenance - Double Blind Treatment||15||
48527679|NCT00974974|101628213|FG001|NOT COMPLETED|Maintenance - Double Blind Treatment||10||
48527680|NCT00786994|101628214|FG000|STARTED|Overall Study||57||
48527681|NCT00786994|101628215|FG001|STARTED|Overall Study||54||
48527682|NCT00786994|101628216|FG002|STARTED|Overall Study||26||
48527683|NCT00786994|101628217|FG003|STARTED|Overall Study||28||
48527684|NCT00786994|101628214|FG000|ITT|Overall Study||53||
48527685|NCT00786994|101628215|FG001|ITT|Overall Study||51||
48527686|NCT00786994|101628216|FG002|ITT|Overall Study||25||
48527687|NCT00786994|101628217|FG003|ITT|Overall Study||28||
48527688|NCT00786994|101628214|FG000|COMPLETED|Overall Study||47||
48527689|NCT00786994|101628215|FG001|COMPLETED|Overall Study||39||
48527690|NCT00786994|101628216|FG002|COMPLETED|Overall Study||24||
48527691|NCT00786994|101628217|FG003|COMPLETED|Overall Study||22||
48527692|NCT00786994|101628214|FG000|NOT COMPLETED|Overall Study||10||
48527693|NCT00786994|101628215|FG001|NOT COMPLETED|Overall Study||15||
48527694|NCT00786994|101628216|FG002|NOT COMPLETED|Overall Study||2||
48527695|NCT00786994|101628217|FG003|NOT COMPLETED|Overall Study||6||
48527696|NCT01822574|101628218|FG000|STARTED|Overall Study||30||
48527697|NCT01822574|101628219|FG001|STARTED|Overall Study||30||
48527698|NCT01822574|101628220|FG002|STARTED|Overall Study||30||
48527699|NCT01822574|101628218|FG000|COMPLETED|Overall Study||30||
48527700|NCT01822574|101628219|FG001|COMPLETED|Overall Study||30||
48527701|NCT01822574|101628220|FG002|COMPLETED|Overall Study||30||
48527702|NCT01822574|101628218|FG000|NOT COMPLETED|Overall Study||0||
48527703|NCT01822574|101628219|FG001|NOT COMPLETED|Overall Study||0||
48527704|NCT01822574|101628220|FG002|NOT COMPLETED|Overall Study||0||
48527705|NCT00392236|101628221|FG000|STARTED|Overall Study||20||
48527706|NCT00392236|101628222|FG001|STARTED|Overall Study||18||
48527707|NCT00392236|101628221|FG000|COMPLETED|Overall Study||8||
48527708|NCT00392236|101628222|FG001|COMPLETED|Overall Study||12||
48527709|NCT00392236|101628221|FG000|NOT COMPLETED|Overall Study||12||
48527710|NCT00392236|101628222|FG001|NOT COMPLETED|Overall Study||6||
48527711|NCT00773734|101628223|FG000|STARTED|Core: Placebo Controlled Phase Week 0-16||88||
48527712|NCT00773734|101628224|FG001|STARTED|Core: Placebo Controlled Phase Week 0-16||89||
48527713|NCT00773734|101628225|FG002|STARTED|Core: Placebo Controlled Phase Week 0-16||87||
48527714|NCT00773734|101628226|FG003|STARTED|Core: Placebo Controlled Phase Week 0-16||88||
48527715|NCT00773734|101628227|FG004|STARTED|Core: Placebo Controlled Phase Week 0-16||0||
48527716|NCT00773734|101628228|FG005|STARTED|Core: Placebo Controlled Phase Week 0-16||0||
48527717|NCT00773734|101628223|FG000|COMPLETED|Core: Placebo Controlled Phase Week 0-16||72||
48527718|NCT00773734|101628224|FG001|COMPLETED|Core: Placebo Controlled Phase Week 0-16||79||
48527719|NCT00773734|101628225|FG002|COMPLETED|Core: Placebo Controlled Phase Week 0-16||66||
48527720|NCT00773734|101628226|FG003|COMPLETED|Core: Placebo Controlled Phase Week 0-16||70||
48527721|NCT00773734|101628227|FG004|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0||
48527722|NCT00773734|101628228|FG005|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0||
48527723|NCT00773734|101628223|FG000|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||16||
48527724|NCT00773734|101628224|FG001|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||10||
48527725|NCT00773734|101628225|FG002|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||21||
48527726|NCT00773734|101628226|FG003|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||18||
48527727|NCT00773734|101628227|FG004|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0||
48527728|NCT00773734|101628228|FG005|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0||
48527729|NCT00773734|101628223|FG000|STARTED|Core: Active Treatment Phase Week 16-24||0||
48527730|NCT00773734|101628224|FG001|STARTED|Core: Active Treatment Phase Week 16-24||77||
48527731|NCT00773734|101628225|FG002|STARTED|Core: Active Treatment Phase Week 16-24||66||
48527732|NCT00773734|101628226|FG003|STARTED|Core: Active Treatment Phase Week 16-24||67||
48527733|NCT00773734|101628227|FG004|STARTED|Core: Active Treatment Phase Week 16-24||34||
48527734|NCT00773734|101628228|FG005|STARTED|Core: Active Treatment Phase Week 16-24||36||
48527735|NCT00773734|101628223|FG000|COMPLETED|Core: Active Treatment Phase Week 16-24||0||
48527736|NCT00773734|101628224|FG001|COMPLETED|Core: Active Treatment Phase Week 16-24||65||
48527737|NCT00773734|101628225|FG002|COMPLETED|Core: Active Treatment Phase Week 16-24||59||
48527738|NCT00773734|101628226|FG003|COMPLETED|Core: Active Treatment Phase Week 16-24||65||
48527739|NCT00773734|101628227|FG004|COMPLETED|Core: Active Treatment Phase Week 16-24||33||
48527740|NCT00773734|101628228|FG005|COMPLETED|Core: Active Treatment Phase Week 16-24||31||
48527741|NCT00773734|101628223|FG000|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||0||
48527742|NCT00773734|101628224|FG001|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||12||
48527743|NCT00773734|101628225|FG002|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||7||
48527744|NCT00773734|101628226|FG003|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||2||
48527745|NCT00773734|101628227|FG004|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||1||
48527746|NCT00773734|101628228|FG005|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||5||
48527747|NCT00773734|101628223|FG000|STARTED|Extension: Active Treatment Week 24-52||0||
48527748|NCT00773734|101628224|FG001|STARTED|Extension: Active Treatment Week 24-52||47||
48527749|NCT00773734|101628225|FG002|STARTED|Extension: Active Treatment Week 24-52||50||
48527750|NCT00773734|101628226|FG003|STARTED|Extension: Active Treatment Week 24-52||58||
48527751|NCT00773734|101628227|FG004|STARTED|Extension: Active Treatment Week 24-52||27||
48527752|NCT00773734|101628228|FG005|STARTED|Extension: Active Treatment Week 24-52||27||
48527753|NCT00773734|101628223|FG000|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||0||
48527754|NCT00773734|101628224|FG001|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||5||
48527755|NCT00773734|101628225|FG002|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10||
48527756|NCT00773734|101628226|FG003|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10||
48527757|NCT00773734|101628227|FG004|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4||
48527758|NCT00773734|101628228|FG005|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4||
48527759|NCT00773734|101628223|FG000|COMPLETED|Extension: Active Treatment Week 24-52||0||
48527760|NCT00773734|101628224|FG001|COMPLETED|Extension: Active Treatment Week 24-52||34||
48527761|NCT00773734|101628225|FG002|COMPLETED|Extension: Active Treatment Week 24-52||33||
48527762|NCT00773734|101628226|FG003|COMPLETED|Extension: Active Treatment Week 24-52||48||
48527763|NCT00773734|101628227|FG004|COMPLETED|Extension: Active Treatment Week 24-52||22||
48527764|NCT00773734|101628228|FG005|COMPLETED|Extension: Active Treatment Week 24-52||19||
48527765|NCT00773734|101628223|FG000|NOT COMPLETED|Extension: Active Treatment Week 24-52||0||
48527766|NCT00773734|101628224|FG001|NOT COMPLETED|Extension: Active Treatment Week 24-52||13||
48527767|NCT00773734|101628225|FG002|NOT COMPLETED|Extension: Active Treatment Week 24-52||17||
48527768|NCT00773734|101628226|FG003|NOT COMPLETED|Extension: Active Treatment Week 24-52||10||
48527769|NCT00773734|101628227|FG004|NOT COMPLETED|Extension: Active Treatment Week 24-52||5||
48527770|NCT00773734|101628228|FG005|NOT COMPLETED|Extension: Active Treatment Week 24-52||8||
48527771|NCT00773734|101628223|FG000|STARTED|LTE Period: Week 52 to 6 Years||0||
48527772|NCT00773734|101628224|FG001|STARTED|LTE Period: Week 52 to 6 Years||0||
48527773|NCT00773734|101628225|FG002|STARTED|LTE Period: Week 52 to 6 Years||16||
48527774|NCT00773734|101628226|FG003|STARTED|LTE Period: Week 52 to 6 Years||17||
48527775|NCT00773734|101628227|FG004|STARTED|LTE Period: Week 52 to 6 Years||0||
48527776|NCT00773734|101628228|FG005|STARTED|LTE Period: Week 52 to 6 Years||0||
48527777|NCT00773734|101628223|FG000|COMPLETED|LTE Period: Week 52 to 6 Years||0||
48527778|NCT00773734|101628224|FG001|COMPLETED|LTE Period: Week 52 to 6 Years||0||
48527779|NCT00773734|101628225|FG002|COMPLETED|LTE Period: Week 52 to 6 Years||4||
48527780|NCT00773734|101628226|FG003|COMPLETED|LTE Period: Week 52 to 6 Years||5||
48527781|NCT00773734|101628227|FG004|COMPLETED|LTE Period: Week 52 to 6 Years||0||
48527782|NCT00773734|101628228|FG005|COMPLETED|LTE Period: Week 52 to 6 Years||0||
48527783|NCT00773734|101628223|FG000|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0||
48527784|NCT00773734|101628224|FG001|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0||
48527785|NCT00773734|101628225|FG002|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12||
48527786|NCT00773734|101628226|FG003|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12||
48527787|NCT00773734|101628227|FG004|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0||
48527788|NCT00773734|101628228|FG005|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0||
48527789|NCT02448706|101628229|FG000|STARTED|Overall Study||25||
48527790|NCT02448706|101628230|FG001|STARTED|Overall Study||24||
48527791|NCT02448706|101628229|FG000|Withdrew for Personal Reasons|Overall Study||1||
48527792|NCT02448706|101628230|FG001|Withdrew for Personal Reasons|Overall Study||1||
48527793|NCT02448706|101628229|FG000|Completed Baseline Testing|Overall Study||24||
48527794|NCT02448706|101628230|FG001|Completed Baseline Testing|Overall Study||23||
48527795|NCT02448706|101628229|FG000|COMPLETED|Overall Study||20||
48527796|NCT02448706|101628230|FG001|COMPLETED|Overall Study||20||
48527797|NCT02448706|101628229|FG000|NOT COMPLETED|Overall Study||5||
48527798|NCT02448706|101628230|FG001|NOT COMPLETED|Overall Study||4||
48527799|NCT01059539|101628231|FG000|STARTED|Overall Study||403||
48527800|NCT01059539|101628231|FG000|COMPLETED|Overall Study||132||
48527801|NCT01059539|101628231|FG000|NOT COMPLETED|Overall Study||271||
48527802|NCT02856880|101628232|FG000|STARTED|Overall Study||45||
48527803|NCT02856880|101628232|FG000|Received Test Zinc-IPMP|Overall Study||44||
48527804|NCT02856880|101628232|FG000|Received Test Zinc Non-IPMP|Overall Study||44||
48527805|NCT02856880|101628232|FG000|Received Positive Control|Overall Study||45||
48527806|NCT02856880|101628232|FG000|Received Non-SLS Negative Control|Overall Study||44||
48527807|NCT02856880|101628232|FG000|Received SLS Negative Control|Overall Study||44||
48527808|NCT02856880|101628232|FG000|COMPLETED|Overall Study||44||
48527809|NCT02856880|101628232|FG000|NOT COMPLETED|Overall Study||1||
48527810|NCT03426566|101628233|FG000|STARTED|Overall Study||974||1948
48527811|NCT03426566|101628233|FG000|COMPLETED|Overall Study||974||1948
48527812|NCT03426566|101628233|FG000|NOT COMPLETED|Overall Study||0||0
48527813|NCT02737332|101628234|FG000|STARTED|Overall Study||29||
48527814|NCT02737332|101628235|FG001|STARTED|Overall Study||24||
48527815|NCT02737332|101628234|FG000|COMPLETED|Overall Study||28||
48527816|NCT02737332|101628235|FG001|COMPLETED|Overall Study||23||
48527817|NCT02737332|101628234|FG000|NOT COMPLETED|Overall Study||1||
48527818|NCT02737332|101628235|FG001|NOT COMPLETED|Overall Study||1||
48527819|NCT01412372|101628236|FG000|STARTED|Overall Study||30||
48527820|NCT01412372|101628237|FG001|STARTED|Overall Study||31||
48527821|NCT01412372|101628236|FG000|COMPLETED|Overall Study||26||
48527822|NCT01412372|101628237|FG001|COMPLETED|Overall Study||28||
48527823|NCT01412372|101628236|FG000|NOT COMPLETED|Overall Study||4||
48527824|NCT01412372|101628237|FG001|NOT COMPLETED|Overall Study||3||
48527825|NCT00929331|101628238|FG000|STARTED|Overall Study||55||
48527826|NCT00929331|101628239|FG001|STARTED|Overall Study||55||
48527827|NCT00929331|101628238|FG000|COMPLETED|Overall Study||55||
48527828|NCT00929331|101628239|FG001|COMPLETED|Overall Study||55||
48527829|NCT00929331|101628238|FG000|NOT COMPLETED|Overall Study||0||
48527830|NCT00929331|101628239|FG001|NOT COMPLETED|Overall Study||0||
48527831|NCT04188301|101628240|FG000|STARTED|Baseline||52||
48527832|NCT04188301|101628241|FG001|STARTED|Baseline||51||
48527833|NCT04188301|101628242|FG002|STARTED|Baseline||51||
48527834|NCT04188301|101628240|FG000|COMPLETED|Baseline||52||
48527835|NCT04188301|101628241|FG001|COMPLETED|Baseline||51||
48527836|NCT04188301|101628242|FG002|COMPLETED|Baseline||51||
48527837|NCT04188301|101628240|FG000|NOT COMPLETED|Baseline||0||
48527838|NCT04188301|101628241|FG001|NOT COMPLETED|Baseline||0||
48527839|NCT04188301|101628242|FG002|NOT COMPLETED|Baseline||0||
48527840|NCT04188301|101628240|FG000|STARTED|Month 3||52||
48527841|NCT04188301|101628241|FG001|STARTED|Month 3||51||
48527842|NCT04188301|101628242|FG002|STARTED|Month 3||51||
48527843|NCT04188301|101628240|FG000|COMPLETED|Month 3||52||
48527844|NCT04188301|101628241|FG001|COMPLETED|Month 3||51||
48527845|NCT04188301|101628242|FG002|COMPLETED|Month 3||50||
48527846|NCT04188301|101628240|FG000|NOT COMPLETED|Month 3||0||
48527847|NCT04188301|101628241|FG001|NOT COMPLETED|Month 3||0||
48228305|NCT02326220|100880651|FG002|NOT COMPLETED|Open-label Treatment Period||2||
48228306|NCT01634165|100880652|FG000|STARTED|Period 1||6||
48228307|NCT01634165|100880653|FG001|STARTED|Period 1||6||
48228308|NCT01634165|100880654|FG002|STARTED|Period 1||6||
48228309|NCT01634165|100880655|FG003|STARTED|Period 1||6||
48228310|NCT01634165|100880652|FG000|Received at Least 1 Dose of Study Drug|Period 1||6||
48228311|NCT01634165|100880653|FG001|Received at Least 1 Dose of Study Drug|Period 1||6||
48228312|NCT01634165|100880654|FG002|Received at Least 1 Dose of Study Drug|Period 1||6||
48228313|NCT01634165|100880655|FG003|Received at Least 1 Dose of Study Drug|Period 1||6||
48228314|NCT01634165|100880652|FG000|COMPLETED|Period 1||6||
48228315|NCT01634165|100880653|FG001|COMPLETED|Period 1||6||
48228316|NCT01634165|100880654|FG002|COMPLETED|Period 1||6||
48228317|NCT01634165|100880655|FG003|COMPLETED|Period 1||6||
48228318|NCT01634165|100880652|FG000|NOT COMPLETED|Period 1||0||
48527848|NCT04188301|101628242|FG002|NOT COMPLETED|Month 3||1||
48527849|NCT04188301|101628240|FG000|STARTED|Month 12||52||
48527850|NCT04188301|101628241|FG001|STARTED|Month 12||51||
48527851|NCT04188301|101628242|FG002|STARTED|Month 12||50||
48527852|NCT04188301|101628240|FG000|COMPLETED|Month 12||51||
48527853|NCT04188301|101628241|FG001|COMPLETED|Month 12||50||
48527854|NCT04188301|101628242|FG002|COMPLETED|Month 12||48||
48527855|NCT04188301|101628240|FG000|NOT COMPLETED|Month 12||1||
48527856|NCT04188301|101628241|FG001|NOT COMPLETED|Month 12||1||
48228319|NCT01634165|100880653|FG001|NOT COMPLETED|Period 1||0||
48228320|NCT01634165|100880654|FG002|NOT COMPLETED|Period 1||0||
48228321|NCT01634165|100880655|FG003|NOT COMPLETED|Period 1||0||
48228322|NCT01634165|100880652|FG000|STARTED|Period 2||6||
48228323|NCT01634165|100880653|FG001|STARTED|Period 2||6||
48228324|NCT01634165|100880654|FG002|STARTED|Period 2||6||
48228325|NCT01634165|100880655|FG003|STARTED|Period 2||6||
48228326|NCT01634165|100880652|FG000|COMPLETED|Period 2||6||
48228327|NCT01634165|100880653|FG001|COMPLETED|Period 2||5||
48228328|NCT01634165|100880654|FG002|COMPLETED|Period 2||6||
48228329|NCT01634165|100880655|FG003|COMPLETED|Period 2||6||
48228330|NCT01634165|100880652|FG000|NOT COMPLETED|Period 2||0||
48228331|NCT01634165|100880653|FG001|NOT COMPLETED|Period 2||1||
48228332|NCT01634165|100880654|FG002|NOT COMPLETED|Period 2||0||
48228333|NCT01634165|100880655|FG003|NOT COMPLETED|Period 2||0||
48228334|NCT01634165|100880652|FG000|STARTED|Period 3||6||
48228335|NCT01634165|100880653|FG001|STARTED|Period 3||5||
48228336|NCT01634165|100880654|FG002|STARTED|Period 3||6||
48228337|NCT01634165|100880655|FG003|STARTED|Period 3||6||
48228338|NCT01634165|100880652|FG000|COMPLETED|Period 3||6||
48228339|NCT01634165|100880653|FG001|COMPLETED|Period 3||5||
48228340|NCT01634165|100880654|FG002|COMPLETED|Period 3||6||
48228341|NCT01634165|100880655|FG003|COMPLETED|Period 3||6||
48228342|NCT01634165|100880652|FG000|NOT COMPLETED|Period 3||0||
48228343|NCT01634165|100880653|FG001|NOT COMPLETED|Period 3||0||
48228344|NCT01634165|100880654|FG002|NOT COMPLETED|Period 3||0||
48228345|NCT01634165|100880655|FG003|NOT COMPLETED|Period 3||0||
48228346|NCT01634165|100880652|FG000|STARTED|Period 4||6||
48228347|NCT01634165|100880653|FG001|STARTED|Period 4||5||
48527857|NCT04188301|101628242|FG002|NOT COMPLETED|Month 12||2||
48527858|NCT04188301|101628240|FG000|STARTED|Month 18||51||
48527859|NCT04188301|101628241|FG001|STARTED|Month 18||50||
48527860|NCT04188301|101628242|FG002|STARTED|Month 18||48||
48527861|NCT04188301|101628240|FG000|COMPLETED|Month 18||45||
48527862|NCT04188301|101628241|FG001|COMPLETED|Month 18||50||
48527863|NCT04188301|101628242|FG002|COMPLETED|Month 18||48||
48527864|NCT04188301|101628240|FG000|NOT COMPLETED|Month 18||6||
48527865|NCT04188301|101628241|FG001|NOT COMPLETED|Month 18||0||
48527866|NCT04188301|101628242|FG002|NOT COMPLETED|Month 18||0||
48527867|NCT05065983|101628243|FG000|STARTED|Overall Study||25||
48527868|NCT05065983|101628243|FG000|Exposed|Overall Study||25|Screened participants who received study vaccination.|
48527869|NCT05065983|101628243|FG000|Safety|Overall Study||25|Participants who received study vaccination and provided safety assessment data.|
48527870|NCT05065983|101628243|FG000|mITT|Overall Study||25|Modified Intent-to-treat Population = All participants who were vaccinated and had at least one post injection anti-CHIKV SNA NT80 result.|
48527871|NCT05065983|101628243|FG000|COMPLETED|Overall Study||23||
48527872|NCT05065983|101628243|FG000|NOT COMPLETED|Overall Study||2||
48527873|NCT03365011|101628244|FG000|STARTED|Overall Study||20||
48527874|NCT03365011|101628245|FG001|STARTED|Overall Study||20||
48527875|NCT03365011|101628244|FG000|COMPLETED|Overall Study||19||
48527876|NCT03365011|101628245|FG001|COMPLETED|Overall Study||18||
48527877|NCT03365011|101628244|FG000|NOT COMPLETED|Overall Study||1||
48527878|NCT03365011|101628245|FG001|NOT COMPLETED|Overall Study||2||
48228348|NCT01634165|100880654|FG002|STARTED|Period 4||6||
48228349|NCT01634165|100880655|FG003|STARTED|Period 4||6||
48228350|NCT01634165|100880652|FG000|COMPLETED|Period 4||6||
48228351|NCT01634165|100880653|FG001|COMPLETED|Period 4||5||
48228352|NCT01634165|100880654|FG002|COMPLETED|Period 4||6||
48228353|NCT01634165|100880655|FG003|COMPLETED|Period 4||6||
48228354|NCT01634165|100880652|FG000|NOT COMPLETED|Period 4||0||
48228355|NCT01634165|100880653|FG001|NOT COMPLETED|Period 4||0||
48228356|NCT01634165|100880654|FG002|NOT COMPLETED|Period 4||0||
48228357|NCT01634165|100880655|FG003|NOT COMPLETED|Period 4||0||
48228358|NCT02455557|100880656|FG000|STARTED|Overall Study||66||
48228359|NCT02455557|100880656|FG000|COMPLETED|Overall Study||64||
48228360|NCT02455557|100880656|FG000|NOT COMPLETED|Overall Study||2||
48228361|NCT03938272|100880657|FG000|STARTED|Overall Study||11||
48228362|NCT03938272|100880658|FG001|STARTED|Overall Study||11||
48228363|NCT03938272|100880657|FG000|COMPLETED|Overall Study||0||
48228364|NCT03938272|100880658|FG001|COMPLETED|Overall Study||1||
48228365|NCT03938272|100880657|FG000|NOT COMPLETED|Overall Study||11||
48228366|NCT03938272|100880658|FG001|NOT COMPLETED|Overall Study||10||
48228367|NCT01840722|100880659|FG000|STARTED|Overall Study||201||
48228368|NCT01840722|100880660|FG001|STARTED|Overall Study||199||
48228369|NCT01840722|100880659|FG000|COMPLETED|Overall Study||201||
48228370|NCT01840722|100880660|FG001|COMPLETED|Overall Study||130||
48228371|NCT01840722|100880659|FG000|NOT COMPLETED|Overall Study||0||
48228372|NCT01840722|100880660|FG001|NOT COMPLETED|Overall Study||69||
48228373|NCT03292406|100880661|FG000|STARTED|Overall Study||30|Participants Randomized|
48228374|NCT03292406|100880662|FG001|STARTED|Overall Study||28|Participants Randomized|
48228375|NCT03292406|100880663|FG002|STARTED|Overall Study||28|Participants Randomized|
48228376|NCT03292406|100880661|FG000|Participants Treated|Overall Study||30||
48228377|NCT03292406|100880662|FG001|Participants Treated|Overall Study||28||
48228378|NCT03292406|100880663|FG002|Participants Treated|Overall Study||27||
48228379|NCT03292406|100880661|FG000|COMPLETED|Overall Study||17||
48228380|NCT03292406|100880662|FG001|COMPLETED|Overall Study||15||
48228381|NCT03292406|100880663|FG002|COMPLETED|Overall Study||15||
48228382|NCT03292406|100880661|FG000|NOT COMPLETED|Overall Study||13||
48228383|NCT03292406|100880662|FG001|NOT COMPLETED|Overall Study||13||
48228384|NCT03292406|100880663|FG002|NOT COMPLETED|Overall Study||13||
48228385|NCT00553332|100880664|FG000|STARTED|Overall Study||29||
48228386|NCT00553332|100880664|FG000|COMPLETED|Overall Study||28||
48228387|NCT00553332|100880664|FG000|NOT COMPLETED|Overall Study||1||
48228388|NCT00343083|100880665|FG000|STARTED|Overall Study||43||
48228389|NCT00343083|100880665|FG000|COMPLETED|Overall Study||22||
48228390|NCT00343083|100880665|FG000|NOT COMPLETED|Overall Study||21||
48228391|NCT02978183|100880666|FG000|STARTED|Overall Study||34||
48228392|NCT02978183|100880667|FG001|STARTED|Overall Study||36||
48527879|NCT04132336|101628246|FG000|STARTED|Overall Study||32||
48527880|NCT04132336|101628247|FG001|STARTED|Overall Study||32||
48527881|NCT04132336|101628248|FG002|STARTED|Overall Study||32||
48527882|NCT04132336|101628249|FG003|STARTED|Overall Study||32||
48527883|NCT04132336|101628250|FG004|STARTED|Overall Study||32||
48527884|NCT04132336|101628251|FG005|STARTED|Overall Study||16||
48527885|NCT04132336|101628252|FG006|STARTED|Overall Study||17||
48527886|NCT04132336|101628246|FG000|COMPLETED|Overall Study||32||
48527887|NCT04132336|101628247|FG001|COMPLETED|Overall Study||31||
48228393|NCT02978183|100880666|FG000|COMPLETED|Overall Study||34||
48228394|NCT02978183|100880667|FG001|COMPLETED|Overall Study||36||
48228395|NCT02978183|100880666|FG000|NOT COMPLETED|Overall Study||0||
48228396|NCT02978183|100880667|FG001|NOT COMPLETED|Overall Study||0||
48228397|NCT01240590|100880668|FG000|STARTED|Phase I||0||
48527888|NCT04132336|101628248|FG002|COMPLETED|Overall Study||32||
48527889|NCT04132336|101628249|FG003|COMPLETED|Overall Study||32||
48228398|NCT01240590|100880669|FG001|STARTED|Phase I||6||
48228399|NCT01240590|100880670|FG002|STARTED|Phase I||3||
48228400|NCT01240590|100880671|FG003|STARTED|Phase I||0||
48228401|NCT01240590|100880672|FG004|STARTED|Phase I||0||
48228402|NCT01240590|100880668|FG000|COMPLETED|Phase I||0||
48228403|NCT01240590|100880669|FG001|COMPLETED|Phase I||6||
48228404|NCT01240590|100880670|FG002|COMPLETED|Phase I||0||
48228405|NCT01240590|100880671|FG003|COMPLETED|Phase I||0||
48228406|NCT01240590|100880672|FG004|COMPLETED|Phase I||0||
48228407|NCT01240590|100880668|FG000|NOT COMPLETED|Phase I||0||
48527890|NCT04132336|101628250|FG004|COMPLETED|Overall Study||32||
48527891|NCT04132336|101628251|FG005|COMPLETED|Overall Study||16||
48527892|NCT04132336|101628252|FG006|COMPLETED|Overall Study||17||
48527893|NCT04132336|101628246|FG000|NOT COMPLETED|Overall Study||0||
48527894|NCT04132336|101628247|FG001|NOT COMPLETED|Overall Study||1||
48527895|NCT04132336|101628248|FG002|NOT COMPLETED|Overall Study||0||
48527896|NCT04132336|101628249|FG003|NOT COMPLETED|Overall Study||0||
48527897|NCT04132336|101628250|FG004|NOT COMPLETED|Overall Study||0||
48527898|NCT04132336|101628251|FG005|NOT COMPLETED|Overall Study||0||
48527899|NCT04132336|101628252|FG006|NOT COMPLETED|Overall Study||0||
48527900|NCT00986180|101628253|FG000|STARTED|Overall Study||321||
48527901|NCT00986180|101628254|FG001|STARTED|Overall Study||324||
48527902|NCT00986180|101628253|FG000|COMPLETED|Overall Study||277||
48527903|NCT00986180|101628254|FG001|COMPLETED|Overall Study||268||
48527904|NCT00986180|101628253|FG000|NOT COMPLETED|Overall Study||44||
48527905|NCT00986180|101628254|FG001|NOT COMPLETED|Overall Study||56||
48527906|NCT00573157|101628255|FG000|STARTED|Overall Study||4||
48527907|NCT00573157|101628256|FG001|STARTED|Overall Study||2||
48527908|NCT00573157|101628255|FG000|COMPLETED|Overall Study||0||
48527909|NCT00573157|101628256|FG001|COMPLETED|Overall Study||0||
48527910|NCT00573157|101628255|FG000|NOT COMPLETED|Overall Study||4||
48527911|NCT00573157|101628256|FG001|NOT COMPLETED|Overall Study||2||
48527912|NCT00270257|101628257|FG000|STARTED|Overall Study||623||
48228408|NCT01240590|100880669|FG001|NOT COMPLETED|Phase I||0||
48228409|NCT01240590|100880670|FG002|NOT COMPLETED|Phase I||3||
48228410|NCT01240590|100880671|FG003|NOT COMPLETED|Phase I||0||
48228411|NCT01240590|100880672|FG004|NOT COMPLETED|Phase I||0||
48228412|NCT01240590|100880668|FG000|STARTED|Phase II||0||
48228413|NCT01240590|100880669|FG001|STARTED|Phase II||0||
48228414|NCT01240590|100880670|FG002|STARTED|Phase II||0||
48228415|NCT01240590|100880671|FG003|STARTED|Phase II||17||
48228416|NCT01240590|100880672|FG004|STARTED|Phase II||1||
48228417|NCT01240590|100880668|FG000|COMPLETED|Phase II||0||
48228418|NCT01240590|100880669|FG001|COMPLETED|Phase II||0||
48228419|NCT01240590|100880670|FG002|COMPLETED|Phase II||0||
48228420|NCT01240590|100880671|FG003|COMPLETED|Phase II||15||
48228421|NCT01240590|100880672|FG004|COMPLETED|Phase II||0||
48228422|NCT01240590|100880668|FG000|NOT COMPLETED|Phase II||0||
48228423|NCT01240590|100880669|FG001|NOT COMPLETED|Phase II||0||
48228424|NCT01240590|100880670|FG002|NOT COMPLETED|Phase II||0||
48228425|NCT01240590|100880671|FG003|NOT COMPLETED|Phase II||2||
48228426|NCT01240590|100880672|FG004|NOT COMPLETED|Phase II||1||
48228427|NCT00620854|100880673|FG000|STARTED|Period 1||4||
48228428|NCT00620854|100880674|FG001|STARTED|Period 1||4||
48228429|NCT00620854|100880675|FG002|STARTED|Period 1||4||
48228430|NCT00620854|100880676|FG003|STARTED|Period 1||4||
48228431|NCT00620854|100880677|FG004|STARTED|Period 1||4||
48228432|NCT00620854|100880678|FG005|STARTED|Period 1||4||
48228433|NCT00620854|100880673|FG000|COMPLETED|Period 1||4||
48228434|NCT00620854|100880674|FG001|COMPLETED|Period 1||4||
48228435|NCT00620854|100880675|FG002|COMPLETED|Period 1||4||
48228436|NCT00620854|100880676|FG003|COMPLETED|Period 1||4||
48228437|NCT00620854|100880677|FG004|COMPLETED|Period 1||4||
48228438|NCT00620854|100880678|FG005|COMPLETED|Period 1||4||
48228439|NCT00620854|100880673|FG000|NOT COMPLETED|Period 1||0||
48228440|NCT00620854|100880674|FG001|NOT COMPLETED|Period 1||0||
48228441|NCT00620854|100880675|FG002|NOT COMPLETED|Period 1||0||
48228442|NCT00620854|100880676|FG003|NOT COMPLETED|Period 1||0||
48228443|NCT00620854|100880677|FG004|NOT COMPLETED|Period 1||0||
48228444|NCT00620854|100880678|FG005|NOT COMPLETED|Period 1||0||
48527913|NCT00270257|101628258|FG001|STARTED|Overall Study||628||
48527914|NCT00270257|101628257|FG000|Week 8|Overall Study||510||
48228445|NCT00620854|100880673|FG000|STARTED|Washout 1||4||
48228446|NCT00620854|100880674|FG001|STARTED|Washout 1||4||
48228447|NCT00620854|100880675|FG002|STARTED|Washout 1||4||
48228448|NCT00620854|100880676|FG003|STARTED|Washout 1||4||
48228449|NCT00620854|100880677|FG004|STARTED|Washout 1||4||
48228450|NCT00620854|100880678|FG005|STARTED|Washout 1||4||
48228451|NCT00620854|100880673|FG000|COMPLETED|Washout 1||4||
48228452|NCT00620854|100880674|FG001|COMPLETED|Washout 1||4||
48228453|NCT00620854|100880675|FG002|COMPLETED|Washout 1||3||
48228454|NCT00620854|100880676|FG003|COMPLETED|Washout 1||3||
48527915|NCT00270257|101628258|FG001|Week 8|Overall Study||443||
48527916|NCT00270257|101628257|FG000|Week 26|Overall Study||460||
48527917|NCT00270257|101628258|FG001|Week 26|Overall Study||440||
48228455|NCT00620854|100880677|FG004|COMPLETED|Washout 1||4||
48228456|NCT00620854|100880678|FG005|COMPLETED|Washout 1||4||
48228457|NCT00620854|100880673|FG000|NOT COMPLETED|Washout 1||0||
48228458|NCT00620854|100880674|FG001|NOT COMPLETED|Washout 1||0||
48228459|NCT00620854|100880675|FG002|NOT COMPLETED|Washout 1||1||
48228460|NCT00620854|100880676|FG003|NOT COMPLETED|Washout 1||1||
48228461|NCT00620854|100880677|FG004|NOT COMPLETED|Washout 1||0||
48228462|NCT00620854|100880678|FG005|NOT COMPLETED|Washout 1||0||
48228463|NCT00620854|100880673|FG000|STARTED|Period 2||4||
48228464|NCT00620854|100880674|FG001|STARTED|Period 2||4||
48228465|NCT00620854|100880675|FG002|STARTED|Period 2||3||
48527918|NCT00270257|101628257|FG000|Week 52|Overall Study||362||
48527919|NCT00270257|101628258|FG001|Week 52|Overall Study||340||
48527920|NCT00270257|101628257|FG000|Week 78|Overall Study||283||
48228466|NCT00620854|100880676|FG003|STARTED|Period 2||3||
48228467|NCT00620854|100880677|FG004|STARTED|Period 2||4||
48228468|NCT00620854|100880678|FG005|STARTED|Period 2||4||
48228469|NCT00620854|100880673|FG000|COMPLETED|Period 2||4||
48228470|NCT00620854|100880674|FG001|COMPLETED|Period 2||4||
48228471|NCT00620854|100880675|FG002|COMPLETED|Period 2||3||
48228472|NCT00620854|100880676|FG003|COMPLETED|Period 2||3||
48228473|NCT00620854|100880677|FG004|COMPLETED|Period 2||4||
48228474|NCT00620854|100880678|FG005|COMPLETED|Period 2||4||
48527921|NCT00270257|101628258|FG001|Week 78|Overall Study||285||
48527922|NCT00270257|101628257|FG000|Visit 104|Overall Study||211||
48527923|NCT00270257|101628258|FG001|Visit 104|Overall Study||204||
48527924|NCT00270257|101628257|FG000|COMPLETED|Overall Study||211||
48527925|NCT00270257|101628258|FG001|COMPLETED|Overall Study||204||
48527926|NCT00270257|101628257|FG000|NOT COMPLETED|Overall Study||412||
48527927|NCT00270257|101628258|FG001|NOT COMPLETED|Overall Study||424||
48527928|NCT01507155|101628259|FG000|STARTED|Overall Study||625||
48527929|NCT01507155|101628260|FG001|STARTED|Overall Study||60||
48527930|NCT01507155|101628259|FG000|COMPLETED|Overall Study||625||
48527931|NCT01507155|101628260|FG001|COMPLETED|Overall Study||60||
48527932|NCT01507155|101628259|FG000|NOT COMPLETED|Overall Study||0||
48527933|NCT01507155|101628260|FG001|NOT COMPLETED|Overall Study||0||
48527934|NCT01387581|101628261|FG000|STARTED|Overall Study||108||
48527935|NCT01387581|101628262|FG001|STARTED|Overall Study||107||
48527936|NCT01387581|101628263|FG002|STARTED|Overall Study||12||
48527937|NCT01387581|101628261|FG000|COMPLETED|Overall Study||101||
48527938|NCT01387581|101628262|FG001|COMPLETED|Overall Study||101||
48527939|NCT01387581|101628263|FG002|COMPLETED|Overall Study||9||
48527940|NCT01387581|101628261|FG000|NOT COMPLETED|Overall Study||7||
48527941|NCT01387581|101628262|FG001|NOT COMPLETED|Overall Study||6||
48527942|NCT01387581|101628263|FG002|NOT COMPLETED|Overall Study||3||
48527943|NCT03039179|101628264|FG000|STARTED|Overall Study||38||
48527944|NCT03039179|101628265|FG001|STARTED|Overall Study||42||
48527945|NCT03039179|101628264|FG000|COMPLETED|Overall Study||38||
48527946|NCT03039179|101628265|FG001|COMPLETED|Overall Study||42||
48527947|NCT03039179|101628264|FG000|NOT COMPLETED|Overall Study||0||
48527948|NCT03039179|101628265|FG001|NOT COMPLETED|Overall Study||0||
48527949|NCT00276549|101628266|FG000|STARTED|Overall Study||35||
48527950|NCT00276549|101628266|FG000|COMPLETED|Overall Study||35||
48527951|NCT00276549|101628266|FG000|NOT COMPLETED|Overall Study||0||
48527952|NCT01418482|101628267|FG000|STARTED|Overall Study||15||
48527953|NCT01418482|101628267|FG000|COMPLETED|Overall Study||15||
48527954|NCT01418482|101628267|FG000|NOT COMPLETED|Overall Study||0||
48228475|NCT00620854|100880673|FG000|NOT COMPLETED|Period 2||0||
48228476|NCT00620854|100880674|FG001|NOT COMPLETED|Period 2||0||
48228477|NCT00620854|100880675|FG002|NOT COMPLETED|Period 2||0||
48228478|NCT00620854|100880676|FG003|NOT COMPLETED|Period 2||0||
48228479|NCT00620854|100880677|FG004|NOT COMPLETED|Period 2||0||
48228480|NCT00620854|100880678|FG005|NOT COMPLETED|Period 2||0||
48228481|NCT00620854|100880673|FG000|STARTED|Washout 2||4||
48228482|NCT00620854|100880674|FG001|STARTED|Washout 2||4||
48228483|NCT00620854|100880675|FG002|STARTED|Washout 2||3||
48228484|NCT00620854|100880676|FG003|STARTED|Washout 2||3||
48228485|NCT00620854|100880677|FG004|STARTED|Washout 2||4||
48228486|NCT00620854|100880678|FG005|STARTED|Washout 2||4||
48228487|NCT00620854|100880673|FG000|COMPLETED|Washout 2||4||
48228488|NCT00620854|100880674|FG001|COMPLETED|Washout 2||4||
48228489|NCT00620854|100880675|FG002|COMPLETED|Washout 2||3||
48527955|NCT02876575|101628268|FG000|STARTED|Overall Study||48||
48527956|NCT02876575|101628268|FG000|COMPLETED|Overall Study||48||
48527957|NCT02876575|101628268|FG000|NOT COMPLETED|Overall Study||0||
48527958|NCT01394952|101628269|FG000|STARTED|Overall Study||4952||
48527959|NCT01394952|101628270|FG001|STARTED|Overall Study||4949||
48527960|NCT01394952|101628269|FG000|Received at Least One Dose of Study Drug|Overall Study||4949||
48527961|NCT01394952|101628270|FG001|Received at Least One Dose of Study Drug|Overall Study||4943||
48527962|NCT01394952|101628269|FG000|COMPLETED|Overall Study||4935||
48527963|NCT01394952|101628270|FG001|COMPLETED|Overall Study||4932||
48228490|NCT00620854|100880676|FG003|COMPLETED|Washout 2||3||
48228491|NCT00620854|100880677|FG004|COMPLETED|Washout 2||4||
48228492|NCT00620854|100880678|FG005|COMPLETED|Washout 2||4||
48228493|NCT00620854|100880673|FG000|NOT COMPLETED|Washout 2||0||
48228494|NCT00620854|100880674|FG001|NOT COMPLETED|Washout 2||0||
48228495|NCT00620854|100880675|FG002|NOT COMPLETED|Washout 2||0||
48228496|NCT00620854|100880676|FG003|NOT COMPLETED|Washout 2||0||
48527964|NCT01394952|101628269|FG000|NOT COMPLETED|Overall Study||17||
48527965|NCT01394952|101628270|FG001|NOT COMPLETED|Overall Study||17||
48527966|NCT00771745|101628271|FG000|STARTED|Overall Study||6||
48527967|NCT00771745|101628272|FG001|STARTED|Overall Study||5||
48527968|NCT00771745|101628271|FG000|COMPLETED|Overall Study||6||
48527969|NCT00771745|101628272|FG001|COMPLETED|Overall Study||5||
48527970|NCT00771745|101628271|FG000|NOT COMPLETED|Overall Study||0||
48527971|NCT00771745|101628272|FG001|NOT COMPLETED|Overall Study||0||
48228497|NCT00620854|100880677|FG004|NOT COMPLETED|Washout 2||0||
48228498|NCT00620854|100880678|FG005|NOT COMPLETED|Washout 2||0||
48228499|NCT00620854|100880673|FG000|STARTED|Period 3||4||
48228500|NCT00620854|100880674|FG001|STARTED|Period 3||4||
48228501|NCT00620854|100880675|FG002|STARTED|Period 3||3||
48228502|NCT00620854|100880676|FG003|STARTED|Period 3||3||
48228503|NCT00620854|100880677|FG004|STARTED|Period 3||4||
48228504|NCT00620854|100880678|FG005|STARTED|Period 3||4||
48527972|NCT01158573|101628273|FG000|STARTED|Overall Study||30||
48527973|NCT01158573|101628274|FG001|STARTED|Overall Study||30||
48527974|NCT01158573|101628275|FG002|STARTED|Overall Study||29||
48527975|NCT01158573|101628276|FG003|STARTED|Overall Study||28||
48527976|NCT01158573|101628273|FG000|COMPLETED|Overall Study||30||
48527977|NCT01158573|101628274|FG001|COMPLETED|Overall Study||30||
48527978|NCT01158573|101628275|FG002|COMPLETED|Overall Study||29||
48527979|NCT01158573|101628276|FG003|COMPLETED|Overall Study||28||
48527980|NCT01158573|101628273|FG000|NOT COMPLETED|Overall Study||0||
48527981|NCT01158573|101628274|FG001|NOT COMPLETED|Overall Study||0||
48527982|NCT01158573|101628275|FG002|NOT COMPLETED|Overall Study||0||
48527983|NCT01158573|101628276|FG003|NOT COMPLETED|Overall Study||0||
48527984|NCT00118131|101628277|FG000|STARTED|Overall Study||49||
48527985|NCT00118131|101628277|FG000|COMPLETED|Overall Study||49||
48527986|NCT00118131|101628277|FG000|NOT COMPLETED|Overall Study||0||
48527987|NCT01338649|101628278|FG000|STARTED|Overall Study||13||
48527988|NCT01338649|101628279|FG001|STARTED|Overall Study||14||
48527989|NCT01338649|101628278|FG000|COMPLETED|Overall Study||13||
48527990|NCT01338649|101628279|FG001|COMPLETED|Overall Study||14||
48527991|NCT01338649|101628278|FG000|NOT COMPLETED|Overall Study||0||
48527992|NCT01338649|101628279|FG001|NOT COMPLETED|Overall Study||0||
48527993|NCT04870138|101628280|FG000|STARTED|Overall Study||5||
48527994|NCT04870138|101628281|FG001|STARTED|Overall Study||5||
48527995|NCT04870138|101628282|FG002|STARTED|Overall Study||6||
48527996|NCT04870138|101628280|FG000|COMPLETED|Overall Study||5||
48527997|NCT04870138|101628281|FG001|COMPLETED|Overall Study||5||
48527998|NCT04870138|101628282|FG002|COMPLETED|Overall Study||6||
48527999|NCT04870138|101628280|FG000|NOT COMPLETED|Overall Study||0||
48528000|NCT04870138|101628281|FG001|NOT COMPLETED|Overall Study||0||
48528001|NCT04870138|101628282|FG002|NOT COMPLETED|Overall Study||0||
48528002|NCT01570283|101628283|FG000|STARTED|Cohort 1: Dose Level 1||1||
48528003|NCT01570283|101628284|FG001|STARTED|Cohort 1: Dose Level 1||3||
48228505|NCT00620854|100880673|FG000|COMPLETED|Period 3||4||
48528004|NCT01570283|101628285|FG002|STARTED|Cohort 1: Dose Level 1||0||
48528005|NCT01570283|101628286|FG003|STARTED|Cohort 1: Dose Level 1||0||
48528006|NCT01570283|101628287|FG004|STARTED|Cohort 1: Dose Level 1||0||
48528007|NCT01570283|101628288|FG005|STARTED|Cohort 1: Dose Level 1||0||
48528008|NCT01570283|101628283|FG000|COMPLETED|Cohort 1: Dose Level 1||1||
48528009|NCT01570283|101628284|FG001|COMPLETED|Cohort 1: Dose Level 1||1||
48528010|NCT01570283|101628285|FG002|COMPLETED|Cohort 1: Dose Level 1||0||
48528011|NCT01570283|101628286|FG003|COMPLETED|Cohort 1: Dose Level 1||0||
48528012|NCT01570283|101628287|FG004|COMPLETED|Cohort 1: Dose Level 1||0||
48528013|NCT01570283|101628288|FG005|COMPLETED|Cohort 1: Dose Level 1||0||
48528014|NCT01570283|101628283|FG000|NOT COMPLETED|Cohort 1: Dose Level 1||0||
48528015|NCT01570283|101628284|FG001|NOT COMPLETED|Cohort 1: Dose Level 1||2||
48528016|NCT01570283|101628285|FG002|NOT COMPLETED|Cohort 1: Dose Level 1||0||
48528017|NCT01570283|101628286|FG003|NOT COMPLETED|Cohort 1: Dose Level 1||0||
48528018|NCT01570283|101628287|FG004|NOT COMPLETED|Cohort 1: Dose Level 1||0||
48528019|NCT01570283|101628288|FG005|NOT COMPLETED|Cohort 1: Dose Level 1||0||
48528020|NCT01570283|101628283|FG000|STARTED|Cohort 2: Dose Level 2||0||
48528021|NCT01570283|101628284|FG001|STARTED|Cohort 2: Dose Level 2||0||
48528022|NCT01570283|101628285|FG002|STARTED|Cohort 2: Dose Level 2||2||
48528023|NCT01570283|101628286|FG003|STARTED|Cohort 2: Dose Level 2||2||
48528024|NCT01570283|101628287|FG004|STARTED|Cohort 2: Dose Level 2||0||
48528025|NCT01570283|101628288|FG005|STARTED|Cohort 2: Dose Level 2||0||
48228506|NCT00620854|100880674|FG001|COMPLETED|Period 3||4||
48528026|NCT01570283|101628283|FG000|COMPLETED|Cohort 2: Dose Level 2||0||
48528027|NCT01570283|101628284|FG001|COMPLETED|Cohort 2: Dose Level 2||0||
48528028|NCT01570283|101628285|FG002|COMPLETED|Cohort 2: Dose Level 2||1||
48528029|NCT01570283|101628286|FG003|COMPLETED|Cohort 2: Dose Level 2||1||
48528030|NCT01570283|101628287|FG004|COMPLETED|Cohort 2: Dose Level 2||0||
48528031|NCT01570283|101628288|FG005|COMPLETED|Cohort 2: Dose Level 2||0||
48528032|NCT01570283|101628283|FG000|NOT COMPLETED|Cohort 2: Dose Level 2||0||
48528033|NCT01570283|101628284|FG001|NOT COMPLETED|Cohort 2: Dose Level 2||0||
48528034|NCT01570283|101628285|FG002|NOT COMPLETED|Cohort 2: Dose Level 2||1||
48528035|NCT01570283|101628286|FG003|NOT COMPLETED|Cohort 2: Dose Level 2||1||
48228507|NCT00620854|100880675|FG002|COMPLETED|Period 3||3||
48228508|NCT00620854|100880676|FG003|COMPLETED|Period 3||3||
48528036|NCT01570283|101628287|FG004|NOT COMPLETED|Cohort 2: Dose Level 2||0||
48228509|NCT00620854|100880677|FG004|COMPLETED|Period 3||4||
48228510|NCT00620854|100880678|FG005|COMPLETED|Period 3||4||
48528037|NCT01570283|101628288|FG005|NOT COMPLETED|Cohort 2: Dose Level 2||0||
48528038|NCT01570283|101628283|FG000|STARTED|Cohort 3: Dose Level 3||0||
48528039|NCT01570283|101628284|FG001|STARTED|Cohort 3: Dose Level 3||0||
48528040|NCT01570283|101628285|FG002|STARTED|Cohort 3: Dose Level 3||0||
48528041|NCT01570283|101628286|FG003|STARTED|Cohort 3: Dose Level 3||0||
48528042|NCT01570283|101628287|FG004|STARTED|Cohort 3: Dose Level 3||1||
48228511|NCT00620854|100880673|FG000|NOT COMPLETED|Period 3||0||
48228512|NCT00620854|100880674|FG001|NOT COMPLETED|Period 3||0||
48228513|NCT00620854|100880675|FG002|NOT COMPLETED|Period 3||0||
48228514|NCT00620854|100880676|FG003|NOT COMPLETED|Period 3||0||
48228515|NCT00620854|100880677|FG004|NOT COMPLETED|Period 3||0||
48228516|NCT00620854|100880678|FG005|NOT COMPLETED|Period 3||0||
48228517|NCT01885559|100880679|FG000|STARTED|Overall Study||242||
48228518|NCT01885559|100880680|FG001|STARTED|Overall Study||244||
48228519|NCT01885559|100880679|FG000|COMPLETED|Overall Study||218||
48228520|NCT01885559|100880680|FG001|COMPLETED|Overall Study||208||
48228521|NCT01885559|100880679|FG000|NOT COMPLETED|Overall Study||24||
48228522|NCT01885559|100880680|FG001|NOT COMPLETED|Overall Study||36||
48228523|NCT00513071|100880681|FG000|STARTED|Overall Study||28||
48228524|NCT00513071|100880681|FG000|COMPLETED|Overall Study||23||
48228525|NCT00513071|100880681|FG000|NOT COMPLETED|Overall Study||5||
48228526|NCT02759575|100880682|FG000|STARTED|Overall Study||9||
48228527|NCT02759575|100880682|FG000|COMPLETED|Overall Study||9||
48228528|NCT02759575|100880682|FG000|NOT COMPLETED|Overall Study||0||
48228529|NCT01542255|100880683|FG000|STARTED|Overall Study||7||
48228530|NCT01542255|100880683|FG000|Analyzed for Time to Progression|Overall Study||7||
48228531|NCT01542255|100880683|FG000|COMPLETED|Overall Study||7||
48228532|NCT01542255|100880683|FG000|NOT COMPLETED|Overall Study||0||
48228533|NCT01271244|100880684|FG000|STARTED|Overall Study||18||
48228534|NCT01271244|100880685|FG001|STARTED|Overall Study||8||
48228535|NCT01271244|100880684|FG000|COMPLETED|Overall Study||11||
48228536|NCT01271244|100880685|FG001|COMPLETED|Overall Study||5||
48228537|NCT01271244|100880684|FG000|NOT COMPLETED|Overall Study||7||
48228538|NCT01271244|100880685|FG001|NOT COMPLETED|Overall Study||3||
48228539|NCT03075878|100880686|FG000|STARTED|Overall Study||8||
48228540|NCT03075878|100880686|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8|Safety Population|
48228541|NCT03075878|100880686|FG000|COMPLETED|Overall Study||7||
48228542|NCT03075878|100880686|FG000|NOT COMPLETED|Overall Study||1||
48228543|NCT01409837|100880687|FG000|STARTED|Overall Study||17||
48528043|NCT01570283|101628288|FG005|STARTED|Cohort 3: Dose Level 3||12||
48528044|NCT01570283|101628283|FG000|COMPLETED|Cohort 3: Dose Level 3||0||
48528045|NCT01570283|101628284|FG001|COMPLETED|Cohort 3: Dose Level 3||0||
48528046|NCT01570283|101628285|FG002|COMPLETED|Cohort 3: Dose Level 3||0||
48528047|NCT01570283|101628286|FG003|COMPLETED|Cohort 3: Dose Level 3||0||
48528048|NCT01570283|101628287|FG004|COMPLETED|Cohort 3: Dose Level 3||1||
48528049|NCT01570283|101628288|FG005|COMPLETED|Cohort 3: Dose Level 3||10||
48228544|NCT01409837|100880688|FG001|STARTED|Overall Study||16||
48228545|NCT01409837|100880687|FG000|6th Week|Overall Study||17||
48228546|NCT01409837|100880688|FG001|6th Week|Overall Study||16||
48228547|NCT01409837|100880687|FG000|12th Week|Overall Study||16||
48228548|NCT01409837|100880688|FG001|12th Week|Overall Study||16||
48228549|NCT01409837|100880687|FG000|24th Week|Overall Study||16||
48228550|NCT01409837|100880688|FG001|24th Week|Overall Study||15||
48228551|NCT01409837|100880687|FG000|48th Week|Overall Study||15||
48228552|NCT01409837|100880688|FG001|48th Week|Overall Study||15||
48228553|NCT01409837|100880687|FG000|96th Week|Overall Study||15||
48228554|NCT01409837|100880688|FG001|96th Week|Overall Study||15||
48228555|NCT01409837|100880687|FG000|102nd Week|Overall Study||15||
48228556|NCT01409837|100880688|FG001|102nd Week|Overall Study||14||
48228557|NCT01409837|100880687|FG000|114th Week|Overall Study||15||
48228558|NCT01409837|100880688|FG001|114th Week|Overall Study||14||
48228559|NCT01409837|100880687|FG000|138th Week|Overall Study||15||
48228560|NCT01409837|100880688|FG001|138th Week|Overall Study||14||
48228561|NCT01409837|100880687|FG000|186th Week|Overall Study||14||
48528050|NCT01570283|101628283|FG000|NOT COMPLETED|Cohort 3: Dose Level 3||0||
48528051|NCT01570283|101628284|FG001|NOT COMPLETED|Cohort 3: Dose Level 3||0||
48528052|NCT01570283|101628285|FG002|NOT COMPLETED|Cohort 3: Dose Level 3||0||
48528053|NCT01570283|101628286|FG003|NOT COMPLETED|Cohort 3: Dose Level 3||0||
48528054|NCT01570283|101628287|FG004|NOT COMPLETED|Cohort 3: Dose Level 3||0||
48528055|NCT01570283|101628288|FG005|NOT COMPLETED|Cohort 3: Dose Level 3||2||
48528056|NCT02351544|101628289|FG000|STARTED|Overall Study||11||
48528057|NCT02351544|101628290|FG001|STARTED|Overall Study||33||
48528058|NCT02351544|101628289|FG000|COMPLETED|Overall Study||11||
48528059|NCT02351544|101628290|FG001|COMPLETED|Overall Study||33||
48228562|NCT01409837|100880688|FG001|186th Week|Overall Study||14||
48228563|NCT01409837|100880687|FG000|282nd Week|Overall Study||14||
48228564|NCT01409837|100880688|FG001|282nd Week|Overall Study||14||
48228565|NCT01409837|100880687|FG000|COMPLETED|Overall Study||14||
48228566|NCT01409837|100880688|FG001|COMPLETED|Overall Study||14||
48228567|NCT01409837|100880687|FG000|NOT COMPLETED|Overall Study||3||
48228568|NCT01409837|100880688|FG001|NOT COMPLETED|Overall Study||2||
48228569|NCT03547167|100880689|FG000|STARTED|Overall Study||1135||
48228570|NCT03547167|100880690|FG001|STARTED|Overall Study||380||
48528060|NCT02351544|101628289|FG000|NOT COMPLETED|Overall Study||0||
48528061|NCT02351544|101628290|FG001|NOT COMPLETED|Overall Study||0||
48528062|NCT00584844|101628291|FG000|STARTED|Overall Study||484||
48228571|NCT03547167|100880689|FG000|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||1133||
48228572|NCT03547167|100880690|FG001|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||379||
48528063|NCT00584844|101628291|FG000|COMPLETED|Overall Study||405||
48528064|NCT00584844|101628291|FG000|NOT COMPLETED|Overall Study||79||
48528065|NCT04493320|101628292|FG000|STARTED|Overall Study||2||
48528066|NCT04493320|101628293|FG001|STARTED|Overall Study||2||
48528067|NCT04493320|101628292|FG000|COMPLETED|Overall Study||1||
48528068|NCT04493320|101628293|FG001|COMPLETED|Overall Study||1||
48228573|NCT03547167|100880689|FG000|Vaccination 2 - (PNEUMOVAX™23, Month 6)|Overall Study||1035||
48228574|NCT03547167|100880690|FG001|Vaccination 2 - (PNEUMOVAX™23, Month 6)|Overall Study||346||
48228575|NCT03547167|100880689|FG000|COMPLETED|Overall Study||1038||
48228576|NCT03547167|100880690|FG001|COMPLETED|Overall Study||350||
48228577|NCT03547167|100880689|FG000|NOT COMPLETED|Overall Study||97||
48228578|NCT03547167|100880690|FG001|NOT COMPLETED|Overall Study||30||
48228579|NCT00403494|100880691|FG000|STARTED|Overall Study||96||
48228580|NCT00403494|100880692|FG001|STARTED|Overall Study||94||
48228581|NCT00403494|100880691|FG000|Intent to Treat|Overall Study||87|All subjects who were randomized, received 1 dose of study drug and had at least 1 post-baseline treadmill assessment,|
48228582|NCT00403494|100880692|FG001|Intent to Treat|Overall Study||83|All subjects who were randomized, received 1 dose of study drug and had at least 1 post-baseline treadmill assessment,|
48228583|NCT00403494|100880691|FG000|Per-protocol|Overall Study||69|The Per-protocol population will exclude subjects with major protocol deviations or noncompliance of study procedures. Including subjects that did not complete week 24 treadmill test, took less than 80% of the randomized study drug, and/or experienced any acute confounding events preventing them from taking proper treadmill tests.|
48228584|NCT00403494|100880692|FG001|Per-protocol|Overall Study||69|The Per-protocol population will exclude subjects with major protocol deviations or noncompliance of study procedures. Including subjects that did not complete week 24 treadmill test, took less than 80% of the randomized study drug, and/or experienced any acute confounding events preventing them from taking proper treadmill tests.|
48228585|NCT00403494|100880691|FG000|Safety Population|Overall Study||97|Of the 188 patients (96 randomized to study drug and 94 to placebo.) 2 subjects randomized to receive placebo, received at least 1 dose of study drug and were included in the study drug group. 1 participant from each group was excluded from the safety analysis because they did not have at least 1 post-Baseline safety assessment.|
48228586|NCT00403494|100880692|FG001|Safety Population|Overall Study||91|Of the 188 patients (96 randomized to study drug and 94 to placebo.) 2 subjects randomized to receive placebo, received at least 1 dose of study drug and were included in the study drug group. 1 participant from each group was excluded from the safety analysis because they did not have at least 1 post-Baseline safety assessment.|
48528069|NCT04493320|101628292|FG000|NOT COMPLETED|Overall Study||1||
48528070|NCT04493320|101628293|FG001|NOT COMPLETED|Overall Study||1||
48528071|NCT03456960|101628294|FG000|STARTED|Period 1 (1 Day)||12||
48528072|NCT03456960|101628295|FG001|STARTED|Period 1 (1 Day)||12||
48528073|NCT03456960|101628296|FG002|STARTED|Period 1 (1 Day)||120||
48528074|NCT03456960|101628297|FG003|STARTED|Period 1 (1 Day)||120||
48528075|NCT03456960|101628298|FG004|STARTED|Period 1 (1 Day)||6||
48528076|NCT03456960|101628299|FG005|STARTED|Period 1 (1 Day)||6||
48528077|NCT03456960|101628294|FG000|COMPLETED|Period 1 (1 Day)||12||
48528078|NCT03456960|101628295|FG001|COMPLETED|Period 1 (1 Day)||12||
48528079|NCT03456960|101628296|FG002|COMPLETED|Period 1 (1 Day)||120||
48528080|NCT03456960|101628297|FG003|COMPLETED|Period 1 (1 Day)||120||
48528081|NCT03456960|101628298|FG004|COMPLETED|Period 1 (1 Day)||6||
48528082|NCT03456960|101628299|FG005|COMPLETED|Period 1 (1 Day)||6||
48528083|NCT03456960|101628294|FG000|NOT COMPLETED|Period 1 (1 Day)||0||
48528084|NCT03456960|101628295|FG001|NOT COMPLETED|Period 1 (1 Day)||0||
48528085|NCT03456960|101628296|FG002|NOT COMPLETED|Period 1 (1 Day)||0||
48528086|NCT03456960|101628297|FG003|NOT COMPLETED|Period 1 (1 Day)||0||
48528087|NCT03456960|101628298|FG004|NOT COMPLETED|Period 1 (1 Day)||0||
48528088|NCT03456960|101628299|FG005|NOT COMPLETED|Period 1 (1 Day)||0||
48528089|NCT03456960|101628294|FG000|STARTED|Washout Period (at Least 14 Days)||12||
48528090|NCT03456960|101628295|FG001|STARTED|Washout Period (at Least 14 Days)||12||
48528091|NCT03456960|101628296|FG002|STARTED|Washout Period (at Least 14 Days)||120||
48528092|NCT03456960|101628297|FG003|STARTED|Washout Period (at Least 14 Days)||120||
48528093|NCT03456960|101628298|FG004|STARTED|Washout Period (at Least 14 Days)||6||
48528094|NCT03456960|101628299|FG005|STARTED|Washout Period (at Least 14 Days)||6||
48528095|NCT03456960|101628294|FG000|COMPLETED|Washout Period (at Least 14 Days)||12||
48528096|NCT03456960|101628295|FG001|COMPLETED|Washout Period (at Least 14 Days)||12||
48528097|NCT03456960|101628296|FG002|COMPLETED|Washout Period (at Least 14 Days)||119||
48528098|NCT03456960|101628297|FG003|COMPLETED|Washout Period (at Least 14 Days)||118||
48528099|NCT03456960|101628298|FG004|COMPLETED|Washout Period (at Least 14 Days)||6||
48528100|NCT03456960|101628299|FG005|COMPLETED|Washout Period (at Least 14 Days)||6||
48528101|NCT03456960|101628294|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48528102|NCT03456960|101628295|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48528103|NCT03456960|101628296|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||1||
48528104|NCT03456960|101628297|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||2||
48228587|NCT00403494|100880691|FG000|COMPLETED|Overall Study||81||
48228588|NCT00403494|100880692|FG001|COMPLETED|Overall Study||80||
48228589|NCT00403494|100880691|FG000|NOT COMPLETED|Overall Study||15||
48228590|NCT00403494|100880692|FG001|NOT COMPLETED|Overall Study||14||
48228591|NCT01138969|100880693|FG000|STARTED|Overall Study||83||
48228592|NCT01138969|100880694|FG001|STARTED|Overall Study||82||
48228593|NCT01138969|100880693|FG000|COMPLETED|Overall Study||83||
48528105|NCT03456960|101628298|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48528106|NCT03456960|101628299|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48528107|NCT03456960|101628294|FG000|STARTED|Period 2 (1 Day)||12||
48528108|NCT03456960|101628295|FG001|STARTED|Period 2 (1 Day)||12||
48528109|NCT03456960|101628296|FG002|STARTED|Period 2 (1 Day)||119||
48228594|NCT01138969|100880694|FG001|COMPLETED|Overall Study||82||
48228595|NCT01138969|100880693|FG000|NOT COMPLETED|Overall Study||0||
48228596|NCT01138969|100880694|FG001|NOT COMPLETED|Overall Study||0||
48228597|NCT02384382|100880695|FG000|STARTED|Overall Study||23||
48228598|NCT02384382|100880695|FG000|COMPLETED|Overall Study||0||
48228599|NCT02384382|100880695|FG000|NOT COMPLETED|Overall Study||23||
48228600|NCT01604824|100880696|FG000|STARTED|Double-blind (DB) Period||6||
48228601|NCT01604824|100880697|FG001|STARTED|Double-blind (DB) Period||7||
48228602|NCT01604824|100880698|FG002|STARTED|Double-blind (DB) Period||5||
48228603|NCT01604824|100880699|FG003|STARTED|Double-blind (DB) Period||5||
48228604|NCT01604824|100880700|FG004|STARTED|Double-blind (DB) Period||0||
48228605|NCT01604824|100880701|FG005|STARTED|Double-blind (DB) Period||0||
48228606|NCT01604824|100880696|FG000|Completed DB Period (Day 99)|Double-blind (DB) Period||6||
48528110|NCT03456960|101628297|FG003|STARTED|Period 2 (1 Day)||118||
48228607|NCT01604824|100880697|FG001|Completed DB Period (Day 99)|Double-blind (DB) Period||7||
48228608|NCT01604824|100880698|FG002|Completed DB Period (Day 99)|Double-blind (DB) Period||5||
48228609|NCT01604824|100880699|FG003|Completed DB Period (Day 99)|Double-blind (DB) Period||5||
48228610|NCT01604824|100880700|FG004|Completed DB Period (Day 99)|Double-blind (DB) Period||0||
48228611|NCT01604824|100880701|FG005|Completed DB Period (Day 99)|Double-blind (DB) Period||0||
48228612|NCT01604824|100880696|FG000|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||6||
48228613|NCT01604824|100880697|FG001|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||7||
48228614|NCT01604824|100880698|FG002|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||5||
48228615|NCT01604824|100880699|FG003|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||5||
48228616|NCT01604824|100880700|FG004|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||0||
48228617|NCT01604824|100880701|FG005|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||0||
48228618|NCT01604824|100880696|FG000|COMPLETED|Double-blind (DB) Period||6||
48228619|NCT01604824|100880697|FG001|COMPLETED|Double-blind (DB) Period||7||
48228620|NCT01604824|100880698|FG002|COMPLETED|Double-blind (DB) Period||5||
48228621|NCT01604824|100880699|FG003|COMPLETED|Double-blind (DB) Period||5||
48228622|NCT01604824|100880700|FG004|COMPLETED|Double-blind (DB) Period||0||
48228623|NCT01604824|100880701|FG005|COMPLETED|Double-blind (DB) Period||0||
48228624|NCT01604824|100880696|FG000|NOT COMPLETED|Double-blind (DB) Period||0||
48228625|NCT01604824|100880697|FG001|NOT COMPLETED|Double-blind (DB) Period||0||
48228626|NCT01604824|100880698|FG002|NOT COMPLETED|Double-blind (DB) Period||0||
48228627|NCT01604824|100880699|FG003|NOT COMPLETED|Double-blind (DB) Period||0||
48528111|NCT03456960|101628298|FG004|STARTED|Period 2 (1 Day)||6||
48528112|NCT03456960|101628299|FG005|STARTED|Period 2 (1 Day)||6||
48228628|NCT01604824|100880700|FG004|NOT COMPLETED|Double-blind (DB) Period||0||
48228629|NCT01604824|100880701|FG005|NOT COMPLETED|Double-blind (DB) Period||0||
48228630|NCT01604824|100880696|FG000|STARTED|Open-label Extension (OLE) Period||0||
48228631|NCT01604824|100880697|FG001|STARTED|Open-label Extension (OLE) Period||0||
48228632|NCT01604824|100880698|FG002|STARTED|Open-label Extension (OLE) Period||0||
48228633|NCT01604824|100880699|FG003|STARTED|Open-label Extension (OLE) Period||0||
48228634|NCT01604824|100880700|FG004|STARTED|Open-label Extension (OLE) Period||13||
48228635|NCT01604824|100880701|FG005|STARTED|Open-label Extension (OLE) Period||10||
48228636|NCT01604824|100880696|FG000|Started Open-label Extension Period|Open-label Extension (OLE) Period||0||
48228637|NCT01604824|100880697|FG001|Started Open-label Extension Period|Open-label Extension (OLE) Period||0||
48228638|NCT01604824|100880698|FG002|Started Open-label Extension Period|Open-label Extension (OLE) Period||0||
48228639|NCT01604824|100880699|FG003|Started Open-label Extension Period|Open-label Extension (OLE) Period||0||
48228640|NCT01604824|100880700|FG004|Started Open-label Extension Period|Open-label Extension (OLE) Period||11||
48228641|NCT01604824|100880701|FG005|Started Open-label Extension Period|Open-label Extension (OLE) Period||10||
48228642|NCT01604824|100880696|FG000|Completed Study|Open-label Extension (OLE) Period||0||
48228643|NCT01604824|100880697|FG001|Completed Study|Open-label Extension (OLE) Period||0||
48228644|NCT01604824|100880698|FG002|Completed Study|Open-label Extension (OLE) Period||0||
48228645|NCT01604824|100880699|FG003|Completed Study|Open-label Extension (OLE) Period||0||
48228646|NCT01604824|100880700|FG004|Completed Study|Open-label Extension (OLE) Period||10||
48228647|NCT01604824|100880701|FG005|Completed Study|Open-label Extension (OLE) Period||10||
48228648|NCT01604824|100880696|FG000|COMPLETED|Open-label Extension (OLE) Period||0||
48228649|NCT01604824|100880697|FG001|COMPLETED|Open-label Extension (OLE) Period||0||
48228650|NCT01604824|100880698|FG002|COMPLETED|Open-label Extension (OLE) Period||0||
48228651|NCT01604824|100880699|FG003|COMPLETED|Open-label Extension (OLE) Period||0||
48228652|NCT01604824|100880700|FG004|COMPLETED|Open-label Extension (OLE) Period||10||
48228653|NCT01604824|100880701|FG005|COMPLETED|Open-label Extension (OLE) Period||10||
48228654|NCT01604824|100880696|FG000|NOT COMPLETED|Open-label Extension (OLE) Period||0||
48228655|NCT01604824|100880697|FG001|NOT COMPLETED|Open-label Extension (OLE) Period||0||
48528113|NCT03456960|101628294|FG000|COMPLETED|Period 2 (1 Day)||11||
48528114|NCT03456960|101628295|FG001|COMPLETED|Period 2 (1 Day)||12||
48528115|NCT03456960|101628296|FG002|COMPLETED|Period 2 (1 Day)||119||
48528116|NCT03456960|101628297|FG003|COMPLETED|Period 2 (1 Day)||117||
48528117|NCT03456960|101628298|FG004|COMPLETED|Period 2 (1 Day)||6||
48528118|NCT03456960|101628299|FG005|COMPLETED|Period 2 (1 Day)||6||
48528119|NCT03456960|101628294|FG000|NOT COMPLETED|Period 2 (1 Day)||1||
48528120|NCT03456960|101628295|FG001|NOT COMPLETED|Period 2 (1 Day)||0||
48528121|NCT03456960|101628296|FG002|NOT COMPLETED|Period 2 (1 Day)||0||
48528122|NCT03456960|101628297|FG003|NOT COMPLETED|Period 2 (1 Day)||1||
48528123|NCT03456960|101628298|FG004|NOT COMPLETED|Period 2 (1 Day)||0||
48528124|NCT03456960|101628299|FG005|NOT COMPLETED|Period 2 (1 Day)||0||
48528125|NCT03760250|101628300|FG000|STARTED|Overall Study||6||
48528126|NCT03760250|101628300|FG000|COMPLETED|Overall Study||4||
48528127|NCT03760250|101628300|FG000|NOT COMPLETED|Overall Study||2||
48528128|NCT00712985|101628301|FG000|STARTED|Overall Study||18||
48528129|NCT00712985|101628301|FG000|COMPLETED|Overall Study||13||
48528130|NCT00712985|101628301|FG000|NOT COMPLETED|Overall Study||5||
48528131|NCT03758404|101628302|FG000|STARTED|Overall Study||3||
48528132|NCT03758404|101628303|FG001|STARTED|Overall Study||3||
48528133|NCT03758404|101628304|FG002|STARTED|Overall Study||5||
48528134|NCT03758404|101628302|FG000|COMPLETED|Overall Study||3||
48528135|NCT03758404|101628303|FG001|COMPLETED|Overall Study||3||
48528136|NCT03758404|101628304|FG002|COMPLETED|Overall Study||5||
48528137|NCT03758404|101628302|FG000|NOT COMPLETED|Overall Study||0||
48528138|NCT03758404|101628303|FG001|NOT COMPLETED|Overall Study||0||
48528139|NCT03758404|101628304|FG002|NOT COMPLETED|Overall Study||0||
48528140|NCT00706381|101628305|FG000|STARTED|Overall Study||10||
48528141|NCT00706381|101628306|FG001|STARTED|Overall Study||6||
48528142|NCT00706381|101628307|FG002|STARTED|Overall Study||6||
48528143|NCT00706381|101628308|FG003|STARTED|Overall Study||9||
48228656|NCT01604824|100880698|FG002|NOT COMPLETED|Open-label Extension (OLE) Period||0||
48228657|NCT01604824|100880699|FG003|NOT COMPLETED|Open-label Extension (OLE) Period||0||
48228658|NCT01604824|100880700|FG004|NOT COMPLETED|Open-label Extension (OLE) Period||3||
48228659|NCT01604824|100880701|FG005|NOT COMPLETED|Open-label Extension (OLE) Period||0||
48228660|NCT01262456|100880702|FG000|STARTED|3-Month Double-Blind Period||143||
48228661|NCT01262456|100880703|FG001|STARTED|3-Month Double-Blind Period||123||
48528144|NCT00706381|101628305|FG000|Intervention 1 (1 Day)|Overall Study||10||
48528145|NCT00706381|101628306|FG001|Intervention 1 (1 Day)|Overall Study||6||
48528146|NCT00706381|101628307|FG002|Intervention 1 (1 Day)|Overall Study||6||
48528147|NCT00706381|101628308|FG003|Intervention 1 (1 Day)|Overall Study||9||
48528148|NCT00706381|101628305|FG000|Intervention 2 (1 Day)|Overall Study||10||
48528149|NCT00706381|101628306|FG001|Intervention 2 (1 Day)|Overall Study||6||
48528150|NCT00706381|101628307|FG002|Intervention 2 (1 Day)|Overall Study||6||
48528151|NCT00706381|101628308|FG003|Intervention 2 (1 Day)|Overall Study||9||
48528152|NCT00706381|101628305|FG000|Intervention 3 (1 Day)|Overall Study||10||
48528153|NCT00706381|101628306|FG001|Intervention 3 (1 Day)|Overall Study||6||
48528154|NCT00706381|101628307|FG002|Intervention 3 (1 Day)|Overall Study||6||
48528155|NCT00706381|101628308|FG003|Intervention 3 (1 Day)|Overall Study||9||
48528156|NCT00706381|101628305|FG000|Intervention 4 (1 Day)|Overall Study||10||
48528157|NCT00706381|101628306|FG001|Intervention 4 (1 Day)|Overall Study||5||
48528158|NCT00706381|101628307|FG002|Intervention 4 (1 Day)|Overall Study||6||
48528159|NCT00706381|101628308|FG003|Intervention 4 (1 Day)|Overall Study||9||
48528160|NCT00706381|101628305|FG000|Intervention 5 (1 Day)|Overall Study||10||
48528161|NCT00706381|101628306|FG001|Intervention 5 (1 Day)|Overall Study||5||
48528162|NCT00706381|101628307|FG002|Intervention 5 (1 Day)|Overall Study||5||
48528163|NCT00706381|101628308|FG003|Intervention 5 (1 Day)|Overall Study||9||
48528164|NCT00706381|101628305|FG000|COMPLETED|Overall Study||10||
48528165|NCT00706381|101628306|FG001|COMPLETED|Overall Study||5||
48528166|NCT00706381|101628307|FG002|COMPLETED|Overall Study||5||
48528167|NCT00706381|101628308|FG003|COMPLETED|Overall Study||9||
48528168|NCT00706381|101628305|FG000|NOT COMPLETED|Overall Study||0||
48528169|NCT00706381|101628306|FG001|NOT COMPLETED|Overall Study||1||
48528170|NCT00706381|101628307|FG002|NOT COMPLETED|Overall Study||1||
48528171|NCT00706381|101628308|FG003|NOT COMPLETED|Overall Study||0||
48528172|NCT04271020|101628309|FG000|STARTED|Overall Study||12||
48528173|NCT04271020|101628309|FG000|COMPLETED|Overall Study||12||
48528174|NCT04271020|101628309|FG000|NOT COMPLETED|Overall Study||0||
48528175|NCT02570113|101628310|FG000|STARTED|Overall Study||45||
48528176|NCT02570113|101628310|FG000|COMPLETED|Overall Study||42||
48528177|NCT02570113|101628310|FG000|NOT COMPLETED|Overall Study||3||
48228662|NCT01262456|100880704|FG002|STARTED|3-Month Double-Blind Period||129||
48228663|NCT01262456|100880702|FG000|Full Analysis Set (FAS)|3-Month Double-Blind Period||142||
48228664|NCT01262456|100880703|FG001|Full Analysis Set (FAS)|3-Month Double-Blind Period||119||
48228665|NCT01262456|100880704|FG002|Full Analysis Set (FAS)|3-Month Double-Blind Period||124||
48228666|NCT01262456|100880702|FG000|Safety Analysis Set (SAS)|3-Month Double-Blind Period||143||
48228667|NCT01262456|100880703|FG001|Safety Analysis Set (SAS)|3-Month Double-Blind Period||119||
48228668|NCT01262456|100880704|FG002|Safety Analysis Set (SAS)|3-Month Double-Blind Period||122||
48228669|NCT01262456|100880702|FG000|COMPLETED|3-Month Double-Blind Period||124||
48528178|NCT00522171|101628311|FG000|STARTED|Overall Study||15||
48528179|NCT00522171|101628312|FG001|STARTED|Overall Study||15||
48528180|NCT00522171|101628311|FG000|COMPLETED|Overall Study||15||
48228670|NCT01262456|100880703|FG001|COMPLETED|3-Month Double-Blind Period||100||
48228671|NCT01262456|100880704|FG002|COMPLETED|3-Month Double-Blind Period||103||
48228672|NCT01262456|100880702|FG000|NOT COMPLETED|3-Month Double-Blind Period||19||
48228673|NCT01262456|100880703|FG001|NOT COMPLETED|3-Month Double-Blind Period||23||
48228674|NCT01262456|100880704|FG002|NOT COMPLETED|3-Month Double-Blind Period||26||
48228675|NCT01262456|100880702|FG000|STARTED|1-Month Open-Label Extension Period||124||
48228676|NCT01262456|100880703|FG001|STARTED|1-Month Open-Label Extension Period||100||
48228677|NCT01262456|100880704|FG002|STARTED|1-Month Open-Label Extension Period||103||
48228678|NCT01262456|100880702|FG000|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||124||
48228679|NCT01262456|100880703|FG001|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||101||
48228680|NCT01262456|100880704|FG002|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||102||
48228681|NCT01262456|100880702|FG000|COMPLETED|1-Month Open-Label Extension Period||120||
48228682|NCT01262456|100880703|FG001|COMPLETED|1-Month Open-Label Extension Period||97||
48228683|NCT01262456|100880704|FG002|COMPLETED|1-Month Open-Label Extension Period||98||
48228684|NCT01262456|100880702|FG000|NOT COMPLETED|1-Month Open-Label Extension Period||4||
48228685|NCT01262456|100880703|FG001|NOT COMPLETED|1-Month Open-Label Extension Period||3||
48228686|NCT01262456|100880704|FG002|NOT COMPLETED|1-Month Open-Label Extension Period||5||
48228687|NCT02060487|100880705|FG000|STARTED|Overall Study||129||
48228688|NCT02060487|100880706|FG001|STARTED|Overall Study||128||
48228689|NCT02060487|100880707|FG002|STARTED|Overall Study||128||
48228690|NCT02060487|100880705|FG000|COMPLETED|Overall Study||0||
48228691|NCT02060487|100880706|FG001|COMPLETED|Overall Study||0||
48228692|NCT02060487|100880707|FG002|COMPLETED|Overall Study||0||
48228693|NCT02060487|100880705|FG000|NOT COMPLETED|Overall Study||129||
48228694|NCT02060487|100880706|FG001|NOT COMPLETED|Overall Study||128||
48228695|NCT02060487|100880707|FG002|NOT COMPLETED|Overall Study||128||
48228696|NCT05376397|100880708|FG000|STARTED|Overall Study||34||
48228697|NCT05376397|100880708|FG000|COMPLETED|Overall Study||33||
48228698|NCT05376397|100880708|FG000|NOT COMPLETED|Overall Study||1||
48228699|NCT01706666|100880709|FG000|STARTED|Overall Study||1||
48228700|NCT01706666|100880710|FG001|STARTED|Overall Study||1||
48228701|NCT01706666|100880711|FG002|STARTED|Overall Study||1||
48228702|NCT01706666|100880709|FG000|COMPLETED|Overall Study||1||
48228703|NCT01706666|100880710|FG001|COMPLETED|Overall Study||1||
48228704|NCT01706666|100880711|FG002|COMPLETED|Overall Study||1||
48228705|NCT01706666|100880709|FG000|NOT COMPLETED|Overall Study||0||
48228706|NCT01706666|100880710|FG001|NOT COMPLETED|Overall Study||0||
48228707|NCT01706666|100880711|FG002|NOT COMPLETED|Overall Study||0||
48228708|NCT01147471|100880712|FG000|STARTED|Through Initial Hospital Discharge||13||
48228709|NCT01147471|100880713|FG001|STARTED|Through Initial Hospital Discharge||11||
48228710|NCT01147471|100880712|FG000|COMPLETED|Through Initial Hospital Discharge||13||
48228711|NCT01147471|100880713|FG001|COMPLETED|Through Initial Hospital Discharge||11||
48228712|NCT01147471|100880712|FG000|NOT COMPLETED|Through Initial Hospital Discharge||0||
48228713|NCT01147471|100880713|FG001|NOT COMPLETED|Through Initial Hospital Discharge||0||
48228714|NCT01147471|100880712|FG000|STARTED|Post-discharge Follow Up (Approx 2 Wks)||13||
48228715|NCT01147471|100880713|FG001|STARTED|Post-discharge Follow Up (Approx 2 Wks)||11||
48228716|NCT01147471|100880712|FG000|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||13||
48228717|NCT01147471|100880713|FG001|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||8||
48228718|NCT01147471|100880712|FG000|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||0||
48228719|NCT01147471|100880713|FG001|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||3||
48228720|NCT01147471|100880712|FG000|STARTED|3 Month Follow Up||13||
48228721|NCT01147471|100880713|FG001|STARTED|3 Month Follow Up||8||
48228722|NCT01147471|100880712|FG000|COMPLETED|3 Month Follow Up||12||
48228723|NCT01147471|100880713|FG001|COMPLETED|3 Month Follow Up||6||
48228724|NCT01147471|100880712|FG000|NOT COMPLETED|3 Month Follow Up||1||
48228725|NCT01147471|100880713|FG001|NOT COMPLETED|3 Month Follow Up||2||
48228726|NCT01147471|100880712|FG000|STARTED|6 Month Follow Up||12||
48228727|NCT01147471|100880713|FG001|STARTED|6 Month Follow Up||6||
48228728|NCT01147471|100880712|FG000|COMPLETED|6 Month Follow Up||8||
48228729|NCT01147471|100880713|FG001|COMPLETED|6 Month Follow Up||4||
48228730|NCT01147471|100880712|FG000|NOT COMPLETED|6 Month Follow Up||4||
48228731|NCT01147471|100880713|FG001|NOT COMPLETED|6 Month Follow Up||2||
48228732|NCT03496545|100880714|FG000|STARTED|Overall Study||21||
48228733|NCT03496545|100880715|FG001|STARTED|Overall Study||26||
48228734|NCT03496545|100880714|FG000|COMPLETED|Overall Study||20||
48228735|NCT03496545|100880715|FG001|COMPLETED|Overall Study||24||
48228736|NCT03496545|100880714|FG000|NOT COMPLETED|Overall Study||1||
48228737|NCT03496545|100880715|FG001|NOT COMPLETED|Overall Study||2||
48228738|NCT00963924|100880716|FG000|STARTED|Overall Study||18||
48228739|NCT00963924|100880717|FG001|STARTED|Overall Study||18||
48228740|NCT00963924|100880716|FG000|COMPLETED|Overall Study||17||
48228741|NCT00963924|100880717|FG001|COMPLETED|Overall Study||15||
48228742|NCT00963924|100880716|FG000|NOT COMPLETED|Overall Study||1||
48228743|NCT00963924|100880717|FG001|NOT COMPLETED|Overall Study||3||
48228744|NCT00622700|100880718|FG000|STARTED|Core Treatment Period||197||
48228745|NCT00622700|100880719|FG001|STARTED|Core Treatment Period||205||
48228746|NCT00622700|100880720|FG002|STARTED|Core Treatment Period||216||
48228747|NCT00622700|100880721|FG003|STARTED|Core Treatment Period||0||
48228748|NCT00622700|100880722|FG004|STARTED|Core Treatment Period||0||
48228749|NCT00622700|100880723|FG005|STARTED|Core Treatment Period||0||
48228750|NCT00622700|100880724|FG006|STARTED|Core Treatment Period||0||
48228751|NCT00622700|100880718|FG000|Treated|Core Treatment Period||197||
48228752|NCT00622700|100880719|FG001|Treated|Core Treatment Period||203||
48228753|NCT00622700|100880720|FG002|Treated|Core Treatment Period||214||
48228754|NCT00622700|100880721|FG003|Treated|Core Treatment Period||0||
48228755|NCT00622700|100880722|FG004|Treated|Core Treatment Period||0||
48228756|NCT00622700|100880723|FG005|Treated|Core Treatment Period||0||
48228757|NCT00622700|100880724|FG006|Treated|Core Treatment Period||0||
48228758|NCT00622700|100880718|FG000|COMPLETED|Core Treatment Period||141||
48228759|NCT00622700|100880719|FG001|COMPLETED|Core Treatment Period||150||
48228760|NCT00622700|100880720|FG002|COMPLETED|Core Treatment Period||163||
48228761|NCT00622700|100880721|FG003|COMPLETED|Core Treatment Period||0||
48228762|NCT00622700|100880722|FG004|COMPLETED|Core Treatment Period||0||
48528181|NCT00522171|101628312|FG001|COMPLETED|Overall Study||15||
48528182|NCT00522171|101628311|FG000|NOT COMPLETED|Overall Study||0||
48528183|NCT00522171|101628312|FG001|NOT COMPLETED|Overall Study||0||
48528184|NCT02751359|101628313|FG000|STARTED|Overall Study||18||
48528185|NCT02751359|101628313|FG000|COMPLETED|Overall Study||17||
48528186|NCT02751359|101628313|FG000|NOT COMPLETED|Overall Study||1||
48528187|NCT02229539|101628314|FG000|STARTED|Cycle 1 (Treatment Per Protocol)||77||
48528188|NCT02229539|101628315|FG001|STARTED|Cycle 1 (Treatment Per Protocol)||76||
48528189|NCT02229539|101628316|FG002|STARTED|Cycle 1 (Treatment Per Protocol)||75||
48528190|NCT02229539|101628314|FG000|COMPLETED|Cycle 1 (Treatment Per Protocol)||74||
48528191|NCT02229539|101628315|FG001|COMPLETED|Cycle 1 (Treatment Per Protocol)||71||
48528192|NCT02229539|101628316|FG002|COMPLETED|Cycle 1 (Treatment Per Protocol)||72||
48528193|NCT02229539|101628314|FG000|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3||
48528194|NCT02229539|101628315|FG001|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||5||
48528195|NCT02229539|101628316|FG002|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3||
48528196|NCT02229539|101628314|FG000|STARTED|Cycle 2 (Optional Continuation Phase)||35|Include only those who completed cycle 1 and chose to continue the study drug for up to 7 days.|
48528197|NCT02229539|101628315|FG001|STARTED|Cycle 2 (Optional Continuation Phase)||36|Include only those who completed cycle 1 and chose to continue the study drug for up to 7 days.|
48528198|NCT02229539|101628316|FG002|STARTED|Cycle 2 (Optional Continuation Phase)||32|Include only those who completed cycle 1 and chose to continue the study drug for up to 7 days.|
48528199|NCT02229539|101628314|FG000|COMPLETED|Cycle 2 (Optional Continuation Phase)||26||
48528200|NCT02229539|101628315|FG001|COMPLETED|Cycle 2 (Optional Continuation Phase)||29||
48528201|NCT02229539|101628316|FG002|COMPLETED|Cycle 2 (Optional Continuation Phase)||22||
48528202|NCT02229539|101628314|FG000|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||9||
48528203|NCT02229539|101628315|FG001|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||7||
48528204|NCT02229539|101628316|FG002|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||10||
48528205|NCT03254602|101628317|FG000|STARTED|Overall Study||33||
48528206|NCT03254602|101628317|FG000|COMPLETED|Overall Study||29||
48228763|NCT00622700|100880723|FG005|COMPLETED|Core Treatment Period||0||
48228764|NCT00622700|100880724|FG006|COMPLETED|Core Treatment Period||0||
48228765|NCT00622700|100880718|FG000|NOT COMPLETED|Core Treatment Period||56||
48228766|NCT00622700|100880719|FG001|NOT COMPLETED|Core Treatment Period||55||
48228767|NCT00622700|100880720|FG002|NOT COMPLETED|Core Treatment Period||53||
48228768|NCT00622700|100880721|FG003|NOT COMPLETED|Core Treatment Period||0||
48228769|NCT00622700|100880722|FG004|NOT COMPLETED|Core Treatment Period||0||
48228770|NCT00622700|100880723|FG005|NOT COMPLETED|Core Treatment Period||0||
48228771|NCT00622700|100880724|FG006|NOT COMPLETED|Core Treatment Period||0||
48228772|NCT00622700|100880718|FG000|STARTED|Extension Treatment Period||0||
48228773|NCT00622700|100880719|FG001|STARTED|Extension Treatment Period||0||
48228774|NCT00622700|100880720|FG002|STARTED|Extension Treatment Period||0||
48228775|NCT00622700|100880721|FG003|STARTED|Extension Treatment Period||64||
48228776|NCT00622700|100880722|FG004|STARTED|Extension Treatment Period||142||
48228777|NCT00622700|100880723|FG005|STARTED|Extension Treatment Period||67||
48228778|NCT00622700|100880724|FG006|STARTED|Extension Treatment Period||150||
48228779|NCT00622700|100880718|FG000|COMPLETED|Extension Treatment Period||0||
48228780|NCT00622700|100880719|FG001|COMPLETED|Extension Treatment Period||0||
48228781|NCT00622700|100880720|FG002|COMPLETED|Extension Treatment Period||0||
48228782|NCT00622700|100880721|FG003|COMPLETED|Extension Treatment Period||43||
48528207|NCT03254602|101628317|FG000|NOT COMPLETED|Overall Study||4||
48528208|NCT01403064|101628318|FG000|STARTED|Overall Study||24||
48528209|NCT01403064|101628319|FG001|STARTED|Overall Study||7||
48228783|NCT00622700|100880722|FG004|COMPLETED|Extension Treatment Period||103||
48228784|NCT00622700|100880723|FG005|COMPLETED|Extension Treatment Period||50||
48228785|NCT00622700|100880724|FG006|COMPLETED|Extension Treatment Period||120||
48228786|NCT00622700|100880718|FG000|NOT COMPLETED|Extension Treatment Period||0||
48228787|NCT00622700|100880719|FG001|NOT COMPLETED|Extension Treatment Period||0||
48228788|NCT00622700|100880720|FG002|NOT COMPLETED|Extension Treatment Period||0||
48228789|NCT00622700|100880721|FG003|NOT COMPLETED|Extension Treatment Period||21||
48228790|NCT00622700|100880722|FG004|NOT COMPLETED|Extension Treatment Period||39||
48528210|NCT01403064|101628320|FG002|STARTED|Overall Study||23||
48228791|NCT00622700|100880723|FG005|NOT COMPLETED|Extension Treatment Period||17||
48528211|NCT01403064|101628321|FG003|STARTED|Overall Study||22||
48528212|NCT01403064|101628318|FG000|COMPLETED|Overall Study||23||
48528213|NCT01403064|101628319|FG001|COMPLETED|Overall Study||7||
48528214|NCT01403064|101628320|FG002|COMPLETED|Overall Study||19||
48528215|NCT01403064|101628321|FG003|COMPLETED|Overall Study||19||
48528216|NCT01403064|101628318|FG000|NOT COMPLETED|Overall Study||1||
48528217|NCT01403064|101628319|FG001|NOT COMPLETED|Overall Study||0||
48528218|NCT01403064|101628320|FG002|NOT COMPLETED|Overall Study||4||
48528219|NCT01403064|101628321|FG003|NOT COMPLETED|Overall Study||3||
48528220|NCT01708629|101628322|FG000|STARTED|Overall Study||624||
48528221|NCT01708629|101628323|FG001|STARTED|Overall Study||629||
48528222|NCT01708629|101628324|FG002|STARTED|Overall Study||313||
48528223|NCT01708629|101628325|FG003|STARTED|Overall Study||315||
48528224|NCT01708629|101628322|FG000|COMPLETED|Overall Study||608||
48528225|NCT01708629|101628323|FG001|COMPLETED|Overall Study||604||
48528226|NCT01708629|101628324|FG002|COMPLETED|Overall Study||303||
48528227|NCT01708629|101628325|FG003|COMPLETED|Overall Study||301||
48528228|NCT01708629|101628322|FG000|NOT COMPLETED|Overall Study||16||
48528229|NCT01708629|101628323|FG001|NOT COMPLETED|Overall Study||25||
48528230|NCT01708629|101628324|FG002|NOT COMPLETED|Overall Study||10||
48528231|NCT01708629|101628325|FG003|NOT COMPLETED|Overall Study||14||
48528232|NCT00673387|101628326|FG000|STARTED|Overall Study||75||
48528233|NCT00673387|101628327|FG001|STARTED|Overall Study||77||
48528234|NCT00673387|101628328|FG002|STARTED|Overall Study||72||
48528235|NCT00673387|101628329|FG003|STARTED|Overall Study||75||
48528236|NCT00673387|101628330|FG004|STARTED|Overall Study||78||
48528237|NCT00673387|101628331|FG005|STARTED|Overall Study||78||
48528238|NCT00673387|101628332|FG006|STARTED|Overall Study||78||
48528239|NCT00673387|101628333|FG007|STARTED|Overall Study||75||
48228792|NCT00622700|100880724|FG006|NOT COMPLETED|Extension Treatment Period||30||
48228793|NCT00252382|100880725|FG000|STARTED|Overall Study||31||
48228794|NCT00252382|100880725|FG000|COMPLETED|Overall Study||5||
48528240|NCT00673387|101628326|FG000|COMPLETED|Overall Study||46||
48528241|NCT00673387|101628327|FG001|COMPLETED|Overall Study||54||
48528242|NCT00673387|101628328|FG002|COMPLETED|Overall Study||41||
48528243|NCT00673387|101628329|FG003|COMPLETED|Overall Study||49||
48528244|NCT00673387|101628330|FG004|COMPLETED|Overall Study||48||
48528245|NCT00673387|101628331|FG005|COMPLETED|Overall Study||44||
48528246|NCT00673387|101628332|FG006|COMPLETED|Overall Study||48||
48528247|NCT00673387|101628333|FG007|COMPLETED|Overall Study||40||
48528248|NCT00673387|101628326|FG000|NOT COMPLETED|Overall Study||29||
48528249|NCT00673387|101628327|FG001|NOT COMPLETED|Overall Study||23||
48528250|NCT00673387|101628328|FG002|NOT COMPLETED|Overall Study||31||
48528251|NCT00673387|101628329|FG003|NOT COMPLETED|Overall Study||26||
48528252|NCT00673387|101628330|FG004|NOT COMPLETED|Overall Study||30||
48528253|NCT00673387|101628331|FG005|NOT COMPLETED|Overall Study||34||
48528254|NCT00673387|101628332|FG006|NOT COMPLETED|Overall Study||30||
48528255|NCT00673387|101628333|FG007|NOT COMPLETED|Overall Study||35||
48528256|NCT03028740|101628334|FG000|STARTED|Overall Study||593||
48528257|NCT03028740|101628335|FG001|STARTED|Overall Study||1185||
48528258|NCT03028740|101628334|FG000|Full Study Cohort: Received Study Drug|Overall Study||589||
48528259|NCT03028740|101628335|FG001|Full Study Cohort: Received Study Drug|Overall Study||1180||
48528260|NCT03028740|101628334|FG000|Participated in Part 1|Overall Study||432||
48528261|NCT03028740|101628335|FG001|Participated in Part 1|Overall Study||861||
48528262|NCT03028740|101628334|FG000|Part 1: Received Study Drug|Overall Study||429||
48528263|NCT03028740|101628335|FG001|Part 1: Received Study Drug|Overall Study||859||
48528264|NCT03028740|101628334|FG000|COMPLETED|Overall Study||0||
48528265|NCT03028740|101628335|FG001|COMPLETED|Overall Study||0||
48528266|NCT03028740|101628334|FG000|NOT COMPLETED|Overall Study||593||
48528267|NCT03028740|101628335|FG001|NOT COMPLETED|Overall Study||1185||
48528268|NCT05882279|101628336|FG000|STARTED|Overall Study||330||
48528269|NCT05882279|101628336|FG000|COMPLETED|Overall Study||330||
48228795|NCT00252382|100880725|FG000|NOT COMPLETED|Overall Study||26||
48228796|NCT01828021|100880726|FG000|STARTED|Overall Study||25||
48528270|NCT05882279|101628336|FG000|NOT COMPLETED|Overall Study||0||
48528271|NCT00857584|101628337|FG000|STARTED|Overall Study||14||
48528272|NCT00857584|101628338|FG001|STARTED|Overall Study||13||
48528273|NCT00857584|101628337|FG000|Week 1|Overall Study||14||
48528274|NCT00857584|101628338|FG001|Week 1|Overall Study||13||
48528275|NCT00857584|101628337|FG000|Week 2|Overall Study||14||
48228797|NCT01828021|100880726|FG000|COMPLETED|Overall Study||0||
48228798|NCT01828021|100880726|FG000|NOT COMPLETED|Overall Study||25||
48228799|NCT00666705|100880727|FG000|STARTED|Overall Study||18||
48228800|NCT00666705|100880727|FG000|Raltegravir Alone (Days 1 - 3)|Overall Study||18||
48528276|NCT00857584|101628338|FG001|Week 2|Overall Study||11||
48528277|NCT00857584|101628337|FG000|Week 4|Overall Study||11||
48528278|NCT00857584|101628338|FG001|Week 4|Overall Study||9||
48528279|NCT00857584|101628337|FG000|Week 8|Overall Study||10||
48528280|NCT00857584|101628338|FG001|Week 8|Overall Study||8||
48228801|NCT00666705|100880727|FG000|Washout (Days 4 - 5)|Overall Study||18||
48528281|NCT00857584|101628337|FG000|COMPLETED|Overall Study||10||
48528282|NCT00857584|101628338|FG001|COMPLETED|Overall Study||8||
48528283|NCT00857584|101628337|FG000|NOT COMPLETED|Overall Study||4||
48528284|NCT00857584|101628338|FG001|NOT COMPLETED|Overall Study||5||
48528285|NCT01169532|101628339|FG000|STARTED|Overall Study||16||
48528286|NCT01169532|101628339|FG000|COMPLETED|Overall Study||15||
48528287|NCT01169532|101628339|FG000|NOT COMPLETED|Overall Study||1||
48528288|NCT02963441|101628340|FG000|STARTED|Overall Study||900||
48528289|NCT02963441|101628340|FG000|COMPLETED|Overall Study||819||
48528290|NCT02963441|101628340|FG000|NOT COMPLETED|Overall Study||81||
48528291|NCT02435836|101628341|FG000|STARTED|Overall Study||631||
48528292|NCT02435836|101628341|FG000|COMPLETED|Overall Study||0||
48528293|NCT02435836|101628341|FG000|NOT COMPLETED|Overall Study||631||
48528294|NCT02394730|101628342|FG000|STARTED|Overall Study||34||
48528295|NCT02394730|101628343|FG001|STARTED|Overall Study||31||
48528296|NCT02394730|101628342|FG000|COMPLETED|Overall Study||33||
48528297|NCT02394730|101628343|FG001|COMPLETED|Overall Study||30||
48528298|NCT02394730|101628342|FG000|NOT COMPLETED|Overall Study||1||
48528299|NCT02394730|101628343|FG001|NOT COMPLETED|Overall Study||1||
48528300|NCT00725751|101628344|FG000|STARTED|Overall Study||90||
48528301|NCT00725751|101628345|FG001|STARTED|Overall Study||258||
48528302|NCT00725751|101628344|FG000|COMPLETED|Overall Study||56||
48528303|NCT00725751|101628345|FG001|COMPLETED|Overall Study||150||
48528304|NCT00725751|101628344|FG000|NOT COMPLETED|Overall Study||34||
48528305|NCT00725751|101628345|FG001|NOT COMPLETED|Overall Study||108||
48528306|NCT00678041|101628346|FG000|STARTED|Overall Study||5||
48528307|NCT00678041|101628347|FG001|STARTED|Overall Study||5||
48528308|NCT00678041|101628346|FG000|COMPLETED|Overall Study||0||
48528309|NCT00678041|101628347|FG001|COMPLETED|Overall Study||0||
48528310|NCT00678041|101628346|FG000|NOT COMPLETED|Overall Study||5||
48528311|NCT00678041|101628347|FG001|NOT COMPLETED|Overall Study||5||
48528312|NCT02568566|101628348|FG000|STARTED|Overall Study||201||
48528313|NCT02568566|101628348|FG000|COMPLETED|Overall Study||187||
48528314|NCT02568566|101628348|FG000|NOT COMPLETED|Overall Study||14||
48528315|NCT01461226|101628349|FG000|STARTED|Overall Study||33||
48528316|NCT01461226|101628350|FG001|STARTED|Overall Study||28||
48528317|NCT01461226|101628349|FG000|COMPLETED|Overall Study||27||
48528318|NCT01461226|101628350|FG001|COMPLETED|Overall Study||21||
48528319|NCT01461226|101628349|FG000|NOT COMPLETED|Overall Study||6||
48528320|NCT01461226|101628350|FG001|NOT COMPLETED|Overall Study||7||
48528321|NCT03493386|101628351|FG000|STARTED|Part 1, Intervention Period 1 (2 Days)||26||
48528322|NCT03493386|101628352|FG001|STARTED|Part 1, Intervention Period 1 (2 Days)||26||
48528323|NCT03493386|101628353|FG002|STARTED|Part 1, Intervention Period 1 (2 Days)||0||
48528324|NCT03493386|101628354|FG003|STARTED|Part 1, Intervention Period 1 (2 Days)||0||
48528325|NCT03493386|101628351|FG000|COMPLETED|Part 1, Intervention Period 1 (2 Days)||26||
48528326|NCT03493386|101628352|FG001|COMPLETED|Part 1, Intervention Period 1 (2 Days)||26||
48528327|NCT03493386|101628353|FG002|COMPLETED|Part 1, Intervention Period 1 (2 Days)||0||
48528328|NCT03493386|101628354|FG003|COMPLETED|Part 1, Intervention Period 1 (2 Days)||0||
48228802|NCT00666705|100880727|FG000|Maraviroc Alone (Days 6 - 11)|Overall Study||18||
48228803|NCT00666705|100880727|FG000|Raltegravir + Maraviroc (Days 12 - 14)|Overall Study||17||
48228804|NCT00666705|100880727|FG000|COMPLETED|Overall Study||17||
48528329|NCT03493386|101628351|FG000|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0||
48528330|NCT03493386|101628352|FG001|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0||
48528331|NCT03493386|101628353|FG002|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0||
48528332|NCT03493386|101628354|FG003|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0||
48528333|NCT03493386|101628351|FG000|STARTED|Part 1, Washout Period (at Least 5 Days)||26||
48528334|NCT03493386|101628352|FG001|STARTED|Part 1, Washout Period (at Least 5 Days)||26||
48528335|NCT03493386|101628353|FG002|STARTED|Part 1, Washout Period (at Least 5 Days)||0||
48528336|NCT03493386|101628354|FG003|STARTED|Part 1, Washout Period (at Least 5 Days)||0||
48528337|NCT03493386|101628351|FG000|COMPLETED|Part 1, Washout Period (at Least 5 Days)||26||
48528338|NCT03493386|101628352|FG001|COMPLETED|Part 1, Washout Period (at Least 5 Days)||25||
48528339|NCT03493386|101628353|FG002|COMPLETED|Part 1, Washout Period (at Least 5 Days)||0||
48528340|NCT03493386|101628354|FG003|COMPLETED|Part 1, Washout Period (at Least 5 Days)||0||
48228805|NCT00666705|100880727|FG000|NOT COMPLETED|Overall Study||1||
48228806|NCT02656199|100880728|FG000|STARTED|Overall Study||0||
48228807|NCT02656199|100880728|FG000|COMPLETED|Overall Study||0||
48528341|NCT03493386|101628351|FG000|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0||
48228808|NCT02656199|100880728|FG000|NOT COMPLETED|Overall Study||0||
48228809|NCT01128959|100880729|FG000|STARTED|Lead in Period||108||
48228810|NCT01128959|100880729|FG000|COMPLETED|Lead in Period||105||
48228811|NCT01128959|100880729|FG000|NOT COMPLETED|Lead in Period||3||
48228812|NCT01128959|100880729|FG000|STARTED|Treatment Period||105||
48228813|NCT01128959|100880729|FG000|COMPLETED|Treatment Period||101||
48228814|NCT01128959|100880729|FG000|NOT COMPLETED|Treatment Period||4||
48528342|NCT03493386|101628352|FG001|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||1||
48528343|NCT03493386|101628353|FG002|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0||
48528344|NCT03493386|101628354|FG003|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0||
48528345|NCT03493386|101628351|FG000|STARTED|Part 1, Intervention Period 2 (2 Days)||26||
48528346|NCT03493386|101628352|FG001|STARTED|Part 1, Intervention Period 2 (2 Days)||25||
48528347|NCT03493386|101628353|FG002|STARTED|Part 1, Intervention Period 2 (2 Days)||0||
48228815|NCT02773732|100880730|FG000|STARTED|Ciprofloxacin Dose Level 0||3||
48528348|NCT03493386|101628354|FG003|STARTED|Part 1, Intervention Period 2 (2 Days)||0||
48528349|NCT03493386|101628351|FG000|COMPLETED|Part 1, Intervention Period 2 (2 Days)||26||
48528350|NCT03493386|101628352|FG001|COMPLETED|Part 1, Intervention Period 2 (2 Days)||25||
48528351|NCT03493386|101628353|FG002|COMPLETED|Part 1, Intervention Period 2 (2 Days)||0||
48528352|NCT03493386|101628354|FG003|COMPLETED|Part 1, Intervention Period 2 (2 Days)||0||
48528353|NCT03493386|101628351|FG000|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0||
48528354|NCT03493386|101628352|FG001|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0||
48528355|NCT03493386|101628353|FG002|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0||
48528356|NCT03493386|101628354|FG003|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0||
48528357|NCT03493386|101628351|FG000|STARTED|Part 2, Intervention Period 1 (2 Days)||0||
48528358|NCT03493386|101628352|FG001|STARTED|Part 2, Intervention Period 1 (2 Days)||0||
48528359|NCT03493386|101628353|FG002|STARTED|Part 2, Intervention Period 1 (2 Days)||6||
48528360|NCT03493386|101628354|FG003|STARTED|Part 2, Intervention Period 1 (2 Days)||6||
48528361|NCT03493386|101628351|FG000|COMPLETED|Part 2, Intervention Period 1 (2 Days)||0||
48528362|NCT03493386|101628352|FG001|COMPLETED|Part 2, Intervention Period 1 (2 Days)||0||
48528363|NCT03493386|101628353|FG002|COMPLETED|Part 2, Intervention Period 1 (2 Days)||6||
48528364|NCT03493386|101628354|FG003|COMPLETED|Part 2, Intervention Period 1 (2 Days)||6||
48528365|NCT03493386|101628351|FG000|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0||
48528366|NCT03493386|101628352|FG001|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0||
48528367|NCT03493386|101628353|FG002|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0||
48528368|NCT03493386|101628354|FG003|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0||
48528369|NCT03493386|101628351|FG000|STARTED|Part 2, Washout Period (at Least 5 Days)||0||
48528370|NCT03493386|101628352|FG001|STARTED|Part 2, Washout Period (at Least 5 Days)||0||
48528371|NCT03493386|101628353|FG002|STARTED|Part 2, Washout Period (at Least 5 Days)||6||
48528372|NCT03493386|101628354|FG003|STARTED|Part 2, Washout Period (at Least 5 Days)||6||
48528373|NCT03493386|101628351|FG000|COMPLETED|Part 2, Washout Period (at Least 5 Days)||0||
48528374|NCT03493386|101628352|FG001|COMPLETED|Part 2, Washout Period (at Least 5 Days)||0||
48528375|NCT03493386|101628353|FG002|COMPLETED|Part 2, Washout Period (at Least 5 Days)||6||
48528376|NCT03493386|101628354|FG003|COMPLETED|Part 2, Washout Period (at Least 5 Days)||6||
48528377|NCT03493386|101628351|FG000|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0||
48528378|NCT03493386|101628352|FG001|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0||
48528379|NCT03493386|101628353|FG002|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0||
48528380|NCT03493386|101628354|FG003|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0||
48528381|NCT03493386|101628351|FG000|STARTED|Part 2, Intervention Period 2 (2 Days)||0||
48528382|NCT03493386|101628352|FG001|STARTED|Part 2, Intervention Period 2 (2 Days)||0||
48528383|NCT03493386|101628353|FG002|STARTED|Part 2, Intervention Period 2 (2 Days)||6||
48528384|NCT03493386|101628354|FG003|STARTED|Part 2, Intervention Period 2 (2 Days)||6||
48528385|NCT03493386|101628351|FG000|COMPLETED|Part 2, Intervention Period 2 (2 Days)||0||
48528386|NCT03493386|101628352|FG001|COMPLETED|Part 2, Intervention Period 2 (2 Days)||0||
48528387|NCT03493386|101628353|FG002|COMPLETED|Part 2, Intervention Period 2 (2 Days)||6||
48528388|NCT03493386|101628354|FG003|COMPLETED|Part 2, Intervention Period 2 (2 Days)||6||
48528389|NCT03493386|101628351|FG000|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0||
48528390|NCT03493386|101628352|FG001|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0||
48528391|NCT03493386|101628353|FG002|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0||
48528392|NCT03493386|101628354|FG003|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0||
48528393|NCT01345175|101628355|FG000|STARTED|Overall Study||36||
48528394|NCT01345175|101628356|FG001|STARTED|Overall Study||33||
48528395|NCT01345175|101628355|FG000|COMPLETED|Overall Study||30||
48528396|NCT01345175|101628356|FG001|COMPLETED|Overall Study||27||
48528397|NCT01345175|101628355|FG000|NOT COMPLETED|Overall Study||6||
48528398|NCT01345175|101628356|FG001|NOT COMPLETED|Overall Study||6||
48528399|NCT01520532|101628357|FG000|STARTED|Overall Study||60||
48528400|NCT01520532|101628357|FG000|COMPLETED|Overall Study||60||
48528401|NCT01520532|101628357|FG000|NOT COMPLETED|Overall Study||0||
48528402|NCT00894738|101628358|FG000|STARTED|Overall Study||25||
48528403|NCT00894738|101628359|FG001|STARTED|Overall Study||19||
48528404|NCT00894738|101628358|FG000|COMPLETED|Overall Study||25||
48528405|NCT00894738|101628359|FG001|COMPLETED|Overall Study||19||
48528406|NCT00894738|101628358|FG000|NOT COMPLETED|Overall Study||0||
48528407|NCT00894738|101628359|FG001|NOT COMPLETED|Overall Study||0||
48528408|NCT00910091|101628360|FG000|STARTED|Pre-assignment||36||
48528409|NCT00910091|101628361|FG001|STARTED|Pre-assignment||37||
48528410|NCT00910091|101628360|FG000|COMPLETED|Pre-assignment||36||
48528411|NCT00910091|101628361|FG001|COMPLETED|Pre-assignment||35||
48528412|NCT00910091|101628360|FG000|NOT COMPLETED|Pre-assignment||0||
48528413|NCT00910091|101628361|FG001|NOT COMPLETED|Pre-assignment||2||
48528414|NCT00910091|101628360|FG000|STARTED|Treatment and Survival||36||
48528415|NCT00910091|101628361|FG001|STARTED|Treatment and Survival||35||
48528416|NCT00910091|101628360|FG000|COMPLETED|Treatment and Survival||32||
48528417|NCT00910091|101628361|FG001|COMPLETED|Treatment and Survival||31||
48528418|NCT00910091|101628360|FG000|NOT COMPLETED|Treatment and Survival||4||
48528419|NCT00910091|101628361|FG001|NOT COMPLETED|Treatment and Survival||4||
48528420|NCT02372071|101628362|FG000|STARTED|Overall Study||111||
48528421|NCT02372071|101628362|FG000|COMPLETED|Overall Study||93||
48528422|NCT02372071|101628362|FG000|NOT COMPLETED|Overall Study||18||
48528423|NCT01321008|101628363|FG000|STARTED|Overall Study||1||
48528424|NCT01321008|101628363|FG000|COMPLETED|Overall Study||0||
48528425|NCT01321008|101628363|FG000|NOT COMPLETED|Overall Study||1||
48528426|NCT02005887|101628364|FG000|STARTED|Overall Study||26||
48228816|NCT02773732|100880731|FG001|STARTED|Ciprofloxacin Dose Level 0||0||
48228817|NCT02773732|100880730|FG000|COMPLETED|Ciprofloxacin Dose Level 0||3||
48228818|NCT02773732|100880731|FG001|COMPLETED|Ciprofloxacin Dose Level 0||0||
48228819|NCT02773732|100880730|FG000|NOT COMPLETED|Ciprofloxacin Dose Level 0||0||
48228820|NCT02773732|100880731|FG001|NOT COMPLETED|Ciprofloxacin Dose Level 0||0||
48528427|NCT02005887|101628365|FG001|STARTED|Overall Study||25||
48528428|NCT02005887|101628364|FG000|COMPLETED|Overall Study||26||
48528429|NCT02005887|101628365|FG001|COMPLETED|Overall Study||23||
48528430|NCT02005887|101628364|FG000|NOT COMPLETED|Overall Study||0||
48528431|NCT02005887|101628365|FG001|NOT COMPLETED|Overall Study||2||
48528432|NCT01912274|101628366|FG000|STARTED|Overall Study||50||
48528433|NCT01912274|101628366|FG000|COMPLETED|Overall Study||50||
48528434|NCT01912274|101628366|FG000|NOT COMPLETED|Overall Study||0||
48528435|NCT01183221|101628367|FG000|STARTED|First Dose||15||
48528436|NCT01183221|101628368|FG001|STARTED|First Dose||15||
48528437|NCT01183221|101628367|FG000|COMPLETED|First Dose||15||
48528438|NCT01183221|101628368|FG001|COMPLETED|First Dose||15||
48528439|NCT01183221|101628367|FG000|NOT COMPLETED|First Dose||0||
48528440|NCT01183221|101628368|FG001|NOT COMPLETED|First Dose||0||
48528441|NCT01183221|101628367|FG000|STARTED|3 Weeks Wash Out||15||
48528442|NCT01183221|101628368|FG001|STARTED|3 Weeks Wash Out||15||
48528443|NCT01183221|101628367|FG000|COMPLETED|3 Weeks Wash Out||14||
48528444|NCT01183221|101628368|FG001|COMPLETED|3 Weeks Wash Out||14||
48528445|NCT01183221|101628367|FG000|NOT COMPLETED|3 Weeks Wash Out||1||
48528446|NCT01183221|101628368|FG001|NOT COMPLETED|3 Weeks Wash Out||1||
48528447|NCT01183221|101628367|FG000|STARTED|Second Dose||14||
48228821|NCT02773732|100880730|FG000|STARTED|Ciprofloxacin Dose Level +1||0||
48228822|NCT02773732|100880731|FG001|STARTED|Ciprofloxacin Dose Level +1||8||
48228823|NCT02773732|100880730|FG000|COMPLETED|Ciprofloxacin Dose Level +1||0||
48228824|NCT02773732|100880731|FG001|COMPLETED|Ciprofloxacin Dose Level +1||8||
48228825|NCT02773732|100880730|FG000|NOT COMPLETED|Ciprofloxacin Dose Level +1||0||
48228826|NCT02773732|100880731|FG001|NOT COMPLETED|Ciprofloxacin Dose Level +1||0||
48528448|NCT01183221|101628368|FG001|STARTED|Second Dose||14||
48528449|NCT01183221|101628367|FG000|COMPLETED|Second Dose||14||
48528450|NCT01183221|101628368|FG001|COMPLETED|Second Dose||14||
48528451|NCT01183221|101628367|FG000|NOT COMPLETED|Second Dose||0||
48528452|NCT01183221|101628368|FG001|NOT COMPLETED|Second Dose||0||
48528453|NCT00289757|101628369|FG000|STARTED|Overall Study||78||
48528454|NCT00289757|101628369|FG000|COMPLETED|Overall Study||78||
48228827|NCT00454194|100880732|FG000|STARTED|Overall Study||47||
48228828|NCT00454194|100880733|FG001|STARTED|Overall Study||51||
48228829|NCT00454194|100880732|FG000|COMPLETED|Overall Study||25||
48528455|NCT00289757|101628369|FG000|NOT COMPLETED|Overall Study||0||
48528456|NCT01661179|101628370|FG000|STARTED|Overall Study||14||
48528457|NCT01661179|101628370|FG000|COMPLETED|Overall Study||8||
48528458|NCT01661179|101628370|FG000|NOT COMPLETED|Overall Study||6||
48528459|NCT01708590|101628371|FG000|STARTED|Induction Phase||222||
48528460|NCT01708590|101628372|FG001|STARTED|Induction Phase||219||
48528461|NCT01708590|101628373|FG002|STARTED|Induction Phase||220||
48528462|NCT01708590|101628374|FG003|STARTED|Induction Phase||0||
48528463|NCT01708590|101628375|FG004|STARTED|Induction Phase||0||
48528464|NCT01708590|101628376|FG005|STARTED|Induction Phase||0||
48228830|NCT00454194|100880733|FG001|COMPLETED|Overall Study||37||
48228831|NCT00454194|100880732|FG000|NOT COMPLETED|Overall Study||22||
48228832|NCT00454194|100880733|FG001|NOT COMPLETED|Overall Study||14||
48228833|NCT03138499|100880734|FG000|STARTED|Overall Study||12||
48228834|NCT03138499|100880735|FG001|STARTED|Overall Study||11||
48228835|NCT03138499|100880734|FG000|COMPLETED|Overall Study||3||
48228836|NCT03138499|100880735|FG001|COMPLETED|Overall Study||1||
48528465|NCT01708590|101628377|FG006|STARTED|Induction Phase||0||
48528466|NCT01708590|101628371|FG000|COMPLETED|Induction Phase||212||
48528467|NCT01708590|101628372|FG001|COMPLETED|Induction Phase||212||
48528468|NCT01708590|101628373|FG002|COMPLETED|Induction Phase||209||
48528469|NCT01708590|101628374|FG003|COMPLETED|Induction Phase||0||
48228837|NCT03138499|100880734|FG000|NOT COMPLETED|Overall Study||9||
48228838|NCT03138499|100880735|FG001|NOT COMPLETED|Overall Study||10||
48228839|NCT01708278|100880736|FG000|STARTED|Overall Study||1||
48228840|NCT01708278|100880737|FG001|STARTED|Overall Study||2||
48228841|NCT01708278|100880738|FG002|STARTED|Overall Study||2||
48228842|NCT01708278|100880739|FG003|STARTED|Overall Study||2||
48528470|NCT01708590|101628375|FG004|COMPLETED|Induction Phase||0||
48528471|NCT01708590|101628376|FG005|COMPLETED|Induction Phase||0||
48528472|NCT01708590|101628377|FG006|COMPLETED|Induction Phase||0||
48528473|NCT01708590|101628371|FG000|NOT COMPLETED|Induction Phase||10||
48528474|NCT01708590|101628372|FG001|NOT COMPLETED|Induction Phase||7||
48528475|NCT01708590|101628373|FG002|NOT COMPLETED|Induction Phase||11||
48528476|NCT01708590|101628374|FG003|NOT COMPLETED|Induction Phase||0||
48528477|NCT01708590|101628375|FG004|NOT COMPLETED|Induction Phase||0||
48528478|NCT01708590|101628376|FG005|NOT COMPLETED|Induction Phase||0||
48528479|NCT01708590|101628377|FG006|NOT COMPLETED|Induction Phase||0||
48228843|NCT01708278|100880740|FG004|STARTED|Overall Study||1||
48228844|NCT01708278|100880741|FG005|STARTED|Overall Study||1||
48228845|NCT01708278|100880736|FG000|COMPLETED|Overall Study||1||
48228846|NCT01708278|100880737|FG001|COMPLETED|Overall Study||2||
48228847|NCT01708278|100880738|FG002|COMPLETED|Overall Study||2||
48228848|NCT01708278|100880739|FG003|COMPLETED|Overall Study||2||
48228849|NCT01708278|100880740|FG004|COMPLETED|Overall Study||1||
48228850|NCT01708278|100880741|FG005|COMPLETED|Overall Study||1||
48228851|NCT01708278|100880736|FG000|NOT COMPLETED|Overall Study||0||
48228852|NCT01708278|100880737|FG001|NOT COMPLETED|Overall Study||0||
48228853|NCT01708278|100880738|FG002|NOT COMPLETED|Overall Study||0||
48228854|NCT01708278|100880739|FG003|NOT COMPLETED|Overall Study||0||
48228855|NCT01708278|100880740|FG004|NOT COMPLETED|Overall Study||0||
48228856|NCT01708278|100880741|FG005|NOT COMPLETED|Overall Study||0||
48228857|NCT04026256|100880742|FG000|STARTED|Overall Study||13||
48228858|NCT04026256|100880743|FG001|STARTED|Overall Study||9||
48228859|NCT04026256|100880744|FG002|STARTED|Overall Study||12||
48528480|NCT01708590|101628371|FG000|STARTED|Withdrawal Phase||0|A subset of 283 subjects were rerandomized to Placebo or Brodalumab in the Withdrawal Phase.|
48528481|NCT01708590|101628372|FG001|STARTED|Withdrawal Phase||0|A subset of 283 subjects were rerandomized to Placebo or Brodalumab in the Withdrawal Phase.|
48528482|NCT01708590|101628373|FG002|STARTED|Withdrawal Phase||0|A subset of 283 subjects were rerandomized to Placebo or Brodalumab in the Withdrawal Phase.|
48528483|NCT01708590|101628374|FG003|STARTED|Withdrawal Phase||59|A subset of 283 subjects were rerandomized to Placebo or Brodalumab in the Withdrawal Phase.|
48228860|NCT04026256|100880742|FG000|COMPLETED|Overall Study||10||
48228861|NCT04026256|100880743|FG001|COMPLETED|Overall Study||8||
48228862|NCT04026256|100880744|FG002|COMPLETED|Overall Study||9||
48228863|NCT04026256|100880742|FG000|NOT COMPLETED|Overall Study||3||
48228864|NCT04026256|100880743|FG001|NOT COMPLETED|Overall Study||1||
48228865|NCT04026256|100880744|FG002|NOT COMPLETED|Overall Study||3||
48228866|NCT01719172|100880745|FG000|STARTED|Overall Study||30||
48228867|NCT01719172|100880745|FG000|COMPLETED|Overall Study||28||
48228868|NCT01719172|100880745|FG000|NOT COMPLETED|Overall Study||2||
48228869|NCT04347941|100880746|FG000|STARTED|Overall Study||12||
48228870|NCT04347941|100880747|FG001|STARTED|Overall Study||12||
48228871|NCT04347941|100880746|FG000|COMPLETED|Overall Study||12||
48528484|NCT01708590|101628375|FG004|STARTED|Withdrawal Phase||57|A subset of 283 subjects were rerandomized to Placebo or Brodalumab in the Withdrawal Phase.|
48528485|NCT01708590|101628376|FG005|STARTED|Withdrawal Phase||84|A subset of 283 subjects were rerandomized to Placebo or Brodalumab in the Withdrawal Phase.|
48528486|NCT01708590|101628377|FG006|STARTED|Withdrawal Phase||83|A subset of 283 subjects were rerandomized to Placebo or Brodalumab in the Withdrawal Phase.|
48528487|NCT01708590|101628371|FG000|COMPLETED|Withdrawal Phase||0||
48528488|NCT01708590|101628372|FG001|COMPLETED|Withdrawal Phase||0||
48528489|NCT01708590|101628373|FG002|COMPLETED|Withdrawal Phase||0||
48528490|NCT01708590|101628374|FG003|COMPLETED|Withdrawal Phase||6||
48528491|NCT01708590|101628375|FG004|COMPLETED|Withdrawal Phase||45||
48528492|NCT01708590|101628376|FG005|COMPLETED|Withdrawal Phase||2||
48528493|NCT01708590|101628377|FG006|COMPLETED|Withdrawal Phase||74||
48528494|NCT01708590|101628371|FG000|NOT COMPLETED|Withdrawal Phase||0||
48528495|NCT01708590|101628372|FG001|NOT COMPLETED|Withdrawal Phase||0||
48528496|NCT01708590|101628373|FG002|NOT COMPLETED|Withdrawal Phase||0||
48528497|NCT01708590|101628374|FG003|NOT COMPLETED|Withdrawal Phase||53||
48528498|NCT01708590|101628375|FG004|NOT COMPLETED|Withdrawal Phase||12||
48528499|NCT01708590|101628376|FG005|NOT COMPLETED|Withdrawal Phase||82||
48528500|NCT01708590|101628377|FG006|NOT COMPLETED|Withdrawal Phase||9||
48528501|NCT03537274|101628378|FG000|STARTED|Overall Study||315||
48528502|NCT03537274|101628379|FG001|STARTED|Overall Study||298||
48528503|NCT03537274|101628380|FG002|STARTED|Overall Study||304||
48528504|NCT03537274|101628381|FG003|STARTED|Overall Study||307||
48528505|NCT03537274|101628378|FG000|Treated|Overall Study||315||
48528506|NCT03537274|101628379|FG001|Treated|Overall Study||297||
48528507|NCT03537274|101628380|FG002|Treated|Overall Study||304||
48528508|NCT03537274|101628381|FG003|Treated|Overall Study||303||
48528509|NCT03537274|101628378|FG000|COMPLETED|Overall Study||255||
48528510|NCT03537274|101628379|FG001|COMPLETED|Overall Study||229||
48528511|NCT03537274|101628380|FG002|COMPLETED|Overall Study||228||
48528512|NCT03537274|101628381|FG003|COMPLETED|Overall Study||231||
48528513|NCT03537274|101628378|FG000|NOT COMPLETED|Overall Study||60||
48528514|NCT03537274|101628379|FG001|NOT COMPLETED|Overall Study||69||
48528515|NCT03537274|101628380|FG002|NOT COMPLETED|Overall Study||76||
48528516|NCT03537274|101628381|FG003|NOT COMPLETED|Overall Study||76||
48228872|NCT04347941|100880747|FG001|COMPLETED|Overall Study||12||
48228873|NCT04347941|100880746|FG000|NOT COMPLETED|Overall Study||0||
48228874|NCT04347941|100880747|FG001|NOT COMPLETED|Overall Study||0||
48228875|NCT00857766|100880748|FG000|STARTED|Overall Study||123||
48228876|NCT00857766|100880749|FG001|STARTED|Overall Study||126||
48228877|NCT00857766|100880748|FG000|COMPLETED|Overall Study||92||
48228878|NCT00857766|100880749|FG001|COMPLETED|Overall Study||96||
48228879|NCT00857766|100880748|FG000|NOT COMPLETED|Overall Study||31||
48228880|NCT00857766|100880749|FG001|NOT COMPLETED|Overall Study||30||
48228881|NCT03883828|100880750|FG000|STARTED|Overall Study||40||
48228882|NCT03883828|100880751|FG001|STARTED|Overall Study||40||
48228883|NCT03883828|100880750|FG000|COMPLETED|Overall Study||39||
48528517|NCT01289665|101628382|FG000|STARTED|Overall Study||60||
48528518|NCT01289665|101628383|FG001|STARTED|Overall Study||60||
48528519|NCT01289665|101628382|FG000|COMPLETED|Overall Study||59||
48528520|NCT01289665|101628383|FG001|COMPLETED|Overall Study||60||
48528521|NCT01289665|101628382|FG000|NOT COMPLETED|Overall Study||1||
48528522|NCT01289665|101628383|FG001|NOT COMPLETED|Overall Study||0||
48528523|NCT02803229|101628384|FG000|STARTED|Overall Study||15|5 participants were not randomized following the placebo lead-in week.|
48528524|NCT02803229|101628385|FG001|STARTED|Overall Study||13|5 participants were not randomized following the placebo lead-in week.|
48528525|NCT02803229|101628384|FG000|COMPLETED|Overall Study||11||
48528526|NCT02803229|101628385|FG001|COMPLETED|Overall Study||7||
48528527|NCT02803229|101628384|FG000|NOT COMPLETED|Overall Study||4||
48528528|NCT02803229|101628385|FG001|NOT COMPLETED|Overall Study||6||
48528529|NCT00838435|101628386|FG000|STARTED|Part 1 (4 Weeks)||95||
48528530|NCT00838435|101628386|FG000|COMPLETED|Part 1 (4 Weeks)||95||
48528531|NCT00838435|101628386|FG000|NOT COMPLETED|Part 1 (4 Weeks)||0||
48528532|NCT00838435|101628386|FG000|STARTED|PK Sub-Study 2 (4 Weeks)||94||
48528533|NCT00838435|101628386|FG000|COMPLETED|PK Sub-Study 2 (4 Weeks)||93|of the 95 who started Part 1.|
48528534|NCT00838435|101628386|FG000|NOT COMPLETED|PK Sub-Study 2 (4 Weeks)||1||
48528535|NCT00838435|101628386|FG000|STARTED|Safety/Efficacy Sub-Study 1 (6 Months)||65||
48528536|NCT00838435|101628386|FG000|COMPLETED|Safety/Efficacy Sub-Study 1 (6 Months)||63||
48528537|NCT00838435|101628386|FG000|NOT COMPLETED|Safety/Efficacy Sub-Study 1 (6 Months)||2||
48528538|NCT00838435|101628386|FG000|STARTED|Part 2 (7 Years)||65||
48528539|NCT00838435|101628386|FG000|COMPLETED|Part 2 (7 Years)||49||
48528540|NCT00838435|101628386|FG000|NOT COMPLETED|Part 2 (7 Years)||16||
48528541|NCT03201250|101628387|FG000|STARTED|Overall Study||8||
48528542|NCT03201250|101628388|FG001|STARTED|Overall Study||3||
48528543|NCT03201250|101628389|FG002|STARTED|Overall Study||0||
48528544|NCT03201250|101628387|FG000|COMPLETED|Overall Study||5||
48528545|NCT03201250|101628388|FG001|COMPLETED|Overall Study||3||
48528546|NCT03201250|101628389|FG002|COMPLETED|Overall Study||0||
48528547|NCT03201250|101628387|FG000|NOT COMPLETED|Overall Study||3||
48528548|NCT03201250|101628388|FG001|NOT COMPLETED|Overall Study||0||
48528549|NCT03201250|101628389|FG002|NOT COMPLETED|Overall Study||0||
48528550|NCT03347422|101628390|FG000|STARTED|Part A (26 Weeks)||22||
48528551|NCT03347422|101628391|FG001|STARTED|Part A (26 Weeks)||20||
48528552|NCT03347422|101628390|FG000|COMPLETED|Part A (26 Weeks)||19||
48528553|NCT03347422|101628391|FG001|COMPLETED|Part A (26 Weeks)||20||
48528554|NCT03347422|101628390|FG000|NOT COMPLETED|Part A (26 Weeks)||3||
48528555|NCT03347422|101628391|FG001|NOT COMPLETED|Part A (26 Weeks)||0||
48528556|NCT03347422|101628390|FG000|STARTED|Part B (149 Weeks)||19||
48528557|NCT03347422|101628391|FG001|STARTED|Part B (149 Weeks)||20||
48528558|NCT03347422|101628390|FG000|COMPLETED|Part B (149 Weeks)||16||
48528559|NCT03347422|101628391|FG001|COMPLETED|Part B (149 Weeks)||16||
48528560|NCT03347422|101628390|FG000|NOT COMPLETED|Part B (149 Weeks)||3||
48528561|NCT03347422|101628391|FG001|NOT COMPLETED|Part B (149 Weeks)||4||
48528562|NCT01111019|101628392|FG000|STARTED|Overall Study||19||
48528563|NCT01111019|101628392|FG000|COMPLETED|Overall Study||16||
48528564|NCT01111019|101628392|FG000|NOT COMPLETED|Overall Study||3||
48528565|NCT02722148|101628393|FG000|STARTED|Overall Study||24||
48528566|NCT02722148|101628393|FG000|COMPLETED|Overall Study||19||
48528567|NCT02722148|101628393|FG000|NOT COMPLETED|Overall Study||5||
48528568|NCT00846521|101628394|FG000|STARTED|Overall Study||23||
48528569|NCT00846521|101628394|FG000|COMPLETED|Overall Study||12||
48528570|NCT00846521|101628394|FG000|NOT COMPLETED|Overall Study||11||
48528571|NCT00112866|101628395|FG000|STARTED|Overall Study||15||
48528572|NCT00112866|101628396|FG001|STARTED|Overall Study||15||
48528573|NCT00112866|101628395|FG000|COMPLETED|Overall Study||13||
48528574|NCT00112866|101628396|FG001|COMPLETED|Overall Study||13||
48528575|NCT00112866|101628395|FG000|NOT COMPLETED|Overall Study||2||
48528576|NCT00112866|101628396|FG001|NOT COMPLETED|Overall Study||2||
48528577|NCT03535675|101628397|FG000|STARTED|Overall Study||29||
48528578|NCT03535675|101628398|FG001|STARTED|Overall Study||30||
48528579|NCT03535675|101628397|FG000|COMPLETED|Overall Study||29||
48528580|NCT03535675|101628398|FG001|COMPLETED|Overall Study||30||
48528581|NCT03535675|101628397|FG000|NOT COMPLETED|Overall Study||0||
48528582|NCT03535675|101628398|FG001|NOT COMPLETED|Overall Study||0||
48528583|NCT02369900|101628399|FG000|STARTED|Overall Study||18||
48528584|NCT02369900|101628400|FG001|STARTED|Overall Study||22||
48528585|NCT02369900|101628399|FG000|COMPLETED|Overall Study||18||
48528586|NCT02369900|101628400|FG001|COMPLETED|Overall Study||22||
48528587|NCT02369900|101628399|FG000|NOT COMPLETED|Overall Study||0||
48528588|NCT02369900|101628400|FG001|NOT COMPLETED|Overall Study||0||
48528589|NCT04619992|101628401|FG000|STARTED|Overall Study||55||
48528590|NCT04619992|101628402|FG001|STARTED|Overall Study||7||
48528591|NCT04619992|101628401|FG000|COMPLETED|Overall Study||54||
48528592|NCT04619992|101628402|FG001|COMPLETED|Overall Study||7||
48528593|NCT04619992|101628401|FG000|NOT COMPLETED|Overall Study||1||
48528594|NCT04619992|101628402|FG001|NOT COMPLETED|Overall Study||0||
48528595|NCT01335997|101628403|FG000|STARTED|Period I and II||577||
48528596|NCT01335997|101628404|FG001|STARTED|Period I and II||562||
48528597|NCT01335997|101628403|FG000|COMPLETED|Period I and II||84||
48528598|NCT01335997|101628404|FG001|COMPLETED|Period I and II||83||
48528599|NCT01335997|101628403|FG000|NOT COMPLETED|Period I and II||493||
48528600|NCT01335997|101628404|FG001|NOT COMPLETED|Period I and II||479||
48528601|NCT01335997|101628403|FG000|STARTED|Period III||84||
48528602|NCT01335997|101628404|FG001|STARTED|Period III||83||
48528603|NCT01335997|101628403|FG000|COMPLETED|Period III||6||
48528604|NCT01335997|101628404|FG001|COMPLETED|Period III||4||
48528605|NCT01335997|101628403|FG000|NOT COMPLETED|Period III||78||
48528606|NCT01335997|101628404|FG001|NOT COMPLETED|Period III||79||
48228884|NCT03883828|100880751|FG001|COMPLETED|Overall Study||38||
48528607|NCT02177136|101628405|FG000|STARTED|DB Phase||26||
48528608|NCT02177136|101628406|FG001|STARTED|DB Phase||26||
48528609|NCT02177136|101628407|FG002|STARTED|DB Phase||25||
48528610|NCT02177136|101628408|FG003|STARTED|DB Phase||0||
48528611|NCT02177136|101628405|FG000|Received At Least 1 Dose Of Study Drug|DB Phase||25||
48528612|NCT02177136|101628406|FG001|Received At Least 1 Dose Of Study Drug|DB Phase||26||
48528613|NCT02177136|101628407|FG002|Received At Least 1 Dose Of Study Drug|DB Phase||25||
48528614|NCT02177136|101628408|FG003|Received At Least 1 Dose Of Study Drug|DB Phase||0||
48528615|NCT02177136|101628405|FG000|COMPLETED|DB Phase||19||
48528616|NCT02177136|101628406|FG001|COMPLETED|DB Phase||21||
48528617|NCT02177136|101628407|FG002|COMPLETED|DB Phase||21||
48528618|NCT02177136|101628408|FG003|COMPLETED|DB Phase||0||
48528619|NCT02177136|101628405|FG000|NOT COMPLETED|DB Phase||7||
48528620|NCT02177136|101628406|FG001|NOT COMPLETED|DB Phase||5||
48528621|NCT02177136|101628407|FG002|NOT COMPLETED|DB Phase||4||
48528622|NCT02177136|101628408|FG003|NOT COMPLETED|DB Phase||0||
48528623|NCT02177136|101628405|FG000|STARTED|LTSE Phase||0||
48528624|NCT02177136|101628406|FG001|STARTED|LTSE Phase||0||
48528625|NCT02177136|101628407|FG002|STARTED|LTSE Phase||0||
48528626|NCT02177136|101628408|FG003|STARTED|LTSE Phase||59||
48528627|NCT02177136|101628405|FG000|Received At Least 1 Dose Of Study Drug|LTSE Phase||0|All participants received open-label OCA during the LTSE phase of the study.|
48528628|NCT02177136|101628406|FG001|Received At Least 1 Dose Of Study Drug|LTSE Phase||0|All participants received open-label OCA during the LTSE phase of the study.|
48528629|NCT02177136|101628407|FG002|Received At Least 1 Dose Of Study Drug|LTSE Phase||0|All participants received open-label OCA during the LTSE phase of the study.|
48528630|NCT02177136|101628408|FG003|Received At Least 1 Dose Of Study Drug|LTSE Phase||59|All participants received open-label OCA during the LTSE phase of the study.|
48228885|NCT03883828|100880750|FG000|NOT COMPLETED|Overall Study||1||
48228886|NCT03883828|100880751|FG001|NOT COMPLETED|Overall Study||2||
48228887|NCT01313884|100880752|FG000|STARTED|Overall Study||3||
48228888|NCT01313884|100880752|FG000|COMPLETED|Overall Study||2||
48228889|NCT01313884|100880752|FG000|NOT COMPLETED|Overall Study||1||
48228890|NCT04213807|100880753|FG000|STARTED|Overall Study||5||
48228891|NCT04213807|100880754|FG001|STARTED|Overall Study||6||
48228892|NCT04213807|100880755|FG002|STARTED|Overall Study||7||
48528631|NCT02177136|101628405|FG000|COMPLETED|LTSE Phase||0||
48528632|NCT02177136|101628406|FG001|COMPLETED|LTSE Phase||0||
48528633|NCT02177136|101628407|FG002|COMPLETED|LTSE Phase||0||
48528634|NCT02177136|101628408|FG003|COMPLETED|LTSE Phase||35||
48528635|NCT02177136|101628405|FG000|NOT COMPLETED|LTSE Phase||0||
48528636|NCT02177136|101628406|FG001|NOT COMPLETED|LTSE Phase||0||
48528637|NCT02177136|101628407|FG002|NOT COMPLETED|LTSE Phase||0||
48528638|NCT02177136|101628408|FG003|NOT COMPLETED|LTSE Phase||24||
48528639|NCT03914950|101628409|FG000|STARTED|Overall Study||174||
48528640|NCT03914950|101628409|FG000|COMPLETED|Overall Study||120||
48528641|NCT03914950|101628409|FG000|NOT COMPLETED|Overall Study||54||
48528642|NCT03374241|101628410|FG000|STARTED|Overall Study||6||
48528643|NCT03374241|101628411|FG001|STARTED|Overall Study||6||
48528644|NCT03374241|101628412|FG002|STARTED|Overall Study||6||
48528645|NCT03374241|101628413|FG003|STARTED|Overall Study||7||
48528646|NCT03374241|101628414|FG004|STARTED|Overall Study||6||
48528647|NCT03374241|101628415|FG005|STARTED|Overall Study||10||
48528648|NCT03374241|101628410|FG000|COMPLETED|Overall Study||6||
48228893|NCT04213807|100880753|FG000|COMPLETED|Overall Study||5||
48228894|NCT04213807|100880754|FG001|COMPLETED|Overall Study||6||
48228895|NCT04213807|100880755|FG002|COMPLETED|Overall Study||6||
48228896|NCT04213807|100880753|FG000|NOT COMPLETED|Overall Study||0||
48228897|NCT04213807|100880754|FG001|NOT COMPLETED|Overall Study||0||
48228898|NCT04213807|100880755|FG002|NOT COMPLETED|Overall Study||1||
48228899|NCT01332266|100880756|FG000|STARTED|Phase 1b||4||
48228900|NCT01332266|100880757|FG001|STARTED|Phase 1b||5||
48228901|NCT01332266|100880758|FG002|STARTED|Phase 1b||3||
48228902|NCT01332266|100880759|FG003|STARTED|Phase 1b||0||
48228903|NCT01332266|100880760|FG004|STARTED|Phase 1b||0||
48528649|NCT03374241|101628411|FG001|COMPLETED|Overall Study||6||
48528650|NCT03374241|101628412|FG002|COMPLETED|Overall Study||5||
48528651|NCT03374241|101628413|FG003|COMPLETED|Overall Study||5||
48528652|NCT03374241|101628414|FG004|COMPLETED|Overall Study||5||
48528653|NCT03374241|101628415|FG005|COMPLETED|Overall Study||10||
48528654|NCT03374241|101628410|FG000|NOT COMPLETED|Overall Study||0||
48528655|NCT03374241|101628411|FG001|NOT COMPLETED|Overall Study||0||
48528656|NCT03374241|101628412|FG002|NOT COMPLETED|Overall Study||1||
48528657|NCT03374241|101628413|FG003|NOT COMPLETED|Overall Study||2||
48528658|NCT03374241|101628414|FG004|NOT COMPLETED|Overall Study||1||
48528659|NCT03374241|101628415|FG005|NOT COMPLETED|Overall Study||0||
48528660|NCT02274844|101628416|FG000|STARTED|Overall Study||203||
48528661|NCT02274844|101628417|FG001|STARTED|Overall Study||270||
48528662|NCT02274844|101628416|FG000|COMPLETED|Overall Study||165||
48528663|NCT02274844|101628417|FG001|COMPLETED|Overall Study||238||
48228904|NCT01332266|100880756|FG000|COMPLETED|Phase 1b||0||
48228905|NCT01332266|100880757|FG001|COMPLETED|Phase 1b||0||
48228906|NCT01332266|100880758|FG002|COMPLETED|Phase 1b||0||
48228907|NCT01332266|100880759|FG003|COMPLETED|Phase 1b||0||
48228908|NCT01332266|100880760|FG004|COMPLETED|Phase 1b||0||
48228909|NCT01332266|100880756|FG000|NOT COMPLETED|Phase 1b||4||
48528664|NCT02274844|101628416|FG000|NOT COMPLETED|Overall Study||38||
48528665|NCT02274844|101628417|FG001|NOT COMPLETED|Overall Study||32||
48528666|NCT00541970|101628418|FG000|STARTED|Month 7||240||
48528667|NCT00541970|101628419|FG001|STARTED|Month 7||241||
48528668|NCT00541970|101628420|FG002|STARTED|Month 7||240||
48528669|NCT00541970|101628421|FG003|STARTED|Month 7||239||
48528670|NCT00541970|101628418|FG000|COMPLETED|Month 7||231||
48528671|NCT00541970|101628419|FG001|COMPLETED|Month 7||228||
48528672|NCT00541970|101628420|FG002|COMPLETED|Month 7||229||
48528673|NCT00541970|101628421|FG003|COMPLETED|Month 7||234||
48528674|NCT00541970|101628418|FG000|NOT COMPLETED|Month 7||9||
48528675|NCT00541970|101628419|FG001|NOT COMPLETED|Month 7||13||
48528676|NCT00541970|101628420|FG002|NOT COMPLETED|Month 7||11||
48528677|NCT00541970|101628421|FG003|NOT COMPLETED|Month 7||5||
48528678|NCT00541970|101628418|FG000|STARTED|Month 12||240||
48528679|NCT00541970|101628419|FG001|STARTED|Month 12||241||
48528680|NCT00541970|101628420|FG002|STARTED|Month 12||240||
48528681|NCT00541970|101628421|FG003|STARTED|Month 12||239||
48528682|NCT00541970|101628418|FG000|COMPLETED|Month 12||228||
48528683|NCT00541970|101628419|FG001|COMPLETED|Month 12||219||
48528684|NCT00541970|101628420|FG002|COMPLETED|Month 12||219||
48528685|NCT00541970|101628421|FG003|COMPLETED|Month 12||223||
48528686|NCT00541970|101628418|FG000|NOT COMPLETED|Month 12||12||
48528687|NCT00541970|101628419|FG001|NOT COMPLETED|Month 12||22||
48528688|NCT00541970|101628420|FG002|NOT COMPLETED|Month 12||21||
48528689|NCT00541970|101628421|FG003|NOT COMPLETED|Month 12||16||
48528690|NCT00541970|101628418|FG000|STARTED|Month 18||240||
48528691|NCT00541970|101628419|FG001|STARTED|Month 18||241||
48528692|NCT00541970|101628420|FG002|STARTED|Month 18||240||
48528693|NCT00541970|101628421|FG003|STARTED|Month 18||239||
48528694|NCT00541970|101628418|FG000|COMPLETED|Month 18||226||
48528695|NCT00541970|101628419|FG001|COMPLETED|Month 18||217||
48528696|NCT00541970|101628420|FG002|COMPLETED|Month 18||215||
48528697|NCT00541970|101628421|FG003|COMPLETED|Month 18||222||
48528698|NCT00541970|101628418|FG000|NOT COMPLETED|Month 18||14||
48528699|NCT00541970|101628419|FG001|NOT COMPLETED|Month 18||24||
48528700|NCT00541970|101628420|FG002|NOT COMPLETED|Month 18||25||
48528701|NCT00541970|101628421|FG003|NOT COMPLETED|Month 18||17||
48528702|NCT00541970|101628418|FG000|STARTED|Month 24||240||
48528703|NCT00541970|101628419|FG001|STARTED|Month 24||241||
48528704|NCT00541970|101628420|FG002|STARTED|Month 24||240||
48528705|NCT00541970|101628421|FG003|STARTED|Month 24||239||
48528706|NCT00541970|101628418|FG000|COMPLETED|Month 24||211||
48528707|NCT00541970|101628419|FG001|COMPLETED|Month 24||209||
48528708|NCT00541970|101628420|FG002|COMPLETED|Month 24||208||
48528709|NCT00541970|101628421|FG003|COMPLETED|Month 24||217||
48528710|NCT00541970|101628418|FG000|NOT COMPLETED|Month 24||29||
48528711|NCT00541970|101628419|FG001|NOT COMPLETED|Month 24||32||
48528712|NCT00541970|101628420|FG002|NOT COMPLETED|Month 24||32||
48528713|NCT00541970|101628421|FG003|NOT COMPLETED|Month 24||22||
48528714|NCT00541970|101628418|FG000|STARTED|Month 36||240||
48228910|NCT01332266|100880757|FG001|NOT COMPLETED|Phase 1b||5||
48228911|NCT01332266|100880758|FG002|NOT COMPLETED|Phase 1b||3||
48228912|NCT01332266|100880759|FG003|NOT COMPLETED|Phase 1b||0||
48228913|NCT01332266|100880760|FG004|NOT COMPLETED|Phase 1b||0||
48228914|NCT01332266|100880756|FG000|STARTED|Phase 2||0||
48228915|NCT01332266|100880757|FG001|STARTED|Phase 2||0||
48228916|NCT01332266|100880758|FG002|STARTED|Phase 2||0||
48228917|NCT01332266|100880759|FG003|STARTED|Phase 2||42||
48228918|NCT01332266|100880760|FG004|STARTED|Phase 2||41||
48228919|NCT01332266|100880756|FG000|COMPLETED|Phase 2||0||
48228920|NCT01332266|100880757|FG001|COMPLETED|Phase 2||0||
48228921|NCT01332266|100880758|FG002|COMPLETED|Phase 2||0||
48228922|NCT01332266|100880759|FG003|COMPLETED|Phase 2||0||
48228923|NCT01332266|100880760|FG004|COMPLETED|Phase 2||0||
48228924|NCT01332266|100880756|FG000|NOT COMPLETED|Phase 2||0||
48228925|NCT01332266|100880757|FG001|NOT COMPLETED|Phase 2||0||
48228926|NCT01332266|100880758|FG002|NOT COMPLETED|Phase 2||0||
48228927|NCT01332266|100880759|FG003|NOT COMPLETED|Phase 2||42||
48228928|NCT01332266|100880760|FG004|NOT COMPLETED|Phase 2||41||
48228929|NCT01328496|100880761|FG000|STARTED|Overall Study||10||
48228930|NCT01328496|100880762|FG001|STARTED|Overall Study||4||
48228931|NCT01328496|100880761|FG000|COMPLETED|Overall Study||9||
48528715|NCT00541970|101628419|FG001|STARTED|Month 36||241||
48528716|NCT00541970|101628420|FG002|STARTED|Month 36||240||
48528717|NCT00541970|101628421|FG003|STARTED|Month 36||239||
48528718|NCT00541970|101628418|FG000|COMPLETED|Month 36||179||
48528719|NCT00541970|101628419|FG001|COMPLETED|Month 36||175||
48528720|NCT00541970|101628420|FG002|COMPLETED|Month 36||174||
48528721|NCT00541970|101628421|FG003|COMPLETED|Month 36||179||
48528722|NCT00541970|101628418|FG000|NOT COMPLETED|Month 36||61||
48228932|NCT01328496|100880762|FG001|COMPLETED|Overall Study||4||
48228933|NCT01328496|100880761|FG000|NOT COMPLETED|Overall Study||1||
48228934|NCT01328496|100880762|FG001|NOT COMPLETED|Overall Study||0||
48228935|NCT01801007|100880763|FG000|STARTED|Overall Study||145||
48228936|NCT01801007|100880763|FG000|COMPLETED|Overall Study||134||
48228937|NCT01801007|100880763|FG000|NOT COMPLETED|Overall Study||11||
48228938|NCT00777049|100880764|FG000|STARTED|Overall Study||33||
48228939|NCT00777049|100880765|FG001|STARTED|Overall Study||21||
48228940|NCT00777049|100880764|FG000|COMPLETED|Overall Study||32||
48228941|NCT00777049|100880765|FG001|COMPLETED|Overall Study||20||
48228942|NCT00777049|100880764|FG000|NOT COMPLETED|Overall Study||1||
48228943|NCT00777049|100880765|FG001|NOT COMPLETED|Overall Study||1||
48228944|NCT01728324|100880766|FG000|STARTED|Termination of DBV||211||
48228945|NCT01728324|100880767|FG001|STARTED|Termination of DBV||213||
48228946|NCT01728324|100880768|FG002|STARTED|Termination of DBV||72||
48228947|NCT01728324|100880766|FG000|COMPLETED|Termination of DBV||173||
48228948|NCT01728324|100880767|FG001|COMPLETED|Termination of DBV||177||
48228949|NCT01728324|100880768|FG002|COMPLETED|Termination of DBV||58||
48228950|NCT01728324|100880766|FG000|NOT COMPLETED|Termination of DBV||38||
48228951|NCT01728324|100880767|FG001|NOT COMPLETED|Termination of DBV||36||
48228952|NCT01728324|100880768|FG002|NOT COMPLETED|Termination of DBV||14||
48228953|NCT01728324|100880766|FG000|STARTED|Termination of FDV||211||
48228954|NCT01728324|100880767|FG001|STARTED|Termination of FDV||213||
48228955|NCT01728324|100880768|FG002|STARTED|Termination of FDV||72||
48528723|NCT00541970|101628419|FG001|NOT COMPLETED|Month 36||66||
48528724|NCT00541970|101628420|FG002|NOT COMPLETED|Month 36||66||
48528725|NCT00541970|101628421|FG003|NOT COMPLETED|Month 36||60||
48528726|NCT00541970|101628418|FG000|STARTED|Month 48||240||
48528727|NCT00541970|101628419|FG001|STARTED|Month 48||241||
48528728|NCT00541970|101628420|FG002|STARTED|Month 48||240||
48528729|NCT00541970|101628421|FG003|STARTED|Month 48||239||
48528730|NCT00541970|101628418|FG000|COMPLETED|Month 48||169||
48528731|NCT00541970|101628419|FG001|COMPLETED|Month 48||168||
48528732|NCT00541970|101628420|FG002|COMPLETED|Month 48||167||
48528733|NCT00541970|101628421|FG003|COMPLETED|Month 48||164||
48528734|NCT00541970|101628418|FG000|NOT COMPLETED|Month 48||71||
48528735|NCT00541970|101628419|FG001|NOT COMPLETED|Month 48||73||
48528736|NCT00541970|101628420|FG002|NOT COMPLETED|Month 48||73||
48528737|NCT00541970|101628421|FG003|NOT COMPLETED|Month 48||75||
48528738|NCT00541970|101628418|FG000|STARTED|Month 60||240||
48528739|NCT00541970|101628419|FG001|STARTED|Month 60||241||
48528740|NCT00541970|101628420|FG002|STARTED|Month 60||240||
48528741|NCT00541970|101628421|FG003|STARTED|Month 60||239||
48528742|NCT00541970|101628418|FG000|COMPLETED|Month 60||162||
48528743|NCT00541970|101628419|FG001|COMPLETED|Month 60||164||
48528744|NCT00541970|101628420|FG002|COMPLETED|Month 60||158||
48528745|NCT00541970|101628421|FG003|COMPLETED|Month 60||167||
48228956|NCT01728324|100880766|FG000|COMPLETED|Termination of FDV||173||
48228957|NCT01728324|100880767|FG001|COMPLETED|Termination of FDV||177||
48228958|NCT01728324|100880768|FG002|COMPLETED|Termination of FDV||58||
48228959|NCT01728324|100880766|FG000|NOT COMPLETED|Termination of FDV||38||
48228960|NCT01728324|100880767|FG001|NOT COMPLETED|Termination of FDV||36||
48228961|NCT01728324|100880768|FG002|NOT COMPLETED|Termination of FDV||14||
48228962|NCT01728324|100880766|FG000|STARTED|Termination of RBV||211||
48228963|NCT01728324|100880767|FG001|STARTED|Termination of RBV||213||
48228964|NCT01728324|100880768|FG002|STARTED|Termination of RBV||72||
48228965|NCT01728324|100880766|FG000|COMPLETED|Termination of RBV||172||
48228966|NCT01728324|100880767|FG001|COMPLETED|Termination of RBV||176||
48228967|NCT01728324|100880768|FG002|COMPLETED|Termination of RBV||57||
48228968|NCT01728324|100880766|FG000|NOT COMPLETED|Termination of RBV||39||
48228969|NCT01728324|100880767|FG001|NOT COMPLETED|Termination of RBV||37||
48228970|NCT01728324|100880768|FG002|NOT COMPLETED|Termination of RBV||15||
48228971|NCT04660799|100880769|FG000|STARTED|Overall Study||24||
48228972|NCT04660799|100880770|FG001|STARTED|Overall Study||26||
48228973|NCT04660799|100880769|FG000|COMPLETED|Overall Study||17||
48228974|NCT04660799|100880770|FG001|COMPLETED|Overall Study||18||
48228975|NCT04660799|100880769|FG000|NOT COMPLETED|Overall Study||7||
48228976|NCT04660799|100880770|FG001|NOT COMPLETED|Overall Study||8||
48228977|NCT00686257|100880771|FG000|STARTED|Overall Study||29||
48228978|NCT00686257|100880772|FG001|STARTED|Overall Study||31||
48228979|NCT00686257|100880771|FG000|COMPLETED|Overall Study||29||
48228980|NCT00686257|100880772|FG001|COMPLETED|Overall Study||31||
48228981|NCT00686257|100880771|FG000|NOT COMPLETED|Overall Study||0||
48228982|NCT00686257|100880772|FG001|NOT COMPLETED|Overall Study||0||
48228983|NCT01934452|100880773|FG000|STARTED|Overall Study||35||
48228984|NCT01934452|100880774|FG001|STARTED|Overall Study||42||
48228985|NCT01934452|100880773|FG000|COMPLETED|Overall Study||35||
48228986|NCT01934452|100880774|FG001|COMPLETED|Overall Study||42||
48228987|NCT01934452|100880773|FG000|NOT COMPLETED|Overall Study||0||
48228988|NCT01934452|100880774|FG001|NOT COMPLETED|Overall Study||0||
48228989|NCT03241810|100880775|FG000|STARTED|Overall Study||11||
48228990|NCT03241810|100880776|FG001|STARTED|Overall Study||11||
48228991|NCT03241810|100880775|FG000|COMPLETED|Overall Study||11||
48228992|NCT03241810|100880776|FG001|COMPLETED|Overall Study||11||
48528746|NCT00541970|101628418|FG000|NOT COMPLETED|Month 60||78||
48528747|NCT00541970|101628419|FG001|NOT COMPLETED|Month 60||77||
48528748|NCT00541970|101628420|FG002|NOT COMPLETED|Month 60||82||
48228993|NCT03241810|100880775|FG000|NOT COMPLETED|Overall Study||0||
48228994|NCT03241810|100880776|FG001|NOT COMPLETED|Overall Study||0||
48228995|NCT01085513|100880777|FG000|STARTED|Phase I - Development Phase||54||
48528749|NCT00541970|101628421|FG003|NOT COMPLETED|Month 60||72||
48528750|NCT03123861|101628422|FG000|STARTED|Overall Study||22||
48528751|NCT03123861|101628423|FG001|STARTED|Overall Study||23||
48528752|NCT03123861|101628422|FG000|Received Intervention|Overall Study||21||
48528753|NCT03123861|101628423|FG001|Received Intervention|Overall Study||22||
48528754|NCT03123861|101628422|FG000|COMPLETED|Overall Study||19||
48528755|NCT03123861|101628423|FG001|COMPLETED|Overall Study||20||
48528756|NCT03123861|101628422|FG000|NOT COMPLETED|Overall Study||3||
48528757|NCT03123861|101628423|FG001|NOT COMPLETED|Overall Study||3||
48528758|NCT01208220|101628424|FG000|STARTED|Overall Study||1||
48528759|NCT01208220|101628425|FG001|STARTED|Overall Study||1||
48528760|NCT01208220|101628424|FG000|COMPLETED|Overall Study||1||
48528761|NCT01208220|101628425|FG001|COMPLETED|Overall Study||1||
48528762|NCT01208220|101628424|FG000|NOT COMPLETED|Overall Study||0||
48528763|NCT01208220|101628425|FG001|NOT COMPLETED|Overall Study||0||
48528764|NCT02906930|101628426|FG000|STARTED|Overall Study||175||
48528765|NCT02906930|101628427|FG001|STARTED|Overall Study||175||
48528766|NCT02906930|101628428|FG002|STARTED|Overall Study||175||
48528767|NCT02906930|101628429|FG003|STARTED|Overall Study||178||
48528768|NCT02906930|101628426|FG000|Full Analysis Set (FAS)|Overall Study||175||
48528769|NCT02906930|101628427|FG001|Full Analysis Set (FAS)|Overall Study||175||
48528770|NCT02906930|101628428|FG002|Full Analysis Set (FAS)|Overall Study||175||
48528771|NCT02906930|101628429|FG003|Full Analysis Set (FAS)|Overall Study||178||
48528772|NCT02906930|101628426|FG000|Safety Analysis Set (SAS)|Overall Study||175||
48528773|NCT02906930|101628427|FG001|Safety Analysis Set (SAS)|Overall Study||175||
48528774|NCT02906930|101628428|FG002|Safety Analysis Set (SAS)|Overall Study||175||
48528775|NCT02906930|101628429|FG003|Safety Analysis Set (SAS)|Overall Study||178||
48528776|NCT02906930|101628426|FG000|COMPLETED|Overall Study||169||
48528777|NCT02906930|101628427|FG001|COMPLETED|Overall Study||161||
48528778|NCT02906930|101628428|FG002|COMPLETED|Overall Study||163||
48528779|NCT02906930|101628429|FG003|COMPLETED|Overall Study||170||
48528780|NCT02906930|101628426|FG000|NOT COMPLETED|Overall Study||6||
48528781|NCT02906930|101628427|FG001|NOT COMPLETED|Overall Study||14||
48528782|NCT02906930|101628428|FG002|NOT COMPLETED|Overall Study||12||
48528783|NCT02906930|101628429|FG003|NOT COMPLETED|Overall Study||8||
48528784|NCT01436799|101628430|FG000|STARTED|Overall Study||20||
48528785|NCT01436799|101628431|FG001|STARTED|Overall Study||20||
48528786|NCT01436799|101628430|FG000|COMPLETED|Overall Study||20||
48080662|NCT01235351|100518823|FG001|150 mg First Then 75 mg|Treatment With Different Dose Sequences||0||
48080663|NCT01235351|100518822|FG000|225 mg First Then 300 mg|Treatment With Different Dose Sequences||0||
48080664|NCT01235351|100518823|FG001|225 mg First Then 300 mg|Treatment With Different Dose Sequences||41||
48080665|NCT01235351|100518822|FG000|300 mg First Then 225 mg|Treatment With Different Dose Sequences||0||
48080666|NCT01235351|100518823|FG001|300 mg First Then 225 mg|Treatment With Different Dose Sequences||41||
48080667|NCT01235351|100518822|FG000|COMPLETED|Treatment With Different Dose Sequences||233||
48080668|NCT01235351|100518823|FG001|COMPLETED|Treatment With Different Dose Sequences||82||
48080669|NCT01235351|100518822|FG000|NOT COMPLETED|Treatment With Different Dose Sequences||0||
48080670|NCT01235351|100518823|FG001|NOT COMPLETED|Treatment With Different Dose Sequences||0||
48080671|NCT01929460|100518824|FG000|STARTED|Overall Study||13||
48080672|NCT01929460|100518825|FG001|STARTED|Overall Study||13||
48080673|NCT01929460|100518824|FG000|COMPLETED|Overall Study||13||
48080674|NCT01929460|100518825|FG001|COMPLETED|Overall Study||13||
48080675|NCT01929460|100518824|FG000|NOT COMPLETED|Overall Study||0||
48080676|NCT01929460|100518825|FG001|NOT COMPLETED|Overall Study||0||
48080677|NCT01749137|100518826|FG000|STARTED|Overall Study||37||
48080678|NCT01749137|100518827|FG001|STARTED|Overall Study||37||
48080679|NCT01749137|100518826|FG000|COMPLETED|Overall Study||22||
48080680|NCT01749137|100518827|FG001|COMPLETED|Overall Study||26||
48080681|NCT01749137|100518826|FG000|NOT COMPLETED|Overall Study||15||
48080682|NCT01749137|100518827|FG001|NOT COMPLETED|Overall Study||11||
48080683|NCT00471328|100518828|FG000|STARTED|Core Phase||165||
48080684|NCT00471328|100518829|FG001|STARTED|Core Phase||83||
48080685|NCT00471328|100518828|FG000|Crossover to Nilotinib:Started Extension|Core Phase||0||
48080686|NCT00471328|100518829|FG001|Crossover to Nilotinib:Started Extension|Core Phase||53||
48228996|NCT01085513|100880778|FG001|STARTED|Phase I - Development Phase||52||
48228997|NCT01085513|100880777|FG000|COMPLETED|Phase I - Development Phase||54||
48228998|NCT01085513|100880778|FG001|COMPLETED|Phase I - Development Phase||52||
48228999|NCT01085513|100880777|FG000|NOT COMPLETED|Phase I - Development Phase||0||
48229000|NCT01085513|100880778|FG001|NOT COMPLETED|Phase I - Development Phase||0||
48528787|NCT01436799|101628431|FG001|COMPLETED|Overall Study||20||
48080687|NCT00471328|100518828|FG000|COMPLETED|Core Phase||58||
48080688|NCT00471328|100518829|FG001|COMPLETED|Core Phase||16||
48528788|NCT01436799|101628430|FG000|NOT COMPLETED|Overall Study||0||
48528789|NCT01436799|101628431|FG001|NOT COMPLETED|Overall Study||0||
48528790|NCT01155024|101628432|FG000|STARTED|First Socket Intervention Fitting||5||
48528791|NCT01155024|101628433|FG001|STARTED|First Socket Intervention Fitting||5||
48592649|NCT01877382|101783151|FG001|NOT COMPLETED|Dose Escalation||1||
48528792|NCT01155024|101628432|FG000|COMPLETED|First Socket Intervention Fitting||5||
48528793|NCT01155024|101628433|FG001|COMPLETED|First Socket Intervention Fitting||5||
48528794|NCT01155024|101628432|FG000|NOT COMPLETED|First Socket Intervention Fitting||0||
48528795|NCT01155024|101628433|FG001|NOT COMPLETED|First Socket Intervention Fitting||0||
48528796|NCT01155024|101628432|FG000|STARTED|Second Socket Intervention Fitting||5||
48528797|NCT01155024|101628433|FG001|STARTED|Second Socket Intervention Fitting||5||
48528798|NCT01155024|101628432|FG000|COMPLETED|Second Socket Intervention Fitting||5||
48528799|NCT01155024|101628433|FG001|COMPLETED|Second Socket Intervention Fitting||5||
48528800|NCT01155024|101628432|FG000|NOT COMPLETED|Second Socket Intervention Fitting||0||
48528801|NCT01155024|101628433|FG001|NOT COMPLETED|Second Socket Intervention Fitting||0||
48528802|NCT01155024|101628432|FG000|STARTED|Direct Manufactured Socket 3 Month Trial||0||
48229001|NCT01085513|100880777|FG000|STARTED|Phase II - Validation Phase||21||
48229002|NCT01085513|100880778|FG001|STARTED|Phase II - Validation Phase||16||
48229003|NCT01085513|100880777|FG000|COMPLETED|Phase II - Validation Phase||21||
48229004|NCT01085513|100880778|FG001|COMPLETED|Phase II - Validation Phase||16||
48229005|NCT01085513|100880777|FG000|NOT COMPLETED|Phase II - Validation Phase||0||
48229006|NCT01085513|100880778|FG001|NOT COMPLETED|Phase II - Validation Phase||0||
48229007|NCT00825344|100880779|FG000|STARTED|Overall Study||34||
48528803|NCT01155024|101628433|FG001|STARTED|Direct Manufactured Socket 3 Month Trial||10||
48528804|NCT01155024|101628432|FG000|COMPLETED|Direct Manufactured Socket 3 Month Trial||0||
48528805|NCT01155024|101628433|FG001|COMPLETED|Direct Manufactured Socket 3 Month Trial||4||
48528806|NCT01155024|101628432|FG000|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||0||
48528807|NCT01155024|101628433|FG001|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||6||
48528808|NCT02288182|101628434|FG000|STARTED|Overall Study||25||
48528809|NCT02288182|101628435|FG001|STARTED|Overall Study||27||
48528810|NCT02288182|101628434|FG000|COMPLETED|Overall Study||25||
48528811|NCT02288182|101628435|FG001|COMPLETED|Overall Study||25||
48528812|NCT02288182|101628434|FG000|NOT COMPLETED|Overall Study||0||
48528813|NCT02288182|101628435|FG001|NOT COMPLETED|Overall Study||2||
48528814|NCT05256134|101628436|FG000|STARTED|Overall Study||12||
48528815|NCT05256134|101628437|FG001|STARTED|Overall Study||13||
48528816|NCT05256134|101628436|FG000|COMPLETED|Overall Study||0||
48528817|NCT05256134|101628437|FG001|COMPLETED|Overall Study||0||
48528818|NCT05256134|101628436|FG000|NOT COMPLETED|Overall Study||12||
48528819|NCT05256134|101628437|FG001|NOT COMPLETED|Overall Study||13||
48528820|NCT01705236|101628438|FG000|STARTED|Overall Study||87||
48528821|NCT01705236|101628438|FG000|COMPLETED|Overall Study||60||
48528822|NCT01705236|101628438|FG000|NOT COMPLETED|Overall Study||27||
48528823|NCT02674061|101628439|FG000|STARTED|Overall Study||285||
48528824|NCT02674061|101628440|FG001|STARTED|Overall Study||91||
48528825|NCT02674061|101628439|FG000|COMPLETED|Overall Study||0||
48528826|NCT02674061|101628440|FG001|COMPLETED|Overall Study||0||
48528827|NCT02674061|101628439|FG000|NOT COMPLETED|Overall Study||285||
48528828|NCT02674061|101628440|FG001|NOT COMPLETED|Overall Study||91||
48528829|NCT00971841|101628441|FG000|STARTED|Overall Study||1||
48528830|NCT00971841|101628441|FG000|COMPLETED|Overall Study||1||
48528831|NCT00971841|101628441|FG000|NOT COMPLETED|Overall Study||0||
48528832|NCT02196701|101628442|FG000|STARTED|Overall Study||46||
48528833|NCT02196701|101628442|FG000|COMPLETED|Overall Study||43||
48528834|NCT02196701|101628442|FG000|NOT COMPLETED|Overall Study||3||
48528835|NCT01856361|101628443|FG000|STARTED|Overall Study||1||
48528836|NCT01856361|101628444|FG001|STARTED|Overall Study||1||
48528837|NCT01856361|101628443|FG000|COMPLETED|Overall Study||1||
48528838|NCT01856361|101628444|FG001|COMPLETED|Overall Study||1||
48528839|NCT01856361|101628443|FG000|NOT COMPLETED|Overall Study||0||
48528840|NCT01856361|101628444|FG001|NOT COMPLETED|Overall Study||0||
48528841|NCT00158756|101628445|FG000|STARTED|Overall Study||80||
48528842|NCT00158756|101628446|FG001|STARTED|Overall Study||25||
48528843|NCT00158756|101628447|FG002|STARTED|Overall Study||81||
48528844|NCT00158756|101628448|FG003|STARTED|Overall Study||23||
48528845|NCT00158756|101628449|FG004|STARTED|Overall Study||99||
48528846|NCT00158756|101628445|FG000|COMPLETED|Overall Study||75||
48528847|NCT00158756|101628446|FG001|COMPLETED|Overall Study||25||
48229008|NCT00825344|100880780|FG001|STARTED|Overall Study||43||
48229009|NCT00825344|100880779|FG000|COMPLETED|Overall Study||33||
48229010|NCT00825344|100880780|FG001|COMPLETED|Overall Study||42||
48229011|NCT00825344|100880779|FG000|NOT COMPLETED|Overall Study||1||
48229012|NCT00825344|100880780|FG001|NOT COMPLETED|Overall Study||1||
48229013|NCT04534738|100880781|FG000|STARTED|Overall Study||23||
48229014|NCT04534738|100880782|FG001|STARTED|Overall Study||10||
48229015|NCT04534738|100880781|FG000|COMPLETED|Overall Study||23||
48229016|NCT04534738|100880782|FG001|COMPLETED|Overall Study||10||
48229017|NCT04534738|100880781|FG000|NOT COMPLETED|Overall Study||0||
48229018|NCT04534738|100880782|FG001|NOT COMPLETED|Overall Study||0||
48229019|NCT03131713|100880783|FG000|STARTED|Overall Study||50||
48528848|NCT00158756|101628447|FG002|COMPLETED|Overall Study||73||
48528849|NCT00158756|101628448|FG003|COMPLETED|Overall Study||22||
48528850|NCT00158756|101628449|FG004|COMPLETED|Overall Study||96||
48528851|NCT00158756|101628445|FG000|NOT COMPLETED|Overall Study||5||
48528852|NCT00158756|101628446|FG001|NOT COMPLETED|Overall Study||0||
48528853|NCT00158756|101628447|FG002|NOT COMPLETED|Overall Study||8||
48229020|NCT03131713|100880784|FG001|STARTED|Overall Study||51||
48229021|NCT03131713|100880783|FG000|COMPLETED|Overall Study||45||
48229022|NCT03131713|100880784|FG001|COMPLETED|Overall Study||51||
48229023|NCT03131713|100880783|FG000|NOT COMPLETED|Overall Study||5||
48229024|NCT03131713|100880784|FG001|NOT COMPLETED|Overall Study||0||
48229025|NCT00019604|100880785|FG000|STARTED|Overall Study||44||
48229026|NCT00019604|100880785|FG000|COMPLETED|Overall Study||5||
48229027|NCT00019604|100880785|FG000|NOT COMPLETED|Overall Study||39||
48229028|NCT01545583|100880786|FG000|STARTED|Overall Study||12||
48229029|NCT01545583|100880787|FG001|STARTED|Overall Study||2||
48229030|NCT01545583|100880788|FG002|STARTED|Overall Study||6||
48229031|NCT01545583|100880789|FG003|STARTED|Overall Study||6||
48229032|NCT01545583|100880790|FG004|STARTED|Overall Study||6||
48229033|NCT01545583|100880791|FG005|STARTED|Overall Study||6||
48229034|NCT01545583|100880792|FG006|STARTED|Overall Study||6||
48229035|NCT01545583|100880793|FG007|STARTED|Overall Study||6||
48229036|NCT01545583|100880794|FG008|STARTED|Overall Study||6||
48229037|NCT01545583|100880786|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12||
48229038|NCT01545583|100880787|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2||
48229039|NCT01545583|100880788|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
48229040|NCT01545583|100880789|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6||
48528854|NCT00158756|101628448|FG003|NOT COMPLETED|Overall Study||1||
48528855|NCT00158756|101628449|FG004|NOT COMPLETED|Overall Study||3||
48528856|NCT00858962|101628450|FG000|STARTED|Overall Study||12||
48528857|NCT00858962|101628450|FG000|COMPLETED|Overall Study||12||
48528858|NCT00858962|101628450|FG000|NOT COMPLETED|Overall Study||0||
48528859|NCT00325195|101628451|FG000|STARTED|Randomized||90||
48528860|NCT00325195|101628452|FG001|STARTED|Randomized||89||
48528861|NCT00325195|101628453|FG002|STARTED|Randomized||46||
48229041|NCT01545583|100880790|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6||
48229042|NCT01545583|100880791|FG005|Received at Least 1 Dose of Study Drug|Overall Study||6||
48229043|NCT01545583|100880792|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6||
48229044|NCT01545583|100880793|FG007|Received at Least 1 Dose of Study Drug|Overall Study||6||
48229045|NCT01545583|100880794|FG008|Received at Least 1 Dose of Study Drug|Overall Study||6||
48229046|NCT01545583|100880786|FG000|COMPLETED|Overall Study||12||
48229047|NCT01545583|100880787|FG001|COMPLETED|Overall Study||2||
48229048|NCT01545583|100880788|FG002|COMPLETED|Overall Study||6||
48229049|NCT01545583|100880789|FG003|COMPLETED|Overall Study||6||
48528862|NCT00325195|101628451|FG000|COMPLETED|Randomized||85||
48528863|NCT00325195|101628452|FG001|COMPLETED|Randomized||84||
48528864|NCT00325195|101628453|FG002|COMPLETED|Randomized||43||
48528865|NCT00325195|101628451|FG000|NOT COMPLETED|Randomized||5||
48528866|NCT00325195|101628452|FG001|NOT COMPLETED|Randomized||5||
48528867|NCT00325195|101628453|FG002|NOT COMPLETED|Randomized||3||
48528868|NCT00325195|101628451|FG000|STARTED|Received Intervention: ITT Population||85||
48528869|NCT00325195|101628452|FG001|STARTED|Received Intervention: ITT Population||84||
48528870|NCT00325195|101628453|FG002|STARTED|Received Intervention: ITT Population||43||
48528871|NCT00325195|101628451|FG000|COMPLETED|Received Intervention: ITT Population||59||
48528872|NCT00325195|101628452|FG001|COMPLETED|Received Intervention: ITT Population||59||
48528873|NCT00325195|101628453|FG002|COMPLETED|Received Intervention: ITT Population||39||
48528874|NCT00325195|101628451|FG000|NOT COMPLETED|Received Intervention: ITT Population||26||
48528875|NCT00325195|101628452|FG001|NOT COMPLETED|Received Intervention: ITT Population||25||
48528876|NCT00325195|101628453|FG002|NOT COMPLETED|Received Intervention: ITT Population||4||
48528877|NCT00891839|101628454|FG000|STARTED|Overall Study||45||
48528878|NCT00891839|101628454|FG000|COMPLETED|Overall Study||38||
48528879|NCT00891839|101628454|FG000|NOT COMPLETED|Overall Study||7||
48528880|NCT02356003|101628455|FG000|STARTED|Overall Study||10||
48528881|NCT02356003|101628455|FG000|COMPLETED|Overall Study||10||
48528882|NCT02356003|101628455|FG000|NOT COMPLETED|Overall Study||0||
48528883|NCT00609466|101628456|FG000|STARTED|Overall Study||96||
48229050|NCT01545583|100880790|FG004|COMPLETED|Overall Study||6||
48229051|NCT01545583|100880791|FG005|COMPLETED|Overall Study||6||
48528884|NCT00609466|101628457|FG001|STARTED|Overall Study||96||
48528885|NCT00609466|101628458|FG002|STARTED|Overall Study||99||
48528886|NCT00609466|101628456|FG000|COMPLETED|Overall Study||94||
48528887|NCT00609466|101628457|FG001|COMPLETED|Overall Study||90||
48528888|NCT00609466|101628458|FG002|COMPLETED|Overall Study||95||
48528889|NCT00609466|101628456|FG000|NOT COMPLETED|Overall Study||2||
48528890|NCT00609466|101628457|FG001|NOT COMPLETED|Overall Study||6||
48528891|NCT00609466|101628458|FG002|NOT COMPLETED|Overall Study||4||
48528892|NCT00193427|101628459|FG000|STARTED|Overall Study||75||
48528893|NCT00193427|101628459|FG000|COMPLETED|Overall Study||26||
48229052|NCT01545583|100880792|FG006|COMPLETED|Overall Study||6||
48229053|NCT01545583|100880793|FG007|COMPLETED|Overall Study||6||
48229054|NCT01545583|100880794|FG008|COMPLETED|Overall Study||6||
48229055|NCT01545583|100880786|FG000|NOT COMPLETED|Overall Study||0||
48229056|NCT01545583|100880787|FG001|NOT COMPLETED|Overall Study||0||
48528894|NCT00193427|101628459|FG000|NOT COMPLETED|Overall Study||49||
48528895|NCT00334061|101628460|FG000|STARTED|Overall Study||125||
48528896|NCT00334061|101628460|FG000|COMPLETED|Overall Study||125||
48528897|NCT00334061|101628460|FG000|NOT COMPLETED|Overall Study||0||
48528898|NCT01551888|101628461|FG000|STARTED|Period 1||12||
48528899|NCT01551888|101628462|FG001|STARTED|Period 1||12||
48528900|NCT01551888|101628461|FG000|COMPLETED|Period 1||12||
48528901|NCT01551888|101628462|FG001|COMPLETED|Period 1||12||
48229057|NCT01545583|100880788|FG002|NOT COMPLETED|Overall Study||0||
48229058|NCT01545583|100880789|FG003|NOT COMPLETED|Overall Study||0||
48229059|NCT01545583|100880790|FG004|NOT COMPLETED|Overall Study||0||
48229060|NCT01545583|100880791|FG005|NOT COMPLETED|Overall Study||0||
48528902|NCT01551888|101628461|FG000|NOT COMPLETED|Period 1||0||
48528903|NCT01551888|101628462|FG001|NOT COMPLETED|Period 1||0||
48528904|NCT01551888|101628461|FG000|STARTED|Period 2||12||
48528905|NCT01551888|101628462|FG001|STARTED|Period 2||12||
48528906|NCT01551888|101628461|FG000|COMPLETED|Period 2||12||
48528907|NCT01551888|101628462|FG001|COMPLETED|Period 2||12||
48528908|NCT01551888|101628461|FG000|NOT COMPLETED|Period 2||0||
48528909|NCT01551888|101628462|FG001|NOT COMPLETED|Period 2||0||
48528910|NCT01233921|101628463|FG000|STARTED|Overall Study||3||
48528911|NCT01233921|101628464|FG001|STARTED|Overall Study||3||
48528912|NCT01233921|101628463|FG000|COMPLETED|Overall Study||3||
48528913|NCT01233921|101628464|FG001|COMPLETED|Overall Study||3||
48528914|NCT01233921|101628463|FG000|NOT COMPLETED|Overall Study||0||
48528915|NCT01233921|101628464|FG001|NOT COMPLETED|Overall Study||0||
48528916|NCT03309007|101628465|FG000|STARTED|Overall Study||13||
48528917|NCT03309007|101628466|FG001|STARTED|Overall Study||12||
48528918|NCT03309007|101628465|FG000|COMPLETED|Overall Study||13||
48528919|NCT03309007|101628466|FG001|COMPLETED|Overall Study||12||
48528920|NCT03309007|101628465|FG000|NOT COMPLETED|Overall Study||0||
48528921|NCT03309007|101628466|FG001|NOT COMPLETED|Overall Study||0||
48528922|NCT02558231|101628467|FG000|STARTED|Overall Study||123||
48528923|NCT02558231|101628468|FG001|STARTED|Overall Study||124||
48528924|NCT02558231|101628467|FG000|Treated|Overall Study||123||
48528925|NCT02558231|101628468|FG001|Treated|Overall Study||123||
48528926|NCT02558231|101628467|FG000|COMPLETED|Overall Study||98||
48528927|NCT02558231|101628468|FG001|COMPLETED|Overall Study||98||
48528928|NCT02558231|101628467|FG000|NOT COMPLETED|Overall Study||25||
48528929|NCT02558231|101628468|FG001|NOT COMPLETED|Overall Study||26||
48528930|NCT00003138|101628469|FG000|STARTED|Step 1||61||
48528931|NCT00003138|101628470|FG001|STARTED|Step 1||57||
48528932|NCT00003138|101628469|FG000|Patients With Complete Data|Step 1||57||
48528933|NCT00003138|101628470|FG001|Patients With Complete Data|Step 1||53||
48528934|NCT00003138|101628469|FG000|Treated|Step 1||56||
48528935|NCT00003138|101628470|FG001|Treated|Step 1||53||
48528936|NCT00003138|101628469|FG000|Eligible and Treated|Step 1||52||
48528937|NCT00003138|101628470|FG001|Eligible and Treated|Step 1||50||
48528938|NCT00003138|101628469|FG000|Patients With QOL Data at 4 Months|Step 1||42||
48528939|NCT00003138|101628470|FG001|Patients With QOL Data at 4 Months|Step 1||42||
48528940|NCT00003138|101628469|FG000|Patients With Transfusion Data|Step 1||37||
48528941|NCT00003138|101628470|FG001|Patients With Transfusion Data|Step 1||42||
48528942|NCT00003138|101628469|FG000|COMPLETED|Step 1||0||
48528943|NCT00003138|101628470|FG001|COMPLETED|Step 1||0||
48528944|NCT00003138|101628469|FG000|NOT COMPLETED|Step 1||61||
48528945|NCT00003138|101628470|FG001|NOT COMPLETED|Step 1||57||
48528946|NCT00003138|101628469|FG000|STARTED|Step 2 (Cross Over)||26||
48528947|NCT00003138|101628470|FG001|STARTED|Step 2 (Cross Over)||0||
48229061|NCT01545583|100880792|FG006|NOT COMPLETED|Overall Study||0||
48229062|NCT01545583|100880793|FG007|NOT COMPLETED|Overall Study||0||
48528948|NCT00003138|101628469|FG000|COMPLETED|Step 2 (Cross Over)||0||
48528949|NCT00003138|101628470|FG001|COMPLETED|Step 2 (Cross Over)||0||
48528950|NCT00003138|101628469|FG000|NOT COMPLETED|Step 2 (Cross Over)||26||
48528951|NCT00003138|101628470|FG001|NOT COMPLETED|Step 2 (Cross Over)||0||
48528952|NCT00003138|101628469|FG000|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||12||
48229063|NCT01545583|100880794|FG008|NOT COMPLETED|Overall Study||0||
48229064|NCT02442622|100880795|FG000|STARTED|Overall Study||15||
48528953|NCT00003138|101628470|FG001|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||20||
48528954|NCT00003138|101628469|FG000|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||12||
48229065|NCT02442622|100880796|FG001|STARTED|Overall Study||17||
48229066|NCT02442622|100880795|FG000|COMPLETED|Overall Study||12||
48229067|NCT02442622|100880796|FG001|COMPLETED|Overall Study||16||
48229068|NCT02442622|100880795|FG000|NOT COMPLETED|Overall Study||3||
48229069|NCT02442622|100880796|FG001|NOT COMPLETED|Overall Study||1||
48229070|NCT01695291|100880797|FG000|STARTED|Overall Study||10||
48528955|NCT00003138|101628470|FG001|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||19||
48528956|NCT00003138|101628469|FG000|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0||
48528957|NCT00003138|101628470|FG001|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0||
48528958|NCT00003138|101628469|FG000|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||12||
48528959|NCT00003138|101628470|FG001|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||20||
48528960|NCT00003138|101628469|FG000|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||6||
48528961|NCT00003138|101628470|FG001|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||7||
48528962|NCT00003138|101628469|FG000|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0||
48528963|NCT00003138|101628470|FG001|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0||
48528964|NCT00003138|101628469|FG000|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||6||
48528965|NCT00003138|101628470|FG001|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||7||
48528966|NCT02327117|101628471|FG000|STARTED|Overall Study||45||
48528967|NCT02327117|101628472|FG001|STARTED|Overall Study||45||
48528968|NCT02327117|101628471|FG000|COMPLETED|Overall Study||45||
48528969|NCT02327117|101628472|FG001|COMPLETED|Overall Study||45||
48528970|NCT02327117|101628471|FG000|NOT COMPLETED|Overall Study||0||
48528971|NCT02327117|101628472|FG001|NOT COMPLETED|Overall Study||0||
48528972|NCT00390221|101628473|FG000|STARTED|Overall Study||204||
48528973|NCT00390221|101628474|FG001|STARTED|Overall Study||208||
48528974|NCT00390221|101628475|FG002|STARTED|Overall Study||209||
48528975|NCT00390221|101628473|FG000|COMPLETED|Overall Study||186||
48528976|NCT00390221|101628474|FG001|COMPLETED|Overall Study||188||
48528977|NCT00390221|101628475|FG002|COMPLETED|Overall Study||194||
48528978|NCT00390221|101628473|FG000|NOT COMPLETED|Overall Study||18||
48528979|NCT00390221|101628474|FG001|NOT COMPLETED|Overall Study||20||
48528980|NCT00390221|101628475|FG002|NOT COMPLETED|Overall Study||15||
48528981|NCT03861481|101628476|FG000|STARTED|Overall Study||17||
48528982|NCT03861481|101628477|FG001|STARTED|Overall Study||17||
48528983|NCT03861481|101628476|FG000|COMPLETED|Overall Study||11||
48528984|NCT03861481|101628477|FG001|COMPLETED|Overall Study||10||
48528985|NCT03861481|101628476|FG000|NOT COMPLETED|Overall Study||6||
48528986|NCT03861481|101628477|FG001|NOT COMPLETED|Overall Study||7||
48528987|NCT00415194|101628478|FG000|STARTED|Overall Study||398||
48528988|NCT00415194|101628479|FG001|STARTED|Overall Study||397||
48528989|NCT00415194|101628478|FG000|Received at Least 1 Dose of Study Drug|Overall Study||392||
48528990|NCT00415194|101628479|FG001|Received at Least 1 Dose of Study Drug|Overall Study||385||
48528991|NCT00415194|101628478|FG000|COMPLETED|Overall Study||70||
48528992|NCT00415194|101628479|FG001|COMPLETED|Overall Study||55||
48528993|NCT00415194|101628478|FG000|NOT COMPLETED|Overall Study||328||
48528994|NCT00415194|101628479|FG001|NOT COMPLETED|Overall Study||342||
48528995|NCT03258853|101628480|FG000|STARTED|First Intervention (14 Days)||11||
48528996|NCT03258853|101628481|FG001|STARTED|First Intervention (14 Days)||11||
48528997|NCT03258853|101628480|FG000|COMPLETED|First Intervention (14 Days)||10||
48528998|NCT03258853|101628481|FG001|COMPLETED|First Intervention (14 Days)||10||
48528999|NCT03258853|101628480|FG000|NOT COMPLETED|First Intervention (14 Days)||1||
48529000|NCT03258853|101628481|FG001|NOT COMPLETED|First Intervention (14 Days)||1||
48529001|NCT03258853|101628480|FG000|STARTED|Second Intervention (14 Days)||10||
48529002|NCT03258853|101628481|FG001|STARTED|Second Intervention (14 Days)||10||
48529003|NCT03258853|101628480|FG000|COMPLETED|Second Intervention (14 Days)||10||
48529004|NCT03258853|101628481|FG001|COMPLETED|Second Intervention (14 Days)||10||
48529005|NCT03258853|101628480|FG000|NOT COMPLETED|Second Intervention (14 Days)||0||
48529006|NCT03258853|101628481|FG001|NOT COMPLETED|Second Intervention (14 Days)||0||
48529007|NCT00063635|101628482|FG000|STARTED|Overall Study||57||
48529008|NCT00063635|101628483|FG001|STARTED|Overall Study||58||
48529009|NCT00063635|101628484|FG002|STARTED|Overall Study||58||
48529010|NCT00063635|101628482|FG000|COMPLETED|Overall Study||51||
48529011|NCT00063635|101628483|FG001|COMPLETED|Overall Study||50||
48529012|NCT00063635|101628484|FG002|COMPLETED|Overall Study||49||
48529013|NCT00063635|101628482|FG000|NOT COMPLETED|Overall Study||6||
48529014|NCT00063635|101628483|FG001|NOT COMPLETED|Overall Study||8||
48529015|NCT00063635|101628484|FG002|NOT COMPLETED|Overall Study||9||
48529016|NCT02122406|101628485|FG000|STARTED|Overall Study||200||
48529017|NCT02122406|101628485|FG000|COMPLETED|Overall Study||200||
48529018|NCT02122406|101628485|FG000|NOT COMPLETED|Overall Study||0||
48529019|NCT04853992|101628486|FG000|STARTED|Treatment Period A||11||
48529020|NCT04853992|101628487|FG001|STARTED|Treatment Period A||9||
48529021|NCT04853992|101628486|FG000|COMPLETED|Treatment Period A||11||
48529022|NCT04853992|101628487|FG001|COMPLETED|Treatment Period A||8||
48529023|NCT04853992|101628486|FG000|NOT COMPLETED|Treatment Period A||0||
48529024|NCT04853992|101628487|FG001|NOT COMPLETED|Treatment Period A||1||
48529025|NCT04853992|101628486|FG000|STARTED|Wash Out||11||
48529026|NCT04853992|101628487|FG001|STARTED|Wash Out||8||
48529027|NCT04853992|101628486|FG000|COMPLETED|Wash Out||10||
48529028|NCT04853992|101628487|FG001|COMPLETED|Wash Out||8||
48529029|NCT04853992|101628486|FG000|NOT COMPLETED|Wash Out||1||
48529030|NCT04853992|101628487|FG001|NOT COMPLETED|Wash Out||0||
48529031|NCT04853992|101628486|FG000|STARTED|Treatment Period B||10||
48529032|NCT04853992|101628487|FG001|STARTED|Treatment Period B||8||
48529033|NCT04853992|101628486|FG000|COMPLETED|Treatment Period B||10||
48529034|NCT04853992|101628487|FG001|COMPLETED|Treatment Period B||8||
48529035|NCT04853992|101628486|FG000|NOT COMPLETED|Treatment Period B||0||
48529036|NCT04853992|101628487|FG001|NOT COMPLETED|Treatment Period B||0||
48529037|NCT00197496|101628488|FG000|STARTED|Baseline to Discharge||14||
48529038|NCT00197496|101628489|FG001|STARTED|Baseline to Discharge||7||
48529039|NCT00197496|101628488|FG000|COMPLETED|Baseline to Discharge||12||
48529040|NCT00197496|101628489|FG001|COMPLETED|Baseline to Discharge||5||
48529041|NCT00197496|101628488|FG000|NOT COMPLETED|Baseline to Discharge||2||
48529042|NCT00197496|101628489|FG001|NOT COMPLETED|Baseline to Discharge||2||
48529043|NCT00197496|101628488|FG000|STARTED|Follow-up||12||
48529044|NCT00197496|101628489|FG001|STARTED|Follow-up||5||
48529045|NCT00197496|101628488|FG000|COMPLETED|Follow-up||10||
48529046|NCT00197496|101628489|FG001|COMPLETED|Follow-up||4||
48529047|NCT00197496|101628488|FG000|NOT COMPLETED|Follow-up||2||
48529048|NCT00197496|101628489|FG001|NOT COMPLETED|Follow-up||1||
48529049|NCT00123955|101628490|FG000|STARTED|Overall Study||42||
48529050|NCT00123955|101628491|FG001|STARTED|Overall Study||38||
48529051|NCT00123955|101628490|FG000|COMPLETED|Overall Study||37||
48529052|NCT00123955|101628491|FG001|COMPLETED|Overall Study||34||
48529053|NCT00123955|101628490|FG000|NOT COMPLETED|Overall Study||5||
48529054|NCT00123955|101628491|FG001|NOT COMPLETED|Overall Study||4||
48529055|NCT00418821|101628492|FG000|STARTED|Overall Study||2||
48529056|NCT00418821|101628492|FG000|COMPLETED|Overall Study||1||
48529057|NCT00418821|101628492|FG000|NOT COMPLETED|Overall Study||1||
48529058|NCT02283294|101628493|FG000|STARTED|Overall Study||41|Started indicates randomized to medication assignment. This does not necessarily indicate patient started the medication they were randomized to.|
48529059|NCT02283294|101628494|FG001|STARTED|Overall Study||47|Started indicates randomized to medication assignment. This does not necessarily indicate patient started the medication they were randomized to.|
48529060|NCT02283294|101628493|FG000|Received Allocated Treatment Intervention|Overall Study||38||
48529061|NCT02283294|101628494|FG001|Received Allocated Treatment Intervention|Overall Study||31||
48529062|NCT02283294|101628493|FG000|COMPLETED|Overall Study||38||
48529063|NCT02283294|101628494|FG001|COMPLETED|Overall Study||39||
48529064|NCT02283294|101628493|FG000|NOT COMPLETED|Overall Study||3||
48529065|NCT02283294|101628494|FG001|NOT COMPLETED|Overall Study||8||
48529066|NCT02091141|101628495|FG000|STARTED|Overall Study||357||
48529067|NCT02091141|101628496|FG001|STARTED|Overall Study||175||
48529068|NCT02091141|101628497|FG002|STARTED|Overall Study||55||
48529069|NCT02091141|101628498|FG003|STARTED|Overall Study||15||
48529070|NCT02091141|101628499|FG004|STARTED|Overall Study||37||
48529071|NCT02091141|101628500|FG005|STARTED|Overall Study||21||
48529072|NCT02091141|101628501|FG006|STARTED|Overall Study||13||
48529073|NCT02091141|101628495|FG000|COMPLETED|Overall Study||28||
48529074|NCT02091141|101628496|FG001|COMPLETED|Overall Study||24||
48529075|NCT02091141|101628497|FG002|COMPLETED|Overall Study||3||
48529076|NCT02091141|101628498|FG003|COMPLETED|Overall Study||0||
48529077|NCT02091141|101628499|FG004|COMPLETED|Overall Study||3||
48529078|NCT02091141|101628500|FG005|COMPLETED|Overall Study||0||
48529079|NCT02091141|101628501|FG006|COMPLETED|Overall Study||0||
48529080|NCT02091141|101628495|FG000|NOT COMPLETED|Overall Study||329||
48529081|NCT02091141|101628496|FG001|NOT COMPLETED|Overall Study||151||
48529082|NCT02091141|101628497|FG002|NOT COMPLETED|Overall Study||52||
48529083|NCT02091141|101628498|FG003|NOT COMPLETED|Overall Study||15||
48529084|NCT02091141|101628499|FG004|NOT COMPLETED|Overall Study||34||
48529085|NCT02091141|101628500|FG005|NOT COMPLETED|Overall Study||21||
48529086|NCT02091141|101628501|FG006|NOT COMPLETED|Overall Study||13||
48529087|NCT01206816|101628502|FG000|STARTED|Overall Study||3||
48529088|NCT01206816|101628503|FG001|STARTED|Overall Study||3||
48529089|NCT01206816|101628504|FG002|STARTED|Overall Study||20||
48529090|NCT01206816|101628505|FG003|STARTED|Overall Study||3||
48529091|NCT01206816|101628506|FG004|STARTED|Overall Study||3||
48529092|NCT01206816|101628507|FG005|STARTED|Overall Study||19||
48529093|NCT01206816|101628508|FG006|STARTED|Overall Study||6||
48529094|NCT01206816|101628502|FG000|COMPLETED|Overall Study||0||
48529095|NCT01206816|101628503|FG001|COMPLETED|Overall Study||0||
48529096|NCT01206816|101628504|FG002|COMPLETED|Overall Study||0||
48529097|NCT01206816|101628505|FG003|COMPLETED|Overall Study||0||
48529098|NCT01206816|101628506|FG004|COMPLETED|Overall Study||0||
48529099|NCT01206816|101628507|FG005|COMPLETED|Overall Study||0||
48529100|NCT01206816|101628508|FG006|COMPLETED|Overall Study||0||
48529101|NCT01206816|101628502|FG000|NOT COMPLETED|Overall Study||3||
48529102|NCT01206816|101628503|FG001|NOT COMPLETED|Overall Study||3||
48529103|NCT01206816|101628504|FG002|NOT COMPLETED|Overall Study||20||
48529104|NCT01206816|101628505|FG003|NOT COMPLETED|Overall Study||3||
48529105|NCT01206816|101628506|FG004|NOT COMPLETED|Overall Study||3||
48529106|NCT01206816|101628507|FG005|NOT COMPLETED|Overall Study||19||
48529107|NCT01206816|101628508|FG006|NOT COMPLETED|Overall Study||6||
48529108|NCT01916590|101628509|FG000|STARTED|Overall Study||4||
48529109|NCT01916590|101628510|FG001|STARTED|Overall Study||3||
48529110|NCT01916590|101628509|FG000|COMPLETED|Overall Study||4||
48529111|NCT01916590|101628510|FG001|COMPLETED|Overall Study||3||
48529112|NCT01916590|101628509|FG000|NOT COMPLETED|Overall Study||0||
48529113|NCT01916590|101628510|FG001|NOT COMPLETED|Overall Study||0||
48529114|NCT00166036|101628511|FG000|STARTED|Overall Study||17||
48529115|NCT00166036|101628512|FG001|STARTED|Overall Study||19||
48529116|NCT00166036|101628511|FG000|COMPLETED|Overall Study||17||
48529117|NCT00166036|101628512|FG001|COMPLETED|Overall Study||19||
48529118|NCT00166036|101628511|FG000|NOT COMPLETED|Overall Study||0||
48529119|NCT00166036|101628512|FG001|NOT COMPLETED|Overall Study||0||
48529120|NCT00667810|101628513|FG000|STARTED|Overall Study||269||
48529121|NCT00667810|101628514|FG001|STARTED|Overall Study||264||
48529122|NCT00667810|101628515|FG002|STARTED|Overall Study||346||
48529123|NCT00667810|101628516|FG003|STARTED|Overall Study||11||
48529124|NCT00667810|101628513|FG000|Treated|Overall Study||267||
48529125|NCT00667810|101628514|FG001|Treated|Overall Study||263||
48529126|NCT00667810|101628515|FG002|Treated|Overall Study||344||
48529127|NCT00667810|101628516|FG003|Treated|Overall Study||11||
48529128|NCT00667810|101628513|FG000|COMPLETED|Overall Study||102||
48529129|NCT00667810|101628514|FG001|COMPLETED|Overall Study||94||
48529130|NCT00667810|101628515|FG002|COMPLETED|Overall Study||124||
48529131|NCT00667810|101628516|FG003|COMPLETED|Overall Study||9||
48529132|NCT00667810|101628513|FG000|NOT COMPLETED|Overall Study||167||
48529133|NCT00667810|101628514|FG001|NOT COMPLETED|Overall Study||170||
48529134|NCT00667810|101628515|FG002|NOT COMPLETED|Overall Study||222||
48529135|NCT00667810|101628516|FG003|NOT COMPLETED|Overall Study||2||
48529136|NCT01685073|101628517|FG000|STARTED|Overall Study||62||
48529137|NCT01685073|101628518|FG001|STARTED|Overall Study||65||
48529138|NCT01685073|101628517|FG000|COMPLETED|Overall Study||32||
48529139|NCT01685073|101628518|FG001|COMPLETED|Overall Study||33||
48529140|NCT01685073|101628517|FG000|NOT COMPLETED|Overall Study||30||
48529141|NCT01685073|101628518|FG001|NOT COMPLETED|Overall Study||32||
48529142|NCT02683265|101628519|FG000|STARTED|Open-label Treatment Phase||119||
48529143|NCT02683265|101628520|FG001|STARTED|Open-label Treatment Phase||0||
48529144|NCT02683265|101628521|FG002|STARTED|Open-label Treatment Phase||0||
48529145|NCT02683265|101628519|FG000|COMPLETED|Open-label Treatment Phase||90|The number who completed the Open-label Treatment Phase were randomized to 1 of 2 groups in the Double-blind Treatment Phase.|
48529146|NCT02683265|101628520|FG001|COMPLETED|Open-label Treatment Phase||0|The number who completed the Open-label Treatment Phase were randomized to 1 of 2 groups in the Double-blind Treatment Phase.|
48529147|NCT02683265|101628521|FG002|COMPLETED|Open-label Treatment Phase||0|The number who completed the Open-label Treatment Phase were randomized to 1 of 2 groups in the Double-blind Treatment Phase.|
48529148|NCT02683265|101628519|FG000|NOT COMPLETED|Open-label Treatment Phase||29||
48529149|NCT02683265|101628520|FG001|NOT COMPLETED|Open-label Treatment Phase||0||
48529150|NCT02683265|101628521|FG002|NOT COMPLETED|Open-label Treatment Phase||0||
48529151|NCT02683265|101628519|FG000|STARTED|Double-blind Treatment Phase||0||
48529152|NCT02683265|101628520|FG001|STARTED|Double-blind Treatment Phase||40||
48529153|NCT02683265|101628521|FG002|STARTED|Double-blind Treatment Phase||50||
48529154|NCT02683265|101628519|FG000|COMPLETED|Double-blind Treatment Phase||0||
48529155|NCT02683265|101628520|FG001|COMPLETED|Double-blind Treatment Phase||38||
48529156|NCT02683265|101628521|FG002|COMPLETED|Double-blind Treatment Phase||48||
48529157|NCT02683265|101628519|FG000|NOT COMPLETED|Double-blind Treatment Phase||0||
48529158|NCT02683265|101628520|FG001|NOT COMPLETED|Double-blind Treatment Phase||2||
48229071|NCT01695291|100880798|FG001|STARTED|Overall Study||21||
48229072|NCT01695291|100880797|FG000|COMPLETED|Overall Study||8||
48229073|NCT01695291|100880798|FG001|COMPLETED|Overall Study||14||
48229074|NCT01695291|100880797|FG000|NOT COMPLETED|Overall Study||2||
48229075|NCT01695291|100880798|FG001|NOT COMPLETED|Overall Study||7||
48229076|NCT00667017|100880799|FG000|STARTED|Overall Study||1||
48229077|NCT00667017|100880799|FG000|COMPLETED|Overall Study||0||
48229078|NCT00667017|100880799|FG000|NOT COMPLETED|Overall Study||1||
48229079|NCT01213940|100880800|FG000|STARTED|Overall Study||14||
48229080|NCT01213940|100880801|FG001|STARTED|Overall Study||6||
48229081|NCT01213940|100880800|FG000|COMPLETED|Overall Study||14||
48229082|NCT01213940|100880801|FG001|COMPLETED|Overall Study||6||
48229083|NCT01213940|100880800|FG000|NOT COMPLETED|Overall Study||0||
48229084|NCT01213940|100880801|FG001|NOT COMPLETED|Overall Study||0||
48229085|NCT02744066|100880802|FG000|STARTED|Overall Study||25||
48229086|NCT02744066|100880803|FG001|STARTED|Overall Study||30||
48229087|NCT02744066|100880802|FG000|COMPLETED|Overall Study||25||
48229088|NCT02744066|100880803|FG001|COMPLETED|Overall Study||25||
48529159|NCT02683265|101628521|FG002|NOT COMPLETED|Double-blind Treatment Phase||2||
48529160|NCT03071094|101628522|FG000|STARTED|Overall Study||7||
48529161|NCT03071094|101628523|FG001|STARTED|Overall Study||5||
48529162|NCT03071094|101628522|FG000|COMPLETED|Overall Study||5||
48529163|NCT03071094|101628523|FG001|COMPLETED|Overall Study||4||
48529164|NCT03071094|101628522|FG000|NOT COMPLETED|Overall Study||2||
48529165|NCT03071094|101628523|FG001|NOT COMPLETED|Overall Study||1||
48529166|NCT04060719|101628524|FG000|STARTED|Period 1||16||
48529167|NCT04060719|101628524|FG000|COMPLETED|Period 1||16||
48529168|NCT04060719|101628524|FG000|NOT COMPLETED|Period 1||0||
48529169|NCT04060719|101628524|FG000|STARTED|Washout Period||16||
48529170|NCT04060719|101628524|FG000|COMPLETED|Washout Period||16||
48529171|NCT04060719|101628524|FG000|NOT COMPLETED|Washout Period||0||
48529172|NCT04060719|101628524|FG000|STARTED|Period 2||16||
48529173|NCT04060719|101628524|FG000|COMPLETED|Period 2||16||
48529174|NCT04060719|101628524|FG000|NOT COMPLETED|Period 2||0||
48529175|NCT01855074|101628525|FG000|STARTED|Overall Study||80||
48529176|NCT01855074|101628525|FG000|Treated|Overall Study||79||
48529177|NCT01855074|101628525|FG000|COMPLETED|Overall Study||66||
48529178|NCT01855074|101628525|FG000|NOT COMPLETED|Overall Study||14||
48529179|NCT00026221|101628526|FG000|STARTED|Overall Study||16||
48529180|NCT00026221|101628527|FG001|STARTED|Overall Study||16||
48529181|NCT00026221|101628528|FG002|STARTED|Overall Study||25||
48529182|NCT00026221|101628526|FG000|COMPLETED|Overall Study||16||
48529183|NCT00026221|101628527|FG001|COMPLETED|Overall Study||16||
48529184|NCT00026221|101628528|FG002|COMPLETED|Overall Study||25||
48529185|NCT00026221|101628526|FG000|NOT COMPLETED|Overall Study||0||
48529186|NCT00026221|101628527|FG001|NOT COMPLETED|Overall Study||0||
48229089|NCT02744066|100880802|FG000|NOT COMPLETED|Overall Study||0||
48229090|NCT02744066|100880803|FG001|NOT COMPLETED|Overall Study||5||
48229091|NCT02483468|100880804|FG000|STARTED|Overall Study||65||
48229092|NCT02483468|100880805|FG001|STARTED|Overall Study||51||
48229093|NCT02483468|100880804|FG000|COMPLETED|Overall Study||46|completed defined as followed up to 3 months|
48229094|NCT02483468|100880805|FG001|COMPLETED|Overall Study||30|completed defined as followed up to 3 months|
48229095|NCT02483468|100880804|FG000|NOT COMPLETED|Overall Study||19||
48229096|NCT02483468|100880805|FG001|NOT COMPLETED|Overall Study||21||
48229097|NCT00597376|100880806|FG000|STARTED|Overall Study||51||
48229098|NCT00597376|100880807|FG001|STARTED|Overall Study||53||
48529187|NCT00026221|101628528|FG002|NOT COMPLETED|Overall Study||0||
48529188|NCT00793780|101628529|FG000|STARTED|Overall Study||12||
48529189|NCT00793780|101628530|FG001|STARTED|Overall Study||12||
48229099|NCT00597376|100880806|FG000|COMPLETED|Overall Study||43||
48229100|NCT00597376|100880807|FG001|COMPLETED|Overall Study||49||
48229101|NCT00597376|100880806|FG000|NOT COMPLETED|Overall Study||8||
48229102|NCT00597376|100880807|FG001|NOT COMPLETED|Overall Study||4||
48229103|NCT01794299|100880808|FG000|STARTED|Overall Study||31||
48229104|NCT01794299|100880808|FG000|COMPLETED|Overall Study||9||
48229105|NCT01794299|100880808|FG000|NOT COMPLETED|Overall Study||22||
48229106|NCT02233998|100880809|FG000|STARTED|Overall Study||53||
48229107|NCT02233998|100880810|FG001|STARTED|Overall Study||52||
48229108|NCT02233998|100880811|FG002|STARTED|Overall Study||53||
48229109|NCT02233998|100880809|FG000|COMPLETED|Overall Study||53||
48229110|NCT02233998|100880810|FG001|COMPLETED|Overall Study||52||
48229111|NCT02233998|100880811|FG002|COMPLETED|Overall Study||53||
48229112|NCT02233998|100880809|FG000|NOT COMPLETED|Overall Study||0||
48229113|NCT02233998|100880810|FG001|NOT COMPLETED|Overall Study||0||
48229114|NCT02233998|100880811|FG002|NOT COMPLETED|Overall Study||0||
48229115|NCT02542696|100880812|FG000|STARTED|Overall Study||496||
48229116|NCT02542696|100880812|FG000|Titration Full Analysis Population|Overall Study||449||
48529190|NCT00793780|101628529|FG000|Randomization|Overall Study||12||
48529191|NCT00793780|101628530|FG001|Randomization|Overall Study||12||
48529192|NCT00793780|101628529|FG000|Collected Baseline Data|Overall Study||11||
48529193|NCT00793780|101628530|FG001|Collected Baseline Data|Overall Study||12||
48529194|NCT00793780|101628529|FG000|COMPLETED|Overall Study||10||
48529195|NCT00793780|101628530|FG001|COMPLETED|Overall Study||11||
48529196|NCT00793780|101628529|FG000|NOT COMPLETED|Overall Study||2||
48529197|NCT00793780|101628530|FG001|NOT COMPLETED|Overall Study||1||
48529198|NCT00706095|101628531|FG000|STARTED|Overall Study||6||
48529199|NCT00706095|101628532|FG001|STARTED|Overall Study||7||
48529200|NCT00706095|101628533|FG002|STARTED|Overall Study||5||
48529201|NCT00706095|101628531|FG000|COMPLETED|Overall Study||0||
48529202|NCT00706095|101628532|FG001|COMPLETED|Overall Study||0||
48529203|NCT00706095|101628533|FG002|COMPLETED|Overall Study||0||
48529204|NCT00706095|101628531|FG000|NOT COMPLETED|Overall Study||6||
48229117|NCT02542696|100880812|FG000|LTS Phase Full Analysis Population|Overall Study||426||
48229118|NCT02542696|100880812|FG000|COMPLETED|Overall Study||120||
48229119|NCT02542696|100880812|FG000|NOT COMPLETED|Overall Study||376||
48229120|NCT02085941|100880813|FG000|STARTED|Overall Study||25||
48229121|NCT02085941|100880814|FG001|STARTED|Overall Study||5||
48229122|NCT02085941|100880813|FG000|COMPLETED|Overall Study||17||
48229123|NCT02085941|100880814|FG001|COMPLETED|Overall Study||2||
48229124|NCT02085941|100880813|FG000|NOT COMPLETED|Overall Study||8||
48229125|NCT02085941|100880814|FG001|NOT COMPLETED|Overall Study||3||
48229126|NCT02736188|100880815|FG000|STARTED|Overall Study||142||
48229127|NCT02736188|100880815|FG000|COMPLETED|Overall Study||0||
48229128|NCT02736188|100880815|FG000|NOT COMPLETED|Overall Study||142||
48229129|NCT04144088|100880816|FG000|STARTED|Overall Study||20||
48229130|NCT04144088|100880817|FG001|STARTED|Overall Study||20||
48229131|NCT04144088|100880818|FG002|STARTED|Overall Study||20||
48229132|NCT04144088|100880816|FG000|COMPLETED|Overall Study||14||
48229133|NCT04144088|100880817|FG001|COMPLETED|Overall Study||15||
48229134|NCT04144088|100880818|FG002|COMPLETED|Overall Study||13||
48229135|NCT04144088|100880816|FG000|NOT COMPLETED|Overall Study||6||
48529205|NCT00706095|101628532|FG001|NOT COMPLETED|Overall Study||7||
48529206|NCT00706095|101628533|FG002|NOT COMPLETED|Overall Study||5||
48529207|NCT02800213|101631692|FG000|STARTED|First Intervention||35||
48529208|NCT02800213|101631693|FG001|STARTED|First Intervention||35||
48529209|NCT02800213|101631692|FG000|COMPLETED|First Intervention||35||
48529210|NCT02800213|101631693|FG001|COMPLETED|First Intervention||35||
48529211|NCT02800213|101631692|FG000|NOT COMPLETED|First Intervention||0||
48529212|NCT02800213|101631693|FG001|NOT COMPLETED|First Intervention||0||
48529213|NCT02800213|101631692|FG000|STARTED|Second Intervention||35||
48529214|NCT02800213|101631693|FG001|STARTED|Second Intervention||35||
48529215|NCT02800213|101631692|FG000|COMPLETED|Second Intervention||35||
48529216|NCT02800213|101631693|FG001|COMPLETED|Second Intervention||35||
48529217|NCT02800213|101631692|FG000|NOT COMPLETED|Second Intervention||0||
48529218|NCT02800213|101631693|FG001|NOT COMPLETED|Second Intervention||0||
48529219|NCT00616941|101631694|FG000|STARTED|Overall Study||4||
48529220|NCT00616941|101631695|FG001|STARTED|Overall Study||13||
48529221|NCT00616941|101631696|FG002|STARTED|Overall Study||11||
48529222|NCT00616941|101631694|FG000|COMPLETED|Overall Study||3||
48529223|NCT00616941|101631695|FG001|COMPLETED|Overall Study||8||
48529224|NCT00616941|101631696|FG002|COMPLETED|Overall Study||5||
48529225|NCT00616941|101631694|FG000|NOT COMPLETED|Overall Study||1||
48529226|NCT00616941|101631695|FG001|NOT COMPLETED|Overall Study||5||
48529227|NCT00616941|101631696|FG002|NOT COMPLETED|Overall Study||6||
48529228|NCT01573169|101631697|FG000|STARTED|Overall Study||38||
48529229|NCT01573169|101631698|FG001|STARTED|Overall Study||35||
48529230|NCT01573169|101631697|FG000|COMPLETED|Overall Study||38||
48529231|NCT01573169|101631698|FG001|COMPLETED|Overall Study||35||
48229136|NCT04144088|100880817|FG001|NOT COMPLETED|Overall Study||5||
48529232|NCT01573169|101631697|FG000|NOT COMPLETED|Overall Study||0||
48529233|NCT01573169|101631698|FG001|NOT COMPLETED|Overall Study||0||
48529234|NCT01284296|101631699|FG000|STARTED|Overall Study||20||
48529235|NCT01284296|101631699|FG000|COMPLETED|Overall Study||20||
48529236|NCT01284296|101631699|FG000|NOT COMPLETED|Overall Study||0||
48529237|NCT00450619|101631700|FG000|STARTED|Overall Study||22||
48529238|NCT00450619|101631701|FG001|STARTED|Overall Study||22||
48529239|NCT00450619|101631700|FG000|COMPLETED|Overall Study||18||
48529240|NCT00450619|101631701|FG001|COMPLETED|Overall Study||21||
48529241|NCT00450619|101631700|FG000|NOT COMPLETED|Overall Study||4||
48529242|NCT00450619|101631701|FG001|NOT COMPLETED|Overall Study||1||
48529243|NCT05012163|101631702|FG000|STARTED|Overall Study||14394||
48529244|NCT05012163|101631703|FG001|STARTED|Overall Study||14394||
48529245|NCT05012163|101631704|FG002|STARTED|Overall Study||14394||
48529246|NCT05012163|101631705|FG003|STARTED|Overall Study||14399||
48529247|NCT05012163|101631702|FG000|COMPLETED|Overall Study||14394||
48529248|NCT05012163|101631703|FG001|COMPLETED|Overall Study||14394||
48529249|NCT05012163|101631704|FG002|COMPLETED|Overall Study||14393||
48529250|NCT05012163|101631705|FG003|COMPLETED|Overall Study||14398||
48529251|NCT05012163|101631702|FG000|NOT COMPLETED|Overall Study||0||
48529252|NCT05012163|101631703|FG001|NOT COMPLETED|Overall Study||0||
48529253|NCT05012163|101631704|FG002|NOT COMPLETED|Overall Study||1||
48529254|NCT05012163|101631705|FG003|NOT COMPLETED|Overall Study||1||
48529255|NCT01024686|101631706|FG000|STARTED|Overall Study||6||
48529256|NCT01024686|101631707|FG001|STARTED|Overall Study||0||
48529257|NCT01024686|101631708|FG002|STARTED|Overall Study||0||
48529258|NCT01024686|101631706|FG000|COMPLETED|Overall Study||6||
48529259|NCT01024686|101631707|FG001|COMPLETED|Overall Study||0||
48529260|NCT01024686|101631708|FG002|COMPLETED|Overall Study||0||
48529261|NCT01024686|101631706|FG000|NOT COMPLETED|Overall Study||0||
48529262|NCT01024686|101631707|FG001|NOT COMPLETED|Overall Study||0||
48529263|NCT01024686|101631708|FG002|NOT COMPLETED|Overall Study||0||
48529264|NCT01196078|101631709|FG000|STARTED|Overall Study||57||
48529265|NCT01196078|101631710|FG001|STARTED|Overall Study||57||
48529266|NCT01196078|101631709|FG000|COMPLETED|Overall Study||24||
48529267|NCT01196078|101631710|FG001|COMPLETED|Overall Study||20||
48529268|NCT01196078|101631709|FG000|NOT COMPLETED|Overall Study||33||
48529269|NCT01196078|101631710|FG001|NOT COMPLETED|Overall Study||37||
48529270|NCT00423683|101631711|FG000|STARTED|Overall Study||31||
48529271|NCT00423683|101631712|FG001|STARTED|Overall Study||33||
48529272|NCT00423683|101631711|FG000|COMPLETED|Overall Study||30||
48529273|NCT00423683|101631712|FG001|COMPLETED|Overall Study||33||
48529274|NCT00423683|101631711|FG000|NOT COMPLETED|Overall Study||1||
48529275|NCT00423683|101631712|FG001|NOT COMPLETED|Overall Study||0||
48529276|NCT01032018|101631713|FG000|STARTED|Overall Study||77||
48529277|NCT01032018|101631714|FG001|STARTED|Overall Study||73||
48529278|NCT01032018|101631713|FG000|COMPLETED|Overall Study||71||
48529279|NCT01032018|101631714|FG001|COMPLETED|Overall Study||67||
48529280|NCT01032018|101631713|FG000|NOT COMPLETED|Overall Study||6||
48529281|NCT01032018|101631714|FG001|NOT COMPLETED|Overall Study||6||
48529282|NCT01580813|101631715|FG000|STARTED|Overall Study||4||
48529283|NCT01580813|101631716|FG001|STARTED|Overall Study||3||
48529284|NCT01580813|101631715|FG000|Completed First Intervention|Overall Study||4||
48529285|NCT01580813|101631716|FG001|Completed First Intervention|Overall Study||3||
48529286|NCT01580813|101631715|FG000|Completed 1 Week Washout|Overall Study||4||
48529287|NCT01580813|101631716|FG001|Completed 1 Week Washout|Overall Study||3||
48529288|NCT01580813|101631715|FG000|Started Second Intervention|Overall Study||4||
48529289|NCT01580813|101631716|FG001|Started Second Intervention|Overall Study||3||
48529290|NCT01580813|101631715|FG000|COMPLETED|Overall Study||4||
48529291|NCT01580813|101631716|FG001|COMPLETED|Overall Study||3||
48529292|NCT01580813|101631715|FG000|NOT COMPLETED|Overall Study||0||
48529293|NCT01580813|101631716|FG001|NOT COMPLETED|Overall Study||0||
48529294|NCT04051463|101631717|FG000|STARTED|Overall Study||15||
48229137|NCT04144088|100880818|FG002|NOT COMPLETED|Overall Study||7||
48529295|NCT04051463|101631718|FG001|STARTED|Overall Study||14||
48529296|NCT04051463|101631717|FG000|COMPLETED|Overall Study||13||
48529297|NCT04051463|101631718|FG001|COMPLETED|Overall Study||13||
48529298|NCT04051463|101631717|FG000|NOT COMPLETED|Overall Study||2||
48529299|NCT04051463|101631718|FG001|NOT COMPLETED|Overall Study||1||
48529300|NCT01401049|101631719|FG000|STARTED|Overall Study||0||
48529301|NCT01401049|101631720|FG001|STARTED|Overall Study||0||
48529302|NCT01401049|101631719|FG000|COMPLETED|Overall Study||0||
48529303|NCT01401049|101631720|FG001|COMPLETED|Overall Study||0||
48529304|NCT01401049|101631719|FG000|NOT COMPLETED|Overall Study||0||
48529305|NCT01401049|101631720|FG001|NOT COMPLETED|Overall Study||0||
48529306|NCT01175031|101631721|FG000|STARTED|Overall Study||45||
48529307|NCT01175031|101631721|FG000|COMPLETED|Overall Study||45||
48529308|NCT01175031|101631721|FG000|NOT COMPLETED|Overall Study||0||
48529309|NCT00140621|101631722|FG000|STARTED|Overall Study||6||
48529310|NCT00140621|101631722|FG000|COMPLETED|Overall Study||6||
48529311|NCT00140621|101631722|FG000|NOT COMPLETED|Overall Study||0||
48529312|NCT01584843|101631723|FG000|STARTED|First Treatment Period||3||
48529313|NCT01584843|101631724|FG001|STARTED|First Treatment Period||4||
48529314|NCT01584843|101631725|FG002|STARTED|First Treatment Period||3||
48529315|NCT01584843|101631726|FG003|STARTED|First Treatment Period||10||
48529316|NCT01584843|101631727|FG004|STARTED|First Treatment Period||10||
48529317|NCT01584843|101631728|FG005|STARTED|First Treatment Period||11||
48529318|NCT01584843|101631723|FG000|COMPLETED|First Treatment Period||3||
48529319|NCT01584843|101631724|FG001|COMPLETED|First Treatment Period||4||
48529320|NCT01584843|101631725|FG002|COMPLETED|First Treatment Period||2||
48529321|NCT01584843|101631726|FG003|COMPLETED|First Treatment Period||10||
48529322|NCT01584843|101631727|FG004|COMPLETED|First Treatment Period||10||
48529323|NCT01584843|101631728|FG005|COMPLETED|First Treatment Period||9||
48529324|NCT01584843|101631723|FG000|NOT COMPLETED|First Treatment Period||0||
48529325|NCT01584843|101631724|FG001|NOT COMPLETED|First Treatment Period||0||
48529326|NCT01584843|101631725|FG002|NOT COMPLETED|First Treatment Period||1||
48529327|NCT01584843|101631726|FG003|NOT COMPLETED|First Treatment Period||0||
48529328|NCT01584843|101631727|FG004|NOT COMPLETED|First Treatment Period||0||
48529329|NCT01584843|101631728|FG005|NOT COMPLETED|First Treatment Period||2||
48529330|NCT01584843|101631723|FG000|STARTED|Second Treatment Period||2||
48529331|NCT01584843|101631724|FG001|STARTED|Second Treatment Period||1||
48529332|NCT01584843|101631725|FG002|STARTED|Second Treatment Period||2||
48529333|NCT01584843|101631726|FG003|STARTED|Second Treatment Period||6||
48529334|NCT01584843|101631727|FG004|STARTED|Second Treatment Period||3||
48529335|NCT01584843|101631728|FG005|STARTED|Second Treatment Period||1||
48529336|NCT01584843|101631723|FG000|COMPLETED|Second Treatment Period||2||
48529337|NCT01584843|101631724|FG001|COMPLETED|Second Treatment Period||1||
48529338|NCT01584843|101631725|FG002|COMPLETED|Second Treatment Period||2||
48529339|NCT01584843|101631726|FG003|COMPLETED|Second Treatment Period||6||
48529340|NCT01584843|101631727|FG004|COMPLETED|Second Treatment Period||3||
48529341|NCT01584843|101631728|FG005|COMPLETED|Second Treatment Period||0||
48529342|NCT01584843|101631723|FG000|NOT COMPLETED|Second Treatment Period||0||
48529343|NCT01584843|101631724|FG001|NOT COMPLETED|Second Treatment Period||0||
48529344|NCT01584843|101631725|FG002|NOT COMPLETED|Second Treatment Period||0||
48529345|NCT01584843|101631726|FG003|NOT COMPLETED|Second Treatment Period||0||
48529346|NCT01584843|101631727|FG004|NOT COMPLETED|Second Treatment Period||0||
48529347|NCT01584843|101631728|FG005|NOT COMPLETED|Second Treatment Period||1||
48529348|NCT05227300|101631729|FG000|STARTED|Overall Study||20||
48529349|NCT05227300|101631730|FG001|STARTED|Overall Study||20||
48529350|NCT05227300|101631729|FG000|COMPLETED|Overall Study||20||
48529351|NCT05227300|101631730|FG001|COMPLETED|Overall Study||20||
48529352|NCT05227300|101631729|FG000|NOT COMPLETED|Overall Study||0||
48529353|NCT05227300|101631730|FG001|NOT COMPLETED|Overall Study||0||
48529354|NCT01660191|101631731|FG000|STARTED|Enrollment and Washout||45||
48529355|NCT01660191|101631732|FG001|STARTED|Enrollment and Washout||45||
48529356|NCT01660191|101631733|FG002|STARTED|Enrollment and Washout||44||
48529357|NCT01660191|101631731|FG000|COMPLETED|Enrollment and Washout||45||
48529358|NCT01660191|101631732|FG001|COMPLETED|Enrollment and Washout||45||
48529359|NCT01660191|101631733|FG002|COMPLETED|Enrollment and Washout||44||
48529360|NCT01660191|101631731|FG000|NOT COMPLETED|Enrollment and Washout||0||
48529361|NCT01660191|101631732|FG001|NOT COMPLETED|Enrollment and Washout||0||
48529362|NCT01660191|101631733|FG002|NOT COMPLETED|Enrollment and Washout||0||
48529363|NCT01660191|101631731|FG000|STARTED|Randomization||45||
48529364|NCT01660191|101631732|FG001|STARTED|Randomization||45||
48529365|NCT01660191|101631733|FG002|STARTED|Randomization||44||
48529366|NCT01660191|101631731|FG000|COMPLETED|Randomization||45||
48529367|NCT01660191|101631732|FG001|COMPLETED|Randomization||45||
48529368|NCT01660191|101631733|FG002|COMPLETED|Randomization||44||
48529369|NCT01660191|101631731|FG000|NOT COMPLETED|Randomization||0||
48529370|NCT01660191|101631732|FG001|NOT COMPLETED|Randomization||0||
48529371|NCT01660191|101631733|FG002|NOT COMPLETED|Randomization||0||
48529372|NCT01660191|101631731|FG000|STARTED|End of Treatment||45||
48529373|NCT01660191|101631732|FG001|STARTED|End of Treatment||45||
48529374|NCT01660191|101631733|FG002|STARTED|End of Treatment||44||
48529375|NCT01660191|101631731|FG000|COMPLETED|End of Treatment||44||
48529376|NCT01660191|101631732|FG001|COMPLETED|End of Treatment||39||
48529377|NCT01660191|101631733|FG002|COMPLETED|End of Treatment||43||
48529378|NCT01660191|101631731|FG000|NOT COMPLETED|End of Treatment||1||
48529379|NCT01660191|101631732|FG001|NOT COMPLETED|End of Treatment||6||
48529380|NCT01660191|101631733|FG002|NOT COMPLETED|End of Treatment||1||
48529381|NCT02056392|101631734|FG000|STARTED|Overall Study||10||
48529382|NCT02056392|101631735|FG001|STARTED|Overall Study||9||
48529383|NCT02056392|101631736|FG002|STARTED|Overall Study||9||
48529384|NCT02056392|101631737|FG003|STARTED|Overall Study||9||
48529385|NCT02056392|101631738|FG004|STARTED|Overall Study||8||
48529386|NCT02056392|101631739|FG005|STARTED|Overall Study||9||
48529387|NCT02056392|101631734|FG000|COMPLETED|Overall Study||8||
48529388|NCT02056392|101631735|FG001|COMPLETED|Overall Study||8||
48529389|NCT02056392|101631736|FG002|COMPLETED|Overall Study||6||
48529390|NCT02056392|101631737|FG003|COMPLETED|Overall Study||9||
48529391|NCT02056392|101631738|FG004|COMPLETED|Overall Study||7||
48529392|NCT02056392|101631739|FG005|COMPLETED|Overall Study||9||
48529393|NCT02056392|101631734|FG000|NOT COMPLETED|Overall Study||2||
48529394|NCT02056392|101631735|FG001|NOT COMPLETED|Overall Study||1||
48529395|NCT02056392|101631736|FG002|NOT COMPLETED|Overall Study||3||
48529396|NCT02056392|101631737|FG003|NOT COMPLETED|Overall Study||0||
48529397|NCT02056392|101631738|FG004|NOT COMPLETED|Overall Study||1||
48529398|NCT02056392|101631739|FG005|NOT COMPLETED|Overall Study||0||
48529399|NCT02287909|101631740|FG000|STARTED|Overall Study||20||
48529400|NCT02287909|101631741|FG001|STARTED|Overall Study||20||
48529401|NCT02287909|101631742|FG002|STARTED|Overall Study||20||
48529402|NCT02287909|101631743|FG003|STARTED|Overall Study||20||
48529403|NCT02287909|101631740|FG000|COMPLETED|Overall Study||18||
48529404|NCT02287909|101631741|FG001|COMPLETED|Overall Study||19||
48529405|NCT02287909|101631742|FG002|COMPLETED|Overall Study||20||
48529406|NCT02287909|101631743|FG003|COMPLETED|Overall Study||19||
48529407|NCT02287909|101631740|FG000|NOT COMPLETED|Overall Study||2||
48229138|NCT01939288|100880819|FG000|STARTED|Overall Study||5||
48229139|NCT01939288|100880820|FG001|STARTED|Overall Study||5||
48229140|NCT01939288|100880819|FG000|COMPLETED|Overall Study||5||
48229141|NCT01939288|100880820|FG001|COMPLETED|Overall Study||5||
48229142|NCT01939288|100880819|FG000|NOT COMPLETED|Overall Study||0||
48229143|NCT01939288|100880820|FG001|NOT COMPLETED|Overall Study||0||
48529408|NCT02287909|101631741|FG001|NOT COMPLETED|Overall Study||1||
48529409|NCT02287909|101631742|FG002|NOT COMPLETED|Overall Study||0||
48529410|NCT02287909|101631743|FG003|NOT COMPLETED|Overall Study||1||
48529411|NCT01280409|101631744|FG000|STARTED|Overall Study||59||
48529412|NCT01280409|101631745|FG001|STARTED|Overall Study||55||
48529413|NCT01280409|101631744|FG000|COMPLETED|Overall Study||43||
48529414|NCT01280409|101631745|FG001|COMPLETED|Overall Study||36||
48529415|NCT01280409|101631744|FG000|NOT COMPLETED|Overall Study||16||
48529416|NCT01280409|101631745|FG001|NOT COMPLETED|Overall Study||19||
48529417|NCT00548171|101631746|FG000|STARTED|Overall Study||164||
48529418|NCT00548171|101631747|FG001|STARTED|Overall Study||39||
48529419|NCT00548171|101631746|FG000|COMPLETED|Overall Study||164||
48229144|NCT02659540|100880821|FG000|STARTED|Overall Study||10||
48529420|NCT00548171|101631747|FG001|COMPLETED|Overall Study||39||
48529421|NCT00548171|101631746|FG000|NOT COMPLETED|Overall Study||0||
48529422|NCT00548171|101631747|FG001|NOT COMPLETED|Overall Study||0||
48529423|NCT02331368|101631748|FG000|STARTED|Overall Study||32||
48529424|NCT02331368|101631748|FG000|COMPLETED|Overall Study||29||
48529425|NCT02331368|101631748|FG000|NOT COMPLETED|Overall Study||3||
48529426|NCT00319982|101631749|FG000|STARTED|Overall Study||19||
48529427|NCT00319982|101631750|FG001|STARTED|Overall Study||20||
48529428|NCT00319982|101631749|FG000|COMPLETED|Overall Study||18||
48529429|NCT00319982|101631750|FG001|COMPLETED|Overall Study||20||
48529430|NCT00319982|101631749|FG000|NOT COMPLETED|Overall Study||1||
48529431|NCT00319982|101631750|FG001|NOT COMPLETED|Overall Study||0||
48529432|NCT03514641|101631751|FG000|STARTED|603A: 0-12 Week Study Period||334||
48529433|NCT03514641|101631752|FG001|STARTED|603A: 0-12 Week Study Period||339||
48529434|NCT03514641|101631753|FG002|STARTED|603A: 0-12 Week Study Period||0||
48529435|NCT03514641|101631754|FG003|STARTED|603A: 0-12 Week Study Period||0||
48529436|NCT03514641|101631751|FG000|COMPLETED|603A: 0-12 Week Study Period||307||
48529437|NCT03514641|101631752|FG001|COMPLETED|603A: 0-12 Week Study Period||319||
48529438|NCT03514641|101631753|FG002|COMPLETED|603A: 0-12 Week Study Period||0||
48529439|NCT03514641|101631754|FG003|COMPLETED|603A: 0-12 Week Study Period||0||
48529440|NCT03514641|101631751|FG000|NOT COMPLETED|603A: 0-12 Week Study Period||27||
48529441|NCT03514641|101631752|FG001|NOT COMPLETED|603A: 0-12 Week Study Period||20||
48529442|NCT03514641|101631753|FG002|NOT COMPLETED|603A: 0-12 Week Study Period||0||
48529443|NCT03514641|101631754|FG003|NOT COMPLETED|603A: 0-12 Week Study Period||0||
48529444|NCT03514641|101631751|FG000|STARTED|603B: 24-36 Week Study Period||0||
48529445|NCT03514641|101631752|FG001|STARTED|603B: 24-36 Week Study Period||0||
48529446|NCT03514641|101631753|FG002|STARTED|603B: 24-36 Week Study Period||281||
48529447|NCT03514641|101631754|FG003|STARTED|603B: 24-36 Week Study Period||281||
48529448|NCT03514641|101631751|FG000|COMPLETED|603B: 24-36 Week Study Period||0||
48529449|NCT03514641|101631752|FG001|COMPLETED|603B: 24-36 Week Study Period||0||
48529450|NCT03514641|101631753|FG002|COMPLETED|603B: 24-36 Week Study Period||267||
48529451|NCT03514641|101631754|FG003|COMPLETED|603B: 24-36 Week Study Period||266||
48529452|NCT03514641|101631751|FG000|NOT COMPLETED|603B: 24-36 Week Study Period||0||
48529453|NCT03514641|101631752|FG001|NOT COMPLETED|603B: 24-36 Week Study Period||0||
48529454|NCT03514641|101631753|FG002|NOT COMPLETED|603B: 24-36 Week Study Period||14||
48529455|NCT03514641|101631754|FG003|NOT COMPLETED|603B: 24-36 Week Study Period||15||
48529456|NCT01172821|101631755|FG000|STARTED|Overall Study||254||
48529457|NCT01172821|101631756|FG001|STARTED|Overall Study||257||
48229145|NCT02659540|100880822|FG001|STARTED|Overall Study||10||
48229146|NCT02659540|100880821|FG000|COMPLETED|Overall Study||4|Completed treatment through Week 18|
48229147|NCT02659540|100880822|FG001|COMPLETED|Overall Study||2|Completed treatment through Week 18|
48529458|NCT01172821|101631757|FG002|STARTED|Overall Study||253||
48529459|NCT01172821|101631758|FG003|STARTED|Overall Study||266||
48529460|NCT01172821|101631755|FG000|COMPLETED|Overall Study||240||
48529461|NCT01172821|101631756|FG001|COMPLETED|Overall Study||245||
48529462|NCT01172821|101631757|FG002|COMPLETED|Overall Study||240||
48529463|NCT01172821|101631758|FG003|COMPLETED|Overall Study||249||
48529464|NCT01172821|101631755|FG000|NOT COMPLETED|Overall Study||14||
48529465|NCT01172821|101631756|FG001|NOT COMPLETED|Overall Study||12||
48529466|NCT01172821|101631757|FG002|NOT COMPLETED|Overall Study||13||
48529467|NCT01172821|101631758|FG003|NOT COMPLETED|Overall Study||17||
48529468|NCT01175811|101631759|FG000|STARTED|Overall Study||199||
48529469|NCT01175811|101631760|FG001|STARTED|Overall Study||203||
48529470|NCT01175811|101631759|FG000|Received at Least 1 Dose of Study Drug|Overall Study||197||
48529471|NCT01175811|101631760|FG001|Received at Least 1 Dose of Study Drug|Overall Study||202||
48529472|NCT01175811|101631759|FG000|COMPLETED|Overall Study||183||
48529473|NCT01175811|101631760|FG001|COMPLETED|Overall Study||189||
48529474|NCT01175811|101631759|FG000|NOT COMPLETED|Overall Study||16||
48529475|NCT01175811|101631760|FG001|NOT COMPLETED|Overall Study||14||
48529476|NCT04505293|101631761|FG000|STARTED|Overall Study||672||
48529477|NCT04505293|101631761|FG000|COMPLETED|Overall Study||387||
48529478|NCT04505293|101631761|FG000|NOT COMPLETED|Overall Study||285||
48529479|NCT01531738|101631762|FG000|STARTED|Overall Study||11||
48529480|NCT01531738|101631763|FG001|STARTED|Overall Study||11||
48529481|NCT01531738|101631762|FG000|COMPLETED|Overall Study||11||
48529482|NCT01531738|101631763|FG001|COMPLETED|Overall Study||11||
48529483|NCT01531738|101631762|FG000|NOT COMPLETED|Overall Study||0||
48529484|NCT01531738|101631763|FG001|NOT COMPLETED|Overall Study||0||
48529485|NCT01948986|101631764|FG000|STARTED|Overall Study||6||
48529486|NCT01948986|101631765|FG001|STARTED|Overall Study||8||
48529487|NCT01948986|101631766|FG002|STARTED|Overall Study||8||
48529488|NCT01948986|101631767|FG003|STARTED|Overall Study||6||
48529489|NCT01948986|101631768|FG004|STARTED|Overall Study||8||
48529490|NCT01948986|101631764|FG000|COMPLETED|Overall Study||6||
48529491|NCT01948986|101631765|FG001|COMPLETED|Overall Study||8||
48529492|NCT01948986|101631766|FG002|COMPLETED|Overall Study||8||
48529493|NCT01948986|101631767|FG003|COMPLETED|Overall Study||6||
48529494|NCT01948986|101631768|FG004|COMPLETED|Overall Study||8||
48529495|NCT01948986|101631764|FG000|NOT COMPLETED|Overall Study||0||
48529496|NCT01948986|101631765|FG001|NOT COMPLETED|Overall Study||0||
48529497|NCT01948986|101631766|FG002|NOT COMPLETED|Overall Study||0||
48529498|NCT01948986|101631767|FG003|NOT COMPLETED|Overall Study||0||
48529499|NCT01948986|101631768|FG004|NOT COMPLETED|Overall Study||0||
48529500|NCT02603393|101631769|FG000|STARTED|Overall Study||527||
48529501|NCT02603393|101631770|FG001|STARTED|Overall Study||526||
48529502|NCT02603393|101631769|FG000|COMPLETED|Overall Study||456||
48529503|NCT02603393|101631770|FG001|COMPLETED|Overall Study||472||
48529504|NCT02603393|101631769|FG000|NOT COMPLETED|Overall Study||71||
48529505|NCT02603393|101631770|FG001|NOT COMPLETED|Overall Study||54||
48529506|NCT00134043|101631771|FG000|STARTED|Overall Study||16||
48529507|NCT00134043|101631772|FG001|STARTED|Overall Study||3||
48529508|NCT00134043|101631771|FG000|COMPLETED|Overall Study||16||
48529509|NCT00134043|101631772|FG001|COMPLETED|Overall Study||3||
48529510|NCT00134043|101631771|FG000|NOT COMPLETED|Overall Study||0||
48529511|NCT00134043|101631772|FG001|NOT COMPLETED|Overall Study||0||
48529512|NCT01659866|101631773|FG000|STARTED|Overall Study||430||
48529513|NCT01659866|101631774|FG001|STARTED|Overall Study||80||
48529514|NCT01659866|101631773|FG000|COMPLETED|Overall Study||430||
48529515|NCT01659866|101631774|FG001|COMPLETED|Overall Study||80||
48529516|NCT01659866|101631773|FG000|NOT COMPLETED|Overall Study||0||
48529517|NCT01659866|101631774|FG001|NOT COMPLETED|Overall Study||0||
48529518|NCT04408599|101631775|FG000|STARTED|Overall Study||3||
48529519|NCT04408599|101631776|FG001|STARTED|Overall Study||3||
48529520|NCT04408599|101631777|FG002|STARTED|Overall Study||4||
48529521|NCT04408599|101631778|FG003|STARTED|Overall Study||10||
48529522|NCT04408599|101631779|FG004|STARTED|Overall Study||10||
48529523|NCT04408599|101631780|FG005|STARTED|Overall Study||10||
48529524|NCT04408599|101631781|FG006|STARTED|Overall Study||6||
48529525|NCT04408599|101631775|FG000|COMPLETED|Overall Study||1||
48529526|NCT04408599|101631776|FG001|COMPLETED|Overall Study||2||
48529527|NCT04408599|101631777|FG002|COMPLETED|Overall Study||1||
48529528|NCT04408599|101631778|FG003|COMPLETED|Overall Study||7||
48529529|NCT04408599|101631779|FG004|COMPLETED|Overall Study||7||
48529530|NCT04408599|101631780|FG005|COMPLETED|Overall Study||6||
48529531|NCT04408599|101631781|FG006|COMPLETED|Overall Study||1||
48529532|NCT04408599|101631775|FG000|NOT COMPLETED|Overall Study||2||
48529533|NCT04408599|101631776|FG001|NOT COMPLETED|Overall Study||1||
48529534|NCT04408599|101631777|FG002|NOT COMPLETED|Overall Study||3||
48529535|NCT04408599|101631778|FG003|NOT COMPLETED|Overall Study||3||
48529536|NCT04408599|101631779|FG004|NOT COMPLETED|Overall Study||3||
48529537|NCT04408599|101631780|FG005|NOT COMPLETED|Overall Study||4||
48529538|NCT04408599|101631781|FG006|NOT COMPLETED|Overall Study||5||
48529539|NCT02528123|101631782|FG000|STARTED|Overall Study||114||187
48529540|NCT02528123|101631782|FG000|COMPLETED|Overall Study||113||185
48529541|NCT02528123|101631782|FG000|NOT COMPLETED|Overall Study||1||2
48529542|NCT02642536|101631783|FG000|STARTED|Overall Study||21||
48529543|NCT02642536|101631784|FG001|STARTED|Overall Study||23||
48529544|NCT02642536|101631783|FG000|COMPLETED|Overall Study||19||
48529545|NCT02642536|101631784|FG001|COMPLETED|Overall Study||18||
48529546|NCT02642536|101631783|FG000|NOT COMPLETED|Overall Study||2||
48529547|NCT02642536|101631784|FG001|NOT COMPLETED|Overall Study||5||
48529548|NCT01411527|101631785|FG000|STARTED|Overall Study||1864||
48529549|NCT01411527|101631786|FG001|STARTED|Overall Study||93||
48529550|NCT01411527|101631785|FG000|COMPLETED|Overall Study||1864|116 participants were later transferred to the longitudinal cohort|
48529551|NCT01411527|101631786|FG001|COMPLETED|Overall Study||93|116 participants were later transferred to the longitudinal cohort|
48529552|NCT01411527|101631785|FG000|NOT COMPLETED|Overall Study||0||
48529553|NCT01411527|101631786|FG001|NOT COMPLETED|Overall Study||0||
48529554|NCT05142566|101631787|FG000|STARTED|Overall Study||18||
48529555|NCT05142566|101631787|FG000|COMPLETED|Overall Study||17||
48529556|NCT05142566|101631787|FG000|NOT COMPLETED|Overall Study||1||
48529557|NCT00655876|101631788|FG000|STARTED|Overall Study||168||
48529558|NCT00655876|101631789|FG001|STARTED|Overall Study||176||
48529559|NCT00655876|101631788|FG000|COMPLETED|Overall Study||159||
48529560|NCT00655876|101631789|FG001|COMPLETED|Overall Study||169||
48529561|NCT00655876|101631788|FG000|NOT COMPLETED|Overall Study||9||
48529562|NCT00655876|101631789|FG001|NOT COMPLETED|Overall Study||7||
48529563|NCT01207648|101631790|FG000|STARTED|Overall Study||307||
48529564|NCT01207648|101631790|FG000|COMPLETED|Overall Study||307||
48529565|NCT01207648|101631790|FG000|NOT COMPLETED|Overall Study||0||
48529566|NCT01177059|101631791|FG000|STARTED|Overall Study||68||
48529567|NCT01177059|101631791|FG000|COMPLETED|Overall Study||18||
48529568|NCT01177059|101631791|FG000|NOT COMPLETED|Overall Study||50||
48529569|NCT00578669|101631792|FG000|STARTED|Overall Study||107||
48529570|NCT00578669|101631793|FG001|STARTED|Overall Study||99||
48529571|NCT00578669|101631792|FG000|COMPLETED|Overall Study||107||
48529572|NCT00578669|101631793|FG001|COMPLETED|Overall Study||99||
48529573|NCT00578669|101631792|FG000|NOT COMPLETED|Overall Study||0||
48529574|NCT00578669|101631793|FG001|NOT COMPLETED|Overall Study||0||
48529575|NCT03050203|101631794|FG000|STARTED|Overall Study||19||
48529576|NCT03050203|101631795|FG001|STARTED|Overall Study||18||
48529577|NCT03050203|101631794|FG000|COMPLETED|Overall Study||19||
48529578|NCT03050203|101631795|FG001|COMPLETED|Overall Study||18||
48529579|NCT03050203|101631794|FG000|NOT COMPLETED|Overall Study||0||
48229148|NCT02659540|100880821|FG000|NOT COMPLETED|Overall Study||6||
48229149|NCT02659540|100880822|FG001|NOT COMPLETED|Overall Study||8||
48229150|NCT01229176|100880823|FG000|STARTED|Overall Study||40||
48529580|NCT03050203|101631795|FG001|NOT COMPLETED|Overall Study||0||
48529581|NCT02923674|101631796|FG000|STARTED|Overall Study||60||
48529582|NCT02923674|101631797|FG001|STARTED|Overall Study||60||
48529583|NCT02923674|101631798|FG002|STARTED|Overall Study||63||
48529584|NCT02923674|101631796|FG000|COMPLETED|Overall Study||32||
48529585|NCT02923674|101631797|FG001|COMPLETED|Overall Study||32||
48529586|NCT02923674|101631798|FG002|COMPLETED|Overall Study||38||
48529587|NCT02923674|101631796|FG000|NOT COMPLETED|Overall Study||28||
48529588|NCT02923674|101631797|FG001|NOT COMPLETED|Overall Study||28||
48529589|NCT02923674|101631798|FG002|NOT COMPLETED|Overall Study||25||
48529590|NCT01732874|101631799|FG000|STARTED|Overall Study||16||
48529591|NCT01732874|101631800|FG001|STARTED|Overall Study||11||
48529592|NCT01732874|101631799|FG000|COMPLETED|Overall Study||8||
48529593|NCT01732874|101631800|FG001|COMPLETED|Overall Study||8||
48529594|NCT01732874|101631799|FG000|NOT COMPLETED|Overall Study||8||
48529595|NCT01732874|101631800|FG001|NOT COMPLETED|Overall Study||3||
48529596|NCT02981303|101631801|FG000|STARTED|Overall Study||20||
48529597|NCT02981303|101631802|FG001|STARTED|Overall Study||44||
48529598|NCT02981303|101631801|FG000|COMPLETED|Overall Study||2||
48529599|NCT02981303|101631802|FG001|COMPLETED|Overall Study||2||
48529600|NCT02981303|101631801|FG000|NOT COMPLETED|Overall Study||18||
48529601|NCT02981303|101631802|FG001|NOT COMPLETED|Overall Study||42||
48529602|NCT01453894|101631803|FG000|STARTED|Overall Study||225||
48529603|NCT01453894|101631804|FG001|STARTED|Overall Study||225||
48529604|NCT01453894|101631803|FG000|COMPLETED|Overall Study||225||
48529605|NCT01453894|101631804|FG001|COMPLETED|Overall Study||225||
48529606|NCT01453894|101631803|FG000|NOT COMPLETED|Overall Study||0||
48529607|NCT01453894|101631804|FG001|NOT COMPLETED|Overall Study||0||
48529608|NCT03285308|101631805|FG000|STARTED|Overall Study||167||
48529609|NCT03285308|101631806|FG001|STARTED|Overall Study||169||
48529610|NCT03285308|101631805|FG000|Safety Population|Overall Study||163|Safety Population included participants who received ≥1 administration of Double-blind study treatment.|
48529611|NCT03285308|101631806|FG001|Safety Population|Overall Study||163|Safety Population included participants who received ≥1 administration of Double-blind study treatment.|
48229151|NCT01229176|100880824|FG001|STARTED|Overall Study||40||
48229152|NCT01229176|100880825|FG002|STARTED|Overall Study||20||
48229153|NCT01229176|100880826|FG003|STARTED|Overall Study||20||
48229154|NCT01229176|100880827|FG004|STARTED|Overall Study||20||
48529612|NCT03285308|101631805|FG000|COMPLETED|Overall Study||147||
48529613|NCT03285308|101631806|FG001|COMPLETED|Overall Study||146||
48529614|NCT03285308|101631805|FG000|NOT COMPLETED|Overall Study||20||
48529615|NCT03285308|101631806|FG001|NOT COMPLETED|Overall Study||23||
48529616|NCT01736241|101631807|FG000|STARTED|Overall Study||6||
48529617|NCT01736241|101631808|FG001|STARTED|Overall Study||6||
48529618|NCT01736241|101631809|FG002|STARTED|Overall Study||6||
48529619|NCT01736241|101631810|FG003|STARTED|Overall Study||5||
48529620|NCT01736241|101631811|FG004|STARTED|Overall Study||6||
48529621|NCT01736241|101631812|FG005|STARTED|Overall Study||6||
48229155|NCT01229176|100880828|FG005|STARTED|Overall Study||20||
48529622|NCT01736241|101631813|FG006|STARTED|Overall Study||6||
48529623|NCT01736241|101631807|FG000|Received at Least One Dose of Study Drug|Overall Study||6||
48229156|NCT01229176|100880829|FG006|STARTED|Overall Study||20||
48229157|NCT01229176|100880830|FG007|STARTED|Overall Study||20||
48529624|NCT01736241|101631808|FG001|Received at Least One Dose of Study Drug|Overall Study||6||
48229158|NCT01229176|100880823|FG000|COMPLETED|Overall Study||40||
48229159|NCT01229176|100880824|FG001|COMPLETED|Overall Study||37||
48229160|NCT01229176|100880825|FG002|COMPLETED|Overall Study||20||
48229161|NCT01229176|100880826|FG003|COMPLETED|Overall Study||19||
48229162|NCT01229176|100880827|FG004|COMPLETED|Overall Study||18||
48229163|NCT01229176|100880828|FG005|COMPLETED|Overall Study||18||
48229164|NCT01229176|100880829|FG006|COMPLETED|Overall Study||20||
48229165|NCT01229176|100880830|FG007|COMPLETED|Overall Study||17||
48229166|NCT01229176|100880823|FG000|NOT COMPLETED|Overall Study||0||
48229167|NCT01229176|100880824|FG001|NOT COMPLETED|Overall Study||3||
48229168|NCT01229176|100880825|FG002|NOT COMPLETED|Overall Study||0||
48229169|NCT01229176|100880826|FG003|NOT COMPLETED|Overall Study||1||
48229170|NCT01229176|100880827|FG004|NOT COMPLETED|Overall Study||2||
48229171|NCT01229176|100880828|FG005|NOT COMPLETED|Overall Study||2||
48229172|NCT01229176|100880829|FG006|NOT COMPLETED|Overall Study||0||
48229173|NCT01229176|100880830|FG007|NOT COMPLETED|Overall Study||3||
48229174|NCT02454959|100880831|FG000|STARTED|Overall Study||79||
48229175|NCT02454959|100880831|FG000|GFF MDI (PT003) With Aerochamber|Overall Study||73||
48529625|NCT01736241|101631809|FG002|Received at Least One Dose of Study Drug|Overall Study||6||
48529626|NCT01736241|101631810|FG003|Received at Least One Dose of Study Drug|Overall Study||5||
48529627|NCT01736241|101631811|FG004|Received at Least One Dose of Study Drug|Overall Study||6||
48529628|NCT01736241|101631812|FG005|Received at Least One Dose of Study Drug|Overall Study||6||
48529629|NCT01736241|101631813|FG006|Received at Least One Dose of Study Drug|Overall Study||6||
48229176|NCT02454959|100880831|FG000|GFF MDI (PT003) Without Aerochamber|Overall Study||77||
48229177|NCT02454959|100880831|FG000|COMPLETED|Overall Study||70||
48229178|NCT02454959|100880831|FG000|NOT COMPLETED|Overall Study||9||
48229179|NCT01228734|100880832|FG000|STARTED|Overall Study||193||
48229180|NCT01228734|100880833|FG001|STARTED|Overall Study||204||
48229181|NCT01228734|100880832|FG000|Modified Intent-to-treat Population|Overall Study||193||
48229182|NCT01228734|100880833|FG001|Modified Intent-to-treat Population|Overall Study||200||
48229183|NCT01228734|100880832|FG000|Modified Safety Population|Overall Study||194||
48229184|NCT01228734|100880833|FG001|Modified Safety Population|Overall Study||199||
48229185|NCT01228734|100880832|FG000|COMPLETED|Overall Study||193||
48229186|NCT01228734|100880833|FG001|COMPLETED|Overall Study||200||
48229187|NCT01228734|100880832|FG000|NOT COMPLETED|Overall Study||0||
48229188|NCT01228734|100880833|FG001|NOT COMPLETED|Overall Study||4||
48229189|NCT02165202|100880834|FG000|STARTED|Oral Phase||91||
48229190|NCT02165202|100880835|FG001|STARTED|Oral Phase||45||
48229191|NCT02165202|100880834|FG000|COMPLETED|Oral Phase||80|Participants who completed oral run in phase (0-week 4) and received at least 1 injection.|
48229192|NCT02165202|100880835|FG001|COMPLETED|Oral Phase||42|Participants who completed oral run in phase (0-week 4) and received at least 1 injection.|
48529630|NCT01736241|101631807|FG000|COMPLETED|Overall Study||6||
48529631|NCT01736241|101631808|FG001|COMPLETED|Overall Study||6||
48529632|NCT01736241|101631809|FG002|COMPLETED|Overall Study||6||
48529633|NCT01736241|101631810|FG003|COMPLETED|Overall Study||5||
48529634|NCT01736241|101631811|FG004|COMPLETED|Overall Study||6||
48529635|NCT01736241|101631812|FG005|COMPLETED|Overall Study||6||
48529636|NCT01736241|101631813|FG006|COMPLETED|Overall Study||6||
48529637|NCT01736241|101631807|FG000|NOT COMPLETED|Overall Study||0||
48529638|NCT01736241|101631808|FG001|NOT COMPLETED|Overall Study||0||
48529639|NCT01736241|101631809|FG002|NOT COMPLETED|Overall Study||0||
48529640|NCT01736241|101631810|FG003|NOT COMPLETED|Overall Study||0||
48529641|NCT01736241|101631811|FG004|NOT COMPLETED|Overall Study||0||
48529642|NCT01736241|101631812|FG005|NOT COMPLETED|Overall Study||0||
48529643|NCT01736241|101631813|FG006|NOT COMPLETED|Overall Study||0||
48529644|NCT01434186|101631814|FG000|STARTED|Overall Study||2||
48529645|NCT01434186|101631815|FG001|STARTED|Overall Study||4||
48529646|NCT01434186|101631814|FG000|COMPLETED|Overall Study||2||
48529647|NCT01434186|101631815|FG001|COMPLETED|Overall Study||4||
48529648|NCT01434186|101631814|FG000|NOT COMPLETED|Overall Study||0||
48529649|NCT01434186|101631815|FG001|NOT COMPLETED|Overall Study||0||
48529650|NCT00468650|101631816|FG000|STARTED|Overall Study||117||
48529651|NCT00468650|101631816|FG000|COMPLETED|Overall Study||110||
48229193|NCT02165202|100880834|FG000|NOT COMPLETED|Oral Phase||11||
48229194|NCT02165202|100880835|FG001|NOT COMPLETED|Oral Phase||3||
48529652|NCT00468650|101631816|FG000|NOT COMPLETED|Overall Study||7||
48529653|NCT02618408|101631817|FG000|STARTED|Overall Study||130|The number of subjects is based on the randomized population that included all those enrolled subjects who complete the Baseline Period, meet the inclusion/exclusion criteria and are randomized.|
48529654|NCT02618408|101631818|FG001|STARTED|Overall Study||65|The number of subjects is based on the randomized population that included all those enrolled subjects who complete the Baseline Period, meet the inclusion/exclusion criteria and are randomized.|
48229195|NCT02165202|100880834|FG000|STARTED|Injection Phase||80||
48229196|NCT02165202|100880835|FG001|STARTED|Injection Phase||42||
48229197|NCT02165202|100880834|FG000|COMPLETED|Injection Phase||70|Ppts who received at least 1 injection but were not discontinued or terminated till the end of study|
48229198|NCT02165202|100880835|FG001|COMPLETED|Injection Phase||36|Ppts who received at least 1 injection but were not discontinued or terminated till the end of study|
48529655|NCT02618408|101631819|FG002|STARTED|Overall Study||138|The number of subjects is based on the randomized population that included all those enrolled subjects who complete the Baseline Period, meet the inclusion/exclusion criteria and are randomized.|
48229199|NCT02165202|100880834|FG000|NOT COMPLETED|Injection Phase||10||
48229200|NCT02165202|100880835|FG001|NOT COMPLETED|Injection Phase||6||
48529656|NCT02618408|101631817|FG000|Intent-to-Treat|Overall Study||125|The number of subjects is based on the intent-to-treat population (ITT) which include all subjects who received at least 1 dose of study drug and have a baseline and at least 1 valid post-randomization assessment of frequency of IA behaviors based on IA diary entry.|
48529657|NCT02618408|101631818|FG001|Intent-to-Treat|Overall Study||65|The number of subjects is based on the intent-to-treat population (ITT) which include all subjects who received at least 1 dose of study drug and have a baseline and at least 1 valid post-randomization assessment of frequency of IA behaviors based on IA diary entry.|
48592650|NCT01877382|101783152|FG002|NOT COMPLETED|Dose Escalation||1||
48592651|NCT01877382|101783153|FG003|NOT COMPLETED|Dose Escalation||13||
48229201|NCT01411137|100880836|FG000|STARTED|Part 1: Dose Conversion||43||
48229202|NCT01411137|100880836|FG000|COMPLETED|Part 1: Dose Conversion||33||
48229203|NCT01411137|100880836|FG000|NOT COMPLETED|Part 1: Dose Conversion||10||
48229204|NCT01411137|100880836|FG000|STARTED|Part 2: Open-Label Extension||32||
48229205|NCT01411137|100880836|FG000|COMPLETED|Part 2: Open-Label Extension||25||
48229206|NCT01411137|100880836|FG000|NOT COMPLETED|Part 2: Open-Label Extension||7||
48229207|NCT01411137|100880836|FG000|STARTED|Part 3: Open-Label Extension||12||
48229208|NCT01411137|100880836|FG000|COMPLETED|Part 3: Open-Label Extension||12||
48229209|NCT01411137|100880836|FG000|NOT COMPLETED|Part 3: Open-Label Extension||0||
48229210|NCT03406325|100884218|FG000|STARTED|Overall Study||12||
48229211|NCT03406325|100884219|FG001|STARTED|Overall Study||1||
48229212|NCT03406325|100884220|FG002|STARTED|Overall Study||1||
48229213|NCT03406325|100884221|FG003|STARTED|Overall Study||1||
48229214|NCT03406325|100884222|FG004|STARTED|Overall Study||1||
48229215|NCT03406325|100884223|FG005|STARTED|Overall Study||1||
48229216|NCT03406325|100884224|FG006|STARTED|Overall Study||1||
48229217|NCT03406325|100884225|FG007|STARTED|Overall Study||1||
48229218|NCT03406325|100884218|FG000|COMPLETED|Overall Study||12||
48229219|NCT03406325|100884219|FG001|COMPLETED|Overall Study||1||
48229220|NCT03406325|100884220|FG002|COMPLETED|Overall Study||1||
48229221|NCT03406325|100884221|FG003|COMPLETED|Overall Study||1||
48229222|NCT03406325|100884222|FG004|COMPLETED|Overall Study||1||
48229223|NCT03406325|100884223|FG005|COMPLETED|Overall Study||1||
48229224|NCT03406325|100884224|FG006|COMPLETED|Overall Study||1||
48229225|NCT03406325|100884225|FG007|COMPLETED|Overall Study||1||
48229226|NCT03406325|100884218|FG000|NOT COMPLETED|Overall Study||0||
48229227|NCT03406325|100884219|FG001|NOT COMPLETED|Overall Study||0||
48229228|NCT03406325|100884220|FG002|NOT COMPLETED|Overall Study||0||
48229229|NCT03406325|100884221|FG003|NOT COMPLETED|Overall Study||0||
48229230|NCT03406325|100884222|FG004|NOT COMPLETED|Overall Study||0||
48229231|NCT03406325|100884223|FG005|NOT COMPLETED|Overall Study||0||
48229232|NCT03406325|100884224|FG006|NOT COMPLETED|Overall Study||0||
48229233|NCT03406325|100884225|FG007|NOT COMPLETED|Overall Study||0||
48229234|NCT01380145|100884226|FG000|STARTED|Overall Study||13||
48229235|NCT01380145|100884226|FG000|COMPLETED|Overall Study||9||
48229236|NCT01380145|100884226|FG000|NOT COMPLETED|Overall Study||4||
48229237|NCT03418922|100884227|FG000|STARTED|Overall Study||6||
48229238|NCT03418922|100884228|FG001|STARTED|Overall Study||24||
48229239|NCT03418922|100884227|FG000|COMPLETED|Overall Study||4||
48229240|NCT03418922|100884228|FG001|COMPLETED|Overall Study||18||
48229241|NCT03418922|100884227|FG000|NOT COMPLETED|Overall Study||2||
48229242|NCT03418922|100884228|FG001|NOT COMPLETED|Overall Study||6||
48229243|NCT04063124|100884229|FG000|STARTED|Overall Study||5||
48229244|NCT04063124|100884229|FG000|COMPLETED|Overall Study||5||
48229245|NCT04063124|100884229|FG000|NOT COMPLETED|Overall Study||0||
48229246|NCT00337610|100884230|FG000|STARTED|Overall Study||96||
48229247|NCT00337610|100884231|FG001|STARTED|Overall Study||94||
48229248|NCT00337610|100884230|FG000|Completed Week 18|Overall Study||89||
48229249|NCT00337610|100884231|FG001|Completed Week 18|Overall Study||82||
48229250|NCT00337610|100884230|FG000|COMPLETED|Overall Study||79||
48229251|NCT00337610|100884231|FG001|COMPLETED|Overall Study||80||
48229252|NCT00337610|100884230|FG000|NOT COMPLETED|Overall Study||17||
48229253|NCT00337610|100884231|FG001|NOT COMPLETED|Overall Study||14||
48229254|NCT04864834|100884232|FG000|STARTED|Overall Study||245||
48229255|NCT04864834|100884233|FG001|STARTED|Overall Study||240||
48229256|NCT04864834|100884232|FG000|Safety Set|Overall Study||244||
48229257|NCT04864834|100884233|FG001|Safety Set|Overall Study||240||
48229258|NCT04864834|100884232|FG000|Full Analysis Set|Overall Study||243||
48229259|NCT04864834|100884233|FG001|Full Analysis Set|Overall Study||240||
48229260|NCT04864834|100884232|FG000|Per-Protocol Set|Overall Study||235||
48229261|NCT04864834|100884233|FG001|Per-Protocol Set|Overall Study||226||
48229262|NCT04864834|100884232|FG000|PK Analysis Set|Overall Study||23||
48229263|NCT04864834|100884233|FG001|PK Analysis Set|Overall Study||20||
48229264|NCT04864834|100884232|FG000|Immunogenicity Analysis Set|Overall Study||234||
48229265|NCT04864834|100884233|FG001|Immunogenicity Analysis Set|Overall Study||231||
48229266|NCT04864834|100884232|FG000|VEGF Analysis Set|Overall Study||60||
48229267|NCT04864834|100884233|FG001|VEGF Analysis Set|Overall Study||67||
48229268|NCT04864834|100884232|FG000|COMPLETED|Overall Study||216||
48229269|NCT04864834|100884233|FG001|COMPLETED|Overall Study||215||
48229270|NCT04864834|100884232|FG000|NOT COMPLETED|Overall Study||29||
48229271|NCT04864834|100884233|FG001|NOT COMPLETED|Overall Study||25||
48229272|NCT00860457|100884234|FG000|STARTED|Overall Study||22||
48229273|NCT00860457|100884234|FG000|COMPLETED|Overall Study||11||
48229274|NCT00860457|100884234|FG000|NOT COMPLETED|Overall Study||11||
48229275|NCT00725959|100884235|FG000|STARTED|Overall Study||942||
48229276|NCT00725959|100884236|FG001|STARTED|Overall Study||636||
48229277|NCT00725959|100884235|FG000|COMPLETED|Overall Study||653||
48229278|NCT00725959|100884236|FG001|COMPLETED|Overall Study||439||
48229279|NCT00725959|100884235|FG000|NOT COMPLETED|Overall Study||289||
48229280|NCT00725959|100884236|FG001|NOT COMPLETED|Overall Study||197||
48229281|NCT03775213|100884237|FG000|STARTED|Overall Study||160||
48229282|NCT03775213|100884238|FG001|STARTED|Overall Study||162||
48229283|NCT03775213|100884237|FG000|COMPLETED|Overall Study||102||
48229284|NCT03775213|100884238|FG001|COMPLETED|Overall Study||102||
48229285|NCT03775213|100884237|FG000|NOT COMPLETED|Overall Study||58||
48229286|NCT03775213|100884238|FG001|NOT COMPLETED|Overall Study||60||
48229287|NCT00635700|100884239|FG000|STARTED|Overall Study||24||
48229288|NCT00635700|100884240|FG001|STARTED|Overall Study||27||
48229289|NCT00635700|100884239|FG000|COMPLETED|Overall Study||9||
48229290|NCT00635700|100884240|FG001|COMPLETED|Overall Study||13||
48229291|NCT00635700|100884239|FG000|NOT COMPLETED|Overall Study||15||
48229292|NCT00635700|100884240|FG001|NOT COMPLETED|Overall Study||14||
48229293|NCT00357994|100884241|FG000|STARTED|Overall Study||37||
48229294|NCT00357994|100884242|FG001|STARTED|Overall Study||34||
48229295|NCT00357994|100884241|FG000|COMPLETED|Overall Study||35||
48229296|NCT00357994|100884242|FG001|COMPLETED|Overall Study||31||
48229297|NCT00357994|100884241|FG000|NOT COMPLETED|Overall Study||2||
48229298|NCT00357994|100884242|FG001|NOT COMPLETED|Overall Study||3||
48229299|NCT02941692|100884243|FG000|STARTED|Overall Study||32||
48229300|NCT02941692|100884244|FG001|STARTED|Overall Study||34||
48229301|NCT02941692|100884243|FG000|COMPLETED|Overall Study||32||
48229302|NCT02941692|100884244|FG001|COMPLETED|Overall Study||34||
48229303|NCT02941692|100884243|FG000|NOT COMPLETED|Overall Study||0||
48229304|NCT02941692|100884244|FG001|NOT COMPLETED|Overall Study||0||
48229305|NCT00220805|100884245|FG000|STARTED|Overall Study||30||
48229306|NCT00220805|100884246|FG001|STARTED|Overall Study||27||
48229307|NCT00220805|100884245|FG000|COMPLETED|Overall Study||22||
48229308|NCT00220805|100884246|FG001|COMPLETED|Overall Study||16||
48229309|NCT00220805|100884245|FG000|NOT COMPLETED|Overall Study||8||
48529658|NCT02618408|101631819|FG002|Intent-to-Treat|Overall Study||135|The number of subjects is based on the intent-to-treat population (ITT) which include all subjects who received at least 1 dose of study drug and have a baseline and at least 1 valid post-randomization assessment of frequency of IA behaviors based on IA diary entry.|
48529659|NCT02618408|101631817|FG000|Safety|Overall Study||126|The number of subjects is based on the Safety Population which includes all randomized subjects who received at least 1 dose of study drug and have at least one post-randomization safety measurements.|
48229310|NCT00220805|100884246|FG001|NOT COMPLETED|Overall Study||11||
48229311|NCT03005106|100884247|FG000|STARTED|Overall Study||71||
48229312|NCT03005106|100884247|FG000|Completed Month 3 Visit|Overall Study||64||
48229313|NCT03005106|100884247|FG000|Completed Month 12 Visit|Overall Study||51||
48229314|NCT03005106|100884247|FG000|COMPLETED|Overall Study||51||
48229315|NCT03005106|100884247|FG000|NOT COMPLETED|Overall Study||20||
48229316|NCT02502019|100884248|FG000|STARTED|Overall Study||27||
48229317|NCT02502019|100884248|FG000|COMPLETED|Overall Study||27||
48229318|NCT02502019|100884248|FG000|NOT COMPLETED|Overall Study||0||
48229319|NCT00681109|100884249|FG000|STARTED|Overall Study||30||
48229320|NCT00681109|100884250|FG001|STARTED|Overall Study||30||
48229321|NCT00681109|100884251|FG002|STARTED|Overall Study||15||
48229322|NCT00681109|100884249|FG000|COMPLETED|Overall Study||28||
48229323|NCT00681109|100884250|FG001|COMPLETED|Overall Study||24||
48229324|NCT00681109|100884251|FG002|COMPLETED|Overall Study||15||
48229325|NCT00681109|100884249|FG000|NOT COMPLETED|Overall Study||2||
48229326|NCT00681109|100884250|FG001|NOT COMPLETED|Overall Study||6||
48229327|NCT00681109|100884251|FG002|NOT COMPLETED|Overall Study||0||
48229328|NCT00761267|100884252|FG000|STARTED|Overall Study||20||
48229329|NCT00761267|100884253|FG001|STARTED|Overall Study||20||
48229330|NCT00761267|100884254|FG002|STARTED|Overall Study||30||
48529660|NCT02618408|101631818|FG001|Safety|Overall Study||65|The number of subjects is based on the Safety Population which includes all randomized subjects who received at least 1 dose of study drug and have at least one post-randomization safety measurements.|
48229331|NCT00761267|100884252|FG000|Treated|Overall Study||19||
48229332|NCT00761267|100884253|FG001|Treated|Overall Study||19||
48229333|NCT00761267|100884254|FG002|Treated|Overall Study||30||
48229334|NCT00761267|100884252|FG000|COMPLETED|Overall Study||18||
48229335|NCT00761267|100884253|FG001|COMPLETED|Overall Study||16||
48229336|NCT00761267|100884254|FG002|COMPLETED|Overall Study||24||
48229337|NCT00761267|100884252|FG000|NOT COMPLETED|Overall Study||2||
48229338|NCT00761267|100884253|FG001|NOT COMPLETED|Overall Study||4||
48229339|NCT00761267|100884254|FG002|NOT COMPLETED|Overall Study||6||
48229340|NCT02499497|100884255|FG000|STARTED|Overall Study||36||
48229341|NCT02499497|100884256|FG001|STARTED|Overall Study||28||
48229342|NCT02499497|100884257|FG002|STARTED|Overall Study||36||
48229343|NCT02499497|100884258|FG003|STARTED|Overall Study||14||
48229344|NCT02499497|100884255|FG000|COMPLETED|Overall Study||32||
48229345|NCT02499497|100884256|FG001|COMPLETED|Overall Study||22||
48229346|NCT02499497|100884257|FG002|COMPLETED|Overall Study||35||
48229347|NCT02499497|100884258|FG003|COMPLETED|Overall Study||13||
48229348|NCT02499497|100884255|FG000|NOT COMPLETED|Overall Study||4||
48229349|NCT02499497|100884256|FG001|NOT COMPLETED|Overall Study||6||
48229350|NCT02499497|100884257|FG002|NOT COMPLETED|Overall Study||1||
48229351|NCT02499497|100884258|FG003|NOT COMPLETED|Overall Study||1||
48229352|NCT03137784|100884259|FG000|STARTED|Overall Study||24||
48229353|NCT03137784|100884260|FG001|STARTED|Overall Study||25||
48229354|NCT03137784|100884261|FG002|STARTED|Overall Study||25||
48229355|NCT03137784|100884262|FG003|STARTED|Overall Study||24||
48229356|NCT03137784|100884263|FG004|STARTED|Overall Study||25||
48229357|NCT03137784|100884264|FG005|STARTED|Overall Study||25||
48229358|NCT03137784|100884259|FG000|COMPLETED|Overall Study||22||
48229359|NCT03137784|100884260|FG001|COMPLETED|Overall Study||24||
48229360|NCT03137784|100884261|FG002|COMPLETED|Overall Study||25||
48229361|NCT03137784|100884262|FG003|COMPLETED|Overall Study||24||
48229362|NCT03137784|100884263|FG004|COMPLETED|Overall Study||24||
48229363|NCT03137784|100884264|FG005|COMPLETED|Overall Study||25||
48229364|NCT03137784|100884259|FG000|NOT COMPLETED|Overall Study||2||
48229365|NCT03137784|100884260|FG001|NOT COMPLETED|Overall Study||1||
48529661|NCT02618408|101631819|FG002|Safety|Overall Study||137|The number of subjects is based on the Safety Population which includes all randomized subjects who received at least 1 dose of study drug and have at least one post-randomization safety measurements.|
48529662|NCT02618408|101631817|FG000|COMPLETED|Overall Study||114|Randomized Population only|
48529663|NCT02618408|101631818|FG001|COMPLETED|Overall Study||58|Randomized Population only|
48080689|NCT00471328|100518828|FG000|NOT COMPLETED|Core Phase||107||
48080690|NCT00471328|100518829|FG001|NOT COMPLETED|Core Phase||67||
48229366|NCT03137784|100884261|FG002|NOT COMPLETED|Overall Study||0||
48229367|NCT03137784|100884262|FG003|NOT COMPLETED|Overall Study||0||
48229368|NCT03137784|100884263|FG004|NOT COMPLETED|Overall Study||1||
48229369|NCT03137784|100884264|FG005|NOT COMPLETED|Overall Study||0||
48229370|NCT01779141|100884265|FG000|STARTED|Overall Study||481||
48229371|NCT01779141|100884265|FG000|COMPLETED|Overall Study||300||
48229372|NCT01779141|100884265|FG000|NOT COMPLETED|Overall Study||181||
48229373|NCT00240994|100884266|FG000|STARTED|Overall Study||35||
48229374|NCT00240994|100884266|FG000|COMPLETED|Overall Study||32||
48229375|NCT00240994|100884266|FG000|NOT COMPLETED|Overall Study||3||
48229376|NCT03072862|100884267|FG000|STARTED|Overall Study||100||
48229377|NCT03072862|100884267|FG000|COMPLETED|Overall Study||82||
48229378|NCT03072862|100884267|FG000|NOT COMPLETED|Overall Study||18||
48229379|NCT01706159|100884268|FG000|STARTED|Overall Study||14||
48229380|NCT01706159|100884269|FG001|STARTED|Overall Study||6||
48229381|NCT01706159|100884268|FG000|Exposed|Overall Study||13||
48229382|NCT01706159|100884269|FG001|Exposed|Overall Study||5||
48229383|NCT01706159|100884268|FG000|Completers (With Baron Score at Week 8)|Overall Study||6||
48229384|NCT01706159|100884269|FG001|Completers (With Baron Score at Week 8)|Overall Study||3||
48229385|NCT01706159|100884268|FG000|COMPLETED|Overall Study||6||
48229386|NCT01706159|100884269|FG001|COMPLETED|Overall Study||4||
48229387|NCT01706159|100884268|FG000|NOT COMPLETED|Overall Study||8||
48229388|NCT01706159|100884269|FG001|NOT COMPLETED|Overall Study||2||
48229389|NCT02424968|100884270|FG000|STARTED|Overall Study||18||
48229390|NCT02424968|100884270|FG000|COMPLETED|Overall Study||18||
48229391|NCT02424968|100884270|FG000|NOT COMPLETED|Overall Study||0||
48229392|NCT05139615|100884271|FG000|STARTED|Overall Study||4||
48229393|NCT05139615|100884272|FG001|STARTED|Overall Study||3||
48229394|NCT05139615|100884273|FG002|STARTED|Overall Study||11||
48229395|NCT05139615|100884274|FG003|STARTED|Overall Study||4||
48229396|NCT05139615|100884271|FG000|COMPLETED|Overall Study||4||
48080691|NCT00471328|100518828|FG000|STARTED|Extension Phase||41||
48080692|NCT00471328|100518829|FG001|STARTED|Extension Phase||67||
48080693|NCT00471328|100518828|FG000|Started:CrossOver Before PrimaryAnalysis|Extension Phase||0||
48529664|NCT02618408|101631819|FG002|COMPLETED|Overall Study||101|Randomized Population only|
48080694|NCT00471328|100518829|FG001|Started:CrossOver Before PrimaryAnalysis|Extension Phase||53||
48080695|NCT00471328|100518828|FG000|Started:CrossOver After PrimaryAnalysis|Extension Phase||0||
48080696|NCT00471328|100518829|FG001|Started:CrossOver After PrimaryAnalysis|Extension Phase||4||
48080697|NCT00471328|100518828|FG000|Started:CrossOver During Extension|Extension Phase||0||
48080698|NCT00471328|100518829|FG001|Started:CrossOver During Extension|Extension Phase||10||
48229397|NCT05139615|100884272|FG001|COMPLETED|Overall Study||3||
48529665|NCT02618408|101631817|FG000|NOT COMPLETED|Overall Study||16||
48529666|NCT02618408|101631818|FG001|NOT COMPLETED|Overall Study||7||
48529667|NCT02618408|101631819|FG002|NOT COMPLETED|Overall Study||37||
48229398|NCT05139615|100884273|FG002|COMPLETED|Overall Study||11||
48229399|NCT05139615|100884274|FG003|COMPLETED|Overall Study||4||
48229400|NCT05139615|100884271|FG000|NOT COMPLETED|Overall Study||0||
48229401|NCT05139615|100884272|FG001|NOT COMPLETED|Overall Study||0||
48229402|NCT05139615|100884273|FG002|NOT COMPLETED|Overall Study||0||
48229403|NCT05139615|100884274|FG003|NOT COMPLETED|Overall Study||0||
48229404|NCT03849066|100884275|FG000|STARTED|Overall Study||136||
48229405|NCT03849066|100884275|FG000|COMPLETED|Overall Study||123||
48229406|NCT03849066|100884275|FG000|NOT COMPLETED|Overall Study||13||
48229407|NCT03851094|100884276|FG000|STARTED|Overall Study||111||
48229408|NCT03851094|100884277|FG001|STARTED|Overall Study||55||
48229409|NCT03851094|100884276|FG000|COMPLETED|Overall Study||111||
48229410|NCT03851094|100884277|FG001|COMPLETED|Overall Study||51||
48229411|NCT03851094|100884276|FG000|NOT COMPLETED|Overall Study||0||
48229412|NCT03851094|100884277|FG001|NOT COMPLETED|Overall Study||4||
48229413|NCT00407888|100884278|FG000|STARTED|Overall Study||60||
48229414|NCT00407888|100884278|FG000|COMPLETED|Overall Study||60||
48229415|NCT00407888|100884278|FG000|NOT COMPLETED|Overall Study||0||
48229416|NCT02359916|100884279|FG000|STARTED|Overall Study||0|"The unit of analysis for this study was vending machine sales (vends)."|5481
48229417|NCT02359916|100884280|FG001|STARTED|Overall Study||0|"The unit of analysis for this study was vending machine sales (vends)."|5784
48229418|NCT02359916|100884281|FG002|STARTED|Overall Study||0|"The unit of analysis for this study was vending machine sales (vends)."|7473
48229419|NCT02359916|100884282|FG003|STARTED|Overall Study||0|"The unit of analysis for this study was vending machine sales (vends)."|1996
48229420|NCT02359916|100884283|FG004|STARTED|Overall Study||0|"The unit of analysis for this study was vending machine sales (vends)."|2846
48229421|NCT02359916|100884284|FG005|STARTED|Overall Study||0|"The unit of analysis for this study was vending machine sales (vends)."|3438
48229422|NCT02359916|100884285|FG006|STARTED|Overall Study||0|"The unit of analysis for this study was vending machine sales (vends)."|5644
48229423|NCT02359916|100884279|FG000|COMPLETED|Overall Study||0||5481
48229424|NCT02359916|100884280|FG001|COMPLETED|Overall Study||0||5784
48229425|NCT02359916|100884281|FG002|COMPLETED|Overall Study||0||7473
48229426|NCT02359916|100884282|FG003|COMPLETED|Overall Study||0||1996
48229427|NCT02359916|100884283|FG004|COMPLETED|Overall Study||0||2846
48229428|NCT02359916|100884284|FG005|COMPLETED|Overall Study||0||3438
48229429|NCT02359916|100884285|FG006|COMPLETED|Overall Study||0||5644
48229430|NCT02359916|100884279|FG000|NOT COMPLETED|Overall Study||0||0
48229431|NCT02359916|100884280|FG001|NOT COMPLETED|Overall Study||0||0
48229432|NCT02359916|100884281|FG002|NOT COMPLETED|Overall Study||0||0
48229433|NCT02359916|100884282|FG003|NOT COMPLETED|Overall Study||0||0
48229434|NCT02359916|100884283|FG004|NOT COMPLETED|Overall Study||0||0
48229435|NCT02359916|100884284|FG005|NOT COMPLETED|Overall Study||0||0
48229436|NCT02359916|100884285|FG006|NOT COMPLETED|Overall Study||0||0
48229437|NCT01021748|100884286|FG000|STARTED|Overall Study||6||
48229438|NCT01021748|100884287|FG001|STARTED|Overall Study||5||
48229439|NCT01021748|100884288|FG002|STARTED|Overall Study||7||
48229440|NCT01021748|100884289|FG003|STARTED|Overall Study||7||
48229441|NCT01021748|100884290|FG004|STARTED|Overall Study||9||
48229442|NCT01021748|100884291|FG005|STARTED|Overall Study||3||
48229443|NCT01021748|100884292|FG006|STARTED|Overall Study||3||
48229444|NCT01021748|100884293|FG007|STARTED|Overall Study||6||
48229445|NCT01021748|100884294|FG008|STARTED|Overall Study||17||
48229446|NCT01021748|100884286|FG000|Treated|Overall Study||6||
48229447|NCT01021748|100884287|FG001|Treated|Overall Study||4||
48229448|NCT01021748|100884288|FG002|Treated|Overall Study||7||
48229449|NCT01021748|100884289|FG003|Treated|Overall Study||7||
48229450|NCT01021748|100884290|FG004|Treated|Overall Study||9||
48229451|NCT01021748|100884291|FG005|Treated|Overall Study||3||
48229452|NCT01021748|100884292|FG006|Treated|Overall Study||3||
48229453|NCT01021748|100884293|FG007|Treated|Overall Study||6||
48229454|NCT01021748|100884294|FG008|Treated|Overall Study||17||
48229455|NCT01021748|100884286|FG000|COMPLETED|Overall Study||0||
48229456|NCT01021748|100884287|FG001|COMPLETED|Overall Study||0||
48229457|NCT01021748|100884288|FG002|COMPLETED|Overall Study||0||
48229458|NCT01021748|100884289|FG003|COMPLETED|Overall Study||0||
48229459|NCT01021748|100884290|FG004|COMPLETED|Overall Study||0||
48229460|NCT01021748|100884291|FG005|COMPLETED|Overall Study||0||
48229461|NCT01021748|100884292|FG006|COMPLETED|Overall Study||0||
48229462|NCT01021748|100884293|FG007|COMPLETED|Overall Study||0||
48229463|NCT01021748|100884294|FG008|COMPLETED|Overall Study||1||
48229464|NCT01021748|100884286|FG000|NOT COMPLETED|Overall Study||6||
48229465|NCT01021748|100884287|FG001|NOT COMPLETED|Overall Study||5||
48229466|NCT01021748|100884288|FG002|NOT COMPLETED|Overall Study||7||
48229467|NCT01021748|100884289|FG003|NOT COMPLETED|Overall Study||7||
48229468|NCT01021748|100884290|FG004|NOT COMPLETED|Overall Study||9||
48229469|NCT01021748|100884291|FG005|NOT COMPLETED|Overall Study||3||
48229470|NCT01021748|100884292|FG006|NOT COMPLETED|Overall Study||3||
48229471|NCT01021748|100884293|FG007|NOT COMPLETED|Overall Study||6||
48229472|NCT01021748|100884294|FG008|NOT COMPLETED|Overall Study||16||
48229473|NCT01429454|100884295|FG000|STARTED|Overall Study||62||
48229474|NCT01429454|100884296|FG001|STARTED|Overall Study||65||
48229475|NCT01429454|100884295|FG000|COMPLETED|Overall Study||35||
48229476|NCT01429454|100884296|FG001|COMPLETED|Overall Study||35||
48229477|NCT01429454|100884295|FG000|NOT COMPLETED|Overall Study||27||
48229478|NCT01429454|100884296|FG001|NOT COMPLETED|Overall Study||30||
48229479|NCT01989793|100884297|FG000|STARTED|Overall Study||18||
48229480|NCT01989793|100884298|FG001|STARTED|Overall Study||19||
48229481|NCT01989793|100884297|FG000|COMPLETED|Overall Study||10||
48229482|NCT01989793|100884298|FG001|COMPLETED|Overall Study||15||
48229483|NCT01989793|100884297|FG000|NOT COMPLETED|Overall Study||8||
48229484|NCT01989793|100884298|FG001|NOT COMPLETED|Overall Study||4||
48229485|NCT04497415|100884299|FG000|STARTED|Overall Study||229|Pre-intervention assessment (day 1)|
48229486|NCT04497415|100884300|FG001|STARTED|Overall Study||121|Pre-intervention assessment (day 1)|
48229487|NCT04497415|100884299|FG000|Post-intervention Assessment (Day 1)|Overall Study||229||
48529668|NCT05034276|101631820|FG000|STARTED|Overall Study||28||
48529669|NCT05034276|101631820|FG000|COMPLETED|Overall Study||23||
48529670|NCT05034276|101631820|FG000|NOT COMPLETED|Overall Study||5||
48529671|NCT03233230|101631821|FG000|STARTED|Overall Study||97||
48229488|NCT04497415|100884300|FG001|Post-intervention Assessment (Day 1)|Overall Study||121||
48229489|NCT04497415|100884299|FG000|First Follow-up Assessment (Day 14)|Overall Study||195||
48229490|NCT04497415|100884300|FG001|First Follow-up Assessment (Day 14)|Overall Study||102||
48229491|NCT04497415|100884299|FG000|COMPLETED|Overall Study||186|Second follow-up assessment (day 30)|
48229492|NCT04497415|100884300|FG001|COMPLETED|Overall Study||94|Second follow-up assessment (day 30)|
48229493|NCT04497415|100884299|FG000|NOT COMPLETED|Overall Study||43||
48229494|NCT04497415|100884300|FG001|NOT COMPLETED|Overall Study||27||
48229495|NCT00529204|100884301|FG000|STARTED|Overall Study||1||
48229496|NCT00529204|100884301|FG000|COMPLETED|Overall Study||1||
48229497|NCT00529204|100884301|FG000|NOT COMPLETED|Overall Study||0||
48229498|NCT03335488|100884302|FG000|STARTED|Initial Treatment Period||11||
48229499|NCT03335488|100884303|FG001|STARTED|Initial Treatment Period||5||
48229500|NCT03335488|100884302|FG000|COMPLETED|Initial Treatment Period||11||
48229501|NCT03335488|100884303|FG001|COMPLETED|Initial Treatment Period||5||
48229502|NCT03335488|100884302|FG000|NOT COMPLETED|Initial Treatment Period||0||
48229503|NCT03335488|100884303|FG001|NOT COMPLETED|Initial Treatment Period||0||
48529672|NCT03233230|101631822|FG001|STARTED|Overall Study||98||
48529673|NCT03233230|101631823|FG002|STARTED|Overall Study||96||
48529674|NCT03233230|101631824|FG003|STARTED|Overall Study||99||
48529675|NCT03233230|101631821|FG000|COMPLETED|Overall Study||82||
48529676|NCT03233230|101631822|FG001|COMPLETED|Overall Study||83||
48529677|NCT03233230|101631823|FG002|COMPLETED|Overall Study||84||
48529678|NCT03233230|101631824|FG003|COMPLETED|Overall Study||91||
48529679|NCT03233230|101631821|FG000|NOT COMPLETED|Overall Study||15||
48529680|NCT03233230|101631822|FG001|NOT COMPLETED|Overall Study||15||
48529681|NCT03233230|101631823|FG002|NOT COMPLETED|Overall Study||12||
48529682|NCT03233230|101631824|FG003|NOT COMPLETED|Overall Study||8||
48529683|NCT00631449|101631825|FG000|STARTED|Overall Study||15||
48529684|NCT00631449|101631826|FG001|STARTED|Overall Study||15||
48529685|NCT00631449|101631825|FG000|COMPLETED|Overall Study||15||
48529686|NCT00631449|101631826|FG001|COMPLETED|Overall Study||15||
48529687|NCT00631449|101631825|FG000|NOT COMPLETED|Overall Study||0||
48529688|NCT00631449|101631826|FG001|NOT COMPLETED|Overall Study||0||
48529689|NCT00520286|101631827|FG000|STARTED|Overall Study||142||
48529690|NCT00520286|101631828|FG001|STARTED|Overall Study||68||
48529691|NCT00520286|101631827|FG000|COMPLETED|Overall Study||76||
48529692|NCT00520286|101631828|FG001|COMPLETED|Overall Study||36||
48529693|NCT00520286|101631827|FG000|NOT COMPLETED|Overall Study||66||
48529694|NCT00520286|101631828|FG001|NOT COMPLETED|Overall Study||32||
48529695|NCT00903448|101631829|FG000|STARTED|Period 1: 5 Days Then 10 Day Washout||20||
48529696|NCT00903448|101631830|FG001|STARTED|Period 1: 5 Days Then 10 Day Washout||20||
48529697|NCT00903448|101631829|FG000|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20||
48529698|NCT00903448|101631830|FG001|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20||
48529699|NCT00903448|101631829|FG000|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0||
48529700|NCT00903448|101631830|FG001|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0||
48529701|NCT00903448|101631829|FG000|STARTED|Period 2: 5 Days Then 10 Day Washout||20||
48529702|NCT00903448|101631830|FG001|STARTED|Period 2: 5 Days Then 10 Day Washout||20||
48529703|NCT00903448|101631829|FG000|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20||
48529704|NCT00903448|101631830|FG001|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20||
48229504|NCT03335488|100884302|FG000|STARTED|Transition Period||0||
48229505|NCT03335488|100884303|FG001|STARTED|Transition Period||5||
48229506|NCT03335488|100884302|FG000|COMPLETED|Transition Period||0||
48229507|NCT03335488|100884303|FG001|COMPLETED|Transition Period||5||
48229508|NCT03335488|100884302|FG000|NOT COMPLETED|Transition Period||0||
48229509|NCT03335488|100884303|FG001|NOT COMPLETED|Transition Period||0||
48229510|NCT03335488|100884302|FG000|STARTED|Maintenance Period||11||
48229511|NCT03335488|100884303|FG001|STARTED|Maintenance Period||5||
48229512|NCT03335488|100884302|FG000|COMPLETED|Maintenance Period||10||
48229513|NCT03335488|100884303|FG001|COMPLETED|Maintenance Period||5||
48229514|NCT03335488|100884302|FG000|NOT COMPLETED|Maintenance Period||1||
48229515|NCT03335488|100884303|FG001|NOT COMPLETED|Maintenance Period||0||
48229516|NCT03335488|100884302|FG000|STARTED|Safety Extension Period||10||
48529705|NCT00903448|101631829|FG000|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0||
48529706|NCT00903448|101631830|FG001|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0||
48529707|NCT00903448|101631829|FG000|STARTED|Period 3: 5 Days||20||
48529708|NCT00903448|101631830|FG001|STARTED|Period 3: 5 Days||20||
48529709|NCT00903448|101631829|FG000|COMPLETED|Period 3: 5 Days||20||
48529710|NCT00903448|101631830|FG001|COMPLETED|Period 3: 5 Days||20||
48529711|NCT00903448|101631829|FG000|NOT COMPLETED|Period 3: 5 Days||0||
48529712|NCT00903448|101631830|FG001|NOT COMPLETED|Period 3: 5 Days||0||
48529713|NCT00477295|101631831|FG000|STARTED|Overall Study||282||
48529714|NCT00477295|101631832|FG001|STARTED|Overall Study||301||
48529715|NCT00477295|101631831|FG000|COMPLETED|Overall Study||161||
48529716|NCT00477295|101631832|FG001|COMPLETED|Overall Study||192||
48529717|NCT00477295|101631831|FG000|NOT COMPLETED|Overall Study||121||
48529718|NCT00477295|101631832|FG001|NOT COMPLETED|Overall Study||109||
48529719|NCT00076804|101631833|FG000|STARTED|Overall Study||137||
48529720|NCT00076804|101631834|FG001|STARTED|Overall Study||137||
48529721|NCT00076804|101631833|FG000|COMPLETED|Overall Study||77||
48529722|NCT00076804|101631834|FG001|COMPLETED|Overall Study||68||
48529723|NCT00076804|101631833|FG000|NOT COMPLETED|Overall Study||60||
48229517|NCT03335488|100884303|FG001|STARTED|Safety Extension Period||5||
48229518|NCT03335488|100884302|FG000|COMPLETED|Safety Extension Period||8||
48229519|NCT03335488|100884303|FG001|COMPLETED|Safety Extension Period||5||
48229520|NCT03335488|100884302|FG000|NOT COMPLETED|Safety Extension Period||2||
48229521|NCT03335488|100884303|FG001|NOT COMPLETED|Safety Extension Period||0||
48229522|NCT02941549|100884304|FG000|STARTED|Overall Study||31||
48229523|NCT02941549|100884305|FG001|STARTED|Overall Study||32||
48229524|NCT02941549|100884306|FG002|STARTED|Overall Study||33||
48229525|NCT02941549|100884304|FG000|COMPLETED|Overall Study||28||
48229526|NCT02941549|100884305|FG001|COMPLETED|Overall Study||31||
48529724|NCT00076804|101631834|FG001|NOT COMPLETED|Overall Study||69||
48529725|NCT00548093|101631835|FG000|STARTED|Overall Study||50||
48529726|NCT00548093|101631836|FG001|STARTED|Overall Study||16||
48529727|NCT00548093|101631835|FG000|COMPLETED|Overall Study||0||
48529728|NCT00548093|101631836|FG001|COMPLETED|Overall Study||0||
48529729|NCT00548093|101631835|FG000|NOT COMPLETED|Overall Study||50||
48529730|NCT00548093|101631836|FG001|NOT COMPLETED|Overall Study||16||
48529731|NCT03567382|101631837|FG000|STARTED|Overall Study||10||
48529732|NCT03567382|101631838|FG001|STARTED|Overall Study||81||
48529733|NCT03567382|101631839|FG002|STARTED|Overall Study||9||
48529734|NCT03567382|101631840|FG003|STARTED|Overall Study||79||
48529735|NCT03567382|101631837|FG000|Received Tenofovir|Overall Study||9||
48529736|NCT03567382|101631838|FG001|Received Tenofovir|Overall Study||0||
48529737|NCT03567382|101631839|FG002|Received Tenofovir|Overall Study||0||
48529738|NCT03567382|101631840|FG003|Received Tenofovir|Overall Study||0||
48529739|NCT03567382|101631837|FG000|COMPLETED|Overall Study||7||
48529740|NCT03567382|101631838|FG001|COMPLETED|Overall Study||46||
48529741|NCT03567382|101631839|FG002|COMPLETED|Overall Study||7||
48529742|NCT03567382|101631840|FG003|COMPLETED|Overall Study||46||
48529743|NCT03567382|101631837|FG000|NOT COMPLETED|Overall Study||3||
48529744|NCT03567382|101631838|FG001|NOT COMPLETED|Overall Study||35||
48529745|NCT03567382|101631839|FG002|NOT COMPLETED|Overall Study||2||
48529746|NCT03567382|101631840|FG003|NOT COMPLETED|Overall Study||33||
48529747|NCT00158600|101631841|FG000|STARTED|Overall Study||60||
48529748|NCT00158600|101631842|FG001|STARTED|Overall Study||30||
48529749|NCT00158600|101631841|FG000|COMPLETED|Overall Study||55||
48529750|NCT00158600|101631842|FG001|COMPLETED|Overall Study||26||
48529751|NCT00158600|101631841|FG000|NOT COMPLETED|Overall Study||5||
48529752|NCT00158600|101631842|FG001|NOT COMPLETED|Overall Study||4||
48529753|NCT00719849|101631843|FG000|STARTED|Overall Study||4||
48529754|NCT00719849|101631844|FG001|STARTED|Overall Study||9||
48529755|NCT00719849|101631843|FG000|COMPLETED|Overall Study||4||
48529756|NCT00719849|101631844|FG001|COMPLETED|Overall Study||8||
48529757|NCT00719849|101631843|FG000|NOT COMPLETED|Overall Study||0||
48529758|NCT00719849|101631844|FG001|NOT COMPLETED|Overall Study||1||
48529759|NCT02944383|101631845|FG000|STARTED|Overall Study||30||
48529760|NCT02944383|101631846|FG001|STARTED|Overall Study||30||
48529761|NCT02944383|101631847|FG002|STARTED|Overall Study||31||
48229527|NCT02941549|100884306|FG002|COMPLETED|Overall Study||31||
48229528|NCT02941549|100884304|FG000|NOT COMPLETED|Overall Study||3||
48229529|NCT02941549|100884305|FG001|NOT COMPLETED|Overall Study||1||
48529762|NCT02944383|101631845|FG000|COMPLETED|Overall Study||29||
48529763|NCT02944383|101631846|FG001|COMPLETED|Overall Study||30||
48529764|NCT02944383|101631847|FG002|COMPLETED|Overall Study||30||
48529765|NCT02944383|101631845|FG000|NOT COMPLETED|Overall Study||1||
48529766|NCT02944383|101631846|FG001|NOT COMPLETED|Overall Study||0||
48229530|NCT02941549|100884306|FG002|NOT COMPLETED|Overall Study||2||
48229531|NCT01335061|100884307|FG000|STARTED|Overall Study||25||
48529767|NCT02944383|101631847|FG002|NOT COMPLETED|Overall Study||1||
48529768|NCT00103311|101631848|FG000|STARTED|Overall Study||33||
48529769|NCT00103311|101631849|FG001|STARTED|Overall Study||31||
48529770|NCT00103311|101631848|FG000|COMPLETED|Overall Study||29||
48529771|NCT00103311|101631849|FG001|COMPLETED|Overall Study||30||
48529772|NCT00103311|101631848|FG000|NOT COMPLETED|Overall Study||4||
48529773|NCT00103311|101631849|FG001|NOT COMPLETED|Overall Study||1||
48529774|NCT01019928|101631850|FG000|STARTED|Period 1||7||
48529775|NCT01019928|101631851|FG001|STARTED|Period 1||7||
48529776|NCT01019928|101631850|FG000|COMPLETED|Period 1||7||
48529777|NCT01019928|101631851|FG001|COMPLETED|Period 1||7||
48529778|NCT01019928|101631850|FG000|NOT COMPLETED|Period 1||0||
48529779|NCT01019928|101631851|FG001|NOT COMPLETED|Period 1||0||
48529780|NCT01019928|101631850|FG000|STARTED|Period 2||7||
48529781|NCT01019928|101631851|FG001|STARTED|Period 2||7||
48529782|NCT01019928|101631850|FG000|COMPLETED|Period 2||7||
48529783|NCT01019928|101631851|FG001|COMPLETED|Period 2||6||
48529784|NCT01019928|101631850|FG000|NOT COMPLETED|Period 2||0||
48529785|NCT01019928|101631851|FG001|NOT COMPLETED|Period 2||1||
48529786|NCT01019928|101631850|FG000|STARTED|Period 3||7||
48529787|NCT01019928|101631851|FG001|STARTED|Period 3||6||
48529788|NCT01019928|101631850|FG000|COMPLETED|Period 3||7||
48229532|NCT01335061|100884307|FG000|COMPLETED|Overall Study||25||
48229533|NCT01335061|100884307|FG000|NOT COMPLETED|Overall Study||0||
48229534|NCT03672032|100884308|FG000|STARTED|Overall Study||67||75
48229535|NCT03672032|100884309|FG001|STARTED|Overall Study||67||75
48229536|NCT03672032|100884308|FG000|COMPLETED|Overall Study||67||75
48229537|NCT03672032|100884309|FG001|COMPLETED|Overall Study||67||75
48229538|NCT03672032|100884308|FG000|NOT COMPLETED|Overall Study||0||0
48229539|NCT03672032|100884309|FG001|NOT COMPLETED|Overall Study||0||0
48229540|NCT03002194|100884310|FG000|STARTED|Overall Study||48||
48229541|NCT03002194|100884310|FG000|COMPLETED|Overall Study||38||
48229542|NCT03002194|100884310|FG000|NOT COMPLETED|Overall Study||10||
48229543|NCT00614614|100884311|FG000|STARTED|Primary Vaccination Phase||1272||
48229544|NCT00614614|100884312|FG001|STARTED|Primary Vaccination Phase||282||
48229545|NCT00614614|100884313|FG002|STARTED|Primary Vaccination Phase||0||
48229546|NCT00614614|100884314|FG003|STARTED|Primary Vaccination Phase||0||
48529789|NCT01019928|101631851|FG001|COMPLETED|Period 3||6||
48529790|NCT01019928|101631850|FG000|NOT COMPLETED|Period 3||0||
48529791|NCT01019928|101631851|FG001|NOT COMPLETED|Period 3||0||
48529792|NCT03738020|101631852|FG000|STARTED|Overall Study||58||
48529793|NCT03738020|101631852|FG000|COMPLETED|Overall Study||57||
48529794|NCT03738020|101631852|FG000|NOT COMPLETED|Overall Study||1||
48529795|NCT00612430|101631853|FG000|STARTED|Overall Study||32||
48529796|NCT00612430|101631854|FG001|STARTED|Overall Study||27||
48529797|NCT00612430|101631853|FG000|COMPLETED|Overall Study||32||
48529798|NCT00612430|101631854|FG001|COMPLETED|Overall Study||27||
48529799|NCT00612430|101631853|FG000|NOT COMPLETED|Overall Study||0||
48529800|NCT00612430|101631854|FG001|NOT COMPLETED|Overall Study||0||
48529801|NCT02473783|101631855|FG000|STARTED|Overall Study||20||
48529802|NCT02473783|101631856|FG001|STARTED|Overall Study||17||
48529803|NCT02473783|101631855|FG000|COMPLETED|Overall Study||20||
48529804|NCT02473783|101631856|FG001|COMPLETED|Overall Study||17||
48529805|NCT02473783|101631855|FG000|NOT COMPLETED|Overall Study||0||
48529806|NCT02473783|101631856|FG001|NOT COMPLETED|Overall Study||0||
48529807|NCT00085423|101631857|FG000|STARTED|Overall Study||20||
48529808|NCT00085423|101631857|FG000|COMPLETED|Overall Study||18||
48529809|NCT00085423|101631857|FG000|NOT COMPLETED|Overall Study||2||
48529810|NCT02054130|101631858|FG000|STARTED|Overall Study||138||
48529811|NCT02054130|101631859|FG001|STARTED|Overall Study||138||
48529812|NCT02054130|101631860|FG002|STARTED|Overall Study||137||
48529813|NCT02054130|101631861|FG003|STARTED|Overall Study||137||
48529814|NCT02054130|101631858|FG000|COMPLETED|Overall Study||130||
48529815|NCT02054130|101631859|FG001|COMPLETED|Overall Study||127||
48529816|NCT02054130|101631860|FG002|COMPLETED|Overall Study||122||
48529817|NCT02054130|101631861|FG003|COMPLETED|Overall Study||115||
48529818|NCT02054130|101631858|FG000|NOT COMPLETED|Overall Study||8||
48229547|NCT00614614|100884315|FG004|STARTED|Primary Vaccination Phase||0||
48229548|NCT00614614|100884311|FG000|COMPLETED|Primary Vaccination Phase||1182||
48229549|NCT00614614|100884312|FG001|COMPLETED|Primary Vaccination Phase||265||
48229550|NCT00614614|100884313|FG002|COMPLETED|Primary Vaccination Phase||0||
48529819|NCT02054130|101631859|FG001|NOT COMPLETED|Overall Study||11||
48529820|NCT02054130|101631860|FG002|NOT COMPLETED|Overall Study||15||
48529821|NCT02054130|101631861|FG003|NOT COMPLETED|Overall Study||22||
48529822|NCT02488330|101631862|FG000|STARTED|Overall Study||12||
48529823|NCT02488330|101631862|FG000|COMPLETED|Overall Study||0||
48529824|NCT02488330|101631862|FG000|NOT COMPLETED|Overall Study||12||
48229551|NCT00614614|100884314|FG003|COMPLETED|Primary Vaccination Phase||0||
48229552|NCT00614614|100884315|FG004|COMPLETED|Primary Vaccination Phase||0||
48229553|NCT00614614|100884311|FG000|NOT COMPLETED|Primary Vaccination Phase||90||
48529825|NCT01763684|101631863|FG000|STARTED|Overall Study||133||
48529826|NCT01763684|101631864|FG001|STARTED|Overall Study||133||
48529827|NCT01763684|101631863|FG000|Completed Surgery|Overall Study||126||
48529828|NCT01763684|101631864|FG001|Completed Surgery|Overall Study||127||
48529829|NCT01763684|101631863|FG000|COMPLETED|Overall Study||0||
48529830|NCT01763684|101631864|FG001|COMPLETED|Overall Study||0||
48229554|NCT00614614|100884312|FG001|NOT COMPLETED|Primary Vaccination Phase||17||
48229555|NCT00614614|100884313|FG002|NOT COMPLETED|Primary Vaccination Phase||0||
48229556|NCT00614614|100884314|FG003|NOT COMPLETED|Primary Vaccination Phase||0||
48229557|NCT00614614|100884315|FG004|NOT COMPLETED|Primary Vaccination Phase||0||
48529831|NCT01763684|101631863|FG000|NOT COMPLETED|Overall Study||133||
48529832|NCT01763684|101631864|FG001|NOT COMPLETED|Overall Study||133||
48529833|NCT04442490|101631865|FG000|STARTED|Overall Study||272||
48529834|NCT04442490|101631866|FG001|STARTED|Overall Study||271||
48529835|NCT04442490|101631865|FG000|Safety Set|Overall Study||269|Safety Set included all participants who were administered investigational product (IP).|
48529836|NCT04442490|101631866|FG001|Safety Set|Overall Study||268|Safety Set included all participants who were administered investigational product (IP).|
48529837|NCT04442490|101631865|FG000|COMPLETED|Overall Study||235||
48529838|NCT04442490|101631866|FG001|COMPLETED|Overall Study||242||
48529839|NCT04442490|101631865|FG000|NOT COMPLETED|Overall Study||37||
48529840|NCT04442490|101631866|FG001|NOT COMPLETED|Overall Study||29||
48529841|NCT03050060|101631867|FG000|STARTED|Overall Study||20||
48529842|NCT03050060|101631867|FG000|COMPLETED|Overall Study||5||
48529843|NCT03050060|101631867|FG000|NOT COMPLETED|Overall Study||15||
48529844|NCT00321828|101631868|FG000|STARTED|Overall Study||90||
48529845|NCT00321828|101631868|FG000|COMPLETED|Overall Study||86||
48529846|NCT00321828|101631868|FG000|NOT COMPLETED|Overall Study||4||
48529847|NCT02533375|101631869|FG000|STARTED|Overall Study||10||
48529848|NCT02533375|101631869|FG000|COMPLETED|Overall Study||5||
48529849|NCT02533375|101631869|FG000|NOT COMPLETED|Overall Study||5||
48529850|NCT00506129|101631870|FG000|STARTED|Overall Study||33||
48529851|NCT00506129|101631870|FG000|COMPLETED|Overall Study||11||
48529852|NCT00506129|101631870|FG000|NOT COMPLETED|Overall Study||22||
48529853|NCT03275766|101631871|FG000|STARTED|Overall Study||12||
48529854|NCT03275766|101631872|FG001|STARTED|Overall Study||12||
48529855|NCT03275766|101631873|FG002|STARTED|Overall Study||11||
48529856|NCT03275766|101631874|FG003|STARTED|Overall Study||10||
48229558|NCT00614614|100884311|FG000|STARTED|Booster Vaccination Phase||0||
48229559|NCT00614614|100884312|FG001|STARTED|Booster Vaccination Phase||233||
48529857|NCT03275766|101631871|FG000|Received Intervention|Overall Study||9||
48529858|NCT03275766|101631872|FG001|Received Intervention|Overall Study||11||
48529859|NCT03275766|101631873|FG002|Received Intervention|Overall Study||10||
48529860|NCT03275766|101631874|FG003|Received Intervention|Overall Study||9||
48529861|NCT03275766|101631871|FG000|COMPLETED|Overall Study||7||
48529862|NCT03275766|101631872|FG001|COMPLETED|Overall Study||5||
48529863|NCT03275766|101631873|FG002|COMPLETED|Overall Study||7||
48529864|NCT03275766|101631874|FG003|COMPLETED|Overall Study||4||
48529865|NCT03275766|101631871|FG000|NOT COMPLETED|Overall Study||5||
48529866|NCT03275766|101631872|FG001|NOT COMPLETED|Overall Study||7||
48529867|NCT03275766|101631873|FG002|NOT COMPLETED|Overall Study||4||
48529868|NCT03275766|101631874|FG003|NOT COMPLETED|Overall Study||6||
48529869|NCT04639713|101631875|FG000|STARTED|Overall Study||51||
48529870|NCT04639713|101631875|FG000|COMPLETED|Overall Study||48||
48529871|NCT04639713|101631875|FG000|NOT COMPLETED|Overall Study||3||
48529872|NCT02119286|101631876|FG000|STARTED|Overall Study||206||
48529873|NCT02119286|101631877|FG001|STARTED|Overall Study||206||
48529874|NCT02119286|101631878|FG002|STARTED|Overall Study||207||
48529875|NCT02119286|101631876|FG000|COMPLETED|Overall Study||180||
48529876|NCT02119286|101631877|FG001|COMPLETED|Overall Study||195||
48529877|NCT02119286|101631878|FG002|COMPLETED|Overall Study||200||
48529878|NCT02119286|101631876|FG000|NOT COMPLETED|Overall Study||26||
48529879|NCT02119286|101631877|FG001|NOT COMPLETED|Overall Study||11||
48529880|NCT02119286|101631878|FG002|NOT COMPLETED|Overall Study||7||
48529881|NCT00499174|101631879|FG000|STARTED|Overall Study||78||
48529882|NCT00499174|101631880|FG001|STARTED|Overall Study||102||
48529883|NCT00499174|101631879|FG000|COMPLETED|Overall Study||0||
48529884|NCT00499174|101631880|FG001|COMPLETED|Overall Study||93||
48229560|NCT00614614|100884313|FG002|STARTED|Booster Vaccination Phase||432||
48229561|NCT00614614|100884314|FG003|STARTED|Booster Vaccination Phase||229||
48229562|NCT00614614|100884315|FG004|STARTED|Booster Vaccination Phase||409||
48529885|NCT00499174|101631879|FG000|NOT COMPLETED|Overall Study||78||
48529886|NCT00499174|101631880|FG001|NOT COMPLETED|Overall Study||9||
48229563|NCT00614614|100884311|FG000|COMPLETED|Booster Vaccination Phase||0||
48229564|NCT00614614|100884312|FG001|COMPLETED|Booster Vaccination Phase||227||
48229565|NCT00614614|100884313|FG002|COMPLETED|Booster Vaccination Phase||405||
48529887|NCT01986010|101631881|FG000|STARTED|Overall Study||13||
48529888|NCT01986010|101631882|FG001|STARTED|Overall Study||14||
48529889|NCT01986010|101631883|FG002|STARTED|Overall Study||14||
48529890|NCT01986010|101631884|FG003|STARTED|Overall Study||10||
48529891|NCT01986010|101631885|FG004|STARTED|Overall Study||11||
48529892|NCT01986010|101631886|FG005|STARTED|Overall Study||19||
48529893|NCT01986010|101631887|FG006|STARTED|Overall Study||10||
48529894|NCT01986010|101631888|FG007|STARTED|Overall Study||4||
48529895|NCT01986010|101631889|FG008|STARTED|Overall Study||12||
48529896|NCT01986010|101631890|FG009|STARTED|Overall Study||10||
48529897|NCT01986010|101631891|FG010|STARTED|Overall Study||10||
48529898|NCT01986010|101631892|FG011|STARTED|Overall Study||11||
48529899|NCT01986010|101631893|FG012|STARTED|Overall Study||10||
48529900|NCT01986010|101631894|FG013|STARTED|Overall Study||11||
48529901|NCT01986010|101631895|FG014|STARTED|Overall Study||16||
48529902|NCT01986010|101631896|FG015|STARTED|Overall Study||11||
48529903|NCT01986010|101631897|FG016|STARTED|Overall Study||4||
48529904|NCT01986010|101631881|FG000|Vaccination 1|Overall Study||13||
48229566|NCT00614614|100884314|FG003|COMPLETED|Booster Vaccination Phase||210||
48229567|NCT00614614|100884315|FG004|COMPLETED|Booster Vaccination Phase||396||
48229568|NCT00614614|100884311|FG000|NOT COMPLETED|Booster Vaccination Phase||0||
48229569|NCT00614614|100884312|FG001|NOT COMPLETED|Booster Vaccination Phase||6||
48229570|NCT00614614|100884313|FG002|NOT COMPLETED|Booster Vaccination Phase||27||
48229571|NCT00614614|100884314|FG003|NOT COMPLETED|Booster Vaccination Phase||19||
48229572|NCT00614614|100884315|FG004|NOT COMPLETED|Booster Vaccination Phase||13||
48229573|NCT05405244|100884316|FG000|STARTED|First Intervention (Single 1-Day Visit)||28||
48229574|NCT05405244|100884317|FG001|STARTED|First Intervention (Single 1-Day Visit)||27||
48229575|NCT05405244|100884316|FG000|COMPLETED|First Intervention (Single 1-Day Visit)||28||
48229576|NCT05405244|100884317|FG001|COMPLETED|First Intervention (Single 1-Day Visit)||27||
48229577|NCT05405244|100884316|FG000|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0||
48229578|NCT05405244|100884317|FG001|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0||
48229579|NCT05405244|100884316|FG000|STARTED|Washout (2 Weeks)||28||
48229580|NCT05405244|100884317|FG001|STARTED|Washout (2 Weeks)||27||
48229581|NCT05405244|100884316|FG000|COMPLETED|Washout (2 Weeks)||24||
48229582|NCT05405244|100884317|FG001|COMPLETED|Washout (2 Weeks)||26||
48229583|NCT05405244|100884316|FG000|NOT COMPLETED|Washout (2 Weeks)||4||
48229584|NCT05405244|100884317|FG001|NOT COMPLETED|Washout (2 Weeks)||1||
48229585|NCT05405244|100884316|FG000|STARTED|Second Intervention (Single 1-Day Visit)||24||
48229586|NCT05405244|100884317|FG001|STARTED|Second Intervention (Single 1-Day Visit)||26||
48229587|NCT05405244|100884316|FG000|COMPLETED|Second Intervention (Single 1-Day Visit)||24||
48229588|NCT05405244|100884317|FG001|COMPLETED|Second Intervention (Single 1-Day Visit)||26||
48229589|NCT05405244|100884316|FG000|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0||
48529905|NCT01986010|101631882|FG001|Vaccination 1|Overall Study||14||
48229590|NCT05405244|100884317|FG001|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0||
48229591|NCT03009344|100884318|FG000|STARTED|Overall Study||7||
48229592|NCT03009344|100884318|FG000|COMPLETED|Overall Study||0||
48229593|NCT03009344|100884318|FG000|NOT COMPLETED|Overall Study||7||
48229594|NCT00048932|100884319|FG000|STARTED|Double Blind Period (DB)||959||
48229595|NCT00048932|100884320|FG001|STARTED|Double Blind Period (DB)||482||
48229596|NCT00048932|100884321|FG002|STARTED|Double Blind Period (DB)||0||
48529906|NCT01986010|101631883|FG002|Vaccination 1|Overall Study||14||
48229597|NCT00048932|100884319|FG000|COMPLETED|Double Blind Period (DB)||836||
48229598|NCT00048932|100884320|FG001|COMPLETED|Double Blind Period (DB)||395||
48229599|NCT00048932|100884321|FG002|COMPLETED|Double Blind Period (DB)||0||
48229600|NCT00048932|100884319|FG000|NOT COMPLETED|Double Blind Period (DB)||123||
48229601|NCT00048932|100884320|FG001|NOT COMPLETED|Double Blind Period (DB)||87||
48229602|NCT00048932|100884321|FG002|NOT COMPLETED|Double Blind Period (DB)||0||
48229603|NCT00048932|100884319|FG000|STARTED|Open Label Period (OL)||0||
48229604|NCT00048932|100884320|FG001|STARTED|Open Label Period (OL)||0||
48229605|NCT00048932|100884321|FG002|STARTED|Open Label Period (OL)||1184||
48229606|NCT00048932|100884319|FG000|COMPLETED|Open Label Period (OL)||0||
48529907|NCT01986010|101631884|FG003|Vaccination 1|Overall Study||10||
48229607|NCT00048932|100884320|FG001|COMPLETED|Open Label Period (OL)||0||
48229608|NCT00048932|100884321|FG002|COMPLETED|Open Label Period (OL)||743||
48229609|NCT00048932|100884319|FG000|NOT COMPLETED|Open Label Period (OL)||0||
48229610|NCT00048932|100884320|FG001|NOT COMPLETED|Open Label Period (OL)||0||
48229611|NCT00048932|100884321|FG002|NOT COMPLETED|Open Label Period (OL)||441||
48529908|NCT01986010|101631885|FG004|Vaccination 1|Overall Study||11||
48529909|NCT01986010|101631886|FG005|Vaccination 1|Overall Study||19||
48529910|NCT01986010|101631887|FG006|Vaccination 1|Overall Study||10||
48529911|NCT01986010|101631888|FG007|Vaccination 1|Overall Study||4||
48529912|NCT01986010|101631889|FG008|Vaccination 1|Overall Study||12||
48529913|NCT01986010|101631890|FG009|Vaccination 1|Overall Study||10||
48529914|NCT01986010|101631891|FG010|Vaccination 1|Overall Study||10||
48529915|NCT01986010|101631892|FG011|Vaccination 1|Overall Study||11||
48529916|NCT01986010|101631893|FG012|Vaccination 1|Overall Study||10||
48529917|NCT01986010|101631894|FG013|Vaccination 1|Overall Study||11||
48529918|NCT01986010|101631895|FG014|Vaccination 1|Overall Study||16||
48529919|NCT01986010|101631896|FG015|Vaccination 1|Overall Study||11||
48529920|NCT01986010|101631897|FG016|Vaccination 1|Overall Study||4||
48529921|NCT01986010|101631881|FG000|Vaccination 2|Overall Study||12||
48229612|NCT02574286|100884322|FG000|STARTED|Overall Study||21||
48229613|NCT02574286|100884322|FG000|COMPLETED|Overall Study||16||
48529922|NCT01986010|101631882|FG001|Vaccination 2|Overall Study||13||
48529923|NCT01986010|101631883|FG002|Vaccination 2|Overall Study||12||
48229614|NCT02574286|100884322|FG000|NOT COMPLETED|Overall Study||5||
48229615|NCT01450397|100884323|FG000|STARTED|Overall Study||5||
48229616|NCT01450397|100884323|FG000|COMPLETED|Overall Study||5||
48529924|NCT01986010|101631884|FG003|Vaccination 2|Overall Study||10||
48529925|NCT01986010|101631885|FG004|Vaccination 2|Overall Study||9||
48529926|NCT01986010|101631886|FG005|Vaccination 2|Overall Study||19||
48529927|NCT01986010|101631887|FG006|Vaccination 2|Overall Study||10||
48229617|NCT01450397|100884323|FG000|NOT COMPLETED|Overall Study||0||
48229618|NCT00462072|100884324|FG000|STARTED|Baseline (Week 0)||10||
48229619|NCT00462072|100884325|FG001|STARTED|Baseline (Week 0)||12||
48229620|NCT00462072|100884326|FG002|STARTED|Baseline (Week 0)||9||
48229621|NCT00462072|100884324|FG000|COMPLETED|Baseline (Week 0)||10||
48229622|NCT00462072|100884325|FG001|COMPLETED|Baseline (Week 0)||12||
48229623|NCT00462072|100884326|FG002|COMPLETED|Baseline (Week 0)||9||
48229624|NCT00462072|100884324|FG000|NOT COMPLETED|Baseline (Week 0)||0||
48529928|NCT01986010|101631888|FG007|Vaccination 2|Overall Study||4||
48529929|NCT01986010|101631889|FG008|Vaccination 2|Overall Study||11||
48529930|NCT01986010|101631890|FG009|Vaccination 2|Overall Study||10||
48529931|NCT01986010|101631891|FG010|Vaccination 2|Overall Study||10||
48529932|NCT01986010|101631892|FG011|Vaccination 2|Overall Study||10||
48529933|NCT01986010|101631893|FG012|Vaccination 2|Overall Study||10||
48529934|NCT01986010|101631894|FG013|Vaccination 2|Overall Study||9||
48529935|NCT01986010|101631895|FG014|Vaccination 2|Overall Study||16||
48529936|NCT01986010|101631896|FG015|Vaccination 2|Overall Study||10||
48529937|NCT01986010|101631897|FG016|Vaccination 2|Overall Study||4||
48529938|NCT01986010|101631881|FG000|Vaccination 3|Overall Study||10||
48529939|NCT01986010|101631882|FG001|Vaccination 3|Overall Study||10||
48529940|NCT01986010|101631883|FG002|Vaccination 3|Overall Study||9||
48529941|NCT01986010|101631884|FG003|Vaccination 3|Overall Study||10||
48529942|NCT01986010|101631885|FG004|Vaccination 3|Overall Study||9||
48529943|NCT01986010|101631886|FG005|Vaccination 3|Overall Study||15||
48529944|NCT01986010|101631887|FG006|Vaccination 3|Overall Study||10||
48529945|NCT01986010|101631888|FG007|Vaccination 3|Overall Study||4||
48229625|NCT00462072|100884325|FG001|NOT COMPLETED|Baseline (Week 0)||0||
48529946|NCT01986010|101631889|FG008|Vaccination 3|Overall Study||10||
48529947|NCT01986010|101631890|FG009|Vaccination 3|Overall Study||10||
48529948|NCT01986010|101631891|FG010|Vaccination 3|Overall Study||10||
48529949|NCT01986010|101631892|FG011|Vaccination 3|Overall Study||8||
48529950|NCT01986010|101631893|FG012|Vaccination 3|Overall Study||10||
48529951|NCT01986010|101631894|FG013|Vaccination 3|Overall Study||9||
48529952|NCT01986010|101631895|FG014|Vaccination 3|Overall Study||13||
48529953|NCT01986010|101631896|FG015|Vaccination 3|Overall Study||10||
48529954|NCT01986010|101631897|FG016|Vaccination 3|Overall Study||4||
48529955|NCT01986010|101631881|FG000|COMPLETED|Overall Study||7||
48529956|NCT01986010|101631882|FG001|COMPLETED|Overall Study||6||
48529957|NCT01986010|101631883|FG002|COMPLETED|Overall Study||7||
48529958|NCT01986010|101631884|FG003|COMPLETED|Overall Study||8||
48529959|NCT01986010|101631885|FG004|COMPLETED|Overall Study||6||
48529960|NCT01986010|101631886|FG005|COMPLETED|Overall Study||11||
48529961|NCT01986010|101631887|FG006|COMPLETED|Overall Study||10||
48529962|NCT01986010|101631888|FG007|COMPLETED|Overall Study||4||
48529963|NCT01986010|101631889|FG008|COMPLETED|Overall Study||6||
48529964|NCT01986010|101631890|FG009|COMPLETED|Overall Study||7||
48529965|NCT01986010|101631891|FG010|COMPLETED|Overall Study||3||
48529966|NCT01986010|101631892|FG011|COMPLETED|Overall Study||1||
48229626|NCT00462072|100884326|FG002|NOT COMPLETED|Baseline (Week 0)||0||
48229627|NCT00462072|100884324|FG000|STARTED|Week 10||10||
48229628|NCT00462072|100884325|FG001|STARTED|Week 10||12||
48229629|NCT00462072|100884326|FG002|STARTED|Week 10||9||
48529967|NCT01986010|101631893|FG012|COMPLETED|Overall Study||0||
48529968|NCT01986010|101631894|FG013|COMPLETED|Overall Study||0||
48529969|NCT01986010|101631895|FG014|COMPLETED|Overall Study||6||
48529970|NCT01986010|101631896|FG015|COMPLETED|Overall Study||0||
48529971|NCT01986010|101631897|FG016|COMPLETED|Overall Study||0||
48529972|NCT01986010|101631881|FG000|NOT COMPLETED|Overall Study||6||
48529973|NCT01986010|101631882|FG001|NOT COMPLETED|Overall Study||8||
48529974|NCT01986010|101631883|FG002|NOT COMPLETED|Overall Study||7||
48529975|NCT01986010|101631884|FG003|NOT COMPLETED|Overall Study||2||
48529976|NCT01986010|101631885|FG004|NOT COMPLETED|Overall Study||5||
48529977|NCT01986010|101631886|FG005|NOT COMPLETED|Overall Study||8||
48229630|NCT00462072|100884324|FG000|COMPLETED|Week 10||10||
48229631|NCT00462072|100884325|FG001|COMPLETED|Week 10||12||
48229632|NCT00462072|100884326|FG002|COMPLETED|Week 10||9||
48229633|NCT00462072|100884324|FG000|NOT COMPLETED|Week 10||0||
48229634|NCT00462072|100884325|FG001|NOT COMPLETED|Week 10||0||
48229635|NCT00462072|100884326|FG002|NOT COMPLETED|Week 10||0||
48229636|NCT00392197|100884327|FG000|STARTED|Overall Study||48||
48229637|NCT00392197|100884328|FG001|STARTED|Overall Study||63||
48529978|NCT01986010|101631887|FG006|NOT COMPLETED|Overall Study||0||
48529979|NCT01986010|101631888|FG007|NOT COMPLETED|Overall Study||0||
48529980|NCT01986010|101631889|FG008|NOT COMPLETED|Overall Study||6||
48529981|NCT01986010|101631890|FG009|NOT COMPLETED|Overall Study||3||
48229638|NCT00392197|100884327|FG000|COMPLETED|Overall Study||27||
48229639|NCT00392197|100884328|FG001|COMPLETED|Overall Study||33||
48229640|NCT00392197|100884327|FG000|NOT COMPLETED|Overall Study||21||
48229641|NCT00392197|100884328|FG001|NOT COMPLETED|Overall Study||30||
48229642|NCT03026166|100884329|FG000|STARTED|Overall Study||30||
48229643|NCT03026166|100884330|FG001|STARTED|Overall Study||12||
48529982|NCT01986010|101631891|FG010|NOT COMPLETED|Overall Study||7||
48529983|NCT01986010|101631892|FG011|NOT COMPLETED|Overall Study||10||
48529984|NCT01986010|101631893|FG012|NOT COMPLETED|Overall Study||10||
48529985|NCT01986010|101631894|FG013|NOT COMPLETED|Overall Study||11||
48529986|NCT01986010|101631895|FG014|NOT COMPLETED|Overall Study||10||
48529987|NCT01986010|101631896|FG015|NOT COMPLETED|Overall Study||11||
48529988|NCT01986010|101631897|FG016|NOT COMPLETED|Overall Study||4||
48529989|NCT03003949|101631898|FG000|STARTED|Overall Study||40||
48529990|NCT03003949|101631899|FG001|STARTED|Overall Study||42||
48529991|NCT03003949|101631898|FG000|Week 8|Overall Study||40||
48229644|NCT03026166|100884329|FG000|COMPLETED|Overall Study||0||
48229645|NCT03026166|100884330|FG001|COMPLETED|Overall Study||0||
48229646|NCT03026166|100884329|FG000|NOT COMPLETED|Overall Study||30||
48529992|NCT03003949|101631899|FG001|Week 8|Overall Study||42||
48529993|NCT03003949|101631898|FG000|Week 16|Overall Study||38||
48529994|NCT03003949|101631899|FG001|Week 16|Overall Study||35||
48529995|NCT03003949|101631898|FG000|Week 20|Overall Study||35||
48529996|NCT03003949|101631899|FG001|Week 20|Overall Study||33||
48529997|NCT03003949|101631898|FG000|Week 24|Overall Study||35||
48529998|NCT03003949|101631899|FG001|Week 24|Overall Study||32||
48529999|NCT03003949|101631898|FG000|COMPLETED|Overall Study||35||
48530000|NCT03003949|101631899|FG001|COMPLETED|Overall Study||32||
48530001|NCT03003949|101631898|FG000|NOT COMPLETED|Overall Study||5||
48530002|NCT03003949|101631899|FG001|NOT COMPLETED|Overall Study||10||
48530003|NCT02175576|101631900|FG000|STARTED|Overall Study||20||22
48530004|NCT02175576|101631901|FG001|STARTED|Overall Study||30||33
48530005|NCT02175576|101631900|FG000|12 Month Follow-Up Visit|Overall Study||8|Participants for which the primary endpoint of Modified Knee Society Score (mKSS) at 12 months could be analyzed.|10
48530006|NCT02175576|101631901|FG001|12 Month Follow-Up Visit|Overall Study||18|Participants for which the primary endpoint of Modified Knee Society Score (mKSS) at 12 months could be analyzed.|21
48530007|NCT02175576|101631900|FG000|COMPLETED|Overall Study||0||0
48530008|NCT02175576|101631901|FG001|COMPLETED|Overall Study||0||0
48530009|NCT02175576|101631900|FG000|NOT COMPLETED|Overall Study||20||22
48530010|NCT02175576|101631901|FG001|NOT COMPLETED|Overall Study||30||33
48530011|NCT00937378|101631902|FG000|STARTED|Overall Study||167||
48530012|NCT00937378|101631903|FG001|STARTED|Overall Study||159||
48530013|NCT00937378|101631902|FG000|COMPLETED|Overall Study||149||
48530014|NCT00937378|101631903|FG001|COMPLETED|Overall Study||141||
48530015|NCT00937378|101631902|FG000|NOT COMPLETED|Overall Study||18||
48530016|NCT00937378|101631903|FG001|NOT COMPLETED|Overall Study||18||
48530017|NCT03576183|101631904|FG000|STARTED|Overall Study||17||
48530018|NCT03576183|101631905|FG001|STARTED|Overall Study||17||
48530019|NCT03576183|101631904|FG000|COMPLETED|Overall Study||15||
48530020|NCT03576183|101631905|FG001|COMPLETED|Overall Study||16||
48530021|NCT03576183|101631904|FG000|NOT COMPLETED|Overall Study||2||
48229647|NCT03026166|100884330|FG001|NOT COMPLETED|Overall Study||12||
48229648|NCT01951703|100884331|FG000|STARTED|First Intervention||64||
48530022|NCT03576183|101631905|FG001|NOT COMPLETED|Overall Study||1||
48530023|NCT01490931|101631906|FG000|STARTED|Overall Study||25||
48530024|NCT01490931|101631906|FG000|COMPLETED|Overall Study||25||
48530025|NCT01490931|101631906|FG000|NOT COMPLETED|Overall Study||0||
48530026|NCT00001586|101631907|FG000|STARTED|Overall Study||49||
48530027|NCT00001586|101631908|FG001|STARTED|Overall Study||56||
48530028|NCT00001586|101631907|FG000|COMPLETED|Overall Study||49||
48530029|NCT00001586|101631908|FG001|COMPLETED|Overall Study||56||
48530030|NCT00001586|101631907|FG000|NOT COMPLETED|Overall Study||0||
48530031|NCT00001586|101631908|FG001|NOT COMPLETED|Overall Study||0||
48530032|NCT01449279|101631909|FG000|STARTED|Overall Study||22||
48530033|NCT01449279|101631909|FG000|COMPLETED|Overall Study||15||
48530034|NCT01449279|101631909|FG000|NOT COMPLETED|Overall Study||7||
48530035|NCT00228423|101631910|FG000|STARTED|Overall Study||56||
48530036|NCT00228423|101631911|FG001|STARTED|Overall Study||57||
48530037|NCT00228423|101631910|FG000|COMPLETED|Overall Study||46||
48530038|NCT00228423|101631911|FG001|COMPLETED|Overall Study||45||
48530039|NCT00228423|101631910|FG000|NOT COMPLETED|Overall Study||10||
48530040|NCT00228423|101631911|FG001|NOT COMPLETED|Overall Study||12||
48530041|NCT00658658|101631912|FG000|STARTED|Overall Study||6||
48530042|NCT00658658|101631913|FG001|STARTED|Overall Study||7||
48530043|NCT00658658|101631914|FG002|STARTED|Overall Study||4||
48530044|NCT00658658|101631915|FG003|STARTED|Overall Study||6||
48229649|NCT01951703|100884332|FG001|STARTED|First Intervention||63||
48229650|NCT01951703|100884331|FG000|COMPLETED|First Intervention||61||
48530045|NCT00658658|101631916|FG004|STARTED|Overall Study||8||
48530046|NCT00658658|101631912|FG000|COMPLETED|Overall Study||1||
48530047|NCT00658658|101631913|FG001|COMPLETED|Overall Study||5||
48530048|NCT00658658|101631914|FG002|COMPLETED|Overall Study||4||
48229651|NCT01951703|100884332|FG001|COMPLETED|First Intervention||62||
48229652|NCT01951703|100884331|FG000|NOT COMPLETED|First Intervention||3||
48229653|NCT01951703|100884332|FG001|NOT COMPLETED|First Intervention||1||
48530049|NCT00658658|101631915|FG003|COMPLETED|Overall Study||4||
48530050|NCT00658658|101631916|FG004|COMPLETED|Overall Study||3||
48530051|NCT00658658|101631912|FG000|NOT COMPLETED|Overall Study||5||
48530052|NCT00658658|101631913|FG001|NOT COMPLETED|Overall Study||2||
48530053|NCT00658658|101631914|FG002|NOT COMPLETED|Overall Study||0||
48530054|NCT00658658|101631915|FG003|NOT COMPLETED|Overall Study||2||
48530055|NCT00658658|101631916|FG004|NOT COMPLETED|Overall Study||5||
48229654|NCT01951703|100884331|FG000|STARTED|Second Intervention||61||
48229655|NCT01951703|100884332|FG001|STARTED|Second Intervention||62||
48229656|NCT01951703|100884331|FG000|COMPLETED|Second Intervention||61||
48229657|NCT01951703|100884332|FG001|COMPLETED|Second Intervention||60||
48229658|NCT01951703|100884331|FG000|NOT COMPLETED|Second Intervention||0||
48229659|NCT01951703|100884332|FG001|NOT COMPLETED|Second Intervention||2||
48530056|NCT02358343|101631917|FG000|STARTED|Screening Intervention||92||
48530057|NCT02358343|101631918|FG001|STARTED|Screening Intervention||92||
48530058|NCT02358343|101631919|FG002|STARTED|Screening Intervention||0||
48530059|NCT02358343|101631920|FG003|STARTED|Screening Intervention||0||
48530060|NCT02358343|101631921|FG004|STARTED|Screening Intervention||0||
48530061|NCT02358343|101631917|FG000|COMPLETED|Screening Intervention||86||
48530062|NCT02358343|101631918|FG001|COMPLETED|Screening Intervention||84||
48229660|NCT02950961|100884333|FG000|STARTED|Overall Study||123||
48229661|NCT02950961|100884333|FG000|COMPLETED|Overall Study||116||
48229662|NCT02950961|100884333|FG000|NOT COMPLETED|Overall Study||7||
48229663|NCT03150758|100884334|FG000|STARTED|Overall Study||6||
48229664|NCT03150758|100884334|FG000|COMPLETED|Overall Study||6||
48229665|NCT03150758|100884334|FG000|NOT COMPLETED|Overall Study||0||
48229666|NCT00380250|100884335|FG000|STARTED|Overall Study||396||
48229667|NCT00380250|100884336|FG001|STARTED|Overall Study||194||
48229668|NCT00380250|100884335|FG000|COMPLETED|Overall Study||297||
48530063|NCT02358343|101631919|FG002|COMPLETED|Screening Intervention||0||
48530064|NCT02358343|101631920|FG003|COMPLETED|Screening Intervention||0||
48530065|NCT02358343|101631921|FG004|COMPLETED|Screening Intervention||0||
48530066|NCT02358343|101631917|FG000|NOT COMPLETED|Screening Intervention||6||
48530067|NCT02358343|101631918|FG001|NOT COMPLETED|Screening Intervention||8||
48530068|NCT02358343|101631919|FG002|NOT COMPLETED|Screening Intervention||0||
48530069|NCT02358343|101631920|FG003|NOT COMPLETED|Screening Intervention||0||
48530070|NCT02358343|101631921|FG004|NOT COMPLETED|Screening Intervention||0||
48530071|NCT02358343|101631917|FG000|STARTED|Comparative Efficacy Trial / Observation||0||
48530072|NCT02358343|101631918|FG001|STARTED|Comparative Efficacy Trial / Observation||0||
48530073|NCT02358343|101631919|FG002|STARTED|Comparative Efficacy Trial / Observation||60||
48530074|NCT02358343|101631920|FG003|STARTED|Comparative Efficacy Trial / Observation||60||
48530075|NCT02358343|101631921|FG004|STARTED|Comparative Efficacy Trial / Observation||20||
48530076|NCT02358343|101631917|FG000|COMPLETED|Comparative Efficacy Trial / Observation||0||
48530077|NCT02358343|101631918|FG001|COMPLETED|Comparative Efficacy Trial / Observation||0||
48530078|NCT02358343|101631919|FG002|COMPLETED|Comparative Efficacy Trial / Observation||55||
48530079|NCT02358343|101631920|FG003|COMPLETED|Comparative Efficacy Trial / Observation||58||
48530080|NCT02358343|101631921|FG004|COMPLETED|Comparative Efficacy Trial / Observation||18||
48530081|NCT02358343|101631917|FG000|NOT COMPLETED|Comparative Efficacy Trial / Observation||0||
48530082|NCT02358343|101631918|FG001|NOT COMPLETED|Comparative Efficacy Trial / Observation||0||
48530083|NCT02358343|101631919|FG002|NOT COMPLETED|Comparative Efficacy Trial / Observation||5||
48530084|NCT02358343|101631920|FG003|NOT COMPLETED|Comparative Efficacy Trial / Observation||2||
48530085|NCT02358343|101631921|FG004|NOT COMPLETED|Comparative Efficacy Trial / Observation||2||
48530086|NCT01045174|101631922|FG000|STARTED|Overall Study||90||
48530087|NCT01045174|101631923|FG001|STARTED|Overall Study||90||
48530088|NCT01045174|101631922|FG000|COMPLETED|Overall Study||90||
48530089|NCT01045174|101631923|FG001|COMPLETED|Overall Study||90||
48530090|NCT01045174|101631922|FG000|NOT COMPLETED|Overall Study||0||
48530091|NCT01045174|101631923|FG001|NOT COMPLETED|Overall Study||0||
48530092|NCT03272464|101631924|FG000|STARTED|Overall Study||1||
48530093|NCT03272464|101631924|FG000|COMPLETED|Overall Study||0||
48530094|NCT03272464|101631924|FG000|NOT COMPLETED|Overall Study||1||
48530095|NCT02128217|101631925|FG000|STARTED|Overall Study||17||
48530096|NCT02128217|101631926|FG001|STARTED|Overall Study||27||
48229669|NCT00380250|100884336|FG001|COMPLETED|Overall Study||139||
48530097|NCT02128217|101631925|FG000|COMPLETED|Overall Study||17||
48530098|NCT02128217|101631926|FG001|COMPLETED|Overall Study||26||
48530099|NCT02128217|101631925|FG000|NOT COMPLETED|Overall Study||0||
48530100|NCT02128217|101631926|FG001|NOT COMPLETED|Overall Study||1||
48530101|NCT04319159|101631927|FG000|STARTED|Overall Study||48||
48530102|NCT04319159|101631927|FG000|COMPLETED|Overall Study||32||
48530103|NCT04319159|101631927|FG000|NOT COMPLETED|Overall Study||16||
48530104|NCT00856830|101631928|FG000|STARTED|Irinotecan & Bendamustine||3||
48530105|NCT00856830|101631929|FG001|STARTED|Irinotecan & Bendamustine||6||
48530106|NCT00856830|101631930|FG002|STARTED|Irinotecan & Bendamustine||6||
48530107|NCT00856830|101631931|FG003|STARTED|Irinotecan & Bendamustine||15||
48530108|NCT00856830|101631928|FG000|Maximum Tolerated Dose|Irinotecan & Bendamustine||3||
48530109|NCT00856830|101631929|FG001|Maximum Tolerated Dose|Irinotecan & Bendamustine||6||
48229670|NCT00380250|100884335|FG000|NOT COMPLETED|Overall Study||99||
48530110|NCT00856830|101631930|FG002|Maximum Tolerated Dose|Irinotecan & Bendamustine||6||
48530111|NCT00856830|101631931|FG003|Maximum Tolerated Dose|Irinotecan & Bendamustine||12||
48530112|NCT00856830|101631928|FG000|COMPLETED|Irinotecan & Bendamustine||3||
48530113|NCT00856830|101631929|FG001|COMPLETED|Irinotecan & Bendamustine||6||
48229671|NCT00380250|100884336|FG001|NOT COMPLETED|Overall Study||55||
48229672|NCT00998517|100884337|FG000|STARTED|Overall Study||888||
48229673|NCT00998517|100884338|FG001|STARTED|Overall Study||906||
48229674|NCT00998517|100884339|FG002|STARTED|Overall Study||918||
48229675|NCT00998517|100884337|FG000|COMPLETED|Overall Study||888||
48229676|NCT00998517|100884338|FG001|COMPLETED|Overall Study||906||
48229677|NCT00998517|100884339|FG002|COMPLETED|Overall Study||918||
48530114|NCT00856830|101631930|FG002|COMPLETED|Irinotecan & Bendamustine||6||
48530115|NCT00856830|101631931|FG003|COMPLETED|Irinotecan & Bendamustine||12||
48229678|NCT00998517|100884337|FG000|NOT COMPLETED|Overall Study||0||
48229679|NCT00998517|100884338|FG001|NOT COMPLETED|Overall Study||0||
48229680|NCT00998517|100884339|FG002|NOT COMPLETED|Overall Study||0||
48229681|NCT01523392|100884340|FG000|STARTED|Treatment Period 1||20||
48229682|NCT01523392|100884341|FG001|STARTED|Treatment Period 1||14||
48229683|NCT01523392|100884340|FG000|COMPLETED|Treatment Period 1||17||
48229684|NCT01523392|100884341|FG001|COMPLETED|Treatment Period 1||14||
48229685|NCT01523392|100884340|FG000|NOT COMPLETED|Treatment Period 1||3||
48229686|NCT01523392|100884341|FG001|NOT COMPLETED|Treatment Period 1||0||
48229687|NCT01523392|100884340|FG000|STARTED|Washout Period - 10 to 14 Days||18||
48229688|NCT01523392|100884341|FG001|STARTED|Washout Period - 10 to 14 Days||14||
48229689|NCT01523392|100884340|FG000|COMPLETED|Washout Period - 10 to 14 Days||17||
48229690|NCT01523392|100884341|FG001|COMPLETED|Washout Period - 10 to 14 Days||14||
48229691|NCT01523392|100884340|FG000|NOT COMPLETED|Washout Period - 10 to 14 Days||1||
48229692|NCT01523392|100884341|FG001|NOT COMPLETED|Washout Period - 10 to 14 Days||0||
48229693|NCT01523392|100884340|FG000|STARTED|Treatment Period 2||17||
48229694|NCT01523392|100884341|FG001|STARTED|Treatment Period 2||14||
48229695|NCT01523392|100884340|FG000|COMPLETED|Treatment Period 2||17||
48229696|NCT01523392|100884341|FG001|COMPLETED|Treatment Period 2||14||
48229697|NCT01523392|100884340|FG000|NOT COMPLETED|Treatment Period 2||0||
48229698|NCT01523392|100884341|FG001|NOT COMPLETED|Treatment Period 2||0||
48229699|NCT02067663|100884342|FG000|STARTED|Overall Study||68||
48229700|NCT02067663|100884343|FG001|STARTED|Overall Study||55||
48229701|NCT02067663|100884342|FG000|COMPLETED|Overall Study||55||
48229702|NCT02067663|100884343|FG001|COMPLETED|Overall Study||41||
48229703|NCT02067663|100884342|FG000|NOT COMPLETED|Overall Study||13||
48229704|NCT02067663|100884343|FG001|NOT COMPLETED|Overall Study||14||
48229705|NCT01427517|100884344|FG000|STARTED|Overall Study||3||
48229706|NCT01427517|100884345|FG001|STARTED|Overall Study||3||
48229707|NCT01427517|100884346|FG002|STARTED|Overall Study||3||
48229708|NCT01427517|100884344|FG000|COMPLETED|Overall Study||3||
48229709|NCT01427517|100884345|FG001|COMPLETED|Overall Study||3||
48229710|NCT01427517|100884346|FG002|COMPLETED|Overall Study||3||
48229711|NCT01427517|100884344|FG000|NOT COMPLETED|Overall Study||0||
48229712|NCT01427517|100884345|FG001|NOT COMPLETED|Overall Study||0||
48229713|NCT01427517|100884346|FG002|NOT COMPLETED|Overall Study||0||
48229714|NCT00667732|100884347|FG000|STARTED|Run -In (8 Weeks)||41||
48229715|NCT00667732|100884348|FG001|STARTED|Run -In (8 Weeks)||0||
48229716|NCT00667732|100884349|FG002|STARTED|Run -In (8 Weeks)||0||
48229717|NCT00667732|100884347|FG000|Participants Enrolled in Substudy|Run -In (8 Weeks)||20||
48229718|NCT00667732|100884348|FG001|Participants Enrolled in Substudy|Run -In (8 Weeks)||0||
48229719|NCT00667732|100884349|FG002|Participants Enrolled in Substudy|Run -In (8 Weeks)||0||
48229720|NCT00667732|100884347|FG000|COMPLETED|Run -In (8 Weeks)||34||
48229721|NCT00667732|100884348|FG001|COMPLETED|Run -In (8 Weeks)||0||
48229722|NCT00667732|100884349|FG002|COMPLETED|Run -In (8 Weeks)||0||
48229723|NCT00667732|100884347|FG000|NOT COMPLETED|Run -In (8 Weeks)||7||
48229724|NCT00667732|100884348|FG001|NOT COMPLETED|Run -In (8 Weeks)||0||
48229725|NCT00667732|100884349|FG002|NOT COMPLETED|Run -In (8 Weeks)||0||
48229726|NCT00667732|100884347|FG000|STARTED|Randomization (24 Weeks)||0||
48229727|NCT00667732|100884348|FG001|STARTED|Randomization (24 Weeks)||17||
48229728|NCT00667732|100884349|FG002|STARTED|Randomization (24 Weeks)||17||
48229729|NCT00667732|100884347|FG000|Participants Enrolled in Substudy|Randomization (24 Weeks)||0||
48229730|NCT00667732|100884348|FG001|Participants Enrolled in Substudy|Randomization (24 Weeks)||11||
48229731|NCT00667732|100884349|FG002|Participants Enrolled in Substudy|Randomization (24 Weeks)||9||
48229732|NCT00667732|100884347|FG000|COMPLETED|Randomization (24 Weeks)||0||
48229733|NCT00667732|100884348|FG001|COMPLETED|Randomization (24 Weeks)||16||
48229734|NCT00667732|100884349|FG002|COMPLETED|Randomization (24 Weeks)||17||
48229735|NCT00667732|100884347|FG000|NOT COMPLETED|Randomization (24 Weeks)||0||
48229736|NCT00667732|100884348|FG001|NOT COMPLETED|Randomization (24 Weeks)||1||
48229737|NCT00667732|100884349|FG002|NOT COMPLETED|Randomization (24 Weeks)||0||
48530116|NCT00856830|101631928|FG000|NOT COMPLETED|Irinotecan & Bendamustine||0||
48530117|NCT00856830|101631929|FG001|NOT COMPLETED|Irinotecan & Bendamustine||0||
48530118|NCT00856830|101631930|FG002|NOT COMPLETED|Irinotecan & Bendamustine||0||
48530119|NCT00856830|101631931|FG003|NOT COMPLETED|Irinotecan & Bendamustine||3||
48229738|NCT00667732|100884347|FG000|STARTED|Extension (26 Weeks)||0||
48229739|NCT00667732|100884348|FG001|STARTED|Extension (26 Weeks)||14||
48229740|NCT00667732|100884349|FG002|STARTED|Extension (26 Weeks)||17||
48229741|NCT00667732|100884347|FG000|COMPLETED|Extension (26 Weeks)||0||
48229742|NCT00667732|100884348|FG001|COMPLETED|Extension (26 Weeks)||14||
48229743|NCT00667732|100884349|FG002|COMPLETED|Extension (26 Weeks)||17||
48229744|NCT00667732|100884347|FG000|NOT COMPLETED|Extension (26 Weeks)||0||
48229745|NCT00667732|100884348|FG001|NOT COMPLETED|Extension (26 Weeks)||0||
48229746|NCT00667732|100884349|FG002|NOT COMPLETED|Extension (26 Weeks)||0||
48530120|NCT00856830|101631928|FG000|STARTED|Regimen - B (Carboplatin & Etoposide)||3||
48530121|NCT00856830|101631929|FG001|STARTED|Regimen - B (Carboplatin & Etoposide)||6||
48530122|NCT00856830|101631930|FG002|STARTED|Regimen - B (Carboplatin & Etoposide)||6||
48530123|NCT00856830|101631931|FG003|STARTED|Regimen - B (Carboplatin & Etoposide)||12||
48530124|NCT00856830|101631928|FG000|COMPLETED|Regimen - B (Carboplatin & Etoposide)||3||
48530125|NCT00856830|101631929|FG001|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6||
48530126|NCT00856830|101631930|FG002|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6||
48530127|NCT00856830|101631931|FG003|COMPLETED|Regimen - B (Carboplatin & Etoposide)||12||
48530128|NCT00856830|101631928|FG000|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0||
48530129|NCT00856830|101631929|FG001|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0||
48530130|NCT00856830|101631930|FG002|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0||
48530131|NCT00856830|101631931|FG003|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0||
48530132|NCT01995266|101631932|FG000|STARTED|Overall Study||159||
48530133|NCT01995266|101631932|FG000|COMPLETED|Overall Study||150||
48530134|NCT01995266|101631932|FG000|NOT COMPLETED|Overall Study||9||
48530135|NCT03688282|101631933|FG000|STARTED|Sham Treatment for 30 Minutes||18||
48530136|NCT03688282|101631933|FG000|COMPLETED|Sham Treatment for 30 Minutes||17||
48530137|NCT03688282|101631933|FG000|NOT COMPLETED|Sham Treatment for 30 Minutes||1||
48530138|NCT03688282|101631933|FG000|STARTED|Washout (7 Days)||17||
48229747|NCT01829711|100884350|FG000|STARTED|Overall Study||80||
48229748|NCT01829711|100884350|FG000|COMPLETED|Overall Study||37||
48229749|NCT01829711|100884350|FG000|NOT COMPLETED|Overall Study||43||
48229750|NCT00724009|100884351|FG000|STARTED|Overall Study||29||
48229751|NCT00724009|100884351|FG000|COMPLETED|Overall Study||29||
48229752|NCT00724009|100884351|FG000|NOT COMPLETED|Overall Study||0||
48229753|NCT01976507|100884352|FG000|STARTED|Overall Study||101||
48229754|NCT01976507|100884352|FG000|Received Initial Dose of Dabigatran|Overall Study||100||
48229755|NCT01976507|100884352|FG000|COMPLETED|Overall Study||94||
48229756|NCT01976507|100884352|FG000|NOT COMPLETED|Overall Study||7||
48229757|NCT04705051|100884353|FG000|STARTED|Overall Study||24||
48229758|NCT04705051|100884353|FG000|Treated|Overall Study||23||
48229759|NCT04705051|100884353|FG000|COMPLETED|Overall Study||0||
48229760|NCT04705051|100884353|FG000|NOT COMPLETED|Overall Study||24||
48229761|NCT00701415|100884354|FG000|STARTED|Overall Study||16||
48229762|NCT00701415|100884355|FG001|STARTED|Overall Study||15||
48229763|NCT00701415|100884354|FG000|COMPLETED|Overall Study||15||
48229764|NCT00701415|100884355|FG001|COMPLETED|Overall Study||14||
48229765|NCT00701415|100884354|FG000|NOT COMPLETED|Overall Study||1||
48229766|NCT00701415|100884355|FG001|NOT COMPLETED|Overall Study||1||
48229767|NCT01536704|100884356|FG000|STARTED|Period 1||12||
48229768|NCT01536704|100884357|FG001|STARTED|Period 1||12||
48229769|NCT01536704|100884358|FG002|STARTED|Period 1||13||
48229770|NCT01536704|100884359|FG003|STARTED|Period 1||13||
48229771|NCT01536704|100884356|FG000|COMPLETED|Period 1||12||
48229772|NCT01536704|100884357|FG001|COMPLETED|Period 1||12||
48229773|NCT01536704|100884358|FG002|COMPLETED|Period 1||13||
48229774|NCT01536704|100884359|FG003|COMPLETED|Period 1||13||
48229775|NCT01536704|100884356|FG000|NOT COMPLETED|Period 1||0||
48229776|NCT01536704|100884357|FG001|NOT COMPLETED|Period 1||0||
48229777|NCT01536704|100884358|FG002|NOT COMPLETED|Period 1||0||
48229778|NCT01536704|100884359|FG003|NOT COMPLETED|Period 1||0||
48530139|NCT03688282|101631933|FG000|COMPLETED|Washout (7 Days)||17||
48530140|NCT03688282|101631933|FG000|NOT COMPLETED|Washout (7 Days)||0||
48530141|NCT03688282|101631933|FG000|STARTED|Active Treatment for 30 Minutes||17||
48530142|NCT03688282|101631933|FG000|COMPLETED|Active Treatment for 30 Minutes||17||
48530143|NCT03688282|101631933|FG000|NOT COMPLETED|Active Treatment for 30 Minutes||0||
48530144|NCT00302081|101631934|FG000|STARTED|Overall Study||237||
48530145|NCT00302081|101631935|FG001|STARTED|Overall Study||229||
48530146|NCT00302081|101631936|FG002|STARTED|Overall Study||230||
48530147|NCT00302081|101631934|FG000|COMPLETED|Overall Study||181||
48530148|NCT00302081|101631935|FG001|COMPLETED|Overall Study||186||
48530149|NCT00302081|101631936|FG002|COMPLETED|Overall Study||178||
48530150|NCT00302081|101631934|FG000|NOT COMPLETED|Overall Study||56||
48530151|NCT00302081|101631935|FG001|NOT COMPLETED|Overall Study||43||
48530152|NCT00302081|101631936|FG002|NOT COMPLETED|Overall Study||52||
48530153|NCT02987959|101631937|FG000|STARTED|Overall Study||6||
48229779|NCT01536704|100884356|FG000|STARTED|Washout Period 1||12||
48229780|NCT01536704|100884357|FG001|STARTED|Washout Period 1||12||
48229781|NCT01536704|100884358|FG002|STARTED|Washout Period 1||13||
48229782|NCT01536704|100884359|FG003|STARTED|Washout Period 1||13||
48229783|NCT01536704|100884356|FG000|COMPLETED|Washout Period 1||11||
48229784|NCT01536704|100884357|FG001|COMPLETED|Washout Period 1||10||
48229785|NCT01536704|100884358|FG002|COMPLETED|Washout Period 1||13||
48229786|NCT01536704|100884359|FG003|COMPLETED|Washout Period 1||13||
48229787|NCT01536704|100884356|FG000|NOT COMPLETED|Washout Period 1||1||
48530154|NCT02987959|101631937|FG000|COMPLETED|Overall Study||0||
48229788|NCT01536704|100884357|FG001|NOT COMPLETED|Washout Period 1||2||
48229789|NCT01536704|100884358|FG002|NOT COMPLETED|Washout Period 1||0||
48229790|NCT01536704|100884359|FG003|NOT COMPLETED|Washout Period 1||0||
48530155|NCT02987959|101631937|FG000|NOT COMPLETED|Overall Study||6||
48229791|NCT01536704|100884356|FG000|STARTED|Period 2||13||
48229792|NCT01536704|100884357|FG001|STARTED|Period 2||11||
48229793|NCT01536704|100884358|FG002|STARTED|Period 2||10||
48229794|NCT01536704|100884359|FG003|STARTED|Period 2||13||
48229795|NCT01536704|100884356|FG000|COMPLETED|Period 2||13||
48229796|NCT01536704|100884357|FG001|COMPLETED|Period 2||11||
48229797|NCT01536704|100884358|FG002|COMPLETED|Period 2||10||
48530156|NCT00424775|101631938|FG000|STARTED|Overall Study||3||
48530157|NCT00424775|101631939|FG001|STARTED|Overall Study||0||
48229798|NCT01536704|100884359|FG003|COMPLETED|Period 2||13||
48229799|NCT01536704|100884356|FG000|NOT COMPLETED|Period 2||0||
48229800|NCT01536704|100884357|FG001|NOT COMPLETED|Period 2||0||
48229801|NCT01536704|100884358|FG002|NOT COMPLETED|Period 2||0||
48229802|NCT01536704|100884359|FG003|NOT COMPLETED|Period 2||0||
48229803|NCT01536704|100884356|FG000|STARTED|Washout Period 2||13||
48229804|NCT01536704|100884357|FG001|STARTED|Washout Period 2||11||
48229805|NCT01536704|100884358|FG002|STARTED|Washout Period 2||10||
48229806|NCT01536704|100884359|FG003|STARTED|Washout Period 2||13||
48229807|NCT01536704|100884356|FG000|COMPLETED|Washout Period 2||12||
48229808|NCT01536704|100884357|FG001|COMPLETED|Washout Period 2||11||
48229809|NCT01536704|100884358|FG002|COMPLETED|Washout Period 2||10||
48229810|NCT01536704|100884359|FG003|COMPLETED|Washout Period 2||12||
48530158|NCT00424775|101631938|FG000|COMPLETED|Overall Study||0||
48530159|NCT00424775|101631939|FG001|COMPLETED|Overall Study||0||
48530160|NCT00424775|101631938|FG000|NOT COMPLETED|Overall Study||3||
48530161|NCT00424775|101631939|FG001|NOT COMPLETED|Overall Study||0||
48530162|NCT00757848|101631940|FG000|STARTED|Overall Study||27||
48530163|NCT00757848|101631941|FG001|STARTED|Overall Study||29||
48530164|NCT00757848|101631940|FG000|COMPLETED|Overall Study||24||
48530165|NCT00757848|101631941|FG001|COMPLETED|Overall Study||27||
48530166|NCT00757848|101631940|FG000|NOT COMPLETED|Overall Study||3||
48530167|NCT00757848|101631941|FG001|NOT COMPLETED|Overall Study||2||
48530168|NCT04421586|101631942|FG000|STARTED|Overall Study||30||5
48530169|NCT04421586|101631943|FG001|STARTED|Overall Study||30||5
48530170|NCT04421586|101631942|FG000|COMPLETED|Overall Study||25||5
48530171|NCT04421586|101631943|FG001|COMPLETED|Overall Study||24||5
48530172|NCT04421586|101631942|FG000|NOT COMPLETED|Overall Study||5||0
48530173|NCT04421586|101631943|FG001|NOT COMPLETED|Overall Study||6||0
48530174|NCT00714493|101631944|FG000|STARTED|Overall Study||203||
48530175|NCT00714493|101631944|FG000|COMPLETED|Overall Study||154||
48530176|NCT00714493|101631944|FG000|NOT COMPLETED|Overall Study||49||
48530177|NCT00761865|101631945|FG000|STARTED|Overall Study||16||
48530178|NCT00761865|101631946|FG001|STARTED|Overall Study||18||
48530179|NCT00761865|101631945|FG000|COMPLETED|Overall Study||8||
48530180|NCT00761865|101631946|FG001|COMPLETED|Overall Study||11||
48530181|NCT00761865|101631945|FG000|NOT COMPLETED|Overall Study||8||
48530182|NCT00761865|101631946|FG001|NOT COMPLETED|Overall Study||7||
48530183|NCT00364949|101631947|FG000|STARTED|Overall Study||31||
48530184|NCT00364949|101631948|FG001|STARTED|Overall Study||39||
48530185|NCT00364949|101631947|FG000|COMPLETED|Overall Study||31||
48530186|NCT00364949|101631948|FG001|COMPLETED|Overall Study||39||
48530187|NCT00364949|101631947|FG000|NOT COMPLETED|Overall Study||0||
48530188|NCT00364949|101631948|FG001|NOT COMPLETED|Overall Study||0||
48530189|NCT03052959|101631949|FG000|STARTED|Overall Study||59||5
48530190|NCT03052959|101631950|FG001|STARTED|Overall Study||66||5
48530191|NCT03052959|101631949|FG000|COMPLETED|Overall Study||55||5
48080699|NCT00471328|100518828|FG000|COMPLETED|Extension Phase||0||
48080700|NCT00471328|100518829|FG001|COMPLETED|Extension Phase||0||
48080701|NCT00471328|100518828|FG000|NOT COMPLETED|Extension Phase||41||
48080702|NCT00471328|100518829|FG001|NOT COMPLETED|Extension Phase||67||
48080703|NCT01385566|100518830|FG000|STARTED|Overall Study||52||
48080704|NCT01385566|100518831|FG001|STARTED|Overall Study||34||
48080705|NCT01385566|100518832|FG002|STARTED|Overall Study||34||
48080706|NCT01385566|100518833|FG003|STARTED|Overall Study||35||
48080707|NCT01385566|100518834|FG004|STARTED|Overall Study||34||
48080708|NCT01385566|100518835|FG005|STARTED|Overall Study||34||
48080709|NCT01385566|100518830|FG000|COMPLETED|Overall Study||51||
48080710|NCT01385566|100518831|FG001|COMPLETED|Overall Study||34||
48080711|NCT01385566|100518832|FG002|COMPLETED|Overall Study||34||
48080712|NCT01385566|100518833|FG003|COMPLETED|Overall Study||34||
48080713|NCT01385566|100518834|FG004|COMPLETED|Overall Study||34||
48080714|NCT01385566|100518835|FG005|COMPLETED|Overall Study||34||
48080715|NCT01385566|100518830|FG000|NOT COMPLETED|Overall Study||1||
48080716|NCT01385566|100518831|FG001|NOT COMPLETED|Overall Study||0||
48080717|NCT01385566|100518832|FG002|NOT COMPLETED|Overall Study||0||
48080718|NCT01385566|100518833|FG003|NOT COMPLETED|Overall Study||1||
48080719|NCT01385566|100518834|FG004|NOT COMPLETED|Overall Study||0||
48080720|NCT01385566|100518835|FG005|NOT COMPLETED|Overall Study||0||
48080721|NCT00787852|100518836|FG000|STARTED|Overall Study||6||
48080722|NCT00787852|100518837|FG001|STARTED|Overall Study||5||
48229811|NCT01536704|100884356|FG000|NOT COMPLETED|Washout Period 2||1||
48229812|NCT01536704|100884357|FG001|NOT COMPLETED|Washout Period 2||0||
48229813|NCT01536704|100884358|FG002|NOT COMPLETED|Washout Period 2||0||
48229814|NCT01536704|100884359|FG003|NOT COMPLETED|Washout Period 2||1||
48530192|NCT03052959|101631950|FG001|COMPLETED|Overall Study||61||5
48530193|NCT03052959|101631949|FG000|NOT COMPLETED|Overall Study||4||0
48080723|NCT00787852|100518836|FG000|COMPLETED|Overall Study||5||
48080724|NCT00787852|100518837|FG001|COMPLETED|Overall Study||5||
48530194|NCT03052959|101631950|FG001|NOT COMPLETED|Overall Study||5||0
48530195|NCT01249365|101631951|FG000|STARTED|Overall Study||199||
48080725|NCT00787852|100518836|FG000|NOT COMPLETED|Overall Study||1||
48229815|NCT01536704|100884356|FG000|STARTED|Period 3||10||
48229816|NCT01536704|100884357|FG001|STARTED|Period 3||12||
48229817|NCT01536704|100884358|FG002|STARTED|Period 3||12||
48229818|NCT01536704|100884359|FG003|STARTED|Period 3||11||
48530196|NCT01249365|101631951|FG000|COMPLETED|Overall Study||198||
48530197|NCT01249365|101631951|FG000|NOT COMPLETED|Overall Study||1||
48530198|NCT03582826|101631952|FG000|STARTED|Overall Study||119||
48229819|NCT01536704|100884356|FG000|COMPLETED|Period 3||10||
48229820|NCT01536704|100884357|FG001|COMPLETED|Period 3||12||
48229821|NCT01536704|100884358|FG002|COMPLETED|Period 3||12||
48229822|NCT01536704|100884359|FG003|COMPLETED|Period 3||10||
48229823|NCT01536704|100884356|FG000|NOT COMPLETED|Period 3||0||
48229824|NCT01536704|100884357|FG001|NOT COMPLETED|Period 3||0||
48229825|NCT01536704|100884358|FG002|NOT COMPLETED|Period 3||0||
48229826|NCT01536704|100884359|FG003|NOT COMPLETED|Period 3||1||
48229827|NCT01536704|100884356|FG000|STARTED|Washout Period 3||10||
48229828|NCT01536704|100884357|FG001|STARTED|Washout Period 3||12||
48229829|NCT01536704|100884358|FG002|STARTED|Washout Period 3||12||
48229830|NCT01536704|100884359|FG003|STARTED|Washout Period 3||10||
48229831|NCT01536704|100884356|FG000|COMPLETED|Washout Period 3||10||
48229832|NCT01536704|100884357|FG001|COMPLETED|Washout Period 3||12||
48229833|NCT01536704|100884358|FG002|COMPLETED|Washout Period 3||11||
48229834|NCT01536704|100884359|FG003|COMPLETED|Washout Period 3||10||
48229835|NCT01536704|100884356|FG000|NOT COMPLETED|Washout Period 3||0||
48229836|NCT01536704|100884357|FG001|NOT COMPLETED|Washout Period 3||0||
48229837|NCT01536704|100884358|FG002|NOT COMPLETED|Washout Period 3||1||
48229838|NCT01536704|100884359|FG003|NOT COMPLETED|Washout Period 3||0||
48229839|NCT01536704|100884356|FG000|STARTED|Period 4||12||
48229840|NCT01536704|100884357|FG001|STARTED|Period 4||11||
48229841|NCT01536704|100884358|FG002|STARTED|Period 4||10||
48229842|NCT01536704|100884359|FG003|STARTED|Period 4||10||
48229843|NCT01536704|100884356|FG000|COMPLETED|Period 4||12||
48229844|NCT01536704|100884357|FG001|COMPLETED|Period 4||11||
48229845|NCT01536704|100884358|FG002|COMPLETED|Period 4||10||
48229846|NCT01536704|100884359|FG003|COMPLETED|Period 4||10||
48229847|NCT01536704|100884356|FG000|NOT COMPLETED|Period 4||0||
48229848|NCT01536704|100884357|FG001|NOT COMPLETED|Period 4||0||
48229849|NCT01536704|100884358|FG002|NOT COMPLETED|Period 4||0||
48530199|NCT03582826|101631953|FG001|STARTED|Overall Study||6||
48229850|NCT01536704|100884359|FG003|NOT COMPLETED|Period 4||0||
48229851|NCT02522104|100884360|FG000|STARTED|Overall Study||13||
48229852|NCT02522104|100884361|FG001|STARTED|Overall Study||15||
48229853|NCT02522104|100884362|FG002|STARTED|Overall Study||12||
48229854|NCT02522104|100884360|FG000|COMPLETED|Overall Study||10||
48229855|NCT02522104|100884361|FG001|COMPLETED|Overall Study||12||
48229856|NCT02522104|100884362|FG002|COMPLETED|Overall Study||5||
48530200|NCT03582826|101631952|FG000|COMPLETED|Overall Study||78|submitted stool samples|
48530201|NCT03582826|101631953|FG001|COMPLETED|Overall Study||6|submitted stool samples|
48530202|NCT03582826|101631952|FG000|NOT COMPLETED|Overall Study||41||
48530203|NCT03582826|101631953|FG001|NOT COMPLETED|Overall Study||0||
48530204|NCT03251963|101631954|FG000|STARTED|Overall Study||65||
48530205|NCT03251963|101631955|FG001|STARTED|Overall Study||66||
48080726|NCT00787852|100518837|FG001|NOT COMPLETED|Overall Study||0||
48080727|NCT03132220|100518838|FG000|STARTED|Overall Study||65||
48080728|NCT03132220|100518839|FG001|STARTED|Overall Study||66||
48080729|NCT03132220|100518838|FG000|Began Study Sessions|Overall Study||48||
48080730|NCT03132220|100518839|FG001|Began Study Sessions|Overall Study||58||
48080731|NCT03132220|100518838|FG000|COMPLETED|Overall Study||47||
48080732|NCT03132220|100518839|FG001|COMPLETED|Overall Study||54||
48080733|NCT03132220|100518838|FG000|NOT COMPLETED|Overall Study||18||
48080734|NCT03132220|100518839|FG001|NOT COMPLETED|Overall Study||12||
48080735|NCT01603355|100518840|FG000|STARTED|Overall Study||3||
48080736|NCT01603355|100518840|FG000|COMPLETED|Overall Study||1||
48080737|NCT01603355|100518840|FG000|NOT COMPLETED|Overall Study||2||
48080738|NCT03808545|100518841|FG000|STARTED|Overall Study||6||
48080739|NCT03808545|100518842|FG001|STARTED|Overall Study||5||
48080740|NCT03808545|100518841|FG000|COMPLETED|Overall Study||5||
48080741|NCT03808545|100518842|FG001|COMPLETED|Overall Study||4||
48229857|NCT02522104|100884360|FG000|NOT COMPLETED|Overall Study||3||
48229858|NCT02522104|100884361|FG001|NOT COMPLETED|Overall Study||3||
48229859|NCT02522104|100884362|FG002|NOT COMPLETED|Overall Study||7||
48229860|NCT04689932|100884363|FG000|STARTED|Overall Study||12||
48080742|NCT03808545|100518841|FG000|NOT COMPLETED|Overall Study||1||
48080743|NCT03808545|100518842|FG001|NOT COMPLETED|Overall Study||1||
48080744|NCT01308060|100518843|FG000|STARTED|Part A||252||
48229861|NCT04689932|100884363|FG000|COMPLETED|Overall Study||12||
48229862|NCT04689932|100884363|FG000|NOT COMPLETED|Overall Study||0||
48229863|NCT02309892|100884364|FG000|STARTED|Overall Study||3||
48229864|NCT02309892|100884365|FG001|STARTED|Overall Study||6||
48229865|NCT02309892|100884366|FG002|STARTED|Overall Study||1||
48229866|NCT02309892|100884367|FG003|STARTED|Overall Study||1||
48229867|NCT02309892|100884368|FG004|STARTED|Overall Study||1||
48229868|NCT02309892|100884369|FG005|STARTED|Overall Study||2||
48530206|NCT03251963|101631954|FG000|COMPLETED|Overall Study||56||
48530207|NCT03251963|101631955|FG001|COMPLETED|Overall Study||61||
48530208|NCT03251963|101631954|FG000|NOT COMPLETED|Overall Study||9||
48530209|NCT03251963|101631955|FG001|NOT COMPLETED|Overall Study||5||
48530210|NCT01610453|101631956|FG000|STARTED|Overall Study||150||
48530211|NCT01610453|101631956|FG000|COMPLETED|Overall Study||150||
48530212|NCT01610453|101631956|FG000|NOT COMPLETED|Overall Study||0||
48530213|NCT02252718|101631957|FG000|STARTED|Overall Study||100||
48530214|NCT02252718|101631957|FG000|COMPLETED|Overall Study||100||
48530215|NCT02252718|101631957|FG000|NOT COMPLETED|Overall Study||0||
48530216|NCT03529461|101631958|FG000|STARTED|Overall Study||28||
48530217|NCT03529461|101631959|FG001|STARTED|Overall Study||28||
48530218|NCT03529461|101631958|FG000|COMPLETED|Overall Study||28||
48530219|NCT03529461|101631959|FG001|COMPLETED|Overall Study||28||
48530220|NCT03529461|101631958|FG000|NOT COMPLETED|Overall Study||0||
48530221|NCT03529461|101631959|FG001|NOT COMPLETED|Overall Study||0||
48530222|NCT01680497|101631960|FG000|STARTED|Overall Study||70||
48229869|NCT02309892|100884370|FG006|STARTED|Overall Study||0||
48229870|NCT02309892|100884364|FG000|COMPLETED|Overall Study||1||
48229871|NCT02309892|100884365|FG001|COMPLETED|Overall Study||5||
48229872|NCT02309892|100884366|FG002|COMPLETED|Overall Study||0||
48229873|NCT02309892|100884367|FG003|COMPLETED|Overall Study||1||
48229874|NCT02309892|100884368|FG004|COMPLETED|Overall Study||0||
48229875|NCT02309892|100884369|FG005|COMPLETED|Overall Study||1||
48229876|NCT02309892|100884370|FG006|COMPLETED|Overall Study||0||
48229877|NCT02309892|100884364|FG000|NOT COMPLETED|Overall Study||2||
48229878|NCT02309892|100884365|FG001|NOT COMPLETED|Overall Study||1||
48229879|NCT02309892|100884366|FG002|NOT COMPLETED|Overall Study||1||
48229880|NCT02309892|100884367|FG003|NOT COMPLETED|Overall Study||0||
48229881|NCT02309892|100884368|FG004|NOT COMPLETED|Overall Study||1||
48229882|NCT02309892|100884369|FG005|NOT COMPLETED|Overall Study||1||
48229883|NCT02309892|100884370|FG006|NOT COMPLETED|Overall Study||0||
48229884|NCT03340961|100884371|FG000|STARTED|Overall Study||53||
48229885|NCT03340961|100884372|FG001|STARTED|Overall Study||50||
48229886|NCT03340961|100884373|FG002|STARTED|Overall Study||49||
48229887|NCT03340961|100884374|FG003|STARTED|Overall Study||53||
48229888|NCT03340961|100884371|FG000|COMPLETED|Overall Study||47||
48229889|NCT03340961|100884372|FG001|COMPLETED|Overall Study||38||
48229890|NCT03340961|100884373|FG002|COMPLETED|Overall Study||40||
48229891|NCT03340961|100884374|FG003|COMPLETED|Overall Study||35||
48229892|NCT03340961|100884371|FG000|NOT COMPLETED|Overall Study||6||
48530223|NCT01680497|101631960|FG000|COMPLETED|Overall Study||68||
48530224|NCT01680497|101631960|FG000|NOT COMPLETED|Overall Study||2||
48530225|NCT04319718|101631961|FG000|STARTED|Overall Study||25||
48530226|NCT04319718|101631962|FG001|STARTED|Overall Study||12||
48530227|NCT04319718|101631961|FG000|COMPLETED|Overall Study||24||
48530228|NCT04319718|101631962|FG001|COMPLETED|Overall Study||10||
48530229|NCT04319718|101631961|FG000|NOT COMPLETED|Overall Study||1||
48530230|NCT04319718|101631962|FG001|NOT COMPLETED|Overall Study||2||
48530231|NCT03247517|101631963|FG000|STARTED|Overall Study||104|The number of subjects reported here is based on the Safety Population (assigned treatment arm); includes subjects who were randomized and took at least one dose of study medication.|
48530232|NCT03247517|101631964|FG001|STARTED|Overall Study||98|The number of subjects reported here is based on the Safety Population (assigned treatment arm); includes subjects who were randomized and took at least one dose of study medication.|
48530233|NCT03247517|101631965|FG002|STARTED|Overall Study||106|The number of subjects reported here is based on the Safety Population (assigned treatment arm); includes subjects who were randomized and took at least one dose of study medication.|
48530234|NCT03247517|101631963|FG000|COMPLETED|Overall Study||96||
48530235|NCT03247517|101631964|FG001|COMPLETED|Overall Study||78||
48530236|NCT03247517|101631965|FG002|COMPLETED|Overall Study||92||
48530237|NCT03247517|101631963|FG000|NOT COMPLETED|Overall Study||8||
48530238|NCT03247517|101631964|FG001|NOT COMPLETED|Overall Study||20||
48530239|NCT03247517|101631965|FG002|NOT COMPLETED|Overall Study||14||
48530240|NCT00679926|101631966|FG000|STARTED|Overall Study||15||
48530241|NCT00679926|101631966|FG000|COMPLETED|Overall Study||2||
48530242|NCT00679926|101631966|FG000|NOT COMPLETED|Overall Study||13||
48530243|NCT00333879|101631967|FG000|STARTED|Overall Study||4||
48530244|NCT00333879|101631967|FG000|COMPLETED|Overall Study||4||
48530245|NCT00333879|101631967|FG000|NOT COMPLETED|Overall Study||0||
48530246|NCT01108406|101631968|FG000|STARTED|Overall Study||22||
48530247|NCT01108406|101631968|FG000|COMPLETED|Overall Study||22||
48530248|NCT01108406|101631968|FG000|NOT COMPLETED|Overall Study||0||
48530249|NCT01825889|101631969|FG000|STARTED|Overall Study||10||
48530250|NCT01825889|101631970|FG001|STARTED|Overall Study||10||
48530251|NCT01825889|101631969|FG000|Received One Dose of Study Drug|Overall Study||10||
48530252|NCT01825889|101631970|FG001|Received One Dose of Study Drug|Overall Study||10||
48530253|NCT01825889|101631969|FG000|COMPLETED|Overall Study||10||
48530254|NCT01825889|101631970|FG001|COMPLETED|Overall Study||10||
48530255|NCT01825889|101631969|FG000|NOT COMPLETED|Overall Study||0||
48530256|NCT01825889|101631970|FG001|NOT COMPLETED|Overall Study||0||
48229893|NCT03340961|100884372|FG001|NOT COMPLETED|Overall Study||12||
48229894|NCT03340961|100884373|FG002|NOT COMPLETED|Overall Study||9||
48229895|NCT03340961|100884374|FG003|NOT COMPLETED|Overall Study||18||
48229896|NCT01698918|100884375|FG000|STARTED|First Line Treatment (Core+Extension)||202||
48530257|NCT00380692|101631971|FG000|STARTED|Study Period II - Double Blind||48||
48530258|NCT00380692|101631972|FG001|STARTED|Study Period II - Double Blind||49||
48229897|NCT01698918|100884375|FG000|Dexamethasone Randomized Set (Stomatitis Sub-study)|First Line Treatment (Core+Extension)||11|Participants experiencing stomatitis (in countries where the alcohol-free 0.5 mg/5 mL dexamethasone oral solution was commercially available) randomized to take 0.5 mg/5 mL dexamethasone mouth rinse.|
48229898|NCT01698918|100884375|FG000|Standard of Care Randomized Set (Stomatitis Sub-study)|First Line Treatment (Core+Extension)||13|Participants experiencing stomatitis (in countries where the alcohol-free 0.5 mg/5 mL dexamethasone oral solution was commercially available) randomized to take standard of care to treat stomatitis|
48229899|NCT01698918|100884375|FG000|COMPLETED|First Line Treatment (Core+Extension)||29||
48229900|NCT01698918|100884375|FG000|NOT COMPLETED|First Line Treatment (Core+Extension)||173||
48229901|NCT01698918|100884375|FG000|STARTED|Second Line Treatment (Core+Extension)||53||
48229902|NCT01698918|100884375|FG000|COMPLETED|Second Line Treatment (Core+Extension)||7||
48229903|NCT01698918|100884375|FG000|NOT COMPLETED|Second Line Treatment (Core+Extension)||46||
48229904|NCT01584648|100884376|FG000|STARTED|Overall Study||211|All randomized patients included into Intent-to-Treat (ITT) population.|
48229905|NCT01584648|100884377|FG001|STARTED|Overall Study||212|All randomized patients included into Intent-to-Treat (ITT) population.|
48229906|NCT01584648|100884376|FG000|Safety Set|Overall Study||209|All patients who received at least one dose of study treatment|
48229907|NCT01584648|100884377|FG001|Safety Set|Overall Study||211|All patients who received at least one dose of study treatment|
48229908|NCT01584648|100884376|FG000|Crossover Population|Overall Study||0|All monotherapy randomized patients who crossed over to combination therapy|
48229909|NCT01584648|100884377|FG001|Crossover Population|Overall Study||28|All monotherapy randomized patients who crossed over to combination therapy|
48229910|NCT01584648|100884376|FG000|COMPLETED|Overall Study||0||
48229911|NCT01584648|100884377|FG001|COMPLETED|Overall Study||0||
48229912|NCT01584648|100884376|FG000|NOT COMPLETED|Overall Study||211||
48229913|NCT01584648|100884377|FG001|NOT COMPLETED|Overall Study||212||
48229914|NCT02202317|100884378|FG000|STARTED|Overall Study||9||
48229915|NCT02202317|100884378|FG000|COMPLETED|Overall Study||8||
48229916|NCT02202317|100884378|FG000|NOT COMPLETED|Overall Study||1||
48229917|NCT00927849|100884379|FG000|STARTED|Overall Study||21||
48229918|NCT00927849|100884380|FG001|STARTED|Overall Study||21||
48229919|NCT00927849|100884381|FG002|STARTED|Overall Study||21||
48229920|NCT00927849|100884379|FG000|COMPLETED|Overall Study||21||
48229921|NCT00927849|100884380|FG001|COMPLETED|Overall Study||21||
48229922|NCT00927849|100884381|FG002|COMPLETED|Overall Study||21||
48229923|NCT00927849|100884379|FG000|NOT COMPLETED|Overall Study||0||
48229924|NCT00927849|100884380|FG001|NOT COMPLETED|Overall Study||0||
48229925|NCT00927849|100884381|FG002|NOT COMPLETED|Overall Study||0||
48229926|NCT03288506|100884382|FG000|STARTED|Overall Study||60||
48229927|NCT03288506|100884382|FG000|COMPLETED|Overall Study||8|Due to low numbers the control arm was dropped from the design and ethical amendment was sought from university committee|
48229928|NCT03288506|100884382|FG000|NOT COMPLETED|Overall Study||52||
48229929|NCT02038049|100884383|FG000|STARTED|Overall Study||4|All randomized patients were included in the Full Analysis (FAS) and Safety Set|
48229930|NCT02038049|100884384|FG001|STARTED|Overall Study||4|All randomized patients were included in the Full Analysis (FAS) and Safety Set|
48229931|NCT02038049|100884383|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||4|At least one dose of study drug and one evaluable PD assessment|
48229932|NCT02038049|100884384|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||4|At least one dose of study drug and one evaluable PD assessment|
48229933|NCT02038049|100884383|FG000|COMPLETED|Overall Study||3||
48229934|NCT02038049|100884384|FG001|COMPLETED|Overall Study||4||
48229935|NCT02038049|100884383|FG000|NOT COMPLETED|Overall Study||1||
48229936|NCT02038049|100884384|FG001|NOT COMPLETED|Overall Study||0||
48229937|NCT03377049|100884385|FG000|STARTED|Overall Study||11||
48229938|NCT03377049|100884385|FG000|COMPLETED|Overall Study||11||
48229939|NCT03377049|100884385|FG000|NOT COMPLETED|Overall Study||0||
48229940|NCT00569166|100884386|FG000|STARTED|Overall Study||30||
48229941|NCT00569166|100884387|FG001|STARTED|Overall Study||31||
48229942|NCT00569166|100884388|FG002|STARTED|Overall Study||31||
48229943|NCT00569166|100884386|FG000|COMPLETED|Overall Study||21||
48229944|NCT00569166|100884387|FG001|COMPLETED|Overall Study||25||
48229945|NCT00569166|100884388|FG002|COMPLETED|Overall Study||27||
48229946|NCT00569166|100884386|FG000|NOT COMPLETED|Overall Study||9||
48229947|NCT00569166|100884387|FG001|NOT COMPLETED|Overall Study||6||
48229948|NCT00569166|100884388|FG002|NOT COMPLETED|Overall Study||4||
48229949|NCT03015220|100884389|FG000|STARTED|Overall Study||131||
48229950|NCT03015220|100884390|FG001|STARTED|Overall Study||132||
48229951|NCT03015220|100884391|FG002|STARTED|Overall Study||130||
48229952|NCT03015220|100884392|FG003|STARTED|Overall Study||65||
48229953|NCT03015220|100884389|FG000|Full Analysis Set (FAS)|Overall Study||131||
48229954|NCT03015220|100884390|FG001|Full Analysis Set (FAS)|Overall Study||132||
48229955|NCT03015220|100884391|FG002|Full Analysis Set (FAS)|Overall Study||130||
48229956|NCT03015220|100884392|FG003|Full Analysis Set (FAS)|Overall Study||65||
48229957|NCT03015220|100884389|FG000|Safety Analysis Set (SAS)|Overall Study||131||
48229958|NCT03015220|100884390|FG001|Safety Analysis Set (SAS)|Overall Study||132||
48229959|NCT03015220|100884391|FG002|Safety Analysis Set (SAS)|Overall Study||130||
48229960|NCT03015220|100884392|FG003|Safety Analysis Set (SAS)|Overall Study||65||
48229961|NCT03015220|100884389|FG000|COMPLETED|Overall Study||128||
48229962|NCT03015220|100884390|FG001|COMPLETED|Overall Study||130||
48229963|NCT03015220|100884391|FG002|COMPLETED|Overall Study||127||
48229964|NCT03015220|100884392|FG003|COMPLETED|Overall Study||63||
48229965|NCT03015220|100884389|FG000|NOT COMPLETED|Overall Study||3||
48229966|NCT03015220|100884390|FG001|NOT COMPLETED|Overall Study||2||
48229967|NCT03015220|100884391|FG002|NOT COMPLETED|Overall Study||3||
48229968|NCT03015220|100884392|FG003|NOT COMPLETED|Overall Study||2||
48229969|NCT00089609|100884393|FG000|STARTED|Overall Study||60||
48229970|NCT00089609|100884394|FG001|STARTED|Overall Study||13||
48229971|NCT00089609|100884393|FG000|COMPLETED|Overall Study||57||
48229972|NCT00089609|100884394|FG001|COMPLETED|Overall Study||12||
48229973|NCT00089609|100884393|FG000|NOT COMPLETED|Overall Study||3||
48229974|NCT00089609|100884394|FG001|NOT COMPLETED|Overall Study||1||
48229975|NCT00736502|100884395|FG000|STARTED|Overall Study||278||
48229976|NCT00736502|100884395|FG000|COMPLETED|Overall Study||213||
48229977|NCT00736502|100884395|FG000|NOT COMPLETED|Overall Study||65||
48229978|NCT02993926|100884396|FG000|STARTED|Enantone Treatment Phase||108||
48229979|NCT02993926|100884397|FG001|STARTED|Enantone Treatment Phase||0||
48229980|NCT02993926|100884398|FG002|STARTED|Enantone Treatment Phase||0||
48530259|NCT00380692|101631971|FG000|COMPLETED|Study Period II - Double Blind||43||
48530260|NCT00380692|101631972|FG001|COMPLETED|Study Period II - Double Blind||46||
48530261|NCT00380692|101631971|FG000|NOT COMPLETED|Study Period II - Double Blind||5||
48229981|NCT02993926|100884396|FG000|COMPLETED|Enantone Treatment Phase||76||
48229982|NCT02993926|100884397|FG001|COMPLETED|Enantone Treatment Phase||0||
48229983|NCT02993926|100884398|FG002|COMPLETED|Enantone Treatment Phase||0||
48229984|NCT02993926|100884396|FG000|NOT COMPLETED|Enantone Treatment Phase||32||
48229985|NCT02993926|100884397|FG001|NOT COMPLETED|Enantone Treatment Phase||0||
48229986|NCT02993926|100884398|FG002|NOT COMPLETED|Enantone Treatment Phase||0||
48229987|NCT02993926|100884396|FG000|STARTED|Follow-Up Phase||0||
48229988|NCT02993926|100884397|FG001|STARTED|Follow-Up Phase||44||
48229989|NCT02993926|100884398|FG002|STARTED|Follow-Up Phase||26||
48530262|NCT00380692|101631972|FG001|NOT COMPLETED|Study Period II - Double Blind||3||
48530263|NCT00380692|101631971|FG000|STARTED|Study Period III - Open Label||42||
48530264|NCT00380692|101631972|FG001|STARTED|Study Period III - Open Label||46||
48530265|NCT00380692|101631971|FG000|COMPLETED|Study Period III - Open Label||36||
48530266|NCT00380692|101631972|FG001|COMPLETED|Study Period III - Open Label||34||
48530267|NCT00380692|101631971|FG000|NOT COMPLETED|Study Period III - Open Label||6||
48530268|NCT00380692|101631972|FG001|NOT COMPLETED|Study Period III - Open Label||12||
48530269|NCT03840616|101631973|FG000|STARTED|2-Week Induction Phase||147||
48530270|NCT03840616|101631974|FG001|STARTED|2-Week Induction Phase||72||
48530271|NCT03840616|101631973|FG000|COMPLETED|2-Week Induction Phase||123||
48530272|NCT03840616|101631974|FG001|COMPLETED|2-Week Induction Phase||62||
48530273|NCT03840616|101631973|FG000|NOT COMPLETED|2-Week Induction Phase||24||
48530274|NCT03840616|101631974|FG001|NOT COMPLETED|2-Week Induction Phase||10||
48530275|NCT03840616|101631973|FG000|STARTED|48-Week Maintenance Phase||123||
48530276|NCT03840616|101631974|FG001|STARTED|48-Week Maintenance Phase||62||
48530277|NCT03840616|101631973|FG000|COMPLETED|48-Week Maintenance Phase||112||
48530278|NCT03840616|101631974|FG001|COMPLETED|48-Week Maintenance Phase||55||
48530279|NCT03840616|101631973|FG000|NOT COMPLETED|48-Week Maintenance Phase||11||
48530280|NCT03840616|101631974|FG001|NOT COMPLETED|48-Week Maintenance Phase||7||
48229990|NCT02993926|100884396|FG000|COMPLETED|Follow-Up Phase||0||
48229991|NCT02993926|100884397|FG001|COMPLETED|Follow-Up Phase||44||
48229992|NCT02993926|100884398|FG002|COMPLETED|Follow-Up Phase||26||
48229993|NCT02993926|100884396|FG000|NOT COMPLETED|Follow-Up Phase||0||
48229994|NCT02993926|100884397|FG001|NOT COMPLETED|Follow-Up Phase||0||
48229995|NCT02993926|100884398|FG002|NOT COMPLETED|Follow-Up Phase||0||
48229996|NCT02102724|100884399|FG000|STARTED|Overall Study||18||
48229997|NCT02102724|100884400|FG001|STARTED|Overall Study||19||
48229998|NCT02102724|100884399|FG000|COMPLETED|Overall Study||16||
48229999|NCT02102724|100884400|FG001|COMPLETED|Overall Study||18||
48230000|NCT02102724|100884399|FG000|NOT COMPLETED|Overall Study||2||
48230001|NCT02102724|100884400|FG001|NOT COMPLETED|Overall Study||1||
48230002|NCT01214200|100884401|FG000|STARTED|Overall Study||20||
48230003|NCT01214200|100884401|FG000|COMPLETED|Overall Study||9||
48230004|NCT01214200|100884401|FG000|NOT COMPLETED|Overall Study||11||
48230005|NCT01604122|100884402|FG000|STARTED|Overall Study||60||
48230006|NCT01604122|100884403|FG001|STARTED|Overall Study||32||
48230007|NCT01604122|100884402|FG000|COMPLETED|Overall Study||60||
48230008|NCT01604122|100884403|FG001|COMPLETED|Overall Study||32||
48230009|NCT01604122|100884402|FG000|NOT COMPLETED|Overall Study||0||
48230010|NCT01604122|100884403|FG001|NOT COMPLETED|Overall Study||0||
48230011|NCT00800176|100884404|FG000|STARTED|Overall Study||66||
48230012|NCT00800176|100884405|FG001|STARTED|Overall Study||66||
48230013|NCT00800176|100884406|FG002|STARTED|Overall Study||65||
48230014|NCT00800176|100884407|FG003|STARTED|Overall Study||66||
48230015|NCT00800176|100884408|FG004|STARTED|Overall Study||64||
48230016|NCT00800176|100884409|FG005|STARTED|Overall Study||67||
48530281|NCT04280705|101631975|FG000|STARTED|Overall Study||521||
48530282|NCT04280705|101631976|FG001|STARTED|Overall Study||541||
48230017|NCT00800176|100884404|FG000|COMPLETED|Overall Study||57||
48230018|NCT00800176|100884405|FG001|COMPLETED|Overall Study||60||
48230019|NCT00800176|100884406|FG002|COMPLETED|Overall Study||65||
48230020|NCT00800176|100884407|FG003|COMPLETED|Overall Study||62||
48230021|NCT00800176|100884408|FG004|COMPLETED|Overall Study||60||
48230022|NCT00800176|100884409|FG005|COMPLETED|Overall Study||62||
48530283|NCT04280705|101631975|FG000|Received Treatment|Overall Study||517||
48530284|NCT04280705|101631976|FG001|Received Treatment|Overall Study||531||
48530285|NCT04280705|101631975|FG000|COMPLETED|Overall Study||508||
48530286|NCT04280705|101631976|FG001|COMPLETED|Overall Study||517||
48530287|NCT04280705|101631975|FG000|NOT COMPLETED|Overall Study||13||
48530288|NCT04280705|101631976|FG001|NOT COMPLETED|Overall Study||24||
48530289|NCT02307266|101631977|FG000|STARTED|Overall Study||33||
48530290|NCT02307266|101631978|FG001|STARTED|Overall Study||33||
48530291|NCT02307266|101631979|FG002|STARTED|Overall Study||31||
48530292|NCT02307266|101631977|FG000|COMPLETED|Overall Study||25||
48530293|NCT02307266|101631978|FG001|COMPLETED|Overall Study||32||
48530294|NCT02307266|101631979|FG002|COMPLETED|Overall Study||25||
48530295|NCT02307266|101631977|FG000|NOT COMPLETED|Overall Study||8||
48530296|NCT02307266|101631978|FG001|NOT COMPLETED|Overall Study||1||
48530297|NCT02307266|101631979|FG002|NOT COMPLETED|Overall Study||6||
48530298|NCT02582866|101631980|FG000|STARTED|Overall Study||106||
48530299|NCT02582866|101631980|FG000|COMPLETED|Overall Study||84||
48530300|NCT02582866|101631980|FG000|NOT COMPLETED|Overall Study||22||
48530301|NCT04314414|101635729|FG000|STARTED|3 Months||31||
48530302|NCT04314414|101635729|FG000|COMPLETED|3 Months||31||
48530303|NCT04314414|101635729|FG000|NOT COMPLETED|3 Months||0||
48530304|NCT04314414|101635729|FG000|STARTED|6 Months||31||
48530305|NCT04314414|101635729|FG000|COMPLETED|6 Months||29||
48530306|NCT04314414|101635729|FG000|NOT COMPLETED|6 Months||2||
48530307|NCT01342107|101635730|FG000|STARTED|Overall Study||34||
48530308|NCT01342107|101635731|FG001|STARTED|Overall Study||32||
48530309|NCT01342107|101635730|FG000|COMPLETED|Overall Study||34||
48530310|NCT01342107|101635731|FG001|COMPLETED|Overall Study||32||
48530311|NCT01342107|101635730|FG000|NOT COMPLETED|Overall Study||0||
48530312|NCT01342107|101635731|FG001|NOT COMPLETED|Overall Study||0||
48530313|NCT02551432|101635732|FG000|STARTED|Overall Study||26||
48530314|NCT02551432|101635732|FG000|COMPLETED|Overall Study||26||
48530315|NCT02551432|101635732|FG000|NOT COMPLETED|Overall Study||0||
48530316|NCT04740814|101635733|FG000|STARTED|Overall Study||33||
48530317|NCT04740814|101635733|FG000|COMPLETED|Overall Study||23||
48530318|NCT04740814|101635733|FG000|NOT COMPLETED|Overall Study||10||
48530319|NCT01102374|101635734|FG000|STARTED|Overall Study||55||
48530320|NCT01102374|101635735|FG001|STARTED|Overall Study||52||
48530321|NCT01102374|101635734|FG000|COMPLETED|Overall Study||39||
48530322|NCT01102374|101635735|FG001|COMPLETED|Overall Study||33||
48530323|NCT01102374|101635734|FG000|NOT COMPLETED|Overall Study||16||
48530324|NCT01102374|101635735|FG001|NOT COMPLETED|Overall Study||19||
48530325|NCT03728634|101635736|FG000|STARTED|Overall Study||6||
48530326|NCT03728634|101635737|FG001|STARTED|Overall Study||10||
48530327|NCT03728634|101635738|FG002|STARTED|Overall Study||10||
48530328|NCT03728634|101635739|FG003|STARTED|Overall Study||10||
48530329|NCT03728634|101635740|FG004|STARTED|Overall Study||2||
48530330|NCT03728634|101635741|FG005|STARTED|Overall Study||9||
48530331|NCT03728634|101635736|FG000|COMPLETED|Overall Study||6||
48530332|NCT03728634|101635737|FG001|COMPLETED|Overall Study||10||
48530333|NCT03728634|101635738|FG002|COMPLETED|Overall Study||10||
48530334|NCT03728634|101635739|FG003|COMPLETED|Overall Study||10||
48530335|NCT03728634|101635740|FG004|COMPLETED|Overall Study||2||
48530336|NCT03728634|101635741|FG005|COMPLETED|Overall Study||9||
48530337|NCT03728634|101635736|FG000|NOT COMPLETED|Overall Study||0||
48530338|NCT03728634|101635737|FG001|NOT COMPLETED|Overall Study||0||
48530339|NCT03728634|101635738|FG002|NOT COMPLETED|Overall Study||0||
48530340|NCT03728634|101635739|FG003|NOT COMPLETED|Overall Study||0||
48530341|NCT03728634|101635740|FG004|NOT COMPLETED|Overall Study||0||
48530342|NCT03728634|101635741|FG005|NOT COMPLETED|Overall Study||0||
48530343|NCT00171301|101635742|FG000|STARTED|Overall Study||162||
48530344|NCT00171301|101635743|FG001|STARTED|Overall Study||71||
48530345|NCT00171301|101635742|FG000|Received Deferasirox|Overall Study||162||
48530346|NCT00171301|101635743|FG001|Received Deferasirox|Overall Study||69||
48530347|NCT00171301|101635742|FG000|COMPLETED|Overall Study||154||
48530348|NCT00171301|101635743|FG001|COMPLETED|Overall Study||62||
48530349|NCT00171301|101635742|FG000|NOT COMPLETED|Overall Study||8||
48530350|NCT00171301|101635743|FG001|NOT COMPLETED|Overall Study||9||
48530351|NCT02534844|101635744|FG000|STARTED|Part A||3||
48530352|NCT02534844|101635745|FG001|STARTED|Part A||3||
48530353|NCT02534844|101635746|FG002|STARTED|Part A||3||
48530354|NCT02534844|101635747|FG003|STARTED|Part A||3||
48530355|NCT02534844|101635748|FG004|STARTED|Part A||0||
48530356|NCT02534844|101635749|FG005|STARTED|Part A||0||
48530357|NCT02534844|101635744|FG000|Received at Least One Dose of Study Drug|Part A||3||
48530358|NCT02534844|101635745|FG001|Received at Least One Dose of Study Drug|Part A||3||
48530359|NCT02534844|101635746|FG002|Received at Least One Dose of Study Drug|Part A||3||
48530360|NCT02534844|101635747|FG003|Received at Least One Dose of Study Drug|Part A||3||
48530361|NCT02534844|101635748|FG004|Received at Least One Dose of Study Drug|Part A||0||
48530362|NCT02534844|101635749|FG005|Received at Least One Dose of Study Drug|Part A||0||
48530363|NCT02534844|101635744|FG000|COMPLETED|Part A||3||
48530364|NCT02534844|101635745|FG001|COMPLETED|Part A||3||
48530365|NCT02534844|101635746|FG002|COMPLETED|Part A||3||
48530366|NCT02534844|101635747|FG003|COMPLETED|Part A||3||
48530367|NCT02534844|101635748|FG004|COMPLETED|Part A||0||
48530368|NCT02534844|101635749|FG005|COMPLETED|Part A||0||
48530369|NCT02534844|101635744|FG000|NOT COMPLETED|Part A||0||
48530370|NCT02534844|101635745|FG001|NOT COMPLETED|Part A||0||
48530371|NCT02534844|101635746|FG002|NOT COMPLETED|Part A||0||
48530372|NCT02534844|101635747|FG003|NOT COMPLETED|Part A||0||
48530373|NCT02534844|101635748|FG004|NOT COMPLETED|Part A||0||
48530374|NCT02534844|101635749|FG005|NOT COMPLETED|Part A||0||
48530375|NCT02534844|101635744|FG000|STARTED|Part B||0||
48530376|NCT02534844|101635745|FG001|STARTED|Part B||0||
48530377|NCT02534844|101635746|FG002|STARTED|Part B||0||
48530378|NCT02534844|101635747|FG003|STARTED|Part B||0||
48530379|NCT02534844|101635748|FG004|STARTED|Part B||29||
48530380|NCT02534844|101635749|FG005|STARTED|Part B||15||
48530381|NCT02534844|101635744|FG000|Received at Least One Dose of Study Drug|Part B||0||
48530382|NCT02534844|101635745|FG001|Received at Least One Dose of Study Drug|Part B||0||
48530383|NCT02534844|101635746|FG002|Received at Least One Dose of Study Drug|Part B||0||
48530384|NCT02534844|101635747|FG003|Received at Least One Dose of Study Drug|Part B||0||
48530385|NCT02534844|101635748|FG004|Received at Least One Dose of Study Drug|Part B||29||
48530386|NCT02534844|101635749|FG005|Received at Least One Dose of Study Drug|Part B||15||
48530387|NCT02534844|101635744|FG000|COMPLETED|Part B||0||
48530388|NCT02534844|101635745|FG001|COMPLETED|Part B||0||
48530389|NCT02534844|101635746|FG002|COMPLETED|Part B||0||
48530390|NCT02534844|101635747|FG003|COMPLETED|Part B||0||
48530391|NCT02534844|101635748|FG004|COMPLETED|Part B||27||
48530392|NCT02534844|101635749|FG005|COMPLETED|Part B||14||
48530393|NCT02534844|101635744|FG000|NOT COMPLETED|Part B||0||
48530394|NCT02534844|101635745|FG001|NOT COMPLETED|Part B||0||
48530395|NCT02534844|101635746|FG002|NOT COMPLETED|Part B||0||
48530396|NCT02534844|101635747|FG003|NOT COMPLETED|Part B||0||
48530397|NCT02534844|101635748|FG004|NOT COMPLETED|Part B||2||
48530398|NCT02534844|101635749|FG005|NOT COMPLETED|Part B||1||
48530399|NCT01968694|101635750|FG000|STARTED|Visit 1 (1 Day)||10||
48530400|NCT01968694|101635751|FG001|STARTED|Visit 1 (1 Day)||9||
48530401|NCT01968694|101635750|FG000|COMPLETED|Visit 1 (1 Day)||10||
48530402|NCT01968694|101635751|FG001|COMPLETED|Visit 1 (1 Day)||9||
48530403|NCT01968694|101635750|FG000|NOT COMPLETED|Visit 1 (1 Day)||0||
48530404|NCT01968694|101635751|FG001|NOT COMPLETED|Visit 1 (1 Day)||0||
48530405|NCT01968694|101635750|FG000|STARTED|Washout (1 Month)||10||
48530406|NCT01968694|101635751|FG001|STARTED|Washout (1 Month)||9||
48530407|NCT01968694|101635750|FG000|COMPLETED|Washout (1 Month)||10||
48530408|NCT01968694|101635751|FG001|COMPLETED|Washout (1 Month)||8||
48530409|NCT01968694|101635750|FG000|NOT COMPLETED|Washout (1 Month)||0||
48530410|NCT01968694|101635751|FG001|NOT COMPLETED|Washout (1 Month)||1||
48530411|NCT01968694|101635750|FG000|STARTED|Visit 2 (1 Day)||10||
48530412|NCT01968694|101635751|FG001|STARTED|Visit 2 (1 Day)||8||
48530413|NCT01968694|101635750|FG000|COMPLETED|Visit 2 (1 Day)||10||
48530414|NCT01968694|101635751|FG001|COMPLETED|Visit 2 (1 Day)||8||
48530415|NCT01968694|101635750|FG000|NOT COMPLETED|Visit 2 (1 Day)||0||
48530416|NCT01968694|101635751|FG001|NOT COMPLETED|Visit 2 (1 Day)||0||
48530417|NCT03300544|101635752|FG000|STARTED|Overall Study||3||
48530418|NCT03300544|101635752|FG000|COMPLETED|Overall Study||3||
48530419|NCT03300544|101635752|FG000|NOT COMPLETED|Overall Study||0||
48530420|NCT02044796|101635753|FG000|STARTED|Overall Study||9||
48530421|NCT02044796|101635754|FG001|STARTED|Overall Study||9||
48530422|NCT02044796|101635755|FG002|STARTED|Overall Study||9||
48530423|NCT02044796|101635756|FG003|STARTED|Overall Study||6||
48530424|NCT02044796|101635757|FG004|STARTED|Overall Study||10||
48530425|NCT02044796|101635758|FG005|STARTED|Overall Study||6||
48530426|NCT02044796|101635759|FG006|STARTED|Overall Study||6||
48530427|NCT02044796|101635760|FG007|STARTED|Overall Study||4||
48530428|NCT02044796|101635761|FG008|STARTED|Overall Study||106||
48530429|NCT02044796|101635762|FG009|STARTED|Overall Study||34||
48530430|NCT02044796|101635753|FG000|COMPLETED|Overall Study||9||
48230023|NCT00800176|100884404|FG000|NOT COMPLETED|Overall Study||9||
48230024|NCT00800176|100884405|FG001|NOT COMPLETED|Overall Study||6||
48530431|NCT02044796|101635754|FG001|COMPLETED|Overall Study||9||
48530432|NCT02044796|101635755|FG002|COMPLETED|Overall Study||9||
48530433|NCT02044796|101635756|FG003|COMPLETED|Overall Study||6||
48530434|NCT02044796|101635757|FG004|COMPLETED|Overall Study||10||
48530435|NCT02044796|101635758|FG005|COMPLETED|Overall Study||6||
48530436|NCT02044796|101635759|FG006|COMPLETED|Overall Study||6||
48530437|NCT02044796|101635760|FG007|COMPLETED|Overall Study||4||
48530438|NCT02044796|101635761|FG008|COMPLETED|Overall Study||106||
48530439|NCT02044796|101635762|FG009|COMPLETED|Overall Study||34||
48230025|NCT00800176|100884406|FG002|NOT COMPLETED|Overall Study||0||
48230026|NCT00800176|100884407|FG003|NOT COMPLETED|Overall Study||4||
48230027|NCT00800176|100884408|FG004|NOT COMPLETED|Overall Study||4||
48530440|NCT02044796|101635753|FG000|NOT COMPLETED|Overall Study||0||
48530441|NCT02044796|101635754|FG001|NOT COMPLETED|Overall Study||0||
48530442|NCT02044796|101635755|FG002|NOT COMPLETED|Overall Study||0||
48530443|NCT02044796|101635756|FG003|NOT COMPLETED|Overall Study||0||
48530444|NCT02044796|101635757|FG004|NOT COMPLETED|Overall Study||0||
48530445|NCT02044796|101635758|FG005|NOT COMPLETED|Overall Study||0||
48530446|NCT02044796|101635759|FG006|NOT COMPLETED|Overall Study||0||
48530447|NCT02044796|101635760|FG007|NOT COMPLETED|Overall Study||0||
48530448|NCT02044796|101635761|FG008|NOT COMPLETED|Overall Study||0||
48530449|NCT02044796|101635762|FG009|NOT COMPLETED|Overall Study||0||
48530450|NCT03822832|101635763|FG000|STARTED|Period 1 - Double Blind Period||18||
48530451|NCT03822832|101635764|FG001|STARTED|Period 1 - Double Blind Period||33||
48530452|NCT03822832|101635763|FG000|COMPLETED|Period 1 - Double Blind Period||8||
48530453|NCT03822832|101635764|FG001|COMPLETED|Period 1 - Double Blind Period||22||
48530454|NCT03822832|101635763|FG000|NOT COMPLETED|Period 1 - Double Blind Period||10||
48530455|NCT03822832|101635764|FG001|NOT COMPLETED|Period 1 - Double Blind Period||11||
48530456|NCT03822832|101635763|FG000|STARTED|Re-allocation||8||
48530457|NCT03822832|101635764|FG001|STARTED|Re-allocation||22||
48530458|NCT03822832|101635763|FG000|COMPLETED|Re-allocation||6|Patient re-allocated to open label Spesolimab treatment|
48530459|NCT03822832|101635764|FG001|COMPLETED|Re-allocation||16|Patient re-allocated to open label Spesolimab treatment|
48530460|NCT03822832|101635763|FG000|NOT COMPLETED|Re-allocation||2||
48530461|NCT03822832|101635764|FG001|NOT COMPLETED|Re-allocation||6||
48530462|NCT03822832|101635763|FG000|STARTED|Period 2 - Open Label Period||6||
48530463|NCT03822832|101635764|FG001|STARTED|Period 2 - Open Label Period||16||
48530464|NCT03822832|101635763|FG000|COMPLETED|Period 2 - Open Label Period||5||
48530465|NCT03822832|101635764|FG001|COMPLETED|Period 2 - Open Label Period||13||
48530466|NCT03822832|101635763|FG000|NOT COMPLETED|Period 2 - Open Label Period||1||
48530467|NCT03822832|101635764|FG001|NOT COMPLETED|Period 2 - Open Label Period||3||
48530468|NCT02858492|101635765|FG000|STARTED|Overall Study||3||
48530469|NCT02858492|101635766|FG001|STARTED|Overall Study||15||
48530470|NCT02858492|101635767|FG002|STARTED|Overall Study||5||
48530471|NCT02858492|101635768|FG003|STARTED|Overall Study||28||
48530472|NCT02858492|101635765|FG000|COMPLETED|Overall Study||3||
48530473|NCT02858492|101635766|FG001|COMPLETED|Overall Study||14||
48530474|NCT02858492|101635767|FG002|COMPLETED|Overall Study||5||
48530475|NCT02858492|101635768|FG003|COMPLETED|Overall Study||22||
48530476|NCT02858492|101635765|FG000|NOT COMPLETED|Overall Study||0||
48530477|NCT02858492|101635766|FG001|NOT COMPLETED|Overall Study||1||
48530478|NCT02858492|101635767|FG002|NOT COMPLETED|Overall Study||0||
48530479|NCT02858492|101635768|FG003|NOT COMPLETED|Overall Study||6||
48230028|NCT00800176|100884409|FG005|NOT COMPLETED|Overall Study||5||
48230029|NCT00886834|100884410|FG000|STARTED|Overall Study||54||
48230030|NCT00886834|100884411|FG001|STARTED|Overall Study||54||
48230031|NCT00886834|100884410|FG000|COMPLETED|Overall Study||54||
48230032|NCT00886834|100884411|FG001|COMPLETED|Overall Study||51||
48530480|NCT01939496|101635769|FG000|STARTED|Overall Study||56||
48530481|NCT01939496|101635770|FG001|STARTED|Overall Study||57||
48530482|NCT01939496|101635771|FG002|STARTED|Overall Study||56||
48530483|NCT01939496|101635769|FG000|COMPLETED|Overall Study||47||
48530484|NCT01939496|101635770|FG001|COMPLETED|Overall Study||54||
48530485|NCT01939496|101635771|FG002|COMPLETED|Overall Study||54||
48530486|NCT01939496|101635769|FG000|NOT COMPLETED|Overall Study||9||
48530487|NCT01939496|101635770|FG001|NOT COMPLETED|Overall Study||3||
48530488|NCT01939496|101635771|FG002|NOT COMPLETED|Overall Study||2||
48530489|NCT00706511|101635772|FG000|STARTED|Overall Study||10||
48530490|NCT00706511|101635773|FG001|STARTED|Overall Study||4||
48230033|NCT00886834|100884410|FG000|NOT COMPLETED|Overall Study||0||
48530491|NCT00706511|101635774|FG002|STARTED|Overall Study||3||
48530492|NCT00706511|101635775|FG003|STARTED|Overall Study||10||
48530493|NCT00706511|101635772|FG000|COMPLETED|Overall Study||9||
48530494|NCT00706511|101635773|FG001|COMPLETED|Overall Study||4||
48530495|NCT00706511|101635774|FG002|COMPLETED|Overall Study||3||
48530496|NCT00706511|101635775|FG003|COMPLETED|Overall Study||10||
48530497|NCT00706511|101635772|FG000|NOT COMPLETED|Overall Study||1||
48530498|NCT00706511|101635773|FG001|NOT COMPLETED|Overall Study||0||
48530499|NCT00706511|101635774|FG002|NOT COMPLETED|Overall Study||0||
48530500|NCT00706511|101635775|FG003|NOT COMPLETED|Overall Study||0||
48530501|NCT01593696|101635776|FG000|STARTED|Dose Escalation||16||
48530502|NCT01593696|101635777|FG001|STARTED|Dose Escalation||5||
48530503|NCT01593696|101635778|FG002|STARTED|Dose Escalation||0||
48530504|NCT01593696|101635779|FG003|STARTED|Dose Escalation||0||
48530505|NCT01593696|101635776|FG000|Prior Transplant|Dose Escalation||7||
48530506|NCT01593696|101635777|FG001|Prior Transplant|Dose Escalation||1||
48530507|NCT01593696|101635778|FG002|Prior Transplant|Dose Escalation||0||
48530508|NCT01593696|101635779|FG003|Prior Transplant|Dose Escalation||0||
48530509|NCT01593696|101635776|FG000|No Prior Transplant|Dose Escalation||9||
48230034|NCT00886834|100884411|FG001|NOT COMPLETED|Overall Study||3||
48530510|NCT01593696|101635777|FG001|No Prior Transplant|Dose Escalation||4||
48230035|NCT04895085|100884412|FG000|STARTED|Overall Study||51||
48530511|NCT01593696|101635778|FG002|No Prior Transplant|Dose Escalation||0||
48530512|NCT01593696|101635779|FG003|No Prior Transplant|Dose Escalation||0||
48530513|NCT01593696|101635776|FG000|COMPLETED|Dose Escalation||14||
48530514|NCT01593696|101635777|FG001|COMPLETED|Dose Escalation||5||
48530515|NCT01593696|101635778|FG002|COMPLETED|Dose Escalation||0||
48530516|NCT01593696|101635779|FG003|COMPLETED|Dose Escalation||0||
48530517|NCT01593696|101635776|FG000|NOT COMPLETED|Dose Escalation||2||
48530518|NCT01593696|101635777|FG001|NOT COMPLETED|Dose Escalation||0||
48530519|NCT01593696|101635778|FG002|NOT COMPLETED|Dose Escalation||0||
48230036|NCT04895085|100884412|FG000|COMPLETED|Overall Study||48||
48230037|NCT04895085|100884412|FG000|NOT COMPLETED|Overall Study||3||
48230038|NCT03042767|100884413|FG000|STARTED|Overall Study||12||
48230039|NCT03042767|100884414|FG001|STARTED|Overall Study||13||
48530520|NCT01593696|101635779|FG003|NOT COMPLETED|Dose Escalation||0||
48530521|NCT01593696|101635776|FG000|STARTED|Dose Expansion||0||
48230040|NCT03042767|100884413|FG000|COMPLETED|Overall Study||11||
48230041|NCT03042767|100884414|FG001|COMPLETED|Overall Study||11||
48530522|NCT01593696|101635777|FG001|STARTED|Dose Expansion||0||
48530523|NCT01593696|101635778|FG002|STARTED|Dose Expansion||16||
48530524|NCT01593696|101635779|FG003|STARTED|Dose Expansion||16||
48530525|NCT01593696|101635776|FG000|COMPLETED|Dose Expansion||0||
48530526|NCT01593696|101635777|FG001|COMPLETED|Dose Expansion||0||
48530527|NCT01593696|101635778|FG002|COMPLETED|Dose Expansion||15||
48530528|NCT01593696|101635779|FG003|COMPLETED|Dose Expansion||16||
48530529|NCT01593696|101635776|FG000|NOT COMPLETED|Dose Expansion||0||
48530530|NCT01593696|101635777|FG001|NOT COMPLETED|Dose Expansion||0||
48530531|NCT01593696|101635778|FG002|NOT COMPLETED|Dose Expansion||1||
48530532|NCT01593696|101635779|FG003|NOT COMPLETED|Dose Expansion||0||
48530533|NCT00960115|101635780|FG000|STARTED|Overall Study||114||
48530534|NCT00960115|101635781|FG001|STARTED|Overall Study||58||
48530535|NCT00960115|101635780|FG000|COMPLETED|Overall Study||95||
48530536|NCT00960115|101635781|FG001|COMPLETED|Overall Study||43||
48530537|NCT00960115|101635780|FG000|NOT COMPLETED|Overall Study||19||
48530538|NCT00960115|101635781|FG001|NOT COMPLETED|Overall Study||15||
48530539|NCT00661141|101635782|FG000|STARTED|Overall Study||8||
48530540|NCT00661141|101635783|FG001|STARTED|Overall Study||8||
48530541|NCT00661141|101635784|FG002|STARTED|Overall Study||4||
48530542|NCT00661141|101635785|FG003|STARTED|Overall Study||4||
48530543|NCT00661141|101635786|FG004|STARTED|Overall Study||4||
48530544|NCT00661141|101635787|FG005|STARTED|Overall Study||4||
48530545|NCT00661141|101635782|FG000|Administered 30 Minutes Prior to Ethanol|Overall Study||6||
48530546|NCT00661141|101635783|FG001|Administered 30 Minutes Prior to Ethanol|Overall Study||6||
48530547|NCT00661141|101635784|FG002|Administered 30 Minutes Prior to Ethanol|Overall Study||2||
48530548|NCT00661141|101635785|FG003|Administered 30 Minutes Prior to Ethanol|Overall Study||2||
48530549|NCT00661141|101635786|FG004|Administered 30 Minutes Prior to Ethanol|Overall Study||4||
48530550|NCT00661141|101635787|FG005|Administered 30 Minutes Prior to Ethanol|Overall Study||4||
48530551|NCT00661141|101635782|FG000|Administered 30 Minutes After Ethanol|Overall Study||2||
48530552|NCT00661141|101635783|FG001|Administered 30 Minutes After Ethanol|Overall Study||2||
48530553|NCT00661141|101635784|FG002|Administered 30 Minutes After Ethanol|Overall Study||2||
48530554|NCT00661141|101635785|FG003|Administered 30 Minutes After Ethanol|Overall Study||2||
48530555|NCT00661141|101635786|FG004|Administered 30 Minutes After Ethanol|Overall Study||0||
48530556|NCT00661141|101635787|FG005|Administered 30 Minutes After Ethanol|Overall Study||0||
48530557|NCT00661141|101635782|FG000|COMPLETED|Overall Study||8||
48530558|NCT00661141|101635783|FG001|COMPLETED|Overall Study||8||
48530559|NCT00661141|101635784|FG002|COMPLETED|Overall Study||4||
48530560|NCT00661141|101635785|FG003|COMPLETED|Overall Study||4||
48530561|NCT00661141|101635786|FG004|COMPLETED|Overall Study||4||
48530562|NCT00661141|101635787|FG005|COMPLETED|Overall Study||4||
48530563|NCT00661141|101635782|FG000|NOT COMPLETED|Overall Study||0||
48530564|NCT00661141|101635783|FG001|NOT COMPLETED|Overall Study||0||
48530565|NCT00661141|101635784|FG002|NOT COMPLETED|Overall Study||0||
48530566|NCT00661141|101635785|FG003|NOT COMPLETED|Overall Study||0||
48530567|NCT00661141|101635786|FG004|NOT COMPLETED|Overall Study||0||
48530568|NCT00661141|101635787|FG005|NOT COMPLETED|Overall Study||0||
48530569|NCT00893737|101635788|FG000|STARTED|Overall Study||147||
48530570|NCT00893737|101635788|FG000|COMPLETED|Overall Study||135||
48530571|NCT00893737|101635788|FG000|NOT COMPLETED|Overall Study||12||
48530572|NCT01319773|101635789|FG000|STARTED|Overall Study||10||
48530573|NCT01319773|101635790|FG001|STARTED|Overall Study||10||
48530574|NCT01319773|101635791|FG002|STARTED|Overall Study||8||
48080745|NCT01308060|100518844|FG001|STARTED|Part A||83||
48080746|NCT01308060|100518843|FG000|COMPLETED|Part A||238||
48080747|NCT01308060|100518844|FG001|COMPLETED|Part A||77||
48080748|NCT01308060|100518843|FG000|NOT COMPLETED|Part A||14||
48080749|NCT01308060|100518844|FG001|NOT COMPLETED|Part A||6||
48080750|NCT01308060|100518843|FG000|STARTED|Part B||238||
48080751|NCT01308060|100518844|FG001|STARTED|Part B||77||
48080752|NCT01308060|100518843|FG000|COMPLETED|Part B||219||
48080753|NCT01308060|100518844|FG001|COMPLETED|Part B||69||
48080754|NCT01308060|100518843|FG000|NOT COMPLETED|Part B||19||
48080755|NCT01308060|100518844|FG001|NOT COMPLETED|Part B||8||
48080756|NCT02036294|100518845|FG000|STARTED|Overall Study||120||
48080757|NCT02036294|100518846|FG001|STARTED|Overall Study||120||
48080758|NCT02036294|100518845|FG000|COMPLETED|Overall Study||111||
48080759|NCT02036294|100518846|FG001|COMPLETED|Overall Study||109||
48080760|NCT02036294|100518845|FG000|NOT COMPLETED|Overall Study||9||
48080761|NCT02036294|100518846|FG001|NOT COMPLETED|Overall Study||11||
48080762|NCT00381485|100518847|FG000|STARTED|Open-Label Run-In Period||834||
48080763|NCT00381485|100518848|FG001|STARTED|Open-Label Run-In Period||0||
48080764|NCT00381485|100518849|FG002|STARTED|Open-Label Run-In Period||0||
48080765|NCT00381485|100518850|FG003|STARTED|Open-Label Run-In Period||0||
48080766|NCT00381485|100518847|FG000|COMPLETED|Open-Label Run-In Period||728||
48080767|NCT00381485|100518848|FG001|COMPLETED|Open-Label Run-In Period||0||
48230042|NCT03042767|100884413|FG000|NOT COMPLETED|Overall Study||1||
48230043|NCT03042767|100884414|FG001|NOT COMPLETED|Overall Study||2||
48530575|NCT01319773|101635792|FG003|STARTED|Overall Study||8||
48530576|NCT01319773|101635793|FG004|STARTED|Overall Study||8||
48530577|NCT01319773|101635789|FG000|COMPLETED|Overall Study||10||
48530578|NCT01319773|101635790|FG001|COMPLETED|Overall Study||10||
48530579|NCT01319773|101635791|FG002|COMPLETED|Overall Study||8||
48530580|NCT01319773|101635792|FG003|COMPLETED|Overall Study||8||
48530581|NCT01319773|101635793|FG004|COMPLETED|Overall Study||8||
48530582|NCT01319773|101635789|FG000|NOT COMPLETED|Overall Study||0||
48530583|NCT01319773|101635790|FG001|NOT COMPLETED|Overall Study||0||
48530584|NCT01319773|101635791|FG002|NOT COMPLETED|Overall Study||0||
48530585|NCT01319773|101635792|FG003|NOT COMPLETED|Overall Study||0||
48530586|NCT01319773|101635793|FG004|NOT COMPLETED|Overall Study||0||
48530587|NCT02038907|101635794|FG000|STARTED|Overall Study||30||
48530588|NCT02038907|101635795|FG001|STARTED|Overall Study||30||
48530589|NCT02038907|101635796|FG002|STARTED|Overall Study||30||
48530590|NCT02038907|101635797|FG003|STARTED|Overall Study||31||
48530591|NCT02038907|101635798|FG004|STARTED|Overall Study||30||
48530592|NCT02038907|101635799|FG005|STARTED|Overall Study||31||
48530593|NCT02038907|101635800|FG006|STARTED|Overall Study||30||
48530594|NCT02038907|101635801|FG007|STARTED|Overall Study||32||
48530595|NCT02038907|101635802|FG008|STARTED|Overall Study||29||
48530596|NCT02038907|101635803|FG009|STARTED|Overall Study||30||
48530597|NCT02038907|101635804|FG010|STARTED|Overall Study||29||
48530598|NCT02038907|101635805|FG011|STARTED|Overall Study||28||
48530599|NCT02038907|101635806|FG012|STARTED|Overall Study||29||
48530600|NCT02038907|101635807|FG013|STARTED|Overall Study||31||
48530601|NCT02038907|101635794|FG000|COMPLETED|Overall Study||30||
48530602|NCT02038907|101635795|FG001|COMPLETED|Overall Study||30||
48530603|NCT02038907|101635796|FG002|COMPLETED|Overall Study||30||
48530604|NCT02038907|101635797|FG003|COMPLETED|Overall Study||31||
48530605|NCT02038907|101635798|FG004|COMPLETED|Overall Study||30||
48530606|NCT02038907|101635799|FG005|COMPLETED|Overall Study||31||
48530607|NCT02038907|101635800|FG006|COMPLETED|Overall Study||30||
48530608|NCT02038907|101635801|FG007|COMPLETED|Overall Study||32||
48530609|NCT02038907|101635802|FG008|COMPLETED|Overall Study||29||
48530610|NCT02038907|101635803|FG009|COMPLETED|Overall Study||30||
48530611|NCT02038907|101635804|FG010|COMPLETED|Overall Study||27||
48530612|NCT02038907|101635805|FG011|COMPLETED|Overall Study||28||
48530613|NCT02038907|101635806|FG012|COMPLETED|Overall Study||29||
48530614|NCT02038907|101635807|FG013|COMPLETED|Overall Study||31||
48530615|NCT02038907|101635794|FG000|NOT COMPLETED|Overall Study||0||
48530616|NCT02038907|101635795|FG001|NOT COMPLETED|Overall Study||0||
48530617|NCT02038907|101635796|FG002|NOT COMPLETED|Overall Study||0||
48530618|NCT02038907|101635797|FG003|NOT COMPLETED|Overall Study||0||
48530619|NCT02038907|101635798|FG004|NOT COMPLETED|Overall Study||0||
48530620|NCT02038907|101635799|FG005|NOT COMPLETED|Overall Study||0||
48530621|NCT02038907|101635800|FG006|NOT COMPLETED|Overall Study||0||
48530622|NCT02038907|101635801|FG007|NOT COMPLETED|Overall Study||0||
48530623|NCT02038907|101635802|FG008|NOT COMPLETED|Overall Study||0||
48530624|NCT02038907|101635803|FG009|NOT COMPLETED|Overall Study||0||
48530625|NCT02038907|101635804|FG010|NOT COMPLETED|Overall Study||2||
48530626|NCT02038907|101635805|FG011|NOT COMPLETED|Overall Study||0||
48530627|NCT02038907|101635806|FG012|NOT COMPLETED|Overall Study||0||
48530628|NCT02038907|101635807|FG013|NOT COMPLETED|Overall Study||0||
48530629|NCT01642914|101635808|FG000|STARTED|Overall Study||173||
48530630|NCT01642914|101635809|FG001|STARTED|Overall Study||154||
48530631|NCT01642914|101635810|FG002|STARTED|Overall Study||160||
48530632|NCT01642914|101635808|FG000|COMPLETED|Overall Study||127||
48530633|NCT01642914|101635809|FG001|COMPLETED|Overall Study||122||
48530634|NCT01642914|101635810|FG002|COMPLETED|Overall Study||120||
48530635|NCT01642914|101635808|FG000|NOT COMPLETED|Overall Study||46||
48530636|NCT01642914|101635809|FG001|NOT COMPLETED|Overall Study||32||
48530637|NCT01642914|101635810|FG002|NOT COMPLETED|Overall Study||40||
48530638|NCT02269163|101635811|FG000|STARTED|Overall Study||50||
48530639|NCT02269163|101635812|FG001|STARTED|Overall Study||25||
48530640|NCT02269163|101635811|FG000|COMPLETED|Overall Study||47||
48530641|NCT02269163|101635812|FG001|COMPLETED|Overall Study||18||
48530642|NCT02269163|101635811|FG000|NOT COMPLETED|Overall Study||3||
48530643|NCT02269163|101635812|FG001|NOT COMPLETED|Overall Study||7||
48530644|NCT02924727|101635813|FG000|STARTED|Overall Study||2834|All randomized patients (RAN)|
48530645|NCT02924727|101635814|FG001|STARTED|Overall Study||2835|All randomized patients (RAN)|
48530646|NCT02924727|101635813|FG000|Full Analysis Set (FAS)|Overall Study||2830|All patients in the RAN population who were not mis-randomized patients (who were not qualified for randomization and who did not take study drug, but were inadvertently randomized into the study).|
48530647|NCT02924727|101635814|FG001|Full Analysis Set (FAS)|Overall Study||2831|All patients in the RAN population who were not mis-randomized patients (who were not qualified for randomization and who did not take study drug, but were inadvertently randomized into the study).|
48530648|NCT02924727|101635813|FG000|Safety Set (SAF)|Overall Study||2820|All randomized patients who received at least one dose of study drug.|
48530649|NCT02924727|101635814|FG001|Safety Set (SAF)|Overall Study||2816|All randomized patients who received at least one dose of study drug.|
48530650|NCT02924727|101635813|FG000|COMPLETED|Overall Study||2605||
48530651|NCT02924727|101635814|FG001|COMPLETED|Overall Study||2576||
48530652|NCT02924727|101635813|FG000|NOT COMPLETED|Overall Study||229||
48530653|NCT02924727|101635814|FG001|NOT COMPLETED|Overall Study||259||
48530654|NCT00536263|101635815|FG000|STARTED|Overall Study||225||
48530655|NCT00536263|101635816|FG001|STARTED|Overall Study||221||
48530656|NCT00536263|101635817|FG002|STARTED|Overall Study||225||
48530657|NCT00536263|101635815|FG000|COMPLETED|Overall Study||214||
48530658|NCT00536263|101635816|FG001|COMPLETED|Overall Study||207||
48530659|NCT00536263|101635817|FG002|COMPLETED|Overall Study||204||
48530660|NCT00536263|101635815|FG000|NOT COMPLETED|Overall Study||11||
48530661|NCT00536263|101635816|FG001|NOT COMPLETED|Overall Study||14||
48530662|NCT00536263|101635817|FG002|NOT COMPLETED|Overall Study||21||
48530663|NCT03310411|101635818|FG000|STARTED|Period 1||10||
48530664|NCT03310411|101635819|FG001|STARTED|Period 1||10||
48530665|NCT03310411|101635820|FG002|STARTED|Period 1||10||
48530666|NCT03310411|101635821|FG003|STARTED|Period 1||10||
48530667|NCT03310411|101635818|FG000|Received at Least 1 Dose of Study Drug|Period 1||10||
48530668|NCT03310411|101635819|FG001|Received at Least 1 Dose of Study Drug|Period 1||10||
48530669|NCT03310411|101635820|FG002|Received at Least 1 Dose of Study Drug|Period 1||10||
48530670|NCT03310411|101635821|FG003|Received at Least 1 Dose of Study Drug|Period 1||10||
48530671|NCT03310411|101635818|FG000|COMPLETED|Period 1||10||
48530672|NCT03310411|101635819|FG001|COMPLETED|Period 1||10||
48530673|NCT03310411|101635820|FG002|COMPLETED|Period 1||10||
48530674|NCT03310411|101635821|FG003|COMPLETED|Period 1||9||
48530675|NCT03310411|101635818|FG000|NOT COMPLETED|Period 1||0||
48530676|NCT03310411|101635819|FG001|NOT COMPLETED|Period 1||0||
48530677|NCT03310411|101635820|FG002|NOT COMPLETED|Period 1||0||
48530678|NCT03310411|101635821|FG003|NOT COMPLETED|Period 1||1||
48530679|NCT03310411|101635818|FG000|STARTED|Period 2||10||
48530680|NCT03310411|101635819|FG001|STARTED|Period 2||10||
48530681|NCT03310411|101635820|FG002|STARTED|Period 2||10||
48530682|NCT03310411|101635821|FG003|STARTED|Period 2||9||
48530683|NCT03310411|101635818|FG000|COMPLETED|Period 2||10||
48530684|NCT03310411|101635819|FG001|COMPLETED|Period 2||10||
48530685|NCT03310411|101635820|FG002|COMPLETED|Period 2||10||
48530686|NCT03310411|101635821|FG003|COMPLETED|Period 2||9||
48530687|NCT03310411|101635818|FG000|NOT COMPLETED|Period 2||0||
48530688|NCT03310411|101635819|FG001|NOT COMPLETED|Period 2||0||
48530689|NCT03310411|101635820|FG002|NOT COMPLETED|Period 2||0||
48530690|NCT03310411|101635821|FG003|NOT COMPLETED|Period 2||0||
48530691|NCT03310411|101635818|FG000|STARTED|Period 3||10||
48530692|NCT03310411|101635819|FG001|STARTED|Period 3||10||
48530693|NCT03310411|101635820|FG002|STARTED|Period 3||10||
48530694|NCT03310411|101635821|FG003|STARTED|Period 3||9||
48530695|NCT03310411|101635818|FG000|COMPLETED|Period 3||10||
48530696|NCT03310411|101635819|FG001|COMPLETED|Period 3||10||
48530697|NCT03310411|101635820|FG002|COMPLETED|Period 3||10||
48530698|NCT03310411|101635821|FG003|COMPLETED|Period 3||9||
48530699|NCT03310411|101635818|FG000|NOT COMPLETED|Period 3||0||
48530700|NCT03310411|101635819|FG001|NOT COMPLETED|Period 3||0||
48530701|NCT03310411|101635820|FG002|NOT COMPLETED|Period 3||0||
48530702|NCT03310411|101635821|FG003|NOT COMPLETED|Period 3||0||
48530703|NCT03310411|101635818|FG000|STARTED|Period Title: Period 4||10||
48530704|NCT03310411|101635819|FG001|STARTED|Period Title: Period 4||10||
48530705|NCT03310411|101635820|FG002|STARTED|Period Title: Period 4||10||
48530706|NCT03310411|101635821|FG003|STARTED|Period Title: Period 4||9||
48530707|NCT03310411|101635818|FG000|COMPLETED|Period Title: Period 4||10||
48530708|NCT03310411|101635819|FG001|COMPLETED|Period Title: Period 4||10||
48530709|NCT03310411|101635820|FG002|COMPLETED|Period Title: Period 4||10||
48530710|NCT03310411|101635821|FG003|COMPLETED|Period Title: Period 4||9||
48530711|NCT03310411|101635818|FG000|NOT COMPLETED|Period Title: Period 4||0||
48530712|NCT03310411|101635819|FG001|NOT COMPLETED|Period Title: Period 4||0||
48530713|NCT03310411|101635820|FG002|NOT COMPLETED|Period Title: Period 4||0||
48530714|NCT03310411|101635821|FG003|NOT COMPLETED|Period Title: Period 4||0||
48530715|NCT00440466|101635822|FG000|STARTED|Overall Study||108||
48530716|NCT00440466|101635823|FG001|STARTED|Overall Study||107||
48530717|NCT00440466|101635824|FG002|STARTED|Overall Study||215||
48530718|NCT00440466|101635822|FG000|COMPLETED|Overall Study||95||
48530719|NCT00440466|101635823|FG001|COMPLETED|Overall Study||92||
48530720|NCT00440466|101635824|FG002|COMPLETED|Overall Study||174||
48530721|NCT00440466|101635822|FG000|NOT COMPLETED|Overall Study||13||
48530722|NCT00440466|101635823|FG001|NOT COMPLETED|Overall Study||15||
48530723|NCT00440466|101635824|FG002|NOT COMPLETED|Overall Study||41||
48530724|NCT04688931|101635825|FG000|STARTED|Overall Study||142||
48530725|NCT04688931|101635826|FG001|STARTED|Overall Study||140||
48530726|NCT04688931|101635825|FG000|COMPLETED|Overall Study||123||
48530727|NCT04688931|101635826|FG001|COMPLETED|Overall Study||106||
48530728|NCT04688931|101635825|FG000|NOT COMPLETED|Overall Study||19||
48530729|NCT04688931|101635826|FG001|NOT COMPLETED|Overall Study||34||
48530730|NCT03111914|101635827|FG000|STARTED|Overall Study||7||
48530731|NCT03111914|101635827|FG000|COMPLETED|Overall Study||0||
48530732|NCT03111914|101635827|FG000|NOT COMPLETED|Overall Study||7||
48530733|NCT02669758|101635828|FG000|STARTED|Overall Study||277||
48530734|NCT02669758|101635828|FG000|COMPLETED|Overall Study||183||
48530735|NCT02669758|101635828|FG000|NOT COMPLETED|Overall Study||94||
48530736|NCT01540773|101635829|FG000|STARTED|First Intervention||8||
48530737|NCT01540773|101635830|FG001|STARTED|First Intervention||8||
48530738|NCT01540773|101635829|FG000|COMPLETED|First Intervention||8||
48530739|NCT01540773|101635830|FG001|COMPLETED|First Intervention||8||
48530740|NCT01540773|101635829|FG000|NOT COMPLETED|First Intervention||0||
48530741|NCT01540773|101635830|FG001|NOT COMPLETED|First Intervention||0||
48530742|NCT01540773|101635829|FG000|STARTED|Wash Out Period of 1 Week||8||
48530743|NCT01540773|101635830|FG001|STARTED|Wash Out Period of 1 Week||8||
48530744|NCT01540773|101635829|FG000|COMPLETED|Wash Out Period of 1 Week||8||
48530745|NCT01540773|101635830|FG001|COMPLETED|Wash Out Period of 1 Week||8||
48530746|NCT01540773|101635829|FG000|NOT COMPLETED|Wash Out Period of 1 Week||0||
48530747|NCT01540773|101635830|FG001|NOT COMPLETED|Wash Out Period of 1 Week||0||
48530748|NCT01540773|101635829|FG000|STARTED|Second Intervention||8||
48530749|NCT01540773|101635830|FG001|STARTED|Second Intervention||8||
48530750|NCT01540773|101635829|FG000|COMPLETED|Second Intervention||8||
48530751|NCT01540773|101635830|FG001|COMPLETED|Second Intervention||8||
48530752|NCT01540773|101635829|FG000|NOT COMPLETED|Second Intervention||0||
48530753|NCT01540773|101635830|FG001|NOT COMPLETED|Second Intervention||0||
48530754|NCT02408068|101635831|FG000|STARTED|Treatment 1 (1.5 Days)||3||
48530755|NCT02408068|101635832|FG001|STARTED|Treatment 1 (1.5 Days)||3||
48530756|NCT02408068|101635833|FG002|STARTED|Treatment 1 (1.5 Days)||3||
48530757|NCT02408068|101635834|FG003|STARTED|Treatment 1 (1.5 Days)||3||
48530758|NCT02408068|101635835|FG004|STARTED|Treatment 1 (1.5 Days)||3||
48530759|NCT02408068|101635836|FG005|STARTED|Treatment 1 (1.5 Days)||3||
48530760|NCT02408068|101635831|FG000|COMPLETED|Treatment 1 (1.5 Days)||3||
48530761|NCT02408068|101635832|FG001|COMPLETED|Treatment 1 (1.5 Days)||3||
48530762|NCT02408068|101635833|FG002|COMPLETED|Treatment 1 (1.5 Days)||3||
48530763|NCT02408068|101635834|FG003|COMPLETED|Treatment 1 (1.5 Days)||3||
48530764|NCT02408068|101635835|FG004|COMPLETED|Treatment 1 (1.5 Days)||3||
48530765|NCT02408068|101635836|FG005|COMPLETED|Treatment 1 (1.5 Days)||3||
48530766|NCT02408068|101635831|FG000|NOT COMPLETED|Treatment 1 (1.5 Days)||0||
48530767|NCT02408068|101635832|FG001|NOT COMPLETED|Treatment 1 (1.5 Days)||0||
48230044|NCT04070105|100884415|FG000|STARTED|Overall Study||0||
48230045|NCT04070105|100884416|FG001|STARTED|Overall Study||2||
48230046|NCT04070105|100884417|FG002|STARTED|Overall Study||1||
48230047|NCT04070105|100884418|FG003|STARTED|Overall Study||1||
48230048|NCT04070105|100884419|FG004|STARTED|Overall Study||1||
48230049|NCT04070105|100884420|FG005|STARTED|Overall Study||1||
48230050|NCT04070105|100884415|FG000|COMPLETED|Overall Study||0||
48230051|NCT04070105|100884416|FG001|COMPLETED|Overall Study||2||
48230052|NCT04070105|100884417|FG002|COMPLETED|Overall Study||1||
48230053|NCT04070105|100884418|FG003|COMPLETED|Overall Study||1||
48230054|NCT04070105|100884419|FG004|COMPLETED|Overall Study||1||
48230055|NCT04070105|100884420|FG005|COMPLETED|Overall Study||0||
48530768|NCT02408068|101635833|FG002|NOT COMPLETED|Treatment 1 (1.5 Days)||0||
48530769|NCT02408068|101635834|FG003|NOT COMPLETED|Treatment 1 (1.5 Days)||0||
48530770|NCT02408068|101635835|FG004|NOT COMPLETED|Treatment 1 (1.5 Days)||0||
48530771|NCT02408068|101635836|FG005|NOT COMPLETED|Treatment 1 (1.5 Days)||0||
48530772|NCT02408068|101635831|FG000|STARTED|Washout Period 1 (7 Days)||3||
48530773|NCT02408068|101635832|FG001|STARTED|Washout Period 1 (7 Days)||3||
48530774|NCT02408068|101635833|FG002|STARTED|Washout Period 1 (7 Days)||3||
48530775|NCT02408068|101635834|FG003|STARTED|Washout Period 1 (7 Days)||3||
48530776|NCT02408068|101635835|FG004|STARTED|Washout Period 1 (7 Days)||3||
48530777|NCT02408068|101635836|FG005|STARTED|Washout Period 1 (7 Days)||3||
48530778|NCT02408068|101635831|FG000|COMPLETED|Washout Period 1 (7 Days)||3||
48530779|NCT02408068|101635832|FG001|COMPLETED|Washout Period 1 (7 Days)||3||
48230056|NCT04070105|100884415|FG000|NOT COMPLETED|Overall Study||0||
48230057|NCT04070105|100884416|FG001|NOT COMPLETED|Overall Study||0||
48230058|NCT04070105|100884417|FG002|NOT COMPLETED|Overall Study||0||
48230059|NCT04070105|100884418|FG003|NOT COMPLETED|Overall Study||0||
48230060|NCT04070105|100884419|FG004|NOT COMPLETED|Overall Study||0||
48230061|NCT04070105|100884420|FG005|NOT COMPLETED|Overall Study||1||
48230062|NCT04820491|100884421|FG000|STARTED|Overall Study||5||
48230063|NCT04820491|100884422|FG001|STARTED|Overall Study||4||
48530780|NCT02408068|101635833|FG002|COMPLETED|Washout Period 1 (7 Days)||3||
48530781|NCT02408068|101635834|FG003|COMPLETED|Washout Period 1 (7 Days)||3||
48530782|NCT02408068|101635835|FG004|COMPLETED|Washout Period 1 (7 Days)||3||
48530783|NCT02408068|101635836|FG005|COMPLETED|Washout Period 1 (7 Days)||3||
48230064|NCT04820491|100884421|FG000|COMPLETED|Overall Study||4||
48530784|NCT02408068|101635831|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48530785|NCT02408068|101635832|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48530786|NCT02408068|101635833|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48530787|NCT02408068|101635834|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48530788|NCT02408068|101635835|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48530789|NCT02408068|101635836|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48530790|NCT02408068|101635831|FG000|STARTED|Treatment 2 (1.5 Days)||3||
48530791|NCT02408068|101635832|FG001|STARTED|Treatment 2 (1.5 Days)||3||
48530792|NCT02408068|101635833|FG002|STARTED|Treatment 2 (1.5 Days)||3||
48230065|NCT04820491|100884422|FG001|COMPLETED|Overall Study||4||
48230066|NCT04820491|100884421|FG000|NOT COMPLETED|Overall Study||1||
48230067|NCT04820491|100884422|FG001|NOT COMPLETED|Overall Study||0||
48230068|NCT03176407|100884423|FG000|STARTED|Overall Study||30||
48230069|NCT03176407|100884423|FG000|COMPLETED|Overall Study||27||
48230070|NCT03176407|100884423|FG000|NOT COMPLETED|Overall Study||3||
48230071|NCT02255474|100884424|FG000|STARTED|Overall Study||98||98
48530793|NCT02408068|101635834|FG003|STARTED|Treatment 2 (1.5 Days)||3||
48530794|NCT02408068|101635835|FG004|STARTED|Treatment 2 (1.5 Days)||3||
48530795|NCT02408068|101635836|FG005|STARTED|Treatment 2 (1.5 Days)||3||
48530796|NCT02408068|101635831|FG000|COMPLETED|Treatment 2 (1.5 Days)||3||
48530797|NCT02408068|101635832|FG001|COMPLETED|Treatment 2 (1.5 Days)||3||
48530798|NCT02408068|101635833|FG002|COMPLETED|Treatment 2 (1.5 Days)||3||
48530799|NCT02408068|101635834|FG003|COMPLETED|Treatment 2 (1.5 Days)||3||
48530800|NCT02408068|101635835|FG004|COMPLETED|Treatment 2 (1.5 Days)||3||
48530801|NCT02408068|101635836|FG005|COMPLETED|Treatment 2 (1.5 Days)||3||
48530802|NCT02408068|101635831|FG000|NOT COMPLETED|Treatment 2 (1.5 Days)||0||
48530803|NCT02408068|101635832|FG001|NOT COMPLETED|Treatment 2 (1.5 Days)||0||
48530804|NCT02408068|101635833|FG002|NOT COMPLETED|Treatment 2 (1.5 Days)||0||
48530805|NCT02408068|101635834|FG003|NOT COMPLETED|Treatment 2 (1.5 Days)||0||
48530806|NCT02408068|101635835|FG004|NOT COMPLETED|Treatment 2 (1.5 Days)||0||
48530807|NCT02408068|101635836|FG005|NOT COMPLETED|Treatment 2 (1.5 Days)||0||
48530808|NCT02408068|101635831|FG000|STARTED|Washout Period 2 (7 Days)||3||
48230072|NCT02255474|100884425|FG001|STARTED|Overall Study||98||98
48530809|NCT02408068|101635832|FG001|STARTED|Washout Period 2 (7 Days)||3||
48530810|NCT02408068|101635833|FG002|STARTED|Washout Period 2 (7 Days)||3||
48530811|NCT02408068|101635834|FG003|STARTED|Washout Period 2 (7 Days)||3||
48530812|NCT02408068|101635835|FG004|STARTED|Washout Period 2 (7 Days)||3||
48530813|NCT02408068|101635836|FG005|STARTED|Washout Period 2 (7 Days)||3||
48530814|NCT02408068|101635831|FG000|COMPLETED|Washout Period 2 (7 Days)||3||
48530815|NCT02408068|101635832|FG001|COMPLETED|Washout Period 2 (7 Days)||3||
48530816|NCT02408068|101635833|FG002|COMPLETED|Washout Period 2 (7 Days)||3||
48530817|NCT02408068|101635834|FG003|COMPLETED|Washout Period 2 (7 Days)||3||
48230073|NCT02255474|100884426|FG002|STARTED|Overall Study||98||98
48230074|NCT02255474|100884424|FG000|COMPLETED|Overall Study||96||96
48230075|NCT02255474|100884425|FG001|COMPLETED|Overall Study||96||96
48530818|NCT02408068|101635835|FG004|COMPLETED|Washout Period 2 (7 Days)||3||
48530819|NCT02408068|101635836|FG005|COMPLETED|Washout Period 2 (7 Days)||3||
48530820|NCT02408068|101635831|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48530821|NCT02408068|101635832|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48530822|NCT02408068|101635833|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48530823|NCT02408068|101635834|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48530824|NCT02408068|101635835|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48530825|NCT02408068|101635836|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48530826|NCT02408068|101635831|FG000|STARTED|Treatment 3 (1.5 Days)||3||
48530827|NCT02408068|101635832|FG001|STARTED|Treatment 3 (1.5 Days)||3||
48530828|NCT02408068|101635833|FG002|STARTED|Treatment 3 (1.5 Days)||3||
48530829|NCT02408068|101635834|FG003|STARTED|Treatment 3 (1.5 Days)||3||
48530830|NCT02408068|101635835|FG004|STARTED|Treatment 3 (1.5 Days)||3||
48530831|NCT02408068|101635836|FG005|STARTED|Treatment 3 (1.5 Days)||3||
48530832|NCT02408068|101635831|FG000|COMPLETED|Treatment 3 (1.5 Days)||3||
48530833|NCT02408068|101635832|FG001|COMPLETED|Treatment 3 (1.5 Days)||3||
48530834|NCT02408068|101635833|FG002|COMPLETED|Treatment 3 (1.5 Days)||2||
48530835|NCT02408068|101635834|FG003|COMPLETED|Treatment 3 (1.5 Days)||3||
48530836|NCT02408068|101635835|FG004|COMPLETED|Treatment 3 (1.5 Days)||3||
48530837|NCT02408068|101635836|FG005|COMPLETED|Treatment 3 (1.5 Days)||3||
48530838|NCT02408068|101635831|FG000|NOT COMPLETED|Treatment 3 (1.5 Days)||0||
48530839|NCT02408068|101635832|FG001|NOT COMPLETED|Treatment 3 (1.5 Days)||0||
48530840|NCT02408068|101635833|FG002|NOT COMPLETED|Treatment 3 (1.5 Days)||1||
48530841|NCT02408068|101635834|FG003|NOT COMPLETED|Treatment 3 (1.5 Days)||0||
48230076|NCT02255474|100884426|FG002|COMPLETED|Overall Study||95||95
48230077|NCT02255474|100884424|FG000|NOT COMPLETED|Overall Study||2||2
48230078|NCT02255474|100884425|FG001|NOT COMPLETED|Overall Study||2||2
48230079|NCT02255474|100884426|FG002|NOT COMPLETED|Overall Study||3||3
48230080|NCT02827201|100884427|FG000|STARTED|Overall Study||64||
48230081|NCT02827201|100884428|FG001|STARTED|Overall Study||63||
48230082|NCT02827201|100884427|FG000|COMPLETED|Overall Study||62||
48530842|NCT02408068|101635835|FG004|NOT COMPLETED|Treatment 3 (1.5 Days)||0||
48530843|NCT02408068|101635836|FG005|NOT COMPLETED|Treatment 3 (1.5 Days)||0||
48530844|NCT00895947|101635837|FG000|STARTED|Overall Study||100||
48530845|NCT00895947|101635838|FG001|STARTED|Overall Study||100||
48530846|NCT00895947|101635837|FG000|COMPLETED|Overall Study||88||
48530847|NCT00895947|101635838|FG001|COMPLETED|Overall Study||90||
48530848|NCT00895947|101635837|FG000|NOT COMPLETED|Overall Study||12||
48230083|NCT02827201|100884428|FG001|COMPLETED|Overall Study||60||
48530849|NCT00895947|101635838|FG001|NOT COMPLETED|Overall Study||10||
48530850|NCT00574912|101635839|FG000|STARTED|Overall Study||20||
48230084|NCT02827201|100884427|FG000|NOT COMPLETED|Overall Study||2||
48530851|NCT00574912|101635839|FG000|Completed Placebo|Overall Study||12||
48230085|NCT02827201|100884428|FG001|NOT COMPLETED|Overall Study||3||
48230086|NCT01429285|100884429|FG000|STARTED|Overall Study||175||
48530852|NCT00574912|101635839|FG000|Completed 0.5|Overall Study||12||
48530853|NCT00574912|101635839|FG000|Completed 1.0|Overall Study||12||
48530854|NCT00574912|101635839|FG000|Completed 1.5|Overall Study||12||
48530855|NCT00574912|101635839|FG000|Completed 2.0|Overall Study||12||
48230087|NCT01429285|100884430|FG001|STARTED|Overall Study||175||
48230088|NCT01429285|100884429|FG000|Given IV Opioids|Overall Study||166||
48530856|NCT00574912|101635839|FG000|COMPLETED|Overall Study||12||
48530857|NCT00574912|101635839|FG000|NOT COMPLETED|Overall Study||8||
48230089|NCT01429285|100884430|FG001|Given IV Opioids|Overall Study||171||
48230090|NCT01429285|100884429|FG000|Completed Primary Outcome Data|Overall Study||161||
48230091|NCT01429285|100884430|FG001|Completed Primary Outcome Data|Overall Study||168||
48230092|NCT01429285|100884429|FG000|Confirmation of no Duplicate Enrollment|Overall Study||153||
48230093|NCT01429285|100884430|FG001|Confirmation of no Duplicate Enrollment|Overall Study||166||
48230094|NCT01429285|100884429|FG000|COMPLETED|Overall Study||153||
48230095|NCT01429285|100884430|FG001|COMPLETED|Overall Study||166||
48230096|NCT01429285|100884429|FG000|NOT COMPLETED|Overall Study||22||
48230097|NCT01429285|100884430|FG001|NOT COMPLETED|Overall Study||9||
48230098|NCT04183491|100884431|FG000|STARTED|Overall Study||12||
48230099|NCT04183491|100884432|FG001|STARTED|Overall Study||12||
48230100|NCT04183491|100884433|FG002|STARTED|Overall Study||12||
48230101|NCT04183491|100884434|FG003|STARTED|Overall Study||12||
48230102|NCT04183491|100884435|FG004|STARTED|Overall Study||12||
48230103|NCT04183491|100884436|FG005|STARTED|Overall Study||12||
48230104|NCT04183491|100884437|FG006|STARTED|Overall Study||12||
48230105|NCT04183491|100884431|FG000|COMPLETED|Overall Study||12||
48230106|NCT04183491|100884432|FG001|COMPLETED|Overall Study||12||
48230107|NCT04183491|100884433|FG002|COMPLETED|Overall Study||11||
48230108|NCT04183491|100884434|FG003|COMPLETED|Overall Study||12||
48230109|NCT04183491|100884435|FG004|COMPLETED|Overall Study||12||
48230110|NCT04183491|100884436|FG005|COMPLETED|Overall Study||11||
48230111|NCT04183491|100884437|FG006|COMPLETED|Overall Study||12||
48230112|NCT04183491|100884431|FG000|NOT COMPLETED|Overall Study||0||
48230113|NCT04183491|100884432|FG001|NOT COMPLETED|Overall Study||0||
48230114|NCT04183491|100884433|FG002|NOT COMPLETED|Overall Study||1||
48230115|NCT04183491|100884434|FG003|NOT COMPLETED|Overall Study||0||
48230116|NCT04183491|100884435|FG004|NOT COMPLETED|Overall Study||0||
48230117|NCT04183491|100884436|FG005|NOT COMPLETED|Overall Study||1||
48230118|NCT04183491|100884437|FG006|NOT COMPLETED|Overall Study||0||
48230119|NCT02005172|100884438|FG000|STARTED|Overall Study||33||
48230120|NCT02005172|100884438|FG000|ITT|Overall Study||38|This group includes the patients who met the inclusion criteria and were enrolled into the study but did not complete the study|
48230121|NCT02005172|100884438|FG000|COMPLETED|Overall Study||33||
48230122|NCT02005172|100884438|FG000|NOT COMPLETED|Overall Study||0||
48230123|NCT01124045|100884439|FG000|STARTED|Overall Study||39||
48230124|NCT01124045|100884440|FG001|STARTED|Overall Study||40||
48230125|NCT01124045|100884439|FG000|COMPLETED|Overall Study||39||
48230126|NCT01124045|100884440|FG001|COMPLETED|Overall Study||37||
48230127|NCT01124045|100884439|FG000|NOT COMPLETED|Overall Study||0||
48230128|NCT01124045|100884440|FG001|NOT COMPLETED|Overall Study||3||
48230129|NCT01929291|100884441|FG000|STARTED|Overall Study||672||
48230130|NCT01929291|100884441|FG000|COMPLETED|Overall Study||672||
48230131|NCT01929291|100884441|FG000|NOT COMPLETED|Overall Study||0||
48230132|NCT01338506|100884442|FG000|STARTED|Overall Study||54||
48230133|NCT01338506|100884443|FG001|STARTED|Overall Study||27||
48230134|NCT01338506|100884442|FG000|COMPLETED|Overall Study||29||
48230135|NCT01338506|100884443|FG001|COMPLETED|Overall Study||13||
48230136|NCT01338506|100884442|FG000|NOT COMPLETED|Overall Study||25||
48230137|NCT01338506|100884443|FG001|NOT COMPLETED|Overall Study||14||
48230138|NCT03205488|100884444|FG000|STARTED|Overall Study||25||
48230139|NCT03205488|100884445|FG001|STARTED|Overall Study||25||
48230140|NCT03205488|100884446|FG002|STARTED|Overall Study||26||
48230141|NCT03205488|100884444|FG000|COMPLETED|Overall Study||24||
48230142|NCT03205488|100884445|FG001|COMPLETED|Overall Study||23||
48230143|NCT03205488|100884446|FG002|COMPLETED|Overall Study||21||
48230144|NCT03205488|100884444|FG000|NOT COMPLETED|Overall Study||1||
48230145|NCT03205488|100884445|FG001|NOT COMPLETED|Overall Study||2||
48230146|NCT03205488|100884446|FG002|NOT COMPLETED|Overall Study||5||
48530858|NCT02135653|101635840|FG000|STARTED|Overall Study||35||
48530859|NCT02135653|101635841|FG001|STARTED|Overall Study||33||
48530860|NCT02135653|101635840|FG000|COMPLETED|Overall Study||22||
48530861|NCT02135653|101635841|FG001|COMPLETED|Overall Study||28||
48530862|NCT02135653|101635840|FG000|NOT COMPLETED|Overall Study||13||
48230147|NCT01487954|100884447|FG000|STARTED|Overall Study||29||
48230148|NCT01487954|100884448|FG001|STARTED|Overall Study||16||
48230149|NCT01487954|100884447|FG000|Safety lead-in|Overall Study||10||
48230150|NCT01487954|100884448|FG001|Safety lead-in|Overall Study||0||
48230151|NCT01487954|100884447|FG000|COMPLETED|Overall Study||29||
48230152|NCT01487954|100884448|FG001|COMPLETED|Overall Study||16||
48230153|NCT01487954|100884447|FG000|NOT COMPLETED|Overall Study||0||
48230154|NCT01487954|100884448|FG001|NOT COMPLETED|Overall Study||0||
48230155|NCT02302157|100884449|FG000|STARTED|Overall Study||3||
48230156|NCT02302157|100884450|FG001|STARTED|Overall Study||6||
48230157|NCT02302157|100884451|FG002|STARTED|Overall Study||6||
48230158|NCT02302157|100884452|FG003|STARTED|Overall Study||6||
48230159|NCT02302157|100884453|FG004|STARTED|Overall Study||4||
48230160|NCT02302157|100884449|FG000|COMPLETED|Overall Study||3||
48230161|NCT02302157|100884450|FG001|COMPLETED|Overall Study||6||
48230162|NCT02302157|100884451|FG002|COMPLETED|Overall Study||6||
48230163|NCT02302157|100884452|FG003|COMPLETED|Overall Study||6||
48230164|NCT02302157|100884453|FG004|COMPLETED|Overall Study||4||
48530863|NCT02135653|101635841|FG001|NOT COMPLETED|Overall Study||5||
48230165|NCT02302157|100884449|FG000|NOT COMPLETED|Overall Study||0||
48230166|NCT02302157|100884450|FG001|NOT COMPLETED|Overall Study||0||
48230167|NCT02302157|100884451|FG002|NOT COMPLETED|Overall Study||0||
48230168|NCT02302157|100884452|FG003|NOT COMPLETED|Overall Study||0||
48230169|NCT02302157|100884453|FG004|NOT COMPLETED|Overall Study||0||
48530864|NCT00278889|101635842|FG000|STARTED|Overall Study||73||
48230170|NCT01138657|100884454|FG000|STARTED|Overall Study||120||
48230171|NCT01138657|100884455|FG001|STARTED|Overall Study||119||
48230172|NCT01138657|100884454|FG000|Enrolled in Main Study|Overall Study||112||
48230173|NCT01138657|100884455|FG001|Enrolled in Main Study|Overall Study||111||
48230174|NCT01138657|100884454|FG000|Enrolled in Japan Sub-study|Overall Study||8||
48230175|NCT01138657|100884455|FG001|Enrolled in Japan Sub-study|Overall Study||8||
48230176|NCT01138657|100884454|FG000|COMPLETED|Overall Study||112||
48230177|NCT01138657|100884455|FG001|COMPLETED|Overall Study||101||
48230178|NCT01138657|100884454|FG000|NOT COMPLETED|Overall Study||8||
48230179|NCT01138657|100884455|FG001|NOT COMPLETED|Overall Study||18||
48230180|NCT01703598|100884456|FG000|STARTED|Overall Study||69||
48230181|NCT01703598|100884456|FG000|COMPLETED|Overall Study||69||
48230182|NCT01703598|100884456|FG000|NOT COMPLETED|Overall Study||0||
48230183|NCT04588207|100884457|FG000|STARTED|Period 1||1||
48230184|NCT04588207|100884458|FG001|STARTED|Period 1||1||
48230185|NCT04588207|100884457|FG000|COMPLETED|Period 1||1||
48230186|NCT04588207|100884458|FG001|COMPLETED|Period 1||1||
48230187|NCT04588207|100884457|FG000|NOT COMPLETED|Period 1||0||
48230188|NCT04588207|100884458|FG001|NOT COMPLETED|Period 1||0||
48230189|NCT04588207|100884457|FG000|STARTED|Washout Period||1||
48230190|NCT04588207|100884458|FG001|STARTED|Washout Period||1||
48230191|NCT04588207|100884457|FG000|COMPLETED|Washout Period||1||
48230192|NCT04588207|100884458|FG001|COMPLETED|Washout Period||1||
48230193|NCT04588207|100884457|FG000|NOT COMPLETED|Washout Period||0||
48230194|NCT04588207|100884458|FG001|NOT COMPLETED|Washout Period||0||
48230195|NCT04588207|100884457|FG000|STARTED|Period 2||1||
48230196|NCT04588207|100884458|FG001|STARTED|Period 2||1||
48230197|NCT04588207|100884457|FG000|COMPLETED|Period 2||1||
48230198|NCT04588207|100884458|FG001|COMPLETED|Period 2||1||
48530865|NCT00278889|101635843|FG001|STARTED|Overall Study||74||
48530866|NCT00278889|101635844|FG002|STARTED|Overall Study||68||
48530867|NCT00278889|101635842|FG000|Overall Survival Analysis|Overall Study||16||
48530868|NCT00278889|101635843|FG001|Overall Survival Analysis|Overall Study||20||
48530869|NCT00278889|101635844|FG002|Overall Survival Analysis|Overall Study||19||
48530870|NCT00278889|101635842|FG000|COMPLETED|Overall Study||48||
48530871|NCT00278889|101635843|FG001|COMPLETED|Overall Study||47||
48530872|NCT00278889|101635844|FG002|COMPLETED|Overall Study||48||
48530873|NCT00278889|101635842|FG000|NOT COMPLETED|Overall Study||25||
48530874|NCT00278889|101635843|FG001|NOT COMPLETED|Overall Study||27||
48530875|NCT00278889|101635844|FG002|NOT COMPLETED|Overall Study||20||
48530876|NCT02032706|101635845|FG000|STARTED|Overall Study||36||
48530877|NCT02032706|101635845|FG000|COMPLETED|Overall Study||30||
48530878|NCT02032706|101635845|FG000|NOT COMPLETED|Overall Study||6||
48530879|NCT02746471|101635846|FG000|STARTED|Overall Study||1604||
48530880|NCT02746471|101635846|FG000|COMPLETED|Overall Study||442||
48530881|NCT02746471|101635846|FG000|NOT COMPLETED|Overall Study||1162||
48530882|NCT01884311|101635847|FG000|STARTED|Overall Study||38||
48230199|NCT04588207|100884457|FG000|NOT COMPLETED|Period 2||0||
48230200|NCT04588207|100884458|FG001|NOT COMPLETED|Period 2||0||
48530883|NCT01884311|101635847|FG000|COMPLETED|Overall Study||33||
48530884|NCT01884311|101635847|FG000|NOT COMPLETED|Overall Study||5||
48530885|NCT03023176|101635848|FG000|STARTED|Overall Study||20||
48530886|NCT03023176|101635848|FG000|COMPLETED|Overall Study||20||
48230201|NCT01159600|100884459|FG000|STARTED|Overall Study||207||
48530887|NCT03023176|101635848|FG000|NOT COMPLETED|Overall Study||0||
48530888|NCT00114166|101635849|FG000|STARTED|Overall Study||15||
48530889|NCT00114166|101635850|FG001|STARTED|Overall Study||66||
48530890|NCT00114166|101635849|FG000|COMPLETED|Overall Study||15||
48530891|NCT00114166|101635850|FG001|COMPLETED|Overall Study||65||
48530892|NCT00114166|101635849|FG000|NOT COMPLETED|Overall Study||0||
48230202|NCT01159600|100884460|FG001|STARTED|Overall Study||217||
48230203|NCT01159600|100884461|FG002|STARTED|Overall Study||214||
48230204|NCT01159600|100884462|FG003|STARTED|Overall Study||69||
48230205|NCT01159600|100884463|FG004|STARTED|Overall Study||225||
48230206|NCT01159600|100884464|FG005|STARTED|Overall Study||226||
48230207|NCT01159600|100884465|FG006|STARTED|Overall Study||218||
48530893|NCT00114166|101635850|FG001|NOT COMPLETED|Overall Study||1||
48530894|NCT01288053|101635851|FG000|STARTED|Overall Study||9||
48530895|NCT01288053|101635851|FG000|COMPLETED|Overall Study||8||
48530896|NCT01288053|101635851|FG000|NOT COMPLETED|Overall Study||1||
48530897|NCT02500641|101635852|FG000|STARTED|Overall Study||98||
48230208|NCT01159600|100884466|FG007|STARTED|Overall Study||103||
48230209|NCT01159600|100884459|FG000|COMPLETED|Overall Study||186||
48230210|NCT01159600|100884460|FG001|COMPLETED|Overall Study||209||
48230211|NCT01159600|100884461|FG002|COMPLETED|Overall Study||196||
48230212|NCT01159600|100884462|FG003|COMPLETED|Overall Study||58||
48230213|NCT01159600|100884463|FG004|COMPLETED|Overall Study||201||
48230214|NCT01159600|100884464|FG005|COMPLETED|Overall Study||208||
48530898|NCT02500641|101635853|FG001|STARTED|Overall Study||98||
48530899|NCT02500641|101635852|FG000|COMPLETED|Overall Study||88||
48530900|NCT02500641|101635853|FG001|COMPLETED|Overall Study||86||
48530901|NCT02500641|101635852|FG000|NOT COMPLETED|Overall Study||10||
48530902|NCT02500641|101635853|FG001|NOT COMPLETED|Overall Study||12||
48530903|NCT02130882|101635854|FG000|STARTED|Overall Study||10||
48530904|NCT02130882|101635855|FG001|STARTED|Overall Study||10||
48530905|NCT02130882|101635854|FG000|COMPLETED|Overall Study||10||
48530906|NCT02130882|101635855|FG001|COMPLETED|Overall Study||9||
48530907|NCT02130882|101635854|FG000|NOT COMPLETED|Overall Study||0||
48530908|NCT02130882|101635855|FG001|NOT COMPLETED|Overall Study||1||
48530909|NCT00688376|101635856|FG000|STARTED|Double-Blind Phase||40||
48530910|NCT00688376|101635857|FG001|STARTED|Double-Blind Phase||32||
48230215|NCT01159600|100884465|FG006|COMPLETED|Overall Study||199||
48230216|NCT01159600|100884466|FG007|COMPLETED|Overall Study||85||
48230217|NCT01159600|100884459|FG000|NOT COMPLETED|Overall Study||21||
48230218|NCT01159600|100884460|FG001|NOT COMPLETED|Overall Study||8||
48230219|NCT01159600|100884461|FG002|NOT COMPLETED|Overall Study||18||
48230220|NCT01159600|100884462|FG003|NOT COMPLETED|Overall Study||11||
48230221|NCT01159600|100884463|FG004|NOT COMPLETED|Overall Study||24||
48230222|NCT01159600|100884464|FG005|NOT COMPLETED|Overall Study||18||
48530911|NCT00688376|101635856|FG000|Safety Population|Double-Blind Phase||40||
48530912|NCT00688376|101635857|FG001|Safety Population|Double-Blind Phase||31||
48530913|NCT00688376|101635856|FG000|COMPLETED|Double-Blind Phase||34||
48530914|NCT00688376|101635857|FG001|COMPLETED|Double-Blind Phase||25||
48530915|NCT00688376|101635856|FG000|NOT COMPLETED|Double-Blind Phase||6||
48530916|NCT00688376|101635857|FG001|NOT COMPLETED|Double-Blind Phase||7||
48530917|NCT00688376|101635856|FG000|STARTED|Blinded Extension Phase||34||
48530918|NCT00688376|101635857|FG001|STARTED|Blinded Extension Phase||25||
48530919|NCT00688376|101635856|FG000|COMPLETED|Blinded Extension Phase||29||
48530920|NCT00688376|101635857|FG001|COMPLETED|Blinded Extension Phase||20||
48530921|NCT00688376|101635856|FG000|NOT COMPLETED|Blinded Extension Phase||5||
48530922|NCT00688376|101635857|FG001|NOT COMPLETED|Blinded Extension Phase||5||
48530923|NCT00673153|101635858|FG000|STARTED|Overall Study||31||
48530924|NCT00673153|101635858|FG000|COMPLETED|Overall Study||30||
48530925|NCT00673153|101635858|FG000|NOT COMPLETED|Overall Study||1||
48530926|NCT02802631|101635859|FG000|STARTED|Overall Study||8||
48530927|NCT02802631|101635860|FG001|STARTED|Overall Study||8||
48530928|NCT02802631|101635861|FG002|STARTED|Overall Study||6||
48530929|NCT02802631|101635862|FG003|STARTED|Overall Study||8||
48530930|NCT02802631|101635863|FG004|STARTED|Overall Study||8||
48530931|NCT02802631|101635864|FG005|STARTED|Overall Study||8||
48530932|NCT02802631|101635865|FG006|STARTED|Overall Study||9||
48530933|NCT02802631|101635866|FG007|STARTED|Overall Study||14||
48530934|NCT02802631|101635859|FG000|COMPLETED|Overall Study||6||
48530935|NCT02802631|101635860|FG001|COMPLETED|Overall Study||6||
48530936|NCT02802631|101635861|FG002|COMPLETED|Overall Study||0||
48530937|NCT02802631|101635862|FG003|COMPLETED|Overall Study||7||
48530938|NCT02802631|101635863|FG004|COMPLETED|Overall Study||0||
48530939|NCT02802631|101635864|FG005|COMPLETED|Overall Study||7||
48530940|NCT02802631|101635865|FG006|COMPLETED|Overall Study||4||
48530941|NCT02802631|101635866|FG007|COMPLETED|Overall Study||10||
48530942|NCT02802631|101635859|FG000|NOT COMPLETED|Overall Study||2||
48530943|NCT02802631|101635860|FG001|NOT COMPLETED|Overall Study||2||
48530944|NCT02802631|101635861|FG002|NOT COMPLETED|Overall Study||6||
48530945|NCT02802631|101635862|FG003|NOT COMPLETED|Overall Study||1||
48530946|NCT02802631|101635863|FG004|NOT COMPLETED|Overall Study||8||
48530947|NCT02802631|101635864|FG005|NOT COMPLETED|Overall Study||1||
48530948|NCT02802631|101635865|FG006|NOT COMPLETED|Overall Study||5||
48530949|NCT02802631|101635866|FG007|NOT COMPLETED|Overall Study||4||
48530950|NCT02132637|101635867|FG000|STARTED|Study Period 1||34||
48530951|NCT02132637|101635868|FG001|STARTED|Study Period 1||34||
48230223|NCT01159600|100884465|FG006|NOT COMPLETED|Overall Study||19||
48230224|NCT01159600|100884466|FG007|NOT COMPLETED|Overall Study||18||
48230225|NCT01686152|100884467|FG000|STARTED|Overall Study||252||
48230226|NCT01686152|100884468|FG001|STARTED|Overall Study||253||
48230227|NCT01686152|100884469|FG002|STARTED|Overall Study||84||
48230228|NCT01686152|100884467|FG000|COMPLETED|Overall Study||211||
48230229|NCT01686152|100884468|FG001|COMPLETED|Overall Study||218||
48230230|NCT01686152|100884469|FG002|COMPLETED|Overall Study||75||
48530952|NCT02132637|101635867|FG000|Received at Least One Dose of Study Drug|Study Period 1||34||
48530953|NCT02132637|101635868|FG001|Received at Least One Dose of Study Drug|Study Period 1||34||
48530954|NCT02132637|101635867|FG000|COMPLETED|Study Period 1||33||
48530955|NCT02132637|101635868|FG001|COMPLETED|Study Period 1||30||
48530956|NCT02132637|101635867|FG000|NOT COMPLETED|Study Period 1||1||
48530957|NCT02132637|101635868|FG001|NOT COMPLETED|Study Period 1||4||
48530958|NCT02132637|101635867|FG000|STARTED|Study Period 2 (Crossover)||33||
48530959|NCT02132637|101635868|FG001|STARTED|Study Period 2 (Crossover)||30||
48530960|NCT02132637|101635867|FG000|COMPLETED|Study Period 2 (Crossover)||31||
48530961|NCT02132637|101635868|FG001|COMPLETED|Study Period 2 (Crossover)||29||
48530962|NCT02132637|101635867|FG000|NOT COMPLETED|Study Period 2 (Crossover)||2||
48530963|NCT02132637|101635868|FG001|NOT COMPLETED|Study Period 2 (Crossover)||1||
48530964|NCT00967044|101635869|FG000|STARTED|Overall Study||30||
48530965|NCT00967044|101635869|FG000|COMPLETED|Overall Study||30||
48530966|NCT00967044|101635869|FG000|NOT COMPLETED|Overall Study||0||
48530967|NCT04972123|101635870|FG000|STARTED|Overall Study||66||
48230231|NCT01686152|100884467|FG000|NOT COMPLETED|Overall Study||41||
48230232|NCT01686152|100884468|FG001|NOT COMPLETED|Overall Study||35||
48230233|NCT01686152|100884469|FG002|NOT COMPLETED|Overall Study||9||
48230234|NCT04053699|100884470|FG000|STARTED|Full Analysis Set||56||
48230235|NCT04053699|100884470|FG000|COMPLETED|Full Analysis Set||51||
48230236|NCT04053699|100884470|FG000|NOT COMPLETED|Full Analysis Set||5||
48230237|NCT04053699|100884470|FG000|STARTED|Per Protocol Set||42||
48230238|NCT04053699|100884470|FG000|COMPLETED|Per Protocol Set||42||
48230239|NCT04053699|100884470|FG000|NOT COMPLETED|Per Protocol Set||0||
48230240|NCT02677766|100884471|FG000|STARTED|Overall Study||20||
48230241|NCT02677766|100884472|FG001|STARTED|Overall Study||20||
48230242|NCT02677766|100884471|FG000|COMPLETED|Overall Study||15||
48230243|NCT02677766|100884472|FG001|COMPLETED|Overall Study||17||
48230244|NCT02677766|100884471|FG000|NOT COMPLETED|Overall Study||5||
48230245|NCT02677766|100884472|FG001|NOT COMPLETED|Overall Study||3||
48230246|NCT03100370|100884473|FG000|STARTED|First Intervention (2 Weeks)||2||
48230247|NCT03100370|100884474|FG001|STARTED|First Intervention (2 Weeks)||1||
48230248|NCT03100370|100884475|FG002|STARTED|First Intervention (2 Weeks)||1||
48230249|NCT03100370|100884476|FG003|STARTED|First Intervention (2 Weeks)||2||
48230250|NCT03100370|100884477|FG004|STARTED|First Intervention (2 Weeks)||2||
48230251|NCT03100370|100884478|FG005|STARTED|First Intervention (2 Weeks)||1||
48230252|NCT03100370|100884473|FG000|COMPLETED|First Intervention (2 Weeks)||2||
48230253|NCT03100370|100884474|FG001|COMPLETED|First Intervention (2 Weeks)||1||
48230254|NCT03100370|100884475|FG002|COMPLETED|First Intervention (2 Weeks)||1||
48230255|NCT03100370|100884476|FG003|COMPLETED|First Intervention (2 Weeks)||1||
48230256|NCT03100370|100884477|FG004|COMPLETED|First Intervention (2 Weeks)||2||
48230257|NCT03100370|100884478|FG005|COMPLETED|First Intervention (2 Weeks)||1||
48230258|NCT03100370|100884473|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0||
48230259|NCT03100370|100884474|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0||
48230260|NCT03100370|100884475|FG002|NOT COMPLETED|First Intervention (2 Weeks)||0||
48230261|NCT03100370|100884476|FG003|NOT COMPLETED|First Intervention (2 Weeks)||1||
48230262|NCT03100370|100884477|FG004|NOT COMPLETED|First Intervention (2 Weeks)||0||
48230263|NCT03100370|100884478|FG005|NOT COMPLETED|First Intervention (2 Weeks)||0||
48230264|NCT03100370|100884473|FG000|STARTED|Washout (30 Days)||2||
48230265|NCT03100370|100884474|FG001|STARTED|Washout (30 Days)||1||
48230266|NCT03100370|100884475|FG002|STARTED|Washout (30 Days)||1||
48230267|NCT03100370|100884476|FG003|STARTED|Washout (30 Days)||1||
48230268|NCT03100370|100884477|FG004|STARTED|Washout (30 Days)||2||
48230269|NCT03100370|100884478|FG005|STARTED|Washout (30 Days)||1||
48230270|NCT03100370|100884473|FG000|COMPLETED|Washout (30 Days)||2||
48230271|NCT03100370|100884474|FG001|COMPLETED|Washout (30 Days)||1||
48230272|NCT03100370|100884475|FG002|COMPLETED|Washout (30 Days)||1||
48230273|NCT03100370|100884476|FG003|COMPLETED|Washout (30 Days)||1||
48230274|NCT03100370|100884477|FG004|COMPLETED|Washout (30 Days)||2||
48230275|NCT03100370|100884478|FG005|COMPLETED|Washout (30 Days)||1||
48230276|NCT03100370|100884473|FG000|NOT COMPLETED|Washout (30 Days)||0||
48230277|NCT03100370|100884474|FG001|NOT COMPLETED|Washout (30 Days)||0||
48230278|NCT03100370|100884475|FG002|NOT COMPLETED|Washout (30 Days)||0||
48230279|NCT03100370|100884476|FG003|NOT COMPLETED|Washout (30 Days)||0||
48230280|NCT03100370|100884477|FG004|NOT COMPLETED|Washout (30 Days)||0||
48230281|NCT03100370|100884478|FG005|NOT COMPLETED|Washout (30 Days)||0||
48230282|NCT03100370|100884473|FG000|STARTED|Second Intervention (2 Weeks)||2||
48230283|NCT03100370|100884474|FG001|STARTED|Second Intervention (2 Weeks)||1||
48230284|NCT03100370|100884475|FG002|STARTED|Second Intervention (2 Weeks)||0||
48230285|NCT03100370|100884476|FG003|STARTED|Second Intervention (2 Weeks)||1||
48230286|NCT03100370|100884477|FG004|STARTED|Second Intervention (2 Weeks)||2||
48530968|NCT04972123|101635871|FG001|STARTED|Overall Study||63||
48530969|NCT04972123|101635870|FG000|Primary Analysis Population|Overall Study||65|Primary Analysis was completed for participants where BP could be obtained at the time of near syncope (technical issues for N=2 participants where BP could not be obtained)|
48530970|NCT04972123|101635871|FG001|Primary Analysis Population|Overall Study||62|Primary Analysis was completed for participants where BP could be obtained at the time of near syncope (technical issues for N=2 participants where BP could not be obtained)|
48530971|NCT04972123|101635870|FG000|Secondary Analysis Population|Overall Study||32|Secondary analyses were limited to participants who had syncope or near syncope with systolic BP less than or equal to 70 mmHg|
48530972|NCT04972123|101635871|FG001|Secondary Analysis Population|Overall Study||27|Secondary analyses were limited to participants who had syncope or near syncope with systolic BP less than or equal to 70 mmHg|
48230287|NCT03100370|100884478|FG005|STARTED|Second Intervention (2 Weeks)||1||
48230288|NCT03100370|100884473|FG000|COMPLETED|Second Intervention (2 Weeks)||2||
48230289|NCT03100370|100884474|FG001|COMPLETED|Second Intervention (2 Weeks)||1||
48230290|NCT03100370|100884475|FG002|COMPLETED|Second Intervention (2 Weeks)||0||
48230291|NCT03100370|100884476|FG003|COMPLETED|Second Intervention (2 Weeks)||1||
48230292|NCT03100370|100884477|FG004|COMPLETED|Second Intervention (2 Weeks)||2||
48230293|NCT03100370|100884478|FG005|COMPLETED|Second Intervention (2 Weeks)||1||
48230294|NCT03100370|100884473|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48230295|NCT03100370|100884474|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48530973|NCT04972123|101635870|FG000|COMPLETED|Overall Study||66||
48530974|NCT04972123|101635871|FG001|COMPLETED|Overall Study||63||
48530975|NCT04972123|101635870|FG000|NOT COMPLETED|Overall Study||0||
48530976|NCT04972123|101635871|FG001|NOT COMPLETED|Overall Study||0||
48530977|NCT01297465|101635872|FG000|STARTED|Overall Study||99||
48530978|NCT01297465|101635873|FG001|STARTED|Overall Study||103||
48530979|NCT01297465|101635872|FG000|COMPLETED|Overall Study||91||
48230296|NCT03100370|100884475|FG002|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48230297|NCT03100370|100884476|FG003|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48230298|NCT03100370|100884477|FG004|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48230299|NCT03100370|100884478|FG005|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48230300|NCT03100370|100884473|FG000|STARTED|Washout (30 Days)||2||
48230301|NCT03100370|100884474|FG001|STARTED|Washout (30 Days)||1||
48230302|NCT03100370|100884475|FG002|STARTED|Washout (30 Days)||0||
48230303|NCT03100370|100884476|FG003|STARTED|Washout (30 Days)||1||
48230304|NCT03100370|100884477|FG004|STARTED|Washout (30 Days)||2||
48230305|NCT03100370|100884478|FG005|STARTED|Washout (30 Days)||1||
48230306|NCT03100370|100884473|FG000|COMPLETED|Washout (30 Days)||2||
48230307|NCT03100370|100884474|FG001|COMPLETED|Washout (30 Days)||1||
48230308|NCT03100370|100884475|FG002|COMPLETED|Washout (30 Days)||0||
48230309|NCT03100370|100884476|FG003|COMPLETED|Washout (30 Days)||1||
48230310|NCT03100370|100884477|FG004|COMPLETED|Washout (30 Days)||2||
48230311|NCT03100370|100884478|FG005|COMPLETED|Washout (30 Days)||1||
48230312|NCT03100370|100884473|FG000|NOT COMPLETED|Washout (30 Days)||0||
48230313|NCT03100370|100884474|FG001|NOT COMPLETED|Washout (30 Days)||0||
48230314|NCT03100370|100884475|FG002|NOT COMPLETED|Washout (30 Days)||0||
48530980|NCT01297465|101635873|FG001|COMPLETED|Overall Study||93||
48530981|NCT01297465|101635872|FG000|NOT COMPLETED|Overall Study||8||
48530982|NCT01297465|101635873|FG001|NOT COMPLETED|Overall Study||10||
48530983|NCT04616547|101635874|FG000|STARTED|Overall Study||1||
48530984|NCT04616547|101635874|FG000|COMPLETED|Overall Study||1||
48530985|NCT04616547|101635874|FG000|NOT COMPLETED|Overall Study||0||
48530986|NCT03041324|101635875|FG000|STARTED|Overall Study||2||
48530987|NCT03041324|101635876|FG001|STARTED|Overall Study||2||
48530988|NCT03041324|101635877|FG002|STARTED|Overall Study||5||
48530989|NCT03041324|101635875|FG000|COMPLETED|Overall Study||2||
48530990|NCT03041324|101635876|FG001|COMPLETED|Overall Study||2||
48530991|NCT03041324|101635877|FG002|COMPLETED|Overall Study||5||
48530992|NCT03041324|101635875|FG000|NOT COMPLETED|Overall Study||0||
48530993|NCT03041324|101635876|FG001|NOT COMPLETED|Overall Study||0||
48530994|NCT03041324|101635877|FG002|NOT COMPLETED|Overall Study||0||
48530995|NCT01780987|101635878|FG000|STARTED|Overall Study||40||
48530996|NCT01780987|101635879|FG001|STARTED|Overall Study||40||
48230315|NCT03100370|100884476|FG003|NOT COMPLETED|Washout (30 Days)||0||
48230316|NCT03100370|100884477|FG004|NOT COMPLETED|Washout (30 Days)||0||
48230317|NCT03100370|100884478|FG005|NOT COMPLETED|Washout (30 Days)||0||
48230318|NCT03100370|100884473|FG000|STARTED|Third Intervention (2 Weeks)||2||
48530997|NCT01780987|101635878|FG000|COMPLETED|Overall Study||37||
48530998|NCT01780987|101635879|FG001|COMPLETED|Overall Study||34||
48530999|NCT01780987|101635878|FG000|NOT COMPLETED|Overall Study||3||
48230319|NCT03100370|100884474|FG001|STARTED|Third Intervention (2 Weeks)||0||
48230320|NCT03100370|100884475|FG002|STARTED|Third Intervention (2 Weeks)||0||
48531000|NCT01780987|101635879|FG001|NOT COMPLETED|Overall Study||6||
48531001|NCT01715064|101635880|FG000|STARTED|Overall Study||18||
48531002|NCT01715064|101635881|FG001|STARTED|Overall Study||18||
48230321|NCT03100370|100884476|FG003|STARTED|Third Intervention (2 Weeks)||1||
48230322|NCT03100370|100884477|FG004|STARTED|Third Intervention (2 Weeks)||2||
48230323|NCT03100370|100884478|FG005|STARTED|Third Intervention (2 Weeks)||1||
48230324|NCT03100370|100884473|FG000|COMPLETED|Third Intervention (2 Weeks)||2||
48230325|NCT03100370|100884474|FG001|COMPLETED|Third Intervention (2 Weeks)||0||
48230326|NCT03100370|100884475|FG002|COMPLETED|Third Intervention (2 Weeks)||0||
48531003|NCT01715064|101635880|FG000|COMPLETED|Overall Study||18||
48531004|NCT01715064|101635881|FG001|COMPLETED|Overall Study||18||
48531005|NCT01715064|101635880|FG000|NOT COMPLETED|Overall Study||0||
48531006|NCT01715064|101635881|FG001|NOT COMPLETED|Overall Study||0||
48531007|NCT00821873|101635882|FG000|STARTED|Overall Study||9||
48531008|NCT00821873|101635882|FG000|COMPLETED|Overall Study||5||
48531009|NCT00821873|101635882|FG000|NOT COMPLETED|Overall Study||4||
48531010|NCT00673244|101635883|FG000|STARTED|Overall Study||52||
48531011|NCT00673244|101635884|FG001|STARTED|Overall Study||25||
48230327|NCT03100370|100884476|FG003|COMPLETED|Third Intervention (2 Weeks)||1||
48230328|NCT03100370|100884477|FG004|COMPLETED|Third Intervention (2 Weeks)||2||
48230329|NCT03100370|100884478|FG005|COMPLETED|Third Intervention (2 Weeks)||1||
48230330|NCT03100370|100884473|FG000|NOT COMPLETED|Third Intervention (2 Weeks)||0||
48531012|NCT00673244|101635883|FG000|COMPLETED|Overall Study||52||
48230331|NCT03100370|100884474|FG001|NOT COMPLETED|Third Intervention (2 Weeks)||0||
48531013|NCT00673244|101635884|FG001|COMPLETED|Overall Study||25||
48531014|NCT00673244|101635883|FG000|NOT COMPLETED|Overall Study||0||
48531015|NCT00673244|101635884|FG001|NOT COMPLETED|Overall Study||0||
48531016|NCT01996943|101635885|FG000|STARTED|Overall Study||50||
48531017|NCT01996943|101635886|FG001|STARTED|Overall Study||50||
48531018|NCT01996943|101635885|FG000|COMPLETED|Overall Study||50||
48531019|NCT01996943|101635886|FG001|COMPLETED|Overall Study||50||
48531020|NCT01996943|101635885|FG000|NOT COMPLETED|Overall Study||0||
48531021|NCT01996943|101635886|FG001|NOT COMPLETED|Overall Study||0||
48531022|NCT01246011|101635887|FG000|STARTED|Overall Study||0||
48531023|NCT01246011|101635888|FG001|STARTED|Overall Study||0||
48531024|NCT01246011|101635889|FG002|STARTED|Overall Study||9||
48531025|NCT01246011|101635887|FG000|COMPLETED|Overall Study||0||
48531026|NCT01246011|101635888|FG001|COMPLETED|Overall Study||0||
48531027|NCT01246011|101635889|FG002|COMPLETED|Overall Study||5||
48531028|NCT01246011|101635887|FG000|NOT COMPLETED|Overall Study||0||
48531029|NCT01246011|101635888|FG001|NOT COMPLETED|Overall Study||0||
48531030|NCT01246011|101635889|FG002|NOT COMPLETED|Overall Study||4||
48531031|NCT02910674|101635890|FG000|STARTED|Overall Study||102||
48531032|NCT02910674|101635890|FG000|COMPLETED|Overall Study||102||
48531033|NCT02910674|101635890|FG000|NOT COMPLETED|Overall Study||0||
48531034|NCT03596151|101635891|FG000|STARTED|Overall Study||295||
48531035|NCT03596151|101635891|FG000|COMPLETED|Overall Study||294||
48531036|NCT03596151|101635891|FG000|NOT COMPLETED|Overall Study||1||
48531037|NCT00121134|101635892|FG000|STARTED|Overall Study||40||
48531038|NCT00121134|101635893|FG001|STARTED|Overall Study||41||
48531039|NCT00121134|101635894|FG002|STARTED|Overall Study||41||
48531040|NCT00121134|101635895|FG003|STARTED|Overall Study||40||
48531041|NCT00121134|101635892|FG000|COMPLETED|Overall Study||24||
48531042|NCT00121134|101635893|FG001|COMPLETED|Overall Study||26||
48531043|NCT00121134|101635894|FG002|COMPLETED|Overall Study||20||
48531044|NCT00121134|101635895|FG003|COMPLETED|Overall Study||31||
48531045|NCT00121134|101635892|FG000|NOT COMPLETED|Overall Study||16||
48531046|NCT00121134|101635893|FG001|NOT COMPLETED|Overall Study||15||
48531047|NCT00121134|101635894|FG002|NOT COMPLETED|Overall Study||21||
48531048|NCT00121134|101635895|FG003|NOT COMPLETED|Overall Study||9||
48531049|NCT02585934|101635896|FG000|STARTED|Overall Study||661||
48531050|NCT02585934|101635897|FG001|STARTED|Overall Study||654||
48531051|NCT02585934|101635896|FG000|Safety Population|Overall Study||656|The Safety population included subjects who took at least 1 dose of double-blind study drug|
48531052|NCT02585934|101635897|FG001|Safety Population|Overall Study||651|The Safety population included subjects who took at least 1 dose of double-blind study drug|
48531053|NCT02585934|101635896|FG000|Intent to Treat (ITT)|Overall Study||643|Subjects took at least 1 dose of double-blind study drug and had at least 1 post-baseline assessment|
48531054|NCT02585934|101635897|FG001|Intent to Treat (ITT)|Overall Study||633|Subjects took at least 1 dose of double-blind study drug and had at least 1 post-baseline assessment|
48531055|NCT02585934|101635896|FG000|Per Protocol (PP)|Overall Study||603|Subjects in the ITT population who had no major protocol violations|
48531056|NCT02585934|101635897|FG001|Per Protocol (PP)|Overall Study||582|Subjects in the ITT population who had no major protocol violations|
48531057|NCT02585934|101635896|FG000|COMPLETED|Overall Study||592|Subjects in the ITT population who completed the study|
48531058|NCT02585934|101635897|FG001|COMPLETED|Overall Study||581|Subjects in the ITT population who completed the study|
48531059|NCT02585934|101635896|FG000|NOT COMPLETED|Overall Study||69||
48531060|NCT02585934|101635897|FG001|NOT COMPLETED|Overall Study||73||
48531061|NCT03127644|101635898|FG000|STARTED|Overall Study||34||
48531062|NCT03127644|101635899|FG001|STARTED|Overall Study||36||
48531063|NCT03127644|101635900|FG002|STARTED|Overall Study||33||
48531064|NCT03127644|101635898|FG000|COMPLETED|Overall Study||34||
48531065|NCT03127644|101635899|FG001|COMPLETED|Overall Study||36||
48531066|NCT03127644|101635900|FG002|COMPLETED|Overall Study||31||
48531067|NCT03127644|101635898|FG000|NOT COMPLETED|Overall Study||0||
48531068|NCT03127644|101635899|FG001|NOT COMPLETED|Overall Study||0||
48531069|NCT03127644|101635900|FG002|NOT COMPLETED|Overall Study||2||
48531070|NCT02518919|101635901|FG000|STARTED|Overall Study||21||
48531071|NCT02518919|101635902|FG001|STARTED|Overall Study||21||
48531072|NCT02518919|101635903|FG002|STARTED|Overall Study||21||
48531073|NCT02518919|101635901|FG000|COMPLETED|Overall Study||20||
48531074|NCT02518919|101635902|FG001|COMPLETED|Overall Study||20||
48531075|NCT02518919|101635903|FG002|COMPLETED|Overall Study||19||
48531076|NCT02518919|101635901|FG000|NOT COMPLETED|Overall Study||1||
48531077|NCT02518919|101635902|FG001|NOT COMPLETED|Overall Study||1||
48531078|NCT02518919|101635903|FG002|NOT COMPLETED|Overall Study||2||
48531079|NCT04234984|101635904|FG000|STARTED|Follow-up at 6 Weeks||61||
48531080|NCT04234984|101635904|FG000|COMPLETED|Follow-up at 6 Weeks||59||
48531081|NCT04234984|101635904|FG000|NOT COMPLETED|Follow-up at 6 Weeks||2||
48531082|NCT04234984|101635904|FG000|STARTED|Follow-up at the Second Time Point||19|All patients experiencing a successful treatment at 6 weeks were followed up at the second time point.|
48531083|NCT04234984|101635904|FG000|COMPLETED|Follow-up at the Second Time Point||17||
48531084|NCT04234984|101635904|FG000|NOT COMPLETED|Follow-up at the Second Time Point||2||
48531085|NCT01259115|101635905|FG000|STARTED|Period 1||10||
48531086|NCT01259115|101635906|FG001|STARTED|Period 1||10||
48531087|NCT01259115|101635905|FG000|COMPLETED|Period 1||7||
48531088|NCT01259115|101635906|FG001|COMPLETED|Period 1||9||
48531089|NCT01259115|101635905|FG000|NOT COMPLETED|Period 1||3||
48531090|NCT01259115|101635906|FG001|NOT COMPLETED|Period 1||1||
48531091|NCT01259115|101635905|FG000|STARTED|Period: Washout Period of 4 to 18 Days||7||
48531092|NCT01259115|101635906|FG001|STARTED|Period: Washout Period of 4 to 18 Days||9||
48531093|NCT01259115|101635905|FG000|COMPLETED|Period: Washout Period of 4 to 18 Days||7||
48531094|NCT01259115|101635906|FG001|COMPLETED|Period: Washout Period of 4 to 18 Days||9||
48230332|NCT03100370|100884475|FG002|NOT COMPLETED|Third Intervention (2 Weeks)||0||
48230333|NCT03100370|100884476|FG003|NOT COMPLETED|Third Intervention (2 Weeks)||0||
48230334|NCT03100370|100884477|FG004|NOT COMPLETED|Third Intervention (2 Weeks)||0||
48230335|NCT03100370|100884478|FG005|NOT COMPLETED|Third Intervention (2 Weeks)||0||
48230336|NCT03100370|100884473|FG000|STARTED|Washout (30 Days)||2||
48230337|NCT03100370|100884474|FG001|STARTED|Washout (30 Days)||0||
48230338|NCT03100370|100884475|FG002|STARTED|Washout (30 Days)||0||
48531095|NCT01259115|101635905|FG000|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0||
48531096|NCT01259115|101635906|FG001|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0||
48531097|NCT01259115|101635905|FG000|STARTED|Period 2||7||
48531098|NCT01259115|101635906|FG001|STARTED|Period 2||9||
48531099|NCT01259115|101635905|FG000|COMPLETED|Period 2||6||
48531100|NCT01259115|101635906|FG001|COMPLETED|Period 2||9||
48531101|NCT01259115|101635905|FG000|NOT COMPLETED|Period 2||1||
48531102|NCT01259115|101635906|FG001|NOT COMPLETED|Period 2||0||
48531103|NCT00742924|101635907|FG000|STARTED|Overall Study||6||
48531104|NCT00742924|101635908|FG001|STARTED|Overall Study||6||
48531105|NCT00742924|101635909|FG002|STARTED|Overall Study||6||
48531106|NCT00742924|101635910|FG003|STARTED|Overall Study||6||
48531107|NCT00742924|101635907|FG000|COMPLETED|Overall Study||1||
48531108|NCT00742924|101635908|FG001|COMPLETED|Overall Study||4||
48531109|NCT00742924|101635909|FG002|COMPLETED|Overall Study||2||
48531110|NCT00742924|101635910|FG003|COMPLETED|Overall Study||0||
48531111|NCT00742924|101635907|FG000|NOT COMPLETED|Overall Study||5||
48531112|NCT00742924|101635908|FG001|NOT COMPLETED|Overall Study||2||
48531113|NCT00742924|101635909|FG002|NOT COMPLETED|Overall Study||4||
48531114|NCT00742924|101635910|FG003|NOT COMPLETED|Overall Study||6||
48531115|NCT03599271|101635911|FG000|STARTED|Overall Study||70||140
48531116|NCT03599271|101635912|FG001|STARTED|Overall Study||5||10
48531117|NCT03599271|101635911|FG000|Drug-Coated Device|Overall Study||70||70
48531118|NCT03599271|101635912|FG001|Drug-Coated Device|Overall Study||5||10
48531119|NCT03599271|101635911|FG000|Control Device|Overall Study||70||70
48531120|NCT03599271|101635912|FG001|Control Device|Overall Study||0||0
48531121|NCT03599271|101635911|FG000|COMPLETED|Overall Study||70||140
48531122|NCT03599271|101635912|FG001|COMPLETED|Overall Study||5||10
48531123|NCT03599271|101635911|FG000|NOT COMPLETED|Overall Study||0||0
48531124|NCT03599271|101635912|FG001|NOT COMPLETED|Overall Study||0||0
48531125|NCT04614246|101635913|FG000|STARTED|Overall Study||44||
48531126|NCT04614246|101635914|FG001|STARTED|Overall Study||44||
48531127|NCT04614246|101635915|FG002|STARTED|Overall Study||43||
48531128|NCT04614246|101635916|FG003|STARTED|Overall Study||43||
48531129|NCT04614246|101635917|FG004|STARTED|Overall Study||41||
48531130|NCT04614246|101635913|FG000|Valid for Safety Analysis Set (SAF)|Overall Study||39||
48230339|NCT03100370|100884476|FG003|STARTED|Washout (30 Days)||1||
48230340|NCT03100370|100884477|FG004|STARTED|Washout (30 Days)||2||
48230341|NCT03100370|100884478|FG005|STARTED|Washout (30 Days)||1||
48230342|NCT03100370|100884473|FG000|COMPLETED|Washout (30 Days)||2||
48230343|NCT03100370|100884474|FG001|COMPLETED|Washout (30 Days)||0||
48230344|NCT03100370|100884475|FG002|COMPLETED|Washout (30 Days)||0||
48531131|NCT04614246|101635914|FG001|Valid for Safety Analysis Set (SAF)|Overall Study||38||
48531132|NCT04614246|101635915|FG002|Valid for Safety Analysis Set (SAF)|Overall Study||38||
48531133|NCT04614246|101635916|FG003|Valid for Safety Analysis Set (SAF)|Overall Study||37||
48531134|NCT04614246|101635917|FG004|Valid for Safety Analysis Set (SAF)|Overall Study||38||
48531135|NCT04614246|101635913|FG000|COMPLETED|Overall Study||28||
48531136|NCT04614246|101635914|FG001|COMPLETED|Overall Study||22||
48531137|NCT04614246|101635915|FG002|COMPLETED|Overall Study||22||
48531138|NCT04614246|101635916|FG003|COMPLETED|Overall Study||24||
48531139|NCT04614246|101635917|FG004|COMPLETED|Overall Study||24||
48531140|NCT04614246|101635913|FG000|NOT COMPLETED|Overall Study||16||
48531141|NCT04614246|101635914|FG001|NOT COMPLETED|Overall Study||22||
48531142|NCT04614246|101635915|FG002|NOT COMPLETED|Overall Study||21||
48531143|NCT04614246|101635916|FG003|NOT COMPLETED|Overall Study||19||
48531144|NCT04614246|101635917|FG004|NOT COMPLETED|Overall Study||17||
48531145|NCT04257552|101635918|FG000|STARTED|Overall Study||42||
48531146|NCT04257552|101635919|FG001|STARTED|Overall Study||43||
48531147|NCT04257552|101635920|FG002|STARTED|Overall Study||43||
48531148|NCT04257552|101635918|FG000|COMPLETED|Overall Study||42||
48531149|NCT04257552|101635919|FG001|COMPLETED|Overall Study||43||
48230345|NCT03100370|100884476|FG003|COMPLETED|Washout (30 Days)||1||
48230346|NCT03100370|100884477|FG004|COMPLETED|Washout (30 Days)||2||
48531150|NCT04257552|101635920|FG002|COMPLETED|Overall Study||43||
48531151|NCT04257552|101635918|FG000|NOT COMPLETED|Overall Study||0||
48531152|NCT04257552|101635919|FG001|NOT COMPLETED|Overall Study||0||
48531153|NCT04257552|101635920|FG002|NOT COMPLETED|Overall Study||0||
48531154|NCT02440022|101635921|FG000|STARTED|Overall Study||141||
48531155|NCT02440022|101635922|FG001|STARTED|Overall Study||144||
48531156|NCT02440022|101635921|FG000|COMPLETED|Overall Study||114||
48531157|NCT02440022|101635922|FG001|COMPLETED|Overall Study||131||
48531158|NCT02440022|101635921|FG000|NOT COMPLETED|Overall Study||27||
48230347|NCT03100370|100884478|FG005|COMPLETED|Washout (30 Days)||1||
48531159|NCT02440022|101635922|FG001|NOT COMPLETED|Overall Study||13||
48531160|NCT03837743|101635923|FG000|STARTED|Overall Study||25||50
48531161|NCT03837743|101635923|FG000|DUR-928 Topical Solution Lesion|Overall Study||25||25
48230348|NCT03100370|100884473|FG000|NOT COMPLETED|Washout (30 Days)||0||
48230349|NCT03100370|100884474|FG001|NOT COMPLETED|Washout (30 Days)||0||
48531162|NCT03837743|101635923|FG000|Vehicle Topical Solution Lesion|Overall Study||25||25
48531163|NCT03837743|101635923|FG000|COMPLETED|Overall Study||22||44
48531164|NCT03837743|101635923|FG000|NOT COMPLETED|Overall Study||3||6
48531165|NCT02130583|101635924|FG000|STARTED|Overall Study||26||
48531166|NCT02130583|101635925|FG001|STARTED|Overall Study||26||
48531167|NCT02130583|101635924|FG000|COMPLETED|Overall Study||17||
48531168|NCT02130583|101635925|FG001|COMPLETED|Overall Study||19||
48531169|NCT02130583|101635924|FG000|NOT COMPLETED|Overall Study||9||
48531170|NCT02130583|101635925|FG001|NOT COMPLETED|Overall Study||7||
48531171|NCT02493777|101635926|FG000|STARTED|Overall Study||65|Randomized safety population|
48531172|NCT02493777|101635927|FG001|STARTED|Overall Study||54|Randomized safety population|
48531173|NCT02493777|101635926|FG000|COMPLETED|Overall Study||65|Population completing 1-week randomized treatment|
48531174|NCT02493777|101635927|FG001|COMPLETED|Overall Study||53|Population completing 1-week randomized treatment|
48531175|NCT02493777|101635926|FG000|NOT COMPLETED|Overall Study||0||
48531176|NCT02493777|101635927|FG001|NOT COMPLETED|Overall Study||1||
48230350|NCT03100370|100884475|FG002|NOT COMPLETED|Washout (30 Days)||0||
48230351|NCT03100370|100884476|FG003|NOT COMPLETED|Washout (30 Days)||0||
48230352|NCT03100370|100884477|FG004|NOT COMPLETED|Washout (30 Days)||0||
48230353|NCT03100370|100884478|FG005|NOT COMPLETED|Washout (30 Days)||0||
48230354|NCT00748982|100884479|FG000|STARTED|Overall Study||12||
48230355|NCT00748982|100884480|FG001|STARTED|Overall Study||4||
48230356|NCT00748982|100884479|FG000|COMPLETED|Overall Study||12||
48230357|NCT00748982|100884480|FG001|COMPLETED|Overall Study||4||
48230358|NCT00748982|100884479|FG000|NOT COMPLETED|Overall Study||0||
48230359|NCT00748982|100884480|FG001|NOT COMPLETED|Overall Study||0||
48230360|NCT03652610|100884481|FG000|STARTED|Overall Study||490||
48230361|NCT03652610|100884482|FG001|STARTED|Overall Study||489||
48230362|NCT03652610|100884481|FG000|COMPLETED|Overall Study||486||
48230363|NCT03652610|100884482|FG001|COMPLETED|Overall Study||484||
48230364|NCT03652610|100884481|FG000|NOT COMPLETED|Overall Study||4||
48230365|NCT03652610|100884482|FG001|NOT COMPLETED|Overall Study||5||
48230366|NCT02095678|100884483|FG000|STARTED|Overall Study||34||
48230367|NCT02095678|100884484|FG001|STARTED|Overall Study||18||
48230368|NCT02095678|100884483|FG000|COMPLETED|Overall Study||17||
48531177|NCT00540293|101635928|FG000|STARTED|Overall Study||425||
48531178|NCT00540293|101635928|FG000|COMPLETED|Overall Study||390||
48531179|NCT00540293|101635928|FG000|NOT COMPLETED|Overall Study||35||
48531180|NCT00324649|101635929|FG000|STARTED|Overall Study||39||
48080768|NCT00381485|100518849|FG002|COMPLETED|Open-Label Run-In Period||0||
48080769|NCT00381485|100518850|FG003|COMPLETED|Open-Label Run-In Period||0||
48080770|NCT00381485|100518847|FG000|NOT COMPLETED|Open-Label Run-In Period||106||
48080771|NCT00381485|100518848|FG001|NOT COMPLETED|Open-Label Run-In Period||0||
48080772|NCT00381485|100518849|FG002|NOT COMPLETED|Open-Label Run-In Period||0||
48080773|NCT00381485|100518850|FG003|NOT COMPLETED|Open-Label Run-In Period||0||
48080774|NCT00381485|100518847|FG000|STARTED|Double-Blind Treatment Period||0||
48080775|NCT00381485|100518848|FG001|STARTED|Double-Blind Treatment Period||255||
48080776|NCT00381485|100518849|FG002|STARTED|Double-Blind Treatment Period||233||
48080777|NCT00381485|100518850|FG003|STARTED|Double-Blind Treatment Period||240||
48080778|NCT00381485|100518847|FG000|COMPLETED|Double-Blind Treatment Period||0||
48080779|NCT00381485|100518848|FG001|COMPLETED|Double-Blind Treatment Period||228||
48080780|NCT00381485|100518849|FG002|COMPLETED|Double-Blind Treatment Period||208||
48080781|NCT00381485|100518850|FG003|COMPLETED|Double-Blind Treatment Period||207||
48080782|NCT00381485|100518847|FG000|NOT COMPLETED|Double-Blind Treatment Period||0||
48080783|NCT00381485|100518848|FG001|NOT COMPLETED|Double-Blind Treatment Period||27||
48080784|NCT00381485|100518849|FG002|NOT COMPLETED|Double-Blind Treatment Period||25||
48080785|NCT00381485|100518850|FG003|NOT COMPLETED|Double-Blind Treatment Period||33||
48080786|NCT00790985|100518851|FG000|STARTED|Overall Study||108||
48080787|NCT00790985|100518852|FG001|STARTED|Overall Study||115||
48080788|NCT00790985|100518851|FG000|COMPLETED|Overall Study||106||
48080789|NCT00790985|100518852|FG001|COMPLETED|Overall Study||114||
48080790|NCT00790985|100518851|FG000|NOT COMPLETED|Overall Study||2||
48080791|NCT00790985|100518852|FG001|NOT COMPLETED|Overall Study||1||
48080792|NCT01317160|100518853|FG000|STARTED|Overall Study||75||
48080793|NCT01317160|100518854|FG001|STARTED|Overall Study||75||
48080794|NCT01317160|100518853|FG000|Allocation to Treatment|Overall Study||74||
48080795|NCT01317160|100518854|FG001|Allocation to Treatment|Overall Study||74||
48080796|NCT01317160|100518853|FG000|COMPLETED|Overall Study||71||
48080797|NCT01317160|100518854|FG001|COMPLETED|Overall Study||69||
48080798|NCT01317160|100518853|FG000|NOT COMPLETED|Overall Study||4||
48080799|NCT01317160|100518854|FG001|NOT COMPLETED|Overall Study||6||
48080800|NCT01835587|100518855|FG000|STARTED|Overall Study||3|Participants who received study treatment.|
48230369|NCT02095678|100884484|FG001|COMPLETED|Overall Study||0||
48230370|NCT02095678|100884483|FG000|NOT COMPLETED|Overall Study||17||
48230371|NCT02095678|100884484|FG001|NOT COMPLETED|Overall Study||18||
48230372|NCT00310037|100884485|FG000|STARTED|Overall Study||52||
48230373|NCT00310037|100884486|FG001|STARTED|Overall Study||50||
48230374|NCT00310037|100884485|FG000|COMPLETED|Overall Study||34||
48230375|NCT00310037|100884486|FG001|COMPLETED|Overall Study||33||
48230376|NCT00310037|100884485|FG000|NOT COMPLETED|Overall Study||18||
48230377|NCT00310037|100884486|FG001|NOT COMPLETED|Overall Study||17||
48230378|NCT00878189|100884487|FG000|STARTED|Overall Study||3||
48230379|NCT00878189|100884488|FG001|STARTED|Overall Study||3||
48230380|NCT00878189|100884489|FG002|STARTED|Overall Study||4||
48230381|NCT00878189|100884490|FG003|STARTED|Overall Study||8||
48230382|NCT00878189|100884491|FG004|STARTED|Overall Study||4||
48230383|NCT00878189|100884492|FG005|STARTED|Overall Study||23||
48230384|NCT00878189|100884493|FG006|STARTED|Overall Study||16||
48230385|NCT00878189|100884494|FG007|STARTED|Overall Study||3||
48230386|NCT00878189|100884495|FG008|STARTED|Overall Study||8||
48230387|NCT00878189|100884487|FG000|COMPLETED|Overall Study||0||
48230388|NCT00878189|100884488|FG001|COMPLETED|Overall Study||0||
48230389|NCT00878189|100884489|FG002|COMPLETED|Overall Study||0||
48230390|NCT00878189|100884490|FG003|COMPLETED|Overall Study||0||
48230391|NCT00878189|100884491|FG004|COMPLETED|Overall Study||0||
48230392|NCT00878189|100884492|FG005|COMPLETED|Overall Study||0||
48230393|NCT00878189|100884493|FG006|COMPLETED|Overall Study||0||
48230394|NCT00878189|100884494|FG007|COMPLETED|Overall Study||0||
48230395|NCT00878189|100884495|FG008|COMPLETED|Overall Study||0||
48230396|NCT00878189|100884487|FG000|NOT COMPLETED|Overall Study||3||
48230397|NCT00878189|100884488|FG001|NOT COMPLETED|Overall Study||3||
48230398|NCT00878189|100884489|FG002|NOT COMPLETED|Overall Study||4||
48531181|NCT00324649|101635930|FG001|STARTED|Overall Study||41||
48531182|NCT00324649|101635929|FG000|COMPLETED|Overall Study||37||
48531183|NCT00324649|101635930|FG001|COMPLETED|Overall Study||36||
48531184|NCT00324649|101635929|FG000|NOT COMPLETED|Overall Study||2||
48531185|NCT00324649|101635930|FG001|NOT COMPLETED|Overall Study||5||
48531186|NCT02257541|101635931|FG000|STARTED|Overall Study||3||
48531187|NCT02257541|101635932|FG001|STARTED|Overall Study||8||
48531188|NCT02257541|101635933|FG002|STARTED|Overall Study||1||
48531189|NCT02257541|101635934|FG003|STARTED|Overall Study||3||
48531190|NCT02257541|101635935|FG004|STARTED|Overall Study||1||
48531191|NCT02257541|101635931|FG000|COMPLETED|Overall Study||3||
48531192|NCT02257541|101635932|FG001|COMPLETED|Overall Study||8||
48531193|NCT02257541|101635933|FG002|COMPLETED|Overall Study||1||
48531194|NCT02257541|101635934|FG003|COMPLETED|Overall Study||3||
48531195|NCT02257541|101635935|FG004|COMPLETED|Overall Study||1||
48531196|NCT02257541|101635931|FG000|NOT COMPLETED|Overall Study||0||
48531197|NCT02257541|101635932|FG001|NOT COMPLETED|Overall Study||0||
48531198|NCT02257541|101635933|FG002|NOT COMPLETED|Overall Study||0||
48531199|NCT02257541|101635934|FG003|NOT COMPLETED|Overall Study||0||
48531200|NCT02257541|101635935|FG004|NOT COMPLETED|Overall Study||0||
48531201|NCT00117325|101635936|FG000|STARTED|Overall Study||173||
48531202|NCT00117325|101635937|FG001|STARTED|Overall Study||179||
48531203|NCT00117325|101635936|FG000|COMPLETED|Overall Study||160||
48230399|NCT00878189|100884490|FG003|NOT COMPLETED|Overall Study||8||
48230400|NCT00878189|100884491|FG004|NOT COMPLETED|Overall Study||4||
48230401|NCT00878189|100884492|FG005|NOT COMPLETED|Overall Study||23||
48230402|NCT00878189|100884493|FG006|NOT COMPLETED|Overall Study||16||
48230403|NCT00878189|100884494|FG007|NOT COMPLETED|Overall Study||3||
48230404|NCT00878189|100884495|FG008|NOT COMPLETED|Overall Study||8||
48230405|NCT03820024|100884496|FG000|STARTED|Overall Study||19||
48230406|NCT03820024|100884497|FG001|STARTED|Overall Study||20||
48230407|NCT03820024|100884496|FG000|COMPLETED|Overall Study||18||
48230408|NCT03820024|100884497|FG001|COMPLETED|Overall Study||18||
48230409|NCT03820024|100884496|FG000|NOT COMPLETED|Overall Study||1||
48531204|NCT00117325|101635937|FG001|COMPLETED|Overall Study||167||
48531205|NCT00117325|101635936|FG000|NOT COMPLETED|Overall Study||13||
48531206|NCT00117325|101635937|FG001|NOT COMPLETED|Overall Study||12||
48531207|NCT01197755|101635938|FG000|STARTED|Overall Study||105||
48531208|NCT01197755|101635939|FG001|STARTED|Overall Study||108||
48230410|NCT03820024|100884497|FG001|NOT COMPLETED|Overall Study||2||
48230411|NCT00068107|100884498|FG000|STARTED|Overall Study||12||
48230412|NCT00068107|100884498|FG000|COMPLETED|Overall Study||3||
48230413|NCT00068107|100884498|FG000|NOT COMPLETED|Overall Study||9||
48230414|NCT01852045|100884499|FG000|STARTED|Overall Study||39||
48531209|NCT01197755|101635940|FG002|STARTED|Overall Study||109||
48531210|NCT01197755|101635938|FG000|Randomised But Did Not Receive Treatment|Overall Study||0||
48230415|NCT01852045|100884500|FG001|STARTED|Overall Study||45||
48230416|NCT01852045|100884501|FG002|STARTED|Overall Study||30||
48230417|NCT01852045|100884499|FG000|mITT Population|Overall Study||38||
48230418|NCT01852045|100884500|FG001|mITT Population|Overall Study||45||
48230419|NCT01852045|100884501|FG002|mITT Population|Overall Study||30||
48230420|NCT01852045|100884499|FG000|Safety Population|Overall Study||38||
48531211|NCT01197755|101635939|FG001|Randomised But Did Not Receive Treatment|Overall Study||0||
48531212|NCT01197755|101635940|FG002|Randomised But Did Not Receive Treatment|Overall Study||1||
48531213|NCT01197755|101635938|FG000|COMPLETED|Overall Study||67||
48230421|NCT01852045|100884500|FG001|Safety Population|Overall Study||45||
48230422|NCT01852045|100884501|FG002|Safety Population|Overall Study||30||
48230423|NCT01852045|100884499|FG000|COMPLETED|Overall Study||33||
48230424|NCT01852045|100884500|FG001|COMPLETED|Overall Study||41||
48230425|NCT01852045|100884501|FG002|COMPLETED|Overall Study||26||
48230426|NCT01852045|100884499|FG000|NOT COMPLETED|Overall Study||6||
48230427|NCT01852045|100884500|FG001|NOT COMPLETED|Overall Study||4||
48230428|NCT01852045|100884501|FG002|NOT COMPLETED|Overall Study||4||
48230429|NCT00853593|100884502|FG000|STARTED|Overall Study||197||
48230430|NCT00853593|100884502|FG000|Implant Attempted|Overall Study||193||
48230431|NCT00853593|100884502|FG000|Model 4396 Lead Attempted|Overall Study||164||
48230432|NCT00853593|100884502|FG000|COMPLETED|Overall Study||152||
48230433|NCT00853593|100884502|FG000|NOT COMPLETED|Overall Study||45||
48230434|NCT00645411|100884503|FG000|STARTED|Overall Study||656||
48230435|NCT00645411|100884504|FG001|STARTED|Overall Study||318||
48230436|NCT00645411|100884505|FG002|STARTED|Overall Study||1608||
48230437|NCT00645411|100884506|FG003|STARTED|Overall Study||1022||
48230438|NCT00645411|100884503|FG000|COMPLETED|Overall Study||643||
48230439|NCT00645411|100884504|FG001|COMPLETED|Overall Study||312||
48230440|NCT00645411|100884505|FG002|COMPLETED|Overall Study||1457||
48230441|NCT00645411|100884506|FG003|COMPLETED|Overall Study||919||
48230442|NCT00645411|100884503|FG000|NOT COMPLETED|Overall Study||13||
48230443|NCT00645411|100884504|FG001|NOT COMPLETED|Overall Study||6||
48230444|NCT00645411|100884505|FG002|NOT COMPLETED|Overall Study||151||
48230445|NCT00645411|100884506|FG003|NOT COMPLETED|Overall Study||103||
48230446|NCT01439854|100884507|FG000|STARTED|Overall Study||8||
48230447|NCT01439854|100884508|FG001|STARTED|Overall Study||10||
48230448|NCT01439854|100884507|FG000|COMPLETED|Overall Study||8||
48230449|NCT01439854|100884508|FG001|COMPLETED|Overall Study||10||
48230450|NCT01439854|100884507|FG000|NOT COMPLETED|Overall Study||0||
48230451|NCT01439854|100884508|FG001|NOT COMPLETED|Overall Study||0||
48230452|NCT05919732|100884509|FG000|STARTED|Overall Study||11||
48230453|NCT05919732|100884510|FG001|STARTED|Overall Study||9||
48230454|NCT05919732|100884509|FG000|COMPLETED|Overall Study||11||
48230455|NCT05919732|100884510|FG001|COMPLETED|Overall Study||9||
48230456|NCT05919732|100884509|FG000|NOT COMPLETED|Overall Study||0||
48230457|NCT05919732|100884510|FG001|NOT COMPLETED|Overall Study||0||
48230458|NCT03163472|100884511|FG000|STARTED|Overall Study||15||
48230459|NCT03163472|100884512|FG001|STARTED|Overall Study||15||
48230460|NCT03163472|100884511|FG000|COMPLETED|Overall Study||15||
48230461|NCT03163472|100884512|FG001|COMPLETED|Overall Study||15||
48230462|NCT03163472|100884511|FG000|NOT COMPLETED|Overall Study||0||
48230463|NCT03163472|100884512|FG001|NOT COMPLETED|Overall Study||0||
48230464|NCT01005615|100884513|FG000|STARTED|Intervention 1||5||
48230465|NCT01005615|100884514|FG001|STARTED|Intervention 1||12||
48230466|NCT01005615|100884513|FG000|COMPLETED|Intervention 1||1||
48230467|NCT01005615|100884514|FG001|COMPLETED|Intervention 1||9||
48230468|NCT01005615|100884513|FG000|NOT COMPLETED|Intervention 1||4||
48230469|NCT01005615|100884514|FG001|NOT COMPLETED|Intervention 1||3||
48230470|NCT01005615|100884513|FG000|STARTED|Washout ()||1||
48230471|NCT01005615|100884514|FG001|STARTED|Washout ()||9||
48230472|NCT01005615|100884513|FG000|COMPLETED|Washout ()||1||
48230473|NCT01005615|100884514|FG001|COMPLETED|Washout ()||9||
48230474|NCT01005615|100884513|FG000|NOT COMPLETED|Washout ()||0||
48230475|NCT01005615|100884514|FG001|NOT COMPLETED|Washout ()||0||
48230476|NCT01005615|100884513|FG000|STARTED|Intervention 2||1||
48230477|NCT01005615|100884514|FG001|STARTED|Intervention 2||9||
48230478|NCT01005615|100884513|FG000|COMPLETED|Intervention 2||1||
48230479|NCT01005615|100884514|FG001|COMPLETED|Intervention 2||9||
48230480|NCT01005615|100884513|FG000|NOT COMPLETED|Intervention 2||0||
48230481|NCT01005615|100884514|FG001|NOT COMPLETED|Intervention 2||0||
48230482|NCT03675321|100884515|FG000|STARTED|Overall Study||54||
48230483|NCT03675321|100884516|FG001|STARTED|Overall Study||54||
48230484|NCT03675321|100884515|FG000|COMPLETED|Overall Study||51||
48230485|NCT03675321|100884516|FG001|COMPLETED|Overall Study||49||
48230486|NCT03675321|100884515|FG000|NOT COMPLETED|Overall Study||3||
48080801|NCT01835587|100518856|FG001|STARTED|Overall Study||4|Participants who received study treatment.|
48141202|NCT03581305|100670361|FG001|NOT COMPLETED|Serotonergic Study||1||
48230487|NCT03675321|100884516|FG001|NOT COMPLETED|Overall Study||5||
48230488|NCT01560429|100884517|FG000|STARTED|Overall Study||26||
48230489|NCT01560429|100884518|FG001|STARTED|Overall Study||26||
48230490|NCT01560429|100884517|FG000|COMPLETED|Overall Study||23||
48230491|NCT01560429|100884518|FG001|COMPLETED|Overall Study||20||
48230492|NCT01560429|100884517|FG000|NOT COMPLETED|Overall Study||3||
48230493|NCT01560429|100884518|FG001|NOT COMPLETED|Overall Study||6||
48230494|NCT01567852|100884519|FG000|STARTED|Overall Study||8||
48531214|NCT01197755|101635939|FG001|COMPLETED|Overall Study||65||
48531215|NCT01197755|101635940|FG002|COMPLETED|Overall Study||55||
48531216|NCT01197755|101635938|FG000|NOT COMPLETED|Overall Study||38||
48230495|NCT01567852|100884520|FG001|STARTED|Overall Study||12||
48230496|NCT01567852|100884519|FG000|COMPLETED|Overall Study||4||
48230497|NCT01567852|100884520|FG001|COMPLETED|Overall Study||5||
48230498|NCT01567852|100884519|FG000|NOT COMPLETED|Overall Study||4||
48230499|NCT01567852|100884520|FG001|NOT COMPLETED|Overall Study||7||
48230500|NCT02232737|100884521|FG000|STARTED|Overall Study||254||
48531217|NCT01197755|101635939|FG001|NOT COMPLETED|Overall Study||43||
48531218|NCT01197755|101635940|FG002|NOT COMPLETED|Overall Study||54||
48531219|NCT02317614|101635941|FG000|STARTED|Overall Study||26||
48531220|NCT02317614|101635942|FG001|STARTED|Overall Study||25||
48531221|NCT02317614|101635941|FG000|COMPLETED|Overall Study||23|1 non-complete lost to follow-up prior to accessing intervention (immediately after enrollment)|
48531222|NCT02317614|101635942|FG001|COMPLETED|Overall Study||23|1 non-complete lost to follow-up prior to accessing intervention (immediately after enrollment)|
48230501|NCT02232737|100884522|FG001|STARTED|Overall Study||235||
48230502|NCT02232737|100884523|FG002|STARTED|Overall Study||286||
48230503|NCT02232737|100884521|FG000|COMPLETED|Overall Study||218||
48230504|NCT02232737|100884522|FG001|COMPLETED|Overall Study||190||
48230505|NCT02232737|100884523|FG002|COMPLETED|Overall Study||224||
48230506|NCT02232737|100884521|FG000|NOT COMPLETED|Overall Study||36||
48230507|NCT02232737|100884522|FG001|NOT COMPLETED|Overall Study||45||
48230508|NCT02232737|100884523|FG002|NOT COMPLETED|Overall Study||62||
48230509|NCT01597856|100884524|FG000|STARTED|Overall Study||85||
48230510|NCT01597856|100884525|FG001|STARTED|Overall Study||87||
48230511|NCT01597856|100884526|FG002|STARTED|Overall Study||174||
48230512|NCT01597856|100884524|FG000|Week 4 Follow-up|Overall Study||62||
48230513|NCT01597856|100884525|FG001|Week 4 Follow-up|Overall Study||67||
48230514|NCT01597856|100884526|FG002|Week 4 Follow-up|Overall Study||129||
48230515|NCT01597856|100884524|FG000|COMPLETED|Overall Study||63||
48230516|NCT01597856|100884525|FG001|COMPLETED|Overall Study||61||
48230517|NCT01597856|100884526|FG002|COMPLETED|Overall Study||120||
48230518|NCT01597856|100884524|FG000|NOT COMPLETED|Overall Study||22||
48230519|NCT01597856|100884525|FG001|NOT COMPLETED|Overall Study||26||
48230520|NCT01597856|100884526|FG002|NOT COMPLETED|Overall Study||54||
48230521|NCT01218594|100884527|FG000|STARTED|Overall Study||48||
48230522|NCT01218594|100884527|FG000|COMPLETED|Overall Study||36||
48230523|NCT01218594|100884527|FG000|NOT COMPLETED|Overall Study||12||
48230524|NCT03849937|100884528|FG000|STARTED|Overall Study||147||
48230525|NCT03849937|100884529|FG001|STARTED|Overall Study||72||
48230526|NCT03849937|100884528|FG000|COMPLETED|Overall Study||94||
48230527|NCT03849937|100884529|FG001|COMPLETED|Overall Study||35||
48230528|NCT03849937|100884528|FG000|NOT COMPLETED|Overall Study||53||
48531223|NCT02317614|101635941|FG000|NOT COMPLETED|Overall Study||3||
48230529|NCT03849937|100884529|FG001|NOT COMPLETED|Overall Study||37||
48230530|NCT00428714|100884530|FG000|STARTED|Overall Study||31||
48230531|NCT00428714|100884531|FG001|STARTED|Overall Study||42||
48230532|NCT00428714|100884530|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31||
48230533|NCT00428714|100884531|FG001|Received at Least 1 Dose of Study Drug|Overall Study||42||
48230534|NCT00428714|100884530|FG000|COMPLETED|Overall Study||0||
48230535|NCT00428714|100884531|FG001|COMPLETED|Overall Study||0||
48080802|NCT01835587|100518857|FG002|STARTED|Overall Study||4|Participants who received study treatment.|
48080803|NCT01835587|100518858|FG003|STARTED|Overall Study||19|Participants who received study treatment.|
48080804|NCT01835587|100518855|FG000|COMPLETED|Overall Study||1|Completed entire study treatment|
48080805|NCT01835587|100518856|FG001|COMPLETED|Overall Study||0|Completed entire study treatment|
48080806|NCT01835587|100518857|FG002|COMPLETED|Overall Study||2|Completed entire study treatment|
48080807|NCT01835587|100518858|FG003|COMPLETED|Overall Study||10|Completed entire study treatment|
48080808|NCT01835587|100518855|FG000|NOT COMPLETED|Overall Study||2||
48080809|NCT01835587|100518856|FG001|NOT COMPLETED|Overall Study||4||
48230536|NCT00428714|100884530|FG000|NOT COMPLETED|Overall Study||31||
48230537|NCT00428714|100884531|FG001|NOT COMPLETED|Overall Study||42||
48230538|NCT03909100|100884532|FG000|STARTED|Overall Study||120||
48230539|NCT03909100|100884532|FG000|Safety Population|Overall Study||112|All participants who had at least 1 of the treatment procedures conducted.|
48230540|NCT03909100|100884532|FG000|Received Treatment in Session 2|Overall Study||107||
48230541|NCT03909100|100884532|FG000|Evaluable Population|Overall Study||106|Evaluable Population included all participants who signed the informed consent form (ICF), had at least 1 of the procedures conducted, and also reported the Cryolipolysis Satisfaction Questionnaire (CSQ) Item 1 at 12 weeks after the final treatment (measured at Week 12 for participants who received 1 treatment session and at Week 20 for participants who received 2 treatment sessions).|
48080810|NCT01835587|100518857|FG002|NOT COMPLETED|Overall Study||2||
48230542|NCT03909100|100884532|FG000|COMPLETED|Overall Study||105||
48230543|NCT03909100|100884532|FG000|NOT COMPLETED|Overall Study||15||
48230544|NCT03122548|100884533|FG000|STARTED|Overall Study||5||
48230545|NCT03122548|100884533|FG000|COMPLETED|Overall Study||0||
48230546|NCT03122548|100884533|FG000|NOT COMPLETED|Overall Study||5||
48230547|NCT02367794|100884534|FG000|STARTED|Overall Study||340||
48230548|NCT02367794|100884535|FG001|STARTED|Overall Study||343||
48230549|NCT02367794|100884536|FG002|STARTED|Overall Study||338||
48531224|NCT02317614|101635942|FG001|NOT COMPLETED|Overall Study||2||
48230550|NCT02367794|100884534|FG000|COMPLETED|Overall Study||0||
48230551|NCT02367794|100884535|FG001|COMPLETED|Overall Study||0||
48230552|NCT02367794|100884536|FG002|COMPLETED|Overall Study||0||
48230553|NCT02367794|100884534|FG000|NOT COMPLETED|Overall Study||340||
48230554|NCT02367794|100884535|FG001|NOT COMPLETED|Overall Study||343||
48230555|NCT02367794|100884536|FG002|NOT COMPLETED|Overall Study||338||
48230556|NCT00655499|100884537|FG000|STARTED|Overall Study||69||
48230557|NCT00655499|100884537|FG000|COMPLETED|Overall Study||65||
48230558|NCT00655499|100884537|FG000|NOT COMPLETED|Overall Study||4||
48230559|NCT02309294|100884538|FG000|STARTED|Overall Study||43||
48230560|NCT02309294|100884538|FG000|COMPLETED|Overall Study||41||
48230561|NCT02309294|100884538|FG000|NOT COMPLETED|Overall Study||2||
48230562|NCT03055988|100884539|FG000|STARTED|Period 1||38||
48230563|NCT03055988|100884540|FG001|STARTED|Period 1||38||
48230564|NCT03055988|100884539|FG000|COMPLETED|Period 1||37||
48230565|NCT03055988|100884540|FG001|COMPLETED|Period 1||33||
48230566|NCT03055988|100884539|FG000|NOT COMPLETED|Period 1||1||
48230567|NCT03055988|100884540|FG001|NOT COMPLETED|Period 1||5||
48230568|NCT03055988|100884539|FG000|STARTED|Period 2||37||
48230569|NCT03055988|100884540|FG001|STARTED|Period 2||33||
48230570|NCT03055988|100884539|FG000|COMPLETED|Period 2||36||
48230571|NCT03055988|100884540|FG001|COMPLETED|Period 2||31||
48230572|NCT03055988|100884539|FG000|NOT COMPLETED|Period 2||1||
48230573|NCT03055988|100884540|FG001|NOT COMPLETED|Period 2||2||
48230574|NCT00424502|100887308|FG000|STARTED|Overall Study||20||
48230575|NCT00424502|100887308|FG000|COMPLETED|Overall Study||20||
48230576|NCT00424502|100887308|FG000|NOT COMPLETED|Overall Study||0||
48230577|NCT02236611|100887309|FG000|STARTED|Overall Study||516||
48230578|NCT02236611|100887310|FG001|STARTED|Overall Study||518||
48230579|NCT02236611|100887309|FG000|COMPLETED|Overall Study||490||
48230580|NCT02236611|100887310|FG001|COMPLETED|Overall Study||484||
48230581|NCT02236611|100887309|FG000|NOT COMPLETED|Overall Study||26||
48230582|NCT02236611|100887310|FG001|NOT COMPLETED|Overall Study||34||
48230583|NCT02332889|100887311|FG000|STARTED|Overall Study||1||
48230584|NCT02332889|100887311|FG000|COMPLETED|Overall Study||0||
48230585|NCT02332889|100887311|FG000|NOT COMPLETED|Overall Study||1||
48230586|NCT01286311|100887312|FG000|STARTED|Overall Study||232||
48230587|NCT01286311|100887313|FG001|STARTED|Overall Study||232||
48230588|NCT01286311|100887312|FG000|COMPLETED|Overall Study||218||
48230589|NCT01286311|100887313|FG001|COMPLETED|Overall Study||232||
48230590|NCT01286311|100887312|FG000|NOT COMPLETED|Overall Study||14||
48230591|NCT01286311|100887313|FG001|NOT COMPLETED|Overall Study||0||
48230592|NCT00799409|100887314|FG000|STARTED|Overall Study||7||
48230593|NCT00799409|100887315|FG001|STARTED|Overall Study||36||
48230594|NCT00799409|100887316|FG002|STARTED|Overall Study||35||
48230595|NCT00799409|100887314|FG000|COMPLETED|Overall Study||0||
48230596|NCT00799409|100887315|FG001|COMPLETED|Overall Study||36||
48230597|NCT00799409|100887316|FG002|COMPLETED|Overall Study||35||
48230598|NCT00799409|100887314|FG000|NOT COMPLETED|Overall Study||7||
48230599|NCT00799409|100887315|FG001|NOT COMPLETED|Overall Study||0||
48230600|NCT00799409|100887316|FG002|NOT COMPLETED|Overall Study||0||
48230601|NCT00491400|100887317|FG000|STARTED|Overall Study||15||
48230602|NCT00491400|100887318|FG001|STARTED|Overall Study||13||
48230603|NCT00491400|100887317|FG000|Started First Treatment|Overall Study||14||
48230604|NCT00491400|100887318|FG001|Started First Treatment|Overall Study||13||
48230605|NCT00491400|100887317|FG000|Completed First Treatment|Overall Study||14||
48230606|NCT00491400|100887318|FG001|Completed First Treatment|Overall Study||9||
48230607|NCT00491400|100887317|FG000|Started Second Treatment|Overall Study||12||
48230608|NCT00491400|100887318|FG001|Started Second Treatment|Overall Study||9||
48230609|NCT00491400|100887317|FG000|Finished Second Treatment|Overall Study||10||
48230610|NCT00491400|100887318|FG001|Finished Second Treatment|Overall Study||9||
48230611|NCT00491400|100887317|FG000|COMPLETED|Overall Study||10||
48230612|NCT00491400|100887318|FG001|COMPLETED|Overall Study||9||
48230613|NCT00491400|100887317|FG000|NOT COMPLETED|Overall Study||5||
48230614|NCT00491400|100887318|FG001|NOT COMPLETED|Overall Study||4||
48230615|NCT03068312|100887319|FG000|STARTED|Overall Study||19||
48230616|NCT03068312|100887320|FG001|STARTED|Overall Study||19||
48230617|NCT03068312|100887319|FG000|COMPLETED|Overall Study||19||
48230618|NCT03068312|100887320|FG001|COMPLETED|Overall Study||19||
48230619|NCT03068312|100887319|FG000|NOT COMPLETED|Overall Study||0||
48230620|NCT03068312|100887320|FG001|NOT COMPLETED|Overall Study||0||
48230621|NCT03854734|100887321|FG000|STARTED|Overall Study||70||2
48230622|NCT03854734|100887322|FG001|STARTED|Overall Study||78||2
48230623|NCT03854734|100887321|FG000|COMPLETED|Overall Study||70||2
48230624|NCT03854734|100887322|FG001|COMPLETED|Overall Study||78||2
48230625|NCT03854734|100887321|FG000|NOT COMPLETED|Overall Study||0||0
48230626|NCT03854734|100887322|FG001|NOT COMPLETED|Overall Study||0||0
48230627|NCT02584257|100887323|FG000|STARTED|Period 1||9||
48230628|NCT02584257|100887324|FG001|STARTED|Period 1||9||
48230629|NCT02584257|100887325|FG002|STARTED|Period 1||9||
48230630|NCT02584257|100887326|FG003|STARTED|Period 1||8||
48230631|NCT02584257|100887327|FG004|STARTED|Period 1||10||
48230632|NCT02584257|100887328|FG005|STARTED|Period 1||10||
48230633|NCT02584257|100887329|FG006|STARTED|Period 1||18||
48230634|NCT02584257|100887330|FG007|STARTED|Period 1||9||
48230635|NCT02584257|100887331|FG008|STARTED|Period 1||9||
48230636|NCT02584257|100887323|FG000|COMPLETED|Period 1||9||
48230637|NCT02584257|100887324|FG001|COMPLETED|Period 1||9||
48230638|NCT02584257|100887325|FG002|COMPLETED|Period 1||9||
48230639|NCT02584257|100887326|FG003|COMPLETED|Period 1||8||
48230640|NCT02584257|100887327|FG004|COMPLETED|Period 1||10||
48230641|NCT02584257|100887328|FG005|COMPLETED|Period 1||10||
48230642|NCT02584257|100887329|FG006|COMPLETED|Period 1||17||
48230643|NCT02584257|100887330|FG007|COMPLETED|Period 1||9||
48230644|NCT02584257|100887331|FG008|COMPLETED|Period 1||9||
48230645|NCT02584257|100887323|FG000|NOT COMPLETED|Period 1||0||
48531225|NCT04625426|101635943|FG000|STARTED|Overall Study||23||
48531226|NCT04625426|101635944|FG001|STARTED|Overall Study||37||
48531227|NCT04625426|101635945|FG002|STARTED|Overall Study||24||
48230646|NCT02584257|100887324|FG001|NOT COMPLETED|Period 1||0||
48230647|NCT02584257|100887325|FG002|NOT COMPLETED|Period 1||0||
48230648|NCT02584257|100887326|FG003|NOT COMPLETED|Period 1||0||
48230649|NCT02584257|100887327|FG004|NOT COMPLETED|Period 1||0||
48230650|NCT02584257|100887328|FG005|NOT COMPLETED|Period 1||0||
48230651|NCT02584257|100887329|FG006|NOT COMPLETED|Period 1||1||
48230652|NCT02584257|100887330|FG007|NOT COMPLETED|Period 1||0||
48230653|NCT02584257|100887331|FG008|NOT COMPLETED|Period 1||0||
48230654|NCT02584257|100887323|FG000|STARTED|Period 2||9||
48230655|NCT02584257|100887324|FG001|STARTED|Period 2||9||
48230656|NCT02584257|100887325|FG002|STARTED|Period 2||9||
48230657|NCT02584257|100887326|FG003|STARTED|Period 2||8||
48230658|NCT02584257|100887327|FG004|STARTED|Period 2||10||
48230659|NCT02584257|100887328|FG005|STARTED|Period 2||10||
48230660|NCT02584257|100887329|FG006|STARTED|Period 2||17||
48230661|NCT02584257|100887330|FG007|STARTED|Period 2||9||
48230662|NCT02584257|100887331|FG008|STARTED|Period 2||9||
48230663|NCT02584257|100887323|FG000|COMPLETED|Period 2||8||
48230664|NCT02584257|100887324|FG001|COMPLETED|Period 2||8||
48230665|NCT02584257|100887325|FG002|COMPLETED|Period 2||9||
48230666|NCT02584257|100887326|FG003|COMPLETED|Period 2||8||
48230667|NCT02584257|100887327|FG004|COMPLETED|Period 2||10||
48230668|NCT02584257|100887328|FG005|COMPLETED|Period 2||10||
48230669|NCT02584257|100887329|FG006|COMPLETED|Period 2||17||
48230670|NCT02584257|100887330|FG007|COMPLETED|Period 2||9||
48230671|NCT02584257|100887331|FG008|COMPLETED|Period 2||9||
48230672|NCT02584257|100887323|FG000|NOT COMPLETED|Period 2||1||
48230673|NCT02584257|100887324|FG001|NOT COMPLETED|Period 2||1||
48230674|NCT02584257|100887325|FG002|NOT COMPLETED|Period 2||0||
48230675|NCT02584257|100887326|FG003|NOT COMPLETED|Period 2||0||
48230676|NCT02584257|100887327|FG004|NOT COMPLETED|Period 2||0||
48230677|NCT02584257|100887328|FG005|NOT COMPLETED|Period 2||0||
48230678|NCT02584257|100887329|FG006|NOT COMPLETED|Period 2||0||
48230679|NCT02584257|100887330|FG007|NOT COMPLETED|Period 2||0||
48230680|NCT02584257|100887331|FG008|NOT COMPLETED|Period 2||0||
48230681|NCT02584257|100887323|FG000|STARTED|Period 3||8||
48230682|NCT02584257|100887324|FG001|STARTED|Period 3||8||
48230683|NCT02584257|100887325|FG002|STARTED|Period 3||9||
48230684|NCT02584257|100887326|FG003|STARTED|Period 3||8||
48230685|NCT02584257|100887327|FG004|STARTED|Period 3||10||
48230686|NCT02584257|100887328|FG005|STARTED|Period 3||10||
48230687|NCT02584257|100887329|FG006|STARTED|Period 3||17||
48230688|NCT02584257|100887330|FG007|STARTED|Period 3||9||
48230689|NCT02584257|100887331|FG008|STARTED|Period 3||9||
48230690|NCT02584257|100887323|FG000|COMPLETED|Period 3||8||
48230691|NCT02584257|100887324|FG001|COMPLETED|Period 3||8||
48230692|NCT02584257|100887325|FG002|COMPLETED|Period 3||9||
48230693|NCT02584257|100887326|FG003|COMPLETED|Period 3||8||
48230694|NCT02584257|100887327|FG004|COMPLETED|Period 3||10||
48230695|NCT02584257|100887328|FG005|COMPLETED|Period 3||10||
48230696|NCT02584257|100887329|FG006|COMPLETED|Period 3||17||
48230697|NCT02584257|100887330|FG007|COMPLETED|Period 3||9||
48230698|NCT02584257|100887331|FG008|COMPLETED|Period 3||9||
48230699|NCT02584257|100887323|FG000|NOT COMPLETED|Period 3||0||
48230700|NCT02584257|100887324|FG001|NOT COMPLETED|Period 3||0||
48230701|NCT02584257|100887325|FG002|NOT COMPLETED|Period 3||0||
48230702|NCT02584257|100887326|FG003|NOT COMPLETED|Period 3||0||
48230703|NCT02584257|100887327|FG004|NOT COMPLETED|Period 3||0||
48230704|NCT02584257|100887328|FG005|NOT COMPLETED|Period 3||0||
48230705|NCT02584257|100887329|FG006|NOT COMPLETED|Period 3||0||
48230706|NCT02584257|100887330|FG007|NOT COMPLETED|Period 3||0||
48230707|NCT02584257|100887331|FG008|NOT COMPLETED|Period 3||0||
48230708|NCT02584257|100887323|FG000|STARTED|Period 4||8||
48230709|NCT02584257|100887324|FG001|STARTED|Period 4||8||
48230710|NCT02584257|100887325|FG002|STARTED|Period 4||9||
48230711|NCT02584257|100887326|FG003|STARTED|Period 4||8||
48230712|NCT02584257|100887327|FG004|STARTED|Period 4||10||
48230713|NCT02584257|100887328|FG005|STARTED|Period 4||10||
48230714|NCT02584257|100887329|FG006|STARTED|Period 4||17||
48230715|NCT02584257|100887330|FG007|STARTED|Period 4||9||
48230716|NCT02584257|100887331|FG008|STARTED|Period 4||9||
48230717|NCT02584257|100887323|FG000|COMPLETED|Period 4||8||
48230718|NCT02584257|100887324|FG001|COMPLETED|Period 4||8||
48230719|NCT02584257|100887325|FG002|COMPLETED|Period 4||9||
48230720|NCT02584257|100887326|FG003|COMPLETED|Period 4||8||
48230721|NCT02584257|100887327|FG004|COMPLETED|Period 4||10||
48230722|NCT02584257|100887328|FG005|COMPLETED|Period 4||10||
48531228|NCT04625426|101635943|FG000|COMPLETED|Overall Study||9||
48230723|NCT02584257|100887329|FG006|COMPLETED|Period 4||17||
48230724|NCT02584257|100887330|FG007|COMPLETED|Period 4||9||
48230725|NCT02584257|100887331|FG008|COMPLETED|Period 4||9||
48230726|NCT02584257|100887323|FG000|NOT COMPLETED|Period 4||0||
48230727|NCT02584257|100887324|FG001|NOT COMPLETED|Period 4||0||
48230728|NCT02584257|100887325|FG002|NOT COMPLETED|Period 4||0||
48230729|NCT02584257|100887326|FG003|NOT COMPLETED|Period 4||0||
48230730|NCT02584257|100887327|FG004|NOT COMPLETED|Period 4||0||
48230731|NCT02584257|100887328|FG005|NOT COMPLETED|Period 4||0||
48230732|NCT02584257|100887329|FG006|NOT COMPLETED|Period 4||0||
48230733|NCT02584257|100887330|FG007|NOT COMPLETED|Period 4||0||
48230734|NCT02584257|100887331|FG008|NOT COMPLETED|Period 4||0||
48230735|NCT02584257|100887323|FG000|STARTED|Period 5||8||
48230736|NCT02584257|100887324|FG001|STARTED|Period 5||8||
48230737|NCT02584257|100887325|FG002|STARTED|Period 5||9||
48230738|NCT02584257|100887326|FG003|STARTED|Period 5||8||
48230739|NCT02584257|100887327|FG004|STARTED|Period 5||10||
48230740|NCT02584257|100887328|FG005|STARTED|Period 5||10||
48230741|NCT02584257|100887329|FG006|STARTED|Period 5||17||
48230742|NCT02584257|100887330|FG007|STARTED|Period 5||9||
48230743|NCT02584257|100887331|FG008|STARTED|Period 5||9||
48230744|NCT02584257|100887323|FG000|COMPLETED|Period 5||8||
48230745|NCT02584257|100887324|FG001|COMPLETED|Period 5||8||
48230746|NCT02584257|100887325|FG002|COMPLETED|Period 5||9||
48230747|NCT02584257|100887326|FG003|COMPLETED|Period 5||8||
48230748|NCT02584257|100887327|FG004|COMPLETED|Period 5||10||
48230749|NCT02584257|100887328|FG005|COMPLETED|Period 5||10||
48230750|NCT02584257|100887329|FG006|COMPLETED|Period 5||17||
48230751|NCT02584257|100887330|FG007|COMPLETED|Period 5||9||
48230752|NCT02584257|100887331|FG008|COMPLETED|Period 5||9||
48230753|NCT02584257|100887323|FG000|NOT COMPLETED|Period 5||0||
48230754|NCT02584257|100887324|FG001|NOT COMPLETED|Period 5||0||
48531229|NCT04625426|101635944|FG001|COMPLETED|Overall Study||12||
48531230|NCT04625426|101635945|FG002|COMPLETED|Overall Study||12||
48531231|NCT04625426|101635943|FG000|NOT COMPLETED|Overall Study||14||
48531232|NCT04625426|101635944|FG001|NOT COMPLETED|Overall Study||25||
48531233|NCT04625426|101635945|FG002|NOT COMPLETED|Overall Study||12||
48531234|NCT01090921|101635946|FG000|STARTED|Overall Study||50||
48531235|NCT01090921|101635946|FG000|COMPLETED|Overall Study||23||
48531236|NCT01090921|101635946|FG000|NOT COMPLETED|Overall Study||27||
48531237|NCT00569530|101635947|FG000|STARTED|Overall Study||43||
48531238|NCT00569530|101635948|FG001|STARTED|Overall Study||42||
48531239|NCT00569530|101635947|FG000|COMPLETED|Overall Study||43||
48531240|NCT00569530|101635948|FG001|COMPLETED|Overall Study||42||
48531241|NCT00569530|101635947|FG000|NOT COMPLETED|Overall Study||0||
48531242|NCT00569530|101635948|FG001|NOT COMPLETED|Overall Study||0||
48531243|NCT01104792|101635949|FG000|STARTED|Overall Study||752||
48230755|NCT02584257|100887325|FG002|NOT COMPLETED|Period 5||0||
48230756|NCT02584257|100887326|FG003|NOT COMPLETED|Period 5||0||
48230757|NCT02584257|100887327|FG004|NOT COMPLETED|Period 5||0||
48230758|NCT02584257|100887328|FG005|NOT COMPLETED|Period 5||0||
48230759|NCT02584257|100887329|FG006|NOT COMPLETED|Period 5||0||
48230760|NCT02584257|100887330|FG007|NOT COMPLETED|Period 5||0||
48230761|NCT02584257|100887331|FG008|NOT COMPLETED|Period 5||0||
48230762|NCT02309515|100887332|FG000|STARTED|Overall Study||5||
48230763|NCT02309515|100887333|FG001|STARTED|Overall Study||7||
48230764|NCT02309515|100887332|FG000|COMPLETED|Overall Study||5||
48230765|NCT02309515|100887333|FG001|COMPLETED|Overall Study||6||
48230766|NCT02309515|100887332|FG000|NOT COMPLETED|Overall Study||0||
48230767|NCT02309515|100887333|FG001|NOT COMPLETED|Overall Study||1||
48230768|NCT05777772|100887334|FG000|STARTED|Overall Study||114||
48230769|NCT05777772|100887335|FG001|STARTED|Overall Study||9||
48230770|NCT05777772|100887334|FG000|COMPLETED|Overall Study||114||
48230771|NCT05777772|100887335|FG001|COMPLETED|Overall Study||9||
48230772|NCT05777772|100887334|FG000|NOT COMPLETED|Overall Study||0||
48230773|NCT05777772|100887335|FG001|NOT COMPLETED|Overall Study||0||
48230774|NCT03964974|100887336|FG000|STARTED|Overall Study||30||
48230775|NCT03964974|100887337|FG001|STARTED|Overall Study||27||
48230776|NCT03964974|100887336|FG000|Assigned and Received Intervention|Overall Study||26||
48230777|NCT03964974|100887337|FG001|Assigned and Received Intervention|Overall Study||21||
48230778|NCT03964974|100887336|FG000|8 Week Follow Up|Overall Study||26||
48230779|NCT03964974|100887337|FG001|8 Week Follow Up|Overall Study||22||
48531244|NCT01104792|101635949|FG000|COMPLETED|Overall Study||226||
48531245|NCT01104792|101635949|FG000|NOT COMPLETED|Overall Study||526||
48531246|NCT00160641|101635950|FG000|STARTED|Overall Study||567||
48531247|NCT00160641|101635950|FG000|COMPLETED|Overall Study||346||
48531248|NCT00160641|101635950|FG000|NOT COMPLETED|Overall Study||221||
48531249|NCT01663935|101635951|FG000|STARTED|Overall Study||20||
48531250|NCT01663935|101635951|FG000|COMPLETED|Overall Study||20||
48230780|NCT03964974|100887336|FG000|16 Week Follow Up|Overall Study||27||
48230781|NCT03964974|100887337|FG001|16 Week Follow Up|Overall Study||22||
48230782|NCT03964974|100887336|FG000|COMPLETED|Overall Study||27||
48230783|NCT03964974|100887337|FG001|COMPLETED|Overall Study||22||
48230784|NCT03964974|100887336|FG000|NOT COMPLETED|Overall Study||3||
48230785|NCT03964974|100887337|FG001|NOT COMPLETED|Overall Study||5||
48230786|NCT02580799|100887338|FG000|STARTED|Overall Study||30||
48230787|NCT02580799|100887338|FG000|COMPLETED|Overall Study||30||
48230788|NCT02580799|100887338|FG000|NOT COMPLETED|Overall Study||0||
48531251|NCT01663935|101635951|FG000|NOT COMPLETED|Overall Study||0||
48531252|NCT00354341|101635952|FG000|STARTED|Overall Study||88||
48080811|NCT01835587|100518858|FG003|NOT COMPLETED|Overall Study||9||
48080812|NCT01200602|100518859|FG000|STARTED|Overall Study||0||
48080813|NCT01200602|100518860|FG001|STARTED|Overall Study||0||
48080814|NCT01200602|100518859|FG000|COMPLETED|Overall Study||0||
48080815|NCT01200602|100518860|FG001|COMPLETED|Overall Study||0||
48080816|NCT01200602|100518859|FG000|NOT COMPLETED|Overall Study||0||
48080817|NCT01200602|100518860|FG001|NOT COMPLETED|Overall Study||0||
48080818|NCT02771093|100518861|FG000|STARTED|Overall Study||13||
48080819|NCT02771093|100518862|FG001|STARTED|Overall Study||14||
48080820|NCT02771093|100518861|FG000|COMPLETED|Overall Study||13||
48080821|NCT02771093|100518862|FG001|COMPLETED|Overall Study||14||
48080822|NCT02771093|100518861|FG000|NOT COMPLETED|Overall Study||0||
48080823|NCT02771093|100518862|FG001|NOT COMPLETED|Overall Study||0||
48080824|NCT01815515|100518863|FG000|STARTED|Overall Study||17||
48080825|NCT01815515|100518863|FG000|COMPLETED|Overall Study||17||
48080826|NCT01815515|100518863|FG000|NOT COMPLETED|Overall Study||0||
48080827|NCT04051008|100518864|FG000|STARTED|Overall Study||21||
48080828|NCT04051008|100518865|FG001|STARTED|Overall Study||21||
48080829|NCT04051008|100518866|FG002|STARTED|Overall Study||23||
48080830|NCT04051008|100518864|FG000|COMPLETED|Overall Study||19||
48080831|NCT04051008|100518865|FG001|COMPLETED|Overall Study||21||
48080832|NCT04051008|100518866|FG002|COMPLETED|Overall Study||22||
48080833|NCT04051008|100518864|FG000|NOT COMPLETED|Overall Study||2||
48080834|NCT04051008|100518865|FG001|NOT COMPLETED|Overall Study||0||
48080835|NCT04051008|100518866|FG002|NOT COMPLETED|Overall Study||1||
48080836|NCT05466682|100518867|FG000|STARTED|Overall Study||24||
48080837|NCT05466682|100518868|FG001|STARTED|Overall Study||24||
48080838|NCT05466682|100518867|FG000|COMPLETED|Overall Study||22||
48080839|NCT05466682|100518868|FG001|COMPLETED|Overall Study||21||
48080840|NCT05466682|100518867|FG000|NOT COMPLETED|Overall Study||2||
48080841|NCT05466682|100518868|FG001|NOT COMPLETED|Overall Study||3||
48080842|NCT02454296|100518869|FG000|STARTED|Overall Study||20||
48080843|NCT02454296|100518870|FG001|STARTED|Overall Study||21||
48080844|NCT02454296|100518869|FG000|COMPLETED|Overall Study||20||
48080845|NCT02454296|100518870|FG001|COMPLETED|Overall Study||21||
48080846|NCT02454296|100518869|FG000|NOT COMPLETED|Overall Study||0||
48080847|NCT02454296|100518870|FG001|NOT COMPLETED|Overall Study||0||
48080848|NCT01001377|100518871|FG000|STARTED|Overall Study||504||
48080849|NCT01001377|100518872|FG001|STARTED|Overall Study||506||
48080850|NCT01001377|100518871|FG000|Received Treatment|Overall Study||500||
48080851|NCT01001377|100518872|FG001|Received Treatment|Overall Study||499||
48080852|NCT01001377|100518871|FG000|COMPLETED|Overall Study||78||
48080853|NCT01001377|100518872|FG001|COMPLETED|Overall Study||85||
48080854|NCT01001377|100518871|FG000|NOT COMPLETED|Overall Study||426||
48080855|NCT01001377|100518872|FG001|NOT COMPLETED|Overall Study||421||
48080856|NCT04803370|100518873|FG000|STARTED|Overall Study||17||
48080857|NCT04803370|100518874|FG001|STARTED|Overall Study||38||
48080858|NCT04803370|100518873|FG000|COMPLETED|Overall Study||17||
48080859|NCT04803370|100518874|FG001|COMPLETED|Overall Study||37||
48080860|NCT04803370|100518873|FG000|NOT COMPLETED|Overall Study||0||
48080861|NCT04803370|100518874|FG001|NOT COMPLETED|Overall Study||1||
48080862|NCT02248103|100518875|FG000|STARTED|Overall Study||10||
48080863|NCT02248103|100518876|FG001|STARTED|Overall Study||10||
48080864|NCT02248103|100518875|FG000|COMPLETED|Overall Study||10||
48080865|NCT02248103|100518876|FG001|COMPLETED|Overall Study||10||
48080866|NCT02248103|100518875|FG000|NOT COMPLETED|Overall Study||0||
48080867|NCT02248103|100518876|FG001|NOT COMPLETED|Overall Study||0||
48080868|NCT01948947|100518877|FG000|STARTED|Overall Study||14||
48080869|NCT01948947|100518878|FG001|STARTED|Overall Study||15||
48080870|NCT01948947|100518877|FG000|COMPLETED|Overall Study||14||
48080871|NCT01948947|100518878|FG001|COMPLETED|Overall Study||15||
48080872|NCT01948947|100518877|FG000|NOT COMPLETED|Overall Study||0||
48080873|NCT01948947|100518878|FG001|NOT COMPLETED|Overall Study||0||
48080874|NCT02256189|100518879|FG000|STARTED|Overall Study||15||
48080875|NCT02256189|100518880|FG001|STARTED|Overall Study||13||
48080876|NCT02256189|100518879|FG000|COMPLETED|Overall Study||15||
48080877|NCT02256189|100518880|FG001|COMPLETED|Overall Study||13||
48080878|NCT02256189|100518879|FG000|NOT COMPLETED|Overall Study||0||
48080879|NCT02256189|100518880|FG001|NOT COMPLETED|Overall Study||0||
48080880|NCT00996307|100518881|FG000|STARTED|Overall Study||164||
48080881|NCT00996307|100518882|FG001|STARTED|Overall Study||165||
48080882|NCT00996307|100518883|FG002|STARTED|Overall Study||160||
48080883|NCT00996307|100518884|FG003|STARTED|Overall Study||165||
48080884|NCT00996307|100518881|FG000|COMPLETED|Overall Study||144||
48080885|NCT00996307|100518882|FG001|COMPLETED|Overall Study||148||
48080886|NCT00996307|100518883|FG002|COMPLETED|Overall Study||146||
48080887|NCT00996307|100518884|FG003|COMPLETED|Overall Study||144||
48531253|NCT00354341|101635953|FG001|STARTED|Overall Study||82||
48080888|NCT00996307|100518881|FG000|NOT COMPLETED|Overall Study||20||
48080889|NCT00996307|100518882|FG001|NOT COMPLETED|Overall Study||17||
48080890|NCT00996307|100518883|FG002|NOT COMPLETED|Overall Study||14||
48080891|NCT00996307|100518884|FG003|NOT COMPLETED|Overall Study||21||
48531254|NCT00354341|101635952|FG000|COMPLETED|Overall Study||85||
48230789|NCT02188459|100887339|FG000|STARTED|Overall Study||64||
48230790|NCT02188459|100887340|FG001|STARTED|Overall Study||65||
48230791|NCT02188459|100887339|FG000|COMPLETED|Overall Study||61||
48230792|NCT02188459|100887340|FG001|COMPLETED|Overall Study||58||
48230793|NCT02188459|100887339|FG000|NOT COMPLETED|Overall Study||3||
48230794|NCT02188459|100887340|FG001|NOT COMPLETED|Overall Study||7||
48230795|NCT00578344|100887341|FG000|STARTED|Overall Study||8||
48230796|NCT00578344|100887341|FG000|COMPLETED|Overall Study||6||
48230797|NCT00578344|100887341|FG000|NOT COMPLETED|Overall Study||2||
48230798|NCT01419184|100887342|FG000|STARTED|Overall Study||128||
48230799|NCT01419184|100887343|FG001|STARTED|Overall Study||121||
48230800|NCT01419184|100887342|FG000|Received at Least 1 Dose of Study Drug|Overall Study||118||
48230801|NCT01419184|100887343|FG001|Received at Least 1 Dose of Study Drug|Overall Study||106||
48230802|NCT01419184|100887342|FG000|COMPLETED|Overall Study||118||
48230803|NCT01419184|100887343|FG001|COMPLETED|Overall Study||106||
48230804|NCT01419184|100887342|FG000|NOT COMPLETED|Overall Study||10||
48230805|NCT01419184|100887343|FG001|NOT COMPLETED|Overall Study||15||
48230806|NCT01999335|100887344|FG000|STARTED|Overall Study||3||
48230807|NCT01999335|100887345|FG001|STARTED|Overall Study||1||
48230808|NCT01999335|100887346|FG002|STARTED|Overall Study||7||
48230809|NCT01999335|100887347|FG003|STARTED|Overall Study||10||
48230810|NCT01999335|100887348|FG004|STARTED|Overall Study||12||
48230811|NCT01999335|100887344|FG000|Received Study Treatment|Overall Study||3||
48230812|NCT01999335|100887345|FG001|Received Study Treatment|Overall Study||1||
48230813|NCT01999335|100887346|FG002|Received Study Treatment|Overall Study||7||
48230814|NCT01999335|100887347|FG003|Received Study Treatment|Overall Study||10||
48230815|NCT01999335|100887348|FG004|Received Study Treatment|Overall Study||10||
48230816|NCT01999335|100887344|FG000|COMPLETED|Overall Study||3||
48230817|NCT01999335|100887345|FG001|COMPLETED|Overall Study||1||
48230818|NCT01999335|100887346|FG002|COMPLETED|Overall Study||7||
48230819|NCT01999335|100887347|FG003|COMPLETED|Overall Study||10||
48230820|NCT01999335|100887348|FG004|COMPLETED|Overall Study||10||
48230821|NCT01999335|100887344|FG000|NOT COMPLETED|Overall Study||0||
48230822|NCT01999335|100887345|FG001|NOT COMPLETED|Overall Study||0||
48230823|NCT01999335|100887346|FG002|NOT COMPLETED|Overall Study||0||
48230824|NCT01999335|100887347|FG003|NOT COMPLETED|Overall Study||0||
48230825|NCT01999335|100887348|FG004|NOT COMPLETED|Overall Study||2||
48230826|NCT02279732|100887349|FG000|STARTED|Overall Study||98|Started = Participants treated with double blind therapy|
48230827|NCT02279732|100887350|FG001|STARTED|Overall Study||106|Started = Participants treated with double blind therapy|
48230828|NCT02279732|100887349|FG000|COMPLETED|Overall Study||0|Completed|
48230829|NCT02279732|100887350|FG001|COMPLETED|Overall Study||0|Completed|
48230830|NCT02279732|100887349|FG000|NOT COMPLETED|Overall Study||98||
48230831|NCT02279732|100887350|FG001|NOT COMPLETED|Overall Study||106||
48230832|NCT01047709|100887351|FG000|STARTED|Positional Therapy (1 Night)||9||
48230833|NCT01047709|100887352|FG001|STARTED|Positional Therapy (1 Night)||9||
48230834|NCT01047709|100887351|FG000|COMPLETED|Positional Therapy (1 Night)||9||
48230835|NCT01047709|100887352|FG001|COMPLETED|Positional Therapy (1 Night)||9||
48230836|NCT01047709|100887351|FG000|NOT COMPLETED|Positional Therapy (1 Night)||0||
48230837|NCT01047709|100887352|FG001|NOT COMPLETED|Positional Therapy (1 Night)||0||
48230838|NCT01047709|100887351|FG000|STARTED|Control/Positioning ad Lib (1 Night)||9||
48230839|NCT01047709|100887352|FG001|STARTED|Control/Positioning ad Lib (1 Night)||9||
48230840|NCT01047709|100887351|FG000|COMPLETED|Control/Positioning ad Lib (1 Night)||9||
48230841|NCT01047709|100887352|FG001|COMPLETED|Control/Positioning ad Lib (1 Night)||9||
48230842|NCT01047709|100887351|FG000|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0||
48230843|NCT01047709|100887352|FG001|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0||
48230844|NCT04328467|100887353|FG000|STARTED|Overall Study||494||
48230845|NCT04328467|100887354|FG001|STARTED|Overall Study||495||
48230846|NCT04328467|100887355|FG002|STARTED|Overall Study||494||
48230847|NCT04328467|100887353|FG000|COMPLETED|Overall Study||490||
48230848|NCT04328467|100887354|FG001|COMPLETED|Overall Study||493||
48230849|NCT04328467|100887355|FG002|COMPLETED|Overall Study||493||
48230850|NCT04328467|100887353|FG000|NOT COMPLETED|Overall Study||4||
48230851|NCT04328467|100887354|FG001|NOT COMPLETED|Overall Study||2||
48230852|NCT04328467|100887355|FG002|NOT COMPLETED|Overall Study||1||
48230853|NCT04131556|100887356|FG000|STARTED|Overall Study||20||
48230854|NCT04131556|100887356|FG000|COMPLETED|Overall Study||18||
48230855|NCT04131556|100887356|FG000|NOT COMPLETED|Overall Study||2||
48230856|NCT04237792|100887357|FG000|STARTED|Treatment (Day 1)||21||
48230857|NCT04237792|100887358|FG001|STARTED|Treatment (Day 1)||22||
48230858|NCT04237792|100887359|FG002|STARTED|Treatment (Day 1)||20||
48230859|NCT04237792|100887360|FG003|STARTED|Treatment (Day 1)||23||
48230860|NCT04237792|100887361|FG004|STARTED|Treatment (Day 1)||21||
48230861|NCT04237792|100887362|FG005|STARTED|Treatment (Day 1)||21||
48230862|NCT04237792|100887357|FG000|Treated With DEX|Treatment (Day 1)||20||
48230863|NCT04237792|100887358|FG001|Treated With DEX|Treatment (Day 1)||21||
48230864|NCT04237792|100887359|FG002|Treated With DEX|Treatment (Day 1)||18||
48230865|NCT04237792|100887360|FG003|Treated With DEX|Treatment (Day 1)||22||
48230866|NCT04237792|100887361|FG004|Treated With DEX|Treatment (Day 1)||21||
48230867|NCT04237792|100887362|FG005|Treated With DEX|Treatment (Day 1)||20||
48230868|NCT04237792|100887357|FG000|COMPLETED|Treatment (Day 1)||19||
48230869|NCT04237792|100887358|FG001|COMPLETED|Treatment (Day 1)||21||
48230870|NCT04237792|100887359|FG002|COMPLETED|Treatment (Day 1)||17||
48230871|NCT04237792|100887360|FG003|COMPLETED|Treatment (Day 1)||22||
48230872|NCT04237792|100887361|FG004|COMPLETED|Treatment (Day 1)||20||
48230873|NCT04237792|100887362|FG005|COMPLETED|Treatment (Day 1)||18||
48230874|NCT04237792|100887357|FG000|NOT COMPLETED|Treatment (Day 1)||2||
48230875|NCT04237792|100887358|FG001|NOT COMPLETED|Treatment (Day 1)||1||
48230876|NCT04237792|100887359|FG002|NOT COMPLETED|Treatment (Day 1)||3||
48230877|NCT04237792|100887360|FG003|NOT COMPLETED|Treatment (Day 1)||1||
48230878|NCT04237792|100887361|FG004|NOT COMPLETED|Treatment (Day 1)||1||
48230879|NCT04237792|100887362|FG005|NOT COMPLETED|Treatment (Day 1)||3||
48230880|NCT04237792|100887357|FG000|STARTED|MRI Scan (Day 1)||20||
48230881|NCT04237792|100887358|FG001|STARTED|MRI Scan (Day 1)||21||
48230882|NCT04237792|100887359|FG002|STARTED|MRI Scan (Day 1)||18||
48531255|NCT00354341|101635953|FG001|COMPLETED|Overall Study||75||
48531256|NCT00354341|101635952|FG000|NOT COMPLETED|Overall Study||3||
48531257|NCT00354341|101635953|FG001|NOT COMPLETED|Overall Study||7||
48531258|NCT03246126|101635954|FG000|STARTED|Overall Study||5||
48531259|NCT03246126|101635955|FG001|STARTED|Overall Study||5||
48531260|NCT03246126|101635954|FG000|COMPLETED|Overall Study||5||
48531261|NCT03246126|101635955|FG001|COMPLETED|Overall Study||4||
48531262|NCT03246126|101635954|FG000|NOT COMPLETED|Overall Study||0||
48531263|NCT03246126|101635955|FG001|NOT COMPLETED|Overall Study||1||
48230883|NCT04237792|100887360|FG003|STARTED|MRI Scan (Day 1)||22||
48230884|NCT04237792|100887361|FG004|STARTED|MRI Scan (Day 1)||21||
48230885|NCT04237792|100887362|FG005|STARTED|MRI Scan (Day 1)||20||
48230886|NCT04237792|100887357|FG000|COMPLETED|MRI Scan (Day 1)||20||
48230887|NCT04237792|100887358|FG001|COMPLETED|MRI Scan (Day 1)||21||
48230888|NCT04237792|100887359|FG002|COMPLETED|MRI Scan (Day 1)||18||
48230889|NCT04237792|100887360|FG003|COMPLETED|MRI Scan (Day 1)||22||
48230890|NCT04237792|100887361|FG004|COMPLETED|MRI Scan (Day 1)||21||
48230891|NCT04237792|100887362|FG005|COMPLETED|MRI Scan (Day 1)||20||
48230892|NCT04237792|100887357|FG000|NOT COMPLETED|MRI Scan (Day 1)||0||
48230893|NCT04237792|100887358|FG001|NOT COMPLETED|MRI Scan (Day 1)||0||
48230894|NCT04237792|100887359|FG002|NOT COMPLETED|MRI Scan (Day 1)||0||
48230895|NCT04237792|100887360|FG003|NOT COMPLETED|MRI Scan (Day 1)||0||
48230896|NCT04237792|100887361|FG004|NOT COMPLETED|MRI Scan (Day 1)||0||
48230897|NCT04237792|100887362|FG005|NOT COMPLETED|MRI Scan (Day 1)||0||
48230898|NCT04237792|100887357|FG000|STARTED|Post MRI Scan Recovery (Day 1)||20||
48230899|NCT04237792|100887358|FG001|STARTED|Post MRI Scan Recovery (Day 1)||21||
48230900|NCT04237792|100887359|FG002|STARTED|Post MRI Scan Recovery (Day 1)||18||
48230901|NCT04237792|100887360|FG003|STARTED|Post MRI Scan Recovery (Day 1)||22||
48230902|NCT04237792|100887361|FG004|STARTED|Post MRI Scan Recovery (Day 1)||21||
48230903|NCT04237792|100887362|FG005|STARTED|Post MRI Scan Recovery (Day 1)||20||
48531264|NCT00852969|101635956|FG000|STARTED|Overall Study||15||
48230904|NCT04237792|100887357|FG000|COMPLETED|Post MRI Scan Recovery (Day 1)||20||
48230905|NCT04237792|100887358|FG001|COMPLETED|Post MRI Scan Recovery (Day 1)||21||
48230906|NCT04237792|100887359|FG002|COMPLETED|Post MRI Scan Recovery (Day 1)||18||
48230907|NCT04237792|100887360|FG003|COMPLETED|Post MRI Scan Recovery (Day 1)||22||
48230908|NCT04237792|100887361|FG004|COMPLETED|Post MRI Scan Recovery (Day 1)||21||
48230909|NCT04237792|100887362|FG005|COMPLETED|Post MRI Scan Recovery (Day 1)||20||
48230910|NCT04237792|100887357|FG000|NOT COMPLETED|Post MRI Scan Recovery (Day 1)||0||
48230911|NCT04237792|100887358|FG001|NOT COMPLETED|Post MRI Scan Recovery (Day 1)||0||
48230912|NCT04237792|100887359|FG002|NOT COMPLETED|Post MRI Scan Recovery (Day 1)||0||
48230913|NCT04237792|100887360|FG003|NOT COMPLETED|Post MRI Scan Recovery (Day 1)||0||
48230914|NCT04237792|100887361|FG004|NOT COMPLETED|Post MRI Scan Recovery (Day 1)||0||
48230915|NCT04237792|100887362|FG005|NOT COMPLETED|Post MRI Scan Recovery (Day 1)||0||
48230916|NCT04237792|100887357|FG000|STARTED|Follow-up (FU) (Day 2)||20||
48230917|NCT04237792|100887358|FG001|STARTED|Follow-up (FU) (Day 2)||21||
48230918|NCT04237792|100887359|FG002|STARTED|Follow-up (FU) (Day 2)||18||
48230919|NCT04237792|100887360|FG003|STARTED|Follow-up (FU) (Day 2)||22||
48230920|NCT04237792|100887361|FG004|STARTED|Follow-up (FU) (Day 2)||21||
48230921|NCT04237792|100887362|FG005|STARTED|Follow-up (FU) (Day 2)||20||
48230922|NCT04237792|100887357|FG000|COMPLETED|Follow-up (FU) (Day 2)||20||
48230923|NCT04237792|100887358|FG001|COMPLETED|Follow-up (FU) (Day 2)||21||
48230924|NCT04237792|100887359|FG002|COMPLETED|Follow-up (FU) (Day 2)||18||
48230925|NCT04237792|100887360|FG003|COMPLETED|Follow-up (FU) (Day 2)||22||
48230926|NCT04237792|100887361|FG004|COMPLETED|Follow-up (FU) (Day 2)||21||
48230927|NCT04237792|100887362|FG005|COMPLETED|Follow-up (FU) (Day 2)||20||
48230928|NCT04237792|100887357|FG000|NOT COMPLETED|Follow-up (FU) (Day 2)||0||
48230929|NCT04237792|100887358|FG001|NOT COMPLETED|Follow-up (FU) (Day 2)||0||
48230930|NCT04237792|100887359|FG002|NOT COMPLETED|Follow-up (FU) (Day 2)||0||
48230931|NCT04237792|100887360|FG003|NOT COMPLETED|Follow-up (FU) (Day 2)||0||
48230932|NCT04237792|100887361|FG004|NOT COMPLETED|Follow-up (FU) (Day 2)||0||
48230933|NCT04237792|100887362|FG005|NOT COMPLETED|Follow-up (FU) (Day 2)||0||
48230934|NCT04237792|100887357|FG000|STARTED|Long Term FU (Any Day From Day 29 to 32)||20||
48230935|NCT04237792|100887358|FG001|STARTED|Long Term FU (Any Day From Day 29 to 32)||21||
48531265|NCT00852969|101635957|FG001|STARTED|Overall Study||15||
48531266|NCT00852969|101635956|FG000|COMPLETED|Overall Study||15||
48531267|NCT00852969|101635957|FG001|COMPLETED|Overall Study||13||
48230936|NCT04237792|100887359|FG002|STARTED|Long Term FU (Any Day From Day 29 to 32)||18||
48230937|NCT04237792|100887360|FG003|STARTED|Long Term FU (Any Day From Day 29 to 32)||22||
48230938|NCT04237792|100887361|FG004|STARTED|Long Term FU (Any Day From Day 29 to 32)||21||
48230939|NCT04237792|100887362|FG005|STARTED|Long Term FU (Any Day From Day 29 to 32)||20||
48230940|NCT04237792|100887357|FG000|COMPLETED|Long Term FU (Any Day From Day 29 to 32)||20||
48230941|NCT04237792|100887358|FG001|COMPLETED|Long Term FU (Any Day From Day 29 to 32)||21||
48230942|NCT04237792|100887359|FG002|COMPLETED|Long Term FU (Any Day From Day 29 to 32)||18||
48230943|NCT04237792|100887360|FG003|COMPLETED|Long Term FU (Any Day From Day 29 to 32)||22||
48230944|NCT04237792|100887361|FG004|COMPLETED|Long Term FU (Any Day From Day 29 to 32)||21||
48230945|NCT04237792|100887362|FG005|COMPLETED|Long Term FU (Any Day From Day 29 to 32)||20||
48230946|NCT04237792|100887357|FG000|NOT COMPLETED|Long Term FU (Any Day From Day 29 to 32)||0||
48230947|NCT04237792|100887358|FG001|NOT COMPLETED|Long Term FU (Any Day From Day 29 to 32)||0||
48230948|NCT04237792|100887359|FG002|NOT COMPLETED|Long Term FU (Any Day From Day 29 to 32)||0||
48531268|NCT00852969|101635956|FG000|NOT COMPLETED|Overall Study||0||
48531269|NCT00852969|101635957|FG001|NOT COMPLETED|Overall Study||2||
48531270|NCT03614897|101635958|FG000|STARTED|Overall Study||43||
48531271|NCT03614897|101635958|FG000|COMPLETED|Overall Study||43||
48531272|NCT03614897|101635958|FG000|NOT COMPLETED|Overall Study||0||
48531273|NCT01076686|101635959|FG000|STARTED|Overall Study||17||
48230949|NCT04237792|100887360|FG003|NOT COMPLETED|Long Term FU (Any Day From Day 29 to 32)||0||
48230950|NCT04237792|100887361|FG004|NOT COMPLETED|Long Term FU (Any Day From Day 29 to 32)||0||
48230951|NCT04237792|100887362|FG005|NOT COMPLETED|Long Term FU (Any Day From Day 29 to 32)||0||
48230952|NCT00807599|100887363|FG000|STARTED|Overall Study||26||
48230953|NCT00807599|100887364|FG001|STARTED|Overall Study||24||
48230954|NCT00807599|100887365|FG002|STARTED|Overall Study||17||
48230955|NCT00807599|100887363|FG000|COMPLETED|Overall Study||26||
48230956|NCT00807599|100887364|FG001|COMPLETED|Overall Study||24||
48230957|NCT00807599|100887365|FG002|COMPLETED|Overall Study||0||
48230958|NCT00807599|100887363|FG000|NOT COMPLETED|Overall Study||0||
48230959|NCT00807599|100887364|FG001|NOT COMPLETED|Overall Study||0||
48230960|NCT00807599|100887365|FG002|NOT COMPLETED|Overall Study||17||
48230961|NCT02696200|100887366|FG000|STARTED|Overall Study||32||
48230962|NCT02696200|100887367|FG001|STARTED|Overall Study||30||
48230963|NCT02696200|100887366|FG000|COMPLETED|Overall Study||32||
48230964|NCT02696200|100887367|FG001|COMPLETED|Overall Study||30||
48230965|NCT02696200|100887366|FG000|NOT COMPLETED|Overall Study||0||
48230966|NCT02696200|100887367|FG001|NOT COMPLETED|Overall Study||0||
48230967|NCT02394912|100887368|FG000|STARTED|Overall Study||21||
48230968|NCT02394912|100887368|FG000|COMPLETED|Overall Study||21||
48230969|NCT02394912|100887368|FG000|NOT COMPLETED|Overall Study||0||
48230970|NCT04693637|100887369|FG000|STARTED|Overall Study||26||
48230971|NCT04693637|100887369|FG000|COMPLETED|Overall Study||16||
48230972|NCT04693637|100887369|FG000|NOT COMPLETED|Overall Study||10||
48230973|NCT01186809|100887370|FG000|STARTED|Overall Study||73||
48230974|NCT01186809|100887370|FG000|COMPLETED|Overall Study||43||
48230975|NCT01186809|100887370|FG000|NOT COMPLETED|Overall Study||30||
48230976|NCT03162614|100887371|FG000|STARTED|Overall Study||26||
48230977|NCT03162614|100887372|FG001|STARTED|Overall Study||26||
48230978|NCT03162614|100887373|FG002|STARTED|Overall Study||26||
48230979|NCT03162614|100887374|FG003|STARTED|Overall Study||26||
48230980|NCT03162614|100887375|FG004|STARTED|Overall Study||26||
48230981|NCT03162614|100887376|FG005|STARTED|Overall Study||24||
48230982|NCT03162614|100887371|FG000|COMPLETED|Overall Study||20||
48230983|NCT03162614|100887372|FG001|COMPLETED|Overall Study||21||
48230984|NCT03162614|100887373|FG002|COMPLETED|Overall Study||22||
48230985|NCT03162614|100887374|FG003|COMPLETED|Overall Study||19||
48531274|NCT01076686|101635960|FG001|STARTED|Overall Study||14||
48531275|NCT01076686|101635961|FG002|STARTED|Overall Study||32||
48531276|NCT01076686|101635962|FG003|STARTED|Overall Study||31||
48531277|NCT01076686|101635959|FG000|COMPLETED|Overall Study||17||
48531278|NCT01076686|101635960|FG001|COMPLETED|Overall Study||14||
48531279|NCT01076686|101635961|FG002|COMPLETED|Overall Study||32||
48531280|NCT01076686|101635962|FG003|COMPLETED|Overall Study||31||
48531281|NCT01076686|101635959|FG000|NOT COMPLETED|Overall Study||0||
48531282|NCT01076686|101635960|FG001|NOT COMPLETED|Overall Study||0||
48230986|NCT03162614|100887375|FG004|COMPLETED|Overall Study||21||
48230987|NCT03162614|100887376|FG005|COMPLETED|Overall Study||24||
48230988|NCT03162614|100887371|FG000|NOT COMPLETED|Overall Study||6||
48230989|NCT03162614|100887372|FG001|NOT COMPLETED|Overall Study||5||
48230990|NCT03162614|100887373|FG002|NOT COMPLETED|Overall Study||4||
48230991|NCT03162614|100887374|FG003|NOT COMPLETED|Overall Study||7||
48230992|NCT03162614|100887375|FG004|NOT COMPLETED|Overall Study||5||
48230993|NCT03162614|100887376|FG005|NOT COMPLETED|Overall Study||0||
48230994|NCT02637063|100887377|FG000|STARTED|Overall Study||67||
48230995|NCT02637063|100887378|FG001|STARTED|Overall Study||68||
48230996|NCT02637063|100887379|FG002|STARTED|Overall Study||68||
48531283|NCT01076686|101635961|FG002|NOT COMPLETED|Overall Study||0||
48531284|NCT01076686|101635962|FG003|NOT COMPLETED|Overall Study||0||
48531285|NCT00758680|101635963|FG000|STARTED|Overall Study||6||
48531286|NCT00758680|101635964|FG001|STARTED|Overall Study||6||
48531287|NCT00758680|101635965|FG002|STARTED|Overall Study||6||
48531288|NCT00758680|101635966|FG003|STARTED|Overall Study||6||
48531289|NCT00758680|101635967|FG004|STARTED|Overall Study||6||
48531290|NCT00758680|101635968|FG005|STARTED|Overall Study||6||
48531291|NCT00758680|101635969|FG006|STARTED|Overall Study||7||
48531292|NCT00758680|101635970|FG007|STARTED|Overall Study||20||
48230997|NCT02637063|100887377|FG000|COMPLETED|Overall Study||62||
48230998|NCT02637063|100887378|FG001|COMPLETED|Overall Study||64||
48230999|NCT02637063|100887379|FG002|COMPLETED|Overall Study||62||
48231000|NCT02637063|100887377|FG000|NOT COMPLETED|Overall Study||5||
48231001|NCT02637063|100887378|FG001|NOT COMPLETED|Overall Study||4||
48231002|NCT02637063|100887379|FG002|NOT COMPLETED|Overall Study||6||
48231003|NCT03692871|100887380|FG000|STARTED|Overall Study||1972||
48231004|NCT03692871|100887381|FG001|STARTED|Overall Study||437||
48231005|NCT03692871|100887380|FG000|COMPLETED|Overall Study||1847||
48231006|NCT03692871|100887381|FG001|COMPLETED|Overall Study||400||
48231007|NCT03692871|100887380|FG000|NOT COMPLETED|Overall Study||125||
48231008|NCT03692871|100887381|FG001|NOT COMPLETED|Overall Study||37||
48231009|NCT03142932|100887382|FG000|STARTED|Overall Study||52||
48231010|NCT03142932|100887383|FG001|STARTED|Overall Study||50||
48231011|NCT03142932|100887382|FG000|COMPLETED|Overall Study||50||
48231012|NCT03142932|100887383|FG001|COMPLETED|Overall Study||39||
48231013|NCT03142932|100887382|FG000|NOT COMPLETED|Overall Study||2||
48231014|NCT03142932|100887383|FG001|NOT COMPLETED|Overall Study||11||
48231015|NCT03711279|100887384|FG000|STARTED|Overall Study||51||
48231016|NCT03711279|100887385|FG001|STARTED|Overall Study||48||
48231017|NCT03711279|100887384|FG000|COMPLETED|Overall Study||50||
48231018|NCT03711279|100887385|FG001|COMPLETED|Overall Study||47||
48231019|NCT03711279|100887384|FG000|NOT COMPLETED|Overall Study||1||
48231020|NCT03711279|100887385|FG001|NOT COMPLETED|Overall Study||1||
48231021|NCT01947491|100887386|FG000|STARTED|Overall Study||174||
48231022|NCT01947491|100887387|FG001|STARTED|Overall Study||87||
48231023|NCT01947491|100887388|FG002|STARTED|Overall Study||90||
48231024|NCT01947491|100887389|FG003|STARTED|Overall Study||43||
48231025|NCT01947491|100887386|FG000|COMPLETED|Overall Study||166||
48231026|NCT01947491|100887387|FG001|COMPLETED|Overall Study||81||
48231027|NCT01947491|100887388|FG002|COMPLETED|Overall Study||88||
48531293|NCT00758680|101635971|FG008|STARTED|Overall Study||20||
48531294|NCT00758680|101635972|FG009|STARTED|Overall Study||29||
48531295|NCT00758680|101635963|FG000|COMPLETED|Overall Study||6||
48531296|NCT00758680|101635964|FG001|COMPLETED|Overall Study||6||
48531297|NCT00758680|101635965|FG002|COMPLETED|Overall Study||6||
48531298|NCT00758680|101635966|FG003|COMPLETED|Overall Study||6||
48531299|NCT00758680|101635967|FG004|COMPLETED|Overall Study||6||
48531300|NCT00758680|101635968|FG005|COMPLETED|Overall Study||6||
48531301|NCT00758680|101635969|FG006|COMPLETED|Overall Study||6||
48531302|NCT00758680|101635970|FG007|COMPLETED|Overall Study||19||
48531303|NCT00758680|101635971|FG008|COMPLETED|Overall Study||18||
48531304|NCT00758680|101635972|FG009|COMPLETED|Overall Study||28||
48531305|NCT00758680|101635963|FG000|NOT COMPLETED|Overall Study||0||
48231028|NCT01947491|100887389|FG003|COMPLETED|Overall Study||38||
48231029|NCT01947491|100887386|FG000|NOT COMPLETED|Overall Study||8||
48231030|NCT01947491|100887387|FG001|NOT COMPLETED|Overall Study||6||
48231031|NCT01947491|100887388|FG002|NOT COMPLETED|Overall Study||2||
48231032|NCT01947491|100887389|FG003|NOT COMPLETED|Overall Study||5||
48231033|NCT01316913|100887390|FG000|STARTED|Overall Study||222||
48231034|NCT01316913|100887391|FG001|STARTED|Overall Study||217||
48231035|NCT01316913|100887392|FG002|STARTED|Overall Study||215||
48231036|NCT01316913|100887393|FG003|STARTED|Overall Study||215||
48231037|NCT01316913|100887390|FG000|COMPLETED|Overall Study||165||
48231038|NCT01316913|100887391|FG001|COMPLETED|Overall Study||163||
48531306|NCT00758680|101635964|FG001|NOT COMPLETED|Overall Study||0||
48531307|NCT00758680|101635965|FG002|NOT COMPLETED|Overall Study||0||
48531308|NCT00758680|101635966|FG003|NOT COMPLETED|Overall Study||0||
48531309|NCT00758680|101635967|FG004|NOT COMPLETED|Overall Study||0||
48531310|NCT00758680|101635968|FG005|NOT COMPLETED|Overall Study||0||
48531311|NCT00758680|101635969|FG006|NOT COMPLETED|Overall Study||1||
48531312|NCT00758680|101635970|FG007|NOT COMPLETED|Overall Study||1||
48531313|NCT00758680|101635971|FG008|NOT COMPLETED|Overall Study||2||
48531314|NCT00758680|101635972|FG009|NOT COMPLETED|Overall Study||1||
48531315|NCT03709823|101635973|FG000|STARTED|Overall Study||51||
48531316|NCT03709823|101635974|FG001|STARTED|Overall Study||50||
48531317|NCT03709823|101635975|FG002|STARTED|Overall Study||25||
48531318|NCT03709823|101635976|FG003|STARTED|Overall Study||52||
48531319|NCT03709823|101635977|FG004|STARTED|Overall Study||50||
48531320|NCT03709823|101635978|FG005|STARTED|Overall Study||26||
48531321|NCT03709823|101635973|FG000|COMPLETED|Overall Study||48||
48531322|NCT03709823|101635974|FG001|COMPLETED|Overall Study||45||
48531323|NCT03709823|101635975|FG002|COMPLETED|Overall Study||22||
48231039|NCT01316913|100887392|FG002|COMPLETED|Overall Study||166||
48231040|NCT01316913|100887393|FG003|COMPLETED|Overall Study||176||
48231041|NCT01316913|100887390|FG000|NOT COMPLETED|Overall Study||57||
48231042|NCT01316913|100887391|FG001|NOT COMPLETED|Overall Study||54||
48231043|NCT01316913|100887392|FG002|NOT COMPLETED|Overall Study||49||
48231044|NCT01316913|100887393|FG003|NOT COMPLETED|Overall Study||39||
48231045|NCT00599196|100887394|FG000|STARTED|Overall Study||381||
48531324|NCT03709823|101635976|FG003|COMPLETED|Overall Study||50||
48531325|NCT03709823|101635977|FG004|COMPLETED|Overall Study||49||
48231046|NCT00599196|100887394|FG000|COMPLETED|Overall Study||0||
48231047|NCT00599196|100887394|FG000|NOT COMPLETED|Overall Study||381||
48231048|NCT02068157|100887395|FG000|STARTED|Overall Study||3||
48231049|NCT02068157|100887395|FG000|COMPLETED|Overall Study||3||
48231050|NCT02068157|100887395|FG000|NOT COMPLETED|Overall Study||0||
48231051|NCT01297595|100887396|FG000|STARTED|First Intervention Period||11||
48231052|NCT01297595|100887397|FG001|STARTED|First Intervention Period||11||
48231053|NCT01297595|100887396|FG000|COMPLETED|First Intervention Period||11||
48231054|NCT01297595|100887397|FG001|COMPLETED|First Intervention Period||11||
48231055|NCT01297595|100887396|FG000|NOT COMPLETED|First Intervention Period||0||
48231056|NCT01297595|100887397|FG001|NOT COMPLETED|First Intervention Period||0||
48231057|NCT01297595|100887396|FG000|STARTED|Washout Period (At Least 14 Days)||11||
48531326|NCT03709823|101635978|FG005|COMPLETED|Overall Study||26||
48531327|NCT03709823|101635973|FG000|NOT COMPLETED|Overall Study||3||
48231058|NCT01297595|100887397|FG001|STARTED|Washout Period (At Least 14 Days)||11||
48531328|NCT03709823|101635974|FG001|NOT COMPLETED|Overall Study||5||
48531329|NCT03709823|101635975|FG002|NOT COMPLETED|Overall Study||3||
48531330|NCT03709823|101635976|FG003|NOT COMPLETED|Overall Study||2||
48531331|NCT03709823|101635977|FG004|NOT COMPLETED|Overall Study||1||
48531332|NCT03709823|101635978|FG005|NOT COMPLETED|Overall Study||0||
48531333|NCT03796039|101635979|FG000|STARTED|Overall Study||50||
48531334|NCT03796039|101635980|FG001|STARTED|Overall Study||47||
48531335|NCT03796039|101635979|FG000|COMPLETED|Overall Study||41||
48531336|NCT03796039|101635980|FG001|COMPLETED|Overall Study||42||
48531337|NCT03796039|101635979|FG000|NOT COMPLETED|Overall Study||9||
48531338|NCT03796039|101635980|FG001|NOT COMPLETED|Overall Study||5||
48531339|NCT03014180|101635981|FG000|STARTED|Overall Study||60||
48531340|NCT03014180|101635981|FG000|COMPLETED|Overall Study||58||
48531341|NCT03014180|101635981|FG000|NOT COMPLETED|Overall Study||2||
48531342|NCT02227147|101635982|FG000|STARTED|Controlled Treatment Period||24||
48531343|NCT02227147|101635983|FG001|STARTED|Controlled Treatment Period||24||
48531344|NCT02227147|101635982|FG000|COMPLETED|Controlled Treatment Period||18||
48531345|NCT02227147|101635983|FG001|COMPLETED|Controlled Treatment Period||21||
48531346|NCT02227147|101635982|FG000|NOT COMPLETED|Controlled Treatment Period||6||
48531347|NCT02227147|101635983|FG001|NOT COMPLETED|Controlled Treatment Period||3||
48531348|NCT02227147|101635982|FG000|STARTED|Follow-up Period||18||
48531349|NCT02227147|101635983|FG001|STARTED|Follow-up Period||21||
48531350|NCT02227147|101635982|FG000|COMPLETED|Follow-up Period||15||
48531351|NCT02227147|101635983|FG001|COMPLETED|Follow-up Period||16||
48531352|NCT02227147|101635982|FG000|NOT COMPLETED|Follow-up Period||3||
48531353|NCT02227147|101635983|FG001|NOT COMPLETED|Follow-up Period||5||
48531354|NCT04168190|101635984|FG000|STARTED|Overall Study||30||
48531355|NCT04168190|101635985|FG001|STARTED|Overall Study||30||
48531356|NCT04168190|101635986|FG002|STARTED|Overall Study||30||
48531357|NCT04168190|101635987|FG003|STARTED|Overall Study||254||
48531358|NCT04168190|101635988|FG004|STARTED|Overall Study||256||
48531359|NCT04168190|101635984|FG000|Treated|Overall Study||30||
48531360|NCT04168190|101635985|FG001|Treated|Overall Study||30||
48531361|NCT04168190|101635986|FG002|Treated|Overall Study||30||
48531362|NCT04168190|101635987|FG003|Treated|Overall Study||254||
48531363|NCT04168190|101635988|FG004|Treated|Overall Study||254||
48531364|NCT04168190|101635984|FG000|COMPLETED|Overall Study||29||
48531365|NCT04168190|101635985|FG001|COMPLETED|Overall Study||29||
48531366|NCT04168190|101635986|FG002|COMPLETED|Overall Study||30||
48531367|NCT04168190|101635987|FG003|COMPLETED|Overall Study||244||
48531368|NCT04168190|101635988|FG004|COMPLETED|Overall Study||247||
48531369|NCT04168190|101635984|FG000|NOT COMPLETED|Overall Study||1||
48531370|NCT04168190|101635985|FG001|NOT COMPLETED|Overall Study||1||
48531371|NCT04168190|101635986|FG002|NOT COMPLETED|Overall Study||0||
48531372|NCT04168190|101635987|FG003|NOT COMPLETED|Overall Study||10||
48231059|NCT01297595|100887396|FG000|COMPLETED|Washout Period (At Least 14 Days)||11||
48231060|NCT01297595|100887397|FG001|COMPLETED|Washout Period (At Least 14 Days)||11||
48231061|NCT01297595|100887396|FG000|NOT COMPLETED|Washout Period (At Least 14 Days)||0||
48531373|NCT04168190|101635988|FG004|NOT COMPLETED|Overall Study||9||
48531374|NCT01700036|101635989|FG000|STARTED|Overall Study||40||
48531375|NCT01700036|101635989|FG000|COMPLETED|Overall Study||40||
48531376|NCT01700036|101635989|FG000|NOT COMPLETED|Overall Study||0||
48531377|NCT04392583|101635990|FG000|STARTED|Overall Study||40||
48231062|NCT01297595|100887397|FG001|NOT COMPLETED|Washout Period (At Least 14 Days)||0||
48231063|NCT01297595|100887396|FG000|STARTED|Second Intervention Period||11||
48231064|NCT01297595|100887397|FG001|STARTED|Second Intervention Period||11||
48231065|NCT01297595|100887396|FG000|COMPLETED|Second Intervention Period||11||
48231066|NCT01297595|100887397|FG001|COMPLETED|Second Intervention Period||11||
48531378|NCT04392583|101635990|FG000|COMPLETED|Overall Study||39||
48531379|NCT04392583|101635990|FG000|NOT COMPLETED|Overall Study||1||
48531380|NCT02351960|101635991|FG000|STARTED|Overall Study||208||
48531381|NCT02351960|101635992|FG001|STARTED|Overall Study||88||
48531382|NCT02351960|101635991|FG000|COMPLETED|Overall Study||197||
48531383|NCT02351960|101635992|FG001|COMPLETED|Overall Study||76||
48531384|NCT02351960|101635991|FG000|NOT COMPLETED|Overall Study||11||
48531385|NCT02351960|101635992|FG001|NOT COMPLETED|Overall Study||12||
48531386|NCT00511095|101635993|FG000|STARTED|Overall Study||207||
48531387|NCT00511095|101635993|FG000|COMPLETED|Overall Study||196||
48531388|NCT00511095|101635993|FG000|NOT COMPLETED|Overall Study||11||
48531389|NCT02699684|101635994|FG000|STARTED|Period 1, First 30 Days of Wear||37||
48531390|NCT02699684|101635995|FG001|STARTED|Period 1, First 30 Days of Wear||38||
48531391|NCT02699684|101635994|FG000|COMPLETED|Period 1, First 30 Days of Wear||37||
48531392|NCT02699684|101635995|FG001|COMPLETED|Period 1, First 30 Days of Wear||38||
48531393|NCT02699684|101635994|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||0||
48531394|NCT02699684|101635995|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||0||
48531395|NCT02699684|101635994|FG000|STARTED|Period 2, Second 30 Days of Wear||37||
48531396|NCT02699684|101635995|FG001|STARTED|Period 2, Second 30 Days of Wear||38||
48531397|NCT02699684|101635994|FG000|COMPLETED|Period 2, Second 30 Days of Wear||36||
48231067|NCT01297595|100887396|FG000|NOT COMPLETED|Second Intervention Period||0||
48231068|NCT01297595|100887397|FG001|NOT COMPLETED|Second Intervention Period||0||
48231069|NCT01673256|100887398|FG000|STARTED|Overall Study||90||
48231070|NCT01673256|100887398|FG000|COMPLETED|Overall Study||90||
48231071|NCT01673256|100887398|FG000|NOT COMPLETED|Overall Study||0||
48231072|NCT01519882|100887399|FG000|STARTED|Overall Study||1||
48231073|NCT01519882|100887400|FG001|STARTED|Overall Study||0||
48231074|NCT01519882|100887399|FG000|COMPLETED|Overall Study||1||
48231075|NCT01519882|100887400|FG001|COMPLETED|Overall Study||0||
48231076|NCT01519882|100887399|FG000|NOT COMPLETED|Overall Study||0||
48231077|NCT01519882|100887400|FG001|NOT COMPLETED|Overall Study||0||
48231078|NCT02340806|100887401|FG000|STARTED|Overall Study||108||
48231079|NCT02340806|100887402|FG001|STARTED|Overall Study||112||
48231080|NCT02340806|100887401|FG000|COMPLETED|Overall Study||102||
48231081|NCT02340806|100887402|FG001|COMPLETED|Overall Study||108||
48231082|NCT02340806|100887401|FG000|NOT COMPLETED|Overall Study||6||
48231083|NCT02340806|100887402|FG001|NOT COMPLETED|Overall Study||4||
48231084|NCT00712179|100887403|FG000|STARTED|Overall Study||49||
48231085|NCT00712179|100887403|FG000|COMPLETED|Overall Study||37||
48231086|NCT00712179|100887403|FG000|NOT COMPLETED|Overall Study||12||
48231087|NCT01303744|100887404|FG000|STARTED|Overall Study||24||
48231088|NCT01303744|100887405|FG001|STARTED|Overall Study||24||
48231089|NCT01303744|100887406|FG002|STARTED|Overall Study||24||
48231090|NCT01303744|100887407|FG003|STARTED|Overall Study||24||
48231091|NCT01303744|100887404|FG000|COMPLETED|Overall Study||24||
48231092|NCT01303744|100887405|FG001|COMPLETED|Overall Study||24||
48231093|NCT01303744|100887406|FG002|COMPLETED|Overall Study||24||
48231094|NCT01303744|100887407|FG003|COMPLETED|Overall Study||24||
48231095|NCT01303744|100887404|FG000|NOT COMPLETED|Overall Study||0||
48231096|NCT01303744|100887405|FG001|NOT COMPLETED|Overall Study||0||
48231097|NCT01303744|100887406|FG002|NOT COMPLETED|Overall Study||0||
48231098|NCT01303744|100887407|FG003|NOT COMPLETED|Overall Study||0||
48231099|NCT03150589|100887408|FG000|STARTED|Overall Study||351||
48231100|NCT03150589|100887409|FG001|STARTED|Overall Study||354||
48231101|NCT03150589|100887408|FG000|COMPLETED|Overall Study||307||
48231102|NCT03150589|100887409|FG001|COMPLETED|Overall Study||327||
48231103|NCT03150589|100887408|FG000|NOT COMPLETED|Overall Study||44||
48231104|NCT03150589|100887409|FG001|NOT COMPLETED|Overall Study||27||
48231105|NCT03265132|100887410|FG000|STARTED|Overall Study||6||
48531398|NCT02699684|101635995|FG001|COMPLETED|Period 2, Second 30 Days of Wear||38||
48531399|NCT02699684|101635994|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||1||
48531400|NCT02699684|101635995|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||0||
48531401|NCT01007942|101635996|FG000|STARTED|Overall Study||284||
48531402|NCT01007942|101635997|FG001|STARTED|Overall Study||285||
48531403|NCT01007942|101635996|FG000|COMPLETED|Overall Study||3||
48531404|NCT01007942|101635997|FG001|COMPLETED|Overall Study||7||
48231106|NCT03265132|100887411|FG001|STARTED|Overall Study||6||
48231107|NCT03265132|100887410|FG000|COMPLETED|Overall Study||6||
48231108|NCT03265132|100887411|FG001|COMPLETED|Overall Study||0||
48231109|NCT03265132|100887410|FG000|NOT COMPLETED|Overall Study||0||
48231110|NCT03265132|100887411|FG001|NOT COMPLETED|Overall Study||6||
48231111|NCT03070548|100887412|FG000|STARTED|Overall Study||6||
48231112|NCT03070548|100887412|FG000|COMPLETED|Overall Study||6||
48231113|NCT03070548|100887412|FG000|NOT COMPLETED|Overall Study||0||
48231114|NCT00378898|100887413|FG000|STARTED|Overall Study||22||
48231115|NCT00378898|100887414|FG001|STARTED|Overall Study||17||
48231116|NCT00378898|100887413|FG000|COMPLETED|Overall Study||11||
48231117|NCT00378898|100887414|FG001|COMPLETED|Overall Study||11||
48231118|NCT00378898|100887413|FG000|NOT COMPLETED|Overall Study||11||
48231119|NCT00378898|100887414|FG001|NOT COMPLETED|Overall Study||6||
48231120|NCT01853384|100887415|FG000|STARTED|Randomized||131||
48231121|NCT01853384|100887416|FG001|STARTED|Randomized||121||
48531405|NCT01007942|101635996|FG000|NOT COMPLETED|Overall Study||281||
48531406|NCT01007942|101635997|FG001|NOT COMPLETED|Overall Study||278||
48231122|NCT01853384|100887415|FG000|COMPLETED|Randomized||69||
48231123|NCT01853384|100887416|FG001|COMPLETED|Randomized||75||
48231124|NCT01853384|100887415|FG000|NOT COMPLETED|Randomized||62||
48231125|NCT01853384|100887416|FG001|NOT COMPLETED|Randomized||46||
48231126|NCT01853384|100887415|FG000|STARTED|Enrolled in Follow up Period||96||
48231127|NCT01853384|100887416|FG001|STARTED|Enrolled in Follow up Period||94||
48231128|NCT01853384|100887415|FG000|Not Enrolled in Follow-up|Enrolled in Follow up Period||35||
48231129|NCT01853384|100887416|FG001|Not Enrolled in Follow-up|Enrolled in Follow up Period||27||
48231130|NCT01853384|100887415|FG000|COMPLETED|Enrolled in Follow up Period||96||
48231131|NCT01853384|100887416|FG001|COMPLETED|Enrolled in Follow up Period||94||
48231132|NCT01853384|100887415|FG000|NOT COMPLETED|Enrolled in Follow up Period||0||
48231133|NCT01853384|100887416|FG001|NOT COMPLETED|Enrolled in Follow up Period||0||
48231134|NCT01853384|100887415|FG000|STARTED|Completed Follow up Visit 1||96||
48231135|NCT01853384|100887416|FG001|STARTED|Completed Follow up Visit 1||94||
48231136|NCT01853384|100887415|FG000|COMPLETED|Completed Follow up Visit 1||82||
48231137|NCT01853384|100887416|FG001|COMPLETED|Completed Follow up Visit 1||85||
48231138|NCT01853384|100887415|FG000|NOT COMPLETED|Completed Follow up Visit 1||14||
48231139|NCT01853384|100887416|FG001|NOT COMPLETED|Completed Follow up Visit 1||9||
48231140|NCT01853384|100887415|FG000|STARTED|Completed Follow up Visit 2||96||
48231141|NCT01853384|100887416|FG001|STARTED|Completed Follow up Visit 2||94||
48231142|NCT01853384|100887415|FG000|COMPLETED|Completed Follow up Visit 2||93||
48231143|NCT01853384|100887416|FG001|COMPLETED|Completed Follow up Visit 2||91||
48231144|NCT01853384|100887415|FG000|NOT COMPLETED|Completed Follow up Visit 2||3||
48231145|NCT01853384|100887416|FG001|NOT COMPLETED|Completed Follow up Visit 2||3||
48531407|NCT01595386|101635998|FG000|STARTED|Overall Study||21||
48531408|NCT01595386|101635999|FG001|STARTED|Overall Study||19||
48531409|NCT01595386|101635998|FG000|COMPLETED|Overall Study||21||
48531410|NCT01595386|101635999|FG001|COMPLETED|Overall Study||19||
48531411|NCT01595386|101635998|FG000|NOT COMPLETED|Overall Study||0||
48531412|NCT01595386|101635999|FG001|NOT COMPLETED|Overall Study||0||
48531413|NCT03397771|101636000|FG000|STARTED|Overall Study||53|Total number is reported as 84; data is reported for 82 subjects as 2 were randomisation errors.|
48531414|NCT03397771|101636001|FG001|STARTED|Overall Study||29|Total number is reported as 84; data is reported for 82 subjects as 2 were randomisation errors.|
48531415|NCT03397771|101636000|FG000|COMPLETED|Overall Study||45||
48531416|NCT03397771|101636001|FG001|COMPLETED|Overall Study||22||
48531417|NCT03397771|101636000|FG000|NOT COMPLETED|Overall Study||8||
48531418|NCT03397771|101636001|FG001|NOT COMPLETED|Overall Study||7||
48531419|NCT01853930|101636002|FG000|STARTED|Overall Study||25||
48531420|NCT01853930|101636003|FG001|STARTED|Overall Study||8||
48531421|NCT01853930|101636002|FG000|COMPLETED|Overall Study||25||
48531422|NCT01853930|101636003|FG001|COMPLETED|Overall Study||8||
48531423|NCT01853930|101636002|FG000|NOT COMPLETED|Overall Study||0||
48531424|NCT01853930|101636003|FG001|NOT COMPLETED|Overall Study||0||
48531425|NCT02716727|101636004|FG000|STARTED|Overall Study||7||
48531426|NCT02716727|101636005|FG001|STARTED|Overall Study||9||
48531427|NCT02716727|101636004|FG000|COMPLETED|Overall Study||7||
48531428|NCT02716727|101636005|FG001|COMPLETED|Overall Study||9||
48531429|NCT02716727|101636004|FG000|NOT COMPLETED|Overall Study||0||
48231146|NCT01180959|100887417|FG000|STARTED|Overall Study||44||
48231147|NCT01180959|100887417|FG000|COMPLETED|Overall Study||44||
48231148|NCT01180959|100887417|FG000|NOT COMPLETED|Overall Study||0||
48231149|NCT01613599|100887418|FG000|STARTED|Overall Study||97||
48231150|NCT01613599|100887418|FG000|COMPLETED|Overall Study||72||
48231151|NCT01613599|100887418|FG000|NOT COMPLETED|Overall Study||25||
48231152|NCT03345979|100887419|FG000|STARTED|Overall Study||99||
48231153|NCT03345979|100887420|FG001|STARTED|Overall Study||101||
48231154|NCT03345979|100887419|FG000|COMPLETED|Overall Study||56||
48231155|NCT03345979|100887420|FG001|COMPLETED|Overall Study||43||
48231156|NCT03345979|100887419|FG000|NOT COMPLETED|Overall Study||43||
48231157|NCT03345979|100887420|FG001|NOT COMPLETED|Overall Study||58||
48231158|NCT01000649|100887421|FG000|STARTED|Overall Study||10||
48231159|NCT01000649|100887422|FG001|STARTED|Overall Study||19||
48531430|NCT02716727|101636005|FG001|NOT COMPLETED|Overall Study||0||
48531431|NCT00589329|101636006|FG000|STARTED|Overall Study||10||
48531432|NCT00589329|101636007|FG001|STARTED|Overall Study||10||
48531433|NCT00589329|101636006|FG000|COMPLETED|Overall Study||10||
48531434|NCT00589329|101636007|FG001|COMPLETED|Overall Study||10||
48531435|NCT00589329|101636006|FG000|NOT COMPLETED|Overall Study||0||
48531436|NCT00589329|101636007|FG001|NOT COMPLETED|Overall Study||0||
48531437|NCT00915928|101636008|FG000|STARTED|Overall Study||25||
48231160|NCT01000649|100887423|FG002|STARTED|Overall Study||2||
48231161|NCT01000649|100887424|FG003|STARTED|Overall Study||21||
48231162|NCT01000649|100887421|FG000|Intention-to-Treat (ITT) Analysis Set|Overall Study||10||
48231163|NCT01000649|100887422|FG001|Intention-to-Treat (ITT) Analysis Set|Overall Study||20||
48231164|NCT01000649|100887423|FG002|Intention-to-Treat (ITT) Analysis Set|Overall Study||2||
48231165|NCT01000649|100887424|FG003|Intention-to-Treat (ITT) Analysis Set|Overall Study||21||
48231166|NCT01000649|100887421|FG000|COMPLETED|Overall Study||5||
48231167|NCT01000649|100887422|FG001|COMPLETED|Overall Study||16||
48231168|NCT01000649|100887423|FG002|COMPLETED|Overall Study||0||
48231169|NCT01000649|100887424|FG003|COMPLETED|Overall Study||15||
48231170|NCT01000649|100887421|FG000|NOT COMPLETED|Overall Study||5||
48231171|NCT01000649|100887422|FG001|NOT COMPLETED|Overall Study||3||
48231172|NCT01000649|100887423|FG002|NOT COMPLETED|Overall Study||2||
48231173|NCT01000649|100887424|FG003|NOT COMPLETED|Overall Study||6||
48531438|NCT00915928|101636009|FG001|STARTED|Overall Study||22||
48531439|NCT00915928|101636008|FG000|COMPLETED|Overall Study||25||
48531440|NCT00915928|101636009|FG001|COMPLETED|Overall Study||22||
48531441|NCT00915928|101636008|FG000|NOT COMPLETED|Overall Study||0||
48231174|NCT02671266|100887425|FG000|STARTED|Overall Study||20||
48231175|NCT02671266|100887426|FG001|STARTED|Overall Study||21||
48231176|NCT02671266|100887425|FG000|BDD Participants|Overall Study||9||
48531442|NCT00915928|101636009|FG001|NOT COMPLETED|Overall Study||0||
48531443|NCT01026181|101636010|FG000|STARTED|Overall Study||51||
48531444|NCT01026181|101636011|FG001|STARTED|Overall Study||51||
48531445|NCT01026181|101636012|FG002|STARTED|Overall Study||48||
48531446|NCT01026181|101636010|FG000|COMPLETED|Overall Study||51||
48531447|NCT01026181|101636011|FG001|COMPLETED|Overall Study||51||
48531448|NCT01026181|101636012|FG002|COMPLETED|Overall Study||48||
48531449|NCT01026181|101636010|FG000|NOT COMPLETED|Overall Study||0||
48531450|NCT01026181|101636011|FG001|NOT COMPLETED|Overall Study||0||
48531451|NCT01026181|101636012|FG002|NOT COMPLETED|Overall Study||0||
48531452|NCT03484117|101636013|FG000|STARTED|Overall Study||32||
48531453|NCT03484117|101636014|FG001|STARTED|Overall Study||35||
48531454|NCT03484117|101636013|FG000|COMPLETED|Overall Study||30||
48531455|NCT03484117|101636014|FG001|COMPLETED|Overall Study||31||
48531456|NCT03484117|101636013|FG000|NOT COMPLETED|Overall Study||2||
48531457|NCT03484117|101636014|FG001|NOT COMPLETED|Overall Study||4||
48531458|NCT01325181|101636015|FG000|STARTED|Overall Study||18||
48531459|NCT01325181|101636016|FG001|STARTED|Overall Study||16||
48531460|NCT01325181|101636015|FG000|COMPLETED|Overall Study||18||
48531461|NCT01325181|101636016|FG001|COMPLETED|Overall Study||14||
48531462|NCT01325181|101636015|FG000|NOT COMPLETED|Overall Study||0||
48531463|NCT01325181|101636016|FG001|NOT COMPLETED|Overall Study||2||
48531464|NCT00459121|101636017|FG000|STARTED|Overall Study||2||
48531465|NCT00459121|101636017|FG000|COMPLETED|Overall Study||2||
48531466|NCT00459121|101636017|FG000|NOT COMPLETED|Overall Study||0||
48531467|NCT02034058|101636018|FG000|STARTED|Overall Study||152||
48531468|NCT02034058|101636018|FG000|COMPLETED|Overall Study||149||
48531469|NCT02034058|101636018|FG000|NOT COMPLETED|Overall Study||3||
48531470|NCT02516553|101636019|FG000|STARTED|Overall Study||2||
48531471|NCT02516553|101636020|FG001|STARTED|Overall Study||2||
48531472|NCT02516553|101636021|FG002|STARTED|Overall Study||3||
48531473|NCT02516553|101636022|FG003|STARTED|Overall Study||6||
48531474|NCT02516553|101636023|FG004|STARTED|Overall Study||6||
48531475|NCT02516553|101636024|FG005|STARTED|Overall Study||2||
48531476|NCT02516553|101636025|FG006|STARTED|Overall Study||6||
48531477|NCT02516553|101636026|FG007|STARTED|Overall Study||6||
48531478|NCT02516553|101636027|FG008|STARTED|Overall Study||13||
48531479|NCT02516553|101636028|FG009|STARTED|Overall Study||4||
48531480|NCT02516553|101636029|FG010|STARTED|Overall Study||15||
48531481|NCT02516553|101636030|FG011|STARTED|Overall Study||12||
48531482|NCT02516553|101636031|FG012|STARTED|Overall Study||8||
48531483|NCT02516553|101636032|FG013|STARTED|Overall Study||4||
48531484|NCT02516553|101636033|FG014|STARTED|Overall Study||2||
48531485|NCT02516553|101636034|FG015|STARTED|Overall Study||2||
48531486|NCT02516553|101636035|FG016|STARTED|Overall Study||2||
48531487|NCT02516553|101636036|FG017|STARTED|Overall Study||12||
48531488|NCT02516553|101636037|FG018|STARTED|Overall Study||14||
48531489|NCT02516553|101636038|FG019|STARTED|Overall Study||11||
48531490|NCT02516553|101636039|FG020|STARTED|Overall Study||20||
48531491|NCT02516553|101636040|FG021|STARTED|Overall Study||22||
48531492|NCT02516553|101636019|FG000|COMPLETED|Overall Study||0||
48531493|NCT02516553|101636020|FG001|COMPLETED|Overall Study||0||
48531494|NCT02516553|101636021|FG002|COMPLETED|Overall Study||0||
48531495|NCT02516553|101636022|FG003|COMPLETED|Overall Study||0||
48531496|NCT02516553|101636023|FG004|COMPLETED|Overall Study||0||
48531497|NCT02516553|101636024|FG005|COMPLETED|Overall Study||0||
48531498|NCT02516553|101636025|FG006|COMPLETED|Overall Study||0||
48531499|NCT02516553|101636026|FG007|COMPLETED|Overall Study||0||
48531500|NCT02516553|101636027|FG008|COMPLETED|Overall Study||0||
48531501|NCT02516553|101636028|FG009|COMPLETED|Overall Study||0||
48531502|NCT02516553|101636029|FG010|COMPLETED|Overall Study||0||
48531503|NCT02516553|101636030|FG011|COMPLETED|Overall Study||0||
48531504|NCT02516553|101636031|FG012|COMPLETED|Overall Study||0||
48531505|NCT02516553|101636032|FG013|COMPLETED|Overall Study||0||
48531506|NCT02516553|101636033|FG014|COMPLETED|Overall Study||0||
48531507|NCT02516553|101636034|FG015|COMPLETED|Overall Study||0||
48531508|NCT02516553|101636035|FG016|COMPLETED|Overall Study||0||
48531509|NCT02516553|101636036|FG017|COMPLETED|Overall Study||0||
48531510|NCT02516553|101636037|FG018|COMPLETED|Overall Study||0||
48531511|NCT02516553|101636038|FG019|COMPLETED|Overall Study||0||
48231177|NCT02671266|100887426|FG001|BDD Participants|Overall Study||9||
48231178|NCT02671266|100887425|FG000|OCD Participants|Overall Study||2||
48231179|NCT02671266|100887426|FG001|OCD Participants|Overall Study||3||
48231180|NCT02671266|100887425|FG000|Healthy Participants|Overall Study||8||
48231181|NCT02671266|100887426|FG001|Healthy Participants|Overall Study||8||
48231182|NCT02671266|100887425|FG000|COMPLETED|Overall Study||19||
48231183|NCT02671266|100887426|FG001|COMPLETED|Overall Study||20||
48231184|NCT02671266|100887425|FG000|NOT COMPLETED|Overall Study||1||
48231185|NCT02671266|100887426|FG001|NOT COMPLETED|Overall Study||1||
48231186|NCT00047385|100887427|FG000|STARTED|Overall Study||26722||
48231187|NCT00047385|100887428|FG001|STARTED|Overall Study||26732||
48531512|NCT02516553|101636039|FG020|COMPLETED|Overall Study||0||
48531513|NCT02516553|101636040|FG021|COMPLETED|Overall Study||0||
48531514|NCT02516553|101636019|FG000|NOT COMPLETED|Overall Study||2||
48531515|NCT02516553|101636020|FG001|NOT COMPLETED|Overall Study||2||
48531516|NCT02516553|101636021|FG002|NOT COMPLETED|Overall Study||3||
48531517|NCT02516553|101636022|FG003|NOT COMPLETED|Overall Study||6||
48531518|NCT02516553|101636023|FG004|NOT COMPLETED|Overall Study||6||
48531519|NCT02516553|101636024|FG005|NOT COMPLETED|Overall Study||2||
48531520|NCT02516553|101636025|FG006|NOT COMPLETED|Overall Study||6||
48531521|NCT02516553|101636026|FG007|NOT COMPLETED|Overall Study||6||
48531522|NCT02516553|101636027|FG008|NOT COMPLETED|Overall Study||13||
48531523|NCT02516553|101636028|FG009|NOT COMPLETED|Overall Study||4||
48531524|NCT02516553|101636029|FG010|NOT COMPLETED|Overall Study||15||
48531525|NCT02516553|101636030|FG011|NOT COMPLETED|Overall Study||12||
48531526|NCT02516553|101636031|FG012|NOT COMPLETED|Overall Study||8||
48531527|NCT02516553|101636032|FG013|NOT COMPLETED|Overall Study||4||
48531528|NCT02516553|101636033|FG014|NOT COMPLETED|Overall Study||2||
48531529|NCT02516553|101636034|FG015|NOT COMPLETED|Overall Study||2||
48531530|NCT02516553|101636035|FG016|NOT COMPLETED|Overall Study||2||
48531531|NCT02516553|101636036|FG017|NOT COMPLETED|Overall Study||12||
48531532|NCT02516553|101636037|FG018|NOT COMPLETED|Overall Study||14||
48531533|NCT02516553|101636038|FG019|NOT COMPLETED|Overall Study||11||
48531534|NCT02516553|101636039|FG020|NOT COMPLETED|Overall Study||20||
48531535|NCT02516553|101636040|FG021|NOT COMPLETED|Overall Study||22||
48531536|NCT01229735|101636041|FG000|STARTED|Overall Study||177||
48531537|NCT01229735|101636042|FG001|STARTED|Overall Study||166||
48531538|NCT01229735|101636041|FG000|COMPLETED|Overall Study||111||
48531539|NCT01229735|101636042|FG001|COMPLETED|Overall Study||100||
48531540|NCT01229735|101636041|FG000|NOT COMPLETED|Overall Study||66||
48531541|NCT01229735|101636042|FG001|NOT COMPLETED|Overall Study||66||
48531542|NCT00436904|101636043|FG000|STARTED|Overall Study||30||
48531543|NCT00436904|101636043|FG000|COMPLETED|Overall Study||30||
48231188|NCT00047385|100887427|FG000|COMPLETED|Overall Study||26455||
48231189|NCT00047385|100887428|FG001|COMPLETED|Overall Study||26232||
48531544|NCT00436904|101636043|FG000|NOT COMPLETED|Overall Study||0||
48531545|NCT01517659|101636044|FG000|STARTED|Overall Study||45||
48531546|NCT01517659|101636044|FG000|COMPLETED|Overall Study||45||
48531547|NCT01517659|101636044|FG000|NOT COMPLETED|Overall Study||0||
48531548|NCT02620150|101636045|FG000|STARTED|Overall Study||55||
48531549|NCT02620150|101636046|FG001|STARTED|Overall Study||53||
48531550|NCT02620150|101636045|FG000|COMPLETED|Overall Study||48||
48531551|NCT02620150|101636046|FG001|COMPLETED|Overall Study||50||
48531552|NCT02620150|101636045|FG000|NOT COMPLETED|Overall Study||7||
48531553|NCT02620150|101636046|FG001|NOT COMPLETED|Overall Study||3||
48531554|NCT00030992|101636047|FG000|STARTED|Overall Study||102||
48531555|NCT00030992|101636047|FG000|COMPLETED|Overall Study||102||
48531556|NCT00030992|101636047|FG000|NOT COMPLETED|Overall Study||0||
48531557|NCT03255655|101636048|FG000|STARTED|Overall Study||29||
48531558|NCT03255655|101636049|FG001|STARTED|Overall Study||12||
48531559|NCT03255655|101636048|FG000|COMPLETED|Overall Study||22||
48531560|NCT03255655|101636049|FG001|COMPLETED|Overall Study||8||
48531561|NCT03255655|101636048|FG000|NOT COMPLETED|Overall Study||7||
48531562|NCT03255655|101636049|FG001|NOT COMPLETED|Overall Study||4||
48531563|NCT01011179|101636050|FG000|STARTED|Overall Study||24||
48531564|NCT01011179|101636051|FG001|STARTED|Overall Study||22||
48531565|NCT01011179|101636050|FG000|COMPLETED|Overall Study||20||
48531566|NCT01011179|101636051|FG001|COMPLETED|Overall Study||20||
48531567|NCT01011179|101636050|FG000|NOT COMPLETED|Overall Study||4||
48531568|NCT01011179|101636051|FG001|NOT COMPLETED|Overall Study||2||
48531569|NCT03670264|101636052|FG000|STARTED|Overall Study||5||
48531570|NCT03670264|101636053|FG001|STARTED|Overall Study||5||
48531571|NCT03670264|101636054|FG002|STARTED|Overall Study||5||
48531572|NCT03670264|101636052|FG000|COMPLETED|Overall Study||5||
48231190|NCT00047385|100887427|FG000|NOT COMPLETED|Overall Study||267||
48231191|NCT00047385|100887428|FG001|NOT COMPLETED|Overall Study||500||
48231192|NCT04108858|100887429|FG000|STARTED|Overall Study||2||
48231193|NCT04108858|100887429|FG000|COMPLETED|Overall Study||1||
48231194|NCT04108858|100887429|FG000|NOT COMPLETED|Overall Study||1||
48531573|NCT03670264|101636053|FG001|COMPLETED|Overall Study||5||
48531574|NCT03670264|101636054|FG002|COMPLETED|Overall Study||5||
48531575|NCT03670264|101636052|FG000|NOT COMPLETED|Overall Study||0||
48531576|NCT03670264|101636053|FG001|NOT COMPLETED|Overall Study||0||
48531577|NCT03670264|101636054|FG002|NOT COMPLETED|Overall Study||0||
48531578|NCT03551496|101636055|FG000|STARTED|Overall Study||130||
48531579|NCT03551496|101636056|FG001|STARTED|Overall Study||71||
48531580|NCT03551496|101636055|FG000|COMPLETED|Overall Study||114||
48531581|NCT03551496|101636056|FG001|COMPLETED|Overall Study||61||
48531582|NCT03551496|101636055|FG000|NOT COMPLETED|Overall Study||16||
48231195|NCT03500406|100887430|FG000|STARTED|Overall Study||4||
48531583|NCT03551496|101636056|FG001|NOT COMPLETED|Overall Study||10||
48531584|NCT04112173|101636057|FG000|STARTED|Overall Study||1||
48531585|NCT04112173|101636057|FG000|COMPLETED|Overall Study||0||
48231196|NCT03500406|100887431|FG001|STARTED|Overall Study||20||
48231197|NCT03500406|100887430|FG000|COMPLETED|Overall Study||4||
48231198|NCT03500406|100887431|FG001|COMPLETED|Overall Study||20||
48231199|NCT03500406|100887430|FG000|NOT COMPLETED|Overall Study||0||
48531586|NCT04112173|101636057|FG000|NOT COMPLETED|Overall Study||1||
48531587|NCT03107026|101636058|FG000|STARTED|Overall Study||163||
48531588|NCT03107026|101636059|FG001|STARTED|Overall Study||161||
48531589|NCT03107026|101636060|FG002|STARTED|Overall Study||162||
48531590|NCT03107026|101636058|FG000|COMPLETED|Overall Study||131||
48531591|NCT03107026|101636059|FG001|COMPLETED|Overall Study||123||
48531592|NCT03107026|101636060|FG002|COMPLETED|Overall Study||106||
48531593|NCT03107026|101636058|FG000|NOT COMPLETED|Overall Study||32||
48531594|NCT03107026|101636059|FG001|NOT COMPLETED|Overall Study||38||
48531595|NCT03107026|101636060|FG002|NOT COMPLETED|Overall Study||56||
48531596|NCT00725205|101636061|FG000|STARTED|Overall Study||294||
48531597|NCT00725205|101636061|FG000|COMPLETED|Overall Study||207||
48531598|NCT00725205|101636061|FG000|NOT COMPLETED|Overall Study||87||
48531599|NCT00826449|101636062|FG000|STARTED|Overall Study||47||
48531600|NCT00826449|101636062|FG000|Phase I|Overall Study||12||
48531601|NCT00826449|101636062|FG000|Phase II|Overall Study||35||
48531602|NCT00826449|101636062|FG000|COMPLETED|Overall Study||42||
48531603|NCT00826449|101636062|FG000|NOT COMPLETED|Overall Study||5||
48531604|NCT03276221|101636063|FG000|STARTED|Overall Study||64||
48531605|NCT03276221|101636064|FG001|STARTED|Overall Study||68||
48531606|NCT03276221|101636065|FG002|STARTED|Overall Study||69||
48531607|NCT03276221|101636063|FG000|COMPLETED|Overall Study||54||
48531608|NCT03276221|101636064|FG001|COMPLETED|Overall Study||66||
48531609|NCT03276221|101636065|FG002|COMPLETED|Overall Study||69||
48531610|NCT03276221|101636063|FG000|NOT COMPLETED|Overall Study||10||
48531611|NCT03276221|101636064|FG001|NOT COMPLETED|Overall Study||2||
48531612|NCT03276221|101636065|FG002|NOT COMPLETED|Overall Study||0||
48531613|NCT01775852|101636066|FG000|STARTED|Overall Study||31||
48531614|NCT01775852|101636067|FG001|STARTED|Overall Study||14||
48531615|NCT01775852|101636066|FG000|COMPLETED|Overall Study||31||
48531616|NCT01775852|101636067|FG001|COMPLETED|Overall Study||13||
48531617|NCT01775852|101636066|FG000|NOT COMPLETED|Overall Study||0||
48531618|NCT01775852|101636067|FG001|NOT COMPLETED|Overall Study||1||
48531619|NCT04498403|101636068|FG000|STARTED|Overall Study||30||
48531620|NCT04498403|101636069|FG001|STARTED|Overall Study||10||
48531621|NCT04498403|101636068|FG000|Completed Follow up|Overall Study||30||
48531622|NCT04498403|101636069|FG001|Completed Follow up|Overall Study||10||
48531623|NCT04498403|101636068|FG000|COMPLETED|Overall Study||0||
48231200|NCT03500406|100887431|FG001|NOT COMPLETED|Overall Study||0||
48231201|NCT02924051|100887432|FG000|STARTED|Overall Study||82||
48231202|NCT02924051|100887433|FG001|STARTED|Overall Study||106||
48231203|NCT02924051|100887432|FG000|COMPLETED|Overall Study||81||
48231204|NCT02924051|100887433|FG001|COMPLETED|Overall Study||97||
48231205|NCT02924051|100887432|FG000|NOT COMPLETED|Overall Study||1||
48231206|NCT02924051|100887433|FG001|NOT COMPLETED|Overall Study||9||
48231207|NCT01672242|100887434|FG000|STARTED|Period 1||4||
48231208|NCT01672242|100887435|FG001|STARTED|Period 1||2||
48231209|NCT01672242|100887434|FG000|COMPLETED|Period 1||4||
48231210|NCT01672242|100887435|FG001|COMPLETED|Period 1||2||
48231211|NCT01672242|100887434|FG000|NOT COMPLETED|Period 1||0||
48231212|NCT01672242|100887435|FG001|NOT COMPLETED|Period 1||0||
48531624|NCT04498403|101636069|FG001|COMPLETED|Overall Study||0||
48531625|NCT04498403|101636068|FG000|NOT COMPLETED|Overall Study||30||
48531626|NCT04498403|101636069|FG001|NOT COMPLETED|Overall Study||10||
48531627|NCT00131378|101636070|FG000|STARTED|Overall Study||40||
48231213|NCT01672242|100887434|FG000|STARTED|Period 2||4||
48231214|NCT01672242|100887435|FG001|STARTED|Period 2||2||
48231215|NCT01672242|100887434|FG000|COMPLETED|Period 2||4||
48231216|NCT01672242|100887435|FG001|COMPLETED|Period 2||2||
48231217|NCT01672242|100887434|FG000|NOT COMPLETED|Period 2||0||
48231218|NCT01672242|100887435|FG001|NOT COMPLETED|Period 2||0||
48231219|NCT03711058|100887436|FG000|STARTED|Overall Study||6|started = enrolled and received at least one dose of study drug|
48231220|NCT03711058|100887437|FG001|STARTED|Overall Study||21|started = enrolled and received at least one dose of study drug|
48231221|NCT03711058|100887438|FG002|STARTED|Overall Study||12|started = enrolled and received at least one dose of study drug|
48231222|NCT03711058|100887436|FG000|COMPLETED|Overall Study||6||
48231223|NCT03711058|100887437|FG001|COMPLETED|Overall Study||21||
48231224|NCT03711058|100887438|FG002|COMPLETED|Overall Study||12||
48231225|NCT03711058|100887436|FG000|NOT COMPLETED|Overall Study||0||
48531628|NCT00131378|101636071|FG001|STARTED|Overall Study||40||
48531629|NCT00131378|101636072|FG002|STARTED|Overall Study||32||
48531630|NCT00131378|101636073|FG003|STARTED|Overall Study||30||
48531631|NCT00131378|101636070|FG000|COMPLETED|Overall Study||29||
48531632|NCT00131378|101636071|FG001|COMPLETED|Overall Study||22||
48531633|NCT00131378|101636072|FG002|COMPLETED|Overall Study||22||
48531634|NCT00131378|101636073|FG003|COMPLETED|Overall Study||21||
48531635|NCT00131378|101636070|FG000|NOT COMPLETED|Overall Study||11||
48531636|NCT00131378|101636071|FG001|NOT COMPLETED|Overall Study||18||
48531637|NCT00131378|101636072|FG002|NOT COMPLETED|Overall Study||10||
48531638|NCT00131378|101636073|FG003|NOT COMPLETED|Overall Study||9||
48531639|NCT04713553|101636074|FG000|STARTED|Primary Study (2 Months)||351||
48531640|NCT04713553|101636075|FG001|STARTED|Primary Study (2 Months)||352||
48531641|NCT04713553|101636076|FG002|STARTED|Primary Study (2 Months)||347||
48531642|NCT04713553|101636077|FG003|STARTED|Primary Study (2 Months)||173||
48531643|NCT04713553|101636078|FG004|STARTED|Primary Study (2 Months)||351||
48231226|NCT03711058|100887437|FG001|NOT COMPLETED|Overall Study||0||
48531644|NCT04713553|101636079|FG005|STARTED|Primary Study (2 Months)||0||
48531645|NCT04713553|101636080|FG006|STARTED|Primary Study (2 Months)||0||
48531646|NCT04713553|101636074|FG000|Treated|Primary Study (2 Months)||351||
48531647|NCT04713553|101636075|FG001|Treated|Primary Study (2 Months)||352||
48531648|NCT04713553|101636076|FG002|Treated|Primary Study (2 Months)||346||
48531649|NCT04713553|101636077|FG003|Treated|Primary Study (2 Months)||173||
48531650|NCT04713553|101636078|FG004|Treated|Primary Study (2 Months)||351||
48531651|NCT04713553|101636079|FG005|Treated|Primary Study (2 Months)||0||
48531652|NCT04713553|101636080|FG006|Treated|Primary Study (2 Months)||0||
48531653|NCT04713553|101636074|FG000|COMPLETED|Primary Study (2 Months)||347||
48531654|NCT04713553|101636075|FG001|COMPLETED|Primary Study (2 Months)||346||
48531655|NCT04713553|101636076|FG002|COMPLETED|Primary Study (2 Months)||344||
48531656|NCT04713553|101636077|FG003|COMPLETED|Primary Study (2 Months)||171||
48531657|NCT04713553|101636078|FG004|COMPLETED|Primary Study (2 Months)||349||
48531658|NCT04713553|101636079|FG005|COMPLETED|Primary Study (2 Months)||0||
48531659|NCT04713553|101636080|FG006|COMPLETED|Primary Study (2 Months)||0||
48231227|NCT03711058|100887438|FG002|NOT COMPLETED|Overall Study||0||
48231228|NCT03200574|100887439|FG000|STARTED|Overall Study||88||
48231229|NCT03200574|100887439|FG000|COMPLETED|Overall Study||71||
48231230|NCT03200574|100887439|FG000|NOT COMPLETED|Overall Study||17||
48231231|NCT03456856|100887440|FG000|STARTED|Overall Study||30||
48231232|NCT03456856|100887440|FG000|COMPLETED|Overall Study||27||
48231233|NCT03456856|100887440|FG000|NOT COMPLETED|Overall Study||3||
48231234|NCT00910962|100887441|FG000|STARTED|Overall Study||135||
48231235|NCT00910962|100887442|FG001|STARTED|Overall Study||199||
48231236|NCT00910962|100887443|FG002|STARTED|Overall Study||192||
48231237|NCT00910962|100887441|FG000|COMPLETED|Overall Study||92||
48231238|NCT00910962|100887442|FG001|COMPLETED|Overall Study||121||
48231239|NCT00910962|100887443|FG002|COMPLETED|Overall Study||116||
48231240|NCT00910962|100887441|FG000|NOT COMPLETED|Overall Study||43||
48231241|NCT00910962|100887442|FG001|NOT COMPLETED|Overall Study||78||
48231242|NCT00910962|100887443|FG002|NOT COMPLETED|Overall Study||76||
48231243|NCT05197452|100887444|FG000|STARTED|Overall Study||2167||
48231244|NCT05197452|100887444|FG000|COMPLETED|Overall Study||2167|Enrollment closed. All collected data reported.|
48231245|NCT05197452|100887444|FG000|NOT COMPLETED|Overall Study||0||
48231246|NCT00446095|100887445|FG000|STARTED|Phase II (8 Weeks)||23||
48231247|NCT00446095|100887446|FG001|STARTED|Phase II (8 Weeks)||21||
48231248|NCT00446095|100887447|FG002|STARTED|Phase II (8 Weeks)||24||
48231249|NCT00446095|100887448|FG003|STARTED|Phase II (8 Weeks)||0||
48231250|NCT00446095|100887449|FG004|STARTED|Phase II (8 Weeks)||0||
48231251|NCT00446095|100887445|FG000|COMPLETED|Phase II (8 Weeks)||11||
48231252|NCT00446095|100887446|FG001|COMPLETED|Phase II (8 Weeks)||18||
48231253|NCT00446095|100887447|FG002|COMPLETED|Phase II (8 Weeks)||21||
48231254|NCT00446095|100887448|FG003|COMPLETED|Phase II (8 Weeks)||0||
48231255|NCT00446095|100887449|FG004|COMPLETED|Phase II (8 Weeks)||0||
48231256|NCT00446095|100887445|FG000|NOT COMPLETED|Phase II (8 Weeks)||12||
48231257|NCT00446095|100887446|FG001|NOT COMPLETED|Phase II (8 Weeks)||3||
48231258|NCT00446095|100887447|FG002|NOT COMPLETED|Phase II (8 Weeks)||3||
48231259|NCT00446095|100887448|FG003|NOT COMPLETED|Phase II (8 Weeks)||0||
48231260|NCT00446095|100887449|FG004|NOT COMPLETED|Phase II (8 Weeks)||0||
48231261|NCT00446095|100887445|FG000|STARTED|Phase I (28 Days)||0||
48231262|NCT00446095|100887446|FG001|STARTED|Phase I (28 Days)||0||
48231263|NCT00446095|100887447|FG002|STARTED|Phase I (28 Days)||0||
48231264|NCT00446095|100887448|FG003|STARTED|Phase I (28 Days)||6||
48231265|NCT00446095|100887449|FG004|STARTED|Phase I (28 Days)||7||
48231266|NCT00446095|100887445|FG000|COMPLETED|Phase I (28 Days)||0||
48231267|NCT00446095|100887446|FG001|COMPLETED|Phase I (28 Days)||0||
48231268|NCT00446095|100887447|FG002|COMPLETED|Phase I (28 Days)||0||
48231269|NCT00446095|100887448|FG003|COMPLETED|Phase I (28 Days)||5||
48231270|NCT00446095|100887449|FG004|COMPLETED|Phase I (28 Days)||4||
48531660|NCT04713553|101636074|FG000|NOT COMPLETED|Primary Study (2 Months)||4||
48531661|NCT04713553|101636075|FG001|NOT COMPLETED|Primary Study (2 Months)||6||
48531662|NCT04713553|101636076|FG002|NOT COMPLETED|Primary Study (2 Months)||3||
48231271|NCT00446095|100887445|FG000|NOT COMPLETED|Phase I (28 Days)||0||
48231272|NCT00446095|100887446|FG001|NOT COMPLETED|Phase I (28 Days)||0||
48231273|NCT00446095|100887447|FG002|NOT COMPLETED|Phase I (28 Days)||0||
48231274|NCT00446095|100887448|FG003|NOT COMPLETED|Phase I (28 Days)||1||
48231275|NCT00446095|100887449|FG004|NOT COMPLETED|Phase I (28 Days)||3||
48231276|NCT00442507|100887450|FG000|STARTED|Overall Study||6||
48231277|NCT00442507|100887450|FG000|COMPLETED|Overall Study||6||
48231278|NCT00442507|100887450|FG000|NOT COMPLETED|Overall Study||0||
48531663|NCT04713553|101636077|FG003|NOT COMPLETED|Primary Study (2 Months)||2||
48531664|NCT04713553|101636078|FG004|NOT COMPLETED|Primary Study (2 Months)||2||
48592652|NCT01877382|101783154|FG004|NOT COMPLETED|Dose Escalation||2||
48231279|NCT02000752|100887451|FG000|STARTED|Overall Study||60||
48231280|NCT02000752|100887452|FG001|STARTED|Overall Study||60||
48231281|NCT02000752|100887451|FG000|COMPLETED|Overall Study||29||
48231282|NCT02000752|100887452|FG001|COMPLETED|Overall Study||47||
48231283|NCT02000752|100887451|FG000|NOT COMPLETED|Overall Study||31||
48231284|NCT02000752|100887452|FG001|NOT COMPLETED|Overall Study||13||
48231285|NCT03678688|100887453|FG000|STARTED|Overall Study||14||
48231286|NCT03678688|100887454|FG001|STARTED|Overall Study||14||
48231287|NCT03678688|100887455|FG002|STARTED|Overall Study||17||
48231288|NCT03678688|100887456|FG003|STARTED|Overall Study||14||
48231289|NCT03678688|100887457|FG004|STARTED|Overall Study||17||
48231290|NCT03678688|100887458|FG005|STARTED|Overall Study||14||
48231291|NCT03678688|100887459|FG006|STARTED|Overall Study||14||
48231292|NCT03678688|100887460|FG007|STARTED|Overall Study||14||
48231293|NCT03678688|100887461|FG008|STARTED|Overall Study||4||
48531665|NCT04713553|101636079|FG005|NOT COMPLETED|Primary Study (2 Months)||0||
48531666|NCT04713553|101636080|FG006|NOT COMPLETED|Primary Study (2 Months)||0||
48531667|NCT04713553|101636074|FG000|STARTED|Booster Study (1 Month)||0||
48531668|NCT04713553|101636075|FG001|STARTED|Booster Study (1 Month)||0||
48531669|NCT04713553|101636076|FG002|STARTED|Booster Study (1 Month)||0||
48531670|NCT04713553|101636077|FG003|STARTED|Booster Study (1 Month)||0||
48531671|NCT04713553|101636078|FG004|STARTED|Booster Study (1 Month)||0||
48531672|NCT04713553|101636079|FG005|STARTED|Booster Study (1 Month)||31||
48531673|NCT04713553|101636080|FG006|STARTED|Booster Study (1 Month)||31||
48531674|NCT04713553|101636074|FG000|COMPLETED|Booster Study (1 Month)||0||
48531675|NCT04713553|101636075|FG001|COMPLETED|Booster Study (1 Month)||0||
48531676|NCT04713553|101636076|FG002|COMPLETED|Booster Study (1 Month)||0||
48531677|NCT04713553|101636077|FG003|COMPLETED|Booster Study (1 Month)||0||
48531678|NCT04713553|101636078|FG004|COMPLETED|Booster Study (1 Month)||0||
48531679|NCT04713553|101636079|FG005|COMPLETED|Booster Study (1 Month)||31||
48531680|NCT04713553|101636080|FG006|COMPLETED|Booster Study (1 Month)||31||
48531681|NCT04713553|101636074|FG000|NOT COMPLETED|Booster Study (1 Month)||0||
48531682|NCT04713553|101636075|FG001|NOT COMPLETED|Booster Study (1 Month)||0||
48531683|NCT04713553|101636076|FG002|NOT COMPLETED|Booster Study (1 Month)||0||
48531684|NCT04713553|101636077|FG003|NOT COMPLETED|Booster Study (1 Month)||0||
48531685|NCT04713553|101636078|FG004|NOT COMPLETED|Booster Study (1 Month)||0||
48231294|NCT03678688|100887453|FG000|Efficacy Analysis Set/ MITT Set|Overall Study||14|Modified Intent-to-Treat (MITT) Analysis Set included randomized participants who were agar media culture positive at baseline (either at Day -2 or at Day -1, or both), received any dose of investigational medicinal product (IMP), and had at least one post-baseline colony forming unit (CFU) count value.|
48231295|NCT03678688|100887454|FG001|Efficacy Analysis Set/ MITT Set|Overall Study||11|Modified Intent-to-Treat (MITT) Analysis Set included randomized participants who were agar media culture positive at baseline (either at Day -2 or at Day -1, or both), received any dose of investigational medicinal product (IMP), and had at least one post-baseline colony forming unit (CFU) count value.|
48231296|NCT03678688|100887455|FG002|Efficacy Analysis Set/ MITT Set|Overall Study||14|Modified Intent-to-Treat (MITT) Analysis Set included randomized participants who were agar media culture positive at baseline (either at Day -2 or at Day -1, or both), received any dose of investigational medicinal product (IMP), and had at least one post-baseline colony forming unit (CFU) count value.|
48231297|NCT03678688|100887456|FG003|Efficacy Analysis Set/ MITT Set|Overall Study||14|Modified Intent-to-Treat (MITT) Analysis Set included randomized participants who were agar media culture positive at baseline (either at Day -2 or at Day -1, or both), received any dose of investigational medicinal product (IMP), and had at least one post-baseline colony forming unit (CFU) count value.|
48231298|NCT03678688|100887457|FG004|Efficacy Analysis Set/ MITT Set|Overall Study||15|Modified Intent-to-Treat (MITT) Analysis Set included randomized participants who were agar media culture positive at baseline (either at Day -2 or at Day -1, or both), received any dose of investigational medicinal product (IMP), and had at least one post-baseline colony forming unit (CFU) count value.|
48231299|NCT03678688|100887458|FG005|Efficacy Analysis Set/ MITT Set|Overall Study||11|Modified Intent-to-Treat (MITT) Analysis Set included randomized participants who were agar media culture positive at baseline (either at Day -2 or at Day -1, or both), received any dose of investigational medicinal product (IMP), and had at least one post-baseline colony forming unit (CFU) count value.|
48231300|NCT03678688|100887459|FG006|Efficacy Analysis Set/ MITT Set|Overall Study||11|Modified Intent-to-Treat (MITT) Analysis Set included randomized participants who were agar media culture positive at baseline (either at Day -2 or at Day -1, or both), received any dose of investigational medicinal product (IMP), and had at least one post-baseline colony forming unit (CFU) count value.|
48231301|NCT03678688|100887460|FG007|Efficacy Analysis Set/ MITT Set|Overall Study||12|Modified Intent-to-Treat (MITT) Analysis Set included randomized participants who were agar media culture positive at baseline (either at Day -2 or at Day -1, or both), received any dose of investigational medicinal product (IMP), and had at least one post-baseline colony forming unit (CFU) count value.|
48531686|NCT04713553|101636079|FG005|NOT COMPLETED|Booster Study (1 Month)||0||
48531687|NCT04713553|101636080|FG006|NOT COMPLETED|Booster Study (1 Month)||0||
48531688|NCT00505375|101636081|FG000|STARTED|Overall Study||77||
48531689|NCT00505375|101636082|FG001|STARTED|Overall Study||35||
48531690|NCT00505375|101636081|FG000|COMPLETED|Overall Study||73||
48531691|NCT00505375|101636082|FG001|COMPLETED|Overall Study||30||
48531692|NCT00505375|101636081|FG000|NOT COMPLETED|Overall Study||4||
48531693|NCT00505375|101636082|FG001|NOT COMPLETED|Overall Study||5||
48531694|NCT01088802|101636083|FG000|STARTED|Overall Study||60||
48531695|NCT01088802|101636083|FG000|COMPLETED|Overall Study||60||
48531696|NCT01088802|101636083|FG000|NOT COMPLETED|Overall Study||0||
48531697|NCT01936623|101636084|FG000|STARTED|Overall Study||40||
48531698|NCT01936623|101636085|FG001|STARTED|Overall Study||40||
48531699|NCT01936623|101636084|FG000|COMPLETED|Overall Study||40||
48531700|NCT01936623|101636085|FG001|COMPLETED|Overall Study||35||
48531701|NCT01936623|101636084|FG000|NOT COMPLETED|Overall Study||0||
48531702|NCT01936623|101636085|FG001|NOT COMPLETED|Overall Study||5||
48531703|NCT00510289|101636086|FG000|STARTED|Overall Study||19||
48531704|NCT00510289|101636086|FG000|Started Study Drug|Overall Study||16||
48531705|NCT00510289|101636086|FG000|COMPLETED|Overall Study||7||
48531706|NCT00510289|101636086|FG000|NOT COMPLETED|Overall Study||12||
48531707|NCT02387983|101636087|FG000|STARTED|Overall Study||65||
48531708|NCT02387983|101636087|FG000|COMPLETED|Overall Study||58||
48531709|NCT02387983|101636087|FG000|NOT COMPLETED|Overall Study||7||
48531710|NCT02633488|101636088|FG000|STARTED|Overall Study||6||
48531711|NCT02633488|101636089|FG001|STARTED|Overall Study||5||
48531712|NCT02633488|101636088|FG000|COMPLETED|Overall Study||6||
48531713|NCT02633488|101636089|FG001|COMPLETED|Overall Study||5||
48531714|NCT02633488|101636088|FG000|NOT COMPLETED|Overall Study||0||
48531715|NCT02633488|101636089|FG001|NOT COMPLETED|Overall Study||0||
48531716|NCT00242619|101636090|FG000|STARTED|Overall Study||8||
48531717|NCT00242619|101636091|FG001|STARTED|Overall Study||4||
48531718|NCT00242619|101636090|FG000|COMPLETED|Overall Study||8||
48531719|NCT00242619|101636091|FG001|COMPLETED|Overall Study||4||
48531720|NCT00242619|101636090|FG000|NOT COMPLETED|Overall Study||0||
48531721|NCT00242619|101636091|FG001|NOT COMPLETED|Overall Study||0||
48531722|NCT02731326|101636092|FG000|STARTED|Overall Study||131||
48531723|NCT02731326|101636093|FG001|STARTED|Overall Study||131||
48531724|NCT02731326|101636092|FG000|COMPLETED|Overall Study||115||
48531725|NCT02731326|101636093|FG001|COMPLETED|Overall Study||123||
48531726|NCT02731326|101636092|FG000|NOT COMPLETED|Overall Study||16||
48531727|NCT02731326|101636093|FG001|NOT COMPLETED|Overall Study||8||
48531728|NCT00080938|101639171|FG000|STARTED|Overall Study||26||
48531729|NCT00080938|101639171|FG000|Began Protocol Therapy|Overall Study||25||
48531730|NCT00080938|101639171|FG000|Eligible and Treated|Overall Study||21||
48531731|NCT00080938|101639171|FG000|COMPLETED|Overall Study||2||
48231302|NCT03678688|100887461|FG008|Efficacy Analysis Set/ MITT Set|Overall Study||4|Modified Intent-to-Treat (MITT) Analysis Set included randomized participants who were agar media culture positive at baseline (either at Day -2 or at Day -1, or both), received any dose of investigational medicinal product (IMP), and had at least one post-baseline colony forming unit (CFU) count value.|
48231303|NCT03678688|100887453|FG000|Safety Analysis Set|Overall Study||14|Safety Analysis Set included participants who were randomized and took any dose of IMP.|
48531732|NCT00080938|101639171|FG000|NOT COMPLETED|Overall Study||24||
48531733|NCT00090610|101639172|FG000|STARTED|Overall Study||75||
48531734|NCT00090610|101639173|FG001|STARTED|Overall Study||75||
48531735|NCT00090610|101639172|FG000|COMPLETED|Overall Study||74||
48531736|NCT00090610|101639173|FG001|COMPLETED|Overall Study||74||
48531737|NCT00090610|101639172|FG000|NOT COMPLETED|Overall Study||1||
48531738|NCT00090610|101639173|FG001|NOT COMPLETED|Overall Study||1||
48531739|NCT02524730|101639174|FG000|STARTED|Overall Study||205||
48531740|NCT02524730|101639174|FG000|COMPLETED|Overall Study||159||
48531741|NCT02524730|101639174|FG000|NOT COMPLETED|Overall Study||46||
48531742|NCT00088621|101639175|FG000|STARTED|Overall Study||61||
48531743|NCT00088621|101639175|FG000|COMPLETED|Overall Study||7||
48531744|NCT00088621|101639175|FG000|NOT COMPLETED|Overall Study||54||
48531745|NCT04539886|101639176|FG000|STARTED|Overall Study||60||188
48531746|NCT04539886|101639177|FG001|STARTED|Overall Study||60||190
48531747|NCT04539886|101639176|FG000|COMPLETED|Overall Study||60||187
48531748|NCT04539886|101639177|FG001|COMPLETED|Overall Study||60||189
48531749|NCT04539886|101639176|FG000|NOT COMPLETED|Overall Study||0||1
48531750|NCT04539886|101639177|FG001|NOT COMPLETED|Overall Study||0||1
48531751|NCT01992523|101639178|FG000|STARTED|Overall Study||41||
48531752|NCT01992523|101639179|FG001|STARTED|Overall Study||41||
48531753|NCT01992523|101639178|FG000|COMPLETED|Overall Study||41||
48531754|NCT01992523|101639179|FG001|COMPLETED|Overall Study||41||
48531755|NCT01992523|101639178|FG000|NOT COMPLETED|Overall Study||0||
48531756|NCT01992523|101639179|FG001|NOT COMPLETED|Overall Study||0||
48531757|NCT02836496|101639180|FG000|STARTED|Overall Study||54||
48531758|NCT02836496|101639181|FG001|STARTED|Overall Study||54||
48531759|NCT02836496|101639180|FG000|COMPLETED|Overall Study||52||
48531760|NCT02836496|101639181|FG001|COMPLETED|Overall Study||52||
48531761|NCT02836496|101639180|FG000|NOT COMPLETED|Overall Study||2||
48531762|NCT02836496|101639181|FG001|NOT COMPLETED|Overall Study||2||
48531763|NCT01400919|101639182|FG000|STARTED|Overall Study||75||
48531764|NCT01400919|101639182|FG000|COMPLETED|Overall Study||67||
48531765|NCT01400919|101639182|FG000|NOT COMPLETED|Overall Study||8||
48531766|NCT04425538|101639183|FG000|STARTED|Overall Study||17||
48531767|NCT04425538|101639183|FG000|COMPLETED|Overall Study||17||
48531768|NCT04425538|101639183|FG000|NOT COMPLETED|Overall Study||0||
48531769|NCT01432379|101639184|FG000|STARTED|Overall Study||1168||
48531770|NCT01432379|101639184|FG000|COMPLETED|Overall Study||783||
48531771|NCT01432379|101639184|FG000|NOT COMPLETED|Overall Study||385||
48531772|NCT01199471|101639185|FG000|STARTED|Overall Study||4000||
48531773|NCT01199471|101639185|FG000|COMPLETED|Overall Study||3994||
48531774|NCT01199471|101639185|FG000|NOT COMPLETED|Overall Study||6||
48531775|NCT04561375|101639186|FG000|STARTED|Overall Study||35||
48531776|NCT04561375|101639187|FG001|STARTED|Overall Study||26||
48531777|NCT04561375|101639186|FG000|COMPLETED|Overall Study||35||
48531778|NCT04561375|101639187|FG001|COMPLETED|Overall Study||26||
48531779|NCT04561375|101639186|FG000|NOT COMPLETED|Overall Study||0||
48531780|NCT04561375|101639187|FG001|NOT COMPLETED|Overall Study||0||
48531781|NCT03265288|101639188|FG000|STARTED|Overall Study||83||
48531782|NCT03265288|101639189|FG001|STARTED|Overall Study||83||
48531783|NCT03265288|101639188|FG000|COMPLETED|Overall Study||60||
48531784|NCT03265288|101639189|FG001|COMPLETED|Overall Study||71||
48531785|NCT03265288|101639188|FG000|NOT COMPLETED|Overall Study||23||
48531786|NCT03265288|101639189|FG001|NOT COMPLETED|Overall Study||12||
48231304|NCT03678688|100887454|FG001|Safety Analysis Set|Overall Study||14|Safety Analysis Set included participants who were randomized and took any dose of IMP.|
48531787|NCT04682730|101639190|FG000|STARTED|Overall Study||47||1
48531788|NCT04682730|101639191|FG001|STARTED|Overall Study||166||3
48531789|NCT04682730|101639192|FG002|STARTED|Overall Study||190||3
48231305|NCT03678688|100887455|FG002|Safety Analysis Set|Overall Study||17|Safety Analysis Set included participants who were randomized and took any dose of IMP.|
48231306|NCT03678688|100887456|FG003|Safety Analysis Set|Overall Study||14|Safety Analysis Set included participants who were randomized and took any dose of IMP.|
48231307|NCT03678688|100887457|FG004|Safety Analysis Set|Overall Study||16|Safety Analysis Set included participants who were randomized and took any dose of IMP.|
48231308|NCT03678688|100887458|FG005|Safety Analysis Set|Overall Study||13|Safety Analysis Set included participants who were randomized and took any dose of IMP.|
48231309|NCT03678688|100887459|FG006|Safety Analysis Set|Overall Study||13|Safety Analysis Set included participants who were randomized and took any dose of IMP.|
48231310|NCT03678688|100887460|FG007|Safety Analysis Set|Overall Study||14|Safety Analysis Set included participants who were randomized and took any dose of IMP.|
48531790|NCT04682730|101639193|FG003|STARTED|Overall Study||164||3
48531791|NCT04682730|101639194|FG004|STARTED|Overall Study||131||3
48531792|NCT04682730|101639195|FG005|STARTED|Overall Study||198||3
48531793|NCT04682730|101639190|FG000|Intro Session|Overall Study||48||1
48531794|NCT04682730|101639191|FG001|Intro Session|Overall Study||80||3
48531795|NCT04682730|101639192|FG002|Intro Session|Overall Study||83||3
48531796|NCT04682730|101639193|FG003|Intro Session|Overall Study||68||3
48531797|NCT04682730|101639194|FG004|Intro Session|Overall Study||60||3
48531798|NCT04682730|101639195|FG005|Intro Session|Overall Study||58||3
48531799|NCT04682730|101639190|FG000|Deliberative Forum|Overall Study||25||1
48231311|NCT03678688|100887461|FG008|Safety Analysis Set|Overall Study||4|Safety Analysis Set included participants who were randomized and took any dose of IMP.|
48231312|NCT03678688|100887453|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||14|PK Analysis Set included all participants who received at least one dose of IMP and had 1 quantifiable drug concentration.|
48231313|NCT03678688|100887454|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||14|PK Analysis Set included all participants who received at least one dose of IMP and had 1 quantifiable drug concentration.|
48531800|NCT04682730|101639191|FG001|Deliberative Forum|Overall Study||89||3
48531801|NCT04682730|101639192|FG002|Deliberative Forum|Overall Study||76||3
48531802|NCT04682730|101639193|FG003|Deliberative Forum|Overall Study||64||3
48231314|NCT03678688|100887455|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||17|PK Analysis Set included all participants who received at least one dose of IMP and had 1 quantifiable drug concentration.|
48231315|NCT03678688|100887456|FG003|Pharmacokinetic (PK) Analysis Set|Overall Study||14|PK Analysis Set included all participants who received at least one dose of IMP and had 1 quantifiable drug concentration.|
48231316|NCT03678688|100887457|FG004|Pharmacokinetic (PK) Analysis Set|Overall Study||11|PK Analysis Set included all participants who received at least one dose of IMP and had 1 quantifiable drug concentration.|
48231317|NCT03678688|100887458|FG005|Pharmacokinetic (PK) Analysis Set|Overall Study||13|PK Analysis Set included all participants who received at least one dose of IMP and had 1 quantifiable drug concentration.|
48231318|NCT03678688|100887459|FG006|Pharmacokinetic (PK) Analysis Set|Overall Study||13|PK Analysis Set included all participants who received at least one dose of IMP and had 1 quantifiable drug concentration.|
48231319|NCT03678688|100887460|FG007|Pharmacokinetic (PK) Analysis Set|Overall Study||14|PK Analysis Set included all participants who received at least one dose of IMP and had 1 quantifiable drug concentration.|
48231320|NCT03678688|100887461|FG008|Pharmacokinetic (PK) Analysis Set|Overall Study||4|PK Analysis Set included all participants who received at least one dose of IMP and had 1 quantifiable drug concentration.|
48231321|NCT03678688|100887453|FG000|COMPLETED|Overall Study||14||
48231322|NCT03678688|100887454|FG001|COMPLETED|Overall Study||14||
48231323|NCT03678688|100887455|FG002|COMPLETED|Overall Study||14||
48231324|NCT03678688|100887456|FG003|COMPLETED|Overall Study||13||
48531803|NCT04682730|101639194|FG004|Deliberative Forum|Overall Study||54||3
48531804|NCT04682730|101639195|FG005|Deliberative Forum|Overall Study||55||3
48531805|NCT04682730|101639190|FG000|Surveys Received|Overall Study||8||1
48531806|NCT04682730|101639191|FG001|Surveys Received|Overall Study||70||3
48531807|NCT04682730|101639192|FG002|Surveys Received|Overall Study||55||3
48531808|NCT04682730|101639193|FG003|Surveys Received|Overall Study||42||3
48531809|NCT04682730|101639194|FG004|Surveys Received|Overall Study||48||3
48531810|NCT04682730|101639195|FG005|Surveys Received|Overall Study||30||3
48531811|NCT04682730|101639190|FG000|COMPLETED|Overall Study||8||1
48531812|NCT04682730|101639191|FG001|COMPLETED|Overall Study||70||3
48531813|NCT04682730|101639192|FG002|COMPLETED|Overall Study||55||3
48531814|NCT04682730|101639193|FG003|COMPLETED|Overall Study||42||3
48531815|NCT04682730|101639194|FG004|COMPLETED|Overall Study||48||3
48531816|NCT04682730|101639195|FG005|COMPLETED|Overall Study||30||3
48531817|NCT04682730|101639190|FG000|NOT COMPLETED|Overall Study||39||0
48531818|NCT04682730|101639191|FG001|NOT COMPLETED|Overall Study||96||0
48531819|NCT04682730|101639192|FG002|NOT COMPLETED|Overall Study||135||0
48531820|NCT04682730|101639193|FG003|NOT COMPLETED|Overall Study||122||0
48531821|NCT04682730|101639194|FG004|NOT COMPLETED|Overall Study||83||0
48531822|NCT04682730|101639195|FG005|NOT COMPLETED|Overall Study||168||0
48531823|NCT03062228|101639196|FG000|STARTED|Overall Study||162||
48531824|NCT03062228|101639196|FG000|COMPLETED|Overall Study||162||
48531825|NCT03062228|101639196|FG000|NOT COMPLETED|Overall Study||0||
48531826|NCT00003875|101639197|FG000|STARTED|Overall Study||30||
48231325|NCT03678688|100887457|FG004|COMPLETED|Overall Study||16||
48231326|NCT03678688|100887458|FG005|COMPLETED|Overall Study||10||
48231327|NCT03678688|100887459|FG006|COMPLETED|Overall Study||9||
48231328|NCT03678688|100887460|FG007|COMPLETED|Overall Study||11||
48231329|NCT03678688|100887461|FG008|COMPLETED|Overall Study||4||
48231330|NCT03678688|100887453|FG000|NOT COMPLETED|Overall Study||0||
48231331|NCT03678688|100887454|FG001|NOT COMPLETED|Overall Study||0||
48231332|NCT03678688|100887455|FG002|NOT COMPLETED|Overall Study||3||
48231333|NCT03678688|100887456|FG003|NOT COMPLETED|Overall Study||1||
48231334|NCT03678688|100887457|FG004|NOT COMPLETED|Overall Study||1||
48231335|NCT03678688|100887458|FG005|NOT COMPLETED|Overall Study||4||
48231336|NCT03678688|100887459|FG006|NOT COMPLETED|Overall Study||5||
48231337|NCT03678688|100887460|FG007|NOT COMPLETED|Overall Study||3||
48231338|NCT03678688|100887461|FG008|NOT COMPLETED|Overall Study||0||
48231339|NCT03737110|100887462|FG000|STARTED|Run-in (RI) Period||86||
48231340|NCT03737110|100887463|FG001|STARTED|Run-in (RI) Period||0||
48231341|NCT03737110|100887464|FG002|STARTED|Run-in (RI) Period||0||
48231342|NCT03737110|100887465|FG003|STARTED|Run-in (RI) Period||0||
48231343|NCT03737110|100887466|FG004|STARTED|Run-in (RI) Period||0||
48231344|NCT03737110|100887467|FG005|STARTED|Run-in (RI) Period||0||
48231345|NCT03737110|100887462|FG000|Continue to RW Period|Run-in (RI) Period||61||
48231346|NCT03737110|100887463|FG001|Continue to RW Period|Run-in (RI) Period||0||
48231347|NCT03737110|100887464|FG002|Continue to RW Period|Run-in (RI) Period||0||
48231348|NCT03737110|100887465|FG003|Continue to RW Period|Run-in (RI) Period||0||
48231349|NCT03737110|100887466|FG004|Continue to RW Period|Run-in (RI) Period||0||
48231350|NCT03737110|100887467|FG005|Continue to RW Period|Run-in (RI) Period||0||
48231351|NCT03737110|100887462|FG000|Continue Directly to LTE Period|Run-in (RI) Period||15||
48231352|NCT03737110|100887463|FG001|Continue Directly to LTE Period|Run-in (RI) Period||0||
48231353|NCT03737110|100887464|FG002|Continue Directly to LTE Period|Run-in (RI) Period||0||
48231354|NCT03737110|100887465|FG003|Continue Directly to LTE Period|Run-in (RI) Period||0||
48231355|NCT03737110|100887466|FG004|Continue Directly to LTE Period|Run-in (RI) Period||0||
48231356|NCT03737110|100887467|FG005|Continue Directly to LTE Period|Run-in (RI) Period||0||
48231357|NCT03737110|100887462|FG000|COMPLETED|Run-in (RI) Period||76||
48231358|NCT03737110|100887463|FG001|COMPLETED|Run-in (RI) Period||0||
48231359|NCT03737110|100887464|FG002|COMPLETED|Run-in (RI) Period||0||
48231360|NCT03737110|100887465|FG003|COMPLETED|Run-in (RI) Period||0||
48231361|NCT03737110|100887466|FG004|COMPLETED|Run-in (RI) Period||0||
48231362|NCT03737110|100887467|FG005|COMPLETED|Run-in (RI) Period||0||
48231363|NCT03737110|100887462|FG000|NOT COMPLETED|Run-in (RI) Period||10||
48231364|NCT03737110|100887463|FG001|NOT COMPLETED|Run-in (RI) Period||0||
48231365|NCT03737110|100887464|FG002|NOT COMPLETED|Run-in (RI) Period||0||
48231366|NCT03737110|100887465|FG003|NOT COMPLETED|Run-in (RI) Period||0||
48231367|NCT03737110|100887466|FG004|NOT COMPLETED|Run-in (RI) Period||0||
48231368|NCT03737110|100887467|FG005|NOT COMPLETED|Run-in (RI) Period||0||
48231369|NCT03737110|100887462|FG000|STARTED|Randomized Withdrawal (RW) Period||0|Met protocol-defined clinical response criteria and entered into RW Period.|
48231370|NCT03737110|100887463|FG001|STARTED|Randomized Withdrawal (RW) Period||30|Met protocol-defined clinical response criteria and entered into RW Period.|
48231371|NCT03737110|100887464|FG002|STARTED|Randomized Withdrawal (RW) Period||31|Met protocol-defined clinical response criteria and entered into RW Period.|
48231372|NCT03737110|100887465|FG003|STARTED|Randomized Withdrawal (RW) Period||0|Met protocol-defined clinical response criteria and entered into RW Period.|
48231373|NCT03737110|100887466|FG004|STARTED|Randomized Withdrawal (RW) Period||0|Met protocol-defined clinical response criteria and entered into RW Period.|
48231374|NCT03737110|100887467|FG005|STARTED|Randomized Withdrawal (RW) Period||0|Met protocol-defined clinical response criteria and entered into RW Period.|
48231375|NCT03737110|100887462|FG000|COMPLETED|Randomized Withdrawal (RW) Period||0|Completed, Continuing into LTE|
48231376|NCT03737110|100887463|FG001|COMPLETED|Randomized Withdrawal (RW) Period||29|Completed, Continuing into LTE|
48231377|NCT03737110|100887464|FG002|COMPLETED|Randomized Withdrawal (RW) Period||30|Completed, Continuing into LTE|
48231378|NCT03737110|100887465|FG003|COMPLETED|Randomized Withdrawal (RW) Period||0|Completed, Continuing into LTE|
48231379|NCT03737110|100887466|FG004|COMPLETED|Randomized Withdrawal (RW) Period||0|Completed, Continuing into LTE|
48231380|NCT03737110|100887467|FG005|COMPLETED|Randomized Withdrawal (RW) Period||0|Completed, Continuing into LTE|
48231381|NCT03737110|100887462|FG000|NOT COMPLETED|Randomized Withdrawal (RW) Period||0||
48231382|NCT03737110|100887463|FG001|NOT COMPLETED|Randomized Withdrawal (RW) Period||1||
48231383|NCT03737110|100887464|FG002|NOT COMPLETED|Randomized Withdrawal (RW) Period||1||
48531827|NCT00003875|101639197|FG000|COMPLETED|Overall Study||29||
48231384|NCT03737110|100887465|FG003|NOT COMPLETED|Randomized Withdrawal (RW) Period||0||
48231385|NCT03737110|100887466|FG004|NOT COMPLETED|Randomized Withdrawal (RW) Period||0||
48231386|NCT03737110|100887467|FG005|NOT COMPLETED|Randomized Withdrawal (RW) Period||0||
48231387|NCT03737110|100887462|FG000|STARTED|Long-Term Extension (LTE) Period||0||
48231388|NCT03737110|100887463|FG001|STARTED|Long-Term Extension (LTE) Period||0||
48531828|NCT00003875|101639197|FG000|NOT COMPLETED|Overall Study||1||
48531829|NCT00470067|101639198|FG000|STARTED|Overall Study||9||
48531830|NCT00470067|101639198|FG000|COMPLETED|Overall Study||2||
48231389|NCT03737110|100887464|FG002|STARTED|Long-Term Extension (LTE) Period||0||
48231390|NCT03737110|100887465|FG003|STARTED|Long-Term Extension (LTE) Period||15||
48231391|NCT03737110|100887466|FG004|STARTED|Long-Term Extension (LTE) Period||25||
48231392|NCT03737110|100887467|FG005|STARTED|Long-Term Extension (LTE) Period||34||
48231393|NCT03737110|100887462|FG000|COMPLETED|Long-Term Extension (LTE) Period||0||
48231394|NCT03737110|100887463|FG001|COMPLETED|Long-Term Extension (LTE) Period||0||
48231395|NCT03737110|100887464|FG002|COMPLETED|Long-Term Extension (LTE) Period||0||
48231396|NCT03737110|100887465|FG003|COMPLETED|Long-Term Extension (LTE) Period||13||
48231397|NCT03737110|100887466|FG004|COMPLETED|Long-Term Extension (LTE) Period||24||
48231398|NCT03737110|100887467|FG005|COMPLETED|Long-Term Extension (LTE) Period||32||
48231399|NCT03737110|100887462|FG000|NOT COMPLETED|Long-Term Extension (LTE) Period||0||
48231400|NCT03737110|100887463|FG001|NOT COMPLETED|Long-Term Extension (LTE) Period||0||
48231401|NCT03737110|100887464|FG002|NOT COMPLETED|Long-Term Extension (LTE) Period||0||
48231402|NCT03737110|100887465|FG003|NOT COMPLETED|Long-Term Extension (LTE) Period||2||
48231403|NCT03737110|100887466|FG004|NOT COMPLETED|Long-Term Extension (LTE) Period||1||
48231404|NCT03737110|100887467|FG005|NOT COMPLETED|Long-Term Extension (LTE) Period||2||
48231405|NCT01970878|100887468|FG000|STARTED|Overall Study||290||
48231406|NCT01970878|100887469|FG001|STARTED|Overall Study||218||
48231407|NCT01970878|100887470|FG002|STARTED|Overall Study||213||
48231408|NCT01970878|100887471|FG003|STARTED|Overall Study||171||
48231409|NCT01970878|100887468|FG000|COMPLETED|Overall Study||253||
48231410|NCT01970878|100887469|FG001|COMPLETED|Overall Study||191||
48231411|NCT01970878|100887470|FG002|COMPLETED|Overall Study||187||
48231412|NCT01970878|100887471|FG003|COMPLETED|Overall Study||147||
48231413|NCT01970878|100887468|FG000|NOT COMPLETED|Overall Study||37||
48231414|NCT01970878|100887469|FG001|NOT COMPLETED|Overall Study||27||
48231415|NCT01970878|100887470|FG002|NOT COMPLETED|Overall Study||26||
48231416|NCT01970878|100887471|FG003|NOT COMPLETED|Overall Study||24||
48231417|NCT04938453|100887472|FG000|STARTED|Period 1||10||
48231418|NCT04938453|100887473|FG001|STARTED|Period 1||10||
48231419|NCT04938453|100887472|FG000|COMPLETED|Period 1||10||
48231420|NCT04938453|100887473|FG001|COMPLETED|Period 1||10||
48231421|NCT04938453|100887472|FG000|NOT COMPLETED|Period 1||0||
48231422|NCT04938453|100887473|FG001|NOT COMPLETED|Period 1||0||
48231423|NCT04938453|100887472|FG000|STARTED|Washout Period 1||10||
48231424|NCT04938453|100887473|FG001|STARTED|Washout Period 1||10||
48231425|NCT04938453|100887472|FG000|COMPLETED|Washout Period 1||9||
48231426|NCT04938453|100887473|FG001|COMPLETED|Washout Period 1||9||
48231427|NCT04938453|100887472|FG000|NOT COMPLETED|Washout Period 1||1||
48231428|NCT04938453|100887473|FG001|NOT COMPLETED|Washout Period 1||1||
48231429|NCT04938453|100887472|FG000|STARTED|Period 2||9||
48231430|NCT04938453|100887473|FG001|STARTED|Period 2||9||
48231431|NCT04938453|100887472|FG000|COMPLETED|Period 2||9||
48231432|NCT04938453|100887473|FG001|COMPLETED|Period 2||9||
48231433|NCT04938453|100887472|FG000|NOT COMPLETED|Period 2||0||
48231434|NCT04938453|100887473|FG001|NOT COMPLETED|Period 2||0||
48231435|NCT01052272|100887474|FG000|STARTED|Overall Study||18||
48231436|NCT01052272|100887475|FG001|STARTED|Overall Study||18||
48231437|NCT01052272|100887476|FG002|STARTED|Overall Study||18||
48231438|NCT01052272|100887477|FG003|STARTED|Overall Study||18||
48231439|NCT01052272|100887474|FG000|COMPLETED|Overall Study||13||
48231440|NCT01052272|100887475|FG001|COMPLETED|Overall Study||11||
48231441|NCT01052272|100887476|FG002|COMPLETED|Overall Study||10||
48231442|NCT01052272|100887477|FG003|COMPLETED|Overall Study||11||
48231443|NCT01052272|100887474|FG000|NOT COMPLETED|Overall Study||5||
48231444|NCT01052272|100887475|FG001|NOT COMPLETED|Overall Study||7||
48231445|NCT01052272|100887476|FG002|NOT COMPLETED|Overall Study||8||
48231446|NCT01052272|100887477|FG003|NOT COMPLETED|Overall Study||7||
48231447|NCT01005914|100887478|FG000|STARTED|Overall Study||11||
48231448|NCT01005914|100887478|FG000|COMPLETED|Overall Study||1||
48231449|NCT01005914|100887478|FG000|NOT COMPLETED|Overall Study||10||
48231450|NCT00655824|100887479|FG000|STARTED|Overall Study||92||
48231451|NCT00655824|100887479|FG000|COMPLETED|Overall Study||8||
48231452|NCT00655824|100887479|FG000|NOT COMPLETED|Overall Study||84||
48231453|NCT01735214|100887480|FG000|STARTED|Overall Study||358||
48231454|NCT01735214|100887480|FG000|COMPLETED|Overall Study||358||
48231455|NCT01735214|100887480|FG000|NOT COMPLETED|Overall Study||0||
48231456|NCT00482911|100887481|FG000|STARTED|Dosing Schedule 1: Len & Cyc||3||
48231457|NCT00482911|100887482|FG001|STARTED|Dosing Schedule 1: Len & Cyc||0||
48231458|NCT00482911|100887481|FG000|COMPLETED|Dosing Schedule 1: Len & Cyc||3||
48231459|NCT00482911|100887482|FG001|COMPLETED|Dosing Schedule 1: Len & Cyc||0||
48231460|NCT00482911|100887481|FG000|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0||
48231461|NCT00482911|100887482|FG001|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0||
48231462|NCT00482911|100887481|FG000|STARTED|Dosing Schedule 1: Len, Cyc, & Sun||3||
48231463|NCT00482911|100887482|FG001|STARTED|Dosing Schedule 1: Len, Cyc, & Sun||2||
48231464|NCT00482911|100887481|FG000|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||3||
48231465|NCT00482911|100887482|FG001|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||2||
48231466|NCT00482911|100887481|FG000|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0||
48231467|NCT00482911|100887482|FG001|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0||
48231468|NCT00482911|100887481|FG000|STARTED|Dosing Schedule 2: Len, Cyc, & Sun||0||
48231469|NCT00482911|100887482|FG001|STARTED|Dosing Schedule 2: Len, Cyc, & Sun||7||
48231470|NCT00482911|100887481|FG000|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0||
48231471|NCT00482911|100887482|FG001|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||7||
48231472|NCT00482911|100887481|FG000|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0||
48231473|NCT00482911|100887482|FG001|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0||
48231474|NCT03136159|100887483|FG000|STARTED|Overall Study||190||
48231475|NCT03136159|100887484|FG001|STARTED|Overall Study||190||
48231476|NCT03136159|100887483|FG000|COMPLETED|Overall Study||185||
48231477|NCT03136159|100887484|FG001|COMPLETED|Overall Study||190||
48231478|NCT03136159|100887483|FG000|NOT COMPLETED|Overall Study||5||
48231479|NCT03136159|100887484|FG001|NOT COMPLETED|Overall Study||0||
48231480|NCT00825318|100887485|FG000|STARTED|Overall Study||13||
48231481|NCT00825318|100887485|FG000|COMPLETED|Overall Study||12||
48231482|NCT00825318|100887485|FG000|NOT COMPLETED|Overall Study||1||
48231483|NCT03146845|100887486|FG000|STARTED|Overall Study||25||
48231484|NCT03146845|100887487|FG001|STARTED|Overall Study||15||
48231485|NCT03146845|100887486|FG000|COMPLETED|Overall Study||20||
48231486|NCT03146845|100887487|FG001|COMPLETED|Overall Study||11||
48231487|NCT03146845|100887486|FG000|NOT COMPLETED|Overall Study||5||
48231488|NCT03146845|100887487|FG001|NOT COMPLETED|Overall Study||4||
48231489|NCT00853606|100887488|FG000|STARTED|Overall Study||712||
48231490|NCT00853606|100887488|FG000|COMPLETED|Overall Study||492||
48231491|NCT00853606|100887488|FG000|NOT COMPLETED|Overall Study||220||
48231492|NCT04220983|100887489|FG000|STARTED|Overall Study||22||
48231493|NCT04220983|100887489|FG000|COMPLETED|Overall Study||22||
48231494|NCT04220983|100887489|FG000|NOT COMPLETED|Overall Study||0||
48231495|NCT00704340|100887490|FG000|STARTED|Overall Study||120||
48231496|NCT00704340|100887491|FG001|STARTED|Overall Study||117||
48231497|NCT00704340|100887490|FG000|COMPLETED|Overall Study||118||
48231498|NCT00704340|100887491|FG001|COMPLETED|Overall Study||115||
48231499|NCT00704340|100887490|FG000|NOT COMPLETED|Overall Study||2||
48231500|NCT00704340|100887491|FG001|NOT COMPLETED|Overall Study||2||
48231501|NCT01867307|100887492|FG000|STARTED|Overall Study||18||
48231502|NCT01867307|100887493|FG001|STARTED|Overall Study||19||
48231503|NCT01867307|100887492|FG000|COMPLETED|Overall Study||15||
48231504|NCT01867307|100887493|FG001|COMPLETED|Overall Study||16||
48231505|NCT01867307|100887492|FG000|NOT COMPLETED|Overall Study||3||
48231506|NCT01867307|100887493|FG001|NOT COMPLETED|Overall Study||3||
48231507|NCT03883724|100887494|FG000|STARTED|Overall Study||29||
48231508|NCT03883724|100887495|FG001|STARTED|Overall Study||27||
48231509|NCT03883724|100887494|FG000|COMPLETED|Overall Study||29||
48231510|NCT03883724|100887495|FG001|COMPLETED|Overall Study||27||
48231511|NCT03883724|100887494|FG000|NOT COMPLETED|Overall Study||0||
48231512|NCT03883724|100887495|FG001|NOT COMPLETED|Overall Study||0||
48231513|NCT01702259|100887496|FG000|STARTED|Overall Study||34||
48231514|NCT01702259|100887497|FG001|STARTED|Overall Study||34||
48231515|NCT01702259|100887496|FG000|COMPLETED|Overall Study||34||
48231516|NCT01702259|100887497|FG001|COMPLETED|Overall Study||34||
48231517|NCT01702259|100887496|FG000|NOT COMPLETED|Overall Study||0||
48231518|NCT01702259|100887497|FG001|NOT COMPLETED|Overall Study||0||
48231519|NCT00546156|100887498|FG000|STARTED|Overall Study||84||
48231520|NCT00546156|100887499|FG001|STARTED|Overall Study||20||
48231521|NCT00546156|100887498|FG000|COMPLETED|Overall Study||70||
48231522|NCT00546156|100887499|FG001|COMPLETED|Overall Study||19||
48231523|NCT00546156|100887498|FG000|NOT COMPLETED|Overall Study||14||
48231524|NCT00546156|100887499|FG001|NOT COMPLETED|Overall Study||1||
48531831|NCT00470067|101639198|FG000|NOT COMPLETED|Overall Study||7||
48531832|NCT05472662|101639199|FG000|STARTED|Overall Study||14||
48531833|NCT05472662|101639200|FG001|STARTED|Overall Study||11||
48231525|NCT02680145|100887500|FG000|STARTED|Overall Study||58||
48231526|NCT02680145|100887500|FG000|COMPLETED|Overall Study||47||
48231527|NCT02680145|100887500|FG000|NOT COMPLETED|Overall Study||11||
48231528|NCT01045057|100887501|FG000|STARTED|Overall Study||27||
48231529|NCT01045057|100887501|FG000|COMPLETED|Overall Study||27||
48231530|NCT01045057|100887501|FG000|NOT COMPLETED|Overall Study||0||
48231531|NCT05005351|100887502|FG000|STARTED|Overall Study||39||
48231532|NCT05005351|100887503|FG001|STARTED|Overall Study||28||
48531834|NCT05472662|101639199|FG000|COMPLETED|Overall Study||14||
48231533|NCT05005351|100887502|FG000|COMPLETED|Overall Study||37||
48231534|NCT05005351|100887503|FG001|COMPLETED|Overall Study||27||
48231535|NCT05005351|100887502|FG000|NOT COMPLETED|Overall Study||2||
48231536|NCT05005351|100887503|FG001|NOT COMPLETED|Overall Study||1||
48231537|NCT01782209|100887504|FG000|STARTED|Overall Study||335||
48231538|NCT01782209|100887504|FG000|COMPLETED|Overall Study||225||
48231539|NCT01782209|100887504|FG000|NOT COMPLETED|Overall Study||110||
48231540|NCT01777932|100887505|FG000|STARTED|Overall Study||220||
48231541|NCT01777932|100887505|FG000|COMPLETED|Overall Study||15||
48231542|NCT01777932|100887505|FG000|NOT COMPLETED|Overall Study||205||
48231543|NCT02538094|100887506|FG000|STARTED|Intervention 1 (5 Days Per Participant)||2||
48231544|NCT02538094|100887507|FG001|STARTED|Intervention 1 (5 Days Per Participant)||5||
48231545|NCT02538094|100887506|FG000|COMPLETED|Intervention 1 (5 Days Per Participant)||2||
48231546|NCT02538094|100887507|FG001|COMPLETED|Intervention 1 (5 Days Per Participant)||4||
48231547|NCT02538094|100887506|FG000|NOT COMPLETED|Intervention 1 (5 Days Per Participant)||0||
48531835|NCT05472662|101639200|FG001|COMPLETED|Overall Study||11||
48231548|NCT02538094|100887507|FG001|NOT COMPLETED|Intervention 1 (5 Days Per Participant)||1||
48231549|NCT02538094|100887506|FG000|STARTED|Washout (4 Weeks)||2||
48231550|NCT02538094|100887507|FG001|STARTED|Washout (4 Weeks)||4||
48231551|NCT02538094|100887506|FG000|COMPLETED|Washout (4 Weeks)||2||
48231552|NCT02538094|100887507|FG001|COMPLETED|Washout (4 Weeks)||3||
48231553|NCT02538094|100887506|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
48231554|NCT02538094|100887507|FG001|NOT COMPLETED|Washout (4 Weeks)||1||
48231555|NCT02538094|100887506|FG000|STARTED|Intervention 2 (5 Days Per Participant)||2||
48231556|NCT02538094|100887507|FG001|STARTED|Intervention 2 (5 Days Per Participant)||3||
48231557|NCT02538094|100887506|FG000|COMPLETED|Intervention 2 (5 Days Per Participant)||2||
48231558|NCT02538094|100887507|FG001|COMPLETED|Intervention 2 (5 Days Per Participant)||3||
48231559|NCT02538094|100887506|FG000|NOT COMPLETED|Intervention 2 (5 Days Per Participant)||0||
48231560|NCT02538094|100887507|FG001|NOT COMPLETED|Intervention 2 (5 Days Per Participant)||0||
48231561|NCT00195819|100887508|FG000|STARTED|Double-Blind||44||
48231562|NCT00195819|100887509|FG001|STARTED|Double-Blind||38||
48231563|NCT00195819|100887508|FG000|COMPLETED|Double-Blind||42||
48231564|NCT00195819|100887509|FG001|COMPLETED|Double-Blind||38||
48531836|NCT05472662|101639199|FG000|NOT COMPLETED|Overall Study||0||
48531837|NCT05472662|101639200|FG001|NOT COMPLETED|Overall Study||0||
48231565|NCT00195819|100887508|FG000|NOT COMPLETED|Double-Blind||2||
48231566|NCT00195819|100887509|FG001|NOT COMPLETED|Double-Blind||0||
48231567|NCT00195819|100887508|FG000|STARTED|Open-label||0||
48531838|NCT02669940|101639201|FG000|STARTED|Overall Study||63||
48531839|NCT02669940|101639202|FG001|STARTED|Overall Study||95||
48531840|NCT02669940|101639201|FG000|COMPLETED|Overall Study||62||
48531841|NCT02669940|101639202|FG001|COMPLETED|Overall Study||92||
48531842|NCT02669940|101639201|FG000|NOT COMPLETED|Overall Study||1||
48531843|NCT02669940|101639202|FG001|NOT COMPLETED|Overall Study||3||
48531844|NCT00515541|101639203|FG000|STARTED|Overall Study||10||
48531845|NCT00515541|101639204|FG001|STARTED|Overall Study||12||
48531846|NCT00515541|101639205|FG002|STARTED|Overall Study||10||
48531847|NCT00515541|101639206|FG003|STARTED|Overall Study||11||
48531848|NCT00515541|101639203|FG000|6 Weeks (1 gm Lovaza)|Overall Study||10||
48531849|NCT00515541|101639204|FG001|6 Weeks (1 gm Lovaza)|Overall Study||10||
48531850|NCT00515541|101639205|FG002|6 Weeks (1 gm Lovaza)|Overall Study||10||
48531851|NCT00515541|101639206|FG003|6 Weeks (1 gm Lovaza)|Overall Study||10||
48531852|NCT00515541|101639203|FG000|12 Weeks (2 gm Lovaza)|Overall Study||10||
48531853|NCT00515541|101639204|FG001|12 Weeks (2 gm Lovaza)|Overall Study||10||
48531854|NCT00515541|101639205|FG002|12 Weeks (2 gm Lovaza)|Overall Study||10||
48531855|NCT00515541|101639206|FG003|12 Weeks (2 gm Lovaza)|Overall Study||10||
48531856|NCT00515541|101639203|FG000|18 Weeks (4 gm Lovaza)|Overall Study||10||
48531857|NCT00515541|101639204|FG001|18 Weeks (4 gm Lovaza)|Overall Study||9||
48531858|NCT00515541|101639205|FG002|18 Weeks (4 gm Lovaza)|Overall Study||10||
48531859|NCT00515541|101639206|FG003|18 Weeks (4 gm Lovaza)|Overall Study||9||
48531860|NCT00515541|101639203|FG000|24 Weeks (8 gm Lovaza)|Overall Study||10||
48531861|NCT00515541|101639204|FG001|24 Weeks (8 gm Lovaza)|Overall Study||7||
48531862|NCT00515541|101639205|FG002|24 Weeks (8 gm Lovaza)|Overall Study||10||
48531863|NCT00515541|101639206|FG003|24 Weeks (8 gm Lovaza)|Overall Study||6||
48531864|NCT00515541|101639203|FG000|COMPLETED|Overall Study||10||
48531865|NCT00515541|101639204|FG001|COMPLETED|Overall Study||7||
48531866|NCT00515541|101639205|FG002|COMPLETED|Overall Study||10||
48531867|NCT00515541|101639206|FG003|COMPLETED|Overall Study||6||
48531868|NCT00515541|101639203|FG000|NOT COMPLETED|Overall Study||0||
48531869|NCT00515541|101639204|FG001|NOT COMPLETED|Overall Study||5||
48531870|NCT00515541|101639205|FG002|NOT COMPLETED|Overall Study||0||
48531871|NCT00515541|101639206|FG003|NOT COMPLETED|Overall Study||5||
48531872|NCT01267994|101639207|FG000|STARTED|Overall Study||12||
48531873|NCT01267994|101639207|FG000|COMPLETED|Overall Study||10||
48531874|NCT01267994|101639207|FG000|NOT COMPLETED|Overall Study||2||
48531875|NCT01682863|101639208|FG000|STARTED|Overall Study||204||
48531876|NCT01682863|101639209|FG001|STARTED|Overall Study||204||
48531877|NCT01682863|101639210|FG002|STARTED|Overall Study||207||
48531878|NCT01682863|101639208|FG000|Safety Set|Overall Study||204||
48531879|NCT01682863|101639209|FG001|Safety Set|Overall Study||204||
48531880|NCT01682863|101639210|FG002|Safety Set|Overall Study||206||
48531881|NCT01682863|101639208|FG000|Full Analysis Set (FAS)|Overall Study||204||
48531882|NCT01682863|101639209|FG001|Full Analysis Set (FAS)|Overall Study||204||
48531883|NCT01682863|101639210|FG002|Full Analysis Set (FAS)|Overall Study||206||
48531884|NCT01682863|101639208|FG000|Randomized Set|Overall Study||204||
48531885|NCT01682863|101639209|FG001|Randomized Set|Overall Study||204||
48531886|NCT01682863|101639210|FG002|Randomized Set|Overall Study||207||
48231568|NCT00195819|100887509|FG001|STARTED|Open-label||82||
48531887|NCT01682863|101639208|FG000|COMPLETED|Overall Study||177||
48531888|NCT01682863|101639209|FG001|COMPLETED|Overall Study||187||
48531889|NCT01682863|101639210|FG002|COMPLETED|Overall Study||183||
48231569|NCT00195819|100887508|FG000|COMPLETED|Open-label||0||
48231570|NCT00195819|100887509|FG001|COMPLETED|Open-label||62||
48231571|NCT00195819|100887508|FG000|NOT COMPLETED|Open-label||0||
48531890|NCT01682863|101639208|FG000|NOT COMPLETED|Overall Study||27||
48531891|NCT01682863|101639209|FG001|NOT COMPLETED|Overall Study||17||
48531892|NCT01682863|101639210|FG002|NOT COMPLETED|Overall Study||24||
48531893|NCT00848107|101639211|FG000|STARTED|Overall Study||115||
48531894|NCT00848107|101639211|FG000|COMPLETED|Overall Study||94||
48531895|NCT00848107|101639211|FG000|NOT COMPLETED|Overall Study||21||
48531896|NCT00281671|101639212|FG000|STARTED|Overall Study||5||
48531897|NCT00281671|101639213|FG001|STARTED|Overall Study||4||
48531898|NCT00281671|101639212|FG000|COMPLETED|Overall Study||5||
48531899|NCT00281671|101639213|FG001|COMPLETED|Overall Study||4||
48531900|NCT00281671|101639212|FG000|NOT COMPLETED|Overall Study||0||
48531901|NCT00281671|101639213|FG001|NOT COMPLETED|Overall Study||0||
48531902|NCT03344861|101639214|FG000|STARTED|Overall Study||10||
48531903|NCT03344861|101639214|FG000|COMPLETED|Overall Study||10||
48231572|NCT00195819|100887509|FG001|NOT COMPLETED|Open-label||20||
48231573|NCT01890954|100887510|FG000|STARTED|Overall Study||9||
48231574|NCT01890954|100887511|FG001|STARTED|Overall Study||8||
48231575|NCT01890954|100887510|FG000|COMPLETED|Overall Study||8||
48231576|NCT01890954|100887511|FG001|COMPLETED|Overall Study||8||
48231577|NCT01890954|100887510|FG000|NOT COMPLETED|Overall Study||1||
48231578|NCT01890954|100887511|FG001|NOT COMPLETED|Overall Study||0||
48231579|NCT03936699|100887512|FG000|STARTED|Overall Study||83||
48231580|NCT03936699|100887513|FG001|STARTED|Overall Study||78||
48231581|NCT03936699|100887512|FG000|COMPLETED|Overall Study||61||
48231582|NCT03936699|100887513|FG001|COMPLETED|Overall Study||55||
48231583|NCT03936699|100887512|FG000|NOT COMPLETED|Overall Study||22||
48231584|NCT03936699|100887513|FG001|NOT COMPLETED|Overall Study||23||
48231585|NCT02514824|100887514|FG000|STARTED|Overall Study||4||
48231586|NCT02514824|100887515|FG001|STARTED|Overall Study||5||
48231587|NCT02514824|100887516|FG002|STARTED|Overall Study||0||
48231588|NCT02514824|100887517|FG003|STARTED|Overall Study||0||
48231589|NCT02514824|100887514|FG000|Evaluable for Dose-limiting Toxicity|Overall Study||3||
48231590|NCT02514824|100887515|FG001|Evaluable for Dose-limiting Toxicity|Overall Study||5||
48231591|NCT02514824|100887516|FG002|Evaluable for Dose-limiting Toxicity|Overall Study||0||
48231592|NCT02514824|100887517|FG003|Evaluable for Dose-limiting Toxicity|Overall Study||0||
48231593|NCT02514824|100887514|FG000|COMPLETED|Overall Study||3||
48231594|NCT02514824|100887515|FG001|COMPLETED|Overall Study||4||
48231595|NCT02514824|100887516|FG002|COMPLETED|Overall Study||0||
48231596|NCT02514824|100887517|FG003|COMPLETED|Overall Study||0||
48231597|NCT02514824|100887514|FG000|NOT COMPLETED|Overall Study||1||
48231598|NCT02514824|100887515|FG001|NOT COMPLETED|Overall Study||1||
48231599|NCT02514824|100887516|FG002|NOT COMPLETED|Overall Study||0||
48231600|NCT02514824|100887517|FG003|NOT COMPLETED|Overall Study||0||
48231601|NCT03132636|100887518|FG000|STARTED|Overall Study||54||
48231602|NCT03132636|100887519|FG001|STARTED|Overall Study||84||
48231603|NCT03132636|100887518|FG000|Completed Treatment|Overall Study||11||
48231604|NCT03132636|100887519|FG001|Completed Treatment|Overall Study||28||
48531904|NCT03344861|101639214|FG000|NOT COMPLETED|Overall Study||0||
48531905|NCT00259272|101639215|FG000|STARTED|Overall Study||36||
48531906|NCT00259272|101639216|FG001|STARTED|Overall Study||31||
48531907|NCT00259272|101639217|FG002|STARTED|Overall Study||26||
48531908|NCT00259272|101639218|FG003|STARTED|Overall Study||48||
48231605|NCT03132636|100887518|FG000|COMPLETED|Overall Study||6|Completed Study|
48231606|NCT03132636|100887519|FG001|COMPLETED|Overall Study||19|Completed Study|
48231607|NCT03132636|100887518|FG000|NOT COMPLETED|Overall Study||48||
48231608|NCT03132636|100887519|FG001|NOT COMPLETED|Overall Study||65||
48231609|NCT02137785|100887520|FG000|STARTED|Overall Study||135||
48231610|NCT02137785|100887521|FG001|STARTED|Overall Study||134||
48231611|NCT02137785|100887520|FG000|COMPLETED|Overall Study||132||
48231612|NCT02137785|100887521|FG001|COMPLETED|Overall Study||130||
48231613|NCT02137785|100887520|FG000|NOT COMPLETED|Overall Study||3||
48231614|NCT02137785|100887521|FG001|NOT COMPLETED|Overall Study||4||
48231615|NCT04803734|100887522|FG000|STARTED|Overall Study||30||
48231616|NCT04803734|100887523|FG001|STARTED|Overall Study||30||
48231617|NCT04803734|100887522|FG000|COMPLETED|Overall Study||30||
48231618|NCT04803734|100887523|FG001|COMPLETED|Overall Study||28||
48231619|NCT04803734|100887522|FG000|NOT COMPLETED|Overall Study||0||
48231620|NCT04803734|100887523|FG001|NOT COMPLETED|Overall Study||2||
48531909|NCT00259272|101639215|FG000|COMPLETED|Overall Study||21||
48531910|NCT00259272|101639216|FG001|COMPLETED|Overall Study||24||
48531911|NCT00259272|101639217|FG002|COMPLETED|Overall Study||21||
48531912|NCT00259272|101639218|FG003|COMPLETED|Overall Study||27||
48531913|NCT00259272|101639215|FG000|NOT COMPLETED|Overall Study||15||
48531914|NCT00259272|101639216|FG001|NOT COMPLETED|Overall Study||7||
48531915|NCT00259272|101639217|FG002|NOT COMPLETED|Overall Study||5||
48231621|NCT03390166|100887524|FG000|STARTED|Overall Study||630||
48231622|NCT03390166|100887525|FG001|STARTED|Overall Study||315||
48231623|NCT03390166|100887524|FG000|COMPLETED|Overall Study||618||
48531916|NCT00259272|101639218|FG003|NOT COMPLETED|Overall Study||21||
48531917|NCT02011113|101639219|FG000|STARTED|Overall Study||36||
48231624|NCT03390166|100887525|FG001|COMPLETED|Overall Study||305||
48231625|NCT03390166|100887524|FG000|NOT COMPLETED|Overall Study||12||
48231626|NCT03390166|100887525|FG001|NOT COMPLETED|Overall Study||10||
48231627|NCT02065609|100887526|FG000|STARTED|Overall Study||12||
48531918|NCT02011113|101639219|FG000|COMPLETED|Overall Study||0||
48531919|NCT02011113|101639219|FG000|NOT COMPLETED|Overall Study||36||
48531920|NCT00996775|101639220|FG000|STARTED|Overall Study||78||
48531921|NCT00996775|101639221|FG001|STARTED|Overall Study||89||
48531922|NCT00996775|101639220|FG000|COMPLETED|Overall Study||67||
48531923|NCT00996775|101639221|FG001|COMPLETED|Overall Study||75||
48531924|NCT00996775|101639220|FG000|NOT COMPLETED|Overall Study||11||
48531925|NCT00996775|101639221|FG001|NOT COMPLETED|Overall Study||14||
48531926|NCT04492020|101639222|FG000|STARTED|Overall Study||264|Intent-to-Treat population consists of all randomized participants|
48531927|NCT04492020|101639223|FG001|STARTED|Overall Study||254|Intent-to-Treat population consists of all randomized participants|
48531928|NCT04492020|101639222|FG000|Safety Population|Overall Study||247|Safety population consists of all treated participants who take at least 1 administration of study intervention|
48231628|NCT02065609|100887527|FG001|STARTED|Overall Study||40||
48231629|NCT02065609|100887526|FG000|COMPLETED|Overall Study||12||
48231630|NCT02065609|100887527|FG001|COMPLETED|Overall Study||40||
48231631|NCT02065609|100887526|FG000|NOT COMPLETED|Overall Study||0||
48231632|NCT02065609|100887527|FG001|NOT COMPLETED|Overall Study||0||
48231633|NCT01868230|100887528|FG000|STARTED|Overall Study||74||
48231634|NCT01868230|100887529|FG001|STARTED|Overall Study||74||
48231635|NCT01868230|100887528|FG000|6 Week Postpartum Data|Overall Study||35||
48231636|NCT01868230|100887529|FG001|6 Week Postpartum Data|Overall Study||41||
48231637|NCT01868230|100887528|FG000|6 Month Postpartum Data|Overall Study||20||
48231638|NCT01868230|100887529|FG001|6 Month Postpartum Data|Overall Study||33||
48231639|NCT01868230|100887528|FG000|12 Months Postpartum|Overall Study||22||
48231640|NCT01868230|100887529|FG001|12 Months Postpartum|Overall Study||24||
48231641|NCT01868230|100887528|FG000|COMPLETED|Overall Study||74||
48231642|NCT01868230|100887529|FG001|COMPLETED|Overall Study||74||
48231643|NCT01868230|100887528|FG000|NOT COMPLETED|Overall Study||0||
48231644|NCT01868230|100887529|FG001|NOT COMPLETED|Overall Study||0||
48531929|NCT04492020|101639223|FG001|Safety Population|Overall Study||233|Safety population consists of all treated participants who take at least 1 administration of study intervention|
48231645|NCT01918033|100887530|FG000|STARTED|Overall Study||203||
48231646|NCT01918033|100887531|FG001|STARTED|Overall Study||203||
48231647|NCT01918033|100887532|FG002|STARTED|Overall Study||202||
48231648|NCT01918033|100887530|FG000|Treated|Overall Study||202||
48231649|NCT01918033|100887531|FG001|Treated|Overall Study||203||
48231650|NCT01918033|100887532|FG002|Treated|Overall Study||201||
48231651|NCT01918033|100887530|FG000|COMPLETED|Overall Study||198||
48231652|NCT01918033|100887531|FG001|COMPLETED|Overall Study||201||
48231653|NCT01918033|100887532|FG002|COMPLETED|Overall Study||199||
48231654|NCT01918033|100887530|FG000|NOT COMPLETED|Overall Study||5||
48231655|NCT01918033|100887531|FG001|NOT COMPLETED|Overall Study||2||
48231656|NCT01918033|100887532|FG002|NOT COMPLETED|Overall Study||3||
48231657|NCT02356198|100887533|FG000|STARTED|Overall Study||104||
48231658|NCT02356198|100887534|FG001|STARTED|Overall Study||105||
48231659|NCT02356198|100887533|FG000|COMPLETED|Overall Study||102||
48231660|NCT02356198|100887534|FG001|COMPLETED|Overall Study||98||
48231661|NCT02356198|100887533|FG000|NOT COMPLETED|Overall Study||2||
48231662|NCT02356198|100887534|FG001|NOT COMPLETED|Overall Study||7||
48231663|NCT01862159|100887535|FG000|STARTED|Overall Study||25038||
48231664|NCT01862159|100887535|FG000|COMPLETED|Overall Study||25038||
48231665|NCT01862159|100887535|FG000|NOT COMPLETED|Overall Study||0||
48231666|NCT00659373|100887536|FG000|STARTED|Overall Study||25||
48231667|NCT00659373|100887537|FG001|STARTED|Overall Study||61||
48231668|NCT00659373|100887536|FG000|COMPLETED|Overall Study||20||
48231669|NCT00659373|100887537|FG001|COMPLETED|Overall Study||54||
48231670|NCT00659373|100887536|FG000|NOT COMPLETED|Overall Study||5||
48231671|NCT00659373|100887537|FG001|NOT COMPLETED|Overall Study||7||
48231672|NCT03266419|100887538|FG000|STARTED|Overall Study||51||
48231673|NCT03266419|100887539|FG001|STARTED|Overall Study||49||
48231674|NCT03266419|100887538|FG000|COMPLETED|Overall Study||51||
48231675|NCT03266419|100887539|FG001|COMPLETED|Overall Study||49||
48231676|NCT03266419|100887538|FG000|NOT COMPLETED|Overall Study||0||
48231677|NCT03266419|100887539|FG001|NOT COMPLETED|Overall Study||0||
48231678|NCT01567150|100887540|FG000|STARTED|Overall Study||21||
48231679|NCT01567150|100887541|FG001|STARTED|Overall Study||18||
48231680|NCT01567150|100887540|FG000|COMPLETED|Overall Study||19||
48231681|NCT01567150|100887541|FG001|COMPLETED|Overall Study||16||
48531930|NCT04492020|101639222|FG000|COMPLETED|Overall Study||223||
48531931|NCT04492020|101639223|FG001|COMPLETED|Overall Study||215||
48531932|NCT04492020|101639222|FG000|NOT COMPLETED|Overall Study||41||
48531933|NCT04492020|101639223|FG001|NOT COMPLETED|Overall Study||39||
48531934|NCT01908816|101639224|FG000|STARTED|Overall Study||93||
48231682|NCT01567150|100887540|FG000|NOT COMPLETED|Overall Study||2||
48231683|NCT01567150|100887541|FG001|NOT COMPLETED|Overall Study||2||
48231684|NCT03125148|100887542|FG000|STARTED|Overall Study||9||
48231685|NCT03125148|100887543|FG001|STARTED|Overall Study||8||
48231686|NCT03125148|100887542|FG000|COMPLETED|Overall Study||9||
48231687|NCT03125148|100887543|FG001|COMPLETED|Overall Study||8||
48231688|NCT03125148|100887542|FG000|NOT COMPLETED|Overall Study||0||
48231689|NCT03125148|100887543|FG001|NOT COMPLETED|Overall Study||0||
48231690|NCT02630186|100887544|FG000|STARTED|Overall Study||3||
48231691|NCT02630186|100887544|FG000|COMPLETED|Overall Study||2||
48231692|NCT02630186|100887544|FG000|NOT COMPLETED|Overall Study||1||
48231693|NCT00590759|100887545|FG000|STARTED|Overall Study||150||
48231694|NCT00590759|100887545|FG000|COMPLETED|Overall Study||70||
48231695|NCT00590759|100887545|FG000|NOT COMPLETED|Overall Study||80||
48231696|NCT04463004|100887546|FG000|STARTED|Overall Study||1||
48231697|NCT04463004|100887547|FG001|STARTED|Overall Study||1||
48231698|NCT04463004|100887546|FG000|COMPLETED|Overall Study||1||
48231699|NCT04463004|100887547|FG001|COMPLETED|Overall Study||1||
48231700|NCT04463004|100887546|FG000|NOT COMPLETED|Overall Study||0||
48231701|NCT04463004|100887547|FG001|NOT COMPLETED|Overall Study||0||
48231702|NCT01676298|100887548|FG000|STARTED|Overall Study||1||
48231703|NCT01676298|100887549|FG001|STARTED|Overall Study||1||
48231704|NCT01676298|100887550|FG002|STARTED|Overall Study||1||
48231705|NCT01676298|100887551|FG003|STARTED|Overall Study||1||
48231706|NCT01676298|100887552|FG004|STARTED|Overall Study||1||
48231707|NCT01676298|100887553|FG005|STARTED|Overall Study||1||
48231708|NCT01676298|100887554|FG006|STARTED|Overall Study||1||
48231709|NCT01676298|100887555|FG007|STARTED|Overall Study||1||
48231710|NCT01676298|100887548|FG000|All Genotypes Confirmed With Reference|Overall Study||1||
48231711|NCT01676298|100887549|FG001|All Genotypes Confirmed With Reference|Overall Study||1||
48531935|NCT01908816|101639225|FG001|STARTED|Overall Study||84||
48531936|NCT01908816|101639226|FG002|STARTED|Overall Study||58||
48531937|NCT01908816|101639227|FG003|STARTED|Overall Study||35||
48531938|NCT01908816|101639224|FG000|COMPLETED|Overall Study||0||
48531939|NCT01908816|101639225|FG001|COMPLETED|Overall Study||0||
48531940|NCT01908816|101639226|FG002|COMPLETED|Overall Study||0||
48531941|NCT01908816|101639227|FG003|COMPLETED|Overall Study||0||
48531942|NCT01908816|101639224|FG000|NOT COMPLETED|Overall Study||93||
48531943|NCT01908816|101639225|FG001|NOT COMPLETED|Overall Study||84||
48531944|NCT01908816|101639226|FG002|NOT COMPLETED|Overall Study||58||
48531945|NCT01908816|101639227|FG003|NOT COMPLETED|Overall Study||35||
48531946|NCT02109419|101639228|FG000|STARTED|Overall Study||57||
48531947|NCT02109419|101639228|FG000|COMPLETED|Overall Study||57||
48531948|NCT02109419|101639228|FG000|NOT COMPLETED|Overall Study||0||
48531949|NCT00102518|101639229|FG000|STARTED|Overall Study||325||
48531950|NCT00102518|101639229|FG000|COMPLETED|Overall Study||238||
48231712|NCT01676298|100887550|FG002|All Genotypes Confirmed With Reference|Overall Study||1||
48231713|NCT01676298|100887551|FG003|All Genotypes Confirmed With Reference|Overall Study||1||
48231714|NCT01676298|100887552|FG004|All Genotypes Confirmed With Reference|Overall Study||1||
48231715|NCT01676298|100887553|FG005|All Genotypes Confirmed With Reference|Overall Study||1||
48531951|NCT00102518|101639229|FG000|NOT COMPLETED|Overall Study||87||
48531952|NCT03065218|101639230|FG000|STARTED|Overall Study||4||
48531953|NCT03065218|101639230|FG000|COMPLETED|Overall Study||4||
48531954|NCT03065218|101639230|FG000|NOT COMPLETED|Overall Study||0||
48231716|NCT01676298|100887554|FG006|All Genotypes Confirmed With Reference|Overall Study||1||
48231717|NCT01676298|100887555|FG007|All Genotypes Confirmed With Reference|Overall Study||1||
48231718|NCT01676298|100887548|FG000|Participated in All Tests|Overall Study||1||
48231719|NCT01676298|100887549|FG001|Participated in All Tests|Overall Study||1||
48231720|NCT01676298|100887550|FG002|Participated in All Tests|Overall Study||1||
48231721|NCT01676298|100887551|FG003|Participated in All Tests|Overall Study||1||
48231722|NCT01676298|100887552|FG004|Participated in All Tests|Overall Study||1||
48231723|NCT01676298|100887553|FG005|Participated in All Tests|Overall Study||1||
48231724|NCT01676298|100887554|FG006|Participated in All Tests|Overall Study||1||
48231725|NCT01676298|100887555|FG007|Participated in All Tests|Overall Study||1||
48231726|NCT01676298|100887548|FG000|COMPLETED|Overall Study||1||
48231727|NCT01676298|100887549|FG001|COMPLETED|Overall Study||1||
48231728|NCT01676298|100887550|FG002|COMPLETED|Overall Study||1||
48231729|NCT01676298|100887551|FG003|COMPLETED|Overall Study||1||
48231730|NCT01676298|100887552|FG004|COMPLETED|Overall Study||1||
48231731|NCT01676298|100887553|FG005|COMPLETED|Overall Study||1||
48231732|NCT01676298|100887554|FG006|COMPLETED|Overall Study||1||
48231733|NCT01676298|100887555|FG007|COMPLETED|Overall Study||1||
48231734|NCT01676298|100887548|FG000|NOT COMPLETED|Overall Study||0||
48231735|NCT01676298|100887549|FG001|NOT COMPLETED|Overall Study||0||
48231736|NCT01676298|100887550|FG002|NOT COMPLETED|Overall Study||0||
48231737|NCT01676298|100887551|FG003|NOT COMPLETED|Overall Study||0||
48231738|NCT01676298|100887552|FG004|NOT COMPLETED|Overall Study||0||
48231739|NCT01676298|100887553|FG005|NOT COMPLETED|Overall Study||0||
48231740|NCT01676298|100887554|FG006|NOT COMPLETED|Overall Study||0||
48231741|NCT01676298|100887555|FG007|NOT COMPLETED|Overall Study||0||
48231742|NCT01858688|100887556|FG000|STARTED|Overall Study||101||
48231743|NCT01858688|100887556|FG000|Biopsied at Baseline|Overall Study||97||
48231744|NCT01858688|100887556|FG000|MRI Assessed|Overall Study||91||
48231745|NCT01858688|100887556|FG000|COMPLETED|Overall Study||81|Participants with TRUS biopsy at baseline as well as MRI and TRUS Biopsy post-baseline|
48231746|NCT01858688|100887556|FG000|NOT COMPLETED|Overall Study||20||
48231747|NCT01137682|100887557|FG000|STARTED|Overall Study||65||
48231748|NCT01137682|100887558|FG001|STARTED|Overall Study||65||
48231749|NCT01137682|100887559|FG002|STARTED|Overall Study||68||
48231750|NCT01137682|100887557|FG000|Not Treated|Overall Study||2||
48531955|NCT03400943|101639231|FG000|STARTED|Treatment Period 1||23|Randomized|
48531956|NCT03400943|101639232|FG001|STARTED|Treatment Period 1||23|Randomized|
48531957|NCT03400943|101639233|FG002|STARTED|Treatment Period 1||24|Randomized|
48531958|NCT03400943|101639234|FG003|STARTED|Treatment Period 1||23|Randomized|
48231751|NCT01137682|100887558|FG001|Not Treated|Overall Study||2||
48231752|NCT01137682|100887559|FG002|Not Treated|Overall Study||1||
48231753|NCT01137682|100887557|FG000|Treated|Overall Study||63||
48231754|NCT01137682|100887558|FG001|Treated|Overall Study||63||
48231755|NCT01137682|100887559|FG002|Treated|Overall Study||67||
48231756|NCT01137682|100887557|FG000|Completed 24-Week Core Phase|Overall Study||59||
48231757|NCT01137682|100887558|FG001|Completed 24-Week Core Phase|Overall Study||57||
48231758|NCT01137682|100887559|FG002|Completed 24-Week Core Phase|Overall Study||65||
48231759|NCT01137682|100887557|FG000|Not Continuing Into Extension|Overall Study||2||
48231760|NCT01137682|100887558|FG001|Not Continuing Into Extension|Overall Study||3||
48231761|NCT01137682|100887559|FG002|Not Continuing Into Extension|Overall Study||2||
48231762|NCT01137682|100887557|FG000|Continuing Into Extension|Overall Study||57||
48231763|NCT01137682|100887558|FG001|Continuing Into Extension|Overall Study||54||
48231764|NCT01137682|100887559|FG002|Continuing Into Extension|Overall Study||63||
48231765|NCT01137682|100887557|FG000|Safety Set - CORE|Overall Study||63||
48231766|NCT01137682|100887558|FG001|Safety Set - CORE|Overall Study||62||
48231767|NCT01137682|100887559|FG002|Safety Set - CORE|Overall Study||66||
48231768|NCT01137682|100887557|FG000|Safety Set - Extension|Overall Study||57||
48231769|NCT01137682|100887558|FG001|Safety Set - Extension|Overall Study||54||
48531959|NCT03400943|101639231|FG000|Treated|Treatment Period 1||18||
48531960|NCT03400943|101639232|FG001|Treated|Treatment Period 1||21||
48531961|NCT03400943|101639233|FG002|Treated|Treatment Period 1||20||
48531962|NCT03400943|101639234|FG003|Treated|Treatment Period 1||20||
48531963|NCT03400943|101639231|FG000|COMPLETED|Treatment Period 1||18||
48531964|NCT03400943|101639232|FG001|COMPLETED|Treatment Period 1||21||
48531965|NCT03400943|101639233|FG002|COMPLETED|Treatment Period 1||18||
48531966|NCT03400943|101639234|FG003|COMPLETED|Treatment Period 1||18||
48531967|NCT03400943|101639231|FG000|NOT COMPLETED|Treatment Period 1||5||
48531968|NCT03400943|101639232|FG001|NOT COMPLETED|Treatment Period 1||2||
48231770|NCT01137682|100887559|FG002|Safety Set - Extension|Overall Study||62||
48231771|NCT01137682|100887557|FG000|COMPLETED|Overall Study||28||
48231772|NCT01137682|100887558|FG001|COMPLETED|Overall Study||25||
48231773|NCT01137682|100887559|FG002|COMPLETED|Overall Study||34||
48231774|NCT01137682|100887557|FG000|NOT COMPLETED|Overall Study||37||
48231775|NCT01137682|100887558|FG001|NOT COMPLETED|Overall Study||40||
48231776|NCT01137682|100887559|FG002|NOT COMPLETED|Overall Study||34||
48231777|NCT00641537|100887560|FG000|STARTED|96-week Period||98||
48231778|NCT00641537|100887561|FG001|STARTED|96-week Period||92||
48231779|NCT00641537|100887562|FG002|STARTED|96-week Period||186||
48231780|NCT00641537|100887563|FG003|STARTED|96-week Period||186||
48231781|NCT00641537|100887564|FG004|STARTED|96-week Period||244||
48231782|NCT00641537|100887565|FG005|STARTED|96-week Period||22||
48231783|NCT00641537|100887566|FG006|STARTED|96-week Period||17||
48231784|NCT00641537|100887567|FG007|STARTED|96-week Period||22||
48231785|NCT00641537|100887560|FG000|COMPLETED|96-week Period||89||
48231786|NCT00641537|100887561|FG001|COMPLETED|96-week Period||82||
48231787|NCT00641537|100887562|FG002|COMPLETED|96-week Period||166||
48231788|NCT00641537|100887563|FG003|COMPLETED|96-week Period||174||
48231789|NCT00641537|100887564|FG004|COMPLETED|96-week Period||227||
48231790|NCT00641537|100887565|FG005|COMPLETED|96-week Period||15||
48231791|NCT00641537|100887566|FG006|COMPLETED|96-week Period||12||
48231792|NCT00641537|100887567|FG007|COMPLETED|96-week Period||16||
48231793|NCT00641537|100887560|FG000|NOT COMPLETED|96-week Period||9||
48231794|NCT00641537|100887561|FG001|NOT COMPLETED|96-week Period||10||
48231795|NCT00641537|100887562|FG002|NOT COMPLETED|96-week Period||20||
48231796|NCT00641537|100887563|FG003|NOT COMPLETED|96-week Period||12||
48231797|NCT00641537|100887564|FG004|NOT COMPLETED|96-week Period||17||
48231798|NCT00641537|100887565|FG005|NOT COMPLETED|96-week Period||7||
48231799|NCT00641537|100887566|FG006|NOT COMPLETED|96-week Period||5||
48231800|NCT00641537|100887567|FG007|NOT COMPLETED|96-week Period||6||
48231801|NCT00641537|100887560|FG000|STARTED|24-Week Supplemental Follow-up Period||75||
48231802|NCT00641537|100887561|FG001|STARTED|24-Week Supplemental Follow-up Period||69||
48231803|NCT00641537|100887562|FG002|STARTED|24-Week Supplemental Follow-up Period||143||
48531969|NCT03400943|101639233|FG002|NOT COMPLETED|Treatment Period 1||6||
48531970|NCT03400943|101639234|FG003|NOT COMPLETED|Treatment Period 1||5||
48531971|NCT03400943|101639231|FG000|STARTED|Post-treatment Period 1||18||
48231804|NCT00641537|100887563|FG003|STARTED|24-Week Supplemental Follow-up Period||151||
48231805|NCT00641537|100887564|FG004|STARTED|24-Week Supplemental Follow-up Period||198||
48231806|NCT00641537|100887565|FG005|STARTED|24-Week Supplemental Follow-up Period||15||
48231807|NCT00641537|100887566|FG006|STARTED|24-Week Supplemental Follow-up Period||9||
48231808|NCT00641537|100887567|FG007|STARTED|24-Week Supplemental Follow-up Period||11||
48231809|NCT00641537|100887560|FG000|COMPLETED|24-Week Supplemental Follow-up Period||75||
48231810|NCT00641537|100887561|FG001|COMPLETED|24-Week Supplemental Follow-up Period||66||
48231811|NCT00641537|100887562|FG002|COMPLETED|24-Week Supplemental Follow-up Period||140||
48231812|NCT00641537|100887563|FG003|COMPLETED|24-Week Supplemental Follow-up Period||147||
48231813|NCT00641537|100887564|FG004|COMPLETED|24-Week Supplemental Follow-up Period||193||
48231814|NCT00641537|100887565|FG005|COMPLETED|24-Week Supplemental Follow-up Period||14||
48231815|NCT00641537|100887566|FG006|COMPLETED|24-Week Supplemental Follow-up Period||8||
48231816|NCT00641537|100887567|FG007|COMPLETED|24-Week Supplemental Follow-up Period||10||
48231817|NCT00641537|100887560|FG000|NOT COMPLETED|24-Week Supplemental Follow-up Period||0||
48231818|NCT00641537|100887561|FG001|NOT COMPLETED|24-Week Supplemental Follow-up Period||3||
48231819|NCT00641537|100887562|FG002|NOT COMPLETED|24-Week Supplemental Follow-up Period||3||
48231820|NCT00641537|100887563|FG003|NOT COMPLETED|24-Week Supplemental Follow-up Period||4||
48231821|NCT00641537|100887564|FG004|NOT COMPLETED|24-Week Supplemental Follow-up Period||5||
48231822|NCT00641537|100887565|FG005|NOT COMPLETED|24-Week Supplemental Follow-up Period||1||
48231823|NCT00641537|100887566|FG006|NOT COMPLETED|24-Week Supplemental Follow-up Period||1||
48231824|NCT00641537|100887567|FG007|NOT COMPLETED|24-Week Supplemental Follow-up Period||1||
48231825|NCT04669366|100891247|FG000|STARTED|Overall Study||704||
48231826|NCT04669366|100891248|FG001|STARTED|Overall Study||320||
48231827|NCT04669366|100891249|FG002|STARTED|Overall Study||71||
48231828|NCT04669366|100891250|FG003|STARTED|Overall Study||110||
48231829|NCT04669366|100891247|FG000|COMPLETED|Overall Study||704||
48231830|NCT04669366|100891248|FG001|COMPLETED|Overall Study||320||
48231831|NCT04669366|100891249|FG002|COMPLETED|Overall Study||71||
48231832|NCT04669366|100891250|FG003|COMPLETED|Overall Study||110||
48231833|NCT04669366|100891247|FG000|NOT COMPLETED|Overall Study||0||
48231834|NCT04669366|100891248|FG001|NOT COMPLETED|Overall Study||0||
48531972|NCT03400943|101639232|FG001|STARTED|Post-treatment Period 1||0||
48531973|NCT03400943|101639233|FG002|STARTED|Post-treatment Period 1||18||
48231835|NCT04669366|100891249|FG002|NOT COMPLETED|Overall Study||0||
48231836|NCT04669366|100891250|FG003|NOT COMPLETED|Overall Study||0||
48231837|NCT02095145|100891251|FG000|STARTED|Overall Study||15||
48231838|NCT02095145|100891252|FG001|STARTED|Overall Study||15||
48231839|NCT02095145|100891251|FG000|COMPLETED|Overall Study||14||
48231840|NCT02095145|100891252|FG001|COMPLETED|Overall Study||15||
48231841|NCT02095145|100891251|FG000|NOT COMPLETED|Overall Study||1||
48231842|NCT02095145|100891252|FG001|NOT COMPLETED|Overall Study||0||
48231843|NCT01670877|100891253|FG000|STARTED|Part I and Part 2||16||
48231844|NCT01670877|100891254|FG001|STARTED|Part I and Part 2||5||
48231845|NCT01670877|100891255|FG002|STARTED|Part I and Part 2||11||
48231846|NCT01670877|100891256|FG003|STARTED|Part I and Part 2||24||
48231847|NCT01670877|100891257|FG004|STARTED|Part I and Part 2||0||
48231848|NCT01670877|100891258|FG005|STARTED|Part I and Part 2||0||
48231849|NCT01670877|100891253|FG000|COMPLETED|Part I and Part 2||16||
48231850|NCT01670877|100891254|FG001|COMPLETED|Part I and Part 2||4||
48231851|NCT01670877|100891255|FG002|COMPLETED|Part I and Part 2||10||
48231852|NCT01670877|100891256|FG003|COMPLETED|Part I and Part 2||21||
48231853|NCT01670877|100891257|FG004|COMPLETED|Part I and Part 2||0||
48231854|NCT01670877|100891258|FG005|COMPLETED|Part I and Part 2||0||
48231855|NCT01670877|100891253|FG000|NOT COMPLETED|Part I and Part 2||0||
48231856|NCT01670877|100891254|FG001|NOT COMPLETED|Part I and Part 2||1||
48231857|NCT01670877|100891255|FG002|NOT COMPLETED|Part I and Part 2||1||
48231858|NCT01670877|100891256|FG003|NOT COMPLETED|Part I and Part 2||3||
48231859|NCT01670877|100891257|FG004|NOT COMPLETED|Part I and Part 2||0||
48231860|NCT01670877|100891258|FG005|NOT COMPLETED|Part I and Part 2||0||
48531974|NCT03400943|101639234|FG003|STARTED|Post-treatment Period 1||18||
48231861|NCT01670877|100891253|FG000|STARTED|Crossover||0||
48231862|NCT01670877|100891254|FG001|STARTED|Crossover||0||
48231863|NCT01670877|100891255|FG002|STARTED|Crossover||0||
48231864|NCT01670877|100891256|FG003|STARTED|Crossover||0||
48231865|NCT01670877|100891257|FG004|STARTED|Crossover||3||
48231866|NCT01670877|100891258|FG005|STARTED|Crossover||5||
48231867|NCT01670877|100891253|FG000|COMPLETED|Crossover||0||
48231868|NCT01670877|100891254|FG001|COMPLETED|Crossover||0||
48231869|NCT01670877|100891255|FG002|COMPLETED|Crossover||0||
48231870|NCT01670877|100891256|FG003|COMPLETED|Crossover||0||
48231871|NCT01670877|100891257|FG004|COMPLETED|Crossover||3||
48231872|NCT01670877|100891258|FG005|COMPLETED|Crossover||5||
48231873|NCT01670877|100891253|FG000|NOT COMPLETED|Crossover||0||
48231874|NCT01670877|100891254|FG001|NOT COMPLETED|Crossover||0||
48231875|NCT01670877|100891255|FG002|NOT COMPLETED|Crossover||0||
48231876|NCT01670877|100891256|FG003|NOT COMPLETED|Crossover||0||
48531975|NCT03400943|101639231|FG000|COMPLETED|Post-treatment Period 1||7||
48531976|NCT03400943|101639232|FG001|COMPLETED|Post-treatment Period 1||0||
48531977|NCT03400943|101639233|FG002|COMPLETED|Post-treatment Period 1||7||
48531978|NCT03400943|101639234|FG003|COMPLETED|Post-treatment Period 1||5||
48531979|NCT03400943|101639231|FG000|NOT COMPLETED|Post-treatment Period 1||11||
48531980|NCT03400943|101639232|FG001|NOT COMPLETED|Post-treatment Period 1||0||
48531981|NCT03400943|101639233|FG002|NOT COMPLETED|Post-treatment Period 1||11||
48531982|NCT03400943|101639234|FG003|NOT COMPLETED|Post-treatment Period 1||13||
48531983|NCT03400943|101639231|FG000|STARTED|Treatment Period 2||7|Treatment started|
48231877|NCT01670877|100891257|FG004|NOT COMPLETED|Crossover||0||
48231878|NCT01670877|100891258|FG005|NOT COMPLETED|Crossover||0||
48231879|NCT04658888|100891259|FG000|STARTED|Overall Study||333||
48231880|NCT04658888|100891260|FG001|STARTED|Overall Study||631||
48231881|NCT04658888|100891259|FG000|COMPLETED|Overall Study||333||
48231882|NCT04658888|100891260|FG001|COMPLETED|Overall Study||631||
48231883|NCT04658888|100891259|FG000|NOT COMPLETED|Overall Study||0||
48231884|NCT04658888|100891260|FG001|NOT COMPLETED|Overall Study||0||
48231885|NCT03302091|100891261|FG000|STARTED|Overall Study||10|Started are treated|
48231886|NCT03302091|100891262|FG001|STARTED|Overall Study||10|Started are treated|
48231887|NCT03302091|100891261|FG000|COMPLETED|Overall Study||10||
48231888|NCT03302091|100891262|FG001|COMPLETED|Overall Study||10||
48231889|NCT03302091|100891261|FG000|NOT COMPLETED|Overall Study||0||
48231890|NCT03302091|100891262|FG001|NOT COMPLETED|Overall Study||0||
48231891|NCT01368874|100891263|FG000|STARTED|Overall Study||34||
48231892|NCT01368874|100891264|FG001|STARTED|Overall Study||5||
48231893|NCT01368874|100891265|FG002|STARTED|Overall Study||25||
48231894|NCT01368874|100891263|FG000|COMPLETED|Overall Study||31||
48231895|NCT01368874|100891264|FG001|COMPLETED|Overall Study||5||
48231896|NCT01368874|100891265|FG002|COMPLETED|Overall Study||24||
48231897|NCT01368874|100891263|FG000|NOT COMPLETED|Overall Study||3||
48231898|NCT01368874|100891264|FG001|NOT COMPLETED|Overall Study||0||
48231899|NCT01368874|100891265|FG002|NOT COMPLETED|Overall Study||1||
48231900|NCT02991118|100891266|FG000|STARTED|Overall Study||257||
48231901|NCT02991118|100891267|FG001|STARTED|Overall Study||522||
48231902|NCT02991118|100891266|FG000|COMPLETED|Overall Study||250||
48231903|NCT02991118|100891267|FG001|COMPLETED|Overall Study||490||
48231904|NCT02991118|100891266|FG000|NOT COMPLETED|Overall Study||7||
48231905|NCT02991118|100891267|FG001|NOT COMPLETED|Overall Study||32||
48231906|NCT01682928|100891268|FG000|STARTED|Overall Study||2||
48231907|NCT01682928|100891269|FG001|STARTED|Overall Study||2||
48231908|NCT01682928|100891268|FG000|COMPLETED|Overall Study||2||
48231909|NCT01682928|100891269|FG001|COMPLETED|Overall Study||2||
48231910|NCT01682928|100891268|FG000|NOT COMPLETED|Overall Study||0||
48231911|NCT01682928|100891269|FG001|NOT COMPLETED|Overall Study||0||
48231912|NCT04658784|100891270|FG000|STARTED|Enrollment to 6-week Follow-up||36||
48231913|NCT04658784|100891271|FG001|STARTED|Enrollment to 6-week Follow-up||36||
48231914|NCT04658784|100891270|FG000|COMPLETED|Enrollment to 6-week Follow-up||36||
48231915|NCT04658784|100891271|FG001|COMPLETED|Enrollment to 6-week Follow-up||36||
48231916|NCT04658784|100891270|FG000|NOT COMPLETED|Enrollment to 6-week Follow-up||0||
48231917|NCT04658784|100891271|FG001|NOT COMPLETED|Enrollment to 6-week Follow-up||0||
48231918|NCT04658784|100891270|FG000|STARTED|6-month Follow-up||36||
48231919|NCT04658784|100891271|FG001|STARTED|6-month Follow-up||36||
48231920|NCT04658784|100891270|FG000|COMPLETED|6-month Follow-up||34||
48231921|NCT04658784|100891271|FG001|COMPLETED|6-month Follow-up||31||
48231922|NCT04658784|100891270|FG000|NOT COMPLETED|6-month Follow-up||2||
48231923|NCT04658784|100891271|FG001|NOT COMPLETED|6-month Follow-up||5||
48231924|NCT01083706|100891272|FG000|STARTED|Overall Study||39||
48231925|NCT01083706|100891272|FG000|COMPLETED|Overall Study||39||
48231926|NCT01083706|100891272|FG000|NOT COMPLETED|Overall Study||0||
48231927|NCT02527694|100891273|FG000|STARTED|Overall Study||20||
48231928|NCT02527694|100891274|FG001|STARTED|Overall Study||29||
48231929|NCT02527694|100891273|FG000|COMPLETED|Overall Study||10||
48231930|NCT02527694|100891274|FG001|COMPLETED|Overall Study||21||
48231931|NCT02527694|100891273|FG000|NOT COMPLETED|Overall Study||10||
48231932|NCT02527694|100891274|FG001|NOT COMPLETED|Overall Study||8||
48231933|NCT03054506|100891275|FG000|STARTED|Overall Study||20||
48231934|NCT03054506|100891276|FG001|STARTED|Overall Study||11||
48231935|NCT03054506|100891277|FG002|STARTED|Overall Study||9||
48231936|NCT03054506|100891275|FG000|COMPLETED|Overall Study||19||
48231937|NCT03054506|100891276|FG001|COMPLETED|Overall Study||11||
48231938|NCT03054506|100891277|FG002|COMPLETED|Overall Study||9||
48231939|NCT03054506|100891275|FG000|NOT COMPLETED|Overall Study||1||
48231940|NCT03054506|100891276|FG001|NOT COMPLETED|Overall Study||0||
48531984|NCT03400943|101639232|FG001|STARTED|Treatment Period 2||21|Treatment started|
48231941|NCT03054506|100891277|FG002|NOT COMPLETED|Overall Study||0||
48531985|NCT03400943|101639233|FG002|STARTED|Treatment Period 2||7|Treatment started|
48531986|NCT03400943|101639234|FG003|STARTED|Treatment Period 2||5|Treatment started|
48531987|NCT03400943|101639231|FG000|COMPLETED|Treatment Period 2||6||
48231942|NCT03032965|100891278|FG000|STARTED|Overall Study||61||
48231943|NCT03032965|100891279|FG001|STARTED|Overall Study||68||
48231944|NCT03032965|100891278|FG000|COMPLETED|Overall Study||61||
48231945|NCT03032965|100891279|FG001|COMPLETED|Overall Study||68||
48231946|NCT03032965|100891278|FG000|NOT COMPLETED|Overall Study||0||
48231947|NCT03032965|100891279|FG001|NOT COMPLETED|Overall Study||0||
48231948|NCT02958553|100891280|FG000|STARTED|Phase I, 1st Visit -Passive Prosthesis||8||
48231949|NCT02958553|100891280|FG000|COMPLETED|Phase I, 1st Visit -Passive Prosthesis||8||
48531988|NCT03400943|101639232|FG001|COMPLETED|Treatment Period 2||13||
48531989|NCT03400943|101639233|FG002|COMPLETED|Treatment Period 2||7||
48531990|NCT03400943|101639234|FG003|COMPLETED|Treatment Period 2||5||
48231950|NCT02958553|100891280|FG000|NOT COMPLETED|Phase I, 1st Visit -Passive Prosthesis||0||
48531991|NCT03400943|101639231|FG000|NOT COMPLETED|Treatment Period 2||1||
48531992|NCT03400943|101639232|FG001|NOT COMPLETED|Treatment Period 2||8||
48531993|NCT03400943|101639233|FG002|NOT COMPLETED|Treatment Period 2||0||
48531994|NCT03400943|101639234|FG003|NOT COMPLETED|Treatment Period 2||0||
48531995|NCT03400943|101639231|FG000|STARTED|Follow-up Period||7||
48531996|NCT03400943|101639232|FG001|STARTED|Follow-up Period||15||
48531997|NCT03400943|101639233|FG002|STARTED|Follow-up Period||7||
48531998|NCT03400943|101639234|FG003|STARTED|Follow-up Period||5||
48531999|NCT03400943|101639231|FG000|COMPLETED|Follow-up Period||6||
48532000|NCT03400943|101639232|FG001|COMPLETED|Follow-up Period||15||
48532001|NCT03400943|101639233|FG002|COMPLETED|Follow-up Period||7||
48231951|NCT02958553|100891280|FG000|STARTED|Phase I, 2nd Visit -Fitted With emPOWER||8||
48231952|NCT02958553|100891280|FG000|COMPLETED|Phase I, 2nd Visit -Fitted With emPOWER||8||
48231953|NCT02958553|100891280|FG000|NOT COMPLETED|Phase I, 2nd Visit -Fitted With emPOWER||0||
48231954|NCT02958553|100891280|FG000|STARTED|Phase I, 3rd Visit -2 Week emPOWER FU||8||
48231955|NCT02958553|100891280|FG000|COMPLETED|Phase I, 3rd Visit -2 Week emPOWER FU||7||
48231956|NCT02958553|100891280|FG000|NOT COMPLETED|Phase I, 3rd Visit -2 Week emPOWER FU||1||
48231957|NCT02958553|100891280|FG000|STARTED|Phase II, 4th Visit -3 Month emPOWER FU||7||
48231958|NCT02958553|100891280|FG000|COMPLETED|Phase II, 4th Visit -3 Month emPOWER FU||4||
48231959|NCT02958553|100891280|FG000|NOT COMPLETED|Phase II, 4th Visit -3 Month emPOWER FU||3||
48231960|NCT02958553|100891280|FG000|STARTED|Phase II, 5th Visit -Crossover Visit||4||
48231961|NCT02958553|100891280|FG000|COMPLETED|Phase II, 5th Visit -Crossover Visit||4||
48231962|NCT02958553|100891280|FG000|NOT COMPLETED|Phase II, 5th Visit -Crossover Visit||0||
48231963|NCT02958553|100891280|FG000|STARTED|Phase II, 6th Visit -6 Month emPOWER FU||4||
48231964|NCT02958553|100891280|FG000|COMPLETED|Phase II, 6th Visit -6 Month emPOWER FU||2||
48532002|NCT03400943|101639234|FG003|COMPLETED|Follow-up Period||5||
48532003|NCT03400943|101639231|FG000|NOT COMPLETED|Follow-up Period||1||
48532004|NCT03400943|101639232|FG001|NOT COMPLETED|Follow-up Period||0||
48532005|NCT03400943|101639233|FG002|NOT COMPLETED|Follow-up Period||0||
48532006|NCT03400943|101639234|FG003|NOT COMPLETED|Follow-up Period||0||
48532007|NCT02936180|101639235|FG000|STARTED|Overall Study||140||
48532008|NCT02936180|101639236|FG001|STARTED|Overall Study||139||
48532009|NCT02936180|101639235|FG000|COMPLETED|Overall Study||127||
48532010|NCT02936180|101639236|FG001|COMPLETED|Overall Study||121||
48532011|NCT02936180|101639235|FG000|NOT COMPLETED|Overall Study||13||
48532012|NCT02936180|101639236|FG001|NOT COMPLETED|Overall Study||18||
48532013|NCT00918138|101639237|FG000|STARTED|Overall Study||46||
48532014|NCT00918138|101639238|FG001|STARTED|Overall Study||47||
48532015|NCT00918138|101639237|FG000|COMPLETED|Overall Study||44||
48532016|NCT00918138|101639238|FG001|COMPLETED|Overall Study||46||
48532017|NCT00918138|101639237|FG000|NOT COMPLETED|Overall Study||2||
48532018|NCT00918138|101639238|FG001|NOT COMPLETED|Overall Study||1||
48532019|NCT01070771|101639239|FG000|STARTED|Overall Study||203||
48532020|NCT01070771|101639239|FG000|COMPLETED|Overall Study||200||
48532021|NCT01070771|101639239|FG000|NOT COMPLETED|Overall Study||3||
48532022|NCT01675661|101639240|FG000|STARTED|Overall Study||153||
48532023|NCT01675661|101639241|FG001|STARTED|Overall Study||149||
48532024|NCT01675661|101639240|FG000|COMPLETED|Overall Study||113||
48532025|NCT01675661|101639241|FG001|COMPLETED|Overall Study||103||
48532026|NCT01675661|101639240|FG000|NOT COMPLETED|Overall Study||40||
48532027|NCT01675661|101639241|FG001|NOT COMPLETED|Overall Study||46||
48532028|NCT00658021|101639242|FG000|STARTED|28-Week Treatment Period||42|Randomized to treatment.|
48532029|NCT00658021|101639243|FG001|STARTED|28-Week Treatment Period||38|Randomized to treatment.|
48532030|NCT00658021|101639244|FG002|STARTED|28-Week Treatment Period||42|Randomized to treatment.|
48532031|NCT00658021|101639242|FG000|Received Treatment|28-Week Treatment Period||40||
48532032|NCT00658021|101639243|FG001|Received Treatment|28-Week Treatment Period||38||
48532033|NCT00658021|101639244|FG002|Received Treatment|28-Week Treatment Period||42||
48532034|NCT00658021|101639242|FG000|COMPLETED|28-Week Treatment Period||31|Completed the Week 28 treatment period.|
48532035|NCT00658021|101639243|FG001|COMPLETED|28-Week Treatment Period||25|Completed the Week 28 treatment period.|
48532036|NCT00658021|101639244|FG002|COMPLETED|28-Week Treatment Period||25|Completed the Week 28 treatment period.|
48532037|NCT00658021|101639242|FG000|NOT COMPLETED|28-Week Treatment Period||11||
48231965|NCT02958553|100891280|FG000|NOT COMPLETED|Phase II, 6th Visit -6 Month emPOWER FU||2||
48231966|NCT02958553|100891280|FG000|STARTED|Phase II, 7th Visit -12 Month emPOWER FU||2||
48231967|NCT02958553|100891280|FG000|COMPLETED|Phase II, 7th Visit -12 Month emPOWER FU||2||
48231968|NCT02958553|100891280|FG000|NOT COMPLETED|Phase II, 7th Visit -12 Month emPOWER FU||0||
48231969|NCT00703092|100891281|FG000|STARTED|Overall Study||2||
48231970|NCT00703092|100891281|FG000|COMPLETED|Overall Study||0||
48231971|NCT00703092|100891281|FG000|NOT COMPLETED|Overall Study||2||
48532038|NCT00658021|101639243|FG001|NOT COMPLETED|28-Week Treatment Period||13||
48532039|NCT00658021|101639244|FG002|NOT COMPLETED|28-Week Treatment Period||17||
48231972|NCT02802111|100891282|FG000|STARTED|First Intervention (5 Min of Drug)||12||
48231973|NCT02802111|100891283|FG001|STARTED|First Intervention (5 Min of Drug)||12||
48231974|NCT02802111|100891282|FG000|COMPLETED|First Intervention (5 Min of Drug)||12||
48231975|NCT02802111|100891283|FG001|COMPLETED|First Intervention (5 Min of Drug)||12||
48231976|NCT02802111|100891282|FG000|NOT COMPLETED|First Intervention (5 Min of Drug)||0||
48231977|NCT02802111|100891283|FG001|NOT COMPLETED|First Intervention (5 Min of Drug)||0||
48231978|NCT02802111|100891282|FG000|STARTED|Washout (4 Hours)||12||
48231979|NCT02802111|100891283|FG001|STARTED|Washout (4 Hours)||12||
48231980|NCT02802111|100891282|FG000|COMPLETED|Washout (4 Hours)||12||
48231981|NCT02802111|100891283|FG001|COMPLETED|Washout (4 Hours)||12||
48231982|NCT02802111|100891282|FG000|NOT COMPLETED|Washout (4 Hours)||0||
48231983|NCT02802111|100891283|FG001|NOT COMPLETED|Washout (4 Hours)||0||
48231984|NCT02802111|100891282|FG000|STARTED|Second Intervention (5 Min of Drug)||12||
48231985|NCT02802111|100891283|FG001|STARTED|Second Intervention (5 Min of Drug)||12||
48231986|NCT02802111|100891282|FG000|COMPLETED|Second Intervention (5 Min of Drug)||12||
48231987|NCT02802111|100891283|FG001|COMPLETED|Second Intervention (5 Min of Drug)||12||
48231988|NCT02802111|100891282|FG000|NOT COMPLETED|Second Intervention (5 Min of Drug)||0||
48231989|NCT02802111|100891283|FG001|NOT COMPLETED|Second Intervention (5 Min of Drug)||0||
48231990|NCT02124044|100891284|FG000|STARTED|Overall Study||20||
48231991|NCT02124044|100891285|FG001|STARTED|Overall Study||10||
48231992|NCT02124044|100891284|FG000|COMPLETED|Overall Study||20||
48231993|NCT02124044|100891285|FG001|COMPLETED|Overall Study||9||
48231994|NCT02124044|100891284|FG000|NOT COMPLETED|Overall Study||0||
48231995|NCT02124044|100891285|FG001|NOT COMPLETED|Overall Study||1||
48231996|NCT00458783|100891286|FG000|STARTED|Overall Study||1914||
48231997|NCT00458783|100891287|FG001|STARTED|Overall Study||1921||
48231998|NCT00458783|100891286|FG000|COMPLETED|Overall Study||686||
48231999|NCT00458783|100891287|FG001|COMPLETED|Overall Study||701||
48232000|NCT00458783|100891286|FG000|NOT COMPLETED|Overall Study||1228||
48232001|NCT00458783|100891287|FG001|NOT COMPLETED|Overall Study||1220||
48232002|NCT01482325|100891288|FG000|STARTED|Overall Study||31||
48232003|NCT01482325|100891288|FG000|COMPLETED|Overall Study||31||
48232004|NCT01482325|100891288|FG000|NOT COMPLETED|Overall Study||0||
48232005|NCT00486954|100891289|FG000|STARTED|Pilot Part||6||
48232006|NCT00486954|100891290|FG001|STARTED|Pilot Part||0||
48232007|NCT00486954|100891291|FG002|STARTED|Pilot Part||6||
48232008|NCT00486954|100891292|FG003|STARTED|Pilot Part||0||
48232009|NCT00486954|100891293|FG004|STARTED|Pilot Part||0||
48232010|NCT00486954|100891289|FG000|COMPLETED|Pilot Part||0||
48232011|NCT00486954|100891290|FG001|COMPLETED|Pilot Part||0||
48232012|NCT00486954|100891291|FG002|COMPLETED|Pilot Part||0||
48232013|NCT00486954|100891292|FG003|COMPLETED|Pilot Part||0||
48232014|NCT00486954|100891293|FG004|COMPLETED|Pilot Part||0||
48232015|NCT00486954|100891289|FG000|NOT COMPLETED|Pilot Part||6||
48232016|NCT00486954|100891290|FG001|NOT COMPLETED|Pilot Part||0||
48532040|NCT00658021|101639242|FG000|STARTED|Long-term Safety Follow-up Period||7|Entered safety follow-up period.|
48532041|NCT00658021|101639243|FG001|STARTED|Long-term Safety Follow-up Period||5|Entered safety follow-up period.|
48532042|NCT00658021|101639244|FG002|STARTED|Long-term Safety Follow-up Period||7|Entered safety follow-up period.|
48532043|NCT00658021|101639242|FG000|COMPLETED|Long-term Safety Follow-up Period||7|Completed safety follow-up period.|
48532044|NCT00658021|101639243|FG001|COMPLETED|Long-term Safety Follow-up Period||2|Completed safety follow-up period.|
48532045|NCT00658021|101639244|FG002|COMPLETED|Long-term Safety Follow-up Period||7|Completed safety follow-up period.|
48232017|NCT00486954|100891291|FG002|NOT COMPLETED|Pilot Part||6||
48232018|NCT00486954|100891292|FG003|NOT COMPLETED|Pilot Part||0||
48232019|NCT00486954|100891293|FG004|NOT COMPLETED|Pilot Part||0||
48232020|NCT00486954|100891289|FG000|STARTED|Randomized Part||0||
48532046|NCT00658021|101639242|FG000|NOT COMPLETED|Long-term Safety Follow-up Period||0||
48532047|NCT00658021|101639243|FG001|NOT COMPLETED|Long-term Safety Follow-up Period||3||
48532048|NCT00658021|101639244|FG002|NOT COMPLETED|Long-term Safety Follow-up Period||0||
48532049|NCT00804713|101639245|FG000|STARTED|Overall Study||1978||
48232021|NCT00486954|100891290|FG001|STARTED|Randomized Part||0||
48232022|NCT00486954|100891291|FG002|STARTED|Randomized Part||0||
48232023|NCT00486954|100891292|FG003|STARTED|Randomized Part||132||
48232024|NCT00486954|100891293|FG004|STARTED|Randomized Part||129||
48232025|NCT00486954|100891289|FG000|COMPLETED|Randomized Part||0||
48232026|NCT00486954|100891290|FG001|COMPLETED|Randomized Part||0||
48232027|NCT00486954|100891291|FG002|COMPLETED|Randomized Part||0||
48232028|NCT00486954|100891292|FG003|COMPLETED|Randomized Part||112||
48232029|NCT00486954|100891293|FG004|COMPLETED|Randomized Part||115||
48232030|NCT00486954|100891289|FG000|NOT COMPLETED|Randomized Part||0||
48232031|NCT00486954|100891290|FG001|NOT COMPLETED|Randomized Part||0||
48232032|NCT00486954|100891291|FG002|NOT COMPLETED|Randomized Part||0||
48232033|NCT00486954|100891292|FG003|NOT COMPLETED|Randomized Part||20||
48232034|NCT00486954|100891293|FG004|NOT COMPLETED|Randomized Part||14||
48232035|NCT00308308|100891294|FG000|STARTED|Overall Study||301||
48232036|NCT00308308|100891295|FG001|STARTED|Overall Study||288||
48232037|NCT00308308|100891294|FG000|COMPLETED|Overall Study||198||
48232038|NCT00308308|100891295|FG001|COMPLETED|Overall Study||220||
48232039|NCT00308308|100891294|FG000|NOT COMPLETED|Overall Study||103||
48232040|NCT00308308|100891295|FG001|NOT COMPLETED|Overall Study||68||
48232041|NCT00787176|100891296|FG000|STARTED|Overall Study||69||
48232042|NCT00787176|100891297|FG001|STARTED|Overall Study||62||
48232043|NCT00787176|100891298|FG002|STARTED|Overall Study||60||
48232044|NCT00787176|100891299|FG003|STARTED|Overall Study||60||
48232045|NCT00787176|100891296|FG000|COMPLETED|Overall Study||62||
48232046|NCT00787176|100891297|FG001|COMPLETED|Overall Study||59||
48232047|NCT00787176|100891298|FG002|COMPLETED|Overall Study||54||
48232048|NCT00787176|100891299|FG003|COMPLETED|Overall Study||55||
48232049|NCT00787176|100891296|FG000|NOT COMPLETED|Overall Study||7||
48232050|NCT00787176|100891297|FG001|NOT COMPLETED|Overall Study||3||
48232051|NCT00787176|100891298|FG002|NOT COMPLETED|Overall Study||6||
48232052|NCT00787176|100891299|FG003|NOT COMPLETED|Overall Study||5||
48232053|NCT03960645|100891300|FG000|STARTED|Overall Study||33||
48232054|NCT03960645|100891301|FG001|STARTED|Overall Study||29||
48232055|NCT03960645|100891300|FG000|COMPLETED|Overall Study||32||
48232056|NCT03960645|100891301|FG001|COMPLETED|Overall Study||29||
48232057|NCT03960645|100891300|FG000|NOT COMPLETED|Overall Study||1||
48232058|NCT03960645|100891301|FG001|NOT COMPLETED|Overall Study||0||
48232059|NCT03136861|100891302|FG000|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||285|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
48232060|NCT03136861|100891303|FG001|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||95|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
48232061|NCT03136861|100891304|FG002|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
48232062|NCT03136861|100891305|FG003|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
48232063|NCT03136861|100891306|FG004|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
48232064|NCT03136861|100891307|FG005|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
48232065|NCT03136861|100891308|FG006|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
48232066|NCT03136861|100891302|FG000|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||278||
48232067|NCT03136861|100891303|FG001|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||89||
48232068|NCT03136861|100891304|FG002|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0||
48232069|NCT03136861|100891305|FG003|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0||
48232070|NCT03136861|100891306|FG004|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0||
48232071|NCT03136861|100891307|FG005|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0||
48232072|NCT03136861|100891308|FG006|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0||
48232073|NCT03136861|100891302|FG000|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||7||
48232074|NCT03136861|100891303|FG001|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||6||
48232075|NCT03136861|100891304|FG002|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0||
48232076|NCT03136861|100891305|FG003|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0||
48232077|NCT03136861|100891306|FG004|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0||
48232078|NCT03136861|100891307|FG005|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0||
48232079|NCT03136861|100891308|FG006|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0||
48232080|NCT03136861|100891302|FG000|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
48232081|NCT03136861|100891303|FG001|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
48232082|NCT03136861|100891304|FG002|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||90|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
48532050|NCT00804713|101639245|FG000|COMPLETED|Overall Study||1978||
48532051|NCT00804713|101639245|FG000|NOT COMPLETED|Overall Study||0||
48532052|NCT02593682|101639246|FG000|STARTED|Overall Study||0||
48532053|NCT02593682|101639247|FG001|STARTED|Overall Study||0||
48532054|NCT02593682|101639246|FG000|COMPLETED|Overall Study||0||
48532055|NCT02593682|101639247|FG001|COMPLETED|Overall Study||0||
48532056|NCT02593682|101639246|FG000|NOT COMPLETED|Overall Study||0||
48532057|NCT02593682|101639247|FG001|NOT COMPLETED|Overall Study||0||
48532058|NCT02569112|101639248|FG000|STARTED|Overall Study||10||20
48532059|NCT02569112|101639249|FG001|STARTED|Overall Study||10||10
48532060|NCT02569112|101639248|FG000|COMPLETED|Overall Study||10|Each subject received a single cryolipolysis treatment on both sides of their body.|20
48532061|NCT02569112|101639249|FG001|COMPLETED|Overall Study||10|Each subject received a single cryolipolysis treatment on both sides of their body.|10
48532062|NCT02569112|101639248|FG000|NOT COMPLETED|Overall Study||0||0
48532063|NCT02569112|101639249|FG001|NOT COMPLETED|Overall Study||0||0
48532064|NCT03312595|101639250|FG000|STARTED|Overall Study||30||
48532065|NCT03312595|101639250|FG000|COMPLETED|Overall Study||24||
48532066|NCT03312595|101639250|FG000|NOT COMPLETED|Overall Study||6||
48532067|NCT01193127|101639251|FG000|STARTED|Randomized||57||
48532068|NCT01193127|101639252|FG001|STARTED|Randomized||54||
48532069|NCT01193127|101639253|FG002|STARTED|Randomized||55||
48532070|NCT01193127|101639254|FG003|STARTED|Randomized||57||
48532071|NCT01193127|101639251|FG000|COMPLETED|Randomized||57||
48532072|NCT01193127|101639252|FG001|COMPLETED|Randomized||54||
48532073|NCT01193127|101639253|FG002|COMPLETED|Randomized||55||
48532074|NCT01193127|101639254|FG003|COMPLETED|Randomized||56||
48532075|NCT01193127|101639251|FG000|NOT COMPLETED|Randomized||0||
48532076|NCT01193127|101639252|FG001|NOT COMPLETED|Randomized||0||
48532077|NCT01193127|101639253|FG002|NOT COMPLETED|Randomized||0||
48532078|NCT01193127|101639254|FG003|NOT COMPLETED|Randomized||1||
48532079|NCT01193127|101639251|FG000|STARTED|Treated||57||
48532080|NCT01193127|101639252|FG001|STARTED|Treated||54||
48532081|NCT01193127|101639253|FG002|STARTED|Treated||55||
48532082|NCT01193127|101639254|FG003|STARTED|Treated||56||
48532083|NCT01193127|101639251|FG000|COMPLETED|Treated||57||
48532084|NCT01193127|101639252|FG001|COMPLETED|Treated||54||
48532085|NCT01193127|101639253|FG002|COMPLETED|Treated||55||
48532086|NCT01193127|101639254|FG003|COMPLETED|Treated||55||
48532087|NCT01193127|101639251|FG000|NOT COMPLETED|Treated||0||
48532088|NCT01193127|101639252|FG001|NOT COMPLETED|Treated||0||
48532089|NCT01193127|101639253|FG002|NOT COMPLETED|Treated||0||
48532090|NCT01193127|101639254|FG003|NOT COMPLETED|Treated||1||
48532091|NCT00831766|101639255|FG000|STARTED|Overall Study||23||
48532092|NCT00831766|101639256|FG001|STARTED|Overall Study||28||
48532093|NCT00831766|101639255|FG000|COMPLETED|Overall Study||23||
48532094|NCT00831766|101639256|FG001|COMPLETED|Overall Study||28||
48532095|NCT00831766|101639255|FG000|NOT COMPLETED|Overall Study||0||
48532096|NCT00831766|101639256|FG001|NOT COMPLETED|Overall Study||0||
48532097|NCT04126213|101639257|FG000|STARTED|Overall Study||70||
48532098|NCT04126213|101639258|FG001|STARTED|Overall Study||75||
48532099|NCT04126213|101639259|FG002|STARTED|Overall Study||68||
48532100|NCT04126213|101639260|FG003|STARTED|Overall Study||67||
48532101|NCT04126213|101639261|FG004|STARTED|Overall Study||73||
48532102|NCT04126213|101639262|FG005|STARTED|Overall Study||66||
48532103|NCT04126213|101639257|FG000|COMPLETED|Overall Study||58||
48532104|NCT04126213|101639258|FG001|COMPLETED|Overall Study||70||
48532105|NCT04126213|101639259|FG002|COMPLETED|Overall Study||59||
48532106|NCT04126213|101639260|FG003|COMPLETED|Overall Study||54||
48532107|NCT04126213|101639261|FG004|COMPLETED|Overall Study||67||
48532108|NCT04126213|101639262|FG005|COMPLETED|Overall Study||55||
48532109|NCT04126213|101639257|FG000|NOT COMPLETED|Overall Study||12||
48532110|NCT04126213|101639258|FG001|NOT COMPLETED|Overall Study||5||
48532111|NCT04126213|101639259|FG002|NOT COMPLETED|Overall Study||9||
48532112|NCT04126213|101639260|FG003|NOT COMPLETED|Overall Study||13||
48532113|NCT04126213|101639261|FG004|NOT COMPLETED|Overall Study||6||
48532114|NCT04126213|101639262|FG005|NOT COMPLETED|Overall Study||11||
48532115|NCT05080426|101639263|FG000|STARTED|Overall Study||802||1
48532116|NCT05080426|101639264|FG001|STARTED|Overall Study||132||1
48532117|NCT05080426|101639263|FG000|Managers|Overall Study||172||1
48532118|NCT05080426|101639264|FG001|Managers|Overall Study||80||1
48532119|NCT05080426|101639263|FG000|Employees|Overall Study||630||1
48532120|NCT05080426|101639264|FG001|Employees|Overall Study||52||1
48532121|NCT05080426|101639263|FG000|COMPLETED|Overall Study||802|Completed at least 1 survey in the study.|1
48532122|NCT05080426|101639264|FG001|COMPLETED|Overall Study||132|Completed at least 1 survey in the study.|1
48532123|NCT05080426|101639263|FG000|NOT COMPLETED|Overall Study||0||0
48532124|NCT05080426|101639264|FG001|NOT COMPLETED|Overall Study||0||0
48232083|NCT03136861|100891305|FG003|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||94|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
48232084|NCT03136861|100891306|FG004|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||94|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
48232085|NCT03136861|100891307|FG005|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||45|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
48232086|NCT03136861|100891308|FG006|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||44|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
48232087|NCT03136861|100891302|FG000|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0||
48232088|NCT03136861|100891303|FG001|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0||
48232089|NCT03136861|100891304|FG002|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||88||
48532125|NCT04176406|101639265|FG000|STARTED|Overall Study||0|None of the participants were randomized to any of the Arms/Groups|
48532126|NCT04176406|101639266|FG001|STARTED|Overall Study||0|None of the participants were randomized to any of the Arms/Groups|
48532127|NCT04176406|101639267|FG002|STARTED|Overall Study||0|None of the participants were randomized to any of the Arms/Groups|
48532128|NCT04176406|101639268|FG003|STARTED|Overall Study||0|None of the participants were randomized to any of the Arms/Groups|
48532129|NCT04176406|101639265|FG000|COMPLETED|Overall Study||0||
48532130|NCT04176406|101639266|FG001|COMPLETED|Overall Study||0||
48532131|NCT04176406|101639267|FG002|COMPLETED|Overall Study||0||
48532132|NCT04176406|101639268|FG003|COMPLETED|Overall Study||0||
48532133|NCT04176406|101639265|FG000|NOT COMPLETED|Overall Study||0||
48532134|NCT04176406|101639266|FG001|NOT COMPLETED|Overall Study||0||
48532135|NCT04176406|101639267|FG002|NOT COMPLETED|Overall Study||0||
48532136|NCT04176406|101639268|FG003|NOT COMPLETED|Overall Study||0||
48532137|NCT02853370|101639269|FG000|STARTED|Overall Study||56||
48532138|NCT02853370|101639269|FG000|COMPLETED|Overall Study||45||
48532139|NCT02853370|101639269|FG000|NOT COMPLETED|Overall Study||11||
48532140|NCT02737748|101639270|FG000|STARTED|Overall Study||20||
48532141|NCT02737748|101639271|FG001|STARTED|Overall Study||20||
48532142|NCT02737748|101639270|FG000|Phase I|Overall Study||3||
48532143|NCT02737748|101639271|FG001|Phase I|Overall Study||4||
48532144|NCT02737748|101639270|FG000|Phase II|Overall Study||17||
48532145|NCT02737748|101639271|FG001|Phase II|Overall Study||16||
48232090|NCT03136861|100891305|FG003|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||93||
48232091|NCT03136861|100891306|FG004|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||92||
48232092|NCT03136861|100891307|FG005|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||45||
48232093|NCT03136861|100891308|FG006|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||43||
48232094|NCT03136861|100891302|FG000|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0||
48232095|NCT03136861|100891303|FG001|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0||
48232096|NCT03136861|100891304|FG002|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||2||
48232097|NCT03136861|100891305|FG003|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||1||
48232098|NCT03136861|100891306|FG004|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||2||
48232099|NCT03136861|100891307|FG005|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0||
48232100|NCT03136861|100891308|FG006|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||1||
48232101|NCT00439218|100891309|FG000|STARTED|Cohort 1 (500 mg/kg/Day)||4||
48232102|NCT00439218|100891309|FG000|COMPLETED|Cohort 1 (500 mg/kg/Day)||3||
48232103|NCT00439218|100891309|FG000|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||1||
48232104|NCT00439218|100891309|FG000|STARTED|Cohort 2 (500 mg/kg/Day)||1||
48232105|NCT00439218|100891309|FG000|COMPLETED|Cohort 2 (500 mg/kg/Day)||1||
48232106|NCT00439218|100891309|FG000|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||0||
48232107|NCT00983294|100891310|FG000|STARTED|Colchicine Alone||24||
48232108|NCT00983294|100891310|FG000|COMPLETED|Colchicine Alone||24||
48232109|NCT00983294|100891310|FG000|NOT COMPLETED|Colchicine Alone||0||
48232110|NCT00983294|100891310|FG000|STARTED|14 Day Washout Period||24||
48232111|NCT00983294|100891310|FG000|COMPLETED|14 Day Washout Period||22||
48232112|NCT00983294|100891310|FG000|NOT COMPLETED|14 Day Washout Period||2||
48232113|NCT00983294|100891310|FG000|STARTED|Azithromycin Alone||22||
48232114|NCT00983294|100891310|FG000|COMPLETED|Azithromycin Alone||22||
48232115|NCT00983294|100891310|FG000|NOT COMPLETED|Azithromycin Alone||0||
48532146|NCT02737748|101639270|FG000|COMPLETED|Overall Study||19||
48532147|NCT02737748|101639271|FG001|COMPLETED|Overall Study||18||
48532148|NCT02737748|101639270|FG000|NOT COMPLETED|Overall Study||1||
48232116|NCT00983294|100891310|FG000|STARTED|Colchicine With Azithromycin||22||
48232117|NCT00983294|100891310|FG000|COMPLETED|Colchicine With Azithromycin||21||
48232118|NCT00983294|100891310|FG000|NOT COMPLETED|Colchicine With Azithromycin||1||
48232119|NCT00813709|100891311|FG000|STARTED|Double Blind Period||84||
48232120|NCT00813709|100891312|FG001|STARTED|Double Blind Period||117||
48232121|NCT00813709|100891313|FG002|STARTED|Double Blind Period||99||
48232122|NCT00813709|100891314|FG003|STARTED|Double Blind Period||0||
48232123|NCT00813709|100891315|FG004|STARTED|Double Blind Period||0||
48232124|NCT00813709|100891316|FG005|STARTED|Double Blind Period||0||
48232125|NCT00813709|100891311|FG000|Treated|Double Blind Period||83||
48232126|NCT00813709|100891312|FG001|Treated|Double Blind Period||114||
48232127|NCT00813709|100891313|FG002|Treated|Double Blind Period||98||
48232128|NCT00813709|100891314|FG003|Treated|Double Blind Period||0||
48232129|NCT00813709|100891315|FG004|Treated|Double Blind Period||0||
48232130|NCT00813709|100891316|FG005|Treated|Double Blind Period||0||
48232131|NCT00813709|100891311|FG000|COMPLETED|Double Blind Period||53||
48232132|NCT00813709|100891312|FG001|COMPLETED|Double Blind Period||76||
48232133|NCT00813709|100891313|FG002|COMPLETED|Double Blind Period||68||
48232134|NCT00813709|100891314|FG003|COMPLETED|Double Blind Period||0||
48232135|NCT00813709|100891315|FG004|COMPLETED|Double Blind Period||0||
48232136|NCT00813709|100891316|FG005|COMPLETED|Double Blind Period||0||
48232137|NCT00813709|100891311|FG000|NOT COMPLETED|Double Blind Period||31||
48232138|NCT00813709|100891312|FG001|NOT COMPLETED|Double Blind Period||41||
48232139|NCT00813709|100891313|FG002|NOT COMPLETED|Double Blind Period||31||
48232140|NCT00813709|100891314|FG003|NOT COMPLETED|Double Blind Period||0||
48232141|NCT00813709|100891315|FG004|NOT COMPLETED|Double Blind Period||0||
48232142|NCT00813709|100891316|FG005|NOT COMPLETED|Double Blind Period||0||
48232143|NCT00813709|100891311|FG000|STARTED|Open Label Period||0||
48232144|NCT00813709|100891312|FG001|STARTED|Open Label Period||0||
48232145|NCT00813709|100891313|FG002|STARTED|Open Label Period||0||
48232146|NCT00813709|100891314|FG003|STARTED|Open Label Period||58||
48232147|NCT00813709|100891315|FG004|STARTED|Open Label Period||51||
48232148|NCT00813709|100891316|FG005|STARTED|Open Label Period||46||
48232149|NCT00813709|100891311|FG000|Treated|Open Label Period||0||
48232150|NCT00813709|100891312|FG001|Treated|Open Label Period||0||
48232151|NCT00813709|100891313|FG002|Treated|Open Label Period||0||
48232152|NCT00813709|100891314|FG003|Treated|Open Label Period||57||
48232153|NCT00813709|100891315|FG004|Treated|Open Label Period||51||
48232154|NCT00813709|100891316|FG005|Treated|Open Label Period||45||
48232155|NCT00813709|100891311|FG000|COMPLETED|Open Label Period||0||
48232156|NCT00813709|100891312|FG001|COMPLETED|Open Label Period||0||
48232157|NCT00813709|100891313|FG002|COMPLETED|Open Label Period||0||
48232158|NCT00813709|100891314|FG003|COMPLETED|Open Label Period||38||
48232159|NCT00813709|100891315|FG004|COMPLETED|Open Label Period||41||
48232160|NCT00813709|100891316|FG005|COMPLETED|Open Label Period||35||
48232161|NCT00813709|100891311|FG000|NOT COMPLETED|Open Label Period||0||
48232162|NCT00813709|100891312|FG001|NOT COMPLETED|Open Label Period||0||
48232163|NCT00813709|100891313|FG002|NOT COMPLETED|Open Label Period||0||
48532149|NCT02737748|101639271|FG001|NOT COMPLETED|Overall Study||2||
48532150|NCT02470390|101639272|FG000|STARTED|Overall Study||6||
48532151|NCT02470390|101639273|FG001|STARTED|Overall Study||7||
48232164|NCT00813709|100891314|FG003|NOT COMPLETED|Open Label Period||20||
48232165|NCT00813709|100891315|FG004|NOT COMPLETED|Open Label Period||10||
48232166|NCT00813709|100891316|FG005|NOT COMPLETED|Open Label Period||11||
48232167|NCT03823703|100891317|FG000|STARTED|Overall Study||3||
48232168|NCT03823703|100891318|FG001|STARTED|Overall Study||5||
48232169|NCT03823703|100891319|FG002|STARTED|Overall Study||4||
48232170|NCT03823703|100891317|FG000|Treated|Overall Study||3||
48232171|NCT03823703|100891318|FG001|Treated|Overall Study||5||
48232172|NCT03823703|100891319|FG002|Treated|Overall Study||4||
48232173|NCT03823703|100891317|FG000|COMPLETED|Overall Study||0||
48232174|NCT03823703|100891318|FG001|COMPLETED|Overall Study||0||
48232175|NCT03823703|100891319|FG002|COMPLETED|Overall Study||0||
48232176|NCT03823703|100891317|FG000|NOT COMPLETED|Overall Study||3||
48232177|NCT03823703|100891318|FG001|NOT COMPLETED|Overall Study||5||
48232178|NCT03823703|100891319|FG002|NOT COMPLETED|Overall Study||4||
48232179|NCT01737398|100891320|FG000|STARTED|Overall Study||113||
48232180|NCT01737398|100891321|FG001|STARTED|Overall Study||60||
48232181|NCT01737398|100891320|FG000|Received at Least 1 Dose of Study Drug|Overall Study||112|One participant in the inotersen group was ineligible, but was randomized in error.|
48232182|NCT01737398|100891321|FG001|Received at Least 1 Dose of Study Drug|Overall Study||60|One participant in the inotersen group was ineligible, but was randomized in error.|
48232183|NCT01737398|100891320|FG000|Safety Set|Overall Study||112||
48232184|NCT01737398|100891321|FG001|Safety Set|Overall Study||60||
48232185|NCT01737398|100891320|FG000|COMPLETED|Overall Study||87||
48232186|NCT01737398|100891321|FG001|COMPLETED|Overall Study||52||
48232187|NCT01737398|100891320|FG000|NOT COMPLETED|Overall Study||26||
48232188|NCT01737398|100891321|FG001|NOT COMPLETED|Overall Study||8||
48232189|NCT05260437|100891322|FG000|STARTED|Overall Study||24||
48232190|NCT05260437|100891323|FG001|STARTED|Overall Study||23||
48232191|NCT05260437|100891324|FG002|STARTED|Overall Study||20||
48232192|NCT05260437|100891325|FG003|STARTED|Overall Study||21||
48232193|NCT05260437|100891326|FG004|STARTED|Overall Study||11||
48232194|NCT05260437|100891322|FG000|COMPLETED|Overall Study||16||
48232195|NCT05260437|100891323|FG001|COMPLETED|Overall Study||20||
48232196|NCT05260437|100891324|FG002|COMPLETED|Overall Study||15||
48232197|NCT05260437|100891325|FG003|COMPLETED|Overall Study||14||
48232198|NCT05260437|100891326|FG004|COMPLETED|Overall Study||9||
48232199|NCT05260437|100891322|FG000|NOT COMPLETED|Overall Study||8||
48232200|NCT05260437|100891323|FG001|NOT COMPLETED|Overall Study||3||
48232201|NCT05260437|100891324|FG002|NOT COMPLETED|Overall Study||5||
48232202|NCT05260437|100891325|FG003|NOT COMPLETED|Overall Study||7||
48232203|NCT05260437|100891326|FG004|NOT COMPLETED|Overall Study||2||
48232204|NCT02170207|100891327|FG000|STARTED|Overall Study||63||
48232205|NCT02170207|100891327|FG000|COMPLETED|Overall Study||58||
48232206|NCT02170207|100891327|FG000|NOT COMPLETED|Overall Study||5||
48232207|NCT01127737|100891328|FG000|STARTED|Overall Study||37||
48232208|NCT01127737|100891329|FG001|STARTED|Overall Study||38||
48232209|NCT01127737|100891328|FG000|COMPLETED|Overall Study||37||
48232210|NCT01127737|100891329|FG001|COMPLETED|Overall Study||38||
48232211|NCT01127737|100891328|FG000|NOT COMPLETED|Overall Study||0||
48232212|NCT01127737|100891329|FG001|NOT COMPLETED|Overall Study||0||
48232213|NCT01690000|100891330|FG000|STARTED|Overall Study||40||
48232214|NCT01690000|100891331|FG001|STARTED|Overall Study||41||
48232215|NCT01690000|100891330|FG000|COMPLETED|Overall Study||37||
48232216|NCT01690000|100891331|FG001|COMPLETED|Overall Study||35||
48232217|NCT01690000|100891330|FG000|NOT COMPLETED|Overall Study||3||
48232218|NCT01690000|100891331|FG001|NOT COMPLETED|Overall Study||6||
48232219|NCT00687297|100891332|FG000|STARTED|Randomization||80||
48232220|NCT00687297|100891333|FG001|STARTED|Randomization||82||
48232221|NCT00687297|100891332|FG000|COMPLETED|Randomization||77||
48232222|NCT00687297|100891333|FG001|COMPLETED|Randomization||81||
48232223|NCT00687297|100891332|FG000|NOT COMPLETED|Randomization||3||
48232224|NCT00687297|100891333|FG001|NOT COMPLETED|Randomization||1||
48232225|NCT00687297|100891332|FG000|STARTED|Induction||77||
48232226|NCT00687297|100891333|FG001|STARTED|Induction||81||
48232227|NCT00687297|100891332|FG000|COMPLETED|Induction||32||
48232228|NCT00687297|100891333|FG001|COMPLETED|Induction||26||
48232229|NCT00687297|100891332|FG000|NOT COMPLETED|Induction||45||
48232230|NCT00687297|100891333|FG001|NOT COMPLETED|Induction||55||
48232231|NCT00687297|100891332|FG000|STARTED|Maintenance||32||
48232232|NCT00687297|100891333|FG001|STARTED|Maintenance||26||
48232233|NCT00687297|100891332|FG000|COMPLETED|Maintenance||29||
48232234|NCT00687297|100891333|FG001|COMPLETED|Maintenance||25||
48232235|NCT00687297|100891332|FG000|NOT COMPLETED|Maintenance||3||
48232236|NCT00687297|100891333|FG001|NOT COMPLETED|Maintenance||1||
48232237|NCT02203799|100891334|FG000|STARTED|Overall Study||15||
48232238|NCT02203799|100891334|FG000|COMPLETED|Overall Study||12||
48232239|NCT02203799|100891334|FG000|NOT COMPLETED|Overall Study||3||
48232240|NCT01029704|100891335|FG000|STARTED|Overall Study||5||
48232241|NCT01029704|100891336|FG001|STARTED|Overall Study||5||
48232242|NCT01029704|100891337|FG002|STARTED|Overall Study||5||
48232243|NCT01029704|100891338|FG003|STARTED|Overall Study||5||
48232244|NCT01029704|100891339|FG004|STARTED|Overall Study||28||
48232245|NCT01029704|100891340|FG005|STARTED|Overall Study||24||
48232246|NCT01029704|100891341|FG006|STARTED|Overall Study||23||
48232247|NCT01029704|100891342|FG007|STARTED|Overall Study||28||
48232248|NCT01029704|100891343|FG008|STARTED|Overall Study||26||
48232249|NCT01029704|100891335|FG000|COMPLETED|Overall Study||5||
48232250|NCT01029704|100891336|FG001|COMPLETED|Overall Study||5||
48232251|NCT01029704|100891337|FG002|COMPLETED|Overall Study||5||
48232252|NCT01029704|100891338|FG003|COMPLETED|Overall Study||5||
48232253|NCT01029704|100891339|FG004|COMPLETED|Overall Study||23||
48232254|NCT01029704|100891340|FG005|COMPLETED|Overall Study||20||
48232255|NCT01029704|100891341|FG006|COMPLETED|Overall Study||19||
48232256|NCT01029704|100891342|FG007|COMPLETED|Overall Study||22||
48232257|NCT01029704|100891343|FG008|COMPLETED|Overall Study||25||
48232258|NCT01029704|100891335|FG000|NOT COMPLETED|Overall Study||0||
48232259|NCT01029704|100891336|FG001|NOT COMPLETED|Overall Study||0||
48232260|NCT01029704|100891337|FG002|NOT COMPLETED|Overall Study||0||
48532152|NCT02470390|101639272|FG000|COMPLETED|Overall Study||6||
48532153|NCT02470390|101639273|FG001|COMPLETED|Overall Study||6||
48532154|NCT02470390|101639272|FG000|NOT COMPLETED|Overall Study||0||
48532155|NCT02470390|101639273|FG001|NOT COMPLETED|Overall Study||1||
48532156|NCT03564444|101639274|FG000|STARTED|Overall Study||60||
48532157|NCT03564444|101639275|FG001|STARTED|Overall Study||240||
48532158|NCT03564444|101639274|FG000|COMPLETED|Overall Study||60||
48532159|NCT03564444|101639275|FG001|COMPLETED|Overall Study||240||
48232261|NCT01029704|100891338|FG003|NOT COMPLETED|Overall Study||0||
48232262|NCT01029704|100891339|FG004|NOT COMPLETED|Overall Study||5||
48232263|NCT01029704|100891340|FG005|NOT COMPLETED|Overall Study||4||
48232264|NCT01029704|100891341|FG006|NOT COMPLETED|Overall Study||4||
48232265|NCT01029704|100891342|FG007|NOT COMPLETED|Overall Study||6||
48232266|NCT01029704|100891343|FG008|NOT COMPLETED|Overall Study||1||
48232267|NCT00824850|100891344|FG000|STARTED|Overall Study||38||
48232268|NCT00824850|100891345|FG001|STARTED|Overall Study||37||
48232269|NCT00824850|100891344|FG000|Received Vaccination 13vPnC|Overall Study||38||
48232270|NCT00824850|100891345|FG001|Received Vaccination 13vPnC|Overall Study||36||
48232271|NCT00824850|100891344|FG000|COMPLETED|Overall Study||38||
48232272|NCT00824850|100891345|FG001|COMPLETED|Overall Study||36||
48232273|NCT00824850|100891344|FG000|NOT COMPLETED|Overall Study||0||
48232274|NCT00824850|100891345|FG001|NOT COMPLETED|Overall Study||1||
48232275|NCT01084772|100891346|FG000|STARTED|Baseline||68||
48232276|NCT01084772|100891347|FG001|STARTED|Baseline||66||
48232277|NCT01084772|100891346|FG000|COMPLETED|Baseline||61||
48232278|NCT01084772|100891347|FG001|COMPLETED|Baseline||60||
48232279|NCT01084772|100891346|FG000|NOT COMPLETED|Baseline||7||
48232280|NCT01084772|100891347|FG001|NOT COMPLETED|Baseline||6||
48232281|NCT01084772|100891346|FG000|STARTED|3 Months||61||
48232282|NCT01084772|100891347|FG001|STARTED|3 Months||60||
48232283|NCT01084772|100891346|FG000|COMPLETED|3 Months||58||
48232284|NCT01084772|100891347|FG001|COMPLETED|3 Months||58||
48232285|NCT01084772|100891346|FG000|NOT COMPLETED|3 Months||3||
48232286|NCT01084772|100891347|FG001|NOT COMPLETED|3 Months||2||
48232287|NCT01084772|100891346|FG000|STARTED|1 Year||58||
48232288|NCT01084772|100891347|FG001|STARTED|1 Year||58||
48232289|NCT01084772|100891346|FG000|COMPLETED|1 Year||55||
48232290|NCT01084772|100891347|FG001|COMPLETED|1 Year||50||
48232291|NCT01084772|100891346|FG000|NOT COMPLETED|1 Year||3||
48232292|NCT01084772|100891347|FG001|NOT COMPLETED|1 Year||8||
48232293|NCT01084772|100891346|FG000|STARTED|2 Years||55||
48232294|NCT01084772|100891347|FG001|STARTED|2 Years||50||
48232295|NCT01084772|100891346|FG000|COMPLETED|2 Years||46||
48232296|NCT01084772|100891347|FG001|COMPLETED|2 Years||46||
48232297|NCT01084772|100891346|FG000|NOT COMPLETED|2 Years||9||
48232298|NCT01084772|100891347|FG001|NOT COMPLETED|2 Years||4||
48232299|NCT01762982|100891348|FG000|STARTED|Overall Study||36||
48232300|NCT01762982|100891348|FG000|Received Saline Water|Overall Study||36||
48232301|NCT01762982|100891348|FG000|Received Benzalkonium Chloride|Overall Study||36||
48232302|NCT01762982|100891348|FG000|Received SLS|Overall Study||36||
48232303|NCT01762982|100891348|FG000|Received Empty Finn Chamber|Overall Study||36||
48232304|NCT01762982|100891348|FG000|COMPLETED|Overall Study||36||
48232305|NCT01762982|100891348|FG000|NOT COMPLETED|Overall Study||0||
48232306|NCT02125292|100891349|FG000|STARTED|First Intervention (1 Hour)||3||
48232307|NCT02125292|100891350|FG001|STARTED|First Intervention (1 Hour)||3||
48232308|NCT02125292|100891351|FG002|STARTED|First Intervention (1 Hour)||3||
48232309|NCT02125292|100891352|FG003|STARTED|First Intervention (1 Hour)||3||
48232310|NCT02125292|100891353|FG004|STARTED|First Intervention (1 Hour)||3||
48232311|NCT02125292|100891354|FG005|STARTED|First Intervention (1 Hour)||3||
48232312|NCT02125292|100891349|FG000|COMPLETED|First Intervention (1 Hour)||3||
48232313|NCT02125292|100891350|FG001|COMPLETED|First Intervention (1 Hour)||3||
48232314|NCT02125292|100891351|FG002|COMPLETED|First Intervention (1 Hour)||3||
48232315|NCT02125292|100891352|FG003|COMPLETED|First Intervention (1 Hour)||3||
48532160|NCT03564444|101639274|FG000|NOT COMPLETED|Overall Study||0||
48532161|NCT03564444|101639275|FG001|NOT COMPLETED|Overall Study||0||
48532162|NCT02444793|101639276|FG000|STARTED|Overall Study||11||
48532163|NCT02444793|101639277|FG001|STARTED|Overall Study||6||
48532164|NCT02444793|101639278|FG002|STARTED|Overall Study||4||
48532165|NCT02444793|101639279|FG003|STARTED|Overall Study||3||
48532166|NCT02444793|101639276|FG000|COMPLETED|Overall Study||0||
48532167|NCT02444793|101639277|FG001|COMPLETED|Overall Study||0||
48532168|NCT02444793|101639278|FG002|COMPLETED|Overall Study||0||
48232316|NCT02125292|100891353|FG004|COMPLETED|First Intervention (1 Hour)||3||
48232317|NCT02125292|100891354|FG005|COMPLETED|First Intervention (1 Hour)||3||
48232318|NCT02125292|100891349|FG000|NOT COMPLETED|First Intervention (1 Hour)||0||
48232319|NCT02125292|100891350|FG001|NOT COMPLETED|First Intervention (1 Hour)||0||
48232320|NCT02125292|100891351|FG002|NOT COMPLETED|First Intervention (1 Hour)||0||
48232321|NCT02125292|100891352|FG003|NOT COMPLETED|First Intervention (1 Hour)||0||
48232322|NCT02125292|100891353|FG004|NOT COMPLETED|First Intervention (1 Hour)||0||
48232323|NCT02125292|100891354|FG005|NOT COMPLETED|First Intervention (1 Hour)||0||
48232324|NCT02125292|100891349|FG000|STARTED|Washout (2 Hours)||3||
48232325|NCT02125292|100891350|FG001|STARTED|Washout (2 Hours)||3||
48232326|NCT02125292|100891351|FG002|STARTED|Washout (2 Hours)||3||
48232327|NCT02125292|100891352|FG003|STARTED|Washout (2 Hours)||3||
48232328|NCT02125292|100891353|FG004|STARTED|Washout (2 Hours)||3||
48232329|NCT02125292|100891354|FG005|STARTED|Washout (2 Hours)||3||
48232330|NCT02125292|100891349|FG000|COMPLETED|Washout (2 Hours)||3||
48232331|NCT02125292|100891350|FG001|COMPLETED|Washout (2 Hours)||3||
48232332|NCT02125292|100891351|FG002|COMPLETED|Washout (2 Hours)||3||
48232333|NCT02125292|100891352|FG003|COMPLETED|Washout (2 Hours)||3||
48232334|NCT02125292|100891353|FG004|COMPLETED|Washout (2 Hours)||3||
48232335|NCT02125292|100891354|FG005|COMPLETED|Washout (2 Hours)||3||
48232336|NCT02125292|100891349|FG000|NOT COMPLETED|Washout (2 Hours)||0||
48232337|NCT02125292|100891350|FG001|NOT COMPLETED|Washout (2 Hours)||0||
48232338|NCT02125292|100891351|FG002|NOT COMPLETED|Washout (2 Hours)||0||
48232339|NCT02125292|100891352|FG003|NOT COMPLETED|Washout (2 Hours)||0||
48232340|NCT02125292|100891353|FG004|NOT COMPLETED|Washout (2 Hours)||0||
48232341|NCT02125292|100891354|FG005|NOT COMPLETED|Washout (2 Hours)||0||
48232342|NCT02125292|100891349|FG000|STARTED|Second Intervention (1 Hour)||3||
48232343|NCT02125292|100891350|FG001|STARTED|Second Intervention (1 Hour)||3||
48232344|NCT02125292|100891351|FG002|STARTED|Second Intervention (1 Hour)||3||
48232345|NCT02125292|100891352|FG003|STARTED|Second Intervention (1 Hour)||3||
48232346|NCT02125292|100891353|FG004|STARTED|Second Intervention (1 Hour)||3||
48232347|NCT02125292|100891354|FG005|STARTED|Second Intervention (1 Hour)||3||
48232348|NCT02125292|100891349|FG000|COMPLETED|Second Intervention (1 Hour)||3||
48232349|NCT02125292|100891350|FG001|COMPLETED|Second Intervention (1 Hour)||3||
48232350|NCT02125292|100891351|FG002|COMPLETED|Second Intervention (1 Hour)||3||
48232351|NCT02125292|100891352|FG003|COMPLETED|Second Intervention (1 Hour)||3||
48232352|NCT02125292|100891353|FG004|COMPLETED|Second Intervention (1 Hour)||3||
48232353|NCT02125292|100891354|FG005|COMPLETED|Second Intervention (1 Hour)||3||
48232354|NCT02125292|100891349|FG000|NOT COMPLETED|Second Intervention (1 Hour)||0||
48232355|NCT02125292|100891350|FG001|NOT COMPLETED|Second Intervention (1 Hour)||0||
48232356|NCT02125292|100891351|FG002|NOT COMPLETED|Second Intervention (1 Hour)||0||
48232357|NCT02125292|100891352|FG003|NOT COMPLETED|Second Intervention (1 Hour)||0||
48232358|NCT02125292|100891353|FG004|NOT COMPLETED|Second Intervention (1 Hour)||0||
48232359|NCT02125292|100891354|FG005|NOT COMPLETED|Second Intervention (1 Hour)||0||
48232360|NCT02125292|100891349|FG000|STARTED|Washout (2 Hours)||3||
48532169|NCT02444793|101639279|FG003|COMPLETED|Overall Study||0||
48532170|NCT02444793|101639276|FG000|NOT COMPLETED|Overall Study||11||
48532171|NCT02444793|101639277|FG001|NOT COMPLETED|Overall Study||6||
48532172|NCT02444793|101639278|FG002|NOT COMPLETED|Overall Study||4||
48532173|NCT02444793|101639279|FG003|NOT COMPLETED|Overall Study||3||
48532174|NCT03682224|101639280|FG000|STARTED|Overall Study||29||
48532175|NCT03682224|101639281|FG001|STARTED|Overall Study||28||
48532176|NCT03682224|101639280|FG000|COMPLETED|Overall Study||26||
48532177|NCT03682224|101639281|FG001|COMPLETED|Overall Study||24||
48532178|NCT03682224|101639280|FG000|NOT COMPLETED|Overall Study||3||
48532179|NCT03682224|101639281|FG001|NOT COMPLETED|Overall Study||4||
48232361|NCT02125292|100891350|FG001|STARTED|Washout (2 Hours)||3||
48232362|NCT02125292|100891351|FG002|STARTED|Washout (2 Hours)||3||
48232363|NCT02125292|100891352|FG003|STARTED|Washout (2 Hours)||3||
48232364|NCT02125292|100891353|FG004|STARTED|Washout (2 Hours)||3||
48232365|NCT02125292|100891354|FG005|STARTED|Washout (2 Hours)||3||
48232366|NCT02125292|100891349|FG000|COMPLETED|Washout (2 Hours)||3||
48232367|NCT02125292|100891350|FG001|COMPLETED|Washout (2 Hours)||3||
48232368|NCT02125292|100891351|FG002|COMPLETED|Washout (2 Hours)||3||
48232369|NCT02125292|100891352|FG003|COMPLETED|Washout (2 Hours)||3||
48232370|NCT02125292|100891353|FG004|COMPLETED|Washout (2 Hours)||3||
48232371|NCT02125292|100891354|FG005|COMPLETED|Washout (2 Hours)||3||
48232372|NCT02125292|100891349|FG000|NOT COMPLETED|Washout (2 Hours)||0||
48232373|NCT02125292|100891350|FG001|NOT COMPLETED|Washout (2 Hours)||0||
48232374|NCT02125292|100891351|FG002|NOT COMPLETED|Washout (2 Hours)||0||
48532180|NCT04180163|101639282|FG000|STARTED|Run-in Period (4 or up to 8 Weeks)||12||
48532181|NCT04180163|101639282|FG000|COMPLETED|Run-in Period (4 or up to 8 Weeks)||12||
48532182|NCT04180163|101639282|FG000|NOT COMPLETED|Run-in Period (4 or up to 8 Weeks)||0||
48532183|NCT04180163|101639282|FG000|STARTED|Treatment Period A (Weeks 1 to 26)||12||
48532184|NCT04180163|101639282|FG000|COMPLETED|Treatment Period A (Weeks 1 to 26)||12|Completion of Treatment Period A was defined as completion of any of the Day 182 visit assessments.|
48532185|NCT04180163|101639282|FG000|NOT COMPLETED|Treatment Period A (Weeks 1 to 26)||0||
48532186|NCT04180163|101639282|FG000|STARTED|Treatment Period B (Weeks 27 to 52)||12||
48592653|NCT01877382|101783155|FG005|NOT COMPLETED|Dose Escalation||5||
48232375|NCT02125292|100891352|FG003|NOT COMPLETED|Washout (2 Hours)||0||
48232376|NCT02125292|100891353|FG004|NOT COMPLETED|Washout (2 Hours)||0||
48232377|NCT02125292|100891354|FG005|NOT COMPLETED|Washout (2 Hours)||0||
48232378|NCT02125292|100891349|FG000|STARTED|Third Intervention (1 Hour)||3||
48232379|NCT02125292|100891350|FG001|STARTED|Third Intervention (1 Hour)||3||
48232380|NCT02125292|100891351|FG002|STARTED|Third Intervention (1 Hour)||3||
48232381|NCT02125292|100891352|FG003|STARTED|Third Intervention (1 Hour)||3||
48232382|NCT02125292|100891353|FG004|STARTED|Third Intervention (1 Hour)||3||
48232383|NCT02125292|100891354|FG005|STARTED|Third Intervention (1 Hour)||3||
48232384|NCT02125292|100891349|FG000|COMPLETED|Third Intervention (1 Hour)||3||
48232385|NCT02125292|100891350|FG001|COMPLETED|Third Intervention (1 Hour)||3||
48232386|NCT02125292|100891351|FG002|COMPLETED|Third Intervention (1 Hour)||3||
48232387|NCT02125292|100891352|FG003|COMPLETED|Third Intervention (1 Hour)||3||
48232388|NCT02125292|100891353|FG004|COMPLETED|Third Intervention (1 Hour)||3||
48232389|NCT02125292|100891354|FG005|COMPLETED|Third Intervention (1 Hour)||3||
48232390|NCT02125292|100891349|FG000|NOT COMPLETED|Third Intervention (1 Hour)||0||
48232391|NCT02125292|100891350|FG001|NOT COMPLETED|Third Intervention (1 Hour)||0||
48232392|NCT02125292|100891351|FG002|NOT COMPLETED|Third Intervention (1 Hour)||0||
48232393|NCT02125292|100891352|FG003|NOT COMPLETED|Third Intervention (1 Hour)||0||
48232394|NCT02125292|100891353|FG004|NOT COMPLETED|Third Intervention (1 Hour)||0||
48232395|NCT02125292|100891354|FG005|NOT COMPLETED|Third Intervention (1 Hour)||0||
48232396|NCT01884571|100891355|FG000|STARTED|Overall Study||31||
48232397|NCT01884571|100891355|FG000|COMPLETED|Overall Study||23||
48232398|NCT01884571|100891355|FG000|NOT COMPLETED|Overall Study||8||
48232399|NCT01836523|100891356|FG000|STARTED|Overall Study||351||
48232400|NCT01836523|100891357|FG001|STARTED|Overall Study||350||
48232401|NCT01836523|100891358|FG002|STARTED|Overall Study||349||
48232402|NCT01836523|100891359|FG003|STARTED|Overall Study||348||
48232403|NCT01836523|100891356|FG000|Exposed|Overall Study||350||
48232404|NCT01836523|100891357|FG001|Exposed|Overall Study||348||
48232405|NCT01836523|100891358|FG002|Exposed|Overall Study||347||
48232406|NCT01836523|100891359|FG003|Exposed|Overall Study||348||
48232407|NCT01836523|100891356|FG000|COMPLETED|Overall Study||300||
48232408|NCT01836523|100891357|FG001|COMPLETED|Overall Study||265||
48232409|NCT01836523|100891358|FG002|COMPLETED|Overall Study||258||
48232410|NCT01836523|100891359|FG003|COMPLETED|Overall Study||274||
48232411|NCT01836523|100891356|FG000|NOT COMPLETED|Overall Study||51||
48232412|NCT01836523|100891357|FG001|NOT COMPLETED|Overall Study||85||
48232413|NCT01836523|100891358|FG002|NOT COMPLETED|Overall Study||91||
48232414|NCT01836523|100891359|FG003|NOT COMPLETED|Overall Study||74||
48232415|NCT00786188|100891360|FG000|STARTED|Overall Study||50||
48232416|NCT00786188|100891361|FG001|STARTED|Overall Study||52||
48232417|NCT00786188|100891360|FG000|COMPLETED|Overall Study||45||
48232418|NCT00786188|100891361|FG001|COMPLETED|Overall Study||51||
48532187|NCT04180163|101639282|FG000|COMPLETED|Treatment Period B (Weeks 27 to 52)||12|Completion of Treatment Period B was defined as completion of any of the Day 364 visit assessments.|
48532188|NCT04180163|101639282|FG000|NOT COMPLETED|Treatment Period B (Weeks 27 to 52)||0||
48232419|NCT00786188|100891360|FG000|NOT COMPLETED|Overall Study||5||
48232420|NCT00786188|100891361|FG001|NOT COMPLETED|Overall Study||1||
48232421|NCT02372799|100891362|FG000|STARTED|Treatment Period||186||
48232422|NCT02372799|100891363|FG001|STARTED|Treatment Period||187||
48232423|NCT02372799|100891364|FG002|STARTED|Treatment Period||97||
48232424|NCT02372799|100891362|FG000|COMPLETED|Treatment Period||152||
48232425|NCT02372799|100891363|FG001|COMPLETED|Treatment Period||155||
48232426|NCT02372799|100891364|FG002|COMPLETED|Treatment Period||82||
48232427|NCT02372799|100891362|FG000|NOT COMPLETED|Treatment Period||34||
48232428|NCT02372799|100891363|FG001|NOT COMPLETED|Treatment Period||32||
48232429|NCT02372799|100891364|FG002|NOT COMPLETED|Treatment Period||15||
48232430|NCT02372799|100891362|FG000|STARTED|Down-taper Period||152||
48232431|NCT02372799|100891363|FG001|STARTED|Down-taper Period||159||
48232432|NCT02372799|100891364|FG002|STARTED|Down-taper Period||82||
48232433|NCT02372799|100891362|FG000|COMPLETED|Down-taper Period||151||
48232434|NCT02372799|100891363|FG001|COMPLETED|Down-taper Period||157||
48232435|NCT02372799|100891364|FG002|COMPLETED|Down-taper Period||80||
48232436|NCT02372799|100891362|FG000|NOT COMPLETED|Down-taper Period||1||
48232437|NCT02372799|100891363|FG001|NOT COMPLETED|Down-taper Period||2||
48532189|NCT04180163|101639282|FG000|STARTED|Safety Follow-up Period (Weeks 53 to 56)||12|Participants who rolled over to TAK-743-5007 (NCT04687137) had a 2-week follow-up while others had 4 weeks of follow-up.|
48232438|NCT02372799|100891364|FG002|NOT COMPLETED|Down-taper Period||2||
48232439|NCT02489357|100891365|FG000|STARTED|Overall Study||12||
48232440|NCT02489357|100891365|FG000|COMPLETED|Overall Study||12||
48232441|NCT02489357|100891365|FG000|NOT COMPLETED|Overall Study||0||
48232442|NCT00551421|100891366|FG000|STARTED|Original Protocol, Dose Level 1||3||
48232443|NCT00551421|100891366|FG000|COMPLETED|Original Protocol, Dose Level 1||3||
48232444|NCT00551421|100891366|FG000|NOT COMPLETED|Original Protocol, Dose Level 1||0||
48232445|NCT00551421|100891366|FG000|STARTED|Amended Protocol (Cetuximab-refr. mCRC)||14||
48232446|NCT00551421|100891366|FG000|COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||13||
48232447|NCT00551421|100891366|FG000|NOT COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||1||
48232448|NCT03693989|100891367|FG000|STARTED|Overall Study||88||
48532190|NCT04180163|101639282|FG000|COMPLETED|Safety Follow-up Period (Weeks 53 to 56)||12||
48232449|NCT03693989|100891368|FG001|STARTED|Overall Study||90||
48232450|NCT03693989|100891367|FG000|COMPLETED|Overall Study||85||
48232451|NCT03693989|100891368|FG001|COMPLETED|Overall Study||86||
48232452|NCT03693989|100891367|FG000|NOT COMPLETED|Overall Study||3||
48232453|NCT03693989|100891368|FG001|NOT COMPLETED|Overall Study||4||
48232454|NCT01894503|100891369|FG000|STARTED|Overall Study||5||
48232455|NCT01894503|100891369|FG000|COMPLETED|Overall Study||5||
48232456|NCT01894503|100891369|FG000|NOT COMPLETED|Overall Study||0||
48232457|NCT03019289|100891370|FG000|STARTED|Overall Study||5||
48232458|NCT03019289|100891371|FG001|STARTED|Overall Study||1||
48232459|NCT03019289|100891372|FG002|STARTED|Overall Study||3||
48232460|NCT03019289|100891373|FG003|STARTED|Overall Study||2||
48232461|NCT03019289|100891374|FG004|STARTED|Overall Study||1||
48232462|NCT03019289|100891375|FG005|STARTED|Overall Study||1||
48232463|NCT03019289|100891376|FG006|STARTED|Overall Study||3||
48232464|NCT03019289|100891377|FG007|STARTED|Overall Study||4||
48232465|NCT03019289|100891378|FG008|STARTED|Overall Study||3||
48232466|NCT03019289|100891370|FG000|COMPLETED|Overall Study||3||
48232467|NCT03019289|100891371|FG001|COMPLETED|Overall Study||1||
48232468|NCT03019289|100891372|FG002|COMPLETED|Overall Study||3||
48232469|NCT03019289|100891373|FG003|COMPLETED|Overall Study||2||
48532191|NCT04180163|101639282|FG000|NOT COMPLETED|Safety Follow-up Period (Weeks 53 to 56)||0||
48532192|NCT00121472|101639283|FG000|STARTED|Overall Study||194||
48532193|NCT00121472|101639283|FG000|COMPLETED|Overall Study||194||
48532194|NCT00121472|101639283|FG000|NOT COMPLETED|Overall Study||0||
48232470|NCT03019289|100891374|FG004|COMPLETED|Overall Study||1||
48532195|NCT03573505|101639284|FG000|STARTED|Overall Study||52|Started=Participants who received at least one dose of treatment.|
48532196|NCT03573505|101639285|FG001|STARTED|Overall Study||54|Started=Participants who received at least one dose of treatment.|
48532197|NCT03573505|101639284|FG000|COMPLETED|Overall Study||0||
48532198|NCT03573505|101639285|FG001|COMPLETED|Overall Study||0||
48232471|NCT03019289|100891375|FG005|COMPLETED|Overall Study||1||
48532199|NCT03573505|101639284|FG000|NOT COMPLETED|Overall Study||52||
48532200|NCT03573505|101639285|FG001|NOT COMPLETED|Overall Study||54||
48532201|NCT03579966|101639286|FG000|STARTED|Overall Study||63||
48532202|NCT03579966|101639286|FG000|COMPLETED|Overall Study||3||
48532203|NCT03579966|101639286|FG000|NOT COMPLETED|Overall Study||60||
48532204|NCT02365870|101639287|FG000|STARTED|Overall Study||1||
48532205|NCT02365870|101639288|FG001|STARTED|Overall Study||3||
48532206|NCT02365870|101639287|FG000|COMPLETED|Overall Study||1||
48532207|NCT02365870|101639288|FG001|COMPLETED|Overall Study||3||
48232472|NCT03019289|100891376|FG006|COMPLETED|Overall Study||3||
48232473|NCT03019289|100891377|FG007|COMPLETED|Overall Study||4||
48232474|NCT03019289|100891378|FG008|COMPLETED|Overall Study||2||
48232475|NCT03019289|100891370|FG000|NOT COMPLETED|Overall Study||2||
48232476|NCT03019289|100891371|FG001|NOT COMPLETED|Overall Study||0||
48232477|NCT03019289|100891372|FG002|NOT COMPLETED|Overall Study||0||
48232478|NCT03019289|100891373|FG003|NOT COMPLETED|Overall Study||0||
48232479|NCT03019289|100891374|FG004|NOT COMPLETED|Overall Study||0||
48232480|NCT03019289|100891375|FG005|NOT COMPLETED|Overall Study||0||
48232481|NCT03019289|100891376|FG006|NOT COMPLETED|Overall Study||0||
48232482|NCT03019289|100891377|FG007|NOT COMPLETED|Overall Study||0||
48232483|NCT03019289|100891378|FG008|NOT COMPLETED|Overall Study||1||
48232484|NCT03953079|100891379|FG000|STARTED|Core Study||21||
48232485|NCT03953079|100891380|FG001|STARTED|Core Study||22||
48232486|NCT03953079|100891381|FG002|STARTED|Core Study||13||
48232487|NCT03953079|100891379|FG000|COMPLETED|Core Study||20||
48232488|NCT03953079|100891380|FG001|COMPLETED|Core Study||18||
48232489|NCT03953079|100891381|FG002|COMPLETED|Core Study||12||
48232490|NCT03953079|100891379|FG000|NOT COMPLETED|Core Study||1||
48232491|NCT03953079|100891380|FG001|NOT COMPLETED|Core Study||4||
48232492|NCT03953079|100891381|FG002|NOT COMPLETED|Core Study||1||
48232493|NCT03953079|100891379|FG000|STARTED|Extension Study||12||
48232494|NCT03953079|100891380|FG001|STARTED|Extension Study||10||
48232495|NCT03953079|100891381|FG002|STARTED|Extension Study||6||
48532208|NCT02365870|101639287|FG000|NOT COMPLETED|Overall Study||0||
48532209|NCT02365870|101639288|FG001|NOT COMPLETED|Overall Study||0||
48532210|NCT01287039|101639289|FG000|STARTED|Overall Study||244||
48532211|NCT01287039|101639290|FG001|STARTED|Overall Study||245||
48532212|NCT01287039|101639289|FG000|COMPLETED|Overall Study||215||
48532213|NCT01287039|101639290|FG001|COMPLETED|Overall Study||218||
48532214|NCT01287039|101639289|FG000|NOT COMPLETED|Overall Study||29||
48532215|NCT01287039|101639290|FG001|NOT COMPLETED|Overall Study||27||
48532216|NCT02365558|101639291|FG000|STARTED|Period 1 (Day 1 Through Day 7)||34||
48532217|NCT02365558|101639292|FG001|STARTED|Period 1 (Day 1 Through Day 7)||0||
48532218|NCT02365558|101639291|FG000|Received at Least One Dose of Study Drug|Period 1 (Day 1 Through Day 7)||34||
48532219|NCT02365558|101639292|FG001|Received at Least One Dose of Study Drug|Period 1 (Day 1 Through Day 7)||0||
48532220|NCT02365558|101639291|FG000|COMPLETED|Period 1 (Day 1 Through Day 7)||33||
48532221|NCT02365558|101639292|FG001|COMPLETED|Period 1 (Day 1 Through Day 7)||0||
48532222|NCT02365558|101639291|FG000|NOT COMPLETED|Period 1 (Day 1 Through Day 7)||1||
48532223|NCT02365558|101639292|FG001|NOT COMPLETED|Period 1 (Day 1 Through Day 7)||0||
48532224|NCT02365558|101639291|FG000|STARTED|Period 2 (Day 8 Through Day 20)||0||
48532225|NCT02365558|101639292|FG001|STARTED|Period 2 (Day 8 Through Day 20)||33||
48232496|NCT03953079|100891379|FG000|COMPLETED|Extension Study||6|Completed Month 18 without receiving a rescue treatment.|
48532226|NCT02365558|101639291|FG000|COMPLETED|Period 2 (Day 8 Through Day 20)||0||
48532227|NCT02365558|101639292|FG001|COMPLETED|Period 2 (Day 8 Through Day 20)||32||
48232497|NCT03953079|100891380|FG001|COMPLETED|Extension Study||4|Completed Month 18 without receiving a rescue treatment.|
48232498|NCT03953079|100891381|FG002|COMPLETED|Extension Study||1|Completed Month 18 without receiving a rescue treatment.|
48232499|NCT03953079|100891379|FG000|NOT COMPLETED|Extension Study||6||
48232500|NCT03953079|100891380|FG001|NOT COMPLETED|Extension Study||6||
48232501|NCT03953079|100891381|FG002|NOT COMPLETED|Extension Study||5||
48232502|NCT00667953|100891382|FG000|STARTED|Overall Study||32||
48232503|NCT00667953|100891382|FG000|COMPLETED|Overall Study||28||
48232504|NCT00667953|100891382|FG000|NOT COMPLETED|Overall Study||4||
48232505|NCT00871715|100891383|FG000|STARTED|Overall Study||119||
48232506|NCT00871715|100891384|FG001|STARTED|Overall Study||120||
48232507|NCT00871715|100891385|FG002|STARTED|Overall Study||122||
48232508|NCT00871715|100891383|FG000|Post-Intervention|Overall Study||112||
48232509|NCT00871715|100891384|FG001|Post-Intervention|Overall Study||115||
48232510|NCT00871715|100891385|FG002|Post-Intervention|Overall Study||115||
48232511|NCT00871715|100891383|FG000|6-mo Follow-up|Overall Study||110||
48232512|NCT00871715|100891384|FG001|6-mo Follow-up|Overall Study||113||
48232513|NCT00871715|100891385|FG002|6-mo Follow-up|Overall Study||112||
48232514|NCT00871715|100891383|FG000|COMPLETED|Overall Study||104||
48232515|NCT00871715|100891384|FG001|COMPLETED|Overall Study||104||
48232516|NCT00871715|100891385|FG002|COMPLETED|Overall Study||96||
48232517|NCT00871715|100891383|FG000|NOT COMPLETED|Overall Study||15||
48232518|NCT00871715|100891384|FG001|NOT COMPLETED|Overall Study||16||
48232519|NCT00871715|100891385|FG002|NOT COMPLETED|Overall Study||26||
48232520|NCT01727167|100891386|FG000|STARTED|Overall Study||1||
48232521|NCT01727167|100891387|FG001|STARTED|Overall Study||0||
48232522|NCT01727167|100891386|FG000|COMPLETED|Overall Study||1||
48232523|NCT01727167|100891387|FG001|COMPLETED|Overall Study||0||
48232524|NCT01727167|100891386|FG000|NOT COMPLETED|Overall Study||0||
48232525|NCT01727167|100891387|FG001|NOT COMPLETED|Overall Study||0||
48232526|NCT00768755|100891388|FG000|STARTED|Phase 1||10||
48232527|NCT00768755|100891389|FG001|STARTED|Phase 1||0||
48232528|NCT00768755|100891390|FG002|STARTED|Phase 1||0||
48232529|NCT00768755|100891391|FG003|STARTED|Phase 1||0||
48232530|NCT00768755|100891388|FG000|COMPLETED|Phase 1||0||
48232531|NCT00768755|100891389|FG001|COMPLETED|Phase 1||0||
48232532|NCT00768755|100891390|FG002|COMPLETED|Phase 1||0||
48232533|NCT00768755|100891391|FG003|COMPLETED|Phase 1||0||
48232534|NCT00768755|100891388|FG000|NOT COMPLETED|Phase 1||10||
48232535|NCT00768755|100891389|FG001|NOT COMPLETED|Phase 1||0||
48232536|NCT00768755|100891390|FG002|NOT COMPLETED|Phase 1||0||
48232537|NCT00768755|100891391|FG003|NOT COMPLETED|Phase 1||0||
48232538|NCT00768755|100891388|FG000|STARTED|Phase 2||0||
48232539|NCT00768755|100891389|FG001|STARTED|Phase 2||55||
48232540|NCT00768755|100891390|FG002|STARTED|Phase 2||58||
48232541|NCT00768755|100891391|FG003|STARTED|Phase 2||57||
48232542|NCT00768755|100891388|FG000|Treated|Phase 2||0||
48232543|NCT00768755|100891389|FG001|Treated|Phase 2||55||
48232544|NCT00768755|100891390|FG002|Treated|Phase 2||58||
48232545|NCT00768755|100891391|FG003|Treated|Phase 2||55||
48232546|NCT00768755|100891388|FG000|COMPLETED|Phase 2||0||
48232547|NCT00768755|100891389|FG001|COMPLETED|Phase 2||0||
48232548|NCT00768755|100891390|FG002|COMPLETED|Phase 2||0||
48232549|NCT00768755|100891391|FG003|COMPLETED|Phase 2||0||
48232550|NCT00768755|100891388|FG000|NOT COMPLETED|Phase 2||0||
48232551|NCT00768755|100891389|FG001|NOT COMPLETED|Phase 2||55||
48232552|NCT00768755|100891390|FG002|NOT COMPLETED|Phase 2||58||
48232553|NCT00768755|100891391|FG003|NOT COMPLETED|Phase 2||57||
48232554|NCT00754325|100891392|FG000|STARTED|Initial Treatment||50||
48232555|NCT00754325|100891393|FG001|STARTED|Initial Treatment||49||
48232556|NCT00754325|100891392|FG000|COMPLETED|Initial Treatment||0||
48232557|NCT00754325|100891393|FG001|COMPLETED|Initial Treatment||0||
48232558|NCT00754325|100891392|FG000|NOT COMPLETED|Initial Treatment||50||
48232559|NCT00754325|100891393|FG001|NOT COMPLETED|Initial Treatment||49||
48232560|NCT00754325|100891392|FG000|STARTED|Progression and Cross-over||0||
48232561|NCT00754325|100891393|FG001|STARTED|Progression and Cross-over||21||
48232562|NCT00754325|100891392|FG000|COMPLETED|Progression and Cross-over||0||
48232563|NCT00754325|100891393|FG001|COMPLETED|Progression and Cross-over||0||
48232564|NCT00754325|100891392|FG000|NOT COMPLETED|Progression and Cross-over||0||
48232565|NCT00754325|100891393|FG001|NOT COMPLETED|Progression and Cross-over||21||
48232566|NCT00638456|100891394|FG000|STARTED|Overall Study||21||
48232567|NCT00638456|100891395|FG001|STARTED|Overall Study||11||
48232568|NCT00638456|100891394|FG000|COMPLETED|Overall Study||15||
48232569|NCT00638456|100891395|FG001|COMPLETED|Overall Study||9||
48232570|NCT00638456|100891394|FG000|NOT COMPLETED|Overall Study||6||
48232571|NCT00638456|100891395|FG001|NOT COMPLETED|Overall Study||2||
48232572|NCT04633200|100891396|FG000|STARTED|Overall Study||57||
48232573|NCT04633200|100891397|FG001|STARTED|Overall Study||51||
48532228|NCT02365558|101639291|FG000|NOT COMPLETED|Period 2 (Day 8 Through Day 20)||0||
48532229|NCT02365558|101639292|FG001|NOT COMPLETED|Period 2 (Day 8 Through Day 20)||1||
48532230|NCT02994940|101639293|FG000|STARTED|Overall Study||37||
48532231|NCT02994940|101639294|FG001|STARTED|Overall Study||37||
48232574|NCT04633200|100891396|FG000|COMPLETED|Overall Study||54||
48232575|NCT04633200|100891397|FG001|COMPLETED|Overall Study||46||
48232576|NCT04633200|100891396|FG000|NOT COMPLETED|Overall Study||3||
48232577|NCT04633200|100891397|FG001|NOT COMPLETED|Overall Study||5||
48232578|NCT01549951|100891398|FG000|STARTED|Overall Study||50||
48232579|NCT01549951|100891398|FG000|Primary Reason Off Study Treatment|Overall Study||50||
48232580|NCT01549951|100891398|FG000|COMPLETED|Overall Study||0||
48232581|NCT01549951|100891398|FG000|NOT COMPLETED|Overall Study||50||
48232582|NCT02833948|100891399|FG000|STARTED|Overall Study||116||
48232583|NCT02833948|100891400|FG001|STARTED|Overall Study||115||
48232584|NCT02833948|100891399|FG000|COMPLETED|Overall Study||101||
48232585|NCT02833948|100891400|FG001|COMPLETED|Overall Study||97||
48232586|NCT02833948|100891399|FG000|NOT COMPLETED|Overall Study||15||
48232587|NCT02833948|100891400|FG001|NOT COMPLETED|Overall Study||18||
48232588|NCT02362789|100891401|FG000|STARTED|Run-in Phase (Week 0 to 16)||130||
48232589|NCT02362789|100891402|FG001|STARTED|Run-in Phase (Week 0 to 16)||0||
48232590|NCT02362789|100891403|FG002|STARTED|Run-in Phase (Week 0 to 16)||0||
48232591|NCT02362789|100891401|FG000|COMPLETED|Run-in Phase (Week 0 to 16)||128||
48232592|NCT02362789|100891402|FG001|COMPLETED|Run-in Phase (Week 0 to 16)||0||
48232593|NCT02362789|100891403|FG002|COMPLETED|Run-in Phase (Week 0 to 16)||0||
48232594|NCT02362789|100891401|FG000|NOT COMPLETED|Run-in Phase (Week 0 to 16)||2||
48232595|NCT02362789|100891402|FG001|NOT COMPLETED|Run-in Phase (Week 0 to 16)||0||
48232596|NCT02362789|100891403|FG002|NOT COMPLETED|Run-in Phase (Week 0 to 16)||0||
48232597|NCT02362789|100891401|FG000|STARTED|Randomized Withdrawal (Wk 16 to 32)||0||
48232598|NCT02362789|100891402|FG001|STARTED|Randomized Withdrawal (Wk 16 to 32)||42||
48232599|NCT02362789|100891403|FG002|STARTED|Randomized Withdrawal (Wk 16 to 32)||38||
48232600|NCT02362789|100891401|FG000|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||0||
48232601|NCT02362789|100891402|FG001|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||38||
48232602|NCT02362789|100891403|FG002|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||26||
48232603|NCT02362789|100891401|FG000|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||0||
48232604|NCT02362789|100891402|FG001|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||4||
48232605|NCT02362789|100891403|FG002|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||12||
48232606|NCT01065779|100891404|FG000|STARTED|Overall Study||880||
48232607|NCT01065779|100891404|FG000|COMPLETED|Overall Study||798||
48232608|NCT01065779|100891404|FG000|NOT COMPLETED|Overall Study||82||
48232609|NCT03695185|100891405|FG000|STARTED|Induction Period (Week 0 to Week 12)||42||
48232610|NCT03695185|100891405|FG000|COMPLETED|Induction Period (Week 0 to Week 12)||29||
48232611|NCT03695185|100891405|FG000|NOT COMPLETED|Induction Period (Week 0 to Week 12)||13||
48232612|NCT03695185|100891405|FG000|STARTED|Maintenance Period (Week 12 to Week 102)||29|Participants who completed the Induction Period and had a clinical response at Week 12 entered the Maintenance Period.|
48232613|NCT03695185|100891405|FG000|COMPLETED|Maintenance Period (Week 12 to Week 102)||1||
48232614|NCT03695185|100891405|FG000|NOT COMPLETED|Maintenance Period (Week 12 to Week 102)||28||
48232615|NCT02002689|100891406|FG000|STARTED|Overall Study||10||
48232616|NCT02002689|100891406|FG000|COMPLETED|Overall Study||0||
48232617|NCT02002689|100891406|FG000|NOT COMPLETED|Overall Study||10||
48232618|NCT01109979|100891407|FG000|STARTED|Overall Study||12||
48232619|NCT01109979|100891408|FG001|STARTED|Overall Study||12||
48232620|NCT01109979|100891407|FG000|COMPLETED|Overall Study||10||
48232621|NCT01109979|100891408|FG001|COMPLETED|Overall Study||11||
48232622|NCT01109979|100891407|FG000|NOT COMPLETED|Overall Study||2||
48232623|NCT01109979|100891408|FG001|NOT COMPLETED|Overall Study||1||
48232624|NCT03462966|100891409|FG000|STARTED|Overall Study||4||
48232625|NCT03462966|100891409|FG000|COMPLETED|Overall Study||4||
48232626|NCT03462966|100891409|FG000|NOT COMPLETED|Overall Study||0||
48532232|NCT02994940|101639293|FG000|COMPLETED|Overall Study||30||
48532233|NCT02994940|101639294|FG001|COMPLETED|Overall Study||36||
48532234|NCT02994940|101639293|FG000|NOT COMPLETED|Overall Study||7||
48232627|NCT02006641|100891410|FG000|STARTED|Overall Study||284||
48232628|NCT02006641|100891411|FG001|STARTED|Overall Study||290||
48232629|NCT02006641|100891412|FG002|STARTED|Overall Study||284||
48232630|NCT02006641|100891410|FG000|Treated|Overall Study||282||
48232631|NCT02006641|100891411|FG001|Treated|Overall Study||285||
48232632|NCT02006641|100891412|FG002|Treated|Overall Study||281||
48232633|NCT02006641|100891410|FG000|COMPLETED|Overall Study||258||
48232634|NCT02006641|100891411|FG001|COMPLETED|Overall Study||257||
48232635|NCT02006641|100891412|FG002|COMPLETED|Overall Study||248||
48232636|NCT02006641|100891410|FG000|NOT COMPLETED|Overall Study||26||
48232637|NCT02006641|100891411|FG001|NOT COMPLETED|Overall Study||33||
48232638|NCT02006641|100891412|FG002|NOT COMPLETED|Overall Study||36||
48232639|NCT03052517|100891413|FG000|STARTED|Overall Study||1093||
48232640|NCT03052517|100891414|FG001|STARTED|Overall Study||1085||
48232641|NCT03052517|100891415|FG002|STARTED|Overall Study||360||
48232642|NCT03052517|100891413|FG000|Safety Set (SAF)|Overall Study||1092|All patients who received at least one dose of study drug during this study.|
48232643|NCT03052517|100891414|FG001|Safety Set (SAF)|Overall Study||1084|All patients who received at least one dose of study drug during this study.|
48232644|NCT03052517|100891415|FG002|Safety Set (SAF)|Overall Study||361|All patients who received at least one dose of study drug during this study.|
48532235|NCT02994940|101639294|FG001|NOT COMPLETED|Overall Study||1||
48532236|NCT02819050|101639295|FG000|STARTED|Overall Study||40||
48532237|NCT02819050|101639296|FG001|STARTED|Overall Study||40||
48232645|NCT03052517|100891413|FG000|COMPLETED|Overall Study||76||
48232646|NCT03052517|100891414|FG001|COMPLETED|Overall Study||71||
48232647|NCT03052517|100891415|FG002|COMPLETED|Overall Study||32||
48232648|NCT03052517|100891413|FG000|NOT COMPLETED|Overall Study||1017||
48232649|NCT03052517|100891414|FG001|NOT COMPLETED|Overall Study||1014||
48232650|NCT03052517|100891415|FG002|NOT COMPLETED|Overall Study||328||
48232651|NCT00639418|100891416|FG000|STARTED|Overall Study||28101||
48232652|NCT00639418|100891417|FG001|STARTED|Overall Study||35967||
48232653|NCT00639418|100891418|FG002|STARTED|Overall Study||36496||
48232654|NCT00639418|100891419|FG003|STARTED|Overall Study||46930||
48232655|NCT00639418|100891416|FG000|COMPLETED|Overall Study||28101||
48232656|NCT00639418|100891417|FG001|COMPLETED|Overall Study||35967||
48232657|NCT00639418|100891418|FG002|COMPLETED|Overall Study||36496||
48232658|NCT00639418|100891419|FG003|COMPLETED|Overall Study||46930||
48232659|NCT00639418|100891416|FG000|NOT COMPLETED|Overall Study||0||
48232660|NCT00639418|100891417|FG001|NOT COMPLETED|Overall Study||0||
48232661|NCT00639418|100891418|FG002|NOT COMPLETED|Overall Study||0||
48232662|NCT00639418|100891419|FG003|NOT COMPLETED|Overall Study||0||
48532238|NCT02819050|101639295|FG000|COMPLETED|Overall Study||40||
48532239|NCT02819050|101639296|FG001|COMPLETED|Overall Study||40||
48532240|NCT02819050|101639295|FG000|NOT COMPLETED|Overall Study||0||
48532241|NCT02819050|101639296|FG001|NOT COMPLETED|Overall Study||0||
48532242|NCT01837524|101639297|FG000|STARTED|Overall Study||28||
48532243|NCT01837524|101639298|FG001|STARTED|Overall Study||27||
48232663|NCT01256359|100891420|FG000|STARTED|Overall Study||41||
48232664|NCT01256359|100891421|FG001|STARTED|Overall Study||42||
48232665|NCT01256359|100891420|FG000|COMPLETED|Overall Study||38|Numbers completed here are those who started treatment i.e. only excludes those who received no allocated intervention. Treatment duration is flexible, there is not mark for treatment completion, patients can keep receiving cycles of treatment up to 6 cycles.|
48232666|NCT01256359|100891421|FG001|COMPLETED|Overall Study||41|Numbers completed here are those who started treatment i.e. only excludes those who received no allocated intervention. Treatment duration is flexible, there is not mark for treatment completion, patients can keep receiving cycles of treatment up to 6 cycles.|
48232667|NCT01256359|100891420|FG000|NOT COMPLETED|Overall Study||3||
48232668|NCT01256359|100891421|FG001|NOT COMPLETED|Overall Study||1||
48232669|NCT00321672|100891422|FG000|STARTED|Overall Study||165||
48232670|NCT00321672|100891423|FG001|STARTED|Overall Study||89||
48232671|NCT00321672|100891424|FG002|STARTED|Overall Study||167||
48232672|NCT00321672|100891425|FG003|STARTED|Overall Study||73||
48232673|NCT00321672|100891422|FG000|COMPLETED|Overall Study||153||
48232674|NCT00321672|100891423|FG001|COMPLETED|Overall Study||81||
48232675|NCT00321672|100891424|FG002|COMPLETED|Overall Study||156||
48232676|NCT00321672|100891425|FG003|COMPLETED|Overall Study||71||
48232677|NCT00321672|100891422|FG000|NOT COMPLETED|Overall Study||12||
48232678|NCT00321672|100891423|FG001|NOT COMPLETED|Overall Study||8||
48232679|NCT00321672|100891424|FG002|NOT COMPLETED|Overall Study||11||
48232680|NCT00321672|100891425|FG003|NOT COMPLETED|Overall Study||2||
48232681|NCT02790788|100891426|FG000|STARTED|Overall Study||46||
48232682|NCT02790788|100891427|FG001|STARTED|Overall Study||54||
48232683|NCT02790788|100891426|FG000|COMPLETED|Overall Study||46||
48532244|NCT01837524|101639297|FG000|COMPLETED|Overall Study||25||
48232684|NCT02790788|100891427|FG001|COMPLETED|Overall Study||54||
48232685|NCT02790788|100891426|FG000|NOT COMPLETED|Overall Study||0||
48232686|NCT02790788|100891427|FG001|NOT COMPLETED|Overall Study||0||
48232687|NCT02138838|100891428|FG000|STARTED|Overall Study||28||
48232688|NCT02138838|100891429|FG001|STARTED|Overall Study||27||
48232689|NCT02138838|100891428|FG000|Received Study Drug|Overall Study||28||
48232690|NCT02138838|100891429|FG001|Received Study Drug|Overall Study||25||
48232691|NCT02138838|100891428|FG000|COMPLETED|Overall Study||20||
48232692|NCT02138838|100891429|FG001|COMPLETED|Overall Study||16||
48232693|NCT02138838|100891428|FG000|NOT COMPLETED|Overall Study||8||
48232694|NCT02138838|100891429|FG001|NOT COMPLETED|Overall Study||11||
48232695|NCT00635609|100891430|FG000|STARTED|Overall Study||48||
48232696|NCT00635609|100891431|FG001|STARTED|Overall Study||45||
48232697|NCT00635609|100891430|FG000|COMPLETED|Overall Study||41||
48232698|NCT00635609|100891431|FG001|COMPLETED|Overall Study||42||
48232699|NCT00635609|100891430|FG000|NOT COMPLETED|Overall Study||7||
48232700|NCT00635609|100891431|FG001|NOT COMPLETED|Overall Study||3||
48232701|NCT03006393|100891432|FG000|STARTED|Overall Study||21||
48232702|NCT03006393|100891433|FG001|STARTED|Overall Study||21||
48232703|NCT03006393|100891432|FG000|COMPLETED|Overall Study||20||
48532245|NCT01837524|101639298|FG001|COMPLETED|Overall Study||25||
48532246|NCT01837524|101639297|FG000|NOT COMPLETED|Overall Study||3||
48232704|NCT03006393|100891433|FG001|COMPLETED|Overall Study||18||
48532247|NCT01837524|101639298|FG001|NOT COMPLETED|Overall Study||2||
48532248|NCT01671332|101639299|FG000|STARTED|Overall Study||40||
48232705|NCT03006393|100891432|FG000|NOT COMPLETED|Overall Study||1||
48232706|NCT03006393|100891433|FG001|NOT COMPLETED|Overall Study||3||
48232707|NCT00854594|100891434|FG000|STARTED|Overall Study||48||
48232708|NCT00854594|100891435|FG001|STARTED|Overall Study||69||
48532249|NCT01671332|101639300|FG001|STARTED|Overall Study||40||
48532250|NCT01671332|101639299|FG000|Crossed Over to Docetaxel Plus Suramin|Overall Study||0|Participants with disease progression on Docetaxel Arm were allowed to crossover to Suramin.|
48592654|NCT01877382|101783156|FG006|NOT COMPLETED|Dose Escalation||9||
48592655|NCT01877382|101783157|FG007|NOT COMPLETED|Dose Escalation||15||
48232709|NCT00854594|100891434|FG000|COMPLETED|Overall Study||48||
48232710|NCT00854594|100891435|FG001|COMPLETED|Overall Study||69||
48232711|NCT00854594|100891434|FG000|NOT COMPLETED|Overall Study||0||
48232712|NCT00854594|100891435|FG001|NOT COMPLETED|Overall Study||0||
48232713|NCT02168855|100891436|FG000|STARTED|Overall Study||181||
48232714|NCT02168855|100891437|FG001|STARTED|Overall Study||188||
48232715|NCT02168855|100891436|FG000|COMPLETED|Overall Study||169||
48232716|NCT02168855|100891437|FG001|COMPLETED|Overall Study||177||
48232717|NCT02168855|100891436|FG000|NOT COMPLETED|Overall Study||12||
48232718|NCT02168855|100891437|FG001|NOT COMPLETED|Overall Study||11||
48232719|NCT01428583|100891438|FG000|STARTED|Overall Study||395||
48232720|NCT01428583|100891438|FG000|COMPLETED|Overall Study||158||
48232721|NCT01428583|100891438|FG000|NOT COMPLETED|Overall Study||237||
48232722|NCT00929526|100891439|FG000|STARTED|Overall Study||375||
48232723|NCT00929526|100891440|FG001|STARTED|Overall Study||377||
48232724|NCT00929526|100891439|FG000|COMPLETED|Overall Study||358||
48232725|NCT00929526|100891440|FG001|COMPLETED|Overall Study||348||
48232726|NCT00929526|100891439|FG000|NOT COMPLETED|Overall Study||17||
48232727|NCT00929526|100891440|FG001|NOT COMPLETED|Overall Study||29||
48232728|NCT02077374|100891441|FG000|STARTED|Overall Study||19||
48232729|NCT02077374|100891442|FG001|STARTED|Overall Study||19||
48232730|NCT02077374|100891441|FG000|COMPLETED|Overall Study||19||
48232731|NCT02077374|100891442|FG001|COMPLETED|Overall Study||17||
48232732|NCT02077374|100891441|FG000|NOT COMPLETED|Overall Study||0||
48232733|NCT02077374|100891442|FG001|NOT COMPLETED|Overall Study||2||
48232734|NCT04313985|100891443|FG000|STARTED|Treatment Period 1 (1 Week)||2||
48232735|NCT04313985|100891444|FG001|STARTED|Treatment Period 1 (1 Week)||2||
48232736|NCT04313985|100891443|FG000|COMPLETED|Treatment Period 1 (1 Week)||2||
48232737|NCT04313985|100891444|FG001|COMPLETED|Treatment Period 1 (1 Week)||2||
48232738|NCT04313985|100891443|FG000|NOT COMPLETED|Treatment Period 1 (1 Week)||0||
48232739|NCT04313985|100891444|FG001|NOT COMPLETED|Treatment Period 1 (1 Week)||0||
48232740|NCT04313985|100891443|FG000|STARTED|Treatment Period 2 (1 Week)||2||
48232741|NCT04313985|100891444|FG001|STARTED|Treatment Period 2 (1 Week)||2||
48232742|NCT04313985|100891443|FG000|COMPLETED|Treatment Period 2 (1 Week)||2||
48232743|NCT04313985|100891444|FG001|COMPLETED|Treatment Period 2 (1 Week)||2||
48232744|NCT04313985|100891443|FG000|NOT COMPLETED|Treatment Period 2 (1 Week)||0||
48532251|NCT01671332|101639300|FG001|Crossed Over to Docetaxel Plus Suramin|Overall Study||13|Participants with disease progression on Docetaxel Arm were allowed to crossover to Suramin.|
48532252|NCT01671332|101639299|FG000|COMPLETED|Overall Study||39||
48532253|NCT01671332|101639300|FG001|COMPLETED|Overall Study||39||
48532254|NCT01671332|101639299|FG000|NOT COMPLETED|Overall Study||1||
48532255|NCT01671332|101639300|FG001|NOT COMPLETED|Overall Study||1||
48532256|NCT00587990|101639301|FG000|STARTED|Overall Study||2||
48532257|NCT00587990|101639302|FG001|STARTED|Overall Study||4||
48532258|NCT00587990|101639303|FG002|STARTED|Overall Study||3||
48532259|NCT00587990|101639301|FG000|COMPLETED|Overall Study||2||
48532260|NCT00587990|101639302|FG001|COMPLETED|Overall Study||4||
48532261|NCT00587990|101639303|FG002|COMPLETED|Overall Study||2||
48532262|NCT00587990|101639301|FG000|NOT COMPLETED|Overall Study||0||
48532263|NCT00587990|101639302|FG001|NOT COMPLETED|Overall Study||0||
48532264|NCT00587990|101639303|FG002|NOT COMPLETED|Overall Study||1||
48532265|NCT04941521|101639304|FG000|STARTED|Overall Study||3||
48532266|NCT04941521|101639304|FG000|COMPLETED|Overall Study||3||
48232745|NCT04313985|100891444|FG001|NOT COMPLETED|Treatment Period 2 (1 Week)||0||
48232746|NCT04313985|100891443|FG000|STARTED|Follow-up Period (1 Week)||2||
48232747|NCT04313985|100891444|FG001|STARTED|Follow-up Period (1 Week)||2||
48232748|NCT04313985|100891443|FG000|COMPLETED|Follow-up Period (1 Week)||2||
48232749|NCT04313985|100891444|FG001|COMPLETED|Follow-up Period (1 Week)||2||
48232750|NCT04313985|100891443|FG000|NOT COMPLETED|Follow-up Period (1 Week)||0||
48232751|NCT04313985|100891444|FG001|NOT COMPLETED|Follow-up Period (1 Week)||0||
48232752|NCT00985088|100891445|FG000|STARTED|Overall Study||222||
48232753|NCT00985088|100891446|FG001|STARTED|Overall Study||114||
48232754|NCT00985088|100891447|FG002|STARTED|Overall Study||112||
48532267|NCT04941521|101639304|FG000|NOT COMPLETED|Overall Study||0||
48532268|NCT04268316|101639305|FG000|STARTED|Overall Study||5||
48532269|NCT04268316|101639306|FG001|STARTED|Overall Study||4||
48532270|NCT04268316|101639307|FG002|STARTED|Overall Study||4||
48532271|NCT04268316|101639305|FG000|COMPLETED|Overall Study||3||
48532272|NCT04268316|101639306|FG001|COMPLETED|Overall Study||3||
48532273|NCT04268316|101639307|FG002|COMPLETED|Overall Study||4||
48232755|NCT00985088|100891448|FG003|STARTED|Overall Study||221||
48232756|NCT00985088|100891449|FG004|STARTED|Overall Study||223||
48232757|NCT00985088|100891450|FG005|STARTED|Overall Study||115||
48232758|NCT00985088|100891451|FG006|STARTED|Overall Study||111||
48232759|NCT00985088|100891452|FG007|STARTED|Overall Study||222||
48232760|NCT00985088|100891445|FG000|COMPLETED|Overall Study||211||
48232761|NCT00985088|100891446|FG001|COMPLETED|Overall Study||112||
48532274|NCT04268316|101639305|FG000|NOT COMPLETED|Overall Study||2||
48532275|NCT04268316|101639306|FG001|NOT COMPLETED|Overall Study||1||
48532276|NCT04268316|101639307|FG002|NOT COMPLETED|Overall Study||0||
48232762|NCT00985088|100891447|FG002|COMPLETED|Overall Study||108||
48232763|NCT00985088|100891448|FG003|COMPLETED|Overall Study||214||
48232764|NCT00985088|100891449|FG004|COMPLETED|Overall Study||214||
48532277|NCT00375830|101639308|FG000|STARTED|Overall Study||10||
48532278|NCT00375830|101639309|FG001|STARTED|Overall Study||30||
48532279|NCT00375830|101639310|FG002|STARTED|Overall Study||74||
48532280|NCT00375830|101639308|FG000|COMPLETED|Overall Study||10||
48532281|NCT00375830|101639309|FG001|COMPLETED|Overall Study||30||
48532282|NCT00375830|101639310|FG002|COMPLETED|Overall Study||74||
48532283|NCT00375830|101639308|FG000|NOT COMPLETED|Overall Study||0||
48532284|NCT00375830|101639309|FG001|NOT COMPLETED|Overall Study||0||
48532285|NCT00375830|101639310|FG002|NOT COMPLETED|Overall Study||0||
48532286|NCT02062294|101639311|FG000|STARTED|Overall Study||14||
48532287|NCT02062294|101639311|FG000|COMPLETED|Overall Study||14||
48532288|NCT02062294|101639311|FG000|NOT COMPLETED|Overall Study||0||
48532289|NCT01480843|101639312|FG000|STARTED|Overall Study||65||
48532290|NCT01480843|101639312|FG000|COMPLETED|Overall Study||60||
48232765|NCT00985088|100891450|FG005|COMPLETED|Overall Study||108||
48532291|NCT01480843|101639312|FG000|NOT COMPLETED|Overall Study||5||
48532292|NCT01777620|101639313|FG000|STARTED|Overall Study||63||
48532293|NCT01777620|101639314|FG001|STARTED|Overall Study||62||
48532294|NCT01777620|101639313|FG000|COMPLETED|Overall Study||62||
48532295|NCT01777620|101639314|FG001|COMPLETED|Overall Study||62||
48532296|NCT01777620|101639313|FG000|NOT COMPLETED|Overall Study||1||
48532297|NCT01777620|101639314|FG001|NOT COMPLETED|Overall Study||0||
48532298|NCT02588950|101639315|FG000|STARTED|Period 1 (Part A)||3||
48532299|NCT02588950|101639316|FG001|STARTED|Period 1 (Part A)||2||
48532300|NCT02588950|101639317|FG002|STARTED|Period 1 (Part A)||3||
48532301|NCT02588950|101639318|FG003|STARTED|Period 1 (Part A)||3||
48532302|NCT02588950|101639315|FG000|Received at Least One Dose of Study Drug|Period 1 (Part A)||3||
48532303|NCT02588950|101639316|FG001|Received at Least One Dose of Study Drug|Period 1 (Part A)||2||
48532304|NCT02588950|101639317|FG002|Received at Least One Dose of Study Drug|Period 1 (Part A)||3||
48532305|NCT02588950|101639318|FG003|Received at Least One Dose of Study Drug|Period 1 (Part A)||3||
48532306|NCT02588950|101639315|FG000|COMPLETED|Period 1 (Part A)||3||
48532307|NCT02588950|101639316|FG001|COMPLETED|Period 1 (Part A)||2||
48532308|NCT02588950|101639317|FG002|COMPLETED|Period 1 (Part A)||3||
48532309|NCT02588950|101639318|FG003|COMPLETED|Period 1 (Part A)||3||
48232766|NCT00985088|100891451|FG006|COMPLETED|Overall Study||107||
48232767|NCT00985088|100891452|FG007|COMPLETED|Overall Study||216||
48232768|NCT00985088|100891445|FG000|NOT COMPLETED|Overall Study||11||
48232769|NCT00985088|100891446|FG001|NOT COMPLETED|Overall Study||2||
48232770|NCT00985088|100891447|FG002|NOT COMPLETED|Overall Study||4||
48232771|NCT00985088|100891448|FG003|NOT COMPLETED|Overall Study||7||
48232772|NCT00985088|100891449|FG004|NOT COMPLETED|Overall Study||9||
48232773|NCT00985088|100891450|FG005|NOT COMPLETED|Overall Study||7||
48232774|NCT00985088|100891451|FG006|NOT COMPLETED|Overall Study||4||
48232775|NCT00985088|100891452|FG007|NOT COMPLETED|Overall Study||6||
48532310|NCT02588950|101639315|FG000|NOT COMPLETED|Period 1 (Part A)||0||
48532311|NCT02588950|101639316|FG001|NOT COMPLETED|Period 1 (Part A)||0||
48532312|NCT02588950|101639317|FG002|NOT COMPLETED|Period 1 (Part A)||0||
48532313|NCT02588950|101639318|FG003|NOT COMPLETED|Period 1 (Part A)||0||
48532314|NCT02588950|101639315|FG000|STARTED|Period 2 (Part A)||3||
48532315|NCT02588950|101639316|FG001|STARTED|Period 2 (Part A)||2||
48532316|NCT02588950|101639317|FG002|STARTED|Period 2 (Part A)||3||
48532317|NCT02588950|101639318|FG003|STARTED|Period 2 (Part A)||3||
48532318|NCT02588950|101639315|FG000|COMPLETED|Period 2 (Part A)||3||
48532319|NCT02588950|101639316|FG001|COMPLETED|Period 2 (Part A)||2||
48532320|NCT02588950|101639317|FG002|COMPLETED|Period 2 (Part A)||2||
48232776|NCT00489554|100891453|FG000|STARTED|Overall Study||230||
48232777|NCT00489554|100891453|FG000|COMPLETED|Overall Study||226||
48232778|NCT00489554|100891453|FG000|NOT COMPLETED|Overall Study||4||
48232779|NCT02009332|100891454|FG000|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||3||
48232780|NCT02009332|100891455|FG001|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0||
48232781|NCT02009332|100891456|FG002|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0||
48232782|NCT02009332|100891457|FG003|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0||
48232783|NCT02009332|100891458|FG004|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0||
48232784|NCT02009332|100891459|FG005|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0||
48232785|NCT02009332|100891454|FG000|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||3||
48232786|NCT02009332|100891455|FG001|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0||
48232787|NCT02009332|100891456|FG002|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0||
48232788|NCT02009332|100891457|FG003|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0||
48232789|NCT02009332|100891458|FG004|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0||
48232790|NCT02009332|100891459|FG005|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0||
48232791|NCT02009332|100891454|FG000|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0||
48232792|NCT02009332|100891455|FG001|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0||
48232793|NCT02009332|100891456|FG002|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0||
48232794|NCT02009332|100891457|FG003|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0||
48232795|NCT02009332|100891458|FG004|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0||
48532321|NCT02588950|101639318|FG003|COMPLETED|Period 2 (Part A)||3||
48532322|NCT02588950|101639315|FG000|NOT COMPLETED|Period 2 (Part A)||0||
48532323|NCT02588950|101639316|FG001|NOT COMPLETED|Period 2 (Part A)||0||
48532324|NCT02588950|101639317|FG002|NOT COMPLETED|Period 2 (Part A)||1||
48532325|NCT02588950|101639318|FG003|NOT COMPLETED|Period 2 (Part A)||0||
48532326|NCT02588950|101639315|FG000|STARTED|Period 3 (Part B)||3||
48532327|NCT02588950|101639316|FG001|STARTED|Period 3 (Part B)||2||
48232796|NCT02009332|100891459|FG005|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0||
48232797|NCT02009332|100891454|FG000|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0||
48232798|NCT02009332|100891455|FG001|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||4||
48232799|NCT02009332|100891456|FG002|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||1||
48232800|NCT02009332|100891457|FG003|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0||
48232801|NCT02009332|100891458|FG004|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0||
48232802|NCT02009332|100891459|FG005|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0||
48232803|NCT02009332|100891454|FG000|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0||
48232804|NCT02009332|100891455|FG001|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||3||
48232805|NCT02009332|100891456|FG002|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||1||
48232806|NCT02009332|100891457|FG003|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0||
48232807|NCT02009332|100891458|FG004|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0||
48232808|NCT02009332|100891459|FG005|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0||
48232809|NCT02009332|100891454|FG000|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0||
48232810|NCT02009332|100891455|FG001|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||1||
48232811|NCT02009332|100891456|FG002|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0||
48232812|NCT02009332|100891457|FG003|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0||
48232813|NCT02009332|100891458|FG004|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0||
48232814|NCT02009332|100891459|FG005|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0||
48232815|NCT02009332|100891454|FG000|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0||
48232816|NCT02009332|100891455|FG001|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0||
48232817|NCT02009332|100891456|FG002|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0||
48232818|NCT02009332|100891457|FG003|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||3||
48232819|NCT02009332|100891458|FG004|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0||
48232820|NCT02009332|100891459|FG005|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0||
48232821|NCT02009332|100891454|FG000|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0||
48232822|NCT02009332|100891455|FG001|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0||
48232823|NCT02009332|100891456|FG002|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0||
48532328|NCT02588950|101639317|FG002|STARTED|Period 3 (Part B)||2||
48532329|NCT02588950|101639318|FG003|STARTED|Period 3 (Part B)||3||
48532330|NCT02588950|101639315|FG000|COMPLETED|Period 3 (Part B)||3||
48532331|NCT02588950|101639316|FG001|COMPLETED|Period 3 (Part B)||2||
48532332|NCT02588950|101639317|FG002|COMPLETED|Period 3 (Part B)||2||
48532333|NCT02588950|101639318|FG003|COMPLETED|Period 3 (Part B)||2||
48532334|NCT02588950|101639315|FG000|NOT COMPLETED|Period 3 (Part B)||0||
48532335|NCT02588950|101639316|FG001|NOT COMPLETED|Period 3 (Part B)||0||
48532336|NCT02588950|101639317|FG002|NOT COMPLETED|Period 3 (Part B)||0||
48532337|NCT02588950|101639318|FG003|NOT COMPLETED|Period 3 (Part B)||1||
48532338|NCT01413516|101639319|FG000|STARTED|Overall Study||8||
48532339|NCT01413516|101639320|FG001|STARTED|Overall Study||9||
48532340|NCT01413516|101639319|FG000|COMPLETED|Overall Study||8||
48532341|NCT01413516|101639320|FG001|COMPLETED|Overall Study||9||
48532342|NCT01413516|101639319|FG000|NOT COMPLETED|Overall Study||0||
48532343|NCT01413516|101639320|FG001|NOT COMPLETED|Overall Study||0||
48532344|NCT01561430|101639321|FG000|STARTED|Overall Study||9||
48532345|NCT01561430|101639322|FG001|STARTED|Overall Study||23||
48532346|NCT01561430|101639323|FG002|STARTED|Overall Study||18||
48532347|NCT01561430|101639324|FG003|STARTED|Overall Study||20||
48532348|NCT01561430|101639321|FG000|Received at Least One Dose of Study Drug|Overall Study||9||
48532349|NCT01561430|101639322|FG001|Received at Least One Dose of Study Drug|Overall Study||23||
48532350|NCT01561430|101639323|FG002|Received at Least One Dose of Study Drug|Overall Study||18||
48532351|NCT01561430|101639324|FG003|Received at Least One Dose of Study Drug|Overall Study||20||
48532352|NCT01561430|101639321|FG000|COMPLETED|Overall Study||8||
48532353|NCT01561430|101639322|FG001|COMPLETED|Overall Study||8||
48532354|NCT01561430|101639323|FG002|COMPLETED|Overall Study||1||
48532355|NCT01561430|101639324|FG003|COMPLETED|Overall Study||7||
48532356|NCT01561430|101639321|FG000|NOT COMPLETED|Overall Study||1||
48532357|NCT01561430|101639322|FG001|NOT COMPLETED|Overall Study||15||
48532358|NCT01561430|101639323|FG002|NOT COMPLETED|Overall Study||17||
48232824|NCT02009332|100891457|FG003|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||3||
48232825|NCT02009332|100891458|FG004|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0||
48232826|NCT02009332|100891459|FG005|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0||
48232827|NCT02009332|100891454|FG000|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0||
48232828|NCT02009332|100891455|FG001|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0||
48232829|NCT02009332|100891456|FG002|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0||
48232830|NCT02009332|100891457|FG003|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0||
48532359|NCT01561430|101639324|FG003|NOT COMPLETED|Overall Study||13||
48532360|NCT01831765|101639325|FG000|STARTED|Overall Study||381||
48532361|NCT01831765|101639326|FG001|STARTED|Overall Study||382||
48532362|NCT01831765|101639327|FG002|STARTED|Overall Study||380||
48532363|NCT01831765|101639325|FG000|Completed 26 Weeks|Overall Study||351||
48532364|NCT01831765|101639326|FG001|Completed 26 Weeks|Overall Study||355||
48532365|NCT01831765|101639327|FG002|Completed 26 Weeks|Overall Study||356||
48532366|NCT01831765|101639325|FG000|Completed 52 Weeks|Overall Study||337||
48532367|NCT01831765|101639326|FG001|Completed 52 Weeks|Overall Study||0||
48532368|NCT01831765|101639327|FG002|Completed 52 Weeks|Overall Study||338||
48532369|NCT01831765|101639325|FG000|COMPLETED|Overall Study||337||
48532370|NCT01831765|101639326|FG001|COMPLETED|Overall Study||355||
48532371|NCT01831765|101639327|FG002|COMPLETED|Overall Study||338||
48532372|NCT01831765|101639325|FG000|NOT COMPLETED|Overall Study||44||
48532373|NCT01831765|101639326|FG001|NOT COMPLETED|Overall Study||27||
48532374|NCT01831765|101639327|FG002|NOT COMPLETED|Overall Study||42||
48532375|NCT00599521|101639328|FG000|STARTED|Overall Study||535||
48532376|NCT00599521|101639329|FG001|STARTED|Overall Study||531||
48532377|NCT00599521|101639328|FG000|COMPLETED|Overall Study||475||
48532378|NCT00599521|101639329|FG001|COMPLETED|Overall Study||462||
48532379|NCT00599521|101639328|FG000|NOT COMPLETED|Overall Study||60||
48532380|NCT00599521|101639329|FG001|NOT COMPLETED|Overall Study||69||
48532381|NCT00923273|101639330|FG000|STARTED|Phase I Treatment Period||4||
48532382|NCT00923273|101639331|FG001|STARTED|Phase I Treatment Period||3||
48532383|NCT00923273|101639332|FG002|STARTED|Phase I Treatment Period||3||
48532384|NCT00923273|101639333|FG003|STARTED|Phase I Treatment Period||7||
48532385|NCT00923273|101639334|FG004|STARTED|Phase I Treatment Period||5||
48532386|NCT00923273|101639330|FG000|COMPLETED|Phase I Treatment Period||4||
48532387|NCT00923273|101639331|FG001|COMPLETED|Phase I Treatment Period||3||
48532388|NCT00923273|101639332|FG002|COMPLETED|Phase I Treatment Period||3||
48532389|NCT00923273|101639333|FG003|COMPLETED|Phase I Treatment Period||7||
48532390|NCT00923273|101639334|FG004|COMPLETED|Phase I Treatment Period||5||
48532391|NCT00923273|101639330|FG000|NOT COMPLETED|Phase I Treatment Period||0||
48532392|NCT00923273|101639331|FG001|NOT COMPLETED|Phase I Treatment Period||0||
48532393|NCT00923273|101639332|FG002|NOT COMPLETED|Phase I Treatment Period||0||
48532394|NCT00923273|101639333|FG003|NOT COMPLETED|Phase I Treatment Period||0||
48532395|NCT00923273|101639334|FG004|NOT COMPLETED|Phase I Treatment Period||0||
48532396|NCT00923273|101639330|FG000|STARTED|Phase II Treatment Period||0||
48532397|NCT00923273|101639331|FG001|STARTED|Phase II Treatment Period||0||
48532398|NCT00923273|101639332|FG002|STARTED|Phase II Treatment Period||0||
48532399|NCT00923273|101639333|FG003|STARTED|Phase II Treatment Period||27||
48532400|NCT00923273|101639334|FG004|STARTED|Phase II Treatment Period||0||
48532401|NCT00923273|101639330|FG000|COMPLETED|Phase II Treatment Period||0||
48532402|NCT00923273|101639331|FG001|COMPLETED|Phase II Treatment Period||0||
48532403|NCT00923273|101639332|FG002|COMPLETED|Phase II Treatment Period||0||
48532404|NCT00923273|101639333|FG003|COMPLETED|Phase II Treatment Period||20||
48532405|NCT00923273|101639334|FG004|COMPLETED|Phase II Treatment Period||0||
48532406|NCT00923273|101639330|FG000|NOT COMPLETED|Phase II Treatment Period||0||
48532407|NCT00923273|101639331|FG001|NOT COMPLETED|Phase II Treatment Period||0||
48532408|NCT00923273|101639332|FG002|NOT COMPLETED|Phase II Treatment Period||0||
48532409|NCT00923273|101639333|FG003|NOT COMPLETED|Phase II Treatment Period||7||
48532410|NCT00923273|101639334|FG004|NOT COMPLETED|Phase II Treatment Period||0||
48532411|NCT02119819|101639335|FG000|STARTED|Overall Study||66||
48532412|NCT02119819|101639336|FG001|STARTED|Overall Study||71||
48532413|NCT02119819|101639337|FG002|STARTED|Overall Study||73||
48532414|NCT02119819|101639338|FG003|STARTED|Overall Study||70||
48532415|NCT02119819|101639339|FG004|STARTED|Overall Study||69||
48532416|NCT02119819|101639340|FG005|STARTED|Overall Study||71||
48532417|NCT02119819|101639335|FG000|COMPLETED|Overall Study||57||
48532418|NCT02119819|101639336|FG001|COMPLETED|Overall Study||66||
48532419|NCT02119819|101639337|FG002|COMPLETED|Overall Study||69||
48532420|NCT02119819|101639338|FG003|COMPLETED|Overall Study||63||
48532421|NCT02119819|101639339|FG004|COMPLETED|Overall Study||62||
48532422|NCT02119819|101639340|FG005|COMPLETED|Overall Study||56||
48532423|NCT02119819|101639335|FG000|NOT COMPLETED|Overall Study||9||
48532424|NCT02119819|101639336|FG001|NOT COMPLETED|Overall Study||5||
48532425|NCT02119819|101639337|FG002|NOT COMPLETED|Overall Study||4||
48532426|NCT02119819|101639338|FG003|NOT COMPLETED|Overall Study||7||
48532427|NCT02119819|101639339|FG004|NOT COMPLETED|Overall Study||7||
48532428|NCT02119819|101639340|FG005|NOT COMPLETED|Overall Study||15||
48532429|NCT02563106|101639341|FG000|STARTED|Overall Study||206||
48532430|NCT02563106|101639342|FG001|STARTED|Overall Study||207||
48532431|NCT02563106|101639341|FG000|COMPLETED|Overall Study||172||
48532432|NCT02563106|101639342|FG001|COMPLETED|Overall Study||178||
48532433|NCT02563106|101639341|FG000|NOT COMPLETED|Overall Study||34||
48532434|NCT02563106|101639342|FG001|NOT COMPLETED|Overall Study||29||
48532435|NCT00807248|101639343|FG000|STARTED|Overall Study||71||
48532436|NCT00807248|101639344|FG001|STARTED|Overall Study||140||
48532437|NCT00807248|101639345|FG002|STARTED|Overall Study||139||
48532438|NCT00807248|101639346|FG003|STARTED|Overall Study||140||
48532439|NCT00807248|101639343|FG000|COMPLETED|Overall Study||50||
48532440|NCT00807248|101639344|FG001|COMPLETED|Overall Study||128||
48532441|NCT00807248|101639345|FG002|COMPLETED|Overall Study||121||
48532442|NCT00807248|101639346|FG003|COMPLETED|Overall Study||126||
48532443|NCT00807248|101639343|FG000|NOT COMPLETED|Overall Study||21||
48532444|NCT00807248|101639344|FG001|NOT COMPLETED|Overall Study||12||
48532445|NCT00807248|101639345|FG002|NOT COMPLETED|Overall Study||18||
48532446|NCT00807248|101639346|FG003|NOT COMPLETED|Overall Study||14||
48532447|NCT03768726|101639347|FG000|STARTED|Treatment Phase||10||
48532448|NCT03768726|101639348|FG001|STARTED|Treatment Phase||13||
48532449|NCT03768726|101639347|FG000|COMPLETED|Treatment Phase||2||
48532450|NCT03768726|101639348|FG001|COMPLETED|Treatment Phase||10||
48532451|NCT03768726|101639347|FG000|NOT COMPLETED|Treatment Phase||8||
48532452|NCT03768726|101639348|FG001|NOT COMPLETED|Treatment Phase||3||
48532453|NCT03768726|101639347|FG000|STARTED|Follow-Up||8||
48532454|NCT03768726|101639348|FG001|STARTED|Follow-Up||12||
48532455|NCT03768726|101639347|FG000|Received Treatment|Follow-Up||8||
48532456|NCT03768726|101639348|FG001|Received Treatment|Follow-Up||12||
48532457|NCT03768726|101639347|FG000|COMPLETED|Follow-Up||2||
48532458|NCT03768726|101639348|FG001|COMPLETED|Follow-Up||9||
48532459|NCT03768726|101639347|FG000|NOT COMPLETED|Follow-Up||6||
48532460|NCT03768726|101639348|FG001|NOT COMPLETED|Follow-Up||3||
48532461|NCT00950963|101639349|FG000|STARTED|Overall Study||381||
48532462|NCT00950963|101639350|FG001|STARTED|Overall Study||381||
48532463|NCT00950963|101639349|FG000|COMPLETED|Overall Study||352||
48532464|NCT00950963|101639350|FG001|COMPLETED|Overall Study||357||
48532465|NCT00950963|101639349|FG000|NOT COMPLETED|Overall Study||29||
48532466|NCT00950963|101639350|FG001|NOT COMPLETED|Overall Study||24||
48532467|NCT01772758|101639351|FG000|STARTED|Overall Study||18||
48532468|NCT01772758|101639352|FG001|STARTED|Overall Study||17||
48532469|NCT01772758|101639353|FG002|STARTED|Overall Study||12||
48532470|NCT01772758|101639354|FG003|STARTED|Overall Study||17||
48532471|NCT01772758|101639351|FG000|COMPLETED|Overall Study||18||
48532472|NCT01772758|101639352|FG001|COMPLETED|Overall Study||17||
48532473|NCT01772758|101639353|FG002|COMPLETED|Overall Study||12||
48532474|NCT01772758|101639354|FG003|COMPLETED|Overall Study||17||
48532475|NCT01772758|101639351|FG000|NOT COMPLETED|Overall Study||0||
48532476|NCT01772758|101639352|FG001|NOT COMPLETED|Overall Study||0||
48532477|NCT01772758|101639353|FG002|NOT COMPLETED|Overall Study||0||
48532478|NCT01772758|101639354|FG003|NOT COMPLETED|Overall Study||0||
48532479|NCT01523457|101639355|FG000|STARTED|Overall Study||44||
48532480|NCT01523457|101639356|FG001|STARTED|Overall Study||31||
48532481|NCT01523457|101639355|FG000|COMPLETED|Overall Study||37||
48532482|NCT01523457|101639356|FG001|COMPLETED|Overall Study||29||
48532483|NCT01523457|101639355|FG000|NOT COMPLETED|Overall Study||7||
48532484|NCT01523457|101639356|FG001|NOT COMPLETED|Overall Study||2||
48532485|NCT00128830|101639357|FG000|STARTED|Overall Study||211||
48532486|NCT00128830|101639357|FG000|COMPLETED|Overall Study||139||
48532487|NCT00128830|101639357|FG000|NOT COMPLETED|Overall Study||72||
48532488|NCT03203564|101639358|FG000|STARTED|Overall Study||8||
48532489|NCT03203564|101639359|FG001|STARTED|Overall Study||8||
48532490|NCT03203564|101639360|FG002|STARTED|Overall Study||8||
48532491|NCT03203564|101639361|FG003|STARTED|Overall Study||9||
48532492|NCT03203564|101639358|FG000|COMPLETED|Overall Study||8||
48532493|NCT03203564|101639359|FG001|COMPLETED|Overall Study||8||
48532494|NCT03203564|101639360|FG002|COMPLETED|Overall Study||8||
48532495|NCT03203564|101639361|FG003|COMPLETED|Overall Study||9||
48532496|NCT03203564|101639358|FG000|NOT COMPLETED|Overall Study||0||
48532497|NCT03203564|101639359|FG001|NOT COMPLETED|Overall Study||0||
48532498|NCT03203564|101639360|FG002|NOT COMPLETED|Overall Study||0||
48532499|NCT03203564|101639361|FG003|NOT COMPLETED|Overall Study||0||
48532500|NCT01220297|101639362|FG000|STARTED|Overall Study||3||
48532501|NCT01220297|101639362|FG000|COMPLETED|Overall Study||0||
48532502|NCT01220297|101639362|FG000|NOT COMPLETED|Overall Study||3||
48532503|NCT02163486|101639363|FG000|STARTED|Overall Study||51||
48532504|NCT02163486|101639364|FG001|STARTED|Overall Study||52||
48232831|NCT02009332|100891458|FG004|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0||
48232832|NCT02009332|100891459|FG005|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0||
48232833|NCT02009332|100891454|FG000|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0||
48232834|NCT02009332|100891455|FG001|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0||
48532505|NCT02163486|101639363|FG000|COMPLETED|Overall Study||50||
48532506|NCT02163486|101639364|FG001|COMPLETED|Overall Study||50||
48532507|NCT02163486|101639363|FG000|NOT COMPLETED|Overall Study||1||
48532508|NCT02163486|101639364|FG001|NOT COMPLETED|Overall Study||2||
48532509|NCT02575911|101639365|FG000|STARTED|Overall Study||30||
48532510|NCT02575911|101639365|FG000|COMPLETED|Overall Study||29||
48532511|NCT02575911|101639365|FG000|NOT COMPLETED|Overall Study||1||
48532512|NCT00968799|101639366|FG000|STARTED|Overall Study||6||
48532513|NCT00968799|101639366|FG000|COMPLETED|Overall Study||4||
48532514|NCT00968799|101639366|FG000|NOT COMPLETED|Overall Study||2||
48532515|NCT01749995|101639367|FG000|STARTED|Overall Study||200||
48532516|NCT01749995|101639367|FG000|COMPLETED|Overall Study||196||
48532517|NCT01749995|101639367|FG000|NOT COMPLETED|Overall Study||4||
48532518|NCT01203020|101639368|FG000|STARTED|Overall Study||22||
48532519|NCT01203020|101639368|FG000|COMPLETED|Overall Study||22||
48532520|NCT01203020|101639368|FG000|NOT COMPLETED|Overall Study||0||
48532521|NCT01770392|101639369|FG000|STARTED|Nintedanib||26||
48532522|NCT01770392|101639369|FG000|COMPLETED|Nintedanib||26||
48532523|NCT01770392|101639369|FG000|NOT COMPLETED|Nintedanib||0||
48532524|NCT01770392|101639369|FG000|STARTED|Washout Period of at Least 14 Days||26||
48532525|NCT01770392|101639369|FG000|COMPLETED|Washout Period of at Least 14 Days||25||
48532526|NCT01770392|101639369|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||1||
48532527|NCT01770392|101639369|FG000|STARTED|Nintedanib+ Rifampicin||25||
48532528|NCT01770392|101639369|FG000|COMPLETED|Nintedanib+ Rifampicin||25||
48232835|NCT02009332|100891456|FG002|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0||
48532529|NCT01770392|101639369|FG000|NOT COMPLETED|Nintedanib+ Rifampicin||0||
48232836|NCT02009332|100891457|FG003|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0||
48232837|NCT02009332|100891458|FG004|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||4||
48232838|NCT02009332|100891459|FG005|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0||
48232839|NCT02009332|100891454|FG000|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0||
48232840|NCT02009332|100891455|FG001|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0||
48232841|NCT02009332|100891456|FG002|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0||
48232842|NCT02009332|100891457|FG003|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0||
48232843|NCT02009332|100891458|FG004|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||3||
48232844|NCT02009332|100891459|FG005|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0||
48232845|NCT02009332|100891454|FG000|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0||
48232846|NCT02009332|100891455|FG001|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0||
48232847|NCT02009332|100891456|FG002|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0||
48232848|NCT02009332|100891457|FG003|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0||
48232849|NCT02009332|100891458|FG004|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||1||
48232850|NCT02009332|100891459|FG005|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0||
48532530|NCT04647721|101639370|FG000|STARTED|Overall Study||61||122
48532531|NCT04647721|101639371|FG001|STARTED|Overall Study||60||120
48532532|NCT04647721|101639370|FG000|Safety Population|Overall Study||61|1 subject randomized to Left side Restylane® / RIght side Radiesse® did not receive any treatment and was excluded from the safety population.|122
48532533|NCT04647721|101639371|FG001|Safety Population|Overall Study||59|1 subject randomized to Left side Restylane® / RIght side Radiesse® did not receive any treatment and was excluded from the safety population.|118
48532534|NCT04647721|101639370|FG000|COMPLETED|Overall Study||59||118
48532535|NCT04647721|101639371|FG001|COMPLETED|Overall Study||58||116
48532536|NCT04647721|101639370|FG000|NOT COMPLETED|Overall Study||2||4
48532537|NCT04647721|101639371|FG001|NOT COMPLETED|Overall Study||2||4
48532538|NCT00643565|101639372|FG000|STARTED|Overall Study||80||
48532539|NCT00643565|101639373|FG001|STARTED|Overall Study||74||
48532540|NCT00643565|101639372|FG000|COMPLETED|Overall Study||7||
48532541|NCT00643565|101639373|FG001|COMPLETED|Overall Study||7||
48532542|NCT00643565|101639372|FG000|NOT COMPLETED|Overall Study||73||
48532543|NCT00643565|101639373|FG001|NOT COMPLETED|Overall Study||67||
48532544|NCT01971970|101639374|FG000|STARTED|Baseline Until Week 6||24||
48532545|NCT01971970|101639375|FG001|STARTED|Baseline Until Week 6||21||
48532546|NCT01971970|101639374|FG000|Receiving Standard Therapy|Baseline Until Week 6||23||
48532547|NCT01971970|101639375|FG001|Receiving Standard Therapy|Baseline Until Week 6||21||
48532548|NCT01971970|101639374|FG000|Therapy Escalation|Baseline Until Week 6||1|Therapy escalation defined as either increasing anti-TNF dose or shortening interval between doses|
48532549|NCT01971970|101639375|FG001|Therapy Escalation|Baseline Until Week 6||0|Therapy escalation defined as either increasing anti-TNF dose or shortening interval between doses|
48532550|NCT01971970|101639374|FG000|COMPLETED|Baseline Until Week 6||23||
48532551|NCT01971970|101639375|FG001|COMPLETED|Baseline Until Week 6||21||
48532552|NCT01971970|101639374|FG000|NOT COMPLETED|Baseline Until Week 6||1||
48532553|NCT01971970|101639375|FG001|NOT COMPLETED|Baseline Until Week 6||0||
48232851|NCT02009332|100891454|FG000|STARTED|Phase 2 (Weeks 206-252)||0||
48232852|NCT02009332|100891455|FG001|STARTED|Phase 2 (Weeks 206-252)||0||
48232853|NCT02009332|100891456|FG002|STARTED|Phase 2 (Weeks 206-252)||0||
48232854|NCT02009332|100891457|FG003|STARTED|Phase 2 (Weeks 206-252)||0||
48232855|NCT02009332|100891458|FG004|STARTED|Phase 2 (Weeks 206-252)||0||
48232856|NCT02009332|100891459|FG005|STARTED|Phase 2 (Weeks 206-252)||6||
48232857|NCT02009332|100891454|FG000|COMPLETED|Phase 2 (Weeks 206-252)||0||
48232858|NCT02009332|100891455|FG001|COMPLETED|Phase 2 (Weeks 206-252)||0||
48232859|NCT02009332|100891456|FG002|COMPLETED|Phase 2 (Weeks 206-252)||0||
48232860|NCT02009332|100891457|FG003|COMPLETED|Phase 2 (Weeks 206-252)||0||
48232861|NCT02009332|100891458|FG004|COMPLETED|Phase 2 (Weeks 206-252)||0||
48232862|NCT02009332|100891459|FG005|COMPLETED|Phase 2 (Weeks 206-252)||5||
48232863|NCT02009332|100891454|FG000|NOT COMPLETED|Phase 2 (Weeks 206-252)||0||
48532554|NCT01971970|101639374|FG000|STARTED|Week 6 Until Week 8||23||
48532555|NCT01971970|101639375|FG001|STARTED|Week 6 Until Week 8||21||
48532556|NCT01971970|101639374|FG000|Receiving Standard Therapy|Week 6 Until Week 8||23||
48532557|NCT01971970|101639375|FG001|Receiving Standard Therapy|Week 6 Until Week 8||20||
48532558|NCT01971970|101639374|FG000|COMPLETED|Week 6 Until Week 8||23||
48532559|NCT01971970|101639375|FG001|COMPLETED|Week 6 Until Week 8||20||
48532560|NCT01971970|101639374|FG000|NOT COMPLETED|Week 6 Until Week 8||0||
48532561|NCT01971970|101639375|FG001|NOT COMPLETED|Week 6 Until Week 8||1||
48532562|NCT01971970|101639374|FG000|STARTED|Week 8 Until Week 14||23||
48532563|NCT01971970|101639375|FG001|STARTED|Week 8 Until Week 14||20||
48532564|NCT01971970|101639374|FG000|Receiving Standard Therapy|Week 8 Until Week 14||16||
48232864|NCT02009332|100891455|FG001|NOT COMPLETED|Phase 2 (Weeks 206-252)||0||
48232865|NCT02009332|100891456|FG002|NOT COMPLETED|Phase 2 (Weeks 206-252)||0||
48232866|NCT02009332|100891457|FG003|NOT COMPLETED|Phase 2 (Weeks 206-252)||0||
48232867|NCT02009332|100891458|FG004|NOT COMPLETED|Phase 2 (Weeks 206-252)||0||
48232868|NCT02009332|100891459|FG005|NOT COMPLETED|Phase 2 (Weeks 206-252)||1||
48232869|NCT01607320|100891460|FG000|STARTED|Overall Study||0||
48532565|NCT01971970|101639375|FG001|Receiving Standard Therapy|Week 8 Until Week 14||19||
48532566|NCT01971970|101639374|FG000|Therapy Escalation|Week 8 Until Week 14||7|Therapy escalation defined as either increasing anti-TNF dose or shortening interval between doses|
48532567|NCT01971970|101639375|FG001|Therapy Escalation|Week 8 Until Week 14||1|Therapy escalation defined as either increasing anti-TNF dose or shortening interval between doses|
48532568|NCT01971970|101639374|FG000|COMPLETED|Week 8 Until Week 14||23||
48532569|NCT01971970|101639375|FG001|COMPLETED|Week 8 Until Week 14||20||
48532570|NCT01971970|101639374|FG000|NOT COMPLETED|Week 8 Until Week 14||0||
48532571|NCT01971970|101639375|FG001|NOT COMPLETED|Week 8 Until Week 14||0||
48532572|NCT01971970|101639374|FG000|STARTED|Week 14 Until Week 22||23||
48532573|NCT01971970|101639375|FG001|STARTED|Week 14 Until Week 22||20||
48532574|NCT01971970|101639374|FG000|Receiving Standard Therapy|Week 14 Until Week 22||12||
48532575|NCT01971970|101639375|FG001|Receiving Standard Therapy|Week 14 Until Week 22||16||
48532576|NCT01971970|101639374|FG000|Therapy Escalation|Week 14 Until Week 22||3|Therapy escalation defined as either increasing anti-TNF dose or shortening interval between doses|
48532577|NCT01971970|101639375|FG001|Therapy Escalation|Week 14 Until Week 22||2|Therapy escalation defined as either increasing anti-TNF dose or shortening interval between doses|
48532578|NCT01971970|101639374|FG000|COMPLETED|Week 14 Until Week 22||23||
48532579|NCT01971970|101639375|FG001|COMPLETED|Week 14 Until Week 22||19||
48532580|NCT01971970|101639374|FG000|NOT COMPLETED|Week 14 Until Week 22||0||
48532581|NCT01971970|101639375|FG001|NOT COMPLETED|Week 14 Until Week 22||1||
48532582|NCT01971970|101639374|FG000|STARTED|Week 22 Until Week 52||23||
48532583|NCT01971970|101639375|FG001|STARTED|Week 22 Until Week 52||19||
48532584|NCT01971970|101639374|FG000|Receiving Standard Therapy|Week 22 Until Week 52||5|Therapy escalation defined as either increasing anti-TNF dose or shortening interval between doses|
48532585|NCT01971970|101639375|FG001|Receiving Standard Therapy|Week 22 Until Week 52||9|Therapy escalation defined as either increasing anti-TNF dose or shortening interval between doses|
48232870|NCT01607320|100891461|FG001|STARTED|Overall Study||0||
48232871|NCT01607320|100891460|FG000|COMPLETED|Overall Study||0||
48232872|NCT01607320|100891461|FG001|COMPLETED|Overall Study||0||
48232873|NCT01607320|100891460|FG000|NOT COMPLETED|Overall Study||0||
48232874|NCT01607320|100891461|FG001|NOT COMPLETED|Overall Study||0||
48232875|NCT02428595|100891462|FG000|STARTED|Fitting||137||
48232876|NCT02428595|100891462|FG000|COMPLETED|Fitting||73||
48232877|NCT02428595|100891462|FG000|NOT COMPLETED|Fitting||64||
48232878|NCT02428595|100891462|FG000|STARTED|Treatment||73||
48232879|NCT02428595|100891462|FG000|COMPLETED|Treatment||54||
48232880|NCT02428595|100891462|FG000|NOT COMPLETED|Treatment||19||
48232881|NCT02627794|100891463|FG000|STARTED|Overall Study||3||6
48232882|NCT02627794|100891463|FG000|COMPLETED|Overall Study||3||6
48232883|NCT02627794|100891463|FG000|NOT COMPLETED|Overall Study||0||0
48232884|NCT01990794|100891464|FG000|STARTED|Overall Study||13||
48532586|NCT01971970|101639374|FG000|Therapy Escalation|Week 22 Until Week 52||6|Therapy escalation defined as either increasing anti-TNF dose or shortening interval between doses|
48532587|NCT01971970|101639375|FG001|Therapy Escalation|Week 22 Until Week 52||6|Therapy escalation defined as either increasing anti-TNF dose or shortening interval between doses|
48532588|NCT01971970|101639374|FG000|COMPLETED|Week 22 Until Week 52||15||
48532589|NCT01971970|101639375|FG001|COMPLETED|Week 22 Until Week 52||15||
48532590|NCT01971970|101639374|FG000|NOT COMPLETED|Week 22 Until Week 52||8||
48532591|NCT01971970|101639375|FG001|NOT COMPLETED|Week 22 Until Week 52||4||
48532592|NCT01971970|101639374|FG000|STARTED|Week 52 Until Week 78||15||
48532593|NCT01971970|101639375|FG001|STARTED|Week 52 Until Week 78||15||
48532594|NCT01971970|101639374|FG000|COMPLETED|Week 52 Until Week 78||14||
48532595|NCT01971970|101639375|FG001|COMPLETED|Week 52 Until Week 78||12||
48532596|NCT01971970|101639374|FG000|NOT COMPLETED|Week 52 Until Week 78||1||
48532597|NCT01971970|101639375|FG001|NOT COMPLETED|Week 52 Until Week 78||3||
48532598|NCT01340768|101639376|FG000|STARTED|Overall Study||436||
48532599|NCT01340768|101639377|FG001|STARTED|Overall Study||434||
48232885|NCT01990794|100891464|FG000|One Month Into Study|Overall Study||10||
48532600|NCT01340768|101639376|FG000|COMPLETED|Overall Study||419||
48532601|NCT01340768|101639377|FG001|COMPLETED|Overall Study||429||
48532602|NCT01340768|101639376|FG000|NOT COMPLETED|Overall Study||17||
48532603|NCT01340768|101639377|FG001|NOT COMPLETED|Overall Study||5||
48532604|NCT01316302|101639378|FG000|STARTED|Overall Study||30||
48532605|NCT01316302|101639379|FG001|STARTED|Overall Study||33||
48532606|NCT01316302|101639378|FG000|COMPLETED|Overall Study||20||
48532607|NCT01316302|101639379|FG001|COMPLETED|Overall Study||22||
48532608|NCT01316302|101639378|FG000|NOT COMPLETED|Overall Study||10||
48532609|NCT01316302|101639379|FG001|NOT COMPLETED|Overall Study||11||
48532610|NCT01195103|101639380|FG000|STARTED|Overall Study||6||
48232886|NCT01990794|100891464|FG000|COMPLETED|Overall Study||10||
48232887|NCT01990794|100891464|FG000|NOT COMPLETED|Overall Study||3||
48232888|NCT01754389|100891465|FG000|STARTED|Overall Study||46||
48232889|NCT01754389|100891466|FG001|STARTED|Overall Study||45||
48232890|NCT01754389|100891467|FG002|STARTED|Overall Study||47||
48232891|NCT01754389|100891465|FG000|COMPLETED|Overall Study||46||
48232892|NCT01754389|100891466|FG001|COMPLETED|Overall Study||45||
48232893|NCT01754389|100891467|FG002|COMPLETED|Overall Study||47||
48232894|NCT01754389|100891465|FG000|NOT COMPLETED|Overall Study||0||
48232895|NCT01754389|100891466|FG001|NOT COMPLETED|Overall Study||0||
48232896|NCT01754389|100891467|FG002|NOT COMPLETED|Overall Study||0||
48532611|NCT01195103|101639381|FG001|STARTED|Overall Study||2||
48532612|NCT01195103|101639382|FG002|STARTED|Overall Study||5||
48532613|NCT01195103|101639380|FG000|COMPLETED|Overall Study||5||
48232897|NCT03541369|100891468|FG000|STARTED|Overall Study||1||
48232898|NCT03541369|100891469|FG001|STARTED|Overall Study||1||
48232899|NCT03541369|100891470|FG002|STARTED|Overall Study||1||
48232900|NCT03541369|100891471|FG003|STARTED|Overall Study||1||
48232901|NCT03541369|100891472|FG004|STARTED|Overall Study||5||
48232902|NCT03541369|100891473|FG005|STARTED|Overall Study||4||
48232903|NCT03541369|100891474|FG006|STARTED|Overall Study||2||
48232904|NCT03541369|100891475|FG007|STARTED|Overall Study||3||
48232905|NCT03541369|100891476|FG008|STARTED|Overall Study||4||
48232906|NCT03541369|100891477|FG009|STARTED|Overall Study||4||
48232907|NCT03541369|100891478|FG010|STARTED|Overall Study||4||
48232908|NCT03541369|100891479|FG011|STARTED|Overall Study||4||
48232909|NCT03541369|100891480|FG012|STARTED|Overall Study||7||
48232910|NCT03541369|100891481|FG013|STARTED|Overall Study||3||
48232911|NCT03541369|100891482|FG014|STARTED|Overall Study||7||
48232912|NCT03541369|100891483|FG015|STARTED|Overall Study||3||
48232913|NCT03541369|100891484|FG016|STARTED|Overall Study||6||
48232914|NCT03541369|100891485|FG017|STARTED|Overall Study||4||
48232915|NCT03541369|100891468|FG000|COMPLETED|Overall Study||1||
48232916|NCT03541369|100891469|FG001|COMPLETED|Overall Study||1||
48232917|NCT03541369|100891470|FG002|COMPLETED|Overall Study||1||
48232918|NCT03541369|100891471|FG003|COMPLETED|Overall Study||0||
48232919|NCT03541369|100891472|FG004|COMPLETED|Overall Study||3||
48232920|NCT03541369|100891473|FG005|COMPLETED|Overall Study||1||
48232921|NCT03541369|100891474|FG006|COMPLETED|Overall Study||1||
48232922|NCT03541369|100891475|FG007|COMPLETED|Overall Study||0||
48232923|NCT03541369|100891476|FG008|COMPLETED|Overall Study||0||
48232924|NCT03541369|100891477|FG009|COMPLETED|Overall Study||2||
48232925|NCT03541369|100891478|FG010|COMPLETED|Overall Study||3||
48232926|NCT03541369|100891479|FG011|COMPLETED|Overall Study||3||
48232927|NCT03541369|100891480|FG012|COMPLETED|Overall Study||2||
48232928|NCT03541369|100891481|FG013|COMPLETED|Overall Study||0||
48232929|NCT03541369|100891482|FG014|COMPLETED|Overall Study||3||
48232930|NCT03541369|100891483|FG015|COMPLETED|Overall Study||1||
48232931|NCT03541369|100891484|FG016|COMPLETED|Overall Study||1||
48232932|NCT03541369|100891485|FG017|COMPLETED|Overall Study||0||
48532614|NCT01195103|101639381|FG001|COMPLETED|Overall Study||2||
48532615|NCT01195103|101639382|FG002|COMPLETED|Overall Study||5||
48532616|NCT01195103|101639380|FG000|NOT COMPLETED|Overall Study||1||
48532617|NCT01195103|101639381|FG001|NOT COMPLETED|Overall Study||0||
48532618|NCT01195103|101639382|FG002|NOT COMPLETED|Overall Study||0||
48532619|NCT00988065|101639383|FG000|STARTED|Overall Study||148||
48532620|NCT00988065|101639384|FG001|STARTED|Overall Study||150||
48532621|NCT00988065|101639385|FG002|STARTED|Overall Study||150||
48532622|NCT00988065|101639383|FG000|Received First Randomized Dose|Overall Study||148||
48532623|NCT00988065|101639384|FG001|Received First Randomized Dose|Overall Study||150||
48532624|NCT00988065|101639385|FG002|Received First Randomized Dose|Overall Study||150||
48532625|NCT00988065|101639383|FG000|Received Second Randomized Dose|Overall Study||139||
48532626|NCT00988065|101639384|FG001|Received Second Randomized Dose|Overall Study||135||
48532627|NCT00988065|101639385|FG002|Received Second Randomized Dose|Overall Study||145||
48232933|NCT03541369|100891468|FG000|NOT COMPLETED|Overall Study||0||
48232934|NCT03541369|100891469|FG001|NOT COMPLETED|Overall Study||0||
48232935|NCT03541369|100891470|FG002|NOT COMPLETED|Overall Study||0||
48232936|NCT03541369|100891471|FG003|NOT COMPLETED|Overall Study||1||
48232937|NCT03541369|100891472|FG004|NOT COMPLETED|Overall Study||2||
48232938|NCT03541369|100891473|FG005|NOT COMPLETED|Overall Study||3||
48232939|NCT03541369|100891474|FG006|NOT COMPLETED|Overall Study||1||
48232940|NCT03541369|100891475|FG007|NOT COMPLETED|Overall Study||3||
48232941|NCT03541369|100891476|FG008|NOT COMPLETED|Overall Study||4||
48232942|NCT03541369|100891477|FG009|NOT COMPLETED|Overall Study||2||
48232943|NCT03541369|100891478|FG010|NOT COMPLETED|Overall Study||1||
48232944|NCT03541369|100891479|FG011|NOT COMPLETED|Overall Study||1||
48232945|NCT03541369|100891480|FG012|NOT COMPLETED|Overall Study||5||
48232946|NCT03541369|100891481|FG013|NOT COMPLETED|Overall Study||3||
48232947|NCT03541369|100891482|FG014|NOT COMPLETED|Overall Study||4||
48232948|NCT03541369|100891483|FG015|NOT COMPLETED|Overall Study||2||
48232949|NCT03541369|100891484|FG016|NOT COMPLETED|Overall Study||5||
48232950|NCT03541369|100891485|FG017|NOT COMPLETED|Overall Study||4||
48232951|NCT01019135|100891486|FG000|STARTED|Overall Study||55||
48232952|NCT01019135|100891487|FG001|STARTED|Overall Study||59||
48232953|NCT01019135|100891488|FG002|STARTED|Overall Study||55||
48232954|NCT01019135|100891486|FG000|COMPLETED|Overall Study||35||
48232955|NCT01019135|100891487|FG001|COMPLETED|Overall Study||40||
48232956|NCT01019135|100891488|FG002|COMPLETED|Overall Study||24||
48232957|NCT01019135|100891486|FG000|NOT COMPLETED|Overall Study||20||
48532628|NCT00988065|101639383|FG000|Received Third Randomized Dose|Overall Study||135||
48532629|NCT00988065|101639384|FG001|Received Third Randomized Dose|Overall Study||127||
48532630|NCT00988065|101639385|FG002|Received Third Randomized Dose|Overall Study||135||
48532631|NCT00988065|101639383|FG000|COMPLETED|Overall Study||135||
48232958|NCT01019135|100891487|FG001|NOT COMPLETED|Overall Study||19||
48232959|NCT01019135|100891488|FG002|NOT COMPLETED|Overall Study||31||
48232960|NCT03560206|100891489|FG000|STARTED|Overall Study||158||
48532632|NCT00988065|101639384|FG001|COMPLETED|Overall Study||127||
48532633|NCT00988065|101639385|FG002|COMPLETED|Overall Study||135||
48532634|NCT00988065|101639383|FG000|NOT COMPLETED|Overall Study||13||
48532635|NCT00988065|101639384|FG001|NOT COMPLETED|Overall Study||23||
48532636|NCT00988065|101639385|FG002|NOT COMPLETED|Overall Study||15||
48532637|NCT01103466|101639386|FG000|STARTED|First Period (14 +/- 3 Days)||12||
48532638|NCT01103466|101639387|FG001|STARTED|First Period (14 +/- 3 Days)||12||
48532639|NCT01103466|101639388|FG002|STARTED|First Period (14 +/- 3 Days)||13||
48532640|NCT01103466|101639386|FG000|COMPLETED|First Period (14 +/- 3 Days)||10||
48532641|NCT01103466|101639387|FG001|COMPLETED|First Period (14 +/- 3 Days)||12||
48532642|NCT01103466|101639388|FG002|COMPLETED|First Period (14 +/- 3 Days)||13||
48532643|NCT01103466|101639386|FG000|NOT COMPLETED|First Period (14 +/- 3 Days)||2||
48532644|NCT01103466|101639387|FG001|NOT COMPLETED|First Period (14 +/- 3 Days)||0||
48532645|NCT01103466|101639388|FG002|NOT COMPLETED|First Period (14 +/- 3 Days)||0||
48532646|NCT01103466|101639386|FG000|STARTED|Second Period (14 +/- 3 Days)||15||
48532647|NCT01103466|101639387|FG001|STARTED|Second Period (14 +/- 3 Days)||13||
48532648|NCT01103466|101639388|FG002|STARTED|Second Period (14 +/- 3 Days)||7||
48532649|NCT01103466|101639386|FG000|COMPLETED|Second Period (14 +/- 3 Days)||13||
48532650|NCT01103466|101639387|FG001|COMPLETED|Second Period (14 +/- 3 Days)||11||
48532651|NCT01103466|101639388|FG002|COMPLETED|Second Period (14 +/- 3 Days)||6||
48532652|NCT01103466|101639386|FG000|NOT COMPLETED|Second Period (14 +/- 3 Days)||2||
48532653|NCT01103466|101639387|FG001|NOT COMPLETED|Second Period (14 +/- 3 Days)||2||
48532654|NCT01103466|101639388|FG002|NOT COMPLETED|Second Period (14 +/- 3 Days)||1||
48532655|NCT01103466|101639386|FG000|STARTED|Third Period (14 +/- 3 Days)||8||
48532656|NCT01103466|101639387|FG001|STARTED|Third Period (14 +/- 3 Days)||8||
48080892|NCT02025621|100518885|FG000|STARTED|Overall Study||442||
48080893|NCT02025621|100518886|FG001|STARTED|Overall Study||440||
48080894|NCT02025621|100518885|FG000|COMPLETED|Overall Study||428||
48080895|NCT02025621|100518886|FG001|COMPLETED|Overall Study||421||
48080896|NCT02025621|100518885|FG000|NOT COMPLETED|Overall Study||14||
48080897|NCT02025621|100518886|FG001|NOT COMPLETED|Overall Study||19||
48080898|NCT00729651|100518887|FG000|STARTED|Overall Study||173||
48080899|NCT00729651|100518888|FG001|STARTED|Overall Study||170||
48080900|NCT00729651|100518887|FG000|COMPLETED|Overall Study||154||
48080901|NCT00729651|100518888|FG001|COMPLETED|Overall Study||152||
48080902|NCT00729651|100518887|FG000|NOT COMPLETED|Overall Study||19||
48080903|NCT00729651|100518888|FG001|NOT COMPLETED|Overall Study||18||
48080904|NCT00382252|100518889|FG000|STARTED|Overall Study||89||
48080905|NCT00382252|100518889|FG000|COMPLETED|Overall Study||76||
48080906|NCT00382252|100518889|FG000|NOT COMPLETED|Overall Study||13||
48080907|NCT01307397|100518890|FG000|STARTED|Overall Study||3219||
48080908|NCT01307397|100518890|FG000|COMPLETED|Overall Study||3219||
48080909|NCT01307397|100518890|FG000|NOT COMPLETED|Overall Study||0||
48080910|NCT00357968|100518891|FG000|STARTED|First Maintenance Dose Phase||102||
48080911|NCT00357968|100518892|FG001|STARTED|First Maintenance Dose Phase||99||
48080912|NCT00357968|100518891|FG000|Received Loading Dose|First Maintenance Dose Phase||102||
48080913|NCT00357968|100518892|FG001|Received Loading Dose|First Maintenance Dose Phase||99||
48080914|NCT00357968|100518891|FG000|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||55||
48080915|NCT00357968|100518892|FG001|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||57||
48080916|NCT00357968|100518891|FG000|Started Maintenance Dose|First Maintenance Dose Phase||55||
48080917|NCT00357968|100518892|FG001|Started Maintenance Dose|First Maintenance Dose Phase||55||
48080918|NCT00357968|100518891|FG000|COMPLETED|First Maintenance Dose Phase||54||
48080919|NCT00357968|100518892|FG001|COMPLETED|First Maintenance Dose Phase||55||
48080920|NCT00357968|100518891|FG000|NOT COMPLETED|First Maintenance Dose Phase||48||
48080921|NCT00357968|100518892|FG001|NOT COMPLETED|First Maintenance Dose Phase||44||
48080922|NCT00357968|100518891|FG000|STARTED|Crossover Maintenance Dose Phase||54||
48080923|NCT00357968|100518892|FG001|STARTED|Crossover Maintenance Dose Phase||55||
48080924|NCT00357968|100518891|FG000|COMPLETED|Crossover Maintenance Dose Phase||54||
48080925|NCT00357968|100518892|FG001|COMPLETED|Crossover Maintenance Dose Phase||55||
48080926|NCT00357968|100518891|FG000|NOT COMPLETED|Crossover Maintenance Dose Phase||0||
48080927|NCT00357968|100518892|FG001|NOT COMPLETED|Crossover Maintenance Dose Phase||0||
48080928|NCT02818569|100518893|FG000|STARTED|Overall Study||8|All 15 patients were enrolled in both study arms, undergoing sleep with oral dex and a placebo.|
48080929|NCT02818569|100518894|FG001|STARTED|Overall Study||7|All 15 patients were enrolled in both study arms, undergoing sleep with oral dex and a placebo.|
48080930|NCT02818569|100518893|FG000|COMPLETED|Overall Study||8||
48080931|NCT02818569|100518894|FG001|COMPLETED|Overall Study||7||
48080932|NCT02818569|100518893|FG000|NOT COMPLETED|Overall Study||0||
48080933|NCT02818569|100518894|FG001|NOT COMPLETED|Overall Study||0||
48080934|NCT02615145|100518895|FG000|STARTED|Overall Study||145||
48080935|NCT02615145|100518896|FG001|STARTED|Overall Study||278||
48080936|NCT02615145|100518897|FG002|STARTED|Overall Study||48||
48080937|NCT02615145|100518898|FG003|STARTED|Overall Study||1||
48080938|NCT02615145|100518895|FG000|2 DAA + Ribavirin (RBV)|Overall Study||0|2 direct-acting antivirals (2DAA): paritaprevir/ritonavir - ombitasvir (ABBVIE REGIMEN) plus RBV|
48141203|NCT01260350|100670362|FG000|STARTED|Overall Study||10||
48141204|NCT01260350|100670363|FG001|STARTED|Overall Study||9||
48232961|NCT03560206|100891490|FG001|STARTED|Overall Study||158||
48232962|NCT03560206|100891489|FG000|COMPLETED|Overall Study||108||
48232963|NCT03560206|100891490|FG001|COMPLETED|Overall Study||140||
48232964|NCT03560206|100891489|FG000|NOT COMPLETED|Overall Study||50||
48232965|NCT03560206|100891490|FG001|NOT COMPLETED|Overall Study||18||
48232966|NCT00487240|100891491|FG000|STARTED|Overall Study||195||
48232967|NCT00487240|100891492|FG001|STARTED|Overall Study||192||
48232968|NCT00487240|100891491|FG000|Full Analysis Set (ITT Population)|Overall Study||192||
48232969|NCT00487240|100891492|FG001|Full Analysis Set (ITT Population)|Overall Study||189||
48232970|NCT00487240|100891491|FG000|COMPLETED|Overall Study||164||
48232971|NCT00487240|100891492|FG001|COMPLETED|Overall Study||166||
48232972|NCT00487240|100891491|FG000|NOT COMPLETED|Overall Study||31||
48232973|NCT00487240|100891492|FG001|NOT COMPLETED|Overall Study||26||
48232974|NCT01115309|100891493|FG000|STARTED|Procedure Safety (1-Month)||175||
48532657|NCT01103466|101639388|FG002|STARTED|Third Period (14 +/- 3 Days)||14||
48532658|NCT01103466|101639386|FG000|COMPLETED|Third Period (14 +/- 3 Days)||6||
48532659|NCT01103466|101639387|FG001|COMPLETED|Third Period (14 +/- 3 Days)||8||
48232975|NCT01115309|100891493|FG000|COMPLETED|Procedure Safety (1-Month)||172||
48232976|NCT01115309|100891493|FG000|NOT COMPLETED|Procedure Safety (1-Month)||3||
48232977|NCT01115309|100891493|FG000|STARTED|Long-term Follow-up||50||
48232978|NCT01115309|100891493|FG000|6-Month Follow-up|Long-term Follow-up||46||
48232979|NCT01115309|100891493|FG000|12-Month Follow-up|Long-term Follow-up||44||
48232980|NCT01115309|100891493|FG000|COMPLETED|Long-term Follow-up||44||
48232981|NCT01115309|100891493|FG000|NOT COMPLETED|Long-term Follow-up||6||
48232982|NCT01480258|100891494|FG000|STARTED|Infant Series||656||
48232983|NCT01480258|100891495|FG001|STARTED|Infant Series||659||
48232984|NCT01480258|100891494|FG000|Vaccinated|Infant Series||653||
48232985|NCT01480258|100891495|FG001|Vaccinated|Infant Series||659||
48232986|NCT01480258|100891494|FG000|COMPLETED|Infant Series||649||
48232987|NCT01480258|100891495|FG001|COMPLETED|Infant Series||651||
48232988|NCT01480258|100891494|FG000|NOT COMPLETED|Infant Series||7||
48232989|NCT01480258|100891495|FG001|NOT COMPLETED|Infant Series||8||
48232990|NCT01480258|100891494|FG000|STARTED|Interim Period||649||
48232991|NCT01480258|100891495|FG001|STARTED|Interim Period||651||
48232992|NCT01480258|100891494|FG000|COMPLETED|Interim Period||639||
48232993|NCT01480258|100891495|FG001|COMPLETED|Interim Period||642||
48232994|NCT01480258|100891494|FG000|NOT COMPLETED|Interim Period||10||
48232995|NCT01480258|100891495|FG001|NOT COMPLETED|Interim Period||9||
48532660|NCT01103466|101639388|FG002|COMPLETED|Third Period (14 +/- 3 Days)||13||
48532661|NCT01103466|101639386|FG000|NOT COMPLETED|Third Period (14 +/- 3 Days)||2||
48532662|NCT01103466|101639387|FG001|NOT COMPLETED|Third Period (14 +/- 3 Days)||0||
48532663|NCT01103466|101639388|FG002|NOT COMPLETED|Third Period (14 +/- 3 Days)||1||
48532664|NCT00686075|101639389|FG000|STARTED|Overall Study||79||
48532665|NCT00686075|101639390|FG001|STARTED|Overall Study||81||
48532666|NCT00686075|101639391|FG002|STARTED|Overall Study||80||
48532667|NCT00686075|101639392|FG003|STARTED|Overall Study||80||
48532668|NCT00686075|101639393|FG004|STARTED|Overall Study||40||
48532669|NCT00686075|101639394|FG005|STARTED|Overall Study||40||
48532670|NCT00686075|101639395|FG006|STARTED|Overall Study||82||
48532671|NCT00686075|101639396|FG007|STARTED|Overall Study||78||
48532672|NCT00686075|101639397|FG008|STARTED|Overall Study||81||
48532673|NCT00686075|101639398|FG009|STARTED|Overall Study||79||
48532674|NCT00686075|101639389|FG000|Treated|Overall Study||78||
48532675|NCT00686075|101639390|FG001|Treated|Overall Study||79||
48532676|NCT00686075|101639391|FG002|Treated|Overall Study||80||
48532677|NCT00686075|101639392|FG003|Treated|Overall Study||80||
48532678|NCT00686075|101639393|FG004|Treated|Overall Study||40||
48232996|NCT01480258|100891494|FG000|STARTED|Toddler Dose||639||
48232997|NCT01480258|100891495|FG001|STARTED|Toddler Dose||642||
48232998|NCT01480258|100891494|FG000|COMPLETED|Toddler Dose||639||
48232999|NCT01480258|100891495|FG001|COMPLETED|Toddler Dose||642||
48233000|NCT01480258|100891494|FG000|NOT COMPLETED|Toddler Dose||0||
48233001|NCT01480258|100891495|FG001|NOT COMPLETED|Toddler Dose||0||
48532679|NCT00686075|101639394|FG005|Treated|Overall Study||40||
48532680|NCT00686075|101639395|FG006|Treated|Overall Study||82||
48532681|NCT00686075|101639396|FG007|Treated|Overall Study||77||
48532682|NCT00686075|101639397|FG008|Treated|Overall Study||80||
48532683|NCT00686075|101639398|FG009|Treated|Overall Study||78||
48532684|NCT00686075|101639389|FG000|COMPLETED|Overall Study||71||
48532685|NCT00686075|101639390|FG001|COMPLETED|Overall Study||71||
48532686|NCT00686075|101639391|FG002|COMPLETED|Overall Study||74||
48233002|NCT02196259|100891496|FG000|STARTED|Overall Study||3||
48233003|NCT02196259|100891497|FG001|STARTED|Overall Study||7||
48233004|NCT02196259|100891498|FG002|STARTED|Overall Study||3||
48233005|NCT02196259|100891496|FG000|COMPLETED|Overall Study||3||
48233006|NCT02196259|100891497|FG001|COMPLETED|Overall Study||4||
48233007|NCT02196259|100891498|FG002|COMPLETED|Overall Study||2||
48233008|NCT02196259|100891496|FG000|NOT COMPLETED|Overall Study||0||
48233009|NCT02196259|100891497|FG001|NOT COMPLETED|Overall Study||3||
48233010|NCT02196259|100891498|FG002|NOT COMPLETED|Overall Study||1||
48233011|NCT01299285|100891499|FG000|STARTED|Overall Study||6||
48233012|NCT01299285|100891499|FG000|COMPLETED|Overall Study||6||
48532687|NCT00686075|101639392|FG003|COMPLETED|Overall Study||71||
48532688|NCT00686075|101639393|FG004|COMPLETED|Overall Study||36||
48532689|NCT00686075|101639394|FG005|COMPLETED|Overall Study||37||
48532690|NCT00686075|101639395|FG006|COMPLETED|Overall Study||82||
48233013|NCT01299285|100891499|FG000|NOT COMPLETED|Overall Study||0||
48233014|NCT02058992|100891500|FG000|STARTED|Overall Study||3339||
48233015|NCT02058992|100891500|FG000|COMPLETED|Overall Study||3223||
48233016|NCT02058992|100891500|FG000|NOT COMPLETED|Overall Study||116||
48233017|NCT02066636|100891501|FG000|STARTED|Overall Study||127||
48233018|NCT02066636|100891502|FG001|STARTED|Overall Study||125||
48233019|NCT02066636|100891503|FG002|STARTED|Overall Study||1176||
48233020|NCT02066636|100891501|FG000|COMPLETED|Overall Study||0||
48233021|NCT02066636|100891502|FG001|COMPLETED|Overall Study||0||
48233022|NCT02066636|100891503|FG002|COMPLETED|Overall Study||0||
48233023|NCT02066636|100891501|FG000|NOT COMPLETED|Overall Study||127||
48532691|NCT00686075|101639396|FG007|COMPLETED|Overall Study||76||
48532692|NCT00686075|101639397|FG008|COMPLETED|Overall Study||75||
48532693|NCT00686075|101639398|FG009|COMPLETED|Overall Study||69||
48532694|NCT00686075|101639389|FG000|NOT COMPLETED|Overall Study||8||
48532695|NCT00686075|101639390|FG001|NOT COMPLETED|Overall Study||10||
48532696|NCT00686075|101639391|FG002|NOT COMPLETED|Overall Study||6||
48532697|NCT00686075|101639392|FG003|NOT COMPLETED|Overall Study||9||
48532698|NCT00686075|101639393|FG004|NOT COMPLETED|Overall Study||4||
48532699|NCT00686075|101639394|FG005|NOT COMPLETED|Overall Study||3||
48532700|NCT00686075|101639395|FG006|NOT COMPLETED|Overall Study||0||
48532701|NCT00686075|101639396|FG007|NOT COMPLETED|Overall Study||2||
48532702|NCT00686075|101639397|FG008|NOT COMPLETED|Overall Study||6||
48532703|NCT00686075|101639398|FG009|NOT COMPLETED|Overall Study||10||
48532704|NCT02348723|101639399|FG000|STARTED|Overall Study||338||
48532705|NCT02348723|101639400|FG001|STARTED|Overall Study||338||
48532706|NCT02348723|101639399|FG000|COMPLETED|Overall Study||310||
48532707|NCT02348723|101639400|FG001|COMPLETED|Overall Study||312||
48532708|NCT02348723|101639399|FG000|NOT COMPLETED|Overall Study||28||
48532709|NCT02348723|101639400|FG001|NOT COMPLETED|Overall Study||26||
48532710|NCT00289536|101639401|FG000|STARTED|Period 1||9||
48532711|NCT00289536|101639402|FG001|STARTED|Period 1||8||
48532712|NCT00289536|101639403|FG002|STARTED|Period 1||9||
48532713|NCT00289536|101639401|FG000|COMPLETED|Period 1||9||
48532714|NCT00289536|101639402|FG001|COMPLETED|Period 1||8||
48532715|NCT00289536|101639403|FG002|COMPLETED|Period 1||9||
48532716|NCT00289536|101639401|FG000|NOT COMPLETED|Period 1||0||
48532717|NCT00289536|101639402|FG001|NOT COMPLETED|Period 1||0||
48532718|NCT00289536|101639403|FG002|NOT COMPLETED|Period 1||0||
48532719|NCT00289536|101639401|FG000|STARTED|Period 2||10||
48532720|NCT00289536|101639402|FG001|STARTED|Period 2||9||
48532721|NCT00289536|101639403|FG002|STARTED|Period 2||7||
48532722|NCT00289536|101639401|FG000|COMPLETED|Period 2||10||
48532723|NCT00289536|101639402|FG001|COMPLETED|Period 2||9||
48532724|NCT00289536|101639403|FG002|COMPLETED|Period 2||7||
48532725|NCT00289536|101639401|FG000|NOT COMPLETED|Period 2||0||
48532726|NCT00289536|101639402|FG001|NOT COMPLETED|Period 2||0||
48532727|NCT00289536|101639403|FG002|NOT COMPLETED|Period 2||0||
48532728|NCT00289536|101639401|FG000|STARTED|Period 3||7||
48532729|NCT00289536|101639402|FG001|STARTED|Period 3||9||
48532730|NCT00289536|101639403|FG002|STARTED|Period 3||10||
48532731|NCT00289536|101639401|FG000|COMPLETED|Period 3||7||
48233024|NCT02066636|100891502|FG001|NOT COMPLETED|Overall Study||125||
48233025|NCT02066636|100891503|FG002|NOT COMPLETED|Overall Study||1176||
48233026|NCT01958346|100891504|FG000|STARTED|Overall Study||39||
48233027|NCT01958346|100891505|FG001|STARTED|Overall Study||39||
48233028|NCT01958346|100891504|FG000|COMPLETED|Overall Study||39||
48233029|NCT01958346|100891505|FG001|COMPLETED|Overall Study||39||
48233030|NCT01958346|100891504|FG000|NOT COMPLETED|Overall Study||0||
48233031|NCT01958346|100891505|FG001|NOT COMPLETED|Overall Study||0||
48233032|NCT03447912|100891506|FG000|STARTED|Overall Study||1481||14
48233033|NCT03447912|100891507|FG001|STARTED|Overall Study||1443||14
48233034|NCT03447912|100891506|FG000|Community Members Who Completed the Baseline Survey|Overall Study||732||14
48233035|NCT03447912|100891507|FG001|Community Members Who Completed the Baseline Survey|Overall Study||724||14
48233036|NCT03447912|100891506|FG000|Community Members Who Completed the Follow-up Survey|Overall Study||749||14
48233037|NCT03447912|100891507|FG001|Community Members Who Completed the Follow-up Survey|Overall Study||719||14
48233038|NCT03447912|100891506|FG000|COMPLETED|Overall Study||1481||14
48233039|NCT03447912|100891507|FG001|COMPLETED|Overall Study||1443||14
48233040|NCT03447912|100891506|FG000|NOT COMPLETED|Overall Study||0||0
48233041|NCT03447912|100891507|FG001|NOT COMPLETED|Overall Study||0||0
48233042|NCT00721734|100891508|FG000|STARTED|Overall Study||12||
48532732|NCT00289536|101639402|FG001|COMPLETED|Period 3||9||
48532733|NCT00289536|101639403|FG002|COMPLETED|Period 3||9||
48532734|NCT00289536|101639401|FG000|NOT COMPLETED|Period 3||0||
48532735|NCT00289536|101639402|FG001|NOT COMPLETED|Period 3||0||
48532736|NCT00289536|101639403|FG002|NOT COMPLETED|Period 3||1||
48532737|NCT00276861|101639404|FG000|STARTED|Overall Study||10||
48532738|NCT00276861|101639404|FG000|COMPLETED|Overall Study||10||
48532739|NCT00276861|101639404|FG000|NOT COMPLETED|Overall Study||0||
48532740|NCT01282723|101639405|FG000|STARTED|Overall Study||20||
48532741|NCT01282723|101639405|FG000|COMPLETED|Overall Study||20||
48233043|NCT00721734|100891509|FG001|STARTED|Overall Study||12||
48532742|NCT01282723|101639405|FG000|NOT COMPLETED|Overall Study||0||
48532743|NCT03321630|101639406|FG000|STARTED|Overall Study||24||
48532744|NCT03321630|101639406|FG000|COMPLETED|Overall Study||20||
48532745|NCT03321630|101639406|FG000|NOT COMPLETED|Overall Study||4||
48532746|NCT04594707|101639407|FG000|STARTED|Overall Study||21||
48532747|NCT04594707|101639408|FG001|STARTED|Overall Study||49||
48532748|NCT04594707|101639409|FG002|STARTED|Overall Study||47||
48532749|NCT04594707|101639407|FG000|COMPLETED|Overall Study||0||
48532750|NCT04594707|101639408|FG001|COMPLETED|Overall Study||0||
48532751|NCT04594707|101639409|FG002|COMPLETED|Overall Study||0||
48532752|NCT04594707|101639407|FG000|NOT COMPLETED|Overall Study||21||
48532753|NCT04594707|101639408|FG001|NOT COMPLETED|Overall Study||49||
48532754|NCT04594707|101639409|FG002|NOT COMPLETED|Overall Study||47||
48532755|NCT00369317|101639410|FG000|STARTED|Overall Study||205||
48532756|NCT00369317|101639410|FG000|COMPLETED|Overall Study||185||
48532757|NCT00369317|101639410|FG000|NOT COMPLETED|Overall Study||20||
48532758|NCT01709838|101639411|FG000|STARTED|Overall Study||134||
48532759|NCT01709838|101639411|FG000|COMPLETED|Overall Study||67||
48532760|NCT01709838|101639411|FG000|NOT COMPLETED|Overall Study||67||
48532761|NCT01524679|101639412|FG000|STARTED|Overall Study||112||
48532762|NCT01524679|101639413|FG001|STARTED|Overall Study||58||
48532763|NCT01524679|101639412|FG000|COMPLETED|Overall Study||89||
48532764|NCT01524679|101639413|FG001|COMPLETED|Overall Study||49||
48532765|NCT01524679|101639412|FG000|NOT COMPLETED|Overall Study||23||
48532766|NCT01524679|101639413|FG001|NOT COMPLETED|Overall Study||9||
48532767|NCT01898650|101639414|FG000|STARTED|Overall Study||12||
48532768|NCT01898650|101639414|FG000|Scanned|Overall Study||11||
48532769|NCT01898650|101639414|FG000|COMPLETED|Overall Study||11||
48532770|NCT01898650|101639414|FG000|NOT COMPLETED|Overall Study||1||
48532771|NCT03322930|101639415|FG000|STARTED|Overall Study||20|recruitment of 40 patients|
48532772|NCT03322930|101639416|FG001|STARTED|Overall Study||20|recruitment of 40 patients|
48532773|NCT03322930|101639415|FG000|COMPLETED|Overall Study||20||
48532774|NCT03322930|101639416|FG001|COMPLETED|Overall Study||20||
48532775|NCT03322930|101639415|FG000|NOT COMPLETED|Overall Study||0||
48532776|NCT03322930|101639416|FG001|NOT COMPLETED|Overall Study||0||
48532777|NCT01372774|101639417|FG000|STARTED|Overall Study||96||
48532778|NCT01372774|101639418|FG001|STARTED|Overall Study||98||
48532779|NCT01372774|101639417|FG000|COMPLETED|Overall Study||92||
48532780|NCT01372774|101639418|FG001|COMPLETED|Overall Study||93||
48532781|NCT01372774|101639417|FG000|NOT COMPLETED|Overall Study||4||
48532782|NCT01372774|101639418|FG001|NOT COMPLETED|Overall Study||5||
48532783|NCT01806506|101639419|FG000|STARTED|Overall Study||36||
48532784|NCT01806506|101639420|FG001|STARTED|Overall Study||36||
48532785|NCT01806506|101639419|FG000|1 Month|Overall Study||36||
48532786|NCT01806506|101639420|FG001|1 Month|Overall Study||36||
48532787|NCT01806506|101639419|FG000|3 Months|Overall Study||35||
48532788|NCT01806506|101639420|FG001|3 Months|Overall Study||36||
48532789|NCT01806506|101639419|FG000|6 Months|Overall Study||34||
48532790|NCT01806506|101639420|FG001|6 Months|Overall Study||36||
48532791|NCT01806506|101639419|FG000|9 Months|Overall Study||34||
48532792|NCT01806506|101639420|FG001|9 Months|Overall Study||35||
48532793|NCT01806506|101639419|FG000|COMPLETED|Overall Study||34||
48532794|NCT01806506|101639420|FG001|COMPLETED|Overall Study||35||
48532795|NCT01806506|101639419|FG000|NOT COMPLETED|Overall Study||2||
48532796|NCT01806506|101639420|FG001|NOT COMPLETED|Overall Study||1||
48532797|NCT04620135|101639421|FG000|STARTED|Intent-to-Treat (ITT) Population||122||
48532798|NCT04620135|101639422|FG001|STARTED|Intent-to-Treat (ITT) Population||123||
48532799|NCT04620135|101639421|FG000|COMPLETED|Intent-to-Treat (ITT) Population||118||
48532800|NCT04620135|101639422|FG001|COMPLETED|Intent-to-Treat (ITT) Population||120||
48532801|NCT04620135|101639421|FG000|NOT COMPLETED|Intent-to-Treat (ITT) Population||4||
48532802|NCT04620135|101639422|FG001|NOT COMPLETED|Intent-to-Treat (ITT) Population||3||
48532803|NCT04620135|101639421|FG000|STARTED|Per-Protocol (PP) Population||121||
48532804|NCT04620135|101639422|FG001|STARTED|Per-Protocol (PP) Population||122||
48532805|NCT04620135|101639421|FG000|COMPLETED|Per-Protocol (PP) Population||117||
48532806|NCT04620135|101639422|FG001|COMPLETED|Per-Protocol (PP) Population||119||
48532807|NCT04620135|101639421|FG000|NOT COMPLETED|Per-Protocol (PP) Population||4||
48532808|NCT04620135|101639422|FG001|NOT COMPLETED|Per-Protocol (PP) Population||3||
48532809|NCT04620135|101639421|FG000|STARTED|Safety Population||122||
48532810|NCT04620135|101639422|FG001|STARTED|Safety Population||123||
48532811|NCT04620135|101639421|FG000|COMPLETED|Safety Population||118||
48532812|NCT04620135|101639422|FG001|COMPLETED|Safety Population||120||
48532813|NCT04620135|101639421|FG000|NOT COMPLETED|Safety Population||4||
48532814|NCT04620135|101639422|FG001|NOT COMPLETED|Safety Population||3||
48532815|NCT04620135|101639421|FG000|STARTED|Study Completion||122||
48532816|NCT04620135|101639422|FG001|STARTED|Study Completion||123||
48532817|NCT04620135|101639421|FG000|COMPLETED|Study Completion||118||
48532818|NCT04620135|101639422|FG001|COMPLETED|Study Completion||120||
48532819|NCT04620135|101639421|FG000|NOT COMPLETED|Study Completion||4||
48532820|NCT04620135|101639422|FG001|NOT COMPLETED|Study Completion||3||
48532821|NCT02352779|101639423|FG000|STARTED|Overall Study||37||
48532822|NCT02352779|101639424|FG001|STARTED|Overall Study||36||
48532823|NCT02352779|101639425|FG002|STARTED|Overall Study||35||
48532824|NCT02352779|101639423|FG000|COMPLETED|Overall Study||29||
48532825|NCT02352779|101639424|FG001|COMPLETED|Overall Study||35||
48532826|NCT02352779|101639425|FG002|COMPLETED|Overall Study||33||
48532827|NCT02352779|101639423|FG000|NOT COMPLETED|Overall Study||8||
48532828|NCT02352779|101639424|FG001|NOT COMPLETED|Overall Study||1||
48532829|NCT02352779|101639425|FG002|NOT COMPLETED|Overall Study||2||
48532830|NCT01167257|101639426|FG000|STARTED|Overall Study||31||
48532831|NCT01167257|101639427|FG001|STARTED|Overall Study||31||
48233044|NCT00721734|100891510|FG002|STARTED|Overall Study||10||
48233045|NCT00721734|100891511|FG003|STARTED|Overall Study||8||
48233046|NCT00721734|100891512|FG004|STARTED|Overall Study||8||
48233047|NCT00721734|100891508|FG000|COMPLETED|Overall Study||4||
48233048|NCT00721734|100891509|FG001|COMPLETED|Overall Study||0||
48233049|NCT00721734|100891510|FG002|COMPLETED|Overall Study||2||
48532832|NCT01167257|101639426|FG000|COMPLETED|Overall Study||28||
48532833|NCT01167257|101639427|FG001|COMPLETED|Overall Study||28||
48532834|NCT01167257|101639426|FG000|NOT COMPLETED|Overall Study||3||
48532835|NCT01167257|101639427|FG001|NOT COMPLETED|Overall Study||3||
48532836|NCT02950818|101639428|FG000|STARTED|Overall Study||228||
48532837|NCT02950818|101639429|FG001|STARTED|Overall Study||225||
48532838|NCT02950818|101639428|FG000|COMPLETED|Overall Study||161||
48532839|NCT02950818|101639429|FG001|COMPLETED|Overall Study||201||
48532840|NCT02950818|101639428|FG000|NOT COMPLETED|Overall Study||67||
48532841|NCT02950818|101639429|FG001|NOT COMPLETED|Overall Study||24||
48532842|NCT02067273|101639430|FG000|STARTED|Overall Study||5||
48532843|NCT02067273|101639431|FG001|STARTED|Overall Study||15||
48532844|NCT02067273|101639430|FG000|COMPLETED|Overall Study||5||
48532845|NCT02067273|101639431|FG001|COMPLETED|Overall Study||12||
48532846|NCT02067273|101639430|FG000|NOT COMPLETED|Overall Study||0||
48233050|NCT00721734|100891511|FG003|COMPLETED|Overall Study||2||
48233051|NCT00721734|100891512|FG004|COMPLETED|Overall Study||2||
48233052|NCT00721734|100891508|FG000|NOT COMPLETED|Overall Study||8||
48233053|NCT00721734|100891509|FG001|NOT COMPLETED|Overall Study||12||
48233054|NCT00721734|100891510|FG002|NOT COMPLETED|Overall Study||8||
48233055|NCT00721734|100891511|FG003|NOT COMPLETED|Overall Study||6||
48233056|NCT00721734|100891512|FG004|NOT COMPLETED|Overall Study||6||
48233057|NCT01366976|100891513|FG000|STARTED|Overall Study||30||
48233058|NCT01366976|100891514|FG001|STARTED|Overall Study||30||
48532847|NCT02067273|101639431|FG001|NOT COMPLETED|Overall Study||3||
48532848|NCT02642575|101643114|FG000|STARTED|Overall Study||67||
48532849|NCT02642575|101643114|FG000|COMPLETED|Overall Study||67||
48532850|NCT02642575|101643114|FG000|NOT COMPLETED|Overall Study||0||
48532851|NCT00724048|101643115|FG000|STARTED|Overall Study||58||
48532852|NCT00724048|101643116|FG001|STARTED|Overall Study||56||
48532853|NCT00724048|101643117|FG002|STARTED|Overall Study||55||
48532854|NCT00724048|101643118|FG003|STARTED|Overall Study||58||
48532855|NCT00724048|101643115|FG000|Received at Least 1 Dose of Study Drug|Overall Study||58||
48532856|NCT00724048|101643116|FG001|Received at Least 1 Dose of Study Drug|Overall Study||56||
48532857|NCT00724048|101643117|FG002|Received at Least 1 Dose of Study Drug|Overall Study||55||
48532858|NCT00724048|101643118|FG003|Received at Least 1 Dose of Study Drug|Overall Study||58||
48532859|NCT00724048|101643115|FG000|Full Analysis Set|Overall Study||58|All randomized participants who received at least 1 dose of study drug and had undergone at least 1 clinical assessment post randomization.|
48532860|NCT00724048|101643116|FG001|Full Analysis Set|Overall Study||55|All randomized participants who received at least 1 dose of study drug and had undergone at least 1 clinical assessment post randomization.|
48532861|NCT00724048|101643117|FG002|Full Analysis Set|Overall Study||55|All randomized participants who received at least 1 dose of study drug and had undergone at least 1 clinical assessment post randomization.|
48233059|NCT01366976|100891513|FG000|COMPLETED|Overall Study||30||
48233060|NCT01366976|100891514|FG001|COMPLETED|Overall Study||30||
48233061|NCT01366976|100891513|FG000|NOT COMPLETED|Overall Study||0||
48233062|NCT01366976|100891514|FG001|NOT COMPLETED|Overall Study||0||
48233063|NCT02486939|100891515|FG000|STARTED|Overall Study||225||
48233064|NCT02486939|100891516|FG001|STARTED|Overall Study||134||
48233065|NCT02486939|100891515|FG000|COMPLETED|Overall Study||224||
48233066|NCT02486939|100891516|FG001|COMPLETED|Overall Study||132||
48233067|NCT02486939|100891515|FG000|NOT COMPLETED|Overall Study||1||
48233068|NCT02486939|100891516|FG001|NOT COMPLETED|Overall Study||2||
48233069|NCT01363128|100891517|FG000|STARTED|Overall Study||69||
48233070|NCT01363128|100891517|FG000|COMPLETED|Overall Study||69||
48233071|NCT01363128|100891517|FG000|NOT COMPLETED|Overall Study||0||
48233072|NCT02706483|100891518|FG000|STARTED|Overall Study||2272||
48233073|NCT02706483|100891518|FG000|COMPLETED|Overall Study||1842||
48233074|NCT02706483|100891518|FG000|NOT COMPLETED|Overall Study||430||
48233075|NCT03784898|100891519|FG000|STARTED|Overall Study||13||
48233076|NCT03784898|100891519|FG000|COMPLETED|Overall Study||13||
48233077|NCT03784898|100891519|FG000|NOT COMPLETED|Overall Study||0||
48233078|NCT00696241|100891520|FG000|STARTED|Overall Study||283||
48532862|NCT00724048|101643118|FG003|Full Analysis Set|Overall Study||58|All randomized participants who received at least 1 dose of study drug and had undergone at least 1 clinical assessment post randomization.|
48233079|NCT00696241|100891521|FG001|STARTED|Overall Study||283||
48233080|NCT00696241|100891522|FG002|STARTED|Overall Study||285||
48233081|NCT00696241|100891523|FG003|STARTED|Overall Study||282||
48233082|NCT00696241|100891524|FG004|STARTED|Overall Study||142||
48233083|NCT00696241|100891520|FG000|COMPLETED|Overall Study||259||
48233084|NCT00696241|100891521|FG001|COMPLETED|Overall Study||261||
48532863|NCT00724048|101643115|FG000|COMPLETED|Overall Study||55||
48532864|NCT00724048|101643116|FG001|COMPLETED|Overall Study||51||
48532865|NCT00724048|101643117|FG002|COMPLETED|Overall Study||52||
48532866|NCT00724048|101643118|FG003|COMPLETED|Overall Study||55||
48532867|NCT00724048|101643115|FG000|NOT COMPLETED|Overall Study||3||
48532868|NCT00724048|101643116|FG001|NOT COMPLETED|Overall Study||5||
48532869|NCT00724048|101643117|FG002|NOT COMPLETED|Overall Study||3||
48532870|NCT00724048|101643118|FG003|NOT COMPLETED|Overall Study||3||
48532871|NCT04271735|101643119|FG000|STARTED|Overall Study||17||
48532872|NCT04271735|101643120|FG001|STARTED|Overall Study||12||
48532873|NCT04271735|101643119|FG000|COMPLETED|Overall Study||15||
48532874|NCT04271735|101643120|FG001|COMPLETED|Overall Study||12||
48532875|NCT04271735|101643119|FG000|NOT COMPLETED|Overall Study||2||
48532876|NCT04271735|101643120|FG001|NOT COMPLETED|Overall Study||0||
48532877|NCT02712333|101643121|FG000|STARTED|First Period||34||
48532878|NCT02712333|101643122|FG001|STARTED|First Period||26||
48532879|NCT02712333|101643121|FG000|COMPLETED|First Period||31||
48532880|NCT02712333|101643122|FG001|COMPLETED|First Period||24||
48532881|NCT02712333|101643121|FG000|NOT COMPLETED|First Period||3||
48532882|NCT02712333|101643122|FG001|NOT COMPLETED|First Period||2||
48532883|NCT02712333|101643121|FG000|STARTED|Second Period||31||
48532884|NCT02712333|101643122|FG001|STARTED|Second Period||24||
48532885|NCT02712333|101643121|FG000|COMPLETED|Second Period||31||
48532886|NCT02712333|101643122|FG001|COMPLETED|Second Period||24||
48532887|NCT02712333|101643121|FG000|NOT COMPLETED|Second Period||0||
48532888|NCT02712333|101643122|FG001|NOT COMPLETED|Second Period||0||
48532889|NCT00326963|101643123|FG000|STARTED|Overall Study||140||
48532890|NCT00326963|101643123|FG000|COMPLETED|Overall Study||107||
48532891|NCT00326963|101643123|FG000|NOT COMPLETED|Overall Study||33||
48532892|NCT02181426|101643124|FG000|STARTED|Overall Study||28||
48532893|NCT02181426|101643125|FG001|STARTED|Overall Study||28||
48532894|NCT02181426|101643126|FG002|STARTED|Overall Study||28||
48532895|NCT02181426|101643127|FG003|STARTED|Overall Study||28||
48532896|NCT02181426|101643124|FG000|COMPLETED|Overall Study||28||
48532897|NCT02181426|101643125|FG001|COMPLETED|Overall Study||28||
48532898|NCT02181426|101643126|FG002|COMPLETED|Overall Study||28||
48532899|NCT02181426|101643127|FG003|COMPLETED|Overall Study||28||
48532900|NCT02181426|101643124|FG000|NOT COMPLETED|Overall Study||0||
48532901|NCT02181426|101643125|FG001|NOT COMPLETED|Overall Study||0||
48532902|NCT02181426|101643126|FG002|NOT COMPLETED|Overall Study||0||
48532903|NCT02181426|101643127|FG003|NOT COMPLETED|Overall Study||0||
48532904|NCT03084367|101643128|FG000|STARTED|Overall Study||500||
48532905|NCT03084367|101643128|FG000|Analyzable iFR Pullback Assessment Post Angiographically Successful PCI|Overall Study||467||
48233085|NCT00696241|100891522|FG002|COMPLETED|Overall Study||261||
48233086|NCT00696241|100891523|FG003|COMPLETED|Overall Study||268||
48233087|NCT00696241|100891524|FG004|COMPLETED|Overall Study||130||
48532906|NCT03084367|101643128|FG000|COMPLETED|Overall Study||463|completed means study follow-up at 1 year completed|
48532907|NCT03084367|101643128|FG000|NOT COMPLETED|Overall Study||37||
48532908|NCT04663295|101643129|FG000|STARTED|Run-in Period||65||
48532909|NCT04663295|101643129|FG000|COMPLETED|Run-in Period||62||
48532910|NCT04663295|101643129|FG000|NOT COMPLETED|Run-in Period||3||
48532911|NCT04663295|101643129|FG000|STARTED|Overall Study Period||62||
48532912|NCT04663295|101643129|FG000|COMPLETED|Overall Study Period||60||
48532913|NCT04663295|101643129|FG000|NOT COMPLETED|Overall Study Period||2||
48532914|NCT02605993|101643130|FG000|STARTED|Treatment Period||6||
48532915|NCT02605993|101643131|FG001|STARTED|Treatment Period||6||
48532916|NCT02605993|101643132|FG002|STARTED|Treatment Period||7||
48532917|NCT02605993|101643133|FG003|STARTED|Treatment Period||7||
48532918|NCT02605993|101643130|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||6||
48233088|NCT00696241|100891520|FG000|NOT COMPLETED|Overall Study||24||
48233089|NCT00696241|100891521|FG001|NOT COMPLETED|Overall Study||22||
48233090|NCT00696241|100891522|FG002|NOT COMPLETED|Overall Study||24||
48233091|NCT00696241|100891523|FG003|NOT COMPLETED|Overall Study||14||
48532919|NCT02605993|101643131|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||6||
48532920|NCT02605993|101643132|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||7||
48532921|NCT02605993|101643133|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||7||
48532922|NCT02605993|101643130|FG000|COMPLETED|Treatment Period||6||
48532923|NCT02605993|101643131|FG001|COMPLETED|Treatment Period||6||
48532924|NCT02605993|101643132|FG002|COMPLETED|Treatment Period||7||
48532925|NCT02605993|101643133|FG003|COMPLETED|Treatment Period||7||
48532926|NCT02605993|101643130|FG000|NOT COMPLETED|Treatment Period||0||
48532927|NCT02605993|101643131|FG001|NOT COMPLETED|Treatment Period||0||
48532928|NCT02605993|101643132|FG002|NOT COMPLETED|Treatment Period||0||
48532929|NCT02605993|101643133|FG003|NOT COMPLETED|Treatment Period||0||
48532930|NCT02605993|101643130|FG000|STARTED|Extension Period||6||
48532931|NCT02605993|101643131|FG001|STARTED|Extension Period||6||
48532932|NCT02605993|101643132|FG002|STARTED|Extension Period||7||
48532933|NCT02605993|101643133|FG003|STARTED|Extension Period||7||
48233092|NCT00696241|100891524|FG004|NOT COMPLETED|Overall Study||12||
48233093|NCT04323800|100891525|FG000|STARTED|Overall Study||87||
48532934|NCT02605993|101643130|FG000|Received at Least 1 Dose of Study Drug|Extension Period||6||
48532935|NCT02605993|101643131|FG001|Received at Least 1 Dose of Study Drug|Extension Period||6||
48532936|NCT02605993|101643132|FG002|Received at Least 1 Dose of Study Drug|Extension Period||7||
48532937|NCT02605993|101643133|FG003|Received at Least 1 Dose of Study Drug|Extension Period||7||
48532938|NCT02605993|101643130|FG000|COMPLETED|Extension Period||6|Extension Period ongoing|
48532939|NCT02605993|101643131|FG001|COMPLETED|Extension Period||6|Extension Period ongoing|
48532940|NCT02605993|101643132|FG002|COMPLETED|Extension Period||6|Extension Period ongoing|
48532941|NCT02605993|101643133|FG003|COMPLETED|Extension Period||7|Extension Period ongoing|
48532942|NCT02605993|101643130|FG000|NOT COMPLETED|Extension Period||0||
48532943|NCT02605993|101643131|FG001|NOT COMPLETED|Extension Period||0||
48532944|NCT02605993|101643132|FG002|NOT COMPLETED|Extension Period||1||
48532945|NCT02605993|101643133|FG003|NOT COMPLETED|Extension Period||0||
48532946|NCT03188666|101643134|FG000|STARTED|Period 1 (28 Weeks Double-blind)||24||
48532947|NCT03188666|101643135|FG001|STARTED|Period 1 (28 Weeks Double-blind)||20||
48532948|NCT03188666|101643136|FG002|STARTED|Period 1 (28 Weeks Double-blind)||0||
48532949|NCT03188666|101643137|FG003|STARTED|Period 1 (28 Weeks Double-blind)||0||
48532950|NCT03188666|101643134|FG000|COMPLETED|Period 1 (28 Weeks Double-blind)||24||
48532951|NCT03188666|101643135|FG001|COMPLETED|Period 1 (28 Weeks Double-blind)||19||
48532952|NCT03188666|101643136|FG002|COMPLETED|Period 1 (28 Weeks Double-blind)||0||
48532953|NCT03188666|101643137|FG003|COMPLETED|Period 1 (28 Weeks Double-blind)||0||
48532954|NCT03188666|101643134|FG000|NOT COMPLETED|Period 1 (28 Weeks Double-blind)||0||
48532955|NCT03188666|101643135|FG001|NOT COMPLETED|Period 1 (28 Weeks Double-blind)||1||
48532956|NCT03188666|101643136|FG002|NOT COMPLETED|Period 1 (28 Weeks Double-blind)||0||
48532957|NCT03188666|101643137|FG003|NOT COMPLETED|Period 1 (28 Weeks Double-blind)||0||
48532958|NCT03188666|101643134|FG000|STARTED|Period 2 (28 Weeks Open-label)||0||
48532959|NCT03188666|101643135|FG001|STARTED|Period 2 (28 Weeks Open-label)||0||
48532960|NCT03188666|101643136|FG002|STARTED|Period 2 (28 Weeks Open-label)||24||
48532961|NCT03188666|101643137|FG003|STARTED|Period 2 (28 Weeks Open-label)||19||
48532962|NCT03188666|101643134|FG000|COMPLETED|Period 2 (28 Weeks Open-label)||0||
48532963|NCT03188666|101643135|FG001|COMPLETED|Period 2 (28 Weeks Open-label)||0||
48233094|NCT04323800|100891526|FG001|STARTED|Overall Study||93||
48233095|NCT04323800|100891525|FG000|COMPLETED|Overall Study||81||
48233096|NCT04323800|100891526|FG001|COMPLETED|Overall Study||87||
48233097|NCT04323800|100891525|FG000|NOT COMPLETED|Overall Study||6||
48233098|NCT04323800|100891526|FG001|NOT COMPLETED|Overall Study||6||
48233099|NCT01892007|100891527|FG000|STARTED|Overall Study||27||
48233100|NCT01892007|100891528|FG001|STARTED|Overall Study||30||
48233101|NCT01892007|100891527|FG000|COMPLETED|Overall Study||27||
48233102|NCT01892007|100891528|FG001|COMPLETED|Overall Study||30||
48233103|NCT01892007|100891527|FG000|NOT COMPLETED|Overall Study||0||
48233104|NCT01892007|100891528|FG001|NOT COMPLETED|Overall Study||0||
48233105|NCT00257894|100891529|FG000|STARTED|Overall Study||21||
48233106|NCT00257894|100891530|FG001|STARTED|Overall Study||20||
48233107|NCT00257894|100891529|FG000|COMPLETED|Overall Study||17||
48233108|NCT00257894|100891530|FG001|COMPLETED|Overall Study||15||
48233109|NCT00257894|100891529|FG000|NOT COMPLETED|Overall Study||4||
48233110|NCT00257894|100891530|FG001|NOT COMPLETED|Overall Study||5||
48233111|NCT02704156|100891531|FG000|STARTED|Overall Study||85||
48233112|NCT02704156|100891532|FG001|STARTED|Overall Study||85||
48233113|NCT02704156|100891531|FG000|COMPLETED|Overall Study||85||
48233114|NCT02704156|100891532|FG001|COMPLETED|Overall Study||85||
48233115|NCT02704156|100891531|FG000|NOT COMPLETED|Overall Study||0||
48233116|NCT02704156|100891532|FG001|NOT COMPLETED|Overall Study||0||
48233117|NCT01020435|100891533|FG000|STARTED|Overall Study||24||
48233118|NCT01020435|100891534|FG001|STARTED|Overall Study||27||
48233119|NCT01020435|100891533|FG000|COMPLETED|Overall Study||24||
48233120|NCT01020435|100891534|FG001|COMPLETED|Overall Study||26||
48233121|NCT01020435|100891533|FG000|NOT COMPLETED|Overall Study||0||
48233122|NCT01020435|100891534|FG001|NOT COMPLETED|Overall Study||1||
48233123|NCT01916109|100891535|FG000|STARTED|Overall Study||4||
48233124|NCT01916109|100891535|FG000|COMPLETED|Overall Study||3||
48233125|NCT01916109|100891535|FG000|NOT COMPLETED|Overall Study||1||
48233126|NCT01670526|100891536|FG000|STARTED|Overall Study||49||
48233127|NCT01670526|100891537|FG001|STARTED|Overall Study||45||
48233128|NCT01670526|100891536|FG000|COMPLETED|Overall Study||37||
48233129|NCT01670526|100891537|FG001|COMPLETED|Overall Study||39||
48532964|NCT03188666|101643136|FG002|COMPLETED|Period 2 (28 Weeks Open-label)||24||
48532965|NCT03188666|101643137|FG003|COMPLETED|Period 2 (28 Weeks Open-label)||18||
48532966|NCT03188666|101643134|FG000|NOT COMPLETED|Period 2 (28 Weeks Open-label)||0||
48532967|NCT03188666|101643135|FG001|NOT COMPLETED|Period 2 (28 Weeks Open-label)||0||
48532968|NCT03188666|101643136|FG002|NOT COMPLETED|Period 2 (28 Weeks Open-label)||0||
48532969|NCT03188666|101643137|FG003|NOT COMPLETED|Period 2 (28 Weeks Open-label)||1||
48532970|NCT03188666|101643134|FG000|STARTED|Period 3 (20 Weeks Follow-up)||0||
48532971|NCT03188666|101643135|FG001|STARTED|Period 3 (20 Weeks Follow-up)||0||
48532972|NCT03188666|101643136|FG002|STARTED|Period 3 (20 Weeks Follow-up)||24||
48233130|NCT01670526|100891536|FG000|NOT COMPLETED|Overall Study||12||
48233131|NCT01670526|100891537|FG001|NOT COMPLETED|Overall Study||6||
48233132|NCT02007070|100891538|FG000|STARTED|Overall Study||38||
48233133|NCT02007070|100891538|FG000|COMPLETED|Overall Study||5||
48233134|NCT02007070|100891538|FG000|NOT COMPLETED|Overall Study||33||
48233135|NCT02010684|100891539|FG000|STARTED|Overall Study||39||
48233136|NCT02010684|100891540|FG001|STARTED|Overall Study||82||
48233137|NCT02010684|100891539|FG000|COMPLETED|Overall Study||27||
48233138|NCT02010684|100891540|FG001|COMPLETED|Overall Study||59||
48233139|NCT02010684|100891539|FG000|NOT COMPLETED|Overall Study||12||
48233140|NCT02010684|100891540|FG001|NOT COMPLETED|Overall Study||23||
48233141|NCT00046475|100891541|FG000|STARTED|Screening/Washout Period (Up to 2 Weeks)||140||
48532973|NCT03188666|101643137|FG003|STARTED|Period 3 (20 Weeks Follow-up)||18||
48532974|NCT03188666|101643134|FG000|COMPLETED|Period 3 (20 Weeks Follow-up)||0||
48080939|NCT02615145|100518896|FG001|2 DAA + Ribavirin (RBV)|Overall Study||0|2 direct-acting antivirals (2DAA): paritaprevir/ritonavir - ombitasvir (ABBVIE REGIMEN) plus RBV|
48080940|NCT02615145|100518897|FG002|2 DAA + Ribavirin (RBV)|Overall Study||45|2 direct-acting antivirals (2DAA): paritaprevir/ritonavir - ombitasvir (ABBVIE REGIMEN) plus RBV|
48233142|NCT00046475|100891542|FG001|STARTED|Screening/Washout Period (Up to 2 Weeks)||0||
48233143|NCT00046475|100891543|FG002|STARTED|Screening/Washout Period (Up to 2 Weeks)||0||
48233144|NCT00046475|100891541|FG000|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||136||
48233145|NCT00046475|100891542|FG001|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0||
48233146|NCT00046475|100891543|FG002|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0||
48233147|NCT00046475|100891541|FG000|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||4||
48233148|NCT00046475|100891542|FG001|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0||
48233149|NCT00046475|100891543|FG002|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0||
48233150|NCT00046475|100891541|FG000|STARTED|Titration (1 Week)||136||
48233151|NCT00046475|100891542|FG001|STARTED|Titration (1 Week)||0||
48233152|NCT00046475|100891543|FG002|STARTED|Titration (1 Week)||0||
48233153|NCT00046475|100891541|FG000|COMPLETED|Titration (1 Week)||136||
48233154|NCT00046475|100891542|FG001|COMPLETED|Titration (1 Week)||0||
48233155|NCT00046475|100891543|FG002|COMPLETED|Titration (1 Week)||0||
48233156|NCT00046475|100891541|FG000|NOT COMPLETED|Titration (1 Week)||0||
48233157|NCT00046475|100891542|FG001|NOT COMPLETED|Titration (1 Week)||0||
48233158|NCT00046475|100891543|FG002|NOT COMPLETED|Titration (1 Week)||0||
48233159|NCT00046475|100891541|FG000|STARTED|Treatment Period 1 (Up to 2 Weeks)||0||
48233160|NCT00046475|100891542|FG001|STARTED|Treatment Period 1 (Up to 2 Weeks)||45||
48233161|NCT00046475|100891543|FG002|STARTED|Treatment Period 1 (Up to 2 Weeks)||60||
48233162|NCT00046475|100891541|FG000|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0||
48233163|NCT00046475|100891542|FG001|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||45||
48233164|NCT00046475|100891543|FG002|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||59||
48233165|NCT00046475|100891541|FG000|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0||
48233166|NCT00046475|100891542|FG001|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0||
48233167|NCT00046475|100891543|FG002|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||1||
48233168|NCT00046475|100891541|FG000|STARTED|Treatment Period 2 (Up to 2 Weeks)||0||
48532975|NCT03188666|101643135|FG001|COMPLETED|Period 3 (20 Weeks Follow-up)||0||
48532976|NCT03188666|101643136|FG002|COMPLETED|Period 3 (20 Weeks Follow-up)||21||
48080941|NCT02615145|100518898|FG003|2 DAA + Ribavirin (RBV)|Overall Study||0|2 direct-acting antivirals (2DAA): paritaprevir/ritonavir - ombitasvir (ABBVIE REGIMEN) plus RBV|
48080942|NCT02615145|100518895|FG000|3DAA|Overall Study||5|3 direct-acting antivirals (3DAA): paritaprevir/ritonavir - ombitasvir + dasabuvir (ABBVIE REGIMEN)|
48080943|NCT02615145|100518896|FG001|3DAA|Overall Study||261|3 direct-acting antivirals (3DAA): paritaprevir/ritonavir - ombitasvir + dasabuvir (ABBVIE REGIMEN)|
48080944|NCT02615145|100518897|FG002|3DAA|Overall Study||0|3 direct-acting antivirals (3DAA): paritaprevir/ritonavir - ombitasvir + dasabuvir (ABBVIE REGIMEN)|
48080945|NCT02615145|100518898|FG003|3DAA|Overall Study||0|3 direct-acting antivirals (3DAA): paritaprevir/ritonavir - ombitasvir + dasabuvir (ABBVIE REGIMEN)|
48080946|NCT02615145|100518895|FG000|3DAA + RBV|Overall Study||140|3DAA: paritaprevir/ritonavir - ombitasvir + dasabuvir (ABBVIE REGIMEN) plus RBV|
48080947|NCT02615145|100518896|FG001|3DAA + RBV|Overall Study||17|3DAA: paritaprevir/ritonavir - ombitasvir + dasabuvir (ABBVIE REGIMEN) plus RBV|
48080948|NCT02615145|100518897|FG002|3DAA + RBV|Overall Study||2|3DAA: paritaprevir/ritonavir - ombitasvir + dasabuvir (ABBVIE REGIMEN) plus RBV|
48080949|NCT02615145|100518898|FG003|3DAA + RBV|Overall Study||0|3DAA: paritaprevir/ritonavir - ombitasvir + dasabuvir (ABBVIE REGIMEN) plus RBV|
48080950|NCT02615145|100518895|FG000|COMPLETED|Overall Study||118||
48080951|NCT02615145|100518896|FG001|COMPLETED|Overall Study||263||
48080952|NCT02615145|100518897|FG002|COMPLETED|Overall Study||40||
48080953|NCT02615145|100518898|FG003|COMPLETED|Overall Study||0||
48080954|NCT02615145|100518895|FG000|NOT COMPLETED|Overall Study||27||
48080955|NCT02615145|100518896|FG001|NOT COMPLETED|Overall Study||15||
48080956|NCT02615145|100518897|FG002|NOT COMPLETED|Overall Study||8||
48080957|NCT02615145|100518898|FG003|NOT COMPLETED|Overall Study||1||
48080958|NCT02577510|100521596|FG000|STARTED|Overall Study||21||21
48080959|NCT02577510|100521597|FG001|STARTED|Overall Study||21||21
48080960|NCT02577510|100521596|FG000|COMPLETED|Overall Study||21||21
48080961|NCT02577510|100521597|FG001|COMPLETED|Overall Study||21||21
48080962|NCT02577510|100521596|FG000|NOT COMPLETED|Overall Study||0||0
48080963|NCT02577510|100521597|FG001|NOT COMPLETED|Overall Study||0||0
48080964|NCT03033394|100521598|FG000|STARTED|Completed Sampling||65||
48080965|NCT03033394|100521598|FG000|COMPLETED|Completed Sampling||65||
48080966|NCT03033394|100521598|FG000|NOT COMPLETED|Completed Sampling||0||
48080967|NCT03033394|100521598|FG000|STARTED|Completed Pharmacokinetic Analysis||65||
48233169|NCT00046475|100891542|FG001|STARTED|Treatment Period 2 (Up to 2 Weeks)||45||
48233170|NCT00046475|100891543|FG002|STARTED|Treatment Period 2 (Up to 2 Weeks)||59||
48233171|NCT00046475|100891541|FG000|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0||
48233172|NCT00046475|100891542|FG001|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||44||
48233173|NCT00046475|100891543|FG002|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||59||
48233174|NCT00046475|100891541|FG000|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0||
48233175|NCT00046475|100891542|FG001|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||1||
48532977|NCT03188666|101643137|FG003|COMPLETED|Period 3 (20 Weeks Follow-up)||16||
48532978|NCT03188666|101643134|FG000|NOT COMPLETED|Period 3 (20 Weeks Follow-up)||0||
48532979|NCT03188666|101643135|FG001|NOT COMPLETED|Period 3 (20 Weeks Follow-up)||0||
48532980|NCT03188666|101643136|FG002|NOT COMPLETED|Period 3 (20 Weeks Follow-up)||3||
48532981|NCT03188666|101643137|FG003|NOT COMPLETED|Period 3 (20 Weeks Follow-up)||2||
48532982|NCT03222583|101643138|FG000|STARTED|Overall Study||363||
48532983|NCT03222583|101643139|FG001|STARTED|Overall Study||183||
48532984|NCT03222583|101643138|FG000|Received Double-blind Treatment|Overall Study||362||
48532985|NCT03222583|101643139|FG001|Received Double-blind Treatment|Overall Study||183||
48532986|NCT03222583|101643138|FG000|Completed Double-blind Period|Overall Study||360||
48532987|NCT03222583|101643139|FG001|Completed Double-blind Period|Overall Study||183||
48532988|NCT03222583|101643138|FG000|Entered Open-label Period|Overall Study||0|The open-label treatment period was only applicable for participants assigned to Arm B (placebo).|
48532989|NCT03222583|101643139|FG001|Entered Open-label Period|Overall Study||182|The open-label treatment period was only applicable for participants assigned to Arm B (placebo).|
48532990|NCT03222583|101643138|FG000|Completed Open-label Period|Overall Study||0||
48532991|NCT03222583|101643139|FG001|Completed Open-label Period|Overall Study||181||
48532992|NCT03222583|101643138|FG000|COMPLETED|Overall Study||358||
48532993|NCT03222583|101643139|FG001|COMPLETED|Overall Study||177||
48532994|NCT03222583|101643138|FG000|NOT COMPLETED|Overall Study||5||
48532995|NCT03222583|101643139|FG001|NOT COMPLETED|Overall Study||6||
48532996|NCT04091659|101643140|FG000|STARTED|Overall Study||40||
48532997|NCT04091659|101643141|FG001|STARTED|Overall Study||58||
48532998|NCT04091659|101643140|FG000|COMPLETED|Overall Study||37||
48532999|NCT04091659|101643141|FG001|COMPLETED|Overall Study||57||
48533000|NCT04091659|101643140|FG000|NOT COMPLETED|Overall Study||3||
48533001|NCT04091659|101643141|FG001|NOT COMPLETED|Overall Study||1||
48533002|NCT02766374|101643142|FG000|STARTED|Overall Study||35||
48533003|NCT02766374|101643143|FG001|STARTED|Overall Study||33||
48533004|NCT02766374|101643142|FG000|COMPLETED|Overall Study||25||
48533005|NCT02766374|101643143|FG001|COMPLETED|Overall Study||30||
48533006|NCT02766374|101643142|FG000|NOT COMPLETED|Overall Study||10||
48533007|NCT02766374|101643143|FG001|NOT COMPLETED|Overall Study||3||
48533008|NCT00426361|101643144|FG000|STARTED|Overall Study||248||
48533009|NCT00426361|101643145|FG001|STARTED|Overall Study||255||
48533010|NCT00426361|101643146|FG002|STARTED|Overall Study||248||
48533011|NCT00426361|101643144|FG000|COMPLETED|Overall Study||244||
48533012|NCT00426361|101643145|FG001|COMPLETED|Overall Study||250||
48533013|NCT00426361|101643146|FG002|COMPLETED|Overall Study||243||
48533014|NCT00426361|101643144|FG000|NOT COMPLETED|Overall Study||4||
48533015|NCT00426361|101643145|FG001|NOT COMPLETED|Overall Study||5||
48533016|NCT00426361|101643146|FG002|NOT COMPLETED|Overall Study||5||
48533017|NCT00593736|101643147|FG000|STARTED|Screening Period and Placebo Run-in||0||
48533018|NCT00593736|101643148|FG001|STARTED|Screening Period and Placebo Run-in||0||
48533019|NCT00593736|101643149|FG002|STARTED|Screening Period and Placebo Run-in||0||
48533020|NCT00593736|101643150|FG003|STARTED|Screening Period and Placebo Run-in||549||
48533021|NCT00593736|101643147|FG000|COMPLETED|Screening Period and Placebo Run-in||0||
48533022|NCT00593736|101643148|FG001|COMPLETED|Screening Period and Placebo Run-in||0||
48533023|NCT00593736|101643149|FG002|COMPLETED|Screening Period and Placebo Run-in||0||
48533024|NCT00593736|101643150|FG003|COMPLETED|Screening Period and Placebo Run-in||132||
48533025|NCT00593736|101643147|FG000|NOT COMPLETED|Screening Period and Placebo Run-in||0||
48533026|NCT00593736|101643148|FG001|NOT COMPLETED|Screening Period and Placebo Run-in||0||
48233176|NCT00046475|100891543|FG002|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0||
48233177|NCT03132571|100891544|FG000|STARTED|Overall Study||3||
48533027|NCT00593736|101643149|FG002|NOT COMPLETED|Screening Period and Placebo Run-in||0||
48533028|NCT00593736|101643150|FG003|NOT COMPLETED|Screening Period and Placebo Run-in||417||
48533029|NCT00593736|101643147|FG000|STARTED|Treatment Period and Placebo Run-out||32||
48533030|NCT00593736|101643148|FG001|STARTED|Treatment Period and Placebo Run-out||33||
48533031|NCT00593736|101643149|FG002|STARTED|Treatment Period and Placebo Run-out||35||
48533032|NCT00593736|101643150|FG003|STARTED|Treatment Period and Placebo Run-out||32||
48533033|NCT00593736|101643147|FG000|COMPLETED|Treatment Period and Placebo Run-out||29||
48533034|NCT00593736|101643148|FG001|COMPLETED|Treatment Period and Placebo Run-out||31||
48533035|NCT00593736|101643149|FG002|COMPLETED|Treatment Period and Placebo Run-out||30||
48533036|NCT00593736|101643150|FG003|COMPLETED|Treatment Period and Placebo Run-out||28||
48533037|NCT00593736|101643147|FG000|NOT COMPLETED|Treatment Period and Placebo Run-out||3||
48533038|NCT00593736|101643148|FG001|NOT COMPLETED|Treatment Period and Placebo Run-out||2||
48533039|NCT00593736|101643149|FG002|NOT COMPLETED|Treatment Period and Placebo Run-out||5||
48533040|NCT00593736|101643150|FG003|NOT COMPLETED|Treatment Period and Placebo Run-out||4||
48533041|NCT00912925|101643151|FG000|STARTED|Overall Study||23||
48233178|NCT03132571|100891545|FG001|STARTED|Overall Study||2||
48533042|NCT00912925|101643152|FG001|STARTED|Overall Study||22||
48533043|NCT00912925|101643151|FG000|COMPLETED|Overall Study||23||
48533044|NCT00912925|101643152|FG001|COMPLETED|Overall Study||22||
48533045|NCT00912925|101643151|FG000|NOT COMPLETED|Overall Study||0||
48533046|NCT00912925|101643152|FG001|NOT COMPLETED|Overall Study||0||
48533047|NCT02011386|101643153|FG000|STARTED|Overall Study||53||
48533048|NCT02011386|101643153|FG000|COMPLETED|Overall Study||48||
48533049|NCT02011386|101643153|FG000|NOT COMPLETED|Overall Study||5||
48533050|NCT01030653|101643154|FG000|STARTED|Loading Dose & First Maintenance Regimen||4||
48533051|NCT01030653|101643155|FG001|STARTED|Loading Dose & First Maintenance Regimen||4||
48533052|NCT01030653|101643154|FG000|COMPLETED|Loading Dose & First Maintenance Regimen||4||
48533053|NCT01030653|101643155|FG001|COMPLETED|Loading Dose & First Maintenance Regimen||4||
48533054|NCT01030653|101643154|FG000|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0||
48533055|NCT01030653|101643155|FG001|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0||
48533056|NCT01030653|101643154|FG000|STARTED|7-Day Washout Period||4||
48533057|NCT01030653|101643155|FG001|STARTED|7-Day Washout Period||4||
48533058|NCT01030653|101643154|FG000|COMPLETED|7-Day Washout Period||4||
48533059|NCT01030653|101643155|FG001|COMPLETED|7-Day Washout Period||4||
48080968|NCT03033394|100521598|FG000|COMPLETED|Completed Pharmacokinetic Analysis||59||
48080969|NCT03033394|100521598|FG000|NOT COMPLETED|Completed Pharmacokinetic Analysis||6||
48080970|NCT03033394|100521598|FG000|STARTED|Completed Final Analysis||59||
48080971|NCT03033394|100521598|FG000|COMPLETED|Completed Final Analysis||58||
48080972|NCT03033394|100521598|FG000|NOT COMPLETED|Completed Final Analysis||1||
48080973|NCT02732119|100521599|FG000|STARTED|Phase I||8||
48080974|NCT02732119|100521600|FG001|STARTED|Phase I||10||
48080975|NCT02732119|100521601|FG002|STARTED|Phase I||7||
48080976|NCT02732119|100521602|FG003|STARTED|Phase I||0||
48080977|NCT02732119|100521603|FG004|STARTED|Phase I||0||
48533060|NCT01030653|101643154|FG000|NOT COMPLETED|7-Day Washout Period||0||
48533061|NCT01030653|101643155|FG001|NOT COMPLETED|7-Day Washout Period||0||
48533062|NCT01030653|101643154|FG000|STARTED|Loading Dose & 2nd Maintenance Regimen||4||
48533063|NCT01030653|101643155|FG001|STARTED|Loading Dose & 2nd Maintenance Regimen||4||
48533064|NCT01030653|101643154|FG000|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4||
48533065|NCT01030653|101643155|FG001|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4||
48533066|NCT01030653|101643154|FG000|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0||
48533067|NCT01030653|101643155|FG001|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0||
48533068|NCT04146116|101643156|FG000|STARTED|Overall Study||65||
48533069|NCT04146116|101643156|FG000|COMPLETED|Overall Study||51||
48533070|NCT04146116|101643156|FG000|NOT COMPLETED|Overall Study||14||
48533071|NCT04709835|101643157|FG000|STARTED|Overall Study||40||
48533072|NCT04709835|101643158|FG001|STARTED|Overall Study||30||
48533073|NCT04709835|101643159|FG002|STARTED|Overall Study||30||
48533074|NCT04709835|101643157|FG000|COMPLETED|Overall Study||40||
48533075|NCT04709835|101643158|FG001|COMPLETED|Overall Study||29||
48533076|NCT04709835|101643159|FG002|COMPLETED|Overall Study||30||
48533077|NCT04709835|101643157|FG000|NOT COMPLETED|Overall Study||0||
48533078|NCT04709835|101643158|FG001|NOT COMPLETED|Overall Study||1||
48533079|NCT04709835|101643159|FG002|NOT COMPLETED|Overall Study||0||
48533080|NCT00418301|101643160|FG000|STARTED|Overall Study||15||
48533081|NCT00418301|101643160|FG000|COMPLETED|Overall Study||12||
48533082|NCT00418301|101643160|FG000|NOT COMPLETED|Overall Study||3||
48533083|NCT03801265|101643161|FG000|STARTED|Overall Study||23||
48533084|NCT03801265|101643162|FG001|STARTED|Overall Study||23||
48533085|NCT03801265|101643161|FG000|COMPLETED|Overall Study||23||
48533086|NCT03801265|101643162|FG001|COMPLETED|Overall Study||23||
48533087|NCT03801265|101643161|FG000|NOT COMPLETED|Overall Study||0||
48533088|NCT03801265|101643162|FG001|NOT COMPLETED|Overall Study||0||
48533089|NCT04729309|101643163|FG000|STARTED|Period 1||16||
48533090|NCT04729309|101643164|FG001|STARTED|Period 1||6||
48533091|NCT04729309|101643163|FG000|COMPLETED|Period 1||12||
48533092|NCT04729309|101643164|FG001|COMPLETED|Period 1||6||
48533093|NCT04729309|101643163|FG000|NOT COMPLETED|Period 1||4||
48533094|NCT04729309|101643164|FG001|NOT COMPLETED|Period 1||0||
48533095|NCT04729309|101643163|FG000|STARTED|Period 2||12||
48533096|NCT04729309|101643164|FG001|STARTED|Period 2||0||
48533097|NCT04729309|101643163|FG000|COMPLETED|Period 2||12||
48533098|NCT04729309|101643164|FG001|COMPLETED|Period 2||0||
48533099|NCT04729309|101643163|FG000|NOT COMPLETED|Period 2||0||
48533100|NCT04729309|101643164|FG001|NOT COMPLETED|Period 2||0||
48533101|NCT04669691|101643165|FG000|STARTED|Overall Study||69||
48533102|NCT04669691|101643166|FG001|STARTED|Overall Study||72||
48533103|NCT04669691|101643167|FG002|STARTED|Overall Study||70||
48533104|NCT04669691|101643168|FG003|STARTED|Overall Study||70||
48533105|NCT04669691|101643169|FG004|STARTED|Overall Study||69||
48533106|NCT04669691|101643170|FG005|STARTED|Overall Study||70||
48533107|NCT04669691|101643165|FG000|COMPLETED|Overall Study||69||
48533108|NCT04669691|101643166|FG001|COMPLETED|Overall Study||71||
48533109|NCT04669691|101643167|FG002|COMPLETED|Overall Study||70||
48080978|NCT02732119|100521599|FG000|COMPLETED|Phase I||0||
48533110|NCT04669691|101643168|FG003|COMPLETED|Overall Study||70||
48080979|NCT02732119|100521600|FG001|COMPLETED|Phase I||0||
48080980|NCT02732119|100521601|FG002|COMPLETED|Phase I||0||
48080981|NCT02732119|100521602|FG003|COMPLETED|Phase I||0||
48533111|NCT04669691|101643169|FG004|COMPLETED|Overall Study||69||
48533112|NCT04669691|101643170|FG005|COMPLETED|Overall Study||70||
48533113|NCT04669691|101643165|FG000|NOT COMPLETED|Overall Study||0||
48533114|NCT04669691|101643166|FG001|NOT COMPLETED|Overall Study||1||
48533115|NCT04669691|101643167|FG002|NOT COMPLETED|Overall Study||0||
48533116|NCT04669691|101643168|FG003|NOT COMPLETED|Overall Study||0||
48533117|NCT04669691|101643169|FG004|NOT COMPLETED|Overall Study||0||
48533118|NCT04669691|101643170|FG005|NOT COMPLETED|Overall Study||0||
48533119|NCT03623386|101643171|FG000|STARTED|Overall Study||26||
48533120|NCT03623386|101643172|FG001|STARTED|Overall Study||28||
48533121|NCT03623386|101643173|FG002|STARTED|Overall Study||9||
48533122|NCT03623386|101643171|FG000|COMPLETED|Overall Study||22||
48533123|NCT03623386|101643172|FG001|COMPLETED|Overall Study||22||
48533124|NCT03623386|101643173|FG002|COMPLETED|Overall Study||9||
48533125|NCT03623386|101643171|FG000|NOT COMPLETED|Overall Study||4||
48533126|NCT03623386|101643172|FG001|NOT COMPLETED|Overall Study||6||
48533127|NCT03623386|101643173|FG002|NOT COMPLETED|Overall Study||0||
48533128|NCT00895414|101643174|FG000|STARTED|First Intervention (14 Days)||9||
48533129|NCT00895414|101643175|FG001|STARTED|First Intervention (14 Days)||10||
48533130|NCT00895414|101643174|FG000|COMPLETED|First Intervention (14 Days)||8||
48533131|NCT00895414|101643175|FG001|COMPLETED|First Intervention (14 Days)||9||
48533132|NCT00895414|101643174|FG000|NOT COMPLETED|First Intervention (14 Days)||1||
48533133|NCT00895414|101643175|FG001|NOT COMPLETED|First Intervention (14 Days)||1||
48533134|NCT00895414|101643174|FG000|STARTED|Second Intervention (14 Days)||8||
48533135|NCT00895414|101643175|FG001|STARTED|Second Intervention (14 Days)||9||
48533136|NCT00895414|101643174|FG000|COMPLETED|Second Intervention (14 Days)||8||
48533137|NCT00895414|101643175|FG001|COMPLETED|Second Intervention (14 Days)||9||
48533138|NCT00895414|101643174|FG000|NOT COMPLETED|Second Intervention (14 Days)||0||
48533139|NCT00895414|101643175|FG001|NOT COMPLETED|Second Intervention (14 Days)||0||
48533140|NCT04625725|101643176|FG000|STARTED|Overall Study||3460||
48533141|NCT04625725|101643177|FG001|STARTED|Overall Study||1737||
48533142|NCT04625725|101643176|FG000|Dosed (Full Analysis Set)|Overall Study||3460||
48233179|NCT03132571|100891544|FG000|COMPLETED|Overall Study||3||
48233180|NCT03132571|100891545|FG001|COMPLETED|Overall Study||2||
48233181|NCT03132571|100891544|FG000|NOT COMPLETED|Overall Study||0||
48233182|NCT03132571|100891545|FG001|NOT COMPLETED|Overall Study||0||
48233183|NCT00722865|100891546|FG000|STARTED|Overall Study||25||
48233184|NCT00722865|100891546|FG000|COMPLETED|Overall Study||23||
48233185|NCT00722865|100891546|FG000|NOT COMPLETED|Overall Study||2||
48533143|NCT04625725|101643177|FG001|Dosed (Full Analysis Set)|Overall Study||1737||
48533144|NCT04625725|101643176|FG000|COMPLETED|Overall Study||2490||
48533145|NCT04625725|101643177|FG001|COMPLETED|Overall Study||1179||
48533146|NCT04625725|101643176|FG000|NOT COMPLETED|Overall Study||970||
48533147|NCT04625725|101643177|FG001|NOT COMPLETED|Overall Study||558||
48533148|NCT00373698|101643178|FG000|STARTED|Overall Study||96||
48533149|NCT00373698|101643179|FG001|STARTED|Overall Study||99||
48533150|NCT00373698|101643178|FG000|COMPLETED|Overall Study||85||
48533151|NCT00373698|101643179|FG001|COMPLETED|Overall Study||99||
48533152|NCT00373698|101643178|FG000|NOT COMPLETED|Overall Study||11||
48533153|NCT00373698|101643179|FG001|NOT COMPLETED|Overall Study||0||
48533154|NCT01214915|101643180|FG000|STARTED|Overall Study||53||
48533155|NCT01214915|101643180|FG000|COMPLETED|Overall Study||42||
48533156|NCT01214915|101643180|FG000|NOT COMPLETED|Overall Study||11||
48533157|NCT00271154|101643181|FG000|STARTED|Overall Study||191||
48533158|NCT00271154|101643182|FG001|STARTED|Overall Study||419||
48533159|NCT00271154|101643181|FG000|COMPLETED|Overall Study||191||
48533160|NCT00271154|101643182|FG001|COMPLETED|Overall Study||419||
48533161|NCT00271154|101643181|FG000|NOT COMPLETED|Overall Study||0||
48533162|NCT00271154|101643182|FG001|NOT COMPLETED|Overall Study||0||
48533163|NCT03735316|101643183|FG000|STARTED|Overall Study||4||
48533164|NCT03735316|101643184|FG001|STARTED|Overall Study||4||
48533165|NCT03735316|101643183|FG000|COMPLETED|Overall Study||4||
48533166|NCT03735316|101643184|FG001|COMPLETED|Overall Study||4||
48533167|NCT03735316|101643183|FG000|NOT COMPLETED|Overall Study||0||
48533168|NCT03735316|101643184|FG001|NOT COMPLETED|Overall Study||0||
48233186|NCT00828178|100891547|FG000|STARTED|Overall Study||42||
48233187|NCT00828178|100891548|FG001|STARTED|Overall Study||45||
48233188|NCT00828178|100891547|FG000|COMPLETED|Overall Study||42||
48233189|NCT00828178|100891548|FG001|COMPLETED|Overall Study||43||
48233190|NCT00828178|100891547|FG000|NOT COMPLETED|Overall Study||0||
48233191|NCT00828178|100891548|FG001|NOT COMPLETED|Overall Study||2||
48533169|NCT02629354|101643185|FG000|STARTED|Period 1||18||
48533170|NCT02629354|101643186|FG001|STARTED|Period 1||18||
48533171|NCT02629354|101643185|FG000|COMPLETED|Period 1||18||
48533172|NCT02629354|101643186|FG001|COMPLETED|Period 1||18||
48533173|NCT02629354|101643185|FG000|NOT COMPLETED|Period 1||0||
48533174|NCT02629354|101643186|FG001|NOT COMPLETED|Period 1||0||
48533175|NCT02629354|101643185|FG000|STARTED|Washout Period||18||
48533176|NCT02629354|101643186|FG001|STARTED|Washout Period||18||
48533177|NCT02629354|101643185|FG000|COMPLETED|Washout Period||18||
48533178|NCT02629354|101643186|FG001|COMPLETED|Washout Period||18||
48533179|NCT02629354|101643185|FG000|NOT COMPLETED|Washout Period||0||
48533180|NCT02629354|101643186|FG001|NOT COMPLETED|Washout Period||0||
48533181|NCT02629354|101643185|FG000|STARTED|Period 2||18||
48533182|NCT02629354|101643186|FG001|STARTED|Period 2||18||
48233192|NCT03971539|100891549|FG000|STARTED|Overall Study||6||
48233193|NCT03971539|100891550|FG001|STARTED|Overall Study||7||
48233194|NCT03971539|100891551|FG002|STARTED|Overall Study||8||
48233195|NCT03971539|100891552|FG003|STARTED|Overall Study||8||
48233196|NCT03971539|100891553|FG004|STARTED|Overall Study||8||
48233197|NCT03971539|100891554|FG005|STARTED|Overall Study||7||
48233198|NCT03971539|100891555|FG006|STARTED|Overall Study||8||
48233199|NCT03971539|100891556|FG007|STARTED|Overall Study||8||
48233200|NCT03971539|100891557|FG008|STARTED|Overall Study||8||
48233201|NCT03971539|100891549|FG000|COMPLETED|Overall Study||6||
48233202|NCT03971539|100891550|FG001|COMPLETED|Overall Study||7||
48233203|NCT03971539|100891551|FG002|COMPLETED|Overall Study||8||
48233204|NCT03971539|100891552|FG003|COMPLETED|Overall Study||8||
48233205|NCT03971539|100891553|FG004|COMPLETED|Overall Study||8||
48233206|NCT03971539|100891554|FG005|COMPLETED|Overall Study||7||
48233207|NCT03971539|100891555|FG006|COMPLETED|Overall Study||8||
48233208|NCT03971539|100891556|FG007|COMPLETED|Overall Study||8||
48233209|NCT03971539|100891557|FG008|COMPLETED|Overall Study||8||
48233210|NCT03971539|100891549|FG000|NOT COMPLETED|Overall Study||0||
48233211|NCT03971539|100891550|FG001|NOT COMPLETED|Overall Study||0||
48233212|NCT03971539|100891551|FG002|NOT COMPLETED|Overall Study||0||
48233213|NCT03971539|100891552|FG003|NOT COMPLETED|Overall Study||0||
48233214|NCT03971539|100891553|FG004|NOT COMPLETED|Overall Study||0||
48533183|NCT02629354|101643185|FG000|COMPLETED|Period 2||18||
48533184|NCT02629354|101643186|FG001|COMPLETED|Period 2||18||
48533185|NCT02629354|101643185|FG000|NOT COMPLETED|Period 2||0||
48533186|NCT02629354|101643186|FG001|NOT COMPLETED|Period 2||0||
48533187|NCT02629354|101643185|FG000|STARTED|Follow-up||18||
48533188|NCT02629354|101643186|FG001|STARTED|Follow-up||18||
48533189|NCT02629354|101643185|FG000|COMPLETED|Follow-up||18||
48533190|NCT02629354|101643186|FG001|COMPLETED|Follow-up||18||
48533191|NCT02629354|101643185|FG000|NOT COMPLETED|Follow-up||0||
48533192|NCT02629354|101643186|FG001|NOT COMPLETED|Follow-up||0||
48533193|NCT00399880|101643187|FG000|STARTED|Overall Study||65||
48533194|NCT00399880|101643188|FG001|STARTED|Overall Study||65||
48533195|NCT00399880|101643187|FG000|COMPLETED|Overall Study||65||
48533196|NCT00399880|101643188|FG001|COMPLETED|Overall Study||65||
48533197|NCT00399880|101643187|FG000|NOT COMPLETED|Overall Study||0||
48533198|NCT00399880|101643188|FG001|NOT COMPLETED|Overall Study||0||
48533199|NCT02338193|101643189|FG000|STARTED|Overall Study||20||
48533200|NCT02338193|101643190|FG001|STARTED|Overall Study||21||
48233215|NCT03971539|100891554|FG005|NOT COMPLETED|Overall Study||0||
48233216|NCT03971539|100891555|FG006|NOT COMPLETED|Overall Study||0||
48533201|NCT02338193|101643191|FG002|STARTED|Overall Study||25||
48533202|NCT02338193|101643189|FG000|COMPLETED|Overall Study||17||
48533203|NCT02338193|101643190|FG001|COMPLETED|Overall Study||17||
48533204|NCT02338193|101643191|FG002|COMPLETED|Overall Study||15||
48533205|NCT02338193|101643189|FG000|NOT COMPLETED|Overall Study||3||
48533206|NCT02338193|101643190|FG001|NOT COMPLETED|Overall Study||4||
48533207|NCT02338193|101643191|FG002|NOT COMPLETED|Overall Study||10||
48533208|NCT01315132|101643192|FG000|STARTED|Overall Study||47||
48533209|NCT01315132|101643192|FG000|COMPLETED|Overall Study||46||
48533210|NCT01315132|101643192|FG000|NOT COMPLETED|Overall Study||1||
48533211|NCT04645966|101643193|FG000|STARTED|Vaccination Phase||23||
48533212|NCT04645966|101643194|FG001|STARTED|Vaccination Phase||25||
48533213|NCT04645966|101643195|FG002|STARTED|Vaccination Phase||36||
48533214|NCT04645966|101643196|FG003|STARTED|Vaccination Phase||16||
48533215|NCT04645966|101643197|FG004|STARTED|Vaccination Phase||53||
48533216|NCT04645966|101643198|FG005|STARTED|Vaccination Phase||50||
48533217|NCT04645966|101643199|FG006|STARTED|Vaccination Phase||55||
48533218|NCT04645966|101643200|FG007|STARTED|Vaccination Phase||55||
48533219|NCT04645966|101643201|FG008|STARTED|Vaccination Phase||12||
48533220|NCT04645966|101643193|FG000|Primary Vaccination 1|Vaccination Phase||23||
48533221|NCT04645966|101643194|FG001|Primary Vaccination 1|Vaccination Phase||25||
48533222|NCT04645966|101643195|FG002|Primary Vaccination 1|Vaccination Phase||39||
48533223|NCT04645966|101643196|FG003|Primary Vaccination 1|Vaccination Phase||16||
48233217|NCT03971539|100891556|FG007|NOT COMPLETED|Overall Study||0||
48233218|NCT03971539|100891557|FG008|NOT COMPLETED|Overall Study||0||
48233219|NCT02070276|100891558|FG000|STARTED|Overall Study||149||
48233220|NCT02070276|100891559|FG001|STARTED|Overall Study||132||
48533224|NCT04645966|101643197|FG004|Primary Vaccination 1|Vaccination Phase||50||
48533225|NCT04645966|101643198|FG005|Primary Vaccination 1|Vaccination Phase||50||
48533226|NCT04645966|101643199|FG006|Primary Vaccination 1|Vaccination Phase||55||
48233221|NCT02070276|100891560|FG002|STARTED|Overall Study||148||
48233222|NCT02070276|100891558|FG000|COMPLETED|Overall Study||149||
48233223|NCT02070276|100891559|FG001|COMPLETED|Overall Study||132||
48233224|NCT02070276|100891560|FG002|COMPLETED|Overall Study||148||
48233225|NCT02070276|100891558|FG000|NOT COMPLETED|Overall Study||0||
48233226|NCT02070276|100891559|FG001|NOT COMPLETED|Overall Study||0||
48533227|NCT04645966|101643200|FG007|Primary Vaccination 1|Vaccination Phase||55||
48533228|NCT04645966|101643201|FG008|Primary Vaccination 1|Vaccination Phase||12||
48233227|NCT02070276|100891560|FG002|NOT COMPLETED|Overall Study||0||
48233228|NCT02039401|100891561|FG000|STARTED|Overall Study||9||
48533229|NCT04645966|101643193|FG000|Primary Vaccination 2|Vaccination Phase||22||
48533230|NCT04645966|101643194|FG001|Primary Vaccination 2|Vaccination Phase||25||
48533231|NCT04645966|101643195|FG002|Primary Vaccination 2|Vaccination Phase||23||
48533232|NCT04645966|101643196|FG003|Primary Vaccination 2|Vaccination Phase||16||
48533233|NCT04645966|101643197|FG004|Primary Vaccination 2|Vaccination Phase||50||
48533234|NCT04645966|101643198|FG005|Primary Vaccination 2|Vaccination Phase||42||
48533235|NCT04645966|101643199|FG006|Primary Vaccination 2|Vaccination Phase||54||
48533236|NCT04645966|101643200|FG007|Primary Vaccination 2|Vaccination Phase||55||
48533237|NCT04645966|101643201|FG008|Primary Vaccination 2|Vaccination Phase||0||
48533238|NCT04645966|101643193|FG000|Booster Vaccination|Vaccination Phase||22||
48533239|NCT04645966|101643194|FG001|Booster Vaccination|Vaccination Phase||25||
48533240|NCT04645966|101643195|FG002|Booster Vaccination|Vaccination Phase||22||
48533241|NCT04645966|101643196|FG003|Booster Vaccination|Vaccination Phase||4||
48533242|NCT04645966|101643197|FG004|Booster Vaccination|Vaccination Phase||9||
48533243|NCT04645966|101643198|FG005|Booster Vaccination|Vaccination Phase||0||
48533244|NCT04645966|101643199|FG006|Booster Vaccination|Vaccination Phase||47||
48533245|NCT04645966|101643200|FG007|Booster Vaccination|Vaccination Phase||45||
48533246|NCT04645966|101643201|FG008|Booster Vaccination|Vaccination Phase||0||
48533247|NCT04645966|101643193|FG000|COMPLETED|Vaccination Phase||22||
48533248|NCT04645966|101643194|FG001|COMPLETED|Vaccination Phase||25||
48533249|NCT04645966|101643195|FG002|COMPLETED|Vaccination Phase||20||
48533250|NCT04645966|101643196|FG003|COMPLETED|Vaccination Phase||0||
48533251|NCT04645966|101643197|FG004|COMPLETED|Vaccination Phase||2||
48533252|NCT04645966|101643198|FG005|COMPLETED|Vaccination Phase||0||
48533253|NCT04645966|101643199|FG006|COMPLETED|Vaccination Phase||25||
48233229|NCT02039401|100891562|FG001|STARTED|Overall Study||9||
48233230|NCT02039401|100891561|FG000|COMPLETED|Overall Study||9||
48233231|NCT02039401|100891562|FG001|COMPLETED|Overall Study||8||
48233232|NCT02039401|100891561|FG000|NOT COMPLETED|Overall Study||0||
48533254|NCT04645966|101643200|FG007|COMPLETED|Vaccination Phase||22||
48533255|NCT04645966|101643201|FG008|COMPLETED|Vaccination Phase||0||
48533256|NCT04645966|101643193|FG000|NOT COMPLETED|Vaccination Phase||1||
48533257|NCT04645966|101643194|FG001|NOT COMPLETED|Vaccination Phase||0||
48533258|NCT04645966|101643195|FG002|NOT COMPLETED|Vaccination Phase||16||
48533259|NCT04645966|101643196|FG003|NOT COMPLETED|Vaccination Phase||16||
48533260|NCT04645966|101643197|FG004|NOT COMPLETED|Vaccination Phase||51||
48533261|NCT04645966|101643198|FG005|NOT COMPLETED|Vaccination Phase||50||
48533262|NCT04645966|101643199|FG006|NOT COMPLETED|Vaccination Phase||30||
48533263|NCT04645966|101643200|FG007|NOT COMPLETED|Vaccination Phase||33||
48533264|NCT04645966|101643201|FG008|NOT COMPLETED|Vaccination Phase||12||
48533265|NCT04645966|101643193|FG000|STARTED|Follow-up Phase||22||
48533266|NCT04645966|101643194|FG001|STARTED|Follow-up Phase||25||
48533267|NCT04645966|101643195|FG002|STARTED|Follow-up Phase||20||
48533268|NCT04645966|101643196|FG003|STARTED|Follow-up Phase||0||
48533269|NCT04645966|101643197|FG004|STARTED|Follow-up Phase||2||
48533270|NCT04645966|101643198|FG005|STARTED|Follow-up Phase||0||
48533271|NCT04645966|101643199|FG006|STARTED|Follow-up Phase||25||
48533272|NCT04645966|101643200|FG007|STARTED|Follow-up Phase||22||
48533273|NCT04645966|101643201|FG008|STARTED|Follow-up Phase||0||
48533274|NCT04645966|101643193|FG000|COMPLETED|Follow-up Phase||22||
48533275|NCT04645966|101643194|FG001|COMPLETED|Follow-up Phase||25||
48533276|NCT04645966|101643195|FG002|COMPLETED|Follow-up Phase||20||
48533277|NCT04645966|101643196|FG003|COMPLETED|Follow-up Phase||0||
48533278|NCT04645966|101643197|FG004|COMPLETED|Follow-up Phase||2||
48533279|NCT04645966|101643198|FG005|COMPLETED|Follow-up Phase||0||
48533280|NCT04645966|101643199|FG006|COMPLETED|Follow-up Phase||25||
48533281|NCT04645966|101643200|FG007|COMPLETED|Follow-up Phase||21||
48533282|NCT04645966|101643201|FG008|COMPLETED|Follow-up Phase||0||
48533283|NCT04645966|101643193|FG000|NOT COMPLETED|Follow-up Phase||0||
48533284|NCT04645966|101643194|FG001|NOT COMPLETED|Follow-up Phase||0||
48533285|NCT04645966|101643195|FG002|NOT COMPLETED|Follow-up Phase||0||
48533286|NCT04645966|101643196|FG003|NOT COMPLETED|Follow-up Phase||0||
48533287|NCT04645966|101643197|FG004|NOT COMPLETED|Follow-up Phase||0||
48533288|NCT04645966|101643198|FG005|NOT COMPLETED|Follow-up Phase||0||
48533289|NCT04645966|101643199|FG006|NOT COMPLETED|Follow-up Phase||0||
48233233|NCT02039401|100891562|FG001|NOT COMPLETED|Overall Study||1||
48233234|NCT04749797|100891563|FG000|STARTED|Overall Study||3||
48533290|NCT04645966|101643200|FG007|NOT COMPLETED|Follow-up Phase||1||
48533291|NCT04645966|101643201|FG008|NOT COMPLETED|Follow-up Phase||0||
48233235|NCT04749797|100891564|FG001|STARTED|Overall Study||4||
48233236|NCT04749797|100891565|FG002|STARTED|Overall Study||4||
48233237|NCT04749797|100891563|FG000|COMPLETED|Overall Study||2||
48233238|NCT04749797|100891564|FG001|COMPLETED|Overall Study||4||
48233239|NCT04749797|100891565|FG002|COMPLETED|Overall Study||4||
48533292|NCT02517463|101643202|FG000|STARTED|Overall Study||369||
48533293|NCT02517463|101643203|FG001|STARTED|Overall Study||331||
48533294|NCT02517463|101643202|FG000|COMPLETED|Overall Study||364||
48533295|NCT02517463|101643203|FG001|COMPLETED|Overall Study||329||
48533296|NCT02517463|101643202|FG000|NOT COMPLETED|Overall Study||5||
48533297|NCT02517463|101643203|FG001|NOT COMPLETED|Overall Study||2||
48533298|NCT01714232|101643204|FG000|STARTED|Overall Study||106||
48533299|NCT01714232|101643204|FG000|COMPLETED|Overall Study||106||
48533300|NCT01714232|101643204|FG000|NOT COMPLETED|Overall Study||0||
48533301|NCT02958982|101643205|FG000|STARTED|Cohort 1: 25 mg in SAD Study||1||
48533302|NCT02958982|101643206|FG001|STARTED|Cohort 1: 25 mg in SAD Study||3||
48533303|NCT02958982|101643207|FG002|STARTED|Cohort 1: 25 mg in SAD Study||0||
48533304|NCT02958982|101643208|FG003|STARTED|Cohort 1: 25 mg in SAD Study||0||
48533305|NCT02958982|101643209|FG004|STARTED|Cohort 1: 25 mg in SAD Study||0||
48533306|NCT02958982|101643210|FG005|STARTED|Cohort 1: 25 mg in SAD Study||0||
48533307|NCT02958982|101643211|FG006|STARTED|Cohort 1: 25 mg in SAD Study||0||
48533308|NCT02958982|101643212|FG007|STARTED|Cohort 1: 25 mg in SAD Study||0||
48533309|NCT02958982|101643213|FG008|STARTED|Cohort 1: 25 mg in SAD Study||0||
48533310|NCT02958982|101643214|FG009|STARTED|Cohort 1: 25 mg in SAD Study||0||
48533311|NCT02958982|101643215|FG010|STARTED|Cohort 1: 25 mg in SAD Study||0||
48533312|NCT02958982|101643205|FG000|COMPLETED|Cohort 1: 25 mg in SAD Study||1||
48533313|NCT02958982|101643206|FG001|COMPLETED|Cohort 1: 25 mg in SAD Study||3||
48533314|NCT02958982|101643207|FG002|COMPLETED|Cohort 1: 25 mg in SAD Study||0||
48533315|NCT02958982|101643208|FG003|COMPLETED|Cohort 1: 25 mg in SAD Study||0||
48533316|NCT02958982|101643209|FG004|COMPLETED|Cohort 1: 25 mg in SAD Study||0||
48533317|NCT02958982|101643210|FG005|COMPLETED|Cohort 1: 25 mg in SAD Study||0||
48533318|NCT02958982|101643211|FG006|COMPLETED|Cohort 1: 25 mg in SAD Study||0||
48533319|NCT02958982|101643212|FG007|COMPLETED|Cohort 1: 25 mg in SAD Study||0||
48533320|NCT02958982|101643213|FG008|COMPLETED|Cohort 1: 25 mg in SAD Study||0||
48533321|NCT02958982|101643214|FG009|COMPLETED|Cohort 1: 25 mg in SAD Study||0||
48533322|NCT02958982|101643215|FG010|COMPLETED|Cohort 1: 25 mg in SAD Study||0||
48533323|NCT02958982|101643205|FG000|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0||
48533324|NCT02958982|101643206|FG001|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0||
48533325|NCT02958982|101643207|FG002|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0||
48533326|NCT02958982|101643208|FG003|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0||
48533327|NCT02958982|101643209|FG004|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0||
48533328|NCT02958982|101643210|FG005|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0||
48533329|NCT02958982|101643211|FG006|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0||
48533330|NCT02958982|101643212|FG007|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0||
48233240|NCT04749797|100891563|FG000|NOT COMPLETED|Overall Study||1||
48233241|NCT04749797|100891564|FG001|NOT COMPLETED|Overall Study||0||
48233242|NCT04749797|100891565|FG002|NOT COMPLETED|Overall Study||0||
48233243|NCT01509183|100891566|FG000|STARTED|Overall Study||250||
48533331|NCT02958982|101643213|FG008|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0||
48533332|NCT02958982|101643214|FG009|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0||
48533333|NCT02958982|101643215|FG010|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0||
48533334|NCT02958982|101643205|FG000|STARTED|Cohort 2: 50 mg in SAD Study||2||
48533335|NCT02958982|101643206|FG001|STARTED|Cohort 2: 50 mg in SAD Study||0||
48533336|NCT02958982|101643207|FG002|STARTED|Cohort 2: 50 mg in SAD Study||4||
48533337|NCT02958982|101643208|FG003|STARTED|Cohort 2: 50 mg in SAD Study||0||
48533338|NCT02958982|101643209|FG004|STARTED|Cohort 2: 50 mg in SAD Study||0||
48533339|NCT02958982|101643210|FG005|STARTED|Cohort 2: 50 mg in SAD Study||0||
48533340|NCT02958982|101643211|FG006|STARTED|Cohort 2: 50 mg in SAD Study||0||
48533341|NCT02958982|101643212|FG007|STARTED|Cohort 2: 50 mg in SAD Study||0||
48533342|NCT02958982|101643213|FG008|STARTED|Cohort 2: 50 mg in SAD Study||0||
48533343|NCT02958982|101643214|FG009|STARTED|Cohort 2: 50 mg in SAD Study||0||
48533344|NCT02958982|101643215|FG010|STARTED|Cohort 2: 50 mg in SAD Study||0||
48533345|NCT02958982|101643205|FG000|COMPLETED|Cohort 2: 50 mg in SAD Study||2||
48533346|NCT02958982|101643206|FG001|COMPLETED|Cohort 2: 50 mg in SAD Study||0||
48533347|NCT02958982|101643207|FG002|COMPLETED|Cohort 2: 50 mg in SAD Study||4||
48533348|NCT02958982|101643208|FG003|COMPLETED|Cohort 2: 50 mg in SAD Study||0||
48533349|NCT02958982|101643209|FG004|COMPLETED|Cohort 2: 50 mg in SAD Study||0||
48533350|NCT02958982|101643210|FG005|COMPLETED|Cohort 2: 50 mg in SAD Study||0||
48533351|NCT02958982|101643211|FG006|COMPLETED|Cohort 2: 50 mg in SAD Study||0||
48533352|NCT02958982|101643212|FG007|COMPLETED|Cohort 2: 50 mg in SAD Study||0||
48533353|NCT02958982|101643213|FG008|COMPLETED|Cohort 2: 50 mg in SAD Study||0||
48533354|NCT02958982|101643214|FG009|COMPLETED|Cohort 2: 50 mg in SAD Study||0||
48533355|NCT02958982|101643215|FG010|COMPLETED|Cohort 2: 50 mg in SAD Study||0||
48533356|NCT02958982|101643205|FG000|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0||
48233244|NCT01509183|100891567|FG001|STARTED|Overall Study||245||
48233245|NCT01509183|100891566|FG000|COMPLETED|Overall Study||141||
48233246|NCT01509183|100891567|FG001|COMPLETED|Overall Study||134||
48233247|NCT01509183|100891566|FG000|NOT COMPLETED|Overall Study||109||
48233248|NCT01509183|100891567|FG001|NOT COMPLETED|Overall Study||111||
48533357|NCT02958982|101643206|FG001|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0||
48533358|NCT02958982|101643207|FG002|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0||
48533359|NCT02958982|101643208|FG003|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0||
48533360|NCT02958982|101643209|FG004|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0||
48533361|NCT02958982|101643210|FG005|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0||
48533362|NCT02958982|101643211|FG006|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0||
48533363|NCT02958982|101643212|FG007|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0||
48233249|NCT01313663|100891568|FG000|STARTED|Overall Study||9||
48233250|NCT01313663|100891569|FG001|STARTED|Overall Study||11||
48233251|NCT01313663|100891568|FG000|COMPLETED|Overall Study||5||
48233252|NCT01313663|100891569|FG001|COMPLETED|Overall Study||3||
48233253|NCT01313663|100891568|FG000|NOT COMPLETED|Overall Study||4||
48233254|NCT01313663|100891569|FG001|NOT COMPLETED|Overall Study||8||
48533364|NCT02958982|101643213|FG008|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0||
48533365|NCT02958982|101643214|FG009|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0||
48533366|NCT02958982|101643215|FG010|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0||
48533367|NCT02958982|101643205|FG000|STARTED|Cohort 3: 100 mg in SAD Study||2||
48533368|NCT02958982|101643206|FG001|STARTED|Cohort 3: 100 mg in SAD Study||0||
48533369|NCT02958982|101643207|FG002|STARTED|Cohort 3: 100 mg in SAD Study||0||
48533370|NCT02958982|101643208|FG003|STARTED|Cohort 3: 100 mg in SAD Study||4||
48533371|NCT02958982|101643209|FG004|STARTED|Cohort 3: 100 mg in SAD Study||0||
48533372|NCT02958982|101643210|FG005|STARTED|Cohort 3: 100 mg in SAD Study||0||
48533373|NCT02958982|101643211|FG006|STARTED|Cohort 3: 100 mg in SAD Study||0||
48533374|NCT02958982|101643212|FG007|STARTED|Cohort 3: 100 mg in SAD Study||0||
48533375|NCT02958982|101643213|FG008|STARTED|Cohort 3: 100 mg in SAD Study||0||
48533376|NCT02958982|101643214|FG009|STARTED|Cohort 3: 100 mg in SAD Study||0||
48533377|NCT02958982|101643215|FG010|STARTED|Cohort 3: 100 mg in SAD Study||0||
48533378|NCT02958982|101643205|FG000|COMPLETED|Cohort 3: 100 mg in SAD Study||2||
48533379|NCT02958982|101643206|FG001|COMPLETED|Cohort 3: 100 mg in SAD Study||0||
48533380|NCT02958982|101643207|FG002|COMPLETED|Cohort 3: 100 mg in SAD Study||0||
48533381|NCT02958982|101643208|FG003|COMPLETED|Cohort 3: 100 mg in SAD Study||4||
48533382|NCT02958982|101643209|FG004|COMPLETED|Cohort 3: 100 mg in SAD Study||0||
48533383|NCT02958982|101643210|FG005|COMPLETED|Cohort 3: 100 mg in SAD Study||0||
48533384|NCT02958982|101643211|FG006|COMPLETED|Cohort 3: 100 mg in SAD Study||0||
48533385|NCT02958982|101643212|FG007|COMPLETED|Cohort 3: 100 mg in SAD Study||0||
48533386|NCT02958982|101643213|FG008|COMPLETED|Cohort 3: 100 mg in SAD Study||0||
48533387|NCT02958982|101643214|FG009|COMPLETED|Cohort 3: 100 mg in SAD Study||0||
48533388|NCT02958982|101643215|FG010|COMPLETED|Cohort 3: 100 mg in SAD Study||0||
48533389|NCT02958982|101643205|FG000|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0||
48533390|NCT02958982|101643206|FG001|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0||
48533391|NCT02958982|101643207|FG002|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0||
48533392|NCT02958982|101643208|FG003|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0||
48533393|NCT02958982|101643209|FG004|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0||
48533394|NCT02958982|101643210|FG005|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0||
48533395|NCT02958982|101643211|FG006|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0||
48533396|NCT02958982|101643212|FG007|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0||
48533397|NCT02958982|101643213|FG008|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0||
48533398|NCT02958982|101643214|FG009|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0||
48233255|NCT02271906|100891570|FG000|STARTED|Overall Study||2||
48233256|NCT02271906|100891570|FG000|COMPLETED|Overall Study||2||
48533399|NCT02958982|101643215|FG010|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0||
48533400|NCT02958982|101643205|FG000|STARTED|Cohort 4: 200 mg in SAD Study||2||
48533401|NCT02958982|101643206|FG001|STARTED|Cohort 4: 200 mg in SAD Study||0||
48533402|NCT02958982|101643207|FG002|STARTED|Cohort 4: 200 mg in SAD Study||0||
48533403|NCT02958982|101643208|FG003|STARTED|Cohort 4: 200 mg in SAD Study||0||
48533404|NCT02958982|101643209|FG004|STARTED|Cohort 4: 200 mg in SAD Study||6||
48533405|NCT02958982|101643210|FG005|STARTED|Cohort 4: 200 mg in SAD Study||0||
48533406|NCT02958982|101643211|FG006|STARTED|Cohort 4: 200 mg in SAD Study||0||
48533407|NCT02958982|101643212|FG007|STARTED|Cohort 4: 200 mg in SAD Study||0||
48533408|NCT02958982|101643213|FG008|STARTED|Cohort 4: 200 mg in SAD Study||0||
48233257|NCT02271906|100891570|FG000|NOT COMPLETED|Overall Study||0||
48233258|NCT00670488|100891571|FG000|STARTED|Overall Study||3||
48233259|NCT00670488|100891572|FG001|STARTED|Overall Study||58||
48233260|NCT00670488|100891573|FG002|STARTED|Overall Study||3||
48233261|NCT00670488|100891574|FG003|STARTED|Overall Study||7||
48233262|NCT00670488|100891575|FG004|STARTED|Overall Study||3||
48233263|NCT00670488|100891576|FG005|STARTED|Overall Study||5||
48233264|NCT00670488|100891577|FG006|STARTED|Overall Study||17||
48233265|NCT00670488|100891578|FG007|STARTED|Overall Study||3||
48233266|NCT00670488|100891579|FG008|STARTED|Overall Study||3||
48233267|NCT00670488|100891580|FG009|STARTED|Overall Study||2||
48233268|NCT00670488|100891571|FG000|COMPLETED|Overall Study||0||
48233269|NCT00670488|100891572|FG001|COMPLETED|Overall Study||0||
48533409|NCT02958982|101643214|FG009|STARTED|Cohort 4: 200 mg in SAD Study||0||
48533410|NCT02958982|101643215|FG010|STARTED|Cohort 4: 200 mg in SAD Study||0||
48533411|NCT02958982|101643205|FG000|COMPLETED|Cohort 4: 200 mg in SAD Study||2||
48533412|NCT02958982|101643206|FG001|COMPLETED|Cohort 4: 200 mg in SAD Study||0||
48233270|NCT00670488|100891573|FG002|COMPLETED|Overall Study||0||
48233271|NCT00670488|100891574|FG003|COMPLETED|Overall Study||0||
48233272|NCT00670488|100891575|FG004|COMPLETED|Overall Study||0||
48233273|NCT00670488|100891576|FG005|COMPLETED|Overall Study||0||
48233274|NCT00670488|100891577|FG006|COMPLETED|Overall Study||0||
48233275|NCT00670488|100891578|FG007|COMPLETED|Overall Study||0||
48233276|NCT00670488|100891579|FG008|COMPLETED|Overall Study||0||
48233277|NCT00670488|100891580|FG009|COMPLETED|Overall Study||0||
48233278|NCT00670488|100891571|FG000|NOT COMPLETED|Overall Study||3||
48233279|NCT00670488|100891572|FG001|NOT COMPLETED|Overall Study||58||
48233280|NCT00670488|100891573|FG002|NOT COMPLETED|Overall Study||3||
48533413|NCT02958982|101643207|FG002|COMPLETED|Cohort 4: 200 mg in SAD Study||0||
48233281|NCT00670488|100891574|FG003|NOT COMPLETED|Overall Study||7||
48233282|NCT00670488|100891575|FG004|NOT COMPLETED|Overall Study||3||
48233283|NCT00670488|100891576|FG005|NOT COMPLETED|Overall Study||5||
48233284|NCT00670488|100891577|FG006|NOT COMPLETED|Overall Study||17||
48233285|NCT00670488|100891578|FG007|NOT COMPLETED|Overall Study||3||
48233286|NCT00670488|100891579|FG008|NOT COMPLETED|Overall Study||3||
48233287|NCT00670488|100891580|FG009|NOT COMPLETED|Overall Study||2||
48233288|NCT00952523|100891581|FG000|STARTED|Overall Study||162||
48233289|NCT00952523|100891581|FG000|COMPLETED|Overall Study||155||
48233290|NCT00952523|100891581|FG000|NOT COMPLETED|Overall Study||7||
48233291|NCT04410445|100891582|FG000|STARTED|Overall Study||378||
48233292|NCT04410445|100891583|FG001|STARTED|Overall Study||387||
48233293|NCT04410445|100891582|FG000|COMPLETED|Overall Study||348||
48233294|NCT04410445|100891583|FG001|COMPLETED|Overall Study||363||
48233295|NCT04410445|100891582|FG000|NOT COMPLETED|Overall Study||30||
48233296|NCT04410445|100891583|FG001|NOT COMPLETED|Overall Study||24||
48233297|NCT03819543|100891584|FG000|STARTED|Overall Study||10||
48233298|NCT03819543|100891584|FG000|COMPLETED|Overall Study||10||
48233299|NCT03819543|100891584|FG000|NOT COMPLETED|Overall Study||0||
48233300|NCT01930188|100891585|FG000|STARTED|Overall Study||409||
48233301|NCT01930188|100891586|FG001|STARTED|Overall Study||409||
48233302|NCT01930188|100891587|FG002|STARTED|Overall Study||407||
48233303|NCT01930188|100891585|FG000|Premature Discontinuation of Treatment|Overall Study||53||
48233304|NCT01930188|100891586|FG001|Premature Discontinuation of Treatment|Overall Study||61||
48233305|NCT01930188|100891587|FG002|Premature Discontinuation of Treatment|Overall Study||32||
48233306|NCT01930188|100891585|FG000|COMPLETED|Overall Study||387||
48233307|NCT01930188|100891586|FG001|COMPLETED|Overall Study||388||
48233308|NCT01930188|100891587|FG002|COMPLETED|Overall Study||388||
48233309|NCT01930188|100891585|FG000|NOT COMPLETED|Overall Study||22||
48233310|NCT01930188|100891586|FG001|NOT COMPLETED|Overall Study||21||
48233311|NCT01930188|100891587|FG002|NOT COMPLETED|Overall Study||19||
48233312|NCT02338999|100891588|FG000|STARTED|First Intervention||39||
48233313|NCT02338999|100891589|FG001|STARTED|First Intervention||41||
48233314|NCT02338999|100891588|FG000|COMPLETED|First Intervention||36||
48233315|NCT02338999|100891589|FG001|COMPLETED|First Intervention||40||
48233316|NCT02338999|100891588|FG000|NOT COMPLETED|First Intervention||3||
48233317|NCT02338999|100891589|FG001|NOT COMPLETED|First Intervention||1||
48233318|NCT02338999|100891588|FG000|STARTED|Washout Period||36||
48233319|NCT02338999|100891589|FG001|STARTED|Washout Period||40||
48233320|NCT02338999|100891588|FG000|COMPLETED|Washout Period||36||
48233321|NCT02338999|100891589|FG001|COMPLETED|Washout Period||38||
48233322|NCT02338999|100891588|FG000|NOT COMPLETED|Washout Period||0||
48233323|NCT02338999|100891589|FG001|NOT COMPLETED|Washout Period||2||
48233324|NCT02338999|100891588|FG000|STARTED|Second Intervention||36||
48233325|NCT02338999|100891589|FG001|STARTED|Second Intervention||38||
48233326|NCT02338999|100891588|FG000|COMPLETED|Second Intervention||36||
48233327|NCT02338999|100891589|FG001|COMPLETED|Second Intervention||36||
48233328|NCT02338999|100891588|FG000|NOT COMPLETED|Second Intervention||0||
48233329|NCT02338999|100891589|FG001|NOT COMPLETED|Second Intervention||2||
48233330|NCT03783936|100891590|FG000|STARTED|Overall Study||18||
48233331|NCT03783936|100891590|FG000|COMPLETED|Overall Study||18||
48233332|NCT03783936|100891590|FG000|NOT COMPLETED|Overall Study||0||
48233333|NCT03865732|100891591|FG000|STARTED|Overall Study||11||
48233334|NCT03865732|100891592|FG001|STARTED|Overall Study||10||
48233335|NCT03865732|100891591|FG000|COMPLETED|Overall Study||11||
48233336|NCT03865732|100891592|FG001|COMPLETED|Overall Study||9||
48533414|NCT02958982|101643208|FG003|COMPLETED|Cohort 4: 200 mg in SAD Study||0||
48233337|NCT03865732|100891591|FG000|NOT COMPLETED|Overall Study||0||
48233338|NCT03865732|100891592|FG001|NOT COMPLETED|Overall Study||1||
48233339|NCT01220999|100891593|FG000|STARTED|Overall Study||2||
48233340|NCT01220999|100891594|FG001|STARTED|Overall Study||4||
48233341|NCT01220999|100891595|FG002|STARTED|Overall Study||5||
48233342|NCT01220999|100891596|FG003|STARTED|Overall Study||3||
48233343|NCT01220999|100891597|FG004|STARTED|Overall Study||5||
48233344|NCT01220999|100891593|FG000|COMPLETED|Overall Study||2|Completed Cycle 1 (through Day 43) as planned|
48233345|NCT01220999|100891594|FG001|COMPLETED|Overall Study||4|Completed Cycle 1 (through Day 43) as planned|
48233346|NCT01220999|100891595|FG002|COMPLETED|Overall Study||4|Completed Cycle 1 (through Day 43) as planned|
48533415|NCT02958982|101643209|FG004|COMPLETED|Cohort 4: 200 mg in SAD Study||6||
48533416|NCT02958982|101643210|FG005|COMPLETED|Cohort 4: 200 mg in SAD Study||0||
48533417|NCT02958982|101643211|FG006|COMPLETED|Cohort 4: 200 mg in SAD Study||0||
48233347|NCT01220999|100891596|FG003|COMPLETED|Overall Study||3|Completed Cycle 1 (through Day 43) as planned|
48233348|NCT01220999|100891597|FG004|COMPLETED|Overall Study||5|Completed Cycle 1 (through Day 43) as planned|
48233349|NCT01220999|100891593|FG000|NOT COMPLETED|Overall Study||0||
48233350|NCT01220999|100891594|FG001|NOT COMPLETED|Overall Study||0||
48233351|NCT01220999|100891595|FG002|NOT COMPLETED|Overall Study||1||
48233352|NCT01220999|100891596|FG003|NOT COMPLETED|Overall Study||0||
48233353|NCT01220999|100891597|FG004|NOT COMPLETED|Overall Study||0||
48233354|NCT01005602|100891598|FG000|STARTED|Overall Study||66||
48233355|NCT01005602|100891599|FG001|STARTED|Overall Study||66||
48533418|NCT02958982|101643212|FG007|COMPLETED|Cohort 4: 200 mg in SAD Study||0||
48233356|NCT01005602|100891598|FG000|COMPLETED|Overall Study||65||
48533419|NCT02958982|101643213|FG008|COMPLETED|Cohort 4: 200 mg in SAD Study||0||
48533420|NCT02958982|101643214|FG009|COMPLETED|Cohort 4: 200 mg in SAD Study||0||
48533421|NCT02958982|101643215|FG010|COMPLETED|Cohort 4: 200 mg in SAD Study||0||
48533422|NCT02958982|101643205|FG000|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0||
48533423|NCT02958982|101643206|FG001|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0||
48233357|NCT01005602|100891599|FG001|COMPLETED|Overall Study||66||
48233358|NCT01005602|100891598|FG000|NOT COMPLETED|Overall Study||1||
48233359|NCT01005602|100891599|FG001|NOT COMPLETED|Overall Study||0||
48233360|NCT04721600|100891600|FG000|STARTED|Overall Study||15||
48233361|NCT04721600|100891600|FG000|COMPLETED|Overall Study||12||
48233362|NCT04721600|100891600|FG000|NOT COMPLETED|Overall Study||3||
48233363|NCT01071317|100891601|FG000|STARTED|Overall Study||25||
48233364|NCT01071317|100891602|FG001|STARTED|Overall Study||25||
48233365|NCT01071317|100891601|FG000|COMPLETED|Overall Study||23||
48233366|NCT01071317|100891602|FG001|COMPLETED|Overall Study||23||
48233367|NCT01071317|100891601|FG000|NOT COMPLETED|Overall Study||2||
48233368|NCT01071317|100891602|FG001|NOT COMPLETED|Overall Study||2||
48233369|NCT02074384|100891603|FG000|STARTED|Overall Study||74||
48233370|NCT02074384|100891604|FG001|STARTED|Overall Study||70||
48233371|NCT02074384|100891605|FG002|STARTED|Overall Study||17||
48233372|NCT02074384|100891603|FG000|COMPLETED|Overall Study||74||
48233373|NCT02074384|100891604|FG001|COMPLETED|Overall Study||70||
48233374|NCT02074384|100891605|FG002|COMPLETED|Overall Study||17||
48233375|NCT02074384|100891603|FG000|NOT COMPLETED|Overall Study||0||
48233376|NCT02074384|100891604|FG001|NOT COMPLETED|Overall Study||0||
48233377|NCT02074384|100891605|FG002|NOT COMPLETED|Overall Study||0||
48233378|NCT02033174|100891606|FG000|STARTED|First Intervention||8||
48233379|NCT02033174|100891607|FG001|STARTED|First Intervention||8||
48233380|NCT02033174|100891606|FG000|COMPLETED|First Intervention||8||
48233381|NCT02033174|100891607|FG001|COMPLETED|First Intervention||8||
48533424|NCT02958982|101643207|FG002|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0||
48533425|NCT02958982|101643208|FG003|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0||
48533426|NCT02958982|101643209|FG004|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0||
48533427|NCT02958982|101643210|FG005|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0||
48533428|NCT02958982|101643211|FG006|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0||
48533429|NCT02958982|101643212|FG007|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0||
48533430|NCT02958982|101643213|FG008|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0||
48533431|NCT02958982|101643214|FG009|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0||
48533432|NCT02958982|101643215|FG010|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0||
48533433|NCT02958982|101643205|FG000|STARTED|Cohort 5: 400 mg in SAD Study||2||
48533434|NCT02958982|101643206|FG001|STARTED|Cohort 5: 400 mg in SAD Study||0||
48233382|NCT02033174|100891606|FG000|NOT COMPLETED|First Intervention||0||
48233383|NCT02033174|100891607|FG001|NOT COMPLETED|First Intervention||0||
48233384|NCT02033174|100891606|FG000|STARTED|Washout (1 Week)||8||
48233385|NCT02033174|100891607|FG001|STARTED|Washout (1 Week)||8||
48233386|NCT02033174|100891606|FG000|COMPLETED|Washout (1 Week)||8||
48233387|NCT02033174|100891607|FG001|COMPLETED|Washout (1 Week)||8||
48233388|NCT02033174|100891606|FG000|NOT COMPLETED|Washout (1 Week)||0||
48233389|NCT02033174|100891607|FG001|NOT COMPLETED|Washout (1 Week)||0||
48233390|NCT02033174|100891606|FG000|STARTED|Second Intervention||8||
48233391|NCT02033174|100891607|FG001|STARTED|Second Intervention||8||
48233392|NCT02033174|100891606|FG000|COMPLETED|Second Intervention||8||
48233393|NCT02033174|100891607|FG001|COMPLETED|Second Intervention||8||
48233394|NCT02033174|100891606|FG000|NOT COMPLETED|Second Intervention||0||
48533435|NCT02958982|101643207|FG002|STARTED|Cohort 5: 400 mg in SAD Study||0||
48533436|NCT02958982|101643208|FG003|STARTED|Cohort 5: 400 mg in SAD Study||0||
48533437|NCT02958982|101643209|FG004|STARTED|Cohort 5: 400 mg in SAD Study||0||
48533438|NCT02958982|101643210|FG005|STARTED|Cohort 5: 400 mg in SAD Study||6||
48533439|NCT02958982|101643211|FG006|STARTED|Cohort 5: 400 mg in SAD Study||0||
48533440|NCT02958982|101643212|FG007|STARTED|Cohort 5: 400 mg in SAD Study||0||
48533441|NCT02958982|101643213|FG008|STARTED|Cohort 5: 400 mg in SAD Study||0||
48533442|NCT02958982|101643214|FG009|STARTED|Cohort 5: 400 mg in SAD Study||0||
48533443|NCT02958982|101643215|FG010|STARTED|Cohort 5: 400 mg in SAD Study||0||
48533444|NCT02958982|101643205|FG000|COMPLETED|Cohort 5: 400 mg in SAD Study||2||
48533445|NCT02958982|101643206|FG001|COMPLETED|Cohort 5: 400 mg in SAD Study||0||
48533446|NCT02958982|101643207|FG002|COMPLETED|Cohort 5: 400 mg in SAD Study||0||
48533447|NCT02958982|101643208|FG003|COMPLETED|Cohort 5: 400 mg in SAD Study||0||
48533448|NCT02958982|101643209|FG004|COMPLETED|Cohort 5: 400 mg in SAD Study||0||
48533449|NCT02958982|101643210|FG005|COMPLETED|Cohort 5: 400 mg in SAD Study||6||
48233395|NCT02033174|100891607|FG001|NOT COMPLETED|Second Intervention||0||
48233396|NCT01852175|100894842|FG000|STARTED|Overall Study||55||
48233397|NCT01852175|100894843|FG001|STARTED|Overall Study||55||
48233398|NCT01852175|100894842|FG000|COMPLETED|Overall Study||55||
48233399|NCT01852175|100894843|FG001|COMPLETED|Overall Study||55||
48233400|NCT01852175|100894842|FG000|NOT COMPLETED|Overall Study||0||
48233401|NCT01852175|100894843|FG001|NOT COMPLETED|Overall Study||0||
48233402|NCT01681511|100894844|FG000|STARTED|Overall Study||46||
48233403|NCT01681511|100894845|FG001|STARTED|Overall Study||49||
48533450|NCT02958982|101643211|FG006|COMPLETED|Cohort 5: 400 mg in SAD Study||0||
48233404|NCT01681511|100894844|FG000|Intent to Treat (ITT) Population|Overall Study||45||
48233405|NCT01681511|100894845|FG001|Intent to Treat (ITT) Population|Overall Study||46||
48233406|NCT01681511|100894844|FG000|Evaluable Population|Overall Study||16||
48233407|NCT01681511|100894845|FG001|Evaluable Population|Overall Study||14||
48233408|NCT01681511|100894844|FG000|COMPLETED|Overall Study||28||
48233409|NCT01681511|100894845|FG001|COMPLETED|Overall Study||35||
48233410|NCT01681511|100894844|FG000|NOT COMPLETED|Overall Study||18||
48233411|NCT01681511|100894845|FG001|NOT COMPLETED|Overall Study||14||
48233412|NCT02674399|100894846|FG000|STARTED|Overall Study||19||
48233413|NCT02674399|100894847|FG001|STARTED|Overall Study||9||
48233414|NCT02674399|100894846|FG000|COMPLETED|Overall Study||17||
48233415|NCT02674399|100894847|FG001|COMPLETED|Overall Study||9||
48233416|NCT02674399|100894846|FG000|NOT COMPLETED|Overall Study||2||
48233417|NCT02674399|100894847|FG001|NOT COMPLETED|Overall Study||0||
48233418|NCT02562521|100894848|FG000|STARTED|Overall Study||18||
48533451|NCT02958982|101643212|FG007|COMPLETED|Cohort 5: 400 mg in SAD Study||0||
48533452|NCT02958982|101643213|FG008|COMPLETED|Cohort 5: 400 mg in SAD Study||0||
48533453|NCT02958982|101643214|FG009|COMPLETED|Cohort 5: 400 mg in SAD Study||0||
48533454|NCT02958982|101643215|FG010|COMPLETED|Cohort 5: 400 mg in SAD Study||0||
48533455|NCT02958982|101643205|FG000|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0||
48533456|NCT02958982|101643206|FG001|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0||
48533457|NCT02958982|101643207|FG002|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0||
48533458|NCT02958982|101643208|FG003|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0||
48533459|NCT02958982|101643209|FG004|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0||
48533460|NCT02958982|101643210|FG005|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0||
48533461|NCT02958982|101643211|FG006|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0||
48533462|NCT02958982|101643212|FG007|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0||
48533463|NCT02958982|101643213|FG008|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0||
48233419|NCT02562521|100894849|FG001|STARTED|Overall Study||7||
48233420|NCT02562521|100894848|FG000|COMPLETED|Overall Study||18||
48233421|NCT02562521|100894849|FG001|COMPLETED|Overall Study||7||
48233422|NCT02562521|100894848|FG000|NOT COMPLETED|Overall Study||0||
48233423|NCT02562521|100894849|FG001|NOT COMPLETED|Overall Study||0||
48233424|NCT02399111|100894850|FG000|STARTED|Overall Study||4||
48233425|NCT02399111|100894851|FG001|STARTED|Overall Study||1||
48233426|NCT02399111|100894852|FG002|STARTED|Overall Study||4||
48233427|NCT02399111|100894853|FG003|STARTED|Overall Study||0||
48233428|NCT02399111|100894850|FG000|COMPLETED|Overall Study||4||
48233429|NCT02399111|100894851|FG001|COMPLETED|Overall Study||1||
48233430|NCT02399111|100894852|FG002|COMPLETED|Overall Study||4||
48233431|NCT02399111|100894853|FG003|COMPLETED|Overall Study||0||
48233432|NCT02399111|100894850|FG000|NOT COMPLETED|Overall Study||0||
48233433|NCT02399111|100894851|FG001|NOT COMPLETED|Overall Study||0||
48233434|NCT02399111|100894852|FG002|NOT COMPLETED|Overall Study||0||
48233435|NCT02399111|100894853|FG003|NOT COMPLETED|Overall Study||0||
48233436|NCT00346398|100894854|FG000|STARTED|Overall Study||25||
48233437|NCT00346398|100894855|FG001|STARTED|Overall Study||26||
48233438|NCT00346398|100894854|FG000|COMPLETED|Overall Study||22||
48233439|NCT00346398|100894855|FG001|COMPLETED|Overall Study||24||
48233440|NCT00346398|100894854|FG000|NOT COMPLETED|Overall Study||3||
48233441|NCT00346398|100894855|FG001|NOT COMPLETED|Overall Study||2||
48233442|NCT01986348|100894856|FG000|STARTED|Overall Study||8||
48233443|NCT01986348|100894857|FG001|STARTED|Overall Study||24||
48233444|NCT01986348|100894858|FG002|STARTED|Overall Study||14||
48233445|NCT01986348|100894859|FG003|STARTED|Overall Study||30||
48233446|NCT01986348|100894856|FG000|COMPLETED|Overall Study||0||
48233447|NCT01986348|100894857|FG001|COMPLETED|Overall Study||0||
48233448|NCT01986348|100894858|FG002|COMPLETED|Overall Study||0||
48233449|NCT01986348|100894859|FG003|COMPLETED|Overall Study||0||
48233450|NCT01986348|100894856|FG000|NOT COMPLETED|Overall Study||8||
48233451|NCT01986348|100894857|FG001|NOT COMPLETED|Overall Study||24||
48233452|NCT01986348|100894858|FG002|NOT COMPLETED|Overall Study||14||
48533464|NCT02958982|101643214|FG009|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0||
48533465|NCT02958982|101643215|FG010|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0||
48533466|NCT02958982|101643205|FG000|STARTED|Cohort 1 : 25 mg in MAD Study||0||
48533467|NCT02958982|101643206|FG001|STARTED|Cohort 1 : 25 mg in MAD Study||0||
48533468|NCT02958982|101643207|FG002|STARTED|Cohort 1 : 25 mg in MAD Study||0||
48533469|NCT02958982|101643208|FG003|STARTED|Cohort 1 : 25 mg in MAD Study||0||
48533470|NCT02958982|101643209|FG004|STARTED|Cohort 1 : 25 mg in MAD Study||0||
48533471|NCT02958982|101643210|FG005|STARTED|Cohort 1 : 25 mg in MAD Study||0||
48533472|NCT02958982|101643211|FG006|STARTED|Cohort 1 : 25 mg in MAD Study||2||
48533473|NCT02958982|101643212|FG007|STARTED|Cohort 1 : 25 mg in MAD Study||6||
48533474|NCT02958982|101643213|FG008|STARTED|Cohort 1 : 25 mg in MAD Study||0||
48533475|NCT02958982|101643214|FG009|STARTED|Cohort 1 : 25 mg in MAD Study||0||
48533476|NCT02958982|101643215|FG010|STARTED|Cohort 1 : 25 mg in MAD Study||0||
48533477|NCT02958982|101643205|FG000|COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
48233453|NCT01986348|100894859|FG003|NOT COMPLETED|Overall Study||30||
48533478|NCT02958982|101643206|FG001|COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
48533479|NCT02958982|101643207|FG002|COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
48533480|NCT02958982|101643208|FG003|COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
48233454|NCT01817491|100894860|FG000|STARTED|Overall Study||32||
48533481|NCT02958982|101643209|FG004|COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
48533482|NCT02958982|101643210|FG005|COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
48533483|NCT02958982|101643211|FG006|COMPLETED|Cohort 1 : 25 mg in MAD Study||2||
48533484|NCT02958982|101643212|FG007|COMPLETED|Cohort 1 : 25 mg in MAD Study||6||
48533485|NCT02958982|101643213|FG008|COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
48533486|NCT02958982|101643214|FG009|COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
48533487|NCT02958982|101643215|FG010|COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
48533488|NCT02958982|101643205|FG000|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
48533489|NCT02958982|101643206|FG001|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
48533490|NCT02958982|101643207|FG002|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
48233455|NCT01817491|100894861|FG001|STARTED|Overall Study||28||
48233456|NCT01817491|100894860|FG000|COMPLETED|Overall Study||28||
48233457|NCT01817491|100894861|FG001|COMPLETED|Overall Study||28||
48233458|NCT01817491|100894860|FG000|NOT COMPLETED|Overall Study||4||
48233459|NCT01817491|100894861|FG001|NOT COMPLETED|Overall Study||0||
48233460|NCT00632736|100894862|FG000|STARTED|Overall Study||419||
48233461|NCT00632736|100894862|FG000|COMPLETED|Overall Study||151||
48233462|NCT00632736|100894862|FG000|NOT COMPLETED|Overall Study||268||
48233463|NCT01214109|100894863|FG000|STARTED|Overall Study||24||
48233464|NCT01214109|100894864|FG001|STARTED|Overall Study||24||
48233465|NCT01214109|100894865|FG002|STARTED|Overall Study||24||
48233466|NCT01214109|100894866|FG003|STARTED|Overall Study||24||
48233467|NCT01214109|100894863|FG000|COMPLETED|Overall Study||24||
48233468|NCT01214109|100894864|FG001|COMPLETED|Overall Study||24||
48233469|NCT01214109|100894865|FG002|COMPLETED|Overall Study||24||
48233470|NCT01214109|100894866|FG003|COMPLETED|Overall Study||24||
48233471|NCT01214109|100894863|FG000|NOT COMPLETED|Overall Study||0||
48233472|NCT01214109|100894864|FG001|NOT COMPLETED|Overall Study||0||
48233473|NCT01214109|100894865|FG002|NOT COMPLETED|Overall Study||0||
48233474|NCT01214109|100894866|FG003|NOT COMPLETED|Overall Study||0||
48233475|NCT00658632|100894867|FG000|STARTED|Overall Study||682||
48233476|NCT00658632|100894868|FG001|STARTED|Overall Study||698||
48233477|NCT00658632|100894867|FG000|COMPLETED|Overall Study||618||
48233478|NCT00658632|100894868|FG001|COMPLETED|Overall Study||633||
48233479|NCT00658632|100894867|FG000|NOT COMPLETED|Overall Study||64||
48233480|NCT00658632|100894868|FG001|NOT COMPLETED|Overall Study||65||
48233481|NCT01078402|100894869|FG000|STARTED|Overall Study||431||
48233482|NCT01078402|100894870|FG001|STARTED|Overall Study||124||
48233483|NCT01078402|100894871|FG002|STARTED|Overall Study||234||
48233484|NCT01078402|100894869|FG000|COMPLETED|Overall Study||324||
48233485|NCT01078402|100894870|FG001|COMPLETED|Overall Study||95||
48233486|NCT01078402|100894871|FG002|COMPLETED|Overall Study||166||
48233487|NCT01078402|100894869|FG000|NOT COMPLETED|Overall Study||107||
48233488|NCT01078402|100894870|FG001|NOT COMPLETED|Overall Study||29||
48233489|NCT01078402|100894871|FG002|NOT COMPLETED|Overall Study||68||
48233490|NCT01722097|100894872|FG000|STARTED|Overall Study||55||
48233491|NCT01722097|100894873|FG001|STARTED|Overall Study||55||
48233492|NCT01722097|100894872|FG000|COMPLETED|Overall Study||49||
48233493|NCT01722097|100894873|FG001|COMPLETED|Overall Study||50||
48233494|NCT01722097|100894872|FG000|NOT COMPLETED|Overall Study||6||
48233495|NCT01722097|100894873|FG001|NOT COMPLETED|Overall Study||5||
48233496|NCT01260883|100894874|FG000|STARTED|Overall Study||22||
48233497|NCT01260883|100894875|FG001|STARTED|Overall Study||11||
48233498|NCT01260883|100894876|FG002|STARTED|Overall Study||18||
48233499|NCT01260883|100894874|FG000|COMPLETED|Overall Study||22||
48233500|NCT01260883|100894875|FG001|COMPLETED|Overall Study||11||
48233501|NCT01260883|100894876|FG002|COMPLETED|Overall Study||18||
48233502|NCT01260883|100894874|FG000|NOT COMPLETED|Overall Study||0||
48533491|NCT02958982|101643208|FG003|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
48233503|NCT01260883|100894875|FG001|NOT COMPLETED|Overall Study||0||
48233504|NCT01260883|100894876|FG002|NOT COMPLETED|Overall Study||0||
48233505|NCT00990314|100894877|FG000|STARTED|Overall Study||31||
48233506|NCT00990314|100894877|FG000|COMPLETED|Overall Study||19||
48233507|NCT00990314|100894877|FG000|NOT COMPLETED|Overall Study||12||
48233508|NCT01970527|100894878|FG000|STARTED|Pre-treatment/Baseline||9||
48233509|NCT01970527|100894879|FG001|STARTED|Pre-treatment/Baseline||14||
48233510|NCT01970527|100894878|FG000|COMPLETED|Pre-treatment/Baseline||8||
48233511|NCT01970527|100894879|FG001|COMPLETED|Pre-treatment/Baseline||14||
48233512|NCT01970527|100894878|FG000|NOT COMPLETED|Pre-treatment/Baseline||1||
48233513|NCT01970527|100894879|FG001|NOT COMPLETED|Pre-treatment/Baseline||0||
48233514|NCT01970527|100894878|FG000|STARTED|Treatment||8||
48233515|NCT01970527|100894879|FG001|STARTED|Treatment||14||
48233516|NCT01970527|100894878|FG000|COMPLETED|Treatment||8||
48233517|NCT01970527|100894879|FG001|COMPLETED|Treatment||11||
48233518|NCT01970527|100894878|FG000|NOT COMPLETED|Treatment||0||
48233519|NCT01970527|100894879|FG001|NOT COMPLETED|Treatment||3||
48233520|NCT01970527|100894878|FG000|STARTED|Follow-up Clinic Visit||8||
48233521|NCT01970527|100894879|FG001|STARTED|Follow-up Clinic Visit||11||
48233522|NCT01970527|100894878|FG000|COMPLETED|Follow-up Clinic Visit||7||
48233523|NCT01970527|100894879|FG001|COMPLETED|Follow-up Clinic Visit||8||
48233524|NCT01970527|100894878|FG000|NOT COMPLETED|Follow-up Clinic Visit||1||
48233525|NCT01970527|100894879|FG001|NOT COMPLETED|Follow-up Clinic Visit||3||
48233526|NCT00942266|100894880|FG000|STARTED|Overall Study||43||
48233527|NCT00942266|100894881|FG001|STARTED|Overall Study||15||
48233528|NCT00942266|100894880|FG000|COMPLETED|Overall Study||0||
48233529|NCT00942266|100894881|FG001|COMPLETED|Overall Study||0||
48533492|NCT02958982|101643209|FG004|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
48533493|NCT02958982|101643210|FG005|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
48533494|NCT02958982|101643211|FG006|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
48233530|NCT00942266|100894880|FG000|NOT COMPLETED|Overall Study||43||
48233531|NCT00942266|100894881|FG001|NOT COMPLETED|Overall Study||15||
48233532|NCT00091572|100894882|FG000|STARTED|Overall Study||429||
48233533|NCT00091572|100894883|FG001|STARTED|Overall Study||430||
48233534|NCT00091572|100894882|FG000|COMPLETED|Overall Study||334||
48233535|NCT00091572|100894883|FG001|COMPLETED|Overall Study||348||
48233536|NCT00091572|100894882|FG000|NOT COMPLETED|Overall Study||95||
48233537|NCT00091572|100894883|FG001|NOT COMPLETED|Overall Study||82||
48233538|NCT02332824|100894884|FG000|STARTED|Overall Study||67||
48533495|NCT02958982|101643212|FG007|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
48533496|NCT02958982|101643213|FG008|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
48533497|NCT02958982|101643214|FG009|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
48233539|NCT02332824|100894885|FG001|STARTED|Overall Study||67||
48233540|NCT02332824|100894886|FG002|STARTED|Overall Study||74||
48233541|NCT02332824|100894887|FG003|STARTED|Overall Study||68||
48233542|NCT02332824|100894888|FG004|STARTED|Overall Study||69||
48233543|NCT02332824|100894889|FG005|STARTED|Overall Study||70||
48233544|NCT02332824|100894884|FG000|COMPLETED|Overall Study||61||
48233545|NCT02332824|100894885|FG001|COMPLETED|Overall Study||66||
48233546|NCT02332824|100894886|FG002|COMPLETED|Overall Study||72||
48233547|NCT02332824|100894887|FG003|COMPLETED|Overall Study||66||
48533498|NCT02958982|101643215|FG010|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
48233548|NCT02332824|100894888|FG004|COMPLETED|Overall Study||65||
48233549|NCT02332824|100894889|FG005|COMPLETED|Overall Study||69||
48233550|NCT02332824|100894884|FG000|NOT COMPLETED|Overall Study||6||
48233551|NCT02332824|100894885|FG001|NOT COMPLETED|Overall Study||1||
48233552|NCT02332824|100894886|FG002|NOT COMPLETED|Overall Study||2||
48233553|NCT02332824|100894887|FG003|NOT COMPLETED|Overall Study||2||
48233554|NCT02332824|100894888|FG004|NOT COMPLETED|Overall Study||4||
48233555|NCT02332824|100894889|FG005|NOT COMPLETED|Overall Study||1||
48233556|NCT00512902|100894890|FG000|STARTED|Overall Study||20||
48233557|NCT00512902|100894890|FG000|COMPLETED|Overall Study||12||
48233558|NCT00512902|100894890|FG000|NOT COMPLETED|Overall Study||8||
48233559|NCT00537914|100894891|FG000|STARTED|Overall Study||278||
48233560|NCT00537914|100894891|FG000|Full Analysis Set (FAS)|Overall Study||278|The FAS followed the ITT principle and comprised all patients who received at least 1 dose of study medication|
48233561|NCT00537914|100894891|FG000|Safety Analysis Set (SAS)|Overall Study||277|The SAF comprised all patients who received at least 1 dose of study medication and had at least 1 post-baseline safety assessment|
48233562|NCT00537914|100894891|FG000|COMPLETED|Overall Study||166||
48233563|NCT00537914|100894891|FG000|NOT COMPLETED|Overall Study||112||
48233564|NCT00239642|100894892|FG000|STARTED|Overall Study||49||
48233565|NCT00239642|100894893|FG001|STARTED|Overall Study||47||
48233566|NCT00239642|100894894|FG002|STARTED|Overall Study||49||
48233567|NCT00239642|100894892|FG000|COMPLETED|Overall Study||47||
48233568|NCT00239642|100894893|FG001|COMPLETED|Overall Study||47||
48233569|NCT00239642|100894894|FG002|COMPLETED|Overall Study||47||
48233570|NCT00239642|100894892|FG000|NOT COMPLETED|Overall Study||2||
48233571|NCT00239642|100894893|FG001|NOT COMPLETED|Overall Study||0||
48233572|NCT00239642|100894894|FG002|NOT COMPLETED|Overall Study||2||
48533499|NCT02958982|101643205|FG000|STARTED|Cohort 2: 100 mg in MAD Study||0||
48233573|NCT01190124|100894895|FG000|STARTED|Overall Study||107||
48233574|NCT01190124|100894896|FG001|STARTED|Overall Study||24||
48233575|NCT01190124|100894897|FG002|STARTED|Overall Study||20||
48233576|NCT01190124|100894895|FG000|COMPLETED|Overall Study||90||
48233577|NCT01190124|100894896|FG001|COMPLETED|Overall Study||24||
48233578|NCT01190124|100894897|FG002|COMPLETED|Overall Study||19||
48233579|NCT01190124|100894895|FG000|NOT COMPLETED|Overall Study||17||
48233580|NCT01190124|100894896|FG001|NOT COMPLETED|Overall Study||0||
48233581|NCT01190124|100894897|FG002|NOT COMPLETED|Overall Study||1||
48233582|NCT05228834|100894898|FG000|STARTED|Overall Study||0||
48233583|NCT05228834|100894899|FG001|STARTED|Overall Study||0||
48233584|NCT05228834|100894898|FG000|COMPLETED|Overall Study||0||
48233585|NCT05228834|100894899|FG001|COMPLETED|Overall Study||0||
48233586|NCT05228834|100894898|FG000|NOT COMPLETED|Overall Study||0||
48233587|NCT05228834|100894899|FG001|NOT COMPLETED|Overall Study||0||
48233588|NCT00498797|100894900|FG000|STARTED|Overall Study||43||
48233589|NCT00498797|100894901|FG001|STARTED|Overall Study||43||
48233590|NCT00498797|100894900|FG000|COMPLETED|Overall Study||5||
48233591|NCT00498797|100894901|FG001|COMPLETED|Overall Study||14||
48533500|NCT02958982|101643206|FG001|STARTED|Cohort 2: 100 mg in MAD Study||0||
48233592|NCT00498797|100894900|FG000|NOT COMPLETED|Overall Study||38||
48233593|NCT00498797|100894901|FG001|NOT COMPLETED|Overall Study||29||
48233594|NCT01386632|100894902|FG000|STARTED|Overall Study||25||
48233595|NCT01386632|100894903|FG001|STARTED|Overall Study||25||
48233596|NCT01386632|100894902|FG000|COMPLETED|Overall Study||20||
48233597|NCT01386632|100894903|FG001|COMPLETED|Overall Study||21||
48533501|NCT02958982|101643207|FG002|STARTED|Cohort 2: 100 mg in MAD Study||0||
48233598|NCT01386632|100894902|FG000|NOT COMPLETED|Overall Study||5||
48233599|NCT01386632|100894903|FG001|NOT COMPLETED|Overall Study||4||
48233600|NCT02245620|100894904|FG000|STARTED|Overall Study||20||
48233601|NCT02245620|100894905|FG001|STARTED|Overall Study||21||
48233602|NCT02245620|100894904|FG000|COMPLETED|Overall Study||19||
48233603|NCT02245620|100894905|FG001|COMPLETED|Overall Study||20||
48233604|NCT02245620|100894904|FG000|NOT COMPLETED|Overall Study||1||
48233605|NCT02245620|100894905|FG001|NOT COMPLETED|Overall Study||1||
48233606|NCT02764320|100894906|FG000|STARTED|Overall Study||361||
48233607|NCT02764320|100894907|FG001|STARTED|Overall Study||359||
48233608|NCT02764320|100894906|FG000|COMPLETED|Overall Study||310||
48233609|NCT02764320|100894907|FG001|COMPLETED|Overall Study||310||
48233610|NCT02764320|100894906|FG000|NOT COMPLETED|Overall Study||51||
48533502|NCT02958982|101643208|FG003|STARTED|Cohort 2: 100 mg in MAD Study||0||
48533503|NCT02958982|101643209|FG004|STARTED|Cohort 2: 100 mg in MAD Study||0||
48533504|NCT02958982|101643210|FG005|STARTED|Cohort 2: 100 mg in MAD Study||0||
48533505|NCT02958982|101643211|FG006|STARTED|Cohort 2: 100 mg in MAD Study||2||
48533506|NCT02958982|101643212|FG007|STARTED|Cohort 2: 100 mg in MAD Study||0||
48533507|NCT02958982|101643213|FG008|STARTED|Cohort 2: 100 mg in MAD Study||6||
48533508|NCT02958982|101643214|FG009|STARTED|Cohort 2: 100 mg in MAD Study||0||
48533509|NCT02958982|101643215|FG010|STARTED|Cohort 2: 100 mg in MAD Study||0||
48533510|NCT02958982|101643205|FG000|COMPLETED|Cohort 2: 100 mg in MAD Study||0||
48533511|NCT02958982|101643206|FG001|COMPLETED|Cohort 2: 100 mg in MAD Study||0||
48533512|NCT02958982|101643207|FG002|COMPLETED|Cohort 2: 100 mg in MAD Study||0||
48533513|NCT02958982|101643208|FG003|COMPLETED|Cohort 2: 100 mg in MAD Study||0||
48533514|NCT02958982|101643209|FG004|COMPLETED|Cohort 2: 100 mg in MAD Study||0||
48533515|NCT02958982|101643210|FG005|COMPLETED|Cohort 2: 100 mg in MAD Study||0||
48533516|NCT02958982|101643211|FG006|COMPLETED|Cohort 2: 100 mg in MAD Study||2||
48533517|NCT02958982|101643212|FG007|COMPLETED|Cohort 2: 100 mg in MAD Study||0||
48533518|NCT02958982|101643213|FG008|COMPLETED|Cohort 2: 100 mg in MAD Study||6||
48533519|NCT02958982|101643214|FG009|COMPLETED|Cohort 2: 100 mg in MAD Study||0||
48533520|NCT02958982|101643215|FG010|COMPLETED|Cohort 2: 100 mg in MAD Study||0||
48533521|NCT02958982|101643205|FG000|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0||
48533522|NCT02958982|101643206|FG001|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0||
48533523|NCT02958982|101643207|FG002|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0||
48533524|NCT02958982|101643208|FG003|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0||
48533525|NCT02958982|101643209|FG004|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0||
48533526|NCT02958982|101643210|FG005|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0||
48533527|NCT02958982|101643211|FG006|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0||
48533528|NCT02958982|101643212|FG007|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0||
48533529|NCT02958982|101643213|FG008|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0||
48533530|NCT02958982|101643214|FG009|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0||
48533531|NCT02958982|101643215|FG010|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0||
48533532|NCT02958982|101643205|FG000|STARTED|Cohort 3: 400 mg in MAD Study||0||
48533533|NCT02958982|101643206|FG001|STARTED|Cohort 3: 400 mg in MAD Study||0||
48533534|NCT02958982|101643207|FG002|STARTED|Cohort 3: 400 mg in MAD Study||0||
48533535|NCT02958982|101643208|FG003|STARTED|Cohort 3: 400 mg in MAD Study||0||
48533536|NCT02958982|101643209|FG004|STARTED|Cohort 3: 400 mg in MAD Study||0||
48533537|NCT02958982|101643210|FG005|STARTED|Cohort 3: 400 mg in MAD Study||0||
48533538|NCT02958982|101643211|FG006|STARTED|Cohort 3: 400 mg in MAD Study||2||
48533539|NCT02958982|101643212|FG007|STARTED|Cohort 3: 400 mg in MAD Study||0||
48533540|NCT02958982|101643213|FG008|STARTED|Cohort 3: 400 mg in MAD Study||0||
48533541|NCT02958982|101643214|FG009|STARTED|Cohort 3: 400 mg in MAD Study||6||
48533542|NCT02958982|101643215|FG010|STARTED|Cohort 3: 400 mg in MAD Study||0||
48233611|NCT02764320|100894907|FG001|NOT COMPLETED|Overall Study||49||
48233612|NCT02128269|100894908|FG000|STARTED|Treatment Period||9||
48533543|NCT02958982|101643205|FG000|COMPLETED|Cohort 3: 400 mg in MAD Study||0||
48533544|NCT02958982|101643206|FG001|COMPLETED|Cohort 3: 400 mg in MAD Study||0||
48533545|NCT02958982|101643207|FG002|COMPLETED|Cohort 3: 400 mg in MAD Study||0||
48533546|NCT02958982|101643208|FG003|COMPLETED|Cohort 3: 400 mg in MAD Study||0||
48233613|NCT02128269|100894908|FG000|COMPLETED|Treatment Period||7||
48533547|NCT02958982|101643209|FG004|COMPLETED|Cohort 3: 400 mg in MAD Study||0||
48533548|NCT02958982|101643210|FG005|COMPLETED|Cohort 3: 400 mg in MAD Study||0||
48533549|NCT02958982|101643211|FG006|COMPLETED|Cohort 3: 400 mg in MAD Study||2||
48533550|NCT02958982|101643212|FG007|COMPLETED|Cohort 3: 400 mg in MAD Study||0||
48533551|NCT02958982|101643213|FG008|COMPLETED|Cohort 3: 400 mg in MAD Study||0||
48533552|NCT02958982|101643214|FG009|COMPLETED|Cohort 3: 400 mg in MAD Study||6||
48533553|NCT02958982|101643215|FG010|COMPLETED|Cohort 3: 400 mg in MAD Study||0||
48233614|NCT02128269|100894908|FG000|NOT COMPLETED|Treatment Period||2||
48233615|NCT02128269|100894908|FG000|STARTED|Follow-up||9||
48233616|NCT02128269|100894908|FG000|COMPLETED|Follow-up||9||
48233617|NCT02128269|100894908|FG000|NOT COMPLETED|Follow-up||0||
48233618|NCT05124210|100894909|FG000|STARTED|Overall Study||3||
48233619|NCT05124210|100894910|FG001|STARTED|Overall Study||5||
48233620|NCT05124210|100894909|FG000|COMPLETED|Overall Study||1||
48233621|NCT05124210|100894910|FG001|COMPLETED|Overall Study||5||
48233622|NCT05124210|100894909|FG000|NOT COMPLETED|Overall Study||2||
48233623|NCT05124210|100894910|FG001|NOT COMPLETED|Overall Study||0||
48533554|NCT02958982|101643205|FG000|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0||
48533555|NCT02958982|101643206|FG001|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0||
48533556|NCT02958982|101643207|FG002|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0||
48533557|NCT02958982|101643208|FG003|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0||
48533558|NCT02958982|101643209|FG004|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0||
48533559|NCT02958982|101643210|FG005|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0||
48533560|NCT02958982|101643211|FG006|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0||
48533561|NCT02958982|101643212|FG007|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0||
48533562|NCT02958982|101643213|FG008|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0||
48533563|NCT02958982|101643214|FG009|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0||
48533564|NCT02958982|101643215|FG010|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0||
48533565|NCT02958982|101643205|FG000|STARTED|Proof of Concept Study||0||
48533566|NCT02958982|101643206|FG001|STARTED|Proof of Concept Study||0||
48533567|NCT02958982|101643207|FG002|STARTED|Proof of Concept Study||0||
48533568|NCT02958982|101643208|FG003|STARTED|Proof of Concept Study||0||
48233624|NCT01381549|100894911|FG000|STARTED|Overall Study||6||
48233625|NCT01381549|100894912|FG001|STARTED|Overall Study||8||
48233626|NCT01381549|100894913|FG002|STARTED|Overall Study||6||
48233627|NCT01381549|100894911|FG000|COMPLETED|Overall Study||6||
48233628|NCT01381549|100894912|FG001|COMPLETED|Overall Study||8||
48233629|NCT01381549|100894913|FG002|COMPLETED|Overall Study||5||
48233630|NCT01381549|100894911|FG000|NOT COMPLETED|Overall Study||0||
48233631|NCT01381549|100894912|FG001|NOT COMPLETED|Overall Study||0||
48233632|NCT01381549|100894913|FG002|NOT COMPLETED|Overall Study||1||
48233633|NCT02470312|100894914|FG000|STARTED|Overall Study||147||
48233634|NCT02470312|100894915|FG001|STARTED|Overall Study||431||
48233635|NCT02470312|100894914|FG000|COMPLETED|Overall Study||142||
48233636|NCT02470312|100894915|FG001|COMPLETED|Overall Study||419||
48233637|NCT02470312|100894914|FG000|NOT COMPLETED|Overall Study||5||
48233638|NCT02470312|100894915|FG001|NOT COMPLETED|Overall Study||12||
48233639|NCT02923349|100894916|FG000|STARTED|Overall Study||4||
48233640|NCT02923349|100894917|FG001|STARTED|Overall Study||4||
48233641|NCT02923349|100894918|FG002|STARTED|Overall Study||22||
48233642|NCT02923349|100894919|FG003|STARTED|Overall Study||18||
48233643|NCT02923349|100894920|FG004|STARTED|Overall Study||23||
48233644|NCT02923349|100894921|FG005|STARTED|Overall Study||12||
48233645|NCT02923349|100894922|FG006|STARTED|Overall Study||4||
48233646|NCT02923349|100894916|FG000|COMPLETED|Overall Study||0||
48233647|NCT02923349|100894917|FG001|COMPLETED|Overall Study||0||
48233648|NCT02923349|100894918|FG002|COMPLETED|Overall Study||5||
48233649|NCT02923349|100894919|FG003|COMPLETED|Overall Study||2||
48233650|NCT02923349|100894920|FG004|COMPLETED|Overall Study||4||
48233651|NCT02923349|100894921|FG005|COMPLETED|Overall Study||5||
48233652|NCT02923349|100894922|FG006|COMPLETED|Overall Study||1||
48233653|NCT02923349|100894916|FG000|NOT COMPLETED|Overall Study||4||
48233654|NCT02923349|100894917|FG001|NOT COMPLETED|Overall Study||4||
48233655|NCT02923349|100894918|FG002|NOT COMPLETED|Overall Study||17||
48233656|NCT02923349|100894919|FG003|NOT COMPLETED|Overall Study||16||
48233657|NCT02923349|100894920|FG004|NOT COMPLETED|Overall Study||19||
48233658|NCT02923349|100894921|FG005|NOT COMPLETED|Overall Study||7||
48233659|NCT02923349|100894922|FG006|NOT COMPLETED|Overall Study||3||
48233660|NCT01195584|100894923|FG000|STARTED|Overall Study||20||
48233661|NCT01195584|100894924|FG001|STARTED|Overall Study||25||
48233662|NCT01195584|100894925|FG002|STARTED|Overall Study||27||
48233663|NCT01195584|100894923|FG000|COMPLETED|Overall Study||20||
48233664|NCT01195584|100894924|FG001|COMPLETED|Overall Study||25||
48233665|NCT01195584|100894925|FG002|COMPLETED|Overall Study||27||
48233666|NCT01195584|100894923|FG000|NOT COMPLETED|Overall Study||0||
48233667|NCT01195584|100894924|FG001|NOT COMPLETED|Overall Study||0||
48233668|NCT01195584|100894925|FG002|NOT COMPLETED|Overall Study||0||
48533569|NCT02958982|101643209|FG004|STARTED|Proof of Concept Study||0||
48233669|NCT01843920|100894926|FG000|STARTED|Overall Study||12||
48233670|NCT01843920|100894927|FG001|STARTED|Overall Study||9||
48233671|NCT01843920|100894926|FG000|COMPLETED|Overall Study||12||
48233672|NCT01843920|100894927|FG001|COMPLETED|Overall Study||9||
48233673|NCT01843920|100894926|FG000|NOT COMPLETED|Overall Study||0||
48233674|NCT01843920|100894927|FG001|NOT COMPLETED|Overall Study||0||
48233675|NCT00603798|100894928|FG000|STARTED|Overall Study||162||
48233676|NCT00603798|100894929|FG001|STARTED|Overall Study||164||
48233677|NCT00603798|100894930|FG002|STARTED|Overall Study||164||
48233678|NCT00603798|100894928|FG000|COMPLETED|Overall Study||152||
48233679|NCT00603798|100894929|FG001|COMPLETED|Overall Study||157||
48233680|NCT00603798|100894930|FG002|COMPLETED|Overall Study||154||
48233681|NCT00603798|100894928|FG000|NOT COMPLETED|Overall Study||10||
48233682|NCT00603798|100894929|FG001|NOT COMPLETED|Overall Study||7||
48233683|NCT00603798|100894930|FG002|NOT COMPLETED|Overall Study||10||
48233684|NCT03137459|100894931|FG000|STARTED|2-month Assessment||455||
48233685|NCT03137459|100894932|FG001|STARTED|2-month Assessment||454||
48233686|NCT03137459|100894931|FG000|COMPLETED|2-month Assessment||387||
48533570|NCT02958982|101643210|FG005|STARTED|Proof of Concept Study||0||
48533571|NCT02958982|101643211|FG006|STARTED|Proof of Concept Study||0||
48233687|NCT03137459|100894932|FG001|COMPLETED|2-month Assessment||412||
48233688|NCT03137459|100894931|FG000|NOT COMPLETED|2-month Assessment||68||
48233689|NCT03137459|100894932|FG001|NOT COMPLETED|2-month Assessment||42||
48233690|NCT03137459|100894931|FG000|STARTED|4-month Assessment||442||
48233691|NCT03137459|100894932|FG001|STARTED|4-month Assessment||451||
48233692|NCT03137459|100894931|FG000|COMPLETED|4-month Assessment||364||
48233693|NCT03137459|100894932|FG001|COMPLETED|4-month Assessment||405||
48233694|NCT03137459|100894931|FG000|NOT COMPLETED|4-month Assessment||78||
48233695|NCT03137459|100894932|FG001|NOT COMPLETED|4-month Assessment||46||
48233696|NCT03137459|100894931|FG000|STARTED|6-months||434||
48233697|NCT03137459|100894932|FG001|STARTED|6-months||447||
48233698|NCT03137459|100894931|FG000|COMPLETED|6-months||413||
48233699|NCT03137459|100894932|FG001|COMPLETED|6-months||430||
48233700|NCT03137459|100894931|FG000|NOT COMPLETED|6-months||21||
48233701|NCT03137459|100894932|FG001|NOT COMPLETED|6-months||17||
48233702|NCT01328756|100894933|FG000|STARTED|Overall Study||314||
48233703|NCT01328756|100894933|FG000|COMPLETED|Overall Study||191||
48233704|NCT01328756|100894933|FG000|NOT COMPLETED|Overall Study||123||
48233705|NCT02607956|100894934|FG000|STARTED|Double-Blinded Phase||327||
48233706|NCT02607956|100894935|FG001|STARTED|Double-Blinded Phase||330||
48533572|NCT02958982|101643212|FG007|STARTED|Proof of Concept Study||0||
48233707|NCT02607956|100894936|FG002|STARTED|Double-Blinded Phase||0||
48233708|NCT02607956|100894937|FG003|STARTED|Double-Blinded Phase||0||
48533573|NCT02958982|101643213|FG008|STARTED|Proof of Concept Study||0||
48533574|NCT02958982|101643214|FG009|STARTED|Proof of Concept Study||0||
48533575|NCT02958982|101643215|FG010|STARTED|Proof of Concept Study||1||
48533576|NCT02958982|101643205|FG000|COMPLETED|Proof of Concept Study||0||
48533577|NCT02958982|101643206|FG001|COMPLETED|Proof of Concept Study||0||
48533578|NCT02958982|101643207|FG002|COMPLETED|Proof of Concept Study||0||
48533579|NCT02958982|101643208|FG003|COMPLETED|Proof of Concept Study||0||
48533580|NCT02958982|101643209|FG004|COMPLETED|Proof of Concept Study||0||
48533581|NCT02958982|101643210|FG005|COMPLETED|Proof of Concept Study||0||
48533582|NCT02958982|101643211|FG006|COMPLETED|Proof of Concept Study||0||
48533583|NCT02958982|101643212|FG007|COMPLETED|Proof of Concept Study||0||
48533584|NCT02958982|101643213|FG008|COMPLETED|Proof of Concept Study||0||
48533585|NCT02958982|101643214|FG009|COMPLETED|Proof of Concept Study||0||
48533586|NCT02958982|101643215|FG010|COMPLETED|Proof of Concept Study||1||
48533587|NCT02958982|101643205|FG000|NOT COMPLETED|Proof of Concept Study||0||
48533588|NCT02958982|101643206|FG001|NOT COMPLETED|Proof of Concept Study||0||
48533589|NCT02958982|101643207|FG002|NOT COMPLETED|Proof of Concept Study||0||
48533590|NCT02958982|101643208|FG003|NOT COMPLETED|Proof of Concept Study||0||
48533591|NCT02958982|101643209|FG004|NOT COMPLETED|Proof of Concept Study||0||
48533592|NCT02958982|101643210|FG005|NOT COMPLETED|Proof of Concept Study||0||
48533593|NCT02958982|101643211|FG006|NOT COMPLETED|Proof of Concept Study||0||
48233709|NCT02607956|100894934|FG000|COMPLETED|Double-Blinded Phase||266||
48233710|NCT02607956|100894935|FG001|COMPLETED|Double-Blinded Phase||277||
48233711|NCT02607956|100894936|FG002|COMPLETED|Double-Blinded Phase||0||
48233712|NCT02607956|100894937|FG003|COMPLETED|Double-Blinded Phase||0||
48233713|NCT02607956|100894934|FG000|NOT COMPLETED|Double-Blinded Phase||61||
48233714|NCT02607956|100894935|FG001|NOT COMPLETED|Double-Blinded Phase||53||
48233715|NCT02607956|100894936|FG002|NOT COMPLETED|Double-Blinded Phase||0||
48533594|NCT02958982|101643212|FG007|NOT COMPLETED|Proof of Concept Study||0||
48533595|NCT02958982|101643213|FG008|NOT COMPLETED|Proof of Concept Study||0||
48533596|NCT02958982|101643214|FG009|NOT COMPLETED|Proof of Concept Study||0||
48533597|NCT02958982|101643215|FG010|NOT COMPLETED|Proof of Concept Study||0||
48533598|NCT00252239|101643216|FG000|STARTED|Overall Study||31||
48533599|NCT00252239|101643217|FG001|STARTED|Overall Study||31||
48533600|NCT00252239|101643218|FG002|STARTED|Overall Study||19||
48533601|NCT00252239|101643219|FG003|STARTED|Overall Study||31||
48533602|NCT00252239|101643216|FG000|COMPLETED|Overall Study||30||
48533603|NCT00252239|101643217|FG001|COMPLETED|Overall Study||31||
48533604|NCT00252239|101643218|FG002|COMPLETED|Overall Study||17||
48533605|NCT00252239|101643219|FG003|COMPLETED|Overall Study||30||
48533606|NCT00252239|101643216|FG000|NOT COMPLETED|Overall Study||1||
48533607|NCT00252239|101643217|FG001|NOT COMPLETED|Overall Study||0||
48533608|NCT00252239|101643218|FG002|NOT COMPLETED|Overall Study||2||
48533609|NCT00252239|101643219|FG003|NOT COMPLETED|Overall Study||1||
48533610|NCT01996332|101643220|FG000|STARTED|Overall Study||1805||
48533611|NCT01996332|101643220|FG000|COMPLETED|Overall Study||0||
48533612|NCT01996332|101643220|FG000|NOT COMPLETED|Overall Study||1805||
48533613|NCT00619112|101643221|FG000|STARTED|Overall Study||40||
48533614|NCT00619112|101643222|FG001|STARTED|Overall Study||20||
48533615|NCT00619112|101643221|FG000|COMPLETED|Overall Study||39||
48233716|NCT02607956|100894937|FG003|NOT COMPLETED|Double-Blinded Phase||0||
48233717|NCT02607956|100894934|FG000|STARTED|Open-Label Extension Phase||0||
48233718|NCT02607956|100894935|FG001|STARTED|Open-Label Extension Phase||0||
48533616|NCT00619112|101643222|FG001|COMPLETED|Overall Study||18||
48533617|NCT00619112|101643221|FG000|NOT COMPLETED|Overall Study||1||
48533618|NCT00619112|101643222|FG001|NOT COMPLETED|Overall Study||2||
48533619|NCT01830205|101643223|FG000|STARTED|Overall Study||12||
48533620|NCT01830205|101643224|FG001|STARTED|Overall Study||6||
48533621|NCT01830205|101643225|FG002|STARTED|Overall Study||6||
48533622|NCT01830205|101643226|FG003|STARTED|Overall Study||12||
48533623|NCT01830205|101643223|FG000|COMPLETED|Overall Study||12||
48533624|NCT01830205|101643224|FG001|COMPLETED|Overall Study||6||
48533625|NCT01830205|101643225|FG002|COMPLETED|Overall Study||6||
48533626|NCT01830205|101643226|FG003|COMPLETED|Overall Study||12||
48533627|NCT01830205|101643223|FG000|NOT COMPLETED|Overall Study||0||
48533628|NCT01830205|101643224|FG001|NOT COMPLETED|Overall Study||0||
48533629|NCT01830205|101643225|FG002|NOT COMPLETED|Overall Study||0||
48533630|NCT01830205|101643226|FG003|NOT COMPLETED|Overall Study||0||
48533631|NCT01268501|101643227|FG000|STARTED|Overall Study||96||
48533632|NCT01268501|101643227|FG000|COMPLETED|Overall Study||87||
48533633|NCT01268501|101643227|FG000|NOT COMPLETED|Overall Study||9||
48533634|NCT03301623|101643228|FG000|STARTED|Overall Study||462||
48533635|NCT03301623|101643229|FG001|STARTED|Overall Study||521||
48533636|NCT03301623|101643228|FG000|COMPLETED|Overall Study||445||
48533637|NCT03301623|101643229|FG001|COMPLETED|Overall Study||506||
48533638|NCT03301623|101643228|FG000|NOT COMPLETED|Overall Study||17||
48533639|NCT03301623|101643229|FG001|NOT COMPLETED|Overall Study||15||
48533640|NCT02885181|101643230|FG000|STARTED|Overall Study||20||
48533641|NCT02885181|101643231|FG001|STARTED|Overall Study||20||
48533642|NCT02885181|101643232|FG002|STARTED|Overall Study||21||
48533643|NCT02885181|101643233|FG003|STARTED|Overall Study||22||
48533644|NCT02885181|101643230|FG000|COMPLETED|Overall Study||20||
48533645|NCT02885181|101643231|FG001|COMPLETED|Overall Study||19||
48533646|NCT02885181|101643232|FG002|COMPLETED|Overall Study||21||
48533647|NCT02885181|101643233|FG003|COMPLETED|Overall Study||19||
48533648|NCT02885181|101643230|FG000|NOT COMPLETED|Overall Study||0||
48533649|NCT02885181|101643231|FG001|NOT COMPLETED|Overall Study||1||
48533650|NCT02885181|101643232|FG002|NOT COMPLETED|Overall Study||0||
48533651|NCT02885181|101643233|FG003|NOT COMPLETED|Overall Study||3||
48533652|NCT02564211|101643234|FG000|STARTED|Overall Study||77||
48533653|NCT02564211|101643234|FG000|COMPLETED|Overall Study||73||
48533654|NCT02564211|101643234|FG000|NOT COMPLETED|Overall Study||4||
48533655|NCT03654599|101643235|FG000|STARTED|Overall Study||106|The Enrollment number includes all participants (both patients and caregivers). 106 participants = 53 patient-caregiver dyads.|
48533656|NCT03654599|101643236|FG001|STARTED|Overall Study||92|The Enrollment number includes all participants (both patients and caregivers). 106 participants = 53 patient-caregiver dyads.|
48533657|NCT03654599|101643235|FG000|COMPLETED|Overall Study||78||
48533658|NCT03654599|101643236|FG001|COMPLETED|Overall Study||70||
48533659|NCT03654599|101643235|FG000|NOT COMPLETED|Overall Study||28||
48533660|NCT03654599|101643236|FG001|NOT COMPLETED|Overall Study||22||
48533661|NCT03469336|101643237|FG000|STARTED|Overall Study||18||
48533662|NCT03469336|101643237|FG000|COMPLETED|Overall Study||17||
48533663|NCT03469336|101643237|FG000|NOT COMPLETED|Overall Study||1||
48533664|NCT04844762|101643238|FG000|STARTED|Phase 1 First Smoking Session (2 Hrs)||17||
48533665|NCT04844762|101643239|FG001|STARTED|Phase 1 First Smoking Session (2 Hrs)||17||
48533666|NCT04844762|101643240|FG002|STARTED|Phase 1 First Smoking Session (2 Hrs)||17||
48533667|NCT04844762|101643241|FG003|STARTED|Phase 1 First Smoking Session (2 Hrs)||18||
48533668|NCT04844762|101643242|FG004|STARTED|Phase 1 First Smoking Session (2 Hrs)||17||
48533669|NCT04844762|101643243|FG005|STARTED|Phase 1 First Smoking Session (2 Hrs)||17||
48533670|NCT04844762|101643238|FG000|COMPLETED|Phase 1 First Smoking Session (2 Hrs)||17||
48533671|NCT04844762|101643239|FG001|COMPLETED|Phase 1 First Smoking Session (2 Hrs)||16||
48533672|NCT04844762|101643240|FG002|COMPLETED|Phase 1 First Smoking Session (2 Hrs)||15||
48533673|NCT04844762|101643241|FG003|COMPLETED|Phase 1 First Smoking Session (2 Hrs)||17||
48533674|NCT04844762|101643242|FG004|COMPLETED|Phase 1 First Smoking Session (2 Hrs)||17||
48533675|NCT04844762|101643243|FG005|COMPLETED|Phase 1 First Smoking Session (2 Hrs)||16||
48533676|NCT04844762|101643238|FG000|NOT COMPLETED|Phase 1 First Smoking Session (2 Hrs)||0||
48533677|NCT04844762|101643239|FG001|NOT COMPLETED|Phase 1 First Smoking Session (2 Hrs)||1||
48533678|NCT04844762|101643240|FG002|NOT COMPLETED|Phase 1 First Smoking Session (2 Hrs)||2||
48533679|NCT04844762|101643241|FG003|NOT COMPLETED|Phase 1 First Smoking Session (2 Hrs)||1||
48533680|NCT04844762|101643242|FG004|NOT COMPLETED|Phase 1 First Smoking Session (2 Hrs)||0||
48533681|NCT04844762|101643243|FG005|NOT COMPLETED|Phase 1 First Smoking Session (2 Hrs)||1||
48533682|NCT04844762|101643238|FG000|STARTED|Phase 1 Second Smoking Session (2 Hrs)||17||
48533683|NCT04844762|101643239|FG001|STARTED|Phase 1 Second Smoking Session (2 Hrs)||16||
48533684|NCT04844762|101643240|FG002|STARTED|Phase 1 Second Smoking Session (2 Hrs)||15||
48533685|NCT04844762|101643241|FG003|STARTED|Phase 1 Second Smoking Session (2 Hrs)||17||
48533686|NCT04844762|101643242|FG004|STARTED|Phase 1 Second Smoking Session (2 Hrs)||17||
48533687|NCT04844762|101643243|FG005|STARTED|Phase 1 Second Smoking Session (2 Hrs)||16||
48533688|NCT04844762|101643238|FG000|COMPLETED|Phase 1 Second Smoking Session (2 Hrs)||16||
48533689|NCT04844762|101643239|FG001|COMPLETED|Phase 1 Second Smoking Session (2 Hrs)||14||
48533690|NCT04844762|101643240|FG002|COMPLETED|Phase 1 Second Smoking Session (2 Hrs)||13||
48533691|NCT04844762|101643241|FG003|COMPLETED|Phase 1 Second Smoking Session (2 Hrs)||13||
48533692|NCT04844762|101643242|FG004|COMPLETED|Phase 1 Second Smoking Session (2 Hrs)||15||
48533693|NCT04844762|101643243|FG005|COMPLETED|Phase 1 Second Smoking Session (2 Hrs)||15||
48533694|NCT04844762|101643238|FG000|NOT COMPLETED|Phase 1 Second Smoking Session (2 Hrs)||1||
48533695|NCT04844762|101643239|FG001|NOT COMPLETED|Phase 1 Second Smoking Session (2 Hrs)||2||
48533696|NCT04844762|101643240|FG002|NOT COMPLETED|Phase 1 Second Smoking Session (2 Hrs)||2||
48233719|NCT02607956|100894936|FG002|STARTED|Open-Label Extension Phase||254||
48233720|NCT02607956|100894937|FG003|STARTED|Open-Label Extension Phase||265||
48233721|NCT02607956|100894934|FG000|COMPLETED|Open-Label Extension Phase||0||
48233722|NCT02607956|100894935|FG001|COMPLETED|Open-Label Extension Phase||0||
48233723|NCT02607956|100894936|FG002|COMPLETED|Open-Label Extension Phase||225||
48233724|NCT02607956|100894937|FG003|COMPLETED|Open-Label Extension Phase||235||
48233725|NCT02607956|100894934|FG000|NOT COMPLETED|Open-Label Extension Phase||0||
48233726|NCT02607956|100894935|FG001|NOT COMPLETED|Open-Label Extension Phase||0||
48233727|NCT02607956|100894936|FG002|NOT COMPLETED|Open-Label Extension Phase||29||
48233728|NCT02607956|100894937|FG003|NOT COMPLETED|Open-Label Extension Phase||30||
48233729|NCT01542502|100894938|FG000|STARTED|Overall Study||6||
48233730|NCT01542502|100894939|FG001|STARTED|Overall Study||6||
48233731|NCT01542502|100894938|FG000|COMPLETED|Overall Study||6||
48233732|NCT01542502|100894939|FG001|COMPLETED|Overall Study||6||
48233733|NCT01542502|100894938|FG000|NOT COMPLETED|Overall Study||0||
48233734|NCT01542502|100894939|FG001|NOT COMPLETED|Overall Study||0||
48233735|NCT01945086|100894940|FG000|STARTED|Overall Study||27||
48233736|NCT01945086|100894941|FG001|STARTED|Overall Study||24||
48233737|NCT01945086|100894942|FG002|STARTED|Overall Study||28||
48233738|NCT01945086|100894940|FG000|COMPLETED|Overall Study||26||
48233739|NCT01945086|100894941|FG001|COMPLETED|Overall Study||24||
48233740|NCT01945086|100894942|FG002|COMPLETED|Overall Study||26||
48233741|NCT01945086|100894940|FG000|NOT COMPLETED|Overall Study||1||
48233742|NCT01945086|100894941|FG001|NOT COMPLETED|Overall Study||0||
48233743|NCT01945086|100894942|FG002|NOT COMPLETED|Overall Study||2||
48233744|NCT03746015|100894943|FG000|STARTED|Overall Study||22||
48233745|NCT03746015|100894944|FG001|STARTED|Overall Study||4||
48233746|NCT03746015|100894945|FG002|STARTED|Overall Study||3||
48233747|NCT03746015|100894943|FG000|Safety Population|Overall Study||22|Safety Analysis Set included all participants who received at least one dose of trial vaccine. One participant was seropositive for all dengue strains at Screening and was therefore not allocated to dengue serotype 1 or 3 positive groups. The participant did receive two vaccine doses and was thus included in Safety Analysis Set.|
48233748|NCT03746015|100894944|FG001|Safety Population|Overall Study||4|Safety Analysis Set included all participants who received at least one dose of trial vaccine. One participant was seropositive for all dengue strains at Screening and was therefore not allocated to dengue serotype 1 or 3 positive groups. The participant did receive two vaccine doses and was thus included in Safety Analysis Set.|
48233749|NCT03746015|100894945|FG002|Safety Population|Overall Study||3|Safety Analysis Set included all participants who received at least one dose of trial vaccine. One participant was seropositive for all dengue strains at Screening and was therefore not allocated to dengue serotype 1 or 3 positive groups. The participant did receive two vaccine doses and was thus included in Safety Analysis Set.|
48233750|NCT03746015|100894943|FG000|COMPLETED|Overall Study||21||
48233751|NCT03746015|100894944|FG001|COMPLETED|Overall Study||4||
48233752|NCT03746015|100894945|FG002|COMPLETED|Overall Study||3||
48233753|NCT03746015|100894943|FG000|NOT COMPLETED|Overall Study||1||
48233754|NCT03746015|100894944|FG001|NOT COMPLETED|Overall Study||0||
48233755|NCT03746015|100894945|FG002|NOT COMPLETED|Overall Study||0||
48233756|NCT03345407|100894946|FG000|STARTED|Overall Study||276||
48233757|NCT03345407|100894947|FG001|STARTED|Overall Study||22||
48233758|NCT03345407|100894948|FG002|STARTED|Overall Study||91||
48233759|NCT03345407|100894949|FG003|STARTED|Overall Study||92||
48233760|NCT03345407|100894950|FG004|STARTED|Overall Study||90||
48233761|NCT03345407|100894951|FG005|STARTED|Overall Study||89||
48233762|NCT03345407|100894952|FG006|STARTED|Overall Study||278||
48233763|NCT03345407|100894946|FG000|COMPLETED|Overall Study||244||
48233764|NCT03345407|100894947|FG001|COMPLETED|Overall Study||19||
48233765|NCT03345407|100894948|FG002|COMPLETED|Overall Study||79||
48233766|NCT03345407|100894949|FG003|COMPLETED|Overall Study||81||
48233767|NCT03345407|100894950|FG004|COMPLETED|Overall Study||75||
48233768|NCT03345407|100894951|FG005|COMPLETED|Overall Study||73||
48233769|NCT03345407|100894952|FG006|COMPLETED|Overall Study||233||
48233770|NCT03345407|100894946|FG000|NOT COMPLETED|Overall Study||32||
48233771|NCT03345407|100894947|FG001|NOT COMPLETED|Overall Study||3||
48233772|NCT03345407|100894948|FG002|NOT COMPLETED|Overall Study||12||
48233773|NCT03345407|100894949|FG003|NOT COMPLETED|Overall Study||11||
48233774|NCT03345407|100894950|FG004|NOT COMPLETED|Overall Study||15||
48233775|NCT03345407|100894951|FG005|NOT COMPLETED|Overall Study||16||
48233776|NCT03345407|100894952|FG006|NOT COMPLETED|Overall Study||45||
48233777|NCT00872339|100894953|FG000|STARTED|Overall Study||201||
48233778|NCT00872339|100894954|FG001|STARTED|Overall Study||14||
48233779|NCT00872339|100894955|FG002|STARTED|Overall Study||37||
48233780|NCT00872339|100894953|FG000|COMPLETED|Overall Study||201||
48233781|NCT00872339|100894954|FG001|COMPLETED|Overall Study||14||
48233782|NCT00872339|100894955|FG002|COMPLETED|Overall Study||37||
48233783|NCT00872339|100894953|FG000|NOT COMPLETED|Overall Study||0||
48233784|NCT00872339|100894954|FG001|NOT COMPLETED|Overall Study||0||
48233785|NCT00872339|100894955|FG002|NOT COMPLETED|Overall Study||0||
48233786|NCT05303324|100894956|FG000|STARTED|Treatment Period 1||25||
48233787|NCT05303324|100894957|FG001|STARTED|Treatment Period 1||23||
48233788|NCT05303324|100894956|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||25||
48233789|NCT05303324|100894957|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||23||
48233790|NCT05303324|100894956|FG000|COMPLETED|Treatment Period 1||25||
48233791|NCT05303324|100894957|FG001|COMPLETED|Treatment Period 1||23||
48233792|NCT05303324|100894956|FG000|NOT COMPLETED|Treatment Period 1||0||
48233793|NCT05303324|100894957|FG001|NOT COMPLETED|Treatment Period 1||0||
48233794|NCT05303324|100894956|FG000|STARTED|Treatment Period 2||25||
48533697|NCT04844762|101643241|FG003|NOT COMPLETED|Phase 1 Second Smoking Session (2 Hrs)||4||
48533698|NCT04844762|101643242|FG004|NOT COMPLETED|Phase 1 Second Smoking Session (2 Hrs)||2||
48533699|NCT04844762|101643243|FG005|NOT COMPLETED|Phase 1 Second Smoking Session (2 Hrs)||1||
48233795|NCT05303324|100894957|FG001|STARTED|Treatment Period 2||23||
48233796|NCT05303324|100894956|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||25||
48233797|NCT05303324|100894957|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2||23||
48233798|NCT05303324|100894956|FG000|COMPLETED|Treatment Period 2||25||
48233799|NCT05303324|100894957|FG001|COMPLETED|Treatment Period 2||23||
48533700|NCT04844762|101643238|FG000|STARTED|Phase 1 Third Smoking Session (2 Hrs)||16||
48533701|NCT04844762|101643239|FG001|STARTED|Phase 1 Third Smoking Session (2 Hrs)||14||
48533702|NCT04844762|101643240|FG002|STARTED|Phase 1 Third Smoking Session (2 Hrs)||13||
48533703|NCT04844762|101643241|FG003|STARTED|Phase 1 Third Smoking Session (2 Hrs)||13||
48533704|NCT04844762|101643242|FG004|STARTED|Phase 1 Third Smoking Session (2 Hrs)||15||
48533705|NCT04844762|101643243|FG005|STARTED|Phase 1 Third Smoking Session (2 Hrs)||15||
48533706|NCT04844762|101643238|FG000|COMPLETED|Phase 1 Third Smoking Session (2 Hrs)||14||
48533707|NCT04844762|101643239|FG001|COMPLETED|Phase 1 Third Smoking Session (2 Hrs)||14||
48533708|NCT04844762|101643240|FG002|COMPLETED|Phase 1 Third Smoking Session (2 Hrs)||13||
48533709|NCT04844762|101643241|FG003|COMPLETED|Phase 1 Third Smoking Session (2 Hrs)||13||
48533710|NCT04844762|101643242|FG004|COMPLETED|Phase 1 Third Smoking Session (2 Hrs)||14||
48533711|NCT04844762|101643243|FG005|COMPLETED|Phase 1 Third Smoking Session (2 Hrs)||15||
48533712|NCT04844762|101643238|FG000|NOT COMPLETED|Phase 1 Third Smoking Session (2 Hrs)||2||
48533713|NCT04844762|101643239|FG001|NOT COMPLETED|Phase 1 Third Smoking Session (2 Hrs)||0||
48533714|NCT04844762|101643240|FG002|NOT COMPLETED|Phase 1 Third Smoking Session (2 Hrs)||0||
48533715|NCT04844762|101643241|FG003|NOT COMPLETED|Phase 1 Third Smoking Session (2 Hrs)||0||
48533716|NCT04844762|101643242|FG004|NOT COMPLETED|Phase 1 Third Smoking Session (2 Hrs)||1||
48533717|NCT04844762|101643243|FG005|NOT COMPLETED|Phase 1 Third Smoking Session (2 Hrs)||0||
48533718|NCT04844762|101643238|FG000|STARTED|Phase 1 Fourth Smoking Session (2 Hrs)||14||
48533719|NCT04844762|101643239|FG001|STARTED|Phase 1 Fourth Smoking Session (2 Hrs)||14||
48533720|NCT04844762|101643240|FG002|STARTED|Phase 1 Fourth Smoking Session (2 Hrs)||13||
48533721|NCT04844762|101643241|FG003|STARTED|Phase 1 Fourth Smoking Session (2 Hrs)||13||
48533722|NCT04844762|101643242|FG004|STARTED|Phase 1 Fourth Smoking Session (2 Hrs)||14||
48533723|NCT04844762|101643243|FG005|STARTED|Phase 1 Fourth Smoking Session (2 Hrs)||15||
48533724|NCT04844762|101643238|FG000|COMPLETED|Phase 1 Fourth Smoking Session (2 Hrs)||13||
48533725|NCT04844762|101643239|FG001|COMPLETED|Phase 1 Fourth Smoking Session (2 Hrs)||13||
48533726|NCT04844762|101643240|FG002|COMPLETED|Phase 1 Fourth Smoking Session (2 Hrs)||13||
48533727|NCT04844762|101643241|FG003|COMPLETED|Phase 1 Fourth Smoking Session (2 Hrs)||13||
48533728|NCT04844762|101643242|FG004|COMPLETED|Phase 1 Fourth Smoking Session (2 Hrs)||14||
48533729|NCT04844762|101643243|FG005|COMPLETED|Phase 1 Fourth Smoking Session (2 Hrs)||14||
48533730|NCT04844762|101643238|FG000|NOT COMPLETED|Phase 1 Fourth Smoking Session (2 Hrs)||1||
48533731|NCT04844762|101643239|FG001|NOT COMPLETED|Phase 1 Fourth Smoking Session (2 Hrs)||1||
48533732|NCT04844762|101643240|FG002|NOT COMPLETED|Phase 1 Fourth Smoking Session (2 Hrs)||0||
48533733|NCT04844762|101643241|FG003|NOT COMPLETED|Phase 1 Fourth Smoking Session (2 Hrs)||0||
48533734|NCT04844762|101643242|FG004|NOT COMPLETED|Phase 1 Fourth Smoking Session (2 Hrs)||0||
48533735|NCT04844762|101643243|FG005|NOT COMPLETED|Phase 1 Fourth Smoking Session (2 Hrs)||1||
48533736|NCT04844762|101643238|FG000|STARTED|Phase 2 - 1 Week of Daily Diaries||13||
48233800|NCT05303324|100894956|FG000|NOT COMPLETED|Treatment Period 2||0||
48233801|NCT05303324|100894957|FG001|NOT COMPLETED|Treatment Period 2||0||
48233802|NCT01062165|100894958|FG000|STARTED|Overall Study||18||
48233803|NCT01062165|100894958|FG000|COMPLETED|Overall Study||18||
48233804|NCT01062165|100894958|FG000|NOT COMPLETED|Overall Study||0||
48233805|NCT00869609|100894959|FG000|STARTED|Overall Study||31||
48233806|NCT00869609|100894960|FG001|STARTED|Overall Study||29||
48233807|NCT00869609|100894959|FG000|COMPLETED|Overall Study||25||
48533737|NCT04844762|101643239|FG001|STARTED|Phase 2 - 1 Week of Daily Diaries||13||
48533738|NCT04844762|101643240|FG002|STARTED|Phase 2 - 1 Week of Daily Diaries||13||
48233808|NCT00869609|100894960|FG001|COMPLETED|Overall Study||26||
48233809|NCT00869609|100894959|FG000|NOT COMPLETED|Overall Study||6||
48233810|NCT00869609|100894960|FG001|NOT COMPLETED|Overall Study||3||
48233811|NCT01330953|100894961|FG000|STARTED|Overall Study||8||
48233812|NCT01330953|100894962|FG001|STARTED|Overall Study||6||
48233813|NCT01330953|100894963|FG002|STARTED|Overall Study||6||
48233814|NCT01330953|100894964|FG003|STARTED|Overall Study||6||
48233815|NCT01330953|100894965|FG004|STARTED|Overall Study||6||
48533739|NCT04844762|101643241|FG003|STARTED|Phase 2 - 1 Week of Daily Diaries||13||
48533740|NCT04844762|101643242|FG004|STARTED|Phase 2 - 1 Week of Daily Diaries||14||
48533741|NCT04844762|101643243|FG005|STARTED|Phase 2 - 1 Week of Daily Diaries||14||
48233816|NCT01330953|100894961|FG000|COMPLETED|Overall Study||8||
48233817|NCT01330953|100894962|FG001|COMPLETED|Overall Study||6||
48233818|NCT01330953|100894963|FG002|COMPLETED|Overall Study||6||
48233819|NCT01330953|100894964|FG003|COMPLETED|Overall Study||6||
48233820|NCT01330953|100894965|FG004|COMPLETED|Overall Study||6||
48233821|NCT01330953|100894961|FG000|NOT COMPLETED|Overall Study||0||
48233822|NCT01330953|100894962|FG001|NOT COMPLETED|Overall Study||0||
48233823|NCT01330953|100894963|FG002|NOT COMPLETED|Overall Study||0||
48233824|NCT01330953|100894964|FG003|NOT COMPLETED|Overall Study||0||
48233825|NCT01330953|100894965|FG004|NOT COMPLETED|Overall Study||0||
48233826|NCT00547456|100894966|FG000|STARTED|Overall Study||20||
48233827|NCT00547456|100894966|FG000|COMPLETED|Overall Study||20||
48233828|NCT00547456|100894966|FG000|NOT COMPLETED|Overall Study||0||
48233829|NCT02446015|100894967|FG000|STARTED|Overall Study||34||
48233830|NCT02446015|100894968|FG001|STARTED|Overall Study||63||
48233831|NCT02446015|100894967|FG000|COMPLETED|Overall Study||33||
48533742|NCT04844762|101643238|FG000|Menthol Roll Your Own|Phase 2 - 1 Week of Daily Diaries||9||
48533743|NCT04844762|101643239|FG001|Menthol Roll Your Own|Phase 2 - 1 Week of Daily Diaries||9||
48533744|NCT04844762|101643240|FG002|Menthol Roll Your Own|Phase 2 - 1 Week of Daily Diaries||9||
48533745|NCT04844762|101643241|FG003|Menthol Roll Your Own|Phase 2 - 1 Week of Daily Diaries||8||
48533746|NCT04844762|101643242|FG004|Menthol Roll Your Own|Phase 2 - 1 Week of Daily Diaries||7||
48533747|NCT04844762|101643243|FG005|Menthol Roll Your Own|Phase 2 - 1 Week of Daily Diaries||10||
48533748|NCT04844762|101643238|FG000|Menthol Filtered Little Cigars|Phase 2 - 1 Week of Daily Diaries||1||
48533749|NCT04844762|101643239|FG001|Menthol Filtered Little Cigars|Phase 2 - 1 Week of Daily Diaries||2||
48533750|NCT04844762|101643240|FG002|Menthol Filtered Little Cigars|Phase 2 - 1 Week of Daily Diaries||1||
48533751|NCT04844762|101643241|FG003|Menthol Filtered Little Cigars|Phase 2 - 1 Week of Daily Diaries||3||
48533752|NCT04844762|101643242|FG004|Menthol Filtered Little Cigars|Phase 2 - 1 Week of Daily Diaries||2||
48533753|NCT04844762|101643243|FG005|Menthol Filtered Little Cigars|Phase 2 - 1 Week of Daily Diaries||1||
48533754|NCT04844762|101643238|FG000|Non-Menthol Cigarettes|Phase 2 - 1 Week of Daily Diaries||3||
48533755|NCT04844762|101643239|FG001|Non-Menthol Cigarettes|Phase 2 - 1 Week of Daily Diaries||2||
48533756|NCT04844762|101643240|FG002|Non-Menthol Cigarettes|Phase 2 - 1 Week of Daily Diaries||3||
48533757|NCT04844762|101643241|FG003|Non-Menthol Cigarettes|Phase 2 - 1 Week of Daily Diaries||2||
48533758|NCT04844762|101643242|FG004|Non-Menthol Cigarettes|Phase 2 - 1 Week of Daily Diaries||5||
48533759|NCT04844762|101643243|FG005|Non-Menthol Cigarettes|Phase 2 - 1 Week of Daily Diaries||3||
48533760|NCT04844762|101643238|FG000|COMPLETED|Phase 2 - 1 Week of Daily Diaries||13||
48533761|NCT04844762|101643239|FG001|COMPLETED|Phase 2 - 1 Week of Daily Diaries||13||
48533762|NCT04844762|101643240|FG002|COMPLETED|Phase 2 - 1 Week of Daily Diaries||13||
48533763|NCT04844762|101643241|FG003|COMPLETED|Phase 2 - 1 Week of Daily Diaries||13||
48533764|NCT04844762|101643242|FG004|COMPLETED|Phase 2 - 1 Week of Daily Diaries||14||
48533765|NCT04844762|101643243|FG005|COMPLETED|Phase 2 - 1 Week of Daily Diaries||14||
48533766|NCT04844762|101643238|FG000|NOT COMPLETED|Phase 2 - 1 Week of Daily Diaries||0||
48533767|NCT04844762|101643239|FG001|NOT COMPLETED|Phase 2 - 1 Week of Daily Diaries||0||
48533768|NCT04844762|101643240|FG002|NOT COMPLETED|Phase 2 - 1 Week of Daily Diaries||0||
48533769|NCT04844762|101643241|FG003|NOT COMPLETED|Phase 2 - 1 Week of Daily Diaries||0||
48533770|NCT04844762|101643242|FG004|NOT COMPLETED|Phase 2 - 1 Week of Daily Diaries||0||
48533771|NCT04844762|101643243|FG005|NOT COMPLETED|Phase 2 - 1 Week of Daily Diaries||0||
48533772|NCT04844762|101643238|FG000|STARTED|Phase 3 Chosen Product Visit (~3 Hrs)||13||
48233832|NCT02446015|100894968|FG001|COMPLETED|Overall Study||62||
48233833|NCT02446015|100894967|FG000|NOT COMPLETED|Overall Study||1||
48233834|NCT02446015|100894968|FG001|NOT COMPLETED|Overall Study||1||
48233835|NCT04405180|100894969|FG000|STARTED|Overall Study||32||
48533773|NCT04844762|101643239|FG001|STARTED|Phase 3 Chosen Product Visit (~3 Hrs)||13||
48533774|NCT04844762|101643240|FG002|STARTED|Phase 3 Chosen Product Visit (~3 Hrs)||13||
48533775|NCT04844762|101643241|FG003|STARTED|Phase 3 Chosen Product Visit (~3 Hrs)||13||
48533776|NCT04844762|101643242|FG004|STARTED|Phase 3 Chosen Product Visit (~3 Hrs)||14||
48533777|NCT04844762|101643243|FG005|STARTED|Phase 3 Chosen Product Visit (~3 Hrs)||14||
48533778|NCT04844762|101643238|FG000|COMPLETED|Phase 3 Chosen Product Visit (~3 Hrs)||13||
48533779|NCT04844762|101643239|FG001|COMPLETED|Phase 3 Chosen Product Visit (~3 Hrs)||13||
48533780|NCT04844762|101643240|FG002|COMPLETED|Phase 3 Chosen Product Visit (~3 Hrs)||13||
48533781|NCT04844762|101643241|FG003|COMPLETED|Phase 3 Chosen Product Visit (~3 Hrs)||12||
48533782|NCT04844762|101643242|FG004|COMPLETED|Phase 3 Chosen Product Visit (~3 Hrs)||14||
48533783|NCT04844762|101643243|FG005|COMPLETED|Phase 3 Chosen Product Visit (~3 Hrs)||14||
48533784|NCT04844762|101643238|FG000|NOT COMPLETED|Phase 3 Chosen Product Visit (~3 Hrs)||0||
48533785|NCT04844762|101643239|FG001|NOT COMPLETED|Phase 3 Chosen Product Visit (~3 Hrs)||0||
48533786|NCT04844762|101643240|FG002|NOT COMPLETED|Phase 3 Chosen Product Visit (~3 Hrs)||0||
48533787|NCT04844762|101643241|FG003|NOT COMPLETED|Phase 3 Chosen Product Visit (~3 Hrs)||1||
48533788|NCT04844762|101643242|FG004|NOT COMPLETED|Phase 3 Chosen Product Visit (~3 Hrs)||0||
48533789|NCT04844762|101643243|FG005|NOT COMPLETED|Phase 3 Chosen Product Visit (~3 Hrs)||0||
48533790|NCT04428333|101643244|FG000|STARTED|Overall Study||57||
48233836|NCT04405180|100894970|FG001|STARTED|Overall Study||32||
48233837|NCT04405180|100894969|FG000|COMPLETED|Overall Study||32||
48233838|NCT04405180|100894970|FG001|COMPLETED|Overall Study||32||
48233839|NCT04405180|100894969|FG000|NOT COMPLETED|Overall Study||0||
48233840|NCT04405180|100894970|FG001|NOT COMPLETED|Overall Study||0||
48233841|NCT00624377|100894971|FG000|STARTED|Overall Study||2031||
48233842|NCT00624377|100894971|FG000|COMPLETED|Overall Study||1387||
48233843|NCT00624377|100894971|FG000|NOT COMPLETED|Overall Study||644||
48533791|NCT04428333|101643245|FG001|STARTED|Overall Study||60||
48533792|NCT04428333|101643244|FG000|Modified Intent-to-Treat (mITT) Population|Overall Study||52|5 participants initially randomized to feladilimab + chemotherapy arm and 5 participants initially randomized to placebo + chemotherapy arm were dosed only after DIL date requesting immediate discontinuation of feladilimab/placebo and were not included in the mITT population.|
48533793|NCT04428333|101643245|FG001|Modified Intent-to-Treat (mITT) Population|Overall Study||55|5 participants initially randomized to feladilimab + chemotherapy arm and 5 participants initially randomized to placebo + chemotherapy arm were dosed only after DIL date requesting immediate discontinuation of feladilimab/placebo and were not included in the mITT population.|
48533794|NCT04428333|101643244|FG000|Safety Population|Overall Study||51|6 participants were initially randomized to feladilimab+pembrolizumab+5-FU-platinum chemotherapy arm but never received feladilimab. 5 of them were dosed after the DIL date and reassigned to the placebo+pembrolizumab+5-FU-platinum chemotherapy arm. 1 participant was initially randomized to feladilimab+pembrolizumab+5-FU-platinum chemotherapy arm but never dosed. An additional participant,randomized post-data cut off,received only pembrolizumab and is included in the end of study safety analysis.|
48533795|NCT04428333|101643245|FG001|Safety Population|Overall Study||65|6 participants were initially randomized to feladilimab+pembrolizumab+5-FU-platinum chemotherapy arm but never received feladilimab. 5 of them were dosed after the DIL date and reassigned to the placebo+pembrolizumab+5-FU-platinum chemotherapy arm. 1 participant was initially randomized to feladilimab+pembrolizumab+5-FU-platinum chemotherapy arm but never dosed. An additional participant,randomized post-data cut off,received only pembrolizumab and is included in the end of study safety analysis.|
48533796|NCT04428333|101643244|FG000|COMPLETED|Overall Study||37||
48533797|NCT04428333|101643245|FG001|COMPLETED|Overall Study||35||
48533798|NCT04428333|101643244|FG000|NOT COMPLETED|Overall Study||20||
48533799|NCT04428333|101643245|FG001|NOT COMPLETED|Overall Study||25||
48533800|NCT00746018|101643246|FG000|STARTED|Overall Study||39||
48533801|NCT00746018|101643246|FG000|COMPLETED|Overall Study||39||
48533802|NCT00746018|101643246|FG000|NOT COMPLETED|Overall Study||0||
48533803|NCT03964649|101643247|FG000|STARTED|Overall Study||349||
48533804|NCT03964649|101643248|FG001|STARTED|Overall Study||304||
48533805|NCT03964649|101643249|FG002|STARTED|Overall Study||2728||
48533806|NCT03964649|101643250|FG003|STARTED|Overall Study||192||
48533807|NCT03964649|101643251|FG004|STARTED|Overall Study||1948||
48533808|NCT03964649|101643252|FG005|STARTED|Overall Study||349||
48533809|NCT03964649|101643253|FG006|STARTED|Overall Study||376||
48533810|NCT03964649|101643254|FG007|STARTED|Overall Study||325||
48533811|NCT03964649|101643255|FG008|STARTED|Overall Study||204||
48533812|NCT03964649|101643256|FG009|STARTED|Overall Study||533||
48533813|NCT03964649|101643247|FG000|COMPLETED|Overall Study||349||
48533814|NCT03964649|101643248|FG001|COMPLETED|Overall Study||304||
48533815|NCT03964649|101643249|FG002|COMPLETED|Overall Study||2728||
48533816|NCT03964649|101643250|FG003|COMPLETED|Overall Study||192||
48533817|NCT03964649|101643251|FG004|COMPLETED|Overall Study||1948||
48533818|NCT03964649|101643252|FG005|COMPLETED|Overall Study||349||
48533819|NCT03964649|101643253|FG006|COMPLETED|Overall Study||376||
48533820|NCT03964649|101643254|FG007|COMPLETED|Overall Study||325||
48533821|NCT03964649|101643255|FG008|COMPLETED|Overall Study||204||
48533822|NCT03964649|101643256|FG009|COMPLETED|Overall Study||533||
48533823|NCT03964649|101643247|FG000|NOT COMPLETED|Overall Study||0||
48533824|NCT03964649|101643248|FG001|NOT COMPLETED|Overall Study||0||
48533825|NCT03964649|101643249|FG002|NOT COMPLETED|Overall Study||0||
48533826|NCT03964649|101643250|FG003|NOT COMPLETED|Overall Study||0||
48533827|NCT03964649|101643251|FG004|NOT COMPLETED|Overall Study||0||
48533828|NCT03964649|101643252|FG005|NOT COMPLETED|Overall Study||0||
48533829|NCT03964649|101643253|FG006|NOT COMPLETED|Overall Study||0||
48533830|NCT03964649|101643254|FG007|NOT COMPLETED|Overall Study||0||
48533831|NCT03964649|101643255|FG008|NOT COMPLETED|Overall Study||0||
48533832|NCT03964649|101643256|FG009|NOT COMPLETED|Overall Study||0||
48533833|NCT01687478|101643257|FG000|STARTED|Overall Study||88||
48533834|NCT01687478|101643258|FG001|STARTED|Overall Study||88||
48533835|NCT01687478|101643257|FG000|Safety Analysis Set|Overall Study||88||
48533836|NCT01687478|101643258|FG001|Safety Analysis Set|Overall Study||87||
48533837|NCT01687478|101643257|FG000|COMPLETED|Overall Study||56||
48533838|NCT01687478|101643258|FG001|COMPLETED|Overall Study||49||
48533839|NCT01687478|101643257|FG000|NOT COMPLETED|Overall Study||32||
48533840|NCT01687478|101643258|FG001|NOT COMPLETED|Overall Study||39||
48533841|NCT04495283|101643259|FG000|STARTED|Overall Study||35||
48533842|NCT04495283|101643260|FG001|STARTED|Overall Study||35||
48533843|NCT04495283|101643261|FG002|STARTED|Overall Study||17||
48533844|NCT04495283|101643259|FG000|COMPLETED|Overall Study||34||
48533845|NCT04495283|101643260|FG001|COMPLETED|Overall Study||34||
48533846|NCT04495283|101643261|FG002|COMPLETED|Overall Study||14||
48533847|NCT04495283|101643259|FG000|NOT COMPLETED|Overall Study||1||
48533848|NCT04495283|101643260|FG001|NOT COMPLETED|Overall Study||1||
48533849|NCT04495283|101643261|FG002|NOT COMPLETED|Overall Study||3||
48533850|NCT01957176|101643262|FG000|STARTED|Overall Study||8|All the subjects who were treated with at least one dose of eltrombopag were included in the All Treated Subjects analysis set (ATS analysis set)|
48533851|NCT01957176|101643263|FG001|STARTED|Overall Study||14|All the subjects who were treated with at least one dose of eltrombopag were included in the All Treated Subjects analysis set (ATS analysis set)|
48533852|NCT01957176|101643262|FG000|COMPLETED|Overall Study||3||
48533853|NCT01957176|101643263|FG001|COMPLETED|Overall Study||13||
48533854|NCT01957176|101643262|FG000|NOT COMPLETED|Overall Study||5||
48533855|NCT01957176|101643263|FG001|NOT COMPLETED|Overall Study||1||
48533856|NCT00616629|101643264|FG000|STARTED|Overall Study||13||
48533857|NCT00616629|101643265|FG001|STARTED|Overall Study||14||
48533858|NCT00616629|101643266|FG002|STARTED|Overall Study||14||
48533859|NCT00616629|101643267|FG003|STARTED|Overall Study||2||
48533860|NCT00616629|101643268|FG004|STARTED|Overall Study||12||
48533861|NCT00616629|101643264|FG000|COMPLETED|Overall Study||11||
48533862|NCT00616629|101643265|FG001|COMPLETED|Overall Study||12||
48533863|NCT00616629|101643266|FG002|COMPLETED|Overall Study||13||
48533864|NCT00616629|101643267|FG003|COMPLETED|Overall Study||2||
48533865|NCT00616629|101643268|FG004|COMPLETED|Overall Study||12||
48533866|NCT00616629|101643264|FG000|NOT COMPLETED|Overall Study||2||
48533867|NCT00616629|101643265|FG001|NOT COMPLETED|Overall Study||2||
48533868|NCT00616629|101643266|FG002|NOT COMPLETED|Overall Study||1||
48533869|NCT00616629|101643267|FG003|NOT COMPLETED|Overall Study||0||
48533870|NCT00616629|101643268|FG004|NOT COMPLETED|Overall Study||0||
48533871|NCT02325518|101643269|FG000|STARTED|Overall Study||98||
48533872|NCT02325518|101643270|FG001|STARTED|Overall Study||103||
48533873|NCT02325518|101643269|FG000|Safety Set|Overall Study||98||
48533874|NCT02325518|101643270|FG001|Safety Set|Overall Study||103||
48533875|NCT02325518|101643269|FG000|Full Analysis Set (FAS)|Overall Study||98||
48533876|NCT02325518|101643270|FG001|Full Analysis Set (FAS)|Overall Study||101||
48533877|NCT02325518|101643269|FG000|Per Protocol Set (PPS)|Overall Study||92||
48533878|NCT02325518|101643270|FG001|Per Protocol Set (PPS)|Overall Study||97||
48533879|NCT02325518|101643269|FG000|COMPLETED|Overall Study||94||
48533880|NCT02325518|101643270|FG001|COMPLETED|Overall Study||100||
48533881|NCT02325518|101643269|FG000|NOT COMPLETED|Overall Study||4||
48533882|NCT02325518|101643270|FG001|NOT COMPLETED|Overall Study||3||
48533883|NCT03052127|101643271|FG000|STARTED|Overall Study||3||
48533884|NCT03052127|101643272|FG001|STARTED|Overall Study||3||
48533885|NCT03052127|101643273|FG002|STARTED|Overall Study||3||
48533886|NCT03052127|101643274|FG003|STARTED|Overall Study||3||
48533887|NCT03052127|101643275|FG004|STARTED|Overall Study||3||
48533888|NCT03052127|101643276|FG005|STARTED|Overall Study||3||
48533889|NCT03052127|101643277|FG006|STARTED|Overall Study||3||
48533890|NCT03052127|101643278|FG007|STARTED|Overall Study||3||
48533891|NCT03052127|101643279|FG008|STARTED|Overall Study||12||
48533892|NCT03052127|101643280|FG009|STARTED|Overall Study||3||
48533893|NCT03052127|101643281|FG010|STARTED|Overall Study||5||
48533894|NCT03052127|101643282|FG011|STARTED|Overall Study||13||
48533895|NCT03052127|101643271|FG000|COMPLETED|Overall Study||2||
48533896|NCT03052127|101643272|FG001|COMPLETED|Overall Study||3||
48533897|NCT03052127|101643273|FG002|COMPLETED|Overall Study||2||
48533898|NCT03052127|101643274|FG003|COMPLETED|Overall Study||3||
48233844|NCT02684136|100894972|FG000|STARTED|First Intervention (9 Nights)||5||
48233845|NCT02684136|100894973|FG001|STARTED|First Intervention (9 Nights)||5||
48233846|NCT02684136|100894972|FG000|COMPLETED|First Intervention (9 Nights)||5||
48233847|NCT02684136|100894973|FG001|COMPLETED|First Intervention (9 Nights)||5||
48233848|NCT02684136|100894972|FG000|NOT COMPLETED|First Intervention (9 Nights)||0||
48233849|NCT02684136|100894973|FG001|NOT COMPLETED|First Intervention (9 Nights)||0||
48233850|NCT02684136|100894972|FG000|STARTED|Washout (7 Days)||5||
48233851|NCT02684136|100894973|FG001|STARTED|Washout (7 Days)||5||
48233852|NCT02684136|100894972|FG000|COMPLETED|Washout (7 Days)||5||
48533899|NCT03052127|101643275|FG004|COMPLETED|Overall Study||2||
48533900|NCT03052127|101643276|FG005|COMPLETED|Overall Study||2||
48533901|NCT03052127|101643277|FG006|COMPLETED|Overall Study||2||
48533902|NCT03052127|101643278|FG007|COMPLETED|Overall Study||2||
48533903|NCT03052127|101643279|FG008|COMPLETED|Overall Study||7||
48533904|NCT03052127|101643280|FG009|COMPLETED|Overall Study||0||
48533905|NCT03052127|101643281|FG010|COMPLETED|Overall Study||0||
48533906|NCT03052127|101643282|FG011|COMPLETED|Overall Study||0||
48533907|NCT03052127|101643271|FG000|NOT COMPLETED|Overall Study||1||
48533908|NCT03052127|101643272|FG001|NOT COMPLETED|Overall Study||0||
48533909|NCT03052127|101643273|FG002|NOT COMPLETED|Overall Study||1||
48533910|NCT03052127|101643274|FG003|NOT COMPLETED|Overall Study||0||
48533911|NCT03052127|101643275|FG004|NOT COMPLETED|Overall Study||1||
48533912|NCT03052127|101643276|FG005|NOT COMPLETED|Overall Study||1||
48533913|NCT03052127|101643277|FG006|NOT COMPLETED|Overall Study||1||
48233853|NCT02684136|100894973|FG001|COMPLETED|Washout (7 Days)||5||
48233854|NCT02684136|100894972|FG000|NOT COMPLETED|Washout (7 Days)||0||
48233855|NCT02684136|100894973|FG001|NOT COMPLETED|Washout (7 Days)||0||
48233856|NCT02684136|100894972|FG000|STARTED|Second Intervention (9 Nights)||5||
48233857|NCT02684136|100894973|FG001|STARTED|Second Intervention (9 Nights)||5||
48233858|NCT02684136|100894972|FG000|COMPLETED|Second Intervention (9 Nights)||5||
48233859|NCT02684136|100894973|FG001|COMPLETED|Second Intervention (9 Nights)||5||
48533914|NCT03052127|101643278|FG007|NOT COMPLETED|Overall Study||1||
48533915|NCT03052127|101643279|FG008|NOT COMPLETED|Overall Study||5||
48533916|NCT03052127|101643280|FG009|NOT COMPLETED|Overall Study||3||
48533917|NCT03052127|101643281|FG010|NOT COMPLETED|Overall Study||5||
48533918|NCT03052127|101643282|FG011|NOT COMPLETED|Overall Study||13||
48533919|NCT02447744|101643283|FG000|STARTED|Overall Study||21||
48533920|NCT02447744|101643284|FG001|STARTED|Overall Study||22||
48533921|NCT02447744|101643283|FG000|COMPLETED|Overall Study||15||
48533922|NCT02447744|101643284|FG001|COMPLETED|Overall Study||21||
48533923|NCT02447744|101643283|FG000|NOT COMPLETED|Overall Study||6||
48533924|NCT02447744|101643284|FG001|NOT COMPLETED|Overall Study||1||
48533925|NCT02623348|101643285|FG000|STARTED|Overall Study||30||
48533926|NCT02623348|101643286|FG001|STARTED|Overall Study||30||
48533927|NCT02623348|101643285|FG000|3-month Assessment|Overall Study||27||
48533928|NCT02623348|101643286|FG001|3-month Assessment|Overall Study||26||
48533929|NCT02623348|101643285|FG000|COMPLETED|Overall Study||27||
48533930|NCT02623348|101643286|FG001|COMPLETED|Overall Study||28||
48533931|NCT02623348|101643285|FG000|NOT COMPLETED|Overall Study||3||
48533932|NCT02623348|101643286|FG001|NOT COMPLETED|Overall Study||2||
48533933|NCT01857271|101643287|FG000|STARTED|Overall Study||3||
48533934|NCT01857271|101643287|FG000|COMPLETED|Overall Study||2||
48533935|NCT01857271|101643287|FG000|NOT COMPLETED|Overall Study||1||
48533936|NCT05177718|101643288|FG000|STARTED|Overall Study||1||
48533937|NCT05177718|101643288|FG000|COMPLETED|Overall Study||0||
48533938|NCT05177718|101643288|FG000|NOT COMPLETED|Overall Study||1||
48533939|NCT02519738|101643289|FG000|STARTED|Overall Study||20||
48533940|NCT02519738|101643290|FG001|STARTED|Overall Study||17||
48533941|NCT02519738|101643291|FG002|STARTED|Overall Study||15||
48533942|NCT02519738|101643289|FG000|COMPLETED|Overall Study||6||
48533943|NCT02519738|101643290|FG001|COMPLETED|Overall Study||4||
48533944|NCT02519738|101643291|FG002|COMPLETED|Overall Study||3||
48533945|NCT02519738|101643289|FG000|NOT COMPLETED|Overall Study||14||
48533946|NCT02519738|101643290|FG001|NOT COMPLETED|Overall Study||13||
48533947|NCT02519738|101643291|FG002|NOT COMPLETED|Overall Study||12||
48233860|NCT02684136|100894972|FG000|NOT COMPLETED|Second Intervention (9 Nights)||0||
48233861|NCT02684136|100894973|FG001|NOT COMPLETED|Second Intervention (9 Nights)||0||
48233862|NCT00805441|100894974|FG000|STARTED|Overall Study||94||
48233863|NCT00805441|100894975|FG001|STARTED|Overall Study||96||
48533948|NCT04058249|101643292|FG000|STARTED|Overall Study||1||
48533949|NCT04058249|101643292|FG000|COMPLETED|Overall Study||1||
48533950|NCT04058249|101643292|FG000|NOT COMPLETED|Overall Study||0||
48533951|NCT00420459|101643293|FG000|STARTED|Overall Study||12||
48533952|NCT00420459|101643293|FG000|COMPLETED|Overall Study||12||
48533953|NCT00420459|101643293|FG000|NOT COMPLETED|Overall Study||0||
48533954|NCT02099682|101643294|FG000|STARTED|Overall Study||3366||
48533955|NCT02099682|101643294|FG000|Safety Analysis Set (SAS)|Overall Study||3255||
48533956|NCT02099682|101643294|FG000|COMPLETED|Overall Study||3255||
48533957|NCT02099682|101643294|FG000|NOT COMPLETED|Overall Study||111||
48533958|NCT01119716|101643295|FG000|STARTED|Overall Study||4658||
48533959|NCT01119716|101643295|FG000|COMPLETED|Overall Study||4658||
48533960|NCT01119716|101643295|FG000|NOT COMPLETED|Overall Study||0||
48533961|NCT01235195|101643296|FG000|STARTED|First Intervention||15||
48533962|NCT01235195|101643297|FG001|STARTED|First Intervention||15||
48533963|NCT01235195|101643296|FG000|COMPLETED|First Intervention||15||
48533964|NCT01235195|101643297|FG001|COMPLETED|First Intervention||15||
48533965|NCT01235195|101643296|FG000|NOT COMPLETED|First Intervention||0||
48533966|NCT01235195|101643297|FG001|NOT COMPLETED|First Intervention||0||
48533967|NCT01235195|101643296|FG000|STARTED|Washout Period of At Least 8 Days||15||
48533968|NCT01235195|101643297|FG001|STARTED|Washout Period of At Least 8 Days||15||
48533969|NCT01235195|101643296|FG000|COMPLETED|Washout Period of At Least 8 Days||15||
48533970|NCT01235195|101643297|FG001|COMPLETED|Washout Period of At Least 8 Days||15||
48533971|NCT01235195|101643296|FG000|NOT COMPLETED|Washout Period of At Least 8 Days||0||
48533972|NCT01235195|101643297|FG001|NOT COMPLETED|Washout Period of At Least 8 Days||0||
48533973|NCT01235195|101643296|FG000|STARTED|Second Intervention||15||
48533974|NCT01235195|101643297|FG001|STARTED|Second Intervention||15||
48533975|NCT01235195|101643296|FG000|COMPLETED|Second Intervention||15||
48533976|NCT01235195|101643297|FG001|COMPLETED|Second Intervention||15||
48533977|NCT01235195|101643296|FG000|NOT COMPLETED|Second Intervention||0||
48533978|NCT01235195|101643297|FG001|NOT COMPLETED|Second Intervention||0||
48533979|NCT02140411|101643298|FG000|STARTED|Overall Study||21||
48533980|NCT02140411|101643298|FG000|COMPLETED|Overall Study||20||
48533981|NCT02140411|101643298|FG000|NOT COMPLETED|Overall Study||1||
48533982|NCT00699374|101643299|FG000|STARTED|Overall Study||530||
48533983|NCT00699374|101643300|FG001|STARTED|Overall Study||544||
48533984|NCT00699374|101643299|FG000|Treated|Overall Study||526||
48533985|NCT00699374|101643300|FG001|Treated|Overall Study||542||
48533986|NCT00699374|101643299|FG000|COMPLETED|Overall Study||0||
48533987|NCT00699374|101643300|FG001|COMPLETED|Overall Study||0||
48533988|NCT00699374|101643299|FG000|NOT COMPLETED|Overall Study||530||
48533989|NCT00699374|101643300|FG001|NOT COMPLETED|Overall Study||544||
48533990|NCT04791514|101643301|FG000|STARTED|Overall Study||0||
48533991|NCT04791514|101643301|FG000|COMPLETED|Overall Study||0||
48533992|NCT04791514|101643301|FG000|NOT COMPLETED|Overall Study||0||
48533993|NCT02472223|101643302|FG000|STARTED|Overall Study||16||
48533994|NCT02472223|101643303|FG001|STARTED|Overall Study||12||
48533995|NCT02472223|101643302|FG000|COMPLETED|Overall Study||10||
48533996|NCT02472223|101643303|FG001|COMPLETED|Overall Study||7||
48533997|NCT02472223|101643302|FG000|NOT COMPLETED|Overall Study||6||
48533998|NCT02472223|101643303|FG001|NOT COMPLETED|Overall Study||5||
48233864|NCT00805441|100894974|FG000|Full Analysis Set (FAS)|Overall Study||92||
48233865|NCT00805441|100894975|FG001|Full Analysis Set (FAS)|Overall Study||91||
48533999|NCT04305587|101643304|FG000|STARTED|Overall Study||9||
48534000|NCT04305587|101643305|FG001|STARTED|Overall Study||7||
48534001|NCT04305587|101643306|FG002|STARTED|Overall Study||8||
48534002|NCT04305587|101643307|FG003|STARTED|Overall Study||8||
48534003|NCT04305587|101643308|FG004|STARTED|Overall Study||8||
48534004|NCT04305587|101643309|FG005|STARTED|Overall Study||3||
48233866|NCT00805441|100894974|FG000|COMPLETED|Overall Study||60||
48233867|NCT00805441|100894975|FG001|COMPLETED|Overall Study||60||
48233868|NCT00805441|100894974|FG000|NOT COMPLETED|Overall Study||34||
48233869|NCT00805441|100894975|FG001|NOT COMPLETED|Overall Study||36||
48233870|NCT02392507|100894976|FG000|STARTED|Induction Regimen||54||
48233871|NCT02392507|100894976|FG000|Received at Least 1 Dose of Study Drug|Induction Regimen||54||
48233872|NCT02392507|100894976|FG000|COMPLETED|Induction Regimen||47||
48233873|NCT02392507|100894976|FG000|NOT COMPLETED|Induction Regimen||7||
48233874|NCT02392507|100894976|FG000|STARTED|Maintenance Regimen||34||
48233875|NCT02392507|100894976|FG000|COMPLETED|Maintenance Regimen||32||
48233876|NCT02392507|100894976|FG000|NOT COMPLETED|Maintenance Regimen||2||
48233877|NCT04766996|100894977|FG000|STARTED|Overall Study||7||
48534005|NCT04305587|101643310|FG006|STARTED|Overall Study||12||
48534006|NCT04305587|101643311|FG007|STARTED|Overall Study||2||
48534007|NCT04305587|101643312|FG008|STARTED|Overall Study||9||
48534008|NCT04305587|101643304|FG000|COMPLETED|Overall Study||9||
48534009|NCT04305587|101643305|FG001|COMPLETED|Overall Study||7||
48534010|NCT04305587|101643306|FG002|COMPLETED|Overall Study||8||
48534011|NCT04305587|101643307|FG003|COMPLETED|Overall Study||7||
48534012|NCT04305587|101643308|FG004|COMPLETED|Overall Study||8||
48534013|NCT04305587|101643309|FG005|COMPLETED|Overall Study||3||
48534014|NCT04305587|101643310|FG006|COMPLETED|Overall Study||12||
48534015|NCT04305587|101643311|FG007|COMPLETED|Overall Study||2||
48534016|NCT04305587|101643312|FG008|COMPLETED|Overall Study||9||
48534017|NCT04305587|101643304|FG000|NOT COMPLETED|Overall Study||0||
48534018|NCT04305587|101643305|FG001|NOT COMPLETED|Overall Study||0||
48534019|NCT04305587|101643306|FG002|NOT COMPLETED|Overall Study||0||
48534020|NCT04305587|101643307|FG003|NOT COMPLETED|Overall Study||1||
48534021|NCT04305587|101643308|FG004|NOT COMPLETED|Overall Study||0||
48534022|NCT04305587|101643309|FG005|NOT COMPLETED|Overall Study||0||
48534023|NCT04305587|101643310|FG006|NOT COMPLETED|Overall Study||0||
48534024|NCT04305587|101643311|FG007|NOT COMPLETED|Overall Study||0||
48534025|NCT04305587|101643312|FG008|NOT COMPLETED|Overall Study||0||
48534026|NCT01447420|101643313|FG000|STARTED|Overall Study||39||
48534027|NCT01447420|101643314|FG001|STARTED|Overall Study||72||
48534028|NCT01447420|101643315|FG002|STARTED|Overall Study||18||
48534029|NCT01447420|101643313|FG000|COMPLETED|Overall Study||29||
48534030|NCT01447420|101643314|FG001|COMPLETED|Overall Study||45||
48534031|NCT01447420|101643315|FG002|COMPLETED|Overall Study||8||
48233878|NCT04766996|100894978|FG001|STARTED|Overall Study||0||
48233879|NCT04766996|100894979|FG002|STARTED|Overall Study||50||
48233880|NCT04766996|100894977|FG000|COMPLETED|Overall Study||6||
48233881|NCT04766996|100894978|FG001|COMPLETED|Overall Study||0||
48233882|NCT04766996|100894979|FG002|COMPLETED|Overall Study||37||
48534032|NCT01447420|101643313|FG000|NOT COMPLETED|Overall Study||10||
48534033|NCT01447420|101643314|FG001|NOT COMPLETED|Overall Study||27||
48534034|NCT01447420|101643315|FG002|NOT COMPLETED|Overall Study||10||
48534035|NCT02266134|101643316|FG000|STARTED|Clinics #1-2: Beginning Aug 2015||9||1
48534036|NCT02266134|101643317|FG001|STARTED|Clinics #1-2: Beginning Aug 2015||11||1
48534037|NCT02266134|101643318|FG002|STARTED|Clinics #1-2: Beginning Aug 2015||14||1
48534038|NCT02266134|101643319|FG003|STARTED|Clinics #1-2: Beginning Aug 2015||14||1
48534039|NCT02266134|101643316|FG000|COMPLETED|Clinics #1-2: Beginning Aug 2015||3|"For patients, completion of the study refers to patients who completed both a baseline PHQ-9 and a 12-week PHQ-9.~For therapists, completion of the study refers to therapists who completed a baseline assessment and contributed to PHQ-9 fidelity data."|1
48534040|NCT02266134|101643317|FG001|COMPLETED|Clinics #1-2: Beginning Aug 2015||8|"For patients, completion of the study refers to patients who completed both a baseline PHQ-9 and a 12-week PHQ-9.~For therapists, completion of the study refers to therapists who completed a baseline assessment and contributed to PHQ-9 fidelity data."|1
48534041|NCT02266134|101643318|FG002|COMPLETED|Clinics #1-2: Beginning Aug 2015||14|"For patients, completion of the study refers to patients who completed both a baseline PHQ-9 and a 12-week PHQ-9.~For therapists, completion of the study refers to therapists who completed a baseline assessment and contributed to PHQ-9 fidelity data."|1
48534042|NCT02266134|101643319|FG003|COMPLETED|Clinics #1-2: Beginning Aug 2015||14|"For patients, completion of the study refers to patients who completed both a baseline PHQ-9 and a 12-week PHQ-9.~For therapists, completion of the study refers to therapists who completed a baseline assessment and contributed to PHQ-9 fidelity data."|1
48534043|NCT02266134|101643316|FG000|NOT COMPLETED|Clinics #1-2: Beginning Aug 2015||6||0
48534044|NCT02266134|101643317|FG001|NOT COMPLETED|Clinics #1-2: Beginning Aug 2015||3||0
48534045|NCT02266134|101643318|FG002|NOT COMPLETED|Clinics #1-2: Beginning Aug 2015||0||0
48534046|NCT02266134|101643319|FG003|NOT COMPLETED|Clinics #1-2: Beginning Aug 2015||0||0
48534047|NCT02266134|101643316|FG000|STARTED|Clinics #3-6: Beginning Dec 2015||47||2
48534048|NCT02266134|101643317|FG001|STARTED|Clinics #3-6: Beginning Dec 2015||24||2
48233883|NCT04766996|100894977|FG000|NOT COMPLETED|Overall Study||1||
48233884|NCT04766996|100894978|FG001|NOT COMPLETED|Overall Study||0||
48233885|NCT04766996|100894979|FG002|NOT COMPLETED|Overall Study||13||
48233886|NCT02106325|100894980|FG000|STARTED|Phase 1||5||
48534049|NCT02266134|101643318|FG002|STARTED|Clinics #3-6: Beginning Dec 2015||14||2
48534050|NCT02266134|101643319|FG003|STARTED|Clinics #3-6: Beginning Dec 2015||17||2
48534051|NCT02266134|101643316|FG000|COMPLETED|Clinics #3-6: Beginning Dec 2015||39||2
48534052|NCT02266134|101643317|FG001|COMPLETED|Clinics #3-6: Beginning Dec 2015||22||2
48534053|NCT02266134|101643318|FG002|COMPLETED|Clinics #3-6: Beginning Dec 2015||14||2
48534054|NCT02266134|101643319|FG003|COMPLETED|Clinics #3-6: Beginning Dec 2015||17||2
48534055|NCT02266134|101643316|FG000|NOT COMPLETED|Clinics #3-6: Beginning Dec 2015||8||0
48534056|NCT02266134|101643317|FG001|NOT COMPLETED|Clinics #3-6: Beginning Dec 2015||2||0
48534057|NCT02266134|101643318|FG002|NOT COMPLETED|Clinics #3-6: Beginning Dec 2015||0||0
48534058|NCT02266134|101643319|FG003|NOT COMPLETED|Clinics #3-6: Beginning Dec 2015||0||0
48534059|NCT02266134|101643316|FG000|STARTED|Clinics #7-10: Beginning May 2016||39||2
48534060|NCT02266134|101643317|FG001|STARTED|Clinics #7-10: Beginning May 2016||33||2
48233887|NCT02106325|100894981|FG001|STARTED|Phase 1||3||
48233888|NCT02106325|100894980|FG000|COMPLETED|Phase 1||3||
48233889|NCT02106325|100894981|FG001|COMPLETED|Phase 1||1||
48233890|NCT02106325|100894980|FG000|NOT COMPLETED|Phase 1||2||
48233891|NCT02106325|100894981|FG001|NOT COMPLETED|Phase 1||2||
48233892|NCT02106325|100894980|FG000|STARTED|Phase 2||4||
48233893|NCT02106325|100894981|FG001|STARTED|Phase 2||4||
48233894|NCT02106325|100894980|FG000|COMPLETED|Phase 2||2||
48534061|NCT02266134|101643318|FG002|STARTED|Clinics #7-10: Beginning May 2016||28||2
48534062|NCT02266134|101643319|FG003|STARTED|Clinics #7-10: Beginning May 2016||29||2
48534063|NCT02266134|101643316|FG000|COMPLETED|Clinics #7-10: Beginning May 2016||26||2
48534064|NCT02266134|101643317|FG001|COMPLETED|Clinics #7-10: Beginning May 2016||28||2
48534065|NCT02266134|101643318|FG002|COMPLETED|Clinics #7-10: Beginning May 2016||28||2
48534066|NCT02266134|101643319|FG003|COMPLETED|Clinics #7-10: Beginning May 2016||29||2
48534067|NCT02266134|101643316|FG000|NOT COMPLETED|Clinics #7-10: Beginning May 2016||13||0
48534068|NCT02266134|101643317|FG001|NOT COMPLETED|Clinics #7-10: Beginning May 2016||5||0
48534069|NCT02266134|101643318|FG002|NOT COMPLETED|Clinics #7-10: Beginning May 2016||0||0
48534070|NCT02266134|101643319|FG003|NOT COMPLETED|Clinics #7-10: Beginning May 2016||0||0
48534071|NCT02266134|101643316|FG000|STARTED|Clinics #11-12: Beginning Dec 2016||46||1
48534072|NCT02266134|101643317|FG001|STARTED|Clinics #11-12: Beginning Dec 2016||19||1
48534073|NCT02266134|101643318|FG002|STARTED|Clinics #11-12: Beginning Dec 2016||15||1
48534074|NCT02266134|101643319|FG003|STARTED|Clinics #11-12: Beginning Dec 2016||23||1
48534075|NCT02266134|101643316|FG000|COMPLETED|Clinics #11-12: Beginning Dec 2016||37||1
48534076|NCT02266134|101643317|FG001|COMPLETED|Clinics #11-12: Beginning Dec 2016||17||1
48534077|NCT02266134|101643318|FG002|COMPLETED|Clinics #11-12: Beginning Dec 2016||15||1
48534078|NCT02266134|101643319|FG003|COMPLETED|Clinics #11-12: Beginning Dec 2016||23||1
48534079|NCT02266134|101643316|FG000|NOT COMPLETED|Clinics #11-12: Beginning Dec 2016||9||0
48534080|NCT02266134|101643317|FG001|NOT COMPLETED|Clinics #11-12: Beginning Dec 2016||2||0
48534081|NCT02266134|101643318|FG002|NOT COMPLETED|Clinics #11-12: Beginning Dec 2016||0||0
48534082|NCT02266134|101643319|FG003|NOT COMPLETED|Clinics #11-12: Beginning Dec 2016||0||0
48534083|NCT01433549|101643320|FG000|STARTED|Phase 1: First Study Product||12||
48534084|NCT01433549|101643321|FG001|STARTED|Phase 1: First Study Product||13||
48534085|NCT01433549|101643320|FG000|COMPLETED|Phase 1: First Study Product||12||
48534086|NCT01433549|101643321|FG001|COMPLETED|Phase 1: First Study Product||13||
48534087|NCT01433549|101643320|FG000|NOT COMPLETED|Phase 1: First Study Product||0||
48534088|NCT01433549|101643321|FG001|NOT COMPLETED|Phase 1: First Study Product||0||
48534089|NCT01433549|101643320|FG000|STARTED|Phase 2: Second Study Product||12||
48534090|NCT01433549|101643321|FG001|STARTED|Phase 2: Second Study Product||13||
48534091|NCT01433549|101643320|FG000|COMPLETED|Phase 2: Second Study Product||12||
48534092|NCT01433549|101643321|FG001|COMPLETED|Phase 2: Second Study Product||12||
48534093|NCT01433549|101643320|FG000|NOT COMPLETED|Phase 2: Second Study Product||0||
48534094|NCT01433549|101643321|FG001|NOT COMPLETED|Phase 2: Second Study Product||1||
48534095|NCT02906566|101643322|FG000|STARTED|Overall Study||24||48
48233895|NCT02106325|100894981|FG001|COMPLETED|Phase 2||1||
48233896|NCT02106325|100894980|FG000|NOT COMPLETED|Phase 2||2||
48233897|NCT02106325|100894981|FG001|NOT COMPLETED|Phase 2||3||
48233898|NCT02106325|100894980|FG000|STARTED|Phase 3||2||
48233899|NCT02106325|100894981|FG001|STARTED|Phase 3||3||
48233900|NCT02106325|100894980|FG000|COMPLETED|Phase 3||0||
48233901|NCT02106325|100894981|FG001|COMPLETED|Phase 3||2||
48233902|NCT02106325|100894980|FG000|NOT COMPLETED|Phase 3||2||
48233903|NCT02106325|100894981|FG001|NOT COMPLETED|Phase 3||1||
48534096|NCT02906566|101643323|FG001|STARTED|Overall Study||10||10
48534097|NCT02906566|101643322|FG000|COMPLETED|Overall Study||21||42
48534098|NCT02906566|101643323|FG001|COMPLETED|Overall Study||10||10
48534099|NCT02906566|101643322|FG000|NOT COMPLETED|Overall Study||3||6
48534100|NCT02906566|101643323|FG001|NOT COMPLETED|Overall Study||0||0
48534101|NCT04007991|101643324|FG000|STARTED|Overall Study||76||
48534102|NCT04007991|101643325|FG001|STARTED|Overall Study||77||
48233904|NCT02382640|100894982|FG000|STARTED|Intervention Period 1 (3 Days)||9||
48233905|NCT02382640|100894983|FG001|STARTED|Intervention Period 1 (3 Days)||9||
48233906|NCT02382640|100894984|FG002|STARTED|Intervention Period 1 (3 Days)||9||
48233907|NCT02382640|100894985|FG003|STARTED|Intervention Period 1 (3 Days)||9||
48534103|NCT04007991|101643324|FG000|Safety Set|Overall Study||76|The Safety Set (SS) included all participants who received at least one dose of study drug.|
48534104|NCT04007991|101643325|FG001|Safety Set|Overall Study||77|The Safety Set (SS) included all participants who received at least one dose of study drug.|
48534105|NCT04007991|101643324|FG000|The Modified Intention-to-Treat Set|Overall Study||74|The Modified Intention-to-Treat (mITT) set included all randomized participants who received at least one dose of study drug and had at least 1 post-baseline scoring of the YGTSS (Yale Global Tic Severity Scale).|
48534106|NCT04007991|101643325|FG001|The Modified Intention-to-Treat Set|Overall Study||75|The Modified Intention-to-Treat (mITT) set included all randomized participants who received at least one dose of study drug and had at least 1 post-baseline scoring of the YGTSS (Yale Global Tic Severity Scale).|
48534107|NCT04007991|101643324|FG000|COMPLETED|Overall Study||66||
48233908|NCT02382640|100894982|FG000|COMPLETED|Intervention Period 1 (3 Days)||9||
48233909|NCT02382640|100894983|FG001|COMPLETED|Intervention Period 1 (3 Days)||9||
48233910|NCT02382640|100894984|FG002|COMPLETED|Intervention Period 1 (3 Days)||9||
48233911|NCT02382640|100894985|FG003|COMPLETED|Intervention Period 1 (3 Days)||9||
48233912|NCT02382640|100894982|FG000|NOT COMPLETED|Intervention Period 1 (3 Days)||0||
48233913|NCT02382640|100894983|FG001|NOT COMPLETED|Intervention Period 1 (3 Days)||0||
48233914|NCT02382640|100894984|FG002|NOT COMPLETED|Intervention Period 1 (3 Days)||0||
48233915|NCT02382640|100894985|FG003|NOT COMPLETED|Intervention Period 1 (3 Days)||0||
48233916|NCT02382640|100894982|FG000|STARTED|Washout Period 1 (7 Days)||9||
48233917|NCT02382640|100894983|FG001|STARTED|Washout Period 1 (7 Days)||9||
48233918|NCT02382640|100894984|FG002|STARTED|Washout Period 1 (7 Days)||9||
48233919|NCT02382640|100894985|FG003|STARTED|Washout Period 1 (7 Days)||9||
48233920|NCT02382640|100894982|FG000|COMPLETED|Washout Period 1 (7 Days)||9||
48233921|NCT02382640|100894983|FG001|COMPLETED|Washout Period 1 (7 Days)||9||
48233922|NCT02382640|100894984|FG002|COMPLETED|Washout Period 1 (7 Days)||9||
48233923|NCT02382640|100894985|FG003|COMPLETED|Washout Period 1 (7 Days)||9||
48233924|NCT02382640|100894982|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48233925|NCT02382640|100894983|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48233926|NCT02382640|100894984|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48233927|NCT02382640|100894985|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48233928|NCT02382640|100894982|FG000|STARTED|Intervention Period 2 (3 Days)||9||
48233929|NCT02382640|100894983|FG001|STARTED|Intervention Period 2 (3 Days)||9||
48233930|NCT02382640|100894984|FG002|STARTED|Intervention Period 2 (3 Days)||9||
48233931|NCT02382640|100894985|FG003|STARTED|Intervention Period 2 (3 Days)||9||
48233932|NCT02382640|100894982|FG000|COMPLETED|Intervention Period 2 (3 Days)||9||
48233933|NCT02382640|100894983|FG001|COMPLETED|Intervention Period 2 (3 Days)||9||
48233934|NCT02382640|100894984|FG002|COMPLETED|Intervention Period 2 (3 Days)||9||
48233935|NCT02382640|100894985|FG003|COMPLETED|Intervention Period 2 (3 Days)||9||
48233936|NCT02382640|100894982|FG000|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
48233937|NCT02382640|100894983|FG001|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
48233938|NCT02382640|100894984|FG002|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
48233939|NCT02382640|100894985|FG003|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
48233940|NCT02382640|100894982|FG000|STARTED|Washout Period 2 (7 Days)||9||
48233941|NCT02382640|100894983|FG001|STARTED|Washout Period 2 (7 Days)||9||
48233942|NCT02382640|100894984|FG002|STARTED|Washout Period 2 (7 Days)||9||
48233943|NCT02382640|100894985|FG003|STARTED|Washout Period 2 (7 Days)||9||
48233944|NCT02382640|100894982|FG000|COMPLETED|Washout Period 2 (7 Days)||9||
48233945|NCT02382640|100894983|FG001|COMPLETED|Washout Period 2 (7 Days)||9||
48233946|NCT02382640|100894984|FG002|COMPLETED|Washout Period 2 (7 Days)||9||
48233947|NCT02382640|100894985|FG003|COMPLETED|Washout Period 2 (7 Days)||9||
48233948|NCT02382640|100894982|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48233949|NCT02382640|100894983|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48233950|NCT02382640|100894984|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48233951|NCT02382640|100894985|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48233952|NCT02382640|100894982|FG000|STARTED|Intervention Period 3 (3 Days)||9||
48233953|NCT02382640|100894983|FG001|STARTED|Intervention Period 3 (3 Days)||9||
48233954|NCT02382640|100894984|FG002|STARTED|Intervention Period 3 (3 Days)||9||
48233955|NCT02382640|100894985|FG003|STARTED|Intervention Period 3 (3 Days)||9||
48233956|NCT02382640|100894982|FG000|COMPLETED|Intervention Period 3 (3 Days)||9||
48233957|NCT02382640|100894983|FG001|COMPLETED|Intervention Period 3 (3 Days)||9||
48233958|NCT02382640|100894984|FG002|COMPLETED|Intervention Period 3 (3 Days)||9||
48233959|NCT02382640|100894985|FG003|COMPLETED|Intervention Period 3 (3 Days)||9||
48233960|NCT02382640|100894982|FG000|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
48534108|NCT04007991|101643325|FG001|COMPLETED|Overall Study||71||
48534109|NCT04007991|101643324|FG000|NOT COMPLETED|Overall Study||10||
48534110|NCT04007991|101643325|FG001|NOT COMPLETED|Overall Study||6||
48534111|NCT02655666|101643326|FG000|STARTED|Overall Study||16||
48534112|NCT02655666|101643326|FG000|COMPLETED|Overall Study||4||
48534113|NCT02655666|101643326|FG000|NOT COMPLETED|Overall Study||12||
48534114|NCT03151408|101643327|FG000|STARTED|Overall Study||203||
48534115|NCT03151408|101643328|FG001|STARTED|Overall Study||203||
48534116|NCT03151408|101643327|FG000|Treated|Overall Study||201||
48534117|NCT03151408|101643328|FG001|Treated|Overall Study||201||
48534118|NCT03151408|101643327|FG000|COMPLETED|Overall Study||0||
48233961|NCT02382640|100894983|FG001|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
48534119|NCT03151408|101643328|FG001|COMPLETED|Overall Study||0||
48534120|NCT03151408|101643327|FG000|NOT COMPLETED|Overall Study||203||
48534121|NCT03151408|101643328|FG001|NOT COMPLETED|Overall Study||203||
48534122|NCT00369655|101643329|FG000|STARTED|Overall Study||21||
48534123|NCT00369655|101643329|FG000|COMPLETED|Overall Study||19||
48534124|NCT00369655|101643329|FG000|NOT COMPLETED|Overall Study||2||
48534125|NCT02205983|101643330|FG000|STARTED|Overall Study||12||
48534126|NCT02205983|101643331|FG001|STARTED|Overall Study||12||
48534127|NCT02205983|101643332|FG002|STARTED|Overall Study||13||
48534128|NCT02205983|101643333|FG003|STARTED|Overall Study||13||
48534129|NCT02205983|101643330|FG000|COMPLETED|Overall Study||12||
48534130|NCT02205983|101643331|FG001|COMPLETED|Overall Study||12||
48534131|NCT02205983|101643332|FG002|COMPLETED|Overall Study||13||
48534132|NCT02205983|101643333|FG003|COMPLETED|Overall Study||13||
48534133|NCT02205983|101643330|FG000|NOT COMPLETED|Overall Study||0||
48534134|NCT02205983|101643331|FG001|NOT COMPLETED|Overall Study||0||
48534135|NCT02205983|101643332|FG002|NOT COMPLETED|Overall Study||0||
48534136|NCT02205983|101643333|FG003|NOT COMPLETED|Overall Study||0||
48534137|NCT03402555|101643334|FG000|STARTED|Overall Study||96||
48534138|NCT03402555|101643334|FG000|COMPLETED|Overall Study||91||
48534139|NCT03402555|101643334|FG000|NOT COMPLETED|Overall Study||5||
48534140|NCT02932306|101643335|FG000|STARTED|Overall Study||406||
48534141|NCT02932306|101643336|FG001|STARTED|Overall Study||414||
48534142|NCT02932306|101643335|FG000|Intent-to-treat (ITT) Population|Overall Study||406|All randomized participants who received study drug.|
48534143|NCT02932306|101643336|FG001|Intent-to-treat (ITT) Population|Overall Study||414|All randomized participants who received study drug.|
48534144|NCT02932306|101643335|FG000|Safety Population|Overall Study||378|All randomized participants with ≥1 confirmed dose of study drug and ≥1 post baseline evaluation.|
48534145|NCT02932306|101643336|FG001|Safety Population|Overall Study||385|All randomized participants with ≥1 confirmed dose of study drug and ≥1 post baseline evaluation.|
48534146|NCT02932306|101643335|FG000|COMPLETED|Overall Study||338||
48534147|NCT02932306|101643336|FG001|COMPLETED|Overall Study||337||
48534148|NCT02932306|101643335|FG000|NOT COMPLETED|Overall Study||68||
48534149|NCT02932306|101643336|FG001|NOT COMPLETED|Overall Study||77||
48534150|NCT03857750|101643337|FG000|STARTED|Overall Study||16||
48233962|NCT02382640|100894984|FG002|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
48534151|NCT03857750|101643338|FG001|STARTED|Overall Study||16||
48534152|NCT03857750|101643337|FG000|COMPLETED|Overall Study||16||
48534153|NCT03857750|101643338|FG001|COMPLETED|Overall Study||16||
48534154|NCT03857750|101643337|FG000|NOT COMPLETED|Overall Study||0||
48534155|NCT03857750|101643338|FG001|NOT COMPLETED|Overall Study||0||
48534156|NCT02730351|101643339|FG000|STARTED|Treatment Period 1 (2 Weeks)||37||
48534157|NCT02730351|101643340|FG001|STARTED|Treatment Period 1 (2 Weeks)||37||
48534158|NCT02730351|101643339|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||36||
48534159|NCT02730351|101643340|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||37||
48534160|NCT02730351|101643339|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1||
48534161|NCT02730351|101643340|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0||
48534162|NCT02730351|101643339|FG000|STARTED|Wash-out Period (2 Weeks)||36||
48233963|NCT02382640|100894985|FG003|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
48233964|NCT02382640|100894982|FG000|STARTED|Washout Period 3 (7 Days)||9||
48233965|NCT02382640|100894983|FG001|STARTED|Washout Period 3 (7 Days)||9||
48233966|NCT02382640|100894984|FG002|STARTED|Washout Period 3 (7 Days)||9||
48233967|NCT02382640|100894985|FG003|STARTED|Washout Period 3 (7 Days)||9||
48233968|NCT02382640|100894982|FG000|COMPLETED|Washout Period 3 (7 Days)||9||
48233969|NCT02382640|100894983|FG001|COMPLETED|Washout Period 3 (7 Days)||9||
48233970|NCT02382640|100894984|FG002|COMPLETED|Washout Period 3 (7 Days)||9||
48233971|NCT02382640|100894985|FG003|COMPLETED|Washout Period 3 (7 Days)||9||
48233972|NCT02382640|100894982|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48233973|NCT02382640|100894983|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48233974|NCT02382640|100894984|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48233975|NCT02382640|100894985|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48233976|NCT02382640|100894982|FG000|STARTED|Intervention Period 4 (3 Days)||9||
48233977|NCT02382640|100894983|FG001|STARTED|Intervention Period 4 (3 Days)||9||
48233978|NCT02382640|100894984|FG002|STARTED|Intervention Period 4 (3 Days)||9||
48233979|NCT02382640|100894985|FG003|STARTED|Intervention Period 4 (3 Days)||9||
48233980|NCT02382640|100894982|FG000|COMPLETED|Intervention Period 4 (3 Days)||8||
48233981|NCT02382640|100894983|FG001|COMPLETED|Intervention Period 4 (3 Days)||9||
48233982|NCT02382640|100894984|FG002|COMPLETED|Intervention Period 4 (3 Days)||9||
48233983|NCT02382640|100894985|FG003|COMPLETED|Intervention Period 4 (3 Days)||9||
48534163|NCT02730351|101643340|FG001|STARTED|Wash-out Period (2 Weeks)||37||
48534164|NCT02730351|101643339|FG000|COMPLETED|Wash-out Period (2 Weeks)||35||
48534165|NCT02730351|101643340|FG001|COMPLETED|Wash-out Period (2 Weeks)||36||
48534166|NCT02730351|101643339|FG000|NOT COMPLETED|Wash-out Period (2 Weeks)||1||
48233984|NCT02382640|100894982|FG000|NOT COMPLETED|Intervention Period 4 (3 Days)||1||
48233985|NCT02382640|100894983|FG001|NOT COMPLETED|Intervention Period 4 (3 Days)||0||
48233986|NCT02382640|100894984|FG002|NOT COMPLETED|Intervention Period 4 (3 Days)||0||
48233987|NCT02382640|100894985|FG003|NOT COMPLETED|Intervention Period 4 (3 Days)||0||
48233988|NCT00201825|100894986|FG000|STARTED|Overall Study||29||
48233989|NCT00201825|100894986|FG000|COMPLETED|Overall Study||29||
48233990|NCT00201825|100894986|FG000|NOT COMPLETED|Overall Study||0||
48534167|NCT02730351|101643340|FG001|NOT COMPLETED|Wash-out Period (2 Weeks)||1||
48534168|NCT02730351|101643339|FG000|STARTED|Treatment Period 2 (2 Weeks)||35||
48534169|NCT02730351|101643340|FG001|STARTED|Treatment Period 2 (2 Weeks)||36||
48534170|NCT02730351|101643339|FG000|COMPLETED|Treatment Period 2 (2 Weeks)||33||
48534171|NCT02730351|101643340|FG001|COMPLETED|Treatment Period 2 (2 Weeks)||36||
48534172|NCT02730351|101643339|FG000|NOT COMPLETED|Treatment Period 2 (2 Weeks)||2||
48534173|NCT02730351|101643340|FG001|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0||
48534174|NCT00256984|101643341|FG000|STARTED|Overall Study||75||
48534175|NCT00256984|101643341|FG000|COMPLETED|Overall Study||59||
48534176|NCT00256984|101643341|FG000|NOT COMPLETED|Overall Study||16||
48534177|NCT00620555|101643342|FG000|STARTED|Overall Study||65||
48233991|NCT03875729|100894987|FG000|STARTED|Overall Study||111||
48233992|NCT03875729|100894988|FG001|STARTED|Overall Study||217||
48534178|NCT00620555|101643342|FG000|COMPLETED|Overall Study||44||
48534179|NCT00620555|101643342|FG000|NOT COMPLETED|Overall Study||21||
48534180|NCT00475150|101643343|FG000|STARTED|Overall Study||23||
48534181|NCT00475150|101643344|FG001|STARTED|Overall Study||16||
48534182|NCT00475150|101643343|FG000|COMPLETED|Overall Study||23||
48534183|NCT00475150|101643344|FG001|COMPLETED|Overall Study||16||
48534184|NCT00475150|101643343|FG000|NOT COMPLETED|Overall Study||0||
48534185|NCT00475150|101643344|FG001|NOT COMPLETED|Overall Study||0||
48534186|NCT00123474|101643345|FG000|STARTED|Randomized to Treatment||167||
48534187|NCT00123474|101643346|FG001|STARTED|Randomized to Treatment||167||
48534188|NCT00123474|101643347|FG002|STARTED|Randomized to Treatment||168||
48534189|NCT00123474|101643348|FG003|STARTED|Randomized to Treatment||168||
48534190|NCT00123474|101643345|FG000|COMPLETED|Randomized to Treatment||166||
48534191|NCT00123474|101643346|FG001|COMPLETED|Randomized to Treatment||163||
48534192|NCT00123474|101643347|FG002|COMPLETED|Randomized to Treatment||166||
48534193|NCT00123474|101643348|FG003|COMPLETED|Randomized to Treatment||167||
48534194|NCT00123474|101643345|FG000|NOT COMPLETED|Randomized to Treatment||1||
48534195|NCT00123474|101643346|FG001|NOT COMPLETED|Randomized to Treatment||4||
48534196|NCT00123474|101643347|FG002|NOT COMPLETED|Randomized to Treatment||2||
48534197|NCT00123474|101643348|FG003|NOT COMPLETED|Randomized to Treatment||1||
48534198|NCT00123474|101643345|FG000|STARTED|As Treated at Study Closure||165||
48534199|NCT00123474|101643346|FG001|STARTED|As Treated at Study Closure||163||
48534200|NCT00123474|101643347|FG002|STARTED|As Treated at Study Closure||167||
48534201|NCT00123474|101643348|FG003|STARTED|As Treated at Study Closure||167||
48534202|NCT00123474|101643345|FG000|COMPLETED|As Treated at Study Closure||0||
48534203|NCT00123474|101643346|FG001|COMPLETED|As Treated at Study Closure||0||
48534204|NCT00123474|101643347|FG002|COMPLETED|As Treated at Study Closure||0||
48534205|NCT00123474|101643348|FG003|COMPLETED|As Treated at Study Closure||0||
48534206|NCT00123474|101643345|FG000|NOT COMPLETED|As Treated at Study Closure||165||
48534207|NCT00123474|101643346|FG001|NOT COMPLETED|As Treated at Study Closure||163||
48534208|NCT00123474|101643347|FG002|NOT COMPLETED|As Treated at Study Closure||167||
48534209|NCT00123474|101643348|FG003|NOT COMPLETED|As Treated at Study Closure||167||
48534210|NCT00851318|101643349|FG000|STARTED|Overall Study||81||
48534211|NCT00851318|101643350|FG001|STARTED|Overall Study||19||
48534212|NCT00851318|101643351|FG002|STARTED|Overall Study||93||
48233993|NCT03875729|100894987|FG000|COMPLETED|Overall Study||101||
48233994|NCT03875729|100894988|FG001|COMPLETED|Overall Study||195||
48233995|NCT03875729|100894987|FG000|NOT COMPLETED|Overall Study||10||
48233996|NCT03875729|100894988|FG001|NOT COMPLETED|Overall Study||22||
48534213|NCT00851318|101643352|FG003|STARTED|Overall Study||92||
48534214|NCT00851318|101643349|FG000|Completed Week 24|Overall Study||69||
48534215|NCT00851318|101643350|FG001|Completed Week 24|Overall Study||17||
48534216|NCT00851318|101643351|FG002|Completed Week 24|Overall Study||90||
48534217|NCT00851318|101643352|FG003|Completed Week 24|Overall Study||87||
48534218|NCT00851318|101643349|FG000|Completed Week 52|Overall Study||64||
48233997|NCT02009865|100894989|FG000|STARTED|Overall Study||81||
48233998|NCT02009865|100894990|FG001|STARTED|Overall Study||81||
48534219|NCT00851318|101643350|FG001|Completed Week 52|Overall Study||16||
48534220|NCT00851318|101643351|FG002|Completed Week 52|Overall Study||87||
48534221|NCT00851318|101643352|FG003|Completed Week 52|Overall Study||85||
48534222|NCT00851318|101643349|FG000|COMPLETED|Overall Study||51||
48534223|NCT00851318|101643350|FG001|COMPLETED|Overall Study||14||
48233999|NCT02009865|100894989|FG000|COMPLETED|Overall Study||80||
48234000|NCT02009865|100894990|FG001|COMPLETED|Overall Study||76||
48534224|NCT00851318|101643351|FG002|COMPLETED|Overall Study||72||
48534225|NCT00851318|101643352|FG003|COMPLETED|Overall Study||73||
48534226|NCT00851318|101643349|FG000|NOT COMPLETED|Overall Study||30||
48534227|NCT00851318|101643350|FG001|NOT COMPLETED|Overall Study||5||
48534228|NCT00851318|101643351|FG002|NOT COMPLETED|Overall Study||21||
48534229|NCT00851318|101643352|FG003|NOT COMPLETED|Overall Study||19||
48534230|NCT00671918|101643353|FG000|STARTED|Overall Study||186||
48534231|NCT00671918|101643353|FG000|COMPLETED|Overall Study||169||
48534232|NCT00671918|101643353|FG000|NOT COMPLETED|Overall Study||17||
48534233|NCT02677714|101643354|FG000|STARTED|Overall Study||12|All enrolled patients who were dosed were included in both the full analysis set (FAS) and the safety set|
48234001|NCT02009865|100894989|FG000|NOT COMPLETED|Overall Study||1||
48234002|NCT02009865|100894990|FG001|NOT COMPLETED|Overall Study||5||
48234003|NCT01205126|100894991|FG000|STARTED|Titration Phase||130||
48234004|NCT01205126|100894992|FG001|STARTED|Titration Phase||130||
48234005|NCT01205126|100894991|FG000|COMPLETED|Titration Phase||107||
48234006|NCT01205126|100894992|FG001|COMPLETED|Titration Phase||111||
48234007|NCT01205126|100894991|FG000|NOT COMPLETED|Titration Phase||23||
48234008|NCT01205126|100894992|FG001|NOT COMPLETED|Titration Phase||19||
48234009|NCT01205126|100894991|FG000|STARTED|Between Titration & Maintenance Phase||107||
48234010|NCT01205126|100894992|FG001|STARTED|Between Titration & Maintenance Phase||111||
48234011|NCT01205126|100894991|FG000|COMPLETED|Between Titration & Maintenance Phase||107||
48234012|NCT01205126|100894992|FG001|COMPLETED|Between Titration & Maintenance Phase||107||
48234013|NCT01205126|100894991|FG000|NOT COMPLETED|Between Titration & Maintenance Phase||0||
48234014|NCT01205126|100894992|FG001|NOT COMPLETED|Between Titration & Maintenance Phase||4||
48234015|NCT01205126|100894991|FG000|STARTED|Maintenance Phase||107||
48234016|NCT01205126|100894992|FG001|STARTED|Maintenance Phase||107||
48234017|NCT01205126|100894991|FG000|COMPLETED|Maintenance Phase||70||
48234018|NCT01205126|100894992|FG001|COMPLETED|Maintenance Phase||67||
48234019|NCT01205126|100894991|FG000|NOT COMPLETED|Maintenance Phase||37||
48234020|NCT01205126|100894992|FG001|NOT COMPLETED|Maintenance Phase||40||
48234021|NCT02889900|100894993|FG000|STARTED|Overall Study||62||
48234022|NCT02889900|100894993|FG000|Received Treatment|Overall Study||60||
48234023|NCT02889900|100894993|FG000|COMPLETED|Overall Study||5||
48234024|NCT02889900|100894993|FG000|NOT COMPLETED|Overall Study||57||
48534234|NCT02677714|101643355|FG001|STARTED|Overall Study||2|All enrolled patients who were dosed were included in both the full analysis set (FAS) and the safety set|
48534235|NCT02677714|101643354|FG000|COMPLETED|Overall Study||10||
48534236|NCT02677714|101643355|FG001|COMPLETED|Overall Study||2||
48534237|NCT02677714|101643354|FG000|NOT COMPLETED|Overall Study||2||
48534238|NCT02677714|101643355|FG001|NOT COMPLETED|Overall Study||0||
48534239|NCT01383135|101643356|FG000|STARTED|Overall Study||6||
48534240|NCT01383135|101643357|FG001|STARTED|Overall Study||8||
48534241|NCT01383135|101643358|FG002|STARTED|Overall Study||9||
48534242|NCT01383135|101643359|FG003|STARTED|Overall Study||4||
48534243|NCT01383135|101643356|FG000|COMPLETED|Overall Study||5||
48534244|NCT01383135|101643357|FG001|COMPLETED|Overall Study||8||
48534245|NCT01383135|101643358|FG002|COMPLETED|Overall Study||8||
48534246|NCT01383135|101643359|FG003|COMPLETED|Overall Study||4||
48534247|NCT01383135|101643356|FG000|NOT COMPLETED|Overall Study||1||
48534248|NCT01383135|101643357|FG001|NOT COMPLETED|Overall Study||0||
48534249|NCT01383135|101643358|FG002|NOT COMPLETED|Overall Study||1||
48534250|NCT01383135|101643359|FG003|NOT COMPLETED|Overall Study||0||
48534251|NCT00987389|101643360|FG000|STARTED|Overall Study||176||
48534252|NCT00987389|101643361|FG001|STARTED|Overall Study||176||
48534253|NCT00987389|101643362|FG002|STARTED|Overall Study||175||
48534254|NCT00987389|101643363|FG003|STARTED|Overall Study||177||
48534255|NCT00987389|101643360|FG000|COMPLETED|Overall Study||167||
48234025|NCT03884478|100894994|FG000|STARTED|Baseline to 2 Months Post-intervention||144||
48234026|NCT03884478|100894995|FG001|STARTED|Baseline to 2 Months Post-intervention||179||
48234027|NCT03884478|100894996|FG002|STARTED|Baseline to 2 Months Post-intervention||177||
48234028|NCT03884478|100894994|FG000|COMPLETED|Baseline to 2 Months Post-intervention||113||
48234029|NCT03884478|100894995|FG001|COMPLETED|Baseline to 2 Months Post-intervention||146||
48234030|NCT03884478|100894996|FG002|COMPLETED|Baseline to 2 Months Post-intervention||141||
48234031|NCT03884478|100894994|FG000|NOT COMPLETED|Baseline to 2 Months Post-intervention||31||
48234032|NCT03884478|100894995|FG001|NOT COMPLETED|Baseline to 2 Months Post-intervention||33||
48234033|NCT03884478|100894996|FG002|NOT COMPLETED|Baseline to 2 Months Post-intervention||36||
48234034|NCT03884478|100894994|FG000|STARTED|Baseline to 4 Months Post-intervention||144||
48234035|NCT03884478|100894995|FG001|STARTED|Baseline to 4 Months Post-intervention||179||
48234036|NCT03884478|100894996|FG002|STARTED|Baseline to 4 Months Post-intervention||177||
48234037|NCT03884478|100894994|FG000|COMPLETED|Baseline to 4 Months Post-intervention||101||
48234038|NCT03884478|100894995|FG001|COMPLETED|Baseline to 4 Months Post-intervention||129||
48234039|NCT03884478|100894996|FG002|COMPLETED|Baseline to 4 Months Post-intervention||126||
48234040|NCT03884478|100894994|FG000|NOT COMPLETED|Baseline to 4 Months Post-intervention||43||
48234041|NCT03884478|100894995|FG001|NOT COMPLETED|Baseline to 4 Months Post-intervention||50||
48234042|NCT03884478|100894996|FG002|NOT COMPLETED|Baseline to 4 Months Post-intervention||51||
48234043|NCT01123200|100894997|FG000|STARTED|Overall Study||1||
48234044|NCT01123200|100894997|FG000|COMPLETED|Overall Study||0||
48234045|NCT01123200|100894997|FG000|NOT COMPLETED|Overall Study||1||
48534256|NCT00987389|101643361|FG001|COMPLETED|Overall Study||168||
48534257|NCT00987389|101643362|FG002|COMPLETED|Overall Study||167||
48534258|NCT00987389|101643363|FG003|COMPLETED|Overall Study||174||
48534259|NCT00987389|101643360|FG000|NOT COMPLETED|Overall Study||9||
48534260|NCT00987389|101643361|FG001|NOT COMPLETED|Overall Study||8||
48534261|NCT00987389|101643362|FG002|NOT COMPLETED|Overall Study||8||
48234046|NCT03400748|100894998|FG000|STARTED|Overall Study||6||
48234047|NCT03400748|100894998|FG000|COMPLETED|Overall Study||6||
48234048|NCT03400748|100894998|FG000|NOT COMPLETED|Overall Study||0||
48234049|NCT02981953|100894999|FG000|STARTED|Overall Study||40||
48534262|NCT00987389|101643363|FG003|NOT COMPLETED|Overall Study||3||
48534263|NCT01330459|101643364|FG000|STARTED|Overall Study||61||
48534264|NCT01330459|101643365|FG001|STARTED|Overall Study||60||
48234050|NCT02981953|100894999|FG000|COMPLETED|Overall Study||29||
48234051|NCT02981953|100894999|FG000|NOT COMPLETED|Overall Study||11||
48234052|NCT01190436|100895000|FG000|STARTED|Overall Study||125||
48234053|NCT01190436|100895000|FG000|COMPLETED|Overall Study||86||
48234054|NCT01190436|100895000|FG000|NOT COMPLETED|Overall Study||39||
48234055|NCT02598388|100895001|FG000|STARTED|Overall Study||40||
48234056|NCT02598388|100895002|FG001|STARTED|Overall Study||10||
48234057|NCT02598388|100895003|FG002|STARTED|Overall Study||20||
48234058|NCT02598388|100895004|FG003|STARTED|Overall Study||5||
48234059|NCT02598388|100895005|FG004|STARTED|Overall Study||161||
48234060|NCT02598388|100895006|FG005|STARTED|Overall Study||39||
48234061|NCT02598388|100895007|FG006|STARTED|Overall Study||161||
48234062|NCT02598388|100895008|FG007|STARTED|Overall Study||39||
48234063|NCT02598388|100895009|FG008|STARTED|Overall Study||39||
48234064|NCT02598388|100895010|FG009|STARTED|Overall Study||10||
48234065|NCT02598388|100895011|FG010|STARTED|Overall Study||40||
48234066|NCT02598388|100895012|FG011|STARTED|Overall Study||10||
48234067|NCT02598388|100895001|FG000|COMPLETED|Overall Study||39||
48234068|NCT02598388|100895002|FG001|COMPLETED|Overall Study||10||
48234069|NCT02598388|100895003|FG002|COMPLETED|Overall Study||18||
48234070|NCT02598388|100895004|FG003|COMPLETED|Overall Study||5||
48234071|NCT02598388|100895005|FG004|COMPLETED|Overall Study||151||
48234072|NCT02598388|100895006|FG005|COMPLETED|Overall Study||38||
48234073|NCT02598388|100895007|FG006|COMPLETED|Overall Study||156||
48234074|NCT02598388|100895008|FG007|COMPLETED|Overall Study||38||
48234075|NCT02598388|100895009|FG008|COMPLETED|Overall Study||39||
48234076|NCT02598388|100895010|FG009|COMPLETED|Overall Study||9||
48234077|NCT02598388|100895011|FG010|COMPLETED|Overall Study||39||
48234078|NCT02598388|100895012|FG011|COMPLETED|Overall Study||10||
48234079|NCT02598388|100895001|FG000|NOT COMPLETED|Overall Study||1||
48234080|NCT02598388|100895002|FG001|NOT COMPLETED|Overall Study||0||
48234081|NCT02598388|100895003|FG002|NOT COMPLETED|Overall Study||2||
48234082|NCT02598388|100895004|FG003|NOT COMPLETED|Overall Study||0||
48234083|NCT02598388|100895005|FG004|NOT COMPLETED|Overall Study||10||
48234084|NCT02598388|100895006|FG005|NOT COMPLETED|Overall Study||1||
48234085|NCT02598388|100895007|FG006|NOT COMPLETED|Overall Study||5||
48234086|NCT02598388|100895008|FG007|NOT COMPLETED|Overall Study||1||
48234087|NCT02598388|100895009|FG008|NOT COMPLETED|Overall Study||0||
48234088|NCT02598388|100895010|FG009|NOT COMPLETED|Overall Study||1||
48234089|NCT02598388|100895011|FG010|NOT COMPLETED|Overall Study||1||
48234090|NCT02598388|100895012|FG011|NOT COMPLETED|Overall Study||0||
48234091|NCT02037568|100895013|FG000|STARTED|Overall Study||83||
48234092|NCT02037568|100895014|FG001|STARTED|Overall Study||76||
48234093|NCT02037568|100895013|FG000|Month 1.5 (Post Transplantation)|Overall Study||79||
48234094|NCT02037568|100895014|FG001|Month 1.5 (Post Transplantation)|Overall Study||76||
48234095|NCT02037568|100895013|FG000|Month 3 (Post Transplantation)|Overall Study||66||
48234096|NCT02037568|100895014|FG001|Month 3 (Post Transplantation)|Overall Study||62||
48234097|NCT02037568|100895013|FG000|Month 6 (Post Transplantation)|Overall Study||63||
48234098|NCT02037568|100895014|FG001|Month 6 (Post Transplantation)|Overall Study||52||
48234099|NCT02037568|100895013|FG000|COMPLETED|Overall Study||47||
48234100|NCT02037568|100895014|FG001|COMPLETED|Overall Study||37||
48234101|NCT02037568|100895013|FG000|NOT COMPLETED|Overall Study||36||
48234102|NCT02037568|100895014|FG001|NOT COMPLETED|Overall Study||39||
48234103|NCT03954106|100895015|FG000|STARTED|Part 1: Safety Lead In Phase||4||
48234104|NCT03954106|100895016|FG001|STARTED|Part 1: Safety Lead In Phase||0||
48234105|NCT03954106|100895015|FG000|COMPLETED|Part 1: Safety Lead In Phase||4||
48234106|NCT03954106|100895016|FG001|COMPLETED|Part 1: Safety Lead In Phase||0||
48234107|NCT03954106|100895015|FG000|NOT COMPLETED|Part 1: Safety Lead In Phase||0||
48234108|NCT03954106|100895016|FG001|NOT COMPLETED|Part 1: Safety Lead In Phase||0||
48234109|NCT03954106|100895015|FG000|STARTED|Phase 2: Treatment at RP2D||0||
48534265|NCT01330459|101643364|FG000|COMPLETED|Overall Study||61||
48534266|NCT01330459|101643365|FG001|COMPLETED|Overall Study||58||
48534267|NCT01330459|101643364|FG000|NOT COMPLETED|Overall Study||0||
48534268|NCT01330459|101643365|FG001|NOT COMPLETED|Overall Study||2||
48234110|NCT03954106|100895016|FG001|STARTED|Phase 2: Treatment at RP2D||21||
48234111|NCT03954106|100895015|FG000|COMPLETED|Phase 2: Treatment at RP2D||0||
48234112|NCT03954106|100895016|FG001|COMPLETED|Phase 2: Treatment at RP2D||21||
48234113|NCT03954106|100895015|FG000|NOT COMPLETED|Phase 2: Treatment at RP2D||0||
48234114|NCT03954106|100895016|FG001|NOT COMPLETED|Phase 2: Treatment at RP2D||0||
48234115|NCT04351243|100895017|FG000|STARTED|Overall Study||114||
48234116|NCT04351243|100895018|FG001|STARTED|Overall Study||113||
48234117|NCT04351243|100895017|FG000|Completed Baseline Assessment|Overall Study||113||
48234118|NCT04351243|100895018|FG001|Completed Baseline Assessment|Overall Study||112||
48234119|NCT04351243|100895017|FG000|COMPLETED|Overall Study||74||
48234120|NCT04351243|100895018|FG001|COMPLETED|Overall Study||75||
48234121|NCT04351243|100895017|FG000|NOT COMPLETED|Overall Study||40||
48234122|NCT04351243|100895018|FG001|NOT COMPLETED|Overall Study||38||
48234123|NCT03662698|100895019|FG000|STARTED|Overall Study||26||
48234124|NCT03662698|100895020|FG001|STARTED|Overall Study||31||
48234125|NCT03662698|100895019|FG000|COMPLETED|Overall Study||19||
48234126|NCT03662698|100895020|FG001|COMPLETED|Overall Study||25||
48234127|NCT03662698|100895019|FG000|NOT COMPLETED|Overall Study||7||
48234128|NCT03662698|100895020|FG001|NOT COMPLETED|Overall Study||6||
48534269|NCT02397408|101643366|FG000|STARTED|Overall Study||18||
48534270|NCT02397408|101643366|FG000|Completed Surgery Per Protocol|Overall Study||16||
48534271|NCT02397408|101643366|FG000|COMPLETED|Overall Study||12||
48534272|NCT02397408|101643366|FG000|NOT COMPLETED|Overall Study||6||
48534273|NCT03056157|101643367|FG000|STARTED|Overall Study||89|Completed baseline assessments.|
48534274|NCT03056157|101643368|FG001|STARTED|Overall Study||85|Completed baseline assessments.|
48534275|NCT03056157|101643367|FG000|Started Treatment (Attended at Least One Therapy Session)|Overall Study||80||
48534276|NCT03056157|101643368|FG001|Started Treatment (Attended at Least One Therapy Session)|Overall Study||83||
48534277|NCT03056157|101643367|FG000|Completed Treatment|Overall Study||59|A participant was considered to have completed treatment if they received twelve sessions within the allotted 16-week interval or were deemed an early completer by their study therapist.|
48534278|NCT03056157|101643368|FG001|Completed Treatment|Overall Study||52|A participant was considered to have completed treatment if they received twelve sessions within the allotted 16-week interval or were deemed an early completer by their study therapist.|
48534279|NCT03056157|101643367|FG000|Completed 12 Sessions|Overall Study||56||
48534280|NCT03056157|101643368|FG001|Completed 12 Sessions|Overall Study||50||
48234129|NCT02680314|100895021|FG000|STARTED|Overall Study||120||
48234130|NCT02680314|100895022|FG001|STARTED|Overall Study||123||
48234131|NCT02680314|100895021|FG000|COMPLETED|Overall Study||120||
48234132|NCT02680314|100895022|FG001|COMPLETED|Overall Study||123||
48234133|NCT02680314|100895021|FG000|NOT COMPLETED|Overall Study||0||
48234134|NCT02680314|100895022|FG001|NOT COMPLETED|Overall Study||0||
48234135|NCT02291549|100895023|FG000|STARTED|Overall Study||201||
48234136|NCT02291549|100895024|FG001|STARTED|Overall Study||99||
48234137|NCT02291549|100895023|FG000|COMPLETED|Overall Study||200||
48234138|NCT02291549|100895024|FG001|COMPLETED|Overall Study||98||
48234139|NCT02291549|100895023|FG000|NOT COMPLETED|Overall Study||1||
48234140|NCT02291549|100895024|FG001|NOT COMPLETED|Overall Study||1||
48234141|NCT02395692|100895025|FG000|STARTED|Overall Study||19||
48234142|NCT02395692|100895026|FG001|STARTED|Overall Study||0||
48234143|NCT02395692|100895025|FG000|COMPLETED|Overall Study||19||
48234144|NCT02395692|100895026|FG001|COMPLETED|Overall Study||0||
48234145|NCT02395692|100895025|FG000|NOT COMPLETED|Overall Study||0||
48234146|NCT02395692|100895026|FG001|NOT COMPLETED|Overall Study||0||
48234147|NCT00065611|100895027|FG000|STARTED|Overall Study||4||
48234148|NCT00065611|100895028|FG001|STARTED|Overall Study||4||
48234149|NCT00065611|100895027|FG000|COMPLETED|Overall Study||4||
48534281|NCT03056157|101643367|FG000|Completed 3-month Follow up|Overall Study||54||
48534282|NCT03056157|101643368|FG001|Completed 3-month Follow up|Overall Study||62||
48234150|NCT00065611|100895028|FG001|COMPLETED|Overall Study||3||
48234151|NCT00065611|100895027|FG000|NOT COMPLETED|Overall Study||0||
48234152|NCT00065611|100895028|FG001|NOT COMPLETED|Overall Study||1||
48234153|NCT00022490|100895029|FG000|STARTED|Overall Study||24||
48234154|NCT00022490|100895029|FG000|COMPLETED|Overall Study||24||
48234155|NCT00022490|100895029|FG000|NOT COMPLETED|Overall Study||0||
48234156|NCT00403845|100895030|FG000|STARTED|Treatment Period 1||12||
48234157|NCT00403845|100895031|FG001|STARTED|Treatment Period 1||13||
48234158|NCT00403845|100895032|FG002|STARTED|Treatment Period 1||11||
48234159|NCT00403845|100895033|FG003|STARTED|Treatment Period 1||14||
48234160|NCT00403845|100895030|FG000|COMPLETED|Treatment Period 1||11||
48234161|NCT00403845|100895031|FG001|COMPLETED|Treatment Period 1||13||
48234162|NCT00403845|100895032|FG002|COMPLETED|Treatment Period 1||11||
48234163|NCT00403845|100895033|FG003|COMPLETED|Treatment Period 1||13||
48234164|NCT00403845|100895030|FG000|NOT COMPLETED|Treatment Period 1||1||
48234165|NCT00403845|100895031|FG001|NOT COMPLETED|Treatment Period 1||0||
48234166|NCT00403845|100895032|FG002|NOT COMPLETED|Treatment Period 1||0||
48234167|NCT00403845|100895033|FG003|NOT COMPLETED|Treatment Period 1||1||
48234168|NCT00403845|100895030|FG000|STARTED|Treatment Period 2||11||
48234169|NCT00403845|100895031|FG001|STARTED|Treatment Period 2||13||
48234170|NCT00403845|100895032|FG002|STARTED|Treatment Period 2||11||
48234171|NCT00403845|100895033|FG003|STARTED|Treatment Period 2||13||
48234172|NCT00403845|100895030|FG000|COMPLETED|Treatment Period 2||10||
48234173|NCT00403845|100895031|FG001|COMPLETED|Treatment Period 2||13||
48234174|NCT00403845|100895032|FG002|COMPLETED|Treatment Period 2||11||
48234175|NCT00403845|100895033|FG003|COMPLETED|Treatment Period 2||13||
48234176|NCT00403845|100895030|FG000|NOT COMPLETED|Treatment Period 2||1||
48234177|NCT00403845|100895031|FG001|NOT COMPLETED|Treatment Period 2||0||
48234178|NCT00403845|100895032|FG002|NOT COMPLETED|Treatment Period 2||0||
48234179|NCT00403845|100895033|FG003|NOT COMPLETED|Treatment Period 2||0||
48234180|NCT00403845|100895030|FG000|STARTED|Treatment Period 3||10||
48234181|NCT00403845|100895031|FG001|STARTED|Treatment Period 3||13||
48234182|NCT00403845|100895032|FG002|STARTED|Treatment Period 3||11||
48234183|NCT00403845|100895033|FG003|STARTED|Treatment Period 3||13||
48234184|NCT00403845|100895030|FG000|COMPLETED|Treatment Period 3||10||
48234185|NCT00403845|100895031|FG001|COMPLETED|Treatment Period 3||13||
48234186|NCT00403845|100895032|FG002|COMPLETED|Treatment Period 3||11||
48234187|NCT00403845|100895033|FG003|COMPLETED|Treatment Period 3||11||
48234188|NCT00403845|100895030|FG000|NOT COMPLETED|Treatment Period 3||0||
48234189|NCT00403845|100895031|FG001|NOT COMPLETED|Treatment Period 3||0||
48234190|NCT00403845|100895032|FG002|NOT COMPLETED|Treatment Period 3||0||
48234191|NCT00403845|100895033|FG003|NOT COMPLETED|Treatment Period 3||2||
48534283|NCT03056157|101643367|FG000|Completed 6-month Follow up|Overall Study||43||
48534284|NCT03056157|101643368|FG001|Completed 6-month Follow up|Overall Study||41||
48534285|NCT03056157|101643367|FG000|COVID-19 Cohort|Overall Study||21|Participants who started the study after December 1, 2020 are considered to be in the COVID-19 cohort.|
48534286|NCT03056157|101643368|FG001|COVID-19 Cohort|Overall Study||22|Participants who started the study after December 1, 2020 are considered to be in the COVID-19 cohort.|
48534287|NCT03056157|101643367|FG000|COMPLETED|Overall Study||59||
48534288|NCT03056157|101643368|FG001|COMPLETED|Overall Study||52||
48534289|NCT03056157|101643367|FG000|NOT COMPLETED|Overall Study||30||
48534290|NCT03056157|101643368|FG001|NOT COMPLETED|Overall Study||33||
48534291|NCT04763564|101643369|FG000|STARTED|First Intervention||3||
48534292|NCT04763564|101643370|FG001|STARTED|First Intervention||5||
48534293|NCT04763564|101643369|FG000|COMPLETED|First Intervention||3||
48534294|NCT04763564|101643370|FG001|COMPLETED|First Intervention||5||
48534295|NCT04763564|101643369|FG000|NOT COMPLETED|First Intervention||0||
48534296|NCT04763564|101643370|FG001|NOT COMPLETED|First Intervention||0||
48234192|NCT00403845|100895030|FG000|STARTED|Treatment Period 4||10||
48534297|NCT04763564|101643369|FG000|STARTED|Washout||3||
48534298|NCT04763564|101643370|FG001|STARTED|Washout||5||
48534299|NCT04763564|101643369|FG000|COMPLETED|Washout||3||
48534300|NCT04763564|101643370|FG001|COMPLETED|Washout||5||
48534301|NCT04763564|101643369|FG000|NOT COMPLETED|Washout||0||
48534302|NCT04763564|101643370|FG001|NOT COMPLETED|Washout||0||
48534303|NCT04763564|101643369|FG000|STARTED|Second Intervention||3||
48534304|NCT04763564|101643370|FG001|STARTED|Second Intervention||5||
48534305|NCT04763564|101643369|FG000|COMPLETED|Second Intervention||3||
48534306|NCT04763564|101643370|FG001|COMPLETED|Second Intervention||5||
48534307|NCT04763564|101643369|FG000|NOT COMPLETED|Second Intervention||0||
48080982|NCT02732119|100521603|FG004|COMPLETED|Phase I||0||
48234193|NCT00403845|100895031|FG001|STARTED|Treatment Period 4||13||
48234194|NCT00403845|100895032|FG002|STARTED|Treatment Period 4||11||
48234195|NCT00403845|100895033|FG003|STARTED|Treatment Period 4||11||
48234196|NCT00403845|100895030|FG000|COMPLETED|Treatment Period 4||10||
48080983|NCT02732119|100521599|FG000|NOT COMPLETED|Phase I||8||
48080984|NCT02732119|100521600|FG001|NOT COMPLETED|Phase I||10||
48234197|NCT00403845|100895031|FG001|COMPLETED|Treatment Period 4||13||
48234198|NCT00403845|100895032|FG002|COMPLETED|Treatment Period 4||11||
48234199|NCT00403845|100895033|FG003|COMPLETED|Treatment Period 4||11||
48534308|NCT04763564|101643370|FG001|NOT COMPLETED|Second Intervention||0||
48534309|NCT04029311|101643371|FG000|STARTED|Overall Study||15||
48080985|NCT02732119|100521601|FG002|NOT COMPLETED|Phase I||7||
48080986|NCT02732119|100521602|FG003|NOT COMPLETED|Phase I||0||
48080987|NCT02732119|100521603|FG004|NOT COMPLETED|Phase I||0||
48080988|NCT02732119|100521599|FG000|STARTED|Phase II||0||
48080989|NCT02732119|100521600|FG001|STARTED|Phase II||0||
48080990|NCT02732119|100521601|FG002|STARTED|Phase II||0||
48080991|NCT02732119|100521602|FG003|STARTED|Phase II||46||
48080992|NCT02732119|100521603|FG004|STARTED|Phase II||33||
48080993|NCT02732119|100521599|FG000|Protocol Analysis Set|Phase II||0|One patient had a major protocol deviation in Group II|
48080994|NCT02732119|100521600|FG001|Protocol Analysis Set|Phase II||0|One patient had a major protocol deviation in Group II|
48080995|NCT02732119|100521601|FG002|Protocol Analysis Set|Phase II||0|One patient had a major protocol deviation in Group II|
48080996|NCT02732119|100521602|FG003|Protocol Analysis Set|Phase II||46|One patient had a major protocol deviation in Group II|
48080997|NCT02732119|100521603|FG004|Protocol Analysis Set|Phase II||32|One patient had a major protocol deviation in Group II|
48080998|NCT02732119|100521599|FG000|COMPLETED|Phase II||0||
48080999|NCT02732119|100521600|FG001|COMPLETED|Phase II||0||
48234200|NCT00403845|100895030|FG000|NOT COMPLETED|Treatment Period 4||0||
48234201|NCT00403845|100895031|FG001|NOT COMPLETED|Treatment Period 4||0||
48234202|NCT00403845|100895032|FG002|NOT COMPLETED|Treatment Period 4||0||
48234203|NCT00403845|100895033|FG003|NOT COMPLETED|Treatment Period 4||0||
48234204|NCT00185692|100895034|FG000|STARTED|Overall Study||16||
48234205|NCT00185692|100895034|FG000|COMPLETED|Overall Study||0||
48234206|NCT00185692|100895034|FG000|NOT COMPLETED|Overall Study||16||
48234207|NCT00103857|100895035|FG000|STARTED|54-Week Base Study||179||
48234208|NCT00103857|100895036|FG001|STARTED|54-Week Base Study||182||
48234209|NCT00103857|100895037|FG002|STARTED|54-Week Base Study||182||
48234210|NCT00103857|100895038|FG003|STARTED|54-Week Base Study||190||
48234211|NCT00103857|100895039|FG004|STARTED|54-Week Base Study||182||
48234212|NCT00103857|100895040|FG005|STARTED|54-Week Base Study||176||
48234213|NCT00103857|100895041|FG006|STARTED|54-Week Base Study||117||
48234214|NCT00103857|100895035|FG000|COMPLETED|54-Week Base Study||122||
48234215|NCT00103857|100895036|FG001|COMPLETED|54-Week Base Study||126||
48234216|NCT00103857|100895037|FG002|COMPLETED|54-Week Base Study||135||
48234217|NCT00103857|100895038|FG003|COMPLETED|54-Week Base Study||148||
48234218|NCT00103857|100895039|FG004|COMPLETED|54-Week Base Study||141||
48234219|NCT00103857|100895040|FG005|COMPLETED|54-Week Base Study||115||
48534310|NCT04029311|101643372|FG001|STARTED|Overall Study||13||
48534311|NCT04029311|101643371|FG000|COMPLETED|Overall Study||12||
48234220|NCT00103857|100895041|FG006|COMPLETED|54-Week Base Study||79||
48234221|NCT00103857|100895035|FG000|NOT COMPLETED|54-Week Base Study||57||
48234222|NCT00103857|100895036|FG001|NOT COMPLETED|54-Week Base Study||56||
48234223|NCT00103857|100895037|FG002|NOT COMPLETED|54-Week Base Study||47||
48534312|NCT04029311|101643372|FG001|COMPLETED|Overall Study||13||
48534313|NCT04029311|101643371|FG000|NOT COMPLETED|Overall Study||3||
48534314|NCT04029311|101643372|FG001|NOT COMPLETED|Overall Study||0||
48534315|NCT03866902|101643373|FG000|STARTED|Overall Study||288||
48534316|NCT03866902|101643374|FG001|STARTED|Overall Study||286||
48534317|NCT03866902|101643373|FG000|Mother|Overall Study||144||
48534318|NCT03866902|101643374|FG001|Mother|Overall Study||143||
48534319|NCT03866902|101643373|FG000|Child|Overall Study||144||
48534320|NCT03866902|101643374|FG001|Child|Overall Study||143||
48534321|NCT03866902|101643373|FG000|COMPLETED|Overall Study||172||
48534322|NCT03866902|101643374|FG001|COMPLETED|Overall Study||180||
48534323|NCT03866902|101643373|FG000|NOT COMPLETED|Overall Study||116||
48534324|NCT03866902|101643374|FG001|NOT COMPLETED|Overall Study||106||
48534325|NCT03402750|101643375|FG000|STARTED|Overall Study||20||
48534326|NCT03402750|101643376|FG001|STARTED|Overall Study||20||
48534327|NCT03402750|101643375|FG000|COMPLETED|Overall Study||18||
48534328|NCT03402750|101643376|FG001|COMPLETED|Overall Study||19||
48534329|NCT03402750|101643375|FG000|NOT COMPLETED|Overall Study||2||
48534330|NCT03402750|101643376|FG001|NOT COMPLETED|Overall Study||1||
48534331|NCT01462773|101643377|FG000|STARTED|Overall Study||16||
48534332|NCT01462773|101643377|FG000|COMPLETED|Overall Study||16||
48234224|NCT00103857|100895038|FG003|NOT COMPLETED|54-Week Base Study||42||
48234225|NCT00103857|100895039|FG004|NOT COMPLETED|54-Week Base Study||41||
48234226|NCT00103857|100895040|FG005|NOT COMPLETED|54-Week Base Study||61||
48234227|NCT00103857|100895041|FG006|NOT COMPLETED|54-Week Base Study||38||
48234228|NCT00103857|100895035|FG000|STARTED|50-Week Extension Study||103||
48234229|NCT00103857|100895036|FG001|STARTED|50-Week Extension Study||107||
48534333|NCT01462773|101643377|FG000|NOT COMPLETED|Overall Study||0||
48534334|NCT00801099|101643378|FG000|STARTED|Overall Study||276||
48534335|NCT00801099|101643378|FG000|COMPLETED|Overall Study||175||
48234230|NCT00103857|100895037|FG002|STARTED|50-Week Extension Study||121||
48534336|NCT00801099|101643378|FG000|NOT COMPLETED|Overall Study||101||
48534337|NCT02176408|101643379|FG000|STARTED|Overall Study||15||
48534338|NCT02176408|101643380|FG001|STARTED|Overall Study||16||
48534339|NCT02176408|101643379|FG000|COMPLETED|Overall Study||9||
48534340|NCT02176408|101643380|FG001|COMPLETED|Overall Study||12||
48534341|NCT02176408|101643379|FG000|NOT COMPLETED|Overall Study||6||
48534342|NCT02176408|101643380|FG001|NOT COMPLETED|Overall Study||4||
48534343|NCT02802449|101643381|FG000|STARTED|Overall Study||111||
48534344|NCT02802449|101643382|FG001|STARTED|Overall Study||219||
48534345|NCT02802449|101643381|FG000|COMPLETED|Overall Study||102||
48534346|NCT02802449|101643382|FG001|COMPLETED|Overall Study||202||
48534347|NCT02802449|101643381|FG000|NOT COMPLETED|Overall Study||9||
48534348|NCT02802449|101643382|FG001|NOT COMPLETED|Overall Study||17||
48234231|NCT00103857|100895038|FG003|STARTED|50-Week Extension Study||134||
48534349|NCT01676415|101643383|FG000|STARTED|Overall Study||4||
48534350|NCT01676415|101643384|FG001|STARTED|Overall Study||5||
48534351|NCT01676415|101643383|FG000|COMPLETED|Overall Study||4||
48534352|NCT01676415|101643384|FG001|COMPLETED|Overall Study||5||
48534353|NCT01676415|101643383|FG000|NOT COMPLETED|Overall Study||0||
48534354|NCT01676415|101643384|FG001|NOT COMPLETED|Overall Study||0||
48534355|NCT00186888|101643385|FG000|STARTED|Overall Study||23||
48534356|NCT00186888|101643386|FG001|STARTED|Overall Study||27||
48534357|NCT00186888|101643387|FG002|STARTED|Overall Study||55||
48534358|NCT00186888|101643385|FG000|Window Therapy|Overall Study||0||
48534359|NCT00186888|101643386|FG001|Window Therapy|Overall Study||27||
48534360|NCT00186888|101643387|FG002|Window Therapy|Overall Study||0||
48534361|NCT00186888|101643385|FG000|COMPLETED|Overall Study||19||
48534362|NCT00186888|101643386|FG001|COMPLETED|Overall Study||24||
48534363|NCT00186888|101643387|FG002|COMPLETED|Overall Study||55||
48234232|NCT00103857|100895039|FG004|STARTED|50-Week Extension Study||122||
48234233|NCT00103857|100895040|FG005|STARTED|50-Week Extension Study||98||
48234234|NCT00103857|100895041|FG006|STARTED|50-Week Extension Study||0||
48534364|NCT00186888|101643385|FG000|NOT COMPLETED|Overall Study||4||
48534365|NCT00186888|101643386|FG001|NOT COMPLETED|Overall Study||3||
48534366|NCT00186888|101643387|FG002|NOT COMPLETED|Overall Study||0||
48534367|NCT00345943|101643388|FG000|STARTED|Overall Study||38||
48534368|NCT00345943|101643389|FG001|STARTED|Overall Study||33||
48234235|NCT00103857|100895035|FG000|COMPLETED|50-Week Extension Study||65||
48234236|NCT00103857|100895036|FG001|COMPLETED|50-Week Extension Study||80||
48234237|NCT00103857|100895037|FG002|COMPLETED|50-Week Extension Study||95||
48234238|NCT00103857|100895038|FG003|COMPLETED|50-Week Extension Study||98||
48234239|NCT00103857|100895039|FG004|COMPLETED|50-Week Extension Study||101||
48234240|NCT00103857|100895040|FG005|COMPLETED|50-Week Extension Study||78||
48234241|NCT00103857|100895041|FG006|COMPLETED|50-Week Extension Study||0||
48534369|NCT00345943|101643388|FG000|COMPLETED|Overall Study||33||
48534370|NCT00345943|101643389|FG001|COMPLETED|Overall Study||28||
48534371|NCT00345943|101643388|FG000|NOT COMPLETED|Overall Study||5||
48534372|NCT00345943|101643389|FG001|NOT COMPLETED|Overall Study||5||
48234242|NCT00103857|100895035|FG000|NOT COMPLETED|50-Week Extension Study||38||
48234243|NCT00103857|100895036|FG001|NOT COMPLETED|50-Week Extension Study||27||
48234244|NCT00103857|100895037|FG002|NOT COMPLETED|50-Week Extension Study||26||
48534373|NCT00201409|101643390|FG000|STARTED|Overall Study||65||
48534374|NCT00201409|101643391|FG001|STARTED|Overall Study||67||
48534375|NCT00201409|101643390|FG000|COMPLETED|Overall Study||64||
48534376|NCT00201409|101643391|FG001|COMPLETED|Overall Study||66||
48534377|NCT00201409|101643390|FG000|NOT COMPLETED|Overall Study||1||
48534378|NCT00201409|101643391|FG001|NOT COMPLETED|Overall Study||1||
48534379|NCT02878486|101643392|FG000|STARTED|Overall Study||3||
48534380|NCT02878486|101643393|FG001|STARTED|Overall Study||3||
48534381|NCT02878486|101643392|FG000|COMPLETED|Overall Study||3||
48534382|NCT02878486|101643393|FG001|COMPLETED|Overall Study||3||
48534383|NCT02878486|101643392|FG000|NOT COMPLETED|Overall Study||0||
48534384|NCT02878486|101643393|FG001|NOT COMPLETED|Overall Study||0||
48534385|NCT02881840|101643394|FG000|STARTED|Overall Study||6||
48534386|NCT02881840|101643394|FG000|COMPLETED|Overall Study||6||
48534387|NCT02881840|101643394|FG000|NOT COMPLETED|Overall Study||0||
48534388|NCT01539135|101643395|FG000|STARTED|Overall Study||43||
48534389|NCT01539135|101643396|FG001|STARTED|Overall Study||37||
48534390|NCT01539135|101643395|FG000|COMPLETED|Overall Study||43||
48534391|NCT01539135|101643396|FG001|COMPLETED|Overall Study||37||
48534392|NCT01539135|101643395|FG000|NOT COMPLETED|Overall Study||0||
48534393|NCT01539135|101643396|FG001|NOT COMPLETED|Overall Study||0||
48534394|NCT00119067|101643397|FG000|STARTED|Overall Study||260||
48534395|NCT00119067|101643398|FG001|STARTED|Overall Study||262||
48534396|NCT00119067|101643399|FG002|STARTED|Overall Study||256||
48534397|NCT00119067|101643400|FG003|STARTED|Overall Study||258||
48534398|NCT00119067|101643401|FG004|STARTED|Overall Study||268||
48534399|NCT00119067|101643402|FG005|STARTED|Overall Study||260||
48534400|NCT00119067|101643397|FG000|COMPLETED|Overall Study||148||
48534401|NCT00119067|101643398|FG001|COMPLETED|Overall Study||157||
48534402|NCT00119067|101643399|FG002|COMPLETED|Overall Study||146||
48534403|NCT00119067|101643400|FG003|COMPLETED|Overall Study||144||
48534404|NCT00119067|101643401|FG004|COMPLETED|Overall Study||158||
48534405|NCT00119067|101643402|FG005|COMPLETED|Overall Study||144||
48534406|NCT00119067|101643397|FG000|NOT COMPLETED|Overall Study||112||
48534407|NCT00119067|101643398|FG001|NOT COMPLETED|Overall Study||105||
48534408|NCT00119067|101643399|FG002|NOT COMPLETED|Overall Study||110||
48534409|NCT00119067|101643400|FG003|NOT COMPLETED|Overall Study||114||
48534410|NCT00119067|101643401|FG004|NOT COMPLETED|Overall Study||110||
48534411|NCT00119067|101643402|FG005|NOT COMPLETED|Overall Study||116||
48534412|NCT02149108|101643403|FG000|STARTED|Overall Study||382||
48534413|NCT02149108|101643404|FG001|STARTED|Overall Study||386||
48534414|NCT02149108|101643403|FG000|COMPLETED|Overall Study||2||
48534415|NCT02149108|101643404|FG001|COMPLETED|Overall Study||3||
48534416|NCT02149108|101643403|FG000|NOT COMPLETED|Overall Study||380||
48534417|NCT02149108|101643404|FG001|NOT COMPLETED|Overall Study||383||
48534418|NCT00210249|101643405|FG000|STARTED|Overall Study||364||
48534419|NCT00210249|101643405|FG000|COMPLETED|Overall Study||348||
48534420|NCT00210249|101643405|FG000|NOT COMPLETED|Overall Study||16||
48534421|NCT04300010|101643406|FG000|STARTED|Overall Study||20||20
48534422|NCT04300010|101643407|FG001|STARTED|Overall Study||20||20
48534423|NCT04300010|101643408|FG002|STARTED|Overall Study||20||20
48534424|NCT04300010|101643409|FG003|STARTED|Overall Study||60||60
48534425|NCT04300010|101643406|FG000|COMPLETED|Overall Study||20||20
48534426|NCT04300010|101643407|FG001|COMPLETED|Overall Study||20||20
48534427|NCT04300010|101643408|FG002|COMPLETED|Overall Study||20||20
48534428|NCT04300010|101643409|FG003|COMPLETED|Overall Study||60||60
48534429|NCT04300010|101643406|FG000|NOT COMPLETED|Overall Study||0||0
48534430|NCT04300010|101643407|FG001|NOT COMPLETED|Overall Study||0||0
48534431|NCT04300010|101643408|FG002|NOT COMPLETED|Overall Study||0||0
48534432|NCT04300010|101643409|FG003|NOT COMPLETED|Overall Study||0||0
48534433|NCT01383213|101643410|FG000|STARTED|Overall Study||40||
48534434|NCT01383213|101643411|FG001|STARTED|Overall Study||41||
48534435|NCT01383213|101643410|FG000|COMPLETED|Overall Study||40||
48534436|NCT01383213|101643411|FG001|COMPLETED|Overall Study||41||
48534437|NCT01383213|101643410|FG000|NOT COMPLETED|Overall Study||0||
48534438|NCT01383213|101643411|FG001|NOT COMPLETED|Overall Study||0||
48534439|NCT01350583|101643412|FG000|STARTED|Overall Study||2||
48534440|NCT01350583|101643412|FG000|COMPLETED|Overall Study||2||
48534441|NCT01350583|101643412|FG000|NOT COMPLETED|Overall Study||0||
48534442|NCT01631071|101643413|FG000|STARTED|Overall Study||55||
48534443|NCT01631071|101643414|FG001|STARTED|Overall Study||55||
48534444|NCT01631071|101643413|FG000|COMPLETED|Overall Study||55||
48534445|NCT01631071|101643414|FG001|COMPLETED|Overall Study||55||
48534446|NCT01631071|101643413|FG000|NOT COMPLETED|Overall Study||0||
48534447|NCT01631071|101643414|FG001|NOT COMPLETED|Overall Study||0||
48534448|NCT04295135|101643415|FG000|STARTED|Overall Study||69||
48534449|NCT04295135|101643416|FG001|STARTED|Overall Study||68||
48534450|NCT04295135|101643415|FG000|COMPLETED|Overall Study||59||
48534451|NCT04295135|101643416|FG001|COMPLETED|Overall Study||63||
48534452|NCT04295135|101643415|FG000|NOT COMPLETED|Overall Study||10||
48534453|NCT04295135|101643416|FG001|NOT COMPLETED|Overall Study||5||
48534454|NCT03853148|101643417|FG000|STARTED|Overall Study||10||
48534455|NCT03853148|101643418|FG001|STARTED|Overall Study||10||
48534456|NCT03853148|101643419|FG002|STARTED|Overall Study||10||
48534457|NCT03853148|101643420|FG003|STARTED|Overall Study||20||
48592656|NCT01877382|101783158|FG008|NOT COMPLETED|Dose Escalation||6||
48592657|NCT01877382|101783159|FG009|NOT COMPLETED|Dose Escalation||3||
48534458|NCT03853148|101643417|FG000|COMPLETED|Overall Study||5|"The participant completers varied throughout the study for each of the outcomes which ranged from 8 completers to as low as 2 completers, depending on the outcome. Reported in the Not Completed section here are the lowest numbers of completers in any one outcome."|
48534459|NCT03853148|101643418|FG001|COMPLETED|Overall Study||2|"The participant completers varied throughout the study for each of the outcomes which ranged from 8 completers to as low as 2 completers, depending on the outcome. Reported in the Not Completed section here are the lowest numbers of completers in any one outcome."|
48234245|NCT00103857|100895038|FG003|NOT COMPLETED|50-Week Extension Study||36||
48234246|NCT00103857|100895039|FG004|NOT COMPLETED|50-Week Extension Study||21||
48234247|NCT00103857|100895040|FG005|NOT COMPLETED|50-Week Extension Study||20||
48534460|NCT03853148|101643419|FG002|COMPLETED|Overall Study||2|"The participant completers varied throughout the study for each of the outcomes which ranged from 8 completers to as low as 2 completers, depending on the outcome. Reported in the Not Completed section here are the lowest numbers of completers in any one outcome."|
48534461|NCT03853148|101643420|FG003|COMPLETED|Overall Study||15|"The participant completers varied throughout the study for each of the outcomes which ranged from 8 completers to as low as 2 completers, depending on the outcome. Reported in the Not Completed section here are the lowest numbers of completers in any one outcome."|
48534462|NCT03853148|101643417|FG000|NOT COMPLETED|Overall Study||5||
48534463|NCT03853148|101643418|FG001|NOT COMPLETED|Overall Study||8||
48534464|NCT03853148|101643419|FG002|NOT COMPLETED|Overall Study||8||
48534465|NCT03853148|101643420|FG003|NOT COMPLETED|Overall Study||5||
48534466|NCT02912650|101643421|FG000|STARTED|Overall Study||56||
48534467|NCT02912650|101643422|FG001|STARTED|Overall Study||172||
48534468|NCT02912650|101643423|FG002|STARTED|Overall Study||175||
48534469|NCT02912650|101643424|FG003|STARTED|Overall Study||165||
48534470|NCT02912650|101643421|FG000|COMPLETED|Overall Study||55||
48534471|NCT02912650|101643422|FG001|COMPLETED|Overall Study||172||
48534472|NCT02912650|101643423|FG002|COMPLETED|Overall Study||173||
48534473|NCT02912650|101643424|FG003|COMPLETED|Overall Study||160||
48534474|NCT02912650|101643421|FG000|NOT COMPLETED|Overall Study||1||
48534475|NCT02912650|101643422|FG001|NOT COMPLETED|Overall Study||0||
48534476|NCT02912650|101643423|FG002|NOT COMPLETED|Overall Study||2||
48534477|NCT02912650|101643424|FG003|NOT COMPLETED|Overall Study||5||
48534478|NCT00469911|101643425|FG000|STARTED|Overall Study||8||
48534479|NCT00469911|101643426|FG001|STARTED|Overall Study||10||
48534480|NCT00469911|101643425|FG000|COMPLETED|Overall Study||8||
48534481|NCT00469911|101643426|FG001|COMPLETED|Overall Study||10||
48534482|NCT00469911|101643425|FG000|NOT COMPLETED|Overall Study||0||
48534483|NCT00469911|101643426|FG001|NOT COMPLETED|Overall Study||0||
48534484|NCT04771403|101643427|FG000|STARTED|Dexcom Training Visit (1 Week)||13||
48534485|NCT04771403|101643428|FG001|STARTED|Dexcom Training Visit (1 Week)||12||
48534486|NCT04771403|101643427|FG000|COMPLETED|Dexcom Training Visit (1 Week)||13||
48534487|NCT04771403|101643428|FG001|COMPLETED|Dexcom Training Visit (1 Week)||12||
48534488|NCT04771403|101643427|FG000|NOT COMPLETED|Dexcom Training Visit (1 Week)||0||
48534489|NCT04771403|101643428|FG001|NOT COMPLETED|Dexcom Training Visit (1 Week)||0||
48534490|NCT04771403|101643427|FG000|STARTED|First Rest Period (1-12 Weeks)||13||
48534491|NCT04771403|101643428|FG001|STARTED|First Rest Period (1-12 Weeks)||12||
48534492|NCT04771403|101643427|FG000|COMPLETED|First Rest Period (1-12 Weeks)||13||
48534493|NCT04771403|101643428|FG001|COMPLETED|First Rest Period (1-12 Weeks)||12||
48534494|NCT04771403|101643427|FG000|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
48534495|NCT04771403|101643428|FG001|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
48534496|NCT04771403|101643427|FG000|STARTED|First Intervention (~76 Hours)||13||
48534497|NCT04771403|101643428|FG001|STARTED|First Intervention (~76 Hours)||12||
48534498|NCT04771403|101643427|FG000|COMPLETED|First Intervention (~76 Hours)||9||
48534499|NCT04771403|101643428|FG001|COMPLETED|First Intervention (~76 Hours)||10||
48534500|NCT04771403|101643427|FG000|NOT COMPLETED|First Intervention (~76 Hours)||4||
48534501|NCT04771403|101643428|FG001|NOT COMPLETED|First Intervention (~76 Hours)||2||
48534502|NCT04771403|101643427|FG000|STARTED|Second Rest Period (1-10 Weeks)||13||
48534503|NCT04771403|101643428|FG001|STARTED|Second Rest Period (1-10 Weeks)||12||
48534504|NCT04771403|101643427|FG000|COMPLETED|Second Rest Period (1-10 Weeks)||12||
48534505|NCT04771403|101643428|FG001|COMPLETED|Second Rest Period (1-10 Weeks)||12||
48534506|NCT04771403|101643427|FG000|NOT COMPLETED|Second Rest Period (1-10 Weeks)||1||
48534507|NCT04771403|101643428|FG001|NOT COMPLETED|Second Rest Period (1-10 Weeks)||0||
48534508|NCT04771403|101643427|FG000|STARTED|Second Intervention Visit (~76 Hours)||12||
48534509|NCT04771403|101643428|FG001|STARTED|Second Intervention Visit (~76 Hours)||12||
48534510|NCT04771403|101643427|FG000|COMPLETED|Second Intervention Visit (~76 Hours)||11||
48534511|NCT04771403|101643428|FG001|COMPLETED|Second Intervention Visit (~76 Hours)||12||
48234248|NCT00103857|100895041|FG006|NOT COMPLETED|50-Week Extension Study||0||
48234249|NCT00636168|100895042|FG000|STARTED|Randomized to Study Drug||475||
48234250|NCT00636168|100895043|FG001|STARTED|Randomized to Study Drug||476||
48234251|NCT00636168|100895042|FG000|COMPLETED|Randomized to Study Drug||471||
48234252|NCT00636168|100895043|FG001|COMPLETED|Randomized to Study Drug||474||
48234253|NCT00636168|100895042|FG000|NOT COMPLETED|Randomized to Study Drug||4||
48234254|NCT00636168|100895043|FG001|NOT COMPLETED|Randomized to Study Drug||2||
48234255|NCT00636168|100895042|FG000|STARTED|Treated With Study Drug||471||
48234256|NCT00636168|100895043|FG001|STARTED|Treated With Study Drug||474||
48234257|NCT00636168|100895042|FG000|COMPLETED|Treated With Study Drug||63|Normal Completion|
48234258|NCT00636168|100895043|FG001|COMPLETED|Treated With Study Drug||143|Normal Completion|
48234259|NCT00636168|100895042|FG000|NOT COMPLETED|Treated With Study Drug||408||
48234260|NCT00636168|100895043|FG001|NOT COMPLETED|Treated With Study Drug||331||
48234261|NCT00636168|100895042|FG000|STARTED|Long Term Follow-Up||141|Continuing in Long Term Follow Up|
48534512|NCT04771403|101643427|FG000|NOT COMPLETED|Second Intervention Visit (~76 Hours)||1||
48534513|NCT04771403|101643428|FG001|NOT COMPLETED|Second Intervention Visit (~76 Hours)||0||
48534514|NCT03559400|101643429|FG000|STARTED|Overall Study||45||
48534515|NCT03559400|101643430|FG001|STARTED|Overall Study||55||
48534516|NCT03559400|101643429|FG000|COMPLETED|Overall Study||36||
48534517|NCT03559400|101643430|FG001|COMPLETED|Overall Study||46||
48534518|NCT03559400|101643429|FG000|NOT COMPLETED|Overall Study||9||
48534519|NCT03559400|101643430|FG001|NOT COMPLETED|Overall Study||9||
48534520|NCT01666197|101643431|FG000|STARTED|Overall Study||50||
48534521|NCT01666197|101643432|FG001|STARTED|Overall Study||50||
48534522|NCT01666197|101643431|FG000|COMPLETED|Overall Study||50||
48534523|NCT01666197|101643432|FG001|COMPLETED|Overall Study||50||
48534524|NCT01666197|101643431|FG000|NOT COMPLETED|Overall Study||0||
48534525|NCT01666197|101643432|FG001|NOT COMPLETED|Overall Study||0||
48534526|NCT02351271|101643433|FG000|STARTED|Overall Study||68||
48534527|NCT02351271|101643434|FG001|STARTED|Overall Study||62||
48534528|NCT02351271|101643433|FG000|COMPLETED|Overall Study||68||
48534529|NCT02351271|101643434|FG001|COMPLETED|Overall Study||62||
48534530|NCT02351271|101643433|FG000|NOT COMPLETED|Overall Study||0||
48534531|NCT02351271|101643434|FG001|NOT COMPLETED|Overall Study||0||
48534532|NCT02337959|101643435|FG000|STARTED|Overall Study||10||
48534533|NCT02337959|101643436|FG001|STARTED|Overall Study||10||
48534534|NCT02337959|101643437|FG002|STARTED|Overall Study||7||
48534535|NCT02337959|101643435|FG000|COMPLETED|Overall Study||10||
48534536|NCT02337959|101643436|FG001|COMPLETED|Overall Study||7||
48534537|NCT02337959|101643437|FG002|COMPLETED|Overall Study||7||
48534538|NCT02337959|101643435|FG000|NOT COMPLETED|Overall Study||0||
48534539|NCT02337959|101643436|FG001|NOT COMPLETED|Overall Study||3||
48534540|NCT02337959|101643437|FG002|NOT COMPLETED|Overall Study||0||
48534541|NCT01473524|101643438|FG000|STARTED|DB Phase||71||
48534542|NCT01473524|101643439|FG001|STARTED|DB Phase||73||
48534543|NCT01473524|101643440|FG002|STARTED|DB Phase||73||
48534544|NCT01473524|101643441|FG003|STARTED|DB Phase||0||
48534545|NCT01473524|101643442|FG004|STARTED|DB Phase||0||
48534546|NCT01473524|101643443|FG005|STARTED|DB Phase||0||
48534547|NCT01473524|101643438|FG000|Received at Least 1 Dose of Study Drug|DB Phase||70||
48534548|NCT01473524|101643439|FG001|Received at Least 1 Dose of Study Drug|DB Phase||73||
48534549|NCT01473524|101643440|FG002|Received at Least 1 Dose of Study Drug|DB Phase||73||
48534550|NCT01473524|101643441|FG003|Received at Least 1 Dose of Study Drug|DB Phase||0||
48534551|NCT01473524|101643442|FG004|Received at Least 1 Dose of Study Drug|DB Phase||0||
48534552|NCT01473524|101643443|FG005|Received at Least 1 Dose of Study Drug|DB Phase||0||
48534553|NCT01473524|101643438|FG000|COMPLETED|DB Phase||64||
48534554|NCT01473524|101643439|FG001|COMPLETED|DB Phase||64||
48534555|NCT01473524|101643440|FG002|COMPLETED|DB Phase||70||
48534556|NCT01473524|101643441|FG003|COMPLETED|DB Phase||0||
48534557|NCT01473524|101643442|FG004|COMPLETED|DB Phase||0||
48534558|NCT01473524|101643443|FG005|COMPLETED|DB Phase||0||
48534559|NCT01473524|101643438|FG000|NOT COMPLETED|DB Phase||7||
48534560|NCT01473524|101643439|FG001|NOT COMPLETED|DB Phase||9||
48534561|NCT01473524|101643440|FG002|NOT COMPLETED|DB Phase||3||
48534562|NCT01473524|101643441|FG003|NOT COMPLETED|DB Phase||0||
48534563|NCT01473524|101643442|FG004|NOT COMPLETED|DB Phase||0||
48534564|NCT01473524|101643443|FG005|NOT COMPLETED|DB Phase||0||
48534565|NCT01473524|101643438|FG000|STARTED|LTSE Phase||0||
48081000|NCT02732119|100521601|FG002|COMPLETED|Phase II||0||
48081001|NCT02732119|100521602|FG003|COMPLETED|Phase II||0||
48081002|NCT02732119|100521603|FG004|COMPLETED|Phase II||0||
48081003|NCT02732119|100521599|FG000|NOT COMPLETED|Phase II||0||
48081004|NCT02732119|100521600|FG001|NOT COMPLETED|Phase II||0||
48081005|NCT02732119|100521601|FG002|NOT COMPLETED|Phase II||0||
48081006|NCT02732119|100521602|FG003|NOT COMPLETED|Phase II||46||
48234262|NCT00636168|100895043|FG001|STARTED|Long Term Follow-Up||143|Continuing in Long Term Follow Up|
48534566|NCT01473524|101643439|FG001|STARTED|LTSE Phase||0||
48534567|NCT01473524|101643440|FG002|STARTED|LTSE Phase||0||
48534568|NCT01473524|101643441|FG003|STARTED|LTSE Phase||63||
48534569|NCT01473524|101643442|FG004|STARTED|LTSE Phase||64||
48534570|NCT01473524|101643443|FG005|STARTED|LTSE Phase||66||
48534571|NCT01473524|101643438|FG000|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0||
48534572|NCT01473524|101643439|FG001|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0||
48534573|NCT01473524|101643440|FG002|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0||
48534574|NCT01473524|101643441|FG003|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||63||
48534575|NCT01473524|101643442|FG004|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||64||
48534576|NCT01473524|101643443|FG005|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||66||
48534577|NCT01473524|101643438|FG000|COMPLETED|LTSE Phase||0||
48534578|NCT01473524|101643439|FG001|COMPLETED|LTSE Phase||0||
48534579|NCT01473524|101643440|FG002|COMPLETED|LTSE Phase||0||
48081007|NCT02732119|100521603|FG004|NOT COMPLETED|Phase II||33||
48081008|NCT02228460|100521604|FG000|STARTED|Overall Study||11||
48534580|NCT01473524|101643441|FG003|COMPLETED|LTSE Phase||54||
48534581|NCT01473524|101643442|FG004|COMPLETED|LTSE Phase||47||
48534582|NCT01473524|101643443|FG005|COMPLETED|LTSE Phase||45||
48534583|NCT01473524|101643438|FG000|NOT COMPLETED|LTSE Phase||0||
48534584|NCT01473524|101643439|FG001|NOT COMPLETED|LTSE Phase||0||
48234263|NCT00636168|100895042|FG000|COMPLETED|Long Term Follow-Up||130||
48234264|NCT00636168|100895043|FG001|COMPLETED|Long Term Follow-Up||129||
48234265|NCT00636168|100895042|FG000|NOT COMPLETED|Long Term Follow-Up||11||
48234266|NCT00636168|100895043|FG001|NOT COMPLETED|Long Term Follow-Up||14||
48234267|NCT00267865|100895044|FG000|STARTED|Induction Treatment||12||
48234268|NCT00267865|100895044|FG000|COMPLETED|Induction Treatment||9||
48234269|NCT00267865|100895044|FG000|NOT COMPLETED|Induction Treatment||3||
48234270|NCT00267865|100895044|FG000|STARTED|Consolidation Treatment||5||
48234271|NCT00267865|100895044|FG000|COMPLETED|Consolidation Treatment||5||
48234272|NCT00267865|100895044|FG000|NOT COMPLETED|Consolidation Treatment||0||
48234273|NCT03615404|100895045|FG000|STARTED|Overall Study||11||
48234274|NCT03615404|100895045|FG000|COMPLETED|Overall Study||9||
48234275|NCT03615404|100895045|FG000|NOT COMPLETED|Overall Study||2||
48534585|NCT01473524|101643440|FG002|NOT COMPLETED|LTSE Phase||0||
48534586|NCT01473524|101643441|FG003|NOT COMPLETED|LTSE Phase||9||
48534587|NCT01473524|101643442|FG004|NOT COMPLETED|LTSE Phase||17||
48534588|NCT01473524|101643443|FG005|NOT COMPLETED|LTSE Phase||21||
48534589|NCT00311402|101643444|FG000|STARTED|Overall Study||655||
48534590|NCT00311402|101643445|FG001|STARTED|Overall Study||639||
48534591|NCT00311402|101643444|FG000|COMPLETED|Overall Study||445||
48534592|NCT00311402|101643445|FG001|COMPLETED|Overall Study||462||
48534593|NCT00311402|101643444|FG000|NOT COMPLETED|Overall Study||210||
48534594|NCT00311402|101643445|FG001|NOT COMPLETED|Overall Study||177||
48534595|NCT00265395|101643446|FG000|STARTED|Overall Study||86||
48534596|NCT00265395|101643447|FG001|STARTED|Overall Study||73||
48534597|NCT00265395|101643446|FG000|COMPLETED|Overall Study||78||
48534598|NCT00265395|101643447|FG001|COMPLETED|Overall Study||56||
48534599|NCT00265395|101643446|FG000|NOT COMPLETED|Overall Study||8||
48534600|NCT00265395|101643447|FG001|NOT COMPLETED|Overall Study||17||
48534601|NCT03393806|101643448|FG000|STARTED|Overall Study||9||
48534602|NCT03393806|101643449|FG001|STARTED|Overall Study||8||
48534603|NCT03393806|101643448|FG000|COMPLETED|Overall Study||8||
48534604|NCT03393806|101643449|FG001|COMPLETED|Overall Study||8||
48534605|NCT03393806|101643448|FG000|NOT COMPLETED|Overall Study||1||
48534606|NCT03393806|101643449|FG001|NOT COMPLETED|Overall Study||0||
48534607|NCT02829294|101643450|FG000|STARTED|Overall Study||19||
48534608|NCT02829294|101643450|FG000|COMPLETED|Overall Study||19||
48534609|NCT02829294|101643450|FG000|NOT COMPLETED|Overall Study||0||
48534610|NCT03584724|101643451|FG000|STARTED|Overall Study||25||
48534611|NCT03584724|101643452|FG001|STARTED|Overall Study||24||
48534612|NCT03584724|101643451|FG000|COMPLETED|Overall Study||18||
48534613|NCT03584724|101643452|FG001|COMPLETED|Overall Study||23||
48534614|NCT03584724|101643451|FG000|NOT COMPLETED|Overall Study||7||
48534615|NCT03584724|101643452|FG001|NOT COMPLETED|Overall Study||1||
48534616|NCT04078126|101643453|FG000|STARTED|Period 1||18||
48534617|NCT04078126|101643454|FG001|STARTED|Period 1||17||
48534618|NCT04078126|101643453|FG000|COMPLETED|Period 1||18||
48534619|NCT04078126|101643454|FG001|COMPLETED|Period 1||17||
48534620|NCT04078126|101643453|FG000|NOT COMPLETED|Period 1||0||
48534621|NCT04078126|101643454|FG001|NOT COMPLETED|Period 1||0||
48234276|NCT01052714|100895046|FG000|STARTED|Overall Study||42||
48234277|NCT01052714|100895047|FG001|STARTED|Overall Study||62||
48234278|NCT01052714|100895048|FG002|STARTED|Overall Study||17||
48234279|NCT01052714|100895046|FG000|COMPLETED|Overall Study||17||
48234280|NCT01052714|100895047|FG001|COMPLETED|Overall Study||33||
48234281|NCT01052714|100895048|FG002|COMPLETED|Overall Study||15||
48234282|NCT01052714|100895046|FG000|NOT COMPLETED|Overall Study||25||
48234283|NCT01052714|100895047|FG001|NOT COMPLETED|Overall Study||29||
48234284|NCT01052714|100895048|FG002|NOT COMPLETED|Overall Study||2||
48234285|NCT03775915|100895049|FG000|STARTED|Overall Study||12||
48234286|NCT03775915|100895050|FG001|STARTED|Overall Study||12||
48234287|NCT03775915|100895049|FG000|COMPLETED|Overall Study||12||
48234288|NCT03775915|100895050|FG001|COMPLETED|Overall Study||12||
48234289|NCT03775915|100895049|FG000|NOT COMPLETED|Overall Study||0||
48534622|NCT04078126|101643453|FG000|STARTED|Washout||18||
48534623|NCT04078126|101643454|FG001|STARTED|Washout||17||
48534624|NCT04078126|101643453|FG000|COMPLETED|Washout||18||
48534625|NCT04078126|101643454|FG001|COMPLETED|Washout||15||
48534626|NCT04078126|101643453|FG000|NOT COMPLETED|Washout||0||
48534627|NCT04078126|101643454|FG001|NOT COMPLETED|Washout||2||
48534628|NCT04078126|101643453|FG000|STARTED|Period 2||18||
48534629|NCT04078126|101643454|FG001|STARTED|Period 2||15||
48234290|NCT03775915|100895050|FG001|NOT COMPLETED|Overall Study||0||
48234291|NCT02949297|100895051|FG000|STARTED|1 Month||75||
48234292|NCT02949297|100895051|FG000|COMPLETED|1 Month||75||
48234293|NCT02949297|100895051|FG000|NOT COMPLETED|1 Month||0||
48234294|NCT02949297|100895051|FG000|STARTED|6 Months||75||
48234295|NCT02949297|100895051|FG000|COMPLETED|6 Months||72||
48234296|NCT02949297|100895051|FG000|NOT COMPLETED|6 Months||3||
48534630|NCT04078126|101643453|FG000|COMPLETED|Period 2||17||
48534631|NCT04078126|101643454|FG001|COMPLETED|Period 2||14||
48534632|NCT04078126|101643453|FG000|NOT COMPLETED|Period 2||1||
48534633|NCT04078126|101643454|FG001|NOT COMPLETED|Period 2||1||
48534634|NCT01359969|101643455|FG000|STARTED|Overall Study||57||
48534635|NCT01359969|101643455|FG000|COMPLETED|Overall Study||20||
48534636|NCT01359969|101643455|FG000|NOT COMPLETED|Overall Study||37||
48534637|NCT04536935|101646979|FG000|STARTED|RCT Baseline||204||
48534638|NCT04536935|101646980|FG001|STARTED|RCT Baseline||212||
48534639|NCT04536935|101646981|FG002|STARTED|RCT Baseline||209||
48534640|NCT04536935|101646982|FG003|STARTED|RCT Baseline||213||
48534641|NCT04536935|101646979|FG000|COMPLETED|RCT Baseline||204||
48534642|NCT04536935|101646980|FG001|COMPLETED|RCT Baseline||212||
48534643|NCT04536935|101646981|FG002|COMPLETED|RCT Baseline||209||
48534644|NCT04536935|101646982|FG003|COMPLETED|RCT Baseline||213||
48534645|NCT04536935|101646979|FG000|NOT COMPLETED|RCT Baseline||0||
48534646|NCT04536935|101646980|FG001|NOT COMPLETED|RCT Baseline||0||
48534647|NCT04536935|101646981|FG002|NOT COMPLETED|RCT Baseline||0||
48534648|NCT04536935|101646982|FG003|NOT COMPLETED|RCT Baseline||0||
48534649|NCT04536935|101646979|FG000|STARTED|RCT Follow-Up||204||
48534650|NCT04536935|101646980|FG001|STARTED|RCT Follow-Up||212||
48534651|NCT04536935|101646981|FG002|STARTED|RCT Follow-Up||209||
48534652|NCT04536935|101646982|FG003|STARTED|RCT Follow-Up||213||
48534653|NCT04536935|101646979|FG000|COMPLETED|RCT Follow-Up||155||
48534654|NCT04536935|101646980|FG001|COMPLETED|RCT Follow-Up||168||
48534655|NCT04536935|101646981|FG002|COMPLETED|RCT Follow-Up||152||
48534656|NCT04536935|101646982|FG003|COMPLETED|RCT Follow-Up||168||
48534657|NCT04536935|101646979|FG000|NOT COMPLETED|RCT Follow-Up||49||
48534658|NCT04536935|101646980|FG001|NOT COMPLETED|RCT Follow-Up||44||
48534659|NCT04536935|101646981|FG002|NOT COMPLETED|RCT Follow-Up||57||
48534660|NCT04536935|101646982|FG003|NOT COMPLETED|RCT Follow-Up||45||
48534661|NCT00191113|101646983|FG000|STARTED|Core Study||78||
48534662|NCT00191113|101646984|FG001|STARTED|Core Study||76||
48534663|NCT00191113|101646983|FG000|COMPLETED|Core Study||43||
48534664|NCT00191113|101646984|FG001|COMPLETED|Core Study||61||
48534665|NCT00191113|101646983|FG000|NOT COMPLETED|Core Study||35||
48534666|NCT00191113|101646984|FG001|NOT COMPLETED|Core Study||15||
48534667|NCT00191113|101646983|FG000|STARTED|Addendum 1||2||
48534668|NCT00191113|101646984|FG001|STARTED|Addendum 1||0||
48534669|NCT00191113|101646983|FG000|COMPLETED|Addendum 1||2||
48534670|NCT00191113|101646984|FG001|COMPLETED|Addendum 1||0||
48534671|NCT00191113|101646983|FG000|NOT COMPLETED|Addendum 1||0||
48534672|NCT00191113|101646984|FG001|NOT COMPLETED|Addendum 1||0||
48534673|NCT00191113|101646983|FG000|STARTED|Addendum 2||28||
48534674|NCT00191113|101646984|FG001|STARTED|Addendum 2||48||
48534675|NCT00191113|101646983|FG000|COMPLETED|Addendum 2||18||
48534676|NCT00191113|101646984|FG001|COMPLETED|Addendum 2||31||
48534677|NCT00191113|101646983|FG000|NOT COMPLETED|Addendum 2||10||
48534678|NCT00191113|101646984|FG001|NOT COMPLETED|Addendum 2||17||
48534679|NCT00191113|101646983|FG000|STARTED|Addendum 3||20||
48081009|NCT02228460|100521604|FG000|COMPLETED|Overall Study||9||
48234297|NCT02949297|100895051|FG000|STARTED|12 Months||72||
48234298|NCT02949297|100895051|FG000|COMPLETED|12 Months||67||
48534680|NCT00191113|101646984|FG001|STARTED|Addendum 3||37||
48534681|NCT00191113|101646983|FG000|COMPLETED|Addendum 3||20||
48534682|NCT00191113|101646984|FG001|COMPLETED|Addendum 3||37||
48534683|NCT00191113|101646983|FG000|NOT COMPLETED|Addendum 3||0||
48534684|NCT00191113|101646984|FG001|NOT COMPLETED|Addendum 3||0||
48534685|NCT00721630|101646985|FG000|STARTED|Overall Study||24||
48534686|NCT00721630|101646985|FG000|COMPLETED|Overall Study||23||
48534687|NCT00721630|101646985|FG000|NOT COMPLETED|Overall Study||1||
48534688|NCT02065700|101646986|FG000|STARTED|Overall Study||497||
48534689|NCT02065700|101646987|FG001|STARTED|Overall Study||242||
48234299|NCT02949297|100895051|FG000|NOT COMPLETED|12 Months||5||
48234300|NCT01288729|100895052|FG000|STARTED|Overall Study||10||
48234301|NCT01288729|100895053|FG001|STARTED|Overall Study||10||
48534690|NCT02065700|101646986|FG000|Male US Participants|Overall Study||7||
48534691|NCT02065700|101646987|FG001|Male US Participants|Overall Study||0||
48534692|NCT02065700|101646986|FG000|COMPLETED|Overall Study||161||
48534693|NCT02065700|101646987|FG001|COMPLETED|Overall Study||81||
48534694|NCT02065700|101646986|FG000|NOT COMPLETED|Overall Study||336||
48534695|NCT02065700|101646987|FG001|NOT COMPLETED|Overall Study||161||
48534696|NCT03859765|101646988|FG000|STARTED|Overall Study||20||
48534697|NCT03859765|101646989|FG001|STARTED|Overall Study||20||
48534698|NCT03859765|101646988|FG000|COMPLETED|Overall Study||17||
48534699|NCT03859765|101646989|FG001|COMPLETED|Overall Study||18||
48534700|NCT03859765|101646988|FG000|NOT COMPLETED|Overall Study||3||
48534701|NCT03859765|101646989|FG001|NOT COMPLETED|Overall Study||2||
48534702|NCT00837473|101646990|FG000|STARTED|Overall Study||15||
48234302|NCT01288729|100895052|FG000|COMPLETED|Overall Study||9||
48534703|NCT00837473|101646990|FG000|COMPLETED|Overall Study||12||
48534704|NCT00837473|101646990|FG000|NOT COMPLETED|Overall Study||3||
48534705|NCT01156142|101646991|FG000|STARTED|Overall Study||77||
48534706|NCT01156142|101646992|FG001|STARTED|Overall Study||78||
48534707|NCT01156142|101646991|FG000|COMPLETED|Overall Study||69||
48534708|NCT01156142|101646992|FG001|COMPLETED|Overall Study||71||
48234303|NCT01288729|100895053|FG001|COMPLETED|Overall Study||10||
48534709|NCT01156142|101646991|FG000|NOT COMPLETED|Overall Study||8||
48534710|NCT01156142|101646992|FG001|NOT COMPLETED|Overall Study||7||
48534711|NCT00810576|101646993|FG000|STARTED|Overall Study||1||
48534712|NCT00810576|101646993|FG000|COMPLETED|Overall Study||1||
48534713|NCT00810576|101646993|FG000|NOT COMPLETED|Overall Study||0||
48534714|NCT03365752|101646994|FG000|STARTED|Overall Study||13||
48534715|NCT03365752|101646995|FG001|STARTED|Overall Study||13||
48534716|NCT03365752|101646996|FG002|STARTED|Overall Study||13||
48534717|NCT03365752|101646994|FG000|COMPLETED|Overall Study||13||
48534718|NCT03365752|101646995|FG001|COMPLETED|Overall Study||13||
48534719|NCT03365752|101646996|FG002|COMPLETED|Overall Study||13||
48534720|NCT03365752|101646994|FG000|NOT COMPLETED|Overall Study||0||
48534721|NCT03365752|101646995|FG001|NOT COMPLETED|Overall Study||0||
48534722|NCT03365752|101646996|FG002|NOT COMPLETED|Overall Study||0||
48534723|NCT00077857|101646997|FG000|STARTED|Overall Study||235||
48534724|NCT00077857|101646998|FG001|STARTED|Overall Study||235||
48534725|NCT00077857|101646997|FG000|Received Study Drug|Overall Study||231||
48534726|NCT00077857|101646998|FG001|Received Study Drug|Overall Study||234||
48534727|NCT00077857|101646997|FG000|Safety Population: Actual Dose Received|Overall Study||217||
48534728|NCT00077857|101646998|FG001|Safety Population: Actual Dose Received|Overall Study||248||
48534729|NCT00077857|101646997|FG000|COMPLETED|Overall Study||34||
48534730|NCT00077857|101646998|FG001|COMPLETED|Overall Study||31||
48534731|NCT00077857|101646997|FG000|NOT COMPLETED|Overall Study||201||
48534732|NCT00077857|101646998|FG001|NOT COMPLETED|Overall Study||204||
48534733|NCT01329900|101646999|FG000|STARTED|Overall Study||50||
48534734|NCT01329900|101646999|FG000|COMPLETED|Overall Study||49||
48534735|NCT01329900|101646999|FG000|NOT COMPLETED|Overall Study||1||
48534736|NCT02492880|101647000|FG000|STARTED|Overall Study||15||
48534737|NCT02492880|101647000|FG000|COMPLETED|Overall Study||13||
48534738|NCT02492880|101647000|FG000|NOT COMPLETED|Overall Study||2||
48534739|NCT02297698|101647001|FG000|STARTED|Overall Study||50||
48534740|NCT02297698|101647002|FG001|STARTED|Overall Study||50||
48534741|NCT02297698|101647001|FG000|COMPLETED|Overall Study||31||
48534742|NCT02297698|101647002|FG001|COMPLETED|Overall Study||36||
48534743|NCT02297698|101647001|FG000|NOT COMPLETED|Overall Study||19||
48534744|NCT02297698|101647002|FG001|NOT COMPLETED|Overall Study||14||
48534745|NCT02651259|101647003|FG000|STARTED|Overall Study||25||
48534746|NCT02651259|101647004|FG001|STARTED|Overall Study||25||
48534747|NCT02651259|101647003|FG000|COMPLETED|Overall Study||25||
48534748|NCT02651259|101647004|FG001|COMPLETED|Overall Study||25||
48534749|NCT02651259|101647003|FG000|NOT COMPLETED|Overall Study||0||
48534750|NCT02651259|101647004|FG001|NOT COMPLETED|Overall Study||0||
48534751|NCT01943110|101647005|FG000|STARTED|Overall Study||30||
48534752|NCT01943110|101647005|FG000|COMPLETED|Overall Study||30||
48534753|NCT01943110|101647005|FG000|NOT COMPLETED|Overall Study||0||
48534754|NCT01085734|101647006|FG000|STARTED|Overall Study||15||
48534755|NCT01085734|101647007|FG001|STARTED|Overall Study||15||
48234304|NCT01288729|100895052|FG000|NOT COMPLETED|Overall Study||1||
48234305|NCT01288729|100895053|FG001|NOT COMPLETED|Overall Study||0||
48234306|NCT02935673|100895054|FG000|STARTED|Overall Study||16||
48234307|NCT02935673|100895055|FG001|STARTED|Overall Study||27||
48534756|NCT01085734|101647006|FG000|COMPLETED|Overall Study||14||
48534757|NCT01085734|101647007|FG001|COMPLETED|Overall Study||11||
48534758|NCT01085734|101647006|FG000|NOT COMPLETED|Overall Study||1||
48534759|NCT01085734|101647007|FG001|NOT COMPLETED|Overall Study||4||
48534760|NCT02828241|101647008|FG000|STARTED|Overall Study||38||
48534761|NCT02828241|101647009|FG001|STARTED|Overall Study||23||
48534762|NCT02828241|101647008|FG000|COMPLETED|Overall Study||30||
48534763|NCT02828241|101647009|FG001|COMPLETED|Overall Study||21||
48534764|NCT02828241|101647008|FG000|NOT COMPLETED|Overall Study||8||
48534765|NCT02828241|101647009|FG001|NOT COMPLETED|Overall Study||2||
48534766|NCT00372411|101647010|FG000|STARTED|Overall Study||49||
48534767|NCT00372411|101647011|FG001|STARTED|Overall Study||50||
48534768|NCT00372411|101647012|FG002|STARTED|Overall Study||28||
48534769|NCT00372411|101647010|FG000|COMPLETED|Overall Study||44||
48534770|NCT00372411|101647011|FG001|COMPLETED|Overall Study||42||
48534771|NCT00372411|101647012|FG002|COMPLETED|Overall Study||25||
48534772|NCT00372411|101647010|FG000|NOT COMPLETED|Overall Study||5||
48534773|NCT00372411|101647011|FG001|NOT COMPLETED|Overall Study||8||
48534774|NCT00372411|101647012|FG002|NOT COMPLETED|Overall Study||3||
48534775|NCT02549027|101647013|FG000|STARTED|Period 1 - MK-1064 or Placebo||5||
48534776|NCT02549027|101647014|FG001|STARTED|Period 1 - MK-1064 or Placebo||5||
48534777|NCT02549027|101647015|FG002|STARTED|Period 1 - MK-1064 or Placebo||5||
48534778|NCT02549027|101647016|FG003|STARTED|Period 1 - MK-1064 or Placebo||5||
48534779|NCT02549027|101647017|FG004|STARTED|Period 1 - MK-1064 or Placebo||0||
48234308|NCT02935673|100895056|FG002|STARTED|Overall Study||6||
48234309|NCT02935673|100895054|FG000|COMPLETED|Overall Study||15||
48534780|NCT02549027|101647018|FG005|STARTED|Period 1 - MK-1064 or Placebo||0||
48234310|NCT02935673|100895055|FG001|COMPLETED|Overall Study||24||
48234311|NCT02935673|100895056|FG002|COMPLETED|Overall Study||6||
48234312|NCT02935673|100895054|FG000|NOT COMPLETED|Overall Study||1||
48534781|NCT02549027|101647013|FG000|COMPLETED|Period 1 - MK-1064 or Placebo||5||
48534782|NCT02549027|101647014|FG001|COMPLETED|Period 1 - MK-1064 or Placebo||5||
48534783|NCT02549027|101647015|FG002|COMPLETED|Period 1 - MK-1064 or Placebo||5||
48534784|NCT02549027|101647016|FG003|COMPLETED|Period 1 - MK-1064 or Placebo||5||
48534785|NCT02549027|101647017|FG004|COMPLETED|Period 1 - MK-1064 or Placebo||0||
48534786|NCT02549027|101647018|FG005|COMPLETED|Period 1 - MK-1064 or Placebo||0||
48534787|NCT02549027|101647013|FG000|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0||
48534788|NCT02549027|101647014|FG001|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0||
48534789|NCT02549027|101647015|FG002|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0||
48534790|NCT02549027|101647016|FG003|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0||
48534791|NCT02549027|101647017|FG004|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0||
48534792|NCT02549027|101647018|FG005|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0||
48534793|NCT02549027|101647013|FG000|STARTED|Washout After Period 1||5||
48534794|NCT02549027|101647014|FG001|STARTED|Washout After Period 1||5||
48534795|NCT02549027|101647015|FG002|STARTED|Washout After Period 1||5||
48534796|NCT02549027|101647016|FG003|STARTED|Washout After Period 1||5||
48534797|NCT02549027|101647017|FG004|STARTED|Washout After Period 1||0||
48534798|NCT02549027|101647018|FG005|STARTED|Washout After Period 1||0||
48534799|NCT02549027|101647013|FG000|COMPLETED|Washout After Period 1||5||
48534800|NCT02549027|101647014|FG001|COMPLETED|Washout After Period 1||5||
48534801|NCT02549027|101647015|FG002|COMPLETED|Washout After Period 1||5||
48534802|NCT02549027|101647016|FG003|COMPLETED|Washout After Period 1||5||
48534803|NCT02549027|101647017|FG004|COMPLETED|Washout After Period 1||0||
48534804|NCT02549027|101647018|FG005|COMPLETED|Washout After Period 1||0||
48534805|NCT02549027|101647013|FG000|NOT COMPLETED|Washout After Period 1||0||
48534806|NCT02549027|101647014|FG001|NOT COMPLETED|Washout After Period 1||0||
48534807|NCT02549027|101647015|FG002|NOT COMPLETED|Washout After Period 1||0||
48534808|NCT02549027|101647016|FG003|NOT COMPLETED|Washout After Period 1||0||
48534809|NCT02549027|101647017|FG004|NOT COMPLETED|Washout After Period 1||0||
48534810|NCT02549027|101647018|FG005|NOT COMPLETED|Washout After Period 1||0||
48534811|NCT02549027|101647013|FG000|STARTED|Period 2 - MK-1064 or Placebo||5||
48534812|NCT02549027|101647014|FG001|STARTED|Period 2 - MK-1064 or Placebo||5||
48534813|NCT02549027|101647015|FG002|STARTED|Period 2 - MK-1064 or Placebo||5||
48534814|NCT02549027|101647016|FG003|STARTED|Period 2 - MK-1064 or Placebo||5||
48534815|NCT02549027|101647017|FG004|STARTED|Period 2 - MK-1064 or Placebo||0||
48534816|NCT02549027|101647018|FG005|STARTED|Period 2 - MK-1064 or Placebo||0||
48534817|NCT02549027|101647013|FG000|COMPLETED|Period 2 - MK-1064 or Placebo||5||
48534818|NCT02549027|101647014|FG001|COMPLETED|Period 2 - MK-1064 or Placebo||5||
48534819|NCT02549027|101647015|FG002|COMPLETED|Period 2 - MK-1064 or Placebo||5||
48534820|NCT02549027|101647016|FG003|COMPLETED|Period 2 - MK-1064 or Placebo||5||
48534821|NCT02549027|101647017|FG004|COMPLETED|Period 2 - MK-1064 or Placebo||0||
48534822|NCT02549027|101647018|FG005|COMPLETED|Period 2 - MK-1064 or Placebo||0||
48534823|NCT02549027|101647013|FG000|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0||
48534824|NCT02549027|101647014|FG001|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0||
48534825|NCT02549027|101647015|FG002|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0||
48534826|NCT02549027|101647016|FG003|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0||
48534827|NCT02549027|101647017|FG004|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0||
48534828|NCT02549027|101647018|FG005|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0||
48534829|NCT02549027|101647013|FG000|STARTED|Washout After Period 2||5||
48534830|NCT02549027|101647014|FG001|STARTED|Washout After Period 2||5||
48534831|NCT02549027|101647015|FG002|STARTED|Washout After Period 2||5||
48534832|NCT02549027|101647016|FG003|STARTED|Washout After Period 2||5||
48534833|NCT02549027|101647017|FG004|STARTED|Washout After Period 2||0||
48534834|NCT02549027|101647018|FG005|STARTED|Washout After Period 2||0||
48534835|NCT02549027|101647013|FG000|COMPLETED|Washout After Period 2||5||
48534836|NCT02549027|101647014|FG001|COMPLETED|Washout After Period 2||5||
48534837|NCT02549027|101647015|FG002|COMPLETED|Washout After Period 2||5||
48534838|NCT02549027|101647016|FG003|COMPLETED|Washout After Period 2||5||
48534839|NCT02549027|101647017|FG004|COMPLETED|Washout After Period 2||0||
48534840|NCT02549027|101647018|FG005|COMPLETED|Washout After Period 2||0||
48534841|NCT02549027|101647013|FG000|NOT COMPLETED|Washout After Period 2||0||
48534842|NCT02549027|101647014|FG001|NOT COMPLETED|Washout After Period 2||0||
48534843|NCT02549027|101647015|FG002|NOT COMPLETED|Washout After Period 2||0||
48534844|NCT02549027|101647016|FG003|NOT COMPLETED|Washout After Period 2||0||
48534845|NCT02549027|101647017|FG004|NOT COMPLETED|Washout After Period 2||0||
48534846|NCT02549027|101647018|FG005|NOT COMPLETED|Washout After Period 2||0||
48534847|NCT02549027|101647013|FG000|STARTED|Period 3 - MK-1064 or Placebo||5||
48534848|NCT02549027|101647014|FG001|STARTED|Period 3 - MK-1064 or Placebo||5||
48534849|NCT02549027|101647015|FG002|STARTED|Period 3 - MK-1064 or Placebo||5||
48534850|NCT02549027|101647016|FG003|STARTED|Period 3 - MK-1064 or Placebo||5||
48534851|NCT02549027|101647017|FG004|STARTED|Period 3 - MK-1064 or Placebo||0||
48534852|NCT02549027|101647018|FG005|STARTED|Period 3 - MK-1064 or Placebo||0||
48534853|NCT02549027|101647013|FG000|COMPLETED|Period 3 - MK-1064 or Placebo||5||
48534854|NCT02549027|101647014|FG001|COMPLETED|Period 3 - MK-1064 or Placebo||5||
48534855|NCT02549027|101647015|FG002|COMPLETED|Period 3 - MK-1064 or Placebo||5||
48534856|NCT02549027|101647016|FG003|COMPLETED|Period 3 - MK-1064 or Placebo||5||
48534857|NCT02549027|101647017|FG004|COMPLETED|Period 3 - MK-1064 or Placebo||0||
48534858|NCT02549027|101647018|FG005|COMPLETED|Period 3 - MK-1064 or Placebo||0||
48534859|NCT02549027|101647013|FG000|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0||
48534860|NCT02549027|101647014|FG001|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0||
48534861|NCT02549027|101647015|FG002|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0||
48534862|NCT02549027|101647016|FG003|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0||
48534863|NCT02549027|101647017|FG004|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0||
48534864|NCT02549027|101647018|FG005|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0||
48534865|NCT02549027|101647013|FG000|STARTED|Washout After Period 3||5||
48534866|NCT02549027|101647014|FG001|STARTED|Washout After Period 3||5||
48534867|NCT02549027|101647015|FG002|STARTED|Washout After Period 3||5||
48534868|NCT02549027|101647016|FG003|STARTED|Washout After Period 3||5||
48534869|NCT02549027|101647017|FG004|STARTED|Washout After Period 3||0||
48534870|NCT02549027|101647018|FG005|STARTED|Washout After Period 3||0||
48534871|NCT02549027|101647013|FG000|COMPLETED|Washout After Period 3||5||
48534872|NCT02549027|101647014|FG001|COMPLETED|Washout After Period 3||5||
48534873|NCT02549027|101647015|FG002|COMPLETED|Washout After Period 3||5||
48534874|NCT02549027|101647016|FG003|COMPLETED|Washout After Period 3||5||
48534875|NCT02549027|101647017|FG004|COMPLETED|Washout After Period 3||0||
48534876|NCT02549027|101647018|FG005|COMPLETED|Washout After Period 3||0||
48534877|NCT02549027|101647013|FG000|NOT COMPLETED|Washout After Period 3||0||
48534878|NCT02549027|101647014|FG001|NOT COMPLETED|Washout After Period 3||0||
48534879|NCT02549027|101647015|FG002|NOT COMPLETED|Washout After Period 3||0||
48534880|NCT02549027|101647016|FG003|NOT COMPLETED|Washout After Period 3||0||
48534881|NCT02549027|101647017|FG004|NOT COMPLETED|Washout After Period 3||0||
48534882|NCT02549027|101647018|FG005|NOT COMPLETED|Washout After Period 3||0||
48534883|NCT02549027|101647013|FG000|STARTED|Period 4 - MK-1064 or Placebo||5||
48234313|NCT02935673|100895055|FG001|NOT COMPLETED|Overall Study||3||
48234314|NCT02935673|100895056|FG002|NOT COMPLETED|Overall Study||0||
48234315|NCT02354417|100895057|FG000|STARTED|Overall Study||3||
48234316|NCT02354417|100895057|FG000|COMPLETED|Overall Study||2||
48234317|NCT02354417|100895057|FG000|NOT COMPLETED|Overall Study||1||
48234318|NCT00923078|100895058|FG000|STARTED|First Intervention (Weeks 1-4)||20||
48534884|NCT02549027|101647014|FG001|STARTED|Period 4 - MK-1064 or Placebo||5||
48534885|NCT02549027|101647015|FG002|STARTED|Period 4 - MK-1064 or Placebo||5||
48534886|NCT02549027|101647016|FG003|STARTED|Period 4 - MK-1064 or Placebo||5||
48534887|NCT02549027|101647017|FG004|STARTED|Period 4 - MK-1064 or Placebo||0||
48534888|NCT02549027|101647018|FG005|STARTED|Period 4 - MK-1064 or Placebo||0||
48534889|NCT02549027|101647013|FG000|COMPLETED|Period 4 - MK-1064 or Placebo||5||
48534890|NCT02549027|101647014|FG001|COMPLETED|Period 4 - MK-1064 or Placebo||5||
48534891|NCT02549027|101647015|FG002|COMPLETED|Period 4 - MK-1064 or Placebo||5||
48534892|NCT02549027|101647016|FG003|COMPLETED|Period 4 - MK-1064 or Placebo||5||
48534893|NCT02549027|101647017|FG004|COMPLETED|Period 4 - MK-1064 or Placebo||0||
48534894|NCT02549027|101647018|FG005|COMPLETED|Period 4 - MK-1064 or Placebo||0||
48534895|NCT02549027|101647013|FG000|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0||
48534896|NCT02549027|101647014|FG001|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0||
48534897|NCT02549027|101647015|FG002|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0||
48534898|NCT02549027|101647016|FG003|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0||
48534899|NCT02549027|101647017|FG004|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0||
48534900|NCT02549027|101647018|FG005|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0||
48534901|NCT02549027|101647013|FG000|STARTED|Washout After Period 4||5||
48534902|NCT02549027|101647014|FG001|STARTED|Washout After Period 4||5||
48534903|NCT02549027|101647015|FG002|STARTED|Washout After Period 4||5||
48534904|NCT02549027|101647016|FG003|STARTED|Washout After Period 4||5||
48534905|NCT02549027|101647017|FG004|STARTED|Washout After Period 4||0||
48534906|NCT02549027|101647018|FG005|STARTED|Washout After Period 4||0||
48534907|NCT02549027|101647013|FG000|COMPLETED|Washout After Period 4||5||
48534908|NCT02549027|101647014|FG001|COMPLETED|Washout After Period 4||4||
48534909|NCT02549027|101647015|FG002|COMPLETED|Washout After Period 4||4||
48534910|NCT02549027|101647016|FG003|COMPLETED|Washout After Period 4||4||
48534911|NCT02549027|101647017|FG004|COMPLETED|Washout After Period 4||0||
48534912|NCT02549027|101647018|FG005|COMPLETED|Washout After Period 4||0||
48534913|NCT02549027|101647013|FG000|NOT COMPLETED|Washout After Period 4||0||
48534914|NCT02549027|101647014|FG001|NOT COMPLETED|Washout After Period 4||1||
48234319|NCT00923078|100895059|FG001|STARTED|First Intervention (Weeks 1-4)||20||
48534915|NCT02549027|101647015|FG002|NOT COMPLETED|Washout After Period 4||1||
48534916|NCT02549027|101647016|FG003|NOT COMPLETED|Washout After Period 4||1||
48534917|NCT02549027|101647017|FG004|NOT COMPLETED|Washout After Period 4||0||
48534918|NCT02549027|101647018|FG005|NOT COMPLETED|Washout After Period 4||0||
48534919|NCT02549027|101647013|FG000|STARTED|Period 5 - MK-6096 or Placebo||0||
48534920|NCT02549027|101647014|FG001|STARTED|Period 5 - MK-6096 or Placebo||0||
48534921|NCT02549027|101647015|FG002|STARTED|Period 5 - MK-6096 or Placebo||0||
48534922|NCT02549027|101647016|FG003|STARTED|Period 5 - MK-6096 or Placebo||0||
48534923|NCT02549027|101647017|FG004|STARTED|Period 5 - MK-6096 or Placebo||16||
48534924|NCT02549027|101647018|FG005|STARTED|Period 5 - MK-6096 or Placebo||1||
48534925|NCT02549027|101647013|FG000|COMPLETED|Period 5 - MK-6096 or Placebo||0||
48534926|NCT02549027|101647014|FG001|COMPLETED|Period 5 - MK-6096 or Placebo||0||
48534927|NCT02549027|101647015|FG002|COMPLETED|Period 5 - MK-6096 or Placebo||0||
48534928|NCT02549027|101647016|FG003|COMPLETED|Period 5 - MK-6096 or Placebo||0||
48534929|NCT02549027|101647017|FG004|COMPLETED|Period 5 - MK-6096 or Placebo||14||
48234320|NCT00923078|100895060|FG002|STARTED|First Intervention (Weeks 1-4)||20||
48234321|NCT00923078|100895058|FG000|COMPLETED|First Intervention (Weeks 1-4)||19||
48234322|NCT00923078|100895059|FG001|COMPLETED|First Intervention (Weeks 1-4)||19||
48234323|NCT00923078|100895060|FG002|COMPLETED|First Intervention (Weeks 1-4)||0||
48234324|NCT00923078|100895058|FG000|NOT COMPLETED|First Intervention (Weeks 1-4)||1||
48234325|NCT00923078|100895059|FG001|NOT COMPLETED|First Intervention (Weeks 1-4)||1||
48234326|NCT00923078|100895060|FG002|NOT COMPLETED|First Intervention (Weeks 1-4)||20||
48234327|NCT00923078|100895058|FG000|STARTED|Second Intervention (Weeks 5-8)||19||
48234328|NCT00923078|100895059|FG001|STARTED|Second Intervention (Weeks 5-8)||19||
48234329|NCT00923078|100895060|FG002|STARTED|Second Intervention (Weeks 5-8)||0||
48234330|NCT00923078|100895058|FG000|COMPLETED|Second Intervention (Weeks 5-8)||19||
48234331|NCT00923078|100895059|FG001|COMPLETED|Second Intervention (Weeks 5-8)||19||
48234332|NCT00923078|100895060|FG002|COMPLETED|Second Intervention (Weeks 5-8)||0||
48234333|NCT00923078|100895058|FG000|NOT COMPLETED|Second Intervention (Weeks 5-8)||0||
48234334|NCT00923078|100895059|FG001|NOT COMPLETED|Second Intervention (Weeks 5-8)||0||
48234335|NCT00923078|100895060|FG002|NOT COMPLETED|Second Intervention (Weeks 5-8)||0||
48234336|NCT00417885|100895061|FG000|STARTED|Overall Study||6||
48234337|NCT00417885|100895061|FG000|COMPLETED|Overall Study||0||
48234338|NCT00417885|100895061|FG000|NOT COMPLETED|Overall Study||6||
48234339|NCT00237809|100895062|FG000|STARTED|Overall Study||27||
48234340|NCT00237809|100895063|FG001|STARTED|Overall Study||27||
48234341|NCT00237809|100895064|FG002|STARTED|Overall Study||24||
48234342|NCT00237809|100895065|FG003|STARTED|Overall Study||26||
48234343|NCT00237809|100895062|FG000|COMPLETED|Overall Study||16||
48234344|NCT00237809|100895063|FG001|COMPLETED|Overall Study||17||
48234345|NCT00237809|100895064|FG002|COMPLETED|Overall Study||15||
48234346|NCT00237809|100895065|FG003|COMPLETED|Overall Study||17||
48234347|NCT00237809|100895062|FG000|NOT COMPLETED|Overall Study||11||
48234348|NCT00237809|100895063|FG001|NOT COMPLETED|Overall Study||10||
48234349|NCT00237809|100895064|FG002|NOT COMPLETED|Overall Study||9||
48234350|NCT00237809|100895065|FG003|NOT COMPLETED|Overall Study||9||
48234351|NCT02224755|100895066|FG000|STARTED|Randomization to Device Implant||512||
48234352|NCT02224755|100895067|FG001|STARTED|Randomization to Device Implant||516||
48234353|NCT02224755|100895066|FG000|COMPLETED|Randomization to Device Implant||505||
48234354|NCT02224755|100895067|FG001|COMPLETED|Randomization to Device Implant||515||
48234355|NCT02224755|100895066|FG000|NOT COMPLETED|Randomization to Device Implant||7||
48234356|NCT02224755|100895067|FG001|NOT COMPLETED|Randomization to Device Implant||1||
48234357|NCT02224755|100895066|FG000|STARTED|Two Year Follow up Post-implant||505||
48234358|NCT02224755|100895067|FG001|STARTED|Two Year Follow up Post-implant||515||
48234359|NCT02224755|100895066|FG000|COMPLETED|Two Year Follow up Post-implant||247||
48234360|NCT02224755|100895067|FG001|COMPLETED|Two Year Follow up Post-implant||289||
48234361|NCT02224755|100895066|FG000|NOT COMPLETED|Two Year Follow up Post-implant||258||
48234362|NCT02224755|100895067|FG001|NOT COMPLETED|Two Year Follow up Post-implant||226||
48234363|NCT00506025|100895068|FG000|STARTED|Overall Study||10||
48234364|NCT00506025|100895069|FG001|STARTED|Overall Study||9||
48234365|NCT00506025|100895070|FG002|STARTED|Overall Study||8||
48234366|NCT00506025|100895068|FG000|COMPLETED|Overall Study||10||
48234367|NCT00506025|100895069|FG001|COMPLETED|Overall Study||9||
48234368|NCT00506025|100895070|FG002|COMPLETED|Overall Study||8||
48234369|NCT00506025|100895068|FG000|NOT COMPLETED|Overall Study||0||
48234370|NCT00506025|100895069|FG001|NOT COMPLETED|Overall Study||0||
48234371|NCT00506025|100895070|FG002|NOT COMPLETED|Overall Study||0||
48234372|NCT00604461|100895071|FG000|STARTED|Overall Study||13||
48234373|NCT00604461|100895071|FG000|COMPLETED|Overall Study||12||
48234374|NCT00604461|100895071|FG000|NOT COMPLETED|Overall Study||1||
48234375|NCT01156675|100895072|FG000|STARTED|Overall Study||107||
48234376|NCT01156675|100895073|FG001|STARTED|Overall Study||106||
48234377|NCT01156675|100895074|FG002|STARTED|Overall Study||2||
48234378|NCT01156675|100895072|FG000|COMPLETED|Overall Study||73||
48234379|NCT01156675|100895073|FG001|COMPLETED|Overall Study||81||
48234380|NCT01156675|100895074|FG002|COMPLETED|Overall Study||0||
48234381|NCT01156675|100895072|FG000|NOT COMPLETED|Overall Study||34||
48234382|NCT01156675|100895073|FG001|NOT COMPLETED|Overall Study||25||
48234383|NCT01156675|100895074|FG002|NOT COMPLETED|Overall Study||2||
48234384|NCT01928732|100895075|FG000|STARTED|Overall Study||455||
48234385|NCT01928732|100895076|FG001|STARTED|Overall Study||461||
48234386|NCT01928732|100895075|FG000|COMPLETED|Overall Study||326||
48234387|NCT01928732|100895076|FG001|COMPLETED|Overall Study||334||
48234388|NCT01928732|100895075|FG000|NOT COMPLETED|Overall Study||129||
48234389|NCT01928732|100895076|FG001|NOT COMPLETED|Overall Study||127||
48234390|NCT00996164|100895077|FG000|STARTED|Overall Study||543||
48234391|NCT00996164|100895078|FG001|STARTED|Overall Study||547||
48234392|NCT00996164|100895077|FG000|COMPLETED|Overall Study||408||
48234393|NCT00996164|100895078|FG001|COMPLETED|Overall Study||446||
48234394|NCT00996164|100895077|FG000|NOT COMPLETED|Overall Study||135||
48234395|NCT00996164|100895078|FG001|NOT COMPLETED|Overall Study||101||
48234396|NCT00508144|100895079|FG000|STARTED|Overall Study||64||
48234397|NCT00508144|100895079|FG000|COMPLETED|Overall Study||53||
48234398|NCT00508144|100895079|FG000|NOT COMPLETED|Overall Study||11||
48234399|NCT00749944|100895080|FG000|STARTED|Overall Study||55||
48234400|NCT00749944|100895081|FG001|STARTED|Overall Study||55||
48234401|NCT00749944|100895080|FG000|COMPLETED|Overall Study||50||
48234402|NCT00749944|100895081|FG001|COMPLETED|Overall Study||54||
48234403|NCT00749944|100895080|FG000|NOT COMPLETED|Overall Study||5||
48234404|NCT00749944|100895081|FG001|NOT COMPLETED|Overall Study||1||
48234405|NCT01322386|100895082|FG000|STARTED|Overall Study||10||
48234406|NCT01322386|100895083|FG001|STARTED|Overall Study||11||
48234407|NCT01322386|100895082|FG000|COMPLETED|Overall Study||10||
48234408|NCT01322386|100895083|FG001|COMPLETED|Overall Study||9||
48234409|NCT01322386|100895082|FG000|NOT COMPLETED|Overall Study||0||
48234410|NCT01322386|100895083|FG001|NOT COMPLETED|Overall Study||2||
48234411|NCT01964547|100895084|FG000|STARTED|Overall Study||62||
48234412|NCT01964547|100895085|FG001|STARTED|Overall Study||59||
48234413|NCT01964547|100895084|FG000|COMPLETED|Overall Study||50||
48234414|NCT01964547|100895085|FG001|COMPLETED|Overall Study||48||
48234415|NCT01964547|100895084|FG000|NOT COMPLETED|Overall Study||12||
48234416|NCT01964547|100895085|FG001|NOT COMPLETED|Overall Study||11||
48234417|NCT04710576|100895086|FG000|STARTED|Overall Study||80||
48234418|NCT04710576|100895087|FG001|STARTED|Overall Study||81||
48234419|NCT04710576|100895088|FG002|STARTED|Overall Study||80||
48234420|NCT04710576|100895086|FG000|Received at Least 1 Dose of Study Drug|Overall Study||79||
48234421|NCT04710576|100895087|FG001|Received at Least 1 Dose of Study Drug|Overall Study||81||
48234422|NCT04710576|100895088|FG002|Received at Least 1 Dose of Study Drug|Overall Study||79||
48234423|NCT04710576|100895086|FG000|COMPLETED|Overall Study||0||
48534930|NCT02549027|101647018|FG005|COMPLETED|Period 5 - MK-6096 or Placebo||1||
48534931|NCT02549027|101647013|FG000|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0||
48534932|NCT02549027|101647014|FG001|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0||
48534933|NCT02549027|101647015|FG002|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0||
48534934|NCT02549027|101647016|FG003|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0||
48234424|NCT04710576|100895087|FG001|COMPLETED|Overall Study||1||
48234425|NCT04710576|100895088|FG002|COMPLETED|Overall Study||1||
48234426|NCT04710576|100895086|FG000|NOT COMPLETED|Overall Study||80||
48234427|NCT04710576|100895087|FG001|NOT COMPLETED|Overall Study||80||
48234428|NCT04710576|100895088|FG002|NOT COMPLETED|Overall Study||79||
48534935|NCT02549027|101647017|FG004|NOT COMPLETED|Period 5 - MK-6096 or Placebo||2||
48534936|NCT02549027|101647018|FG005|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0||
48534937|NCT00307437|101647019|FG000|STARTED|Controlled Period||410||
48534938|NCT00307437|101647020|FG001|STARTED|Controlled Period||409||
48534939|NCT00307437|101647021|FG002|STARTED|Controlled Period||411||
48534940|NCT00307437|101647022|FG003|STARTED|Controlled Period||0||
48534941|NCT00307437|101647023|FG004|STARTED|Controlled Period||0||
48534942|NCT00307437|101647024|FG005|STARTED|Controlled Period||0||
48534943|NCT00307437|101647025|FG006|STARTED|Controlled Period||0||
48534944|NCT00307437|101647019|FG000|COMPLETED|Controlled Period||394||
48534945|NCT00307437|101647020|FG001|COMPLETED|Controlled Period||403||
48234429|NCT02822599|100895089|FG000|STARTED|Overall Study||15||
48234430|NCT02822599|100895090|FG001|STARTED|Overall Study||15||
48234431|NCT02822599|100895089|FG000|COMPLETED|Overall Study||15||
48234432|NCT02822599|100895090|FG001|COMPLETED|Overall Study||15||
48234433|NCT02822599|100895089|FG000|NOT COMPLETED|Overall Study||0||
48234434|NCT02822599|100895090|FG001|NOT COMPLETED|Overall Study||0||
48234435|NCT00113529|100895091|FG000|STARTED|Overall Study||35||
48234436|NCT00113529|100895091|FG000|COMPLETED|Overall Study||1||
48234437|NCT00113529|100895091|FG000|NOT COMPLETED|Overall Study||34||
48234438|NCT03979040|100895092|FG000|STARTED|Overall Study||125||
48234439|NCT03979040|100895093|FG001|STARTED|Overall Study||118||
48234440|NCT03979040|100895092|FG000|COMPLETED|Overall Study||69||
48234441|NCT03979040|100895093|FG001|COMPLETED|Overall Study||46||
48234442|NCT03979040|100895092|FG000|NOT COMPLETED|Overall Study||56||
48234443|NCT03979040|100895093|FG001|NOT COMPLETED|Overall Study||72||
48234444|NCT00603278|100895094|FG000|STARTED|Overall Study||107||
48234445|NCT00603278|100895095|FG001|STARTED|Overall Study||105||
48234446|NCT00603278|100895096|FG002|STARTED|Overall Study||101||
48234447|NCT00603278|100895097|FG003|STARTED|Overall Study||103||
48234448|NCT00603278|100895098|FG004|STARTED|Overall Study||99||
48234449|NCT00603278|100895099|FG005|STARTED|Overall Study||100||
48534946|NCT00307437|101647021|FG002|COMPLETED|Controlled Period||402||
48534947|NCT00307437|101647022|FG003|COMPLETED|Controlled Period||0||
48534948|NCT00307437|101647023|FG004|COMPLETED|Controlled Period||0||
48534949|NCT00307437|101647024|FG005|COMPLETED|Controlled Period||0||
48534950|NCT00307437|101647025|FG006|COMPLETED|Controlled Period||0||
48234450|NCT00603278|100895094|FG000|COMPLETED|Overall Study||66||
48234451|NCT00603278|100895095|FG001|COMPLETED|Overall Study||88||
48234452|NCT00603278|100895096|FG002|COMPLETED|Overall Study||87||
48234453|NCT00603278|100895097|FG003|COMPLETED|Overall Study||92||
48234454|NCT00603278|100895098|FG004|COMPLETED|Overall Study||86||
48234455|NCT00603278|100895099|FG005|COMPLETED|Overall Study||81||
48234456|NCT00603278|100895094|FG000|NOT COMPLETED|Overall Study||41||
48234457|NCT00603278|100895095|FG001|NOT COMPLETED|Overall Study||17||
48534951|NCT00307437|101647019|FG000|NOT COMPLETED|Controlled Period||16||
48534952|NCT00307437|101647020|FG001|NOT COMPLETED|Controlled Period||6||
48534953|NCT00307437|101647021|FG002|NOT COMPLETED|Controlled Period||9||
48534954|NCT00307437|101647022|FG003|NOT COMPLETED|Controlled Period||0||
48234458|NCT00603278|100895096|FG002|NOT COMPLETED|Overall Study||14||
48234459|NCT00603278|100895097|FG003|NOT COMPLETED|Overall Study||11||
48234460|NCT00603278|100895098|FG004|NOT COMPLETED|Overall Study||13||
48534955|NCT00307437|101647023|FG004|NOT COMPLETED|Controlled Period||0||
48234461|NCT00603278|100895099|FG005|NOT COMPLETED|Overall Study||19||
48234462|NCT01482091|100895100|FG000|STARTED|Overall Study||25||
48234463|NCT01482091|100895101|FG001|STARTED|Overall Study||24||
48234464|NCT01482091|100895100|FG000|COMPLETED|Overall Study||25||
48234465|NCT01482091|100895101|FG001|COMPLETED|Overall Study||24||
48234466|NCT01482091|100895100|FG000|NOT COMPLETED|Overall Study||0||
48534956|NCT00307437|101647024|FG005|NOT COMPLETED|Controlled Period||0||
48534957|NCT00307437|101647025|FG006|NOT COMPLETED|Controlled Period||0||
48534958|NCT00307437|101647019|FG000|STARTED|After Controlled Period||0||
48534959|NCT00307437|101647020|FG001|STARTED|After Controlled Period||0||
48234467|NCT01482091|100895101|FG001|NOT COMPLETED|Overall Study||0||
48234468|NCT04520321|100895102|FG000|STARTED|Overall Study||5||
48234469|NCT04520321|100895103|FG001|STARTED|Overall Study||7||
48234470|NCT04520321|100895104|FG002|STARTED|Overall Study||3||
48234471|NCT04520321|100895105|FG003|STARTED|Overall Study||7||
48234472|NCT04520321|100895102|FG000|COMPLETED|Overall Study||5||
48234473|NCT04520321|100895103|FG001|COMPLETED|Overall Study||7||
48234474|NCT04520321|100895104|FG002|COMPLETED|Overall Study||3||
48234475|NCT04520321|100895105|FG003|COMPLETED|Overall Study||7||
48234476|NCT04520321|100895102|FG000|NOT COMPLETED|Overall Study||0||
48234477|NCT04520321|100895103|FG001|NOT COMPLETED|Overall Study||0||
48534960|NCT00307437|101647021|FG002|STARTED|After Controlled Period||0||
48534961|NCT00307437|101647022|FG003|STARTED|After Controlled Period||197||
48234478|NCT04520321|100895104|FG002|NOT COMPLETED|Overall Study||0||
48234479|NCT04520321|100895105|FG003|NOT COMPLETED|Overall Study||0||
48234480|NCT00853957|100895106|FG000|STARTED|Overall Study||220||
48234481|NCT00853957|100895107|FG001|STARTED|Overall Study||223||
48234482|NCT00853957|100895106|FG000|COMPLETED|Overall Study||206||
48234483|NCT00853957|100895107|FG001|COMPLETED|Overall Study||204||
48234484|NCT00853957|100895106|FG000|NOT COMPLETED|Overall Study||14||
48234485|NCT00853957|100895107|FG001|NOT COMPLETED|Overall Study||19||
48234486|NCT03493282|100895108|FG000|STARTED|Primary Double-blind Study (180 Days)||8||
48234487|NCT03493282|100895109|FG001|STARTED|Primary Double-blind Study (180 Days)||8||
48234488|NCT03493282|100895110|FG002|STARTED|Primary Double-blind Study (180 Days)||7||
48234489|NCT03493282|100895108|FG000|COMPLETED|Primary Double-blind Study (180 Days)||5||
48234490|NCT03493282|100895109|FG001|COMPLETED|Primary Double-blind Study (180 Days)||6||
48234491|NCT03493282|100895110|FG002|COMPLETED|Primary Double-blind Study (180 Days)||6||
48234492|NCT03493282|100895108|FG000|NOT COMPLETED|Primary Double-blind Study (180 Days)||3||
48234493|NCT03493282|100895109|FG001|NOT COMPLETED|Primary Double-blind Study (180 Days)||2||
48234494|NCT03493282|100895110|FG002|NOT COMPLETED|Primary Double-blind Study (180 Days)||1||
48234495|NCT03493282|100895108|FG000|STARTED|Double-blind Extension Study (180 Days)||3||
48234496|NCT03493282|100895109|FG001|STARTED|Double-blind Extension Study (180 Days)||6||
48234497|NCT03493282|100895110|FG002|STARTED|Double-blind Extension Study (180 Days)||4||
48234498|NCT03493282|100895108|FG000|COMPLETED|Double-blind Extension Study (180 Days)||3||
48234499|NCT03493282|100895109|FG001|COMPLETED|Double-blind Extension Study (180 Days)||6||
48234500|NCT03493282|100895110|FG002|COMPLETED|Double-blind Extension Study (180 Days)||4||
48234501|NCT03493282|100895108|FG000|NOT COMPLETED|Double-blind Extension Study (180 Days)||0||
48234502|NCT03493282|100895109|FG001|NOT COMPLETED|Double-blind Extension Study (180 Days)||0||
48234503|NCT03493282|100895110|FG002|NOT COMPLETED|Double-blind Extension Study (180 Days)||0||
48234504|NCT01543204|100895111|FG000|STARTED|Overall Study||64||
48234505|NCT01543204|100895111|FG000|COMPLETED|Overall Study||56||
48234506|NCT01543204|100895111|FG000|NOT COMPLETED|Overall Study||8||
48234507|NCT04884191|100895112|FG000|STARTED|Overall Study||55||
48234508|NCT04884191|100895113|FG001|STARTED|Overall Study||55||
48234509|NCT04884191|100895114|FG002|STARTED|Overall Study||55||
48234510|NCT04884191|100895112|FG000|COMPLETED|Overall Study||52||
48234511|NCT04884191|100895113|FG001|COMPLETED|Overall Study||55||
48234512|NCT04884191|100895114|FG002|COMPLETED|Overall Study||54||
48234513|NCT04884191|100895112|FG000|NOT COMPLETED|Overall Study||3||
48234514|NCT04884191|100895113|FG001|NOT COMPLETED|Overall Study||0||
48534962|NCT00307437|101647023|FG004|STARTED|After Controlled Period||195||
48534963|NCT00307437|101647024|FG005|STARTED|After Controlled Period||403||
48534964|NCT00307437|101647025|FG006|STARTED|After Controlled Period||402||
48534965|NCT00307437|101647019|FG000|COMPLETED|After Controlled Period||0||
48234515|NCT04884191|100895114|FG002|NOT COMPLETED|Overall Study||1||
48234516|NCT00088166|100895115|FG000|STARTED|Overall Study||100||
48234517|NCT00088166|100895116|FG001|STARTED|Overall Study||100||
48234518|NCT00088166|100895115|FG000|COMPLETED|Overall Study||47||
48234519|NCT00088166|100895116|FG001|COMPLETED|Overall Study||39||
48234520|NCT00088166|100895115|FG000|NOT COMPLETED|Overall Study||53||
48534966|NCT00307437|101647020|FG001|COMPLETED|After Controlled Period||0||
48534967|NCT00307437|101647021|FG002|COMPLETED|After Controlled Period||0||
48234521|NCT00088166|100895116|FG001|NOT COMPLETED|Overall Study||61||
48534968|NCT00307437|101647022|FG003|COMPLETED|After Controlled Period||139||
48534969|NCT00307437|101647023|FG004|COMPLETED|After Controlled Period||140||
48534970|NCT00307437|101647024|FG005|COMPLETED|After Controlled Period||281||
48234522|NCT04739306|100895117|FG000|STARTED|Main Study Period||173||
48234523|NCT04739306|100895118|FG001|STARTED|Main Study Period||175||
48234524|NCT04739306|100895117|FG000|COMPLETED|Main Study Period||153||
48234525|NCT04739306|100895118|FG001|COMPLETED|Main Study Period||153||
48234526|NCT04739306|100895117|FG000|NOT COMPLETED|Main Study Period||20||
48234527|NCT04739306|100895118|FG001|NOT COMPLETED|Main Study Period||22||
48234528|NCT04739306|100895117|FG000|STARTED|CT-P42 PFS (Extension Study Period)||15||
48234529|NCT04739306|100895118|FG001|STARTED|CT-P42 PFS (Extension Study Period)||16||
48234530|NCT04739306|100895117|FG000|COMPLETED|CT-P42 PFS (Extension Study Period)||15||
48234531|NCT04739306|100895118|FG001|COMPLETED|CT-P42 PFS (Extension Study Period)||16||
48234532|NCT04739306|100895117|FG000|NOT COMPLETED|CT-P42 PFS (Extension Study Period)||0||
48234533|NCT04739306|100895118|FG001|NOT COMPLETED|CT-P42 PFS (Extension Study Period)||0||
48234534|NCT04765046|100895119|FG000|STARTED|Overall Study||90||
48234535|NCT04765046|100895119|FG000|COMPLETED|Overall Study||72||
48234536|NCT04765046|100895119|FG000|NOT COMPLETED|Overall Study||18||
48234537|NCT03122860|100895120|FG000|STARTED|Overall Study||117||
48234538|NCT03122860|100895121|FG001|STARTED|Overall Study||116||
48534971|NCT00307437|101647025|FG006|COMPLETED|After Controlled Period||289||
48534972|NCT00307437|101647019|FG000|NOT COMPLETED|After Controlled Period||0||
48534973|NCT00307437|101647020|FG001|NOT COMPLETED|After Controlled Period||0||
48534974|NCT00307437|101647021|FG002|NOT COMPLETED|After Controlled Period||0||
48534975|NCT00307437|101647022|FG003|NOT COMPLETED|After Controlled Period||58||
48534976|NCT00307437|101647023|FG004|NOT COMPLETED|After Controlled Period||55||
48534977|NCT00307437|101647024|FG005|NOT COMPLETED|After Controlled Period||122||
48534978|NCT00307437|101647025|FG006|NOT COMPLETED|After Controlled Period||113||
48534979|NCT00936897|101647026|FG000|STARTED|Overall Study||417||
48534980|NCT00936897|101647027|FG001|STARTED|Overall Study||416||
48534981|NCT00936897|101647026|FG000|COMPLETED|Overall Study||398||
48534982|NCT00936897|101647027|FG001|COMPLETED|Overall Study||356||
48534983|NCT00936897|101647026|FG000|NOT COMPLETED|Overall Study||19||
48534984|NCT00936897|101647027|FG001|NOT COMPLETED|Overall Study||60||
48534985|NCT03634475|101647028|FG000|STARTED|Overall Study||12||
48534986|NCT03634475|101647028|FG000|COMPLETED|Overall Study||12||
48534987|NCT03634475|101647028|FG000|NOT COMPLETED|Overall Study||0||
48534988|NCT01140503|101647029|FG000|STARTED|Overall Study||5||
48234539|NCT03122860|100895122|FG002|STARTED|Overall Study||117||
48234540|NCT03122860|100895123|FG003|STARTED|Overall Study||116||
48534989|NCT01140503|101647029|FG000|COMPLETED|Overall Study||4||
48534990|NCT01140503|101647029|FG000|NOT COMPLETED|Overall Study||1||
48534991|NCT03665441|101647030|FG000|STARTED|Overall Study||255||
48534992|NCT03665441|101647031|FG001|STARTED|Overall Study||257||
48534993|NCT03665441|101647030|FG000|COMPLETED|Overall Study||216||
48234541|NCT03122860|100895124|FG004|STARTED|Overall Study||117||
48234542|NCT03122860|100895125|FG005|STARTED|Overall Study||117||
48234543|NCT03122860|100895120|FG000|Full Analysis Set|Overall Study||116||
48234544|NCT03122860|100895121|FG001|Full Analysis Set|Overall Study||115||
48234545|NCT03122860|100895122|FG002|Full Analysis Set|Overall Study||115||
48234546|NCT03122860|100895123|FG003|Full Analysis Set|Overall Study||116||
48234547|NCT03122860|100895124|FG004|Full Analysis Set|Overall Study||116||
48234548|NCT03122860|100895125|FG005|Full Analysis Set|Overall Study||117||
48234549|NCT03122860|100895120|FG000|COMPLETED|Overall Study||107||
48234550|NCT03122860|100895121|FG001|COMPLETED|Overall Study||111||
48234551|NCT03122860|100895122|FG002|COMPLETED|Overall Study||105||
48234552|NCT03122860|100895123|FG003|COMPLETED|Overall Study||105||
48234553|NCT03122860|100895124|FG004|COMPLETED|Overall Study||102||
48234554|NCT03122860|100895125|FG005|COMPLETED|Overall Study||105||
48234555|NCT03122860|100895120|FG000|NOT COMPLETED|Overall Study||10||
48234556|NCT03122860|100895121|FG001|NOT COMPLETED|Overall Study||5||
48234557|NCT03122860|100895122|FG002|NOT COMPLETED|Overall Study||12||
48234558|NCT03122860|100895123|FG003|NOT COMPLETED|Overall Study||11||
48234559|NCT03122860|100895124|FG004|NOT COMPLETED|Overall Study||15||
48234560|NCT03122860|100895125|FG005|NOT COMPLETED|Overall Study||12||
48234561|NCT00924833|100895126|FG000|STARTED|Overall Study||9||
48234562|NCT00924833|100895127|FG001|STARTED|Overall Study||9||
48234563|NCT00924833|100895128|FG002|STARTED|Overall Study||9||
48234564|NCT00924833|100895126|FG000|COMPLETED|Overall Study||9||
48534994|NCT03665441|101647031|FG001|COMPLETED|Overall Study||240||
48534995|NCT03665441|101647030|FG000|NOT COMPLETED|Overall Study||39||
48534996|NCT03665441|101647031|FG001|NOT COMPLETED|Overall Study||17||
48534997|NCT02303041|101647032|FG000|STARTED|Overall Study||4||
48234565|NCT00924833|100895127|FG001|COMPLETED|Overall Study||9||
48234566|NCT00924833|100895128|FG002|COMPLETED|Overall Study||9||
48234567|NCT00924833|100895126|FG000|NOT COMPLETED|Overall Study||0||
48234568|NCT00924833|100895127|FG001|NOT COMPLETED|Overall Study||0||
48234569|NCT00924833|100895128|FG002|NOT COMPLETED|Overall Study||0||
48534998|NCT02303041|101647033|FG001|STARTED|Overall Study||6||
48534999|NCT02303041|101647032|FG000|COMPLETED|Overall Study||3||
48535000|NCT02303041|101647033|FG001|COMPLETED|Overall Study||4||
48535001|NCT02303041|101647032|FG000|NOT COMPLETED|Overall Study||1||
48234570|NCT00096278|100895129|FG000|STARTED|Overall Study||1356||
48234571|NCT00096278|100895130|FG001|STARTED|Overall Study||1354||
48234572|NCT00096278|100895129|FG000|COMPLETED|Overall Study||1338||
48234573|NCT00096278|100895130|FG001|COMPLETED|Overall Study||1334||
48234574|NCT00096278|100895129|FG000|NOT COMPLETED|Overall Study||18||
48234575|NCT00096278|100895130|FG001|NOT COMPLETED|Overall Study||20||
48234576|NCT00546884|100895131|FG000|STARTED|Overall Study||145||
48234577|NCT00546884|100895132|FG001|STARTED|Overall Study||117||
48234578|NCT00546884|100895131|FG000|COMPLETED|Overall Study||145||
48234579|NCT00546884|100895132|FG001|COMPLETED|Overall Study||117||
48234580|NCT00546884|100895131|FG000|NOT COMPLETED|Overall Study||0||
48234581|NCT00546884|100895132|FG001|NOT COMPLETED|Overall Study||0||
48234582|NCT00648895|100895133|FG000|STARTED|Overall Study||6||
48234583|NCT00648895|100895134|FG001|STARTED|Overall Study||6||
48234584|NCT00648895|100895133|FG000|COMPLETED|Overall Study||6||
48234585|NCT00648895|100895134|FG001|COMPLETED|Overall Study||5||
48234586|NCT00648895|100895133|FG000|NOT COMPLETED|Overall Study||0||
48234587|NCT00648895|100895134|FG001|NOT COMPLETED|Overall Study||1||
48234588|NCT04222088|100895135|FG000|STARTED|Overall Study||84||
48234589|NCT04222088|100895136|FG001|STARTED|Overall Study||75||
48234590|NCT04222088|100895135|FG000|COMPLETED|Overall Study||75||
48234591|NCT04222088|100895136|FG001|COMPLETED|Overall Study||74||
48234592|NCT04222088|100895135|FG000|NOT COMPLETED|Overall Study||9||
48234593|NCT04222088|100895136|FG001|NOT COMPLETED|Overall Study||1||
48234594|NCT03236779|100895137|FG000|STARTED|Overall Study||51||
48234595|NCT03236779|100895138|FG001|STARTED|Overall Study||51||
48234596|NCT03236779|100895137|FG000|COMPLETED|Overall Study||38||
48234597|NCT03236779|100895138|FG001|COMPLETED|Overall Study||30||
48234598|NCT03236779|100895137|FG000|NOT COMPLETED|Overall Study||13||
48234599|NCT03236779|100895138|FG001|NOT COMPLETED|Overall Study||21||
48234600|NCT03060525|100895139|FG000|STARTED|Overall Study||16||
48234601|NCT03060525|100895140|FG001|STARTED|Overall Study||18||
48234602|NCT03060525|100895141|FG002|STARTED|Overall Study||21||
48234603|NCT03060525|100895142|FG003|STARTED|Overall Study||21||
48234604|NCT03060525|100895139|FG000|COMPLETED|Overall Study||13||
48234605|NCT03060525|100895140|FG001|COMPLETED|Overall Study||14||
48234606|NCT03060525|100895141|FG002|COMPLETED|Overall Study||17||
48234607|NCT03060525|100895142|FG003|COMPLETED|Overall Study||18||
48234608|NCT03060525|100895139|FG000|NOT COMPLETED|Overall Study||3||
48234609|NCT03060525|100895140|FG001|NOT COMPLETED|Overall Study||4||
48234610|NCT03060525|100895141|FG002|NOT COMPLETED|Overall Study||4||
48234611|NCT03060525|100895142|FG003|NOT COMPLETED|Overall Study||3||
48234612|NCT01802333|100895143|FG000|STARTED|Overall Study||263||
48234613|NCT01802333|100895144|FG001|STARTED|Overall Study||267||
48234614|NCT01802333|100895145|FG002|STARTED|Overall Study||224||
48234615|NCT01802333|100895143|FG000|High Risk Patients|Overall Study||60||
48234616|NCT01802333|100895144|FG001|High Risk Patients|Overall Study||61||
48234617|NCT01802333|100895145|FG002|High Risk Patients|Overall Study||38||
48234618|NCT01802333|100895143|FG000|High Risk Patients Achieved CR/CRi|Overall Study||38||
48234619|NCT01802333|100895144|FG001|High Risk Patients Achieved CR/CRi|Overall Study||40||
48234620|NCT01802333|100895145|FG002|High Risk Patients Achieved CR/CRi|Overall Study||29||
48234621|NCT01802333|100895143|FG000|Known NPM1 Status at Baseline|Overall Study||169||
48234622|NCT01802333|100895144|FG001|Known NPM1 Status at Baseline|Overall Study||156||
48234623|NCT01802333|100895145|FG002|Known NPM1 Status at Baseline|Overall Study||142||
48234624|NCT01802333|100895143|FG000|Known Cytogenetic Risk at Baseline|Overall Study||252||
48234625|NCT01802333|100895144|FG001|Known Cytogenetic Risk at Baseline|Overall Study||250||
48234626|NCT01802333|100895145|FG002|Known Cytogenetic Risk at Baseline|Overall Study||210||
48234627|NCT01802333|100895143|FG000|COMPLETED|Overall Study||214||
48234628|NCT01802333|100895144|FG001|COMPLETED|Overall Study||206||
48234629|NCT01802333|100895145|FG002|COMPLETED|Overall Study||161||
48234630|NCT01802333|100895143|FG000|NOT COMPLETED|Overall Study||49||
48234631|NCT01802333|100895144|FG001|NOT COMPLETED|Overall Study||61||
48234632|NCT01802333|100895145|FG002|NOT COMPLETED|Overall Study||63||
48234633|NCT00623714|100895146|FG000|STARTED|Period 1||6||
48234634|NCT00623714|100895147|FG001|STARTED|Period 1||7||
48234635|NCT00623714|100895146|FG000|COMPLETED|Period 1||6||
48234636|NCT00623714|100895147|FG001|COMPLETED|Period 1||7||
48234637|NCT00623714|100895146|FG000|NOT COMPLETED|Period 1||0||
48234638|NCT00623714|100895147|FG001|NOT COMPLETED|Period 1||0||
48234639|NCT00623714|100895146|FG000|STARTED|Period 2||6||
48234640|NCT00623714|100895147|FG001|STARTED|Period 2||7||
48234641|NCT00623714|100895146|FG000|COMPLETED|Period 2||6||
48234642|NCT00623714|100895147|FG001|COMPLETED|Period 2||7||
48234643|NCT00623714|100895146|FG000|NOT COMPLETED|Period 2||0||
48234644|NCT00623714|100895147|FG001|NOT COMPLETED|Period 2||0||
48234645|NCT01416285|100897559|FG000|STARTED|Overall Study||175||
48234646|NCT01416285|100897560|FG001|STARTED|Overall Study||174||
48234647|NCT01416285|100897559|FG000|COMPLETED|Overall Study||175||
48234648|NCT01416285|100897560|FG001|COMPLETED|Overall Study||165||
48234649|NCT01416285|100897559|FG000|NOT COMPLETED|Overall Study||0||
48234650|NCT01416285|100897560|FG001|NOT COMPLETED|Overall Study||9||
48234651|NCT02312258|100897561|FG000|STARTED|Overall Study||281||
48234652|NCT02312258|100897562|FG001|STARTED|Overall Study||425||
48234653|NCT02312258|100897561|FG000|Safety Population|Overall Study||276|"The safety population was defined as all participants who received at least 1 dose of ixazomib or placebo.~Three placebo participants who erroneously received a single dose of ixazomib were included in the ixazomib arm of the safety population."|
48234654|NCT02312258|100897562|FG001|Safety Population|Overall Study||426|"The safety population was defined as all participants who received at least 1 dose of ixazomib or placebo.~Three placebo participants who erroneously received a single dose of ixazomib were included in the ixazomib arm of the safety population."|
48234655|NCT02312258|100897561|FG000|COMPLETED|Overall Study||0||
48234656|NCT02312258|100897562|FG001|COMPLETED|Overall Study||0||
48234657|NCT02312258|100897561|FG000|NOT COMPLETED|Overall Study||281||
48234658|NCT02312258|100897562|FG001|NOT COMPLETED|Overall Study||425||
48234659|NCT02070640|100897563|FG000|STARTED|Overall Study||93||
48234660|NCT02070640|100897564|FG001|STARTED|Overall Study||6||
48234661|NCT02070640|100897563|FG000|COMPLETED|Overall Study||82||
48234662|NCT02070640|100897564|FG001|COMPLETED|Overall Study||6||
48234663|NCT02070640|100897563|FG000|NOT COMPLETED|Overall Study||11||
48234664|NCT02070640|100897564|FG001|NOT COMPLETED|Overall Study||0||
48234665|NCT02727998|100897565|FG000|STARTED|Overall Study||14||
48234666|NCT02727998|100897566|FG001|STARTED|Overall Study||14||
48234667|NCT02727998|100897565|FG000|End of Treatment (7 Days)|Overall Study||13||
48234668|NCT02727998|100897566|FG001|End of Treatment (7 Days)|Overall Study||13||
48234669|NCT02727998|100897565|FG000|30 Days Follow Up|Overall Study||13||
48234670|NCT02727998|100897566|FG001|30 Days Follow Up|Overall Study||11||
48234671|NCT02727998|100897565|FG000|90 Days Follow Up|Overall Study||11||
48234672|NCT02727998|100897566|FG001|90 Days Follow Up|Overall Study||10||
48234673|NCT02727998|100897565|FG000|COMPLETED|Overall Study||11||
48234674|NCT02727998|100897566|FG001|COMPLETED|Overall Study||10||
48234675|NCT02727998|100897565|FG000|NOT COMPLETED|Overall Study||3||
48234676|NCT02727998|100897566|FG001|NOT COMPLETED|Overall Study||4||
48234677|NCT01393600|100897567|FG000|STARTED|Treatment Period 1 (Day 1 to 14)||9||
48234678|NCT01393600|100897568|FG001|STARTED|Treatment Period 1 (Day 1 to 14)||8||
48234679|NCT01393600|100897569|FG002|STARTED|Treatment Period 1 (Day 1 to 14)||10||
48234680|NCT01393600|100897570|FG003|STARTED|Treatment Period 1 (Day 1 to 14)||10||
48234681|NCT01393600|100897567|FG000|COMPLETED|Treatment Period 1 (Day 1 to 14)||9||
48234682|NCT01393600|100897568|FG001|COMPLETED|Treatment Period 1 (Day 1 to 14)||7||
48234683|NCT01393600|100897569|FG002|COMPLETED|Treatment Period 1 (Day 1 to 14)||9||
48234684|NCT01393600|100897570|FG003|COMPLETED|Treatment Period 1 (Day 1 to 14)||9||
48234685|NCT01393600|100897567|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||0||
48234686|NCT01393600|100897568|FG001|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1||
48234687|NCT01393600|100897569|FG002|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1||
48234688|NCT01393600|100897570|FG003|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1||
48234689|NCT01393600|100897567|FG000|STARTED|Treatment Period 2 (Day 15 to 28)||9||
48234690|NCT01393600|100897568|FG001|STARTED|Treatment Period 2 (Day 15 to 28)||7||
48234691|NCT01393600|100897569|FG002|STARTED|Treatment Period 2 (Day 15 to 28)||9||
48234692|NCT01393600|100897570|FG003|STARTED|Treatment Period 2 (Day 15 to 28)||9||
48234693|NCT01393600|100897567|FG000|COMPLETED|Treatment Period 2 (Day 15 to 28)||9||
48535002|NCT02303041|101647033|FG001|NOT COMPLETED|Overall Study||2||
48535003|NCT05119348|101647034|FG000|STARTED|Overall Study||137||
48535004|NCT05119348|101647035|FG001|STARTED|Overall Study||108||
48535005|NCT05119348|101647034|FG000|COMPLETED|Overall Study||137||
48535006|NCT05119348|101647035|FG001|COMPLETED|Overall Study||108||
48535007|NCT05119348|101647034|FG000|NOT COMPLETED|Overall Study||0||
48234694|NCT01393600|100897568|FG001|COMPLETED|Treatment Period 2 (Day 15 to 28)||7||
48234695|NCT01393600|100897569|FG002|COMPLETED|Treatment Period 2 (Day 15 to 28)||7||
48234696|NCT01393600|100897570|FG003|COMPLETED|Treatment Period 2 (Day 15 to 28)||8||
48535008|NCT05119348|101647035|FG001|NOT COMPLETED|Overall Study||0||
48535009|NCT01087489|101647036|FG000|STARTED|Overall Study||19||
48535010|NCT01087489|101647037|FG001|STARTED|Overall Study||34||
48535011|NCT01087489|101647036|FG000|COMPLETED|Overall Study||19||
48535012|NCT01087489|101647037|FG001|COMPLETED|Overall Study||31||
48535013|NCT01087489|101647036|FG000|NOT COMPLETED|Overall Study||0||
48535014|NCT01087489|101647037|FG001|NOT COMPLETED|Overall Study||3||
48535015|NCT03275064|101647038|FG000|STARTED|Treatment Period Part A and Part B||43||
48535016|NCT03275064|101647039|FG001|STARTED|Treatment Period Part A and Part B||15||
48535017|NCT03275064|101647040|FG002|STARTED|Treatment Period Part A and Part B||27||
48535018|NCT03275064|101647041|FG003|STARTED|Treatment Period Part A and Part B||27||
48535019|NCT03275064|101647042|FG004|STARTED|Treatment Period Part A and Part B||29||
48535020|NCT03275064|101647038|FG000|COMPLETED|Treatment Period Part A and Part B||42||
48234697|NCT01393600|100897567|FG000|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0||
48234698|NCT01393600|100897568|FG001|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0||
48234699|NCT01393600|100897569|FG002|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||2||
48234700|NCT01393600|100897570|FG003|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||1||
48234701|NCT01393600|100897567|FG000|STARTED|Follow-up Period (Day 29 to 35)||9||
48535021|NCT03275064|101647039|FG001|COMPLETED|Treatment Period Part A and Part B||15||
48535022|NCT03275064|101647040|FG002|COMPLETED|Treatment Period Part A and Part B||27||
48535023|NCT03275064|101647041|FG003|COMPLETED|Treatment Period Part A and Part B||26||
48234702|NCT01393600|100897568|FG001|STARTED|Follow-up Period (Day 29 to 35)||7||
48234703|NCT01393600|100897569|FG002|STARTED|Follow-up Period (Day 29 to 35)||7||
48234704|NCT01393600|100897570|FG003|STARTED|Follow-up Period (Day 29 to 35)||8||
48234705|NCT01393600|100897567|FG000|COMPLETED|Follow-up Period (Day 29 to 35)||9||
48234706|NCT01393600|100897568|FG001|COMPLETED|Follow-up Period (Day 29 to 35)||7||
48234707|NCT01393600|100897569|FG002|COMPLETED|Follow-up Period (Day 29 to 35)||6||
48234708|NCT01393600|100897570|FG003|COMPLETED|Follow-up Period (Day 29 to 35)||8||
48234709|NCT01393600|100897567|FG000|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0||
48535024|NCT03275064|101647042|FG004|COMPLETED|Treatment Period Part A and Part B||29||
48535025|NCT03275064|101647038|FG000|NOT COMPLETED|Treatment Period Part A and Part B||1||
48535026|NCT03275064|101647039|FG001|NOT COMPLETED|Treatment Period Part A and Part B||0||
48535027|NCT03275064|101647040|FG002|NOT COMPLETED|Treatment Period Part A and Part B||0||
48535028|NCT03275064|101647041|FG003|NOT COMPLETED|Treatment Period Part A and Part B||1||
48234710|NCT01393600|100897568|FG001|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0||
48234711|NCT01393600|100897569|FG002|NOT COMPLETED|Follow-up Period (Day 29 to 35)||1||
48234712|NCT01393600|100897570|FG003|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0||
48234713|NCT03406507|100897571|FG000|STARTED|Primary Evaluation Period||5||
48234714|NCT03406507|100897572|FG001|STARTED|Primary Evaluation Period||8||
48234715|NCT03406507|100897571|FG000|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||5||
48234716|NCT03406507|100897572|FG001|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||8||
48234717|NCT03406507|100897571|FG000|COMPLETED|Primary Evaluation Period||5||
48234718|NCT03406507|100897572|FG001|COMPLETED|Primary Evaluation Period||8||
48234719|NCT03406507|100897571|FG000|NOT COMPLETED|Primary Evaluation Period||0||
48234720|NCT03406507|100897572|FG001|NOT COMPLETED|Primary Evaluation Period||0||
48234721|NCT03406507|100897571|FG000|STARTED|Extension Period||5||
48234722|NCT03406507|100897572|FG001|STARTED|Extension Period||8||
48234723|NCT03406507|100897571|FG000|Received at Least 1 Dose of Study Drug|Extension Period||5||
48234724|NCT03406507|100897572|FG001|Received at Least 1 Dose of Study Drug|Extension Period||8||
48234725|NCT03406507|100897571|FG000|COMPLETED|Extension Period||5||
48234726|NCT03406507|100897572|FG001|COMPLETED|Extension Period||7||
48234727|NCT03406507|100897571|FG000|NOT COMPLETED|Extension Period||0||
48234728|NCT03406507|100897572|FG001|NOT COMPLETED|Extension Period||1||
48234729|NCT02676778|100897573|FG000|STARTED|Overall Study||17||
48234730|NCT02676778|100897574|FG001|STARTED|Overall Study||19||
48234731|NCT02676778|100897575|FG002|STARTED|Overall Study||1||
48234732|NCT02676778|100897573|FG000|COMPLETED|Overall Study||0||
48234733|NCT02676778|100897574|FG001|COMPLETED|Overall Study||7||
48234734|NCT02676778|100897575|FG002|COMPLETED|Overall Study||0||
48234735|NCT02676778|100897573|FG000|NOT COMPLETED|Overall Study||17||
48234736|NCT02676778|100897574|FG001|NOT COMPLETED|Overall Study||12||
48234737|NCT02676778|100897575|FG002|NOT COMPLETED|Overall Study||1||
48234738|NCT02124304|100897576|FG000|STARTED|Overall Study||15||
48234739|NCT02124304|100897577|FG001|STARTED|Overall Study||15||
48234740|NCT02124304|100897576|FG000|COMPLETED|Overall Study||15||
48234741|NCT02124304|100897577|FG001|COMPLETED|Overall Study||15||
48234742|NCT02124304|100897576|FG000|NOT COMPLETED|Overall Study||0||
48234743|NCT02124304|100897577|FG001|NOT COMPLETED|Overall Study||0||
48234744|NCT02713594|100897578|FG000|STARTED|Overall Study||952||
48234745|NCT02713594|100897579|FG001|STARTED|Overall Study||948||
48234746|NCT02713594|100897578|FG000|COMPLETED|Overall Study||562||
48234747|NCT02713594|100897579|FG001|COMPLETED|Overall Study||552||
48535029|NCT03275064|101647042|FG004|NOT COMPLETED|Treatment Period Part A and Part B||0||
48535030|NCT03275064|101647038|FG000|STARTED|Post-treatment Follow-up Parts A and B||41||
48535031|NCT03275064|101647039|FG001|STARTED|Post-treatment Follow-up Parts A and B||15||
48535032|NCT03275064|101647040|FG002|STARTED|Post-treatment Follow-up Parts A and B||27||
48535033|NCT03275064|101647041|FG003|STARTED|Post-treatment Follow-up Parts A and B||26||
48535034|NCT03275064|101647042|FG004|STARTED|Post-treatment Follow-up Parts A and B||29||
48535035|NCT03275064|101647038|FG000|COMPLETED|Post-treatment Follow-up Parts A and B||39||
48535036|NCT03275064|101647039|FG001|COMPLETED|Post-treatment Follow-up Parts A and B||15||
48535037|NCT03275064|101647040|FG002|COMPLETED|Post-treatment Follow-up Parts A and B||24||
48535038|NCT03275064|101647041|FG003|COMPLETED|Post-treatment Follow-up Parts A and B||25||
48535039|NCT03275064|101647042|FG004|COMPLETED|Post-treatment Follow-up Parts A and B||28||
48234748|NCT02713594|100897578|FG000|NOT COMPLETED|Overall Study||390||
48234749|NCT02713594|100897579|FG001|NOT COMPLETED|Overall Study||396||
48234750|NCT03316170|100897580|FG000|STARTED|Overall Study||24||
48234751|NCT03316170|100897581|FG001|STARTED|Overall Study||25||
48234752|NCT03316170|100897580|FG000|COMPLETED|Overall Study||17||
48234753|NCT03316170|100897581|FG001|COMPLETED|Overall Study||18||
48234754|NCT03316170|100897580|FG000|NOT COMPLETED|Overall Study||7||
48234755|NCT03316170|100897581|FG001|NOT COMPLETED|Overall Study||7||
48234756|NCT02035345|100897582|FG000|STARTED|Overall Study||15||
48234757|NCT02035345|100897582|FG000|COMPLETED|Overall Study||15||
48234758|NCT02035345|100897582|FG000|NOT COMPLETED|Overall Study||0||
48234759|NCT02825550|100897583|FG000|STARTED|Overall Study||13||
48234760|NCT02825550|100897583|FG000|COMPLETED|Overall Study||12||
48234761|NCT02825550|100897583|FG000|NOT COMPLETED|Overall Study||1||
48234762|NCT01517282|100897584|FG000|STARTED|Overall Study||9||
48234763|NCT01517282|100897585|FG001|STARTED|Overall Study||8||
48535040|NCT03275064|101647038|FG000|NOT COMPLETED|Post-treatment Follow-up Parts A and B||2||
48535041|NCT03275064|101647039|FG001|NOT COMPLETED|Post-treatment Follow-up Parts A and B||0||
48535042|NCT03275064|101647040|FG002|NOT COMPLETED|Post-treatment Follow-up Parts A and B||3||
48592658|NCT01877382|101783160|FG010|NOT COMPLETED|Dose Escalation||3||
48234764|NCT01517282|100897586|FG002|STARTED|Overall Study||9||
48234765|NCT01517282|100897587|FG003|STARTED|Overall Study||6||
48234766|NCT01517282|100897584|FG000|COMPLETED|Overall Study||8||
48234767|NCT01517282|100897585|FG001|COMPLETED|Overall Study||7||
48234768|NCT01517282|100897586|FG002|COMPLETED|Overall Study||8||
48234769|NCT01517282|100897587|FG003|COMPLETED|Overall Study||5||
48234770|NCT01517282|100897584|FG000|NOT COMPLETED|Overall Study||1||
48234771|NCT01517282|100897585|FG001|NOT COMPLETED|Overall Study||1||
48234772|NCT01517282|100897586|FG002|NOT COMPLETED|Overall Study||1||
48234773|NCT01517282|100897587|FG003|NOT COMPLETED|Overall Study||1||
48234774|NCT03584282|100897588|FG000|STARTED|Overall Study||12||
48234775|NCT03584282|100897589|FG001|STARTED|Overall Study||9||
48234776|NCT03584282|100897588|FG000|COMPLETED|Overall Study||5||
48234777|NCT03584282|100897589|FG001|COMPLETED|Overall Study||6||
48234778|NCT03584282|100897588|FG000|NOT COMPLETED|Overall Study||7||
48234779|NCT03584282|100897589|FG001|NOT COMPLETED|Overall Study||3||
48234780|NCT02152384|100897590|FG000|STARTED|Run In (1-5 Week Transition)||14||
48234781|NCT02152384|100897591|FG001|STARTED|Run In (1-5 Week Transition)||14||
48535043|NCT03275064|101647041|FG003|NOT COMPLETED|Post-treatment Follow-up Parts A and B||1||
48535044|NCT03275064|101647042|FG004|NOT COMPLETED|Post-treatment Follow-up Parts A and B||1||
48535045|NCT01001988|101647043|FG000|STARTED|Overall Study||596||
48535046|NCT01001988|101647043|FG000|COMPLETED|Overall Study||479||
48535047|NCT01001988|101647043|FG000|NOT COMPLETED|Overall Study||117||
48234782|NCT02152384|100897590|FG000|COMPLETED|Run In (1-5 Week Transition)||14||
48535048|NCT00555360|101647044|FG000|STARTED|Overall Study||183||
48535049|NCT00555360|101647045|FG001|STARTED|Overall Study||189||
48535050|NCT00555360|101647044|FG000|COMPLETED|Overall Study||156||
48535051|NCT00555360|101647045|FG001|COMPLETED|Overall Study||153||
48535052|NCT00555360|101647044|FG000|NOT COMPLETED|Overall Study||27||
48535053|NCT00555360|101647045|FG001|NOT COMPLETED|Overall Study||36||
48535054|NCT03283319|101647046|FG000|STARTED|Overall Study||62||
48535055|NCT03283319|101647047|FG001|STARTED|Overall Study||60||
48535056|NCT03283319|101647048|FG002|STARTED|Overall Study||62||
48535057|NCT03283319|101647049|FG003|STARTED|Overall Study||61||
48535058|NCT03283319|101647050|FG004|STARTED|Overall Study||60||
48535059|NCT03283319|101647051|FG005|STARTED|Overall Study||61||
48535060|NCT03283319|101647046|FG000|COMPLETED|Overall Study||55||
48535061|NCT03283319|101647047|FG001|COMPLETED|Overall Study||54||
48535062|NCT03283319|101647048|FG002|COMPLETED|Overall Study||55||
48535063|NCT03283319|101647049|FG003|COMPLETED|Overall Study||54||
48535064|NCT03283319|101647050|FG004|COMPLETED|Overall Study||56||
48535065|NCT03283319|101647051|FG005|COMPLETED|Overall Study||57||
48535066|NCT03283319|101647046|FG000|NOT COMPLETED|Overall Study||7||
48535067|NCT03283319|101647047|FG001|NOT COMPLETED|Overall Study||6||
48535068|NCT03283319|101647048|FG002|NOT COMPLETED|Overall Study||7||
48535069|NCT03283319|101647049|FG003|NOT COMPLETED|Overall Study||7||
48535070|NCT03283319|101647050|FG004|NOT COMPLETED|Overall Study||4||
48535071|NCT03283319|101647051|FG005|NOT COMPLETED|Overall Study||4||
48234783|NCT02152384|100897591|FG001|COMPLETED|Run In (1-5 Week Transition)||14||
48234784|NCT02152384|100897590|FG000|NOT COMPLETED|Run In (1-5 Week Transition)||0||
48535072|NCT01284621|101647052|FG000|STARTED|First Intervention (8 Days)||3||
48535073|NCT01284621|101647053|FG001|STARTED|First Intervention (8 Days)||4||
48535074|NCT01284621|101647054|FG002|STARTED|First Intervention (8 Days)||4||
48535075|NCT01284621|101647055|FG003|STARTED|First Intervention (8 Days)||4||
48535076|NCT01284621|101647056|FG004|STARTED|First Intervention (8 Days)||4||
48535077|NCT01284621|101647057|FG005|STARTED|First Intervention (8 Days)||4||
48535078|NCT01284621|101647052|FG000|COMPLETED|First Intervention (8 Days)||3||
48535079|NCT01284621|101647053|FG001|COMPLETED|First Intervention (8 Days)||4||
48535080|NCT01284621|101647054|FG002|COMPLETED|First Intervention (8 Days)||4||
48535081|NCT01284621|101647055|FG003|COMPLETED|First Intervention (8 Days)||4||
48535082|NCT01284621|101647056|FG004|COMPLETED|First Intervention (8 Days)||4||
48535083|NCT01284621|101647057|FG005|COMPLETED|First Intervention (8 Days)||4||
48535084|NCT01284621|101647052|FG000|NOT COMPLETED|First Intervention (8 Days)||0||
48535085|NCT01284621|101647053|FG001|NOT COMPLETED|First Intervention (8 Days)||0||
48535086|NCT01284621|101647054|FG002|NOT COMPLETED|First Intervention (8 Days)||0||
48535087|NCT01284621|101647055|FG003|NOT COMPLETED|First Intervention (8 Days)||0||
48535088|NCT01284621|101647056|FG004|NOT COMPLETED|First Intervention (8 Days)||0||
48535089|NCT01284621|101647057|FG005|NOT COMPLETED|First Intervention (8 Days)||0||
48535090|NCT01284621|101647052|FG000|STARTED|Washout Period 1 (7 Days)||3||
48535091|NCT01284621|101647053|FG001|STARTED|Washout Period 1 (7 Days)||4||
48535092|NCT01284621|101647054|FG002|STARTED|Washout Period 1 (7 Days)||4||
48535093|NCT01284621|101647055|FG003|STARTED|Washout Period 1 (7 Days)||4||
48234785|NCT02152384|100897591|FG001|NOT COMPLETED|Run In (1-5 Week Transition)||0||
48234786|NCT02152384|100897590|FG000|STARTED|Period 1||14||
48535094|NCT01284621|101647056|FG004|STARTED|Washout Period 1 (7 Days)||4||
48234787|NCT02152384|100897591|FG001|STARTED|Period 1||14||
48234788|NCT02152384|100897590|FG000|Received at Least 1 Dose of Study Drug|Period 1||14||
48234789|NCT02152384|100897591|FG001|Received at Least 1 Dose of Study Drug|Period 1||14||
48234790|NCT02152384|100897590|FG000|COMPLETED|Period 1||13||
48234791|NCT02152384|100897591|FG001|COMPLETED|Period 1||12||
48535095|NCT01284621|101647057|FG005|STARTED|Washout Period 1 (7 Days)||4||
48535096|NCT01284621|101647052|FG000|COMPLETED|Washout Period 1 (7 Days)||3||
48535097|NCT01284621|101647053|FG001|COMPLETED|Washout Period 1 (7 Days)||4||
48535098|NCT01284621|101647054|FG002|COMPLETED|Washout Period 1 (7 Days)||4||
48535099|NCT01284621|101647055|FG003|COMPLETED|Washout Period 1 (7 Days)||4||
48535100|NCT01284621|101647056|FG004|COMPLETED|Washout Period 1 (7 Days)||3||
48535101|NCT01284621|101647057|FG005|COMPLETED|Washout Period 1 (7 Days)||4||
48535102|NCT01284621|101647052|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48535103|NCT01284621|101647053|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48535104|NCT01284621|101647054|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48535105|NCT01284621|101647055|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48535106|NCT01284621|101647056|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||1||
48535107|NCT01284621|101647057|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48535108|NCT01284621|101647052|FG000|STARTED|Second Intervention (8 Days)||3||
48535109|NCT01284621|101647053|FG001|STARTED|Second Intervention (8 Days)||4||
48535110|NCT01284621|101647054|FG002|STARTED|Second Intervention (8 Days)||4||
48535111|NCT01284621|101647055|FG003|STARTED|Second Intervention (8 Days)||4||
48234792|NCT02152384|100897590|FG000|NOT COMPLETED|Period 1||1||
48234793|NCT02152384|100897591|FG001|NOT COMPLETED|Period 1||2||
48234794|NCT02152384|100897590|FG000|STARTED|Period 2||13||
48535112|NCT01284621|101647056|FG004|STARTED|Second Intervention (8 Days)||3||
48535113|NCT01284621|101647057|FG005|STARTED|Second Intervention (8 Days)||4||
48535114|NCT01284621|101647052|FG000|COMPLETED|Second Intervention (8 Days)||3||
48535115|NCT01284621|101647053|FG001|COMPLETED|Second Intervention (8 Days)||4||
48535116|NCT01284621|101647054|FG002|COMPLETED|Second Intervention (8 Days)||4||
48535117|NCT01284621|101647055|FG003|COMPLETED|Second Intervention (8 Days)||4||
48535118|NCT01284621|101647056|FG004|COMPLETED|Second Intervention (8 Days)||3||
48535119|NCT01284621|101647057|FG005|COMPLETED|Second Intervention (8 Days)||4||
48535120|NCT01284621|101647052|FG000|NOT COMPLETED|Second Intervention (8 Days)||0||
48535121|NCT01284621|101647053|FG001|NOT COMPLETED|Second Intervention (8 Days)||0||
48535122|NCT01284621|101647054|FG002|NOT COMPLETED|Second Intervention (8 Days)||0||
48535123|NCT01284621|101647055|FG003|NOT COMPLETED|Second Intervention (8 Days)||0||
48535124|NCT01284621|101647056|FG004|NOT COMPLETED|Second Intervention (8 Days)||0||
48535125|NCT01284621|101647057|FG005|NOT COMPLETED|Second Intervention (8 Days)||0||
48535126|NCT01284621|101647052|FG000|STARTED|Washout Period 2 (7 Days)||3||
48535127|NCT01284621|101647053|FG001|STARTED|Washout Period 2 (7 Days)||4||
48535128|NCT01284621|101647054|FG002|STARTED|Washout Period 2 (7 Days)||4||
48535129|NCT01284621|101647055|FG003|STARTED|Washout Period 2 (7 Days)||4||
48535130|NCT01284621|101647056|FG004|STARTED|Washout Period 2 (7 Days)||3||
48535131|NCT01284621|101647057|FG005|STARTED|Washout Period 2 (7 Days)||4||
48535132|NCT01284621|101647052|FG000|COMPLETED|Washout Period 2 (7 Days)||3||
48535133|NCT01284621|101647053|FG001|COMPLETED|Washout Period 2 (7 Days)||4||
48535134|NCT01284621|101647054|FG002|COMPLETED|Washout Period 2 (7 Days)||4||
48535135|NCT01284621|101647055|FG003|COMPLETED|Washout Period 2 (7 Days)||4||
48535136|NCT01284621|101647056|FG004|COMPLETED|Washout Period 2 (7 Days)||3||
48535137|NCT01284621|101647057|FG005|COMPLETED|Washout Period 2 (7 Days)||4||
48535138|NCT01284621|101647052|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48535139|NCT01284621|101647053|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48535140|NCT01284621|101647054|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48535141|NCT01284621|101647055|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48535142|NCT01284621|101647056|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48535143|NCT01284621|101647057|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48535144|NCT01284621|101647052|FG000|STARTED|Third Intervention (8 Days)||3||
48535145|NCT01284621|101647053|FG001|STARTED|Third Intervention (8 Days)||4||
48234795|NCT02152384|100897591|FG001|STARTED|Period 2||12||
48535146|NCT01284621|101647054|FG002|STARTED|Third Intervention (8 Days)||4||
48535147|NCT01284621|101647055|FG003|STARTED|Third Intervention (8 Days)||4||
48535148|NCT01284621|101647056|FG004|STARTED|Third Intervention (8 Days)||3||
48535149|NCT01284621|101647057|FG005|STARTED|Third Intervention (8 Days)||4||
48535150|NCT01284621|101647052|FG000|COMPLETED|Third Intervention (8 Days)||3||
48535151|NCT01284621|101647053|FG001|COMPLETED|Third Intervention (8 Days)||4||
48535152|NCT01284621|101647054|FG002|COMPLETED|Third Intervention (8 Days)||4||
48535153|NCT01284621|101647055|FG003|COMPLETED|Third Intervention (8 Days)||4||
48535154|NCT01284621|101647056|FG004|COMPLETED|Third Intervention (8 Days)||3||
48535155|NCT01284621|101647057|FG005|COMPLETED|Third Intervention (8 Days)||4||
48535156|NCT01284621|101647052|FG000|NOT COMPLETED|Third Intervention (8 Days)||0||
48535157|NCT01284621|101647053|FG001|NOT COMPLETED|Third Intervention (8 Days)||0||
48535158|NCT01284621|101647054|FG002|NOT COMPLETED|Third Intervention (8 Days)||0||
48535159|NCT01284621|101647055|FG003|NOT COMPLETED|Third Intervention (8 Days)||0||
48535160|NCT01284621|101647056|FG004|NOT COMPLETED|Third Intervention (8 Days)||0||
48234796|NCT02152384|100897590|FG000|COMPLETED|Period 2||13||
48234797|NCT02152384|100897591|FG001|COMPLETED|Period 2||12||
48234798|NCT02152384|100897590|FG000|NOT COMPLETED|Period 2||0||
48234799|NCT02152384|100897591|FG001|NOT COMPLETED|Period 2||0||
48535161|NCT01284621|101647057|FG005|NOT COMPLETED|Third Intervention (8 Days)||0||
48535162|NCT03186781|101647058|FG000|STARTED|Overall Study||5||
48535163|NCT03186781|101647059|FG001|STARTED|Overall Study||5||
48535164|NCT03186781|101647060|FG002|STARTED|Overall Study||10||
48535165|NCT03186781|101647061|FG003|STARTED|Overall Study||10||
48234800|NCT05005247|100897592|FG000|STARTED|Overall Study||10||
48535166|NCT03186781|101647062|FG004|STARTED|Overall Study||10||
48535167|NCT03186781|101647063|FG005|STARTED|Overall Study||10||
48592659|NCT01877382|101783161|FG011|NOT COMPLETED|Dose Escalation||3||
48234801|NCT05005247|100897593|FG001|STARTED|Overall Study||7||
48234802|NCT05005247|100897594|FG002|STARTED|Overall Study||10||
48234803|NCT05005247|100897592|FG000|COMPLETED|Overall Study||10||
48234804|NCT05005247|100897593|FG001|COMPLETED|Overall Study||6||
48234805|NCT05005247|100897594|FG002|COMPLETED|Overall Study||10||
48234806|NCT05005247|100897592|FG000|NOT COMPLETED|Overall Study||0||
48535168|NCT03186781|101647058|FG000|Received First Product Administration|Overall Study||5||
48234807|NCT05005247|100897593|FG001|NOT COMPLETED|Overall Study||1||
48234808|NCT05005247|100897594|FG002|NOT COMPLETED|Overall Study||0||
48234809|NCT02516202|100897595|FG000|STARTED|Overall Study||102||
48535169|NCT03186781|101647059|FG001|Received First Product Administration|Overall Study||5||
48535170|NCT03186781|101647060|FG002|Received First Product Administration|Overall Study||10||
48535171|NCT03186781|101647061|FG003|Received First Product Administration|Overall Study||10||
48535172|NCT03186781|101647062|FG004|Received First Product Administration|Overall Study||10||
48535173|NCT03186781|101647063|FG005|Received First Product Administration|Overall Study||10||
48535174|NCT03186781|101647058|FG000|Received All Product Administrations|Overall Study||5||
48535175|NCT03186781|101647059|FG001|Received All Product Administrations|Overall Study||5||
48535176|NCT03186781|101647060|FG002|Received All Product Administrations|Overall Study||8||
48535177|NCT03186781|101647061|FG003|Received All Product Administrations|Overall Study||9||
48535178|NCT03186781|101647062|FG004|Received All Product Administrations|Overall Study||8||
48535179|NCT03186781|101647063|FG005|Received All Product Administrations|Overall Study||9||
48535180|NCT03186781|101647058|FG000|COMPLETED|Overall Study||5||
48535181|NCT03186781|101647059|FG001|COMPLETED|Overall Study||5||
48535182|NCT03186781|101647060|FG002|COMPLETED|Overall Study||9||
48535183|NCT03186781|101647061|FG003|COMPLETED|Overall Study||10||
48535184|NCT03186781|101647062|FG004|COMPLETED|Overall Study||7||
48535185|NCT03186781|101647063|FG005|COMPLETED|Overall Study||10||
48535186|NCT03186781|101647058|FG000|NOT COMPLETED|Overall Study||0||
48535187|NCT03186781|101647059|FG001|NOT COMPLETED|Overall Study||0||
48535188|NCT03186781|101647060|FG002|NOT COMPLETED|Overall Study||1||
48535189|NCT03186781|101647061|FG003|NOT COMPLETED|Overall Study||0||
48535190|NCT03186781|101647062|FG004|NOT COMPLETED|Overall Study||3||
48535191|NCT03186781|101647063|FG005|NOT COMPLETED|Overall Study||0||
48535192|NCT00827632|101647064|FG000|STARTED|Overall Study||128||
48535193|NCT00827632|101647065|FG001|STARTED|Overall Study||98||
48535194|NCT00827632|101647064|FG000|COMPLETED|Overall Study||106||
48535195|NCT00827632|101647065|FG001|COMPLETED|Overall Study||75||
48535196|NCT00827632|101647064|FG000|NOT COMPLETED|Overall Study||22||
48535197|NCT00827632|101647065|FG001|NOT COMPLETED|Overall Study||23||
48535198|NCT01025271|101647066|FG000|STARTED|Overall Study||2||
48535199|NCT01025271|101647066|FG000|COMPLETED|Overall Study||2||
48535200|NCT01025271|101647066|FG000|NOT COMPLETED|Overall Study||0||
48535201|NCT01276301|101647067|FG000|STARTED|First Intervention||8||
48535202|NCT01276301|101647068|FG001|STARTED|First Intervention||8||
48535203|NCT01276301|101647067|FG000|COMPLETED|First Intervention||8||
48535204|NCT01276301|101647068|FG001|COMPLETED|First Intervention||8||
48535205|NCT01276301|101647067|FG000|NOT COMPLETED|First Intervention||0||
48535206|NCT01276301|101647068|FG001|NOT COMPLETED|First Intervention||0||
48535207|NCT01276301|101647067|FG000|STARTED|Washout Period of 7 Days||8||
48234810|NCT02516202|100897596|FG001|STARTED|Overall Study||100||
48234811|NCT02516202|100897597|FG002|STARTED|Overall Study||100||
48234812|NCT02516202|100897595|FG000|COMPLETED|Overall Study||100||
48234813|NCT02516202|100897596|FG001|COMPLETED|Overall Study||99||
48234814|NCT02516202|100897597|FG002|COMPLETED|Overall Study||97||
48234815|NCT02516202|100897595|FG000|NOT COMPLETED|Overall Study||2||
48234816|NCT02516202|100897596|FG001|NOT COMPLETED|Overall Study||1||
48234817|NCT02516202|100897597|FG002|NOT COMPLETED|Overall Study||3||
48234818|NCT04311983|100897598|FG000|STARTED|Overall Study||987||
48234819|NCT04311983|100897599|FG001|STARTED|Overall Study||986||
48234820|NCT04311983|100897598|FG000|COMPLETED|Overall Study||558||
48234821|NCT04311983|100897599|FG001|COMPLETED|Overall Study||521||
48234822|NCT04311983|100897598|FG000|NOT COMPLETED|Overall Study||429||
48234823|NCT04311983|100897599|FG001|NOT COMPLETED|Overall Study||465||
48234824|NCT00476151|100897600|FG000|STARTED|Overall Study||112||
48234825|NCT00476151|100897601|FG001|STARTED|Overall Study||114||
48234826|NCT00476151|100897600|FG000|COMPLETED|Overall Study||109||
48234827|NCT00476151|100897601|FG001|COMPLETED|Overall Study||107||
48234828|NCT00476151|100897600|FG000|NOT COMPLETED|Overall Study||3||
48234829|NCT00476151|100897601|FG001|NOT COMPLETED|Overall Study||7||
48234830|NCT01668355|100897602|FG000|STARTED|Overall Study||164||
48234831|NCT01668355|100897603|FG001|STARTED|Overall Study||167||
48535208|NCT01276301|101647068|FG001|STARTED|Washout Period of 7 Days||8||
48535209|NCT01276301|101647067|FG000|COMPLETED|Washout Period of 7 Days||8||
48535210|NCT01276301|101647068|FG001|COMPLETED|Washout Period of 7 Days||8||
48535211|NCT01276301|101647067|FG000|NOT COMPLETED|Washout Period of 7 Days||0||
48535212|NCT01276301|101647068|FG001|NOT COMPLETED|Washout Period of 7 Days||0||
48535213|NCT01276301|101647067|FG000|STARTED|Second Intervention||8||
48535214|NCT01276301|101647068|FG001|STARTED|Second Intervention||8||
48234832|NCT01668355|100897602|FG000|COMPLETED|Overall Study||155||
48234833|NCT01668355|100897603|FG001|COMPLETED|Overall Study||165||
48234834|NCT01668355|100897602|FG000|NOT COMPLETED|Overall Study||9||
48234835|NCT01668355|100897603|FG001|NOT COMPLETED|Overall Study||2||
48535215|NCT01276301|101647067|FG000|COMPLETED|Second Intervention||8||
48535216|NCT01276301|101647068|FG001|COMPLETED|Second Intervention||8||
48535217|NCT01276301|101647067|FG000|NOT COMPLETED|Second Intervention||0||
48535218|NCT01276301|101647068|FG001|NOT COMPLETED|Second Intervention||0||
48535219|NCT03246646|101647069|FG000|STARTED|Overall Study||26||
48535220|NCT03246646|101647070|FG001|STARTED|Overall Study||26||
48535221|NCT03246646|101647069|FG000|COMPLETED|Overall Study||15||
48535222|NCT03246646|101647070|FG001|COMPLETED|Overall Study||26||
48535223|NCT03246646|101647069|FG000|NOT COMPLETED|Overall Study||11||
48535224|NCT03246646|101647070|FG001|NOT COMPLETED|Overall Study||0||
48535225|NCT01135186|101647071|FG000|STARTED|Overall Study||9||
48535226|NCT01135186|101647071|FG000|COMPLETED|Overall Study||9||
48535227|NCT01135186|101647071|FG000|NOT COMPLETED|Overall Study||0||
48535228|NCT02185053|101647072|FG000|STARTED|Solifenacin Dose Escalation Phase||41||
48535229|NCT02185053|101647073|FG001|STARTED|Solifenacin Dose Escalation Phase||0||
48535230|NCT02185053|101647074|FG002|STARTED|Solifenacin Dose Escalation Phase||0||
48535231|NCT02185053|101647072|FG000|COMPLETED|Solifenacin Dose Escalation Phase||38||
48535232|NCT02185053|101647073|FG001|COMPLETED|Solifenacin Dose Escalation Phase||0||
48535233|NCT02185053|101647074|FG002|COMPLETED|Solifenacin Dose Escalation Phase||0||
48535234|NCT02185053|101647072|FG000|NOT COMPLETED|Solifenacin Dose Escalation Phase||3||
48535235|NCT02185053|101647073|FG001|NOT COMPLETED|Solifenacin Dose Escalation Phase||0||
48535236|NCT02185053|101647074|FG002|NOT COMPLETED|Solifenacin Dose Escalation Phase||0||
48535237|NCT02185053|101647072|FG000|STARTED|Donepezil Dose Escalation Phase||0||
48535238|NCT02185053|101647073|FG001|STARTED|Donepezil Dose Escalation Phase||38||
48535239|NCT02185053|101647074|FG002|STARTED|Donepezil Dose Escalation Phase||0||
48535240|NCT02185053|101647072|FG000|COMPLETED|Donepezil Dose Escalation Phase||0||
48535241|NCT02185053|101647073|FG001|COMPLETED|Donepezil Dose Escalation Phase||33||
48234836|NCT01528605|100897604|FG000|STARTED|Overall Study||28||
48234837|NCT01528605|100897605|FG001|STARTED|Overall Study||28||
48234838|NCT01528605|100897606|FG002|STARTED|Overall Study||28||
48234839|NCT01528605|100897607|FG003|STARTED|Overall Study||28||
48234840|NCT01528605|100897608|FG004|STARTED|Overall Study||28||
48535242|NCT02185053|101647074|FG002|COMPLETED|Donepezil Dose Escalation Phase||0||
48535243|NCT02185053|101647072|FG000|NOT COMPLETED|Donepezil Dose Escalation Phase||0||
48535244|NCT02185053|101647073|FG001|NOT COMPLETED|Donepezil Dose Escalation Phase||5||
48535245|NCT02185053|101647074|FG002|NOT COMPLETED|Donepezil Dose Escalation Phase||0||
48535246|NCT02185053|101647072|FG000|STARTED|Donepezil Dose Maintenance Phase||0||
48535247|NCT02185053|101647073|FG001|STARTED|Donepezil Dose Maintenance Phase||0||
48535248|NCT02185053|101647074|FG002|STARTED|Donepezil Dose Maintenance Phase||33||
48535249|NCT02185053|101647072|FG000|COMPLETED|Donepezil Dose Maintenance Phase||0||
48535250|NCT02185053|101647073|FG001|COMPLETED|Donepezil Dose Maintenance Phase||0||
48535251|NCT02185053|101647074|FG002|COMPLETED|Donepezil Dose Maintenance Phase||30||
48535252|NCT02185053|101647072|FG000|NOT COMPLETED|Donepezil Dose Maintenance Phase||0||
48535253|NCT02185053|101647073|FG001|NOT COMPLETED|Donepezil Dose Maintenance Phase||0||
48535254|NCT02185053|101647074|FG002|NOT COMPLETED|Donepezil Dose Maintenance Phase||3||
48535255|NCT01687244|101647075|FG000|STARTED|Overall Study||21||
48535256|NCT01687244|101647076|FG001|STARTED|Overall Study||19||
48535257|NCT01687244|101647075|FG000|COMPLETED|Overall Study||21||
48535258|NCT01687244|101647076|FG001|COMPLETED|Overall Study||19||
48535259|NCT01687244|101647075|FG000|NOT COMPLETED|Overall Study||0||
48535260|NCT01687244|101647076|FG001|NOT COMPLETED|Overall Study||0||
48535261|NCT02067468|101647077|FG000|STARTED|Overall Study||882||
48535262|NCT02067468|101647078|FG001|STARTED|Overall Study||890||
48535263|NCT02067468|101647079|FG002|STARTED|Overall Study||889||
48535264|NCT02067468|101647077|FG000|Followed-up Through Medical Records|Overall Study||882|All included women followed through databases and medical records manually ascertained from HMOs|
48535265|NCT02067468|101647078|FG001|Followed-up Through Medical Records|Overall Study||890|All included women followed through databases and medical records manually ascertained from HMOs|
48535266|NCT02067468|101647079|FG002|Followed-up Through Medical Records|Overall Study||889|All included women followed through databases and medical records manually ascertained from HMOs|
48535267|NCT02067468|101647077|FG000|Had at Least One Routine Colposcopy|Overall Study||772|Referred to colposcopy: 100% for COLPOSCOPY, abnormal Pap for CYTOLOGY (31%), and HPV+ for HPV (41%)|
48535268|NCT02067468|101647078|FG001|Had at Least One Routine Colposcopy|Overall Study||372|Referred to colposcopy: 100% for COLPOSCOPY, abnormal Pap for CYTOLOGY (31%), and HPV+ for HPV (41%)|
48535269|NCT02067468|101647079|FG002|Had at Least One Routine Colposcopy|Overall Study||462|Referred to colposcopy: 100% for COLPOSCOPY, abnormal Pap for CYTOLOGY (31%), and HPV+ for HPV (41%)|
48535270|NCT02067468|101647077|FG000|COMPLETED|Overall Study||882||
48535271|NCT02067468|101647078|FG001|COMPLETED|Overall Study||890||
48535272|NCT02067468|101647079|FG002|COMPLETED|Overall Study||889||
48535273|NCT02067468|101647077|FG000|NOT COMPLETED|Overall Study||0||
48535274|NCT02067468|101647078|FG001|NOT COMPLETED|Overall Study||0||
48535275|NCT02067468|101647079|FG002|NOT COMPLETED|Overall Study||0||
48234841|NCT01528605|100897609|FG005|STARTED|Overall Study||28||
48234842|NCT01528605|100897604|FG000|COMPLETED|Overall Study||26||
48535276|NCT03333590|101647080|FG000|STARTED|Overall Study||1||
48535277|NCT03333590|101647081|FG001|STARTED|Overall Study||1||
48535278|NCT03333590|101647080|FG000|COMPLETED|Overall Study||1||
48535279|NCT03333590|101647081|FG001|COMPLETED|Overall Study||1||
48234843|NCT01528605|100897605|FG001|COMPLETED|Overall Study||28||
48535280|NCT03333590|101647080|FG000|NOT COMPLETED|Overall Study||0||
48535281|NCT03333590|101647081|FG001|NOT COMPLETED|Overall Study||0||
48535282|NCT04485039|101647082|FG000|STARTED|TPOXX Only||44||
48535283|NCT04485039|101647082|FG000|COMPLETED|TPOXX Only||41||
48535284|NCT04485039|101647082|FG000|NOT COMPLETED|TPOXX Only||3||
48535285|NCT04485039|101647082|FG000|STARTED|TPOXX With Sevelamer Carbonate||41||
48535286|NCT04485039|101647082|FG000|COMPLETED|TPOXX With Sevelamer Carbonate||39||
48535287|NCT04485039|101647082|FG000|NOT COMPLETED|TPOXX With Sevelamer Carbonate||2||
48535288|NCT04485039|101647082|FG000|STARTED|TPOXX With Sucroferric Oxyhydroxide||39||
48535289|NCT04485039|101647082|FG000|COMPLETED|TPOXX With Sucroferric Oxyhydroxide||39||
48535290|NCT04485039|101647082|FG000|NOT COMPLETED|TPOXX With Sucroferric Oxyhydroxide||0||
48535291|NCT04485039|101647082|FG000|STARTED|TPOXX With Calcium Acetate||39||
48535292|NCT04485039|101647082|FG000|COMPLETED|TPOXX With Calcium Acetate||39||
48535293|NCT04485039|101647082|FG000|NOT COMPLETED|TPOXX With Calcium Acetate||0||
48535294|NCT04485039|101647082|FG000|STARTED|TPOXX With Lanthanum Carbonate||39||
48535295|NCT04485039|101647082|FG000|COMPLETED|TPOXX With Lanthanum Carbonate||39||
48535296|NCT04485039|101647082|FG000|NOT COMPLETED|TPOXX With Lanthanum Carbonate||0||
48535297|NCT01043653|101647083|FG000|STARTED|Overall Study||250||
48535298|NCT01043653|101647083|FG000|COMPLETED|Overall Study||186||
48535299|NCT01043653|101647083|FG000|NOT COMPLETED|Overall Study||64||
48535300|NCT01768013|101647084|FG000|STARTED|Overall Study||13||
48535301|NCT01768013|101647084|FG000|COMPLETED|Overall Study||13||
48535302|NCT01768013|101647084|FG000|NOT COMPLETED|Overall Study||0||
48535303|NCT02468570|101647085|FG000|STARTED|Overall Study||6||
48535304|NCT02468570|101647086|FG001|STARTED|Overall Study||3||
48535305|NCT02468570|101647085|FG000|COMPLETED|Overall Study||6||
48535306|NCT02468570|101647086|FG001|COMPLETED|Overall Study||3||
48535307|NCT02468570|101647085|FG000|NOT COMPLETED|Overall Study||0||
48535308|NCT02468570|101647086|FG001|NOT COMPLETED|Overall Study||0||
48234844|NCT01528605|100897606|FG002|COMPLETED|Overall Study||27||
48234845|NCT01528605|100897607|FG003|COMPLETED|Overall Study||27||
48234846|NCT01528605|100897608|FG004|COMPLETED|Overall Study||28||
48234847|NCT01528605|100897609|FG005|COMPLETED|Overall Study||28||
48234848|NCT01528605|100897604|FG000|NOT COMPLETED|Overall Study||2||
48234849|NCT01528605|100897605|FG001|NOT COMPLETED|Overall Study||0||
48234850|NCT01528605|100897606|FG002|NOT COMPLETED|Overall Study||1||
48234851|NCT01528605|100897607|FG003|NOT COMPLETED|Overall Study||1||
48234852|NCT01528605|100897608|FG004|NOT COMPLETED|Overall Study||0||
48234853|NCT01528605|100897609|FG005|NOT COMPLETED|Overall Study||0||
48234854|NCT00568087|100897610|FG000|STARTED|Overall Study||22||
48234855|NCT00568087|100897611|FG001|STARTED|Overall Study||24||
48535309|NCT01982812|101647087|FG000|STARTED|Overall Study||23||
48535310|NCT01982812|101647088|FG001|STARTED|Overall Study||21||
48535311|NCT01982812|101647087|FG000|COMPLETED|Overall Study||22||
48535312|NCT01982812|101647088|FG001|COMPLETED|Overall Study||11||
48535313|NCT01982812|101647087|FG000|NOT COMPLETED|Overall Study||1||
48535314|NCT01982812|101647088|FG001|NOT COMPLETED|Overall Study||10||
48535315|NCT00638027|101647089|FG000|STARTED|Overall Study||11||
48535316|NCT00638027|101647090|FG001|STARTED|Overall Study||10||
48535317|NCT00638027|101647089|FG000|COMPLETED|Overall Study||11||
48535318|NCT00638027|101647090|FG001|COMPLETED|Overall Study||8||
48535319|NCT00638027|101647089|FG000|NOT COMPLETED|Overall Study||0||
48535320|NCT00638027|101647090|FG001|NOT COMPLETED|Overall Study||2||
48535321|NCT00110136|101647091|FG000|STARTED|Overall Study||9||
48535322|NCT00110136|101647091|FG000|COMPLETED|Overall Study||9||
48535323|NCT00110136|101647091|FG000|NOT COMPLETED|Overall Study||0||
48535324|NCT00951496|101647092|FG000|STARTED|Overall Study||521||
48535325|NCT00951496|101647093|FG001|STARTED|Overall Study||518||
48535326|NCT00951496|101647094|FG002|STARTED|Overall Study||521||
48535327|NCT00951496|101647092|FG000|COMPLETED|Overall Study||511||
48535328|NCT00951496|101647093|FG001|COMPLETED|Overall Study||510||
48535329|NCT00951496|101647094|FG002|COMPLETED|Overall Study||508||
48535330|NCT00951496|101647092|FG000|NOT COMPLETED|Overall Study||10||
48535331|NCT00951496|101647093|FG001|NOT COMPLETED|Overall Study||8||
48535332|NCT00951496|101647094|FG002|NOT COMPLETED|Overall Study||13||
48535333|NCT03511326|101647095|FG000|STARTED|Overall Study||50||
48535334|NCT03511326|101647095|FG000|COMPLETED|Overall Study||49||
48535335|NCT03511326|101647095|FG000|NOT COMPLETED|Overall Study||1||
48535336|NCT00858143|101647096|FG000|STARTED|Overall Study||311||
48535337|NCT00858143|101647096|FG000|COMPLETED|Overall Study||261||
48535338|NCT00858143|101647096|FG000|NOT COMPLETED|Overall Study||50||
48535339|NCT00565617|101647097|FG000|STARTED|Overall Study||6||
48535340|NCT00565617|101647097|FG000|COMPLETED|Overall Study||5||
48535341|NCT00565617|101647097|FG000|NOT COMPLETED|Overall Study||1||
48535342|NCT03002571|101647098|FG000|STARTED|Overall Study||224||
48535343|NCT03002571|101647099|FG001|STARTED|Overall Study||113||
48535344|NCT03002571|101647098|FG000|COMPLETED|Overall Study||202||
48535345|NCT03002571|101647099|FG001|COMPLETED|Overall Study||99||
48535346|NCT03002571|101647098|FG000|NOT COMPLETED|Overall Study||22||
48535347|NCT03002571|101647099|FG001|NOT COMPLETED|Overall Study||14||
48535348|NCT02392351|101647100|FG000|STARTED|Overall Study||34||
48234856|NCT00568087|100897610|FG000|Received Intervention|Overall Study||21||
48234857|NCT00568087|100897611|FG001|Received Intervention|Overall Study||23||
48535349|NCT02392351|101647101|FG001|STARTED|Overall Study||17||
48535350|NCT02392351|101647100|FG000|COMPLETED|Overall Study||0||
48535351|NCT02392351|101647101|FG001|COMPLETED|Overall Study||0||
48535352|NCT02392351|101647100|FG000|NOT COMPLETED|Overall Study||34||
48535353|NCT02392351|101647101|FG001|NOT COMPLETED|Overall Study||17||
48535354|NCT00988442|101647102|FG000|STARTED|Overall Study||30||
48535355|NCT00988442|101647103|FG001|STARTED|Overall Study||29||
48535356|NCT00988442|101647102|FG000|COMPLETED|Overall Study||0||
48535357|NCT00988442|101647103|FG001|COMPLETED|Overall Study||1||
48535358|NCT00988442|101647102|FG000|NOT COMPLETED|Overall Study||30||
48535359|NCT00988442|101647103|FG001|NOT COMPLETED|Overall Study||28||
48535360|NCT01171118|101647104|FG000|STARTED|Overall Study||10||
48535361|NCT01171118|101647104|FG000|COMPLETED|Overall Study||10||
48535362|NCT01171118|101647104|FG000|NOT COMPLETED|Overall Study||0||
48535363|NCT02373189|101647105|FG000|STARTED|Overall Study||37||
48535364|NCT02373189|101647105|FG000|COMPLETED|Overall Study||25||
48535365|NCT02373189|101647105|FG000|NOT COMPLETED|Overall Study||12||
48535366|NCT00132028|101647106|FG000|STARTED|Overall Study||27||
48535367|NCT00132028|101647106|FG000|Eligible|Overall Study||25||
48535368|NCT00132028|101647106|FG000|Eligible and Began Protocol Therapy|Overall Study||25||
48535369|NCT00132028|101647106|FG000|COMPLETED|Overall Study||0||
48535370|NCT00132028|101647106|FG000|NOT COMPLETED|Overall Study||27||
48535371|NCT00977379|101647107|FG000|STARTED|Overall Study||12||
48535372|NCT00977379|101647108|FG001|STARTED|Overall Study||12||
48535373|NCT00977379|101647107|FG000|Treated|Overall Study||12||
48535374|NCT00977379|101647108|FG001|Treated|Overall Study||11||
48535375|NCT00977379|101647107|FG000|COMPLETED|Overall Study||0||
48535376|NCT00977379|101647108|FG001|COMPLETED|Overall Study||0||
48535377|NCT00977379|101647107|FG000|NOT COMPLETED|Overall Study||12||
48535378|NCT00977379|101647108|FG001|NOT COMPLETED|Overall Study||12||
48535379|NCT02049450|101647109|FG000|STARTED|Overall Study||30||
48535380|NCT02049450|101647109|FG000|Discontinued Treatment Prior to Week 30|Overall Study||4||
48535381|NCT02049450|101647109|FG000|Entered Extension Phase|Overall Study||18||
48535382|NCT02049450|101647109|FG000|COMPLETED|Overall Study||26||
48535383|NCT02049450|101647109|FG000|NOT COMPLETED|Overall Study||4||
48535384|NCT02455050|101647110|FG000|STARTED|Treatment Period 1||20||
48535385|NCT02455050|101647111|FG001|STARTED|Treatment Period 1||19||
48535386|NCT02455050|101647112|FG002|STARTED|Treatment Period 1||20||
48535387|NCT02455050|101647113|FG003|STARTED|Treatment Period 1||20||
48535388|NCT02455050|101647110|FG000|COMPLETED|Treatment Period 1||19||
48535389|NCT02455050|101647111|FG001|COMPLETED|Treatment Period 1||18||
48535390|NCT02455050|101647112|FG002|COMPLETED|Treatment Period 1||19||
48535391|NCT02455050|101647113|FG003|COMPLETED|Treatment Period 1||18||
48535392|NCT02455050|101647110|FG000|NOT COMPLETED|Treatment Period 1||1||
48535393|NCT02455050|101647111|FG001|NOT COMPLETED|Treatment Period 1||1||
48535394|NCT02455050|101647112|FG002|NOT COMPLETED|Treatment Period 1||1||
48535395|NCT02455050|101647113|FG003|NOT COMPLETED|Treatment Period 1||2||
48535396|NCT02455050|101647110|FG000|STARTED|Treatment Period 2||19||
48535397|NCT02455050|101647111|FG001|STARTED|Treatment Period 2||18||
48535398|NCT02455050|101647112|FG002|STARTED|Treatment Period 2||19||
48535399|NCT02455050|101647113|FG003|STARTED|Treatment Period 2||18||
48535400|NCT02455050|101647110|FG000|COMPLETED|Treatment Period 2||18||
48535401|NCT02455050|101647111|FG001|COMPLETED|Treatment Period 2||18||
48535402|NCT02455050|101647112|FG002|COMPLETED|Treatment Period 2||17||
48535403|NCT02455050|101647113|FG003|COMPLETED|Treatment Period 2||17||
48535404|NCT02455050|101647110|FG000|NOT COMPLETED|Treatment Period 2||1||
48535405|NCT02455050|101647111|FG001|NOT COMPLETED|Treatment Period 2||0||
48535406|NCT02455050|101647112|FG002|NOT COMPLETED|Treatment Period 2||2||
48535407|NCT02455050|101647113|FG003|NOT COMPLETED|Treatment Period 2||1||
48535408|NCT00777036|101647114|FG000|STARTED|On Treatment||29||
48535409|NCT00777036|101647115|FG001|STARTED|On Treatment||17||
48535410|NCT00777036|101647116|FG002|STARTED|On Treatment||84||
48535411|NCT00777036|101647114|FG000|COMPLETED|On Treatment||14||
48535412|NCT00777036|101647115|FG001|COMPLETED|On Treatment||1||
48535413|NCT00777036|101647116|FG002|COMPLETED|On Treatment||61||
48535414|NCT00777036|101647114|FG000|NOT COMPLETED|On Treatment||15||
48535415|NCT00777036|101647115|FG001|NOT COMPLETED|On Treatment||16||
48535416|NCT00777036|101647116|FG002|NOT COMPLETED|On Treatment||23||
48535417|NCT00777036|101647114|FG000|STARTED|Follow-Up||14||
48535418|NCT00777036|101647115|FG001|STARTED|Follow-Up||13||
48535419|NCT00777036|101647116|FG002|STARTED|Follow-Up||23||
48535420|NCT00777036|101647114|FG000|COMPLETED|Follow-Up||9||
48535421|NCT00777036|101647115|FG001|COMPLETED|Follow-Up||5||
48535422|NCT00777036|101647116|FG002|COMPLETED|Follow-Up||19||
48535423|NCT00777036|101647114|FG000|NOT COMPLETED|Follow-Up||5||
48535424|NCT00777036|101647115|FG001|NOT COMPLETED|Follow-Up||8||
48535425|NCT00777036|101647116|FG002|NOT COMPLETED|Follow-Up||4||
48535426|NCT03456583|101647117|FG000|STARTED|Overall Study||500||
48535427|NCT03456583|101647117|FG000|COMPLETED|Overall Study||500||
48535428|NCT03456583|101647117|FG000|NOT COMPLETED|Overall Study||0||
48535429|NCT01437943|101647118|FG000|STARTED|Overall Study||7||
48535430|NCT01437943|101647119|FG001|STARTED|Overall Study||3||
48535431|NCT01437943|101647118|FG000|COMPLETED|Overall Study||0||
48535432|NCT01437943|101647119|FG001|COMPLETED|Overall Study||1||
48535433|NCT01437943|101647118|FG000|NOT COMPLETED|Overall Study||7||
48535434|NCT01437943|101647119|FG001|NOT COMPLETED|Overall Study||2||
48535435|NCT01234922|101647120|FG000|STARTED|Overall Study||1||
48535436|NCT01234922|101647121|FG001|STARTED|Overall Study||1||
48535437|NCT01234922|101647122|FG002|STARTED|Overall Study||2||
48535438|NCT01234922|101647123|FG003|STARTED|Overall Study||2||
48535439|NCT01234922|101647120|FG000|COMPLETED|Overall Study||1||
48535440|NCT01234922|101647121|FG001|COMPLETED|Overall Study||1||
48535441|NCT01234922|101647122|FG002|COMPLETED|Overall Study||2||
48535442|NCT01234922|101647123|FG003|COMPLETED|Overall Study||2||
48535443|NCT01234922|101647120|FG000|NOT COMPLETED|Overall Study||0||
48535444|NCT01234922|101647121|FG001|NOT COMPLETED|Overall Study||0||
48535445|NCT01234922|101647122|FG002|NOT COMPLETED|Overall Study||0||
48535446|NCT01234922|101647123|FG003|NOT COMPLETED|Overall Study||0||
48535447|NCT01844856|101647124|FG000|STARTED|Overall Study||270||
48535448|NCT01844856|101647125|FG001|STARTED|Overall Study||271||
48535449|NCT01844856|101647124|FG000|Received at Least 1 Dose of Study Drug|Overall Study||270||
48535450|NCT01844856|101647125|FG001|Received at Least 1 Dose of Study Drug|Overall Study||268||
48535451|NCT01844856|101647124|FG000|COMPLETED|Overall Study||246||
48535452|NCT01844856|101647125|FG001|COMPLETED|Overall Study||255||
48535453|NCT01844856|101647124|FG000|NOT COMPLETED|Overall Study||24||
48535454|NCT01844856|101647125|FG001|NOT COMPLETED|Overall Study||16||
48535455|NCT03167723|101647126|FG000|STARTED|Overall Study||55||
48234858|NCT00568087|100897610|FG000|COMPLETED|Overall Study||15||
48234859|NCT00568087|100897611|FG001|COMPLETED|Overall Study||17||
48234860|NCT00568087|100897610|FG000|NOT COMPLETED|Overall Study||7||
48234861|NCT00568087|100897611|FG001|NOT COMPLETED|Overall Study||7||
48234862|NCT01794689|100897612|FG000|STARTED|Intervention 1 (2 Nights)||25||
48234863|NCT01794689|100897613|FG001|STARTED|Intervention 1 (2 Nights)||29||
48234864|NCT01794689|100897614|FG002|STARTED|Intervention 1 (2 Nights)||24||
48234865|NCT01794689|100897615|FG003|STARTED|Intervention 1 (2 Nights)||22||
48234866|NCT01794689|100897612|FG000|COMPLETED|Intervention 1 (2 Nights)||20||
48234867|NCT01794689|100897613|FG001|COMPLETED|Intervention 1 (2 Nights)||27||
48234868|NCT01794689|100897614|FG002|COMPLETED|Intervention 1 (2 Nights)||21||
48234869|NCT01794689|100897615|FG003|COMPLETED|Intervention 1 (2 Nights)||18||
48234870|NCT01794689|100897612|FG000|NOT COMPLETED|Intervention 1 (2 Nights)||5||
48234871|NCT01794689|100897613|FG001|NOT COMPLETED|Intervention 1 (2 Nights)||2||
48234872|NCT01794689|100897614|FG002|NOT COMPLETED|Intervention 1 (2 Nights)||3||
48535456|NCT03167723|101647127|FG001|STARTED|Overall Study||54||
48535457|NCT03167723|101647126|FG000|COMPLETED|Overall Study||51||
48535458|NCT03167723|101647127|FG001|COMPLETED|Overall Study||48||
48535459|NCT03167723|101647126|FG000|NOT COMPLETED|Overall Study||4||
48535460|NCT03167723|101647127|FG001|NOT COMPLETED|Overall Study||6||
48535461|NCT00003224|101647128|FG000|STARTED|Overall Study||4||
48535462|NCT00003224|101647129|FG001|STARTED|Overall Study||5||
48535463|NCT00003224|101647130|FG002|STARTED|Overall Study||4||
48535464|NCT00003224|101647131|FG003|STARTED|Overall Study||2||
48535465|NCT00003224|101647132|FG004|STARTED|Overall Study||4||
48535466|NCT00003224|101647133|FG005|STARTED|Overall Study||3||
48535467|NCT00003224|101647128|FG000|COMPLETED|Overall Study||4||
48535468|NCT00003224|101647129|FG001|COMPLETED|Overall Study||5||
48535469|NCT00003224|101647130|FG002|COMPLETED|Overall Study||4||
48535470|NCT00003224|101647131|FG003|COMPLETED|Overall Study||2||
48535471|NCT00003224|101647132|FG004|COMPLETED|Overall Study||4||
48535472|NCT00003224|101647133|FG005|COMPLETED|Overall Study||3||
48535473|NCT00003224|101647128|FG000|NOT COMPLETED|Overall Study||0||
48535474|NCT00003224|101647129|FG001|NOT COMPLETED|Overall Study||0||
48535475|NCT00003224|101647130|FG002|NOT COMPLETED|Overall Study||0||
48535476|NCT00003224|101647131|FG003|NOT COMPLETED|Overall Study||0||
48535477|NCT00003224|101647132|FG004|NOT COMPLETED|Overall Study||0||
48535478|NCT00003224|101647133|FG005|NOT COMPLETED|Overall Study||0||
48535479|NCT03783039|101647134|FG000|STARTED|Overall Study||119||
48535480|NCT03783039|101647135|FG001|STARTED|Overall Study||115||
48535481|NCT03783039|101647134|FG000|COMPLETED|Overall Study||117|6 month follow-up|
48234873|NCT01794689|100897615|FG003|NOT COMPLETED|Intervention 1 (2 Nights)||4||
48234874|NCT01794689|100897612|FG000|STARTED|Washout (2 Weeks)||20||
48535482|NCT03783039|101647135|FG001|COMPLETED|Overall Study||114|6 month follow-up|
48535483|NCT03783039|101647134|FG000|NOT COMPLETED|Overall Study||2||
48535484|NCT03783039|101647135|FG001|NOT COMPLETED|Overall Study||1||
48535485|NCT02728843|101647136|FG000|STARTED|Overall Study||28||
48535486|NCT02728843|101647137|FG001|STARTED|Overall Study||28||
48535487|NCT02728843|101647138|FG002|STARTED|Overall Study||28||
48535488|NCT02728843|101647139|FG003|STARTED|Overall Study||28||
48535489|NCT02728843|101647140|FG004|STARTED|Overall Study||28||
48535490|NCT02728843|101647136|FG000|COMPLETED|Overall Study||25||
48535491|NCT02728843|101647137|FG001|COMPLETED|Overall Study||23||
48535492|NCT02728843|101647138|FG002|COMPLETED|Overall Study||20||
48535493|NCT02728843|101647139|FG003|COMPLETED|Overall Study||22||
48535494|NCT02728843|101647140|FG004|COMPLETED|Overall Study||23||
48535495|NCT02728843|101647136|FG000|NOT COMPLETED|Overall Study||3||
48535496|NCT02728843|101647137|FG001|NOT COMPLETED|Overall Study||5||
48535497|NCT02728843|101647138|FG002|NOT COMPLETED|Overall Study||8||
48535498|NCT02728843|101647139|FG003|NOT COMPLETED|Overall Study||6||
48535499|NCT02728843|101647140|FG004|NOT COMPLETED|Overall Study||5||
48535500|NCT02494180|101647141|FG000|STARTED|Overall Study||85||
48535501|NCT02494180|101647142|FG001|STARTED|Overall Study||85||
48535502|NCT02494180|101647141|FG000|COMPLETED|Overall Study||85||
48535503|NCT02494180|101647142|FG001|COMPLETED|Overall Study||85||
48535504|NCT02494180|101647141|FG000|NOT COMPLETED|Overall Study||0||
48535505|NCT02494180|101647142|FG001|NOT COMPLETED|Overall Study||0||
48535506|NCT00537303|101647143|FG000|STARTED|Overall Study||146||
48535507|NCT00537303|101647144|FG001|STARTED|Overall Study||150||
48535508|NCT00537303|101647143|FG000|COMPLETED|Overall Study||120||
48535509|NCT00537303|101647144|FG001|COMPLETED|Overall Study||125||
48535510|NCT00537303|101647143|FG000|NOT COMPLETED|Overall Study||26||
48535511|NCT00537303|101647144|FG001|NOT COMPLETED|Overall Study||25||
48535512|NCT02628743|101647145|FG000|STARTED|Overall Study||131||
48535513|NCT02628743|101647145|FG000|COMPLETED|Overall Study||0||
48535514|NCT02628743|101647145|FG000|NOT COMPLETED|Overall Study||131||
48535515|NCT01119794|101647146|FG000|STARTED|Overall Study||10||
48535516|NCT01119794|101647146|FG000|COMPLETED|Overall Study||10||
48535517|NCT01119794|101647146|FG000|NOT COMPLETED|Overall Study||0||
48535518|NCT03261960|101647147|FG000|STARTED|Overall Study||190|Safety population - all patients that took preparation.|
48535519|NCT03261960|101647148|FG001|STARTED|Overall Study||199|Safety population - all patients that took preparation.|
48535520|NCT03261960|101647147|FG000|COMPLETED|Overall Study||176||
48535521|NCT03261960|101647148|FG001|COMPLETED|Overall Study||185||
48535522|NCT03261960|101647147|FG000|NOT COMPLETED|Overall Study||14||
48535523|NCT03261960|101647148|FG001|NOT COMPLETED|Overall Study||14||
48535524|NCT03131544|101647149|FG000|STARTED|Overall Study||10||
48535525|NCT03131544|101647149|FG000|COMPLETED|Overall Study||9||
48535526|NCT03131544|101647149|FG000|NOT COMPLETED|Overall Study||1||
48535527|NCT02335983|101647150|FG000|STARTED|Overall Study||10||
48535528|NCT02335983|101647151|FG001|STARTED|Overall Study||12||
48535529|NCT02335983|101647152|FG002|STARTED|Overall Study||34||
48535530|NCT02335983|101647153|FG003|STARTED|Overall Study||9||
48535531|NCT02335983|101647154|FG004|STARTED|Overall Study||9||
48535532|NCT02335983|101647155|FG005|STARTED|Overall Study||33||
48535533|NCT02335983|101647150|FG000|COMPLETED|Overall Study||2||
48535534|NCT02335983|101647151|FG001|COMPLETED|Overall Study||3||
48535535|NCT02335983|101647152|FG002|COMPLETED|Overall Study||2||
48535536|NCT02335983|101647153|FG003|COMPLETED|Overall Study||0||
48535537|NCT02335983|101647154|FG004|COMPLETED|Overall Study||1||
48535538|NCT02335983|101647155|FG005|COMPLETED|Overall Study||1||
48535539|NCT02335983|101647150|FG000|NOT COMPLETED|Overall Study||8||
48535540|NCT02335983|101647151|FG001|NOT COMPLETED|Overall Study||9||
48535541|NCT02335983|101647152|FG002|NOT COMPLETED|Overall Study||32||
48535542|NCT02335983|101647153|FG003|NOT COMPLETED|Overall Study||9||
48535543|NCT02335983|101647154|FG004|NOT COMPLETED|Overall Study||8||
48234875|NCT01794689|100897613|FG001|STARTED|Washout (2 Weeks)||27||
48234876|NCT01794689|100897614|FG002|STARTED|Washout (2 Weeks)||21||
48234877|NCT01794689|100897615|FG003|STARTED|Washout (2 Weeks)||18||
48234878|NCT01794689|100897612|FG000|COMPLETED|Washout (2 Weeks)||20||
48234879|NCT01794689|100897613|FG001|COMPLETED|Washout (2 Weeks)||27||
48234880|NCT01794689|100897614|FG002|COMPLETED|Washout (2 Weeks)||21||
48234881|NCT01794689|100897615|FG003|COMPLETED|Washout (2 Weeks)||18||
48234882|NCT01794689|100897612|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
48535544|NCT02335983|101647155|FG005|NOT COMPLETED|Overall Study||32||
48535545|NCT01206101|101647156|FG000|STARTED|Overall Study||2||
48535546|NCT01206101|101647157|FG001|STARTED|Overall Study||1||
48535547|NCT01206101|101647156|FG000|COMPLETED|Overall Study||0||
48535548|NCT01206101|101647157|FG001|COMPLETED|Overall Study||0||
48535549|NCT01206101|101647156|FG000|NOT COMPLETED|Overall Study||2||
48535550|NCT01206101|101647157|FG001|NOT COMPLETED|Overall Study||1||
48535551|NCT01934335|101647158|FG000|STARTED|Overall Study||7||
48535552|NCT01934335|101647159|FG001|STARTED|Overall Study||5||
48535553|NCT01934335|101647158|FG000|COMPLETED|Overall Study||6||
48535554|NCT01934335|101647159|FG001|COMPLETED|Overall Study||4||
48535555|NCT01934335|101647158|FG000|NOT COMPLETED|Overall Study||1||
48535556|NCT01934335|101647159|FG001|NOT COMPLETED|Overall Study||1||
48535557|NCT00090363|101647160|FG000|STARTED|Overall Study||107||
48535558|NCT00090363|101647161|FG001|STARTED|Overall Study||107||
48535559|NCT00090363|101647162|FG002|STARTED|Overall Study||98||
48535560|NCT00090363|101647160|FG000|Received Study Treatment.|Overall Study||107||
48535561|NCT00090363|101647161|FG001|Received Study Treatment.|Overall Study||107||
48535562|NCT00090363|101647162|FG002|Received Study Treatment.|Overall Study||98||
48535563|NCT00090363|101647160|FG000|COMPLETED|Overall Study||1||
48535564|NCT00090363|101647161|FG001|COMPLETED|Overall Study||0||
48535565|NCT00090363|101647162|FG002|COMPLETED|Overall Study||2||
48535566|NCT00090363|101647160|FG000|NOT COMPLETED|Overall Study||106||
48234883|NCT01794689|100897613|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
48234884|NCT01794689|100897614|FG002|NOT COMPLETED|Washout (2 Weeks)||0||
48234885|NCT01794689|100897615|FG003|NOT COMPLETED|Washout (2 Weeks)||0||
48535567|NCT00090363|101647161|FG001|NOT COMPLETED|Overall Study||107||
48535568|NCT00090363|101647162|FG002|NOT COMPLETED|Overall Study||96||
48535569|NCT00416884|101647163|FG000|STARTED|Overall Study||1||
48535570|NCT00416884|101647163|FG000|COMPLETED|Overall Study||0||
48535571|NCT00416884|101647163|FG000|NOT COMPLETED|Overall Study||1||
48535572|NCT00556400|101647164|FG000|STARTED|Overall Study||1||
48535573|NCT00556400|101647165|FG001|STARTED|Overall Study||0||
48535574|NCT00556400|101647164|FG000|COMPLETED|Overall Study||1||
48535575|NCT00556400|101647165|FG001|COMPLETED|Overall Study||0||
48535576|NCT00556400|101647164|FG000|NOT COMPLETED|Overall Study||0||
48535577|NCT00556400|101647165|FG001|NOT COMPLETED|Overall Study||0||
48535578|NCT02393248|101647166|FG000|STARTED|Part 1: Monotherapy Dose Escalation||3||
48535579|NCT02393248|101647167|FG001|STARTED|Part 1: Monotherapy Dose Escalation||4||
48535580|NCT02393248|101647168|FG002|STARTED|Part 1: Monotherapy Dose Escalation||3||
48535581|NCT02393248|101647169|FG003|STARTED|Part 1: Monotherapy Dose Escalation||6||
48535582|NCT02393248|101647170|FG004|STARTED|Part 1: Monotherapy Dose Escalation||6||
48535583|NCT02393248|101647171|FG005|STARTED|Part 1: Monotherapy Dose Escalation||9||
48535584|NCT02393248|101647172|FG006|STARTED|Part 1: Monotherapy Dose Escalation||10||
48535585|NCT02393248|101647173|FG007|STARTED|Part 1: Monotherapy Dose Escalation||9||
48535586|NCT02393248|101647174|FG008|STARTED|Part 1: Monotherapy Dose Escalation||4||
48535587|NCT02393248|101647175|FG009|STARTED|Part 1: Monotherapy Dose Escalation||3||
48535588|NCT02393248|101647176|FG010|STARTED|Part 1: Monotherapy Dose Escalation||0||
48535589|NCT02393248|101647177|FG011|STARTED|Part 1: Monotherapy Dose Escalation||0||
48535590|NCT02393248|101647178|FG012|STARTED|Part 1: Monotherapy Dose Escalation||0||
48535591|NCT02393248|101647179|FG013|STARTED|Part 1: Monotherapy Dose Escalation||0||
48535592|NCT02393248|101647180|FG014|STARTED|Part 1: Monotherapy Dose Escalation||0||
48535593|NCT02393248|101647181|FG015|STARTED|Part 1: Monotherapy Dose Escalation||0||
48535594|NCT02393248|101647182|FG016|STARTED|Part 1: Monotherapy Dose Escalation||0||
48535595|NCT02393248|101647183|FG017|STARTED|Part 1: Monotherapy Dose Escalation||0||
48535596|NCT02393248|101647184|FG018|STARTED|Part 1: Monotherapy Dose Escalation||0||
48535597|NCT02393248|101647185|FG019|STARTED|Part 1: Monotherapy Dose Escalation||0||
48535598|NCT02393248|101647186|FG020|STARTED|Part 1: Monotherapy Dose Escalation||0||
48535599|NCT02393248|101647187|FG021|STARTED|Part 1: Monotherapy Dose Escalation||0||
48535600|NCT02393248|101647188|FG022|STARTED|Part 1: Monotherapy Dose Escalation||0||
48535601|NCT02393248|101647189|FG023|STARTED|Part 1: Monotherapy Dose Escalation||0||
48535602|NCT02393248|101647190|FG024|STARTED|Part 1: Monotherapy Dose Escalation||0||
48535603|NCT02393248|101647166|FG000|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535604|NCT02393248|101647167|FG001|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535605|NCT02393248|101647168|FG002|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535606|NCT02393248|101647169|FG003|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535607|NCT02393248|101647170|FG004|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535608|NCT02393248|101647171|FG005|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535609|NCT02393248|101647172|FG006|COMPLETED|Part 1: Monotherapy Dose Escalation||1||
48535610|NCT02393248|101647173|FG007|COMPLETED|Part 1: Monotherapy Dose Escalation||1||
48535611|NCT02393248|101647174|FG008|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535612|NCT02393248|101647175|FG009|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535613|NCT02393248|101647176|FG010|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535614|NCT02393248|101647177|FG011|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535615|NCT02393248|101647178|FG012|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535616|NCT02393248|101647179|FG013|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48234886|NCT01794689|100897612|FG000|STARTED|Intervention 2 (2 Nights)||20||
48234887|NCT01794689|100897613|FG001|STARTED|Intervention 2 (2 Nights)||27||
48535617|NCT02393248|101647180|FG014|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535618|NCT02393248|101647181|FG015|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535619|NCT02393248|101647182|FG016|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535620|NCT02393248|101647183|FG017|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535621|NCT02393248|101647184|FG018|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535622|NCT02393248|101647185|FG019|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535623|NCT02393248|101647186|FG020|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535624|NCT02393248|101647187|FG021|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535625|NCT02393248|101647188|FG022|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535626|NCT02393248|101647189|FG023|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535627|NCT02393248|101647190|FG024|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535628|NCT02393248|101647166|FG000|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||3||
48535629|NCT02393248|101647167|FG001|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||4||
48535630|NCT02393248|101647168|FG002|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||3||
48535631|NCT02393248|101647169|FG003|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||6||
48535632|NCT02393248|101647170|FG004|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||6||
48535633|NCT02393248|101647171|FG005|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||9||
48535634|NCT02393248|101647172|FG006|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||9||
48535635|NCT02393248|101647173|FG007|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||8||
48234888|NCT01794689|100897614|FG002|STARTED|Intervention 2 (2 Nights)||21||
48535636|NCT02393248|101647174|FG008|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||4||
48535637|NCT02393248|101647175|FG009|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||3||
48535638|NCT02393248|101647176|FG010|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535639|NCT02393248|101647177|FG011|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535640|NCT02393248|101647178|FG012|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535641|NCT02393248|101647179|FG013|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535642|NCT02393248|101647180|FG014|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535643|NCT02393248|101647181|FG015|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535644|NCT02393248|101647182|FG016|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535645|NCT02393248|101647183|FG017|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535646|NCT02393248|101647184|FG018|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535647|NCT02393248|101647185|FG019|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535648|NCT02393248|101647186|FG020|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535649|NCT02393248|101647187|FG021|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535650|NCT02393248|101647188|FG022|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535651|NCT02393248|101647189|FG023|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535652|NCT02393248|101647190|FG024|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||0||
48535653|NCT02393248|101647166|FG000|STARTED|Part 2: Monotherapy Dose Expansion||0||
48535654|NCT02393248|101647167|FG001|STARTED|Part 2: Monotherapy Dose Expansion||0||
48535655|NCT02393248|101647168|FG002|STARTED|Part 2: Monotherapy Dose Expansion||0||
48535656|NCT02393248|101647169|FG003|STARTED|Part 2: Monotherapy Dose Expansion||0||
48535657|NCT02393248|101647170|FG004|STARTED|Part 2: Monotherapy Dose Expansion||0||
48535658|NCT02393248|101647171|FG005|STARTED|Part 2: Monotherapy Dose Expansion||0||
48535659|NCT02393248|101647172|FG006|STARTED|Part 2: Monotherapy Dose Expansion||0||
48535660|NCT02393248|101647173|FG007|STARTED|Part 2: Monotherapy Dose Expansion||0||
48535661|NCT02393248|101647174|FG008|STARTED|Part 2: Monotherapy Dose Expansion||0||
48535662|NCT02393248|101647175|FG009|STARTED|Part 2: Monotherapy Dose Expansion||0||
48535663|NCT02393248|101647176|FG010|STARTED|Part 2: Monotherapy Dose Expansion||4||
48535664|NCT02393248|101647177|FG011|STARTED|Part 2: Monotherapy Dose Expansion||44||
48535665|NCT02393248|101647178|FG012|STARTED|Part 2: Monotherapy Dose Expansion||5||
48535666|NCT02393248|101647179|FG013|STARTED|Part 2: Monotherapy Dose Expansion||20||
48535667|NCT02393248|101647180|FG014|STARTED|Part 2: Monotherapy Dose Expansion||6||
48535668|NCT02393248|101647181|FG015|STARTED|Part 2: Monotherapy Dose Expansion||0||
48535669|NCT02393248|101647182|FG016|STARTED|Part 2: Monotherapy Dose Expansion||0||
48535670|NCT02393248|101647183|FG017|STARTED|Part 2: Monotherapy Dose Expansion||0||
48535671|NCT02393248|101647184|FG018|STARTED|Part 2: Monotherapy Dose Expansion||0||
48535672|NCT02393248|101647185|FG019|STARTED|Part 2: Monotherapy Dose Expansion||0||
48535673|NCT02393248|101647186|FG020|STARTED|Part 2: Monotherapy Dose Expansion||0||
48535674|NCT02393248|101647187|FG021|STARTED|Part 2: Monotherapy Dose Expansion||0||
48535675|NCT02393248|101647188|FG022|STARTED|Part 2: Monotherapy Dose Expansion||0||
48535676|NCT02393248|101647189|FG023|STARTED|Part 2: Monotherapy Dose Expansion||0||
48535677|NCT02393248|101647190|FG024|STARTED|Part 2: Monotherapy Dose Expansion||0||
48234889|NCT01794689|100897615|FG003|STARTED|Intervention 2 (2 Nights)||18||
48234890|NCT01794689|100897612|FG000|COMPLETED|Intervention 2 (2 Nights)||20||
48234891|NCT01794689|100897613|FG001|COMPLETED|Intervention 2 (2 Nights)||27||
48234892|NCT01794689|100897614|FG002|COMPLETED|Intervention 2 (2 Nights)||21||
48234893|NCT01794689|100897615|FG003|COMPLETED|Intervention 2 (2 Nights)||18||
48234894|NCT01794689|100897612|FG000|NOT COMPLETED|Intervention 2 (2 Nights)||0||
48234895|NCT01794689|100897613|FG001|NOT COMPLETED|Intervention 2 (2 Nights)||0||
48535678|NCT02393248|101647166|FG000|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535679|NCT02393248|101647167|FG001|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535680|NCT02393248|101647168|FG002|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535681|NCT02393248|101647169|FG003|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535682|NCT02393248|101647170|FG004|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535683|NCT02393248|101647171|FG005|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535684|NCT02393248|101647172|FG006|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535685|NCT02393248|101647173|FG007|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48234896|NCT01794689|100897614|FG002|NOT COMPLETED|Intervention 2 (2 Nights)||0||
48234897|NCT01794689|100897615|FG003|NOT COMPLETED|Intervention 2 (2 Nights)||0||
48535686|NCT02393248|101647174|FG008|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535687|NCT02393248|101647175|FG009|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535688|NCT02393248|101647176|FG010|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535689|NCT02393248|101647177|FG011|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535690|NCT02393248|101647178|FG012|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535691|NCT02393248|101647179|FG013|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535692|NCT02393248|101647180|FG014|COMPLETED|Part 2: Monotherapy Dose Expansion||1||
48234898|NCT01009645|100897616|FG000|STARTED|Overall Study||31||
48234899|NCT01009645|100897617|FG001|STARTED|Overall Study||31||
48234900|NCT01009645|100897618|FG002|STARTED|Overall Study||32||
48234901|NCT01009645|100897619|FG003|STARTED|Overall Study||31||
48234902|NCT01009645|100897616|FG000|COMPLETED|Overall Study||29||
48535693|NCT02393248|101647181|FG015|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535694|NCT02393248|101647182|FG016|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535695|NCT02393248|101647183|FG017|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535696|NCT02393248|101647184|FG018|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535697|NCT02393248|101647185|FG019|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535698|NCT02393248|101647186|FG020|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535699|NCT02393248|101647187|FG021|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535700|NCT02393248|101647188|FG022|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535701|NCT02393248|101647189|FG023|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535702|NCT02393248|101647190|FG024|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535703|NCT02393248|101647166|FG000|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535704|NCT02393248|101647167|FG001|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535705|NCT02393248|101647168|FG002|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535706|NCT02393248|101647169|FG003|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535707|NCT02393248|101647170|FG004|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535708|NCT02393248|101647171|FG005|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535709|NCT02393248|101647172|FG006|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535710|NCT02393248|101647173|FG007|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535711|NCT02393248|101647174|FG008|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535712|NCT02393248|101647175|FG009|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535713|NCT02393248|101647176|FG010|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||4||
48535714|NCT02393248|101647177|FG011|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||44||
48535715|NCT02393248|101647178|FG012|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||5||
48535716|NCT02393248|101647179|FG013|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||20||
48535717|NCT02393248|101647180|FG014|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||5||
48234903|NCT01009645|100897617|FG001|COMPLETED|Overall Study||23||
48234904|NCT01009645|100897618|FG002|COMPLETED|Overall Study||28||
48234905|NCT01009645|100897619|FG003|COMPLETED|Overall Study||26||
48234906|NCT01009645|100897616|FG000|NOT COMPLETED|Overall Study||2||
48234907|NCT01009645|100897617|FG001|NOT COMPLETED|Overall Study||8||
48234908|NCT01009645|100897618|FG002|NOT COMPLETED|Overall Study||4||
48234909|NCT01009645|100897619|FG003|NOT COMPLETED|Overall Study||5||
48234910|NCT01218048|100897620|FG000|STARTED|Overall Study||40||
48234911|NCT01218048|100897620|FG000|COMPLETED|Overall Study||40||
48535718|NCT02393248|101647181|FG015|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535719|NCT02393248|101647182|FG016|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535720|NCT02393248|101647183|FG017|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535721|NCT02393248|101647184|FG018|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535722|NCT02393248|101647185|FG019|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535723|NCT02393248|101647186|FG020|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48234912|NCT01218048|100897620|FG000|NOT COMPLETED|Overall Study||0||
48234913|NCT01441596|100897621|FG000|STARTED|Overall Study||40||
48234914|NCT01441596|100897622|FG001|STARTED|Overall Study||38||
48234915|NCT01441596|100897623|FG002|STARTED|Overall Study||43||
48234916|NCT01441596|100897621|FG000|COMPLETED|Overall Study||36||
48234917|NCT01441596|100897622|FG001|COMPLETED|Overall Study||35||
48535724|NCT02393248|101647187|FG021|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48234918|NCT01441596|100897623|FG002|COMPLETED|Overall Study||39||
48234919|NCT01441596|100897621|FG000|NOT COMPLETED|Overall Study||4||
48234920|NCT01441596|100897622|FG001|NOT COMPLETED|Overall Study||3||
48234921|NCT01441596|100897623|FG002|NOT COMPLETED|Overall Study||4||
48234922|NCT01365546|100897624|FG000|STARTED|Overall Study||41||
48234923|NCT01365546|100897624|FG000|COMPLETED|Overall Study||30||
48234924|NCT01365546|100897624|FG000|NOT COMPLETED|Overall Study||11||
48234925|NCT02133131|100897625|FG000|STARTED|Overall Study||31||
48234926|NCT02133131|100897626|FG001|STARTED|Overall Study||30||
48234927|NCT02133131|100897627|FG002|STARTED|Overall Study||20||
48535725|NCT02393248|101647188|FG022|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535726|NCT02393248|101647189|FG023|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535727|NCT02393248|101647190|FG024|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
48535728|NCT02393248|101647166|FG000|STARTED|Part 3: Combination Therapy||0||
48535729|NCT02393248|101647167|FG001|STARTED|Part 3: Combination Therapy||0||
48535730|NCT02393248|101647168|FG002|STARTED|Part 3: Combination Therapy||0||
48234928|NCT02133131|100897628|FG003|STARTED|Overall Study||21||
48234929|NCT02133131|100897629|FG004|STARTED|Overall Study||15||
48234930|NCT02133131|100897630|FG005|STARTED|Overall Study||14||
48234931|NCT02133131|100897631|FG006|STARTED|Overall Study||12||
48234932|NCT02133131|100897625|FG000|COMPLETED|Overall Study||26||
48234933|NCT02133131|100897626|FG001|COMPLETED|Overall Study||25||
48234934|NCT02133131|100897627|FG002|COMPLETED|Overall Study||19||
48234935|NCT02133131|100897628|FG003|COMPLETED|Overall Study||15||
48234936|NCT02133131|100897629|FG004|COMPLETED|Overall Study||0||
48535731|NCT02393248|101647169|FG003|STARTED|Part 3: Combination Therapy||0||
48535732|NCT02393248|101647170|FG004|STARTED|Part 3: Combination Therapy||0||
48535733|NCT02393248|101647171|FG005|STARTED|Part 3: Combination Therapy||0||
48535734|NCT02393248|101647172|FG006|STARTED|Part 3: Combination Therapy||0||
48535735|NCT02393248|101647173|FG007|STARTED|Part 3: Combination Therapy||0||
48535736|NCT02393248|101647174|FG008|STARTED|Part 3: Combination Therapy||0||
48535737|NCT02393248|101647175|FG009|STARTED|Part 3: Combination Therapy||0||
48535738|NCT02393248|101647176|FG010|STARTED|Part 3: Combination Therapy||0||
48535739|NCT02393248|101647177|FG011|STARTED|Part 3: Combination Therapy||0||
48535740|NCT02393248|101647178|FG012|STARTED|Part 3: Combination Therapy||0||
48535741|NCT02393248|101647179|FG013|STARTED|Part 3: Combination Therapy||0||
48535742|NCT02393248|101647180|FG014|STARTED|Part 3: Combination Therapy||0||
48535743|NCT02393248|101647181|FG015|STARTED|Part 3: Combination Therapy||1||
48535744|NCT02393248|101647182|FG016|STARTED|Part 3: Combination Therapy||7||
48535745|NCT02393248|101647183|FG017|STARTED|Part 3: Combination Therapy||6||
48535746|NCT02393248|101647184|FG018|STARTED|Part 3: Combination Therapy||7||
48535747|NCT02393248|101647185|FG019|STARTED|Part 3: Combination Therapy||3||
48535748|NCT02393248|101647186|FG020|STARTED|Part 3: Combination Therapy||14||
48535749|NCT02393248|101647187|FG021|STARTED|Part 3: Combination Therapy||9||
48535750|NCT02393248|101647188|FG022|STARTED|Part 3: Combination Therapy||7||
48535751|NCT02393248|101647189|FG023|STARTED|Part 3: Combination Therapy||9||
48535752|NCT02393248|101647190|FG024|STARTED|Part 3: Combination Therapy||2||
48535753|NCT02393248|101647166|FG000|COMPLETED|Part 3: Combination Therapy||0||
48535754|NCT02393248|101647167|FG001|COMPLETED|Part 3: Combination Therapy||0||
48535755|NCT02393248|101647168|FG002|COMPLETED|Part 3: Combination Therapy||0||
48535756|NCT02393248|101647169|FG003|COMPLETED|Part 3: Combination Therapy||0||
48234937|NCT02133131|100897630|FG005|COMPLETED|Overall Study||0||
48234938|NCT02133131|100897631|FG006|COMPLETED|Overall Study||0||
48234939|NCT02133131|100897625|FG000|NOT COMPLETED|Overall Study||5||
48234940|NCT02133131|100897626|FG001|NOT COMPLETED|Overall Study||5||
48234941|NCT02133131|100897627|FG002|NOT COMPLETED|Overall Study||1||
48234942|NCT02133131|100897628|FG003|NOT COMPLETED|Overall Study||6||
48234943|NCT02133131|100897629|FG004|NOT COMPLETED|Overall Study||15||
48234944|NCT02133131|100897630|FG005|NOT COMPLETED|Overall Study||14||
48234945|NCT02133131|100897631|FG006|NOT COMPLETED|Overall Study||12||
48234946|NCT00390806|100897632|FG000|STARTED|Overall Study||236||
48234947|NCT00390806|100897633|FG001|STARTED|Overall Study||236||
48234948|NCT00390806|100897632|FG000|Ongoing|Overall Study||4||
48234949|NCT00390806|100897633|FG001|Ongoing|Overall Study||2||
48234950|NCT00390806|100897632|FG000|COMPLETED|Overall Study||206||
48535757|NCT02393248|101647170|FG004|COMPLETED|Part 3: Combination Therapy||0||
48535758|NCT02393248|101647171|FG005|COMPLETED|Part 3: Combination Therapy||0||
48535759|NCT02393248|101647172|FG006|COMPLETED|Part 3: Combination Therapy||0||
48535760|NCT02393248|101647173|FG007|COMPLETED|Part 3: Combination Therapy||0||
48535761|NCT02393248|101647174|FG008|COMPLETED|Part 3: Combination Therapy||0||
48535762|NCT02393248|101647175|FG009|COMPLETED|Part 3: Combination Therapy||0||
48535763|NCT02393248|101647176|FG010|COMPLETED|Part 3: Combination Therapy||0||
48535764|NCT02393248|101647177|FG011|COMPLETED|Part 3: Combination Therapy||0||
48535765|NCT02393248|101647178|FG012|COMPLETED|Part 3: Combination Therapy||0||
48535766|NCT02393248|101647179|FG013|COMPLETED|Part 3: Combination Therapy||0||
48535767|NCT02393248|101647180|FG014|COMPLETED|Part 3: Combination Therapy||0||
48535768|NCT02393248|101647181|FG015|COMPLETED|Part 3: Combination Therapy||0||
48535769|NCT02393248|101647182|FG016|COMPLETED|Part 3: Combination Therapy||0||
48535770|NCT02393248|101647183|FG017|COMPLETED|Part 3: Combination Therapy||0||
48234951|NCT00390806|100897633|FG001|COMPLETED|Overall Study||204||
48234952|NCT00390806|100897632|FG000|NOT COMPLETED|Overall Study||30||
48234953|NCT00390806|100897633|FG001|NOT COMPLETED|Overall Study||32||
48234954|NCT00529529|100897634|FG000|STARTED|Overall Study||268||
48234955|NCT00529529|100897635|FG001|STARTED|Overall Study||268||
48234956|NCT00529529|100897636|FG002|STARTED|Overall Study||269||
48234957|NCT00529529|100897634|FG000|COMPLETED|Overall Study||225||
48234958|NCT00529529|100897635|FG001|COMPLETED|Overall Study||225||
48535771|NCT02393248|101647184|FG018|COMPLETED|Part 3: Combination Therapy||0||
48535772|NCT02393248|101647185|FG019|COMPLETED|Part 3: Combination Therapy||0||
48535773|NCT02393248|101647186|FG020|COMPLETED|Part 3: Combination Therapy||0||
48535774|NCT02393248|101647187|FG021|COMPLETED|Part 3: Combination Therapy||0||
48535775|NCT02393248|101647188|FG022|COMPLETED|Part 3: Combination Therapy||0||
48535776|NCT02393248|101647189|FG023|COMPLETED|Part 3: Combination Therapy||1||
48535777|NCT02393248|101647190|FG024|COMPLETED|Part 3: Combination Therapy||1||
48535778|NCT02393248|101647166|FG000|NOT COMPLETED|Part 3: Combination Therapy||0||
48535779|NCT02393248|101647167|FG001|NOT COMPLETED|Part 3: Combination Therapy||0||
48535780|NCT02393248|101647168|FG002|NOT COMPLETED|Part 3: Combination Therapy||0||
48535781|NCT02393248|101647169|FG003|NOT COMPLETED|Part 3: Combination Therapy||0||
48535782|NCT02393248|101647170|FG004|NOT COMPLETED|Part 3: Combination Therapy||0||
48535783|NCT02393248|101647171|FG005|NOT COMPLETED|Part 3: Combination Therapy||0||
48535784|NCT02393248|101647172|FG006|NOT COMPLETED|Part 3: Combination Therapy||0||
48592660|NCT01877382|101783162|FG012|NOT COMPLETED|Dose Escalation||20||
48234959|NCT00529529|100897636|FG002|COMPLETED|Overall Study||238||
48234960|NCT00529529|100897634|FG000|NOT COMPLETED|Overall Study||43||
48234961|NCT00529529|100897635|FG001|NOT COMPLETED|Overall Study||43||
48234962|NCT00529529|100897636|FG002|NOT COMPLETED|Overall Study||31||
48234963|NCT00508183|100897637|FG000|STARTED|Overall Study||48||
48234964|NCT00508183|100897638|FG001|STARTED|Overall Study||42||
48234965|NCT00508183|100897637|FG000|COMPLETED|Overall Study||39||
48535785|NCT02393248|101647173|FG007|NOT COMPLETED|Part 3: Combination Therapy||0||
48535786|NCT02393248|101647174|FG008|NOT COMPLETED|Part 3: Combination Therapy||0||
48535787|NCT02393248|101647175|FG009|NOT COMPLETED|Part 3: Combination Therapy||0||
48535788|NCT02393248|101647176|FG010|NOT COMPLETED|Part 3: Combination Therapy||0||
48535789|NCT02393248|101647177|FG011|NOT COMPLETED|Part 3: Combination Therapy||0||
48535790|NCT02393248|101647178|FG012|NOT COMPLETED|Part 3: Combination Therapy||0||
48535791|NCT02393248|101647179|FG013|NOT COMPLETED|Part 3: Combination Therapy||0||
48535792|NCT02393248|101647180|FG014|NOT COMPLETED|Part 3: Combination Therapy||0||
48234966|NCT00508183|100897638|FG001|COMPLETED|Overall Study||34||
48234967|NCT00508183|100897637|FG000|NOT COMPLETED|Overall Study||9||
48234968|NCT00508183|100897638|FG001|NOT COMPLETED|Overall Study||8||
48234969|NCT02542202|100897639|FG000|STARTED|Overall Study||15||
48234970|NCT02542202|100897639|FG000|COMPLETED|Overall Study||15||
48234971|NCT02542202|100897639|FG000|NOT COMPLETED|Overall Study||0||
48234972|NCT02151994|100897640|FG000|STARTED|Single Ascending Dose (SAD)||18||
48234973|NCT02151994|100897641|FG001|STARTED|Single Ascending Dose (SAD)||6||
48234974|NCT02151994|100897642|FG002|STARTED|Single Ascending Dose (SAD)||6||
48234975|NCT02151994|100897643|FG003|STARTED|Single Ascending Dose (SAD)||6||
48234976|NCT02151994|100897644|FG004|STARTED|Single Ascending Dose (SAD)||6||
48234977|NCT02151994|100897645|FG005|STARTED|Single Ascending Dose (SAD)||6||
48234978|NCT02151994|100897646|FG006|STARTED|Single Ascending Dose (SAD)||6||
48234979|NCT02151994|100897647|FG007|STARTED|Single Ascending Dose (SAD)||6||
48234980|NCT02151994|100897648|FG008|STARTED|Single Ascending Dose (SAD)||0||
48234981|NCT02151994|100897649|FG009|STARTED|Single Ascending Dose (SAD)||6||
48234982|NCT02151994|100897650|FG010|STARTED|Single Ascending Dose (SAD)||6||
48234983|NCT02151994|100897651|FG011|STARTED|Single Ascending Dose (SAD)||0||
48234984|NCT02151994|100897652|FG012|STARTED|Single Ascending Dose (SAD)||0||
48234985|NCT02151994|100897640|FG000|COMPLETED|Single Ascending Dose (SAD)||18||
48234986|NCT02151994|100897641|FG001|COMPLETED|Single Ascending Dose (SAD)||6||
48234987|NCT02151994|100897642|FG002|COMPLETED|Single Ascending Dose (SAD)||6||
48234988|NCT02151994|100897643|FG003|COMPLETED|Single Ascending Dose (SAD)||6||
48234989|NCT02151994|100897644|FG004|COMPLETED|Single Ascending Dose (SAD)||6||
48234990|NCT02151994|100897645|FG005|COMPLETED|Single Ascending Dose (SAD)||6||
48234991|NCT02151994|100897646|FG006|COMPLETED|Single Ascending Dose (SAD)||6||
48234992|NCT02151994|100897647|FG007|COMPLETED|Single Ascending Dose (SAD)||6||
48234993|NCT02151994|100897648|FG008|COMPLETED|Single Ascending Dose (SAD)||0||
48234994|NCT02151994|100897649|FG009|COMPLETED|Single Ascending Dose (SAD)||6||
48234995|NCT02151994|100897650|FG010|COMPLETED|Single Ascending Dose (SAD)||6||
48234996|NCT02151994|100897651|FG011|COMPLETED|Single Ascending Dose (SAD)||0||
48234997|NCT02151994|100897652|FG012|COMPLETED|Single Ascending Dose (SAD)||0||
48234998|NCT02151994|100897640|FG000|NOT COMPLETED|Single Ascending Dose (SAD)||0||
48234999|NCT02151994|100897641|FG001|NOT COMPLETED|Single Ascending Dose (SAD)||0||
48235000|NCT02151994|100897642|FG002|NOT COMPLETED|Single Ascending Dose (SAD)||0||
48235001|NCT02151994|100897643|FG003|NOT COMPLETED|Single Ascending Dose (SAD)||0||
48235002|NCT02151994|100897644|FG004|NOT COMPLETED|Single Ascending Dose (SAD)||0||
48235003|NCT02151994|100897645|FG005|NOT COMPLETED|Single Ascending Dose (SAD)||0||
48235004|NCT02151994|100897646|FG006|NOT COMPLETED|Single Ascending Dose (SAD)||0||
48235005|NCT02151994|100897647|FG007|NOT COMPLETED|Single Ascending Dose (SAD)||0||
48235006|NCT02151994|100897648|FG008|NOT COMPLETED|Single Ascending Dose (SAD)||0||
48235007|NCT02151994|100897649|FG009|NOT COMPLETED|Single Ascending Dose (SAD)||0||
48235008|NCT02151994|100897650|FG010|NOT COMPLETED|Single Ascending Dose (SAD)||0||
48235009|NCT02151994|100897651|FG011|NOT COMPLETED|Single Ascending Dose (SAD)||0||
48235010|NCT02151994|100897652|FG012|NOT COMPLETED|Single Ascending Dose (SAD)||0||
48235011|NCT02151994|100897640|FG000|STARTED|Multiple Ascending Dose (MAD)||10||
48235012|NCT02151994|100897641|FG001|STARTED|Multiple Ascending Dose (MAD)||0||
48235013|NCT02151994|100897642|FG002|STARTED|Multiple Ascending Dose (MAD)||0||
48235014|NCT02151994|100897643|FG003|STARTED|Multiple Ascending Dose (MAD)||6||
48235015|NCT02151994|100897644|FG004|STARTED|Multiple Ascending Dose (MAD)||6||
48235016|NCT02151994|100897645|FG005|STARTED|Multiple Ascending Dose (MAD)||6||
48535793|NCT02393248|101647181|FG015|NOT COMPLETED|Part 3: Combination Therapy||1||
48535794|NCT02393248|101647182|FG016|NOT COMPLETED|Part 3: Combination Therapy||7||
48235017|NCT02151994|100897646|FG006|STARTED|Multiple Ascending Dose (MAD)||6||
48235018|NCT02151994|100897647|FG007|STARTED|Multiple Ascending Dose (MAD)||0||
48235019|NCT02151994|100897648|FG008|STARTED|Multiple Ascending Dose (MAD)||6||
48235020|NCT02151994|100897649|FG009|STARTED|Multiple Ascending Dose (MAD)||0||
48235021|NCT02151994|100897650|FG010|STARTED|Multiple Ascending Dose (MAD)||0||
48235022|NCT02151994|100897651|FG011|STARTED|Multiple Ascending Dose (MAD)||0||
48235023|NCT02151994|100897652|FG012|STARTED|Multiple Ascending Dose (MAD)||0||
48235024|NCT02151994|100897640|FG000|COMPLETED|Multiple Ascending Dose (MAD)||10||
48535795|NCT02393248|101647183|FG017|NOT COMPLETED|Part 3: Combination Therapy||6||
48535796|NCT02393248|101647184|FG018|NOT COMPLETED|Part 3: Combination Therapy||7||
48535797|NCT02393248|101647185|FG019|NOT COMPLETED|Part 3: Combination Therapy||3||
48535798|NCT02393248|101647186|FG020|NOT COMPLETED|Part 3: Combination Therapy||14||
48535799|NCT02393248|101647187|FG021|NOT COMPLETED|Part 3: Combination Therapy||9||
48535800|NCT02393248|101647188|FG022|NOT COMPLETED|Part 3: Combination Therapy||7||
48535801|NCT02393248|101647189|FG023|NOT COMPLETED|Part 3: Combination Therapy||8||
48535802|NCT02393248|101647190|FG024|NOT COMPLETED|Part 3: Combination Therapy||1||
48535803|NCT02087995|101647191|FG000|STARTED|Overall Study||51||
48535804|NCT02087995|101647191|FG000|COMPLETED|Overall Study||51||
48535805|NCT02087995|101647191|FG000|NOT COMPLETED|Overall Study||0||
48535806|NCT01081834|101647192|FG000|STARTED|Core Period: Baseline to Week 26||192||
48535807|NCT01081834|101647193|FG001|STARTED|Core Period: Baseline to Week 26||195||
48535808|NCT01081834|101647194|FG002|STARTED|Core Period: Baseline to Week 26||197||
48535809|NCT01081834|101647195|FG003|STARTED|Core Period: Baseline to Week 26||47||
48535810|NCT01081834|101647196|FG004|STARTED|Core Period: Baseline to Week 26||44||
48535811|NCT01081834|101647192|FG000|COMPLETED|Core Period: Baseline to Week 26||160||
48535812|NCT01081834|101647193|FG001|COMPLETED|Core Period: Baseline to Week 26||172||
48535813|NCT01081834|101647194|FG002|COMPLETED|Core Period: Baseline to Week 26||175||
48535814|NCT01081834|101647195|FG003|COMPLETED|Core Period: Baseline to Week 26||40||
48535815|NCT01081834|101647196|FG004|COMPLETED|Core Period: Baseline to Week 26||40||
48535816|NCT01081834|101647192|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||32||
48535817|NCT01081834|101647193|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||23||
48535818|NCT01081834|101647194|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||22||
48535819|NCT01081834|101647195|FG003|NOT COMPLETED|Core Period: Baseline to Week 26||7||
48535820|NCT01081834|101647196|FG004|NOT COMPLETED|Core Period: Baseline to Week 26||4||
48535821|NCT01081834|101647192|FG000|STARTED|Extension Period: Week 26 to Week 52||155||
48535822|NCT01081834|101647193|FG001|STARTED|Extension Period: Week 26 to Week 52||170||
48535823|NCT01081834|101647194|FG002|STARTED|Extension Period: Week 26 to Week 52||170||
48235025|NCT02151994|100897641|FG001|COMPLETED|Multiple Ascending Dose (MAD)||0||
48235026|NCT02151994|100897642|FG002|COMPLETED|Multiple Ascending Dose (MAD)||0||
48235027|NCT02151994|100897643|FG003|COMPLETED|Multiple Ascending Dose (MAD)||6||
48235028|NCT02151994|100897644|FG004|COMPLETED|Multiple Ascending Dose (MAD)||6||
48535824|NCT01081834|101647195|FG003|STARTED|Extension Period: Week 26 to Week 52||0||
48235029|NCT02151994|100897645|FG005|COMPLETED|Multiple Ascending Dose (MAD)||6||
48235030|NCT02151994|100897646|FG006|COMPLETED|Multiple Ascending Dose (MAD)||6||
48235031|NCT02151994|100897647|FG007|COMPLETED|Multiple Ascending Dose (MAD)||0||
48235032|NCT02151994|100897648|FG008|COMPLETED|Multiple Ascending Dose (MAD)||6||
48235033|NCT02151994|100897649|FG009|COMPLETED|Multiple Ascending Dose (MAD)||0||
48235034|NCT02151994|100897650|FG010|COMPLETED|Multiple Ascending Dose (MAD)||0||
48235035|NCT02151994|100897651|FG011|COMPLETED|Multiple Ascending Dose (MAD)||0||
48235036|NCT02151994|100897652|FG012|COMPLETED|Multiple Ascending Dose (MAD)||0||
48235037|NCT02151994|100897640|FG000|NOT COMPLETED|Multiple Ascending Dose (MAD)||0||
48235038|NCT02151994|100897641|FG001|NOT COMPLETED|Multiple Ascending Dose (MAD)||0||
48235039|NCT02151994|100897642|FG002|NOT COMPLETED|Multiple Ascending Dose (MAD)||0||
48235040|NCT02151994|100897643|FG003|NOT COMPLETED|Multiple Ascending Dose (MAD)||0||
48535825|NCT01081834|101647196|FG004|STARTED|Extension Period: Week 26 to Week 52||0||
48535826|NCT01081834|101647192|FG000|COMPLETED|Extension Period: Week 26 to Week 52||135||
48535827|NCT01081834|101647193|FG001|COMPLETED|Extension Period: Week 26 to Week 52||152||
48535828|NCT01081834|101647194|FG002|COMPLETED|Extension Period: Week 26 to Week 52||165||
48535829|NCT01081834|101647195|FG003|COMPLETED|Extension Period: Week 26 to Week 52||0||
48535830|NCT01081834|101647196|FG004|COMPLETED|Extension Period: Week 26 to Week 52||0||
48535831|NCT01081834|101647192|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||20||
48235041|NCT02151994|100897644|FG004|NOT COMPLETED|Multiple Ascending Dose (MAD)||0||
48235042|NCT02151994|100897645|FG005|NOT COMPLETED|Multiple Ascending Dose (MAD)||0||
48235043|NCT02151994|100897646|FG006|NOT COMPLETED|Multiple Ascending Dose (MAD)||0||
48235044|NCT02151994|100897647|FG007|NOT COMPLETED|Multiple Ascending Dose (MAD)||0||
48235045|NCT02151994|100897648|FG008|NOT COMPLETED|Multiple Ascending Dose (MAD)||0||
48235046|NCT02151994|100897649|FG009|NOT COMPLETED|Multiple Ascending Dose (MAD)||0||
48235047|NCT02151994|100897650|FG010|NOT COMPLETED|Multiple Ascending Dose (MAD)||0||
48235048|NCT02151994|100897651|FG011|NOT COMPLETED|Multiple Ascending Dose (MAD)||0||
48235049|NCT02151994|100897652|FG012|NOT COMPLETED|Multiple Ascending Dose (MAD)||0||
48535832|NCT01081834|101647193|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||18||
48535833|NCT01081834|101647194|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||5||
48535834|NCT01081834|101647195|FG003|NOT COMPLETED|Extension Period: Week 26 to Week 52||0||
48535835|NCT01081834|101647196|FG004|NOT COMPLETED|Extension Period: Week 26 to Week 52||0||
48535836|NCT04597632|101647197|FG000|STARTED|Overall Study||248||
48535837|NCT04597632|101647197|FG000|COMPLETED|Overall Study||231||
48535838|NCT04597632|101647197|FG000|NOT COMPLETED|Overall Study||17||
48535839|NCT01212588|101647198|FG000|STARTED|Overall Study||10||
48535840|NCT01212588|101647199|FG001|STARTED|Overall Study||12||
48535841|NCT01212588|101647198|FG000|COMPLETED|Overall Study||9||
48535842|NCT01212588|101647199|FG001|COMPLETED|Overall Study||10||
48235050|NCT02151994|100897640|FG000|STARTED|Food Effect (FE): Fasted||0||
48235051|NCT02151994|100897641|FG001|STARTED|Food Effect (FE): Fasted||0||
48235052|NCT02151994|100897642|FG002|STARTED|Food Effect (FE): Fasted||0||
48535843|NCT01212588|101647198|FG000|NOT COMPLETED|Overall Study||1||
48535844|NCT01212588|101647199|FG001|NOT COMPLETED|Overall Study||2||
48235053|NCT02151994|100897643|FG003|STARTED|Food Effect (FE): Fasted||0||
48235054|NCT02151994|100897644|FG004|STARTED|Food Effect (FE): Fasted||0||
48535845|NCT03055650|101647200|FG000|STARTED|Overall Study||30||
48235055|NCT02151994|100897645|FG005|STARTED|Food Effect (FE): Fasted||0||
48235056|NCT02151994|100897646|FG006|STARTED|Food Effect (FE): Fasted||0||
48235057|NCT02151994|100897647|FG007|STARTED|Food Effect (FE): Fasted||0||
48235058|NCT02151994|100897648|FG008|STARTED|Food Effect (FE): Fasted||0||
48235059|NCT02151994|100897649|FG009|STARTED|Food Effect (FE): Fasted||0||
48235060|NCT02151994|100897650|FG010|STARTED|Food Effect (FE): Fasted||0||
48235061|NCT02151994|100897651|FG011|STARTED|Food Effect (FE): Fasted||12||
48235062|NCT02151994|100897652|FG012|STARTED|Food Effect (FE): Fasted||0||
48235063|NCT02151994|100897640|FG000|COMPLETED|Food Effect (FE): Fasted||0||
48235064|NCT02151994|100897641|FG001|COMPLETED|Food Effect (FE): Fasted||0||
48235065|NCT02151994|100897642|FG002|COMPLETED|Food Effect (FE): Fasted||0||
48235066|NCT02151994|100897643|FG003|COMPLETED|Food Effect (FE): Fasted||0||
48235067|NCT02151994|100897644|FG004|COMPLETED|Food Effect (FE): Fasted||0||
48235068|NCT02151994|100897645|FG005|COMPLETED|Food Effect (FE): Fasted||0||
48235069|NCT02151994|100897646|FG006|COMPLETED|Food Effect (FE): Fasted||0||
48235070|NCT02151994|100897647|FG007|COMPLETED|Food Effect (FE): Fasted||0||
48235071|NCT02151994|100897648|FG008|COMPLETED|Food Effect (FE): Fasted||0||
48235072|NCT02151994|100897649|FG009|COMPLETED|Food Effect (FE): Fasted||0||
48235073|NCT02151994|100897650|FG010|COMPLETED|Food Effect (FE): Fasted||0||
48235074|NCT02151994|100897651|FG011|COMPLETED|Food Effect (FE): Fasted||12||
48235075|NCT02151994|100897652|FG012|COMPLETED|Food Effect (FE): Fasted||0||
48235076|NCT02151994|100897640|FG000|NOT COMPLETED|Food Effect (FE): Fasted||0||
48235077|NCT02151994|100897641|FG001|NOT COMPLETED|Food Effect (FE): Fasted||0||
48235078|NCT02151994|100897642|FG002|NOT COMPLETED|Food Effect (FE): Fasted||0||
48235079|NCT02151994|100897643|FG003|NOT COMPLETED|Food Effect (FE): Fasted||0||
48235080|NCT02151994|100897644|FG004|NOT COMPLETED|Food Effect (FE): Fasted||0||
48235081|NCT02151994|100897645|FG005|NOT COMPLETED|Food Effect (FE): Fasted||0||
48235082|NCT02151994|100897646|FG006|NOT COMPLETED|Food Effect (FE): Fasted||0||
48235083|NCT02151994|100897647|FG007|NOT COMPLETED|Food Effect (FE): Fasted||0||
48235084|NCT02151994|100897648|FG008|NOT COMPLETED|Food Effect (FE): Fasted||0||
48235085|NCT02151994|100897649|FG009|NOT COMPLETED|Food Effect (FE): Fasted||0||
48235086|NCT02151994|100897650|FG010|NOT COMPLETED|Food Effect (FE): Fasted||0||
48235087|NCT02151994|100897651|FG011|NOT COMPLETED|Food Effect (FE): Fasted||0||
48235088|NCT02151994|100897652|FG012|NOT COMPLETED|Food Effect (FE): Fasted||0||
48235089|NCT02151994|100897640|FG000|STARTED|Food Effect (FE): Fed||0||
48235090|NCT02151994|100897641|FG001|STARTED|Food Effect (FE): Fed||0||
48235091|NCT02151994|100897642|FG002|STARTED|Food Effect (FE): Fed||0||
48235092|NCT02151994|100897643|FG003|STARTED|Food Effect (FE): Fed||0||
48235093|NCT02151994|100897644|FG004|STARTED|Food Effect (FE): Fed||0||
48235094|NCT02151994|100897645|FG005|STARTED|Food Effect (FE): Fed||0||
48235095|NCT02151994|100897646|FG006|STARTED|Food Effect (FE): Fed||0||
48235096|NCT02151994|100897647|FG007|STARTED|Food Effect (FE): Fed||0||
48235097|NCT02151994|100897648|FG008|STARTED|Food Effect (FE): Fed||0||
48235098|NCT02151994|100897649|FG009|STARTED|Food Effect (FE): Fed||0||
48235099|NCT02151994|100897650|FG010|STARTED|Food Effect (FE): Fed||0||
48235100|NCT02151994|100897651|FG011|STARTED|Food Effect (FE): Fed||0||
48235101|NCT02151994|100897652|FG012|STARTED|Food Effect (FE): Fed||12||
48235102|NCT02151994|100897640|FG000|COMPLETED|Food Effect (FE): Fed||0||
48235103|NCT02151994|100897641|FG001|COMPLETED|Food Effect (FE): Fed||0||
48235104|NCT02151994|100897642|FG002|COMPLETED|Food Effect (FE): Fed||0||
48235105|NCT02151994|100897643|FG003|COMPLETED|Food Effect (FE): Fed||0||
48235106|NCT02151994|100897644|FG004|COMPLETED|Food Effect (FE): Fed||0||
48235107|NCT02151994|100897645|FG005|COMPLETED|Food Effect (FE): Fed||0||
48235108|NCT02151994|100897646|FG006|COMPLETED|Food Effect (FE): Fed||0||
48235109|NCT02151994|100897647|FG007|COMPLETED|Food Effect (FE): Fed||0||
48235110|NCT02151994|100897648|FG008|COMPLETED|Food Effect (FE): Fed||0||
48235111|NCT02151994|100897649|FG009|COMPLETED|Food Effect (FE): Fed||0||
48235112|NCT02151994|100897650|FG010|COMPLETED|Food Effect (FE): Fed||0||
48235113|NCT02151994|100897651|FG011|COMPLETED|Food Effect (FE): Fed||0||
48235114|NCT02151994|100897652|FG012|COMPLETED|Food Effect (FE): Fed||12||
48235115|NCT02151994|100897640|FG000|NOT COMPLETED|Food Effect (FE): Fed||0||
48235116|NCT02151994|100897641|FG001|NOT COMPLETED|Food Effect (FE): Fed||0||
48235117|NCT02151994|100897642|FG002|NOT COMPLETED|Food Effect (FE): Fed||0||
48235118|NCT02151994|100897643|FG003|NOT COMPLETED|Food Effect (FE): Fed||0||
48235119|NCT02151994|100897644|FG004|NOT COMPLETED|Food Effect (FE): Fed||0||
48235120|NCT02151994|100897645|FG005|NOT COMPLETED|Food Effect (FE): Fed||0||
48235121|NCT02151994|100897646|FG006|NOT COMPLETED|Food Effect (FE): Fed||0||
48535846|NCT03055650|101647200|FG000|COMPLETED|Overall Study||30||
48535847|NCT03055650|101647200|FG000|NOT COMPLETED|Overall Study||0||
48535848|NCT03151811|101647201|FG000|STARTED|Overall Study||246||
48535849|NCT03151811|101647202|FG001|STARTED|Overall Study||249||
48535850|NCT03151811|101647201|FG000|COMPLETED|Overall Study||0|Patients were to receive treatment until there was documented disease progression, unacceptable toxicity, or the patient/treating physician determined it was not in the patient's best interest to continue. The study Sponsor terminated the study before all patients reached one of these endpoints. Shown here are the reasons for study treatment discontinuation.|
48592661|NCT01877382|101783163|FG013|NOT COMPLETED|Dose Escalation||3||
48592662|NCT01877382|101783164|FG014|NOT COMPLETED|Dose Escalation||0||
48592663|NCT01877382|101783150|FG000|STARTED|Dose Expansion||0||
48235122|NCT02151994|100897647|FG007|NOT COMPLETED|Food Effect (FE): Fed||0||
48235123|NCT02151994|100897648|FG008|NOT COMPLETED|Food Effect (FE): Fed||0||
48235124|NCT02151994|100897649|FG009|NOT COMPLETED|Food Effect (FE): Fed||0||
48235125|NCT02151994|100897650|FG010|NOT COMPLETED|Food Effect (FE): Fed||0||
48235126|NCT02151994|100897651|FG011|NOT COMPLETED|Food Effect (FE): Fed||0||
48235127|NCT02151994|100897652|FG012|NOT COMPLETED|Food Effect (FE): Fed||0||
48235128|NCT03242863|100897653|FG000|STARTED|Study Week 1||13||
48235129|NCT03242863|100897654|FG001|STARTED|Study Week 1||16||
48235130|NCT03242863|100897655|FG002|STARTED|Study Week 1||4||
48235131|NCT03242863|100897656|FG003|STARTED|Study Week 1||4||
48235132|NCT03242863|100897657|FG004|STARTED|Study Week 1||15||
48235133|NCT03242863|100897658|FG005|STARTED|Study Week 1||5||
48235134|NCT03242863|100897653|FG000|COMPLETED|Study Week 1||13||
48235135|NCT03242863|100897654|FG001|COMPLETED|Study Week 1||15||
48235136|NCT03242863|100897655|FG002|COMPLETED|Study Week 1||4||
48535851|NCT03151811|101647202|FG001|COMPLETED|Overall Study||0|Patients were to receive treatment until there was documented disease progression, unacceptable toxicity, or the patient/treating physician determined it was not in the patient's best interest to continue. The study Sponsor terminated the study before all patients reached one of these endpoints. Shown here are the reasons for study treatment discontinuation.|
48535852|NCT03151811|101647201|FG000|NOT COMPLETED|Overall Study||246||
48535853|NCT03151811|101647202|FG001|NOT COMPLETED|Overall Study||249||
48535854|NCT00554606|101647203|FG000|STARTED|Overall Study||115||
48535855|NCT00554606|101647203|FG000|COMPLETED|Overall Study||30||
48535856|NCT00554606|101647203|FG000|NOT COMPLETED|Overall Study||85||
48235137|NCT03242863|100897656|FG003|COMPLETED|Study Week 1||4||
48235138|NCT03242863|100897657|FG004|COMPLETED|Study Week 1||12||
48235139|NCT03242863|100897658|FG005|COMPLETED|Study Week 1||5||
48235140|NCT03242863|100897653|FG000|NOT COMPLETED|Study Week 1||0||
48235141|NCT03242863|100897654|FG001|NOT COMPLETED|Study Week 1||1||
48235142|NCT03242863|100897655|FG002|NOT COMPLETED|Study Week 1||0||
48235143|NCT03242863|100897656|FG003|NOT COMPLETED|Study Week 1||0||
48235144|NCT03242863|100897657|FG004|NOT COMPLETED|Study Week 1||3||
48235145|NCT03242863|100897658|FG005|NOT COMPLETED|Study Week 1||0||
48235146|NCT03242863|100897653|FG000|STARTED|Study Week 2||13||
48235147|NCT03242863|100897654|FG001|STARTED|Study Week 2||15||
48235148|NCT03242863|100897655|FG002|STARTED|Study Week 2||4||
48235149|NCT03242863|100897656|FG003|STARTED|Study Week 2||4||
48235150|NCT03242863|100897657|FG004|STARTED|Study Week 2||12||
48235151|NCT03242863|100897658|FG005|STARTED|Study Week 2||5||
48235152|NCT03242863|100897653|FG000|COMPLETED|Study Week 2||13||
48235153|NCT03242863|100897654|FG001|COMPLETED|Study Week 2||15||
48235154|NCT03242863|100897655|FG002|COMPLETED|Study Week 2||4||
48235155|NCT03242863|100897656|FG003|COMPLETED|Study Week 2||4||
48235156|NCT03242863|100897657|FG004|COMPLETED|Study Week 2||12||
48235157|NCT03242863|100897658|FG005|COMPLETED|Study Week 2||5||
48235158|NCT03242863|100897653|FG000|NOT COMPLETED|Study Week 2||0||
48235159|NCT03242863|100897654|FG001|NOT COMPLETED|Study Week 2||0||
48235160|NCT03242863|100897655|FG002|NOT COMPLETED|Study Week 2||0||
48235161|NCT03242863|100897656|FG003|NOT COMPLETED|Study Week 2||0||
48235162|NCT03242863|100897657|FG004|NOT COMPLETED|Study Week 2||0||
48235163|NCT03242863|100897658|FG005|NOT COMPLETED|Study Week 2||0||
48235164|NCT03242863|100897653|FG000|STARTED|Study Week 3||13||
48235165|NCT03242863|100897654|FG001|STARTED|Study Week 3||15||
48235166|NCT03242863|100897655|FG002|STARTED|Study Week 3||4||
48235167|NCT03242863|100897656|FG003|STARTED|Study Week 3||4||
48235168|NCT03242863|100897657|FG004|STARTED|Study Week 3||12||
48235169|NCT03242863|100897658|FG005|STARTED|Study Week 3||5||
48235170|NCT03242863|100897653|FG000|COMPLETED|Study Week 3||13||
48235171|NCT03242863|100897654|FG001|COMPLETED|Study Week 3||15||
48235172|NCT03242863|100897655|FG002|COMPLETED|Study Week 3||4||
48235173|NCT03242863|100897656|FG003|COMPLETED|Study Week 3||4||
48235174|NCT03242863|100897657|FG004|COMPLETED|Study Week 3||12||
48235175|NCT03242863|100897658|FG005|COMPLETED|Study Week 3||5||
48235176|NCT03242863|100897653|FG000|NOT COMPLETED|Study Week 3||0||
48235177|NCT03242863|100897654|FG001|NOT COMPLETED|Study Week 3||0||
48235178|NCT03242863|100897655|FG002|NOT COMPLETED|Study Week 3||0||
48535857|NCT00859586|101647204|FG000|STARTED|Overall Study||8||
48535858|NCT00859586|101647204|FG000|COMPLETED|Overall Study||4||
48535859|NCT00859586|101647204|FG000|NOT COMPLETED|Overall Study||4||
48235179|NCT03242863|100897656|FG003|NOT COMPLETED|Study Week 3||0||
48235180|NCT03242863|100897657|FG004|NOT COMPLETED|Study Week 3||0||
48235181|NCT03242863|100897658|FG005|NOT COMPLETED|Study Week 3||0||
48235182|NCT00476957|100897659|FG000|STARTED|Overall Study||4357||
48235183|NCT00476957|100897660|FG001|STARTED|Overall Study||4352||
48235184|NCT00476957|100897659|FG000|COMPLETED|Overall Study||4181||
48235185|NCT00476957|100897660|FG001|COMPLETED|Overall Study||4159||
48235186|NCT00476957|100897659|FG000|NOT COMPLETED|Overall Study||176||
48235187|NCT00476957|100897660|FG001|NOT COMPLETED|Overall Study||193||
48235188|NCT01334606|100897661|FG000|STARTED|Overall Study||21||
48235189|NCT01334606|100897661|FG000|COMPLETED|Overall Study||3||
48235190|NCT01334606|100897661|FG000|NOT COMPLETED|Overall Study||18||
48235191|NCT00257556|100897662|FG000|STARTED|Overall Study||38||
48535860|NCT01868893|101647205|FG000|STARTED|Overall Study||20||
48235192|NCT00257556|100897663|FG001|STARTED|Overall Study||42||
48235193|NCT00257556|100897662|FG000|All Patients Treated Population|Overall Study||37||
48235194|NCT00257556|100897663|FG001|All Patients Treated Population|Overall Study||39||
48235195|NCT00257556|100897662|FG000|COMPLETED|Overall Study||24||
48235196|NCT00257556|100897663|FG001|COMPLETED|Overall Study||32||
48235197|NCT00257556|100897662|FG000|NOT COMPLETED|Overall Study||14||
48235198|NCT00257556|100897663|FG001|NOT COMPLETED|Overall Study||10||
48235199|NCT00413283|100897664|FG000|STARTED|Overall Study||12||
48235200|NCT00413283|100897665|FG001|STARTED|Overall Study||16||
48235201|NCT00413283|100897666|FG002|STARTED|Overall Study||18||
48235202|NCT00413283|100897667|FG003|STARTED|Overall Study||17||
48235203|NCT00413283|100897664|FG000|Received Study Drug|Overall Study||12||
48235204|NCT00413283|100897665|FG001|Received Study Drug|Overall Study||16||
48235205|NCT00413283|100897666|FG002|Received Study Drug|Overall Study||18||
48235206|NCT00413283|100897667|FG003|Received Study Drug|Overall Study||16||
48235207|NCT00413283|100897664|FG000|COMPLETED|Overall Study||11||
48235208|NCT00413283|100897665|FG001|COMPLETED|Overall Study||13||
48235209|NCT00413283|100897666|FG002|COMPLETED|Overall Study||16||
48235210|NCT00413283|100897667|FG003|COMPLETED|Overall Study||13||
48235211|NCT00413283|100897664|FG000|NOT COMPLETED|Overall Study||1||
48235212|NCT00413283|100897665|FG001|NOT COMPLETED|Overall Study||3||
48235213|NCT00413283|100897666|FG002|NOT COMPLETED|Overall Study||2||
48235214|NCT00413283|100897667|FG003|NOT COMPLETED|Overall Study||4||
48235215|NCT01944774|100897668|FG000|STARTED|Overall Study||69||
48235216|NCT01944774|100897669|FG001|STARTED|Overall Study||68||
48235217|NCT01944774|100897670|FG002|STARTED|Overall Study||70||
48235218|NCT01944774|100897668|FG000|Received Treatment|Overall Study||68||
48535861|NCT01868893|101647205|FG000|COMPLETED|Overall Study||0||
48535862|NCT01868893|101647205|FG000|NOT COMPLETED|Overall Study||20||
48535863|NCT00390559|101647206|FG000|STARTED|Overall Study||124||
48535864|NCT00390559|101647206|FG000|Received PlaceboP/Active C|Overall Study||93||
48535865|NCT00390559|101647206|FG000|ActiveP/ActiveC|Overall Study||87||
48535866|NCT00390559|101647206|FG000|PlaceboP/PlaceboC|Overall Study||93||
48535867|NCT00390559|101647206|FG000|ActiveP/PlaceboC|Overall Study||90||
48535868|NCT00390559|101647206|FG000|COMPLETED|Overall Study||80||
48535869|NCT00390559|101647206|FG000|NOT COMPLETED|Overall Study||44||
48535870|NCT04732624|101647207|FG000|STARTED|Overall Study||15||
48535871|NCT04732624|101647208|FG001|STARTED|Overall Study||15||
48535872|NCT04732624|101647207|FG000|COMPLETED|Overall Study||15||
48535873|NCT04732624|101647208|FG001|COMPLETED|Overall Study||15||
48535874|NCT04732624|101647207|FG000|NOT COMPLETED|Overall Study||0||
48535875|NCT04732624|101647208|FG001|NOT COMPLETED|Overall Study||0||
48535876|NCT00328016|101647209|FG000|STARTED|Overall Study||23||
48535877|NCT00328016|101647210|FG001|STARTED|Overall Study||21||
48535878|NCT00328016|101647209|FG000|COMPLETED|Overall Study||23||
48535879|NCT00328016|101647210|FG001|COMPLETED|Overall Study||21||
48535880|NCT00328016|101647209|FG000|NOT COMPLETED|Overall Study||0||
48535881|NCT00328016|101647210|FG001|NOT COMPLETED|Overall Study||0||
48535882|NCT00969540|101647211|FG000|STARTED|Overall Study||4||
48535883|NCT00969540|101647212|FG001|STARTED|Overall Study||4||
48535884|NCT00969540|101647211|FG000|COMPLETED|Overall Study||3||
48535885|NCT00969540|101647212|FG001|COMPLETED|Overall Study||3||
48535886|NCT00969540|101647211|FG000|NOT COMPLETED|Overall Study||1||
48535887|NCT00969540|101647212|FG001|NOT COMPLETED|Overall Study||1||
48535888|NCT03981419|101647213|FG000|STARTED|Overall Study||18||
48535889|NCT03981419|101647214|FG001|STARTED|Overall Study||20||
48535890|NCT03981419|101647213|FG000|Intent-to-Treat (ITT) Population|Overall Study||18|ITT population included all randomized participants.|
48535891|NCT03981419|101647214|FG001|Intent-to-Treat (ITT) Population|Overall Study||20|ITT population included all randomized participants.|
48535892|NCT03981419|101647213|FG000|Safety Population|Overall Study||18|Safety population included all participants who received at least 1 dose of the study treatment.|
48535893|NCT03981419|101647214|FG001|Safety Population|Overall Study||20|Safety population included all participants who received at least 1 dose of the study treatment.|
48535894|NCT03981419|101647213|FG000|Evaluable Population|Overall Study||18|Evaluable population included all participants who received all 4 doses of study treatment and in whom all blood samples were collected.|
48535895|NCT03981419|101647214|FG001|Evaluable Population|Overall Study||19|Evaluable population included all participants who received all 4 doses of study treatment and in whom all blood samples were collected.|
48535896|NCT03981419|101647213|FG000|COMPLETED|Overall Study||18||
48235219|NCT01944774|100897669|FG001|Received Treatment|Overall Study||67||
48235220|NCT01944774|100897670|FG002|Received Treatment|Overall Study||70||
48235221|NCT01944774|100897668|FG000|COMPLETED|Overall Study||63||
48235222|NCT01944774|100897669|FG001|COMPLETED|Overall Study||60||
48535897|NCT03981419|101647214|FG001|COMPLETED|Overall Study||19||
48535898|NCT03981419|101647213|FG000|NOT COMPLETED|Overall Study||0||
48535899|NCT03981419|101647214|FG001|NOT COMPLETED|Overall Study||1||
48535900|NCT03362112|101647215|FG000|STARTED|Overall Study||1713||
48535901|NCT03362112|101647215|FG000|COMPLETED|Overall Study||1622||
48235223|NCT01944774|100897670|FG002|COMPLETED|Overall Study||62||
48235224|NCT01944774|100897668|FG000|NOT COMPLETED|Overall Study||6||
48235225|NCT01944774|100897669|FG001|NOT COMPLETED|Overall Study||8||
48235226|NCT01944774|100897670|FG002|NOT COMPLETED|Overall Study||8||
48235227|NCT03166215|100897671|FG000|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||4||
48235228|NCT03166215|100897672|FG001|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||14||
48535902|NCT03362112|101647215|FG000|NOT COMPLETED|Overall Study||91||
48535903|NCT03648853|101647216|FG000|STARTED|Overall Study||12||
48535904|NCT03648853|101647216|FG000|COMPLETED|Overall Study||12||
48535905|NCT03648853|101647216|FG000|NOT COMPLETED|Overall Study||0||
48535906|NCT02701270|101647217|FG000|STARTED|First Intervention at Visit 1||2||
48535907|NCT02701270|101647218|FG001|STARTED|First Intervention at Visit 1||3||
48535908|NCT02701270|101647219|FG002|STARTED|First Intervention at Visit 1||3||
48535909|NCT02701270|101647220|FG003|STARTED|First Intervention at Visit 1||3||
48535910|NCT02701270|101647217|FG000|COMPLETED|First Intervention at Visit 1||2||
48535911|NCT02701270|101647218|FG001|COMPLETED|First Intervention at Visit 1||3||
48535912|NCT02701270|101647219|FG002|COMPLETED|First Intervention at Visit 1||3||
48535913|NCT02701270|101647220|FG003|COMPLETED|First Intervention at Visit 1||3||
48535914|NCT02701270|101647217|FG000|NOT COMPLETED|First Intervention at Visit 1||0||
48535915|NCT02701270|101647218|FG001|NOT COMPLETED|First Intervention at Visit 1||0||
48535916|NCT02701270|101647219|FG002|NOT COMPLETED|First Intervention at Visit 1||0||
48535917|NCT02701270|101647220|FG003|NOT COMPLETED|First Intervention at Visit 1||0||
48535918|NCT02701270|101647217|FG000|STARTED|Second Intervention at Visit 2||2||
48535919|NCT02701270|101647218|FG001|STARTED|Second Intervention at Visit 2||3||
48535920|NCT02701270|101647219|FG002|STARTED|Second Intervention at Visit 2||3||
48535921|NCT02701270|101647220|FG003|STARTED|Second Intervention at Visit 2||3||
48535922|NCT02701270|101647217|FG000|COMPLETED|Second Intervention at Visit 2||2||
48535923|NCT02701270|101647218|FG001|COMPLETED|Second Intervention at Visit 2||3||
48535924|NCT02701270|101647219|FG002|COMPLETED|Second Intervention at Visit 2||3||
48535925|NCT02701270|101647220|FG003|COMPLETED|Second Intervention at Visit 2||3||
48535926|NCT02701270|101647217|FG000|NOT COMPLETED|Second Intervention at Visit 2||0||
48535927|NCT02701270|101647218|FG001|NOT COMPLETED|Second Intervention at Visit 2||0||
48535928|NCT02701270|101647219|FG002|NOT COMPLETED|Second Intervention at Visit 2||0||
48535929|NCT02701270|101647220|FG003|NOT COMPLETED|Second Intervention at Visit 2||0||
48535930|NCT02701270|101647217|FG000|STARTED|Third Intervention at Visit 3||2||
48535931|NCT02701270|101647218|FG001|STARTED|Third Intervention at Visit 3||3||
48535932|NCT02701270|101647219|FG002|STARTED|Third Intervention at Visit 3||3||
48535933|NCT02701270|101647220|FG003|STARTED|Third Intervention at Visit 3||3||
48535934|NCT02701270|101647217|FG000|COMPLETED|Third Intervention at Visit 3||2||
48535935|NCT02701270|101647218|FG001|COMPLETED|Third Intervention at Visit 3||3||
48535936|NCT02701270|101647219|FG002|COMPLETED|Third Intervention at Visit 3||3||
48535937|NCT02701270|101647220|FG003|COMPLETED|Third Intervention at Visit 3||3||
48535938|NCT02701270|101647217|FG000|NOT COMPLETED|Third Intervention at Visit 3||0||
48535939|NCT02701270|101647218|FG001|NOT COMPLETED|Third Intervention at Visit 3||0||
48535940|NCT02701270|101647219|FG002|NOT COMPLETED|Third Intervention at Visit 3||0||
48535941|NCT02701270|101647220|FG003|NOT COMPLETED|Third Intervention at Visit 3||0||
48535942|NCT02701270|101647217|FG000|STARTED|Fourth Intervention at Visit 4||2||
48535943|NCT02701270|101647218|FG001|STARTED|Fourth Intervention at Visit 4||3||
48535944|NCT02701270|101647219|FG002|STARTED|Fourth Intervention at Visit 4||3||
48535945|NCT02701270|101647220|FG003|STARTED|Fourth Intervention at Visit 4||3||
48535946|NCT02701270|101647217|FG000|COMPLETED|Fourth Intervention at Visit 4||2||
48535947|NCT02701270|101647218|FG001|COMPLETED|Fourth Intervention at Visit 4||3||
48535948|NCT02701270|101647219|FG002|COMPLETED|Fourth Intervention at Visit 4||3||
48535949|NCT02701270|101647220|FG003|COMPLETED|Fourth Intervention at Visit 4||3||
48535950|NCT02701270|101647217|FG000|NOT COMPLETED|Fourth Intervention at Visit 4||0||
48535951|NCT02701270|101647218|FG001|NOT COMPLETED|Fourth Intervention at Visit 4||0||
48535952|NCT02701270|101647219|FG002|NOT COMPLETED|Fourth Intervention at Visit 4||0||
48535953|NCT02701270|101647220|FG003|NOT COMPLETED|Fourth Intervention at Visit 4||0||
48535954|NCT00563576|101647221|FG000|STARTED|Overall Study||35||
48535955|NCT00563576|101647222|FG001|STARTED|Overall Study||36||
48535956|NCT00563576|101647221|FG000|COMPLETED|Overall Study||21||
48535957|NCT00563576|101647222|FG001|COMPLETED|Overall Study||22||
48535958|NCT00563576|101647221|FG000|NOT COMPLETED|Overall Study||14||
48535959|NCT00563576|101647222|FG001|NOT COMPLETED|Overall Study||14||
48235229|NCT03166215|100897673|FG002|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||0||
48235230|NCT03166215|100897671|FG000|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||4||
48235231|NCT03166215|100897672|FG001|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||12||
48535960|NCT02752906|101647223|FG000|STARTED|Overall Study||403||
48535961|NCT02752906|101647224|FG001|STARTED|Overall Study||407||
48535962|NCT02752906|101647223|FG000|Vaccinated|Overall Study||402||
48535963|NCT02752906|101647224|FG001|Vaccinated|Overall Study||407||
48535964|NCT02752906|101647223|FG000|COMPLETED|Overall Study||396||
48535965|NCT02752906|101647224|FG001|COMPLETED|Overall Study||402||
48535966|NCT02752906|101647223|FG000|NOT COMPLETED|Overall Study||7||
48535967|NCT02752906|101647224|FG001|NOT COMPLETED|Overall Study||5||
48535968|NCT00478426|101647225|FG000|STARTED|Overall Study||34||
48535969|NCT00478426|101647225|FG000|COMPLETED|Overall Study||33||
48535970|NCT00478426|101647225|FG000|NOT COMPLETED|Overall Study||1||
48535971|NCT02992418|101647226|FG000|STARTED|Overall Study||346||
48535972|NCT02992418|101647227|FG001|STARTED|Overall Study||342||
48535973|NCT02992418|101647226|FG000|Safety Analysis Set (SafAS)|Overall Study||338|SafAS: Participants who received at least one dose of the study vaccines (CYD and Tdap).|
48592664|NCT01877382|101783151|FG001|STARTED|Dose Expansion||0||
48235232|NCT03166215|100897673|FG002|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0||
48235233|NCT03166215|100897671|FG000|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0||
48235234|NCT03166215|100897672|FG001|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||2||
48235235|NCT03166215|100897673|FG002|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0||
48235236|NCT03166215|100897671|FG000|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||0||
48235237|NCT03166215|100897672|FG001|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||0||
48235238|NCT03166215|100897673|FG002|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||16||
48235239|NCT03166215|100897671|FG000|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0||
48235240|NCT03166215|100897672|FG001|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0||
48235241|NCT03166215|100897673|FG002|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||14||
48235242|NCT03166215|100897671|FG000|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0||
48235243|NCT03166215|100897672|FG001|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0||
48235244|NCT03166215|100897673|FG002|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||2||
48235245|NCT02991456|100897674|FG000|STARTED|Overall Study||25||
48235246|NCT02991456|100897675|FG001|STARTED|Overall Study||23||
48235247|NCT02991456|100897674|FG000|COMPLETED|Overall Study||22||
48235248|NCT02991456|100897675|FG001|COMPLETED|Overall Study||21||
48235249|NCT02991456|100897674|FG000|NOT COMPLETED|Overall Study||3||
48235250|NCT02991456|100897675|FG001|NOT COMPLETED|Overall Study||2||
48235251|NCT01287832|100897676|FG000|STARTED|Overall Study||6||
48235252|NCT01287832|100897677|FG001|STARTED|Overall Study||5||
48235253|NCT01287832|100897676|FG000|COMPLETED|Overall Study||5||
48235254|NCT01287832|100897677|FG001|COMPLETED|Overall Study||4||
48235255|NCT01287832|100897676|FG000|NOT COMPLETED|Overall Study||1||
48235256|NCT01287832|100897677|FG001|NOT COMPLETED|Overall Study||1||
48235257|NCT03326856|100897678|FG000|STARTED|Overall Study||13||
48235258|NCT03326856|100897679|FG001|STARTED|Overall Study||9||
48535974|NCT02992418|101647227|FG001|Safety Analysis Set (SafAS)|Overall Study||342|SafAS: Participants who received at least one dose of the study vaccines (CYD and Tdap).|
48535975|NCT02992418|101647226|FG000|COMPLETED|Overall Study||0||
48535976|NCT02992418|101647227|FG001|COMPLETED|Overall Study||0||
48535977|NCT02992418|101647226|FG000|NOT COMPLETED|Overall Study||346||
48535978|NCT02992418|101647227|FG001|NOT COMPLETED|Overall Study||342||
48535979|NCT02105974|101647228|FG000|STARTED|2 Week Run-in Period||2423||
48535980|NCT02105974|101647229|FG001|STARTED|2 Week Run-in Period||0||
48535981|NCT02105974|101647230|FG002|STARTED|2 Week Run-in Period||0||
48535982|NCT02105974|101647228|FG000|COMPLETED|2 Week Run-in Period||1622||
48535983|NCT02105974|101647229|FG001|COMPLETED|2 Week Run-in Period||0||
48535984|NCT02105974|101647230|FG002|COMPLETED|2 Week Run-in Period||0||
48535985|NCT02105974|101647228|FG000|NOT COMPLETED|2 Week Run-in Period||801||
48535986|NCT02105974|101647229|FG001|NOT COMPLETED|2 Week Run-in Period||0||
48535987|NCT02105974|101647230|FG002|NOT COMPLETED|2 Week Run-in Period||0||
48535988|NCT02105974|101647228|FG000|STARTED|12 Week (Wk) Treatment Period (TP)||0||
48535989|NCT02105974|101647229|FG001|STARTED|12 Week (Wk) Treatment Period (TP)||806||
48535990|NCT02105974|101647230|FG002|STARTED|12 Week (Wk) Treatment Period (TP)||814||
48535991|NCT02105974|101647228|FG000|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)||0||
48535992|NCT02105974|101647229|FG001|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)||764||
48535993|NCT02105974|101647230|FG002|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)||754||
48535994|NCT02105974|101647228|FG000|COMPLETED|12 Week (Wk) Treatment Period (TP)||0||
48535995|NCT02105974|101647229|FG001|COMPLETED|12 Week (Wk) Treatment Period (TP)||764||
48535996|NCT02105974|101647230|FG002|COMPLETED|12 Week (Wk) Treatment Period (TP)||756||
48535997|NCT02105974|101647228|FG000|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||0||
48535998|NCT02105974|101647229|FG001|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||42||
48535999|NCT02105974|101647230|FG002|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||58||
48536000|NCT00529282|101647231|FG000|STARTED|Overall Study||0||
48536001|NCT00529282|101647232|FG001|STARTED|Overall Study||2||
48536002|NCT00529282|101647231|FG000|COMPLETED|Overall Study||0||
48536003|NCT00529282|101647232|FG001|COMPLETED|Overall Study||2||
48536004|NCT00529282|101647231|FG000|NOT COMPLETED|Overall Study||0||
48536005|NCT00529282|101647232|FG001|NOT COMPLETED|Overall Study||0||
48235259|NCT03326856|100897680|FG002|STARTED|Overall Study||9||
48235260|NCT03326856|100897681|FG003|STARTED|Overall Study||9||
48235261|NCT03326856|100897682|FG004|STARTED|Overall Study||8||
48235262|NCT03326856|100897678|FG000|COMPLETED|Overall Study||12||
48235263|NCT03326856|100897679|FG001|COMPLETED|Overall Study||8||
48235264|NCT03326856|100897680|FG002|COMPLETED|Overall Study||9||
48235265|NCT03326856|100897681|FG003|COMPLETED|Overall Study||9||
48235266|NCT03326856|100897682|FG004|COMPLETED|Overall Study||8||
48235267|NCT03326856|100897678|FG000|NOT COMPLETED|Overall Study||1||
48235268|NCT03326856|100897679|FG001|NOT COMPLETED|Overall Study||1||
48536006|NCT00094861|101647233|FG000|STARTED|Overall Study||46||
48536007|NCT00094861|101647234|FG001|STARTED|Overall Study||49||
48536008|NCT00094861|101647233|FG000|Participants Treated|Overall Study||46||
48235269|NCT03326856|100897680|FG002|NOT COMPLETED|Overall Study||0||
48235270|NCT03326856|100897681|FG003|NOT COMPLETED|Overall Study||0||
48235271|NCT03326856|100897682|FG004|NOT COMPLETED|Overall Study||0||
48235272|NCT03029156|100897683|FG000|STARTED|Overall Study||15||
48235273|NCT03029156|100897684|FG001|STARTED|Overall Study||16||
48235274|NCT03029156|100897683|FG000|COMPLETED|Overall Study||15||
48235275|NCT03029156|100897684|FG001|COMPLETED|Overall Study||16||
48235276|NCT03029156|100897683|FG000|NOT COMPLETED|Overall Study||0||
48235277|NCT03029156|100897684|FG001|NOT COMPLETED|Overall Study||0||
48235278|NCT01163214|100897685|FG000|STARTED|Overall Study||79||
48235279|NCT01163214|100897686|FG001|STARTED|Overall Study||81||
48235280|NCT01163214|100897685|FG000|COMPLETED|Overall Study||79||
48536009|NCT00094861|101647234|FG001|Participants Treated|Overall Study||48||
48536010|NCT00094861|101647233|FG000|COMPLETED|Overall Study||28||
48235281|NCT01163214|100897686|FG001|COMPLETED|Overall Study||81||
48235282|NCT01163214|100897685|FG000|NOT COMPLETED|Overall Study||0||
48235283|NCT01163214|100897686|FG001|NOT COMPLETED|Overall Study||0||
48235284|NCT04617847|100897687|FG000|STARTED|Overall Study||3||
48235285|NCT04617847|100897688|FG001|STARTED|Overall Study||24||
48235286|NCT04617847|100897687|FG000|Dose Modified to 16 mg WVE-120101|Overall Study||3||
48235287|NCT04617847|100897688|FG001|Dose Modified to 16 mg WVE-120101|Overall Study||1||
48235288|NCT04617847|100897687|FG000|Dose Modified to 32 mg WVE-120101|Overall Study||0||
48235289|NCT04617847|100897688|FG001|Dose Modified to 32 mg WVE-120101|Overall Study||5||
48235290|NCT04617847|100897687|FG000|COMPLETED|Overall Study||0||
48235291|NCT04617847|100897688|FG001|COMPLETED|Overall Study||0||
48235292|NCT04617847|100897687|FG000|NOT COMPLETED|Overall Study||3||
48235293|NCT04617847|100897688|FG001|NOT COMPLETED|Overall Study||24||
48235294|NCT00321555|100897689|FG000|STARTED|Overall Study||15||
48235295|NCT00321555|100897689|FG000|COMPLETED|Overall Study||9||
48235296|NCT00321555|100897689|FG000|NOT COMPLETED|Overall Study||6||
48235297|NCT00179478|100897690|FG000|STARTED|Overall Study||81||
48235298|NCT00179478|100897691|FG001|STARTED|Overall Study||74||
48235299|NCT00179478|100897690|FG000|COMPLETED|Overall Study||68||
48235300|NCT00179478|100897691|FG001|COMPLETED|Overall Study||59||
48235301|NCT00179478|100897690|FG000|NOT COMPLETED|Overall Study||13||
48235302|NCT00179478|100897691|FG001|NOT COMPLETED|Overall Study||15||
48235303|NCT01175980|100897692|FG000|STARTED|Overall Study||30||
48235304|NCT01175980|100897692|FG000|COMPLETED|Overall Study||30||
48235305|NCT01175980|100897692|FG000|NOT COMPLETED|Overall Study||0||
48235306|NCT01513902|100897693|FG000|STARTED|Overall Study||8||
48235307|NCT01513902|100897694|FG001|STARTED|Overall Study||9||
48235308|NCT01513902|100897695|FG002|STARTED|Overall Study||9||
48235309|NCT01513902|100897693|FG000|COMPLETED|Overall Study||8||
48235310|NCT01513902|100897694|FG001|COMPLETED|Overall Study||9||
48235311|NCT01513902|100897695|FG002|COMPLETED|Overall Study||9||
48235312|NCT01513902|100897693|FG000|NOT COMPLETED|Overall Study||0||
48235313|NCT01513902|100897694|FG001|NOT COMPLETED|Overall Study||0||
48235314|NCT01513902|100897695|FG002|NOT COMPLETED|Overall Study||0||
48235315|NCT01757288|100897696|FG000|STARTED|Overall Study||6||
48235316|NCT01757288|100897697|FG001|STARTED|Overall Study||46||
48235317|NCT01757288|100897698|FG002|STARTED|Overall Study||46||
48235318|NCT01757288|100897696|FG000|COMPLETED|Overall Study||6||
48235319|NCT01757288|100897697|FG001|COMPLETED|Overall Study||38||
48235320|NCT01757288|100897698|FG002|COMPLETED|Overall Study||37||
48536011|NCT00094861|101647234|FG001|COMPLETED|Overall Study||40||
48536012|NCT00094861|101647233|FG000|NOT COMPLETED|Overall Study||18||
48536013|NCT00094861|101647234|FG001|NOT COMPLETED|Overall Study||9||
48536014|NCT01685411|101647235|FG000|STARTED|Overall Study||5||
48536015|NCT01685411|101647235|FG000|COMPLETED|Overall Study||5||
48536016|NCT01685411|101647235|FG000|NOT COMPLETED|Overall Study||0||
48536017|NCT06017479|101647236|FG000|STARTED|Overall Study||63||
48536018|NCT06017479|101647237|FG001|STARTED|Overall Study||63||
48536019|NCT06017479|101647236|FG000|COMPLETED|Overall Study||63||
48536020|NCT06017479|101647237|FG001|COMPLETED|Overall Study||63||
48536021|NCT06017479|101647236|FG000|NOT COMPLETED|Overall Study||0||
48536022|NCT06017479|101647237|FG001|NOT COMPLETED|Overall Study||0||
48536023|NCT04325204|101647238|FG000|STARTED|Overall Study||27|Completed baseline survey|
48536024|NCT04325204|101647239|FG001|STARTED|Overall Study||27|Completed baseline survey|
48536025|NCT04325204|101647238|FG000|Began the Intervention|Overall Study||26||
48536026|NCT04325204|101647239|FG001|Began the Intervention|Overall Study||26||
48536027|NCT04325204|101647238|FG000|COMPLETED|Overall Study||17|Completed the 6 week intervention and the post-intervention assessment 6 weeks after the end of the intervention.|
48536028|NCT04325204|101647239|FG001|COMPLETED|Overall Study||17|Completed the 6 week intervention and the post-intervention assessment 6 weeks after the end of the intervention.|
48235321|NCT01757288|100897696|FG000|NOT COMPLETED|Overall Study||0||
48235322|NCT01757288|100897697|FG001|NOT COMPLETED|Overall Study||8||
48235323|NCT01757288|100897698|FG002|NOT COMPLETED|Overall Study||9||
48235324|NCT02955225|100897699|FG000|STARTED|Overall Study||26||
48235325|NCT02955225|100897700|FG001|STARTED|Overall Study||12||
48235326|NCT02955225|100897699|FG000|COMPLETED|Overall Study||21||
48235327|NCT02955225|100897700|FG001|COMPLETED|Overall Study||12||
48235328|NCT02955225|100897699|FG000|NOT COMPLETED|Overall Study||5||
48235329|NCT02955225|100897700|FG001|NOT COMPLETED|Overall Study||0||
48536029|NCT04325204|101647238|FG000|NOT COMPLETED|Overall Study||10||
48536030|NCT04325204|101647239|FG001|NOT COMPLETED|Overall Study||10||
48235330|NCT04212299|100897701|FG000|STARTED|Baseline in Ischial Containment Socket||5||
48235331|NCT04212299|100897701|FG000|COMPLETED|Baseline in Ischial Containment Socket||5||
48536031|NCT03562559|101647240|FG000|STARTED|Overall Study||40||
48536032|NCT03562559|101647240|FG000|COMPLETED|Overall Study||40||
48536033|NCT03562559|101647240|FG000|NOT COMPLETED|Overall Study||0||
48536034|NCT00824616|101647241|FG000|STARTED|Overall Study||34||
48536035|NCT00824616|101647242|FG001|STARTED|Overall Study||34||
48235332|NCT04212299|100897701|FG000|NOT COMPLETED|Baseline in Ischial Containment Socket||0||
48235333|NCT04212299|100897701|FG000|STARTED|8-week Follow up in Sub-ischial Socket||5||
48235334|NCT04212299|100897701|FG000|COMPLETED|8-week Follow up in Sub-ischial Socket||5||
48235335|NCT04212299|100897701|FG000|NOT COMPLETED|8-week Follow up in Sub-ischial Socket||0||
48235336|NCT04212299|100897701|FG000|STARTED|42-week Follow up in Sub-ischial Socket||5||
48235337|NCT04212299|100897701|FG000|COMPLETED|42-week Follow up in Sub-ischial Socket||4||
48235338|NCT04212299|100897701|FG000|NOT COMPLETED|42-week Follow up in Sub-ischial Socket||1||
48235339|NCT00818519|100897702|FG000|STARTED|Overall Study||89||
48235340|NCT00818519|100897703|FG001|STARTED|Overall Study||90||
48235341|NCT00818519|100897702|FG000|Participants Received Treatment|Overall Study||87||
48235342|NCT00818519|100897703|FG001|Participants Received Treatment|Overall Study||86||
48235343|NCT00818519|100897702|FG000|COMPLETED|Overall Study||75||
48235344|NCT00818519|100897703|FG001|COMPLETED|Overall Study||71||
48235345|NCT00818519|100897702|FG000|NOT COMPLETED|Overall Study||14||
48235346|NCT00818519|100897703|FG001|NOT COMPLETED|Overall Study||19||
48235347|NCT00595764|100897704|FG000|STARTED|Overall Study||71||
48235348|NCT00595764|100897705|FG001|STARTED|Overall Study||70||
48235349|NCT00595764|100897704|FG000|COMPLETED|Overall Study||32||
48235350|NCT00595764|100897705|FG001|COMPLETED|Overall Study||27||
48235351|NCT00595764|100897704|FG000|NOT COMPLETED|Overall Study||39||
48235352|NCT00595764|100897705|FG001|NOT COMPLETED|Overall Study||43||
48235353|NCT00589628|100897706|FG000|STARTED|Overall Study||7||
48235354|NCT00589628|100897707|FG001|STARTED|Overall Study||6||
48235355|NCT00589628|100897706|FG000|COMPLETED|Overall Study||7||
48235356|NCT00589628|100897707|FG001|COMPLETED|Overall Study||5||
48235357|NCT00589628|100897706|FG000|NOT COMPLETED|Overall Study||0||
48235358|NCT00589628|100897707|FG001|NOT COMPLETED|Overall Study||1||
48235359|NCT03000829|100897708|FG000|STARTED|Overall Study||521||45
48235360|NCT03000829|100897709|FG001|STARTED|Overall Study||466||37
48235361|NCT03000829|100897710|FG002|STARTED|Overall Study||14||0
48235362|NCT03000829|100897708|FG000|COMPLETED|Overall Study||521||45
48235363|NCT03000829|100897709|FG001|COMPLETED|Overall Study||466||37
48235364|NCT03000829|100897710|FG002|COMPLETED|Overall Study||14||0
48235365|NCT03000829|100897708|FG000|NOT COMPLETED|Overall Study||0||0
48235366|NCT03000829|100897709|FG001|NOT COMPLETED|Overall Study||0||0
48235367|NCT03000829|100897710|FG002|NOT COMPLETED|Overall Study||0||0
48235368|NCT05188248|100897711|FG000|STARTED|Overall Study||21||
48235369|NCT05188248|100897711|FG000|COMPLETED|Overall Study||21||
48235370|NCT05188248|100897711|FG000|NOT COMPLETED|Overall Study||0||
48235371|NCT01245699|100897712|FG000|STARTED|Overall Study||61||
48235372|NCT01245699|100897713|FG001|STARTED|Overall Study||54||
48235373|NCT01245699|100897712|FG000|COMPLETED|Overall Study||52||
48235374|NCT01245699|100897713|FG001|COMPLETED|Overall Study||49||
48235375|NCT01245699|100897712|FG000|NOT COMPLETED|Overall Study||9||
48235376|NCT01245699|100897713|FG001|NOT COMPLETED|Overall Study||5||
48235377|NCT01280721|100897714|FG000|STARTED|Overall Study||135||
48235378|NCT01280721|100897714|FG000|COMPLETED|Overall Study||113||
48235379|NCT01280721|100897714|FG000|NOT COMPLETED|Overall Study||22||
48235380|NCT03769090|100897715|FG000|STARTED|Overall Study||1016||
48235381|NCT03769090|100897716|FG001|STARTED|Overall Study||1057||
48235382|NCT03769090|100897717|FG002|STARTED|Overall Study||1059||
48235383|NCT03769090|100897715|FG000|COMPLETED|Overall Study||915||
48235384|NCT03769090|100897716|FG001|COMPLETED|Overall Study||933||
48235385|NCT03769090|100897717|FG002|COMPLETED|Overall Study||916||
48235386|NCT03769090|100897715|FG000|NOT COMPLETED|Overall Study||101||
48235387|NCT03769090|100897716|FG001|NOT COMPLETED|Overall Study||124||
48235388|NCT03769090|100897717|FG002|NOT COMPLETED|Overall Study||143||
48536036|NCT00824616|101647241|FG000|COMPLETED|Overall Study||28||
48536037|NCT00824616|101647242|FG001|COMPLETED|Overall Study||27||
48536038|NCT00824616|101647241|FG000|NOT COMPLETED|Overall Study||6||
48235389|NCT04992494|100897718|FG000|STARTED|Overall Study||8||
48235390|NCT04992494|100897719|FG001|STARTED|Overall Study||8||
48235391|NCT04992494|100897718|FG000|COMPLETED|Overall Study||8||
48235392|NCT04992494|100897719|FG001|COMPLETED|Overall Study||8||
48235393|NCT04992494|100897718|FG000|NOT COMPLETED|Overall Study||0||
48235394|NCT04992494|100897719|FG001|NOT COMPLETED|Overall Study||0||
48235395|NCT02555397|100897720|FG000|STARTED|Overall Study||3||
48235396|NCT02555397|100897721|FG001|STARTED|Overall Study||3||
48235397|NCT02555397|100897722|FG002|STARTED|Overall Study||3||
48235398|NCT02555397|100897723|FG003|STARTED|Overall Study||3||
48235399|NCT02555397|100897724|FG004|STARTED|Overall Study||3||
48235400|NCT02555397|100897720|FG000|COMPLETED|Overall Study||2||
48235401|NCT02555397|100897721|FG001|COMPLETED|Overall Study||3||
48235402|NCT02555397|100897722|FG002|COMPLETED|Overall Study||3||
48235403|NCT02555397|100897723|FG003|COMPLETED|Overall Study||3||
48536039|NCT00824616|101647242|FG001|NOT COMPLETED|Overall Study||7||
48235404|NCT02555397|100897724|FG004|COMPLETED|Overall Study||3||
48235405|NCT02555397|100897720|FG000|NOT COMPLETED|Overall Study||1||
48235406|NCT02555397|100897721|FG001|NOT COMPLETED|Overall Study||0||
48235407|NCT02555397|100897722|FG002|NOT COMPLETED|Overall Study||0||
48235408|NCT02555397|100897723|FG003|NOT COMPLETED|Overall Study||0||
48235409|NCT02555397|100897724|FG004|NOT COMPLETED|Overall Study||0||
48536040|NCT00140426|101647243|FG000|STARTED|Overall Study||22||
48536041|NCT00140426|101647244|FG001|STARTED|Overall Study||19||
48235410|NCT01185340|100897725|FG000|STARTED|Confirmation (CF) Phase, 3 Weeks||1056||
48235411|NCT01185340|100897726|FG001|STARTED|Confirmation (CF) Phase, 3 Weeks||0||
48235412|NCT01185340|100897727|FG002|STARTED|Confirmation (CF) Phase, 3 Weeks||0||
48235413|NCT01185340|100897728|FG003|STARTED|Confirmation (CF) Phase, 3 Weeks||0||
48235414|NCT01185340|100897725|FG000|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||18||
48235415|NCT01185340|100897726|FG001|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0||
48235416|NCT01185340|100897727|FG002|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0||
48235417|NCT01185340|100897728|FG003|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0||
48235418|NCT01185340|100897725|FG000|COMPLETED|Confirmation (CF) Phase, 3 Weeks||968||
48235419|NCT01185340|100897726|FG001|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
48235420|NCT01185340|100897727|FG002|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
48235421|NCT01185340|100897728|FG003|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
48235422|NCT01185340|100897725|FG000|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88||
48235423|NCT01185340|100897726|FG001|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
48235424|NCT01185340|100897727|FG002|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
48235425|NCT01185340|100897728|FG003|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
48235426|NCT01185340|100897725|FG000|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0||
48235427|NCT01185340|100897726|FG001|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230||
48235428|NCT01185340|100897727|FG002|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||219||
48235429|NCT01185340|100897728|FG003|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||519||
48235430|NCT01185340|100897725|FG000|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0||
48536042|NCT00140426|101647243|FG000|COMPLETED|Overall Study||22||
48536043|NCT00140426|101647244|FG001|COMPLETED|Overall Study||16||
48536044|NCT00140426|101647243|FG000|NOT COMPLETED|Overall Study||0||
48536045|NCT00140426|101647244|FG001|NOT COMPLETED|Overall Study||3||
48536046|NCT01783548|101647245|FG000|STARTED|Overall Study||362||
48536047|NCT01783548|101647246|FG001|STARTED|Overall Study||185||
48536048|NCT01783548|101647245|FG000|Full Analysis Set (FAS)|Overall Study||358||
48536049|NCT01783548|101647246|FG001|Full Analysis Set (FAS)|Overall Study||184||
48536050|NCT01783548|101647245|FG000|COMPLETED|Overall Study||328||
48536051|NCT01783548|101647246|FG001|COMPLETED|Overall Study||167||
48536052|NCT01783548|101647245|FG000|NOT COMPLETED|Overall Study||34||
48536053|NCT01783548|101647246|FG001|NOT COMPLETED|Overall Study||18||
48536054|NCT02272634|101647247|FG000|STARTED|Overall Study||20||
48536055|NCT02272634|101647248|FG001|STARTED|Overall Study||21||
48536056|NCT02272634|101647249|FG002|STARTED|Overall Study||20||
48536057|NCT02272634|101647247|FG000|COMPLETED|Overall Study||19||
48536058|NCT02272634|101647248|FG001|COMPLETED|Overall Study||20||
48536059|NCT02272634|101647249|FG002|COMPLETED|Overall Study||19||
48536060|NCT02272634|101647247|FG000|NOT COMPLETED|Overall Study||1||
48536061|NCT02272634|101647248|FG001|NOT COMPLETED|Overall Study||1||
48536062|NCT02272634|101647249|FG002|NOT COMPLETED|Overall Study||1||
48536063|NCT01293539|101647250|FG000|STARTED|Overall Study||10||
48536064|NCT01293539|101647250|FG000|COMPLETED|Overall Study||9||
48536065|NCT01293539|101647250|FG000|NOT COMPLETED|Overall Study||1||
48536066|NCT00789737|101647251|FG000|STARTED|Overall Study||176||
48536067|NCT00789737|101647252|FG001|STARTED|Overall Study||181||
48536068|NCT00789737|101647251|FG000|COMPLETED|Overall Study||128||
48536069|NCT00789737|101647252|FG001|COMPLETED|Overall Study||126||
48536070|NCT00789737|101647251|FG000|NOT COMPLETED|Overall Study||48||
48536071|NCT00789737|101647252|FG001|NOT COMPLETED|Overall Study||55||
48536072|NCT02315196|101647253|FG000|STARTED|Overall Study||62||
48536073|NCT02315196|101647253|FG000|COMPLETED|Overall Study||53||
48536074|NCT02315196|101647253|FG000|NOT COMPLETED|Overall Study||9||
48536075|NCT02520063|101647254|FG000|STARTED|Overall Study||6||
48235431|NCT01185340|100897726|FG001|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||206||
48235432|NCT01185340|100897727|FG002|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||204||
48235433|NCT01185340|100897728|FG003|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||483||
48235434|NCT01185340|100897725|FG000|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0||
48235435|NCT01185340|100897726|FG001|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||195||
48536076|NCT02520063|101647255|FG001|STARTED|Overall Study||4||
48536077|NCT02520063|101647256|FG002|STARTED|Overall Study||0||
48536078|NCT02520063|101647257|FG003|STARTED|Overall Study||5||
48536079|NCT02520063|101647254|FG000|COMPLETED|Overall Study||5||
48536080|NCT02520063|101647255|FG001|COMPLETED|Overall Study||3||
48536081|NCT02520063|101647256|FG002|COMPLETED|Overall Study||0||
48536082|NCT02520063|101647257|FG003|COMPLETED|Overall Study||5||
48536083|NCT02520063|101647254|FG000|NOT COMPLETED|Overall Study||1||
48536084|NCT02520063|101647255|FG001|NOT COMPLETED|Overall Study||1||
48536085|NCT02520063|101647256|FG002|NOT COMPLETED|Overall Study||0||
48536086|NCT02520063|101647257|FG003|NOT COMPLETED|Overall Study||0||
48536087|NCT02092467|101647258|FG000|STARTED|Overall Study||1457||
48235436|NCT01185340|100897727|FG002|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||186||
48235437|NCT01185340|100897728|FG003|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||458||
48235438|NCT01185340|100897725|FG000|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0||
48235439|NCT01185340|100897726|FG001|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35||
48235440|NCT01185340|100897727|FG002|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33||
48235441|NCT01185340|100897728|FG003|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||61||
48235442|NCT01675063|100897729|FG000|STARTED|Overall Study||77||
48235443|NCT01675063|100897729|FG000|COMPLETED|Overall Study||77||
48235444|NCT01675063|100897729|FG000|NOT COMPLETED|Overall Study||0||
48235445|NCT03576118|100897730|FG000|STARTED|Overall Study||37||
48235446|NCT03576118|100897731|FG001|STARTED|Overall Study||37||
48235447|NCT03576118|100897730|FG000|COMPLETED|Overall Study||34||
48235448|NCT03576118|100897731|FG001|COMPLETED|Overall Study||33||
48235449|NCT03576118|100897730|FG000|NOT COMPLETED|Overall Study||3||
48235450|NCT03576118|100897731|FG001|NOT COMPLETED|Overall Study||4||
48235451|NCT02314000|100897732|FG000|STARTED|Overall Study||75||
48235452|NCT02314000|100897733|FG001|STARTED|Overall Study||65||
48235453|NCT02314000|100897732|FG000|COMPLETED|Overall Study||62||
48235454|NCT02314000|100897733|FG001|COMPLETED|Overall Study||57||
48235455|NCT02314000|100897732|FG000|NOT COMPLETED|Overall Study||13||
48235456|NCT02314000|100897733|FG001|NOT COMPLETED|Overall Study||8||
48235457|NCT00409747|100897734|FG000|STARTED|Overall Study||11||
48235458|NCT00409747|100897734|FG000|COMPLETED|Overall Study||10||
48235459|NCT00409747|100897734|FG000|NOT COMPLETED|Overall Study||1||
48235460|NCT03696342|100897735|FG000|STARTED|Overall Study||23||23
48235461|NCT03696342|100897736|FG001|STARTED|Overall Study||23||23
48235462|NCT03696342|100897735|FG000|COMPLETED|Overall Study||22||22
48235463|NCT03696342|100897736|FG001|COMPLETED|Overall Study||23||23
48235464|NCT03696342|100897735|FG000|NOT COMPLETED|Overall Study||1||1
48235465|NCT03696342|100897736|FG001|NOT COMPLETED|Overall Study||0||0
48235466|NCT00742560|100897737|FG000|STARTED|Overall Study||3|Safety population: all randomized participants who received at least 1 dose of study drug|
48235467|NCT00742560|100897738|FG001|STARTED|Overall Study||3|Safety population: all randomized participants who received at least 1 dose of study drug|
48235468|NCT00742560|100897739|FG002|STARTED|Overall Study||22|Safety population: all randomized participants who received at least 1 dose of study drug|
48235469|NCT00742560|100897740|FG003|STARTED|Overall Study||36|Safety population: all randomized participants who received at least 1 dose of study drug|
48235470|NCT00742560|100897741|FG004|STARTED|Overall Study||37|Safety population: all randomized participants who received at least 1 dose of study drug|
48235471|NCT00742560|100897737|FG000|COMPLETED|Overall Study||0||
48235472|NCT00742560|100897738|FG001|COMPLETED|Overall Study||0||
48235473|NCT00742560|100897739|FG002|COMPLETED|Overall Study||0||
48235474|NCT00742560|100897740|FG003|COMPLETED|Overall Study||0||
48235475|NCT00742560|100897741|FG004|COMPLETED|Overall Study||0||
48235476|NCT00742560|100897737|FG000|NOT COMPLETED|Overall Study||3||
48235477|NCT00742560|100897738|FG001|NOT COMPLETED|Overall Study||3||
48235478|NCT00742560|100897739|FG002|NOT COMPLETED|Overall Study||22||
48235479|NCT00742560|100897740|FG003|NOT COMPLETED|Overall Study||36||
48235480|NCT00742560|100897741|FG004|NOT COMPLETED|Overall Study||37||
48235481|NCT01437540|100897742|FG000|STARTED|Overall Study||392||
48235482|NCT01437540|100897743|FG001|STARTED|Overall Study||198||
48235483|NCT01437540|100897742|FG000|COMPLETED|Overall Study||265||
48235484|NCT01437540|100897743|FG001|COMPLETED|Overall Study||133||
48235485|NCT01437540|100897742|FG000|NOT COMPLETED|Overall Study||127||
48235486|NCT01437540|100897743|FG001|NOT COMPLETED|Overall Study||65||
48235487|NCT00670449|100897744|FG000|STARTED|Overall Study||47||
48235488|NCT00670449|100897745|FG001|STARTED|Overall Study||46||
48235489|NCT00670449|100897746|FG002|STARTED|Overall Study||27||
48235490|NCT00670449|100897747|FG003|STARTED|Overall Study||23||
48235491|NCT00670449|100897744|FG000|Switched to 0.5mg (Open Label)|Overall Study||45||
48235492|NCT00670449|100897745|FG001|Switched to 0.5mg (Open Label)|Overall Study||41||
48235493|NCT00670449|100897746|FG002|Switched to 0.5mg (Open Label)|Overall Study||23||
48235494|NCT00670449|100897747|FG003|Switched to 0.5mg (Open Label)|Overall Study||17||
48235495|NCT00670449|100897744|FG000|COMPLETED|Overall Study||38||
48235496|NCT00670449|100897745|FG001|COMPLETED|Overall Study||36||
48235497|NCT00670449|100897746|FG002|COMPLETED|Overall Study||18||
48235498|NCT00670449|100897747|FG003|COMPLETED|Overall Study||15||
48235499|NCT00670449|100897744|FG000|NOT COMPLETED|Overall Study||9||
48235500|NCT00670449|100897745|FG001|NOT COMPLETED|Overall Study||10||
48235501|NCT00670449|100897746|FG002|NOT COMPLETED|Overall Study||9||
48235502|NCT00670449|100897747|FG003|NOT COMPLETED|Overall Study||8||
48235503|NCT00603018|100897748|FG000|STARTED|Overall Study||23||
48235504|NCT00603018|100897748|FG000|COMPLETED|Overall Study||23||
48235505|NCT00603018|100897748|FG000|NOT COMPLETED|Overall Study||0||
48235506|NCT03034863|100897749|FG000|STARTED|Overall Study||38||
48235507|NCT03034863|100897750|FG001|STARTED|Overall Study||40||
48235508|NCT03034863|100897749|FG000|Veterans|Overall Study||19||
48235509|NCT03034863|100897750|FG001|Veterans|Overall Study||20||
48235510|NCT03034863|100897749|FG000|Supporting Partners|Overall Study||19||
48235511|NCT03034863|100897750|FG001|Supporting Partners|Overall Study||20||
48235512|NCT03034863|100897749|FG000|COMPLETED|Overall Study||28||
48235513|NCT03034863|100897750|FG001|COMPLETED|Overall Study||28||
48536088|NCT02092467|101647259|FG001|STARTED|Overall Study||1457||
48536089|NCT02092467|101647260|FG002|STARTED|Overall Study||1458||
48536090|NCT02092467|101647258|FG000|Treated|Overall Study||1455||
48536091|NCT02092467|101647259|FG001|Treated|Overall Study||1456||
48235514|NCT03034863|100897749|FG000|NOT COMPLETED|Overall Study||10||
48235515|NCT03034863|100897750|FG001|NOT COMPLETED|Overall Study||12||
48235516|NCT03014726|100897751|FG000|STARTED|Overall Study||53||
48235517|NCT03014726|100897751|FG000|COMPLETED|Overall Study||29||
48235518|NCT03014726|100897751|FG000|NOT COMPLETED|Overall Study||24||
48235519|NCT04382053|100897752|FG000|STARTED|Overall Study||71|All randomized Participants|
48235520|NCT04382053|100897753|FG001|STARTED|Overall Study||72|All randomized Participants|
48235521|NCT04382053|100897752|FG000|Safety Analysis Set|Overall Study||70|All randomized participants, who attended at least one post-baseline visit|
48235522|NCT04382053|100897753|FG001|Safety Analysis Set|Overall Study||72|All randomized participants, who attended at least one post-baseline visit|
48235523|NCT04382053|100897752|FG000|PD Analysis Set|Overall Study||62|All randomized participants with no protocol deviations with relevant impact on Pharmacodynamics (PD) data|
48235524|NCT04382053|100897753|FG001|PD Analysis Set|Overall Study||68|All randomized participants with no protocol deviations with relevant impact on Pharmacodynamics (PD) data|
48235525|NCT04382053|100897752|FG000|COMPLETED|Overall Study||62||
48235526|NCT04382053|100897753|FG001|COMPLETED|Overall Study||59||
48235527|NCT04382053|100897752|FG000|NOT COMPLETED|Overall Study||9||
48235528|NCT04382053|100897753|FG001|NOT COMPLETED|Overall Study||13||
48235529|NCT00274287|100897754|FG000|STARTED|Overall Study||15||
48235530|NCT00274287|100897754|FG000|COMPLETED|Overall Study||13||
48235531|NCT00274287|100897754|FG000|NOT COMPLETED|Overall Study||2||
48235532|NCT02132195|100897755|FG000|STARTED|Initial Assignment||15||
48235533|NCT02132195|100897756|FG001|STARTED|Initial Assignment||16||
48235534|NCT02132195|100897757|FG002|STARTED|Initial Assignment||0||
48235535|NCT02132195|100897755|FG000|COMPLETED|Initial Assignment||1||
48235536|NCT02132195|100897756|FG001|COMPLETED|Initial Assignment||16||
48235537|NCT02132195|100897757|FG002|COMPLETED|Initial Assignment||0||
48235538|NCT02132195|100897755|FG000|NOT COMPLETED|Initial Assignment||14||
48235539|NCT02132195|100897756|FG001|NOT COMPLETED|Initial Assignment||0||
48536092|NCT02092467|101647260|FG002|Treated|Overall Study||1451||
48536093|NCT02092467|101647258|FG000|COMPLETED|Overall Study||1053||
48536094|NCT02092467|101647259|FG001|COMPLETED|Overall Study||998||
48536095|NCT02092467|101647260|FG002|COMPLETED|Overall Study||1060||
48536096|NCT02092467|101647258|FG000|NOT COMPLETED|Overall Study||404||
48536097|NCT02092467|101647259|FG001|NOT COMPLETED|Overall Study||459||
48536098|NCT02092467|101647260|FG002|NOT COMPLETED|Overall Study||398||
48536099|NCT02740699|101647261|FG000|STARTED|Overall Study||79||
48536100|NCT02740699|101647261|FG000|COMPLETED|Overall Study||55||
48536101|NCT02740699|101647261|FG000|NOT COMPLETED|Overall Study||24||
48536102|NCT01735955|101647262|FG000|STARTED|Overall Study||57||
48536103|NCT01735955|101647262|FG000|COMPLETED|Overall Study||20||
48536104|NCT01735955|101647262|FG000|NOT COMPLETED|Overall Study||37||
48536105|NCT03862755|101647263|FG000|STARTED|Overall Study||581||
48536106|NCT03862755|101647263|FG000|COMPLETED|Overall Study||581||
48536107|NCT03862755|101647263|FG000|NOT COMPLETED|Overall Study||0||
48536108|NCT00985712|101647264|FG000|STARTED|Overall Study||133||
48536109|NCT00985712|101647265|FG001|STARTED|Overall Study||130||
48536110|NCT00985712|101647264|FG000|Received at Least One Dose of Study Drug|Overall Study||131||
48536111|NCT00985712|101647265|FG001|Received at Least One Dose of Study Drug|Overall Study||130||
48536112|NCT00985712|101647264|FG000|Full Analysis Set (FAS)|Overall Study||128||
48536113|NCT00985712|101647265|FG001|Full Analysis Set (FAS)|Overall Study||129||
48536114|NCT00985712|101647264|FG000|COMPLETED|Overall Study||127||
48536115|NCT00985712|101647265|FG001|COMPLETED|Overall Study||123||
48536116|NCT00985712|101647264|FG000|NOT COMPLETED|Overall Study||6||
48536117|NCT00985712|101647265|FG001|NOT COMPLETED|Overall Study||7||
48536118|NCT02283983|101647266|FG000|STARTED|Overall Study||141||
48536119|NCT02283983|101647267|FG001|STARTED|Overall Study||139||
48536120|NCT02283983|101647266|FG000|COMPLETED|Overall Study||123||
48536121|NCT02283983|101647267|FG001|COMPLETED|Overall Study||120||
48536122|NCT02283983|101647266|FG000|NOT COMPLETED|Overall Study||18||
48536123|NCT02283983|101647267|FG001|NOT COMPLETED|Overall Study||19||
48235540|NCT02132195|100897757|FG002|NOT COMPLETED|Initial Assignment||0||
48235541|NCT02132195|100897755|FG000|STARTED|Rescue Therapy||0|There was an option for No-treatment pts to be placed on ACTH (rescue therapy). 13 pts used it|
48235542|NCT02132195|100897756|FG001|STARTED|Rescue Therapy||0|There was an option for No-treatment pts to be placed on ACTH (rescue therapy). 13 pts used it|
48235543|NCT02132195|100897757|FG002|STARTED|Rescue Therapy||13|There was an option for No-treatment pts to be placed on ACTH (rescue therapy). 13 pts used it|
48536124|NCT00528411|101647268|FG000|STARTED|Overall Study||57||
48536125|NCT00528411|101647269|FG001|STARTED|Overall Study||54||
48536126|NCT00528411|101647270|FG002|STARTED|Overall Study||12||
48536127|NCT00528411|101647268|FG000|COMPLETED|Overall Study||52||
48536128|NCT00528411|101647269|FG001|COMPLETED|Overall Study||51||
48536129|NCT00528411|101647270|FG002|COMPLETED|Overall Study||11||
48536130|NCT00528411|101647268|FG000|NOT COMPLETED|Overall Study||5||
48536131|NCT00528411|101647269|FG001|NOT COMPLETED|Overall Study||3||
48536132|NCT00528411|101647270|FG002|NOT COMPLETED|Overall Study||1||
48536133|NCT05819203|101647271|FG000|STARTED|Overall Study||100||
48536134|NCT05819203|101647272|FG001|STARTED|Overall Study||100||
48536135|NCT05819203|101647271|FG000|COMPLETED|Overall Study||98||
48536136|NCT05819203|101647272|FG001|COMPLETED|Overall Study||98||
48536137|NCT05819203|101647271|FG000|NOT COMPLETED|Overall Study||2||
48235544|NCT02132195|100897755|FG000|COMPLETED|Rescue Therapy||0||
48235545|NCT02132195|100897756|FG001|COMPLETED|Rescue Therapy||0||
48235546|NCT02132195|100897757|FG002|COMPLETED|Rescue Therapy||2||
48235547|NCT02132195|100897755|FG000|NOT COMPLETED|Rescue Therapy||0||
48235548|NCT02132195|100897756|FG001|NOT COMPLETED|Rescue Therapy||0||
48235549|NCT02132195|100897757|FG002|NOT COMPLETED|Rescue Therapy||11||
48235550|NCT01248715|100897758|FG000|STARTED|Overall Study||556||
48536138|NCT05819203|101647272|FG001|NOT COMPLETED|Overall Study||2||
48536139|NCT01778686|101647273|FG000|STARTED|Overall Study||8||
48536140|NCT01778686|101647274|FG001|STARTED|Overall Study||8||
48536141|NCT01778686|101647275|FG002|STARTED|Overall Study||8||
48536142|NCT01778686|101647273|FG000|COMPLETED|Overall Study||8||
48536143|NCT01778686|101647274|FG001|COMPLETED|Overall Study||8||
48536144|NCT01778686|101647275|FG002|COMPLETED|Overall Study||7||
48536145|NCT01778686|101647273|FG000|NOT COMPLETED|Overall Study||0||
48536146|NCT01778686|101647274|FG001|NOT COMPLETED|Overall Study||0||
48536147|NCT01778686|101647275|FG002|NOT COMPLETED|Overall Study||1||
48536148|NCT04730349|101647276|FG000|STARTED|Overall Study||8|Started = Started treatment|
48536149|NCT04730349|101647277|FG001|STARTED|Overall Study||7|Started = Started treatment|
48536150|NCT04730349|101647276|FG000|COMPLETED|Overall Study||1|Completed = Completed treatment|
48536151|NCT04730349|101647277|FG001|COMPLETED|Overall Study||2|Completed = Completed treatment|
48536152|NCT04730349|101647276|FG000|NOT COMPLETED|Overall Study||7||
48536153|NCT04730349|101647277|FG001|NOT COMPLETED|Overall Study||5||
48536154|NCT01367665|101647278|FG000|STARTED|Overall Study||1119||
48536155|NCT01367665|101647279|FG001|STARTED|Overall Study||96||
48235551|NCT01248715|100897759|FG001|STARTED|Overall Study||551||
48235552|NCT01248715|100897758|FG000|COMPLETED|Overall Study||55||
48235553|NCT01248715|100897759|FG001|COMPLETED|Overall Study||41||
48235554|NCT01248715|100897758|FG000|NOT COMPLETED|Overall Study||501||
48235555|NCT01248715|100897759|FG001|NOT COMPLETED|Overall Study||510||
48235556|NCT02091102|100897760|FG000|STARTED|Overall Study||20||
48536156|NCT01367665|101647278|FG000|COMPLETED|Overall Study||677||
48536157|NCT01367665|101647279|FG001|COMPLETED|Overall Study||41||
48536158|NCT01367665|101647278|FG000|NOT COMPLETED|Overall Study||442||
48536159|NCT01367665|101647279|FG001|NOT COMPLETED|Overall Study||55||
48536160|NCT01910389|101647280|FG000|STARTED|Overall Study||15||
48536161|NCT01910389|101647281|FG001|STARTED|Overall Study||8||
48536162|NCT01910389|101647280|FG000|COMPLETED|Overall Study||0||
48536163|NCT01910389|101647281|FG001|COMPLETED|Overall Study||0||
48536164|NCT01910389|101647280|FG000|NOT COMPLETED|Overall Study||15||
48536165|NCT01910389|101647281|FG001|NOT COMPLETED|Overall Study||8||
48536166|NCT01695863|101647282|FG000|STARTED|Overall Study||62||
48536167|NCT01695863|101647283|FG001|STARTED|Overall Study||66||
48536168|NCT01695863|101647282|FG000|COMPLETED|Overall Study||62||
48536169|NCT01695863|101647283|FG001|COMPLETED|Overall Study||66||
48536170|NCT01695863|101647282|FG000|NOT COMPLETED|Overall Study||0||
48536171|NCT01695863|101647283|FG001|NOT COMPLETED|Overall Study||0||
48536172|NCT04715932|101647284|FG000|STARTED|Overall Study||107||
48536173|NCT04715932|101647285|FG001|STARTED|Overall Study||109||
48536174|NCT04715932|101647284|FG000|COMPLETED|Overall Study||106||
48536175|NCT04715932|101647285|FG001|COMPLETED|Overall Study||109||
48536176|NCT04715932|101647284|FG000|NOT COMPLETED|Overall Study||1||
48536177|NCT04715932|101647285|FG001|NOT COMPLETED|Overall Study||0||
48536178|NCT01341782|101647286|FG000|STARTED|Overall Study||127||
48536179|NCT01341782|101647287|FG001|STARTED|Overall Study||128||
48235557|NCT02091102|100897760|FG000|COMPLETED|Overall Study||20||
48235558|NCT02091102|100897760|FG000|NOT COMPLETED|Overall Study||0||
48235559|NCT02605876|100897761|FG000|STARTED|Overall Study||25||
48235560|NCT02605876|100897762|FG001|STARTED|Overall Study||25||
48536180|NCT01341782|101647286|FG000|COMPLETED|Overall Study||112||
48536181|NCT01341782|101647287|FG001|COMPLETED|Overall Study||114||
48536182|NCT01341782|101647286|FG000|NOT COMPLETED|Overall Study||15||
48536183|NCT01341782|101647287|FG001|NOT COMPLETED|Overall Study||14||
48536184|NCT04645264|101647288|FG000|STARTED|Overall Study||3||
48536185|NCT04645264|101647289|FG001|STARTED|Overall Study||2||
48536186|NCT04645264|101647290|FG002|STARTED|Overall Study||2||
48536187|NCT04645264|101647288|FG000|COMPLETED|Overall Study||3||
48536188|NCT04645264|101647289|FG001|COMPLETED|Overall Study||2||
48536189|NCT04645264|101647290|FG002|COMPLETED|Overall Study||2||
48536190|NCT04645264|101647288|FG000|NOT COMPLETED|Overall Study||0||
48536191|NCT04645264|101647289|FG001|NOT COMPLETED|Overall Study||0||
48536192|NCT04645264|101647290|FG002|NOT COMPLETED|Overall Study||0||
48536193|NCT01136967|101647291|FG000|STARTED|Overall Study||93||
48536194|NCT01136967|101647292|FG001|STARTED|Overall Study||89||
48536195|NCT01136967|101647291|FG000|Disease Progression|Overall Study||55||
48235561|NCT02605876|100897763|FG002|STARTED|Overall Study||25||
48536196|NCT01136967|101647292|FG001|Disease Progression|Overall Study||56||
48536197|NCT01136967|101647291|FG000|Treatment Ongoing at Data Cutoff|Overall Study||14||
48536198|NCT01136967|101647292|FG001|Treatment Ongoing at Data Cutoff|Overall Study||6||
48235562|NCT02605876|100897761|FG000|COMPLETED|Overall Study||25||
48235563|NCT02605876|100897762|FG001|COMPLETED|Overall Study||25||
48536199|NCT01136967|101647291|FG000|COMPLETED|Overall Study||69||
48536200|NCT01136967|101647292|FG001|COMPLETED|Overall Study||62||
48536201|NCT01136967|101647291|FG000|NOT COMPLETED|Overall Study||24||
48536202|NCT01136967|101647292|FG001|NOT COMPLETED|Overall Study||27||
48536203|NCT02640053|101647293|FG000|STARTED|Overall Study||21|Treatment|
48536204|NCT02640053|101647294|FG001|STARTED|Overall Study||21|Treatment|
48536205|NCT02640053|101647293|FG000|COMPLETED|Overall Study||17||
48536206|NCT02640053|101647294|FG001|COMPLETED|Overall Study||17||
48536207|NCT02640053|101647293|FG000|NOT COMPLETED|Overall Study||4||
48536208|NCT02640053|101647294|FG001|NOT COMPLETED|Overall Study||4||
48536209|NCT03875859|101647295|FG000|STARTED|Overall Study||4||
48536210|NCT03875859|101647295|FG000|COMPLETED|Overall Study||4||
48536211|NCT03875859|101647295|FG000|NOT COMPLETED|Overall Study||0||
48536212|NCT03753763|101647296|FG000|STARTED|Overall Study||32||
48536213|NCT03753763|101647297|FG001|STARTED|Overall Study||17||
48536214|NCT03753763|101647296|FG000|COMPLETED|Overall Study||26|Completed the study (at week 14)|
48536215|NCT03753763|101647297|FG001|COMPLETED|Overall Study||16|Completed the study (at week 14)|
48536216|NCT03753763|101647296|FG000|NOT COMPLETED|Overall Study||6||
48536217|NCT03753763|101647297|FG001|NOT COMPLETED|Overall Study||1||
48536218|NCT03560986|101647298|FG000|STARTED|Treatment Period A/Follow-up Period 1||48||
48536219|NCT03560986|101647299|FG001|STARTED|Treatment Period A/Follow-up Period 1||51||
48536220|NCT03560986|101647298|FG000|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||45||
48536221|NCT03560986|101647299|FG001|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||45||
48536222|NCT03560986|101647298|FG000|COMPLETED|Treatment Period A/Follow-up Period 1||12|Participants completing Follow-up Period 1.|
48536223|NCT03560986|101647299|FG001|COMPLETED|Treatment Period A/Follow-up Period 1||13|Participants completing Follow-up Period 1.|
48536224|NCT03560986|101647298|FG000|NOT COMPLETED|Treatment Period A/Follow-up Period 1||36||
48536225|NCT03560986|101647299|FG001|NOT COMPLETED|Treatment Period A/Follow-up Period 1||38||
48536226|NCT03560986|101647298|FG000|STARTED|Treatment Period B/Follow-up Period 2||9||
48536227|NCT03560986|101647299|FG001|STARTED|Treatment Period B/Follow-up Period 2||8||
48536228|NCT03560986|101647298|FG000|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||8||
48536229|NCT03560986|101647299|FG001|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||8||
48536230|NCT03560986|101647298|FG000|COMPLETED|Treatment Period B/Follow-up Period 2||1|Participants completing Follow-up Period 2.|
48536231|NCT03560986|101647299|FG001|COMPLETED|Treatment Period B/Follow-up Period 2||0|Participants completing Follow-up Period 2.|
48536232|NCT03560986|101647298|FG000|NOT COMPLETED|Treatment Period B/Follow-up Period 2||8||
48235564|NCT02605876|100897763|FG002|COMPLETED|Overall Study||25||
48235565|NCT02605876|100897761|FG000|NOT COMPLETED|Overall Study||0||
48235566|NCT02605876|100897762|FG001|NOT COMPLETED|Overall Study||0||
48235567|NCT02605876|100897763|FG002|NOT COMPLETED|Overall Study||0||
48235568|NCT02109172|100897764|FG000|STARTED|Overall Study||11||
48235569|NCT02109172|100897765|FG001|STARTED|Overall Study||11||
48536233|NCT03560986|101647299|FG001|NOT COMPLETED|Treatment Period B/Follow-up Period 2||8||
48235570|NCT02109172|100897766|FG002|STARTED|Overall Study||10||
48235571|NCT02109172|100897767|FG003|STARTED|Overall Study||11||
48536234|NCT00296231|101647300|FG000|STARTED|Overall Study||14||
48536235|NCT00296231|101647300|FG000|COMPLETED|Overall Study||14||
48536236|NCT00296231|101647300|FG000|NOT COMPLETED|Overall Study||0||
48536237|NCT03694327|101647301|FG000|STARTED|Overall Study||79||
48536238|NCT03694327|101647302|FG001|STARTED|Overall Study||79||
48536239|NCT03694327|101647301|FG000|COMPLETED|Overall Study||66||
48536240|NCT03694327|101647302|FG001|COMPLETED|Overall Study||56||
48536241|NCT03694327|101647301|FG000|NOT COMPLETED|Overall Study||13||
48536242|NCT03694327|101647302|FG001|NOT COMPLETED|Overall Study||23||
48536243|NCT02085135|101647303|FG000|STARTED|Overall Study||34||
48536244|NCT02085135|101647304|FG001|STARTED|Overall Study||32||
48536245|NCT02085135|101647303|FG000|COMPLETED|Overall Study||23||
48536246|NCT02085135|101647304|FG001|COMPLETED|Overall Study||23||
48536247|NCT02085135|101647303|FG000|NOT COMPLETED|Overall Study||11||
48536248|NCT02085135|101647304|FG001|NOT COMPLETED|Overall Study||9||
48536249|NCT01740726|101651518|FG000|STARTED|Overall Study||0||
48536250|NCT01740726|101651519|FG001|STARTED|Overall Study||1||
48536251|NCT01740726|101651518|FG000|COMPLETED|Overall Study||0||
48536252|NCT01740726|101651519|FG001|COMPLETED|Overall Study||1||
48536253|NCT01740726|101651518|FG000|NOT COMPLETED|Overall Study||0||
48536254|NCT01740726|101651519|FG001|NOT COMPLETED|Overall Study||0||
48536255|NCT03247816|101651520|FG000|STARTED|Overall Study||59||
48536256|NCT03247816|101651520|FG000|COMPLETED|Overall Study||30||
48536257|NCT03247816|101651520|FG000|NOT COMPLETED|Overall Study||29||
48536258|NCT01822275|101651521|FG000|STARTED|Overall Study||24||
48536259|NCT01822275|101651521|FG000|COMPLETED|Overall Study||2||
48536260|NCT01822275|101651521|FG000|NOT COMPLETED|Overall Study||22||
48536261|NCT02504671|101651522|FG000|STARTED|Overall Study||37||
48536262|NCT02504671|101651523|FG001|STARTED|Overall Study||37||
48536263|NCT02504671|101651524|FG002|STARTED|Overall Study||37||
48536264|NCT02504671|101651525|FG003|STARTED|Overall Study||37||
48536265|NCT02504671|101651526|FG004|STARTED|Overall Study||37||
48536266|NCT02504671|101651527|FG005|STARTED|Overall Study||37||
48235572|NCT02109172|100897768|FG004|STARTED|Overall Study||10||
48235573|NCT02109172|100897769|FG005|STARTED|Overall Study||11||
48536267|NCT02504671|101651522|FG000|COMPLETED|Overall Study||25||
48536268|NCT02504671|101651523|FG001|COMPLETED|Overall Study||23||
48536269|NCT02504671|101651524|FG002|COMPLETED|Overall Study||27||
48536270|NCT02504671|101651525|FG003|COMPLETED|Overall Study||27||
48536271|NCT02504671|101651526|FG004|COMPLETED|Overall Study||25||
48235574|NCT02109172|100897764|FG000|COMPLETED|Overall Study||10||
48235575|NCT02109172|100897765|FG001|COMPLETED|Overall Study||11||
48235576|NCT02109172|100897766|FG002|COMPLETED|Overall Study||9||
48235577|NCT02109172|100897767|FG003|COMPLETED|Overall Study||10||
48235578|NCT02109172|100897768|FG004|COMPLETED|Overall Study||9||
48235579|NCT02109172|100897769|FG005|COMPLETED|Overall Study||10||
48235580|NCT02109172|100897764|FG000|NOT COMPLETED|Overall Study||1||
48235581|NCT02109172|100897765|FG001|NOT COMPLETED|Overall Study||0||
48235582|NCT02109172|100897766|FG002|NOT COMPLETED|Overall Study||1||
48235583|NCT02109172|100897767|FG003|NOT COMPLETED|Overall Study||1||
48235584|NCT02109172|100897768|FG004|NOT COMPLETED|Overall Study||1||
48235585|NCT02109172|100897769|FG005|NOT COMPLETED|Overall Study||1||
48235586|NCT04407442|100897770|FG000|STARTED|Overall Study||5||
48536272|NCT02504671|101651527|FG005|COMPLETED|Overall Study||23||
48536273|NCT02504671|101651522|FG000|NOT COMPLETED|Overall Study||12||
48235587|NCT04407442|100897770|FG000|COMPLETED|Overall Study||5||
48235588|NCT04407442|100897770|FG000|NOT COMPLETED|Overall Study||0||
48235589|NCT00617708|100897771|FG000|STARTED|Overall Study||10||
48235590|NCT00617708|100897772|FG001|STARTED|Overall Study||60||
48235591|NCT00617708|100897773|FG002|STARTED|Overall Study||64||
48235592|NCT00617708|100897771|FG000|Eligible and Began Protocol Therapy|Overall Study||9||
48536274|NCT02504671|101651523|FG001|NOT COMPLETED|Overall Study||14||
48536275|NCT02504671|101651524|FG002|NOT COMPLETED|Overall Study||10||
48235593|NCT00617708|100897772|FG001|Eligible and Began Protocol Therapy|Overall Study||57||
48235594|NCT00617708|100897773|FG002|Eligible and Began Protocol Therapy|Overall Study||59||
48235595|NCT00617708|100897771|FG000|COMPLETED|Overall Study||0||
48235596|NCT00617708|100897772|FG001|COMPLETED|Overall Study||0||
48235597|NCT00617708|100897773|FG002|COMPLETED|Overall Study||0||
48235598|NCT00617708|100897771|FG000|NOT COMPLETED|Overall Study||10||
48235599|NCT00617708|100897772|FG001|NOT COMPLETED|Overall Study||60||
48235600|NCT00617708|100897773|FG002|NOT COMPLETED|Overall Study||64||
48235601|NCT01279447|100897774|FG000|STARTED|Overall Study||34||
48235602|NCT01279447|100897775|FG001|STARTED|Overall Study||34||
48235603|NCT01279447|100897774|FG000|COMPLETED|Overall Study||31||
48235604|NCT01279447|100897775|FG001|COMPLETED|Overall Study||33||
48235605|NCT01279447|100897774|FG000|NOT COMPLETED|Overall Study||3||
48235606|NCT01279447|100897775|FG001|NOT COMPLETED|Overall Study||1||
48235607|NCT02771366|100897776|FG000|STARTED|Period 1||15||
48235608|NCT02771366|100897777|FG001|STARTED|Period 1||15||
48235609|NCT02771366|100897776|FG000|COMPLETED|Period 1||15||
48235610|NCT02771366|100897777|FG001|COMPLETED|Period 1||13||
48235611|NCT02771366|100897776|FG000|NOT COMPLETED|Period 1||0||
48235612|NCT02771366|100897777|FG001|NOT COMPLETED|Period 1||2||
48235613|NCT02771366|100897776|FG000|STARTED|Period 2 (Crossover)||15||
48235614|NCT02771366|100897777|FG001|STARTED|Period 2 (Crossover)||13||
48235615|NCT02771366|100897776|FG000|COMPLETED|Period 2 (Crossover)||13||
48235616|NCT02771366|100897777|FG001|COMPLETED|Period 2 (Crossover)||13||
48235617|NCT02771366|100897776|FG000|NOT COMPLETED|Period 2 (Crossover)||2||
48235618|NCT02771366|100897777|FG001|NOT COMPLETED|Period 2 (Crossover)||0||
48235619|NCT02708498|100897778|FG000|STARTED|Overall Study||42||
48235620|NCT02708498|100897779|FG001|STARTED|Overall Study||40||
48235621|NCT02708498|100897780|FG002|STARTED|Overall Study||152||
48235622|NCT02708498|100897781|FG003|STARTED|Overall Study||156||
48235623|NCT02708498|100897782|FG004|STARTED|Overall Study||363||
48235624|NCT02708498|100897783|FG005|STARTED|Overall Study||330||
48235625|NCT02708498|100897784|FG006|STARTED|Overall Study||20||
48235626|NCT02708498|100897785|FG007|STARTED|Overall Study||48||
48235627|NCT02708498|100897778|FG000|COMPLETED|Overall Study||22||
48536276|NCT02504671|101651525|FG003|NOT COMPLETED|Overall Study||10||
48536277|NCT02504671|101651526|FG004|NOT COMPLETED|Overall Study||12||
48536278|NCT02504671|101651527|FG005|NOT COMPLETED|Overall Study||14||
48536279|NCT04308226|101651528|FG000|STARTED|Overall Study||87||
48536280|NCT04308226|101651529|FG001|STARTED|Overall Study||173||
48536281|NCT04308226|101651528|FG000|COMPLETED|Overall Study||87||
48536282|NCT04308226|101651529|FG001|COMPLETED|Overall Study||173||
48235628|NCT02708498|100897779|FG001|COMPLETED|Overall Study||21||
48235629|NCT02708498|100897780|FG002|COMPLETED|Overall Study||90||
48235630|NCT02708498|100897781|FG003|COMPLETED|Overall Study||105||
48235631|NCT02708498|100897782|FG004|COMPLETED|Overall Study||167||
48235632|NCT02708498|100897783|FG005|COMPLETED|Overall Study||198||
48235633|NCT02708498|100897784|FG006|COMPLETED|Overall Study||20||
48235634|NCT02708498|100897785|FG007|COMPLETED|Overall Study||48||
48235635|NCT02708498|100897778|FG000|NOT COMPLETED|Overall Study||20||
48235636|NCT02708498|100897779|FG001|NOT COMPLETED|Overall Study||19||
48235637|NCT02708498|100897780|FG002|NOT COMPLETED|Overall Study||62||
48536283|NCT04308226|101651528|FG000|NOT COMPLETED|Overall Study||0||
48536284|NCT04308226|101651529|FG001|NOT COMPLETED|Overall Study||0||
48536285|NCT01120704|101651530|FG000|STARTED|Overall Study||13||
48235638|NCT02708498|100897781|FG003|NOT COMPLETED|Overall Study||51||
48536286|NCT01120704|101651531|FG001|STARTED|Overall Study||17||
48536287|NCT01120704|101651532|FG002|STARTED|Overall Study||14||
48536288|NCT01120704|101651533|FG003|STARTED|Overall Study||19||
48235639|NCT02708498|100897782|FG004|NOT COMPLETED|Overall Study||196||
48235640|NCT02708498|100897783|FG005|NOT COMPLETED|Overall Study||132||
48235641|NCT02708498|100897784|FG006|NOT COMPLETED|Overall Study||0||
48235642|NCT02708498|100897785|FG007|NOT COMPLETED|Overall Study||0||
48235643|NCT00925548|100897786|FG000|STARTED|Overall Study||11||
48235644|NCT00925548|100897787|FG001|STARTED|Overall Study||5||
48536289|NCT01120704|101651534|FG004|STARTED|Overall Study||16||
48536290|NCT01120704|101651535|FG005|STARTED|Overall Study||19||
48536291|NCT01120704|101651536|FG006|STARTED|Overall Study||15||
48536292|NCT01120704|101651537|FG007|STARTED|Overall Study||15||
48536293|NCT01120704|101651538|FG008|STARTED|Overall Study||22||
48536294|NCT01120704|101651539|FG009|STARTED|Overall Study||20||
48536295|NCT01120704|101651540|FG010|STARTED|Overall Study||17||
48536296|NCT01120704|101651541|FG011|STARTED|Overall Study||16||
48536297|NCT01120704|101651542|FG012|STARTED|Overall Study||17||
48536298|NCT01120704|101651543|FG013|STARTED|Overall Study||19||
48536299|NCT01120704|101651544|FG014|STARTED|Overall Study||18||
48536300|NCT01120704|101651545|FG015|STARTED|Overall Study||18||
48536301|NCT01120704|101651546|FG016|STARTED|Overall Study||14||
48536302|NCT01120704|101651547|FG017|STARTED|Overall Study||16||
48536303|NCT01120704|101651548|FG018|STARTED|Overall Study||17||
48536304|NCT01120704|101651549|FG019|STARTED|Overall Study||18||
48536305|NCT01120704|101651550|FG020|STARTED|Overall Study||17||
48536306|NCT01120704|101651551|FG021|STARTED|Overall Study||16||
48235645|NCT00925548|100897786|FG000|COMPLETED|Overall Study||1||
48235646|NCT00925548|100897787|FG001|COMPLETED|Overall Study||0||
48235647|NCT00925548|100897786|FG000|NOT COMPLETED|Overall Study||10||
48235648|NCT00925548|100897787|FG001|NOT COMPLETED|Overall Study||5||
48235649|NCT01697956|100897788|FG000|STARTED|Overall Study||67||
48235650|NCT01697956|100897789|FG001|STARTED|Overall Study||32||
48235651|NCT01697956|100897788|FG000|Per Protocol Population|Overall Study||66||
48235652|NCT01697956|100897789|FG001|Per Protocol Population|Overall Study||31||
48235653|NCT01697956|100897788|FG000|COMPLETED|Overall Study||66||
48235654|NCT01697956|100897789|FG001|COMPLETED|Overall Study||31||
48235655|NCT01697956|100897788|FG000|NOT COMPLETED|Overall Study||1||
48235656|NCT01697956|100897789|FG001|NOT COMPLETED|Overall Study||1||
48235657|NCT00805792|100897790|FG000|STARTED|Overall Study||33||
48235658|NCT00805792|100897790|FG000|COMPLETED|Overall Study||28||
48235659|NCT00805792|100897790|FG000|NOT COMPLETED|Overall Study||5||
48235660|NCT02416102|100897791|FG000|STARTED|Overall Study||16||
48235661|NCT02416102|100897792|FG001|STARTED|Overall Study||15||
48235662|NCT02416102|100897793|FG002|STARTED|Overall Study||0||
48235663|NCT02416102|100897791|FG000|COMPLETED|Overall Study||7||
48235664|NCT02416102|100897792|FG001|COMPLETED|Overall Study||7||
48536307|NCT01120704|101651552|FG022|STARTED|Overall Study||21||
48536308|NCT01120704|101651553|FG023|STARTED|Overall Study||16||
48536309|NCT01120704|101651554|FG024|STARTED|Overall Study||18||
48536310|NCT01120704|101651555|FG025|STARTED|Overall Study||14||
48536311|NCT01120704|101651556|FG026|STARTED|Overall Study||18||
48235665|NCT02416102|100897793|FG002|COMPLETED|Overall Study||0||
48536312|NCT01120704|101651557|FG027|STARTED|Overall Study||18||
48536313|NCT01120704|101651558|FG028|STARTED|Overall Study||19||
48536314|NCT01120704|101651559|FG029|STARTED|Overall Study||15||
48536315|NCT01120704|101651560|FG030|STARTED|Overall Study||14||
48536316|NCT01120704|101651561|FG031|STARTED|Overall Study||18||
48536317|NCT01120704|101651530|FG000|COMPLETED|Overall Study||10||
48536318|NCT01120704|101651531|FG001|COMPLETED|Overall Study||13||
48536319|NCT01120704|101651532|FG002|COMPLETED|Overall Study||13||
48536320|NCT01120704|101651533|FG003|COMPLETED|Overall Study||15||
48536321|NCT01120704|101651534|FG004|COMPLETED|Overall Study||14||
48536322|NCT01120704|101651535|FG005|COMPLETED|Overall Study||18||
48536323|NCT01120704|101651536|FG006|COMPLETED|Overall Study||12||
48536324|NCT01120704|101651537|FG007|COMPLETED|Overall Study||13||
48536325|NCT01120704|101651538|FG008|COMPLETED|Overall Study||19||
48536326|NCT01120704|101651539|FG009|COMPLETED|Overall Study||19||
48536327|NCT01120704|101651540|FG010|COMPLETED|Overall Study||16||
48536328|NCT01120704|101651541|FG011|COMPLETED|Overall Study||14||
48536329|NCT01120704|101651542|FG012|COMPLETED|Overall Study||14||
48536330|NCT01120704|101651543|FG013|COMPLETED|Overall Study||15||
48235666|NCT02416102|100897791|FG000|NOT COMPLETED|Overall Study||9||
48235667|NCT02416102|100897792|FG001|NOT COMPLETED|Overall Study||8||
48235668|NCT02416102|100897793|FG002|NOT COMPLETED|Overall Study||0||
48235669|NCT04471805|100897794|FG000|STARTED|Overall Study||10||
48235670|NCT04471805|100897794|FG000|tDCS, Early Follicular Phase|Overall Study||10||
48536331|NCT01120704|101651544|FG014|COMPLETED|Overall Study||17||
48536332|NCT01120704|101651545|FG015|COMPLETED|Overall Study||16||
48536333|NCT01120704|101651546|FG016|COMPLETED|Overall Study||13||
48536334|NCT01120704|101651547|FG017|COMPLETED|Overall Study||16||
48536335|NCT01120704|101651548|FG018|COMPLETED|Overall Study||15||
48536336|NCT01120704|101651549|FG019|COMPLETED|Overall Study||15||
48536337|NCT01120704|101651550|FG020|COMPLETED|Overall Study||14||
48536338|NCT01120704|101651551|FG021|COMPLETED|Overall Study||16||
48536339|NCT01120704|101651552|FG022|COMPLETED|Overall Study||17||
48536340|NCT01120704|101651553|FG023|COMPLETED|Overall Study||13||
48536341|NCT01120704|101651554|FG024|COMPLETED|Overall Study||16||
48536342|NCT01120704|101651555|FG025|COMPLETED|Overall Study||14||
48536343|NCT01120704|101651556|FG026|COMPLETED|Overall Study||15||
48536344|NCT01120704|101651557|FG027|COMPLETED|Overall Study||16||
48536345|NCT01120704|101651558|FG028|COMPLETED|Overall Study||14||
48536346|NCT01120704|101651559|FG029|COMPLETED|Overall Study||12||
48536347|NCT01120704|101651560|FG030|COMPLETED|Overall Study||12||
48536348|NCT01120704|101651561|FG031|COMPLETED|Overall Study||17||
48536349|NCT01120704|101651530|FG000|NOT COMPLETED|Overall Study||3||
48536350|NCT01120704|101651531|FG001|NOT COMPLETED|Overall Study||4||
48536351|NCT01120704|101651532|FG002|NOT COMPLETED|Overall Study||1||
48536352|NCT01120704|101651533|FG003|NOT COMPLETED|Overall Study||4||
48536353|NCT01120704|101651534|FG004|NOT COMPLETED|Overall Study||2||
48536354|NCT01120704|101651535|FG005|NOT COMPLETED|Overall Study||1||
48536355|NCT01120704|101651536|FG006|NOT COMPLETED|Overall Study||3||
48536356|NCT01120704|101651537|FG007|NOT COMPLETED|Overall Study||2||
48536357|NCT01120704|101651538|FG008|NOT COMPLETED|Overall Study||3||
48536358|NCT01120704|101651539|FG009|NOT COMPLETED|Overall Study||1||
48235671|NCT04471805|100897794|FG000|Sham, Early Follicular Phase|Overall Study||10||
48235672|NCT04471805|100897794|FG000|tDCS, Late Follicular Phase|Overall Study||10||
48235673|NCT04471805|100897794|FG000|Sham, Late Follicular Phase|Overall Study||10||
48235674|NCT04471805|100897794|FG000|tDCS, Mid-Luteal Phase|Overall Study||10||
48235675|NCT04471805|100897794|FG000|Sham, Mid-Luteal Phase|Overall Study||10||
48235676|NCT04471805|100897794|FG000|COMPLETED|Overall Study||10||
48235677|NCT04471805|100897794|FG000|NOT COMPLETED|Overall Study||0||
48235678|NCT01318356|100897795|FG000|STARTED|Overall Study||51||
48235679|NCT01318356|100897796|FG001|STARTED|Overall Study||52||
48235680|NCT01318356|100897797|FG002|STARTED|Overall Study||52||
48235681|NCT01318356|100897795|FG000|COMPLETED|Overall Study||43||
48235682|NCT01318356|100897796|FG001|COMPLETED|Overall Study||49||
48235683|NCT01318356|100897797|FG002|COMPLETED|Overall Study||50||
48235684|NCT01318356|100897795|FG000|NOT COMPLETED|Overall Study||8||
48235685|NCT01318356|100897796|FG001|NOT COMPLETED|Overall Study||3||
48235686|NCT01318356|100897797|FG002|NOT COMPLETED|Overall Study||2||
48235687|NCT02791308|100897798|FG000|STARTED|Overall Study||195||
48235688|NCT02791308|100897799|FG001|STARTED|Overall Study||196||
48235689|NCT02791308|100897800|FG002|STARTED|Overall Study||196||
48235690|NCT02791308|100897798|FG000|COMPLETED|Overall Study||185||
48235691|NCT02791308|100897799|FG001|COMPLETED|Overall Study||187||
48235692|NCT02791308|100897800|FG002|COMPLETED|Overall Study||179||
48235693|NCT02791308|100897798|FG000|NOT COMPLETED|Overall Study||10||
48235694|NCT02791308|100897799|FG001|NOT COMPLETED|Overall Study||9||
48235695|NCT02791308|100897800|FG002|NOT COMPLETED|Overall Study||17||
48235696|NCT00451906|100897801|FG000|STARTED|Overall Study||2252||
48235697|NCT00451906|100897801|FG000|COMPLETED|Overall Study||13||
48235698|NCT00451906|100897801|FG000|NOT COMPLETED|Overall Study||2239||
48235699|NCT00141271|100897802|FG000|STARTED|Overall Study||171||
48235700|NCT00141271|100897803|FG001|STARTED|Overall Study||165||
48235701|NCT00141271|100897804|FG002|STARTED|Overall Study||168||
48235702|NCT00141271|100897802|FG000|COMPLETED|Overall Study||91||
48235703|NCT00141271|100897803|FG001|COMPLETED|Overall Study||102||
48235704|NCT00141271|100897804|FG002|COMPLETED|Overall Study||111||
48235705|NCT00141271|100897802|FG000|NOT COMPLETED|Overall Study||80||
48235706|NCT00141271|100897803|FG001|NOT COMPLETED|Overall Study||63||
48235707|NCT00141271|100897804|FG002|NOT COMPLETED|Overall Study||57||
48235708|NCT03677986|100897805|FG000|STARTED|Overall Study||20||
48235709|NCT03677986|100897806|FG001|STARTED|Overall Study||21||
48235710|NCT03677986|100897805|FG000|COMPLETED|Overall Study||20||
48235711|NCT03677986|100897806|FG001|COMPLETED|Overall Study||21||
48235712|NCT03677986|100897805|FG000|NOT COMPLETED|Overall Study||0||
48235713|NCT03677986|100897806|FG001|NOT COMPLETED|Overall Study||0||
48235714|NCT00671853|100897807|FG000|STARTED|Overall Study||46||
48235715|NCT00671853|100897808|FG001|STARTED|Overall Study||45||
48235716|NCT00671853|100897807|FG000|COMPLETED|Overall Study||26||
48235717|NCT00671853|100897808|FG001|COMPLETED|Overall Study||18||
48235718|NCT00671853|100897807|FG000|NOT COMPLETED|Overall Study||20||
48235719|NCT00671853|100897808|FG001|NOT COMPLETED|Overall Study||27||
48235720|NCT02301299|100897809|FG000|STARTED|Overall Study||1322||
48536359|NCT01120704|101651540|FG010|NOT COMPLETED|Overall Study||1||
48536360|NCT01120704|101651541|FG011|NOT COMPLETED|Overall Study||2||
48536361|NCT01120704|101651542|FG012|NOT COMPLETED|Overall Study||3||
48536362|NCT01120704|101651543|FG013|NOT COMPLETED|Overall Study||4||
48536363|NCT01120704|101651544|FG014|NOT COMPLETED|Overall Study||1||
48536364|NCT01120704|101651545|FG015|NOT COMPLETED|Overall Study||2||
48536365|NCT01120704|101651546|FG016|NOT COMPLETED|Overall Study||1||
48536366|NCT01120704|101651547|FG017|NOT COMPLETED|Overall Study||0||
48536367|NCT01120704|101651548|FG018|NOT COMPLETED|Overall Study||2||
48536368|NCT01120704|101651549|FG019|NOT COMPLETED|Overall Study||3||
48536369|NCT01120704|101651550|FG020|NOT COMPLETED|Overall Study||3||
48536370|NCT01120704|101651551|FG021|NOT COMPLETED|Overall Study||0||
48536371|NCT01120704|101651552|FG022|NOT COMPLETED|Overall Study||4||
48536372|NCT01120704|101651553|FG023|NOT COMPLETED|Overall Study||3||
48235721|NCT02301299|100897809|FG000|COMPLETED|Overall Study||1322||
48536373|NCT01120704|101651554|FG024|NOT COMPLETED|Overall Study||2||
48536374|NCT01120704|101651555|FG025|NOT COMPLETED|Overall Study||0||
48235722|NCT02301299|100897809|FG000|NOT COMPLETED|Overall Study||0||
48235723|NCT00753896|100897810|FG000|STARTED|Overall Study||134||
48235724|NCT00753896|100897810|FG000|COMPLETED|Overall Study||118||
48235725|NCT00753896|100897810|FG000|NOT COMPLETED|Overall Study||16||
48235726|NCT00316121|100897811|FG000|STARTED|Overall Study||92||
48235727|NCT00316121|100897812|FG001|STARTED|Overall Study||46||
48235728|NCT00316121|100897811|FG000|COMPLETED|Overall Study||70||
48235729|NCT00316121|100897812|FG001|COMPLETED|Overall Study||37||
48235730|NCT00316121|100897811|FG000|NOT COMPLETED|Overall Study||22||
48235731|NCT00316121|100897812|FG001|NOT COMPLETED|Overall Study||9||
48235732|NCT03840993|100897813|FG000|STARTED|Overall Study||39||
48536375|NCT01120704|101651556|FG026|NOT COMPLETED|Overall Study||3||
48536376|NCT01120704|101651557|FG027|NOT COMPLETED|Overall Study||2||
48536377|NCT01120704|101651558|FG028|NOT COMPLETED|Overall Study||5||
48536378|NCT01120704|101651559|FG029|NOT COMPLETED|Overall Study||3||
48536379|NCT01120704|101651560|FG030|NOT COMPLETED|Overall Study||2||
48536380|NCT01120704|101651561|FG031|NOT COMPLETED|Overall Study||1||
48235733|NCT03840993|100897814|FG001|STARTED|Overall Study||37||
48235734|NCT03840993|100897813|FG000|COMPLETED|Overall Study||30||
48235735|NCT03840993|100897814|FG001|COMPLETED|Overall Study||30||
48536381|NCT02679235|101651562|FG000|STARTED|Overall Study||15||
48536382|NCT02679235|101651562|FG000|COMPLETED|Overall Study||11||
48536383|NCT02679235|101651562|FG000|NOT COMPLETED|Overall Study||4||
48536384|NCT00517556|101651563|FG000|STARTED|Overall Study||19||
48536385|NCT00517556|101651564|FG001|STARTED|Overall Study||19||
48536386|NCT00517556|101651563|FG000|COMPLETED|Overall Study||15||
48536387|NCT00517556|101651564|FG001|COMPLETED|Overall Study||14||
48235736|NCT03840993|100897813|FG000|NOT COMPLETED|Overall Study||9||
48235737|NCT03840993|100897814|FG001|NOT COMPLETED|Overall Study||7||
48235738|NCT03349476|100897815|FG000|STARTED|Overall Study||109||
48235739|NCT03349476|100897815|FG000|COMPLETED|Overall Study||106||
48235740|NCT03349476|100897815|FG000|NOT COMPLETED|Overall Study||3||
48235741|NCT03738826|100897816|FG000|STARTED|Overall Study||130||
48235742|NCT03738826|100897817|FG001|STARTED|Overall Study||5||
48235743|NCT03738826|100897816|FG000|COMPLETED|Overall Study||130||
48235744|NCT03738826|100897817|FG001|COMPLETED|Overall Study||5||
48235745|NCT03738826|100897816|FG000|NOT COMPLETED|Overall Study||0||
48235746|NCT03738826|100897817|FG001|NOT COMPLETED|Overall Study||0||
48235747|NCT03070301|100897818|FG000|STARTED|Overall Study||21||
48235748|NCT03070301|100897818|FG000|COMPLETED|Overall Study||1||
48235749|NCT03070301|100897818|FG000|NOT COMPLETED|Overall Study||20||
48235750|NCT02354144|100897819|FG000|STARTED|Overall Study||127||
48235751|NCT02354144|100897820|FG001|STARTED|Overall Study||128||
48235752|NCT02354144|100897819|FG000|COMPLETED|Overall Study||48||
48235753|NCT02354144|100897820|FG001|COMPLETED|Overall Study||51||
48235754|NCT02354144|100897819|FG000|NOT COMPLETED|Overall Study||79||
48235755|NCT02354144|100897820|FG001|NOT COMPLETED|Overall Study||77||
48235756|NCT02721147|100897821|FG000|STARTED|Overall Study||40||
48235757|NCT02721147|100897822|FG001|STARTED|Overall Study||18||
48235758|NCT02721147|100897823|FG002|STARTED|Overall Study||31||
48235759|NCT02721147|100897821|FG000|COMPLETED|Overall Study||38||
48235760|NCT02721147|100897822|FG001|COMPLETED|Overall Study||18||
48235761|NCT02721147|100897823|FG002|COMPLETED|Overall Study||31||
48235762|NCT02721147|100897821|FG000|NOT COMPLETED|Overall Study||2||
48235763|NCT02721147|100897822|FG001|NOT COMPLETED|Overall Study||0||
48235764|NCT02721147|100897823|FG002|NOT COMPLETED|Overall Study||0||
48235765|NCT00355784|100897824|FG000|STARTED|Overall Study||9||
48235766|NCT00355784|100897825|FG001|STARTED|Overall Study||8||
48235767|NCT00355784|100897826|FG002|STARTED|Overall Study||7||
48235768|NCT00355784|100897824|FG000|COMPLETED|Overall Study||9||
48235769|NCT00355784|100897825|FG001|COMPLETED|Overall Study||8||
48235770|NCT00355784|100897826|FG002|COMPLETED|Overall Study||5||
48235771|NCT00355784|100897824|FG000|NOT COMPLETED|Overall Study||0||
48235772|NCT00355784|100897825|FG001|NOT COMPLETED|Overall Study||0||
48235773|NCT00355784|100897826|FG002|NOT COMPLETED|Overall Study||2||
48235774|NCT00564447|100897827|FG000|STARTED|Overall Study||6||
48235775|NCT00564447|100897828|FG001|STARTED|Overall Study||6||
48235776|NCT00564447|100897829|FG002|STARTED|Overall Study||6||
48235777|NCT00564447|100897830|FG003|STARTED|Overall Study||6||
48235778|NCT00564447|100897831|FG004|STARTED|Overall Study||6||
48235779|NCT00564447|100897832|FG005|STARTED|Overall Study||6||
48536388|NCT00517556|101651563|FG000|NOT COMPLETED|Overall Study||4||
48536389|NCT00517556|101651564|FG001|NOT COMPLETED|Overall Study||5||
48536390|NCT00054665|101651565|FG000|STARTED|Part A||23||
48536391|NCT00054665|101651566|FG001|STARTED|Part A||0||
48536392|NCT00054665|101651565|FG000|COMPLETED|Part A||23||
48536393|NCT00054665|101651566|FG001|COMPLETED|Part A||0||
48536394|NCT00054665|101651565|FG000|NOT COMPLETED|Part A||0||
48536395|NCT00054665|101651566|FG001|NOT COMPLETED|Part A||0||
48536396|NCT00054665|101651565|FG000|STARTED|Part B||0||
48536397|NCT00054665|101651566|FG001|STARTED|Part B||44||
48536398|NCT00054665|101651565|FG000|COMPLETED|Part B||0||
48536399|NCT00054665|101651566|FG001|COMPLETED|Part B||44||
48536400|NCT00054665|101651565|FG000|NOT COMPLETED|Part B||0||
48235780|NCT00564447|100897833|FG006|STARTED|Overall Study||6||
48536401|NCT00054665|101651566|FG001|NOT COMPLETED|Part B||0||
48536402|NCT01231399|101651567|FG000|STARTED|Overall Study||6||
48235781|NCT00564447|100897834|FG007|STARTED|Overall Study||6||
48235782|NCT00564447|100897827|FG000|COMPLETED|Overall Study||6||
48235783|NCT00564447|100897828|FG001|COMPLETED|Overall Study||6||
48235784|NCT00564447|100897829|FG002|COMPLETED|Overall Study||6||
48235785|NCT00564447|100897830|FG003|COMPLETED|Overall Study||6||
48235786|NCT00564447|100897831|FG004|COMPLETED|Overall Study||6||
48235787|NCT00564447|100897832|FG005|COMPLETED|Overall Study||6||
48235788|NCT00564447|100897833|FG006|COMPLETED|Overall Study||6||
48235789|NCT00564447|100897834|FG007|COMPLETED|Overall Study||6||
48235790|NCT00564447|100897827|FG000|NOT COMPLETED|Overall Study||0||
48235791|NCT00564447|100897828|FG001|NOT COMPLETED|Overall Study||0||
48235792|NCT00564447|100897829|FG002|NOT COMPLETED|Overall Study||0||
48235793|NCT00564447|100897830|FG003|NOT COMPLETED|Overall Study||0||
48235794|NCT00564447|100897831|FG004|NOT COMPLETED|Overall Study||0||
48235795|NCT00564447|100897832|FG005|NOT COMPLETED|Overall Study||0||
48235796|NCT00564447|100897833|FG006|NOT COMPLETED|Overall Study||0||
48235797|NCT00564447|100897834|FG007|NOT COMPLETED|Overall Study||0||
48235798|NCT01029925|100897835|FG000|STARTED|Completion of Cycle 1 (28 Days)||7||
48235799|NCT01029925|100897835|FG000|COMPLETED|Completion of Cycle 1 (28 Days)||3||
48235800|NCT01029925|100897835|FG000|NOT COMPLETED|Completion of Cycle 1 (28 Days)||4||
48235801|NCT01029925|100897835|FG000|STARTED|Completion of Cycle 2 (56 Days)||3||
48235802|NCT01029925|100897835|FG000|COMPLETED|Completion of Cycle 2 (56 Days)||2||
48235803|NCT01029925|100897835|FG000|NOT COMPLETED|Completion of Cycle 2 (56 Days)||1||
48235804|NCT01640288|100897836|FG000|STARTED|Overall Study||100||
48235805|NCT01640288|100897837|FG001|STARTED|Overall Study||71||
48235806|NCT01640288|100897836|FG000|Received Allocated Intervention|Overall Study||70||
48235807|NCT01640288|100897837|FG001|Received Allocated Intervention|Overall Study||48||
48235808|NCT01640288|100897836|FG000|Did Not Receive Allocated Intervention|Overall Study||26||
48235809|NCT01640288|100897837|FG001|Did Not Receive Allocated Intervention|Overall Study||18||
48235810|NCT01640288|100897836|FG000|COMPLETED|Overall Study||70||
48235811|NCT01640288|100897837|FG001|COMPLETED|Overall Study||48||
48235812|NCT01640288|100897836|FG000|NOT COMPLETED|Overall Study||30||
48536403|NCT01231399|101651567|FG000|COMPLETED|Overall Study||6||
48536404|NCT01231399|101651567|FG000|NOT COMPLETED|Overall Study||0||
48235813|NCT01640288|100897837|FG001|NOT COMPLETED|Overall Study||23||
48235814|NCT01468597|100897838|FG000|STARTED|Overall Study||184||
48235815|NCT01468597|100897838|FG000|COMPLETED|Overall Study||149||
48235816|NCT01468597|100897838|FG000|NOT COMPLETED|Overall Study||35||
48235817|NCT00936065|100897839|FG000|STARTED|Overall Study||21||
48235818|NCT00936065|100897840|FG001|STARTED|Overall Study||20||
48235819|NCT00936065|100897841|FG002|STARTED|Overall Study||19||
48235820|NCT00936065|100897839|FG000|Received Treatment|Overall Study||21||
48235821|NCT00936065|100897840|FG001|Received Treatment|Overall Study||20||
48235822|NCT00936065|100897841|FG002|Received Treatment|Overall Study||18||
48235823|NCT00936065|100897839|FG000|Study Assessments Performed|Overall Study||21||
48235824|NCT00936065|100897840|FG001|Study Assessments Performed|Overall Study||19||
48235825|NCT00936065|100897841|FG002|Study Assessments Performed|Overall Study||18||
48235826|NCT00936065|100897839|FG000|COMPLETED|Overall Study||17||
48235827|NCT00936065|100897840|FG001|COMPLETED|Overall Study||16||
48235828|NCT00936065|100897841|FG002|COMPLETED|Overall Study||12||
48235829|NCT00936065|100897839|FG000|NOT COMPLETED|Overall Study||4||
48235830|NCT00936065|100897840|FG001|NOT COMPLETED|Overall Study||4||
48235831|NCT00936065|100897841|FG002|NOT COMPLETED|Overall Study||7||
48235832|NCT03928743|100900225|FG000|STARTED|Double-Blind Treatment Period:Weeks 1-16||111||
48235833|NCT03928743|100900226|FG001|STARTED|Double-Blind Treatment Period:Weeks 1-16||221||
48235834|NCT03928743|100900227|FG002|STARTED|Double-Blind Treatment Period:Weeks 1-16||0||
48235835|NCT03928743|100900225|FG000|COMPLETED|Double-Blind Treatment Period:Weeks 1-16||109||
48235836|NCT03928743|100900226|FG001|COMPLETED|Double-Blind Treatment Period:Weeks 1-16||213||
48235837|NCT03928743|100900227|FG002|COMPLETED|Double-Blind Treatment Period:Weeks 1-16||0||
48235838|NCT03928743|100900225|FG000|NOT COMPLETED|Double-Blind Treatment Period:Weeks 1-16||2||
48235839|NCT03928743|100900226|FG001|NOT COMPLETED|Double-Blind Treatment Period:Weeks 1-16||8||
48235840|NCT03928743|100900227|FG002|NOT COMPLETED|Double-Blind Treatment Period:Weeks 1-16||0||
48235841|NCT03928743|100900225|FG000|STARTED|Maintenance Period: Weeks 16-52||0||
48235842|NCT03928743|100900226|FG001|STARTED|Maintenance Period: Weeks 16-52||0||
48235843|NCT03928743|100900227|FG002|STARTED|Maintenance Period: Weeks 16-52||319||
48235844|NCT03928743|100900225|FG000|COMPLETED|Maintenance Period: Weeks 16-52||0||
48235845|NCT03928743|100900226|FG001|COMPLETED|Maintenance Period: Weeks 16-52||0||
48235846|NCT03928743|100900227|FG002|COMPLETED|Maintenance Period: Weeks 16-52||298||
48235847|NCT03928743|100900225|FG000|NOT COMPLETED|Maintenance Period: Weeks 16-52||0||
48235848|NCT03928743|100900226|FG001|NOT COMPLETED|Maintenance Period: Weeks 16-52||0||
48235849|NCT03928743|100900227|FG002|NOT COMPLETED|Maintenance Period: Weeks 16-52||21||
48235850|NCT04812977|100900228|FG000|STARTED|Overall Study||15||
48536405|NCT02903030|101651568|FG000|STARTED|First Intervention (8 Weeks)||8||
48536406|NCT02903030|101651569|FG001|STARTED|First Intervention (8 Weeks)||5||
48235851|NCT04812977|100900229|FG001|STARTED|Overall Study||15||
48235852|NCT04812977|100900228|FG000|COMPLETED|Overall Study||15||
48235853|NCT04812977|100900229|FG001|COMPLETED|Overall Study||15||
48536407|NCT02903030|101651568|FG000|Received Intervention|First Intervention (8 Weeks)||6||
48536408|NCT02903030|101651569|FG001|Received Intervention|First Intervention (8 Weeks)||4||
48536409|NCT02903030|101651568|FG000|COMPLETED|First Intervention (8 Weeks)||6||
48536410|NCT02903030|101651569|FG001|COMPLETED|First Intervention (8 Weeks)||4||
48536411|NCT02903030|101651568|FG000|NOT COMPLETED|First Intervention (8 Weeks)||2||
48536412|NCT02903030|101651569|FG001|NOT COMPLETED|First Intervention (8 Weeks)||1||
48536413|NCT02903030|101651568|FG000|STARTED|Washout (3 Weeks)||6||
48536414|NCT02903030|101651569|FG001|STARTED|Washout (3 Weeks)||4||
48536415|NCT02903030|101651568|FG000|COMPLETED|Washout (3 Weeks)||6||
48536416|NCT02903030|101651569|FG001|COMPLETED|Washout (3 Weeks)||4||
48536417|NCT02903030|101651568|FG000|NOT COMPLETED|Washout (3 Weeks)||0||
48536418|NCT02903030|101651569|FG001|NOT COMPLETED|Washout (3 Weeks)||0||
48536419|NCT02903030|101651568|FG000|STARTED|Second Intervention (8 Weeks)||6||
48536420|NCT02903030|101651569|FG001|STARTED|Second Intervention (8 Weeks)||4||
48536421|NCT02903030|101651568|FG000|COMPLETED|Second Intervention (8 Weeks)||6||
48536422|NCT02903030|101651569|FG001|COMPLETED|Second Intervention (8 Weeks)||4||
48536423|NCT02903030|101651568|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0||
48536424|NCT02903030|101651569|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0||
48536425|NCT04345601|101651570|FG000|STARTED|Overall Study||6||
48536426|NCT04345601|101651571|FG001|STARTED|Overall Study||10||
48536427|NCT04345601|101651572|FG002|STARTED|Overall Study||12||
48536428|NCT04345601|101651570|FG000|COMPLETED|Overall Study||6||
48536429|NCT04345601|101651571|FG001|COMPLETED|Overall Study||7||
48536430|NCT04345601|101651572|FG002|COMPLETED|Overall Study||8||
48536431|NCT04345601|101651570|FG000|NOT COMPLETED|Overall Study||0||
48536432|NCT04345601|101651571|FG001|NOT COMPLETED|Overall Study||3||
48536433|NCT04345601|101651572|FG002|NOT COMPLETED|Overall Study||4||
48536434|NCT04555720|101651573|FG000|STARTED|Overall Study||24||
48536435|NCT04555720|101651574|FG001|STARTED|Overall Study||25||
48536436|NCT04555720|101651575|FG002|STARTED|Overall Study||7||
48536437|NCT04555720|101651576|FG003|STARTED|Overall Study||5||
48536438|NCT04555720|101651573|FG000|COMPLETED|Overall Study||18||
48536439|NCT04555720|101651574|FG001|COMPLETED|Overall Study||19||
48536440|NCT04555720|101651575|FG002|COMPLETED|Overall Study||7||
48536441|NCT04555720|101651576|FG003|COMPLETED|Overall Study||5||
48536442|NCT04555720|101651573|FG000|NOT COMPLETED|Overall Study||6||
48235854|NCT04812977|100900228|FG000|NOT COMPLETED|Overall Study||0||
48235855|NCT04812977|100900229|FG001|NOT COMPLETED|Overall Study||0||
48235856|NCT01074034|100900230|FG000|STARTED|Overall Study||211||
48235857|NCT01074034|100900230|FG000|COMPLETED|Overall Study||205||
48235858|NCT01074034|100900230|FG000|NOT COMPLETED|Overall Study||6||
48536443|NCT04555720|101651574|FG001|NOT COMPLETED|Overall Study||6||
48536444|NCT04555720|101651575|FG002|NOT COMPLETED|Overall Study||0||
48536445|NCT04555720|101651576|FG003|NOT COMPLETED|Overall Study||0||
48536446|NCT03136965|101651577|FG000|STARTED|Overall Study||10||
48536447|NCT03136965|101651578|FG001|STARTED|Overall Study||10||
48536448|NCT03136965|101651579|FG002|STARTED|Overall Study||9||
48536449|NCT03136965|101651577|FG000|COMPLETED|Overall Study||10||
48536450|NCT03136965|101651578|FG001|COMPLETED|Overall Study||9||
48235859|NCT00264576|100900231|FG000|STARTED|Overall Study||308||
48235860|NCT00264576|100900232|FG001|STARTED|Overall Study||305||
48235861|NCT00264576|100900231|FG000|COMPLETED|Overall Study||307||
48235862|NCT00264576|100900232|FG001|COMPLETED|Overall Study||304||
48536451|NCT03136965|101651579|FG002|COMPLETED|Overall Study||9||
48536452|NCT03136965|101651577|FG000|NOT COMPLETED|Overall Study||0||
48536453|NCT03136965|101651578|FG001|NOT COMPLETED|Overall Study||1||
48536454|NCT03136965|101651579|FG002|NOT COMPLETED|Overall Study||0||
48536455|NCT03210714|101651580|FG000|STARTED|Overall Study||20||
48536456|NCT03210714|101651580|FG000|COMPLETED|Overall Study||0||
48536457|NCT03210714|101651580|FG000|NOT COMPLETED|Overall Study||20||
48536458|NCT02377427|101651581|FG000|STARTED|Part A (Up to Week 20)||26||
48536459|NCT02377427|101651582|FG001|STARTED|Part A (Up to Week 20)||10||
48536460|NCT02377427|101651583|FG002|STARTED|Part A (Up to Week 20)||0||
48536461|NCT02377427|101651584|FG003|STARTED|Part A (Up to Week 20)||0||
48536462|NCT02377427|101651585|FG004|STARTED|Part A (Up to Week 20)||0||
48536463|NCT02377427|101651581|FG000|COMPLETED|Part A (Up to Week 20)||22||
48536464|NCT02377427|101651582|FG001|COMPLETED|Part A (Up to Week 20)||10||
48536465|NCT02377427|101651583|FG002|COMPLETED|Part A (Up to Week 20)||0||
48536466|NCT02377427|101651584|FG003|COMPLETED|Part A (Up to Week 20)||0||
48536467|NCT02377427|101651585|FG004|COMPLETED|Part A (Up to Week 20)||0||
48536468|NCT02377427|101651581|FG000|NOT COMPLETED|Part A (Up to Week 20)||4||
48536469|NCT02377427|101651582|FG001|NOT COMPLETED|Part A (Up to Week 20)||0||
48536470|NCT02377427|101651583|FG002|NOT COMPLETED|Part A (Up to Week 20)||0||
48536471|NCT02377427|101651584|FG003|NOT COMPLETED|Part A (Up to Week 20)||0||
48536472|NCT02377427|101651585|FG004|NOT COMPLETED|Part A (Up to Week 20)||0||
48536473|NCT02377427|101651581|FG000|STARTED|Part B (From Week 20 and up to Week 80)||0||
48536474|NCT02377427|101651582|FG001|STARTED|Part B (From Week 20 and up to Week 80)||0||
48536475|NCT02377427|101651583|FG002|STARTED|Part B (From Week 20 and up to Week 80)||16||
48536476|NCT02377427|101651584|FG003|STARTED|Part B (From Week 20 and up to Week 80)||10||
48536477|NCT02377427|101651585|FG004|STARTED|Part B (From Week 20 and up to Week 80)||4||
48536478|NCT02377427|101651581|FG000|COMPLETED|Part B (From Week 20 and up to Week 80)||0||
48536479|NCT02377427|101651582|FG001|COMPLETED|Part B (From Week 20 and up to Week 80)||0||
48536480|NCT02377427|101651583|FG002|COMPLETED|Part B (From Week 20 and up to Week 80)||15||
48536481|NCT02377427|101651584|FG003|COMPLETED|Part B (From Week 20 and up to Week 80)||10||
48536482|NCT02377427|101651585|FG004|COMPLETED|Part B (From Week 20 and up to Week 80)||4||
48536483|NCT02377427|101651581|FG000|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0||
48536484|NCT02377427|101651582|FG001|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0||
48536485|NCT02377427|101651583|FG002|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||1||
48536486|NCT02377427|101651584|FG003|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0||
48235863|NCT00264576|100900231|FG000|NOT COMPLETED|Overall Study||1||
48235864|NCT00264576|100900232|FG001|NOT COMPLETED|Overall Study||1||
48235865|NCT03989232|100900233|FG000|STARTED|Overall Study||481||
48235866|NCT03989232|100900234|FG001|STARTED|Overall Study||480||
48235867|NCT03989232|100900233|FG000|Exposed|Overall Study||480||
48536487|NCT02377427|101651585|FG004|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0||
48536488|NCT04505956|101651586|FG000|STARTED|Overall Study||86||
48536489|NCT04505956|101651587|FG001|STARTED|Overall Study||85||
48536490|NCT04505956|101651586|FG000|COMPLETED|Overall Study||74||
48536491|NCT04505956|101651587|FG001|COMPLETED|Overall Study||79||
48536492|NCT04505956|101651586|FG000|NOT COMPLETED|Overall Study||12||
48536493|NCT04505956|101651587|FG001|NOT COMPLETED|Overall Study||6||
48536494|NCT00806286|101651588|FG000|STARTED|Overall Study||54||
48536495|NCT00806286|101651589|FG001|STARTED|Overall Study||54||
48536496|NCT00806286|101651590|FG002|STARTED|Overall Study||3||
48536497|NCT00806286|101651588|FG000|COMPLETED|Overall Study||0||
48536498|NCT00806286|101651589|FG001|COMPLETED|Overall Study||0||
48536499|NCT00806286|101651590|FG002|COMPLETED|Overall Study||0||
48536500|NCT00806286|101651588|FG000|NOT COMPLETED|Overall Study||54||
48536501|NCT00806286|101651589|FG001|NOT COMPLETED|Overall Study||54||
48536502|NCT00806286|101651590|FG002|NOT COMPLETED|Overall Study||3||
48536503|NCT00839254|101651591|FG000|STARTED|Overall Study||1849||
48536504|NCT00839254|101651592|FG001|STARTED|Overall Study||1316||
48536505|NCT00839254|101651593|FG002|STARTED|Overall Study||1069||
48536506|NCT00839254|101651594|FG003|STARTED|Overall Study||859||
48536507|NCT00839254|101651595|FG004|STARTED|Overall Study||241||
48536508|NCT00839254|101651596|FG005|STARTED|Overall Study||204||
48536509|NCT00839254|101651597|FG006|STARTED|Overall Study||368||
48536510|NCT00839254|101651598|FG007|STARTED|Overall Study||271||
48536511|NCT00839254|101651591|FG000|COMPLETED|Overall Study||1696||
48536512|NCT00839254|101651592|FG001|COMPLETED|Overall Study||1224||
48536513|NCT00839254|101651593|FG002|COMPLETED|Overall Study||979||
48536514|NCT00839254|101651594|FG003|COMPLETED|Overall Study||797||
48536515|NCT00839254|101651595|FG004|COMPLETED|Overall Study||204||
48536516|NCT00839254|101651596|FG005|COMPLETED|Overall Study||178||
48536517|NCT00839254|101651597|FG006|COMPLETED|Overall Study||340||
48536518|NCT00839254|101651598|FG007|COMPLETED|Overall Study||256||
48536519|NCT00839254|101651591|FG000|NOT COMPLETED|Overall Study||153||
48536520|NCT00839254|101651592|FG001|NOT COMPLETED|Overall Study||92||
48235868|NCT03989232|100900234|FG001|Exposed|Overall Study||479||
48235869|NCT03989232|100900233|FG000|Safety Analysis Set (SAS)|Overall Study||480||
48536521|NCT00839254|101651593|FG002|NOT COMPLETED|Overall Study||90||
48536522|NCT00839254|101651594|FG003|NOT COMPLETED|Overall Study||62||
48536523|NCT00839254|101651595|FG004|NOT COMPLETED|Overall Study||37||
48235870|NCT03989232|100900234|FG001|Safety Analysis Set (SAS)|Overall Study||479||
48235871|NCT03989232|100900233|FG000|Full Analysis Set (FAS)|Overall Study||481||
48235872|NCT03989232|100900234|FG001|Full Analysis Set (FAS)|Overall Study||480||
48235873|NCT03989232|100900233|FG000|COMPLETED|Overall Study||471||
48235874|NCT03989232|100900234|FG001|COMPLETED|Overall Study||462||
48235875|NCT03989232|100900233|FG000|NOT COMPLETED|Overall Study||10||
48536524|NCT00839254|101651596|FG005|NOT COMPLETED|Overall Study||26||
48536525|NCT00839254|101651597|FG006|NOT COMPLETED|Overall Study||28||
48536526|NCT00839254|101651598|FG007|NOT COMPLETED|Overall Study||15||
48536527|NCT02752087|101651599|FG000|STARTED|Study Period 1||12||
48536528|NCT02752087|101651600|FG001|STARTED|Study Period 1||12||
48536529|NCT02752087|101651599|FG000|Received Study Drug|Study Period 1||12||
48536530|NCT02752087|101651600|FG001|Received Study Drug|Study Period 1||12||
48536531|NCT02752087|101651599|FG000|COMPLETED|Study Period 1||12||
48536532|NCT02752087|101651600|FG001|COMPLETED|Study Period 1||12||
48536533|NCT02752087|101651599|FG000|NOT COMPLETED|Study Period 1||0||
48536534|NCT02752087|101651600|FG001|NOT COMPLETED|Study Period 1||0||
48536535|NCT02752087|101651599|FG000|STARTED|Washout||12||
48536536|NCT02752087|101651600|FG001|STARTED|Washout||12||
48536537|NCT02752087|101651599|FG000|COMPLETED|Washout||11||
48536538|NCT02752087|101651600|FG001|COMPLETED|Washout||12||
48536539|NCT02752087|101651599|FG000|NOT COMPLETED|Washout||1||
48536540|NCT02752087|101651600|FG001|NOT COMPLETED|Washout||0||
48536541|NCT02752087|101651599|FG000|STARTED|Study Period 2||11||
48536542|NCT02752087|101651600|FG001|STARTED|Study Period 2||12||
48536543|NCT02752087|101651599|FG000|Received Study Drug|Study Period 2||11||
48235876|NCT03989232|100900234|FG001|NOT COMPLETED|Overall Study||18||
48235877|NCT00882050|100900235|FG000|STARTED|Overall Study||32||
48536544|NCT02752087|101651600|FG001|Received Study Drug|Study Period 2||12||
48536545|NCT02752087|101651599|FG000|COMPLETED|Study Period 2||11||
48536546|NCT02752087|101651600|FG001|COMPLETED|Study Period 2||12||
48536547|NCT02752087|101651599|FG000|NOT COMPLETED|Study Period 2||0||
48536548|NCT02752087|101651600|FG001|NOT COMPLETED|Study Period 2||0||
48536549|NCT02752087|101651599|FG000|STARTED|Washout||11||
48536550|NCT02752087|101651600|FG001|STARTED|Washout||12||
48536551|NCT02752087|101651599|FG000|COMPLETED|Washout||11||
48536552|NCT02752087|101651600|FG001|COMPLETED|Washout||12||
48536553|NCT02752087|101651599|FG000|NOT COMPLETED|Washout||0||
48536554|NCT02752087|101651600|FG001|NOT COMPLETED|Washout||0||
48536555|NCT02752087|101651599|FG000|STARTED|Study Period 3||11||
48235878|NCT00882050|100900236|FG001|STARTED|Overall Study||33||
48235879|NCT00882050|100900237|FG002|STARTED|Overall Study||39||
48235880|NCT00882050|100900235|FG000|COMPLETED|Overall Study||31||
48235881|NCT00882050|100900236|FG001|COMPLETED|Overall Study||33||
48235882|NCT00882050|100900237|FG002|COMPLETED|Overall Study||39||
48235883|NCT00882050|100900235|FG000|NOT COMPLETED|Overall Study||1||
48235884|NCT00882050|100900236|FG001|NOT COMPLETED|Overall Study||0||
48235885|NCT00882050|100900237|FG002|NOT COMPLETED|Overall Study||0||
48235886|NCT00321971|100900238|FG000|STARTED|Overall Study||36||
48235887|NCT00321971|100900239|FG001|STARTED|Overall Study||37||
48235888|NCT00321971|100900238|FG000|COMPLETED|Overall Study||28||
48235889|NCT00321971|100900239|FG001|COMPLETED|Overall Study||26||
48235890|NCT00321971|100900238|FG000|NOT COMPLETED|Overall Study||8||
48235891|NCT00321971|100900239|FG001|NOT COMPLETED|Overall Study||11||
48235892|NCT01494467|100900240|FG000|STARTED|Part A Vehicle Control (12 Weeks)||459||
48235893|NCT01494467|100900241|FG001|STARTED|Part A Vehicle Control (12 Weeks)||229||
48235894|NCT01494467|100900240|FG000|COMPLETED|Part A Vehicle Control (12 Weeks)||429||
48235895|NCT01494467|100900241|FG001|COMPLETED|Part A Vehicle Control (12 Weeks)||208||
48235896|NCT01494467|100900240|FG000|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||30||
48235897|NCT01494467|100900241|FG001|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||21||
48235898|NCT01494467|100900240|FG000|STARTED|Part B Long Term Active Control 40 Weeks||428||
48235899|NCT01494467|100900241|FG001|STARTED|Part B Long Term Active Control 40 Weeks||208||
48235900|NCT01494467|100900240|FG000|COMPLETED|Part B Long Term Active Control 40 Weeks||353||
48536556|NCT02752087|101651600|FG001|STARTED|Study Period 3||12||
48536557|NCT02752087|101651599|FG000|Received Study Drug|Study Period 3||11||
48536558|NCT02752087|101651600|FG001|Received Study Drug|Study Period 3||12||
48536559|NCT02752087|101651599|FG000|COMPLETED|Study Period 3||11||
48536560|NCT02752087|101651600|FG001|COMPLETED|Study Period 3||12||
48536561|NCT02752087|101651599|FG000|NOT COMPLETED|Study Period 3||0||
48536562|NCT02752087|101651600|FG001|NOT COMPLETED|Study Period 3||0||
48536563|NCT02752087|101651599|FG000|STARTED|Washout||11||
48536564|NCT02752087|101651600|FG001|STARTED|Washout||12||
48536565|NCT02752087|101651599|FG000|COMPLETED|Washout||11||
48536566|NCT02752087|101651600|FG001|COMPLETED|Washout||12||
48536567|NCT02752087|101651599|FG000|NOT COMPLETED|Washout||0||
48536568|NCT02752087|101651600|FG001|NOT COMPLETED|Washout||0||
48536569|NCT02752087|101651599|FG000|STARTED|Study Period 4||11||
48536570|NCT02752087|101651600|FG001|STARTED|Study Period 4||12||
48536571|NCT02752087|101651599|FG000|Received Study Drug|Study Period 4||11||
48536572|NCT02752087|101651600|FG001|Received Study Drug|Study Period 4||12||
48536573|NCT02752087|101651599|FG000|COMPLETED|Study Period 4||11||
48536574|NCT02752087|101651600|FG001|COMPLETED|Study Period 4||12||
48536575|NCT02752087|101651599|FG000|NOT COMPLETED|Study Period 4||0||
48536576|NCT02752087|101651600|FG001|NOT COMPLETED|Study Period 4||0||
48536577|NCT02752087|101651599|FG000|STARTED|Follow-up||11||
48536578|NCT02752087|101651600|FG001|STARTED|Follow-up||12||
48536579|NCT02752087|101651599|FG000|COMPLETED|Follow-up||11||
48536580|NCT02752087|101651600|FG001|COMPLETED|Follow-up||12||
48536581|NCT02752087|101651599|FG000|NOT COMPLETED|Follow-up||0||
48536582|NCT02752087|101651600|FG001|NOT COMPLETED|Follow-up||0||
48536583|NCT01404832|101651601|FG000|STARTED|Overall Study||21||
48536584|NCT01404832|101651601|FG000|COMPLETED|Overall Study||21||
48536585|NCT01404832|101651601|FG000|NOT COMPLETED|Overall Study||0||
48536586|NCT01475097|101651602|FG000|STARTED|Overall Study||128||
48536587|NCT01475097|101651603|FG001|STARTED|Overall Study||127||
48536588|NCT01475097|101651602|FG000|COMPLETED|Overall Study||127||
48235901|NCT01494467|100900241|FG001|COMPLETED|Part B Long Term Active Control 40 Weeks||159||
48235902|NCT01494467|100900240|FG000|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||75||
48235903|NCT01494467|100900241|FG001|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||49||
48235904|NCT01494467|100900240|FG000|STARTED|Part C Safety Follow up (4 Weeks)||353||
48235905|NCT01494467|100900241|FG001|STARTED|Part C Safety Follow up (4 Weeks)||159||
48235906|NCT01494467|100900240|FG000|COMPLETED|Part C Safety Follow up (4 Weeks)||353||
48235907|NCT01494467|100900241|FG001|COMPLETED|Part C Safety Follow up (4 Weeks)||159||
48235908|NCT01494467|100900240|FG000|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0||
48235909|NCT01494467|100900241|FG001|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0||
48235910|NCT03689452|100900242|FG000|STARTED|Overall Study||15||
48235911|NCT03689452|100900243|FG001|STARTED|Overall Study||15||
48235912|NCT03689452|100900242|FG000|COMPLETED|Overall Study||14||
48536589|NCT01475097|101651603|FG001|COMPLETED|Overall Study||126||
48536590|NCT01475097|101651602|FG000|NOT COMPLETED|Overall Study||1||
48536591|NCT01475097|101651603|FG001|NOT COMPLETED|Overall Study||1||
48536592|NCT03825341|101651604|FG000|STARTED|Overall Study||0||
48536593|NCT03825341|101651605|FG001|STARTED|Overall Study||1||
48536594|NCT03825341|101651604|FG000|COMPLETED|Overall Study||0||
48536595|NCT03825341|101651605|FG001|COMPLETED|Overall Study||0||
48536596|NCT03825341|101651604|FG000|NOT COMPLETED|Overall Study||0||
48536597|NCT03825341|101651605|FG001|NOT COMPLETED|Overall Study||1||
48536598|NCT02113189|101651606|FG000|STARTED|Overall Study||4||
48536599|NCT02113189|101651607|FG001|STARTED|Overall Study||4||
48536600|NCT02113189|101651608|FG002|STARTED|Overall Study||5||
48536601|NCT02113189|101651606|FG000|COMPLETED|Overall Study||2||
48536602|NCT02113189|101651607|FG001|COMPLETED|Overall Study||3||
48536603|NCT02113189|101651608|FG002|COMPLETED|Overall Study||2||
48536604|NCT02113189|101651606|FG000|NOT COMPLETED|Overall Study||2||
48536605|NCT02113189|101651607|FG001|NOT COMPLETED|Overall Study||1||
48235913|NCT03689452|100900243|FG001|COMPLETED|Overall Study||14||
48235914|NCT03689452|100900242|FG000|NOT COMPLETED|Overall Study||1||
48235915|NCT03689452|100900243|FG001|NOT COMPLETED|Overall Study||1||
48235916|NCT00448344|100900244|FG000|STARTED|Overall Study||235||
48235917|NCT00448344|100900245|FG001|STARTED|Overall Study||236||
48235918|NCT00448344|100900244|FG000|COMPLETED|Overall Study||205||
48235919|NCT00448344|100900245|FG001|COMPLETED|Overall Study||200||
48235920|NCT00448344|100900244|FG000|NOT COMPLETED|Overall Study||30||
48235921|NCT00448344|100900245|FG001|NOT COMPLETED|Overall Study||36||
48235922|NCT02144285|100900246|FG000|STARTED|Overall Study||14||
48536606|NCT02113189|101651608|FG002|NOT COMPLETED|Overall Study||3||
48235923|NCT02144285|100900247|FG001|STARTED|Overall Study||6||
48536607|NCT03713619|101651609|FG000|STARTED|Treatment Period 1 (Until Week 16)||182||
48536608|NCT03713619|101651610|FG001|STARTED|Treatment Period 1 (Until Week 16)||181||
48536609|NCT03713619|101651611|FG002|STARTED|Treatment Period 1 (Until Week 16)||181||
48536610|NCT03713619|101651612|FG003|STARTED|Treatment Period 1 (Until Week 16)||0||
48536611|NCT03713619|101651613|FG004|STARTED|Treatment Period 1 (Until Week 16)||0||
48536612|NCT03713619|101651609|FG000|Full Analysis Set (FAS)|Treatment Period 1 (Until Week 16)||181|The FAS excluded participants who were misrandomized or had severe GCP violations|
48536613|NCT03713619|101651610|FG001|Full Analysis Set (FAS)|Treatment Period 1 (Until Week 16)||180|The FAS excluded participants who were misrandomized or had severe GCP violations|
48536614|NCT03713619|101651611|FG002|Full Analysis Set (FAS)|Treatment Period 1 (Until Week 16)||180|The FAS excluded participants who were misrandomized or had severe GCP violations|
48536615|NCT03713619|101651612|FG003|Full Analysis Set (FAS)|Treatment Period 1 (Until Week 16)||0|The FAS excluded participants who were misrandomized or had severe GCP violations|
48536616|NCT03713619|101651613|FG004|Full Analysis Set (FAS)|Treatment Period 1 (Until Week 16)||0|The FAS excluded participants who were misrandomized or had severe GCP violations|
48536617|NCT03713619|101651609|FG000|COMPLETED|Treatment Period 1 (Until Week 16)||168||
48536618|NCT03713619|101651610|FG001|COMPLETED|Treatment Period 1 (Until Week 16)||169||
48536619|NCT03713619|101651611|FG002|COMPLETED|Treatment Period 1 (Until Week 16)||172||
48536620|NCT03713619|101651612|FG003|COMPLETED|Treatment Period 1 (Until Week 16)||0||
48536621|NCT03713619|101651613|FG004|COMPLETED|Treatment Period 1 (Until Week 16)||0||
48235924|NCT02144285|100900248|FG002|STARTED|Overall Study||6||
48235925|NCT02144285|100900249|FG003|STARTED|Overall Study||6||
48536622|NCT03713619|101651609|FG000|NOT COMPLETED|Treatment Period 1 (Until Week 16)||14||
48536623|NCT03713619|101651610|FG001|NOT COMPLETED|Treatment Period 1 (Until Week 16)||12||
48536624|NCT03713619|101651611|FG002|NOT COMPLETED|Treatment Period 1 (Until Week 16)||9||
48536625|NCT03713619|101651612|FG003|NOT COMPLETED|Treatment Period 1 (Until Week 16)||0||
48536626|NCT03713619|101651613|FG004|NOT COMPLETED|Treatment Period 1 (Until Week 16)||0||
48536627|NCT03713619|101651609|FG000|STARTED|Treatment Period 2 (After Week 16)||168||
48235926|NCT02144285|100900250|FG004|STARTED|Overall Study||6||
48235927|NCT02144285|100900251|FG005|STARTED|Overall Study||6||
48235928|NCT02144285|100900252|FG006|STARTED|Overall Study||6||
48235929|NCT02144285|100900253|FG007|STARTED|Overall Study||6||
48235930|NCT02144285|100900254|FG008|STARTED|Overall Study||2||
48235931|NCT02144285|100900255|FG009|STARTED|Overall Study||6||
48235932|NCT02144285|100900246|FG000|Received At Least One Dose of Study Drug|Overall Study||14||
48235933|NCT02144285|100900247|FG001|Received At Least One Dose of Study Drug|Overall Study||6||
48235934|NCT02144285|100900248|FG002|Received At Least One Dose of Study Drug|Overall Study||6||
48536628|NCT03713619|101651610|FG001|STARTED|Treatment Period 2 (After Week 16)||169||
48536629|NCT03713619|101651611|FG002|STARTED|Treatment Period 2 (After Week 16)||0||
48536630|NCT03713619|101651612|FG003|STARTED|Treatment Period 2 (After Week 16)||85||
48536631|NCT03713619|101651613|FG004|STARTED|Treatment Period 2 (After Week 16)||87||
48536632|NCT03713619|101651609|FG000|COMPLETED|Treatment Period 2 (After Week 16)||131||
48536633|NCT03713619|101651610|FG001|COMPLETED|Treatment Period 2 (After Week 16)||137||
48235935|NCT02144285|100900249|FG003|Received At Least One Dose of Study Drug|Overall Study||6||
48235936|NCT02144285|100900250|FG004|Received At Least One Dose of Study Drug|Overall Study||6||
48235937|NCT02144285|100900251|FG005|Received At Least One Dose of Study Drug|Overall Study||6||
48235938|NCT02144285|100900252|FG006|Received At Least One Dose of Study Drug|Overall Study||6||
48235939|NCT02144285|100900253|FG007|Received At Least One Dose of Study Drug|Overall Study||6||
48235940|NCT02144285|100900254|FG008|Received At Least One Dose of Study Drug|Overall Study||2||
48235941|NCT02144285|100900255|FG009|Received At Least One Dose of Study Drug|Overall Study||6||
48235942|NCT02144285|100900246|FG000|COMPLETED|Overall Study||14||
48235943|NCT02144285|100900247|FG001|COMPLETED|Overall Study||6||
48235944|NCT02144285|100900248|FG002|COMPLETED|Overall Study||6||
48235945|NCT02144285|100900249|FG003|COMPLETED|Overall Study||6||
48235946|NCT02144285|100900250|FG004|COMPLETED|Overall Study||5||
48235947|NCT02144285|100900251|FG005|COMPLETED|Overall Study||6||
48235948|NCT02144285|100900252|FG006|COMPLETED|Overall Study||6||
48235949|NCT02144285|100900253|FG007|COMPLETED|Overall Study||6||
48235950|NCT02144285|100900254|FG008|COMPLETED|Overall Study||2||
48235951|NCT02144285|100900255|FG009|COMPLETED|Overall Study||6||
48235952|NCT02144285|100900246|FG000|NOT COMPLETED|Overall Study||0||
48235953|NCT02144285|100900247|FG001|NOT COMPLETED|Overall Study||0||
48235954|NCT02144285|100900248|FG002|NOT COMPLETED|Overall Study||0||
48235955|NCT02144285|100900249|FG003|NOT COMPLETED|Overall Study||0||
48235956|NCT02144285|100900250|FG004|NOT COMPLETED|Overall Study||1||
48235957|NCT02144285|100900251|FG005|NOT COMPLETED|Overall Study||0||
48235958|NCT02144285|100900252|FG006|NOT COMPLETED|Overall Study||0||
48235959|NCT02144285|100900253|FG007|NOT COMPLETED|Overall Study||0||
48235960|NCT02144285|100900254|FG008|NOT COMPLETED|Overall Study||0||
48235961|NCT02144285|100900255|FG009|NOT COMPLETED|Overall Study||0||
48235962|NCT01294644|100900256|FG000|STARTED|Overall Study||121||
48235963|NCT01294644|100900257|FG001|STARTED|Overall Study||122||
48235964|NCT01294644|100900258|FG002|STARTED|Overall Study||117||
48536634|NCT03713619|101651611|FG002|COMPLETED|Treatment Period 2 (After Week 16)||0||
48536635|NCT03713619|101651612|FG003|COMPLETED|Treatment Period 2 (After Week 16)||68||
48536636|NCT03713619|101651613|FG004|COMPLETED|Treatment Period 2 (After Week 16)||75||
48536637|NCT03713619|101651609|FG000|NOT COMPLETED|Treatment Period 2 (After Week 16)||37||
48536638|NCT03713619|101651610|FG001|NOT COMPLETED|Treatment Period 2 (After Week 16)||32||
48536639|NCT03713619|101651611|FG002|NOT COMPLETED|Treatment Period 2 (After Week 16)||0||
48235965|NCT01294644|100900256|FG000|Received Treatment|Overall Study||118||
48235966|NCT01294644|100900257|FG001|Received Treatment|Overall Study||122||
48235967|NCT01294644|100900258|FG002|Received Treatment|Overall Study||114||
48235968|NCT01294644|100900256|FG000|COMPLETED|Overall Study||111||
48235969|NCT01294644|100900257|FG001|COMPLETED|Overall Study||112||
48235970|NCT01294644|100900258|FG002|COMPLETED|Overall Study||103||
48235971|NCT01294644|100900256|FG000|NOT COMPLETED|Overall Study||10||
48235972|NCT01294644|100900257|FG001|NOT COMPLETED|Overall Study||10||
48235973|NCT01294644|100900258|FG002|NOT COMPLETED|Overall Study||14||
48235974|NCT01921166|100900259|FG000|STARTED|Overall Study||8||
48235975|NCT01921166|100900260|FG001|STARTED|Overall Study||15||
48235976|NCT01921166|100900259|FG000|COMPLETED|Overall Study||8||
48235977|NCT01921166|100900260|FG001|COMPLETED|Overall Study||15||
48235978|NCT01921166|100900259|FG000|NOT COMPLETED|Overall Study||0||
48235979|NCT01921166|100900260|FG001|NOT COMPLETED|Overall Study||0||
48235980|NCT02400749|100900261|FG000|STARTED|Week 0 -16||50||
48235981|NCT02400749|100900262|FG001|STARTED|Week 0 -16||50||
48235982|NCT02400749|100900261|FG000|COMPLETED|Week 0 -16||39||
48235983|NCT02400749|100900262|FG001|COMPLETED|Week 0 -16||44||
48235984|NCT02400749|100900261|FG000|NOT COMPLETED|Week 0 -16||11||
48235985|NCT02400749|100900262|FG001|NOT COMPLETED|Week 0 -16||6||
48235986|NCT02400749|100900261|FG000|STARTED|Week 17 - 32||39||
48235987|NCT02400749|100900262|FG001|STARTED|Week 17 - 32||44||
48536640|NCT03713619|101651612|FG003|NOT COMPLETED|Treatment Period 2 (After Week 16)||17||
48536641|NCT03713619|101651613|FG004|NOT COMPLETED|Treatment Period 2 (After Week 16)||12||
48536642|NCT02968849|101651614|FG000|STARTED|Overall Study||2704||
48536643|NCT02968849|101651615|FG001|STARTED|Overall Study||2700||
48536644|NCT02968849|101651614|FG000|Modified Intent-to-Treat (MITT) Cohort|Overall Study||2695||
48536645|NCT02968849|101651615|FG001|Modified Intent-to-Treat (MITT) Cohort|Overall Study||2689||
48536646|NCT02968849|101651614|FG000|MITT Infected Cohort|Overall Study||151||
48536647|NCT02968849|101651615|FG001|MITT Infected Cohort|Overall Study||143||
48536648|NCT02968849|101651614|FG000|Week 26 At-Risk Cohort|Overall Study||2430||
48235988|NCT02400749|100900261|FG000|COMPLETED|Week 17 - 32||34||
48235989|NCT02400749|100900262|FG001|COMPLETED|Week 17 - 32||41||
48235990|NCT02400749|100900261|FG000|NOT COMPLETED|Week 17 - 32||5||
48235991|NCT02400749|100900262|FG001|NOT COMPLETED|Week 17 - 32||3||
48235992|NCT03209492|100900263|FG000|STARTED|Overall Study||333||
48235993|NCT03209492|100900263|FG000|COMPLETED|Overall Study||328||
48235994|NCT03209492|100900263|FG000|NOT COMPLETED|Overall Study||5||
48235995|NCT02942771|100900264|FG000|STARTED|Overall Study||9||
48235996|NCT02942771|100900265|FG001|STARTED|Overall Study||6||
48235997|NCT02942771|100900266|FG002|STARTED|Overall Study||6||
48235998|NCT02942771|100900267|FG003|STARTED|Overall Study||6||
48235999|NCT02942771|100900268|FG004|STARTED|Overall Study||8||
48236000|NCT02942771|100900264|FG000|COMPLETED|Overall Study||6||
48236001|NCT02942771|100900265|FG001|COMPLETED|Overall Study||6||
48236002|NCT02942771|100900266|FG002|COMPLETED|Overall Study||6||
48236003|NCT02942771|100900267|FG003|COMPLETED|Overall Study||6||
48236004|NCT02942771|100900268|FG004|COMPLETED|Overall Study||4||
48236005|NCT02942771|100900264|FG000|NOT COMPLETED|Overall Study||3||
48236006|NCT02942771|100900265|FG001|NOT COMPLETED|Overall Study||0||
48236007|NCT02942771|100900266|FG002|NOT COMPLETED|Overall Study||0||
48236008|NCT02942771|100900267|FG003|NOT COMPLETED|Overall Study||0||
48236009|NCT02942771|100900268|FG004|NOT COMPLETED|Overall Study||4||
48236010|NCT01714947|100900269|FG000|STARTED|Part A||3||
48236011|NCT01714947|100900269|FG000|COMPLETED|Part A||3||
48236012|NCT01714947|100900269|FG000|NOT COMPLETED|Part A||0||
48236013|NCT01714947|100900269|FG000|STARTED|Part B||3||
48236014|NCT01714947|100900269|FG000|COMPLETED|Part B||0||
48236015|NCT01714947|100900269|FG000|NOT COMPLETED|Part B||3||
48236016|NCT01430299|100900270|FG000|STARTED|Overall Study||20||
48236017|NCT01430299|100900271|FG001|STARTED|Overall Study||23||
48236018|NCT01430299|100900270|FG000|COMPLETED|Overall Study||16||
48236019|NCT01430299|100900271|FG001|COMPLETED|Overall Study||21||
48236020|NCT01430299|100900270|FG000|NOT COMPLETED|Overall Study||4||
48236021|NCT01430299|100900271|FG001|NOT COMPLETED|Overall Study||2||
48236022|NCT00785798|100900272|FG000|STARTED|Overall Study||17||
48236023|NCT00785798|100900272|FG000|COMPLETED|Overall Study||16||
48236024|NCT00785798|100900272|FG000|NOT COMPLETED|Overall Study||1||
48236025|NCT02691702|100900273|FG000|STARTED|Overall Study||10||
48536649|NCT02968849|101651615|FG001|Week 26 At-Risk Cohort|Overall Study||2393||
48536650|NCT02968849|101651614|FG000|Immunogenicity Cohort|Overall Study||120||
48236026|NCT02691702|100900274|FG001|STARTED|Overall Study||11||
48236027|NCT02691702|100900275|FG002|STARTED|Overall Study||8||
48236028|NCT02691702|100900276|FG003|STARTED|Overall Study||8||
48236029|NCT02691702|100900277|FG004|STARTED|Overall Study||8||
48236030|NCT02691702|100900278|FG005|STARTED|Overall Study||8||
48236031|NCT02691702|100900279|FG006|STARTED|Overall Study||8||
48236032|NCT02691702|100900280|FG007|STARTED|Overall Study||12||
48236033|NCT02691702|100900281|FG008|STARTED|Overall Study||8||
48236034|NCT02691702|100900282|FG009|STARTED|Overall Study||8||
48236035|NCT02691702|100900283|FG010|STARTED|Overall Study||8||
48236036|NCT02691702|100900273|FG000|COMPLETED|Overall Study||8||
48236037|NCT02691702|100900274|FG001|COMPLETED|Overall Study||10||
48236038|NCT02691702|100900275|FG002|COMPLETED|Overall Study||7||
48236039|NCT02691702|100900276|FG003|COMPLETED|Overall Study||8||
48536651|NCT02968849|101651615|FG001|Immunogenicity Cohort|Overall Study||10||
48536652|NCT02968849|101651614|FG000|COMPLETED|Overall Study||2557||
48536653|NCT02968849|101651615|FG001|COMPLETED|Overall Study||2557||
48536654|NCT02968849|101651614|FG000|NOT COMPLETED|Overall Study||147||
48536655|NCT02968849|101651615|FG001|NOT COMPLETED|Overall Study||143||
48536656|NCT00963560|101651616|FG000|STARTED|Overall Study||47||
48536657|NCT00963560|101651617|FG001|STARTED|Overall Study||44||
48536658|NCT00963560|101651618|FG002|STARTED|Overall Study||41||
48536659|NCT00963560|101651616|FG000|COMPLETED|Overall Study||44||
48536660|NCT00963560|101651617|FG001|COMPLETED|Overall Study||41||
48536661|NCT00963560|101651618|FG002|COMPLETED|Overall Study||41||
48536662|NCT00963560|101651616|FG000|NOT COMPLETED|Overall Study||3||
48536663|NCT00963560|101651617|FG001|NOT COMPLETED|Overall Study||3||
48536664|NCT00963560|101651618|FG002|NOT COMPLETED|Overall Study||0||
48536665|NCT01646138|101651619|FG000|STARTED|Overall Study||5||
48536666|NCT01646138|101651620|FG001|STARTED|Overall Study||4||
48536667|NCT01646138|101651621|FG002|STARTED|Overall Study||5||
48536668|NCT01646138|101651622|FG003|STARTED|Overall Study||19||
48536669|NCT01646138|101651623|FG004|STARTED|Overall Study||15||
48536670|NCT01646138|101651619|FG000|COMPLETED|Overall Study||5||
48536671|NCT01646138|101651620|FG001|COMPLETED|Overall Study||4||
48536672|NCT01646138|101651621|FG002|COMPLETED|Overall Study||5||
48536673|NCT01646138|101651622|FG003|COMPLETED|Overall Study||19||
48236040|NCT02691702|100900277|FG004|COMPLETED|Overall Study||8||
48236041|NCT02691702|100900278|FG005|COMPLETED|Overall Study||5||
48236042|NCT02691702|100900279|FG006|COMPLETED|Overall Study||5||
48236043|NCT02691702|100900280|FG007|COMPLETED|Overall Study||12||
48236044|NCT02691702|100900281|FG008|COMPLETED|Overall Study||6||
48236045|NCT02691702|100900282|FG009|COMPLETED|Overall Study||6||
48236046|NCT02691702|100900283|FG010|COMPLETED|Overall Study||6||
48236047|NCT02691702|100900273|FG000|NOT COMPLETED|Overall Study||2||
48236048|NCT02691702|100900274|FG001|NOT COMPLETED|Overall Study||1||
48236049|NCT02691702|100900275|FG002|NOT COMPLETED|Overall Study||1||
48236050|NCT02691702|100900276|FG003|NOT COMPLETED|Overall Study||0||
48236051|NCT02691702|100900277|FG004|NOT COMPLETED|Overall Study||0||
48236052|NCT02691702|100900278|FG005|NOT COMPLETED|Overall Study||3||
48236053|NCT02691702|100900279|FG006|NOT COMPLETED|Overall Study||3||
48236054|NCT02691702|100900280|FG007|NOT COMPLETED|Overall Study||0||
48236055|NCT02691702|100900281|FG008|NOT COMPLETED|Overall Study||2||
48236056|NCT02691702|100900282|FG009|NOT COMPLETED|Overall Study||2||
48236057|NCT02691702|100900283|FG010|NOT COMPLETED|Overall Study||2||
48236058|NCT02753075|100900284|FG000|STARTED|Overall Study||79||
48236059|NCT02753075|100900285|FG001|STARTED|Overall Study||80||
48236060|NCT02753075|100900286|FG002|STARTED|Overall Study||81||
48536674|NCT01646138|101651623|FG004|COMPLETED|Overall Study||13||
48536675|NCT01646138|101651619|FG000|NOT COMPLETED|Overall Study||0||
48536676|NCT01646138|101651620|FG001|NOT COMPLETED|Overall Study||0||
48536677|NCT01646138|101651621|FG002|NOT COMPLETED|Overall Study||0||
48536678|NCT01646138|101651622|FG003|NOT COMPLETED|Overall Study||0||
48536679|NCT01646138|101651623|FG004|NOT COMPLETED|Overall Study||2||
48536680|NCT00509366|101651624|FG000|STARTED|Overall Study||18||
48536681|NCT00509366|101651625|FG001|STARTED|Overall Study||8||
48536682|NCT00509366|101651626|FG002|STARTED|Overall Study||22||
48536683|NCT00509366|101651627|FG003|STARTED|Overall Study||2||
48236061|NCT02753075|100900284|FG000|COMPLETED|Overall Study||71||
48236062|NCT02753075|100900285|FG001|COMPLETED|Overall Study||77||
48236063|NCT02753075|100900286|FG002|COMPLETED|Overall Study||78||
48236064|NCT02753075|100900284|FG000|NOT COMPLETED|Overall Study||8||
48536684|NCT00509366|101651628|FG004|STARTED|Overall Study||51||
48536685|NCT00509366|101651624|FG000|Assigned Treatment|Overall Study||18||
48536686|NCT00509366|101651625|FG001|Assigned Treatment|Overall Study||8||
48536687|NCT00509366|101651626|FG002|Assigned Treatment|Overall Study||22||
48536688|NCT00509366|101651627|FG003|Assigned Treatment|Overall Study||2||
48536689|NCT00509366|101651628|FG004|Assigned Treatment|Overall Study||0||
48536690|NCT00509366|101651624|FG000|COMPLETED|Overall Study||17||
48536691|NCT00509366|101651625|FG001|COMPLETED|Overall Study||7||
48536692|NCT00509366|101651626|FG002|COMPLETED|Overall Study||21||
48536693|NCT00509366|101651627|FG003|COMPLETED|Overall Study||2||
48536694|NCT00509366|101651628|FG004|COMPLETED|Overall Study||51||
48536695|NCT00509366|101651624|FG000|NOT COMPLETED|Overall Study||1||
48536696|NCT00509366|101651625|FG001|NOT COMPLETED|Overall Study||1||
48536697|NCT00509366|101651626|FG002|NOT COMPLETED|Overall Study||1||
48536698|NCT00509366|101651627|FG003|NOT COMPLETED|Overall Study||0||
48536699|NCT00509366|101651628|FG004|NOT COMPLETED|Overall Study||0||
48536700|NCT01462812|101651629|FG000|STARTED|Overall Study||111||
48536701|NCT01462812|101651630|FG001|STARTED|Overall Study||112||
48536702|NCT01462812|101651629|FG000|COMPLETED|Overall Study||111||
48536703|NCT01462812|101651630|FG001|COMPLETED|Overall Study||111||
48536704|NCT01462812|101651629|FG000|NOT COMPLETED|Overall Study||0||
48536705|NCT01462812|101651630|FG001|NOT COMPLETED|Overall Study||1||
48536706|NCT03317834|101651631|FG000|STARTED|Overall Study||122||
48536707|NCT03317834|101651631|FG000|COMPLETED|Overall Study||89||
48236065|NCT02753075|100900285|FG001|NOT COMPLETED|Overall Study||3||
48236066|NCT02753075|100900286|FG002|NOT COMPLETED|Overall Study||3||
48236067|NCT03458416|100900287|FG000|STARTED|Overall Study||0||
48236068|NCT03458416|100900287|FG000|COMPLETED|Overall Study||0||
48236069|NCT03458416|100900287|FG000|NOT COMPLETED|Overall Study||0||
48236070|NCT03219216|100900288|FG000|STARTED|Overall Study||75||
48236071|NCT03219216|100900289|FG001|STARTED|Overall Study||25||
48236072|NCT03219216|100900288|FG000|COMPLETED|Overall Study||75||
48236073|NCT03219216|100900289|FG001|COMPLETED|Overall Study||24||
48236074|NCT03219216|100900288|FG000|NOT COMPLETED|Overall Study||0||
48236075|NCT03219216|100900289|FG001|NOT COMPLETED|Overall Study||1||
48236076|NCT00641797|100900290|FG000|STARTED|Overall Study||11||
48236077|NCT00641797|100900291|FG001|STARTED|Overall Study||15||
48236078|NCT00641797|100900290|FG000|COMPLETED|Overall Study||11||
48236079|NCT00641797|100900291|FG001|COMPLETED|Overall Study||15||
48236080|NCT00641797|100900290|FG000|NOT COMPLETED|Overall Study||0||
48236081|NCT00641797|100900291|FG001|NOT COMPLETED|Overall Study||0||
48236082|NCT04995601|100900292|FG000|STARTED|Overall Study||49||
48236083|NCT04995601|100900293|FG001|STARTED|Overall Study||57||
48236084|NCT04995601|100900292|FG000|COMPLETED|Overall Study||49||
48236085|NCT04995601|100900293|FG001|COMPLETED|Overall Study||57||
48236086|NCT04995601|100900292|FG000|NOT COMPLETED|Overall Study||0||
48236087|NCT04995601|100900293|FG001|NOT COMPLETED|Overall Study||0||
48236088|NCT01790659|100900294|FG000|STARTED|Overall Study||201||
48236089|NCT01790659|100900295|FG001|STARTED|Overall Study||198||
48236090|NCT01790659|100900294|FG000|COMPLETED|Overall Study||195||
48236091|NCT01790659|100900295|FG001|COMPLETED|Overall Study||192||
48236092|NCT01790659|100900294|FG000|NOT COMPLETED|Overall Study||6||
48236093|NCT01790659|100900295|FG001|NOT COMPLETED|Overall Study||6||
48236094|NCT01648491|100900296|FG000|STARTED|Overall Study||1||
48236095|NCT01648491|100900296|FG000|COMPLETED|Overall Study||1||
48236096|NCT01648491|100900296|FG000|NOT COMPLETED|Overall Study||0||
48236097|NCT02203513|100900297|FG000|STARTED|Overall Study||22||
48236098|NCT02203513|100900298|FG001|STARTED|Overall Study||29||
48236099|NCT02203513|100900299|FG002|STARTED|Overall Study||9||
48236100|NCT02203513|100900300|FG003|STARTED|Overall Study||2||
48236101|NCT02203513|100900301|FG004|STARTED|Overall Study||49||
48236102|NCT02203513|100900297|FG000|COMPLETED|Overall Study||16||
48236103|NCT02203513|100900298|FG001|COMPLETED|Overall Study||21||
48236104|NCT02203513|100900299|FG002|COMPLETED|Overall Study||6||
48236105|NCT02203513|100900300|FG003|COMPLETED|Overall Study||1||
48236106|NCT02203513|100900301|FG004|COMPLETED|Overall Study||43||
48236107|NCT02203513|100900297|FG000|NOT COMPLETED|Overall Study||6||
48536708|NCT03317834|101651631|FG000|NOT COMPLETED|Overall Study||33||
48536709|NCT04933968|101651632|FG000|STARTED|Overall Study||3||
48536710|NCT04933968|101651633|FG001|STARTED|Overall Study||3||
48536711|NCT04933968|101651634|FG002|STARTED|Overall Study||4||
48536712|NCT04933968|101651635|FG003|STARTED|Overall Study||4||
48536713|NCT04933968|101651636|FG004|STARTED|Overall Study||3||
48536714|NCT04933968|101651637|FG005|STARTED|Overall Study||0||
48536715|NCT04933968|101651632|FG000|COMPLETED|Overall Study||0||
48536716|NCT04933968|101651633|FG001|COMPLETED|Overall Study||0||
48536717|NCT04933968|101651634|FG002|COMPLETED|Overall Study||0||
48536718|NCT04933968|101651635|FG003|COMPLETED|Overall Study||0||
48536719|NCT04933968|101651636|FG004|COMPLETED|Overall Study||0||
48536720|NCT04933968|101651637|FG005|COMPLETED|Overall Study||0||
48236108|NCT02203513|100900298|FG001|NOT COMPLETED|Overall Study||8||
48236109|NCT02203513|100900299|FG002|NOT COMPLETED|Overall Study||3||
48236110|NCT02203513|100900300|FG003|NOT COMPLETED|Overall Study||1||
48236111|NCT02203513|100900301|FG004|NOT COMPLETED|Overall Study||6||
48536721|NCT04933968|101651632|FG000|NOT COMPLETED|Overall Study||3||
48536722|NCT04933968|101651633|FG001|NOT COMPLETED|Overall Study||3||
48236112|NCT00621842|100900302|FG000|STARTED|Overall Study||57||
48236113|NCT00621842|100900302|FG000|COMPLETED|Overall Study||38||
48236114|NCT00621842|100900302|FG000|NOT COMPLETED|Overall Study||19||
48236115|NCT00484198|100900303|FG000|STARTED|Overall Study||137||
48236116|NCT00484198|100900304|FG001|STARTED|Overall Study||274||
48236117|NCT00484198|100900305|FG002|STARTED|Overall Study||750||
48536723|NCT04933968|101651634|FG002|NOT COMPLETED|Overall Study||4||
48536724|NCT04933968|101651635|FG003|NOT COMPLETED|Overall Study||4||
48536725|NCT04933968|101651636|FG004|NOT COMPLETED|Overall Study||3||
48536726|NCT04933968|101651637|FG005|NOT COMPLETED|Overall Study||0||
48536727|NCT00635232|101651638|FG000|STARTED|Overall Study||58||
48536728|NCT00635232|101651639|FG001|STARTED|Overall Study||59||
48536729|NCT00635232|101651640|FG002|STARTED|Overall Study||58||
48536730|NCT00635232|101651641|FG003|STARTED|Overall Study||58||
48536731|NCT00635232|101651642|FG004|STARTED|Overall Study||28||
48536732|NCT00635232|101651638|FG000|COMPLETED|Overall Study||44||
48536733|NCT00635232|101651639|FG001|COMPLETED|Overall Study||39||
48536734|NCT00635232|101651640|FG002|COMPLETED|Overall Study||55||
48536735|NCT00635232|101651641|FG003|COMPLETED|Overall Study||48||
48536736|NCT00635232|101651642|FG004|COMPLETED|Overall Study||20||
48536737|NCT00635232|101651638|FG000|NOT COMPLETED|Overall Study||14||
48536738|NCT00635232|101651639|FG001|NOT COMPLETED|Overall Study||20||
48536739|NCT00635232|101651640|FG002|NOT COMPLETED|Overall Study||3||
48536740|NCT00635232|101651641|FG003|NOT COMPLETED|Overall Study||10||
48536741|NCT00635232|101651642|FG004|NOT COMPLETED|Overall Study||8||
48536742|NCT02777073|101651643|FG000|STARTED|Overall Study||13||
48536743|NCT02777073|101651644|FG001|STARTED|Overall Study||17||
48536744|NCT02777073|101651645|FG002|STARTED|Overall Study||13||
48536745|NCT02777073|101651643|FG000|COMPLETED|Overall Study||13||
48536746|NCT02777073|101651644|FG001|COMPLETED|Overall Study||17||
48536747|NCT02777073|101651645|FG002|COMPLETED|Overall Study||13||
48536748|NCT02777073|101651643|FG000|NOT COMPLETED|Overall Study||0||
48536749|NCT02777073|101651644|FG001|NOT COMPLETED|Overall Study||0||
48536750|NCT02777073|101651645|FG002|NOT COMPLETED|Overall Study||0||
48536751|NCT00922272|101651646|FG000|STARTED|Open-label Phase||92||
48536752|NCT00922272|101651647|FG001|STARTED|Open-label Phase||0||
48536753|NCT00922272|101651646|FG000|COMPLETED|Open-label Phase||69||
48536754|NCT00922272|101651647|FG001|COMPLETED|Open-label Phase||0||
48536755|NCT00922272|101651646|FG000|NOT COMPLETED|Open-label Phase||23||
48536756|NCT00922272|101651647|FG001|NOT COMPLETED|Open-label Phase||0||
48536757|NCT00922272|101651646|FG000|STARTED|Double-blind Phase||34||
48536758|NCT00922272|101651647|FG001|STARTED|Double-blind Phase||35||
48536759|NCT00922272|101651646|FG000|COMPLETED|Double-blind Phase||27||
48536760|NCT00922272|101651647|FG001|COMPLETED|Double-blind Phase||29||
48536761|NCT00922272|101651646|FG000|NOT COMPLETED|Double-blind Phase||7||
48536762|NCT00922272|101651647|FG001|NOT COMPLETED|Double-blind Phase||6||
48536763|NCT00609518|101651648|FG000|STARTED|Overall Study||54||
48536764|NCT00609518|101651649|FG001|STARTED|Overall Study||57||
48536765|NCT00609518|101651648|FG000|Completed 6 Treatment Cycles|Overall Study||19||
48536766|NCT00609518|101651649|FG001|Completed 6 Treatment Cycles|Overall Study||22||
48536767|NCT00609518|101651648|FG000|COMPLETED|Overall Study||11||
48536768|NCT00609518|101651649|FG001|COMPLETED|Overall Study||17||
48536769|NCT00609518|101651648|FG000|NOT COMPLETED|Overall Study||43||
48536770|NCT00609518|101651649|FG001|NOT COMPLETED|Overall Study||40||
48536771|NCT00213135|101651650|FG000|STARTED|Overall Study||456||
48536772|NCT00213135|101651651|FG001|STARTED|Overall Study||433||
48536773|NCT00213135|101651652|FG002|STARTED|Overall Study||437||
48236118|NCT00484198|100900306|FG003|STARTED|Overall Study||751||
48236119|NCT00484198|100900303|FG000|COMPLETED|Overall Study||96||
48236120|NCT00484198|100900304|FG001|COMPLETED|Overall Study||208||
48236121|NCT00484198|100900305|FG002|COMPLETED|Overall Study||599||
48236122|NCT00484198|100900306|FG003|COMPLETED|Overall Study||579||
48236123|NCT00484198|100900303|FG000|NOT COMPLETED|Overall Study||41||
48236124|NCT00484198|100900304|FG001|NOT COMPLETED|Overall Study||66||
48236125|NCT00484198|100900305|FG002|NOT COMPLETED|Overall Study||151||
48236126|NCT00484198|100900306|FG003|NOT COMPLETED|Overall Study||172||
48236127|NCT01979211|100900307|FG000|STARTED|Overall Study||24||
48236128|NCT01979211|100900307|FG000|COMPLETED|Overall Study||24||
48236129|NCT01979211|100900307|FG000|NOT COMPLETED|Overall Study||0||
48236130|NCT02964234|100900308|FG000|STARTED|Overall Study||76||
48536774|NCT00213135|101651650|FG000|COMPLETED|Overall Study||406||
48536775|NCT00213135|101651651|FG001|COMPLETED|Overall Study||398||
48536776|NCT00213135|101651652|FG002|COMPLETED|Overall Study||380||
48536777|NCT00213135|101651650|FG000|NOT COMPLETED|Overall Study||50||
48536778|NCT00213135|101651651|FG001|NOT COMPLETED|Overall Study||35||
48536779|NCT00213135|101651652|FG002|NOT COMPLETED|Overall Study||57||
48536780|NCT03996148|101651653|FG000|STARTED|Overall Study||7||
48536781|NCT03996148|101651654|FG001|STARTED|Overall Study||7||
48536782|NCT03996148|101651655|FG002|STARTED|Overall Study||7||
48536783|NCT03996148|101651653|FG000|COMPLETED|Overall Study||7||
48536784|NCT03996148|101651654|FG001|COMPLETED|Overall Study||6||
48536785|NCT03996148|101651655|FG002|COMPLETED|Overall Study||7||
48236131|NCT02964234|100900309|FG001|STARTED|Overall Study||69||
48236132|NCT02964234|100900308|FG000|COMPLETED|Overall Study||54||
48236133|NCT02964234|100900309|FG001|COMPLETED|Overall Study||56||
48536786|NCT03996148|101651653|FG000|NOT COMPLETED|Overall Study||0||
48536787|NCT03996148|101651654|FG001|NOT COMPLETED|Overall Study||1||
48536788|NCT03996148|101651655|FG002|NOT COMPLETED|Overall Study||0||
48536789|NCT02971735|101651656|FG000|STARTED|Overall Study||30||
48536790|NCT02971735|101651657|FG001|STARTED|Overall Study||30||
48536791|NCT02971735|101651656|FG000|COMPLETED|Overall Study||30||
48536792|NCT02971735|101651657|FG001|COMPLETED|Overall Study||30||
48536793|NCT02971735|101651656|FG000|NOT COMPLETED|Overall Study||0||
48536794|NCT02971735|101651657|FG001|NOT COMPLETED|Overall Study||0||
48536795|NCT02116608|101651658|FG000|STARTED|Overall Study||9||
48536796|NCT02116608|101651659|FG001|STARTED|Overall Study||9||
48536797|NCT02116608|101651660|FG002|STARTED|Overall Study||8||
48536798|NCT02116608|101651658|FG000|COMPLETED|Overall Study||9||
48536799|NCT02116608|101651659|FG001|COMPLETED|Overall Study||7||
48536800|NCT02116608|101651660|FG002|COMPLETED|Overall Study||7||
48536801|NCT02116608|101651658|FG000|NOT COMPLETED|Overall Study||0||
48536802|NCT02116608|101651659|FG001|NOT COMPLETED|Overall Study||2||
48536803|NCT02116608|101651660|FG002|NOT COMPLETED|Overall Study||1||
48536804|NCT02036775|101651661|FG000|STARTED|Treatment Period 1 (6 Days)||4||
48536805|NCT02036775|101651662|FG001|STARTED|Treatment Period 1 (6 Days)||4||
48536806|NCT02036775|101651663|FG002|STARTED|Treatment Period 1 (6 Days)||4||
48536807|NCT02036775|101651664|FG003|STARTED|Treatment Period 1 (6 Days)||4||
48536808|NCT02036775|101651665|FG004|STARTED|Treatment Period 1 (6 Days)||4||
48536809|NCT02036775|101651666|FG005|STARTED|Treatment Period 1 (6 Days)||4||
48536810|NCT02036775|101651661|FG000|COMPLETED|Treatment Period 1 (6 Days)||4||
48536811|NCT02036775|101651662|FG001|COMPLETED|Treatment Period 1 (6 Days)||4||
48536812|NCT02036775|101651663|FG002|COMPLETED|Treatment Period 1 (6 Days)||4||
48536813|NCT02036775|101651664|FG003|COMPLETED|Treatment Period 1 (6 Days)||4||
48536814|NCT02036775|101651665|FG004|COMPLETED|Treatment Period 1 (6 Days)||4||
48536815|NCT02036775|101651666|FG005|COMPLETED|Treatment Period 1 (6 Days)||4||
48536816|NCT02036775|101651661|FG000|NOT COMPLETED|Treatment Period 1 (6 Days)||0||
48536817|NCT02036775|101651662|FG001|NOT COMPLETED|Treatment Period 1 (6 Days)||0||
48536818|NCT02036775|101651663|FG002|NOT COMPLETED|Treatment Period 1 (6 Days)||0||
48536819|NCT02036775|101651664|FG003|NOT COMPLETED|Treatment Period 1 (6 Days)||0||
48536820|NCT02036775|101651665|FG004|NOT COMPLETED|Treatment Period 1 (6 Days)||0||
48536821|NCT02036775|101651666|FG005|NOT COMPLETED|Treatment Period 1 (6 Days)||0||
48536822|NCT02036775|101651661|FG000|STARTED|Treatment Period 2 (6 Days)||4||
48536823|NCT02036775|101651662|FG001|STARTED|Treatment Period 2 (6 Days)||4||
48536824|NCT02036775|101651663|FG002|STARTED|Treatment Period 2 (6 Days)||4||
48536825|NCT02036775|101651664|FG003|STARTED|Treatment Period 2 (6 Days)||4||
48536826|NCT02036775|101651665|FG004|STARTED|Treatment Period 2 (6 Days)||4||
48536827|NCT02036775|101651666|FG005|STARTED|Treatment Period 2 (6 Days)||4||
48536828|NCT02036775|101651661|FG000|COMPLETED|Treatment Period 2 (6 Days)||4||
48536829|NCT02036775|101651662|FG001|COMPLETED|Treatment Period 2 (6 Days)||4||
48536830|NCT02036775|101651663|FG002|COMPLETED|Treatment Period 2 (6 Days)||4||
48536831|NCT02036775|101651664|FG003|COMPLETED|Treatment Period 2 (6 Days)||4||
48236134|NCT02964234|100900308|FG000|NOT COMPLETED|Overall Study||22||
48236135|NCT02964234|100900309|FG001|NOT COMPLETED|Overall Study||13||
48236136|NCT01732757|100900310|FG000|STARTED|Overall Study||53||
48236137|NCT01732757|100900311|FG001|STARTED|Overall Study||52||
48236138|NCT01732757|100900312|FG002|STARTED|Overall Study||52||
48236139|NCT01732757|100900310|FG000|COMPLETED|Overall Study||52||
48236140|NCT01732757|100900311|FG001|COMPLETED|Overall Study||52||
48536832|NCT02036775|101651665|FG004|COMPLETED|Treatment Period 2 (6 Days)||4||
48536833|NCT02036775|101651666|FG005|COMPLETED|Treatment Period 2 (6 Days)||3||
48536834|NCT02036775|101651661|FG000|NOT COMPLETED|Treatment Period 2 (6 Days)||0||
48536835|NCT02036775|101651662|FG001|NOT COMPLETED|Treatment Period 2 (6 Days)||0||
48536836|NCT02036775|101651663|FG002|NOT COMPLETED|Treatment Period 2 (6 Days)||0||
48536837|NCT02036775|101651664|FG003|NOT COMPLETED|Treatment Period 2 (6 Days)||0||
48536838|NCT02036775|101651665|FG004|NOT COMPLETED|Treatment Period 2 (6 Days)||0||
48536839|NCT02036775|101651666|FG005|NOT COMPLETED|Treatment Period 2 (6 Days)||1||
48536840|NCT02036775|101651661|FG000|STARTED|Treatment Period 3 (6 Days)||4||
48536841|NCT02036775|101651662|FG001|STARTED|Treatment Period 3 (6 Days)||4||
48536842|NCT02036775|101651663|FG002|STARTED|Treatment Period 3 (6 Days)||4||
48236141|NCT01732757|100900312|FG002|COMPLETED|Overall Study||52||
48236142|NCT01732757|100900310|FG000|NOT COMPLETED|Overall Study||1||
48236143|NCT01732757|100900311|FG001|NOT COMPLETED|Overall Study||0||
48236144|NCT01732757|100900312|FG002|NOT COMPLETED|Overall Study||0||
48236145|NCT03800563|100900313|FG000|STARTED|Overall Study||20||
48236146|NCT03800563|100900313|FG000|COMPLETED|Overall Study||20||
48236147|NCT03800563|100900313|FG000|NOT COMPLETED|Overall Study||0||
48236148|NCT04791917|100900314|FG000|STARTED|Overall Study||26||
48236149|NCT04791917|100900315|FG001|STARTED|Overall Study||25||
48236150|NCT04791917|100900314|FG000|COMPLETED|Overall Study||26||
48236151|NCT04791917|100900315|FG001|COMPLETED|Overall Study||25||
48236152|NCT04791917|100900314|FG000|NOT COMPLETED|Overall Study||0||
48236153|NCT04791917|100900315|FG001|NOT COMPLETED|Overall Study||0||
48236154|NCT00823966|100900316|FG000|STARTED|Overall Study||3||
48236155|NCT00823966|100900316|FG000|COMPLETED|Overall Study||3||
48236156|NCT00823966|100900316|FG000|NOT COMPLETED|Overall Study||0||
48536843|NCT02036775|101651664|FG003|STARTED|Treatment Period 3 (6 Days)||4||
48536844|NCT02036775|101651665|FG004|STARTED|Treatment Period 3 (6 Days)||4||
48536845|NCT02036775|101651666|FG005|STARTED|Treatment Period 3 (6 Days)||3||
48536846|NCT02036775|101651661|FG000|COMPLETED|Treatment Period 3 (6 Days)||4||
48536847|NCT02036775|101651662|FG001|COMPLETED|Treatment Period 3 (6 Days)||4||
48536848|NCT02036775|101651663|FG002|COMPLETED|Treatment Period 3 (6 Days)||4||
48536849|NCT02036775|101651664|FG003|COMPLETED|Treatment Period 3 (6 Days)||4||
48536850|NCT02036775|101651665|FG004|COMPLETED|Treatment Period 3 (6 Days)||4||
48536851|NCT02036775|101651666|FG005|COMPLETED|Treatment Period 3 (6 Days)||3||
48536852|NCT02036775|101651661|FG000|NOT COMPLETED|Treatment Period 3 (6 Days)||0||
48536853|NCT02036775|101651662|FG001|NOT COMPLETED|Treatment Period 3 (6 Days)||0||
48536854|NCT02036775|101651663|FG002|NOT COMPLETED|Treatment Period 3 (6 Days)||0||
48536855|NCT02036775|101651664|FG003|NOT COMPLETED|Treatment Period 3 (6 Days)||0||
48536856|NCT02036775|101651665|FG004|NOT COMPLETED|Treatment Period 3 (6 Days)||0||
48536857|NCT02036775|101651666|FG005|NOT COMPLETED|Treatment Period 3 (6 Days)||0||
48536858|NCT03858634|101651667|FG000|STARTED|Overall Study||39||
48536859|NCT03858634|101651668|FG001|STARTED|Overall Study||19||
48536860|NCT03858634|101651667|FG000|Participants With Chronic Idiopathic Urticaria (CIU)|Overall Study||4||
48536861|NCT03858634|101651668|FG001|Participants With Chronic Idiopathic Urticaria (CIU)|Overall Study||2||
48536862|NCT03858634|101651667|FG000|Participants With Chronic Idiopathic Pruritus (CIP)|Overall Study||14||
48536863|NCT03858634|101651668|FG001|Participants With Chronic Idiopathic Pruritus (CIP)|Overall Study||9||
48536864|NCT03858634|101651667|FG000|Participants With Lichen Planus (LP)|Overall Study||3||
48536865|NCT03858634|101651668|FG001|Participants With Lichen Planus (LP)|Overall Study||0||
48536866|NCT03858634|101651667|FG000|Participants With Lichen Simplex Chronicus (LSC)|Overall Study||4||
48536867|NCT03858634|101651668|FG001|Participants With Lichen Simplex Chronicus (LSC)|Overall Study||1||
48536868|NCT03858634|101651667|FG000|Participants With Plaque Psoriasis (PPs)|Overall Study||14||
48536869|NCT03858634|101651668|FG001|Participants With Plaque Psoriasis (PPs)|Overall Study||7||
48536870|NCT03858634|101651667|FG000|COMPLETED|Overall Study||36||
48536871|NCT03858634|101651668|FG001|COMPLETED|Overall Study||17||
48536872|NCT03858634|101651667|FG000|NOT COMPLETED|Overall Study||3||
48536873|NCT03858634|101651668|FG001|NOT COMPLETED|Overall Study||2||
48536874|NCT04630158|101651669|FG000|STARTED|Overall Study||50||
48536875|NCT04630158|101651670|FG001|STARTED|Overall Study||49||
48536876|NCT04630158|101651671|FG002|STARTED|Overall Study||51||
48536877|NCT04630158|101651669|FG000|COMPLETED|Overall Study||46||
48536878|NCT04630158|101651670|FG001|COMPLETED|Overall Study||45||
48536879|NCT04630158|101651671|FG002|COMPLETED|Overall Study||47||
48536880|NCT04630158|101651669|FG000|NOT COMPLETED|Overall Study||4||
48536881|NCT04630158|101651670|FG001|NOT COMPLETED|Overall Study||4||
48536882|NCT04630158|101651671|FG002|NOT COMPLETED|Overall Study||4||
48536883|NCT03398070|101651672|FG000|STARTED|Overall Study||30||
48536884|NCT03398070|101651672|FG000|COMPLETED|Overall Study||22||
48536885|NCT03398070|101651672|FG000|NOT COMPLETED|Overall Study||8||
48536886|NCT01517373|101651673|FG000|STARTED|Run-in Period||361||
48536887|NCT01517373|101651674|FG001|STARTED|Run-in Period||0||
48536888|NCT01517373|101651675|FG002|STARTED|Run-in Period||0||
48536889|NCT01517373|101651676|FG003|STARTED|Run-in Period||0||
48536890|NCT01517373|101651677|FG004|STARTED|Run-in Period||0||
48536891|NCT01517373|101651678|FG005|STARTED|Run-in Period||0||
48536892|NCT01517373|101651673|FG000|COMPLETED|Run-in Period||304||
48536893|NCT01517373|101651674|FG001|COMPLETED|Run-in Period||0||
48536894|NCT01517373|101651675|FG002|COMPLETED|Run-in Period||0||
48536895|NCT01517373|101651676|FG003|COMPLETED|Run-in Period||0||
48536896|NCT01517373|101651677|FG004|COMPLETED|Run-in Period||0||
48536897|NCT01517373|101651678|FG005|COMPLETED|Run-in Period||0||
48536898|NCT01517373|101651673|FG000|NOT COMPLETED|Run-in Period||57||
48536899|NCT01517373|101651674|FG001|NOT COMPLETED|Run-in Period||0||
48536900|NCT01517373|101651675|FG002|NOT COMPLETED|Run-in Period||0||
48536901|NCT01517373|101651676|FG003|NOT COMPLETED|Run-in Period||0||
48536902|NCT01517373|101651677|FG004|NOT COMPLETED|Run-in Period||0||
48536903|NCT01517373|101651678|FG005|NOT COMPLETED|Run-in Period||0||
48536904|NCT01517373|101651673|FG000|STARTED|Treatment Period||0||
48536905|NCT01517373|101651674|FG001|STARTED|Treatment Period||61||
48536906|NCT01517373|101651675|FG002|STARTED|Treatment Period||60||
48536907|NCT01517373|101651676|FG003|STARTED|Treatment Period||61||
48536908|NCT01517373|101651677|FG004|STARTED|Treatment Period||61||
48536909|NCT01517373|101651678|FG005|STARTED|Treatment Period||61||
48536910|NCT01517373|101651673|FG000|COMPLETED|Treatment Period||0||
48536911|NCT01517373|101651674|FG001|COMPLETED|Treatment Period||57||
48536912|NCT01517373|101651675|FG002|COMPLETED|Treatment Period||54||
48536913|NCT01517373|101651676|FG003|COMPLETED|Treatment Period||54||
48536914|NCT01517373|101651677|FG004|COMPLETED|Treatment Period||55||
48536915|NCT01517373|101651678|FG005|COMPLETED|Treatment Period||54||
48536916|NCT01517373|101651673|FG000|NOT COMPLETED|Treatment Period||0||
48536917|NCT01517373|101651674|FG001|NOT COMPLETED|Treatment Period||4||
48536918|NCT01517373|101651675|FG002|NOT COMPLETED|Treatment Period||6||
48536919|NCT01517373|101651676|FG003|NOT COMPLETED|Treatment Period||7||
48536920|NCT01517373|101651677|FG004|NOT COMPLETED|Treatment Period||6||
48536921|NCT01517373|101651678|FG005|NOT COMPLETED|Treatment Period||7||
48536922|NCT00507130|101651679|FG000|STARTED|Overall Study||9||
48536923|NCT00507130|101651680|FG001|STARTED|Overall Study||9||
48536924|NCT00507130|101651681|FG002|STARTED|Overall Study||9||
48536925|NCT00507130|101651682|FG003|STARTED|Overall Study||9||
48536926|NCT00507130|101651679|FG000|COMPLETED|Overall Study||8||
48536927|NCT00507130|101651680|FG001|COMPLETED|Overall Study||9||
48536928|NCT00507130|101651681|FG002|COMPLETED|Overall Study||8||
48536929|NCT00507130|101651682|FG003|COMPLETED|Overall Study||8||
48536930|NCT00507130|101651679|FG000|NOT COMPLETED|Overall Study||1||
48536931|NCT00507130|101651680|FG001|NOT COMPLETED|Overall Study||0||
48536932|NCT00507130|101651681|FG002|NOT COMPLETED|Overall Study||1||
48536933|NCT00507130|101651682|FG003|NOT COMPLETED|Overall Study||1||
48536934|NCT00144781|101651683|FG000|STARTED|Overall Study||8||
48536935|NCT00144781|101651684|FG001|STARTED|Overall Study||9||
48536936|NCT00144781|101651685|FG002|STARTED|Overall Study||8||
48536937|NCT00144781|101651686|FG003|STARTED|Overall Study||9||
48536938|NCT00144781|101651683|FG000|COMPLETED|Overall Study||8||
48536939|NCT00144781|101651684|FG001|COMPLETED|Overall Study||7||
48536940|NCT00144781|101651685|FG002|COMPLETED|Overall Study||8||
48236157|NCT02074709|100900317|FG000|STARTED|Overall Study||30||
48236158|NCT02074709|100900318|FG001|STARTED|Overall Study||30||
48236159|NCT02074709|100900317|FG000|COMPLETED|Overall Study||29||
48236160|NCT02074709|100900318|FG001|COMPLETED|Overall Study||29||
48236161|NCT02074709|100900317|FG000|NOT COMPLETED|Overall Study||1||
48236162|NCT02074709|100900318|FG001|NOT COMPLETED|Overall Study||1||
48536941|NCT00144781|101651686|FG003|COMPLETED|Overall Study||9||
48536942|NCT00144781|101651683|FG000|NOT COMPLETED|Overall Study||0||
48536943|NCT00144781|101651684|FG001|NOT COMPLETED|Overall Study||2||
48536944|NCT00144781|101651685|FG002|NOT COMPLETED|Overall Study||0||
48536945|NCT00144781|101651686|FG003|NOT COMPLETED|Overall Study||0||
48536946|NCT01094886|101651687|FG000|STARTED|Overall Study||53||
48536947|NCT01094886|101651687|FG000|COMPLETED|Overall Study||46||
48536948|NCT01094886|101651687|FG000|NOT COMPLETED|Overall Study||7||
48536949|NCT01955837|101651688|FG000|STARTED|Overall Study||271||
48236163|NCT00042939|100900319|FG000|STARTED|Overall Study||48||
48236164|NCT00042939|100900320|FG001|STARTED|Overall Study||46||
48236165|NCT00042939|100900319|FG000|Treated|Overall Study||46||
48236166|NCT00042939|100900320|FG001|Treated|Overall Study||45||
48236167|NCT00042939|100900319|FG000|Eligible and Began Protocol Therapy|Overall Study||44||
48236168|NCT00042939|100900320|FG001|Eligible and Began Protocol Therapy|Overall Study||43||
48236169|NCT00042939|100900319|FG000|Patients With EGFR Results Available|Overall Study||30||
48236170|NCT00042939|100900320|FG001|Patients With EGFR Results Available|Overall Study||31||
48236171|NCT00042939|100900319|FG000|COMPLETED|Overall Study||24||
48236172|NCT00042939|100900320|FG001|COMPLETED|Overall Study||25||
48236173|NCT00042939|100900319|FG000|NOT COMPLETED|Overall Study||24||
48236174|NCT00042939|100900320|FG001|NOT COMPLETED|Overall Study||21||
48236175|NCT00821093|100900321|FG000|STARTED|Overall Study||560||
48236176|NCT00821093|100900322|FG001|STARTED|Overall Study||563||
48236177|NCT00821093|100900321|FG000|Exposed to Drug|Overall Study||559||
48236178|NCT00821093|100900322|FG001|Exposed to Drug|Overall Study||562||
48236179|NCT00821093|100900321|FG000|COMPLETED|Overall Study||511||
48236180|NCT00821093|100900322|FG001|COMPLETED|Overall Study||523||
48236181|NCT00821093|100900321|FG000|NOT COMPLETED|Overall Study||49||
48536950|NCT01955837|101651689|FG001|STARTED|Overall Study||135||
48536951|NCT01955837|101651688|FG000|COMPLETED|Overall Study||271||
48536952|NCT01955837|101651689|FG001|COMPLETED|Overall Study||135||
48536953|NCT01955837|101651688|FG000|NOT COMPLETED|Overall Study||0||
48536954|NCT01955837|101651689|FG001|NOT COMPLETED|Overall Study||0||
48536955|NCT00049530|101651690|FG000|STARTED|Overall Study||32||
48536956|NCT00049530|101651690|FG000|Eligible and Treated|Overall Study||29||
48536957|NCT00049530|101651690|FG000|COMPLETED|Overall Study||0||
48536958|NCT00049530|101651690|FG000|NOT COMPLETED|Overall Study||32||
48536959|NCT00401986|101651691|FG000|STARTED|Overall Study||14||
48536960|NCT00401986|101651691|FG000|COMPLETED|Overall Study||12||
48536961|NCT00401986|101651691|FG000|NOT COMPLETED|Overall Study||2||
48536962|NCT02699060|101651692|FG000|STARTED|Overall Study||68||
48536963|NCT02699060|101651692|FG000|COMPLETED|Overall Study||68||
48536964|NCT02699060|101651692|FG000|NOT COMPLETED|Overall Study||0||
48536965|NCT02040779|101651693|FG000|STARTED|Overall Study||91||
48536966|NCT02040779|101651694|FG001|STARTED|Overall Study||90||
48536967|NCT02040779|101651695|FG002|STARTED|Overall Study||92||
48536968|NCT02040779|101651693|FG000|Full Analysis Set (FAS)|Overall Study||90||
48536969|NCT02040779|101651694|FG001|Full Analysis Set (FAS)|Overall Study||88||
48536970|NCT02040779|101651695|FG002|Full Analysis Set (FAS)|Overall Study||92||
48536971|NCT02040779|101651693|FG000|COMPLETED|Overall Study||79||
48536972|NCT02040779|101651694|FG001|COMPLETED|Overall Study||83||
48536973|NCT02040779|101651695|FG002|COMPLETED|Overall Study||88||
48536974|NCT02040779|101651693|FG000|NOT COMPLETED|Overall Study||12||
48536975|NCT02040779|101651694|FG001|NOT COMPLETED|Overall Study||7||
48536976|NCT02040779|101651695|FG002|NOT COMPLETED|Overall Study||4||
48536977|NCT03371459|101651696|FG000|STARTED|Period 1||23||
48236182|NCT00821093|100900322|FG001|NOT COMPLETED|Overall Study||40||
48236183|NCT01653509|100900323|FG000|STARTED|Overall Study||12||
48236184|NCT01653509|100900324|FG001|STARTED|Overall Study||13||
48236185|NCT01653509|100900323|FG000|COMPLETED|Overall Study||12||
48236186|NCT01653509|100900324|FG001|COMPLETED|Overall Study||13||
48236187|NCT01653509|100900323|FG000|NOT COMPLETED|Overall Study||0||
48236188|NCT01653509|100900324|FG001|NOT COMPLETED|Overall Study||0||
48236189|NCT01102426|100900325|FG000|STARTED|Overall Study||171||
48536978|NCT03371459|101651697|FG001|STARTED|Period 1||23||
48536979|NCT03371459|101651696|FG000|COMPLETED|Period 1||23||
48536980|NCT03371459|101651697|FG001|COMPLETED|Period 1||23||
48536981|NCT03371459|101651696|FG000|NOT COMPLETED|Period 1||0||
48536982|NCT03371459|101651697|FG001|NOT COMPLETED|Period 1||0||
48536983|NCT03371459|101651696|FG000|STARTED|Washout||23||
48536984|NCT03371459|101651697|FG001|STARTED|Washout||23||
48536985|NCT03371459|101651696|FG000|COMPLETED|Washout||23||
48536986|NCT03371459|101651697|FG001|COMPLETED|Washout||22||
48536987|NCT03371459|101651696|FG000|NOT COMPLETED|Washout||0||
48536988|NCT03371459|101651697|FG001|NOT COMPLETED|Washout||1||
48536989|NCT03371459|101651696|FG000|STARTED|Period 2||23||
48536990|NCT03371459|101651697|FG001|STARTED|Period 2||22||
48536991|NCT03371459|101651696|FG000|COMPLETED|Period 2||23||
48536992|NCT03371459|101651697|FG001|COMPLETED|Period 2||22||
48536993|NCT03371459|101651696|FG000|NOT COMPLETED|Period 2||0||
48536994|NCT03371459|101651697|FG001|NOT COMPLETED|Period 2||0||
48536995|NCT01154816|101651698|FG000|STARTED|Overall Study||20||
48536996|NCT01154816|101651699|FG001|STARTED|Overall Study||12||
48536997|NCT01154816|101651700|FG002|STARTED|Overall Study||10||
48236190|NCT01102426|100900326|FG001|STARTED|Overall Study||84||
48236191|NCT01102426|100900325|FG000|COMPLETED|Overall Study||6||
48236192|NCT01102426|100900326|FG001|COMPLETED|Overall Study||3||
48236193|NCT01102426|100900325|FG000|NOT COMPLETED|Overall Study||165||
48236194|NCT01102426|100900326|FG001|NOT COMPLETED|Overall Study||81||
48536998|NCT01154816|101651701|FG003|STARTED|Overall Study||10||
48536999|NCT01154816|101651702|FG004|STARTED|Overall Study||10||
48537000|NCT01154816|101651703|FG005|STARTED|Overall Study||8||
48537001|NCT01154816|101651704|FG006|STARTED|Overall Study||6||
48537002|NCT01154816|101651705|FG007|STARTED|Overall Study||7||
48537003|NCT01154816|101651706|FG008|STARTED|Overall Study||10||
48537004|NCT01154816|101651707|FG009|STARTED|Overall Study||10||
48537005|NCT01154816|101651708|FG010|STARTED|Overall Study||11||
48537006|NCT01154816|101651709|FG011|STARTED|Overall Study||4||
48537007|NCT01154816|101651698|FG000|COMPLETED|Overall Study||0||
48537008|NCT01154816|101651699|FG001|COMPLETED|Overall Study||2||
48537009|NCT01154816|101651700|FG002|COMPLETED|Overall Study||0||
48537010|NCT01154816|101651701|FG003|COMPLETED|Overall Study||0||
48537011|NCT01154816|101651702|FG004|COMPLETED|Overall Study||0||
48537012|NCT01154816|101651703|FG005|COMPLETED|Overall Study||0||
48537013|NCT01154816|101651704|FG006|COMPLETED|Overall Study||0||
48537014|NCT01154816|101651705|FG007|COMPLETED|Overall Study||0||
48537015|NCT01154816|101651706|FG008|COMPLETED|Overall Study||1||
48537016|NCT01154816|101651707|FG009|COMPLETED|Overall Study||0||
48537017|NCT01154816|101651708|FG010|COMPLETED|Overall Study||0||
48537018|NCT01154816|101651709|FG011|COMPLETED|Overall Study||0||
48537019|NCT01154816|101651698|FG000|NOT COMPLETED|Overall Study||20||
48537020|NCT01154816|101651699|FG001|NOT COMPLETED|Overall Study||10||
48537021|NCT01154816|101651700|FG002|NOT COMPLETED|Overall Study||10||
48537022|NCT01154816|101651701|FG003|NOT COMPLETED|Overall Study||10||
48537023|NCT01154816|101651702|FG004|NOT COMPLETED|Overall Study||10||
48537024|NCT01154816|101651703|FG005|NOT COMPLETED|Overall Study||8||
48537025|NCT01154816|101651704|FG006|NOT COMPLETED|Overall Study||6||
48537026|NCT01154816|101651705|FG007|NOT COMPLETED|Overall Study||7||
48537027|NCT01154816|101651706|FG008|NOT COMPLETED|Overall Study||9||
48537028|NCT01154816|101651707|FG009|NOT COMPLETED|Overall Study||10||
48537029|NCT01154816|101651708|FG010|NOT COMPLETED|Overall Study||11||
48537030|NCT01154816|101651709|FG011|NOT COMPLETED|Overall Study||4||
48537031|NCT05502081|101651710|FG000|STARTED|Overall Study||53||
48537032|NCT05502081|101651711|FG001|STARTED|Overall Study||106||
48537033|NCT05502081|101651712|FG002|STARTED|Overall Study||106||
48537034|NCT05502081|101651710|FG000|COMPLETED|Overall Study||53||
48537035|NCT05502081|101651711|FG001|COMPLETED|Overall Study||106||
48537036|NCT05502081|101651712|FG002|COMPLETED|Overall Study||106||
48537037|NCT05502081|101651710|FG000|NOT COMPLETED|Overall Study||0||
48537038|NCT05502081|101651711|FG001|NOT COMPLETED|Overall Study||0||
48537039|NCT05502081|101651712|FG002|NOT COMPLETED|Overall Study||0||
48537040|NCT02149290|101651713|FG000|STARTED|Overall Study||198||
48537041|NCT02149290|101651713|FG000|COMPLETED|Overall Study||198||
48537042|NCT02149290|101651713|FG000|NOT COMPLETED|Overall Study||0||
48537043|NCT04497948|101651714|FG000|STARTED|Overall Study||9||
48537044|NCT04497948|101651714|FG000|COMPLETED|Overall Study||7||
48537045|NCT04497948|101651714|FG000|NOT COMPLETED|Overall Study||2||
48537046|NCT02006693|101651715|FG000|STARTED|Overall Study||112||120
48537047|NCT02006693|101651716|FG001|STARTED|Overall Study||87||98
48236195|NCT01933776|100900327|FG000|STARTED|Overall Study||20||
48537048|NCT02006693|101651715|FG000|COMPLETED|Overall Study||84||91
48537049|NCT02006693|101651716|FG001|COMPLETED|Overall Study||74||83
48537050|NCT02006693|101651715|FG000|NOT COMPLETED|Overall Study||28||29
48537051|NCT02006693|101651716|FG001|NOT COMPLETED|Overall Study||13||15
48537052|NCT03468075|101651717|FG000|STARTED|Overall Study||10||
48537053|NCT03468075|101651717|FG000|COMPLETED|Overall Study||10||
48537054|NCT03468075|101651717|FG000|NOT COMPLETED|Overall Study||0||
48537055|NCT01502410|101651718|FG000|STARTED|Overall Study||10||
48537056|NCT01502410|101651719|FG001|STARTED|Overall Study||10||
48537057|NCT01502410|101651720|FG002|STARTED|Overall Study||0||
48537058|NCT01502410|101651721|FG003|STARTED|Overall Study||0||
48537059|NCT01502410|101651718|FG000|COMPLETED|Overall Study||0||
48537060|NCT01502410|101651719|FG001|COMPLETED|Overall Study||0||
48537061|NCT01502410|101651720|FG002|COMPLETED|Overall Study||0||
48537062|NCT01502410|101651721|FG003|COMPLETED|Overall Study||0||
48537063|NCT01502410|101651718|FG000|NOT COMPLETED|Overall Study||10||
48537064|NCT01502410|101651719|FG001|NOT COMPLETED|Overall Study||10||
48537065|NCT01502410|101651720|FG002|NOT COMPLETED|Overall Study||0||
48537066|NCT01502410|101651721|FG003|NOT COMPLETED|Overall Study||0||
48537067|NCT00106964|101651722|FG000|STARTED|Overall Study||118||
48537068|NCT00106964|101651723|FG001|STARTED|Overall Study||126||
48081010|NCT02228460|100521604|FG000|NOT COMPLETED|Overall Study||2||
48236196|NCT01933776|100900328|FG001|STARTED|Overall Study||20||
48236197|NCT01933776|100900327|FG000|COMPLETED|Overall Study||20||
48236198|NCT01933776|100900328|FG001|COMPLETED|Overall Study||20||
48236199|NCT01933776|100900327|FG000|NOT COMPLETED|Overall Study||0||
48236200|NCT01933776|100900328|FG001|NOT COMPLETED|Overall Study||0||
48236201|NCT03331978|100900329|FG000|STARTED|Overall Study||122||
48236202|NCT03331978|100900330|FG001|STARTED|Overall Study||123||
48537069|NCT00106964|101651724|FG002|STARTED|Overall Study||127||
48537070|NCT00106964|101651722|FG000|COMPLETED|Overall Study||105||
48537071|NCT00106964|101651723|FG001|COMPLETED|Overall Study||111||
48537072|NCT00106964|101651724|FG002|COMPLETED|Overall Study||120||
48537073|NCT00106964|101651722|FG000|NOT COMPLETED|Overall Study||13||
48537074|NCT00106964|101651723|FG001|NOT COMPLETED|Overall Study||15||
48537075|NCT00106964|101651724|FG002|NOT COMPLETED|Overall Study||7||
48537076|NCT04689867|101651725|FG000|STARTED|Overall Study||5||
48537077|NCT04689867|101651725|FG000|COMPLETED|Overall Study||5||
48537078|NCT04689867|101651725|FG000|NOT COMPLETED|Overall Study||0||
48537079|NCT00729248|101651726|FG000|STARTED|Overall Study||12||
48537080|NCT00729248|101651726|FG000|COMPLETED|Overall Study||10||
48537081|NCT00729248|101651726|FG000|NOT COMPLETED|Overall Study||2||
48537082|NCT01248013|101651727|FG000|STARTED|Overall Study||89||
48537083|NCT01248013|101651727|FG000|Irritable Bowel Syndrome Hypnotherapy|Overall Study||75||
48537084|NCT01248013|101651727|FG000|COMPLETED|Overall Study||75||
48537085|NCT01248013|101651727|FG000|NOT COMPLETED|Overall Study||14||
48537086|NCT02458287|101651728|FG000|STARTED|Overall Study||50||
48537087|NCT02458287|101651729|FG001|STARTED|Overall Study||100||
48537088|NCT02458287|101651730|FG002|STARTED|Overall Study||49||
48537089|NCT02458287|101651731|FG003|STARTED|Overall Study||100||
48537090|NCT02458287|101651728|FG000|COMPLETED|Overall Study||50||
48537091|NCT02458287|101651729|FG001|COMPLETED|Overall Study||96||
48537092|NCT02458287|101651730|FG002|COMPLETED|Overall Study||46||
48537093|NCT02458287|101651731|FG003|COMPLETED|Overall Study||97||
48537094|NCT02458287|101651728|FG000|NOT COMPLETED|Overall Study||0||
48537095|NCT02458287|101651729|FG001|NOT COMPLETED|Overall Study||4||
48537096|NCT02458287|101651730|FG002|NOT COMPLETED|Overall Study||3||
48537097|NCT02458287|101651731|FG003|NOT COMPLETED|Overall Study||3||
48537098|NCT00605540|101651732|FG000|STARTED|Overall Study||133||
48537099|NCT00605540|101651732|FG000|COMPLETED|Overall Study||95||
48537100|NCT00605540|101651732|FG000|NOT COMPLETED|Overall Study||38||
48537101|NCT01004003|101651733|FG000|STARTED|Overall Study||6||
48537102|NCT01004003|101651734|FG001|STARTED|Overall Study||3||
48537103|NCT01004003|101651735|FG002|STARTED|Overall Study||4||
48537104|NCT01004003|101651736|FG003|STARTED|Overall Study||3||
48537105|NCT01004003|101651737|FG004|STARTED|Overall Study||4||
48236203|NCT03331978|100900329|FG000|COMPLETED|Overall Study||85||
48236204|NCT03331978|100900330|FG001|COMPLETED|Overall Study||81||
48236205|NCT03331978|100900329|FG000|NOT COMPLETED|Overall Study||37||
48236206|NCT03331978|100900330|FG001|NOT COMPLETED|Overall Study||42||
48236207|NCT00795639|100900331|FG000|STARTED|Overall Study||91||
48236208|NCT00795639|100900332|FG001|STARTED|Overall Study||92||
48537106|NCT01004003|101651738|FG005|STARTED|Overall Study||4||
48537107|NCT01004003|101651739|FG006|STARTED|Overall Study||8||
48537108|NCT01004003|101651740|FG007|STARTED|Overall Study||62||
48537109|NCT01004003|101651741|FG008|STARTED|Overall Study||31||
48537110|NCT01004003|101651733|FG000|COMPLETED|Overall Study||0||
48537111|NCT01004003|101651734|FG001|COMPLETED|Overall Study||0||
48537112|NCT01004003|101651735|FG002|COMPLETED|Overall Study||0||
48537113|NCT01004003|101651736|FG003|COMPLETED|Overall Study||0||
48537114|NCT01004003|101651737|FG004|COMPLETED|Overall Study||0||
48537115|NCT01004003|101651738|FG005|COMPLETED|Overall Study||0||
48537116|NCT01004003|101651739|FG006|COMPLETED|Overall Study||0||
48537117|NCT01004003|101651740|FG007|COMPLETED|Overall Study||2||
48537118|NCT01004003|101651741|FG008|COMPLETED|Overall Study||1||
48236209|NCT00795639|100900331|FG000|Randomized and Not Treated|Overall Study||0||
48537119|NCT01004003|101651733|FG000|NOT COMPLETED|Overall Study||6||
48537120|NCT01004003|101651734|FG001|NOT COMPLETED|Overall Study||3||
48537121|NCT01004003|101651735|FG002|NOT COMPLETED|Overall Study||4||
48537122|NCT01004003|101651736|FG003|NOT COMPLETED|Overall Study||3||
48537123|NCT01004003|101651737|FG004|NOT COMPLETED|Overall Study||4||
48537124|NCT01004003|101651738|FG005|NOT COMPLETED|Overall Study||4||
48537125|NCT01004003|101651739|FG006|NOT COMPLETED|Overall Study||8||
48537126|NCT01004003|101651740|FG007|NOT COMPLETED|Overall Study||60||
48537127|NCT01004003|101651741|FG008|NOT COMPLETED|Overall Study||30||
48537128|NCT03786718|101651742|FG000|STARTED|Overall Study||67||
48537129|NCT03786718|101651742|FG000|COMPLETED|Overall Study||60||
48537130|NCT03786718|101651742|FG000|NOT COMPLETED|Overall Study||7||
48537131|NCT02287818|101651743|FG000|STARTED|Overall Study||60||
48537132|NCT02287818|101651744|FG001|STARTED|Overall Study||67||
48537133|NCT02287818|101651743|FG000|COMPLETED|Overall Study||53||
48537134|NCT02287818|101651744|FG001|COMPLETED|Overall Study||54||
48537135|NCT02287818|101651743|FG000|NOT COMPLETED|Overall Study||7||
48537136|NCT02287818|101651744|FG001|NOT COMPLETED|Overall Study||13||
48537137|NCT04283500|101651745|FG000|STARTED|Overall Study||15||
48537138|NCT04283500|101651745|FG000|Completed Day 0|Overall Study||14||
48537139|NCT04283500|101651745|FG000|Completed Day 1|Overall Study||14||
48537140|NCT04283500|101651745|FG000|Completed Day 2|Overall Study||13||
48537141|NCT04283500|101651745|FG000|Completed Day 3|Overall Study||11||
48537142|NCT04283500|101651745|FG000|COMPLETED|Overall Study||6|Day 30|
48537143|NCT04283500|101651745|FG000|NOT COMPLETED|Overall Study||9||
48537144|NCT02031458|101651746|FG000|STARTED|May 8, 2015 to January 11, 2019||138||
48537145|NCT02031458|101651747|FG001|STARTED|May 8, 2015 to January 11, 2019||269||
48537146|NCT02031458|101651748|FG002|STARTED|May 8, 2015 to January 11, 2019||252||
48537147|NCT02031458|101651746|FG000|COMPLETED|May 8, 2015 to January 11, 2019||0||
48537148|NCT02031458|101651747|FG001|COMPLETED|May 8, 2015 to January 11, 2019||0||
48537149|NCT02031458|101651748|FG002|COMPLETED|May 8, 2015 to January 11, 2019||0||
48537150|NCT02031458|101651746|FG000|NOT COMPLETED|May 8, 2015 to January 11, 2019||138||
48537151|NCT02031458|101651747|FG001|NOT COMPLETED|May 8, 2015 to January 11, 2019||269||
48537152|NCT02031458|101651748|FG002|NOT COMPLETED|May 8, 2015 to January 11, 2019||252||
48537153|NCT02031458|101651746|FG000|STARTED|Baseline to May 8, 2015||139||
48537154|NCT02031458|101651747|FG001|STARTED|Baseline to May 8, 2015||267||
48537155|NCT02031458|101651748|FG002|STARTED|Baseline to May 8, 2015||253||
48537156|NCT02031458|101651746|FG000|COMPLETED|Baseline to May 8, 2015||0||
48537157|NCT02031458|101651747|FG001|COMPLETED|Baseline to May 8, 2015||0||
48537158|NCT02031458|101651748|FG002|COMPLETED|Baseline to May 8, 2015||0||
48537159|NCT02031458|101651746|FG000|NOT COMPLETED|Baseline to May 8, 2015||139||
48537160|NCT02031458|101651747|FG001|NOT COMPLETED|Baseline to May 8, 2015||267||
48537161|NCT02031458|101651748|FG002|NOT COMPLETED|Baseline to May 8, 2015||253||
48537162|NCT03327792|101651749|FG000|STARTED|Overall Study||17||
48537163|NCT03327792|101651750|FG001|STARTED|Overall Study||17||
48537164|NCT03327792|101651749|FG000|COMPLETED|Overall Study||10||
48537165|NCT03327792|101651750|FG001|COMPLETED|Overall Study||14||
48537166|NCT03327792|101651749|FG000|NOT COMPLETED|Overall Study||7||
48537167|NCT03327792|101651750|FG001|NOT COMPLETED|Overall Study||3||
48537168|NCT03207243|101651751|FG000|STARTED|Overall Study||82||
48537169|NCT03207243|101651752|FG001|STARTED|Overall Study||83||
48537170|NCT03207243|101651751|FG000|COMPLETED|Overall Study||23||
48537171|NCT03207243|101651752|FG001|COMPLETED|Overall Study||39||
48537172|NCT03207243|101651751|FG000|NOT COMPLETED|Overall Study||59||
48537173|NCT03207243|101651752|FG001|NOT COMPLETED|Overall Study||44||
48537174|NCT04159935|101651753|FG000|STARTED|Overall Study||4||
48537175|NCT04159935|101651754|FG001|STARTED|Overall Study||4||
48537176|NCT04159935|101651753|FG000|Month 1 Post-treatment|Overall Study||3||
48537177|NCT04159935|101651754|FG001|Month 1 Post-treatment|Overall Study||3||
48537178|NCT04159935|101651753|FG000|Month 3 Post-treatment|Overall Study||3||
48537179|NCT04159935|101651754|FG001|Month 3 Post-treatment|Overall Study||1||
48537180|NCT04159935|101651753|FG000|COMPLETED|Overall Study||3||
48537181|NCT04159935|101651754|FG001|COMPLETED|Overall Study||1||
48537182|NCT04159935|101651753|FG000|NOT COMPLETED|Overall Study||1||
48537183|NCT04159935|101651754|FG001|NOT COMPLETED|Overall Study||3||
48537184|NCT02240030|101651755|FG000|STARTED|Overall Study||113||
48537185|NCT02240030|101651756|FG001|STARTED|Overall Study||114||
48537186|NCT02240030|101651757|FG002|STARTED|Overall Study||112||
48537187|NCT02240030|101651755|FG000|COMPLETED|Overall Study||96||
48537188|NCT02240030|101651756|FG001|COMPLETED|Overall Study||97||
48537189|NCT02240030|101651757|FG002|COMPLETED|Overall Study||97||
48537190|NCT02240030|101651755|FG000|NOT COMPLETED|Overall Study||17||
48537191|NCT02240030|101651756|FG001|NOT COMPLETED|Overall Study||17||
48537192|NCT02240030|101651757|FG002|NOT COMPLETED|Overall Study||15||
48537193|NCT01119508|101651758|FG000|STARTED|Overall Study||64||
48537194|NCT01119508|101651758|FG000|Received Four Induction Doses|Overall Study||45||
48537195|NCT01119508|101651758|FG000|Received Fifth Consolidation Dose week12|Overall Study||32||
48537196|NCT01119508|101651758|FG000|COMPLETED|Overall Study||5||
48537197|NCT01119508|101651758|FG000|NOT COMPLETED|Overall Study||59||
48537198|NCT01996449|101651759|FG000|STARTED|Period 1: First Drug||6||
48537199|NCT01996449|101651760|FG001|STARTED|Period 1: First Drug||8||
48537200|NCT01996449|101651759|FG000|COMPLETED|Period 1: First Drug||6||
48537201|NCT01996449|101651760|FG001|COMPLETED|Period 1: First Drug||8||
48537202|NCT01996449|101651759|FG000|NOT COMPLETED|Period 1: First Drug||0||
48537203|NCT01996449|101651760|FG001|NOT COMPLETED|Period 1: First Drug||0||
48537204|NCT01996449|101651759|FG000|STARTED|Period 2: Second Drug||6||
48537205|NCT01996449|101651760|FG001|STARTED|Period 2: Second Drug||8||
48537206|NCT01996449|101651759|FG000|COMPLETED|Period 2: Second Drug||6||
48537207|NCT01996449|101651760|FG001|COMPLETED|Period 2: Second Drug||8||
48537208|NCT01996449|101651759|FG000|NOT COMPLETED|Period 2: Second Drug||0||
48537209|NCT01996449|101651760|FG001|NOT COMPLETED|Period 2: Second Drug||0||
48537210|NCT03882528|101651761|FG000|STARTED|Overall Study||12||
48537211|NCT03882528|101651761|FG000|COMPLETED|Overall Study||12||
48537212|NCT03882528|101651761|FG000|NOT COMPLETED|Overall Study||0||
48236210|NCT00795639|100900332|FG001|Randomized and Not Treated|Overall Study||1||
48236211|NCT00795639|100900331|FG000|COMPLETED|Overall Study||70||
48236212|NCT00795639|100900332|FG001|COMPLETED|Overall Study||66||
48236213|NCT00795639|100900331|FG000|NOT COMPLETED|Overall Study||21||
48236214|NCT00795639|100900332|FG001|NOT COMPLETED|Overall Study||26||
48236215|NCT00905255|100900333|FG000|STARTED|Overall Study||33||
48236216|NCT00905255|100900334|FG001|STARTED|Overall Study||36||
48236217|NCT00905255|100900333|FG000|Safety Population|Overall Study||33||
48236218|NCT00905255|100900334|FG001|Safety Population|Overall Study||36||
48236219|NCT00905255|100900333|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study||33||
48236220|NCT00905255|100900334|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||36||
48236221|NCT00905255|100900333|FG000|COMPLETED|Overall Study||20||
48236222|NCT00905255|100900334|FG001|COMPLETED|Overall Study||27||
48236223|NCT00905255|100900333|FG000|NOT COMPLETED|Overall Study||13||
48236224|NCT00905255|100900334|FG001|NOT COMPLETED|Overall Study||9||
48236225|NCT01695044|100900335|FG000|STARTED|Overall Study||119||
48236226|NCT01695044|100900335|FG000|COMPLETED|Overall Study||17||
48236227|NCT01695044|100900335|FG000|NOT COMPLETED|Overall Study||102||
48236228|NCT02907489|100900336|FG000|STARTED|Overall Study||42||
48236229|NCT02907489|100900337|FG001|STARTED|Overall Study||42||
48236230|NCT02907489|100900336|FG000|COMPLETED|Overall Study||40||
48236231|NCT02907489|100900337|FG001|COMPLETED|Overall Study||41||
48236232|NCT02907489|100900336|FG000|NOT COMPLETED|Overall Study||2||
48236233|NCT02907489|100900337|FG001|NOT COMPLETED|Overall Study||1||
48236234|NCT04203225|100900338|FG000|STARTED|Overall Study||21||
48236235|NCT04203225|100900339|FG001|STARTED|Overall Study||27||
48236236|NCT04203225|100900338|FG000|COMPLETED|Overall Study||21||
48236237|NCT04203225|100900339|FG001|COMPLETED|Overall Study||27||
48236238|NCT04203225|100900338|FG000|NOT COMPLETED|Overall Study||0||
48236239|NCT04203225|100900339|FG001|NOT COMPLETED|Overall Study||0||
48236240|NCT02736175|100900340|FG000|STARTED|Overall Study||216||
48236241|NCT02736175|100900341|FG001|STARTED|Overall Study||222||
48236242|NCT02736175|100900340|FG000|COMPLETED|Overall Study||214||
48236243|NCT02736175|100900341|FG001|COMPLETED|Overall Study||221||
48236244|NCT02736175|100900340|FG000|NOT COMPLETED|Overall Study||2||
48236245|NCT02736175|100900341|FG001|NOT COMPLETED|Overall Study||1||
48236246|NCT02525744|100900342|FG000|STARTED|Period 1||6||
48236247|NCT02525744|100900343|FG001|STARTED|Period 1||6||
48236248|NCT02525744|100900344|FG002|STARTED|Period 1||6||
48236249|NCT02525744|100900345|FG003|STARTED|Period 1||6||
48236250|NCT02525744|100900342|FG000|Received at Least 1 Dose of Study Drug|Period 1||6||
48236251|NCT02525744|100900343|FG001|Received at Least 1 Dose of Study Drug|Period 1||6||
48236252|NCT02525744|100900344|FG002|Received at Least 1 Dose of Study Drug|Period 1||5||
48236253|NCT02525744|100900345|FG003|Received at Least 1 Dose of Study Drug|Period 1||6||
48236254|NCT02525744|100900342|FG000|COMPLETED|Period 1||6||
48236255|NCT02525744|100900343|FG001|COMPLETED|Period 1||6||
48236256|NCT02525744|100900344|FG002|COMPLETED|Period 1||5||
48236257|NCT02525744|100900345|FG003|COMPLETED|Period 1||6||
48236258|NCT02525744|100900342|FG000|NOT COMPLETED|Period 1||0||
48236259|NCT02525744|100900343|FG001|NOT COMPLETED|Period 1||0||
48236260|NCT02525744|100900344|FG002|NOT COMPLETED|Period 1||1||
48236261|NCT02525744|100900345|FG003|NOT COMPLETED|Period 1||0||
48236262|NCT02525744|100900342|FG000|STARTED|Period 2||6||
48236263|NCT02525744|100900343|FG001|STARTED|Period 2||6||
48236264|NCT02525744|100900344|FG002|STARTED|Period 2||5||
48236265|NCT02525744|100900345|FG003|STARTED|Period 2||6||
48236266|NCT02525744|100900342|FG000|Received at Least 1 Dose of Study Drug|Period 2||6||
48236267|NCT02525744|100900343|FG001|Received at Least 1 Dose of Study Drug|Period 2||6||
48236268|NCT02525744|100900344|FG002|Received at Least 1 Dose of Study Drug|Period 2||5||
48537213|NCT00849186|101651762|FG000|STARTED|Overall Study||26||
48537214|NCT00849186|101651762|FG000|COMPLETED|Overall Study||16||
48537215|NCT00849186|101651762|FG000|NOT COMPLETED|Overall Study||10||
48236269|NCT02525744|100900345|FG003|Received at Least 1 Dose of Study Drug|Period 2||6||
48236270|NCT02525744|100900342|FG000|COMPLETED|Period 2||6||
48537216|NCT03839823|101651763|FG000|STARTED|Overall Study||112||
48537217|NCT03839823|101651764|FG001|STARTED|Overall Study||110||
48236271|NCT02525744|100900343|FG001|COMPLETED|Period 2||6||
48236272|NCT02525744|100900344|FG002|COMPLETED|Period 2||5||
48236273|NCT02525744|100900345|FG003|COMPLETED|Period 2||6||
48537218|NCT03839823|101651763|FG000|Treated|Overall Study||112||
48537219|NCT03839823|101651764|FG001|Treated|Overall Study||100||
48537220|NCT03839823|101651763|FG000|Not Treated|Overall Study||0||
48236274|NCT02525744|100900342|FG000|NOT COMPLETED|Period 2||0||
48236275|NCT02525744|100900343|FG001|NOT COMPLETED|Period 2||0||
48537221|NCT03839823|101651764|FG001|Not Treated|Overall Study||10||
48537222|NCT03839823|101651763|FG000|COMPLETED|Overall Study||35||
48537223|NCT03839823|101651764|FG001|COMPLETED|Overall Study||17||
48537224|NCT03839823|101651763|FG000|NOT COMPLETED|Overall Study||77||
48537225|NCT03839823|101651764|FG001|NOT COMPLETED|Overall Study||93||
48537226|NCT03323437|101651765|FG000|STARTED|Overall Study||13||
48537227|NCT03323437|101651766|FG001|STARTED|Overall Study||13||
48537228|NCT03323437|101651765|FG000|COMPLETED|Overall Study||13||
48537229|NCT03323437|101651766|FG001|COMPLETED|Overall Study||9||
48537230|NCT03323437|101651765|FG000|NOT COMPLETED|Overall Study||0||
48537231|NCT03323437|101651766|FG001|NOT COMPLETED|Overall Study||4||
48537232|NCT01161407|101651767|FG000|STARTED|Overall Study||6||
48537233|NCT01161407|101651768|FG001|STARTED|Overall Study||6||
48537234|NCT01161407|101651767|FG000|COMPLETED|Overall Study||3||
48537235|NCT01161407|101651768|FG001|COMPLETED|Overall Study||5||
48537236|NCT01161407|101651767|FG000|NOT COMPLETED|Overall Study||3||
48537237|NCT01161407|101651768|FG001|NOT COMPLETED|Overall Study||1||
48537238|NCT00759187|101651769|FG000|STARTED|Overall Study||8||
48537239|NCT00759187|101651770|FG001|STARTED|Overall Study||8||
48537240|NCT00759187|101651771|FG002|STARTED|Overall Study||9||
48537241|NCT00759187|101651769|FG000|COMPLETED|Overall Study||8||
48537242|NCT00759187|101651770|FG001|COMPLETED|Overall Study||8||
48537243|NCT00759187|101651771|FG002|COMPLETED|Overall Study||9||
48537244|NCT00759187|101651769|FG000|NOT COMPLETED|Overall Study||0||
48537245|NCT00759187|101651770|FG001|NOT COMPLETED|Overall Study||0||
48537246|NCT00759187|101651771|FG002|NOT COMPLETED|Overall Study||0||
48537247|NCT03207867|101651772|FG000|STARTED|Overall Study||11||
48537248|NCT03207867|101651773|FG001|STARTED|Overall Study||12||
48537249|NCT03207867|101651774|FG002|STARTED|Overall Study||11||
48537250|NCT03207867|101651775|FG003|STARTED|Overall Study||14||
48537251|NCT03207867|101651776|FG004|STARTED|Overall Study||14||
48537252|NCT03207867|101651777|FG005|STARTED|Overall Study||15||
48537253|NCT03207867|101651778|FG006|STARTED|Overall Study||11||
48236276|NCT02525744|100900344|FG002|NOT COMPLETED|Period 2||0||
48236277|NCT02525744|100900345|FG003|NOT COMPLETED|Period 2||0||
48236278|NCT02525744|100900342|FG000|STARTED|Period 3||6||
48236279|NCT02525744|100900343|FG001|STARTED|Period 3||6||
48236280|NCT02525744|100900344|FG002|STARTED|Period 3||5||
48236281|NCT02525744|100900345|FG003|STARTED|Period 3||6||
48236282|NCT02525744|100900342|FG000|Received at Least 1 Dose of Study Drug|Period 3||6||
48236283|NCT02525744|100900343|FG001|Received at Least 1 Dose of Study Drug|Period 3||6||
48236284|NCT02525744|100900344|FG002|Received at Least 1 Dose of Study Drug|Period 3||5||
48236285|NCT02525744|100900345|FG003|Received at Least 1 Dose of Study Drug|Period 3||6||
48236286|NCT02525744|100900342|FG000|COMPLETED|Period 3||6||
48236287|NCT02525744|100900343|FG001|COMPLETED|Period 3||5||
48236288|NCT02525744|100900344|FG002|COMPLETED|Period 3||5||
48537254|NCT03207867|101651779|FG007|STARTED|Overall Study||12||
48537255|NCT03207867|101651780|FG008|STARTED|Overall Study||27||
48537256|NCT03207867|101651781|FG009|STARTED|Overall Study||29||
48537257|NCT03207867|101651782|FG010|STARTED|Overall Study||2||
48537258|NCT03207867|101651783|FG011|STARTED|Overall Study||30||
48537259|NCT03207867|101651784|FG012|STARTED|Overall Study||3||
48537260|NCT03207867|101651785|FG013|STARTED|Overall Study||13||
48537261|NCT03207867|101651786|FG014|STARTED|Overall Study||13||
48537262|NCT03207867|101651787|FG015|STARTED|Overall Study||6||
48537263|NCT03207867|101651788|FG016|STARTED|Overall Study||15||
48537264|NCT03207867|101651789|FG017|STARTED|Overall Study||22||
48537265|NCT03207867|101651790|FG018|STARTED|Overall Study||20||
48537266|NCT03207867|101651791|FG019|STARTED|Overall Study||20||
48537267|NCT03207867|101651792|FG020|STARTED|Overall Study||6||
48236289|NCT02525744|100900345|FG003|COMPLETED|Period 3||6||
48236290|NCT02525744|100900342|FG000|NOT COMPLETED|Period 3||0||
48236291|NCT02525744|100900343|FG001|NOT COMPLETED|Period 3||1||
48236292|NCT02525744|100900344|FG002|NOT COMPLETED|Period 3||0||
48236293|NCT02525744|100900345|FG003|NOT COMPLETED|Period 3||0||
48236294|NCT02525744|100900342|FG000|STARTED|Period 4||6||
48236295|NCT02525744|100900343|FG001|STARTED|Period 4||5||
48236296|NCT02525744|100900344|FG002|STARTED|Period 4||5||
48236297|NCT02525744|100900345|FG003|STARTED|Period 4||6||
48537268|NCT03207867|101651793|FG021|STARTED|Overall Study||3||
48236298|NCT02525744|100900342|FG000|Received at Least 1 Dose of Study Drug|Period 4||6||
48236299|NCT02525744|100900343|FG001|Received at Least 1 Dose of Study Drug|Period 4||5||
48236300|NCT02525744|100900344|FG002|Received at Least 1 Dose of Study Drug|Period 4||5||
48236301|NCT02525744|100900345|FG003|Received at Least 1 Dose of Study Drug|Period 4||6||
48236302|NCT02525744|100900342|FG000|COMPLETED|Period 4||5||
48537269|NCT03207867|101651794|FG022|STARTED|Overall Study||3||
48537270|NCT03207867|101651795|FG023|STARTED|Overall Study||3||
48537271|NCT03207867|101651772|FG000|COMPLETED|Overall Study||0||
48537272|NCT03207867|101651773|FG001|COMPLETED|Overall Study||0||
48537273|NCT03207867|101651774|FG002|COMPLETED|Overall Study||0||
48537274|NCT03207867|101651775|FG003|COMPLETED|Overall Study||0||
48537275|NCT03207867|101651776|FG004|COMPLETED|Overall Study||0||
48537276|NCT03207867|101651777|FG005|COMPLETED|Overall Study||0||
48537277|NCT03207867|101651778|FG006|COMPLETED|Overall Study||0||
48537278|NCT03207867|101651779|FG007|COMPLETED|Overall Study||0||
48537279|NCT03207867|101651780|FG008|COMPLETED|Overall Study||0||
48236303|NCT02525744|100900343|FG001|COMPLETED|Period 4||5||
48236304|NCT02525744|100900344|FG002|COMPLETED|Period 4||5||
48236305|NCT02525744|100900345|FG003|COMPLETED|Period 4||6||
48236306|NCT02525744|100900342|FG000|NOT COMPLETED|Period 4||1||
48236307|NCT02525744|100900343|FG001|NOT COMPLETED|Period 4||0||
48236308|NCT02525744|100900344|FG002|NOT COMPLETED|Period 4||0||
48236309|NCT02525744|100900345|FG003|NOT COMPLETED|Period 4||0||
48236310|NCT02525744|100900342|FG000|STARTED|Period 5||5||
48236311|NCT02525744|100900343|FG001|STARTED|Period 5||5||
48236312|NCT02525744|100900344|FG002|STARTED|Period 5||5||
48236313|NCT02525744|100900345|FG003|STARTED|Period 5||6||
48236314|NCT02525744|100900342|FG000|Received at Least 1 Dose of Study Drug|Period 5||4||
48236315|NCT02525744|100900343|FG001|Received at Least 1 Dose of Study Drug|Period 5||5||
48236316|NCT02525744|100900344|FG002|Received at Least 1 Dose of Study Drug|Period 5||5||
48236317|NCT02525744|100900345|FG003|Received at Least 1 Dose of Study Drug|Period 5||6||
48236318|NCT02525744|100900342|FG000|COMPLETED|Period 5||4||
48236319|NCT02525744|100900343|FG001|COMPLETED|Period 5||5||
48236320|NCT02525744|100900344|FG002|COMPLETED|Period 5||5||
48236321|NCT02525744|100900345|FG003|COMPLETED|Period 5||6||
48236322|NCT02525744|100900342|FG000|NOT COMPLETED|Period 5||1||
48236323|NCT02525744|100900343|FG001|NOT COMPLETED|Period 5||0||
48236324|NCT02525744|100900344|FG002|NOT COMPLETED|Period 5||0||
48236325|NCT02525744|100900345|FG003|NOT COMPLETED|Period 5||0||
48236326|NCT01508117|100900346|FG000|STARTED|Overall Study||1||
48236327|NCT01508117|100900346|FG000|COMPLETED|Overall Study||1||
48236328|NCT01508117|100900346|FG000|NOT COMPLETED|Overall Study||0||
48236329|NCT01082159|100900347|FG000|STARTED|Overall Study||55||
48236330|NCT01082159|100900347|FG000|COMPLETED|Overall Study||46||
48236331|NCT01082159|100900347|FG000|NOT COMPLETED|Overall Study||9||
48236332|NCT01399905|100900348|FG000|STARTED|Overall Study||7||
48236333|NCT01399905|100900349|FG001|STARTED|Overall Study||7||
48236334|NCT01399905|100900348|FG000|COMPLETED|Overall Study||6||
48236335|NCT01399905|100900349|FG001|COMPLETED|Overall Study||6||
48236336|NCT01399905|100900348|FG000|NOT COMPLETED|Overall Study||1||
48236337|NCT01399905|100900349|FG001|NOT COMPLETED|Overall Study||1||
48236338|NCT00307489|100900350|FG000|STARTED|Baseline Through Week 48||53||
48236339|NCT00307489|100900351|FG001|STARTED|Baseline Through Week 48||52||
48236340|NCT00307489|100900350|FG000|COMPLETED|Baseline Through Week 48||52||
48236341|NCT00307489|100900351|FG001|COMPLETED|Baseline Through Week 48||50||
48236342|NCT00307489|100900350|FG000|NOT COMPLETED|Baseline Through Week 48||1||
48236343|NCT00307489|100900351|FG001|NOT COMPLETED|Baseline Through Week 48||2||
48236344|NCT00307489|100900350|FG000|STARTED|Week 48 Through Week 168||52||
48236345|NCT00307489|100900351|FG001|STARTED|Week 48 Through Week 168||50||
48236346|NCT00307489|100900350|FG000|COMPLETED|Week 48 Through Week 168||46||
48236347|NCT00307489|100900351|FG001|COMPLETED|Week 48 Through Week 168||44||
48236348|NCT00307489|100900350|FG000|NOT COMPLETED|Week 48 Through Week 168||6||
48236349|NCT00307489|100900351|FG001|NOT COMPLETED|Week 48 Through Week 168||6||
48236350|NCT04361617|100900352|FG000|STARTED|Overall Study||17||
48236351|NCT04361617|100900353|FG001|STARTED|Overall Study||17||
48236352|NCT04361617|100900352|FG000|COMPLETED|Overall Study||17||
48236353|NCT04361617|100900353|FG001|COMPLETED|Overall Study||16||
48236354|NCT04361617|100900352|FG000|NOT COMPLETED|Overall Study||0||
48236355|NCT04361617|100900353|FG001|NOT COMPLETED|Overall Study||1||
48236356|NCT03785756|100900354|FG000|STARTED|Overall Study||120||
48236357|NCT03785756|100900355|FG001|STARTED|Overall Study||120||
48236358|NCT03785756|100900356|FG002|STARTED|Overall Study||40||
48236359|NCT03785756|100900354|FG000|COMPLETED|Overall Study||111||
48236360|NCT03785756|100900355|FG001|COMPLETED|Overall Study||112||
48236361|NCT03785756|100900356|FG002|COMPLETED|Overall Study||35||
48236362|NCT03785756|100900354|FG000|NOT COMPLETED|Overall Study||9||
48236363|NCT03785756|100900355|FG001|NOT COMPLETED|Overall Study||8||
48236364|NCT03785756|100900356|FG002|NOT COMPLETED|Overall Study||5||
48236365|NCT02612285|100900357|FG000|STARTED|Overall Study||1||
48236366|NCT02612285|100900357|FG000|COMPLETED|Overall Study||0||
48236367|NCT02612285|100900357|FG000|NOT COMPLETED|Overall Study||1||
48236368|NCT00731692|100900358|FG000|STARTED|Core Study (36 Months)||147||
48236369|NCT00731692|100900359|FG001|STARTED|Core Study (36 Months)||336||
48236370|NCT00731692|100900360|FG002|STARTED|Core Study (36 Months)||487||
48236371|NCT00731692|100900358|FG000|Safety Set (SAF)|Core Study (36 Months)||0||
48236372|NCT00731692|100900359|FG001|Safety Set (SAF)|Core Study (36 Months)||336||
48236373|NCT00731692|100900360|FG002|Safety Set (SAF)|Core Study (36 Months)||487||
48236374|NCT00731692|100900358|FG000|Full Analysis Set (FAS)|Core Study (36 Months)||0||
48236375|NCT00731692|100900359|FG001|Full Analysis Set (FAS)|Core Study (36 Months)||336||
48236376|NCT00731692|100900360|FG002|Full Analysis Set (FAS)|Core Study (36 Months)||487||
48236377|NCT00731692|100900358|FG000|Pharmacokinetic Analysis Set|Core Study (36 Months)||102||
48236378|NCT00731692|100900359|FG001|Pharmacokinetic Analysis Set|Core Study (36 Months)||249||
48236379|NCT00731692|100900360|FG002|Pharmacokinetic Analysis Set|Core Study (36 Months)||0||
48236380|NCT00731692|100900358|FG000|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0||
48236381|NCT00731692|100900359|FG001|Post Protocol Amendment 5 Switch|Core Study (36 Months)||121||
48236382|NCT00731692|100900360|FG002|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0||
48236383|NCT00731692|100900358|FG000|COMPLETED|Core Study (36 Months)||79||
48236384|NCT00731692|100900359|FG001|COMPLETED|Core Study (36 Months)||220||
48236385|NCT00731692|100900360|FG002|COMPLETED|Core Study (36 Months)||317||
48236386|NCT00731692|100900358|FG000|NOT COMPLETED|Core Study (36 Months)||68||
48236387|NCT00731692|100900359|FG001|NOT COMPLETED|Core Study (36 Months)||116||
48236388|NCT00731692|100900360|FG002|NOT COMPLETED|Core Study (36 Months)||170||
48236389|NCT00731692|100900358|FG000|STARTED|Extension Phase||74||
48236390|NCT00731692|100900359|FG001|STARTED|Extension Phase||196||
48236391|NCT00731692|100900360|FG002|STARTED|Extension Phase||301||
48236392|NCT00731692|100900358|FG000|COMPLETED|Extension Phase||0||
48236393|NCT00731692|100900359|FG001|COMPLETED|Extension Phase||0||
48236394|NCT00731692|100900360|FG002|COMPLETED|Extension Phase||0||
48236395|NCT00731692|100900358|FG000|NOT COMPLETED|Extension Phase||74||
48236396|NCT00731692|100900359|FG001|NOT COMPLETED|Extension Phase||196||
48236397|NCT00731692|100900360|FG002|NOT COMPLETED|Extension Phase||301||
48236398|NCT01199302|100900361|FG000|STARTED|Overall Study||20||
48236399|NCT01199302|100900362|FG001|STARTED|Overall Study||16||
48236400|NCT01199302|100900363|FG002|STARTED|Overall Study||20||
48236401|NCT01199302|100900364|FG003|STARTED|Overall Study||11||
48236402|NCT01199302|100900361|FG000|COMPLETED|Overall Study||0||
48236403|NCT01199302|100900362|FG001|COMPLETED|Overall Study||0||
48236404|NCT01199302|100900363|FG002|COMPLETED|Overall Study||0||
48236405|NCT01199302|100900364|FG003|COMPLETED|Overall Study||0||
48236406|NCT01199302|100900361|FG000|NOT COMPLETED|Overall Study||20||
48236407|NCT01199302|100900362|FG001|NOT COMPLETED|Overall Study||16||
48236408|NCT01199302|100900363|FG002|NOT COMPLETED|Overall Study||20||
48236409|NCT01199302|100900364|FG003|NOT COMPLETED|Overall Study||11||
48236410|NCT01207453|100900365|FG000|STARTED|First Intervention||23||
48236411|NCT01207453|100900366|FG001|STARTED|First Intervention||18||
48236412|NCT01207453|100900365|FG000|COMPLETED|First Intervention||21||
48236413|NCT01207453|100900366|FG001|COMPLETED|First Intervention||17||
48236414|NCT01207453|100900365|FG000|NOT COMPLETED|First Intervention||2||
48236415|NCT01207453|100900366|FG001|NOT COMPLETED|First Intervention||1||
48236416|NCT01207453|100900365|FG000|STARTED|Washout||21||
48236417|NCT01207453|100900366|FG001|STARTED|Washout||17||
48236418|NCT01207453|100900365|FG000|COMPLETED|Washout||19||
48236419|NCT01207453|100900366|FG001|COMPLETED|Washout||17||
48236420|NCT01207453|100900365|FG000|NOT COMPLETED|Washout||2||
48236421|NCT01207453|100900366|FG001|NOT COMPLETED|Washout||0||
48236422|NCT01207453|100900365|FG000|STARTED|2nd Intervention||19||
48236423|NCT01207453|100900366|FG001|STARTED|2nd Intervention||17||
48236424|NCT01207453|100900365|FG000|COMPLETED|2nd Intervention||17||
48236425|NCT01207453|100900366|FG001|COMPLETED|2nd Intervention||15||
48236426|NCT01207453|100900365|FG000|NOT COMPLETED|2nd Intervention||2||
48236427|NCT01207453|100900366|FG001|NOT COMPLETED|2nd Intervention||2||
48236428|NCT03403153|100900367|FG000|STARTED|Overall Study||21||
48236429|NCT03403153|100900368|FG001|STARTED|Overall Study||53||
48236430|NCT03403153|100900367|FG000|COMPLETED|Overall Study||20||
48236431|NCT03403153|100900368|FG001|COMPLETED|Overall Study||47||
48236432|NCT03403153|100900367|FG000|NOT COMPLETED|Overall Study||1||
48236433|NCT03403153|100900368|FG001|NOT COMPLETED|Overall Study||6||
48236434|NCT04387773|100900369|FG000|STARTED|Overall Study||8||
48236435|NCT04387773|100900369|FG000|COMPLETED|Overall Study||5||
48236436|NCT04387773|100900369|FG000|NOT COMPLETED|Overall Study||3||
48236437|NCT00630409|100900370|FG000|STARTED|Overall Study||5||
48236438|NCT00630409|100900370|FG000|COMPLETED|Overall Study||4||
48236439|NCT00630409|100900370|FG000|NOT COMPLETED|Overall Study||1||
48236440|NCT02784834|100900371|FG000|STARTED|Overall Study||2||
48236441|NCT02784834|100900371|FG000|COMPLETED|Overall Study||1||
48236442|NCT02784834|100900371|FG000|NOT COMPLETED|Overall Study||1||
48236443|NCT04930263|100900372|FG000|STARTED|Overall Study||33||
48236444|NCT04930263|100900373|FG001|STARTED|Overall Study||33||
48236445|NCT04930263|100900372|FG000|COMPLETED|Overall Study||30||
48236446|NCT04930263|100900373|FG001|COMPLETED|Overall Study||28||
48236447|NCT04930263|100900372|FG000|NOT COMPLETED|Overall Study||3||
48236448|NCT04930263|100900373|FG001|NOT COMPLETED|Overall Study||5||
48236449|NCT00991185|100900374|FG000|STARTED|Overall Study||8||
48236450|NCT00991185|100900374|FG000|COMPLETED|Overall Study||8||
48236451|NCT00991185|100900374|FG000|NOT COMPLETED|Overall Study||0||
48236452|NCT03263117|100900375|FG000|STARTED|Overall Study||130||
48236453|NCT03263117|100900376|FG001|STARTED|Overall Study||130||
48236454|NCT03263117|100900375|FG000|Pass Screening|Overall Study||129||
48236455|NCT03263117|100900376|FG001|Pass Screening|Overall Study||128||
48236456|NCT03263117|100900375|FG000|COMPLETED|Overall Study||121||
48236457|NCT03263117|100900376|FG001|COMPLETED|Overall Study||123||
48236458|NCT03263117|100900375|FG000|NOT COMPLETED|Overall Study||9||
48236459|NCT03263117|100900376|FG001|NOT COMPLETED|Overall Study||7||
48236460|NCT00674609|100900377|FG000|STARTED|Overall Study||60||
48236461|NCT00674609|100900378|FG001|STARTED|Overall Study||58||
48236462|NCT00674609|100900379|FG002|STARTED|Overall Study||59||
48236463|NCT00674609|100900377|FG000|COMPLETED|Overall Study||48||
48236464|NCT00674609|100900378|FG001|COMPLETED|Overall Study||45||
48236465|NCT00674609|100900379|FG002|COMPLETED|Overall Study||51||
48236466|NCT00674609|100900377|FG000|NOT COMPLETED|Overall Study||12||
48236467|NCT00674609|100900378|FG001|NOT COMPLETED|Overall Study||13||
48236468|NCT00674609|100900379|FG002|NOT COMPLETED|Overall Study||8||
48236469|NCT02213094|100900380|FG000|STARTED|Overall Study||5||
48236470|NCT02213094|100900381|FG001|STARTED|Overall Study||5||
48537280|NCT03207867|101651781|FG009|COMPLETED|Overall Study||0||
48537281|NCT03207867|101651782|FG010|COMPLETED|Overall Study||0||
48537282|NCT03207867|101651783|FG011|COMPLETED|Overall Study||0||
48537283|NCT03207867|101651784|FG012|COMPLETED|Overall Study||0||
48537284|NCT03207867|101651785|FG013|COMPLETED|Overall Study||0||
48537285|NCT03207867|101651786|FG014|COMPLETED|Overall Study||0||
48537286|NCT03207867|101651787|FG015|COMPLETED|Overall Study||0||
48537287|NCT03207867|101651788|FG016|COMPLETED|Overall Study||0||
48537288|NCT03207867|101651789|FG017|COMPLETED|Overall Study||0||
48537289|NCT03207867|101651790|FG018|COMPLETED|Overall Study||0||
48537290|NCT03207867|101651791|FG019|COMPLETED|Overall Study||0||
48537291|NCT03207867|101651792|FG020|COMPLETED|Overall Study||0||
48537292|NCT03207867|101651793|FG021|COMPLETED|Overall Study||0||
48537293|NCT03207867|101651794|FG022|COMPLETED|Overall Study||0||
48537294|NCT03207867|101651795|FG023|COMPLETED|Overall Study||0||
48537295|NCT03207867|101651772|FG000|NOT COMPLETED|Overall Study||11||
48537296|NCT03207867|101651773|FG001|NOT COMPLETED|Overall Study||12||
48537297|NCT03207867|101651774|FG002|NOT COMPLETED|Overall Study||11||
48537298|NCT03207867|101651775|FG003|NOT COMPLETED|Overall Study||14||
48537299|NCT03207867|101651776|FG004|NOT COMPLETED|Overall Study||14||
48537300|NCT03207867|101651777|FG005|NOT COMPLETED|Overall Study||15||
48537301|NCT03207867|101651778|FG006|NOT COMPLETED|Overall Study||11||
48537302|NCT03207867|101651779|FG007|NOT COMPLETED|Overall Study||12||
48537303|NCT03207867|101651780|FG008|NOT COMPLETED|Overall Study||27||
48537304|NCT03207867|101651781|FG009|NOT COMPLETED|Overall Study||29||
48537305|NCT03207867|101651782|FG010|NOT COMPLETED|Overall Study||2||
48537306|NCT03207867|101651783|FG011|NOT COMPLETED|Overall Study||30||
48537307|NCT03207867|101651784|FG012|NOT COMPLETED|Overall Study||3||
48537308|NCT03207867|101651785|FG013|NOT COMPLETED|Overall Study||13||
48537309|NCT03207867|101651786|FG014|NOT COMPLETED|Overall Study||13||
48537310|NCT03207867|101651787|FG015|NOT COMPLETED|Overall Study||6||
48537311|NCT03207867|101651788|FG016|NOT COMPLETED|Overall Study||15||
48537312|NCT03207867|101651789|FG017|NOT COMPLETED|Overall Study||22||
48537313|NCT03207867|101651790|FG018|NOT COMPLETED|Overall Study||20||
48537314|NCT03207867|101651791|FG019|NOT COMPLETED|Overall Study||20||
48537315|NCT03207867|101651792|FG020|NOT COMPLETED|Overall Study||6||
48537316|NCT03207867|101651793|FG021|NOT COMPLETED|Overall Study||3||
48537317|NCT03207867|101651794|FG022|NOT COMPLETED|Overall Study||3||
48537318|NCT03207867|101651795|FG023|NOT COMPLETED|Overall Study||3||
48537319|NCT00315731|101651796|FG000|STARTED|Overall Study||15||
48537320|NCT00315731|101651796|FG000|COMPLETED|Overall Study||9||
48537321|NCT00315731|101651796|FG000|NOT COMPLETED|Overall Study||6||
48537322|NCT04431726|101651797|FG000|STARTED|Overall Study||55||
48537323|NCT04431726|101651797|FG000|Received at Least One Dose of Study Drug|Overall Study||55|Safety Population|
48537324|NCT04431726|101651797|FG000|Completed 52 Weeks in the Study|Overall Study||55||
48537325|NCT04431726|101651797|FG000|Started the Long-Term Follow-Up Period|Overall Study||55||
48537326|NCT04431726|101651797|FG000|COMPLETED|Overall Study||0||
48537327|NCT04431726|101651797|FG000|NOT COMPLETED|Overall Study||55||
48537328|NCT06219278|101651798|FG000|STARTED|Overall Study||32||
48537329|NCT06219278|101651798|FG000|COMPLETED|Overall Study||32||
48537330|NCT06219278|101651798|FG000|NOT COMPLETED|Overall Study||0||
48537331|NCT02155543|101651799|FG000|STARTED|Overall Study||9||
48537332|NCT02155543|101651800|FG001|STARTED|Overall Study||9||
48537333|NCT02155543|101651801|FG002|STARTED|Overall Study||9||
48537334|NCT02155543|101651802|FG003|STARTED|Overall Study||9||
48537335|NCT02155543|101651803|FG004|STARTED|Overall Study||3||
48537336|NCT02155543|101651804|FG005|STARTED|Overall Study||3||
48537337|NCT02155543|101651805|FG006|STARTED|Overall Study||9||
48537338|NCT02155543|101651799|FG000|COMPLETED|Overall Study||9||
48537339|NCT02155543|101651800|FG001|COMPLETED|Overall Study||9||
48537340|NCT02155543|101651801|FG002|COMPLETED|Overall Study||9||
48537341|NCT02155543|101651802|FG003|COMPLETED|Overall Study||9||
48537342|NCT02155543|101651803|FG004|COMPLETED|Overall Study||3||
48537343|NCT02155543|101651804|FG005|COMPLETED|Overall Study||3||
48537344|NCT02155543|101651805|FG006|COMPLETED|Overall Study||9||
48537345|NCT02155543|101651799|FG000|NOT COMPLETED|Overall Study||0||
48537346|NCT02155543|101651800|FG001|NOT COMPLETED|Overall Study||0||
48537347|NCT02155543|101651801|FG002|NOT COMPLETED|Overall Study||0||
48537348|NCT02155543|101651802|FG003|NOT COMPLETED|Overall Study||0||
48537349|NCT02155543|101651803|FG004|NOT COMPLETED|Overall Study||0||
48537350|NCT02155543|101651804|FG005|NOT COMPLETED|Overall Study||0||
48537351|NCT02155543|101651805|FG006|NOT COMPLETED|Overall Study||0||
48537352|NCT02105558|101651806|FG000|STARTED|Overall Study||15||
48537353|NCT02105558|101651807|FG001|STARTED|Overall Study||28||
48537354|NCT02105558|101651806|FG000|COMPLETED|Overall Study||15||
48537355|NCT02105558|101651807|FG001|COMPLETED|Overall Study||28||
48537356|NCT02105558|101651806|FG000|NOT COMPLETED|Overall Study||0||
48537357|NCT02105558|101651807|FG001|NOT COMPLETED|Overall Study||0||
48537358|NCT05084716|101651808|FG000|STARTED|Overall Study||199||1
48537359|NCT05084716|101651809|FG001|STARTED|Overall Study||142||1
48236471|NCT02213094|100900380|FG000|COMPLETED|Overall Study||4||
48236472|NCT02213094|100900381|FG001|COMPLETED|Overall Study||5||
48236473|NCT02213094|100900380|FG000|NOT COMPLETED|Overall Study||1||
48537360|NCT05084716|101651810|FG002|STARTED|Overall Study||544||1
48537361|NCT05084716|101651808|FG000|COMPLETED|Overall Study||199||1
48537362|NCT05084716|101651809|FG001|COMPLETED|Overall Study||142||1
48537363|NCT05084716|101651810|FG002|COMPLETED|Overall Study||544||1
48537364|NCT05084716|101651808|FG000|NOT COMPLETED|Overall Study||0||0
48537365|NCT05084716|101651809|FG001|NOT COMPLETED|Overall Study||0||0
48537366|NCT05084716|101651810|FG002|NOT COMPLETED|Overall Study||0||0
48537367|NCT00912912|101651811|FG000|STARTED|Overall Study||5||
48236474|NCT02213094|100900381|FG001|NOT COMPLETED|Overall Study||0||
48236475|NCT02547974|100900382|FG000|STARTED|Overall Study||15||
48236476|NCT02547974|100900383|FG001|STARTED|Overall Study||31||
48236477|NCT02547974|100900384|FG002|STARTED|Overall Study||30||
48236478|NCT02547974|100900385|FG003|STARTED|Overall Study||44||
48537368|NCT00912912|101651811|FG000|COMPLETED|Overall Study||1||
48537369|NCT00912912|101651811|FG000|NOT COMPLETED|Overall Study||4||
48537370|NCT01716715|101651812|FG000|STARTED|Overall Study||57||
48537371|NCT01716715|101651813|FG001|STARTED|Overall Study||54||
48537372|NCT01716715|101651812|FG000|COMPLETED|Overall Study||55||
48537373|NCT01716715|101651813|FG001|COMPLETED|Overall Study||50||
48537374|NCT01716715|101651812|FG000|NOT COMPLETED|Overall Study||2||
48537375|NCT01716715|101651813|FG001|NOT COMPLETED|Overall Study||4||
48537376|NCT03756506|101651814|FG000|STARTED|Overall Study||7||
48537377|NCT03756506|101651815|FG001|STARTED|Overall Study||6||
48537378|NCT03756506|101651814|FG000|COMPLETED|Overall Study||6||
48537379|NCT03756506|101651815|FG001|COMPLETED|Overall Study||6||
48537380|NCT03756506|101651814|FG000|NOT COMPLETED|Overall Study||1||
48537381|NCT03756506|101651815|FG001|NOT COMPLETED|Overall Study||0||
48537382|NCT00886288|101651816|FG000|STARTED|Overall Study||2027||
48537383|NCT00886288|101651817|FG001|STARTED|Overall Study||684||
48537384|NCT00886288|101651816|FG000|COMPLETED|Overall Study||1284||
48537385|NCT00886288|101651817|FG001|COMPLETED|Overall Study||457||
48537386|NCT00886288|101651816|FG000|NOT COMPLETED|Overall Study||743||
48537387|NCT00886288|101651817|FG001|NOT COMPLETED|Overall Study||227||
48537388|NCT02087189|101651818|FG000|STARTED|Overall Study||30||
48537389|NCT02087189|101651818|FG000|COMPLETED|Overall Study||28||
48537390|NCT02087189|101651818|FG000|NOT COMPLETED|Overall Study||2||
48537391|NCT01874353|101651819|FG000|STARTED|Overall Study||196||
48537392|NCT01874353|101651820|FG001|STARTED|Overall Study||99||
48537393|NCT01874353|101651821|FG002|STARTED|Overall Study||22||
48236479|NCT02547974|100900382|FG000|COMPLETED|Overall Study||14||
48236480|NCT02547974|100900383|FG001|COMPLETED|Overall Study||31||
48236481|NCT02547974|100900384|FG002|COMPLETED|Overall Study||30||
48236482|NCT02547974|100900385|FG003|COMPLETED|Overall Study||44||
48236483|NCT02547974|100900382|FG000|NOT COMPLETED|Overall Study||1||
48236484|NCT02547974|100900383|FG001|NOT COMPLETED|Overall Study||0||
48236485|NCT02547974|100900384|FG002|NOT COMPLETED|Overall Study||0||
48537394|NCT01874353|101651822|FG003|STARTED|Overall Study||10||
48537395|NCT01874353|101651819|FG000|COMPLETED|Overall Study||69||
48537396|NCT01874353|101651820|FG001|COMPLETED|Overall Study||26||
48537397|NCT01874353|101651821|FG002|COMPLETED|Overall Study||7||
48537398|NCT01874353|101651822|FG003|COMPLETED|Overall Study||3||
48537399|NCT01874353|101651819|FG000|NOT COMPLETED|Overall Study||127||
48537400|NCT01874353|101651820|FG001|NOT COMPLETED|Overall Study||73||
48537401|NCT01874353|101651821|FG002|NOT COMPLETED|Overall Study||15||
48537402|NCT01874353|101651822|FG003|NOT COMPLETED|Overall Study||7||
48537403|NCT03375203|101651823|FG000|STARTED|Overall Study||75||
48537404|NCT03375203|101651824|FG001|STARTED|Overall Study||72||
48537405|NCT03375203|101651825|FG002|STARTED|Overall Study||74||
48537406|NCT03375203|101651826|FG003|STARTED|Overall Study||71||
48236486|NCT02547974|100900385|FG003|NOT COMPLETED|Overall Study||0||
48236487|NCT00901459|100900386|FG000|STARTED|Overall Study||21||
48236488|NCT00901459|100900386|FG000|COMPLETED|Overall Study||15||
48236489|NCT00901459|100900386|FG000|NOT COMPLETED|Overall Study||6||
48236490|NCT00674765|100900387|FG000|STARTED|Overall Study||81||
48236491|NCT00674765|100900388|FG001|STARTED|Overall Study||75||
48236492|NCT00674765|100900387|FG000|COMPLETED|Overall Study||45||
48236493|NCT00674765|100900388|FG001|COMPLETED|Overall Study||46||
48236494|NCT00674765|100900387|FG000|NOT COMPLETED|Overall Study||36||
48236495|NCT00674765|100900388|FG001|NOT COMPLETED|Overall Study||29||
48537407|NCT03375203|101651827|FG004|STARTED|Overall Study||73||
48537408|NCT03375203|101651823|FG000|COMPLETED|Overall Study||69||
48537409|NCT03375203|101651824|FG001|COMPLETED|Overall Study||68||
48537410|NCT03375203|101651825|FG002|COMPLETED|Overall Study||72||
48537411|NCT03375203|101651826|FG003|COMPLETED|Overall Study||69||
48537412|NCT03375203|101651827|FG004|COMPLETED|Overall Study||69||
48537413|NCT03375203|101651823|FG000|NOT COMPLETED|Overall Study||6||
48537414|NCT03375203|101651824|FG001|NOT COMPLETED|Overall Study||4||
48537415|NCT03375203|101651825|FG002|NOT COMPLETED|Overall Study||2||
48537416|NCT03375203|101651826|FG003|NOT COMPLETED|Overall Study||2||
48537417|NCT03375203|101651827|FG004|NOT COMPLETED|Overall Study||4||
48537418|NCT00952211|101651828|FG000|STARTED|Overall Study||3||
48537419|NCT00952211|101651829|FG001|STARTED|Overall Study||0||
48537420|NCT00952211|101651828|FG000|COMPLETED|Overall Study||3||
48236496|NCT00134056|100900389|FG000|STARTED|Randomization||518||
48236497|NCT00134056|100900390|FG001|STARTED|Randomization||520||
48236498|NCT00134056|100900389|FG000|COMPLETED|Randomization||496||
48236499|NCT00134056|100900390|FG001|COMPLETED|Randomization||500||
48236500|NCT00134056|100900389|FG000|NOT COMPLETED|Randomization||22||
48236501|NCT00134056|100900390|FG001|NOT COMPLETED|Randomization||20||
48236502|NCT00134056|100900389|FG000|STARTED|Eligible for Protocol Assigned Treatment||496||
48236503|NCT00134056|100900390|FG001|STARTED|Eligible for Protocol Assigned Treatment||500||
48236504|NCT00134056|100900389|FG000|COMPLETED|Eligible for Protocol Assigned Treatment||169||
48236505|NCT00134056|100900390|FG001|COMPLETED|Eligible for Protocol Assigned Treatment||185||
48236506|NCT00134056|100900389|FG000|NOT COMPLETED|Eligible for Protocol Assigned Treatment||327||
48236507|NCT00134056|100900390|FG001|NOT COMPLETED|Eligible for Protocol Assigned Treatment||315||
48236508|NCT00990184|100900391|FG000|STARTED|Overall Study||21||
48236509|NCT00990184|100900391|FG000|COMPLETED|Overall Study||20||
48236510|NCT00990184|100900391|FG000|NOT COMPLETED|Overall Study||1||
48236511|NCT00663923|100900392|FG000|STARTED|Overall Study||50||
48236512|NCT00663923|100900392|FG000|COMPLETED|Overall Study||48||
48236513|NCT00663923|100900392|FG000|NOT COMPLETED|Overall Study||2||
48537421|NCT00952211|101651829|FG001|COMPLETED|Overall Study||0||
48537422|NCT00952211|101651828|FG000|NOT COMPLETED|Overall Study||0||
48537423|NCT00952211|101651829|FG001|NOT COMPLETED|Overall Study||0||
48537424|NCT02425904|101651830|FG000|STARTED|Overall Study||20||
48537425|NCT02425904|101651831|FG001|STARTED|Overall Study||5||
48537426|NCT02425904|101651830|FG000|Efficacy Analysis|Overall Study||20||
48236514|NCT01574105|100900393|FG000|STARTED|Overall Study||29||
48236515|NCT01574105|100900394|FG001|STARTED|Overall Study||37||
48236516|NCT01574105|100900393|FG000|COMPLETED|Overall Study||29||
48236517|NCT01574105|100900394|FG001|COMPLETED|Overall Study||37||
48236518|NCT01574105|100900393|FG000|NOT COMPLETED|Overall Study||0||
48236519|NCT01574105|100900394|FG001|NOT COMPLETED|Overall Study||0||
48236520|NCT00763919|100900395|FG000|STARTED|Overall Study||43||
48236521|NCT00763919|100900395|FG000|COMPLETED|Overall Study||30||
48236522|NCT00763919|100900395|FG000|NOT COMPLETED|Overall Study||13||
48236523|NCT00410150|100900396|FG000|STARTED|Overall Study||22||
48236524|NCT00410150|100900397|FG001|STARTED|Overall Study||20||
48236525|NCT00410150|100900396|FG000|COMPLETED|Overall Study||20||
48236526|NCT00410150|100900397|FG001|COMPLETED|Overall Study||17||
48236527|NCT00410150|100900396|FG000|NOT COMPLETED|Overall Study||2||
48236528|NCT00410150|100900397|FG001|NOT COMPLETED|Overall Study||3||
48236529|NCT02092909|100900398|FG000|STARTED|Overall Study||6||
48236530|NCT02092909|100900399|FG001|STARTED|Overall Study||5||
48236531|NCT02092909|100900400|FG002|STARTED|Overall Study||14||
48537427|NCT02425904|101651831|FG001|Efficacy Analysis|Overall Study||4||
48537428|NCT02425904|101651830|FG000|COMPLETED|Overall Study||17||
48537429|NCT02425904|101651831|FG001|COMPLETED|Overall Study||2||
48537430|NCT02425904|101651830|FG000|NOT COMPLETED|Overall Study||3||
48537431|NCT02425904|101651831|FG001|NOT COMPLETED|Overall Study||3||
48236532|NCT02092909|100900401|FG003|STARTED|Overall Study||6||
48236533|NCT02092909|100900398|FG000|COMPLETED|Overall Study||5||
48236534|NCT02092909|100900399|FG001|COMPLETED|Overall Study||2||
48236535|NCT02092909|100900400|FG002|COMPLETED|Overall Study||5||
48236536|NCT02092909|100900401|FG003|COMPLETED|Overall Study||0||
48236537|NCT02092909|100900398|FG000|NOT COMPLETED|Overall Study||1||
48236538|NCT02092909|100900399|FG001|NOT COMPLETED|Overall Study||3||
48236539|NCT02092909|100900400|FG002|NOT COMPLETED|Overall Study||9||
48236540|NCT02092909|100900401|FG003|NOT COMPLETED|Overall Study||6||
48236541|NCT02710669|100900402|FG000|STARTED|Overall Study||85||
48236542|NCT02710669|100900403|FG001|STARTED|Overall Study||86||
48236543|NCT02710669|100900404|FG002|STARTED|Overall Study||21||
48236544|NCT02710669|100900402|FG000|COMPLETED|Overall Study||71||
48236545|NCT02710669|100900403|FG001|COMPLETED|Overall Study||75||
48236546|NCT02710669|100900404|FG002|COMPLETED|Overall Study||19||
48236547|NCT02710669|100900402|FG000|NOT COMPLETED|Overall Study||14||
48236548|NCT02710669|100900403|FG001|NOT COMPLETED|Overall Study||11||
48537432|NCT02955758|101651832|FG000|STARTED|Overall Study||25||
48236549|NCT02710669|100900404|FG002|NOT COMPLETED|Overall Study||2||
48236550|NCT02802176|100900405|FG000|STARTED|Overall Study||16||
48236551|NCT02802176|100900406|FG001|STARTED|Overall Study||14||
48236552|NCT02802176|100900405|FG000|COMPLETED|Overall Study||16||
48236553|NCT02802176|100900406|FG001|COMPLETED|Overall Study||14||
48236554|NCT02802176|100900405|FG000|NOT COMPLETED|Overall Study||0||
48537433|NCT02955758|101651832|FG000|COMPLETED|Overall Study||25||
48537434|NCT02955758|101651832|FG000|NOT COMPLETED|Overall Study||0||
48236555|NCT02802176|100900406|FG001|NOT COMPLETED|Overall Study||0||
48236556|NCT01742832|100900407|FG000|STARTED|Overall Study||20||
48236557|NCT01742832|100900408|FG001|STARTED|Overall Study||28||
48236558|NCT01742832|100900407|FG000|COMPLETED|Overall Study||19||
48236559|NCT01742832|100900408|FG001|COMPLETED|Overall Study||23||
48236560|NCT01742832|100900407|FG000|NOT COMPLETED|Overall Study||1||
48236561|NCT01742832|100900408|FG001|NOT COMPLETED|Overall Study||5||
48236562|NCT00835328|100900409|FG000|STARTED|Cohort 1: Dose Level 1||5||
48537435|NCT03283761|101651833|FG000|STARTED|Study Treatment||39||
48537436|NCT03283761|101651833|FG000|COMPLETED|Study Treatment||0||
48537437|NCT03283761|101651833|FG000|NOT COMPLETED|Study Treatment||39||
48236563|NCT00835328|100900410|FG001|STARTED|Cohort 1: Dose Level 1||0||
48236564|NCT00835328|100900411|FG002|STARTED|Cohort 1: Dose Level 1||0||
48236565|NCT00835328|100900412|FG003|STARTED|Cohort 1: Dose Level 1||0||
48537438|NCT03283761|101651833|FG000|STARTED|Follow up||38||
48537439|NCT03283761|101651833|FG000|COMPLETED|Follow up||0||
48537440|NCT03283761|101651833|FG000|NOT COMPLETED|Follow up||38||
48537441|NCT02552212|101651834|FG000|STARTED|Double-Blind Period (Week 0 - 52)||158||
48537442|NCT02552212|101651835|FG001|STARTED|Double-Blind Period (Week 0 - 52)||159||
48537443|NCT02552212|101651836|FG002|STARTED|Double-Blind Period (Week 0 - 52)||0||
48537444|NCT02552212|101651834|FG000|Received OL CZP|Double-Blind Period (Week 0 - 52)||96||
48537445|NCT02552212|101651835|FG001|Received OL CZP|Double-Blind Period (Week 0 - 52)||20||
48537446|NCT02552212|101651836|FG002|Received OL CZP|Double-Blind Period (Week 0 - 52)||0||
48537447|NCT02552212|101651834|FG000|Completed Week 52 Without Starting SFE|Double-Blind Period (Week 0 - 52)||20||
48537448|NCT02552212|101651835|FG001|Completed Week 52 Without Starting SFE|Double-Blind Period (Week 0 - 52)||22||
48537449|NCT02552212|101651836|FG002|Completed Week 52 Without Starting SFE|Double-Blind Period (Week 0 - 52)||0||
48537450|NCT02552212|101651834|FG000|COMPLETED|Double-Blind Period (Week 0 - 52)||143||
48537451|NCT02552212|101651835|FG001|COMPLETED|Double-Blind Period (Week 0 - 52)||142||
48537452|NCT02552212|101651836|FG002|COMPLETED|Double-Blind Period (Week 0 - 52)||0||
48236566|NCT00835328|100900409|FG000|COMPLETED|Cohort 1: Dose Level 1||5||
48236567|NCT00835328|100900410|FG001|COMPLETED|Cohort 1: Dose Level 1||0||
48236568|NCT00835328|100900411|FG002|COMPLETED|Cohort 1: Dose Level 1||0||
48236569|NCT00835328|100900412|FG003|COMPLETED|Cohort 1: Dose Level 1||0||
48236570|NCT00835328|100900409|FG000|NOT COMPLETED|Cohort 1: Dose Level 1||0||
48236571|NCT00835328|100900410|FG001|NOT COMPLETED|Cohort 1: Dose Level 1||0||
48236572|NCT00835328|100900411|FG002|NOT COMPLETED|Cohort 1: Dose Level 1||0||
48236573|NCT00835328|100900412|FG003|NOT COMPLETED|Cohort 1: Dose Level 1||0||
48236574|NCT00835328|100900409|FG000|STARTED|Cohort 2: Dose Level 2||0||
48537453|NCT02552212|101651834|FG000|NOT COMPLETED|Double-Blind Period (Week 0 - 52)||15||
48537454|NCT02552212|101651835|FG001|NOT COMPLETED|Double-Blind Period (Week 0 - 52)||17||
48537455|NCT02552212|101651836|FG002|NOT COMPLETED|Double-Blind Period (Week 0 - 52)||0||
48236575|NCT00835328|100900410|FG001|STARTED|Cohort 2: Dose Level 2||2||
48236576|NCT00835328|100900411|FG002|STARTED|Cohort 2: Dose Level 2||0||
48537456|NCT02552212|101651834|FG000|STARTED|SFE Period (Week 52 - 156)||0||
48537457|NCT02552212|101651835|FG001|STARTED|SFE Period (Week 52 - 156)||0||
48537458|NCT02552212|101651836|FG002|STARTED|SFE Period (Week 52 - 156)||243||
48537459|NCT02552212|101651834|FG000|COMPLETED|SFE Period (Week 52 - 156)||0||
48537460|NCT02552212|101651835|FG001|COMPLETED|SFE Period (Week 52 - 156)||0||
48537461|NCT02552212|101651836|FG002|COMPLETED|SFE Period (Week 52 - 156)||206||
48537462|NCT02552212|101651834|FG000|NOT COMPLETED|SFE Period (Week 52 - 156)||0||
48537463|NCT02552212|101651835|FG001|NOT COMPLETED|SFE Period (Week 52 - 156)||0||
48537464|NCT02552212|101651836|FG002|NOT COMPLETED|SFE Period (Week 52 - 156)||37||
48537465|NCT04461158|101651837|FG000|STARTED|Overall Study||52||
48537466|NCT04461158|101651838|FG001|STARTED|Overall Study||23||
48537467|NCT04461158|101651837|FG000|COMPLETED|Overall Study||46||
48537468|NCT04461158|101651838|FG001|COMPLETED|Overall Study||23||
48537469|NCT04461158|101651837|FG000|NOT COMPLETED|Overall Study||6||
48537470|NCT04461158|101651838|FG001|NOT COMPLETED|Overall Study||0||
48537471|NCT00371397|101651839|FG000|STARTED|Session 1||5||
48537472|NCT00371397|101651840|FG001|STARTED|Session 1||7||
48537473|NCT00371397|101651841|FG002|STARTED|Session 1||5||
48537474|NCT00371397|101651842|FG003|STARTED|Session 1||2||
48236577|NCT00835328|100900412|FG003|STARTED|Cohort 2: Dose Level 2||0||
48537475|NCT00371397|101651843|FG004|STARTED|Session 1||3||
48537476|NCT00371397|101651844|FG005|STARTED|Session 1||4||
48537477|NCT00371397|101651845|FG006|STARTED|Session 1||4||
48537478|NCT00371397|101651846|FG007|STARTED|Session 1||5||
48537479|NCT00371397|101651847|FG008|STARTED|Session 1||6||
48537480|NCT00371397|101651848|FG009|STARTED|Session 1||5||
48537481|NCT00371397|101651849|FG010|STARTED|Session 1||4||
48537482|NCT00371397|101651850|FG011|STARTED|Session 1||2||
48537483|NCT00371397|101651839|FG000|COMPLETED|Session 1||4||
48537484|NCT00371397|101651840|FG001|COMPLETED|Session 1||7||
48537485|NCT00371397|101651841|FG002|COMPLETED|Session 1||5||
48537486|NCT00371397|101651842|FG003|COMPLETED|Session 1||2||
48537487|NCT00371397|101651843|FG004|COMPLETED|Session 1||3||
48537488|NCT00371397|101651844|FG005|COMPLETED|Session 1||4||
48236578|NCT00835328|100900409|FG000|COMPLETED|Cohort 2: Dose Level 2||0||
48236579|NCT00835328|100900410|FG001|COMPLETED|Cohort 2: Dose Level 2||2||
48236580|NCT00835328|100900411|FG002|COMPLETED|Cohort 2: Dose Level 2||0||
48236581|NCT00835328|100900412|FG003|COMPLETED|Cohort 2: Dose Level 2||0||
48236582|NCT00835328|100900409|FG000|NOT COMPLETED|Cohort 2: Dose Level 2||0||
48236583|NCT00835328|100900410|FG001|NOT COMPLETED|Cohort 2: Dose Level 2||0||
48236584|NCT00835328|100900411|FG002|NOT COMPLETED|Cohort 2: Dose Level 2||0||
48236585|NCT00835328|100900412|FG003|NOT COMPLETED|Cohort 2: Dose Level 2||0||
48537489|NCT00371397|101651845|FG006|COMPLETED|Session 1||4||
48537490|NCT00371397|101651846|FG007|COMPLETED|Session 1||4||
48537491|NCT00371397|101651847|FG008|COMPLETED|Session 1||6||
48537492|NCT00371397|101651848|FG009|COMPLETED|Session 1||5||
48537493|NCT00371397|101651849|FG010|COMPLETED|Session 1||4||
48537494|NCT00371397|101651850|FG011|COMPLETED|Session 1||2||
48537495|NCT00371397|101651839|FG000|NOT COMPLETED|Session 1||1||
48537496|NCT00371397|101651840|FG001|NOT COMPLETED|Session 1||0||
48537497|NCT00371397|101651841|FG002|NOT COMPLETED|Session 1||0||
48537498|NCT00371397|101651842|FG003|NOT COMPLETED|Session 1||0||
48537499|NCT00371397|101651843|FG004|NOT COMPLETED|Session 1||0||
48537500|NCT00371397|101651844|FG005|NOT COMPLETED|Session 1||0||
48236586|NCT00835328|100900409|FG000|STARTED|Cohort 3: Dose Level 3||0||
48236587|NCT00835328|100900410|FG001|STARTED|Cohort 3: Dose Level 3||0||
48236588|NCT00835328|100900411|FG002|STARTED|Cohort 3: Dose Level 3||2||
48236589|NCT00835328|100900412|FG003|STARTED|Cohort 3: Dose Level 3||0||
48236590|NCT00835328|100900409|FG000|COMPLETED|Cohort 3: Dose Level 3||0||
48236591|NCT00835328|100900410|FG001|COMPLETED|Cohort 3: Dose Level 3||0||
48236592|NCT00835328|100900411|FG002|COMPLETED|Cohort 3: Dose Level 3||2||
48236593|NCT00835328|100900412|FG003|COMPLETED|Cohort 3: Dose Level 3||0||
48236594|NCT00835328|100900409|FG000|NOT COMPLETED|Cohort 3: Dose Level 3||0||
48236595|NCT00835328|100900410|FG001|NOT COMPLETED|Cohort 3: Dose Level 3||0||
48236596|NCT00835328|100900411|FG002|NOT COMPLETED|Cohort 3: Dose Level 3||0||
48236597|NCT00835328|100900412|FG003|NOT COMPLETED|Cohort 3: Dose Level 3||0||
48236598|NCT00835328|100900409|FG000|STARTED|Cohort 4: Dose Level 4||0||
48236599|NCT00835328|100900410|FG001|STARTED|Cohort 4: Dose Level 4||0||
48236600|NCT00835328|100900411|FG002|STARTED|Cohort 4: Dose Level 4||0||
48236601|NCT00835328|100900412|FG003|STARTED|Cohort 4: Dose Level 4||4||
48236602|NCT00835328|100900409|FG000|COMPLETED|Cohort 4: Dose Level 4||0||
48236603|NCT00835328|100900410|FG001|COMPLETED|Cohort 4: Dose Level 4||0||
48236604|NCT00835328|100900411|FG002|COMPLETED|Cohort 4: Dose Level 4||0||
48236605|NCT00835328|100900412|FG003|COMPLETED|Cohort 4: Dose Level 4||4||
48236606|NCT00835328|100900409|FG000|NOT COMPLETED|Cohort 4: Dose Level 4||0||
48236607|NCT00835328|100900410|FG001|NOT COMPLETED|Cohort 4: Dose Level 4||0||
48236608|NCT00835328|100900411|FG002|NOT COMPLETED|Cohort 4: Dose Level 4||0||
48236609|NCT00835328|100900412|FG003|NOT COMPLETED|Cohort 4: Dose Level 4||0||
48236610|NCT00753337|100900413|FG000|STARTED|Overall Study||123||
48236611|NCT00753337|100900413|FG000|COMPLETED|Overall Study||123||
48236612|NCT00753337|100900413|FG000|NOT COMPLETED|Overall Study||0||
48236613|NCT00657709|100900414|FG000|STARTED|Overall Study||833||
48236614|NCT00657709|100900415|FG001|STARTED|Overall Study||828||
48236615|NCT00657709|100900416|FG002|STARTED|Overall Study||820||
48236616|NCT00657709|100900417|FG003|STARTED|Overall Study||659||
48236617|NCT00657709|100900418|FG004|STARTED|Overall Study||490||
48236618|NCT00657709|100900414|FG000|COMPLETED|Overall Study||810||
48236619|NCT00657709|100900415|FG001|COMPLETED|Overall Study||795||
48236620|NCT00657709|100900416|FG002|COMPLETED|Overall Study||792||
48236621|NCT00657709|100900417|FG003|COMPLETED|Overall Study||645||
48236622|NCT00657709|100900418|FG004|COMPLETED|Overall Study||457||
48236623|NCT00657709|100900414|FG000|NOT COMPLETED|Overall Study||23||
48236624|NCT00657709|100900415|FG001|NOT COMPLETED|Overall Study||33||
48236625|NCT00657709|100900416|FG002|NOT COMPLETED|Overall Study||28||
48236626|NCT00657709|100900417|FG003|NOT COMPLETED|Overall Study||14||
48236627|NCT00657709|100900418|FG004|NOT COMPLETED|Overall Study||33||
48236628|NCT04184271|100900419|FG000|STARTED|Overall Study||16||
48236629|NCT04184271|100900419|FG000|COMPLETED|Overall Study||16||
48236630|NCT04184271|100900419|FG000|NOT COMPLETED|Overall Study||0||
48236631|NCT03031782|100900420|FG000|STARTED|Treatment Period 1||86||
48537501|NCT00371397|101651845|FG006|NOT COMPLETED|Session 1||0||
48537502|NCT00371397|101651846|FG007|NOT COMPLETED|Session 1||1||
48537503|NCT00371397|101651847|FG008|NOT COMPLETED|Session 1||0||
48537504|NCT00371397|101651848|FG009|NOT COMPLETED|Session 1||0||
48537505|NCT00371397|101651849|FG010|NOT COMPLETED|Session 1||0||
48537506|NCT00371397|101651850|FG011|NOT COMPLETED|Session 1||0||
48537507|NCT00371397|101651839|FG000|STARTED|Session 2||4||
48537508|NCT00371397|101651840|FG001|STARTED|Session 2||7||
48537509|NCT00371397|101651841|FG002|STARTED|Session 2||5||
48537510|NCT00371397|101651842|FG003|STARTED|Session 2||2||
48537511|NCT00371397|101651843|FG004|STARTED|Session 2||3||
48537512|NCT00371397|101651844|FG005|STARTED|Session 2||4||
48236632|NCT03031782|100900421|FG001|STARTED|Treatment Period 1||0||
48236633|NCT03031782|100900422|FG002|STARTED|Treatment Period 1||0||
48236634|NCT03031782|100900423|FG003|STARTED|Treatment Period 1||0||
48236635|NCT03031782|100900424|FG004|STARTED|Treatment Period 1||0||
48236636|NCT03031782|100900420|FG000|COMPLETED|Treatment Period 1||83||
48236637|NCT03031782|100900421|FG001|COMPLETED|Treatment Period 1||0||
48236638|NCT03031782|100900422|FG002|COMPLETED|Treatment Period 1||0||
48236639|NCT03031782|100900423|FG003|COMPLETED|Treatment Period 1||0||
48236640|NCT03031782|100900424|FG004|COMPLETED|Treatment Period 1||0||
48236641|NCT03031782|100900420|FG000|NOT COMPLETED|Treatment Period 1||3||
48537513|NCT00371397|101651845|FG006|STARTED|Session 2||4||
48236642|NCT03031782|100900421|FG001|NOT COMPLETED|Treatment Period 1||0||
48236643|NCT03031782|100900422|FG002|NOT COMPLETED|Treatment Period 1||0||
48236644|NCT03031782|100900423|FG003|NOT COMPLETED|Treatment Period 1||0||
48236645|NCT03031782|100900424|FG004|NOT COMPLETED|Treatment Period 1||0||
48236646|NCT03031782|100900420|FG000|STARTED|Treatment Period 2||0||
48236647|NCT03031782|100900421|FG001|STARTED|Treatment Period 2||37||
48236648|NCT03031782|100900422|FG002|STARTED|Treatment Period 2||38||
48537514|NCT00371397|101651846|FG007|STARTED|Session 2||4||
48537515|NCT00371397|101651847|FG008|STARTED|Session 2||6||
48537516|NCT00371397|101651848|FG009|STARTED|Session 2||5||
48537517|NCT00371397|101651849|FG010|STARTED|Session 2||4||
48537518|NCT00371397|101651850|FG011|STARTED|Session 2||2||
48537519|NCT00371397|101651839|FG000|COMPLETED|Session 2||4||
48537520|NCT00371397|101651840|FG001|COMPLETED|Session 2||7||
48537521|NCT00371397|101651841|FG002|COMPLETED|Session 2||5||
48537522|NCT00371397|101651842|FG003|COMPLETED|Session 2||2||
48537523|NCT00371397|101651843|FG004|COMPLETED|Session 2||3||
48537524|NCT00371397|101651844|FG005|COMPLETED|Session 2||4||
48537525|NCT00371397|101651845|FG006|COMPLETED|Session 2||4||
48537526|NCT00371397|101651846|FG007|COMPLETED|Session 2||4||
48537527|NCT00371397|101651847|FG008|COMPLETED|Session 2||6||
48537528|NCT00371397|101651848|FG009|COMPLETED|Session 2||5||
48537529|NCT00371397|101651849|FG010|COMPLETED|Session 2||4||
48537530|NCT00371397|101651850|FG011|COMPLETED|Session 2||2||
48537531|NCT00371397|101651839|FG000|NOT COMPLETED|Session 2||0||
48537532|NCT00371397|101651840|FG001|NOT COMPLETED|Session 2||0||
48537533|NCT00371397|101651841|FG002|NOT COMPLETED|Session 2||0||
48537534|NCT00371397|101651842|FG003|NOT COMPLETED|Session 2||0||
48537535|NCT00371397|101651843|FG004|NOT COMPLETED|Session 2||0||
48537536|NCT00371397|101651844|FG005|NOT COMPLETED|Session 2||0||
48537537|NCT00371397|101651845|FG006|NOT COMPLETED|Session 2||0||
48537538|NCT00371397|101651846|FG007|NOT COMPLETED|Session 2||0||
48537539|NCT00371397|101651847|FG008|NOT COMPLETED|Session 2||0||
48537540|NCT00371397|101651848|FG009|NOT COMPLETED|Session 2||0||
48537541|NCT00371397|101651849|FG010|NOT COMPLETED|Session 2||0||
48537542|NCT00371397|101651850|FG011|NOT COMPLETED|Session 2||0||
48537543|NCT00371397|101651839|FG000|STARTED|Session 3||4||
48537544|NCT00371397|101651840|FG001|STARTED|Session 3||7||
48537545|NCT00371397|101651841|FG002|STARTED|Session 3||5||
48537546|NCT00371397|101651842|FG003|STARTED|Session 3||2||
48537547|NCT00371397|101651843|FG004|STARTED|Session 3||3||
48537548|NCT00371397|101651844|FG005|STARTED|Session 3||4||
48537549|NCT00371397|101651845|FG006|STARTED|Session 3||4||
48537550|NCT00371397|101651846|FG007|STARTED|Session 3||4||
48537551|NCT00371397|101651847|FG008|STARTED|Session 3||6||
48537552|NCT00371397|101651848|FG009|STARTED|Session 3||5||
48537553|NCT00371397|101651849|FG010|STARTED|Session 3||4||
48537554|NCT00371397|101651850|FG011|STARTED|Session 3||2||
48537555|NCT00371397|101651839|FG000|COMPLETED|Session 3||4||
48537556|NCT00371397|101651840|FG001|COMPLETED|Session 3||7||
48537557|NCT00371397|101651841|FG002|COMPLETED|Session 3||5||
48537558|NCT00371397|101651842|FG003|COMPLETED|Session 3||2||
48537559|NCT00371397|101651843|FG004|COMPLETED|Session 3||3||
48537560|NCT00371397|101651844|FG005|COMPLETED|Session 3||4||
48537561|NCT00371397|101651845|FG006|COMPLETED|Session 3||4||
48537562|NCT00371397|101651846|FG007|COMPLETED|Session 3||4||
48537563|NCT00371397|101651847|FG008|COMPLETED|Session 3||6||
48537564|NCT00371397|101651848|FG009|COMPLETED|Session 3||5||
48537565|NCT00371397|101651849|FG010|COMPLETED|Session 3||4||
48537566|NCT00371397|101651850|FG011|COMPLETED|Session 3||2||
48537567|NCT00371397|101651839|FG000|NOT COMPLETED|Session 3||0||
48537568|NCT00371397|101651840|FG001|NOT COMPLETED|Session 3||0||
48537569|NCT00371397|101651841|FG002|NOT COMPLETED|Session 3||0||
48537570|NCT00371397|101651842|FG003|NOT COMPLETED|Session 3||0||
48537571|NCT00371397|101651843|FG004|NOT COMPLETED|Session 3||0||
48537572|NCT00371397|101651844|FG005|NOT COMPLETED|Session 3||0||
48236649|NCT03031782|100900423|FG003|STARTED|Treatment Period 2||0||
48236650|NCT03031782|100900424|FG004|STARTED|Treatment Period 2||21||
48236651|NCT03031782|100900420|FG000|COMPLETED|Treatment Period 2||0||
48537573|NCT00371397|101651845|FG006|NOT COMPLETED|Session 3||0||
48537574|NCT00371397|101651846|FG007|NOT COMPLETED|Session 3||0||
48236652|NCT03031782|100900421|FG001|COMPLETED|Treatment Period 2||31||
48537575|NCT00371397|101651847|FG008|NOT COMPLETED|Session 3||0||
48537576|NCT00371397|101651848|FG009|NOT COMPLETED|Session 3||0||
48537577|NCT00371397|101651849|FG010|NOT COMPLETED|Session 3||0||
48537578|NCT00371397|101651850|FG011|NOT COMPLETED|Session 3||0||
48537579|NCT04740320|101651851|FG000|STARTED|Overall Study||36||
48537580|NCT04740320|101651851|FG000|COMPLETED|Overall Study||36||
48537581|NCT04740320|101651851|FG000|NOT COMPLETED|Overall Study||0||
48537582|NCT01191827|101651852|FG000|STARTED|Overall Study||20||
48537583|NCT01191827|101651853|FG001|STARTED|Overall Study||20||
48537584|NCT01191827|101651852|FG000|COMPLETED|Overall Study||20||
48537585|NCT01191827|101651853|FG001|COMPLETED|Overall Study||20||
48537586|NCT01191827|101651852|FG000|NOT COMPLETED|Overall Study||0||
48537587|NCT01191827|101651853|FG001|NOT COMPLETED|Overall Study||0||
48537588|NCT01292226|101651854|FG000|STARTED|Overall Study||45||
48537589|NCT01292226|101651854|FG000|COMPLETED|Overall Study||32||
48537590|NCT01292226|101651854|FG000|NOT COMPLETED|Overall Study||13||
48537591|NCT04540406|101651855|FG000|STARTED|Overall Study||23||
48537592|NCT04540406|101651856|FG001|STARTED|Overall Study||19||
48236653|NCT03031782|100900422|FG002|COMPLETED|Treatment Period 2||36||
48236654|NCT03031782|100900423|FG003|COMPLETED|Treatment Period 2||0||
48537593|NCT04540406|101651855|FG000|COMPLETED|Overall Study||16||
48537594|NCT04540406|101651856|FG001|COMPLETED|Overall Study||15||
48537595|NCT04540406|101651855|FG000|NOT COMPLETED|Overall Study||7||
48537596|NCT04540406|101651856|FG001|NOT COMPLETED|Overall Study||4||
48537597|NCT00509795|101651857|FG000|STARTED|Overall Study||306||
48537598|NCT00509795|101651858|FG001|STARTED|Overall Study||304||
48236655|NCT03031782|100900424|FG004|COMPLETED|Treatment Period 2||16||
48236656|NCT03031782|100900420|FG000|NOT COMPLETED|Treatment Period 2||0||
48236657|NCT03031782|100900421|FG001|NOT COMPLETED|Treatment Period 2||6||
48236658|NCT03031782|100900422|FG002|NOT COMPLETED|Treatment Period 2||2||
48236659|NCT03031782|100900423|FG003|NOT COMPLETED|Treatment Period 2||0||
48236660|NCT03031782|100900424|FG004|NOT COMPLETED|Treatment Period 2||5||
48236661|NCT03031782|100900420|FG000|STARTED|Treatment Period 3||0||
48236662|NCT03031782|100900421|FG001|STARTED|Treatment Period 3||0||
48236663|NCT03031782|100900422|FG002|STARTED|Treatment Period 3||0||
48236664|NCT03031782|100900423|FG003|STARTED|Treatment Period 3||11||
48236665|NCT03031782|100900424|FG004|STARTED|Treatment Period 3||0||
48236666|NCT03031782|100900420|FG000|COMPLETED|Treatment Period 3||0||
48236667|NCT03031782|100900421|FG001|COMPLETED|Treatment Period 3||0||
48236668|NCT03031782|100900422|FG002|COMPLETED|Treatment Period 3||0||
48236669|NCT03031782|100900423|FG003|COMPLETED|Treatment Period 3||10||
48236670|NCT03031782|100900424|FG004|COMPLETED|Treatment Period 3||0||
48236671|NCT03031782|100900420|FG000|NOT COMPLETED|Treatment Period 3||0||
48236672|NCT03031782|100900421|FG001|NOT COMPLETED|Treatment Period 3||0||
48236673|NCT03031782|100900422|FG002|NOT COMPLETED|Treatment Period 3||0||
48236674|NCT03031782|100900423|FG003|NOT COMPLETED|Treatment Period 3||1||
48236675|NCT03031782|100900424|FG004|NOT COMPLETED|Treatment Period 3||0||
48236676|NCT01414192|100900425|FG000|STARTED|Overall Study||490||
48236677|NCT01414192|100900426|FG001|STARTED|Overall Study||575||
48236678|NCT01414192|100900427|FG002|STARTED|Overall Study||424||
48236679|NCT01414192|100900428|FG003|STARTED|Overall Study||1726||
48236680|NCT01414192|100900425|FG000|COMPLETED|Overall Study||490||
48236681|NCT01414192|100900426|FG001|COMPLETED|Overall Study||575||
48236682|NCT01414192|100900427|FG002|COMPLETED|Overall Study||424||
48236683|NCT01414192|100900428|FG003|COMPLETED|Overall Study||1726||
48236684|NCT01414192|100900425|FG000|NOT COMPLETED|Overall Study||0||
48236685|NCT01414192|100900426|FG001|NOT COMPLETED|Overall Study||0||
48236686|NCT01414192|100900427|FG002|NOT COMPLETED|Overall Study||0||
48236687|NCT01414192|100900428|FG003|NOT COMPLETED|Overall Study||0||
48236688|NCT02169089|100900429|FG000|STARTED|Overall Study||37||
48236689|NCT02169089|100900430|FG001|STARTED|Overall Study||42||
48236690|NCT02169089|100900429|FG000|COMPLETED|Overall Study||26||
48236691|NCT02169089|100900430|FG001|COMPLETED|Overall Study||25||
48236692|NCT02169089|100900429|FG000|NOT COMPLETED|Overall Study||11||
48236693|NCT02169089|100900430|FG001|NOT COMPLETED|Overall Study||17||
48537599|NCT00509795|101651859|FG002|STARTED|Overall Study||304||
48537600|NCT00509795|101651860|FG003|STARTED|Overall Study||303||
48537601|NCT00509795|101651857|FG000|Patients Received Treatment (SAF)|Overall Study||304||
48537602|NCT00509795|101651858|FG001|Patients Received Treatment (SAF)|Overall Study||304||
48537603|NCT00509795|101651859|FG002|Patients Received Treatment (SAF)|Overall Study||304||
48537604|NCT00509795|101651860|FG003|Patients Received Treatment (SAF)|Overall Study||303||
48537605|NCT00509795|101651857|FG000|Full Analysis Set (FAS) Population|Overall Study||304||
48537606|NCT00509795|101651858|FG001|Full Analysis Set (FAS) Population|Overall Study||304||
48537607|NCT00509795|101651859|FG002|Full Analysis Set (FAS) Population|Overall Study||301||
48537608|NCT00509795|101651860|FG003|Full Analysis Set (FAS) Population|Overall Study||301||
48537609|NCT00509795|101651857|FG000|Per Protocol Set (PPS) Population|Overall Study||269||
48537610|NCT00509795|101651858|FG001|Per Protocol Set (PPS) Population|Overall Study||285||
48537611|NCT00509795|101651859|FG002|Per Protocol Set (PPS) Population|Overall Study||270||
48537612|NCT00509795|101651860|FG003|Per Protocol Set (PPS) Population|Overall Study||265||
48537613|NCT00509795|101651857|FG000|COMPLETED|Overall Study||284||
48537614|NCT00509795|101651858|FG001|COMPLETED|Overall Study||293||
48537615|NCT00509795|101651859|FG002|COMPLETED|Overall Study||277||
48236694|NCT00939211|100900431|FG000|STARTED|AZD9164 100 Mcg First, Then Placebo||28||
48236695|NCT00939211|100900431|FG000|COMPLETED|AZD9164 100 Mcg First, Then Placebo||28||
48236696|NCT00939211|100900431|FG000|NOT COMPLETED|AZD9164 100 Mcg First, Then Placebo||0||
48236697|NCT00939211|100900431|FG000|STARTED|AZD9164 400 Mcg First, Then Placebo||28||
48236698|NCT00939211|100900431|FG000|COMPLETED|AZD9164 400 Mcg First, Then Placebo||28||
48236699|NCT00939211|100900431|FG000|NOT COMPLETED|AZD9164 400 Mcg First, Then Placebo||0||
48236700|NCT00939211|100900431|FG000|STARTED|AZD9164 1200 Mcg First, Then Placebo||28||
48236701|NCT00939211|100900431|FG000|COMPLETED|AZD9164 1200 Mcg First, Then Placebo||28||
48236702|NCT00939211|100900431|FG000|NOT COMPLETED|AZD9164 1200 Mcg First, Then Placebo||0||
48236703|NCT00939211|100900431|FG000|STARTED|Spiriva 18 Mcg First, Then Placebo||28||
48236704|NCT00939211|100900431|FG000|COMPLETED|Spiriva 18 Mcg First, Then Placebo||28||
48236705|NCT00939211|100900431|FG000|NOT COMPLETED|Spiriva 18 Mcg First, Then Placebo||0||
48236706|NCT00939211|100900431|FG000|STARTED|Placebo||28||
48236707|NCT00939211|100900431|FG000|COMPLETED|Placebo||28||
48236708|NCT00939211|100900431|FG000|NOT COMPLETED|Placebo||0||
48236709|NCT04425252|100900432|FG000|STARTED|Overall Study||8||
48236710|NCT04425252|100900433|FG001|STARTED|Overall Study||15||
48236711|NCT04425252|100900432|FG000|COMPLETED|Overall Study||4||
48236712|NCT04425252|100900433|FG001|COMPLETED|Overall Study||13||
48236713|NCT04425252|100900432|FG000|NOT COMPLETED|Overall Study||4||
48236714|NCT04425252|100900433|FG001|NOT COMPLETED|Overall Study||2||
48236715|NCT00608959|100900434|FG000|STARTED|Part 1||25||
48236716|NCT00608959|100900434|FG000|COMPLETED|Part 1||24||
48236717|NCT00608959|100900434|FG000|NOT COMPLETED|Part 1||1||
48236718|NCT00608959|100900434|FG000|STARTED|Part 2||25||
48236719|NCT00608959|100900434|FG000|COMPLETED|Part 2||25||
48236720|NCT00608959|100900434|FG000|NOT COMPLETED|Part 2||0||
48236721|NCT02935894|100900435|FG000|STARTED|Overall Study||14||
48236722|NCT02935894|100900435|FG000|COMPLETED|Overall Study||13||
48537616|NCT00509795|101651860|FG003|COMPLETED|Overall Study||276||
48537617|NCT00509795|101651857|FG000|NOT COMPLETED|Overall Study||22||
48537618|NCT00509795|101651858|FG001|NOT COMPLETED|Overall Study||11||
48537619|NCT00509795|101651859|FG002|NOT COMPLETED|Overall Study||27||
48537620|NCT00509795|101651860|FG003|NOT COMPLETED|Overall Study||27||
48537621|NCT01796912|101651861|FG000|STARTED|First Intervention||10||
48537622|NCT01796912|101651862|FG001|STARTED|First Intervention||10||
48537623|NCT01796912|101651861|FG000|COMPLETED|First Intervention||10||
48537624|NCT01796912|101651862|FG001|COMPLETED|First Intervention||10||
48537625|NCT01796912|101651861|FG000|NOT COMPLETED|First Intervention||0||
48537626|NCT01796912|101651862|FG001|NOT COMPLETED|First Intervention||0||
48537627|NCT01796912|101651861|FG000|STARTED|Washout||10||
48537628|NCT01796912|101651862|FG001|STARTED|Washout||10||
48537629|NCT01796912|101651861|FG000|COMPLETED|Washout||10||
48537630|NCT01796912|101651862|FG001|COMPLETED|Washout||10||
48537631|NCT01796912|101651861|FG000|NOT COMPLETED|Washout||0||
48537632|NCT01796912|101651862|FG001|NOT COMPLETED|Washout||0||
48537633|NCT01796912|101651861|FG000|STARTED|Second Intervention||10||
48537634|NCT01796912|101651862|FG001|STARTED|Second Intervention||10||
48537635|NCT01796912|101651861|FG000|COMPLETED|Second Intervention||10||
48537636|NCT01796912|101651862|FG001|COMPLETED|Second Intervention||10||
48537637|NCT01796912|101651861|FG000|NOT COMPLETED|Second Intervention||0||
48537638|NCT01796912|101651862|FG001|NOT COMPLETED|Second Intervention||0||
48537639|NCT00928707|101651863|FG000|STARTED|Overall Study||23||
48537640|NCT00928707|101651864|FG001|STARTED|Overall Study||22||
48537641|NCT00928707|101651863|FG000|COMPLETED|Overall Study||22||
48537642|NCT00928707|101651864|FG001|COMPLETED|Overall Study||22||
48537643|NCT00928707|101651863|FG000|NOT COMPLETED|Overall Study||1||
48537644|NCT00928707|101651864|FG001|NOT COMPLETED|Overall Study||0||
48537645|NCT00866658|101651865|FG000|STARTED|Overall Study||157||
48537646|NCT00866658|101651866|FG001|STARTED|Overall Study||154||
48537647|NCT00866658|101651865|FG000|Safety Population|Overall Study||157||
48537648|NCT00866658|101651866|FG001|Safety Population|Overall Study||154||
48537649|NCT00866658|101651865|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study||157||
48537650|NCT00866658|101651866|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||154||
48537651|NCT00866658|101651865|FG000|COMPLETED|Overall Study||144||
48537652|NCT00866658|101651866|FG001|COMPLETED|Overall Study||133||
48537653|NCT00866658|101651865|FG000|NOT COMPLETED|Overall Study||13||
48537654|NCT00866658|101651866|FG001|NOT COMPLETED|Overall Study||21||
48537655|NCT00699283|101651867|FG000|STARTED|Overall Study||47||
48537656|NCT00699283|101651868|FG001|STARTED|Overall Study||15||
48537657|NCT00699283|101651867|FG000|COMPLETED|Overall Study||14||
48537658|NCT00699283|101651868|FG001|COMPLETED|Overall Study||7||
48537659|NCT00699283|101651867|FG000|NOT COMPLETED|Overall Study||33||
48537660|NCT00699283|101651868|FG001|NOT COMPLETED|Overall Study||8||
48537661|NCT01839318|101651869|FG000|STARTED|Period 1, First Day of Wear||4||
48537662|NCT01839318|101651870|FG001|STARTED|Period 1, First Day of Wear||4||
48537663|NCT01839318|101651871|FG002|STARTED|Period 1, First Day of Wear||5||
48537664|NCT01839318|101651872|FG003|STARTED|Period 1, First Day of Wear||6||
48537665|NCT01839318|101651873|FG004|STARTED|Period 1, First Day of Wear||7||
48537666|NCT01839318|101651874|FG005|STARTED|Period 1, First Day of Wear||2||
48537667|NCT01839318|101651869|FG000|COMPLETED|Period 1, First Day of Wear||4||
48537668|NCT01839318|101651870|FG001|COMPLETED|Period 1, First Day of Wear||4||
48537669|NCT01839318|101651871|FG002|COMPLETED|Period 1, First Day of Wear||5||
48537670|NCT01839318|101651872|FG003|COMPLETED|Period 1, First Day of Wear||6||
48537671|NCT01839318|101651873|FG004|COMPLETED|Period 1, First Day of Wear||7||
48537672|NCT01839318|101651874|FG005|COMPLETED|Period 1, First Day of Wear||2||
48537673|NCT01839318|101651869|FG000|NOT COMPLETED|Period 1, First Day of Wear||0||
48537674|NCT01839318|101651870|FG001|NOT COMPLETED|Period 1, First Day of Wear||0||
48537675|NCT01839318|101651871|FG002|NOT COMPLETED|Period 1, First Day of Wear||0||
48537676|NCT01839318|101651872|FG003|NOT COMPLETED|Period 1, First Day of Wear||0||
48537677|NCT01839318|101651873|FG004|NOT COMPLETED|Period 1, First Day of Wear||0||
48537678|NCT01839318|101651874|FG005|NOT COMPLETED|Period 1, First Day of Wear||0||
48537679|NCT01839318|101651869|FG000|STARTED|Period 2, Second Day of Wear||4||
48537680|NCT01839318|101651870|FG001|STARTED|Period 2, Second Day of Wear||4||
48537681|NCT01839318|101651871|FG002|STARTED|Period 2, Second Day of Wear||5||
48537682|NCT01839318|101651872|FG003|STARTED|Period 2, Second Day of Wear||6||
48537683|NCT01839318|101651873|FG004|STARTED|Period 2, Second Day of Wear||7||
48537684|NCT01839318|101651874|FG005|STARTED|Period 2, Second Day of Wear||2||
48236723|NCT02935894|100900435|FG000|NOT COMPLETED|Overall Study||1||
48236724|NCT00442559|100900436|FG000|STARTED|Overall Study||100||
48236725|NCT00442559|100900437|FG001|STARTED|Overall Study||91||
48236726|NCT00442559|100900436|FG000|12 Weeks After Randomization|Overall Study||68||
48236727|NCT00442559|100900437|FG001|12 Weeks After Randomization|Overall Study||60||
48236728|NCT00442559|100900436|FG000|COMPLETED|Overall Study||66||
48236729|NCT00442559|100900437|FG001|COMPLETED|Overall Study||56||
48537685|NCT01839318|101651869|FG000|COMPLETED|Period 2, Second Day of Wear||4||
48537686|NCT01839318|101651870|FG001|COMPLETED|Period 2, Second Day of Wear||4||
48537687|NCT01839318|101651871|FG002|COMPLETED|Period 2, Second Day of Wear||5||
48537688|NCT01839318|101651872|FG003|COMPLETED|Period 2, Second Day of Wear||6||
48537689|NCT01839318|101651873|FG004|COMPLETED|Period 2, Second Day of Wear||7||
48537690|NCT01839318|101651874|FG005|COMPLETED|Period 2, Second Day of Wear||2||
48537691|NCT01839318|101651869|FG000|NOT COMPLETED|Period 2, Second Day of Wear||0||
48537692|NCT01839318|101651870|FG001|NOT COMPLETED|Period 2, Second Day of Wear||0||
48537693|NCT01839318|101651871|FG002|NOT COMPLETED|Period 2, Second Day of Wear||0||
48537694|NCT01839318|101651872|FG003|NOT COMPLETED|Period 2, Second Day of Wear||0||
48537695|NCT01839318|101651873|FG004|NOT COMPLETED|Period 2, Second Day of Wear||0||
48537696|NCT01839318|101651874|FG005|NOT COMPLETED|Period 2, Second Day of Wear||0||
48537697|NCT01839318|101651869|FG000|STARTED|Period 3, Third Day of Wear||4||
48537698|NCT01839318|101651870|FG001|STARTED|Period 3, Third Day of Wear||4||
48537699|NCT01839318|101651871|FG002|STARTED|Period 3, Third Day of Wear||5||
48537700|NCT01839318|101651872|FG003|STARTED|Period 3, Third Day of Wear||6||
48537701|NCT01839318|101651873|FG004|STARTED|Period 3, Third Day of Wear||7||
48537702|NCT01839318|101651874|FG005|STARTED|Period 3, Third Day of Wear||2||
48537703|NCT01839318|101651869|FG000|COMPLETED|Period 3, Third Day of Wear||4||
48537704|NCT01839318|101651870|FG001|COMPLETED|Period 3, Third Day of Wear||4||
48537705|NCT01839318|101651871|FG002|COMPLETED|Period 3, Third Day of Wear||5||
48537706|NCT01839318|101651872|FG003|COMPLETED|Period 3, Third Day of Wear||6||
48537707|NCT01839318|101651873|FG004|COMPLETED|Period 3, Third Day of Wear||7||
48537708|NCT01839318|101651874|FG005|COMPLETED|Period 3, Third Day of Wear||2||
48537709|NCT01839318|101651869|FG000|NOT COMPLETED|Period 3, Third Day of Wear||0||
48537710|NCT01839318|101651870|FG001|NOT COMPLETED|Period 3, Third Day of Wear||0||
48537711|NCT01839318|101651871|FG002|NOT COMPLETED|Period 3, Third Day of Wear||0||
48537712|NCT01839318|101651872|FG003|NOT COMPLETED|Period 3, Third Day of Wear||0||
48537713|NCT01839318|101651873|FG004|NOT COMPLETED|Period 3, Third Day of Wear||0||
48537714|NCT01839318|101651874|FG005|NOT COMPLETED|Period 3, Third Day of Wear||0||
48537715|NCT02201212|101651875|FG000|STARTED|Overall Study||30||
48537716|NCT02201212|101651875|FG000|COMPLETED|Overall Study||30||
48537717|NCT02201212|101651875|FG000|NOT COMPLETED|Overall Study||0||
48537718|NCT01320150|101651876|FG000|STARTED|Overall Study||311||
48537719|NCT01320150|101651876|FG000|PPP|Overall Study||34|Subjects with Persistent Post-Operative Pain (PPP)|
48537720|NCT01320150|101651876|FG000|Non-PPP|Overall Study||211|Subjects without Persistent Post-Operative Pain (Non-PPP)|
48537721|NCT01320150|101651876|FG000|COMPLETED|Overall Study||245||
48537722|NCT01320150|101651876|FG000|NOT COMPLETED|Overall Study||66||
48537723|NCT00945100|101651877|FG000|STARTED|10-week Primary Outcome||83||
48537724|NCT00945100|101651878|FG001|STARTED|10-week Primary Outcome||86||
48537725|NCT00945100|101651877|FG000|Completed, Eligible|10-week Primary Outcome||55||
48537726|NCT00945100|101651878|FG001|Completed, Eligible|10-week Primary Outcome||63||
48537727|NCT00945100|101651877|FG000|Completed, Not Eligible|10-week Primary Outcome||27||
48537728|NCT00945100|101651878|FG001|Completed, Not Eligible|10-week Primary Outcome||20||
48537729|NCT00945100|101651877|FG000|COMPLETED|10-week Primary Outcome||82||
48537730|NCT00945100|101651878|FG001|COMPLETED|10-week Primary Outcome||83||
48537731|NCT00945100|101651877|FG000|NOT COMPLETED|10-week Primary Outcome||1||
48537732|NCT00945100|101651878|FG001|NOT COMPLETED|10-week Primary Outcome||3||
48537733|NCT00945100|101651877|FG000|STARTED|Post-10 Week Primary Outcome||55||
48537734|NCT00945100|101651878|FG001|STARTED|Post-10 Week Primary Outcome||63||
48537735|NCT00945100|101651877|FG000|COMPLETED|Post-10 Week Primary Outcome||51||
48537736|NCT00945100|101651878|FG001|COMPLETED|Post-10 Week Primary Outcome||56||
48537737|NCT00945100|101651877|FG000|NOT COMPLETED|Post-10 Week Primary Outcome||4||
48537738|NCT00945100|101651878|FG001|NOT COMPLETED|Post-10 Week Primary Outcome||7||
48537739|NCT01468818|101651879|FG000|STARTED|Overall Study||18||
48537740|NCT01468818|101651879|FG000|COMPLETED|Overall Study||16||
48537741|NCT01468818|101651879|FG000|NOT COMPLETED|Overall Study||2||
48537742|NCT02784444|101651880|FG000|STARTED|Overall Study||94||
48537743|NCT02784444|101651881|FG001|STARTED|Overall Study||99||
48537744|NCT02784444|101651882|FG002|STARTED|Overall Study||98||
48537745|NCT02784444|101651883|FG003|STARTED|Overall Study||101||
48537746|NCT02784444|101651880|FG000|COMPLETED|Overall Study||78||
48537747|NCT02784444|101651881|FG001|COMPLETED|Overall Study||90||
48537748|NCT02784444|101651882|FG002|COMPLETED|Overall Study||86||
48537749|NCT02784444|101651883|FG003|COMPLETED|Overall Study||88||
48537750|NCT02784444|101651880|FG000|NOT COMPLETED|Overall Study||16||
48537751|NCT02784444|101651881|FG001|NOT COMPLETED|Overall Study||9||
48537752|NCT02784444|101651882|FG002|NOT COMPLETED|Overall Study||12||
48537753|NCT02784444|101651883|FG003|NOT COMPLETED|Overall Study||13||
48537754|NCT04916444|101651884|FG000|STARTED|First Intervention (4 Days)||3||
48537755|NCT04916444|101651885|FG001|STARTED|First Intervention (4 Days)||2||
48537756|NCT04916444|101651884|FG000|COMPLETED|First Intervention (4 Days)||3||
48537757|NCT04916444|101651885|FG001|COMPLETED|First Intervention (4 Days)||2||
48537758|NCT04916444|101651884|FG000|NOT COMPLETED|First Intervention (4 Days)||0||
48537759|NCT04916444|101651885|FG001|NOT COMPLETED|First Intervention (4 Days)||0||
48537760|NCT04916444|101651884|FG000|STARTED|Washout (12 Weeks)||3||
48537761|NCT04916444|101651885|FG001|STARTED|Washout (12 Weeks)||2||
48537762|NCT04916444|101651884|FG000|COMPLETED|Washout (12 Weeks)||3||
48537763|NCT04916444|101651885|FG001|COMPLETED|Washout (12 Weeks)||2||
48537764|NCT04916444|101651884|FG000|NOT COMPLETED|Washout (12 Weeks)||0||
48537765|NCT04916444|101651885|FG001|NOT COMPLETED|Washout (12 Weeks)||0||
48537766|NCT04916444|101651884|FG000|STARTED|Second Intervention (4 Days)||3||
48537767|NCT04916444|101651885|FG001|STARTED|Second Intervention (4 Days)||2||
48537768|NCT04916444|101651884|FG000|COMPLETED|Second Intervention (4 Days)||3||
48537769|NCT04916444|101651885|FG001|COMPLETED|Second Intervention (4 Days)||2||
48537770|NCT04916444|101651884|FG000|NOT COMPLETED|Second Intervention (4 Days)||0||
48537771|NCT04916444|101651885|FG001|NOT COMPLETED|Second Intervention (4 Days)||0||
48537772|NCT00174954|101651886|FG000|STARTED|Overall Study||32||
48537773|NCT00174954|101651886|FG000|COMPLETED|Overall Study||28||
48537774|NCT00174954|101651886|FG000|NOT COMPLETED|Overall Study||4||
48537775|NCT01724489|101651887|FG000|STARTED|Overall Study||39||
48537776|NCT01724489|101651888|FG001|STARTED|Overall Study||38||
48537777|NCT01724489|101651887|FG000|COMPLETED|Overall Study||23||
48537778|NCT01724489|101651888|FG001|COMPLETED|Overall Study||26||
48537779|NCT01724489|101651887|FG000|NOT COMPLETED|Overall Study||16||
48537780|NCT01724489|101651888|FG001|NOT COMPLETED|Overall Study||12||
48537781|NCT03249792|101651889|FG000|STARTED|Arms 1, 2, and 4||1||
48537782|NCT03249792|101651890|FG001|STARTED|Arms 1, 2, and 4||1||
48537783|NCT03249792|101651891|FG002|STARTED|Arms 1, 2, and 4||1||
48537784|NCT03249792|101651892|FG003|STARTED|Arms 1, 2, and 4||2||
48537785|NCT03249792|101651893|FG004|STARTED|Arms 1, 2, and 4||3||
48537786|NCT03249792|101651894|FG005|STARTED|Arms 1, 2, and 4||3||
48537787|NCT03249792|101651895|FG006|STARTED|Arms 1, 2, and 4||6||
48537788|NCT03249792|101651896|FG007|STARTED|Arms 1, 2, and 4||4||
48537789|NCT03249792|101651897|FG008|STARTED|Arms 1, 2, and 4||6||
48537790|NCT03249792|101651898|FG009|STARTED|Arms 1, 2, and 4||2||
48537791|NCT03249792|101651899|FG010|STARTED|Arms 1, 2, and 4||13||
48537792|NCT03249792|101651900|FG011|STARTED|Arms 1, 2, and 4||11||
48537793|NCT03249792|101651901|FG012|STARTED|Arms 1, 2, and 4||18||
48537794|NCT03249792|101651902|FG013|STARTED|Arms 1, 2, and 4||13||
48537795|NCT03249792|101651903|FG014|STARTED|Arms 1, 2, and 4||0||
48537796|NCT03249792|101651904|FG015|STARTED|Arms 1, 2, and 4||4||
48537797|NCT03249792|101651905|FG016|STARTED|Arms 1, 2, and 4||8||
48537798|NCT03249792|101651906|FG017|STARTED|Arms 1, 2, and 4||14||
48537799|NCT03249792|101651907|FG018|STARTED|Arms 1, 2, and 4||7||
48537800|NCT03249792|101651908|FG019|STARTED|Arms 1, 2, and 4||6||
48537801|NCT03249792|101651909|FG020|STARTED|Arms 1, 2, and 4||3||
48537802|NCT03249792|101651910|FG021|STARTED|Arms 1, 2, and 4||3||
48537803|NCT03249792|101651911|FG022|STARTED|Arms 1, 2, and 4||3||
48537804|NCT03249792|101651912|FG023|STARTED|Arms 1, 2, and 4||4||
48537805|NCT03249792|101651913|FG024|STARTED|Arms 1, 2, and 4||4||
48537806|NCT03249792|101651914|FG025|STARTED|Arms 1, 2, and 4||0||
48537807|NCT03249792|101651915|FG026|STARTED|Arms 1, 2, and 4||0||
48537808|NCT03249792|101651916|FG027|STARTED|Arms 1, 2, and 4||0||
48537809|NCT03249792|101651917|FG028|STARTED|Arms 1, 2, and 4||0||
48537810|NCT03249792|101651918|FG029|STARTED|Arms 1, 2, and 4||0||
48537811|NCT03249792|101651919|FG030|STARTED|Arms 1, 2, and 4||0||
48537812|NCT03249792|101651920|FG031|STARTED|Arms 1, 2, and 4||0||
48537813|NCT03249792|101651921|FG032|STARTED|Arms 1, 2, and 4||0||
48537814|NCT03249792|101651889|FG000|Treated|Arms 1, 2, and 4||1||
48537815|NCT03249792|101651890|FG001|Treated|Arms 1, 2, and 4||1||
48537816|NCT03249792|101651891|FG002|Treated|Arms 1, 2, and 4||1||
48537817|NCT03249792|101651892|FG003|Treated|Arms 1, 2, and 4||2||
48537818|NCT03249792|101651893|FG004|Treated|Arms 1, 2, and 4||3||
48537819|NCT03249792|101651894|FG005|Treated|Arms 1, 2, and 4||3||
48537820|NCT03249792|101651895|FG006|Treated|Arms 1, 2, and 4||6||
48537821|NCT03249792|101651896|FG007|Treated|Arms 1, 2, and 4||4||
48537822|NCT03249792|101651897|FG008|Treated|Arms 1, 2, and 4||6||
48537823|NCT03249792|101651898|FG009|Treated|Arms 1, 2, and 4||2||
48537824|NCT03249792|101651899|FG010|Treated|Arms 1, 2, and 4||13||
48537825|NCT03249792|101651900|FG011|Treated|Arms 1, 2, and 4||11||
48537826|NCT03249792|101651901|FG012|Treated|Arms 1, 2, and 4||16||
48537827|NCT03249792|101651902|FG013|Treated|Arms 1, 2, and 4||13||
48537828|NCT03249792|101651903|FG014|Treated|Arms 1, 2, and 4||0||
48537829|NCT03249792|101651904|FG015|Treated|Arms 1, 2, and 4||4||
48537830|NCT03249792|101651905|FG016|Treated|Arms 1, 2, and 4||8||
48537831|NCT03249792|101651906|FG017|Treated|Arms 1, 2, and 4||14||
48537832|NCT03249792|101651907|FG018|Treated|Arms 1, 2, and 4||7||
48537833|NCT03249792|101651908|FG019|Treated|Arms 1, 2, and 4||6||
48537834|NCT03249792|101651909|FG020|Treated|Arms 1, 2, and 4||3||
48537835|NCT03249792|101651910|FG021|Treated|Arms 1, 2, and 4||3||
48537836|NCT03249792|101651911|FG022|Treated|Arms 1, 2, and 4||3||
48537837|NCT03249792|101651912|FG023|Treated|Arms 1, 2, and 4||4||
48537838|NCT03249792|101651913|FG024|Treated|Arms 1, 2, and 4||4||
48537839|NCT03249792|101651914|FG025|Treated|Arms 1, 2, and 4||0||
48537840|NCT03249792|101651915|FG026|Treated|Arms 1, 2, and 4||0||
48537841|NCT03249792|101651916|FG027|Treated|Arms 1, 2, and 4||0||
48537842|NCT03249792|101651917|FG028|Treated|Arms 1, 2, and 4||0||
48537843|NCT03249792|101651918|FG029|Treated|Arms 1, 2, and 4||0||
48537844|NCT03249792|101651919|FG030|Treated|Arms 1, 2, and 4||0||
48537845|NCT03249792|101651920|FG031|Treated|Arms 1, 2, and 4||0||
48537846|NCT03249792|101651921|FG032|Treated|Arms 1, 2, and 4||0||
48537847|NCT03249792|101651889|FG000|COMPLETED|Arms 1, 2, and 4||0||
48537848|NCT03249792|101651890|FG001|COMPLETED|Arms 1, 2, and 4||0||
48537849|NCT03249792|101651891|FG002|COMPLETED|Arms 1, 2, and 4||0||
48537850|NCT03249792|101651892|FG003|COMPLETED|Arms 1, 2, and 4||0||
48537851|NCT03249792|101651893|FG004|COMPLETED|Arms 1, 2, and 4||0||
48537852|NCT03249792|101651894|FG005|COMPLETED|Arms 1, 2, and 4||0||
48537853|NCT03249792|101651895|FG006|COMPLETED|Arms 1, 2, and 4||0||
48537854|NCT03249792|101651896|FG007|COMPLETED|Arms 1, 2, and 4||0||
48537855|NCT03249792|101651897|FG008|COMPLETED|Arms 1, 2, and 4||0||
48537856|NCT03249792|101651898|FG009|COMPLETED|Arms 1, 2, and 4||0||
48537857|NCT03249792|101651899|FG010|COMPLETED|Arms 1, 2, and 4||0||
48537858|NCT03249792|101651900|FG011|COMPLETED|Arms 1, 2, and 4||0||
48537859|NCT03249792|101651901|FG012|COMPLETED|Arms 1, 2, and 4||0||
48236730|NCT00442559|100900436|FG000|NOT COMPLETED|Overall Study||34||
48236731|NCT00442559|100900437|FG001|NOT COMPLETED|Overall Study||35||
48236732|NCT00884806|100900438|FG000|STARTED|Overall Study||110||
48236733|NCT00884806|100900438|FG000|COMPLETED|Overall Study||110||
48236734|NCT00884806|100900438|FG000|NOT COMPLETED|Overall Study||0||
48236735|NCT02449902|100900439|FG000|STARTED|Overall Study||24||
48236736|NCT02449902|100900440|FG001|STARTED|Overall Study||26||
48236737|NCT02449902|100900439|FG000|COMPLETED|Overall Study||24||
48236738|NCT02449902|100900440|FG001|COMPLETED|Overall Study||24||
48236739|NCT02449902|100900439|FG000|NOT COMPLETED|Overall Study||0||
48236740|NCT02449902|100900440|FG001|NOT COMPLETED|Overall Study||2||
48236741|NCT05607147|100900441|FG000|STARTED|Overall Study||10||
48236742|NCT05607147|100900441|FG000|COMPLETED|Overall Study||10||
48236743|NCT05607147|100900441|FG000|NOT COMPLETED|Overall Study||0||
48236744|NCT00443820|100900442|FG000|STARTED|Overall Study||133||
48236745|NCT00443820|100900443|FG001|STARTED|Overall Study||130||
48236746|NCT00443820|100900444|FG002|STARTED|Overall Study||135||
48236747|NCT00443820|100900445|FG003|STARTED|Overall Study||128||
48236748|NCT00443820|100900442|FG000|Safety Population|Overall Study||131||
48236749|NCT00443820|100900443|FG001|Safety Population|Overall Study||129||
48236750|NCT00443820|100900444|FG002|Safety Population|Overall Study||134||
48236751|NCT00443820|100900445|FG003|Safety Population|Overall Study||126||
48236752|NCT00443820|100900442|FG000|COMPLETED|Overall Study||112||
48236753|NCT00443820|100900443|FG001|COMPLETED|Overall Study||111||
48236754|NCT00443820|100900444|FG002|COMPLETED|Overall Study||117||
48236755|NCT00443820|100900445|FG003|COMPLETED|Overall Study||111||
48537860|NCT03249792|101651902|FG013|COMPLETED|Arms 1, 2, and 4||0||
48537861|NCT03249792|101651903|FG014|COMPLETED|Arms 1, 2, and 4||0||
48537862|NCT03249792|101651904|FG015|COMPLETED|Arms 1, 2, and 4||0||
48537863|NCT03249792|101651905|FG016|COMPLETED|Arms 1, 2, and 4||0||
48537864|NCT03249792|101651906|FG017|COMPLETED|Arms 1, 2, and 4||0||
48537865|NCT03249792|101651907|FG018|COMPLETED|Arms 1, 2, and 4||0||
48537866|NCT03249792|101651908|FG019|COMPLETED|Arms 1, 2, and 4||0||
48537867|NCT03249792|101651909|FG020|COMPLETED|Arms 1, 2, and 4||0||
48537868|NCT03249792|101651910|FG021|COMPLETED|Arms 1, 2, and 4||0||
48537869|NCT03249792|101651911|FG022|COMPLETED|Arms 1, 2, and 4||0||
48537870|NCT03249792|101651912|FG023|COMPLETED|Arms 1, 2, and 4||0||
48537871|NCT03249792|101651913|FG024|COMPLETED|Arms 1, 2, and 4||0||
48537872|NCT03249792|101651914|FG025|COMPLETED|Arms 1, 2, and 4||0||
48236756|NCT00443820|100900442|FG000|NOT COMPLETED|Overall Study||21||
48236757|NCT00443820|100900443|FG001|NOT COMPLETED|Overall Study||19||
48236758|NCT00443820|100900444|FG002|NOT COMPLETED|Overall Study||18||
48537873|NCT03249792|101651915|FG026|COMPLETED|Arms 1, 2, and 4||0||
48537874|NCT03249792|101651916|FG027|COMPLETED|Arms 1, 2, and 4||0||
48537875|NCT03249792|101651917|FG028|COMPLETED|Arms 1, 2, and 4||0||
48537876|NCT03249792|101651918|FG029|COMPLETED|Arms 1, 2, and 4||0||
48537877|NCT03249792|101651919|FG030|COMPLETED|Arms 1, 2, and 4||0||
48537878|NCT03249792|101651920|FG031|COMPLETED|Arms 1, 2, and 4||0||
48537879|NCT03249792|101651921|FG032|COMPLETED|Arms 1, 2, and 4||0||
48236759|NCT00443820|100900445|FG003|NOT COMPLETED|Overall Study||17||
48537880|NCT03249792|101651889|FG000|NOT COMPLETED|Arms 1, 2, and 4||1||
48537881|NCT03249792|101651890|FG001|NOT COMPLETED|Arms 1, 2, and 4||1||
48537882|NCT03249792|101651891|FG002|NOT COMPLETED|Arms 1, 2, and 4||1||
48537883|NCT03249792|101651892|FG003|NOT COMPLETED|Arms 1, 2, and 4||2||
48537884|NCT03249792|101651893|FG004|NOT COMPLETED|Arms 1, 2, and 4||3||
48537885|NCT03249792|101651894|FG005|NOT COMPLETED|Arms 1, 2, and 4||3||
48537886|NCT03249792|101651895|FG006|NOT COMPLETED|Arms 1, 2, and 4||6||
48537887|NCT03249792|101651896|FG007|NOT COMPLETED|Arms 1, 2, and 4||4||
48236760|NCT01919489|100900446|FG000|STARTED|Overall Study||136||
48236761|NCT01919489|100900447|FG001|STARTED|Overall Study||137||
48236762|NCT01919489|100900446|FG000|COMPLETED|Overall Study||80||
48236763|NCT01919489|100900447|FG001|COMPLETED|Overall Study||93||
48236764|NCT01919489|100900446|FG000|NOT COMPLETED|Overall Study||56||
48537888|NCT03249792|101651897|FG008|NOT COMPLETED|Arms 1, 2, and 4||6||
48537889|NCT03249792|101651898|FG009|NOT COMPLETED|Arms 1, 2, and 4||2||
48537890|NCT03249792|101651899|FG010|NOT COMPLETED|Arms 1, 2, and 4||13||
48537891|NCT03249792|101651900|FG011|NOT COMPLETED|Arms 1, 2, and 4||11||
48537892|NCT03249792|101651901|FG012|NOT COMPLETED|Arms 1, 2, and 4||18||
48537893|NCT03249792|101651902|FG013|NOT COMPLETED|Arms 1, 2, and 4||13||
48537894|NCT03249792|101651903|FG014|NOT COMPLETED|Arms 1, 2, and 4||0||
48236765|NCT01919489|100900447|FG001|NOT COMPLETED|Overall Study||44||
48537895|NCT03249792|101651904|FG015|NOT COMPLETED|Arms 1, 2, and 4||4||
48537896|NCT03249792|101651905|FG016|NOT COMPLETED|Arms 1, 2, and 4||8||
48236766|NCT04085614|100900448|FG000|STARTED|Overall Study||188||
48236767|NCT04085614|100900449|FG001|STARTED|Overall Study||183||
48236768|NCT04085614|100900448|FG000|COMPLETED|Overall Study||179||
48236769|NCT04085614|100900449|FG001|COMPLETED|Overall Study||177||
48236770|NCT04085614|100900448|FG000|NOT COMPLETED|Overall Study||9||
48236771|NCT04085614|100900449|FG001|NOT COMPLETED|Overall Study||6||
48537897|NCT03249792|101651906|FG017|NOT COMPLETED|Arms 1, 2, and 4||14||
48537898|NCT03249792|101651907|FG018|NOT COMPLETED|Arms 1, 2, and 4||7||
48537899|NCT03249792|101651908|FG019|NOT COMPLETED|Arms 1, 2, and 4||6||
48537900|NCT03249792|101651909|FG020|NOT COMPLETED|Arms 1, 2, and 4||3||
48537901|NCT03249792|101651910|FG021|NOT COMPLETED|Arms 1, 2, and 4||3||
48537902|NCT03249792|101651911|FG022|NOT COMPLETED|Arms 1, 2, and 4||3||
48537903|NCT03249792|101651912|FG023|NOT COMPLETED|Arms 1, 2, and 4||4||
48537904|NCT03249792|101651913|FG024|NOT COMPLETED|Arms 1, 2, and 4||4||
48537905|NCT03249792|101651914|FG025|NOT COMPLETED|Arms 1, 2, and 4||0||
48236772|NCT01760876|100900450|FG000|STARTED|Overall Study||106||
48236773|NCT01760876|100900450|FG000|COMPLETED|Overall Study||100||
48236774|NCT01760876|100900450|FG000|NOT COMPLETED|Overall Study||6||
48236775|NCT01405508|100900451|FG000|STARTED|Overall Study||26||
48236776|NCT01405508|100900452|FG001|STARTED|Overall Study||26||
48236777|NCT01405508|100900453|FG002|STARTED|Overall Study||27||
48236778|NCT01405508|100900454|FG003|STARTED|Overall Study||26||
48236779|NCT01405508|100900451|FG000|COMPLETED|Overall Study||25||
48537906|NCT03249792|101651915|FG026|NOT COMPLETED|Arms 1, 2, and 4||0||
48537907|NCT03249792|101651916|FG027|NOT COMPLETED|Arms 1, 2, and 4||0||
48537908|NCT03249792|101651917|FG028|NOT COMPLETED|Arms 1, 2, and 4||0||
48537909|NCT03249792|101651918|FG029|NOT COMPLETED|Arms 1, 2, and 4||0||
48537910|NCT03249792|101651919|FG030|NOT COMPLETED|Arms 1, 2, and 4||0||
48537911|NCT03249792|101651920|FG031|NOT COMPLETED|Arms 1, 2, and 4||0||
48236780|NCT01405508|100900452|FG001|COMPLETED|Overall Study||25||
48236781|NCT01405508|100900453|FG002|COMPLETED|Overall Study||27||
48236782|NCT01405508|100900454|FG003|COMPLETED|Overall Study||26||
48236783|NCT01405508|100900451|FG000|NOT COMPLETED|Overall Study||1||
48236784|NCT01405508|100900452|FG001|NOT COMPLETED|Overall Study||1||
48236785|NCT01405508|100900453|FG002|NOT COMPLETED|Overall Study||0||
48236786|NCT01405508|100900454|FG003|NOT COMPLETED|Overall Study||0||
48236787|NCT04604899|100900455|FG000|STARTED|Overall Study||30||
48236788|NCT04604899|100900455|FG000|COMPLETED|Overall Study||23||
48537912|NCT03249792|101651921|FG032|NOT COMPLETED|Arms 1, 2, and 4||0||
48537913|NCT03249792|101651889|FG000|STARTED|Switch Over Period||0|The protocol-specified optional switch over period included qualified participants from Arm 1 who switched over to receive combination therapy in Arm 2 at an eligible dose.|
48537914|NCT03249792|101651890|FG001|STARTED|Switch Over Period||0|The protocol-specified optional switch over period included qualified participants from Arm 1 who switched over to receive combination therapy in Arm 2 at an eligible dose.|
48537915|NCT03249792|101651891|FG002|STARTED|Switch Over Period||0|The protocol-specified optional switch over period included qualified participants from Arm 1 who switched over to receive combination therapy in Arm 2 at an eligible dose.|
48537916|NCT03249792|101651892|FG003|STARTED|Switch Over Period||0|The protocol-specified optional switch over period included qualified participants from Arm 1 who switched over to receive combination therapy in Arm 2 at an eligible dose.|
48537917|NCT03249792|101651893|FG004|STARTED|Switch Over Period||0|The protocol-specified optional switch over period included qualified participants from Arm 1 who switched over to receive combination therapy in Arm 2 at an eligible dose.|
48537918|NCT03249792|101651894|FG005|STARTED|Switch Over Period||0|The protocol-specified optional switch over period included qualified participants from Arm 1 who switched over to receive combination therapy in Arm 2 at an eligible dose.|
48537919|NCT03249792|101651895|FG006|STARTED|Switch Over Period||0|The protocol-specified optional switch over period included qualified participants from Arm 1 who switched over to receive combination therapy in Arm 2 at an eligible dose.|
48537920|NCT03249792|101651896|FG007|STARTED|Switch Over Period||0|The protocol-specified optional switch over period included qualified participants from Arm 1 who switched over to receive combination therapy in Arm 2 at an eligible dose.|
48537921|NCT03249792|101651897|FG008|STARTED|Switch Over Period||0|The protocol-specified optional switch over period included qualified participants from Arm 1 who switched over to receive combination therapy in Arm 2 at an eligible dose.|
48537922|NCT03249792|101651898|FG009|STARTED|Switch Over Period||0|The protocol-specified optional switch over period included qualified participants from Arm 1 who switched over to receive combination therapy in Arm 2 at an eligible dose.|
48537923|NCT03249792|101651899|FG010|STARTED|Switch Over Period||0|The protocol-specified optional switch over period included qualified participants from Arm 1 who switched over to receive combination therapy in Arm 2 at an eligible dose.|
48537924|NCT03249792|101651900|FG011|STARTED|Switch Over Period||0|The protocol-specified optional switch over period included qualified participants from Arm 1 who switched over to receive combination therapy in Arm 2 at an eligible dose.|
48537925|NCT03249792|101651901|FG012|STARTED|Switch Over Period||0|The protocol-specified optional switch over period included qualified participants from Arm 1 who switched over to receive combination therapy in Arm 2 at an eligible dose.|
48592665|NCT01877382|101783152|FG002|STARTED|Dose Expansion||0||
48592666|NCT01877382|101783153|FG003|STARTED|Dose Expansion||0||
48236789|NCT04604899|100900455|FG000|NOT COMPLETED|Overall Study||7||
48236790|NCT00950235|100900456|FG000|STARTED|Overall Study||60||
48236791|NCT00950235|100900457|FG001|STARTED|Overall Study||58||
48236792|NCT00950235|100900456|FG000|COMPLETED|Overall Study||58||
48236793|NCT00950235|100900457|FG001|COMPLETED|Overall Study||54||
48537926|NCT03249792|101651902|FG013|STARTED|Switch Over Period||0|The protocol-specified optional switch over period included qualified participants from Arm 1 who switched over to receive combination therapy in Arm 2 at an eligible dose.|
48537927|NCT03249792|101651903|FG014|STARTED|Switch Over Period||0|The protocol-specified optional switch over period included qualified participants from Arm 1 who switched over to receive combination therapy in Arm 2 at an eligible dose.|
48537928|NCT03249792|101651904|FG015|STARTED|Switch Over Period||0|The protocol-specified optional switch over period included qualified participants from Arm 1 who switched over to receive combination therapy in Arm 2 at an eligible dose.|
48537929|NCT03249792|101651905|FG016|STARTED|Switch Over Period||0|The protocol-specified optional switch over period included qualified participants from Arm 1 who switched over to receive combination therapy in Arm 2 at an eligible dose.|
48537930|NCT03249792|101651906|FG017|STARTED|Switch Over Period||0|The protocol-specified optional switch over period included qualified participants from Arm 1 who switched over to receive combination therapy in Arm 2 at an eligible dose.|
48537931|NCT03249792|101651907|FG018|STARTED|Switch Over Period||0|The protocol-specified optional switch over period included qualified participants from Arm 1 who switched over to receive combination therapy in Arm 2 at an eligible dose.|
48537932|NCT03249792|101651908|FG019|STARTED|Switch Over Period||0|The protocol-specified optional switch over period included qualified participants from Arm 1 who switched over to receive combination therapy in Arm 2 at an eligible dose.|
48537933|NCT03249792|101651909|FG020|STARTED|Switch Over Period||0|The protocol-specified optional switch over period included qualified participants from Arm 1 who switched over to receive combination therapy in Arm 2 at an eligible dose.|
48537934|NCT03249792|101651910|FG021|STARTED|Switch Over Period||0|The protocol-specified optional switch over period included qualified participants from Arm 1 who switched over to receive combination therapy in Arm 2 at an eligible dose.|
48537935|NCT03249792|101651911|FG022|STARTED|Switch Over Period||0|The protocol-specified optional switch over period included qualified participants from Arm 1 who switched over to receive combination therapy in Arm 2 at an eligible dose.|
48537936|NCT03249792|101651912|FG023|STARTED|Switch Over Period||0|The protocol-specified optional switch over period included qualified participants from Arm 1 who switched over to receive combination therapy in Arm 2 at an eligible dose.|
48537937|NCT03249792|101651913|FG024|STARTED|Switch Over Period||0|The protocol-specified optional switch over period included qualified participants from Arm 1 who switched over to receive combination therapy in Arm 2 at an eligible dose.|
48537938|NCT03249792|101651914|FG025|STARTED|Switch Over Period||1|The protocol-specified optional switch over period included qualified participants from Arm 1 who switched over to receive combination therapy in Arm 2 at an eligible dose.|
48537939|NCT03249792|101651915|FG026|STARTED|Switch Over Period||1|The protocol-specified optional switch over period included qualified participants from Arm 1 who switched over to receive combination therapy in Arm 2 at an eligible dose.|
48537940|NCT03249792|101651916|FG027|STARTED|Switch Over Period||1|The protocol-specified optional switch over period included qualified participants from Arm 1 who switched over to receive combination therapy in Arm 2 at an eligible dose.|
48537941|NCT03249792|101651917|FG028|STARTED|Switch Over Period||1|The protocol-specified optional switch over period included qualified participants from Arm 1 who switched over to receive combination therapy in Arm 2 at an eligible dose.|
48236794|NCT00950235|100900456|FG000|NOT COMPLETED|Overall Study||2||
48236795|NCT00950235|100900457|FG001|NOT COMPLETED|Overall Study||4||
48236796|NCT03395197|100900458|FG000|STARTED|Study Recruitment||13||
48236797|NCT03395197|100900459|FG001|STARTED|Study Recruitment||6||
48236798|NCT03395197|100900460|FG002|STARTED|Study Recruitment||402||
48236799|NCT03395197|100900461|FG003|STARTED|Study Recruitment||403||
48537942|NCT03249792|101651918|FG029|STARTED|Switch Over Period||2|The protocol-specified optional switch over period included qualified participants from Arm 1 who switched over to receive combination therapy in Arm 2 at an eligible dose.|
48537943|NCT03249792|101651919|FG030|STARTED|Switch Over Period||1|The protocol-specified optional switch over period included qualified participants from Arm 1 who switched over to receive combination therapy in Arm 2 at an eligible dose.|
48537944|NCT03249792|101651920|FG031|STARTED|Switch Over Period||1|The protocol-specified optional switch over period included qualified participants from Arm 1 who switched over to receive combination therapy in Arm 2 at an eligible dose.|
48537945|NCT03249792|101651921|FG032|STARTED|Switch Over Period||1|The protocol-specified optional switch over period included qualified participants from Arm 1 who switched over to receive combination therapy in Arm 2 at an eligible dose.|
48537946|NCT03249792|101651889|FG000|COMPLETED|Switch Over Period||0||
48537947|NCT03249792|101651890|FG001|COMPLETED|Switch Over Period||0||
48537948|NCT03249792|101651891|FG002|COMPLETED|Switch Over Period||0||
48537949|NCT03249792|101651892|FG003|COMPLETED|Switch Over Period||0||
48537950|NCT03249792|101651893|FG004|COMPLETED|Switch Over Period||0||
48537951|NCT03249792|101651894|FG005|COMPLETED|Switch Over Period||0||
48537952|NCT03249792|101651895|FG006|COMPLETED|Switch Over Period||0||
48537953|NCT03249792|101651896|FG007|COMPLETED|Switch Over Period||0||
48537954|NCT03249792|101651897|FG008|COMPLETED|Switch Over Period||0||
48537955|NCT03249792|101651898|FG009|COMPLETED|Switch Over Period||0||
48537956|NCT03249792|101651899|FG010|COMPLETED|Switch Over Period||0||
48537957|NCT03249792|101651900|FG011|COMPLETED|Switch Over Period||0||
48236800|NCT03395197|100900462|FG004|STARTED|Study Recruitment||115||
48236801|NCT03395197|100900463|FG005|STARTED|Study Recruitment||115||
48236802|NCT03395197|100900458|FG000|COMPLETED|Study Recruitment||13||
48236803|NCT03395197|100900459|FG001|COMPLETED|Study Recruitment||6||
48236804|NCT03395197|100900460|FG002|COMPLETED|Study Recruitment||402||
48537958|NCT03249792|101651901|FG012|COMPLETED|Switch Over Period||0||
48537959|NCT03249792|101651902|FG013|COMPLETED|Switch Over Period||0||
48537960|NCT03249792|101651903|FG014|COMPLETED|Switch Over Period||0||
48537961|NCT03249792|101651904|FG015|COMPLETED|Switch Over Period||0||
48537962|NCT03249792|101651905|FG016|COMPLETED|Switch Over Period||0||
48537963|NCT03249792|101651906|FG017|COMPLETED|Switch Over Period||0||
48537964|NCT03249792|101651907|FG018|COMPLETED|Switch Over Period||0||
48537965|NCT03249792|101651908|FG019|COMPLETED|Switch Over Period||0||
48537966|NCT03249792|101651909|FG020|COMPLETED|Switch Over Period||0||
48537967|NCT03249792|101651910|FG021|COMPLETED|Switch Over Period||0||
48537968|NCT03249792|101651911|FG022|COMPLETED|Switch Over Period||0||
48537969|NCT03249792|101651912|FG023|COMPLETED|Switch Over Period||0||
48537970|NCT03249792|101651913|FG024|COMPLETED|Switch Over Period||0||
48537971|NCT03249792|101651914|FG025|COMPLETED|Switch Over Period||0||
48537972|NCT03249792|101651915|FG026|COMPLETED|Switch Over Period||0||
48537973|NCT03249792|101651916|FG027|COMPLETED|Switch Over Period||0||
48537974|NCT03249792|101651917|FG028|COMPLETED|Switch Over Period||0||
48537975|NCT03249792|101651918|FG029|COMPLETED|Switch Over Period||0||
48537976|NCT03249792|101651919|FG030|COMPLETED|Switch Over Period||0||
48537977|NCT03249792|101651920|FG031|COMPLETED|Switch Over Period||0||
48537978|NCT03249792|101651921|FG032|COMPLETED|Switch Over Period||0||
48537979|NCT03249792|101651889|FG000|NOT COMPLETED|Switch Over Period||0||
48537980|NCT03249792|101651890|FG001|NOT COMPLETED|Switch Over Period||0||
48537981|NCT03249792|101651891|FG002|NOT COMPLETED|Switch Over Period||0||
48537982|NCT03249792|101651892|FG003|NOT COMPLETED|Switch Over Period||0||
48537983|NCT03249792|101651893|FG004|NOT COMPLETED|Switch Over Period||0||
48537984|NCT03249792|101651894|FG005|NOT COMPLETED|Switch Over Period||0||
48537985|NCT03249792|101651895|FG006|NOT COMPLETED|Switch Over Period||0||
48537986|NCT03249792|101651896|FG007|NOT COMPLETED|Switch Over Period||0||
48537987|NCT03249792|101651897|FG008|NOT COMPLETED|Switch Over Period||0||
48537988|NCT03249792|101651898|FG009|NOT COMPLETED|Switch Over Period||0||
48537989|NCT03249792|101651899|FG010|NOT COMPLETED|Switch Over Period||0||
48537990|NCT03249792|101651900|FG011|NOT COMPLETED|Switch Over Period||0||
48537991|NCT03249792|101651901|FG012|NOT COMPLETED|Switch Over Period||0||
48537992|NCT03249792|101651902|FG013|NOT COMPLETED|Switch Over Period||0||
48537993|NCT03249792|101651903|FG014|NOT COMPLETED|Switch Over Period||0||
48537994|NCT03249792|101651904|FG015|NOT COMPLETED|Switch Over Period||0||
48537995|NCT03249792|101651905|FG016|NOT COMPLETED|Switch Over Period||0||
48537996|NCT03249792|101651906|FG017|NOT COMPLETED|Switch Over Period||0||
48537997|NCT03249792|101651907|FG018|NOT COMPLETED|Switch Over Period||0||
48537998|NCT03249792|101651908|FG019|NOT COMPLETED|Switch Over Period||0||
48537999|NCT03249792|101651909|FG020|NOT COMPLETED|Switch Over Period||0||
48538000|NCT03249792|101651910|FG021|NOT COMPLETED|Switch Over Period||0||
48538001|NCT03249792|101651911|FG022|NOT COMPLETED|Switch Over Period||0||
48538002|NCT03249792|101651912|FG023|NOT COMPLETED|Switch Over Period||0||
48538003|NCT03249792|101651913|FG024|NOT COMPLETED|Switch Over Period||0||
48538004|NCT03249792|101651914|FG025|NOT COMPLETED|Switch Over Period||1||
48538005|NCT03249792|101651915|FG026|NOT COMPLETED|Switch Over Period||1||
48538006|NCT03249792|101651916|FG027|NOT COMPLETED|Switch Over Period||1||
48538007|NCT03249792|101651917|FG028|NOT COMPLETED|Switch Over Period||1||
48538008|NCT03249792|101651918|FG029|NOT COMPLETED|Switch Over Period||2||
48538009|NCT03249792|101651919|FG030|NOT COMPLETED|Switch Over Period||1||
48538010|NCT03249792|101651920|FG031|NOT COMPLETED|Switch Over Period||1||
48538011|NCT03249792|101651921|FG032|NOT COMPLETED|Switch Over Period||1||
48538012|NCT01739348|101651922|FG000|STARTED|Part I (Base Study)||703||
48538013|NCT01739348|101651923|FG001|STARTED|Part I (Base Study)||700||
48538014|NCT01739348|101651924|FG002|STARTED|Part I (Base Study)||103||
48538015|NCT01739348|101651925|FG003|STARTED|Part I (Base Study)||705||
48538016|NCT01739348|101651922|FG000|Treated|Part I (Base Study)||702||
48538017|NCT01739348|101651923|FG001|Treated|Part I (Base Study)||700||
48538018|NCT01739348|101651924|FG002|Treated|Part I (Base Study)||103||
48538019|NCT01739348|101651925|FG003|Treated|Part I (Base Study)||705||
48538020|NCT01739348|101651922|FG000|COMPLETED|Part I (Base Study)||501||
48538021|NCT01739348|101651923|FG001|COMPLETED|Part I (Base Study)||497||
48538022|NCT01739348|101651924|FG002|COMPLETED|Part I (Base Study)||77||
48538023|NCT01739348|101651925|FG003|COMPLETED|Part I (Base Study)||516||
48538024|NCT01739348|101651922|FG000|NOT COMPLETED|Part I (Base Study)||202||
48538025|NCT01739348|101651923|FG001|NOT COMPLETED|Part I (Base Study)||203||
48538026|NCT01739348|101651924|FG002|NOT COMPLETED|Part I (Base Study)||26||
48538027|NCT01739348|101651925|FG003|NOT COMPLETED|Part I (Base Study)||189||
48538028|NCT01739348|101651922|FG000|STARTED|Part II (Extension Study)||379||
48538029|NCT01739348|101651923|FG001|STARTED|Part II (Extension Study)||366||
48538030|NCT01739348|101651924|FG002|STARTED|Part II (Extension Study)||61||
48538031|NCT01739348|101651925|FG003|STARTED|Part II (Extension Study)||396||
48538032|NCT01739348|101651922|FG000|Treated|Part II (Extension Study)||379||
48538033|NCT01739348|101651923|FG001|Treated|Part II (Extension Study)||365||
48538034|NCT01739348|101651924|FG002|Treated|Part II (Extension Study)||61||
48538035|NCT01739348|101651925|FG003|Treated|Part II (Extension Study)||394||
48538036|NCT01739348|101651922|FG000|COMPLETED|Part II (Extension Study)||0||
48538037|NCT01739348|101651923|FG001|COMPLETED|Part II (Extension Study)||0||
48538038|NCT01739348|101651924|FG002|COMPLETED|Part II (Extension Study)||0||
48538039|NCT01739348|101651925|FG003|COMPLETED|Part II (Extension Study)||0||
48538040|NCT01739348|101651922|FG000|NOT COMPLETED|Part II (Extension Study)||379||
48538041|NCT01739348|101651923|FG001|NOT COMPLETED|Part II (Extension Study)||366||
48538042|NCT01739348|101651924|FG002|NOT COMPLETED|Part II (Extension Study)||61||
48538043|NCT01739348|101651925|FG003|NOT COMPLETED|Part II (Extension Study)||396||
48538044|NCT02342639|101651926|FG000|STARTED|Overall Study||19||
48538045|NCT02342639|101651927|FG001|STARTED|Overall Study||19||
48538046|NCT02342639|101651926|FG000|COMPLETED|Overall Study||17||
48538047|NCT02342639|101651927|FG001|COMPLETED|Overall Study||14||
48538048|NCT02342639|101651926|FG000|NOT COMPLETED|Overall Study||2||
48538049|NCT02342639|101651927|FG001|NOT COMPLETED|Overall Study||5||
48538050|NCT02288156|101651928|FG000|STARTED|Overall Study||20||
48538051|NCT02288156|101651929|FG001|STARTED|Overall Study||20||
48538052|NCT02288156|101651930|FG002|STARTED|Overall Study||20||
48538053|NCT02288156|101651931|FG003|STARTED|Overall Study||20||
48538054|NCT02288156|101651928|FG000|COMPLETED|Overall Study||16||
48538055|NCT02288156|101651929|FG001|COMPLETED|Overall Study||16||
48538056|NCT02288156|101651930|FG002|COMPLETED|Overall Study||18||
48538057|NCT02288156|101651931|FG003|COMPLETED|Overall Study||18||
48538058|NCT02288156|101651928|FG000|NOT COMPLETED|Overall Study||4||
48538059|NCT02288156|101651929|FG001|NOT COMPLETED|Overall Study||4||
48538060|NCT02288156|101651930|FG002|NOT COMPLETED|Overall Study||2||
48538061|NCT02288156|101651931|FG003|NOT COMPLETED|Overall Study||2||
48538062|NCT02952898|101651932|FG000|STARTED|Overall Study||220||
48538063|NCT02952898|101651933|FG001|STARTED|Overall Study||221||
48538064|NCT02952898|101651934|FG002|STARTED|Overall Study||224||
48538065|NCT02952898|101651932|FG000|COMPLETED|Overall Study||198||
48538066|NCT02952898|101651933|FG001|COMPLETED|Overall Study||202||
48538067|NCT02952898|101651934|FG002|COMPLETED|Overall Study||209||
48538068|NCT02952898|101651932|FG000|NOT COMPLETED|Overall Study||22||
48538069|NCT02952898|101651933|FG001|NOT COMPLETED|Overall Study||19||
48538070|NCT02952898|101651934|FG002|NOT COMPLETED|Overall Study||15||
48538071|NCT01104779|101651935|FG000|STARTED|Overall Study||147||
48538072|NCT01104779|101651936|FG001|STARTED|Overall Study||151||
48538073|NCT01104779|101651937|FG002|STARTED|Overall Study||148||
48538074|NCT01104779|101651935|FG000|COMPLETED|Overall Study||88||
48538075|NCT01104779|101651936|FG001|COMPLETED|Overall Study||96||
48538076|NCT01104779|101651937|FG002|COMPLETED|Overall Study||86||
48538077|NCT01104779|101651935|FG000|NOT COMPLETED|Overall Study||59||
48538078|NCT01104779|101651936|FG001|NOT COMPLETED|Overall Study||55||
48538079|NCT01104779|101651937|FG002|NOT COMPLETED|Overall Study||62||
48538080|NCT00658515|101651938|FG000|STARTED|Overall Study||7938||
48538081|NCT00658515|101651939|FG001|STARTED|Overall Study||7933||
48538082|NCT00658515|101651938|FG000|COMPLETED|Overall Study||7626||
48538083|NCT00658515|101651939|FG001|COMPLETED|Overall Study||7668||
48538084|NCT00658515|101651938|FG000|NOT COMPLETED|Overall Study||312||
48538085|NCT00658515|101651939|FG001|NOT COMPLETED|Overall Study||265||
48538086|NCT00780910|101655165|FG000|STARTED|Overall Study||109||
48538087|NCT00780910|101655165|FG000|COMPLETED|Overall Study||107||
48538088|NCT00780910|101655165|FG000|NOT COMPLETED|Overall Study||2||
48538089|NCT05275920|101655166|FG000|STARTED|Overall Study||755||
48538090|NCT05275920|101655167|FG001|STARTED|Overall Study||812||
48538091|NCT05275920|101655168|FG002|STARTED|Overall Study||644||
48538092|NCT05275920|101655166|FG000|COMPLETED|Overall Study||755||
48538093|NCT05275920|101655167|FG001|COMPLETED|Overall Study||812||
48538094|NCT05275920|101655168|FG002|COMPLETED|Overall Study||644||
48538095|NCT05275920|101655166|FG000|NOT COMPLETED|Overall Study||0||
48538096|NCT05275920|101655167|FG001|NOT COMPLETED|Overall Study||0||
48538097|NCT05275920|101655168|FG002|NOT COMPLETED|Overall Study||0||
48538098|NCT01683838|101655169|FG000|STARTED|Overall Study||104||
48538099|NCT01683838|101655170|FG001|STARTED|Overall Study||100||
48538100|NCT01683838|101655169|FG000|Intent to Treat (ITT) Population|Overall Study||103||
48538101|NCT01683838|101655170|FG001|Intent to Treat (ITT) Population|Overall Study||100||
48538102|NCT01683838|101655169|FG000|Safety Population|Overall Study||103||
48538103|NCT01683838|101655170|FG001|Safety Population|Overall Study||100||
48538104|NCT01683838|101655169|FG000|Efficacy Population|Overall Study||89||
48538105|NCT01683838|101655170|FG001|Efficacy Population|Overall Study||93||
48538106|NCT01683838|101655169|FG000|COMPLETED|Overall Study||78||
48538107|NCT01683838|101655170|FG001|COMPLETED|Overall Study||88||
48538108|NCT01683838|101655169|FG000|NOT COMPLETED|Overall Study||26||
48538109|NCT01683838|101655170|FG001|NOT COMPLETED|Overall Study||12||
48538110|NCT02906358|101655171|FG000|STARTED|Overall Study||58||
48538111|NCT02906358|101655172|FG001|STARTED|Overall Study||53||
48538112|NCT02906358|101655171|FG000|Completed 3 Month Measures|Overall Study||36||
48538113|NCT02906358|101655172|FG001|Completed 3 Month Measures|Overall Study||33||
48538114|NCT02906358|101655171|FG000|COMPLETED|Overall Study||36|Includes participants who completed the entire program and 6 month measures|
48538115|NCT02906358|101655172|FG001|COMPLETED|Overall Study||31|Includes participants who completed the entire program and 6 month measures|
48538116|NCT02906358|101655171|FG000|NOT COMPLETED|Overall Study||22||
48538117|NCT02906358|101655172|FG001|NOT COMPLETED|Overall Study||22||
48538118|NCT00552578|101655173|FG000|STARTED|Overall Study||6||
48538119|NCT00552578|101655174|FG001|STARTED|Overall Study||6||
48538120|NCT00552578|101655173|FG000|COMPLETED|Overall Study||5||
48538121|NCT00552578|101655174|FG001|COMPLETED|Overall Study||5||
48236805|NCT03395197|100900461|FG003|COMPLETED|Study Recruitment||403||
48236806|NCT03395197|100900462|FG004|COMPLETED|Study Recruitment||115||
48236807|NCT03395197|100900463|FG005|COMPLETED|Study Recruitment||115||
48236808|NCT03395197|100900458|FG000|NOT COMPLETED|Study Recruitment||0||
48236809|NCT03395197|100900459|FG001|NOT COMPLETED|Study Recruitment||0||
48236810|NCT03395197|100900460|FG002|NOT COMPLETED|Study Recruitment||0||
48236811|NCT03395197|100900461|FG003|NOT COMPLETED|Study Recruitment||0||
48236812|NCT03395197|100900462|FG004|NOT COMPLETED|Study Recruitment||0||
48538122|NCT00552578|101655173|FG000|NOT COMPLETED|Overall Study||1||
48538123|NCT00552578|101655174|FG001|NOT COMPLETED|Overall Study||1||
48538124|NCT01439009|101655175|FG000|STARTED|Overall Study||50||
48538125|NCT01439009|101655176|FG001|STARTED|Overall Study||50||
48538126|NCT01439009|101655175|FG000|COMPLETED|Overall Study||42||
48538127|NCT01439009|101655176|FG001|COMPLETED|Overall Study||47||
48538128|NCT01439009|101655175|FG000|NOT COMPLETED|Overall Study||8||
48538129|NCT01439009|101655176|FG001|NOT COMPLETED|Overall Study||3||
48538130|NCT01147107|101655177|FG000|STARTED|Overall Study||39||
48538131|NCT01147107|101655178|FG001|STARTED|Overall Study||41||
48538132|NCT01147107|101655177|FG000|COMPLETED|Overall Study||33||
48538133|NCT01147107|101655178|FG001|COMPLETED|Overall Study||40||
48538134|NCT01147107|101655177|FG000|NOT COMPLETED|Overall Study||6||
48538135|NCT01147107|101655178|FG001|NOT COMPLETED|Overall Study||1||
48538136|NCT01963143|101655179|FG000|STARTED|Overall Study||14||
48538137|NCT01963143|101655180|FG001|STARTED|Overall Study||19||
48538138|NCT01963143|101655181|FG002|STARTED|Overall Study||15||
48538139|NCT01963143|101655179|FG000|COMPLETED|Overall Study||14||
48538140|NCT01963143|101655180|FG001|COMPLETED|Overall Study||18||
48538141|NCT01963143|101655181|FG002|COMPLETED|Overall Study||14||
48538142|NCT01963143|101655179|FG000|NOT COMPLETED|Overall Study||0||
48538143|NCT01963143|101655180|FG001|NOT COMPLETED|Overall Study||1||
48538144|NCT01963143|101655181|FG002|NOT COMPLETED|Overall Study||1||
48538145|NCT01798316|101655182|FG000|STARTED|Overall Study||52||
48538146|NCT01798316|101655183|FG001|STARTED|Overall Study||53||
48538147|NCT01798316|101655182|FG000|COMPLETED|Overall Study||52||
48538148|NCT01798316|101655183|FG001|COMPLETED|Overall Study||53||
48538149|NCT01798316|101655182|FG000|NOT COMPLETED|Overall Study||0||
48538150|NCT01798316|101655183|FG001|NOT COMPLETED|Overall Study||0||
48538151|NCT00462124|101655184|FG000|STARTED|Overall Study||7||
48538152|NCT00462124|101655184|FG000|COMPLETED|Overall Study||6||
48538153|NCT00462124|101655184|FG000|NOT COMPLETED|Overall Study||1||
48538154|NCT00368979|101655185|FG000|STARTED|Overall Study||185||
48538155|NCT00368979|101655186|FG001|STARTED|Overall Study||193||
48538156|NCT00368979|101655185|FG000|COMPLETED|Overall Study||160||
48538157|NCT00368979|101655186|FG001|COMPLETED|Overall Study||163||
48538158|NCT00368979|101655185|FG000|NOT COMPLETED|Overall Study||25||
48538159|NCT00368979|101655186|FG001|NOT COMPLETED|Overall Study||30||
48538160|NCT03262038|101655187|FG000|STARTED|Overall Study||18||
48538161|NCT03262038|101655188|FG001|STARTED|Overall Study||28||
48538162|NCT03262038|101655187|FG000|COMPLETED|Overall Study||18||
48538163|NCT03262038|101655188|FG001|COMPLETED|Overall Study||27||
48538164|NCT03262038|101655187|FG000|NOT COMPLETED|Overall Study||0||
48538165|NCT03262038|101655188|FG001|NOT COMPLETED|Overall Study||1||
48538166|NCT01327508|101655189|FG000|STARTED|Overall Study||30||
48538167|NCT01327508|101655190|FG001|STARTED|Overall Study||30||
48538168|NCT01327508|101655189|FG000|COMPLETED|Overall Study||30||
48538169|NCT01327508|101655190|FG001|COMPLETED|Overall Study||30||
48538170|NCT01327508|101655189|FG000|NOT COMPLETED|Overall Study||0||
48538171|NCT01327508|101655190|FG001|NOT COMPLETED|Overall Study||0||
48538172|NCT02654860|101655191|FG000|STARTED|First Part||3||
48538173|NCT02654860|101655192|FG001|STARTED|First Part||3||
48538174|NCT02654860|101655193|FG002|STARTED|First Part||3||
48538175|NCT02654860|101655194|FG003|STARTED|First Part||0||
48538176|NCT02654860|101655191|FG000|COMPLETED|First Part||3||
48538177|NCT02654860|101655192|FG001|COMPLETED|First Part||3||
48538178|NCT02654860|101655193|FG002|COMPLETED|First Part||3||
48538179|NCT02654860|101655194|FG003|COMPLETED|First Part||0||
48538180|NCT02654860|101655191|FG000|NOT COMPLETED|First Part||0||
48538181|NCT02654860|101655192|FG001|NOT COMPLETED|First Part||0||
48538182|NCT02654860|101655193|FG002|NOT COMPLETED|First Part||0||
48538183|NCT02654860|101655194|FG003|NOT COMPLETED|First Part||0||
48538184|NCT02654860|101655191|FG000|STARTED|Second Part||15||
48538185|NCT02654860|101655192|FG001|STARTED|Second Part||15||
48538186|NCT02654860|101655193|FG002|STARTED|Second Part||15||
48538187|NCT02654860|101655194|FG003|STARTED|Second Part||15||
48538188|NCT02654860|101655191|FG000|COMPLETED|Second Part||15||
48236813|NCT03395197|100900463|FG005|NOT COMPLETED|Study Recruitment||0||
48236814|NCT03395197|100900458|FG000|STARTED|Analysis for Part 1 and Part 2 Cohort 1||13||
48236815|NCT03395197|100900459|FG001|STARTED|Analysis for Part 1 and Part 2 Cohort 1||6||
48236816|NCT03395197|100900460|FG002|STARTED|Analysis for Part 1 and Part 2 Cohort 1||402||
48236817|NCT03395197|100900461|FG003|STARTED|Analysis for Part 1 and Part 2 Cohort 1||403||
48236818|NCT03395197|100900462|FG004|STARTED|Analysis for Part 1 and Part 2 Cohort 1||0||
48236819|NCT03395197|100900463|FG005|STARTED|Analysis for Part 1 and Part 2 Cohort 1||0||
48236820|NCT03395197|100900458|FG000|COMPLETED|Analysis for Part 1 and Part 2 Cohort 1||0||
48236821|NCT03395197|100900459|FG001|COMPLETED|Analysis for Part 1 and Part 2 Cohort 1||0||
48538189|NCT02654860|101655192|FG001|COMPLETED|Second Part||15||
48538190|NCT02654860|101655193|FG002|COMPLETED|Second Part||15||
48538191|NCT02654860|101655194|FG003|COMPLETED|Second Part||15||
48538192|NCT02654860|101655191|FG000|NOT COMPLETED|Second Part||0||
48538193|NCT02654860|101655192|FG001|NOT COMPLETED|Second Part||0||
48538194|NCT02654860|101655193|FG002|NOT COMPLETED|Second Part||0||
48538195|NCT02654860|101655194|FG003|NOT COMPLETED|Second Part||0||
48538196|NCT03421730|101655195|FG000|STARTED|First Intervention (Day 1, Visit 2)||1||
48538197|NCT03421730|101655196|FG001|STARTED|First Intervention (Day 1, Visit 2)||3||
48538198|NCT03421730|101655197|FG002|STARTED|First Intervention (Day 1, Visit 2)||1||
48538199|NCT03421730|101655198|FG003|STARTED|First Intervention (Day 1, Visit 2)||1||
48538200|NCT03421730|101655199|FG004|STARTED|First Intervention (Day 1, Visit 2)||3||
48538201|NCT03421730|101655200|FG005|STARTED|First Intervention (Day 1, Visit 2)||1||
48538202|NCT03421730|101655201|FG006|STARTED|First Intervention (Day 1, Visit 2)||1||
48538203|NCT03421730|101655202|FG007|STARTED|First Intervention (Day 1, Visit 2)||1||
48538204|NCT03421730|101655203|FG008|STARTED|First Intervention (Day 1, Visit 2)||1||
48538205|NCT03421730|101655204|FG009|STARTED|First Intervention (Day 1, Visit 2)||2||
48538206|NCT03421730|101655205|FG010|STARTED|First Intervention (Day 1, Visit 2)||1||
48538207|NCT03421730|101655206|FG011|STARTED|First Intervention (Day 1, Visit 2)||1||
48538208|NCT03421730|101655195|FG000|COMPLETED|First Intervention (Day 1, Visit 2)||1||
48538209|NCT03421730|101655196|FG001|COMPLETED|First Intervention (Day 1, Visit 2)||1||
48538210|NCT03421730|101655197|FG002|COMPLETED|First Intervention (Day 1, Visit 2)||1||
48538211|NCT03421730|101655198|FG003|COMPLETED|First Intervention (Day 1, Visit 2)||1||
48538212|NCT03421730|101655199|FG004|COMPLETED|First Intervention (Day 1, Visit 2)||3||
48538213|NCT03421730|101655200|FG005|COMPLETED|First Intervention (Day 1, Visit 2)||1||
48538214|NCT03421730|101655201|FG006|COMPLETED|First Intervention (Day 1, Visit 2)||1||
48538215|NCT03421730|101655202|FG007|COMPLETED|First Intervention (Day 1, Visit 2)||1||
48538216|NCT03421730|101655203|FG008|COMPLETED|First Intervention (Day 1, Visit 2)||1||
48538217|NCT03421730|101655204|FG009|COMPLETED|First Intervention (Day 1, Visit 2)||2||
48538218|NCT03421730|101655205|FG010|COMPLETED|First Intervention (Day 1, Visit 2)||1||
48538219|NCT03421730|101655206|FG011|COMPLETED|First Intervention (Day 1, Visit 2)||1||
48538220|NCT03421730|101655195|FG000|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0||
48538221|NCT03421730|101655196|FG001|NOT COMPLETED|First Intervention (Day 1, Visit 2)||2||
48538222|NCT03421730|101655197|FG002|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0||
48538223|NCT03421730|101655198|FG003|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0||
48538224|NCT03421730|101655199|FG004|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0||
48538225|NCT03421730|101655200|FG005|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0||
48538226|NCT03421730|101655201|FG006|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0||
48538227|NCT03421730|101655202|FG007|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0||
48538228|NCT03421730|101655203|FG008|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0||
48538229|NCT03421730|101655204|FG009|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0||
48538230|NCT03421730|101655205|FG010|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0||
48538231|NCT03421730|101655206|FG011|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0||
48538232|NCT03421730|101655195|FG000|STARTED|Washout (Days 4 to 10)||1||
48538233|NCT03421730|101655196|FG001|STARTED|Washout (Days 4 to 10)||1||
48538234|NCT03421730|101655197|FG002|STARTED|Washout (Days 4 to 10)||1||
48538235|NCT03421730|101655198|FG003|STARTED|Washout (Days 4 to 10)||1||
48538236|NCT03421730|101655199|FG004|STARTED|Washout (Days 4 to 10)||3||
48538237|NCT03421730|101655200|FG005|STARTED|Washout (Days 4 to 10)||1||
48538238|NCT03421730|101655201|FG006|STARTED|Washout (Days 4 to 10)||1||
48538239|NCT03421730|101655202|FG007|STARTED|Washout (Days 4 to 10)||1||
48538240|NCT03421730|101655203|FG008|STARTED|Washout (Days 4 to 10)||1||
48538241|NCT03421730|101655204|FG009|STARTED|Washout (Days 4 to 10)||2||
48538242|NCT03421730|101655205|FG010|STARTED|Washout (Days 4 to 10)||1||
48538243|NCT03421730|101655206|FG011|STARTED|Washout (Days 4 to 10)||1||
48538244|NCT03421730|101655195|FG000|COMPLETED|Washout (Days 4 to 10)||1||
48538245|NCT03421730|101655196|FG001|COMPLETED|Washout (Days 4 to 10)||1||
48538246|NCT03421730|101655197|FG002|COMPLETED|Washout (Days 4 to 10)||1||
48538247|NCT03421730|101655198|FG003|COMPLETED|Washout (Days 4 to 10)||1||
48538248|NCT03421730|101655199|FG004|COMPLETED|Washout (Days 4 to 10)||1||
48538249|NCT03421730|101655200|FG005|COMPLETED|Washout (Days 4 to 10)||1||
48538250|NCT03421730|101655201|FG006|COMPLETED|Washout (Days 4 to 10)||1||
48538251|NCT03421730|101655202|FG007|COMPLETED|Washout (Days 4 to 10)||1||
48538252|NCT03421730|101655203|FG008|COMPLETED|Washout (Days 4 to 10)||1||
48538253|NCT03421730|101655204|FG009|COMPLETED|Washout (Days 4 to 10)||2||
48538254|NCT03421730|101655205|FG010|COMPLETED|Washout (Days 4 to 10)||1||
48538255|NCT03421730|101655206|FG011|COMPLETED|Washout (Days 4 to 10)||1||
48538256|NCT03421730|101655195|FG000|NOT COMPLETED|Washout (Days 4 to 10)||0||
48538257|NCT03421730|101655196|FG001|NOT COMPLETED|Washout (Days 4 to 10)||0||
48538258|NCT03421730|101655197|FG002|NOT COMPLETED|Washout (Days 4 to 10)||0||
48538259|NCT03421730|101655198|FG003|NOT COMPLETED|Washout (Days 4 to 10)||0||
48538260|NCT03421730|101655199|FG004|NOT COMPLETED|Washout (Days 4 to 10)||2||
48538261|NCT03421730|101655200|FG005|NOT COMPLETED|Washout (Days 4 to 10)||0||
48538262|NCT03421730|101655201|FG006|NOT COMPLETED|Washout (Days 4 to 10)||0||
48081011|NCT02381288|100521605|FG000|STARTED|Overall Study||5||
48592667|NCT01877382|101783154|FG004|STARTED|Dose Expansion||0||
48236822|NCT03395197|100900460|FG002|COMPLETED|Analysis for Part 1 and Part 2 Cohort 1||0||
48236823|NCT03395197|100900461|FG003|COMPLETED|Analysis for Part 1 and Part 2 Cohort 1||0||
48236824|NCT03395197|100900462|FG004|COMPLETED|Analysis for Part 1 and Part 2 Cohort 1||0||
48236825|NCT03395197|100900463|FG005|COMPLETED|Analysis for Part 1 and Part 2 Cohort 1||0||
48236826|NCT03395197|100900458|FG000|NOT COMPLETED|Analysis for Part 1 and Part 2 Cohort 1||13||
48236827|NCT03395197|100900459|FG001|NOT COMPLETED|Analysis for Part 1 and Part 2 Cohort 1||6||
48236828|NCT03395197|100900460|FG002|NOT COMPLETED|Analysis for Part 1 and Part 2 Cohort 1||402||
48236829|NCT03395197|100900461|FG003|NOT COMPLETED|Analysis for Part 1 and Part 2 Cohort 1||403||
48236830|NCT03395197|100900462|FG004|NOT COMPLETED|Analysis for Part 1 and Part 2 Cohort 1||0||
48236831|NCT03395197|100900463|FG005|NOT COMPLETED|Analysis for Part 1 and Part 2 Cohort 1||0||
48236832|NCT03395197|100900458|FG000|STARTED|Analysis for DDR-Deficient Participants||0||
48236833|NCT03395197|100900459|FG001|STARTED|Analysis for DDR-Deficient Participants||0||
48236834|NCT03395197|100900460|FG002|STARTED|Analysis for DDR-Deficient Participants||0||
48236835|NCT03395197|100900461|FG003|STARTED|Analysis for DDR-Deficient Participants||0||
48236836|NCT03395197|100900462|FG004|STARTED|Analysis for DDR-Deficient Participants||200||
48236837|NCT03395197|100900463|FG005|STARTED|Analysis for DDR-Deficient Participants||199||
48236838|NCT03395197|100900458|FG000|COMPLETED|Analysis for DDR-Deficient Participants||0||
48236839|NCT03395197|100900459|FG001|COMPLETED|Analysis for DDR-Deficient Participants||0||
48236840|NCT03395197|100900460|FG002|COMPLETED|Analysis for DDR-Deficient Participants||0||
48236841|NCT03395197|100900461|FG003|COMPLETED|Analysis for DDR-Deficient Participants||0||
48236842|NCT03395197|100900462|FG004|COMPLETED|Analysis for DDR-Deficient Participants||0||
48236843|NCT03395197|100900463|FG005|COMPLETED|Analysis for DDR-Deficient Participants||0||
48236844|NCT03395197|100900458|FG000|NOT COMPLETED|Analysis for DDR-Deficient Participants||0||
48236845|NCT03395197|100900459|FG001|NOT COMPLETED|Analysis for DDR-Deficient Participants||0||
48236846|NCT03395197|100900460|FG002|NOT COMPLETED|Analysis for DDR-Deficient Participants||0||
48538263|NCT03421730|101655202|FG007|NOT COMPLETED|Washout (Days 4 to 10)||0||
48538264|NCT03421730|101655203|FG008|NOT COMPLETED|Washout (Days 4 to 10)||0||
48538265|NCT03421730|101655204|FG009|NOT COMPLETED|Washout (Days 4 to 10)||0||
48538266|NCT03421730|101655205|FG010|NOT COMPLETED|Washout (Days 4 to 10)||0||
48538267|NCT03421730|101655206|FG011|NOT COMPLETED|Washout (Days 4 to 10)||0||
48538268|NCT03421730|101655195|FG000|STARTED|Second Intervention (Day 8±3, Visit 3)||1||
48538269|NCT03421730|101655196|FG001|STARTED|Second Intervention (Day 8±3, Visit 3)||1||
48538270|NCT03421730|101655197|FG002|STARTED|Second Intervention (Day 8±3, Visit 3)||1||
48538271|NCT03421730|101655198|FG003|STARTED|Second Intervention (Day 8±3, Visit 3)||1||
48538272|NCT03421730|101655199|FG004|STARTED|Second Intervention (Day 8±3, Visit 3)||1||
48538273|NCT03421730|101655200|FG005|STARTED|Second Intervention (Day 8±3, Visit 3)||1||
48538274|NCT03421730|101655201|FG006|STARTED|Second Intervention (Day 8±3, Visit 3)||1||
48538275|NCT03421730|101655202|FG007|STARTED|Second Intervention (Day 8±3, Visit 3)||1||
48538276|NCT03421730|101655203|FG008|STARTED|Second Intervention (Day 8±3, Visit 3)||1||
48538277|NCT03421730|101655204|FG009|STARTED|Second Intervention (Day 8±3, Visit 3)||2||
48538278|NCT03421730|101655205|FG010|STARTED|Second Intervention (Day 8±3, Visit 3)||1||
48538279|NCT03421730|101655206|FG011|STARTED|Second Intervention (Day 8±3, Visit 3)||1||
48538280|NCT03421730|101655195|FG000|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1||
48538281|NCT03421730|101655196|FG001|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1||
48538282|NCT03421730|101655197|FG002|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1||
48538283|NCT03421730|101655198|FG003|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1||
48538284|NCT03421730|101655199|FG004|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1||
48538285|NCT03421730|101655200|FG005|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1||
48538286|NCT03421730|101655201|FG006|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1||
48538287|NCT03421730|101655202|FG007|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1||
48538288|NCT03421730|101655203|FG008|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1||
48538289|NCT03421730|101655204|FG009|COMPLETED|Second Intervention (Day 8±3, Visit 3)||2||
48538290|NCT03421730|101655205|FG010|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1||
48538291|NCT03421730|101655206|FG011|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1||
48538292|NCT03421730|101655195|FG000|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0||
48538293|NCT03421730|101655196|FG001|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0||
48538294|NCT03421730|101655197|FG002|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0||
48538295|NCT03421730|101655198|FG003|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0||
48538296|NCT03421730|101655199|FG004|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0||
48538297|NCT03421730|101655200|FG005|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0||
48538298|NCT03421730|101655201|FG006|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0||
48538299|NCT03421730|101655202|FG007|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0||
48538300|NCT03421730|101655203|FG008|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0||
48538301|NCT03421730|101655204|FG009|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0||
48538302|NCT03421730|101655205|FG010|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0||
48538303|NCT03421730|101655206|FG011|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0||
48538304|NCT01210612|101655207|FG000|STARTED|Overall Study||23||
48538305|NCT01210612|101655208|FG001|STARTED|Overall Study||30||
48538306|NCT01210612|101655207|FG000|COMPLETED|Overall Study||23||
48538307|NCT01210612|101655208|FG001|COMPLETED|Overall Study||28||
48538308|NCT01210612|101655207|FG000|NOT COMPLETED|Overall Study||0||
48538309|NCT01210612|101655208|FG001|NOT COMPLETED|Overall Study||2||
48538310|NCT04074616|101655209|FG000|STARTED|Overall Study||25||
48538311|NCT04074616|101655210|FG001|STARTED|Overall Study||25||
48538312|NCT04074616|101655209|FG000|COMPLETED|Overall Study||20||
48538313|NCT04074616|101655210|FG001|COMPLETED|Overall Study||22||
48538314|NCT04074616|101655209|FG000|NOT COMPLETED|Overall Study||5||
48236847|NCT03395197|100900461|FG003|NOT COMPLETED|Analysis for DDR-Deficient Participants||0||
48236848|NCT03395197|100900462|FG004|NOT COMPLETED|Analysis for DDR-Deficient Participants||200||
48236849|NCT03395197|100900463|FG005|NOT COMPLETED|Analysis for DDR-Deficient Participants||199||
48236850|NCT00584909|100900464|FG000|STARTED|Overall Study||13||
48236851|NCT00584909|100900464|FG000|COMPLETED|Overall Study||9||
48236852|NCT00584909|100900464|FG000|NOT COMPLETED|Overall Study||4||
48236853|NCT00407485|100900465|FG000|STARTED|Overall Study||22||
48236854|NCT00407485|100900465|FG000|COMPLETED|Overall Study||22||
48236855|NCT00407485|100900465|FG000|NOT COMPLETED|Overall Study||0||
48236856|NCT04421456|100900466|FG000|STARTED|Randomized Placebo Run-in Period||0||
48236857|NCT04421456|100900467|FG001|STARTED|Randomized Placebo Run-in Period||0||
48236858|NCT04421456|100900468|FG002|STARTED|Randomized Placebo Run-in Period||95||
48236859|NCT04421456|100900466|FG000|COMPLETED|Randomized Placebo Run-in Period||0||
48236860|NCT04421456|100900467|FG001|COMPLETED|Randomized Placebo Run-in Period||0||
48236861|NCT04421456|100900468|FG002|COMPLETED|Randomized Placebo Run-in Period||77||
48236862|NCT04421456|100900466|FG000|NOT COMPLETED|Randomized Placebo Run-in Period||0||
48236863|NCT04421456|100900467|FG001|NOT COMPLETED|Randomized Placebo Run-in Period||0||
48236864|NCT04421456|100900468|FG002|NOT COMPLETED|Randomized Placebo Run-in Period||18||
48236865|NCT04421456|100900466|FG000|STARTED|Randomized Treatment Period||27||
48236866|NCT04421456|100900467|FG001|STARTED|Randomized Treatment Period||24||
48538315|NCT04074616|101655210|FG001|NOT COMPLETED|Overall Study||3||
48538316|NCT03565679|101655211|FG000|STARTED|Overall Study||10||
48538317|NCT03565679|101655211|FG000|COMPLETED|Overall Study||10||
48538318|NCT03565679|101655211|FG000|NOT COMPLETED|Overall Study||0||
48538319|NCT04868968|101655212|FG000|STARTED|Overall Study||4|All participants enrolled in the trial|
48538320|NCT04868968|101655212|FG000|COMPLETED|Overall Study||3||
48538321|NCT04868968|101655212|FG000|NOT COMPLETED|Overall Study||1||
48538322|NCT03610516|101655213|FG000|STARTED|Treatment Epoch||39||
48538323|NCT03610516|101655214|FG001|STARTED|Treatment Epoch||18||
48538324|NCT03610516|101655213|FG000|COMPLETED|Treatment Epoch||21||
48538325|NCT03610516|101655214|FG001|COMPLETED|Treatment Epoch||10||
48538326|NCT03610516|101655213|FG000|NOT COMPLETED|Treatment Epoch||18||
48538327|NCT03610516|101655214|FG001|NOT COMPLETED|Treatment Epoch||8||
48538328|NCT03610516|101655213|FG000|STARTED|Post-Treatment Follow-up||34||
48538329|NCT03610516|101655214|FG001|STARTED|Post-Treatment Follow-up||16||
48538330|NCT03610516|101655213|FG000|COMPLETED|Post-Treatment Follow-up||32||
48538331|NCT03610516|101655214|FG001|COMPLETED|Post-Treatment Follow-up||16||
48538332|NCT03610516|101655213|FG000|NOT COMPLETED|Post-Treatment Follow-up||2||
48538333|NCT03610516|101655214|FG001|NOT COMPLETED|Post-Treatment Follow-up||0||
48538334|NCT00554190|101655215|FG000|STARTED|Overall Study||29||
48538335|NCT00554190|101655215|FG000|COMPLETED|Overall Study||19||
48538336|NCT00554190|101655215|FG000|NOT COMPLETED|Overall Study||10||
48538337|NCT01884337|101655216|FG000|STARTED|Treatment||326||
48538338|NCT01884337|101655217|FG001|STARTED|Treatment||172||
48538339|NCT01884337|101655216|FG000|Continuing Into Follow-up Period|Treatment||324||
48538340|NCT01884337|101655217|FG001|Continuing Into Follow-up Period|Treatment||171||
48538341|NCT01884337|101655216|FG000|COMPLETED|Treatment||322||
48538342|NCT01884337|101655217|FG001|COMPLETED|Treatment||170||
48538343|NCT01884337|101655216|FG000|NOT COMPLETED|Treatment||4||
48538344|NCT01884337|101655217|FG001|NOT COMPLETED|Treatment||2||
48538345|NCT01884337|101655216|FG000|STARTED|Follow-up Period||324||
48538346|NCT01884337|101655217|FG001|STARTED|Follow-up Period||171||
48538347|NCT01884337|101655216|FG000|COMPLETED|Follow-up Period||323||
48538348|NCT01884337|101655217|FG001|COMPLETED|Follow-up Period||170||
48538349|NCT01884337|101655216|FG000|NOT COMPLETED|Follow-up Period||1||
48538350|NCT01884337|101655217|FG001|NOT COMPLETED|Follow-up Period||1||
48538351|NCT01189487|101655218|FG000|STARTED|Overall Study||47||
48538352|NCT01189487|101655218|FG000|COMPLETED|Overall Study||44||
48538353|NCT01189487|101655218|FG000|NOT COMPLETED|Overall Study||3||
48538354|NCT04123561|101655219|FG000|STARTED|Overall Study||252||
48538355|NCT04123561|101655220|FG001|STARTED|Overall Study||126||
48538356|NCT04123561|101655221|FG002|STARTED|Overall Study||126||
48236867|NCT04421456|100900468|FG002|STARTED|Randomized Treatment Period||26||
48236868|NCT04421456|100900466|FG000|COMPLETED|Randomized Treatment Period||23||
48236869|NCT04421456|100900467|FG001|COMPLETED|Randomized Treatment Period||19||
48538357|NCT04123561|101655219|FG000|COMPLETED|Overall Study||208||
48538358|NCT04123561|101655220|FG001|COMPLETED|Overall Study||96||
48538359|NCT04123561|101655221|FG002|COMPLETED|Overall Study||101||
48538360|NCT04123561|101655219|FG000|NOT COMPLETED|Overall Study||44||
48538361|NCT04123561|101655220|FG001|NOT COMPLETED|Overall Study||30||
48538362|NCT04123561|101655221|FG002|NOT COMPLETED|Overall Study||25||
48236870|NCT04421456|100900468|FG002|COMPLETED|Randomized Treatment Period||19||
48236871|NCT04421456|100900466|FG000|NOT COMPLETED|Randomized Treatment Period||4||
48538363|NCT01555671|101655222|FG000|STARTED|Overall Study||125||
48236872|NCT04421456|100900467|FG001|NOT COMPLETED|Randomized Treatment Period||5||
48236873|NCT04421456|100900468|FG002|NOT COMPLETED|Randomized Treatment Period||7||
48236874|NCT03262389|100900469|FG000|STARTED|Overall Study||10||
48236875|NCT03262389|100900469|FG000|COMPLETED|Overall Study||7||
48236876|NCT03262389|100900469|FG000|NOT COMPLETED|Overall Study||3||
48236877|NCT02043652|100900470|FG000|STARTED|Overall Study||119|We corrected the information in the patient flow section.|
48236878|NCT02043652|100900470|FG000|COMPLETED|Overall Study||93||
48236879|NCT02043652|100900470|FG000|NOT COMPLETED|Overall Study||26||
48236880|NCT01090739|100902844|FG000|STARTED|Enrollment||207||
48236881|NCT01090739|100902844|FG000|COMPLETED|Enrollment||152||
48236882|NCT01090739|100902844|FG000|NOT COMPLETED|Enrollment||55||
48236883|NCT01090739|100902844|FG000|STARTED|12 Month Follow-up||152||
48236884|NCT01090739|100902844|FG000|COMPLETED|12 Month Follow-up||147||
48538364|NCT01555671|101655223|FG001|STARTED|Overall Study||125||
48538365|NCT01555671|101655222|FG000|COMPLETED|Overall Study||105||
48538366|NCT01555671|101655223|FG001|COMPLETED|Overall Study||100||
48236885|NCT01090739|100902844|FG000|NOT COMPLETED|12 Month Follow-up||5||
48236886|NCT01090739|100902844|FG000|STARTED|24 Month Follow-up||147||
48236887|NCT01090739|100902844|FG000|COMPLETED|24 Month Follow-up||138||
48236888|NCT01090739|100902844|FG000|NOT COMPLETED|24 Month Follow-up||9||
48236889|NCT01090739|100902844|FG000|STARTED|36 Month Follow-up||138||
48236890|NCT01090739|100902844|FG000|COMPLETED|36 Month Follow-up||115||
48236891|NCT01090739|100902844|FG000|NOT COMPLETED|36 Month Follow-up||23||
48236892|NCT03798756|100902845|FG000|STARTED|Overall Study||9274||
48538367|NCT01555671|101655222|FG000|NOT COMPLETED|Overall Study||20||
48538368|NCT01555671|101655223|FG001|NOT COMPLETED|Overall Study||25||
48538369|NCT01997216|101655224|FG000|STARTED|First 9 Hours||18||
48538370|NCT01997216|101655225|FG001|STARTED|First 9 Hours||21||
48236893|NCT03798756|100902845|FG000|COMPLETED|Overall Study||9274||
48236894|NCT03798756|100902845|FG000|NOT COMPLETED|Overall Study||0||
48236895|NCT02660086|100902846|FG000|STARTED|Overall Study- 12-month||299||
48236896|NCT02660086|100902847|FG001|STARTED|Overall Study- 12-month||303||
48236897|NCT02660086|100902846|FG000|COMPLETED|Overall Study- 12-month||273||
48236898|NCT02660086|100902847|FG001|COMPLETED|Overall Study- 12-month||274||
48236899|NCT02660086|100902846|FG000|NOT COMPLETED|Overall Study- 12-month||26||
48236900|NCT02660086|100902847|FG001|NOT COMPLETED|Overall Study- 12-month||29||
48236901|NCT02660086|100902846|FG000|STARTED|Overall Study: 24-month Follow-up||281||
48236902|NCT02660086|100902847|FG001|STARTED|Overall Study: 24-month Follow-up||278||
48236903|NCT02660086|100902846|FG000|COMPLETED|Overall Study: 24-month Follow-up||255||
48236904|NCT02660086|100902847|FG001|COMPLETED|Overall Study: 24-month Follow-up||254||
48236905|NCT02660086|100902846|FG000|NOT COMPLETED|Overall Study: 24-month Follow-up||26||
48236906|NCT02660086|100902847|FG001|NOT COMPLETED|Overall Study: 24-month Follow-up||24||
48236907|NCT03686176|100902848|FG000|STARTED|Overall Study||19||
48236908|NCT03686176|100902849|FG001|STARTED|Overall Study||25||
48236909|NCT03686176|100902850|FG002|STARTED|Overall Study||20||
48236910|NCT03686176|100902848|FG000|COMPLETED|Overall Study||17||
48236911|NCT03686176|100902849|FG001|COMPLETED|Overall Study||25||
48236912|NCT03686176|100902850|FG002|COMPLETED|Overall Study||20||
48236913|NCT03686176|100902848|FG000|NOT COMPLETED|Overall Study||2||
48236914|NCT03686176|100902849|FG001|NOT COMPLETED|Overall Study||0||
48538371|NCT01997216|101655224|FG000|COMPLETED|First 9 Hours||18||
48538372|NCT01997216|101655225|FG001|COMPLETED|First 9 Hours||21||
48538373|NCT01997216|101655224|FG000|NOT COMPLETED|First 9 Hours||0||
48538374|NCT01997216|101655225|FG001|NOT COMPLETED|First 9 Hours||0||
48538375|NCT01997216|101655224|FG000|STARTED|Second 9 Hours||19||
48538376|NCT01997216|101655225|FG001|STARTED|Second 9 Hours||21||
48538377|NCT01997216|101655224|FG000|COMPLETED|Second 9 Hours||19||
48538378|NCT01997216|101655225|FG001|COMPLETED|Second 9 Hours||21||
48538379|NCT01997216|101655224|FG000|NOT COMPLETED|Second 9 Hours||0||
48538380|NCT01997216|101655225|FG001|NOT COMPLETED|Second 9 Hours||0||
48538381|NCT04516759|101655226|FG000|STARTED|Overall Study||80||
48538382|NCT04516759|101655227|FG001|STARTED|Overall Study||73||
48538383|NCT04516759|101655226|FG000|COMPLETED|Overall Study||79||
48538384|NCT04516759|101655227|FG001|COMPLETED|Overall Study||71||
48538385|NCT04516759|101655226|FG000|NOT COMPLETED|Overall Study||1||
48538386|NCT04516759|101655227|FG001|NOT COMPLETED|Overall Study||2||
48538387|NCT01685840|101655228|FG000|STARTED|Overall Study||448||
48236915|NCT03686176|100902850|FG002|NOT COMPLETED|Overall Study||0||
48236916|NCT00406276|100902851|FG000|STARTED|Overall Study||28||
48538388|NCT01685840|101655229|FG001|STARTED|Overall Study||446||
48538389|NCT01685840|101655228|FG000|COMPLETED|Overall Study||119||
48538390|NCT01685840|101655229|FG001|COMPLETED|Overall Study||114||
48236917|NCT00406276|100902851|FG000|COMPLETED|Overall Study||24||
48236918|NCT00406276|100902851|FG000|NOT COMPLETED|Overall Study||4||
48236919|NCT02316171|100902852|FG000|STARTED|Overall Study||4||
48236920|NCT02316171|100902853|FG001|STARTED|Overall Study||6||
48538391|NCT01685840|101655228|FG000|NOT COMPLETED|Overall Study||329||
48538392|NCT01685840|101655229|FG001|NOT COMPLETED|Overall Study||332||
48236921|NCT02316171|100902854|FG002|STARTED|Overall Study||3||
48236922|NCT02316171|100902855|FG003|STARTED|Overall Study||3||
48236923|NCT02316171|100902852|FG000|COMPLETED|Overall Study||3||
48538393|NCT01056315|101655230|FG000|STARTED|Overall Study||27||
48538394|NCT01056315|101655231|FG001|STARTED|Overall Study||23||
48236924|NCT02316171|100902853|FG001|COMPLETED|Overall Study||6||
48236925|NCT02316171|100902854|FG002|COMPLETED|Overall Study||3||
48236926|NCT02316171|100902855|FG003|COMPLETED|Overall Study||3||
48236927|NCT02316171|100902852|FG000|NOT COMPLETED|Overall Study||1||
48236928|NCT02316171|100902853|FG001|NOT COMPLETED|Overall Study||0||
48236929|NCT02316171|100902854|FG002|NOT COMPLETED|Overall Study||0||
48236930|NCT02316171|100902855|FG003|NOT COMPLETED|Overall Study||0||
48236931|NCT01699178|100902856|FG000|STARTED|Overall Study||88||
48236932|NCT01699178|100902857|FG001|STARTED|Overall Study||94||
48236933|NCT01699178|100902856|FG000|COMPLETED|Overall Study||69||
48236934|NCT01699178|100902857|FG001|COMPLETED|Overall Study||62||
48236935|NCT01699178|100902856|FG000|NOT COMPLETED|Overall Study||19||
48236936|NCT01699178|100902857|FG001|NOT COMPLETED|Overall Study||32||
48236937|NCT05329402|100902858|FG000|STARTED|Overall Study||80||
48236938|NCT05329402|100902859|FG001|STARTED|Overall Study||84||
48236939|NCT05329402|100902858|FG000|COMPLETED|Overall Study||79||
48236940|NCT05329402|100902859|FG001|COMPLETED|Overall Study||83||
48236941|NCT05329402|100902858|FG000|NOT COMPLETED|Overall Study||1||
48236942|NCT05329402|100902859|FG001|NOT COMPLETED|Overall Study||1||
48236943|NCT04182217|100902860|FG000|STARTED|Overall Study||91||
48236944|NCT04182217|100902860|FG000|COMPLETED|Overall Study||91||
48236945|NCT04182217|100902860|FG000|NOT COMPLETED|Overall Study||0||
48236946|NCT00828139|100902861|FG000|STARTED|Overall Study||42||
48236947|NCT00828139|100902862|FG001|STARTED|Overall Study||41||
48236948|NCT00828139|100902863|FG002|STARTED|Overall Study||55||
48236949|NCT00828139|100902864|FG003|STARTED|Overall Study||51||
48236950|NCT00828139|100902861|FG000|COMPLETED|Overall Study||1||
48236951|NCT00828139|100902862|FG001|COMPLETED|Overall Study||0||
48236952|NCT00828139|100902863|FG002|COMPLETED|Overall Study||0||
48236953|NCT00828139|100902864|FG003|COMPLETED|Overall Study||0||
48236954|NCT00828139|100902861|FG000|NOT COMPLETED|Overall Study||41||
48236955|NCT00828139|100902862|FG001|NOT COMPLETED|Overall Study||41||
48236956|NCT00828139|100902863|FG002|NOT COMPLETED|Overall Study||55||
48236957|NCT00828139|100902864|FG003|NOT COMPLETED|Overall Study||51||
48236958|NCT03622580|100902865|FG000|STARTED|Overall Study||315|Intent-to-Treat (ITT) Population|
48236959|NCT03622580|100902866|FG001|STARTED|Overall Study||313|Intent-to-Treat (ITT) Population|
48236960|NCT03622580|100902867|FG002|STARTED|Overall Study||312|Intent-to-Treat (ITT) Population|
48236961|NCT03622580|100902865|FG000|Received at Least One Dose of Study Drug|Overall Study||313|Safety-Evaluable Population|
48236962|NCT03622580|100902866|FG001|Received at Least One Dose of Study Drug|Overall Study||313|Safety-Evaluable Population|
48236963|NCT03622580|100902867|FG002|Received at Least One Dose of Study Drug|Overall Study||311|Safety-Evaluable Population|
48236964|NCT03622580|100902865|FG000|Completed up to Week 56|Overall Study||291|Primary Completion Date Cutoff|
48236965|NCT03622580|100902866|FG001|Completed up to Week 56|Overall Study||289|Primary Completion Date Cutoff|
48236966|NCT03622580|100902867|FG002|Completed up to Week 56|Overall Study||292|Primary Completion Date Cutoff|
48236967|NCT03622580|100902865|FG000|COMPLETED|Overall Study||263||
48236968|NCT03622580|100902866|FG001|COMPLETED|Overall Study||269||
48236969|NCT03622580|100902867|FG002|COMPLETED|Overall Study||260||
48236970|NCT03622580|100902865|FG000|NOT COMPLETED|Overall Study||52||
48236971|NCT03622580|100902866|FG001|NOT COMPLETED|Overall Study||44||
48538395|NCT01056315|101655230|FG000|COMPLETED|Overall Study||13||
48236972|NCT03622580|100902867|FG002|NOT COMPLETED|Overall Study||52||
48538396|NCT01056315|101655231|FG001|COMPLETED|Overall Study||12||
48538397|NCT01056315|101655230|FG000|NOT COMPLETED|Overall Study||14||
48538398|NCT01056315|101655231|FG001|NOT COMPLETED|Overall Study||11||
48538399|NCT03781037|101655232|FG000|STARTED|Overall Study||18||
48538400|NCT03781037|101655232|FG000|COMPLETED|Overall Study||18||
48538401|NCT03781037|101655232|FG000|NOT COMPLETED|Overall Study||0||
48538402|NCT01635218|101655233|FG000|STARTED|Overall Study||44||
48538403|NCT01635218|101655234|FG001|STARTED|Overall Study||46||
48538404|NCT01635218|101655235|FG002|STARTED|Overall Study||43||
48538405|NCT01635218|101655233|FG000|COMPLETED|Overall Study||41||
48538406|NCT01635218|101655234|FG001|COMPLETED|Overall Study||39||
48538407|NCT01635218|101655235|FG002|COMPLETED|Overall Study||37||
48538408|NCT01635218|101655233|FG000|NOT COMPLETED|Overall Study||3||
48538409|NCT01635218|101655234|FG001|NOT COMPLETED|Overall Study||7||
48236973|NCT00329771|100902868|FG000|STARTED|Overall Study||28||
48236974|NCT00329771|100902868|FG000|COMPLETED|Overall Study||25||
48538410|NCT01635218|101655235|FG002|NOT COMPLETED|Overall Study||6||
48538411|NCT04988087|101655236|FG000|STARTED|Overall Study||12||
48538412|NCT04988087|101655237|FG001|STARTED|Overall Study||14||
48236975|NCT00329771|100902868|FG000|NOT COMPLETED|Overall Study||3||
48236976|NCT02105688|100902869|FG000|STARTED|Part A: Double-Blind||201||
48236977|NCT02105688|100902870|FG001|STARTED|Part A: Double-Blind||100||
48236978|NCT02105688|100902869|FG000|COMPLETED|Part A: Double-Blind||181||
48236979|NCT02105688|100902870|FG001|COMPLETED|Part A: Double-Blind||83||
48236980|NCT02105688|100902869|FG000|NOT COMPLETED|Part A: Double-Blind||20||
48236981|NCT02105688|100902870|FG001|NOT COMPLETED|Part A: Double-Blind||17||
48236982|NCT02105688|100902869|FG000|STARTED|Part B: Observational Follow-up||131||
48538413|NCT04988087|101655238|FG002|STARTED|Overall Study||2||
48538414|NCT04988087|101655239|FG003|STARTED|Overall Study||2||
48538415|NCT04988087|101655236|FG000|COMPLETED|Overall Study||0||
48538416|NCT04988087|101655237|FG001|COMPLETED|Overall Study||4||
48236983|NCT02105688|100902870|FG001|STARTED|Part B: Observational Follow-up||68||
48236984|NCT02105688|100902869|FG000|COMPLETED|Part B: Observational Follow-up||94||
48538417|NCT04988087|101655238|FG002|COMPLETED|Overall Study||1||
48538418|NCT04988087|101655239|FG003|COMPLETED|Overall Study||0||
48538419|NCT04988087|101655236|FG000|NOT COMPLETED|Overall Study||12||
48236985|NCT02105688|100902870|FG001|COMPLETED|Part B: Observational Follow-up||48||
48236986|NCT02105688|100902869|FG000|NOT COMPLETED|Part B: Observational Follow-up||37||
48236987|NCT02105688|100902870|FG001|NOT COMPLETED|Part B: Observational Follow-up||20||
48236988|NCT03473665|100902871|FG000|STARTED|Overall Study||9||
48236989|NCT03473665|100902871|FG000|COMPLETED|Overall Study||9||
48236990|NCT03473665|100902871|FG000|NOT COMPLETED|Overall Study||0||
48236991|NCT00409006|100902872|FG000|STARTED|Overall Study||39||
48236992|NCT00409006|100902873|FG001|STARTED|Overall Study||31||
48236993|NCT00409006|100902872|FG000|COMPLETED|Overall Study||19||
48236994|NCT00409006|100902873|FG001|COMPLETED|Overall Study||19||
48236995|NCT00409006|100902872|FG000|NOT COMPLETED|Overall Study||20||
48236996|NCT00409006|100902873|FG001|NOT COMPLETED|Overall Study||12||
48236997|NCT00949234|100902874|FG000|STARTED|Overall Study||267||
48236998|NCT00949234|100902874|FG000|COMPLETED|Overall Study||225||
48538420|NCT04988087|101655237|FG001|NOT COMPLETED|Overall Study||10||
48538421|NCT04988087|101655238|FG002|NOT COMPLETED|Overall Study||1||
48538422|NCT04988087|101655239|FG003|NOT COMPLETED|Overall Study||2||
48538423|NCT05297578|101655240|FG000|STARTED|Overall Study||52||
48538424|NCT05297578|101655241|FG001|STARTED|Overall Study||52||
48538425|NCT05297578|101655242|FG002|STARTED|Overall Study||52||
48538426|NCT05297578|101655243|FG003|STARTED|Overall Study||51||
48236999|NCT00949234|100902874|FG000|NOT COMPLETED|Overall Study||42||
48237000|NCT02465632|100902875|FG000|STARTED|Overall Study||440||
48237001|NCT02465632|100902876|FG001|STARTED|Overall Study||440||
48237002|NCT02465632|100902877|FG002|STARTED|Overall Study||220||
48237003|NCT02465632|100902875|FG000|COMPLETED|Overall Study||409||
48237004|NCT02465632|100902876|FG001|COMPLETED|Overall Study||417||
48538427|NCT05297578|101655240|FG000|Safety Population|Overall Study||52|The Safety Population is defined as all subjects in the Exposed Population who provided safety assessment data. One subject was excluded from the safety population because they were lost to follow up on Day 1 without any solicited or unsolicited AEs collected.|
48538428|NCT05297578|101655241|FG001|Safety Population|Overall Study||52|The Safety Population is defined as all subjects in the Exposed Population who provided safety assessment data. One subject was excluded from the safety population because they were lost to follow up on Day 1 without any solicited or unsolicited AEs collected.|
48237005|NCT02465632|100902877|FG002|COMPLETED|Overall Study||203||
48237006|NCT02465632|100902875|FG000|NOT COMPLETED|Overall Study||31||
48237007|NCT02465632|100902876|FG001|NOT COMPLETED|Overall Study||23||
48237008|NCT02465632|100902877|FG002|NOT COMPLETED|Overall Study||17||
48237009|NCT03800602|100902878|FG000|STARTED|Overall Study||29||
48237010|NCT03800602|100902878|FG000|COMPLETED|Overall Study||24||
48237011|NCT03800602|100902878|FG000|NOT COMPLETED|Overall Study||5||
48237012|NCT00711022|100902879|FG000|STARTED|Overall Study||51||
48538429|NCT05297578|101655242|FG002|Safety Population|Overall Study||52|The Safety Population is defined as all subjects in the Exposed Population who provided safety assessment data. One subject was excluded from the safety population because they were lost to follow up on Day 1 without any solicited or unsolicited AEs collected.|
48538430|NCT05297578|101655243|FG003|Safety Population|Overall Study||50|The Safety Population is defined as all subjects in the Exposed Population who provided safety assessment data. One subject was excluded from the safety population because they were lost to follow up on Day 1 without any solicited or unsolicited AEs collected.|
48538431|NCT05297578|101655240|FG000|Immunogenicity Evaluable Population|Overall Study||48|The Immunogenicity Evaluable Population includes all subjects in the Exposed Population who had no major protocol deviation that would impact immunogenicity assessment or other reason to be excluded as defined prior to unblinding or analysis, who had not received a prohibited medication or vaccine, and who provided evaluable serum sample results for baseline and Day 29 within the required protocol time frames.|
48538432|NCT05297578|101655241|FG001|Immunogenicity Evaluable Population|Overall Study||48|The Immunogenicity Evaluable Population includes all subjects in the Exposed Population who had no major protocol deviation that would impact immunogenicity assessment or other reason to be excluded as defined prior to unblinding or analysis, who had not received a prohibited medication or vaccine, and who provided evaluable serum sample results for baseline and Day 29 within the required protocol time frames.|
48592668|NCT01877382|101783155|FG005|STARTED|Dose Expansion||0||
48592669|NCT01877382|101783156|FG006|STARTED|Dose Expansion||0||
48592670|NCT01877382|101783157|FG007|STARTED|Dose Expansion||0||
48592671|NCT01877382|101783158|FG008|STARTED|Dose Expansion||0||
48592672|NCT01877382|101783159|FG009|STARTED|Dose Expansion||0||
48237013|NCT00711022|100902879|FG000|COMPLETED|Overall Study||40||
48237014|NCT00711022|100902879|FG000|NOT COMPLETED|Overall Study||11||
48237015|NCT02865083|100902880|FG000|STARTED|Overall Study||3||
48237016|NCT02865083|100902881|FG001|STARTED|Overall Study||1||
48237017|NCT02865083|100902880|FG000|COMPLETED|Overall Study||0||
48237018|NCT02865083|100902881|FG001|COMPLETED|Overall Study||0||
48237019|NCT02865083|100902880|FG000|NOT COMPLETED|Overall Study||3||
48237020|NCT02865083|100902881|FG001|NOT COMPLETED|Overall Study||1||
48237021|NCT03386344|100902882|FG000|STARTED|Overall Study||126||
48237022|NCT03386344|100902883|FG001|STARTED|Overall Study||125||
48237023|NCT03386344|100902884|FG002|STARTED|Overall Study||125||
48237024|NCT03386344|100902882|FG000|COMPLETED|Overall Study||9||
48237025|NCT03386344|100902883|FG001|COMPLETED|Overall Study||9||
48237026|NCT03386344|100902884|FG002|COMPLETED|Overall Study||9||
48237027|NCT03386344|100902882|FG000|NOT COMPLETED|Overall Study||117||
48237028|NCT03386344|100902883|FG001|NOT COMPLETED|Overall Study||116||
48237029|NCT03386344|100902884|FG002|NOT COMPLETED|Overall Study||116||
48237030|NCT00080119|100902885|FG000|STARTED|Overall Study||403||
48237031|NCT00080119|100902886|FG001|STARTED|Overall Study||401||
48237032|NCT00080119|100902887|FG002|STARTED|Overall Study||273||
48237033|NCT00080119|100902888|FG003|STARTED|Overall Study||274||
48237034|NCT00080119|100902885|FG000|COMPLETED|Overall Study||347||
48237035|NCT00080119|100902886|FG001|COMPLETED|Overall Study||339||
48237036|NCT00080119|100902887|FG002|COMPLETED|Overall Study||108||
48237037|NCT00080119|100902888|FG003|COMPLETED|Overall Study||111||
48237038|NCT00080119|100902885|FG000|NOT COMPLETED|Overall Study||56||
48237039|NCT00080119|100902886|FG001|NOT COMPLETED|Overall Study||62||
48237040|NCT00080119|100902887|FG002|NOT COMPLETED|Overall Study||165||
48237041|NCT00080119|100902888|FG003|NOT COMPLETED|Overall Study||163||
48237042|NCT00279409|100902889|FG000|STARTED|Overall Study||0||
48237043|NCT00279409|100902890|FG001|STARTED|Overall Study||0||
48237044|NCT00279409|100902889|FG000|COMPLETED|Overall Study||0||
48538433|NCT05297578|101655242|FG002|Immunogenicity Evaluable Population|Overall Study||47|The Immunogenicity Evaluable Population includes all subjects in the Exposed Population who had no major protocol deviation that would impact immunogenicity assessment or other reason to be excluded as defined prior to unblinding or analysis, who had not received a prohibited medication or vaccine, and who provided evaluable serum sample results for baseline and Day 29 within the required protocol time frames.|
48538434|NCT05297578|101655243|FG003|Immunogenicity Evaluable Population|Overall Study||45|The Immunogenicity Evaluable Population includes all subjects in the Exposed Population who had no major protocol deviation that would impact immunogenicity assessment or other reason to be excluded as defined prior to unblinding or analysis, who had not received a prohibited medication or vaccine, and who provided evaluable serum sample results for baseline and Day 29 within the required protocol time frames.|
48538435|NCT05297578|101655240|FG000|COMPLETED|Overall Study||51||
48538436|NCT05297578|101655241|FG001|COMPLETED|Overall Study||50||
48538437|NCT05297578|101655242|FG002|COMPLETED|Overall Study||49||
48538438|NCT05297578|101655243|FG003|COMPLETED|Overall Study||50||
48538439|NCT05297578|101655240|FG000|NOT COMPLETED|Overall Study||1||
48237045|NCT00279409|100902890|FG001|COMPLETED|Overall Study||0||
48237046|NCT00279409|100902889|FG000|NOT COMPLETED|Overall Study||0||
48237047|NCT00279409|100902890|FG001|NOT COMPLETED|Overall Study||0||
48237048|NCT00984334|100902891|FG000|STARTED|Overall Study||8||
48237049|NCT00984334|100902892|FG001|STARTED|Overall Study||8||
48237050|NCT00984334|100902893|FG002|STARTED|Overall Study||8||
48237051|NCT00984334|100902894|FG003|STARTED|Overall Study||8||
48237052|NCT00984334|100902895|FG004|STARTED|Overall Study||8||
48237053|NCT00984334|100902891|FG000|COMPLETED|Overall Study||7||
48237054|NCT00984334|100902892|FG001|COMPLETED|Overall Study||7||
48237055|NCT00984334|100902893|FG002|COMPLETED|Overall Study||8||
48237056|NCT00984334|100902894|FG003|COMPLETED|Overall Study||7||
48237057|NCT00984334|100902895|FG004|COMPLETED|Overall Study||7||
48237058|NCT00984334|100902891|FG000|NOT COMPLETED|Overall Study||1||
48237059|NCT00984334|100902892|FG001|NOT COMPLETED|Overall Study||1||
48237060|NCT00984334|100902893|FG002|NOT COMPLETED|Overall Study||0||
48237061|NCT00984334|100902894|FG003|NOT COMPLETED|Overall Study||1||
48237062|NCT00984334|100902895|FG004|NOT COMPLETED|Overall Study||1||
48237063|NCT03627299|100902896|FG000|STARTED|Overall Study||10||
48237064|NCT03627299|100902896|FG000|COMPLETED|Overall Study||10||
48237065|NCT03627299|100902896|FG000|NOT COMPLETED|Overall Study||0||
48237066|NCT03503188|100902897|FG000|STARTED|Overall Study||128|Started are enrolled in entire study|
48237067|NCT03503188|100902898|FG001|STARTED|Overall Study||146|Started are enrolled in entire study|
48237068|NCT03503188|100902897|FG000|Entered in the Entire Study|Overall Study||128||
48538440|NCT05297578|101655241|FG001|NOT COMPLETED|Overall Study||2||
48538441|NCT05297578|101655242|FG002|NOT COMPLETED|Overall Study||3||
48538442|NCT05297578|101655243|FG003|NOT COMPLETED|Overall Study||1||
48538443|NCT02754856|101655244|FG000|STARTED|Overall Study||24||
48538444|NCT02754856|101655244|FG000|COMPLETED|Overall Study||23||
48538445|NCT02754856|101655244|FG000|NOT COMPLETED|Overall Study||1||
48237069|NCT03503188|100902898|FG001|Entered in the Entire Study|Overall Study||145||
48237070|NCT03503188|100902897|FG000|Main Study|Overall Study||99|Only eligible participants|
48237071|NCT03503188|100902898|FG001|Main Study|Overall Study||101|Only eligible participants|
48237072|NCT03503188|100902897|FG000|Sub-study|Overall Study||29|Only eligible participants|
48237073|NCT03503188|100902898|FG001|Sub-study|Overall Study||44|Only eligible participants|
48237074|NCT03503188|100902897|FG000|COMPLETED|Overall Study||128||
48237075|NCT03503188|100902898|FG001|COMPLETED|Overall Study||145||
48237076|NCT03503188|100902897|FG000|NOT COMPLETED|Overall Study||0||
48237077|NCT03503188|100902898|FG001|NOT COMPLETED|Overall Study||1||
48237078|NCT02577315|100902899|FG000|STARTED|Treatment Period 1 (4 Days)||12||
48237079|NCT02577315|100902900|FG001|STARTED|Treatment Period 1 (4 Days)||13||
48237080|NCT02577315|100902899|FG000|COMPLETED|Treatment Period 1 (4 Days)||12||
48237081|NCT02577315|100902900|FG001|COMPLETED|Treatment Period 1 (4 Days)||12||
48237082|NCT02577315|100902899|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
48237083|NCT02577315|100902900|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||1||
48237084|NCT02577315|100902899|FG000|STARTED|Washout Period (5 Days)||12||
48237085|NCT02577315|100902900|FG001|STARTED|Washout Period (5 Days)||12||
48237086|NCT02577315|100902899|FG000|COMPLETED|Washout Period (5 Days)||12||
48237087|NCT02577315|100902900|FG001|COMPLETED|Washout Period (5 Days)||12||
48237088|NCT02577315|100902899|FG000|NOT COMPLETED|Washout Period (5 Days)||0||
48237089|NCT02577315|100902900|FG001|NOT COMPLETED|Washout Period (5 Days)||0||
48237090|NCT02577315|100902899|FG000|STARTED|Treatment Period 2 (4 Days)||12||
48237091|NCT02577315|100902900|FG001|STARTED|Treatment Period 2 (4 Days)||12||
48237092|NCT02577315|100902899|FG000|COMPLETED|Treatment Period 2 (4 Days)||12||
48237093|NCT02577315|100902900|FG001|COMPLETED|Treatment Period 2 (4 Days)||12||
48237094|NCT02577315|100902899|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
48237095|NCT02577315|100902900|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
48237096|NCT01377844|100902901|FG000|STARTED|Overall Study||145||
48237097|NCT01377844|100902902|FG001|STARTED|Overall Study||143||
48237098|NCT01377844|100902901|FG000|Safety Population|Overall Study||145|Two subjects did not meet the eligibility criteria and were not dosed. They were excluded from the safety population.|
48237099|NCT01377844|100902902|FG001|Safety Population|Overall Study||141|Two subjects did not meet the eligibility criteria and were not dosed. They were excluded from the safety population.|
48237100|NCT01377844|100902901|FG000|COMPLETED|Overall Study||109||
48237101|NCT01377844|100902902|FG001|COMPLETED|Overall Study||108||
48237102|NCT01377844|100902901|FG000|NOT COMPLETED|Overall Study||36||
48237103|NCT01377844|100902902|FG001|NOT COMPLETED|Overall Study||35||
48237104|NCT02069379|100902903|FG000|STARTED|Baseline Measurements||30||
48237105|NCT02069379|100902904|FG001|STARTED|Baseline Measurements||4||
48237106|NCT02069379|100902905|FG002|STARTED|Baseline Measurements||2||
48237107|NCT02069379|100902906|FG003|STARTED|Baseline Measurements||6||
48237108|NCT02069379|100902903|FG000|Baseline Measurements Taken|Baseline Measurements||30||
48237109|NCT02069379|100902904|FG001|Baseline Measurements Taken|Baseline Measurements||4||
48237110|NCT02069379|100902905|FG002|Baseline Measurements Taken|Baseline Measurements||2||
48237111|NCT02069379|100902906|FG003|Baseline Measurements Taken|Baseline Measurements||6||
48237112|NCT02069379|100902903|FG000|COMPLETED|Baseline Measurements||27||
48237113|NCT02069379|100902904|FG001|COMPLETED|Baseline Measurements||4||
48237114|NCT02069379|100902905|FG002|COMPLETED|Baseline Measurements||2||
48237115|NCT02069379|100902906|FG003|COMPLETED|Baseline Measurements||4||
48538446|NCT00103610|101655245|FG000|STARTED|Overall Study||150||
48538447|NCT00103610|101655246|FG001|STARTED|Overall Study||148||
48538448|NCT00103610|101655245|FG000|COMPLETED|Overall Study||112||
48538449|NCT00103610|101655246|FG001|COMPLETED|Overall Study||68||
48538450|NCT00103610|101655245|FG000|NOT COMPLETED|Overall Study||38||
48538451|NCT00103610|101655246|FG001|NOT COMPLETED|Overall Study||80||
48538452|NCT02521376|101655247|FG000|STARTED|Overall Study||8||
48538453|NCT02521376|101655248|FG001|STARTED|Overall Study||18||
48538454|NCT02521376|101655249|FG002|STARTED|Overall Study||10||
48538455|NCT02521376|101655250|FG003|STARTED|Overall Study||20||
48538456|NCT02521376|101655247|FG000|COMPLETED|Overall Study||7||
48538457|NCT02521376|101655248|FG001|COMPLETED|Overall Study||18||
48538458|NCT02521376|101655249|FG002|COMPLETED|Overall Study||10||
48538459|NCT02521376|101655250|FG003|COMPLETED|Overall Study||20||
48538460|NCT02521376|101655247|FG000|NOT COMPLETED|Overall Study||1||
48538461|NCT02521376|101655248|FG001|NOT COMPLETED|Overall Study||0||
48538462|NCT02521376|101655249|FG002|NOT COMPLETED|Overall Study||0||
48538463|NCT02521376|101655250|FG003|NOT COMPLETED|Overall Study||0||
48538464|NCT01814553|101655251|FG000|STARTED|Overall Study||18||
48538465|NCT01814553|101655252|FG001|STARTED|Overall Study||22||
48538466|NCT01814553|101655251|FG000|COMPLETED|Overall Study||0||
48538467|NCT01814553|101655252|FG001|COMPLETED|Overall Study||0||
48538468|NCT01814553|101655251|FG000|NOT COMPLETED|Overall Study||18||
48538469|NCT01814553|101655252|FG001|NOT COMPLETED|Overall Study||22||
48538470|NCT04576923|101655253|FG000|STARTED|Overall Study||36||
48538471|NCT04576923|101655253|FG000|COMPLETED|Overall Study||21||
48538472|NCT04576923|101655253|FG000|NOT COMPLETED|Overall Study||15||
48538473|NCT04380090|101655254|FG000|STARTED|Overall Study||76||
48538474|NCT04380090|101655255|FG001|STARTED|Overall Study||78||
48538475|NCT04380090|101655254|FG000|COMPLETED|Overall Study||60||
48538476|NCT04380090|101655255|FG001|COMPLETED|Overall Study||58||
48538477|NCT04380090|101655254|FG000|NOT COMPLETED|Overall Study||16||
48538478|NCT04380090|101655255|FG001|NOT COMPLETED|Overall Study||20||
48237116|NCT02069379|100902903|FG000|NOT COMPLETED|Baseline Measurements||3||
48237117|NCT02069379|100902904|FG001|NOT COMPLETED|Baseline Measurements||0||
48237118|NCT02069379|100902905|FG002|NOT COMPLETED|Baseline Measurements||0||
48237119|NCT02069379|100902906|FG003|NOT COMPLETED|Baseline Measurements||2||
48237120|NCT02069379|100902903|FG000|STARTED|First Treatment Arm||0||
48237121|NCT02069379|100902904|FG001|STARTED|First Treatment Arm||4||
48237122|NCT02069379|100902905|FG002|STARTED|First Treatment Arm||2||
48237123|NCT02069379|100902906|FG003|STARTED|First Treatment Arm||0||
48237124|NCT02069379|100902903|FG000|COMPLETED|First Treatment Arm||0||
48237125|NCT02069379|100902904|FG001|COMPLETED|First Treatment Arm||3||
48237126|NCT02069379|100902905|FG002|COMPLETED|First Treatment Arm||1||
48237127|NCT02069379|100902906|FG003|COMPLETED|First Treatment Arm||0||
48538479|NCT00678886|101655256|FG000|STARTED|Overall Study||10||
48538480|NCT00678886|101655257|FG001|STARTED|Overall Study||19||
48538481|NCT00678886|101655258|FG002|STARTED|Overall Study||81||
48538482|NCT00678886|101655259|FG003|STARTED|Overall Study||162||
48538483|NCT00678886|101655256|FG000|COMPLETED|Overall Study||10||
48538484|NCT00678886|101655257|FG001|COMPLETED|Overall Study||19||
48538485|NCT00678886|101655258|FG002|COMPLETED|Overall Study||72||
48538486|NCT00678886|101655259|FG003|COMPLETED|Overall Study||153||
48538487|NCT00678886|101655256|FG000|NOT COMPLETED|Overall Study||0||
48538488|NCT00678886|101655257|FG001|NOT COMPLETED|Overall Study||0||
48538489|NCT00678886|101655258|FG002|NOT COMPLETED|Overall Study||9||
48237128|NCT02069379|100902903|FG000|NOT COMPLETED|First Treatment Arm||0||
48237129|NCT02069379|100902904|FG001|NOT COMPLETED|First Treatment Arm||1||
48237130|NCT02069379|100902905|FG002|NOT COMPLETED|First Treatment Arm||1||
48237131|NCT02069379|100902906|FG003|NOT COMPLETED|First Treatment Arm||0||
48237132|NCT02069379|100902903|FG000|STARTED|Washout Period (4 Weeks)||0||
48237133|NCT02069379|100902904|FG001|STARTED|Washout Period (4 Weeks)||3||
48237134|NCT02069379|100902905|FG002|STARTED|Washout Period (4 Weeks)||1||
48237135|NCT02069379|100902906|FG003|STARTED|Washout Period (4 Weeks)||0||
48237136|NCT02069379|100902903|FG000|COMPLETED|Washout Period (4 Weeks)||0||
48237137|NCT02069379|100902904|FG001|COMPLETED|Washout Period (4 Weeks)||1||
48237138|NCT02069379|100902905|FG002|COMPLETED|Washout Period (4 Weeks)||1||
48237139|NCT02069379|100902906|FG003|COMPLETED|Washout Period (4 Weeks)||0||
48237140|NCT02069379|100902903|FG000|NOT COMPLETED|Washout Period (4 Weeks)||0||
48237141|NCT02069379|100902904|FG001|NOT COMPLETED|Washout Period (4 Weeks)||2||
48237142|NCT02069379|100902905|FG002|NOT COMPLETED|Washout Period (4 Weeks)||0||
48237143|NCT02069379|100902906|FG003|NOT COMPLETED|Washout Period (4 Weeks)||0||
48237144|NCT02069379|100902903|FG000|STARTED|Second Treatment Arm||0||
48237145|NCT02069379|100902904|FG001|STARTED|Second Treatment Arm||1||
48237146|NCT02069379|100902905|FG002|STARTED|Second Treatment Arm||1||
48237147|NCT02069379|100902906|FG003|STARTED|Second Treatment Arm||0||
48237148|NCT02069379|100902903|FG000|COMPLETED|Second Treatment Arm||0||
48237149|NCT02069379|100902904|FG001|COMPLETED|Second Treatment Arm||1||
48237150|NCT02069379|100902905|FG002|COMPLETED|Second Treatment Arm||0||
48237151|NCT02069379|100902906|FG003|COMPLETED|Second Treatment Arm||0||
48237152|NCT02069379|100902903|FG000|NOT COMPLETED|Second Treatment Arm||0||
48237153|NCT02069379|100902904|FG001|NOT COMPLETED|Second Treatment Arm||0||
48237154|NCT02069379|100902905|FG002|NOT COMPLETED|Second Treatment Arm||1||
48538490|NCT00678886|101655259|FG003|NOT COMPLETED|Overall Study||9||
48237155|NCT02069379|100902906|FG003|NOT COMPLETED|Second Treatment Arm||0||
48237156|NCT00440037|100902907|FG000|STARTED|Overall Study||44||
48237157|NCT00440037|100902907|FG000|COMPLETED|Overall Study||35||
48237158|NCT00440037|100902907|FG000|NOT COMPLETED|Overall Study||9||
48237159|NCT02489799|100902908|FG000|STARTED|Overall Study||45||
48237160|NCT02489799|100902909|FG001|STARTED|Overall Study||47||
48237161|NCT02489799|100902908|FG000|Presurgical Consent Visit (V2)|Overall Study||40||
48237162|NCT02489799|100902909|FG001|Presurgical Consent Visit (V2)|Overall Study||39||
48237163|NCT02489799|100902908|FG000|Postsurgical One Week Visit (V3)|Overall Study||40||
48237164|NCT02489799|100902909|FG001|Postsurgical One Week Visit (V3)|Overall Study||39||
48237165|NCT02489799|100902908|FG000|COMPLETED|Overall Study||36||
48237166|NCT02489799|100902909|FG001|COMPLETED|Overall Study||38||
48237167|NCT02489799|100902908|FG000|NOT COMPLETED|Overall Study||9||
48237168|NCT02489799|100902909|FG001|NOT COMPLETED|Overall Study||9||
48237169|NCT01478256|100902910|FG000|STARTED|Overall Study||15||
48237170|NCT01478256|100902911|FG001|STARTED|Overall Study||15||
48237171|NCT01478256|100902910|FG000|COMPLETED|Overall Study||15||
48538491|NCT00492024|101655260|FG000|STARTED|Treatment||251||
48673652|NCT03373435|101985842|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||0||
48673653|NCT03373435|101985841|FG000|STARTED|Treatment Period 2 (14 Days)||8||
48673654|NCT03373435|101985842|FG001|STARTED|Treatment Period 2 (14 Days)||10||
48673655|NCT03373435|101985841|FG000|COMPLETED|Treatment Period 2 (14 Days)||8||
48673656|NCT03373435|101985842|FG001|COMPLETED|Treatment Period 2 (14 Days)||10||
48673657|NCT03373435|101985841|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
48673658|NCT03373435|101985842|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
48673659|NCT03373435|101985841|FG000|STARTED|Treatment Period 3 (14 Days)||8||
48237172|NCT01478256|100902911|FG001|COMPLETED|Overall Study||15||
48538492|NCT00492024|101655261|FG001|STARTED|Treatment||123||
48538493|NCT00492024|101655260|FG000|COMPLETED|Treatment||222||
48237173|NCT01478256|100902910|FG000|NOT COMPLETED|Overall Study||0||
48237174|NCT01478256|100902911|FG001|NOT COMPLETED|Overall Study||0||
48237175|NCT00383500|100902912|FG000|STARTED|Overall Study||27||
48237176|NCT00383500|100902913|FG001|STARTED|Overall Study||24||
48237177|NCT00383500|100902914|FG002|STARTED|Overall Study||24||
48538494|NCT00492024|101655261|FG001|COMPLETED|Treatment||101||
48538495|NCT00492024|101655260|FG000|NOT COMPLETED|Treatment||29||
48538496|NCT00492024|101655261|FG001|NOT COMPLETED|Treatment||22||
48538497|NCT00492024|101655260|FG000|STARTED|Follow up||222||
48538498|NCT00492024|101655261|FG001|STARTED|Follow up||101||
48538499|NCT00492024|101655260|FG000|COMPLETED|Follow up||221||
48673660|NCT03373435|101985842|FG001|STARTED|Treatment Period 3 (14 Days)||10||
48237178|NCT00383500|100902912|FG000|COMPLETED|Overall Study||19||
48237179|NCT00383500|100902913|FG001|COMPLETED|Overall Study||21||
48237180|NCT00383500|100902914|FG002|COMPLETED|Overall Study||22||
48237181|NCT00383500|100902912|FG000|NOT COMPLETED|Overall Study||8||
48538500|NCT00492024|101655261|FG001|COMPLETED|Follow up||99||
48237182|NCT00383500|100902913|FG001|NOT COMPLETED|Overall Study||3||
48237183|NCT00383500|100902914|FG002|NOT COMPLETED|Overall Study||2||
48237184|NCT03928821|100902915|FG000|STARTED|Overall Study||6||
48237185|NCT03928821|100902916|FG001|STARTED|Overall Study||6||
48237186|NCT03928821|100902917|FG002|STARTED|Overall Study||6||
48237187|NCT03928821|100902918|FG003|STARTED|Overall Study||9||
48237188|NCT03928821|100902915|FG000|COMPLETED|Overall Study||6||
48237189|NCT03928821|100902916|FG001|COMPLETED|Overall Study||3||
48237190|NCT03928821|100902917|FG002|COMPLETED|Overall Study||3||
48237191|NCT03928821|100902918|FG003|COMPLETED|Overall Study||8||
48237192|NCT03928821|100902915|FG000|NOT COMPLETED|Overall Study||0||
48237193|NCT03928821|100902916|FG001|NOT COMPLETED|Overall Study||3||
48237194|NCT03928821|100902917|FG002|NOT COMPLETED|Overall Study||3||
48237195|NCT03928821|100902918|FG003|NOT COMPLETED|Overall Study||1||
48237196|NCT01768572|100902919|FG000|STARTED|Overall Study||49||
48237197|NCT01768572|100902920|FG001|STARTED|Overall Study||51||
48237198|NCT01768572|100902921|FG002|STARTED|Overall Study||102||
48237199|NCT01768572|100902919|FG000|COMPLETED|Overall Study||40||
48237200|NCT01768572|100902920|FG001|COMPLETED|Overall Study||39||
48237201|NCT01768572|100902921|FG002|COMPLETED|Overall Study||96||
48237202|NCT01768572|100902919|FG000|NOT COMPLETED|Overall Study||9||
48237203|NCT01768572|100902920|FG001|NOT COMPLETED|Overall Study||12||
48237204|NCT01768572|100902921|FG002|NOT COMPLETED|Overall Study||6||
48237205|NCT02097056|100902922|FG000|STARTED|Overall Study||171||
48237206|NCT02097056|100902922|FG000|ParticipantsTreated|Overall Study||170||
48237207|NCT02097056|100902922|FG000|COMPLETED|Overall Study||113||
48237208|NCT02097056|100902922|FG000|NOT COMPLETED|Overall Study||58||
48237209|NCT01131325|100902923|FG000|STARTED|Overall Study||3||
48237210|NCT01131325|100902923|FG000|COMPLETED|Overall Study||0||
48237211|NCT01131325|100902923|FG000|NOT COMPLETED|Overall Study||3||
48237212|NCT02481934|100902924|FG000|STARTED|Overall Study||5||
48237213|NCT02481934|100902924|FG000|COMPLETED|Overall Study||3||
48237214|NCT02481934|100902924|FG000|NOT COMPLETED|Overall Study||2||
48237215|NCT03029585|100902925|FG000|STARTED|Overall Study||7||
48237216|NCT03029585|100902926|FG001|STARTED|Overall Study||3||
48237217|NCT03029585|100902925|FG000|COMPLETED|Overall Study||5||
48237218|NCT03029585|100902926|FG001|COMPLETED|Overall Study||2||
48237219|NCT03029585|100902925|FG000|NOT COMPLETED|Overall Study||2||
48237220|NCT03029585|100902926|FG001|NOT COMPLETED|Overall Study||1||
48237221|NCT00441168|100902927|FG000|STARTED|Treatment Period||17||
48237222|NCT00441168|100902928|FG001|STARTED|Treatment Period||13||
48237223|NCT00441168|100902927|FG000|TREATED|Treatment Period||16||
48237224|NCT00441168|100902928|FG001|TREATED|Treatment Period||13||
48237225|NCT00441168|100902927|FG000|COMPLETED|Treatment Period||6||
48237226|NCT00441168|100902928|FG001|COMPLETED|Treatment Period||7||
48237227|NCT00441168|100902927|FG000|NOT COMPLETED|Treatment Period||11||
48237228|NCT00441168|100902928|FG001|NOT COMPLETED|Treatment Period||6||
48237229|NCT00441168|100902927|FG000|STARTED|Follow-up Period||17||
48237230|NCT00441168|100902928|FG001|STARTED|Follow-up Period||13||
48237231|NCT00441168|100902927|FG000|COMPLETED|Follow-up Period||5||
48538501|NCT00492024|101655260|FG000|NOT COMPLETED|Follow up||1||
48538502|NCT00492024|101655261|FG001|NOT COMPLETED|Follow up||2||
48538503|NCT00469144|101655262|FG000|STARTED|Overall Study||114||
48237232|NCT00441168|100902928|FG001|COMPLETED|Follow-up Period||4||
48237233|NCT00441168|100902927|FG000|NOT COMPLETED|Follow-up Period||12||
48237234|NCT00441168|100902928|FG001|NOT COMPLETED|Follow-up Period||9||
48237235|NCT00668746|100902929|FG000|STARTED|Overall Study||23||
48237236|NCT00668746|100902930|FG001|STARTED|Overall Study||12||
48237237|NCT00668746|100902929|FG000|COMPLETED|Overall Study||21||
48237238|NCT00668746|100902930|FG001|COMPLETED|Overall Study||11||
48237239|NCT00668746|100902929|FG000|NOT COMPLETED|Overall Study||2||
48237240|NCT00668746|100902930|FG001|NOT COMPLETED|Overall Study||1||
48538504|NCT00469144|101655263|FG001|STARTED|Overall Study||111||
48538505|NCT00469144|101655262|FG000|COMPLETED|Overall Study||108||
48538506|NCT00469144|101655263|FG001|COMPLETED|Overall Study||105||
48538507|NCT00469144|101655262|FG000|NOT COMPLETED|Overall Study||6||
48538508|NCT00469144|101655263|FG001|NOT COMPLETED|Overall Study||6||
48538509|NCT02212379|101655264|FG000|STARTED|From Baseline to Week 48||165||
48538510|NCT02212379|101655264|FG000|COMPLETED|From Baseline to Week 48||156||
48538511|NCT02212379|101655264|FG000|NOT COMPLETED|From Baseline to Week 48||9||
48538512|NCT02212379|101655264|FG000|STARTED|From Week 48 to Week 96||156||
48538513|NCT02212379|101655264|FG000|COMPLETED|From Week 48 to Week 96||152||
48538514|NCT02212379|101655264|FG000|NOT COMPLETED|From Week 48 to Week 96||4||
48538515|NCT01006135|101655265|FG000|STARTED|Overall Study||4852||
48538516|NCT01006135|101655265|FG000|COMPLETED|Overall Study||4712||
48538517|NCT01006135|101655265|FG000|NOT COMPLETED|Overall Study||140||
48538518|NCT02293863|101655266|FG000|STARTED|Overall Study||56||
48538519|NCT02293863|101655267|FG001|STARTED|Overall Study||55||
48538520|NCT02293863|101655268|FG002|STARTED|Overall Study||47||
48538521|NCT02293863|101655266|FG000|COMPLETED|Overall Study||47||
48538522|NCT02293863|101655267|FG001|COMPLETED|Overall Study||42||
48237241|NCT01077284|100902931|FG000|STARTED|Overall Study||33||
48237242|NCT01077284|100902932|FG001|STARTED|Overall Study||33||
48237243|NCT01077284|100902933|FG002|STARTED|Overall Study||33||
48237244|NCT01077284|100902931|FG000|COMPLETED|Overall Study||28||
48673661|NCT03373435|101985841|FG000|COMPLETED|Treatment Period 3 (14 Days)||8||
48673662|NCT03373435|101985842|FG001|COMPLETED|Treatment Period 3 (14 Days)||10||
48673663|NCT03373435|101985841|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0||
48673664|NCT03373435|101985842|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||0||
48673665|NCT01685684|101985843|FG000|STARTED|Titration Phase||740||
48673666|NCT01685684|101985844|FG001|STARTED|Titration Phase||0||
48673667|NCT01685684|101985845|FG002|STARTED|Titration Phase||0||
48673668|NCT01685684|101985843|FG000|COMPLETED|Titration Phase||389||
48673669|NCT01685684|101985844|FG001|COMPLETED|Titration Phase||0||
48673670|NCT01685684|101985845|FG002|COMPLETED|Titration Phase||0||
48673671|NCT01685684|101985843|FG000|NOT COMPLETED|Titration Phase||351||
48673672|NCT01685684|101985844|FG001|NOT COMPLETED|Titration Phase||0||
48673673|NCT01685684|101985845|FG002|NOT COMPLETED|Titration Phase||0||
48673674|NCT01685684|101985843|FG000|STARTED|Double-blind Maintenance Phase||0||
48673675|NCT01685684|101985844|FG001|STARTED|Double-blind Maintenance Phase||193||
48673676|NCT01685684|101985845|FG002|STARTED|Double-blind Maintenance Phase||196||
48673677|NCT01685684|101985843|FG000|COMPLETED|Double-blind Maintenance Phase||0||
48237245|NCT01077284|100902932|FG001|COMPLETED|Overall Study||28||
48237246|NCT01077284|100902933|FG002|COMPLETED|Overall Study||30||
48237247|NCT01077284|100902931|FG000|NOT COMPLETED|Overall Study||5||
48237248|NCT01077284|100902932|FG001|NOT COMPLETED|Overall Study||5||
48237249|NCT01077284|100902933|FG002|NOT COMPLETED|Overall Study||3||
48237250|NCT02450747|100902934|FG000|STARTED|Overall Study||39||
48237251|NCT02450747|100902934|FG000|COMPLETED|Overall Study||39||
48237252|NCT02450747|100902934|FG000|NOT COMPLETED|Overall Study||0||
48237253|NCT01759459|100902935|FG000|STARTED|Overall Study||50||
48237254|NCT01759459|100902936|FG001|STARTED|Overall Study||50||
48237255|NCT01759459|100902937|FG002|STARTED|Overall Study||50||
48237256|NCT01759459|100902935|FG000|COMPLETED|Overall Study||50||
48237257|NCT01759459|100902936|FG001|COMPLETED|Overall Study||50||
48237258|NCT01759459|100902937|FG002|COMPLETED|Overall Study||50||
48237259|NCT01759459|100902935|FG000|NOT COMPLETED|Overall Study||0||
48237260|NCT01759459|100902936|FG001|NOT COMPLETED|Overall Study||0||
48237261|NCT01759459|100902937|FG002|NOT COMPLETED|Overall Study||0||
48237262|NCT03747575|100902938|FG000|STARTED|Overall Study||32||
48237263|NCT03747575|100902939|FG001|STARTED|Overall Study||33||
48237264|NCT03747575|100902938|FG000|COMPLETED|Overall Study||23||
48237265|NCT03747575|100902939|FG001|COMPLETED|Overall Study||26||
48237266|NCT03747575|100902938|FG000|NOT COMPLETED|Overall Study||9||
48237267|NCT03747575|100902939|FG001|NOT COMPLETED|Overall Study||7||
48237268|NCT00547300|100902940|FG000|STARTED|Overall Study||25||
48237269|NCT00547300|100902941|FG001|STARTED|Overall Study||26||
48237270|NCT00547300|100902940|FG000|COMPLETED|Overall Study||0||
48237271|NCT00547300|100902941|FG001|COMPLETED|Overall Study||0||
48237272|NCT00547300|100902940|FG000|NOT COMPLETED|Overall Study||25||
48237273|NCT00547300|100902941|FG001|NOT COMPLETED|Overall Study||26||
48237274|NCT04173000|100902942|FG000|STARTED|Overall Study||8||
48237275|NCT04173000|100902942|FG000|COMPLETED|Overall Study||8||
48237276|NCT04173000|100902942|FG000|NOT COMPLETED|Overall Study||0||
48237277|NCT00848198|100902943|FG000|STARTED|Overall Study||314||
48237278|NCT00848198|100902943|FG000|COMPLETED|Overall Study||299||
48237279|NCT00848198|100902943|FG000|NOT COMPLETED|Overall Study||15||
48237280|NCT00257309|100902944|FG000|STARTED|Overall Study||134||
48237281|NCT00257309|100902945|FG001|STARTED|Overall Study||132||
48237282|NCT00257309|100902944|FG000|COMPLETED|Overall Study||132||
48237283|NCT00257309|100902945|FG001|COMPLETED|Overall Study||130||
48237284|NCT00257309|100902944|FG000|NOT COMPLETED|Overall Study||2||
48673678|NCT01685684|101985844|FG001|COMPLETED|Double-blind Maintenance Phase||122||
48673679|NCT01685684|101985845|FG002|COMPLETED|Double-blind Maintenance Phase||100||
48237285|NCT00257309|100902945|FG001|NOT COMPLETED|Overall Study||2||
48237286|NCT00135200|100902946|FG000|STARTED|Overall Study||16||
48237287|NCT00135200|100902946|FG000|COMPLETED|Overall Study||16||
48237288|NCT00135200|100902946|FG000|NOT COMPLETED|Overall Study||0||
48237289|NCT03249272|100902947|FG000|STARTED|Overall Study||19||
48237290|NCT03249272|100902948|FG001|STARTED|Overall Study||6||
48237291|NCT03249272|100902949|FG002|STARTED|Overall Study||6||
48237292|NCT03249272|100902947|FG000|COMPLETED|Overall Study||19||
48237293|NCT03249272|100902948|FG001|COMPLETED|Overall Study||6||
48237294|NCT03249272|100902949|FG002|COMPLETED|Overall Study||6||
48237295|NCT03249272|100902947|FG000|NOT COMPLETED|Overall Study||0||
48237296|NCT03249272|100902948|FG001|NOT COMPLETED|Overall Study||0||
48237297|NCT03249272|100902949|FG002|NOT COMPLETED|Overall Study||0||
48237298|NCT02256553|100902950|FG000|STARTED|Period I||102||
48237299|NCT02256553|100902950|FG000|COMPLETED|Period I||96||
48237300|NCT02256553|100902950|FG000|NOT COMPLETED|Period I||6||
48237301|NCT02256553|100902950|FG000|STARTED|Period II||96||
48237302|NCT02256553|100902950|FG000|COMPLETED|Period II||94||
48237303|NCT02256553|100902950|FG000|NOT COMPLETED|Period II||2||
48237304|NCT02256553|100902950|FG000|STARTED|Period III||94||
48237305|NCT02256553|100902950|FG000|COMPLETED|Period III||91||
48237306|NCT02256553|100902950|FG000|NOT COMPLETED|Period III||3||
48237307|NCT00472082|100902951|FG000|STARTED|Overall Study||5||
48673680|NCT01685684|101985843|FG000|NOT COMPLETED|Double-blind Maintenance Phase||0||
48673681|NCT01685684|101985844|FG001|NOT COMPLETED|Double-blind Maintenance Phase||71||
48673682|NCT01685684|101985845|FG002|NOT COMPLETED|Double-blind Maintenance Phase||96||
48673683|NCT02234362|101985846|FG000|STARTED|Overall Study||47||
48673684|NCT02234362|101985846|FG000|Received at Least One Dose of Medication|Overall Study||27||
48673685|NCT02234362|101985846|FG000|COMPLETED|Overall Study||21||
48673686|NCT02234362|101985846|FG000|NOT COMPLETED|Overall Study||26||
48673687|NCT03610048|101985847|FG000|STARTED|Overall Study||175||
48673688|NCT03610048|101985847|FG000|Completed Treatment|Overall Study||15||
48673689|NCT03610048|101985847|FG000|COMPLETED|Overall Study||14|Completed study|
48673690|NCT03610048|101985847|FG000|NOT COMPLETED|Overall Study||161||
48673691|NCT00548886|101985848|FG000|STARTED|Overall Study||7||
48673692|NCT00548886|101985848|FG000|COMPLETED|Overall Study||7||
48673693|NCT00548886|101985848|FG000|NOT COMPLETED|Overall Study||0||
48673694|NCT01280942|101985849|FG000|STARTED|Overall Study||10120||
48673695|NCT01280942|101985850|FG001|STARTED|Overall Study||9911||
48673696|NCT01280942|101985849|FG000|COMPLETED|Overall Study||10120||
48673697|NCT01280942|101985850|FG001|COMPLETED|Overall Study||9911||
48673698|NCT01280942|101985849|FG000|NOT COMPLETED|Overall Study||0||
48673699|NCT01280942|101985850|FG001|NOT COMPLETED|Overall Study||0||
48673700|NCT01987557|101985851|FG000|STARTED|Overall Study||16||
48673701|NCT01987557|101985852|FG001|STARTED|Overall Study||16||
48673702|NCT01987557|101985853|FG002|STARTED|Overall Study||16||
48673703|NCT01987557|101985851|FG000|COMPLETED|Overall Study||13||
48673704|NCT01987557|101985852|FG001|COMPLETED|Overall Study||13||
48673705|NCT01987557|101985853|FG002|COMPLETED|Overall Study||13||
48237308|NCT00472082|100902951|FG000|COMPLETED|Overall Study||0||
48237309|NCT00472082|100902951|FG000|NOT COMPLETED|Overall Study||5||
48237310|NCT01732406|100902952|FG000|STARTED|Overall Study||31||
48237311|NCT01732406|100902953|FG001|STARTED|Overall Study||60||
48237312|NCT01732406|100902954|FG002|STARTED|Overall Study||35||
48673706|NCT01987557|101985851|FG000|NOT COMPLETED|Overall Study||3||
48673707|NCT01987557|101985852|FG001|NOT COMPLETED|Overall Study||3||
48673708|NCT01987557|101985853|FG002|NOT COMPLETED|Overall Study||3||
48673709|NCT02051426|101985854|FG000|STARTED|First Intervention||16||
48673710|NCT02051426|101985855|FG001|STARTED|First Intervention||19||
48673711|NCT02051426|101985854|FG000|COMPLETED|First Intervention||16||
48673712|NCT02051426|101985855|FG001|COMPLETED|First Intervention||19||
48673713|NCT02051426|101985854|FG000|NOT COMPLETED|First Intervention||0||
48673714|NCT02051426|101985855|FG001|NOT COMPLETED|First Intervention||0||
48673715|NCT02051426|101985854|FG000|STARTED|Washout Period of 1 Month||16||
48673716|NCT02051426|101985855|FG001|STARTED|Washout Period of 1 Month||19||
48673717|NCT02051426|101985854|FG000|COMPLETED|Washout Period of 1 Month||16||
48673718|NCT02051426|101985855|FG001|COMPLETED|Washout Period of 1 Month||19||
48673719|NCT02051426|101985854|FG000|NOT COMPLETED|Washout Period of 1 Month||0||
48673720|NCT02051426|101985855|FG001|NOT COMPLETED|Washout Period of 1 Month||0||
48673721|NCT02051426|101985854|FG000|STARTED|Second Intervention||16||
48673722|NCT02051426|101985855|FG001|STARTED|Second Intervention||19||
48673723|NCT02051426|101985854|FG000|COMPLETED|Second Intervention||16||
48673724|NCT02051426|101985855|FG001|COMPLETED|Second Intervention||19||
48673725|NCT02051426|101985854|FG000|NOT COMPLETED|Second Intervention||0||
48673726|NCT02051426|101985855|FG001|NOT COMPLETED|Second Intervention||0||
48673727|NCT04133415|101985856|FG000|STARTED|Overall Study||20||
48673728|NCT04133415|101985856|FG000|COMPLETED|Overall Study||20||
48673729|NCT04133415|101985856|FG000|NOT COMPLETED|Overall Study||0||
48237313|NCT01732406|100902952|FG000|COMPLETED|Overall Study||31||
48237314|NCT01732406|100902953|FG001|COMPLETED|Overall Study||60||
48237315|NCT01732406|100902954|FG002|COMPLETED|Overall Study||35||
48237316|NCT01732406|100902952|FG000|NOT COMPLETED|Overall Study||0||
48237317|NCT01732406|100902953|FG001|NOT COMPLETED|Overall Study||0||
48237318|NCT01732406|100902954|FG002|NOT COMPLETED|Overall Study||0||
48237319|NCT03444298|100902955|FG000|STARTED|Period 1 (Dosing Followed by Exposure)||7||
48237320|NCT03444298|100902956|FG001|STARTED|Period 1 (Dosing Followed by Exposure)||9||
48237321|NCT03444298|100902955|FG000|COMPLETED|Period 1 (Dosing Followed by Exposure)||7||
48237322|NCT03444298|100902956|FG001|COMPLETED|Period 1 (Dosing Followed by Exposure)||9||
48237323|NCT03444298|100902955|FG000|NOT COMPLETED|Period 1 (Dosing Followed by Exposure)||0||
48237324|NCT03444298|100902956|FG001|NOT COMPLETED|Period 1 (Dosing Followed by Exposure)||0||
48237325|NCT03444298|100902955|FG000|STARTED|Washout (>/= 4 Weeks)||7||
48237326|NCT03444298|100902956|FG001|STARTED|Washout (>/= 4 Weeks)||9||
48673730|NCT00133705|101985857|FG000|STARTED|Overall Study||22||
48673731|NCT00133705|101985858|FG001|STARTED|Overall Study||20||
48673732|NCT00133705|101985857|FG000|COMPLETED|Overall Study||20||
48673733|NCT00133705|101985858|FG001|COMPLETED|Overall Study||17||
48673734|NCT00133705|101985857|FG000|NOT COMPLETED|Overall Study||2||
48673735|NCT00133705|101985858|FG001|NOT COMPLETED|Overall Study||3||
48673736|NCT01342094|101985859|FG000|STARTED|Overall Study||82||
48673737|NCT01342094|101985860|FG001|STARTED|Overall Study||84||
48673738|NCT01342094|101985859|FG000|COMPLETED|Overall Study||77||
48673739|NCT01342094|101985860|FG001|COMPLETED|Overall Study||81||
48673740|NCT01342094|101985859|FG000|NOT COMPLETED|Overall Study||5||
48673741|NCT01342094|101985860|FG001|NOT COMPLETED|Overall Study||3||
48673742|NCT01005290|101985861|FG000|STARTED|Run-In||52||
48673743|NCT01005290|101985862|FG001|STARTED|Run-In||0||
48673744|NCT01005290|101985863|FG002|STARTED|Run-In||0||
48673745|NCT01005290|101985861|FG000|COMPLETED|Run-In||38||
48673746|NCT01005290|101985862|FG001|COMPLETED|Run-In||0||
48673747|NCT01005290|101985863|FG002|COMPLETED|Run-In||0||
48673748|NCT01005290|101985861|FG000|NOT COMPLETED|Run-In||14||
48673749|NCT01005290|101985862|FG001|NOT COMPLETED|Run-In||0||
48673750|NCT01005290|101985863|FG002|NOT COMPLETED|Run-In||0||
48673751|NCT01005290|101985861|FG000|STARTED|Period 1 (5 Weeks)||0||
48673752|NCT01005290|101985862|FG001|STARTED|Period 1 (5 Weeks)||20||
48673753|NCT01005290|101985863|FG002|STARTED|Period 1 (5 Weeks)||18||
48673754|NCT01005290|101985861|FG000|COMPLETED|Period 1 (5 Weeks)||0||
48538523|NCT02293863|101655268|FG002|COMPLETED|Overall Study||38||
48538524|NCT02293863|101655266|FG000|NOT COMPLETED|Overall Study||9||
48538525|NCT02293863|101655267|FG001|NOT COMPLETED|Overall Study||13||
48538526|NCT02293863|101655268|FG002|NOT COMPLETED|Overall Study||9||
48538527|NCT01275430|101655269|FG000|STARTED|Overall Study||27||
48538528|NCT01275430|101655269|FG000|COMPLETED|Overall Study||18||
48538529|NCT01275430|101655269|FG000|NOT COMPLETED|Overall Study||9||
48538530|NCT05384171|101655270|FG000|STARTED|Overall Study||27||
48538531|NCT05384171|101655271|FG001|STARTED|Overall Study||19||
48673755|NCT01005290|101985862|FG001|COMPLETED|Period 1 (5 Weeks)||13||
48673756|NCT01005290|101985863|FG002|COMPLETED|Period 1 (5 Weeks)||9||
48673757|NCT01005290|101985861|FG000|NOT COMPLETED|Period 1 (5 Weeks)||0||
48673758|NCT01005290|101985862|FG001|NOT COMPLETED|Period 1 (5 Weeks)||7||
48673759|NCT01005290|101985863|FG002|NOT COMPLETED|Period 1 (5 Weeks)||9||
48673760|NCT01005290|101985861|FG000|STARTED|Washout Period (2 Weeks)||0||
48673761|NCT01005290|101985862|FG001|STARTED|Washout Period (2 Weeks)||13||
48673762|NCT01005290|101985863|FG002|STARTED|Washout Period (2 Weeks)||9||
48673763|NCT01005290|101985861|FG000|COMPLETED|Washout Period (2 Weeks)||0||
48538532|NCT05384171|101655270|FG000|COMPLETED|Overall Study||15|completed both baseline and follow-up|
48538533|NCT05384171|101655271|FG001|COMPLETED|Overall Study||10|completed both baseline and follow-up|
48538534|NCT05384171|101655270|FG000|NOT COMPLETED|Overall Study||12||
48538535|NCT05384171|101655271|FG001|NOT COMPLETED|Overall Study||9||
48538536|NCT05162014|101655272|FG000|STARTED|Overall Study||72661||
48538537|NCT05162014|101655273|FG001|STARTED|Overall Study||422018||
48538538|NCT05162014|101655272|FG000|Pooled- PS Matched|Overall Study||72621|Matched on propensity scores|
48538539|NCT05162014|101655273|FG001|Pooled- PS Matched|Overall Study||72621|Matched on propensity scores|
48538540|NCT05162014|101655272|FG000|COMPLETED|Overall Study||72661||
48673764|NCT01005290|101985862|FG001|COMPLETED|Washout Period (2 Weeks)||13||
48673765|NCT01005290|101985863|FG002|COMPLETED|Washout Period (2 Weeks)||9||
48673766|NCT01005290|101985861|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0||
48673767|NCT01005290|101985862|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0||
48673768|NCT01005290|101985863|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0||
48673769|NCT01005290|101985861|FG000|STARTED|Period 2 (5 Weeks)||0||
48673770|NCT01005290|101985862|FG001|STARTED|Period 2 (5 Weeks)||13||
48673771|NCT01005290|101985863|FG002|STARTED|Period 2 (5 Weeks)||9||
48673772|NCT01005290|101985861|FG000|COMPLETED|Period 2 (5 Weeks)||0||
48673773|NCT01005290|101985862|FG001|COMPLETED|Period 2 (5 Weeks)||13||
48673774|NCT01005290|101985863|FG002|COMPLETED|Period 2 (5 Weeks)||7||
48673775|NCT01005290|101985861|FG000|NOT COMPLETED|Period 2 (5 Weeks)||0||
48237327|NCT03444298|100902955|FG000|COMPLETED|Washout (>/= 4 Weeks)||4||
48237328|NCT03444298|100902956|FG001|COMPLETED|Washout (>/= 4 Weeks)||7||
48237329|NCT03444298|100902955|FG000|NOT COMPLETED|Washout (>/= 4 Weeks)||3||
48237330|NCT03444298|100902956|FG001|NOT COMPLETED|Washout (>/= 4 Weeks)||2||
48237331|NCT03444298|100902955|FG000|STARTED|Period 2 (Dosing Followed by Exposure)||4||
48237332|NCT03444298|100902956|FG001|STARTED|Period 2 (Dosing Followed by Exposure)||7||
48237333|NCT03444298|100902955|FG000|COMPLETED|Period 2 (Dosing Followed by Exposure)||4||
48538541|NCT05162014|101655273|FG001|COMPLETED|Overall Study||422018||
48538542|NCT05162014|101655272|FG000|NOT COMPLETED|Overall Study||0||
48538543|NCT05162014|101655273|FG001|NOT COMPLETED|Overall Study||0||
48538544|NCT00642278|101655274|FG000|STARTED|Overall Study||65||
48538545|NCT00642278|101655275|FG001|STARTED|Overall Study||64||
48538546|NCT00642278|101655276|FG002|STARTED|Overall Study||64||
48538547|NCT00642278|101655277|FG003|STARTED|Overall Study||65||
48673776|NCT01005290|101985862|FG001|NOT COMPLETED|Period 2 (5 Weeks)||0||
48673777|NCT01005290|101985863|FG002|NOT COMPLETED|Period 2 (5 Weeks)||2||
48673778|NCT02284191|101985864|FG000|STARTED|Overall Study||877||
48673779|NCT02284191|101985865|FG001|STARTED|Overall Study||871||
48673780|NCT02284191|101985864|FG000|COMPLETED|Overall Study||875||
48673781|NCT02284191|101985865|FG001|COMPLETED|Overall Study||868||
48673782|NCT02284191|101985864|FG000|NOT COMPLETED|Overall Study||2||
48237334|NCT03444298|100902956|FG001|COMPLETED|Period 2 (Dosing Followed by Exposure)||7||
48538548|NCT00642278|101655278|FG004|STARTED|Overall Study||64||
48538549|NCT00642278|101655279|FG005|STARTED|Overall Study||64||
48538550|NCT00642278|101655280|FG006|STARTED|Overall Study||65||
48538551|NCT00642278|101655274|FG000|COMPLETED|Overall Study||55||
48538552|NCT00642278|101655275|FG001|COMPLETED|Overall Study||59||
48673783|NCT02284191|101985865|FG001|NOT COMPLETED|Overall Study||3||
48673784|NCT01214837|101985866|FG000|STARTED|Overall Study||249||
48673785|NCT01214837|101985867|FG001|STARTED|Overall Study||256||
48673786|NCT01214837|101985868|FG002|STARTED|Overall Study||246||
48673787|NCT01214837|101985866|FG000|COMPLETED|Overall Study||195||
48673788|NCT01214837|101985867|FG001|COMPLETED|Overall Study||192||
48237335|NCT03444298|100902955|FG000|NOT COMPLETED|Period 2 (Dosing Followed by Exposure)||0||
48237336|NCT03444298|100902956|FG001|NOT COMPLETED|Period 2 (Dosing Followed by Exposure)||0||
48237337|NCT00535626|100902957|FG000|STARTED|Overall Study||190||193
48237338|NCT00535626|100902957|FG000|COMPLETED|Overall Study||85||86
48237339|NCT00535626|100902957|FG000|NOT COMPLETED|Overall Study||105||107
48237340|NCT04405089|100902958|FG000|STARTED|Overall Study||15||
48237341|NCT04405089|100902959|FG001|STARTED|Overall Study||16||
48237342|NCT04405089|100902958|FG000|COMPLETED|Overall Study||8||
48237343|NCT04405089|100902959|FG001|COMPLETED|Overall Study||9||
48237344|NCT04405089|100902958|FG000|NOT COMPLETED|Overall Study||7||
48237345|NCT04405089|100902959|FG001|NOT COMPLETED|Overall Study||7||
48237346|NCT00515879|100902960|FG000|STARTED|Overall Study||87||
48237347|NCT00515879|100902961|FG001|STARTED|Overall Study||82||
48237348|NCT00515879|100902960|FG000|COMPLETED|Overall Study||62||
48237349|NCT00515879|100902961|FG001|COMPLETED|Overall Study||62||
48237350|NCT00515879|100902960|FG000|NOT COMPLETED|Overall Study||25||
48237351|NCT00515879|100902961|FG001|NOT COMPLETED|Overall Study||20||
48237352|NCT01074229|100902962|FG000|STARTED|Overall Study||25||
48237353|NCT01074229|100902963|FG001|STARTED|Overall Study||25||
48237354|NCT01074229|100902964|FG002|STARTED|Overall Study||25||
48538553|NCT00642278|101655276|FG002|COMPLETED|Overall Study||59||
48538554|NCT00642278|101655277|FG003|COMPLETED|Overall Study||56||
48538555|NCT00642278|101655278|FG004|COMPLETED|Overall Study||56||
48538556|NCT00642278|101655279|FG005|COMPLETED|Overall Study||57||
48538557|NCT00642278|101655280|FG006|COMPLETED|Overall Study||60||
48538558|NCT00642278|101655274|FG000|NOT COMPLETED|Overall Study||10||
48538559|NCT00642278|101655275|FG001|NOT COMPLETED|Overall Study||5||
48538560|NCT00642278|101655276|FG002|NOT COMPLETED|Overall Study||5||
48538561|NCT00642278|101655277|FG003|NOT COMPLETED|Overall Study||9||
48538562|NCT00642278|101655278|FG004|NOT COMPLETED|Overall Study||8||
48538563|NCT00642278|101655279|FG005|NOT COMPLETED|Overall Study||7||
48538564|NCT00642278|101655280|FG006|NOT COMPLETED|Overall Study||5||
48538565|NCT00790335|101655281|FG000|STARTED|Overall Study||337||
48538566|NCT00790335|101655282|FG001|STARTED|Overall Study||355||
48538567|NCT00790335|101655281|FG000|COMPLETED|Overall Study||257||
48538568|NCT00790335|101655282|FG001|COMPLETED|Overall Study||243||
48538569|NCT00790335|101655281|FG000|NOT COMPLETED|Overall Study||80||
48538570|NCT00790335|101655282|FG001|NOT COMPLETED|Overall Study||112||
48538571|NCT02151877|101655283|FG000|STARTED|Overall Study||12||
48538572|NCT02151877|101655284|FG001|STARTED|Overall Study||12||
48538573|NCT02151877|101655283|FG000|COMPLETED|Overall Study||12||
48538574|NCT02151877|101655284|FG001|COMPLETED|Overall Study||12||
48538575|NCT02151877|101655283|FG000|NOT COMPLETED|Overall Study||0||
48538576|NCT02151877|101655284|FG001|NOT COMPLETED|Overall Study||0||
48538577|NCT00127218|101655285|FG000|STARTED|Overall Study||72||
48538578|NCT00127218|101655286|FG001|STARTED|Overall Study||73||
48538579|NCT00127218|101655285|FG000|COMPLETED|Overall Study||59||
48538580|NCT00127218|101655286|FG001|COMPLETED|Overall Study||58||
48538581|NCT00127218|101655285|FG000|NOT COMPLETED|Overall Study||13||
48538582|NCT00127218|101655286|FG001|NOT COMPLETED|Overall Study||15||
48538583|NCT04820530|101655287|FG000|STARTED|Core Treatment Period||40||
48538584|NCT04820530|101655287|FG000|COMPLETED|Core Treatment Period||40||
48538585|NCT04820530|101655287|FG000|NOT COMPLETED|Core Treatment Period||0||
48538586|NCT04820530|101655287|FG000|STARTED|Extension Treatment Period||40||
48538587|NCT04820530|101655287|FG000|COMPLETED|Extension Treatment Period||40||
48538588|NCT04820530|101655287|FG000|NOT COMPLETED|Extension Treatment Period||0||
48538589|NCT04241315|101655288|FG000|STARTED|Overall Study||100||
48538590|NCT04241315|101655289|FG001|STARTED|Overall Study||12||
48538591|NCT04241315|101655288|FG000|COMPLETED|Overall Study||100||
48538592|NCT04241315|101655289|FG001|COMPLETED|Overall Study||11||
48538593|NCT04241315|101655288|FG000|NOT COMPLETED|Overall Study||0||
48538594|NCT04241315|101655289|FG001|NOT COMPLETED|Overall Study||1||
48538595|NCT04181723|101655290|FG000|STARTED|Overall Study||93||
48538596|NCT04181723|101655291|FG001|STARTED|Overall Study||94||
48538597|NCT04181723|101655290|FG000|COMPLETED|Overall Study||70||
48538598|NCT04181723|101655291|FG001|COMPLETED|Overall Study||85||
48538599|NCT04181723|101655290|FG000|NOT COMPLETED|Overall Study||23||
48538600|NCT04181723|101655291|FG001|NOT COMPLETED|Overall Study||9||
48538601|NCT03480386|101655292|FG000|STARTED|Overall Study||188||
48538602|NCT03480386|101655293|FG001|STARTED|Overall Study||187||
48538603|NCT03480386|101655292|FG000|COMPLETED|Overall Study||143||
48538604|NCT03480386|101655293|FG001|COMPLETED|Overall Study||142||
48538605|NCT03480386|101655292|FG000|NOT COMPLETED|Overall Study||45||
48538606|NCT03480386|101655293|FG001|NOT COMPLETED|Overall Study||45||
48538607|NCT01987479|101655294|FG000|STARTED|Overall Study||150||
48538608|NCT01987479|101655294|FG000|COMPLETED|Overall Study||133||
48538609|NCT01987479|101655294|FG000|NOT COMPLETED|Overall Study||17||
48538610|NCT02358135|101655295|FG000|STARTED|Overall Study||150||
48538611|NCT02358135|101655296|FG001|STARTED|Overall Study||150||
48538612|NCT02358135|101655295|FG000|Randomized|Overall Study||148||
48538613|NCT02358135|101655296|FG001|Randomized|Overall Study||148||
48538614|NCT02358135|101655295|FG000|COMPLETED|Overall Study||135||
48538615|NCT02358135|101655296|FG001|COMPLETED|Overall Study||131||
48538616|NCT02358135|101655295|FG000|NOT COMPLETED|Overall Study||15||
48237355|NCT01074229|100902962|FG000|COMPLETED|Overall Study||23||
48237356|NCT01074229|100902963|FG001|COMPLETED|Overall Study||22||
48237357|NCT01074229|100902964|FG002|COMPLETED|Overall Study||21||
48237358|NCT01074229|100902962|FG000|NOT COMPLETED|Overall Study||2||
48237359|NCT01074229|100902963|FG001|NOT COMPLETED|Overall Study||3||
48237360|NCT01074229|100902964|FG002|NOT COMPLETED|Overall Study||4||
48237361|NCT00318591|100902965|FG000|STARTED|Overall Study||105||
48237362|NCT00318591|100902966|FG001|STARTED|Overall Study||114||
48237363|NCT00318591|100902965|FG000|COMPLETED|Overall Study||45||
48237364|NCT00318591|100902966|FG001|COMPLETED|Overall Study||69||
48237365|NCT00318591|100902965|FG000|NOT COMPLETED|Overall Study||60||
48237366|NCT00318591|100902966|FG001|NOT COMPLETED|Overall Study||45||
48237367|NCT01911819|100902967|FG000|STARTED|Overall Study||10||10
48237368|NCT01911819|100902968|FG001|STARTED|Overall Study||11||11
48237369|NCT01911819|100902969|FG002|STARTED|Overall Study||10||10
48237370|NCT01911819|100902967|FG000|COMPLETED|Overall Study||9||9
48237371|NCT01911819|100902968|FG001|COMPLETED|Overall Study||9||9
48237372|NCT01911819|100902969|FG002|COMPLETED|Overall Study||10||10
48237373|NCT01911819|100902967|FG000|NOT COMPLETED|Overall Study||1||1
48237374|NCT01911819|100902968|FG001|NOT COMPLETED|Overall Study||2||2
48237375|NCT01911819|100902969|FG002|NOT COMPLETED|Overall Study||0||0
48237376|NCT04785794|100902970|FG000|STARTED|Overall Study||10||
48237377|NCT04785794|100902971|FG001|STARTED|Overall Study||5||
48538617|NCT02358135|101655296|FG001|NOT COMPLETED|Overall Study||19||
48538618|NCT01110135|101655297|FG000|STARTED|Overall Study||43||
48538619|NCT01110135|101655297|FG000|COMPLETED|Overall Study||34||
48538620|NCT01110135|101655297|FG000|NOT COMPLETED|Overall Study||9||
48538621|NCT03760185|101655298|FG000|STARTED|Overall Study||13||13
48538622|NCT03760185|101655299|FG001|STARTED|Overall Study||13||13
48673789|NCT01214837|101985868|FG002|COMPLETED|Overall Study||184||
48673790|NCT01214837|101985866|FG000|NOT COMPLETED|Overall Study||54||
48673791|NCT01214837|101985867|FG001|NOT COMPLETED|Overall Study||64||
48673792|NCT01214837|101985868|FG002|NOT COMPLETED|Overall Study||62||
48673793|NCT01681147|101985869|FG000|STARTED|Overall Study||10||
48673794|NCT01681147|101985870|FG001|STARTED|Overall Study||8||
48673795|NCT01681147|101985871|FG002|STARTED|Overall Study||12||
48673796|NCT01681147|101985869|FG000|Baseline|Overall Study||9||
48673797|NCT01681147|101985870|FG001|Baseline|Overall Study||7||
48673798|NCT01681147|101985871|FG002|Baseline|Overall Study||10||
48673799|NCT01681147|101985869|FG000|3 Months|Overall Study||8||
48673800|NCT01681147|101985870|FG001|3 Months|Overall Study||5||
48673801|NCT01681147|101985871|FG002|3 Months|Overall Study||8||
48673802|NCT01681147|101985869|FG000|6 Months|Overall Study||7||
48673803|NCT01681147|101985870|FG001|6 Months|Overall Study||6||
48673804|NCT01681147|101985871|FG002|6 Months|Overall Study||7||
48673805|NCT01681147|101985869|FG000|9 Months|Overall Study||7||
48673806|NCT01681147|101985870|FG001|9 Months|Overall Study||5||
48673807|NCT01681147|101985871|FG002|9 Months|Overall Study||6||
48673808|NCT01681147|101985869|FG000|12 Months|Overall Study||5||
48673809|NCT01681147|101985870|FG001|12 Months|Overall Study||4||
48673810|NCT01681147|101985871|FG002|12 Months|Overall Study||5||
48673811|NCT01681147|101985869|FG000|COMPLETED|Overall Study||0||
48673812|NCT01681147|101985870|FG001|COMPLETED|Overall Study||0||
48673813|NCT01681147|101985871|FG002|COMPLETED|Overall Study||1||
48673814|NCT01681147|101985869|FG000|NOT COMPLETED|Overall Study||10||
48673815|NCT01681147|101985870|FG001|NOT COMPLETED|Overall Study||8||
48237378|NCT04785794|100902972|FG002|STARTED|Overall Study||70||
48237379|NCT04785794|100902973|FG003|STARTED|Overall Study||37||
48237380|NCT04785794|100902970|FG000|COMPLETED|Overall Study||9||
48237381|NCT04785794|100902971|FG001|COMPLETED|Overall Study||5||
48237382|NCT04785794|100902972|FG002|COMPLETED|Overall Study||67||
48237383|NCT04785794|100902973|FG003|COMPLETED|Overall Study||37||
48237384|NCT04785794|100902970|FG000|NOT COMPLETED|Overall Study||1||
48237385|NCT04785794|100902971|FG001|NOT COMPLETED|Overall Study||0||
48237386|NCT04785794|100902972|FG002|NOT COMPLETED|Overall Study||3||
48237387|NCT04785794|100902973|FG003|NOT COMPLETED|Overall Study||0||
48237388|NCT04783389|100902974|FG000|STARTED|Overall Study||13||
48538623|NCT03760185|101655298|FG000|COMPLETED|Overall Study||12||12
48538624|NCT03760185|101655299|FG001|COMPLETED|Overall Study||12||12
48538625|NCT03760185|101655298|FG000|NOT COMPLETED|Overall Study||1||1
48538626|NCT03760185|101655299|FG001|NOT COMPLETED|Overall Study||1||1
48538627|NCT03276078|101655300|FG000|STARTED|Overall Study||20||
48538628|NCT03276078|101655300|FG000|COMPLETED|Overall Study||19||
48538629|NCT03276078|101655300|FG000|NOT COMPLETED|Overall Study||1||
48538630|NCT02227446|101655301|FG000|STARTED|Overall Study||521||
48538631|NCT02227446|101655302|FG001|STARTED|Overall Study||515||
48538632|NCT02227446|101655301|FG000|COMPLETED|Overall Study||499||
48538633|NCT02227446|101655302|FG001|COMPLETED|Overall Study||481||
48538634|NCT02227446|101655301|FG000|NOT COMPLETED|Overall Study||22||
48538635|NCT02227446|101655302|FG001|NOT COMPLETED|Overall Study||34||
48673816|NCT01681147|101985871|FG002|NOT COMPLETED|Overall Study||11||
48673817|NCT00448448|101985872|FG000|STARTED|Overall Study||246||
48673818|NCT00448448|101985873|FG001|STARTED|Overall Study||137||
48538636|NCT01812681|101655303|FG000|STARTED|Overall Study||60||
48673819|NCT00448448|101985872|FG000|COMPLETED|Overall Study||146||
48673820|NCT00448448|101985873|FG001|COMPLETED|Overall Study||96||
48673821|NCT00448448|101985872|FG000|NOT COMPLETED|Overall Study||100||
48673822|NCT00448448|101985873|FG001|NOT COMPLETED|Overall Study||41||
48673823|NCT05130593|101985874|FG000|STARTED|Overall Study||10||
48673824|NCT05130593|101985875|FG001|STARTED|Overall Study||10||
48673825|NCT05130593|101985874|FG000|COMPLETED|Overall Study||10||
48673826|NCT05130593|101985875|FG001|COMPLETED|Overall Study||10||
48673827|NCT05130593|101985874|FG000|NOT COMPLETED|Overall Study||0||
48673828|NCT05130593|101985875|FG001|NOT COMPLETED|Overall Study||0||
48237389|NCT04783389|100902975|FG001|STARTED|Overall Study||13||
48237390|NCT04783389|100902976|FG002|STARTED|Overall Study||14||
48237391|NCT04783389|100902974|FG000|COMPLETED|Overall Study||1||
48237392|NCT04783389|100902975|FG001|COMPLETED|Overall Study||1||
48237393|NCT04783389|100902976|FG002|COMPLETED|Overall Study||0||
48237394|NCT04783389|100902974|FG000|NOT COMPLETED|Overall Study||12||
48237395|NCT04783389|100902975|FG001|NOT COMPLETED|Overall Study||12||
48237396|NCT04783389|100902976|FG002|NOT COMPLETED|Overall Study||14||
48237397|NCT03906240|100902977|FG000|STARTED|Overall Study||24||
48237398|NCT03906240|100902978|FG001|STARTED|Overall Study||24||
48237399|NCT03906240|100902977|FG000|COMPLETED|Overall Study||19|Participants who completed greater than 4 out of 8 sessions were considered to have completed the intervention.|
48237400|NCT03906240|100902978|FG001|COMPLETED|Overall Study||23|Participants who completed greater than 4 out of 8 sessions were considered to have completed the intervention.|
48237401|NCT03906240|100902977|FG000|NOT COMPLETED|Overall Study||5||
48237402|NCT03906240|100902978|FG001|NOT COMPLETED|Overall Study||1||
48237403|NCT01180400|100902979|FG000|STARTED|Overall Study||147||
48237404|NCT01180400|100902980|FG001|STARTED|Overall Study||148||
48237405|NCT01180400|100902979|FG000|Received Treatment|Overall Study||147||
48237406|NCT01180400|100902980|FG001|Received Treatment|Overall Study||146||
48237407|NCT01180400|100902979|FG000|COMPLETED|Overall Study||122||
48237408|NCT01180400|100902980|FG001|COMPLETED|Overall Study||121||
48237409|NCT01180400|100902979|FG000|NOT COMPLETED|Overall Study||25||
48237410|NCT01180400|100902980|FG001|NOT COMPLETED|Overall Study||27||
48237411|NCT03840278|100902981|FG000|STARTED|Overall Study||5||
48538637|NCT01812681|101655304|FG001|STARTED|Overall Study||24||
48538638|NCT01812681|101655303|FG000|COMPLETED|Overall Study||57||
48538639|NCT01812681|101655304|FG001|COMPLETED|Overall Study||24||
48538640|NCT01812681|101655303|FG000|NOT COMPLETED|Overall Study||3||
48237412|NCT03840278|100902982|FG001|STARTED|Overall Study||5||
48237413|NCT03840278|100902981|FG000|COMPLETED|Overall Study||5|This is a crossover study. All subjects will participate in both arms.|
48237414|NCT03840278|100902982|FG001|COMPLETED|Overall Study||5|This is a crossover study. All subjects will participate in both arms.|
48237415|NCT03840278|100902981|FG000|NOT COMPLETED|Overall Study||0||
48237416|NCT03840278|100902982|FG001|NOT COMPLETED|Overall Study||0||
48237417|NCT01721109|100902983|FG000|STARTED|Overall Study||50||
48237418|NCT01721109|100902983|FG000|COMPLETED|Overall Study||43||
48237419|NCT01721109|100902983|FG000|NOT COMPLETED|Overall Study||7||
48538641|NCT01812681|101655304|FG001|NOT COMPLETED|Overall Study||0||
48538642|NCT05314816|101655305|FG000|STARTED|Overall Study||159||
48538643|NCT05314816|101655306|FG001|STARTED|Overall Study||221||
48538644|NCT05314816|101655307|FG002|STARTED|Overall Study||99||
48538645|NCT05314816|101655305|FG000|Analyzed in Concurrent Control Group|Overall Study||6|enrolled in intervention, but analyzed in concurrent control group because they did not receive the allocated intervention|
48538646|NCT05314816|101655306|FG001|Analyzed in Concurrent Control Group|Overall Study||0|enrolled in intervention, but analyzed in concurrent control group because they did not receive the allocated intervention|
48538647|NCT05314816|101655307|FG002|Analyzed in Concurrent Control Group|Overall Study||0|enrolled in intervention, but analyzed in concurrent control group because they did not receive the allocated intervention|
48673829|NCT04749914|101985876|FG000|STARTED|Period 1||66||
48237420|NCT02135445|100902984|FG000|STARTED|Overall Study||65||
48237421|NCT02135445|100902985|FG001|STARTED|Overall Study||38||
48237422|NCT02135445|100902984|FG000|COMPLETED|Overall Study||63||
48237423|NCT02135445|100902985|FG001|COMPLETED|Overall Study||38||
48237424|NCT02135445|100902984|FG000|NOT COMPLETED|Overall Study||2||
48237425|NCT02135445|100902985|FG001|NOT COMPLETED|Overall Study||0||
48538648|NCT05314816|101655305|FG000|COMPLETED|Overall Study||141||
48538649|NCT05314816|101655306|FG001|COMPLETED|Overall Study||213||
48538650|NCT05314816|101655307|FG002|COMPLETED|Overall Study||98||
48538651|NCT05314816|101655305|FG000|NOT COMPLETED|Overall Study||18||
48538652|NCT05314816|101655306|FG001|NOT COMPLETED|Overall Study||8||
48538653|NCT05314816|101655307|FG002|NOT COMPLETED|Overall Study||1||
48538654|NCT04058067|101655308|FG000|STARTED|Overall Study||132||
48538655|NCT04058067|101655309|FG001|STARTED|Overall Study||131||
48538656|NCT04058067|101655308|FG000|COMPLETED|Overall Study||120||
48538657|NCT04058067|101655309|FG001|COMPLETED|Overall Study||120||
48673830|NCT04749914|101985877|FG001|STARTED|Period 1||0||
48673831|NCT04749914|101985878|FG002|STARTED|Period 1||31||
48673832|NCT04749914|101985879|FG003|STARTED|Period 1||0||
48673833|NCT04749914|101985876|FG000|Received at Least One Dose of Study Drug|Period 1||66||
48673834|NCT04749914|101985877|FG001|Received at Least One Dose of Study Drug|Period 1||0||
48673835|NCT04749914|101985878|FG002|Received at Least One Dose of Study Drug|Period 1||30||
48673836|NCT04749914|101985879|FG003|Received at Least One Dose of Study Drug|Period 1||0||
48237426|NCT04623996|100902986|FG000|STARTED|Overall Study||2||
48237427|NCT04623996|100902987|FG001|STARTED|Overall Study||0||
48237428|NCT04623996|100902986|FG000|COMPLETED|Overall Study||2||
48237429|NCT04623996|100902987|FG001|COMPLETED|Overall Study||0||
48237430|NCT04623996|100902986|FG000|NOT COMPLETED|Overall Study||0||
48237431|NCT04623996|100902987|FG001|NOT COMPLETED|Overall Study||0||
48237432|NCT03720717|100902988|FG000|STARTED|Overall Study||5|Enrollment for all four groups of the study started on October 27, 2020. Study occurred during a single 24 hour period. Code was broken at midpoint analysis identifying specific groups|
48237433|NCT03720717|100902989|FG001|STARTED|Overall Study||7|Enrollment for all four groups of the study started on October 27, 2020. Study occurred during a single 24 hour period. Code was broken at midpoint analysis identifying specific groups|
48237434|NCT03720717|100902990|FG002|STARTED|Overall Study||12|Enrollment for all four groups of the study started on October 27, 2020. Study occurred during a single 24 hour period. Code was broken at midpoint analysis identifying specific groups|
48237435|NCT03720717|100902991|FG003|STARTED|Overall Study||10|Enrollment for all four groups of the study started on October 27, 2020. Study occurred during a single 24 hour period. Code was broken at midpoint analysis identifying specific groups|
48237436|NCT03720717|100902988|FG000|COMPLETED|Overall Study||5||
48237437|NCT03720717|100902989|FG001|COMPLETED|Overall Study||7||
48237438|NCT03720717|100902990|FG002|COMPLETED|Overall Study||12||
48237439|NCT03720717|100902991|FG003|COMPLETED|Overall Study||10||
48237440|NCT03720717|100902988|FG000|NOT COMPLETED|Overall Study||0||
48237441|NCT03720717|100902989|FG001|NOT COMPLETED|Overall Study||0||
48237442|NCT03720717|100902990|FG002|NOT COMPLETED|Overall Study||0||
48237443|NCT03720717|100902991|FG003|NOT COMPLETED|Overall Study||0||
48237444|NCT03075449|100902992|FG000|STARTED|Overall Study||170||
48237445|NCT03075449|100902992|FG000|COMPLETED|Overall Study||170||
48237446|NCT03075449|100902992|FG000|NOT COMPLETED|Overall Study||0||
48237447|NCT01426217|100902993|FG000|STARTED|Overall Study||314||
48237448|NCT01426217|100902994|FG001|STARTED|Overall Study||280||
48237449|NCT01426217|100902993|FG000|COMPLETED|Overall Study||306||
48237450|NCT01426217|100902994|FG001|COMPLETED|Overall Study||266||
48237451|NCT01426217|100902993|FG000|NOT COMPLETED|Overall Study||8||
48237452|NCT01426217|100902994|FG001|NOT COMPLETED|Overall Study||14||
48237453|NCT00942188|100902995|FG000|STARTED|Overall Study||26||
48237454|NCT00942188|100902996|FG001|STARTED|Overall Study||26||
48237455|NCT00942188|100902997|FG002|STARTED|Overall Study||27||
48237456|NCT00942188|100902998|FG003|STARTED|Overall Study||27||
48237457|NCT00942188|100902995|FG000|COMPLETED|Overall Study||22||
48237458|NCT00942188|100902996|FG001|COMPLETED|Overall Study||16||
48237459|NCT00942188|100902997|FG002|COMPLETED|Overall Study||18||
48237460|NCT00942188|100902998|FG003|COMPLETED|Overall Study||23||
48237461|NCT00942188|100902995|FG000|NOT COMPLETED|Overall Study||4||
48237462|NCT00942188|100902996|FG001|NOT COMPLETED|Overall Study||10||
48237463|NCT00942188|100902997|FG002|NOT COMPLETED|Overall Study||9||
48237464|NCT00942188|100902998|FG003|NOT COMPLETED|Overall Study||4||
48237465|NCT01280656|100902999|FG000|STARTED|Overall Study||62||
48237466|NCT01280656|100903000|FG001|STARTED|Overall Study||312||
48237467|NCT01280656|100903001|FG002|STARTED|Overall Study||286||
48237468|NCT01280656|100902999|FG000|COMPLETED|Overall Study||59||
48237469|NCT01280656|100903000|FG001|COMPLETED|Overall Study||265||
48237470|NCT01280656|100903001|FG002|COMPLETED|Overall Study||223||
48237471|NCT01280656|100902999|FG000|NOT COMPLETED|Overall Study||3||
48237472|NCT01280656|100903000|FG001|NOT COMPLETED|Overall Study||47||
48237473|NCT01280656|100903001|FG002|NOT COMPLETED|Overall Study||63||
48237474|NCT01755598|100903002|FG000|STARTED|Overall Study||1786||
48237475|NCT01755598|100903003|FG001|STARTED|Overall Study||1787||
48237476|NCT01755598|100903002|FG000|COMPLETED|Overall Study||1521||
48237477|NCT01755598|100903003|FG001|COMPLETED|Overall Study||1504||
48237478|NCT01755598|100903002|FG000|NOT COMPLETED|Overall Study||265||
48237479|NCT01755598|100903003|FG001|NOT COMPLETED|Overall Study||283||
48237480|NCT01894620|100903004|FG000|STARTED|Overall Study||6||
48237481|NCT01894620|100903005|FG001|STARTED|Overall Study||5||
48237482|NCT01894620|100903004|FG000|COMPLETED|Overall Study||6||
48237483|NCT01894620|100903005|FG001|COMPLETED|Overall Study||4||
48237484|NCT01894620|100903004|FG000|NOT COMPLETED|Overall Study||0||
48237485|NCT01894620|100903005|FG001|NOT COMPLETED|Overall Study||1||
48237486|NCT00578929|100903006|FG000|STARTED|Vehicle Run-In Period||0||
48237487|NCT00578929|100903007|FG001|STARTED|Vehicle Run-In Period||2388||
48237488|NCT00578929|100903008|FG002|STARTED|Vehicle Run-In Period||0||
48237489|NCT00578929|100903009|FG003|STARTED|Vehicle Run-In Period||0||
48237490|NCT00578929|100903006|FG000|COMPLETED|Vehicle Run-In Period||0||
48237491|NCT00578929|100903007|FG001|COMPLETED|Vehicle Run-In Period||2388||
48237492|NCT00578929|100903008|FG002|COMPLETED|Vehicle Run-In Period||0||
48237493|NCT00578929|100903009|FG003|COMPLETED|Vehicle Run-In Period||0||
48237494|NCT00578929|100903006|FG000|NOT COMPLETED|Vehicle Run-In Period||0||
48237495|NCT00578929|100903007|FG001|NOT COMPLETED|Vehicle Run-In Period||0||
48237496|NCT00578929|100903008|FG002|NOT COMPLETED|Vehicle Run-In Period||0||
48237497|NCT00578929|100903009|FG003|NOT COMPLETED|Vehicle Run-In Period||0||
48237498|NCT00578929|100903006|FG000|STARTED|Randomized Period||298||
48237499|NCT00578929|100903007|FG001|STARTED|Randomized Period||297||
48237500|NCT00578929|100903008|FG002|STARTED|Randomized Period||296||
48237501|NCT00578929|100903009|FG003|STARTED|Randomized Period||297||
48237502|NCT00578929|100903006|FG000|COMPLETED|Randomized Period||281||
48237503|NCT00578929|100903007|FG001|COMPLETED|Randomized Period||283||
48237504|NCT00578929|100903008|FG002|COMPLETED|Randomized Period||288||
48237505|NCT00578929|100903009|FG003|COMPLETED|Randomized Period||283||
48237506|NCT00578929|100903006|FG000|NOT COMPLETED|Randomized Period||17||
48237507|NCT00578929|100903007|FG001|NOT COMPLETED|Randomized Period||14||
48237508|NCT00578929|100903008|FG002|NOT COMPLETED|Randomized Period||8||
48237509|NCT00578929|100903009|FG003|NOT COMPLETED|Randomized Period||14||
48237510|NCT01301183|100903010|FG000|STARTED|Overall Study||38||
48237511|NCT01301183|100903011|FG001|STARTED|Overall Study||37||
48237512|NCT01301183|100903010|FG000|COMPLETED|Overall Study||12||
48237513|NCT01301183|100903011|FG001|COMPLETED|Overall Study||21||
48237514|NCT01301183|100903010|FG000|NOT COMPLETED|Overall Study||26||
48237515|NCT01301183|100903011|FG001|NOT COMPLETED|Overall Study||16||
48237516|NCT01261793|100903012|FG000|STARTED|Overall Study||263||
48237517|NCT01261793|100903013|FG001|STARTED|Overall Study||262||
48237518|NCT01261793|100903014|FG002|STARTED|Overall Study||266||
48237519|NCT01261793|100903012|FG000|COMPLETED|Overall Study||178||
48237520|NCT01261793|100903013|FG001|COMPLETED|Overall Study||171||
48237521|NCT01261793|100903014|FG002|COMPLETED|Overall Study||184||
48237522|NCT01261793|100903012|FG000|NOT COMPLETED|Overall Study||85||
48237523|NCT01261793|100903013|FG001|NOT COMPLETED|Overall Study||91||
48237524|NCT01261793|100903014|FG002|NOT COMPLETED|Overall Study||82||
48237525|NCT00215943|100903015|FG000|STARTED|Overall Study||36||
48237526|NCT00215943|100903016|FG001|STARTED|Overall Study||37||
48237527|NCT00215943|100903015|FG000|COMPLETED|Overall Study||27||
48237528|NCT00215943|100903016|FG001|COMPLETED|Overall Study||23||
48237529|NCT00215943|100903015|FG000|NOT COMPLETED|Overall Study||9||
48237530|NCT00215943|100903016|FG001|NOT COMPLETED|Overall Study||14||
48237531|NCT04179799|100903017|FG000|STARTED|Overall Study||6||
48237532|NCT04179799|100903017|FG000|COMPLETED|Overall Study||6||
48237533|NCT04179799|100903017|FG000|NOT COMPLETED|Overall Study||0||
48237534|NCT04743999|100903018|FG000|STARTED|Baseline Questionnaire||9||
48237535|NCT04743999|100903018|FG000|COMPLETED|Baseline Questionnaire||9||
48237536|NCT04743999|100903018|FG000|NOT COMPLETED|Baseline Questionnaire||0||
48237537|NCT04743999|100903018|FG000|STARTED|3-month Questionnaire||9||
48237538|NCT04743999|100903018|FG000|COMPLETED|3-month Questionnaire||8||
48237539|NCT04743999|100903018|FG000|NOT COMPLETED|3-month Questionnaire||1||
48237540|NCT04743999|100903018|FG000|STARTED|6-month Questionnaire||8||
48237541|NCT04743999|100903018|FG000|COMPLETED|6-month Questionnaire||7||
48237542|NCT04743999|100903018|FG000|NOT COMPLETED|6-month Questionnaire||1||
48237543|NCT04743999|100903018|FG000|STARTED|12-month Questionnaire||7||
48237544|NCT04743999|100903018|FG000|COMPLETED|12-month Questionnaire||6||
48237545|NCT04743999|100903018|FG000|NOT COMPLETED|12-month Questionnaire||1||
48237546|NCT04743999|100903018|FG000|STARTED|24-month Questionnaire||6||
48237547|NCT04743999|100903018|FG000|COMPLETED|24-month Questionnaire||1||
48237548|NCT04743999|100903018|FG000|NOT COMPLETED|24-month Questionnaire||5||
48237549|NCT00135226|100903019|FG000|STARTED|Overall Study||3870||
48237550|NCT00135226|100903020|FG001|STARTED|Overall Study||3870||
48237551|NCT00135226|100903021|FG002|STARTED|Overall Study||3870||
48237552|NCT00135226|100903022|FG003|STARTED|Overall Study||3870||
48237553|NCT00135226|100903019|FG000|COMPLETED|Overall Study||3836||
48237554|NCT00135226|100903020|FG001|COMPLETED|Overall Study||3835||
48237555|NCT00135226|100903021|FG002|COMPLETED|Overall Study||3836||
48237556|NCT00135226|100903022|FG003|COMPLETED|Overall Study||3834||
48237557|NCT00135226|100903019|FG000|NOT COMPLETED|Overall Study||34||
48237558|NCT00135226|100903020|FG001|NOT COMPLETED|Overall Study||35||
48237559|NCT00135226|100903021|FG002|NOT COMPLETED|Overall Study||34||
48237560|NCT00135226|100903022|FG003|NOT COMPLETED|Overall Study||36||
48237561|NCT02637999|100903023|FG000|STARTED|Overall Study||8||
48237562|NCT02637999|100903024|FG001|STARTED|Overall Study||8||
48237563|NCT02637999|100903025|FG002|STARTED|Overall Study||8||
48673837|NCT04749914|101985876|FG000|COMPLETED|Period 1||64||
48673838|NCT04749914|101985877|FG001|COMPLETED|Period 1||0||
48673839|NCT04749914|101985878|FG002|COMPLETED|Period 1||30||
48673840|NCT04749914|101985879|FG003|COMPLETED|Period 1||0||
48673841|NCT04749914|101985876|FG000|NOT COMPLETED|Period 1||2||
48673842|NCT04749914|101985877|FG001|NOT COMPLETED|Period 1||0||
48237564|NCT02637999|100903023|FG000|COMPLETED|Overall Study||7||
48237565|NCT02637999|100903024|FG001|COMPLETED|Overall Study||6||
48237566|NCT02637999|100903025|FG002|COMPLETED|Overall Study||6||
48237567|NCT02637999|100903023|FG000|NOT COMPLETED|Overall Study||1||
48237568|NCT02637999|100903024|FG001|NOT COMPLETED|Overall Study||2||
48237569|NCT02637999|100903025|FG002|NOT COMPLETED|Overall Study||2||
48237570|NCT02465866|100903026|FG000|STARTED|Period 1||5||
48673843|NCT04749914|101985878|FG002|NOT COMPLETED|Period 1||1||
48673844|NCT04749914|101985879|FG003|NOT COMPLETED|Period 1||0||
48237571|NCT02465866|100903027|FG001|STARTED|Period 1||5||
48673845|NCT04749914|101985876|FG000|STARTED|Period 2||0||
48673846|NCT04749914|101985877|FG001|STARTED|Period 2||64||
48673847|NCT04749914|101985878|FG002|STARTED|Period 2||0||
48673848|NCT04749914|101985879|FG003|STARTED|Period 2||30||
48237572|NCT02465866|100903028|FG002|STARTED|Period 1||5||
48237573|NCT02465866|100903029|FG003|STARTED|Period 1||5||
48237574|NCT02465866|100903026|FG000|COMPLETED|Period 1||5||
48237575|NCT02465866|100903027|FG001|COMPLETED|Period 1||5||
48237576|NCT02465866|100903028|FG002|COMPLETED|Period 1||5||
48237577|NCT02465866|100903029|FG003|COMPLETED|Period 1||5||
48673849|NCT04749914|101985876|FG000|Received at Least One Dose of Study Drug|Period 2||0||
48673850|NCT04749914|101985877|FG001|Received at Least One Dose of Study Drug|Period 2||64||
48673851|NCT04749914|101985878|FG002|Received at Least One Dose of Study Drug|Period 2||0||
48673852|NCT04749914|101985879|FG003|Received at Least One Dose of Study Drug|Period 2||30||
48673853|NCT04749914|101985876|FG000|COMPLETED|Period 2||0||
48673854|NCT04749914|101985877|FG001|COMPLETED|Period 2||64||
48673855|NCT04749914|101985878|FG002|COMPLETED|Period 2||0||
48673856|NCT04749914|101985879|FG003|COMPLETED|Period 2||30||
48673857|NCT04749914|101985876|FG000|NOT COMPLETED|Period 2||0||
48673858|NCT04749914|101985877|FG001|NOT COMPLETED|Period 2||0||
48673859|NCT04749914|101985878|FG002|NOT COMPLETED|Period 2||0||
48673860|NCT04749914|101985879|FG003|NOT COMPLETED|Period 2||0||
48673861|NCT02135484|101985880|FG000|STARTED|Overall Study||25||
48673862|NCT02135484|101985880|FG000|COMPLETED|Overall Study||25||
48673863|NCT02135484|101985880|FG000|NOT COMPLETED|Overall Study||0||
48673864|NCT03412929|101985881|FG000|STARTED|Overall Study||8||
48673865|NCT03412929|101985881|FG000|COMPLETED|Overall Study||5||
48673866|NCT03412929|101985881|FG000|NOT COMPLETED|Overall Study||3||
48673867|NCT01832727|101985882|FG000|STARTED|Overall Study||9||
48673868|NCT01832727|101985883|FG001|STARTED|Overall Study||7||
48673869|NCT01832727|101985884|FG002|STARTED|Overall Study||3||
48673870|NCT01832727|101985885|FG003|STARTED|Overall Study||4||
48673871|NCT01832727|101985886|FG004|STARTED|Overall Study||4||
48673872|NCT01832727|101985887|FG005|STARTED|Overall Study||6||
48673873|NCT01832727|101985888|FG006|STARTED|Overall Study||8||
48673874|NCT01832727|101985889|FG007|STARTED|Overall Study||6||
48673875|NCT01832727|101985890|FG008|STARTED|Overall Study||18||
48673876|NCT01832727|101985882|FG000|COMPLETED|Overall Study||0||
48673877|NCT01832727|101985883|FG001|COMPLETED|Overall Study||0||
48673878|NCT01832727|101985884|FG002|COMPLETED|Overall Study||0||
48673879|NCT01832727|101985885|FG003|COMPLETED|Overall Study||0||
48673880|NCT01832727|101985886|FG004|COMPLETED|Overall Study||0||
48673881|NCT01832727|101985887|FG005|COMPLETED|Overall Study||0||
48673882|NCT01832727|101985888|FG006|COMPLETED|Overall Study||0||
48673883|NCT01832727|101985889|FG007|COMPLETED|Overall Study||0||
48673884|NCT01832727|101985890|FG008|COMPLETED|Overall Study||0||
48673885|NCT01832727|101985882|FG000|NOT COMPLETED|Overall Study||9||
48673886|NCT01832727|101985883|FG001|NOT COMPLETED|Overall Study||7||
48673887|NCT01832727|101985884|FG002|NOT COMPLETED|Overall Study||3||
48673888|NCT01832727|101985885|FG003|NOT COMPLETED|Overall Study||4||
48673889|NCT01832727|101985886|FG004|NOT COMPLETED|Overall Study||4||
48673890|NCT01832727|101985887|FG005|NOT COMPLETED|Overall Study||6||
48673891|NCT01832727|101985888|FG006|NOT COMPLETED|Overall Study||8||
48673892|NCT01832727|101985889|FG007|NOT COMPLETED|Overall Study||6||
48673893|NCT01832727|101985890|FG008|NOT COMPLETED|Overall Study||18||
48673894|NCT01999530|101985891|FG000|STARTED|Overall Study||20||
48673895|NCT01999530|101985891|FG000|COMPLETED|Overall Study||7||
48673896|NCT01999530|101985891|FG000|NOT COMPLETED|Overall Study||13||
48673897|NCT02993263|101985892|FG000|STARTED|Overall Study||323||
48673898|NCT02993263|101985892|FG000|COMPLETED|Overall Study||0||
48237578|NCT02465866|100903026|FG000|NOT COMPLETED|Period 1||0||
48237579|NCT02465866|100903027|FG001|NOT COMPLETED|Period 1||0||
48237580|NCT02465866|100903028|FG002|NOT COMPLETED|Period 1||0||
48237581|NCT02465866|100903029|FG003|NOT COMPLETED|Period 1||0||
48237582|NCT02465866|100903026|FG000|STARTED|Period 1: Washout (14 Days)||5||
48237583|NCT02465866|100903027|FG001|STARTED|Period 1: Washout (14 Days)||5||
48237584|NCT02465866|100903028|FG002|STARTED|Period 1: Washout (14 Days)||5||
48237585|NCT02465866|100903029|FG003|STARTED|Period 1: Washout (14 Days)||5||
48237586|NCT02465866|100903026|FG000|COMPLETED|Period 1: Washout (14 Days)||5||
48237587|NCT02465866|100903027|FG001|COMPLETED|Period 1: Washout (14 Days)||5||
48237588|NCT02465866|100903028|FG002|COMPLETED|Period 1: Washout (14 Days)||5||
48237589|NCT02465866|100903029|FG003|COMPLETED|Period 1: Washout (14 Days)||5||
48237590|NCT02465866|100903026|FG000|NOT COMPLETED|Period 1: Washout (14 Days)||0||
48673899|NCT02993263|101985892|FG000|NOT COMPLETED|Overall Study||323||
48673900|NCT01093014|101985893|FG000|STARTED|Overall Study||12||
48673901|NCT01093014|101985894|FG001|STARTED|Overall Study||9||
48673902|NCT01093014|101985895|FG002|STARTED|Overall Study||12||
48673903|NCT01093014|101985893|FG000|COMPLETED|Overall Study||12||
48673904|NCT01093014|101985894|FG001|COMPLETED|Overall Study||9||
48673905|NCT01093014|101985895|FG002|COMPLETED|Overall Study||12||
48673906|NCT01093014|101985893|FG000|NOT COMPLETED|Overall Study||0||
48673907|NCT01093014|101985894|FG001|NOT COMPLETED|Overall Study||0||
48673908|NCT01093014|101985895|FG002|NOT COMPLETED|Overall Study||0||
48673909|NCT03381989|101985896|FG000|STARTED|Overall Study||30||
48673910|NCT03381989|101985896|FG000|COMPLETED|Overall Study||22||
48673911|NCT03381989|101985896|FG000|NOT COMPLETED|Overall Study||8||
48673912|NCT00854360|101985897|FG000|STARTED|Overall Study||118||
48237591|NCT02465866|100903027|FG001|NOT COMPLETED|Period 1: Washout (14 Days)||0||
48673913|NCT00854360|101985898|FG001|STARTED|Overall Study||123||
48673914|NCT00854360|101985899|FG002|STARTED|Overall Study||122||
48673915|NCT00854360|101985900|FG003|STARTED|Overall Study||124||
48673916|NCT00854360|101985897|FG000|Intent to Treat / Safety Population|Overall Study||118||
48673917|NCT00854360|101985898|FG001|Intent to Treat / Safety Population|Overall Study||123||
48237592|NCT02465866|100903028|FG002|NOT COMPLETED|Period 1: Washout (14 Days)||0||
48237593|NCT02465866|100903029|FG003|NOT COMPLETED|Period 1: Washout (14 Days)||0||
48237594|NCT02465866|100903026|FG000|STARTED|Period 2||5||
48237595|NCT02465866|100903027|FG001|STARTED|Period 2||5||
48237596|NCT02465866|100903028|FG002|STARTED|Period 2||5||
48237597|NCT02465866|100903029|FG003|STARTED|Period 2||5||
48237598|NCT02465866|100903026|FG000|COMPLETED|Period 2||5||
48237599|NCT02465866|100903027|FG001|COMPLETED|Period 2||5||
48237600|NCT02465866|100903028|FG002|COMPLETED|Period 2||5||
48237601|NCT02465866|100903029|FG003|COMPLETED|Period 2||5||
48237602|NCT02465866|100903026|FG000|NOT COMPLETED|Period 2||0||
48237603|NCT02465866|100903027|FG001|NOT COMPLETED|Period 2||0||
48237604|NCT02465866|100903028|FG002|NOT COMPLETED|Period 2||0||
48237605|NCT02465866|100903029|FG003|NOT COMPLETED|Period 2||0||
48237606|NCT02465866|100903026|FG000|STARTED|Period 2: Washout (14 Days)||5||
48237607|NCT02465866|100903027|FG001|STARTED|Period 2: Washout (14 Days)||5||
48237608|NCT02465866|100903028|FG002|STARTED|Period 2: Washout (14 Days)||5||
48237609|NCT02465866|100903029|FG003|STARTED|Period 2: Washout (14 Days)||5||
48237610|NCT02465866|100903026|FG000|COMPLETED|Period 2: Washout (14 Days)||5||
48237611|NCT02465866|100903027|FG001|COMPLETED|Period 2: Washout (14 Days)||5||
48237612|NCT02465866|100903028|FG002|COMPLETED|Period 2: Washout (14 Days)||5||
48237613|NCT02465866|100903029|FG003|COMPLETED|Period 2: Washout (14 Days)||5||
48237614|NCT02465866|100903026|FG000|NOT COMPLETED|Period 2: Washout (14 Days)||0||
48237615|NCT02465866|100903027|FG001|NOT COMPLETED|Period 2: Washout (14 Days)||0||
48237616|NCT02465866|100903028|FG002|NOT COMPLETED|Period 2: Washout (14 Days)||0||
48237617|NCT02465866|100903029|FG003|NOT COMPLETED|Period 2: Washout (14 Days)||0||
48237618|NCT02465866|100903026|FG000|STARTED|Period 3||5||
48237619|NCT02465866|100903027|FG001|STARTED|Period 3||5||
48673918|NCT00854360|101985899|FG002|Intent to Treat / Safety Population|Overall Study||122||
48673919|NCT00854360|101985900|FG003|Intent to Treat / Safety Population|Overall Study||123||
48673920|NCT00854360|101985897|FG000|COMPLETED|Overall Study||116||
48673921|NCT00854360|101985898|FG001|COMPLETED|Overall Study||120||
48673922|NCT00854360|101985899|FG002|COMPLETED|Overall Study||120||
48673923|NCT00854360|101985900|FG003|COMPLETED|Overall Study||114||
48673924|NCT00854360|101985897|FG000|NOT COMPLETED|Overall Study||2||
48673925|NCT00854360|101985898|FG001|NOT COMPLETED|Overall Study||3||
48673926|NCT00854360|101985899|FG002|NOT COMPLETED|Overall Study||2||
48673927|NCT00854360|101985900|FG003|NOT COMPLETED|Overall Study||10||
48673928|NCT01656161|101985901|FG000|STARTED|Overall Study||120||
48673929|NCT01656161|101985901|FG000|Received Triptorelin at Day 1|Overall Study||120||
48673930|NCT01656161|101985901|FG000|Received Triptorelin at Day 169|Overall Study||115||
48673931|NCT01656161|101985901|FG000|COMPLETED|Overall Study||113||
48673932|NCT01656161|101985901|FG000|NOT COMPLETED|Overall Study||7||
48673933|NCT04138056|101985902|FG000|STARTED|Primary Study||101||
48673934|NCT04138056|101985903|FG001|STARTED|Primary Study||101||
48673935|NCT04138056|101985904|FG002|STARTED|Primary Study||103||
48673936|NCT04138056|101985905|FG003|STARTED|Primary Study||102||
48673937|NCT04138056|101985906|FG004|STARTED|Primary Study||102||
48673938|NCT04138056|101985902|FG000|COMPLETED|Primary Study||95||
48673939|NCT04138056|101985903|FG001|COMPLETED|Primary Study||93||
48673940|NCT04138056|101985904|FG002|COMPLETED|Primary Study||100||
48673941|NCT04138056|101985905|FG003|COMPLETED|Primary Study||100||
48673942|NCT04138056|101985906|FG004|COMPLETED|Primary Study||98||
48673943|NCT04138056|101985902|FG000|NOT COMPLETED|Primary Study||6||
48673944|NCT04138056|101985903|FG001|NOT COMPLETED|Primary Study||8||
48673945|NCT04138056|101985904|FG002|NOT COMPLETED|Primary Study||3||
48673946|NCT04138056|101985905|FG003|NOT COMPLETED|Primary Study||2||
48673947|NCT04138056|101985906|FG004|NOT COMPLETED|Primary Study||4||
48673948|NCT04138056|101985902|FG000|STARTED|Extension Study||39||
48673949|NCT04138056|101985903|FG001|STARTED|Extension Study||41||
48237620|NCT02465866|100903028|FG002|STARTED|Period 3||5||
48237621|NCT02465866|100903029|FG003|STARTED|Period 3||5||
48237622|NCT02465866|100903026|FG000|COMPLETED|Period 3||5||
48673950|NCT04138056|101985904|FG002|STARTED|Extension Study||46||
48673951|NCT04138056|101985905|FG003|STARTED|Extension Study||41||
48673952|NCT04138056|101985906|FG004|STARTED|Extension Study||46||
48673953|NCT04138056|101985902|FG000|COMPLETED|Extension Study||38||
48673954|NCT04138056|101985903|FG001|COMPLETED|Extension Study||39||
48673955|NCT04138056|101985904|FG002|COMPLETED|Extension Study||45||
48673956|NCT04138056|101985905|FG003|COMPLETED|Extension Study||41||
48237623|NCT02465866|100903027|FG001|COMPLETED|Period 3||4||
48237624|NCT02465866|100903028|FG002|COMPLETED|Period 3||5||
48673957|NCT04138056|101985906|FG004|COMPLETED|Extension Study||45||
48673958|NCT04138056|101985902|FG000|NOT COMPLETED|Extension Study||1||
48673959|NCT04138056|101985903|FG001|NOT COMPLETED|Extension Study||2||
48237625|NCT02465866|100903029|FG003|COMPLETED|Period 3||5||
48237626|NCT02465866|100903026|FG000|NOT COMPLETED|Period 3||0||
48237627|NCT02465866|100903027|FG001|NOT COMPLETED|Period 3||1||
48237628|NCT02465866|100903028|FG002|NOT COMPLETED|Period 3||0||
48237629|NCT02465866|100903029|FG003|NOT COMPLETED|Period 3||0||
48673960|NCT04138056|101985904|FG002|NOT COMPLETED|Extension Study||1||
48673961|NCT04138056|101985905|FG003|NOT COMPLETED|Extension Study||0||
48673962|NCT04138056|101985906|FG004|NOT COMPLETED|Extension Study||1||
48673963|NCT04050384|101985907|FG000|STARTED|Overall Study||67||
48673964|NCT04050384|101985908|FG001|STARTED|Overall Study||67||
48673965|NCT04050384|101985907|FG000|COMPLETED|Overall Study||67||
48673966|NCT04050384|101985908|FG001|COMPLETED|Overall Study||67||
48673967|NCT04050384|101985907|FG000|NOT COMPLETED|Overall Study||0||
48673968|NCT04050384|101985908|FG001|NOT COMPLETED|Overall Study||0||
48673969|NCT00560417|101985909|FG000|STARTED|Overall Study||171||
48673970|NCT00560417|101985910|FG001|STARTED|Overall Study||168||
48673971|NCT00560417|101985909|FG000|Intention to Treat (ITT) Population|Overall Study||170||
48673972|NCT00560417|101985910|FG001|Intention to Treat (ITT) Population|Overall Study||167||
48673973|NCT00560417|101985909|FG000|COMPLETED|Overall Study||154||
48673974|NCT00560417|101985910|FG001|COMPLETED|Overall Study||151||
48673975|NCT00560417|101985909|FG000|NOT COMPLETED|Overall Study||17||
48673976|NCT00560417|101985910|FG001|NOT COMPLETED|Overall Study||17||
48673977|NCT02243358|101985911|FG000|STARTED|Overall Study||24||
48673978|NCT02243358|101985911|FG000|COMPLETED|Overall Study||24||
48673979|NCT02243358|101985911|FG000|NOT COMPLETED|Overall Study||0||
48673980|NCT04484857|101985912|FG000|STARTED|Overall Study||283||
48673981|NCT04484857|101985912|FG000|Received at Least 1 Dose of Study Drug|Overall Study||283||
48673982|NCT04484857|101985912|FG000|Full Analysis Set|Overall Study||282|All enrolled participants who provided baseline Hb data and data for at least 1 postbaseline Hb time point.|
48673983|NCT04484857|101985912|FG000|COMPLETED|Overall Study||36||
48673984|NCT04484857|101985912|FG000|NOT COMPLETED|Overall Study||247||
48673985|NCT02908178|101985913|FG000|STARTED|Overall Study||2409||
48673986|NCT02908178|101985914|FG001|STARTED|Overall Study||13106||
48673987|NCT02908178|101985915|FG002|STARTED|Overall Study||1992||
48673988|NCT02908178|101985916|FG003|STARTED|Overall Study||10784||
48673989|NCT02908178|101985913|FG000|COMPLETED|Overall Study||2409||
48673990|NCT02908178|101985914|FG001|COMPLETED|Overall Study||4718||
48673991|NCT02908178|101985915|FG002|COMPLETED|Overall Study||1992||
48673992|NCT02908178|101985916|FG003|COMPLETED|Overall Study||3965||
48673993|NCT02908178|101985913|FG000|NOT COMPLETED|Overall Study||0||
48673994|NCT02908178|101985914|FG001|NOT COMPLETED|Overall Study||8388||
48673995|NCT02908178|101985915|FG002|NOT COMPLETED|Overall Study||0||
48673996|NCT02908178|101985916|FG003|NOT COMPLETED|Overall Study||6819||
48673997|NCT03605693|101985917|FG000|STARTED|Overall Study||5||
48673998|NCT03605693|101985918|FG001|STARTED|Overall Study||5||
48673999|NCT03605693|101985917|FG000|COMPLETED|Overall Study||0||
48674000|NCT03605693|101985918|FG001|COMPLETED|Overall Study||5||
48674001|NCT03605693|101985917|FG000|NOT COMPLETED|Overall Study||5||
48674002|NCT03605693|101985918|FG001|NOT COMPLETED|Overall Study||0||
48674003|NCT03502681|101985919|FG000|STARTED|Overall Study||3||
48674004|NCT03502681|101985920|FG001|STARTED|Overall Study||3||
48674005|NCT03502681|101985919|FG000|COMPLETED|Overall Study||0||
48674006|NCT03502681|101985920|FG001|COMPLETED|Overall Study||1||
48674007|NCT03502681|101985919|FG000|NOT COMPLETED|Overall Study||3||
48674008|NCT03502681|101985920|FG001|NOT COMPLETED|Overall Study||2||
48674009|NCT01083602|101985921|FG000|STARTED|Overall Study||55||
48674010|NCT01083602|101985921|FG000|COMPLETED|Overall Study||0||
48674011|NCT01083602|101985921|FG000|NOT COMPLETED|Overall Study||55||
48674012|NCT00963872|101985922|FG000|STARTED|Overall Study||25||
48237630|NCT02465866|100903026|FG000|STARTED|Period 3: Washout (14 Days)||5||
48237631|NCT02465866|100903027|FG001|STARTED|Period 3: Washout (14 Days)||4||
48237632|NCT02465866|100903028|FG002|STARTED|Period 3: Washout (14 Days)||5||
48237633|NCT02465866|100903029|FG003|STARTED|Period 3: Washout (14 Days)||5||
48237634|NCT02465866|100903026|FG000|COMPLETED|Period 3: Washout (14 Days)||5||
48237635|NCT02465866|100903027|FG001|COMPLETED|Period 3: Washout (14 Days)||4||
48237636|NCT02465866|100903028|FG002|COMPLETED|Period 3: Washout (14 Days)||5||
48237637|NCT02465866|100903029|FG003|COMPLETED|Period 3: Washout (14 Days)||5||
48237638|NCT02465866|100903026|FG000|NOT COMPLETED|Period 3: Washout (14 Days)||0||
48237639|NCT02465866|100903027|FG001|NOT COMPLETED|Period 3: Washout (14 Days)||0||
48237640|NCT02465866|100903028|FG002|NOT COMPLETED|Period 3: Washout (14 Days)||0||
48237641|NCT02465866|100903029|FG003|NOT COMPLETED|Period 3: Washout (14 Days)||0||
48237642|NCT02465866|100903026|FG000|STARTED|Period 4||5||
48237643|NCT02465866|100903027|FG001|STARTED|Period 4||4||
48237644|NCT02465866|100903028|FG002|STARTED|Period 4||5||
48237645|NCT02465866|100903029|FG003|STARTED|Period 4||5||
48237646|NCT02465866|100903026|FG000|COMPLETED|Period 4||5||
48237647|NCT02465866|100903027|FG001|COMPLETED|Period 4||4||
48237648|NCT02465866|100903028|FG002|COMPLETED|Period 4||5||
48674013|NCT00963872|101985923|FG001|STARTED|Overall Study||6||
48674014|NCT00963872|101985922|FG000|COMPLETED|Overall Study||24||
48674015|NCT00963872|101985923|FG001|COMPLETED|Overall Study||5||
48674016|NCT00963872|101985922|FG000|NOT COMPLETED|Overall Study||1||
48674017|NCT00963872|101985923|FG001|NOT COMPLETED|Overall Study||1||
48674018|NCT01307449|101985924|FG000|STARTED|Overall Study||33||
48674019|NCT01307449|101985925|FG001|STARTED|Overall Study||33||
48674020|NCT01307449|101985926|FG002|STARTED|Overall Study||11||
48674021|NCT01307449|101985927|FG003|STARTED|Overall Study||11||
48674022|NCT01307449|101985924|FG000|COMPLETED|Overall Study||32||
48237649|NCT02465866|100903029|FG003|COMPLETED|Period 4||5||
48237650|NCT02465866|100903026|FG000|NOT COMPLETED|Period 4||0||
48237651|NCT02465866|100903027|FG001|NOT COMPLETED|Period 4||0||
48674023|NCT01307449|101985925|FG001|COMPLETED|Overall Study||33||
48674024|NCT01307449|101985926|FG002|COMPLETED|Overall Study||11||
48237652|NCT02465866|100903028|FG002|NOT COMPLETED|Period 4||0||
48237653|NCT02465866|100903029|FG003|NOT COMPLETED|Period 4||0||
48237654|NCT02465866|100903026|FG000|STARTED|Period 4: Washout (14 Days)||5||
48237655|NCT02465866|100903027|FG001|STARTED|Period 4: Washout (14 Days)||4||
48237656|NCT02465866|100903028|FG002|STARTED|Period 4: Washout (14 Days)||5||
48237657|NCT02465866|100903029|FG003|STARTED|Period 4: Washout (14 Days)||5||
48237658|NCT02465866|100903026|FG000|COMPLETED|Period 4: Washout (14 Days)||5||
48237659|NCT02465866|100903027|FG001|COMPLETED|Period 4: Washout (14 Days)||4||
48237660|NCT02465866|100903028|FG002|COMPLETED|Period 4: Washout (14 Days)||5||
48237661|NCT02465866|100903029|FG003|COMPLETED|Period 4: Washout (14 Days)||5||
48237662|NCT02465866|100903026|FG000|NOT COMPLETED|Period 4: Washout (14 Days)||0||
48237663|NCT02465866|100903027|FG001|NOT COMPLETED|Period 4: Washout (14 Days)||0||
48237664|NCT02465866|100903028|FG002|NOT COMPLETED|Period 4: Washout (14 Days)||0||
48237665|NCT02465866|100903029|FG003|NOT COMPLETED|Period 4: Washout (14 Days)||0||
48237666|NCT02951702|100903030|FG000|STARTED|Overall Study||34||
48237667|NCT02951702|100903031|FG001|STARTED|Overall Study||17||
48538658|NCT04058067|101655308|FG000|NOT COMPLETED|Overall Study||12||
48538659|NCT04058067|101655309|FG001|NOT COMPLETED|Overall Study||11||
48538660|NCT03149445|101655310|FG000|STARTED|Double-blind (DB) Step 1||6||
48237668|NCT02951702|100903030|FG000|COMPLETED|Overall Study||34||
48237669|NCT02951702|100903031|FG001|COMPLETED|Overall Study||17||
48237670|NCT02951702|100903030|FG000|NOT COMPLETED|Overall Study||0||
48237671|NCT02951702|100903031|FG001|NOT COMPLETED|Overall Study||0||
48237672|NCT01215253|100903032|FG000|STARTED|Overall Study||510||
48237673|NCT01215253|100903033|FG001|STARTED|Overall Study||502||
48237674|NCT01215253|100903032|FG000|COMPLETED|Overall Study||424||
48237675|NCT01215253|100903033|FG001|COMPLETED|Overall Study||439||
48237676|NCT01215253|100903032|FG000|NOT COMPLETED|Overall Study||86||
48237677|NCT01215253|100903033|FG001|NOT COMPLETED|Overall Study||63||
48237678|NCT01133678|100903034|FG000|STARTED|Overall Study||25||
48237679|NCT01133678|100903035|FG001|STARTED|Overall Study||25||
48237680|NCT01133678|100903034|FG000|COMPLETED|Overall Study||24||
48237681|NCT01133678|100903035|FG001|COMPLETED|Overall Study||24||
48237682|NCT01133678|100903034|FG000|NOT COMPLETED|Overall Study||1||
48237683|NCT01133678|100903035|FG001|NOT COMPLETED|Overall Study||1||
48237684|NCT00513292|100903036|FG000|STARTED|Overall Study||138||
48237685|NCT00513292|100903037|FG001|STARTED|Overall Study||142||
48237686|NCT00513292|100903036|FG000|COMPLETED|Overall Study||138||
48237687|NCT00513292|100903037|FG001|COMPLETED|Overall Study||142||
48237688|NCT00513292|100903036|FG000|NOT COMPLETED|Overall Study||0||
48237689|NCT00513292|100903037|FG001|NOT COMPLETED|Overall Study||0||
48237690|NCT00732498|100903038|FG000|STARTED|Overall Study||28||
48237691|NCT00732498|100903038|FG000|COMPLETED|Overall Study||22||
48237692|NCT00732498|100903038|FG000|NOT COMPLETED|Overall Study||6||
48237693|NCT00376935|100903039|FG000|STARTED|Overall Study||25||
48237694|NCT00376935|100903040|FG001|STARTED|Overall Study||25||
48237695|NCT00376935|100903041|FG002|STARTED|Overall Study||25||
48237696|NCT00376935|100903042|FG003|STARTED|Overall Study||24||
48237697|NCT00376935|100903039|FG000|COMPLETED|Overall Study||25||
48237698|NCT00376935|100903040|FG001|COMPLETED|Overall Study||25||
48237699|NCT00376935|100903041|FG002|COMPLETED|Overall Study||25||
48237700|NCT00376935|100903042|FG003|COMPLETED|Overall Study||24||
48237701|NCT00376935|100903039|FG000|NOT COMPLETED|Overall Study||0||
48237702|NCT00376935|100903040|FG001|NOT COMPLETED|Overall Study||0||
48237703|NCT00376935|100903041|FG002|NOT COMPLETED|Overall Study||0||
48237704|NCT00376935|100903042|FG003|NOT COMPLETED|Overall Study||0||
48237705|NCT03782545|100903043|FG000|STARTED|Overall Study||34||
48237706|NCT03782545|100903043|FG000|COMPLETED|Overall Study||30||
48237707|NCT03782545|100903043|FG000|NOT COMPLETED|Overall Study||4||
48237708|NCT01804140|100903044|FG000|STARTED|Overall Study||662||
48237709|NCT01804140|100903044|FG000|COMPLETED|Overall Study||548||
48237710|NCT01804140|100903044|FG000|NOT COMPLETED|Overall Study||114||
48237711|NCT02206607|100903045|FG000|STARTED|Open-Label Run-In||42||
48237712|NCT02206607|100903046|FG001|STARTED|Open-Label Run-In||0||
48538661|NCT03149445|101655311|FG001|STARTED|Double-blind (DB) Step 1||3||
48538662|NCT03149445|101655312|FG002|STARTED|Double-blind (DB) Step 1||0||
48237713|NCT02206607|100903047|FG002|STARTED|Open-Label Run-In||0||
48538663|NCT03149445|101655313|FG003|STARTED|Double-blind (DB) Step 1||0||
48538664|NCT03149445|101655314|FG004|STARTED|Double-blind (DB) Step 1||0||
48538665|NCT03149445|101655315|FG005|STARTED|Double-blind (DB) Step 1||0||
48237714|NCT02206607|100903048|FG003|STARTED|Open-Label Run-In||0||
48237715|NCT02206607|100903049|FG004|STARTED|Open-Label Run-In||0||
48237716|NCT02206607|100903045|FG000|COMPLETED|Open-Label Run-In||39||
48237717|NCT02206607|100903046|FG001|COMPLETED|Open-Label Run-In||0||
48237718|NCT02206607|100903047|FG002|COMPLETED|Open-Label Run-In||0||
48237719|NCT02206607|100903048|FG003|COMPLETED|Open-Label Run-In||0||
48237720|NCT02206607|100903049|FG004|COMPLETED|Open-Label Run-In||0||
48538666|NCT03149445|101655316|FG006|STARTED|Double-blind (DB) Step 1||0||
48237721|NCT02206607|100903045|FG000|NOT COMPLETED|Open-Label Run-In||3||
48237722|NCT02206607|100903046|FG001|NOT COMPLETED|Open-Label Run-In||0||
48237723|NCT02206607|100903047|FG002|NOT COMPLETED|Open-Label Run-In||0||
48237724|NCT02206607|100903048|FG003|NOT COMPLETED|Open-Label Run-In||0||
48237725|NCT02206607|100903049|FG004|NOT COMPLETED|Open-Label Run-In||0||
48237726|NCT02206607|100903045|FG000|STARTED|First Intervention Period||0||
48237727|NCT02206607|100903046|FG001|STARTED|First Intervention Period||9||
48237728|NCT02206607|100903047|FG002|STARTED|First Intervention Period||9||
48237729|NCT02206607|100903048|FG003|STARTED|First Intervention Period||11||
48237730|NCT02206607|100903049|FG004|STARTED|First Intervention Period||10||
48237731|NCT02206607|100903045|FG000|COMPLETED|First Intervention Period||0||
48237732|NCT02206607|100903046|FG001|COMPLETED|First Intervention Period||9||
48237733|NCT02206607|100903047|FG002|COMPLETED|First Intervention Period||9||
48538667|NCT03149445|101655317|FG007|STARTED|Double-blind (DB) Step 1||0||
48538668|NCT03149445|101655310|FG000|COMPLETED|Double-blind (DB) Step 1||2||
48538669|NCT03149445|101655311|FG001|COMPLETED|Double-blind (DB) Step 1||2||
48538670|NCT03149445|101655312|FG002|COMPLETED|Double-blind (DB) Step 1||0||
48538671|NCT03149445|101655313|FG003|COMPLETED|Double-blind (DB) Step 1||0||
48538672|NCT03149445|101655314|FG004|COMPLETED|Double-blind (DB) Step 1||0||
48237734|NCT02206607|100903048|FG003|COMPLETED|First Intervention Period||11||
48237735|NCT02206607|100903049|FG004|COMPLETED|First Intervention Period||10||
48237736|NCT02206607|100903045|FG000|NOT COMPLETED|First Intervention Period||0||
48237737|NCT02206607|100903046|FG001|NOT COMPLETED|First Intervention Period||0||
48538673|NCT03149445|101655315|FG005|COMPLETED|Double-blind (DB) Step 1||0||
48538674|NCT03149445|101655316|FG006|COMPLETED|Double-blind (DB) Step 1||0||
48538675|NCT03149445|101655317|FG007|COMPLETED|Double-blind (DB) Step 1||0||
48538676|NCT03149445|101655310|FG000|NOT COMPLETED|Double-blind (DB) Step 1||4||
48538677|NCT03149445|101655311|FG001|NOT COMPLETED|Double-blind (DB) Step 1||1||
48538678|NCT03149445|101655312|FG002|NOT COMPLETED|Double-blind (DB) Step 1||0||
48538679|NCT03149445|101655313|FG003|NOT COMPLETED|Double-blind (DB) Step 1||0||
48538680|NCT03149445|101655314|FG004|NOT COMPLETED|Double-blind (DB) Step 1||0||
48538681|NCT03149445|101655315|FG005|NOT COMPLETED|Double-blind (DB) Step 1||0||
48538682|NCT03149445|101655316|FG006|NOT COMPLETED|Double-blind (DB) Step 1||0||
48538683|NCT03149445|101655317|FG007|NOT COMPLETED|Double-blind (DB) Step 1||0||
48538684|NCT03149445|101655310|FG000|STARTED|Double-blind (DB) Step 2||0||
48538685|NCT03149445|101655311|FG001|STARTED|Double-blind (DB) Step 2||0||
48538686|NCT03149445|101655312|FG002|STARTED|Double-blind (DB) Step 2||5||
48538687|NCT03149445|101655313|FG003|STARTED|Double-blind (DB) Step 2||4||
48538688|NCT03149445|101655314|FG004|STARTED|Double-blind (DB) Step 2||0||
48538689|NCT03149445|101655315|FG005|STARTED|Double-blind (DB) Step 2||0||
48538690|NCT03149445|101655316|FG006|STARTED|Double-blind (DB) Step 2||0||
48538691|NCT03149445|101655317|FG007|STARTED|Double-blind (DB) Step 2||0||
48538692|NCT03149445|101655310|FG000|COMPLETED|Double-blind (DB) Step 2||0||
48538693|NCT03149445|101655311|FG001|COMPLETED|Double-blind (DB) Step 2||0||
48538694|NCT03149445|101655312|FG002|COMPLETED|Double-blind (DB) Step 2||5||
48538695|NCT03149445|101655313|FG003|COMPLETED|Double-blind (DB) Step 2||4||
48538696|NCT03149445|101655314|FG004|COMPLETED|Double-blind (DB) Step 2||0||
48538697|NCT03149445|101655315|FG005|COMPLETED|Double-blind (DB) Step 2||0||
48538698|NCT03149445|101655316|FG006|COMPLETED|Double-blind (DB) Step 2||0||
48538699|NCT03149445|101655317|FG007|COMPLETED|Double-blind (DB) Step 2||0||
48538700|NCT03149445|101655310|FG000|NOT COMPLETED|Double-blind (DB) Step 2||0||
48538701|NCT03149445|101655311|FG001|NOT COMPLETED|Double-blind (DB) Step 2||0||
48538702|NCT03149445|101655312|FG002|NOT COMPLETED|Double-blind (DB) Step 2||0||
48538703|NCT03149445|101655313|FG003|NOT COMPLETED|Double-blind (DB) Step 2||0||
48538704|NCT03149445|101655314|FG004|NOT COMPLETED|Double-blind (DB) Step 2||0||
48538705|NCT03149445|101655315|FG005|NOT COMPLETED|Double-blind (DB) Step 2||0||
48538706|NCT03149445|101655316|FG006|NOT COMPLETED|Double-blind (DB) Step 2||0||
48538707|NCT03149445|101655317|FG007|NOT COMPLETED|Double-blind (DB) Step 2||0||
48538708|NCT03149445|101655310|FG000|STARTED|Open Label Extension (OLE) I||0||
48538709|NCT03149445|101655311|FG001|STARTED|Open Label Extension (OLE) I||0||
48538710|NCT03149445|101655312|FG002|STARTED|Open Label Extension (OLE) I||0||
48538711|NCT03149445|101655313|FG003|STARTED|Open Label Extension (OLE) I||0||
48538712|NCT03149445|101655314|FG004|STARTED|Open Label Extension (OLE) I||4||
48538713|NCT03149445|101655315|FG005|STARTED|Open Label Extension (OLE) I||4||
48538714|NCT03149445|101655316|FG006|STARTED|Open Label Extension (OLE) I||0||
48538715|NCT03149445|101655317|FG007|STARTED|Open Label Extension (OLE) I||0||
48538716|NCT03149445|101655310|FG000|COMPLETED|Open Label Extension (OLE) I||0||
48538717|NCT03149445|101655311|FG001|COMPLETED|Open Label Extension (OLE) I||0||
48538718|NCT03149445|101655312|FG002|COMPLETED|Open Label Extension (OLE) I||0||
48538719|NCT03149445|101655313|FG003|COMPLETED|Open Label Extension (OLE) I||0||
48538720|NCT03149445|101655314|FG004|COMPLETED|Open Label Extension (OLE) I||4||
48538721|NCT03149445|101655315|FG005|COMPLETED|Open Label Extension (OLE) I||3||
48538722|NCT03149445|101655316|FG006|COMPLETED|Open Label Extension (OLE) I||0||
48237738|NCT02206607|100903047|FG002|NOT COMPLETED|First Intervention Period||0||
48538723|NCT03149445|101655317|FG007|COMPLETED|Open Label Extension (OLE) I||0||
48538724|NCT03149445|101655310|FG000|NOT COMPLETED|Open Label Extension (OLE) I||0||
48538725|NCT03149445|101655311|FG001|NOT COMPLETED|Open Label Extension (OLE) I||0||
48538726|NCT03149445|101655312|FG002|NOT COMPLETED|Open Label Extension (OLE) I||0||
48538727|NCT03149445|101655313|FG003|NOT COMPLETED|Open Label Extension (OLE) I||0||
48538728|NCT03149445|101655314|FG004|NOT COMPLETED|Open Label Extension (OLE) I||0||
48538729|NCT03149445|101655315|FG005|NOT COMPLETED|Open Label Extension (OLE) I||1||
48237739|NCT02206607|100903048|FG003|NOT COMPLETED|First Intervention Period||0||
48237740|NCT02206607|100903049|FG004|NOT COMPLETED|First Intervention Period||0||
48237741|NCT02206607|100903045|FG000|STARTED|First Washout Period 5 to 10 Days||0||
48237742|NCT02206607|100903046|FG001|STARTED|First Washout Period 5 to 10 Days||9||
48237743|NCT02206607|100903047|FG002|STARTED|First Washout Period 5 to 10 Days||9||
48237744|NCT02206607|100903048|FG003|STARTED|First Washout Period 5 to 10 Days||11||
48237745|NCT02206607|100903049|FG004|STARTED|First Washout Period 5 to 10 Days||10||
48237746|NCT02206607|100903045|FG000|COMPLETED|First Washout Period 5 to 10 Days||0||
48237747|NCT02206607|100903046|FG001|COMPLETED|First Washout Period 5 to 10 Days||9||
48538730|NCT03149445|101655316|FG006|NOT COMPLETED|Open Label Extension (OLE) I||0||
48538731|NCT03149445|101655317|FG007|NOT COMPLETED|Open Label Extension (OLE) I||0||
48674025|NCT01307449|101985927|FG003|COMPLETED|Overall Study||11||
48674026|NCT01307449|101985924|FG000|NOT COMPLETED|Overall Study||1||
48674027|NCT01307449|101985925|FG001|NOT COMPLETED|Overall Study||0||
48674028|NCT01307449|101985926|FG002|NOT COMPLETED|Overall Study||0||
48674029|NCT01307449|101985927|FG003|NOT COMPLETED|Overall Study||0||
48674030|NCT00508521|101985928|FG000|STARTED|Overall Study||4||
48674031|NCT00508521|101985928|FG000|COMPLETED|Overall Study||4||
48674032|NCT00508521|101985928|FG000|NOT COMPLETED|Overall Study||0||
48674033|NCT00744861|101985929|FG000|STARTED|Feasibility Stage 1||8||
48674034|NCT00744861|101985930|FG001|STARTED|Feasibility Stage 1||10||
48674035|NCT00744861|101985931|FG002|STARTED|Feasibility Stage 1||0||
48674036|NCT00744861|101985932|FG003|STARTED|Feasibility Stage 1||0||
48538732|NCT03149445|101655310|FG000|STARTED|Open Label Extension (OLE) II||0||
48538733|NCT03149445|101655311|FG001|STARTED|Open Label Extension (OLE) II||0||
48538734|NCT03149445|101655312|FG002|STARTED|Open Label Extension (OLE) II||0||
48538735|NCT03149445|101655313|FG003|STARTED|Open Label Extension (OLE) II||0||
48538736|NCT03149445|101655314|FG004|STARTED|Open Label Extension (OLE) II||0||
48538737|NCT03149445|101655315|FG005|STARTED|Open Label Extension (OLE) II||0||
48538738|NCT03149445|101655316|FG006|STARTED|Open Label Extension (OLE) II||5||
48538739|NCT03149445|101655317|FG007|STARTED|Open Label Extension (OLE) II||1||
48538740|NCT03149445|101655310|FG000|COMPLETED|Open Label Extension (OLE) II||0||
48538741|NCT03149445|101655311|FG001|COMPLETED|Open Label Extension (OLE) II||0||
48237748|NCT02206607|100903047|FG002|COMPLETED|First Washout Period 5 to 10 Days||9||
48237749|NCT02206607|100903048|FG003|COMPLETED|First Washout Period 5 to 10 Days||11||
48237750|NCT02206607|100903049|FG004|COMPLETED|First Washout Period 5 to 10 Days||10||
48237751|NCT02206607|100903045|FG000|NOT COMPLETED|First Washout Period 5 to 10 Days||0||
48237752|NCT02206607|100903046|FG001|NOT COMPLETED|First Washout Period 5 to 10 Days||0||
48237753|NCT02206607|100903047|FG002|NOT COMPLETED|First Washout Period 5 to 10 Days||0||
48237754|NCT02206607|100903048|FG003|NOT COMPLETED|First Washout Period 5 to 10 Days||0||
48237755|NCT02206607|100903049|FG004|NOT COMPLETED|First Washout Period 5 to 10 Days||0||
48237756|NCT02206607|100903045|FG000|STARTED|Second Intervention Period||0||
48237757|NCT02206607|100903046|FG001|STARTED|Second Intervention Period||9||
48237758|NCT02206607|100903047|FG002|STARTED|Second Intervention Period||9||
48237759|NCT02206607|100903048|FG003|STARTED|Second Intervention Period||11||
48237760|NCT02206607|100903049|FG004|STARTED|Second Intervention Period||10||
48237761|NCT02206607|100903045|FG000|COMPLETED|Second Intervention Period||0||
48237762|NCT02206607|100903046|FG001|COMPLETED|Second Intervention Period||9||
48237763|NCT02206607|100903047|FG002|COMPLETED|Second Intervention Period||9||
48538742|NCT03149445|101655312|FG002|COMPLETED|Open Label Extension (OLE) II||0||
48538743|NCT03149445|101655313|FG003|COMPLETED|Open Label Extension (OLE) II||0||
48538744|NCT03149445|101655314|FG004|COMPLETED|Open Label Extension (OLE) II||0||
48538745|NCT03149445|101655315|FG005|COMPLETED|Open Label Extension (OLE) II||0||
48538746|NCT03149445|101655316|FG006|COMPLETED|Open Label Extension (OLE) II||3||
48538747|NCT03149445|101655317|FG007|COMPLETED|Open Label Extension (OLE) II||1||
48674037|NCT00744861|101985929|FG000|COMPLETED|Feasibility Stage 1||7||
48674038|NCT00744861|101985930|FG001|COMPLETED|Feasibility Stage 1||8||
48237764|NCT02206607|100903048|FG003|COMPLETED|Second Intervention Period||10||
48538748|NCT03149445|101655310|FG000|NOT COMPLETED|Open Label Extension (OLE) II||0||
48538749|NCT03149445|101655311|FG001|NOT COMPLETED|Open Label Extension (OLE) II||0||
48538750|NCT03149445|101655312|FG002|NOT COMPLETED|Open Label Extension (OLE) II||0||
48538751|NCT03149445|101655313|FG003|NOT COMPLETED|Open Label Extension (OLE) II||0||
48538752|NCT03149445|101655314|FG004|NOT COMPLETED|Open Label Extension (OLE) II||0||
48538753|NCT03149445|101655315|FG005|NOT COMPLETED|Open Label Extension (OLE) II||0||
48538754|NCT03149445|101655316|FG006|NOT COMPLETED|Open Label Extension (OLE) II||2||
48538755|NCT03149445|101655317|FG007|NOT COMPLETED|Open Label Extension (OLE) II||0||
48674039|NCT00744861|101985931|FG002|COMPLETED|Feasibility Stage 1||0||
48674040|NCT00744861|101985932|FG003|COMPLETED|Feasibility Stage 1||0||
48674041|NCT00744861|101985929|FG000|NOT COMPLETED|Feasibility Stage 1||1||
48674042|NCT00744861|101985930|FG001|NOT COMPLETED|Feasibility Stage 1||2||
48674043|NCT00744861|101985931|FG002|NOT COMPLETED|Feasibility Stage 1||0||
48674044|NCT00744861|101985932|FG003|NOT COMPLETED|Feasibility Stage 1||0||
48674045|NCT00744861|101985929|FG000|STARTED|Pivotal Stage 2||0||
48674046|NCT00744861|101985930|FG001|STARTED|Pivotal Stage 2||0||
48674047|NCT00744861|101985931|FG002|STARTED|Pivotal Stage 2||154||
48674048|NCT00744861|101985932|FG003|STARTED|Pivotal Stage 2||156||
48538756|NCT03340207|101655318|FG000|STARTED|Overall Study||16||
48237765|NCT02206607|100903049|FG004|COMPLETED|Second Intervention Period||10||
48237766|NCT02206607|100903045|FG000|NOT COMPLETED|Second Intervention Period||0||
48237767|NCT02206607|100903046|FG001|NOT COMPLETED|Second Intervention Period||0||
48237768|NCT02206607|100903047|FG002|NOT COMPLETED|Second Intervention Period||0||
48237769|NCT02206607|100903048|FG003|NOT COMPLETED|Second Intervention Period||1||
48538757|NCT03340207|101655319|FG001|STARTED|Overall Study||16||
48538758|NCT03340207|101655318|FG000|COMPLETED|Overall Study||16||
48538759|NCT03340207|101655319|FG001|COMPLETED|Overall Study||16||
48538760|NCT03340207|101655318|FG000|NOT COMPLETED|Overall Study||0||
48538761|NCT03340207|101655319|FG001|NOT COMPLETED|Overall Study||0||
48538762|NCT00089024|101655320|FG000|STARTED|Overall Study||29||
48538763|NCT00089024|101655320|FG000|Treated Subjects|Overall Study||29||
48538764|NCT00089024|101655320|FG000|COMPLETED|Overall Study||24||
48538765|NCT00089024|101655320|FG000|NOT COMPLETED|Overall Study||5||
48538766|NCT02257385|101655321|FG000|STARTED|Overall Study||482||
48538767|NCT02257385|101655322|FG001|STARTED|Overall Study||479||
48538768|NCT02257385|101655321|FG000|COMPLETED|Overall Study||460||
48538769|NCT02257385|101655322|FG001|COMPLETED|Overall Study||457||
48538770|NCT02257385|101655321|FG000|NOT COMPLETED|Overall Study||22||
48538771|NCT02257385|101655322|FG001|NOT COMPLETED|Overall Study||22||
48538772|NCT04784533|101655323|FG000|STARTED|Part A: Period 1 (Day 1 to Week 24)||180||
48538773|NCT04784533|101655324|FG001|STARTED|Part A: Period 1 (Day 1 to Week 24)||137||
48538774|NCT04784533|101655325|FG002|STARTED|Part A: Period 1 (Day 1 to Week 24)||0||
48674049|NCT00744861|101985929|FG000|COMPLETED|Pivotal Stage 2||0||
48237770|NCT02206607|100903049|FG004|NOT COMPLETED|Second Intervention Period||0||
48237771|NCT02206607|100903045|FG000|STARTED|Second Washout Period 5 to 10 Days||0||
48237772|NCT02206607|100903046|FG001|STARTED|Second Washout Period 5 to 10 Days||9||
48237773|NCT02206607|100903047|FG002|STARTED|Second Washout Period 5 to 10 Days||9||
48237774|NCT02206607|100903048|FG003|STARTED|Second Washout Period 5 to 10 Days||10||
48237775|NCT02206607|100903049|FG004|STARTED|Second Washout Period 5 to 10 Days||10||
48237776|NCT02206607|100903045|FG000|COMPLETED|Second Washout Period 5 to 10 Days||0||
48237777|NCT02206607|100903046|FG001|COMPLETED|Second Washout Period 5 to 10 Days||9||
48237778|NCT02206607|100903047|FG002|COMPLETED|Second Washout Period 5 to 10 Days||9||
48237779|NCT02206607|100903048|FG003|COMPLETED|Second Washout Period 5 to 10 Days||10||
48237780|NCT02206607|100903049|FG004|COMPLETED|Second Washout Period 5 to 10 Days||10||
48237781|NCT02206607|100903045|FG000|NOT COMPLETED|Second Washout Period 5 to 10 Days||0||
48538775|NCT04784533|101655326|FG003|STARTED|Part A: Period 1 (Day 1 to Week 24)||0||
48538776|NCT04784533|101655327|FG004|STARTED|Part A: Period 1 (Day 1 to Week 24)||0||
48538777|NCT04784533|101655328|FG005|STARTED|Part A: Period 1 (Day 1 to Week 24)||0||
48538778|NCT04784533|101655329|FG006|STARTED|Part A: Period 1 (Day 1 to Week 24)||0||
48538779|NCT04784533|101655330|FG007|STARTED|Part A: Period 1 (Day 1 to Week 24)||0||
48538780|NCT04784533|101655331|FG008|STARTED|Part A: Period 1 (Day 1 to Week 24)||0||
48538781|NCT04784533|101655332|FG009|STARTED|Part A: Period 1 (Day 1 to Week 24)||0||
48538782|NCT04784533|101655323|FG000|Efficacy Population|Part A: Period 1 (Day 1 to Week 24)||178|Efficacy population included all participants who were randomized in the study, dispensed study drug, and had at least 1 post treatment severity of alopecia tool (SALT) assessment.|
48538783|NCT04784533|101655324|FG001|Efficacy Population|Part A: Period 1 (Day 1 to Week 24)||135|Efficacy population included all participants who were randomized in the study, dispensed study drug, and had at least 1 post treatment severity of alopecia tool (SALT) assessment.|
48538784|NCT04784533|101655325|FG002|Efficacy Population|Part A: Period 1 (Day 1 to Week 24)||0|Efficacy population included all participants who were randomized in the study, dispensed study drug, and had at least 1 post treatment severity of alopecia tool (SALT) assessment.|
48538785|NCT04784533|101655326|FG003|Efficacy Population|Part A: Period 1 (Day 1 to Week 24)||0|Efficacy population included all participants who were randomized in the study, dispensed study drug, and had at least 1 post treatment severity of alopecia tool (SALT) assessment.|
48538786|NCT04784533|101655327|FG004|Efficacy Population|Part A: Period 1 (Day 1 to Week 24)||0|Efficacy population included all participants who were randomized in the study, dispensed study drug, and had at least 1 post treatment severity of alopecia tool (SALT) assessment.|
48538787|NCT04784533|101655328|FG005|Efficacy Population|Part A: Period 1 (Day 1 to Week 24)||0|Efficacy population included all participants who were randomized in the study, dispensed study drug, and had at least 1 post treatment severity of alopecia tool (SALT) assessment.|
48538788|NCT04784533|101655329|FG006|Efficacy Population|Part A: Period 1 (Day 1 to Week 24)||0|Efficacy population included all participants who were randomized in the study, dispensed study drug, and had at least 1 post treatment severity of alopecia tool (SALT) assessment.|
48538789|NCT04784533|101655330|FG007|Efficacy Population|Part A: Period 1 (Day 1 to Week 24)||0|Efficacy population included all participants who were randomized in the study, dispensed study drug, and had at least 1 post treatment severity of alopecia tool (SALT) assessment.|
48538790|NCT04784533|101655331|FG008|Efficacy Population|Part A: Period 1 (Day 1 to Week 24)||0|Efficacy population included all participants who were randomized in the study, dispensed study drug, and had at least 1 post treatment severity of alopecia tool (SALT) assessment.|
48538791|NCT04784533|101655332|FG009|Efficacy Population|Part A: Period 1 (Day 1 to Week 24)||0|Efficacy population included all participants who were randomized in the study, dispensed study drug, and had at least 1 post treatment severity of alopecia tool (SALT) assessment.|
48674050|NCT00744861|101985930|FG001|COMPLETED|Pivotal Stage 2||0||
48674051|NCT00744861|101985931|FG002|COMPLETED|Pivotal Stage 2||52||
48674052|NCT00744861|101985932|FG003|COMPLETED|Pivotal Stage 2||51||
48674053|NCT00744861|101985929|FG000|NOT COMPLETED|Pivotal Stage 2||0||
48237782|NCT02206607|100903046|FG001|NOT COMPLETED|Second Washout Period 5 to 10 Days||0||
48237783|NCT02206607|100903047|FG002|NOT COMPLETED|Second Washout Period 5 to 10 Days||0||
48538792|NCT04784533|101655323|FG000|COMPLETED|Part A: Period 1 (Day 1 to Week 24)||162||
48538793|NCT04784533|101655324|FG001|COMPLETED|Part A: Period 1 (Day 1 to Week 24)||118||
48538794|NCT04784533|101655325|FG002|COMPLETED|Part A: Period 1 (Day 1 to Week 24)||0||
48538795|NCT04784533|101655326|FG003|COMPLETED|Part A: Period 1 (Day 1 to Week 24)||0||
48538796|NCT04784533|101655327|FG004|COMPLETED|Part A: Period 1 (Day 1 to Week 24)||0||
48538797|NCT04784533|101655328|FG005|COMPLETED|Part A: Period 1 (Day 1 to Week 24)||0||
48538798|NCT04784533|101655329|FG006|COMPLETED|Part A: Period 1 (Day 1 to Week 24)||0||
48538799|NCT04784533|101655330|FG007|COMPLETED|Part A: Period 1 (Day 1 to Week 24)||0||
48538800|NCT04784533|101655331|FG008|COMPLETED|Part A: Period 1 (Day 1 to Week 24)||0||
48538801|NCT04784533|101655332|FG009|COMPLETED|Part A: Period 1 (Day 1 to Week 24)||0||
48538802|NCT04784533|101655323|FG000|NOT COMPLETED|Part A: Period 1 (Day 1 to Week 24)||18||
48538803|NCT04784533|101655324|FG001|NOT COMPLETED|Part A: Period 1 (Day 1 to Week 24)||19||
48538804|NCT04784533|101655325|FG002|NOT COMPLETED|Part A: Period 1 (Day 1 to Week 24)||0||
48538805|NCT04784533|101655326|FG003|NOT COMPLETED|Part A: Period 1 (Day 1 to Week 24)||0||
48538806|NCT04784533|101655327|FG004|NOT COMPLETED|Part A: Period 1 (Day 1 to Week 24)||0||
48538807|NCT04784533|101655328|FG005|NOT COMPLETED|Part A: Period 1 (Day 1 to Week 24)||0||
48538808|NCT04784533|101655329|FG006|NOT COMPLETED|Part A: Period 1 (Day 1 to Week 24)||0||
48538809|NCT04784533|101655330|FG007|NOT COMPLETED|Part A: Period 1 (Day 1 to Week 24)||0||
48538810|NCT04784533|101655331|FG008|NOT COMPLETED|Part A: Period 1 (Day 1 to Week 24)||0||
48538811|NCT04784533|101655332|FG009|NOT COMPLETED|Part A: Period 1 (Day 1 to Week 24)||0||
48538812|NCT04784533|101655323|FG000|STARTED|Part A: Period 2 (Week 24 to Week 48)||0|The Part A Period 2 consists of participants from Part A Period 1 from each dose group who achieved an absolute SALT score of ≤20 at Week 24.|
48538813|NCT04784533|101655324|FG001|STARTED|Part A: Period 2 (Week 24 to Week 48)||0|The Part A Period 2 consists of participants from Part A Period 1 from each dose group who achieved an absolute SALT score of ≤20 at Week 24.|
48538814|NCT04784533|101655325|FG002|STARTED|Part A: Period 2 (Week 24 to Week 48)||18|The Part A Period 2 consists of participants from Part A Period 1 from each dose group who achieved an absolute SALT score of ≤20 at Week 24.|
48538815|NCT04784533|101655326|FG003|STARTED|Part A: Period 2 (Week 24 to Week 48)||25|The Part A Period 2 consists of participants from Part A Period 1 from each dose group who achieved an absolute SALT score of ≤20 at Week 24.|
48538816|NCT04784533|101655327|FG004|STARTED|Part A: Period 2 (Week 24 to Week 48)||18|The Part A Period 2 consists of participants from Part A Period 1 from each dose group who achieved an absolute SALT score of ≤20 at Week 24.|
48538817|NCT04784533|101655328|FG005|STARTED|Part A: Period 2 (Week 24 to Week 48)||25|The Part A Period 2 consists of participants from Part A Period 1 from each dose group who achieved an absolute SALT score of ≤20 at Week 24.|
48538818|NCT04784533|101655329|FG006|STARTED|Part A: Period 2 (Week 24 to Week 48)||0|The Part A Period 2 consists of participants from Part A Period 1 from each dose group who achieved an absolute SALT score of ≤20 at Week 24.|
48538819|NCT04784533|101655330|FG007|STARTED|Part A: Period 2 (Week 24 to Week 48)||0|The Part A Period 2 consists of participants from Part A Period 1 from each dose group who achieved an absolute SALT score of ≤20 at Week 24.|
48538820|NCT04784533|101655331|FG008|STARTED|Part A: Period 2 (Week 24 to Week 48)||0|The Part A Period 2 consists of participants from Part A Period 1 from each dose group who achieved an absolute SALT score of ≤20 at Week 24.|
48538821|NCT04784533|101655332|FG009|STARTED|Part A: Period 2 (Week 24 to Week 48)||0|The Part A Period 2 consists of participants from Part A Period 1 from each dose group who achieved an absolute SALT score of ≤20 at Week 24.|
48538822|NCT04784533|101655323|FG000|COMPLETED|Part A: Period 2 (Week 24 to Week 48)||0||
48538823|NCT04784533|101655324|FG001|COMPLETED|Part A: Period 2 (Week 24 to Week 48)||0||
48538824|NCT04784533|101655325|FG002|COMPLETED|Part A: Period 2 (Week 24 to Week 48)||17||
48538825|NCT04784533|101655326|FG003|COMPLETED|Part A: Period 2 (Week 24 to Week 48)||25||
48538826|NCT04784533|101655327|FG004|COMPLETED|Part A: Period 2 (Week 24 to Week 48)||18||
48538827|NCT04784533|101655328|FG005|COMPLETED|Part A: Period 2 (Week 24 to Week 48)||25||
48538828|NCT04784533|101655329|FG006|COMPLETED|Part A: Period 2 (Week 24 to Week 48)||0||
48538829|NCT04784533|101655330|FG007|COMPLETED|Part A: Period 2 (Week 24 to Week 48)||0||
48538830|NCT04784533|101655331|FG008|COMPLETED|Part A: Period 2 (Week 24 to Week 48)||0||
48538831|NCT04784533|101655332|FG009|COMPLETED|Part A: Period 2 (Week 24 to Week 48)||0||
48538832|NCT04784533|101655323|FG000|NOT COMPLETED|Part A: Period 2 (Week 24 to Week 48)||0||
48538833|NCT04784533|101655324|FG001|NOT COMPLETED|Part A: Period 2 (Week 24 to Week 48)||0||
48538834|NCT04784533|101655325|FG002|NOT COMPLETED|Part A: Period 2 (Week 24 to Week 48)||1||
48538835|NCT04784533|101655326|FG003|NOT COMPLETED|Part A: Period 2 (Week 24 to Week 48)||0||
48538836|NCT04784533|101655327|FG004|NOT COMPLETED|Part A: Period 2 (Week 24 to Week 48)||0||
48538837|NCT04784533|101655328|FG005|NOT COMPLETED|Part A: Period 2 (Week 24 to Week 48)||0||
48538838|NCT04784533|101655329|FG006|NOT COMPLETED|Part A: Period 2 (Week 24 to Week 48)||0||
48538839|NCT04784533|101655330|FG007|NOT COMPLETED|Part A: Period 2 (Week 24 to Week 48)||0||
48538840|NCT04784533|101655331|FG008|NOT COMPLETED|Part A: Period 2 (Week 24 to Week 48)||0||
48538841|NCT04784533|101655332|FG009|NOT COMPLETED|Part A: Period 2 (Week 24 to Week 48)||0||
48538842|NCT04784533|101655323|FG000|STARTED|Part B (Day 1 to Week 24)||0|The Part B consists of participants who achieved loss of regrowth maintenance (absolute SALT score of \> 20) from Part A Period 2.|
48538843|NCT04784533|101655324|FG001|STARTED|Part B (Day 1 to Week 24)||0|The Part B consists of participants who achieved loss of regrowth maintenance (absolute SALT score of \> 20) from Part A Period 2.|
48592673|NCT01877382|101783160|FG010|STARTED|Dose Expansion||0||
48674054|NCT00744861|101985930|FG001|NOT COMPLETED|Pivotal Stage 2||0||
48674055|NCT00744861|101985931|FG002|NOT COMPLETED|Pivotal Stage 2||102||
48674056|NCT00744861|101985932|FG003|NOT COMPLETED|Pivotal Stage 2||105||
48674057|NCT02254291|101985933|FG000|STARTED|Overall Study||103||
48674058|NCT02254291|101985934|FG001|STARTED|Overall Study||102||
48674059|NCT02254291|101985935|FG002|STARTED|Overall Study||103||
48674060|NCT02254291|101985933|FG000|Exposed|Overall Study||103||
48674061|NCT02254291|101985934|FG001|Exposed|Overall Study||102||
48674062|NCT02254291|101985935|FG002|Exposed|Overall Study||103||
48237784|NCT02206607|100903048|FG003|NOT COMPLETED|Second Washout Period 5 to 10 Days||0||
48237785|NCT02206607|100903049|FG004|NOT COMPLETED|Second Washout Period 5 to 10 Days||0||
48237786|NCT02206607|100903045|FG000|STARTED|Third Intervention Period||0||
48674063|NCT02254291|101985933|FG000|COMPLETED|Overall Study||103||
48674064|NCT02254291|101985934|FG001|COMPLETED|Overall Study||99||
48674065|NCT02254291|101985935|FG002|COMPLETED|Overall Study||101||
48674066|NCT02254291|101985933|FG000|NOT COMPLETED|Overall Study||0||
48674067|NCT02254291|101985934|FG001|NOT COMPLETED|Overall Study||3||
48674068|NCT02254291|101985935|FG002|NOT COMPLETED|Overall Study||2||
48674069|NCT03949517|101985936|FG000|STARTED|Pre-HIFU Period, Imaging Timepoint 1||7||
48674070|NCT03949517|101985937|FG001|STARTED|Pre-HIFU Period, Imaging Timepoint 1||7||
48674071|NCT03949517|101985936|FG000|COMPLETED|Pre-HIFU Period, Imaging Timepoint 1||7||
48674072|NCT03949517|101985937|FG001|COMPLETED|Pre-HIFU Period, Imaging Timepoint 1||7||
48674073|NCT03949517|101985936|FG000|NOT COMPLETED|Pre-HIFU Period, Imaging Timepoint 1||0||
48674074|NCT03949517|101985937|FG001|NOT COMPLETED|Pre-HIFU Period, Imaging Timepoint 1||0||
48674075|NCT03949517|101985936|FG000|STARTED|Pre-HIFU Period, Imaging Timepoint 2||7||
48674076|NCT03949517|101985937|FG001|STARTED|Pre-HIFU Period, Imaging Timepoint 2||7||
48674077|NCT03949517|101985936|FG000|COMPLETED|Pre-HIFU Period, Imaging Timepoint 2||7||
48674078|NCT03949517|101985937|FG001|COMPLETED|Pre-HIFU Period, Imaging Timepoint 2||7||
48674079|NCT03949517|101985936|FG000|NOT COMPLETED|Pre-HIFU Period, Imaging Timepoint 2||0||
48674080|NCT03949517|101985937|FG001|NOT COMPLETED|Pre-HIFU Period, Imaging Timepoint 2||0||
48674081|NCT03949517|101985936|FG000|STARTED|HIFU Treatment||7||
48674082|NCT03949517|101985937|FG001|STARTED|HIFU Treatment||7||
48674083|NCT03949517|101985936|FG000|COMPLETED|HIFU Treatment||7||
48674084|NCT03949517|101985937|FG001|COMPLETED|HIFU Treatment||7||
48674085|NCT03949517|101985936|FG000|NOT COMPLETED|HIFU Treatment||0||
48674086|NCT03949517|101985937|FG001|NOT COMPLETED|HIFU Treatment||0||
48674087|NCT03949517|101985936|FG000|STARTED|Post-HIFU Period, Imaging Timepoint 1||7||
48674088|NCT03949517|101985937|FG001|STARTED|Post-HIFU Period, Imaging Timepoint 1||7||
48674089|NCT03949517|101985936|FG000|COMPLETED|Post-HIFU Period, Imaging Timepoint 1||7||
48674090|NCT03949517|101985937|FG001|COMPLETED|Post-HIFU Period, Imaging Timepoint 1||7||
48674091|NCT03949517|101985936|FG000|NOT COMPLETED|Post-HIFU Period, Imaging Timepoint 1||0||
48674092|NCT03949517|101985937|FG001|NOT COMPLETED|Post-HIFU Period, Imaging Timepoint 1||0||
48674093|NCT03949517|101985936|FG000|STARTED|Post-HIFU Period, Imaging Timepoint 2||7||
48674094|NCT03949517|101985937|FG001|STARTED|Post-HIFU Period, Imaging Timepoint 2||7||
48674095|NCT03949517|101985936|FG000|COMPLETED|Post-HIFU Period, Imaging Timepoint 2||7||
48674096|NCT03949517|101985937|FG001|COMPLETED|Post-HIFU Period, Imaging Timepoint 2||7||
48674097|NCT03949517|101985936|FG000|NOT COMPLETED|Post-HIFU Period, Imaging Timepoint 2||0||
48674098|NCT03949517|101985937|FG001|NOT COMPLETED|Post-HIFU Period, Imaging Timepoint 2||0||
48674099|NCT01876381|101985938|FG000|STARTED|Overall Study||23||
48674100|NCT01876381|101985938|FG000|COMPLETED|Overall Study||16||
48674101|NCT01876381|101985938|FG000|NOT COMPLETED|Overall Study||7||
48674102|NCT02682056|101985939|FG000|STARTED|Overall Study||15||
48674103|NCT02682056|101985939|FG000|COMPLETED|Overall Study||15||
48674104|NCT02682056|101985939|FG000|NOT COMPLETED|Overall Study||0||
48237787|NCT02206607|100903046|FG001|STARTED|Third Intervention Period||9||
48237788|NCT02206607|100903047|FG002|STARTED|Third Intervention Period||9||
48674105|NCT02441218|101985940|FG000|STARTED|Overall Study||3241||
48674106|NCT02441218|101985941|FG001|STARTED|Overall Study||3264||
48674107|NCT02441218|101985940|FG000|COMPLETED|Overall Study||2663||
48674108|NCT02441218|101985941|FG001|COMPLETED|Overall Study||2652||
48674109|NCT02441218|101985940|FG000|NOT COMPLETED|Overall Study||578||
48674110|NCT02441218|101985941|FG001|NOT COMPLETED|Overall Study||612||
48674111|NCT02525679|101985942|FG000|STARTED|Overall Study||6||
48674112|NCT02525679|101985943|FG001|STARTED|Overall Study||6||
48674113|NCT02525679|101985944|FG002|STARTED|Overall Study||6||
48237789|NCT02206607|100903048|FG003|STARTED|Third Intervention Period||10||
48237790|NCT02206607|100903049|FG004|STARTED|Third Intervention Period||10||
48674114|NCT02525679|101985945|FG003|STARTED|Overall Study||6||
48674115|NCT02525679|101985946|FG004|STARTED|Overall Study||5||
48674116|NCT02525679|101985947|FG005|STARTED|Overall Study||4||
48674117|NCT02525679|101985948|FG006|STARTED|Overall Study||6||
48674118|NCT02525679|101985949|FG007|STARTED|Overall Study||6||
48674119|NCT02525679|101985950|FG008|STARTED|Overall Study||6||
48674120|NCT02525679|101985951|FG009|STARTED|Overall Study||4||
48674121|NCT02525679|101985952|FG010|STARTED|Overall Study||3||
48674122|NCT02525679|101985953|FG011|STARTED|Overall Study||20||
48237791|NCT02206607|100903045|FG000|COMPLETED|Third Intervention Period||0||
48237792|NCT02206607|100903046|FG001|COMPLETED|Third Intervention Period||9||
48237793|NCT02206607|100903047|FG002|COMPLETED|Third Intervention Period||9||
48237794|NCT02206607|100903048|FG003|COMPLETED|Third Intervention Period||10||
48237795|NCT02206607|100903049|FG004|COMPLETED|Third Intervention Period||10||
48237796|NCT02206607|100903045|FG000|NOT COMPLETED|Third Intervention Period||0||
48237797|NCT02206607|100903046|FG001|NOT COMPLETED|Third Intervention Period||0||
48237798|NCT02206607|100903047|FG002|NOT COMPLETED|Third Intervention Period||0||
48237799|NCT02206607|100903048|FG003|NOT COMPLETED|Third Intervention Period||0||
48237800|NCT02206607|100903049|FG004|NOT COMPLETED|Third Intervention Period||0||
48237801|NCT02206607|100903045|FG000|STARTED|Third Washout Period 5 to 10 Days||0||
48237802|NCT02206607|100903046|FG001|STARTED|Third Washout Period 5 to 10 Days||9||
48237803|NCT02206607|100903047|FG002|STARTED|Third Washout Period 5 to 10 Days||9||
48237804|NCT02206607|100903048|FG003|STARTED|Third Washout Period 5 to 10 Days||10||
48237805|NCT02206607|100903049|FG004|STARTED|Third Washout Period 5 to 10 Days||10||
48237806|NCT02206607|100903045|FG000|COMPLETED|Third Washout Period 5 to 10 Days||0||
48237807|NCT02206607|100903046|FG001|COMPLETED|Third Washout Period 5 to 10 Days||9||
48237808|NCT02206607|100903047|FG002|COMPLETED|Third Washout Period 5 to 10 Days||9||
48237809|NCT02206607|100903048|FG003|COMPLETED|Third Washout Period 5 to 10 Days||10||
48237810|NCT02206607|100903049|FG004|COMPLETED|Third Washout Period 5 to 10 Days||10||
48237811|NCT02206607|100903045|FG000|NOT COMPLETED|Third Washout Period 5 to 10 Days||0||
48237812|NCT02206607|100903046|FG001|NOT COMPLETED|Third Washout Period 5 to 10 Days||0||
48237813|NCT02206607|100903047|FG002|NOT COMPLETED|Third Washout Period 5 to 10 Days||0||
48237814|NCT02206607|100903048|FG003|NOT COMPLETED|Third Washout Period 5 to 10 Days||0||
48538844|NCT04784533|101655325|FG002|STARTED|Part B (Day 1 to Week 24)||0|The Part B consists of participants who achieved loss of regrowth maintenance (absolute SALT score of \> 20) from Part A Period 2.|
48538845|NCT04784533|101655326|FG003|STARTED|Part B (Day 1 to Week 24)||0|The Part B consists of participants who achieved loss of regrowth maintenance (absolute SALT score of \> 20) from Part A Period 2.|
48538846|NCT04784533|101655327|FG004|STARTED|Part B (Day 1 to Week 24)||0|The Part B consists of participants who achieved loss of regrowth maintenance (absolute SALT score of \> 20) from Part A Period 2.|
48538847|NCT04784533|101655328|FG005|STARTED|Part B (Day 1 to Week 24)||0|The Part B consists of participants who achieved loss of regrowth maintenance (absolute SALT score of \> 20) from Part A Period 2.|
48538848|NCT04784533|101655329|FG006|STARTED|Part B (Day 1 to Week 24)||5|The Part B consists of participants who achieved loss of regrowth maintenance (absolute SALT score of \> 20) from Part A Period 2.|
48237815|NCT02206607|100903049|FG004|NOT COMPLETED|Third Washout Period 5 to 10 Days||0||
48237816|NCT02206607|100903045|FG000|STARTED|Fourth Intervention Period||0||
48237817|NCT02206607|100903046|FG001|STARTED|Fourth Intervention Period||9||
48237818|NCT02206607|100903047|FG002|STARTED|Fourth Intervention Period||9||
48237819|NCT02206607|100903048|FG003|STARTED|Fourth Intervention Period||10||
48237820|NCT02206607|100903049|FG004|STARTED|Fourth Intervention Period||10||
48237821|NCT02206607|100903045|FG000|COMPLETED|Fourth Intervention Period||0||
48237822|NCT02206607|100903046|FG001|COMPLETED|Fourth Intervention Period||9||
48237823|NCT02206607|100903047|FG002|COMPLETED|Fourth Intervention Period||9||
48237824|NCT02206607|100903048|FG003|COMPLETED|Fourth Intervention Period||10||
48237825|NCT02206607|100903049|FG004|COMPLETED|Fourth Intervention Period||10||
48237826|NCT02206607|100903045|FG000|NOT COMPLETED|Fourth Intervention Period||0||
48237827|NCT02206607|100903046|FG001|NOT COMPLETED|Fourth Intervention Period||0||
48237828|NCT02206607|100903047|FG002|NOT COMPLETED|Fourth Intervention Period||0||
48237829|NCT02206607|100903048|FG003|NOT COMPLETED|Fourth Intervention Period||0||
48237830|NCT02206607|100903049|FG004|NOT COMPLETED|Fourth Intervention Period||0||
48237831|NCT03694210|100903050|FG000|STARTED|Overall Study||37|37 patients were screened, 7 were screen failures, 30 were enrolled and treated.|
48237832|NCT03694210|100903050|FG000|COMPLETED|Overall Study||29|1 subject passed away just prior to completing the study but all analysis points were collected prior to this.|
48237833|NCT03694210|100903050|FG000|NOT COMPLETED|Overall Study||8||
48237834|NCT02168153|100903051|FG000|STARTED|Overall Study||60||
48237835|NCT02168153|100903052|FG001|STARTED|Overall Study||60||
48237836|NCT02168153|100903051|FG000|COMPLETED|Overall Study||57||
48237837|NCT02168153|100903052|FG001|COMPLETED|Overall Study||60||
48237838|NCT02168153|100903051|FG000|NOT COMPLETED|Overall Study||3||
48237839|NCT02168153|100903052|FG001|NOT COMPLETED|Overall Study||0||
48237840|NCT00234832|100903053|FG000|STARTED|Overall Study||4906||
48237841|NCT00234832|100903054|FG001|STARTED|Overall Study||4898||
48237842|NCT00234832|100903053|FG000|COMPLETED|Overall Study||3890||
48237843|NCT00234832|100903054|FG001|COMPLETED|Overall Study||3902||
48538849|NCT04784533|101655330|FG007|STARTED|Part B (Day 1 to Week 24)||8|The Part B consists of participants who achieved loss of regrowth maintenance (absolute SALT score of \> 20) from Part A Period 2.|
48538850|NCT04784533|101655331|FG008|STARTED|Part B (Day 1 to Week 24)||15|The Part B consists of participants who achieved loss of regrowth maintenance (absolute SALT score of \> 20) from Part A Period 2.|
48538851|NCT04784533|101655332|FG009|STARTED|Part B (Day 1 to Week 24)||19|The Part B consists of participants who achieved loss of regrowth maintenance (absolute SALT score of \> 20) from Part A Period 2.|
48674123|NCT02525679|101985942|FG000|COMPLETED|Overall Study||6||
48674124|NCT02525679|101985943|FG001|COMPLETED|Overall Study||6||
48237844|NCT00234832|100903053|FG000|NOT COMPLETED|Overall Study||1016||
48237845|NCT00234832|100903054|FG001|NOT COMPLETED|Overall Study||996||
48237846|NCT00889863|100903055|FG000|STARTED|Part I: Open Label||177||
48237847|NCT00889863|100903056|FG001|STARTED|Part I: Open Label||0||
48237848|NCT00889863|100903055|FG000|Entered Part Ia|Part I: Open Label||145||
48237849|NCT00889863|100903056|FG001|Entered Part Ia|Part I: Open Label||0||
48237850|NCT00889863|100903055|FG000|Entered Part Ib|Part I: Open Label||142||
48237851|NCT00889863|100903056|FG001|Entered Part Ib|Part I: Open Label||0||
48237852|NCT00889863|100903055|FG000|Entered Part Ic|Part I: Open Label||92||
48237853|NCT00889863|100903056|FG001|Entered Part Ic|Part I: Open Label||0||
48237854|NCT00889863|100903055|FG000|Entered Part 1d|Part I: Open Label||103||
48237855|NCT00889863|100903056|FG001|Entered Part 1d|Part I: Open Label||0||
48237856|NCT00889863|100903055|FG000|COMPLETED|Part I: Open Label||100||
48237857|NCT00889863|100903056|FG001|COMPLETED|Part I: Open Label||0||
48237858|NCT00889863|100903055|FG000|NOT COMPLETED|Part I: Open Label||77||
48237859|NCT00889863|100903056|FG001|NOT COMPLETED|Part I: Open Label||0||
48237860|NCT00889863|100903055|FG000|STARTED|Part II: Randomized Double Blind||50||
48237861|NCT00889863|100903056|FG001|STARTED|Part II: Randomized Double Blind||50||
48237862|NCT00889863|100903055|FG000|COMPLETED|Part II: Randomized Double Blind||39||
48237863|NCT00889863|100903056|FG001|COMPLETED|Part II: Randomized Double Blind||24||
48237864|NCT00889863|100903055|FG000|NOT COMPLETED|Part II: Randomized Double Blind||11||
48237865|NCT00889863|100903056|FG001|NOT COMPLETED|Part II: Randomized Double Blind||26||
48237866|NCT00157209|100903057|FG000|STARTED|Overall Study||88||
48237867|NCT00157209|100903058|FG001|STARTED|Overall Study||83||
48237868|NCT00157209|100903057|FG000|COMPLETED|Overall Study||78||
48237869|NCT00157209|100903058|FG001|COMPLETED|Overall Study||83||
48237870|NCT00157209|100903057|FG000|NOT COMPLETED|Overall Study||10||
48237871|NCT00157209|100903058|FG001|NOT COMPLETED|Overall Study||0||
48237872|NCT02319304|100903059|FG000|STARTED|Overall Study||3||
48237873|NCT02319304|100903059|FG000|COMPLETED|Overall Study||2||
48237874|NCT02319304|100903059|FG000|NOT COMPLETED|Overall Study||1||
48237875|NCT01773707|100903060|FG000|STARTED|Overall Study||101||
48237876|NCT01773707|100903061|FG001|STARTED|Overall Study||111||
48237877|NCT01773707|100903060|FG000|COMPLETED|Overall Study||99||
48237878|NCT01773707|100903061|FG001|COMPLETED|Overall Study||108||
48237879|NCT01773707|100903060|FG000|NOT COMPLETED|Overall Study||2||
48237880|NCT01773707|100903061|FG001|NOT COMPLETED|Overall Study||3||
48237881|NCT03557307|100903062|FG000|STARTED|Period 1: To End of OCS Reduction Phase||598|Received study drug|
48237882|NCT03557307|100903062|FG000|COMPLETED|Period 1: To End of OCS Reduction Phase||563|Could not reduce OCS dose further according to protocol.|
48237883|NCT03557307|100903062|FG000|NOT COMPLETED|Period 1: To End of OCS Reduction Phase||35||
48237884|NCT03557307|100903062|FG000|STARTED|Period 2: Maintenance Phase||563|Completed OCS reduction phase.|
48237885|NCT03557307|100903062|FG000|COMPLETED|Period 2: Maintenance Phase||536|Marked 'Completed' to subject's status on the Disposition CRF|
48237886|NCT03557307|100903062|FG000|NOT COMPLETED|Period 2: Maintenance Phase||27||
48237887|NCT03557307|100903062|FG000|STARTED|Period 3: Long Term Follow up Substudy||195|Patients enrolled in long term follow up substudy|
48237888|NCT03557307|100903062|FG000|Asthma Treatment as Per Healthcare Provider Discretion|Period 3: Long Term Follow up Substudy||195|Treated as per healthcare provider's discretion, including Benra 30 mg administered subcutaneously every 4-8 weeks or other biologics. IP or medications were not provided by the sponsor.|
48237889|NCT03557307|100903062|FG000|>=50% Any Biologic|Period 3: Long Term Follow up Substudy||78|\>=50% exposure to any biologic treatment for asthma from the end of maintenance phase of the main study to the Long Term Follow Up visit|
48237890|NCT03557307|100903062|FG000|>=50% Benra|Period 3: Long Term Follow up Substudy||69|\>=50% exposure to benralizumab from the end of maintenance phase of the main study to the Long Term follow Up visit, and no previous or concurrent exposure to any other biologic during this period|
48237891|NCT03557307|100903062|FG000|COMPLETED|Period 3: Long Term Follow up Substudy||195||
48237892|NCT03557307|100903062|FG000|NOT COMPLETED|Period 3: Long Term Follow up Substudy||0||
48237893|NCT03152409|100903063|FG000|STARTED|Overall Study||6||
48237894|NCT03152409|100903064|FG001|STARTED|Overall Study||5||
48237895|NCT03152409|100903063|FG000|COMPLETED|Overall Study||3||
48237896|NCT03152409|100903064|FG001|COMPLETED|Overall Study||3||
48237897|NCT03152409|100903063|FG000|NOT COMPLETED|Overall Study||3||
48237898|NCT03152409|100903064|FG001|NOT COMPLETED|Overall Study||2||
48237899|NCT03873038|100903065|FG000|STARTED|Part 1||6||
48237900|NCT03873038|100903066|FG001|STARTED|Part 1||7||
48237901|NCT03873038|100903067|FG002|STARTED|Part 1||6||
48237902|NCT03873038|100903068|FG003|STARTED|Part 1||5||
48237903|NCT03873038|100903069|FG004|STARTED|Part 1||0||
48237904|NCT03873038|100903070|FG005|STARTED|Part 1||0||
48237905|NCT03873038|100903065|FG000|COMPLETED|Part 1||6||
48237906|NCT03873038|100903066|FG001|COMPLETED|Part 1||7||
48237907|NCT03873038|100903067|FG002|COMPLETED|Part 1||6||
48237908|NCT03873038|100903068|FG003|COMPLETED|Part 1||5||
48237909|NCT03873038|100903069|FG004|COMPLETED|Part 1||0||
48237910|NCT03873038|100903070|FG005|COMPLETED|Part 1||0||
48237911|NCT03873038|100903065|FG000|NOT COMPLETED|Part 1||0||
48237912|NCT03873038|100903066|FG001|NOT COMPLETED|Part 1||0||
48237913|NCT03873038|100903067|FG002|NOT COMPLETED|Part 1||0||
48237914|NCT03873038|100903068|FG003|NOT COMPLETED|Part 1||0||
48237915|NCT03873038|100903069|FG004|NOT COMPLETED|Part 1||0||
48237916|NCT03873038|100903070|FG005|NOT COMPLETED|Part 1||0||
48237917|NCT03873038|100903065|FG000|STARTED|Part 2||0||
48237918|NCT03873038|100903066|FG001|STARTED|Part 2||0||
48237919|NCT03873038|100903067|FG002|STARTED|Part 2||0||
48237920|NCT03873038|100903068|FG003|STARTED|Part 2||0||
48237921|NCT03873038|100903069|FG004|STARTED|Part 2||16||
48237922|NCT03873038|100903070|FG005|STARTED|Part 2||5||
48237923|NCT03873038|100903065|FG000|COMPLETED|Part 2||0||
48237924|NCT03873038|100903066|FG001|COMPLETED|Part 2||0||
48237925|NCT03873038|100903067|FG002|COMPLETED|Part 2||0||
48237926|NCT03873038|100903068|FG003|COMPLETED|Part 2||0||
48237927|NCT03873038|100903069|FG004|COMPLETED|Part 2||15||
48237928|NCT03873038|100903070|FG005|COMPLETED|Part 2||4||
48237929|NCT03873038|100903065|FG000|NOT COMPLETED|Part 2||0||
48237930|NCT03873038|100903066|FG001|NOT COMPLETED|Part 2||0||
48237931|NCT03873038|100903067|FG002|NOT COMPLETED|Part 2||0||
48237932|NCT03873038|100903068|FG003|NOT COMPLETED|Part 2||0||
48237933|NCT03873038|100903069|FG004|NOT COMPLETED|Part 2||1||
48237934|NCT03873038|100903070|FG005|NOT COMPLETED|Part 2||1||
48237935|NCT00424476|100903071|FG000|STARTED|Overall Study||287||
48237936|NCT00424476|100903072|FG001|STARTED|Overall Study||288||
48237937|NCT00424476|100903073|FG002|STARTED|Overall Study||290||
48237938|NCT00424476|100903071|FG000|COMPLETED|Overall Study||226||
48237939|NCT00424476|100903072|FG001|COMPLETED|Overall Study||240||
48237940|NCT00424476|100903073|FG002|COMPLETED|Overall Study||241||
48237941|NCT00424476|100903071|FG000|NOT COMPLETED|Overall Study||61||
48237942|NCT00424476|100903072|FG001|NOT COMPLETED|Overall Study||48||
48237943|NCT00424476|100903073|FG002|NOT COMPLETED|Overall Study||49||
48237944|NCT04626128|100903074|FG000|STARTED|Overall Study||6||
48237945|NCT04626128|100903075|FG001|STARTED|Overall Study||5||
48674125|NCT02525679|101985944|FG002|COMPLETED|Overall Study||6||
48674126|NCT02525679|101985945|FG003|COMPLETED|Overall Study||6||
48674127|NCT02525679|101985946|FG004|COMPLETED|Overall Study||5||
48674128|NCT02525679|101985947|FG005|COMPLETED|Overall Study||4||
48674129|NCT02525679|101985948|FG006|COMPLETED|Overall Study||6||
48674130|NCT02525679|101985949|FG007|COMPLETED|Overall Study||6||
48674131|NCT02525679|101985950|FG008|COMPLETED|Overall Study||6||
48674132|NCT02525679|101985951|FG009|COMPLETED|Overall Study||4||
48674133|NCT02525679|101985952|FG010|COMPLETED|Overall Study||3||
48674134|NCT02525679|101985953|FG011|COMPLETED|Overall Study||20||
48674135|NCT02525679|101985942|FG000|NOT COMPLETED|Overall Study||0||
48674136|NCT02525679|101985943|FG001|NOT COMPLETED|Overall Study||0||
48674137|NCT02525679|101985944|FG002|NOT COMPLETED|Overall Study||0||
48674138|NCT02525679|101985945|FG003|NOT COMPLETED|Overall Study||0||
48674139|NCT02525679|101985946|FG004|NOT COMPLETED|Overall Study||0||
48674140|NCT02525679|101985947|FG005|NOT COMPLETED|Overall Study||0||
48674141|NCT02525679|101985948|FG006|NOT COMPLETED|Overall Study||0||
48674142|NCT02525679|101985949|FG007|NOT COMPLETED|Overall Study||0||
48674143|NCT02525679|101985950|FG008|NOT COMPLETED|Overall Study||0||
48674144|NCT02525679|101985951|FG009|NOT COMPLETED|Overall Study||0||
48674145|NCT02525679|101985952|FG010|NOT COMPLETED|Overall Study||0||
48674146|NCT02525679|101985953|FG011|NOT COMPLETED|Overall Study||0||
48674147|NCT01444781|101985954|FG000|STARTED|Overall Study||416||
48674148|NCT01444781|101985955|FG001|STARTED|Overall Study||415||
48674149|NCT01444781|101985956|FG002|STARTED|Overall Study||275||
48674150|NCT01444781|101985954|FG000|COMPLETED|Overall Study||413||
48674151|NCT01444781|101985955|FG001|COMPLETED|Overall Study||411||
48237946|NCT04626128|100903076|FG002|STARTED|Overall Study||8||
48237947|NCT04626128|100903077|FG003|STARTED|Overall Study||8||
48237948|NCT04626128|100903074|FG000|Safety Population|Overall Study||6|Defined as all enrolled participants who were administered CLS-AX, and from whom at least one post-Baseline safety measurement was obtained.|
48237949|NCT04626128|100903075|FG001|Safety Population|Overall Study||5|Defined as all enrolled participants who were administered CLS-AX, and from whom at least one post-Baseline safety measurement was obtained.|
48237950|NCT04626128|100903076|FG002|Safety Population|Overall Study||8|Defined as all enrolled participants who were administered CLS-AX, and from whom at least one post-Baseline safety measurement was obtained.|
48237951|NCT04626128|100903077|FG003|Safety Population|Overall Study||8|Defined as all enrolled participants who were administered CLS-AX, and from whom at least one post-Baseline safety measurement was obtained.|
48237952|NCT04626128|100903074|FG000|Pharmacokinetic Population|Overall Study||6|Defined as all participants that provide plasma samples for axitinib concentration analysis.|
48237953|NCT04626128|100903075|FG001|Pharmacokinetic Population|Overall Study||5|Defined as all participants that provide plasma samples for axitinib concentration analysis.|
48237954|NCT04626128|100903076|FG002|Pharmacokinetic Population|Overall Study||8|Defined as all participants that provide plasma samples for axitinib concentration analysis.|
48237955|NCT04626128|100903077|FG003|Pharmacokinetic Population|Overall Study||8|Defined as all participants that provide plasma samples for axitinib concentration analysis.|
48674152|NCT01444781|101985956|FG002|COMPLETED|Overall Study||272||
48674153|NCT01444781|101985954|FG000|NOT COMPLETED|Overall Study||3||
48674154|NCT01444781|101985955|FG001|NOT COMPLETED|Overall Study||4||
48674155|NCT01444781|101985956|FG002|NOT COMPLETED|Overall Study||3||
48674156|NCT00790673|101985957|FG000|STARTED|Overall Study||6||
48674157|NCT00790673|101985958|FG001|STARTED|Overall Study||6||
48674158|NCT00790673|101985959|FG002|STARTED|Overall Study||12||
48674159|NCT00790673|101985960|FG003|STARTED|Overall Study||8||
48674160|NCT00790673|101985957|FG000|COMPLETED|Overall Study||6||
48674161|NCT00790673|101985958|FG001|COMPLETED|Overall Study||6||
48674162|NCT00790673|101985959|FG002|COMPLETED|Overall Study||12||
48674163|NCT00790673|101985960|FG003|COMPLETED|Overall Study||8||
48674164|NCT00790673|101985957|FG000|NOT COMPLETED|Overall Study||0||
48674165|NCT00790673|101985958|FG001|NOT COMPLETED|Overall Study||0||
48674166|NCT00790673|101985959|FG002|NOT COMPLETED|Overall Study||0||
48237956|NCT04626128|100903074|FG000|COMPLETED|Overall Study||6||
48237957|NCT04626128|100903075|FG001|COMPLETED|Overall Study||4||
48237958|NCT04626128|100903076|FG002|COMPLETED|Overall Study||8||
48237959|NCT04626128|100903077|FG003|COMPLETED|Overall Study||8||
48237960|NCT04626128|100903074|FG000|NOT COMPLETED|Overall Study||0||
48237961|NCT04626128|100903075|FG001|NOT COMPLETED|Overall Study||1||
48237962|NCT04626128|100903076|FG002|NOT COMPLETED|Overall Study||0||
48237963|NCT04626128|100903077|FG003|NOT COMPLETED|Overall Study||0||
48237964|NCT01123356|100903078|FG000|STARTED|Overall Study||21||
48237965|NCT01123356|100903078|FG000|COMPLETED|Overall Study||14||
48237966|NCT01123356|100903078|FG000|NOT COMPLETED|Overall Study||7||
48237967|NCT03602053|100903079|FG000|STARTED|Overall Study||150||
48237968|NCT03602053|100903080|FG001|STARTED|Overall Study||150||
48674167|NCT00790673|101985960|FG003|NOT COMPLETED|Overall Study||0||
48674168|NCT02629861|101985961|FG000|STARTED|Overall Study||294||
48674169|NCT02629861|101985962|FG001|STARTED|Overall Study||291||
48538852|NCT04784533|101655323|FG000|COMPLETED|Part B (Day 1 to Week 24)||0||
48674170|NCT02629861|101985963|FG002|STARTED|Overall Study||290||
48674171|NCT02629861|101985961|FG000|Intent to Treat (ITT)|Overall Study||294||
48674172|NCT02629861|101985962|FG001|Intent to Treat (ITT)|Overall Study||291||
48674173|NCT02629861|101985963|FG002|Intent to Treat (ITT)|Overall Study||290||
48674174|NCT02629861|101985961|FG000|Safety Population|Overall Study||294||
48674175|NCT02629861|101985962|FG001|Safety Population|Overall Study||291||
48674176|NCT02629861|101985963|FG002|Safety Population|Overall Study||289||
48674177|NCT02629861|101985961|FG000|Full Analysis Set|Overall Study||290||
48674178|NCT02629861|101985962|FG001|Full Analysis Set|Overall Study||288||
48674179|NCT02629861|101985963|FG002|Full Analysis Set|Overall Study||287||
48674180|NCT02629861|101985961|FG000|COMPLETED|Overall Study||265||
48674181|NCT02629861|101985962|FG001|COMPLETED|Overall Study||264||
48237969|NCT03602053|100903081|FG002|STARTED|Overall Study||150||
48237970|NCT03602053|100903079|FG000|COMPLETED|Overall Study||131||
48538853|NCT04784533|101655324|FG001|COMPLETED|Part B (Day 1 to Week 24)||0||
48538854|NCT04784533|101655325|FG002|COMPLETED|Part B (Day 1 to Week 24)||0||
48538855|NCT04784533|101655326|FG003|COMPLETED|Part B (Day 1 to Week 24)||0||
48538856|NCT04784533|101655327|FG004|COMPLETED|Part B (Day 1 to Week 24)||0||
48538857|NCT04784533|101655328|FG005|COMPLETED|Part B (Day 1 to Week 24)||0||
48538858|NCT04784533|101655329|FG006|COMPLETED|Part B (Day 1 to Week 24)||5||
48538859|NCT04784533|101655330|FG007|COMPLETED|Part B (Day 1 to Week 24)||8||
48538860|NCT04784533|101655331|FG008|COMPLETED|Part B (Day 1 to Week 24)||13||
48538861|NCT04784533|101655332|FG009|COMPLETED|Part B (Day 1 to Week 24)||18||
48538862|NCT04784533|101655323|FG000|NOT COMPLETED|Part B (Day 1 to Week 24)||0||
48538863|NCT04784533|101655324|FG001|NOT COMPLETED|Part B (Day 1 to Week 24)||0||
48538864|NCT04784533|101655325|FG002|NOT COMPLETED|Part B (Day 1 to Week 24)||0||
48538865|NCT04784533|101655326|FG003|NOT COMPLETED|Part B (Day 1 to Week 24)||0||
48538866|NCT04784533|101655327|FG004|NOT COMPLETED|Part B (Day 1 to Week 24)||0||
48538867|NCT04784533|101655328|FG005|NOT COMPLETED|Part B (Day 1 to Week 24)||0||
48538868|NCT04784533|101655329|FG006|NOT COMPLETED|Part B (Day 1 to Week 24)||0||
48538869|NCT04784533|101655330|FG007|NOT COMPLETED|Part B (Day 1 to Week 24)||0||
48538870|NCT04784533|101655331|FG008|NOT COMPLETED|Part B (Day 1 to Week 24)||2||
48538871|NCT04784533|101655332|FG009|NOT COMPLETED|Part B (Day 1 to Week 24)||1||
48674182|NCT02629861|101985963|FG002|COMPLETED|Overall Study||262||
48674183|NCT02629861|101985961|FG000|NOT COMPLETED|Overall Study||29||
48674184|NCT02629861|101985962|FG001|NOT COMPLETED|Overall Study||27||
48674185|NCT02629861|101985963|FG002|NOT COMPLETED|Overall Study||28||
48674186|NCT02100826|101985964|FG000|STARTED|Period 1 (7 Days)||14||
48674187|NCT02100826|101985965|FG001|STARTED|Period 1 (7 Days)||14||
48674188|NCT02100826|101985964|FG000|COMPLETED|Period 1 (7 Days)||14||
48674189|NCT02100826|101985965|FG001|COMPLETED|Period 1 (7 Days)||14||
48674190|NCT02100826|101985964|FG000|NOT COMPLETED|Period 1 (7 Days)||0||
48674191|NCT02100826|101985965|FG001|NOT COMPLETED|Period 1 (7 Days)||0||
48237971|NCT03602053|100903080|FG001|COMPLETED|Overall Study||132||
48237972|NCT03602053|100903081|FG002|COMPLETED|Overall Study||139||
48237973|NCT03602053|100903079|FG000|NOT COMPLETED|Overall Study||19||
48538872|NCT00896480|101655333|FG000|STARTED|Overall Study||24||
48538873|NCT00896480|101655333|FG000|COMPLETED|Overall Study||3||
48538874|NCT00896480|101655333|FG000|NOT COMPLETED|Overall Study||21||
48538875|NCT03477903|101655334|FG000|STARTED|Overall Study||1||
48538876|NCT03477903|101655334|FG000|COMPLETED|Overall Study||0||
48538877|NCT03477903|101655334|FG000|NOT COMPLETED|Overall Study||1||
48237974|NCT03602053|100903080|FG001|NOT COMPLETED|Overall Study||18||
48237975|NCT03602053|100903081|FG002|NOT COMPLETED|Overall Study||11||
48237976|NCT00379210|100903082|FG000|STARTED|Overall Study||30||
48538878|NCT01246063|101655335|FG000|STARTED|Overall Study||3||
48538879|NCT01246063|101655336|FG001|STARTED|Overall Study||4||
48237977|NCT00379210|100903083|FG001|STARTED|Overall Study||30||
48237978|NCT00379210|100903082|FG000|COMPLETED|Overall Study||20||
48237979|NCT00379210|100903083|FG001|COMPLETED|Overall Study||23||
48538880|NCT01246063|101655337|FG002|STARTED|Overall Study||4||
48538881|NCT01246063|101655338|FG003|STARTED|Overall Study||5||
48674192|NCT02100826|101985964|FG000|STARTED|Washout Period (1 Day)||14||
48674193|NCT02100826|101985965|FG001|STARTED|Washout Period (1 Day)||14||
48674194|NCT02100826|101985964|FG000|COMPLETED|Washout Period (1 Day)||14||
48674195|NCT02100826|101985965|FG001|COMPLETED|Washout Period (1 Day)||14||
48674196|NCT02100826|101985964|FG000|NOT COMPLETED|Washout Period (1 Day)||0||
48674197|NCT02100826|101985965|FG001|NOT COMPLETED|Washout Period (1 Day)||0||
48674198|NCT02100826|101985964|FG000|STARTED|Period 2 (7 Days)||14||
48674199|NCT02100826|101985965|FG001|STARTED|Period 2 (7 Days)||14||
48674200|NCT02100826|101985964|FG000|COMPLETED|Period 2 (7 Days)||14||
48674201|NCT02100826|101985965|FG001|COMPLETED|Period 2 (7 Days)||14||
48237980|NCT00379210|100903082|FG000|NOT COMPLETED|Overall Study||10||
48237981|NCT00379210|100903083|FG001|NOT COMPLETED|Overall Study||7||
48237982|NCT02291861|100903084|FG000|STARTED|Overall Study||74||
48237983|NCT02291861|100903085|FG001|STARTED|Overall Study||75||
48237984|NCT02291861|100903086|FG002|STARTED|Overall Study||74||
48237985|NCT02291861|100903087|FG003|STARTED|Overall Study||75||
48237986|NCT02291861|100903084|FG000|Safety Population|Overall Study||72||
48237987|NCT02291861|100903085|FG001|Safety Population|Overall Study||74||
48237988|NCT02291861|100903086|FG002|Safety Population|Overall Study||73||
48237989|NCT02291861|100903087|FG003|Safety Population|Overall Study||74||
48237990|NCT02291861|100903084|FG000|Modified Intent to Treat Pop (mITT)|Overall Study||58||
48237991|NCT02291861|100903085|FG001|Modified Intent to Treat Pop (mITT)|Overall Study||60||
48237992|NCT02291861|100903086|FG002|Modified Intent to Treat Pop (mITT)|Overall Study||49||
48237993|NCT02291861|100903087|FG003|Modified Intent to Treat Pop (mITT)|Overall Study||55||
48237994|NCT02291861|100903084|FG000|COMPLETED|Overall Study||67||
48237995|NCT02291861|100903085|FG001|COMPLETED|Overall Study||67||
48237996|NCT02291861|100903086|FG002|COMPLETED|Overall Study||65||
48237997|NCT02291861|100903087|FG003|COMPLETED|Overall Study||65||
48237998|NCT02291861|100903084|FG000|NOT COMPLETED|Overall Study||7||
48237999|NCT02291861|100903085|FG001|NOT COMPLETED|Overall Study||8||
48238000|NCT02291861|100903086|FG002|NOT COMPLETED|Overall Study||9||
48238001|NCT02291861|100903087|FG003|NOT COMPLETED|Overall Study||10||
48238002|NCT05265247|100906481|FG000|STARTED|Period 1 (2 Days)||26||
48238003|NCT05265247|100906482|FG001|STARTED|Period 1 (2 Days)||29||
48238004|NCT05265247|100906481|FG000|COMPLETED|Period 1 (2 Days)||26||
48238005|NCT05265247|100906482|FG001|COMPLETED|Period 1 (2 Days)||29||
48238006|NCT05265247|100906481|FG000|NOT COMPLETED|Period 1 (2 Days)||0||
48238007|NCT05265247|100906482|FG001|NOT COMPLETED|Period 1 (2 Days)||0||
48238008|NCT05265247|100906481|FG000|STARTED|Washout Period (7 Days)||26||
48238009|NCT05265247|100906482|FG001|STARTED|Washout Period (7 Days)||29||
48238010|NCT05265247|100906481|FG000|COMPLETED|Washout Period (7 Days)||22||
48238011|NCT05265247|100906482|FG001|COMPLETED|Washout Period (7 Days)||22||
48238012|NCT05265247|100906481|FG000|NOT COMPLETED|Washout Period (7 Days)||4||
48238013|NCT05265247|100906482|FG001|NOT COMPLETED|Washout Period (7 Days)||7||
48238014|NCT05265247|100906481|FG000|STARTED|Period 2 (2 Days)||22||
48538882|NCT01246063|101655339|FG004|STARTED|Overall Study||7||
48538883|NCT01246063|101655340|FG005|STARTED|Overall Study||17||
48538884|NCT01246063|101655335|FG000|COMPLETED|Overall Study||3||
48538885|NCT01246063|101655336|FG001|COMPLETED|Overall Study||4||
48538886|NCT01246063|101655337|FG002|COMPLETED|Overall Study||4||
48538887|NCT01246063|101655338|FG003|COMPLETED|Overall Study||5||
48538888|NCT01246063|101655339|FG004|COMPLETED|Overall Study||7||
48538889|NCT01246063|101655340|FG005|COMPLETED|Overall Study||17||
48538890|NCT01246063|101655335|FG000|NOT COMPLETED|Overall Study||0||
48538891|NCT01246063|101655336|FG001|NOT COMPLETED|Overall Study||0||
48674202|NCT02100826|101985964|FG000|NOT COMPLETED|Period 2 (7 Days)||0||
48238015|NCT05265247|100906482|FG001|STARTED|Period 2 (2 Days)||22||
48238016|NCT05265247|100906481|FG000|COMPLETED|Period 2 (2 Days)||22||
48238017|NCT05265247|100906482|FG001|COMPLETED|Period 2 (2 Days)||22||
48538892|NCT01246063|101655337|FG002|NOT COMPLETED|Overall Study||0||
48538893|NCT01246063|101655338|FG003|NOT COMPLETED|Overall Study||0||
48674203|NCT02100826|101985965|FG001|NOT COMPLETED|Period 2 (7 Days)||0||
48674204|NCT01373281|101985966|FG000|STARTED|Vaccination Phase (Up to 25 Months)||6851||
48674205|NCT01373281|101985967|FG001|STARTED|Vaccination Phase (Up to 25 Months)||3424||
48674206|NCT01373281|101985966|FG000|COMPLETED|Vaccination Phase (Up to 25 Months)||6797||
48674207|NCT01373281|101985967|FG001|COMPLETED|Vaccination Phase (Up to 25 Months)||3397||
48674208|NCT01373281|101985966|FG000|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||54||
48674209|NCT01373281|101985967|FG001|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||27||
48674210|NCT01373281|101985966|FG000|STARTED|Surveillance Expansion Period||6797||
48674211|NCT01373281|101985967|FG001|STARTED|Surveillance Expansion Period||3397||
48674212|NCT01373281|101985966|FG000|COMPLETED|Surveillance Expansion Period||6595||
48674213|NCT01373281|101985967|FG001|COMPLETED|Surveillance Expansion Period||3279||
48674214|NCT01373281|101985966|FG000|NOT COMPLETED|Surveillance Expansion Period||202||
48674215|NCT01373281|101985967|FG001|NOT COMPLETED|Surveillance Expansion Period||118||
48674216|NCT01677988|101985968|FG000|STARTED|Overall Study||3||
48238018|NCT05265247|100906481|FG000|NOT COMPLETED|Period 2 (2 Days)||0||
48238019|NCT05265247|100906482|FG001|NOT COMPLETED|Period 2 (2 Days)||0||
48238020|NCT04995497|100906483|FG000|STARTED|Overall Study||36||
48238021|NCT04995497|100906484|FG001|STARTED|Overall Study||34||
48238022|NCT04995497|100906483|FG000|COMPLETED|Overall Study||29||
48538894|NCT01246063|101655339|FG004|NOT COMPLETED|Overall Study||0||
48538895|NCT01246063|101655340|FG005|NOT COMPLETED|Overall Study||0||
48538896|NCT02704403|101655341|FG000|STARTED|Overall Study||1437||
48538897|NCT02704403|101655342|FG001|STARTED|Overall Study||720||
48674217|NCT01677988|101985968|FG000|COMPLETED|Overall Study||1||
48674218|NCT01677988|101985968|FG000|NOT COMPLETED|Overall Study||2||
48674219|NCT01475721|101985969|FG000|STARTED|Overall Study||5834||
48674220|NCT01475721|101985970|FG001|STARTED|Overall Study||5845||
48674221|NCT01475721|101985969|FG000|COMPLETED|Overall Study||5823||
48674222|NCT01475721|101985970|FG001|COMPLETED|Overall Study||5831||
48674223|NCT01475721|101985969|FG000|NOT COMPLETED|Overall Study||11||
48674224|NCT01475721|101985970|FG001|NOT COMPLETED|Overall Study||14||
48674225|NCT02976181|101985971|FG000|STARTED|Overall Study||113||
48674226|NCT02976181|101985971|FG000|COMPLETED|Overall Study||112||
48674227|NCT02976181|101985971|FG000|NOT COMPLETED|Overall Study||1||
48674228|NCT02434081|101985972|FG000|STARTED|Overall Study||79||
48674229|NCT02434081|101985972|FG000|COMPLETED|Overall Study||31||
48674230|NCT02434081|101985972|FG000|NOT COMPLETED|Overall Study||48||
48674231|NCT01072526|101985973|FG000|STARTED|Overall Study||6||
48674232|NCT01072526|101985974|FG001|STARTED|Overall Study||0||
48674233|NCT01072526|101985973|FG000|COMPLETED|Overall Study||6||
48674234|NCT01072526|101985974|FG001|COMPLETED|Overall Study||0||
48674235|NCT01072526|101985973|FG000|NOT COMPLETED|Overall Study||0||
48674236|NCT01072526|101985974|FG001|NOT COMPLETED|Overall Study||0||
48674237|NCT01038323|101985975|FG000|STARTED|Overall Study||20||
48674238|NCT01038323|101985976|FG001|STARTED|Overall Study||19||
48674239|NCT01038323|101985977|FG002|STARTED|Overall Study||19||
48674240|NCT01038323|101985975|FG000|COMPLETED|Overall Study||17||
48674241|NCT01038323|101985976|FG001|COMPLETED|Overall Study||17||
48238023|NCT04995497|100906484|FG001|COMPLETED|Overall Study||28||
48238024|NCT04995497|100906483|FG000|NOT COMPLETED|Overall Study||7||
48238025|NCT04995497|100906484|FG001|NOT COMPLETED|Overall Study||6||
48238026|NCT01241448|100906485|FG000|STARTED|Overall Study||66||
48238027|NCT01241448|100906486|FG001|STARTED|Overall Study||65||
48238028|NCT01241448|100906487|FG002|STARTED|Overall Study||66||
48238029|NCT01241448|100906488|FG003|STARTED|Overall Study||66||
48238030|NCT01241448|100906485|FG000|Intent-to-Treat Population (ITT)|Overall Study||63||
48238031|NCT01241448|100906486|FG001|Intent-to-Treat Population (ITT)|Overall Study||63||
48238032|NCT01241448|100906487|FG002|Intent-to-Treat Population (ITT)|Overall Study||64||
48238033|NCT01241448|100906488|FG003|Intent-to-Treat Population (ITT)|Overall Study||64||
48238034|NCT01241448|100906485|FG000|ITT With ≥1 Post-Baseline Measure|Overall Study||61||
48238035|NCT01241448|100906486|FG001|ITT With ≥1 Post-Baseline Measure|Overall Study||61||
48238036|NCT01241448|100906487|FG002|ITT With ≥1 Post-Baseline Measure|Overall Study||64||
48238037|NCT01241448|100906488|FG003|ITT With ≥1 Post-Baseline Measure|Overall Study||62||
48238038|NCT01241448|100906485|FG000|COMPLETED|Overall Study||29||
48238039|NCT01241448|100906486|FG001|COMPLETED|Overall Study||36||
48238040|NCT01241448|100906487|FG002|COMPLETED|Overall Study||43||
48238041|NCT01241448|100906488|FG003|COMPLETED|Overall Study||43||
48238042|NCT01241448|100906485|FG000|NOT COMPLETED|Overall Study||37||
48238043|NCT01241448|100906486|FG001|NOT COMPLETED|Overall Study||29||
48238044|NCT01241448|100906487|FG002|NOT COMPLETED|Overall Study||23||
48238045|NCT01241448|100906488|FG003|NOT COMPLETED|Overall Study||23||
48238046|NCT02830893|100906489|FG000|STARTED|Overall Study||12||
48238047|NCT02830893|100906490|FG001|STARTED|Overall Study||11||
48238048|NCT02830893|100906489|FG000|COMPLETED|Overall Study||11||
48238049|NCT02830893|100906490|FG001|COMPLETED|Overall Study||8||
48238050|NCT02830893|100906489|FG000|NOT COMPLETED|Overall Study||1||
48238051|NCT02830893|100906490|FG001|NOT COMPLETED|Overall Study||3||
48238052|NCT02694198|100906491|FG000|STARTED|Overall Study||135||
48238053|NCT02694198|100906491|FG000|COMPLETED|Overall Study||135||
48238054|NCT02694198|100906491|FG000|NOT COMPLETED|Overall Study||0||
48674242|NCT01038323|101985977|FG002|COMPLETED|Overall Study||15||
48674243|NCT01038323|101985975|FG000|NOT COMPLETED|Overall Study||3||
48674244|NCT01038323|101985976|FG001|NOT COMPLETED|Overall Study||2||
48674245|NCT01038323|101985977|FG002|NOT COMPLETED|Overall Study||4||
48674246|NCT00582907|101985978|FG000|STARTED|1st Course||4||
48674247|NCT00582907|101985979|FG001|STARTED|1st Course||3||
48674248|NCT00582907|101985980|FG002|STARTED|1st Course||3||
48674249|NCT00582907|101985981|FG003|STARTED|1st Course||4||
48674250|NCT00582907|101985978|FG000|COMPLETED|1st Course||3||
48674251|NCT00582907|101985979|FG001|COMPLETED|1st Course||3||
48674252|NCT00582907|101985980|FG002|COMPLETED|1st Course||3||
48238055|NCT03481725|100906492|FG000|STARTED|Overall Study||31||
48238056|NCT03481725|100906493|FG001|STARTED|Overall Study||34||
48238057|NCT03481725|100906492|FG000|COMPLETED|Overall Study||30||
48674253|NCT00582907|101985981|FG003|COMPLETED|1st Course||3||
48674254|NCT00582907|101985978|FG000|NOT COMPLETED|1st Course||1||
48674255|NCT00582907|101985979|FG001|NOT COMPLETED|1st Course||0||
48674256|NCT00582907|101985980|FG002|NOT COMPLETED|1st Course||0||
48674257|NCT00582907|101985981|FG003|NOT COMPLETED|1st Course||1||
48674258|NCT00582907|101985978|FG000|STARTED|2nd Course||3||
48674259|NCT00582907|101985979|FG001|STARTED|2nd Course||3||
48238058|NCT03481725|100906493|FG001|COMPLETED|Overall Study||34||
48238059|NCT03481725|100906492|FG000|NOT COMPLETED|Overall Study||1||
48674260|NCT00582907|101985980|FG002|STARTED|2nd Course||3||
48674261|NCT00582907|101985981|FG003|STARTED|2nd Course||3||
48674262|NCT00582907|101985978|FG000|COMPLETED|2nd Course||2||
48674263|NCT00582907|101985979|FG001|COMPLETED|2nd Course||3||
48238060|NCT03481725|100906493|FG001|NOT COMPLETED|Overall Study||0||
48238061|NCT05072795|100906494|FG000|STARTED|Overall Study||47||
48238062|NCT05072795|100906494|FG000|COMPLETED|Overall Study||42||
48238063|NCT05072795|100906494|FG000|NOT COMPLETED|Overall Study||5||
48238064|NCT00267774|100906495|FG000|STARTED|Overall Study||509||
48538898|NCT02704403|101655341|FG000|Full Intent-to-Treat Population|Overall Study||1437||
48538899|NCT02704403|101655342|FG001|Full Intent-to-Treat Population|Overall Study||720||
48538900|NCT02704403|101655341|FG000|Full Safety Population|Overall Study||1433||
48538901|NCT02704403|101655342|FG001|Full Safety Population|Overall Study||717||
48538902|NCT02704403|101655341|FG000|COMPLETED|Overall Study||0||
48538903|NCT02704403|101655342|FG001|COMPLETED|Overall Study||0||
48538904|NCT02704403|101655341|FG000|NOT COMPLETED|Overall Study||1437||
48538905|NCT02704403|101655342|FG001|NOT COMPLETED|Overall Study||720||
48538906|NCT03303196|101655343|FG000|STARTED|Overall Study||5|4 days|
48538907|NCT03303196|101655344|FG001|STARTED|Overall Study||5|4 days|
48538908|NCT03303196|101655343|FG000|Washout|Overall Study||5|Minimum 1 week at home in between study admissions.|
48538909|NCT03303196|101655344|FG001|Washout|Overall Study||5|Minimum 1 week at home in between study admissions.|
48538910|NCT03303196|101655343|FG000|COMPLETED|Overall Study||5|4 days|
48538911|NCT03303196|101655344|FG001|COMPLETED|Overall Study||5|4 days|
48538912|NCT03303196|101655343|FG000|NOT COMPLETED|Overall Study||0||
48538913|NCT03303196|101655344|FG001|NOT COMPLETED|Overall Study||0||
48538914|NCT00815360|101655345|FG000|STARTED|Overall Study||11||
48538915|NCT00815360|101655346|FG001|STARTED|Overall Study||11||
48538916|NCT00815360|101655345|FG000|COMPLETED|Overall Study||11||
48538917|NCT00815360|101655346|FG001|COMPLETED|Overall Study||11||
48538918|NCT00815360|101655345|FG000|NOT COMPLETED|Overall Study||0||
48538919|NCT00815360|101655346|FG001|NOT COMPLETED|Overall Study||0||
48538920|NCT03661697|101655347|FG000|STARTED|Overall Study||7||
48538921|NCT03661697|101655348|FG001|STARTED|Overall Study||7||
48538922|NCT03661697|101655347|FG000|COMPLETED|Overall Study||7||
48538923|NCT03661697|101655348|FG001|COMPLETED|Overall Study||7||
48538924|NCT03661697|101655347|FG000|NOT COMPLETED|Overall Study||0||
48538925|NCT03661697|101655348|FG001|NOT COMPLETED|Overall Study||0||
48538926|NCT05307510|101655349|FG000|STARTED|Overall Study||9||
48538927|NCT05307510|101655350|FG001|STARTED|Overall Study||12||
48538928|NCT05307510|101655349|FG000|Data Collection I|Overall Study||9||
48538929|NCT05307510|101655350|FG001|Data Collection I|Overall Study||12||
48538930|NCT05307510|101655349|FG000|Data Collection II|Overall Study||7||
48538931|NCT05307510|101655350|FG001|Data Collection II|Overall Study||8||
48538932|NCT05307510|101655349|FG000|Data Collection III|Overall Study||6||
48538933|NCT05307510|101655350|FG001|Data Collection III|Overall Study||5||
48538934|NCT05307510|101655349|FG000|COMPLETED|Overall Study||6||
48538935|NCT05307510|101655350|FG001|COMPLETED|Overall Study||5||
48538936|NCT05307510|101655349|FG000|NOT COMPLETED|Overall Study||3||
48538937|NCT05307510|101655350|FG001|NOT COMPLETED|Overall Study||7||
48538938|NCT01404078|101655351|FG000|STARTED|Overall Study||261||
48538939|NCT01404078|101655352|FG001|STARTED|Overall Study||257||
48538940|NCT01404078|101655351|FG000|COMPLETED|Overall Study||243||
48538941|NCT01404078|101655352|FG001|COMPLETED|Overall Study||237||
48538942|NCT01404078|101655351|FG000|NOT COMPLETED|Overall Study||18||
48538943|NCT01404078|101655352|FG001|NOT COMPLETED|Overall Study||20||
48538944|NCT05147324|101655353|FG000|STARTED|Overall Study||52|Number Started reflects dyad pairs (i.e., 52 Guardians + 52 Youth).|
48538945|NCT05147324|101655353|FG000|COMPLETED|Overall Study||44|Number Completed reflects dyad pairs (i.e., 44 Guardians + 44 Youth).|
48538946|NCT05147324|101655353|FG000|NOT COMPLETED|Overall Study||8||
48538947|NCT02495259|101655354|FG000|STARTED|Overall Study||7||
48538948|NCT02495259|101655355|FG001|STARTED|Overall Study||4||
48538949|NCT02495259|101655356|FG002|STARTED|Overall Study||8||
48538950|NCT02495259|101655354|FG000|COMPLETED|Overall Study||7||
48538951|NCT02495259|101655355|FG001|COMPLETED|Overall Study||3||
48538952|NCT02495259|101655356|FG002|COMPLETED|Overall Study||8||
48538953|NCT02495259|101655354|FG000|NOT COMPLETED|Overall Study||0||
48538954|NCT02495259|101655355|FG001|NOT COMPLETED|Overall Study||1||
48538955|NCT02495259|101655356|FG002|NOT COMPLETED|Overall Study||0||
48538956|NCT00394524|101655357|FG000|STARTED|Overall Study||80||
48538957|NCT00394524|101655358|FG001|STARTED|Overall Study||80||
48538958|NCT00394524|101655357|FG000|COMPLETED|Overall Study||77||
48538959|NCT00394524|101655358|FG001|COMPLETED|Overall Study||76||
48238065|NCT00267774|100906496|FG001|STARTED|Overall Study||496||
48538960|NCT00394524|101655357|FG000|NOT COMPLETED|Overall Study||3||
48538961|NCT00394524|101655358|FG001|NOT COMPLETED|Overall Study||4||
48538962|NCT03968978|101655359|FG000|STARTED|Overall Study||111||
48538963|NCT03968978|101655360|FG001|STARTED|Overall Study||105||
48238066|NCT00267774|100906495|FG000|COMPLETED|Overall Study||509||
48538964|NCT03968978|101655359|FG000|COMPLETED|Overall Study||110||
48538965|NCT03968978|101655360|FG001|COMPLETED|Overall Study||105||
48538966|NCT03968978|101655359|FG000|NOT COMPLETED|Overall Study||1||
48538967|NCT03968978|101655360|FG001|NOT COMPLETED|Overall Study||0||
48538968|NCT01823835|101655361|FG000|STARTED|Overall Study||3||
48538969|NCT01823835|101655362|FG001|STARTED|Overall Study||4||
48538970|NCT01823835|101655363|FG002|STARTED|Overall Study||4||
48538971|NCT01823835|101655364|FG003|STARTED|Overall Study||6||
48538972|NCT01823835|101655365|FG004|STARTED|Overall Study||6||
48538973|NCT01823835|101655366|FG005|STARTED|Overall Study||6||
48538974|NCT01823835|101655367|FG006|STARTED|Overall Study||6||
48538975|NCT01823835|101655368|FG007|STARTED|Overall Study||3||
48538976|NCT01823835|101655369|FG008|STARTED|Overall Study||3||
48538977|NCT01823835|101655370|FG009|STARTED|Overall Study||19||
48538978|NCT01823835|101655371|FG010|STARTED|Overall Study||10||
48538979|NCT01823835|101655372|FG011|STARTED|Overall Study||53||
48538980|NCT01823835|101655373|FG012|STARTED|Overall Study||19||
48538981|NCT01823835|101655374|FG013|STARTED|Overall Study||4||
48674264|NCT00582907|101985980|FG002|COMPLETED|2nd Course||3||
48674265|NCT00582907|101985981|FG003|COMPLETED|2nd Course||3||
48674266|NCT00582907|101985978|FG000|NOT COMPLETED|2nd Course||1||
48674267|NCT00582907|101985979|FG001|NOT COMPLETED|2nd Course||0||
48674268|NCT00582907|101985980|FG002|NOT COMPLETED|2nd Course||0||
48674269|NCT00582907|101985981|FG003|NOT COMPLETED|2nd Course||0||
48674270|NCT00582907|101985978|FG000|STARTED|3rd Course||2||
48674271|NCT00582907|101985979|FG001|STARTED|3rd Course||3||
48674272|NCT00582907|101985980|FG002|STARTED|3rd Course||3||
48238067|NCT00267774|100906496|FG001|COMPLETED|Overall Study||496||
48238068|NCT00267774|100906495|FG000|NOT COMPLETED|Overall Study||0||
48238069|NCT00267774|100906496|FG001|NOT COMPLETED|Overall Study||0||
48238070|NCT04271254|100906497|FG000|STARTED|Overall Study||5||
48238071|NCT04271254|100906497|FG000|COMPLETED|Overall Study||2||
48238072|NCT04271254|100906497|FG000|NOT COMPLETED|Overall Study||3||
48238073|NCT00585910|100906498|FG000|STARTED|Atomoxetine (ATMX) Alone||72||
48238074|NCT00585910|100906498|FG000|COMPLETED|Atomoxetine (ATMX) Alone||55||
48238075|NCT00585910|100906498|FG000|NOT COMPLETED|Atomoxetine (ATMX) Alone||17||
48238076|NCT00585910|100906498|FG000|STARTED|ATMX + Osmotic-Release Methylphenidate||50||
48238077|NCT00585910|100906498|FG000|COMPLETED|ATMX + Osmotic-Release Methylphenidate||41||
48238078|NCT00585910|100906498|FG000|NOT COMPLETED|ATMX + Osmotic-Release Methylphenidate||9||
48238079|NCT04454125|100906499|FG000|STARTED|Overall Study||20||
48238080|NCT04454125|100906500|FG001|STARTED|Overall Study||20||
48238081|NCT04454125|100906499|FG000|COMPLETED|Overall Study||20||
48238082|NCT04454125|100906500|FG001|COMPLETED|Overall Study||19||
48238083|NCT04454125|100906499|FG000|NOT COMPLETED|Overall Study||0||
48238084|NCT04454125|100906500|FG001|NOT COMPLETED|Overall Study||1||
48238085|NCT00460434|100906501|FG000|STARTED|Overall Study||165||
48238086|NCT00460434|100906502|FG001|STARTED|Overall Study||172||
48238087|NCT00460434|100906501|FG000|3 Months|Overall Study||163||
48238088|NCT00460434|100906502|FG001|3 Months|Overall Study||171||
48238089|NCT00460434|100906501|FG000|12 Months|Overall Study||162||
48238090|NCT00460434|100906502|FG001|12 Months|Overall Study||165||
48238091|NCT00460434|100906501|FG000|COMPLETED|Overall Study||162||
48238092|NCT00460434|100906502|FG001|COMPLETED|Overall Study||165||
48238093|NCT00460434|100906501|FG000|NOT COMPLETED|Overall Study||3||
48238094|NCT00460434|100906502|FG001|NOT COMPLETED|Overall Study||7||
48238095|NCT02548585|100906503|FG000|STARTED|Overall Study||45||
48238096|NCT02548585|100906504|FG001|STARTED|Overall Study||6||
48238097|NCT02548585|100906505|FG002|STARTED|Overall Study||6||
48674273|NCT00582907|101985981|FG003|STARTED|3rd Course||3||
48674274|NCT00582907|101985978|FG000|COMPLETED|3rd Course||2||
48674275|NCT00582907|101985979|FG001|COMPLETED|3rd Course||3||
48674276|NCT00582907|101985980|FG002|COMPLETED|3rd Course||3||
48674277|NCT00582907|101985981|FG003|COMPLETED|3rd Course||3||
48674278|NCT00582907|101985978|FG000|NOT COMPLETED|3rd Course||0||
48674279|NCT00582907|101985979|FG001|NOT COMPLETED|3rd Course||0||
48674280|NCT00582907|101985980|FG002|NOT COMPLETED|3rd Course||0||
48238098|NCT02548585|100906506|FG003|STARTED|Overall Study||7||
48238099|NCT02548585|100906507|FG004|STARTED|Overall Study||25||
48238100|NCT02548585|100906508|FG005|STARTED|Overall Study||12||
48538982|NCT01823835|101655375|FG014|STARTED|Overall Study||6||
48538983|NCT01823835|101655361|FG000|COMPLETED|Overall Study||0||
48538984|NCT01823835|101655362|FG001|COMPLETED|Overall Study||0||
48538985|NCT01823835|101655363|FG002|COMPLETED|Overall Study||0||
48538986|NCT01823835|101655364|FG003|COMPLETED|Overall Study||0||
48538987|NCT01823835|101655365|FG004|COMPLETED|Overall Study||0||
48538988|NCT01823835|101655366|FG005|COMPLETED|Overall Study||0||
48538989|NCT01823835|101655367|FG006|COMPLETED|Overall Study||0||
48674281|NCT00582907|101985981|FG003|NOT COMPLETED|3rd Course||0||
48674282|NCT00582907|101985978|FG000|STARTED|4th Course||2||
48674283|NCT00582907|101985979|FG001|STARTED|4th Course||3||
48674284|NCT00582907|101985980|FG002|STARTED|4th Course||3||
48674285|NCT00582907|101985981|FG003|STARTED|4th Course||3||
48674286|NCT00582907|101985978|FG000|COMPLETED|4th Course||2||
48238101|NCT02548585|100906509|FG006|STARTED|Overall Study||12||
48238102|NCT02548585|100906503|FG000|Treated|Overall Study||45||
48238103|NCT02548585|100906504|FG001|Treated|Overall Study||6||
48238104|NCT02548585|100906505|FG002|Treated|Overall Study||6||
48238105|NCT02548585|100906506|FG003|Treated|Overall Study||7||
48238106|NCT02548585|100906507|FG004|Treated|Overall Study||25||
48238107|NCT02548585|100906508|FG005|Treated|Overall Study||11||
48538990|NCT01823835|101655368|FG007|COMPLETED|Overall Study||0||
48238108|NCT02548585|100906509|FG006|Treated|Overall Study||12||
48538991|NCT01823835|101655369|FG008|COMPLETED|Overall Study||0||
48538992|NCT01823835|101655370|FG009|COMPLETED|Overall Study||0||
48674287|NCT00582907|101985979|FG001|COMPLETED|4th Course||3||
48674288|NCT00582907|101985980|FG002|COMPLETED|4th Course||3||
48674289|NCT00582907|101985981|FG003|COMPLETED|4th Course||3||
48674290|NCT00582907|101985978|FG000|NOT COMPLETED|4th Course||0||
48674291|NCT00582907|101985979|FG001|NOT COMPLETED|4th Course||0||
48674292|NCT00582907|101985980|FG002|NOT COMPLETED|4th Course||0||
48674293|NCT00582907|101985981|FG003|NOT COMPLETED|4th Course||0||
48674294|NCT04999267|101985982|FG000|STARTED|Overall Study||6745||2
48674295|NCT04999267|101985982|FG000|COMPLETED|Overall Study||6745||2
48238109|NCT02548585|100906503|FG000|COMPLETED|Overall Study||43||
48238110|NCT02548585|100906504|FG001|COMPLETED|Overall Study||6||
48238111|NCT02548585|100906505|FG002|COMPLETED|Overall Study||6||
48674296|NCT04999267|101985982|FG000|NOT COMPLETED|Overall Study||0||0
48674297|NCT05489328|101985983|FG000|STARTED|Overall Study||41|Participants who were randomized|
48674298|NCT05489328|101985984|FG001|STARTED|Overall Study||42|Participants who were randomized|
48674299|NCT05489328|101985985|FG002|STARTED|Overall Study||39|Participants who were randomized|
48674300|NCT05489328|101985986|FG003|STARTED|Overall Study||43|Participants who were randomized|
48674301|NCT05489328|101985987|FG004|STARTED|Overall Study||45|Participants who were randomized|
48674302|NCT05489328|101985988|FG005|STARTED|Overall Study||46|Participants who were randomized|
48674303|NCT05489328|101985989|FG006|STARTED|Overall Study||47|Participants who were randomized|
48674304|NCT05489328|101985990|FG007|STARTED|Overall Study||44|Participants who were randomized|
48674305|NCT05489328|101985991|FG008|STARTED|Overall Study||47|Participants who were randomized|
48674306|NCT05489328|101985983|FG000|Vaccinated|Overall Study||41|Participants who were administered the study intervention|
48674307|NCT05489328|101985984|FG001|Vaccinated|Overall Study||42|Participants who were administered the study intervention|
48674308|NCT05489328|101985985|FG002|Vaccinated|Overall Study||39|Participants who were administered the study intervention|
48674309|NCT05489328|101985986|FG003|Vaccinated|Overall Study||43|Participants who were administered the study intervention|
48674310|NCT05489328|101985987|FG004|Vaccinated|Overall Study||45|Participants who were administered the study intervention|
48674311|NCT05489328|101985988|FG005|Vaccinated|Overall Study||46|Participants who were administered the study intervention|
48674312|NCT05489328|101985989|FG006|Vaccinated|Overall Study||46|Participants who were administered the study intervention|
48674313|NCT05489328|101985990|FG007|Vaccinated|Overall Study||43|Participants who were administered the study intervention|
48674314|NCT05489328|101985991|FG008|Vaccinated|Overall Study||46|Participants who were administered the study intervention|
48674315|NCT05489328|101985983|FG000|COMPLETED|Overall Study||41||
48674316|NCT05489328|101985984|FG001|COMPLETED|Overall Study||42||
48674317|NCT05489328|101985985|FG002|COMPLETED|Overall Study||38||
48674318|NCT05489328|101985986|FG003|COMPLETED|Overall Study||43||
48674319|NCT05489328|101985987|FG004|COMPLETED|Overall Study||43||
48674320|NCT05489328|101985988|FG005|COMPLETED|Overall Study||46||
48674321|NCT05489328|101985989|FG006|COMPLETED|Overall Study||46||
48674322|NCT05489328|101985990|FG007|COMPLETED|Overall Study||41||
48674323|NCT05489328|101985991|FG008|COMPLETED|Overall Study||46||
48674324|NCT05489328|101985983|FG000|NOT COMPLETED|Overall Study||0||
48674325|NCT05489328|101985984|FG001|NOT COMPLETED|Overall Study||0||
48674326|NCT05489328|101985985|FG002|NOT COMPLETED|Overall Study||1||
48674327|NCT05489328|101985986|FG003|NOT COMPLETED|Overall Study||0||
48674328|NCT05489328|101985987|FG004|NOT COMPLETED|Overall Study||2||
48674329|NCT05489328|101985988|FG005|NOT COMPLETED|Overall Study||0||
48674330|NCT05489328|101985989|FG006|NOT COMPLETED|Overall Study||1||
48674331|NCT05489328|101985990|FG007|NOT COMPLETED|Overall Study||3||
48674332|NCT05489328|101985991|FG008|NOT COMPLETED|Overall Study||1||
48674333|NCT04089020|101985992|FG000|STARTED|Overall Study||32||
48674334|NCT04089020|101985992|FG000|COMPLETED|Overall Study||31||
48674335|NCT04089020|101985992|FG000|NOT COMPLETED|Overall Study||1||
48674336|NCT03639610|101985993|FG000|STARTED|Overall Study||21||
48674337|NCT03639610|101985994|FG001|STARTED|Overall Study||10||
48674338|NCT03639610|101985995|FG002|STARTED|Overall Study||4||
48674339|NCT03639610|101985993|FG000|COMPLETED|Overall Study||0||
48674340|NCT03639610|101985994|FG001|COMPLETED|Overall Study||0||
48674341|NCT03639610|101985995|FG002|COMPLETED|Overall Study||0||
48674342|NCT03639610|101985993|FG000|NOT COMPLETED|Overall Study||21||
48674343|NCT03639610|101985994|FG001|NOT COMPLETED|Overall Study||10||
48674344|NCT03639610|101985995|FG002|NOT COMPLETED|Overall Study||4||
48674345|NCT01561976|101985996|FG000|STARTED|Period 1||5||
48674346|NCT01561976|101985997|FG001|STARTED|Period 1||5||
48674347|NCT01561976|101985998|FG002|STARTED|Period 1||5||
48674348|NCT01561976|101985999|FG003|STARTED|Period 1||5||
48674349|NCT01561976|101986000|FG004|STARTED|Period 1||5||
48674350|NCT01561976|101986001|FG005|STARTED|Period 1||5||
48674351|NCT01561976|101985996|FG000|COMPLETED|Period 1||5||
48674352|NCT01561976|101985997|FG001|COMPLETED|Period 1||5||
48674353|NCT01561976|101985998|FG002|COMPLETED|Period 1||4||
48674354|NCT01561976|101985999|FG003|COMPLETED|Period 1||5||
48674355|NCT01561976|101986000|FG004|COMPLETED|Period 1||5||
48674356|NCT01561976|101986001|FG005|COMPLETED|Period 1||5||
48674357|NCT01561976|101985996|FG000|NOT COMPLETED|Period 1||0||
48674358|NCT01561976|101985997|FG001|NOT COMPLETED|Period 1||0||
48238112|NCT02548585|100906506|FG003|COMPLETED|Overall Study||5||
48238113|NCT02548585|100906507|FG004|COMPLETED|Overall Study||22||
48238114|NCT02548585|100906508|FG005|COMPLETED|Overall Study||10||
48238115|NCT02548585|100906509|FG006|COMPLETED|Overall Study||11||
48238116|NCT02548585|100906503|FG000|NOT COMPLETED|Overall Study||2||
48238117|NCT02548585|100906504|FG001|NOT COMPLETED|Overall Study||0||
48238118|NCT02548585|100906505|FG002|NOT COMPLETED|Overall Study||0||
48238119|NCT02548585|100906506|FG003|NOT COMPLETED|Overall Study||2||
48238120|NCT02548585|100906507|FG004|NOT COMPLETED|Overall Study||3||
48238121|NCT02548585|100906508|FG005|NOT COMPLETED|Overall Study||2||
48238122|NCT02548585|100906509|FG006|NOT COMPLETED|Overall Study||1||
48238123|NCT03805698|100906510|FG000|STARTED|Overall Study||10||
48238124|NCT03805698|100906511|FG001|STARTED|Overall Study||0||
48238125|NCT03805698|100906510|FG000|COMPLETED|Overall Study||10||
48238126|NCT03805698|100906511|FG001|COMPLETED|Overall Study||0||
48238127|NCT03805698|100906510|FG000|NOT COMPLETED|Overall Study||0||
48238128|NCT03805698|100906511|FG001|NOT COMPLETED|Overall Study||0||
48238129|NCT00887471|100906512|FG000|STARTED|Overall Study||15||
48238130|NCT00887471|100906513|FG001|STARTED|Overall Study||15||
48238131|NCT00887471|100906512|FG000|COMPLETED|Overall Study||15||
48238132|NCT00887471|100906513|FG001|COMPLETED|Overall Study||15||
48238133|NCT00887471|100906512|FG000|NOT COMPLETED|Overall Study||0||
48238134|NCT00887471|100906513|FG001|NOT COMPLETED|Overall Study||0||
48238135|NCT01922102|100906514|FG000|STARTED|Overall Study||182||
48238136|NCT01922102|100906515|FG001|STARTED|Overall Study||184||
48238137|NCT01922102|100906516|FG002|STARTED|Overall Study||91||
48238138|NCT01922102|100906514|FG000|COMPLETED|Overall Study||173||
48238139|NCT01922102|100906515|FG001|COMPLETED|Overall Study||175||
48238140|NCT01922102|100906516|FG002|COMPLETED|Overall Study||83||
48238141|NCT01922102|100906514|FG000|NOT COMPLETED|Overall Study||9||
48238142|NCT01922102|100906515|FG001|NOT COMPLETED|Overall Study||9||
48238143|NCT01922102|100906516|FG002|NOT COMPLETED|Overall Study||8||
48238144|NCT03562117|100906517|FG000|STARTED|Part 1, Up to 3 Days||8||
48238145|NCT03562117|100906518|FG001|STARTED|Part 1, Up to 3 Days||8||
48238146|NCT03562117|100906519|FG002|STARTED|Part 1, Up to 3 Days||0||
48238147|NCT03562117|100906517|FG000|COMPLETED|Part 1, Up to 3 Days||7||
48238148|NCT03562117|100906518|FG001|COMPLETED|Part 1, Up to 3 Days||8||
48238149|NCT03562117|100906519|FG002|COMPLETED|Part 1, Up to 3 Days||0||
48238150|NCT03562117|100906517|FG000|NOT COMPLETED|Part 1, Up to 3 Days||1||
48238151|NCT03562117|100906518|FG001|NOT COMPLETED|Part 1, Up to 3 Days||0||
48238152|NCT03562117|100906519|FG002|NOT COMPLETED|Part 1, Up to 3 Days||0||
48238153|NCT03562117|100906517|FG000|STARTED|Part 2, Up to 3 Days||8||
48238154|NCT03562117|100906518|FG001|STARTED|Part 2, Up to 3 Days||0||
48538993|NCT01823835|101655371|FG010|COMPLETED|Overall Study||0||
48538994|NCT01823835|101655372|FG011|COMPLETED|Overall Study||0||
48538995|NCT01823835|101655373|FG012|COMPLETED|Overall Study||0||
48538996|NCT01823835|101655374|FG013|COMPLETED|Overall Study||0||
48538997|NCT01823835|101655375|FG014|COMPLETED|Overall Study||0||
48538998|NCT01823835|101655361|FG000|NOT COMPLETED|Overall Study||3||
48538999|NCT01823835|101655362|FG001|NOT COMPLETED|Overall Study||4||
48539000|NCT01823835|101655363|FG002|NOT COMPLETED|Overall Study||4||
48539001|NCT01823835|101655364|FG003|NOT COMPLETED|Overall Study||6||
48539002|NCT01823835|101655365|FG004|NOT COMPLETED|Overall Study||6||
48539003|NCT01823835|101655366|FG005|NOT COMPLETED|Overall Study||6||
48539004|NCT01823835|101655367|FG006|NOT COMPLETED|Overall Study||6||
48539005|NCT01823835|101655368|FG007|NOT COMPLETED|Overall Study||3||
48539006|NCT01823835|101655369|FG008|NOT COMPLETED|Overall Study||3||
48539007|NCT01823835|101655370|FG009|NOT COMPLETED|Overall Study||19||
48539008|NCT01823835|101655371|FG010|NOT COMPLETED|Overall Study||10||
48539009|NCT01823835|101655372|FG011|NOT COMPLETED|Overall Study||53||
48539010|NCT01823835|101655373|FG012|NOT COMPLETED|Overall Study||19||
48539011|NCT01823835|101655374|FG013|NOT COMPLETED|Overall Study||4||
48539012|NCT01823835|101655375|FG014|NOT COMPLETED|Overall Study||6||
48539013|NCT05958888|101655376|FG000|STARTED|First Label Viewing (Self-paced)||63||
48539014|NCT05958888|101655376|FG000|Text Only Sodium Label|First Label Viewing (Self-paced)||17||
48539015|NCT05958888|101655376|FG000|Icon Sodium Label|First Label Viewing (Self-paced)||18||
48539016|NCT05958888|101655376|FG000|Pictorial Sodium Label|First Label Viewing (Self-paced)||11||
48674359|NCT01561976|101985998|FG002|NOT COMPLETED|Period 1||1||
48238155|NCT03562117|100906519|FG002|STARTED|Part 2, Up to 3 Days||8||
48238156|NCT03562117|100906517|FG000|COMPLETED|Part 2, Up to 3 Days||8||
48238157|NCT03562117|100906518|FG001|COMPLETED|Part 2, Up to 3 Days||0||
48238158|NCT03562117|100906519|FG002|COMPLETED|Part 2, Up to 3 Days||8||
48238159|NCT03562117|100906517|FG000|NOT COMPLETED|Part 2, Up to 3 Days||0||
48238160|NCT03562117|100906518|FG001|NOT COMPLETED|Part 2, Up to 3 Days||0||
48238161|NCT03562117|100906519|FG002|NOT COMPLETED|Part 2, Up to 3 Days||0||
48238162|NCT02391714|100906520|FG000|STARTED|Overall Study||40||
48238163|NCT02391714|100906521|FG001|STARTED|Overall Study||40||
48238164|NCT02391714|100906520|FG000|COMPLETED|Overall Study||40||
48238165|NCT02391714|100906521|FG001|COMPLETED|Overall Study||40||
48539017|NCT05958888|101655376|FG000|Barcode Label|First Label Viewing (Self-paced)||17||
48539018|NCT05958888|101655376|FG000|COMPLETED|First Label Viewing (Self-paced)||63||
48539019|NCT05958888|101655376|FG000|NOT COMPLETED|First Label Viewing (Self-paced)||0||
48238166|NCT02391714|100906520|FG000|NOT COMPLETED|Overall Study||0||
48539020|NCT05958888|101655376|FG000|STARTED|Washout (Self-paced)||63||
48539021|NCT05958888|101655376|FG000|Text Only Sodium Label|Washout (Self-paced)||17||
48238167|NCT02391714|100906521|FG001|NOT COMPLETED|Overall Study||0||
48238168|NCT04264156|100906522|FG000|STARTED|Overall Study||11||
48238169|NCT04264156|100906523|FG001|STARTED|Overall Study||1||
48539022|NCT05958888|101655376|FG000|Icon Sodium Label|Washout (Self-paced)||18||
48539023|NCT05958888|101655376|FG000|Pictorial Sodium Label|Washout (Self-paced)||11||
48539024|NCT05958888|101655376|FG000|Barcode Label|Washout (Self-paced)||17||
48539025|NCT05958888|101655376|FG000|COMPLETED|Washout (Self-paced)||63||
48539026|NCT05958888|101655376|FG000|NOT COMPLETED|Washout (Self-paced)||0||
48539027|NCT05958888|101655376|FG000|STARTED|Second Label Viewing (Self-paced)||63||
48539028|NCT05958888|101655376|FG000|Text Only Sodium Label|Second Label Viewing (Self-paced)||15||
48539029|NCT05958888|101655376|FG000|Icon Sodium Label|Second Label Viewing (Self-paced)||13||
48539030|NCT05958888|101655376|FG000|Pictorial Sodium Label|Second Label Viewing (Self-paced)||22||
48539031|NCT05958888|101655376|FG000|Barcode Label|Second Label Viewing (Self-paced)||13||
48539032|NCT05958888|101655376|FG000|COMPLETED|Second Label Viewing (Self-paced)||63||
48539033|NCT05958888|101655376|FG000|NOT COMPLETED|Second Label Viewing (Self-paced)||0||
48539034|NCT05958888|101655376|FG000|STARTED|Washout (Self Paced)||63||
48539035|NCT05958888|101655376|FG000|Text Only Sodium Label|Washout (Self Paced)||15||
48539036|NCT05958888|101655376|FG000|Icon Sodium Label|Washout (Self Paced)||13||
48592674|NCT01877382|101783161|FG011|STARTED|Dose Expansion||0||
48238170|NCT04264156|100906522|FG000|COMPLETED|Overall Study||11||
48238171|NCT04264156|100906523|FG001|COMPLETED|Overall Study||1||
48238172|NCT04264156|100906522|FG000|NOT COMPLETED|Overall Study||0||
48238173|NCT04264156|100906523|FG001|NOT COMPLETED|Overall Study||0||
48238174|NCT00230009|100906524|FG000|STARTED|Single Session Intervention/Control||50||
48238175|NCT00230009|100906525|FG001|STARTED|Single Session Intervention/Control||50||
48238176|NCT00230009|100906524|FG000|COMPLETED|Single Session Intervention/Control||50||
48238177|NCT00230009|100906525|FG001|COMPLETED|Single Session Intervention/Control||50||
48238178|NCT00230009|100906524|FG000|NOT COMPLETED|Single Session Intervention/Control||0||
48238179|NCT00230009|100906525|FG001|NOT COMPLETED|Single Session Intervention/Control||0||
48238180|NCT00230009|100906524|FG000|STARTED|Follow-up||50||
48238181|NCT00230009|100906525|FG001|STARTED|Follow-up||50||
48238182|NCT00230009|100906524|FG000|COMPLETED|Follow-up||19||
48238183|NCT00230009|100906525|FG001|COMPLETED|Follow-up||24||
48238184|NCT00230009|100906524|FG000|NOT COMPLETED|Follow-up||31||
48238185|NCT00230009|100906525|FG001|NOT COMPLETED|Follow-up||26||
48238186|NCT01107717|100906526|FG000|STARTED|Overall Study||157||
48238187|NCT01107717|100906527|FG001|STARTED|Overall Study||161||
48238188|NCT01107717|100906526|FG000|COMPLETED|Overall Study||103||
48238189|NCT01107717|100906527|FG001|COMPLETED|Overall Study||114||
48238190|NCT01107717|100906526|FG000|NOT COMPLETED|Overall Study||54||
48238191|NCT01107717|100906527|FG001|NOT COMPLETED|Overall Study||47||
48238192|NCT04422210|100906528|FG000|STARTED|Overall Study||0||
48238193|NCT04422210|100906529|FG001|STARTED|Overall Study||0||
48238194|NCT04422210|100906530|FG002|STARTED|Overall Study||0||
48238195|NCT04422210|100906531|FG003|STARTED|Overall Study||0||
48238196|NCT04422210|100906532|FG004|STARTED|Overall Study||0||
48238197|NCT04422210|100906533|FG005|STARTED|Overall Study||0||
48238198|NCT04422210|100906534|FG006|STARTED|Overall Study||0||
48238199|NCT04422210|100906535|FG007|STARTED|Overall Study||0||
48238200|NCT04422210|100906528|FG000|COMPLETED|Overall Study||0||
48238201|NCT04422210|100906529|FG001|COMPLETED|Overall Study||0||
48238202|NCT04422210|100906530|FG002|COMPLETED|Overall Study||0||
48674360|NCT01561976|101985999|FG003|NOT COMPLETED|Period 1||0||
48674361|NCT01561976|101986000|FG004|NOT COMPLETED|Period 1||0||
48674362|NCT01561976|101986001|FG005|NOT COMPLETED|Period 1||0||
48238203|NCT04422210|100906531|FG003|COMPLETED|Overall Study||0||
48238204|NCT04422210|100906532|FG004|COMPLETED|Overall Study||0||
48238205|NCT04422210|100906533|FG005|COMPLETED|Overall Study||0||
48238206|NCT04422210|100906534|FG006|COMPLETED|Overall Study||0||
48238207|NCT04422210|100906535|FG007|COMPLETED|Overall Study||0||
48238208|NCT04422210|100906528|FG000|NOT COMPLETED|Overall Study||0||
48238209|NCT04422210|100906529|FG001|NOT COMPLETED|Overall Study||0||
48238210|NCT04422210|100906530|FG002|NOT COMPLETED|Overall Study||0||
48238211|NCT04422210|100906531|FG003|NOT COMPLETED|Overall Study||0||
48238212|NCT04422210|100906532|FG004|NOT COMPLETED|Overall Study||0||
48238213|NCT04422210|100906533|FG005|NOT COMPLETED|Overall Study||0||
48238214|NCT04422210|100906534|FG006|NOT COMPLETED|Overall Study||0||
48238215|NCT04422210|100906535|FG007|NOT COMPLETED|Overall Study||0||
48238216|NCT01732419|100906536|FG000|STARTED|Overall Study||45||
48238217|NCT01732419|100906537|FG001|STARTED|Overall Study||45||
48238218|NCT01732419|100906536|FG000|COMPLETED|Overall Study||37||
48238219|NCT01732419|100906537|FG001|COMPLETED|Overall Study||41||
48238220|NCT01732419|100906536|FG000|NOT COMPLETED|Overall Study||8||
48238221|NCT01732419|100906537|FG001|NOT COMPLETED|Overall Study||4||
48238222|NCT02240810|100906538|FG000|STARTED|Overall Study||1501||
48238223|NCT02240810|100906539|FG001|STARTED|Overall Study||2681||
48238224|NCT02240810|100906538|FG000|COMPLETED|Overall Study||1441||
48238225|NCT02240810|100906539|FG001|COMPLETED|Overall Study||2621||
48238226|NCT02240810|100906538|FG000|NOT COMPLETED|Overall Study||60||
48238227|NCT02240810|100906539|FG001|NOT COMPLETED|Overall Study||60||
48238228|NCT01277302|100906540|FG000|STARTED|7-Month Fixed Treatment Period||85||
48238229|NCT01277302|100906541|FG001|STARTED|7-Month Fixed Treatment Period||86||
48238230|NCT01277302|100906542|FG002|STARTED|7-Month Fixed Treatment Period||31||
48238231|NCT01277302|100906540|FG000|COMPLETED|7-Month Fixed Treatment Period||85||
48238232|NCT01277302|100906541|FG001|COMPLETED|7-Month Fixed Treatment Period||86||
48238233|NCT01277302|100906542|FG002|COMPLETED|7-Month Fixed Treatment Period||19||
48238234|NCT01277302|100906540|FG000|NOT COMPLETED|7-Month Fixed Treatment Period||0||
48238235|NCT01277302|100906541|FG001|NOT COMPLETED|7-Month Fixed Treatment Period||0||
48238236|NCT01277302|100906542|FG002|NOT COMPLETED|7-Month Fixed Treatment Period||12||
48238237|NCT01277302|100906540|FG000|STARTED|8-Month Alternate Dose Regimen Period||85||
48238238|NCT01277302|100906541|FG001|STARTED|8-Month Alternate Dose Regimen Period||86||
48238239|NCT01277302|100906542|FG002|STARTED|8-Month Alternate Dose Regimen Period||19||
48238240|NCT01277302|100906540|FG000|COMPLETED|8-Month Alternate Dose Regimen Period||80||
48238241|NCT01277302|100906541|FG001|COMPLETED|8-Month Alternate Dose Regimen Period||82||
48238242|NCT01277302|100906542|FG002|COMPLETED|8-Month Alternate Dose Regimen Period||13||
48238243|NCT01277302|100906540|FG000|NOT COMPLETED|8-Month Alternate Dose Regimen Period||5||
48539037|NCT05958888|101655376|FG000|Pictorial Sodium Label|Washout (Self Paced)||22||
48539038|NCT05958888|101655376|FG000|Barcode Label|Washout (Self Paced)||13||
48238244|NCT01277302|100906541|FG001|NOT COMPLETED|8-Month Alternate Dose Regimen Period||4||
48238245|NCT01277302|100906542|FG002|NOT COMPLETED|8-Month Alternate Dose Regimen Period||6||
48238246|NCT05810285|100906543|FG000|STARTED|Overall Study||95||102
48539039|NCT05958888|101655376|FG000|COMPLETED|Washout (Self Paced)||63||
48539040|NCT05958888|101655376|FG000|NOT COMPLETED|Washout (Self Paced)||0||
48539041|NCT05958888|101655376|FG000|STARTED|Third Label Viewing (Self-paced)||63||
48238247|NCT05810285|100906544|FG001|STARTED|Overall Study||91||97
48238248|NCT05810285|100906543|FG000|COMPLETED|Overall Study||73||80
48238249|NCT05810285|100906544|FG001|COMPLETED|Overall Study||54||60
48238250|NCT05810285|100906543|FG000|NOT COMPLETED|Overall Study||22||22
48238251|NCT05810285|100906544|FG001|NOT COMPLETED|Overall Study||37||37
48238252|NCT00237718|100906545|FG000|STARTED|Overall Study||160||
48238253|NCT00237718|100906546|FG001|STARTED|Overall Study||165||
48238254|NCT00237718|100906545|FG000|COMPLETED|Overall Study||114||
48238255|NCT00237718|100906546|FG001|COMPLETED|Overall Study||124||
48238256|NCT00237718|100906545|FG000|NOT COMPLETED|Overall Study||46||
48238257|NCT00237718|100906546|FG001|NOT COMPLETED|Overall Study||41||
48238258|NCT01184755|100906547|FG000|STARTED|Overall Study||126||
48238259|NCT01184755|100906548|FG001|STARTED|Overall Study||65||
48238260|NCT01184755|100906549|FG002|STARTED|Overall Study||62||
48238261|NCT01184755|100906547|FG000|COMPLETED|Overall Study||101||
48238262|NCT01184755|100906548|FG001|COMPLETED|Overall Study||54||
48238263|NCT01184755|100906549|FG002|COMPLETED|Overall Study||56||
48238264|NCT01184755|100906547|FG000|NOT COMPLETED|Overall Study||25||
48238265|NCT01184755|100906548|FG001|NOT COMPLETED|Overall Study||11||
48238266|NCT01184755|100906549|FG002|NOT COMPLETED|Overall Study||6||
48238267|NCT02005484|100906550|FG000|STARTED|Overall Study||6||
48238268|NCT02005484|100906550|FG000|COMPLETED|Overall Study||2||
48238269|NCT02005484|100906550|FG000|NOT COMPLETED|Overall Study||4||
48238270|NCT03839355|100906551|FG000|STARTED|Overall Study||18||
48238271|NCT03839355|100906552|FG001|STARTED|Overall Study||16||
48238272|NCT03839355|100906551|FG000|COMPLETED|Overall Study||17||
48238273|NCT03839355|100906552|FG001|COMPLETED|Overall Study||16||
48238274|NCT03839355|100906551|FG000|NOT COMPLETED|Overall Study||1||
48238275|NCT03839355|100906552|FG001|NOT COMPLETED|Overall Study||0||
48238276|NCT01540474|100906553|FG000|STARTED|Vaccination Period||10||
48238277|NCT01540474|100906554|FG001|STARTED|Vaccination Period||10||
48238278|NCT01540474|100906555|FG002|STARTED|Vaccination Period||10||
48238279|NCT01540474|100906556|FG003|STARTED|Vaccination Period||0||
48238280|NCT01540474|100906553|FG000|COMPLETED|Vaccination Period||10||
48238281|NCT01540474|100906554|FG001|COMPLETED|Vaccination Period||9||
48238282|NCT01540474|100906555|FG002|COMPLETED|Vaccination Period||10||
48238283|NCT01540474|100906556|FG003|COMPLETED|Vaccination Period||0||
48238284|NCT01540474|100906553|FG000|NOT COMPLETED|Vaccination Period||0||
48238285|NCT01540474|100906554|FG001|NOT COMPLETED|Vaccination Period||1||
48238286|NCT01540474|100906555|FG002|NOT COMPLETED|Vaccination Period||0||
48238287|NCT01540474|100906556|FG003|NOT COMPLETED|Vaccination Period||0||
48238288|NCT01540474|100906553|FG000|STARTED|Malaria Challenge||10||
48238289|NCT01540474|100906554|FG001|STARTED|Malaria Challenge||9||
48238290|NCT01540474|100906555|FG002|STARTED|Malaria Challenge||10||
48238291|NCT01540474|100906556|FG003|STARTED|Malaria Challenge||6||
48238292|NCT01540474|100906553|FG000|COMPLETED|Malaria Challenge||10||
48238293|NCT01540474|100906554|FG001|COMPLETED|Malaria Challenge||9||
48238294|NCT01540474|100906555|FG002|COMPLETED|Malaria Challenge||10||
48238295|NCT01540474|100906556|FG003|COMPLETED|Malaria Challenge||5||
48238296|NCT01540474|100906553|FG000|NOT COMPLETED|Malaria Challenge||0||
48238297|NCT01540474|100906554|FG001|NOT COMPLETED|Malaria Challenge||0||
48238298|NCT01540474|100906555|FG002|NOT COMPLETED|Malaria Challenge||0||
48238299|NCT01540474|100906556|FG003|NOT COMPLETED|Malaria Challenge||1||
48238300|NCT01292005|100906557|FG000|STARTED|Overall Study||14||
48238301|NCT01292005|100906558|FG001|STARTED|Overall Study||14||
48238302|NCT01292005|100906557|FG000|COMPLETED|Overall Study||14||
48238303|NCT01292005|100906558|FG001|COMPLETED|Overall Study||14||
48539042|NCT05958888|101655376|FG000|Text Only Sodium Label|Third Label Viewing (Self-paced)||21||
48238304|NCT01292005|100906557|FG000|NOT COMPLETED|Overall Study||0||
48238305|NCT01292005|100906558|FG001|NOT COMPLETED|Overall Study||0||
48238306|NCT01912599|100906559|FG000|STARTED|Overall Study||20||
48238307|NCT01912599|100906560|FG001|STARTED|Overall Study||16||
48238308|NCT01912599|100906559|FG000|COMPLETED|Overall Study||20||
48238309|NCT01912599|100906560|FG001|COMPLETED|Overall Study||15||
48238310|NCT01912599|100906559|FG000|NOT COMPLETED|Overall Study||0||
48238311|NCT01912599|100906560|FG001|NOT COMPLETED|Overall Study||1||
48238312|NCT03424187|100906561|FG000|STARTED|Overall Study||2||
48238313|NCT03424187|100906562|FG001|STARTED|Overall Study||3||
48238314|NCT03424187|100906563|FG002|STARTED|Overall Study||2||
48238315|NCT03424187|100906564|FG003|STARTED|Overall Study||3||
48539043|NCT05958888|101655376|FG000|Icon Sodium Label|Third Label Viewing (Self-paced)||10||
48539044|NCT05958888|101655376|FG000|Pictorial Sodium Label|Third Label Viewing (Self-paced)||14||
48539045|NCT05958888|101655376|FG000|Barcode Label|Third Label Viewing (Self-paced)||18||
48238316|NCT03424187|100906565|FG004|STARTED|Overall Study||2||
48238317|NCT03424187|100906566|FG005|STARTED|Overall Study||3||
48238318|NCT03424187|100906561|FG000|COMPLETED|Overall Study||2||
48238319|NCT03424187|100906562|FG001|COMPLETED|Overall Study||3||
48238320|NCT03424187|100906563|FG002|COMPLETED|Overall Study||2||
48238321|NCT03424187|100906564|FG003|COMPLETED|Overall Study||3||
48238322|NCT03424187|100906565|FG004|COMPLETED|Overall Study||2||
48238323|NCT03424187|100906566|FG005|COMPLETED|Overall Study||3||
48238324|NCT03424187|100906561|FG000|NOT COMPLETED|Overall Study||0||
48238325|NCT03424187|100906562|FG001|NOT COMPLETED|Overall Study||0||
48238326|NCT03424187|100906563|FG002|NOT COMPLETED|Overall Study||0||
48238327|NCT03424187|100906564|FG003|NOT COMPLETED|Overall Study||0||
48238328|NCT03424187|100906565|FG004|NOT COMPLETED|Overall Study||0||
48238329|NCT03424187|100906566|FG005|NOT COMPLETED|Overall Study||0||
48238330|NCT03529942|100906567|FG000|STARTED|Overall Study||129||
48238331|NCT03529942|100906567|FG000|Reached Week 6 With Paired MRI|Overall Study||108||
48238332|NCT03529942|100906567|FG000|COMPLETED|Overall Study||106||
48238333|NCT03529942|100906567|FG000|NOT COMPLETED|Overall Study||23||
48238334|NCT04879823|100906568|FG000|STARTED|Overall Study||110||
48238335|NCT04879823|100906569|FG001|STARTED|Overall Study||112||
48238336|NCT04879823|100906568|FG000|COMPLETED|Overall Study||62||
48238337|NCT04879823|100906569|FG001|COMPLETED|Overall Study||73||
48238338|NCT04879823|100906568|FG000|NOT COMPLETED|Overall Study||48||
48238339|NCT04879823|100906569|FG001|NOT COMPLETED|Overall Study||39||
48238340|NCT01393964|100906570|FG000|STARTED|Overall Study||8||
48238341|NCT01393964|100906571|FG001|STARTED|Overall Study||9||
48238342|NCT01393964|100906572|FG002|STARTED|Overall Study||9||
48238343|NCT01393964|100906570|FG000|COMPLETED|Overall Study||0||
48238344|NCT01393964|100906571|FG001|COMPLETED|Overall Study||0||
48238345|NCT01393964|100906572|FG002|COMPLETED|Overall Study||0||
48238346|NCT01393964|100906570|FG000|NOT COMPLETED|Overall Study||8||
48674363|NCT01561976|101985996|FG000|STARTED|Washout Period 1 (7 Days)||5||
48674364|NCT01561976|101985997|FG001|STARTED|Washout Period 1 (7 Days)||5||
48539046|NCT05958888|101655376|FG000|COMPLETED|Third Label Viewing (Self-paced)||63||
48238347|NCT01393964|100906571|FG001|NOT COMPLETED|Overall Study||9||
48238348|NCT01393964|100906572|FG002|NOT COMPLETED|Overall Study||9||
48238349|NCT04050722|100906573|FG000|STARTED|Overall Study||65||
48238350|NCT04050722|100906574|FG001|STARTED|Overall Study||65||
48238351|NCT04050722|100906573|FG000|COMPLETED|Overall Study||64||
48539047|NCT05958888|101655376|FG000|NOT COMPLETED|Third Label Viewing (Self-paced)||0||
48238352|NCT04050722|100906574|FG001|COMPLETED|Overall Study||65||
48238353|NCT04050722|100906573|FG000|NOT COMPLETED|Overall Study||1||
48238354|NCT04050722|100906574|FG001|NOT COMPLETED|Overall Study||0||
48238355|NCT00748098|100906575|FG000|STARTED|First Treatment Intervention Period||69||
48238356|NCT00748098|100906576|FG001|STARTED|First Treatment Intervention Period||67||
48238357|NCT00748098|100906575|FG000|COMPLETED|First Treatment Intervention Period||64||
48238358|NCT00748098|100906576|FG001|COMPLETED|First Treatment Intervention Period||66||
48238359|NCT00748098|100906575|FG000|NOT COMPLETED|First Treatment Intervention Period||5||
48539048|NCT05958888|101655376|FG000|STARTED|Washout (Self Paced)||63||
48539049|NCT05958888|101655376|FG000|Text Only Sodium Label|Washout (Self Paced)||21||
48238360|NCT00748098|100906576|FG001|NOT COMPLETED|First Treatment Intervention Period||1||
48238361|NCT00748098|100906575|FG000|STARTED|First Taper Period||64||
48238362|NCT00748098|100906576|FG001|STARTED|First Taper Period||66||
48674365|NCT01561976|101985998|FG002|STARTED|Washout Period 1 (7 Days)||4||
48238363|NCT00748098|100906575|FG000|COMPLETED|First Taper Period||61||
48238364|NCT00748098|100906576|FG001|COMPLETED|First Taper Period||65||
48238365|NCT00748098|100906575|FG000|NOT COMPLETED|First Taper Period||3||
48238366|NCT00748098|100906576|FG001|NOT COMPLETED|First Taper Period||1||
48238367|NCT00748098|100906575|FG000|STARTED|1-Week Washout Period||61||
48238368|NCT00748098|100906576|FG001|STARTED|1-Week Washout Period||65||
48238369|NCT00748098|100906575|FG000|COMPLETED|1-Week Washout Period||59||
48238370|NCT00748098|100906576|FG001|COMPLETED|1-Week Washout Period||64||
48238371|NCT00748098|100906575|FG000|NOT COMPLETED|1-Week Washout Period||2||
48539050|NCT05958888|101655376|FG000|Icon Sodium Label|Washout (Self Paced)||10||
48539051|NCT05958888|101655376|FG000|Pictorial Sodium Label|Washout (Self Paced)||14||
48592675|NCT01877382|101783162|FG012|STARTED|Dose Expansion||0||
48238372|NCT00748098|100906576|FG001|NOT COMPLETED|1-Week Washout Period||1||
48238373|NCT00748098|100906575|FG000|STARTED|Second Treatment Intervention Period||59||
48238374|NCT00748098|100906576|FG001|STARTED|Second Treatment Intervention Period||64||
48238375|NCT00748098|100906575|FG000|COMPLETED|Second Treatment Intervention Period||53||
48238376|NCT00748098|100906576|FG001|COMPLETED|Second Treatment Intervention Period||61||
48238377|NCT00748098|100906575|FG000|NOT COMPLETED|Second Treatment Intervention Period||6||
48238378|NCT00748098|100906576|FG001|NOT COMPLETED|Second Treatment Intervention Period||3||
48238379|NCT00748098|100906575|FG000|STARTED|Second Taper Period||53||
48238380|NCT00748098|100906576|FG001|STARTED|Second Taper Period||61||
48238381|NCT00748098|100906575|FG000|COMPLETED|Second Taper Period||53||
48238382|NCT00748098|100906576|FG001|COMPLETED|Second Taper Period||61||
48238383|NCT00748098|100906575|FG000|NOT COMPLETED|Second Taper Period||0||
48238384|NCT00748098|100906576|FG001|NOT COMPLETED|Second Taper Period||0||
48238385|NCT02799745|100906577|FG000|STARTED|Overall Study||114||
48238386|NCT02799745|100906578|FG001|STARTED|Overall Study||113||
48238387|NCT02799745|100906577|FG000|Treated|Overall Study||112||
48238388|NCT02799745|100906578|FG001|Treated|Overall Study||113||
48238389|NCT02799745|100906577|FG000|COMPLETED|Overall Study||58||
48238390|NCT02799745|100906578|FG001|COMPLETED|Overall Study||42||
48238391|NCT02799745|100906577|FG000|NOT COMPLETED|Overall Study||56||
48238392|NCT02799745|100906578|FG001|NOT COMPLETED|Overall Study||71||
48238393|NCT00555620|100906579|FG000|STARTED|Overall Study||6||
48238394|NCT00555620|100906580|FG001|STARTED|Overall Study||7||
48539052|NCT05958888|101655376|FG000|Barcode Label|Washout (Self Paced)||18||
48539053|NCT05958888|101655376|FG000|COMPLETED|Washout (Self Paced)||63||
48539054|NCT05958888|101655376|FG000|NOT COMPLETED|Washout (Self Paced)||0||
48539055|NCT05958888|101655376|FG000|STARTED|Fourth Label Viewing (Self-paced)||63||
48539056|NCT05958888|101655376|FG000|Text Only Sodium Label|Fourth Label Viewing (Self-paced)||10||
48539057|NCT05958888|101655376|FG000|Icon Sodium Label|Fourth Label Viewing (Self-paced)||22||
48539058|NCT05958888|101655376|FG000|Pictorial Sodium Label|Fourth Label Viewing (Self-paced)||16||
48674366|NCT01561976|101985999|FG003|STARTED|Washout Period 1 (7 Days)||5||
48674367|NCT01561976|101986000|FG004|STARTED|Washout Period 1 (7 Days)||5||
48674368|NCT01561976|101986001|FG005|STARTED|Washout Period 1 (7 Days)||5||
48674369|NCT01561976|101985996|FG000|COMPLETED|Washout Period 1 (7 Days)||5||
48674370|NCT01561976|101985997|FG001|COMPLETED|Washout Period 1 (7 Days)||5||
48674371|NCT01561976|101985998|FG002|COMPLETED|Washout Period 1 (7 Days)||4||
48674372|NCT01561976|101985999|FG003|COMPLETED|Washout Period 1 (7 Days)||4||
48674373|NCT01561976|101986000|FG004|COMPLETED|Washout Period 1 (7 Days)||5||
48674374|NCT01561976|101986001|FG005|COMPLETED|Washout Period 1 (7 Days)||4||
48674375|NCT01561976|101985996|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48238395|NCT00555620|100906581|FG002|STARTED|Overall Study||15||
48238396|NCT00555620|100906582|FG003|STARTED|Overall Study||23||
48238397|NCT00555620|100906583|FG004|STARTED|Overall Study||3||
48238398|NCT00555620|100906584|FG005|STARTED|Overall Study||22||
48238399|NCT00555620|100906579|FG000|COMPLETED|Overall Study||0||
48238400|NCT00555620|100906580|FG001|COMPLETED|Overall Study||0||
48238401|NCT00555620|100906581|FG002|COMPLETED|Overall Study||0||
48238402|NCT00555620|100906582|FG003|COMPLETED|Overall Study||0||
48238403|NCT00555620|100906583|FG004|COMPLETED|Overall Study||0||
48238404|NCT00555620|100906584|FG005|COMPLETED|Overall Study||0||
48238405|NCT00555620|100906579|FG000|NOT COMPLETED|Overall Study||6||
48238406|NCT00555620|100906580|FG001|NOT COMPLETED|Overall Study||7||
48238407|NCT00555620|100906581|FG002|NOT COMPLETED|Overall Study||15||
48238408|NCT00555620|100906582|FG003|NOT COMPLETED|Overall Study||23||
48238409|NCT00555620|100906583|FG004|NOT COMPLETED|Overall Study||3||
48539059|NCT05958888|101655376|FG000|Barcode Label|Fourth Label Viewing (Self-paced)||15||
48539060|NCT05958888|101655376|FG000|COMPLETED|Fourth Label Viewing (Self-paced)||63||
48539061|NCT05958888|101655376|FG000|NOT COMPLETED|Fourth Label Viewing (Self-paced)||0||
48539062|NCT01497808|101655377|FG000|STARTED|Overall Study||6||
48539063|NCT01497808|101655378|FG001|STARTED|Overall Study||4||
48539064|NCT01497808|101655379|FG002|STARTED|Overall Study||6||
48539065|NCT01497808|101655380|FG003|STARTED|Overall Study||6||
48674376|NCT01561976|101985997|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48674377|NCT01561976|101985998|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48674378|NCT01561976|101985999|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1||
48539066|NCT01497808|101655377|FG000|COMPLETED|Overall Study||6||
48539067|NCT01497808|101655378|FG001|COMPLETED|Overall Study||4||
48539068|NCT01497808|101655379|FG002|COMPLETED|Overall Study||6||
48539069|NCT01497808|101655380|FG003|COMPLETED|Overall Study||6||
48539070|NCT01497808|101655377|FG000|NOT COMPLETED|Overall Study||0||
48539071|NCT01497808|101655378|FG001|NOT COMPLETED|Overall Study||0||
48539072|NCT01497808|101655379|FG002|NOT COMPLETED|Overall Study||0||
48238410|NCT00555620|100906584|FG005|NOT COMPLETED|Overall Study||22||
48238411|NCT03394508|100906585|FG000|STARTED|Overall Study||13||
48238412|NCT03394508|100906586|FG001|STARTED|Overall Study||17||
48238413|NCT03394508|100906585|FG000|COMPLETED|Overall Study||12||
48539073|NCT01497808|101655380|FG003|NOT COMPLETED|Overall Study||0||
48238414|NCT03394508|100906586|FG001|COMPLETED|Overall Study||14||
48238415|NCT03394508|100906585|FG000|NOT COMPLETED|Overall Study||1||
48238416|NCT03394508|100906586|FG001|NOT COMPLETED|Overall Study||3||
48674379|NCT01561976|101986000|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48674380|NCT01561976|101986001|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||1||
48674381|NCT01561976|101985996|FG000|STARTED|Period 2||5||
48674382|NCT01561976|101985997|FG001|STARTED|Period 2||5||
48674383|NCT01561976|101985998|FG002|STARTED|Period 2||4||
48674384|NCT01561976|101985999|FG003|STARTED|Period 2||4||
48674385|NCT01561976|101986000|FG004|STARTED|Period 2||5||
48674386|NCT01561976|101986001|FG005|STARTED|Period 2||4||
48674387|NCT01561976|101985996|FG000|COMPLETED|Period 2||5||
48674388|NCT01561976|101985997|FG001|COMPLETED|Period 2||5||
48674389|NCT01561976|101985998|FG002|COMPLETED|Period 2||4||
48674390|NCT01561976|101985999|FG003|COMPLETED|Period 2||4||
48674391|NCT01561976|101986000|FG004|COMPLETED|Period 2||5||
48238417|NCT02722278|100906587|FG000|STARTED|Overall Study||166||
48238418|NCT02722278|100906588|FG001|STARTED|Overall Study||56||
48238419|NCT02722278|100906587|FG000|COMPLETED|Overall Study||154||
48238420|NCT02722278|100906588|FG001|COMPLETED|Overall Study||49||
48238421|NCT02722278|100906587|FG000|NOT COMPLETED|Overall Study||12||
48238422|NCT02722278|100906588|FG001|NOT COMPLETED|Overall Study||7||
48238423|NCT03020914|100906589|FG000|STARTED|Overall Study||10||
48238424|NCT03020914|100906590|FG001|STARTED|Overall Study||9||
48238425|NCT03020914|100906589|FG000|COMPLETED|Overall Study||9||
48238426|NCT03020914|100906590|FG001|COMPLETED|Overall Study||9||
48238427|NCT03020914|100906589|FG000|NOT COMPLETED|Overall Study||1||
48238428|NCT03020914|100906590|FG001|NOT COMPLETED|Overall Study||0||
48238429|NCT01018992|100906591|FG000|STARTED|Overall Study||63||
48238430|NCT01018992|100906592|FG001|STARTED|Overall Study||65||
48238431|NCT01018992|100906591|FG000|COMPLETED|Overall Study||47||
48238432|NCT01018992|100906592|FG001|COMPLETED|Overall Study||49||
48238433|NCT01018992|100906591|FG000|NOT COMPLETED|Overall Study||16||
48238434|NCT01018992|100906592|FG001|NOT COMPLETED|Overall Study||16||
48238435|NCT02556606|100906593|FG000|STARTED|Overall Study||4||
48238436|NCT02556606|100906594|FG001|STARTED|Overall Study||5||
48539074|NCT05594264|101655381|FG000|STARTED|Overall Study||0||
48539075|NCT05594264|101655382|FG001|STARTED|Overall Study||31||
48539076|NCT05594264|101655381|FG000|COMPLETED|Overall Study||0|Pilot phase was not initiated, participants were not recruited for this phase of the study.|
48539077|NCT05594264|101655382|FG001|COMPLETED|Overall Study||0|Pilot phase was not initiated, participants were not recruited for this phase of the study.|
48539078|NCT05594264|101655381|FG000|NOT COMPLETED|Overall Study||0||
48539079|NCT05594264|101655382|FG001|NOT COMPLETED|Overall Study||31||
48539080|NCT00927394|101655383|FG000|STARTED|Overall Study||575||
48539081|NCT00927394|101655384|FG001|STARTED|Overall Study||568||
48539082|NCT00927394|101655383|FG000|Cohort 1 (Randomized)|Overall Study||157||
48539083|NCT00927394|101655384|FG001|Cohort 1 (Randomized)|Overall Study||165||
48539084|NCT00927394|101655383|FG000|Cohort 2 (Randomized)|Overall Study||418||
48539085|NCT00927394|101655384|FG001|Cohort 2 (Randomized)|Overall Study||403||
48539086|NCT00927394|101655383|FG000|Combined Safety Set (Cohort 1 and 2)|Overall Study||574||
48539087|NCT00927394|101655384|FG001|Combined Safety Set (Cohort 1 and 2)|Overall Study||565||
48539088|NCT00927394|101655383|FG000|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study||157||
48539089|NCT00927394|101655384|FG001|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study||164||
48539090|NCT00927394|101655383|FG000|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study||417||
48238437|NCT02556606|100906595|FG002|STARTED|Overall Study||11||
48539091|NCT00927394|101655384|FG001|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study||398||
48539092|NCT00927394|101655383|FG000|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study||342||
48539093|NCT00927394|101655384|FG001|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study||323||
48539094|NCT00927394|101655383|FG000|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||574||
48539095|NCT00927394|101655384|FG001|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||562||
48539096|NCT00927394|101655383|FG000|COMPLETED|Overall Study||498||
48539097|NCT00927394|101655384|FG001|COMPLETED|Overall Study||483||
48539098|NCT00927394|101655383|FG000|NOT COMPLETED|Overall Study||77||
48539099|NCT00927394|101655384|FG001|NOT COMPLETED|Overall Study||85||
48539100|NCT02684630|101655385|FG000|STARTED|Overall Study||65||
48539101|NCT02684630|101655386|FG001|STARTED|Overall Study||63||
48539102|NCT02684630|101655385|FG000|COMPLETED|Overall Study||60||
48539103|NCT02684630|101655386|FG001|COMPLETED|Overall Study||60||
48539104|NCT02684630|101655385|FG000|NOT COMPLETED|Overall Study||5||
48539105|NCT02684630|101655386|FG001|NOT COMPLETED|Overall Study||3||
48539106|NCT02013674|101655387|FG000|STARTED|Overall Study||15||
48539107|NCT02013674|101655388|FG001|STARTED|Overall Study||15||
48539108|NCT02013674|101655387|FG000|COMPLETED|Overall Study||14||
48539109|NCT02013674|101655388|FG001|COMPLETED|Overall Study||14||
48539110|NCT02013674|101655387|FG000|NOT COMPLETED|Overall Study||1||
48539111|NCT02013674|101655388|FG001|NOT COMPLETED|Overall Study||1||
48539112|NCT00447993|101655389|FG000|STARTED|Overall Study||22||22
48539113|NCT00447993|101655390|FG001|STARTED|Overall Study||22||22
48539114|NCT00447993|101655391|FG002|STARTED|Overall Study||45||45
48539115|NCT00447993|101655392|FG003|STARTED|Overall Study||45||45
48238438|NCT02556606|100906596|FG003|STARTED|Overall Study||13||
48238439|NCT02556606|100906593|FG000|COMPLETED|Overall Study||4||
48674392|NCT01561976|101986001|FG005|COMPLETED|Period 2||4||
48238440|NCT02556606|100906594|FG001|COMPLETED|Overall Study||5||
48238441|NCT02556606|100906595|FG002|COMPLETED|Overall Study||11||
48674393|NCT01561976|101985996|FG000|NOT COMPLETED|Period 2||0||
48674394|NCT01561976|101985997|FG001|NOT COMPLETED|Period 2||0||
48674395|NCT01561976|101985998|FG002|NOT COMPLETED|Period 2||0||
48674396|NCT01561976|101985999|FG003|NOT COMPLETED|Period 2||0||
48674397|NCT01561976|101986000|FG004|NOT COMPLETED|Period 2||0||
48674398|NCT01561976|101986001|FG005|NOT COMPLETED|Period 2||0||
48674399|NCT01561976|101985996|FG000|STARTED|Washout Period 2 (7 Days)||5||
48674400|NCT01561976|101985997|FG001|STARTED|Washout Period 2 (7 Days)||5||
48674401|NCT01561976|101985998|FG002|STARTED|Washout Period 2 (7 Days)||4||
48674402|NCT01561976|101985999|FG003|STARTED|Washout Period 2 (7 Days)||4||
48674403|NCT01561976|101986000|FG004|STARTED|Washout Period 2 (7 Days)||5||
48674404|NCT01561976|101986001|FG005|STARTED|Washout Period 2 (7 Days)||4||
48674405|NCT01561976|101985996|FG000|COMPLETED|Washout Period 2 (7 Days)||4||
48674406|NCT01561976|101985997|FG001|COMPLETED|Washout Period 2 (7 Days)||5||
48674407|NCT01561976|101985998|FG002|COMPLETED|Washout Period 2 (7 Days)||3||
48674408|NCT01561976|101985999|FG003|COMPLETED|Washout Period 2 (7 Days)||4||
48674409|NCT01561976|101986000|FG004|COMPLETED|Washout Period 2 (7 Days)||5||
48674410|NCT01561976|101986001|FG005|COMPLETED|Washout Period 2 (7 Days)||4||
48674411|NCT01561976|101985996|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||1||
48674412|NCT01561976|101985997|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48674413|NCT01561976|101985998|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||1||
48674414|NCT01561976|101985999|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48674415|NCT01561976|101986000|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48674416|NCT01561976|101986001|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48674417|NCT01561976|101985996|FG000|STARTED|Period 3||4||
48674418|NCT01561976|101985997|FG001|STARTED|Period 3||5||
48674419|NCT01561976|101985998|FG002|STARTED|Period 3||3||
48674420|NCT01561976|101985999|FG003|STARTED|Period 3||4||
48674421|NCT01561976|101986000|FG004|STARTED|Period 3||5||
48674422|NCT01561976|101986001|FG005|STARTED|Period 3||4||
48674423|NCT01561976|101985996|FG000|COMPLETED|Period 3||4||
48674424|NCT01561976|101985997|FG001|COMPLETED|Period 3||5||
48674425|NCT01561976|101985998|FG002|COMPLETED|Period 3||3||
48674426|NCT01561976|101985999|FG003|COMPLETED|Period 3||4||
48674427|NCT01561976|101986000|FG004|COMPLETED|Period 3||5||
48674428|NCT01561976|101986001|FG005|COMPLETED|Period 3||4||
48674429|NCT01561976|101985996|FG000|NOT COMPLETED|Period 3||0||
48674430|NCT01561976|101985997|FG001|NOT COMPLETED|Period 3||0||
48674431|NCT01561976|101985998|FG002|NOT COMPLETED|Period 3||0||
48674432|NCT01561976|101985999|FG003|NOT COMPLETED|Period 3||0||
48674433|NCT01561976|101986000|FG004|NOT COMPLETED|Period 3||0||
48674434|NCT01561976|101986001|FG005|NOT COMPLETED|Period 3||0||
48674435|NCT00545779|101986002|FG000|STARTED|Overall Study||677||
48238442|NCT02556606|100906596|FG003|COMPLETED|Overall Study||13||
48238443|NCT02556606|100906593|FG000|NOT COMPLETED|Overall Study||0||
48238444|NCT02556606|100906594|FG001|NOT COMPLETED|Overall Study||0||
48238445|NCT02556606|100906595|FG002|NOT COMPLETED|Overall Study||0||
48238446|NCT02556606|100906596|FG003|NOT COMPLETED|Overall Study||0||
48238447|NCT01989156|100906597|FG000|STARTED|Confinement Period (Population at Day 5)||80||
48238448|NCT01989156|100906598|FG001|STARTED|Confinement Period (Population at Day 5)||41||
48238449|NCT01989156|100906599|FG002|STARTED|Confinement Period (Population at Day 5)||39||
48238450|NCT01989156|100906597|FG000|COMPLETED|Confinement Period (Population at Day 5)||80||
48238451|NCT01989156|100906598|FG001|COMPLETED|Confinement Period (Population at Day 5)||40||
48539116|NCT00447993|101655389|FG000|COMPLETED|Overall Study||22||22
48539117|NCT00447993|101655390|FG001|COMPLETED|Overall Study||22||22
48539118|NCT00447993|101655391|FG002|COMPLETED|Overall Study||41||41
48539119|NCT00447993|101655392|FG003|COMPLETED|Overall Study||41||41
48238452|NCT01989156|100906599|FG002|COMPLETED|Confinement Period (Population at Day 5)||34||
48238453|NCT01989156|100906597|FG000|NOT COMPLETED|Confinement Period (Population at Day 5)||0||
48238454|NCT01989156|100906598|FG001|NOT COMPLETED|Confinement Period (Population at Day 5)||1||
48238455|NCT01989156|100906599|FG002|NOT COMPLETED|Confinement Period (Population at Day 5)||5||
48238456|NCT01989156|100906597|FG000|STARTED|End of Study (Population at Day 90)||80||
48238457|NCT01989156|100906598|FG001|STARTED|End of Study (Population at Day 90)||40||
48238458|NCT01989156|100906599|FG002|STARTED|End of Study (Population at Day 90)||34||
48238459|NCT01989156|100906597|FG000|COMPLETED|End of Study (Population at Day 90)||73||
48238460|NCT01989156|100906598|FG001|COMPLETED|End of Study (Population at Day 90)||35||
48238461|NCT01989156|100906599|FG002|COMPLETED|End of Study (Population at Day 90)||31||
48238462|NCT01989156|100906597|FG000|NOT COMPLETED|End of Study (Population at Day 90)||7||
48539120|NCT00447993|101655389|FG000|NOT COMPLETED|Overall Study||0||0
48539121|NCT00447993|101655390|FG001|NOT COMPLETED|Overall Study||0||0
48539122|NCT00447993|101655391|FG002|NOT COMPLETED|Overall Study||4||4
48539123|NCT00447993|101655392|FG003|NOT COMPLETED|Overall Study||4||4
48674436|NCT00545779|101986002|FG000|COMPLETED|Overall Study||633||
48674437|NCT00545779|101986002|FG000|NOT COMPLETED|Overall Study||44||
48674438|NCT00805389|101986003|FG000|STARTED|Overall Study||143||
48674439|NCT00805389|101986004|FG001|STARTED|Overall Study||142||
48674440|NCT00805389|101986005|FG002|STARTED|Overall Study||141||
48674441|NCT00805389|101986006|FG003|STARTED|Overall Study||145||
48674442|NCT00805389|101986007|FG004|STARTED|Overall Study||142||
48674443|NCT00805389|101986003|FG000|COMPLETED|Overall Study||136||
48674444|NCT00805389|101986004|FG001|COMPLETED|Overall Study||137||
48674445|NCT00805389|101986005|FG002|COMPLETED|Overall Study||129||
48674446|NCT00805389|101986006|FG003|COMPLETED|Overall Study||128||
48674447|NCT00805389|101986007|FG004|COMPLETED|Overall Study||129||
48674448|NCT00805389|101986003|FG000|NOT COMPLETED|Overall Study||7||
48674449|NCT00805389|101986004|FG001|NOT COMPLETED|Overall Study||5||
48674450|NCT00805389|101986005|FG002|NOT COMPLETED|Overall Study||12||
48674451|NCT00805389|101986006|FG003|NOT COMPLETED|Overall Study||17||
48674452|NCT00805389|101986007|FG004|NOT COMPLETED|Overall Study||13||
48674453|NCT00673920|101986008|FG000|STARTED|Baseline up to Week 48||64||
48674454|NCT00673920|101986009|FG001|STARTED|Baseline up to Week 48||117||
48674455|NCT00673920|101986010|FG002|STARTED|Baseline up to Week 48||133||
48674456|NCT00673920|101986011|FG003|STARTED|Baseline up to Week 48||0||
48674457|NCT00673920|101986012|FG004|STARTED|Baseline up to Week 48||0||
48238463|NCT01989156|100906598|FG001|NOT COMPLETED|End of Study (Population at Day 90)||5||
48674458|NCT00673920|101986013|FG005|STARTED|Baseline up to Week 48||0||
48674459|NCT00673920|101986014|FG006|STARTED|Baseline up to Week 48||0||
48674460|NCT00673920|101986015|FG007|STARTED|Baseline up to Week 48||0||
48674461|NCT00673920|101986008|FG000|COMPLETED|Baseline up to Week 48||60||
48674462|NCT00673920|101986009|FG001|COMPLETED|Baseline up to Week 48||114||
48674463|NCT00673920|101986010|FG002|COMPLETED|Baseline up to Week 48||126||
48674464|NCT00673920|101986011|FG003|COMPLETED|Baseline up to Week 48||0||
48674465|NCT00673920|101986012|FG004|COMPLETED|Baseline up to Week 48||0||
48674466|NCT00673920|101986013|FG005|COMPLETED|Baseline up to Week 48||0||
48674467|NCT00673920|101986014|FG006|COMPLETED|Baseline up to Week 48||0||
48674468|NCT00673920|101986015|FG007|COMPLETED|Baseline up to Week 48||0||
48674469|NCT00673920|101986008|FG000|NOT COMPLETED|Baseline up to Week 48||4||
48674470|NCT00673920|101986009|FG001|NOT COMPLETED|Baseline up to Week 48||3||
48674471|NCT00673920|101986010|FG002|NOT COMPLETED|Baseline up to Week 48||7||
48674472|NCT00673920|101986011|FG003|NOT COMPLETED|Baseline up to Week 48||0||
48674473|NCT00673920|101986012|FG004|NOT COMPLETED|Baseline up to Week 48||0||
48674474|NCT00673920|101986013|FG005|NOT COMPLETED|Baseline up to Week 48||0||
48674475|NCT00673920|101986014|FG006|NOT COMPLETED|Baseline up to Week 48||0||
48674476|NCT00673920|101986015|FG007|NOT COMPLETED|Baseline up to Week 48||0||
48674477|NCT00673920|101986008|FG000|STARTED|Week 24 to Week 48||0||
48674478|NCT00673920|101986009|FG001|STARTED|Week 24 to Week 48||0||
48674479|NCT00673920|101986010|FG002|STARTED|Week 24 to Week 48||0||
48674480|NCT00673920|101986011|FG003|STARTED|Week 24 to Week 48||61||
48674481|NCT00673920|101986012|FG004|STARTED|Week 24 to Week 48||61||
48674482|NCT00673920|101986013|FG005|STARTED|Week 24 to Week 48||109||
48674483|NCT00673920|101986014|FG006|STARTED|Week 24 to Week 48||29||
48674484|NCT00673920|101986015|FG007|STARTED|Week 24 to Week 48||28||
48674485|NCT00673920|101986008|FG000|COMPLETED|Week 24 to Week 48||0||
48674486|NCT00673920|101986009|FG001|COMPLETED|Week 24 to Week 48||0||
48674487|NCT00673920|101986010|FG002|COMPLETED|Week 24 to Week 48||0||
48238464|NCT01989156|100906599|FG002|NOT COMPLETED|End of Study (Population at Day 90)||3||
48238465|NCT01458288|100906600|FG000|STARTED|Overall Study||12||
48238466|NCT01458288|100906600|FG000|COMPLETED|Overall Study||12||
48238467|NCT01458288|100906600|FG000|NOT COMPLETED|Overall Study||0||
48238468|NCT03034772|100906601|FG000|STARTED|Overall Study||27||
48238469|NCT03034772|100906602|FG001|STARTED|Overall Study||25||
48238470|NCT03034772|100906601|FG000|COMPLETED|Overall Study||27||
48238471|NCT03034772|100906602|FG001|COMPLETED|Overall Study||23||
48238472|NCT03034772|100906601|FG000|NOT COMPLETED|Overall Study||0||
48238473|NCT03034772|100906602|FG001|NOT COMPLETED|Overall Study||2||
48238474|NCT04853394|100906603|FG000|STARTED|Baseline Interview||210||
48238475|NCT04853394|100906604|FG001|STARTED|Baseline Interview||210||
48674488|NCT00673920|101986011|FG003|COMPLETED|Week 24 to Week 48||60||
48674489|NCT00673920|101986012|FG004|COMPLETED|Week 24 to Week 48||61||
48674490|NCT00673920|101986013|FG005|COMPLETED|Week 24 to Week 48||106||
48674491|NCT00673920|101986014|FG006|COMPLETED|Week 24 to Week 48||28||
48674492|NCT00673920|101986015|FG007|COMPLETED|Week 24 to Week 48||28||
48674493|NCT00673920|101986008|FG000|NOT COMPLETED|Week 24 to Week 48||0||
48674494|NCT00673920|101986009|FG001|NOT COMPLETED|Week 24 to Week 48||0||
48674495|NCT00673920|101986010|FG002|NOT COMPLETED|Week 24 to Week 48||0||
48674496|NCT00673920|101986011|FG003|NOT COMPLETED|Week 24 to Week 48||1||
48674497|NCT00673920|101986012|FG004|NOT COMPLETED|Week 24 to Week 48||0||
48674498|NCT00673920|101986013|FG005|NOT COMPLETED|Week 24 to Week 48||3||
48674499|NCT00673920|101986014|FG006|NOT COMPLETED|Week 24 to Week 48||1||
48674500|NCT00673920|101986015|FG007|NOT COMPLETED|Week 24 to Week 48||0||
48674501|NCT02348203|101986016|FG000|STARTED|Overall Study||31||
48674502|NCT02348203|101986017|FG001|STARTED|Overall Study||32||
48674503|NCT02348203|101986016|FG000|COMPLETED|Overall Study||21||
48674504|NCT02348203|101986017|FG001|COMPLETED|Overall Study||22||
48674505|NCT02348203|101986016|FG000|NOT COMPLETED|Overall Study||10||
48674506|NCT02348203|101986017|FG001|NOT COMPLETED|Overall Study||10||
48674507|NCT00237042|101986018|FG000|STARTED|Treatment||60||
48674508|NCT00237042|101986019|FG001|STARTED|Treatment||57||
48674509|NCT00237042|101986020|FG002|STARTED|Treatment||74||
48238476|NCT04853394|100906603|FG000|COMPLETED|Baseline Interview||210||
48238477|NCT04853394|100906604|FG001|COMPLETED|Baseline Interview||210||
48674510|NCT00237042|101986018|FG000|COMPLETED|Treatment||54||
48238478|NCT04853394|100906603|FG000|NOT COMPLETED|Baseline Interview||0||
48238479|NCT04853394|100906604|FG001|NOT COMPLETED|Baseline Interview||0||
48238480|NCT04853394|100906603|FG000|STARTED|Intervention Sessions||70|Network member participated in interviews only|
48674511|NCT00237042|101986019|FG001|COMPLETED|Treatment||50||
48238481|NCT04853394|100906604|FG001|STARTED|Intervention Sessions||70|Network member participated in interviews only|
48238482|NCT04853394|100906603|FG000|COMPLETED|Intervention Sessions||70||
48238483|NCT04853394|100906604|FG001|COMPLETED|Intervention Sessions||70||
48238484|NCT04853394|100906603|FG000|NOT COMPLETED|Intervention Sessions||0||
48238485|NCT04853394|100906604|FG001|NOT COMPLETED|Intervention Sessions||0||
48238486|NCT04853394|100906603|FG000|STARTED|Follow-up Interviews||210||
48238487|NCT04853394|100906604|FG001|STARTED|Follow-up Interviews||210||
48238488|NCT04853394|100906603|FG000|COMPLETED|Follow-up Interviews||188||
48238489|NCT04853394|100906604|FG001|COMPLETED|Follow-up Interviews||195||
48238490|NCT04853394|100906603|FG000|NOT COMPLETED|Follow-up Interviews||22||
48238491|NCT04853394|100906604|FG001|NOT COMPLETED|Follow-up Interviews||15||
48238492|NCT02962076|100906605|FG000|STARTED|Overall Study||11||
48238493|NCT02962076|100906605|FG000|COMPLETED|Overall Study||4||
48539124|NCT04581369|101655393|FG000|STARTED|Overall Study||20||
48539125|NCT04581369|101655394|FG001|STARTED|Overall Study||20||
48539126|NCT04581369|101655395|FG002|STARTED|Overall Study||4||
48539127|NCT04581369|101655393|FG000|COMPLETED|Overall Study||4||
48539128|NCT04581369|101655394|FG001|COMPLETED|Overall Study||4||
48539129|NCT04581369|101655395|FG002|COMPLETED|Overall Study||4||
48539130|NCT04581369|101655393|FG000|NOT COMPLETED|Overall Study||16||
48539131|NCT04581369|101655394|FG001|NOT COMPLETED|Overall Study||16||
48539132|NCT04581369|101655395|FG002|NOT COMPLETED|Overall Study||0||
48539133|NCT02910063|101655396|FG000|STARTED|Phase 2||41||
48539134|NCT02910063|101655397|FG001|STARTED|Phase 2||0||
48539135|NCT02910063|101655398|FG002|STARTED|Phase 2||0||
48539136|NCT02910063|101655396|FG000|Started Cycle 1|Phase 2||41||
48539137|NCT02910063|101655397|FG001|Started Cycle 1|Phase 2||0||
48539138|NCT02910063|101655398|FG002|Started Cycle 1|Phase 2||0||
48539139|NCT02910063|101655396|FG000|Started Optional Cycle 2|Phase 2||4||
48539140|NCT02910063|101655397|FG001|Started Optional Cycle 2|Phase 2||0||
48539141|NCT02910063|101655398|FG002|Started Optional Cycle 2|Phase 2||0||
48539142|NCT02910063|101655396|FG000|COMPLETED|Phase 2||13||
48539143|NCT02910063|101655397|FG001|COMPLETED|Phase 2||0||
48539144|NCT02910063|101655398|FG002|COMPLETED|Phase 2||0||
48539145|NCT02910063|101655396|FG000|NOT COMPLETED|Phase 2||28||
48539146|NCT02910063|101655397|FG001|NOT COMPLETED|Phase 2||0||
48539147|NCT02910063|101655398|FG002|NOT COMPLETED|Phase 2||0||
48539148|NCT02910063|101655396|FG000|STARTED|Phase 3||0||
48539149|NCT02910063|101655397|FG001|STARTED|Phase 3||0||
48539150|NCT02910063|101655398|FG002|STARTED|Phase 3||0||
48674512|NCT00237042|101986020|FG002|COMPLETED|Treatment||36||
48674513|NCT00237042|101986018|FG000|NOT COMPLETED|Treatment||6||
48674514|NCT00237042|101986019|FG001|NOT COMPLETED|Treatment||7||
48674515|NCT00237042|101986020|FG002|NOT COMPLETED|Treatment||38||
48674516|NCT00237042|101986018|FG000|STARTED|Short Term (6 Month) Follow up||59||
48674517|NCT00237042|101986019|FG001|STARTED|Short Term (6 Month) Follow up||55||
48674518|NCT00237042|101986020|FG002|STARTED|Short Term (6 Month) Follow up||57||
48674519|NCT00237042|101986018|FG000|COMPLETED|Short Term (6 Month) Follow up||50||
48674520|NCT00237042|101986019|FG001|COMPLETED|Short Term (6 Month) Follow up||47||
48674521|NCT00237042|101986020|FG002|COMPLETED|Short Term (6 Month) Follow up||46||
48674522|NCT00237042|101986018|FG000|NOT COMPLETED|Short Term (6 Month) Follow up||9||
48674523|NCT00237042|101986019|FG001|NOT COMPLETED|Short Term (6 Month) Follow up||8||
48674524|NCT00237042|101986020|FG002|NOT COMPLETED|Short Term (6 Month) Follow up||11||
48674525|NCT00237042|101986018|FG000|STARTED|Long Term (12 Month) Follow up||59||
48674526|NCT00237042|101986019|FG001|STARTED|Long Term (12 Month) Follow up||55||
48674527|NCT00237042|101986020|FG002|STARTED|Long Term (12 Month) Follow up||57||
48674528|NCT00237042|101986018|FG000|COMPLETED|Long Term (12 Month) Follow up||48||
48674529|NCT00237042|101986019|FG001|COMPLETED|Long Term (12 Month) Follow up||46||
48674530|NCT00237042|101986020|FG002|COMPLETED|Long Term (12 Month) Follow up||48||
48674531|NCT00237042|101986018|FG000|NOT COMPLETED|Long Term (12 Month) Follow up||11||
48674532|NCT00237042|101986019|FG001|NOT COMPLETED|Long Term (12 Month) Follow up||9||
48238494|NCT02962076|100906605|FG000|NOT COMPLETED|Overall Study||7||
48238495|NCT01864200|100906606|FG000|STARTED|Overall Study||45||
48674533|NCT00237042|101986020|FG002|NOT COMPLETED|Long Term (12 Month) Follow up||9||
48238496|NCT01864200|100906607|FG001|STARTED|Overall Study||29||
48238497|NCT01864200|100906606|FG000|COMPLETED|Overall Study||43||
48539151|NCT02910063|101655396|FG000|COMPLETED|Phase 3||0||
48539152|NCT02910063|101655397|FG001|COMPLETED|Phase 3||0||
48539153|NCT02910063|101655398|FG002|COMPLETED|Phase 3||0||
48539154|NCT02910063|101655396|FG000|NOT COMPLETED|Phase 3||0||
48539155|NCT02910063|101655397|FG001|NOT COMPLETED|Phase 3||0||
48539156|NCT02910063|101655398|FG002|NOT COMPLETED|Phase 3||0||
48674534|NCT01734525|101986021|FG000|STARTED|Overall Study||85||
48674535|NCT01734525|101986021|FG000|COMPLETED|Overall Study||85||
48539157|NCT04839692|101655399|FG000|STARTED|Overall Study||23||
48539158|NCT04839692|101655400|FG001|STARTED|Overall Study||14||
48539159|NCT04839692|101655399|FG000|COMPLETED|Overall Study||22||
48539160|NCT04839692|101655400|FG001|COMPLETED|Overall Study||11||
48674536|NCT01734525|101986021|FG000|NOT COMPLETED|Overall Study||0||
48238498|NCT01864200|100906607|FG001|COMPLETED|Overall Study||26||
48238499|NCT01864200|100906606|FG000|NOT COMPLETED|Overall Study||2||
48238500|NCT01864200|100906607|FG001|NOT COMPLETED|Overall Study||3||
48238501|NCT01250717|100906608|FG000|STARTED|Overall Study||28||
48238502|NCT01250717|100906608|FG000|COMPLETED|Overall Study||28||
48238503|NCT01250717|100906608|FG000|NOT COMPLETED|Overall Study||0||
48238504|NCT01469819|100906609|FG000|STARTED|Overall Study||37||
48238505|NCT01469819|100906609|FG000|COMPLETED|Overall Study||29||
48238506|NCT01469819|100906609|FG000|NOT COMPLETED|Overall Study||8||
48238507|NCT04474691|100906610|FG000|STARTED|Overall Study||15||240
48238508|NCT04474691|100906610|FG000|Visual-acoustic Biofeedback|Overall Study||8||56
48238509|NCT04474691|100906610|FG000|Traditional Articulation Treatment|Overall Study||8||53
48238510|NCT04474691|100906610|FG000|COMPLETED|Overall Study||6||96
48238511|NCT04474691|100906610|FG000|NOT COMPLETED|Overall Study||9||144
48238512|NCT03849300|100906611|FG000|STARTED|Overall Study||42||
48238513|NCT03849300|100906612|FG001|STARTED|Overall Study||42||
48238514|NCT03849300|100906613|FG002|STARTED|Overall Study||32||
48238515|NCT03849300|100906614|FG003|STARTED|Overall Study||31||
48238516|NCT03849300|100906611|FG000|COMPLETED|Overall Study||37||
48238517|NCT03849300|100906612|FG001|COMPLETED|Overall Study||35||
48238518|NCT03849300|100906613|FG002|COMPLETED|Overall Study||28||
48539161|NCT04839692|101655399|FG000|NOT COMPLETED|Overall Study||1||
48238519|NCT03849300|100906614|FG003|COMPLETED|Overall Study||25||
48539162|NCT04839692|101655400|FG001|NOT COMPLETED|Overall Study||3||
48539163|NCT00681590|101655401|FG000|STARTED|Overall Study||34||
48539164|NCT00681590|101655402|FG001|STARTED|Overall Study||71||
48539165|NCT00681590|101655401|FG000|COMPLETED|Overall Study||32||
48674537|NCT03383666|101986022|FG000|STARTED|Overall Study||21||
48674538|NCT03383666|101986022|FG000|Implanted With Pulse Rider|Overall Study||18||
48674539|NCT03383666|101986022|FG000|Attempted But Unsuccessful Implantation|Overall Study||3||
48674540|NCT03383666|101986022|FG000|COMPLETED|Overall Study||17||
48539166|NCT00681590|101655402|FG001|COMPLETED|Overall Study||59||
48539167|NCT00681590|101655401|FG000|NOT COMPLETED|Overall Study||2||
48539168|NCT00681590|101655402|FG001|NOT COMPLETED|Overall Study||12||
48539169|NCT02643355|101655403|FG000|STARTED|Overall Study||34||
48539170|NCT02643355|101655404|FG001|STARTED|Overall Study||35||
48539171|NCT02643355|101655403|FG000|COMPLETED|Overall Study||33||
48539172|NCT02643355|101655404|FG001|COMPLETED|Overall Study||30||
48539173|NCT02643355|101655403|FG000|NOT COMPLETED|Overall Study||1||
48539174|NCT02643355|101655404|FG001|NOT COMPLETED|Overall Study||5||
48674541|NCT03383666|101986022|FG000|NOT COMPLETED|Overall Study||4||
48674542|NCT02257684|101986023|FG000|STARTED|Overall Study||4||
48674543|NCT02257684|101986023|FG000|COMPLETED|Overall Study||0||
48674544|NCT02257684|101986023|FG000|NOT COMPLETED|Overall Study||4||
48238520|NCT03849300|100906611|FG000|NOT COMPLETED|Overall Study||5||
48238521|NCT03849300|100906612|FG001|NOT COMPLETED|Overall Study||7||
48238522|NCT03849300|100906613|FG002|NOT COMPLETED|Overall Study||4||
48238523|NCT03849300|100906614|FG003|NOT COMPLETED|Overall Study||6||
48238524|NCT03344458|100906615|FG000|STARTED|Overall Study||298||
48238525|NCT03344458|100906615|FG000|COMPLETED|Overall Study||259||
48238526|NCT03344458|100906615|FG000|NOT COMPLETED|Overall Study||39||
48238527|NCT01767376|100906616|FG000|STARTED|Overall Study||231||
48238528|NCT01767376|100906617|FG001|STARTED|Overall Study||228||
48238529|NCT01767376|100906618|FG002|STARTED|Overall Study||232||
48238530|NCT01767376|100906616|FG000|COMPLETED|Overall Study||227||
48238531|NCT01767376|100906617|FG001|COMPLETED|Overall Study||225||
48238532|NCT01767376|100906618|FG002|COMPLETED|Overall Study||232||
48238533|NCT01767376|100906616|FG000|NOT COMPLETED|Overall Study||4||
48238534|NCT01767376|100906617|FG001|NOT COMPLETED|Overall Study||3||
48238535|NCT01767376|100906618|FG002|NOT COMPLETED|Overall Study||0||
48238536|NCT02205476|100906619|FG000|STARTED|Overall Study||7||
48238537|NCT02205476|100906620|FG001|STARTED|Overall Study||3||
48238538|NCT02205476|100906619|FG000|COMPLETED|Overall Study||0||
48238539|NCT02205476|100906620|FG001|COMPLETED|Overall Study||0||
48238540|NCT02205476|100906619|FG000|NOT COMPLETED|Overall Study||7||
48539175|NCT02186834|101655405|FG000|STARTED|Dose Escalation||6||
48539176|NCT02186834|101655406|FG001|STARTED|Dose Escalation||3||
48539177|NCT02186834|101655407|FG002|STARTED|Dose Escalation||0||
48539178|NCT02186834|101655408|FG003|STARTED|Dose Escalation||7||
48539179|NCT02186834|101655409|FG004|STARTED|Dose Escalation||4||
48539180|NCT02186834|101655410|FG005|STARTED|Dose Escalation||0||
48539181|NCT02186834|101655405|FG000|COMPLETED|Dose Escalation||6||
48539182|NCT02186834|101655406|FG001|COMPLETED|Dose Escalation||3||
48539183|NCT02186834|101655407|FG002|COMPLETED|Dose Escalation||0||
48674545|NCT00698841|101986024|FG000|STARTED|Overall Study||51||
48674546|NCT00698841|101986024|FG000|COMPLETED|Overall Study||33||
48674547|NCT00698841|101986024|FG000|NOT COMPLETED|Overall Study||18||
48238541|NCT02205476|100906620|FG001|NOT COMPLETED|Overall Study||3||
48238542|NCT04184622|100906621|FG000|STARTED|Overall Study||643||
48238543|NCT04184622|100906622|FG001|STARTED|Overall Study||630||
48238544|NCT04184622|100906623|FG002|STARTED|Overall Study||636||
48238545|NCT04184622|100906624|FG003|STARTED|Overall Study||630||
48238546|NCT04184622|100906621|FG000|COMPLETED|Overall Study||495||
48539184|NCT02186834|101655408|FG003|COMPLETED|Dose Escalation||6||
48539185|NCT02186834|101655409|FG004|COMPLETED|Dose Escalation||4||
48539186|NCT02186834|101655410|FG005|COMPLETED|Dose Escalation||0||
48539187|NCT02186834|101655405|FG000|NOT COMPLETED|Dose Escalation||0||
48674548|NCT00902330|101986025|FG000|STARTED|Overall Study||81||
48674549|NCT00902330|101986026|FG001|STARTED|Overall Study||80||
48674550|NCT00902330|101986025|FG000|COMPLETED|Overall Study||77||
48674551|NCT00902330|101986026|FG001|COMPLETED|Overall Study||75||
48674552|NCT00902330|101986025|FG000|NOT COMPLETED|Overall Study||4||
48674553|NCT00902330|101986026|FG001|NOT COMPLETED|Overall Study||5||
48539188|NCT02186834|101655406|FG001|NOT COMPLETED|Dose Escalation||0||
48539189|NCT02186834|101655407|FG002|NOT COMPLETED|Dose Escalation||0||
48238547|NCT04184622|100906622|FG001|COMPLETED|Overall Study||561||
48238548|NCT04184622|100906623|FG002|COMPLETED|Overall Study||562||
48238549|NCT04184622|100906624|FG003|COMPLETED|Overall Study||566||
48238550|NCT04184622|100906621|FG000|NOT COMPLETED|Overall Study||148||
48238551|NCT04184622|100906622|FG001|NOT COMPLETED|Overall Study||69||
48238552|NCT04184622|100906623|FG002|NOT COMPLETED|Overall Study||74||
48539190|NCT02186834|101655408|FG003|NOT COMPLETED|Dose Escalation||1||
48539191|NCT02186834|101655409|FG004|NOT COMPLETED|Dose Escalation||0||
48539192|NCT02186834|101655410|FG005|NOT COMPLETED|Dose Escalation||0||
48539193|NCT02186834|101655405|FG000|STARTED|Treatment at RP2D||0||
48539194|NCT02186834|101655406|FG001|STARTED|Treatment at RP2D||0||
48674554|NCT00474903|101986027|FG000|STARTED|Overall Study||30||
48674555|NCT00474903|101986028|FG001|STARTED|Overall Study||47||
48674556|NCT00474903|101986029|FG002|STARTED|Overall Study||45||
48674557|NCT00474903|101986027|FG000|COMPLETED|Overall Study||29||
48674558|NCT00474903|101986028|FG001|COMPLETED|Overall Study||42||
48674559|NCT00474903|101986029|FG002|COMPLETED|Overall Study||43||
48674560|NCT00474903|101986027|FG000|NOT COMPLETED|Overall Study||1||
48674561|NCT00474903|101986028|FG001|NOT COMPLETED|Overall Study||5||
48674562|NCT00474903|101986029|FG002|NOT COMPLETED|Overall Study||2||
48674563|NCT04046939|101986030|FG000|STARTED|Screening Period||534||
48238553|NCT04184622|100906624|FG003|NOT COMPLETED|Overall Study||64||
48539195|NCT02186834|101655407|FG002|STARTED|Treatment at RP2D||0||
48539196|NCT02186834|101655408|FG003|STARTED|Treatment at RP2D||0||
48674564|NCT04046939|101986031|FG001|STARTED|Screening Period||0||
48539197|NCT02186834|101655409|FG004|STARTED|Treatment at RP2D||0||
48539198|NCT02186834|101655410|FG005|STARTED|Treatment at RP2D||14||
48539199|NCT02186834|101655405|FG000|COMPLETED|Treatment at RP2D||0||
48539200|NCT02186834|101655406|FG001|COMPLETED|Treatment at RP2D||0||
48539201|NCT02186834|101655407|FG002|COMPLETED|Treatment at RP2D||0||
48539202|NCT02186834|101655408|FG003|COMPLETED|Treatment at RP2D||0||
48539203|NCT02186834|101655409|FG004|COMPLETED|Treatment at RP2D||0||
48539204|NCT02186834|101655410|FG005|COMPLETED|Treatment at RP2D||13||
48539205|NCT02186834|101655405|FG000|NOT COMPLETED|Treatment at RP2D||0||
48539206|NCT02186834|101655406|FG001|NOT COMPLETED|Treatment at RP2D||0||
48674565|NCT04046939|101986032|FG002|STARTED|Screening Period||0||
48674566|NCT04046939|101986033|FG003|STARTED|Screening Period||0||
48674567|NCT04046939|101986030|FG000|Received Placebo During Run-In Period|Screening Period||144||
48674568|NCT04046939|101986031|FG001|Received Placebo During Run-In Period|Screening Period||0||
48674569|NCT04046939|101986032|FG002|Received Placebo During Run-In Period|Screening Period||0||
48674570|NCT04046939|101986033|FG003|Received Placebo During Run-In Period|Screening Period||0||
48674571|NCT04046939|101986030|FG000|COMPLETED|Screening Period||103||
48674572|NCT04046939|101986031|FG001|COMPLETED|Screening Period||0||
48674573|NCT04046939|101986032|FG002|COMPLETED|Screening Period||0||
48674574|NCT04046939|101986033|FG003|COMPLETED|Screening Period||0||
48238554|NCT01391234|100906625|FG000|STARTED|Overall Study||28||
48238555|NCT01391234|100906625|FG000|COMPLETED|Overall Study||28||
48238556|NCT01391234|100906625|FG000|NOT COMPLETED|Overall Study||0||
48238557|NCT02374476|100906626|FG000|STARTED|VT Induced Ablation||145||
48238558|NCT02374476|100906627|FG001|STARTED|VT Induced Ablation||0||
48238559|NCT02374476|100906628|FG002|STARTED|VT Induced Ablation||0||
48238560|NCT02374476|100906626|FG000|COMPLETED|VT Induced Ablation||109||
48238561|NCT02374476|100906627|FG001|COMPLETED|VT Induced Ablation||0||
48539207|NCT02186834|101655407|FG002|NOT COMPLETED|Treatment at RP2D||0||
48539208|NCT02186834|101655408|FG003|NOT COMPLETED|Treatment at RP2D||0||
48539209|NCT02186834|101655409|FG004|NOT COMPLETED|Treatment at RP2D||0||
48539210|NCT02186834|101655410|FG005|NOT COMPLETED|Treatment at RP2D||1||
48674575|NCT04046939|101986030|FG000|NOT COMPLETED|Screening Period||431||
48674576|NCT04046939|101986031|FG001|NOT COMPLETED|Screening Period||0||
48674577|NCT04046939|101986032|FG002|NOT COMPLETED|Screening Period||0||
48674578|NCT04046939|101986033|FG003|NOT COMPLETED|Screening Period||0||
48674579|NCT04046939|101986030|FG000|STARTED|Primary Assessment Period||27||
48238562|NCT02374476|100906628|FG002|COMPLETED|VT Induced Ablation||0||
48238563|NCT02374476|100906626|FG000|NOT COMPLETED|VT Induced Ablation||36||
48238564|NCT02374476|100906627|FG001|NOT COMPLETED|VT Induced Ablation||0||
48238565|NCT02374476|100906628|FG002|NOT COMPLETED|VT Induced Ablation||0||
48238566|NCT02374476|100906626|FG000|STARTED|Arm Assignment||0||
48238567|NCT02374476|100906627|FG001|STARTED|Arm Assignment||49||
48539211|NCT00820443|101655411|FG000|STARTED|Pre-Op||253||
48539212|NCT00820443|101655411|FG000|COMPLETED|Pre-Op||253||
48539213|NCT00820443|101655411|FG000|NOT COMPLETED|Pre-Op||0||
48539214|NCT00820443|101655411|FG000|STARTED|Op||253||
48674580|NCT04046939|101986031|FG001|STARTED|Primary Assessment Period||22||
48539215|NCT00820443|101655411|FG000|COMPLETED|Op||253||
48539216|NCT00820443|101655411|FG000|NOT COMPLETED|Op||0||
48539217|NCT00820443|101655411|FG000|STARTED|Immediately||253||
48539218|NCT00820443|101655411|FG000|COMPLETED|Immediately||248||
48539219|NCT00820443|101655411|FG000|NOT COMPLETED|Immediately||5||
48539220|NCT00820443|101655411|FG000|STARTED|3 Month||253||
48238568|NCT02374476|100906628|FG002|STARTED|Arm Assignment||60||
48238569|NCT02374476|100906626|FG000|COMPLETED|Arm Assignment||0||
48238570|NCT02374476|100906627|FG001|COMPLETED|Arm Assignment||49||
48238571|NCT02374476|100906628|FG002|COMPLETED|Arm Assignment||59||
48539221|NCT00820443|101655411|FG000|COMPLETED|3 Month||244||
48539222|NCT00820443|101655411|FG000|NOT COMPLETED|3 Month||9||
48539223|NCT00820443|101655411|FG000|STARTED|6 Month||253||
48539224|NCT00820443|101655411|FG000|COMPLETED|6 Month||233||
48539225|NCT00820443|101655411|FG000|NOT COMPLETED|6 Month||20||
48539226|NCT00820443|101655411|FG000|STARTED|12 Month||250||
48539227|NCT00820443|101655411|FG000|COMPLETED|12 Month||226||
48539228|NCT00820443|101655411|FG000|NOT COMPLETED|12 Month||24||
48674581|NCT04046939|101986032|FG002|STARTED|Primary Assessment Period||26||
48539229|NCT00820443|101655411|FG000|STARTED|24 Month||245||
48539230|NCT00820443|101655411|FG000|COMPLETED|24 Month||202||
48539231|NCT00820443|101655411|FG000|NOT COMPLETED|24 Month||43||
48539232|NCT00813800|101655412|FG000|STARTED|Overall Study||11||
48539233|NCT00813800|101655412|FG000|COMPLETED|Overall Study||5||
48539234|NCT00813800|101655412|FG000|NOT COMPLETED|Overall Study||6||
48539235|NCT02697240|101655413|FG000|STARTED|Overall Study||4||
48539236|NCT02697240|101655413|FG000|COMPLETED|Overall Study||4||
48539237|NCT02697240|101655413|FG000|NOT COMPLETED|Overall Study||0||
48539238|NCT00603837|101655414|FG000|STARTED|Overall Study||20||
48539239|NCT00603837|101655415|FG001|STARTED|Overall Study||19||
48539240|NCT00603837|101655414|FG000|COMPLETED|Overall Study||17||
48539241|NCT00603837|101655415|FG001|COMPLETED|Overall Study||19||
48539242|NCT00603837|101655414|FG000|NOT COMPLETED|Overall Study||3||
48539243|NCT00603837|101655415|FG001|NOT COMPLETED|Overall Study||0||
48539244|NCT03489109|101655416|FG000|STARTED|Overall Study||14||
48539245|NCT03489109|101655417|FG001|STARTED|Overall Study||16||
48539246|NCT03489109|101655416|FG000|COMPLETED|Overall Study||13||
48539247|NCT03489109|101655417|FG001|COMPLETED|Overall Study||14||
48539248|NCT03489109|101655416|FG000|NOT COMPLETED|Overall Study||1||
48539249|NCT03489109|101655417|FG001|NOT COMPLETED|Overall Study||2||
48539250|NCT02648932|101655418|FG000|STARTED|Overall Study||5||
48539251|NCT02648932|101655419|FG001|STARTED|Overall Study||4||
48539252|NCT02648932|101655418|FG000|COMPLETED|Overall Study||2||
48539253|NCT02648932|101655419|FG001|COMPLETED|Overall Study||3||
48539254|NCT02648932|101655418|FG000|NOT COMPLETED|Overall Study||3||
48539255|NCT02648932|101655419|FG001|NOT COMPLETED|Overall Study||1||
48539256|NCT03597529|101655420|FG000|STARTED|Overall Study||42||
48539257|NCT03597529|101655421|FG001|STARTED|Overall Study||42||
48539258|NCT03597529|101655420|FG000|Follow-up|Overall Study||22||
48539259|NCT03597529|101655421|FG001|Follow-up|Overall Study||24||
48539260|NCT03597529|101655420|FG000|COMPLETED|Overall Study||22||
48539261|NCT03597529|101655421|FG001|COMPLETED|Overall Study||24||
48539262|NCT03597529|101655420|FG000|NOT COMPLETED|Overall Study||20||
48539263|NCT03597529|101655421|FG001|NOT COMPLETED|Overall Study||18||
48539264|NCT03893565|101655422|FG000|STARTED|Double-blind Induction Phase (10 Weeks)||27||
48539265|NCT03893565|101655423|FG001|STARTED|Double-blind Induction Phase (10 Weeks)||48||
48539266|NCT03893565|101655424|FG002|STARTED|Double-blind Induction Phase (10 Weeks)||11||
48674582|NCT04046939|101986033|FG003|STARTED|Primary Assessment Period||28||
48238572|NCT02374476|100906626|FG000|NOT COMPLETED|Arm Assignment||0||
48238573|NCT02374476|100906627|FG001|NOT COMPLETED|Arm Assignment||0||
48238574|NCT02374476|100906628|FG002|NOT COMPLETED|Arm Assignment||1||
48238575|NCT04362111|100906629|FG000|STARTED|Overall Study||15||
48238576|NCT04362111|100906630|FG001|STARTED|Overall Study||17||
48238577|NCT04362111|100906629|FG000|COMPLETED|Overall Study||15||
48238578|NCT04362111|100906630|FG001|COMPLETED|Overall Study||15||
48539267|NCT03893565|101655425|FG003|STARTED|Double-blind Induction Phase (10 Weeks)||10||
48539268|NCT03893565|101655426|FG004|STARTED|Double-blind Induction Phase (10 Weeks)||8||
48539269|NCT03893565|101655427|FG005|STARTED|Double-blind Induction Phase (10 Weeks)||0||
48539270|NCT03893565|101655428|FG006|STARTED|Double-blind Induction Phase (10 Weeks)||0||
48539271|NCT03893565|101655429|FG007|STARTED|Double-blind Induction Phase (10 Weeks)||0||
48539272|NCT03893565|101655430|FG008|STARTED|Double-blind Induction Phase (10 Weeks)||0||
48539273|NCT03893565|101655422|FG000|COMPLETED|Double-blind Induction Phase (10 Weeks)||21||
48539274|NCT03893565|101655423|FG001|COMPLETED|Double-blind Induction Phase (10 Weeks)||32||
48539275|NCT03893565|101655424|FG002|COMPLETED|Double-blind Induction Phase (10 Weeks)||1||
48539276|NCT03893565|101655425|FG003|COMPLETED|Double-blind Induction Phase (10 Weeks)||1||
48539277|NCT03893565|101655426|FG004|COMPLETED|Double-blind Induction Phase (10 Weeks)||1||
48539278|NCT03893565|101655427|FG005|COMPLETED|Double-blind Induction Phase (10 Weeks)||0||
48539279|NCT03893565|101655428|FG006|COMPLETED|Double-blind Induction Phase (10 Weeks)||0||
48539280|NCT03893565|101655429|FG007|COMPLETED|Double-blind Induction Phase (10 Weeks)||0||
48238579|NCT04362111|100906629|FG000|NOT COMPLETED|Overall Study||0||
48238580|NCT04362111|100906630|FG001|NOT COMPLETED|Overall Study||2||
48238581|NCT00472199|100906631|FG000|STARTED|Overall Study||166||
48238582|NCT00472199|100906632|FG001|STARTED|Overall Study||163||
48238583|NCT00472199|100906631|FG000|COMPLETED|Overall Study||131||
48539281|NCT03893565|101655430|FG008|COMPLETED|Double-blind Induction Phase (10 Weeks)||0||
48539282|NCT03893565|101655422|FG000|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||6||
48539283|NCT03893565|101655423|FG001|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||16||
48539284|NCT03893565|101655424|FG002|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||10||
48539285|NCT03893565|101655425|FG003|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||9||
48539286|NCT03893565|101655426|FG004|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||7||
48539287|NCT03893565|101655427|FG005|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||0||
48539288|NCT03893565|101655428|FG006|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||0||
48539289|NCT03893565|101655429|FG007|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||0||
48539290|NCT03893565|101655430|FG008|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||0||
48539291|NCT03893565|101655422|FG000|STARTED|Double-blind Extended Treatment(20weeks)||0||
48539292|NCT03893565|101655423|FG001|STARTED|Double-blind Extended Treatment(20weeks)||0||
48539293|NCT03893565|101655424|FG002|STARTED|Double-blind Extended Treatment(20weeks)||0||
48539294|NCT03893565|101655425|FG003|STARTED|Double-blind Extended Treatment(20weeks)||0||
48539295|NCT03893565|101655426|FG004|STARTED|Double-blind Extended Treatment(20weeks)||0||
48539296|NCT03893565|101655427|FG005|STARTED|Double-blind Extended Treatment(20weeks)||5||
48539297|NCT03893565|101655428|FG006|STARTED|Double-blind Extended Treatment(20weeks)||8||
48539298|NCT03893565|101655429|FG007|STARTED|Double-blind Extended Treatment(20weeks)||0||
48539299|NCT03893565|101655430|FG008|STARTED|Double-blind Extended Treatment(20weeks)||0||
48539300|NCT03893565|101655422|FG000|COMPLETED|Double-blind Extended Treatment(20weeks)||0||
48539301|NCT03893565|101655423|FG001|COMPLETED|Double-blind Extended Treatment(20weeks)||0||
48539302|NCT03893565|101655424|FG002|COMPLETED|Double-blind Extended Treatment(20weeks)||0||
48539303|NCT03893565|101655425|FG003|COMPLETED|Double-blind Extended Treatment(20weeks)||0||
48539304|NCT03893565|101655426|FG004|COMPLETED|Double-blind Extended Treatment(20weeks)||0||
48539305|NCT03893565|101655427|FG005|COMPLETED|Double-blind Extended Treatment(20weeks)||2||
48539306|NCT03893565|101655428|FG006|COMPLETED|Double-blind Extended Treatment(20weeks)||4||
48539307|NCT03893565|101655429|FG007|COMPLETED|Double-blind Extended Treatment(20weeks)||0||
48539308|NCT03893565|101655430|FG008|COMPLETED|Double-blind Extended Treatment(20weeks)||0||
48539309|NCT03893565|101655422|FG000|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0||
48539310|NCT03893565|101655423|FG001|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0||
48539311|NCT03893565|101655424|FG002|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0||
48539312|NCT03893565|101655425|FG003|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0||
48539313|NCT03893565|101655426|FG004|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0||
48539314|NCT03893565|101655427|FG005|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||3||
48539315|NCT03893565|101655428|FG006|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||4||
48539316|NCT03893565|101655429|FG007|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0||
48539317|NCT03893565|101655430|FG008|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0||
48539318|NCT03893565|101655422|FG000|STARTED|Open-label Induction Phase (10 Weeks)||0||
48539319|NCT03893565|101655423|FG001|STARTED|Open-label Induction Phase (10 Weeks)||0||
48539320|NCT03893565|101655424|FG002|STARTED|Open-label Induction Phase (10 Weeks)||0||
48539321|NCT03893565|101655425|FG003|STARTED|Open-label Induction Phase (10 Weeks)||0||
48539322|NCT03893565|101655426|FG004|STARTED|Open-label Induction Phase (10 Weeks)||0||
48539323|NCT03893565|101655427|FG005|STARTED|Open-label Induction Phase (10 Weeks)||0||
48539324|NCT03893565|101655428|FG006|STARTED|Open-label Induction Phase (10 Weeks)||0||
48539325|NCT03893565|101655429|FG007|STARTED|Open-label Induction Phase (10 Weeks)||42||
48539326|NCT03893565|101655430|FG008|STARTED|Open-label Induction Phase (10 Weeks)||0||
48539327|NCT03893565|101655422|FG000|COMPLETED|Open-label Induction Phase (10 Weeks)||0||
48539328|NCT03893565|101655423|FG001|COMPLETED|Open-label Induction Phase (10 Weeks)||0||
48539329|NCT03893565|101655424|FG002|COMPLETED|Open-label Induction Phase (10 Weeks)||0||
48539330|NCT03893565|101655425|FG003|COMPLETED|Open-label Induction Phase (10 Weeks)||0||
48539331|NCT03893565|101655426|FG004|COMPLETED|Open-label Induction Phase (10 Weeks)||0||
48539332|NCT03893565|101655427|FG005|COMPLETED|Open-label Induction Phase (10 Weeks)||0||
48539333|NCT03893565|101655428|FG006|COMPLETED|Open-label Induction Phase (10 Weeks)||0||
48539334|NCT03893565|101655429|FG007|COMPLETED|Open-label Induction Phase (10 Weeks)||12||
48539335|NCT03893565|101655430|FG008|COMPLETED|Open-label Induction Phase (10 Weeks)||0||
48539336|NCT03893565|101655422|FG000|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0||
48539337|NCT03893565|101655423|FG001|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0||
48539338|NCT03893565|101655424|FG002|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0||
48539339|NCT03893565|101655425|FG003|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0||
48539340|NCT03893565|101655426|FG004|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0||
48539341|NCT03893565|101655427|FG005|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0||
48539342|NCT03893565|101655428|FG006|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0||
48539343|NCT03893565|101655429|FG007|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||30||
48539344|NCT03893565|101655430|FG008|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0||
48539345|NCT03893565|101655422|FG000|STARTED|Open-label Extended Treatment (20 Weeks)||0||
48539346|NCT03893565|101655423|FG001|STARTED|Open-label Extended Treatment (20 Weeks)||0||
48238584|NCT00472199|100906632|FG001|COMPLETED|Overall Study||103||
48238585|NCT00472199|100906631|FG000|NOT COMPLETED|Overall Study||35||
48238586|NCT00472199|100906632|FG001|NOT COMPLETED|Overall Study||60||
48238587|NCT04025762|100906633|FG000|STARTED|Run-in (3-4 Weeks)||20||
48238588|NCT04025762|100906634|FG001|STARTED|Run-in (3-4 Weeks)||17||
48238589|NCT04025762|100906633|FG000|COMPLETED|Run-in (3-4 Weeks)||20||
48238590|NCT04025762|100906634|FG001|COMPLETED|Run-in (3-4 Weeks)||17||
48238591|NCT04025762|100906633|FG000|NOT COMPLETED|Run-in (3-4 Weeks)||0||
48238592|NCT04025762|100906634|FG001|NOT COMPLETED|Run-in (3-4 Weeks)||0||
48238593|NCT04025762|100906633|FG000|STARTED|Crossover Study Period 1 (16 Weeks)||20||
48238594|NCT04025762|100906634|FG001|STARTED|Crossover Study Period 1 (16 Weeks)||17||
48238595|NCT04025762|100906633|FG000|COMPLETED|Crossover Study Period 1 (16 Weeks)||20||
48238596|NCT04025762|100906634|FG001|COMPLETED|Crossover Study Period 1 (16 Weeks)||16||
48238597|NCT04025762|100906633|FG000|NOT COMPLETED|Crossover Study Period 1 (16 Weeks)||0||
48238598|NCT04025762|100906634|FG001|NOT COMPLETED|Crossover Study Period 1 (16 Weeks)||1||
48238599|NCT04025762|100906633|FG000|STARTED|Washout Period (4 Weeks)||20||
48238600|NCT04025762|100906634|FG001|STARTED|Washout Period (4 Weeks)||16||
48238601|NCT04025762|100906633|FG000|COMPLETED|Washout Period (4 Weeks)||20||
48238602|NCT04025762|100906634|FG001|COMPLETED|Washout Period (4 Weeks)||16||
48238603|NCT04025762|100906633|FG000|NOT COMPLETED|Washout Period (4 Weeks)||0||
48238604|NCT04025762|100906634|FG001|NOT COMPLETED|Washout Period (4 Weeks)||0||
48238605|NCT04025762|100906633|FG000|STARTED|Crossover Study Period 2 (16 Weeks)||20||
48238606|NCT04025762|100906634|FG001|STARTED|Crossover Study Period 2 (16 Weeks)||16||
48238607|NCT04025762|100906633|FG000|COMPLETED|Crossover Study Period 2 (16 Weeks)||20||
48238608|NCT04025762|100906634|FG001|COMPLETED|Crossover Study Period 2 (16 Weeks)||16||
48238609|NCT04025762|100906633|FG000|NOT COMPLETED|Crossover Study Period 2 (16 Weeks)||0||
48674583|NCT04046939|101986030|FG000|COMPLETED|Primary Assessment Period||25||
48674584|NCT04046939|101986031|FG001|COMPLETED|Primary Assessment Period||22||
48674585|NCT04046939|101986032|FG002|COMPLETED|Primary Assessment Period||24||
48674586|NCT04046939|101986033|FG003|COMPLETED|Primary Assessment Period||28||
48674587|NCT04046939|101986030|FG000|NOT COMPLETED|Primary Assessment Period||2||
48674588|NCT04046939|101986031|FG001|NOT COMPLETED|Primary Assessment Period||0||
48674589|NCT04046939|101986032|FG002|NOT COMPLETED|Primary Assessment Period||2||
48674590|NCT04046939|101986033|FG003|NOT COMPLETED|Primary Assessment Period||0||
48674591|NCT04046939|101986030|FG000|STARTED|Eosinophil Recovery Period||25||
48674592|NCT04046939|101986031|FG001|STARTED|Eosinophil Recovery Period||22||
48674593|NCT04046939|101986032|FG002|STARTED|Eosinophil Recovery Period||24||
48674594|NCT04046939|101986033|FG003|STARTED|Eosinophil Recovery Period||28||
48674595|NCT04046939|101986030|FG000|COMPLETED|Eosinophil Recovery Period||24||
48674596|NCT04046939|101986031|FG001|COMPLETED|Eosinophil Recovery Period||22||
48674597|NCT04046939|101986032|FG002|COMPLETED|Eosinophil Recovery Period||24||
48674598|NCT04046939|101986033|FG003|COMPLETED|Eosinophil Recovery Period||27||
48674599|NCT04046939|101986030|FG000|NOT COMPLETED|Eosinophil Recovery Period||1||
48674600|NCT04046939|101986031|FG001|NOT COMPLETED|Eosinophil Recovery Period||0||
48674601|NCT04046939|101986032|FG002|NOT COMPLETED|Eosinophil Recovery Period||0||
48674602|NCT04046939|101986033|FG003|NOT COMPLETED|Eosinophil Recovery Period||1||
48674603|NCT01074931|101986034|FG000|STARTED|Overall Study||98||
48674604|NCT01074931|101986034|FG000|COMPLETED|Overall Study||92||
48674605|NCT01074931|101986034|FG000|NOT COMPLETED|Overall Study||6||
48674606|NCT03434834|101986035|FG000|STARTED|Overall Study||53||
48674607|NCT03434834|101986035|FG000|COMPLETED|Overall Study||37||
48674608|NCT03434834|101986035|FG000|NOT COMPLETED|Overall Study||16||
48674609|NCT04618471|101986036|FG000|STARTED|Overall Study||177||
48674610|NCT04618471|101986036|FG000|COMPLETED|Overall Study||20||
48674611|NCT04618471|101986036|FG000|NOT COMPLETED|Overall Study||157||
48674612|NCT03122184|101986037|FG000|STARTED|Overall Study||24||
48674613|NCT03122184|101986038|FG001|STARTED|Overall Study||23||
48674614|NCT03122184|101986037|FG000|COMPLETED|Overall Study||16||
48674615|NCT03122184|101986038|FG001|COMPLETED|Overall Study||17||
48674616|NCT03122184|101986037|FG000|NOT COMPLETED|Overall Study||8||
48674617|NCT03122184|101986038|FG001|NOT COMPLETED|Overall Study||6||
48674618|NCT00320606|101986039|FG000|STARTED|Overall Study||20||
48238610|NCT04025762|100906634|FG001|NOT COMPLETED|Crossover Study Period 2 (16 Weeks)||0||
48238611|NCT00067808|100906635|FG000|STARTED|Overall Study||17||
48238612|NCT00067808|100906636|FG001|STARTED|Overall Study||93||
48238613|NCT00067808|100906637|FG002|STARTED|Overall Study||14||
48238614|NCT00067808|100906635|FG000|COMPLETED|Overall Study||17||
48238615|NCT00067808|100906636|FG001|COMPLETED|Overall Study||93||
48238616|NCT00067808|100906637|FG002|COMPLETED|Overall Study||14||
48238617|NCT00067808|100906635|FG000|NOT COMPLETED|Overall Study||0||
48674619|NCT00320606|101986039|FG000|COMPLETED|Overall Study||17||
48674620|NCT00320606|101986039|FG000|NOT COMPLETED|Overall Study||3||
48238618|NCT00067808|100906636|FG001|NOT COMPLETED|Overall Study||0||
48674621|NCT01382108|101986040|FG000|STARTED|Overall Study||20||
48674622|NCT01382108|101986041|FG001|STARTED|Overall Study||19||
48674623|NCT01382108|101986040|FG000|COMPLETED|Overall Study||20||
48674624|NCT01382108|101986041|FG001|COMPLETED|Overall Study||19||
48238619|NCT00067808|100906637|FG002|NOT COMPLETED|Overall Study||0||
48238620|NCT01420328|100906638|FG000|STARTED|Overall Study||10||
48674625|NCT01382108|101986040|FG000|NOT COMPLETED|Overall Study||0||
48674626|NCT01382108|101986041|FG001|NOT COMPLETED|Overall Study||0||
48674627|NCT01570387|101986042|FG000|STARTED|Overall Study||6||
48674628|NCT01570387|101986043|FG001|STARTED|Overall Study||3||
48674629|NCT01570387|101986044|FG002|STARTED|Overall Study||6||
48674630|NCT01570387|101986045|FG003|STARTED|Overall Study||12||
48674631|NCT01570387|101986042|FG000|Dose Limiting Toxicity|Overall Study||0||
48674632|NCT01570387|101986043|FG001|Dose Limiting Toxicity|Overall Study||0||
48674633|NCT01570387|101986044|FG002|Dose Limiting Toxicity|Overall Study||6||
48674634|NCT01570387|101986045|FG003|Dose Limiting Toxicity|Overall Study||12||
48238621|NCT01420328|100906639|FG001|STARTED|Overall Study||10||
48238622|NCT01420328|100906638|FG000|COMPLETED|Overall Study||10||
48238623|NCT01420328|100906639|FG001|COMPLETED|Overall Study||10||
48238624|NCT01420328|100906638|FG000|NOT COMPLETED|Overall Study||0||
48238625|NCT01420328|100906639|FG001|NOT COMPLETED|Overall Study||0||
48238626|NCT05319756|100906640|FG000|STARTED|Overall Study||9||
48238627|NCT05319756|100906641|FG001|STARTED|Overall Study||9||
48238628|NCT05319756|100906642|FG002|STARTED|Overall Study||9||
48674635|NCT01570387|101986042|FG000|Response to Maximal Tolerated Dose|Overall Study||0||
48674636|NCT01570387|101986043|FG001|Response to Maximal Tolerated Dose|Overall Study||0||
48674637|NCT01570387|101986044|FG002|Response to Maximal Tolerated Dose|Overall Study||3||
48674638|NCT01570387|101986045|FG003|Response to Maximal Tolerated Dose|Overall Study||6||
48674639|NCT01570387|101986042|FG000|COMPLETED|Overall Study||5||
48674640|NCT01570387|101986043|FG001|COMPLETED|Overall Study||3||
48674641|NCT01570387|101986044|FG002|COMPLETED|Overall Study||6||
48674642|NCT01570387|101986045|FG003|COMPLETED|Overall Study||10||
48674643|NCT01570387|101986042|FG000|NOT COMPLETED|Overall Study||1||
48674644|NCT01570387|101986043|FG001|NOT COMPLETED|Overall Study||0||
48674645|NCT01570387|101986044|FG002|NOT COMPLETED|Overall Study||0||
48674646|NCT01570387|101986045|FG003|NOT COMPLETED|Overall Study||2||
48674647|NCT01854528|101986046|FG000|STARTED|Overall Study||101||
48674648|NCT01854528|101986047|FG001|STARTED|Overall Study||47||
48674649|NCT01854528|101986046|FG000|COMPLETED|Overall Study||101||
48674650|NCT01854528|101986047|FG001|COMPLETED|Overall Study||32||
48674651|NCT01854528|101986046|FG000|NOT COMPLETED|Overall Study||0||
48674652|NCT01854528|101986047|FG001|NOT COMPLETED|Overall Study||15||
48674653|NCT02519842|101986048|FG000|STARTED|Base Study: Cycle 1||38||
48674654|NCT02519842|101986049|FG001|STARTED|Base Study: Cycle 1||37||
48674655|NCT02519842|101986050|FG002|STARTED|Base Study: Cycle 1||0||
48674656|NCT02519842|101986048|FG000|Treated|Base Study: Cycle 1||37||
48674657|NCT02519842|101986049|FG001|Treated|Base Study: Cycle 1||34||
48674658|NCT02519842|101986050|FG002|Treated|Base Study: Cycle 1||0||
48674659|NCT02519842|101986048|FG000|COMPLETED|Base Study: Cycle 1||36||
48674660|NCT02519842|101986049|FG001|COMPLETED|Base Study: Cycle 1||34||
48674661|NCT02519842|101986050|FG002|COMPLETED|Base Study: Cycle 1||0||
48674662|NCT02519842|101986048|FG000|NOT COMPLETED|Base Study: Cycle 1||2||
48674663|NCT02519842|101986049|FG001|NOT COMPLETED|Base Study: Cycle 1||3||
48674664|NCT02519842|101986050|FG002|NOT COMPLETED|Base Study: Cycle 1||0||
48674665|NCT02519842|101986048|FG000|STARTED|Optional Extension: Cycles 2-6||0||
48674666|NCT02519842|101986049|FG001|STARTED|Optional Extension: Cycles 2-6||0||
48674667|NCT02519842|101986050|FG002|STARTED|Optional Extension: Cycles 2-6||55||
48674668|NCT02519842|101986048|FG000|Treated|Optional Extension: Cycles 2-6||0||
48674669|NCT02519842|101986049|FG001|Treated|Optional Extension: Cycles 2-6||0||
48674670|NCT02519842|101986050|FG002|Treated|Optional Extension: Cycles 2-6||55||
48674671|NCT02519842|101986048|FG000|COMPLETED|Optional Extension: Cycles 2-6||0||
48674672|NCT02519842|101986049|FG001|COMPLETED|Optional Extension: Cycles 2-6||0||
48238629|NCT05319756|100906643|FG003|STARTED|Overall Study||9||
48238630|NCT05319756|100906644|FG004|STARTED|Overall Study||9||
48238631|NCT05319756|100906645|FG005|STARTED|Overall Study||9||
48238632|NCT05319756|100906640|FG000|COMPLETED|Overall Study||8||
48238633|NCT05319756|100906641|FG001|COMPLETED|Overall Study||8||
48238634|NCT05319756|100906642|FG002|COMPLETED|Overall Study||9||
48238635|NCT05319756|100906643|FG003|COMPLETED|Overall Study||9||
48238636|NCT05319756|100906644|FG004|COMPLETED|Overall Study||8||
48238637|NCT05319756|100906645|FG005|COMPLETED|Overall Study||8||
48674673|NCT02519842|101986050|FG002|COMPLETED|Optional Extension: Cycles 2-6||26||
48674674|NCT02519842|101986048|FG000|NOT COMPLETED|Optional Extension: Cycles 2-6||0||
48674675|NCT02519842|101986049|FG001|NOT COMPLETED|Optional Extension: Cycles 2-6||0||
48238638|NCT05319756|100906640|FG000|NOT COMPLETED|Overall Study||1||
48238639|NCT05319756|100906641|FG001|NOT COMPLETED|Overall Study||1||
48674676|NCT02519842|101986050|FG002|NOT COMPLETED|Optional Extension: Cycles 2-6||29||
48674677|NCT01374425|101986051|FG000|STARTED|Overall Study||188||
48674678|NCT01374425|101986052|FG001|STARTED|Overall Study||188||
48238640|NCT05319756|100906642|FG002|NOT COMPLETED|Overall Study||0||
48238641|NCT05319756|100906643|FG003|NOT COMPLETED|Overall Study||0||
48238642|NCT05319756|100906644|FG004|NOT COMPLETED|Overall Study||1||
48238643|NCT05319756|100906645|FG005|NOT COMPLETED|Overall Study||1||
48674679|NCT01374425|101986051|FG000|COMPLETED|Overall Study||0||
48674680|NCT01374425|101986052|FG001|COMPLETED|Overall Study||0||
48674681|NCT01374425|101986051|FG000|NOT COMPLETED|Overall Study||188||
48674682|NCT01374425|101986052|FG001|NOT COMPLETED|Overall Study||188||
48674683|NCT00431964|101986053|FG000|STARTED|Overall Study||131||
48674684|NCT00431964|101986054|FG001|STARTED|Overall Study||132||
48674685|NCT00431964|101986053|FG000|Randomized/Received Drug|Overall Study||131||
48674686|NCT00431964|101986054|FG001|Randomized/Received Drug|Overall Study||129||
48674687|NCT00431964|101986053|FG000|Did Not Receive Drug|Overall Study||0||
48674688|NCT00431964|101986054|FG001|Did Not Receive Drug|Overall Study||3||
48674689|NCT00431964|101986053|FG000|Withdrew From Study|Overall Study||6||
48674690|NCT00431964|101986054|FG001|Withdrew From Study|Overall Study||5||
48674691|NCT00431964|101986053|FG000|COMPLETED|Overall Study||125||
48674692|NCT00431964|101986054|FG001|COMPLETED|Overall Study||124||
48674693|NCT00431964|101986053|FG000|NOT COMPLETED|Overall Study||6||
48674694|NCT00431964|101986054|FG001|NOT COMPLETED|Overall Study||8||
48674695|NCT01928433|101986055|FG000|STARTED|Overall Study||76||
48674696|NCT01928433|101986056|FG001|STARTED|Overall Study||75||
48674697|NCT01928433|101986057|FG002|STARTED|Overall Study||74||
48674698|NCT01928433|101986055|FG000|COMPLETED|Overall Study||56||
48674699|NCT01928433|101986056|FG001|COMPLETED|Overall Study||54||
48674700|NCT01928433|101986057|FG002|COMPLETED|Overall Study||46||
48674701|NCT01928433|101986055|FG000|NOT COMPLETED|Overall Study||20||
48674702|NCT01928433|101986056|FG001|NOT COMPLETED|Overall Study||21||
48674703|NCT01928433|101986057|FG002|NOT COMPLETED|Overall Study||28||
48674704|NCT00575666|101986058|FG000|STARTED|Overall Study||21||
48674705|NCT00575666|101986059|FG001|STARTED|Overall Study||24||
48674706|NCT00575666|101986058|FG000|COMPLETED|Overall Study||17||
48674707|NCT00575666|101986059|FG001|COMPLETED|Overall Study||21||
48674708|NCT00575666|101986058|FG000|NOT COMPLETED|Overall Study||4||
48674709|NCT00575666|101986059|FG001|NOT COMPLETED|Overall Study||3||
48674710|NCT01765400|101986060|FG000|STARTED|First Intervention (14 Days)||15||
48674711|NCT01765400|101986061|FG001|STARTED|First Intervention (14 Days)||15||
48674712|NCT01765400|101986060|FG000|COMPLETED|First Intervention (14 Days)||15||
48674713|NCT01765400|101986061|FG001|COMPLETED|First Intervention (14 Days)||15||
48674714|NCT01765400|101986060|FG000|NOT COMPLETED|First Intervention (14 Days)||0||
48674715|NCT01765400|101986061|FG001|NOT COMPLETED|First Intervention (14 Days)||0||
48674716|NCT01765400|101986060|FG000|STARTED|Second Intervention (14 Days)||15||
48674717|NCT01765400|101986061|FG001|STARTED|Second Intervention (14 Days)||15||
48674718|NCT01765400|101986060|FG000|COMPLETED|Second Intervention (14 Days)||15||
48674719|NCT01765400|101986061|FG001|COMPLETED|Second Intervention (14 Days)||15||
48674720|NCT01765400|101986060|FG000|NOT COMPLETED|Second Intervention (14 Days)||0||
48674721|NCT01765400|101986061|FG001|NOT COMPLETED|Second Intervention (14 Days)||0||
48674722|NCT00030264|101986062|FG000|STARTED|Overall Study||23||
48674723|NCT00030264|101986062|FG000|COMPLETED|Overall Study||23||
48674724|NCT00030264|101986062|FG000|NOT COMPLETED|Overall Study||0||
48674725|NCT01849276|101986063|FG000|STARTED|Registered to the Study||2||
48674726|NCT01849276|101986063|FG000|COMPLETED|Registered to the Study||2||
48674727|NCT01849276|101986063|FG000|NOT COMPLETED|Registered to the Study||0||
48674728|NCT01849276|101986063|FG000|STARTED|Completed Treatment||2||
48674729|NCT01849276|101986063|FG000|COMPLETED|Completed Treatment||2||
48674730|NCT01849276|101986063|FG000|NOT COMPLETED|Completed Treatment||0||
48674731|NCT01849276|101986063|FG000|STARTED|Followed for Survival for 5 Years||2||
48674732|NCT01849276|101986063|FG000|COMPLETED|Followed for Survival for 5 Years||0||
48674733|NCT01849276|101986063|FG000|NOT COMPLETED|Followed for Survival for 5 Years||2||
48674734|NCT03057704|101986064|FG000|STARTED|Overall Study||25||
48674735|NCT03057704|101986065|FG001|STARTED|Overall Study||25||
48674736|NCT03057704|101986064|FG000|COMPLETED|Overall Study||25||
48674737|NCT03057704|101986065|FG001|COMPLETED|Overall Study||25||
48674738|NCT03057704|101986064|FG000|NOT COMPLETED|Overall Study||0||
48674739|NCT03057704|101986065|FG001|NOT COMPLETED|Overall Study||0||
48674740|NCT02092181|101986066|FG000|STARTED|Overall Study||15||
48674741|NCT02092181|101986067|FG001|STARTED|Overall Study||15||
48674742|NCT02092181|101986066|FG000|COMPLETED|Overall Study||12||
48674743|NCT02092181|101986067|FG001|COMPLETED|Overall Study||14||
48674744|NCT02092181|101986066|FG000|NOT COMPLETED|Overall Study||3||
48674745|NCT02092181|101986067|FG001|NOT COMPLETED|Overall Study||1||
48674746|NCT01152437|101986068|FG000|STARTED|Overall Study||36||
48674747|NCT01152437|101986069|FG001|STARTED|Overall Study||15||
48674748|NCT01152437|101986070|FG002|STARTED|Overall Study||43||
48674749|NCT01152437|101986068|FG000|COMPLETED|Overall Study||0||
48674750|NCT01152437|101986069|FG001|COMPLETED|Overall Study||0||
48674751|NCT01152437|101986070|FG002|COMPLETED|Overall Study||0||
48674752|NCT01152437|101986068|FG000|NOT COMPLETED|Overall Study||36||
48674753|NCT01152437|101986069|FG001|NOT COMPLETED|Overall Study||15||
48674754|NCT01152437|101986070|FG002|NOT COMPLETED|Overall Study||43||
48674755|NCT02806414|101986071|FG000|STARTED|Overall Study||25||
48674756|NCT02806414|101986071|FG000|COMPLETED|Overall Study||23||
48674757|NCT02806414|101986071|FG000|NOT COMPLETED|Overall Study||2||
48674758|NCT02303262|101986072|FG000|STARTED|Overall Study||20||
48674759|NCT02303262|101986072|FG000|COMPLETED|Overall Study||18||
48674760|NCT02303262|101986072|FG000|NOT COMPLETED|Overall Study||2||
48674761|NCT03136055|101986073|FG000|STARTED|Overall Study||14||
48674762|NCT03136055|101986074|FG001|STARTED|Overall Study||22||
48674763|NCT03136055|101986073|FG000|COMPLETED|Overall Study||14||
48674764|NCT03136055|101986074|FG001|COMPLETED|Overall Study||22||
48674765|NCT03136055|101986073|FG000|NOT COMPLETED|Overall Study||0||
48674766|NCT03136055|101986074|FG001|NOT COMPLETED|Overall Study||0||
48674767|NCT04252014|101986075|FG000|STARTED|Overall Study||414||
48674768|NCT04252014|101986076|FG001|STARTED|Overall Study||416||
48674769|NCT04252014|101986075|FG000|COMPLETED|Overall Study||325||
48674770|NCT04252014|101986076|FG001|COMPLETED|Overall Study||332||
48674771|NCT04252014|101986075|FG000|NOT COMPLETED|Overall Study||89||
48674772|NCT04252014|101986076|FG001|NOT COMPLETED|Overall Study||84||
48674773|NCT01563055|101986077|FG000|STARTED|Overall Study||10||
48539347|NCT03893565|101655424|FG002|STARTED|Open-label Extended Treatment (20 Weeks)||0||
48539348|NCT03893565|101655425|FG003|STARTED|Open-label Extended Treatment (20 Weeks)||0||
48539349|NCT03893565|101655426|FG004|STARTED|Open-label Extended Treatment (20 Weeks)||0||
48539350|NCT03893565|101655427|FG005|STARTED|Open-label Extended Treatment (20 Weeks)||0||
48539351|NCT03893565|101655428|FG006|STARTED|Open-label Extended Treatment (20 Weeks)||0||
48539352|NCT03893565|101655429|FG007|STARTED|Open-label Extended Treatment (20 Weeks)||0||
48539353|NCT03893565|101655430|FG008|STARTED|Open-label Extended Treatment (20 Weeks)||7||
48539354|NCT03893565|101655422|FG000|COMPLETED|Open-label Extended Treatment (20 Weeks)||0||
48539355|NCT03893565|101655423|FG001|COMPLETED|Open-label Extended Treatment (20 Weeks)||0||
48539356|NCT03893565|101655424|FG002|COMPLETED|Open-label Extended Treatment (20 Weeks)||0||
48539357|NCT03893565|101655425|FG003|COMPLETED|Open-label Extended Treatment (20 Weeks)||0||
48539358|NCT03893565|101655426|FG004|COMPLETED|Open-label Extended Treatment (20 Weeks)||0||
48539359|NCT03893565|101655427|FG005|COMPLETED|Open-label Extended Treatment (20 Weeks)||0||
48539360|NCT03893565|101655428|FG006|COMPLETED|Open-label Extended Treatment (20 Weeks)||0||
48539361|NCT03893565|101655429|FG007|COMPLETED|Open-label Extended Treatment (20 Weeks)||0||
48539362|NCT03893565|101655430|FG008|COMPLETED|Open-label Extended Treatment (20 Weeks)||3||
48539363|NCT03893565|101655422|FG000|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0||
48539364|NCT03893565|101655423|FG001|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0||
48539365|NCT03893565|101655424|FG002|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0||
48539366|NCT03893565|101655425|FG003|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0||
48539367|NCT03893565|101655426|FG004|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0||
48539368|NCT03893565|101655427|FG005|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0||
48539369|NCT03893565|101655428|FG006|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0||
48539370|NCT03893565|101655429|FG007|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0||
48539371|NCT03893565|101655430|FG008|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||4||
48539372|NCT03146962|101655431|FG000|STARTED|Overall Study||7||
48539373|NCT03146962|101655432|FG001|STARTED|Overall Study||21||
48539374|NCT03146962|101655433|FG002|STARTED|Overall Study||3||
48539375|NCT03146962|101655434|FG003|STARTED|Overall Study||3||
48539376|NCT03146962|101655435|FG004|STARTED|Overall Study||4||
48539377|NCT03146962|101655436|FG005|STARTED|Overall Study||3||
48539378|NCT03146962|101655437|FG006|STARTED|Overall Study||3||
48539379|NCT03146962|101655438|FG007|STARTED|Overall Study||7||
48539380|NCT03146962|101655439|FG008|STARTED|Overall Study||3||
48539381|NCT03146962|101655440|FG009|STARTED|Overall Study||7||
48539382|NCT03146962|101655431|FG000|COMPLETED|Overall Study||5||
48539383|NCT03146962|101655432|FG001|COMPLETED|Overall Study||15||
48539384|NCT03146962|101655433|FG002|COMPLETED|Overall Study||3||
48539385|NCT03146962|101655434|FG003|COMPLETED|Overall Study||3||
48539386|NCT03146962|101655435|FG004|COMPLETED|Overall Study||3||
48539387|NCT03146962|101655436|FG005|COMPLETED|Overall Study||3||
48539388|NCT03146962|101655437|FG006|COMPLETED|Overall Study||3||
48539389|NCT03146962|101655438|FG007|COMPLETED|Overall Study||6||
48539390|NCT03146962|101655439|FG008|COMPLETED|Overall Study||3||
48539391|NCT03146962|101655440|FG009|COMPLETED|Overall Study||6||
48539392|NCT03146962|101655431|FG000|NOT COMPLETED|Overall Study||2||
48539393|NCT03146962|101655432|FG001|NOT COMPLETED|Overall Study||6||
48539394|NCT03146962|101655433|FG002|NOT COMPLETED|Overall Study||0||
48539395|NCT03146962|101655434|FG003|NOT COMPLETED|Overall Study||0||
48539396|NCT03146962|101655435|FG004|NOT COMPLETED|Overall Study||1||
48539397|NCT03146962|101655436|FG005|NOT COMPLETED|Overall Study||0||
48539398|NCT03146962|101655437|FG006|NOT COMPLETED|Overall Study||0||
48539399|NCT03146962|101655438|FG007|NOT COMPLETED|Overall Study||1||
48539400|NCT03146962|101655439|FG008|NOT COMPLETED|Overall Study||0||
48539401|NCT03146962|101655440|FG009|NOT COMPLETED|Overall Study||1||
48539402|NCT01221363|101655441|FG000|STARTED|Overall Study||93||
48539403|NCT01221363|101655442|FG001|STARTED|Overall Study||73||
48674774|NCT01563055|101986077|FG000|COMPLETED|Overall Study||10||
48674775|NCT01563055|101986077|FG000|NOT COMPLETED|Overall Study||0||
48674776|NCT01599286|101986078|FG000|STARTED|Overall Study||24||54
48539404|NCT01221363|101655441|FG000|COMPLETED|Overall Study||81||
48539405|NCT01221363|101655442|FG001|COMPLETED|Overall Study||68||
48539406|NCT01221363|101655441|FG000|NOT COMPLETED|Overall Study||12||
48539407|NCT01221363|101655442|FG001|NOT COMPLETED|Overall Study||5||
48539408|NCT02552732|101655443|FG000|STARTED|Overall Study||29||
48539409|NCT02552732|101655443|FG000|Used Device|Overall Study||23||
48539410|NCT02552732|101655443|FG000|Completed Week 1|Overall Study||21||
48674777|NCT01599286|101986079|FG001|STARTED|Overall Study||23||52
48539411|NCT02552732|101655443|FG000|Completed Week 2|Overall Study||20||
48539412|NCT02552732|101655443|FG000|Completed Week 3|Overall Study||19||
48674778|NCT01599286|101986078|FG000|COMPLETED|Overall Study||24||54
48674779|NCT01599286|101986079|FG001|COMPLETED|Overall Study||23||52
48674780|NCT01599286|101986078|FG000|NOT COMPLETED|Overall Study||0||0
48081012|NCT02381288|100521606|FG001|STARTED|Overall Study||2||
48238644|NCT02406859|100906646|FG000|STARTED|Part 1 - Manometric Parameters||15||
48674781|NCT01599286|101986079|FG001|NOT COMPLETED|Overall Study||0||0
48674782|NCT00786422|101986080|FG000|STARTED|Rivaroxaban Treatment||25||
48674783|NCT00786422|101986080|FG000|COMPLETED|Rivaroxaban Treatment||14||
48674784|NCT00786422|101986080|FG000|NOT COMPLETED|Rivaroxaban Treatment||11||
48674785|NCT00786422|101986080|FG000|STARTED|Follow-up Period||20||
48238645|NCT02406859|100906647|FG001|STARTED|Part 1 - Manometric Parameters||14||
48238646|NCT02406859|100906648|FG002|STARTED|Part 1 - Manometric Parameters||21||
48238647|NCT02406859|100906646|FG000|COMPLETED|Part 1 - Manometric Parameters||12||
48238648|NCT02406859|100906647|FG001|COMPLETED|Part 1 - Manometric Parameters||13||
48238649|NCT02406859|100906648|FG002|COMPLETED|Part 1 - Manometric Parameters||17||
48238650|NCT02406859|100906646|FG000|NOT COMPLETED|Part 1 - Manometric Parameters||3||
48238651|NCT02406859|100906647|FG001|NOT COMPLETED|Part 1 - Manometric Parameters||1||
48238652|NCT02406859|100906648|FG002|NOT COMPLETED|Part 1 - Manometric Parameters||4||
48238653|NCT02406859|100906646|FG000|STARTED|Part 2 - Biofeedback Training||12||
48238654|NCT02406859|100906647|FG001|STARTED|Part 2 - Biofeedback Training||13||
48539413|NCT02552732|101655443|FG000|Completed Week 4|Overall Study||19||
48674786|NCT00786422|101986080|FG000|COMPLETED|Follow-up Period||17||
48674787|NCT00786422|101986080|FG000|NOT COMPLETED|Follow-up Period||3||
48674788|NCT02112656|101986081|FG000|STARTED|Overall Study||277||
48081013|NCT02381288|100521607|FG002|STARTED|Overall Study||5||
48081014|NCT02381288|100521608|FG003|STARTED|Overall Study||5||
48081015|NCT02381288|100521605|FG000|COMPLETED|Overall Study||5||
48081016|NCT02381288|100521606|FG001|COMPLETED|Overall Study||2||
48081017|NCT02381288|100521607|FG002|COMPLETED|Overall Study||5||
48081018|NCT02381288|100521608|FG003|COMPLETED|Overall Study||5||
48081019|NCT02381288|100521605|FG000|NOT COMPLETED|Overall Study||0||
48081020|NCT02381288|100521606|FG001|NOT COMPLETED|Overall Study||0||
48081021|NCT02381288|100521607|FG002|NOT COMPLETED|Overall Study||0||
48081022|NCT02381288|100521608|FG003|NOT COMPLETED|Overall Study||0||
48081023|NCT01473836|100521609|FG000|STARTED|Overall Study||38||
48081024|NCT01473836|100521609|FG000|COMPLETED|Overall Study||32||
48081025|NCT01473836|100521609|FG000|NOT COMPLETED|Overall Study||6||
48081026|NCT02760069|100521610|FG000|STARTED|Overall Study||40||
48081027|NCT02760069|100521611|FG001|STARTED|Overall Study||41||
48081028|NCT02760069|100521612|FG002|STARTED|Overall Study||41||
48081029|NCT02760069|100521610|FG000|COMPLETED|Overall Study||40||
48081030|NCT02760069|100521611|FG001|COMPLETED|Overall Study||40||
48081031|NCT02760069|100521612|FG002|COMPLETED|Overall Study||40||
48081032|NCT02760069|100521610|FG000|NOT COMPLETED|Overall Study||0||
48081033|NCT02760069|100521611|FG001|NOT COMPLETED|Overall Study||1||
48081034|NCT02760069|100521612|FG002|NOT COMPLETED|Overall Study||1||
48081035|NCT03129100|100521613|FG000|STARTED|Lead-In Period (Period 1)||350||
48081036|NCT03129100|100521614|FG001|STARTED|Lead-In Period (Period 1)||423||
48081037|NCT03129100|100521615|FG002|STARTED|Lead-In Period (Period 1)||0||
48081038|NCT03129100|100521616|FG003|STARTED|Lead-In Period (Period 1)||0||
48081039|NCT03129100|100521617|FG004|STARTED|Lead-In Period (Period 1)||0||
48081040|NCT03129100|100521618|FG005|STARTED|Lead-In Period (Period 1)||0||
48081041|NCT03129100|100521619|FG006|STARTED|Lead-In Period (Period 1)||0||
48081042|NCT03129100|100521620|FG007|STARTED|Lead-In Period (Period 1)||0||
48081043|NCT03129100|100521621|FG008|STARTED|Lead-In Period (Period 1)||0||
48081044|NCT03129100|100521622|FG009|STARTED|Lead-In Period (Period 1)||0||
48081045|NCT03129100|100521623|FG010|STARTED|Lead-In Period (Period 1)||0||
48081046|NCT03129100|100521624|FG011|STARTED|Lead-In Period (Period 1)||0||
48081047|NCT03129100|100521625|FG012|STARTED|Lead-In Period (Period 1)||0||
48081048|NCT03129100|100521626|FG013|STARTED|Lead-In Period (Period 1)||0||
48081049|NCT03129100|100521627|FG014|STARTED|Lead-In Period (Period 1)||0||
48081050|NCT03129100|100521628|FG015|STARTED|Lead-In Period (Period 1)||0||
48081051|NCT03129100|100521629|FG016|STARTED|Lead-In Period (Period 1)||0||
48081052|NCT03129100|100521630|FG017|STARTED|Lead-In Period (Period 1)||0||
48081053|NCT03129100|100521631|FG018|STARTED|Lead-In Period (Period 1)||0||
48081054|NCT03129100|100521632|FG019|STARTED|Lead-In Period (Period 1)||0||
48081055|NCT03129100|100521633|FG020|STARTED|Lead-In Period (Period 1)||0||
48081056|NCT03129100|100521634|FG021|STARTED|Lead-In Period (Period 1)||0||
48081057|NCT03129100|100521635|FG022|STARTED|Lead-In Period (Period 1)||0||
48081058|NCT03129100|100521636|FG023|STARTED|Lead-In Period (Period 1)||0||
48081059|NCT03129100|100521637|FG024|STARTED|Lead-In Period (Period 1)||0||
48081060|NCT03129100|100521638|FG025|STARTED|Lead-In Period (Period 1)||0||
48081061|NCT03129100|100521613|FG000|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||348||
48081062|NCT03129100|100521614|FG001|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||423||
48081063|NCT03129100|100521615|FG002|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
48081064|NCT03129100|100521616|FG003|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
48081065|NCT03129100|100521617|FG004|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
48081066|NCT03129100|100521618|FG005|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
48141205|NCT01260350|100670364|FG002|STARTED|Overall Study||10||
48539414|NCT02552732|101655443|FG000|Completed Day 1 and Day 31 Spirometry|Overall Study||12||
48539415|NCT02552732|101655443|FG000|COMPLETED|Overall Study||19||
48539416|NCT02552732|101655443|FG000|NOT COMPLETED|Overall Study||10||
48539417|NCT03155945|101655444|FG000|STARTED|Overall Study||6||
48539418|NCT03155945|101655445|FG001|STARTED|Overall Study||8||
48539419|NCT03155945|101655444|FG000|COMPLETED|Overall Study||6||
48539420|NCT03155945|101655445|FG001|COMPLETED|Overall Study||5||
48539421|NCT03155945|101655444|FG000|NOT COMPLETED|Overall Study||0||
48539422|NCT03155945|101655445|FG001|NOT COMPLETED|Overall Study||3||
48674789|NCT02112656|101986082|FG001|STARTED|Overall Study||277||
48674790|NCT02112656|101986081|FG000|COMPLETED|Overall Study||187||
48674791|NCT02112656|101986082|FG001|COMPLETED|Overall Study||178||
48674792|NCT02112656|101986081|FG000|NOT COMPLETED|Overall Study||90||
48674793|NCT02112656|101986082|FG001|NOT COMPLETED|Overall Study||99||
48674794|NCT02004158|101986083|FG000|STARTED|Overall Study||23||
48674795|NCT02004158|101986083|FG000|COMPLETED|Overall Study||20||
48674796|NCT02004158|101986083|FG000|NOT COMPLETED|Overall Study||3||
48238655|NCT02406859|100906648|FG002|STARTED|Part 2 - Biofeedback Training||17||
48238656|NCT02406859|100906646|FG000|COMPLETED|Part 2 - Biofeedback Training||12||
48238657|NCT02406859|100906647|FG001|COMPLETED|Part 2 - Biofeedback Training||13||
48238658|NCT02406859|100906648|FG002|COMPLETED|Part 2 - Biofeedback Training||17||
48238659|NCT02406859|100906646|FG000|NOT COMPLETED|Part 2 - Biofeedback Training||0||
48238660|NCT02406859|100906647|FG001|NOT COMPLETED|Part 2 - Biofeedback Training||0||
48238661|NCT02406859|100906648|FG002|NOT COMPLETED|Part 2 - Biofeedback Training||0||
48238662|NCT02958826|100906649|FG000|STARTED|Overall Study||80||
48238663|NCT02958826|100906650|FG001|STARTED|Overall Study||80||
48238664|NCT02958826|100906649|FG000|COMPLETED|Overall Study||80||
48238665|NCT02958826|100906650|FG001|COMPLETED|Overall Study||80||
48238666|NCT02958826|100906649|FG000|NOT COMPLETED|Overall Study||0||
48238667|NCT02958826|100906650|FG001|NOT COMPLETED|Overall Study||0||
48238668|NCT02724423|100906651|FG000|STARTED|Overall Study||57||
48238669|NCT02724423|100906651|FG000|COMPLETED|Overall Study||54||
48238670|NCT02724423|100906651|FG000|NOT COMPLETED|Overall Study||3||
48238671|NCT02604199|100906652|FG000|STARTED|Overall Study||9||
48238672|NCT02604199|100906653|FG001|STARTED|Overall Study||11||
48238673|NCT02604199|100906654|FG002|STARTED|Overall Study||17||
48238674|NCT02604199|100906655|FG003|STARTED|Overall Study||21||
48238675|NCT02604199|100906652|FG000|COMPLETED|Overall Study||9||
48238676|NCT02604199|100906653|FG001|COMPLETED|Overall Study||8||
48238677|NCT02604199|100906654|FG002|COMPLETED|Overall Study||17||
48238678|NCT02604199|100906655|FG003|COMPLETED|Overall Study||18||
48238679|NCT02604199|100906652|FG000|NOT COMPLETED|Overall Study||0||
48238680|NCT02604199|100906653|FG001|NOT COMPLETED|Overall Study||3||
48238681|NCT02604199|100906654|FG002|NOT COMPLETED|Overall Study||0||
48238682|NCT02604199|100906655|FG003|NOT COMPLETED|Overall Study||3||
48238683|NCT05431543|100906656|FG000|STARTED|Overall Study||18||
48238684|NCT05431543|100906657|FG001|STARTED|Overall Study||18||
48238685|NCT05431543|100906658|FG002|STARTED|Overall Study||23||
48238686|NCT05431543|100906656|FG000|COMPLETED|Overall Study||17||
48238687|NCT05431543|100906657|FG001|COMPLETED|Overall Study||18||
48238688|NCT05431543|100906658|FG002|COMPLETED|Overall Study||23||
48238689|NCT05431543|100906656|FG000|NOT COMPLETED|Overall Study||1||
48238690|NCT05431543|100906657|FG001|NOT COMPLETED|Overall Study||0||
48238691|NCT05431543|100906658|FG002|NOT COMPLETED|Overall Study||0||
48238692|NCT00267956|100906659|FG000|STARTED|Controlled Period||70||
48238693|NCT00267956|100906660|FG001|STARTED|Controlled Period||76||
48238694|NCT00267956|100906661|FG002|STARTED|Controlled Period||0||
48238695|NCT00267956|100906662|FG003|STARTED|Controlled Period||0||
48238696|NCT00267956|100906659|FG000|COMPLETED|Controlled Period||57||
48238697|NCT00267956|100906660|FG001|COMPLETED|Controlled Period||72||
48238698|NCT00267956|100906661|FG002|COMPLETED|Controlled Period||0||
48238699|NCT00267956|100906662|FG003|COMPLETED|Controlled Period||0||
48238700|NCT00267956|100906659|FG000|NOT COMPLETED|Controlled Period||13||
48539423|NCT00525798|101655446|FG000|STARTED|Overall Study||2334||
48539424|NCT00525798|101655447|FG001|STARTED|Overall Study||2331||
48539425|NCT00525798|101655446|FG000|COMPLETED|Overall Study||1578||
48539426|NCT00525798|101655447|FG001|COMPLETED|Overall Study||1732||
48539427|NCT00525798|101655446|FG000|NOT COMPLETED|Overall Study||756||
48539428|NCT00525798|101655447|FG001|NOT COMPLETED|Overall Study||599||
48539429|NCT01781481|101655448|FG000|STARTED|Overall Study||148||
48674797|NCT00876447|101986084|FG000|STARTED|Overall Study||185||
48674798|NCT00876447|101986085|FG001|STARTED|Overall Study||203||
48674799|NCT00876447|101986084|FG000|COMPLETED|Overall Study||105||
48674800|NCT00876447|101986085|FG001|COMPLETED|Overall Study||122||
48674801|NCT00876447|101986084|FG000|NOT COMPLETED|Overall Study||80||
48674802|NCT00876447|101986085|FG001|NOT COMPLETED|Overall Study||81||
48238701|NCT00267956|100906660|FG001|NOT COMPLETED|Controlled Period||4||
48238702|NCT00267956|100906661|FG002|NOT COMPLETED|Controlled Period||0||
48238703|NCT00267956|100906662|FG003|NOT COMPLETED|Controlled Period||0||
48238704|NCT00267956|100906659|FG000|STARTED|After Controlled Period||0||
48674803|NCT03047135|101986086|FG000|STARTED|Overall Study||51||
48674804|NCT03047135|101986086|FG000|COMPLETED|Overall Study||48||
48539430|NCT01781481|101655448|FG000|COMPLETED|Overall Study||148||
48539431|NCT01781481|101655448|FG000|NOT COMPLETED|Overall Study||0||
48238705|NCT00267956|100906660|FG001|STARTED|After Controlled Period||0||
48238706|NCT00267956|100906661|FG002|STARTED|After Controlled Period||57||
48238707|NCT00267956|100906662|FG003|STARTED|After Controlled Period||72||
48238708|NCT00267956|100906659|FG000|COMPLETED|After Controlled Period||0||
48238709|NCT00267956|100906660|FG001|COMPLETED|After Controlled Period||0||
48238710|NCT00267956|100906661|FG002|COMPLETED|After Controlled Period||52||
48238711|NCT00267956|100906662|FG003|COMPLETED|After Controlled Period||70||
48238712|NCT00267956|100906659|FG000|NOT COMPLETED|After Controlled Period||0||
48238713|NCT00267956|100906660|FG001|NOT COMPLETED|After Controlled Period||0||
48238714|NCT00267956|100906661|FG002|NOT COMPLETED|After Controlled Period||5||
48238715|NCT00267956|100906662|FG003|NOT COMPLETED|After Controlled Period||2||
48238716|NCT01309802|100906663|FG000|STARTED|Overall Study||25||
48238717|NCT01309802|100906664|FG001|STARTED|Overall Study||23||
48238718|NCT01309802|100906663|FG000|COMPLETED|Overall Study||13||
48238719|NCT01309802|100906664|FG001|COMPLETED|Overall Study||14||
48238720|NCT01309802|100906663|FG000|NOT COMPLETED|Overall Study||12||
48539432|NCT04239027|101655449|FG000|STARTED|Overall Study||210||
48539433|NCT04239027|101655449|FG000|COMPLETED|Overall Study||184||
48539434|NCT04239027|101655449|FG000|NOT COMPLETED|Overall Study||26||
48539435|NCT03696953|101655450|FG000|STARTED|Overall Study||55||
48539436|NCT03696953|101655451|FG001|STARTED|Overall Study||54||
48539437|NCT03696953|101655450|FG000|COMPLETED|Overall Study||39||
48674805|NCT03047135|101986086|FG000|NOT COMPLETED|Overall Study||3||
48674806|NCT01061528|101986087|FG000|STARTED|Overall Study||62||
48674807|NCT01061528|101986088|FG001|STARTED|Overall Study||54||
48674808|NCT01061528|101986087|FG000|COMPLETED|Overall Study||59||
48674809|NCT01061528|101986088|FG001|COMPLETED|Overall Study||52||
48674810|NCT01061528|101986087|FG000|NOT COMPLETED|Overall Study||3||
48674811|NCT01061528|101986088|FG001|NOT COMPLETED|Overall Study||2||
48674812|NCT02108288|101986089|FG000|STARTED|Overall Study||10||
48674813|NCT02108288|101986090|FG001|STARTED|Overall Study||10||
48674814|NCT02108288|101986091|FG002|STARTED|Overall Study||10||
48674815|NCT02108288|101986089|FG000|COMPLETED|Overall Study||10||
48674816|NCT02108288|101986090|FG001|COMPLETED|Overall Study||10||
48674817|NCT02108288|101986091|FG002|COMPLETED|Overall Study||10||
48674818|NCT02108288|101986089|FG000|NOT COMPLETED|Overall Study||0||
48674819|NCT02108288|101986090|FG001|NOT COMPLETED|Overall Study||0||
48674820|NCT02108288|101986091|FG002|NOT COMPLETED|Overall Study||0||
48238721|NCT01309802|100906664|FG001|NOT COMPLETED|Overall Study||9||
48674821|NCT02651545|101986092|FG000|STARTED|Overall Study||30||
48674822|NCT02651545|101986093|FG001|STARTED|Overall Study||30||
48674823|NCT02651545|101986092|FG000|COMPLETED|Overall Study||7||
48674824|NCT02651545|101986093|FG001|COMPLETED|Overall Study||17||
48674825|NCT02651545|101986092|FG000|NOT COMPLETED|Overall Study||23||
48674826|NCT02651545|101986093|FG001|NOT COMPLETED|Overall Study||13||
48674827|NCT02712788|101986094|FG000|STARTED|Overall Study||2||
48674828|NCT02712788|101986095|FG001|STARTED|Overall Study||2||
48674829|NCT02712788|101986094|FG000|COMPLETED|Overall Study||0||
48674830|NCT02712788|101986095|FG001|COMPLETED|Overall Study||2||
48674831|NCT02712788|101986094|FG000|NOT COMPLETED|Overall Study||2||
48674832|NCT02712788|101986095|FG001|NOT COMPLETED|Overall Study||0||
48674833|NCT04976777|101986096|FG000|STARTED|Overall Study||36||
48674834|NCT04976777|101986097|FG001|STARTED|Overall Study||18||
48674835|NCT04976777|101986096|FG000|COMPLETED|Overall Study||35||
48674836|NCT04976777|101986097|FG001|COMPLETED|Overall Study||18||
48674837|NCT04976777|101986096|FG000|NOT COMPLETED|Overall Study||1||
48674838|NCT04976777|101986097|FG001|NOT COMPLETED|Overall Study||0||
48674839|NCT02394561|101986098|FG000|STARTED|CORE Phase||185||
48674840|NCT02394561|101986099|FG001|STARTED|CORE Phase||246||
48674841|NCT02394561|101986098|FG000|Full Analysis Set|CORE Phase||185||
48674842|NCT02394561|101986099|FG001|Full Analysis Set|CORE Phase||246||
48674843|NCT02394561|101986098|FG000|Safety Set|CORE Phase||185||
48674844|NCT02394561|101986099|FG001|Safety Set|CORE Phase||246||
48674845|NCT02394561|101986098|FG000|ITT Set|CORE Phase||184||
48238722|NCT01075815|100906665|FG000|STARTED|Overall Study||40||
48238723|NCT01075815|100906666|FG001|STARTED|Overall Study||35||
48238724|NCT01075815|100906665|FG000|COMPLETED|Overall Study||30||
48238725|NCT01075815|100906666|FG001|COMPLETED|Overall Study||31||
48238726|NCT01075815|100906665|FG000|NOT COMPLETED|Overall Study||10||
48539438|NCT03696953|101655451|FG001|COMPLETED|Overall Study||44||
48539439|NCT03696953|101655450|FG000|NOT COMPLETED|Overall Study||16||
48539440|NCT03696953|101655451|FG001|NOT COMPLETED|Overall Study||10||
48539441|NCT02278055|101655452|FG000|STARTED|Overall Study||29||
48674846|NCT02394561|101986099|FG001|ITT Set|CORE Phase||246||
48674847|NCT02394561|101986098|FG000|COMPLETED|CORE Phase||172||
48674848|NCT02394561|101986099|FG001|COMPLETED|CORE Phase||227||
48674849|NCT02394561|101986098|FG000|NOT COMPLETED|CORE Phase||13||
48238727|NCT01075815|100906666|FG001|NOT COMPLETED|Overall Study||4||
48238728|NCT02389894|100906667|FG000|STARTED|Overall Study||133||
48539442|NCT02278055|101655452|FG000|COMPLETED|Overall Study||21||
48539443|NCT02278055|101655452|FG000|NOT COMPLETED|Overall Study||8||
48674850|NCT02394561|101986099|FG001|NOT COMPLETED|CORE Phase||19||
48674851|NCT02394561|101986098|FG000|STARTED|Extension Phase||162||
48674852|NCT02394561|101986099|FG001|STARTED|Extension Phase||219||
48674853|NCT02394561|101986098|FG000|COMPLETED|Extension Phase||151||
48674854|NCT02394561|101986099|FG001|COMPLETED|Extension Phase||207||
48238729|NCT02389894|100906668|FG001|STARTED|Overall Study||118||
48238730|NCT02389894|100906669|FG002|STARTED|Overall Study||132||
48238731|NCT02389894|100906667|FG000|COMPLETED|Overall Study||125||
48238732|NCT02389894|100906668|FG001|COMPLETED|Overall Study||108||
48238733|NCT02389894|100906669|FG002|COMPLETED|Overall Study||123||
48238734|NCT02389894|100906667|FG000|NOT COMPLETED|Overall Study||8||
48238735|NCT02389894|100906668|FG001|NOT COMPLETED|Overall Study||10||
48238736|NCT02389894|100906669|FG002|NOT COMPLETED|Overall Study||9||
48238737|NCT01562275|100906670|FG000|STARTED|Stage 1||3||
48238738|NCT01562275|100906671|FG001|STARTED|Stage 1||7||
48238739|NCT01562275|100906672|FG002|STARTED|Stage 1||3||
48238740|NCT01562275|100906673|FG003|STARTED|Stage 1||4||
48238741|NCT01562275|100906674|FG004|STARTED|Stage 1||4||
48238742|NCT01562275|100906675|FG005|STARTED|Stage 1||4||
48238743|NCT01562275|100906676|FG006|STARTED|Stage 1||3||
48238744|NCT01562275|100906677|FG007|STARTED|Stage 1||7||
48238745|NCT01562275|100906678|FG008|STARTED|Stage 1||3||
48238746|NCT01562275|100906679|FG009|STARTED|Stage 1||7||
48238747|NCT01562275|100906680|FG010|STARTED|Stage 1||3||
48238748|NCT01562275|100906681|FG011|STARTED|Stage 1||0||
48238749|NCT01562275|100906682|FG012|STARTED|Stage 1||0||
48238750|NCT01562275|100906670|FG000|COMPLETED|Stage 1||0||
48238751|NCT01562275|100906671|FG001|COMPLETED|Stage 1||0||
48238752|NCT01562275|100906672|FG002|COMPLETED|Stage 1||0||
48238753|NCT01562275|100906673|FG003|COMPLETED|Stage 1||0||
48238754|NCT01562275|100906674|FG004|COMPLETED|Stage 1||0||
48238755|NCT01562275|100906675|FG005|COMPLETED|Stage 1||0||
48238756|NCT01562275|100906676|FG006|COMPLETED|Stage 1||0||
48238757|NCT01562275|100906677|FG007|COMPLETED|Stage 1||0||
48238758|NCT01562275|100906678|FG008|COMPLETED|Stage 1||0||
48238759|NCT01562275|100906679|FG009|COMPLETED|Stage 1||0||
48238760|NCT01562275|100906680|FG010|COMPLETED|Stage 1||0||
48238761|NCT01562275|100906681|FG011|COMPLETED|Stage 1||0||
48238762|NCT01562275|100906682|FG012|COMPLETED|Stage 1||0||
48238763|NCT01562275|100906670|FG000|NOT COMPLETED|Stage 1||3||
48238764|NCT01562275|100906671|FG001|NOT COMPLETED|Stage 1||7||
48238765|NCT01562275|100906672|FG002|NOT COMPLETED|Stage 1||3||
48539444|NCT03017612|101655453|FG000|STARTED|Overall Study||13||
48539445|NCT03017612|101655453|FG000|COMPLETED|Overall Study||11||
48539446|NCT03017612|101655453|FG000|NOT COMPLETED|Overall Study||2||
48539447|NCT01664130|101655454|FG000|STARTED|Overall Study||35||
48539448|NCT01664130|101655454|FG000|COMPLETED|Overall Study||33||
48539449|NCT01664130|101655454|FG000|NOT COMPLETED|Overall Study||2||
48539450|NCT00919854|101655455|FG000|STARTED|Overall Study||21||
48539451|NCT00919854|101655455|FG000|COMPLETED|Overall Study||20||
48539452|NCT00919854|101655455|FG000|NOT COMPLETED|Overall Study||1||
48539453|NCT01265433|101655456|FG000|STARTED|Overall Study||20||
48539454|NCT01265433|101655457|FG001|STARTED|Overall Study||21||
48539455|NCT01265433|101655456|FG000|COMPLETED|Overall Study||20||
48539456|NCT01265433|101655457|FG001|COMPLETED|Overall Study||21||
48539457|NCT01265433|101655456|FG000|NOT COMPLETED|Overall Study||0||
48539458|NCT01265433|101655457|FG001|NOT COMPLETED|Overall Study||0||
48539459|NCT00792935|101655458|FG000|STARTED|Overall Study||72||
48539460|NCT00792935|101655459|FG001|STARTED|Overall Study||71||
48539461|NCT00792935|101655458|FG000|COMPLETED|Overall Study||68||
48539462|NCT00792935|101655459|FG001|COMPLETED|Overall Study||68||
48539463|NCT00792935|101655458|FG000|NOT COMPLETED|Overall Study||4||
48539464|NCT00792935|101655459|FG001|NOT COMPLETED|Overall Study||3||
48539465|NCT02045147|101655460|FG000|STARTED|Overall Study||32||
48539466|NCT02045147|101655461|FG001|STARTED|Overall Study||44||
48539467|NCT02045147|101655462|FG002|STARTED|Overall Study||20||
48539468|NCT02045147|101655463|FG003|STARTED|Overall Study||36||
48539469|NCT02045147|101655464|FG004|STARTED|Overall Study||30||
48539470|NCT02045147|101655465|FG005|STARTED|Overall Study||46||
48539471|NCT02045147|101655466|FG006|STARTED|Overall Study||19||
48539472|NCT02045147|101655467|FG007|STARTED|Overall Study||36||
48539473|NCT02045147|101655460|FG000|COMPLETED|Overall Study||21||
48539474|NCT02045147|101655461|FG001|COMPLETED|Overall Study||32||
48539475|NCT02045147|101655462|FG002|COMPLETED|Overall Study||20||
48674855|NCT02394561|101986098|FG000|NOT COMPLETED|Extension Phase||11||
48238766|NCT01562275|100906673|FG003|NOT COMPLETED|Stage 1||4||
48238767|NCT01562275|100906674|FG004|NOT COMPLETED|Stage 1||4||
48238768|NCT01562275|100906675|FG005|NOT COMPLETED|Stage 1||4||
48238769|NCT01562275|100906676|FG006|NOT COMPLETED|Stage 1||3||
48238770|NCT01562275|100906677|FG007|NOT COMPLETED|Stage 1||7||
48238771|NCT01562275|100906678|FG008|NOT COMPLETED|Stage 1||3||
48238772|NCT01562275|100906679|FG009|NOT COMPLETED|Stage 1||7||
48539476|NCT02045147|101655463|FG003|COMPLETED|Overall Study||34||
48539477|NCT02045147|101655464|FG004|COMPLETED|Overall Study||27||
48238773|NCT01562275|100906680|FG010|NOT COMPLETED|Stage 1||3||
48238774|NCT01562275|100906681|FG011|NOT COMPLETED|Stage 1||0||
48238775|NCT01562275|100906682|FG012|NOT COMPLETED|Stage 1||0||
48238776|NCT01562275|100906670|FG000|STARTED|Stage 2||0||
48238777|NCT01562275|100906671|FG001|STARTED|Stage 2||0||
48238778|NCT01562275|100906672|FG002|STARTED|Stage 2||0||
48238779|NCT01562275|100906673|FG003|STARTED|Stage 2||0||
48539478|NCT02045147|101655465|FG005|COMPLETED|Overall Study||36||
48539479|NCT02045147|101655466|FG006|COMPLETED|Overall Study||19||
48539480|NCT02045147|101655467|FG007|COMPLETED|Overall Study||33||
48674856|NCT02394561|101986099|FG001|NOT COMPLETED|Extension Phase||12||
48674857|NCT05223673|101986100|FG000|STARTED|Overall Study||7||
48674858|NCT05223673|101986100|FG000|COMPLETED|Overall Study||0||
48674859|NCT05223673|101986100|FG000|NOT COMPLETED|Overall Study||7||
48674860|NCT03641287|101986101|FG000|STARTED|Overall Study||31||
48674861|NCT03641287|101986102|FG001|STARTED|Overall Study||33||
48674862|NCT03641287|101986101|FG000|COMPLETED|Overall Study||28||
48674863|NCT03641287|101986102|FG001|COMPLETED|Overall Study||33||
48674864|NCT03641287|101986101|FG000|NOT COMPLETED|Overall Study||3||
48674865|NCT03641287|101986102|FG001|NOT COMPLETED|Overall Study||0||
48674866|NCT03213509|101986103|FG000|STARTED|Overall Study||80||
48674867|NCT03213509|101986104|FG001|STARTED|Overall Study||90||
48674868|NCT03213509|101986103|FG000|COMPLETED|Overall Study||76||
48674869|NCT03213509|101986104|FG001|COMPLETED|Overall Study||85||
48674870|NCT03213509|101986103|FG000|NOT COMPLETED|Overall Study||4||
48674871|NCT03213509|101986104|FG001|NOT COMPLETED|Overall Study||5||
48674872|NCT00462826|101986105|FG000|STARTED|Overall Study||49||
48674873|NCT00462826|101986105|FG000|COMPLETED|Overall Study||44||
48674874|NCT00462826|101986105|FG000|NOT COMPLETED|Overall Study||5||
48674875|NCT01212900|101986106|FG000|STARTED|Overall Study||116||
48674876|NCT01212900|101986107|FG001|STARTED|Overall Study||114||
48674877|NCT01212900|101986106|FG000|COMPLETED|Overall Study||104||
48674878|NCT01212900|101986107|FG001|COMPLETED|Overall Study||107||
48674879|NCT01212900|101986106|FG000|NOT COMPLETED|Overall Study||12||
48674880|NCT01212900|101986107|FG001|NOT COMPLETED|Overall Study||7||
48674881|NCT01263119|101989708|FG000|STARTED|Period 1||18||
48674882|NCT01263119|101989708|FG000|COMPLETED|Period 1||16||
48674883|NCT01263119|101989708|FG000|NOT COMPLETED|Period 1||2||
48674884|NCT01263119|101989708|FG000|STARTED|Period 2||16||
48674885|NCT01263119|101989708|FG000|COMPLETED|Period 2||14||
48674886|NCT01263119|101989708|FG000|NOT COMPLETED|Period 2||2||
48674887|NCT00740181|101989709|FG000|STARTED|Overall Study||9||
48674888|NCT00740181|101989709|FG000|COMPLETED|Overall Study||9||
48674889|NCT00740181|101989709|FG000|NOT COMPLETED|Overall Study||0||
48674890|NCT01766102|101989710|FG000|STARTED|Overall Study||36||
48674891|NCT01766102|101989711|FG001|STARTED|Overall Study||36||
48674892|NCT01766102|101989710|FG000|COMPLETED|Overall Study||36||
48674893|NCT01766102|101989711|FG001|COMPLETED|Overall Study||36||
48674894|NCT01766102|101989710|FG000|NOT COMPLETED|Overall Study||0||
48674895|NCT01766102|101989711|FG001|NOT COMPLETED|Overall Study||0||
48674896|NCT04577781|101989712|FG000|STARTED|Overall Study||16||
48674897|NCT04577781|101989713|FG001|STARTED|Overall Study||12||
48674898|NCT04577781|101989712|FG000|COMPLETED|Overall Study||13||
48674899|NCT04577781|101989713|FG001|COMPLETED|Overall Study||10||
48674900|NCT04577781|101989712|FG000|NOT COMPLETED|Overall Study||3||
48238780|NCT01562275|100906674|FG004|STARTED|Stage 2||0||
48238781|NCT01562275|100906675|FG005|STARTED|Stage 2||0||
48674901|NCT04577781|101989713|FG001|NOT COMPLETED|Overall Study||2||
48674902|NCT00730886|101989714|FG000|STARTED|Overall Study||2||
48674903|NCT00730886|101989715|FG001|STARTED|Overall Study||0||
48674904|NCT00730886|101989714|FG000|COMPLETED|Overall Study||0||
48674905|NCT00730886|101989715|FG001|COMPLETED|Overall Study||0||
48674906|NCT00730886|101989714|FG000|NOT COMPLETED|Overall Study||2||
48674907|NCT00730886|101989715|FG001|NOT COMPLETED|Overall Study||0||
48674908|NCT02081586|101989716|FG000|STARTED|Overall Study||3||
48674909|NCT02081586|101989717|FG001|STARTED|Overall Study||3||
48674910|NCT02081586|101989718|FG002|STARTED|Overall Study||4||
48674911|NCT02081586|101989719|FG003|STARTED|Overall Study||3||
48674912|NCT02081586|101989716|FG000|COMPLETED|Overall Study||3||
48674913|NCT02081586|101989717|FG001|COMPLETED|Overall Study||2||
48674914|NCT02081586|101989718|FG002|COMPLETED|Overall Study||3||
48674915|NCT02081586|101989719|FG003|COMPLETED|Overall Study||2||
48674916|NCT02081586|101989716|FG000|NOT COMPLETED|Overall Study||0||
48674917|NCT02081586|101989717|FG001|NOT COMPLETED|Overall Study||1||
48674918|NCT02081586|101989718|FG002|NOT COMPLETED|Overall Study||1||
48674919|NCT02081586|101989719|FG003|NOT COMPLETED|Overall Study||1||
48674920|NCT03508050|101989720|FG000|STARTED|Overall Study||20||
48674921|NCT03508050|101989721|FG001|STARTED|Overall Study||17||
48674922|NCT03508050|101989720|FG000|COMPLETED|Overall Study||15||
48674923|NCT03508050|101989721|FG001|COMPLETED|Overall Study||15||
48674924|NCT03508050|101989720|FG000|NOT COMPLETED|Overall Study||5||
48674925|NCT03508050|101989721|FG001|NOT COMPLETED|Overall Study||2||
48674926|NCT01425814|101989722|FG000|STARTED|Period 1||12||
48674927|NCT01425814|101989723|FG001|STARTED|Period 1||11||
48141206|NCT01260350|100670365|FG003|STARTED|Overall Study||11||
48238782|NCT01562275|100906676|FG006|STARTED|Stage 2||0||
48674928|NCT01425814|101989724|FG002|STARTED|Period 1||12||
48674929|NCT01425814|101989725|FG003|STARTED|Period 1||10||
48674930|NCT01425814|101989726|FG004|STARTED|Period 1||12||
48674931|NCT01425814|101989727|FG005|STARTED|Period 1||13||
48674932|NCT01425814|101989722|FG000|COMPLETED|Period 1||12||
48674933|NCT01425814|101989723|FG001|COMPLETED|Period 1||10||
48674934|NCT01425814|101989724|FG002|COMPLETED|Period 1||12||
48674935|NCT01425814|101989725|FG003|COMPLETED|Period 1||10||
48674936|NCT01425814|101989726|FG004|COMPLETED|Period 1||12||
48674937|NCT01425814|101989727|FG005|COMPLETED|Period 1||13||
48674938|NCT01425814|101989722|FG000|NOT COMPLETED|Period 1||0||
48674939|NCT01425814|101989723|FG001|NOT COMPLETED|Period 1||1||
48674940|NCT01425814|101989724|FG002|NOT COMPLETED|Period 1||0||
48674941|NCT01425814|101989725|FG003|NOT COMPLETED|Period 1||0||
48674942|NCT01425814|101989726|FG004|NOT COMPLETED|Period 1||0||
48674943|NCT01425814|101989727|FG005|NOT COMPLETED|Period 1||0||
48674944|NCT01425814|101989722|FG000|STARTED|Period 2||12||
48674945|NCT01425814|101989723|FG001|STARTED|Period 2||10||
48238783|NCT01562275|100906677|FG007|STARTED|Stage 2||0||
48238784|NCT01562275|100906678|FG008|STARTED|Stage 2||0||
48238785|NCT01562275|100906679|FG009|STARTED|Stage 2||0||
48238786|NCT01562275|100906680|FG010|STARTED|Stage 2||0||
48238787|NCT01562275|100906681|FG011|STARTED|Stage 2||14||
48238788|NCT01562275|100906682|FG012|STARTED|Stage 2||5||
48238789|NCT01562275|100906670|FG000|COMPLETED|Stage 2||0||
48238790|NCT01562275|100906671|FG001|COMPLETED|Stage 2||0||
48238791|NCT01562275|100906672|FG002|COMPLETED|Stage 2||0||
48238792|NCT01562275|100906673|FG003|COMPLETED|Stage 2||0||
48238793|NCT01562275|100906674|FG004|COMPLETED|Stage 2||0||
48674946|NCT01425814|101989724|FG002|STARTED|Period 2||12||
48674947|NCT01425814|101989725|FG003|STARTED|Period 2||10||
48238794|NCT01562275|100906675|FG005|COMPLETED|Stage 2||0||
48238795|NCT01562275|100906676|FG006|COMPLETED|Stage 2||0||
48238796|NCT01562275|100906677|FG007|COMPLETED|Stage 2||0||
48238797|NCT01562275|100906678|FG008|COMPLETED|Stage 2||0||
48238798|NCT01562275|100906679|FG009|COMPLETED|Stage 2||0||
48238799|NCT01562275|100906680|FG010|COMPLETED|Stage 2||0||
48238800|NCT01562275|100906681|FG011|COMPLETED|Stage 2||0||
48238801|NCT01562275|100906682|FG012|COMPLETED|Stage 2||0||
48674948|NCT01425814|101989726|FG004|STARTED|Period 2||12||
48674949|NCT01425814|101989727|FG005|STARTED|Period 2||13||
48674950|NCT01425814|101989722|FG000|COMPLETED|Period 2||12||
48674951|NCT01425814|101989723|FG001|COMPLETED|Period 2||9||
48674952|NCT01425814|101989724|FG002|COMPLETED|Period 2||12||
48674953|NCT01425814|101989725|FG003|COMPLETED|Period 2||10||
48674954|NCT01425814|101989726|FG004|COMPLETED|Period 2||12||
48674955|NCT01425814|101989727|FG005|COMPLETED|Period 2||13||
48674956|NCT01425814|101989722|FG000|NOT COMPLETED|Period 2||0||
48674957|NCT01425814|101989723|FG001|NOT COMPLETED|Period 2||1||
48674958|NCT01425814|101989724|FG002|NOT COMPLETED|Period 2||0||
48674959|NCT01425814|101989725|FG003|NOT COMPLETED|Period 2||0||
48674960|NCT01425814|101989726|FG004|NOT COMPLETED|Period 2||0||
48674961|NCT01425814|101989727|FG005|NOT COMPLETED|Period 2||0||
48674962|NCT01425814|101989722|FG000|STARTED|Period 3||12||
48674963|NCT01425814|101989723|FG001|STARTED|Period 3||9||
48674964|NCT01425814|101989724|FG002|STARTED|Period 3||12||
48674965|NCT01425814|101989725|FG003|STARTED|Period 3||10||
48674966|NCT01425814|101989726|FG004|STARTED|Period 3||12||
48674967|NCT01425814|101989727|FG005|STARTED|Period 3||13||
48674968|NCT01425814|101989722|FG000|COMPLETED|Period 3||12||
48674969|NCT01425814|101989723|FG001|COMPLETED|Period 3||9||
48674970|NCT01425814|101989724|FG002|COMPLETED|Period 3||12||
48674971|NCT01425814|101989725|FG003|COMPLETED|Period 3||10||
48674972|NCT01425814|101989726|FG004|COMPLETED|Period 3||12||
48674973|NCT01425814|101989727|FG005|COMPLETED|Period 3||12||
48674974|NCT01425814|101989722|FG000|NOT COMPLETED|Period 3||0||
48674975|NCT01425814|101989723|FG001|NOT COMPLETED|Period 3||0||
48674976|NCT01425814|101989724|FG002|NOT COMPLETED|Period 3||0||
48674977|NCT01425814|101989725|FG003|NOT COMPLETED|Period 3||0||
48674978|NCT01425814|101989726|FG004|NOT COMPLETED|Period 3||0||
48674979|NCT01425814|101989727|FG005|NOT COMPLETED|Period 3||1||
48674980|NCT01425814|101989722|FG000|STARTED|Period 4||12||
48674981|NCT01425814|101989723|FG001|STARTED|Period 4||9||
48674982|NCT01425814|101989724|FG002|STARTED|Period 4||12||
48674983|NCT01425814|101989725|FG003|STARTED|Period 4||10||
48674984|NCT01425814|101989726|FG004|STARTED|Period 4||12||
48674985|NCT01425814|101989727|FG005|STARTED|Period 4||12||
48674986|NCT01425814|101989722|FG000|COMPLETED|Period 4||11||
48238802|NCT01562275|100906670|FG000|NOT COMPLETED|Stage 2||0||
48238803|NCT01562275|100906671|FG001|NOT COMPLETED|Stage 2||0||
48238804|NCT01562275|100906672|FG002|NOT COMPLETED|Stage 2||0||
48238805|NCT01562275|100906673|FG003|NOT COMPLETED|Stage 2||0||
48238806|NCT01562275|100906674|FG004|NOT COMPLETED|Stage 2||0||
48238807|NCT01562275|100906675|FG005|NOT COMPLETED|Stage 2||0||
48238808|NCT01562275|100906676|FG006|NOT COMPLETED|Stage 2||0||
48238809|NCT01562275|100906677|FG007|NOT COMPLETED|Stage 2||0||
48238810|NCT01562275|100906678|FG008|NOT COMPLETED|Stage 2||0||
48674987|NCT01425814|101989723|FG001|COMPLETED|Period 4||9||
48674988|NCT01425814|101989724|FG002|COMPLETED|Period 4||11||
48238811|NCT01562275|100906679|FG009|NOT COMPLETED|Stage 2||0||
48238812|NCT01562275|100906680|FG010|NOT COMPLETED|Stage 2||0||
48238813|NCT01562275|100906681|FG011|NOT COMPLETED|Stage 2||14||
48674989|NCT01425814|101989725|FG003|COMPLETED|Period 4||10||
48674990|NCT01425814|101989726|FG004|COMPLETED|Period 4||12||
48674991|NCT01425814|101989727|FG005|COMPLETED|Period 4||12||
48674992|NCT01425814|101989722|FG000|NOT COMPLETED|Period 4||1||
48674993|NCT01425814|101989723|FG001|NOT COMPLETED|Period 4||0||
48674994|NCT01425814|101989724|FG002|NOT COMPLETED|Period 4||1||
48674995|NCT01425814|101989725|FG003|NOT COMPLETED|Period 4||0||
48674996|NCT01425814|101989726|FG004|NOT COMPLETED|Period 4||0||
48674997|NCT01425814|101989727|FG005|NOT COMPLETED|Period 4||0||
48674998|NCT01425814|101989722|FG000|STARTED|Period 5||11||
48674999|NCT01425814|101989723|FG001|STARTED|Period 5||9||
48675000|NCT01425814|101989724|FG002|STARTED|Period 5||11||
48238814|NCT01562275|100906682|FG012|NOT COMPLETED|Stage 2||5||
48238815|NCT03708744|100906683|FG000|STARTED|Overall Study||7||
48238816|NCT03708744|100906684|FG001|STARTED|Overall Study||6||
48238817|NCT03708744|100906685|FG002|STARTED|Overall Study||5||
48238818|NCT03708744|100906686|FG003|STARTED|Overall Study||6||
48238819|NCT03708744|100906683|FG000|COMPLETED|Overall Study||7||
48238820|NCT03708744|100906684|FG001|COMPLETED|Overall Study||6||
48238821|NCT03708744|100906685|FG002|COMPLETED|Overall Study||4||
48675001|NCT01425814|101989725|FG003|STARTED|Period 5||10||
48675002|NCT01425814|101989726|FG004|STARTED|Period 5||12||
48675003|NCT01425814|101989727|FG005|STARTED|Period 5||12||
48675004|NCT01425814|101989722|FG000|COMPLETED|Period 5||11||
48675005|NCT01425814|101989723|FG001|COMPLETED|Period 5||9||
48675006|NCT01425814|101989724|FG002|COMPLETED|Period 5||10||
48675007|NCT01425814|101989725|FG003|COMPLETED|Period 5||10||
48675008|NCT01425814|101989726|FG004|COMPLETED|Period 5||12||
48675009|NCT01425814|101989727|FG005|COMPLETED|Period 5||11||
48675010|NCT01425814|101989722|FG000|NOT COMPLETED|Period 5||0||
48675011|NCT01425814|101989723|FG001|NOT COMPLETED|Period 5||0||
48675012|NCT01425814|101989724|FG002|NOT COMPLETED|Period 5||1||
48675013|NCT01425814|101989725|FG003|NOT COMPLETED|Period 5||0||
48675014|NCT01425814|101989726|FG004|NOT COMPLETED|Period 5||0||
48675015|NCT01425814|101989727|FG005|NOT COMPLETED|Period 5||1||
48675016|NCT03559270|101989728|FG000|STARTED|Overall Study||117||
48675017|NCT03559270|101989729|FG001|STARTED|Overall Study||119||
48675018|NCT03559270|101989730|FG002|STARTED|Overall Study||108||
48675019|NCT03559270|101989731|FG003|STARTED|Overall Study||30||
48675020|NCT03559270|101989728|FG000|Received at Least One Dose of Study Drug|Overall Study||117||
48675021|NCT03559270|101989729|FG001|Received at Least One Dose of Study Drug|Overall Study||119||
48675022|NCT03559270|101989730|FG002|Received at Least One Dose of Study Drug|Overall Study||108||
48675023|NCT03559270|101989731|FG003|Received at Least One Dose of Study Drug|Overall Study||30||
48675024|NCT03559270|101989728|FG000|COMPLETED|Overall Study||0||
48675025|NCT03559270|101989729|FG001|COMPLETED|Overall Study||1||
48675026|NCT03559270|101989730|FG002|COMPLETED|Overall Study||0||
48675027|NCT03559270|101989731|FG003|COMPLETED|Overall Study||0||
48675028|NCT03559270|101989728|FG000|NOT COMPLETED|Overall Study||117||
48675029|NCT03559270|101989729|FG001|NOT COMPLETED|Overall Study||118||
48675030|NCT03559270|101989730|FG002|NOT COMPLETED|Overall Study||108||
48675031|NCT03559270|101989731|FG003|NOT COMPLETED|Overall Study||30||
48675032|NCT04068922|101989732|FG000|STARTED|Overall Study||63||
48675033|NCT04068922|101989732|FG000|Received Intervention|Overall Study||59||
48675034|NCT04068922|101989732|FG000|COMPLETED|Overall Study||50||
48675035|NCT04068922|101989732|FG000|NOT COMPLETED|Overall Study||13||
48675036|NCT01673126|101989733|FG000|STARTED|Overall Study||36||
48675037|NCT01673126|101989734|FG001|STARTED|Overall Study||26||
48675038|NCT01673126|101989733|FG000|COMPLETED|Overall Study||32||
48675039|NCT01673126|101989734|FG001|COMPLETED|Overall Study||23||
48675040|NCT01673126|101989733|FG000|NOT COMPLETED|Overall Study||4||
48675041|NCT01673126|101989734|FG001|NOT COMPLETED|Overall Study||3||
48675042|NCT00529633|101989735|FG000|STARTED|Overall Study||2||
48675043|NCT00529633|101989736|FG001|STARTED|Overall Study||2||
48675044|NCT00529633|101989735|FG000|COMPLETED|Overall Study||1||
48675045|NCT00529633|101989736|FG001|COMPLETED|Overall Study||1||
48675046|NCT00529633|101989735|FG000|NOT COMPLETED|Overall Study||1||
48675047|NCT00529633|101989736|FG001|NOT COMPLETED|Overall Study||1||
48675048|NCT03398330|101989737|FG000|STARTED|Period 1||21||
48675049|NCT03398330|101989738|FG001|STARTED|Period 1||21||
48675050|NCT03398330|101989737|FG000|COMPLETED|Period 1||20||
48675051|NCT03398330|101989738|FG001|COMPLETED|Period 1||17||
48675052|NCT03398330|101989737|FG000|NOT COMPLETED|Period 1||1||
48675053|NCT03398330|101989738|FG001|NOT COMPLETED|Period 1||4||
48675054|NCT03398330|101989737|FG000|STARTED|Period 2||20||
48675055|NCT03398330|101989738|FG001|STARTED|Period 2||17||
48675056|NCT03398330|101989737|FG000|COMPLETED|Period 2||19||
48675057|NCT03398330|101989738|FG001|COMPLETED|Period 2||17||
48675058|NCT03398330|101989737|FG000|NOT COMPLETED|Period 2||1||
48675059|NCT03398330|101989738|FG001|NOT COMPLETED|Period 2||0||
48675060|NCT01349114|101989739|FG000|STARTED|Overall Study||10||
48675061|NCT01349114|101989740|FG001|STARTED|Overall Study||11||
48675062|NCT01349114|101989739|FG000|COMPLETED|Overall Study||10||
48238822|NCT03708744|100906686|FG003|COMPLETED|Overall Study||6||
48238823|NCT03708744|100906683|FG000|NOT COMPLETED|Overall Study||0||
48675063|NCT01349114|101989740|FG001|COMPLETED|Overall Study||11||
48675064|NCT01349114|101989739|FG000|NOT COMPLETED|Overall Study||0||
48238824|NCT03708744|100906684|FG001|NOT COMPLETED|Overall Study||0||
48238825|NCT03708744|100906685|FG002|NOT COMPLETED|Overall Study||1||
48238826|NCT03708744|100906686|FG003|NOT COMPLETED|Overall Study||0||
48675065|NCT01349114|101989740|FG001|NOT COMPLETED|Overall Study||0||
48675066|NCT00806585|101989741|FG000|STARTED|Overall Study||137||
48675067|NCT00806585|101989742|FG001|STARTED|Overall Study||134||
48675068|NCT00806585|101989743|FG002|STARTED|Overall Study||141||
48675069|NCT00806585|101989744|FG003|STARTED|Overall Study||71||
48238827|NCT03867396|100906687|FG000|STARTED|Intervention 1||8||
48238828|NCT03867396|100906688|FG001|STARTED|Intervention 1||8||
48238829|NCT03867396|100906689|FG002|STARTED|Intervention 1||7||
48238830|NCT03867396|100906690|FG003|STARTED|Intervention 1||5||
48238831|NCT03867396|100906691|FG004|STARTED|Intervention 1||7||
48238832|NCT03867396|100906692|FG005|STARTED|Intervention 1||5||
48675070|NCT00806585|101989745|FG004|STARTED|Overall Study||137||
48675071|NCT00806585|101989741|FG000|COMPLETED|Overall Study||105||
48675072|NCT00806585|101989742|FG001|COMPLETED|Overall Study||103||
48675073|NCT00806585|101989743|FG002|COMPLETED|Overall Study||109||
48675074|NCT00806585|101989744|FG003|COMPLETED|Overall Study||56||
48675075|NCT00806585|101989745|FG004|COMPLETED|Overall Study||106||
48238833|NCT03867396|100906687|FG000|Data Collection|Intervention 1||8||
48238834|NCT03867396|100906688|FG001|Data Collection|Intervention 1||5||
48238835|NCT03867396|100906689|FG002|Data Collection|Intervention 1||7||
48238836|NCT03867396|100906690|FG003|Data Collection|Intervention 1||5||
48238837|NCT03867396|100906691|FG004|Data Collection|Intervention 1||0||
48238838|NCT03867396|100906692|FG005|Data Collection|Intervention 1||0||
48238839|NCT03867396|100906687|FG000|COMPLETED|Intervention 1||8||
48238840|NCT03867396|100906688|FG001|COMPLETED|Intervention 1||5||
48238841|NCT03867396|100906689|FG002|COMPLETED|Intervention 1||7||
48238842|NCT03867396|100906690|FG003|COMPLETED|Intervention 1||5||
48238843|NCT03867396|100906691|FG004|COMPLETED|Intervention 1||0||
48238844|NCT03867396|100906692|FG005|COMPLETED|Intervention 1||0||
48238845|NCT03867396|100906687|FG000|NOT COMPLETED|Intervention 1||0||
48675076|NCT00806585|101989741|FG000|NOT COMPLETED|Overall Study||32||
48675077|NCT00806585|101989742|FG001|NOT COMPLETED|Overall Study||31||
48675078|NCT00806585|101989743|FG002|NOT COMPLETED|Overall Study||32||
48539481|NCT02045147|101655460|FG000|NOT COMPLETED|Overall Study||11||
48539482|NCT02045147|101655461|FG001|NOT COMPLETED|Overall Study||12||
48539483|NCT02045147|101655462|FG002|NOT COMPLETED|Overall Study||0||
48238846|NCT03867396|100906688|FG001|NOT COMPLETED|Intervention 1||3||
48238847|NCT03867396|100906689|FG002|NOT COMPLETED|Intervention 1||0||
48238848|NCT03867396|100906690|FG003|NOT COMPLETED|Intervention 1||0||
48238849|NCT03867396|100906691|FG004|NOT COMPLETED|Intervention 1||7||
48238850|NCT03867396|100906692|FG005|NOT COMPLETED|Intervention 1||5||
48238851|NCT03867396|100906687|FG000|STARTED|Intervention 2||8||
48238852|NCT03867396|100906688|FG001|STARTED|Intervention 2||5||
48238853|NCT03867396|100906689|FG002|STARTED|Intervention 2||7||
48238854|NCT03867396|100906690|FG003|STARTED|Intervention 2||5||
48238855|NCT03867396|100906691|FG004|STARTED|Intervention 2||0||
48539484|NCT02045147|101655463|FG003|NOT COMPLETED|Overall Study||2||
48539485|NCT02045147|101655464|FG004|NOT COMPLETED|Overall Study||3||
48539486|NCT02045147|101655465|FG005|NOT COMPLETED|Overall Study||10||
48539487|NCT02045147|101655466|FG006|NOT COMPLETED|Overall Study||0||
48539488|NCT02045147|101655467|FG007|NOT COMPLETED|Overall Study||3||
48675079|NCT00806585|101989744|FG003|NOT COMPLETED|Overall Study||15||
48675080|NCT00806585|101989745|FG004|NOT COMPLETED|Overall Study||31||
48675081|NCT01832610|101989746|FG000|STARTED|Overall Study||101||
48675082|NCT01832610|101989746|FG000|COMPLETED|Overall Study||97||
48675083|NCT01832610|101989746|FG000|NOT COMPLETED|Overall Study||4||
48675084|NCT00016354|101989747|FG000|STARTED|Overall Study||1||
48675085|NCT00016354|101989748|FG001|STARTED|Overall Study||1||
48675086|NCT00016354|101989749|FG002|STARTED|Overall Study||1||
48675087|NCT00016354|101989750|FG003|STARTED|Overall Study||1||
48675088|NCT00016354|101989751|FG004|STARTED|Overall Study||1||
48675089|NCT00016354|101989752|FG005|STARTED|Overall Study||1||
48675090|NCT00016354|101989753|FG006|STARTED|Overall Study||6||
48675091|NCT00016354|101989754|FG007|STARTED|Overall Study||7||
48675092|NCT00016354|101989747|FG000|COMPLETED|Overall Study||1||
48675093|NCT00016354|101989748|FG001|COMPLETED|Overall Study||1||
48675094|NCT00016354|101989749|FG002|COMPLETED|Overall Study||1||
48675095|NCT00016354|101989750|FG003|COMPLETED|Overall Study||1||
48675096|NCT00016354|101989751|FG004|COMPLETED|Overall Study||1||
48675097|NCT00016354|101989752|FG005|COMPLETED|Overall Study||1||
48675098|NCT00016354|101989753|FG006|COMPLETED|Overall Study||6||
48238856|NCT03867396|100906692|FG005|STARTED|Intervention 2||0||
48238857|NCT03867396|100906687|FG000|COMPLETED|Intervention 2||8||
48238858|NCT03867396|100906688|FG001|COMPLETED|Intervention 2||5||
48238859|NCT03867396|100906689|FG002|COMPLETED|Intervention 2||7||
48238860|NCT03867396|100906690|FG003|COMPLETED|Intervention 2||5||
48539489|NCT04823975|101655468|FG000|STARTED|Overall Study||12||
48539490|NCT04823975|101655468|FG000|COMPLETED|Overall Study||9||
48675099|NCT00016354|101989754|FG007|COMPLETED|Overall Study||6||
48675100|NCT00016354|101989747|FG000|NOT COMPLETED|Overall Study||0||
48675101|NCT00016354|101989748|FG001|NOT COMPLETED|Overall Study||0||
48675102|NCT00016354|101989749|FG002|NOT COMPLETED|Overall Study||0||
48238861|NCT03867396|100906691|FG004|COMPLETED|Intervention 2||0||
48238862|NCT03867396|100906692|FG005|COMPLETED|Intervention 2||0||
48238863|NCT03867396|100906687|FG000|NOT COMPLETED|Intervention 2||0||
48539491|NCT04823975|101655468|FG000|NOT COMPLETED|Overall Study||3||
48539492|NCT01283035|101655469|FG000|STARTED|Overall Study||6||
48539493|NCT01283035|101655469|FG000|COMPLETED|Overall Study||5||
48539494|NCT01283035|101655469|FG000|NOT COMPLETED|Overall Study||1||
48675103|NCT00016354|101989750|FG003|NOT COMPLETED|Overall Study||0||
48675104|NCT00016354|101989751|FG004|NOT COMPLETED|Overall Study||0||
48675105|NCT00016354|101989752|FG005|NOT COMPLETED|Overall Study||0||
48675106|NCT00016354|101989753|FG006|NOT COMPLETED|Overall Study||0||
48238864|NCT03867396|100906688|FG001|NOT COMPLETED|Intervention 2||0||
48238865|NCT03867396|100906689|FG002|NOT COMPLETED|Intervention 2||0||
48238866|NCT03867396|100906690|FG003|NOT COMPLETED|Intervention 2||0||
48238867|NCT03867396|100906691|FG004|NOT COMPLETED|Intervention 2||0||
48238868|NCT03867396|100906692|FG005|NOT COMPLETED|Intervention 2||0||
48238869|NCT03867396|100906687|FG000|STARTED|Intervention 3||8||
48238870|NCT03867396|100906688|FG001|STARTED|Intervention 3||5||
48238871|NCT03867396|100906689|FG002|STARTED|Intervention 3||7||
48238872|NCT03867396|100906690|FG003|STARTED|Intervention 3||5||
48238873|NCT03867396|100906691|FG004|STARTED|Intervention 3||0||
48238874|NCT03867396|100906692|FG005|STARTED|Intervention 3||0||
48238875|NCT03867396|100906687|FG000|COMPLETED|Intervention 3||8||
48238876|NCT03867396|100906688|FG001|COMPLETED|Intervention 3||5||
48238877|NCT03867396|100906689|FG002|COMPLETED|Intervention 3||7||
48238878|NCT03867396|100906690|FG003|COMPLETED|Intervention 3||5||
48238879|NCT03867396|100906691|FG004|COMPLETED|Intervention 3||0||
48238880|NCT03867396|100906692|FG005|COMPLETED|Intervention 3||0||
48238881|NCT03867396|100906687|FG000|NOT COMPLETED|Intervention 3||0||
48238882|NCT03867396|100906688|FG001|NOT COMPLETED|Intervention 3||0||
48238883|NCT03867396|100906689|FG002|NOT COMPLETED|Intervention 3||0||
48238884|NCT03867396|100906690|FG003|NOT COMPLETED|Intervention 3||0||
48238885|NCT03867396|100906691|FG004|NOT COMPLETED|Intervention 3||0||
48238886|NCT03867396|100906692|FG005|NOT COMPLETED|Intervention 3||0||
48238887|NCT04676763|100906693|FG000|STARTED|Part 1 (Up to Day 1)||9||
48238888|NCT04676763|100906694|FG001|STARTED|Part 1 (Up to Day 1)||3||
48238889|NCT04676763|100906695|FG002|STARTED|Part 1 (Up to Day 1)||0||
48238890|NCT04676763|100906693|FG000|Number of Participants Who Received SP 5 PMOL|Part 1 (Up to Day 1)||9||
48238891|NCT04676763|100906694|FG001|Number of Participants Who Received SP 5 PMOL|Part 1 (Up to Day 1)||0||
48238892|NCT04676763|100906695|FG002|Number of Participants Who Received SP 5 PMOL|Part 1 (Up to Day 1)||0||
48539495|NCT01200992|101655470|FG000|STARTED|Overall Study||39||
48238893|NCT04676763|100906693|FG000|Number of Participants Who Received SP 15 PMOL|Part 1 (Up to Day 1)||9||
48539496|NCT01200992|101655471|FG001|STARTED|Overall Study||45||
48539497|NCT01200992|101655470|FG000|COMPLETED|Overall Study||2||
48539498|NCT01200992|101655471|FG001|COMPLETED|Overall Study||4||
48539499|NCT01200992|101655470|FG000|NOT COMPLETED|Overall Study||37||
48539500|NCT01200992|101655471|FG001|NOT COMPLETED|Overall Study||41||
48539501|NCT01421511|101655472|FG000|STARTED|Overall Study||332||
48539502|NCT01421511|101655473|FG001|STARTED|Overall Study||334||
48539503|NCT01421511|101655472|FG000|COMPLETED|Overall Study||313||
48539504|NCT01421511|101655473|FG001|COMPLETED|Overall Study||306||
48539505|NCT01421511|101655472|FG000|NOT COMPLETED|Overall Study||19||
48539506|NCT01421511|101655473|FG001|NOT COMPLETED|Overall Study||28||
48539507|NCT03190330|101655474|FG000|STARTED|Overall Study||75||
48539508|NCT03190330|101655474|FG000|Participants With CLL|Overall Study||67||
48539509|NCT03190330|101655474|FG000|Participants With MCL|Overall Study||8||
48539510|NCT03190330|101655474|FG000|COMPLETED|Overall Study||55||
48539511|NCT03190330|101655474|FG000|NOT COMPLETED|Overall Study||20||
48539512|NCT00867503|101655475|FG000|STARTED|Overall Study||10||
48539513|NCT00867503|101655475|FG000|COMPLETED|Overall Study||9||
48539514|NCT00867503|101655475|FG000|NOT COMPLETED|Overall Study||1||
48539515|NCT02552303|101655476|FG000|STARTED|Allocation||10||
48238894|NCT04676763|100906694|FG001|Number of Participants Who Received SP 15 PMOL|Part 1 (Up to Day 1)||0||
48238895|NCT04676763|100906695|FG002|Number of Participants Who Received SP 15 PMOL|Part 1 (Up to Day 1)||0||
48238896|NCT04676763|100906693|FG000|Number of Participants Who Received SP 50 PMOL|Part 1 (Up to Day 1)||4||
48539516|NCT02552303|101655477|FG001|STARTED|Allocation||10||
48539517|NCT02552303|101655478|FG002|STARTED|Allocation||8||
48539518|NCT02552303|101655479|FG003|STARTED|Allocation||11||
48539519|NCT02552303|101655476|FG000|COMPLETED|Allocation||7||
48539520|NCT02552303|101655477|FG001|COMPLETED|Allocation||8||
48539521|NCT02552303|101655478|FG002|COMPLETED|Allocation||7||
48539522|NCT02552303|101655479|FG003|COMPLETED|Allocation||10||
48539523|NCT02552303|101655476|FG000|NOT COMPLETED|Allocation||3||
48539524|NCT02552303|101655477|FG001|NOT COMPLETED|Allocation||2||
48539525|NCT02552303|101655478|FG002|NOT COMPLETED|Allocation||1||
48539526|NCT02552303|101655479|FG003|NOT COMPLETED|Allocation||1||
48539527|NCT02552303|101655476|FG000|STARTED|Follow-Up||7||
48539528|NCT02552303|101655477|FG001|STARTED|Follow-Up||8||
48539529|NCT02552303|101655478|FG002|STARTED|Follow-Up||7||
48238897|NCT04676763|100906694|FG001|Number of Participants Who Received SP 50 PMOL|Part 1 (Up to Day 1)||0||
48539530|NCT02552303|101655479|FG003|STARTED|Follow-Up||10||
48539531|NCT02552303|101655476|FG000|COMPLETED|Follow-Up||7||
48539532|NCT02552303|101655477|FG001|COMPLETED|Follow-Up||6||
48539533|NCT02552303|101655478|FG002|COMPLETED|Follow-Up||6||
48539534|NCT02552303|101655479|FG003|COMPLETED|Follow-Up||10||
48539535|NCT02552303|101655476|FG000|NOT COMPLETED|Follow-Up||0||
48238898|NCT04676763|100906695|FG002|Number of Participants Who Received SP 50 PMOL|Part 1 (Up to Day 1)||0||
48539536|NCT02552303|101655477|FG001|NOT COMPLETED|Follow-Up||2||
48539537|NCT02552303|101655478|FG002|NOT COMPLETED|Follow-Up||1||
48539538|NCT02552303|101655479|FG003|NOT COMPLETED|Follow-Up||0||
48539539|NCT01329549|101655480|FG000|STARTED|Overall Study||2||
48539540|NCT01329549|101655480|FG000|COMPLETED|Overall Study||0||
48539541|NCT01329549|101655480|FG000|NOT COMPLETED|Overall Study||2||
48238899|NCT04676763|100906693|FG000|Number of Participants Who Received SP 150 PMOL|Part 1 (Up to Day 1)||9||
48238900|NCT04676763|100906694|FG001|Number of Participants Who Received SP 150 PMOL|Part 1 (Up to Day 1)||0||
48238901|NCT04676763|100906695|FG002|Number of Participants Who Received SP 150 PMOL|Part 1 (Up to Day 1)||0||
48238902|NCT04676763|100906693|FG000|Number of Participants Who Received SP 500 PMOL|Part 1 (Up to Day 1)||5||
48238903|NCT04676763|100906694|FG001|Number of Participants Who Received SP 500 PMOL|Part 1 (Up to Day 1)||0||
48238904|NCT04676763|100906695|FG002|Number of Participants Who Received SP 500 PMOL|Part 1 (Up to Day 1)||0||
48238905|NCT04676763|100906693|FG000|COMPLETED|Part 1 (Up to Day 1)||9||
48238906|NCT04676763|100906694|FG001|COMPLETED|Part 1 (Up to Day 1)||0||
48238907|NCT04676763|100906695|FG002|COMPLETED|Part 1 (Up to Day 1)||0||
48238908|NCT04676763|100906693|FG000|NOT COMPLETED|Part 1 (Up to Day 1)||0||
48238909|NCT04676763|100906694|FG001|NOT COMPLETED|Part 1 (Up to Day 1)||3||
48238910|NCT04676763|100906695|FG002|NOT COMPLETED|Part 1 (Up to Day 1)||0||
48238911|NCT04676763|100906693|FG000|STARTED|Part 2 (Up to 3 Weeks)||0||
48238912|NCT04676763|100906694|FG001|STARTED|Part 2 (Up to 3 Weeks)||0||
48238913|NCT04676763|100906695|FG002|STARTED|Part 2 (Up to 3 Weeks)||20||
48238914|NCT04676763|100906693|FG000|Number of Participants Who Received SP 5 PMOL|Part 2 (Up to 3 Weeks)||0||
48238915|NCT04676763|100906694|FG001|Number of Participants Who Received SP 5 PMOL|Part 2 (Up to 3 Weeks)||0||
48238916|NCT04676763|100906695|FG002|Number of Participants Who Received SP 5 PMOL|Part 2 (Up to 3 Weeks)||20||
48238917|NCT04676763|100906693|FG000|Number of Participants Who Received SP 15 PMOL|Part 2 (Up to 3 Weeks)||0||
48238918|NCT04676763|100906694|FG001|Number of Participants Who Received SP 15 PMOL|Part 2 (Up to 3 Weeks)||0||
48238919|NCT04676763|100906695|FG002|Number of Participants Who Received SP 15 PMOL|Part 2 (Up to 3 Weeks)||20||
48238920|NCT04676763|100906693|FG000|Number of Participants Who Received SP 50 PMOL|Part 2 (Up to 3 Weeks)||0||
48238921|NCT04676763|100906694|FG001|Number of Participants Who Received SP 50 PMOL|Part 2 (Up to 3 Weeks)||0||
48238922|NCT04676763|100906695|FG002|Number of Participants Who Received SP 50 PMOL|Part 2 (Up to 3 Weeks)||20||
48238923|NCT04676763|100906693|FG000|Number of Participants Who Received SP 150 PMOL|Part 2 (Up to 3 Weeks)||0||
48238924|NCT04676763|100906694|FG001|Number of Participants Who Received SP 150 PMOL|Part 2 (Up to 3 Weeks)||0||
48238925|NCT04676763|100906695|FG002|Number of Participants Who Received SP 150 PMOL|Part 2 (Up to 3 Weeks)||20||
48238926|NCT04676763|100906693|FG000|COMPLETED|Part 2 (Up to 3 Weeks)||0||
48238927|NCT04676763|100906694|FG001|COMPLETED|Part 2 (Up to 3 Weeks)||0||
48238928|NCT04676763|100906695|FG002|COMPLETED|Part 2 (Up to 3 Weeks)||20||
48238929|NCT04676763|100906693|FG000|NOT COMPLETED|Part 2 (Up to 3 Weeks)||0||
48238930|NCT04676763|100906694|FG001|NOT COMPLETED|Part 2 (Up to 3 Weeks)||0||
48238931|NCT04676763|100906695|FG002|NOT COMPLETED|Part 2 (Up to 3 Weeks)||0||
48238932|NCT00587171|100906696|FG000|STARTED|Overall Study||9||
48238933|NCT00587171|100906697|FG001|STARTED|Overall Study||10||
48238934|NCT00587171|100906696|FG000|COMPLETED|Overall Study||8||
48238935|NCT00587171|100906697|FG001|COMPLETED|Overall Study||9||
48238936|NCT00587171|100906696|FG000|NOT COMPLETED|Overall Study||1||
48238937|NCT00587171|100906697|FG001|NOT COMPLETED|Overall Study||1||
48675107|NCT00016354|101989754|FG007|NOT COMPLETED|Overall Study||1||
48675108|NCT05036343|101989755|FG000|STARTED|First Intervention (90 Days)||5||
48675109|NCT05036343|101989756|FG001|STARTED|First Intervention (90 Days)||8||
48675110|NCT05036343|101989755|FG000|COMPLETED|First Intervention (90 Days)||5||
48675111|NCT05036343|101989756|FG001|COMPLETED|First Intervention (90 Days)||8||
48675112|NCT05036343|101989755|FG000|NOT COMPLETED|First Intervention (90 Days)||0||
48675113|NCT05036343|101989756|FG001|NOT COMPLETED|First Intervention (90 Days)||0||
48675114|NCT05036343|101989755|FG000|STARTED|Second Intervention (90 Days)||5||
48675115|NCT05036343|101989756|FG001|STARTED|Second Intervention (90 Days)||8||
48675116|NCT05036343|101989755|FG000|COMPLETED|Second Intervention (90 Days)||5||
48675117|NCT05036343|101989756|FG001|COMPLETED|Second Intervention (90 Days)||8||
48675118|NCT05036343|101989755|FG000|NOT COMPLETED|Second Intervention (90 Days)||0||
48675119|NCT05036343|101989756|FG001|NOT COMPLETED|Second Intervention (90 Days)||0||
48675120|NCT01574144|101989757|FG000|STARTED|Overall Study||70||
48675121|NCT01574144|101989757|FG000|COMPLETED|Overall Study||70||
48675122|NCT01574144|101989757|FG000|NOT COMPLETED|Overall Study||0||
48675123|NCT00523978|101989758|FG000|STARTED|Overall Study||171||
48675124|NCT00523978|101989759|FG001|STARTED|Overall Study||87||
48238938|NCT01848483|100906698|FG000|STARTED|Overall Study||61||
48238939|NCT01848483|100906699|FG001|STARTED|Overall Study||60||
48238940|NCT01848483|100906698|FG000|COMPLETED|Overall Study||50||
48238941|NCT01848483|100906699|FG001|COMPLETED|Overall Study||49||
48238942|NCT01848483|100906698|FG000|NOT COMPLETED|Overall Study||11||
48238943|NCT01848483|100906699|FG001|NOT COMPLETED|Overall Study||11||
48238944|NCT03479502|100906700|FG000|STARTED|Overall Study||1||
48238945|NCT03479502|100906701|FG001|STARTED|Overall Study||0||
48238946|NCT03479502|100906700|FG000|COMPLETED|Overall Study||1||
48238947|NCT03479502|100906701|FG001|COMPLETED|Overall Study||0||
48675125|NCT00523978|101989758|FG000|COMPLETED|Overall Study||162||
48675126|NCT00523978|101989759|FG001|COMPLETED|Overall Study||79||
48675127|NCT00523978|101989758|FG000|NOT COMPLETED|Overall Study||9||
48675128|NCT00523978|101989759|FG001|NOT COMPLETED|Overall Study||8||
48675129|NCT00444106|101989760|FG000|STARTED|Overall Study||159||
48675130|NCT00444106|101989761|FG001|STARTED|Overall Study||53||
48675131|NCT00444106|101989762|FG002|STARTED|Overall Study||53||
48238948|NCT03479502|100906700|FG000|NOT COMPLETED|Overall Study||0||
48238949|NCT03479502|100906701|FG001|NOT COMPLETED|Overall Study||0||
48238950|NCT00422162|100906702|FG000|STARTED|Overall Study||167||
48238951|NCT00422162|100906703|FG001|STARTED|Overall Study||172||
48238952|NCT00422162|100906702|FG000|Received Treatment|Overall Study||167||
48238953|NCT00422162|100906703|FG001|Received Treatment|Overall Study||171||
48238954|NCT00422162|100906702|FG000|COMPLETED|Overall Study||143||
48238955|NCT00422162|100906703|FG001|COMPLETED|Overall Study||142||
48238956|NCT00422162|100906702|FG000|NOT COMPLETED|Overall Study||24||
48238957|NCT00422162|100906703|FG001|NOT COMPLETED|Overall Study||30||
48238958|NCT01322347|100906704|FG000|STARTED|Overall Study||147||
48238959|NCT01322347|100906705|FG001|STARTED|Overall Study||147||
48238960|NCT01322347|100906704|FG000|Completed 48 Wks in St 2|Overall Study||28||
48539542|NCT01758588|101655481|FG000|STARTED|Overall Study||5||
48539543|NCT01758588|101655482|FG001|STARTED|Overall Study||3||
48539544|NCT01758588|101655481|FG000|COMPLETED|Overall Study||5||
48539545|NCT01758588|101655482|FG001|COMPLETED|Overall Study||3||
48539546|NCT01758588|101655481|FG000|NOT COMPLETED|Overall Study||0||
48539547|NCT01758588|101655482|FG001|NOT COMPLETED|Overall Study||0||
48675132|NCT00444106|101989760|FG000|Completed Treatment Period|Overall Study||159||
48675133|NCT00444106|101989761|FG001|Completed Treatment Period|Overall Study||53||
48675134|NCT00444106|101989762|FG002|Completed Treatment Period|Overall Study||53||
48675135|NCT00444106|101989760|FG000|COMPLETED|Overall Study||157||
48675136|NCT00444106|101989761|FG001|COMPLETED|Overall Study||52||
48675137|NCT00444106|101989762|FG002|COMPLETED|Overall Study||52||
48675138|NCT00444106|101989760|FG000|NOT COMPLETED|Overall Study||2||
48675139|NCT00444106|101989761|FG001|NOT COMPLETED|Overall Study||1||
48675140|NCT00444106|101989762|FG002|NOT COMPLETED|Overall Study||1||
48675141|NCT01784029|101989763|FG000|STARTED|Overall Study||61||
48675142|NCT01784029|101989764|FG001|STARTED|Overall Study||59||
48675143|NCT01784029|101989765|FG002|STARTED|Overall Study||63||
48675144|NCT01784029|101989763|FG000|COMPLETED|Overall Study||42||
48675145|NCT01784029|101989764|FG001|COMPLETED|Overall Study||39||
48675146|NCT01784029|101989765|FG002|COMPLETED|Overall Study||41||
48675147|NCT01784029|101989763|FG000|NOT COMPLETED|Overall Study||19||
48675148|NCT01784029|101989764|FG001|NOT COMPLETED|Overall Study||20||
48675149|NCT01784029|101989765|FG002|NOT COMPLETED|Overall Study||22||
48675150|NCT01658059|101989766|FG000|STARTED|First Intervention- 2 Days||12||
48675151|NCT01658059|101989767|FG001|STARTED|First Intervention- 2 Days||10||
48675152|NCT01658059|101989766|FG000|COMPLETED|First Intervention- 2 Days||6||
48675153|NCT01658059|101989767|FG001|COMPLETED|First Intervention- 2 Days||5||
48675154|NCT01658059|101989766|FG000|NOT COMPLETED|First Intervention- 2 Days||6||
48675155|NCT01658059|101989767|FG001|NOT COMPLETED|First Intervention- 2 Days||5||
48675156|NCT01658059|101989766|FG000|STARTED|Washout Period- 14 Days||6||
48675157|NCT01658059|101989767|FG001|STARTED|Washout Period- 14 Days||5||
48675158|NCT01658059|101989766|FG000|COMPLETED|Washout Period- 14 Days||6||
48675159|NCT01658059|101989767|FG001|COMPLETED|Washout Period- 14 Days||5||
48675160|NCT01658059|101989766|FG000|NOT COMPLETED|Washout Period- 14 Days||0||
48675161|NCT01658059|101989767|FG001|NOT COMPLETED|Washout Period- 14 Days||0||
48675162|NCT01658059|101989766|FG000|STARTED|Second Intervention- 2 Days||6||
48675163|NCT01658059|101989767|FG001|STARTED|Second Intervention- 2 Days||5||
48675164|NCT01658059|101989766|FG000|COMPLETED|Second Intervention- 2 Days||6||
48675165|NCT01658059|101989767|FG001|COMPLETED|Second Intervention- 2 Days||5||
48675166|NCT01658059|101989766|FG000|NOT COMPLETED|Second Intervention- 2 Days||0||
48675167|NCT01658059|101989767|FG001|NOT COMPLETED|Second Intervention- 2 Days||0||
48675168|NCT01204788|101989768|FG000|STARTED|Overall Study||1||
48675169|NCT01204788|101989769|FG001|STARTED|Overall Study||3||
48238961|NCT01322347|100906705|FG001|Completed 48 Wks in St 2|Overall Study||22||
48238962|NCT01322347|100906704|FG000|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||68||
48238963|NCT01322347|100906705|FG001|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||90||
48238964|NCT01322347|100906704|FG000|Enrolled in St 3|Overall Study||101||
48238965|NCT01322347|100906705|FG001|Enrolled in St 3|Overall Study||113||
48238966|NCT01322347|100906704|FG000|Completed St 3|Overall Study||82||
48238967|NCT01322347|100906705|FG001|Completed St 3|Overall Study||86||
48238968|NCT01322347|100906704|FG000|COMPLETED|Overall Study||96||
48238969|NCT01322347|100906705|FG001|COMPLETED|Overall Study||112||
48238970|NCT01322347|100906704|FG000|NOT COMPLETED|Overall Study||51||
48238971|NCT01322347|100906705|FG001|NOT COMPLETED|Overall Study||35||
48238972|NCT02755948|100906706|FG000|STARTED|Overall Study||41||
48238973|NCT02755948|100906707|FG001|STARTED|Overall Study||24||
48675170|NCT01204788|101989768|FG000|COMPLETED|Overall Study||0||
48675171|NCT01204788|101989769|FG001|COMPLETED|Overall Study||0||
48238974|NCT02755948|100906708|FG002|STARTED|Overall Study||10||
48238975|NCT02755948|100906706|FG000|COMPLETED|Overall Study||41||
48539548|NCT04773301|101655483|FG000|STARTED|Overall Study||57||
48539549|NCT04773301|101655484|FG001|STARTED|Overall Study||57||
48539550|NCT04773301|101655483|FG000|COMPLETED|Overall Study||56||
48238976|NCT02755948|100906707|FG001|COMPLETED|Overall Study||24||
48238977|NCT02755948|100906708|FG002|COMPLETED|Overall Study||10||
48238978|NCT02755948|100906706|FG000|NOT COMPLETED|Overall Study||0||
48539551|NCT04773301|101655484|FG001|COMPLETED|Overall Study||52||
48539552|NCT04773301|101655483|FG000|NOT COMPLETED|Overall Study||1||
48675172|NCT01204788|101989768|FG000|NOT COMPLETED|Overall Study||1||
48675173|NCT01204788|101989769|FG001|NOT COMPLETED|Overall Study||3||
48675174|NCT02541591|101989770|FG000|STARTED|Overall Study||56||
48675175|NCT02541591|101989771|FG001|STARTED|Overall Study||56||
48675176|NCT02541591|101989770|FG000|COMPLETED|Overall Study||52||
48675177|NCT02541591|101989771|FG001|COMPLETED|Overall Study||55||
48675178|NCT02541591|101989770|FG000|NOT COMPLETED|Overall Study||4||
48675179|NCT02541591|101989771|FG001|NOT COMPLETED|Overall Study||1||
48675180|NCT02471144|101989772|FG000|STARTED|Induction Period (Up to Week 12)||40||
48675181|NCT02471144|101989773|FG001|STARTED|Induction Period (Up to Week 12)||40||
48675182|NCT02471144|101989774|FG002|STARTED|Induction Period (Up to Week 12)||41||
48675183|NCT02471144|101989775|FG003|STARTED|Induction Period (Up to Week 12)||41||
48675184|NCT02471144|101989776|FG004|STARTED|Induction Period (Up to Week 12)||0||
48675185|NCT02471144|101989777|FG005|STARTED|Induction Period (Up to Week 12)||0||
48675186|NCT02471144|101989778|FG006|STARTED|Induction Period (Up to Week 12)||0||
48675187|NCT02471144|101989779|FG007|STARTED|Induction Period (Up to Week 12)||0||
48675188|NCT02471144|101989780|FG008|STARTED|Induction Period (Up to Week 12)||0||
48675189|NCT02471144|101989781|FG009|STARTED|Induction Period (Up to Week 12)||0||
48675190|NCT02471144|101989782|FG010|STARTED|Induction Period (Up to Week 12)||0||
48675191|NCT02471144|101989772|FG000|COMPLETED|Induction Period (Up to Week 12)||39||
48675192|NCT02471144|101989773|FG001|COMPLETED|Induction Period (Up to Week 12)||38||
48675193|NCT02471144|101989774|FG002|COMPLETED|Induction Period (Up to Week 12)||39||
48675194|NCT02471144|101989775|FG003|COMPLETED|Induction Period (Up to Week 12)||40||
48675195|NCT02471144|101989776|FG004|COMPLETED|Induction Period (Up to Week 12)||0||
48675196|NCT02471144|101989777|FG005|COMPLETED|Induction Period (Up to Week 12)||0||
48675197|NCT02471144|101989778|FG006|COMPLETED|Induction Period (Up to Week 12)||0||
48675198|NCT02471144|101989779|FG007|COMPLETED|Induction Period (Up to Week 12)||0||
48675199|NCT02471144|101989780|FG008|COMPLETED|Induction Period (Up to Week 12)||0||
48675200|NCT02471144|101989781|FG009|COMPLETED|Induction Period (Up to Week 12)||0||
48675201|NCT02471144|101989782|FG010|COMPLETED|Induction Period (Up to Week 12)||0||
48675202|NCT02471144|101989772|FG000|NOT COMPLETED|Induction Period (Up to Week 12)||1||
48675203|NCT02471144|101989773|FG001|NOT COMPLETED|Induction Period (Up to Week 12)||2||
48675204|NCT02471144|101989774|FG002|NOT COMPLETED|Induction Period (Up to Week 12)||2||
48675205|NCT02471144|101989775|FG003|NOT COMPLETED|Induction Period (Up to Week 12)||1||
48675206|NCT02471144|101989776|FG004|NOT COMPLETED|Induction Period (Up to Week 12)||0||
48675207|NCT02471144|101989777|FG005|NOT COMPLETED|Induction Period (Up to Week 12)||0||
48675208|NCT02471144|101989778|FG006|NOT COMPLETED|Induction Period (Up to Week 12)||0||
48675209|NCT02471144|101989779|FG007|NOT COMPLETED|Induction Period (Up to Week 12)||0||
48675210|NCT02471144|101989780|FG008|NOT COMPLETED|Induction Period (Up to Week 12)||0||
48675211|NCT02471144|101989781|FG009|NOT COMPLETED|Induction Period (Up to Week 12)||0||
48675212|NCT02471144|101989782|FG010|NOT COMPLETED|Induction Period (Up to Week 12)||0||
48675213|NCT02471144|101989772|FG000|STARTED|Maintenance Period (Week 12 to Week 52)||0||
48675214|NCT02471144|101989773|FG001|STARTED|Maintenance Period (Week 12 to Week 52)||0||
48675215|NCT02471144|101989774|FG002|STARTED|Maintenance Period (Week 12 to Week 52)||0||
48675216|NCT02471144|101989775|FG003|STARTED|Maintenance Period (Week 12 to Week 52)||0||
48675217|NCT02471144|101989776|FG004|STARTED|Maintenance Period (Week 12 to Week 52)||39||
48675218|NCT02471144|101989777|FG005|STARTED|Maintenance Period (Week 12 to Week 52)||38||
48675219|NCT02471144|101989778|FG006|STARTED|Maintenance Period (Week 12 to Week 52)||16||
48675220|NCT02471144|101989779|FG007|STARTED|Maintenance Period (Week 12 to Week 52)||18||
48675221|NCT02471144|101989780|FG008|STARTED|Maintenance Period (Week 12 to Week 52)||40||
48675222|NCT02471144|101989781|FG009|STARTED|Maintenance Period (Week 12 to Week 52)||0||
48675223|NCT02471144|101989782|FG010|STARTED|Maintenance Period (Week 12 to Week 52)||0||
48675224|NCT02471144|101989772|FG000|COMPLETED|Maintenance Period (Week 12 to Week 52)||0||
48675225|NCT02471144|101989773|FG001|COMPLETED|Maintenance Period (Week 12 to Week 52)||0||
48675226|NCT02471144|101989774|FG002|COMPLETED|Maintenance Period (Week 12 to Week 52)||0||
48675227|NCT02471144|101989775|FG003|COMPLETED|Maintenance Period (Week 12 to Week 52)||0||
48675228|NCT02471144|101989776|FG004|COMPLETED|Maintenance Period (Week 12 to Week 52)||38||
48675229|NCT02471144|101989777|FG005|COMPLETED|Maintenance Period (Week 12 to Week 52)||37||
48675230|NCT02471144|101989778|FG006|COMPLETED|Maintenance Period (Week 12 to Week 52)||15||
48675231|NCT02471144|101989779|FG007|COMPLETED|Maintenance Period (Week 12 to Week 52)||16||
48675232|NCT02471144|101989780|FG008|COMPLETED|Maintenance Period (Week 12 to Week 52)||34||
48675233|NCT02471144|101989781|FG009|COMPLETED|Maintenance Period (Week 12 to Week 52)||0||
48675234|NCT02471144|101989782|FG010|COMPLETED|Maintenance Period (Week 12 to Week 52)||0||
48675235|NCT02471144|101989772|FG000|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0||
48675236|NCT02471144|101989773|FG001|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0||
48675237|NCT02471144|101989774|FG002|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0||
48675238|NCT02471144|101989775|FG003|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0||
48675239|NCT02471144|101989776|FG004|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||1||
48675240|NCT02471144|101989777|FG005|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||1||
48675241|NCT02471144|101989778|FG006|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||1||
48675242|NCT02471144|101989779|FG007|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||2||
48710646|NCT01477463|102077981|FG000|NOT COMPLETED|Overall Study||0||
48675243|NCT02471144|101989780|FG008|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||6||
48675244|NCT02471144|101989781|FG009|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0||
48675245|NCT02471144|101989782|FG010|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0||
48675246|NCT02471144|101989772|FG000|STARTED|Extension Period (Week 52 to Week 236)||0||
48675247|NCT02471144|101989773|FG001|STARTED|Extension Period (Week 52 to Week 236)||0||
48675248|NCT02471144|101989774|FG002|STARTED|Extension Period (Week 52 to Week 236)||0||
48675249|NCT02471144|101989775|FG003|STARTED|Extension Period (Week 52 to Week 236)||0||
48675250|NCT02471144|101989776|FG004|STARTED|Extension Period (Week 52 to Week 236)||0||
48675251|NCT02471144|101989777|FG005|STARTED|Extension Period (Week 52 to Week 236)||0||
48675252|NCT02471144|101989778|FG006|STARTED|Extension Period (Week 52 to Week 236)||0||
48675253|NCT02471144|101989779|FG007|STARTED|Extension Period (Week 52 to Week 236)||0||
48675254|NCT02471144|101989780|FG008|STARTED|Extension Period (Week 52 to Week 236)||0||
48675255|NCT02471144|101989781|FG009|STARTED|Extension Period (Week 52 to Week 236)||53||
48675256|NCT02471144|101989782|FG010|STARTED|Extension Period (Week 52 to Week 236)||53||
48675257|NCT02471144|101989772|FG000|COMPLETED|Extension Period (Week 52 to Week 236)||0||
48675258|NCT02471144|101989773|FG001|COMPLETED|Extension Period (Week 52 to Week 236)||0||
48675259|NCT02471144|101989774|FG002|COMPLETED|Extension Period (Week 52 to Week 236)||0||
48675260|NCT02471144|101989775|FG003|COMPLETED|Extension Period (Week 52 to Week 236)||0||
48675261|NCT02471144|101989776|FG004|COMPLETED|Extension Period (Week 52 to Week 236)||0||
48675262|NCT02471144|101989777|FG005|COMPLETED|Extension Period (Week 52 to Week 236)||0||
48675263|NCT02471144|101989778|FG006|COMPLETED|Extension Period (Week 52 to Week 236)||0||
48675264|NCT02471144|101989779|FG007|COMPLETED|Extension Period (Week 52 to Week 236)||0||
48675265|NCT02471144|101989780|FG008|COMPLETED|Extension Period (Week 52 to Week 236)||0||
48675266|NCT02471144|101989781|FG009|COMPLETED|Extension Period (Week 52 to Week 236)||39||
48675267|NCT02471144|101989782|FG010|COMPLETED|Extension Period (Week 52 to Week 236)||43||
48675268|NCT02471144|101989772|FG000|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0||
48675269|NCT02471144|101989773|FG001|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0||
48675270|NCT02471144|101989774|FG002|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0||
48675271|NCT02471144|101989775|FG003|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0||
48675272|NCT02471144|101989776|FG004|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0||
48675273|NCT02471144|101989777|FG005|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0||
48675274|NCT02471144|101989778|FG006|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0||
48675275|NCT02471144|101989779|FG007|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0||
48675276|NCT02471144|101989780|FG008|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0||
48675277|NCT02471144|101989781|FG009|NOT COMPLETED|Extension Period (Week 52 to Week 236)||14||
48675278|NCT02471144|101989782|FG010|NOT COMPLETED|Extension Period (Week 52 to Week 236)||10||
48675279|NCT00125788|101989783|FG000|STARTED|Overall Study||37||
48675280|NCT00125788|101989784|FG001|STARTED|Overall Study||33||
48675281|NCT00125788|101989783|FG000|COMPLETED|Overall Study||33||
48675282|NCT00125788|101989784|FG001|COMPLETED|Overall Study||29||
48675283|NCT00125788|101989783|FG000|NOT COMPLETED|Overall Study||4||
48675284|NCT00125788|101989784|FG001|NOT COMPLETED|Overall Study||4||
48675285|NCT01876212|101989785|FG000|STARTED|Overall Study||9||
48675286|NCT01876212|101989786|FG001|STARTED|Overall Study||6||
48675287|NCT01876212|101989785|FG000|COMPLETED|Overall Study||9||
48675288|NCT01876212|101989786|FG001|COMPLETED|Overall Study||6||
48675289|NCT01876212|101989785|FG000|NOT COMPLETED|Overall Study||0||
48675290|NCT01876212|101989786|FG001|NOT COMPLETED|Overall Study||0||
48675291|NCT02455167|101989787|FG000|STARTED|Overall Study||4||
48675292|NCT02455167|101989787|FG000|COMPLETED|Overall Study||4||
48675293|NCT02455167|101989787|FG000|NOT COMPLETED|Overall Study||0||
48675294|NCT00127855|101989788|FG000|STARTED|Primary Vaccination Course||82||
48675295|NCT00127855|101989789|FG001|STARTED|Primary Vaccination Course||82||
48675296|NCT00127855|101989790|FG002|STARTED|Primary Vaccination Course||80||
48675297|NCT00127855|101989791|FG003|STARTED|Primary Vaccination Course||81||
48675298|NCT00127855|101989792|FG004|STARTED|Primary Vaccination Course||82||
48675299|NCT00127855|101989788|FG000|COMPLETED|Primary Vaccination Course||80||
48675300|NCT00127855|101989789|FG001|COMPLETED|Primary Vaccination Course||81||
48675301|NCT00127855|101989790|FG002|COMPLETED|Primary Vaccination Course||78||
48675302|NCT00127855|101989791|FG003|COMPLETED|Primary Vaccination Course||81||
48675303|NCT00127855|101989792|FG004|COMPLETED|Primary Vaccination Course||78||
48675304|NCT00127855|101989788|FG000|NOT COMPLETED|Primary Vaccination Course||2||
48675305|NCT00127855|101989789|FG001|NOT COMPLETED|Primary Vaccination Course||1||
48675306|NCT00127855|101989790|FG002|NOT COMPLETED|Primary Vaccination Course||2||
48675307|NCT00127855|101989791|FG003|NOT COMPLETED|Primary Vaccination Course||0||
48675308|NCT00127855|101989792|FG004|NOT COMPLETED|Primary Vaccination Course||4||
48675309|NCT00127855|101989788|FG000|STARTED|Polysaccharide Challenge Dose||80||
48675310|NCT00127855|101989789|FG001|STARTED|Polysaccharide Challenge Dose||79||
48675311|NCT00127855|101989790|FG002|STARTED|Polysaccharide Challenge Dose||77||
48238979|NCT02755948|100906707|FG001|NOT COMPLETED|Overall Study||0||
48238980|NCT02755948|100906708|FG002|NOT COMPLETED|Overall Study||0||
48675312|NCT00127855|101989791|FG003|STARTED|Polysaccharide Challenge Dose||81||
48675313|NCT00127855|101989792|FG004|STARTED|Polysaccharide Challenge Dose||77||
48710647|NCT01477463|102077982|FG001|NOT COMPLETED|Overall Study||0||
48675314|NCT00127855|101989788|FG000|COMPLETED|Polysaccharide Challenge Dose||80||
48675315|NCT00127855|101989789|FG001|COMPLETED|Polysaccharide Challenge Dose||79||
48675316|NCT00127855|101989790|FG002|COMPLETED|Polysaccharide Challenge Dose||77||
48675317|NCT00127855|101989791|FG003|COMPLETED|Polysaccharide Challenge Dose||81||
48675318|NCT00127855|101989792|FG004|COMPLETED|Polysaccharide Challenge Dose||77||
48675319|NCT00127855|101989788|FG000|NOT COMPLETED|Polysaccharide Challenge Dose||0||
48675320|NCT00127855|101989789|FG001|NOT COMPLETED|Polysaccharide Challenge Dose||0||
48675321|NCT00127855|101989790|FG002|NOT COMPLETED|Polysaccharide Challenge Dose||0||
48675322|NCT00127855|101989791|FG003|NOT COMPLETED|Polysaccharide Challenge Dose||0||
48675323|NCT00127855|101989792|FG004|NOT COMPLETED|Polysaccharide Challenge Dose||0||
48675324|NCT02071901|101989793|FG000|STARTED|Overall Study||31||
48675325|NCT02071901|101989793|FG000|COMPLETED|Overall Study||31||
48675326|NCT02071901|101989793|FG000|NOT COMPLETED|Overall Study||0||
48675327|NCT02481557|101989794|FG000|STARTED|Overall Study||17||
48675328|NCT02481557|101989795|FG001|STARTED|Overall Study||19||
48238981|NCT01320683|100906709|FG000|STARTED|Overall Study||1||
48675329|NCT02481557|101989794|FG000|COMPLETED|Overall Study||17||
48675330|NCT02481557|101989795|FG001|COMPLETED|Overall Study||19||
48675331|NCT02481557|101989794|FG000|NOT COMPLETED|Overall Study||0||
48675332|NCT02481557|101989795|FG001|NOT COMPLETED|Overall Study||0||
48675333|NCT02639390|101989796|FG000|STARTED|Overall Study||0||
48675334|NCT02639390|101989797|FG001|STARTED|Overall Study||5||
48675335|NCT02639390|101989796|FG000|COMPLETED|Overall Study||0||
48675336|NCT02639390|101989797|FG001|COMPLETED|Overall Study||3||
48675337|NCT02639390|101989796|FG000|NOT COMPLETED|Overall Study||0||
48675338|NCT02639390|101989797|FG001|NOT COMPLETED|Overall Study||2||
48675339|NCT04490278|101989798|FG000|STARTED|Overall Study||20||
48675340|NCT04490278|101989798|FG000|COMPLETED|Overall Study||14||
48675341|NCT04490278|101989798|FG000|NOT COMPLETED|Overall Study||6||
48675342|NCT05157360|101989799|FG000|STARTED|Overall Study||5||
48675343|NCT05157360|101989800|FG001|STARTED|Overall Study||5||
48675344|NCT05157360|101989799|FG000|COMPLETED|Overall Study||5||
48675345|NCT05157360|101989800|FG001|COMPLETED|Overall Study||5||
48675346|NCT05157360|101989799|FG000|NOT COMPLETED|Overall Study||0||
48675347|NCT05157360|101989800|FG001|NOT COMPLETED|Overall Study||0||
48675348|NCT00831389|101989801|FG000|STARTED|Overall Study||6||
48675349|NCT00831389|101989802|FG001|STARTED|Overall Study||7||
48675350|NCT00831389|101989801|FG000|COMPLETED|Overall Study||6||
48675351|NCT00831389|101989802|FG001|COMPLETED|Overall Study||6||
48675352|NCT00831389|101989801|FG000|NOT COMPLETED|Overall Study||0||
48675353|NCT00831389|101989802|FG001|NOT COMPLETED|Overall Study||1||
48675354|NCT02199041|101989803|FG000|STARTED|Overall Study||12||
48675355|NCT02199041|101989803|FG000|COMPLETED|Overall Study||12||
48675356|NCT02199041|101989803|FG000|NOT COMPLETED|Overall Study||0||
48675357|NCT01517984|101989804|FG000|STARTED|Overall Study||5||
48675358|NCT01517984|101989805|FG001|STARTED|Overall Study||26||
48675359|NCT01517984|101989806|FG002|STARTED|Overall Study||14||
48675360|NCT01517984|101989807|FG003|STARTED|Overall Study||7||
48675361|NCT01517984|101989804|FG000|COMPLETED|Overall Study||0||
48675362|NCT01517984|101989805|FG001|COMPLETED|Overall Study||3||
48675363|NCT01517984|101989806|FG002|COMPLETED|Overall Study||10||
48675364|NCT01517984|101989807|FG003|COMPLETED|Overall Study||6||
48675365|NCT01517984|101989804|FG000|NOT COMPLETED|Overall Study||5||
48675366|NCT01517984|101989805|FG001|NOT COMPLETED|Overall Study||23||
48675367|NCT01517984|101989806|FG002|NOT COMPLETED|Overall Study||4||
48675368|NCT01517984|101989807|FG003|NOT COMPLETED|Overall Study||1||
48675369|NCT01359956|101989808|FG000|STARTED|Overall Study||67||
48675370|NCT01359956|101989809|FG001|STARTED|Overall Study||69||
48675371|NCT01359956|101989810|FG002|STARTED|Overall Study||71||
48675372|NCT01359956|101989811|FG003|STARTED|Overall Study||62||
48675373|NCT01359956|101989808|FG000|COMPLETED|Overall Study||6||
48675374|NCT01359956|101989809|FG001|COMPLETED|Overall Study||5||
48675375|NCT01359956|101989810|FG002|COMPLETED|Overall Study||4||
48675376|NCT01359956|101989811|FG003|COMPLETED|Overall Study||4||
48675377|NCT01359956|101989808|FG000|NOT COMPLETED|Overall Study||61||
48675378|NCT01359956|101989809|FG001|NOT COMPLETED|Overall Study||64||
48675379|NCT01359956|101989810|FG002|NOT COMPLETED|Overall Study||67||
48675380|NCT01359956|101989811|FG003|NOT COMPLETED|Overall Study||58||
48675381|NCT00525421|101989812|FG000|STARTED|Overall Study||10||
48675382|NCT00525421|101989813|FG001|STARTED|Overall Study||10||
48675383|NCT00525421|101989812|FG000|COMPLETED|Overall Study||10||
48675384|NCT00525421|101989813|FG001|COMPLETED|Overall Study||10||
48675385|NCT00525421|101989812|FG000|NOT COMPLETED|Overall Study||0||
48675386|NCT00525421|101989813|FG001|NOT COMPLETED|Overall Study||0||
48675387|NCT03198156|101989814|FG000|STARTED|Overall Study||19||
48675388|NCT03198156|101989815|FG001|STARTED|Overall Study||19||
48675389|NCT03198156|101989814|FG000|COMPLETED|Overall Study||19||
48675390|NCT03198156|101989815|FG001|COMPLETED|Overall Study||19||
48675391|NCT03198156|101989814|FG000|NOT COMPLETED|Overall Study||0||
48675392|NCT03198156|101989815|FG001|NOT COMPLETED|Overall Study||0||
48675393|NCT03708367|101989816|FG000|STARTED|Overall Study||59||117
48675394|NCT03708367|101989817|FG001|STARTED|Overall Study||58||115
48675395|NCT03708367|101989816|FG000|COMPLETED|Overall Study||58||116
48675396|NCT03708367|101989817|FG001|COMPLETED|Overall Study||57||114
48675397|NCT03708367|101989816|FG000|NOT COMPLETED|Overall Study||1||1
48675398|NCT03708367|101989817|FG001|NOT COMPLETED|Overall Study||1||1
48675399|NCT03186638|101989818|FG000|STARTED|Overall Study||45|Randomized|
48675400|NCT03186638|101989819|FG001|STARTED|Overall Study||42|Randomized|
48675401|NCT03186638|101989818|FG000|Received Intervention and Completed Baseline Assessments|Overall Study||44||
48238982|NCT01320683|100906709|FG000|COMPLETED|Overall Study||0||
48238983|NCT01320683|100906709|FG000|NOT COMPLETED|Overall Study||1||
48238984|NCT03740919|100906710|FG000|STARTED|Lead-in Period||751||
48238985|NCT03740919|100906711|FG001|STARTED|Lead-in Period||0||
48238986|NCT03740919|100906712|FG002|STARTED|Lead-in Period||0||
48675402|NCT03186638|101989819|FG001|Received Intervention and Completed Baseline Assessments|Overall Study||40||
48675403|NCT03186638|101989818|FG000|COMPLETED|Overall Study||37||
48675404|NCT03186638|101989819|FG001|COMPLETED|Overall Study||36||
48675405|NCT03186638|101989818|FG000|NOT COMPLETED|Overall Study||8||
48675406|NCT03186638|101989819|FG001|NOT COMPLETED|Overall Study||6||
48675407|NCT05645757|101989820|FG000|STARTED|Overall Study||6||
48675408|NCT05645757|101989821|FG001|STARTED|Overall Study||6||
48675409|NCT05645757|101989822|FG002|STARTED|Overall Study||6||
48675410|NCT05645757|101989823|FG003|STARTED|Overall Study||6||
48675411|NCT05645757|101989824|FG004|STARTED|Overall Study||7||
48675412|NCT05645757|101989825|FG005|STARTED|Overall Study||7||
48675413|NCT05645757|101989826|FG006|STARTED|Overall Study||6||
48675414|NCT05645757|101989827|FG007|STARTED|Overall Study||10||
48675415|NCT05645757|101989820|FG000|COMPLETED|Overall Study||6||
48675416|NCT05645757|101989821|FG001|COMPLETED|Overall Study||6||
48675417|NCT05645757|101989822|FG002|COMPLETED|Overall Study||6||
48675418|NCT05645757|101989823|FG003|COMPLETED|Overall Study||6||
48675419|NCT05645757|101989824|FG004|COMPLETED|Overall Study||6||
48675420|NCT05645757|101989825|FG005|COMPLETED|Overall Study||6||
48675421|NCT05645757|101989826|FG006|COMPLETED|Overall Study||6||
48675422|NCT05645757|101989827|FG007|COMPLETED|Overall Study||10||
48675423|NCT05645757|101989820|FG000|NOT COMPLETED|Overall Study||0||
48675424|NCT05645757|101989821|FG001|NOT COMPLETED|Overall Study||0||
48675425|NCT05645757|101989822|FG002|NOT COMPLETED|Overall Study||0||
48675426|NCT05645757|101989823|FG003|NOT COMPLETED|Overall Study||0||
48675427|NCT05645757|101989824|FG004|NOT COMPLETED|Overall Study||1||
48675428|NCT05645757|101989825|FG005|NOT COMPLETED|Overall Study||1||
48675429|NCT05645757|101989826|FG006|NOT COMPLETED|Overall Study||0||
48675430|NCT05645757|101989827|FG007|NOT COMPLETED|Overall Study||0||
48675431|NCT01887717|101989828|FG000|STARTED|Overall Study||17||
48675432|NCT01887717|101989829|FG001|STARTED|Overall Study||19||
48675433|NCT01887717|101989828|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15||
48675434|NCT01887717|101989829|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16||
48675435|NCT01887717|101989828|FG000|COMPLETED|Overall Study||11||
48675436|NCT01887717|101989829|FG001|COMPLETED|Overall Study||8||
48675437|NCT01887717|101989828|FG000|NOT COMPLETED|Overall Study||6||
48675438|NCT01887717|101989829|FG001|NOT COMPLETED|Overall Study||11||
48675439|NCT02180828|101989830|FG000|STARTED|Overall Study||120||
48675440|NCT02180828|101989831|FG001|STARTED|Overall Study||120||
48675441|NCT02180828|101989830|FG000|COMPLETED|Overall Study||115||
48675442|NCT02180828|101989831|FG001|COMPLETED|Overall Study||113||
48675443|NCT02180828|101989830|FG000|NOT COMPLETED|Overall Study||5||
48675444|NCT02180828|101989831|FG001|NOT COMPLETED|Overall Study||7||
48675445|NCT04655157|101989832|FG000|STARTED|Overall Study||1||
48675446|NCT04655157|101989833|FG001|STARTED|Overall Study||1||
48238987|NCT03740919|100906713|FG003|STARTED|Lead-in Period||0||
48675447|NCT04655157|101989832|FG000|COMPLETED|Overall Study||1||
48238988|NCT03740919|100906710|FG000|Received at Least One Dose of Study Drug|Lead-in Period||751||
48238989|NCT03740919|100906711|FG001|Received at Least One Dose of Study Drug|Lead-in Period||0||
48238990|NCT03740919|100906712|FG002|Received at Least One Dose of Study Drug|Lead-in Period||0||
48238991|NCT03740919|100906713|FG003|Received at Least One Dose of Study Drug|Lead-in Period||0||
48238992|NCT03740919|100906710|FG000|COMPLETED|Lead-in Period||716||
48238993|NCT03740919|100906711|FG001|COMPLETED|Lead-in Period||0||
48238994|NCT03740919|100906712|FG002|COMPLETED|Lead-in Period||0||
48238995|NCT03740919|100906713|FG003|COMPLETED|Lead-in Period||0||
48238996|NCT03740919|100906710|FG000|NOT COMPLETED|Lead-in Period||35||
48238997|NCT03740919|100906711|FG001|NOT COMPLETED|Lead-in Period||0||
48238998|NCT03740919|100906712|FG002|NOT COMPLETED|Lead-in Period||0||
48238999|NCT03740919|100906713|FG003|NOT COMPLETED|Lead-in Period||0||
48239000|NCT03740919|100906710|FG000|STARTED|Treatment Period||0|After completion of Lead-in Period, participants were randomized to either blinded LY900014 or Humalog or open-label LY900014.|
48239001|NCT03740919|100906711|FG001|STARTED|Treatment Period||298|After completion of Lead-in Period, participants were randomized to either blinded LY900014 or Humalog or open-label LY900014.|
48239002|NCT03740919|100906712|FG002|STARTED|Treatment Period||280|After completion of Lead-in Period, participants were randomized to either blinded LY900014 or Humalog or open-label LY900014.|
48539553|NCT04773301|101655484|FG001|NOT COMPLETED|Overall Study||5||
48539554|NCT03485365|101655485|FG000|STARTED|Overall Study||6||
48675448|NCT04655157|101989833|FG001|COMPLETED|Overall Study||1||
48675449|NCT04655157|101989832|FG000|NOT COMPLETED|Overall Study||0||
48675450|NCT04655157|101989833|FG001|NOT COMPLETED|Overall Study||0||
48675451|NCT04696146|101989834|FG000|STARTED|Overall Study||21||
48675452|NCT04696146|101989835|FG001|STARTED|Overall Study||24||
48675453|NCT04696146|101989834|FG000|COMPLETED|Overall Study||20||
48675454|NCT04696146|101989835|FG001|COMPLETED|Overall Study||20||
48675455|NCT04696146|101989834|FG000|NOT COMPLETED|Overall Study||1||
48675456|NCT04696146|101989835|FG001|NOT COMPLETED|Overall Study||4||
48675457|NCT03580044|101989836|FG000|STARTED|Overall Study||12||
48675458|NCT03580044|101989837|FG001|STARTED|Overall Study||3||
48675459|NCT03580044|101989836|FG000|Treated|Overall Study||12||
48675460|NCT03580044|101989837|FG001|Treated|Overall Study||2||
48675461|NCT03580044|101989836|FG000|COMPLETED|Overall Study||9||
48675462|NCT03580044|101989837|FG001|COMPLETED|Overall Study||1||
48675463|NCT03580044|101989836|FG000|NOT COMPLETED|Overall Study||3||
48675464|NCT03580044|101989837|FG001|NOT COMPLETED|Overall Study||2||
48675465|NCT01198587|101989838|FG000|STARTED|Overall Study||31||
48675466|NCT01198587|101989839|FG001|STARTED|Overall Study||5||
48675467|NCT01198587|101989840|FG002|STARTED|Overall Study||30||
48675468|NCT01198587|101989841|FG003|STARTED|Overall Study||5||
48675469|NCT01198587|101989838|FG000|COMPLETED|Overall Study||23||
48675470|NCT01198587|101989839|FG001|COMPLETED|Overall Study||5||
48675471|NCT01198587|101989840|FG002|COMPLETED|Overall Study||21||
48675472|NCT01198587|101989841|FG003|COMPLETED|Overall Study||5||
48675473|NCT01198587|101989838|FG000|NOT COMPLETED|Overall Study||8||
48675474|NCT01198587|101989839|FG001|NOT COMPLETED|Overall Study||0||
48675475|NCT01198587|101989840|FG002|NOT COMPLETED|Overall Study||9||
48675476|NCT01198587|101989841|FG003|NOT COMPLETED|Overall Study||0||
48675477|NCT01276704|101989842|FG000|STARTED|Overall Study||115||
48675478|NCT01276704|101989843|FG001|STARTED|Overall Study||62||
48675479|NCT01276704|101989842|FG000|COMPLETED|Overall Study||101||
48675480|NCT01276704|101989843|FG001|COMPLETED|Overall Study||51||
48675481|NCT01276704|101989842|FG000|NOT COMPLETED|Overall Study||14||
48675482|NCT01276704|101989843|FG001|NOT COMPLETED|Overall Study||11||
48675483|NCT01990742|101989844|FG000|STARTED|Overall Study||3259||16
48675484|NCT01990742|101989845|FG001|STARTED|Overall Study||4331||15
48675485|NCT01990742|101989844|FG000|COMPLETED|Overall Study||2852||14
48675486|NCT01990742|101989845|FG001|COMPLETED|Overall Study||2978||11
48675487|NCT01990742|101989844|FG000|NOT COMPLETED|Overall Study||407||2
48675488|NCT01990742|101989845|FG001|NOT COMPLETED|Overall Study||1353||4
48675489|NCT00586157|101989846|FG000|STARTED|First Intervention||15||
48675490|NCT00586157|101989847|FG001|STARTED|First Intervention||15||
48675491|NCT00586157|101989846|FG000|COMPLETED|First Intervention||14||
48675492|NCT00586157|101989847|FG001|COMPLETED|First Intervention||15||
48675493|NCT00586157|101989846|FG000|NOT COMPLETED|First Intervention||1||
48675494|NCT00586157|101989847|FG001|NOT COMPLETED|First Intervention||0||
48675495|NCT00586157|101989846|FG000|STARTED|Second Intervention||14||
48675496|NCT00586157|101989847|FG001|STARTED|Second Intervention||15||
48675497|NCT00586157|101989846|FG000|COMPLETED|Second Intervention||12||
48675498|NCT00586157|101989847|FG001|COMPLETED|Second Intervention||14||
48675499|NCT00586157|101989846|FG000|NOT COMPLETED|Second Intervention||2||
48675500|NCT00586157|101989847|FG001|NOT COMPLETED|Second Intervention||1||
48675501|NCT01880957|101989848|FG000|STARTED|Overall Study||47||
48675502|NCT01880957|101989849|FG001|STARTED|Overall Study||29||
48675503|NCT01880957|101989848|FG000|COMPLETED|Overall Study||19||
48675504|NCT01880957|101989849|FG001|COMPLETED|Overall Study||29||
48675505|NCT01880957|101989848|FG000|NOT COMPLETED|Overall Study||28||
48675506|NCT01880957|101989849|FG001|NOT COMPLETED|Overall Study||0||
48675507|NCT03081689|101989850|FG000|STARTED|Overall Study||46||
48675508|NCT03081689|101989850|FG000|COMPLETED|Overall Study||46||
48675509|NCT03081689|101989850|FG000|NOT COMPLETED|Overall Study||0||
48675510|NCT03440385|101989851|FG000|STARTED|Overall Study||403|Intent to Treat population includes all the randomized participants.|
48675511|NCT03440385|101989852|FG001|STARTED|Overall Study||203|Intent to Treat population includes all the randomized participants.|
48675512|NCT03440385|101989851|FG000|Safety Population|Overall Study||404|Subjects who received at least 1 dose of study drug.|
48675513|NCT03440385|101989852|FG001|Safety Population|Overall Study||202|Subjects who received at least 1 dose of study drug.|
48675514|NCT03440385|101989851|FG000|COMPLETED|Overall Study||360||
48675515|NCT03440385|101989852|FG001|COMPLETED|Overall Study||183||
48675516|NCT03440385|101989851|FG000|NOT COMPLETED|Overall Study||43||
48675517|NCT03440385|101989852|FG001|NOT COMPLETED|Overall Study||20||
48675518|NCT02468830|101989853|FG000|STARTED|Overall Study||58||
48675519|NCT02468830|101989853|FG000|COMPLETED|Overall Study||55||
48675520|NCT02468830|101989853|FG000|NOT COMPLETED|Overall Study||3||
48675521|NCT01464879|101989854|FG000|STARTED|Overall Study||20||
48675522|NCT01464879|101989854|FG000|Hand Application (2.50 mL)|Overall Study||20||
48675523|NCT01464879|101989854|FG000|Washout Period|Overall Study||20||
48675524|NCT01464879|101989854|FG000|Applicator Application (1.25 mL)|Overall Study||19||
48675525|NCT01464879|101989854|FG000|Applicator Application (2.50 mL)|Overall Study||18||
48675526|NCT01464879|101989854|FG000|Applicator Application (3.75 mL)|Overall Study||18||
48675527|NCT01464879|101989854|FG000|COMPLETED|Overall Study||18||
48675528|NCT01464879|101989854|FG000|NOT COMPLETED|Overall Study||2||
48675529|NCT02797821|101989855|FG000|STARTED|Overall Study||8||
48675530|NCT02797821|101989856|FG001|STARTED|Overall Study||10||
48675531|NCT02797821|101989857|FG002|STARTED|Overall Study||9||
48675532|NCT02797821|101989855|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8||
48675533|NCT02797821|101989856|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10||
48675534|NCT02797821|101989857|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9||
48675535|NCT02797821|101989855|FG000|COMPLETED|Overall Study||8||
48675536|NCT02797821|101989856|FG001|COMPLETED|Overall Study||10||
48675537|NCT02797821|101989857|FG002|COMPLETED|Overall Study||9||
48675538|NCT02797821|101989855|FG000|NOT COMPLETED|Overall Study||0||
48675539|NCT02797821|101989856|FG001|NOT COMPLETED|Overall Study||0||
48675540|NCT02797821|101989857|FG002|NOT COMPLETED|Overall Study||0||
48675541|NCT02096107|101989858|FG000|STARTED|Overall Study||30||
48675542|NCT02096107|101989859|FG001|STARTED|Overall Study||30||
48675543|NCT02096107|101989858|FG000|COMPLETED|Overall Study||30||
48675544|NCT02096107|101989859|FG001|COMPLETED|Overall Study||30||
48675545|NCT02096107|101989858|FG000|NOT COMPLETED|Overall Study||0||
48675546|NCT02096107|101989859|FG001|NOT COMPLETED|Overall Study||0||
48675547|NCT05136170|101989860|FG000|STARTED|Overall Study||44||
48675548|NCT05136170|101989861|FG001|STARTED|Overall Study||41||
48675549|NCT05136170|101989860|FG000|Randomized But Not Treated|Overall Study||0||
48675550|NCT05136170|101989861|FG001|Randomized But Not Treated|Overall Study||1||
48675551|NCT05136170|101989860|FG000|Safety Population (SAF)|Overall Study||44||
48675552|NCT05136170|101989861|FG001|Safety Population (SAF)|Overall Study||40||
48675553|NCT05136170|101989860|FG000|Full Analysis Set Population (FAS)|Overall Study||44||
48675554|NCT05136170|101989861|FG001|Full Analysis Set Population (FAS)|Overall Study||40||
48675555|NCT05136170|101989860|FG000|Per Protocol Set (PP)|Overall Study||38||
48675556|NCT05136170|101989861|FG001|Per Protocol Set (PP)|Overall Study||33||
48675557|NCT05136170|101989860|FG000|COMPLETED|Overall Study||41||
48675558|NCT05136170|101989861|FG001|COMPLETED|Overall Study||39||
48675559|NCT05136170|101989860|FG000|NOT COMPLETED|Overall Study||3||
48675560|NCT05136170|101989861|FG001|NOT COMPLETED|Overall Study||2||
48675561|NCT03586973|101989862|FG000|STARTED|Overall Study||20||
48675562|NCT03586973|101989863|FG001|STARTED|Overall Study||14||
48675563|NCT03586973|101989862|FG000|COMPLETED|Overall Study||0||
48675564|NCT03586973|101989863|FG001|COMPLETED|Overall Study||0||
48675565|NCT03586973|101989862|FG000|NOT COMPLETED|Overall Study||20||
48675566|NCT03586973|101989863|FG001|NOT COMPLETED|Overall Study||14||
48675567|NCT03302767|101989864|FG000|STARTED|Overall Study||29||
48675568|NCT03302767|101989864|FG000|COMPLETED|Overall Study||29||
48675569|NCT03302767|101989864|FG000|NOT COMPLETED|Overall Study||0||
48675570|NCT03545672|101989865|FG000|STARTED|Overall Study||60||
48675571|NCT03545672|101989866|FG001|STARTED|Overall Study||59||
48675572|NCT03545672|101989865|FG000|COMPLETED|Overall Study||56||
48675573|NCT03545672|101989866|FG001|COMPLETED|Overall Study||56||
48675574|NCT03545672|101989865|FG000|NOT COMPLETED|Overall Study||4||
48675575|NCT03545672|101989866|FG001|NOT COMPLETED|Overall Study||3||
48675576|NCT01295710|101989867|FG000|STARTED|Overall Study||126||
48675577|NCT01295710|101989868|FG001|STARTED|Overall Study||128||
48675578|NCT01295710|101989867|FG000|COMPLETED|Overall Study||48||
48675579|NCT01295710|101989868|FG001|COMPLETED|Overall Study||78||
48239003|NCT03740919|100906713|FG003|STARTED|Treatment Period||138|After completion of Lead-in Period, participants were randomized to either blinded LY900014 or Humalog or open-label LY900014.|
48239004|NCT03740919|100906710|FG000|Received at Least One Dose of Study Drug|Treatment Period||0||
48239005|NCT03740919|100906711|FG001|Received at Least One Dose of Study Drug|Treatment Period||298||
48239006|NCT03740919|100906712|FG002|Received at Least One Dose of Study Drug|Treatment Period||280||
48239007|NCT03740919|100906713|FG003|Received at Least One Dose of Study Drug|Treatment Period||138||
48239008|NCT03740919|100906710|FG000|COMPLETED|Treatment Period||0||
48239009|NCT03740919|100906711|FG001|COMPLETED|Treatment Period||288||
48239010|NCT03740919|100906712|FG002|COMPLETED|Treatment Period||266||
48239011|NCT03740919|100906713|FG003|COMPLETED|Treatment Period||135||
48239012|NCT03740919|100906710|FG000|NOT COMPLETED|Treatment Period||0||
48239013|NCT03740919|100906711|FG001|NOT COMPLETED|Treatment Period||10||
48239014|NCT03740919|100906712|FG002|NOT COMPLETED|Treatment Period||14||
48239015|NCT03740919|100906713|FG003|NOT COMPLETED|Treatment Period||3||
48239016|NCT02143713|100906714|FG000|STARTED|Treatment Period (6 Months)||102||
48675580|NCT01295710|101989867|FG000|NOT COMPLETED|Overall Study||78||
48675581|NCT01295710|101989868|FG001|NOT COMPLETED|Overall Study||50||
48710648|NCT02961790|102077983|FG000|STARTED|Overall Study||50||
48239017|NCT02143713|100906715|FG001|STARTED|Treatment Period (6 Months)||111||
48239018|NCT02143713|100906716|FG002|STARTED|Treatment Period (6 Months)||142||
48239019|NCT02143713|100906717|FG003|STARTED|Treatment Period (6 Months)||140||
48539555|NCT03485365|101655486|FG001|STARTED|Overall Study||6||
48539556|NCT03485365|101655487|FG002|STARTED|Overall Study||6||
48539557|NCT03485365|101655488|FG003|STARTED|Overall Study||6||
48539558|NCT03485365|101655489|FG004|STARTED|Overall Study||6||
48539559|NCT03485365|101655490|FG005|STARTED|Overall Study||6||
48539560|NCT03485365|101655491|FG006|STARTED|Overall Study||13||
48539561|NCT03485365|101655492|FG007|STARTED|Overall Study||24||
48539562|NCT03485365|101655493|FG008|STARTED|Overall Study||24||
48539563|NCT03485365|101655485|FG000|COMPLETED|Overall Study||6||
48539564|NCT03485365|101655486|FG001|COMPLETED|Overall Study||6||
48539565|NCT03485365|101655487|FG002|COMPLETED|Overall Study||6||
48539566|NCT03485365|101655488|FG003|COMPLETED|Overall Study||5||
48539567|NCT03485365|101655489|FG004|COMPLETED|Overall Study||6||
48539568|NCT03485365|101655490|FG005|COMPLETED|Overall Study||6||
48539569|NCT03485365|101655491|FG006|COMPLETED|Overall Study||12||
48239020|NCT02143713|100906714|FG000|Received Elagolix|Treatment Period (6 Months)||102||
48239021|NCT02143713|100906715|FG001|Received Elagolix|Treatment Period (6 Months)||111||
48239022|NCT02143713|100906716|FG002|Received Elagolix|Treatment Period (6 Months)||142||
48239023|NCT02143713|100906717|FG003|Received Elagolix|Treatment Period (6 Months)||140||
48239024|NCT02143713|100906714|FG000|COMPLETED|Treatment Period (6 Months)||82||
48239025|NCT02143713|100906715|FG001|COMPLETED|Treatment Period (6 Months)||99||
48239026|NCT02143713|100906716|FG002|COMPLETED|Treatment Period (6 Months)||120||
48239027|NCT02143713|100906717|FG003|COMPLETED|Treatment Period (6 Months)||112||
48239028|NCT02143713|100906714|FG000|NOT COMPLETED|Treatment Period (6 Months)||20||
48239029|NCT02143713|100906715|FG001|NOT COMPLETED|Treatment Period (6 Months)||12||
48239030|NCT02143713|100906716|FG002|NOT COMPLETED|Treatment Period (6 Months)||22||
48239031|NCT02143713|100906717|FG003|NOT COMPLETED|Treatment Period (6 Months)||28||
48239032|NCT02143713|100906714|FG000|STARTED|Post-treatment Follow-up (12 Months)||85|Participants who completed the 6-month Treatment Period or prematurely discontinued could enter PTFU|
48239033|NCT02143713|100906715|FG001|STARTED|Post-treatment Follow-up (12 Months)||105|Participants who completed the 6-month Treatment Period or prematurely discontinued could enter PTFU|
48239034|NCT02143713|100906716|FG002|STARTED|Post-treatment Follow-up (12 Months)||125|Participants who completed the 6-month Treatment Period or prematurely discontinued could enter PTFU|
48239035|NCT02143713|100906717|FG003|STARTED|Post-treatment Follow-up (12 Months)||122|Participants who completed the 6-month Treatment Period or prematurely discontinued could enter PTFU|
48239036|NCT02143713|100906714|FG000|COMPLETED|Post-treatment Follow-up (12 Months)||73||
48239037|NCT02143713|100906715|FG001|COMPLETED|Post-treatment Follow-up (12 Months)||81||
48239038|NCT02143713|100906716|FG002|COMPLETED|Post-treatment Follow-up (12 Months)||96||
48239039|NCT02143713|100906717|FG003|COMPLETED|Post-treatment Follow-up (12 Months)||95||
48239040|NCT02143713|100906714|FG000|NOT COMPLETED|Post-treatment Follow-up (12 Months)||12||
48239041|NCT02143713|100906715|FG001|NOT COMPLETED|Post-treatment Follow-up (12 Months)||24||
48675582|NCT05899829|101989869|FG000|STARTED|Part 1 (Up to Day 22)||20|Enrolled|
48675583|NCT05899829|101989870|FG001|STARTED|Part 1 (Up to Day 22)||0|Enrolled|
48675584|NCT05899829|101989869|FG000|Safety Population|Part 1 (Up to Day 22)||16||
48675585|NCT05899829|101989870|FG001|Safety Population|Part 1 (Up to Day 22)||0||
48675586|NCT05899829|101989869|FG000|COMPLETED|Part 1 (Up to Day 22)||16||
48675587|NCT05899829|101989870|FG001|COMPLETED|Part 1 (Up to Day 22)||0||
48675588|NCT05899829|101989869|FG000|NOT COMPLETED|Part 1 (Up to Day 22)||4||
48675589|NCT05899829|101989870|FG001|NOT COMPLETED|Part 1 (Up to Day 22)||0||
48675590|NCT05899829|101989869|FG000|STARTED|Part 2 (up to Day 21)||0|Enrolled|
48675591|NCT05899829|101989870|FG001|STARTED|Part 2 (up to Day 21)||22|Enrolled|
48675592|NCT05899829|101989869|FG000|Safety Population|Part 2 (up to Day 21)||0||
48675593|NCT05899829|101989870|FG001|Safety Population|Part 2 (up to Day 21)||16||
48675594|NCT05899829|101989869|FG000|COMPLETED|Part 2 (up to Day 21)||0||
48675595|NCT05899829|101989870|FG001|COMPLETED|Part 2 (up to Day 21)||16||
48675596|NCT05899829|101989869|FG000|NOT COMPLETED|Part 2 (up to Day 21)||0||
48675597|NCT05899829|101989870|FG001|NOT COMPLETED|Part 2 (up to Day 21)||6||
48675598|NCT03781414|101989871|FG000|STARTED|Overall Study||48|Full analysis set (FAS) included all patients who were transplanted and randomized, excluding mis-randomized patients.|
48675599|NCT03781414|101989872|FG001|STARTED|Overall Study||48|Full analysis set (FAS) included all patients who were transplanted and randomized, excluding mis-randomized patients.|
48675600|NCT03781414|101989873|FG002|STARTED|Overall Study||32|Full analysis set (FAS) included all patients who were transplanted and randomized, excluding mis-randomized patients.|
48675601|NCT03781414|101989871|FG000|Safety Set (SAF)|Overall Study||48|Safety Set (SAF) consisted of all patients in FAS who received at least one dose of study drug (i.e., at least one dose of TAC after randomization in the Control arm and at least one dose of CFZ533 in the CFZ533 arms).|
48675602|NCT03781414|101989872|FG001|Safety Set (SAF)|Overall Study||47|Safety Set (SAF) consisted of all patients in FAS who received at least one dose of study drug (i.e., at least one dose of TAC after randomization in the Control arm and at least one dose of CFZ533 in the CFZ533 arms).|
48675603|NCT03781414|101989873|FG002|Safety Set (SAF)|Overall Study||32|Safety Set (SAF) consisted of all patients in FAS who received at least one dose of study drug (i.e., at least one dose of TAC after randomization in the Control arm and at least one dose of CFZ533 in the CFZ533 arms).|
48675604|NCT03781414|101989871|FG000|COMPLETED|Overall Study||0||
48675605|NCT03781414|101989872|FG001|COMPLETED|Overall Study||0||
48675606|NCT03781414|101989873|FG002|COMPLETED|Overall Study||0||
48675607|NCT03781414|101989871|FG000|NOT COMPLETED|Overall Study||48||
48675608|NCT03781414|101989872|FG001|NOT COMPLETED|Overall Study||48||
48675609|NCT03781414|101989873|FG002|NOT COMPLETED|Overall Study||32||
48675610|NCT04325308|101989874|FG000|STARTED|Overall Study||75||
48675611|NCT04325308|101989875|FG001|STARTED|Overall Study||75||
48239042|NCT02143713|100906716|FG002|NOT COMPLETED|Post-treatment Follow-up (12 Months)||29||
48239043|NCT02143713|100906717|FG003|NOT COMPLETED|Post-treatment Follow-up (12 Months)||27||
48239044|NCT04374435|100906718|FG000|STARTED|Overall Study||7||
48239045|NCT04374435|100906719|FG001|STARTED|Overall Study||7||
48239046|NCT04374435|100906720|FG002|STARTED|Overall Study||3||
48239047|NCT04374435|100906718|FG000|COMPLETED|Overall Study||7||
48239048|NCT04374435|100906719|FG001|COMPLETED|Overall Study||7||
48239049|NCT04374435|100906720|FG002|COMPLETED|Overall Study||3||
48239050|NCT04374435|100906718|FG000|NOT COMPLETED|Overall Study||0||
48239051|NCT04374435|100906719|FG001|NOT COMPLETED|Overall Study||0||
48675612|NCT04325308|101989874|FG000|COMPLETED|Overall Study||52||
48675613|NCT04325308|101989875|FG001|COMPLETED|Overall Study||53||
48239052|NCT04374435|100906720|FG002|NOT COMPLETED|Overall Study||0||
48239053|NCT04540952|100906721|FG000|STARTED|Overall Study||34||
48239054|NCT04540952|100906722|FG001|STARTED|Overall Study||34||
48239055|NCT04540952|100906721|FG000|COMPLETED|Overall Study||34||
48239056|NCT04540952|100906722|FG001|COMPLETED|Overall Study||34||
48239057|NCT04540952|100906721|FG000|NOT COMPLETED|Overall Study||0||
48675614|NCT04325308|101989874|FG000|NOT COMPLETED|Overall Study||23||
48675615|NCT04325308|101989875|FG001|NOT COMPLETED|Overall Study||22||
48675616|NCT01137890|101989876|FG000|STARTED|Overall Study||14||
48675617|NCT01137890|101989877|FG001|STARTED|Overall Study||5||
48675618|NCT01137890|101989876|FG000|COMPLETED|Overall Study||8||
48675619|NCT01137890|101989877|FG001|COMPLETED|Overall Study||2||
48675620|NCT01137890|101989876|FG000|NOT COMPLETED|Overall Study||6||
48675621|NCT01137890|101989877|FG001|NOT COMPLETED|Overall Study||3||
48675622|NCT00688597|101989878|FG000|STARTED|Overall Study||3||
48675623|NCT00688597|101989879|FG001|STARTED|Overall Study||0||
48675624|NCT00688597|101989880|FG002|STARTED|Overall Study||0||
48675625|NCT00688597|101989878|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
48675626|NCT00688597|101989879|FG001|Received at Least 1 Dose of Study Drug|Overall Study||0||
48675627|NCT00688597|101989880|FG002|Received at Least 1 Dose of Study Drug|Overall Study||0||
48675628|NCT00688597|101989878|FG000|COMPLETED|Overall Study||0||
48675629|NCT00688597|101989879|FG001|COMPLETED|Overall Study||0||
48675630|NCT00688597|101989880|FG002|COMPLETED|Overall Study||0||
48675631|NCT00688597|101989878|FG000|NOT COMPLETED|Overall Study||3||
48675632|NCT00688597|101989879|FG001|NOT COMPLETED|Overall Study||0||
48239058|NCT04540952|100906722|FG001|NOT COMPLETED|Overall Study||0||
48539570|NCT03485365|101655492|FG007|COMPLETED|Overall Study||24||
48539571|NCT03485365|101655493|FG008|COMPLETED|Overall Study||24||
48539572|NCT03485365|101655485|FG000|NOT COMPLETED|Overall Study||0||
48539573|NCT03485365|101655486|FG001|NOT COMPLETED|Overall Study||0||
48539574|NCT03485365|101655487|FG002|NOT COMPLETED|Overall Study||0||
48539575|NCT03485365|101655488|FG003|NOT COMPLETED|Overall Study||1||
48539576|NCT03485365|101655489|FG004|NOT COMPLETED|Overall Study||0||
48539577|NCT03485365|101655490|FG005|NOT COMPLETED|Overall Study||0||
48539578|NCT03485365|101655491|FG006|NOT COMPLETED|Overall Study||1||
48539579|NCT03485365|101655492|FG007|NOT COMPLETED|Overall Study||0||
48539580|NCT03485365|101655493|FG008|NOT COMPLETED|Overall Study||0||
48539581|NCT02686138|101655494|FG000|STARTED|Overall Study||293||
48539582|NCT02686138|101655495|FG001|STARTED|Overall Study||300||
48539583|NCT02686138|101655494|FG000|COMPLETED|Overall Study||219||
48539584|NCT02686138|101655495|FG001|COMPLETED|Overall Study||235||
48539585|NCT02686138|101655494|FG000|NOT COMPLETED|Overall Study||74||
48539586|NCT02686138|101655495|FG001|NOT COMPLETED|Overall Study||65||
48539587|NCT02927366|101655496|FG000|STARTED|Overall Study||6|All randomized patients were included in the Safety Analysis Set (SAF).|
48539588|NCT02927366|101655497|FG001|STARTED|Overall Study||2|All randomized patients were included in the Safety Analysis Set (SAF).|
48675633|NCT00688597|101989880|FG002|NOT COMPLETED|Overall Study||0||
48675634|NCT02008617|101989881|FG000|STARTED|Overall Study||8||
48675635|NCT02008617|101989882|FG001|STARTED|Overall Study||10||
48675636|NCT02008617|101989881|FG000|COMPLETED|Overall Study||8||
48675637|NCT02008617|101989882|FG001|COMPLETED|Overall Study||10||
48675638|NCT02008617|101989881|FG000|NOT COMPLETED|Overall Study||0||
48675639|NCT02008617|101989882|FG001|NOT COMPLETED|Overall Study||0||
48675640|NCT01385579|101989883|FG000|STARTED|Overall Study||98||
48675641|NCT01385579|101989884|FG001|STARTED|Overall Study||104||
48675642|NCT01385579|101989883|FG000|COMPLETED|Overall Study||98||
48675643|NCT01385579|101989884|FG001|COMPLETED|Overall Study||104||
48675644|NCT01385579|101989883|FG000|NOT COMPLETED|Overall Study||0||
48675645|NCT01385579|101989884|FG001|NOT COMPLETED|Overall Study||0||
48675646|NCT05099263|101989885|FG000|STARTED|Overall Study||70||
48675647|NCT05099263|101989885|FG000|3-Month|Overall Study||68||
48675648|NCT05099263|101989885|FG000|6-Month|Overall Study||65||
48239059|NCT00700999|100906723|FG000|STARTED|Overall Study||36||
48239060|NCT00700999|100906724|FG001|STARTED|Overall Study||29||
48239061|NCT00700999|100906723|FG000|First MRI Scan|Overall Study||29||
48539589|NCT02927366|101655496|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||6|At least one dose of study drug and one evaluable PD assessment|
48539590|NCT02927366|101655497|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||2|At least one dose of study drug and one evaluable PD assessment|
48539591|NCT02927366|101655496|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||4|At least one dose of study drug and one evaluable PK concentration measurement|
48539592|NCT02927366|101655497|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||0|At least one dose of study drug and one evaluable PK concentration measurement|
48539593|NCT02927366|101655496|FG000|COMPLETED|Overall Study||4||
48539594|NCT02927366|101655497|FG001|COMPLETED|Overall Study||2||
48539595|NCT02927366|101655496|FG000|NOT COMPLETED|Overall Study||2||
48539596|NCT02927366|101655497|FG001|NOT COMPLETED|Overall Study||0||
48539597|NCT01178216|101655498|FG000|STARTED|Overall Study||41||
48675649|NCT05099263|101989885|FG000|12-Month|Overall Study||62||
48675650|NCT05099263|101989885|FG000|COMPLETED|Overall Study||0|A total of 70 patients were treated and 62 reached (12M Visit) 1 year. The study is still in follow-up through 36M (3 years)|
48675651|NCT05099263|101989885|FG000|NOT COMPLETED|Overall Study||70||
48239062|NCT00700999|100906724|FG001|First MRI Scan|Overall Study||22||
48675652|NCT00278161|101989886|FG000|STARTED|Overall Study||81||
48675653|NCT00278161|101989886|FG000|COMPLETED|Overall Study||70||
48675654|NCT00278161|101989886|FG000|NOT COMPLETED|Overall Study||11||
48675655|NCT03870048|101989887|FG000|STARTED|SHAM Effects on Pain and Fatigue||6||
48675656|NCT03870048|101989887|FG000|COMPLETED|SHAM Effects on Pain and Fatigue||6||
48675657|NCT03870048|101989887|FG000|NOT COMPLETED|SHAM Effects on Pain and Fatigue||0||
48675658|NCT03870048|101989887|FG000|STARTED|tDCS Effects on Pain and Fatigue||6||
48675659|NCT03870048|101989887|FG000|COMPLETED|tDCS Effects on Pain and Fatigue||6||
48675660|NCT03870048|101989887|FG000|NOT COMPLETED|tDCS Effects on Pain and Fatigue||0||
48675661|NCT01917318|101989888|FG000|STARTED|First Treatment||0||
48675662|NCT01917318|101989889|FG001|STARTED|First Treatment||1||
48675663|NCT01917318|101989888|FG000|COMPLETED|First Treatment||0||
48675664|NCT01917318|101989889|FG001|COMPLETED|First Treatment||0||
48675665|NCT01917318|101989888|FG000|NOT COMPLETED|First Treatment||0||
48675666|NCT01917318|101989889|FG001|NOT COMPLETED|First Treatment||1||
48675667|NCT01917318|101989888|FG000|STARTED|Second Treatment||0||
48675668|NCT01917318|101989889|FG001|STARTED|Second Treatment||0||
48675669|NCT01917318|101989888|FG000|COMPLETED|Second Treatment||0||
48675670|NCT01917318|101989889|FG001|COMPLETED|Second Treatment||0||
48675671|NCT01917318|101989888|FG000|NOT COMPLETED|Second Treatment||0||
48675672|NCT01917318|101989889|FG001|NOT COMPLETED|Second Treatment||0||
48675673|NCT01225952|101989890|FG000|STARTED|Overall Study||31||
48675674|NCT01225952|101989891|FG001|STARTED|Overall Study||31||
48675675|NCT01225952|101989892|FG002|STARTED|Overall Study||31||
48675676|NCT01225952|101989890|FG000|COMPLETED|Overall Study||25||
48675677|NCT01225952|101989891|FG001|COMPLETED|Overall Study||27||
48675678|NCT01225952|101989892|FG002|COMPLETED|Overall Study||25||
48675679|NCT01225952|101989890|FG000|NOT COMPLETED|Overall Study||6||
48675680|NCT01225952|101989891|FG001|NOT COMPLETED|Overall Study||4||
48675681|NCT01225952|101989892|FG002|NOT COMPLETED|Overall Study||6||
48675682|NCT02259114|101989893|FG000|STARTED|Overall Study||21||
48675683|NCT02259114|101989894|FG001|STARTED|Overall Study||4||
48675684|NCT02259114|101989895|FG002|STARTED|Overall Study||13||
48675685|NCT02259114|101989896|FG003|STARTED|Overall Study||3||
48675686|NCT02259114|101989897|FG004|STARTED|Overall Study||6||
48675687|NCT02259114|101989893|FG000|Treated|Overall Study||20||
48675688|NCT02259114|101989894|FG001|Treated|Overall Study||4||
48675689|NCT02259114|101989895|FG002|Treated|Overall Study||13||
48675690|NCT02259114|101989896|FG003|Treated|Overall Study||3||
48675691|NCT02259114|101989897|FG004|Treated|Overall Study||6||
48675692|NCT02259114|101989893|FG000|COMPLETED|Overall Study||0||
48675693|NCT02259114|101989894|FG001|COMPLETED|Overall Study||0||
48675694|NCT02259114|101989895|FG002|COMPLETED|Overall Study||0||
48675695|NCT02259114|101989896|FG003|COMPLETED|Overall Study||0||
48675696|NCT02259114|101989897|FG004|COMPLETED|Overall Study||0||
48675697|NCT02259114|101989893|FG000|NOT COMPLETED|Overall Study||21||
48675698|NCT02259114|101989894|FG001|NOT COMPLETED|Overall Study||4||
48675699|NCT02259114|101989895|FG002|NOT COMPLETED|Overall Study||13||
48675700|NCT02259114|101989896|FG003|NOT COMPLETED|Overall Study||3||
48675701|NCT02259114|101989897|FG004|NOT COMPLETED|Overall Study||6||
48675702|NCT02979587|101989898|FG000|STARTED|Overall Study||50|Number of subject implanted|
48675703|NCT02979587|101989898|FG000|Catheterized|Overall Study||50|Number of subjects catheterized with the intent to implant Harmony TPV|
48675704|NCT02979587|101989898|FG000|Implanted|Overall Study||50|Number of subjects implanted with a Harmony TPV|
48675705|NCT02979587|101989898|FG000|Implanted > 24 Hours|Overall Study||48|Number of subjects implanted successfully for at least 24 hours|
48675706|NCT02979587|101989898|FG000|COMPLETED|Overall Study||48|Subjects with evaluable data at 6 months|
48675707|NCT02979587|101989898|FG000|NOT COMPLETED|Overall Study||2||
48675708|NCT00714948|101989899|FG000|STARTED|Overall Study||2||
48675709|NCT00714948|101989899|FG000|COMPLETED|Overall Study||0||
48675710|NCT00714948|101989899|FG000|NOT COMPLETED|Overall Study||2||
48675711|NCT01077063|101989900|FG000|STARTED|Overall Study||4||
48675712|NCT01077063|101989901|FG001|STARTED|Overall Study||3||
48675713|NCT01077063|101989900|FG000|COMPLETED|Overall Study||0||
48675714|NCT01077063|101989901|FG001|COMPLETED|Overall Study||0||
48675715|NCT01077063|101989900|FG000|NOT COMPLETED|Overall Study||4||
48675716|NCT01077063|101989901|FG001|NOT COMPLETED|Overall Study||3||
48675717|NCT00461708|101989902|FG000|STARTED|Overall Study||115||
48675718|NCT00461708|101989903|FG001|STARTED|Overall Study||38||
48675719|NCT00461708|101989902|FG000|COMPLETED|Overall Study||0||
48675720|NCT00461708|101989903|FG001|COMPLETED|Overall Study||0||
48675721|NCT00461708|101989902|FG000|NOT COMPLETED|Overall Study||115||
48675722|NCT00461708|101989903|FG001|NOT COMPLETED|Overall Study||38||
48675723|NCT00279214|101989904|FG000|STARTED|Overall Study||22||
48675724|NCT00279214|101989905|FG001|STARTED|Overall Study||21||
48675725|NCT00279214|101989904|FG000|COMPLETED|Overall Study||19||
48675726|NCT00279214|101989905|FG001|COMPLETED|Overall Study||19||
48675727|NCT00279214|101989904|FG000|NOT COMPLETED|Overall Study||3||
48675728|NCT00279214|101989905|FG001|NOT COMPLETED|Overall Study||2||
48675729|NCT02301897|101989906|FG000|STARTED|Treatment Course 1||12||
48675730|NCT02301897|101989907|FG001|STARTED|Treatment Course 1||17||
48675731|NCT02301897|101989908|FG002|STARTED|Treatment Course 1||14||
48675732|NCT02301897|101989906|FG000|COMPLETED|Treatment Course 1||9||
48675733|NCT02301897|101989907|FG001|COMPLETED|Treatment Course 1||14||
48675734|NCT02301897|101989908|FG002|COMPLETED|Treatment Course 1||8||
48675735|NCT02301897|101989906|FG000|NOT COMPLETED|Treatment Course 1||3||
48675736|NCT02301897|101989907|FG001|NOT COMPLETED|Treatment Course 1||3||
48675737|NCT02301897|101989908|FG002|NOT COMPLETED|Treatment Course 1||6||
48675738|NCT02301897|101989906|FG000|STARTED|Treatment Course 2||9||
48675739|NCT02301897|101989907|FG001|STARTED|Treatment Course 2||14||
48675740|NCT02301897|101989908|FG002|STARTED|Treatment Course 2||8||
48675741|NCT02301897|101989906|FG000|COMPLETED|Treatment Course 2||8||
48675742|NCT02301897|101989907|FG001|COMPLETED|Treatment Course 2||9||
48675743|NCT02301897|101989908|FG002|COMPLETED|Treatment Course 2||7||
48675744|NCT02301897|101989906|FG000|NOT COMPLETED|Treatment Course 2||1||
48675745|NCT02301897|101989907|FG001|NOT COMPLETED|Treatment Course 2||5||
48675746|NCT02301897|101989908|FG002|NOT COMPLETED|Treatment Course 2||1||
48675747|NCT05067335|101989909|FG000|STARTED|Double-blind Period: Day 1 - Month 6||109||
48675748|NCT05067335|101989910|FG001|STARTED|Double-blind Period: Day 1 - Month 6||218||
48675749|NCT05067335|101989911|FG002|STARTED|Double-blind Period: Day 1 - Month 6||0||
48675750|NCT05067335|101989912|FG003|STARTED|Double-blind Period: Day 1 - Month 6||0||
48675751|NCT05067335|101989909|FG000|COMPLETED|Double-blind Period: Day 1 - Month 6||100||
48675752|NCT05067335|101989910|FG001|COMPLETED|Double-blind Period: Day 1 - Month 6||204||
48675753|NCT05067335|101989911|FG002|COMPLETED|Double-blind Period: Day 1 - Month 6||0||
48675754|NCT05067335|101989912|FG003|COMPLETED|Double-blind Period: Day 1 - Month 6||0||
48675755|NCT05067335|101989909|FG000|NOT COMPLETED|Double-blind Period: Day 1 - Month 6||9||
48675756|NCT05067335|101989910|FG001|NOT COMPLETED|Double-blind Period: Day 1 - Month 6||14||
48675757|NCT05067335|101989911|FG002|NOT COMPLETED|Double-blind Period: Day 1 - Month 6||0||
48675758|NCT05067335|101989912|FG003|NOT COMPLETED|Double-blind Period: Day 1 - Month 6||0||
48675759|NCT05067335|101989909|FG000|STARTED|Open-label Period: Month 7 - 12||0||
48675760|NCT05067335|101989910|FG001|STARTED|Open-label Period: Month 7 - 12||0||
48675761|NCT05067335|101989911|FG002|STARTED|Open-label Period: Month 7 - 12||99||
48675762|NCT05067335|101989912|FG003|STARTED|Open-label Period: Month 7 - 12||204||
48675763|NCT05067335|101989909|FG000|COMPLETED|Open-label Period: Month 7 - 12||0||
48675764|NCT05067335|101989910|FG001|COMPLETED|Open-label Period: Month 7 - 12||0||
48675765|NCT05067335|101989911|FG002|COMPLETED|Open-label Period: Month 7 - 12||93||
48675766|NCT05067335|101989912|FG003|COMPLETED|Open-label Period: Month 7 - 12||199||
48675767|NCT05067335|101989909|FG000|NOT COMPLETED|Open-label Period: Month 7 - 12||0||
48675768|NCT05067335|101989910|FG001|NOT COMPLETED|Open-label Period: Month 7 - 12||0||
48675769|NCT05067335|101989911|FG002|NOT COMPLETED|Open-label Period: Month 7 - 12||6||
48675770|NCT05067335|101989912|FG003|NOT COMPLETED|Open-label Period: Month 7 - 12||5||
48675771|NCT02951780|101989913|FG000|STARTED|Period 1||3||
48675772|NCT02951780|101989914|FG001|STARTED|Period 1||2||
48675773|NCT02951780|101989915|FG002|STARTED|Period 1||3||
48239063|NCT00700999|100906723|FG000|Second MRI Scan|Overall Study||19||
48239064|NCT00700999|100906724|FG001|Second MRI Scan|Overall Study||18||
48239065|NCT00700999|100906723|FG000|COMPLETED|Overall Study||21||
48239066|NCT00700999|100906724|FG001|COMPLETED|Overall Study||20||
48239067|NCT00700999|100906723|FG000|NOT COMPLETED|Overall Study||15||
48239068|NCT00700999|100906724|FG001|NOT COMPLETED|Overall Study||9||
48239069|NCT04954833|100906725|FG000|STARTED|Period 1||28||
48239070|NCT04954833|100906726|FG001|STARTED|Period 1||29||
48539598|NCT01178216|101655498|FG000|COMPLETED|Overall Study||39||
48539599|NCT01178216|101655498|FG000|NOT COMPLETED|Overall Study||2||
48239071|NCT04954833|100906725|FG000|COMPLETED|Period 1||28||
48239072|NCT04954833|100906726|FG001|COMPLETED|Period 1||29||
48239073|NCT04954833|100906725|FG000|NOT COMPLETED|Period 1||0||
48239074|NCT04954833|100906726|FG001|NOT COMPLETED|Period 1||0||
48239075|NCT04954833|100906725|FG000|STARTED|Period 2||28||
48539600|NCT00576316|101655499|FG000|STARTED|Overall Study||201||
48539601|NCT00576316|101655499|FG000|COMPLETED|Overall Study||181||
48539602|NCT00576316|101655499|FG000|NOT COMPLETED|Overall Study||20||
48539603|NCT05199090|101655500|FG000|STARTED|Overall Study||14||
48539604|NCT05199090|101655501|FG001|STARTED|Overall Study||22||
48539605|NCT05199090|101655502|FG002|STARTED|Overall Study||16||
48539606|NCT05199090|101655503|FG003|STARTED|Overall Study||15||
48539607|NCT05199090|101655504|FG004|STARTED|Overall Study||15||
48675774|NCT02951780|101989916|FG003|STARTED|Period 1||3||
48141207|NCT01260350|100670366|FG004|STARTED|Overall Study||10||
48239076|NCT04954833|100906726|FG001|STARTED|Period 2||29||
48239077|NCT04954833|100906725|FG000|COMPLETED|Period 2||28||
48239078|NCT04954833|100906726|FG001|COMPLETED|Period 2||29||
48539608|NCT05199090|101655505|FG005|STARTED|Overall Study||44||
48539609|NCT05199090|101655500|FG000|COMPLETED|Overall Study||12||
48539610|NCT05199090|101655501|FG001|COMPLETED|Overall Study||8||
48539611|NCT05199090|101655502|FG002|COMPLETED|Overall Study||15||
48539612|NCT05199090|101655503|FG003|COMPLETED|Overall Study||9||
48539613|NCT05199090|101655504|FG004|COMPLETED|Overall Study||10||
48239079|NCT04954833|100906725|FG000|NOT COMPLETED|Period 2||0||
48239080|NCT04954833|100906726|FG001|NOT COMPLETED|Period 2||0||
48239081|NCT01535261|100906727|FG000|STARTED|Overall Study||357||
48239082|NCT01535261|100906727|FG000|COMPLETED|Overall Study||307||
48239083|NCT01535261|100906727|FG000|NOT COMPLETED|Overall Study||50||
48539614|NCT05199090|101655505|FG005|COMPLETED|Overall Study||31||
48675775|NCT02951780|101989917|FG004|STARTED|Period 1||2||
48675776|NCT02951780|101989918|FG005|STARTED|Period 1||3||
48675777|NCT02951780|101989919|FG006|STARTED|Period 1||2||
48675778|NCT02951780|101989920|FG007|STARTED|Period 1||3||
48675779|NCT02951780|101989921|FG008|STARTED|Period 1||2||
48675780|NCT02951780|101989913|FG000|COMPLETED|Period 1||3||
48675781|NCT02951780|101989914|FG001|COMPLETED|Period 1||2||
48675782|NCT02951780|101989915|FG002|COMPLETED|Period 1||3||
48675783|NCT02951780|101989916|FG003|COMPLETED|Period 1||2||
48675784|NCT02951780|101989917|FG004|COMPLETED|Period 1||2||
48675785|NCT02951780|101989918|FG005|COMPLETED|Period 1||3||
48675786|NCT02951780|101989919|FG006|COMPLETED|Period 1||2||
48675787|NCT02951780|101989920|FG007|COMPLETED|Period 1||2||
48675788|NCT02951780|101989921|FG008|COMPLETED|Period 1||2||
48675789|NCT02951780|101989913|FG000|NOT COMPLETED|Period 1||0||
48675790|NCT02951780|101989914|FG001|NOT COMPLETED|Period 1||0||
48675791|NCT02951780|101989915|FG002|NOT COMPLETED|Period 1||0||
48675792|NCT02951780|101989916|FG003|NOT COMPLETED|Period 1||1||
48675793|NCT02951780|101989917|FG004|NOT COMPLETED|Period 1||0||
48239084|NCT04555694|100906728|FG000|STARTED|Overall Study||10||20
48239085|NCT04555694|100906729|FG001|STARTED|Overall Study||10||20
48239086|NCT04555694|100906730|FG002|STARTED|Overall Study||10||20
48539615|NCT05199090|101655500|FG000|NOT COMPLETED|Overall Study||2||
48539616|NCT05199090|101655501|FG001|NOT COMPLETED|Overall Study||14||
48539617|NCT05199090|101655502|FG002|NOT COMPLETED|Overall Study||1||
48539618|NCT05199090|101655503|FG003|NOT COMPLETED|Overall Study||6||
48539619|NCT05199090|101655504|FG004|NOT COMPLETED|Overall Study||5||
48539620|NCT05199090|101655505|FG005|NOT COMPLETED|Overall Study||13||
48539621|NCT03769714|101657896|FG000|STARTED|Overall Study||30||
48539622|NCT03769714|101657897|FG001|STARTED|Overall Study||30||
48539623|NCT03769714|101657896|FG000|COMPLETED|Overall Study||30||
48539624|NCT03769714|101657897|FG001|COMPLETED|Overall Study||30||
48539625|NCT03769714|101657896|FG000|NOT COMPLETED|Overall Study||0||
48539626|NCT03769714|101657897|FG001|NOT COMPLETED|Overall Study||0||
48539627|NCT03047330|101657898|FG000|STARTED|Sleep Block 1||41||
48539628|NCT03047330|101657898|FG000|COMPLETED|Sleep Block 1||38||
48539629|NCT03047330|101657898|FG000|NOT COMPLETED|Sleep Block 1||3||
48539630|NCT03047330|101657898|FG000|STARTED|Sleep Block 2||27||
48539631|NCT03047330|101657898|FG000|COMPLETED|Sleep Block 2||27||
48539632|NCT03047330|101657898|FG000|NOT COMPLETED|Sleep Block 2||0||
48539633|NCT00767624|101657899|FG000|STARTED|Overall Study||75||
48539634|NCT00767624|101657900|FG001|STARTED|Overall Study||75||
48539635|NCT00767624|101657899|FG000|COMPLETED|Overall Study||51||
48539636|NCT00767624|101657900|FG001|COMPLETED|Overall Study||58||
48539637|NCT00767624|101657899|FG000|NOT COMPLETED|Overall Study||24||
48539638|NCT00767624|101657900|FG001|NOT COMPLETED|Overall Study||17||
48539639|NCT01143766|101657901|FG000|STARTED|Overall Study||25||
48539640|NCT01143766|101657902|FG001|STARTED|Overall Study||31||
48539641|NCT01143766|101657901|FG000|COMPLETED|Overall Study||25||
48539642|NCT01143766|101657902|FG001|COMPLETED|Overall Study||31||
48539643|NCT01143766|101657901|FG000|NOT COMPLETED|Overall Study||0||
48539644|NCT01143766|101657902|FG001|NOT COMPLETED|Overall Study||0||
48675794|NCT02951780|101989918|FG005|NOT COMPLETED|Period 1||0||
48675795|NCT02951780|101989919|FG006|NOT COMPLETED|Period 1||0||
48675796|NCT02951780|101989920|FG007|NOT COMPLETED|Period 1||1||
48675797|NCT02951780|101989921|FG008|NOT COMPLETED|Period 1||0||
48675798|NCT02951780|101989913|FG000|STARTED|Period 2||3||
48675799|NCT02951780|101989914|FG001|STARTED|Period 2||2||
48675800|NCT02951780|101989915|FG002|STARTED|Period 2||3||
48675801|NCT02951780|101989916|FG003|STARTED|Period 2||2||
48675802|NCT02951780|101989917|FG004|STARTED|Period 2||2||
48675803|NCT02951780|101989918|FG005|STARTED|Period 2||3||
48675804|NCT02951780|101989919|FG006|STARTED|Period 2||2||
48675805|NCT02951780|101989920|FG007|STARTED|Period 2||2||
48239087|NCT04555694|100906728|FG000|COMPLETED|Overall Study||10||20
48239088|NCT04555694|100906729|FG001|COMPLETED|Overall Study||10||20
48239089|NCT04555694|100906730|FG002|COMPLETED|Overall Study||10||20
48239090|NCT04555694|100906728|FG000|NOT COMPLETED|Overall Study||0||0
48539645|NCT02315430|101657903|FG000|STARTED|Overall Study||13||
48539646|NCT02315430|101657903|FG000|COMPLETED|Overall Study||13||
48539647|NCT02315430|101657903|FG000|NOT COMPLETED|Overall Study||0||
48539648|NCT02111603|101657904|FG000|STARTED|Overall Study||13||
48539649|NCT02111603|101657904|FG000|COMPLETED|Overall Study||12||
48675806|NCT02951780|101989921|FG008|STARTED|Period 2||2||
48239091|NCT04555694|100906729|FG001|NOT COMPLETED|Overall Study||0||0
48539650|NCT02111603|101657904|FG000|NOT COMPLETED|Overall Study||1||
48239092|NCT04555694|100906730|FG002|NOT COMPLETED|Overall Study||0||0
48239093|NCT02659059|100906731|FG000|STARTED|Overall Study||288||
48539651|NCT04480021|101657905|FG000|STARTED|Overall Study||49||
48675807|NCT02951780|101989913|FG000|COMPLETED|Period 2||3||
48675808|NCT02951780|101989914|FG001|COMPLETED|Period 2||2||
48675809|NCT02951780|101989915|FG002|COMPLETED|Period 2||3||
48675810|NCT02951780|101989916|FG003|COMPLETED|Period 2||2||
48675811|NCT02951780|101989917|FG004|COMPLETED|Period 2||2||
48675812|NCT02951780|101989918|FG005|COMPLETED|Period 2||3||
48675813|NCT02951780|101989919|FG006|COMPLETED|Period 2||2||
48675814|NCT02951780|101989920|FG007|COMPLETED|Period 2||1||
48675815|NCT02951780|101989921|FG008|COMPLETED|Period 2||2||
48539652|NCT04480021|101657906|FG001|STARTED|Overall Study||36||
48539653|NCT04480021|101657905|FG000|COMPLETED|Overall Study||46||
48539654|NCT04480021|101657906|FG001|COMPLETED|Overall Study||32||
48539655|NCT04480021|101657905|FG000|NOT COMPLETED|Overall Study||3||
48539656|NCT04480021|101657906|FG001|NOT COMPLETED|Overall Study||4||
48539657|NCT01544179|101657907|FG000|STARTED|Overall Study||133||
48539658|NCT01544179|101657908|FG001|STARTED|Overall Study||132||
48539659|NCT01544179|101657907|FG000|Received Treatment|Overall Study||132||
48539660|NCT01544179|101657908|FG001|Received Treatment|Overall Study||132||
48539661|NCT01544179|101657907|FG000|Did Not Receive Treatment|Overall Study||1||
48539662|NCT01544179|101657908|FG001|Did Not Receive Treatment|Overall Study||0||
48675816|NCT02951780|101989913|FG000|NOT COMPLETED|Period 2||0||
48675817|NCT02951780|101989914|FG001|NOT COMPLETED|Period 2||0||
48675818|NCT02951780|101989915|FG002|NOT COMPLETED|Period 2||0||
48675819|NCT02951780|101989916|FG003|NOT COMPLETED|Period 2||0||
48675820|NCT02951780|101989917|FG004|NOT COMPLETED|Period 2||0||
48675821|NCT02951780|101989918|FG005|NOT COMPLETED|Period 2||0||
48675822|NCT02951780|101989919|FG006|NOT COMPLETED|Period 2||0||
48675823|NCT02951780|101989920|FG007|NOT COMPLETED|Period 2||1||
48675824|NCT02951780|101989921|FG008|NOT COMPLETED|Period 2||0||
48539663|NCT01544179|101657907|FG000|COMPLETED|Overall Study||70||
48539664|NCT01544179|101657908|FG001|COMPLETED|Overall Study||86||
48539665|NCT01544179|101657907|FG000|NOT COMPLETED|Overall Study||63||
48675825|NCT02951780|101989913|FG000|STARTED|Period 3||3||
48675826|NCT02951780|101989914|FG001|STARTED|Period 3||2||
48675827|NCT02951780|101989915|FG002|STARTED|Period 3||3||
48675828|NCT02951780|101989916|FG003|STARTED|Period 3||2||
48675829|NCT02951780|101989917|FG004|STARTED|Period 3||2||
48675830|NCT02951780|101989918|FG005|STARTED|Period 3||3||
48675831|NCT02951780|101989919|FG006|STARTED|Period 3||2||
48675832|NCT02951780|101989920|FG007|STARTED|Period 3||1||
48675833|NCT02951780|101989921|FG008|STARTED|Period 3||2||
48675834|NCT02951780|101989913|FG000|COMPLETED|Period 3||3||
48675835|NCT02951780|101989914|FG001|COMPLETED|Period 3||2||
48675836|NCT02951780|101989915|FG002|COMPLETED|Period 3||3||
48675837|NCT02951780|101989916|FG003|COMPLETED|Period 3||2||
48675838|NCT02951780|101989917|FG004|COMPLETED|Period 3||2||
48675839|NCT02951780|101989918|FG005|COMPLETED|Period 3||3||
48675840|NCT02951780|101989919|FG006|COMPLETED|Period 3||2||
48675841|NCT02951780|101989920|FG007|COMPLETED|Period 3||1||
48675842|NCT02951780|101989921|FG008|COMPLETED|Period 3||2||
48675843|NCT02951780|101989913|FG000|NOT COMPLETED|Period 3||0||
48675844|NCT02951780|101989914|FG001|NOT COMPLETED|Period 3||0||
48675845|NCT02951780|101989915|FG002|NOT COMPLETED|Period 3||0||
48675846|NCT02951780|101989916|FG003|NOT COMPLETED|Period 3||0||
48675847|NCT02951780|101989917|FG004|NOT COMPLETED|Period 3||0||
48675848|NCT02951780|101989918|FG005|NOT COMPLETED|Period 3||0||
48675849|NCT02951780|101989919|FG006|NOT COMPLETED|Period 3||0||
48675850|NCT02951780|101989920|FG007|NOT COMPLETED|Period 3||0||
48675851|NCT02951780|101989921|FG008|NOT COMPLETED|Period 3||0||
48675852|NCT04378153|101989922|FG000|STARTED|Overall Study||987||
48675853|NCT04378153|101989922|FG000|COMPLETED|Overall Study||903||
48675854|NCT04378153|101989922|FG000|NOT COMPLETED|Overall Study||84||
48675855|NCT02411461|101989923|FG000|STARTED|Overall Study||16||
48675856|NCT02411461|101989924|FG001|STARTED|Overall Study||8||
48675857|NCT02411461|101989925|FG002|STARTED|Overall Study||15||
48675858|NCT02411461|101989923|FG000|COMPLETED|Overall Study||16||
48675859|NCT02411461|101989924|FG001|COMPLETED|Overall Study||8||
48675860|NCT02411461|101989925|FG002|COMPLETED|Overall Study||15||
48081067|NCT03129100|100521619|FG006|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
48081068|NCT03129100|100521620|FG007|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
48081069|NCT03129100|100521621|FG008|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
48081070|NCT03129100|100521622|FG009|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
48081071|NCT03129100|100521623|FG010|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
48081072|NCT03129100|100521624|FG011|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
48539666|NCT01544179|101657908|FG001|NOT COMPLETED|Overall Study||46||
48539667|NCT01860677|101657909|FG000|STARTED|First Intervention (1 Day)||8||
48539668|NCT01860677|101657910|FG001|STARTED|First Intervention (1 Day)||0||
48675861|NCT02411461|101989923|FG000|NOT COMPLETED|Overall Study||0||
48675862|NCT02411461|101989924|FG001|NOT COMPLETED|Overall Study||0||
48675863|NCT02411461|101989925|FG002|NOT COMPLETED|Overall Study||0||
48675864|NCT01918189|101989926|FG000|STARTED|Overall Study||59|59 participants enrolled (i.e., signed informed consent) but 58 completed baseline assessment.|
48675865|NCT01918189|101989926|FG000|Completed Baseline Assessment|Overall Study||58||
48675866|NCT01918189|101989926|FG000|Completed Follow-up Assessment|Overall Study||41||
48675867|NCT01918189|101989926|FG000|COMPLETED|Overall Study||41||
48675868|NCT01918189|101989926|FG000|NOT COMPLETED|Overall Study||18||
48675869|NCT03728933|101989927|FG000|STARTED|Overall Study||8||
48675870|NCT03728933|101989928|FG001|STARTED|Overall Study||8||
48675871|NCT03728933|101989929|FG002|STARTED|Overall Study||7||
48675872|NCT03728933|101989927|FG000|COMPLETED|Overall Study||5||
48675873|NCT03728933|101989928|FG001|COMPLETED|Overall Study||7||
48675874|NCT03728933|101989929|FG002|COMPLETED|Overall Study||6||
48239094|NCT02659059|100906732|FG001|STARTED|Overall Study||36||
48239095|NCT02659059|100906731|FG000|COMPLETED|Overall Study||37||
48239096|NCT02659059|100906732|FG001|COMPLETED|Overall Study||4||
48239097|NCT02659059|100906731|FG000|NOT COMPLETED|Overall Study||251||
48239098|NCT02659059|100906732|FG001|NOT COMPLETED|Overall Study||32||
48239099|NCT00538629|100906733|FG000|STARTED|Overall Study||471||
48239100|NCT00538629|100906733|FG000|COMPLETED|Overall Study||449||
48239101|NCT00538629|100906733|FG000|NOT COMPLETED|Overall Study||22||
48239102|NCT00396409|100906734|FG000|STARTED|Period 1 - 2007||65||
48239103|NCT00396409|100906735|FG001|STARTED|Period 1 - 2007||63||
48239104|NCT00396409|100906734|FG000|COMPLETED|Period 1 - 2007||62||
48239105|NCT00396409|100906735|FG001|COMPLETED|Period 1 - 2007||57||
48239106|NCT00396409|100906734|FG000|NOT COMPLETED|Period 1 - 2007||3||
48239107|NCT00396409|100906735|FG001|NOT COMPLETED|Period 1 - 2007||6||
48239108|NCT00396409|100906734|FG000|STARTED|Between Period 1 and Period 2||62||
48239109|NCT00396409|100906735|FG001|STARTED|Between Period 1 and Period 2||57||
48239110|NCT00396409|100906734|FG000|COMPLETED|Between Period 1 and Period 2||59||
48239111|NCT00396409|100906735|FG001|COMPLETED|Between Period 1 and Period 2||55||
48239112|NCT00396409|100906734|FG000|NOT COMPLETED|Between Period 1 and Period 2||3||
48239113|NCT00396409|100906735|FG001|NOT COMPLETED|Between Period 1 and Period 2||2||
48239114|NCT00396409|100906734|FG000|STARTED|Period 2 - 2008||59||
48239115|NCT00396409|100906735|FG001|STARTED|Period 2 - 2008||55||
48239116|NCT00396409|100906734|FG000|COMPLETED|Period 2 - 2008||52||
48239117|NCT00396409|100906735|FG001|COMPLETED|Period 2 - 2008||53||
48239118|NCT00396409|100906734|FG000|NOT COMPLETED|Period 2 - 2008||7||
48239119|NCT00396409|100906735|FG001|NOT COMPLETED|Period 2 - 2008||2||
48239120|NCT01587703|100906736|FG000|STARTED|Part1 QD(Median Exposure of 1.38months)||3||
48239121|NCT01587703|100906737|FG001|STARTED|Part1 QD(Median Exposure of 1.38months)||4||
48239122|NCT01587703|100906738|FG002|STARTED|Part1 QD(Median Exposure of 1.38months)||1||
48239123|NCT01587703|100906739|FG003|STARTED|Part1 QD(Median Exposure of 1.38months)||3||
48239124|NCT01587703|100906740|FG004|STARTED|Part1 QD(Median Exposure of 1.38months)||4||
48239125|NCT01587703|100906741|FG005|STARTED|Part1 QD(Median Exposure of 1.38months)||9||
48239126|NCT01587703|100906742|FG006|STARTED|Part1 QD(Median Exposure of 1.38months)||32||
48239127|NCT01587703|100906743|FG007|STARTED|Part1 QD(Median Exposure of 1.38months)||9||
48239128|NCT01587703|100906744|FG008|STARTED|Part1 QD(Median Exposure of 1.38months)||0||
48239129|NCT01587703|100906745|FG009|STARTED|Part1 QD(Median Exposure of 1.38months)||0||
48239130|NCT01587703|100906746|FG010|STARTED|Part1 QD(Median Exposure of 1.38months)||0||
48239131|NCT01587703|100906747|FG011|STARTED|Part1 QD(Median Exposure of 1.38months)||0||
48239132|NCT01587703|100906748|FG012|STARTED|Part1 QD(Median Exposure of 1.38months)||0||
48239133|NCT01587703|100906749|FG013|STARTED|Part1 QD(Median Exposure of 1.38months)||0||
48239134|NCT01587703|100906750|FG014|STARTED|Part1 QD(Median Exposure of 1.38months)||0||
48239135|NCT01587703|100906751|FG015|STARTED|Part1 QD(Median Exposure of 1.38months)||0||
48239136|NCT01587703|100906752|FG016|STARTED|Part1 QD(Median Exposure of 1.38months)||0||
48239137|NCT01587703|100906753|FG017|STARTED|Part1 QD(Median Exposure of 1.38months)||0||
48239138|NCT01587703|100906754|FG018|STARTED|Part1 QD(Median Exposure of 1.38months)||0||
48239139|NCT01587703|100906736|FG000|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
48239140|NCT01587703|100906737|FG001|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
48239141|NCT01587703|100906738|FG002|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
48239142|NCT01587703|100906739|FG003|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
48239143|NCT01587703|100906740|FG004|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
48239144|NCT01587703|100906741|FG005|COMPLETED|Part1 QD(Median Exposure of 1.38months)||1||
48239145|NCT01587703|100906742|FG006|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
48239146|NCT01587703|100906743|FG007|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
48239147|NCT01587703|100906744|FG008|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
48239148|NCT01587703|100906745|FG009|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
48239149|NCT01587703|100906746|FG010|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
48239150|NCT01587703|100906747|FG011|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
48239151|NCT01587703|100906748|FG012|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
48239152|NCT01587703|100906749|FG013|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
48239153|NCT01587703|100906750|FG014|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
48239154|NCT01587703|100906751|FG015|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
48239155|NCT01587703|100906752|FG016|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
48239156|NCT01587703|100906753|FG017|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
48239157|NCT01587703|100906754|FG018|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
48239158|NCT01587703|100906736|FG000|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||3||
48239159|NCT01587703|100906737|FG001|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||4||
48239160|NCT01587703|100906738|FG002|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||1||
48239161|NCT01587703|100906739|FG003|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||3||
48239162|NCT01587703|100906740|FG004|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||4||
48239163|NCT01587703|100906741|FG005|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||8||
48239164|NCT01587703|100906742|FG006|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||32||
48239165|NCT01587703|100906743|FG007|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||9||
48539669|NCT01860677|101657909|FG000|COMPLETED|First Intervention (1 Day)||8||
48592676|NCT01877382|101783163|FG013|STARTED|Dose Expansion||0||
48239166|NCT01587703|100906744|FG008|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
48239167|NCT01587703|100906745|FG009|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
48239168|NCT01587703|100906746|FG010|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
48239169|NCT01587703|100906747|FG011|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
48239170|NCT01587703|100906748|FG012|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
48239171|NCT01587703|100906749|FG013|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
48239172|NCT01587703|100906750|FG014|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
48239173|NCT01587703|100906751|FG015|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
48239174|NCT01587703|100906752|FG016|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
48239175|NCT01587703|100906753|FG017|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
48239176|NCT01587703|100906754|FG018|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
48239177|NCT01587703|100906736|FG000|STARTED|Part1 BID(Median Exposure of 1.41months)||0||
48239178|NCT01587703|100906737|FG001|STARTED|Part1 BID(Median Exposure of 1.41months)||0||
48239179|NCT01587703|100906738|FG002|STARTED|Part1 BID(Median Exposure of 1.41months)||0||
48239180|NCT01587703|100906739|FG003|STARTED|Part1 BID(Median Exposure of 1.41months)||0||
48239181|NCT01587703|100906740|FG004|STARTED|Part1 BID(Median Exposure of 1.41months)||0||
48239182|NCT01587703|100906741|FG005|STARTED|Part1 BID(Median Exposure of 1.41months)||0||
48239183|NCT01587703|100906742|FG006|STARTED|Part1 BID(Median Exposure of 1.41months)||0||
48239184|NCT01587703|100906743|FG007|STARTED|Part1 BID(Median Exposure of 1.41months)||0||
48239185|NCT01587703|100906744|FG008|STARTED|Part1 BID(Median Exposure of 1.41months)||4||
48539670|NCT01860677|101657910|FG001|COMPLETED|First Intervention (1 Day)||0||
48539671|NCT01860677|101657909|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48539672|NCT01860677|101657910|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48539673|NCT01860677|101657909|FG000|STARTED|Second Intervention (1 Day)||8||
48675875|NCT03728933|101989927|FG000|NOT COMPLETED|Overall Study||3||
48675876|NCT03728933|101989928|FG001|NOT COMPLETED|Overall Study||1||
48675877|NCT03728933|101989929|FG002|NOT COMPLETED|Overall Study||1||
48539674|NCT01860677|101657910|FG001|STARTED|Second Intervention (1 Day)||0||
48539675|NCT01860677|101657909|FG000|COMPLETED|Second Intervention (1 Day)||1||
48539676|NCT01860677|101657910|FG001|COMPLETED|Second Intervention (1 Day)||0||
48539677|NCT01860677|101657909|FG000|NOT COMPLETED|Second Intervention (1 Day)||7||
48539678|NCT01860677|101657910|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48539679|NCT01182376|101657911|FG000|STARTED|Overall Study||15||
48675878|NCT01935947|101989930|FG000|STARTED|Overall Study||4||
48675879|NCT01935947|101989931|FG001|STARTED|Overall Study||4||
48675880|NCT01935947|101989932|FG002|STARTED|Overall Study||2||
48539680|NCT01182376|101657912|FG001|STARTED|Overall Study||18||
48539681|NCT01182376|101657911|FG000|COMPLETED|Overall Study||4||
48539682|NCT01182376|101657912|FG001|COMPLETED|Overall Study||13||
48675881|NCT01935947|101989930|FG000|Epigenetic Therapy|Overall Study||4||
48675882|NCT01935947|101989931|FG001|Epigenetic Therapy|Overall Study||4||
48239186|NCT01587703|100906745|FG009|STARTED|Part1 BID(Median Exposure of 1.41months)||10||
48539683|NCT01182376|101657911|FG000|NOT COMPLETED|Overall Study||11||
48539684|NCT01182376|101657912|FG001|NOT COMPLETED|Overall Study||5||
48539685|NCT00866879|101657913|FG000|STARTED|Overall Study||90||
48539686|NCT00866879|101657914|FG001|STARTED|Overall Study||185||
48539687|NCT00866879|101657913|FG000|COMPLETED|Overall Study||90||
48539688|NCT00866879|101657914|FG001|COMPLETED|Overall Study||185||
48539689|NCT00866879|101657913|FG000|NOT COMPLETED|Overall Study||0||
48539690|NCT00866879|101657914|FG001|NOT COMPLETED|Overall Study||0||
48539691|NCT00205803|101657915|FG000|STARTED|Infant Series||122||
48539692|NCT00205803|101657916|FG001|STARTED|Infant Series||127||
48539693|NCT00205803|101657915|FG000|Vaccinated Dose 1|Infant Series||121||
48539694|NCT00205803|101657916|FG001|Vaccinated Dose 1|Infant Series||126||
48539695|NCT00205803|101657915|FG000|Vaccinated Dose 2|Infant Series||115||
48539696|NCT00205803|101657916|FG001|Vaccinated Dose 2|Infant Series||122||
48539697|NCT00205803|101657915|FG000|Vaccinated Dose 3|Infant Series||110||
48539698|NCT00205803|101657916|FG001|Vaccinated Dose 3|Infant Series||118||
48539699|NCT00205803|101657915|FG000|COMPLETED|Infant Series||104||
48675883|NCT01935947|101989932|FG002|Epigenetic Therapy|Overall Study||0||
48239187|NCT01587703|100906746|FG010|STARTED|Part1 BID(Median Exposure of 1.41months)||5||
48239188|NCT01587703|100906747|FG011|STARTED|Part1 BID(Median Exposure of 1.41months)||0||
48239189|NCT01587703|100906748|FG012|STARTED|Part1 BID(Median Exposure of 1.41months)||0||
48239190|NCT01587703|100906749|FG013|STARTED|Part1 BID(Median Exposure of 1.41months)||0||
48239191|NCT01587703|100906750|FG014|STARTED|Part1 BID(Median Exposure of 1.41months)||0||
48675884|NCT01935947|101989930|FG000|Cytotoxic Therapy|Overall Study||3||
48675885|NCT01935947|101989931|FG001|Cytotoxic Therapy|Overall Study||3||
48675886|NCT01935947|101989932|FG002|Cytotoxic Therapy|Overall Study||2||
48675887|NCT01935947|101989930|FG000|COMPLETED|Overall Study||1||
48675888|NCT01935947|101989931|FG001|COMPLETED|Overall Study||0||
48675889|NCT01935947|101989932|FG002|COMPLETED|Overall Study||0||
48675890|NCT01935947|101989930|FG000|NOT COMPLETED|Overall Study||3||
48675891|NCT01935947|101989931|FG001|NOT COMPLETED|Overall Study||4||
48675892|NCT01935947|101989932|FG002|NOT COMPLETED|Overall Study||2||
48675893|NCT01991860|101989933|FG000|STARTED|Overall Study||176||
48675894|NCT01991860|101989934|FG001|STARTED|Overall Study||166||
48675895|NCT01991860|101989933|FG000|COMPLETED|Overall Study||172||
48675896|NCT01991860|101989934|FG001|COMPLETED|Overall Study||164||
48675897|NCT01991860|101989933|FG000|NOT COMPLETED|Overall Study||4||
48675898|NCT01991860|101989934|FG001|NOT COMPLETED|Overall Study||2||
48239192|NCT01587703|100906751|FG015|STARTED|Part1 BID(Median Exposure of 1.41months)||0||
48239193|NCT01587703|100906752|FG016|STARTED|Part1 BID(Median Exposure of 1.41months)||0||
48239194|NCT01587703|100906753|FG017|STARTED|Part1 BID(Median Exposure of 1.41months)||0||
48239195|NCT01587703|100906754|FG018|STARTED|Part1 BID(Median Exposure of 1.41months)||0||
48239196|NCT01587703|100906736|FG000|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
48239197|NCT01587703|100906737|FG001|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
48239198|NCT01587703|100906738|FG002|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
48239199|NCT01587703|100906739|FG003|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
48239200|NCT01587703|100906740|FG004|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
48239201|NCT01587703|100906741|FG005|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
48239202|NCT01587703|100906742|FG006|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
48239203|NCT01587703|100906743|FG007|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
48239204|NCT01587703|100906744|FG008|COMPLETED|Part1 BID(Median Exposure of 1.41months)||1||
48239205|NCT01587703|100906745|FG009|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
48239206|NCT01587703|100906746|FG010|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
48239207|NCT01587703|100906747|FG011|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
48239208|NCT01587703|100906748|FG012|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
48239209|NCT01587703|100906749|FG013|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
48239210|NCT01587703|100906750|FG014|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
48239211|NCT01587703|100906751|FG015|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
48239212|NCT01587703|100906752|FG016|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
48239213|NCT01587703|100906753|FG017|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
48675899|NCT05089292|101989935|FG000|STARTED|Overall Study||99||
48675900|NCT05089292|101989935|FG000|COMPLETED|Overall Study||99||
48675901|NCT05089292|101989935|FG000|NOT COMPLETED|Overall Study||0||
48675902|NCT01846702|101989936|FG000|STARTED|Overall Study||6||
48675903|NCT01846702|101989937|FG001|STARTED|Overall Study||6||
48675904|NCT01846702|101989938|FG002|STARTED|Overall Study||7||
48675905|NCT01846702|101989939|FG003|STARTED|Overall Study||6||
48675906|NCT01846702|101989940|FG004|STARTED|Overall Study||6||
48675907|NCT01846702|101989941|FG005|STARTED|Overall Study||6||
48675908|NCT01846702|101989942|FG006|STARTED|Overall Study||6||
48675909|NCT01846702|101989936|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
48675910|NCT01846702|101989937|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
48675911|NCT01846702|101989938|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
48239214|NCT01587703|100906754|FG018|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
48239215|NCT01587703|100906736|FG000|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
48239216|NCT01587703|100906737|FG001|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
48239217|NCT01587703|100906738|FG002|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
48675912|NCT01846702|101989939|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6||
48675913|NCT01846702|101989940|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6||
48239218|NCT01587703|100906739|FG003|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
48239219|NCT01587703|100906740|FG004|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
48239220|NCT01587703|100906741|FG005|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
48675914|NCT01846702|101989941|FG005|Received at Least 1 Dose of Study Drug|Overall Study||6||
48675915|NCT01846702|101989942|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6||
48675916|NCT01846702|101989936|FG000|COMPLETED|Overall Study||6||
48675917|NCT01846702|101989937|FG001|COMPLETED|Overall Study||6||
48675918|NCT01846702|101989938|FG002|COMPLETED|Overall Study||6||
48675919|NCT01846702|101989939|FG003|COMPLETED|Overall Study||6||
48675920|NCT01846702|101989940|FG004|COMPLETED|Overall Study||6||
48675921|NCT01846702|101989941|FG005|COMPLETED|Overall Study||6||
48675922|NCT01846702|101989942|FG006|COMPLETED|Overall Study||6||
48675923|NCT01846702|101989936|FG000|NOT COMPLETED|Overall Study||0||
48675924|NCT01846702|101989937|FG001|NOT COMPLETED|Overall Study||0||
48675925|NCT01846702|101989938|FG002|NOT COMPLETED|Overall Study||1||
48675926|NCT01846702|101989939|FG003|NOT COMPLETED|Overall Study||0||
48675927|NCT01846702|101989940|FG004|NOT COMPLETED|Overall Study||0||
48675928|NCT01846702|101989941|FG005|NOT COMPLETED|Overall Study||0||
48675929|NCT01846702|101989942|FG006|NOT COMPLETED|Overall Study||0||
48675930|NCT04541667|101989943|FG000|STARTED|Overall Study||98||98
48675931|NCT04541667|101989944|FG001|STARTED|Overall Study||102||102
48675932|NCT04541667|101989943|FG000|COMPLETED|Overall Study||98||98
48675933|NCT04541667|101989944|FG001|COMPLETED|Overall Study||102||102
48675934|NCT04541667|101989943|FG000|NOT COMPLETED|Overall Study||0||0
48675935|NCT04541667|101989944|FG001|NOT COMPLETED|Overall Study||0||0
48675936|NCT02834819|101989945|FG000|STARTED|Overall Study||9||
48675937|NCT02834819|101989946|FG001|STARTED|Overall Study||9||
48675938|NCT02834819|101989945|FG000|COMPLETED|Overall Study||4||
48675939|NCT02834819|101989946|FG001|COMPLETED|Overall Study||9||
48675940|NCT02834819|101989945|FG000|NOT COMPLETED|Overall Study||5||
48675941|NCT02834819|101989946|FG001|NOT COMPLETED|Overall Study||0||
48675942|NCT01606150|101989947|FG000|STARTED|Overall Study||0||
48675943|NCT01606150|101989948|FG001|STARTED|Overall Study||0||
48675944|NCT01606150|101989947|FG000|COMPLETED|Overall Study||0||
48675945|NCT01606150|101989948|FG001|COMPLETED|Overall Study||0||
48675946|NCT01606150|101989947|FG000|NOT COMPLETED|Overall Study||0||
48675947|NCT01606150|101989948|FG001|NOT COMPLETED|Overall Study||0||
48675948|NCT00060944|101989949|FG000|STARTED|Overall Study||136||
48675949|NCT00060944|101989950|FG001|STARTED|Overall Study||134||
48675950|NCT00060944|101989949|FG000|Treated|Overall Study||130||
48675951|NCT00060944|101989950|FG001|Treated|Overall Study||130||
48675952|NCT00060944|101989949|FG000|COMPLETED|Overall Study||0||
48675953|NCT00060944|101989950|FG001|COMPLETED|Overall Study||0||
48675954|NCT00060944|101989949|FG000|NOT COMPLETED|Overall Study||136||
48675955|NCT00060944|101989950|FG001|NOT COMPLETED|Overall Study||134||
48675956|NCT02536664|101989951|FG000|STARTED|Overall Study||312||
48675957|NCT02536664|101989952|FG001|STARTED|Overall Study||177||
48675958|NCT02536664|101989951|FG000|COMPLETED|Overall Study||205||
48675959|NCT02536664|101989952|FG001|COMPLETED|Overall Study||97||
48675960|NCT02536664|101989951|FG000|NOT COMPLETED|Overall Study||107||
48675961|NCT02536664|101989952|FG001|NOT COMPLETED|Overall Study||80||
48675962|NCT02835690|101989953|FG000|STARTED|Overall Study||14||
48675963|NCT02835690|101989954|FG001|STARTED|Overall Study||15||
48675964|NCT02835690|101989955|FG002|STARTED|Overall Study||15||
48675965|NCT02835690|101989953|FG000|Received First Course of Pembrolizumab|Overall Study||14||
48675966|NCT02835690|101989954|FG001|Received First Course of Pembrolizumab|Overall Study||13||
48675967|NCT02835690|101989955|FG002|Received First Course of Pembrolizumab|Overall Study||15||
48675968|NCT02835690|101989953|FG000|Received Second Course of Pembrolizumab|Overall Study||1||
48675969|NCT02835690|101989954|FG001|Received Second Course of Pembrolizumab|Overall Study||0||
48675970|NCT02835690|101989955|FG002|Received Second Course of Pembrolizumab|Overall Study||0||
48675971|NCT02835690|101989953|FG000|COMPLETED|Overall Study||0||
48675972|NCT02835690|101989954|FG001|COMPLETED|Overall Study||0||
48675973|NCT02835690|101989955|FG002|COMPLETED|Overall Study||0||
48675974|NCT02835690|101989953|FG000|NOT COMPLETED|Overall Study||14||
48675975|NCT02835690|101989954|FG001|NOT COMPLETED|Overall Study||15||
48675976|NCT02835690|101989955|FG002|NOT COMPLETED|Overall Study||15||
48675977|NCT00716274|101989956|FG000|STARTED|Study Period II (16-Weeks)||45||
48675978|NCT00716274|101989957|FG001|STARTED|Study Period II (16-Weeks)||44||
48675979|NCT00716274|101989958|FG002|STARTED|Study Period II (16-Weeks)||0||
48675980|NCT00716274|101989959|FG003|STARTED|Study Period II (16-Weeks)||0||
48675981|NCT00716274|101989960|FG004|STARTED|Study Period II (16-Weeks)||0||
48675982|NCT00716274|101989961|FG005|STARTED|Study Period II (16-Weeks)||21||
48675983|NCT00716274|101989956|FG000|COMPLETED|Study Period II (16-Weeks)||36||
48675984|NCT00716274|101989957|FG001|COMPLETED|Study Period II (16-Weeks)||35||
48675985|NCT00716274|101989958|FG002|COMPLETED|Study Period II (16-Weeks)||0||
48675986|NCT00716274|101989959|FG003|COMPLETED|Study Period II (16-Weeks)||0||
48675987|NCT00716274|101989960|FG004|COMPLETED|Study Period II (16-Weeks)||0||
48675988|NCT00716274|101989961|FG005|COMPLETED|Study Period II (16-Weeks)||19||
48675989|NCT00716274|101989956|FG000|NOT COMPLETED|Study Period II (16-Weeks)||9||
48675990|NCT00716274|101989957|FG001|NOT COMPLETED|Study Period II (16-Weeks)||9||
48675991|NCT00716274|101989958|FG002|NOT COMPLETED|Study Period II (16-Weeks)||0||
48675992|NCT00716274|101989959|FG003|NOT COMPLETED|Study Period II (16-Weeks)||0||
48675993|NCT00716274|101989960|FG004|NOT COMPLETED|Study Period II (16-Weeks)||0||
48675994|NCT00716274|101989961|FG005|NOT COMPLETED|Study Period II (16-Weeks)||2||
48675995|NCT00716274|101989956|FG000|STARTED|Study Period III (16-Weeks)||0||
48675996|NCT00716274|101989957|FG001|STARTED|Study Period III (16-Weeks)||0||
48675997|NCT00716274|101989958|FG002|STARTED|Study Period III (16-Weeks)||18||
48675998|NCT00716274|101989959|FG003|STARTED|Study Period III (16-Weeks)||18||
48675999|NCT00716274|101989960|FG004|STARTED|Study Period III (16-Weeks)||35||
48676000|NCT00716274|101989961|FG005|STARTED|Study Period III (16-Weeks)||19||
48676001|NCT00716274|101989956|FG000|COMPLETED|Study Period III (16-Weeks)||0||
48676002|NCT00716274|101989957|FG001|COMPLETED|Study Period III (16-Weeks)||0||
48676003|NCT00716274|101989958|FG002|COMPLETED|Study Period III (16-Weeks)||16||
48676004|NCT00716274|101989959|FG003|COMPLETED|Study Period III (16-Weeks)||17||
48676005|NCT00716274|101989960|FG004|COMPLETED|Study Period III (16-Weeks)||32||
48676006|NCT00716274|101989961|FG005|COMPLETED|Study Period III (16-Weeks)||19||
48676007|NCT00716274|101989956|FG000|NOT COMPLETED|Study Period III (16-Weeks)||0||
48676008|NCT00716274|101989957|FG001|NOT COMPLETED|Study Period III (16-Weeks)||0||
48676009|NCT00716274|101989958|FG002|NOT COMPLETED|Study Period III (16-Weeks)||2||
48676010|NCT00716274|101989959|FG003|NOT COMPLETED|Study Period III (16-Weeks)||1||
48676011|NCT00716274|101989960|FG004|NOT COMPLETED|Study Period III (16-Weeks)||3||
48676012|NCT00716274|101989961|FG005|NOT COMPLETED|Study Period III (16-Weeks)||0||
48676013|NCT01729039|101989962|FG000|STARTED|Overall Study||23||
48676014|NCT01729039|101989963|FG001|STARTED|Overall Study||26||
48676015|NCT01729039|101989962|FG000|COMPLETED|Overall Study||13||
48676016|NCT01729039|101989963|FG001|COMPLETED|Overall Study||14||
48676017|NCT01729039|101989962|FG000|NOT COMPLETED|Overall Study||10||
48676018|NCT01729039|101989963|FG001|NOT COMPLETED|Overall Study||12||
48676019|NCT02553629|101989964|FG000|STARTED|Overall Study||53||
48676020|NCT02553629|101989965|FG001|STARTED|Overall Study||56||
48676021|NCT02553629|101989964|FG000|COMPLETED|Overall Study||50||
48676022|NCT02553629|101989965|FG001|COMPLETED|Overall Study||50||
48676023|NCT02553629|101989964|FG000|NOT COMPLETED|Overall Study||3||
48676024|NCT02553629|101989965|FG001|NOT COMPLETED|Overall Study||6||
48676025|NCT03259295|101989966|FG000|STARTED|Overall Study||20||
48676026|NCT03259295|101989966|FG000|COMPLETED|Overall Study||20||
48676027|NCT03259295|101989966|FG000|NOT COMPLETED|Overall Study||0||
48676028|NCT01882465|101989967|FG000|STARTED|Period 1||6||
48239221|NCT01587703|100906742|FG006|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
48239222|NCT01587703|100906743|FG007|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
48239223|NCT01587703|100906744|FG008|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||3||
48239224|NCT01587703|100906745|FG009|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||10||
48239225|NCT01587703|100906746|FG010|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||5||
48239226|NCT01587703|100906747|FG011|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
48239227|NCT01587703|100906748|FG012|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
48239228|NCT01587703|100906749|FG013|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
48239229|NCT01587703|100906750|FG014|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
48239230|NCT01587703|100906751|FG015|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
48239231|NCT01587703|100906752|FG016|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
48239232|NCT01587703|100906753|FG017|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
48239233|NCT01587703|100906754|FG018|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
48239234|NCT01587703|100906736|FG000|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239235|NCT01587703|100906737|FG001|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239236|NCT01587703|100906738|FG002|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239237|NCT01587703|100906739|FG003|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239238|NCT01587703|100906740|FG004|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239239|NCT01587703|100906741|FG005|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239240|NCT01587703|100906742|FG006|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239241|NCT01587703|100906743|FG007|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239242|NCT01587703|100906744|FG008|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239243|NCT01587703|100906745|FG009|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239244|NCT01587703|100906746|FG010|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239245|NCT01587703|100906747|FG011|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239246|NCT01587703|100906748|FG012|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239247|NCT01587703|100906749|FG013|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239248|NCT01587703|100906750|FG014|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239249|NCT01587703|100906751|FG015|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239250|NCT01587703|100906752|FG016|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239251|NCT01587703|100906753|FG017|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||5||
48239252|NCT01587703|100906754|FG018|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||5||
48239253|NCT01587703|100906736|FG000|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239254|NCT01587703|100906737|FG001|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239255|NCT01587703|100906738|FG002|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48676029|NCT01882465|101989968|FG001|STARTED|Period 1||6||
48676030|NCT01882465|101989969|FG002|STARTED|Period 1||5||
48676031|NCT01882465|101989970|FG003|STARTED|Period 1||6||
48676032|NCT01882465|101989971|FG004|STARTED|Period 1||5||
48676033|NCT01882465|101989972|FG005|STARTED|Period 1||5||
48676034|NCT01882465|101989973|FG006|STARTED|Period 1||1||
48676035|NCT01882465|101989967|FG000|COMPLETED|Period 1||6||
48676036|NCT01882465|101989968|FG001|COMPLETED|Period 1||6||
48676037|NCT01882465|101989969|FG002|COMPLETED|Period 1||5||
48676038|NCT01882465|101989970|FG003|COMPLETED|Period 1||5||
48676039|NCT01882465|101989971|FG004|COMPLETED|Period 1||5||
48676040|NCT01882465|101989972|FG005|COMPLETED|Period 1||5||
48676041|NCT01882465|101989973|FG006|COMPLETED|Period 1||0||
48676042|NCT01882465|101989967|FG000|NOT COMPLETED|Period 1||0||
48676043|NCT01882465|101989968|FG001|NOT COMPLETED|Period 1||0||
48676044|NCT01882465|101989969|FG002|NOT COMPLETED|Period 1||0||
48239256|NCT01587703|100906739|FG003|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239257|NCT01587703|100906740|FG004|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239258|NCT01587703|100906741|FG005|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239259|NCT01587703|100906742|FG006|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48676045|NCT01882465|101989970|FG003|NOT COMPLETED|Period 1||1||
48676046|NCT01882465|101989971|FG004|NOT COMPLETED|Period 1||0||
48676047|NCT01882465|101989972|FG005|NOT COMPLETED|Period 1||0||
48676048|NCT01882465|101989973|FG006|NOT COMPLETED|Period 1||1||
48239260|NCT01587703|100906743|FG007|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239261|NCT01587703|100906744|FG008|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239262|NCT01587703|100906745|FG009|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239263|NCT01587703|100906746|FG010|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48676049|NCT01882465|101989967|FG000|STARTED|Period 2||6||
48676050|NCT01882465|101989968|FG001|STARTED|Period 2||6||
48676051|NCT01882465|101989969|FG002|STARTED|Period 2||5||
48676052|NCT01882465|101989970|FG003|STARTED|Period 2||5||
48239264|NCT01587703|100906747|FG011|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239265|NCT01587703|100906748|FG012|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239266|NCT01587703|100906749|FG013|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239267|NCT01587703|100906750|FG014|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239268|NCT01587703|100906751|FG015|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239269|NCT01587703|100906752|FG016|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239270|NCT01587703|100906753|FG017|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||5||
48239271|NCT01587703|100906754|FG018|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||5||
48239272|NCT01587703|100906736|FG000|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239273|NCT01587703|100906737|FG001|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239274|NCT01587703|100906738|FG002|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239275|NCT01587703|100906739|FG003|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239276|NCT01587703|100906740|FG004|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239277|NCT01587703|100906741|FG005|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239278|NCT01587703|100906742|FG006|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239279|NCT01587703|100906743|FG007|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239280|NCT01587703|100906744|FG008|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239281|NCT01587703|100906745|FG009|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239282|NCT01587703|100906746|FG010|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239283|NCT01587703|100906747|FG011|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239284|NCT01587703|100906748|FG012|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239285|NCT01587703|100906749|FG013|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239286|NCT01587703|100906750|FG014|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239287|NCT01587703|100906751|FG015|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239288|NCT01587703|100906752|FG016|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239289|NCT01587703|100906753|FG017|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239290|NCT01587703|100906754|FG018|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
48239291|NCT01587703|100906736|FG000|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239292|NCT01587703|100906737|FG001|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239293|NCT01587703|100906738|FG002|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239294|NCT01587703|100906739|FG003|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239295|NCT01587703|100906740|FG004|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239296|NCT01587703|100906741|FG005|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239297|NCT01587703|100906742|FG006|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239298|NCT01587703|100906743|FG007|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239299|NCT01587703|100906744|FG008|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239300|NCT01587703|100906745|FG009|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239301|NCT01587703|100906746|FG010|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239302|NCT01587703|100906747|FG011|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239303|NCT01587703|100906748|FG012|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239304|NCT01587703|100906749|FG013|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239305|NCT01587703|100906750|FG014|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239306|NCT01587703|100906751|FG015|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239307|NCT01587703|100906752|FG016|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239308|NCT01587703|100906753|FG017|STARTED|Substudy-P2, Week1Day3 to Week2Day1||5||
48239309|NCT01587703|100906754|FG018|STARTED|Substudy-P2, Week1Day3 to Week2Day1||5||
48239310|NCT01587703|100906736|FG000|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239311|NCT01587703|100906737|FG001|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239312|NCT01587703|100906738|FG002|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239313|NCT01587703|100906739|FG003|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239314|NCT01587703|100906740|FG004|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239315|NCT01587703|100906741|FG005|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239316|NCT01587703|100906742|FG006|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239317|NCT01587703|100906743|FG007|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239318|NCT01587703|100906744|FG008|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239319|NCT01587703|100906745|FG009|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239320|NCT01587703|100906746|FG010|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239321|NCT01587703|100906747|FG011|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48081073|NCT03129100|100521625|FG012|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
48081074|NCT03129100|100521626|FG013|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
48081075|NCT03129100|100521627|FG014|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
48081076|NCT03129100|100521628|FG015|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
48081077|NCT03129100|100521629|FG016|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
48081078|NCT03129100|100521630|FG017|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
48081079|NCT03129100|100521631|FG018|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
48239322|NCT01587703|100906748|FG012|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239323|NCT01587703|100906749|FG013|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48081080|NCT03129100|100521632|FG019|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
48239324|NCT01587703|100906750|FG014|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239325|NCT01587703|100906751|FG015|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239326|NCT01587703|100906752|FG016|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239327|NCT01587703|100906753|FG017|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||5||
48239328|NCT01587703|100906754|FG018|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||5||
48239329|NCT01587703|100906736|FG000|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239330|NCT01587703|100906737|FG001|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239331|NCT01587703|100906738|FG002|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239332|NCT01587703|100906739|FG003|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239333|NCT01587703|100906740|FG004|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239334|NCT01587703|100906741|FG005|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239335|NCT01587703|100906742|FG006|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239336|NCT01587703|100906743|FG007|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239337|NCT01587703|100906744|FG008|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239338|NCT01587703|100906745|FG009|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239339|NCT01587703|100906746|FG010|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239340|NCT01587703|100906747|FG011|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239341|NCT01587703|100906748|FG012|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239342|NCT01587703|100906749|FG013|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239343|NCT01587703|100906750|FG014|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239344|NCT01587703|100906751|FG015|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239345|NCT01587703|100906752|FG016|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239346|NCT01587703|100906753|FG017|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239347|NCT01587703|100906754|FG018|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
48239348|NCT01587703|100906736|FG000|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239349|NCT01587703|100906737|FG001|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239350|NCT01587703|100906738|FG002|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239351|NCT01587703|100906739|FG003|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239352|NCT01587703|100906740|FG004|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239353|NCT01587703|100906741|FG005|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239354|NCT01587703|100906742|FG006|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239355|NCT01587703|100906743|FG007|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239356|NCT01587703|100906744|FG008|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239357|NCT01587703|100906745|FG009|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239358|NCT01587703|100906746|FG010|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239359|NCT01587703|100906747|FG011|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239360|NCT01587703|100906748|FG012|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239361|NCT01587703|100906749|FG013|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239362|NCT01587703|100906750|FG014|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239363|NCT01587703|100906751|FG015|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239364|NCT01587703|100906752|FG016|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239365|NCT01587703|100906753|FG017|STARTED|Substudy-P3, Week2Day1 to Week2Day3||5||
48239366|NCT01587703|100906754|FG018|STARTED|Substudy-P3, Week2Day1 to Week2Day3||5||
48239367|NCT01587703|100906736|FG000|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239368|NCT01587703|100906737|FG001|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239369|NCT01587703|100906738|FG002|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239370|NCT01587703|100906739|FG003|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239371|NCT01587703|100906740|FG004|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239372|NCT01587703|100906741|FG005|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239373|NCT01587703|100906742|FG006|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239374|NCT01587703|100906743|FG007|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239375|NCT01587703|100906744|FG008|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239376|NCT01587703|100906745|FG009|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239377|NCT01587703|100906746|FG010|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239378|NCT01587703|100906747|FG011|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239379|NCT01587703|100906748|FG012|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239380|NCT01587703|100906749|FG013|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239381|NCT01587703|100906750|FG014|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239382|NCT01587703|100906751|FG015|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239383|NCT01587703|100906752|FG016|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239384|NCT01587703|100906753|FG017|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||5||
48239385|NCT01587703|100906754|FG018|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||5||
48239386|NCT01587703|100906736|FG000|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239387|NCT01587703|100906737|FG001|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239388|NCT01587703|100906738|FG002|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239389|NCT01587703|100906739|FG003|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239390|NCT01587703|100906740|FG004|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239391|NCT01587703|100906741|FG005|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48539700|NCT00205803|101657916|FG001|COMPLETED|Infant Series||116||
48239392|NCT01587703|100906742|FG006|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239393|NCT01587703|100906743|FG007|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239394|NCT01587703|100906744|FG008|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239395|NCT01587703|100906745|FG009|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239396|NCT01587703|100906746|FG010|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239397|NCT01587703|100906747|FG011|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239398|NCT01587703|100906748|FG012|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239399|NCT01587703|100906749|FG013|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239400|NCT01587703|100906750|FG014|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239401|NCT01587703|100906751|FG015|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239402|NCT01587703|100906752|FG016|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239403|NCT01587703|100906753|FG017|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48539701|NCT00205803|101657915|FG000|NOT COMPLETED|Infant Series||18||
48239404|NCT01587703|100906754|FG018|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
48239405|NCT01587703|100906736|FG000|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239406|NCT01587703|100906737|FG001|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239407|NCT01587703|100906738|FG002|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239408|NCT01587703|100906739|FG003|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239409|NCT01587703|100906740|FG004|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239410|NCT01587703|100906741|FG005|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239411|NCT01587703|100906742|FG006|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0||
48539702|NCT00205803|101657916|FG001|NOT COMPLETED|Infant Series||11||
48539703|NCT00205803|101657915|FG000|STARTED|After Infant Series||104||
48539704|NCT00205803|101657916|FG001|STARTED|After Infant Series||116||
48539705|NCT00205803|101657915|FG000|COMPLETED|After Infant Series||86||
48539706|NCT00205803|101657916|FG001|COMPLETED|After Infant Series||103||
48539707|NCT00205803|101657915|FG000|NOT COMPLETED|After Infant Series||18||
48539708|NCT00205803|101657916|FG001|NOT COMPLETED|After Infant Series||13||
48539709|NCT00205803|101657915|FG000|STARTED|Toddler Dose||86||
48539710|NCT00205803|101657916|FG001|STARTED|Toddler Dose||103||
48539711|NCT00205803|101657915|FG000|COMPLETED|Toddler Dose||84||
48539712|NCT00205803|101657916|FG001|COMPLETED|Toddler Dose||100||
48539713|NCT00205803|101657915|FG000|NOT COMPLETED|Toddler Dose||2||
48539714|NCT00205803|101657916|FG001|NOT COMPLETED|Toddler Dose||3||
48539715|NCT04851873|101657917|FG000|STARTED|Overall Study||7||
48539716|NCT04851873|101657918|FG001|STARTED|Overall Study||8||
48539717|NCT04851873|101657919|FG002|STARTED|Overall Study||9||
48539718|NCT04851873|101657917|FG000|COMPLETED|Overall Study||7||
48539719|NCT04851873|101657918|FG001|COMPLETED|Overall Study||8||
48539720|NCT04851873|101657919|FG002|COMPLETED|Overall Study||9||
48539721|NCT04851873|101657917|FG000|NOT COMPLETED|Overall Study||0||
48539722|NCT04851873|101657918|FG001|NOT COMPLETED|Overall Study||0||
48539723|NCT04851873|101657919|FG002|NOT COMPLETED|Overall Study||0||
48539724|NCT02473523|101657920|FG000|STARTED|Overall Study||2||
48539725|NCT02473523|101657920|FG000|COMPLETED|Overall Study||0||
48539726|NCT02473523|101657920|FG000|NOT COMPLETED|Overall Study||2||
48539727|NCT00735306|101657921|FG000|STARTED|Overall Study||12||
48539728|NCT00735306|101657921|FG000|COMPLETED|Overall Study||12||
48539729|NCT00735306|101657921|FG000|NOT COMPLETED|Overall Study||0||
48539730|NCT00908310|101657922|FG000|STARTED|Overall Study||213||
48539731|NCT00908310|101657922|FG000|COMPLETED|Overall Study||153||
48539732|NCT00908310|101657922|FG000|NOT COMPLETED|Overall Study||60||
48539733|NCT01090752|101657923|FG000|STARTED|Overall Study||8||
48539734|NCT01090752|101657924|FG001|STARTED|Overall Study||8||
48539735|NCT01090752|101657923|FG000|COMPLETED|Overall Study||8||
48539736|NCT01090752|101657924|FG001|COMPLETED|Overall Study||8||
48539737|NCT01090752|101657923|FG000|NOT COMPLETED|Overall Study||0||
48539738|NCT01090752|101657924|FG001|NOT COMPLETED|Overall Study||0||
48539739|NCT00134004|101657925|FG000|STARTED|Overall Study||210||
48539740|NCT00134004|101657925|FG000|COMPLETED|Overall Study||210||
48539741|NCT00134004|101657925|FG000|NOT COMPLETED|Overall Study||0||
48539742|NCT04138823|101657926|FG000|STARTED|Overall Study||3||
48539743|NCT04138823|101657927|FG001|STARTED|Overall Study||3||
48539744|NCT04138823|101657928|FG002|STARTED|Overall Study||6||
48539745|NCT04138823|101657926|FG000|COMPLETED|Overall Study||0||
48239412|NCT01587703|100906743|FG007|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239413|NCT01587703|100906744|FG008|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239414|NCT01587703|100906745|FG009|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239415|NCT01587703|100906746|FG010|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239416|NCT01587703|100906747|FG011|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239417|NCT01587703|100906748|FG012|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0||
48539746|NCT04138823|101657927|FG001|COMPLETED|Overall Study||1||
48539747|NCT04138823|101657928|FG002|COMPLETED|Overall Study||0||
48539748|NCT04138823|101657926|FG000|NOT COMPLETED|Overall Study||3||
48539749|NCT04138823|101657927|FG001|NOT COMPLETED|Overall Study||2||
48539750|NCT04138823|101657928|FG002|NOT COMPLETED|Overall Study||6||
48539751|NCT02687529|101657929|FG000|STARTED|Overall Study||34||
48539752|NCT02687529|101657930|FG001|STARTED|Overall Study||32||
48539753|NCT02687529|101657929|FG000|COMPLETED|Overall Study||34||
48676053|NCT01882465|101989971|FG004|STARTED|Period 2||5||
48676054|NCT01882465|101989972|FG005|STARTED|Period 2||5||
48676055|NCT01882465|101989973|FG006|STARTED|Period 2||0||
48676056|NCT01882465|101989967|FG000|COMPLETED|Period 2||6||
48676057|NCT01882465|101989968|FG001|COMPLETED|Period 2||6||
48676058|NCT01882465|101989969|FG002|COMPLETED|Period 2||5||
48676059|NCT01882465|101989970|FG003|COMPLETED|Period 2||5||
48676060|NCT01882465|101989971|FG004|COMPLETED|Period 2||4||
48676061|NCT01882465|101989972|FG005|COMPLETED|Period 2||5||
48676062|NCT01882465|101989973|FG006|COMPLETED|Period 2||0||
48676063|NCT01882465|101989967|FG000|NOT COMPLETED|Period 2||0||
48676064|NCT01882465|101989968|FG001|NOT COMPLETED|Period 2||0||
48676065|NCT01882465|101989969|FG002|NOT COMPLETED|Period 2||0||
48676066|NCT01882465|101989970|FG003|NOT COMPLETED|Period 2||0||
48676067|NCT01882465|101989971|FG004|NOT COMPLETED|Period 2||1||
48676068|NCT01882465|101989972|FG005|NOT COMPLETED|Period 2||0||
48676069|NCT01882465|101989973|FG006|NOT COMPLETED|Period 2||0||
48676070|NCT01882465|101989967|FG000|STARTED|Period 3||6||
48676071|NCT01882465|101989968|FG001|STARTED|Period 3||6||
48676072|NCT01882465|101989969|FG002|STARTED|Period 3||5||
48676073|NCT01882465|101989970|FG003|STARTED|Period 3||5||
48676074|NCT01882465|101989971|FG004|STARTED|Period 3||4||
48676075|NCT01882465|101989972|FG005|STARTED|Period 3||5||
48676076|NCT01882465|101989973|FG006|STARTED|Period 3||0||
48676077|NCT01882465|101989967|FG000|COMPLETED|Period 3||6||
48676078|NCT01882465|101989968|FG001|COMPLETED|Period 3||6||
48676079|NCT01882465|101989969|FG002|COMPLETED|Period 3||5||
48676080|NCT01882465|101989970|FG003|COMPLETED|Period 3||5||
48676081|NCT01882465|101989971|FG004|COMPLETED|Period 3||4||
48676082|NCT01882465|101989972|FG005|COMPLETED|Period 3||5||
48676083|NCT01882465|101989973|FG006|COMPLETED|Period 3||0||
48676084|NCT01882465|101989967|FG000|NOT COMPLETED|Period 3||0||
48081081|NCT03129100|100521633|FG020|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
48081082|NCT03129100|100521634|FG021|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
48081083|NCT03129100|100521635|FG022|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
48081084|NCT03129100|100521636|FG023|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
48081085|NCT03129100|100521637|FG024|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
48081086|NCT03129100|100521638|FG025|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
48081087|NCT03129100|100521613|FG000|COMPLETED|Lead-In Period (Period 1)||335||
48081088|NCT03129100|100521614|FG001|COMPLETED|Lead-In Period (Period 1)||406||
48081089|NCT03129100|100521615|FG002|COMPLETED|Lead-In Period (Period 1)||0||
48081090|NCT03129100|100521616|FG003|COMPLETED|Lead-In Period (Period 1)||0||
48081091|NCT03129100|100521617|FG004|COMPLETED|Lead-In Period (Period 1)||0||
48081092|NCT03129100|100521618|FG005|COMPLETED|Lead-In Period (Period 1)||0||
48081093|NCT03129100|100521619|FG006|COMPLETED|Lead-In Period (Period 1)||0||
48081094|NCT03129100|100521620|FG007|COMPLETED|Lead-In Period (Period 1)||0||
48676085|NCT01882465|101989968|FG001|NOT COMPLETED|Period 3||0||
48676086|NCT01882465|101989969|FG002|NOT COMPLETED|Period 3||0||
48676087|NCT01882465|101989970|FG003|NOT COMPLETED|Period 3||0||
48081095|NCT03129100|100521621|FG008|COMPLETED|Lead-In Period (Period 1)||0||
48081096|NCT03129100|100521622|FG009|COMPLETED|Lead-In Period (Period 1)||0||
48081097|NCT03129100|100521623|FG010|COMPLETED|Lead-In Period (Period 1)||0||
48081098|NCT03129100|100521624|FG011|COMPLETED|Lead-In Period (Period 1)||0||
48081099|NCT03129100|100521625|FG012|COMPLETED|Lead-In Period (Period 1)||0||
48081100|NCT03129100|100521626|FG013|COMPLETED|Lead-In Period (Period 1)||0||
48081101|NCT03129100|100521627|FG014|COMPLETED|Lead-In Period (Period 1)||0||
48081102|NCT03129100|100521628|FG015|COMPLETED|Lead-In Period (Period 1)||0||
48081103|NCT03129100|100521629|FG016|COMPLETED|Lead-In Period (Period 1)||0||
48081104|NCT03129100|100521630|FG017|COMPLETED|Lead-In Period (Period 1)||0||
48081105|NCT03129100|100521631|FG018|COMPLETED|Lead-In Period (Period 1)||0||
48081106|NCT03129100|100521632|FG019|COMPLETED|Lead-In Period (Period 1)||0||
48081107|NCT03129100|100521633|FG020|COMPLETED|Lead-In Period (Period 1)||0||
48676088|NCT01882465|101989971|FG004|NOT COMPLETED|Period 3||0||
48676089|NCT01882465|101989972|FG005|NOT COMPLETED|Period 3||0||
48676090|NCT01882465|101989973|FG006|NOT COMPLETED|Period 3||0||
48676091|NCT00285779|101989974|FG000|STARTED|Placebo-controlled Period (wk 1-12)||14||
48676092|NCT00285779|101989975|FG001|STARTED|Placebo-controlled Period (wk 1-12)||13||
48676093|NCT00285779|101989974|FG000|COMPLETED|Placebo-controlled Period (wk 1-12)||11||
48676094|NCT00285779|101989975|FG001|COMPLETED|Placebo-controlled Period (wk 1-12)||12||
48676095|NCT00285779|101989974|FG000|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||3||
48676096|NCT00285779|101989975|FG001|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||1||
48081108|NCT03129100|100521634|FG021|COMPLETED|Lead-In Period (Period 1)||0||
48081109|NCT03129100|100521635|FG022|COMPLETED|Lead-In Period (Period 1)||0||
48676097|NCT00285779|101989974|FG000|STARTED|Open Label Period (wk 12-24)||11||
48676098|NCT00285779|101989975|FG001|STARTED|Open Label Period (wk 12-24)||12||
48676099|NCT00285779|101989974|FG000|COMPLETED|Open Label Period (wk 12-24)||9||
48676100|NCT00285779|101989975|FG001|COMPLETED|Open Label Period (wk 12-24)||10||
48676101|NCT00285779|101989974|FG000|NOT COMPLETED|Open Label Period (wk 12-24)||2||
48676102|NCT00285779|101989975|FG001|NOT COMPLETED|Open Label Period (wk 12-24)||2||
48676103|NCT00285779|101989974|FG000|STARTED|Follow-up Period (wk 24-32)||9||
48676104|NCT00285779|101989975|FG001|STARTED|Follow-up Period (wk 24-32)||10||
48239418|NCT01587703|100906749|FG013|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239419|NCT01587703|100906750|FG014|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239420|NCT01587703|100906751|FG015|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239421|NCT01587703|100906752|FG016|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239422|NCT01587703|100906753|FG017|STARTED|Substudy-P4,Maximum Exposure of 5.5month||5||
48239423|NCT01587703|100906754|FG018|STARTED|Substudy-P4,Maximum Exposure of 5.5month||5||
48239424|NCT01587703|100906736|FG000|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48676105|NCT00285779|101989974|FG000|COMPLETED|Follow-up Period (wk 24-32)||8||
48676106|NCT00285779|101989975|FG001|COMPLETED|Follow-up Period (wk 24-32)||10||
48676107|NCT00285779|101989974|FG000|NOT COMPLETED|Follow-up Period (wk 24-32)||1||
48676108|NCT00285779|101989975|FG001|NOT COMPLETED|Follow-up Period (wk 24-32)||0||
48676109|NCT02286895|101989976|FG000|STARTED|Randomized and Vaccinated||300||
48676110|NCT02286895|101989977|FG001|STARTED|Randomized and Vaccinated||300||
48676111|NCT02286895|101989976|FG000|COMPLETED|Randomized and Vaccinated||300||
48676112|NCT02286895|101989977|FG001|COMPLETED|Randomized and Vaccinated||300||
48676113|NCT02286895|101989976|FG000|NOT COMPLETED|Randomized and Vaccinated||0||
48676114|NCT02286895|101989977|FG001|NOT COMPLETED|Randomized and Vaccinated||0||
48676115|NCT02286895|101989976|FG000|STARTED|Assessed for Measles Seroconversion||300||
48676116|NCT02286895|101989977|FG001|STARTED|Assessed for Measles Seroconversion||300||
48676117|NCT02286895|101989976|FG000|COMPLETED|Assessed for Measles Seroconversion||252||
48676118|NCT02286895|101989977|FG001|COMPLETED|Assessed for Measles Seroconversion||261||
48676119|NCT02286895|101989976|FG000|NOT COMPLETED|Assessed for Measles Seroconversion||48||
48676120|NCT02286895|101989977|FG001|NOT COMPLETED|Assessed for Measles Seroconversion||39||
48676121|NCT02569853|101989978|FG000|STARTED|Overall Study||131||
48676122|NCT02569853|101989979|FG001|STARTED|Overall Study||137||
48239425|NCT01587703|100906737|FG001|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239426|NCT01587703|100906738|FG002|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239427|NCT01587703|100906739|FG003|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239428|NCT01587703|100906740|FG004|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239429|NCT01587703|100906741|FG005|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239430|NCT01587703|100906742|FG006|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239431|NCT01587703|100906743|FG007|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239432|NCT01587703|100906744|FG008|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239433|NCT01587703|100906745|FG009|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239434|NCT01587703|100906746|FG010|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239435|NCT01587703|100906747|FG011|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239436|NCT01587703|100906748|FG012|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239437|NCT01587703|100906749|FG013|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239438|NCT01587703|100906750|FG014|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239439|NCT01587703|100906751|FG015|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239440|NCT01587703|100906752|FG016|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48676123|NCT02569853|101989978|FG000|COMPLETED|Overall Study||111||
48676124|NCT02569853|101989979|FG001|COMPLETED|Overall Study||123||
48676125|NCT02569853|101989978|FG000|NOT COMPLETED|Overall Study||20||
48676126|NCT02569853|101989979|FG001|NOT COMPLETED|Overall Study||14||
48676127|NCT03892317|101989980|FG000|STARTED|Overall Study||42||
48676128|NCT03892317|101989980|FG000|COMPLETED|Overall Study||42||
48676129|NCT03892317|101989980|FG000|NOT COMPLETED|Overall Study||0||
48676130|NCT00904371|101989981|FG000|STARTED|Overall Study||211||
48676131|NCT00904371|101989981|FG000|COMPLETED|Overall Study||202||
48239441|NCT01587703|100906753|FG017|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239442|NCT01587703|100906754|FG018|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239443|NCT01587703|100906736|FG000|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239444|NCT01587703|100906737|FG001|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239445|NCT01587703|100906738|FG002|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239446|NCT01587703|100906739|FG003|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239447|NCT01587703|100906740|FG004|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239448|NCT01587703|100906741|FG005|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239449|NCT01587703|100906742|FG006|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239450|NCT01587703|100906743|FG007|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48676132|NCT00904371|101989981|FG000|NOT COMPLETED|Overall Study||9||
48676133|NCT00140140|101989982|FG000|STARTED|Overall Study||4||
48676134|NCT00140140|101989983|FG001|STARTED|Overall Study||6||
48676135|NCT00140140|101989984|FG002|STARTED|Overall Study||6||
48676136|NCT00140140|101989982|FG000|COMPLETED|Overall Study||2||
48676137|NCT00140140|101989983|FG001|COMPLETED|Overall Study||4||
48676138|NCT00140140|101989984|FG002|COMPLETED|Overall Study||4||
48676139|NCT00140140|101989982|FG000|NOT COMPLETED|Overall Study||2||
48676140|NCT00140140|101989983|FG001|NOT COMPLETED|Overall Study||2||
48676141|NCT00140140|101989984|FG002|NOT COMPLETED|Overall Study||2||
48676142|NCT02862574|101989985|FG000|STARTED|Double-Blind Treatment Period||5||
48676143|NCT02862574|101989986|FG001|STARTED|Double-Blind Treatment Period||5||
48676144|NCT02862574|101989987|FG002|STARTED|Double-Blind Treatment Period||5||
48676145|NCT02862574|101989985|FG000|COMPLETED|Double-Blind Treatment Period||2||
48676146|NCT02862574|101989986|FG001|COMPLETED|Double-Blind Treatment Period||3||
48676147|NCT02862574|101989987|FG002|COMPLETED|Double-Blind Treatment Period||1||
48676148|NCT02862574|101989985|FG000|NOT COMPLETED|Double-Blind Treatment Period||3||
48676149|NCT02862574|101989986|FG001|NOT COMPLETED|Double-Blind Treatment Period||2||
48676150|NCT02862574|101989987|FG002|NOT COMPLETED|Double-Blind Treatment Period||4||
48676151|NCT02862574|101989985|FG000|STARTED|Open-Label Treatment Period||2||
48676152|NCT02862574|101989986|FG001|STARTED|Open-Label Treatment Period||3||
48676153|NCT02862574|101989987|FG002|STARTED|Open-Label Treatment Period||1||
48239451|NCT01587703|100906744|FG008|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239452|NCT01587703|100906745|FG009|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239453|NCT01587703|100906746|FG010|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239454|NCT01587703|100906747|FG011|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239455|NCT01587703|100906748|FG012|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239456|NCT01587703|100906749|FG013|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239457|NCT01587703|100906750|FG014|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239458|NCT01587703|100906751|FG015|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239459|NCT01587703|100906752|FG016|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
48239460|NCT01587703|100906753|FG017|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||5||
48239461|NCT01587703|100906754|FG018|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||5||
48239462|NCT01587703|100906736|FG000|STARTED|Part2(Median Exposure of 1.41 Months)||0||
48239463|NCT01587703|100906737|FG001|STARTED|Part2(Median Exposure of 1.41 Months)||0||
48239464|NCT01587703|100906738|FG002|STARTED|Part2(Median Exposure of 1.41 Months)||0||
48239465|NCT01587703|100906739|FG003|STARTED|Part2(Median Exposure of 1.41 Months)||0||
48239466|NCT01587703|100906740|FG004|STARTED|Part2(Median Exposure of 1.41 Months)||0||
48239467|NCT01587703|100906741|FG005|STARTED|Part2(Median Exposure of 1.41 Months)||0||
48239468|NCT01587703|100906742|FG006|STARTED|Part2(Median Exposure of 1.41 Months)||0||
48239469|NCT01587703|100906743|FG007|STARTED|Part2(Median Exposure of 1.41 Months)||0||
48239470|NCT01587703|100906744|FG008|STARTED|Part2(Median Exposure of 1.41 Months)||0||
48239471|NCT01587703|100906745|FG009|STARTED|Part2(Median Exposure of 1.41 Months)||0||
48239472|NCT01587703|100906746|FG010|STARTED|Part2(Median Exposure of 1.41 Months)||0||
48239473|NCT01587703|100906747|FG011|STARTED|Part2(Median Exposure of 1.41 Months)||12||
48239474|NCT01587703|100906748|FG012|STARTED|Part2(Median Exposure of 1.41 Months)||14||
48239475|NCT01587703|100906749|FG013|STARTED|Part2(Median Exposure of 1.41 Months)||23||
48239476|NCT01587703|100906750|FG014|STARTED|Part2(Median Exposure of 1.41 Months)||19||
48239477|NCT01587703|100906751|FG015|STARTED|Part2(Median Exposure of 1.41 Months)||21||
48239478|NCT01587703|100906752|FG016|STARTED|Part2(Median Exposure of 1.41 Months)||13||
48676154|NCT02862574|101989985|FG000|COMPLETED|Open-Label Treatment Period||0||
48676155|NCT02862574|101989986|FG001|COMPLETED|Open-Label Treatment Period||0||
48676156|NCT02862574|101989987|FG002|COMPLETED|Open-Label Treatment Period||0||
48676157|NCT02862574|101989985|FG000|NOT COMPLETED|Open-Label Treatment Period||2||
48676158|NCT02862574|101989986|FG001|NOT COMPLETED|Open-Label Treatment Period||3||
48676159|NCT02862574|101989987|FG002|NOT COMPLETED|Open-Label Treatment Period||1||
48676160|NCT00276419|101989988|FG000|STARTED|First Intervention||8||
48676161|NCT00276419|101989989|FG001|STARTED|First Intervention||10||
48676162|NCT00276419|101989988|FG000|COMPLETED|First Intervention||7||
48676163|NCT00276419|101989989|FG001|COMPLETED|First Intervention||8||
48676164|NCT00276419|101989988|FG000|NOT COMPLETED|First Intervention||1||
48676165|NCT00276419|101989989|FG001|NOT COMPLETED|First Intervention||2||
48676166|NCT00276419|101989988|FG000|STARTED|Wash-out Phase||7||
48676167|NCT00276419|101989989|FG001|STARTED|Wash-out Phase||8||
48676168|NCT00276419|101989988|FG000|COMPLETED|Wash-out Phase||7||
48676169|NCT00276419|101989989|FG001|COMPLETED|Wash-out Phase||8||
48676170|NCT00276419|101989988|FG000|NOT COMPLETED|Wash-out Phase||0||
48676171|NCT00276419|101989989|FG001|NOT COMPLETED|Wash-out Phase||0||
48676172|NCT00276419|101989988|FG000|STARTED|Second Intervention||7||
48676173|NCT00276419|101989989|FG001|STARTED|Second Intervention||8||
48676174|NCT00276419|101989988|FG000|COMPLETED|Second Intervention||7||
48676175|NCT00276419|101989989|FG001|COMPLETED|Second Intervention||8||
48676176|NCT00276419|101989988|FG000|NOT COMPLETED|Second Intervention||0||
48676177|NCT00276419|101989989|FG001|NOT COMPLETED|Second Intervention||0||
48676178|NCT00442702|101989990|FG000|STARTED|Titration Period||114||
48676179|NCT00442702|101989991|FG001|STARTED|Titration Period||114||
48676180|NCT00442702|101989990|FG000|Safety Population|Titration Period||115||
48676181|NCT00442702|101989991|FG001|Safety Population|Titration Period||113||
48239479|NCT01587703|100906753|FG017|STARTED|Part2(Median Exposure of 1.41 Months)||0||
48239480|NCT01587703|100906754|FG018|STARTED|Part2(Median Exposure of 1.41 Months)||0||
48239481|NCT01587703|100906736|FG000|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
48676182|NCT00442702|101989990|FG000|COMPLETED|Titration Period||102||
48676183|NCT00442702|101989991|FG001|COMPLETED|Titration Period||111||
48676184|NCT00442702|101989990|FG000|NOT COMPLETED|Titration Period||12||
48676185|NCT00442702|101989991|FG001|NOT COMPLETED|Titration Period||3||
48239482|NCT01587703|100906737|FG001|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
48239483|NCT01587703|100906738|FG002|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
48239484|NCT01587703|100906739|FG003|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
48239485|NCT01587703|100906740|FG004|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
48239486|NCT01587703|100906741|FG005|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
48239487|NCT01587703|100906742|FG006|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
48239488|NCT01587703|100906743|FG007|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
48239489|NCT01587703|100906744|FG008|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
48239490|NCT01587703|100906745|FG009|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
48239491|NCT01587703|100906746|FG010|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
48239492|NCT01587703|100906747|FG011|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
48239493|NCT01587703|100906748|FG012|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
48239494|NCT01587703|100906749|FG013|COMPLETED|Part2(Median Exposure of 1.41 Months)||1||
48239495|NCT01587703|100906750|FG014|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
48239496|NCT01587703|100906751|FG015|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
48239497|NCT01587703|100906752|FG016|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
48239498|NCT01587703|100906753|FG017|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
48239499|NCT01587703|100906754|FG018|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
48239500|NCT01587703|100906736|FG000|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
48239501|NCT01587703|100906737|FG001|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
48239502|NCT01587703|100906738|FG002|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
48239503|NCT01587703|100906739|FG003|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
48239504|NCT01587703|100906740|FG004|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
48239505|NCT01587703|100906741|FG005|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
48239506|NCT01587703|100906742|FG006|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
48239507|NCT01587703|100906743|FG007|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
48239508|NCT01587703|100906744|FG008|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
48239509|NCT01587703|100906745|FG009|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
48239510|NCT01587703|100906746|FG010|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
48239511|NCT01587703|100906747|FG011|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||12||
48239512|NCT01587703|100906748|FG012|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||14||
48239513|NCT01587703|100906749|FG013|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||22||
48239514|NCT01587703|100906750|FG014|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||19||
48239515|NCT01587703|100906751|FG015|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||21||
48239516|NCT01587703|100906752|FG016|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||13||
48239517|NCT01587703|100906753|FG017|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
48239518|NCT01587703|100906754|FG018|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
48239519|NCT00296504|100906755|FG000|STARTED|Interim Analysis||119||
48239520|NCT00296504|100906756|FG001|STARTED|Interim Analysis||18||
48239521|NCT00296504|100906757|FG002|STARTED|Interim Analysis||221||
48239522|NCT00296504|100906758|FG003|STARTED|Interim Analysis||54||
48239523|NCT00296504|100906759|FG004|STARTED|Interim Analysis||73||
48239524|NCT00296504|100906760|FG005|STARTED|Interim Analysis||78||
48239525|NCT00296504|100906761|FG006|STARTED|Interim Analysis||104||
48239526|NCT00296504|100906762|FG007|STARTED|Interim Analysis||86||
48239527|NCT00296504|100906763|FG008|STARTED|Interim Analysis||0||
48239528|NCT00296504|100906755|FG000|Ongoing|Interim Analysis||32||
48239529|NCT00296504|100906756|FG001|Ongoing|Interim Analysis||12||
48239530|NCT00296504|100906757|FG002|Ongoing|Interim Analysis||16||
48239531|NCT00296504|100906758|FG003|Ongoing|Interim Analysis||22||
48239532|NCT00296504|100906759|FG004|Ongoing|Interim Analysis||0||
48239533|NCT00296504|100906760|FG005|Ongoing|Interim Analysis||0||
48239534|NCT00296504|100906761|FG006|Ongoing|Interim Analysis||30||
48239535|NCT00296504|100906762|FG007|Ongoing|Interim Analysis||1||
48239536|NCT00296504|100906763|FG008|Ongoing|Interim Analysis||0||
48239537|NCT00296504|100906755|FG000|COMPLETED|Interim Analysis||43||
48239538|NCT00296504|100906756|FG001|COMPLETED|Interim Analysis||0||
48239539|NCT00296504|100906757|FG002|COMPLETED|Interim Analysis||116||
48239540|NCT00296504|100906758|FG003|COMPLETED|Interim Analysis||11||
48239541|NCT00296504|100906759|FG004|COMPLETED|Interim Analysis||36||
48239542|NCT00296504|100906760|FG005|COMPLETED|Interim Analysis||41||
48239543|NCT00296504|100906761|FG006|COMPLETED|Interim Analysis||30||
48239544|NCT00296504|100906762|FG007|COMPLETED|Interim Analysis||37||
48239545|NCT00296504|100906763|FG008|COMPLETED|Interim Analysis||0||
48239546|NCT00296504|100906755|FG000|NOT COMPLETED|Interim Analysis||76||
48239547|NCT00296504|100906756|FG001|NOT COMPLETED|Interim Analysis||18||
48239548|NCT00296504|100906757|FG002|NOT COMPLETED|Interim Analysis||105||
48239549|NCT00296504|100906758|FG003|NOT COMPLETED|Interim Analysis||43||
48239550|NCT00296504|100906759|FG004|NOT COMPLETED|Interim Analysis||37||
48239551|NCT00296504|100906760|FG005|NOT COMPLETED|Interim Analysis||37||
48239552|NCT00296504|100906761|FG006|NOT COMPLETED|Interim Analysis||74||
48239553|NCT00296504|100906762|FG007|NOT COMPLETED|Interim Analysis||49||
48239554|NCT00296504|100906763|FG008|NOT COMPLETED|Interim Analysis||0||
48239555|NCT00296504|100906755|FG000|STARTED|Final Analysis||0||
48239556|NCT00296504|100906756|FG001|STARTED|Final Analysis||0||
48239557|NCT00296504|100906757|FG002|STARTED|Final Analysis||0||
48239558|NCT00296504|100906758|FG003|STARTED|Final Analysis||0||
48239559|NCT00296504|100906759|FG004|STARTED|Final Analysis||0||
48239560|NCT00296504|100906760|FG005|STARTED|Final Analysis||0||
48239561|NCT00296504|100906761|FG006|STARTED|Final Analysis||0||
48239562|NCT00296504|100906762|FG007|STARTED|Final Analysis||0||
48239563|NCT00296504|100906763|FG008|STARTED|Final Analysis||111||
48239564|NCT00296504|100906755|FG000|COMPLETED|Final Analysis||0||
48239565|NCT00296504|100906756|FG001|COMPLETED|Final Analysis||0||
48239566|NCT00296504|100906757|FG002|COMPLETED|Final Analysis||0||
48239567|NCT00296504|100906758|FG003|COMPLETED|Final Analysis||0||
48239568|NCT00296504|100906759|FG004|COMPLETED|Final Analysis||0||
48239569|NCT00296504|100906760|FG005|COMPLETED|Final Analysis||0||
48239570|NCT00296504|100906761|FG006|COMPLETED|Final Analysis||0||
48239571|NCT00296504|100906762|FG007|COMPLETED|Final Analysis||0||
48239572|NCT00296504|100906763|FG008|COMPLETED|Final Analysis||90||
48239573|NCT00296504|100906755|FG000|NOT COMPLETED|Final Analysis||0||
48239574|NCT00296504|100906756|FG001|NOT COMPLETED|Final Analysis||0||
48239575|NCT00296504|100906757|FG002|NOT COMPLETED|Final Analysis||0||
48239576|NCT00296504|100906758|FG003|NOT COMPLETED|Final Analysis||0||
48239577|NCT00296504|100906759|FG004|NOT COMPLETED|Final Analysis||0||
48239578|NCT00296504|100906760|FG005|NOT COMPLETED|Final Analysis||0||
48239579|NCT00296504|100906761|FG006|NOT COMPLETED|Final Analysis||0||
48239580|NCT00296504|100906762|FG007|NOT COMPLETED|Final Analysis||0||
48239581|NCT00296504|100906763|FG008|NOT COMPLETED|Final Analysis||21||
48239582|NCT05104242|100906764|FG000|STARTED|Overall Study||19||
48239583|NCT05104242|100906765|FG001|STARTED|Overall Study||19||
48239584|NCT05104242|100906764|FG000|COMPLETED|Overall Study||17||
48239585|NCT05104242|100906765|FG001|COMPLETED|Overall Study||13||
48239586|NCT05104242|100906764|FG000|NOT COMPLETED|Overall Study||2||
48239587|NCT05104242|100906765|FG001|NOT COMPLETED|Overall Study||6||
48239588|NCT03427177|100906766|FG000|STARTED|Overall Study||125||
48239589|NCT03427177|100906767|FG001|STARTED|Overall Study||132||
48239590|NCT03427177|100906766|FG000|COMPLETED|Overall Study||92||
48239591|NCT03427177|100906767|FG001|COMPLETED|Overall Study||105||
48239592|NCT03427177|100906766|FG000|NOT COMPLETED|Overall Study||33||
48239593|NCT03427177|100906767|FG001|NOT COMPLETED|Overall Study||27||
48239594|NCT05647304|100906768|FG000|STARTED|Overall Study||26||
48239595|NCT05647304|100906769|FG001|STARTED|Overall Study||24||
48239596|NCT05647304|100906768|FG000|COMPLETED|Overall Study||25||
48239597|NCT05647304|100906769|FG001|COMPLETED|Overall Study||24||
48239598|NCT05647304|100906768|FG000|NOT COMPLETED|Overall Study||1||
48239599|NCT05647304|100906769|FG001|NOT COMPLETED|Overall Study||0||
48239600|NCT01807234|100906770|FG000|STARTED|Overall Study||12||
48239601|NCT01807234|100906771|FG001|STARTED|Overall Study||12||
48239602|NCT01807234|100906772|FG002|STARTED|Overall Study||12||
48239603|NCT01807234|100906773|FG003|STARTED|Overall Study||12||
48239604|NCT01807234|100906774|FG004|STARTED|Overall Study||12||
48239605|NCT01807234|100906775|FG005|STARTED|Overall Study||12||
48239606|NCT01807234|100906770|FG000|Randomized, But Did Not Take Drug|Overall Study||3||
48239607|NCT01807234|100906771|FG001|Randomized, But Did Not Take Drug|Overall Study||5||
48239608|NCT01807234|100906772|FG002|Randomized, But Did Not Take Drug|Overall Study||2||
48239609|NCT01807234|100906773|FG003|Randomized, But Did Not Take Drug|Overall Study||1||
48239610|NCT01807234|100906774|FG004|Randomized, But Did Not Take Drug|Overall Study||4||
48239611|NCT01807234|100906775|FG005|Randomized, But Did Not Take Drug|Overall Study||3||
48239612|NCT01807234|100906770|FG000|Completed Only 1 Attack|Overall Study||2||
48239613|NCT01807234|100906771|FG001|Completed Only 1 Attack|Overall Study||1||
48239614|NCT01807234|100906772|FG002|Completed Only 1 Attack|Overall Study||0||
48239615|NCT01807234|100906773|FG003|Completed Only 1 Attack|Overall Study||1||
48239616|NCT01807234|100906774|FG004|Completed Only 1 Attack|Overall Study||0||
48239617|NCT01807234|100906775|FG005|Completed Only 1 Attack|Overall Study||1||
48239618|NCT01807234|100906770|FG000|COMPLETED|Overall Study||7||
48239619|NCT01807234|100906771|FG001|COMPLETED|Overall Study||6||
48239620|NCT01807234|100906772|FG002|COMPLETED|Overall Study||10||
48239621|NCT01807234|100906773|FG003|COMPLETED|Overall Study||10||
48239622|NCT01807234|100906774|FG004|COMPLETED|Overall Study||8||
48239623|NCT01807234|100906775|FG005|COMPLETED|Overall Study||8||
48539754|NCT02687529|101657930|FG001|COMPLETED|Overall Study||32||
48539755|NCT02687529|101657929|FG000|NOT COMPLETED|Overall Study||0||
48539756|NCT02687529|101657930|FG001|NOT COMPLETED|Overall Study||0||
48539757|NCT02787408|101657931|FG000|STARTED|Overall Study||25||
48539758|NCT02787408|101657931|FG000|COMPLETED|Overall Study||7||
48539759|NCT02787408|101657931|FG000|NOT COMPLETED|Overall Study||18||
48539760|NCT04711902|101657932|FG000|STARTED|Treatment Period 1 (1st 16 Weeks)||20||
48239624|NCT01807234|100906770|FG000|NOT COMPLETED|Overall Study||5||
48239625|NCT01807234|100906771|FG001|NOT COMPLETED|Overall Study||6||
48239626|NCT01807234|100906772|FG002|NOT COMPLETED|Overall Study||2||
48239627|NCT01807234|100906773|FG003|NOT COMPLETED|Overall Study||2||
48239628|NCT01807234|100906774|FG004|NOT COMPLETED|Overall Study||4||
48239629|NCT01807234|100906775|FG005|NOT COMPLETED|Overall Study||4||
48239630|NCT00832650|100908900|FG000|STARTED|Overall Study||25||
48539761|NCT04711902|101657933|FG001|STARTED|Treatment Period 1 (1st 16 Weeks)||21||
48539762|NCT04711902|101657934|FG002|STARTED|Treatment Period 1 (1st 16 Weeks)||0||
48676186|NCT00442702|101989990|FG000|STARTED|Evaluation Period||102||
48239631|NCT00832650|100908901|FG001|STARTED|Overall Study||12||
48239632|NCT00832650|100908902|FG002|STARTED|Overall Study||23||
48539763|NCT04711902|101657935|FG003|STARTED|Treatment Period 1 (1st 16 Weeks)||0||
48539764|NCT04711902|101657936|FG004|STARTED|Treatment Period 1 (1st 16 Weeks)||0||
48539765|NCT04711902|101657937|FG005|STARTED|Treatment Period 1 (1st 16 Weeks)||0||
48539766|NCT04711902|101657932|FG000|COMPLETED|Treatment Period 1 (1st 16 Weeks)||20||
48539767|NCT04711902|101657933|FG001|COMPLETED|Treatment Period 1 (1st 16 Weeks)||21||
48539768|NCT04711902|101657934|FG002|COMPLETED|Treatment Period 1 (1st 16 Weeks)||0||
48539769|NCT04711902|101657935|FG003|COMPLETED|Treatment Period 1 (1st 16 Weeks)||0||
48539770|NCT04711902|101657936|FG004|COMPLETED|Treatment Period 1 (1st 16 Weeks)||0||
48539771|NCT04711902|101657937|FG005|COMPLETED|Treatment Period 1 (1st 16 Weeks)||0||
48539772|NCT04711902|101657932|FG000|NOT COMPLETED|Treatment Period 1 (1st 16 Weeks)||0||
48676187|NCT00442702|101989991|FG001|STARTED|Evaluation Period||111||
48676188|NCT00442702|101989990|FG000|COMPLETED|Evaluation Period||97||
48676189|NCT00442702|101989991|FG001|COMPLETED|Evaluation Period||107||
48676190|NCT00442702|101989990|FG000|NOT COMPLETED|Evaluation Period||5||
48676191|NCT00442702|101989991|FG001|NOT COMPLETED|Evaluation Period||4||
48676192|NCT01182350|101989992|FG000|STARTED|Overall Study||30||
48676193|NCT01182350|101989993|FG001|STARTED|Overall Study||14||
48676194|NCT01182350|101989994|FG002|STARTED|Overall Study||3||
48676195|NCT01182350|101989995|FG003|STARTED|Overall Study||3||
48676196|NCT01182350|101989996|FG004|STARTED|Overall Study||3||
48676197|NCT01182350|101989992|FG000|Underwent Stereotactic Biopsy|Overall Study||30||
48676198|NCT01182350|101989993|FG001|Underwent Stereotactic Biopsy|Overall Study||14||
48676199|NCT01182350|101989994|FG002|Underwent Stereotactic Biopsy|Overall Study||3||
48676200|NCT01182350|101989995|FG003|Underwent Stereotactic Biopsy|Overall Study||3||
48676201|NCT01182350|101989996|FG004|Underwent Stereotactic Biopsy|Overall Study||0||
48676202|NCT01182350|101989992|FG000|Started Assigned Chemoradiation|Overall Study||27||
48676203|NCT01182350|101989993|FG001|Started Assigned Chemoradiation|Overall Study||14||
48676204|NCT01182350|101989994|FG002|Started Assigned Chemoradiation|Overall Study||2||
48676205|NCT01182350|101989995|FG003|Started Assigned Chemoradiation|Overall Study||2||
48676206|NCT01182350|101989996|FG004|Started Assigned Chemoradiation|Overall Study||0||
48676207|NCT01182350|101989992|FG000|COMPLETED|Overall Study||3||
48676208|NCT01182350|101989993|FG001|COMPLETED|Overall Study||0||
48676209|NCT01182350|101989994|FG002|COMPLETED|Overall Study||0||
48676210|NCT01182350|101989995|FG003|COMPLETED|Overall Study||0||
48676211|NCT01182350|101989996|FG004|COMPLETED|Overall Study||0||
48676212|NCT01182350|101989992|FG000|NOT COMPLETED|Overall Study||27||
48676213|NCT01182350|101989993|FG001|NOT COMPLETED|Overall Study||14||
48676214|NCT01182350|101989994|FG002|NOT COMPLETED|Overall Study||3||
48676215|NCT01182350|101989995|FG003|NOT COMPLETED|Overall Study||3||
48676216|NCT01182350|101989996|FG004|NOT COMPLETED|Overall Study||3||
48676217|NCT02947984|101989997|FG000|STARTED|Overall Study||22||
48676218|NCT02947984|101989998|FG001|STARTED|Overall Study||22||
48676219|NCT02947984|101989997|FG000|COMPLETED|Overall Study||22||
48676220|NCT02947984|101989998|FG001|COMPLETED|Overall Study||22||
48676221|NCT02947984|101989997|FG000|NOT COMPLETED|Overall Study||0||
48676222|NCT02947984|101989998|FG001|NOT COMPLETED|Overall Study||0||
48676223|NCT03984825|101989999|FG000|STARTED|Run-in Period (Day -3 to -1)||23||
48676224|NCT03984825|101989999|FG000|COMPLETED|Run-in Period (Day -3 to -1)||23||
48676225|NCT03984825|101989999|FG000|NOT COMPLETED|Run-in Period (Day -3 to -1)||0||
48676226|NCT03984825|101989999|FG000|STARTED|Treatment Period 1 (Day 1 to 10)||23||
48676227|NCT03984825|101989999|FG000|COMPLETED|Treatment Period 1 (Day 1 to 10)||21||
48676228|NCT03984825|101989999|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 to 10)||2||
48676229|NCT03984825|101989999|FG000|STARTED|Treatment Period 2 (Day 11 to 21)||21||
48676230|NCT03984825|101989999|FG000|COMPLETED|Treatment Period 2 (Day 11 to 21)||17||
48676231|NCT03984825|101989999|FG000|NOT COMPLETED|Treatment Period 2 (Day 11 to 21)||4||
48676232|NCT00366457|101990000|FG000|STARTED|Overall Study||32||
48676233|NCT00366457|101990000|FG000|COMPLETED|Overall Study||30||
48676234|NCT00366457|101990000|FG000|NOT COMPLETED|Overall Study||2||
48676235|NCT00633126|101990001|FG000|STARTED|Overall Study||9||
48239633|NCT00832650|100908900|FG000|Treated|Overall Study||25||
48239634|NCT00832650|100908901|FG001|Treated|Overall Study||12||
48239635|NCT00832650|100908902|FG002|Treated|Overall Study||22||
48539773|NCT04711902|101657933|FG001|NOT COMPLETED|Treatment Period 1 (1st 16 Weeks)||0||
48539774|NCT04711902|101657934|FG002|NOT COMPLETED|Treatment Period 1 (1st 16 Weeks)||0||
48539775|NCT04711902|101657935|FG003|NOT COMPLETED|Treatment Period 1 (1st 16 Weeks)||0||
48539776|NCT04711902|101657936|FG004|NOT COMPLETED|Treatment Period 1 (1st 16 Weeks)||0||
48539777|NCT04711902|101657937|FG005|NOT COMPLETED|Treatment Period 1 (1st 16 Weeks)||0||
48539778|NCT04711902|101657932|FG000|STARTED|Treatment Period 2 (From Week 16)||0||
48676236|NCT00633126|101990001|FG000|COMPLETED|Overall Study||8||
48676237|NCT00633126|101990001|FG000|NOT COMPLETED|Overall Study||1||
48676238|NCT02412670|101990002|FG000|STARTED|Overall Study||30||
48676239|NCT02412670|101990003|FG001|STARTED|Overall Study||6||
48676240|NCT02412670|101990002|FG000|Eligible and Treated|Overall Study||29||
48539779|NCT04711902|101657933|FG001|STARTED|Treatment Period 2 (From Week 16)||0||
48239636|NCT00832650|100908900|FG000|COMPLETED|Overall Study||25||
48239637|NCT00832650|100908901|FG001|COMPLETED|Overall Study||12||
48239638|NCT00832650|100908902|FG002|COMPLETED|Overall Study||22||
48239639|NCT00832650|100908900|FG000|NOT COMPLETED|Overall Study||0||
48239640|NCT00832650|100908901|FG001|NOT COMPLETED|Overall Study||0||
48239641|NCT00832650|100908902|FG002|NOT COMPLETED|Overall Study||1||
48239642|NCT04909593|100908903|FG000|STARTED|Overall Study||21||
48676241|NCT02412670|101990003|FG001|Eligible and Treated|Overall Study||6||
48676242|NCT02412670|101990002|FG000|COMPLETED|Overall Study||23||
48676243|NCT02412670|101990003|FG001|COMPLETED|Overall Study||5||
48676244|NCT02412670|101990002|FG000|NOT COMPLETED|Overall Study||7||
48676245|NCT02412670|101990003|FG001|NOT COMPLETED|Overall Study||1||
48676246|NCT03323164|101990004|FG000|STARTED|Overall Study||18||
48676247|NCT03323164|101990005|FG001|STARTED|Overall Study||17||
48676248|NCT03323164|101990004|FG000|COMPLETED|Overall Study||16||
48676249|NCT03323164|101990005|FG001|COMPLETED|Overall Study||15||
48239643|NCT04909593|100908903|FG000|COMPLETED|Overall Study||20||
48239644|NCT04909593|100908903|FG000|NOT COMPLETED|Overall Study||1||
48239645|NCT01816165|100908904|FG000|STARTED|Overall Study||5||
48239646|NCT01816165|100908905|FG001|STARTED|Overall Study||4||
48239647|NCT01816165|100908906|FG002|STARTED|Overall Study||5||
48239648|NCT01816165|100908907|FG003|STARTED|Overall Study||4||
48239649|NCT01816165|100908904|FG000|Completed Intervention 1|Overall Study||4||
48239650|NCT01816165|100908905|FG001|Completed Intervention 1|Overall Study||4||
48676250|NCT03323164|101990004|FG000|NOT COMPLETED|Overall Study||2||
48676251|NCT03323164|101990005|FG001|NOT COMPLETED|Overall Study||2||
48676252|NCT02213250|101990006|FG000|STARTED|Overall Study||4||
48239651|NCT01816165|100908906|FG002|Completed Intervention 1|Overall Study||5||
48239652|NCT01816165|100908907|FG003|Completed Intervention 1|Overall Study||4||
48676253|NCT02213250|101990007|FG001|STARTED|Overall Study||8||
48676254|NCT02213250|101990006|FG000|COMPLETED|Overall Study||4||
48676255|NCT02213250|101990007|FG001|COMPLETED|Overall Study||8||
48676256|NCT02213250|101990006|FG000|NOT COMPLETED|Overall Study||0||
48676257|NCT02213250|101990007|FG001|NOT COMPLETED|Overall Study||0||
48676258|NCT01131052|101990008|FG000|STARTED|Overall Study||75||
48676259|NCT01131052|101990009|FG001|STARTED|Overall Study||75||
48676260|NCT01131052|101990008|FG000|COMPLETED|Overall Study||75||
48676261|NCT01131052|101990009|FG001|COMPLETED|Overall Study||75||
48676262|NCT01131052|101990008|FG000|NOT COMPLETED|Overall Study||0||
48676263|NCT01131052|101990009|FG001|NOT COMPLETED|Overall Study||0||
48676264|NCT00313560|101990010|FG000|STARTED|Overall Study||48||
48676265|NCT00313560|101990010|FG000|COMPLETED|Overall Study||48||
48676266|NCT00313560|101990010|FG000|NOT COMPLETED|Overall Study||0||
48676267|NCT03198871|101990011|FG000|STARTED|Overall Study||90||
48676268|NCT03198871|101990012|FG001|STARTED|Overall Study||90||
48676269|NCT03198871|101990011|FG000|COMPLETED|Overall Study||76||
48676270|NCT03198871|101990012|FG001|COMPLETED|Overall Study||78||
48676271|NCT03198871|101990011|FG000|NOT COMPLETED|Overall Study||14||
48676272|NCT03198871|101990012|FG001|NOT COMPLETED|Overall Study||12||
48239653|NCT01816165|100908904|FG000|Completed ~2 Week Washout|Overall Study||4||
48239654|NCT01816165|100908905|FG001|Completed ~2 Week Washout|Overall Study||4||
48239655|NCT01816165|100908906|FG002|Completed ~2 Week Washout|Overall Study||5||
48239656|NCT01816165|100908907|FG003|Completed ~2 Week Washout|Overall Study||4||
48239657|NCT01816165|100908904|FG000|Started Second Intervention|Overall Study||4||
48239658|NCT01816165|100908905|FG001|Started Second Intervention|Overall Study||4||
48239659|NCT01816165|100908906|FG002|Started Second Intervention|Overall Study||5||
48239660|NCT01816165|100908907|FG003|Started Second Intervention|Overall Study||4||
48239661|NCT01816165|100908904|FG000|COMPLETED|Overall Study||4||
48239662|NCT01816165|100908905|FG001|COMPLETED|Overall Study||4||
48239663|NCT01816165|100908906|FG002|COMPLETED|Overall Study||5||
48239664|NCT01816165|100908907|FG003|COMPLETED|Overall Study||4||
48239665|NCT01816165|100908904|FG000|NOT COMPLETED|Overall Study||1||
48676273|NCT01227057|101990013|FG000|STARTED|Overall Study||31||
48676274|NCT01227057|101990014|FG001|STARTED|Overall Study||27||
48676275|NCT01227057|101990013|FG000|COMPLETED|Overall Study||25||
48676276|NCT01227057|101990014|FG001|COMPLETED|Overall Study||19||
48676277|NCT01227057|101990013|FG000|NOT COMPLETED|Overall Study||6||
48676278|NCT01227057|101990014|FG001|NOT COMPLETED|Overall Study||8||
48239666|NCT01816165|100908905|FG001|NOT COMPLETED|Overall Study||0||
48239667|NCT01816165|100908906|FG002|NOT COMPLETED|Overall Study||0||
48239668|NCT01816165|100908907|FG003|NOT COMPLETED|Overall Study||0||
48239669|NCT04944784|100908908|FG000|STARTED|Double-blind Period||325||
48239670|NCT04944784|100908909|FG001|STARTED|Double-blind Period||161||
48239671|NCT04944784|100908910|FG002|STARTED|Double-blind Period||0||
48239672|NCT04944784|100908911|FG003|STARTED|Double-blind Period||0||
48676279|NCT00512070|101990015|FG000|STARTED|Phase I - Olanzapine Only||17||
48676280|NCT00512070|101990016|FG001|STARTED|Phase I - Olanzapine Only||0||
48676281|NCT00512070|101990017|FG002|STARTED|Phase I - Olanzapine Only||0||
48239673|NCT04944784|100908908|FG000|COMPLETED|Double-blind Period||180||
48239674|NCT04944784|100908909|FG001|COMPLETED|Double-blind Period||96||
48676282|NCT00512070|101990015|FG000|COMPLETED|Phase I - Olanzapine Only||13||
48676283|NCT00512070|101990016|FG001|COMPLETED|Phase I - Olanzapine Only||0||
48676284|NCT00512070|101990017|FG002|COMPLETED|Phase I - Olanzapine Only||0||
48676285|NCT00512070|101990015|FG000|NOT COMPLETED|Phase I - Olanzapine Only||4||
48239675|NCT04944784|100908910|FG002|COMPLETED|Double-blind Period||0||
48239676|NCT04944784|100908911|FG003|COMPLETED|Double-blind Period||0||
48239677|NCT04944784|100908908|FG000|NOT COMPLETED|Double-blind Period||145||
48239678|NCT04944784|100908909|FG001|NOT COMPLETED|Double-blind Period||65||
48676286|NCT00512070|101990016|FG001|NOT COMPLETED|Phase I - Olanzapine Only||0||
48676287|NCT00512070|101990017|FG002|NOT COMPLETED|Phase I - Olanzapine Only||0||
48676288|NCT00512070|101990015|FG000|STARTED|Phase II - Randomization to Melatonin||0||
48676289|NCT00512070|101990016|FG001|STARTED|Phase II - Randomization to Melatonin||6||
48676290|NCT00512070|101990017|FG002|STARTED|Phase II - Randomization to Melatonin||7||
48676291|NCT00512070|101990015|FG000|COMPLETED|Phase II - Randomization to Melatonin||0||
48676292|NCT00512070|101990016|FG001|COMPLETED|Phase II - Randomization to Melatonin||4||
48676293|NCT00512070|101990017|FG002|COMPLETED|Phase II - Randomization to Melatonin||6||
48676294|NCT00512070|101990015|FG000|NOT COMPLETED|Phase II - Randomization to Melatonin||0||
48676295|NCT00512070|101990016|FG001|NOT COMPLETED|Phase II - Randomization to Melatonin||2||
48676296|NCT00512070|101990017|FG002|NOT COMPLETED|Phase II - Randomization to Melatonin||1||
48676297|NCT02161536|101990018|FG000|STARTED|Overall Study||6||
48676298|NCT02161536|101990019|FG001|STARTED|Overall Study||21||
48676299|NCT02161536|101990020|FG002|STARTED|Overall Study||20||
48676300|NCT02161536|101990018|FG000|COMPLETED|Overall Study||6||
48239679|NCT04944784|100908910|FG002|NOT COMPLETED|Double-blind Period||0||
48239680|NCT04944784|100908911|FG003|NOT COMPLETED|Double-blind Period||0||
48239681|NCT04944784|100908908|FG000|STARTED|Active Drug Period||0||
48239682|NCT04944784|100908909|FG001|STARTED|Active Drug Period||0||
48239683|NCT04944784|100908910|FG002|STARTED|Active Drug Period||96||
48239684|NCT04944784|100908911|FG003|STARTED|Active Drug Period||180||
48239685|NCT04944784|100908908|FG000|COMPLETED|Active Drug Period||0||
48239686|NCT04944784|100908909|FG001|COMPLETED|Active Drug Period||0||
48239687|NCT04944784|100908910|FG002|COMPLETED|Active Drug Period||31||
48239688|NCT04944784|100908911|FG003|COMPLETED|Active Drug Period||62||
48239689|NCT04944784|100908908|FG000|NOT COMPLETED|Active Drug Period||0||
48239690|NCT04944784|100908909|FG001|NOT COMPLETED|Active Drug Period||0||
48239691|NCT04944784|100908910|FG002|NOT COMPLETED|Active Drug Period||65||
48239692|NCT04944784|100908911|FG003|NOT COMPLETED|Active Drug Period||118||
48239693|NCT00871494|100908912|FG000|STARTED|Overall Study||76||
48239694|NCT00871494|100908912|FG000|COMPLETED|Overall Study||62||
48239695|NCT00871494|100908912|FG000|NOT COMPLETED|Overall Study||14||
48239696|NCT04908488|100908913|FG000|STARTED|First Wear Period (8 -0/+3 Days)||56||112
48239697|NCT04908488|100908914|FG001|STARTED|First Wear Period (8 -0/+3 Days)||58||116
48239698|NCT04908488|100908913|FG000|COMPLETED|First Wear Period (8 -0/+3 Days)||55||110
48239699|NCT04908488|100908914|FG001|COMPLETED|First Wear Period (8 -0/+3 Days)||58||116
48239700|NCT04908488|100908913|FG000|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||1||2
48239701|NCT04908488|100908914|FG001|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0||0
48239702|NCT04908488|100908913|FG000|STARTED|Second Wear Period (8 -0/+3 Days)||55||110
48239703|NCT04908488|100908914|FG001|STARTED|Second Wear Period (8 -0/+3 Days)||58||116
48239704|NCT04908488|100908913|FG000|COMPLETED|Second Wear Period (8 -0/+3 Days)||54||108
48239705|NCT04908488|100908914|FG001|COMPLETED|Second Wear Period (8 -0/+3 Days)||58||116
48239706|NCT04908488|100908913|FG000|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||1||2
48239707|NCT04908488|100908914|FG001|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0||0
48239708|NCT04417907|100908915|FG000|STARTED|Overall Study||4||
48239709|NCT04417907|100908916|FG001|STARTED|Overall Study||7||
48239710|NCT04417907|100908917|FG002|STARTED|Overall Study||7||
48239711|NCT04417907|100908918|FG003|STARTED|Overall Study||11||
48239712|NCT04417907|100908915|FG000|COMPLETED|Overall Study||2||
48239713|NCT04417907|100908916|FG001|COMPLETED|Overall Study||3||
48239714|NCT04417907|100908917|FG002|COMPLETED|Overall Study||6||
48676301|NCT02161536|101990019|FG001|COMPLETED|Overall Study||21||
48676302|NCT02161536|101990020|FG002|COMPLETED|Overall Study||20||
48676303|NCT02161536|101990018|FG000|NOT COMPLETED|Overall Study||0||
48676304|NCT02161536|101990019|FG001|NOT COMPLETED|Overall Study||0||
48676305|NCT02161536|101990020|FG002|NOT COMPLETED|Overall Study||0||
48676306|NCT02493764|101990021|FG000|STARTED|Overall Study||268||
48676307|NCT02493764|101990022|FG001|STARTED|Overall Study||269||
48676308|NCT02493764|101990021|FG000|COMPLETED|Overall Study||185||
48676309|NCT02493764|101990022|FG001|COMPLETED|Overall Study||187||
48676310|NCT02493764|101990021|FG000|NOT COMPLETED|Overall Study||83||
48676311|NCT02493764|101990022|FG001|NOT COMPLETED|Overall Study||82||
48239715|NCT04417907|100908918|FG003|COMPLETED|Overall Study||8||
48676312|NCT01332981|101990023|FG000|STARTED|Overall Study||220||
48676313|NCT01332981|101990023|FG000|COMPLETED|Overall Study||220||
48676314|NCT01332981|101990023|FG000|NOT COMPLETED|Overall Study||0||
48676315|NCT03139448|101990024|FG000|STARTED|Overall Study||85|All participants randomized|
48676316|NCT03139448|101990025|FG001|STARTED|Overall Study||89|All participants randomized|
48239716|NCT04417907|100908915|FG000|NOT COMPLETED|Overall Study||2||
48239717|NCT04417907|100908916|FG001|NOT COMPLETED|Overall Study||4||
48239718|NCT04417907|100908917|FG002|NOT COMPLETED|Overall Study||1||
48239719|NCT04417907|100908918|FG003|NOT COMPLETED|Overall Study||3||
48239720|NCT01524887|100908919|FG000|STARTED|Overall Study||85||
48239721|NCT01524887|100908920|FG001|STARTED|Overall Study||90||
48710649|NCT02961790|102077984|FG001|STARTED|Overall Study||51||
48676317|NCT03139448|101990024|FG000|Intervention Started|Overall Study||79|All participants that received partial or full intervention|
48676318|NCT03139448|101990025|FG001|Intervention Started|Overall Study||70|All participants that received partial or full intervention|
48676319|NCT03139448|101990024|FG000|COMPLETED|Overall Study||73|Participants that received a full intervention|
48676320|NCT03139448|101990025|FG001|COMPLETED|Overall Study||63|Participants that received a full intervention|
48676321|NCT03139448|101990024|FG000|NOT COMPLETED|Overall Study||12||
48676322|NCT03139448|101990025|FG001|NOT COMPLETED|Overall Study||26||
48676323|NCT00639457|101990026|FG000|STARTED|Overall Study||22||
48676324|NCT00639457|101990027|FG001|STARTED|Overall Study||22||
48676325|NCT00639457|101990026|FG000|COMPLETED|Overall Study||20||
48676326|NCT00639457|101990027|FG001|COMPLETED|Overall Study||19||
48676327|NCT00639457|101990026|FG000|NOT COMPLETED|Overall Study||2||
48676328|NCT00639457|101990027|FG001|NOT COMPLETED|Overall Study||3||
48676329|NCT00271544|101990028|FG000|STARTED|Overall Study||190||
48676330|NCT00271544|101990028|FG000|Implant Attempted|Overall Study||186||
48676331|NCT00271544|101990028|FG000|Model 4196 Lead Attempted|Overall Study||177||
48676332|NCT00271544|101990028|FG000|COMPLETED|Overall Study||170||
48676333|NCT00271544|101990028|FG000|NOT COMPLETED|Overall Study||20||
48676334|NCT00716820|101990029|FG000|STARTED|Overall Study||472||
48676335|NCT00716820|101990029|FG000|COMPLETED|Overall Study||472||
48676336|NCT00716820|101990029|FG000|NOT COMPLETED|Overall Study||0||
48676337|NCT01076010|101991851|FG000|STARTED|Overall Study||161||
48676338|NCT01076010|101991852|FG001|STARTED|Overall Study||88||
48676339|NCT01076010|101991853|FG002|STARTED|Overall Study||28||
48676340|NCT01076010|101991851|FG000|COMPLETED|Overall Study||36||
48676341|NCT01076010|101991852|FG001|COMPLETED|Overall Study||49||
48676342|NCT01076010|101991853|FG002|COMPLETED|Overall Study||26||
48676343|NCT01076010|101991851|FG000|NOT COMPLETED|Overall Study||125||
48676344|NCT01076010|101991852|FG001|NOT COMPLETED|Overall Study||39||
48676345|NCT01076010|101991853|FG002|NOT COMPLETED|Overall Study||2||
48676346|NCT00967616|101991854|FG000|STARTED|Overall Study||50||
48676347|NCT00967616|101991855|FG001|STARTED|Overall Study||50||
48676348|NCT00967616|101991854|FG000|COMPLETED|Overall Study||0||
48676349|NCT00967616|101991855|FG001|COMPLETED|Overall Study||0||
48676350|NCT00967616|101991854|FG000|NOT COMPLETED|Overall Study||50||
48676351|NCT00967616|101991855|FG001|NOT COMPLETED|Overall Study||50||
48676352|NCT01561833|101991856|FG000|STARTED|Overall Study||12||
48676353|NCT01561833|101991856|FG000|COMPLETED|Overall Study||12||
48676354|NCT01561833|101991856|FG000|NOT COMPLETED|Overall Study||0||
48676355|NCT04108273|101991857|FG000|STARTED|Overall Study||30||
48676356|NCT04108273|101991858|FG001|STARTED|Overall Study||29||
48676357|NCT04108273|101991857|FG000|COMPLETED|Overall Study||29||
48676358|NCT04108273|101991858|FG001|COMPLETED|Overall Study||29||
48676359|NCT04108273|101991857|FG000|NOT COMPLETED|Overall Study||1||
48676360|NCT04108273|101991858|FG001|NOT COMPLETED|Overall Study||0||
48676361|NCT04136145|101991859|FG000|STARTED|Overall Study||12||
48676362|NCT04136145|101991860|FG001|STARTED|Overall Study||24||
48676363|NCT04136145|101991859|FG000|COMPLETED|Overall Study||12||
48676364|NCT04136145|101991860|FG001|COMPLETED|Overall Study||24||
48676365|NCT04136145|101991859|FG000|NOT COMPLETED|Overall Study||0||
48676366|NCT04136145|101991860|FG001|NOT COMPLETED|Overall Study||0||
48676367|NCT02078869|101991861|FG000|STARTED|Overall Study||17||
48676368|NCT02078869|101991862|FG001|STARTED|Overall Study||17||
48676369|NCT02078869|101991861|FG000|COMPLETED|Overall Study||17||
48676370|NCT02078869|101991862|FG001|COMPLETED|Overall Study||17||
48676371|NCT02078869|101991861|FG000|NOT COMPLETED|Overall Study||0||
48676372|NCT02078869|101991862|FG001|NOT COMPLETED|Overall Study||0||
48676373|NCT05395936|101991863|FG000|STARTED|Overall Study||19||
48676374|NCT05395936|101991863|FG000|COMPLETED|Overall Study||19||
48676375|NCT05395936|101991863|FG000|NOT COMPLETED|Overall Study||0||
48676376|NCT03085680|101991864|FG000|STARTED|Overall Study||9||
48676377|NCT03085680|101991865|FG001|STARTED|Overall Study||8||
48676378|NCT03085680|101991864|FG000|COMPLETED|Overall Study||9||
48676379|NCT03085680|101991865|FG001|COMPLETED|Overall Study||8||
48676380|NCT03085680|101991864|FG000|NOT COMPLETED|Overall Study||0||
48676381|NCT03085680|101991865|FG001|NOT COMPLETED|Overall Study||0||
48676382|NCT00077974|101991866|FG000|STARTED|Overall Study||106||
48676383|NCT00077974|101991866|FG000|COMPLETED|Overall Study||2||
48676384|NCT00077974|101991866|FG000|NOT COMPLETED|Overall Study||104||
48676385|NCT03722810|101991867|FG000|STARTED|Overall Study||157||
48676386|NCT03722810|101991868|FG001|STARTED|Overall Study||160||
48676387|NCT03722810|101991867|FG000|COMPLETED|Overall Study||150||
48676388|NCT03722810|101991868|FG001|COMPLETED|Overall Study||156||
48676389|NCT03722810|101991867|FG000|NOT COMPLETED|Overall Study||7||
48676390|NCT03722810|101991868|FG001|NOT COMPLETED|Overall Study||4||
48676391|NCT02751814|101991869|FG000|STARTED|Overall Study||175||
48676392|NCT02751814|101991869|FG000|Completed Baseline Assessments|Overall Study||112||
48676393|NCT02751814|101991869|FG000|COMPLETED|Overall Study||130||
48676394|NCT02751814|101991869|FG000|NOT COMPLETED|Overall Study||45||
48676395|NCT01882816|101991870|FG000|STARTED|Overall Study||27||
48676396|NCT01882816|101991870|FG000|COMPLETED|Overall Study||27||
48676397|NCT01882816|101991870|FG000|NOT COMPLETED|Overall Study||0||
48676398|NCT03564886|101991871|FG000|STARTED|Overall Study||24||
48676399|NCT03564886|101991872|FG001|STARTED|Overall Study||24||
48676400|NCT03564886|101991871|FG000|COMPLETED|Overall Study||23||
48676401|NCT03564886|101991872|FG001|COMPLETED|Overall Study||23||
48676402|NCT03564886|101991871|FG000|NOT COMPLETED|Overall Study||1||
48676403|NCT03564886|101991872|FG001|NOT COMPLETED|Overall Study||1||
48676404|NCT00710593|101991873|FG000|STARTED|Overall Study||69||
48676405|NCT00710593|101991874|FG001|STARTED|Overall Study||30||
48676406|NCT00710593|101991873|FG000|COMPLETED|Overall Study||54||
48676407|NCT00710593|101991874|FG001|COMPLETED|Overall Study||25||
48676408|NCT00710593|101991873|FG000|NOT COMPLETED|Overall Study||15||
48676409|NCT00710593|101991874|FG001|NOT COMPLETED|Overall Study||5||
48676410|NCT01161771|101991875|FG000|STARTED|Overall Study||32||
48676411|NCT01161771|101991875|FG000|COMPLETED|Overall Study||32||
48676412|NCT01161771|101991875|FG000|NOT COMPLETED|Overall Study||0||
48676413|NCT02297412|101991876|FG000|STARTED|Overall Study||23||
48676414|NCT02297412|101991877|FG001|STARTED|Overall Study||24||
48676415|NCT02297412|101991876|FG000|COMPLETED|Overall Study||22||
48676416|NCT02297412|101991877|FG001|COMPLETED|Overall Study||23||
48676417|NCT02297412|101991876|FG000|NOT COMPLETED|Overall Study||1||
48676418|NCT02297412|101991877|FG001|NOT COMPLETED|Overall Study||1||
48676419|NCT01645176|101991878|FG000|STARTED|Overall Study||21||21
48676420|NCT01645176|101991878|FG000|COMPLETED|Overall Study||16||16
48676421|NCT01645176|101991878|FG000|NOT COMPLETED|Overall Study||5||5
48676422|NCT00613106|101991879|FG000|STARTED|Overall Study||132||
48676423|NCT00613106|101991880|FG001|STARTED|Overall Study||47||
48676424|NCT00613106|101991879|FG000|COMPLETED|Overall Study||112||
48676425|NCT00613106|101991880|FG001|COMPLETED|Overall Study||38||
48676426|NCT00613106|101991879|FG000|NOT COMPLETED|Overall Study||20||
48676427|NCT00613106|101991880|FG001|NOT COMPLETED|Overall Study||9||
48676428|NCT02972996|101991881|FG000|STARTED|Overall Study||27||
48676429|NCT02972996|101991882|FG001|STARTED|Overall Study||28||
48676430|NCT02972996|101991881|FG000|COMPLETED|Overall Study||26||
48676431|NCT02972996|101991882|FG001|COMPLETED|Overall Study||26||
48676432|NCT02972996|101991881|FG000|NOT COMPLETED|Overall Study||1||
48676433|NCT02972996|101991882|FG001|NOT COMPLETED|Overall Study||2||
48676434|NCT01416025|101991883|FG000|STARTED|Overall Study||14||
48676435|NCT01416025|101991884|FG001|STARTED|Overall Study||15||
48676436|NCT01416025|101991883|FG000|COMPLETED|Overall Study||14||
48676437|NCT01416025|101991884|FG001|COMPLETED|Overall Study||15||
48676438|NCT01416025|101991883|FG000|NOT COMPLETED|Overall Study||0||
48676439|NCT01416025|101991884|FG001|NOT COMPLETED|Overall Study||0||
48676440|NCT02261961|101991885|FG000|STARTED|Overall Study||22||
48676441|NCT02261961|101991886|FG001|STARTED|Overall Study||22||
48676442|NCT02261961|101991885|FG000|COMPLETED|Overall Study||13||
48676443|NCT02261961|101991886|FG001|COMPLETED|Overall Study||20||
48676444|NCT02261961|101991885|FG000|NOT COMPLETED|Overall Study||9||
48676445|NCT02261961|101991886|FG001|NOT COMPLETED|Overall Study||2||
48676446|NCT04031729|101991887|FG000|STARTED|Overall Study||40||
48676447|NCT04031729|101991888|FG001|STARTED|Overall Study||40||
48676448|NCT04031729|101991887|FG000|COMPLETED|Overall Study||37||
48676449|NCT04031729|101991888|FG001|COMPLETED|Overall Study||34||
48676450|NCT04031729|101991887|FG000|NOT COMPLETED|Overall Study||3||
48676451|NCT04031729|101991888|FG001|NOT COMPLETED|Overall Study||6||
48676452|NCT01246960|101991889|FG000|STARTED|Overall Study||84||
48676453|NCT01246960|101991890|FG001|STARTED|Overall Study||84||
48676454|NCT01246960|101991889|FG000|Received Any Quantity of Study Drug|Overall Study||82||
48676455|NCT01246960|101991890|FG001|Received Any Quantity of Study Drug|Overall Study||80||
48676456|NCT01246960|101991889|FG000|COMPLETED|Overall Study||78||
48676457|NCT01246960|101991890|FG001|COMPLETED|Overall Study||80||
48676458|NCT01246960|101991889|FG000|NOT COMPLETED|Overall Study||6||
48676459|NCT01246960|101991890|FG001|NOT COMPLETED|Overall Study||4||
48676460|NCT03763747|101991891|FG000|STARTED|Overall Study||200||
48676461|NCT03763747|101991891|FG000|COMPLETED|Overall Study||200||
48676462|NCT03763747|101991891|FG000|NOT COMPLETED|Overall Study||0||
48676463|NCT04043286|101991892|FG000|STARTED|Overall Study||19||20
48081110|NCT03129100|100521636|FG023|COMPLETED|Lead-In Period (Period 1)||0||
48081111|NCT03129100|100521637|FG024|COMPLETED|Lead-In Period (Period 1)||0||
48676464|NCT04043286|101991893|FG001|STARTED|Overall Study||19||20
48676465|NCT04043286|101991892|FG000|COMPLETED|Overall Study||17||19
48676466|NCT04043286|101991893|FG001|COMPLETED|Overall Study||17||19
48676467|NCT04043286|101991892|FG000|NOT COMPLETED|Overall Study||2||1
48676468|NCT04043286|101991893|FG001|NOT COMPLETED|Overall Study||2||1
48676469|NCT01816295|101991894|FG000|STARTED|Double Blind Phase||357||
48676470|NCT01816295|101991895|FG001|STARTED|Double Blind Phase||358||
48676471|NCT01816295|101991894|FG000|Received Study Drug|Double Blind Phase||356||
48676472|NCT01816295|101991895|FG001|Received Study Drug|Double Blind Phase||354||
48676473|NCT01816295|101991894|FG000|COMPLETED|Double Blind Phase||294||
48676474|NCT01816295|101991895|FG001|COMPLETED|Double Blind Phase||302||
48676475|NCT01816295|101991894|FG000|NOT COMPLETED|Double Blind Phase||63||
48676476|NCT01816295|101991895|FG001|NOT COMPLETED|Double Blind Phase||56||
48676477|NCT01816295|101991894|FG000|STARTED|OLE Phase||275||
48676478|NCT01816295|101991895|FG001|STARTED|OLE Phase||283||
48676479|NCT01816295|101991894|FG000|COMPLETED|OLE Phase||222||
48676480|NCT01816295|101991895|FG001|COMPLETED|OLE Phase||227||
48676481|NCT01816295|101991894|FG000|NOT COMPLETED|OLE Phase||53||
48676482|NCT01816295|101991895|FG001|NOT COMPLETED|OLE Phase||56||
48676483|NCT04358406|101991896|FG000|STARTED|Overall Study||33|Randomized|
48676484|NCT04358406|101991897|FG001|STARTED|Overall Study||31|Randomized|
48676485|NCT04358406|101991896|FG000|Randomized|Overall Study||33||
48676486|NCT04358406|101991897|FG001|Randomized|Overall Study||31||
48676487|NCT04358406|101991896|FG000|Treated|Overall Study||31||
48676488|NCT04358406|101991897|FG001|Treated|Overall Study||30||
48676489|NCT04358406|101991896|FG000|COMPLETED|Overall Study||27||
48676490|NCT04358406|101991897|FG001|COMPLETED|Overall Study||27||
48676491|NCT04358406|101991896|FG000|NOT COMPLETED|Overall Study||6||
48676492|NCT04358406|101991897|FG001|NOT COMPLETED|Overall Study||4||
48676493|NCT00328172|101991898|FG000|STARTED|Overall Study||67||
48676494|NCT00328172|101991899|FG001|STARTED|Overall Study||58||
48676495|NCT00328172|101991900|FG002|STARTED|Overall Study||57||
48676496|NCT00328172|101991901|FG003|STARTED|Overall Study||55||
48676497|NCT00328172|101991902|FG004|STARTED|Overall Study||65||
48676498|NCT00328172|101991898|FG000|COMPLETED|Overall Study||45||
48676499|NCT00328172|101991899|FG001|COMPLETED|Overall Study||44||
48676500|NCT00328172|101991900|FG002|COMPLETED|Overall Study||47||
48676501|NCT00328172|101991901|FG003|COMPLETED|Overall Study||42||
48676502|NCT00328172|101991902|FG004|COMPLETED|Overall Study||60||
48676503|NCT00328172|101991898|FG000|NOT COMPLETED|Overall Study||22||
48676504|NCT00328172|101991899|FG001|NOT COMPLETED|Overall Study||14||
48676505|NCT00328172|101991900|FG002|NOT COMPLETED|Overall Study||10||
48676506|NCT00328172|101991901|FG003|NOT COMPLETED|Overall Study||13||
48676507|NCT00328172|101991902|FG004|NOT COMPLETED|Overall Study||5||
48676508|NCT00598507|101991903|FG000|STARTED|Overall Study||35||
48676509|NCT00598507|101991903|FG000|COMPLETED|Overall Study||35||
48676510|NCT00598507|101991903|FG000|NOT COMPLETED|Overall Study||0||
48676511|NCT01999192|101991904|FG000|STARTED|Main Phase I||83||
48676512|NCT01999192|101991905|FG001|STARTED|Main Phase I||80||
48676513|NCT01999192|101991906|FG002|STARTED|Main Phase I||78||
48676514|NCT01999192|101991907|FG003|STARTED|Main Phase I||80||
48676515|NCT01999192|101991904|FG000|COMPLETED|Main Phase I||72||
48676516|NCT01999192|101991905|FG001|COMPLETED|Main Phase I||70||
48239722|NCT01524887|100908921|FG002|STARTED|Overall Study||86||
48239723|NCT01524887|100908919|FG000|Received Treatment|Overall Study||83||
48239724|NCT01524887|100908920|FG001|Received Treatment|Overall Study||85||
48239725|NCT01524887|100908921|FG002|Received Treatment|Overall Study||83||
48239726|NCT01524887|100908919|FG000|COMPLETED|Overall Study||0||
48239727|NCT01524887|100908920|FG001|COMPLETED|Overall Study||0||
48239728|NCT01524887|100908921|FG002|COMPLETED|Overall Study||0||
48239729|NCT01524887|100908919|FG000|NOT COMPLETED|Overall Study||85||
48239730|NCT01524887|100908920|FG001|NOT COMPLETED|Overall Study||90||
48239731|NCT01524887|100908921|FG002|NOT COMPLETED|Overall Study||86||
48676517|NCT01999192|101991906|FG002|COMPLETED|Main Phase I||70||
48676518|NCT01999192|101991907|FG003|COMPLETED|Main Phase I||72||
48676519|NCT01999192|101991904|FG000|NOT COMPLETED|Main Phase I||11||
48676520|NCT01999192|101991905|FG001|NOT COMPLETED|Main Phase I||10||
48676521|NCT01999192|101991906|FG002|NOT COMPLETED|Main Phase I||8||
48676522|NCT01999192|101991907|FG003|NOT COMPLETED|Main Phase I||8||
48676523|NCT01999192|101991904|FG000|STARTED|Main Phase II||64||
48676524|NCT01999192|101991905|FG001|STARTED|Main Phase II||75||
48676525|NCT01999192|101991906|FG002|STARTED|Main Phase II||98||
48676526|NCT01999192|101991907|FG003|STARTED|Main Phase II||44||
48676527|NCT01999192|101991904|FG000|COMPLETED|Main Phase II||55||
48676528|NCT01999192|101991905|FG001|COMPLETED|Main Phase II||66||
48676529|NCT01999192|101991906|FG002|COMPLETED|Main Phase II||76||
48239732|NCT01786551|100908922|FG000|STARTED|Overall Study||16||
48239733|NCT01786551|100908922|FG000|COMPLETED|Overall Study||14||
48676530|NCT01999192|101991907|FG003|COMPLETED|Main Phase II||43||
48676531|NCT01999192|101991904|FG000|NOT COMPLETED|Main Phase II||9||
48676532|NCT01999192|101991905|FG001|NOT COMPLETED|Main Phase II||9||
48676533|NCT01999192|101991906|FG002|NOT COMPLETED|Main Phase II||22||
48676534|NCT01999192|101991907|FG003|NOT COMPLETED|Main Phase II||1||
48676535|NCT01999192|101991904|FG000|STARTED|Extension Phase||54||
48676536|NCT01999192|101991905|FG001|STARTED|Extension Phase||56||
48676537|NCT01999192|101991906|FG002|STARTED|Extension Phase||68||
48676538|NCT01999192|101991907|FG003|STARTED|Extension Phase||0||
48676539|NCT01999192|101991904|FG000|COMPLETED|Extension Phase||41||
48676540|NCT01999192|101991905|FG001|COMPLETED|Extension Phase||38||
48676541|NCT01999192|101991906|FG002|COMPLETED|Extension Phase||44||
48676542|NCT01999192|101991907|FG003|COMPLETED|Extension Phase||0||
48676543|NCT01999192|101991904|FG000|NOT COMPLETED|Extension Phase||13||
48676544|NCT01999192|101991905|FG001|NOT COMPLETED|Extension Phase||18||
48676545|NCT01999192|101991906|FG002|NOT COMPLETED|Extension Phase||24||
48676546|NCT01999192|101991907|FG003|NOT COMPLETED|Extension Phase||0||
48676547|NCT03528902|101991908|FG000|STARTED|Overall Study||9||
48676548|NCT03528902|101991909|FG001|STARTED|Overall Study||9||
48676549|NCT03528902|101991908|FG000|COMPLETED|Overall Study||8||
48676550|NCT03528902|101991909|FG001|COMPLETED|Overall Study||9||
48676551|NCT03528902|101991908|FG000|NOT COMPLETED|Overall Study||1||
48239734|NCT01786551|100908922|FG000|NOT COMPLETED|Overall Study||2||
48239735|NCT02740517|100908923|FG000|STARTED|Overall Study||19||
48239736|NCT02740517|100908924|FG001|STARTED|Overall Study||11||
48239737|NCT02740517|100908925|FG002|STARTED|Overall Study||18||
48239738|NCT02740517|100908923|FG000|COMPLETED|Overall Study||19||
48239739|NCT02740517|100908924|FG001|COMPLETED|Overall Study||11||
48239740|NCT02740517|100908925|FG002|COMPLETED|Overall Study||18||
48239741|NCT02740517|100908923|FG000|NOT COMPLETED|Overall Study||0||
48239742|NCT02740517|100908924|FG001|NOT COMPLETED|Overall Study||0||
48239743|NCT02740517|100908925|FG002|NOT COMPLETED|Overall Study||0||
48239744|NCT00914732|100908926|FG000|STARTED|Overall Study||165||
48239745|NCT00914732|100908927|FG001|STARTED|Overall Study||167||
48676552|NCT03528902|101991909|FG001|NOT COMPLETED|Overall Study||0||
48676553|NCT02031302|101991910|FG000|STARTED|Overall Study||1014||
48676554|NCT02031302|101991911|FG001|STARTED|Overall Study||50||
48676555|NCT02031302|101991910|FG000|COMPLETED|Overall Study||850||
48676556|NCT02031302|101991911|FG001|COMPLETED|Overall Study||50||
48676557|NCT02031302|101991910|FG000|NOT COMPLETED|Overall Study||164||
48676558|NCT02031302|101991911|FG001|NOT COMPLETED|Overall Study||0||
48676559|NCT04288089|101991912|FG000|STARTED|Overall Study||7||
48676560|NCT04288089|101991913|FG001|STARTED|Overall Study||8||
48676561|NCT04288089|101991914|FG002|STARTED|Overall Study||8||
48676562|NCT04288089|101991915|FG003|STARTED|Overall Study||8||
48676563|NCT04288089|101991912|FG000|COMPLETED|Overall Study||5||
48676564|NCT04288089|101991913|FG001|COMPLETED|Overall Study||7||
48676565|NCT04288089|101991914|FG002|COMPLETED|Overall Study||7||
48676566|NCT04288089|101991915|FG003|COMPLETED|Overall Study||4||
48676567|NCT04288089|101991912|FG000|NOT COMPLETED|Overall Study||2||
48676568|NCT04288089|101991913|FG001|NOT COMPLETED|Overall Study||1||
48676569|NCT04288089|101991914|FG002|NOT COMPLETED|Overall Study||1||
48676570|NCT04288089|101991915|FG003|NOT COMPLETED|Overall Study||4||
48676571|NCT05523323|101991916|FG000|STARTED|Overall Study||61||
48676572|NCT05523323|101991917|FG001|STARTED|Overall Study||51||
48676573|NCT05523323|101991916|FG000|Treated|Overall Study||61||
48676574|NCT05523323|101991917|FG001|Treated|Overall Study||50||
48239746|NCT00914732|100908928|FG002|STARTED|Overall Study||191||
48239747|NCT00914732|100908926|FG000|Received Second Vaccination|Overall Study||150||
48239748|NCT00914732|100908927|FG001|Received Second Vaccination|Overall Study||157||
48676575|NCT05523323|101991916|FG000|COMPLETED|Overall Study||0||
48676576|NCT05523323|101991917|FG001|COMPLETED|Overall Study||0||
48676577|NCT05523323|101991916|FG000|NOT COMPLETED|Overall Study||61||
48676578|NCT05523323|101991917|FG001|NOT COMPLETED|Overall Study||51||
48676579|NCT03807089|101991918|FG000|STARTED|Overall Study||101||
48676580|NCT03807089|101991919|FG001|STARTED|Overall Study||93||
48676581|NCT03807089|101991918|FG000|COMPLETED|Overall Study||101||
48676582|NCT03807089|101991919|FG001|COMPLETED|Overall Study||93||
48676583|NCT03807089|101991918|FG000|NOT COMPLETED|Overall Study||0||
48676584|NCT03807089|101991919|FG001|NOT COMPLETED|Overall Study||0||
48676585|NCT00027560|101991920|FG000|STARTED|Overall Study||51||
48676586|NCT00027560|101991920|FG000|COMPLETED|Overall Study||50||
48676587|NCT00027560|101991920|FG000|NOT COMPLETED|Overall Study||1||
48676588|NCT02421094|101991921|FG000|STARTED|Overall Study||15||
48676589|NCT02421094|101991922|FG001|STARTED|Overall Study||15||
48676590|NCT02421094|101991921|FG000|COMPLETED|Overall Study||15||
48676591|NCT02421094|101991922|FG001|COMPLETED|Overall Study||15||
48676592|NCT02421094|101991921|FG000|NOT COMPLETED|Overall Study||0||
48676593|NCT02421094|101991922|FG001|NOT COMPLETED|Overall Study||0||
48676594|NCT03064074|101991923|FG000|STARTED|Overall Study||4||
48676595|NCT03064074|101991924|FG001|STARTED|Overall Study||4||
48676596|NCT03064074|101991925|FG002|STARTED|Overall Study||2||
48676597|NCT03064074|101991926|FG003|STARTED|Overall Study||1||
48676598|NCT03064074|101991923|FG000|COMPLETED|Overall Study||4||
48676599|NCT03064074|101991924|FG001|COMPLETED|Overall Study||4||
48676600|NCT03064074|101991925|FG002|COMPLETED|Overall Study||2||
48676601|NCT03064074|101991926|FG003|COMPLETED|Overall Study||0||
48676602|NCT03064074|101991923|FG000|NOT COMPLETED|Overall Study||0||
48676603|NCT03064074|101991924|FG001|NOT COMPLETED|Overall Study||0||
48081112|NCT03129100|100521638|FG025|COMPLETED|Lead-In Period (Period 1)||0||
48081113|NCT03129100|100521613|FG000|NOT COMPLETED|Lead-In Period (Period 1)||15||
48239749|NCT00914732|100908928|FG002|Received Second Vaccination|Overall Study||153||
48239750|NCT00914732|100908926|FG000|COMPLETED|Overall Study||155||
48676604|NCT03064074|101991925|FG002|NOT COMPLETED|Overall Study||0||
48676605|NCT03064074|101991926|FG003|NOT COMPLETED|Overall Study||1||
48676606|NCT00361712|101991927|FG000|STARTED|Overall Study||20||
48676607|NCT00361712|101991928|FG001|STARTED|Overall Study||21||
48676608|NCT00361712|101991927|FG000|COMPLETED|Overall Study||20||
48676609|NCT00361712|101991928|FG001|COMPLETED|Overall Study||21||
48676610|NCT00361712|101991927|FG000|NOT COMPLETED|Overall Study||0||
48676611|NCT00361712|101991928|FG001|NOT COMPLETED|Overall Study||0||
48676612|NCT03326245|101991929|FG000|STARTED|Visit Day A (First Intervention)||8||
48676613|NCT03326245|101991930|FG001|STARTED|Visit Day A (First Intervention)||7||
48676614|NCT03326245|101991931|FG002|STARTED|Visit Day A (First Intervention)||7||
48676615|NCT03326245|101991929|FG000|COMPLETED|Visit Day A (First Intervention)||8||
48676616|NCT03326245|101991930|FG001|COMPLETED|Visit Day A (First Intervention)||7||
48676617|NCT03326245|101991931|FG002|COMPLETED|Visit Day A (First Intervention)||7||
48676618|NCT03326245|101991929|FG000|NOT COMPLETED|Visit Day A (First Intervention)||0||
48676619|NCT03326245|101991930|FG001|NOT COMPLETED|Visit Day A (First Intervention)||0||
48676620|NCT03326245|101991931|FG002|NOT COMPLETED|Visit Day A (First Intervention)||0||
48676621|NCT03326245|101991929|FG000|STARTED|Visit Day B (Second Intervention)||8||
48676622|NCT03326245|101991930|FG001|STARTED|Visit Day B (Second Intervention)||7||
48676623|NCT03326245|101991931|FG002|STARTED|Visit Day B (Second Intervention)||7||
48676624|NCT03326245|101991929|FG000|Randomized to Study Arm A|Visit Day B (Second Intervention)||0||
48239751|NCT00914732|100908927|FG001|COMPLETED|Overall Study||160||
48239752|NCT00914732|100908928|FG002|COMPLETED|Overall Study||180||
48239753|NCT00914732|100908926|FG000|NOT COMPLETED|Overall Study||10||
48239754|NCT00914732|100908927|FG001|NOT COMPLETED|Overall Study||7||
48239755|NCT00914732|100908928|FG002|NOT COMPLETED|Overall Study||11||
48239756|NCT04471428|100908929|FG000|STARTED|Overall Study||180||
48676625|NCT03326245|101991930|FG001|Randomized to Study Arm A|Visit Day B (Second Intervention)||4||
48676626|NCT03326245|101991931|FG002|Randomized to Study Arm A|Visit Day B (Second Intervention)||3||
48676627|NCT03326245|101991929|FG000|Randomized to Study Arm B|Visit Day B (Second Intervention)||4||
48239757|NCT04471428|100908930|FG001|STARTED|Overall Study||186||
48239758|NCT04471428|100908929|FG000|COMPLETED|Overall Study||0||
48239759|NCT04471428|100908930|FG001|COMPLETED|Overall Study||0||
48239760|NCT04471428|100908929|FG000|NOT COMPLETED|Overall Study||180||
48239761|NCT04471428|100908930|FG001|NOT COMPLETED|Overall Study||186||
48239762|NCT00402298|100908931|FG000|STARTED|Overall Study||3||
48676628|NCT03326245|101991930|FG001|Randomized to Study Arm B|Visit Day B (Second Intervention)||0||
48676629|NCT03326245|101991931|FG002|Randomized to Study Arm B|Visit Day B (Second Intervention)||4||
48676630|NCT03326245|101991929|FG000|Randomized to Study Arm C|Visit Day B (Second Intervention)||4||
48676631|NCT03326245|101991930|FG001|Randomized to Study Arm C|Visit Day B (Second Intervention)||3||
48676632|NCT03326245|101991931|FG002|Randomized to Study Arm C|Visit Day B (Second Intervention)||0||
48676633|NCT03326245|101991929|FG000|COMPLETED|Visit Day B (Second Intervention)||8||
48239763|NCT00402298|100908932|FG001|STARTED|Overall Study||2||
48239764|NCT00402298|100908931|FG000|COMPLETED|Overall Study||2||
48239765|NCT00402298|100908932|FG001|COMPLETED|Overall Study||2||
48239766|NCT00402298|100908931|FG000|NOT COMPLETED|Overall Study||1||
48239767|NCT00402298|100908932|FG001|NOT COMPLETED|Overall Study||0||
48239768|NCT01345253|100908933|FG000|STARTED|Double-blind (DB) Phase (52 Weeks)||226||
48239769|NCT01345253|100908934|FG001|STARTED|Double-blind (DB) Phase (52 Weeks)||451||
48676634|NCT03326245|101991930|FG001|COMPLETED|Visit Day B (Second Intervention)||7||
48239770|NCT01345253|100908933|FG000|COMPLETED|Double-blind (DB) Phase (52 Weeks)||170||
48239771|NCT01345253|100908934|FG001|COMPLETED|Double-blind (DB) Phase (52 Weeks)||372||
48239772|NCT01345253|100908933|FG000|NOT COMPLETED|Double-blind (DB) Phase (52 Weeks)||56||
48239773|NCT01345253|100908934|FG001|NOT COMPLETED|Double-blind (DB) Phase (52 Weeks)||79||
48239774|NCT01345253|100908933|FG000|STARTED|Open-label Phase (Up to Year 5 Week 44)||134||
48239775|NCT01345253|100908934|FG001|STARTED|Open-label Phase (Up to Year 5 Week 44)||290||
48239776|NCT01345253|100908933|FG000|COMPLETED|Open-label Phase (Up to Year 5 Week 44)||69||
48239777|NCT01345253|100908934|FG001|COMPLETED|Open-label Phase (Up to Year 5 Week 44)||146||
48239778|NCT01345253|100908933|FG000|NOT COMPLETED|Open-label Phase (Up to Year 5 Week 44)||65||
48239779|NCT01345253|100908934|FG001|NOT COMPLETED|Open-label Phase (Up to Year 5 Week 44)||144||
48239780|NCT02877680|100908935|FG000|STARTED|Overall Study||55||
48239781|NCT02877680|100908936|FG001|STARTED|Overall Study||25||
48239782|NCT02877680|100908935|FG000|COMPLETED|Overall Study||54||
48239783|NCT02877680|100908936|FG001|COMPLETED|Overall Study||24||
48239784|NCT02877680|100908935|FG000|NOT COMPLETED|Overall Study||1||
48239785|NCT02877680|100908936|FG001|NOT COMPLETED|Overall Study||1||
48239786|NCT03976102|100908937|FG000|STARTED|Overall Study||162||
48239787|NCT03976102|100908938|FG001|STARTED|Overall Study||155||
48239788|NCT03976102|100908937|FG000|COMPLETED|Overall Study||143||
48239789|NCT03976102|100908938|FG001|COMPLETED|Overall Study||129||
48239790|NCT03976102|100908937|FG000|NOT COMPLETED|Overall Study||19||
48239791|NCT03976102|100908938|FG001|NOT COMPLETED|Overall Study||26||
48239792|NCT01263223|100908939|FG000|STARTED|Period 1||12||
48239793|NCT01263223|100908940|FG001|STARTED|Period 1||12||
48239794|NCT01263223|100908939|FG000|COMPLETED|Period 1||12||
48239795|NCT01263223|100908940|FG001|COMPLETED|Period 1||12||
48239796|NCT01263223|100908939|FG000|NOT COMPLETED|Period 1||0||
48239797|NCT01263223|100908940|FG001|NOT COMPLETED|Period 1||0||
48676635|NCT03326245|101991931|FG002|COMPLETED|Visit Day B (Second Intervention)||7||
48676636|NCT03326245|101991929|FG000|NOT COMPLETED|Visit Day B (Second Intervention)||0||
48239798|NCT01263223|100908939|FG000|STARTED|3-Day Washout||12||
48239799|NCT01263223|100908940|FG001|STARTED|3-Day Washout||12||
48239800|NCT01263223|100908939|FG000|COMPLETED|3-Day Washout||12||
48239801|NCT01263223|100908940|FG001|COMPLETED|3-Day Washout||12||
48239802|NCT01263223|100908939|FG000|NOT COMPLETED|3-Day Washout||0||
48239803|NCT01263223|100908940|FG001|NOT COMPLETED|3-Day Washout||0||
48239804|NCT01263223|100908939|FG000|STARTED|Period 2||12||
48239805|NCT01263223|100908940|FG001|STARTED|Period 2||12||
48239806|NCT01263223|100908939|FG000|COMPLETED|Period 2||12||
48239807|NCT01263223|100908940|FG001|COMPLETED|Period 2||11||
48676637|NCT03326245|101991930|FG001|NOT COMPLETED|Visit Day B (Second Intervention)||0||
48676638|NCT03326245|101991931|FG002|NOT COMPLETED|Visit Day B (Second Intervention)||0||
48676639|NCT03326245|101991929|FG000|STARTED|Visit Day C (Third Intervention)||8||
48676640|NCT03326245|101991930|FG001|STARTED|Visit Day C (Third Intervention)||7||
48081114|NCT03129100|100521614|FG001|NOT COMPLETED|Lead-In Period (Period 1)||17||
48081115|NCT03129100|100521615|FG002|NOT COMPLETED|Lead-In Period (Period 1)||0||
48081116|NCT03129100|100521616|FG003|NOT COMPLETED|Lead-In Period (Period 1)||0||
48676641|NCT03326245|101991931|FG002|STARTED|Visit Day C (Third Intervention)||5||
48676642|NCT03326245|101991929|FG000|Randomized to Study Arm A|Visit Day C (Third Intervention)||0||
48081117|NCT03129100|100521617|FG004|NOT COMPLETED|Lead-In Period (Period 1)||0||
48081118|NCT03129100|100521618|FG005|NOT COMPLETED|Lead-In Period (Period 1)||0||
48081119|NCT03129100|100521619|FG006|NOT COMPLETED|Lead-In Period (Period 1)||0||
48081120|NCT03129100|100521620|FG007|NOT COMPLETED|Lead-In Period (Period 1)||0||
48081121|NCT03129100|100521621|FG008|NOT COMPLETED|Lead-In Period (Period 1)||0||
48081122|NCT03129100|100521622|FG009|NOT COMPLETED|Lead-In Period (Period 1)||0||
48081123|NCT03129100|100521623|FG010|NOT COMPLETED|Lead-In Period (Period 1)||0||
48081124|NCT03129100|100521624|FG011|NOT COMPLETED|Lead-In Period (Period 1)||0||
48081125|NCT03129100|100521625|FG012|NOT COMPLETED|Lead-In Period (Period 1)||0||
48081126|NCT03129100|100521626|FG013|NOT COMPLETED|Lead-In Period (Period 1)||0||
48081127|NCT03129100|100521627|FG014|NOT COMPLETED|Lead-In Period (Period 1)||0||
48081128|NCT03129100|100521628|FG015|NOT COMPLETED|Lead-In Period (Period 1)||0||
48081129|NCT03129100|100521629|FG016|NOT COMPLETED|Lead-In Period (Period 1)||0||
48081130|NCT03129100|100521630|FG017|NOT COMPLETED|Lead-In Period (Period 1)||0||
48081131|NCT03129100|100521631|FG018|NOT COMPLETED|Lead-In Period (Period 1)||0||
48081132|NCT03129100|100521632|FG019|NOT COMPLETED|Lead-In Period (Period 1)||0||
48081133|NCT03129100|100521633|FG020|NOT COMPLETED|Lead-In Period (Period 1)||0||
48081134|NCT03129100|100521634|FG021|NOT COMPLETED|Lead-In Period (Period 1)||0||
48081135|NCT03129100|100521635|FG022|NOT COMPLETED|Lead-In Period (Period 1)||0||
48081136|NCT03129100|100521636|FG023|NOT COMPLETED|Lead-In Period (Period 1)||0||
48081137|NCT03129100|100521637|FG024|NOT COMPLETED|Lead-In Period (Period 1)||0||
48081138|NCT03129100|100521638|FG025|NOT COMPLETED|Lead-In Period (Period 1)||0||
48081139|NCT03129100|100521613|FG000|STARTED|Period2 Extension Period (Group A and B)||0||
48081140|NCT03129100|100521614|FG001|STARTED|Period2 Extension Period (Group A and B)||0||
48081141|NCT03129100|100521615|FG002|STARTED|Period2 Extension Period (Group A and B)||255||
48081142|NCT03129100|100521616|FG003|STARTED|Period2 Extension Period (Group A and B)||318||
48081143|NCT03129100|100521617|FG004|STARTED|Period2 Extension Period (Group A and B)||48||
48081144|NCT03129100|100521618|FG005|STARTED|Period2 Extension Period (Group A and B)||54||
48081145|NCT03129100|100521619|FG006|STARTED|Period2 Extension Period (Group A and B)||53||
48081146|NCT03129100|100521620|FG007|STARTED|Period2 Extension Period (Group A and B)||0||
48081147|NCT03129100|100521621|FG008|STARTED|Period2 Extension Period (Group A and B)||0||
48081148|NCT03129100|100521622|FG009|STARTED|Period2 Extension Period (Group A and B)||0||
48081149|NCT03129100|100521623|FG010|STARTED|Period2 Extension Period (Group A and B)||0||
48081150|NCT03129100|100521624|FG011|STARTED|Period2 Extension Period (Group A and B)||0||
48081151|NCT03129100|100521625|FG012|STARTED|Period2 Extension Period (Group A and B)||0||
48081152|NCT03129100|100521626|FG013|STARTED|Period2 Extension Period (Group A and B)||0||
48081153|NCT03129100|100521627|FG014|STARTED|Period2 Extension Period (Group A and B)||0||
48081154|NCT03129100|100521628|FG015|STARTED|Period2 Extension Period (Group A and B)||0||
48081155|NCT03129100|100521629|FG016|STARTED|Period2 Extension Period (Group A and B)||0||
48081156|NCT03129100|100521630|FG017|STARTED|Period2 Extension Period (Group A and B)||0||
48081157|NCT03129100|100521631|FG018|STARTED|Period2 Extension Period (Group A and B)||0||
48081158|NCT03129100|100521632|FG019|STARTED|Period2 Extension Period (Group A and B)||0||
48081159|NCT03129100|100521633|FG020|STARTED|Period2 Extension Period (Group A and B)||0||
48081160|NCT03129100|100521634|FG021|STARTED|Period2 Extension Period (Group A and B)||0||
48081161|NCT03129100|100521635|FG022|STARTED|Period2 Extension Period (Group A and B)||0||
48081162|NCT03129100|100521636|FG023|STARTED|Period2 Extension Period (Group A and B)||0||
48081163|NCT03129100|100521637|FG024|STARTED|Period2 Extension Period (Group A and B)||0||
48081164|NCT03129100|100521638|FG025|STARTED|Period2 Extension Period (Group A and B)||0||
48081165|NCT03129100|100521613|FG000|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
48081166|NCT03129100|100521614|FG001|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
48081167|NCT03129100|100521615|FG002|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||255||
48081168|NCT03129100|100521616|FG003|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||318||
48081169|NCT03129100|100521617|FG004|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||47||
48081170|NCT03129100|100521618|FG005|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||54||
48081171|NCT03129100|100521619|FG006|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||53||
48081172|NCT03129100|100521620|FG007|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
48081173|NCT03129100|100521621|FG008|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
48081174|NCT03129100|100521622|FG009|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
48676643|NCT03326245|101991930|FG001|Randomized to Study Arm A|Visit Day C (Third Intervention)||3||
48676644|NCT03326245|101991931|FG002|Randomized to Study Arm A|Visit Day C (Third Intervention)||4||
48239808|NCT01263223|100908939|FG000|NOT COMPLETED|Period 2||0||
48239809|NCT01263223|100908940|FG001|NOT COMPLETED|Period 2||1||
48239810|NCT01263223|100908939|FG000|STARTED|Period 3||12||
48239811|NCT01263223|100908940|FG001|STARTED|Period 3||11||
48239812|NCT01263223|100908939|FG000|COMPLETED|Period 3||12||
48239813|NCT01263223|100908940|FG001|COMPLETED|Period 3||11||
48239814|NCT01263223|100908939|FG000|NOT COMPLETED|Period 3||0||
48239815|NCT01263223|100908940|FG001|NOT COMPLETED|Period 3||0||
48239816|NCT01263223|100908939|FG000|STARTED|7-day Follow-up||12||
48239817|NCT01263223|100908940|FG001|STARTED|7-day Follow-up||11||
48239818|NCT01263223|100908939|FG000|COMPLETED|7-day Follow-up||11||
48239819|NCT01263223|100908940|FG001|COMPLETED|7-day Follow-up||10||
48239820|NCT01263223|100908939|FG000|NOT COMPLETED|7-day Follow-up||1||
48239821|NCT01263223|100908940|FG001|NOT COMPLETED|7-day Follow-up||1||
48239822|NCT03670277|100908941|FG000|STARTED|Overall Study||20||
48239823|NCT03670277|100908942|FG001|STARTED|Overall Study||8||
48676645|NCT03326245|101991929|FG000|Randomized to Study Arm B|Visit Day C (Third Intervention)||4||
48676646|NCT03326245|101991930|FG001|Randomized to Study Arm B|Visit Day C (Third Intervention)||0||
48676647|NCT03326245|101991931|FG002|Randomized to Study Arm B|Visit Day C (Third Intervention)||1||
48676648|NCT03326245|101991929|FG000|Randomized to Study Arm C|Visit Day C (Third Intervention)||4||
48676649|NCT03326245|101991930|FG001|Randomized to Study Arm C|Visit Day C (Third Intervention)||4||
48676650|NCT03326245|101991931|FG002|Randomized to Study Arm C|Visit Day C (Third Intervention)||0||
48676651|NCT03326245|101991929|FG000|COMPLETED|Visit Day C (Third Intervention)||8||
48676652|NCT03326245|101991930|FG001|COMPLETED|Visit Day C (Third Intervention)||7||
48676653|NCT03326245|101991931|FG002|COMPLETED|Visit Day C (Third Intervention)||5||
48676654|NCT03326245|101991929|FG000|NOT COMPLETED|Visit Day C (Third Intervention)||0||
48081175|NCT03129100|100521623|FG010|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
48081176|NCT03129100|100521624|FG011|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
48081177|NCT03129100|100521625|FG012|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
48081178|NCT03129100|100521626|FG013|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
48081179|NCT03129100|100521627|FG014|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
48081180|NCT03129100|100521628|FG015|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
48081181|NCT03129100|100521629|FG016|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
48081182|NCT03129100|100521630|FG017|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
48239824|NCT03670277|100908941|FG000|COMPLETED|Overall Study||20||
48239825|NCT03670277|100908942|FG001|COMPLETED|Overall Study||8||
48239826|NCT03670277|100908941|FG000|NOT COMPLETED|Overall Study||0||
48239827|NCT03670277|100908942|FG001|NOT COMPLETED|Overall Study||0||
48539780|NCT04711902|101657934|FG002|STARTED|Treatment Period 2 (From Week 16)||10||
48539781|NCT04711902|101657935|FG003|STARTED|Treatment Period 2 (From Week 16)||10||
48539782|NCT04711902|101657936|FG004|STARTED|Treatment Period 2 (From Week 16)||10||
48539783|NCT04711902|101657937|FG005|STARTED|Treatment Period 2 (From Week 16)||11||
48539784|NCT04711902|101657932|FG000|Discont. From Treatment Before Week 52|Treatment Period 2 (From Week 16)||0||
48539785|NCT04711902|101657933|FG001|Discont. From Treatment Before Week 52|Treatment Period 2 (From Week 16)||0||
48239828|NCT05287178|100908943|FG000|STARTED|Overall Study||12||
48239829|NCT05287178|100908943|FG000|COMPLETED|Overall Study||10||
48539786|NCT04711902|101657934|FG002|Discont. From Treatment Before Week 52|Treatment Period 2 (From Week 16)||0||
48539787|NCT04711902|101657935|FG003|Discont. From Treatment Before Week 52|Treatment Period 2 (From Week 16)||0||
48539788|NCT04711902|101657936|FG004|Discont. From Treatment Before Week 52|Treatment Period 2 (From Week 16)||1||
48539789|NCT04711902|101657937|FG005|Discont. From Treatment Before Week 52|Treatment Period 2 (From Week 16)||0||
48539790|NCT04711902|101657932|FG000|Completed Study Treatment|Treatment Period 2 (From Week 16)||0||
48539791|NCT04711902|101657933|FG001|Completed Study Treatment|Treatment Period 2 (From Week 16)||0||
48539792|NCT04711902|101657934|FG002|Completed Study Treatment|Treatment Period 2 (From Week 16)||10||
48539793|NCT04711902|101657935|FG003|Completed Study Treatment|Treatment Period 2 (From Week 16)||10||
48539794|NCT04711902|101657936|FG004|Completed Study Treatment|Treatment Period 2 (From Week 16)||9||
48539795|NCT04711902|101657937|FG005|Completed Study Treatment|Treatment Period 2 (From Week 16)||11||
48539796|NCT04711902|101657932|FG000|COMPLETED|Treatment Period 2 (From Week 16)||0||
48539797|NCT04711902|101657933|FG001|COMPLETED|Treatment Period 2 (From Week 16)||0||
48539798|NCT04711902|101657934|FG002|COMPLETED|Treatment Period 2 (From Week 16)||8||
48539799|NCT04711902|101657935|FG003|COMPLETED|Treatment Period 2 (From Week 16)||10||
48239830|NCT05287178|100908943|FG000|NOT COMPLETED|Overall Study||2||
48239831|NCT05522777|100908944|FG000|STARTED|Overall Study||26||
48239832|NCT05522777|100908944|FG000|COMPLETED|Overall Study||24||
48239833|NCT05522777|100908944|FG000|NOT COMPLETED|Overall Study||2||
48239834|NCT06080438|100908945|FG000|STARTED|Overall Study||2||2
48239835|NCT06080438|100908945|FG000|COMPLETED|Overall Study||0||0
48239836|NCT06080438|100908945|FG000|NOT COMPLETED|Overall Study||2||2
48239837|NCT00841321|100908946|FG000|STARTED|Overall Study||59||
48239838|NCT00841321|100908947|FG001|STARTED|Overall Study||61||
48239839|NCT00841321|100908946|FG000|COMPLETED|Overall Study||58||
48239840|NCT00841321|100908947|FG001|COMPLETED|Overall Study||58||
48239841|NCT00841321|100908946|FG000|NOT COMPLETED|Overall Study||1||
48239842|NCT00841321|100908947|FG001|NOT COMPLETED|Overall Study||3||
48239843|NCT04430894|100908948|FG000|STARTED|Overall Study||50||
48239844|NCT04430894|100908948|FG000|COMPLETED|Overall Study||47||
48239845|NCT04430894|100908948|FG000|NOT COMPLETED|Overall Study||3||
48239846|NCT00376259|100908949|FG000|STARTED|Overall Study||22||
48239847|NCT00376259|100908950|FG001|STARTED|Overall Study||21||
48239848|NCT00376259|100908949|FG000|Received Study Drug|Overall Study||21||
48239849|NCT00376259|100908950|FG001|Received Study Drug|Overall Study||21||
48239850|NCT00376259|100908949|FG000|COMPLETED|Overall Study||0||
48676655|NCT03326245|101991930|FG001|NOT COMPLETED|Visit Day C (Third Intervention)||0||
48676656|NCT03326245|101991931|FG002|NOT COMPLETED|Visit Day C (Third Intervention)||0||
48676657|NCT00332696|101991932|FG000|STARTED|Overall Study||32||
48676658|NCT00332696|101991933|FG001|STARTED|Overall Study||32||
48676659|NCT00332696|101991932|FG000|Completed Day 14 Visit|Overall Study||21||
48676660|NCT00332696|101991933|FG001|Completed Day 14 Visit|Overall Study||15||
48676661|NCT00332696|101991932|FG000|COMPLETED|Overall Study||2||
48676662|NCT00332696|101991933|FG001|COMPLETED|Overall Study||2||
48676663|NCT00332696|101991932|FG000|NOT COMPLETED|Overall Study||30||
48676664|NCT00332696|101991933|FG001|NOT COMPLETED|Overall Study||30||
48676665|NCT00534001|101991934|FG000|STARTED|Overall Study||48||
48676666|NCT00534001|101991935|FG001|STARTED|Overall Study||47||
48676667|NCT00534001|101991934|FG000|COMPLETED|Overall Study||43||
48676668|NCT00534001|101991935|FG001|COMPLETED|Overall Study||43||
48676669|NCT00534001|101991934|FG000|NOT COMPLETED|Overall Study||5||
48676670|NCT00534001|101991935|FG001|NOT COMPLETED|Overall Study||4||
48676671|NCT03861338|101991936|FG000|STARTED|Overall Study||10||
48676672|NCT03861338|101991936|FG000|COMPLETED|Overall Study||8||
48676673|NCT03861338|101991936|FG000|NOT COMPLETED|Overall Study||2||
48676674|NCT01864434|101991937|FG000|STARTED|Overall Study||25||
48676675|NCT01864434|101991938|FG001|STARTED|Overall Study||25||
48676676|NCT01864434|101991937|FG000|COMPLETED|Overall Study||25||
48676677|NCT01864434|101991938|FG001|COMPLETED|Overall Study||25||
48676678|NCT01864434|101991937|FG000|NOT COMPLETED|Overall Study||0||
48081183|NCT03129100|100521631|FG018|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
48081184|NCT03129100|100521632|FG019|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
48081185|NCT03129100|100521633|FG020|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
48081186|NCT03129100|100521634|FG021|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
48081187|NCT03129100|100521635|FG022|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
48081188|NCT03129100|100521636|FG023|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
48081189|NCT03129100|100521637|FG024|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
48081190|NCT03129100|100521638|FG025|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
48081191|NCT03129100|100521613|FG000|COMPLETED|Period2 Extension Period (Group A and B)||0||
48081192|NCT03129100|100521614|FG001|COMPLETED|Period2 Extension Period (Group A and B)||0||
48081193|NCT03129100|100521615|FG002|COMPLETED|Period2 Extension Period (Group A and B)||234||
48081194|NCT03129100|100521616|FG003|COMPLETED|Period2 Extension Period (Group A and B)||312||
48081195|NCT03129100|100521617|FG004|COMPLETED|Period2 Extension Period (Group A and B)||42||
48081196|NCT03129100|100521618|FG005|COMPLETED|Period2 Extension Period (Group A and B)||45||
48081197|NCT03129100|100521619|FG006|COMPLETED|Period2 Extension Period (Group A and B)||32||
48081198|NCT03129100|100521620|FG007|COMPLETED|Period2 Extension Period (Group A and B)||0||
48081199|NCT03129100|100521621|FG008|COMPLETED|Period2 Extension Period (Group A and B)||0||
48081200|NCT03129100|100521622|FG009|COMPLETED|Period2 Extension Period (Group A and B)||0||
48081201|NCT03129100|100521623|FG010|COMPLETED|Period2 Extension Period (Group A and B)||0||
48081202|NCT03129100|100521624|FG011|COMPLETED|Period2 Extension Period (Group A and B)||0||
48081203|NCT03129100|100521625|FG012|COMPLETED|Period2 Extension Period (Group A and B)||0||
48081204|NCT03129100|100521626|FG013|COMPLETED|Period2 Extension Period (Group A and B)||0||
48081205|NCT03129100|100521627|FG014|COMPLETED|Period2 Extension Period (Group A and B)||0||
48081206|NCT03129100|100521628|FG015|COMPLETED|Period2 Extension Period (Group A and B)||0||
48081207|NCT03129100|100521629|FG016|COMPLETED|Period2 Extension Period (Group A and B)||0||
48081208|NCT03129100|100521630|FG017|COMPLETED|Period2 Extension Period (Group A and B)||0||
48239851|NCT00376259|100908950|FG001|COMPLETED|Overall Study||0||
48676679|NCT01864434|101991938|FG001|NOT COMPLETED|Overall Study||0||
48676680|NCT01593917|101991939|FG000|STARTED|Overall Study||329||
48676681|NCT01593917|101991939|FG000|COMPLETED|Overall Study||159||
48676682|NCT01593917|101991939|FG000|NOT COMPLETED|Overall Study||170||
48676683|NCT01323192|101991940|FG000|STARTED|Overall Study||143||
48676684|NCT01323192|101991941|FG001|STARTED|Overall Study||141||
48676685|NCT01323192|101991940|FG000|COMPLETED|Overall Study||134||
48676686|NCT01323192|101991941|FG001|COMPLETED|Overall Study||135||
48676687|NCT01323192|101991940|FG000|NOT COMPLETED|Overall Study||9||
48676688|NCT01323192|101991941|FG001|NOT COMPLETED|Overall Study||6||
48676689|NCT03663855|101991942|FG000|STARTED|Overall Study||10||
48676690|NCT03663855|101991942|FG000|COMPLETED|Overall Study||10||
48676691|NCT03663855|101991942|FG000|NOT COMPLETED|Overall Study||0||
48676692|NCT03440008|101991943|FG000|STARTED|Overall Study||26||
48676693|NCT03440008|101991944|FG001|STARTED|Overall Study||7||
48676694|NCT03440008|101991943|FG000|COMPLETED|Overall Study||0||
48676695|NCT03440008|101991944|FG001|COMPLETED|Overall Study||0||
48676696|NCT03440008|101991943|FG000|NOT COMPLETED|Overall Study||26||
48676697|NCT03440008|101991944|FG001|NOT COMPLETED|Overall Study||7||
48676698|NCT01465841|101991945|FG000|STARTED|Overall Study||517||
48676699|NCT01465841|101991945|FG000|COMPLETED|Overall Study||449||
48676700|NCT01465841|101991945|FG000|NOT COMPLETED|Overall Study||68||
48676701|NCT00776230|101991946|FG000|STARTED|Overall Study||99||
48676702|NCT00776230|101991947|FG001|STARTED|Overall Study||103||
48676703|NCT00776230|101991948|FG002|STARTED|Overall Study||102||
48239852|NCT00376259|100908949|FG000|NOT COMPLETED|Overall Study||22||
48239853|NCT00376259|100908950|FG001|NOT COMPLETED|Overall Study||21||
48239854|NCT01072149|100908951|FG000|STARTED|Treatment Period 1 (28 Days)||3||
48239855|NCT01072149|100908952|FG001|STARTED|Treatment Period 1 (28 Days)||3||
48239856|NCT01072149|100908953|FG002|STARTED|Treatment Period 1 (28 Days)||3||
48239857|NCT01072149|100908954|FG003|STARTED|Treatment Period 1 (28 Days)||3||
48239858|NCT01072149|100908955|FG004|STARTED|Treatment Period 1 (28 Days)||3||
48676704|NCT00776230|101991946|FG000|Enrolled and Vaccinated at Day 0|Overall Study||98||
48676705|NCT00776230|101991947|FG001|Enrolled and Vaccinated at Day 0|Overall Study||103||
48676706|NCT00776230|101991948|FG002|Enrolled and Vaccinated at Day 0|Overall Study||102||
48676707|NCT00776230|101991946|FG000|COMPLETED|Overall Study||96||
48676708|NCT00776230|101991947|FG001|COMPLETED|Overall Study||100||
48676709|NCT00776230|101991948|FG002|COMPLETED|Overall Study||97||
48676710|NCT00776230|101991946|FG000|NOT COMPLETED|Overall Study||3||
48676711|NCT00776230|101991947|FG001|NOT COMPLETED|Overall Study||3||
48676712|NCT00776230|101991948|FG002|NOT COMPLETED|Overall Study||5||
48676713|NCT05071053|101991949|FG000|STARTED|Overall Study||35|Enrolled|
48676714|NCT05071053|101991949|FG000|COMPLETED|Overall Study||0|Treatment completion|
48676715|NCT05071053|101991949|FG000|NOT COMPLETED|Overall Study||35||
48676716|NCT04447755|101991950|FG000|STARTED|Overall Study||9||
48676717|NCT04447755|101991951|FG001|STARTED|Overall Study||17||
48676718|NCT04447755|101991952|FG002|STARTED|Overall Study||8||
48676719|NCT04447755|101991953|FG003|STARTED|Overall Study||9||
48676720|NCT04447755|101991954|FG004|STARTED|Overall Study||9||
48676721|NCT04447755|101991955|FG005|STARTED|Overall Study||9||
48676722|NCT04447755|101991956|FG006|STARTED|Overall Study||66||
48676723|NCT04447755|101991950|FG000|COMPLETED|Overall Study||0||
48676724|NCT04447755|101991951|FG001|COMPLETED|Overall Study||0||
48676725|NCT04447755|101991952|FG002|COMPLETED|Overall Study||0||
48676726|NCT04447755|101991953|FG003|COMPLETED|Overall Study||0||
48676727|NCT04447755|101991954|FG004|COMPLETED|Overall Study||0||
48676728|NCT04447755|101991955|FG005|COMPLETED|Overall Study||0||
48676729|NCT04447755|101991956|FG006|COMPLETED|Overall Study||0||
48676730|NCT04447755|101991950|FG000|NOT COMPLETED|Overall Study||9||
48676731|NCT04447755|101991951|FG001|NOT COMPLETED|Overall Study||17||
48676732|NCT04447755|101991952|FG002|NOT COMPLETED|Overall Study||8||
48676733|NCT04447755|101991953|FG003|NOT COMPLETED|Overall Study||9||
48676734|NCT04447755|101991954|FG004|NOT COMPLETED|Overall Study||9||
48676735|NCT04447755|101991955|FG005|NOT COMPLETED|Overall Study||9||
48676736|NCT04447755|101991956|FG006|NOT COMPLETED|Overall Study||66||
48676737|NCT04874948|101991957|FG000|STARTED|Overall Study||4||
48676738|NCT04874948|101991957|FG000|COMPLETED|Overall Study||4||
48676739|NCT04874948|101991957|FG000|NOT COMPLETED|Overall Study||0||
48676740|NCT03941483|101991958|FG000|STARTED|Overall Study||70||
48676741|NCT03941483|101991959|FG001|STARTED|Overall Study||81||
48676742|NCT03941483|101991960|FG002|STARTED|Overall Study||200||
48676743|NCT03941483|101991958|FG000|Treated|Overall Study||69||
48676744|NCT03941483|101991959|FG001|Treated|Overall Study||81||
48676745|NCT03941483|101991960|FG002|Treated|Overall Study||0||
48676746|NCT03941483|101991958|FG000|COMPLETED|Overall Study||61||
48676747|NCT03941483|101991959|FG001|COMPLETED|Overall Study||71||
48676748|NCT03941483|101991960|FG002|COMPLETED|Overall Study||185||
48676749|NCT03941483|101991958|FG000|NOT COMPLETED|Overall Study||9||
48676750|NCT03941483|101991959|FG001|NOT COMPLETED|Overall Study||10||
48676751|NCT03941483|101991960|FG002|NOT COMPLETED|Overall Study||15||
48676752|NCT01668004|101991961|FG000|STARTED|Overall Study||101||
48676753|NCT01668004|101991961|FG000|Treated|Overall Study||101||
48239859|NCT01072149|100908956|FG005|STARTED|Treatment Period 1 (28 Days)||3||
48239860|NCT01072149|100908957|FG006|STARTED|Treatment Period 1 (28 Days)||3||
48239861|NCT01072149|100908958|FG007|STARTED|Treatment Period 1 (28 Days)||3||
48239862|NCT01072149|100908959|FG008|STARTED|Treatment Period 1 (28 Days)||3||
48239863|NCT01072149|100908960|FG009|STARTED|Treatment Period 1 (28 Days)||3||
48676754|NCT01668004|101991961|FG000|COMPLETED|Overall Study||76||
48676755|NCT01668004|101991961|FG000|NOT COMPLETED|Overall Study||25||
48676756|NCT01128569|101991962|FG000|STARTED|Treatment Period 1||9||
48676757|NCT01128569|101991963|FG001|STARTED|Treatment Period 1||8||
48676758|NCT01128569|101991964|FG002|STARTED|Treatment Period 1||9||
48676759|NCT01128569|101991965|FG003|STARTED|Treatment Period 1||8||
48676760|NCT01128569|101991966|FG004|STARTED|Treatment Period 1||9||
48676761|NCT01128569|101991967|FG005|STARTED|Treatment Period 1||9||
48676762|NCT01128569|101991962|FG000|COMPLETED|Treatment Period 1||9||
48676763|NCT01128569|101991963|FG001|COMPLETED|Treatment Period 1||8||
48676764|NCT01128569|101991964|FG002|COMPLETED|Treatment Period 1||9||
48676765|NCT01128569|101991965|FG003|COMPLETED|Treatment Period 1||8||
48676766|NCT01128569|101991966|FG004|COMPLETED|Treatment Period 1||9||
48676767|NCT01128569|101991967|FG005|COMPLETED|Treatment Period 1||9||
48676768|NCT01128569|101991962|FG000|NOT COMPLETED|Treatment Period 1||0||
48676769|NCT01128569|101991963|FG001|NOT COMPLETED|Treatment Period 1||0||
48676770|NCT01128569|101991964|FG002|NOT COMPLETED|Treatment Period 1||0||
48676771|NCT01128569|101991965|FG003|NOT COMPLETED|Treatment Period 1||0||
48676772|NCT01128569|101991966|FG004|NOT COMPLETED|Treatment Period 1||0||
48676773|NCT01128569|101991967|FG005|NOT COMPLETED|Treatment Period 1||0||
48676774|NCT01128569|101991962|FG000|STARTED|Washout Period 1||9||
48676775|NCT01128569|101991963|FG001|STARTED|Washout Period 1||8||
48676776|NCT01128569|101991964|FG002|STARTED|Washout Period 1||9||
48676777|NCT01128569|101991965|FG003|STARTED|Washout Period 1||8||
48676778|NCT01128569|101991966|FG004|STARTED|Washout Period 1||9||
48676779|NCT01128569|101991967|FG005|STARTED|Washout Period 1||9||
48676780|NCT01128569|101991962|FG000|COMPLETED|Washout Period 1||9||
48676781|NCT01128569|101991963|FG001|COMPLETED|Washout Period 1||8||
48676782|NCT01128569|101991964|FG002|COMPLETED|Washout Period 1||8||
48676783|NCT01128569|101991965|FG003|COMPLETED|Washout Period 1||8||
48676784|NCT01128569|101991966|FG004|COMPLETED|Washout Period 1||9||
48676785|NCT01128569|101991967|FG005|COMPLETED|Washout Period 1||9||
48676786|NCT01128569|101991962|FG000|NOT COMPLETED|Washout Period 1||0||
48676787|NCT01128569|101991963|FG001|NOT COMPLETED|Washout Period 1||0||
48676788|NCT01128569|101991964|FG002|NOT COMPLETED|Washout Period 1||1||
48676789|NCT01128569|101991965|FG003|NOT COMPLETED|Washout Period 1||0||
48676790|NCT01128569|101991966|FG004|NOT COMPLETED|Washout Period 1||0||
48676791|NCT01128569|101991967|FG005|NOT COMPLETED|Washout Period 1||0||
48676792|NCT01128569|101991962|FG000|STARTED|Treatment Period 2||9||
48676793|NCT01128569|101991963|FG001|STARTED|Treatment Period 2||8||
48676794|NCT01128569|101991964|FG002|STARTED|Treatment Period 2||8||
48676795|NCT01128569|101991965|FG003|STARTED|Treatment Period 2||8||
48676796|NCT01128569|101991966|FG004|STARTED|Treatment Period 2||9||
48676797|NCT01128569|101991967|FG005|STARTED|Treatment Period 2||9||
48676798|NCT01128569|101991962|FG000|COMPLETED|Treatment Period 2||9||
48676799|NCT01128569|101991963|FG001|COMPLETED|Treatment Period 2||7||
48676800|NCT01128569|101991964|FG002|COMPLETED|Treatment Period 2||8||
48676801|NCT01128569|101991965|FG003|COMPLETED|Treatment Period 2||8||
48676802|NCT01128569|101991966|FG004|COMPLETED|Treatment Period 2||9||
48676803|NCT01128569|101991967|FG005|COMPLETED|Treatment Period 2||9||
48676804|NCT01128569|101991962|FG000|NOT COMPLETED|Treatment Period 2||0||
48676805|NCT01128569|101991963|FG001|NOT COMPLETED|Treatment Period 2||1||
48676806|NCT01128569|101991964|FG002|NOT COMPLETED|Treatment Period 2||0||
48676807|NCT01128569|101991965|FG003|NOT COMPLETED|Treatment Period 2||0||
48676808|NCT01128569|101991966|FG004|NOT COMPLETED|Treatment Period 2||0||
48676809|NCT01128569|101991967|FG005|NOT COMPLETED|Treatment Period 2||0||
48676810|NCT01128569|101991962|FG000|STARTED|Washout Period 2||9||
48676811|NCT01128569|101991963|FG001|STARTED|Washout Period 2||7||
48676812|NCT01128569|101991964|FG002|STARTED|Washout Period 2||8||
48676813|NCT01128569|101991965|FG003|STARTED|Washout Period 2||8||
48676814|NCT01128569|101991966|FG004|STARTED|Washout Period 2||9||
48676815|NCT01128569|101991967|FG005|STARTED|Washout Period 2||9||
48676816|NCT01128569|101991962|FG000|COMPLETED|Washout Period 2||9||
48676817|NCT01128569|101991963|FG001|COMPLETED|Washout Period 2||7||
48676818|NCT01128569|101991964|FG002|COMPLETED|Washout Period 2||8||
48676819|NCT01128569|101991965|FG003|COMPLETED|Washout Period 2||8||
48676820|NCT01128569|101991966|FG004|COMPLETED|Washout Period 2||9||
48676821|NCT01128569|101991967|FG005|COMPLETED|Washout Period 2||9||
48676822|NCT01128569|101991962|FG000|NOT COMPLETED|Washout Period 2||0||
48676823|NCT01128569|101991963|FG001|NOT COMPLETED|Washout Period 2||0||
48676824|NCT01128569|101991964|FG002|NOT COMPLETED|Washout Period 2||0||
48676825|NCT01128569|101991965|FG003|NOT COMPLETED|Washout Period 2||0||
48676826|NCT01128569|101991966|FG004|NOT COMPLETED|Washout Period 2||0||
48676827|NCT01128569|101991967|FG005|NOT COMPLETED|Washout Period 2||0||
48676828|NCT01128569|101991962|FG000|STARTED|Treatment Period 3||9||
48676829|NCT01128569|101991963|FG001|STARTED|Treatment Period 3||7||
48676830|NCT01128569|101991964|FG002|STARTED|Treatment Period 3||8||
48676831|NCT01128569|101991965|FG003|STARTED|Treatment Period 3||8||
48676832|NCT01128569|101991966|FG004|STARTED|Treatment Period 3||9||
48676833|NCT01128569|101991967|FG005|STARTED|Treatment Period 3||9||
48676834|NCT01128569|101991962|FG000|COMPLETED|Treatment Period 3||9||
48676835|NCT01128569|101991963|FG001|COMPLETED|Treatment Period 3||7||
48239864|NCT01072149|100908961|FG010|STARTED|Treatment Period 1 (28 Days)||3||
48676836|NCT01128569|101991964|FG002|COMPLETED|Treatment Period 3||8||
48676837|NCT01128569|101991965|FG003|COMPLETED|Treatment Period 3||8||
48676838|NCT01128569|101991966|FG004|COMPLETED|Treatment Period 3||9||
48676839|NCT01128569|101991967|FG005|COMPLETED|Treatment Period 3||9||
48676840|NCT01128569|101991962|FG000|NOT COMPLETED|Treatment Period 3||0||
48676841|NCT01128569|101991963|FG001|NOT COMPLETED|Treatment Period 3||0||
48676842|NCT01128569|101991964|FG002|NOT COMPLETED|Treatment Period 3||0||
48676843|NCT01128569|101991965|FG003|NOT COMPLETED|Treatment Period 3||0||
48676844|NCT01128569|101991966|FG004|NOT COMPLETED|Treatment Period 3||0||
48676845|NCT01128569|101991967|FG005|NOT COMPLETED|Treatment Period 3||0||
48676846|NCT03366337|101991968|FG000|STARTED|Overall Study||31||
48676847|NCT03366337|101991969|FG001|STARTED|Overall Study||26||
48676848|NCT03366337|101991970|FG002|STARTED|Overall Study||28||
48676849|NCT03366337|101991971|FG003|STARTED|Overall Study||18||
48676850|NCT03366337|101991968|FG000|COMPLETED|Overall Study||28||
48676851|NCT03366337|101991969|FG001|COMPLETED|Overall Study||26||
48676852|NCT03366337|101991970|FG002|COMPLETED|Overall Study||26||
48676853|NCT03366337|101991971|FG003|COMPLETED|Overall Study||17||
48676854|NCT03366337|101991968|FG000|NOT COMPLETED|Overall Study||3||
48676855|NCT03366337|101991969|FG001|NOT COMPLETED|Overall Study||0||
48676856|NCT03366337|101991970|FG002|NOT COMPLETED|Overall Study||2||
48676857|NCT03366337|101991971|FG003|NOT COMPLETED|Overall Study||1||
48676858|NCT04773665|101991972|FG000|STARTED|Overall Study||21||
48676859|NCT04773665|101991973|FG001|STARTED|Overall Study||20||
48676860|NCT04773665|101991974|FG002|STARTED|Overall Study||20||
48676861|NCT04773665|101991975|FG003|STARTED|Overall Study||27||
48676862|NCT04773665|101991976|FG004|STARTED|Overall Study||26||
48676863|NCT04773665|101991972|FG000|COMPLETED|Overall Study||19||
48676864|NCT04773665|101991973|FG001|COMPLETED|Overall Study||19||
48676865|NCT04773665|101991974|FG002|COMPLETED|Overall Study||19||
48676866|NCT04773665|101991975|FG003|COMPLETED|Overall Study||24||
48676867|NCT04773665|101991976|FG004|COMPLETED|Overall Study||26||
48676868|NCT04773665|101991972|FG000|NOT COMPLETED|Overall Study||2||
48676869|NCT04773665|101991973|FG001|NOT COMPLETED|Overall Study||1||
48676870|NCT04773665|101991974|FG002|NOT COMPLETED|Overall Study||1||
48676871|NCT04773665|101991975|FG003|NOT COMPLETED|Overall Study||3||
48676872|NCT04773665|101991976|FG004|NOT COMPLETED|Overall Study||0||
48676873|NCT02189889|101991977|FG000|STARTED|Overall Study||2||
48676874|NCT02189889|101991978|FG001|STARTED|Overall Study||3||
48676875|NCT02189889|101991977|FG000|COMPLETED|Overall Study||2||
48676876|NCT02189889|101991978|FG001|COMPLETED|Overall Study||3||
48676877|NCT02189889|101991977|FG000|NOT COMPLETED|Overall Study||0||
48676878|NCT02189889|101991978|FG001|NOT COMPLETED|Overall Study||0||
48676879|NCT00335829|101991979|FG000|STARTED|Overall Study||26||
48676880|NCT00335829|101991979|FG000|Received Bevacizumab|Overall Study||26|Patients reaching this milestone were evaluated for safety and toxicity outcomes|
48676881|NCT00335829|101991979|FG000|Received First TACE|Overall Study||25||
48676882|NCT00335829|101991979|FG000|COMPLETED|Overall Study||23|Patients who were evaluable for tumor response for imaging outcomes|
48676883|NCT00335829|101991979|FG000|NOT COMPLETED|Overall Study||3||
48676884|NCT03767881|101991980|FG000|STARTED|Overall Study||30||
48676885|NCT03767881|101991980|FG000|COMPLETED|Overall Study||25||
48676886|NCT03767881|101991980|FG000|NOT COMPLETED|Overall Study||5||
48676887|NCT01463527|101991981|FG000|STARTED|Overall Study||83||
48676888|NCT01463527|101991982|FG001|STARTED|Overall Study||84||
48676889|NCT01463527|101991981|FG000|COMPLETED|Overall Study||77||
48676890|NCT01463527|101991982|FG001|COMPLETED|Overall Study||77||
48676891|NCT01463527|101991981|FG000|NOT COMPLETED|Overall Study||6||
48676892|NCT01463527|101991982|FG001|NOT COMPLETED|Overall Study||7||
48676893|NCT04778592|101991983|FG000|STARTED|Overall Study||75||
48676894|NCT04778592|101991984|FG001|STARTED|Overall Study||74||
48676895|NCT04778592|101991983|FG000|COMPLETED|Overall Study||73||
48676896|NCT04778592|101991984|FG001|COMPLETED|Overall Study||70||
48676897|NCT04778592|101991983|FG000|NOT COMPLETED|Overall Study||2||
48676898|NCT04778592|101991984|FG001|NOT COMPLETED|Overall Study||4||
48676899|NCT05393245|101991985|FG000|STARTED|Overall Study||5820||
48676900|NCT05393245|101991986|FG001|STARTED|Overall Study||13647||
48676901|NCT05393245|101991985|FG000|COMPLETED|Overall Study||5820||
48676902|NCT05393245|101991986|FG001|COMPLETED|Overall Study||13647||
48676903|NCT05393245|101991985|FG000|NOT COMPLETED|Overall Study||0||
48676904|NCT05393245|101991986|FG001|NOT COMPLETED|Overall Study||0||
48676905|NCT02805790|101991987|FG000|STARTED|First Intervention (4 Weeks)||14||
48676906|NCT02805790|101991988|FG001|STARTED|First Intervention (4 Weeks)||16||
48676907|NCT02805790|101991987|FG000|COMPLETED|First Intervention (4 Weeks)||14||
48676908|NCT02805790|101991988|FG001|COMPLETED|First Intervention (4 Weeks)||16||
48676909|NCT02805790|101991987|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0||
48676910|NCT02805790|101991988|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0||
48676911|NCT02805790|101991987|FG000|STARTED|Washout (4 Weeks)||14||
48676912|NCT02805790|101991988|FG001|STARTED|Washout (4 Weeks)||16||
48676913|NCT02805790|101991987|FG000|COMPLETED|Washout (4 Weeks)||14||
48676914|NCT02805790|101991988|FG001|COMPLETED|Washout (4 Weeks)||16||
48676915|NCT02805790|101991987|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
48676916|NCT02805790|101991988|FG001|NOT COMPLETED|Washout (4 Weeks)||0||
48676917|NCT02805790|101991987|FG000|STARTED|Second Intervention (4 Weeks)||14||
48676918|NCT02805790|101991988|FG001|STARTED|Second Intervention (4 Weeks)||16||
48676919|NCT02805790|101991987|FG000|COMPLETED|Second Intervention (4 Weeks)||14||
48676920|NCT02805790|101991988|FG001|COMPLETED|Second Intervention (4 Weeks)||15||
48676921|NCT02805790|101991987|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0||
48676922|NCT02805790|101991988|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1||
48676923|NCT00800735|101991989|FG000|STARTED|Overall Study||30||
48676924|NCT00800735|101991989|FG000|COMPLETED|Overall Study||16||
48676925|NCT00800735|101991989|FG000|NOT COMPLETED|Overall Study||14||
48676926|NCT03848455|101991990|FG000|STARTED|Overall Study||125||
48676927|NCT03848455|101991991|FG001|STARTED|Overall Study||90||
48676928|NCT03848455|101991992|FG002|STARTED|Overall Study||23||
48676929|NCT03848455|101991990|FG000|COMPLETED|Overall Study||125||
48676930|NCT03848455|101991991|FG001|COMPLETED|Overall Study||90||
48676931|NCT03848455|101991992|FG002|COMPLETED|Overall Study||23||
48676932|NCT03848455|101991990|FG000|NOT COMPLETED|Overall Study||0||
48676933|NCT03848455|101991991|FG001|NOT COMPLETED|Overall Study||0||
48676934|NCT03848455|101991992|FG002|NOT COMPLETED|Overall Study||0||
48676935|NCT02410772|101991993|FG000|STARTED|Overall Study||829||
48676936|NCT02410772|101991994|FG001|STARTED|Overall Study||838||
48676937|NCT02410772|101991995|FG002|STARTED|Overall Study||849||
48676938|NCT02410772|101991993|FG000|Microbiologically Eligible Analysis Population|Overall Study||768|Microbiologically Eligible Population included all enrolled participants that received a treatment assignment but excluded the participants with no evidence of cultures positive for M. tuberculosis, or with resistance to one or more of isoniazid, rifampin or fluoroquinolones, or are enrolled in violation of eligibility criteria|
48676939|NCT02410772|101991994|FG001|Microbiologically Eligible Analysis Population|Overall Study||784|Microbiologically Eligible Population included all enrolled participants that received a treatment assignment but excluded the participants with no evidence of cultures positive for M. tuberculosis, or with resistance to one or more of isoniazid, rifampin or fluoroquinolones, or are enrolled in violation of eligibility criteria|
48676940|NCT02410772|101991995|FG002|Microbiologically Eligible Analysis Population|Overall Study||791|Microbiologically Eligible Population included all enrolled participants that received a treatment assignment but excluded the participants with no evidence of cultures positive for M. tuberculosis, or with resistance to one or more of isoniazid, rifampin or fluoroquinolones, or are enrolled in violation of eligibility criteria|
48676941|NCT02410772|101991993|FG000|Assessable Population|Overall Study||726|Excluded the Microbiologically eligible participants without an assessable outcome (if they were not already classified as unfavorable and additionally did not attend12M visit but were culture negative when last seen, or had treatment changed due to pregnancy, or died during follow-up with cause unrelated to tuberculosis, or received additional treatment for tuberculosis following exogenous reinfection shown by whole genome sequencing, or died from a violent or accidental death during treatment|
48676942|NCT02410772|101991994|FG001|Assessable Population|Overall Study||752|Excluded the Microbiologically eligible participants without an assessable outcome (if they were not already classified as unfavorable and additionally did not attend12M visit but were culture negative when last seen, or had treatment changed due to pregnancy, or died during follow-up with cause unrelated to tuberculosis, or received additional treatment for tuberculosis following exogenous reinfection shown by whole genome sequencing, or died from a violent or accidental death during treatment|
48676943|NCT02410772|101991995|FG002|Assessable Population|Overall Study||756|Excluded the Microbiologically eligible participants without an assessable outcome (if they were not already classified as unfavorable and additionally did not attend12M visit but were culture negative when last seen, or had treatment changed due to pregnancy, or died during follow-up with cause unrelated to tuberculosis, or received additional treatment for tuberculosis following exogenous reinfection shown by whole genome sequencing, or died from a violent or accidental death during treatment|
48676944|NCT02410772|101991993|FG000|COMPLETED|Overall Study||726|Completed Population included all participants that are randomized and are microbiologically eligible with an Assessable outcome (Assessable Population)|
48676945|NCT02410772|101991994|FG001|COMPLETED|Overall Study||752|Completed Population included all participants that are randomized and are microbiologically eligible with an Assessable outcome (Assessable Population)|
48676946|NCT02410772|101991995|FG002|COMPLETED|Overall Study||756|Completed Population included all participants that are randomized and are microbiologically eligible with an Assessable outcome (Assessable Population)|
48676947|NCT02410772|101991993|FG000|NOT COMPLETED|Overall Study||103||
48676948|NCT02410772|101991994|FG001|NOT COMPLETED|Overall Study||86||
48676949|NCT02410772|101991995|FG002|NOT COMPLETED|Overall Study||93||
48676950|NCT01346176|101991996|FG000|STARTED|Recruited||49||
48676951|NCT01346176|101991997|FG001|STARTED|Recruited||40||
48676952|NCT01346176|101991998|FG002|STARTED|Recruited||43||
48676953|NCT01346176|101991996|FG000|COMPLETED|Recruited||48||
48676954|NCT01346176|101991997|FG001|COMPLETED|Recruited||40||
48676955|NCT01346176|101991998|FG002|COMPLETED|Recruited||43||
48676956|NCT01346176|101991996|FG000|NOT COMPLETED|Recruited||1||
48676957|NCT01346176|101991997|FG001|NOT COMPLETED|Recruited||0||
48676958|NCT01346176|101991998|FG002|NOT COMPLETED|Recruited||0||
48676959|NCT01346176|101991996|FG000|STARTED|Completed Advance Directive||48||
48676960|NCT01346176|101991997|FG001|STARTED|Completed Advance Directive||40||
48676961|NCT01346176|101991998|FG002|STARTED|Completed Advance Directive||43||
48676962|NCT01346176|101991996|FG000|COMPLETED|Completed Advance Directive||35||
48676963|NCT01346176|101991997|FG001|COMPLETED|Completed Advance Directive||26||
48676964|NCT01346176|101991998|FG002|COMPLETED|Completed Advance Directive||33||
48676965|NCT01346176|101991996|FG000|NOT COMPLETED|Completed Advance Directive||13||
48676966|NCT01346176|101991997|FG001|NOT COMPLETED|Completed Advance Directive||14||
48676967|NCT01346176|101991998|FG002|NOT COMPLETED|Completed Advance Directive||10||
48676968|NCT01346176|101991996|FG000|STARTED|Completed Satisfaction Survey||35||
48676969|NCT01346176|101991997|FG001|STARTED|Completed Satisfaction Survey||26||
48676970|NCT01346176|101991998|FG002|STARTED|Completed Satisfaction Survey||33||
48676971|NCT01346176|101991996|FG000|COMPLETED|Completed Satisfaction Survey||29||
48676972|NCT01346176|101991997|FG001|COMPLETED|Completed Satisfaction Survey||22||
48676973|NCT01346176|101991998|FG002|COMPLETED|Completed Satisfaction Survey||27||
48676974|NCT01346176|101991996|FG000|NOT COMPLETED|Completed Satisfaction Survey||6||
48676975|NCT01346176|101991997|FG001|NOT COMPLETED|Completed Satisfaction Survey||4||
48676976|NCT01346176|101991998|FG002|NOT COMPLETED|Completed Satisfaction Survey||6||
48676977|NCT02750930|101991999|FG000|STARTED|Overall Study||8||
48676978|NCT02750930|101991999|FG000|COMPLETED|Overall Study||0||
48676979|NCT02750930|101991999|FG000|NOT COMPLETED|Overall Study||8||
48676980|NCT04790786|101992000|FG000|STARTED|Overall Study||128||
48676981|NCT04790786|101992001|FG001|STARTED|Overall Study||2454||
48676982|NCT04790786|101992002|FG002|STARTED|Overall Study||885||
48676983|NCT04790786|101992003|FG003|STARTED|Overall Study||1104||
48676984|NCT04790786|101992000|FG000|COMPLETED|Overall Study||128||
48239865|NCT01072149|100908962|FG011|STARTED|Treatment Period 1 (28 Days)||3||
48239866|NCT01072149|100908963|FG012|STARTED|Treatment Period 1 (28 Days)||3||
48239867|NCT01072149|100908964|FG013|STARTED|Treatment Period 1 (28 Days)||3||
48676985|NCT04790786|101992001|FG001|COMPLETED|Overall Study||2454||
48676986|NCT04790786|101992002|FG002|COMPLETED|Overall Study||885||
48676987|NCT04790786|101992003|FG003|COMPLETED|Overall Study||1104||
48676988|NCT04790786|101992000|FG000|NOT COMPLETED|Overall Study||0||
48676989|NCT04790786|101992001|FG001|NOT COMPLETED|Overall Study||0||
48239868|NCT01072149|100908965|FG014|STARTED|Treatment Period 1 (28 Days)||3||
48239869|NCT01072149|100908966|FG015|STARTED|Treatment Period 1 (28 Days)||3||
48239870|NCT01072149|100908967|FG016|STARTED|Treatment Period 1 (28 Days)||3||
48239871|NCT01072149|100908968|FG017|STARTED|Treatment Period 1 (28 Days)||3||
48239872|NCT01072149|100908951|FG000|COMPLETED|Treatment Period 1 (28 Days)||3||
48676990|NCT04790786|101992002|FG002|NOT COMPLETED|Overall Study||0||
48676991|NCT04790786|101992003|FG003|NOT COMPLETED|Overall Study||0||
48676992|NCT05270876|101992004|FG000|STARTED|Overall Study||20||
48676993|NCT05270876|101992004|FG000|COMPLETED|Overall Study||20||
48676994|NCT05270876|101992004|FG000|NOT COMPLETED|Overall Study||0||
48676995|NCT00427193|101992005|FG000|STARTED|Overall Study||143||
48676996|NCT00427193|101992006|FG001|STARTED|Overall Study||75||
48676997|NCT00427193|101992005|FG000|COMPLETED|Overall Study||117||
48676998|NCT00427193|101992006|FG001|COMPLETED|Overall Study||71||
48676999|NCT00427193|101992005|FG000|NOT COMPLETED|Overall Study||26||
48677000|NCT00427193|101992006|FG001|NOT COMPLETED|Overall Study||4||
48677001|NCT00145626|101992007|FG000|STARTED|Overall Study||19||
48677002|NCT00145626|101992007|FG000|COMPLETED|Overall Study||14||
48677003|NCT00145626|101992007|FG000|NOT COMPLETED|Overall Study||5||
48677004|NCT03473743|101992008|FG000|STARTED|Overall Study||4||
48677005|NCT03473743|101992009|FG001|STARTED|Overall Study||3||
48677006|NCT03473743|101992010|FG002|STARTED|Overall Study||11||
48677007|NCT03473743|101992011|FG003|STARTED|Overall Study||12||
48677008|NCT03473743|101992012|FG004|STARTED|Overall Study||3||
48677009|NCT03473743|101992013|FG005|STARTED|Overall Study||3||
48677010|NCT03473743|101992014|FG006|STARTED|Overall Study||44||
48677011|NCT03473743|101992015|FG007|STARTED|Overall Study||45||
48677012|NCT03473743|101992008|FG000|Treated (Treated Analysis Set)|Overall Study||4||
48677013|NCT03473743|101992009|FG001|Treated (Treated Analysis Set)|Overall Study||3||
48677014|NCT03473743|101992010|FG002|Treated (Treated Analysis Set)|Overall Study||11||
48677015|NCT03473743|101992011|FG003|Treated (Treated Analysis Set)|Overall Study||12||
48677016|NCT03473743|101992012|FG004|Treated (Treated Analysis Set)|Overall Study||3||
48677017|NCT03473743|101992013|FG005|Treated (Treated Analysis Set)|Overall Study||3||
48677018|NCT03473743|101992014|FG006|Treated (Treated Analysis Set)|Overall Study||43||
48677019|NCT03473743|101992015|FG007|Treated (Treated Analysis Set)|Overall Study||44||
48677020|NCT03473743|101992008|FG000|COMPLETED|Overall Study||4||
48677021|NCT03473743|101992009|FG001|COMPLETED|Overall Study||3||
48677022|NCT03473743|101992010|FG002|COMPLETED|Overall Study||5||
48677023|NCT03473743|101992011|FG003|COMPLETED|Overall Study||3||
48677024|NCT03473743|101992012|FG004|COMPLETED|Overall Study||2||
48677025|NCT03473743|101992013|FG005|COMPLETED|Overall Study||2||
48677026|NCT03473743|101992014|FG006|COMPLETED|Overall Study||21||
48677027|NCT03473743|101992015|FG007|COMPLETED|Overall Study||17||
48677028|NCT03473743|101992008|FG000|NOT COMPLETED|Overall Study||0||
48677029|NCT03473743|101992009|FG001|NOT COMPLETED|Overall Study||0||
48239873|NCT01072149|100908952|FG001|COMPLETED|Treatment Period 1 (28 Days)||3||
48239874|NCT01072149|100908953|FG002|COMPLETED|Treatment Period 1 (28 Days)||2||
48239875|NCT01072149|100908954|FG003|COMPLETED|Treatment Period 1 (28 Days)||3||
48239876|NCT01072149|100908955|FG004|COMPLETED|Treatment Period 1 (28 Days)||3||
48239877|NCT01072149|100908956|FG005|COMPLETED|Treatment Period 1 (28 Days)||3||
48239878|NCT01072149|100908957|FG006|COMPLETED|Treatment Period 1 (28 Days)||3||
48239879|NCT01072149|100908958|FG007|COMPLETED|Treatment Period 1 (28 Days)||3||
48677030|NCT03473743|101992010|FG002|NOT COMPLETED|Overall Study||6||
48677031|NCT03473743|101992011|FG003|NOT COMPLETED|Overall Study||9||
48677032|NCT03473743|101992012|FG004|NOT COMPLETED|Overall Study||1||
48677033|NCT03473743|101992013|FG005|NOT COMPLETED|Overall Study||1||
48239880|NCT01072149|100908959|FG008|COMPLETED|Treatment Period 1 (28 Days)||3||
48239881|NCT01072149|100908960|FG009|COMPLETED|Treatment Period 1 (28 Days)||3||
48239882|NCT01072149|100908961|FG010|COMPLETED|Treatment Period 1 (28 Days)||2||
48677034|NCT03473743|101992014|FG006|NOT COMPLETED|Overall Study||23||
48677035|NCT03473743|101992015|FG007|NOT COMPLETED|Overall Study||28||
48677036|NCT02384421|101992016|FG000|STARTED|Overall Study||22||
48677037|NCT02384421|101992016|FG000|COMPLETED|Overall Study||22||
48677038|NCT02384421|101992016|FG000|NOT COMPLETED|Overall Study||0||
48677039|NCT01959529|101992017|FG000|STARTED|Overall Study||3818||
48677040|NCT01959529|101992018|FG001|STARTED|Overall Study||3819||
48239883|NCT01072149|100908962|FG011|COMPLETED|Treatment Period 1 (28 Days)||3||
48239884|NCT01072149|100908963|FG012|COMPLETED|Treatment Period 1 (28 Days)||3||
48239885|NCT01072149|100908964|FG013|COMPLETED|Treatment Period 1 (28 Days)||3||
48239886|NCT01072149|100908965|FG014|COMPLETED|Treatment Period 1 (28 Days)||3||
48239887|NCT01072149|100908966|FG015|COMPLETED|Treatment Period 1 (28 Days)||3||
48239888|NCT01072149|100908967|FG016|COMPLETED|Treatment Period 1 (28 Days)||3||
48239889|NCT01072149|100908968|FG017|COMPLETED|Treatment Period 1 (28 Days)||2||
48239890|NCT01072149|100908951|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
48239891|NCT01072149|100908952|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
48239892|NCT01072149|100908953|FG002|NOT COMPLETED|Treatment Period 1 (28 Days)||1||
48239893|NCT01072149|100908954|FG003|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
48239894|NCT01072149|100908955|FG004|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
48239895|NCT01072149|100908956|FG005|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
48539800|NCT04711902|101657936|FG004|COMPLETED|Treatment Period 2 (From Week 16)||10||
48539801|NCT04711902|101657937|FG005|COMPLETED|Treatment Period 2 (From Week 16)||11||
48539802|NCT04711902|101657932|FG000|NOT COMPLETED|Treatment Period 2 (From Week 16)||0||
48539803|NCT04711902|101657933|FG001|NOT COMPLETED|Treatment Period 2 (From Week 16)||0||
48539804|NCT04711902|101657934|FG002|NOT COMPLETED|Treatment Period 2 (From Week 16)||2||
48539805|NCT04711902|101657935|FG003|NOT COMPLETED|Treatment Period 2 (From Week 16)||0||
48539806|NCT04711902|101657936|FG004|NOT COMPLETED|Treatment Period 2 (From Week 16)||0||
48539807|NCT04711902|101657937|FG005|NOT COMPLETED|Treatment Period 2 (From Week 16)||0||
48539808|NCT04208958|101657938|FG000|STARTED|Overall Study||56||
48539809|NCT04208958|101657938|FG000|Gastric/GEJ Adenocarcinoma|Overall Study||20||
48539810|NCT04208958|101657938|FG000|Melanoma|Overall Study||20||
48539811|NCT04208958|101657938|FG000|CRC-MSS|Overall Study||14||
48539812|NCT04208958|101657938|FG000|Not Treated With VE800|Overall Study||2||
48539813|NCT04208958|101657938|FG000|COMPLETED|Overall Study||0||
48539814|NCT04208958|101657938|FG000|NOT COMPLETED|Overall Study||56||
48539815|NCT02213289|101657939|FG000|STARTED|Overall Study||68||
48539816|NCT02213289|101657940|FG001|STARTED|Overall Study||12||
48539817|NCT02213289|101657939|FG000|Immuno-oncology|Overall Study||5||
48539818|NCT02213289|101657940|FG001|Immuno-oncology|Overall Study||0||
48539819|NCT02213289|101657939|FG000|HER2 Amplified|Overall Study||16||
48539820|NCT02213289|101657940|FG001|HER2 Amplified|Overall Study||0||
48539821|NCT02213289|101657939|FG000|EGFR Amplified|Overall Study||8||
48539822|NCT02213289|101657940|FG001|EGFR Amplified|Overall Study||0||
48539823|NCT02213289|101657939|FG000|FGFR2 Amplified|Overall Study||1||
48539824|NCT02213289|101657940|FG001|FGFR2 Amplified|Overall Study||0||
48539825|NCT02213289|101657939|FG000|MAPK/PIK3CA Aberrant|Overall Study||20||
48539826|NCT02213289|101657940|FG001|MAPK/PIK3CA Aberrant|Overall Study||0||
48539827|NCT02213289|101657939|FG000|EGFR Expressing|Overall Study||9||
48539828|NCT02213289|101657940|FG001|EGFR Expressing|Overall Study||0||
48539829|NCT02213289|101657939|FG000|All Negative|Overall Study||9||
48539830|NCT02213289|101657940|FG001|All Negative|Overall Study||0||
48539831|NCT02213289|101657939|FG000|Other (Non-ITT)|Overall Study||0||
48539832|NCT02213289|101657940|FG001|Other (Non-ITT)|Overall Study||12||
48539833|NCT02213289|101657939|FG000|COMPLETED|Overall Study||68||
48539834|NCT02213289|101657940|FG001|COMPLETED|Overall Study||12||
48539835|NCT02213289|101657939|FG000|NOT COMPLETED|Overall Study||0||
48539836|NCT02213289|101657940|FG001|NOT COMPLETED|Overall Study||0||
48539837|NCT00195338|101657941|FG000|STARTED|Overall Study||25||
48539838|NCT00195338|101657941|FG000|COMPLETED|Overall Study||13||
48539839|NCT00195338|101657941|FG000|NOT COMPLETED|Overall Study||12||
48539840|NCT00168818|101657942|FG000|STARTED|Overall Study||1146||
48539841|NCT00168818|101657943|FG001|STARTED|Overall Study||1163||
48539842|NCT00168818|101657944|FG002|STARTED|Overall Study||1154||
48539843|NCT00168818|101657942|FG000|COMPLETED|Overall Study||1029||
48539844|NCT00168818|101657943|FG001|COMPLETED|Overall Study||1054||
48539845|NCT00168818|101657944|FG002|COMPLETED|Overall Study||1030||
48539846|NCT00168818|101657942|FG000|NOT COMPLETED|Overall Study||117||
48539847|NCT00168818|101657943|FG001|NOT COMPLETED|Overall Study||109||
48539848|NCT00168818|101657944|FG002|NOT COMPLETED|Overall Study||124||
48539849|NCT00168818|101657942|FG000|STARTED|Treatment||1146||
48539850|NCT00168818|101657943|FG001|STARTED|Treatment||1163||
48539851|NCT00168818|101657944|FG002|STARTED|Treatment||1154||
48539852|NCT00168818|101657942|FG000|COMPLETED|Treatment||1013||
48539853|NCT00168818|101657943|FG001|COMPLETED|Treatment||1012||
48539854|NCT00168818|101657944|FG002|COMPLETED|Treatment||1021||
48539855|NCT00168818|101657942|FG000|NOT COMPLETED|Treatment||133||
48539856|NCT00168818|101657943|FG001|NOT COMPLETED|Treatment||151||
48539857|NCT00168818|101657944|FG002|NOT COMPLETED|Treatment||133||
48539858|NCT01059344|101657945|FG000|STARTED|Overall Study||140||
48539859|NCT01059344|101657946|FG001|STARTED|Overall Study||141||
48539860|NCT01059344|101657945|FG000|COMPLETED|Overall Study||118||
48539861|NCT01059344|101657946|FG001|COMPLETED|Overall Study||95||
48539862|NCT01059344|101657945|FG000|NOT COMPLETED|Overall Study||22||
48539863|NCT01059344|101657946|FG001|NOT COMPLETED|Overall Study||46||
48239896|NCT01072149|100908957|FG006|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
48239897|NCT01072149|100908958|FG007|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
48539864|NCT01085201|101657947|FG000|STARTED|Overall Study||18||
48677041|NCT01959529|101992017|FG000|Exposed|Overall Study||3809||
48677042|NCT01959529|101992018|FG001|Exposed|Overall Study||3806||
48677043|NCT01959529|101992017|FG000|COMPLETED|Overall Study||3742||
48677044|NCT01959529|101992018|FG001|COMPLETED|Overall Study||3747||
48677045|NCT01959529|101992017|FG000|NOT COMPLETED|Overall Study||76||
48677046|NCT01959529|101992018|FG001|NOT COMPLETED|Overall Study||72||
48677047|NCT05069649|101992019|FG000|STARTED|Overall Study||526||
48677048|NCT05069649|101992020|FG001|STARTED|Overall Study||524||
48677049|NCT05069649|101992019|FG000|COMPLETED|Overall Study||526||
48677050|NCT05069649|101992020|FG001|COMPLETED|Overall Study||524||
48677051|NCT05069649|101992019|FG000|NOT COMPLETED|Overall Study||0||
48677052|NCT05069649|101992020|FG001|NOT COMPLETED|Overall Study||0||
48677053|NCT03060902|101992021|FG000|STARTED|Overall Study||46||
48677054|NCT03060902|101992022|FG001|STARTED|Overall Study||47||
48677055|NCT03060902|101992021|FG000|COMPLETED|Overall Study||23||
48677056|NCT03060902|101992022|FG001|COMPLETED|Overall Study||47||
48239898|NCT01072149|100908959|FG008|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
48239899|NCT01072149|100908960|FG009|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
48239900|NCT01072149|100908961|FG010|NOT COMPLETED|Treatment Period 1 (28 Days)||1||
48239901|NCT01072149|100908962|FG011|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
48239902|NCT01072149|100908963|FG012|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
48239903|NCT01072149|100908964|FG013|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
48239904|NCT01072149|100908965|FG014|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
48239905|NCT01072149|100908966|FG015|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
48239906|NCT01072149|100908967|FG016|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
48677057|NCT03060902|101992021|FG000|NOT COMPLETED|Overall Study||23||
48677058|NCT03060902|101992022|FG001|NOT COMPLETED|Overall Study||0||
48677059|NCT01497756|101992023|FG000|STARTED|Overall Study||10||
48677060|NCT01497756|101992023|FG000|COMPLETED|Overall Study||10||
48677061|NCT01497756|101992023|FG000|NOT COMPLETED|Overall Study||0||
48677062|NCT00657267|101992024|FG000|STARTED|Overall Study||58||
48677063|NCT00657267|101992024|FG000|COMPLETED|Overall Study||4||
48677064|NCT00657267|101992024|FG000|NOT COMPLETED|Overall Study||54||
48677065|NCT03261830|101992025|FG000|STARTED|Overall Study||82||
48677066|NCT03261830|101992026|FG001|STARTED|Overall Study||78||
48677067|NCT03261830|101992025|FG000|COMPLETED|Overall Study||82||
48677068|NCT03261830|101992026|FG001|COMPLETED|Overall Study||78||
48677069|NCT03261830|101992025|FG000|NOT COMPLETED|Overall Study||0||
48677070|NCT03261830|101992026|FG001|NOT COMPLETED|Overall Study||0||
48677071|NCT00859833|101992027|FG000|STARTED|Overall Study||30||
48677072|NCT00859833|101992027|FG000|COMPLETED|Overall Study||30||
48677073|NCT00859833|101992027|FG000|NOT COMPLETED|Overall Study||0||
48677074|NCT01957865|101992028|FG000|STARTED|Overall Study||21||
48677075|NCT01957865|101992029|FG001|STARTED|Overall Study||20||
48677076|NCT01957865|101992030|FG002|STARTED|Overall Study||22||
48677077|NCT01957865|101992028|FG000|COMPLETED|Overall Study||21||
48677078|NCT01957865|101992029|FG001|COMPLETED|Overall Study||18||
48677079|NCT01957865|101992030|FG002|COMPLETED|Overall Study||19||
48677080|NCT01957865|101992028|FG000|NOT COMPLETED|Overall Study||0||
48677081|NCT01957865|101992029|FG001|NOT COMPLETED|Overall Study||2||
48677082|NCT01957865|101992030|FG002|NOT COMPLETED|Overall Study||3||
48677083|NCT05175014|101992031|FG000|STARTED|Overall Study||20091||27
48677084|NCT05175014|101992032|FG001|STARTED|Overall Study||18821||27
48239907|NCT01072149|100908968|FG017|NOT COMPLETED|Treatment Period 1 (28 Days)||1||
48239908|NCT01072149|100908951|FG000|STARTED|Washout Period 1 (14 Days)||3||
48239909|NCT01072149|100908952|FG001|STARTED|Washout Period 1 (14 Days)||3||
48239910|NCT01072149|100908953|FG002|STARTED|Washout Period 1 (14 Days)||2||
48239911|NCT01072149|100908954|FG003|STARTED|Washout Period 1 (14 Days)||3||
48239912|NCT01072149|100908955|FG004|STARTED|Washout Period 1 (14 Days)||3||
48239913|NCT01072149|100908956|FG005|STARTED|Washout Period 1 (14 Days)||3||
48239914|NCT01072149|100908957|FG006|STARTED|Washout Period 1 (14 Days)||3||
48239915|NCT01072149|100908958|FG007|STARTED|Washout Period 1 (14 Days)||3||
48239916|NCT01072149|100908959|FG008|STARTED|Washout Period 1 (14 Days)||3||
48239917|NCT01072149|100908960|FG009|STARTED|Washout Period 1 (14 Days)||3||
48239918|NCT01072149|100908961|FG010|STARTED|Washout Period 1 (14 Days)||2||
48239919|NCT01072149|100908962|FG011|STARTED|Washout Period 1 (14 Days)||3||
48239920|NCT01072149|100908963|FG012|STARTED|Washout Period 1 (14 Days)||3||
48239921|NCT01072149|100908964|FG013|STARTED|Washout Period 1 (14 Days)||3||
48239922|NCT01072149|100908965|FG014|STARTED|Washout Period 1 (14 Days)||3||
48239923|NCT01072149|100908966|FG015|STARTED|Washout Period 1 (14 Days)||3||
48677085|NCT05175014|101992033|FG002|STARTED|Overall Study||5706||9
48677086|NCT05175014|101992031|FG000|COMPLETED|Overall Study||20091||27
48677087|NCT05175014|101992032|FG001|COMPLETED|Overall Study||18821||27
48677088|NCT05175014|101992033|FG002|COMPLETED|Overall Study||5706||9
48677089|NCT05175014|101992031|FG000|NOT COMPLETED|Overall Study||0||0
48677090|NCT05175014|101992032|FG001|NOT COMPLETED|Overall Study||0||0
48677091|NCT05175014|101992033|FG002|NOT COMPLETED|Overall Study||0||0
48677092|NCT00953706|101992034|FG000|STARTED|Part A (16-Week Double-Blind Treatment)||28||
48677093|NCT00953706|101992035|FG001|STARTED|Part A (16-Week Double-Blind Treatment)||112||
48677094|NCT00953706|101992036|FG002|STARTED|Part A (16-Week Double-Blind Treatment)||0||
48239924|NCT01072149|100908967|FG016|STARTED|Washout Period 1 (14 Days)||3||
48239925|NCT01072149|100908968|FG017|STARTED|Washout Period 1 (14 Days)||2||
48239926|NCT01072149|100908951|FG000|COMPLETED|Washout Period 1 (14 Days)||3||
48239927|NCT01072149|100908952|FG001|COMPLETED|Washout Period 1 (14 Days)||3||
48539865|NCT01085201|101657948|FG001|STARTED|Overall Study||7||
48539866|NCT01085201|101657949|FG002|STARTED|Overall Study||5||
48539867|NCT01085201|101657950|FG003|STARTED|Overall Study||6||
48539868|NCT01085201|101657951|FG004|STARTED|Overall Study||3||
48539869|NCT01085201|101657947|FG000|COMPLETED|Overall Study||15||
48539870|NCT01085201|101657948|FG001|COMPLETED|Overall Study||6||
48539871|NCT01085201|101657949|FG002|COMPLETED|Overall Study||3||
48539872|NCT01085201|101657950|FG003|COMPLETED|Overall Study||6||
48539873|NCT01085201|101657951|FG004|COMPLETED|Overall Study||3||
48539874|NCT01085201|101657947|FG000|NOT COMPLETED|Overall Study||3||
48539875|NCT01085201|101657948|FG001|NOT COMPLETED|Overall Study||1||
48539876|NCT01085201|101657949|FG002|NOT COMPLETED|Overall Study||2||
48539877|NCT01085201|101657950|FG003|NOT COMPLETED|Overall Study||0||
48539878|NCT01085201|101657951|FG004|NOT COMPLETED|Overall Study||0||
48539879|NCT04086407|101657952|FG000|STARTED|Overall Study||8||
48539880|NCT04086407|101657952|FG000|COMPLETED|Overall Study||8||
48539881|NCT04086407|101657952|FG000|NOT COMPLETED|Overall Study||0||
48539882|NCT02954991|101657953|FG000|STARTED|Overall Study||124||
48539883|NCT02954991|101657954|FG001|STARTED|Overall Study||32||
48539884|NCT02954991|101657955|FG002|STARTED|Overall Study||5||
48539885|NCT02954991|101657953|FG000|Received Any Study Treatment|Overall Study||124||
48539886|NCT02954991|101657954|FG001|Received Any Study Treatment|Overall Study||32||
48539887|NCT02954991|101657955|FG002|Received Any Study Treatment|Overall Study||5||
48539888|NCT02954991|101657953|FG000|COMPLETED|Overall Study||0||
48539889|NCT02954991|101657954|FG001|COMPLETED|Overall Study||0||
48539890|NCT02954991|101657955|FG002|COMPLETED|Overall Study||0||
48539891|NCT02954991|101657953|FG000|NOT COMPLETED|Overall Study||124||
48539892|NCT02954991|101657954|FG001|NOT COMPLETED|Overall Study||32||
48539893|NCT02954991|101657955|FG002|NOT COMPLETED|Overall Study||5||
48539894|NCT00676780|101657956|FG000|STARTED|Overall Study||33||
48539895|NCT00676780|101657956|FG000|COMPLETED|Overall Study||26||
48539896|NCT00676780|101657956|FG000|NOT COMPLETED|Overall Study||7||
48539897|NCT05005312|101657957|FG000|STARTED|Overall Study||8||
48539898|NCT05005312|101657958|FG001|STARTED|Overall Study||9||
48539899|NCT05005312|101657957|FG000|Treated|Overall Study||8||
48539900|NCT05005312|101657958|FG001|Treated|Overall Study||8||
48539901|NCT05005312|101657957|FG000|COMPLETED|Overall Study||8||
48539902|NCT05005312|101657958|FG001|COMPLETED|Overall Study||8||
48539903|NCT05005312|101657957|FG000|NOT COMPLETED|Overall Study||0||
48239928|NCT01072149|100908953|FG002|COMPLETED|Washout Period 1 (14 Days)||2||
48239929|NCT01072149|100908954|FG003|COMPLETED|Washout Period 1 (14 Days)||3||
48539904|NCT05005312|101657958|FG001|NOT COMPLETED|Overall Study||1||
48539905|NCT01053000|101657959|FG000|STARTED|Overall Study||5||
48539906|NCT01053000|101657960|FG001|STARTED|Overall Study||5||
48539907|NCT01053000|101657959|FG000|COMPLETED|Overall Study||5||
48539908|NCT01053000|101657960|FG001|COMPLETED|Overall Study||5||
48539909|NCT01053000|101657959|FG000|NOT COMPLETED|Overall Study||0||
48539910|NCT01053000|101657960|FG001|NOT COMPLETED|Overall Study||0||
48539911|NCT02454127|101657961|FG000|STARTED|Overall Study||40||
48539912|NCT02454127|101657962|FG001|STARTED|Overall Study||40||
48539913|NCT02454127|101657963|FG002|STARTED|Overall Study||40||
48539914|NCT02454127|101657964|FG003|STARTED|Overall Study||40||
48539915|NCT02454127|101657961|FG000|COMPLETED|Overall Study||21||
48539916|NCT02454127|101657962|FG001|COMPLETED|Overall Study||26||
48539917|NCT02454127|101657963|FG002|COMPLETED|Overall Study||26||
48539918|NCT02454127|101657964|FG003|COMPLETED|Overall Study||20||
48539919|NCT02454127|101657961|FG000|NOT COMPLETED|Overall Study||19||
48539920|NCT02454127|101657962|FG001|NOT COMPLETED|Overall Study||14||
48539921|NCT02454127|101657963|FG002|NOT COMPLETED|Overall Study||14||
48539922|NCT02454127|101657964|FG003|NOT COMPLETED|Overall Study||20||
48539923|NCT02091466|101657965|FG000|STARTED|Overall Study||20||
48539924|NCT02091466|101657966|FG001|STARTED|Overall Study||20||
48539925|NCT02091466|101657965|FG000|COMPLETED|Overall Study||20||
48539926|NCT02091466|101657966|FG001|COMPLETED|Overall Study||20||
48539927|NCT02091466|101657965|FG000|NOT COMPLETED|Overall Study||0||
48539928|NCT02091466|101657966|FG001|NOT COMPLETED|Overall Study||0||
48539929|NCT00763061|101657967|FG000|STARTED|Overall Study||54||
48539930|NCT00763061|101657968|FG001|STARTED|Overall Study||57||
48539931|NCT00763061|101657967|FG000|COMPLETED|Overall Study||49||
48539932|NCT00763061|101657968|FG001|COMPLETED|Overall Study||44||
48539933|NCT00763061|101657967|FG000|NOT COMPLETED|Overall Study||5||
48539934|NCT00763061|101657968|FG001|NOT COMPLETED|Overall Study||13||
48539935|NCT03558061|101657969|FG000|STARTED|Overall Study||30||
48539936|NCT03558061|101657969|FG000|COMPLETED|Overall Study||29||
48539937|NCT03558061|101657969|FG000|NOT COMPLETED|Overall Study||1||
48539938|NCT02933255|101657970|FG000|STARTED|Overall Study||12||
48539939|NCT02933255|101657971|FG001|STARTED|Overall Study||12||
48539940|NCT02933255|101657970|FG000|Follow Up Period Completed|Overall Study||11||
48539941|NCT02933255|101657971|FG001|Follow Up Period Completed|Overall Study||12||
48539942|NCT02933255|101657970|FG000|COMPLETED|Overall Study||11||
48677095|NCT00953706|101992037|FG003|STARTED|Part A (16-Week Double-Blind Treatment)||0||
48677096|NCT00953706|101992034|FG000|COMPLETED|Part A (16-Week Double-Blind Treatment)||26||
48677097|NCT00953706|101992035|FG001|COMPLETED|Part A (16-Week Double-Blind Treatment)||104||
48677098|NCT00953706|101992036|FG002|COMPLETED|Part A (16-Week Double-Blind Treatment)||0||
48677099|NCT00953706|101992037|FG003|COMPLETED|Part A (16-Week Double-Blind Treatment)||0||
48677100|NCT00953706|101992034|FG000|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||2||
48677101|NCT00953706|101992035|FG001|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||8||
48677102|NCT00953706|101992036|FG002|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0||
48677103|NCT00953706|101992037|FG003|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0||
48677104|NCT00953706|101992034|FG000|STARTED|Part B (96-Week Open-Label Extension)||0||
48677105|NCT00953706|101992035|FG001|STARTED|Part B (96-Week Open-Label Extension)||0||
48677106|NCT00953706|101992036|FG002|STARTED|Part B (96-Week Open-Label Extension)||5||
48677107|NCT00953706|101992037|FG003|STARTED|Part B (96-Week Open-Label Extension)||33||
48677108|NCT00953706|101992034|FG000|COMPLETED|Part B (96-Week Open-Label Extension)||0||
48677109|NCT00953706|101992035|FG001|COMPLETED|Part B (96-Week Open-Label Extension)||0||
48677110|NCT00953706|101992036|FG002|COMPLETED|Part B (96-Week Open-Label Extension)||0||
48677111|NCT00953706|101992037|FG003|COMPLETED|Part B (96-Week Open-Label Extension)||0||
48677112|NCT00953706|101992034|FG000|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0||
48677113|NCT00953706|101992035|FG001|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0||
48677114|NCT00953706|101992036|FG002|NOT COMPLETED|Part B (96-Week Open-Label Extension)||5||
48677115|NCT00953706|101992037|FG003|NOT COMPLETED|Part B (96-Week Open-Label Extension)||33||
48677116|NCT01816984|101992038|FG000|STARTED|Overall Study||12||
48677117|NCT01816984|101992038|FG000|COMPLETED|Overall Study||11||
48677118|NCT01816984|101992038|FG000|NOT COMPLETED|Overall Study||1||
48677119|NCT04098263|101992039|FG000|STARTED|Overall Study||2||
48677120|NCT04098263|101992040|FG001|STARTED|Overall Study||4||
48677121|NCT04098263|101992041|FG002|STARTED|Overall Study||5||
48677122|NCT04098263|101992042|FG003|STARTED|Overall Study||4||
48677123|NCT04098263|101992043|FG004|STARTED|Overall Study||6||
48677124|NCT04098263|101992039|FG000|COMPLETED|Overall Study||2||
48677125|NCT04098263|101992040|FG001|COMPLETED|Overall Study||4||
48677126|NCT04098263|101992041|FG002|COMPLETED|Overall Study||4||
48677127|NCT04098263|101992042|FG003|COMPLETED|Overall Study||4||
48677128|NCT04098263|101992043|FG004|COMPLETED|Overall Study||6||
48677129|NCT04098263|101992039|FG000|NOT COMPLETED|Overall Study||0||
48677130|NCT04098263|101992040|FG001|NOT COMPLETED|Overall Study||0||
48677131|NCT04098263|101992041|FG002|NOT COMPLETED|Overall Study||1||
48677132|NCT04098263|101992042|FG003|NOT COMPLETED|Overall Study||0||
48677133|NCT04098263|101992043|FG004|NOT COMPLETED|Overall Study||0||
48677134|NCT01215851|101992044|FG000|STARTED|Treatment Period||15||
48677135|NCT01215851|101992045|FG001|STARTED|Treatment Period||15||
48677136|NCT01215851|101992046|FG002|STARTED|Treatment Period||15||
48677137|NCT01215851|101992047|FG003|STARTED|Treatment Period||15||
48677138|NCT01215851|101992048|FG004|STARTED|Treatment Period||10||
48677139|NCT01215851|101992049|FG005|STARTED|Treatment Period||15||
48239930|NCT01072149|100908955|FG004|COMPLETED|Washout Period 1 (14 Days)||3||
48239931|NCT01072149|100908956|FG005|COMPLETED|Washout Period 1 (14 Days)||3||
48239932|NCT01072149|100908957|FG006|COMPLETED|Washout Period 1 (14 Days)||3||
48239933|NCT01072149|100908958|FG007|COMPLETED|Washout Period 1 (14 Days)||3||
48239934|NCT01072149|100908959|FG008|COMPLETED|Washout Period 1 (14 Days)||3||
48239935|NCT01072149|100908960|FG009|COMPLETED|Washout Period 1 (14 Days)||3||
48239936|NCT01072149|100908961|FG010|COMPLETED|Washout Period 1 (14 Days)||2||
48677140|NCT01215851|101992044|FG000|COMPLETED|Treatment Period||14||
48677141|NCT01215851|101992045|FG001|COMPLETED|Treatment Period||14||
48677142|NCT01215851|101992046|FG002|COMPLETED|Treatment Period||14||
48677143|NCT01215851|101992047|FG003|COMPLETED|Treatment Period||12||
48677144|NCT01215851|101992048|FG004|COMPLETED|Treatment Period||10||
48677145|NCT01215851|101992049|FG005|COMPLETED|Treatment Period||14||
48239937|NCT01072149|100908962|FG011|COMPLETED|Washout Period 1 (14 Days)||3||
48239938|NCT01072149|100908963|FG012|COMPLETED|Washout Period 1 (14 Days)||3||
48239939|NCT01072149|100908964|FG013|COMPLETED|Washout Period 1 (14 Days)||3||
48239940|NCT01072149|100908965|FG014|COMPLETED|Washout Period 1 (14 Days)||3||
48239941|NCT01072149|100908966|FG015|COMPLETED|Washout Period 1 (14 Days)||3||
48239942|NCT01072149|100908967|FG016|COMPLETED|Washout Period 1 (14 Days)||3||
48239943|NCT01072149|100908968|FG017|COMPLETED|Washout Period 1 (14 Days)||2||
48239944|NCT01072149|100908951|FG000|NOT COMPLETED|Washout Period 1 (14 Days)||0||
48239945|NCT01072149|100908952|FG001|NOT COMPLETED|Washout Period 1 (14 Days)||0||
48239946|NCT01072149|100908953|FG002|NOT COMPLETED|Washout Period 1 (14 Days)||0||
48239947|NCT01072149|100908954|FG003|NOT COMPLETED|Washout Period 1 (14 Days)||0||
48239948|NCT01072149|100908955|FG004|NOT COMPLETED|Washout Period 1 (14 Days)||0||
48239949|NCT01072149|100908956|FG005|NOT COMPLETED|Washout Period 1 (14 Days)||0||
48239950|NCT01072149|100908957|FG006|NOT COMPLETED|Washout Period 1 (14 Days)||0||
48677146|NCT01215851|101992044|FG000|NOT COMPLETED|Treatment Period||1||
48677147|NCT01215851|101992045|FG001|NOT COMPLETED|Treatment Period||1||
48677148|NCT01215851|101992046|FG002|NOT COMPLETED|Treatment Period||1||
48677149|NCT01215851|101992047|FG003|NOT COMPLETED|Treatment Period||3||
48677150|NCT01215851|101992048|FG004|NOT COMPLETED|Treatment Period||0||
48677151|NCT01215851|101992049|FG005|NOT COMPLETED|Treatment Period||1||
48677152|NCT01215851|101992044|FG000|STARTED|Follow up Period||14||
48677153|NCT01215851|101992045|FG001|STARTED|Follow up Period||14||
48677154|NCT01215851|101992046|FG002|STARTED|Follow up Period||14||
48677155|NCT01215851|101992047|FG003|STARTED|Follow up Period||12||
48677156|NCT01215851|101992048|FG004|STARTED|Follow up Period||10||
48677157|NCT01215851|101992049|FG005|STARTED|Follow up Period||14||
48677158|NCT01215851|101992044|FG000|COMPLETED|Follow up Period||14||
48677159|NCT01215851|101992045|FG001|COMPLETED|Follow up Period||14||
48677160|NCT01215851|101992046|FG002|COMPLETED|Follow up Period||14||
48677161|NCT01215851|101992047|FG003|COMPLETED|Follow up Period||12||
48677162|NCT01215851|101992048|FG004|COMPLETED|Follow up Period||10||
48677163|NCT01215851|101992049|FG005|COMPLETED|Follow up Period||13||
48677164|NCT01215851|101992044|FG000|NOT COMPLETED|Follow up Period||0||
48677165|NCT01215851|101992045|FG001|NOT COMPLETED|Follow up Period||0||
48677166|NCT01215851|101992046|FG002|NOT COMPLETED|Follow up Period||0||
48677167|NCT01215851|101992047|FG003|NOT COMPLETED|Follow up Period||0||
48677168|NCT01215851|101992048|FG004|NOT COMPLETED|Follow up Period||0||
48677169|NCT01215851|101992049|FG005|NOT COMPLETED|Follow up Period||1||
48677170|NCT01847443|101992050|FG000|STARTED|Study Period 1||21||
48677171|NCT01847443|101992051|FG001|STARTED|Study Period 1||21||
48677172|NCT01847443|101992052|FG002|STARTED|Study Period 1||21||
48677173|NCT01847443|101992053|FG003|STARTED|Study Period 1||21||
48677174|NCT01847443|101992050|FG000|COMPLETED|Study Period 1||21||
48239951|NCT01072149|100908958|FG007|NOT COMPLETED|Washout Period 1 (14 Days)||0||
48239952|NCT01072149|100908959|FG008|NOT COMPLETED|Washout Period 1 (14 Days)||0||
48677175|NCT01847443|101992051|FG001|COMPLETED|Study Period 1||20||
48677176|NCT01847443|101992052|FG002|COMPLETED|Study Period 1||21||
48677177|NCT01847443|101992053|FG003|COMPLETED|Study Period 1||21||
48677178|NCT01847443|101992050|FG000|NOT COMPLETED|Study Period 1||0||
48677179|NCT01847443|101992051|FG001|NOT COMPLETED|Study Period 1||1||
48677180|NCT01847443|101992052|FG002|NOT COMPLETED|Study Period 1||0||
48677181|NCT01847443|101992053|FG003|NOT COMPLETED|Study Period 1||0||
48677182|NCT01847443|101992050|FG000|STARTED|Washout Period Before Study Period 2||21||
48677183|NCT01847443|101992051|FG001|STARTED|Washout Period Before Study Period 2||20||
48677184|NCT01847443|101992052|FG002|STARTED|Washout Period Before Study Period 2||21||
48677185|NCT01847443|101992053|FG003|STARTED|Washout Period Before Study Period 2||21||
48677186|NCT01847443|101992050|FG000|COMPLETED|Washout Period Before Study Period 2||19||
48677187|NCT01847443|101992051|FG001|COMPLETED|Washout Period Before Study Period 2||19||
48677188|NCT01847443|101992052|FG002|COMPLETED|Washout Period Before Study Period 2||21||
48677189|NCT01847443|101992053|FG003|COMPLETED|Washout Period Before Study Period 2||21||
48677190|NCT01847443|101992050|FG000|NOT COMPLETED|Washout Period Before Study Period 2||2||
48677191|NCT01847443|101992051|FG001|NOT COMPLETED|Washout Period Before Study Period 2||1||
48677192|NCT01847443|101992052|FG002|NOT COMPLETED|Washout Period Before Study Period 2||0||
48677193|NCT01847443|101992053|FG003|NOT COMPLETED|Washout Period Before Study Period 2||0||
48677194|NCT01847443|101992050|FG000|STARTED|Study Period 2||19||
48677195|NCT01847443|101992051|FG001|STARTED|Study Period 2||19||
48677196|NCT01847443|101992052|FG002|STARTED|Study Period 2||21||
48677197|NCT01847443|101992053|FG003|STARTED|Study Period 2||21||
48677198|NCT01847443|101992050|FG000|COMPLETED|Study Period 2||19||
48677199|NCT01847443|101992051|FG001|COMPLETED|Study Period 2||19||
48677200|NCT01847443|101992052|FG002|COMPLETED|Study Period 2||21||
48677201|NCT01847443|101992053|FG003|COMPLETED|Study Period 2||21||
48677202|NCT01847443|101992050|FG000|NOT COMPLETED|Study Period 2||0||
48677203|NCT01847443|101992051|FG001|NOT COMPLETED|Study Period 2||0||
48677204|NCT01847443|101992052|FG002|NOT COMPLETED|Study Period 2||0||
48677205|NCT01847443|101992053|FG003|NOT COMPLETED|Study Period 2||0||
48677206|NCT01847443|101992050|FG000|STARTED|Washout Period Before Study Period 3||19||
48677207|NCT01847443|101992051|FG001|STARTED|Washout Period Before Study Period 3||19||
48677208|NCT01847443|101992052|FG002|STARTED|Washout Period Before Study Period 3||21||
48677209|NCT01847443|101992053|FG003|STARTED|Washout Period Before Study Period 3||21||
48677210|NCT01847443|101992050|FG000|COMPLETED|Washout Period Before Study Period 3||18||
48677211|NCT01847443|101992051|FG001|COMPLETED|Washout Period Before Study Period 3||19||
48677212|NCT01847443|101992052|FG002|COMPLETED|Washout Period Before Study Period 3||21||
48677213|NCT01847443|101992053|FG003|COMPLETED|Washout Period Before Study Period 3||21||
48677214|NCT01847443|101992050|FG000|NOT COMPLETED|Washout Period Before Study Period 3||1||
48677215|NCT01847443|101992051|FG001|NOT COMPLETED|Washout Period Before Study Period 3||0||
48677216|NCT01847443|101992052|FG002|NOT COMPLETED|Washout Period Before Study Period 3||0||
48677217|NCT01847443|101992053|FG003|NOT COMPLETED|Washout Period Before Study Period 3||0||
48677218|NCT01847443|101992050|FG000|STARTED|Study Period 3||18||
48677219|NCT01847443|101992051|FG001|STARTED|Study Period 3||19||
48677220|NCT01847443|101992052|FG002|STARTED|Study Period 3||21||
48677221|NCT01847443|101992053|FG003|STARTED|Study Period 3||21||
48677222|NCT01847443|101992050|FG000|COMPLETED|Study Period 3||18||
48677223|NCT01847443|101992051|FG001|COMPLETED|Study Period 3||19||
48677224|NCT01847443|101992052|FG002|COMPLETED|Study Period 3||21||
48239953|NCT01072149|100908960|FG009|NOT COMPLETED|Washout Period 1 (14 Days)||0||
48239954|NCT01072149|100908961|FG010|NOT COMPLETED|Washout Period 1 (14 Days)||0||
48677225|NCT01847443|101992053|FG003|COMPLETED|Study Period 3||21||
48677226|NCT01847443|101992050|FG000|NOT COMPLETED|Study Period 3||0||
48677227|NCT01847443|101992051|FG001|NOT COMPLETED|Study Period 3||0||
48677228|NCT01847443|101992052|FG002|NOT COMPLETED|Study Period 3||0||
48677229|NCT01847443|101992053|FG003|NOT COMPLETED|Study Period 3||0||
48677230|NCT01847443|101992050|FG000|STARTED|Washout Period Before Study Period 4||18||
48677231|NCT01847443|101992051|FG001|STARTED|Washout Period Before Study Period 4||19||
48677232|NCT01847443|101992052|FG002|STARTED|Washout Period Before Study Period 4||21||
48677233|NCT01847443|101992053|FG003|STARTED|Washout Period Before Study Period 4||21||
48677234|NCT01847443|101992050|FG000|COMPLETED|Washout Period Before Study Period 4||16||
48677235|NCT01847443|101992051|FG001|COMPLETED|Washout Period Before Study Period 4||19||
48677236|NCT01847443|101992052|FG002|COMPLETED|Washout Period Before Study Period 4||21||
48677237|NCT01847443|101992053|FG003|COMPLETED|Washout Period Before Study Period 4||21||
48677238|NCT01847443|101992050|FG000|NOT COMPLETED|Washout Period Before Study Period 4||2||
48677239|NCT01847443|101992051|FG001|NOT COMPLETED|Washout Period Before Study Period 4||0||
48677240|NCT01847443|101992052|FG002|NOT COMPLETED|Washout Period Before Study Period 4||0||
48239955|NCT01072149|100908962|FG011|NOT COMPLETED|Washout Period 1 (14 Days)||0||
48239956|NCT01072149|100908963|FG012|NOT COMPLETED|Washout Period 1 (14 Days)||0||
48239957|NCT01072149|100908964|FG013|NOT COMPLETED|Washout Period 1 (14 Days)||0||
48239958|NCT01072149|100908965|FG014|NOT COMPLETED|Washout Period 1 (14 Days)||0||
48239959|NCT01072149|100908966|FG015|NOT COMPLETED|Washout Period 1 (14 Days)||0||
48239960|NCT01072149|100908967|FG016|NOT COMPLETED|Washout Period 1 (14 Days)||0||
48239961|NCT01072149|100908968|FG017|NOT COMPLETED|Washout Period 1 (14 Days)||0||
48239962|NCT01072149|100908951|FG000|STARTED|Treatment Period 2 (28 Days)||3||
48239963|NCT01072149|100908952|FG001|STARTED|Treatment Period 2 (28 Days)||3||
48239964|NCT01072149|100908953|FG002|STARTED|Treatment Period 2 (28 Days)||2||
48239965|NCT01072149|100908954|FG003|STARTED|Treatment Period 2 (28 Days)||3||
48239966|NCT01072149|100908955|FG004|STARTED|Treatment Period 2 (28 Days)||3||
48239967|NCT01072149|100908956|FG005|STARTED|Treatment Period 2 (28 Days)||3||
48239968|NCT01072149|100908957|FG006|STARTED|Treatment Period 2 (28 Days)||3||
48677241|NCT01847443|101992053|FG003|NOT COMPLETED|Washout Period Before Study Period 4||0||
48677242|NCT01847443|101992050|FG000|STARTED|Study Period 4||16||
48677243|NCT01847443|101992051|FG001|STARTED|Study Period 4||19||
48677244|NCT01847443|101992052|FG002|STARTED|Study Period 4||21||
48677245|NCT01847443|101992053|FG003|STARTED|Study Period 4||21||
48677246|NCT01847443|101992050|FG000|COMPLETED|Study Period 4||16||
48677247|NCT01847443|101992051|FG001|COMPLETED|Study Period 4||19||
48677248|NCT01847443|101992052|FG002|COMPLETED|Study Period 4||21||
48677249|NCT01847443|101992053|FG003|COMPLETED|Study Period 4||21||
48677250|NCT01847443|101992050|FG000|NOT COMPLETED|Study Period 4||0||
48677251|NCT01847443|101992051|FG001|NOT COMPLETED|Study Period 4||0||
48677252|NCT01847443|101992052|FG002|NOT COMPLETED|Study Period 4||0||
48677253|NCT01847443|101992053|FG003|NOT COMPLETED|Study Period 4||0||
48677254|NCT02921789|101992054|FG000|STARTED|Overall Study||34||
48677255|NCT02921789|101992055|FG001|STARTED|Overall Study||29||
48677256|NCT02921789|101992054|FG000|Randomized and Took Study Drug|Overall Study||34||
48677257|NCT02921789|101992055|FG001|Randomized and Took Study Drug|Overall Study||29||
48677258|NCT02921789|101992054|FG000|COMPLETED|Overall Study||26||
48677259|NCT02921789|101992055|FG001|COMPLETED|Overall Study||25||
48677260|NCT02921789|101992054|FG000|NOT COMPLETED|Overall Study||8||
48677261|NCT02921789|101992055|FG001|NOT COMPLETED|Overall Study||4||
48239969|NCT01072149|100908958|FG007|STARTED|Treatment Period 2 (28 Days)||3||
48239970|NCT01072149|100908959|FG008|STARTED|Treatment Period 2 (28 Days)||3||
48239971|NCT01072149|100908960|FG009|STARTED|Treatment Period 2 (28 Days)||3||
48239972|NCT01072149|100908961|FG010|STARTED|Treatment Period 2 (28 Days)||2||
48239973|NCT01072149|100908962|FG011|STARTED|Treatment Period 2 (28 Days)||3||
48239974|NCT01072149|100908963|FG012|STARTED|Treatment Period 2 (28 Days)||3||
48239975|NCT01072149|100908964|FG013|STARTED|Treatment Period 2 (28 Days)||3||
48677262|NCT00976456|101992056|FG000|STARTED|Overall Study||135||
48677263|NCT00976456|101992057|FG001|STARTED|Overall Study||136||
48677264|NCT00976456|101992056|FG000|COMPLETED|Overall Study||92||
48677265|NCT00976456|101992057|FG001|COMPLETED|Overall Study||98||
48677266|NCT00976456|101992056|FG000|NOT COMPLETED|Overall Study||43||
48677267|NCT00976456|101992057|FG001|NOT COMPLETED|Overall Study||38||
48677268|NCT01298323|101992058|FG000|STARTED|Overall Study||102||
48677269|NCT01298323|101992059|FG001|STARTED|Overall Study||103||
48677270|NCT01298323|101992058|FG000|Ongoing|Overall Study||55||
48677271|NCT01298323|101992059|FG001|Ongoing|Overall Study||55||
48677272|NCT01298323|101992058|FG000|COMPLETED|Overall Study||16||
48677273|NCT01298323|101992059|FG001|COMPLETED|Overall Study||15||
48677274|NCT01298323|101992058|FG000|NOT COMPLETED|Overall Study||86||
48677275|NCT01298323|101992059|FG001|NOT COMPLETED|Overall Study||88||
48677276|NCT00731484|101992060|FG000|STARTED|Overall Study||233||
48677277|NCT00731484|101992060|FG000|COMPLETED|Overall Study||233||
48677278|NCT00731484|101992060|FG000|NOT COMPLETED|Overall Study||0||
48677279|NCT03961308|101992061|FG000|STARTED|Overall Study||102||
48239976|NCT01072149|100908965|FG014|STARTED|Treatment Period 2 (28 Days)||3||
48239977|NCT01072149|100908966|FG015|STARTED|Treatment Period 2 (28 Days)||3||
48677280|NCT03961308|101992062|FG001|STARTED|Overall Study||102||
48677281|NCT03961308|101992061|FG000|COMPLETED|Overall Study||100||
48677282|NCT03961308|101992062|FG001|COMPLETED|Overall Study||100||
48677283|NCT03961308|101992061|FG000|NOT COMPLETED|Overall Study||2||
48677284|NCT03961308|101992062|FG001|NOT COMPLETED|Overall Study||2||
48677285|NCT02131766|101992063|FG000|STARTED|Overall Study||44||
48677286|NCT02131766|101992063|FG000|COMPLETED|Overall Study||40||
48677287|NCT02131766|101992063|FG000|NOT COMPLETED|Overall Study||4||
48677288|NCT03816176|101992064|FG000|STARTED|Overall Study||31|31|
48677289|NCT03816176|101992064|FG000|COMPLETED|Overall Study||19||
48677290|NCT03816176|101992064|FG000|NOT COMPLETED|Overall Study||12||
48677291|NCT04567524|101992065|FG000|STARTED|Overall Study||12||
48677292|NCT04567524|101992066|FG001|STARTED|Overall Study||12||
48677293|NCT04567524|101992067|FG002|STARTED|Overall Study||4||
48677294|NCT04567524|101992068|FG003|STARTED|Overall Study||4||
48677295|NCT04567524|101992065|FG000|COMPLETED|Overall Study||9||
48677296|NCT04567524|101992066|FG001|COMPLETED|Overall Study||11||
48239978|NCT01072149|100908967|FG016|STARTED|Treatment Period 2 (28 Days)||3||
48239979|NCT01072149|100908968|FG017|STARTED|Treatment Period 2 (28 Days)||2||
48239980|NCT01072149|100908951|FG000|COMPLETED|Treatment Period 2 (28 Days)||3||
48239981|NCT01072149|100908952|FG001|COMPLETED|Treatment Period 2 (28 Days)||2||
48239982|NCT01072149|100908953|FG002|COMPLETED|Treatment Period 2 (28 Days)||1||
48239983|NCT01072149|100908954|FG003|COMPLETED|Treatment Period 2 (28 Days)||3||
48239984|NCT01072149|100908955|FG004|COMPLETED|Treatment Period 2 (28 Days)||3||
48239985|NCT01072149|100908956|FG005|COMPLETED|Treatment Period 2 (28 Days)||3||
48239986|NCT01072149|100908957|FG006|COMPLETED|Treatment Period 2 (28 Days)||3||
48677297|NCT04567524|101992067|FG002|COMPLETED|Overall Study||4||
48677298|NCT04567524|101992068|FG003|COMPLETED|Overall Study||3||
48677299|NCT04567524|101992065|FG000|NOT COMPLETED|Overall Study||3||
48677300|NCT04567524|101992066|FG001|NOT COMPLETED|Overall Study||1||
48677301|NCT04567524|101992067|FG002|NOT COMPLETED|Overall Study||0||
48677302|NCT04567524|101992068|FG003|NOT COMPLETED|Overall Study||1||
48677303|NCT02708680|101994144|FG000|STARTED|Overall Study||8||
48677304|NCT02708680|101994145|FG001|STARTED|Overall Study||40||
48677305|NCT02708680|101994146|FG002|STARTED|Overall Study||41||
48677306|NCT02708680|101994144|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||8|Safety Population|
48677307|NCT02708680|101994145|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||40|Safety Population|
48677308|NCT02708680|101994146|FG002|Received At Least 1 Dose Of Study Drug|Overall Study||39|Safety Population|
48677309|NCT02708680|101994144|FG000|Dose-limiting Toxicity (DLT) Evaluable|Overall Study||6|A participant that experienced an adverse event (AE) meeting DLT criteria during Cycle 1 or who received the full dose of atezolizumab and all doses of entinostat during Cycle 1 without experiencing a DLT was considered DLT evaluable.|
48677310|NCT02708680|101994145|FG001|Dose-limiting Toxicity (DLT) Evaluable|Overall Study||0|A participant that experienced an adverse event (AE) meeting DLT criteria during Cycle 1 or who received the full dose of atezolizumab and all doses of entinostat during Cycle 1 without experiencing a DLT was considered DLT evaluable.|
48677311|NCT02708680|101994146|FG002|Dose-limiting Toxicity (DLT) Evaluable|Overall Study||0|A participant that experienced an adverse event (AE) meeting DLT criteria during Cycle 1 or who received the full dose of atezolizumab and all doses of entinostat during Cycle 1 without experiencing a DLT was considered DLT evaluable.|
48677312|NCT02708680|101994144|FG000|COMPLETED|Overall Study||0||
48677313|NCT02708680|101994145|FG001|COMPLETED|Overall Study||0||
48677314|NCT02708680|101994146|FG002|COMPLETED|Overall Study||0||
48677315|NCT02708680|101994144|FG000|NOT COMPLETED|Overall Study||8||
48677316|NCT02708680|101994145|FG001|NOT COMPLETED|Overall Study||40||
48677317|NCT02708680|101994146|FG002|NOT COMPLETED|Overall Study||41||
48677318|NCT01905540|101994147|FG000|STARTED|Period 1||7||
48677319|NCT01905540|101994148|FG001|STARTED|Period 1||7||
48677320|NCT01905540|101994149|FG002|STARTED|Period 1||7||
48677321|NCT01905540|101994150|FG003|STARTED|Period 1||7||
48677322|NCT01905540|101994147|FG000|COMPLETED|Period 1||7||
48677323|NCT01905540|101994148|FG001|COMPLETED|Period 1||7||
48677324|NCT01905540|101994149|FG002|COMPLETED|Period 1||7||
48677325|NCT01905540|101994150|FG003|COMPLETED|Period 1||7||
48677326|NCT01905540|101994147|FG000|NOT COMPLETED|Period 1||0||
48677327|NCT01905540|101994148|FG001|NOT COMPLETED|Period 1||0||
48677328|NCT01905540|101994149|FG002|NOT COMPLETED|Period 1||0||
48677329|NCT01905540|101994150|FG003|NOT COMPLETED|Period 1||0||
48677330|NCT01905540|101994147|FG000|STARTED|Period 2||7||
48677331|NCT01905540|101994148|FG001|STARTED|Period 2||7||
48677332|NCT01905540|101994149|FG002|STARTED|Period 2||7||
48677333|NCT01905540|101994150|FG003|STARTED|Period 2||7||
48677334|NCT01905540|101994147|FG000|COMPLETED|Period 2||7||
48677335|NCT01905540|101994148|FG001|COMPLETED|Period 2||7||
48677336|NCT01905540|101994149|FG002|COMPLETED|Period 2||7||
48677337|NCT01905540|101994150|FG003|COMPLETED|Period 2||7||
48677338|NCT01905540|101994147|FG000|NOT COMPLETED|Period 2||0||
48677339|NCT01905540|101994148|FG001|NOT COMPLETED|Period 2||0||
48677340|NCT01905540|101994149|FG002|NOT COMPLETED|Period 2||0||
48677341|NCT01905540|101994150|FG003|NOT COMPLETED|Period 2||0||
48677342|NCT01905540|101994147|FG000|STARTED|Period 3||7||
48239987|NCT01072149|100908958|FG007|COMPLETED|Treatment Period 2 (28 Days)||2||
48239988|NCT01072149|100908959|FG008|COMPLETED|Treatment Period 2 (28 Days)||3||
48239989|NCT01072149|100908960|FG009|COMPLETED|Treatment Period 2 (28 Days)||3||
48239990|NCT01072149|100908961|FG010|COMPLETED|Treatment Period 2 (28 Days)||2||
48239991|NCT01072149|100908962|FG011|COMPLETED|Treatment Period 2 (28 Days)||3||
48677343|NCT01905540|101994148|FG001|STARTED|Period 3||7||
48677344|NCT01905540|101994149|FG002|STARTED|Period 3||7||
48677345|NCT01905540|101994150|FG003|STARTED|Period 3||7||
48677346|NCT01905540|101994147|FG000|COMPLETED|Period 3||6||
48677347|NCT01905540|101994148|FG001|COMPLETED|Period 3||7||
48677348|NCT01905540|101994149|FG002|COMPLETED|Period 3||6||
48677349|NCT01905540|101994150|FG003|COMPLETED|Period 3||6||
48677350|NCT01905540|101994147|FG000|NOT COMPLETED|Period 3||1||
48677351|NCT01905540|101994148|FG001|NOT COMPLETED|Period 3||0||
48677352|NCT01905540|101994149|FG002|NOT COMPLETED|Period 3||1||
48677353|NCT01905540|101994150|FG003|NOT COMPLETED|Period 3||1||
48677354|NCT01071954|101994151|FG000|STARTED|Overall Study||66||
48677355|NCT01071954|101994151|FG000|Received Treatment|Overall Study||65||
48677356|NCT01071954|101994151|FG000|COMPLETED|Overall Study||39||
48677357|NCT01071954|101994151|FG000|NOT COMPLETED|Overall Study||27||
48239992|NCT01072149|100908963|FG012|COMPLETED|Treatment Period 2 (28 Days)||3||
48239993|NCT01072149|100908964|FG013|COMPLETED|Treatment Period 2 (28 Days)||3||
48239994|NCT01072149|100908965|FG014|COMPLETED|Treatment Period 2 (28 Days)||3||
48239995|NCT01072149|100908966|FG015|COMPLETED|Treatment Period 2 (28 Days)||3||
48239996|NCT01072149|100908967|FG016|COMPLETED|Treatment Period 2 (28 Days)||3||
48239997|NCT01072149|100908968|FG017|COMPLETED|Treatment Period 2 (28 Days)||2||
48239998|NCT01072149|100908951|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
48239999|NCT01072149|100908952|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||1||
48240000|NCT01072149|100908953|FG002|NOT COMPLETED|Treatment Period 2 (28 Days)||1||
48240001|NCT01072149|100908954|FG003|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
48240002|NCT01072149|100908955|FG004|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
48240003|NCT01072149|100908956|FG005|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
48240004|NCT01072149|100908957|FG006|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
48677358|NCT05448950|101994152|FG000|STARTED|Overall Study||12||
48677359|NCT05448950|101994152|FG000|COMPLETED|Overall Study||5||
48677360|NCT05448950|101994152|FG000|NOT COMPLETED|Overall Study||7||
48677361|NCT03218917|101994153|FG000|STARTED|Overall Study||82|Intent-to-treat (ITT) population included all the participants who were randomized.|
48677362|NCT03218917|101994154|FG001|STARTED|Overall Study||87|Intent-to-treat (ITT) population included all the participants who were randomized.|
48677363|NCT03218917|101994155|FG002|STARTED|Overall Study||87|Intent-to-treat (ITT) population included all the participants who were randomized.|
48677364|NCT03218917|101994153|FG000|Received Study Treatment (Safety Population)|Overall Study||81|Safety population included all participants who received at least 1 dose of the study drug.|
48677365|NCT03218917|101994154|FG001|Received Study Treatment (Safety Population)|Overall Study||89|Safety population included all participants who received at least 1 dose of the study drug.|
48677366|NCT03218917|101994155|FG002|Received Study Treatment (Safety Population)|Overall Study||85|Safety population included all participants who received at least 1 dose of the study drug.|
48677367|NCT03218917|101994153|FG000|Participants Did Not Receive Drug|Overall Study||0||
48677368|NCT03218917|101994154|FG001|Participants Did Not Receive Drug|Overall Study||0||
48677369|NCT03218917|101994155|FG002|Participants Did Not Receive Drug|Overall Study||1||
48677370|NCT03218917|101994153|FG000|Pharmacodynamic (PD) Population|Overall Study||80|PD population included participants who received at least 1 dose of the study drugs, have at least 1 pre-dose and 1 post-dose measurement for neutrophil elastase (NE), or proteinase 3, or cathepsin G, or other biomarkers, and have no major protocol deviations that considered to impact on the analysis of the PD data.|
48677371|NCT03218917|101994154|FG001|Pharmacodynamic (PD) Population|Overall Study||89|PD population included participants who received at least 1 dose of the study drugs, have at least 1 pre-dose and 1 post-dose measurement for neutrophil elastase (NE), or proteinase 3, or cathepsin G, or other biomarkers, and have no major protocol deviations that considered to impact on the analysis of the PD data.|
48677372|NCT03218917|101994155|FG002|Pharmacodynamic (PD) Population|Overall Study||84|PD population included participants who received at least 1 dose of the study drugs, have at least 1 pre-dose and 1 post-dose measurement for neutrophil elastase (NE), or proteinase 3, or cathepsin G, or other biomarkers, and have no major protocol deviations that considered to impact on the analysis of the PD data.|
48677373|NCT03218917|101994153|FG000|COMPLETED|Overall Study||76||
48677374|NCT03218917|101994154|FG001|COMPLETED|Overall Study||75||
48677375|NCT03218917|101994155|FG002|COMPLETED|Overall Study||74||
48677376|NCT03218917|101994153|FG000|NOT COMPLETED|Overall Study||6||
48677377|NCT03218917|101994154|FG001|NOT COMPLETED|Overall Study||12||
48677378|NCT03218917|101994155|FG002|NOT COMPLETED|Overall Study||13||
48677379|NCT01126957|101994156|FG000|STARTED|Overall Study||103||
48677380|NCT01126957|101994156|FG000|COMPLETED|Overall Study||103||
48677381|NCT01126957|101994156|FG000|NOT COMPLETED|Overall Study||0||
48677382|NCT01913327|101994157|FG000|STARTED|Overall Study||1||
48677383|NCT01913327|101994158|FG001|STARTED|Overall Study||2||
48240005|NCT01072149|100908958|FG007|NOT COMPLETED|Treatment Period 2 (28 Days)||1||
48240006|NCT01072149|100908959|FG008|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
48240007|NCT01072149|100908960|FG009|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
48240008|NCT01072149|100908961|FG010|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
48240009|NCT01072149|100908962|FG011|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
48240010|NCT01072149|100908963|FG012|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
48240011|NCT01072149|100908964|FG013|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
48240012|NCT01072149|100908965|FG014|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
48240013|NCT01072149|100908966|FG015|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
48677384|NCT01913327|101994157|FG000|COMPLETED|Overall Study||1||
48677385|NCT01913327|101994158|FG001|COMPLETED|Overall Study||1||
48677386|NCT01913327|101994157|FG000|NOT COMPLETED|Overall Study||0||
48240014|NCT01072149|100908967|FG016|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
48240015|NCT01072149|100908968|FG017|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
48240016|NCT01072149|100908951|FG000|STARTED|Washout Period 2 (14 Days)||3||
48240017|NCT01072149|100908952|FG001|STARTED|Washout Period 2 (14 Days)||2||
48240018|NCT01072149|100908953|FG002|STARTED|Washout Period 2 (14 Days)||1||
48240019|NCT01072149|100908954|FG003|STARTED|Washout Period 2 (14 Days)||3||
48240020|NCT01072149|100908955|FG004|STARTED|Washout Period 2 (14 Days)||3||
48240021|NCT01072149|100908956|FG005|STARTED|Washout Period 2 (14 Days)||3||
48240022|NCT01072149|100908957|FG006|STARTED|Washout Period 2 (14 Days)||3||
48677387|NCT01913327|101994158|FG001|NOT COMPLETED|Overall Study||1||
48677388|NCT00506142|101994159|FG000|STARTED|Overall Study||35||
48677389|NCT00506142|101994160|FG001|STARTED|Overall Study||19||
48677390|NCT00506142|101994159|FG000|COMPLETED|Overall Study||0||
48677391|NCT00506142|101994160|FG001|COMPLETED|Overall Study||0||
48677392|NCT00506142|101994159|FG000|NOT COMPLETED|Overall Study||35||
48240023|NCT01072149|100908958|FG007|STARTED|Washout Period 2 (14 Days)||2||
48240024|NCT01072149|100908959|FG008|STARTED|Washout Period 2 (14 Days)||3||
48240025|NCT01072149|100908960|FG009|STARTED|Washout Period 2 (14 Days)||3||
48240026|NCT01072149|100908961|FG010|STARTED|Washout Period 2 (14 Days)||2||
48240027|NCT01072149|100908962|FG011|STARTED|Washout Period 2 (14 Days)||3||
48240028|NCT01072149|100908963|FG012|STARTED|Washout Period 2 (14 Days)||3||
48677393|NCT00506142|101994160|FG001|NOT COMPLETED|Overall Study||19||
48677394|NCT05076045|101994161|FG000|STARTED|First Intervention (3 Hours)||16||
48677395|NCT05076045|101994162|FG001|STARTED|First Intervention (3 Hours)||16||
48677396|NCT05076045|101994161|FG000|COMPLETED|First Intervention (3 Hours)||16||
48677397|NCT05076045|101994162|FG001|COMPLETED|First Intervention (3 Hours)||16||
48677398|NCT05076045|101994161|FG000|NOT COMPLETED|First Intervention (3 Hours)||0||
48677399|NCT05076045|101994162|FG001|NOT COMPLETED|First Intervention (3 Hours)||0||
48677400|NCT05076045|101994161|FG000|STARTED|Washout (1 Week)||16||
48677401|NCT05076045|101994162|FG001|STARTED|Washout (1 Week)||16||
48240029|NCT01072149|100908964|FG013|STARTED|Washout Period 2 (14 Days)||3||
48240030|NCT01072149|100908965|FG014|STARTED|Washout Period 2 (14 Days)||3||
48240031|NCT01072149|100908966|FG015|STARTED|Washout Period 2 (14 Days)||3||
48240032|NCT01072149|100908967|FG016|STARTED|Washout Period 2 (14 Days)||3||
48240033|NCT01072149|100908968|FG017|STARTED|Washout Period 2 (14 Days)||2||
48240034|NCT01072149|100908951|FG000|COMPLETED|Washout Period 2 (14 Days)||2||
48240035|NCT01072149|100908952|FG001|COMPLETED|Washout Period 2 (14 Days)||2||
48240036|NCT01072149|100908953|FG002|COMPLETED|Washout Period 2 (14 Days)||1||
48240037|NCT01072149|100908954|FG003|COMPLETED|Washout Period 2 (14 Days)||3||
48240038|NCT01072149|100908955|FG004|COMPLETED|Washout Period 2 (14 Days)||3||
48240039|NCT01072149|100908956|FG005|COMPLETED|Washout Period 2 (14 Days)||3||
48240040|NCT01072149|100908957|FG006|COMPLETED|Washout Period 2 (14 Days)||3||
48240041|NCT01072149|100908958|FG007|COMPLETED|Washout Period 2 (14 Days)||2||
48240042|NCT01072149|100908959|FG008|COMPLETED|Washout Period 2 (14 Days)||3||
48240043|NCT01072149|100908960|FG009|COMPLETED|Washout Period 2 (14 Days)||3||
48240044|NCT01072149|100908961|FG010|COMPLETED|Washout Period 2 (14 Days)||2||
48240045|NCT01072149|100908962|FG011|COMPLETED|Washout Period 2 (14 Days)||3||
48240046|NCT01072149|100908963|FG012|COMPLETED|Washout Period 2 (14 Days)||2||
48240047|NCT01072149|100908964|FG013|COMPLETED|Washout Period 2 (14 Days)||3||
48240048|NCT01072149|100908965|FG014|COMPLETED|Washout Period 2 (14 Days)||3||
48240049|NCT01072149|100908966|FG015|COMPLETED|Washout Period 2 (14 Days)||1||
48240050|NCT01072149|100908967|FG016|COMPLETED|Washout Period 2 (14 Days)||3||
48240051|NCT01072149|100908968|FG017|COMPLETED|Washout Period 2 (14 Days)||2||
48240052|NCT01072149|100908951|FG000|NOT COMPLETED|Washout Period 2 (14 Days)||1||
48240053|NCT01072149|100908952|FG001|NOT COMPLETED|Washout Period 2 (14 Days)||0||
48240054|NCT01072149|100908953|FG002|NOT COMPLETED|Washout Period 2 (14 Days)||0||
48240055|NCT01072149|100908954|FG003|NOT COMPLETED|Washout Period 2 (14 Days)||0||
48539943|NCT02933255|101657971|FG001|COMPLETED|Overall Study||12||
48677402|NCT05076045|101994161|FG000|COMPLETED|Washout (1 Week)||15||
48677403|NCT05076045|101994162|FG001|COMPLETED|Washout (1 Week)||13||
48677404|NCT05076045|101994161|FG000|NOT COMPLETED|Washout (1 Week)||1||
48677405|NCT05076045|101994162|FG001|NOT COMPLETED|Washout (1 Week)||3||
48677406|NCT05076045|101994161|FG000|STARTED|Second Intervention (3 Hours)||15||
48677407|NCT05076045|101994162|FG001|STARTED|Second Intervention (3 Hours)||13||
48677408|NCT05076045|101994161|FG000|COMPLETED|Second Intervention (3 Hours)||15||
48677409|NCT05076045|101994162|FG001|COMPLETED|Second Intervention (3 Hours)||13||
48677410|NCT05076045|101994161|FG000|NOT COMPLETED|Second Intervention (3 Hours)||0||
48677411|NCT05076045|101994162|FG001|NOT COMPLETED|Second Intervention (3 Hours)||0||
48677412|NCT04700423|101994163|FG000|STARTED|Baseline/Treatment||207||
48677413|NCT04700423|101994164|FG001|STARTED|Baseline/Treatment||211||
48677414|NCT04700423|101994165|FG002|STARTED|Baseline/Treatment||19||
48677415|NCT04700423|101994166|FG003|STARTED|Baseline/Treatment||19||
48677416|NCT04700423|101994167|FG004|STARTED|Baseline/Treatment||80||
48677417|NCT04700423|101994163|FG000|COMPLETED|Baseline/Treatment||207||
48240056|NCT01072149|100908955|FG004|NOT COMPLETED|Washout Period 2 (14 Days)||0||
48240057|NCT01072149|100908956|FG005|NOT COMPLETED|Washout Period 2 (14 Days)||0||
48240058|NCT01072149|100908957|FG006|NOT COMPLETED|Washout Period 2 (14 Days)||0||
48240059|NCT01072149|100908958|FG007|NOT COMPLETED|Washout Period 2 (14 Days)||0||
48240060|NCT01072149|100908959|FG008|NOT COMPLETED|Washout Period 2 (14 Days)||0||
48240061|NCT01072149|100908960|FG009|NOT COMPLETED|Washout Period 2 (14 Days)||0||
48240062|NCT01072149|100908961|FG010|NOT COMPLETED|Washout Period 2 (14 Days)||0||
48240063|NCT01072149|100908962|FG011|NOT COMPLETED|Washout Period 2 (14 Days)||0||
48240064|NCT01072149|100908963|FG012|NOT COMPLETED|Washout Period 2 (14 Days)||1||
48240065|NCT01072149|100908964|FG013|NOT COMPLETED|Washout Period 2 (14 Days)||0||
48240066|NCT01072149|100908965|FG014|NOT COMPLETED|Washout Period 2 (14 Days)||0||
48240067|NCT01072149|100908966|FG015|NOT COMPLETED|Washout Period 2 (14 Days)||2||
48240068|NCT01072149|100908967|FG016|NOT COMPLETED|Washout Period 2 (14 Days)||0||
48240069|NCT01072149|100908968|FG017|NOT COMPLETED|Washout Period 2 (14 Days)||0||
48240070|NCT01072149|100908951|FG000|STARTED|Treatment Period 3 (28 Days)||2||
48240071|NCT01072149|100908952|FG001|STARTED|Treatment Period 3 (28 Days)||2||
48240072|NCT01072149|100908953|FG002|STARTED|Treatment Period 3 (28 Days)||1||
48240073|NCT01072149|100908954|FG003|STARTED|Treatment Period 3 (28 Days)||3||
48240074|NCT01072149|100908955|FG004|STARTED|Treatment Period 3 (28 Days)||3||
48240075|NCT01072149|100908956|FG005|STARTED|Treatment Period 3 (28 Days)||3||
48240076|NCT01072149|100908957|FG006|STARTED|Treatment Period 3 (28 Days)||3||
48240077|NCT01072149|100908958|FG007|STARTED|Treatment Period 3 (28 Days)||2||
48240078|NCT01072149|100908959|FG008|STARTED|Treatment Period 3 (28 Days)||3||
48240079|NCT01072149|100908960|FG009|STARTED|Treatment Period 3 (28 Days)||3||
48240080|NCT01072149|100908961|FG010|STARTED|Treatment Period 3 (28 Days)||2||
48240081|NCT01072149|100908962|FG011|STARTED|Treatment Period 3 (28 Days)||3||
48240082|NCT01072149|100908963|FG012|STARTED|Treatment Period 3 (28 Days)||2||
48240083|NCT01072149|100908964|FG013|STARTED|Treatment Period 3 (28 Days)||3||
48240084|NCT01072149|100908965|FG014|STARTED|Treatment Period 3 (28 Days)||3||
48240085|NCT01072149|100908966|FG015|STARTED|Treatment Period 3 (28 Days)||1||
48240086|NCT01072149|100908967|FG016|STARTED|Treatment Period 3 (28 Days)||3||
48240087|NCT01072149|100908968|FG017|STARTED|Treatment Period 3 (28 Days)||2||
48240088|NCT01072149|100908951|FG000|COMPLETED|Treatment Period 3 (28 Days)||2||
48240089|NCT01072149|100908952|FG001|COMPLETED|Treatment Period 3 (28 Days)||2||
48240090|NCT01072149|100908953|FG002|COMPLETED|Treatment Period 3 (28 Days)||0||
48240091|NCT01072149|100908954|FG003|COMPLETED|Treatment Period 3 (28 Days)||3||
48240092|NCT01072149|100908955|FG004|COMPLETED|Treatment Period 3 (28 Days)||3||
48240093|NCT01072149|100908956|FG005|COMPLETED|Treatment Period 3 (28 Days)||3||
48240094|NCT01072149|100908957|FG006|COMPLETED|Treatment Period 3 (28 Days)||3||
48240095|NCT01072149|100908958|FG007|COMPLETED|Treatment Period 3 (28 Days)||2||
48240096|NCT01072149|100908959|FG008|COMPLETED|Treatment Period 3 (28 Days)||3||
48240097|NCT01072149|100908960|FG009|COMPLETED|Treatment Period 3 (28 Days)||3||
48240098|NCT01072149|100908961|FG010|COMPLETED|Treatment Period 3 (28 Days)||2||
48240099|NCT01072149|100908962|FG011|COMPLETED|Treatment Period 3 (28 Days)||3||
48240100|NCT01072149|100908963|FG012|COMPLETED|Treatment Period 3 (28 Days)||2||
48240101|NCT01072149|100908964|FG013|COMPLETED|Treatment Period 3 (28 Days)||2||
48240102|NCT01072149|100908965|FG014|COMPLETED|Treatment Period 3 (28 Days)||3||
48240103|NCT01072149|100908966|FG015|COMPLETED|Treatment Period 3 (28 Days)||1||
48240104|NCT01072149|100908967|FG016|COMPLETED|Treatment Period 3 (28 Days)||3||
48240105|NCT01072149|100908968|FG017|COMPLETED|Treatment Period 3 (28 Days)||2||
48240106|NCT01072149|100908951|FG000|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
48240107|NCT01072149|100908952|FG001|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
48240108|NCT01072149|100908953|FG002|NOT COMPLETED|Treatment Period 3 (28 Days)||1||
48240109|NCT01072149|100908954|FG003|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
48240110|NCT01072149|100908955|FG004|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
48240111|NCT01072149|100908956|FG005|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
48240112|NCT01072149|100908957|FG006|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
48240113|NCT01072149|100908958|FG007|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
48240114|NCT01072149|100908959|FG008|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
48240115|NCT01072149|100908960|FG009|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
48240116|NCT01072149|100908961|FG010|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
48240117|NCT01072149|100908962|FG011|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
48240118|NCT01072149|100908963|FG012|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
48240119|NCT01072149|100908964|FG013|NOT COMPLETED|Treatment Period 3 (28 Days)||1||
48240120|NCT01072149|100908965|FG014|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
48240121|NCT01072149|100908966|FG015|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
48240122|NCT01072149|100908967|FG016|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
48240123|NCT01072149|100908968|FG017|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
48240124|NCT04598776|100908969|FG000|STARTED|Overall Study||98||175
48240125|NCT04598776|100908969|FG000|COMPLETED|Overall Study||89||162
48240126|NCT04598776|100908969|FG000|NOT COMPLETED|Overall Study||9||13
48240127|NCT05203822|100908970|FG000|STARTED|Overall Study||18||
48240128|NCT05203822|100908970|FG000|COMPLETED|Overall Study||16||
48240129|NCT05203822|100908970|FG000|NOT COMPLETED|Overall Study||2||
48240130|NCT02267746|100908971|FG000|STARTED|Overall Study||298||
48240131|NCT02267746|100908972|FG001|STARTED|Overall Study||296||
48240132|NCT02267746|100908973|FG002|STARTED|Overall Study||299||
48240133|NCT02267746|100908971|FG000|COMPLETED|Overall Study||277||
48240134|NCT02267746|100908972|FG001|COMPLETED|Overall Study||274||
48240135|NCT02267746|100908973|FG002|COMPLETED|Overall Study||278||
48240136|NCT02267746|100908971|FG000|NOT COMPLETED|Overall Study||21||
48240137|NCT02267746|100908972|FG001|NOT COMPLETED|Overall Study||22||
48240138|NCT02267746|100908973|FG002|NOT COMPLETED|Overall Study||21||
48240139|NCT04242498|100908974|FG000|STARTED|Initial Treatment Period: Week 0-16||74||
48240140|NCT04242498|100908975|FG001|STARTED|Initial Treatment Period: Week 0-16||144||
48240141|NCT04242498|100908976|FG002|STARTED|Initial Treatment Period: Week 0-16||291||
48240142|NCT04242498|100908977|FG003|STARTED|Initial Treatment Period: Week 0-16||0||
48240143|NCT04242498|100908978|FG004|STARTED|Initial Treatment Period: Week 0-16||0||
48240144|NCT04242498|100908979|FG005|STARTED|Initial Treatment Period: Week 0-16||0||
48240145|NCT04242498|100908980|FG006|STARTED|Initial Treatment Period: Week 0-16||0||
48240146|NCT04242498|100908974|FG000|COMPLETED|Initial Treatment Period: Week 0-16||69||
48677418|NCT04700423|101994164|FG001|COMPLETED|Baseline/Treatment||211||
48677419|NCT04700423|101994165|FG002|COMPLETED|Baseline/Treatment||19||
48677420|NCT04700423|101994166|FG003|COMPLETED|Baseline/Treatment||19||
48677421|NCT04700423|101994167|FG004|COMPLETED|Baseline/Treatment||80||
48677422|NCT04700423|101994163|FG000|NOT COMPLETED|Baseline/Treatment||0||
48677423|NCT04700423|101994164|FG001|NOT COMPLETED|Baseline/Treatment||0||
48240147|NCT04242498|100908975|FG001|COMPLETED|Initial Treatment Period: Week 0-16||133||
48677424|NCT04700423|101994165|FG002|NOT COMPLETED|Baseline/Treatment||0||
48677425|NCT04700423|101994166|FG003|NOT COMPLETED|Baseline/Treatment||0||
48677426|NCT04700423|101994167|FG004|NOT COMPLETED|Baseline/Treatment||0||
48677427|NCT04700423|101994163|FG000|STARTED|Follow-up 1: 14-21 Days Post Treatment||207||
48677428|NCT04700423|101994164|FG001|STARTED|Follow-up 1: 14-21 Days Post Treatment||211||
48677429|NCT04700423|101994165|FG002|STARTED|Follow-up 1: 14-21 Days Post Treatment||19||
48677430|NCT04700423|101994166|FG003|STARTED|Follow-up 1: 14-21 Days Post Treatment||19||
48677431|NCT04700423|101994167|FG004|STARTED|Follow-up 1: 14-21 Days Post Treatment||80||
48677432|NCT04700423|101994163|FG000|COMPLETED|Follow-up 1: 14-21 Days Post Treatment||207||
48677433|NCT04700423|101994164|FG001|COMPLETED|Follow-up 1: 14-21 Days Post Treatment||211||
48677434|NCT04700423|101994165|FG002|COMPLETED|Follow-up 1: 14-21 Days Post Treatment||19||
48677435|NCT04700423|101994166|FG003|COMPLETED|Follow-up 1: 14-21 Days Post Treatment||19||
48677436|NCT04700423|101994167|FG004|COMPLETED|Follow-up 1: 14-21 Days Post Treatment||80||
48677437|NCT04700423|101994163|FG000|NOT COMPLETED|Follow-up 1: 14-21 Days Post Treatment||0||
48677438|NCT04700423|101994164|FG001|NOT COMPLETED|Follow-up 1: 14-21 Days Post Treatment||0||
48240148|NCT04242498|100908976|FG002|COMPLETED|Initial Treatment Period: Week 0-16||262||
48240149|NCT04242498|100908977|FG003|COMPLETED|Initial Treatment Period: Week 0-16||0||
48240150|NCT04242498|100908978|FG004|COMPLETED|Initial Treatment Period: Week 0-16||0||
48240151|NCT04242498|100908979|FG005|COMPLETED|Initial Treatment Period: Week 0-16||0||
48240152|NCT04242498|100908980|FG006|COMPLETED|Initial Treatment Period: Week 0-16||0||
48240153|NCT04242498|100908974|FG000|NOT COMPLETED|Initial Treatment Period: Week 0-16||5||
48240154|NCT04242498|100908975|FG001|NOT COMPLETED|Initial Treatment Period: Week 0-16||11||
48240155|NCT04242498|100908976|FG002|NOT COMPLETED|Initial Treatment Period: Week 0-16||29||
48240156|NCT04242498|100908977|FG003|NOT COMPLETED|Initial Treatment Period: Week 0-16||0||
48677439|NCT04700423|101994165|FG002|NOT COMPLETED|Follow-up 1: 14-21 Days Post Treatment||0||
48677440|NCT04700423|101994166|FG003|NOT COMPLETED|Follow-up 1: 14-21 Days Post Treatment||0||
48677441|NCT04700423|101994167|FG004|NOT COMPLETED|Follow-up 1: 14-21 Days Post Treatment||0||
48677442|NCT04700423|101994163|FG000|STARTED|Follow-up 2: 5-6 Weeks Post Treatment||207||
48677443|NCT04700423|101994164|FG001|STARTED|Follow-up 2: 5-6 Weeks Post Treatment||211||
48677444|NCT04700423|101994165|FG002|STARTED|Follow-up 2: 5-6 Weeks Post Treatment||19||
48677445|NCT04700423|101994166|FG003|STARTED|Follow-up 2: 5-6 Weeks Post Treatment||19||
48677446|NCT04700423|101994167|FG004|STARTED|Follow-up 2: 5-6 Weeks Post Treatment||80||
48677447|NCT04700423|101994163|FG000|COMPLETED|Follow-up 2: 5-6 Weeks Post Treatment||206||
48677448|NCT04700423|101994164|FG001|COMPLETED|Follow-up 2: 5-6 Weeks Post Treatment||211||
48677449|NCT04700423|101994165|FG002|COMPLETED|Follow-up 2: 5-6 Weeks Post Treatment||18||
48677450|NCT04700423|101994166|FG003|COMPLETED|Follow-up 2: 5-6 Weeks Post Treatment||19||
48677451|NCT04700423|101994167|FG004|COMPLETED|Follow-up 2: 5-6 Weeks Post Treatment||80||
48240157|NCT04242498|100908978|FG004|NOT COMPLETED|Initial Treatment Period: Week 0-16||0||
48240158|NCT04242498|100908979|FG005|NOT COMPLETED|Initial Treatment Period: Week 0-16||0||
48240159|NCT04242498|100908980|FG006|NOT COMPLETED|Initial Treatment Period: Week 0-16||0||
48240160|NCT04242498|100908974|FG000|STARTED|Maintenance Treatment Period: Week 16-48||0||
48240161|NCT04242498|100908975|FG001|STARTED|Maintenance Treatment Period: Week 16-48||0||
48677452|NCT04700423|101994163|FG000|NOT COMPLETED|Follow-up 2: 5-6 Weeks Post Treatment||1||
48677453|NCT04700423|101994164|FG001|NOT COMPLETED|Follow-up 2: 5-6 Weeks Post Treatment||0||
48677454|NCT04700423|101994165|FG002|NOT COMPLETED|Follow-up 2: 5-6 Weeks Post Treatment||1||
48677455|NCT04700423|101994166|FG003|NOT COMPLETED|Follow-up 2: 5-6 Weeks Post Treatment||0||
48677456|NCT04700423|101994167|FG004|NOT COMPLETED|Follow-up 2: 5-6 Weeks Post Treatment||0||
48677457|NCT04700423|101994163|FG000|STARTED|Follow-up 3: 3 Months Post Treatment||206||
48677458|NCT04700423|101994164|FG001|STARTED|Follow-up 3: 3 Months Post Treatment||211||
48240162|NCT04242498|100908976|FG002|STARTED|Maintenance Treatment Period: Week 16-48||0||
48240163|NCT04242498|100908977|FG003|STARTED|Maintenance Treatment Period: Week 16-48||69||
48240164|NCT04242498|100908978|FG004|STARTED|Maintenance Treatment Period: Week 16-48||133||
48240165|NCT04242498|100908979|FG005|STARTED|Maintenance Treatment Period: Week 16-48||130||
48240166|NCT04242498|100908980|FG006|STARTED|Maintenance Treatment Period: Week 16-48||131||
48240167|NCT04242498|100908974|FG000|COMPLETED|Maintenance Treatment Period: Week 16-48||0||
48240168|NCT04242498|100908975|FG001|COMPLETED|Maintenance Treatment Period: Week 16-48||0||
48240169|NCT04242498|100908976|FG002|COMPLETED|Maintenance Treatment Period: Week 16-48||0||
48240170|NCT04242498|100908977|FG003|COMPLETED|Maintenance Treatment Period: Week 16-48||61||
48240171|NCT04242498|100908978|FG004|COMPLETED|Maintenance Treatment Period: Week 16-48||109||
48240172|NCT04242498|100908979|FG005|COMPLETED|Maintenance Treatment Period: Week 16-48||107||
48240173|NCT04242498|100908980|FG006|COMPLETED|Maintenance Treatment Period: Week 16-48||110||
48240174|NCT04242498|100908974|FG000|NOT COMPLETED|Maintenance Treatment Period: Week 16-48||0||
48240175|NCT04242498|100908975|FG001|NOT COMPLETED|Maintenance Treatment Period: Week 16-48||0||
48539944|NCT02933255|101657970|FG000|NOT COMPLETED|Overall Study||1||
48539945|NCT02933255|101657971|FG001|NOT COMPLETED|Overall Study||0||
48539946|NCT02542605|101657972|FG000|STARTED|Part A: PACAP-38 Dose Selection Phase||12||
48539947|NCT02542605|101657973|FG001|STARTED|Part A: PACAP-38 Dose Selection Phase||0||
48539948|NCT02542605|101657974|FG002|STARTED|Part A: PACAP-38 Dose Selection Phase||0||
48539949|NCT02542605|101657972|FG000|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||12||
48539950|NCT02542605|101657973|FG001|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||0||
48539951|NCT02542605|101657974|FG002|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||0||
48539952|NCT02542605|101657972|FG000|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||2||
48539953|NCT02542605|101657973|FG001|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||0||
48539954|NCT02542605|101657974|FG002|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||0||
48539955|NCT02542605|101657972|FG000|COMPLETED|Part A: PACAP-38 Dose Selection Phase||12||
48539956|NCT02542605|101657973|FG001|COMPLETED|Part A: PACAP-38 Dose Selection Phase||0||
48539957|NCT02542605|101657974|FG002|COMPLETED|Part A: PACAP-38 Dose Selection Phase||0||
48539958|NCT02542605|101657972|FG000|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0||
48539959|NCT02542605|101657973|FG001|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0||
48539960|NCT02542605|101657974|FG002|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0||
48539961|NCT02542605|101657972|FG000|STARTED|Part B: Challenge Phase||23|Participants starting Part B are all PACAP-38 naïve and did not participate in Part A.|
48539962|NCT02542605|101657973|FG001|STARTED|Part B: Challenge Phase||0|Participants starting Part B are all PACAP-38 naïve and did not participate in Part A.|
48539963|NCT02542605|101657974|FG002|STARTED|Part B: Challenge Phase||0|Participants starting Part B are all PACAP-38 naïve and did not participate in Part A.|
48539964|NCT02542605|101657972|FG000|Received PACAP-38|Part B: Challenge Phase||23||
48539965|NCT02542605|101657973|FG001|Received PACAP-38|Part B: Challenge Phase||0||
48539966|NCT02542605|101657974|FG002|Received PACAP-38|Part B: Challenge Phase||0||
48539967|NCT02542605|101657972|FG000|Proceeded to Randomization Phase|Part B: Challenge Phase||15||
48539968|NCT02542605|101657973|FG001|Proceeded to Randomization Phase|Part B: Challenge Phase||0||
48539969|NCT02542605|101657974|FG002|Proceeded to Randomization Phase|Part B: Challenge Phase||0||
48539970|NCT02542605|101657972|FG000|COMPLETED|Part B: Challenge Phase||22||
48240176|NCT04242498|100908976|FG002|NOT COMPLETED|Maintenance Treatment Period: Week 16-48||0||
48240177|NCT04242498|100908977|FG003|NOT COMPLETED|Maintenance Treatment Period: Week 16-48||8||
48539971|NCT02542605|101657973|FG001|COMPLETED|Part B: Challenge Phase||0||
48539972|NCT02542605|101657974|FG002|COMPLETED|Part B: Challenge Phase||0||
48539973|NCT02542605|101657972|FG000|NOT COMPLETED|Part B: Challenge Phase||1||
48539974|NCT02542605|101657973|FG001|NOT COMPLETED|Part B: Challenge Phase||0||
48539975|NCT02542605|101657974|FG002|NOT COMPLETED|Part B: Challenge Phase||0||
48539976|NCT02542605|101657972|FG000|STARTED|Part B: Randomization Phase||0||
48539977|NCT02542605|101657973|FG001|STARTED|Part B: Randomization Phase||9||
48539978|NCT02542605|101657974|FG002|STARTED|Part B: Randomization Phase||8||
48539979|NCT02542605|101657972|FG000|Not PACAP-38 naïve Participants|Part B: Randomization Phase||0|Participants received PACAP-38 during Part A dose selection.|
48539980|NCT02542605|101657973|FG001|Not PACAP-38 naïve Participants|Part B: Randomization Phase||2|Participants received PACAP-38 during Part A dose selection.|
48539981|NCT02542605|101657974|FG002|Not PACAP-38 naïve Participants|Part B: Randomization Phase||0|Participants received PACAP-38 during Part A dose selection.|
48539982|NCT02542605|101657972|FG000|PACAP-38 naïve Participants|Part B: Randomization Phase||0|Participants joined the study at Part B and did not receive PACAP-38 in Part A.|
48539983|NCT02542605|101657973|FG001|PACAP-38 naïve Participants|Part B: Randomization Phase||7|Participants joined the study at Part B and did not receive PACAP-38 in Part A.|
48539984|NCT02542605|101657974|FG002|PACAP-38 naïve Participants|Part B: Randomization Phase||8|Participants joined the study at Part B and did not receive PACAP-38 in Part A.|
48539985|NCT02542605|101657972|FG000|Received Placebo/Erenumab|Part B: Randomization Phase||0||
48539986|NCT02542605|101657973|FG001|Received Placebo/Erenumab|Part B: Randomization Phase||9||
48539987|NCT02542605|101657974|FG002|Received Placebo/Erenumab|Part B: Randomization Phase||7||
48539988|NCT02542605|101657972|FG000|COMPLETED|Part B: Randomization Phase||0||
48539989|NCT02542605|101657973|FG001|COMPLETED|Part B: Randomization Phase||9||
48539990|NCT02542605|101657974|FG002|COMPLETED|Part B: Randomization Phase||7||
48677459|NCT04700423|101994165|FG002|STARTED|Follow-up 3: 3 Months Post Treatment||18||
48240178|NCT04242498|100908978|FG004|NOT COMPLETED|Maintenance Treatment Period: Week 16-48||24||
48240179|NCT04242498|100908979|FG005|NOT COMPLETED|Maintenance Treatment Period: Week 16-48||23||
48240180|NCT04242498|100908980|FG006|NOT COMPLETED|Maintenance Treatment Period: Week 16-48||21||
48240181|NCT04295499|100908981|FG000|STARTED|Overall Study||50||
48240182|NCT04295499|100908982|FG001|STARTED|Overall Study||25||
48240183|NCT04295499|100908981|FG000|COMPLETED|Overall Study||48||
48240184|NCT04295499|100908982|FG001|COMPLETED|Overall Study||25||
48240185|NCT04295499|100908981|FG000|NOT COMPLETED|Overall Study||2||
48240186|NCT04295499|100908982|FG001|NOT COMPLETED|Overall Study||0||
48240187|NCT02154516|100908983|FG000|STARTED|Overall Study||20||
48240188|NCT02154516|100908984|FG001|STARTED|Overall Study||6||
48240189|NCT02154516|100908983|FG000|COMPLETED|Overall Study||16||
48539991|NCT02542605|101657972|FG000|NOT COMPLETED|Part B: Randomization Phase||0||
48539992|NCT02542605|101657973|FG001|NOT COMPLETED|Part B: Randomization Phase||0||
48539993|NCT02542605|101657974|FG002|NOT COMPLETED|Part B: Randomization Phase||1||
48539994|NCT01621477|101657975|FG000|STARTED|Overall Study||17||
48539995|NCT01621477|101657975|FG000|COMPLETED|Overall Study||17||
48539996|NCT01621477|101657975|FG000|NOT COMPLETED|Overall Study||0||
48539997|NCT01145508|101657976|FG000|STARTED|Overall Study||7||
48539998|NCT01145508|101657977|FG001|STARTED|Overall Study||3||
48539999|NCT01145508|101657976|FG000|Treated|Overall Study||6||
48540000|NCT01145508|101657977|FG001|Treated|Overall Study||2||
48540001|NCT01145508|101657976|FG000|COMPLETED|Overall Study||2||
48540002|NCT01145508|101657977|FG001|COMPLETED|Overall Study||1||
48540003|NCT01145508|101657976|FG000|NOT COMPLETED|Overall Study||5||
48540004|NCT01145508|101657977|FG001|NOT COMPLETED|Overall Study||2||
48540005|NCT00952731|101657978|FG000|STARTED|Overall Study||13||
48240190|NCT02154516|100908984|FG001|COMPLETED|Overall Study||4||
48240191|NCT02154516|100908983|FG000|NOT COMPLETED|Overall Study||4||
48240192|NCT02154516|100908984|FG001|NOT COMPLETED|Overall Study||2||
48240193|NCT04189224|100908985|FG000|STARTED|Period 1||23||
48240194|NCT04189224|100908986|FG001|STARTED|Period 1||21||
48240195|NCT04189224|100908985|FG000|COMPLETED|Period 1||23||
48240196|NCT04189224|100908986|FG001|COMPLETED|Period 1||21||
48240197|NCT04189224|100908985|FG000|NOT COMPLETED|Period 1||0||
48240198|NCT04189224|100908986|FG001|NOT COMPLETED|Period 1||0||
48240199|NCT04189224|100908985|FG000|STARTED|Period 2||23||
48240200|NCT04189224|100908986|FG001|STARTED|Period 2||21||
48240201|NCT04189224|100908985|FG000|COMPLETED|Period 2||23||
48240202|NCT04189224|100908986|FG001|COMPLETED|Period 2||20||
48240203|NCT04189224|100908985|FG000|NOT COMPLETED|Period 2||0||
48240204|NCT04189224|100908986|FG001|NOT COMPLETED|Period 2||1||
48240205|NCT02962609|100908987|FG000|STARTED|Overall Study||38||
48240206|NCT02962609|100908988|FG001|STARTED|Overall Study||42||
48240207|NCT02962609|100908987|FG000|COMPLETED|Overall Study||38||
48240208|NCT02962609|100908988|FG001|COMPLETED|Overall Study||42||
48240209|NCT02962609|100908987|FG000|NOT COMPLETED|Overall Study||0||
48240210|NCT02962609|100908988|FG001|NOT COMPLETED|Overall Study||0||
48240211|NCT01304940|100908989|FG000|STARTED|Overall Study||25||
48240212|NCT01304940|100908990|FG001|STARTED|Overall Study||25||
48240213|NCT01304940|100908989|FG000|Completed Study|Overall Study||25||
48240214|NCT01304940|100908990|FG001|Completed Study|Overall Study||25||
48240215|NCT01304940|100908989|FG000|COMPLETED|Overall Study||22||
48240216|NCT01304940|100908990|FG001|COMPLETED|Overall Study||25||
48240217|NCT01304940|100908989|FG000|NOT COMPLETED|Overall Study||3||
48240218|NCT01304940|100908990|FG001|NOT COMPLETED|Overall Study||0||
48240219|NCT03512041|100908991|FG000|STARTED|Overall Study||10||
48240220|NCT03512041|100908992|FG001|STARTED|Overall Study||10||
48240221|NCT03512041|100908993|FG002|STARTED|Overall Study||11||
48540006|NCT00952731|101657979|FG001|STARTED|Overall Study||14||
48540007|NCT00952731|101657978|FG000|Randomization|Overall Study||13||
48540008|NCT00952731|101657979|FG001|Randomization|Overall Study||14||
48540009|NCT00952731|101657978|FG000|Treatment & Pre-Surgery|Overall Study||12||
48540010|NCT00952731|101657979|FG001|Treatment & Pre-Surgery|Overall Study||14||
48540011|NCT00952731|101657978|FG000|Surgery|Overall Study||12||
48540012|NCT00952731|101657979|FG001|Surgery|Overall Study||14||
48540013|NCT00952731|101657978|FG000|Follow-up|Overall Study||12||
48540014|NCT00952731|101657979|FG001|Follow-up|Overall Study||14||
48540015|NCT00952731|101657978|FG000|COMPLETED|Overall Study||12||
48540016|NCT00952731|101657979|FG001|COMPLETED|Overall Study||14||
48540017|NCT00952731|101657978|FG000|NOT COMPLETED|Overall Study||1||
48540018|NCT00952731|101657979|FG001|NOT COMPLETED|Overall Study||0||
48540019|NCT04328961|101657980|FG000|STARTED|Overall Study||422||
48540020|NCT04328961|101657981|FG001|STARTED|Overall Study||407||
48540021|NCT04328961|101657980|FG000|COMPLETED|Overall Study||336||
48540022|NCT04328961|101657981|FG001|COMPLETED|Overall Study||353||
48540023|NCT04328961|101657980|FG000|NOT COMPLETED|Overall Study||86||
48540024|NCT04328961|101657981|FG001|NOT COMPLETED|Overall Study||54||
48540025|NCT01893346|101657982|FG000|STARTED|Overall Study||11||
48540026|NCT01893346|101657983|FG001|STARTED|Overall Study||8||
48540027|NCT01893346|101657984|FG002|STARTED|Overall Study||8||
48540028|NCT01893346|101657985|FG003|STARTED|Overall Study||8||
48540029|NCT01893346|101657982|FG000|Patients Who Received Full Infusion|Overall Study||8||
48677460|NCT04700423|101994166|FG003|STARTED|Follow-up 3: 3 Months Post Treatment||19||
48677461|NCT04700423|101994167|FG004|STARTED|Follow-up 3: 3 Months Post Treatment||80||
48677462|NCT04700423|101994163|FG000|COMPLETED|Follow-up 3: 3 Months Post Treatment||201||
48677463|NCT04700423|101994164|FG001|COMPLETED|Follow-up 3: 3 Months Post Treatment||210||
48677464|NCT04700423|101994165|FG002|COMPLETED|Follow-up 3: 3 Months Post Treatment||18||
48677465|NCT04700423|101994166|FG003|COMPLETED|Follow-up 3: 3 Months Post Treatment||18||
48677466|NCT04700423|101994167|FG004|COMPLETED|Follow-up 3: 3 Months Post Treatment||77||
48677467|NCT04700423|101994163|FG000|NOT COMPLETED|Follow-up 3: 3 Months Post Treatment||5||
48677468|NCT04700423|101994164|FG001|NOT COMPLETED|Follow-up 3: 3 Months Post Treatment||1||
48677469|NCT04700423|101994165|FG002|NOT COMPLETED|Follow-up 3: 3 Months Post Treatment||0||
48677470|NCT04700423|101994166|FG003|NOT COMPLETED|Follow-up 3: 3 Months Post Treatment||1||
48677471|NCT04700423|101994167|FG004|NOT COMPLETED|Follow-up 3: 3 Months Post Treatment||3||
48677472|NCT01871441|101994168|FG000|STARTED|Overall Study||4||
48677473|NCT01871441|101994168|FG000|COMPLETED|Overall Study||4||
48677474|NCT01871441|101994168|FG000|NOT COMPLETED|Overall Study||0||
48677475|NCT01164007|101994169|FG000|STARTED|Overall Study||40||
48677476|NCT01164007|101994169|FG000|Treated|Overall Study||37||
48677477|NCT01164007|101994169|FG000|COMPLETED|Overall Study||0||
48677478|NCT01164007|101994169|FG000|NOT COMPLETED|Overall Study||40||
48677479|NCT02393859|101994170|FG000|STARTED|Overall Study||57||
48677480|NCT02393859|101994171|FG001|STARTED|Overall Study||54||
48677481|NCT02393859|101994170|FG000|Participants Treated|Overall Study||52||
48677482|NCT02393859|101994171|FG001|Participants Treated|Overall Study||54||
48677483|NCT02393859|101994170|FG000|Participants in the Primary Analysis Population|Overall Study||54|Included all randomized participants analyzed according to their randomized treatment assignment, regardless of treatment received (the full analysis set; FAS) at the primary completion date (17 July 2019)|
48677484|NCT02393859|101994171|FG001|Participants in the Primary Analysis Population|Overall Study||54|Included all randomized participants analyzed according to their randomized treatment assignment, regardless of treatment received (the full analysis set; FAS) at the primary completion date (17 July 2019)|
48677485|NCT02393859|101994170|FG000|Participants in the Final Analysis Population|Overall Study||57|Included all randomized participants analyzed according to their randomized treatment assignment, regardless of treatment received (FAS) at study completion (21 November 2022)|
48677486|NCT02393859|101994171|FG001|Participants in the Final Analysis Population|Overall Study||54|Included all randomized participants analyzed according to their randomized treatment assignment, regardless of treatment received (FAS) at study completion (21 November 2022)|
48677487|NCT02393859|101994170|FG000|COMPLETED|Overall Study||16||
48677488|NCT02393859|101994171|FG001|COMPLETED|Overall Study||33||
48677489|NCT02393859|101994170|FG000|NOT COMPLETED|Overall Study||41||
48677490|NCT02393859|101994171|FG001|NOT COMPLETED|Overall Study||21||
48677491|NCT02317692|101994172|FG000|STARTED|Overall Study||69||30
48677492|NCT02317692|101994173|FG001|STARTED|Overall Study||77||31
48677493|NCT02317692|101994172|FG000|COMPLETED|Overall Study||63||27
48677494|NCT02317692|101994173|FG001|COMPLETED|Overall Study||77||31
48677495|NCT02317692|101994172|FG000|NOT COMPLETED|Overall Study||6||3
48677496|NCT02317692|101994173|FG001|NOT COMPLETED|Overall Study||0||0
48677497|NCT01911351|101994174|FG000|STARTED|Overall Study||39||
48677498|NCT01911351|101994175|FG001|STARTED|Overall Study||43||
48677499|NCT01911351|101994174|FG000|COMPLETED|Overall Study||39||
48677500|NCT01911351|101994175|FG001|COMPLETED|Overall Study||43||
48677501|NCT01911351|101994174|FG000|NOT COMPLETED|Overall Study||0||
48677502|NCT01911351|101994175|FG001|NOT COMPLETED|Overall Study||0||
48677503|NCT00387088|101994176|FG000|STARTED|Overall Study||1989||
48677504|NCT00387088|101994177|FG001|STARTED|Overall Study||2002||
48677505|NCT00387088|101994176|FG000|COMPLETED|Overall Study||1671||
48677506|NCT00387088|101994177|FG001|COMPLETED|Overall Study||1629||
48677507|NCT00387088|101994176|FG000|NOT COMPLETED|Overall Study||318||
48677508|NCT00387088|101994177|FG001|NOT COMPLETED|Overall Study||373||
48677509|NCT03962855|101994178|FG000|STARTED|Overall Study||29||
48677510|NCT03962855|101994179|FG001|STARTED|Overall Study||28||
48677511|NCT03962855|101994178|FG000|COMPLETED|Overall Study||29||
48677512|NCT03962855|101994179|FG001|COMPLETED|Overall Study||23||
48677513|NCT03962855|101994178|FG000|NOT COMPLETED|Overall Study||0||
48677514|NCT03962855|101994179|FG001|NOT COMPLETED|Overall Study||5||
48677515|NCT01903005|101994180|FG000|STARTED|Overall Study||665||
48677516|NCT01903005|101994180|FG000|COMPLETED|Overall Study||292||
48677517|NCT01903005|101994180|FG000|NOT COMPLETED|Overall Study||373||
48677518|NCT01306292|101994181|FG000|STARTED|First Injection||10||
48677519|NCT01306292|101994182|FG001|STARTED|First Injection||8||
48677520|NCT01306292|101994183|FG002|STARTED|First Injection||8||
48677521|NCT01306292|101994184|FG003|STARTED|First Injection||10||
48677522|NCT01306292|101994181|FG000|COMPLETED|First Injection||10||
48677523|NCT01306292|101994182|FG001|COMPLETED|First Injection||8||
48677524|NCT01306292|101994183|FG002|COMPLETED|First Injection||8||
48677525|NCT01306292|101994184|FG003|COMPLETED|First Injection||10||
48677526|NCT01306292|101994181|FG000|NOT COMPLETED|First Injection||0||
48677527|NCT01306292|101994182|FG001|NOT COMPLETED|First Injection||0||
48677528|NCT01306292|101994183|FG002|NOT COMPLETED|First Injection||0||
48677529|NCT01306292|101994184|FG003|NOT COMPLETED|First Injection||0||
48677530|NCT01306292|101994181|FG000|STARTED|Washout (at Least 10 Minutes)||10||
48677531|NCT01306292|101994182|FG001|STARTED|Washout (at Least 10 Minutes)||8||
48677532|NCT01306292|101994183|FG002|STARTED|Washout (at Least 10 Minutes)||8||
48677533|NCT01306292|101994184|FG003|STARTED|Washout (at Least 10 Minutes)||10||
48677534|NCT01306292|101994181|FG000|COMPLETED|Washout (at Least 10 Minutes)||10||
48677535|NCT01306292|101994182|FG001|COMPLETED|Washout (at Least 10 Minutes)||8||
48677536|NCT01306292|101994183|FG002|COMPLETED|Washout (at Least 10 Minutes)||8||
48677537|NCT01306292|101994184|FG003|COMPLETED|Washout (at Least 10 Minutes)||10||
48677538|NCT01306292|101994181|FG000|NOT COMPLETED|Washout (at Least 10 Minutes)||0||
48677539|NCT01306292|101994182|FG001|NOT COMPLETED|Washout (at Least 10 Minutes)||0||
48677540|NCT01306292|101994183|FG002|NOT COMPLETED|Washout (at Least 10 Minutes)||0||
48677541|NCT01306292|101994184|FG003|NOT COMPLETED|Washout (at Least 10 Minutes)||0||
48677542|NCT01306292|101994181|FG000|STARTED|Second Injection||10||
48677543|NCT01306292|101994182|FG001|STARTED|Second Injection||8||
48677544|NCT01306292|101994183|FG002|STARTED|Second Injection||8||
48677545|NCT01306292|101994184|FG003|STARTED|Second Injection||10||
48677546|NCT01306292|101994181|FG000|COMPLETED|Second Injection||10||
48677547|NCT01306292|101994182|FG001|COMPLETED|Second Injection||8||
48677548|NCT01306292|101994183|FG002|COMPLETED|Second Injection||7||
48677549|NCT01306292|101994184|FG003|COMPLETED|Second Injection||10||
48677550|NCT01306292|101994181|FG000|NOT COMPLETED|Second Injection||0||
48677551|NCT01306292|101994182|FG001|NOT COMPLETED|Second Injection||0||
48677552|NCT01306292|101994183|FG002|NOT COMPLETED|Second Injection||1||
48677553|NCT01306292|101994184|FG003|NOT COMPLETED|Second Injection||0||
48677554|NCT05644002|101994185|FG000|STARTED|Overall Study||41||
48677555|NCT05644002|101994186|FG001|STARTED|Overall Study||43||
48677556|NCT05644002|101994185|FG000|Finished Visit 1|Overall Study||41||
48677557|NCT05644002|101994186|FG001|Finished Visit 1|Overall Study||43||
48677558|NCT05644002|101994185|FG000|Began Visit 2|Overall Study||40||
48677559|NCT05644002|101994186|FG001|Began Visit 2|Overall Study||40||
48677560|NCT05644002|101994185|FG000|COMPLETED|Overall Study||40||
48677561|NCT05644002|101994186|FG001|COMPLETED|Overall Study||40||
48677562|NCT05644002|101994185|FG000|NOT COMPLETED|Overall Study||1||
48677563|NCT05644002|101994186|FG001|NOT COMPLETED|Overall Study||3||
48677564|NCT02170064|101994187|FG000|STARTED|Overall Study||15||
48677565|NCT02170064|101994188|FG001|STARTED|Overall Study||9||
48677566|NCT02170064|101994189|FG002|STARTED|Overall Study||11||
48677567|NCT02170064|101994187|FG000|Safety Population (SP)|Overall Study||12||
48677568|NCT02170064|101994188|FG001|Safety Population (SP)|Overall Study||8||
48677569|NCT02170064|101994189|FG002|Safety Population (SP)|Overall Study||11||
48677570|NCT02170064|101994187|FG000|Pharmacokinetic Population (PKP)|Overall Study||11||
48677571|NCT02170064|101994188|FG001|Pharmacokinetic Population (PKP)|Overall Study||8||
48677572|NCT02170064|101994189|FG002|Pharmacokinetic Population (PKP)|Overall Study||10||
48677573|NCT02170064|101994187|FG000|Efficacy Population (EP)|Overall Study||11||
48677574|NCT02170064|101994188|FG001|Efficacy Population (EP)|Overall Study||8||
48677575|NCT02170064|101994189|FG002|Efficacy Population (EP)|Overall Study||10||
48677576|NCT02170064|101994187|FG000|COMPLETED|Overall Study||9||
48677577|NCT02170064|101994188|FG001|COMPLETED|Overall Study||7||
48677578|NCT02170064|101994189|FG002|COMPLETED|Overall Study||10||
48677579|NCT02170064|101994187|FG000|NOT COMPLETED|Overall Study||6||
48677580|NCT02170064|101994188|FG001|NOT COMPLETED|Overall Study||2||
48677581|NCT02170064|101994189|FG002|NOT COMPLETED|Overall Study||1||
48677582|NCT02359903|101994190|FG000|STARTED|Overall Study||45||
48677583|NCT02359903|101994191|FG001|STARTED|Overall Study||45||
48677584|NCT02359903|101994190|FG000|COMPLETED|Overall Study||45||
48677585|NCT02359903|101994191|FG001|COMPLETED|Overall Study||43||
48677586|NCT02359903|101994190|FG000|NOT COMPLETED|Overall Study||0||
48677587|NCT02359903|101994191|FG001|NOT COMPLETED|Overall Study||2||
48677588|NCT01074125|101994192|FG000|STARTED|Overall Study||51||
48677589|NCT01074125|101994193|FG001|STARTED|Overall Study||52||
48677590|NCT01074125|101994194|FG002|STARTED|Overall Study||48||
48677591|NCT01074125|101994192|FG000|COMPLETED|Overall Study||39||
48677592|NCT01074125|101994193|FG001|COMPLETED|Overall Study||47||
48677593|NCT01074125|101994194|FG002|COMPLETED|Overall Study||36||
48677594|NCT01074125|101994192|FG000|NOT COMPLETED|Overall Study||12||
48677595|NCT01074125|101994193|FG001|NOT COMPLETED|Overall Study||5||
48677596|NCT01074125|101994194|FG002|NOT COMPLETED|Overall Study||12||
48677597|NCT01740687|101994195|FG000|STARTED|Overall Study||211||
48677598|NCT01740687|101994195|FG000|Underwent NovaSure EA Treatment|Overall Study||209||
48677599|NCT01740687|101994195|FG000|COMPLETED|Overall Study||174||
48677600|NCT01740687|101994195|FG000|NOT COMPLETED|Overall Study||37||
48677601|NCT03929913|101994196|FG000|STARTED|Overall Study||19||
48677602|NCT03929913|101994196|FG000|COMPLETED|Overall Study||12||
48677603|NCT03929913|101994196|FG000|NOT COMPLETED|Overall Study||7||
48677604|NCT00956384|101994197|FG000|STARTED|Overall Study||102||
48677605|NCT00956384|101994198|FG001|STARTED|Overall Study||96||
48677606|NCT00956384|101994197|FG000|COMPLETED|Overall Study||86||
48677607|NCT00956384|101994198|FG001|COMPLETED|Overall Study||78||
48677608|NCT00956384|101994197|FG000|NOT COMPLETED|Overall Study||16||
48677609|NCT00956384|101994198|FG001|NOT COMPLETED|Overall Study||18||
48677610|NCT02704208|101994199|FG000|STARTED|Overall Study||202||
48677611|NCT02704208|101994200|FG001|STARTED|Overall Study||199||
48677612|NCT02704208|101994199|FG000|COMPLETED|Overall Study||160||
48677613|NCT02704208|101994200|FG001|COMPLETED|Overall Study||162||
48677614|NCT02704208|101994199|FG000|NOT COMPLETED|Overall Study||42||
48677615|NCT02704208|101994200|FG001|NOT COMPLETED|Overall Study||37||
48677616|NCT01029535|101994201|FG000|STARTED|Overall Study||103||
48677617|NCT01029535|101994201|FG000|COMPLETED|Overall Study||72||
48677618|NCT01029535|101994201|FG000|NOT COMPLETED|Overall Study||31||
48677619|NCT05246514|101994202|FG000|STARTED|Overall Study||72||
48677620|NCT05246514|101994202|FG000|COMPLETED|Overall Study||0||
48677621|NCT05246514|101994202|FG000|NOT COMPLETED|Overall Study||72||
48677622|NCT04102007|101994203|FG000|STARTED|Overall Study||244||
48677623|NCT04102007|101994203|FG000|COMPLETED|Overall Study||205||
48677624|NCT04102007|101994203|FG000|NOT COMPLETED|Overall Study||39||
48677625|NCT01897532|101994204|FG000|STARTED|Discontinuation From Treatment||3492|Randomised|
48677626|NCT01897532|101994205|FG001|STARTED|Discontinuation From Treatment||3499|Randomised|
48677627|NCT01897532|101994204|FG000|Treated|Discontinuation From Treatment||3485||
48677628|NCT01897532|101994205|FG001|Treated|Discontinuation From Treatment||3494||
48677629|NCT01897532|101994204|FG000|COMPLETED|Discontinuation From Treatment||2530|Not prematurely discontinued from trial medication|
48677630|NCT01897532|101994205|FG001|COMPLETED|Discontinuation From Treatment||2660|Not prematurely discontinued from trial medication|
48677631|NCT01897532|101994204|FG000|NOT COMPLETED|Discontinuation From Treatment||962||
48677632|NCT01897532|101994205|FG001|NOT COMPLETED|Discontinuation From Treatment||839||
48677633|NCT01897532|101994204|FG000|STARTED|Discontinuation From Trial||3492|Randomised|
48677634|NCT01897532|101994205|FG001|STARTED|Discontinuation From Trial||3499|Randomised|
48677635|NCT01897532|101994204|FG000|Treated|Discontinuation From Trial||3485||
48677636|NCT01897532|101994205|FG001|Treated|Discontinuation From Trial||3494||
48677637|NCT01897532|101994204|FG000|COMPLETED|Discontinuation From Trial||3430|Completed the trial or died|
48677638|NCT01897532|101994205|FG001|COMPLETED|Discontinuation From Trial||3458|Completed the trial or died|
48677639|NCT01897532|101994204|FG000|NOT COMPLETED|Discontinuation From Trial||62||
48677640|NCT01897532|101994205|FG001|NOT COMPLETED|Discontinuation From Trial||41||
48240222|NCT03512041|100908994|FG003|STARTED|Overall Study||9||
48240223|NCT03512041|100908991|FG000|COMPLETED|Overall Study||10||
48240224|NCT03512041|100908992|FG001|COMPLETED|Overall Study||10||
48240225|NCT03512041|100908993|FG002|COMPLETED|Overall Study||11||
48240226|NCT03512041|100908994|FG003|COMPLETED|Overall Study||9||
48240227|NCT03512041|100908991|FG000|NOT COMPLETED|Overall Study||0||
48240228|NCT03512041|100908992|FG001|NOT COMPLETED|Overall Study||0||
48240229|NCT03512041|100908993|FG002|NOT COMPLETED|Overall Study||0||
48240230|NCT03512041|100908994|FG003|NOT COMPLETED|Overall Study||0||
48240231|NCT00538616|100908995|FG000|STARTED|Overall Study||5||
48240232|NCT00538616|100908996|FG001|STARTED|Overall Study||3||
48240233|NCT00538616|100908995|FG000|COMPLETED|Overall Study||5||
48240234|NCT00538616|100908996|FG001|COMPLETED|Overall Study||3||
48240235|NCT00538616|100908995|FG000|NOT COMPLETED|Overall Study||0||
48677641|NCT04562116|101994206|FG000|STARTED|Overall Study||17||
48677642|NCT04562116|101994206|FG000|Safety Population|Overall Study||16|Safety population included all participants who received at least 1 dose of Nemolizumab.|
48240236|NCT00538616|100908996|FG001|NOT COMPLETED|Overall Study||0||
48677643|NCT04562116|101994206|FG000|COMPLETED|Overall Study||13||
48677644|NCT04562116|101994206|FG000|NOT COMPLETED|Overall Study||4||
48677645|NCT01088503|101994207|FG000|STARTED|Overall Study||3123||
48677646|NCT01088503|101994208|FG001|STARTED|Overall Study||8846||
48677647|NCT01088503|101994209|FG002|STARTED|Overall Study||258||
48677648|NCT01088503|101994207|FG000|COMPLETED|Overall Study||2941||
48677649|NCT01088503|101994208|FG001|COMPLETED|Overall Study||8161||
48677650|NCT01088503|101994209|FG002|COMPLETED|Overall Study||241||
48677651|NCT01088503|101994207|FG000|NOT COMPLETED|Overall Study||182||
48677652|NCT01088503|101994208|FG001|NOT COMPLETED|Overall Study||685||
48677653|NCT01088503|101994209|FG002|NOT COMPLETED|Overall Study||17||
48677654|NCT02750514|101994210|FG000|STARTED|Track 1||40||
48677655|NCT02750514|101994211|FG001|STARTED|Track 1||4||
48677656|NCT02750514|101994212|FG002|STARTED|Track 1||0||
48677657|NCT02750514|101994213|FG003|STARTED|Track 1||3||
48240237|NCT02959866|100908997|FG000|STARTED|Overall Study||59||
48240238|NCT02959866|100908997|FG000|Telephone Interview at 1 Month Follow-up|Overall Study||59||
48240239|NCT02959866|100908997|FG000|COMPLETED|Overall Study||58||
48240240|NCT02959866|100908997|FG000|NOT COMPLETED|Overall Study||1||
48240241|NCT03594045|100908998|FG000|STARTED|Overall Study||0||
48240242|NCT03594045|100908999|FG001|STARTED|Overall Study||5||
48240243|NCT03594045|100908998|FG000|COMPLETED|Overall Study||0||
48240244|NCT03594045|100908999|FG001|COMPLETED|Overall Study||5||
48240245|NCT03594045|100908998|FG000|NOT COMPLETED|Overall Study||0||
48240246|NCT03594045|100908999|FG001|NOT COMPLETED|Overall Study||0||
48240247|NCT02312245|100909000|FG000|STARTED|Overall Study||3||
48240248|NCT02312245|100909001|FG001|STARTED|Overall Study||1||
48240249|NCT02312245|100909002|FG002|STARTED|Overall Study||0||
48540030|NCT01893346|101657983|FG001|Patients Who Received Full Infusion|Overall Study||8||
48677658|NCT02750514|101994214|FG004|STARTED|Track 1||0||
48677659|NCT02750514|101994210|FG000|COMPLETED|Track 1||13||
48677660|NCT02750514|101994211|FG001|COMPLETED|Track 1||2||
48677661|NCT02750514|101994212|FG002|COMPLETED|Track 1||0||
48677662|NCT02750514|101994213|FG003|COMPLETED|Track 1||1||
48677663|NCT02750514|101994214|FG004|COMPLETED|Track 1||0||
48677664|NCT02750514|101994210|FG000|NOT COMPLETED|Track 1||27||
48677665|NCT02750514|101994211|FG001|NOT COMPLETED|Track 1||2||
48677666|NCT02750514|101994212|FG002|NOT COMPLETED|Track 1||0||
48677667|NCT02750514|101994213|FG003|NOT COMPLETED|Track 1||2||
48677668|NCT02750514|101994214|FG004|NOT COMPLETED|Track 1||0||
48677669|NCT02750514|101994210|FG000|STARTED|Track 2||9||
48677670|NCT02750514|101994211|FG001|STARTED|Track 2||8||
48677671|NCT02750514|101994212|FG002|STARTED|Track 2||2||
48677672|NCT02750514|101994213|FG003|STARTED|Track 2||12||
48677673|NCT02750514|101994214|FG004|STARTED|Track 2||0||
48677674|NCT02750514|101994210|FG000|COMPLETED|Track 2||3||
48677675|NCT02750514|101994211|FG001|COMPLETED|Track 2||0||
48677676|NCT02750514|101994212|FG002|COMPLETED|Track 2||0||
48677677|NCT02750514|101994213|FG003|COMPLETED|Track 2||5||
48677678|NCT02750514|101994214|FG004|COMPLETED|Track 2||0||
48677679|NCT02750514|101994210|FG000|NOT COMPLETED|Track 2||6||
48677680|NCT02750514|101994211|FG001|NOT COMPLETED|Track 2||8||
48677681|NCT02750514|101994212|FG002|NOT COMPLETED|Track 2||2||
48677682|NCT02750514|101994213|FG003|NOT COMPLETED|Track 2||7||
48677683|NCT02750514|101994214|FG004|NOT COMPLETED|Track 2||0||
48677684|NCT02750514|101994210|FG000|STARTED|Track 3||0||
48677685|NCT02750514|101994211|FG001|STARTED|Track 3||41||
48677686|NCT02750514|101994212|FG002|STARTED|Track 3||16||
48677687|NCT02750514|101994213|FG003|STARTED|Track 3||18||
48677688|NCT02750514|101994214|FG004|STARTED|Track 3||0||
48677689|NCT02750514|101994210|FG000|COMPLETED|Track 3||0||
48677690|NCT02750514|101994211|FG001|COMPLETED|Track 3||5||
48677691|NCT02750514|101994212|FG002|COMPLETED|Track 3||1||
48677692|NCT02750514|101994213|FG003|COMPLETED|Track 3||2||
48677693|NCT02750514|101994214|FG004|COMPLETED|Track 3||0||
48677694|NCT02750514|101994210|FG000|NOT COMPLETED|Track 3||0||
48677695|NCT02750514|101994211|FG001|NOT COMPLETED|Track 3||36||
48677696|NCT02750514|101994212|FG002|NOT COMPLETED|Track 3||15||
48677697|NCT02750514|101994213|FG003|NOT COMPLETED|Track 3||16||
48240250|NCT02312245|100909003|FG003|STARTED|Overall Study||9||
48240251|NCT02312245|100909000|FG000|COMPLETED|Overall Study||0||
48240252|NCT02312245|100909001|FG001|COMPLETED|Overall Study||0||
48240253|NCT02312245|100909002|FG002|COMPLETED|Overall Study||0||
48677698|NCT02750514|101994214|FG004|NOT COMPLETED|Track 3||0||
48677699|NCT02750514|101994210|FG000|STARTED|Track 4||0||
48677700|NCT02750514|101994211|FG001|STARTED|Track 4||53||
48677701|NCT02750514|101994212|FG002|STARTED|Track 4||0||
48677702|NCT02750514|101994213|FG003|STARTED|Track 4||60||
48677703|NCT02750514|101994214|FG004|STARTED|Track 4||0||
48677704|NCT02750514|101994210|FG000|COMPLETED|Track 4||0||
48677705|NCT02750514|101994211|FG001|COMPLETED|Track 4||2||
48677706|NCT02750514|101994212|FG002|COMPLETED|Track 4||0||
48677707|NCT02750514|101994213|FG003|COMPLETED|Track 4||18||
48677708|NCT02750514|101994214|FG004|COMPLETED|Track 4||0||
48677709|NCT02750514|101994210|FG000|NOT COMPLETED|Track 4||0||
48677710|NCT02750514|101994211|FG001|NOT COMPLETED|Track 4||51||
48677711|NCT02750514|101994212|FG002|NOT COMPLETED|Track 4||0||
48677712|NCT02750514|101994213|FG003|NOT COMPLETED|Track 4||42||
48677713|NCT02750514|101994214|FG004|NOT COMPLETED|Track 4||0||
48677714|NCT02750514|101994210|FG000|STARTED|Track 5||0||
48677715|NCT02750514|101994211|FG001|STARTED|Track 5||0||
48677716|NCT02750514|101994212|FG002|STARTED|Track 5||0||
48677717|NCT02750514|101994213|FG003|STARTED|Track 5||0||
48677718|NCT02750514|101994214|FG004|STARTED|Track 5||43||
48677719|NCT02750514|101994210|FG000|COMPLETED|Track 5||0||
48677720|NCT02750514|101994211|FG001|COMPLETED|Track 5||0||
48677721|NCT02750514|101994212|FG002|COMPLETED|Track 5||0||
48677722|NCT02750514|101994213|FG003|COMPLETED|Track 5||0||
48677723|NCT02750514|101994214|FG004|COMPLETED|Track 5||0||
48677724|NCT02750514|101994210|FG000|NOT COMPLETED|Track 5||0||
48677725|NCT02750514|101994211|FG001|NOT COMPLETED|Track 5||0||
48677726|NCT02750514|101994212|FG002|NOT COMPLETED|Track 5||0||
48677727|NCT02750514|101994213|FG003|NOT COMPLETED|Track 5||0||
48677728|NCT02750514|101994214|FG004|NOT COMPLETED|Track 5||43||
48677729|NCT01812057|101994215|FG000|STARTED|Overall Study||25||
48677730|NCT01812057|101994216|FG001|STARTED|Overall Study||24||
48677731|NCT01812057|101994215|FG000|COMPLETED|Overall Study||23||
48677732|NCT01812057|101994216|FG001|COMPLETED|Overall Study||24||
48677733|NCT01812057|101994215|FG000|NOT COMPLETED|Overall Study||2||
48677734|NCT01812057|101994216|FG001|NOT COMPLETED|Overall Study||0||
48240254|NCT02312245|100909003|FG003|COMPLETED|Overall Study||0||
48677735|NCT01638507|101994217|FG000|STARTED|Overall Study||230||
48677736|NCT01638507|101994217|FG000|COMPLETED|Overall Study||224||
48677737|NCT01638507|101994217|FG000|NOT COMPLETED|Overall Study||6||
48677738|NCT01621178|101994218|FG000|STARTED|Overall Study||194||
48677739|NCT01621178|101994219|FG001|STARTED|Overall Study||190||
48677740|NCT01621178|101994220|FG002|STARTED|Overall Study||193||
48240255|NCT02312245|100909000|FG000|NOT COMPLETED|Overall Study||3||
48677741|NCT01621178|101994218|FG000|Received at Least One Dose of Study Drug|Overall Study||194||
48677742|NCT01621178|101994219|FG001|Received at Least One Dose of Study Drug|Overall Study||190||
48677743|NCT01621178|101994220|FG002|Received at Least One Dose of Study Drug|Overall Study||192||
48677744|NCT01621178|101994218|FG000|Modified Intent to Treat Population|Overall Study||186||
48677745|NCT01621178|101994219|FG001|Modified Intent to Treat Population|Overall Study||180||
48677746|NCT01621178|101994220|FG002|Modified Intent to Treat Population|Overall Study||183||
48677747|NCT01621178|101994218|FG000|COMPLETED|Overall Study||163||
48677748|NCT01621178|101994219|FG001|COMPLETED|Overall Study||160||
48677749|NCT01621178|101994220|FG002|COMPLETED|Overall Study||157||
48677750|NCT01621178|101994218|FG000|NOT COMPLETED|Overall Study||31||
48677751|NCT01621178|101994219|FG001|NOT COMPLETED|Overall Study||30||
48677752|NCT01621178|101994220|FG002|NOT COMPLETED|Overall Study||36||
48677753|NCT01977222|101994221|FG000|STARTED|Overall Study||12||
48677754|NCT01977222|101994221|FG000|COMPLETED|Overall Study||11||
48677755|NCT01977222|101994221|FG000|NOT COMPLETED|Overall Study||1||
48677756|NCT00403130|101994222|FG000|STARTED|2 Years From Start of Treatment||31||
48677757|NCT00403130|101994222|FG000|COMPLETED|2 Years From Start of Treatment||26||
48677758|NCT00403130|101994222|FG000|NOT COMPLETED|2 Years From Start of Treatment||5||
48677759|NCT00403130|101994222|FG000|STARTED|Survival Follow-up up to 6 Years||26||
48677760|NCT00403130|101994222|FG000|COMPLETED|Survival Follow-up up to 6 Years||16||
48677761|NCT00403130|101994222|FG000|NOT COMPLETED|Survival Follow-up up to 6 Years||10||
48677762|NCT04073056|101994223|FG000|STARTED|Overall Study||20||
48677763|NCT04073056|101994224|FG001|STARTED|Overall Study||20||
48677764|NCT04073056|101994223|FG000|COMPLETED|Overall Study||20||
48677765|NCT04073056|101994224|FG001|COMPLETED|Overall Study||20||
48240256|NCT02312245|100909001|FG001|NOT COMPLETED|Overall Study||1||
48240257|NCT02312245|100909002|FG002|NOT COMPLETED|Overall Study||0||
48677766|NCT04073056|101994223|FG000|NOT COMPLETED|Overall Study||0||
48677767|NCT04073056|101994224|FG001|NOT COMPLETED|Overall Study||0||
48677768|NCT00812955|101994225|FG000|STARTED|Overall Study||119||
48677769|NCT00812955|101994226|FG001|STARTED|Overall Study||118||
48677770|NCT00812955|101994227|FG002|STARTED|Overall Study||119||
48677771|NCT00812955|101994228|FG003|STARTED|Overall Study||118||
48677772|NCT00812955|101994225|FG000|COMPLETED|Overall Study||109||
48677773|NCT00812955|101994226|FG001|COMPLETED|Overall Study||111||
48677774|NCT00812955|101994227|FG002|COMPLETED|Overall Study||113||
48677775|NCT00812955|101994228|FG003|COMPLETED|Overall Study||110||
48677776|NCT00812955|101994225|FG000|NOT COMPLETED|Overall Study||10||
48677777|NCT00812955|101994226|FG001|NOT COMPLETED|Overall Study||7||
48677778|NCT00812955|101994227|FG002|NOT COMPLETED|Overall Study||6||
48677779|NCT00812955|101994228|FG003|NOT COMPLETED|Overall Study||8||
48677780|NCT03111030|101994229|FG000|STARTED|Overall Study||14||
48677781|NCT03111030|101994230|FG001|STARTED|Overall Study||14||
48677782|NCT03111030|101994229|FG000|COMPLETED|Overall Study||14||
48677783|NCT03111030|101994230|FG001|COMPLETED|Overall Study||14||
48677784|NCT03111030|101994229|FG000|NOT COMPLETED|Overall Study||0||
48677785|NCT03111030|101994230|FG001|NOT COMPLETED|Overall Study||0||
48677786|NCT03364647|101994231|FG000|STARTED|Overall Study||26||
48677787|NCT03364647|101994232|FG001|STARTED|Overall Study||26||
48677788|NCT03364647|101994231|FG000|COMPLETED|Overall Study||23||
48677789|NCT03364647|101994232|FG001|COMPLETED|Overall Study||25||
48677790|NCT03364647|101994231|FG000|NOT COMPLETED|Overall Study||3||
48677791|NCT03364647|101994232|FG001|NOT COMPLETED|Overall Study||1||
48677792|NCT04795531|101994233|FG000|STARTED|Overall Study||294||
48677793|NCT04795531|101994234|FG001|STARTED|Overall Study||294||
48677794|NCT04795531|101994233|FG000|Full Analysis Set (FAS)|Overall Study||294||
48677795|NCT04795531|101994234|FG001|Full Analysis Set (FAS)|Overall Study||294||
48677796|NCT04795531|101994233|FG000|Safety Analysis Set (SAS)|Overall Study||293||
48677797|NCT04795531|101994234|FG001|Safety Analysis Set (SAS)|Overall Study||294||
48677798|NCT04795531|101994233|FG000|Treated|Overall Study||293||
48677799|NCT04795531|101994234|FG001|Treated|Overall Study||294||
48677800|NCT04795531|101994233|FG000|COMPLETED|Overall Study||288||
48677801|NCT04795531|101994234|FG001|COMPLETED|Overall Study||286||
48677802|NCT04795531|101994233|FG000|NOT COMPLETED|Overall Study||6||
48677803|NCT04795531|101994234|FG001|NOT COMPLETED|Overall Study||8||
48677804|NCT00508482|101994235|FG000|STARTED|Over 4 Weeks of Treatment||237||
48677805|NCT00508482|101994236|FG001|STARTED|Over 4 Weeks of Treatment||119||
48677806|NCT00508482|101994237|FG002|STARTED|Over 4 Weeks of Treatment||119||
48677807|NCT00508482|101994235|FG000|COMPLETED|Over 4 Weeks of Treatment||216||
48677808|NCT00508482|101994236|FG001|COMPLETED|Over 4 Weeks of Treatment||102||
48677809|NCT00508482|101994237|FG002|COMPLETED|Over 4 Weeks of Treatment||99||
48677810|NCT00508482|101994235|FG000|NOT COMPLETED|Over 4 Weeks of Treatment||21||
48677811|NCT00508482|101994236|FG001|NOT COMPLETED|Over 4 Weeks of Treatment||17||
48677812|NCT00508482|101994237|FG002|NOT COMPLETED|Over 4 Weeks of Treatment||20||
48677813|NCT00508482|101994235|FG000|STARTED|at the 4th Week of Follow-up||216||
48677814|NCT00508482|101994236|FG001|STARTED|at the 4th Week of Follow-up||102||
48677815|NCT00508482|101994237|FG002|STARTED|at the 4th Week of Follow-up||99||
48240258|NCT02312245|100909003|FG003|NOT COMPLETED|Overall Study||9||
48677816|NCT00508482|101994235|FG000|COMPLETED|at the 4th Week of Follow-up||196||
48677817|NCT00508482|101994236|FG001|COMPLETED|at the 4th Week of Follow-up||96||
48677818|NCT00508482|101994237|FG002|COMPLETED|at the 4th Week of Follow-up||98||
48677819|NCT00508482|101994235|FG000|NOT COMPLETED|at the 4th Week of Follow-up||20||
48677820|NCT00508482|101994236|FG001|NOT COMPLETED|at the 4th Week of Follow-up||6||
48677821|NCT00508482|101994237|FG002|NOT COMPLETED|at the 4th Week of Follow-up||1||
48677822|NCT00508482|101994235|FG000|STARTED|at the 12th Week of Follow-up||196||
48677823|NCT00508482|101994236|FG001|STARTED|at the 12th Week of Follow-up||96||
48677824|NCT00508482|101994237|FG002|STARTED|at the 12th Week of Follow-up||98||
48677825|NCT00508482|101994235|FG000|COMPLETED|at the 12th Week of Follow-up||196||
48240259|NCT00596960|100909004|FG000|STARTED|Overall Study||70||
48677826|NCT00508482|101994236|FG001|COMPLETED|at the 12th Week of Follow-up||96||
48677827|NCT00508482|101994237|FG002|COMPLETED|at the 12th Week of Follow-up||98||
48677828|NCT00508482|101994235|FG000|NOT COMPLETED|at the 12th Week of Follow-up||0||
48677829|NCT00508482|101994236|FG001|NOT COMPLETED|at the 12th Week of Follow-up||0||
48677830|NCT00508482|101994237|FG002|NOT COMPLETED|at the 12th Week of Follow-up||0||
48677831|NCT02622191|101994238|FG000|STARTED|Overall Study||19||
48677832|NCT02622191|101994239|FG001|STARTED|Overall Study||14||
48677833|NCT02622191|101994238|FG000|COMPLETED|Overall Study||19||
48677834|NCT02622191|101994239|FG001|COMPLETED|Overall Study||14||
48677835|NCT02622191|101994238|FG000|NOT COMPLETED|Overall Study||0||
48677836|NCT02622191|101994239|FG001|NOT COMPLETED|Overall Study||0||
48677837|NCT00457392|101994240|FG000|STARTED|Overall Study||480||
48677838|NCT00457392|101994241|FG001|STARTED|Overall Study||480||
48677839|NCT00457392|101994240|FG000|Treated|Overall Study||473||
48240260|NCT00596960|100909005|FG001|STARTED|Overall Study||69||
48240261|NCT00596960|100909004|FG000|COMPLETED|Overall Study||59||
48240262|NCT00596960|100909005|FG001|COMPLETED|Overall Study||60||
48677840|NCT00457392|101994241|FG001|Treated|Overall Study||477||
48677841|NCT00457392|101994240|FG000|COMPLETED|Overall Study||0||
48677842|NCT00457392|101994241|FG001|COMPLETED|Overall Study||0||
48677843|NCT00457392|101994240|FG000|NOT COMPLETED|Overall Study||480||
48677844|NCT00457392|101994241|FG001|NOT COMPLETED|Overall Study||480||
48677845|NCT04565990|101994242|FG000|STARTED|Overall Study||43||
48677846|NCT04565990|101994242|FG000|COMPLETED|Overall Study||36||
48677847|NCT04565990|101994242|FG000|NOT COMPLETED|Overall Study||7||
48677848|NCT00761345|101994243|FG000|STARTED|Overall Study||27||
48677849|NCT00761345|101994243|FG000|COMPLETED|Overall Study||24||
48677850|NCT00761345|101994243|FG000|NOT COMPLETED|Overall Study||3||
48677851|NCT01378117|101994244|FG000|STARTED|Overall Study||31||
48677852|NCT01378117|101994245|FG001|STARTED|Overall Study||30||
48677853|NCT01378117|101994246|FG002|STARTED|Overall Study||29||
48677854|NCT01378117|101994244|FG000|COMPLETED|Overall Study||27||
48677855|NCT01378117|101994245|FG001|COMPLETED|Overall Study||29||
48677856|NCT01378117|101994246|FG002|COMPLETED|Overall Study||26||
48677857|NCT01378117|101994244|FG000|NOT COMPLETED|Overall Study||4||
48677858|NCT01378117|101994245|FG001|NOT COMPLETED|Overall Study||1||
48677859|NCT01378117|101994246|FG002|NOT COMPLETED|Overall Study||3||
48677860|NCT05414175|101994247|FG000|STARTED|Overall Study||38||
48677861|NCT05414175|101994247|FG000|Intent to Treat Population|Overall Study||38|All participants who passed screening or assigned study drug.|
48677862|NCT05414175|101994247|FG000|Safety Population|Overall Study||38|All participants who receive at least one dose of study drug.|
48677863|NCT05414175|101994247|FG000|COMPLETED|Overall Study||36||
48677864|NCT05414175|101994247|FG000|NOT COMPLETED|Overall Study||2||
48677865|NCT05653700|101994248|FG000|STARTED|Overall Study||29||
48677866|NCT05653700|101994249|FG001|STARTED|Overall Study||14||
48677867|NCT05653700|101994248|FG000|COMPLETED|Overall Study||20||
48677868|NCT05653700|101994249|FG001|COMPLETED|Overall Study||14||
48677869|NCT05653700|101994248|FG000|NOT COMPLETED|Overall Study||9||
48677870|NCT05653700|101994249|FG001|NOT COMPLETED|Overall Study||0||
48677871|NCT04211363|101994250|FG000|STARTED|Overall Study||286||
48677872|NCT04211363|101994251|FG001|STARTED|Overall Study||153||
48677873|NCT04211363|101994250|FG000|COMPLETED|Overall Study||255||
48677874|NCT04211363|101994251|FG001|COMPLETED|Overall Study||133||
48677875|NCT04211363|101994250|FG000|NOT COMPLETED|Overall Study||31||
48677876|NCT04211363|101994251|FG001|NOT COMPLETED|Overall Study||20||
48677877|NCT02495285|101994252|FG000|STARTED|Overall Study||121||
48677878|NCT02495285|101994253|FG001|STARTED|Overall Study||480||
48677879|NCT02495285|101994252|FG000|COMPLETED|Overall Study||121||
48677880|NCT02495285|101994253|FG001|COMPLETED|Overall Study||480||
48677881|NCT02495285|101994252|FG000|NOT COMPLETED|Overall Study||0||
48677882|NCT02495285|101994253|FG001|NOT COMPLETED|Overall Study||0||
48677883|NCT00845702|101994254|FG000|STARTED|TOF MRA||33||
48677884|NCT00845702|101994254|FG000|COMPLETED|TOF MRA||32||
48677885|NCT00845702|101994254|FG000|NOT COMPLETED|TOF MRA||1||
48677886|NCT00845702|101994254|FG000|STARTED|Dotarem MRA||32||
48677887|NCT00845702|101994254|FG000|COMPLETED|Dotarem MRA||32||
48677888|NCT00845702|101994254|FG000|NOT COMPLETED|Dotarem MRA||0||
48677889|NCT02476448|101994255|FG000|STARTED|Overall Study||44||
48240263|NCT00596960|100909004|FG000|NOT COMPLETED|Overall Study||11||
48240264|NCT00596960|100909005|FG001|NOT COMPLETED|Overall Study||9||
48677890|NCT02476448|101994256|FG001|STARTED|Overall Study||44||
48677891|NCT02476448|101994257|FG002|STARTED|Overall Study||44||
48677892|NCT02476448|101994258|FG003|STARTED|Overall Study||44||
48677893|NCT02476448|101994255|FG000|COMPLETED|Overall Study||44||
48677894|NCT02476448|101994256|FG001|COMPLETED|Overall Study||44||
48677895|NCT02476448|101994257|FG002|COMPLETED|Overall Study||44||
48677896|NCT02476448|101994258|FG003|COMPLETED|Overall Study||44||
48240265|NCT01196741|100909006|FG000|STARTED|Overall Study||71||
48677897|NCT02476448|101994255|FG000|NOT COMPLETED|Overall Study||0||
48677898|NCT02476448|101994256|FG001|NOT COMPLETED|Overall Study||0||
48677899|NCT02476448|101994257|FG002|NOT COMPLETED|Overall Study||0||
48677900|NCT02476448|101994258|FG003|NOT COMPLETED|Overall Study||0||
48677901|NCT04047446|101994259|FG000|STARTED|Overall Study||56||
48677902|NCT04047446|101994260|FG001|STARTED|Overall Study||56||
48677903|NCT04047446|101994259|FG000|COMPLETED|Overall Study||55||
48677904|NCT04047446|101994260|FG001|COMPLETED|Overall Study||56||
48677905|NCT04047446|101994259|FG000|NOT COMPLETED|Overall Study||1||
48677906|NCT04047446|101994260|FG001|NOT COMPLETED|Overall Study||0||
48677907|NCT02013609|101994261|FG000|STARTED|Overall Study||47||
48677908|NCT02013609|101994261|FG000|COMPLETED|Overall Study||29||
48677909|NCT02013609|101994261|FG000|NOT COMPLETED|Overall Study||18||
48677910|NCT00015847|101994262|FG000|STARTED|Overall Study||25||
48677911|NCT00015847|101994262|FG000|COMPLETED|Overall Study||25||
48677912|NCT00015847|101994262|FG000|NOT COMPLETED|Overall Study||0||
48677913|NCT02138825|101994263|FG000|STARTED|Main Study Treatment||73||
48677914|NCT02138825|101994264|FG001|STARTED|Main Study Treatment||74||
48677915|NCT02138825|101994263|FG000|COMPLETED|Main Study Treatment||33||
48677916|NCT02138825|101994264|FG001|COMPLETED|Main Study Treatment||39||
48677917|NCT02138825|101994263|FG000|NOT COMPLETED|Main Study Treatment||40||
48677918|NCT02138825|101994264|FG001|NOT COMPLETED|Main Study Treatment||35||
48677919|NCT02138825|101994263|FG000|STARTED|Long-term Extension||32||
48677920|NCT02138825|101994264|FG001|STARTED|Long-term Extension||38||
48677921|NCT02138825|101994263|FG000|COMPLETED|Long-term Extension||0||
48677922|NCT02138825|101994264|FG001|COMPLETED|Long-term Extension||0||
48677923|NCT02138825|101994263|FG000|NOT COMPLETED|Long-term Extension||32||
48677924|NCT02138825|101994264|FG001|NOT COMPLETED|Long-term Extension||38||
48677925|NCT02138825|101994263|FG000|STARTED|Safety Follow-up||72||
48677926|NCT02138825|101994264|FG001|STARTED|Safety Follow-up||64||
48677927|NCT02138825|101994263|FG000|COMPLETED|Safety Follow-up||50||
48677928|NCT02138825|101994264|FG001|COMPLETED|Safety Follow-up||47||
48677929|NCT02138825|101994263|FG000|NOT COMPLETED|Safety Follow-up||22||
48677930|NCT02138825|101994264|FG001|NOT COMPLETED|Safety Follow-up||17||
48677931|NCT00776789|101994265|FG000|STARTED|Overall Study||20||
48677932|NCT00776789|101994266|FG001|STARTED|Overall Study||21||
48677933|NCT00776789|101994265|FG000|COMPLETED|Overall Study||17||
48677934|NCT00776789|101994266|FG001|COMPLETED|Overall Study||18||
48677935|NCT00776789|101994265|FG000|NOT COMPLETED|Overall Study||3||
48677936|NCT00776789|101994266|FG001|NOT COMPLETED|Overall Study||3||
48677937|NCT00030147|101994267|FG000|STARTED|Overall Study||17||
48677938|NCT00030147|101994268|FG001|STARTED|Overall Study||19||
48677939|NCT00030147|101994269|FG002|STARTED|Overall Study||16||
48677940|NCT00030147|101994270|FG003|STARTED|Overall Study||11||
48677941|NCT00030147|101994267|FG000|COMPLETED|Overall Study||17||
48677942|NCT00030147|101994268|FG001|COMPLETED|Overall Study||18||
48677943|NCT00030147|101994269|FG002|COMPLETED|Overall Study||16||
48677944|NCT00030147|101994270|FG003|COMPLETED|Overall Study||11||
48677945|NCT00030147|101994267|FG000|NOT COMPLETED|Overall Study||0||
48677946|NCT00030147|101994268|FG001|NOT COMPLETED|Overall Study||1||
48677947|NCT00030147|101994269|FG002|NOT COMPLETED|Overall Study||0||
48677948|NCT00030147|101994270|FG003|NOT COMPLETED|Overall Study||0||
48677949|NCT02003222|101994271|FG000|STARTED|Induction||112||
48677950|NCT02003222|101994272|FG001|STARTED|Induction||112||
48677951|NCT02003222|101994273|FG002|STARTED|Induction||40||
48677952|NCT02003222|101994274|FG003|STARTED|Induction||22||
48677953|NCT02003222|101994275|FG004|STARTED|Induction||202||
48677954|NCT02003222|101994271|FG000|Received Treatment and Adverse Event Assessment Available|Induction||112||
48677955|NCT02003222|101994272|FG001|Received Treatment and Adverse Event Assessment Available|Induction||112||
48677956|NCT02003222|101994273|FG002|Received Treatment and Adverse Event Assessment Available|Induction||40||
48677957|NCT02003222|101994274|FG003|Received Treatment and Adverse Event Assessment Available|Induction||22||
48677958|NCT02003222|101994275|FG004|Received Treatment and Adverse Event Assessment Available|Induction||193||
48677959|NCT02003222|101994271|FG000|COMPLETED|Induction||112||
48677960|NCT02003222|101994272|FG001|COMPLETED|Induction||112||
48677961|NCT02003222|101994273|FG002|COMPLETED|Induction||40||
48677962|NCT02003222|101994274|FG003|COMPLETED|Induction||22||
48677963|NCT02003222|101994275|FG004|COMPLETED|Induction||47||
48677964|NCT02003222|101994271|FG000|NOT COMPLETED|Induction||0||
48677965|NCT02003222|101994272|FG001|NOT COMPLETED|Induction||0||
48677966|NCT02003222|101994273|FG002|NOT COMPLETED|Induction||0||
48677967|NCT02003222|101994274|FG003|NOT COMPLETED|Induction||0||
48677968|NCT02003222|101994275|FG004|NOT COMPLETED|Induction||155||
48677969|NCT02003222|101994271|FG000|STARTED|Intensification||112||
48677970|NCT02003222|101994272|FG001|STARTED|Intensification||112||
48677971|NCT02003222|101994273|FG002|STARTED|Intensification||40||
48677972|NCT02003222|101994274|FG003|STARTED|Intensification||22||
48677973|NCT02003222|101994275|FG004|STARTED|Intensification||47||
48677974|NCT02003222|101994271|FG000|Received Treatment and Adverse Event Assessment Available|Intensification||112||
48677975|NCT02003222|101994272|FG001|Received Treatment and Adverse Event Assessment Available|Intensification||112||
48677976|NCT02003222|101994273|FG002|Received Treatment and Adverse Event Assessment Available|Intensification||40||
48677977|NCT02003222|101994274|FG003|Received Treatment and Adverse Event Assessment Available|Intensification||22||
48677978|NCT02003222|101994275|FG004|Received Treatment and Adverse Event Assessment Available|Intensification||30||
48677979|NCT02003222|101994271|FG000|COMPLETED|Intensification||112||
48677980|NCT02003222|101994272|FG001|COMPLETED|Intensification||112||
48677981|NCT02003222|101994273|FG002|COMPLETED|Intensification||40||
48677982|NCT02003222|101994274|FG003|COMPLETED|Intensification||22||
48677983|NCT02003222|101994275|FG004|COMPLETED|Intensification||0||
48677984|NCT02003222|101994271|FG000|NOT COMPLETED|Intensification||0||
48677985|NCT02003222|101994272|FG001|NOT COMPLETED|Intensification||0||
48677986|NCT02003222|101994273|FG002|NOT COMPLETED|Intensification||0||
48677987|NCT02003222|101994274|FG003|NOT COMPLETED|Intensification||0||
48677988|NCT02003222|101994275|FG004|NOT COMPLETED|Intensification||47||
48677989|NCT02003222|101994271|FG000|STARTED|Randomization/Registration||112||
48677990|NCT02003222|101994272|FG001|STARTED|Randomization/Registration||112||
48677991|NCT02003222|101994273|FG002|STARTED|Randomization/Registration||40||
48677992|NCT02003222|101994274|FG003|STARTED|Randomization/Registration||22||
48677993|NCT02003222|101994275|FG004|STARTED|Randomization/Registration||0||
48677994|NCT02003222|101994271|FG000|Received Treatment and Adverse Event Assessment Available|Randomization/Registration||111||
48677995|NCT02003222|101994272|FG001|Received Treatment and Adverse Event Assessment Available|Randomization/Registration||110||
48677996|NCT02003222|101994273|FG002|Received Treatment and Adverse Event Assessment Available|Randomization/Registration||35||
48677997|NCT02003222|101994274|FG003|Received Treatment and Adverse Event Assessment Available|Randomization/Registration||16||
48677998|NCT02003222|101994275|FG004|Received Treatment and Adverse Event Assessment Available|Randomization/Registration||0||
48677999|NCT02003222|101994271|FG000|COMPLETED|Randomization/Registration||112||
48678000|NCT02003222|101994272|FG001|COMPLETED|Randomization/Registration||112||
48678001|NCT02003222|101994273|FG002|COMPLETED|Randomization/Registration||40||
48678002|NCT02003222|101994274|FG003|COMPLETED|Randomization/Registration||22||
48678003|NCT02003222|101994275|FG004|COMPLETED|Randomization/Registration||0||
48678004|NCT02003222|101994271|FG000|NOT COMPLETED|Randomization/Registration||0||
48678005|NCT02003222|101994272|FG001|NOT COMPLETED|Randomization/Registration||0||
48678006|NCT02003222|101994273|FG002|NOT COMPLETED|Randomization/Registration||0||
48678007|NCT02003222|101994274|FG003|NOT COMPLETED|Randomization/Registration||0||
48678008|NCT02003222|101994275|FG004|NOT COMPLETED|Randomization/Registration||0||
48678009|NCT02003222|101994271|FG000|STARTED|Maintenance||67||
48678010|NCT02003222|101994272|FG001|STARTED|Maintenance||69||
48678011|NCT02003222|101994273|FG002|STARTED|Maintenance||13||
48678012|NCT02003222|101994274|FG003|STARTED|Maintenance||2||
48678013|NCT02003222|101994275|FG004|STARTED|Maintenance||0||
48678014|NCT02003222|101994271|FG000|Received Treatment and Adverse Event Assessment Available|Maintenance||66||
48678015|NCT02003222|101994272|FG001|Received Treatment and Adverse Event Assessment Available|Maintenance||68||
48678016|NCT02003222|101994273|FG002|Received Treatment and Adverse Event Assessment Available|Maintenance||12||
48678017|NCT02003222|101994274|FG003|Received Treatment and Adverse Event Assessment Available|Maintenance||2||
48678018|NCT02003222|101994275|FG004|Received Treatment and Adverse Event Assessment Available|Maintenance||0||
48678019|NCT02003222|101994271|FG000|COMPLETED|Maintenance||67||
48678020|NCT02003222|101994272|FG001|COMPLETED|Maintenance||69||
48678021|NCT02003222|101994273|FG002|COMPLETED|Maintenance||13||
48678022|NCT02003222|101994274|FG003|COMPLETED|Maintenance||2||
48678023|NCT02003222|101994275|FG004|COMPLETED|Maintenance||0||
48678024|NCT02003222|101994271|FG000|NOT COMPLETED|Maintenance||0||
48678025|NCT02003222|101994272|FG001|NOT COMPLETED|Maintenance||0||
48678026|NCT02003222|101994273|FG002|NOT COMPLETED|Maintenance||0||
48678027|NCT02003222|101994274|FG003|NOT COMPLETED|Maintenance||0||
48678028|NCT02003222|101994275|FG004|NOT COMPLETED|Maintenance||0||
48678029|NCT01823289|101994276|FG000|STARTED|Overall Study||71||
48081209|NCT03129100|100521631|FG018|COMPLETED|Period2 Extension Period (Group A and B)||0||
48678030|NCT01823289|101994276|FG000|COMPLETED|Overall Study||47||
48678031|NCT01823289|101994276|FG000|NOT COMPLETED|Overall Study||24||
48678032|NCT02268383|101994277|FG000|STARTED|Overall Study||75||
48678033|NCT02268383|101994277|FG000|COMPLETED|Overall Study||14||
48678034|NCT02268383|101994277|FG000|NOT COMPLETED|Overall Study||61||
48678035|NCT02114177|101994278|FG000|STARTED|Overall Study||155||
48678036|NCT02114177|101994279|FG001|STARTED|Overall Study||155||
48678037|NCT02114177|101994278|FG000|COMPLETED|Overall Study||146||
48678038|NCT02114177|101994279|FG001|COMPLETED|Overall Study||151||
48678039|NCT02114177|101994278|FG000|NOT COMPLETED|Overall Study||9||
48678040|NCT02114177|101994279|FG001|NOT COMPLETED|Overall Study||4||
48678041|NCT04442893|101994280|FG000|STARTED|Overall Study||44||
48678042|NCT04442893|101994281|FG001|STARTED|Overall Study||41||
48678043|NCT04442893|101994280|FG000|COMPLETED|Overall Study||34||
48678044|NCT04442893|101994281|FG001|COMPLETED|Overall Study||36||
48678045|NCT04442893|101994280|FG000|NOT COMPLETED|Overall Study||10||
48081210|NCT03129100|100521632|FG019|COMPLETED|Period2 Extension Period (Group A and B)||0||
48081211|NCT03129100|100521633|FG020|COMPLETED|Period2 Extension Period (Group A and B)||0||
48081212|NCT03129100|100521634|FG021|COMPLETED|Period2 Extension Period (Group A and B)||0||
48081213|NCT03129100|100521635|FG022|COMPLETED|Period2 Extension Period (Group A and B)||0||
48678046|NCT04442893|101994281|FG001|NOT COMPLETED|Overall Study||5||
48678047|NCT01120405|101994282|FG000|STARTED|Overall Study||298||
48678048|NCT01120405|101994283|FG001|STARTED|Overall Study||302||
48678049|NCT01120405|101994282|FG000|COMPLETED|Overall Study||271||
48678050|NCT01120405|101994283|FG001|COMPLETED|Overall Study||269||
48678051|NCT01120405|101994282|FG000|NOT COMPLETED|Overall Study||27||
48678052|NCT01120405|101994283|FG001|NOT COMPLETED|Overall Study||33||
48678053|NCT01865487|101994284|FG000|STARTED|Overall Study||15||
48678054|NCT01865487|101994285|FG001|STARTED|Overall Study||15||
48081214|NCT03129100|100521636|FG023|COMPLETED|Period2 Extension Period (Group A and B)||0||
48678055|NCT01865487|101994286|FG002|STARTED|Overall Study||15||
48678056|NCT01865487|101994287|FG003|STARTED|Overall Study||5||
48678057|NCT01865487|101994288|FG004|STARTED|Overall Study||12||
48678058|NCT01865487|101994289|FG005|STARTED|Overall Study||4||
48678059|NCT01865487|101994290|FG006|STARTED|Overall Study||12||
48678060|NCT01865487|101994291|FG007|STARTED|Overall Study||4||
48678061|NCT01865487|101994292|FG008|STARTED|Overall Study||12||
48678062|NCT01865487|101994293|FG009|STARTED|Overall Study||4||
48678063|NCT01865487|101994284|FG000|COMPLETED|Overall Study||15||
48678064|NCT01865487|101994285|FG001|COMPLETED|Overall Study||15||
48240266|NCT01196741|100909007|FG001|STARTED|Overall Study||36||
48240267|NCT01196741|100909006|FG000|COMPLETED|Overall Study||11||
48240268|NCT01196741|100909007|FG001|COMPLETED|Overall Study||8||
48240269|NCT01196741|100909006|FG000|NOT COMPLETED|Overall Study||60||
48240270|NCT01196741|100909007|FG001|NOT COMPLETED|Overall Study||28||
48240271|NCT03030599|100909008|FG000|STARTED|Open Label Treatment and Titration||201||
48240272|NCT03030599|100909009|FG001|STARTED|Open Label Treatment and Titration||0||
48240273|NCT03030599|100909010|FG002|STARTED|Open Label Treatment and Titration||0||
48240274|NCT03030599|100909008|FG000|COMPLETED|Open Label Treatment and Titration||155||
48240275|NCT03030599|100909009|FG001|COMPLETED|Open Label Treatment and Titration||0||
48240276|NCT03030599|100909010|FG002|COMPLETED|Open Label Treatment and Titration||0||
48240277|NCT03030599|100909008|FG000|NOT COMPLETED|Open Label Treatment and Titration||46||
48240278|NCT03030599|100909009|FG001|NOT COMPLETED|Open Label Treatment and Titration||0||
48240279|NCT03030599|100909010|FG002|NOT COMPLETED|Open Label Treatment and Titration||0||
48240280|NCT03030599|100909008|FG000|STARTED|Stable Dose||149||
48240281|NCT03030599|100909009|FG001|STARTED|Stable Dose||0||
48240282|NCT03030599|100909010|FG002|STARTED|Stable Dose||0||
48240283|NCT03030599|100909008|FG000|COMPLETED|Stable Dose||144||
48240284|NCT03030599|100909009|FG001|COMPLETED|Stable Dose||0||
48240285|NCT03030599|100909010|FG002|COMPLETED|Stable Dose||0||
48240286|NCT03030599|100909008|FG000|NOT COMPLETED|Stable Dose||5||
48240287|NCT03030599|100909009|FG001|NOT COMPLETED|Stable Dose||0||
48240288|NCT03030599|100909010|FG002|NOT COMPLETED|Stable Dose||0||
48240289|NCT03030599|100909008|FG000|STARTED|Double Blind Randomized Withdrawal||0||
48240290|NCT03030599|100909009|FG001|STARTED|Double Blind Randomized Withdrawal||69||
48240291|NCT03030599|100909010|FG002|STARTED|Double Blind Randomized Withdrawal||67||
48240292|NCT03030599|100909008|FG000|COMPLETED|Double Blind Randomized Withdrawal||0||
48240293|NCT03030599|100909009|FG001|COMPLETED|Double Blind Randomized Withdrawal||69||
48240294|NCT03030599|100909010|FG002|COMPLETED|Double Blind Randomized Withdrawal||59||
48240295|NCT03030599|100909008|FG000|NOT COMPLETED|Double Blind Randomized Withdrawal||0||
48240296|NCT03030599|100909009|FG001|NOT COMPLETED|Double Blind Randomized Withdrawal||0||
48678065|NCT01865487|101994286|FG002|COMPLETED|Overall Study||15||
48678066|NCT01865487|101994287|FG003|COMPLETED|Overall Study||4||
48240297|NCT03030599|100909010|FG002|NOT COMPLETED|Double Blind Randomized Withdrawal||8||
48240298|NCT03030599|100909008|FG000|STARTED|Open-label Extension||74||
48240299|NCT03030599|100909009|FG001|STARTED|Open-label Extension||0||
48240300|NCT03030599|100909010|FG002|STARTED|Open-label Extension||0||
48240301|NCT03030599|100909008|FG000|COMPLETED|Open-label Extension||67||
48240302|NCT03030599|100909009|FG001|COMPLETED|Open-label Extension||0||
48240303|NCT03030599|100909010|FG002|COMPLETED|Open-label Extension||0||
48240304|NCT03030599|100909008|FG000|NOT COMPLETED|Open-label Extension||7||
48240305|NCT03030599|100909009|FG001|NOT COMPLETED|Open-label Extension||0||
48240306|NCT03030599|100909010|FG002|NOT COMPLETED|Open-label Extension||0||
48240307|NCT01762345|100909011|FG000|STARTED|Overall Study||83||
48240308|NCT01762345|100909011|FG000|COMPLETED|Overall Study||76||
48240309|NCT01762345|100909011|FG000|NOT COMPLETED|Overall Study||7||
48240310|NCT04999020|100909012|FG000|STARTED|Randomized Controlled Period (RCP)||26||
48240311|NCT04999020|100909013|FG001|STARTED|Randomized Controlled Period (RCP)||12||
48240312|NCT04999020|100909014|FG002|STARTED|Randomized Controlled Period (RCP)||0||
48240313|NCT04999020|100909015|FG003|STARTED|Randomized Controlled Period (RCP)||0||
48240314|NCT04999020|100909012|FG000|Received at Least 1 Dose of Treatment|Randomized Controlled Period (RCP)||26||
48240315|NCT04999020|100909013|FG001|Received at Least 1 Dose of Treatment|Randomized Controlled Period (RCP)||12||
48240316|NCT04999020|100909014|FG002|Received at Least 1 Dose of Treatment|Randomized Controlled Period (RCP)||0||
48240317|NCT04999020|100909015|FG003|Received at Least 1 Dose of Treatment|Randomized Controlled Period (RCP)||0||
48240318|NCT04999020|100909012|FG000|COMPLETED|Randomized Controlled Period (RCP)||22||
48240319|NCT04999020|100909013|FG001|COMPLETED|Randomized Controlled Period (RCP)||9||
48240320|NCT04999020|100909014|FG002|COMPLETED|Randomized Controlled Period (RCP)||0||
48240321|NCT04999020|100909015|FG003|COMPLETED|Randomized Controlled Period (RCP)||0||
48240322|NCT04999020|100909012|FG000|NOT COMPLETED|Randomized Controlled Period (RCP)||4||
48240323|NCT04999020|100909013|FG001|NOT COMPLETED|Randomized Controlled Period (RCP)||3||
48240324|NCT04999020|100909014|FG002|NOT COMPLETED|Randomized Controlled Period (RCP)||0||
48240325|NCT04999020|100909015|FG003|NOT COMPLETED|Randomized Controlled Period (RCP)||0||
48240326|NCT04999020|100909012|FG000|STARTED|Open-Label Extension (OLE) Period||0||
48678067|NCT01865487|101994288|FG004|COMPLETED|Overall Study||11||
48678068|NCT01865487|101994289|FG005|COMPLETED|Overall Study||4||
48678069|NCT01865487|101994290|FG006|COMPLETED|Overall Study||11||
48678070|NCT01865487|101994291|FG007|COMPLETED|Overall Study||4||
48240327|NCT04999020|100909013|FG001|STARTED|Open-Label Extension (OLE) Period||0||
48240328|NCT04999020|100909014|FG002|STARTED|Open-Label Extension (OLE) Period||22||
48240329|NCT04999020|100909015|FG003|STARTED|Open-Label Extension (OLE) Period||9||
48240330|NCT04999020|100909012|FG000|Received at Least 1 Dose of Treatment|Open-Label Extension (OLE) Period||0||
48240331|NCT04999020|100909013|FG001|Received at Least 1 Dose of Treatment|Open-Label Extension (OLE) Period||0||
48240332|NCT04999020|100909014|FG002|Received at Least 1 Dose of Treatment|Open-Label Extension (OLE) Period||22||
48240333|NCT04999020|100909015|FG003|Received at Least 1 Dose of Treatment|Open-Label Extension (OLE) Period||9||
48240334|NCT04999020|100909012|FG000|COMPLETED|Open-Label Extension (OLE) Period||0||
48240335|NCT04999020|100909013|FG001|COMPLETED|Open-Label Extension (OLE) Period||0||
48240336|NCT04999020|100909014|FG002|COMPLETED|Open-Label Extension (OLE) Period||0||
48678071|NCT01865487|101994292|FG008|COMPLETED|Overall Study||12||
48678072|NCT01865487|101994293|FG009|COMPLETED|Overall Study||4||
48081215|NCT03129100|100521637|FG024|COMPLETED|Period2 Extension Period (Group A and B)||0||
48081216|NCT03129100|100521638|FG025|COMPLETED|Period2 Extension Period (Group A and B)||0||
48081217|NCT03129100|100521613|FG000|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
48081218|NCT03129100|100521614|FG001|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
48081219|NCT03129100|100521615|FG002|NOT COMPLETED|Period2 Extension Period (Group A and B)||21||
48081220|NCT03129100|100521616|FG003|NOT COMPLETED|Period2 Extension Period (Group A and B)||6||
48081221|NCT03129100|100521617|FG004|NOT COMPLETED|Period2 Extension Period (Group A and B)||6||
48081222|NCT03129100|100521618|FG005|NOT COMPLETED|Period2 Extension Period (Group A and B)||9||
48081223|NCT03129100|100521619|FG006|NOT COMPLETED|Period2 Extension Period (Group A and B)||21||
48240337|NCT04999020|100909015|FG003|COMPLETED|Open-Label Extension (OLE) Period||0||
48540031|NCT01893346|101657984|FG002|Patients Who Received Full Infusion|Overall Study||8||
48540032|NCT01893346|101657985|FG003|Patients Who Received Full Infusion|Overall Study||8||
48540033|NCT01893346|101657982|FG000|COMPLETED|Overall Study||8||
48540034|NCT01893346|101657983|FG001|COMPLETED|Overall Study||7||
48540035|NCT01893346|101657984|FG002|COMPLETED|Overall Study||8||
48540036|NCT01893346|101657985|FG003|COMPLETED|Overall Study||8||
48540037|NCT01893346|101657982|FG000|NOT COMPLETED|Overall Study||3||
48540038|NCT01893346|101657983|FG001|NOT COMPLETED|Overall Study||1||
48540039|NCT01893346|101657984|FG002|NOT COMPLETED|Overall Study||0||
48540040|NCT01893346|101657985|FG003|NOT COMPLETED|Overall Study||0||
48540041|NCT03954834|101657986|FG000|STARTED|Overall Study||121||
48540042|NCT03954834|101657987|FG001|STARTED|Overall Study||121||
48540043|NCT03954834|101657988|FG002|STARTED|Overall Study||121||
48540044|NCT03954834|101657989|FG003|STARTED|Overall Study||115||
48540045|NCT03954834|101657986|FG000|Received at Least One Dose of Study Drug|Overall Study||121||
48540046|NCT03954834|101657987|FG001|Received at Least One Dose of Study Drug|Overall Study||121||
48540047|NCT03954834|101657988|FG002|Received at Least One Dose of Study Drug|Overall Study||121||
48540048|NCT03954834|101657989|FG003|Received at Least One Dose of Study Drug|Overall Study||115||
48540049|NCT03954834|101657986|FG000|COMPLETED|Overall Study||114||
48540050|NCT03954834|101657987|FG001|COMPLETED|Overall Study||112||
48540051|NCT03954834|101657988|FG002|COMPLETED|Overall Study||103||
48540052|NCT03954834|101657989|FG003|COMPLETED|Overall Study||99||
48540053|NCT03954834|101657986|FG000|NOT COMPLETED|Overall Study||7||
48540054|NCT03954834|101657987|FG001|NOT COMPLETED|Overall Study||9||
48540055|NCT03954834|101657988|FG002|NOT COMPLETED|Overall Study||18||
48540056|NCT03954834|101657989|FG003|NOT COMPLETED|Overall Study||16||
48540057|NCT01307111|101657990|FG000|STARTED|IUD Insertion||42||
48540058|NCT01307111|101657991|FG001|STARTED|IUD Insertion||40||
48540059|NCT01307111|101657990|FG000|COMPLETED|IUD Insertion||40||
48540060|NCT01307111|101657991|FG001|COMPLETED|IUD Insertion||40||
48540061|NCT01307111|101657990|FG000|NOT COMPLETED|IUD Insertion||2||
48540062|NCT01307111|101657991|FG001|NOT COMPLETED|IUD Insertion||0||
48540063|NCT01307111|101657990|FG000|STARTED|1-2 Week IUD Check up||40||
48540064|NCT01307111|101657991|FG001|STARTED|1-2 Week IUD Check up||40||
48540065|NCT01307111|101657990|FG000|COMPLETED|1-2 Week IUD Check up||38||
48540066|NCT01307111|101657991|FG001|COMPLETED|1-2 Week IUD Check up||38||
48540067|NCT01307111|101657990|FG000|NOT COMPLETED|1-2 Week IUD Check up||2||
48540068|NCT01307111|101657991|FG001|NOT COMPLETED|1-2 Week IUD Check up||2||
48678073|NCT01865487|101994284|FG000|NOT COMPLETED|Overall Study||0||
48081224|NCT03129100|100521620|FG007|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
48240338|NCT04999020|100909012|FG000|NOT COMPLETED|Open-Label Extension (OLE) Period||0||
48240339|NCT04999020|100909013|FG001|NOT COMPLETED|Open-Label Extension (OLE) Period||0||
48240340|NCT04999020|100909014|FG002|NOT COMPLETED|Open-Label Extension (OLE) Period||22||
48240341|NCT04999020|100909015|FG003|NOT COMPLETED|Open-Label Extension (OLE) Period||9||
48540069|NCT04480710|101657992|FG000|STARTED|Overall Study||6||
48540070|NCT04480710|101657993|FG001|STARTED|Overall Study||15||
48540071|NCT04480710|101657994|FG002|STARTED|Overall Study||9||
48540072|NCT04480710|101657995|FG003|STARTED|Overall Study||17||
48540073|NCT04480710|101657992|FG000|COMPLETED|Overall Study||6||
48540074|NCT04480710|101657993|FG001|COMPLETED|Overall Study||12||
48540075|NCT04480710|101657994|FG002|COMPLETED|Overall Study||8||
48540076|NCT04480710|101657995|FG003|COMPLETED|Overall Study||17||
48540077|NCT04480710|101657992|FG000|NOT COMPLETED|Overall Study||0||
48540078|NCT04480710|101657993|FG001|NOT COMPLETED|Overall Study||3||
48240342|NCT03530345|100909016|FG000|STARTED|Treatment Period A/Follow-up Period 1||28||
48240343|NCT03530345|100909017|FG001|STARTED|Treatment Period A/Follow-up Period 1||29||
48240344|NCT03530345|100909016|FG000|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||26||
48240345|NCT03530345|100909017|FG001|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||27||
48240346|NCT03530345|100909016|FG000|COMPLETED|Treatment Period A/Follow-up Period 1||7|Participants completing Follow-up Period 1.|
48240347|NCT03530345|100909017|FG001|COMPLETED|Treatment Period A/Follow-up Period 1||7|Participants completing Follow-up Period 1.|
48240348|NCT03530345|100909016|FG000|NOT COMPLETED|Treatment Period A/Follow-up Period 1||21||
48240349|NCT03530345|100909017|FG001|NOT COMPLETED|Treatment Period A/Follow-up Period 1||22||
48240350|NCT03530345|100909016|FG000|STARTED|Treatment Period B/Follow-up Period 2||5||
48240351|NCT03530345|100909017|FG001|STARTED|Treatment Period B/Follow-up Period 2||7||
48540079|NCT04480710|101657994|FG002|NOT COMPLETED|Overall Study||1||
48540080|NCT04480710|101657995|FG003|NOT COMPLETED|Overall Study||0||
48540081|NCT03745716|101657996|FG000|STARTED|Overall Study||78||
48540082|NCT03745716|101657997|FG001|STARTED|Overall Study||76||
48540083|NCT03745716|101657996|FG000|COMPLETED|Overall Study||75||
48540084|NCT03745716|101657997|FG001|COMPLETED|Overall Study||74||
48540085|NCT03745716|101657996|FG000|NOT COMPLETED|Overall Study||3||
48540086|NCT03745716|101657997|FG001|NOT COMPLETED|Overall Study||2||
48540087|NCT04628793|101657998|FG000|STARTED|Overall Study||10||
48540088|NCT04628793|101657999|FG001|STARTED|Overall Study||11||
48540089|NCT04628793|101658000|FG002|STARTED|Overall Study||8||
48540090|NCT04628793|101657998|FG000|Period 1|Overall Study||7||
48540091|NCT04628793|101657999|FG001|Period 1|Overall Study||8||
48540092|NCT04628793|101658000|FG002|Period 1|Overall Study||8||
48540093|NCT04628793|101657998|FG000|Period 2|Overall Study||7||
48540094|NCT04628793|101657999|FG001|Period 2|Overall Study||7||
48540095|NCT04628793|101658000|FG002|Period 2|Overall Study||0||
48540096|NCT04628793|101657998|FG000|Period 3|Overall Study||8||
48540097|NCT04628793|101657999|FG001|Period 3|Overall Study||8||
48540098|NCT04628793|101658000|FG002|Period 3|Overall Study||0||
48540099|NCT04628793|101657998|FG000|Period 4|Overall Study||8||
48540100|NCT04628793|101657999|FG001|Period 4|Overall Study||8||
48540101|NCT04628793|101658000|FG002|Period 4|Overall Study||0||
48540102|NCT04628793|101657998|FG000|COMPLETED|Overall Study||8|Completion of the entire study including the follow-up phase|
48540103|NCT04628793|101657999|FG001|COMPLETED|Overall Study||7|Completion of the entire study including the follow-up phase|
48540104|NCT04628793|101658000|FG002|COMPLETED|Overall Study||0|Completion of the entire study including the follow-up phase|
48540105|NCT04628793|101657998|FG000|NOT COMPLETED|Overall Study||2||
48540106|NCT04628793|101657999|FG001|NOT COMPLETED|Overall Study||4||
48540107|NCT04628793|101658000|FG002|NOT COMPLETED|Overall Study||8||
48540108|NCT04314648|101658001|FG000|STARTED|Overall Study||38||
48540109|NCT04314648|101658002|FG001|STARTED|Overall Study||50||
48540110|NCT04314648|101658001|FG000|COMPLETED|Overall Study||38||
48540111|NCT04314648|101658002|FG001|COMPLETED|Overall Study||50||
48540112|NCT04314648|101658001|FG000|NOT COMPLETED|Overall Study||0||
48540113|NCT04314648|101658002|FG001|NOT COMPLETED|Overall Study||0||
48540114|NCT01504958|101658003|FG000|STARTED|Overall Study||10||
48540115|NCT01504958|101658004|FG001|STARTED|Overall Study||6||
48540116|NCT01504958|101658005|FG002|STARTED|Overall Study||6||
48540117|NCT01504958|101658003|FG000|COMPLETED|Overall Study||10||
48540118|NCT01504958|101658004|FG001|COMPLETED|Overall Study||6||
48540119|NCT01504958|101658005|FG002|COMPLETED|Overall Study||6||
48540120|NCT01504958|101658003|FG000|NOT COMPLETED|Overall Study||0||
48540121|NCT01504958|101658004|FG001|NOT COMPLETED|Overall Study||0||
48540122|NCT01504958|101658005|FG002|NOT COMPLETED|Overall Study||0||
48540123|NCT02121392|101658006|FG000|STARTED|Prior to Intervention||83||
48540124|NCT02121392|101658007|FG001|STARTED|Prior to Intervention||82||
48540125|NCT02121392|101658006|FG000|COMPLETED|Prior to Intervention||35||
48540126|NCT02121392|101658007|FG001|COMPLETED|Prior to Intervention||41||
48540127|NCT02121392|101658006|FG000|NOT COMPLETED|Prior to Intervention||48||
48540128|NCT02121392|101658007|FG001|NOT COMPLETED|Prior to Intervention||41||
48540129|NCT02121392|101658006|FG000|STARTED|After Placement of AC Block vs Sham||35||
48540130|NCT02121392|101658007|FG001|STARTED|After Placement of AC Block vs Sham||41||
48540131|NCT02121392|101658006|FG000|COMPLETED|After Placement of AC Block vs Sham||32||
48540132|NCT02121392|101658007|FG001|COMPLETED|After Placement of AC Block vs Sham||38||
48540133|NCT02121392|101658006|FG000|NOT COMPLETED|After Placement of AC Block vs Sham||3||
48540134|NCT02121392|101658007|FG001|NOT COMPLETED|After Placement of AC Block vs Sham||3||
48240352|NCT03530345|100909016|FG000|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||4||
48240353|NCT03530345|100909017|FG001|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||6||
48240354|NCT03530345|100909016|FG000|COMPLETED|Treatment Period B/Follow-up Period 2||0|Participants completing Follow-up Period 2.|
48240355|NCT03530345|100909017|FG001|COMPLETED|Treatment Period B/Follow-up Period 2||0|Participants completing Follow-up Period 2.|
48240356|NCT03530345|100909016|FG000|NOT COMPLETED|Treatment Period B/Follow-up Period 2||5||
48240357|NCT03530345|100909017|FG001|NOT COMPLETED|Treatment Period B/Follow-up Period 2||7||
48540135|NCT01398514|101658008|FG000|STARTED|Overall Study||26||
48540136|NCT01398514|101658009|FG001|STARTED|Overall Study||26||
48540137|NCT01398514|101658008|FG000|COMPLETED|Overall Study||18||
48678074|NCT01865487|101994285|FG001|NOT COMPLETED|Overall Study||0||
48678075|NCT01865487|101994286|FG002|NOT COMPLETED|Overall Study||0||
48678076|NCT01865487|101994287|FG003|NOT COMPLETED|Overall Study||1||
48678077|NCT01865487|101994288|FG004|NOT COMPLETED|Overall Study||1||
48678078|NCT01865487|101994289|FG005|NOT COMPLETED|Overall Study||0||
48678079|NCT01865487|101994290|FG006|NOT COMPLETED|Overall Study||1||
48678080|NCT01865487|101994291|FG007|NOT COMPLETED|Overall Study||0||
48678081|NCT01865487|101994292|FG008|NOT COMPLETED|Overall Study||0||
48678082|NCT01865487|101994293|FG009|NOT COMPLETED|Overall Study||0||
48240358|NCT00331799|100909018|FG000|STARTED|Overall Study||18||
48240359|NCT00331799|100909018|FG000|COMPLETED|Overall Study||15||
48240360|NCT00331799|100909018|FG000|NOT COMPLETED|Overall Study||3||
48240361|NCT03904693|100909019|FG000|STARTED|Overall Study||35||
48240362|NCT03904693|100909020|FG001|STARTED|Overall Study||44||
48240363|NCT03904693|100909021|FG002|STARTED|Overall Study||108||
48240364|NCT03904693|100909019|FG000|Treated (Safety Analysis Set)|Overall Study||35||
48240365|NCT03904693|100909020|FG001|Treated (Safety Analysis Set)|Overall Study||44||
48240366|NCT03904693|100909021|FG002|Treated (Safety Analysis Set)|Overall Study||107||
48240367|NCT03904693|100909019|FG000|Treatment Naive and Prior ERA Strata: M/T FDC|Overall Study||0||
48240368|NCT03904693|100909020|FG001|Treatment Naive and Prior ERA Strata: M/T FDC|Overall Study||0||
48240369|NCT03904693|100909021|FG002|Treatment Naive and Prior ERA Strata: M/T FDC|Overall Study||70||
48240370|NCT03904693|100909019|FG000|Treatment Naive and Prior PDE-5i Strata: M/T FDC|Overall Study||0||
48240371|NCT03904693|100909020|FG001|Treatment Naive and Prior PDE-5i Strata: M/T FDC|Overall Study||0||
48240372|NCT03904693|100909021|FG002|Treatment Naive and Prior PDE-5i Strata: M/T FDC|Overall Study||86||
48240373|NCT03904693|100909019|FG000|COMPLETED|Overall Study||35||
48240374|NCT03904693|100909020|FG001|COMPLETED|Overall Study||43||
48240375|NCT03904693|100909021|FG002|COMPLETED|Overall Study||99||
48240376|NCT03904693|100909019|FG000|NOT COMPLETED|Overall Study||0||
48240377|NCT03904693|100909020|FG001|NOT COMPLETED|Overall Study||1||
48240378|NCT03904693|100909021|FG002|NOT COMPLETED|Overall Study||9||
48240379|NCT05379400|100909022|FG000|STARTED|Overall Study||23||
48240380|NCT05379400|100909023|FG001|STARTED|Overall Study||23||
48240381|NCT05379400|100909022|FG000|COMPLETED|Overall Study||22||
48240382|NCT05379400|100909023|FG001|COMPLETED|Overall Study||22||
48240383|NCT05379400|100909022|FG000|NOT COMPLETED|Overall Study||1||
48240384|NCT05379400|100909023|FG001|NOT COMPLETED|Overall Study||1||
48240385|NCT02097420|100909024|FG000|STARTED|Overall Study||23||
48240386|NCT02097420|100909024|FG000|COMPLETED|Overall Study||3||
48240387|NCT02097420|100909024|FG000|NOT COMPLETED|Overall Study||20||
48240388|NCT00561678|100909025|FG000|STARTED|Overall Study||197||
48240389|NCT00561678|100909026|FG001|STARTED|Overall Study||207||
48240390|NCT00561678|100909025|FG000|COMPLETED|Overall Study||189||
48240391|NCT00561678|100909026|FG001|COMPLETED|Overall Study||201||
48240392|NCT00561678|100909025|FG000|NOT COMPLETED|Overall Study||8||
48240393|NCT00561678|100909026|FG001|NOT COMPLETED|Overall Study||6||
48678083|NCT01250054|101994294|FG000|STARTED|Period 1, One Week of Wear||8||
48678084|NCT01250054|101994295|FG001|STARTED|Period 1, One Week of Wear||8||
48678085|NCT01250054|101994294|FG000|COMPLETED|Period 1, One Week of Wear||8||
48678086|NCT01250054|101994295|FG001|COMPLETED|Period 1, One Week of Wear||8||
48678087|NCT01250054|101994294|FG000|NOT COMPLETED|Period 1, One Week of Wear||0||
48678088|NCT01250054|101994295|FG001|NOT COMPLETED|Period 1, One Week of Wear||0||
48678089|NCT01250054|101994294|FG000|STARTED|Period 2, One Week of Wear||7||
48240394|NCT01348763|100909027|FG000|STARTED|With Tenofovir/Emtricitabine (10 Days)||13||
48240395|NCT01348763|100909027|FG000|COMPLETED|With Tenofovir/Emtricitabine (10 Days)||11||
48240396|NCT01348763|100909027|FG000|NOT COMPLETED|With Tenofovir/Emtricitabine (10 Days)||2||
48240397|NCT01348763|100909027|FG000|STARTED|Without Tenofovir/Emtricitabine (11 Day)||11||
48240398|NCT01348763|100909027|FG000|COMPLETED|Without Tenofovir/Emtricitabine (11 Day)||11||
48240399|NCT01348763|100909027|FG000|NOT COMPLETED|Without Tenofovir/Emtricitabine (11 Day)||0||
48240400|NCT00963105|100909028|FG000|STARTED|Overall Study||34||
48240401|NCT00963105|100909029|FG001|STARTED|Overall Study||35||
48240402|NCT00963105|100909030|FG002|STARTED|Overall Study||35||
48240403|NCT00963105|100909028|FG000|Received Treatment|Overall Study||34||
48240404|NCT00963105|100909029|FG001|Received Treatment|Overall Study||34||
48240405|NCT00963105|100909030|FG002|Received Treatment|Overall Study||35||
48240406|NCT00963105|100909028|FG000|COMPLETED|Overall Study||34|completed represents participants who discontinued the study.|
48240407|NCT00963105|100909029|FG001|COMPLETED|Overall Study||35|completed represents participants who discontinued the study.|
48240408|NCT00963105|100909030|FG002|COMPLETED|Overall Study||35|completed represents participants who discontinued the study.|
48240409|NCT00963105|100909028|FG000|NOT COMPLETED|Overall Study||0||
48240410|NCT00963105|100909029|FG001|NOT COMPLETED|Overall Study||0||
48240411|NCT00963105|100909030|FG002|NOT COMPLETED|Overall Study||0||
48240412|NCT02834624|100909031|FG000|STARTED|Overall Study||15||
48240413|NCT02834624|100909032|FG001|STARTED|Overall Study||15||
48240414|NCT02834624|100909031|FG000|COMPLETED|Overall Study||15||
48240415|NCT02834624|100909032|FG001|COMPLETED|Overall Study||15||
48240416|NCT02834624|100909031|FG000|NOT COMPLETED|Overall Study||0||
48240417|NCT02834624|100909032|FG001|NOT COMPLETED|Overall Study||0||
48678090|NCT01250054|101994295|FG001|STARTED|Period 2, One Week of Wear||8||
48240418|NCT03761849|100909033|FG000|STARTED|Overall Study||36||
48240419|NCT03761849|100909034|FG001|STARTED|Overall Study||36||
48240420|NCT03761849|100909035|FG002|STARTED|Overall Study||36||
48240421|NCT03761849|100909036|FG003|STARTED|Overall Study||263||
48678091|NCT01250054|101994294|FG000|COMPLETED|Period 2, One Week of Wear||6||
48678092|NCT01250054|101994295|FG001|COMPLETED|Period 2, One Week of Wear||8||
48678093|NCT01250054|101994294|FG000|NOT COMPLETED|Period 2, One Week of Wear||1||
48678094|NCT01250054|101994295|FG001|NOT COMPLETED|Period 2, One Week of Wear||0||
48678095|NCT05134649|101994296|FG000|STARTED|Overall Study||292||
48678096|NCT05134649|101994296|FG000|COMPLETED|Overall Study||262||
48678097|NCT05134649|101994296|FG000|NOT COMPLETED|Overall Study||30||
48678098|NCT01657305|101994297|FG000|STARTED|Overall Study||107||
48678099|NCT01657305|101994297|FG000|COMPLETED|Overall Study||82||
48678100|NCT01657305|101994297|FG000|NOT COMPLETED|Overall Study||25||
48678101|NCT03937479|101994298|FG000|STARTED|Overall Study||83||
48678102|NCT03937479|101994299|FG001|STARTED|Overall Study||85||
48678103|NCT03937479|101994300|FG002|STARTED|Overall Study||82||
48678104|NCT03937479|101994301|FG003|STARTED|Overall Study||82||
48678105|NCT03937479|101994302|FG004|STARTED|Overall Study||84||
48678106|NCT03937479|101994298|FG000|Received Treatment|Overall Study||83||
48678107|NCT03937479|101994299|FG001|Received Treatment|Overall Study||83||
48678108|NCT03937479|101994300|FG002|Received Treatment|Overall Study||81||
48678109|NCT03937479|101994301|FG003|Received Treatment|Overall Study||82||
48678110|NCT03937479|101994302|FG004|Received Treatment|Overall Study||84||
48678111|NCT03937479|101994298|FG000|COMPLETED|Overall Study||73||
48678112|NCT03937479|101994299|FG001|COMPLETED|Overall Study||70||
48678113|NCT03937479|101994300|FG002|COMPLETED|Overall Study||75||
48678114|NCT03937479|101994301|FG003|COMPLETED|Overall Study||76||
48678115|NCT03937479|101994302|FG004|COMPLETED|Overall Study||79||
48678116|NCT03937479|101994298|FG000|NOT COMPLETED|Overall Study||10||
48678117|NCT03937479|101994299|FG001|NOT COMPLETED|Overall Study||15||
48678118|NCT03937479|101994300|FG002|NOT COMPLETED|Overall Study||7||
48678119|NCT03937479|101994301|FG003|NOT COMPLETED|Overall Study||6||
48678120|NCT03937479|101994302|FG004|NOT COMPLETED|Overall Study||5||
48678121|NCT05870345|101994303|FG000|STARTED|Feasibility||22||440
48678122|NCT05870345|101994303|FG000|COMPLETED|Feasibility||22||440
48678123|NCT05870345|101994303|FG000|NOT COMPLETED|Feasibility||0||0
48678124|NCT05870345|101994303|FG000|STARTED|Active||13||260
48678125|NCT05870345|101994303|FG000|COMPLETED|Active||13||260
48678126|NCT05870345|101994303|FG000|NOT COMPLETED|Active||0||0
48678127|NCT02655887|101994304|FG000|STARTED|Overall Study||170||
48678128|NCT02655887|101994304|FG000|COMPLETED|Overall Study||156||
48678129|NCT02655887|101994304|FG000|NOT COMPLETED|Overall Study||14||
48678130|NCT01313507|101994305|FG000|STARTED|Overall Study||21||
48678131|NCT01313507|101994305|FG000|COMPLETED|Overall Study||21||
48678132|NCT01313507|101994305|FG000|NOT COMPLETED|Overall Study||0||
48678133|NCT03130569|101994306|FG000|STARTED|Overall Study||101||
48678134|NCT03130569|101994307|FG001|STARTED|Overall Study||499||
48678135|NCT03130569|101994306|FG000|COMPLETED|Overall Study||82||
48678136|NCT03130569|101994307|FG001|COMPLETED|Overall Study||401||
48678137|NCT03130569|101994306|FG000|NOT COMPLETED|Overall Study||19||
48678138|NCT03130569|101994307|FG001|NOT COMPLETED|Overall Study||98||
48240422|NCT03761849|100909037|FG004|STARTED|Overall Study||264||
48678139|NCT01162551|101994308|FG000|STARTED|Overall Study||3||
48678140|NCT01162551|101994308|FG000|COMPLETED|Overall Study||3||
48678141|NCT01162551|101994308|FG000|NOT COMPLETED|Overall Study||0||
48678142|NCT00546481|101994309|FG000|STARTED|Correction Phase (CERA or Epoetin Beta)||39||
48678143|NCT00546481|101994310|FG001|STARTED|Correction Phase (CERA or Epoetin Beta)||41||
48678144|NCT00546481|101994311|FG002|STARTED|Correction Phase (CERA or Epoetin Beta)||0||
48678145|NCT00546481|101994309|FG000|COMPLETED|Correction Phase (CERA or Epoetin Beta)||33||
48678146|NCT00546481|101994310|FG001|COMPLETED|Correction Phase (CERA or Epoetin Beta)||36||
48678147|NCT00546481|101994311|FG002|COMPLETED|Correction Phase (CERA or Epoetin Beta)||0||
48678148|NCT00546481|101994309|FG000|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||6||
48678149|NCT00546481|101994310|FG001|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||5||
48678150|NCT00546481|101994311|FG002|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||0||
48678151|NCT00546481|101994309|FG000|STARTED|Maintenance Phase (CERA)||0||
48678152|NCT00546481|101994310|FG001|STARTED|Maintenance Phase (CERA)||0||
48678153|NCT00546481|101994311|FG002|STARTED|Maintenance Phase (CERA)||54||
48240423|NCT03761849|100909038|FG005|STARTED|Overall Study||264||
48240424|NCT03761849|100909033|FG000|COMPLETED|Overall Study||0|Participants were transferred to Open Label Extension|
48240425|NCT03761849|100909034|FG001|COMPLETED|Overall Study||0|Participants were transferred to Open Label Extension|
48240426|NCT03761849|100909035|FG002|COMPLETED|Overall Study||0|Participants were transferred to Open Label Extension|
48678154|NCT00546481|101994309|FG000|COMPLETED|Maintenance Phase (CERA)||0||
48678155|NCT00546481|101994310|FG001|COMPLETED|Maintenance Phase (CERA)||0||
48678156|NCT00546481|101994311|FG002|COMPLETED|Maintenance Phase (CERA)||50||
48678157|NCT00546481|101994309|FG000|NOT COMPLETED|Maintenance Phase (CERA)||0||
48678158|NCT00546481|101994310|FG001|NOT COMPLETED|Maintenance Phase (CERA)||0||
48678159|NCT00546481|101994311|FG002|NOT COMPLETED|Maintenance Phase (CERA)||4||
48678160|NCT00894387|101994312|FG000|STARTED|Overall Study||821||
48678161|NCT00894387|101994313|FG001|STARTED|Overall Study||818||
48240427|NCT03761849|100909036|FG003|COMPLETED|Overall Study||216|Participants were transferred to Open Label Extension|
48240428|NCT03761849|100909037|FG004|COMPLETED|Overall Study||207|Participants were transferred to Open Label Extension|
48240429|NCT03761849|100909038|FG005|COMPLETED|Overall Study||211|Participants were transferred to Open Label Extension|
48240430|NCT03761849|100909033|FG000|NOT COMPLETED|Overall Study||36||
48240431|NCT03761849|100909034|FG001|NOT COMPLETED|Overall Study||36||
48240432|NCT03761849|100909035|FG002|NOT COMPLETED|Overall Study||36||
48240433|NCT03761849|100909036|FG003|NOT COMPLETED|Overall Study||47||
48240434|NCT03761849|100909037|FG004|NOT COMPLETED|Overall Study||57||
48240435|NCT03761849|100909038|FG005|NOT COMPLETED|Overall Study||53||
48240436|NCT01477177|100909039|FG000|STARTED|Overall Study||4||
48240437|NCT01477177|100909039|FG000|COMPLETED|Overall Study||4||
48240438|NCT01477177|100909039|FG000|NOT COMPLETED|Overall Study||0||
48240439|NCT04853238|100909040|FG000|STARTED|Overall Study||802|Enrolled|
48240440|NCT04853238|100909041|FG001|STARTED|Overall Study||71|Enrolled|
48240441|NCT04853238|100909042|FG002|STARTED|Overall Study||634|Enrolled|
48240442|NCT04853238|100909040|FG000|Analysis Data Set|Overall Study||797||
48240443|NCT04853238|100909041|FG001|Analysis Data Set|Overall Study||71||
48678162|NCT00894387|101994312|FG000|Safety Set|Overall Study||808||
48678163|NCT00894387|101994313|FG001|Safety Set|Overall Study||810||
48678164|NCT00894387|101994312|FG000|Full Analysis Set|Overall Study||808||
48678165|NCT00894387|101994313|FG001|Full Analysis Set|Overall Study||807||
48678166|NCT00894387|101994312|FG000|Completed Primary Efficacy Phase (6 m)|Overall Study||717||
48678167|NCT00894387|101994313|FG001|Completed Primary Efficacy Phase (6 m)|Overall Study||707||
48678168|NCT00894387|101994312|FG000|Completed Secondary Efficacy Phase (12m)|Overall Study||654||
48678169|NCT00894387|101994313|FG001|Completed Secondary Efficacy Phase (12m)|Overall Study||640||
48678170|NCT00894387|101994312|FG000|COMPLETED|Overall Study||646||
48678171|NCT00894387|101994313|FG001|COMPLETED|Overall Study||643||
48678172|NCT00894387|101994312|FG000|NOT COMPLETED|Overall Study||175||
48678173|NCT00894387|101994313|FG001|NOT COMPLETED|Overall Study||175||
48678174|NCT00402987|101994314|FG000|STARTED|Overall Study||90||
48678175|NCT00402987|101994315|FG001|STARTED|Overall Study||45||
48678176|NCT00402987|101994316|FG002|STARTED|Overall Study||45||
48678177|NCT00402987|101994317|FG003|STARTED|Overall Study||89||
48678178|NCT00402987|101994314|FG000|COMPLETED|Overall Study||90||
48678179|NCT00402987|101994315|FG001|COMPLETED|Overall Study||45||
48678180|NCT00402987|101994316|FG002|COMPLETED|Overall Study||44||
48678181|NCT00402987|101994317|FG003|COMPLETED|Overall Study||89||
48678182|NCT00402987|101994314|FG000|NOT COMPLETED|Overall Study||0||
48678183|NCT00402987|101994315|FG001|NOT COMPLETED|Overall Study||0||
48678184|NCT00402987|101994316|FG002|NOT COMPLETED|Overall Study||1||
48678185|NCT00402987|101994317|FG003|NOT COMPLETED|Overall Study||0||
48678186|NCT01193101|101994318|FG000|STARTED|Overall Study||100||
48678187|NCT01193101|101994319|FG001|STARTED|Overall Study||101||
48678188|NCT01193101|101994320|FG002|STARTED|Overall Study||96||
48678189|NCT01193101|101994321|FG003|STARTED|Overall Study||92||
48678190|NCT01193101|101994318|FG000|Full Analysis Set|Overall Study||100||
48678191|NCT01193101|101994319|FG001|Full Analysis Set|Overall Study||101||
48678192|NCT01193101|101994320|FG002|Full Analysis Set|Overall Study||96||
48678193|NCT01193101|101994321|FG003|Full Analysis Set|Overall Study||92||
48678194|NCT01193101|101994318|FG000|Placebo Withdrawal Set|Overall Study||95||
48678195|NCT01193101|101994319|FG001|Placebo Withdrawal Set|Overall Study||94||
48678196|NCT01193101|101994320|FG002|Placebo Withdrawal Set|Overall Study||93||
48678197|NCT01193101|101994321|FG003|Placebo Withdrawal Set|Overall Study||80||
48678198|NCT01193101|101994318|FG000|COMPLETED|Overall Study||95||
48678199|NCT01193101|101994319|FG001|COMPLETED|Overall Study||94||
48678200|NCT01193101|101994320|FG002|COMPLETED|Overall Study||93||
48678201|NCT01193101|101994321|FG003|COMPLETED|Overall Study||80||
48678202|NCT01193101|101994318|FG000|NOT COMPLETED|Overall Study||5||
48678203|NCT01193101|101994319|FG001|NOT COMPLETED|Overall Study||7||
48240444|NCT04853238|100909042|FG002|Analysis Data Set|Overall Study||615||
48240445|NCT04853238|100909040|FG000|COMPLETED|Overall Study||772||
48240446|NCT04853238|100909041|FG001|COMPLETED|Overall Study||68||
48240447|NCT04853238|100909042|FG002|COMPLETED|Overall Study||561||
48240448|NCT04853238|100909040|FG000|NOT COMPLETED|Overall Study||30||
48240449|NCT04853238|100909041|FG001|NOT COMPLETED|Overall Study||3||
48240450|NCT04853238|100909042|FG002|NOT COMPLETED|Overall Study||73||
48240451|NCT02880293|100909043|FG000|STARTED|Overall Study||44||
48678204|NCT01193101|101994320|FG002|NOT COMPLETED|Overall Study||3||
48678205|NCT01193101|101994321|FG003|NOT COMPLETED|Overall Study||12||
48678206|NCT00265850|101994322|FG000|STARTED|Overall Study||899||
48678207|NCT00265850|101994323|FG001|STARTED|Overall Study||902||
48678208|NCT00265850|101994324|FG002|STARTED|Overall Study||533||
48678209|NCT00265850|101994322|FG000|COMPLETED|Overall Study||899||
48678210|NCT00265850|101994323|FG001|COMPLETED|Overall Study||902||
48678211|NCT00265850|101994324|FG002|COMPLETED|Overall Study||533||
48678212|NCT00265850|101994322|FG000|NOT COMPLETED|Overall Study||0||
48678213|NCT00265850|101994323|FG001|NOT COMPLETED|Overall Study||0||
48678214|NCT00265850|101994324|FG002|NOT COMPLETED|Overall Study||0||
48678215|NCT01173679|101994325|FG000|STARTED|Overall Study||10||
48678216|NCT01173679|101994325|FG000|COMPLETED|Overall Study||9||
48678217|NCT01173679|101994325|FG000|NOT COMPLETED|Overall Study||1||
48678218|NCT03571971|101994326|FG000|STARTED|Overall Study||31||
48678219|NCT03571971|101994327|FG001|STARTED|Overall Study||30||
48678220|NCT03571971|101994326|FG000|COMPLETED|Overall Study||23||
48678221|NCT03571971|101994327|FG001|COMPLETED|Overall Study||25||
48678222|NCT03571971|101994326|FG000|NOT COMPLETED|Overall Study||8||
48678223|NCT03571971|101994327|FG001|NOT COMPLETED|Overall Study||5||
48678224|NCT03179761|101994328|FG000|STARTED|Overall Study||60||
48678225|NCT03179761|101994329|FG001|STARTED|Overall Study||64||
48678226|NCT03179761|101994328|FG000|Visit 1|Overall Study||60|Study vaccine was administered.|
48678227|NCT03179761|101994329|FG001|Visit 1|Overall Study||64|Study vaccine was administered.|
48240452|NCT02880293|100909043|FG000|COMPLETED|Overall Study||39||
48240453|NCT02880293|100909043|FG000|NOT COMPLETED|Overall Study||5||
48240454|NCT04730271|100909044|FG000|STARTED|Overall Study||100|Enrolled and Treated|
48240455|NCT04730271|100909045|FG001|STARTED|Overall Study||100|Enrolled and Treated|
48240456|NCT04730271|100909044|FG000|Intent to Treat and Completed 12 Week Follow up Per Protocol|Overall Study||90|Including required X-rays|
48240457|NCT04730271|100909045|FG001|Intent to Treat and Completed 12 Week Follow up Per Protocol|Overall Study||92|Including required X-rays|
48240458|NCT04730271|100909044|FG000|COMPLETED|Overall Study||88|Completed 1 year follow up (safety analysis set)|
48240459|NCT04730271|100909045|FG001|COMPLETED|Overall Study||81|Completed 1 year follow up (safety analysis set)|
48240460|NCT04730271|100909044|FG000|NOT COMPLETED|Overall Study||12||
48240461|NCT04730271|100909045|FG001|NOT COMPLETED|Overall Study||19||
48240462|NCT00139659|100909046|FG000|STARTED|Overall Study||146||
48240463|NCT00139659|100909047|FG001|STARTED|Overall Study||141||
48240464|NCT00139659|100909046|FG000|COMPLETED|Overall Study||106||
48240465|NCT00139659|100909047|FG001|COMPLETED|Overall Study||123||
48240466|NCT00139659|100909046|FG000|NOT COMPLETED|Overall Study||40||
48240467|NCT00139659|100909047|FG001|NOT COMPLETED|Overall Study||18||
48240468|NCT04175392|100909048|FG000|STARTED|Overall Study||7||
48240469|NCT04175392|100909049|FG001|STARTED|Overall Study||7||
48240470|NCT04175392|100909048|FG000|COMPLETED|Overall Study||4||
48240471|NCT04175392|100909049|FG001|COMPLETED|Overall Study||5||
48240472|NCT04175392|100909048|FG000|NOT COMPLETED|Overall Study||3||
48240473|NCT04175392|100909049|FG001|NOT COMPLETED|Overall Study||2||
48240474|NCT02812706|100909050|FG000|STARTED|Phase 1||3||
48240475|NCT02812706|100909051|FG001|STARTED|Phase 1||5||
48240476|NCT02812706|100909052|FG002|STARTED|Phase 1||0||
48240477|NCT02812706|100909050|FG000|COMPLETED|Phase 1||0||
48240478|NCT02812706|100909051|FG001|COMPLETED|Phase 1||0||
48240479|NCT02812706|100909052|FG002|COMPLETED|Phase 1||0||
48240480|NCT02812706|100909050|FG000|NOT COMPLETED|Phase 1||3||
48240481|NCT02812706|100909051|FG001|NOT COMPLETED|Phase 1||5||
48240482|NCT02812706|100909052|FG002|NOT COMPLETED|Phase 1||0||
48240483|NCT02812706|100909050|FG000|STARTED|Phase 2||0||
48240484|NCT02812706|100909051|FG001|STARTED|Phase 2||0||
48240485|NCT02812706|100909052|FG002|STARTED|Phase 2||28||
48240486|NCT02812706|100909050|FG000|COMPLETED|Phase 2||0||
48678228|NCT03179761|101994328|FG000|Visit 2|Overall Study||59|Study vaccine was administered.|
48678229|NCT03179761|101994329|FG001|Visit 2|Overall Study||59|Study vaccine was administered.|
48678230|NCT03179761|101994328|FG000|Visit 3|Overall Study||59||
48678231|NCT03179761|101994329|FG001|Visit 3|Overall Study||59||
48678232|NCT03179761|101994328|FG000|Visit 4|Overall Study||54||
48678233|NCT03179761|101994329|FG001|Visit 4|Overall Study||51||
48678234|NCT03179761|101994328|FG000|Visit 1 Repeat|Overall Study||23|This visit was attended by subjects who enrolled for a second year following their first year of enrollment, and the study vaccine was administered. See protocol for criteria.|
48678235|NCT03179761|101994329|FG001|Visit 1 Repeat|Overall Study||20|This visit was attended by subjects who enrolled for a second year following their first year of enrollment, and the study vaccine was administered. See protocol for criteria.|
48678236|NCT03179761|101994328|FG000|Visit 2 Repeat|Overall Study||21|This visit was attended by subjects who enrolled for a second year following their first year of enrollment, and the study vaccine was administered. See protocol for criteria.|
48678237|NCT03179761|101994329|FG001|Visit 2 Repeat|Overall Study||20|This visit was attended by subjects who enrolled for a second year following their first year of enrollment, and the study vaccine was administered. See protocol for criteria.|
48678238|NCT03179761|101994328|FG000|Visit 3 Repeat|Overall Study||19|This visit was attended by subjects who enrolled for a second year following their first year of enrollment. See protocol for criteria.|
48678239|NCT03179761|101994329|FG001|Visit 3 Repeat|Overall Study||20|This visit was attended by subjects who enrolled for a second year following their first year of enrollment. See protocol for criteria.|
48678240|NCT03179761|101994328|FG000|Visit 4 Repeat|Overall Study||12|This visit was attended by subjects who enrolled for a second year following their first year of enrollment. See protocol for criteria.|
48710650|NCT02961790|102077985|FG002|STARTED|Overall Study||24||
48240487|NCT02812706|100909051|FG001|COMPLETED|Phase 2||0||
48240488|NCT02812706|100909052|FG002|COMPLETED|Phase 2||0||
48240489|NCT02812706|100909050|FG000|NOT COMPLETED|Phase 2||0||
48240490|NCT02812706|100909051|FG001|NOT COMPLETED|Phase 2||0||
48240491|NCT02812706|100909052|FG002|NOT COMPLETED|Phase 2||28||
48240492|NCT03508830|100909053|FG000|STARTED|Overall Study||46||
48240493|NCT03508830|100909054|FG001|STARTED|Overall Study||45||
48240494|NCT03508830|100909053|FG000|COMPLETED|Overall Study||41||
48240495|NCT03508830|100909054|FG001|COMPLETED|Overall Study||39||
48240496|NCT03508830|100909053|FG000|NOT COMPLETED|Overall Study||5||
48240497|NCT03508830|100909054|FG001|NOT COMPLETED|Overall Study||6||
48240498|NCT05700851|100909055|FG000|STARTED|Overall Study||17||
48240499|NCT05700851|100909055|FG000|COMPLETED|Overall Study||14||
48240500|NCT05700851|100909055|FG000|NOT COMPLETED|Overall Study||3||
48240501|NCT04754594|100909056|FG000|STARTED|Blinded Period||174||
48240502|NCT04754594|100909057|FG001|STARTED|Blinded Period||174||
48240503|NCT04754594|100909058|FG002|STARTED|Blinded Period||0||
48240504|NCT04754594|100909059|FG003|STARTED|Blinded Period||0||
48240505|NCT04754594|100909056|FG000|Vaccination 1|Blinded Period||173||
48240506|NCT04754594|100909057|FG001|Vaccination 1|Blinded Period||173||
48240507|NCT04754594|100909058|FG002|Vaccination 1|Blinded Period||0||
48240508|NCT04754594|100909059|FG003|Vaccination 1|Blinded Period||0||
48240509|NCT04754594|100909056|FG000|Vaccination 2|Blinded Period||170||
48240510|NCT04754594|100909057|FG001|Vaccination 2|Blinded Period||170||
48678241|NCT03179761|101994329|FG001|Visit 4 Repeat|Overall Study||12|This visit was attended by subjects who enrolled for a second year following their first year of enrollment. See protocol for criteria.|
48678242|NCT03179761|101994328|FG000|COMPLETED|Overall Study||54|"This includes subjects who completed all four visits for their first year of enrollment. This does not account for those who participated in a repeater year."|
48678243|NCT03179761|101994329|FG001|COMPLETED|Overall Study||51|"This includes subjects who completed all four visits for their first year of enrollment. This does not account for those who participated in a repeater year."|
48678244|NCT03179761|101994328|FG000|NOT COMPLETED|Overall Study||6||
48678245|NCT03179761|101994329|FG001|NOT COMPLETED|Overall Study||13||
48240511|NCT04754594|100909058|FG002|Vaccination 2|Blinded Period||0||
48240512|NCT04754594|100909059|FG003|Vaccination 2|Blinded Period||0||
48240513|NCT04754594|100909056|FG000|COMPLETED|Blinded Period||161||
48240514|NCT04754594|100909057|FG001|COMPLETED|Blinded Period||159||
48240515|NCT04754594|100909058|FG002|COMPLETED|Blinded Period||0||
48240516|NCT04754594|100909059|FG003|COMPLETED|Blinded Period||0||
48240517|NCT04754594|100909056|FG000|NOT COMPLETED|Blinded Period||13||
48240518|NCT04754594|100909057|FG001|NOT COMPLETED|Blinded Period||15||
48240519|NCT04754594|100909058|FG002|NOT COMPLETED|Blinded Period||0||
48240520|NCT04754594|100909059|FG003|NOT COMPLETED|Blinded Period||0||
48240521|NCT04754594|100909056|FG000|STARTED|Unblinded Period||167||
48240522|NCT04754594|100909057|FG001|STARTED|Unblinded Period||162||
48240523|NCT04754594|100909058|FG002|STARTED|Unblinded Period||0||
48240524|NCT04754594|100909059|FG003|STARTED|Unblinded Period||0||
48240525|NCT04754594|100909056|FG000|Vaccination 3|Unblinded Period||0||
48240526|NCT04754594|100909057|FG001|Vaccination 3|Unblinded Period||152||
48240527|NCT04754594|100909058|FG002|Vaccination 3|Unblinded Period||0||
48240528|NCT04754594|100909059|FG003|Vaccination 3|Unblinded Period||0||
48240529|NCT04754594|100909056|FG000|Vaccination 4|Unblinded Period||0||
48240530|NCT04754594|100909057|FG001|Vaccination 4|Unblinded Period||148||
48240531|NCT04754594|100909058|FG002|Vaccination 4|Unblinded Period||0||
48240532|NCT04754594|100909059|FG003|Vaccination 4|Unblinded Period||0||
48240533|NCT04754594|100909056|FG000|COMPLETED|Unblinded Period||151||
48240534|NCT04754594|100909057|FG001|COMPLETED|Unblinded Period||147||
48240535|NCT04754594|100909058|FG002|COMPLETED|Unblinded Period||0||
48240536|NCT04754594|100909059|FG003|COMPLETED|Unblinded Period||0||
48240537|NCT04754594|100909056|FG000|NOT COMPLETED|Unblinded Period||16||
48240538|NCT04754594|100909057|FG001|NOT COMPLETED|Unblinded Period||15||
48240539|NCT04754594|100909058|FG002|NOT COMPLETED|Unblinded Period||0||
48240540|NCT04754594|100909059|FG003|NOT COMPLETED|Unblinded Period||0||
48240541|NCT04754594|100909056|FG000|STARTED|Infant Participants||0||
48678246|NCT01697709|101994330|FG000|STARTED|Overall Study||64||
48678247|NCT01697709|101994331|FG001|STARTED|Overall Study||66||
48678248|NCT01697709|101994330|FG000|COMPLETED|Overall Study||34||
48240542|NCT04754594|100909057|FG001|STARTED|Infant Participants||0||
48240543|NCT04754594|100909058|FG002|STARTED|Infant Participants||167||
48240544|NCT04754594|100909059|FG003|STARTED|Infant Participants||168||
48240545|NCT04754594|100909056|FG000|COMPLETED|Infant Participants||0||
48240546|NCT04754594|100909057|FG001|COMPLETED|Infant Participants||0||
48240547|NCT04754594|100909058|FG002|COMPLETED|Infant Participants||152||
48240548|NCT04754594|100909059|FG003|COMPLETED|Infant Participants||139||
48240549|NCT04754594|100909056|FG000|NOT COMPLETED|Infant Participants||0||
48240550|NCT04754594|100909057|FG001|NOT COMPLETED|Infant Participants||0||
48240551|NCT04754594|100909058|FG002|NOT COMPLETED|Infant Participants||15||
48240552|NCT04754594|100909059|FG003|NOT COMPLETED|Infant Participants||29||
48240553|NCT03598790|100909060|FG000|STARTED|Treatment Period (TP): Wk0-Wk144||384||
48240554|NCT03598790|100909061|FG001|STARTED|Treatment Period (TP): Wk0-Wk144||833||
48240555|NCT03598790|100909062|FG002|STARTED|Treatment Period (TP): Wk0-Wk144||70||
48240556|NCT03598790|100909063|FG003|STARTED|Treatment Period (TP): Wk0-Wk144||0||
48240557|NCT03598790|100909064|FG004|STARTED|Treatment Period (TP): Wk0-Wk144||0||
48240558|NCT03598790|100909065|FG005|STARTED|Treatment Period (TP): Wk0-Wk144||0||
48240559|NCT03598790|100909066|FG006|STARTED|Treatment Period (TP): Wk0-Wk144||45||
48240560|NCT03598790|100909067|FG007|STARTED|Treatment Period (TP): Wk0-Wk144||11||
48240561|NCT03598790|100909068|FG008|STARTED|Treatment Period (TP): Wk0-Wk144||10||
48240562|NCT03598790|100909060|FG000|COMPLETED|Treatment Period (TP): Wk0-Wk144||326||
48240563|NCT03598790|100909061|FG001|COMPLETED|Treatment Period (TP): Wk0-Wk144||746||
48240564|NCT03598790|100909062|FG002|COMPLETED|Treatment Period (TP): Wk0-Wk144||0||
48240565|NCT03598790|100909063|FG003|COMPLETED|Treatment Period (TP): Wk0-Wk144||0||
48678249|NCT01697709|101994331|FG001|COMPLETED|Overall Study||38||
48678250|NCT01697709|101994330|FG000|NOT COMPLETED|Overall Study||30||
48678251|NCT01697709|101994331|FG001|NOT COMPLETED|Overall Study||28||
48678252|NCT00069641|101994332|FG000|STARTED|Overall Study||32||
48240566|NCT03598790|100909064|FG004|COMPLETED|Treatment Period (TP): Wk0-Wk144||0||
48678253|NCT00069641|101994333|FG001|STARTED|Overall Study||32||
48678254|NCT00069641|101994334|FG002|STARTED|Overall Study||32||
48678255|NCT00069641|101994332|FG000|COMPLETED|Overall Study||31||
48678256|NCT00069641|101994333|FG001|COMPLETED|Overall Study||32||
48678257|NCT00069641|101994334|FG002|COMPLETED|Overall Study||31||
48240567|NCT03598790|100909065|FG005|COMPLETED|Treatment Period (TP): Wk0-Wk144||0||
48240568|NCT03598790|100909066|FG006|COMPLETED|Treatment Period (TP): Wk0-Wk144||38||
48240569|NCT03598790|100909067|FG007|COMPLETED|Treatment Period (TP): Wk0-Wk144||10||
48240570|NCT03598790|100909068|FG008|COMPLETED|Treatment Period (TP): Wk0-Wk144||8||
48240571|NCT03598790|100909060|FG000|NOT COMPLETED|Treatment Period (TP): Wk0-Wk144||58||
48240572|NCT03598790|100909061|FG001|NOT COMPLETED|Treatment Period (TP): Wk0-Wk144||87||
48240573|NCT03598790|100909062|FG002|NOT COMPLETED|Treatment Period (TP): Wk0-Wk144||70||
48240574|NCT03598790|100909063|FG003|NOT COMPLETED|Treatment Period (TP): Wk0-Wk144||0||
48240575|NCT03598790|100909064|FG004|NOT COMPLETED|Treatment Period (TP): Wk0-Wk144||0||
48240576|NCT03598790|100909065|FG005|NOT COMPLETED|Treatment Period (TP): Wk0-Wk144||0||
48240577|NCT03598790|100909066|FG006|NOT COMPLETED|Treatment Period (TP): Wk0-Wk144||7||
48240578|NCT03598790|100909067|FG007|NOT COMPLETED|Treatment Period (TP): Wk0-Wk144||1||
48678258|NCT00069641|101994332|FG000|NOT COMPLETED|Overall Study||1||
48678259|NCT00069641|101994333|FG001|NOT COMPLETED|Overall Study||0||
48678260|NCT00069641|101994334|FG002|NOT COMPLETED|Overall Study||1||
48240579|NCT03598790|100909068|FG008|NOT COMPLETED|Treatment Period (TP): Wk0-Wk144||2||
48240580|NCT03598790|100909060|FG000|STARTED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48240581|NCT03598790|100909061|FG001|STARTED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48240582|NCT03598790|100909062|FG002|STARTED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48678261|NCT01932788|101994335|FG000|STARTED|Overall Study||173||
48678262|NCT01932788|101994336|FG001|STARTED|Overall Study||169||
48678263|NCT01932788|101994335|FG000|COMPLETED|Overall Study||135||
48678264|NCT01932788|101994336|FG001|COMPLETED|Overall Study||118||
48678265|NCT01932788|101994335|FG000|NOT COMPLETED|Overall Study||38||
48678266|NCT01932788|101994336|FG001|NOT COMPLETED|Overall Study||51||
48678267|NCT04683913|101994337|FG000|STARTED|Overall Study||10||
48678268|NCT04683913|101994338|FG001|STARTED|Overall Study||10||
48678269|NCT04683913|101994337|FG000|Baseline|Overall Study||10||
48678270|NCT04683913|101994338|FG001|Baseline|Overall Study||10||
48678271|NCT04683913|101994337|FG000|Follow up|Overall Study||10||
48678272|NCT04683913|101994338|FG001|Follow up|Overall Study||10||
48678273|NCT04683913|101994337|FG000|Secondary Baseline|Overall Study||0||
48240583|NCT03598790|100909063|FG003|STARTED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||226||
48240584|NCT03598790|100909064|FG004|STARTED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||51||
48240585|NCT03598790|100909065|FG005|STARTED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||41||
48240586|NCT03598790|100909066|FG006|STARTED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48240587|NCT03598790|100909067|FG007|STARTED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48240588|NCT03598790|100909068|FG008|STARTED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48240589|NCT03598790|100909060|FG000|COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48240590|NCT03598790|100909061|FG001|COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48240591|NCT03598790|100909062|FG002|COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48240592|NCT03598790|100909063|FG003|COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||216||
48240593|NCT03598790|100909064|FG004|COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||49||
48240594|NCT03598790|100909065|FG005|COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||39||
48240595|NCT03598790|100909066|FG006|COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48240596|NCT03598790|100909067|FG007|COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48240597|NCT03598790|100909068|FG008|COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48240598|NCT03598790|100909060|FG000|NOT COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48240599|NCT03598790|100909061|FG001|NOT COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48240600|NCT03598790|100909062|FG002|NOT COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48240601|NCT03598790|100909063|FG003|NOT COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||10||
48240602|NCT03598790|100909064|FG004|NOT COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||2||
48240603|NCT03598790|100909065|FG005|NOT COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||2||
48240604|NCT03598790|100909066|FG006|NOT COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48240605|NCT03598790|100909067|FG007|NOT COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48240606|NCT03598790|100909068|FG008|NOT COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48240607|NCT01014013|100909069|FG000|STARTED|Overall Study||135||
48240608|NCT01014013|100909070|FG001|STARTED|Overall Study||136||
48240609|NCT01014013|100909069|FG000|Adverse Event Reporting|Overall Study||132||
48240610|NCT01014013|100909070|FG001|Adverse Event Reporting|Overall Study||135||
48678274|NCT04683913|101994338|FG001|Secondary Baseline|Overall Study||10||
48678275|NCT04683913|101994337|FG000|Retention|Overall Study||10||
48678276|NCT04683913|101994338|FG001|Retention|Overall Study||10||
48678277|NCT04683913|101994337|FG000|COMPLETED|Overall Study||10||
48678278|NCT04683913|101994338|FG001|COMPLETED|Overall Study||10||
48678279|NCT04683913|101994337|FG000|NOT COMPLETED|Overall Study||0||
48678280|NCT04683913|101994338|FG001|NOT COMPLETED|Overall Study||0||
48678281|NCT03384875|101994339|FG000|STARTED|Overall Study||56||
48678282|NCT03384875|101994340|FG001|STARTED|Overall Study||60||
48678283|NCT03384875|101994341|FG002|STARTED|Overall Study||36||
48678284|NCT03384875|101994339|FG000|COMPLETED|Overall Study||54||
48678285|NCT03384875|101994340|FG001|COMPLETED|Overall Study||59||
48678286|NCT03384875|101994341|FG002|COMPLETED|Overall Study||36||
48678287|NCT03384875|101994339|FG000|NOT COMPLETED|Overall Study||2||
48678288|NCT03384875|101994340|FG001|NOT COMPLETED|Overall Study||1||
48678289|NCT03384875|101994341|FG002|NOT COMPLETED|Overall Study||0||
48678290|NCT05455580|101994342|FG000|STARTED|Overall Study||31||
48678291|NCT05455580|101994342|FG000|COMPLETED|Overall Study||31||
48678292|NCT05455580|101994342|FG000|NOT COMPLETED|Overall Study||0||
48678293|NCT04343092|101994343|FG000|STARTED|Overall Study||16||
48678294|NCT04343092|101994343|FG000|COMPLETED|Overall Study||16||
48240611|NCT01014013|100909069|FG000|Completed Parenteral Therapy|Overall Study||87||
48240612|NCT01014013|100909070|FG001|Completed Parenteral Therapy|Overall Study||88||
48240613|NCT01014013|100909069|FG000|COMPLETED|Overall Study||84||
48678295|NCT04343092|101994343|FG000|NOT COMPLETED|Overall Study||0||
48678296|NCT00454116|101994344|FG000|STARTED|Overall Study||35||
48678297|NCT00454116|101994345|FG001|STARTED|Overall Study||36||
48678298|NCT00454116|101994346|FG002|STARTED|Overall Study||35||
48678299|NCT00454116|101994344|FG000|COMPLETED|Overall Study||8||
48678300|NCT00454116|101994345|FG001|COMPLETED|Overall Study||7||
48678301|NCT00454116|101994346|FG002|COMPLETED|Overall Study||7||
48678302|NCT00454116|101994344|FG000|NOT COMPLETED|Overall Study||27||
48678303|NCT00454116|101994345|FG001|NOT COMPLETED|Overall Study||29||
48678304|NCT00454116|101994346|FG002|NOT COMPLETED|Overall Study||28||
48678305|NCT01242514|101994347|FG000|STARTED|Overall Study||1343||
48678306|NCT01242514|101994348|FG001|STARTED|Overall Study||357||
48678307|NCT01242514|101994349|FG002|STARTED|Overall Study||212||
48678308|NCT01242514|101994347|FG000|Enrolled But Did Not Receive Treatment|Overall Study||3||
48678309|NCT01242514|101994348|FG001|Enrolled But Did Not Receive Treatment|Overall Study||0||
48678310|NCT01242514|101994349|FG002|Enrolled But Did Not Receive Treatment|Overall Study||2||
48678311|NCT01242514|101994347|FG000|COMPLETED|Overall Study||0||
48678312|NCT01242514|101994348|FG001|COMPLETED|Overall Study||0||
48678313|NCT01242514|101994349|FG002|COMPLETED|Overall Study||0||
48678314|NCT01242514|101994347|FG000|NOT COMPLETED|Overall Study||1343||
48678315|NCT01242514|101994348|FG001|NOT COMPLETED|Overall Study||357||
48678316|NCT01242514|101994349|FG002|NOT COMPLETED|Overall Study||212||
48678317|NCT03097289|101994350|FG000|STARTED|Overall Study||32||
48678318|NCT03097289|101994350|FG000|COMPLETED|Overall Study||26||
48678319|NCT03097289|101994350|FG000|NOT COMPLETED|Overall Study||6||
48678320|NCT00583219|101996468|FG000|STARTED|Phase 1||9||
48678321|NCT00583219|101996468|FG000|COMPLETED|Phase 1||9||
48678322|NCT00583219|101996468|FG000|NOT COMPLETED|Phase 1||0||
48678323|NCT00583219|101996468|FG000|STARTED|Phase 2||22||
48240614|NCT01014013|100909070|FG001|COMPLETED|Overall Study||80||
48240615|NCT01014013|100909069|FG000|NOT COMPLETED|Overall Study||51||
48240616|NCT01014013|100909070|FG001|NOT COMPLETED|Overall Study||56||
48240617|NCT01534052|100909071|FG000|STARTED|Overall Study||52||
48240618|NCT01534052|100909071|FG000|Treatment Received|Overall Study||52||
48240619|NCT01534052|100909071|FG000|COMPLETED|Overall Study||52||
48240620|NCT01534052|100909071|FG000|NOT COMPLETED|Overall Study||0||
48240621|NCT02163499|100909072|FG000|STARTED|Acute Phase: ZS 10 g TID||751||
48240622|NCT02163499|100909072|FG000|COMPLETED|Acute Phase: ZS 10 g TID||746||
48678324|NCT00583219|101996468|FG000|COMPLETED|Phase 2||21||
48678325|NCT00583219|101996468|FG000|NOT COMPLETED|Phase 2||1||
48678326|NCT03096886|101996469|FG000|STARTED|Overall Study||38||
48678327|NCT03096886|101996470|FG001|STARTED|Overall Study||44||
48678328|NCT03096886|101996471|FG002|STARTED|Overall Study||50||
48678329|NCT03096886|101996469|FG000|COMPLETED|Overall Study||30||
48678330|NCT03096886|101996470|FG001|COMPLETED|Overall Study||30||
48678331|NCT03096886|101996471|FG002|COMPLETED|Overall Study||40||
48678332|NCT03096886|101996469|FG000|NOT COMPLETED|Overall Study||8||
48678333|NCT03096886|101996470|FG001|NOT COMPLETED|Overall Study||14||
48678334|NCT03096886|101996471|FG002|NOT COMPLETED|Overall Study||10||
48678335|NCT03300206|101996472|FG000|STARTED|Overall Study||316||
48678336|NCT03300206|101996473|FG001|STARTED|Overall Study||209||
48678337|NCT03300206|101996472|FG000|COMPLETED|Overall Study||316||
48678338|NCT03300206|101996473|FG001|COMPLETED|Overall Study||209||
48678339|NCT03300206|101996472|FG000|NOT COMPLETED|Overall Study||0||
48240623|NCT02163499|100909072|FG000|NOT COMPLETED|Acute Phase: ZS 10 g TID||5||
48240624|NCT02163499|100909072|FG000|STARTED|Extended Dosing Phase: ZS||746||
48678340|NCT03300206|101996473|FG001|NOT COMPLETED|Overall Study||0||
48678341|NCT04411849|101996474|FG000|STARTED|Overall Study||464||
48678342|NCT04411849|101996475|FG001|STARTED|Overall Study||338||
48678343|NCT04411849|101996474|FG000|COMPLETED|Overall Study||464||
48678344|NCT04411849|101996475|FG001|COMPLETED|Overall Study||338||
48678345|NCT04411849|101996474|FG000|NOT COMPLETED|Overall Study||0||
48678346|NCT04411849|101996475|FG001|NOT COMPLETED|Overall Study||0||
48678347|NCT01147302|101996476|FG000|STARTED|Overall Study||9||
48678348|NCT01147302|101996477|FG001|STARTED|Overall Study||9||
48678349|NCT01147302|101996476|FG000|COMPLETED|Overall Study||9||
48678350|NCT01147302|101996477|FG001|COMPLETED|Overall Study||9||
48678351|NCT01147302|101996476|FG000|NOT COMPLETED|Overall Study||0||
48678352|NCT01147302|101996477|FG001|NOT COMPLETED|Overall Study||0||
48678353|NCT03375320|101996478|FG000|STARTED|Overall Study||134||
48678354|NCT03375320|101996479|FG001|STARTED|Overall Study||69||
48678355|NCT03375320|101996480|FG002|STARTED|Overall Study||64||
48678356|NCT03375320|101996481|FG003|STARTED|Overall Study||31||
48678357|NCT03375320|101996478|FG000|Initiated Treatment|Overall Study||132||
48678358|NCT03375320|101996479|FG001|Initiated Treatment|Overall Study||67||
48678359|NCT03375320|101996480|FG002|Initiated Treatment|Overall Study||63||
48678360|NCT03375320|101996481|FG003|Initiated Treatment|Overall Study||31||
48678361|NCT03375320|101996478|FG000|COMPLETED|Overall Study||21||
48678362|NCT03375320|101996479|FG001|COMPLETED|Overall Study||7||
48240625|NCT02163499|100909072|FG000|COMPLETED|Extended Dosing Phase: ZS||466||
48240626|NCT02163499|100909072|FG000|NOT COMPLETED|Extended Dosing Phase: ZS||280||
48240627|NCT00170950|100909073|FG000|STARTED|Overall Study||5744||
48240628|NCT00170950|100909074|FG001|STARTED|Overall Study||5762||
48240629|NCT00170950|100909073|FG000|COMPLETED|Overall Study||4859||
48240630|NCT00170950|100909074|FG001|COMPLETED|Overall Study||4852||
48240631|NCT00170950|100909073|FG000|NOT COMPLETED|Overall Study||885||
48240632|NCT00170950|100909074|FG001|NOT COMPLETED|Overall Study||910||
48240633|NCT04736602|100909075|FG000|STARTED|Main Study Phase||32||
48240634|NCT04736602|100909075|FG000|COMPLETED|Main Study Phase||30||
48240635|NCT04736602|100909075|FG000|NOT COMPLETED|Main Study Phase||2||
48240636|NCT04736602|100909075|FG000|STARTED|Extension Phase||30||
48240637|NCT04736602|100909075|FG000|COMPLETED|Extension Phase||29||
48240638|NCT04736602|100909075|FG000|NOT COMPLETED|Extension Phase||1||
48240639|NCT04332991|100909076|FG000|STARTED|Overall Study||242||
48240640|NCT04332991|100909077|FG001|STARTED|Overall Study||237||
48240641|NCT04332991|100909076|FG000|COMPLETED|Overall Study||242||
48240642|NCT04332991|100909077|FG001|COMPLETED|Overall Study||237||
48678363|NCT03375320|101996480|FG002|COMPLETED|Overall Study||14||
48678364|NCT03375320|101996481|FG003|COMPLETED|Overall Study||2||
48678365|NCT03375320|101996478|FG000|NOT COMPLETED|Overall Study||113||
48678366|NCT03375320|101996479|FG001|NOT COMPLETED|Overall Study||62||
48678367|NCT03375320|101996480|FG002|NOT COMPLETED|Overall Study||50||
48678368|NCT03375320|101996481|FG003|NOT COMPLETED|Overall Study||29||
48678369|NCT00105534|101996482|FG000|STARTED|Overall Study||335||
48678370|NCT00105534|101996483|FG001|STARTED|Overall Study||350||
48678371|NCT00105534|101996482|FG000|COMPLETED|Overall Study||313||
48678372|NCT00105534|101996483|FG001|COMPLETED|Overall Study||317||
48678373|NCT00105534|101996482|FG000|NOT COMPLETED|Overall Study||22||
48240643|NCT04332991|100909076|FG000|NOT COMPLETED|Overall Study||0||
48240644|NCT04332991|100909077|FG001|NOT COMPLETED|Overall Study||0||
48240645|NCT05489770|100909078|FG000|STARTED|Overall Study||102||
48240646|NCT05489770|100909079|FG001|STARTED|Overall Study||102||
48240647|NCT05489770|100909078|FG000|COMPLETED|Overall Study||93||
48240648|NCT05489770|100909079|FG001|COMPLETED|Overall Study||90||
48240649|NCT05489770|100909078|FG000|NOT COMPLETED|Overall Study||9||
48240650|NCT05489770|100909079|FG001|NOT COMPLETED|Overall Study||12||
48240651|NCT00447499|100909080|FG000|STARTED|Overall Study||59||
48240652|NCT00447499|100909080|FG000|COMPLETED|Overall Study||52||
48240653|NCT00447499|100909080|FG000|NOT COMPLETED|Overall Study||7||
48240654|NCT05129592|100909081|FG000|STARTED|Overall Study||42||
48678374|NCT00105534|101996483|FG001|NOT COMPLETED|Overall Study||33||
48678375|NCT04459416|101996484|FG000|STARTED|Overall Study||151||
48678376|NCT04459416|101996485|FG001|STARTED|Overall Study||147||
48678377|NCT04459416|101996484|FG000|COMPLETED|Overall Study||141||
48678378|NCT04459416|101996485|FG001|COMPLETED|Overall Study||134||
48678379|NCT04459416|101996484|FG000|NOT COMPLETED|Overall Study||10||
48678380|NCT04459416|101996485|FG001|NOT COMPLETED|Overall Study||13||
48678381|NCT02343302|101996486|FG000|STARTED|Overall Study||1||
48678382|NCT02343302|101996487|FG001|STARTED|Overall Study||1||
48678383|NCT02343302|101996486|FG000|COMPLETED|Overall Study||0||
48678384|NCT02343302|101996487|FG001|COMPLETED|Overall Study||0||
48678385|NCT02343302|101996486|FG000|NOT COMPLETED|Overall Study||1||
48678386|NCT02343302|101996487|FG001|NOT COMPLETED|Overall Study||1||
48678387|NCT03247829|101996488|FG000|STARTED|Overall Study||53||
48678388|NCT03247829|101996489|FG001|STARTED|Overall Study||48||
48678389|NCT03247829|101996488|FG000|COMPLETED|Overall Study||46||
48678390|NCT03247829|101996489|FG001|COMPLETED|Overall Study||42||
48678391|NCT03247829|101996488|FG000|NOT COMPLETED|Overall Study||7||
48678392|NCT03247829|101996489|FG001|NOT COMPLETED|Overall Study||6||
48678393|NCT02668666|101996490|FG000|STARTED|Overall Study||49||
48678394|NCT02668666|101996490|FG000|COMPLETED|Overall Study||49||
48240655|NCT05129592|100909082|FG001|STARTED|Overall Study||53||
48240656|NCT05129592|100909083|FG002|STARTED|Overall Study||56||
48240657|NCT05129592|100909084|FG003|STARTED|Overall Study||42||
48240658|NCT05129592|100909081|FG000|COMPLETED|Overall Study||42||
48240659|NCT05129592|100909082|FG001|COMPLETED|Overall Study||53||
48240660|NCT05129592|100909083|FG002|COMPLETED|Overall Study||56||
48240661|NCT05129592|100909084|FG003|COMPLETED|Overall Study||42||
48678395|NCT02668666|101996490|FG000|NOT COMPLETED|Overall Study||0||
48678396|NCT04281784|101996491|FG000|STARTED|Overall Study||1255||
48678397|NCT04281784|101996492|FG001|STARTED|Overall Study||1257||
48240662|NCT05129592|100909081|FG000|NOT COMPLETED|Overall Study||0||
48240663|NCT05129592|100909082|FG001|NOT COMPLETED|Overall Study||0||
48240664|NCT05129592|100909083|FG002|NOT COMPLETED|Overall Study||0||
48240665|NCT05129592|100909084|FG003|NOT COMPLETED|Overall Study||0||
48240666|NCT04908800|100909085|FG000|STARTED|Overall Study||12||
48240667|NCT04908800|100909086|FG001|STARTED|Overall Study||5||
48240668|NCT04908800|100909087|FG002|STARTED|Overall Study||6||
48240669|NCT04908800|100909088|FG003|STARTED|Overall Study||6||
48240670|NCT04908800|100909089|FG004|STARTED|Overall Study||6||
48240671|NCT04908800|100909090|FG005|STARTED|Overall Study||6||
48240672|NCT04908800|100909091|FG006|STARTED|Overall Study||6||
48240673|NCT04908800|100909092|FG007|STARTED|Overall Study||8||
48240674|NCT04908800|100909093|FG008|STARTED|Overall Study||8||
48240675|NCT04908800|100909094|FG009|STARTED|Overall Study||8||
48240676|NCT04908800|100909095|FG010|STARTED|Overall Study||8||
48240677|NCT04908800|100909096|FG011|STARTED|Overall Study||8||
48240678|NCT04908800|100909097|FG012|STARTED|Overall Study||12||
48240679|NCT04908800|100909085|FG000|COMPLETED|Overall Study||12||
48240680|NCT04908800|100909086|FG001|COMPLETED|Overall Study||5||
48240681|NCT04908800|100909087|FG002|COMPLETED|Overall Study||6||
48240682|NCT04908800|100909088|FG003|COMPLETED|Overall Study||6||
48240683|NCT04908800|100909089|FG004|COMPLETED|Overall Study||6||
48240684|NCT04908800|100909090|FG005|COMPLETED|Overall Study||6||
48240685|NCT04908800|100909091|FG006|COMPLETED|Overall Study||6||
48240686|NCT04908800|100909092|FG007|COMPLETED|Overall Study||8||
48240687|NCT04908800|100909093|FG008|COMPLETED|Overall Study||8||
48240688|NCT04908800|100909094|FG009|COMPLETED|Overall Study||8||
48240689|NCT04908800|100909095|FG010|COMPLETED|Overall Study||7||
48240690|NCT04908800|100909096|FG011|COMPLETED|Overall Study||8||
48240691|NCT04908800|100909097|FG012|COMPLETED|Overall Study||12||
48240692|NCT04908800|100909085|FG000|NOT COMPLETED|Overall Study||0||
48240693|NCT04908800|100909086|FG001|NOT COMPLETED|Overall Study||0||
48240694|NCT04908800|100909087|FG002|NOT COMPLETED|Overall Study||0||
48240695|NCT04908800|100909088|FG003|NOT COMPLETED|Overall Study||0||
48678398|NCT04281784|101996491|FG000|COMPLETED|Overall Study||1255||
48678399|NCT04281784|101996492|FG001|COMPLETED|Overall Study||1257||
48678400|NCT04281784|101996491|FG000|NOT COMPLETED|Overall Study||0||
48678401|NCT04281784|101996492|FG001|NOT COMPLETED|Overall Study||0||
48678402|NCT02610634|101996493|FG000|STARTED|Overall Study||60||
48678403|NCT02610634|101996494|FG001|STARTED|Overall Study||40||
48240696|NCT04908800|100909089|FG004|NOT COMPLETED|Overall Study||0||
48678404|NCT02610634|101996493|FG000|COMPLETED|Overall Study||60||
48678405|NCT02610634|101996494|FG001|COMPLETED|Overall Study||40||
48678406|NCT02610634|101996493|FG000|NOT COMPLETED|Overall Study||0||
48678407|NCT02610634|101996494|FG001|NOT COMPLETED|Overall Study||0||
48678408|NCT01541371|101996495|FG000|STARTED|Overall Study||403||
48678409|NCT01541371|101996495|FG000|Full Analysis Set|Overall Study||394||
48678410|NCT01541371|101996495|FG000|COMPLETED|Overall Study||326||
48678411|NCT01541371|101996495|FG000|NOT COMPLETED|Overall Study||77||
48678412|NCT01847755|101996496|FG000|STARTED|Overall Study||18||
48678413|NCT01847755|101996496|FG000|COMPLETED|Overall Study||13||
48678414|NCT01847755|101996496|FG000|NOT COMPLETED|Overall Study||5||
48678415|NCT03217266|101996497|FG000|STARTED|Total Enrollment to Step 1||27||
48678416|NCT03217266|101996498|FG001|STARTED|Total Enrollment to Step 1||12||
48678417|NCT03217266|101996499|FG002|STARTED|Total Enrollment to Step 1||0||
48678418|NCT03217266|101996500|FG003|STARTED|Total Enrollment to Step 1||0||
48678419|NCT03217266|101996497|FG000|COMPLETED|Total Enrollment to Step 1||27||
48678420|NCT03217266|101996498|FG001|COMPLETED|Total Enrollment to Step 1||12||
48678421|NCT03217266|101996499|FG002|COMPLETED|Total Enrollment to Step 1||0||
48678422|NCT03217266|101996500|FG003|COMPLETED|Total Enrollment to Step 1||0||
48678423|NCT03217266|101996497|FG000|NOT COMPLETED|Total Enrollment to Step 1||0||
48678424|NCT03217266|101996498|FG001|NOT COMPLETED|Total Enrollment to Step 1||0||
48678425|NCT03217266|101996499|FG002|NOT COMPLETED|Total Enrollment to Step 1||0||
48678426|NCT03217266|101996500|FG003|NOT COMPLETED|Total Enrollment to Step 1||0||
48678427|NCT03217266|101996497|FG000|STARTED|Step 1: Dose Level 1||4||
48678428|NCT03217266|101996498|FG001|STARTED|Step 1: Dose Level 1||5||
48678429|NCT03217266|101996499|FG002|STARTED|Step 1: Dose Level 1||0||
48240697|NCT04908800|100909090|FG005|NOT COMPLETED|Overall Study||0||
48240698|NCT04908800|100909091|FG006|NOT COMPLETED|Overall Study||0||
48240699|NCT04908800|100909092|FG007|NOT COMPLETED|Overall Study||0||
48240700|NCT04908800|100909093|FG008|NOT COMPLETED|Overall Study||0||
48240701|NCT04908800|100909094|FG009|NOT COMPLETED|Overall Study||0||
48240702|NCT04908800|100909095|FG010|NOT COMPLETED|Overall Study||1||
48240703|NCT04908800|100909096|FG011|NOT COMPLETED|Overall Study||0||
48678430|NCT03217266|101996500|FG003|STARTED|Step 1: Dose Level 1||0||
48678431|NCT03217266|101996497|FG000|Eligible|Step 1: Dose Level 1||4||
48678432|NCT03217266|101996498|FG001|Eligible|Step 1: Dose Level 1||5||
48240704|NCT04908800|100909097|FG012|NOT COMPLETED|Overall Study||0||
48240705|NCT02511106|100909098|FG000|STARTED|Overall Study||339||
48678433|NCT03217266|101996499|FG002|Eligible|Step 1: Dose Level 1||0||
48678434|NCT03217266|101996500|FG003|Eligible|Step 1: Dose Level 1||0||
48678435|NCT03217266|101996497|FG000|Started Treatment|Step 1: Dose Level 1||3||
48678436|NCT03217266|101996498|FG001|Started Treatment|Step 1: Dose Level 1||5||
48678437|NCT03217266|101996499|FG002|Started Treatment|Step 1: Dose Level 1||0||
48240706|NCT02511106|100909099|FG001|STARTED|Overall Study||343||
48240707|NCT02511106|100909098|FG000|Received Treatment|Overall Study||337||
48240708|NCT02511106|100909099|FG001|Received Treatment|Overall Study||343||
48240709|NCT02511106|100909098|FG000|COMPLETED|Overall Study||261|(Study)|
48240710|NCT02511106|100909099|FG001|COMPLETED|Overall Study||234|(Study)|
48240711|NCT02511106|100909098|FG000|NOT COMPLETED|Overall Study||78||
48240712|NCT02511106|100909099|FG001|NOT COMPLETED|Overall Study||109||
48240713|NCT05012462|100909100|FG000|STARTED|Overall Study||46||
48240714|NCT05012462|100909101|FG001|STARTED|Overall Study||31||
48240715|NCT05012462|100909100|FG000|COMPLETED|Overall Study||42||
48081225|NCT03129100|100521621|FG008|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
48081226|NCT03129100|100521622|FG009|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
48678438|NCT03217266|101996500|FG003|Started Treatment|Step 1: Dose Level 1||0||
48678439|NCT03217266|101996497|FG000|Determined to Have Wild-type p53 (Group I)|Step 1: Dose Level 1||3||
48678440|NCT03217266|101996498|FG001|Determined to Have Wild-type p53 (Group I)|Step 1: Dose Level 1||3||
48240716|NCT05012462|100909101|FG001|COMPLETED|Overall Study||28||
48240717|NCT05012462|100909100|FG000|NOT COMPLETED|Overall Study||4||
48240718|NCT05012462|100909101|FG001|NOT COMPLETED|Overall Study||3||
48240719|NCT02038803|100909102|FG000|STARTED|Overall Study||5||
48240720|NCT02038803|100909102|FG000|COMPLETED|Overall Study||0||
48240721|NCT02038803|100909102|FG000|NOT COMPLETED|Overall Study||5||
48240722|NCT02522299|100909103|FG000|STARTED|Overall Study||22||
48240723|NCT02522299|100909104|FG001|STARTED|Overall Study||22||
48240724|NCT02522299|100909103|FG000|COMPLETED|Overall Study||18||
48240725|NCT02522299|100909104|FG001|COMPLETED|Overall Study||21||
48240726|NCT02522299|100909103|FG000|NOT COMPLETED|Overall Study||4||
48240727|NCT02522299|100909104|FG001|NOT COMPLETED|Overall Study||1||
48678441|NCT03217266|101996499|FG002|Determined to Have Wild-type p53 (Group I)|Step 1: Dose Level 1||0||
48678442|NCT03217266|101996500|FG003|Determined to Have Wild-type p53 (Group I)|Step 1: Dose Level 1||0||
48678443|NCT03217266|101996497|FG000|Determined to Have Mutant or Unknown p53 (Group II)|Step 1: Dose Level 1||0||
48678444|NCT03217266|101996498|FG001|Determined to Have Mutant or Unknown p53 (Group II)|Step 1: Dose Level 1||2||
48678445|NCT03217266|101996499|FG002|Determined to Have Mutant or Unknown p53 (Group II)|Step 1: Dose Level 1||0||
48678446|NCT03217266|101996500|FG003|Determined to Have Mutant or Unknown p53 (Group II)|Step 1: Dose Level 1||0||
48678447|NCT03217266|101996497|FG000|COMPLETED|Step 1: Dose Level 1||3|Participants continuing to Step 2|
48678448|NCT03217266|101996498|FG001|COMPLETED|Step 1: Dose Level 1||5|Participants continuing to Step 2|
48678449|NCT03217266|101996499|FG002|COMPLETED|Step 1: Dose Level 1||0|Participants continuing to Step 2|
48678450|NCT03217266|101996500|FG003|COMPLETED|Step 1: Dose Level 1||0|Participants continuing to Step 2|
48678451|NCT03217266|101996497|FG000|NOT COMPLETED|Step 1: Dose Level 1||1||
48678452|NCT03217266|101996498|FG001|NOT COMPLETED|Step 1: Dose Level 1||0||
48240728|NCT01107795|100909105|FG000|STARTED|Overall Study||41||
48240729|NCT01107795|100909105|FG000|COMPLETED|Overall Study||41||
48240730|NCT01107795|100909105|FG000|NOT COMPLETED|Overall Study||0||
48240731|NCT01078571|100909106|FG000|STARTED|Overall Study||705||
48240732|NCT01078571|100909106|FG000|Safety Population|Overall Study||675||
48240733|NCT01078571|100909106|FG000|Intent-to-treat (ITT) Population|Overall Study||591||
48540138|NCT01398514|101658009|FG001|COMPLETED|Overall Study||20||
48540139|NCT01398514|101658008|FG000|NOT COMPLETED|Overall Study||8||
48540140|NCT01398514|101658009|FG001|NOT COMPLETED|Overall Study||6||
48540141|NCT04746794|101658010|FG000|STARTED|Overall Study||63820||6
48540142|NCT04746794|101658011|FG001|STARTED|Overall Study||51664||6
48540143|NCT04746794|101658010|FG000|Patients With a Primary Care Visit|Overall Study||63750||6
48540144|NCT04746794|101658011|FG001|Patients With a Primary Care Visit|Overall Study||51664||6
48540145|NCT04746794|101658010|FG000|Clinic Primary Care Providers and Clinic Leaders|Overall Study||70||6
48540146|NCT04746794|101658011|FG001|Clinic Primary Care Providers and Clinic Leaders|Overall Study||95||6
48540147|NCT04746794|101658010|FG000|Completed Surveys Only (Providers and Clinic Leaders)|Overall Study||46|not part of outcome measures|6
48540148|NCT04746794|101658011|FG001|Completed Surveys Only (Providers and Clinic Leaders)|Overall Study||37|not part of outcome measures|6
48540149|NCT04746794|101658010|FG000|Completed Surveys Only (Patients)|Overall Study||2323|not part of outcome measures|6
48540150|NCT04746794|101658011|FG001|Completed Surveys Only (Patients)|Overall Study||2272|not part of outcome measures|6
48540151|NCT04746794|101658010|FG000|Completed Cancer Risk Screening (Patients)|Overall Study||11148||6
48678453|NCT03217266|101996499|FG002|NOT COMPLETED|Step 1: Dose Level 1||0||
48540152|NCT04746794|101658011|FG001|Completed Cancer Risk Screening (Patients)|Overall Study||4358||6
48540153|NCT04746794|101658010|FG000|TOTAL ENROLLED|Overall Study||13517||6
48540154|NCT04746794|101658011|FG001|TOTAL ENROLLED|Overall Study||6667||6
48540155|NCT04746794|101658010|FG000|Patients With a Primary Care Visit During 12m Study Window|Overall Study||51693|Denominator for Outcome Measures|6
48540156|NCT04746794|101658011|FG001|Patients With a Primary Care Visit During 12m Study Window|Overall Study||43930|Denominator for Outcome Measures|6
48540157|NCT04746794|101658010|FG000|Health System A - Patients in 12m Study Window|Overall Study||29862|Only data from Health System A is used in Outcomes 3-5|3
48540158|NCT04746794|101658011|FG001|Health System A - Patients in 12m Study Window|Overall Study||21457|Only data from Health System A is used in Outcomes 3-5|3
48540159|NCT04746794|101658010|FG000|Completed Cancer Risk Screening During 12m Study Window|Overall Study||9892||6
48540160|NCT04746794|101658011|FG001|Completed Cancer Risk Screening During 12m Study Window|Overall Study||3813||6
48540161|NCT04746794|101658010|FG000|Eligible for Genetic Testing|Overall Study||3070||6
48540162|NCT04746794|101658011|FG001|Eligible for Genetic Testing|Overall Study||1603||6
48540163|NCT04746794|101658010|FG000|Completed Genetic Testing|Overall Study||757||6
48540164|NCT04746794|101658011|FG001|Completed Genetic Testing|Overall Study||717||6
48678454|NCT03217266|101996500|FG003|NOT COMPLETED|Step 1: Dose Level 1||0||
48678455|NCT03217266|101996497|FG000|STARTED|Step 1: Dose Level 2||7||
48678456|NCT03217266|101996498|FG001|STARTED|Step 1: Dose Level 2||7||
48678457|NCT03217266|101996499|FG002|STARTED|Step 1: Dose Level 2||0||
48678458|NCT03217266|101996500|FG003|STARTED|Step 1: Dose Level 2||0||
48678459|NCT03217266|101996497|FG000|Eligible|Step 1: Dose Level 2||7||
48678460|NCT03217266|101996498|FG001|Eligible|Step 1: Dose Level 2||7||
48678461|NCT03217266|101996499|FG002|Eligible|Step 1: Dose Level 2||0||
48678462|NCT03217266|101996500|FG003|Eligible|Step 1: Dose Level 2||0||
48678463|NCT03217266|101996497|FG000|Started Treatment|Step 1: Dose Level 2||6||
48678464|NCT03217266|101996498|FG001|Started Treatment|Step 1: Dose Level 2||5||
48678465|NCT03217266|101996499|FG002|Started Treatment|Step 1: Dose Level 2||0||
48678466|NCT03217266|101996500|FG003|Started Treatment|Step 1: Dose Level 2||0||
48678467|NCT03217266|101996497|FG000|Determined to Have Wild-type p53 (Group I)|Step 1: Dose Level 2||4||
48678468|NCT03217266|101996498|FG001|Determined to Have Wild-type p53 (Group I)|Step 1: Dose Level 2||3||
48678469|NCT03217266|101996499|FG002|Determined to Have Wild-type p53 (Group I)|Step 1: Dose Level 2||0||
48678470|NCT03217266|101996500|FG003|Determined to Have Wild-type p53 (Group I)|Step 1: Dose Level 2||0||
48678471|NCT03217266|101996497|FG000|Determined to Have Mutant or Unknown p53 (Group II)|Step 1: Dose Level 2||2||
48678472|NCT03217266|101996498|FG001|Determined to Have Mutant or Unknown p53 (Group II)|Step 1: Dose Level 2||2||
48678473|NCT03217266|101996499|FG002|Determined to Have Mutant or Unknown p53 (Group II)|Step 1: Dose Level 2||0||
48678474|NCT03217266|101996500|FG003|Determined to Have Mutant or Unknown p53 (Group II)|Step 1: Dose Level 2||0||
48678475|NCT03217266|101996497|FG000|COMPLETED|Step 1: Dose Level 2||6||
48678476|NCT03217266|101996498|FG001|COMPLETED|Step 1: Dose Level 2||5||
48678477|NCT03217266|101996499|FG002|COMPLETED|Step 1: Dose Level 2||0||
48678478|NCT03217266|101996500|FG003|COMPLETED|Step 1: Dose Level 2||0||
48678479|NCT03217266|101996497|FG000|NOT COMPLETED|Step 1: Dose Level 2||1||
48678480|NCT03217266|101996498|FG001|NOT COMPLETED|Step 1: Dose Level 2||2||
48678481|NCT03217266|101996499|FG002|NOT COMPLETED|Step 1: Dose Level 2||0||
48678482|NCT03217266|101996500|FG003|NOT COMPLETED|Step 1: Dose Level 2||0||
48678483|NCT03217266|101996497|FG000|STARTED|Step 1: Dose Level 3||16||
48678484|NCT03217266|101996498|FG001|STARTED|Step 1: Dose Level 3||0||
48678485|NCT03217266|101996499|FG002|STARTED|Step 1: Dose Level 3||0||
48678486|NCT03217266|101996500|FG003|STARTED|Step 1: Dose Level 3||0||
48678487|NCT03217266|101996497|FG000|Eligible|Step 1: Dose Level 3||16||
48678488|NCT03217266|101996498|FG001|Eligible|Step 1: Dose Level 3||0||
48081227|NCT03129100|100521623|FG010|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
48678489|NCT03217266|101996499|FG002|Eligible|Step 1: Dose Level 3||0||
48678490|NCT03217266|101996500|FG003|Eligible|Step 1: Dose Level 3||0||
48678491|NCT03217266|101996497|FG000|Started Treatment|Step 1: Dose Level 3||15||
48678492|NCT03217266|101996498|FG001|Started Treatment|Step 1: Dose Level 3||0||
48678493|NCT03217266|101996499|FG002|Started Treatment|Step 1: Dose Level 3||0||
48678494|NCT03217266|101996500|FG003|Started Treatment|Step 1: Dose Level 3||0||
48678495|NCT03217266|101996497|FG000|Determined to Have Wild-type p53 (Group I)|Step 1: Dose Level 3||9||
48678496|NCT03217266|101996498|FG001|Determined to Have Wild-type p53 (Group I)|Step 1: Dose Level 3||0||
48678497|NCT03217266|101996499|FG002|Determined to Have Wild-type p53 (Group I)|Step 1: Dose Level 3||0||
48678498|NCT03217266|101996500|FG003|Determined to Have Wild-type p53 (Group I)|Step 1: Dose Level 3||0||
48678499|NCT03217266|101996497|FG000|Determined to Have Mutant or Unknown p53 (Group II)|Step 1: Dose Level 3||6||
48678500|NCT03217266|101996498|FG001|Determined to Have Mutant or Unknown p53 (Group II)|Step 1: Dose Level 3||0||
48678501|NCT03217266|101996499|FG002|Determined to Have Mutant or Unknown p53 (Group II)|Step 1: Dose Level 3||0||
48678502|NCT03217266|101996500|FG003|Determined to Have Mutant or Unknown p53 (Group II)|Step 1: Dose Level 3||0||
48678503|NCT03217266|101996497|FG000|COMPLETED|Step 1: Dose Level 3||15||
48678504|NCT03217266|101996498|FG001|COMPLETED|Step 1: Dose Level 3||0||
48678505|NCT03217266|101996499|FG002|COMPLETED|Step 1: Dose Level 3||0||
48678506|NCT03217266|101996500|FG003|COMPLETED|Step 1: Dose Level 3||0||
48678507|NCT03217266|101996497|FG000|NOT COMPLETED|Step 1: Dose Level 3||1||
48678508|NCT03217266|101996498|FG001|NOT COMPLETED|Step 1: Dose Level 3||0||
48678509|NCT03217266|101996499|FG002|NOT COMPLETED|Step 1: Dose Level 3||0||
48678510|NCT03217266|101996500|FG003|NOT COMPLETED|Step 1: Dose Level 3||0||
48678511|NCT03217266|101996497|FG000|STARTED|Step 2||0||
48678512|NCT03217266|101996498|FG001|STARTED|Step 2||0||
48678513|NCT03217266|101996499|FG002|STARTED|Step 2||22||
48678514|NCT03217266|101996500|FG003|STARTED|Step 2||12||
48678515|NCT03217266|101996497|FG000|AE Reporting|Step 2||0||
48678516|NCT03217266|101996498|FG001|AE Reporting|Step 2||0||
48678517|NCT03217266|101996499|FG002|AE Reporting|Step 2||22||
48678518|NCT03217266|101996500|FG003|AE Reporting|Step 2||12||
48678519|NCT03217266|101996497|FG000|Protocol Endpoint Reporting|Step 2||0|Only Group I participants are included in study endpoint analysis per design|
48678520|NCT03217266|101996498|FG001|Protocol Endpoint Reporting|Step 2||0|Only Group I participants are included in study endpoint analysis per design|
48678521|NCT03217266|101996499|FG002|Protocol Endpoint Reporting|Step 2||22|Only Group I participants are included in study endpoint analysis per design|
48678522|NCT03217266|101996500|FG003|Protocol Endpoint Reporting|Step 2||0|Only Group I participants are included in study endpoint analysis per design|
48678523|NCT03217266|101996497|FG000|COMPLETED|Step 2||0|Participants contributing data to study endpoint results or AE reporting are considered to have completed the study.|
48678524|NCT03217266|101996498|FG001|COMPLETED|Step 2||0|Participants contributing data to study endpoint results or AE reporting are considered to have completed the study.|
48678525|NCT03217266|101996499|FG002|COMPLETED|Step 2||22|Participants contributing data to study endpoint results or AE reporting are considered to have completed the study.|
48678526|NCT03217266|101996500|FG003|COMPLETED|Step 2||12|Participants contributing data to study endpoint results or AE reporting are considered to have completed the study.|
48678527|NCT03217266|101996497|FG000|NOT COMPLETED|Step 2||0||
48678528|NCT03217266|101996498|FG001|NOT COMPLETED|Step 2||0||
48678529|NCT03217266|101996499|FG002|NOT COMPLETED|Step 2||0||
48678530|NCT03217266|101996500|FG003|NOT COMPLETED|Step 2||0||
48678531|NCT02286726|101996501|FG000|STARTED|Overall Study||16||
48678532|NCT02286726|101996502|FG001|STARTED|Overall Study||24||
48678533|NCT02286726|101996503|FG002|STARTED|Overall Study||16||
48678534|NCT02286726|101996501|FG000|COMPLETED|Overall Study||16||
48678535|NCT02286726|101996502|FG001|COMPLETED|Overall Study||24||
48678536|NCT02286726|101996503|FG002|COMPLETED|Overall Study||16||
48678537|NCT02286726|101996501|FG000|NOT COMPLETED|Overall Study||0||
48678538|NCT02286726|101996502|FG001|NOT COMPLETED|Overall Study||0||
48678539|NCT02286726|101996503|FG002|NOT COMPLETED|Overall Study||0||
48678540|NCT05588440|101996504|FG000|STARTED|Overall Study||3||
48678541|NCT05588440|101996505|FG001|STARTED|Overall Study||2||
48678542|NCT05588440|101996506|FG002|STARTED|Overall Study||4||
48678543|NCT05588440|101996504|FG000|Received ONCT-808 One-time Infusion|Overall Study||3||
48678544|NCT05588440|101996505|FG001|Received ONCT-808 One-time Infusion|Overall Study||1||
48678545|NCT05588440|101996506|FG002|Received ONCT-808 One-time Infusion|Overall Study||2||
48678546|NCT05588440|101996504|FG000|COMPLETED|Overall Study||0||
48678547|NCT05588440|101996505|FG001|COMPLETED|Overall Study||0||
48678548|NCT05588440|101996506|FG002|COMPLETED|Overall Study||0||
48678549|NCT05588440|101996504|FG000|NOT COMPLETED|Overall Study||3||
48678550|NCT05588440|101996505|FG001|NOT COMPLETED|Overall Study||2||
48678551|NCT05588440|101996506|FG002|NOT COMPLETED|Overall Study||4||
48678552|NCT02652221|101996507|FG000|STARTED|Overall Study||55||
48081228|NCT03129100|100521624|FG011|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
48081229|NCT03129100|100521625|FG012|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
48678553|NCT02652221|101996507|FG000|COMPLETED|Overall Study||55||
48678554|NCT02652221|101996507|FG000|NOT COMPLETED|Overall Study||0||
48678555|NCT03430349|101996508|FG000|STARTED|Overall Study||15||
48678556|NCT03430349|101996509|FG001|STARTED|Overall Study||15||
48678557|NCT03430349|101996508|FG000|Received nOPV Vaccination|Overall Study||15||
48678558|NCT03430349|101996509|FG001|Received nOPV Vaccination|Overall Study||15||
48678559|NCT03430349|101996508|FG000|COMPLETED|Overall Study||15||
48678560|NCT03430349|101996509|FG001|COMPLETED|Overall Study||15||
48678561|NCT03430349|101996508|FG000|NOT COMPLETED|Overall Study||0||
48678562|NCT03430349|101996509|FG001|NOT COMPLETED|Overall Study||0||
48678563|NCT04716894|101996510|FG000|STARTED|Period 1: BI 474121 Alone (Reference)||14||
48678564|NCT04716894|101996510|FG000|COMPLETED|Period 1: BI 474121 Alone (Reference)||14||
48678565|NCT04716894|101996510|FG000|NOT COMPLETED|Period 1: BI 474121 Alone (Reference)||0||
48678566|NCT04716894|101996510|FG000|STARTED|Period 2: Itraconazole Alone||14||
48678567|NCT04716894|101996510|FG000|Treated|Period 2: Itraconazole Alone||13||
48678568|NCT04716894|101996510|FG000|COMPLETED|Period 2: Itraconazole Alone||12|Completed planned treatment|
48678569|NCT04716894|101996510|FG000|NOT COMPLETED|Period 2: Itraconazole Alone||2||
48678570|NCT04716894|101996510|FG000|STARTED|Period 2: Itraconazole+BI 474121 (Test)||12||
48678571|NCT04716894|101996510|FG000|COMPLETED|Period 2: Itraconazole+BI 474121 (Test)||12||
48678572|NCT04716894|101996510|FG000|NOT COMPLETED|Period 2: Itraconazole+BI 474121 (Test)||0||
48678573|NCT00590967|101996511|FG000|STARTED|Overall Study||44||
48678574|NCT00590967|101996512|FG001|STARTED|Overall Study||25||
48678575|NCT00590967|101996511|FG000|COMPLETED|Overall Study||41||
48678576|NCT00590967|101996512|FG001|COMPLETED|Overall Study||20||
48678577|NCT00590967|101996511|FG000|NOT COMPLETED|Overall Study||3||
48678578|NCT00590967|101996512|FG001|NOT COMPLETED|Overall Study||5||
48678579|NCT01276106|101996513|FG000|STARTED|Overall Study||65||
48678580|NCT01276106|101996514|FG001|STARTED|Overall Study||64||
48678581|NCT01276106|101996515|FG002|STARTED|Overall Study||65||
48678582|NCT01276106|101996516|FG003|STARTED|Overall Study||65||
48240734|NCT01078571|100909106|FG000|COMPLETED|Overall Study||590||
48678583|NCT01276106|101996513|FG000|COMPLETED|Overall Study||53||
48678584|NCT01276106|101996514|FG001|COMPLETED|Overall Study||55||
48678585|NCT01276106|101996515|FG002|COMPLETED|Overall Study||49||
48678586|NCT01276106|101996516|FG003|COMPLETED|Overall Study||52||
48678587|NCT01276106|101996513|FG000|NOT COMPLETED|Overall Study||12||
48678588|NCT01276106|101996514|FG001|NOT COMPLETED|Overall Study||9||
48678589|NCT01276106|101996515|FG002|NOT COMPLETED|Overall Study||16||
48678590|NCT01276106|101996516|FG003|NOT COMPLETED|Overall Study||13||
48678591|NCT01383005|101996517|FG000|STARTED|Overall Study||34||
48678592|NCT01383005|101996518|FG001|STARTED|Overall Study||60||
48678593|NCT01383005|101996517|FG000|COMPLETED|Overall Study||34||
48678594|NCT01383005|101996518|FG001|COMPLETED|Overall Study||60||
48240735|NCT01078571|100909106|FG000|NOT COMPLETED|Overall Study||115||
48678595|NCT01383005|101996517|FG000|NOT COMPLETED|Overall Study||0||
48678596|NCT01383005|101996518|FG001|NOT COMPLETED|Overall Study||0||
48678597|NCT04207320|101996519|FG000|STARTED|Overall Study||3||
48678598|NCT04207320|101996520|FG001|STARTED|Overall Study||0||
48678599|NCT04207320|101996519|FG000|COMPLETED|Overall Study||0||
48678600|NCT04207320|101996520|FG001|COMPLETED|Overall Study||0||
48678601|NCT04207320|101996519|FG000|NOT COMPLETED|Overall Study||3||
48678602|NCT04207320|101996520|FG001|NOT COMPLETED|Overall Study||0||
48678603|NCT03698019|101996521|FG000|STARTED|Step 1: Registration||159||
48678604|NCT03698019|101996522|FG001|STARTED|Step 1: Registration||154||
48678605|NCT03698019|101996521|FG000|COMPLETED|Step 1: Registration||151||
48678606|NCT03698019|101996522|FG001|COMPLETED|Step 1: Registration||127||
48678607|NCT03698019|101996521|FG000|NOT COMPLETED|Step 1: Registration||8||
48678608|NCT03698019|101996522|FG001|NOT COMPLETED|Step 1: Registration||27||
48678609|NCT03698019|101996521|FG000|STARTED|Step 2: Surgery||151||
48678610|NCT03698019|101996522|FG001|STARTED|Step 2: Surgery||127||
48678611|NCT03698019|101996521|FG000|COMPLETED|Step 2: Surgery||130||
48678612|NCT03698019|101996522|FG001|COMPLETED|Step 2: Surgery||109||
48678613|NCT03698019|101996521|FG000|NOT COMPLETED|Step 2: Surgery||21||
48678614|NCT03698019|101996522|FG001|NOT COMPLETED|Step 2: Surgery||18||
48678615|NCT03698019|101996521|FG000|STARTED|Step 3: Adjuvant Pembrolizumab||130||
48678616|NCT03698019|101996522|FG001|STARTED|Step 3: Adjuvant Pembrolizumab||109||
48678617|NCT03698019|101996521|FG000|COMPLETED|Step 3: Adjuvant Pembrolizumab||38||
48678618|NCT03698019|101996522|FG001|COMPLETED|Step 3: Adjuvant Pembrolizumab||50||
48678619|NCT03698019|101996521|FG000|NOT COMPLETED|Step 3: Adjuvant Pembrolizumab||92||
48678620|NCT03698019|101996522|FG001|NOT COMPLETED|Step 3: Adjuvant Pembrolizumab||59||
48678621|NCT00405288|101996523|FG000|STARTED|Overall Study||204||
48678622|NCT00405288|101996524|FG001|STARTED|Overall Study||204||
48678623|NCT00405288|101996523|FG000|COMPLETED|Overall Study||204||
48678624|NCT00405288|101996524|FG001|COMPLETED|Overall Study||204||
48678625|NCT00405288|101996523|FG000|NOT COMPLETED|Overall Study||0||
48678626|NCT00405288|101996524|FG001|NOT COMPLETED|Overall Study||0||
48678627|NCT02478489|101996525|FG000|STARTED|Overall Study||123||
48678628|NCT02478489|101996526|FG001|STARTED|Overall Study||125||
48678629|NCT02478489|101996525|FG000|COMPLETED|Overall Study||108||
48678630|NCT02478489|101996526|FG001|COMPLETED|Overall Study||109||
48678631|NCT02478489|101996525|FG000|NOT COMPLETED|Overall Study||15||
48678632|NCT02478489|101996526|FG001|NOT COMPLETED|Overall Study||16||
48240736|NCT01648699|100909107|FG000|STARTED|Overall Study||20||
48240737|NCT01648699|100909107|FG000|COMPLETED|Overall Study||15||
48678633|NCT02122380|101996527|FG000|STARTED|First Intervention (30 Days)||11||
48678634|NCT02122380|101996528|FG001|STARTED|First Intervention (30 Days)||12||
48678635|NCT02122380|101996527|FG000|COMPLETED|First Intervention (30 Days)||10||
48678636|NCT02122380|101996528|FG001|COMPLETED|First Intervention (30 Days)||11||
48678637|NCT02122380|101996527|FG000|NOT COMPLETED|First Intervention (30 Days)||1||
48678638|NCT02122380|101996528|FG001|NOT COMPLETED|First Intervention (30 Days)||1||
48678639|NCT02122380|101996527|FG000|STARTED|Washout (8 Weeks)||10||
48678640|NCT02122380|101996528|FG001|STARTED|Washout (8 Weeks)||11||
48678641|NCT02122380|101996527|FG000|COMPLETED|Washout (8 Weeks)||9||
48678642|NCT02122380|101996528|FG001|COMPLETED|Washout (8 Weeks)||9||
48678643|NCT02122380|101996527|FG000|NOT COMPLETED|Washout (8 Weeks)||1||
48678644|NCT02122380|101996528|FG001|NOT COMPLETED|Washout (8 Weeks)||2||
48678645|NCT02122380|101996527|FG000|STARTED|Second Intervention (30 Days)||9||
48678646|NCT02122380|101996528|FG001|STARTED|Second Intervention (30 Days)||9||
48678647|NCT02122380|101996527|FG000|COMPLETED|Second Intervention (30 Days)||9||
48678648|NCT02122380|101996528|FG001|COMPLETED|Second Intervention (30 Days)||7||
48678649|NCT02122380|101996527|FG000|NOT COMPLETED|Second Intervention (30 Days)||0||
48678650|NCT02122380|101996528|FG001|NOT COMPLETED|Second Intervention (30 Days)||2||
48678651|NCT00437398|101996529|FG000|STARTED|Overall Study||2||
48678652|NCT00437398|101996529|FG000|COMPLETED|Overall Study||2||
48678653|NCT00437398|101996529|FG000|NOT COMPLETED|Overall Study||0||
48678654|NCT00399035|101996530|FG000|STARTED|Overall Study||502||
48678655|NCT00399035|101996531|FG001|STARTED|Overall Study||216||
48678656|NCT00399035|101996532|FG002|STARTED|Overall Study||358||
48678657|NCT00399035|101996530|FG000|COMPLETED|Overall Study||189||
48678658|NCT00399035|101996531|FG001|COMPLETED|Overall Study||58||
48678659|NCT00399035|101996532|FG002|COMPLETED|Overall Study||106||
48678660|NCT00399035|101996530|FG000|NOT COMPLETED|Overall Study||313||
48240738|NCT01648699|100909107|FG000|NOT COMPLETED|Overall Study||5||
48240739|NCT04387201|100909108|FG000|STARTED|First Intervention (6 Weeks)||17||
48240740|NCT04387201|100909109|FG001|STARTED|First Intervention (6 Weeks)||6||
48678661|NCT00399035|101996531|FG001|NOT COMPLETED|Overall Study||158||
48678662|NCT00399035|101996532|FG002|NOT COMPLETED|Overall Study||252||
48678663|NCT01342926|101996533|FG000|STARTED|Overall Study||46||
48678664|NCT01342926|101996534|FG001|STARTED|Overall Study||46||
48240741|NCT04387201|100909108|FG000|Received Intervention|First Intervention (6 Weeks)||16||
48240742|NCT04387201|100909109|FG001|Received Intervention|First Intervention (6 Weeks)||6||
48240743|NCT04387201|100909108|FG000|COMPLETED|First Intervention (6 Weeks)||12||
48240744|NCT04387201|100909109|FG001|COMPLETED|First Intervention (6 Weeks)||6||
48240745|NCT04387201|100909108|FG000|NOT COMPLETED|First Intervention (6 Weeks)||5||
48678665|NCT01342926|101996535|FG002|STARTED|Overall Study||48||
48678666|NCT01342926|101996536|FG003|STARTED|Overall Study||51||
48678667|NCT01342926|101996533|FG000|COMPLETED|Overall Study||37||
48678668|NCT01342926|101996534|FG001|COMPLETED|Overall Study||31||
48678669|NCT01342926|101996535|FG002|COMPLETED|Overall Study||34||
48240746|NCT04387201|100909109|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0||
48240747|NCT04387201|100909108|FG000|STARTED|Washout (3 Weeks)||12||
48240748|NCT04387201|100909109|FG001|STARTED|Washout (3 Weeks)||6||
48240749|NCT04387201|100909108|FG000|COMPLETED|Washout (3 Weeks)||12||
48240750|NCT04387201|100909109|FG001|COMPLETED|Washout (3 Weeks)||6||
48240751|NCT04387201|100909108|FG000|NOT COMPLETED|Washout (3 Weeks)||0||
48240752|NCT04387201|100909109|FG001|NOT COMPLETED|Washout (3 Weeks)||0||
48240753|NCT04387201|100909108|FG000|STARTED|Second Intervention (6 Weeks)||12||
48240754|NCT04387201|100909109|FG001|STARTED|Second Intervention (6 Weeks)||6||
48240755|NCT04387201|100909108|FG000|Received Intervention|Second Intervention (6 Weeks)||12||
48240756|NCT04387201|100909109|FG001|Received Intervention|Second Intervention (6 Weeks)||6||
48240757|NCT04387201|100909108|FG000|COMPLETED|Second Intervention (6 Weeks)||11||
48240758|NCT04387201|100909109|FG001|COMPLETED|Second Intervention (6 Weeks)||4||
48240759|NCT04387201|100909108|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||1||
48240760|NCT04387201|100909109|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||2||
48240761|NCT05487300|100909110|FG000|STARTED|Overall Study||20||
48240762|NCT05487300|100909111|FG001|STARTED|Overall Study||20||
48240763|NCT05487300|100909110|FG000|COMPLETED|Overall Study||19||
48240764|NCT05487300|100909111|FG001|COMPLETED|Overall Study||20||
48240765|NCT05487300|100909110|FG000|NOT COMPLETED|Overall Study||1||
48240766|NCT05487300|100909111|FG001|NOT COMPLETED|Overall Study||0||
48240767|NCT00966641|100909112|FG000|STARTED|First Intervention||17||
48240768|NCT00966641|100909113|FG001|STARTED|First Intervention||17||
48240769|NCT00966641|100909112|FG000|COMPLETED|First Intervention||17||
48240770|NCT00966641|100909113|FG001|COMPLETED|First Intervention||17||
48240771|NCT00966641|100909112|FG000|NOT COMPLETED|First Intervention||0||
48240772|NCT00966641|100909113|FG001|NOT COMPLETED|First Intervention||0||
48240773|NCT00966641|100909112|FG000|STARTED|Second Intervention||17||
48240774|NCT00966641|100909113|FG001|STARTED|Second Intervention||17||
48240775|NCT00966641|100909112|FG000|COMPLETED|Second Intervention||17||
48240776|NCT00966641|100909113|FG001|COMPLETED|Second Intervention||17||
48240777|NCT00966641|100909112|FG000|NOT COMPLETED|Second Intervention||0||
48240778|NCT00966641|100909113|FG001|NOT COMPLETED|Second Intervention||0||
48240779|NCT01525875|100909114|FG000|STARTED|Placebo-controlled Period||22||
48240780|NCT01525875|100909115|FG001|STARTED|Placebo-controlled Period||22||
48240781|NCT01525875|100909114|FG000|COMPLETED|Placebo-controlled Period||21||
48240782|NCT01525875|100909115|FG001|COMPLETED|Placebo-controlled Period||20||
48678670|NCT01342926|101996536|FG003|COMPLETED|Overall Study||39||
48678671|NCT01342926|101996533|FG000|NOT COMPLETED|Overall Study||9||
48678672|NCT01342926|101996534|FG001|NOT COMPLETED|Overall Study||15||
48678673|NCT01342926|101996535|FG002|NOT COMPLETED|Overall Study||14||
48678674|NCT01342926|101996536|FG003|NOT COMPLETED|Overall Study||12||
48678675|NCT01100112|101996537|FG000|STARTED|Overall Study||60||
48678676|NCT01100112|101996537|FG000|COMPLETED|Overall Study||52||
48678677|NCT01100112|101996537|FG000|NOT COMPLETED|Overall Study||8||
48678678|NCT01493089|101996538|FG000|STARTED|Overall Study||122||
48678679|NCT01493089|101996539|FG001|STARTED|Overall Study||117||
48678680|NCT01493089|101996538|FG000|COMPLETED|Overall Study||119||
48678681|NCT01493089|101996539|FG001|COMPLETED|Overall Study||114||
48678682|NCT01493089|101996538|FG000|NOT COMPLETED|Overall Study||3||
48678683|NCT01493089|101996539|FG001|NOT COMPLETED|Overall Study||3||
48240783|NCT01525875|100909114|FG000|NOT COMPLETED|Placebo-controlled Period||1||
48240784|NCT01525875|100909115|FG001|NOT COMPLETED|Placebo-controlled Period||2||
48678684|NCT03321071|101996540|FG000|STARTED|Overall Study||60||
48678685|NCT03321071|101996541|FG001|STARTED|Overall Study||60||
48678686|NCT03321071|101996542|FG002|STARTED|Overall Study||60||
48678687|NCT03321071|101996540|FG000|COMPLETED|Overall Study||57||
48678688|NCT03321071|101996541|FG001|COMPLETED|Overall Study||51||
48240785|NCT01525875|100909114|FG000|STARTED|Open-label Period||21||
48240786|NCT01525875|100909115|FG001|STARTED|Open-label Period||20||
48240787|NCT01525875|100909114|FG000|COMPLETED|Open-label Period||21||
48240788|NCT01525875|100909115|FG001|COMPLETED|Open-label Period||18||
48240789|NCT01525875|100909114|FG000|NOT COMPLETED|Open-label Period||0||
48240790|NCT01525875|100909115|FG001|NOT COMPLETED|Open-label Period||2||
48240791|NCT00087516|100911572|FG000|STARTED|Overall Study||238||
48240792|NCT00087516|100911573|FG001|STARTED|Overall Study||250||
48240793|NCT00087516|100911574|FG002|STARTED|Overall Study||130||
48240794|NCT00087516|100911575|FG003|STARTED|Overall Study||123||
48240795|NCT00087516|100911572|FG000|COMPLETED|Overall Study||77||
48240796|NCT00087516|100911573|FG001|COMPLETED|Overall Study||81||
48240797|NCT00087516|100911574|FG002|COMPLETED|Overall Study||33||
48240798|NCT00087516|100911575|FG003|COMPLETED|Overall Study||38||
48240799|NCT00087516|100911572|FG000|NOT COMPLETED|Overall Study||161||
48240800|NCT00087516|100911573|FG001|NOT COMPLETED|Overall Study||169||
48240801|NCT00087516|100911574|FG002|NOT COMPLETED|Overall Study||97||
48240802|NCT00087516|100911575|FG003|NOT COMPLETED|Overall Study||85||
48240803|NCT02588027|100911576|FG000|STARTED|Overall Study||56||
48240804|NCT02588027|100911577|FG001|STARTED|Overall Study||54||
48240805|NCT02588027|100911576|FG000|COMPLETED|Overall Study||51||
48240806|NCT02588027|100911577|FG001|COMPLETED|Overall Study||50||
48240807|NCT02588027|100911576|FG000|NOT COMPLETED|Overall Study||5||
48678689|NCT03321071|101996542|FG002|COMPLETED|Overall Study||55||
48678690|NCT03321071|101996540|FG000|NOT COMPLETED|Overall Study||3||
48678691|NCT03321071|101996541|FG001|NOT COMPLETED|Overall Study||9||
48678692|NCT03321071|101996542|FG002|NOT COMPLETED|Overall Study||5||
48678693|NCT03793621|101996543|FG000|STARTED|Overall Study||6||
48678694|NCT03793621|101996544|FG001|STARTED|Overall Study||6||
48678695|NCT03793621|101996545|FG002|STARTED|Overall Study||6||
48678696|NCT03793621|101996546|FG003|STARTED|Overall Study||6||
48678697|NCT03793621|101996543|FG000|COMPLETED|Overall Study||6||
48678698|NCT03793621|101996544|FG001|COMPLETED|Overall Study||6||
48678699|NCT03793621|101996545|FG002|COMPLETED|Overall Study||6||
48240808|NCT02588027|100911577|FG001|NOT COMPLETED|Overall Study||4||
48240809|NCT01093976|100911578|FG000|STARTED|Overall Study||14||
48240810|NCT01093976|100911578|FG000|COMPLETED|Overall Study||14||
48240811|NCT01093976|100911578|FG000|NOT COMPLETED|Overall Study||0||
48240812|NCT02011568|100911579|FG000|STARTED|Overall Study||193||
48240813|NCT02011568|100911580|FG001|STARTED|Overall Study||196||
48240814|NCT02011568|100911579|FG000|COMPLETED|Overall Study||184||
48240815|NCT02011568|100911580|FG001|COMPLETED|Overall Study||183||
48240816|NCT02011568|100911579|FG000|NOT COMPLETED|Overall Study||9||
48240817|NCT02011568|100911580|FG001|NOT COMPLETED|Overall Study||13||
48240818|NCT01518517|100911581|FG000|STARTED|Overall Study||29||
48240819|NCT01518517|100911582|FG001|STARTED|Overall Study||30||
48240820|NCT01518517|100911583|FG002|STARTED|Overall Study||26||
48240821|NCT01518517|100911581|FG000|COMPLETED|Overall Study||1||
48240822|NCT01518517|100911582|FG001|COMPLETED|Overall Study||3||
48240823|NCT01518517|100911583|FG002|COMPLETED|Overall Study||0||
48240824|NCT01518517|100911581|FG000|NOT COMPLETED|Overall Study||28||
48240825|NCT01518517|100911582|FG001|NOT COMPLETED|Overall Study||27||
48240826|NCT01518517|100911583|FG002|NOT COMPLETED|Overall Study||26||
48240827|NCT02342275|100911584|FG000|STARTED|Overall Study||190||
48240828|NCT02342275|100911585|FG001|STARTED|Overall Study||187||
48240829|NCT02342275|100911584|FG000|COMPLETED|Overall Study||184||
48240830|NCT02342275|100911585|FG001|COMPLETED|Overall Study||182||
48240831|NCT02342275|100911584|FG000|NOT COMPLETED|Overall Study||6||
48240832|NCT02342275|100911585|FG001|NOT COMPLETED|Overall Study||5||
48240833|NCT03590847|100911586|FG000|STARTED|Overall Study||10||
48240834|NCT03590847|100911586|FG000|COMPLETED|Overall Study||9||
48240835|NCT03590847|100911586|FG000|NOT COMPLETED|Overall Study||1||
48240836|NCT03672188|100911587|FG000|STARTED|Overall Study||6||
48240837|NCT03672188|100911588|FG001|STARTED|Overall Study||6||
48240838|NCT03672188|100911589|FG002|STARTED|Overall Study||6||
48240839|NCT03672188|100911590|FG003|STARTED|Overall Study||8||
48240840|NCT03672188|100911591|FG004|STARTED|Overall Study||6||
48240841|NCT03672188|100911592|FG005|STARTED|Overall Study||6||
48240842|NCT03672188|100911593|FG006|STARTED|Overall Study||12||
48240843|NCT03672188|100911594|FG007|STARTED|Overall Study||3||
48240844|NCT03672188|100911595|FG008|STARTED|Overall Study||6||
48678700|NCT03793621|101996546|FG003|COMPLETED|Overall Study||6||
48678701|NCT03793621|101996543|FG000|NOT COMPLETED|Overall Study||0||
48240845|NCT03672188|100911596|FG009|STARTED|Overall Study||6||
48240846|NCT03672188|100911597|FG010|STARTED|Overall Study||3||
48240847|NCT03672188|100911598|FG011|STARTED|Overall Study||3||
48240848|NCT03672188|100911599|FG012|STARTED|Overall Study||3||
48678702|NCT03793621|101996544|FG001|NOT COMPLETED|Overall Study||0||
48678703|NCT03793621|101996545|FG002|NOT COMPLETED|Overall Study||0||
48678704|NCT03793621|101996546|FG003|NOT COMPLETED|Overall Study||0||
48678705|NCT01171677|101996547|FG000|STARTED|Overall Study||17||
48678706|NCT01171677|101996548|FG001|STARTED|Overall Study||15||
48678707|NCT01171677|101996547|FG000|COMPLETED|Overall Study||11||
48678708|NCT01171677|101996548|FG001|COMPLETED|Overall Study||12||
48678709|NCT01171677|101996547|FG000|NOT COMPLETED|Overall Study||6||
48678710|NCT01171677|101996548|FG001|NOT COMPLETED|Overall Study||3||
48678711|NCT04970069|101996549|FG000|STARTED|Overall Study||527||
48678712|NCT04970069|101996550|FG001|STARTED|Overall Study||530||
48678713|NCT04970069|101996549|FG000|COMPLETED|Overall Study||483||
48678714|NCT04970069|101996550|FG001|COMPLETED|Overall Study||474||
48678715|NCT04970069|101996549|FG000|NOT COMPLETED|Overall Study||44||
48240849|NCT03672188|100911600|FG013|STARTED|Overall Study||6||
48240850|NCT03672188|100911601|FG014|STARTED|Overall Study||2||
48240851|NCT03672188|100911587|FG000|Dosed|Overall Study||6||
48240852|NCT03672188|100911588|FG001|Dosed|Overall Study||6||
48240853|NCT03672188|100911589|FG002|Dosed|Overall Study||6||
48240854|NCT03672188|100911590|FG003|Dosed|Overall Study||7||
48240855|NCT03672188|100911591|FG004|Dosed|Overall Study||6||
48240856|NCT03672188|100911592|FG005|Dosed|Overall Study||6||
48240857|NCT03672188|100911593|FG006|Dosed|Overall Study||12||
48678716|NCT04970069|101996550|FG001|NOT COMPLETED|Overall Study||56||
48678717|NCT02742129|101996551|FG000|STARTED|Phase 1||53||
48678718|NCT02742129|101996552|FG001|STARTED|Phase 1||52||
48678719|NCT02742129|101996551|FG000|COMPLETED|Phase 1||51||
48678720|NCT02742129|101996552|FG001|COMPLETED|Phase 1||50||
48678721|NCT02742129|101996551|FG000|NOT COMPLETED|Phase 1||2||
48678722|NCT02742129|101996552|FG001|NOT COMPLETED|Phase 1||2||
48678723|NCT02742129|101996551|FG000|STARTED|Phase 2||51||
48678724|NCT02742129|101996552|FG001|STARTED|Phase 2||50||
48678725|NCT02742129|101996551|FG000|COMPLETED|Phase 2||50||
48678726|NCT02742129|101996552|FG001|COMPLETED|Phase 2||48||
48678727|NCT02742129|101996551|FG000|NOT COMPLETED|Phase 2||1||
48678728|NCT02742129|101996552|FG001|NOT COMPLETED|Phase 2||2||
48678729|NCT03492177|101996553|FG000|STARTED|Overall Study||22||
48678730|NCT03492177|101996554|FG001|STARTED|Overall Study||21||
48678731|NCT03492177|101996555|FG002|STARTED|Overall Study||20||
48678732|NCT03492177|101996553|FG000|COMPLETED|Overall Study||0||
48678733|NCT03492177|101996554|FG001|COMPLETED|Overall Study||0||
48678734|NCT03492177|101996555|FG002|COMPLETED|Overall Study||0||
48678735|NCT03492177|101996553|FG000|NOT COMPLETED|Overall Study||22||
48678736|NCT03492177|101996554|FG001|NOT COMPLETED|Overall Study||21||
48678737|NCT03492177|101996555|FG002|NOT COMPLETED|Overall Study||20||
48678738|NCT00002766|101996556|FG000|STARTED|Overall Study||81||
48678739|NCT00002766|101996557|FG001|STARTED|Overall Study||89||
48678740|NCT00002766|101996556|FG000|COMPLETED|Overall Study||78||
48678741|NCT00002766|101996557|FG001|COMPLETED|Overall Study||85||
48678742|NCT00002766|101996556|FG000|NOT COMPLETED|Overall Study||3||
48678743|NCT00002766|101996557|FG001|NOT COMPLETED|Overall Study||4||
48240858|NCT03672188|100911594|FG007|Dosed|Overall Study||3||
48240859|NCT03672188|100911595|FG008|Dosed|Overall Study||6||
48240860|NCT03672188|100911596|FG009|Dosed|Overall Study||6||
48240861|NCT03672188|100911597|FG010|Dosed|Overall Study||3||
48240862|NCT03672188|100911598|FG011|Dosed|Overall Study||3||
48240863|NCT03672188|100911599|FG012|Dosed|Overall Study||3||
48240864|NCT03672188|100911600|FG013|Dosed|Overall Study||6||
48240865|NCT03672188|100911601|FG014|Dosed|Overall Study||2||
48240866|NCT03672188|100911587|FG000|COMPLETED|Overall Study||6||
48240867|NCT03672188|100911588|FG001|COMPLETED|Overall Study||6||
48240868|NCT03672188|100911589|FG002|COMPLETED|Overall Study||5||
48240869|NCT03672188|100911590|FG003|COMPLETED|Overall Study||5||
48240870|NCT03672188|100911591|FG004|COMPLETED|Overall Study||6||
48240871|NCT03672188|100911592|FG005|COMPLETED|Overall Study||6||
48240872|NCT03672188|100911593|FG006|COMPLETED|Overall Study||12||
48240873|NCT03672188|100911594|FG007|COMPLETED|Overall Study||3||
48240874|NCT03672188|100911595|FG008|COMPLETED|Overall Study||6||
48240875|NCT03672188|100911596|FG009|COMPLETED|Overall Study||6||
48678744|NCT02964377|101996558|FG000|STARTED|Overall Study||5||
48678745|NCT02964377|101996559|FG001|STARTED|Overall Study||5||
48678746|NCT02964377|101996560|FG002|STARTED|Overall Study||5||
48678747|NCT02964377|101996558|FG000|COMPLETED|Overall Study||5||
48678748|NCT02964377|101996559|FG001|COMPLETED|Overall Study||5||
48678749|NCT02964377|101996560|FG002|COMPLETED|Overall Study||5||
48678750|NCT02964377|101996558|FG000|NOT COMPLETED|Overall Study||0||
48678751|NCT02964377|101996559|FG001|NOT COMPLETED|Overall Study||0||
48678752|NCT02964377|101996560|FG002|NOT COMPLETED|Overall Study||0||
48240876|NCT03672188|100911597|FG010|COMPLETED|Overall Study||3||
48240877|NCT03672188|100911598|FG011|COMPLETED|Overall Study||3||
48240878|NCT03672188|100911599|FG012|COMPLETED|Overall Study||2||
48240879|NCT03672188|100911600|FG013|COMPLETED|Overall Study||6||
48678753|NCT00956293|101996561|FG000|STARTED|Main Period (Pre-randomization)||0||
48678754|NCT00956293|101996562|FG001|STARTED|Main Period (Pre-randomization)||0||
48240880|NCT03672188|100911601|FG014|COMPLETED|Overall Study||2||
48240881|NCT03672188|100911587|FG000|NOT COMPLETED|Overall Study||0||
48240882|NCT03672188|100911588|FG001|NOT COMPLETED|Overall Study||0||
48240883|NCT03672188|100911589|FG002|NOT COMPLETED|Overall Study||1||
48240884|NCT03672188|100911590|FG003|NOT COMPLETED|Overall Study||3||
48240885|NCT03672188|100911591|FG004|NOT COMPLETED|Overall Study||0||
48240886|NCT03672188|100911592|FG005|NOT COMPLETED|Overall Study||0||
48240887|NCT03672188|100911593|FG006|NOT COMPLETED|Overall Study||0||
48240888|NCT03672188|100911594|FG007|NOT COMPLETED|Overall Study||0||
48678755|NCT00956293|101996563|FG002|STARTED|Main Period (Pre-randomization)||207||
48678756|NCT00956293|101996561|FG000|Enrolled Safety Set|Main Period (Pre-randomization)||0||
48678757|NCT00956293|101996562|FG001|Enrolled Safety Set|Main Period (Pre-randomization)||0||
48678758|NCT00956293|101996563|FG002|Enrolled Safety Set|Main Period (Pre-randomization)||203||
48678759|NCT00956293|101996561|FG000|COMPLETED|Main Period (Pre-randomization)||0||
48678760|NCT00956293|101996562|FG001|COMPLETED|Main Period (Pre-randomization)||0||
48678761|NCT00956293|101996563|FG002|COMPLETED|Main Period (Pre-randomization)||77||
48678762|NCT00956293|101996561|FG000|NOT COMPLETED|Main Period (Pre-randomization)||0||
48678763|NCT00956293|101996562|FG001|NOT COMPLETED|Main Period (Pre-randomization)||0||
48678764|NCT00956293|101996563|FG002|NOT COMPLETED|Main Period (Pre-randomization)||130||
48678765|NCT00956293|101996561|FG000|STARTED|Main Period (Randomization)||24||
48678766|NCT00956293|101996562|FG001|STARTED|Main Period (Randomization)||53||
48240889|NCT03672188|100911595|FG008|NOT COMPLETED|Overall Study||0||
48240890|NCT03672188|100911596|FG009|NOT COMPLETED|Overall Study||0||
48240891|NCT03672188|100911597|FG010|NOT COMPLETED|Overall Study||0||
48678767|NCT00956293|101996563|FG002|STARTED|Main Period (Randomization)||0||
48678768|NCT00956293|101996561|FG000|Full Analysis Set|Main Period (Randomization)||24||
48678769|NCT00956293|101996562|FG001|Full Analysis Set|Main Period (Randomization)||51||
48678770|NCT00956293|101996563|FG002|Full Analysis Set|Main Period (Randomization)||0||
48240892|NCT03672188|100911598|FG011|NOT COMPLETED|Overall Study||0||
48240893|NCT03672188|100911599|FG012|NOT COMPLETED|Overall Study||1||
48240894|NCT03672188|100911600|FG013|NOT COMPLETED|Overall Study||0||
48240895|NCT03672188|100911601|FG014|NOT COMPLETED|Overall Study||0||
48240896|NCT02432183|100911602|FG000|STARTED|Overall Study||44||
48240897|NCT02432183|100911603|FG001|STARTED|Overall Study||47||
48240898|NCT02432183|100911604|FG002|STARTED|Overall Study||26||
48240899|NCT02432183|100911605|FG003|STARTED|Overall Study||17||
48240900|NCT02432183|100911602|FG000|COMPLETED|Overall Study||44||
48240901|NCT02432183|100911603|FG001|COMPLETED|Overall Study||47||
48240902|NCT02432183|100911604|FG002|COMPLETED|Overall Study||26||
48240903|NCT02432183|100911605|FG003|COMPLETED|Overall Study||17||
48240904|NCT02432183|100911602|FG000|NOT COMPLETED|Overall Study||0||
48240905|NCT02432183|100911603|FG001|NOT COMPLETED|Overall Study||0||
48240906|NCT02432183|100911604|FG002|NOT COMPLETED|Overall Study||0||
48240907|NCT02432183|100911605|FG003|NOT COMPLETED|Overall Study||0||
48240908|NCT00730925|100911606|FG000|STARTED|Overall Study||41||
48240909|NCT00730925|100911606|FG000|COMPLETED|Overall Study||0||
48240910|NCT00730925|100911606|FG000|NOT COMPLETED|Overall Study||41||
48240911|NCT01138098|100911607|FG000|STARTED|Overall Study||95||
48240912|NCT01138098|100911608|FG001|STARTED|Overall Study||90||
48240913|NCT01138098|100911607|FG000|COMPLETED|Overall Study||95||
48240914|NCT01138098|100911608|FG001|COMPLETED|Overall Study||90||
48240915|NCT01138098|100911607|FG000|NOT COMPLETED|Overall Study||0||
48240916|NCT01138098|100911608|FG001|NOT COMPLETED|Overall Study||0||
48240917|NCT02164578|100911609|FG000|STARTED|Treatment Period||89||
48240918|NCT02164578|100911610|FG001|STARTED|Treatment Period||90||
48240919|NCT02164578|100911609|FG000|COMPLETED|Treatment Period||72||
48240920|NCT02164578|100911610|FG001|COMPLETED|Treatment Period||79||
48240921|NCT02164578|100911609|FG000|NOT COMPLETED|Treatment Period||17||
48240922|NCT02164578|100911610|FG001|NOT COMPLETED|Treatment Period||11||
48240923|NCT02164578|100911609|FG000|STARTED|Extension Period||37|According to protocol only 80 patients were planned to participate in the extion period. In total, 73 subjects were included in the extension period.|
48540165|NCT04746794|101658010|FG000|COMPLETED|Overall Study||13517||6
48540166|NCT04746794|101658011|FG001|COMPLETED|Overall Study||6667||6
48540167|NCT04746794|101658010|FG000|NOT COMPLETED|Overall Study||50303||0
48540168|NCT04746794|101658011|FG001|NOT COMPLETED|Overall Study||44997||0
48540169|NCT00338728|101658012|FG000|STARTED|Overall Study||59||
48540170|NCT00338728|101658012|FG000|COMPLETED|Overall Study||45||
48540171|NCT00338728|101658012|FG000|NOT COMPLETED|Overall Study||14||
48540172|NCT04460560|101658013|FG000|STARTED|Overall Study||50||
48540173|NCT04460560|101658013|FG000|COMPLETED|Overall Study||50||
48540174|NCT04460560|101658013|FG000|NOT COMPLETED|Overall Study||0||
48540175|NCT04400682|101658014|FG000|STARTED|Period 1||15||
48540176|NCT04400682|101658015|FG001|STARTED|Period 1||15||
48540177|NCT04400682|101658014|FG000|COMPLETED|Period 1||14||
48540178|NCT04400682|101658015|FG001|COMPLETED|Period 1||11||
48540179|NCT04400682|101658014|FG000|NOT COMPLETED|Period 1||1||
48540180|NCT04400682|101658015|FG001|NOT COMPLETED|Period 1||4||
48540181|NCT04400682|101658014|FG000|STARTED|Period 2||14||
48540182|NCT04400682|101658015|FG001|STARTED|Period 2||11||
48678771|NCT00956293|101996561|FG000|Randomized Safety Set|Main Period (Randomization)||24||
48678772|NCT00956293|101996562|FG001|Randomized Safety Set|Main Period (Randomization)||51||
48678773|NCT00956293|101996563|FG002|Randomized Safety Set|Main Period (Randomization)||0||
48678774|NCT00956293|101996561|FG000|COMPLETED|Main Period (Randomization)||23||
48678775|NCT00956293|101996562|FG001|COMPLETED|Main Period (Randomization)||26||
48678776|NCT00956293|101996563|FG002|COMPLETED|Main Period (Randomization)||0||
48678777|NCT00956293|101996561|FG000|NOT COMPLETED|Main Period (Randomization)||1||
48678778|NCT00956293|101996562|FG001|NOT COMPLETED|Main Period (Randomization)||27||
48240924|NCT02164578|100911610|FG001|STARTED|Extension Period||36|According to protocol only 80 patients were planned to participate in the extion period. In total, 73 subjects were included in the extension period.|
48240925|NCT02164578|100911609|FG000|COMPLETED|Extension Period||30||
48240926|NCT02164578|100911610|FG001|COMPLETED|Extension Period||35||
48240927|NCT02164578|100911609|FG000|NOT COMPLETED|Extension Period||7||
48240928|NCT02164578|100911610|FG001|NOT COMPLETED|Extension Period||1||
48240929|NCT04130061|100911611|FG000|STARTED|Overall Study||13||
48240930|NCT04130061|100911612|FG001|STARTED|Overall Study||14||
48540183|NCT04400682|101658014|FG000|COMPLETED|Period 2||14||
48540184|NCT04400682|101658015|FG001|COMPLETED|Period 2||11||
48540185|NCT04400682|101658014|FG000|NOT COMPLETED|Period 2||0||
48240931|NCT04130061|100911611|FG000|COMPLETED|Overall Study||12||
48240932|NCT04130061|100911612|FG001|COMPLETED|Overall Study||14||
48141208|NCT01260350|100670367|FG005|STARTED|Overall Study||10||
48240933|NCT04130061|100911611|FG000|NOT COMPLETED|Overall Study||1||
48240934|NCT04130061|100911612|FG001|NOT COMPLETED|Overall Study||0||
48240935|NCT03960437|100911613|FG000|STARTED|Overall Study||22||
48240936|NCT03960437|100911613|FG000|COMPLETED|Overall Study||13||
48240937|NCT03960437|100911613|FG000|NOT COMPLETED|Overall Study||9||
48240938|NCT00113334|100911614|FG000|STARTED|Overall Study||6||
48240939|NCT00113334|100911614|FG000|COMPLETED|Overall Study||6||
48240940|NCT00113334|100911614|FG000|NOT COMPLETED|Overall Study||0||
48240941|NCT03647709|100911615|FG000|STARTED|Overall Study||400||
48240942|NCT03647709|100911615|FG000|COMPLETED|Overall Study||386||
48240943|NCT03647709|100911615|FG000|NOT COMPLETED|Overall Study||14||
48240944|NCT01272388|100911616|FG000|STARTED|Overall Study||1||
48240945|NCT01272388|100911617|FG001|STARTED|Overall Study||0||
48240946|NCT01272388|100911616|FG000|COMPLETED|Overall Study||1||
48240947|NCT01272388|100911617|FG001|COMPLETED|Overall Study||0||
48678779|NCT00956293|101996563|FG002|NOT COMPLETED|Main Period (Randomization)||0||
48678780|NCT00956293|101996561|FG000|STARTED|Follow-up Period||20||
48678781|NCT00956293|101996562|FG001|STARTED|Follow-up Period||32||
48678782|NCT00956293|101996563|FG002|STARTED|Follow-up Period||0||
48678783|NCT00956293|101996561|FG000|COMPLETED|Follow-up Period||0||
48678784|NCT00956293|101996562|FG001|COMPLETED|Follow-up Period||0||
48678785|NCT00956293|101996563|FG002|COMPLETED|Follow-up Period||0||
48678786|NCT00956293|101996561|FG000|NOT COMPLETED|Follow-up Period||20||
48678787|NCT00956293|101996562|FG001|NOT COMPLETED|Follow-up Period||32||
48678788|NCT00956293|101996563|FG002|NOT COMPLETED|Follow-up Period||0||
48678789|NCT04099277|101996564|FG000|STARTED|Overall Study||2||
48678790|NCT04099277|101996564|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2||
48678791|NCT04099277|101996564|FG000|COMPLETED|Overall Study||0||
48678792|NCT04099277|101996564|FG000|NOT COMPLETED|Overall Study||2||
48678793|NCT03493958|101996565|FG000|STARTED|Overall Study||25||
48678794|NCT03493958|101996565|FG000|COMPLETED|Overall Study||10||
48678795|NCT03493958|101996565|FG000|NOT COMPLETED|Overall Study||15||
48678796|NCT06158867|101996566|FG000|STARTED|Overall Study||12||12
48678797|NCT06158867|101996567|FG001|STARTED|Overall Study||12||12
48678798|NCT06158867|101996566|FG000|COMPLETED|Overall Study||12||12
48678799|NCT06158867|101996567|FG001|COMPLETED|Overall Study||12||12
48678800|NCT06158867|101996566|FG000|NOT COMPLETED|Overall Study||0||0
48240948|NCT01272388|100911616|FG000|NOT COMPLETED|Overall Study||0||
48240949|NCT01272388|100911617|FG001|NOT COMPLETED|Overall Study||0||
48240950|NCT02820298|100911618|FG000|STARTED|Overall Study||13||
48240951|NCT02820298|100911619|FG001|STARTED|Overall Study||12||
48240952|NCT02820298|100911618|FG000|COMPLETED|Overall Study||12||
48240953|NCT02820298|100911619|FG001|COMPLETED|Overall Study||10||
48240954|NCT02820298|100911618|FG000|NOT COMPLETED|Overall Study||1||
48240955|NCT02820298|100911619|FG001|NOT COMPLETED|Overall Study||2||
48240956|NCT01021683|100911620|FG000|STARTED|Overall Study||203||
48240957|NCT01021683|100911620|FG000|COMPLETED|Overall Study||132||
48240958|NCT01021683|100911620|FG000|NOT COMPLETED|Overall Study||71||
48240959|NCT00050167|100911621|FG000|STARTED|Overall Study||302||
48240960|NCT00050167|100911622|FG001|STARTED|Overall Study||301||
48240961|NCT00050167|100911621|FG000|COMPLETED|Overall Study||301||
48240962|NCT00050167|100911622|FG001|COMPLETED|Overall Study||300||
48240963|NCT00050167|100911621|FG000|NOT COMPLETED|Overall Study||1||
48240964|NCT00050167|100911622|FG001|NOT COMPLETED|Overall Study||1||
48240965|NCT02282917|100911623|FG000|STARTED|Overall Study||7||
48240966|NCT02282917|100911623|FG000|COMPLETED|Overall Study||5||
48240967|NCT02282917|100911623|FG000|NOT COMPLETED|Overall Study||2||
48240968|NCT02586857|100911624|FG000|STARTED|Overall Study||15||
48240969|NCT02586857|100911625|FG001|STARTED|Overall Study||9||
48240970|NCT02586857|100911624|FG000|Enrolled|Overall Study||15||
48240971|NCT02586857|100911625|FG001|Enrolled|Overall Study||9||
48240972|NCT02586857|100911624|FG000|Received Study Medication|Overall Study||15||
48240973|NCT02586857|100911625|FG001|Received Study Medication|Overall Study||9||
48240974|NCT02586857|100911624|FG000|Discontinued Study|Overall Study||14||
48240975|NCT02586857|100911625|FG001|Discontinued Study|Overall Study||9||
48240976|NCT02586857|100911624|FG000|COMPLETED|Overall Study||14||
48240977|NCT02586857|100911625|FG001|COMPLETED|Overall Study||9||
48240978|NCT02586857|100911624|FG000|NOT COMPLETED|Overall Study||1||
48240979|NCT02586857|100911625|FG001|NOT COMPLETED|Overall Study||0||
48240980|NCT02121808|100911626|FG000|STARTED|Overall Study||20||
48240981|NCT02121808|100911626|FG000|COMPLETED|Overall Study||17||
48240982|NCT02121808|100911626|FG000|NOT COMPLETED|Overall Study||3||
48240983|NCT02152995|100911627|FG000|STARTED|Overall Study||25||
48240984|NCT02152995|100911628|FG001|STARTED|Overall Study||9||
48240985|NCT02152995|100911627|FG000|Participants Who Continued Treatment With Trametinib Only|Overall Study||5||
48240986|NCT02152995|100911628|FG001|Participants Who Continued Treatment With Trametinib Only|Overall Study||2||
48240987|NCT02152995|100911627|FG000|COMPLETED|Overall Study||24||
48240988|NCT02152995|100911628|FG001|COMPLETED|Overall Study||9||
48240989|NCT02152995|100911627|FG000|NOT COMPLETED|Overall Study||1||
48240990|NCT02152995|100911628|FG001|NOT COMPLETED|Overall Study||0||
48240991|NCT04150250|100911629|FG000|STARTED|Overall Study||23||
48240992|NCT04150250|100911630|FG001|STARTED|Overall Study||24||
48240993|NCT04150250|100911629|FG000|COMPLETED|Overall Study||23||
48240994|NCT04150250|100911630|FG001|COMPLETED|Overall Study||22||
48240995|NCT04150250|100911629|FG000|NOT COMPLETED|Overall Study||0||
48240996|NCT04150250|100911630|FG001|NOT COMPLETED|Overall Study||2||
48240997|NCT02825849|100911631|FG000|STARTED|Overall Study||22||
48240998|NCT02825849|100911632|FG001|STARTED|Overall Study||5||
48240999|NCT02825849|100911631|FG000|COMPLETED|Overall Study||22||
48241000|NCT02825849|100911632|FG001|COMPLETED|Overall Study||5||
48241001|NCT02825849|100911631|FG000|NOT COMPLETED|Overall Study||0||
48241002|NCT02825849|100911632|FG001|NOT COMPLETED|Overall Study||0||
48241003|NCT02423447|100911633|FG000|STARTED|Overall Study||13||
48241004|NCT02423447|100911634|FG001|STARTED|Overall Study||12||
48241005|NCT02423447|100911633|FG000|COMPLETED|Overall Study||13||
48241006|NCT02423447|100911634|FG001|COMPLETED|Overall Study||12||
48241007|NCT02423447|100911633|FG000|NOT COMPLETED|Overall Study||0||
48241008|NCT02423447|100911634|FG001|NOT COMPLETED|Overall Study||0||
48241009|NCT00070707|100911635|FG000|STARTED|Overall Study||113||
48241010|NCT00070707|100911636|FG001|STARTED|Overall Study||75||
48540186|NCT04400682|101658015|FG001|NOT COMPLETED|Period 2||0||
48540187|NCT01755767|101658016|FG000|STARTED|Overall Study||28||
48540188|NCT01755767|101658017|FG001|STARTED|Overall Study||15||
48540189|NCT01755767|101658018|FG002|STARTED|Overall Study||226||
48540190|NCT01755767|101658019|FG003|STARTED|Overall Study||114||
48540191|NCT01755767|101658016|FG000|COMPLETED|Overall Study||0||
48540192|NCT01755767|101658017|FG001|COMPLETED|Overall Study||0||
48540193|NCT01755767|101658018|FG002|COMPLETED|Overall Study||0||
48540194|NCT01755767|101658019|FG003|COMPLETED|Overall Study||0||
48540195|NCT01755767|101658016|FG000|NOT COMPLETED|Overall Study||28||
48540196|NCT01755767|101658017|FG001|NOT COMPLETED|Overall Study||15||
48540197|NCT01755767|101658018|FG002|NOT COMPLETED|Overall Study||226||
48540198|NCT01755767|101658019|FG003|NOT COMPLETED|Overall Study||114||
48540199|NCT03058289|101658020|FG000|STARTED|Overall Study||6||
48540200|NCT03058289|101658021|FG001|STARTED|Overall Study||4||
48540201|NCT03058289|101658022|FG002|STARTED|Overall Study||4||
48241011|NCT00070707|100911635|FG000|COMPLETED|Overall Study||99||
48241012|NCT00070707|100911636|FG001|COMPLETED|Overall Study||68||
48241013|NCT00070707|100911635|FG000|NOT COMPLETED|Overall Study||14||
48241014|NCT00070707|100911636|FG001|NOT COMPLETED|Overall Study||7||
48241015|NCT03287947|100911637|FG000|STARTED|Overall Study||5||
48241016|NCT03287947|100911637|FG000|COMPLETED|Overall Study||5||
48241017|NCT03287947|100911637|FG000|NOT COMPLETED|Overall Study||0||
48241018|NCT01596699|100911638|FG000|STARTED|Overall Study||10||
48241019|NCT01596699|100911639|FG001|STARTED|Overall Study||6||
48241020|NCT01596699|100911638|FG000|COMPLETED|Overall Study||10||
48241021|NCT01596699|100911639|FG001|COMPLETED|Overall Study||6||
48241022|NCT01596699|100911638|FG000|NOT COMPLETED|Overall Study||0||
48241023|NCT01596699|100911639|FG001|NOT COMPLETED|Overall Study||0||
48241024|NCT00310050|100911640|FG000|STARTED|Overall Study||4||
48241025|NCT00310050|100911640|FG000|COMPLETED|Overall Study||3||
48241026|NCT00310050|100911640|FG000|NOT COMPLETED|Overall Study||1||
48241027|NCT02335242|100911641|FG000|STARTED|Randomized Phase (20 Weeks)||8||
48241028|NCT02335242|100911642|FG001|STARTED|Randomized Phase (20 Weeks)||11||
48241029|NCT02335242|100911641|FG000|COMPLETED|Randomized Phase (20 Weeks)||7||
48241030|NCT02335242|100911642|FG001|COMPLETED|Randomized Phase (20 Weeks)||11||
48241031|NCT02335242|100911641|FG000|NOT COMPLETED|Randomized Phase (20 Weeks)||1||
48241032|NCT02335242|100911642|FG001|NOT COMPLETED|Randomized Phase (20 Weeks)||0||
48241033|NCT02335242|100911641|FG000|STARTED|Open-label Phase (20 Weeks)||6||
48241034|NCT02335242|100911642|FG001|STARTED|Open-label Phase (20 Weeks)||0||
48241035|NCT02335242|100911641|FG000|COMPLETED|Open-label Phase (20 Weeks)||6||
48241036|NCT02335242|100911642|FG001|COMPLETED|Open-label Phase (20 Weeks)||0||
48241037|NCT02335242|100911641|FG000|NOT COMPLETED|Open-label Phase (20 Weeks)||0||
48241038|NCT02335242|100911642|FG001|NOT COMPLETED|Open-label Phase (20 Weeks)||0||
48241039|NCT02335242|100911641|FG000|STARTED|Follow-up Period (12 Weeks)||6||
48241040|NCT02335242|100911642|FG001|STARTED|Follow-up Period (12 Weeks)||11||
48241041|NCT02335242|100911641|FG000|COMPLETED|Follow-up Period (12 Weeks)||4||
48241042|NCT02335242|100911642|FG001|COMPLETED|Follow-up Period (12 Weeks)||10||
48540202|NCT03058289|101658023|FG003|STARTED|Overall Study||21||
48241043|NCT02335242|100911641|FG000|NOT COMPLETED|Follow-up Period (12 Weeks)||2||
48241044|NCT02335242|100911642|FG001|NOT COMPLETED|Follow-up Period (12 Weeks)||1||
48241045|NCT01879735|100911643|FG000|STARTED|Overall Study||6||
48241046|NCT01879735|100911644|FG001|STARTED|Overall Study||16||
48241047|NCT01879735|100911643|FG000|COMPLETED|Overall Study||6||
48241048|NCT01879735|100911644|FG001|COMPLETED|Overall Study||16||
48241049|NCT01879735|100911643|FG000|NOT COMPLETED|Overall Study||0||
48241050|NCT01879735|100911644|FG001|NOT COMPLETED|Overall Study||0||
48241051|NCT01763645|100911645|FG000|STARTED|Overall Study||211||
48241052|NCT01763645|100911646|FG001|STARTED|Overall Study||142||
48241053|NCT01763645|100911645|FG000|Received at Least 1 Dose of Study Drug|Overall Study||206||
48241054|NCT01763645|100911646|FG001|Received at Least 1 Dose of Study Drug|Overall Study||137||
48241055|NCT01763645|100911645|FG000|COMPLETED|Overall Study||87||
48678801|NCT06158867|101996567|FG001|NOT COMPLETED|Overall Study||0||0
48678802|NCT02365597|101996568|FG000|STARTED|Overall Study||33||
48678803|NCT02365597|101996569|FG001|STARTED|Overall Study||79||
48241056|NCT01763645|100911646|FG001|COMPLETED|Overall Study||56||
48241057|NCT01763645|100911645|FG000|NOT COMPLETED|Overall Study||124||
48241058|NCT01763645|100911646|FG001|NOT COMPLETED|Overall Study||86||
48241059|NCT03733899|100911647|FG000|STARTED|Period 1||3||
48540203|NCT03058289|101658024|FG004|STARTED|Overall Study||20||
48540204|NCT03058289|101658025|FG005|STARTED|Overall Study||9||
48540205|NCT03058289|101658026|FG006|STARTED|Overall Study||6||
48540206|NCT03058289|101658027|FG007|STARTED|Overall Study||22||
48540207|NCT03058289|101658028|FG008|STARTED|Overall Study||18||
48540208|NCT03058289|101658020|FG000|COMPLETED|Overall Study||1||
48540209|NCT03058289|101658021|FG001|COMPLETED|Overall Study||1||
48540210|NCT03058289|101658022|FG002|COMPLETED|Overall Study||1||
48241060|NCT03733899|100911648|FG001|STARTED|Period 1||3||
48241061|NCT03733899|100911649|FG002|STARTED|Period 1||3||
48678804|NCT02365597|101996570|FG002|STARTED|Overall Study||102||
48678805|NCT02365597|101996571|FG003|STARTED|Overall Study||25||
48678806|NCT02365597|101996568|FG000|Treated (Safety Analysis Set)|Overall Study||33||
48678807|NCT02365597|101996569|FG001|Treated (Safety Analysis Set)|Overall Study||78||
48678808|NCT02365597|101996570|FG002|Treated (Safety Analysis Set)|Overall Study||101||
48678809|NCT02365597|101996571|FG003|Treated (Safety Analysis Set)|Overall Study||25||
48678810|NCT02365597|101996568|FG000|COMPLETED|Overall Study||31||
48678811|NCT02365597|101996569|FG001|COMPLETED|Overall Study||62||
48678812|NCT02365597|101996570|FG002|COMPLETED|Overall Study||83||
48678813|NCT02365597|101996571|FG003|COMPLETED|Overall Study||6||
48678814|NCT02365597|101996568|FG000|NOT COMPLETED|Overall Study||2||
48678815|NCT02365597|101996569|FG001|NOT COMPLETED|Overall Study||17||
48678816|NCT02365597|101996570|FG002|NOT COMPLETED|Overall Study||19||
48540211|NCT03058289|101658023|FG003|COMPLETED|Overall Study||9||
48540212|NCT03058289|101658024|FG004|COMPLETED|Overall Study||9||
48540213|NCT03058289|101658025|FG005|COMPLETED|Overall Study||3||
48678817|NCT02365597|101996571|FG003|NOT COMPLETED|Overall Study||19||
48678818|NCT01985022|101996572|FG000|STARTED|Overall Study||16||
48678819|NCT01985022|101996573|FG001|STARTED|Overall Study||17||
48678820|NCT01985022|101996572|FG000|COMPLETED|Overall Study||12||
48678821|NCT01985022|101996573|FG001|COMPLETED|Overall Study||14||
48678822|NCT01985022|101996572|FG000|NOT COMPLETED|Overall Study||4||
48678823|NCT01985022|101996573|FG001|NOT COMPLETED|Overall Study||3||
48678824|NCT02115321|101996574|FG000|STARTED|Overall Study||30||
48678825|NCT02115321|101996575|FG001|STARTED|Overall Study||10||
48678826|NCT02115321|101996574|FG000|COMPLETED|Overall Study||29||
48678827|NCT02115321|101996575|FG001|COMPLETED|Overall Study||10||
48678828|NCT02115321|101996574|FG000|NOT COMPLETED|Overall Study||1||
48678829|NCT02115321|101996575|FG001|NOT COMPLETED|Overall Study||0||
48678830|NCT02379052|101996576|FG000|STARTED|Overall Study||24||
48678831|NCT02379052|101996577|FG001|STARTED|Overall Study||23||
48678832|NCT02379052|101996576|FG000|COMPLETED|Overall Study||18||
48678833|NCT02379052|101996577|FG001|COMPLETED|Overall Study||18||
48678834|NCT02379052|101996576|FG000|NOT COMPLETED|Overall Study||6||
48678835|NCT02379052|101996577|FG001|NOT COMPLETED|Overall Study||5||
48678836|NCT02850978|101996578|FG000|STARTED|Overall Study||1335|Strated are registered|
48678837|NCT02850978|101996578|FG000|Case Report Form (CRF) Collected|Overall Study||1308||
48678838|NCT02850978|101996578|FG000|Treated|Overall Study||1308||
48678839|NCT02850978|101996578|FG000|COMPLETED|Overall Study||909||
48678840|NCT02850978|101996578|FG000|NOT COMPLETED|Overall Study||426||
48678841|NCT00503984|101996579|FG000|STARTED|Overall Study||3||
48678842|NCT00503984|101996580|FG001|STARTED|Overall Study||3||
48241062|NCT03733899|100911650|FG003|STARTED|Period 1||4||
48241063|NCT03733899|100911651|FG004|STARTED|Period 1||4||
48241064|NCT03733899|100911652|FG005|STARTED|Period 1||3||
48241065|NCT03733899|100911647|FG000|COMPLETED|Period 1||3||
48241066|NCT03733899|100911648|FG001|COMPLETED|Period 1||3||
48540214|NCT03058289|101658026|FG006|COMPLETED|Overall Study||3||
48540215|NCT03058289|101658027|FG007|COMPLETED|Overall Study||5||
48540216|NCT03058289|101658028|FG008|COMPLETED|Overall Study||13||
48678843|NCT00503984|101996581|FG002|STARTED|Overall Study||3||
48678844|NCT00503984|101996582|FG003|STARTED|Overall Study||6||
48241067|NCT03733899|100911649|FG002|COMPLETED|Period 1||3||
48241068|NCT03733899|100911650|FG003|COMPLETED|Period 1||4||
48241069|NCT03733899|100911651|FG004|COMPLETED|Period 1||4||
48241070|NCT03733899|100911652|FG005|COMPLETED|Period 1||2||
48241071|NCT03733899|100911647|FG000|NOT COMPLETED|Period 1||0||
48241072|NCT03733899|100911648|FG001|NOT COMPLETED|Period 1||0||
48241073|NCT03733899|100911649|FG002|NOT COMPLETED|Period 1||0||
48241074|NCT03733899|100911650|FG003|NOT COMPLETED|Period 1||0||
48241075|NCT03733899|100911651|FG004|NOT COMPLETED|Period 1||0||
48241076|NCT03733899|100911652|FG005|NOT COMPLETED|Period 1||1||
48241077|NCT03733899|100911647|FG000|STARTED|Period 2||3||
48241078|NCT03733899|100911648|FG001|STARTED|Period 2||3||
48241079|NCT03733899|100911649|FG002|STARTED|Period 2||3||
48241080|NCT03733899|100911650|FG003|STARTED|Period 2||4||
48241081|NCT03733899|100911651|FG004|STARTED|Period 2||4||
48241082|NCT03733899|100911652|FG005|STARTED|Period 2||2||
48241083|NCT03733899|100911647|FG000|COMPLETED|Period 2||3||
48241084|NCT03733899|100911648|FG001|COMPLETED|Period 2||2||
48241085|NCT03733899|100911649|FG002|COMPLETED|Period 2||3||
48241086|NCT03733899|100911650|FG003|COMPLETED|Period 2||4||
48241087|NCT03733899|100911651|FG004|COMPLETED|Period 2||4||
48241088|NCT03733899|100911652|FG005|COMPLETED|Period 2||2||
48241089|NCT03733899|100911647|FG000|NOT COMPLETED|Period 2||0||
48241090|NCT03733899|100911648|FG001|NOT COMPLETED|Period 2||1||
48241091|NCT03733899|100911649|FG002|NOT COMPLETED|Period 2||0||
48241092|NCT03733899|100911650|FG003|NOT COMPLETED|Period 2||0||
48241093|NCT03733899|100911651|FG004|NOT COMPLETED|Period 2||0||
48241094|NCT03733899|100911652|FG005|NOT COMPLETED|Period 2||0||
48241095|NCT03733899|100911647|FG000|STARTED|Period 3||3||
48241096|NCT03733899|100911648|FG001|STARTED|Period 3||2||
48241097|NCT03733899|100911649|FG002|STARTED|Period 3||3||
48241098|NCT03733899|100911650|FG003|STARTED|Period 3||4||
48241099|NCT03733899|100911651|FG004|STARTED|Period 3||4||
48241100|NCT03733899|100911652|FG005|STARTED|Period 3||2||
48241101|NCT03733899|100911647|FG000|COMPLETED|Period 3||2||
48241102|NCT03733899|100911648|FG001|COMPLETED|Period 3||2||
48241103|NCT03733899|100911649|FG002|COMPLETED|Period 3||3||
48241104|NCT03733899|100911650|FG003|COMPLETED|Period 3||4||
48241105|NCT03733899|100911651|FG004|COMPLETED|Period 3||4||
48241106|NCT03733899|100911652|FG005|COMPLETED|Period 3||2||
48241107|NCT03733899|100911647|FG000|NOT COMPLETED|Period 3||1||
48241108|NCT03733899|100911648|FG001|NOT COMPLETED|Period 3||0||
48241109|NCT03733899|100911649|FG002|NOT COMPLETED|Period 3||0||
48241110|NCT03733899|100911650|FG003|NOT COMPLETED|Period 3||0||
48241111|NCT03733899|100911651|FG004|NOT COMPLETED|Period 3||0||
48241112|NCT03733899|100911652|FG005|NOT COMPLETED|Period 3||0||
48241113|NCT03749616|100911653|FG000|STARTED|Overall Study||14||
48241114|NCT03749616|100911654|FG001|STARTED|Overall Study||18||
48241115|NCT03749616|100911653|FG000|COMPLETED|Overall Study||7||
48241116|NCT03749616|100911654|FG001|COMPLETED|Overall Study||10||
48241117|NCT03749616|100911653|FG000|NOT COMPLETED|Overall Study||7||
48241118|NCT03749616|100911654|FG001|NOT COMPLETED|Overall Study||8||
48241119|NCT02010021|100911655|FG000|STARTED|Overall Study||10||
48241120|NCT02010021|100911656|FG001|STARTED|Overall Study||7||
48241121|NCT02010021|100911655|FG000|COMPLETED|Overall Study||10||
48241122|NCT02010021|100911656|FG001|COMPLETED|Overall Study||7||
48241123|NCT02010021|100911655|FG000|NOT COMPLETED|Overall Study||0||
48241124|NCT02010021|100911656|FG001|NOT COMPLETED|Overall Study||0||
48241125|NCT01945593|100911657|FG000|STARTED|Overall Study||3||
48241126|NCT01945593|100911658|FG001|STARTED|Overall Study||64||
48241127|NCT01945593|100911659|FG002|STARTED|Overall Study||26||
48241128|NCT01945593|100911660|FG003|STARTED|Overall Study||125||
48241129|NCT01945593|100911657|FG000|COMPLETED|Overall Study||3||
48241130|NCT01945593|100911658|FG001|COMPLETED|Overall Study||56||
48241131|NCT01945593|100911659|FG002|COMPLETED|Overall Study||23||
48241132|NCT01945593|100911660|FG003|COMPLETED|Overall Study||105||
48241133|NCT01945593|100911657|FG000|NOT COMPLETED|Overall Study||0||
48540217|NCT03058289|101658020|FG000|NOT COMPLETED|Overall Study||5||
48540218|NCT03058289|101658021|FG001|NOT COMPLETED|Overall Study||3||
48540219|NCT03058289|101658022|FG002|NOT COMPLETED|Overall Study||3||
48540220|NCT03058289|101658023|FG003|NOT COMPLETED|Overall Study||12||
48241134|NCT01945593|100911658|FG001|NOT COMPLETED|Overall Study||8||
48241135|NCT01945593|100911659|FG002|NOT COMPLETED|Overall Study||3||
48241136|NCT01945593|100911660|FG003|NOT COMPLETED|Overall Study||20||
48241137|NCT03734588|100911661|FG000|STARTED|Overall Study||4||
48241138|NCT03734588|100911661|FG000|COMPLETED|Overall Study||4||
48540221|NCT03058289|101658024|FG004|NOT COMPLETED|Overall Study||11||
48540222|NCT03058289|101658025|FG005|NOT COMPLETED|Overall Study||6||
48241139|NCT03734588|100911661|FG000|NOT COMPLETED|Overall Study||0||
48241140|NCT00365599|100911662|FG000|STARTED|Overall Study||43||
48241141|NCT00365599|100911662|FG000|COMPLETED|Overall Study||43||
48241142|NCT00365599|100911662|FG000|NOT COMPLETED|Overall Study||0||
48241143|NCT04267393|100911663|FG000|STARTED|Randomization||40||
48540223|NCT03058289|101658026|FG006|NOT COMPLETED|Overall Study||3||
48241144|NCT04267393|100911664|FG001|STARTED|Randomization||42||
48241145|NCT04267393|100911665|FG002|STARTED|Randomization||42||
48241146|NCT04267393|100911663|FG000|COMPLETED|Randomization||39|= Randomized and Treated|
48241147|NCT04267393|100911664|FG001|COMPLETED|Randomization||41|= Randomized and Treated|
48241148|NCT04267393|100911665|FG002|COMPLETED|Randomization||42|= Randomized and Treated|
48241149|NCT04267393|100911663|FG000|NOT COMPLETED|Randomization||1||
48241150|NCT04267393|100911664|FG001|NOT COMPLETED|Randomization||1||
48241151|NCT04267393|100911665|FG002|NOT COMPLETED|Randomization||0||
48241152|NCT04267393|100911663|FG000|STARTED|Treatment Period||39||
48241153|NCT04267393|100911664|FG001|STARTED|Treatment Period||41||
48241154|NCT04267393|100911665|FG002|STARTED|Treatment Period||42||
48241155|NCT04267393|100911663|FG000|COMPLETED|Treatment Period||36||
48241156|NCT04267393|100911664|FG001|COMPLETED|Treatment Period||35||
48241157|NCT04267393|100911665|FG002|COMPLETED|Treatment Period||35||
48241158|NCT04267393|100911663|FG000|NOT COMPLETED|Treatment Period||3||
48241159|NCT04267393|100911664|FG001|NOT COMPLETED|Treatment Period||6||
48241160|NCT04267393|100911665|FG002|NOT COMPLETED|Treatment Period||7||
48241161|NCT04763863|100911666|FG000|STARTED|Overall Study||99||
48241162|NCT04763863|100911667|FG001|STARTED|Overall Study||22||
48241163|NCT04763863|100911666|FG000|COMPLETED|Overall Study||68||
48241164|NCT04763863|100911667|FG001|COMPLETED|Overall Study||22||
48241165|NCT04763863|100911666|FG000|NOT COMPLETED|Overall Study||31||
48241166|NCT04763863|100911667|FG001|NOT COMPLETED|Overall Study||0||
48241167|NCT02630147|100911668|FG000|STARTED|First Intervention (First Night)||14||
48241168|NCT02630147|100911669|FG001|STARTED|First Intervention (First Night)||13||
48241169|NCT02630147|100911668|FG000|COMPLETED|First Intervention (First Night)||14||
48241170|NCT02630147|100911669|FG001|COMPLETED|First Intervention (First Night)||13||
48241171|NCT02630147|100911668|FG000|NOT COMPLETED|First Intervention (First Night)||0||
48241172|NCT02630147|100911669|FG001|NOT COMPLETED|First Intervention (First Night)||0||
48241173|NCT02630147|100911668|FG000|STARTED|Washout, no Intervention (Second Night)||14||
48241174|NCT02630147|100911669|FG001|STARTED|Washout, no Intervention (Second Night)||13||
48241175|NCT02630147|100911668|FG000|COMPLETED|Washout, no Intervention (Second Night)||14||
48241176|NCT02630147|100911669|FG001|COMPLETED|Washout, no Intervention (Second Night)||13||
48241177|NCT02630147|100911668|FG000|NOT COMPLETED|Washout, no Intervention (Second Night)||0||
48241178|NCT02630147|100911669|FG001|NOT COMPLETED|Washout, no Intervention (Second Night)||0||
48241179|NCT02630147|100911668|FG000|STARTED|Second Intervention (Third Night)||14||
48241180|NCT02630147|100911669|FG001|STARTED|Second Intervention (Third Night)||13||
48241181|NCT02630147|100911668|FG000|COMPLETED|Second Intervention (Third Night)||14||
48241182|NCT02630147|100911669|FG001|COMPLETED|Second Intervention (Third Night)||13||
48241183|NCT02630147|100911668|FG000|NOT COMPLETED|Second Intervention (Third Night)||0||
48241184|NCT02630147|100911669|FG001|NOT COMPLETED|Second Intervention (Third Night)||0||
48241185|NCT02662023|100911670|FG000|STARTED|Overall Study||12||
48241186|NCT02662023|100911671|FG001|STARTED|Overall Study||12||
48241187|NCT02662023|100911670|FG000|COMPLETED|Overall Study||12||
48241188|NCT02662023|100911671|FG001|COMPLETED|Overall Study||12||
48241189|NCT02662023|100911670|FG000|NOT COMPLETED|Overall Study||0||
48241190|NCT02662023|100911671|FG001|NOT COMPLETED|Overall Study||0||
48241191|NCT02418819|100911672|FG000|STARTED|Overall Study||22||
48241192|NCT02418819|100911673|FG001|STARTED|Overall Study||16||
48241193|NCT02418819|100911674|FG002|STARTED|Overall Study||33||
48241194|NCT02418819|100911675|FG003|STARTED|Overall Study||29||
48241195|NCT02418819|100911672|FG000|COMPLETED|Overall Study||21||
48241196|NCT02418819|100911673|FG001|COMPLETED|Overall Study||16||
48241197|NCT02418819|100911674|FG002|COMPLETED|Overall Study||29||
48241198|NCT02418819|100911675|FG003|COMPLETED|Overall Study||28||
48241199|NCT02418819|100911672|FG000|NOT COMPLETED|Overall Study||1||
48241200|NCT02418819|100911673|FG001|NOT COMPLETED|Overall Study||0||
48241201|NCT02418819|100911674|FG002|NOT COMPLETED|Overall Study||4||
48241202|NCT02418819|100911675|FG003|NOT COMPLETED|Overall Study||1||
48241203|NCT00919061|100911676|FG000|STARTED|Overall Study||39||
48241204|NCT00919061|100911676|FG000|COMPLETED|Overall Study||37||
48241205|NCT00919061|100911676|FG000|NOT COMPLETED|Overall Study||2||
48241206|NCT01268488|100911677|FG000|STARTED|Overall Study||98||
48241207|NCT01268488|100911677|FG000|COMPLETED|Overall Study||93||
48241208|NCT01268488|100911677|FG000|NOT COMPLETED|Overall Study||5||
48241209|NCT01148017|100911678|FG000|STARTED|Overall Study||214||
48241210|NCT01148017|100911679|FG001|STARTED|Overall Study||121||
48241211|NCT01148017|100911680|FG002|STARTED|Overall Study||53||
48241212|NCT01148017|100911681|FG003|STARTED|Overall Study||45||
48241213|NCT01148017|100911678|FG000|COMPLETED|Overall Study||134||
48241214|NCT01148017|100911679|FG001|COMPLETED|Overall Study||87||
48241215|NCT01148017|100911680|FG002|COMPLETED|Overall Study||53||
48241216|NCT01148017|100911681|FG003|COMPLETED|Overall Study||45||
48241217|NCT01148017|100911678|FG000|NOT COMPLETED|Overall Study||80||
48241218|NCT01148017|100911679|FG001|NOT COMPLETED|Overall Study||34||
48241219|NCT01148017|100911680|FG002|NOT COMPLETED|Overall Study||0||
48241220|NCT01148017|100911681|FG003|NOT COMPLETED|Overall Study||0||
48241221|NCT04287036|100911682|FG000|STARTED|Period 1||13||
48241222|NCT04287036|100911683|FG001|STARTED|Period 1||12||
48241223|NCT04287036|100911682|FG000|COMPLETED|Period 1||13||
48241224|NCT04287036|100911683|FG001|COMPLETED|Period 1||12||
48241225|NCT04287036|100911682|FG000|NOT COMPLETED|Period 1||0||
48241226|NCT04287036|100911683|FG001|NOT COMPLETED|Period 1||0||
48241227|NCT04287036|100911682|FG000|STARTED|Period 2||13||
48678845|NCT00503984|101996583|FG004|STARTED|Overall Study||6||
48678846|NCT00503984|101996584|FG005|STARTED|Overall Study||1||
48678847|NCT00503984|101996579|FG000|COMPLETED|Overall Study||3||
48678848|NCT00503984|101996580|FG001|COMPLETED|Overall Study||1||
48678849|NCT00503984|101996581|FG002|COMPLETED|Overall Study||3||
48678850|NCT00503984|101996582|FG003|COMPLETED|Overall Study||6||
48678851|NCT00503984|101996583|FG004|COMPLETED|Overall Study||5||
48678852|NCT00503984|101996584|FG005|COMPLETED|Overall Study||1||
48678853|NCT00503984|101996579|FG000|NOT COMPLETED|Overall Study||0||
48241228|NCT04287036|100911683|FG001|STARTED|Period 2||12||
48241229|NCT04287036|100911682|FG000|COMPLETED|Period 2||13||
48241230|NCT04287036|100911683|FG001|COMPLETED|Period 2||12||
48241231|NCT04287036|100911682|FG000|NOT COMPLETED|Period 2||0||
48241232|NCT04287036|100911683|FG001|NOT COMPLETED|Period 2||0||
48678854|NCT00503984|101996580|FG001|NOT COMPLETED|Overall Study||2||
48678855|NCT00503984|101996581|FG002|NOT COMPLETED|Overall Study||0||
48678856|NCT00503984|101996582|FG003|NOT COMPLETED|Overall Study||0||
48678857|NCT00503984|101996583|FG004|NOT COMPLETED|Overall Study||1||
48678858|NCT00503984|101996584|FG005|NOT COMPLETED|Overall Study||0||
48678859|NCT05142306|101996585|FG000|STARTED|Overall Study||7||
48678860|NCT05142306|101996586|FG001|STARTED|Overall Study||8||
48678861|NCT05142306|101996587|FG002|STARTED|Overall Study||8||
48678862|NCT05142306|101996585|FG000|Safety Population|Overall Study||7||
48678863|NCT05142306|101996586|FG001|Safety Population|Overall Study||8||
48678864|NCT05142306|101996587|FG002|Safety Population|Overall Study||7||
48678865|NCT05142306|101996585|FG000|COMPLETED|Overall Study||7||
48678866|NCT05142306|101996586|FG001|COMPLETED|Overall Study||8||
48678867|NCT05142306|101996587|FG002|COMPLETED|Overall Study||7||
48241233|NCT00308113|100911684|FG000|STARTED|Overall Study||0||
48241234|NCT00308113|100911685|FG001|STARTED|Overall Study||0||
48678868|NCT05142306|101996585|FG000|NOT COMPLETED|Overall Study||0||
48678869|NCT05142306|101996586|FG001|NOT COMPLETED|Overall Study||0||
48678870|NCT05142306|101996587|FG002|NOT COMPLETED|Overall Study||1||
48241235|NCT00308113|100911686|FG002|STARTED|Overall Study||1||
48241236|NCT00308113|100911687|FG003|STARTED|Overall Study||2||
48678871|NCT01299389|101996588|FG000|STARTED|Double-blind||164||
48678872|NCT01299389|101996589|FG001|STARTED|Double-blind||159||
48678873|NCT01299389|101996590|FG002|STARTED|Double-blind||0||
48678874|NCT01299389|101996591|FG003|STARTED|Double-blind||0||
48678875|NCT01299389|101996588|FG000|COMPLETED|Double-blind||55||
48678876|NCT01299389|101996589|FG001|COMPLETED|Double-blind||95||
48678877|NCT01299389|101996590|FG002|COMPLETED|Double-blind||0||
48678878|NCT01299389|101996591|FG003|COMPLETED|Double-blind||0||
48678879|NCT01299389|101996588|FG000|NOT COMPLETED|Double-blind||109||
48678880|NCT01299389|101996589|FG001|NOT COMPLETED|Double-blind||64||
48678881|NCT01299389|101996590|FG002|NOT COMPLETED|Double-blind||0||
48678882|NCT01299389|101996591|FG003|NOT COMPLETED|Double-blind||0||
48678883|NCT01299389|101996588|FG000|STARTED|Post-observational||0||
48678884|NCT01299389|101996589|FG001|STARTED|Post-observational||0||
48678885|NCT01299389|101996590|FG002|STARTED|Post-observational||156||
48678886|NCT01299389|101996591|FG003|STARTED|Post-observational||155||
48678887|NCT01299389|101996588|FG000|COMPLETED|Post-observational||0||
48678888|NCT01299389|101996589|FG001|COMPLETED|Post-observational||0||
48678889|NCT01299389|101996590|FG002|COMPLETED|Post-observational||144||
48678890|NCT01299389|101996591|FG003|COMPLETED|Post-observational||149||
48678891|NCT01299389|101996588|FG000|NOT COMPLETED|Post-observational||0||
48241237|NCT00308113|100911684|FG000|COMPLETED|Overall Study||0||
48241238|NCT00308113|100911685|FG001|COMPLETED|Overall Study||0||
48241239|NCT00308113|100911686|FG002|COMPLETED|Overall Study||1||
48241240|NCT00308113|100911687|FG003|COMPLETED|Overall Study||1||
48241241|NCT00308113|100911684|FG000|NOT COMPLETED|Overall Study||0||
48241242|NCT00308113|100911685|FG001|NOT COMPLETED|Overall Study||0||
48241243|NCT00308113|100911686|FG002|NOT COMPLETED|Overall Study||0||
48678892|NCT01299389|101996589|FG001|NOT COMPLETED|Post-observational||0||
48678893|NCT01299389|101996590|FG002|NOT COMPLETED|Post-observational||12||
48678894|NCT01299389|101996591|FG003|NOT COMPLETED|Post-observational||6||
48678895|NCT01644643|101996592|FG000|STARTED|Overall Study||15||
48678896|NCT01644643|101996593|FG001|STARTED|Overall Study||12||
48678897|NCT01644643|101996594|FG002|STARTED|Overall Study||153||
48678898|NCT01644643|101996595|FG003|STARTED|Overall Study||153||
48678899|NCT01644643|101996592|FG000|COMPLETED|Overall Study||13||
48678900|NCT01644643|101996593|FG001|COMPLETED|Overall Study||12||
48241244|NCT00308113|100911687|FG003|NOT COMPLETED|Overall Study||1||
48241245|NCT03927742|100911688|FG000|STARTED|Overall Study||182||
48241246|NCT03927742|100911689|FG001|STARTED|Overall Study||186||
48241247|NCT03927742|100911688|FG000|COMPLETED|Overall Study||166||
48241248|NCT03927742|100911689|FG001|COMPLETED|Overall Study||174||
48241249|NCT03927742|100911688|FG000|NOT COMPLETED|Overall Study||16||
48241250|NCT03927742|100911689|FG001|NOT COMPLETED|Overall Study||12||
48678901|NCT01644643|101996594|FG002|COMPLETED|Overall Study||148||
48678902|NCT01644643|101996595|FG003|COMPLETED|Overall Study||143||
48678903|NCT01644643|101996592|FG000|NOT COMPLETED|Overall Study||2||
48678904|NCT01644643|101996593|FG001|NOT COMPLETED|Overall Study||0||
48678905|NCT01644643|101996594|FG002|NOT COMPLETED|Overall Study||5||
48678906|NCT01644643|101996595|FG003|NOT COMPLETED|Overall Study||10||
48678907|NCT02701764|101996596|FG000|STARTED|Overall Study||21||
48678908|NCT02701764|101996597|FG001|STARTED|Overall Study||22||
48678909|NCT02701764|101996596|FG000|COMPLETED|Overall Study||21||
48678910|NCT02701764|101996597|FG001|COMPLETED|Overall Study||21||
48678911|NCT02701764|101996596|FG000|NOT COMPLETED|Overall Study||0||
48241251|NCT04435522|100911690|FG000|STARTED|Overall Study||9||
48241252|NCT04435522|100911690|FG000|COMPLETED|Overall Study||7||
48241253|NCT04435522|100911690|FG000|NOT COMPLETED|Overall Study||2||
48241254|NCT03272373|100911691|FG000|STARTED|Overall Study||104||110
48241255|NCT03272373|100911692|FG001|STARTED|Overall Study||56||63
48241256|NCT03272373|100911691|FG000|COMPLETED|Overall Study||83||89
48241257|NCT03272373|100911692|FG001|COMPLETED|Overall Study||48||55
48241258|NCT03272373|100911691|FG000|NOT COMPLETED|Overall Study||21||21
48241259|NCT03272373|100911692|FG001|NOT COMPLETED|Overall Study||8||8
48241260|NCT01876823|100911693|FG000|STARTED|Overall Study||35||
48241261|NCT01876823|100911693|FG000|COMPLETED|Overall Study||26||
48241262|NCT01876823|100911693|FG000|NOT COMPLETED|Overall Study||9||
48241263|NCT01877720|100911694|FG000|STARTED|Overall Study||8||
48241264|NCT01877720|100911695|FG001|STARTED|Overall Study||8||
48241265|NCT01877720|100911694|FG000|1st Intervention|Overall Study||7||
48241266|NCT01877720|100911695|FG001|1st Intervention|Overall Study||8||
48241267|NCT01877720|100911694|FG000|2nd Intervention|Overall Study||7||
48678912|NCT02701764|101996597|FG001|NOT COMPLETED|Overall Study||1||
48678913|NCT03960684|101996598|FG000|STARTED|Overall Study||31||
48678914|NCT03960684|101996598|FG000|COMPLETED|Overall Study||30||
48678915|NCT03960684|101996598|FG000|NOT COMPLETED|Overall Study||1||
48678916|NCT02388906|101996599|FG000|STARTED|Pre-Treatment Period||453|Started=Randomized|
48678917|NCT02388906|101996600|FG001|STARTED|Pre-Treatment Period||453|Started=Randomized|
48678918|NCT02388906|101996599|FG000|COMPLETED|Pre-Treatment Period||452|completed=treated|
48678919|NCT02388906|101996600|FG001|COMPLETED|Pre-Treatment Period||453|completed=treated|
48678920|NCT02388906|101996599|FG000|NOT COMPLETED|Pre-Treatment Period||1||
48678921|NCT02388906|101996600|FG001|NOT COMPLETED|Pre-Treatment Period||0||
48678922|NCT02388906|101996599|FG000|STARTED|Treatment Period||452|Started=Treated|
48678923|NCT02388906|101996600|FG001|STARTED|Treatment Period||453|Started=Treated|
48678924|NCT02388906|101996599|FG000|COMPLETED|Treatment Period||275|Completed=Finished the treatment period|
48678925|NCT02388906|101996600|FG001|COMPLETED|Treatment Period||122|Completed=Finished the treatment period|
48678926|NCT02388906|101996599|FG000|NOT COMPLETED|Treatment Period||177||
48678927|NCT02388906|101996600|FG001|NOT COMPLETED|Treatment Period||331||
48678928|NCT01334918|101996601|FG000|STARTED|Overall Study||63||
48678929|NCT01334918|101996602|FG001|STARTED|Overall Study||61||
48678930|NCT01334918|101996601|FG000|Randomized + 1 Stress Scan|Overall Study||57||
48678931|NCT01334918|101996602|FG001|Randomized + 1 Stress Scan|Overall Study||61||
48678932|NCT01334918|101996601|FG000|COMPLETED|Overall Study||55||
48678933|NCT01334918|101996602|FG001|COMPLETED|Overall Study||60||
48678934|NCT01334918|101996601|FG000|NOT COMPLETED|Overall Study||8||
48678935|NCT01334918|101996602|FG001|NOT COMPLETED|Overall Study||1||
48678936|NCT01402869|101996603|FG000|STARTED|Overall Study||30||
48678937|NCT01402869|101996604|FG001|STARTED|Overall Study||30||
48241268|NCT01877720|100911695|FG001|2nd Intervention|Overall Study||8||
48678938|NCT01402869|101996605|FG002|STARTED|Overall Study||31||
48678939|NCT01402869|101996603|FG000|COMPLETED|Overall Study||30||
48678940|NCT01402869|101996604|FG001|COMPLETED|Overall Study||30||
48678941|NCT01402869|101996605|FG002|COMPLETED|Overall Study||30||
48241269|NCT01877720|100911694|FG000|COMPLETED|Overall Study||7||
48241270|NCT01877720|100911695|FG001|COMPLETED|Overall Study||8||
48241271|NCT01877720|100911694|FG000|NOT COMPLETED|Overall Study||1||
48241272|NCT01877720|100911695|FG001|NOT COMPLETED|Overall Study||0||
48241273|NCT03062488|100911696|FG000|STARTED|Overall Study||51||
48678942|NCT01402869|101996603|FG000|NOT COMPLETED|Overall Study||0||
48678943|NCT01402869|101996604|FG001|NOT COMPLETED|Overall Study||0||
48678944|NCT01402869|101996605|FG002|NOT COMPLETED|Overall Study||1||
48678945|NCT05547412|101996606|FG000|STARTED|Overall Study||10||
48678946|NCT05547412|101996607|FG001|STARTED|Overall Study||17||
48678947|NCT05547412|101996608|FG002|STARTED|Overall Study||0||
48678948|NCT05547412|101996609|FG003|STARTED|Overall Study||0||
48678949|NCT05547412|101996610|FG004|STARTED|Overall Study||0||
48678950|NCT05547412|101996611|FG005|STARTED|Overall Study||0||
48678951|NCT05547412|101996606|FG000|COMPLETED|Overall Study||10||
48678952|NCT05547412|101996607|FG001|COMPLETED|Overall Study||17||
48678953|NCT05547412|101996608|FG002|COMPLETED|Overall Study||0||
48678954|NCT05547412|101996609|FG003|COMPLETED|Overall Study||0||
48678955|NCT05547412|101996610|FG004|COMPLETED|Overall Study||0||
48678956|NCT05547412|101996611|FG005|COMPLETED|Overall Study||0||
48678957|NCT05547412|101996606|FG000|NOT COMPLETED|Overall Study||0||
48678958|NCT05547412|101996607|FG001|NOT COMPLETED|Overall Study||0||
48678959|NCT05547412|101996608|FG002|NOT COMPLETED|Overall Study||0||
48678960|NCT05547412|101996609|FG003|NOT COMPLETED|Overall Study||0||
48678961|NCT05547412|101996610|FG004|NOT COMPLETED|Overall Study||0||
48678962|NCT05547412|101996611|FG005|NOT COMPLETED|Overall Study||0||
48678963|NCT02592421|101996612|FG000|STARTED|Study 1||20||
48678964|NCT02592421|101996613|FG001|STARTED|Study 1||10||
48678965|NCT02592421|101996612|FG000|COMPLETED|Study 1||20||
48678966|NCT02592421|101996613|FG001|COMPLETED|Study 1||10||
48678967|NCT02592421|101996612|FG000|NOT COMPLETED|Study 1||0||
48678968|NCT02592421|101996613|FG001|NOT COMPLETED|Study 1||0||
48678969|NCT02592421|101996612|FG000|STARTED|Study 2: Glucose Clamp Conditions||20||
48678970|NCT02592421|101996613|FG001|STARTED|Study 2: Glucose Clamp Conditions||10||
48678971|NCT02592421|101996612|FG000|COMPLETED|Study 2: Glucose Clamp Conditions||20||
48678972|NCT02592421|101996613|FG001|COMPLETED|Study 2: Glucose Clamp Conditions||10||
48678973|NCT02592421|101996612|FG000|NOT COMPLETED|Study 2: Glucose Clamp Conditions||0||
48678974|NCT02592421|101996613|FG001|NOT COMPLETED|Study 2: Glucose Clamp Conditions||0||
48678975|NCT02592421|101996612|FG000|STARTED|Study 3: Pancreatic Clamp Conditions||20||
48241274|NCT03062488|100911697|FG001|STARTED|Overall Study||51||
48678976|NCT02592421|101996613|FG001|STARTED|Study 3: Pancreatic Clamp Conditions||10||
48678977|NCT02592421|101996612|FG000|COMPLETED|Study 3: Pancreatic Clamp Conditions||20||
48678978|NCT02592421|101996613|FG001|COMPLETED|Study 3: Pancreatic Clamp Conditions||10||
48678979|NCT02592421|101996612|FG000|NOT COMPLETED|Study 3: Pancreatic Clamp Conditions||0||
48678980|NCT02592421|101996613|FG001|NOT COMPLETED|Study 3: Pancreatic Clamp Conditions||0||
48678981|NCT01098747|101996614|FG000|STARTED|Overall Study||48||
48678982|NCT01098747|101996615|FG001|STARTED|Overall Study||95||
48678983|NCT01098747|101996616|FG002|STARTED|Overall Study||86||
48678984|NCT01098747|101996617|FG003|STARTED|Overall Study||87||
48678985|NCT01098747|101996614|FG000|COMPLETED|Overall Study||48||
48678986|NCT01098747|101996615|FG001|COMPLETED|Overall Study||95||
48678987|NCT01098747|101996616|FG002|COMPLETED|Overall Study||86||
48678988|NCT01098747|101996617|FG003|COMPLETED|Overall Study||87||
48081230|NCT03129100|100521626|FG013|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
48081231|NCT03129100|100521627|FG014|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
48081232|NCT03129100|100521628|FG015|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
48081233|NCT03129100|100521629|FG016|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
48081234|NCT03129100|100521630|FG017|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
48081235|NCT03129100|100521631|FG018|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
48081236|NCT03129100|100521632|FG019|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
48081237|NCT03129100|100521633|FG020|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
48081238|NCT03129100|100521634|FG021|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
48241275|NCT03062488|100911698|FG002|STARTED|Overall Study||41||
48241276|NCT03062488|100911696|FG000|COMPLETED|Overall Study||51||
48241277|NCT03062488|100911697|FG001|COMPLETED|Overall Study||51||
48241278|NCT03062488|100911698|FG002|COMPLETED|Overall Study||41||
48678989|NCT01098747|101996614|FG000|NOT COMPLETED|Overall Study||0||
48081239|NCT03129100|100521635|FG022|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
48081240|NCT03129100|100521636|FG023|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
48081241|NCT03129100|100521637|FG024|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
48081242|NCT03129100|100521638|FG025|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
48081243|NCT03129100|100521613|FG000|STARTED|Period 2 (Retreatment Extension Period)||0||
48081244|NCT03129100|100521614|FG001|STARTED|Period 2 (Retreatment Extension Period)||0||
48081245|NCT03129100|100521615|FG002|STARTED|Period 2 (Retreatment Extension Period)||0||
48081246|NCT03129100|100521616|FG003|STARTED|Period 2 (Retreatment Extension Period)||0||
48081247|NCT03129100|100521617|FG004|STARTED|Period 2 (Retreatment Extension Period)||0||
48081248|NCT03129100|100521618|FG005|STARTED|Period 2 (Retreatment Extension Period)||0||
48241279|NCT03062488|100911696|FG000|NOT COMPLETED|Overall Study||0||
48678990|NCT01098747|101996615|FG001|NOT COMPLETED|Overall Study||0||
48678991|NCT01098747|101996616|FG002|NOT COMPLETED|Overall Study||0||
48678992|NCT01098747|101996617|FG003|NOT COMPLETED|Overall Study||0||
48678993|NCT04781816|101996618|FG000|STARTED|Overall Study||40||
48678994|NCT04781816|101996619|FG001|STARTED|Overall Study||38||
48678995|NCT04781816|101996618|FG000|COMPLETED|Overall Study||38||
48678996|NCT04781816|101996619|FG001|COMPLETED|Overall Study||35||
48678997|NCT04781816|101996618|FG000|NOT COMPLETED|Overall Study||2||
48241280|NCT03062488|100911697|FG001|NOT COMPLETED|Overall Study||0||
48241281|NCT03062488|100911698|FG002|NOT COMPLETED|Overall Study||0||
48241282|NCT02246647|100911699|FG000|STARTED|Overall Study||19||
48678998|NCT04781816|101996619|FG001|NOT COMPLETED|Overall Study||3||
48081249|NCT03129100|100521619|FG006|STARTED|Period 2 (Retreatment Extension Period)||0||
48241283|NCT02246647|100911700|FG001|STARTED|Overall Study||20||
48710651|NCT02961790|102077986|FG003|STARTED|Overall Study||25||
48678999|NCT00608062|101996620|FG000|STARTED|Overall Study||12|Randomization to group assignment occurred following GnRHant alone.|
48679000|NCT00608062|101996621|FG001|STARTED|Overall Study||12|Randomization to group assignment occurred following GnRHant alone.|
48679001|NCT00608062|101996622|FG002|STARTED|Overall Study||19|Randomization to group assignment occurred following GnRHant alone.|
48241284|NCT02246647|100911699|FG000|COMPLETED|Overall Study||18|2 subjects (1 in Healthy Volunteers and 1 in IBS-C) would count as screen failures \& hence withdrawn|
48241285|NCT02246647|100911700|FG001|COMPLETED|Overall Study||19|2 subjects (1 in Healthy Volunteers and 1 in IBS-C) would count as screen failures \& hence withdrawn|
48241286|NCT02246647|100911699|FG000|NOT COMPLETED|Overall Study||1||
48241287|NCT02246647|100911700|FG001|NOT COMPLETED|Overall Study||1||
48241288|NCT04380688|100911701|FG000|STARTED|Overall Study||31||
48241289|NCT04380688|100911702|FG001|STARTED|Overall Study||31||
48241290|NCT04380688|100911701|FG000|COMPLETED|Overall Study||24||
48241291|NCT04380688|100911702|FG001|COMPLETED|Overall Study||22||
48679002|NCT00608062|101996623|FG003|STARTED|Overall Study||21|Randomization to group assignment occurred following GnRHant alone.|
48679003|NCT00608062|101996624|FG004|STARTED|Overall Study||13|Randomization to group assignment occurred following GnRHant alone.|
48679004|NCT00608062|101996625|FG005|STARTED|Overall Study||15|Randomization to group assignment occurred following GnRHant alone.|
48679005|NCT00608062|101996620|FG000|COMPLETED|Overall Study||12||
48679006|NCT00608062|101996621|FG001|COMPLETED|Overall Study||12||
48679007|NCT00608062|101996622|FG002|COMPLETED|Overall Study||19||
48679008|NCT00608062|101996623|FG003|COMPLETED|Overall Study||21||
48679009|NCT00608062|101996624|FG004|COMPLETED|Overall Study||13||
48679010|NCT00608062|101996625|FG005|COMPLETED|Overall Study||15||
48679011|NCT00608062|101996620|FG000|NOT COMPLETED|Overall Study||0||
48679012|NCT00608062|101996621|FG001|NOT COMPLETED|Overall Study||0||
48679013|NCT00608062|101996622|FG002|NOT COMPLETED|Overall Study||0||
48679014|NCT00608062|101996623|FG003|NOT COMPLETED|Overall Study||0||
48679015|NCT00608062|101996624|FG004|NOT COMPLETED|Overall Study||0||
48679016|NCT00608062|101996625|FG005|NOT COMPLETED|Overall Study||0||
48679017|NCT03507127|101996626|FG000|STARTED|Overall Study||3||
48679018|NCT03507127|101996627|FG001|STARTED|Overall Study||2||
48679019|NCT03507127|101996626|FG000|COMPLETED|Overall Study||1||
48679020|NCT03507127|101996627|FG001|COMPLETED|Overall Study||1||
48241292|NCT04380688|100911701|FG000|NOT COMPLETED|Overall Study||7||
48241293|NCT04380688|100911702|FG001|NOT COMPLETED|Overall Study||9||
48241294|NCT04582864|100911703|FG000|STARTED|Overall Study||11||
48241295|NCT04582864|100911703|FG000|COMPLETED|Overall Study||8||
48241296|NCT04582864|100911703|FG000|NOT COMPLETED|Overall Study||3||
48241297|NCT02379078|100911704|FG000|STARTED|Overall Study||111||
48241298|NCT02379078|100911705|FG001|STARTED|Overall Study||114||
48241299|NCT02379078|100911704|FG000|COMPLETED|Overall Study||72||
48241300|NCT02379078|100911705|FG001|COMPLETED|Overall Study||79||
48241301|NCT02379078|100911704|FG000|NOT COMPLETED|Overall Study||39||
48241302|NCT02379078|100911705|FG001|NOT COMPLETED|Overall Study||35||
48241303|NCT05878522|100911706|FG000|STARTED|Treatment Period- 1 (3 Days)||2||
48241304|NCT05878522|100911707|FG001|STARTED|Treatment Period- 1 (3 Days)||2||
48241305|NCT05878522|100911708|FG002|STARTED|Treatment Period- 1 (3 Days)||5||
48241306|NCT05878522|100911709|FG003|STARTED|Treatment Period- 1 (3 Days)||5||
48241307|NCT05878522|100911710|FG004|STARTED|Treatment Period- 1 (3 Days)||2||
48241308|NCT05878522|100911711|FG005|STARTED|Treatment Period- 1 (3 Days)||4||
48241309|NCT05878522|100911712|FG006|STARTED|Treatment Period- 1 (3 Days)||2||
48241310|NCT05878522|100911713|FG007|STARTED|Treatment Period- 1 (3 Days)||5||
48241311|NCT05878522|100911714|FG008|STARTED|Treatment Period- 1 (3 Days)||3||
48241312|NCT05878522|100911715|FG009|STARTED|Treatment Period- 1 (3 Days)||5||
48241313|NCT05878522|100911716|FG010|STARTED|Treatment Period- 1 (3 Days)||3||
48241314|NCT05878522|100911717|FG011|STARTED|Treatment Period- 1 (3 Days)||5||
48241315|NCT05878522|100911706|FG000|COMPLETED|Treatment Period- 1 (3 Days)||2||
48241316|NCT05878522|100911707|FG001|COMPLETED|Treatment Period- 1 (3 Days)||2||
48679021|NCT03507127|101996626|FG000|NOT COMPLETED|Overall Study||2||
48679022|NCT03507127|101996627|FG001|NOT COMPLETED|Overall Study||1||
48679023|NCT01824290|101996628|FG000|STARTED|Period 1: Double Blind||18||
48241317|NCT05878522|100911708|FG002|COMPLETED|Treatment Period- 1 (3 Days)||5||
48241318|NCT05878522|100911709|FG003|COMPLETED|Treatment Period- 1 (3 Days)||5||
48241319|NCT05878522|100911710|FG004|COMPLETED|Treatment Period- 1 (3 Days)||2||
48241320|NCT05878522|100911711|FG005|COMPLETED|Treatment Period- 1 (3 Days)||4||
48241321|NCT05878522|100911712|FG006|COMPLETED|Treatment Period- 1 (3 Days)||2||
48241322|NCT05878522|100911713|FG007|COMPLETED|Treatment Period- 1 (3 Days)||5||
48241323|NCT05878522|100911714|FG008|COMPLETED|Treatment Period- 1 (3 Days)||2||
48241324|NCT05878522|100911715|FG009|COMPLETED|Treatment Period- 1 (3 Days)||5||
48241325|NCT05878522|100911716|FG010|COMPLETED|Treatment Period- 1 (3 Days)||3||
48679024|NCT01824290|101996629|FG001|STARTED|Period 1: Double Blind||17||
48679025|NCT01824290|101996630|FG002|STARTED|Period 1: Double Blind||0||
48679026|NCT01824290|101996631|FG003|STARTED|Period 1: Double Blind||0||
48679027|NCT01824290|101996628|FG000|Received at Least One Dose of Study Drug|Period 1: Double Blind||18||
48679028|NCT01824290|101996629|FG001|Received at Least One Dose of Study Drug|Period 1: Double Blind||17||
48679029|NCT01824290|101996630|FG002|Received at Least One Dose of Study Drug|Period 1: Double Blind||0||
48679030|NCT01824290|101996631|FG003|Received at Least One Dose of Study Drug|Period 1: Double Blind||0||
48679031|NCT01824290|101996628|FG000|Received 20 mg|Period 1: Double Blind||0||
48679032|NCT01824290|101996629|FG001|Received 20 mg|Period 1: Double Blind||4||
48679033|NCT01824290|101996630|FG002|Received 20 mg|Period 1: Double Blind||0||
48679034|NCT01824290|101996631|FG003|Received 20 mg|Period 1: Double Blind||0||
48679035|NCT01824290|101996628|FG000|Received 40 mg|Period 1: Double Blind||0||
48679036|NCT01824290|101996629|FG001|Received 40 mg|Period 1: Double Blind||13||
48679037|NCT01824290|101996630|FG002|Received 40 mg|Period 1: Double Blind||0||
48679038|NCT01824290|101996631|FG003|Received 40 mg|Period 1: Double Blind||0||
48679039|NCT01824290|101996628|FG000|COMPLETED|Period 1: Double Blind||15||
48679040|NCT01824290|101996629|FG001|COMPLETED|Period 1: Double Blind||15||
48679041|NCT01824290|101996630|FG002|COMPLETED|Period 1: Double Blind||0||
48679042|NCT01824290|101996631|FG003|COMPLETED|Period 1: Double Blind||0||
48679043|NCT01824290|101996628|FG000|NOT COMPLETED|Period 1: Double Blind||3||
48679044|NCT01824290|101996629|FG001|NOT COMPLETED|Period 1: Double Blind||2||
48679045|NCT01824290|101996630|FG002|NOT COMPLETED|Period 1: Double Blind||0||
48679046|NCT01824290|101996631|FG003|NOT COMPLETED|Period 1: Double Blind||0||
48679047|NCT01824290|101996628|FG000|STARTED|Period 2: Open-Label Treatment||0||
48679048|NCT01824290|101996629|FG001|STARTED|Period 2: Open-Label Treatment||0||
48679049|NCT01824290|101996630|FG002|STARTED|Period 2: Open-Label Treatment||16||
48679050|NCT01824290|101996631|FG003|STARTED|Period 2: Open-Label Treatment||16||
48679051|NCT01824290|101996628|FG000|Received 20 mg|Period 2: Open-Label Treatment||0||
48679052|NCT01824290|101996629|FG001|Received 20 mg|Period 2: Open-Label Treatment||0||
48679053|NCT01824290|101996630|FG002|Received 20 mg|Period 2: Open-Label Treatment||3||
48679054|NCT01824290|101996631|FG003|Received 20 mg|Period 2: Open-Label Treatment||3||
48679055|NCT01824290|101996628|FG000|Received 40 mg|Period 2: Open-Label Treatment||0||
48679056|NCT01824290|101996629|FG001|Received 40 mg|Period 2: Open-Label Treatment||0||
48679057|NCT01824290|101996630|FG002|Received 40 mg|Period 2: Open-Label Treatment||13||
48679058|NCT01824290|101996631|FG003|Received 40 mg|Period 2: Open-Label Treatment||13||
48679059|NCT01824290|101996628|FG000|COMPLETED|Period 2: Open-Label Treatment||0||
48679060|NCT01824290|101996629|FG001|COMPLETED|Period 2: Open-Label Treatment||0||
48679061|NCT01824290|101996630|FG002|COMPLETED|Period 2: Open-Label Treatment||13||
48679062|NCT01824290|101996631|FG003|COMPLETED|Period 2: Open-Label Treatment||13||
48679063|NCT01824290|101996628|FG000|NOT COMPLETED|Period 2: Open-Label Treatment||0||
48679064|NCT01824290|101996629|FG001|NOT COMPLETED|Period 2: Open-Label Treatment||0||
48679065|NCT01824290|101996630|FG002|NOT COMPLETED|Period 2: Open-Label Treatment||3||
48679066|NCT01824290|101996631|FG003|NOT COMPLETED|Period 2: Open-Label Treatment||3||
48679067|NCT04592341|101996632|FG000|STARTED|Overall Study||192||
48679068|NCT04592341|101996632|FG000|COMPLETED|Overall Study||116||
48679069|NCT04592341|101996632|FG000|NOT COMPLETED|Overall Study||76||
48679070|NCT02761642|101996633|FG000|STARTED|Overall Study||200||
48679071|NCT02761642|101996633|FG000|Treated|Overall Study||197||
48679072|NCT02761642|101996633|FG000|COMPLETED|Overall Study||130||
48679073|NCT02761642|101996633|FG000|NOT COMPLETED|Overall Study||70||
48679074|NCT02121509|101996634|FG000|STARTED|Treatment Period-1 (4 Days)||30||
48679075|NCT02121509|101996635|FG001|STARTED|Treatment Period-1 (4 Days)||28||
48679076|NCT02121509|101996636|FG002|STARTED|Treatment Period-1 (4 Days)||8||
48679077|NCT02121509|101996637|FG003|STARTED|Treatment Period-1 (4 Days)||8||
48679078|NCT02121509|101996634|FG000|COMPLETED|Treatment Period-1 (4 Days)||30||
48679079|NCT02121509|101996635|FG001|COMPLETED|Treatment Period-1 (4 Days)||28||
48679080|NCT02121509|101996636|FG002|COMPLETED|Treatment Period-1 (4 Days)||8||
48679081|NCT02121509|101996637|FG003|COMPLETED|Treatment Period-1 (4 Days)||8||
48679082|NCT02121509|101996634|FG000|NOT COMPLETED|Treatment Period-1 (4 Days)||0||
48679083|NCT02121509|101996635|FG001|NOT COMPLETED|Treatment Period-1 (4 Days)||0||
48679084|NCT02121509|101996636|FG002|NOT COMPLETED|Treatment Period-1 (4 Days)||0||
48679085|NCT02121509|101996637|FG003|NOT COMPLETED|Treatment Period-1 (4 Days)||0||
48679086|NCT02121509|101996634|FG000|STARTED|Washout Period (35 Days)||30||
48679087|NCT02121509|101996635|FG001|STARTED|Washout Period (35 Days)||28||
48679088|NCT02121509|101996636|FG002|STARTED|Washout Period (35 Days)||8||
48679089|NCT02121509|101996637|FG003|STARTED|Washout Period (35 Days)||8||
48679090|NCT02121509|101996634|FG000|COMPLETED|Washout Period (35 Days)||28||
48679091|NCT02121509|101996635|FG001|COMPLETED|Washout Period (35 Days)||24||
48679092|NCT02121509|101996636|FG002|COMPLETED|Washout Period (35 Days)||8||
48679093|NCT02121509|101996637|FG003|COMPLETED|Washout Period (35 Days)||8||
48679094|NCT02121509|101996634|FG000|NOT COMPLETED|Washout Period (35 Days)||2||
48679095|NCT02121509|101996635|FG001|NOT COMPLETED|Washout Period (35 Days)||4||
48241326|NCT05878522|100911717|FG011|COMPLETED|Treatment Period- 1 (3 Days)||5||
48241327|NCT05878522|100911706|FG000|NOT COMPLETED|Treatment Period- 1 (3 Days)||0||
48241328|NCT05878522|100911707|FG001|NOT COMPLETED|Treatment Period- 1 (3 Days)||0||
48241329|NCT05878522|100911708|FG002|NOT COMPLETED|Treatment Period- 1 (3 Days)||0||
48241330|NCT05878522|100911709|FG003|NOT COMPLETED|Treatment Period- 1 (3 Days)||0||
48241331|NCT05878522|100911710|FG004|NOT COMPLETED|Treatment Period- 1 (3 Days)||0||
48679096|NCT02121509|101996636|FG002|NOT COMPLETED|Washout Period (35 Days)||0||
48679097|NCT02121509|101996637|FG003|NOT COMPLETED|Washout Period (35 Days)||0||
48679098|NCT02121509|101996634|FG000|STARTED|Treatment Period-2 (4 Days)||28||
48241332|NCT05878522|100911711|FG005|NOT COMPLETED|Treatment Period- 1 (3 Days)||0||
48679099|NCT02121509|101996635|FG001|STARTED|Treatment Period-2 (4 Days)||24||
48679100|NCT02121509|101996636|FG002|STARTED|Treatment Period-2 (4 Days)||8||
48679101|NCT02121509|101996637|FG003|STARTED|Treatment Period-2 (4 Days)||8||
48679102|NCT02121509|101996634|FG000|COMPLETED|Treatment Period-2 (4 Days)||28||
48679103|NCT02121509|101996635|FG001|COMPLETED|Treatment Period-2 (4 Days)||24||
48679104|NCT02121509|101996636|FG002|COMPLETED|Treatment Period-2 (4 Days)||8||
48679105|NCT02121509|101996637|FG003|COMPLETED|Treatment Period-2 (4 Days)||8||
48679106|NCT02121509|101996634|FG000|NOT COMPLETED|Treatment Period-2 (4 Days)||0||
48679107|NCT02121509|101996635|FG001|NOT COMPLETED|Treatment Period-2 (4 Days)||0||
48679108|NCT02121509|101996636|FG002|NOT COMPLETED|Treatment Period-2 (4 Days)||0||
48679109|NCT02121509|101996637|FG003|NOT COMPLETED|Treatment Period-2 (4 Days)||0||
48679110|NCT01459666|101996638|FG000|STARTED|Overall Study||5||
48679111|NCT01459666|101996639|FG001|STARTED|Overall Study||4||
48679112|NCT01459666|101996638|FG000|COMPLETED|Overall Study||0||
48679113|NCT01459666|101996639|FG001|COMPLETED|Overall Study||0||
48679114|NCT01459666|101996638|FG000|NOT COMPLETED|Overall Study||5||
48679115|NCT01459666|101996639|FG001|NOT COMPLETED|Overall Study||4||
48679116|NCT04661033|101996640|FG000|STARTED|Overall Study||3||
48679117|NCT04661033|101996641|FG001|STARTED|Overall Study||3||
48679118|NCT04661033|101996642|FG002|STARTED|Overall Study||2||
48679119|NCT04661033|101996643|FG003|STARTED|Overall Study||0||
48679120|NCT04661033|101996640|FG000|Participants Who Completed the Study Treatment Period|Overall Study||3||
48679121|NCT04661033|101996641|FG001|Participants Who Completed the Study Treatment Period|Overall Study||2||
48679122|NCT04661033|101996642|FG002|Participants Who Completed the Study Treatment Period|Overall Study||1||
48679123|NCT04661033|101996643|FG003|Participants Who Completed the Study Treatment Period|Overall Study||0||
48679124|NCT04661033|101996640|FG000|COMPLETED|Overall Study||0||
48679125|NCT04661033|101996641|FG001|COMPLETED|Overall Study||3||
48679126|NCT04661033|101996642|FG002|COMPLETED|Overall Study||1||
48679127|NCT04661033|101996643|FG003|COMPLETED|Overall Study||0||
48679128|NCT04661033|101996640|FG000|NOT COMPLETED|Overall Study||3||
48679129|NCT04661033|101996641|FG001|NOT COMPLETED|Overall Study||0||
48679130|NCT04661033|101996642|FG002|NOT COMPLETED|Overall Study||1||
48679131|NCT04661033|101996643|FG003|NOT COMPLETED|Overall Study||0||
48679132|NCT00329030|101996644|FG000|STARTED|Overall Study||111||
48241333|NCT05878522|100911712|FG006|NOT COMPLETED|Treatment Period- 1 (3 Days)||0||
48241334|NCT05878522|100911713|FG007|NOT COMPLETED|Treatment Period- 1 (3 Days)||0||
48241335|NCT05878522|100911714|FG008|NOT COMPLETED|Treatment Period- 1 (3 Days)||1||
48241336|NCT05878522|100911715|FG009|NOT COMPLETED|Treatment Period- 1 (3 Days)||0||
48241337|NCT05878522|100911716|FG010|NOT COMPLETED|Treatment Period- 1 (3 Days)||0||
48241338|NCT05878522|100911717|FG011|NOT COMPLETED|Treatment Period- 1 (3 Days)||0||
48241339|NCT05878522|100911706|FG000|STARTED|Washout Period-1 (7 Days)||2||
48679133|NCT00329030|101996645|FG001|STARTED|Overall Study||113||
48679134|NCT00329030|101996644|FG000|COMPLETED|Overall Study||103||
48679135|NCT00329030|101996645|FG001|COMPLETED|Overall Study||107||
48679136|NCT00329030|101996644|FG000|NOT COMPLETED|Overall Study||8||
48679137|NCT00329030|101996645|FG001|NOT COMPLETED|Overall Study||6||
48679138|NCT04133168|101996646|FG000|STARTED|FROzEN AF Clinical Study||404||
48679139|NCT04133168|101996646|FG000|Procedure|FROzEN AF Clinical Study||326||
48679140|NCT04133168|101996646|FG000|Pre-Discharge|FROzEN AF Clinical Study||325||
48679141|NCT04133168|101996646|FG000|7 Day Follow Up|FROzEN AF Clinical Study||321||
48679142|NCT04133168|101996646|FG000|3 Month Follow Up|FROzEN AF Clinical Study||315||
48679143|NCT04133168|101996646|FG000|6 Month Follow Up|FROzEN AF Clinical Study||310||
48679144|NCT04133168|101996646|FG000|12 Month Follow Up|FROzEN AF Clinical Study||308||
48679145|NCT04133168|101996646|FG000|COMPLETED|FROzEN AF Clinical Study||308||
48679146|NCT04133168|101996646|FG000|NOT COMPLETED|FROzEN AF Clinical Study||96||
48679147|NCT04133168|101996646|FG000|STARTED|POLARx FIT Substudy||54||
48679148|NCT04133168|101996646|FG000|Pre-Discharge|POLARx FIT Substudy||50||
48241340|NCT05878522|100911707|FG001|STARTED|Washout Period-1 (7 Days)||2||
48241341|NCT05878522|100911708|FG002|STARTED|Washout Period-1 (7 Days)||5||
48241342|NCT05878522|100911709|FG003|STARTED|Washout Period-1 (7 Days)||5||
48241343|NCT05878522|100911710|FG004|STARTED|Washout Period-1 (7 Days)||2||
48241344|NCT05878522|100911711|FG005|STARTED|Washout Period-1 (7 Days)||4||
48241345|NCT05878522|100911712|FG006|STARTED|Washout Period-1 (7 Days)||2||
48241346|NCT05878522|100911713|FG007|STARTED|Washout Period-1 (7 Days)||5||
48241347|NCT05878522|100911714|FG008|STARTED|Washout Period-1 (7 Days)||2||
48241348|NCT05878522|100911715|FG009|STARTED|Washout Period-1 (7 Days)||5||
48241349|NCT05878522|100911716|FG010|STARTED|Washout Period-1 (7 Days)||3||
48241350|NCT05878522|100911717|FG011|STARTED|Washout Period-1 (7 Days)||5||
48241351|NCT05878522|100911706|FG000|COMPLETED|Washout Period-1 (7 Days)||2||
48241352|NCT05878522|100911707|FG001|COMPLETED|Washout Period-1 (7 Days)||2||
48241353|NCT05878522|100911708|FG002|COMPLETED|Washout Period-1 (7 Days)||5||
48241354|NCT05878522|100911709|FG003|COMPLETED|Washout Period-1 (7 Days)||5||
48241355|NCT05878522|100911710|FG004|COMPLETED|Washout Period-1 (7 Days)||2||
48241356|NCT05878522|100911711|FG005|COMPLETED|Washout Period-1 (7 Days)||4||
48241357|NCT05878522|100911712|FG006|COMPLETED|Washout Period-1 (7 Days)||2||
48241358|NCT05878522|100911713|FG007|COMPLETED|Washout Period-1 (7 Days)||5||
48241359|NCT05878522|100911714|FG008|COMPLETED|Washout Period-1 (7 Days)||2||
48241360|NCT05878522|100911715|FG009|COMPLETED|Washout Period-1 (7 Days)||5||
48241361|NCT05878522|100911716|FG010|COMPLETED|Washout Period-1 (7 Days)||3||
48241362|NCT05878522|100911717|FG011|COMPLETED|Washout Period-1 (7 Days)||5||
48241363|NCT05878522|100911706|FG000|NOT COMPLETED|Washout Period-1 (7 Days)||0||
48241364|NCT05878522|100911707|FG001|NOT COMPLETED|Washout Period-1 (7 Days)||0||
48241365|NCT05878522|100911708|FG002|NOT COMPLETED|Washout Period-1 (7 Days)||0||
48679149|NCT04133168|101996646|FG000|3 Month Follow Up|POLARx FIT Substudy||50||
48679150|NCT04133168|101996646|FG000|6 Month Follow Up|POLARx FIT Substudy||50||
48679151|NCT04133168|101996646|FG000|12 Month Follow Up|POLARx FIT Substudy||49||
48679152|NCT04133168|101996646|FG000|COMPLETED|POLARx FIT Substudy||49||
48679153|NCT04133168|101996646|FG000|NOT COMPLETED|POLARx FIT Substudy||5||
48679154|NCT02481414|101996647|FG000|STARTED|Overall Study||39||
48679155|NCT02481414|101996648|FG001|STARTED|Overall Study||42||
48679156|NCT02481414|101996647|FG000|COMPLETED|Overall Study||35||
48679157|NCT02481414|101996648|FG001|COMPLETED|Overall Study||41||
48679158|NCT02481414|101996647|FG000|NOT COMPLETED|Overall Study||4||
48679159|NCT02481414|101996648|FG001|NOT COMPLETED|Overall Study||1||
48679160|NCT02673944|101996649|FG000|STARTED|Overall Study||10||
48679161|NCT02673944|101996649|FG000|COMPLETED|Overall Study||10||
48679162|NCT02673944|101996649|FG000|NOT COMPLETED|Overall Study||0||
48679163|NCT00487981|101996650|FG000|STARTED|Overall Study||1||
48679164|NCT00487981|101996650|FG000|COMPLETED|Overall Study||0||
48679165|NCT00487981|101996650|FG000|NOT COMPLETED|Overall Study||1||
48679166|NCT00256126|101996651|FG000|STARTED|Overall Study||149||
48679167|NCT00256126|101996652|FG001|STARTED|Overall Study||169||
48679168|NCT00256126|101996651|FG000|COMPLETED|Overall Study||147||
48679169|NCT00256126|101996652|FG001|COMPLETED|Overall Study||167||
48679170|NCT00256126|101996651|FG000|NOT COMPLETED|Overall Study||2||
48679171|NCT00256126|101996652|FG001|NOT COMPLETED|Overall Study||2||
48679172|NCT02250417|101996653|FG000|STARTED|First Intervention (1 Night)||6||
48679173|NCT02250417|101996654|FG001|STARTED|First Intervention (1 Night)||6||
48679174|NCT02250417|101996653|FG000|COMPLETED|First Intervention (1 Night)||6||
48679175|NCT02250417|101996654|FG001|COMPLETED|First Intervention (1 Night)||6||
48679176|NCT02250417|101996653|FG000|NOT COMPLETED|First Intervention (1 Night)||0||
48679177|NCT02250417|101996654|FG001|NOT COMPLETED|First Intervention (1 Night)||0||
48679178|NCT02250417|101996653|FG000|STARTED|Second Intervention (1 Night)||6||
48679179|NCT02250417|101996654|FG001|STARTED|Second Intervention (1 Night)||6||
48679180|NCT02250417|101996653|FG000|COMPLETED|Second Intervention (1 Night)||6||
48679181|NCT02250417|101996654|FG001|COMPLETED|Second Intervention (1 Night)||6||
48679182|NCT02250417|101996653|FG000|NOT COMPLETED|Second Intervention (1 Night)||0||
48679183|NCT02250417|101996654|FG001|NOT COMPLETED|Second Intervention (1 Night)||0||
48679184|NCT03894891|101996655|FG000|STARTED|Overall Study||6||
48679185|NCT03894891|101996655|FG000|COMPLETED|Overall Study||0||
48679186|NCT03894891|101996655|FG000|NOT COMPLETED|Overall Study||6||
48679187|NCT01526629|101996656|FG000|STARTED|Overall Study||354||
48679188|NCT01526629|101996656|FG000|COMPLETED|Overall Study||308||
48679189|NCT01526629|101996656|FG000|NOT COMPLETED|Overall Study||46||
48679190|NCT03557125|101996657|FG000|STARTED|Overall Study||22||
48679191|NCT03557125|101996658|FG001|STARTED|Overall Study||24||
48679192|NCT03557125|101996657|FG000|COMPLETED|Overall Study||22||
48679193|NCT03557125|101996658|FG001|COMPLETED|Overall Study||24||
48679194|NCT03557125|101996657|FG000|NOT COMPLETED|Overall Study||0||
48679195|NCT03557125|101996658|FG001|NOT COMPLETED|Overall Study||0||
48679196|NCT04409834|101996659|FG000|STARTED|Overall Study||197||
48679197|NCT04409834|101996660|FG001|STARTED|Overall Study||193||
48679198|NCT04409834|101996659|FG000|Randomized to Anti-platelet Therapy|Overall Study||74||
48679199|NCT04409834|101996660|FG001|Randomized to Anti-platelet Therapy|Overall Study||78||
48679200|NCT04409834|101996659|FG000|Randomized to no Antiplatelet Therapy|Overall Study||73||
48679201|NCT04409834|101996660|FG001|Randomized to no Antiplatelet Therapy|Overall Study||67||
48679202|NCT04409834|101996659|FG000|COMPLETED|Overall Study||142||
48679203|NCT04409834|101996660|FG001|COMPLETED|Overall Study||131||
48679204|NCT04409834|101996659|FG000|NOT COMPLETED|Overall Study||55||
48679205|NCT04409834|101996660|FG001|NOT COMPLETED|Overall Study||62||
48679206|NCT00692003|101996661|FG000|STARTED|Overall Study||5||
48679207|NCT00692003|101996662|FG001|STARTED|Overall Study||1||
48679208|NCT00692003|101996661|FG000|COMPLETED|Overall Study||0||
48679209|NCT00692003|101996662|FG001|COMPLETED|Overall Study||0||
48679210|NCT00692003|101996661|FG000|NOT COMPLETED|Overall Study||5||
48679211|NCT00692003|101996662|FG001|NOT COMPLETED|Overall Study||1||
48679212|NCT03119168|101996663|FG000|STARTED|Overall Study||129||
48679213|NCT03119168|101996664|FG001|STARTED|Overall Study||139||
48679214|NCT03119168|101996663|FG000|COMPLETED|Overall Study||129||
48679215|NCT03119168|101996664|FG001|COMPLETED|Overall Study||139||
48679216|NCT03119168|101996663|FG000|NOT COMPLETED|Overall Study||0||
48679217|NCT03119168|101996664|FG001|NOT COMPLETED|Overall Study||0||
48679218|NCT01605669|101996665|FG000|STARTED|Overall Study||50||
48679219|NCT01605669|101996665|FG000|COMPLETED|Overall Study||50||
48679220|NCT01605669|101996665|FG000|NOT COMPLETED|Overall Study||0||
48679221|NCT05518461|101996666|FG000|STARTED|Overall Study||60||
48679222|NCT05518461|101996666|FG000|Completed at 3 Months|Overall Study||44||
48679223|NCT05518461|101996666|FG000|Completed at 6 Months|Overall Study||38||
48679224|NCT05518461|101996666|FG000|Completed All 3 Surveys|Overall Study||35||
48679225|NCT05518461|101996666|FG000|Completed Only Baseline and 3 Month|Overall Study||9||
48679226|NCT05518461|101996666|FG000|Completed Only Baseline and 6 Month|Overall Study||3||
48679227|NCT05518461|101996666|FG000|COMPLETED|Overall Study||35||
48679228|NCT05518461|101996666|FG000|NOT COMPLETED|Overall Study||25||
48679229|NCT03761056|101996667|FG000|STARTED|Overall Study||42||
48679230|NCT03761056|101996667|FG000|COMPLETED|Overall Study||29|Completed study and enrolled to long term follow-up (LTFU) protocol, another study (KT-US-982-5968; NCT# NCT05041309).|
48679231|NCT03761056|101996667|FG000|NOT COMPLETED|Overall Study||13||
48679232|NCT02332928|101996668|FG000|STARTED|Overall Study||40||
48679233|NCT02332928|101996669|FG001|STARTED|Overall Study||40||
48679234|NCT02332928|101996668|FG000|COMPLETED|Overall Study||39||
48679235|NCT02332928|101996669|FG001|COMPLETED|Overall Study||38||
48679236|NCT02332928|101996668|FG000|NOT COMPLETED|Overall Study||1||
48241366|NCT05878522|100911709|FG003|NOT COMPLETED|Washout Period-1 (7 Days)||0||
48241367|NCT05878522|100911710|FG004|NOT COMPLETED|Washout Period-1 (7 Days)||0||
48241368|NCT05878522|100911711|FG005|NOT COMPLETED|Washout Period-1 (7 Days)||0||
48241369|NCT05878522|100911712|FG006|NOT COMPLETED|Washout Period-1 (7 Days)||0||
48241370|NCT05878522|100911713|FG007|NOT COMPLETED|Washout Period-1 (7 Days)||0||
48241371|NCT05878522|100911714|FG008|NOT COMPLETED|Washout Period-1 (7 Days)||0||
48241372|NCT05878522|100911715|FG009|NOT COMPLETED|Washout Period-1 (7 Days)||0||
48081250|NCT03129100|100521620|FG007|STARTED|Period 2 (Retreatment Extension Period)||6||
48540224|NCT03058289|101658027|FG007|NOT COMPLETED|Overall Study||17||
48081251|NCT03129100|100521621|FG008|STARTED|Period 2 (Retreatment Extension Period)||5||
48679237|NCT02332928|101996669|FG001|NOT COMPLETED|Overall Study||2||
48679238|NCT00003816|101996670|FG000|STARTED|Overall Study||55||
48679239|NCT00003816|101996671|FG001|STARTED|Overall Study||69||
48679240|NCT00003816|101996672|FG002|STARTED|Overall Study||199||
48679241|NCT00003816|101996673|FG003|STARTED|Overall Study||23||
48241373|NCT05878522|100911716|FG010|NOT COMPLETED|Washout Period-1 (7 Days)||0||
48241374|NCT05878522|100911717|FG011|NOT COMPLETED|Washout Period-1 (7 Days)||0||
48241375|NCT05878522|100911706|FG000|STARTED|Treatment Period- 2 (3 Days)||2||
48241376|NCT05878522|100911707|FG001|STARTED|Treatment Period- 2 (3 Days)||2||
48241377|NCT05878522|100911708|FG002|STARTED|Treatment Period- 2 (3 Days)||5||
48241378|NCT05878522|100911709|FG003|STARTED|Treatment Period- 2 (3 Days)||5||
48241379|NCT05878522|100911710|FG004|STARTED|Treatment Period- 2 (3 Days)||2||
48241380|NCT05878522|100911711|FG005|STARTED|Treatment Period- 2 (3 Days)||4||
48241381|NCT05878522|100911712|FG006|STARTED|Treatment Period- 2 (3 Days)||2||
48241382|NCT05878522|100911713|FG007|STARTED|Treatment Period- 2 (3 Days)||5||
48241383|NCT05878522|100911714|FG008|STARTED|Treatment Period- 2 (3 Days)||2||
48241384|NCT05878522|100911715|FG009|STARTED|Treatment Period- 2 (3 Days)||5||
48241385|NCT05878522|100911716|FG010|STARTED|Treatment Period- 2 (3 Days)||3||
48241386|NCT05878522|100911717|FG011|STARTED|Treatment Period- 2 (3 Days)||5||
48241387|NCT05878522|100911706|FG000|COMPLETED|Treatment Period- 2 (3 Days)||1||
48241388|NCT05878522|100911707|FG001|COMPLETED|Treatment Period- 2 (3 Days)||1||
48241389|NCT05878522|100911708|FG002|COMPLETED|Treatment Period- 2 (3 Days)||5||
48241390|NCT05878522|100911709|FG003|COMPLETED|Treatment Period- 2 (3 Days)||4||
48241391|NCT05878522|100911710|FG004|COMPLETED|Treatment Period- 2 (3 Days)||1||
48241392|NCT05878522|100911711|FG005|COMPLETED|Treatment Period- 2 (3 Days)||4||
48241393|NCT05878522|100911712|FG006|COMPLETED|Treatment Period- 2 (3 Days)||2||
48241394|NCT05878522|100911713|FG007|COMPLETED|Treatment Period- 2 (3 Days)||5||
48241395|NCT05878522|100911714|FG008|COMPLETED|Treatment Period- 2 (3 Days)||2||
48241396|NCT05878522|100911715|FG009|COMPLETED|Treatment Period- 2 (3 Days)||4||
48241397|NCT05878522|100911716|FG010|COMPLETED|Treatment Period- 2 (3 Days)||3||
48241398|NCT05878522|100911717|FG011|COMPLETED|Treatment Period- 2 (3 Days)||5||
48241399|NCT05878522|100911706|FG000|NOT COMPLETED|Treatment Period- 2 (3 Days)||1||
48241400|NCT05878522|100911707|FG001|NOT COMPLETED|Treatment Period- 2 (3 Days)||1||
48241401|NCT05878522|100911708|FG002|NOT COMPLETED|Treatment Period- 2 (3 Days)||0||
48241402|NCT05878522|100911709|FG003|NOT COMPLETED|Treatment Period- 2 (3 Days)||1||
48241403|NCT05878522|100911710|FG004|NOT COMPLETED|Treatment Period- 2 (3 Days)||1||
48241404|NCT05878522|100911711|FG005|NOT COMPLETED|Treatment Period- 2 (3 Days)||0||
48241405|NCT05878522|100911712|FG006|NOT COMPLETED|Treatment Period- 2 (3 Days)||0||
48241406|NCT05878522|100911713|FG007|NOT COMPLETED|Treatment Period- 2 (3 Days)||0||
48241407|NCT05878522|100911714|FG008|NOT COMPLETED|Treatment Period- 2 (3 Days)||0||
48241408|NCT05878522|100911715|FG009|NOT COMPLETED|Treatment Period- 2 (3 Days)||1||
48241409|NCT05878522|100911716|FG010|NOT COMPLETED|Treatment Period- 2 (3 Days)||0||
48241410|NCT05878522|100911717|FG011|NOT COMPLETED|Treatment Period- 2 (3 Days)||0||
48241411|NCT05878522|100911706|FG000|STARTED|Washout Period-2 (7 Days)||1||
48241412|NCT05878522|100911707|FG001|STARTED|Washout Period-2 (7 Days)||1||
48241413|NCT05878522|100911708|FG002|STARTED|Washout Period-2 (7 Days)||5||
48241414|NCT05878522|100911709|FG003|STARTED|Washout Period-2 (7 Days)||4||
48241415|NCT05878522|100911710|FG004|STARTED|Washout Period-2 (7 Days)||1||
48241416|NCT05878522|100911711|FG005|STARTED|Washout Period-2 (7 Days)||4||
48241417|NCT05878522|100911712|FG006|STARTED|Washout Period-2 (7 Days)||2||
48241418|NCT05878522|100911713|FG007|STARTED|Washout Period-2 (7 Days)||5||
48241419|NCT05878522|100911714|FG008|STARTED|Washout Period-2 (7 Days)||2||
48241420|NCT05878522|100911715|FG009|STARTED|Washout Period-2 (7 Days)||4||
48241421|NCT05878522|100911716|FG010|STARTED|Washout Period-2 (7 Days)||3||
48241422|NCT05878522|100911717|FG011|STARTED|Washout Period-2 (7 Days)||5||
48241423|NCT05878522|100911706|FG000|COMPLETED|Washout Period-2 (7 Days)||1||
48241424|NCT05878522|100911707|FG001|COMPLETED|Washout Period-2 (7 Days)||1||
48241425|NCT05878522|100911708|FG002|COMPLETED|Washout Period-2 (7 Days)||5||
48241426|NCT05878522|100911709|FG003|COMPLETED|Washout Period-2 (7 Days)||4||
48241427|NCT05878522|100911710|FG004|COMPLETED|Washout Period-2 (7 Days)||1||
48241428|NCT05878522|100911711|FG005|COMPLETED|Washout Period-2 (7 Days)||4||
48241429|NCT05878522|100911712|FG006|COMPLETED|Washout Period-2 (7 Days)||2||
48241430|NCT05878522|100911713|FG007|COMPLETED|Washout Period-2 (7 Days)||5||
48241431|NCT05878522|100911714|FG008|COMPLETED|Washout Period-2 (7 Days)||2||
48241432|NCT05878522|100911715|FG009|COMPLETED|Washout Period-2 (7 Days)||4||
48241433|NCT05878522|100911716|FG010|COMPLETED|Washout Period-2 (7 Days)||3||
48241434|NCT05878522|100911717|FG011|COMPLETED|Washout Period-2 (7 Days)||5||
48241435|NCT05878522|100911706|FG000|NOT COMPLETED|Washout Period-2 (7 Days)||0||
48241436|NCT05878522|100911707|FG001|NOT COMPLETED|Washout Period-2 (7 Days)||0||
48241437|NCT05878522|100911708|FG002|NOT COMPLETED|Washout Period-2 (7 Days)||0||
48241438|NCT05878522|100911709|FG003|NOT COMPLETED|Washout Period-2 (7 Days)||0||
48241439|NCT05878522|100911710|FG004|NOT COMPLETED|Washout Period-2 (7 Days)||0||
48241440|NCT05878522|100911711|FG005|NOT COMPLETED|Washout Period-2 (7 Days)||0||
48241441|NCT05878522|100911712|FG006|NOT COMPLETED|Washout Period-2 (7 Days)||0||
48241442|NCT05878522|100911713|FG007|NOT COMPLETED|Washout Period-2 (7 Days)||0||
48241443|NCT05878522|100911714|FG008|NOT COMPLETED|Washout Period-2 (7 Days)||0||
48241444|NCT05878522|100911715|FG009|NOT COMPLETED|Washout Period-2 (7 Days)||0||
48241445|NCT05878522|100911716|FG010|NOT COMPLETED|Washout Period-2 (7 Days)||0||
48241446|NCT05878522|100911717|FG011|NOT COMPLETED|Washout Period-2 (7 Days)||0||
48241447|NCT05878522|100911706|FG000|STARTED|Treatment Period- 3 (3 Days)||1||
48241448|NCT05878522|100911707|FG001|STARTED|Treatment Period- 3 (3 Days)||1||
48241449|NCT05878522|100911708|FG002|STARTED|Treatment Period- 3 (3 Days)||5||
48241450|NCT05878522|100911709|FG003|STARTED|Treatment Period- 3 (3 Days)||4||
48241451|NCT05878522|100911710|FG004|STARTED|Treatment Period- 3 (3 Days)||1||
48241452|NCT05878522|100911711|FG005|STARTED|Treatment Period- 3 (3 Days)||4||
48241453|NCT05878522|100911712|FG006|STARTED|Treatment Period- 3 (3 Days)||2||
48679242|NCT00003816|101996674|FG004|STARTED|Overall Study||15||
48679243|NCT00003816|101996670|FG000|COMPLETED|Overall Study||55||
48241454|NCT05878522|100911713|FG007|STARTED|Treatment Period- 3 (3 Days)||5||
48241455|NCT05878522|100911714|FG008|STARTED|Treatment Period- 3 (3 Days)||2||
48241456|NCT05878522|100911715|FG009|STARTED|Treatment Period- 3 (3 Days)||4||
48241457|NCT05878522|100911716|FG010|STARTED|Treatment Period- 3 (3 Days)||3||
48241458|NCT05878522|100911717|FG011|STARTED|Treatment Period- 3 (3 Days)||5||
48241459|NCT05878522|100911706|FG000|COMPLETED|Treatment Period- 3 (3 Days)||1||
48679244|NCT00003816|101996671|FG001|COMPLETED|Overall Study||69||
48679245|NCT00003816|101996672|FG002|COMPLETED|Overall Study||199||
48679246|NCT00003816|101996673|FG003|COMPLETED|Overall Study||23||
48679247|NCT00003816|101996674|FG004|COMPLETED|Overall Study||15||
48679248|NCT00003816|101996670|FG000|NOT COMPLETED|Overall Study||0||
48679249|NCT00003816|101996671|FG001|NOT COMPLETED|Overall Study||0||
48679250|NCT00003816|101996672|FG002|NOT COMPLETED|Overall Study||0||
48679251|NCT00003816|101996673|FG003|NOT COMPLETED|Overall Study||0||
48679252|NCT00003816|101996674|FG004|NOT COMPLETED|Overall Study||0||
48679253|NCT02012218|101996675|FG000|STARTED|Overall Study||12||
48679254|NCT02012218|101996676|FG001|STARTED|Overall Study||11||
48679255|NCT02012218|101996677|FG002|STARTED|Overall Study||13||
48679256|NCT02012218|101996678|FG003|STARTED|Overall Study||19||
48679257|NCT02012218|101996679|FG004|STARTED|Overall Study||6||
48679258|NCT02012218|101996675|FG000|COMPLETED|Overall Study||8||
48679259|NCT02012218|101996676|FG001|COMPLETED|Overall Study||10||
48679260|NCT02012218|101996677|FG002|COMPLETED|Overall Study||11||
48679261|NCT02012218|101996678|FG003|COMPLETED|Overall Study||17||
48241460|NCT05878522|100911707|FG001|COMPLETED|Treatment Period- 3 (3 Days)||1||
48241461|NCT05878522|100911708|FG002|COMPLETED|Treatment Period- 3 (3 Days)||5||
48241462|NCT05878522|100911709|FG003|COMPLETED|Treatment Period- 3 (3 Days)||4||
48241463|NCT05878522|100911710|FG004|COMPLETED|Treatment Period- 3 (3 Days)||1||
48241464|NCT05878522|100911711|FG005|COMPLETED|Treatment Period- 3 (3 Days)||4||
48241465|NCT05878522|100911712|FG006|COMPLETED|Treatment Period- 3 (3 Days)||2||
48241466|NCT05878522|100911713|FG007|COMPLETED|Treatment Period- 3 (3 Days)||5||
48241467|NCT05878522|100911714|FG008|COMPLETED|Treatment Period- 3 (3 Days)||2||
48241468|NCT05878522|100911715|FG009|COMPLETED|Treatment Period- 3 (3 Days)||4||
48241469|NCT05878522|100911716|FG010|COMPLETED|Treatment Period- 3 (3 Days)||3||
48679262|NCT02012218|101996679|FG004|COMPLETED|Overall Study||5||
48679263|NCT02012218|101996675|FG000|NOT COMPLETED|Overall Study||4||
48679264|NCT02012218|101996676|FG001|NOT COMPLETED|Overall Study||1||
48241470|NCT05878522|100911717|FG011|COMPLETED|Treatment Period- 3 (3 Days)||5||
48241471|NCT05878522|100911706|FG000|NOT COMPLETED|Treatment Period- 3 (3 Days)||0||
48241472|NCT05878522|100911707|FG001|NOT COMPLETED|Treatment Period- 3 (3 Days)||0||
48241473|NCT05878522|100911708|FG002|NOT COMPLETED|Treatment Period- 3 (3 Days)||0||
48241474|NCT05878522|100911709|FG003|NOT COMPLETED|Treatment Period- 3 (3 Days)||0||
48241475|NCT05878522|100911710|FG004|NOT COMPLETED|Treatment Period- 3 (3 Days)||0||
48241476|NCT05878522|100911711|FG005|NOT COMPLETED|Treatment Period- 3 (3 Days)||0||
48241477|NCT05878522|100911712|FG006|NOT COMPLETED|Treatment Period- 3 (3 Days)||0||
48241478|NCT05878522|100911713|FG007|NOT COMPLETED|Treatment Period- 3 (3 Days)||0||
48241479|NCT05878522|100911714|FG008|NOT COMPLETED|Treatment Period- 3 (3 Days)||0||
48241480|NCT05878522|100911715|FG009|NOT COMPLETED|Treatment Period- 3 (3 Days)||0||
48241481|NCT05878522|100911716|FG010|NOT COMPLETED|Treatment Period- 3 (3 Days)||0||
48241482|NCT05878522|100911717|FG011|NOT COMPLETED|Treatment Period- 3 (3 Days)||0||
48241483|NCT01023022|100911718|FG000|STARTED|Overall Study||176||
48241484|NCT01023022|100911718|FG000|COMPLETED|Overall Study||162||
48241485|NCT01023022|100911718|FG000|NOT COMPLETED|Overall Study||14||
48241486|NCT05274906|100911719|FG000|STARTED|Overall Study||12||
48241487|NCT05274906|100911720|FG001|STARTED|Overall Study||11||
48241488|NCT05274906|100911719|FG000|COMPLETED|Overall Study||10||
48241489|NCT05274906|100911720|FG001|COMPLETED|Overall Study||10||
48241490|NCT05274906|100911719|FG000|NOT COMPLETED|Overall Study||2||
48241491|NCT05274906|100911720|FG001|NOT COMPLETED|Overall Study||1||
48241492|NCT01770509|100911721|FG000|STARTED|Overall Study||12||
48241493|NCT01770509|100911722|FG001|STARTED|Overall Study||17||
48241494|NCT01770509|100911721|FG000|COMPLETED|Overall Study||11||
48540225|NCT03058289|101658028|FG008|NOT COMPLETED|Overall Study||5||
48540226|NCT01377987|101658029|FG000|STARTED|First Intervention (7 Days)||14||
48241495|NCT01770509|100911722|FG001|COMPLETED|Overall Study||14||
48241496|NCT01770509|100911721|FG000|NOT COMPLETED|Overall Study||1||
48241497|NCT01770509|100911722|FG001|NOT COMPLETED|Overall Study||3||
48241498|NCT05361304|100911723|FG000|STARTED|Overall Study||62||
48241499|NCT05361304|100911724|FG001|STARTED|Overall Study||61||
48241500|NCT05361304|100911723|FG000|COMPLETED|Overall Study||59||
48241501|NCT05361304|100911724|FG001|COMPLETED|Overall Study||59||
48241502|NCT05361304|100911723|FG000|NOT COMPLETED|Overall Study||3||
48241503|NCT05361304|100911724|FG001|NOT COMPLETED|Overall Study||2||
48241504|NCT02713217|100911725|FG000|STARTED|Overall Study||279||
48241505|NCT02713217|100911726|FG001|STARTED|Overall Study||39||
48241506|NCT02713217|100911725|FG000|COMPLETED|Overall Study||223||
48241507|NCT02713217|100911726|FG001|COMPLETED|Overall Study||34||
48241508|NCT02713217|100911725|FG000|NOT COMPLETED|Overall Study||56||
48241509|NCT02713217|100911726|FG001|NOT COMPLETED|Overall Study||5||
48540227|NCT01377987|101658030|FG001|STARTED|First Intervention (7 Days)||15||
48241510|NCT01516710|100911727|FG000|STARTED|Overall Study||147||
48241511|NCT01516710|100911728|FG001|STARTED|Overall Study||133||
48540228|NCT01377987|101658029|FG000|COMPLETED|First Intervention (7 Days)||14||
48540229|NCT01377987|101658030|FG001|COMPLETED|First Intervention (7 Days)||15||
48540230|NCT01377987|101658029|FG000|NOT COMPLETED|First Intervention (7 Days)||0||
48540231|NCT01377987|101658030|FG001|NOT COMPLETED|First Intervention (7 Days)||0||
48540232|NCT01377987|101658029|FG000|STARTED|Washout (7 Days)||14||
48540233|NCT01377987|101658030|FG001|STARTED|Washout (7 Days)||15||
48241512|NCT01516710|100911727|FG000|COMPLETED|Overall Study||143||
48241513|NCT01516710|100911728|FG001|COMPLETED|Overall Study||129||
48241514|NCT01516710|100911727|FG000|NOT COMPLETED|Overall Study||4||
48241515|NCT01516710|100911728|FG001|NOT COMPLETED|Overall Study||4||
48540234|NCT01377987|101658029|FG000|COMPLETED|Washout (7 Days)||13||
48540235|NCT01377987|101658030|FG001|COMPLETED|Washout (7 Days)||14||
48540236|NCT01377987|101658029|FG000|NOT COMPLETED|Washout (7 Days)||1||
48679265|NCT02012218|101996677|FG002|NOT COMPLETED|Overall Study||2||
48241516|NCT00755716|100911729|FG000|STARTED|Overall Study||19||
48241517|NCT00755716|100911730|FG001|STARTED|Overall Study||19||
48241518|NCT00755716|100911731|FG002|STARTED|Overall Study||19||
48241519|NCT00755716|100911729|FG000|COMPLETED|Overall Study||11||
48241520|NCT00755716|100911730|FG001|COMPLETED|Overall Study||11||
48241521|NCT00755716|100911731|FG002|COMPLETED|Overall Study||16||
48241522|NCT00755716|100911729|FG000|NOT COMPLETED|Overall Study||8||
48241523|NCT00755716|100911730|FG001|NOT COMPLETED|Overall Study||8||
48241524|NCT00755716|100911731|FG002|NOT COMPLETED|Overall Study||3||
48241525|NCT01057888|100911732|FG000|STARTED|Overall Study||2504||
48241526|NCT01057888|100911733|FG001|STARTED|Overall Study||2406||
48241527|NCT01057888|100911734|FG002|STARTED|Overall Study||2494||
48241528|NCT01057888|100911732|FG000|COMPLETED|Overall Study||2504||
48241529|NCT01057888|100911733|FG001|COMPLETED|Overall Study||2406||
48241530|NCT01057888|100911734|FG002|COMPLETED|Overall Study||2494||
48679266|NCT02012218|101996678|FG003|NOT COMPLETED|Overall Study||2||
48679267|NCT02012218|101996679|FG004|NOT COMPLETED|Overall Study||1||
48679268|NCT01800786|101996680|FG000|STARTED|Overall Study||17||
48679269|NCT01800786|101996681|FG001|STARTED|Overall Study||16||
48679270|NCT01800786|101996680|FG000|COMPLETED|Overall Study||15||
48679271|NCT01800786|101996681|FG001|COMPLETED|Overall Study||15||
48679272|NCT01800786|101996680|FG000|NOT COMPLETED|Overall Study||2||
48679273|NCT01800786|101996681|FG001|NOT COMPLETED|Overall Study||1||
48679274|NCT00577278|101996682|FG000|STARTED|Overall Study||41||
48679275|NCT00577278|101996682|FG000|COMPLETED|Overall Study||41||
48679276|NCT00577278|101996682|FG000|NOT COMPLETED|Overall Study||0||
48679277|NCT02289469|101996683|FG000|STARTED|Overall Study||250||
48679278|NCT02289469|101996684|FG001|STARTED|Overall Study||244||
48679279|NCT02289469|101996683|FG000|COMPLETED|Overall Study||244||
48679280|NCT02289469|101996684|FG001|COMPLETED|Overall Study||244||
48679281|NCT02289469|101996683|FG000|NOT COMPLETED|Overall Study||6||
48679282|NCT02289469|101996684|FG001|NOT COMPLETED|Overall Study||0||
48679283|NCT03376516|101996685|FG000|STARTED|Overall Study||11||
48679284|NCT03376516|101996685|FG000|Received Treatment|Overall Study||10||
48679285|NCT03376516|101996685|FG000|SAF Population|Overall Study||10|SAF population = study population of patients in safety analysis|
48679286|NCT03376516|101996685|FG000|FAS Population|Overall Study||10|FAS population = full analysis population|
48679287|NCT03376516|101996685|FG000|PK Population|Overall Study||10|PK population = study population of patients who underwent pharmacokinetic analysis|
48679288|NCT03376516|101996685|FG000|PP Population|Overall Study||9|PP population = per-protocol population|
48679289|NCT03376516|101996685|FG000|SURG Population|Overall Study||2|SURG population = study population of patients undergoing surgery treated with Wilate|
48679290|NCT03376516|101996685|FG000|COMPLETED|Overall Study||9||
48679291|NCT03376516|101996685|FG000|NOT COMPLETED|Overall Study||2||
48679292|NCT00943761|101996686|FG000|STARTED|Overall Study||21||
48241531|NCT01057888|100911732|FG000|NOT COMPLETED|Overall Study||0||
48241532|NCT01057888|100911733|FG001|NOT COMPLETED|Overall Study||0||
48241533|NCT01057888|100911734|FG002|NOT COMPLETED|Overall Study||0||
48241534|NCT01975701|100911735|FG000|STARTED|Overall Study||26||
48241535|NCT01975701|100911735|FG000|COMPLETED|Overall Study||1||
48241536|NCT01975701|100911735|FG000|NOT COMPLETED|Overall Study||25||
48241537|NCT01655498|100911736|FG000|STARTED|Overall Study||61||
48679293|NCT00943761|101996687|FG001|STARTED|Overall Study||24||
48679294|NCT00943761|101996686|FG000|COMPLETED|Overall Study||17||
48679295|NCT00943761|101996687|FG001|COMPLETED|Overall Study||23||
48679296|NCT00943761|101996686|FG000|NOT COMPLETED|Overall Study||4||
48679297|NCT00943761|101996687|FG001|NOT COMPLETED|Overall Study||1||
48679298|NCT04619004|101996688|FG000|STARTED|Overall Study||226||
48679299|NCT04619004|101996689|FG001|STARTED|Overall Study||51||
48679300|NCT04619004|101996688|FG000|COMPLETED|Overall Study||87|Ongoing patients as of data cutoff date|
48679301|NCT04619004|101996689|FG001|COMPLETED|Overall Study||14|Ongoing patients as of data cutoff date|
48679302|NCT04619004|101996688|FG000|NOT COMPLETED|Overall Study||139||
48679303|NCT04619004|101996689|FG001|NOT COMPLETED|Overall Study||37||
48679304|NCT02296476|101996690|FG000|STARTED|Overall Study||6||
48679305|NCT02296476|101996691|FG001|STARTED|Overall Study||4||
48679306|NCT02296476|101996692|FG002|STARTED|Overall Study||2||
48679307|NCT02296476|101996690|FG000|COMPLETED|Overall Study||0||
48679308|NCT02296476|101996691|FG001|COMPLETED|Overall Study||0||
48679309|NCT02296476|101996692|FG002|COMPLETED|Overall Study||0||
48679310|NCT02296476|101996690|FG000|NOT COMPLETED|Overall Study||6||
48679311|NCT02296476|101996691|FG001|NOT COMPLETED|Overall Study||4||
48679312|NCT02296476|101996692|FG002|NOT COMPLETED|Overall Study||2||
48679313|NCT01175343|101996693|FG000|STARTED|Overall Study||44||
48241538|NCT01655498|100911736|FG000|COMPLETED|Overall Study||56||
48241539|NCT01655498|100911736|FG000|NOT COMPLETED|Overall Study||5||
48679314|NCT01175343|101996693|FG000|COMPLETED|Overall Study||44||
48679315|NCT01175343|101996693|FG000|NOT COMPLETED|Overall Study||0||
48679316|NCT03702179|101999799|FG000|STARTED|Overall Study||32||
48679317|NCT03702179|101999799|FG000|COMPLETED|Overall Study||32||
48679318|NCT03702179|101999799|FG000|NOT COMPLETED|Overall Study||0||
48679319|NCT02153489|101999800|FG000|STARTED|Period 1||15||
48679320|NCT02153489|101999801|FG001|STARTED|Period 1||15||
48241540|NCT01544153|100911737|FG000|STARTED|Overall Study||1337||
48540237|NCT01377987|101658030|FG001|NOT COMPLETED|Washout (7 Days)||1||
48540238|NCT01377987|101658029|FG000|STARTED|Second Intervention (7 Days)||13||
48540239|NCT01377987|101658030|FG001|STARTED|Second Intervention (7 Days)||14||
48540240|NCT01377987|101658029|FG000|COMPLETED|Second Intervention (7 Days)||13||
48540241|NCT01377987|101658030|FG001|COMPLETED|Second Intervention (7 Days)||14||
48540242|NCT01377987|101658029|FG000|NOT COMPLETED|Second Intervention (7 Days)||0||
48679321|NCT02153489|101999800|FG000|COMPLETED|Period 1||15||
48679322|NCT02153489|101999801|FG001|COMPLETED|Period 1||15||
48679323|NCT02153489|101999800|FG000|NOT COMPLETED|Period 1||0||
48679324|NCT02153489|101999801|FG001|NOT COMPLETED|Period 1||0||
48679325|NCT02153489|101999800|FG000|STARTED|Period 2||15||
48679326|NCT02153489|101999801|FG001|STARTED|Period 2||15||
48679327|NCT02153489|101999800|FG000|COMPLETED|Period 2||15||
48679328|NCT02153489|101999801|FG001|COMPLETED|Period 2||15||
48679329|NCT02153489|101999800|FG000|NOT COMPLETED|Period 2||0||
48679330|NCT02153489|101999801|FG001|NOT COMPLETED|Period 2||0||
48679331|NCT01469039|101999802|FG000|STARTED|Overall Study||207||
48679332|NCT01469039|101999803|FG001|STARTED|Overall Study||208||
48679333|NCT01469039|101999804|FG002|STARTED|Overall Study||208||
48679334|NCT01469039|101999802|FG000|COMPLETED|Overall Study||130||
48679335|NCT01469039|101999803|FG001|COMPLETED|Overall Study||135||
48679336|NCT01469039|101999804|FG002|COMPLETED|Overall Study||95||
48540243|NCT01377987|101658030|FG001|NOT COMPLETED|Second Intervention (7 Days)||0||
48540244|NCT00741286|101658031|FG000|STARTED|Overall Study||103||
48540245|NCT00741286|101658032|FG001|STARTED|Overall Study||100||
48540246|NCT00741286|101658031|FG000|COMPLETED|Overall Study||83||
48540247|NCT00741286|101658032|FG001|COMPLETED|Overall Study||81||
48540248|NCT00741286|101658031|FG000|NOT COMPLETED|Overall Study||20||
48540249|NCT00741286|101658032|FG001|NOT COMPLETED|Overall Study||19||
48540250|NCT00660400|101658033|FG000|STARTED|Overall Study||25||
48540251|NCT00660400|101658033|FG000|COMPLETED|Overall Study||21||
48540252|NCT00660400|101658033|FG000|NOT COMPLETED|Overall Study||4||
48540253|NCT02383810|101658034|FG000|STARTED|Overall Study||120||
48540254|NCT02383810|101658035|FG001|STARTED|Overall Study||122||
48540255|NCT02383810|101658036|FG002|STARTED|Overall Study||120||
48540256|NCT02383810|101658037|FG003|STARTED|Overall Study||123||
48540257|NCT02383810|101658038|FG004|STARTED|Overall Study||4||
48540258|NCT02383810|101658039|FG005|STARTED|Overall Study||4||
48540259|NCT02383810|101658040|FG006|STARTED|Overall Study||3||
48540260|NCT02383810|101658041|FG007|STARTED|Overall Study||2||
48540261|NCT02383810|101658034|FG000|COMPLETED|Overall Study||117||
48540262|NCT02383810|101658035|FG001|COMPLETED|Overall Study||114||
48540263|NCT02383810|101658036|FG002|COMPLETED|Overall Study||113||
48540264|NCT02383810|101658037|FG003|COMPLETED|Overall Study||112||
48679337|NCT01469039|101999802|FG000|NOT COMPLETED|Overall Study||77||
48679338|NCT01469039|101999803|FG001|NOT COMPLETED|Overall Study||73||
48679339|NCT01469039|101999804|FG002|NOT COMPLETED|Overall Study||113||
48679340|NCT01176617|101999805|FG000|STARTED|1 - 6 Months (Ron-randomized)||0||
48679341|NCT01176617|101999806|FG001|STARTED|1 - 6 Months (Ron-randomized)||0||
48679342|NCT01176617|101999807|FG002|STARTED|1 - 6 Months (Ron-randomized)||38||
48679343|NCT01176617|101999805|FG000|COMPLETED|1 - 6 Months (Ron-randomized)||0||
48679344|NCT01176617|101999806|FG001|COMPLETED|1 - 6 Months (Ron-randomized)||0||
48679345|NCT01176617|101999807|FG002|COMPLETED|1 - 6 Months (Ron-randomized)||38||
48679346|NCT01176617|101999805|FG000|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0||
48679347|NCT01176617|101999806|FG001|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0||
48241541|NCT01544153|100911738|FG001|STARTED|Overall Study||1324||
48241542|NCT01544153|100911739|FG002|STARTED|Overall Study||1314||
48241543|NCT01544153|100911740|FG003|STARTED|Overall Study||1317||
48241544|NCT01544153|100911737|FG000|COMPLETED|Overall Study||1337||
48241545|NCT01544153|100911738|FG001|COMPLETED|Overall Study||1323||
48540265|NCT02383810|101658038|FG004|COMPLETED|Overall Study||4||
48540266|NCT02383810|101658039|FG005|COMPLETED|Overall Study||3||
48540267|NCT02383810|101658040|FG006|COMPLETED|Overall Study||2||
48540268|NCT02383810|101658041|FG007|COMPLETED|Overall Study||2||
48540269|NCT02383810|101658034|FG000|NOT COMPLETED|Overall Study||3||
48540270|NCT02383810|101658035|FG001|NOT COMPLETED|Overall Study||8||
48540271|NCT02383810|101658036|FG002|NOT COMPLETED|Overall Study||7||
48540272|NCT02383810|101658037|FG003|NOT COMPLETED|Overall Study||11||
48540273|NCT02383810|101658038|FG004|NOT COMPLETED|Overall Study||0||
48679348|NCT01176617|101999807|FG002|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0||
48679349|NCT01176617|101999805|FG000|STARTED|6 - 12 Months (Randomized)||18||
48679350|NCT01176617|101999806|FG001|STARTED|6 - 12 Months (Randomized)||20||
48679351|NCT01176617|101999807|FG002|STARTED|6 - 12 Months (Randomized)||0||
48679352|NCT01176617|101999805|FG000|COMPLETED|6 - 12 Months (Randomized)||13||
48710652|NCT02961790|102077983|FG000|COMPLETED|Overall Study||35||
48679353|NCT01176617|101999806|FG001|COMPLETED|6 - 12 Months (Randomized)||20||
48679354|NCT01176617|101999807|FG002|COMPLETED|6 - 12 Months (Randomized)||0||
48679355|NCT01176617|101999805|FG000|NOT COMPLETED|6 - 12 Months (Randomized)||5||
48679356|NCT01176617|101999806|FG001|NOT COMPLETED|6 - 12 Months (Randomized)||0||
48679357|NCT01176617|101999807|FG002|NOT COMPLETED|6 - 12 Months (Randomized)||0||
48679358|NCT02136914|101999808|FG000|STARTED|Overall Study||63||
48679359|NCT02136914|101999809|FG001|STARTED|Overall Study||63||
48679360|NCT02136914|101999808|FG000|Received Study Drug|Overall Study||60||
48679361|NCT02136914|101999809|FG001|Received Study Drug|Overall Study||63||
48679362|NCT02136914|101999808|FG000|COMPLETED|Overall Study||42||
48679363|NCT02136914|101999809|FG001|COMPLETED|Overall Study||42||
48679364|NCT02136914|101999808|FG000|NOT COMPLETED|Overall Study||21||
48679365|NCT02136914|101999809|FG001|NOT COMPLETED|Overall Study||21||
48679366|NCT01047189|101999810|FG000|STARTED|Overall Study||13||
48679367|NCT01047189|101999811|FG001|STARTED|Overall Study||13||
48679368|NCT01047189|101999810|FG000|COMPLETED|Overall Study||9||
48679369|NCT01047189|101999811|FG001|COMPLETED|Overall Study||13||
48679370|NCT01047189|101999810|FG000|NOT COMPLETED|Overall Study||4||
48679371|NCT01047189|101999811|FG001|NOT COMPLETED|Overall Study||0||
48679372|NCT02670473|101999812|FG000|STARTED|Overall Study||35||
48679373|NCT02670473|101999812|FG000|COMPLETED|Overall Study||34||
48679374|NCT02670473|101999812|FG000|NOT COMPLETED|Overall Study||1||
48679375|NCT02573948|101999813|FG000|STARTED|RDS||603||
48679376|NCT02573948|101999813|FG000|COMPLETED|RDS||603||
48679377|NCT02573948|101999813|FG000|NOT COMPLETED|RDS||0||
48679378|NCT02573948|101999813|FG000|STARTED|Longitudinal Cohort||250|Among 603 RDS participants, 250 PWID were selected for the longitudinal follow-up.|
48679379|NCT02573948|101999813|FG000|COMPLETED|Longitudinal Cohort||194||
48679380|NCT02573948|101999813|FG000|NOT COMPLETED|Longitudinal Cohort||56||
48679381|NCT02831660|101999814|FG000|STARTED|Overall Study||1||
48679382|NCT02831660|101999814|FG000|COMPLETED|Overall Study||1||
48679383|NCT02831660|101999814|FG000|NOT COMPLETED|Overall Study||0||
48679384|NCT00587041|101999815|FG000|STARTED|Overall Study||12||
48679385|NCT00587041|101999816|FG001|STARTED|Overall Study||14||
48679386|NCT00587041|101999817|FG002|STARTED|Overall Study||14||
48679387|NCT00587041|101999815|FG000|COMPLETED|Overall Study||12||
48679388|NCT00587041|101999816|FG001|COMPLETED|Overall Study||14||
48679389|NCT00587041|101999817|FG002|COMPLETED|Overall Study||14||
48241546|NCT01544153|100911739|FG002|COMPLETED|Overall Study||1313||
48241547|NCT01544153|100911740|FG003|COMPLETED|Overall Study||1317||
48241548|NCT01544153|100911737|FG000|NOT COMPLETED|Overall Study||0||
48241549|NCT01544153|100911738|FG001|NOT COMPLETED|Overall Study||1||
48241550|NCT01544153|100911739|FG002|NOT COMPLETED|Overall Study||1||
48241551|NCT01544153|100911740|FG003|NOT COMPLETED|Overall Study||0||
48241552|NCT03436797|100911741|FG000|STARTED|Main Study||47||
48241553|NCT03436797|100911741|FG000|COMPLETED|Main Study||37||
48241554|NCT03436797|100911741|FG000|NOT COMPLETED|Main Study||10||
48241555|NCT03436797|100911741|FG000|STARTED|Extended Dosing||5||
48241556|NCT03436797|100911741|FG000|COMPLETED|Extended Dosing||4||
48241557|NCT03436797|100911741|FG000|NOT COMPLETED|Extended Dosing||1||
48241558|NCT06016127|100911742|FG000|STARTED|Overall Study||15||
48241559|NCT06016127|100911743|FG001|STARTED|Overall Study||15||
48241560|NCT06016127|100911742|FG000|COMPLETED|Overall Study||11||
48241561|NCT06016127|100911743|FG001|COMPLETED|Overall Study||12||
48241562|NCT06016127|100911742|FG000|NOT COMPLETED|Overall Study||4||
48241563|NCT06016127|100911743|FG001|NOT COMPLETED|Overall Study||3||
48241564|NCT02137603|100911744|FG000|STARTED|Overall Study||18||
48241565|NCT02137603|100911745|FG001|STARTED|Overall Study||18||
48241566|NCT02137603|100911744|FG000|COMPLETED|Overall Study||16||
48241567|NCT02137603|100911745|FG001|COMPLETED|Overall Study||18||
48241568|NCT02137603|100911744|FG000|NOT COMPLETED|Overall Study||2||
48241569|NCT02137603|100911745|FG001|NOT COMPLETED|Overall Study||0||
48241570|NCT01863368|100911746|FG000|STARTED|Phase I, Day 0 to Day 35||46||
48241571|NCT01863368|100911747|FG001|STARTED|Phase I, Day 0 to Day 35||48||
48241572|NCT01863368|100911746|FG000|Treated|Phase I, Day 0 to Day 35||46||
48241573|NCT01863368|100911747|FG001|Treated|Phase I, Day 0 to Day 35||47||
48241574|NCT01863368|100911746|FG000|COMPLETED|Phase I, Day 0 to Day 35||43||
48241575|NCT01863368|100911747|FG001|COMPLETED|Phase I, Day 0 to Day 35||41||
48241576|NCT01863368|100911746|FG000|NOT COMPLETED|Phase I, Day 0 to Day 35||3||
48241577|NCT01863368|100911747|FG001|NOT COMPLETED|Phase I, Day 0 to Day 35||7||
48241578|NCT01863368|100911746|FG000|STARTED|Phase II, Day 35 to Day 90||43||
48679390|NCT00587041|101999815|FG000|NOT COMPLETED|Overall Study||0||
48679391|NCT00587041|101999816|FG001|NOT COMPLETED|Overall Study||0||
48679392|NCT00587041|101999817|FG002|NOT COMPLETED|Overall Study||0||
48679393|NCT01732536|101999818|FG000|STARTED|Overall Study||53||
48679394|NCT01732536|101999819|FG001|STARTED|Overall Study||47||
48679395|NCT01732536|101999818|FG000|COMPLETED|Overall Study||52||
48679396|NCT01732536|101999819|FG001|COMPLETED|Overall Study||46||
48679397|NCT01732536|101999818|FG000|NOT COMPLETED|Overall Study||1||
48679398|NCT01732536|101999819|FG001|NOT COMPLETED|Overall Study||1||
48679399|NCT00598650|101999820|FG000|STARTED|Overall Study||108||
48679400|NCT00598650|101999820|FG000|COMPLETED|Overall Study||81||
48241579|NCT01863368|100911747|FG001|STARTED|Phase II, Day 35 to Day 90||41||
48241580|NCT01863368|100911746|FG000|COMPLETED|Phase II, Day 35 to Day 90||41||
48679401|NCT00598650|101999820|FG000|NOT COMPLETED|Overall Study||27||
48679402|NCT04940130|101999821|FG000|STARTED|Overall Study||139||
48679403|NCT04940130|101999822|FG001|STARTED|Overall Study||138||
48679404|NCT04940130|101999823|FG002|STARTED|Overall Study||13||
48679405|NCT04940130|101999821|FG000|COMPLETED|Overall Study||138||
48679406|NCT04940130|101999822|FG001|COMPLETED|Overall Study||137||
48679407|NCT04940130|101999823|FG002|COMPLETED|Overall Study||0||
48679408|NCT04940130|101999821|FG000|NOT COMPLETED|Overall Study||1||
48679409|NCT04940130|101999822|FG001|NOT COMPLETED|Overall Study||1||
48679410|NCT04940130|101999823|FG002|NOT COMPLETED|Overall Study||13||
48679411|NCT02347085|101999824|FG000|STARTED|Overall Study||43||
48679412|NCT02347085|101999824|FG000|GFF MDI 14.4/9.6 µg|Overall Study||40||
48679413|NCT02347085|101999824|FG000|Placebo MDI|Overall Study||40||
48679414|NCT02347085|101999824|FG000|COMPLETED|Overall Study||33||
48679415|NCT02347085|101999824|FG000|NOT COMPLETED|Overall Study||10||
48679416|NCT05525910|101999825|FG000|STARTED|Period 1||3||
48679417|NCT05525910|101999826|FG001|STARTED|Period 1||3||
48679418|NCT05525910|101999827|FG002|STARTED|Period 1||3||
48679419|NCT05525910|101999828|FG003|STARTED|Period 1||3||
48679420|NCT05525910|101999829|FG004|STARTED|Period 1||3||
48679421|NCT05525910|101999825|FG000|COMPLETED|Period 1||3||
48679422|NCT05525910|101999826|FG001|COMPLETED|Period 1||3||
48679423|NCT05525910|101999827|FG002|COMPLETED|Period 1||3||
48679424|NCT05525910|101999828|FG003|COMPLETED|Period 1||3||
48241581|NCT01863368|100911747|FG001|COMPLETED|Phase II, Day 35 to Day 90||41||
48241582|NCT01863368|100911746|FG000|NOT COMPLETED|Phase II, Day 35 to Day 90||2||
48241583|NCT01863368|100911747|FG001|NOT COMPLETED|Phase II, Day 35 to Day 90||0||
48241584|NCT00720629|100911748|FG000|STARTED|Overall Study||8||
48241585|NCT00720629|100911748|FG000|COMPLETED|Overall Study||8||
48241586|NCT00720629|100911748|FG000|NOT COMPLETED|Overall Study||0||
48241587|NCT01654289|100911749|FG000|STARTED|Overall Study||138||
48241588|NCT01654289|100911750|FG001|STARTED|Overall Study||137||
48241589|NCT01654289|100911751|FG002|STARTED|Overall Study||138||
48679425|NCT05525910|101999829|FG004|COMPLETED|Period 1||3||
48679426|NCT05525910|101999825|FG000|NOT COMPLETED|Period 1||0||
48241590|NCT01654289|100911749|FG000|COMPLETED|Overall Study||111||
48241591|NCT01654289|100911750|FG001|COMPLETED|Overall Study||109||
48241592|NCT01654289|100911751|FG002|COMPLETED|Overall Study||133||
48241593|NCT01654289|100911749|FG000|NOT COMPLETED|Overall Study||27||
48241594|NCT01654289|100911750|FG001|NOT COMPLETED|Overall Study||28||
48241595|NCT01654289|100911751|FG002|NOT COMPLETED|Overall Study||5||
48241596|NCT01669720|100911752|FG000|STARTED|Overall Study||7||
48241597|NCT01669720|100911753|FG001|STARTED|Overall Study||3||
48241598|NCT01669720|100911752|FG000|COMPLETED|Overall Study||7||
48241599|NCT01669720|100911753|FG001|COMPLETED|Overall Study||3||
48241600|NCT01669720|100911752|FG000|NOT COMPLETED|Overall Study||0||
48241601|NCT01669720|100911753|FG001|NOT COMPLETED|Overall Study||0||
48241602|NCT01536795|100911754|FG000|STARTED|Overall Study||24||
48241603|NCT01536795|100911755|FG001|STARTED|Overall Study||24||
48241604|NCT01536795|100911754|FG000|COMPLETED|Overall Study||23||
48241605|NCT01536795|100911755|FG001|COMPLETED|Overall Study||22||
48241606|NCT01536795|100911754|FG000|NOT COMPLETED|Overall Study||1||
48241607|NCT01536795|100911755|FG001|NOT COMPLETED|Overall Study||2||
48241608|NCT00676663|100911756|FG000|STARTED|Overall Study||66||
48241609|NCT00676663|100911757|FG001|STARTED|Overall Study||64||
48241610|NCT00676663|100911756|FG000|COMPLETED|Overall Study||21||
48241611|NCT00676663|100911757|FG001|COMPLETED|Overall Study||26||
48241612|NCT00676663|100911756|FG000|NOT COMPLETED|Overall Study||45||
48241613|NCT00676663|100911757|FG001|NOT COMPLETED|Overall Study||38||
48241614|NCT00930644|100911758|FG000|STARTED|Overall Study||88||
48241615|NCT00930644|100911758|FG000|COMPLETED|Overall Study||65||
48241616|NCT00930644|100911758|FG000|NOT COMPLETED|Overall Study||23||
48241617|NCT00685659|100911759|FG000|STARTED|Overall Study||108||
48241618|NCT00685659|100911760|FG001|STARTED|Overall Study||106||
48241619|NCT00685659|100911761|FG002|STARTED|Overall Study||107||
48241620|NCT00685659|100911759|FG000|COMPLETED|Overall Study||77||
48241621|NCT00685659|100911760|FG001|COMPLETED|Overall Study||81||
48241622|NCT00685659|100911761|FG002|COMPLETED|Overall Study||92||
48241623|NCT00685659|100911759|FG000|NOT COMPLETED|Overall Study||31||
48241624|NCT00685659|100911760|FG001|NOT COMPLETED|Overall Study||25||
48241625|NCT00685659|100911761|FG002|NOT COMPLETED|Overall Study||15||
48241626|NCT03120949|100911762|FG000|STARTED|Overall Study||1058||
48540274|NCT02383810|101658039|FG005|NOT COMPLETED|Overall Study||1||
48241627|NCT03120949|100911763|FG001|STARTED|Overall Study||1047||
48241628|NCT03120949|100911762|FG000|mITT|Overall Study||1057||
48241629|NCT03120949|100911763|FG001|mITT|Overall Study||1047||
48241630|NCT03120949|100911762|FG000|Safety Population|Overall Study||1043||
48241631|NCT03120949|100911763|FG001|Safety Population|Overall Study||1061||
48241632|NCT03120949|100911762|FG000|COMPLETED|Overall Study||830||
48241633|NCT03120949|100911763|FG001|COMPLETED|Overall Study||844||
48241634|NCT03120949|100911762|FG000|NOT COMPLETED|Overall Study||228||
48241635|NCT03120949|100911763|FG001|NOT COMPLETED|Overall Study||203||
48241636|NCT02116582|100911764|FG000|STARTED|Overall Study||215||
48241637|NCT02116582|100911764|FG000|Treated|Overall Study||214||
48241638|NCT02116582|100911764|FG000|COMPLETED|Overall Study||0||
48241639|NCT02116582|100911764|FG000|NOT COMPLETED|Overall Study||215||
48241640|NCT04543942|100911765|FG000|STARTED|First Intervention (2-3 Days)||13||
48241641|NCT04543942|100911766|FG001|STARTED|First Intervention (2-3 Days)||15||
48241642|NCT04543942|100911765|FG000|COMPLETED|First Intervention (2-3 Days)||11||
48241643|NCT04543942|100911766|FG001|COMPLETED|First Intervention (2-3 Days)||13||
48241644|NCT04543942|100911765|FG000|NOT COMPLETED|First Intervention (2-3 Days)||2||
48241645|NCT04543942|100911766|FG001|NOT COMPLETED|First Intervention (2-3 Days)||2||
48241646|NCT04543942|100911765|FG000|STARTED|Interval Period (2 Weeks)||11||
48241647|NCT04543942|100911766|FG001|STARTED|Interval Period (2 Weeks)||13||
48241648|NCT04543942|100911765|FG000|COMPLETED|Interval Period (2 Weeks)||10||
48241649|NCT04543942|100911766|FG001|COMPLETED|Interval Period (2 Weeks)||12||
48241650|NCT04543942|100911765|FG000|NOT COMPLETED|Interval Period (2 Weeks)||1||
48241651|NCT04543942|100911766|FG001|NOT COMPLETED|Interval Period (2 Weeks)||1||
48241652|NCT04543942|100911765|FG000|STARTED|Second Intervention (2-3 Days)||10||
48241653|NCT04543942|100911766|FG001|STARTED|Second Intervention (2-3 Days)||12||
48241654|NCT04543942|100911765|FG000|COMPLETED|Second Intervention (2-3 Days)||10||
48241655|NCT04543942|100911766|FG001|COMPLETED|Second Intervention (2-3 Days)||12||
48241656|NCT04543942|100911765|FG000|NOT COMPLETED|Second Intervention (2-3 Days)||0||
48241657|NCT04543942|100911766|FG001|NOT COMPLETED|Second Intervention (2-3 Days)||0||
48241658|NCT03214198|100911767|FG000|STARTED|Overall Study||1304||
48241659|NCT03214198|100911767|FG000|COMPLETED|Overall Study||1268||
48241660|NCT03214198|100911767|FG000|NOT COMPLETED|Overall Study||36||
48241661|NCT02213458|100911768|FG000|STARTED|Overall Study||1024||
48241662|NCT02213458|100911769|FG001|STARTED|Overall Study||536||
48241663|NCT02213458|100911768|FG000|COMPLETED|Overall Study||970||
48241664|NCT02213458|100911769|FG001|COMPLETED|Overall Study||526||
48241665|NCT02213458|100911768|FG000|NOT COMPLETED|Overall Study||54||
48241666|NCT02213458|100911769|FG001|NOT COMPLETED|Overall Study||10||
48241667|NCT02543294|100911770|FG000|STARTED|Overall Study||20||
48241668|NCT02543294|100911770|FG000|COMPLETED|Overall Study||8||
48241669|NCT02543294|100911770|FG000|NOT COMPLETED|Overall Study||12||
48241670|NCT02475733|100911771|FG000|STARTED|Overall Study||61||
48241671|NCT02475733|100911772|FG001|STARTED|Overall Study||22||
48679427|NCT05525910|101999826|FG001|NOT COMPLETED|Period 1||0||
48679428|NCT05525910|101999827|FG002|NOT COMPLETED|Period 1||0||
48679429|NCT05525910|101999828|FG003|NOT COMPLETED|Period 1||0||
48679430|NCT05525910|101999829|FG004|NOT COMPLETED|Period 1||0||
48679431|NCT05525910|101999825|FG000|STARTED|Period 2||3||
48241672|NCT02475733|100911771|FG000|COMPLETED|Overall Study||59||
48241673|NCT02475733|100911772|FG001|COMPLETED|Overall Study||22||
48241674|NCT02475733|100911771|FG000|NOT COMPLETED|Overall Study||2||
48241675|NCT02475733|100911772|FG001|NOT COMPLETED|Overall Study||0||
48241676|NCT03449979|100911773|FG000|STARTED|Overall Study||21||
48241677|NCT03449979|100911774|FG001|STARTED|Overall Study||20||
48241678|NCT03449979|100911775|FG002|STARTED|Overall Study||21||
48241679|NCT03449979|100911776|FG003|STARTED|Overall Study||22||
48241680|NCT03449979|100911773|FG000|COMPLETED|Overall Study||21||
48241681|NCT03449979|100911774|FG001|COMPLETED|Overall Study||20||
48241682|NCT03449979|100911775|FG002|COMPLETED|Overall Study||21||
48241683|NCT03449979|100911776|FG003|COMPLETED|Overall Study||21||
48241684|NCT03449979|100911773|FG000|NOT COMPLETED|Overall Study||0||
48241685|NCT03449979|100911774|FG001|NOT COMPLETED|Overall Study||0||
48241686|NCT03449979|100911775|FG002|NOT COMPLETED|Overall Study||0||
48241687|NCT03449979|100911776|FG003|NOT COMPLETED|Overall Study||1||
48241688|NCT02632045|100911777|FG000|STARTED|Overall Study||60||
48241689|NCT02632045|100911778|FG001|STARTED|Overall Study||62||
48241690|NCT02632045|100911777|FG000|COMPLETED|Overall Study||59||
48081252|NCT03129100|100521622|FG009|STARTED|Period 2 (Retreatment Extension Period)||9||
48081253|NCT03129100|100521623|FG010|STARTED|Period 2 (Retreatment Extension Period)||10||
48241691|NCT02632045|100911778|FG001|COMPLETED|Overall Study||60||
48241692|NCT02632045|100911777|FG000|NOT COMPLETED|Overall Study||1||
48241693|NCT02632045|100911778|FG001|NOT COMPLETED|Overall Study||2||
48679432|NCT05525910|101999826|FG001|STARTED|Period 2||3||
48679433|NCT05525910|101999827|FG002|STARTED|Period 2||3||
48679434|NCT05525910|101999828|FG003|STARTED|Period 2||3||
48679435|NCT05525910|101999829|FG004|STARTED|Period 2||3||
48679436|NCT05525910|101999825|FG000|COMPLETED|Period 2||3||
48679437|NCT05525910|101999826|FG001|COMPLETED|Period 2||3||
48679438|NCT05525910|101999827|FG002|COMPLETED|Period 2||3||
48679439|NCT05525910|101999828|FG003|COMPLETED|Period 2||3||
48679440|NCT05525910|101999829|FG004|COMPLETED|Period 2||3||
48679441|NCT05525910|101999825|FG000|NOT COMPLETED|Period 2||0||
48679442|NCT05525910|101999826|FG001|NOT COMPLETED|Period 2||0||
48679443|NCT05525910|101999827|FG002|NOT COMPLETED|Period 2||0||
48241694|NCT01113541|100911779|FG000|STARTED|Overall Study||13||
48241695|NCT01113541|100911779|FG000|COMPLETED|Overall Study||0||
48241696|NCT01113541|100911779|FG000|NOT COMPLETED|Overall Study||13||
48241697|NCT02567435|100911780|FG000|STARTED|Overall Study||156||
48241698|NCT02567435|100911781|FG001|STARTED|Overall Study||156||
48241699|NCT02567435|100911782|FG002|STARTED|Overall Study||3||
48679444|NCT05525910|101999828|FG003|NOT COMPLETED|Period 2||0||
48241700|NCT02567435|100911783|FG003|STARTED|Overall Study||10||
48241701|NCT02567435|100911780|FG000|COMPLETED|Overall Study||150||
48241702|NCT02567435|100911781|FG001|COMPLETED|Overall Study||147||
48241703|NCT02567435|100911782|FG002|COMPLETED|Overall Study||3||
48241704|NCT02567435|100911783|FG003|COMPLETED|Overall Study||9||
48241705|NCT02567435|100911780|FG000|NOT COMPLETED|Overall Study||6||
48241706|NCT02567435|100911781|FG001|NOT COMPLETED|Overall Study||9||
48241707|NCT02567435|100911782|FG002|NOT COMPLETED|Overall Study||0||
48241708|NCT02567435|100911783|FG003|NOT COMPLETED|Overall Study||1||
48241709|NCT03745651|100911784|FG000|STARTED|Vehicle Control Period (Day 1 to Week 8)||124||
48241710|NCT03745651|100911785|FG001|STARTED|Vehicle Control Period (Day 1 to Week 8)||248||
48241711|NCT03745651|100911786|FG002|STARTED|Vehicle Control Period (Day 1 to Week 8)||246||
48241712|NCT03745651|100911787|FG003|STARTED|Vehicle Control Period (Day 1 to Week 8)||0||
48241713|NCT03745651|100911788|FG004|STARTED|Vehicle Control Period (Day 1 to Week 8)||0||
48241714|NCT03745651|100911789|FG005|STARTED|Vehicle Control Period (Day 1 to Week 8)||0||
48241715|NCT03745651|100911790|FG006|STARTED|Vehicle Control Period (Day 1 to Week 8)||0||
48241716|NCT03745651|100911784|FG000|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||105||
48241717|NCT03745651|100911785|FG001|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||209||
48241718|NCT03745651|100911786|FG002|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||224||
48241719|NCT03745651|100911787|FG003|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0||
48241720|NCT03745651|100911788|FG004|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0||
48241721|NCT03745651|100911789|FG005|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0||
48241722|NCT03745651|100911790|FG006|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0||
48241723|NCT03745651|100911784|FG000|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||19||
48241724|NCT03745651|100911785|FG001|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||39||
48241725|NCT03745651|100911786|FG002|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||22||
48241726|NCT03745651|100911787|FG003|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0||
48241727|NCT03745651|100911788|FG004|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0||
48241728|NCT03745651|100911789|FG005|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0||
48241729|NCT03745651|100911790|FG006|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0||
48241730|NCT03745651|100911784|FG000|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0||
48241731|NCT03745651|100911785|FG001|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0||
48241732|NCT03745651|100911786|FG002|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0||
48540275|NCT02383810|101658040|FG006|NOT COMPLETED|Overall Study||1||
48241733|NCT03745651|100911787|FG003|STARTED|Long-Term Safety Period (Weeks 8 to 52)||53||
48241734|NCT03745651|100911788|FG004|STARTED|Long-Term Safety Period (Weeks 8 to 52)||52||
48241735|NCT03745651|100911789|FG005|STARTED|Long-Term Safety Period (Weeks 8 to 52)||204||
48241736|NCT03745651|100911790|FG006|STARTED|Long-Term Safety Period (Weeks 8 to 52)||221||
48241737|NCT03745651|100911784|FG000|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0||
48241738|NCT03745651|100911785|FG001|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0||
48241739|NCT03745651|100911786|FG002|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0||
48241740|NCT03745651|100911787|FG003|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||33||
48679445|NCT05525910|101999829|FG004|NOT COMPLETED|Period 2||0||
48679446|NCT05525910|101999825|FG000|STARTED|Period 3||3||
48679447|NCT05525910|101999826|FG001|STARTED|Period 3||3||
48679448|NCT05525910|101999827|FG002|STARTED|Period 3||3||
48679449|NCT05525910|101999828|FG003|STARTED|Period 3||3||
48679450|NCT05525910|101999829|FG004|STARTED|Period 3||3||
48679451|NCT05525910|101999825|FG000|COMPLETED|Period 3||3||
48679452|NCT05525910|101999826|FG001|COMPLETED|Period 3||3||
48679453|NCT05525910|101999827|FG002|COMPLETED|Period 3||3||
48679454|NCT05525910|101999828|FG003|COMPLETED|Period 3||3||
48679455|NCT05525910|101999829|FG004|COMPLETED|Period 3||3||
48679456|NCT05525910|101999825|FG000|NOT COMPLETED|Period 3||0||
48679457|NCT05525910|101999826|FG001|NOT COMPLETED|Period 3||0||
48679458|NCT05525910|101999827|FG002|NOT COMPLETED|Period 3||0||
48679459|NCT05525910|101999828|FG003|NOT COMPLETED|Period 3||0||
48679460|NCT05525910|101999829|FG004|NOT COMPLETED|Period 3||0||
48679461|NCT05525910|101999825|FG000|STARTED|Period 4||3||
48679462|NCT05525910|101999826|FG001|STARTED|Period 4||3||
48679463|NCT05525910|101999827|FG002|STARTED|Period 4||3||
48679464|NCT05525910|101999828|FG003|STARTED|Period 4||3||
48679465|NCT05525910|101999829|FG004|STARTED|Period 4||3||
48679466|NCT05525910|101999825|FG000|COMPLETED|Period 4||3||
48679467|NCT05525910|101999826|FG001|COMPLETED|Period 4||3||
48679468|NCT05525910|101999827|FG002|COMPLETED|Period 4||2||
48679469|NCT05525910|101999828|FG003|COMPLETED|Period 4||2||
48679470|NCT05525910|101999829|FG004|COMPLETED|Period 4||2||
48679471|NCT05525910|101999825|FG000|NOT COMPLETED|Period 4||0||
48679472|NCT05525910|101999826|FG001|NOT COMPLETED|Period 4||0||
48679473|NCT05525910|101999827|FG002|NOT COMPLETED|Period 4||1||
48679474|NCT05525910|101999828|FG003|NOT COMPLETED|Period 4||1||
48679475|NCT05525910|101999829|FG004|NOT COMPLETED|Period 4||1||
48679476|NCT03423121|101999830|FG000|STARTED|Overall Study||28||
48679477|NCT03423121|101999831|FG001|STARTED|Overall Study||26||
48679478|NCT03423121|101999830|FG000|COMPLETED|Overall Study||25||
48679479|NCT03423121|101999831|FG001|COMPLETED|Overall Study||20||
48679480|NCT03423121|101999830|FG000|NOT COMPLETED|Overall Study||3||
48679481|NCT03423121|101999831|FG001|NOT COMPLETED|Overall Study||6||
48679482|NCT03511001|101999832|FG000|STARTED|Overall Study||126||
48679483|NCT03511001|101999833|FG001|STARTED|Overall Study||61||
48679484|NCT03511001|101999832|FG000|Completers Analyzed|Overall Study||114||
48679485|NCT03511001|101999833|FG001|Completers Analyzed|Overall Study||61||
48679486|NCT03511001|101999832|FG000|COMPLETED|Overall Study||115||
48679487|NCT03511001|101999833|FG001|COMPLETED|Overall Study||54||
48679488|NCT03511001|101999832|FG000|NOT COMPLETED|Overall Study||11||
48679489|NCT03511001|101999833|FG001|NOT COMPLETED|Overall Study||7||
48679490|NCT01783444|101999834|FG000|STARTED|Treatment Phase||104|All randomized subjects (FAS)|
48679491|NCT01783444|101999835|FG001|STARTED|Treatment Phase||103|All randomized subjects (FAS)|
48679492|NCT01783444|101999836|FG002|STARTED|Treatment Phase||102|All randomized subjects (FAS)|
48679493|NCT01783444|101999834|FG000|Safety Set|Treatment Phase||104|At least 1 dose of study treatment and a 1 post baseline safety assessment|
48679494|NCT01783444|101999835|FG001|Safety Set|Treatment Phase||103|At least 1 dose of study treatment and a 1 post baseline safety assessment|
48679495|NCT01783444|101999836|FG002|Safety Set|Treatment Phase||102|At least 1 dose of study treatment and a 1 post baseline safety assessment|
48679496|NCT01783444|101999834|FG000|COMPLETED|Treatment Phase||0||
48679497|NCT01783444|101999835|FG001|COMPLETED|Treatment Phase||0||
48679498|NCT01783444|101999836|FG002|COMPLETED|Treatment Phase||0||
48679499|NCT01783444|101999834|FG000|NOT COMPLETED|Treatment Phase||104||
48679500|NCT01783444|101999835|FG001|NOT COMPLETED|Treatment Phase||103||
48679501|NCT01783444|101999836|FG002|NOT COMPLETED|Treatment Phase||102||
48679502|NCT01783444|101999834|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase||96|All patients who discontinued treatment and entered Post-Treatment Efficacy Follow-Up Phase|
48679503|NCT01783444|101999835|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase||93|All patients who discontinued treatment and entered Post-Treatment Efficacy Follow-Up Phase|
48241741|NCT03745651|100911788|FG004|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||41||
48679504|NCT01783444|101999836|FG002|STARTED|Post-Treatment Efficacy Follow-Up Phase||91|All patients who discontinued treatment and entered Post-Treatment Efficacy Follow-Up Phase|
48679505|NCT01783444|101999834|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
48241742|NCT03745651|100911789|FG005|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||151||
48679506|NCT01783444|101999835|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
48679507|NCT01783444|101999836|FG002|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
48710653|NCT02961790|102077984|FG001|COMPLETED|Overall Study||40||
48241743|NCT03745651|100911790|FG006|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||170||
48241744|NCT03745651|100911784|FG000|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0||
48241745|NCT03745651|100911785|FG001|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0||
48241746|NCT03745651|100911786|FG002|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0||
48241747|NCT03745651|100911787|FG003|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||20||
48241748|NCT03745651|100911788|FG004|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||11||
48241749|NCT03745651|100911789|FG005|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||53||
48241750|NCT03745651|100911790|FG006|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||51||
48241751|NCT01695993|100911791|FG000|STARTED|Overall Study||81||
48241752|NCT01695993|100911792|FG001|STARTED|Overall Study||80||
48241753|NCT01695993|100911793|FG002|STARTED|Overall Study||81||
48241754|NCT01695993|100911791|FG000|COMPLETED|Overall Study||76||
48241755|NCT01695993|100911792|FG001|COMPLETED|Overall Study||75||
48241756|NCT01695993|100911793|FG002|COMPLETED|Overall Study||75||
48241757|NCT01695993|100911791|FG000|NOT COMPLETED|Overall Study||5||
48241758|NCT01695993|100911792|FG001|NOT COMPLETED|Overall Study||5||
48241759|NCT01695993|100911793|FG002|NOT COMPLETED|Overall Study||6||
48241760|NCT01247922|100911794|FG000|STARTED|Overall Study||4||
48241761|NCT01247922|100911794|FG000|Treated|Overall Study||4||
48241762|NCT01247922|100911794|FG000|COMPLETED|Overall Study||0||
48241763|NCT01247922|100911794|FG000|NOT COMPLETED|Overall Study||4||
48241764|NCT04049578|100911795|FG000|STARTED|Overall Study||2||
48241765|NCT04049578|100911795|FG000|COMPLETED|Overall Study||1||
48241766|NCT04049578|100911795|FG000|NOT COMPLETED|Overall Study||1||
48241767|NCT01614899|100911796|FG000|STARTED|Overall Study||150||
48241768|NCT01614899|100911797|FG001|STARTED|Overall Study||155||
48241769|NCT01614899|100911798|FG002|STARTED|Overall Study||152||
48241770|NCT01614899|100911796|FG000|COMPLETED|Overall Study||106||
48241771|NCT01614899|100911797|FG001|COMPLETED|Overall Study||116||
48241772|NCT01614899|100911798|FG002|COMPLETED|Overall Study||110||
48241773|NCT01614899|100911796|FG000|NOT COMPLETED|Overall Study||44||
48241774|NCT01614899|100911797|FG001|NOT COMPLETED|Overall Study||39||
48241775|NCT01614899|100911798|FG002|NOT COMPLETED|Overall Study||42||
48241776|NCT03356145|100911799|FG000|STARTED|Overall Study||48||
48241777|NCT03356145|100911800|FG001|STARTED|Overall Study||48||
48241778|NCT03356145|100911799|FG000|Received Allocated Intervention|Overall Study||45||
48241779|NCT03356145|100911800|FG001|Received Allocated Intervention|Overall Study||47||
48241780|NCT03356145|100911799|FG000|COMPLETED|Overall Study||45||
48241781|NCT03356145|100911800|FG001|COMPLETED|Overall Study||47||
48241782|NCT03356145|100911799|FG000|NOT COMPLETED|Overall Study||3||
48241783|NCT03356145|100911800|FG001|NOT COMPLETED|Overall Study||1||
48241784|NCT03018288|100911801|FG000|STARTED|Overall Study||8|Tissue for vaccine production and neo-epitope monitoring.|
48241785|NCT03018288|100911802|FG001|STARTED|Overall Study||9|Tissue for vaccine production and neo-epitope monitoring.|
48241786|NCT03018288|100911803|FG002|STARTED|Overall Study||15|Tissue for vaccine production and neo-epitope monitoring.|
48241787|NCT03018288|100911804|FG003|STARTED|Overall Study||58|Tissue for vaccine production and neo-epitope monitoring.|
48241788|NCT03018288|100911801|FG000|Surgery|Overall Study||8||
48241789|NCT03018288|100911802|FG001|Surgery|Overall Study||9||
48241790|NCT03018288|100911803|FG002|Surgery|Overall Study||15||
48241791|NCT03018288|100911804|FG003|Surgery|Overall Study||56||
48241792|NCT03018288|100911801|FG000|Sufficient Vaccine Made (Minimum of Four). Participants Randomized to Arm 3 and Arm 4|Overall Study||8|Once off treatment, continue follow-up every 8-16 weeks|
48241793|NCT03018288|100911802|FG001|Sufficient Vaccine Made (Minimum of Four). Participants Randomized to Arm 3 and Arm 4|Overall Study||9|Once off treatment, continue follow-up every 8-16 weeks|
48241794|NCT03018288|100911803|FG002|Sufficient Vaccine Made (Minimum of Four). Participants Randomized to Arm 3 and Arm 4|Overall Study||0|Once off treatment, continue follow-up every 8-16 weeks|
48241795|NCT03018288|100911804|FG003|Sufficient Vaccine Made (Minimum of Four). Participants Randomized to Arm 3 and Arm 4|Overall Study||0|Once off treatment, continue follow-up every 8-16 weeks|
48241796|NCT03018288|100911801|FG000|No Sufficient Vaccine Made (Minimum of Four). Participants Randomized to Arm 2.|Overall Study||0|Once off treatment, continue follow-up every 8-16 weeks.|
48540276|NCT02383810|101658041|FG007|NOT COMPLETED|Overall Study||0||
48241797|NCT03018288|100911802|FG001|No Sufficient Vaccine Made (Minimum of Four). Participants Randomized to Arm 2.|Overall Study||0|Once off treatment, continue follow-up every 8-16 weeks.|
48241798|NCT03018288|100911803|FG002|No Sufficient Vaccine Made (Minimum of Four). Participants Randomized to Arm 2.|Overall Study||15|Once off treatment, continue follow-up every 8-16 weeks.|
48241799|NCT03018288|100911804|FG003|No Sufficient Vaccine Made (Minimum of Four). Participants Randomized to Arm 2.|Overall Study||0|Once off treatment, continue follow-up every 8-16 weeks.|
48241800|NCT03018288|100911801|FG000|COMPLETED|Overall Study||7||
48241801|NCT03018288|100911802|FG001|COMPLETED|Overall Study||8||
48241802|NCT03018288|100911803|FG002|COMPLETED|Overall Study||12||
48679508|NCT01783444|101999834|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||96||
48241803|NCT03018288|100911804|FG003|COMPLETED|Overall Study||0||
48241804|NCT03018288|100911801|FG000|NOT COMPLETED|Overall Study||1||
48241805|NCT03018288|100911802|FG001|NOT COMPLETED|Overall Study||1||
48241806|NCT03018288|100911803|FG002|NOT COMPLETED|Overall Study||3||
48241807|NCT03018288|100911804|FG003|NOT COMPLETED|Overall Study||58||
48679509|NCT01783444|101999835|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||93||
48679510|NCT01783444|101999836|FG002|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||91||
48241808|NCT01182285|100911805|FG000|STARTED|First Intervention Week 1-10||13||
48241809|NCT01182285|100911806|FG001|STARTED|First Intervention Week 1-10||0||
48241810|NCT01182285|100911807|FG002|STARTED|First Intervention Week 1-10||0||
48241811|NCT01182285|100911805|FG000|COMPLETED|First Intervention Week 1-10||10||
48241812|NCT01182285|100911806|FG001|COMPLETED|First Intervention Week 1-10||0||
48241813|NCT01182285|100911807|FG002|COMPLETED|First Intervention Week 1-10||0||
48241814|NCT01182285|100911805|FG000|NOT COMPLETED|First Intervention Week 1-10||3||
48241815|NCT01182285|100911806|FG001|NOT COMPLETED|First Intervention Week 1-10||0||
48241816|NCT01182285|100911807|FG002|NOT COMPLETED|First Intervention Week 1-10||0||
48241817|NCT01182285|100911805|FG000|STARTED|Second Intervention Week 11-17||0||
48241818|NCT01182285|100911806|FG001|STARTED|Second Intervention Week 11-17||0||
48679511|NCT00948688|101999837|FG000|STARTED|Period 1: 200 mg Vorinostat||4||
48679512|NCT00948688|101999838|FG001|STARTED|Period 1: 200 mg Vorinostat||0||
48679513|NCT00948688|101999837|FG000|COMPLETED|Period 1: 200 mg Vorinostat||2||
48679514|NCT00948688|101999838|FG001|COMPLETED|Period 1: 200 mg Vorinostat||0||
48679515|NCT00948688|101999837|FG000|NOT COMPLETED|Period 1: 200 mg Vorinostat||2||
48679516|NCT00948688|101999838|FG001|NOT COMPLETED|Period 1: 200 mg Vorinostat||0||
48679517|NCT00948688|101999837|FG000|STARTED|Period 2: 100 mg Vorinostat||0||
48679518|NCT00948688|101999838|FG001|STARTED|Period 2: 100 mg Vorinostat||6||
48679519|NCT00948688|101999837|FG000|COMPLETED|Period 2: 100 mg Vorinostat||0||
48679520|NCT00948688|101999838|FG001|COMPLETED|Period 2: 100 mg Vorinostat||5||
48679521|NCT00948688|101999837|FG000|NOT COMPLETED|Period 2: 100 mg Vorinostat||0||
48679522|NCT00948688|101999838|FG001|NOT COMPLETED|Period 2: 100 mg Vorinostat||1||
48679523|NCT04446312|101999839|FG000|STARTED|Overall Study||250||
48679524|NCT04446312|101999840|FG001|STARTED|Overall Study||250||
48679525|NCT04446312|101999839|FG000|COMPLETED|Overall Study||212||
48679526|NCT04446312|101999840|FG001|COMPLETED|Overall Study||206||
48679527|NCT04446312|101999839|FG000|NOT COMPLETED|Overall Study||38||
48679528|NCT04446312|101999840|FG001|NOT COMPLETED|Overall Study||44||
48679529|NCT01816048|101999841|FG000|STARTED|Overall Study||8||
48679530|NCT01816048|101999841|FG000|COMPLETED|Overall Study||2||
48679531|NCT01816048|101999841|FG000|NOT COMPLETED|Overall Study||6||
48679532|NCT00000134|101999842|FG000|STARTED|Overall Study||89||
48241819|NCT01182285|100911807|FG002|STARTED|Second Intervention Week 11-17||0||
48241820|NCT01182285|100911805|FG000|COMPLETED|Second Intervention Week 11-17||0||
48241821|NCT01182285|100911806|FG001|COMPLETED|Second Intervention Week 11-17||0||
48241822|NCT01182285|100911807|FG002|COMPLETED|Second Intervention Week 11-17||0||
48241823|NCT01182285|100911805|FG000|NOT COMPLETED|Second Intervention Week 11-17||0||
48241824|NCT01182285|100911806|FG001|NOT COMPLETED|Second Intervention Week 11-17||0||
48241825|NCT01182285|100911807|FG002|NOT COMPLETED|Second Intervention Week 11-17||0||
48540277|NCT00575887|101658042|FG000|STARTED|Overall Study||25||
48540278|NCT00575887|101658042|FG000|COMPLETED|Overall Study||25||
48540279|NCT00575887|101658042|FG000|NOT COMPLETED|Overall Study||0||
48540280|NCT01449812|101658043|FG000|STARTED|Overall Study||272||
48540281|NCT01449812|101658044|FG001|STARTED|Overall Study||273||
48540282|NCT01449812|101658045|FG002|STARTED|Overall Study||280||
48540283|NCT01449812|101658043|FG000|COMPLETED|Overall Study||270||
48540284|NCT01449812|101658044|FG001|COMPLETED|Overall Study||273||
48540285|NCT01449812|101658045|FG002|COMPLETED|Overall Study||279||
48540286|NCT01449812|101658043|FG000|NOT COMPLETED|Overall Study||2||
48540287|NCT01449812|101658044|FG001|NOT COMPLETED|Overall Study||0||
48540288|NCT01449812|101658045|FG002|NOT COMPLETED|Overall Study||1||
48592677|NCT01877382|101783164|FG014|STARTED|Dose Expansion||20||
48241826|NCT01182285|100911805|FG000|STARTED|Third Intervention Week 11-52||0||
48241827|NCT01182285|100911806|FG001|STARTED|Third Intervention Week 11-52||0||
48241828|NCT01182285|100911807|FG002|STARTED|Third Intervention Week 11-52||8||
48241829|NCT01182285|100911805|FG000|COMPLETED|Third Intervention Week 11-52||0||
48241830|NCT01182285|100911806|FG001|COMPLETED|Third Intervention Week 11-52||0||
48241831|NCT01182285|100911807|FG002|COMPLETED|Third Intervention Week 11-52||0||
48241832|NCT01182285|100911805|FG000|NOT COMPLETED|Third Intervention Week 11-52||0||
48241833|NCT01182285|100911806|FG001|NOT COMPLETED|Third Intervention Week 11-52||0||
48241834|NCT01182285|100911807|FG002|NOT COMPLETED|Third Intervention Week 11-52||8||
48241835|NCT02592434|100911808|FG000|STARTED|Open-Label Phase (18 Weeks)||225||
48241836|NCT02592434|100911809|FG001|STARTED|Open-Label Phase (18 Weeks)||0||
48241837|NCT02592434|100911810|FG002|STARTED|Open-Label Phase (18 Weeks)||0||
48241838|NCT02592434|100911808|FG000|Treated|Open-Label Phase (18 Weeks)||225||
48241839|NCT02592434|100911809|FG001|Treated|Open-Label Phase (18 Weeks)||0||
48241840|NCT02592434|100911810|FG002|Treated|Open-Label Phase (18 Weeks)||0||
48241841|NCT02592434|100911808|FG000|COMPLETED|Open-Label Phase (18 Weeks)||185||
48241842|NCT02592434|100911809|FG001|COMPLETED|Open-Label Phase (18 Weeks)||0||
48241843|NCT02592434|100911810|FG002|COMPLETED|Open-Label Phase (18 Weeks)||0||
48241844|NCT02592434|100911808|FG000|NOT COMPLETED|Open-Label Phase (18 Weeks)||40||
48241845|NCT02592434|100911809|FG001|NOT COMPLETED|Open-Label Phase (18 Weeks)||0||
48241846|NCT02592434|100911810|FG002|NOT COMPLETED|Open-Label Phase (18 Weeks)||0||
48241847|NCT02592434|100911808|FG000|STARTED|Double Blind Phase (26 Weeks)||0||
48241848|NCT02592434|100911809|FG001|STARTED|Double Blind Phase (26 Weeks)||88||
48241849|NCT02592434|100911810|FG002|STARTED|Double Blind Phase (26 Weeks)||85||
48241850|NCT02592434|100911808|FG000|Treated|Double Blind Phase (26 Weeks)||0||
48241851|NCT02592434|100911809|FG001|Treated|Double Blind Phase (26 Weeks)||88||
48241852|NCT02592434|100911810|FG002|Treated|Double Blind Phase (26 Weeks)||85||
48241853|NCT02592434|100911808|FG000|COMPLETED|Double Blind Phase (26 Weeks)||0||
48241854|NCT02592434|100911809|FG001|COMPLETED|Double Blind Phase (26 Weeks)||61||
48241855|NCT02592434|100911810|FG002|COMPLETED|Double Blind Phase (26 Weeks)||38||
48592678|NCT01877382|101783150|FG000|COMPLETED|Dose Expansion||0||
48081254|NCT03129100|100521624|FG011|STARTED|Period 2 (Retreatment Extension Period)||0||
48081255|NCT03129100|100521625|FG012|STARTED|Period 2 (Retreatment Extension Period)||0||
48081256|NCT03129100|100521626|FG013|STARTED|Period 2 (Retreatment Extension Period)||0||
48081257|NCT03129100|100521627|FG014|STARTED|Period 2 (Retreatment Extension Period)||0||
48081258|NCT03129100|100521628|FG015|STARTED|Period 2 (Retreatment Extension Period)||0||
48081259|NCT03129100|100521629|FG016|STARTED|Period 2 (Retreatment Extension Period)||0||
48081260|NCT03129100|100521630|FG017|STARTED|Period 2 (Retreatment Extension Period)||0||
48081261|NCT03129100|100521631|FG018|STARTED|Period 2 (Retreatment Extension Period)||0||
48081262|NCT03129100|100521632|FG019|STARTED|Period 2 (Retreatment Extension Period)||0||
48081263|NCT03129100|100521633|FG020|STARTED|Period 2 (Retreatment Extension Period)||0||
48081264|NCT03129100|100521634|FG021|STARTED|Period 2 (Retreatment Extension Period)||0||
48081265|NCT03129100|100521635|FG022|STARTED|Period 2 (Retreatment Extension Period)||0||
48081266|NCT03129100|100521636|FG023|STARTED|Period 2 (Retreatment Extension Period)||0||
48081267|NCT03129100|100521637|FG024|STARTED|Period 2 (Retreatment Extension Period)||0||
48081268|NCT03129100|100521638|FG025|STARTED|Period 2 (Retreatment Extension Period)||0||
48081269|NCT03129100|100521613|FG000|COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081270|NCT03129100|100521614|FG001|COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081271|NCT03129100|100521615|FG002|COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081272|NCT03129100|100521616|FG003|COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081273|NCT03129100|100521617|FG004|COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081274|NCT03129100|100521618|FG005|COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081275|NCT03129100|100521619|FG006|COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081276|NCT03129100|100521620|FG007|COMPLETED|Period 2 (Retreatment Extension Period)||6||
48081277|NCT03129100|100521621|FG008|COMPLETED|Period 2 (Retreatment Extension Period)||5||
48081278|NCT03129100|100521622|FG009|COMPLETED|Period 2 (Retreatment Extension Period)||8||
48081279|NCT03129100|100521623|FG010|COMPLETED|Period 2 (Retreatment Extension Period)||10||
48081280|NCT03129100|100521624|FG011|COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081281|NCT03129100|100521625|FG012|COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081282|NCT03129100|100521626|FG013|COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081283|NCT03129100|100521627|FG014|COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081284|NCT03129100|100521628|FG015|COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081285|NCT03129100|100521629|FG016|COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081286|NCT03129100|100521630|FG017|COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081287|NCT03129100|100521631|FG018|COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081288|NCT03129100|100521632|FG019|COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081289|NCT03129100|100521633|FG020|COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081290|NCT03129100|100521634|FG021|COMPLETED|Period 2 (Retreatment Extension Period)||0||
48679533|NCT00000134|101999843|FG001|STARTED|Overall Study||94||
48679534|NCT00000134|101999844|FG002|STARTED|Overall Study||96||
48679535|NCT00000134|101999842|FG000|COMPLETED|Overall Study||89||
48679536|NCT00000134|101999843|FG001|COMPLETED|Overall Study||94||
48679537|NCT00000134|101999844|FG002|COMPLETED|Overall Study||96||
48679538|NCT00000134|101999842|FG000|NOT COMPLETED|Overall Study||0||
48081291|NCT03129100|100521635|FG022|COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081292|NCT03129100|100521636|FG023|COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081293|NCT03129100|100521637|FG024|COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081294|NCT03129100|100521638|FG025|COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081295|NCT03129100|100521613|FG000|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081296|NCT03129100|100521614|FG001|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081297|NCT03129100|100521615|FG002|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081298|NCT03129100|100521616|FG003|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081299|NCT03129100|100521617|FG004|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081300|NCT03129100|100521618|FG005|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081301|NCT03129100|100521619|FG006|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081302|NCT03129100|100521620|FG007|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081303|NCT03129100|100521621|FG008|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081304|NCT03129100|100521622|FG009|NOT COMPLETED|Period 2 (Retreatment Extension Period)||1||
48081305|NCT03129100|100521623|FG010|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081306|NCT03129100|100521624|FG011|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081307|NCT03129100|100521625|FG012|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081308|NCT03129100|100521626|FG013|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081309|NCT03129100|100521627|FG014|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081310|NCT03129100|100521628|FG015|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081311|NCT03129100|100521629|FG016|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081312|NCT03129100|100521630|FG017|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081313|NCT03129100|100521631|FG018|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081314|NCT03129100|100521632|FG019|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081315|NCT03129100|100521633|FG020|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081316|NCT03129100|100521634|FG021|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081317|NCT03129100|100521635|FG022|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
48679539|NCT00000134|101999843|FG001|NOT COMPLETED|Overall Study||0||
48679540|NCT00000134|101999844|FG002|NOT COMPLETED|Overall Study||0||
48679541|NCT01669902|101999845|FG000|STARTED|Overall Study||107||
48679542|NCT01669902|101999845|FG000|COMPLETED|Overall Study||78||
48679543|NCT01669902|101999845|FG000|NOT COMPLETED|Overall Study||29||
48679544|NCT01143402|101999846|FG000|STARTED|Overall Study||51||
48679545|NCT01143402|101999847|FG001|STARTED|Overall Study||50||
48679546|NCT01143402|101999848|FG002|STARTED|Overall Study||19||
48679547|NCT01143402|101999846|FG000|COMPLETED|Overall Study||50||
48081318|NCT03129100|100521636|FG023|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081319|NCT03129100|100521637|FG024|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081320|NCT03129100|100521638|FG025|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
48081321|NCT03129100|100521613|FG000|STARTED|Period3-Long-Term Extension Period A & B||0||
48081322|NCT03129100|100521614|FG001|STARTED|Period3-Long-Term Extension Period A & B||0||
48081323|NCT03129100|100521615|FG002|STARTED|Period3-Long-Term Extension Period A & B||0||
48081324|NCT03129100|100521616|FG003|STARTED|Period3-Long-Term Extension Period A & B||0||
48081325|NCT03129100|100521617|FG004|STARTED|Period3-Long-Term Extension Period A & B||0||
48081326|NCT03129100|100521618|FG005|STARTED|Period3-Long-Term Extension Period A & B||0||
48081327|NCT03129100|100521619|FG006|STARTED|Period3-Long-Term Extension Period A & B||0||
48081328|NCT03129100|100521620|FG007|STARTED|Period3-Long-Term Extension Period A & B||0||
48081329|NCT03129100|100521621|FG008|STARTED|Period3-Long-Term Extension Period A & B||0||
48081330|NCT03129100|100521622|FG009|STARTED|Period3-Long-Term Extension Period A & B||0||
48081331|NCT03129100|100521623|FG010|STARTED|Period3-Long-Term Extension Period A & B||0||
48081332|NCT03129100|100521624|FG011|STARTED|Period3-Long-Term Extension Period A & B||306||
48081333|NCT03129100|100521625|FG012|STARTED|Period3-Long-Term Extension Period A & B||177||
48081334|NCT03129100|100521626|FG013|STARTED|Period3-Long-Term Extension Period A & B||45||
48081335|NCT03129100|100521627|FG014|STARTED|Period3-Long-Term Extension Period A & B||42||
48081336|NCT03129100|100521628|FG015|STARTED|Period3-Long-Term Extension Period A & B||30||
48081337|NCT03129100|100521629|FG016|STARTED|Period3-Long-Term Extension Period A & B||0||
48081338|NCT03129100|100521630|FG017|STARTED|Period3-Long-Term Extension Period A & B||0||
48081339|NCT03129100|100521631|FG018|STARTED|Period3-Long-Term Extension Period A & B||0||
48081340|NCT03129100|100521632|FG019|STARTED|Period3-Long-Term Extension Period A & B||0||
48081341|NCT03129100|100521633|FG020|STARTED|Period3-Long-Term Extension Period A & B||0||
48081342|NCT03129100|100521634|FG021|STARTED|Period3-Long-Term Extension Period A & B||0||
48081343|NCT03129100|100521635|FG022|STARTED|Period3-Long-Term Extension Period A & B||0||
48081344|NCT03129100|100521636|FG023|STARTED|Period3-Long-Term Extension Period A & B||0||
48081345|NCT03129100|100521637|FG024|STARTED|Period3-Long-Term Extension Period A & B||0||
48081346|NCT03129100|100521638|FG025|STARTED|Period3-Long-Term Extension Period A & B||0||
48081347|NCT03129100|100521613|FG000|COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081348|NCT03129100|100521614|FG001|COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081349|NCT03129100|100521615|FG002|COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081350|NCT03129100|100521616|FG003|COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081351|NCT03129100|100521617|FG004|COMPLETED|Period3-Long-Term Extension Period A & B||0||
48679548|NCT01143402|101999847|FG001|COMPLETED|Overall Study||49||
48679549|NCT01143402|101999848|FG002|COMPLETED|Overall Study||18||
48679550|NCT01143402|101999846|FG000|NOT COMPLETED|Overall Study||1||
48679551|NCT01143402|101999847|FG001|NOT COMPLETED|Overall Study||1||
48081352|NCT03129100|100521618|FG005|COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081353|NCT03129100|100521619|FG006|COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081354|NCT03129100|100521620|FG007|COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081355|NCT03129100|100521621|FG008|COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081356|NCT03129100|100521622|FG009|COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081357|NCT03129100|100521623|FG010|COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081358|NCT03129100|100521624|FG011|COMPLETED|Period3-Long-Term Extension Period A & B||287||
48081359|NCT03129100|100521625|FG012|COMPLETED|Period3-Long-Term Extension Period A & B||146||
48081360|NCT03129100|100521626|FG013|COMPLETED|Period3-Long-Term Extension Period A & B||40||
48081361|NCT03129100|100521627|FG014|COMPLETED|Period3-Long-Term Extension Period A & B||37||
48081362|NCT03129100|100521628|FG015|COMPLETED|Period3-Long-Term Extension Period A & B||21||
48081363|NCT03129100|100521629|FG016|COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081364|NCT03129100|100521630|FG017|COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081365|NCT03129100|100521631|FG018|COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081366|NCT03129100|100521632|FG019|COMPLETED|Period3-Long-Term Extension Period A & B||0||
48679552|NCT01143402|101999848|FG002|NOT COMPLETED|Overall Study||1||
48679553|NCT02505425|101999849|FG000|STARTED|Overall Study||208||
48679554|NCT02505425|101999850|FG001|STARTED|Overall Study||207||
48679555|NCT02505425|101999851|FG002|STARTED|Overall Study||82||
48679556|NCT02505425|101999852|FG003|STARTED|Overall Study||76||
48679557|NCT02505425|101999849|FG000|COMPLETED|Overall Study||120||
48679558|NCT02505425|101999850|FG001|COMPLETED|Overall Study||125||
48679559|NCT02505425|101999851|FG002|COMPLETED|Overall Study||32||
48679560|NCT02505425|101999852|FG003|COMPLETED|Overall Study||50||
48679561|NCT02505425|101999849|FG000|NOT COMPLETED|Overall Study||88||
48679562|NCT02505425|101999850|FG001|NOT COMPLETED|Overall Study||82||
48679563|NCT02505425|101999851|FG002|NOT COMPLETED|Overall Study||50||
48081367|NCT03129100|100521633|FG020|COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081368|NCT03129100|100521634|FG021|COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081369|NCT03129100|100521635|FG022|COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081370|NCT03129100|100521636|FG023|COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081371|NCT03129100|100521637|FG024|COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081372|NCT03129100|100521638|FG025|COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081373|NCT03129100|100521613|FG000|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081374|NCT03129100|100521614|FG001|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081375|NCT03129100|100521615|FG002|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081376|NCT03129100|100521616|FG003|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081377|NCT03129100|100521617|FG004|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081378|NCT03129100|100521618|FG005|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081379|NCT03129100|100521619|FG006|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081380|NCT03129100|100521620|FG007|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081381|NCT03129100|100521621|FG008|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081382|NCT03129100|100521622|FG009|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081383|NCT03129100|100521623|FG010|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081384|NCT03129100|100521624|FG011|NOT COMPLETED|Period3-Long-Term Extension Period A & B||19||
48081385|NCT03129100|100521625|FG012|NOT COMPLETED|Period3-Long-Term Extension Period A & B||31||
48081386|NCT03129100|100521626|FG013|NOT COMPLETED|Period3-Long-Term Extension Period A & B||5||
48081387|NCT03129100|100521627|FG014|NOT COMPLETED|Period3-Long-Term Extension Period A & B||5||
48081388|NCT03129100|100521628|FG015|NOT COMPLETED|Period3-Long-Term Extension Period A & B||9||
48141209|NCT01260350|100670368|FG006|STARTED|Overall Study||10||
48081389|NCT03129100|100521629|FG016|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081390|NCT03129100|100521630|FG017|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081391|NCT03129100|100521631|FG018|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081392|NCT03129100|100521632|FG019|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081393|NCT03129100|100521633|FG020|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081394|NCT03129100|100521634|FG021|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081395|NCT03129100|100521635|FG022|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081396|NCT03129100|100521636|FG023|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081397|NCT03129100|100521637|FG024|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081398|NCT03129100|100521638|FG025|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
48081399|NCT03129100|100521613|FG000|STARTED|Period 3 (Flare)||0||
48679564|NCT02505425|101999852|FG003|NOT COMPLETED|Overall Study||26||
48679565|NCT00896012|101999853|FG000|STARTED|Overall Study||29||
48679566|NCT00896012|101999854|FG001|STARTED|Overall Study||23||
48679567|NCT00896012|101999853|FG000|COMPLETED|Overall Study||18||
48679568|NCT00896012|101999854|FG001|COMPLETED|Overall Study||12||
48679569|NCT00896012|101999853|FG000|NOT COMPLETED|Overall Study||11||
48679570|NCT00896012|101999854|FG001|NOT COMPLETED|Overall Study||11||
48679571|NCT01451411|101999855|FG000|STARTED|Overall Study||3||
48679572|NCT01451411|101999856|FG001|STARTED|Overall Study||1||
48679573|NCT01451411|101999855|FG000|COMPLETED|Overall Study||3||
48679574|NCT01451411|101999856|FG001|COMPLETED|Overall Study||1||
48679575|NCT01451411|101999855|FG000|NOT COMPLETED|Overall Study||0||
48679576|NCT01451411|101999856|FG001|NOT COMPLETED|Overall Study||0||
48679577|NCT02927795|101999857|FG000|STARTED|Overall Study||257||
48679578|NCT02927795|101999857|FG000|Treated|Overall Study||253||
48679579|NCT02927795|101999857|FG000|COMPLETED|Overall Study||234||
48679580|NCT02927795|101999857|FG000|NOT COMPLETED|Overall Study||23||
48679581|NCT02292537|101999858|FG000|STARTED|Overall Study||42||
48679582|NCT02292537|101999859|FG001|STARTED|Overall Study||84||
48679583|NCT02292537|101999858|FG000|Completed Treatment|Overall Study||42||
48679584|NCT02292537|101999859|FG001|Completed Treatment|Overall Study||83||
48679585|NCT02292537|101999858|FG000|COMPLETED|Overall Study||42||
48679586|NCT02292537|101999859|FG001|COMPLETED|Overall Study||84||
48679587|NCT02292537|101999858|FG000|NOT COMPLETED|Overall Study||0||
48679588|NCT02292537|101999859|FG001|NOT COMPLETED|Overall Study||0||
48679589|NCT01008618|101999860|FG000|STARTED|Period 1 (Titration Period)||218||
48679590|NCT01008618|101999861|FG001|STARTED|Period 1 (Titration Period)||0||
48679591|NCT01008618|101999862|FG002|STARTED|Period 1 (Titration Period)||0||
48679592|NCT01008618|101999860|FG000|COMPLETED|Period 1 (Titration Period)||150||
48679593|NCT01008618|101999861|FG001|COMPLETED|Period 1 (Titration Period)||0||
48679594|NCT01008618|101999862|FG002|COMPLETED|Period 1 (Titration Period)||0||
48679595|NCT01008618|101999860|FG000|NOT COMPLETED|Period 1 (Titration Period)||68||
48679596|NCT01008618|101999861|FG001|NOT COMPLETED|Period 1 (Titration Period)||0||
48679597|NCT01008618|101999862|FG002|NOT COMPLETED|Period 1 (Titration Period)||0||
48679598|NCT01008618|101999860|FG000|STARTED|Period 2 (Double-Blind Period)||0||
48679599|NCT01008618|101999861|FG001|STARTED|Period 2 (Double-Blind Period)||73||
48679600|NCT01008618|101999862|FG002|STARTED|Period 2 (Double-Blind Period)||77||
48679601|NCT01008618|101999860|FG000|COMPLETED|Period 2 (Double-Blind Period)||0||
48081400|NCT03129100|100521614|FG001|STARTED|Period 3 (Flare)||0||
48081401|NCT03129100|100521615|FG002|STARTED|Period 3 (Flare)||0||
48679602|NCT01008618|101999861|FG001|COMPLETED|Period 2 (Double-Blind Period)||37||
48081402|NCT03129100|100521616|FG003|STARTED|Period 3 (Flare)||0||
48679603|NCT01008618|101999862|FG002|COMPLETED|Period 2 (Double-Blind Period)||39||
48679604|NCT01008618|101999860|FG000|NOT COMPLETED|Period 2 (Double-Blind Period)||0||
48679605|NCT01008618|101999861|FG001|NOT COMPLETED|Period 2 (Double-Blind Period)||36||
48679606|NCT01008618|101999862|FG002|NOT COMPLETED|Period 2 (Double-Blind Period)||38||
48081403|NCT03129100|100521617|FG004|STARTED|Period 3 (Flare)||0||
48081404|NCT03129100|100521618|FG005|STARTED|Period 3 (Flare)||0||
48679607|NCT00372957|101999863|FG000|STARTED|Overall Study||10||
48081405|NCT03129100|100521619|FG006|STARTED|Period 3 (Flare)||0||
48081406|NCT03129100|100521620|FG007|STARTED|Period 3 (Flare)||0||
48081407|NCT03129100|100521621|FG008|STARTED|Period 3 (Flare)||0||
48081408|NCT03129100|100521622|FG009|STARTED|Period 3 (Flare)||0||
48081409|NCT03129100|100521623|FG010|STARTED|Period 3 (Flare)||0||
48081410|NCT03129100|100521624|FG011|STARTED|Period 3 (Flare)||0||
48081411|NCT03129100|100521625|FG012|STARTED|Period 3 (Flare)||0||
48081412|NCT03129100|100521626|FG013|STARTED|Period 3 (Flare)||0||
48081413|NCT03129100|100521627|FG014|STARTED|Period 3 (Flare)||0||
48081414|NCT03129100|100521628|FG015|STARTED|Period 3 (Flare)||0||
48081415|NCT03129100|100521629|FG016|STARTED|Period 3 (Flare)||6||
48540289|NCT03006302|101658046|FG000|STARTED|Overall Study||6|Started = enrolled and received at least one dose of study drug|
48540290|NCT03006302|101658047|FG001|STARTED|Overall Study||4|Started = enrolled and received at least one dose of study drug|
48540291|NCT03006302|101658048|FG002|STARTED|Overall Study||3|Started = enrolled and received at least one dose of study drug|
48081416|NCT03129100|100521630|FG017|STARTED|Period 3 (Flare)||4||
48081417|NCT03129100|100521631|FG018|STARTED|Period 3 (Flare)||11||
48540292|NCT03006302|101658049|FG003|STARTED|Overall Study||7|Started = enrolled and received at least one dose of study drug|
48540293|NCT03006302|101658050|FG004|STARTED|Overall Study||20|Started = enrolled and received at least one dose of study drug|
48081418|NCT03129100|100521632|FG019|STARTED|Period 3 (Flare)||15||
48081419|NCT03129100|100521633|FG020|STARTED|Period 3 (Flare)||0||
48081420|NCT03129100|100521634|FG021|STARTED|Period 3 (Flare)||0||
48081421|NCT03129100|100521635|FG022|STARTED|Period 3 (Flare)||0||
48081422|NCT03129100|100521636|FG023|STARTED|Period 3 (Flare)||0||
48081423|NCT03129100|100521637|FG024|STARTED|Period 3 (Flare)||0||
48081424|NCT03129100|100521638|FG025|STARTED|Period 3 (Flare)||0||
48081425|NCT03129100|100521613|FG000|COMPLETED|Period 3 (Flare)||0||
48081426|NCT03129100|100521614|FG001|COMPLETED|Period 3 (Flare)||0||
48081427|NCT03129100|100521615|FG002|COMPLETED|Period 3 (Flare)||0||
48081428|NCT03129100|100521616|FG003|COMPLETED|Period 3 (Flare)||0||
48081429|NCT03129100|100521617|FG004|COMPLETED|Period 3 (Flare)||0||
48081430|NCT03129100|100521618|FG005|COMPLETED|Period 3 (Flare)||0||
48081431|NCT03129100|100521619|FG006|COMPLETED|Period 3 (Flare)||0||
48679608|NCT00372957|101999864|FG001|STARTED|Overall Study||10||
48679609|NCT00372957|101999865|FG002|STARTED|Overall Study||10||
48679610|NCT00372957|101999863|FG000|COMPLETED|Overall Study||10||
48679611|NCT00372957|101999864|FG001|COMPLETED|Overall Study||10||
48679612|NCT00372957|101999865|FG002|COMPLETED|Overall Study||10||
48679613|NCT00372957|101999863|FG000|NOT COMPLETED|Overall Study||0||
48679614|NCT00372957|101999864|FG001|NOT COMPLETED|Overall Study||0||
48679615|NCT00372957|101999865|FG002|NOT COMPLETED|Overall Study||0||
48679616|NCT04422431|101999866|FG000|STARTED|Treatment Period (48 Weeks)||31||
48679617|NCT04422431|101999866|FG000|Received at Least 1 Dose of Study Drug|Treatment Period (48 Weeks)||31||
48679618|NCT04422431|101999866|FG000|COMPLETED|Treatment Period (48 Weeks)||26||
48679619|NCT04422431|101999866|FG000|NOT COMPLETED|Treatment Period (48 Weeks)||5||
48679620|NCT04422431|101999866|FG000|STARTED|Extension Period (48 Weeks)||25||
48679621|NCT04422431|101999866|FG000|Received at Least 1 Dose of Study Drug|Extension Period (48 Weeks)||25||
48081432|NCT03129100|100521620|FG007|COMPLETED|Period 3 (Flare)||0||
48679622|NCT04422431|101999866|FG000|COMPLETED|Extension Period (48 Weeks)||21||
48679623|NCT04422431|101999866|FG000|NOT COMPLETED|Extension Period (48 Weeks)||4||
48679624|NCT04229888|101999867|FG000|STARTED|Overall Study||14|All 14 subjects total received both treatments|
48679625|NCT04229888|101999867|FG000|COMPLETED|Overall Study||14||
48679626|NCT04229888|101999867|FG000|NOT COMPLETED|Overall Study||0||
48081433|NCT03129100|100521621|FG008|COMPLETED|Period 3 (Flare)||0||
48081434|NCT03129100|100521622|FG009|COMPLETED|Period 3 (Flare)||0||
48081435|NCT03129100|100521623|FG010|COMPLETED|Period 3 (Flare)||0||
48081436|NCT03129100|100521624|FG011|COMPLETED|Period 3 (Flare)||0||
48679627|NCT00947219|101999868|FG000|STARTED|Overall Study||28||
48679628|NCT00947219|101999869|FG001|STARTED|Overall Study||25||
48679629|NCT00947219|101999870|FG002|STARTED|Overall Study||26||
48679630|NCT00947219|101999868|FG000|COMPLETED|Overall Study||22||
48679631|NCT00947219|101999869|FG001|COMPLETED|Overall Study||21||
48679632|NCT00947219|101999870|FG002|COMPLETED|Overall Study||22||
48679633|NCT00947219|101999868|FG000|NOT COMPLETED|Overall Study||6||
48081437|NCT03129100|100521625|FG012|COMPLETED|Period 3 (Flare)||0||
48081438|NCT03129100|100521626|FG013|COMPLETED|Period 3 (Flare)||0||
48081439|NCT03129100|100521627|FG014|COMPLETED|Period 3 (Flare)||0||
48081440|NCT03129100|100521628|FG015|COMPLETED|Period 3 (Flare)||0||
48081441|NCT03129100|100521629|FG016|COMPLETED|Period 3 (Flare)||6||
48081442|NCT03129100|100521630|FG017|COMPLETED|Period 3 (Flare)||2||
48081443|NCT03129100|100521631|FG018|COMPLETED|Period 3 (Flare)||11||
48081444|NCT03129100|100521632|FG019|COMPLETED|Period 3 (Flare)||12||
48081445|NCT03129100|100521633|FG020|COMPLETED|Period 3 (Flare)||0||
48081446|NCT03129100|100521634|FG021|COMPLETED|Period 3 (Flare)||0||
48081447|NCT03129100|100521635|FG022|COMPLETED|Period 3 (Flare)||0||
48081448|NCT03129100|100521636|FG023|COMPLETED|Period 3 (Flare)||0||
48081449|NCT03129100|100521637|FG024|COMPLETED|Period 3 (Flare)||0||
48679634|NCT00947219|101999869|FG001|NOT COMPLETED|Overall Study||4||
48679635|NCT00947219|101999870|FG002|NOT COMPLETED|Overall Study||4||
48679636|NCT01757665|101999871|FG000|STARTED|Overall Study||694||
48679637|NCT01757665|101999872|FG001|STARTED|Overall Study||83||
48679638|NCT01757665|101999871|FG000|Implanted With Device|Overall Study||689||
48679639|NCT01757665|101999872|FG001|Implanted With Device|Overall Study||82||
48679640|NCT01757665|101999871|FG000|COMPLETED|Overall Study||0||
48679641|NCT01757665|101999872|FG001|COMPLETED|Overall Study||0||
48679642|NCT01757665|101999871|FG000|NOT COMPLETED|Overall Study||694||
48679643|NCT01757665|101999872|FG001|NOT COMPLETED|Overall Study||83||
48679644|NCT01049373|101999873|FG000|STARTED|Overall Study||112||
48679645|NCT01049373|101999874|FG001|STARTED|Overall Study||109||
48679646|NCT01049373|101999873|FG000|COMPLETED|Overall Study||73||
48679647|NCT01049373|101999874|FG001|COMPLETED|Overall Study||65||
48679648|NCT01049373|101999873|FG000|NOT COMPLETED|Overall Study||39||
48679649|NCT01049373|101999874|FG001|NOT COMPLETED|Overall Study||44||
48679650|NCT00998010|101999875|FG000|STARTED|Overall Study||24||
48679651|NCT00998010|101999875|FG000|COMPLETED|Overall Study||24||
48679652|NCT00998010|101999875|FG000|NOT COMPLETED|Overall Study||0||
48679653|NCT00003645|101999876|FG000|STARTED|Overall Study||30||
48679654|NCT00003645|101999877|FG001|STARTED|Overall Study||34||
48679655|NCT00003645|101999876|FG000|COMPLETED|Overall Study||18||
48679656|NCT00003645|101999877|FG001|COMPLETED|Overall Study||22||
48679657|NCT00003645|101999876|FG000|NOT COMPLETED|Overall Study||12||
48679658|NCT00003645|101999877|FG001|NOT COMPLETED|Overall Study||12||
48679659|NCT02633735|101999878|FG000|STARTED|Pre-implementation Phase||788||
48679660|NCT02633735|101999879|FG001|STARTED|Pre-implementation Phase||1011||
48679661|NCT02633735|101999878|FG000|COMPLETED|Pre-implementation Phase||788||
48679662|NCT02633735|101999879|FG001|COMPLETED|Pre-implementation Phase||1011||
48679663|NCT02633735|101999878|FG000|NOT COMPLETED|Pre-implementation Phase||0||
48679664|NCT02633735|101999879|FG001|NOT COMPLETED|Pre-implementation Phase||0||
48679665|NCT02633735|101999878|FG000|STARTED|Implementation Phase||1991||
48679666|NCT02633735|101999879|FG001|STARTED|Implementation Phase||2150||
48679667|NCT02633735|101999878|FG000|COMPLETED|Implementation Phase||1991||
48679668|NCT02633735|101999879|FG001|COMPLETED|Implementation Phase||2150||
48679669|NCT02633735|101999878|FG000|NOT COMPLETED|Implementation Phase||0||
48679670|NCT02633735|101999879|FG001|NOT COMPLETED|Implementation Phase||0||
48679671|NCT02961244|101999880|FG000|STARTED|Overall Study||64||
48679672|NCT02961244|101999881|FG001|STARTED|Overall Study||64||
48679673|NCT02961244|101999880|FG000|Patients Excluded During Randomization|Overall Study||0||
48679674|NCT02961244|101999881|FG001|Patients Excluded During Randomization|Overall Study||1||
48679675|NCT02961244|101999880|FG000|COMPLETED|Overall Study||63||
48679676|NCT02961244|101999881|FG001|COMPLETED|Overall Study||55||
48679677|NCT02961244|101999880|FG000|NOT COMPLETED|Overall Study||1||
48679678|NCT02961244|101999881|FG001|NOT COMPLETED|Overall Study||9||
48679679|NCT01819272|101999882|FG000|STARTED|Overall Study||41||
48679680|NCT01819272|101999883|FG001|STARTED|Overall Study||39||
48679681|NCT01819272|101999884|FG002|STARTED|Overall Study||40||
48679682|NCT01819272|101999885|FG003|STARTED|Overall Study||40||
48679683|NCT01819272|101999886|FG004|STARTED|Overall Study||40||
48679684|NCT01819272|101999887|FG005|STARTED|Overall Study||40||
48679685|NCT01819272|101999882|FG000|COMPLETED|Overall Study||35||
48679686|NCT01819272|101999883|FG001|COMPLETED|Overall Study||36||
48679687|NCT01819272|101999884|FG002|COMPLETED|Overall Study||37||
48679688|NCT01819272|101999885|FG003|COMPLETED|Overall Study||35||
48679689|NCT01819272|101999886|FG004|COMPLETED|Overall Study||36||
48679690|NCT01819272|101999887|FG005|COMPLETED|Overall Study||33||
48679691|NCT01819272|101999882|FG000|NOT COMPLETED|Overall Study||6||
48081450|NCT03129100|100521638|FG025|COMPLETED|Period 3 (Flare)||0||
48592679|NCT01877382|101783151|FG001|COMPLETED|Dose Expansion||0||
48679692|NCT01819272|101999883|FG001|NOT COMPLETED|Overall Study||3||
48679693|NCT01819272|101999884|FG002|NOT COMPLETED|Overall Study||3||
48679694|NCT01819272|101999885|FG003|NOT COMPLETED|Overall Study||5||
48679695|NCT01819272|101999886|FG004|NOT COMPLETED|Overall Study||4||
48679696|NCT01819272|101999887|FG005|NOT COMPLETED|Overall Study||7||
48679697|NCT01822665|101999888|FG000|STARTED|Overall Study||28||
48679698|NCT01822665|101999888|FG000|Received Ibuprofen Tablet (400 mg)|Overall Study||23||
48679699|NCT01822665|101999888|FG000|Received Placebo Tablet|Overall Study||23||
48081451|NCT03129100|100521613|FG000|NOT COMPLETED|Period 3 (Flare)||0||
48081452|NCT03129100|100521614|FG001|NOT COMPLETED|Period 3 (Flare)||0||
48679700|NCT01822665|101999888|FG000|Received Ibuprofen Capsule (400 mg)|Overall Study||24||
48679701|NCT01822665|101999888|FG000|Received Paracetamol Tablet (1000 mg)|Overall Study||28||
48679702|NCT01822665|101999888|FG000|COMPLETED|Overall Study||20||
48679703|NCT01822665|101999888|FG000|NOT COMPLETED|Overall Study||8||
48679704|NCT02568722|101999889|FG000|STARTED|Overall Study||1507||
48679705|NCT02568722|101999890|FG001|STARTED|Overall Study||1512||
48679706|NCT02568722|101999889|FG000|Withdrew Consent|Overall Study||18||
48679707|NCT02568722|101999890|FG001|Withdrew Consent|Overall Study||9||
48679708|NCT02568722|101999889|FG000|Randomized Non-eligible|Overall Study||19||
48679709|NCT02568722|101999890|FG001|Randomized Non-eligible|Overall Study||31||
48679710|NCT02568722|101999889|FG000|Lost to Follow-up|Overall Study||8||
48679711|NCT02568722|101999890|FG001|Lost to Follow-up|Overall Study||7||
48679712|NCT02568722|101999889|FG000|COMPLETED|Overall Study||1462||
48679713|NCT02568722|101999890|FG001|COMPLETED|Overall Study||1465||
48679714|NCT02568722|101999889|FG000|NOT COMPLETED|Overall Study||45||
48679715|NCT02568722|101999890|FG001|NOT COMPLETED|Overall Study||47||
48679716|NCT01535287|101999891|FG000|STARTED|Overall Study||70||
48679717|NCT01535287|101999892|FG001|STARTED|Overall Study||70||
48679718|NCT01535287|101999891|FG000|COMPLETED|Overall Study||65||
48679719|NCT01535287|101999892|FG001|COMPLETED|Overall Study||64||
48679720|NCT01535287|101999891|FG000|NOT COMPLETED|Overall Study||5||
48679721|NCT01535287|101999892|FG001|NOT COMPLETED|Overall Study||6||
48679722|NCT01627691|101999893|FG000|STARTED|Overall Study||250||
48679723|NCT01627691|101999893|FG000|Primary Endpoint (30days)|Overall Study||239||
48679724|NCT01627691|101999893|FG000|COMPLETED|Overall Study||232||
48679725|NCT01627691|101999893|FG000|NOT COMPLETED|Overall Study||18||
48679726|NCT02030821|101999894|FG000|STARTED|Overall Study||48||
48679727|NCT02030821|101999895|FG001|STARTED|Overall Study||46||
48679728|NCT02030821|101999896|FG002|STARTED|Overall Study||78||
48679729|NCT02030821|101999897|FG003|STARTED|Overall Study||74||
48679730|NCT02030821|101999894|FG000|COMPLETED|Overall Study||46||
48679731|NCT02030821|101999895|FG001|COMPLETED|Overall Study||44||
48679732|NCT02030821|101999896|FG002|COMPLETED|Overall Study||73||
48679733|NCT02030821|101999897|FG003|COMPLETED|Overall Study||72||
48081453|NCT03129100|100521615|FG002|NOT COMPLETED|Period 3 (Flare)||0||
48081454|NCT03129100|100521616|FG003|NOT COMPLETED|Period 3 (Flare)||0||
48081455|NCT03129100|100521617|FG004|NOT COMPLETED|Period 3 (Flare)||0||
48081456|NCT03129100|100521618|FG005|NOT COMPLETED|Period 3 (Flare)||0||
48081457|NCT03129100|100521619|FG006|NOT COMPLETED|Period 3 (Flare)||0||
48081458|NCT03129100|100521620|FG007|NOT COMPLETED|Period 3 (Flare)||0||
48081459|NCT03129100|100521621|FG008|NOT COMPLETED|Period 3 (Flare)||0||
48081460|NCT03129100|100521622|FG009|NOT COMPLETED|Period 3 (Flare)||0||
48081461|NCT03129100|100521623|FG010|NOT COMPLETED|Period 3 (Flare)||0||
48081462|NCT03129100|100521624|FG011|NOT COMPLETED|Period 3 (Flare)||0||
48081463|NCT03129100|100521625|FG012|NOT COMPLETED|Period 3 (Flare)||0||
48081464|NCT03129100|100521626|FG013|NOT COMPLETED|Period 3 (Flare)||0||
48081465|NCT03129100|100521627|FG014|NOT COMPLETED|Period 3 (Flare)||0||
48081466|NCT03129100|100521628|FG015|NOT COMPLETED|Period 3 (Flare)||0||
48081467|NCT03129100|100521629|FG016|NOT COMPLETED|Period 3 (Flare)||0||
48081468|NCT03129100|100521630|FG017|NOT COMPLETED|Period 3 (Flare)||2||
48081469|NCT03129100|100521631|FG018|NOT COMPLETED|Period 3 (Flare)||0||
48081470|NCT03129100|100521632|FG019|NOT COMPLETED|Period 3 (Flare)||3||
48081471|NCT03129100|100521633|FG020|NOT COMPLETED|Period 3 (Flare)||0||
48081472|NCT03129100|100521634|FG021|NOT COMPLETED|Period 3 (Flare)||0||
48081473|NCT03129100|100521635|FG022|NOT COMPLETED|Period 3 (Flare)||0||
48081474|NCT03129100|100521636|FG023|NOT COMPLETED|Period 3 (Flare)||0||
48081475|NCT03129100|100521637|FG024|NOT COMPLETED|Period 3 (Flare)||0||
48081476|NCT03129100|100521638|FG025|NOT COMPLETED|Period 3 (Flare)||0||
48081477|NCT03129100|100521613|FG000|STARTED|Period 3 (Dose Escalation)||0||
48081478|NCT03129100|100521614|FG001|STARTED|Period 3 (Dose Escalation)||0||
48081479|NCT03129100|100521615|FG002|STARTED|Period 3 (Dose Escalation)||0||
48081480|NCT03129100|100521616|FG003|STARTED|Period 3 (Dose Escalation)||0||
48081481|NCT03129100|100521617|FG004|STARTED|Period 3 (Dose Escalation)||0||
48081482|NCT03129100|100521618|FG005|STARTED|Period 3 (Dose Escalation)||0||
48081483|NCT03129100|100521619|FG006|STARTED|Period 3 (Dose Escalation)||0||
48081484|NCT03129100|100521620|FG007|STARTED|Period 3 (Dose Escalation)||0||
48081485|NCT03129100|100521621|FG008|STARTED|Period 3 (Dose Escalation)||0||
48081486|NCT03129100|100521622|FG009|STARTED|Period 3 (Dose Escalation)||0||
48081487|NCT03129100|100521623|FG010|STARTED|Period 3 (Dose Escalation)||0||
48081488|NCT03129100|100521624|FG011|STARTED|Period 3 (Dose Escalation)||0||
48081489|NCT03129100|100521625|FG012|STARTED|Period 3 (Dose Escalation)||0||
48081490|NCT03129100|100521626|FG013|STARTED|Period 3 (Dose Escalation)||0||
48081491|NCT03129100|100521627|FG014|STARTED|Period 3 (Dose Escalation)||0||
48081492|NCT03129100|100521628|FG015|STARTED|Period 3 (Dose Escalation)||0||
48081493|NCT03129100|100521629|FG016|STARTED|Period 3 (Dose Escalation)||0||
48081494|NCT03129100|100521630|FG017|STARTED|Period 3 (Dose Escalation)||0||
48081495|NCT03129100|100521631|FG018|STARTED|Period 3 (Dose Escalation)||0||
48081496|NCT03129100|100521632|FG019|STARTED|Period 3 (Dose Escalation)||0||
48081497|NCT03129100|100521633|FG020|STARTED|Period 3 (Dose Escalation)||77||
48081498|NCT03129100|100521634|FG021|STARTED|Period 3 (Dose Escalation)||5||
48081499|NCT03129100|100521635|FG022|STARTED|Period 3 (Dose Escalation)||4||
48081500|NCT03129100|100521636|FG023|STARTED|Period 3 (Dose Escalation)||0||
48081501|NCT03129100|100521637|FG024|STARTED|Period 3 (Dose Escalation)||0||
48081502|NCT03129100|100521638|FG025|STARTED|Period 3 (Dose Escalation)||0||
48081503|NCT03129100|100521613|FG000|COMPLETED|Period 3 (Dose Escalation)||0||
48081504|NCT03129100|100521614|FG001|COMPLETED|Period 3 (Dose Escalation)||0||
48081505|NCT03129100|100521615|FG002|COMPLETED|Period 3 (Dose Escalation)||0||
48081506|NCT03129100|100521616|FG003|COMPLETED|Period 3 (Dose Escalation)||0||
48081507|NCT03129100|100521617|FG004|COMPLETED|Period 3 (Dose Escalation)||0||
48241856|NCT02592434|100911808|FG000|NOT COMPLETED|Double Blind Phase (26 Weeks)||0||
48241857|NCT02592434|100911809|FG001|NOT COMPLETED|Double Blind Phase (26 Weeks)||27||
48241858|NCT02592434|100911810|FG002|NOT COMPLETED|Double Blind Phase (26 Weeks)||47||
48241859|NCT02214017|100911811|FG000|STARTED|Overall Study||22||
48241860|NCT02214017|100911812|FG001|STARTED|Overall Study||18||
48241861|NCT02214017|100911811|FG000|COMPLETED|Overall Study||22||
48241862|NCT02214017|100911812|FG001|COMPLETED|Overall Study||18||
48241863|NCT02214017|100911811|FG000|NOT COMPLETED|Overall Study||0||
48241864|NCT02214017|100911812|FG001|NOT COMPLETED|Overall Study||0||
48241865|NCT04343989|100911813|FG000|STARTED|Overall Study||78||
48241866|NCT04343989|100911814|FG001|STARTED|Overall Study||26||
48241867|NCT04343989|100911815|FG002|STARTED|Overall Study||74||
48241868|NCT04343989|100911813|FG000|COMPLETED|Overall Study||78||
48241869|NCT04343989|100911814|FG001|COMPLETED|Overall Study||26||
48241870|NCT04343989|100911815|FG002|COMPLETED|Overall Study||74||
48241871|NCT04343989|100911813|FG000|NOT COMPLETED|Overall Study||0||
48241872|NCT04343989|100911814|FG001|NOT COMPLETED|Overall Study||0||
48241873|NCT04343989|100911815|FG002|NOT COMPLETED|Overall Study||0||
48241874|NCT03317288|100911816|FG000|STARTED|Overall Study||15||
48241875|NCT03317288|100911816|FG000|COMPLETED|Overall Study||15||
48241876|NCT03317288|100911816|FG000|NOT COMPLETED|Overall Study||0||
48241877|NCT01636258|100911817|FG000|STARTED|Overall Study||13||
48241878|NCT01636258|100911818|FG001|STARTED|Overall Study||14||
48241879|NCT01636258|100911817|FG000|COMPLETED|Overall Study||12||
48241880|NCT01636258|100911818|FG001|COMPLETED|Overall Study||14||
48241881|NCT01636258|100911817|FG000|NOT COMPLETED|Overall Study||1||
48241882|NCT01636258|100911818|FG001|NOT COMPLETED|Overall Study||0||
48241883|NCT04117711|100911819|FG000|STARTED|Part A Cohort 1||6||
48241884|NCT04117711|100911820|FG001|STARTED|Part A Cohort 1||0||
48241885|NCT04117711|100911821|FG002|STARTED|Part A Cohort 1||0||
48241886|NCT04117711|100911822|FG003|STARTED|Part A Cohort 1||0||
48241887|NCT04117711|100911823|FG004|STARTED|Part A Cohort 1||0||
48241888|NCT04117711|100911824|FG005|STARTED|Part A Cohort 1||0||
48241889|NCT04117711|100911825|FG006|STARTED|Part A Cohort 1||0||
48241890|NCT04117711|100911826|FG007|STARTED|Part A Cohort 1||0||
48241891|NCT04117711|100911827|FG008|STARTED|Part A Cohort 1||0||
48241892|NCT04117711|100911828|FG009|STARTED|Part A Cohort 1||0||
48679734|NCT02030821|101999894|FG000|NOT COMPLETED|Overall Study||2||
48679735|NCT02030821|101999895|FG001|NOT COMPLETED|Overall Study||2||
48679736|NCT02030821|101999896|FG002|NOT COMPLETED|Overall Study||5||
48679737|NCT02030821|101999897|FG003|NOT COMPLETED|Overall Study||2||
48679738|NCT02986074|101999898|FG000|STARTED|First Trial Period||26||
48679739|NCT02986074|101999899|FG001|STARTED|First Trial Period||29||
48679740|NCT02986074|101999900|FG002|STARTED|First Trial Period||0||
48679741|NCT02986074|101999901|FG003|STARTED|First Trial Period||0||
48679742|NCT02986074|101999898|FG000|COMPLETED|First Trial Period||25||
48679743|NCT02986074|101999899|FG001|COMPLETED|First Trial Period||29||
48679744|NCT02986074|101999900|FG002|COMPLETED|First Trial Period||0||
48679745|NCT02986074|101999901|FG003|COMPLETED|First Trial Period||0||
48241893|NCT04117711|100911829|FG010|STARTED|Part A Cohort 1||0||
48679746|NCT02986074|101999898|FG000|NOT COMPLETED|First Trial Period||1||
48679747|NCT02986074|101999899|FG001|NOT COMPLETED|First Trial Period||0||
48679748|NCT02986074|101999900|FG002|NOT COMPLETED|First Trial Period||0||
48679749|NCT02986074|101999901|FG003|NOT COMPLETED|First Trial Period||0||
48679750|NCT02986074|101999898|FG000|STARTED|Second Trial Period||25||
48679751|NCT02986074|101999899|FG001|STARTED|Second Trial Period||29||
48679752|NCT02986074|101999900|FG002|STARTED|Second Trial Period||0||
48679753|NCT02986074|101999901|FG003|STARTED|Second Trial Period||0||
48679754|NCT02986074|101999898|FG000|COMPLETED|Second Trial Period||25||
48679755|NCT02986074|101999899|FG001|COMPLETED|Second Trial Period||29||
48679756|NCT02986074|101999900|FG002|COMPLETED|Second Trial Period||0||
48679757|NCT02986074|101999901|FG003|COMPLETED|Second Trial Period||0||
48679758|NCT02986074|101999898|FG000|NOT COMPLETED|Second Trial Period||0||
48241894|NCT04117711|100911830|FG011|STARTED|Part A Cohort 1||0||
48241895|NCT04117711|100911831|FG012|STARTED|Part A Cohort 1||0||
48679759|NCT02986074|101999899|FG001|NOT COMPLETED|Second Trial Period||0||
48679760|NCT02986074|101999900|FG002|NOT COMPLETED|Second Trial Period||0||
48241896|NCT04117711|100911832|FG013|STARTED|Part A Cohort 1||0||
48241897|NCT04117711|100911833|FG014|STARTED|Part A Cohort 1||0||
48241898|NCT04117711|100911834|FG015|STARTED|Part A Cohort 1||0||
48241899|NCT04117711|100911835|FG016|STARTED|Part A Cohort 1||0||
48241900|NCT04117711|100911836|FG017|STARTED|Part A Cohort 1||0||
48241901|NCT04117711|100911837|FG018|STARTED|Part A Cohort 1||0||
48241902|NCT04117711|100911838|FG019|STARTED|Part A Cohort 1||0||
48540294|NCT03006302|101658046|FG000|COMPLETED|Overall Study||2|Completed = Received 1 course (6 cycles) of treatment|
48540295|NCT03006302|101658047|FG001|COMPLETED|Overall Study||1|Completed = Received 1 course (6 cycles) of treatment|
48540296|NCT03006302|101658048|FG002|COMPLETED|Overall Study||2|Completed = Received 1 course (6 cycles) of treatment|
48540297|NCT03006302|101658049|FG003|COMPLETED|Overall Study||0|Completed = Received 1 course (6 cycles) of treatment|
48540298|NCT03006302|101658050|FG004|COMPLETED|Overall Study||4|Completed = Received 1 course (6 cycles) of treatment|
48540299|NCT03006302|101658046|FG000|NOT COMPLETED|Overall Study||4||
48540300|NCT03006302|101658047|FG001|NOT COMPLETED|Overall Study||3||
48540301|NCT03006302|101658048|FG002|NOT COMPLETED|Overall Study||1||
48540302|NCT03006302|101658049|FG003|NOT COMPLETED|Overall Study||7||
48540303|NCT03006302|101658050|FG004|NOT COMPLETED|Overall Study||16||
48540304|NCT04562155|101658051|FG000|STARTED|Overall Study||75||
48540305|NCT04562155|101658052|FG001|STARTED|Overall Study||78||
48540306|NCT04562155|101658053|FG002|STARTED|Overall Study||80||
48540307|NCT04562155|101658054|FG003|STARTED|Overall Study||77||
48679761|NCT02986074|101999901|FG003|NOT COMPLETED|Second Trial Period||0||
48679762|NCT02986074|101999898|FG000|STARTED|Follow up Period||0||
48679763|NCT02986074|101999899|FG001|STARTED|Follow up Period||0||
48679764|NCT02986074|101999900|FG002|STARTED|Follow up Period||21||
48679765|NCT02986074|101999901|FG003|STARTED|Follow up Period||22||
48679766|NCT02986074|101999898|FG000|3 Month Follow up|Follow up Period||0||
48679767|NCT02986074|101999899|FG001|3 Month Follow up|Follow up Period||0||
48679768|NCT02986074|101999900|FG002|3 Month Follow up|Follow up Period||21||
48679769|NCT02986074|101999901|FG003|3 Month Follow up|Follow up Period||21||
48679770|NCT02986074|101999898|FG000|6 Month Follow up|Follow up Period||0||
48679771|NCT02986074|101999899|FG001|6 Month Follow up|Follow up Period||0||
48679772|NCT02986074|101999900|FG002|6 Month Follow up|Follow up Period||21||
48679773|NCT02986074|101999901|FG003|6 Month Follow up|Follow up Period||20||
48679774|NCT02986074|101999898|FG000|COMPLETED|Follow up Period||0||
48679775|NCT02986074|101999899|FG001|COMPLETED|Follow up Period||0||
48679776|NCT02986074|101999900|FG002|COMPLETED|Follow up Period||20||
48679777|NCT02986074|101999901|FG003|COMPLETED|Follow up Period||19||
48679778|NCT02986074|101999898|FG000|NOT COMPLETED|Follow up Period||0||
48679779|NCT02986074|101999899|FG001|NOT COMPLETED|Follow up Period||0||
48679780|NCT02986074|101999900|FG002|NOT COMPLETED|Follow up Period||1||
48679781|NCT02986074|101999901|FG003|NOT COMPLETED|Follow up Period||3||
48679782|NCT01730872|101999902|FG000|STARTED|Overall Study||8||
48679783|NCT01730872|101999903|FG001|STARTED|Overall Study||5||
48679784|NCT01730872|101999904|FG002|STARTED|Overall Study||3||
48679785|NCT01730872|101999902|FG000|Full Analysis Set|Overall Study||8||
48679786|NCT01730872|101999903|FG001|Full Analysis Set|Overall Study||4||
48679787|NCT01730872|101999904|FG002|Full Analysis Set|Overall Study||0||
48679788|NCT01730872|101999902|FG000|COMPLETED|Overall Study||8||
48679789|NCT01730872|101999903|FG001|COMPLETED|Overall Study||5||
48679790|NCT01730872|101999904|FG002|COMPLETED|Overall Study||3||
48679791|NCT01730872|101999902|FG000|NOT COMPLETED|Overall Study||0||
48241903|NCT04117711|100911839|FG020|STARTED|Part A Cohort 1||0||
48241904|NCT04117711|100911840|FG021|STARTED|Part A Cohort 1||0||
48241905|NCT04117711|100911819|FG000|COMPLETED|Part A Cohort 1||6||
48241906|NCT04117711|100911820|FG001|COMPLETED|Part A Cohort 1||0||
48241907|NCT04117711|100911821|FG002|COMPLETED|Part A Cohort 1||0||
48241908|NCT04117711|100911822|FG003|COMPLETED|Part A Cohort 1||0||
48241909|NCT04117711|100911823|FG004|COMPLETED|Part A Cohort 1||0||
48241910|NCT04117711|100911824|FG005|COMPLETED|Part A Cohort 1||0||
48241911|NCT04117711|100911825|FG006|COMPLETED|Part A Cohort 1||0||
48241912|NCT04117711|100911826|FG007|COMPLETED|Part A Cohort 1||0||
48241913|NCT04117711|100911827|FG008|COMPLETED|Part A Cohort 1||0||
48679792|NCT01730872|101999903|FG001|NOT COMPLETED|Overall Study||0||
48679793|NCT01730872|101999904|FG002|NOT COMPLETED|Overall Study||0||
48679794|NCT00606489|101999905|FG000|STARTED|Overall Study||21||
48679795|NCT00606489|101999906|FG001|STARTED|Overall Study||40||
48679796|NCT00606489|101999905|FG000|COMPLETED|Overall Study||21||
48679797|NCT00606489|101999906|FG001|COMPLETED|Overall Study||40||
48241914|NCT04117711|100911828|FG009|COMPLETED|Part A Cohort 1||0||
48241915|NCT04117711|100911829|FG010|COMPLETED|Part A Cohort 1||0||
48241916|NCT04117711|100911830|FG011|COMPLETED|Part A Cohort 1||0||
48241917|NCT04117711|100911831|FG012|COMPLETED|Part A Cohort 1||0||
48241918|NCT04117711|100911832|FG013|COMPLETED|Part A Cohort 1||0||
48241919|NCT04117711|100911833|FG014|COMPLETED|Part A Cohort 1||0||
48241920|NCT04117711|100911834|FG015|COMPLETED|Part A Cohort 1||0||
48241921|NCT04117711|100911835|FG016|COMPLETED|Part A Cohort 1||0||
48241922|NCT04117711|100911836|FG017|COMPLETED|Part A Cohort 1||0||
48241923|NCT04117711|100911837|FG018|COMPLETED|Part A Cohort 1||0||
48241924|NCT04117711|100911838|FG019|COMPLETED|Part A Cohort 1||0||
48241925|NCT04117711|100911839|FG020|COMPLETED|Part A Cohort 1||0||
48241926|NCT04117711|100911840|FG021|COMPLETED|Part A Cohort 1||0||
48241927|NCT04117711|100911819|FG000|NOT COMPLETED|Part A Cohort 1||0||
48241928|NCT04117711|100911820|FG001|NOT COMPLETED|Part A Cohort 1||0||
48241929|NCT04117711|100911821|FG002|NOT COMPLETED|Part A Cohort 1||0||
48241930|NCT04117711|100911822|FG003|NOT COMPLETED|Part A Cohort 1||0||
48241931|NCT04117711|100911823|FG004|NOT COMPLETED|Part A Cohort 1||0||
48241932|NCT04117711|100911824|FG005|NOT COMPLETED|Part A Cohort 1||0||
48241933|NCT04117711|100911825|FG006|NOT COMPLETED|Part A Cohort 1||0||
48241934|NCT04117711|100911826|FG007|NOT COMPLETED|Part A Cohort 1||0||
48241935|NCT04117711|100911827|FG008|NOT COMPLETED|Part A Cohort 1||0||
48241936|NCT04117711|100911828|FG009|NOT COMPLETED|Part A Cohort 1||0||
48241937|NCT04117711|100911829|FG010|NOT COMPLETED|Part A Cohort 1||0||
48241938|NCT04117711|100911830|FG011|NOT COMPLETED|Part A Cohort 1||0||
48241939|NCT04117711|100911831|FG012|NOT COMPLETED|Part A Cohort 1||0||
48241940|NCT04117711|100911832|FG013|NOT COMPLETED|Part A Cohort 1||0||
48241941|NCT04117711|100911833|FG014|NOT COMPLETED|Part A Cohort 1||0||
48241942|NCT04117711|100911834|FG015|NOT COMPLETED|Part A Cohort 1||0||
48241943|NCT04117711|100911835|FG016|NOT COMPLETED|Part A Cohort 1||0||
48241944|NCT04117711|100911836|FG017|NOT COMPLETED|Part A Cohort 1||0||
48241945|NCT04117711|100911837|FG018|NOT COMPLETED|Part A Cohort 1||0||
48241946|NCT04117711|100911838|FG019|NOT COMPLETED|Part A Cohort 1||0||
48241947|NCT04117711|100911839|FG020|NOT COMPLETED|Part A Cohort 1||0||
48241948|NCT04117711|100911840|FG021|NOT COMPLETED|Part A Cohort 1||0||
48241949|NCT04117711|100911819|FG000|STARTED|Part A Cohort 2||0||
48241950|NCT04117711|100911820|FG001|STARTED|Part A Cohort 2||6||
48241951|NCT04117711|100911821|FG002|STARTED|Part A Cohort 2||0||
48241952|NCT04117711|100911822|FG003|STARTED|Part A Cohort 2||0||
48241953|NCT04117711|100911823|FG004|STARTED|Part A Cohort 2||0||
48241954|NCT04117711|100911824|FG005|STARTED|Part A Cohort 2||0||
48241955|NCT04117711|100911825|FG006|STARTED|Part A Cohort 2||0||
48241956|NCT04117711|100911826|FG007|STARTED|Part A Cohort 2||0||
48241957|NCT04117711|100911827|FG008|STARTED|Part A Cohort 2||0||
48241958|NCT04117711|100911828|FG009|STARTED|Part A Cohort 2||0||
48241959|NCT04117711|100911829|FG010|STARTED|Part A Cohort 2||0||
48241960|NCT04117711|100911830|FG011|STARTED|Part A Cohort 2||0||
48241961|NCT04117711|100911831|FG012|STARTED|Part A Cohort 2||0||
48241962|NCT04117711|100911832|FG013|STARTED|Part A Cohort 2||0||
48241963|NCT04117711|100911833|FG014|STARTED|Part A Cohort 2||0||
48241964|NCT04117711|100911834|FG015|STARTED|Part A Cohort 2||0||
48241965|NCT04117711|100911835|FG016|STARTED|Part A Cohort 2||0||
48241966|NCT04117711|100911836|FG017|STARTED|Part A Cohort 2||0||
48241967|NCT04117711|100911837|FG018|STARTED|Part A Cohort 2||0||
48241968|NCT04117711|100911838|FG019|STARTED|Part A Cohort 2||0||
48241969|NCT04117711|100911839|FG020|STARTED|Part A Cohort 2||0||
48241970|NCT04117711|100911840|FG021|STARTED|Part A Cohort 2||0||
48241971|NCT04117711|100911819|FG000|COMPLETED|Part A Cohort 2||0||
48241972|NCT04117711|100911820|FG001|COMPLETED|Part A Cohort 2||6||
48241973|NCT04117711|100911821|FG002|COMPLETED|Part A Cohort 2||0||
48241974|NCT04117711|100911822|FG003|COMPLETED|Part A Cohort 2||0||
48241975|NCT04117711|100911823|FG004|COMPLETED|Part A Cohort 2||0||
48241976|NCT04117711|100911824|FG005|COMPLETED|Part A Cohort 2||0||
48241977|NCT04117711|100911825|FG006|COMPLETED|Part A Cohort 2||0||
48241978|NCT04117711|100911826|FG007|COMPLETED|Part A Cohort 2||0||
48241979|NCT04117711|100911827|FG008|COMPLETED|Part A Cohort 2||0||
48241980|NCT04117711|100911828|FG009|COMPLETED|Part A Cohort 2||0||
48241981|NCT04117711|100911829|FG010|COMPLETED|Part A Cohort 2||0||
48241982|NCT04117711|100911830|FG011|COMPLETED|Part A Cohort 2||0||
48241983|NCT04117711|100911831|FG012|COMPLETED|Part A Cohort 2||0||
48081508|NCT03129100|100521618|FG005|COMPLETED|Period 3 (Dose Escalation)||0||
48081509|NCT03129100|100521619|FG006|COMPLETED|Period 3 (Dose Escalation)||0||
48679798|NCT00606489|101999905|FG000|NOT COMPLETED|Overall Study||0||
48679799|NCT00606489|101999906|FG001|NOT COMPLETED|Overall Study||0||
48679800|NCT00382174|101999907|FG000|STARTED|Overall Study||18||
48679801|NCT00382174|101999908|FG001|STARTED|Overall Study||54||
48679802|NCT00382174|101999909|FG002|STARTED|Overall Study||72||
48679803|NCT00382174|101999907|FG000|COMPLETED|Overall Study||14||
48679804|NCT00382174|101999908|FG001|COMPLETED|Overall Study||37||
48679805|NCT00382174|101999909|FG002|COMPLETED|Overall Study||51||
48241984|NCT04117711|100911832|FG013|COMPLETED|Part A Cohort 2||0||
48241985|NCT04117711|100911833|FG014|COMPLETED|Part A Cohort 2||0||
48241986|NCT04117711|100911834|FG015|COMPLETED|Part A Cohort 2||0||
48679806|NCT00382174|101999907|FG000|NOT COMPLETED|Overall Study||4||
48679807|NCT00382174|101999908|FG001|NOT COMPLETED|Overall Study||17||
48679808|NCT00382174|101999909|FG002|NOT COMPLETED|Overall Study||21||
48679809|NCT03510273|101999910|FG000|STARTED|Overall Study||319||
48679810|NCT03510273|101999910|FG000|Treated With Thermal Coagulation|Overall Study||319||
48679811|NCT03510273|101999910|FG000|Completed 1-mth Follow-up Visit & Exited|Overall Study||192|Completed one-month follow-up visit and exited study per protocol|
48679812|NCT03510273|101999910|FG000|Completed 1-mth Follow-up Visit & Cont'd|Overall Study||126|Completed one-month follow-up visit and continued in study for secondary outcomes|
48679813|NCT03510273|101999910|FG000|Completed All One-year Follow up Visits|Overall Study||118||
48679814|NCT03510273|101999910|FG000|COMPLETED|Overall Study||310||
48679815|NCT03510273|101999910|FG000|NOT COMPLETED|Overall Study||9||
48679816|NCT01667250|101999911|FG000|STARTED|Run-in (no Treatment)||0||
48679817|NCT01667250|101999912|FG001|STARTED|Run-in (no Treatment)||0||
48679818|NCT01667250|101999913|FG002|STARTED|Run-in (no Treatment)||73||
48679819|NCT01667250|101999911|FG000|COMPLETED|Run-in (no Treatment)||0||
48679820|NCT01667250|101999912|FG001|COMPLETED|Run-in (no Treatment)||0||
48679821|NCT01667250|101999913|FG002|COMPLETED|Run-in (no Treatment)||59||
48679822|NCT01667250|101999911|FG000|NOT COMPLETED|Run-in (no Treatment)||0||
48679823|NCT01667250|101999912|FG001|NOT COMPLETED|Run-in (no Treatment)||0||
48241987|NCT04117711|100911835|FG016|COMPLETED|Part A Cohort 2||0||
48241988|NCT04117711|100911836|FG017|COMPLETED|Part A Cohort 2||0||
48241989|NCT04117711|100911837|FG018|COMPLETED|Part A Cohort 2||0||
48241990|NCT04117711|100911838|FG019|COMPLETED|Part A Cohort 2||0||
48241991|NCT04117711|100911839|FG020|COMPLETED|Part A Cohort 2||0||
48679824|NCT01667250|101999913|FG002|NOT COMPLETED|Run-in (no Treatment)||14||
48679825|NCT01667250|101999911|FG000|STARTED|Randomised Period||30||
48679826|NCT01667250|101999912|FG001|STARTED|Randomised Period||29||
48679827|NCT01667250|101999913|FG002|STARTED|Randomised Period||0||
48679828|NCT01667250|101999911|FG000|COMPLETED|Randomised Period||29||
48241992|NCT04117711|100911840|FG021|COMPLETED|Part A Cohort 2||0||
48241993|NCT04117711|100911819|FG000|NOT COMPLETED|Part A Cohort 2||0||
48241994|NCT04117711|100911820|FG001|NOT COMPLETED|Part A Cohort 2||0||
48241995|NCT04117711|100911821|FG002|NOT COMPLETED|Part A Cohort 2||0||
48241996|NCT04117711|100911822|FG003|NOT COMPLETED|Part A Cohort 2||0||
48241997|NCT04117711|100911823|FG004|NOT COMPLETED|Part A Cohort 2||0||
48241998|NCT04117711|100911824|FG005|NOT COMPLETED|Part A Cohort 2||0||
48241999|NCT04117711|100911825|FG006|NOT COMPLETED|Part A Cohort 2||0||
48242000|NCT04117711|100911826|FG007|NOT COMPLETED|Part A Cohort 2||0||
48242001|NCT04117711|100911827|FG008|NOT COMPLETED|Part A Cohort 2||0||
48242002|NCT04117711|100911828|FG009|NOT COMPLETED|Part A Cohort 2||0||
48242003|NCT04117711|100911829|FG010|NOT COMPLETED|Part A Cohort 2||0||
48242004|NCT04117711|100911830|FG011|NOT COMPLETED|Part A Cohort 2||0||
48242005|NCT04117711|100911831|FG012|NOT COMPLETED|Part A Cohort 2||0||
48242006|NCT04117711|100911832|FG013|NOT COMPLETED|Part A Cohort 2||0||
48242007|NCT04117711|100911833|FG014|NOT COMPLETED|Part A Cohort 2||0||
48242008|NCT04117711|100911834|FG015|NOT COMPLETED|Part A Cohort 2||0||
48242009|NCT04117711|100911835|FG016|NOT COMPLETED|Part A Cohort 2||0||
48242010|NCT04117711|100911836|FG017|NOT COMPLETED|Part A Cohort 2||0||
48242011|NCT04117711|100911837|FG018|NOT COMPLETED|Part A Cohort 2||0||
48242012|NCT04117711|100911838|FG019|NOT COMPLETED|Part A Cohort 2||0||
48242013|NCT04117711|100911839|FG020|NOT COMPLETED|Part A Cohort 2||0||
48242014|NCT04117711|100911840|FG021|NOT COMPLETED|Part A Cohort 2||0||
48242015|NCT04117711|100911819|FG000|STARTED|Part A Cohort 3||0||
48242016|NCT04117711|100911820|FG001|STARTED|Part A Cohort 3||0||
48242017|NCT04117711|100911821|FG002|STARTED|Part A Cohort 3||6||
48242018|NCT04117711|100911822|FG003|STARTED|Part A Cohort 3||0||
48242019|NCT04117711|100911823|FG004|STARTED|Part A Cohort 3||0||
48242020|NCT04117711|100911824|FG005|STARTED|Part A Cohort 3||0||
48242021|NCT04117711|100911825|FG006|STARTED|Part A Cohort 3||0||
48242022|NCT04117711|100911826|FG007|STARTED|Part A Cohort 3||0||
48242023|NCT04117711|100911827|FG008|STARTED|Part A Cohort 3||0||
48242024|NCT04117711|100911828|FG009|STARTED|Part A Cohort 3||0||
48242025|NCT04117711|100911829|FG010|STARTED|Part A Cohort 3||0||
48242026|NCT04117711|100911830|FG011|STARTED|Part A Cohort 3||0||
48242027|NCT04117711|100911831|FG012|STARTED|Part A Cohort 3||0||
48242028|NCT04117711|100911832|FG013|STARTED|Part A Cohort 3||0||
48242029|NCT04117711|100911833|FG014|STARTED|Part A Cohort 3||0||
48242030|NCT04117711|100911834|FG015|STARTED|Part A Cohort 3||0||
48242031|NCT04117711|100911835|FG016|STARTED|Part A Cohort 3||0||
48242032|NCT04117711|100911836|FG017|STARTED|Part A Cohort 3||0||
48242033|NCT04117711|100911837|FG018|STARTED|Part A Cohort 3||0||
48242034|NCT04117711|100911838|FG019|STARTED|Part A Cohort 3||0||
48242035|NCT04117711|100911839|FG020|STARTED|Part A Cohort 3||0||
48242036|NCT04117711|100911840|FG021|STARTED|Part A Cohort 3||0||
48242037|NCT04117711|100911819|FG000|COMPLETED|Part A Cohort 3||0||
48242038|NCT04117711|100911820|FG001|COMPLETED|Part A Cohort 3||0||
48242039|NCT04117711|100911821|FG002|COMPLETED|Part A Cohort 3||6||
48242040|NCT04117711|100911822|FG003|COMPLETED|Part A Cohort 3||0||
48242041|NCT04117711|100911823|FG004|COMPLETED|Part A Cohort 3||0||
48679829|NCT01667250|101999912|FG001|COMPLETED|Randomised Period||28||
48679830|NCT01667250|101999913|FG002|COMPLETED|Randomised Period||0||
48679831|NCT01667250|101999911|FG000|NOT COMPLETED|Randomised Period||1||
48679832|NCT01667250|101999912|FG001|NOT COMPLETED|Randomised Period||1||
48679833|NCT01667250|101999913|FG002|NOT COMPLETED|Randomised Period||0||
48679834|NCT00532844|101999914|FG000|STARTED|Treatment Period - Day 1 to Day 14||24||
48679835|NCT00532844|101999915|FG001|STARTED|Treatment Period - Day 1 to Day 14||24||
48679836|NCT00532844|101999914|FG000|COMPLETED|Treatment Period - Day 1 to Day 14||24||
48679837|NCT00532844|101999915|FG001|COMPLETED|Treatment Period - Day 1 to Day 14||23||
48679838|NCT00532844|101999914|FG000|NOT COMPLETED|Treatment Period - Day 1 to Day 14||0||
48679839|NCT00532844|101999915|FG001|NOT COMPLETED|Treatment Period - Day 1 to Day 14||1||
48679840|NCT00532844|101999914|FG000|STARTED|Washout (1 Day)||24||
48679841|NCT00532844|101999915|FG001|STARTED|Washout (1 Day)||23||
48679842|NCT00532844|101999914|FG000|COMPLETED|Washout (1 Day)||24||
48679843|NCT00532844|101999915|FG001|COMPLETED|Washout (1 Day)||23||
48679844|NCT00532844|101999914|FG000|NOT COMPLETED|Washout (1 Day)||0||
48679845|NCT00532844|101999915|FG001|NOT COMPLETED|Washout (1 Day)||0||
48679846|NCT00532844|101999914|FG000|STARTED|Treatment Period - Day 15 to Day 28||24||
48679847|NCT00532844|101999915|FG001|STARTED|Treatment Period - Day 15 to Day 28||23||
48242042|NCT04117711|100911824|FG005|COMPLETED|Part A Cohort 3||0||
48242043|NCT04117711|100911825|FG006|COMPLETED|Part A Cohort 3||0||
48242044|NCT04117711|100911826|FG007|COMPLETED|Part A Cohort 3||0||
48679848|NCT00532844|101999914|FG000|COMPLETED|Treatment Period - Day 15 to Day 28||20||
48679849|NCT00532844|101999915|FG001|COMPLETED|Treatment Period - Day 15 to Day 28||23||
48679850|NCT00532844|101999914|FG000|NOT COMPLETED|Treatment Period - Day 15 to Day 28||4||
48679851|NCT00532844|101999915|FG001|NOT COMPLETED|Treatment Period - Day 15 to Day 28||0||
48679852|NCT03692403|101999916|FG000|STARTED|Overall Study||6||
48679853|NCT03692403|101999917|FG001|STARTED|Overall Study||5||
48679854|NCT03692403|101999918|FG002|STARTED|Overall Study||8||
48679855|NCT03692403|101999919|FG003|STARTED|Overall Study||3||
48679856|NCT03692403|101999916|FG000|COMPLETED|Overall Study||5||
48679857|NCT03692403|101999917|FG001|COMPLETED|Overall Study||4||
48679858|NCT03692403|101999918|FG002|COMPLETED|Overall Study||6||
48679859|NCT03692403|101999919|FG003|COMPLETED|Overall Study||2||
48679860|NCT03692403|101999916|FG000|NOT COMPLETED|Overall Study||1||
48679861|NCT03692403|101999917|FG001|NOT COMPLETED|Overall Study||1||
48679862|NCT03692403|101999918|FG002|NOT COMPLETED|Overall Study||2||
48679863|NCT03692403|101999919|FG003|NOT COMPLETED|Overall Study||1||
48679864|NCT00099021|101999920|FG000|STARTED|Overall Study||21||
48679865|NCT00099021|101999920|FG000|COMPLETED|Overall Study||21||
48679866|NCT00099021|101999920|FG000|NOT COMPLETED|Overall Study||0||
48679867|NCT00186628|101999921|FG000|STARTED|Overall Study||36||
48679868|NCT00186628|101999921|FG000|COMPLETED|Overall Study||33||
48679869|NCT00186628|101999921|FG000|NOT COMPLETED|Overall Study||3||
48679870|NCT01453166|101999922|FG000|STARTED|Overall Study||42||
48242045|NCT04117711|100911827|FG008|COMPLETED|Part A Cohort 3||0||
48242046|NCT04117711|100911828|FG009|COMPLETED|Part A Cohort 3||0||
48242047|NCT04117711|100911829|FG010|COMPLETED|Part A Cohort 3||0||
48679871|NCT01453166|101999923|FG001|STARTED|Overall Study||41||
48679872|NCT01453166|101999924|FG002|STARTED|Overall Study||39||
48679873|NCT01453166|101999922|FG000|COMPLETED|Overall Study||40||
48679874|NCT01453166|101999923|FG001|COMPLETED|Overall Study||39||
48679875|NCT01453166|101999924|FG002|COMPLETED|Overall Study||38||
48679876|NCT01453166|101999922|FG000|NOT COMPLETED|Overall Study||2||
48679877|NCT01453166|101999923|FG001|NOT COMPLETED|Overall Study||2||
48679878|NCT01453166|101999924|FG002|NOT COMPLETED|Overall Study||1||
48679879|NCT03965403|101999925|FG000|STARTED|Overall Study||7||
48679880|NCT03965403|101999925|FG000|COMPLETED|Overall Study||6||
48679881|NCT03965403|101999925|FG000|NOT COMPLETED|Overall Study||1||
48679882|NCT04096417|101999926|FG000|STARTED|Overall Study||14||
48679883|NCT04096417|101999926|FG000|COMPLETED|Overall Study||14||
48679884|NCT04096417|101999926|FG000|NOT COMPLETED|Overall Study||0||
48679885|NCT01576783|101999927|FG000|STARTED|Overall Study||189||
48679886|NCT01576783|101999928|FG001|STARTED|Overall Study||188||
48242048|NCT04117711|100911830|FG011|COMPLETED|Part A Cohort 3||0||
48242049|NCT04117711|100911831|FG012|COMPLETED|Part A Cohort 3||0||
48242050|NCT04117711|100911832|FG013|COMPLETED|Part A Cohort 3||0||
48242051|NCT04117711|100911833|FG014|COMPLETED|Part A Cohort 3||0||
48242052|NCT04117711|100911834|FG015|COMPLETED|Part A Cohort 3||0||
48242053|NCT04117711|100911835|FG016|COMPLETED|Part A Cohort 3||0||
48242054|NCT04117711|100911836|FG017|COMPLETED|Part A Cohort 3||0||
48242055|NCT04117711|100911837|FG018|COMPLETED|Part A Cohort 3||0||
48242056|NCT04117711|100911838|FG019|COMPLETED|Part A Cohort 3||0||
48242057|NCT04117711|100911839|FG020|COMPLETED|Part A Cohort 3||0||
48242058|NCT04117711|100911840|FG021|COMPLETED|Part A Cohort 3||0||
48242059|NCT04117711|100911819|FG000|NOT COMPLETED|Part A Cohort 3||0||
48242060|NCT04117711|100911820|FG001|NOT COMPLETED|Part A Cohort 3||0||
48242061|NCT04117711|100911821|FG002|NOT COMPLETED|Part A Cohort 3||0||
48242062|NCT04117711|100911822|FG003|NOT COMPLETED|Part A Cohort 3||0||
48242063|NCT04117711|100911823|FG004|NOT COMPLETED|Part A Cohort 3||0||
48242064|NCT04117711|100911824|FG005|NOT COMPLETED|Part A Cohort 3||0||
48242065|NCT04117711|100911825|FG006|NOT COMPLETED|Part A Cohort 3||0||
48242066|NCT04117711|100911826|FG007|NOT COMPLETED|Part A Cohort 3||0||
48242067|NCT04117711|100911827|FG008|NOT COMPLETED|Part A Cohort 3||0||
48242068|NCT04117711|100911828|FG009|NOT COMPLETED|Part A Cohort 3||0||
48242069|NCT04117711|100911829|FG010|NOT COMPLETED|Part A Cohort 3||0||
48242070|NCT04117711|100911830|FG011|NOT COMPLETED|Part A Cohort 3||0||
48242071|NCT04117711|100911831|FG012|NOT COMPLETED|Part A Cohort 3||0||
48242072|NCT04117711|100911832|FG013|NOT COMPLETED|Part A Cohort 3||0||
48242073|NCT04117711|100911833|FG014|NOT COMPLETED|Part A Cohort 3||0||
48242074|NCT04117711|100911834|FG015|NOT COMPLETED|Part A Cohort 3||0||
48242075|NCT04117711|100911835|FG016|NOT COMPLETED|Part A Cohort 3||0||
48242076|NCT04117711|100911836|FG017|NOT COMPLETED|Part A Cohort 3||0||
48242077|NCT04117711|100911837|FG018|NOT COMPLETED|Part A Cohort 3||0||
48242078|NCT04117711|100911838|FG019|NOT COMPLETED|Part A Cohort 3||0||
48242079|NCT04117711|100911839|FG020|NOT COMPLETED|Part A Cohort 3||0||
48679887|NCT01576783|101999927|FG000|COMPLETED|Overall Study||169||
48679888|NCT01576783|101999928|FG001|COMPLETED|Overall Study||171||
48679889|NCT01576783|101999927|FG000|NOT COMPLETED|Overall Study||20||
48679890|NCT01576783|101999928|FG001|NOT COMPLETED|Overall Study||17||
48242080|NCT04117711|100911840|FG021|NOT COMPLETED|Part A Cohort 3||0||
48242081|NCT04117711|100911819|FG000|STARTED|Part A Cohort 4||0||
48242082|NCT04117711|100911820|FG001|STARTED|Part A Cohort 4||0||
48242083|NCT04117711|100911821|FG002|STARTED|Part A Cohort 4||0||
48242084|NCT04117711|100911822|FG003|STARTED|Part A Cohort 4||6||
48242085|NCT04117711|100911823|FG004|STARTED|Part A Cohort 4||0||
48242086|NCT04117711|100911824|FG005|STARTED|Part A Cohort 4||0||
48679891|NCT01500317|101999929|FG000|STARTED|Overall Study||13||
48679892|NCT01500317|101999930|FG001|STARTED|Overall Study||12||
48679893|NCT01500317|101999931|FG002|STARTED|Overall Study||13||
48679894|NCT01500317|101999929|FG000|COMPLETED|Overall Study||10||
48679895|NCT01500317|101999930|FG001|COMPLETED|Overall Study||10||
48242087|NCT04117711|100911825|FG006|STARTED|Part A Cohort 4||0||
48242088|NCT04117711|100911826|FG007|STARTED|Part A Cohort 4||0||
48242089|NCT04117711|100911827|FG008|STARTED|Part A Cohort 4||0||
48242090|NCT04117711|100911828|FG009|STARTED|Part A Cohort 4||0||
48242091|NCT04117711|100911829|FG010|STARTED|Part A Cohort 4||0||
48242092|NCT04117711|100911830|FG011|STARTED|Part A Cohort 4||0||
48242093|NCT04117711|100911831|FG012|STARTED|Part A Cohort 4||0||
48242094|NCT04117711|100911832|FG013|STARTED|Part A Cohort 4||0||
48242095|NCT04117711|100911833|FG014|STARTED|Part A Cohort 4||0||
48679896|NCT01500317|101999931|FG002|COMPLETED|Overall Study||13||
48679897|NCT01500317|101999929|FG000|NOT COMPLETED|Overall Study||3||
48679898|NCT01500317|101999930|FG001|NOT COMPLETED|Overall Study||2||
48679899|NCT01500317|101999931|FG002|NOT COMPLETED|Overall Study||0||
48679900|NCT01802788|101999932|FG000|STARTED|Overall Study||941||
48679901|NCT01802788|101999933|FG001|STARTED|Overall Study||59||
48242096|NCT04117711|100911834|FG015|STARTED|Part A Cohort 4||0||
48242097|NCT04117711|100911835|FG016|STARTED|Part A Cohort 4||0||
48242098|NCT04117711|100911836|FG017|STARTED|Part A Cohort 4||0||
48242099|NCT04117711|100911837|FG018|STARTED|Part A Cohort 4||0||
48242100|NCT04117711|100911838|FG019|STARTED|Part A Cohort 4||0||
48242101|NCT04117711|100911839|FG020|STARTED|Part A Cohort 4||0||
48242102|NCT04117711|100911840|FG021|STARTED|Part A Cohort 4||0||
48242103|NCT04117711|100911819|FG000|COMPLETED|Part A Cohort 4||0||
48242104|NCT04117711|100911820|FG001|COMPLETED|Part A Cohort 4||0||
48242105|NCT04117711|100911821|FG002|COMPLETED|Part A Cohort 4||0||
48242106|NCT04117711|100911822|FG003|COMPLETED|Part A Cohort 4||6||
48242107|NCT04117711|100911823|FG004|COMPLETED|Part A Cohort 4||0||
48242108|NCT04117711|100911824|FG005|COMPLETED|Part A Cohort 4||0||
48242109|NCT04117711|100911825|FG006|COMPLETED|Part A Cohort 4||0||
48242110|NCT04117711|100911826|FG007|COMPLETED|Part A Cohort 4||0||
48242111|NCT04117711|100911827|FG008|COMPLETED|Part A Cohort 4||0||
48242112|NCT04117711|100911828|FG009|COMPLETED|Part A Cohort 4||0||
48242113|NCT04117711|100911829|FG010|COMPLETED|Part A Cohort 4||0||
48242114|NCT04117711|100911830|FG011|COMPLETED|Part A Cohort 4||0||
48242115|NCT04117711|100911831|FG012|COMPLETED|Part A Cohort 4||0||
48679902|NCT01802788|101999932|FG000|COMPLETED|Overall Study||398||
48679903|NCT01802788|101999933|FG001|COMPLETED|Overall Study||34||
48679904|NCT01802788|101999932|FG000|NOT COMPLETED|Overall Study||543||
48679905|NCT01802788|101999933|FG001|NOT COMPLETED|Overall Study||25||
48679906|NCT00901303|101999934|FG000|STARTED|Overall Study||5||
48242116|NCT04117711|100911832|FG013|COMPLETED|Part A Cohort 4||0||
48242117|NCT04117711|100911833|FG014|COMPLETED|Part A Cohort 4||0||
48242118|NCT04117711|100911834|FG015|COMPLETED|Part A Cohort 4||0||
48242119|NCT04117711|100911835|FG016|COMPLETED|Part A Cohort 4||0||
48242120|NCT04117711|100911836|FG017|COMPLETED|Part A Cohort 4||0||
48679907|NCT00901303|101999935|FG001|STARTED|Overall Study||1||
48679908|NCT00901303|101999934|FG000|COMPLETED|Overall Study||5||
48679909|NCT00901303|101999935|FG001|COMPLETED|Overall Study||1||
48679910|NCT00901303|101999934|FG000|NOT COMPLETED|Overall Study||0||
48242121|NCT04117711|100911837|FG018|COMPLETED|Part A Cohort 4||0||
48242122|NCT04117711|100911838|FG019|COMPLETED|Part A Cohort 4||0||
48242123|NCT04117711|100911839|FG020|COMPLETED|Part A Cohort 4||0||
48242124|NCT04117711|100911840|FG021|COMPLETED|Part A Cohort 4||0||
48242125|NCT04117711|100911819|FG000|NOT COMPLETED|Part A Cohort 4||0||
48242126|NCT04117711|100911820|FG001|NOT COMPLETED|Part A Cohort 4||0||
48242127|NCT04117711|100911821|FG002|NOT COMPLETED|Part A Cohort 4||0||
48242128|NCT04117711|100911822|FG003|NOT COMPLETED|Part A Cohort 4||0||
48679911|NCT00901303|101999935|FG001|NOT COMPLETED|Overall Study||0||
48679912|NCT01282866|101999936|FG000|STARTED|Overall Study||35||
48679913|NCT01282866|101999936|FG000|COMPLETED|Overall Study||34||
48679914|NCT01282866|101999936|FG000|NOT COMPLETED|Overall Study||1||
48679915|NCT03382912|101999937|FG000|STARTED|Overall Study||27||
48679916|NCT03382912|101999938|FG001|STARTED|Overall Study||25||
48242129|NCT04117711|100911823|FG004|NOT COMPLETED|Part A Cohort 4||0||
48242130|NCT04117711|100911824|FG005|NOT COMPLETED|Part A Cohort 4||0||
48242131|NCT04117711|100911825|FG006|NOT COMPLETED|Part A Cohort 4||0||
48540308|NCT04562155|101658051|FG000|COMPLETED|Overall Study||64||
48679917|NCT03382912|101999937|FG000|Received at Least 1 Dose of Study Drug|Overall Study||27||
48679918|NCT03382912|101999938|FG001|Received at Least 1 Dose of Study Drug|Overall Study||24||
48679919|NCT03382912|101999937|FG000|COMPLETED|Overall Study||21||
48679920|NCT03382912|101999938|FG001|COMPLETED|Overall Study||13||
48679921|NCT03382912|101999937|FG000|NOT COMPLETED|Overall Study||6||
48679922|NCT03382912|101999938|FG001|NOT COMPLETED|Overall Study||12||
48679923|NCT02300233|101999939|FG000|STARTED|Overall Study||38||
48679924|NCT02300233|101999940|FG001|STARTED|Overall Study||25||
48679925|NCT02300233|101999941|FG002|STARTED|Overall Study||50||
48679926|NCT02300233|101999939|FG000|COMPLETED|Overall Study||34|Completed here refers to participants who completed the study treatment.|
48679927|NCT02300233|101999940|FG001|COMPLETED|Overall Study||24|Completed here refers to participants who completed the study treatment.|
48679928|NCT02300233|101999941|FG002|COMPLETED|Overall Study||27|Completed here refers to participants who completed the study treatment.|
48679929|NCT02300233|101999939|FG000|NOT COMPLETED|Overall Study||4||
48679930|NCT02300233|101999940|FG001|NOT COMPLETED|Overall Study||1||
48679931|NCT02300233|101999941|FG002|NOT COMPLETED|Overall Study||23||
48679932|NCT02756403|101999942|FG000|STARTED|Overall Study||46||
48679933|NCT02756403|101999943|FG001|STARTED|Overall Study||45||
48679934|NCT02756403|101999944|FG002|STARTED|Overall Study||43||
48679935|NCT02756403|101999945|FG003|STARTED|Overall Study||47||
48679936|NCT02756403|101999942|FG000|COMPLETED|Overall Study||46||
48679937|NCT02756403|101999943|FG001|COMPLETED|Overall Study||42||
48679938|NCT02756403|101999944|FG002|COMPLETED|Overall Study||41||
48679939|NCT02756403|101999945|FG003|COMPLETED|Overall Study||45||
48679940|NCT02756403|101999942|FG000|NOT COMPLETED|Overall Study||0||
48679941|NCT02756403|101999943|FG001|NOT COMPLETED|Overall Study||3||
48679942|NCT02756403|101999944|FG002|NOT COMPLETED|Overall Study||2||
48679943|NCT02756403|101999945|FG003|NOT COMPLETED|Overall Study||2||
48679944|NCT01900665|101999946|FG000|STARTED|Placebo Controlled Period||1057||
48679945|NCT01900665|101999947|FG001|STARTED|Placebo Controlled Period||1072||
48679946|NCT01900665|101999946|FG000|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1054||
48679947|NCT01900665|101999947|FG001|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1067||
48679948|NCT01900665|101999946|FG000|COMPLETED|Placebo Controlled Period||914||
48679949|NCT01900665|101999947|FG001|COMPLETED|Placebo Controlled Period||908||
48679950|NCT01900665|101999946|FG000|NOT COMPLETED|Placebo Controlled Period||143||
48679951|NCT01900665|101999947|FG001|NOT COMPLETED|Placebo Controlled Period||164||
48679952|NCT01900665|101999946|FG000|STARTED|Open Label Period||881||
48679953|NCT01900665|101999947|FG001|STARTED|Open Label Period||859||
48679954|NCT01900665|101999946|FG000|COMPLETED|Open Label Period||0||
48679955|NCT01900665|101999947|FG001|COMPLETED|Open Label Period||0||
48679956|NCT01900665|101999946|FG000|NOT COMPLETED|Open Label Period||881||
48679957|NCT01900665|101999947|FG001|NOT COMPLETED|Open Label Period||859||
48679958|NCT02404168|101999948|FG000|STARTED|Overall Study||4||
48679959|NCT02404168|101999948|FG000|COMPLETED|Overall Study||4||
48679960|NCT02404168|101999948|FG000|NOT COMPLETED|Overall Study||0||
48679961|NCT00370292|101999949|FG000|STARTED|Overall Study||19||
48679962|NCT00370292|101999949|FG000|COMPLETED|Overall Study||6||
48679963|NCT00370292|101999949|FG000|NOT COMPLETED|Overall Study||13||
48679964|NCT01138475|101999950|FG000|STARTED|Overall Study||16||
48679965|NCT01138475|101999951|FG001|STARTED|Overall Study||16||
48679966|NCT01138475|101999952|FG002|STARTED|Overall Study||17||
48679967|NCT01138475|101999950|FG000|COMPLETED|Overall Study||16||
48679968|NCT01138475|101999951|FG001|COMPLETED|Overall Study||16||
48679969|NCT01138475|101999952|FG002|COMPLETED|Overall Study||17||
48679970|NCT01138475|101999950|FG000|NOT COMPLETED|Overall Study||0||
48679971|NCT01138475|101999951|FG001|NOT COMPLETED|Overall Study||0||
48679972|NCT01138475|101999952|FG002|NOT COMPLETED|Overall Study||0||
48679973|NCT03358030|101999953|FG000|STARTED|Overall Study||53||
48679974|NCT03358030|101999954|FG001|STARTED|Overall Study||53||
48242132|NCT04117711|100911826|FG007|NOT COMPLETED|Part A Cohort 4||0||
48242133|NCT04117711|100911827|FG008|NOT COMPLETED|Part A Cohort 4||0||
48242134|NCT04117711|100911828|FG009|NOT COMPLETED|Part A Cohort 4||0||
48679975|NCT03358030|101999955|FG002|STARTED|Overall Study||55||
48679976|NCT03358030|101999956|FG003|STARTED|Overall Study||52||
48679977|NCT03358030|101999953|FG000|Treated|Overall Study||53|Safety population: All participants randomized who have received at least 1 dose of the study drug.|
48679978|NCT03358030|101999954|FG001|Treated|Overall Study||53|Safety population: All participants randomized who have received at least 1 dose of the study drug.|
48679979|NCT03358030|101999955|FG002|Treated|Overall Study||54|Safety population: All participants randomized who have received at least 1 dose of the study drug.|
48679980|NCT03358030|101999956|FG003|Treated|Overall Study||50|Safety population: All participants randomized who have received at least 1 dose of the study drug.|
48679981|NCT03358030|101999953|FG000|Per-protocol (PP) Population|Overall Study||49||
48710654|NCT02961790|102077985|FG002|COMPLETED|Overall Study||18||
48242135|NCT04117711|100911829|FG010|NOT COMPLETED|Part A Cohort 4||0||
48242136|NCT04117711|100911830|FG011|NOT COMPLETED|Part A Cohort 4||0||
48242137|NCT04117711|100911831|FG012|NOT COMPLETED|Part A Cohort 4||0||
48242138|NCT04117711|100911832|FG013|NOT COMPLETED|Part A Cohort 4||0||
48242139|NCT04117711|100911833|FG014|NOT COMPLETED|Part A Cohort 4||0||
48242140|NCT04117711|100911834|FG015|NOT COMPLETED|Part A Cohort 4||0||
48242141|NCT04117711|100911835|FG016|NOT COMPLETED|Part A Cohort 4||0||
48242142|NCT04117711|100911836|FG017|NOT COMPLETED|Part A Cohort 4||0||
48242143|NCT04117711|100911837|FG018|NOT COMPLETED|Part A Cohort 4||0||
48242144|NCT04117711|100911838|FG019|NOT COMPLETED|Part A Cohort 4||0||
48242145|NCT04117711|100911839|FG020|NOT COMPLETED|Part A Cohort 4||0||
48242146|NCT04117711|100911840|FG021|NOT COMPLETED|Part A Cohort 4||0||
48242147|NCT04117711|100911819|FG000|STARTED|Part A Cohort 5||0||
48242148|NCT04117711|100911820|FG001|STARTED|Part A Cohort 5||0||
48242149|NCT04117711|100911821|FG002|STARTED|Part A Cohort 5||0||
48242150|NCT04117711|100911822|FG003|STARTED|Part A Cohort 5||0||
48242151|NCT04117711|100911823|FG004|STARTED|Part A Cohort 5||6||
48540309|NCT04562155|101658052|FG001|COMPLETED|Overall Study||69||
48540310|NCT04562155|101658053|FG002|COMPLETED|Overall Study||67||
48540311|NCT04562155|101658054|FG003|COMPLETED|Overall Study||71||
48540312|NCT04562155|101658051|FG000|NOT COMPLETED|Overall Study||11||
48540313|NCT04562155|101658052|FG001|NOT COMPLETED|Overall Study||9||
48540314|NCT04562155|101658053|FG002|NOT COMPLETED|Overall Study||13||
48540315|NCT04562155|101658054|FG003|NOT COMPLETED|Overall Study||6||
48540316|NCT02359994|101658055|FG000|STARTED|Overall Population Study||161|Enrolled and Randomized|
48540317|NCT02359994|101658056|FG001|STARTED|Overall Population Study||163|Enrolled and Randomized|
48540318|NCT02359994|101658055|FG000|Treated|Overall Population Study||160||
48540319|NCT02359994|101658056|FG001|Treated|Overall Population Study||162||
48540320|NCT02359994|101658055|FG000|COMPLETED|Overall Population Study||156||
48540321|NCT02359994|101658056|FG001|COMPLETED|Overall Population Study||155||
48540322|NCT02359994|101658055|FG000|NOT COMPLETED|Overall Population Study||5||
48540323|NCT02359994|101658056|FG001|NOT COMPLETED|Overall Population Study||8||
48540324|NCT02359994|101658055|FG000|STARTED|Extended Oncology 24-Month Survival||85|Oncology subjects continued to be followed for an extended survival assessment at 24 months post-randomization after the 6 week or 3 month evaluation period in the Overall Population Study.|
48540325|NCT02359994|101658056|FG001|STARTED|Extended Oncology 24-Month Survival||93|Oncology subjects continued to be followed for an extended survival assessment at 24 months post-randomization after the 6 week or 3 month evaluation period in the Overall Population Study.|
48540326|NCT02359994|101658055|FG000|COMPLETED|Extended Oncology 24-Month Survival||65|Completed the 24-month visit.|
48540327|NCT02359994|101658056|FG001|COMPLETED|Extended Oncology 24-Month Survival||72|Completed the 24-month visit.|
48540328|NCT02359994|101658055|FG000|NOT COMPLETED|Extended Oncology 24-Month Survival||20||
48540329|NCT02359994|101658056|FG001|NOT COMPLETED|Extended Oncology 24-Month Survival||21||
48540330|NCT01696058|101658057|FG000|STARTED|Overall Study||566||
48540331|NCT01696058|101658058|FG001|STARTED|Overall Study||569||
48540332|NCT01696058|101658057|FG000|COMPLETED|Overall Study||523||
48540333|NCT01696058|101658058|FG001|COMPLETED|Overall Study||538||
48540334|NCT01696058|101658057|FG000|NOT COMPLETED|Overall Study||43||
48540335|NCT01696058|101658058|FG001|NOT COMPLETED|Overall Study||31||
48540336|NCT01404923|101658059|FG000|STARTED|Overall Study||222||
48540337|NCT01404923|101658060|FG001|STARTED|Overall Study||214||
48540338|NCT01404923|101658059|FG000|COMPLETED|Overall Study||199||
48540339|NCT01404923|101658060|FG001|COMPLETED|Overall Study||197||
48540340|NCT01404923|101658059|FG000|NOT COMPLETED|Overall Study||23||
48540341|NCT01404923|101658060|FG001|NOT COMPLETED|Overall Study||17||
48242152|NCT04117711|100911824|FG005|STARTED|Part A Cohort 5||0||
48242153|NCT04117711|100911825|FG006|STARTED|Part A Cohort 5||0||
48242154|NCT04117711|100911826|FG007|STARTED|Part A Cohort 5||0||
48242155|NCT04117711|100911827|FG008|STARTED|Part A Cohort 5||0||
48679982|NCT03358030|101999954|FG001|Per-protocol (PP) Population|Overall Study||45||
48679983|NCT03358030|101999955|FG002|Per-protocol (PP) Population|Overall Study||43||
48679984|NCT03358030|101999956|FG003|Per-protocol (PP) Population|Overall Study||35||
48679985|NCT03358030|101999953|FG000|COMPLETED|Overall Study||50||
48679986|NCT03358030|101999954|FG001|COMPLETED|Overall Study||52||
48679987|NCT03358030|101999955|FG002|COMPLETED|Overall Study||46||
48679988|NCT03358030|101999956|FG003|COMPLETED|Overall Study||48||
48679989|NCT03358030|101999953|FG000|NOT COMPLETED|Overall Study||3||
48679990|NCT03358030|101999954|FG001|NOT COMPLETED|Overall Study||1||
48242156|NCT04117711|100911828|FG009|STARTED|Part A Cohort 5||0||
48242157|NCT04117711|100911829|FG010|STARTED|Part A Cohort 5||0||
48242158|NCT04117711|100911830|FG011|STARTED|Part A Cohort 5||0||
48242159|NCT04117711|100911831|FG012|STARTED|Part A Cohort 5||0||
48242160|NCT04117711|100911832|FG013|STARTED|Part A Cohort 5||0||
48242161|NCT04117711|100911833|FG014|STARTED|Part A Cohort 5||0||
48242162|NCT04117711|100911834|FG015|STARTED|Part A Cohort 5||0||
48242163|NCT04117711|100911835|FG016|STARTED|Part A Cohort 5||0||
48242164|NCT04117711|100911836|FG017|STARTED|Part A Cohort 5||0||
48242165|NCT04117711|100911837|FG018|STARTED|Part A Cohort 5||0||
48242166|NCT04117711|100911838|FG019|STARTED|Part A Cohort 5||0||
48242167|NCT04117711|100911839|FG020|STARTED|Part A Cohort 5||0||
48242168|NCT04117711|100911840|FG021|STARTED|Part A Cohort 5||0||
48242169|NCT04117711|100911819|FG000|COMPLETED|Part A Cohort 5||0||
48242170|NCT04117711|100911820|FG001|COMPLETED|Part A Cohort 5||0||
48242171|NCT04117711|100911821|FG002|COMPLETED|Part A Cohort 5||0||
48242172|NCT04117711|100911822|FG003|COMPLETED|Part A Cohort 5||0||
48242173|NCT04117711|100911823|FG004|COMPLETED|Part A Cohort 5||6||
48242174|NCT04117711|100911824|FG005|COMPLETED|Part A Cohort 5||0||
48242175|NCT04117711|100911825|FG006|COMPLETED|Part A Cohort 5||0||
48242176|NCT04117711|100911826|FG007|COMPLETED|Part A Cohort 5||0||
48242177|NCT04117711|100911827|FG008|COMPLETED|Part A Cohort 5||0||
48242178|NCT04117711|100911828|FG009|COMPLETED|Part A Cohort 5||0||
48242179|NCT04117711|100911829|FG010|COMPLETED|Part A Cohort 5||0||
48242180|NCT04117711|100911830|FG011|COMPLETED|Part A Cohort 5||0||
48242181|NCT04117711|100911831|FG012|COMPLETED|Part A Cohort 5||0||
48242182|NCT04117711|100911832|FG013|COMPLETED|Part A Cohort 5||0||
48242183|NCT04117711|100911833|FG014|COMPLETED|Part A Cohort 5||0||
48242184|NCT04117711|100911834|FG015|COMPLETED|Part A Cohort 5||0||
48242185|NCT04117711|100911835|FG016|COMPLETED|Part A Cohort 5||0||
48242186|NCT04117711|100911836|FG017|COMPLETED|Part A Cohort 5||0||
48242187|NCT04117711|100911837|FG018|COMPLETED|Part A Cohort 5||0||
48242188|NCT04117711|100911838|FG019|COMPLETED|Part A Cohort 5||0||
48242189|NCT04117711|100911839|FG020|COMPLETED|Part A Cohort 5||0||
48242190|NCT04117711|100911840|FG021|COMPLETED|Part A Cohort 5||0||
48242191|NCT04117711|100911819|FG000|NOT COMPLETED|Part A Cohort 5||0||
48679991|NCT03358030|101999955|FG002|NOT COMPLETED|Overall Study||9||
48679992|NCT03358030|101999956|FG003|NOT COMPLETED|Overall Study||4||
48242192|NCT04117711|100911820|FG001|NOT COMPLETED|Part A Cohort 5||0||
48242193|NCT04117711|100911821|FG002|NOT COMPLETED|Part A Cohort 5||0||
48242194|NCT04117711|100911822|FG003|NOT COMPLETED|Part A Cohort 5||0||
48242195|NCT04117711|100911823|FG004|NOT COMPLETED|Part A Cohort 5||0||
48242196|NCT04117711|100911824|FG005|NOT COMPLETED|Part A Cohort 5||0||
48679993|NCT02239926|101999957|FG000|STARTED|Overall Study||0||
48679994|NCT02239926|101999958|FG001|STARTED|Overall Study||2||
48242197|NCT04117711|100911825|FG006|NOT COMPLETED|Part A Cohort 5||0||
48242198|NCT04117711|100911826|FG007|NOT COMPLETED|Part A Cohort 5||0||
48242199|NCT04117711|100911827|FG008|NOT COMPLETED|Part A Cohort 5||0||
48242200|NCT04117711|100911828|FG009|NOT COMPLETED|Part A Cohort 5||0||
48679995|NCT02239926|101999957|FG000|COMPLETED|Overall Study||0||
48679996|NCT02239926|101999958|FG001|COMPLETED|Overall Study||1||
48679997|NCT02239926|101999957|FG000|NOT COMPLETED|Overall Study||0||
48679998|NCT02239926|101999958|FG001|NOT COMPLETED|Overall Study||1||
48679999|NCT01639469|101999959|FG000|STARTED|Overall Study||89||
48680000|NCT01639469|101999960|FG001|STARTED|Overall Study||80||
48680001|NCT01639469|101999959|FG000|COMPLETED|Overall Study||84||
48680002|NCT01639469|101999960|FG001|COMPLETED|Overall Study||77||
48242201|NCT04117711|100911829|FG010|NOT COMPLETED|Part A Cohort 5||0||
48242202|NCT04117711|100911830|FG011|NOT COMPLETED|Part A Cohort 5||0||
48242203|NCT04117711|100911831|FG012|NOT COMPLETED|Part A Cohort 5||0||
48242204|NCT04117711|100911832|FG013|NOT COMPLETED|Part A Cohort 5||0||
48242205|NCT04117711|100911833|FG014|NOT COMPLETED|Part A Cohort 5||0||
48242206|NCT04117711|100911834|FG015|NOT COMPLETED|Part A Cohort 5||0||
48242207|NCT04117711|100911835|FG016|NOT COMPLETED|Part A Cohort 5||0||
48242208|NCT04117711|100911836|FG017|NOT COMPLETED|Part A Cohort 5||0||
48242209|NCT04117711|100911837|FG018|NOT COMPLETED|Part A Cohort 5||0||
48242210|NCT04117711|100911838|FG019|NOT COMPLETED|Part A Cohort 5||0||
48242211|NCT04117711|100911839|FG020|NOT COMPLETED|Part A Cohort 5||0||
48242212|NCT04117711|100911840|FG021|NOT COMPLETED|Part A Cohort 5||0||
48242213|NCT04117711|100911819|FG000|STARTED|Part A Placebo Comparator||0||
48242214|NCT04117711|100911820|FG001|STARTED|Part A Placebo Comparator||0||
48242215|NCT04117711|100911821|FG002|STARTED|Part A Placebo Comparator||0||
48242216|NCT04117711|100911822|FG003|STARTED|Part A Placebo Comparator||0||
48242217|NCT04117711|100911823|FG004|STARTED|Part A Placebo Comparator||0||
48242218|NCT04117711|100911824|FG005|STARTED|Part A Placebo Comparator||10||
48680003|NCT01639469|101999959|FG000|NOT COMPLETED|Overall Study||5||
48680004|NCT01639469|101999960|FG001|NOT COMPLETED|Overall Study||3||
48680005|NCT01205503|101999961|FG000|STARTED|First Intervention (1st Cycle)||16||
48242219|NCT04117711|100911825|FG006|STARTED|Part A Placebo Comparator||0||
48242220|NCT04117711|100911826|FG007|STARTED|Part A Placebo Comparator||0||
48242221|NCT04117711|100911827|FG008|STARTED|Part A Placebo Comparator||0||
48242222|NCT04117711|100911828|FG009|STARTED|Part A Placebo Comparator||0||
48242223|NCT04117711|100911829|FG010|STARTED|Part A Placebo Comparator||0||
48242224|NCT04117711|100911830|FG011|STARTED|Part A Placebo Comparator||0||
48242225|NCT04117711|100911831|FG012|STARTED|Part A Placebo Comparator||0||
48242226|NCT04117711|100911832|FG013|STARTED|Part A Placebo Comparator||0||
48242227|NCT04117711|100911833|FG014|STARTED|Part A Placebo Comparator||0||
48242228|NCT04117711|100911834|FG015|STARTED|Part A Placebo Comparator||0||
48242229|NCT04117711|100911835|FG016|STARTED|Part A Placebo Comparator||0||
48242230|NCT04117711|100911836|FG017|STARTED|Part A Placebo Comparator||0||
48242231|NCT04117711|100911837|FG018|STARTED|Part A Placebo Comparator||0||
48242232|NCT04117711|100911838|FG019|STARTED|Part A Placebo Comparator||0||
48242233|NCT04117711|100911839|FG020|STARTED|Part A Placebo Comparator||0||
48242234|NCT04117711|100911840|FG021|STARTED|Part A Placebo Comparator||0||
48680006|NCT01205503|101999962|FG001|STARTED|First Intervention (1st Cycle)||16||
48680007|NCT01205503|101999961|FG000|COMPLETED|First Intervention (1st Cycle)||16||
48680008|NCT01205503|101999962|FG001|COMPLETED|First Intervention (1st Cycle)||16||
48680009|NCT01205503|101999961|FG000|NOT COMPLETED|First Intervention (1st Cycle)||0||
48680010|NCT01205503|101999962|FG001|NOT COMPLETED|First Intervention (1st Cycle)||0||
48680011|NCT01205503|101999961|FG000|STARTED|Second Intervention (2nd Cycle)||16||
48680012|NCT01205503|101999962|FG001|STARTED|Second Intervention (2nd Cycle)||16||
48680013|NCT01205503|101999961|FG000|COMPLETED|Second Intervention (2nd Cycle)||16||
48680014|NCT01205503|101999962|FG001|COMPLETED|Second Intervention (2nd Cycle)||16||
48680015|NCT01205503|101999961|FG000|NOT COMPLETED|Second Intervention (2nd Cycle)||0||
48680016|NCT01205503|101999962|FG001|NOT COMPLETED|Second Intervention (2nd Cycle)||0||
48242235|NCT04117711|100911819|FG000|COMPLETED|Part A Placebo Comparator||0||
48242236|NCT04117711|100911820|FG001|COMPLETED|Part A Placebo Comparator||0||
48242237|NCT04117711|100911821|FG002|COMPLETED|Part A Placebo Comparator||0||
48242238|NCT04117711|100911822|FG003|COMPLETED|Part A Placebo Comparator||0||
48242239|NCT04117711|100911823|FG004|COMPLETED|Part A Placebo Comparator||0||
48242240|NCT04117711|100911824|FG005|COMPLETED|Part A Placebo Comparator||10||
48242241|NCT04117711|100911825|FG006|COMPLETED|Part A Placebo Comparator||0||
48242242|NCT04117711|100911826|FG007|COMPLETED|Part A Placebo Comparator||0||
48242243|NCT04117711|100911827|FG008|COMPLETED|Part A Placebo Comparator||0||
48242244|NCT04117711|100911828|FG009|COMPLETED|Part A Placebo Comparator||0||
48242245|NCT04117711|100911829|FG010|COMPLETED|Part A Placebo Comparator||0||
48680017|NCT02217618|101999963|FG000|STARTED|Overall Study||16||
48680018|NCT02217618|101999963|FG000|Received Study Drug|Overall Study||16||
48680019|NCT02217618|101999963|FG000|COMPLETED|Overall Study||16||
48680020|NCT02217618|101999963|FG000|NOT COMPLETED|Overall Study||0||
48680021|NCT02071771|101999964|FG000|STARTED|Period 1: First 10 Days||41||
48242246|NCT04117711|100911830|FG011|COMPLETED|Part A Placebo Comparator||0||
48242247|NCT04117711|100911831|FG012|COMPLETED|Part A Placebo Comparator||0||
48540342|NCT00351533|101658061|FG000|STARTED|Overall Study||41||
48540343|NCT00351533|101658062|FG001|STARTED|Overall Study||49||
48680022|NCT02071771|101999965|FG001|STARTED|Period 1: First 10 Days||39||
48680023|NCT02071771|101999964|FG000|Dispensed|Period 1: First 10 Days||39||
48680024|NCT02071771|101999965|FG001|Dispensed|Period 1: First 10 Days||39||
48680025|NCT02071771|101999964|FG000|COMPLETED|Period 1: First 10 Days||39||
48680026|NCT02071771|101999965|FG001|COMPLETED|Period 1: First 10 Days||39||
48680027|NCT02071771|101999964|FG000|NOT COMPLETED|Period 1: First 10 Days||2||
48680028|NCT02071771|101999965|FG001|NOT COMPLETED|Period 1: First 10 Days||0||
48680029|NCT02071771|101999964|FG000|STARTED|Period 2: Second 10 Days||39||
48680030|NCT02071771|101999965|FG001|STARTED|Period 2: Second 10 Days||38||
48680031|NCT02071771|101999964|FG000|COMPLETED|Period 2: Second 10 Days||39||
48242248|NCT04117711|100911832|FG013|COMPLETED|Part A Placebo Comparator||0||
48540344|NCT00351533|101658061|FG000|COMPLETED|Overall Study||39||
48540345|NCT00351533|101658062|FG001|COMPLETED|Overall Study||44||
48540346|NCT00351533|101658061|FG000|NOT COMPLETED|Overall Study||2||
48540347|NCT00351533|101658062|FG001|NOT COMPLETED|Overall Study||5||
48540348|NCT03678285|101658063|FG000|STARTED|Overall Study||42||
48540349|NCT03678285|101658063|FG000|Started Workout|Overall Study||40||
48540350|NCT03678285|101658063|FG000|COMPLETED|Overall Study||38||
48540351|NCT03678285|101658063|FG000|NOT COMPLETED|Overall Study||4||
48540352|NCT02114385|101658064|FG000|STARTED|Overall Study||249||
48540353|NCT02114385|101658065|FG001|STARTED|Overall Study||251||
48540354|NCT02114385|101658064|FG000|Vaccinated|Overall Study||249||
48540355|NCT02114385|101658065|FG001|Vaccinated|Overall Study||251||
48540356|NCT02114385|101658064|FG000|COMPLETED|Overall Study||246||
48540357|NCT02114385|101658065|FG001|COMPLETED|Overall Study||243||
48540358|NCT02114385|101658064|FG000|NOT COMPLETED|Overall Study||3||
48540359|NCT02114385|101658065|FG001|NOT COMPLETED|Overall Study||8||
48540360|NCT00856375|101658066|FG000|STARTED|Overall Study||42||
48540361|NCT00856375|101658067|FG001|STARTED|Overall Study||41||
48540362|NCT00856375|101658066|FG000|COMPLETED|Overall Study||0||
48540363|NCT00856375|101658067|FG001|COMPLETED|Overall Study||0||
48540364|NCT00856375|101658066|FG000|NOT COMPLETED|Overall Study||42||
48540365|NCT00856375|101658067|FG001|NOT COMPLETED|Overall Study||41||
48540366|NCT00577395|101658068|FG000|STARTED|Overall Study||7||
48540367|NCT00577395|101658069|FG001|STARTED|Overall Study||6||
48540368|NCT00577395|101658068|FG000|COMPLETED|Overall Study||0||
48540369|NCT00577395|101658069|FG001|COMPLETED|Overall Study||0||
48540370|NCT00577395|101658068|FG000|NOT COMPLETED|Overall Study||7||
48540371|NCT00577395|101658069|FG001|NOT COMPLETED|Overall Study||6||
48540372|NCT00613886|101658070|FG000|STARTED|Overall Study||24||
48540373|NCT00613886|101658070|FG000|COMPLETED|Overall Study||0||
48540374|NCT00613886|101658070|FG000|NOT COMPLETED|Overall Study||24||
48680032|NCT02071771|101999965|FG001|COMPLETED|Period 2: Second 10 Days||38||
48242249|NCT04117711|100911833|FG014|COMPLETED|Part A Placebo Comparator||0||
48540375|NCT02064985|101658071|FG000|STARTED|Overall Study||12||
48540376|NCT02064985|101658072|FG001|STARTED|Overall Study||12||
48540377|NCT02064985|101658073|FG002|STARTED|Overall Study||12||
48540378|NCT02064985|101658071|FG000|COMPLETED|Overall Study||12||
48540379|NCT02064985|101658072|FG001|COMPLETED|Overall Study||12||
48540380|NCT02064985|101658073|FG002|COMPLETED|Overall Study||12||
48540381|NCT02064985|101658071|FG000|NOT COMPLETED|Overall Study||0||
48540382|NCT02064985|101658072|FG001|NOT COMPLETED|Overall Study||0||
48242250|NCT04117711|100911834|FG015|COMPLETED|Part A Placebo Comparator||0||
48242251|NCT04117711|100911835|FG016|COMPLETED|Part A Placebo Comparator||0||
48242252|NCT04117711|100911836|FG017|COMPLETED|Part A Placebo Comparator||0||
48242253|NCT04117711|100911837|FG018|COMPLETED|Part A Placebo Comparator||0||
48242254|NCT04117711|100911838|FG019|COMPLETED|Part A Placebo Comparator||0||
48242255|NCT04117711|100911839|FG020|COMPLETED|Part A Placebo Comparator||0||
48242256|NCT04117711|100911840|FG021|COMPLETED|Part A Placebo Comparator||0||
48242257|NCT04117711|100911819|FG000|NOT COMPLETED|Part A Placebo Comparator||0||
48242258|NCT04117711|100911820|FG001|NOT COMPLETED|Part A Placebo Comparator||0||
48540383|NCT02064985|101658073|FG002|NOT COMPLETED|Overall Study||0||
48540384|NCT01822366|101658074|FG000|STARTED|Overall Study||320||
48540385|NCT01822366|101658075|FG001|STARTED|Overall Study||320||
48680033|NCT02071771|101999964|FG000|NOT COMPLETED|Period 2: Second 10 Days||0||
48680034|NCT02071771|101999965|FG001|NOT COMPLETED|Period 2: Second 10 Days||0||
48680035|NCT02319486|101999966|FG000|STARTED|Overall Study||26||
48680036|NCT02319486|101999966|FG000|COMPLETED|Overall Study||26||
48680037|NCT02319486|101999966|FG000|NOT COMPLETED|Overall Study||0||
48680038|NCT00441272|101999967|FG000|STARTED|Overall Study||25||
48680039|NCT00441272|101999968|FG001|STARTED|Overall Study||25||
48680040|NCT00441272|101999967|FG000|COMPLETED|Overall Study||0||
48680041|NCT00441272|101999968|FG001|COMPLETED|Overall Study||0||
48680042|NCT00441272|101999967|FG000|NOT COMPLETED|Overall Study||25||
48680043|NCT00441272|101999968|FG001|NOT COMPLETED|Overall Study||25||
48680044|NCT01248793|101999969|FG000|STARTED|Overall Study||105||
48680045|NCT01248793|101999970|FG001|STARTED|Overall Study||108||
48680046|NCT01248793|101999969|FG000|COMPLETED|Overall Study||101||
48680047|NCT01248793|101999970|FG001|COMPLETED|Overall Study||102||
48680048|NCT01248793|101999969|FG000|NOT COMPLETED|Overall Study||4||
48680049|NCT01248793|101999970|FG001|NOT COMPLETED|Overall Study||6||
48680050|NCT01497197|101999971|FG000|STARTED|Overall Study||89||
48680051|NCT01497197|101999972|FG001|STARTED|Overall Study||85||
48680052|NCT01497197|101999971|FG000|COMPLETED|Overall Study||72||
48680053|NCT01497197|101999972|FG001|COMPLETED|Overall Study||70||
48680054|NCT01497197|101999971|FG000|NOT COMPLETED|Overall Study||17||
48680055|NCT01497197|101999972|FG001|NOT COMPLETED|Overall Study||15||
48680056|NCT02020590|101999973|FG000|STARTED|Overall Study||22||
48680057|NCT02020590|101999973|FG000|COMPLETED|Overall Study||22||
48680058|NCT02020590|101999973|FG000|NOT COMPLETED|Overall Study||0||
48680059|NCT00244621|101999974|FG000|STARTED|Double-blind Treatment Period||29||
48680060|NCT00244621|101999975|FG001|STARTED|Double-blind Treatment Period||32||
48680061|NCT00244621|101999976|FG002|STARTED|Double-blind Treatment Period||32||
48680062|NCT00244621|101999974|FG000|COMPLETED|Double-blind Treatment Period||27||
48680063|NCT00244621|101999975|FG001|COMPLETED|Double-blind Treatment Period||29||
48680064|NCT00244621|101999976|FG002|COMPLETED|Double-blind Treatment Period||30||
48680065|NCT00244621|101999974|FG000|NOT COMPLETED|Double-blind Treatment Period||2||
48680066|NCT00244621|101999975|FG001|NOT COMPLETED|Double-blind Treatment Period||3||
48680067|NCT00244621|101999976|FG002|NOT COMPLETED|Double-blind Treatment Period||2||
48680068|NCT00244621|101999974|FG000|STARTED|Open-label Treatment Period||26||
48680069|NCT00244621|101999975|FG001|STARTED|Open-label Treatment Period||29||
48680070|NCT00244621|101999976|FG002|STARTED|Open-label Treatment Period||30||
48680071|NCT00244621|101999974|FG000|COMPLETED|Open-label Treatment Period||25||
48680072|NCT00244621|101999975|FG001|COMPLETED|Open-label Treatment Period||28||
48680073|NCT00244621|101999976|FG002|COMPLETED|Open-label Treatment Period||28||
48680074|NCT00244621|101999974|FG000|NOT COMPLETED|Open-label Treatment Period||1||
48680075|NCT00244621|101999975|FG001|NOT COMPLETED|Open-label Treatment Period||1||
48680076|NCT00244621|101999976|FG002|NOT COMPLETED|Open-label Treatment Period||2||
48680077|NCT01897493|101999977|FG000|STARTED|Period 1 (Day 1 Through Day 6 Predose)||16||
48680078|NCT01897493|101999977|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Day 1 Through Day 6 Predose)||16||
48680079|NCT01897493|101999977|FG000|COMPLETED|Period 1 (Day 1 Through Day 6 Predose)||15||
48680080|NCT01897493|101999977|FG000|NOT COMPLETED|Period 1 (Day 1 Through Day 6 Predose)||1||
48680081|NCT01897493|101999977|FG000|STARTED|Period 2 (Day 6 Postdose Through Day 20)||15||
48680082|NCT01897493|101999977|FG000|Received at Least 1 Dose of Study Drug|Period 2 (Day 6 Postdose Through Day 20)||15||
48680083|NCT01897493|101999977|FG000|COMPLETED|Period 2 (Day 6 Postdose Through Day 20)||15||
48680084|NCT01897493|101999977|FG000|NOT COMPLETED|Period 2 (Day 6 Postdose Through Day 20)||0||
48680085|NCT02604459|101999978|FG000|STARTED|Overall Study||56||
48680086|NCT02604459|101999979|FG001|STARTED|Overall Study||53||
48680087|NCT02604459|101999980|FG002|STARTED|Overall Study||22||
48680088|NCT02604459|101999981|FG003|STARTED|Overall Study||14||
48680089|NCT02604459|101999978|FG000|COMPLETED|Overall Study||56||
48680090|NCT02604459|101999979|FG001|COMPLETED|Overall Study||53||
48680091|NCT02604459|101999980|FG002|COMPLETED|Overall Study||22||
48680092|NCT02604459|101999981|FG003|COMPLETED|Overall Study||14||
48680093|NCT02604459|101999978|FG000|NOT COMPLETED|Overall Study||0||
48680094|NCT02604459|101999979|FG001|NOT COMPLETED|Overall Study||0||
48680095|NCT02604459|101999980|FG002|NOT COMPLETED|Overall Study||0||
48680096|NCT02604459|101999981|FG003|NOT COMPLETED|Overall Study||0||
48680097|NCT03368781|101999982|FG000|STARTED|Overall Study||128||
48680098|NCT03368781|101999982|FG000|Treated Subjects|Overall Study||106||
48680099|NCT03368781|101999982|FG000|COMPLETED|Overall Study||103||
48680100|NCT03368781|101999982|FG000|NOT COMPLETED|Overall Study||25||
48680101|NCT01044030|101999983|FG000|STARTED|Overall Study||160||
48680102|NCT01044030|101999984|FG001|STARTED|Overall Study||166||
48680103|NCT01044030|101999983|FG000|COMPLETED|Overall Study||141||
48680104|NCT01044030|101999984|FG001|COMPLETED|Overall Study||146||
48680105|NCT01044030|101999983|FG000|NOT COMPLETED|Overall Study||19||
48680106|NCT01044030|101999984|FG001|NOT COMPLETED|Overall Study||20||
48680107|NCT03768427|101999985|FG000|STARTED|Overall Study||88||
48680108|NCT03768427|101999986|FG001|STARTED|Overall Study||89||
48680109|NCT03768427|101999987|FG002|STARTED|Overall Study||137||
48680110|NCT03768427|101999988|FG003|STARTED|Overall Study||140||
48242259|NCT04117711|100911821|FG002|NOT COMPLETED|Part A Placebo Comparator||0||
48242260|NCT04117711|100911822|FG003|NOT COMPLETED|Part A Placebo Comparator||0||
48242261|NCT04117711|100911823|FG004|NOT COMPLETED|Part A Placebo Comparator||0||
48242262|NCT04117711|100911824|FG005|NOT COMPLETED|Part A Placebo Comparator||0||
48680111|NCT03768427|101999985|FG000|COMPLETED|Overall Study||76||
48680112|NCT03768427|101999986|FG001|COMPLETED|Overall Study||85||
48242263|NCT04117711|100911825|FG006|NOT COMPLETED|Part A Placebo Comparator||0||
48242264|NCT04117711|100911826|FG007|NOT COMPLETED|Part A Placebo Comparator||0||
48242265|NCT04117711|100911827|FG008|NOT COMPLETED|Part A Placebo Comparator||0||
48242266|NCT04117711|100911828|FG009|NOT COMPLETED|Part A Placebo Comparator||0||
48242267|NCT04117711|100911829|FG010|NOT COMPLETED|Part A Placebo Comparator||0||
48242268|NCT04117711|100911830|FG011|NOT COMPLETED|Part A Placebo Comparator||0||
48242269|NCT04117711|100911831|FG012|NOT COMPLETED|Part A Placebo Comparator||0||
48242270|NCT04117711|100911832|FG013|NOT COMPLETED|Part A Placebo Comparator||0||
48242271|NCT04117711|100911833|FG014|NOT COMPLETED|Part A Placebo Comparator||0||
48242272|NCT04117711|100911834|FG015|NOT COMPLETED|Part A Placebo Comparator||0||
48242273|NCT04117711|100911835|FG016|NOT COMPLETED|Part A Placebo Comparator||0||
48242274|NCT04117711|100911836|FG017|NOT COMPLETED|Part A Placebo Comparator||0||
48242275|NCT04117711|100911837|FG018|NOT COMPLETED|Part A Placebo Comparator||0||
48680113|NCT03768427|101999987|FG002|COMPLETED|Overall Study||126||
48680114|NCT03768427|101999988|FG003|COMPLETED|Overall Study||129||
48680115|NCT03768427|101999985|FG000|NOT COMPLETED|Overall Study||12||
48680116|NCT03768427|101999986|FG001|NOT COMPLETED|Overall Study||4||
48680117|NCT03768427|101999987|FG002|NOT COMPLETED|Overall Study||11||
48680118|NCT03768427|101999988|FG003|NOT COMPLETED|Overall Study||11||
48680119|NCT00945659|101999989|FG000|STARTED|Overall Study||39||
48680120|NCT00945659|101999990|FG001|STARTED|Overall Study||40||
48680121|NCT00945659|101999991|FG002|STARTED|Overall Study||37||
48680122|NCT00945659|101999989|FG000|Baseline|Overall Study||39||
48680123|NCT00945659|101999990|FG001|Baseline|Overall Study||40||
48680124|NCT00945659|101999991|FG002|Baseline|Overall Study||37||
48680125|NCT00945659|101999989|FG000|3-Months|Overall Study||38||
48680126|NCT00945659|101999990|FG001|3-Months|Overall Study||39||
48680127|NCT00945659|101999991|FG002|3-Months|Overall Study||35||
48680128|NCT00945659|101999989|FG000|6-Months|Overall Study||31||
48680129|NCT00945659|101999990|FG001|6-Months|Overall Study||29||
48680130|NCT00945659|101999991|FG002|6-Months|Overall Study||25||
48680131|NCT00945659|101999989|FG000|9-Months|Overall Study||32||
48680132|NCT00945659|101999990|FG001|9-Months|Overall Study||20||
48680133|NCT00945659|101999991|FG002|9-Months|Overall Study||20||
48680134|NCT00945659|101999989|FG000|12-Months|Overall Study||32||
48680135|NCT00945659|101999990|FG001|12-Months|Overall Study||20||
48242276|NCT04117711|100911838|FG019|NOT COMPLETED|Part A Placebo Comparator||0||
48242277|NCT04117711|100911839|FG020|NOT COMPLETED|Part A Placebo Comparator||0||
48242278|NCT04117711|100911840|FG021|NOT COMPLETED|Part A Placebo Comparator||0||
48242279|NCT04117711|100911819|FG000|STARTED|Part B & C AT-007 5mg/kg Cohort||0||
48680136|NCT00945659|101999991|FG002|12-Months|Overall Study||20||
48680137|NCT00945659|101999989|FG000|COMPLETED|Overall Study||32||
48680138|NCT00945659|101999990|FG001|COMPLETED|Overall Study||20||
48680139|NCT00945659|101999991|FG002|COMPLETED|Overall Study||20||
48680140|NCT00945659|101999989|FG000|NOT COMPLETED|Overall Study||7||
48680141|NCT00945659|101999990|FG001|NOT COMPLETED|Overall Study||20||
48680142|NCT00945659|101999991|FG002|NOT COMPLETED|Overall Study||17||
48680143|NCT03637491|101999992|FG000|STARTED|Overall Study||10||
48680144|NCT03637491|101999993|FG001|STARTED|Overall Study||12||
48242280|NCT04117711|100911820|FG001|STARTED|Part B & C AT-007 5mg/kg Cohort||0||
48242281|NCT04117711|100911821|FG002|STARTED|Part B & C AT-007 5mg/kg Cohort||0||
48242282|NCT04117711|100911822|FG003|STARTED|Part B & C AT-007 5mg/kg Cohort||0||
48242283|NCT04117711|100911823|FG004|STARTED|Part B & C AT-007 5mg/kg Cohort||0||
48242284|NCT04117711|100911824|FG005|STARTED|Part B & C AT-007 5mg/kg Cohort||0||
48242285|NCT04117711|100911825|FG006|STARTED|Part B & C AT-007 5mg/kg Cohort||6||
48242286|NCT04117711|100911826|FG007|STARTED|Part B & C AT-007 5mg/kg Cohort||0||
48242287|NCT04117711|100911827|FG008|STARTED|Part B & C AT-007 5mg/kg Cohort||0||
48242288|NCT04117711|100911828|FG009|STARTED|Part B & C AT-007 5mg/kg Cohort||0||
48242289|NCT04117711|100911829|FG010|STARTED|Part B & C AT-007 5mg/kg Cohort||0||
48242290|NCT04117711|100911830|FG011|STARTED|Part B & C AT-007 5mg/kg Cohort||0||
48242291|NCT04117711|100911831|FG012|STARTED|Part B & C AT-007 5mg/kg Cohort||0||
48242292|NCT04117711|100911832|FG013|STARTED|Part B & C AT-007 5mg/kg Cohort||0||
48242293|NCT04117711|100911833|FG014|STARTED|Part B & C AT-007 5mg/kg Cohort||0||
48242294|NCT04117711|100911834|FG015|STARTED|Part B & C AT-007 5mg/kg Cohort||0||
48242295|NCT04117711|100911835|FG016|STARTED|Part B & C AT-007 5mg/kg Cohort||0||
48242296|NCT04117711|100911836|FG017|STARTED|Part B & C AT-007 5mg/kg Cohort||0||
48242297|NCT04117711|100911837|FG018|STARTED|Part B & C AT-007 5mg/kg Cohort||0||
48242298|NCT04117711|100911838|FG019|STARTED|Part B & C AT-007 5mg/kg Cohort||0||
48242299|NCT04117711|100911839|FG020|STARTED|Part B & C AT-007 5mg/kg Cohort||0||
48242300|NCT04117711|100911840|FG021|STARTED|Part B & C AT-007 5mg/kg Cohort||0||
48242301|NCT04117711|100911819|FG000|COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242302|NCT04117711|100911820|FG001|COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242303|NCT04117711|100911821|FG002|COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242304|NCT04117711|100911822|FG003|COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242305|NCT04117711|100911823|FG004|COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242306|NCT04117711|100911824|FG005|COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242307|NCT04117711|100911825|FG006|COMPLETED|Part B & C AT-007 5mg/kg Cohort||6||
48242308|NCT04117711|100911826|FG007|COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242309|NCT04117711|100911827|FG008|COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48540386|NCT01822366|101658076|FG002|STARTED|Overall Study||320||
48242310|NCT04117711|100911828|FG009|COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242311|NCT04117711|100911829|FG010|COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242312|NCT04117711|100911830|FG011|COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242313|NCT04117711|100911831|FG012|COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242314|NCT04117711|100911832|FG013|COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242315|NCT04117711|100911833|FG014|COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242316|NCT04117711|100911834|FG015|COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242317|NCT04117711|100911835|FG016|COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242318|NCT04117711|100911836|FG017|COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242319|NCT04117711|100911837|FG018|COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48540387|NCT01822366|101658077|FG003|STARTED|Overall Study||320||
48540388|NCT01822366|101658074|FG000|COMPLETED|Overall Study||315||
48540389|NCT01822366|101658075|FG001|COMPLETED|Overall Study||298||
48540390|NCT01822366|101658076|FG002|COMPLETED|Overall Study||315||
48540391|NCT01822366|101658077|FG003|COMPLETED|Overall Study||298||
48540392|NCT01822366|101658074|FG000|NOT COMPLETED|Overall Study||5||
48540393|NCT01822366|101658075|FG001|NOT COMPLETED|Overall Study||22||
48540394|NCT01822366|101658076|FG002|NOT COMPLETED|Overall Study||5||
48540395|NCT01822366|101658077|FG003|NOT COMPLETED|Overall Study||22||
48540396|NCT00338455|101658078|FG000|STARTED|Overall Study||9||
48540397|NCT00338455|101658079|FG001|STARTED|Overall Study||7||
48540398|NCT00338455|101658078|FG000|Administered Study Drug|Overall Study||8||
48540399|NCT00338455|101658079|FG001|Administered Study Drug|Overall Study||7||
48540400|NCT00338455|101658078|FG000|COMPLETED|Overall Study||6||
48540401|NCT00338455|101658079|FG001|COMPLETED|Overall Study||6||
48540402|NCT00338455|101658078|FG000|NOT COMPLETED|Overall Study||3||
48540403|NCT00338455|101658079|FG001|NOT COMPLETED|Overall Study||1||
48540404|NCT03279692|101658080|FG000|STARTED|Overall Study||26||
48540405|NCT03279692|101658080|FG000|COMPLETED|Overall Study||25||
48540406|NCT03279692|101658080|FG000|NOT COMPLETED|Overall Study||1||
48540407|NCT03456453|101658081|FG000|STARTED|Overall Study||30||
48540408|NCT03456453|101658082|FG001|STARTED|Overall Study||30||
48242320|NCT04117711|100911838|FG019|COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242321|NCT04117711|100911839|FG020|COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242322|NCT04117711|100911840|FG021|COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242323|NCT04117711|100911819|FG000|NOT COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242324|NCT04117711|100911820|FG001|NOT COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242325|NCT04117711|100911821|FG002|NOT COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48540409|NCT03456453|101658081|FG000|COMPLETED|Overall Study||27||
48540410|NCT03456453|101658082|FG001|COMPLETED|Overall Study||23||
48540411|NCT03456453|101658081|FG000|NOT COMPLETED|Overall Study||3||
48540412|NCT03456453|101658082|FG001|NOT COMPLETED|Overall Study||7||
48540413|NCT01547130|101658083|FG000|STARTED|Overall Study||74||
48540414|NCT01547130|101658084|FG001|STARTED|Overall Study||73||
48680145|NCT03637491|101999994|FG002|STARTED|Overall Study||7||
48680146|NCT03637491|101999995|FG003|STARTED|Overall Study||6||
48680147|NCT03637491|101999992|FG000|Received Treatment|Overall Study||10||
48680148|NCT03637491|101999993|FG001|Received Treatment|Overall Study||12||
48680149|NCT03637491|101999994|FG002|Received Treatment|Overall Study||7||
48680150|NCT03637491|101999995|FG003|Received Treatment|Overall Study||6||
48680151|NCT03637491|101999992|FG000|COMPLETED|Overall Study||0||
48680152|NCT03637491|101999993|FG001|COMPLETED|Overall Study||0||
48680153|NCT03637491|101999994|FG002|COMPLETED|Overall Study||0||
48680154|NCT03637491|101999995|FG003|COMPLETED|Overall Study||0||
48242326|NCT04117711|100911822|FG003|NOT COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242327|NCT04117711|100911823|FG004|NOT COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242328|NCT04117711|100911824|FG005|NOT COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242329|NCT04117711|100911825|FG006|NOT COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242330|NCT04117711|100911826|FG007|NOT COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48680155|NCT03637491|101999992|FG000|NOT COMPLETED|Overall Study||10||
48680156|NCT03637491|101999993|FG001|NOT COMPLETED|Overall Study||12||
48680157|NCT03637491|101999994|FG002|NOT COMPLETED|Overall Study||7||
48680158|NCT03637491|101999995|FG003|NOT COMPLETED|Overall Study||6||
48680159|NCT01291108|101999996|FG000|STARTED|Month 1 (Monotherapy)||65||
48680160|NCT01291108|101999997|FG001|STARTED|Month 1 (Monotherapy)||0||
48680161|NCT01291108|101999998|FG002|STARTED|Month 1 (Monotherapy)||0||
48680162|NCT01291108|101999999|FG003|STARTED|Month 1 (Monotherapy)||60||
48680163|NCT01291108|102000000|FG004|STARTED|Month 1 (Monotherapy)||0||
48680164|NCT01291108|102000001|FG005|STARTED|Month 1 (Monotherapy)||0||
48680165|NCT01291108|101999996|FG000|COMPLETED|Month 1 (Monotherapy)||64||
48680166|NCT01291108|101999997|FG001|COMPLETED|Month 1 (Monotherapy)||0||
48680167|NCT01291108|101999998|FG002|COMPLETED|Month 1 (Monotherapy)||0||
48680168|NCT01291108|101999999|FG003|COMPLETED|Month 1 (Monotherapy)||60||
48680169|NCT01291108|102000000|FG004|COMPLETED|Month 1 (Monotherapy)||0||
48680170|NCT01291108|102000001|FG005|COMPLETED|Month 1 (Monotherapy)||0||
48680171|NCT01291108|101999996|FG000|NOT COMPLETED|Month 1 (Monotherapy)||1||
48680172|NCT01291108|101999997|FG001|NOT COMPLETED|Month 1 (Monotherapy)||0||
48680173|NCT01291108|101999998|FG002|NOT COMPLETED|Month 1 (Monotherapy)||0||
48680174|NCT01291108|101999999|FG003|NOT COMPLETED|Month 1 (Monotherapy)||0||
48680175|NCT01291108|102000000|FG004|NOT COMPLETED|Month 1 (Monotherapy)||0||
48680176|NCT01291108|102000001|FG005|NOT COMPLETED|Month 1 (Monotherapy)||0||
48680177|NCT01291108|101999996|FG000|STARTED|Month 2 (Adjunctive Therapy)||0||
48680178|NCT01291108|101999997|FG001|STARTED|Month 2 (Adjunctive Therapy)||40||
48680179|NCT01291108|101999998|FG002|STARTED|Month 2 (Adjunctive Therapy)||24||
48680180|NCT01291108|101999999|FG003|STARTED|Month 2 (Adjunctive Therapy)||0||
48242331|NCT04117711|100911827|FG008|NOT COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242332|NCT04117711|100911828|FG009|NOT COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242333|NCT04117711|100911829|FG010|NOT COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242334|NCT04117711|100911830|FG011|NOT COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242335|NCT04117711|100911831|FG012|NOT COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242336|NCT04117711|100911832|FG013|NOT COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242337|NCT04117711|100911833|FG014|NOT COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242338|NCT04117711|100911834|FG015|NOT COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242339|NCT04117711|100911835|FG016|NOT COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242340|NCT04117711|100911836|FG017|NOT COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242341|NCT04117711|100911837|FG018|NOT COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242342|NCT04117711|100911838|FG019|NOT COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242343|NCT04117711|100911839|FG020|NOT COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242344|NCT04117711|100911840|FG021|NOT COMPLETED|Part B & C AT-007 5mg/kg Cohort||0||
48242345|NCT04117711|100911819|FG000|STARTED|Part B & C AT-007 10mg/kg Cohort||0||
48242346|NCT04117711|100911820|FG001|STARTED|Part B & C AT-007 10mg/kg Cohort||0||
48242347|NCT04117711|100911821|FG002|STARTED|Part B & C AT-007 10mg/kg Cohort||0||
48242348|NCT04117711|100911822|FG003|STARTED|Part B & C AT-007 10mg/kg Cohort||0||
48242349|NCT04117711|100911823|FG004|STARTED|Part B & C AT-007 10mg/kg Cohort||0||
48242350|NCT04117711|100911824|FG005|STARTED|Part B & C AT-007 10mg/kg Cohort||0||
48242351|NCT04117711|100911825|FG006|STARTED|Part B & C AT-007 10mg/kg Cohort||0||
48242352|NCT04117711|100911826|FG007|STARTED|Part B & C AT-007 10mg/kg Cohort||8||
48242353|NCT04117711|100911827|FG008|STARTED|Part B & C AT-007 10mg/kg Cohort||0||
48242354|NCT04117711|100911828|FG009|STARTED|Part B & C AT-007 10mg/kg Cohort||0||
48242355|NCT04117711|100911829|FG010|STARTED|Part B & C AT-007 10mg/kg Cohort||0||
48242356|NCT04117711|100911830|FG011|STARTED|Part B & C AT-007 10mg/kg Cohort||0||
48242357|NCT04117711|100911831|FG012|STARTED|Part B & C AT-007 10mg/kg Cohort||0||
48242358|NCT04117711|100911832|FG013|STARTED|Part B & C AT-007 10mg/kg Cohort||0||
48242359|NCT04117711|100911833|FG014|STARTED|Part B & C AT-007 10mg/kg Cohort||0||
48242360|NCT04117711|100911834|FG015|STARTED|Part B & C AT-007 10mg/kg Cohort||0||
48242361|NCT04117711|100911835|FG016|STARTED|Part B & C AT-007 10mg/kg Cohort||0||
48242362|NCT04117711|100911836|FG017|STARTED|Part B & C AT-007 10mg/kg Cohort||0||
48242363|NCT04117711|100911837|FG018|STARTED|Part B & C AT-007 10mg/kg Cohort||0||
48242364|NCT04117711|100911838|FG019|STARTED|Part B & C AT-007 10mg/kg Cohort||0||
48242365|NCT04117711|100911839|FG020|STARTED|Part B & C AT-007 10mg/kg Cohort||0||
48242366|NCT04117711|100911840|FG021|STARTED|Part B & C AT-007 10mg/kg Cohort||0||
48242367|NCT04117711|100911819|FG000|COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242368|NCT04117711|100911820|FG001|COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242369|NCT04117711|100911821|FG002|COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242370|NCT04117711|100911822|FG003|COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242371|NCT04117711|100911823|FG004|COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242372|NCT04117711|100911824|FG005|COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242373|NCT04117711|100911825|FG006|COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242374|NCT04117711|100911826|FG007|COMPLETED|Part B & C AT-007 10mg/kg Cohort||8||
48242375|NCT04117711|100911827|FG008|COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242376|NCT04117711|100911828|FG009|COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48540415|NCT01547130|101658083|FG000|COMPLETED|Overall Study||65||
48242377|NCT04117711|100911829|FG010|COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242378|NCT04117711|100911830|FG011|COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242379|NCT04117711|100911831|FG012|COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242380|NCT04117711|100911832|FG013|COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242381|NCT04117711|100911833|FG014|COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242382|NCT04117711|100911834|FG015|COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242383|NCT04117711|100911835|FG016|COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242384|NCT04117711|100911836|FG017|COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242385|NCT04117711|100911837|FG018|COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242386|NCT04117711|100911838|FG019|COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242387|NCT04117711|100911839|FG020|COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242388|NCT04117711|100911840|FG021|COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48680181|NCT01291108|102000000|FG004|STARTED|Month 2 (Adjunctive Therapy)||34||
48680182|NCT01291108|102000001|FG005|STARTED|Month 2 (Adjunctive Therapy)||26||
48242389|NCT04117711|100911819|FG000|NOT COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242390|NCT04117711|100911820|FG001|NOT COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242391|NCT04117711|100911821|FG002|NOT COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242392|NCT04117711|100911822|FG003|NOT COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242393|NCT04117711|100911823|FG004|NOT COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242394|NCT04117711|100911824|FG005|NOT COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242395|NCT04117711|100911825|FG006|NOT COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242396|NCT04117711|100911826|FG007|NOT COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242397|NCT04117711|100911827|FG008|NOT COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242398|NCT04117711|100911828|FG009|NOT COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242399|NCT04117711|100911829|FG010|NOT COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242400|NCT04117711|100911830|FG011|NOT COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242401|NCT04117711|100911831|FG012|NOT COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242402|NCT04117711|100911832|FG013|NOT COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242403|NCT04117711|100911833|FG014|NOT COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242404|NCT04117711|100911834|FG015|NOT COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242405|NCT04117711|100911835|FG016|NOT COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242406|NCT04117711|100911836|FG017|NOT COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242407|NCT04117711|100911837|FG018|NOT COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242408|NCT04117711|100911838|FG019|NOT COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242409|NCT04117711|100911839|FG020|NOT COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242410|NCT04117711|100911840|FG021|NOT COMPLETED|Part B & C AT-007 10mg/kg Cohort||0||
48242411|NCT04117711|100911819|FG000|STARTED|Part B & C AT-007 20mg/kg Cohort||0||
48242412|NCT04117711|100911820|FG001|STARTED|Part B & C AT-007 20mg/kg Cohort||0||
48242413|NCT04117711|100911821|FG002|STARTED|Part B & C AT-007 20mg/kg Cohort||0||
48242414|NCT04117711|100911822|FG003|STARTED|Part B & C AT-007 20mg/kg Cohort||0||
48242415|NCT04117711|100911823|FG004|STARTED|Part B & C AT-007 20mg/kg Cohort||0||
48680183|NCT01291108|101999996|FG000|COMPLETED|Month 2 (Adjunctive Therapy)||0||
48680184|NCT01291108|101999997|FG001|COMPLETED|Month 2 (Adjunctive Therapy)||38||
48680185|NCT01291108|101999998|FG002|COMPLETED|Month 2 (Adjunctive Therapy)||24||
48680186|NCT01291108|101999999|FG003|COMPLETED|Month 2 (Adjunctive Therapy)||0||
48680187|NCT01291108|102000000|FG004|COMPLETED|Month 2 (Adjunctive Therapy)||34||
48680188|NCT01291108|102000001|FG005|COMPLETED|Month 2 (Adjunctive Therapy)||25||
48680189|NCT01291108|101999996|FG000|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0||
48242416|NCT04117711|100911824|FG005|STARTED|Part B & C AT-007 20mg/kg Cohort||0||
48242417|NCT04117711|100911825|FG006|STARTED|Part B & C AT-007 20mg/kg Cohort||0||
48242418|NCT04117711|100911826|FG007|STARTED|Part B & C AT-007 20mg/kg Cohort||0||
48242419|NCT04117711|100911827|FG008|STARTED|Part B & C AT-007 20mg/kg Cohort||10||
48242420|NCT04117711|100911828|FG009|STARTED|Part B & C AT-007 20mg/kg Cohort||0||
48242421|NCT04117711|100911829|FG010|STARTED|Part B & C AT-007 20mg/kg Cohort||0||
48242422|NCT04117711|100911830|FG011|STARTED|Part B & C AT-007 20mg/kg Cohort||0||
48242423|NCT04117711|100911831|FG012|STARTED|Part B & C AT-007 20mg/kg Cohort||0||
48242424|NCT04117711|100911832|FG013|STARTED|Part B & C AT-007 20mg/kg Cohort||0||
48242425|NCT04117711|100911833|FG014|STARTED|Part B & C AT-007 20mg/kg Cohort||0||
48242426|NCT04117711|100911834|FG015|STARTED|Part B & C AT-007 20mg/kg Cohort||0||
48242427|NCT04117711|100911835|FG016|STARTED|Part B & C AT-007 20mg/kg Cohort||0||
48242428|NCT04117711|100911836|FG017|STARTED|Part B & C AT-007 20mg/kg Cohort||0||
48242429|NCT04117711|100911837|FG018|STARTED|Part B & C AT-007 20mg/kg Cohort||0||
48242430|NCT04117711|100911838|FG019|STARTED|Part B & C AT-007 20mg/kg Cohort||0||
48680190|NCT01291108|101999997|FG001|NOT COMPLETED|Month 2 (Adjunctive Therapy)||2||
48680191|NCT01291108|101999998|FG002|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0||
48680192|NCT01291108|101999999|FG003|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0||
48680193|NCT01291108|102000000|FG004|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0||
48680194|NCT01291108|102000001|FG005|NOT COMPLETED|Month 2 (Adjunctive Therapy)||1||
48680195|NCT03670160|102000002|FG000|STARTED|Overall Study||11||
48680196|NCT03670160|102000003|FG001|STARTED|Overall Study||14||
48680197|NCT03670160|102000002|FG000|COMPLETED|Overall Study||11||
48680198|NCT03670160|102000003|FG001|COMPLETED|Overall Study||14||
48680199|NCT03670160|102000002|FG000|NOT COMPLETED|Overall Study||0||
48242431|NCT04117711|100911839|FG020|STARTED|Part B & C AT-007 20mg/kg Cohort||0||
48242432|NCT04117711|100911840|FG021|STARTED|Part B & C AT-007 20mg/kg Cohort||0||
48242433|NCT04117711|100911819|FG000|COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242434|NCT04117711|100911820|FG001|COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242435|NCT04117711|100911821|FG002|COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242436|NCT04117711|100911822|FG003|COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242437|NCT04117711|100911823|FG004|COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242438|NCT04117711|100911824|FG005|COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242439|NCT04117711|100911825|FG006|COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242440|NCT04117711|100911826|FG007|COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242441|NCT04117711|100911827|FG008|COMPLETED|Part B & C AT-007 20mg/kg Cohort||9||
48242442|NCT04117711|100911828|FG009|COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242443|NCT04117711|100911829|FG010|COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242444|NCT04117711|100911830|FG011|COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242445|NCT04117711|100911831|FG012|COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242446|NCT04117711|100911832|FG013|COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242447|NCT04117711|100911833|FG014|COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242448|NCT04117711|100911834|FG015|COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48540416|NCT01547130|101658084|FG001|COMPLETED|Overall Study||68||
48242449|NCT04117711|100911835|FG016|COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242450|NCT04117711|100911836|FG017|COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242451|NCT04117711|100911837|FG018|COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242452|NCT04117711|100911838|FG019|COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242453|NCT04117711|100911839|FG020|COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242454|NCT04117711|100911840|FG021|COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48540417|NCT01547130|101658083|FG000|NOT COMPLETED|Overall Study||9||
48540418|NCT01547130|101658084|FG001|NOT COMPLETED|Overall Study||5||
48540419|NCT02849938|101658085|FG000|STARTED|Overall Study||9||
48540420|NCT02849938|101658086|FG001|STARTED|Overall Study||15||
48540421|NCT02849938|101658085|FG000|COMPLETED|Overall Study||9||
48540422|NCT02849938|101658086|FG001|COMPLETED|Overall Study||15||
48540423|NCT02849938|101658085|FG000|NOT COMPLETED|Overall Study||0||
48540424|NCT02849938|101658086|FG001|NOT COMPLETED|Overall Study||0||
48540425|NCT00561418|101658087|FG000|STARTED|Overall Study||23||
48540426|NCT00561418|101658087|FG000|COMPLETED|Overall Study||23||
48540427|NCT00561418|101658087|FG000|NOT COMPLETED|Overall Study||0||
48540428|NCT00428116|101658088|FG000|STARTED|Overall Study||21||
48242455|NCT04117711|100911819|FG000|NOT COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242456|NCT04117711|100911820|FG001|NOT COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242457|NCT04117711|100911821|FG002|NOT COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48540429|NCT00428116|101658089|FG001|STARTED|Overall Study||21||
48540430|NCT00428116|101658088|FG000|COMPLETED|Overall Study||18||
48540431|NCT00428116|101658089|FG001|COMPLETED|Overall Study||21||
48540432|NCT00428116|101658088|FG000|NOT COMPLETED|Overall Study||3||
48242458|NCT04117711|100911822|FG003|NOT COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242459|NCT04117711|100911823|FG004|NOT COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242460|NCT04117711|100911824|FG005|NOT COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242461|NCT04117711|100911825|FG006|NOT COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242462|NCT04117711|100911826|FG007|NOT COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242463|NCT04117711|100911827|FG008|NOT COMPLETED|Part B & C AT-007 20mg/kg Cohort||1||
48242464|NCT04117711|100911828|FG009|NOT COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242465|NCT04117711|100911829|FG010|NOT COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242466|NCT04117711|100911830|FG011|NOT COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242467|NCT04117711|100911831|FG012|NOT COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242468|NCT04117711|100911832|FG013|NOT COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242469|NCT04117711|100911833|FG014|NOT COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242470|NCT04117711|100911834|FG015|NOT COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242471|NCT04117711|100911835|FG016|NOT COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242472|NCT04117711|100911836|FG017|NOT COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242473|NCT04117711|100911837|FG018|NOT COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242474|NCT04117711|100911838|FG019|NOT COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242475|NCT04117711|100911839|FG020|NOT COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242476|NCT04117711|100911840|FG021|NOT COMPLETED|Part B & C AT-007 20mg/kg Cohort||0||
48242477|NCT04117711|100911819|FG000|STARTED|Part B & C AT-007 40mg/kg||0||
48242478|NCT04117711|100911820|FG001|STARTED|Part B & C AT-007 40mg/kg||0||
48242479|NCT04117711|100911821|FG002|STARTED|Part B & C AT-007 40mg/kg||0||
48242480|NCT04117711|100911822|FG003|STARTED|Part B & C AT-007 40mg/kg||0||
48242481|NCT04117711|100911823|FG004|STARTED|Part B & C AT-007 40mg/kg||0||
48242482|NCT04117711|100911824|FG005|STARTED|Part B & C AT-007 40mg/kg||0||
48242483|NCT04117711|100911825|FG006|STARTED|Part B & C AT-007 40mg/kg||0||
48242484|NCT04117711|100911826|FG007|STARTED|Part B & C AT-007 40mg/kg||0||
48242485|NCT04117711|100911827|FG008|STARTED|Part B & C AT-007 40mg/kg||0||
48242486|NCT04117711|100911828|FG009|STARTED|Part B & C AT-007 40mg/kg||9||
48242487|NCT04117711|100911829|FG010|STARTED|Part B & C AT-007 40mg/kg||0||
48242488|NCT04117711|100911830|FG011|STARTED|Part B & C AT-007 40mg/kg||0||
48242489|NCT04117711|100911831|FG012|STARTED|Part B & C AT-007 40mg/kg||0||
48242490|NCT04117711|100911832|FG013|STARTED|Part B & C AT-007 40mg/kg||0||
48242491|NCT04117711|100911833|FG014|STARTED|Part B & C AT-007 40mg/kg||0||
48242492|NCT04117711|100911834|FG015|STARTED|Part B & C AT-007 40mg/kg||0||
48242493|NCT04117711|100911835|FG016|STARTED|Part B & C AT-007 40mg/kg||0||
48680200|NCT03670160|102000003|FG001|NOT COMPLETED|Overall Study||0||
48680201|NCT03820011|102000004|FG000|STARTED|Overall Study||6||
48680202|NCT03820011|102000005|FG001|STARTED|Overall Study||22||
48680203|NCT03820011|102000004|FG000|COMPLETED|Overall Study||6||
48680204|NCT03820011|102000005|FG001|COMPLETED|Overall Study||18||
48680205|NCT03820011|102000004|FG000|NOT COMPLETED|Overall Study||0||
48680206|NCT03820011|102000005|FG001|NOT COMPLETED|Overall Study||4||
48680207|NCT03389308|102000006|FG000|STARTED|Overall Study||51||
48680208|NCT03389308|102000006|FG000|COMPLETED|Overall Study||39||
48680209|NCT03389308|102000006|FG000|NOT COMPLETED|Overall Study||12||
48680210|NCT02935192|102000007|FG000|STARTED|Overall Study||320||
48680211|NCT02935192|102000008|FG001|STARTED|Overall Study||160||
48680212|NCT02935192|102000007|FG000|Received Vaccine/Placebo|Overall Study||312||
48680213|NCT02935192|102000008|FG001|Received Vaccine/Placebo|Overall Study||156||
48680214|NCT02935192|102000007|FG000|COMPLETED|Overall Study||312||
48680215|NCT02935192|102000008|FG001|COMPLETED|Overall Study||156||
48680216|NCT02935192|102000007|FG000|NOT COMPLETED|Overall Study||8||
48680217|NCT02935192|102000008|FG001|NOT COMPLETED|Overall Study||4||
48680218|NCT03368066|102000009|FG000|STARTED|Overall Study||58||
48680219|NCT03368066|102000010|FG001|STARTED|Overall Study||37||
48680220|NCT03368066|102000009|FG000|COMPLETED|Overall Study||58||
48680221|NCT03368066|102000010|FG001|COMPLETED|Overall Study||37||
48680222|NCT03368066|102000009|FG000|NOT COMPLETED|Overall Study||0||
48680223|NCT03368066|102000010|FG001|NOT COMPLETED|Overall Study||0||
48680224|NCT00181844|102000011|FG000|STARTED|Signed Consent||51||
48680225|NCT00181844|102000011|FG000|COMPLETED|Signed Consent||39||
48680226|NCT00181844|102000011|FG000|NOT COMPLETED|Signed Consent||12||
48680227|NCT00181844|102000011|FG000|STARTED|Exposed to Study Medication||39||
48680228|NCT00181844|102000011|FG000|COMPLETED|Exposed to Study Medication||22||
48680229|NCT00181844|102000011|FG000|NOT COMPLETED|Exposed to Study Medication||17||
48242494|NCT04117711|100911836|FG017|STARTED|Part B & C AT-007 40mg/kg||0||
48242495|NCT04117711|100911837|FG018|STARTED|Part B & C AT-007 40mg/kg||0||
48081510|NCT03129100|100521620|FG007|COMPLETED|Period 3 (Dose Escalation)||0||
48242496|NCT04117711|100911838|FG019|STARTED|Part B & C AT-007 40mg/kg||0||
48242497|NCT04117711|100911839|FG020|STARTED|Part B & C AT-007 40mg/kg||0||
48242498|NCT04117711|100911840|FG021|STARTED|Part B & C AT-007 40mg/kg||0||
48242499|NCT04117711|100911819|FG000|COMPLETED|Part B & C AT-007 40mg/kg||0||
48242500|NCT04117711|100911820|FG001|COMPLETED|Part B & C AT-007 40mg/kg||0||
48242501|NCT04117711|100911821|FG002|COMPLETED|Part B & C AT-007 40mg/kg||0||
48242502|NCT04117711|100911822|FG003|COMPLETED|Part B & C AT-007 40mg/kg||0||
48242503|NCT04117711|100911823|FG004|COMPLETED|Part B & C AT-007 40mg/kg||0||
48242504|NCT04117711|100911824|FG005|COMPLETED|Part B & C AT-007 40mg/kg||0||
48242505|NCT04117711|100911825|FG006|COMPLETED|Part B & C AT-007 40mg/kg||0||
48242506|NCT04117711|100911826|FG007|COMPLETED|Part B & C AT-007 40mg/kg||0||
48242507|NCT04117711|100911827|FG008|COMPLETED|Part B & C AT-007 40mg/kg||0||
48242508|NCT04117711|100911828|FG009|COMPLETED|Part B & C AT-007 40mg/kg||7||
48242509|NCT04117711|100911829|FG010|COMPLETED|Part B & C AT-007 40mg/kg||0||
48242510|NCT04117711|100911830|FG011|COMPLETED|Part B & C AT-007 40mg/kg||0||
48242511|NCT04117711|100911831|FG012|COMPLETED|Part B & C AT-007 40mg/kg||0||
48680230|NCT00920556|102000012|FG000|STARTED|Overall Study||24||
48680231|NCT00920556|102000012|FG000|COMPLETED|Overall Study||0||
48680232|NCT00920556|102000012|FG000|NOT COMPLETED|Overall Study||24||
48680233|NCT03092479|102000013|FG000|STARTED|Overall Study||24||
48680234|NCT03092479|102000014|FG001|STARTED|Overall Study||26||
48680235|NCT03092479|102000013|FG000|COMPLETED|Overall Study||17||
48680236|NCT03092479|102000014|FG001|COMPLETED|Overall Study||24||
48680237|NCT03092479|102000013|FG000|NOT COMPLETED|Overall Study||7||
48680238|NCT03092479|102000014|FG001|NOT COMPLETED|Overall Study||2||
48680239|NCT02137070|102000015|FG000|STARTED|Overall Study||150||
48680240|NCT02137070|102000016|FG001|STARTED|Overall Study||47||
48680241|NCT02137070|102000015|FG000|COMPLETED|Overall Study||76||
48081511|NCT03129100|100521621|FG008|COMPLETED|Period 3 (Dose Escalation)||0||
48081512|NCT03129100|100521622|FG009|COMPLETED|Period 3 (Dose Escalation)||0||
48081513|NCT03129100|100521623|FG010|COMPLETED|Period 3 (Dose Escalation)||0||
48242512|NCT04117711|100911832|FG013|COMPLETED|Part B & C AT-007 40mg/kg||0||
48680242|NCT02137070|102000016|FG001|COMPLETED|Overall Study||29||
48680243|NCT02137070|102000015|FG000|NOT COMPLETED|Overall Study||74||
48680244|NCT02137070|102000016|FG001|NOT COMPLETED|Overall Study||18||
48680245|NCT01682356|102000017|FG000|STARTED|Overall Study||10||
48680246|NCT01682356|102000018|FG001|STARTED|Overall Study||7||
48680247|NCT01682356|102000017|FG000|COMPLETED|Overall Study||10||
48680248|NCT01682356|102000018|FG001|COMPLETED|Overall Study||7||
48680249|NCT01682356|102000017|FG000|NOT COMPLETED|Overall Study||0||
48680250|NCT01682356|102000018|FG001|NOT COMPLETED|Overall Study||0||
48242513|NCT04117711|100911833|FG014|COMPLETED|Part B & C AT-007 40mg/kg||0||
48680251|NCT04028648|102000019|FG000|STARTED|Overall Study||150||
48680252|NCT04028648|102000019|FG000|COMPLETED|Overall Study||150||
48680253|NCT04028648|102000019|FG000|NOT COMPLETED|Overall Study||0||
48680254|NCT00707993|102000020|FG000|STARTED|Overall Study||222||
48680255|NCT00707993|102000021|FG001|STARTED|Overall Study||219||
48680256|NCT00707993|102000020|FG000|COMPLETED|Overall Study||133||
48680257|NCT00707993|102000021|FG001|COMPLETED|Overall Study||125||
48680258|NCT00707993|102000020|FG000|NOT COMPLETED|Overall Study||89||
48242514|NCT04117711|100911834|FG015|COMPLETED|Part B & C AT-007 40mg/kg||0||
48242515|NCT04117711|100911835|FG016|COMPLETED|Part B & C AT-007 40mg/kg||0||
48242516|NCT04117711|100911836|FG017|COMPLETED|Part B & C AT-007 40mg/kg||0||
48680259|NCT00707993|102000021|FG001|NOT COMPLETED|Overall Study||94||
48680260|NCT01240863|102000022|FG000|STARTED|Open-label Titration Period||391||
48680261|NCT01240863|102000023|FG001|STARTED|Open-label Titration Period||0||
48680262|NCT01240863|102000024|FG002|STARTED|Open-label Titration Period||0||
48680263|NCT01240863|102000022|FG000|Safety Analysis Set|Open-label Titration Period||389||
48680264|NCT01240863|102000023|FG001|Safety Analysis Set|Open-label Titration Period||0||
48680265|NCT01240863|102000024|FG002|Safety Analysis Set|Open-label Titration Period||0||
48680266|NCT01240863|102000022|FG000|COMPLETED|Open-label Titration Period||294||
48680267|NCT01240863|102000023|FG001|COMPLETED|Open-label Titration Period||0||
48680268|NCT01240863|102000024|FG002|COMPLETED|Open-label Titration Period||0||
48680269|NCT01240863|102000022|FG000|NOT COMPLETED|Open-label Titration Period||97||
48242517|NCT04117711|100911837|FG018|COMPLETED|Part B & C AT-007 40mg/kg||0||
48242518|NCT04117711|100911838|FG019|COMPLETED|Part B & C AT-007 40mg/kg||0||
48242519|NCT04117711|100911839|FG020|COMPLETED|Part B & C AT-007 40mg/kg||0||
48242520|NCT04117711|100911840|FG021|COMPLETED|Part B & C AT-007 40mg/kg||0||
48242521|NCT04117711|100911819|FG000|NOT COMPLETED|Part B & C AT-007 40mg/kg||0||
48680270|NCT01240863|102000023|FG001|NOT COMPLETED|Open-label Titration Period||0||
48242522|NCT04117711|100911820|FG001|NOT COMPLETED|Part B & C AT-007 40mg/kg||0||
48242523|NCT04117711|100911821|FG002|NOT COMPLETED|Part B & C AT-007 40mg/kg||0||
48242524|NCT04117711|100911822|FG003|NOT COMPLETED|Part B & C AT-007 40mg/kg||0||
48242525|NCT04117711|100911823|FG004|NOT COMPLETED|Part B & C AT-007 40mg/kg||0||
48242526|NCT04117711|100911824|FG005|NOT COMPLETED|Part B & C AT-007 40mg/kg||0||
48242527|NCT04117711|100911825|FG006|NOT COMPLETED|Part B & C AT-007 40mg/kg||0||
48242528|NCT04117711|100911826|FG007|NOT COMPLETED|Part B & C AT-007 40mg/kg||0||
48242529|NCT04117711|100911827|FG008|NOT COMPLETED|Part B & C AT-007 40mg/kg||0||
48242530|NCT04117711|100911828|FG009|NOT COMPLETED|Part B & C AT-007 40mg/kg||2||
48242531|NCT04117711|100911829|FG010|NOT COMPLETED|Part B & C AT-007 40mg/kg||0||
48242532|NCT04117711|100911830|FG011|NOT COMPLETED|Part B & C AT-007 40mg/kg||0||
48242533|NCT04117711|100911831|FG012|NOT COMPLETED|Part B & C AT-007 40mg/kg||0||
48242534|NCT04117711|100911832|FG013|NOT COMPLETED|Part B & C AT-007 40mg/kg||0||
48242535|NCT04117711|100911833|FG014|NOT COMPLETED|Part B & C AT-007 40mg/kg||0||
48680271|NCT01240863|102000024|FG002|NOT COMPLETED|Open-label Titration Period||0||
48680272|NCT01240863|102000022|FG000|STARTED|Double-blind Treatment Period (12 Weeks)||0||
48680273|NCT01240863|102000023|FG001|STARTED|Double-blind Treatment Period (12 Weeks)||148||
48680274|NCT01240863|102000024|FG002|STARTED|Double-blind Treatment Period (12 Weeks)||146||
48680275|NCT01240863|102000022|FG000|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||0||
48680276|NCT01240863|102000023|FG001|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||147||
48680277|NCT01240863|102000024|FG002|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||146||
48680278|NCT01240863|102000022|FG000|COMPLETED|Double-blind Treatment Period (12 Weeks)||0||
48680279|NCT01240863|102000023|FG001|COMPLETED|Double-blind Treatment Period (12 Weeks)||102||
48680280|NCT01240863|102000024|FG002|COMPLETED|Double-blind Treatment Period (12 Weeks)||94||
48242536|NCT04117711|100911834|FG015|NOT COMPLETED|Part B & C AT-007 40mg/kg||0||
48242537|NCT04117711|100911835|FG016|NOT COMPLETED|Part B & C AT-007 40mg/kg||0||
48242538|NCT04117711|100911836|FG017|NOT COMPLETED|Part B & C AT-007 40mg/kg||0||
48242539|NCT04117711|100911837|FG018|NOT COMPLETED|Part B & C AT-007 40mg/kg||0||
48242540|NCT04117711|100911838|FG019|NOT COMPLETED|Part B & C AT-007 40mg/kg||0||
48242541|NCT04117711|100911839|FG020|NOT COMPLETED|Part B & C AT-007 40mg/kg||0||
48242542|NCT04117711|100911840|FG021|NOT COMPLETED|Part B & C AT-007 40mg/kg||0||
48680281|NCT01240863|102000022|FG000|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0||
48242543|NCT04117711|100911819|FG000|STARTED|Part B & C Placebo Comparator||0||
48242544|NCT04117711|100911820|FG001|STARTED|Part B & C Placebo Comparator||0||
48242545|NCT04117711|100911821|FG002|STARTED|Part B & C Placebo Comparator||0||
48242546|NCT04117711|100911822|FG003|STARTED|Part B & C Placebo Comparator||0||
48242547|NCT04117711|100911823|FG004|STARTED|Part B & C Placebo Comparator||0||
48242548|NCT04117711|100911824|FG005|STARTED|Part B & C Placebo Comparator||0||
48242549|NCT04117711|100911825|FG006|STARTED|Part B & C Placebo Comparator||0||
48242550|NCT04117711|100911826|FG007|STARTED|Part B & C Placebo Comparator||0||
48242551|NCT04117711|100911827|FG008|STARTED|Part B & C Placebo Comparator||0||
48242552|NCT04117711|100911828|FG009|STARTED|Part B & C Placebo Comparator||0||
48242553|NCT04117711|100911829|FG010|STARTED|Part B & C Placebo Comparator||8||
48242554|NCT04117711|100911830|FG011|STARTED|Part B & C Placebo Comparator||0||
48242555|NCT04117711|100911831|FG012|STARTED|Part B & C Placebo Comparator||0||
48242556|NCT04117711|100911832|FG013|STARTED|Part B & C Placebo Comparator||0||
48242557|NCT04117711|100911833|FG014|STARTED|Part B & C Placebo Comparator||0||
48242558|NCT04117711|100911834|FG015|STARTED|Part B & C Placebo Comparator||0||
48242559|NCT04117711|100911835|FG016|STARTED|Part B & C Placebo Comparator||0||
48242560|NCT04117711|100911836|FG017|STARTED|Part B & C Placebo Comparator||0||
48242561|NCT04117711|100911837|FG018|STARTED|Part B & C Placebo Comparator||0||
48242562|NCT04117711|100911838|FG019|STARTED|Part B & C Placebo Comparator||0||
48242563|NCT04117711|100911839|FG020|STARTED|Part B & C Placebo Comparator||0||
48242564|NCT04117711|100911840|FG021|STARTED|Part B & C Placebo Comparator||0||
48242565|NCT04117711|100911819|FG000|COMPLETED|Part B & C Placebo Comparator||0||
48242566|NCT04117711|100911820|FG001|COMPLETED|Part B & C Placebo Comparator||0||
48242567|NCT04117711|100911821|FG002|COMPLETED|Part B & C Placebo Comparator||0||
48242568|NCT04117711|100911822|FG003|COMPLETED|Part B & C Placebo Comparator||0||
48242569|NCT04117711|100911823|FG004|COMPLETED|Part B & C Placebo Comparator||0||
48680282|NCT01240863|102000023|FG001|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||46||
48680283|NCT01240863|102000024|FG002|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||52||
48680284|NCT04419467|102000025|FG000|STARTED|Overall Study||29||
48680285|NCT04419467|102000026|FG001|STARTED|Overall Study||29||
48680286|NCT04419467|102000027|FG002|STARTED|Overall Study||56||
48680287|NCT04419467|102000025|FG000|COMPLETED|Overall Study||27||
48680288|NCT04419467|102000026|FG001|COMPLETED|Overall Study||26||
48680289|NCT04419467|102000027|FG002|COMPLETED|Overall Study||47||
48680290|NCT04419467|102000025|FG000|NOT COMPLETED|Overall Study||2||
48680291|NCT04419467|102000026|FG001|NOT COMPLETED|Overall Study||3||
48680292|NCT04419467|102000027|FG002|NOT COMPLETED|Overall Study||9||
48680293|NCT02160288|102000028|FG000|STARTED|Overall Study||1||
48680294|NCT02160288|102000029|FG001|STARTED|Overall Study||0||
48680295|NCT02160288|102000028|FG000|COMPLETED|Overall Study||1||
48680296|NCT02160288|102000029|FG001|COMPLETED|Overall Study||0||
48680297|NCT02160288|102000028|FG000|NOT COMPLETED|Overall Study||0||
48680298|NCT02160288|102000029|FG001|NOT COMPLETED|Overall Study||0||
48680299|NCT00636181|102000030|FG000|STARTED|Overall Study||54||
48680300|NCT00636181|102000031|FG001|STARTED|Overall Study||53||
48680301|NCT00636181|102000032|FG002|STARTED|Overall Study||57||
48680302|NCT00636181|102000030|FG000|COMPLETED|Overall Study||46||
48680303|NCT00636181|102000031|FG001|COMPLETED|Overall Study||47||
48680304|NCT00636181|102000032|FG002|COMPLETED|Overall Study||47||
48680305|NCT00636181|102000030|FG000|NOT COMPLETED|Overall Study||8||
48680306|NCT00636181|102000031|FG001|NOT COMPLETED|Overall Study||6||
48680307|NCT00636181|102000032|FG002|NOT COMPLETED|Overall Study||10||
48680308|NCT02803203|102000033|FG000|STARTED|Overall Study||49||
48081514|NCT03129100|100521624|FG011|COMPLETED|Period 3 (Dose Escalation)||0||
48680309|NCT02803203|102000033|FG000|COMPLETED|Overall Study||0||
48680310|NCT02803203|102000033|FG000|NOT COMPLETED|Overall Study||49||
48680311|NCT02896257|102000034|FG000|STARTED|Providers||88||111
48680312|NCT02896257|102000035|FG001|STARTED|Providers||93||109
48242570|NCT04117711|100911824|FG005|COMPLETED|Part B & C Placebo Comparator||0||
48242571|NCT04117711|100911825|FG006|COMPLETED|Part B & C Placebo Comparator||0||
48242572|NCT04117711|100911826|FG007|COMPLETED|Part B & C Placebo Comparator||0||
48242573|NCT04117711|100911827|FG008|COMPLETED|Part B & C Placebo Comparator||0||
48242574|NCT04117711|100911828|FG009|COMPLETED|Part B & C Placebo Comparator||0||
48242575|NCT04117711|100911829|FG010|COMPLETED|Part B & C Placebo Comparator||8||
48680313|NCT02896257|102000034|FG000|PCPs Assigned to 1 Primary Care Team|Providers||68||68
48680314|NCT02896257|102000035|FG001|PCPs Assigned to 1 Primary Care Team|Providers||79||79
48680315|NCT02896257|102000034|FG000|PCPs Assigned to Two Primary Care Teams|Providers||18||36
48710655|NCT02961790|102077986|FG003|COMPLETED|Overall Study||20||
48680316|NCT02896257|102000035|FG001|PCPs Assigned to Two Primary Care Teams|Providers||12||24
48680317|NCT02896257|102000034|FG000|PCPs Assigned to 3 Primary Care Teams|Providers||1||3
48680318|NCT02896257|102000035|FG001|PCPs Assigned to 3 Primary Care Teams|Providers||2||6
48680319|NCT02896257|102000034|FG000|PCPs Assigned to Four Primary Care Teams|Providers||1||4
48680320|NCT02896257|102000035|FG001|PCPs Assigned to Four Primary Care Teams|Providers||0||0
48680321|NCT02896257|102000034|FG000|COMPLETED|Providers||67||76
48680322|NCT02896257|102000035|FG001|COMPLETED|Providers||65||72
48680323|NCT02896257|102000034|FG000|NOT COMPLETED|Providers||21||35
48680324|NCT02896257|102000035|FG001|NOT COMPLETED|Providers||28||37
48242576|NCT04117711|100911830|FG011|COMPLETED|Part B & C Placebo Comparator||0||
48242577|NCT04117711|100911831|FG012|COMPLETED|Part B & C Placebo Comparator||0||
48242578|NCT04117711|100911832|FG013|COMPLETED|Part B & C Placebo Comparator||0||
48242579|NCT04117711|100911833|FG014|COMPLETED|Part B & C Placebo Comparator||0||
48242580|NCT04117711|100911834|FG015|COMPLETED|Part B & C Placebo Comparator||0||
48242581|NCT04117711|100911835|FG016|COMPLETED|Part B & C Placebo Comparator||0||
48540433|NCT00428116|101658089|FG001|NOT COMPLETED|Overall Study||0||
48680325|NCT02896257|102000034|FG000|STARTED|Patients||344||111
48680326|NCT02896257|102000035|FG001|STARTED|Patients||342||109
48680327|NCT02896257|102000034|FG000|COMPLETED|Patients||281||76
48680328|NCT02896257|102000035|FG001|COMPLETED|Patients||269||72
48680329|NCT02896257|102000034|FG000|NOT COMPLETED|Patients||63||35
48680330|NCT02896257|102000035|FG001|NOT COMPLETED|Patients||73||37
48680331|NCT01657370|102000036|FG000|STARTED|Overall Study||33||
48680332|NCT01657370|102000037|FG001|STARTED|Overall Study||32||
48680333|NCT01657370|102000038|FG002|STARTED|Overall Study||32||
48680334|NCT01657370|102000039|FG003|STARTED|Overall Study||33||
48680335|NCT01657370|102000040|FG004|STARTED|Overall Study||34||
48680336|NCT01657370|102000041|FG005|STARTED|Overall Study||31||
48680337|NCT01657370|102000036|FG000|COMPLETED|Overall Study||27||
48680338|NCT01657370|102000037|FG001|COMPLETED|Overall Study||28||
48680339|NCT01657370|102000038|FG002|COMPLETED|Overall Study||25||
48680340|NCT01657370|102000039|FG003|COMPLETED|Overall Study||28||
48680341|NCT01657370|102000040|FG004|COMPLETED|Overall Study||27||
48680342|NCT01657370|102000041|FG005|COMPLETED|Overall Study||27||
48680343|NCT01657370|102000036|FG000|NOT COMPLETED|Overall Study||6||
48680344|NCT01657370|102000037|FG001|NOT COMPLETED|Overall Study||4||
48680345|NCT01657370|102000038|FG002|NOT COMPLETED|Overall Study||7||
48680346|NCT01657370|102000039|FG003|NOT COMPLETED|Overall Study||5||
48680347|NCT01657370|102000040|FG004|NOT COMPLETED|Overall Study||7||
48680348|NCT01657370|102000041|FG005|NOT COMPLETED|Overall Study||4||
48680349|NCT03134326|102000042|FG000|STARTED|Overall Study||21||
48242582|NCT04117711|100911836|FG017|COMPLETED|Part B & C Placebo Comparator||0||
48242583|NCT04117711|100911837|FG018|COMPLETED|Part B & C Placebo Comparator||0||
48242584|NCT04117711|100911838|FG019|COMPLETED|Part B & C Placebo Comparator||0||
48242585|NCT04117711|100911839|FG020|COMPLETED|Part B & C Placebo Comparator||0||
48242586|NCT04117711|100911840|FG021|COMPLETED|Part B & C Placebo Comparator||0||
48540434|NCT03300843|101658090|FG000|STARTED|Overall Study||1||
48540435|NCT03300843|101658090|FG000|COMPLETED|Overall Study||1||
48540436|NCT03300843|101658090|FG000|NOT COMPLETED|Overall Study||0||
48540437|NCT01753557|101658091|FG000|STARTED|Overall Study||35||
48540438|NCT01753557|101658092|FG001|STARTED|Overall Study||19||
48540439|NCT01753557|101658091|FG000|COMPLETED|Overall Study||35||
48540440|NCT01753557|101658092|FG001|COMPLETED|Overall Study||19||
48540441|NCT01753557|101658091|FG000|NOT COMPLETED|Overall Study||0||
48540442|NCT01753557|101658092|FG001|NOT COMPLETED|Overall Study||0||
48540443|NCT03597464|101658093|FG000|STARTED|Overall Study||116||
48540444|NCT03597464|101658094|FG001|STARTED|Overall Study||100||
48540445|NCT03597464|101658093|FG000|COMPLETED|Overall Study||101||
48540446|NCT03597464|101658094|FG001|COMPLETED|Overall Study||85||
48540447|NCT03597464|101658093|FG000|NOT COMPLETED|Overall Study||15||
48540448|NCT03597464|101658094|FG001|NOT COMPLETED|Overall Study||15||
48540449|NCT05422625|101658095|FG000|STARTED|Overall Study||2||
48540450|NCT05422625|101658096|FG001|STARTED|Overall Study||0||
48540451|NCT05422625|101658095|FG000|COMPLETED|Overall Study||1||
48540452|NCT05422625|101658096|FG001|COMPLETED|Overall Study||0||
48540453|NCT05422625|101658095|FG000|NOT COMPLETED|Overall Study||1||
48540454|NCT05422625|101658096|FG001|NOT COMPLETED|Overall Study||0||
48540455|NCT02437903|101658097|FG000|STARTED|Overall Study||30||
48540456|NCT02437903|101658097|FG000|COMPLETED|Overall Study||25||
48540457|NCT02437903|101658097|FG000|NOT COMPLETED|Overall Study||5||
48540458|NCT04648696|101658098|FG000|STARTED|Overall Study||4||
48680350|NCT03134326|102000042|FG000|COMPLETED|Overall Study||21||
48680351|NCT03134326|102000042|FG000|NOT COMPLETED|Overall Study||0||
48680352|NCT00512278|102000043|FG000|STARTED|Overall Study||73||
48680353|NCT00512278|102000044|FG001|STARTED|Overall Study||73||
48540459|NCT04648696|101658099|FG001|STARTED|Overall Study||3||
48540460|NCT04648696|101658098|FG000|COMPLETED|Overall Study||4||
48540461|NCT04648696|101658099|FG001|COMPLETED|Overall Study||3||
48540462|NCT04648696|101658098|FG000|NOT COMPLETED|Overall Study||0||
48540463|NCT04648696|101658099|FG001|NOT COMPLETED|Overall Study||0||
48540464|NCT02996487|101658100|FG000|STARTED|Overall Study||14||
48680354|NCT00512278|102000043|FG000|COMPLETED|Overall Study||45||
48680355|NCT00512278|102000044|FG001|COMPLETED|Overall Study||56||
48242587|NCT04117711|100911819|FG000|NOT COMPLETED|Part B & C Placebo Comparator||0||
48242588|NCT04117711|100911820|FG001|NOT COMPLETED|Part B & C Placebo Comparator||0||
48242589|NCT04117711|100911821|FG002|NOT COMPLETED|Part B & C Placebo Comparator||0||
48242590|NCT04117711|100911822|FG003|NOT COMPLETED|Part B & C Placebo Comparator||0||
48242591|NCT04117711|100911823|FG004|NOT COMPLETED|Part B & C Placebo Comparator||0||
48680356|NCT00512278|102000043|FG000|NOT COMPLETED|Overall Study||28||
48680357|NCT00512278|102000044|FG001|NOT COMPLETED|Overall Study||17||
48680358|NCT00881894|102000045|FG000|STARTED|Overall Study||26||
48680359|NCT00881894|102000046|FG001|STARTED|Overall Study||26||
48680360|NCT00881894|102000045|FG000|Pharmacokinetic Set (PKS)|Overall Study||23||
48680361|NCT00881894|102000046|FG001|Pharmacokinetic Set (PKS)|Overall Study||21||
48680362|NCT00881894|102000045|FG000|COMPLETED|Overall Study||25||
48680363|NCT00881894|102000046|FG001|COMPLETED|Overall Study||23||
48680364|NCT00881894|102000045|FG000|NOT COMPLETED|Overall Study||1||
48680365|NCT00881894|102000046|FG001|NOT COMPLETED|Overall Study||3||
48680366|NCT03091361|102000047|FG000|STARTED|Overall Study||30||
48680367|NCT03091361|102000047|FG000|COMPLETED|Overall Study||30||
48680368|NCT03091361|102000047|FG000|NOT COMPLETED|Overall Study||0||
48680369|NCT01114737|102000048|FG000|STARTED|Randomized Treatment Period||108||
48680370|NCT01114737|102000049|FG001|STARTED|Randomized Treatment Period||98||
48680371|NCT01114737|102000048|FG000|COMPLETED|Randomized Treatment Period||105||
48680372|NCT01114737|102000049|FG001|COMPLETED|Randomized Treatment Period||97||
48680373|NCT01114737|102000048|FG000|NOT COMPLETED|Randomized Treatment Period||3||
48680374|NCT01114737|102000049|FG001|NOT COMPLETED|Randomized Treatment Period||1||
48680375|NCT01114737|102000048|FG000|STARTED|Open-Label Treatment Period||105||
48680376|NCT01114737|102000049|FG001|STARTED|Open-Label Treatment Period||97||
48680377|NCT01114737|102000048|FG000|COMPLETED|Open-Label Treatment Period||100||
48680378|NCT01114737|102000049|FG001|COMPLETED|Open-Label Treatment Period||95||
48680379|NCT01114737|102000048|FG000|NOT COMPLETED|Open-Label Treatment Period||5||
48680380|NCT01114737|102000049|FG001|NOT COMPLETED|Open-Label Treatment Period||2||
48680381|NCT03594110|102000050|FG000|STARTED|Overall Study||3305||
48680382|NCT03594110|102000051|FG001|STARTED|Overall Study||3304||
48680383|NCT03594110|102000050|FG000|Treated|Overall Study||3305||
48680384|NCT03594110|102000051|FG001|Treated|Overall Study||3304||
48680385|NCT03594110|102000050|FG000|COMPLETED|Overall Study||2457|Patients who did not prematurely discontinue study treatment.|
48680386|NCT03594110|102000051|FG001|COMPLETED|Overall Study||2549|Patients who did not prematurely discontinue study treatment.|
48680387|NCT03594110|102000050|FG000|NOT COMPLETED|Overall Study||848||
48242592|NCT04117711|100911824|FG005|NOT COMPLETED|Part B & C Placebo Comparator||0||
48242593|NCT04117711|100911825|FG006|NOT COMPLETED|Part B & C Placebo Comparator||0||
48242594|NCT04117711|100911826|FG007|NOT COMPLETED|Part B & C Placebo Comparator||0||
48242595|NCT04117711|100911827|FG008|NOT COMPLETED|Part B & C Placebo Comparator||0||
48680388|NCT03594110|102000051|FG001|NOT COMPLETED|Overall Study||755||
48680389|NCT04373421|102000052|FG000|STARTED|Overall Study||30||
48680390|NCT04373421|102000053|FG001|STARTED|Overall Study||30||
48680391|NCT04373421|102000054|FG002|STARTED|Overall Study||30||
48680392|NCT04373421|102000052|FG000|COMPLETED|Overall Study||26||
48680393|NCT04373421|102000053|FG001|COMPLETED|Overall Study||26||
48680394|NCT04373421|102000054|FG002|COMPLETED|Overall Study||29||
48680395|NCT04373421|102000052|FG000|NOT COMPLETED|Overall Study||4||
48680396|NCT04373421|102000053|FG001|NOT COMPLETED|Overall Study||4||
48680397|NCT04373421|102000054|FG002|NOT COMPLETED|Overall Study||1||
48680398|NCT02431325|102000055|FG000|STARTED|Overall Study||17||
48680399|NCT02431325|102000056|FG001|STARTED|Overall Study||15||
48680400|NCT02431325|102000055|FG000|COMPLETED|Overall Study||9||
48680401|NCT02431325|102000056|FG001|COMPLETED|Overall Study||12||
48680402|NCT02431325|102000055|FG000|NOT COMPLETED|Overall Study||8||
48680403|NCT02431325|102000056|FG001|NOT COMPLETED|Overall Study||3||
48680404|NCT04344184|102000057|FG000|STARTED|Overall Study||22||
48680405|NCT04344184|102000058|FG001|STARTED|Overall Study||25||
48680406|NCT04344184|102000057|FG000|COMPLETED|Overall Study||22||
48680407|NCT04344184|102000058|FG001|COMPLETED|Overall Study||25||
48242596|NCT04117711|100911828|FG009|NOT COMPLETED|Part B & C Placebo Comparator||0||
48242597|NCT04117711|100911829|FG010|NOT COMPLETED|Part B & C Placebo Comparator||0||
48242598|NCT04117711|100911830|FG011|NOT COMPLETED|Part B & C Placebo Comparator||0||
48242599|NCT04117711|100911831|FG012|NOT COMPLETED|Part B & C Placebo Comparator||0||
48242600|NCT04117711|100911832|FG013|NOT COMPLETED|Part B & C Placebo Comparator||0||
48680408|NCT04344184|102000057|FG000|NOT COMPLETED|Overall Study||0||
48680409|NCT04344184|102000058|FG001|NOT COMPLETED|Overall Study||0||
48680410|NCT00100802|102000059|FG000|STARTED|Overall Study||118||
48680411|NCT00100802|102000059|FG000|COMPLETED|Overall Study||38||
48680412|NCT00100802|102000059|FG000|NOT COMPLETED|Overall Study||80||
48680413|NCT01979614|102000060|FG000|STARTED|Overall Study||30||
48680414|NCT01979614|102000061|FG001|STARTED|Overall Study||28||
48680415|NCT01979614|102000060|FG000|Safety Analysis Set|Overall Study||30||
48680416|NCT01979614|102000061|FG001|Safety Analysis Set|Overall Study||28||
48242601|NCT04117711|100911833|FG014|NOT COMPLETED|Part B & C Placebo Comparator||0||
48242602|NCT04117711|100911834|FG015|NOT COMPLETED|Part B & C Placebo Comparator||0||
48242603|NCT04117711|100911835|FG016|NOT COMPLETED|Part B & C Placebo Comparator||0||
48242604|NCT04117711|100911836|FG017|NOT COMPLETED|Part B & C Placebo Comparator||0||
48680417|NCT01979614|102000060|FG000|PK Analysis Set|Overall Study||30||
48680418|NCT01979614|102000061|FG001|PK Analysis Set|Overall Study||0||
48242605|NCT04117711|100911837|FG018|NOT COMPLETED|Part B & C Placebo Comparator||0||
48680419|NCT01979614|102000060|FG000|PD Analysis Set|Overall Study||25||
48680420|NCT01979614|102000061|FG001|PD Analysis Set|Overall Study||26||
48680421|NCT01979614|102000060|FG000|COMPLETED|Overall Study||29||
48680422|NCT01979614|102000061|FG001|COMPLETED|Overall Study||27||
48680423|NCT01979614|102000060|FG000|NOT COMPLETED|Overall Study||1||
48680424|NCT01979614|102000061|FG001|NOT COMPLETED|Overall Study||1||
48680425|NCT00501644|102000062|FG000|STARTED|Overall Study||59||
48680426|NCT00501644|102000062|FG000|COMPLETED|Overall Study||54||
48680427|NCT00501644|102000062|FG000|NOT COMPLETED|Overall Study||5||
48680428|NCT02382588|102000063|FG000|STARTED|Overall Study||4||
48680429|NCT02382588|102000064|FG001|STARTED|Overall Study||4||
48680430|NCT02382588|102000063|FG000|COMPLETED|Overall Study||4||
48680431|NCT02382588|102000064|FG001|COMPLETED|Overall Study||4||
48680432|NCT02382588|102000063|FG000|NOT COMPLETED|Overall Study||0||
48680433|NCT02382588|102000064|FG001|NOT COMPLETED|Overall Study||0||
48680434|NCT00783432|102000065|FG000|STARTED|Overall Study||430||
48242606|NCT04117711|100911838|FG019|NOT COMPLETED|Part B & C Placebo Comparator||0||
48680435|NCT00783432|102000066|FG001|STARTED|Overall Study||432||
48680436|NCT00783432|102000065|FG000|COMPLETED|Overall Study||345||
48680437|NCT00783432|102000066|FG001|COMPLETED|Overall Study||354||
48680438|NCT00783432|102000065|FG000|NOT COMPLETED|Overall Study||85||
48680439|NCT00783432|102000066|FG001|NOT COMPLETED|Overall Study||78||
48680440|NCT00696878|102000067|FG000|STARTED|Overall Study||682||
48680441|NCT00696878|102000067|FG000|COMPLETED|Overall Study||178||
48680442|NCT00696878|102000067|FG000|NOT COMPLETED|Overall Study||504||
48680443|NCT00318929|102000068|FG000|STARTED|Overall Study||14||
48242607|NCT04117711|100911839|FG020|NOT COMPLETED|Part B & C Placebo Comparator||0||
48242608|NCT04117711|100911840|FG021|NOT COMPLETED|Part B & C Placebo Comparator||0||
48242609|NCT04117711|100911819|FG000|STARTED|Part D Cohort 1||0||
48242610|NCT04117711|100911820|FG001|STARTED|Part D Cohort 1||0||
48242611|NCT04117711|100911821|FG002|STARTED|Part D Cohort 1||0||
48242612|NCT04117711|100911822|FG003|STARTED|Part D Cohort 1||0||
48242613|NCT04117711|100911823|FG004|STARTED|Part D Cohort 1||0||
48242614|NCT04117711|100911824|FG005|STARTED|Part D Cohort 1||0||
48242615|NCT04117711|100911825|FG006|STARTED|Part D Cohort 1||0||
48242616|NCT04117711|100911826|FG007|STARTED|Part D Cohort 1||0||
48242617|NCT04117711|100911827|FG008|STARTED|Part D Cohort 1||0||
48242618|NCT04117711|100911828|FG009|STARTED|Part D Cohort 1||0||
48242619|NCT04117711|100911829|FG010|STARTED|Part D Cohort 1||0||
48242620|NCT04117711|100911830|FG011|STARTED|Part D Cohort 1||3||
48242621|NCT04117711|100911831|FG012|STARTED|Part D Cohort 1||1||
48242622|NCT04117711|100911832|FG013|STARTED|Part D Cohort 1||1||
48242623|NCT04117711|100911833|FG014|STARTED|Part D Cohort 1||1||
48242624|NCT04117711|100911834|FG015|STARTED|Part D Cohort 1||0||
48242625|NCT04117711|100911835|FG016|STARTED|Part D Cohort 1||0||
48242626|NCT04117711|100911836|FG017|STARTED|Part D Cohort 1||0||
48242627|NCT04117711|100911837|FG018|STARTED|Part D Cohort 1||0||
48242628|NCT04117711|100911838|FG019|STARTED|Part D Cohort 1||0||
48242629|NCT04117711|100911839|FG020|STARTED|Part D Cohort 1||0||
48242630|NCT04117711|100911840|FG021|STARTED|Part D Cohort 1||0||
48242631|NCT04117711|100911819|FG000|COMPLETED|Part D Cohort 1||0||
48242632|NCT04117711|100911820|FG001|COMPLETED|Part D Cohort 1||0||
48242633|NCT04117711|100911821|FG002|COMPLETED|Part D Cohort 1||0||
48242634|NCT04117711|100911822|FG003|COMPLETED|Part D Cohort 1||0||
48242635|NCT04117711|100911823|FG004|COMPLETED|Part D Cohort 1||0||
48540465|NCT02996487|101658101|FG001|STARTED|Overall Study||13||
48540466|NCT02996487|101658102|FG002|STARTED|Overall Study||647||
48540467|NCT02996487|101658100|FG000|COMPLETED|Overall Study||11||
48540468|NCT02996487|101658101|FG001|COMPLETED|Overall Study||8||
48540469|NCT02996487|101658102|FG002|COMPLETED|Overall Study||647||
48540470|NCT02996487|101658100|FG000|NOT COMPLETED|Overall Study||3||
48540471|NCT02996487|101658101|FG001|NOT COMPLETED|Overall Study||5||
48540472|NCT02996487|101658102|FG002|NOT COMPLETED|Overall Study||0||
48540473|NCT03200912|101658103|FG000|STARTED|Overall Study||170||
48540474|NCT03200912|101658104|FG001|STARTED|Overall Study||169||
48540475|NCT03200912|101658105|FG002|STARTED|Overall Study||168||
48540476|NCT03200912|101658103|FG000|COMPLETED|Overall Study||166||
48540477|NCT03200912|101658104|FG001|COMPLETED|Overall Study||166||
48540478|NCT03200912|101658105|FG002|COMPLETED|Overall Study||164||
48540479|NCT03200912|101658103|FG000|NOT COMPLETED|Overall Study||4||
48540480|NCT03200912|101658104|FG001|NOT COMPLETED|Overall Study||3||
48540481|NCT03200912|101658105|FG002|NOT COMPLETED|Overall Study||4||
48540482|NCT03134092|101658106|FG000|STARTED|Overall Study||434||
48242636|NCT04117711|100911824|FG005|COMPLETED|Part D Cohort 1||0||
48242637|NCT04117711|100911825|FG006|COMPLETED|Part D Cohort 1||0||
48242638|NCT04117711|100911826|FG007|COMPLETED|Part D Cohort 1||0||
48242639|NCT04117711|100911827|FG008|COMPLETED|Part D Cohort 1||0||
48242640|NCT04117711|100911828|FG009|COMPLETED|Part D Cohort 1||0||
48242641|NCT04117711|100911829|FG010|COMPLETED|Part D Cohort 1||0||
48540483|NCT03134092|101658107|FG001|STARTED|Overall Study||435||
48540484|NCT03134092|101658108|FG002|STARTED|Overall Study||433||
48540485|NCT03134092|101658106|FG000|COMPLETED|Overall Study||434||
48540486|NCT03134092|101658107|FG001|COMPLETED|Overall Study||435||
48081515|NCT03129100|100521625|FG012|COMPLETED|Period 3 (Dose Escalation)||0||
48081516|NCT03129100|100521626|FG013|COMPLETED|Period 3 (Dose Escalation)||0||
48081517|NCT03129100|100521627|FG014|COMPLETED|Period 3 (Dose Escalation)||0||
48081518|NCT03129100|100521628|FG015|COMPLETED|Period 3 (Dose Escalation)||0||
48081519|NCT03129100|100521629|FG016|COMPLETED|Period 3 (Dose Escalation)||0||
48081520|NCT03129100|100521630|FG017|COMPLETED|Period 3 (Dose Escalation)||0||
48081521|NCT03129100|100521631|FG018|COMPLETED|Period 3 (Dose Escalation)||0||
48242642|NCT04117711|100911830|FG011|COMPLETED|Part D Cohort 1||3||
48242643|NCT04117711|100911831|FG012|COMPLETED|Part D Cohort 1||1||
48242644|NCT04117711|100911832|FG013|COMPLETED|Part D Cohort 1||1||
48242645|NCT04117711|100911833|FG014|COMPLETED|Part D Cohort 1||1||
48081522|NCT03129100|100521632|FG019|COMPLETED|Period 3 (Dose Escalation)||0||
48081523|NCT03129100|100521633|FG020|COMPLETED|Period 3 (Dose Escalation)||73||
48081524|NCT03129100|100521634|FG021|COMPLETED|Period 3 (Dose Escalation)||5||
48081525|NCT03129100|100521635|FG022|COMPLETED|Period 3 (Dose Escalation)||4||
48081526|NCT03129100|100521636|FG023|COMPLETED|Period 3 (Dose Escalation)||0||
48081527|NCT03129100|100521637|FG024|COMPLETED|Period 3 (Dose Escalation)||0||
48081528|NCT03129100|100521638|FG025|COMPLETED|Period 3 (Dose Escalation)||0||
48081529|NCT03129100|100521613|FG000|NOT COMPLETED|Period 3 (Dose Escalation)||0||
48081530|NCT03129100|100521614|FG001|NOT COMPLETED|Period 3 (Dose Escalation)||0||
48081531|NCT03129100|100521615|FG002|NOT COMPLETED|Period 3 (Dose Escalation)||0||
48081532|NCT03129100|100521616|FG003|NOT COMPLETED|Period 3 (Dose Escalation)||0||
48081533|NCT03129100|100521617|FG004|NOT COMPLETED|Period 3 (Dose Escalation)||0||
48081534|NCT03129100|100521618|FG005|NOT COMPLETED|Period 3 (Dose Escalation)||0||
48081535|NCT03129100|100521619|FG006|NOT COMPLETED|Period 3 (Dose Escalation)||0||
48081536|NCT03129100|100521620|FG007|NOT COMPLETED|Period 3 (Dose Escalation)||0||
48081537|NCT03129100|100521621|FG008|NOT COMPLETED|Period 3 (Dose Escalation)||0||
48081538|NCT03129100|100521622|FG009|NOT COMPLETED|Period 3 (Dose Escalation)||0||
48081539|NCT03129100|100521623|FG010|NOT COMPLETED|Period 3 (Dose Escalation)||0||
48081540|NCT03129100|100521624|FG011|NOT COMPLETED|Period 3 (Dose Escalation)||0||
48081541|NCT03129100|100521625|FG012|NOT COMPLETED|Period 3 (Dose Escalation)||0||
48081542|NCT03129100|100521626|FG013|NOT COMPLETED|Period 3 (Dose Escalation)||0||
48081543|NCT03129100|100521627|FG014|NOT COMPLETED|Period 3 (Dose Escalation)||0||
48081544|NCT03129100|100521628|FG015|NOT COMPLETED|Period 3 (Dose Escalation)||0||
48081545|NCT03129100|100521629|FG016|NOT COMPLETED|Period 3 (Dose Escalation)||0||
48081546|NCT03129100|100521630|FG017|NOT COMPLETED|Period 3 (Dose Escalation)||0||
48081547|NCT03129100|100521631|FG018|NOT COMPLETED|Period 3 (Dose Escalation)||0||
48081548|NCT03129100|100521632|FG019|NOT COMPLETED|Period 3 (Dose Escalation)||0||
48081549|NCT03129100|100521633|FG020|NOT COMPLETED|Period 3 (Dose Escalation)||4||
48081550|NCT03129100|100521634|FG021|NOT COMPLETED|Period 3 (Dose Escalation)||0||
48081551|NCT03129100|100521635|FG022|NOT COMPLETED|Period 3 (Dose Escalation)||0||
48081552|NCT03129100|100521636|FG023|NOT COMPLETED|Period 3 (Dose Escalation)||0||
48081553|NCT03129100|100521637|FG024|NOT COMPLETED|Period 3 (Dose Escalation)||0||
48081554|NCT03129100|100521638|FG025|NOT COMPLETED|Period 3 (Dose Escalation)||0||
48081555|NCT03129100|100521613|FG000|STARTED|Period 4 (Post Treatment Follow-up)||0||
48081556|NCT03129100|100521614|FG001|STARTED|Period 4 (Post Treatment Follow-up)||0||
48081557|NCT03129100|100521615|FG002|STARTED|Period 4 (Post Treatment Follow-up)||0||
48081558|NCT03129100|100521616|FG003|STARTED|Period 4 (Post Treatment Follow-up)||0||
48081559|NCT03129100|100521617|FG004|STARTED|Period 4 (Post Treatment Follow-up)||0||
48081560|NCT03129100|100521618|FG005|STARTED|Period 4 (Post Treatment Follow-up)||0||
48081561|NCT03129100|100521619|FG006|STARTED|Period 4 (Post Treatment Follow-up)||0||
48081562|NCT03129100|100521620|FG007|STARTED|Period 4 (Post Treatment Follow-up)||0||
48081563|NCT03129100|100521621|FG008|STARTED|Period 4 (Post Treatment Follow-up)||0||
48081564|NCT03129100|100521622|FG009|STARTED|Period 4 (Post Treatment Follow-up)||0||
48081565|NCT03129100|100521623|FG010|STARTED|Period 4 (Post Treatment Follow-up)||0||
48081566|NCT03129100|100521624|FG011|STARTED|Period 4 (Post Treatment Follow-up)||0||
48242646|NCT04117711|100911834|FG015|COMPLETED|Part D Cohort 1||0||
48242647|NCT04117711|100911835|FG016|COMPLETED|Part D Cohort 1||0||
48242648|NCT04117711|100911836|FG017|COMPLETED|Part D Cohort 1||0||
48242649|NCT04117711|100911837|FG018|COMPLETED|Part D Cohort 1||0||
48242650|NCT04117711|100911838|FG019|COMPLETED|Part D Cohort 1||0||
48242651|NCT04117711|100911839|FG020|COMPLETED|Part D Cohort 1||0||
48242652|NCT04117711|100911840|FG021|COMPLETED|Part D Cohort 1||0||
48242653|NCT04117711|100911819|FG000|NOT COMPLETED|Part D Cohort 1||0||
48242654|NCT04117711|100911820|FG001|NOT COMPLETED|Part D Cohort 1||0||
48242655|NCT04117711|100911821|FG002|NOT COMPLETED|Part D Cohort 1||0||
48242656|NCT04117711|100911822|FG003|NOT COMPLETED|Part D Cohort 1||0||
48242657|NCT04117711|100911823|FG004|NOT COMPLETED|Part D Cohort 1||0||
48242658|NCT04117711|100911824|FG005|NOT COMPLETED|Part D Cohort 1||0||
48242659|NCT04117711|100911825|FG006|NOT COMPLETED|Part D Cohort 1||0||
48242660|NCT04117711|100911826|FG007|NOT COMPLETED|Part D Cohort 1||0||
48242661|NCT04117711|100911827|FG008|NOT COMPLETED|Part D Cohort 1||0||
48242662|NCT04117711|100911828|FG009|NOT COMPLETED|Part D Cohort 1||0||
48242663|NCT04117711|100911829|FG010|NOT COMPLETED|Part D Cohort 1||0||
48242664|NCT04117711|100911830|FG011|NOT COMPLETED|Part D Cohort 1||0||
48242665|NCT04117711|100911831|FG012|NOT COMPLETED|Part D Cohort 1||0||
48242666|NCT04117711|100911832|FG013|NOT COMPLETED|Part D Cohort 1||0||
48242667|NCT04117711|100911833|FG014|NOT COMPLETED|Part D Cohort 1||0||
48242668|NCT04117711|100911834|FG015|NOT COMPLETED|Part D Cohort 1||0||
48242669|NCT04117711|100911835|FG016|NOT COMPLETED|Part D Cohort 1||0||
48242670|NCT04117711|100911836|FG017|NOT COMPLETED|Part D Cohort 1||0||
48242671|NCT04117711|100911837|FG018|NOT COMPLETED|Part D Cohort 1||0||
48242672|NCT04117711|100911838|FG019|NOT COMPLETED|Part D Cohort 1||0||
48242673|NCT04117711|100911839|FG020|NOT COMPLETED|Part D Cohort 1||0||
48242674|NCT04117711|100911840|FG021|NOT COMPLETED|Part D Cohort 1||0||
48242675|NCT04117711|100911819|FG000|STARTED|Part D Cohort 2||0||
48242676|NCT04117711|100911820|FG001|STARTED|Part D Cohort 2||0||
48242677|NCT04117711|100911821|FG002|STARTED|Part D Cohort 2||0||
48242678|NCT04117711|100911822|FG003|STARTED|Part D Cohort 2||0||
48242679|NCT04117711|100911823|FG004|STARTED|Part D Cohort 2||0||
48242680|NCT04117711|100911824|FG005|STARTED|Part D Cohort 2||0||
48242681|NCT04117711|100911825|FG006|STARTED|Part D Cohort 2||0||
48242682|NCT04117711|100911826|FG007|STARTED|Part D Cohort 2||0||
48242683|NCT04117711|100911827|FG008|STARTED|Part D Cohort 2||0||
48680444|NCT00318929|102000068|FG000|COMPLETED|Overall Study||14||
48680445|NCT00318929|102000068|FG000|NOT COMPLETED|Overall Study||0||
48680446|NCT03662282|102000069|FG000|STARTED|Overall Study||2||
48680447|NCT03662282|102000069|FG000|COMPLETED|Overall Study||2||
48680448|NCT03662282|102000069|FG000|NOT COMPLETED|Overall Study||0||
48680449|NCT03783780|102003029|FG000|STARTED|Overall Study||21||
48680450|NCT03783780|102003029|FG000|COMPLETED|Overall Study||20||
48680451|NCT03783780|102003029|FG000|NOT COMPLETED|Overall Study||1||
48680452|NCT02765399|102003030|FG000|STARTED|Overall Study||16||
48680453|NCT02765399|102003031|FG001|STARTED|Overall Study||7||
48680454|NCT02765399|102003030|FG000|COMPLETED|Overall Study||15||
48680455|NCT02765399|102003031|FG001|COMPLETED|Overall Study||7||
48680456|NCT02765399|102003030|FG000|NOT COMPLETED|Overall Study||1||
48680457|NCT02765399|102003031|FG001|NOT COMPLETED|Overall Study||0||
48680458|NCT02487966|102003032|FG000|STARTED|Overall Study||29||
48680459|NCT02487966|102003033|FG001|STARTED|Overall Study||28||
48680460|NCT02487966|102003034|FG002|STARTED|Overall Study||28||
48680461|NCT02487966|102003035|FG003|STARTED|Overall Study||27||
48680462|NCT02487966|102003032|FG000|COMPLETED|Overall Study||28||
48680463|NCT02487966|102003033|FG001|COMPLETED|Overall Study||24||
48680464|NCT02487966|102003034|FG002|COMPLETED|Overall Study||26||
48680465|NCT02487966|102003035|FG003|COMPLETED|Overall Study||25||
48680466|NCT02487966|102003032|FG000|NOT COMPLETED|Overall Study||1||
48680467|NCT02487966|102003033|FG001|NOT COMPLETED|Overall Study||4||
48680468|NCT02487966|102003034|FG002|NOT COMPLETED|Overall Study||2||
48680469|NCT02487966|102003035|FG003|NOT COMPLETED|Overall Study||2||
48680470|NCT00527618|102003036|FG000|STARTED|Week 1-12 (First Intervention)||16||
48680471|NCT00527618|102003037|FG001|STARTED|Week 1-12 (First Intervention)||18||
48680472|NCT00527618|102003036|FG000|COMPLETED|Week 1-12 (First Intervention)||13||
48680473|NCT00527618|102003037|FG001|COMPLETED|Week 1-12 (First Intervention)||16||
48680474|NCT00527618|102003036|FG000|NOT COMPLETED|Week 1-12 (First Intervention)||3||
48680475|NCT00527618|102003037|FG001|NOT COMPLETED|Week 1-12 (First Intervention)||2||
48680476|NCT00527618|102003036|FG000|STARTED|Week 13-14 (Washout)||13||
48242684|NCT04117711|100911828|FG009|STARTED|Part D Cohort 2||0||
48680477|NCT00527618|102003037|FG001|STARTED|Week 13-14 (Washout)||16||
48242685|NCT04117711|100911829|FG010|STARTED|Part D Cohort 2||0||
48242686|NCT04117711|100911830|FG011|STARTED|Part D Cohort 2||0||
48242687|NCT04117711|100911831|FG012|STARTED|Part D Cohort 2||0||
48242688|NCT04117711|100911832|FG013|STARTED|Part D Cohort 2||0||
48242689|NCT04117711|100911833|FG014|STARTED|Part D Cohort 2||0||
48680478|NCT00527618|102003036|FG000|COMPLETED|Week 13-14 (Washout)||12||
48680479|NCT00527618|102003037|FG001|COMPLETED|Week 13-14 (Washout)||16||
48680480|NCT00527618|102003036|FG000|NOT COMPLETED|Week 13-14 (Washout)||1||
48680481|NCT00527618|102003037|FG001|NOT COMPLETED|Week 13-14 (Washout)||0||
48710656|NCT02961790|102077983|FG000|NOT COMPLETED|Overall Study||15||
48680482|NCT00527618|102003036|FG000|STARTED|Week 15-18 (Second Intervention)||12||
48242690|NCT04117711|100911834|FG015|STARTED|Part D Cohort 2||3||
48242691|NCT04117711|100911835|FG016|STARTED|Part D Cohort 2||1||
48242692|NCT04117711|100911836|FG017|STARTED|Part D Cohort 2||0||
48242693|NCT04117711|100911837|FG018|STARTED|Part D Cohort 2||0||
48242694|NCT04117711|100911838|FG019|STARTED|Part D Cohort 2||0||
48680483|NCT00527618|102003037|FG001|STARTED|Week 15-18 (Second Intervention)||16||
48680484|NCT00527618|102003036|FG000|COMPLETED|Week 15-18 (Second Intervention)||12||
48680485|NCT00527618|102003037|FG001|COMPLETED|Week 15-18 (Second Intervention)||13||
48680486|NCT00527618|102003036|FG000|NOT COMPLETED|Week 15-18 (Second Intervention)||0||
48680487|NCT00527618|102003037|FG001|NOT COMPLETED|Week 15-18 (Second Intervention)||3||
48680488|NCT02639247|102003038|FG000|STARTED|Overall Study||182||
48680489|NCT02639247|102003039|FG001|STARTED|Overall Study||151||
48680490|NCT02639247|102003038|FG000|COMPLETED|Overall Study||177||
48680491|NCT02639247|102003039|FG001|COMPLETED|Overall Study||149||
48680492|NCT02639247|102003038|FG000|NOT COMPLETED|Overall Study||5||
48680493|NCT02639247|102003039|FG001|NOT COMPLETED|Overall Study||2||
48680494|NCT03988426|102003040|FG000|STARTED|Overall Study||25||
48680495|NCT03988426|102003040|FG000|COMPLETED|Overall Study||24||
48680496|NCT03988426|102003040|FG000|NOT COMPLETED|Overall Study||1||
48680497|NCT03745768|102003041|FG000|STARTED|Overall Study||10||
48680498|NCT03745768|102003042|FG001|STARTED|Overall Study||9||
48680499|NCT03745768|102003041|FG000|COMPLETED|Overall Study||8||
48680500|NCT03745768|102003042|FG001|COMPLETED|Overall Study||9||
48680501|NCT03745768|102003041|FG000|NOT COMPLETED|Overall Study||2||
48680502|NCT03745768|102003042|FG001|NOT COMPLETED|Overall Study||0||
48680503|NCT00976716|102003043|FG000|STARTED|Overall Study||80||
48680504|NCT00976716|102003043|FG000|COMPLETED|Overall Study||79||
48680505|NCT00976716|102003043|FG000|NOT COMPLETED|Overall Study||1||
48680506|NCT00641108|102003044|FG000|STARTED|Overall Study||0||
48680507|NCT00641108|102003045|FG001|STARTED|Overall Study||0||
48680508|NCT00641108|102003044|FG000|COMPLETED|Overall Study||0||
48680509|NCT00641108|102003045|FG001|COMPLETED|Overall Study||0||
48680510|NCT00641108|102003044|FG000|NOT COMPLETED|Overall Study||0||
48680511|NCT00641108|102003045|FG001|NOT COMPLETED|Overall Study||0||
48680512|NCT00766116|102003046|FG000|STARTED|Overall Study||50||
48680513|NCT00766116|102003046|FG000|COMPLETED|Overall Study||50||
48680514|NCT00766116|102003046|FG000|NOT COMPLETED|Overall Study||0||
48680515|NCT01349673|102003047|FG000|STARTED|Overall Study||114||
48680516|NCT01349673|102003047|FG000|Participants Entered Cycle 1|Overall Study||114||
48680517|NCT01349673|102003047|FG000|Participants Entered Cycle 2|Overall Study||65||
48680518|NCT01349673|102003047|FG000|Participants Entered Cycle 3|Overall Study||41||
48680519|NCT01349673|102003047|FG000|Participants Entered Cycle 4|Overall Study||22||
48680520|NCT01349673|102003047|FG000|Participants Entered Cycle 5|Overall Study||12||
48680521|NCT01349673|102003047|FG000|Participants Entered Cycle 6|Overall Study||5||
48680522|NCT01349673|102003047|FG000|Participants Entered Cycle 7|Overall Study||3||
48680523|NCT01349673|102003047|FG000|Participants Entered Cycle 8|Overall Study||1||
48680524|NCT01349673|102003047|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||114||
48680525|NCT01349673|102003047|FG000|COMPLETED|Overall Study||0||
48680526|NCT01349673|102003047|FG000|NOT COMPLETED|Overall Study||114||
48680527|NCT00846846|102003048|FG000|STARTED|Overall Study||1018||
48242695|NCT04117711|100911839|FG020|STARTED|Part D Cohort 2||0||
48242696|NCT04117711|100911840|FG021|STARTED|Part D Cohort 2||0||
48680528|NCT00846846|102003048|FG000|COMPLETED|Overall Study||943||
48680529|NCT00846846|102003048|FG000|NOT COMPLETED|Overall Study||75||
48242697|NCT04117711|100911819|FG000|COMPLETED|Part D Cohort 2||0||
48242698|NCT04117711|100911820|FG001|COMPLETED|Part D Cohort 2||0||
48242699|NCT04117711|100911821|FG002|COMPLETED|Part D Cohort 2||0||
48242700|NCT04117711|100911822|FG003|COMPLETED|Part D Cohort 2||0||
48242701|NCT04117711|100911823|FG004|COMPLETED|Part D Cohort 2||0||
48242702|NCT04117711|100911824|FG005|COMPLETED|Part D Cohort 2||0||
48242703|NCT04117711|100911825|FG006|COMPLETED|Part D Cohort 2||0||
48242704|NCT04117711|100911826|FG007|COMPLETED|Part D Cohort 2||0||
48242705|NCT04117711|100911827|FG008|COMPLETED|Part D Cohort 2||0||
48242706|NCT04117711|100911828|FG009|COMPLETED|Part D Cohort 2||0||
48242707|NCT04117711|100911829|FG010|COMPLETED|Part D Cohort 2||0||
48242708|NCT04117711|100911830|FG011|COMPLETED|Part D Cohort 2||0||
48242709|NCT04117711|100911831|FG012|COMPLETED|Part D Cohort 2||0||
48242710|NCT04117711|100911832|FG013|COMPLETED|Part D Cohort 2||0||
48242711|NCT04117711|100911833|FG014|COMPLETED|Part D Cohort 2||0||
48242712|NCT04117711|100911834|FG015|COMPLETED|Part D Cohort 2||3||
48242713|NCT04117711|100911835|FG016|COMPLETED|Part D Cohort 2||1||
48242714|NCT04117711|100911836|FG017|COMPLETED|Part D Cohort 2||0||
48242715|NCT04117711|100911837|FG018|COMPLETED|Part D Cohort 2||0||
48242716|NCT04117711|100911838|FG019|COMPLETED|Part D Cohort 2||0||
48242717|NCT04117711|100911839|FG020|COMPLETED|Part D Cohort 2||0||
48242718|NCT04117711|100911840|FG021|COMPLETED|Part D Cohort 2||0||
48242719|NCT04117711|100911819|FG000|NOT COMPLETED|Part D Cohort 2||0||
48242720|NCT04117711|100911820|FG001|NOT COMPLETED|Part D Cohort 2||0||
48242721|NCT04117711|100911821|FG002|NOT COMPLETED|Part D Cohort 2||0||
48242722|NCT04117711|100911822|FG003|NOT COMPLETED|Part D Cohort 2||0||
48242723|NCT04117711|100911823|FG004|NOT COMPLETED|Part D Cohort 2||0||
48242724|NCT04117711|100911824|FG005|NOT COMPLETED|Part D Cohort 2||0||
48242725|NCT04117711|100911825|FG006|NOT COMPLETED|Part D Cohort 2||0||
48242726|NCT04117711|100911826|FG007|NOT COMPLETED|Part D Cohort 2||0||
48242727|NCT04117711|100911827|FG008|NOT COMPLETED|Part D Cohort 2||0||
48242728|NCT04117711|100911828|FG009|NOT COMPLETED|Part D Cohort 2||0||
48242729|NCT04117711|100911829|FG010|NOT COMPLETED|Part D Cohort 2||0||
48242730|NCT04117711|100911830|FG011|NOT COMPLETED|Part D Cohort 2||0||
48242731|NCT04117711|100911831|FG012|NOT COMPLETED|Part D Cohort 2||0||
48242732|NCT04117711|100911832|FG013|NOT COMPLETED|Part D Cohort 2||0||
48242733|NCT04117711|100911833|FG014|NOT COMPLETED|Part D Cohort 2||0||
48242734|NCT04117711|100911834|FG015|NOT COMPLETED|Part D Cohort 2||0||
48242735|NCT04117711|100911835|FG016|NOT COMPLETED|Part D Cohort 2||0||
48242736|NCT04117711|100911836|FG017|NOT COMPLETED|Part D Cohort 2||0||
48242737|NCT04117711|100911837|FG018|NOT COMPLETED|Part D Cohort 2||0||
48242738|NCT04117711|100911838|FG019|NOT COMPLETED|Part D Cohort 2||0||
48242739|NCT04117711|100911839|FG020|NOT COMPLETED|Part D Cohort 2||0||
48242740|NCT04117711|100911840|FG021|NOT COMPLETED|Part D Cohort 2||0||
48242741|NCT04117711|100911819|FG000|STARTED|Part D Cohort 3||0||
48242742|NCT04117711|100911820|FG001|STARTED|Part D Cohort 3||0||
48242743|NCT04117711|100911821|FG002|STARTED|Part D Cohort 3||0||
48242744|NCT04117711|100911822|FG003|STARTED|Part D Cohort 3||0||
48242745|NCT04117711|100911823|FG004|STARTED|Part D Cohort 3||0||
48242746|NCT04117711|100911824|FG005|STARTED|Part D Cohort 3||0||
48242747|NCT04117711|100911825|FG006|STARTED|Part D Cohort 3||0||
48242748|NCT04117711|100911826|FG007|STARTED|Part D Cohort 3||0||
48242749|NCT04117711|100911827|FG008|STARTED|Part D Cohort 3||0||
48242750|NCT04117711|100911828|FG009|STARTED|Part D Cohort 3||0||
48242751|NCT04117711|100911829|FG010|STARTED|Part D Cohort 3||0||
48242752|NCT04117711|100911830|FG011|STARTED|Part D Cohort 3||0||
48242753|NCT04117711|100911831|FG012|STARTED|Part D Cohort 3||0||
48242754|NCT04117711|100911832|FG013|STARTED|Part D Cohort 3||0||
48242755|NCT04117711|100911833|FG014|STARTED|Part D Cohort 3||0||
48242756|NCT04117711|100911834|FG015|STARTED|Part D Cohort 3||0||
48242757|NCT04117711|100911835|FG016|STARTED|Part D Cohort 3||0||
48242758|NCT04117711|100911836|FG017|STARTED|Part D Cohort 3||1||
48242759|NCT04117711|100911837|FG018|STARTED|Part D Cohort 3||0||
48242760|NCT04117711|100911838|FG019|STARTED|Part D Cohort 3||0||
48242761|NCT04117711|100911839|FG020|STARTED|Part D Cohort 3||0||
48242762|NCT04117711|100911840|FG021|STARTED|Part D Cohort 3||0||
48242763|NCT04117711|100911819|FG000|COMPLETED|Part D Cohort 3||0||
48242764|NCT04117711|100911820|FG001|COMPLETED|Part D Cohort 3||0||
48242765|NCT04117711|100911821|FG002|COMPLETED|Part D Cohort 3||0||
48081567|NCT03129100|100521625|FG012|STARTED|Period 4 (Post Treatment Follow-up)||0||
48081568|NCT03129100|100521626|FG013|STARTED|Period 4 (Post Treatment Follow-up)||0||
48081569|NCT03129100|100521627|FG014|STARTED|Period 4 (Post Treatment Follow-up)||0||
48081570|NCT03129100|100521628|FG015|STARTED|Period 4 (Post Treatment Follow-up)||0||
48081571|NCT03129100|100521629|FG016|STARTED|Period 4 (Post Treatment Follow-up)||0||
48242766|NCT04117711|100911822|FG003|COMPLETED|Part D Cohort 3||0||
48242767|NCT04117711|100911823|FG004|COMPLETED|Part D Cohort 3||0||
48242768|NCT04117711|100911824|FG005|COMPLETED|Part D Cohort 3||0||
48242769|NCT04117711|100911825|FG006|COMPLETED|Part D Cohort 3||0||
48242770|NCT04117711|100911826|FG007|COMPLETED|Part D Cohort 3||0||
48242771|NCT04117711|100911827|FG008|COMPLETED|Part D Cohort 3||0||
48242772|NCT04117711|100911828|FG009|COMPLETED|Part D Cohort 3||0||
48242773|NCT04117711|100911829|FG010|COMPLETED|Part D Cohort 3||0||
48242774|NCT04117711|100911830|FG011|COMPLETED|Part D Cohort 3||0||
48242775|NCT04117711|100911831|FG012|COMPLETED|Part D Cohort 3||0||
48242776|NCT04117711|100911832|FG013|COMPLETED|Part D Cohort 3||0||
48242777|NCT04117711|100911833|FG014|COMPLETED|Part D Cohort 3||0||
48242778|NCT04117711|100911834|FG015|COMPLETED|Part D Cohort 3||0||
48242779|NCT04117711|100911835|FG016|COMPLETED|Part D Cohort 3||0||
48242780|NCT04117711|100911836|FG017|COMPLETED|Part D Cohort 3||1||
48242781|NCT04117711|100911837|FG018|COMPLETED|Part D Cohort 3||0||
48242782|NCT04117711|100911838|FG019|COMPLETED|Part D Cohort 3||0||
48242783|NCT04117711|100911839|FG020|COMPLETED|Part D Cohort 3||0||
48242784|NCT04117711|100911840|FG021|COMPLETED|Part D Cohort 3||0||
48242785|NCT04117711|100911819|FG000|NOT COMPLETED|Part D Cohort 3||0||
48242786|NCT04117711|100911820|FG001|NOT COMPLETED|Part D Cohort 3||0||
48242787|NCT04117711|100911821|FG002|NOT COMPLETED|Part D Cohort 3||0||
48242788|NCT04117711|100911822|FG003|NOT COMPLETED|Part D Cohort 3||0||
48242789|NCT04117711|100911823|FG004|NOT COMPLETED|Part D Cohort 3||0||
48242790|NCT04117711|100911824|FG005|NOT COMPLETED|Part D Cohort 3||0||
48242791|NCT04117711|100911825|FG006|NOT COMPLETED|Part D Cohort 3||0||
48242792|NCT04117711|100911826|FG007|NOT COMPLETED|Part D Cohort 3||0||
48242793|NCT04117711|100911827|FG008|NOT COMPLETED|Part D Cohort 3||0||
48242794|NCT04117711|100911828|FG009|NOT COMPLETED|Part D Cohort 3||0||
48242795|NCT04117711|100911829|FG010|NOT COMPLETED|Part D Cohort 3||0||
48242796|NCT04117711|100911830|FG011|NOT COMPLETED|Part D Cohort 3||0||
48242797|NCT04117711|100911831|FG012|NOT COMPLETED|Part D Cohort 3||0||
48680530|NCT00991809|102003049|FG000|STARTED|Overall Study||12||
48680531|NCT00991809|102003050|FG001|STARTED|Overall Study||10||
48680532|NCT00991809|102003049|FG000|COMPLETED|Overall Study||8||
48680533|NCT00991809|102003050|FG001|COMPLETED|Overall Study||4||
48680534|NCT00991809|102003049|FG000|NOT COMPLETED|Overall Study||4||
48680535|NCT00991809|102003050|FG001|NOT COMPLETED|Overall Study||6||
48680536|NCT01392573|102003051|FG000|STARTED|Overall Study||207||
48680537|NCT01392573|102003052|FG001|STARTED|Overall Study||206||
48680538|NCT01392573|102003051|FG000|Exposed|Overall Study||207||
48680539|NCT01392573|102003052|FG001|Exposed|Overall Study||206||
48680540|NCT01392573|102003051|FG000|COMPLETED|Overall Study||175||
48680541|NCT01392573|102003052|FG001|COMPLETED|Overall Study||171||
48680542|NCT01392573|102003051|FG000|NOT COMPLETED|Overall Study||32||
48680543|NCT01392573|102003052|FG001|NOT COMPLETED|Overall Study||35||
48680544|NCT02197572|102003053|FG000|STARTED|Overall Study||44||
48680545|NCT02197572|102003053|FG000|COMPLETED|Overall Study||0||
48680546|NCT02197572|102003053|FG000|NOT COMPLETED|Overall Study||44||
48680547|NCT00325143|102003054|FG000|STARTED|Overall Study||702||
48680548|NCT00325143|102003054|FG000|COMPLETED|Overall Study||676||
48680549|NCT00325143|102003054|FG000|NOT COMPLETED|Overall Study||26||
48680550|NCT02579811|102003055|FG000|STARTED|Overall Study||40||
48680551|NCT02579811|102003055|FG000|COMPLETED|Overall Study||40||
48680552|NCT02579811|102003055|FG000|NOT COMPLETED|Overall Study||0||
48242798|NCT04117711|100911832|FG013|NOT COMPLETED|Part D Cohort 3||0||
48242799|NCT04117711|100911833|FG014|NOT COMPLETED|Part D Cohort 3||0||
48680553|NCT00272792|102003056|FG000|STARTED|Part 1: Responsiveness||90||
48680554|NCT00272792|102003057|FG001|STARTED|Part 1: Responsiveness||0||
48680555|NCT00272792|102003056|FG000|COMPLETED|Part 1: Responsiveness||89||
48242800|NCT04117711|100911834|FG015|NOT COMPLETED|Part D Cohort 3||0||
48242801|NCT04117711|100911835|FG016|NOT COMPLETED|Part D Cohort 3||0||
48242802|NCT04117711|100911836|FG017|NOT COMPLETED|Part D Cohort 3||0||
48680556|NCT00272792|102003057|FG001|COMPLETED|Part 1: Responsiveness||0||
48680557|NCT00272792|102003056|FG000|NOT COMPLETED|Part 1: Responsiveness||1||
48242803|NCT04117711|100911837|FG018|NOT COMPLETED|Part D Cohort 3||0||
48242804|NCT04117711|100911838|FG019|NOT COMPLETED|Part D Cohort 3||0||
48680558|NCT00272792|102003057|FG001|NOT COMPLETED|Part 1: Responsiveness||0||
48680559|NCT00272792|102003056|FG000|STARTED|Part 2: Blinded, Placebo Control Period||33||
48680560|NCT00272792|102003057|FG001|STARTED|Part 2: Blinded, Placebo Control Period||12||
48680561|NCT00272792|102003056|FG000|COMPLETED|Part 2: Blinded, Placebo Control Period||32||
48242805|NCT04117711|100911839|FG020|NOT COMPLETED|Part D Cohort 3||0||
48242806|NCT04117711|100911840|FG021|NOT COMPLETED|Part D Cohort 3||0||
48242807|NCT04117711|100911819|FG000|STARTED|Part D Placebo Comparator||0||
48242808|NCT04117711|100911820|FG001|STARTED|Part D Placebo Comparator||0||
48242809|NCT04117711|100911821|FG002|STARTED|Part D Placebo Comparator||0||
48242810|NCT04117711|100911822|FG003|STARTED|Part D Placebo Comparator||0||
48242811|NCT04117711|100911823|FG004|STARTED|Part D Placebo Comparator||0||
48680562|NCT00272792|102003057|FG001|COMPLETED|Part 2: Blinded, Placebo Control Period||9||
48680563|NCT00272792|102003056|FG000|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||1||
48680564|NCT00272792|102003057|FG001|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||3||
48680565|NCT00901225|102003058|FG000|STARTED|Overall Study||21||
48680566|NCT00901225|102003058|FG000|COMPLETED|Overall Study||20||
48680567|NCT00901225|102003058|FG000|NOT COMPLETED|Overall Study||1||
48680568|NCT04067492|102003059|FG000|STARTED|Overall Study||15||
48680569|NCT04067492|102003060|FG001|STARTED|Overall Study||6||
48680570|NCT04067492|102003061|FG002|STARTED|Overall Study||6||
48680571|NCT04067492|102003062|FG003|STARTED|Overall Study||6||
48680572|NCT04067492|102003063|FG004|STARTED|Overall Study||5||
48680573|NCT04067492|102003064|FG005|STARTED|Overall Study||9||
48680574|NCT04067492|102003059|FG000|COMPLETED|Overall Study||15||
48680575|NCT04067492|102003060|FG001|COMPLETED|Overall Study||5||
48680576|NCT04067492|102003061|FG002|COMPLETED|Overall Study||6||
48680577|NCT04067492|102003062|FG003|COMPLETED|Overall Study||5||
48680578|NCT04067492|102003063|FG004|COMPLETED|Overall Study||5||
48680579|NCT04067492|102003064|FG005|COMPLETED|Overall Study||8||
48680580|NCT04067492|102003059|FG000|NOT COMPLETED|Overall Study||0||
48680581|NCT04067492|102003060|FG001|NOT COMPLETED|Overall Study||1||
48680582|NCT04067492|102003061|FG002|NOT COMPLETED|Overall Study||0||
48680583|NCT04067492|102003062|FG003|NOT COMPLETED|Overall Study||1||
48680584|NCT04067492|102003063|FG004|NOT COMPLETED|Overall Study||0||
48680585|NCT04067492|102003064|FG005|NOT COMPLETED|Overall Study||1||
48680586|NCT04792190|102003065|FG000|STARTED|Overall Study||12||
48680587|NCT04792190|102003066|FG001|STARTED|Overall Study||13||
48680588|NCT04792190|102003065|FG000|COMPLETED|Overall Study||12||
48680589|NCT04792190|102003066|FG001|COMPLETED|Overall Study||13||
48680590|NCT04792190|102003065|FG000|NOT COMPLETED|Overall Study||0||
48680591|NCT04792190|102003066|FG001|NOT COMPLETED|Overall Study||0||
48680592|NCT01152307|102003067|FG000|STARTED|Overall Study||191||
48680593|NCT01152307|102003068|FG001|STARTED|Overall Study||214||
48680594|NCT01152307|102003067|FG000|COMPLETED|Overall Study||191||
48680595|NCT01152307|102003068|FG001|COMPLETED|Overall Study||214||
48680596|NCT01152307|102003067|FG000|NOT COMPLETED|Overall Study||0||
48680597|NCT01152307|102003068|FG001|NOT COMPLETED|Overall Study||0||
48680598|NCT00959907|102003069|FG000|STARTED|Overall Study||30||
48680599|NCT00959907|102003070|FG001|STARTED|Overall Study||29||
48680600|NCT00959907|102003069|FG000|COMPLETED|Overall Study||27||
48680601|NCT00959907|102003070|FG001|COMPLETED|Overall Study||28||
48242812|NCT04117711|100911824|FG005|STARTED|Part D Placebo Comparator||0||
48242813|NCT04117711|100911825|FG006|STARTED|Part D Placebo Comparator||0||
48242814|NCT04117711|100911826|FG007|STARTED|Part D Placebo Comparator||0||
48242815|NCT04117711|100911827|FG008|STARTED|Part D Placebo Comparator||0||
48242816|NCT04117711|100911828|FG009|STARTED|Part D Placebo Comparator||0||
48680602|NCT00959907|102003069|FG000|NOT COMPLETED|Overall Study||3||
48680603|NCT00959907|102003070|FG001|NOT COMPLETED|Overall Study||1||
48680604|NCT01870869|102003071|FG000|STARTED|Overall Study||288||
48680605|NCT01870869|102003072|FG001|STARTED|Overall Study||206||
48680606|NCT01870869|102003073|FG002|STARTED|Overall Study||1222||
48242817|NCT04117711|100911829|FG010|STARTED|Part D Placebo Comparator||0||
48680607|NCT01870869|102003074|FG003|STARTED|Overall Study||235||
48680608|NCT01870869|102003071|FG000|COMPLETED|Overall Study||260||
48242818|NCT04117711|100911830|FG011|STARTED|Part D Placebo Comparator||0||
48242819|NCT04117711|100911831|FG012|STARTED|Part D Placebo Comparator||0||
48242820|NCT04117711|100911832|FG013|STARTED|Part D Placebo Comparator||0||
48242821|NCT04117711|100911833|FG014|STARTED|Part D Placebo Comparator||0||
48242822|NCT04117711|100911834|FG015|STARTED|Part D Placebo Comparator||0||
48242823|NCT04117711|100911835|FG016|STARTED|Part D Placebo Comparator||0||
48242824|NCT04117711|100911836|FG017|STARTED|Part D Placebo Comparator||0||
48242825|NCT04117711|100911837|FG018|STARTED|Part D Placebo Comparator||4||
48242826|NCT04117711|100911838|FG019|STARTED|Part D Placebo Comparator||0||
48242827|NCT04117711|100911839|FG020|STARTED|Part D Placebo Comparator||0||
48242828|NCT04117711|100911840|FG021|STARTED|Part D Placebo Comparator||0||
48242829|NCT04117711|100911819|FG000|COMPLETED|Part D Placebo Comparator||0||
48242830|NCT04117711|100911820|FG001|COMPLETED|Part D Placebo Comparator||0||
48242831|NCT04117711|100911821|FG002|COMPLETED|Part D Placebo Comparator||0||
48242832|NCT04117711|100911822|FG003|COMPLETED|Part D Placebo Comparator||0||
48242833|NCT04117711|100911823|FG004|COMPLETED|Part D Placebo Comparator||0||
48242834|NCT04117711|100911824|FG005|COMPLETED|Part D Placebo Comparator||0||
48242835|NCT04117711|100911825|FG006|COMPLETED|Part D Placebo Comparator||0||
48242836|NCT04117711|100911826|FG007|COMPLETED|Part D Placebo Comparator||0||
48242837|NCT04117711|100911827|FG008|COMPLETED|Part D Placebo Comparator||0||
48242838|NCT04117711|100911828|FG009|COMPLETED|Part D Placebo Comparator||0||
48242839|NCT04117711|100911829|FG010|COMPLETED|Part D Placebo Comparator||0||
48242840|NCT04117711|100911830|FG011|COMPLETED|Part D Placebo Comparator||0||
48242841|NCT04117711|100911831|FG012|COMPLETED|Part D Placebo Comparator||0||
48242842|NCT04117711|100911832|FG013|COMPLETED|Part D Placebo Comparator||0||
48242843|NCT04117711|100911833|FG014|COMPLETED|Part D Placebo Comparator||0||
48680609|NCT01870869|102003072|FG001|COMPLETED|Overall Study||192||
48680610|NCT01870869|102003073|FG002|COMPLETED|Overall Study||1092||
48680611|NCT01870869|102003074|FG003|COMPLETED|Overall Study||205||
48680612|NCT01870869|102003071|FG000|NOT COMPLETED|Overall Study||28||
48680613|NCT01870869|102003072|FG001|NOT COMPLETED|Overall Study||14||
48680614|NCT01870869|102003073|FG002|NOT COMPLETED|Overall Study||130||
48680615|NCT01870869|102003074|FG003|NOT COMPLETED|Overall Study||30||
48680616|NCT03698279|102003075|FG000|STARTED|Overall Study||124||
48680617|NCT03698279|102003076|FG001|STARTED|Overall Study||122||
48680618|NCT03698279|102003077|FG002|STARTED|Overall Study||159||
48680619|NCT03698279|102003078|FG003|STARTED|Overall Study||234||
48680620|NCT03698279|102003079|FG004|STARTED|Overall Study||13||
48680621|NCT03698279|102003080|FG005|STARTED|Overall Study||13||
48680622|NCT03698279|102003075|FG000|Safety Analysis Set Population (SafAS)|Overall Study||122|SafAS: Included participants who had received at least one dose of the study vaccines.|
48710657|NCT02961790|102077984|FG001|NOT COMPLETED|Overall Study||11||
48242844|NCT04117711|100911834|FG015|COMPLETED|Part D Placebo Comparator||0||
48242845|NCT04117711|100911835|FG016|COMPLETED|Part D Placebo Comparator||0||
48242846|NCT04117711|100911836|FG017|COMPLETED|Part D Placebo Comparator||0||
48242847|NCT04117711|100911837|FG018|COMPLETED|Part D Placebo Comparator||4||
48242848|NCT04117711|100911838|FG019|COMPLETED|Part D Placebo Comparator||0||
48242849|NCT04117711|100911839|FG020|COMPLETED|Part D Placebo Comparator||0||
48242850|NCT04117711|100911840|FG021|COMPLETED|Part D Placebo Comparator||0||
48242851|NCT04117711|100911819|FG000|NOT COMPLETED|Part D Placebo Comparator||0||
48242852|NCT04117711|100911820|FG001|NOT COMPLETED|Part D Placebo Comparator||0||
48242853|NCT04117711|100911821|FG002|NOT COMPLETED|Part D Placebo Comparator||0||
48242854|NCT04117711|100911822|FG003|NOT COMPLETED|Part D Placebo Comparator||0||
48242855|NCT04117711|100911823|FG004|NOT COMPLETED|Part D Placebo Comparator||0||
48242856|NCT04117711|100911824|FG005|NOT COMPLETED|Part D Placebo Comparator||0||
48242857|NCT04117711|100911825|FG006|NOT COMPLETED|Part D Placebo Comparator||0||
48242858|NCT04117711|100911826|FG007|NOT COMPLETED|Part D Placebo Comparator||0||
48242859|NCT04117711|100911827|FG008|NOT COMPLETED|Part D Placebo Comparator||0||
48242860|NCT04117711|100911828|FG009|NOT COMPLETED|Part D Placebo Comparator||0||
48242861|NCT04117711|100911829|FG010|NOT COMPLETED|Part D Placebo Comparator||0||
48242862|NCT04117711|100911830|FG011|NOT COMPLETED|Part D Placebo Comparator||0||
48242863|NCT04117711|100911831|FG012|NOT COMPLETED|Part D Placebo Comparator||0||
48242864|NCT04117711|100911832|FG013|NOT COMPLETED|Part D Placebo Comparator||0||
48242865|NCT04117711|100911833|FG014|NOT COMPLETED|Part D Placebo Comparator||0||
48242866|NCT04117711|100911834|FG015|NOT COMPLETED|Part D Placebo Comparator||0||
48242867|NCT04117711|100911835|FG016|NOT COMPLETED|Part D Placebo Comparator||0||
48242868|NCT04117711|100911836|FG017|NOT COMPLETED|Part D Placebo Comparator||0||
48242869|NCT04117711|100911837|FG018|NOT COMPLETED|Part D Placebo Comparator||0||
48242870|NCT04117711|100911838|FG019|NOT COMPLETED|Part D Placebo Comparator||0||
48242871|NCT04117711|100911839|FG020|NOT COMPLETED|Part D Placebo Comparator||0||
48242872|NCT04117711|100911840|FG021|NOT COMPLETED|Part D Placebo Comparator||0||
48242873|NCT04117711|100911819|FG000|STARTED|Part D Extension Cohort 1||0||
48242874|NCT04117711|100911820|FG001|STARTED|Part D Extension Cohort 1||0||
48242875|NCT04117711|100911821|FG002|STARTED|Part D Extension Cohort 1||0||
48540487|NCT03134092|101658108|FG002|COMPLETED|Overall Study||433||
48242876|NCT04117711|100911822|FG003|STARTED|Part D Extension Cohort 1||0||
48242877|NCT04117711|100911823|FG004|STARTED|Part D Extension Cohort 1||0||
48242878|NCT04117711|100911824|FG005|STARTED|Part D Extension Cohort 1||0||
48242879|NCT04117711|100911825|FG006|STARTED|Part D Extension Cohort 1||0||
48242880|NCT04117711|100911826|FG007|STARTED|Part D Extension Cohort 1||0||
48242881|NCT04117711|100911827|FG008|STARTED|Part D Extension Cohort 1||0||
48242882|NCT04117711|100911828|FG009|STARTED|Part D Extension Cohort 1||0||
48242883|NCT04117711|100911829|FG010|STARTED|Part D Extension Cohort 1||0||
48242884|NCT04117711|100911830|FG011|STARTED|Part D Extension Cohort 1||0||
48242885|NCT04117711|100911831|FG012|STARTED|Part D Extension Cohort 1||0||
48242886|NCT04117711|100911832|FG013|STARTED|Part D Extension Cohort 1||0||
48242887|NCT04117711|100911833|FG014|STARTED|Part D Extension Cohort 1||0||
48242888|NCT04117711|100911834|FG015|STARTED|Part D Extension Cohort 1||0||
48242889|NCT04117711|100911835|FG016|STARTED|Part D Extension Cohort 1||0||
48242890|NCT04117711|100911836|FG017|STARTED|Part D Extension Cohort 1||0||
48242891|NCT04117711|100911837|FG018|STARTED|Part D Extension Cohort 1||0||
48242892|NCT04117711|100911838|FG019|STARTED|Part D Extension Cohort 1||9||
48242893|NCT04117711|100911839|FG020|STARTED|Part D Extension Cohort 1||0||
48242894|NCT04117711|100911840|FG021|STARTED|Part D Extension Cohort 1||0||
48242895|NCT04117711|100911819|FG000|COMPLETED|Part D Extension Cohort 1||0||
48242896|NCT04117711|100911820|FG001|COMPLETED|Part D Extension Cohort 1||0||
48242897|NCT04117711|100911821|FG002|COMPLETED|Part D Extension Cohort 1||0||
48242898|NCT04117711|100911822|FG003|COMPLETED|Part D Extension Cohort 1||0||
48242899|NCT04117711|100911823|FG004|COMPLETED|Part D Extension Cohort 1||0||
48242900|NCT04117711|100911824|FG005|COMPLETED|Part D Extension Cohort 1||0||
48242901|NCT04117711|100911825|FG006|COMPLETED|Part D Extension Cohort 1||0||
48242902|NCT04117711|100911826|FG007|COMPLETED|Part D Extension Cohort 1||0||
48540488|NCT03134092|101658106|FG000|NOT COMPLETED|Overall Study||0||
48540489|NCT03134092|101658107|FG001|NOT COMPLETED|Overall Study||0||
48540490|NCT03134092|101658108|FG002|NOT COMPLETED|Overall Study||0||
48540491|NCT03613727|101658109|FG000|STARTED|Overall Study||55||
48540492|NCT03613727|101658109|FG000|COMPLETED|Overall Study||55||
48540493|NCT03613727|101658109|FG000|NOT COMPLETED|Overall Study||0||
48540494|NCT00000378|101658110|FG000|STARTED|Overall Study||58||
48540495|NCT00000378|101658111|FG001|STARTED|Overall Study||52||
48540496|NCT00000378|101658110|FG000|COMPLETED|Overall Study||42||
48540497|NCT00000378|101658111|FG001|COMPLETED|Overall Study||38||
48540498|NCT00000378|101658110|FG000|NOT COMPLETED|Overall Study||16||
48540499|NCT00000378|101658111|FG001|NOT COMPLETED|Overall Study||14||
48540500|NCT03190213|101658112|FG000|STARTED|Overall Study||6||
48540501|NCT03190213|101658112|FG000|COMPLETED|Overall Study||6||
48540502|NCT03190213|101658112|FG000|NOT COMPLETED|Overall Study||0||
48680623|NCT03698279|102003076|FG001|Safety Analysis Set Population (SafAS)|Overall Study||121|SafAS: Included participants who had received at least one dose of the study vaccines.|
48680624|NCT03698279|102003077|FG002|Safety Analysis Set Population (SafAS)|Overall Study||158|SafAS: Included participants who had received at least one dose of the study vaccines.|
48680625|NCT03698279|102003078|FG003|Safety Analysis Set Population (SafAS)|Overall Study||234|SafAS: Included participants who had received at least one dose of the study vaccines.|
48680626|NCT03698279|102003079|FG004|Safety Analysis Set Population (SafAS)|Overall Study||13|SafAS: Included participants who had received at least one dose of the study vaccines.|
48680627|NCT03698279|102003080|FG005|Safety Analysis Set Population (SafAS)|Overall Study||13|SafAS: Included participants who had received at least one dose of the study vaccines.|
48680628|NCT03698279|102003075|FG000|COMPLETED|Overall Study||119||
48680629|NCT03698279|102003076|FG001|COMPLETED|Overall Study||120||
48680630|NCT03698279|102003077|FG002|COMPLETED|Overall Study||152||
48680631|NCT03698279|102003078|FG003|COMPLETED|Overall Study||228||
48680632|NCT03698279|102003079|FG004|COMPLETED|Overall Study||13||
48680633|NCT03698279|102003080|FG005|COMPLETED|Overall Study||13||
48680634|NCT03698279|102003075|FG000|NOT COMPLETED|Overall Study||5||
48680635|NCT03698279|102003076|FG001|NOT COMPLETED|Overall Study||2||
48680636|NCT03698279|102003077|FG002|NOT COMPLETED|Overall Study||7||
48680637|NCT03698279|102003078|FG003|NOT COMPLETED|Overall Study||6||
48680638|NCT03698279|102003079|FG004|NOT COMPLETED|Overall Study||0||
48680639|NCT03698279|102003080|FG005|NOT COMPLETED|Overall Study||0||
48680640|NCT03500211|102003081|FG000|STARTED|Overall Study||25||
48680641|NCT03500211|102003082|FG001|STARTED|Overall Study||25||
48680642|NCT03500211|102003081|FG000|COMPLETED|Overall Study||24||
48680643|NCT03500211|102003082|FG001|COMPLETED|Overall Study||24||
48680644|NCT03500211|102003081|FG000|NOT COMPLETED|Overall Study||1||
48680645|NCT03500211|102003082|FG001|NOT COMPLETED|Overall Study||1||
48680646|NCT01434654|102003083|FG000|STARTED|Overall Study||7||
48680647|NCT01434654|102003084|FG001|STARTED|Overall Study||12||
48680648|NCT01434654|102003083|FG000|COMPLETED|Overall Study||5||
48680649|NCT01434654|102003084|FG001|COMPLETED|Overall Study||12||
48680650|NCT01434654|102003083|FG000|NOT COMPLETED|Overall Study||2||
48680651|NCT01434654|102003084|FG001|NOT COMPLETED|Overall Study||0||
48680652|NCT00087698|102003085|FG000|STARTED|Overall Study||77||
48680653|NCT00087698|102003085|FG000|COMPLETED|Overall Study||41||
48680654|NCT00087698|102003085|FG000|NOT COMPLETED|Overall Study||36||
48680655|NCT00110214|102003086|FG000|STARTED|Overall Study||526||
48680656|NCT00110214|102003087|FG001|STARTED|Overall Study||524||
48680657|NCT00110214|102003086|FG000|COMPLETED|Overall Study||17||
48680658|NCT00110214|102003087|FG001|COMPLETED|Overall Study||21||
48680659|NCT00110214|102003086|FG000|NOT COMPLETED|Overall Study||509||
48680660|NCT00110214|102003087|FG001|NOT COMPLETED|Overall Study||503||
48680661|NCT02722408|102003088|FG000|STARTED|Overall Study||8||
48680662|NCT02722408|102003088|FG000|COMPLETED|Overall Study||8||
48680663|NCT02722408|102003088|FG000|NOT COMPLETED|Overall Study||0||
48680664|NCT01111162|102003089|FG000|STARTED|Overall Study||120||
48680665|NCT01111162|102003089|FG000|COMPLETED|Overall Study||120||
48680666|NCT01111162|102003089|FG000|NOT COMPLETED|Overall Study||0||
48680667|NCT00956761|102003090|FG000|STARTED|Overall Study||63||
48680668|NCT00956761|102003090|FG000|COMPLETED|Overall Study||63||
48680669|NCT00956761|102003090|FG000|NOT COMPLETED|Overall Study||0||
48680670|NCT01419119|102003091|FG000|STARTED|Overall Study||23||
48680671|NCT01419119|102003092|FG001|STARTED|Overall Study||56||
48242903|NCT04117711|100911827|FG008|COMPLETED|Part D Extension Cohort 1||0||
48242904|NCT04117711|100911828|FG009|COMPLETED|Part D Extension Cohort 1||0||
48242905|NCT04117711|100911829|FG010|COMPLETED|Part D Extension Cohort 1||0||
48242906|NCT04117711|100911830|FG011|COMPLETED|Part D Extension Cohort 1||0||
48242907|NCT04117711|100911831|FG012|COMPLETED|Part D Extension Cohort 1||0||
48242908|NCT04117711|100911832|FG013|COMPLETED|Part D Extension Cohort 1||0||
48242909|NCT04117711|100911833|FG014|COMPLETED|Part D Extension Cohort 1||0||
48242910|NCT04117711|100911834|FG015|COMPLETED|Part D Extension Cohort 1||0||
48540503|NCT03483363|101658113|FG000|STARTED|Overall Study||17||
48540504|NCT03483363|101658114|FG001|STARTED|Overall Study||22||
48540505|NCT03483363|101658113|FG000|COMPLETED|Overall Study||17||
48540506|NCT03483363|101658114|FG001|COMPLETED|Overall Study||22||
48540507|NCT03483363|101658113|FG000|NOT COMPLETED|Overall Study||0||
48540508|NCT03483363|101658114|FG001|NOT COMPLETED|Overall Study||0||
48540509|NCT01422187|101658115|FG000|STARTED|Overall Study||8||
48540510|NCT01422187|101658116|FG001|STARTED|Overall Study||9||
48540511|NCT01422187|101658117|FG002|STARTED|Overall Study||2||
48540512|NCT01422187|101658115|FG000|COMPLETED|Overall Study||7||
48540513|NCT01422187|101658116|FG001|COMPLETED|Overall Study||8||
48540514|NCT01422187|101658117|FG002|COMPLETED|Overall Study||2||
48540515|NCT01422187|101658115|FG000|NOT COMPLETED|Overall Study||1||
48540516|NCT01422187|101658116|FG001|NOT COMPLETED|Overall Study||1||
48540517|NCT01422187|101658117|FG002|NOT COMPLETED|Overall Study||0||
48540518|NCT01635283|101658118|FG000|STARTED|Overall Study||5||
48540519|NCT01635283|101658118|FG000|COMPLETED|Overall Study||1||
48540520|NCT01635283|101658118|FG000|NOT COMPLETED|Overall Study||4||
48540521|NCT00303459|101658119|FG000|STARTED|Overall Study||159||
48540522|NCT00303459|101658120|FG001|STARTED|Overall Study||175||
48540523|NCT00303459|101658119|FG000|COMPLETED|Overall Study||76||
48540524|NCT00303459|101658120|FG001|COMPLETED|Overall Study||86||
48540525|NCT00303459|101658119|FG000|NOT COMPLETED|Overall Study||83||
48540526|NCT00303459|101658120|FG001|NOT COMPLETED|Overall Study||89||
48540527|NCT01406444|101658121|FG000|STARTED|Overall Study||33||
48540528|NCT01406444|101658122|FG001|STARTED|Overall Study||33||
48540529|NCT01406444|101658123|FG002|STARTED|Overall Study||16||
48540530|NCT01406444|101658121|FG000|COMPLETED|Overall Study||23||
48540531|NCT01406444|101658122|FG001|COMPLETED|Overall Study||24||
48540532|NCT01406444|101658123|FG002|COMPLETED|Overall Study||14||
48540533|NCT01406444|101658121|FG000|NOT COMPLETED|Overall Study||10||
48540534|NCT01406444|101658122|FG001|NOT COMPLETED|Overall Study||9||
48540535|NCT01406444|101658123|FG002|NOT COMPLETED|Overall Study||2||
48540536|NCT04502212|101658124|FG000|STARTED|Overall Study||16||
48540537|NCT04502212|101658124|FG000|COMPLETED|Overall Study||14||
48540538|NCT04502212|101658124|FG000|NOT COMPLETED|Overall Study||2||
48540539|NCT01386983|101658125|FG000|STARTED|Overall Study||264||
48540540|NCT01386983|101658126|FG001|STARTED|Overall Study||68||
48540541|NCT01386983|101658125|FG000|COMPLETED|Overall Study||264||
48540542|NCT01386983|101658126|FG001|COMPLETED|Overall Study||68||
48540543|NCT01386983|101658125|FG000|NOT COMPLETED|Overall Study||0||
48242911|NCT04117711|100911835|FG016|COMPLETED|Part D Extension Cohort 1||0||
48242912|NCT04117711|100911836|FG017|COMPLETED|Part D Extension Cohort 1||0||
48242913|NCT04117711|100911837|FG018|COMPLETED|Part D Extension Cohort 1||0||
48242914|NCT04117711|100911838|FG019|COMPLETED|Part D Extension Cohort 1||7||
48242915|NCT04117711|100911839|FG020|COMPLETED|Part D Extension Cohort 1||0||
48242916|NCT04117711|100911840|FG021|COMPLETED|Part D Extension Cohort 1||0||
48242917|NCT04117711|100911819|FG000|NOT COMPLETED|Part D Extension Cohort 1||0||
48242918|NCT04117711|100911820|FG001|NOT COMPLETED|Part D Extension Cohort 1||0||
48242919|NCT04117711|100911821|FG002|NOT COMPLETED|Part D Extension Cohort 1||0||
48242920|NCT04117711|100911822|FG003|NOT COMPLETED|Part D Extension Cohort 1||0||
48242921|NCT04117711|100911823|FG004|NOT COMPLETED|Part D Extension Cohort 1||0||
48242922|NCT04117711|100911824|FG005|NOT COMPLETED|Part D Extension Cohort 1||0||
48242923|NCT04117711|100911825|FG006|NOT COMPLETED|Part D Extension Cohort 1||0||
48242924|NCT04117711|100911826|FG007|NOT COMPLETED|Part D Extension Cohort 1||0||
48242925|NCT04117711|100911827|FG008|NOT COMPLETED|Part D Extension Cohort 1||0||
48242926|NCT04117711|100911828|FG009|NOT COMPLETED|Part D Extension Cohort 1||0||
48242927|NCT04117711|100911829|FG010|NOT COMPLETED|Part D Extension Cohort 1||0||
48242928|NCT04117711|100911830|FG011|NOT COMPLETED|Part D Extension Cohort 1||0||
48242929|NCT04117711|100911831|FG012|NOT COMPLETED|Part D Extension Cohort 1||0||
48242930|NCT04117711|100911832|FG013|NOT COMPLETED|Part D Extension Cohort 1||0||
48242931|NCT04117711|100911833|FG014|NOT COMPLETED|Part D Extension Cohort 1||0||
48242932|NCT04117711|100911834|FG015|NOT COMPLETED|Part D Extension Cohort 1||0||
48242933|NCT04117711|100911835|FG016|NOT COMPLETED|Part D Extension Cohort 1||0||
48242934|NCT04117711|100911836|FG017|NOT COMPLETED|Part D Extension Cohort 1||0||
48242935|NCT04117711|100911837|FG018|NOT COMPLETED|Part D Extension Cohort 1||0||
48242936|NCT04117711|100911838|FG019|NOT COMPLETED|Part D Extension Cohort 1||2||
48242937|NCT04117711|100911839|FG020|NOT COMPLETED|Part D Extension Cohort 1||0||
48242938|NCT04117711|100911840|FG021|NOT COMPLETED|Part D Extension Cohort 1||0||
48242939|NCT04117711|100911819|FG000|STARTED|Part D Extension Cohort 2||0||
48242940|NCT04117711|100911820|FG001|STARTED|Part D Extension Cohort 2||0||
48242941|NCT04117711|100911821|FG002|STARTED|Part D Extension Cohort 2||0||
48242942|NCT04117711|100911822|FG003|STARTED|Part D Extension Cohort 2||0||
48242943|NCT04117711|100911823|FG004|STARTED|Part D Extension Cohort 2||0||
48242944|NCT04117711|100911824|FG005|STARTED|Part D Extension Cohort 2||0||
48242945|NCT04117711|100911825|FG006|STARTED|Part D Extension Cohort 2||0||
48242946|NCT04117711|100911826|FG007|STARTED|Part D Extension Cohort 2||0||
48242947|NCT04117711|100911827|FG008|STARTED|Part D Extension Cohort 2||0||
48242948|NCT04117711|100911828|FG009|STARTED|Part D Extension Cohort 2||0||
48242949|NCT04117711|100911829|FG010|STARTED|Part D Extension Cohort 2||0||
48242950|NCT04117711|100911830|FG011|STARTED|Part D Extension Cohort 2||0||
48242951|NCT04117711|100911831|FG012|STARTED|Part D Extension Cohort 2||0||
48242952|NCT04117711|100911832|FG013|STARTED|Part D Extension Cohort 2||0||
48242953|NCT04117711|100911833|FG014|STARTED|Part D Extension Cohort 2||0||
48242954|NCT04117711|100911834|FG015|STARTED|Part D Extension Cohort 2||0||
48242955|NCT04117711|100911835|FG016|STARTED|Part D Extension Cohort 2||0||
48242956|NCT04117711|100911836|FG017|STARTED|Part D Extension Cohort 2||0||
48242957|NCT04117711|100911837|FG018|STARTED|Part D Extension Cohort 2||0||
48242958|NCT04117711|100911838|FG019|STARTED|Part D Extension Cohort 2||0||
48242959|NCT04117711|100911839|FG020|STARTED|Part D Extension Cohort 2||2||
48242960|NCT04117711|100911840|FG021|STARTED|Part D Extension Cohort 2||0||
48242961|NCT04117711|100911819|FG000|COMPLETED|Part D Extension Cohort 2||0||
48540544|NCT01386983|101658126|FG001|NOT COMPLETED|Overall Study||0||
48540545|NCT03426137|101658127|FG000|STARTED|Overall Study||0||
48242962|NCT04117711|100911820|FG001|COMPLETED|Part D Extension Cohort 2||0||
48242963|NCT04117711|100911821|FG002|COMPLETED|Part D Extension Cohort 2||0||
48242964|NCT04117711|100911822|FG003|COMPLETED|Part D Extension Cohort 2||0||
48242965|NCT04117711|100911823|FG004|COMPLETED|Part D Extension Cohort 2||0||
48242966|NCT04117711|100911824|FG005|COMPLETED|Part D Extension Cohort 2||0||
48242967|NCT04117711|100911825|FG006|COMPLETED|Part D Extension Cohort 2||0||
48242968|NCT04117711|100911826|FG007|COMPLETED|Part D Extension Cohort 2||0||
48242969|NCT04117711|100911827|FG008|COMPLETED|Part D Extension Cohort 2||0||
48242970|NCT04117711|100911828|FG009|COMPLETED|Part D Extension Cohort 2||0||
48242971|NCT04117711|100911829|FG010|COMPLETED|Part D Extension Cohort 2||0||
48242972|NCT04117711|100911830|FG011|COMPLETED|Part D Extension Cohort 2||0||
48242973|NCT04117711|100911831|FG012|COMPLETED|Part D Extension Cohort 2||0||
48242974|NCT04117711|100911832|FG013|COMPLETED|Part D Extension Cohort 2||0||
48242975|NCT04117711|100911833|FG014|COMPLETED|Part D Extension Cohort 2||0||
48242976|NCT04117711|100911834|FG015|COMPLETED|Part D Extension Cohort 2||0||
48242977|NCT04117711|100911835|FG016|COMPLETED|Part D Extension Cohort 2||0||
48242978|NCT04117711|100911836|FG017|COMPLETED|Part D Extension Cohort 2||0||
48242979|NCT04117711|100911837|FG018|COMPLETED|Part D Extension Cohort 2||0||
48242980|NCT04117711|100911838|FG019|COMPLETED|Part D Extension Cohort 2||0||
48242981|NCT04117711|100911839|FG020|COMPLETED|Part D Extension Cohort 2||0||
48242982|NCT04117711|100911840|FG021|COMPLETED|Part D Extension Cohort 2||0||
48242983|NCT04117711|100911819|FG000|NOT COMPLETED|Part D Extension Cohort 2||0||
48242984|NCT04117711|100911820|FG001|NOT COMPLETED|Part D Extension Cohort 2||0||
48242985|NCT04117711|100911821|FG002|NOT COMPLETED|Part D Extension Cohort 2||0||
48242986|NCT04117711|100911822|FG003|NOT COMPLETED|Part D Extension Cohort 2||0||
48242987|NCT04117711|100911823|FG004|NOT COMPLETED|Part D Extension Cohort 2||0||
48242988|NCT04117711|100911824|FG005|NOT COMPLETED|Part D Extension Cohort 2||0||
48242989|NCT04117711|100911825|FG006|NOT COMPLETED|Part D Extension Cohort 2||0||
48242990|NCT04117711|100911826|FG007|NOT COMPLETED|Part D Extension Cohort 2||0||
48242991|NCT04117711|100911827|FG008|NOT COMPLETED|Part D Extension Cohort 2||0||
48242992|NCT04117711|100911828|FG009|NOT COMPLETED|Part D Extension Cohort 2||0||
48242993|NCT04117711|100911829|FG010|NOT COMPLETED|Part D Extension Cohort 2||0||
48242994|NCT04117711|100911830|FG011|NOT COMPLETED|Part D Extension Cohort 2||0||
48242995|NCT04117711|100911831|FG012|NOT COMPLETED|Part D Extension Cohort 2||0||
48242996|NCT04117711|100911832|FG013|NOT COMPLETED|Part D Extension Cohort 2||0||
48242997|NCT04117711|100911833|FG014|NOT COMPLETED|Part D Extension Cohort 2||0||
48242998|NCT04117711|100911834|FG015|NOT COMPLETED|Part D Extension Cohort 2||0||
48242999|NCT04117711|100911835|FG016|NOT COMPLETED|Part D Extension Cohort 2||0||
48243000|NCT04117711|100911836|FG017|NOT COMPLETED|Part D Extension Cohort 2||0||
48243001|NCT04117711|100911837|FG018|NOT COMPLETED|Part D Extension Cohort 2||0||
48243002|NCT04117711|100911838|FG019|NOT COMPLETED|Part D Extension Cohort 2||0||
48243003|NCT04117711|100911839|FG020|NOT COMPLETED|Part D Extension Cohort 2||2||
48243004|NCT04117711|100911840|FG021|NOT COMPLETED|Part D Extension Cohort 2||0||
48243005|NCT04117711|100911819|FG000|STARTED|Part D Extension Placebo Comparator||0||
48243006|NCT04117711|100911820|FG001|STARTED|Part D Extension Placebo Comparator||0||
48243007|NCT04117711|100911821|FG002|STARTED|Part D Extension Placebo Comparator||0||
48243008|NCT04117711|100911822|FG003|STARTED|Part D Extension Placebo Comparator||0||
48243009|NCT04117711|100911823|FG004|STARTED|Part D Extension Placebo Comparator||0||
48243010|NCT04117711|100911824|FG005|STARTED|Part D Extension Placebo Comparator||0||
48243011|NCT04117711|100911825|FG006|STARTED|Part D Extension Placebo Comparator||0||
48243012|NCT04117711|100911826|FG007|STARTED|Part D Extension Placebo Comparator||0||
48243013|NCT04117711|100911827|FG008|STARTED|Part D Extension Placebo Comparator||0||
48243014|NCT04117711|100911828|FG009|STARTED|Part D Extension Placebo Comparator||0||
48243015|NCT04117711|100911829|FG010|STARTED|Part D Extension Placebo Comparator||0||
48243016|NCT04117711|100911830|FG011|STARTED|Part D Extension Placebo Comparator||0||
48243017|NCT04117711|100911831|FG012|STARTED|Part D Extension Placebo Comparator||0||
48243018|NCT04117711|100911832|FG013|STARTED|Part D Extension Placebo Comparator||0||
48243019|NCT04117711|100911833|FG014|STARTED|Part D Extension Placebo Comparator||0||
48081572|NCT03129100|100521630|FG017|STARTED|Period 4 (Post Treatment Follow-up)||0||
48081573|NCT03129100|100521631|FG018|STARTED|Period 4 (Post Treatment Follow-up)||0||
48081574|NCT03129100|100521632|FG019|STARTED|Period 4 (Post Treatment Follow-up)||0||
48081575|NCT03129100|100521633|FG020|STARTED|Period 4 (Post Treatment Follow-up)||0||
48243020|NCT04117711|100911834|FG015|STARTED|Part D Extension Placebo Comparator||0||
48243021|NCT04117711|100911835|FG016|STARTED|Part D Extension Placebo Comparator||0||
48243022|NCT04117711|100911836|FG017|STARTED|Part D Extension Placebo Comparator||0||
48243023|NCT04117711|100911837|FG018|STARTED|Part D Extension Placebo Comparator||0||
48243024|NCT04117711|100911838|FG019|STARTED|Part D Extension Placebo Comparator||0||
48243025|NCT04117711|100911839|FG020|STARTED|Part D Extension Placebo Comparator||0||
48243026|NCT04117711|100911840|FG021|STARTED|Part D Extension Placebo Comparator||4||
48243027|NCT04117711|100911819|FG000|COMPLETED|Part D Extension Placebo Comparator||0||
48081576|NCT03129100|100521634|FG021|STARTED|Period 4 (Post Treatment Follow-up)||0||
48081577|NCT03129100|100521635|FG022|STARTED|Period 4 (Post Treatment Follow-up)||0||
48081578|NCT03129100|100521636|FG023|STARTED|Period 4 (Post Treatment Follow-up)||25||
48680672|NCT01419119|102003093|FG002|STARTED|Overall Study||50||
48243028|NCT04117711|100911820|FG001|COMPLETED|Part D Extension Placebo Comparator||0||
48243029|NCT04117711|100911821|FG002|COMPLETED|Part D Extension Placebo Comparator||0||
48680673|NCT01419119|102003094|FG003|STARTED|Overall Study||31||
48680674|NCT01419119|102003091|FG000|COMPLETED|Overall Study||16||
48680675|NCT01419119|102003092|FG001|COMPLETED|Overall Study||54||
48680676|NCT01419119|102003093|FG002|COMPLETED|Overall Study||49||
48680677|NCT01419119|102003094|FG003|COMPLETED|Overall Study||28||
48680678|NCT01419119|102003091|FG000|NOT COMPLETED|Overall Study||7||
48680679|NCT01419119|102003092|FG001|NOT COMPLETED|Overall Study||2||
48680680|NCT01419119|102003093|FG002|NOT COMPLETED|Overall Study||1||
48680681|NCT01419119|102003094|FG003|NOT COMPLETED|Overall Study||3||
48680682|NCT01544348|102003095|FG000|STARTED|Overall Study||17||
48680683|NCT01544348|102003096|FG001|STARTED|Overall Study||6||
48680684|NCT01544348|102003097|FG002|STARTED|Overall Study||3||
48680685|NCT01544348|102003098|FG003|STARTED|Overall Study||3||
48680686|NCT01544348|102003099|FG004|STARTED|Overall Study||16||
48680687|NCT01544348|102003100|FG005|STARTED|Overall Study||19||
48680688|NCT01544348|102003101|FG006|STARTED|Overall Study||14||
48680689|NCT01544348|102003102|FG007|STARTED|Overall Study||8||
48680690|NCT01544348|102003095|FG000|Treated|Overall Study||17||
48680691|NCT01544348|102003096|FG001|Treated|Overall Study||6||
48680692|NCT01544348|102003097|FG002|Treated|Overall Study||3||
48680693|NCT01544348|102003098|FG003|Treated|Overall Study||3||
48680694|NCT01544348|102003099|FG004|Treated|Overall Study||15||
48680695|NCT01544348|102003100|FG005|Treated|Overall Study||18||
48243030|NCT04117711|100911822|FG003|COMPLETED|Part D Extension Placebo Comparator||0||
48243031|NCT04117711|100911823|FG004|COMPLETED|Part D Extension Placebo Comparator||0||
48680696|NCT01544348|102003101|FG006|Treated|Overall Study||14||
48680697|NCT01544348|102003102|FG007|Treated|Overall Study||8||
48680698|NCT01544348|102003095|FG000|COMPLETED|Overall Study||15||
48680699|NCT01544348|102003096|FG001|COMPLETED|Overall Study||6||
48243032|NCT04117711|100911824|FG005|COMPLETED|Part D Extension Placebo Comparator||0||
48243033|NCT04117711|100911825|FG006|COMPLETED|Part D Extension Placebo Comparator||0||
48243034|NCT04117711|100911826|FG007|COMPLETED|Part D Extension Placebo Comparator||0||
48243035|NCT04117711|100911827|FG008|COMPLETED|Part D Extension Placebo Comparator||0||
48680700|NCT01544348|102003097|FG002|COMPLETED|Overall Study||3||
48680701|NCT01544348|102003098|FG003|COMPLETED|Overall Study||3||
48680702|NCT01544348|102003099|FG004|COMPLETED|Overall Study||15||
48680703|NCT01544348|102003100|FG005|COMPLETED|Overall Study||16||
48680704|NCT01544348|102003101|FG006|COMPLETED|Overall Study||12||
48680705|NCT01544348|102003102|FG007|COMPLETED|Overall Study||8||
48680706|NCT01544348|102003095|FG000|NOT COMPLETED|Overall Study||2||
48680707|NCT01544348|102003096|FG001|NOT COMPLETED|Overall Study||0||
48680708|NCT01544348|102003097|FG002|NOT COMPLETED|Overall Study||0||
48680709|NCT01544348|102003098|FG003|NOT COMPLETED|Overall Study||0||
48680710|NCT01544348|102003099|FG004|NOT COMPLETED|Overall Study||1||
48680711|NCT01544348|102003100|FG005|NOT COMPLETED|Overall Study||3||
48680712|NCT01544348|102003101|FG006|NOT COMPLETED|Overall Study||2||
48680713|NCT01544348|102003102|FG007|NOT COMPLETED|Overall Study||0||
48680714|NCT03121144|102003103|FG000|STARTED|Overall Study||34||
48680715|NCT03121144|102003103|FG000|COMPLETED|Overall Study||34||
48680716|NCT03121144|102003103|FG000|NOT COMPLETED|Overall Study||0||
48680717|NCT00869167|102003104|FG000|STARTED|Overall Study||2||
48680718|NCT00869167|102003105|FG001|STARTED|Overall Study||1||
48680719|NCT00869167|102003104|FG000|COMPLETED|Overall Study||2||
48680720|NCT00869167|102003105|FG001|COMPLETED|Overall Study||0||
48680721|NCT00869167|102003104|FG000|NOT COMPLETED|Overall Study||0||
48680722|NCT00869167|102003105|FG001|NOT COMPLETED|Overall Study||1||
48243036|NCT04117711|100911828|FG009|COMPLETED|Part D Extension Placebo Comparator||0||
48243037|NCT04117711|100911829|FG010|COMPLETED|Part D Extension Placebo Comparator||0||
48243038|NCT04117711|100911830|FG011|COMPLETED|Part D Extension Placebo Comparator||0||
48243039|NCT04117711|100911831|FG012|COMPLETED|Part D Extension Placebo Comparator||0||
48243040|NCT04117711|100911832|FG013|COMPLETED|Part D Extension Placebo Comparator||0||
48243041|NCT04117711|100911833|FG014|COMPLETED|Part D Extension Placebo Comparator||0||
48680723|NCT00326599|102003106|FG000|STARTED|Overall Study||6||
48680724|NCT00326599|102003107|FG001|STARTED|Overall Study||3||
48243042|NCT04117711|100911834|FG015|COMPLETED|Part D Extension Placebo Comparator||0||
48243043|NCT04117711|100911835|FG016|COMPLETED|Part D Extension Placebo Comparator||0||
48243044|NCT04117711|100911836|FG017|COMPLETED|Part D Extension Placebo Comparator||0||
48243045|NCT04117711|100911837|FG018|COMPLETED|Part D Extension Placebo Comparator||0||
48243046|NCT04117711|100911838|FG019|COMPLETED|Part D Extension Placebo Comparator||0||
48243047|NCT04117711|100911839|FG020|COMPLETED|Part D Extension Placebo Comparator||0||
48243048|NCT04117711|100911840|FG021|COMPLETED|Part D Extension Placebo Comparator||3||
48243049|NCT04117711|100911819|FG000|NOT COMPLETED|Part D Extension Placebo Comparator||0||
48243050|NCT04117711|100911820|FG001|NOT COMPLETED|Part D Extension Placebo Comparator||0||
48243051|NCT04117711|100911821|FG002|NOT COMPLETED|Part D Extension Placebo Comparator||0||
48243052|NCT04117711|100911822|FG003|NOT COMPLETED|Part D Extension Placebo Comparator||0||
48243053|NCT04117711|100911823|FG004|NOT COMPLETED|Part D Extension Placebo Comparator||0||
48243054|NCT04117711|100911824|FG005|NOT COMPLETED|Part D Extension Placebo Comparator||0||
48243055|NCT04117711|100911825|FG006|NOT COMPLETED|Part D Extension Placebo Comparator||0||
48243056|NCT04117711|100911826|FG007|NOT COMPLETED|Part D Extension Placebo Comparator||0||
48243057|NCT04117711|100911827|FG008|NOT COMPLETED|Part D Extension Placebo Comparator||0||
48243058|NCT04117711|100911828|FG009|NOT COMPLETED|Part D Extension Placebo Comparator||0||
48243059|NCT04117711|100911829|FG010|NOT COMPLETED|Part D Extension Placebo Comparator||0||
48243060|NCT04117711|100911830|FG011|NOT COMPLETED|Part D Extension Placebo Comparator||0||
48243061|NCT04117711|100911831|FG012|NOT COMPLETED|Part D Extension Placebo Comparator||0||
48243062|NCT04117711|100911832|FG013|NOT COMPLETED|Part D Extension Placebo Comparator||0||
48243063|NCT04117711|100911833|FG014|NOT COMPLETED|Part D Extension Placebo Comparator||0||
48243064|NCT04117711|100911834|FG015|NOT COMPLETED|Part D Extension Placebo Comparator||0||
48243065|NCT04117711|100911835|FG016|NOT COMPLETED|Part D Extension Placebo Comparator||0||
48243066|NCT04117711|100911836|FG017|NOT COMPLETED|Part D Extension Placebo Comparator||0||
48243067|NCT04117711|100911837|FG018|NOT COMPLETED|Part D Extension Placebo Comparator||0||
48243068|NCT04117711|100911838|FG019|NOT COMPLETED|Part D Extension Placebo Comparator||0||
48243069|NCT04117711|100911839|FG020|NOT COMPLETED|Part D Extension Placebo Comparator||0||
48243070|NCT04117711|100911840|FG021|NOT COMPLETED|Part D Extension Placebo Comparator||1||
48243071|NCT00108355|100911841|FG000|STARTED|Overall Study||15||
48243072|NCT00108355|100911842|FG001|STARTED|Overall Study||14||
48243073|NCT00108355|100911841|FG000|COMPLETED|Overall Study||13||
48243074|NCT00108355|100911842|FG001|COMPLETED|Overall Study||12||
48243075|NCT00108355|100911841|FG000|NOT COMPLETED|Overall Study||2||
48243076|NCT00108355|100911842|FG001|NOT COMPLETED|Overall Study||2||
48243077|NCT00794573|100914395|FG000|STARTED|Overall Study||151||
48243078|NCT00794573|100914396|FG001|STARTED|Overall Study||151||
48243079|NCT00794573|100914395|FG000|COMPLETED|Overall Study||113||
48243080|NCT00794573|100914396|FG001|COMPLETED|Overall Study||106||
48243081|NCT00794573|100914395|FG000|NOT COMPLETED|Overall Study||38||
48243082|NCT00794573|100914396|FG001|NOT COMPLETED|Overall Study||45||
48243083|NCT02363933|100914397|FG000|STARTED|Overall Study||8||
48243084|NCT02363933|100914397|FG000|COMPLETED|Overall Study||2||
48243085|NCT02363933|100914397|FG000|NOT COMPLETED|Overall Study||6||
48243086|NCT01803854|100914398|FG000|STARTED|Overall Study||1275||
48243087|NCT01803854|100914398|FG000|COMPLETED|Overall Study||1275||
48243088|NCT01803854|100914398|FG000|NOT COMPLETED|Overall Study||0||
48243089|NCT02294461|100914399|FG000|STARTED|Double-blind Period (up to 29.4 Months)||202||
48243090|NCT02294461|100914400|FG001|STARTED|Double-blind Period (up to 29.4 Months)||193||
48243091|NCT02294461|100914399|FG000|Treated/Received Study Drug|Double-blind Period (up to 29.4 Months)||202||
48243092|NCT02294461|100914400|FG001|Treated/Received Study Drug|Double-blind Period (up to 29.4 Months)||193||
48243093|NCT02294461|100914399|FG000|COMPLETED|Double-blind Period (up to 29.4 Months)||84||
48243094|NCT02294461|100914400|FG001|COMPLETED|Double-blind Period (up to 29.4 Months)||1||
48243095|NCT02294461|100914399|FG000|NOT COMPLETED|Double-blind Period (up to 29.4 Months)||118||
48243096|NCT02294461|100914400|FG001|NOT COMPLETED|Double-blind Period (up to 29.4 Months)||192||
48243097|NCT02294461|100914399|FG000|STARTED|Open-label Period (up to 54.3 Months)||85||
48243098|NCT02294461|100914400|FG001|STARTED|Open-label Period (up to 54.3 Months)||51||
48243099|NCT02294461|100914399|FG000|COMPLETED|Open-label Period (up to 54.3 Months)||0||
48243100|NCT02294461|100914400|FG001|COMPLETED|Open-label Period (up to 54.3 Months)||0||
48243101|NCT02294461|100914399|FG000|NOT COMPLETED|Open-label Period (up to 54.3 Months)||85||
48243102|NCT02294461|100914400|FG001|NOT COMPLETED|Open-label Period (up to 54.3 Months)||51||
48081579|NCT03129100|100521637|FG024|STARTED|Period 4 (Post Treatment Follow-up)||223||
48081580|NCT03129100|100521638|FG025|STARTED|Period 4 (Post Treatment Follow-up)||453||
48141210|NCT01260350|100670369|FG007|STARTED|Overall Study||25||
48243103|NCT00857311|100914401|FG000|STARTED|Overall Study||9||
48243104|NCT00857311|100914402|FG001|STARTED|Overall Study||0||
48243105|NCT00857311|100914403|FG002|STARTED|Overall Study||8||
48243106|NCT00857311|100914404|FG003|STARTED|Overall Study||0||
48243107|NCT00857311|100914401|FG000|COMPLETED|Overall Study||8||
48243108|NCT00857311|100914402|FG001|COMPLETED|Overall Study||0||
48243109|NCT00857311|100914403|FG002|COMPLETED|Overall Study||8||
48243110|NCT00857311|100914404|FG003|COMPLETED|Overall Study||0||
48243111|NCT00857311|100914401|FG000|NOT COMPLETED|Overall Study||1||
48243112|NCT00857311|100914402|FG001|NOT COMPLETED|Overall Study||0||
48243113|NCT00857311|100914403|FG002|NOT COMPLETED|Overall Study||0||
48243114|NCT00857311|100914404|FG003|NOT COMPLETED|Overall Study||0||
48680725|NCT00326599|102003108|FG002|STARTED|Overall Study||58||
48680726|NCT00326599|102003109|FG003|STARTED|Overall Study||29||
48680727|NCT00326599|102003106|FG000|COMPLETED|Overall Study||0||
48680728|NCT00326599|102003107|FG001|COMPLETED|Overall Study||2||
48680729|NCT00326599|102003108|FG002|COMPLETED|Overall Study||5||
48680730|NCT00326599|102003109|FG003|COMPLETED|Overall Study||10||
48680731|NCT00326599|102003106|FG000|NOT COMPLETED|Overall Study||6||
48680732|NCT00326599|102003107|FG001|NOT COMPLETED|Overall Study||1||
48680733|NCT00326599|102003108|FG002|NOT COMPLETED|Overall Study||53||
48680734|NCT00326599|102003109|FG003|NOT COMPLETED|Overall Study||19||
48680735|NCT00539240|102003110|FG000|STARTED|Overall Study||59||
48680736|NCT00539240|102003111|FG001|STARTED|Overall Study||55||
48680737|NCT00539240|102003112|FG002|STARTED|Overall Study||54||
48680738|NCT00539240|102003110|FG000|COMPLETED|Overall Study||53||
48680739|NCT00539240|102003111|FG001|COMPLETED|Overall Study||48||
48680740|NCT00539240|102003112|FG002|COMPLETED|Overall Study||39||
48680741|NCT00539240|102003110|FG000|NOT COMPLETED|Overall Study||6||
48680742|NCT00539240|102003111|FG001|NOT COMPLETED|Overall Study||7||
48680743|NCT00539240|102003112|FG002|NOT COMPLETED|Overall Study||15||
48680744|NCT03423602|102003113|FG000|STARTED|Overall Study||75||84
48680745|NCT03423602|102003113|FG000|Discharge|Overall Study||70||77
48680746|NCT03423602|102003113|FG000|1-month Follow-up|Overall Study||66||71
48243115|NCT03751280|100914405|FG000|STARTED|Overall Study||56|All enrolled participants were in Randomized Set|
48243116|NCT03751280|100914406|FG001|STARTED|Overall Study||56|All enrolled participants were in Randomized Set|
48243117|NCT03751280|100914405|FG000|Full Analysis Set (FAS)|Overall Study||54||
48243118|NCT03751280|100914406|FG001|Full Analysis Set (FAS)|Overall Study||55||
48680747|NCT03423602|102003113|FG000|3-month Follow-up|Overall Study||63||72
48680748|NCT03423602|102003113|FG000|COMPLETED|Overall Study||63||72
48243119|NCT03751280|100914405|FG000|Safety Set (SAF)|Overall Study||55||
48680749|NCT03423602|102003113|FG000|NOT COMPLETED|Overall Study||12||12
48680750|NCT01874392|102003114|FG000|STARTED|Overall Study||9||
48680751|NCT01874392|102003114|FG000|COMPLETED|Overall Study||9||
48081581|NCT03129100|100521613|FG000|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48243120|NCT03751280|100914406|FG001|Safety Set (SAF)|Overall Study||55||
48243121|NCT03751280|100914405|FG000|COMPLETED|Overall Study||48||
48243122|NCT03751280|100914406|FG001|COMPLETED|Overall Study||44||
48243123|NCT03751280|100914405|FG000|NOT COMPLETED|Overall Study||8||
48243124|NCT03751280|100914406|FG001|NOT COMPLETED|Overall Study||12||
48243125|NCT00553800|100914407|FG000|STARTED|Overall Study||32||
48243126|NCT00553800|100914407|FG000|COMPLETED|Overall Study||32||
48243127|NCT00553800|100914407|FG000|NOT COMPLETED|Overall Study||0||
48243128|NCT04206384|100914408|FG000|STARTED|Overall Study||52||
48243129|NCT04206384|100914408|FG000|COMPLETED|Overall Study||42||
48243130|NCT04206384|100914408|FG000|NOT COMPLETED|Overall Study||10||
48243131|NCT01436045|100914409|FG000|STARTED|Overall Study||6||
48243132|NCT01436045|100914410|FG001|STARTED|Overall Study||6||
48243133|NCT01436045|100914409|FG000|COMPLETED|Overall Study||6||
48243134|NCT01436045|100914410|FG001|COMPLETED|Overall Study||6||
48243135|NCT01436045|100914409|FG000|NOT COMPLETED|Overall Study||0||
48243136|NCT01436045|100914410|FG001|NOT COMPLETED|Overall Study||0||
48081582|NCT03129100|100521614|FG001|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081583|NCT03129100|100521615|FG002|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081584|NCT03129100|100521616|FG003|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081585|NCT03129100|100521617|FG004|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081586|NCT03129100|100521618|FG005|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081587|NCT03129100|100521619|FG006|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081588|NCT03129100|100521620|FG007|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081589|NCT03129100|100521621|FG008|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081590|NCT03129100|100521622|FG009|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081591|NCT03129100|100521623|FG010|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081592|NCT03129100|100521624|FG011|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081593|NCT03129100|100521625|FG012|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081594|NCT03129100|100521626|FG013|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081595|NCT03129100|100521627|FG014|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081596|NCT03129100|100521628|FG015|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081597|NCT03129100|100521629|FG016|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081598|NCT03129100|100521630|FG017|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081599|NCT03129100|100521631|FG018|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081600|NCT03129100|100521632|FG019|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081601|NCT03129100|100521633|FG020|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081602|NCT03129100|100521634|FG021|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081603|NCT03129100|100521635|FG022|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081604|NCT03129100|100521636|FG023|COMPLETED|Period 4 (Post Treatment Follow-up)||22||
48081605|NCT03129100|100521637|FG024|COMPLETED|Period 4 (Post Treatment Follow-up)||198||
48081606|NCT03129100|100521638|FG025|COMPLETED|Period 4 (Post Treatment Follow-up)||411||
48081607|NCT03129100|100521613|FG000|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081608|NCT03129100|100521614|FG001|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081609|NCT03129100|100521615|FG002|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081610|NCT03129100|100521616|FG003|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081611|NCT03129100|100521617|FG004|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081612|NCT03129100|100521618|FG005|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081613|NCT03129100|100521619|FG006|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081614|NCT03129100|100521620|FG007|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081615|NCT03129100|100521621|FG008|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081616|NCT03129100|100521622|FG009|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081617|NCT03129100|100521623|FG010|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081618|NCT03129100|100521624|FG011|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081619|NCT03129100|100521625|FG012|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081620|NCT03129100|100521626|FG013|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48243137|NCT01132378|100914411|FG000|STARTED|Overall Study||40||
48243138|NCT01132378|100914411|FG000|COMPLETED|Overall Study||40||
48243139|NCT01132378|100914411|FG000|NOT COMPLETED|Overall Study||0||
48243140|NCT02268526|100914412|FG000|STARTED|Overall Study||6||
48243141|NCT02268526|100914413|FG001|STARTED|Overall Study||59||
48243142|NCT02268526|100914414|FG002|STARTED|Overall Study||21||
48243143|NCT02268526|100914412|FG000|PD Analysis Set (Cohort 2)|Overall Study||0||
48243144|NCT02268526|100914413|FG001|PD Analysis Set (Cohort 2)|Overall Study||42||
48243145|NCT02268526|100914414|FG002|PD Analysis Set (Cohort 2)|Overall Study||17||
48680752|NCT01874392|102003114|FG000|NOT COMPLETED|Overall Study||0||
48680753|NCT01837680|102003115|FG000|STARTED|Overall Study||52||
48243146|NCT02268526|100914412|FG000|COMPLETED|Overall Study||5||
48243147|NCT02268526|100914413|FG001|COMPLETED|Overall Study||38||
48243148|NCT02268526|100914414|FG002|COMPLETED|Overall Study||16||
48243149|NCT02268526|100914412|FG000|NOT COMPLETED|Overall Study||1||
48243150|NCT02268526|100914413|FG001|NOT COMPLETED|Overall Study||21||
48243151|NCT02268526|100914414|FG002|NOT COMPLETED|Overall Study||5||
48243152|NCT03869541|100914415|FG000|STARTED|Overall Study||40||
48243153|NCT03869541|100914416|FG001|STARTED|Overall Study||50||
48243154|NCT03869541|100914417|FG002|STARTED|Overall Study||10||
48243155|NCT03869541|100914415|FG000|COMPLETED|Overall Study||40||
48243156|NCT03869541|100914416|FG001|COMPLETED|Overall Study||50||
48243157|NCT03869541|100914417|FG002|COMPLETED|Overall Study||10||
48680754|NCT01837680|102003116|FG001|STARTED|Overall Study||53||
48243158|NCT03869541|100914415|FG000|NOT COMPLETED|Overall Study||0||
48243159|NCT03869541|100914416|FG001|NOT COMPLETED|Overall Study||0||
48243160|NCT03869541|100914417|FG002|NOT COMPLETED|Overall Study||0||
48243161|NCT01482819|100914418|FG000|STARTED|Overall Study||21||
48243162|NCT01482819|100914418|FG000|COMPLETED|Overall Study||19||
48243163|NCT01482819|100914418|FG000|NOT COMPLETED|Overall Study||2||
48243164|NCT02798861|100914419|FG000|STARTED|Overall Study||160||
48243165|NCT02798861|100914419|FG000|COMPLETED|Overall Study||137||
48243166|NCT02798861|100914419|FG000|NOT COMPLETED|Overall Study||23||
48243167|NCT02446912|100914420|FG000|STARTED|Overall Study||93||
48243168|NCT02446912|100914421|FG001|STARTED|Overall Study||180||
48243169|NCT02446912|100914422|FG002|STARTED|Overall Study||184||
48243170|NCT02446912|100914420|FG000|Participants Who Completed Week 52|Overall Study||80||
48243171|NCT02446912|100914421|FG001|Participants Who Completed Week 52|Overall Study||153||
48243172|NCT02446912|100914422|FG002|Participants Who Completed Week 52|Overall Study||157||
48243173|NCT02446912|100914420|FG000|COMPLETED|Overall Study||75||
48243174|NCT02446912|100914421|FG001|COMPLETED|Overall Study||145||
48243175|NCT02446912|100914422|FG002|COMPLETED|Overall Study||149||
48243176|NCT02446912|100914420|FG000|NOT COMPLETED|Overall Study||18||
48243177|NCT02446912|100914421|FG001|NOT COMPLETED|Overall Study||35||
48243178|NCT02446912|100914422|FG002|NOT COMPLETED|Overall Study||35||
48243179|NCT00276016|100914423|FG000|STARTED|Intervention 1||7||
48243180|NCT00276016|100914424|FG001|STARTED|Intervention 1||7||
48243181|NCT00276016|100914425|FG002|STARTED|Intervention 1||7||
48243182|NCT00276016|100914426|FG003|STARTED|Intervention 1||6||
48243183|NCT00276016|100914427|FG004|STARTED|Intervention 1||6||
48243184|NCT00276016|100914428|FG005|STARTED|Intervention 1||6||
48243185|NCT00276016|100914423|FG000|COMPLETED|Intervention 1||7||
48243186|NCT00276016|100914424|FG001|COMPLETED|Intervention 1||6||
48243187|NCT00276016|100914425|FG002|COMPLETED|Intervention 1||7||
48243188|NCT00276016|100914426|FG003|COMPLETED|Intervention 1||6||
48243189|NCT00276016|100914427|FG004|COMPLETED|Intervention 1||6||
48243190|NCT00276016|100914428|FG005|COMPLETED|Intervention 1||6||
48243191|NCT00276016|100914423|FG000|NOT COMPLETED|Intervention 1||0||
48243192|NCT00276016|100914424|FG001|NOT COMPLETED|Intervention 1||1||
48243193|NCT00276016|100914425|FG002|NOT COMPLETED|Intervention 1||0||
48243194|NCT00276016|100914426|FG003|NOT COMPLETED|Intervention 1||0||
48243195|NCT00276016|100914427|FG004|NOT COMPLETED|Intervention 1||0||
48243196|NCT00276016|100914428|FG005|NOT COMPLETED|Intervention 1||0||
48243197|NCT00276016|100914423|FG000|STARTED|Wash Out 1||7||
48243198|NCT00276016|100914424|FG001|STARTED|Wash Out 1||6||
48243199|NCT00276016|100914425|FG002|STARTED|Wash Out 1||7||
48243200|NCT00276016|100914426|FG003|STARTED|Wash Out 1||6||
48243201|NCT00276016|100914427|FG004|STARTED|Wash Out 1||6||
48243202|NCT00276016|100914428|FG005|STARTED|Wash Out 1||6||
48243203|NCT00276016|100914423|FG000|COMPLETED|Wash Out 1||7||
48243204|NCT00276016|100914424|FG001|COMPLETED|Wash Out 1||6||
48243205|NCT00276016|100914425|FG002|COMPLETED|Wash Out 1||7||
48243206|NCT00276016|100914426|FG003|COMPLETED|Wash Out 1||6||
48243207|NCT00276016|100914427|FG004|COMPLETED|Wash Out 1||6||
48243208|NCT00276016|100914428|FG005|COMPLETED|Wash Out 1||6||
48243209|NCT00276016|100914423|FG000|NOT COMPLETED|Wash Out 1||0||
48243210|NCT00276016|100914424|FG001|NOT COMPLETED|Wash Out 1||0||
48680755|NCT01837680|102003115|FG000|COMPLETED|Overall Study||42||
48680756|NCT01837680|102003116|FG001|COMPLETED|Overall Study||45||
48243211|NCT00276016|100914425|FG002|NOT COMPLETED|Wash Out 1||0||
48243212|NCT00276016|100914426|FG003|NOT COMPLETED|Wash Out 1||0||
48243213|NCT00276016|100914427|FG004|NOT COMPLETED|Wash Out 1||0||
48243214|NCT00276016|100914428|FG005|NOT COMPLETED|Wash Out 1||0||
48243215|NCT00276016|100914423|FG000|STARTED|Intervention 2||7||
48243216|NCT00276016|100914424|FG001|STARTED|Intervention 2||6||
48243217|NCT00276016|100914425|FG002|STARTED|Intervention 2||7||
48243218|NCT00276016|100914426|FG003|STARTED|Intervention 2||6||
48243219|NCT00276016|100914427|FG004|STARTED|Intervention 2||6||
48243220|NCT00276016|100914428|FG005|STARTED|Intervention 2||6||
48680757|NCT01837680|102003115|FG000|NOT COMPLETED|Overall Study||10||
48680758|NCT01837680|102003116|FG001|NOT COMPLETED|Overall Study||8||
48680759|NCT01944020|102003117|FG000|STARTED|Overall Study||17||
48680760|NCT01944020|102003118|FG001|STARTED|Overall Study||12||
48680761|NCT01944020|102003117|FG000|COMPLETED|Overall Study||12||
48680762|NCT01944020|102003118|FG001|COMPLETED|Overall Study||12||
48680763|NCT01944020|102003117|FG000|NOT COMPLETED|Overall Study||5||
48680764|NCT01944020|102003118|FG001|NOT COMPLETED|Overall Study||0||
48680765|NCT01082614|102003119|FG000|STARTED|Overall Study||23||
48680766|NCT01082614|102003120|FG001|STARTED|Overall Study||23||
48680767|NCT01082614|102003119|FG000|COMPLETED|Overall Study||20||
48680768|NCT01082614|102003120|FG001|COMPLETED|Overall Study||18||
48680769|NCT01082614|102003119|FG000|NOT COMPLETED|Overall Study||3||
48680770|NCT01082614|102003120|FG001|NOT COMPLETED|Overall Study||5||
48680771|NCT00710944|102003121|FG000|STARTED|Overall Study||55||
48680772|NCT00710944|102003122|FG001|STARTED|Overall Study||58||
48680773|NCT00710944|102003123|FG002|STARTED|Overall Study||19||
48680774|NCT00710944|102003121|FG000|COMPLETED|Overall Study||45||
48680775|NCT00710944|102003122|FG001|COMPLETED|Overall Study||49||
48680776|NCT00710944|102003123|FG002|COMPLETED|Overall Study||17||
48680777|NCT00710944|102003121|FG000|NOT COMPLETED|Overall Study||10||
48680778|NCT00710944|102003122|FG001|NOT COMPLETED|Overall Study||9||
48680779|NCT00710944|102003123|FG002|NOT COMPLETED|Overall Study||2||
48680780|NCT02727322|102003124|FG000|STARTED|Overall Study||77||
48680781|NCT02727322|102003125|FG001|STARTED|Overall Study||77||
48680782|NCT02727322|102003124|FG000|COMPLETED|Overall Study||75||
48680783|NCT02727322|102003125|FG001|COMPLETED|Overall Study||76||
48680784|NCT02727322|102003124|FG000|NOT COMPLETED|Overall Study||2||
48680785|NCT02727322|102003125|FG001|NOT COMPLETED|Overall Study||1||
48680786|NCT00800982|102003126|FG000|STARTED|Overall Study||15||
48680787|NCT00800982|102003127|FG001|STARTED|Overall Study||15||
48680788|NCT00800982|102003126|FG000|COMPLETED|Overall Study||13||
48680789|NCT00800982|102003127|FG001|COMPLETED|Overall Study||12||
48680790|NCT00800982|102003126|FG000|NOT COMPLETED|Overall Study||2||
48680791|NCT00800982|102003127|FG001|NOT COMPLETED|Overall Study||3||
48680792|NCT03606486|102003128|FG000|STARTED|Overall Study||52||
48680793|NCT03606486|102003128|FG000|COMPLETED|Overall Study||47||
48680794|NCT03606486|102003128|FG000|NOT COMPLETED|Overall Study||5||
48680795|NCT00565409|102003129|FG000|STARTED|Period 1 Open Label||834||
48680796|NCT00565409|102003130|FG001|STARTED|Period 1 Open Label||0||
48680797|NCT00565409|102003131|FG002|STARTED|Period 1 Open Label||0||
48680798|NCT00565409|102003132|FG003|STARTED|Period 1 Open Label||0||
48680799|NCT00565409|102003129|FG000|COMPLETED|Period 1 Open Label||756||
48680800|NCT00565409|102003130|FG001|COMPLETED|Period 1 Open Label||0||
48680801|NCT00565409|102003131|FG002|COMPLETED|Period 1 Open Label||0||
48680802|NCT00565409|102003132|FG003|COMPLETED|Period 1 Open Label||0||
48680803|NCT00565409|102003129|FG000|NOT COMPLETED|Period 1 Open Label||78||
48680804|NCT00565409|102003130|FG001|NOT COMPLETED|Period 1 Open Label||0||
48680805|NCT00565409|102003131|FG002|NOT COMPLETED|Period 1 Open Label||0||
48243221|NCT00276016|100914423|FG000|COMPLETED|Intervention 2||7||
48243222|NCT00276016|100914424|FG001|COMPLETED|Intervention 2||6||
48243223|NCT00276016|100914425|FG002|COMPLETED|Intervention 2||7||
48243224|NCT00276016|100914426|FG003|COMPLETED|Intervention 2||6||
48243225|NCT00276016|100914427|FG004|COMPLETED|Intervention 2||6||
48243226|NCT00276016|100914428|FG005|COMPLETED|Intervention 2||6||
48243227|NCT00276016|100914423|FG000|NOT COMPLETED|Intervention 2||0||
48243228|NCT00276016|100914424|FG001|NOT COMPLETED|Intervention 2||0||
48243229|NCT00276016|100914425|FG002|NOT COMPLETED|Intervention 2||0||
48243230|NCT00276016|100914426|FG003|NOT COMPLETED|Intervention 2||0||
48243231|NCT00276016|100914427|FG004|NOT COMPLETED|Intervention 2||0||
48243232|NCT00276016|100914428|FG005|NOT COMPLETED|Intervention 2||0||
48243233|NCT00276016|100914423|FG000|STARTED|Wash Out 2||7||
48243234|NCT00276016|100914424|FG001|STARTED|Wash Out 2||6||
48243235|NCT00276016|100914425|FG002|STARTED|Wash Out 2||7||
48243236|NCT00276016|100914426|FG003|STARTED|Wash Out 2||6||
48243237|NCT00276016|100914427|FG004|STARTED|Wash Out 2||6||
48243238|NCT00276016|100914428|FG005|STARTED|Wash Out 2||6||
48243239|NCT00276016|100914423|FG000|COMPLETED|Wash Out 2||7||
48680806|NCT00565409|102003132|FG003|NOT COMPLETED|Period 1 Open Label||0||
48680807|NCT00565409|102003129|FG000|STARTED|After Period 1, Prior to Period 2||756||
48680808|NCT00565409|102003130|FG001|STARTED|After Period 1, Prior to Period 2||0||
48680809|NCT00565409|102003131|FG002|STARTED|After Period 1, Prior to Period 2||0||
48680810|NCT00565409|102003132|FG003|STARTED|After Period 1, Prior to Period 2||0||
48680811|NCT00565409|102003129|FG000|COMPLETED|After Period 1, Prior to Period 2||604||
48680812|NCT00565409|102003130|FG001|COMPLETED|After Period 1, Prior to Period 2||0||
48680813|NCT00565409|102003131|FG002|COMPLETED|After Period 1, Prior to Period 2||0||
48680814|NCT00565409|102003132|FG003|COMPLETED|After Period 1, Prior to Period 2||0||
48680815|NCT00565409|102003129|FG000|NOT COMPLETED|After Period 1, Prior to Period 2||152||
48680816|NCT00565409|102003130|FG001|NOT COMPLETED|After Period 1, Prior to Period 2||0||
48680817|NCT00565409|102003131|FG002|NOT COMPLETED|After Period 1, Prior to Period 2||0||
48243240|NCT00276016|100914424|FG001|COMPLETED|Wash Out 2||6||
48243241|NCT00276016|100914425|FG002|COMPLETED|Wash Out 2||7||
48243242|NCT00276016|100914426|FG003|COMPLETED|Wash Out 2||6||
48680818|NCT00565409|102003132|FG003|NOT COMPLETED|After Period 1, Prior to Period 2||0||
48680819|NCT00565409|102003129|FG000|STARTED|Period 2 Double-Blind||0||
48243243|NCT00276016|100914427|FG004|COMPLETED|Wash Out 2||6||
48243244|NCT00276016|100914428|FG005|COMPLETED|Wash Out 2||6||
48243245|NCT00276016|100914423|FG000|NOT COMPLETED|Wash Out 2||0||
48243246|NCT00276016|100914424|FG001|NOT COMPLETED|Wash Out 2||0||
48680820|NCT00565409|102003130|FG001|STARTED|Period 2 Double-Blind||202||
48680821|NCT00565409|102003131|FG002|STARTED|Period 2 Double-Blind||202||
48680822|NCT00565409|102003132|FG003|STARTED|Period 2 Double-Blind||200||
48680823|NCT00565409|102003129|FG000|COMPLETED|Period 2 Double-Blind||0||
48680824|NCT00565409|102003130|FG001|COMPLETED|Period 2 Double-Blind||181||
48680825|NCT00565409|102003131|FG002|COMPLETED|Period 2 Double-Blind||175||
48680826|NCT00565409|102003132|FG003|COMPLETED|Period 2 Double-Blind||141||
48680827|NCT00565409|102003129|FG000|NOT COMPLETED|Period 2 Double-Blind||0||
48680828|NCT00565409|102003130|FG001|NOT COMPLETED|Period 2 Double-Blind||21||
48680829|NCT00565409|102003131|FG002|NOT COMPLETED|Period 2 Double-Blind||27||
48680830|NCT00565409|102003132|FG003|NOT COMPLETED|Period 2 Double-Blind||59||
48680831|NCT01646814|102003133|FG000|STARTED|Overall Study||121||
48680832|NCT01646814|102003134|FG001|STARTED|Overall Study||126||
48680833|NCT01646814|102003133|FG000|COMPLETED|Overall Study||110||
48680834|NCT01646814|102003134|FG001|COMPLETED|Overall Study||120||
48680835|NCT01646814|102003133|FG000|NOT COMPLETED|Overall Study||11||
48680836|NCT01646814|102003134|FG001|NOT COMPLETED|Overall Study||6||
48680837|NCT01444430|102003135|FG000|STARTED|Overall Study||5846||
48680838|NCT01444430|102003136|FG001|STARTED|Overall Study||5847||
48680839|NCT01444430|102003135|FG000|COMPLETED|Overall Study||5785||
48680840|NCT01444430|102003136|FG001|COMPLETED|Overall Study||5766||
48680841|NCT01444430|102003135|FG000|NOT COMPLETED|Overall Study||61||
48680842|NCT01444430|102003136|FG001|NOT COMPLETED|Overall Study||81||
48680843|NCT00383071|102003137|FG000|STARTED|Overall Study||25||
48680844|NCT00383071|102003138|FG001|STARTED|Overall Study||25||
48680845|NCT00383071|102003139|FG002|STARTED|Overall Study||51||
48680846|NCT00383071|102003140|FG003|STARTED|Overall Study||25||
48680847|NCT00383071|102003137|FG000|COMPLETED|Overall Study||25||
48680848|NCT00383071|102003138|FG001|COMPLETED|Overall Study||21||
48680849|NCT00383071|102003139|FG002|COMPLETED|Overall Study||44||
48680850|NCT00383071|102003140|FG003|COMPLETED|Overall Study||22||
48680851|NCT00383071|102003137|FG000|NOT COMPLETED|Overall Study||0||
48680852|NCT00383071|102003138|FG001|NOT COMPLETED|Overall Study||4||
48680853|NCT00383071|102003139|FG002|NOT COMPLETED|Overall Study||7||
48680854|NCT00383071|102003140|FG003|NOT COMPLETED|Overall Study||3||
48680855|NCT01070979|102003141|FG000|STARTED|Overall Study||79||
48680856|NCT01070979|102003142|FG001|STARTED|Overall Study||85||
48680857|NCT01070979|102003143|FG002|STARTED|Overall Study||85||
48680858|NCT01070979|102003141|FG000|COMPLETED|Overall Study||68||
48680859|NCT01070979|102003142|FG001|COMPLETED|Overall Study||73||
48680860|NCT01070979|102003143|FG002|COMPLETED|Overall Study||72||
48680861|NCT01070979|102003141|FG000|NOT COMPLETED|Overall Study||11||
48680862|NCT01070979|102003142|FG001|NOT COMPLETED|Overall Study||12||
48680863|NCT01070979|102003143|FG002|NOT COMPLETED|Overall Study||13||
48680864|NCT02263014|102003144|FG000|STARTED|Overall Study||44||
48680865|NCT02263014|102003145|FG001|STARTED|Overall Study||208||
48680866|NCT02263014|102003144|FG000|COMPLETED|Overall Study||44||
48680867|NCT02263014|102003145|FG001|COMPLETED|Overall Study||208||
48680868|NCT02263014|102003144|FG000|NOT COMPLETED|Overall Study||0||
48680869|NCT02263014|102003145|FG001|NOT COMPLETED|Overall Study||0||
48680870|NCT00165789|102003146|FG000|STARTED|Overall Study||8||
48680871|NCT00165789|102003147|FG001|STARTED|Overall Study||20||
48680872|NCT00165789|102003148|FG002|STARTED|Overall Study||12||
48680873|NCT00165789|102003149|FG003|STARTED|Overall Study||35||
48680874|NCT00165789|102003146|FG000|COMPLETED|Overall Study||8||
48680875|NCT00165789|102003147|FG001|COMPLETED|Overall Study||16||
48680876|NCT00165789|102003148|FG002|COMPLETED|Overall Study||11||
48680877|NCT00165789|102003149|FG003|COMPLETED|Overall Study||21||
48680878|NCT00165789|102003146|FG000|NOT COMPLETED|Overall Study||0||
48680879|NCT00165789|102003147|FG001|NOT COMPLETED|Overall Study||4||
48680880|NCT00165789|102003148|FG002|NOT COMPLETED|Overall Study||1||
48680881|NCT00165789|102003149|FG003|NOT COMPLETED|Overall Study||14||
48680882|NCT02481258|102003150|FG000|STARTED|Overall Study||12||
48680883|NCT02481258|102003151|FG001|STARTED|Overall Study||11||
48680884|NCT02481258|102003150|FG000|COMPLETED|Overall Study||12||
48680885|NCT02481258|102003151|FG001|COMPLETED|Overall Study||11||
48680886|NCT02481258|102003150|FG000|NOT COMPLETED|Overall Study||0||
48680887|NCT02481258|102003151|FG001|NOT COMPLETED|Overall Study||0||
48680888|NCT02146131|102003152|FG000|STARTED|Overall Study||170||
48680889|NCT02146131|102003153|FG001|STARTED|Overall Study||169||
48680890|NCT02146131|102003152|FG000|COMPLETED|Overall Study||109||
48680891|NCT02146131|102003153|FG001|COMPLETED|Overall Study||113||
48680892|NCT02146131|102003152|FG000|NOT COMPLETED|Overall Study||61||
48680893|NCT02146131|102003153|FG001|NOT COMPLETED|Overall Study||56||
48680894|NCT00517699|102003154|FG000|STARTED|Overall Study||5||
48680895|NCT00517699|102003154|FG000|COMPLETED|Overall Study||0||
48680896|NCT00517699|102003154|FG000|NOT COMPLETED|Overall Study||5||
48680897|NCT01788943|102003155|FG000|STARTED|Overall Study||13||
48680898|NCT01788943|102003156|FG001|STARTED|Overall Study||12||
48680899|NCT01788943|102003155|FG000|COMPLETED|Overall Study||12||
48680900|NCT01788943|102003156|FG001|COMPLETED|Overall Study||12||
48680901|NCT01788943|102003155|FG000|NOT COMPLETED|Overall Study||1||
48680902|NCT01788943|102003156|FG001|NOT COMPLETED|Overall Study||0||
48680903|NCT02777086|102003157|FG000|STARTED|Overall Study||261||
48680904|NCT02777086|102003158|FG001|STARTED|Overall Study||250||
48680905|NCT02777086|102003157|FG000|COMPLETED|Overall Study||165||
48680906|NCT02777086|102003158|FG001|COMPLETED|Overall Study||151||
48680907|NCT02777086|102003157|FG000|NOT COMPLETED|Overall Study||96||
48680908|NCT02777086|102003158|FG001|NOT COMPLETED|Overall Study||99||
48680909|NCT02465931|102003159|FG000|STARTED|Overall Study||55||
48680910|NCT02465931|102003160|FG001|STARTED|Overall Study||56||
48680911|NCT02465931|102003159|FG000|COMPLETED|Overall Study||44||
48680912|NCT02465931|102003160|FG001|COMPLETED|Overall Study||45||
48680913|NCT02465931|102003159|FG000|NOT COMPLETED|Overall Study||11||
48680914|NCT02465931|102003160|FG001|NOT COMPLETED|Overall Study||11||
48680915|NCT01445847|102003161|FG000|STARTED|Overall Study||50||
48680916|NCT01445847|102003162|FG001|STARTED|Overall Study||50||
48680917|NCT01445847|102003161|FG000|COMPLETED|Overall Study||36||
48680918|NCT01445847|102003162|FG001|COMPLETED|Overall Study||36||
48680919|NCT01445847|102003161|FG000|NOT COMPLETED|Overall Study||14||
48680920|NCT01445847|102003162|FG001|NOT COMPLETED|Overall Study||14||
48680921|NCT03835078|102003163|FG000|STARTED|Overall Study||39||
48680922|NCT03835078|102003163|FG000|COMPLETED|Overall Study||39||
48680923|NCT03835078|102003163|FG000|NOT COMPLETED|Overall Study||0||
48680924|NCT01224236|102003164|FG000|STARTED|Overall Study||76||
48680925|NCT01224236|102003165|FG001|STARTED|Overall Study||74||
48680926|NCT01224236|102003164|FG000|COMPLETED|Overall Study||75||
48680927|NCT01224236|102003165|FG001|COMPLETED|Overall Study||73||
48680928|NCT01224236|102003164|FG000|NOT COMPLETED|Overall Study||1||
48680929|NCT01224236|102003165|FG001|NOT COMPLETED|Overall Study||1||
48680930|NCT02949011|102003166|FG000|STARTED|Overall Study||730||
48680931|NCT02949011|102003167|FG001|STARTED|Overall Study||729||
48680932|NCT02949011|102003168|FG002|STARTED|Overall Study||725||
48081621|NCT03129100|100521627|FG014|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081622|NCT03129100|100521628|FG015|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48680933|NCT02949011|102003166|FG000|Received Study Drug|Overall Study||728||
48680934|NCT02949011|102003167|FG001|Received Study Drug|Overall Study||728||
48680935|NCT02949011|102003168|FG002|Received Study Drug|Overall Study||722||
48680936|NCT02949011|102003166|FG000|Intention to Treat Infected Population|Overall Study||388||
48680937|NCT02949011|102003167|FG001|Intention to Treat Infected Population|Overall Study||386||
48243247|NCT00276016|100914425|FG002|NOT COMPLETED|Wash Out 2||0||
48243248|NCT00276016|100914426|FG003|NOT COMPLETED|Wash Out 2||0||
48243249|NCT00276016|100914427|FG004|NOT COMPLETED|Wash Out 2||0||
48243250|NCT00276016|100914428|FG005|NOT COMPLETED|Wash Out 2||0||
48243251|NCT00276016|100914423|FG000|STARTED|Intervention 3||7||
48243252|NCT00276016|100914424|FG001|STARTED|Intervention 3||6||
48243253|NCT00276016|100914425|FG002|STARTED|Intervention 3||7||
48540546|NCT03426137|101658128|FG001|STARTED|Overall Study||0||
48243254|NCT00276016|100914426|FG003|STARTED|Intervention 3||6||
48243255|NCT00276016|100914427|FG004|STARTED|Intervention 3||6||
48243256|NCT00276016|100914428|FG005|STARTED|Intervention 3||6||
48243257|NCT00276016|100914423|FG000|COMPLETED|Intervention 3||7||
48243258|NCT00276016|100914424|FG001|COMPLETED|Intervention 3||6||
48243259|NCT00276016|100914425|FG002|COMPLETED|Intervention 3||7||
48243260|NCT00276016|100914426|FG003|COMPLETED|Intervention 3||6||
48680938|NCT02949011|102003168|FG002|Intention to Treat Infected Population|Overall Study||389||
48680939|NCT02949011|102003166|FG000|COMPLETED|Overall Study||697||
48680940|NCT02949011|102003167|FG001|COMPLETED|Overall Study||695||
48680941|NCT02949011|102003168|FG002|COMPLETED|Overall Study||683||
48680942|NCT02949011|102003166|FG000|NOT COMPLETED|Overall Study||33||
48680943|NCT02949011|102003167|FG001|NOT COMPLETED|Overall Study||34||
48680944|NCT02949011|102003168|FG002|NOT COMPLETED|Overall Study||42||
48680945|NCT02227810|102003169|FG000|STARTED|Overall Study||19||
48243261|NCT00276016|100914427|FG004|COMPLETED|Intervention 3||6||
48680946|NCT02227810|102003170|FG001|STARTED|Overall Study||34||
48680947|NCT02227810|102003169|FG000|COMPLETED|Overall Study||17||
48680948|NCT02227810|102003170|FG001|COMPLETED|Overall Study||29||
48680949|NCT02227810|102003169|FG000|NOT COMPLETED|Overall Study||2||
48243262|NCT00276016|100914428|FG005|COMPLETED|Intervention 3||6||
48243263|NCT00276016|100914423|FG000|NOT COMPLETED|Intervention 3||0||
48243264|NCT00276016|100914424|FG001|NOT COMPLETED|Intervention 3||0||
48243265|NCT00276016|100914425|FG002|NOT COMPLETED|Intervention 3||0||
48243266|NCT00276016|100914426|FG003|NOT COMPLETED|Intervention 3||0||
48243267|NCT00276016|100914427|FG004|NOT COMPLETED|Intervention 3||0||
48243268|NCT00276016|100914428|FG005|NOT COMPLETED|Intervention 3||0||
48243269|NCT01332318|100914429|FG000|STARTED|Overall Study||34||
48243270|NCT01332318|100914430|FG001|STARTED|Overall Study||32||
48243271|NCT01332318|100914431|FG002|STARTED|Overall Study||34||
48243272|NCT01332318|100914432|FG003|STARTED|Overall Study||30||
48243273|NCT01332318|100914429|FG000|COMPLETED|Overall Study||32||
48243274|NCT01332318|100914430|FG001|COMPLETED|Overall Study||28||
48243275|NCT01332318|100914431|FG002|COMPLETED|Overall Study||33||
48243276|NCT01332318|100914432|FG003|COMPLETED|Overall Study||28||
48243277|NCT01332318|100914429|FG000|NOT COMPLETED|Overall Study||2||
48243278|NCT01332318|100914430|FG001|NOT COMPLETED|Overall Study||4||
48243279|NCT01332318|100914431|FG002|NOT COMPLETED|Overall Study||1||
48243280|NCT01332318|100914432|FG003|NOT COMPLETED|Overall Study||2||
48243281|NCT00525915|100914433|FG000|STARTED|Overall Study||63||
48243282|NCT00525915|100914434|FG001|STARTED|Overall Study||63||
48243283|NCT00525915|100914433|FG000|COMPLETED|Overall Study||55||
48243284|NCT00525915|100914434|FG001|COMPLETED|Overall Study||54||
48243285|NCT00525915|100914433|FG000|NOT COMPLETED|Overall Study||8||
48243286|NCT00525915|100914434|FG001|NOT COMPLETED|Overall Study||9||
48243287|NCT01078376|100914435|FG000|STARTED|Overall Study||9||
48243288|NCT01078376|100914436|FG001|STARTED|Overall Study||9||
48243289|NCT01078376|100914437|FG002|STARTED|Overall Study||8||
48243290|NCT01078376|100914438|FG003|STARTED|Overall Study||3||
48243291|NCT01078376|100914435|FG000|COMPLETED|Overall Study||9||
48680950|NCT02227810|102003170|FG001|NOT COMPLETED|Overall Study||5||
48680951|NCT01334554|102003171|FG000|STARTED|Overall Study||23||
48680952|NCT01334554|102003172|FG001|STARTED|Overall Study||23||
48680953|NCT01334554|102003171|FG000|COMPLETED|Overall Study||19||
48680954|NCT01334554|102003172|FG001|COMPLETED|Overall Study||21||
48680955|NCT01334554|102003171|FG000|NOT COMPLETED|Overall Study||4||
48680956|NCT01334554|102003172|FG001|NOT COMPLETED|Overall Study||2||
48680957|NCT03465722|102003173|FG000|STARTED|Overall Study||240||
48680958|NCT03465722|102003174|FG001|STARTED|Overall Study||236||
48680959|NCT03465722|102003173|FG000|COMPLETED|Overall Study||0||
48680960|NCT03465722|102003174|FG001|COMPLETED|Overall Study||0||
48243292|NCT01078376|100914436|FG001|COMPLETED|Overall Study||9||
48243293|NCT01078376|100914437|FG002|COMPLETED|Overall Study||8||
48243294|NCT01078376|100914438|FG003|COMPLETED|Overall Study||3||
48243295|NCT01078376|100914435|FG000|NOT COMPLETED|Overall Study||0||
48243296|NCT01078376|100914436|FG001|NOT COMPLETED|Overall Study||0||
48243297|NCT01078376|100914437|FG002|NOT COMPLETED|Overall Study||0||
48243298|NCT01078376|100914438|FG003|NOT COMPLETED|Overall Study||0||
48243299|NCT02438410|100914439|FG000|STARTED|Overall Study||13||
48243300|NCT02438410|100914439|FG000|COMPLETED|Overall Study||13||
48680961|NCT03465722|102003173|FG000|NOT COMPLETED|Overall Study||240||
48243301|NCT02438410|100914439|FG000|NOT COMPLETED|Overall Study||0||
48243302|NCT00605384|100914440|FG000|STARTED|Overall Study||1||
48243303|NCT00605384|100914441|FG001|STARTED|Overall Study||1||
48243304|NCT00605384|100914440|FG000|COMPLETED|Overall Study||0||
48243305|NCT00605384|100914441|FG001|COMPLETED|Overall Study||0||
48243306|NCT00605384|100914440|FG000|NOT COMPLETED|Overall Study||1||
48243307|NCT00605384|100914441|FG001|NOT COMPLETED|Overall Study||1||
48243308|NCT02416973|100914442|FG000|STARTED|Overall Study||14||
48243309|NCT02416973|100914443|FG001|STARTED|Overall Study||13||
48680962|NCT03465722|102003174|FG001|NOT COMPLETED|Overall Study||236||
48680963|NCT01722929|102003175|FG000|STARTED|Overall Study||4||
48680964|NCT01722929|102003175|FG000|COMPLETED|Overall Study||4||
48680965|NCT01722929|102003175|FG000|NOT COMPLETED|Overall Study||0||
48243310|NCT02416973|100914444|FG002|STARTED|Overall Study||14||
48243311|NCT02416973|100914442|FG000|COMPLETED|Overall Study||13||
48243312|NCT02416973|100914443|FG001|COMPLETED|Overall Study||10||
48243313|NCT02416973|100914444|FG002|COMPLETED|Overall Study||13||
48243314|NCT02416973|100914442|FG000|NOT COMPLETED|Overall Study||1||
48243315|NCT02416973|100914443|FG001|NOT COMPLETED|Overall Study||3||
48243316|NCT02416973|100914444|FG002|NOT COMPLETED|Overall Study||1||
48243317|NCT02115542|100914445|FG000|STARTED|Overall Study||39||
48243318|NCT02115542|100914445|FG000|COMPLETED|Overall Study||39||
48243319|NCT02115542|100914445|FG000|NOT COMPLETED|Overall Study||0||
48243320|NCT03023878|100914446|FG000|STARTED|Pre-Study Run-In Period||47|Standard of Care (SOC) rituximab (R)-chemotherapy Analysis Set.|
48243321|NCT03023878|100914446|FG000|COMPLETED|Pre-Study Run-In Period||30||
48243322|NCT03023878|100914446|FG000|NOT COMPLETED|Pre-Study Run-In Period||17||
48243323|NCT03023878|100914446|FG000|STARTED|Between Run-In and Treatment Periods||30||
48243324|NCT03023878|100914446|FG000|COMPLETED|Between Run-In and Treatment Periods||28||
48243325|NCT03023878|100914446|FG000|NOT COMPLETED|Between Run-In and Treatment Periods||2||
48243326|NCT03023878|100914446|FG000|STARTED|Treatment Period||28||
48243327|NCT03023878|100914446|FG000|Started Cycle 1|Treatment Period||28|Full analysis set (FAS)|
48243328|NCT03023878|100914446|FG000|Started Cycle 2|Treatment Period||11||
48243329|NCT03023878|100914446|FG000|COMPLETED|Treatment Period||25||
48243330|NCT03023878|100914446|FG000|NOT COMPLETED|Treatment Period||3||
48243331|NCT03023878|100914446|FG000|STARTED|Long Term Follow-Up Period||28|Treatment period participants are followed|
48243332|NCT03023878|100914446|FG000|COMPLETED|Long Term Follow-Up Period||26||
48243333|NCT03023878|100914446|FG000|NOT COMPLETED|Long Term Follow-Up Period||2||
48243334|NCT00788671|100914447|FG000|STARTED|Overall Study||57||
48243335|NCT00788671|100914447|FG000|COMPLETED|Overall Study||47||
48243336|NCT00788671|100914447|FG000|NOT COMPLETED|Overall Study||10||
48540547|NCT03426137|101658129|FG002|STARTED|Overall Study||0||
48243337|NCT02127892|100914448|FG000|STARTED|Overall Study||7||
48243338|NCT02127892|100914449|FG001|STARTED|Overall Study||2||
48243339|NCT02127892|100914450|FG002|STARTED|Overall Study||0||
48243340|NCT02127892|100914451|FG003|STARTED|Overall Study||0||
48243341|NCT02127892|100914448|FG000|COMPLETED|Overall Study||6||
48243342|NCT02127892|100914449|FG001|COMPLETED|Overall Study||1||
48243343|NCT02127892|100914450|FG002|COMPLETED|Overall Study||0||
48243344|NCT02127892|100914451|FG003|COMPLETED|Overall Study||0||
48243345|NCT02127892|100914448|FG000|NOT COMPLETED|Overall Study||1||
48243346|NCT02127892|100914449|FG001|NOT COMPLETED|Overall Study||1||
48243347|NCT02127892|100914450|FG002|NOT COMPLETED|Overall Study||0||
48540548|NCT03426137|101658127|FG000|COMPLETED|Overall Study||0||
48680966|NCT04460183|102003176|FG000|STARTED|Overall Study||14||
48680967|NCT04460183|102003177|FG001|STARTED|Overall Study||5||
48680968|NCT04460183|102003176|FG000|COMPLETED|Overall Study||10||
48680969|NCT04460183|102003177|FG001|COMPLETED|Overall Study||4||
48680970|NCT04460183|102003176|FG000|NOT COMPLETED|Overall Study||4||
48680971|NCT04460183|102003177|FG001|NOT COMPLETED|Overall Study||1||
48680972|NCT01612676|102003178|FG000|STARTED|Overall Study||6||
48680973|NCT01612676|102003179|FG001|STARTED|Overall Study||7||
48680974|NCT01612676|102003180|FG002|STARTED|Overall Study||5||
48680975|NCT01612676|102003181|FG003|STARTED|Overall Study||13||
48680976|NCT01612676|102003178|FG000|Dosed|Overall Study||5||
48680977|NCT01612676|102003179|FG001|Dosed|Overall Study||7||
48680978|NCT01612676|102003180|FG002|Dosed|Overall Study||5||
48680979|NCT01612676|102003181|FG003|Dosed|Overall Study||13||
48680980|NCT01612676|102003178|FG000|COMPLETED|Overall Study||4||
48680981|NCT01612676|102003179|FG001|COMPLETED|Overall Study||3||
48680982|NCT01612676|102003180|FG002|COMPLETED|Overall Study||4||
48680983|NCT01612676|102003181|FG003|COMPLETED|Overall Study||10||
48680984|NCT01612676|102003178|FG000|NOT COMPLETED|Overall Study||2||
48680985|NCT01612676|102003179|FG001|NOT COMPLETED|Overall Study||4||
48680986|NCT01612676|102003180|FG002|NOT COMPLETED|Overall Study||1||
48680987|NCT01612676|102003181|FG003|NOT COMPLETED|Overall Study||3||
48680988|NCT02155101|102003182|FG000|STARTED|Overall Study||39||
48680989|NCT02155101|102003183|FG001|STARTED|Overall Study||81||
48680990|NCT02155101|102003182|FG000|COMPLETED|Overall Study||39||
48680991|NCT02155101|102003183|FG001|COMPLETED|Overall Study||80||
48680992|NCT02155101|102003182|FG000|NOT COMPLETED|Overall Study||0||
48680993|NCT02155101|102003183|FG001|NOT COMPLETED|Overall Study||1||
48243348|NCT02127892|100914451|FG003|NOT COMPLETED|Overall Study||0||
48243349|NCT01358175|100914452|FG000|STARTED|Overall Study||124||
48243350|NCT01358175|100914453|FG001|STARTED|Overall Study||125||
48243351|NCT01358175|100914454|FG002|STARTED|Overall Study||122||
48243352|NCT01358175|100914452|FG000|COMPLETED|Overall Study||103||
48243353|NCT01358175|100914453|FG001|COMPLETED|Overall Study||97||
48680994|NCT01622296|102003184|FG000|STARTED|First Intervention||10||
48680995|NCT01622296|102003185|FG001|STARTED|First Intervention||10||
48680996|NCT01622296|102003184|FG000|COMPLETED|First Intervention||10||
48680997|NCT01622296|102003185|FG001|COMPLETED|First Intervention||10||
48680998|NCT01622296|102003184|FG000|NOT COMPLETED|First Intervention||0||
48680999|NCT01622296|102003185|FG001|NOT COMPLETED|First Intervention||0||
48681000|NCT01622296|102003184|FG000|STARTED|Washout Period of at Least 1 Week||10||
48681001|NCT01622296|102003185|FG001|STARTED|Washout Period of at Least 1 Week||10||
48681002|NCT01622296|102003184|FG000|COMPLETED|Washout Period of at Least 1 Week||10||
48681003|NCT01622296|102003185|FG001|COMPLETED|Washout Period of at Least 1 Week||10||
48681004|NCT01622296|102003184|FG000|NOT COMPLETED|Washout Period of at Least 1 Week||0||
48681005|NCT01622296|102003185|FG001|NOT COMPLETED|Washout Period of at Least 1 Week||0||
48681006|NCT01622296|102003184|FG000|STARTED|Second Intervention||10||
48681007|NCT01622296|102003185|FG001|STARTED|Second Intervention||10||
48681008|NCT01622296|102003184|FG000|COMPLETED|Second Intervention||10||
48681009|NCT01622296|102003185|FG001|COMPLETED|Second Intervention||10||
48681010|NCT01622296|102003184|FG000|NOT COMPLETED|Second Intervention||0||
48681011|NCT01622296|102003185|FG001|NOT COMPLETED|Second Intervention||0||
48681012|NCT01166347|102003186|FG000|STARTED|Overall Study||297||
48681013|NCT01166347|102003187|FG001|STARTED|Overall Study||149||
48681014|NCT01166347|102003186|FG000|COMPLETED|Overall Study||295||
48243354|NCT01358175|100914454|FG002|COMPLETED|Overall Study||90||
48243355|NCT01358175|100914452|FG000|NOT COMPLETED|Overall Study||21||
48243356|NCT01358175|100914453|FG001|NOT COMPLETED|Overall Study||28||
48681015|NCT01166347|102003187|FG001|COMPLETED|Overall Study||148||
48681016|NCT01166347|102003186|FG000|NOT COMPLETED|Overall Study||2||
48681017|NCT01166347|102003187|FG001|NOT COMPLETED|Overall Study||1||
48243357|NCT01358175|100914454|FG002|NOT COMPLETED|Overall Study||32||
48243358|NCT01812707|100914455|FG000|STARTED|Overall Study||25||
48243359|NCT01812707|100914456|FG001|STARTED|Overall Study||25||
48243360|NCT01812707|100914457|FG002|STARTED|Overall Study||25||
48243361|NCT01812707|100914458|FG003|STARTED|Overall Study||25||
48681018|NCT05018689|102003188|FG000|STARTED|Overall Study||1560||
48681019|NCT05018689|102003189|FG001|STARTED|Overall Study||997||
48681020|NCT05018689|102003188|FG000|COMPLETED|Overall Study||392||
48681021|NCT05018689|102003189|FG001|COMPLETED|Overall Study||345||
48681022|NCT05018689|102003188|FG000|NOT COMPLETED|Overall Study||1168||
48681023|NCT05018689|102003189|FG001|NOT COMPLETED|Overall Study||652||
48681024|NCT01628913|102003190|FG000|STARTED|Overall Study||31||
48681025|NCT01628913|102003191|FG001|STARTED|Overall Study||31||
48681026|NCT01628913|102003190|FG000|COMPLETED|Overall Study||0||
48681027|NCT01628913|102003191|FG001|COMPLETED|Overall Study||0||
48681028|NCT01628913|102003190|FG000|NOT COMPLETED|Overall Study||31||
48681029|NCT01628913|102003191|FG001|NOT COMPLETED|Overall Study||31||
48681030|NCT00305877|102003192|FG000|STARTED|Overall Study||69||
48681031|NCT00305877|102003193|FG001|STARTED|Overall Study||68||
48681032|NCT00305877|102003192|FG000|Treated|Overall Study||67||
48681033|NCT00305877|102003193|FG001|Treated|Overall Study||63||
48681034|NCT00305877|102003192|FG000|Eligible|Overall Study||66||
48681035|NCT00305877|102003193|FG001|Eligible|Overall Study||66||
48681036|NCT00305877|102003192|FG000|Included in Efficacy Analysis|Overall Study||65||
48681037|NCT00305877|102003193|FG001|Included in Efficacy Analysis|Overall Study||62||
48681038|NCT00305877|102003192|FG000|COMPLETED|Overall Study||45||
48681039|NCT00305877|102003193|FG001|COMPLETED|Overall Study||34||
48681040|NCT00305877|102003192|FG000|NOT COMPLETED|Overall Study||24||
48681041|NCT00305877|102003193|FG001|NOT COMPLETED|Overall Study||34||
48681042|NCT02737501|102003194|FG000|STARTED|Randomized Phase||137||
48681043|NCT02737501|102003195|FG001|STARTED|Randomized Phase||138||
48681044|NCT02737501|102003196|FG002|STARTED|Randomized Phase||0||
48681045|NCT02737501|102003194|FG000|Safety Analysis Set|Randomized Phase||136||
48681046|NCT02737501|102003195|FG001|Safety Analysis Set|Randomized Phase||137||
48681047|NCT02737501|102003196|FG002|Safety Analysis Set|Randomized Phase||0||
48243362|NCT01812707|100914455|FG000|Treated|Overall Study||25||
48243363|NCT01812707|100914456|FG001|Treated|Overall Study||25||
48243364|NCT01812707|100914457|FG002|Treated|Overall Study||25||
48243365|NCT01812707|100914458|FG003|Treated|Overall Study||25||
48243366|NCT01812707|100914455|FG000|COMPLETED|Overall Study||23||
48243367|NCT01812707|100914456|FG001|COMPLETED|Overall Study||25||
48243368|NCT01812707|100914457|FG002|COMPLETED|Overall Study||25||
48681048|NCT02737501|102003194|FG000|COMPLETED|Randomized Phase||20||
48681049|NCT02737501|102003195|FG001|COMPLETED|Randomized Phase||84||
48681050|NCT02737501|102003196|FG002|COMPLETED|Randomized Phase||0||
48681051|NCT02737501|102003194|FG000|NOT COMPLETED|Randomized Phase||117||
48681052|NCT02737501|102003195|FG001|NOT COMPLETED|Randomized Phase||54||
48681053|NCT02737501|102003196|FG002|NOT COMPLETED|Randomized Phase||0||
48681054|NCT02737501|102003194|FG000|STARTED|Crossover Phase||0||
48681055|NCT02737501|102003195|FG001|STARTED|Crossover Phase||0||
48681056|NCT02737501|102003196|FG002|STARTED|Crossover Phase||65||
48681057|NCT02737501|102003194|FG000|COMPLETED|Crossover Phase||0||
48243369|NCT01812707|100914458|FG003|COMPLETED|Overall Study||23||
48243370|NCT01812707|100914455|FG000|NOT COMPLETED|Overall Study||2||
48243371|NCT01812707|100914456|FG001|NOT COMPLETED|Overall Study||0||
48243372|NCT01812707|100914457|FG002|NOT COMPLETED|Overall Study||0||
48243373|NCT01812707|100914458|FG003|NOT COMPLETED|Overall Study||2||
48681058|NCT02737501|102003195|FG001|COMPLETED|Crossover Phase||0||
48681059|NCT02737501|102003196|FG002|COMPLETED|Crossover Phase||10||
48681060|NCT02737501|102003194|FG000|NOT COMPLETED|Crossover Phase||0||
48681061|NCT02737501|102003195|FG001|NOT COMPLETED|Crossover Phase||0||
48681062|NCT02737501|102003196|FG002|NOT COMPLETED|Crossover Phase||55||
48681063|NCT01328743|102003197|FG000|STARTED|Overall Study||91||
48681064|NCT01328743|102003198|FG001|STARTED|Overall Study||89||
48681065|NCT01328743|102003197|FG000|COMPLETED|Overall Study||82||
48681066|NCT01328743|102003198|FG001|COMPLETED|Overall Study||79||
48681067|NCT01328743|102003197|FG000|NOT COMPLETED|Overall Study||9||
48681068|NCT01328743|102003198|FG001|NOT COMPLETED|Overall Study||10||
48681069|NCT05111145|102003199|FG000|STARTED|Overall Study||86||
48681070|NCT05111145|102003199|FG000|COMPLETED|Overall Study||0||
48681071|NCT05111145|102003199|FG000|NOT COMPLETED|Overall Study||86||
48681072|NCT00698828|102003200|FG000|STARTED|Overall Study||76||
48681073|NCT00698828|102003201|FG001|STARTED|Overall Study||75||
48681074|NCT00698828|102003202|FG002|STARTED|Overall Study||76||
48681075|NCT00698828|102003200|FG000|COMPLETED|Overall Study||67||
48681076|NCT00698828|102003201|FG001|COMPLETED|Overall Study||60||
48681077|NCT00698828|102003202|FG002|COMPLETED|Overall Study||65||
48681078|NCT00698828|102003200|FG000|NOT COMPLETED|Overall Study||9||
48681079|NCT00698828|102003201|FG001|NOT COMPLETED|Overall Study||15||
48681080|NCT00698828|102003202|FG002|NOT COMPLETED|Overall Study||11||
48681081|NCT04410159|102003203|FG000|STARTED|Overall Study||5||
48243374|NCT01124916|100914459|FG000|STARTED|Overall Study||38||
48243375|NCT01124916|100914460|FG001|STARTED|Overall Study||40||
48243376|NCT01124916|100914459|FG000|COMPLETED|Overall Study||35||
48243377|NCT01124916|100914460|FG001|COMPLETED|Overall Study||38||
48243378|NCT01124916|100914459|FG000|NOT COMPLETED|Overall Study||3||
48243379|NCT01124916|100914460|FG001|NOT COMPLETED|Overall Study||2||
48243380|NCT03441789|100914461|FG000|STARTED|Overall Study||14||
48243381|NCT03441789|100914462|FG001|STARTED|Overall Study||14||
48243382|NCT03441789|100914461|FG000|COMPLETED|Overall Study||13||
48243383|NCT03441789|100914462|FG001|COMPLETED|Overall Study||10||
48681082|NCT04410159|102003204|FG001|STARTED|Overall Study||5||
48681083|NCT04410159|102003205|FG002|STARTED|Overall Study||5||
48681084|NCT04410159|102003206|FG003|STARTED|Overall Study||5||
48681085|NCT04410159|102003203|FG000|COMPLETED|Overall Study||5||
48681086|NCT04410159|102003204|FG001|COMPLETED|Overall Study||5||
48681087|NCT04410159|102003205|FG002|COMPLETED|Overall Study||5||
48681088|NCT04410159|102003206|FG003|COMPLETED|Overall Study||5||
48681089|NCT04410159|102003203|FG000|NOT COMPLETED|Overall Study||0||
48681090|NCT04410159|102003204|FG001|NOT COMPLETED|Overall Study||0||
48681091|NCT04410159|102003205|FG002|NOT COMPLETED|Overall Study||0||
48681092|NCT04410159|102003206|FG003|NOT COMPLETED|Overall Study||0||
48681093|NCT01192126|102003207|FG000|STARTED|First Intervention (1 Week)||51||
48681094|NCT01192126|102003208|FG001|STARTED|First Intervention (1 Week)||51||
48681095|NCT01192126|102003207|FG000|COMPLETED|First Intervention (1 Week)||49||
48681096|NCT01192126|102003208|FG001|COMPLETED|First Intervention (1 Week)||50||
48681097|NCT01192126|102003207|FG000|NOT COMPLETED|First Intervention (1 Week)||2||
48681098|NCT01192126|102003208|FG001|NOT COMPLETED|First Intervention (1 Week)||1||
48681099|NCT01192126|102003207|FG000|STARTED|Second Intervention (1 Week)||49||
48681100|NCT01192126|102003208|FG001|STARTED|Second Intervention (1 Week)||50||
48681101|NCT01192126|102003207|FG000|COMPLETED|Second Intervention (1 Week)||49||
48681102|NCT01192126|102003208|FG001|COMPLETED|Second Intervention (1 Week)||50||
48681103|NCT01192126|102003207|FG000|NOT COMPLETED|Second Intervention (1 Week)||0||
48681104|NCT01192126|102003208|FG001|NOT COMPLETED|Second Intervention (1 Week)||0||
48681105|NCT01244711|102003209|FG000|STARTED|Overall Study||1||
48681106|NCT01244711|102003209|FG000|COMPLETED|Overall Study||1||
48681107|NCT01244711|102003209|FG000|NOT COMPLETED|Overall Study||0||
48681108|NCT02814656|102003210|FG000|STARTED|Overall Study||6||
48681109|NCT02814656|102003211|FG001|STARTED|Overall Study||6||
48681110|NCT02814656|102003212|FG002|STARTED|Overall Study||6||
48681111|NCT02814656|102003213|FG003|STARTED|Overall Study||6||
48681112|NCT02814656|102003210|FG000|COMPLETED|Overall Study||6||
48681113|NCT02814656|102003211|FG001|COMPLETED|Overall Study||6||
48681114|NCT02814656|102003212|FG002|COMPLETED|Overall Study||6||
48243384|NCT03441789|100914461|FG000|NOT COMPLETED|Overall Study||1||
48243385|NCT03441789|100914462|FG001|NOT COMPLETED|Overall Study||4||
48243386|NCT01493947|100914463|FG000|STARTED|Period A Efficacy and Safety Data||478||
48243387|NCT01493947|100914464|FG001|STARTED|Period A Efficacy and Safety Data||484||
48243388|NCT01493947|100914463|FG000|COMPLETED|Period A Efficacy and Safety Data||446||
48681115|NCT02814656|102003213|FG003|COMPLETED|Overall Study||6||
48681116|NCT02814656|102003210|FG000|NOT COMPLETED|Overall Study||0||
48681117|NCT02814656|102003211|FG001|NOT COMPLETED|Overall Study||0||
48243389|NCT01493947|100914464|FG001|COMPLETED|Period A Efficacy and Safety Data||456||
48243390|NCT01493947|100914463|FG000|NOT COMPLETED|Period A Efficacy and Safety Data||32||
48243391|NCT01493947|100914464|FG001|NOT COMPLETED|Period A Efficacy and Safety Data||28||
48243392|NCT01493947|100914463|FG000|STARTED|Period B Extension Period||399||
48243393|NCT01493947|100914464|FG001|STARTED|Period B Extension Period||358||
48681118|NCT02814656|102003212|FG002|NOT COMPLETED|Overall Study||0||
48681119|NCT02814656|102003213|FG003|NOT COMPLETED|Overall Study||0||
48681120|NCT04021290|102003214|FG000|STARTED|Randomized Phase (Day1 to Week 52)||246||
48681121|NCT04021290|102003215|FG001|STARTED|Randomized Phase (Day1 to Week 52)||247||
48243394|NCT01493947|100914463|FG000|COMPLETED|Period B Extension Period||366||
48681122|NCT04021290|102003216|FG002|STARTED|Randomized Phase (Day1 to Week 52)||0||
48681123|NCT04021290|102003214|FG000|COMPLETED|Randomized Phase (Day1 to Week 52)||136||
48681124|NCT04021290|102003215|FG001|COMPLETED|Randomized Phase (Day1 to Week 52)||229||
48243395|NCT01493947|100914464|FG001|COMPLETED|Period B Extension Period||326||
48243396|NCT01493947|100914463|FG000|NOT COMPLETED|Period B Extension Period||33||
48243397|NCT01493947|100914464|FG001|NOT COMPLETED|Period B Extension Period||32||
48243398|NCT00278395|100914465|FG000|STARTED|Overall Study||14||
48681125|NCT04021290|102003216|FG002|COMPLETED|Randomized Phase (Day1 to Week 52)||0||
48243399|NCT00278395|100914465|FG000|COMPLETED|Overall Study||11||
48681126|NCT04021290|102003214|FG000|NOT COMPLETED|Randomized Phase (Day1 to Week 52)||110||
48681127|NCT04021290|102003215|FG001|NOT COMPLETED|Randomized Phase (Day1 to Week 52)||18||
48243400|NCT00278395|100914465|FG000|NOT COMPLETED|Overall Study||3||
48243401|NCT02494076|100914466|FG000|STARTED|Overall Study||26||
48243402|NCT02494076|100914467|FG001|STARTED|Overall Study||26||
48540549|NCT03426137|101658128|FG001|COMPLETED|Overall Study||0||
48243403|NCT02494076|100914466|FG000|COMPLETED|Overall Study||26||
48243404|NCT02494076|100914467|FG001|COMPLETED|Overall Study||26||
48243405|NCT02494076|100914466|FG000|NOT COMPLETED|Overall Study||0||
48243406|NCT02494076|100914467|FG001|NOT COMPLETED|Overall Study||0||
48540550|NCT03426137|101658129|FG002|COMPLETED|Overall Study||0||
48243407|NCT01825785|100914468|FG000|STARTED|Overall Study||12||
48243408|NCT01825785|100914469|FG001|STARTED|Overall Study||6||
48243409|NCT01825785|100914470|FG002|STARTED|Overall Study||6||
48243410|NCT01825785|100914471|FG003|STARTED|Overall Study||6||
48243411|NCT01825785|100914472|FG004|STARTED|Overall Study||6||
48243412|NCT01825785|100914473|FG005|STARTED|Overall Study||6||
48243413|NCT01825785|100914474|FG006|STARTED|Overall Study||6||
48243414|NCT01825785|100914468|FG000|COMPLETED|Overall Study||12||
48243415|NCT01825785|100914469|FG001|COMPLETED|Overall Study||6||
48243416|NCT01825785|100914470|FG002|COMPLETED|Overall Study||6||
48243417|NCT01825785|100914471|FG003|COMPLETED|Overall Study||6||
48243418|NCT01825785|100914472|FG004|COMPLETED|Overall Study||4||
48243419|NCT01825785|100914473|FG005|COMPLETED|Overall Study||5||
48243420|NCT01825785|100914474|FG006|COMPLETED|Overall Study||6||
48243421|NCT01825785|100914468|FG000|NOT COMPLETED|Overall Study||0||
48243422|NCT01825785|100914469|FG001|NOT COMPLETED|Overall Study||0||
48243423|NCT01825785|100914470|FG002|NOT COMPLETED|Overall Study||0||
48243424|NCT01825785|100914471|FG003|NOT COMPLETED|Overall Study||0||
48243425|NCT01825785|100914472|FG004|NOT COMPLETED|Overall Study||2||
48243426|NCT01825785|100914473|FG005|NOT COMPLETED|Overall Study||1||
48243427|NCT01825785|100914474|FG006|NOT COMPLETED|Overall Study||0||
48243428|NCT03160859|100914475|FG000|STARTED|Overall Study||137||
48243429|NCT03160859|100914476|FG001|STARTED|Overall Study||143||
48243430|NCT03160859|100914475|FG000|COMPLETED|Overall Study||137||
48243431|NCT03160859|100914476|FG001|COMPLETED|Overall Study||143||
48243432|NCT03160859|100914475|FG000|NOT COMPLETED|Overall Study||0||
48243433|NCT03160859|100914476|FG001|NOT COMPLETED|Overall Study||0||
48243434|NCT00768716|100914477|FG000|STARTED|Overall Study||54||
48243435|NCT00768716|100914478|FG001|STARTED|Overall Study||41||
48243436|NCT00768716|100914477|FG000|COMPLETED|Overall Study||54||
48243437|NCT00768716|100914478|FG001|COMPLETED|Overall Study||41||
48243438|NCT00768716|100914477|FG000|NOT COMPLETED|Overall Study||0||
48243439|NCT00768716|100914478|FG001|NOT COMPLETED|Overall Study||0||
48243440|NCT00896389|100914479|FG000|STARTED|Salt Loading||124||
48243441|NCT00896389|100914479|FG000|COMPLETED|Salt Loading||124||
48243442|NCT00896389|100914479|FG000|NOT COMPLETED|Salt Loading||0||
48243443|NCT00896389|100914479|FG000|STARTED|HCTZ Low Dose||28||
48243444|NCT00896389|100914479|FG000|COMPLETED|HCTZ Low Dose||28||
48243445|NCT00896389|100914479|FG000|NOT COMPLETED|HCTZ Low Dose||0||
48243446|NCT00896389|100914479|FG000|STARTED|HCTZ High Dose||25|Of the 28 subjects that started HCTZ intervention, 3 terminated the study without completing.|
48243447|NCT00896389|100914479|FG000|COMPLETED|HCTZ High Dose||25||
48243448|NCT00896389|100914479|FG000|NOT COMPLETED|HCTZ High Dose||0||
48243449|NCT03613454|100914480|FG000|STARTED|Overall Study||24||
48243450|NCT03613454|100914481|FG001|STARTED|Overall Study||24||
48243451|NCT03613454|100914480|FG000|COMPLETED|Overall Study||23||
48243452|NCT03613454|100914481|FG001|COMPLETED|Overall Study||23||
48540551|NCT03426137|101658127|FG000|NOT COMPLETED|Overall Study||0||
48540552|NCT03426137|101658128|FG001|NOT COMPLETED|Overall Study||0||
48540553|NCT03426137|101658129|FG002|NOT COMPLETED|Overall Study||0||
48540554|NCT02730299|101658130|FG000|STARTED|Overall Study||62||
48540555|NCT02730299|101658131|FG001|STARTED|Overall Study||63||
48540556|NCT02730299|101658130|FG000|COMPLETED|Overall Study||62||
48540557|NCT02730299|101658131|FG001|COMPLETED|Overall Study||63||
48540558|NCT02730299|101658130|FG000|NOT COMPLETED|Overall Study||0||
48540559|NCT02730299|101658131|FG001|NOT COMPLETED|Overall Study||0||
48540560|NCT00843479|101658132|FG000|STARTED|Overall Study||12||
48540561|NCT00843479|101658133|FG001|STARTED|Overall Study||12||
48540562|NCT00843479|101658132|FG000|COMPLETED|Overall Study||12||
48243453|NCT03613454|100914480|FG000|NOT COMPLETED|Overall Study||1||
48243454|NCT03613454|100914481|FG001|NOT COMPLETED|Overall Study||1||
48243455|NCT00511147|100914482|FG000|STARTED|Overall Study||64||
48243456|NCT00511147|100914482|FG000|COMPLETED|Overall Study||57||
48243457|NCT00511147|100914482|FG000|NOT COMPLETED|Overall Study||7||
48243458|NCT00005908|100914483|FG000|STARTED|Overall Study||10||
48243459|NCT00005908|100914484|FG001|STARTED|Overall Study||20||
48243460|NCT00005908|100914483|FG000|COMPLETED|Overall Study||9||
48243461|NCT00005908|100914484|FG001|COMPLETED|Overall Study||20||
48243462|NCT00005908|100914483|FG000|NOT COMPLETED|Overall Study||1||
48243463|NCT00005908|100914484|FG001|NOT COMPLETED|Overall Study||0||
48243464|NCT06149338|100914485|FG000|STARTED|Overall Study||132||
48243465|NCT06149338|100914486|FG001|STARTED|Overall Study||132||
48243466|NCT06149338|100914485|FG000|COMPLETED|Overall Study||132||
48243467|NCT06149338|100914486|FG001|COMPLETED|Overall Study||132||
48243468|NCT06149338|100914485|FG000|NOT COMPLETED|Overall Study||0||
48243469|NCT06149338|100914486|FG001|NOT COMPLETED|Overall Study||0||
48243470|NCT03865940|100914487|FG000|STARTED|First Intervention (14 Days)||18||
48243471|NCT03865940|100914488|FG001|STARTED|First Intervention (14 Days)||19||
48243472|NCT03865940|100914487|FG000|COMPLETED|First Intervention (14 Days)||18||
48243473|NCT03865940|100914488|FG001|COMPLETED|First Intervention (14 Days)||19||
48243474|NCT03865940|100914487|FG000|NOT COMPLETED|First Intervention (14 Days)||0||
48243475|NCT03865940|100914488|FG001|NOT COMPLETED|First Intervention (14 Days)||0||
48243476|NCT03865940|100914487|FG000|STARTED|Washout Period (14 Days)||18||
48243477|NCT03865940|100914488|FG001|STARTED|Washout Period (14 Days)||19||
48243478|NCT03865940|100914487|FG000|COMPLETED|Washout Period (14 Days)||18||
48243479|NCT03865940|100914488|FG001|COMPLETED|Washout Period (14 Days)||19||
48243480|NCT03865940|100914487|FG000|NOT COMPLETED|Washout Period (14 Days)||0||
48243481|NCT03865940|100914488|FG001|NOT COMPLETED|Washout Period (14 Days)||0||
48243482|NCT03865940|100914487|FG000|STARTED|Second Intervention (14 Days)||18||
48243483|NCT03865940|100914488|FG001|STARTED|Second Intervention (14 Days)||19||
48243484|NCT03865940|100914487|FG000|COMPLETED|Second Intervention (14 Days)||10||
48243485|NCT03865940|100914488|FG001|COMPLETED|Second Intervention (14 Days)||18||
48243486|NCT03865940|100914487|FG000|NOT COMPLETED|Second Intervention (14 Days)||8||
48243487|NCT03865940|100914488|FG001|NOT COMPLETED|Second Intervention (14 Days)||1||
48243488|NCT00739024|100914489|FG000|STARTED|Overall Study||7||
48243489|NCT00739024|100914490|FG001|STARTED|Overall Study||6||
48243490|NCT00739024|100914489|FG000|COMPLETED|Overall Study||7||
48243491|NCT00739024|100914490|FG001|COMPLETED|Overall Study||6||
48243492|NCT00739024|100914489|FG000|NOT COMPLETED|Overall Study||0||
48243493|NCT00739024|100914490|FG001|NOT COMPLETED|Overall Study||0||
48243494|NCT01294358|100914491|FG000|STARTED|Cohort 1: 5/11/11-11/9/11||4||
48243495|NCT01294358|100914492|FG001|STARTED|Cohort 1: 5/11/11-11/9/11||0||
48243496|NCT01294358|100914493|FG002|STARTED|Cohort 1: 5/11/11-11/9/11||0||
48243497|NCT01294358|100914494|FG003|STARTED|Cohort 1: 5/11/11-11/9/11||0||
48243498|NCT01294358|100914495|FG004|STARTED|Cohort 1: 5/11/11-11/9/11||0||
48243499|NCT01294358|100914491|FG000|COMPLETED|Cohort 1: 5/11/11-11/9/11||4||
48243500|NCT01294358|100914492|FG001|COMPLETED|Cohort 1: 5/11/11-11/9/11||0||
48243501|NCT01294358|100914493|FG002|COMPLETED|Cohort 1: 5/11/11-11/9/11||0||
48243502|NCT01294358|100914494|FG003|COMPLETED|Cohort 1: 5/11/11-11/9/11||0||
48243503|NCT01294358|100914495|FG004|COMPLETED|Cohort 1: 5/11/11-11/9/11||0||
48243504|NCT01294358|100914491|FG000|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0||
48243505|NCT01294358|100914492|FG001|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0||
48243506|NCT01294358|100914493|FG002|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0||
48243507|NCT01294358|100914494|FG003|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0||
48243508|NCT01294358|100914495|FG004|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0||
48243509|NCT01294358|100914491|FG000|STARTED|Cohort 2: 6/9/11-9/17/12||0||
48243510|NCT01294358|100914492|FG001|STARTED|Cohort 2: 6/9/11-9/17/12||6||
48243511|NCT01294358|100914493|FG002|STARTED|Cohort 2: 6/9/11-9/17/12||0||
48243512|NCT01294358|100914494|FG003|STARTED|Cohort 2: 6/9/11-9/17/12||0||
48243513|NCT01294358|100914495|FG004|STARTED|Cohort 2: 6/9/11-9/17/12||0||
48243514|NCT01294358|100914491|FG000|COMPLETED|Cohort 2: 6/9/11-9/17/12||0||
48243515|NCT01294358|100914492|FG001|COMPLETED|Cohort 2: 6/9/11-9/17/12||4||
48243516|NCT01294358|100914493|FG002|COMPLETED|Cohort 2: 6/9/11-9/17/12||0||
48243517|NCT01294358|100914494|FG003|COMPLETED|Cohort 2: 6/9/11-9/17/12||0||
48243518|NCT01294358|100914495|FG004|COMPLETED|Cohort 2: 6/9/11-9/17/12||0||
48243519|NCT01294358|100914491|FG000|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0||
48243520|NCT01294358|100914492|FG001|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||2||
48243521|NCT01294358|100914493|FG002|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0||
48243522|NCT01294358|100914494|FG003|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0||
48243523|NCT01294358|100914495|FG004|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0||
48243524|NCT01294358|100914491|FG000|STARTED|Cohort 3: 12/1/11-10/6/12||0||
48243525|NCT01294358|100914492|FG001|STARTED|Cohort 3: 12/1/11-10/6/12||0||
48243526|NCT01294358|100914493|FG002|STARTED|Cohort 3: 12/1/11-10/6/12||4||
48243527|NCT01294358|100914494|FG003|STARTED|Cohort 3: 12/1/11-10/6/12||0||
48243528|NCT01294358|100914495|FG004|STARTED|Cohort 3: 12/1/11-10/6/12||0||
48243529|NCT01294358|100914491|FG000|COMPLETED|Cohort 3: 12/1/11-10/6/12||0||
48243530|NCT01294358|100914492|FG001|COMPLETED|Cohort 3: 12/1/11-10/6/12||0||
48243531|NCT01294358|100914493|FG002|COMPLETED|Cohort 3: 12/1/11-10/6/12||2||
48243532|NCT01294358|100914494|FG003|COMPLETED|Cohort 3: 12/1/11-10/6/12||0||
48243533|NCT01294358|100914495|FG004|COMPLETED|Cohort 3: 12/1/11-10/6/12||0||
48243534|NCT01294358|100914491|FG000|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0||
48243535|NCT01294358|100914492|FG001|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0||
48243536|NCT01294358|100914493|FG002|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||2||
48243537|NCT01294358|100914494|FG003|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0||
48243538|NCT01294358|100914495|FG004|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0||
48243539|NCT01294358|100914491|FG000|STARTED|Cohort 4: 12/30/11-2/17/17||0||
48243540|NCT01294358|100914492|FG001|STARTED|Cohort 4: 12/30/11-2/17/17||0||
48243541|NCT01294358|100914493|FG002|STARTED|Cohort 4: 12/30/11-2/17/17||0||
48243542|NCT01294358|100914494|FG003|STARTED|Cohort 4: 12/30/11-2/17/17||2||
48243543|NCT01294358|100914495|FG004|STARTED|Cohort 4: 12/30/11-2/17/17||0||
48243544|NCT01294358|100914491|FG000|COMPLETED|Cohort 4: 12/30/11-2/17/17||0||
48243545|NCT01294358|100914492|FG001|COMPLETED|Cohort 4: 12/30/11-2/17/17||0||
48243546|NCT01294358|100914493|FG002|COMPLETED|Cohort 4: 12/30/11-2/17/17||0||
48243547|NCT01294358|100914494|FG003|COMPLETED|Cohort 4: 12/30/11-2/17/17||1||
48243548|NCT01294358|100914495|FG004|COMPLETED|Cohort 4: 12/30/11-2/17/17||0||
48243549|NCT01294358|100914491|FG000|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0||
48243550|NCT01294358|100914492|FG001|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0||
48243551|NCT01294358|100914493|FG002|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0||
48243552|NCT01294358|100914494|FG003|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||1||
48243553|NCT01294358|100914495|FG004|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0||
48243554|NCT01294358|100914491|FG000|STARTED|Cohort 5: 3/8/12-3/9/12||0||
48243555|NCT01294358|100914492|FG001|STARTED|Cohort 5: 3/8/12-3/9/12||0||
48243556|NCT01294358|100914493|FG002|STARTED|Cohort 5: 3/8/12-3/9/12||0||
48243557|NCT01294358|100914494|FG003|STARTED|Cohort 5: 3/8/12-3/9/12||0||
48243558|NCT01294358|100914495|FG004|STARTED|Cohort 5: 3/8/12-3/9/12||1||
48243559|NCT01294358|100914491|FG000|COMPLETED|Cohort 5: 3/8/12-3/9/12||0||
48243560|NCT01294358|100914492|FG001|COMPLETED|Cohort 5: 3/8/12-3/9/12||0||
48243561|NCT01294358|100914493|FG002|COMPLETED|Cohort 5: 3/8/12-3/9/12||0||
48243562|NCT01294358|100914494|FG003|COMPLETED|Cohort 5: 3/8/12-3/9/12||0||
48243563|NCT01294358|100914495|FG004|COMPLETED|Cohort 5: 3/8/12-3/9/12||0||
48243564|NCT01294358|100914491|FG000|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0||
48243565|NCT01294358|100914492|FG001|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0||
48243566|NCT01294358|100914493|FG002|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0||
48243567|NCT01294358|100914494|FG003|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0||
48243568|NCT01294358|100914495|FG004|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||1||
48243569|NCT02232009|100914496|FG000|STARTED|Overall Study||9||
48243570|NCT02232009|100914496|FG000|COMPLETED|Overall Study||9||
48243571|NCT02232009|100914496|FG000|NOT COMPLETED|Overall Study||0||
48243572|NCT02741297|100914497|FG000|STARTED|Overall Study||73||
48243573|NCT02741297|100914497|FG000|COMPLETED|Overall Study||59||
48243574|NCT02741297|100914497|FG000|NOT COMPLETED|Overall Study||14||
48243575|NCT05401149|100914498|FG000|STARTED|Overall Study||780|Propensity score matched patients|
48540563|NCT00843479|101658133|FG001|COMPLETED|Overall Study||12||
48540564|NCT00843479|101658132|FG000|NOT COMPLETED|Overall Study||0||
48540565|NCT00843479|101658133|FG001|NOT COMPLETED|Overall Study||0||
48540566|NCT02640690|101658134|FG000|STARTED|Overall Study||72||
48540567|NCT02640690|101658135|FG001|STARTED|Overall Study||59||
48540568|NCT02640690|101658134|FG000|COMPLETED|Overall Study||47||
48540569|NCT02640690|101658135|FG001|COMPLETED|Overall Study||27||
48540570|NCT02640690|101658134|FG000|NOT COMPLETED|Overall Study||25||
48540571|NCT02640690|101658135|FG001|NOT COMPLETED|Overall Study||32||
48540572|NCT00926783|101658136|FG000|STARTED|Overall Study||42||
48540573|NCT00926783|101658137|FG001|STARTED|Overall Study||41||
48540574|NCT00926783|101658136|FG000|COMPLETED|Overall Study||39||
48540575|NCT00926783|101658137|FG001|COMPLETED|Overall Study||38||
48540576|NCT00926783|101658136|FG000|NOT COMPLETED|Overall Study||3||
48540577|NCT00926783|101658137|FG001|NOT COMPLETED|Overall Study||3||
48540578|NCT04191499|101658138|FG000|STARTED|Overall Study||161||
48540579|NCT04191499|101658139|FG001|STARTED|Overall Study||164||
48540580|NCT04191499|101658138|FG000|COMPLETED|Overall Study||0||
48540581|NCT04191499|101658139|FG001|COMPLETED|Overall Study||0||
48540582|NCT04191499|101658138|FG000|NOT COMPLETED|Overall Study||161||
48540583|NCT04191499|101658139|FG001|NOT COMPLETED|Overall Study||164||
48540584|NCT00176423|101658140|FG000|STARTED|Overall Study||42||
48540585|NCT00176423|101658141|FG001|STARTED|Overall Study||44||
48540586|NCT00176423|101658140|FG000|COMPLETED|Overall Study||35||
48540587|NCT00176423|101658141|FG001|COMPLETED|Overall Study||38||
48540588|NCT00176423|101658140|FG000|NOT COMPLETED|Overall Study||7||
48540589|NCT00176423|101658141|FG001|NOT COMPLETED|Overall Study||6||
48540590|NCT01982448|101658142|FG000|STARTED|Preoperative Chemotherapy||75||
48540591|NCT01982448|101658143|FG001|STARTED|Preoperative Chemotherapy||72||
48243576|NCT05401149|100914499|FG001|STARTED|Overall Study||780|Propensity score matched patients|
48243577|NCT05401149|100914498|FG000|COMPLETED|Overall Study||780||
48243578|NCT05401149|100914499|FG001|COMPLETED|Overall Study||780||
48243579|NCT05401149|100914498|FG000|NOT COMPLETED|Overall Study||0||
48243580|NCT05401149|100914499|FG001|NOT COMPLETED|Overall Study||0||
48243581|NCT02684942|100914500|FG000|STARTED|Overall Study||7||
48243582|NCT02684942|100914501|FG001|STARTED|Overall Study||7||
48540592|NCT01982448|101658142|FG000|Eligible & Treated|Preoperative Chemotherapy||72||
48540593|NCT01982448|101658143|FG001|Eligible & Treated|Preoperative Chemotherapy||70||
48592680|NCT01877382|101783152|FG002|COMPLETED|Dose Expansion||0||
48592681|NCT01877382|101783153|FG003|COMPLETED|Dose Expansion||0||
48243583|NCT02684942|100914502|FG002|STARTED|Overall Study||7||
48243584|NCT02684942|100914503|FG003|STARTED|Overall Study||7||
48243585|NCT02684942|100914504|FG004|STARTED|Overall Study||6||
48243586|NCT02684942|100914505|FG005|STARTED|Overall Study||6||
48243587|NCT02684942|100914500|FG000|COMPLETED|Overall Study||7||
48243588|NCT02684942|100914501|FG001|COMPLETED|Overall Study||7||
48243589|NCT02684942|100914502|FG002|COMPLETED|Overall Study||7||
48243590|NCT02684942|100914503|FG003|COMPLETED|Overall Study||7||
48243591|NCT02684942|100914504|FG004|COMPLETED|Overall Study||6||
48243592|NCT02684942|100914505|FG005|COMPLETED|Overall Study||6||
48243593|NCT02684942|100914500|FG000|NOT COMPLETED|Overall Study||0||
48243594|NCT02684942|100914501|FG001|NOT COMPLETED|Overall Study||0||
48243595|NCT02684942|100914502|FG002|NOT COMPLETED|Overall Study||0||
48243596|NCT02684942|100914503|FG003|NOT COMPLETED|Overall Study||0||
48243597|NCT02684942|100914504|FG004|NOT COMPLETED|Overall Study||0||
48243598|NCT02684942|100914505|FG005|NOT COMPLETED|Overall Study||0||
48243599|NCT02066389|100914506|FG000|STARTED|Overall Study||50||
48243600|NCT02066389|100914507|FG001|STARTED|Overall Study||50||
48243601|NCT02066389|100914508|FG002|STARTED|Overall Study||50||
48243602|NCT02066389|100914509|FG003|STARTED|Overall Study||50||
48243603|NCT02066389|100914510|FG004|STARTED|Overall Study||50||
48243604|NCT02066389|100914511|FG005|STARTED|Overall Study||50||
48243605|NCT02066389|100914506|FG000|Received Study Drug|Overall Study||50||
48243606|NCT02066389|100914507|FG001|Received Study Drug|Overall Study||50||
48243607|NCT02066389|100914508|FG002|Received Study Drug|Overall Study||50||
48243608|NCT02066389|100914509|FG003|Received Study Drug|Overall Study||50||
48243609|NCT02066389|100914510|FG004|Received Study Drug|Overall Study||50||
48243610|NCT02066389|100914511|FG005|Received Study Drug|Overall Study||49||
48243611|NCT02066389|100914506|FG000|COMPLETED|Overall Study||45||
48243612|NCT02066389|100914507|FG001|COMPLETED|Overall Study||49||
48243613|NCT02066389|100914508|FG002|COMPLETED|Overall Study||44||
48243614|NCT02066389|100914509|FG003|COMPLETED|Overall Study||47||
48243615|NCT02066389|100914510|FG004|COMPLETED|Overall Study||43||
48243616|NCT02066389|100914511|FG005|COMPLETED|Overall Study||45||
48243617|NCT02066389|100914506|FG000|NOT COMPLETED|Overall Study||5||
48243618|NCT02066389|100914507|FG001|NOT COMPLETED|Overall Study||1||
48243619|NCT02066389|100914508|FG002|NOT COMPLETED|Overall Study||6||
48243620|NCT02066389|100914509|FG003|NOT COMPLETED|Overall Study||3||
48243621|NCT02066389|100914510|FG004|NOT COMPLETED|Overall Study||7||
48243622|NCT02066389|100914511|FG005|NOT COMPLETED|Overall Study||5||
48243623|NCT04086576|100914512|FG000|STARTED|Overall Study||10||
48243624|NCT04086576|100914513|FG001|STARTED|Overall Study||10||
48243625|NCT04086576|100914512|FG000|COMPLETED|Overall Study||10||
48243626|NCT04086576|100914513|FG001|COMPLETED|Overall Study||10||
48243627|NCT04086576|100914512|FG000|NOT COMPLETED|Overall Study||0||
48243628|NCT04086576|100914513|FG001|NOT COMPLETED|Overall Study||0||
48243629|NCT02305797|100914514|FG000|STARTED|Overall Study||247||
48243630|NCT02305797|100914515|FG001|STARTED|Overall Study||248||
48243631|NCT02305797|100914514|FG000|COMPLETED|Overall Study||202||
48243632|NCT02305797|100914515|FG001|COMPLETED|Overall Study||210||
48243633|NCT02305797|100914514|FG000|NOT COMPLETED|Overall Study||45||
48681128|NCT04021290|102003216|FG002|NOT COMPLETED|Randomized Phase (Day1 to Week 52)||0||
48681129|NCT04021290|102003214|FG000|STARTED|Continuation Phase (Week 52 to Week 132)||0||
48681130|NCT04021290|102003215|FG001|STARTED|Continuation Phase (Week 52 to Week 132)||0||
48681131|NCT04021290|102003216|FG002|STARTED|Continuation Phase (Week 52 to Week 132)||96||
48681132|NCT04021290|102003214|FG000|COMPLETED|Continuation Phase (Week 52 to Week 132)||0||
48681133|NCT04021290|102003215|FG001|COMPLETED|Continuation Phase (Week 52 to Week 132)||0||
48681134|NCT04021290|102003216|FG002|COMPLETED|Continuation Phase (Week 52 to Week 132)||91||
48243634|NCT02305797|100914515|FG001|NOT COMPLETED|Overall Study||38||
48681135|NCT04021290|102003214|FG000|NOT COMPLETED|Continuation Phase (Week 52 to Week 132)||0||
48681136|NCT04021290|102003215|FG001|NOT COMPLETED|Continuation Phase (Week 52 to Week 132)||0||
48243635|NCT00784277|100914516|FG000|STARTED|IR Treatment||148||
48243636|NCT00784277|100914517|FG001|STARTED|IR Treatment||151||
48243637|NCT00784277|100914518|FG002|STARTED|IR Treatment||154||
48243638|NCT00784277|100914519|FG003|STARTED|IR Treatment||143||
48243639|NCT00784277|100914520|FG004|STARTED|IR Treatment||0||
48243640|NCT00784277|100914521|FG005|STARTED|IR Treatment||0||
48243641|NCT00784277|100914522|FG006|STARTED|IR Treatment||0||
48243642|NCT00784277|100914516|FG000|COMPLETED|IR Treatment||132||
48243643|NCT00784277|100914517|FG001|COMPLETED|IR Treatment||134||
48243644|NCT00784277|100914518|FG002|COMPLETED|IR Treatment||126||
48243645|NCT00784277|100914519|FG003|COMPLETED|IR Treatment||100||
48243646|NCT00784277|100914520|FG004|COMPLETED|IR Treatment||0||
48243647|NCT00784277|100914521|FG005|COMPLETED|IR Treatment||0||
48243648|NCT00784277|100914522|FG006|COMPLETED|IR Treatment||0||
48243649|NCT00784277|100914516|FG000|NOT COMPLETED|IR Treatment||16||
48243650|NCT00784277|100914517|FG001|NOT COMPLETED|IR Treatment||17||
48243651|NCT00784277|100914518|FG002|NOT COMPLETED|IR Treatment||28||
48243652|NCT00784277|100914519|FG003|NOT COMPLETED|IR Treatment||43||
48243653|NCT00784277|100914520|FG004|NOT COMPLETED|IR Treatment||0||
48681137|NCT04021290|102003216|FG002|NOT COMPLETED|Continuation Phase (Week 52 to Week 132)||5||
48681138|NCT03246087|102003217|FG000|STARTED|Randomized||47||
48681139|NCT03246087|102003218|FG001|STARTED|Randomized||47||
48681140|NCT03246087|102003219|FG002|STARTED|Randomized||0||
48681141|NCT03246087|102003217|FG000|COMPLETED|Randomized||39||
48681142|NCT03246087|102003218|FG001|COMPLETED|Randomized||39||
48681143|NCT03246087|102003219|FG002|COMPLETED|Randomized||0||
48681144|NCT03246087|102003217|FG000|NOT COMPLETED|Randomized||8||
48681145|NCT03246087|102003218|FG001|NOT COMPLETED|Randomized||8||
48681146|NCT03246087|102003219|FG002|NOT COMPLETED|Randomized||0||
48243654|NCT00784277|100914521|FG005|NOT COMPLETED|IR Treatment||0||
48243655|NCT00784277|100914522|FG006|NOT COMPLETED|IR Treatment||0||
48243656|NCT00784277|100914516|FG000|STARTED|ER Treatment||0||
48243657|NCT00784277|100914517|FG001|STARTED|ER Treatment||0||
48243658|NCT00784277|100914518|FG002|STARTED|ER Treatment||0||
48243659|NCT00784277|100914519|FG003|STARTED|ER Treatment||0||
48243660|NCT00784277|100914520|FG004|STARTED|ER Treatment||122||
48243661|NCT00784277|100914521|FG005|STARTED|ER Treatment||250||
48243662|NCT00784277|100914522|FG006|STARTED|ER Treatment||91||
48243663|NCT00784277|100914516|FG000|COMPLETED|ER Treatment||0||
48243664|NCT00784277|100914517|FG001|COMPLETED|ER Treatment||0||
48243665|NCT00784277|100914518|FG002|COMPLETED|ER Treatment||0||
48243666|NCT00784277|100914519|FG003|COMPLETED|ER Treatment||0||
48540594|NCT01982448|101658142|FG000|Evaluable for Safety|Preoperative Chemotherapy||72|Participants who completed at least one cycle of neoadjuvant chemotherapy were evaluable for adverse events.|
48540595|NCT01982448|101658143|FG001|Evaluable for Safety|Preoperative Chemotherapy||68|Participants who completed at least one cycle of neoadjuvant chemotherapy were evaluable for adverse events.|
48540596|NCT01982448|101658142|FG000|COMPLETED|Preoperative Chemotherapy||72||
48540597|NCT01982448|101658143|FG001|COMPLETED|Preoperative Chemotherapy||67||
48540598|NCT01982448|101658142|FG000|NOT COMPLETED|Preoperative Chemotherapy||3||
48540599|NCT01982448|101658143|FG001|NOT COMPLETED|Preoperative Chemotherapy||5||
48540600|NCT01982448|101658142|FG000|STARTED|Definitive Breast Surgery||72||
48681147|NCT03246087|102003217|FG000|STARTED|Crossover to Acupuncture||0||
48681148|NCT03246087|102003218|FG001|STARTED|Crossover to Acupuncture||0||
48681149|NCT03246087|102003219|FG002|STARTED|Crossover to Acupuncture||39||
48681150|NCT03246087|102003217|FG000|COMPLETED|Crossover to Acupuncture||0||
48681151|NCT03246087|102003218|FG001|COMPLETED|Crossover to Acupuncture||0||
48243667|NCT00784277|100914520|FG004|COMPLETED|ER Treatment||113||
48243668|NCT00784277|100914521|FG005|COMPLETED|ER Treatment||226||
48710658|NCT02961790|102077985|FG002|NOT COMPLETED|Overall Study||6||
48710659|NCT02961790|102077986|FG003|NOT COMPLETED|Overall Study||5||
48710660|NCT02945553|102077987|FG000|STARTED|Overall Study||14||
48710661|NCT02945553|102077988|FG001|STARTED|Overall Study||11||
48243669|NCT00784277|100914522|FG006|COMPLETED|ER Treatment||76||
48710662|NCT02945553|102077987|FG000|COMPLETED|Overall Study||11||
48710663|NCT02945553|102077988|FG001|COMPLETED|Overall Study||9||
48710664|NCT02945553|102077987|FG000|NOT COMPLETED|Overall Study||3||
48710665|NCT02945553|102077988|FG001|NOT COMPLETED|Overall Study||2||
48710666|NCT02071420|102077989|FG000|STARTED|Overall Study||30||
48710667|NCT02071420|102077990|FG001|STARTED|Overall Study||30||
48710668|NCT02071420|102077989|FG000|COMPLETED|Overall Study||27||
48710669|NCT02071420|102077990|FG001|COMPLETED|Overall Study||27||
48710670|NCT02071420|102077989|FG000|NOT COMPLETED|Overall Study||3||
48710671|NCT02071420|102077990|FG001|NOT COMPLETED|Overall Study||3||
48710672|NCT01730339|102077991|FG000|STARTED|Overall Study||45||
48710673|NCT01730339|102077992|FG001|STARTED|Overall Study||55||
48710674|NCT01730339|102077991|FG000|COMPLETED|Overall Study||40||
48710675|NCT01730339|102077992|FG001|COMPLETED|Overall Study||52||
48710676|NCT01730339|102077991|FG000|NOT COMPLETED|Overall Study||5||
48710677|NCT01730339|102077992|FG001|NOT COMPLETED|Overall Study||3||
48710678|NCT00846040|102077993|FG000|STARTED|Baseline: Days 1-5||10||
48710679|NCT00846040|102077994|FG001|STARTED|Baseline: Days 1-5||10||
48710680|NCT00846040|102077995|FG002|STARTED|Baseline: Days 1-5||23||
48710681|NCT00846040|102077993|FG000|COMPLETED|Baseline: Days 1-5||9||
48710682|NCT00846040|102077994|FG001|COMPLETED|Baseline: Days 1-5||10||
48710683|NCT00846040|102077995|FG002|COMPLETED|Baseline: Days 1-5||23||
48710684|NCT00846040|102077993|FG000|NOT COMPLETED|Baseline: Days 1-5||1||
48710685|NCT00846040|102077994|FG001|NOT COMPLETED|Baseline: Days 1-5||0||
48710686|NCT00846040|102077995|FG002|NOT COMPLETED|Baseline: Days 1-5||0||
48710687|NCT00846040|102077993|FG000|STARTED|First Treatment Period: Days 6-14||9||
48710688|NCT00846040|102077994|FG001|STARTED|First Treatment Period: Days 6-14||10||
48710689|NCT00846040|102077995|FG002|STARTED|First Treatment Period: Days 6-14||0||
48710690|NCT00846040|102077993|FG000|COMPLETED|First Treatment Period: Days 6-14||9||
48710691|NCT00846040|102077994|FG001|COMPLETED|First Treatment Period: Days 6-14||10||
48710692|NCT00846040|102077995|FG002|COMPLETED|First Treatment Period: Days 6-14||0||
48710693|NCT00846040|102077993|FG000|NOT COMPLETED|First Treatment Period: Days 6-14||0||
48710694|NCT00846040|102077994|FG001|NOT COMPLETED|First Treatment Period: Days 6-14||0||
48710695|NCT00846040|102077995|FG002|NOT COMPLETED|First Treatment Period: Days 6-14||0||
48710696|NCT00846040|102077993|FG000|STARTED|Washout: 2 Weeks to 10 Weeks||9||
48243670|NCT00784277|100914516|FG000|NOT COMPLETED|ER Treatment||0||
48243671|NCT00784277|100914517|FG001|NOT COMPLETED|ER Treatment||0||
48243672|NCT00784277|100914518|FG002|NOT COMPLETED|ER Treatment||0||
48243673|NCT00784277|100914519|FG003|NOT COMPLETED|ER Treatment||0||
48243674|NCT00784277|100914520|FG004|NOT COMPLETED|ER Treatment||9||
48243675|NCT00784277|100914521|FG005|NOT COMPLETED|ER Treatment||24||
48243676|NCT00784277|100914522|FG006|NOT COMPLETED|ER Treatment||15||
48243677|NCT03444155|100914523|FG000|STARTED|First Intervention (6 Weeks)||15||
48243678|NCT03444155|100914524|FG001|STARTED|First Intervention (6 Weeks)||15||
48243679|NCT03444155|100914523|FG000|COMPLETED|First Intervention (6 Weeks)||14||
48243680|NCT03444155|100914524|FG001|COMPLETED|First Intervention (6 Weeks)||15||
48243681|NCT03444155|100914523|FG000|NOT COMPLETED|First Intervention (6 Weeks)||1||
48243682|NCT03444155|100914524|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0||
48243683|NCT03444155|100914523|FG000|STARTED|Washout (2 Weeks)||14||
48243684|NCT03444155|100914524|FG001|STARTED|Washout (2 Weeks)||15||
48243685|NCT03444155|100914523|FG000|COMPLETED|Washout (2 Weeks)||14||
48243686|NCT03444155|100914524|FG001|COMPLETED|Washout (2 Weeks)||15||
48243687|NCT03444155|100914523|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
48243688|NCT03444155|100914524|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
48243689|NCT03444155|100914523|FG000|STARTED|Second Intervention (6 Weeks)||14||
48243690|NCT03444155|100914524|FG001|STARTED|Second Intervention (6 Weeks)||15||
48243691|NCT03444155|100914523|FG000|COMPLETED|Second Intervention (6 Weeks)||14||
48243692|NCT03444155|100914524|FG001|COMPLETED|Second Intervention (6 Weeks)||15||
48243693|NCT03444155|100914523|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0||
48243694|NCT03444155|100914524|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0||
48243695|NCT00607789|100914525|FG000|STARTED|Overall Study||20||
48243696|NCT00607789|100914526|FG001|STARTED|Overall Study||20||
48243697|NCT00607789|100914525|FG000|COMPLETED|Overall Study||13||
48243698|NCT00607789|100914526|FG001|COMPLETED|Overall Study||14||
48243699|NCT00607789|100914525|FG000|NOT COMPLETED|Overall Study||7||
48243700|NCT00607789|100914526|FG001|NOT COMPLETED|Overall Study||6||
48243701|NCT03151551|100914527|FG000|STARTED|Open-Label Treatment Period||283||
48243702|NCT03151551|100914528|FG001|STARTED|Open-Label Treatment Period||283||
48243703|NCT03151551|100914527|FG000|Received at Least One Dose of Study Drug|Open-Label Treatment Period||283||
48243704|NCT03151551|100914528|FG001|Received at Least One Dose of Study Drug|Open-Label Treatment Period||283||
48243705|NCT03151551|100914527|FG000|IXE 160 mg at Baseline, 80 mg Q2W/Q4W|Open-Label Treatment Period||49||
48243706|NCT03151551|100914528|FG001|IXE 160 mg at Baseline, 80 mg Q2W/Q4W|Open-Label Treatment Period||0||
48243707|NCT03151551|100914527|FG000|IXE 160 mg at Baseline, 80 mg Q4W|Open-Label Treatment Period||218||
48243708|NCT03151551|100914528|FG001|IXE 160 mg at Baseline, 80 mg Q4W|Open-Label Treatment Period||0||
48243709|NCT03151551|100914527|FG000|ADA 80 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period||0||
48243710|NCT03151551|100914528|FG001|ADA 80 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period||51||
48243711|NCT03151551|100914527|FG000|ADA 40 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period||0||
48243712|NCT03151551|100914528|FG001|ADA 40 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period||219||
48243713|NCT03151551|100914527|FG000|COMPLETED|Open-Label Treatment Period||265||
48243714|NCT03151551|100914528|FG001|COMPLETED|Open-Label Treatment Period||259||
48243715|NCT03151551|100914527|FG000|NOT COMPLETED|Open-Label Treatment Period||18||
48243716|NCT03151551|100914528|FG001|NOT COMPLETED|Open-Label Treatment Period||24||
48243717|NCT03151551|100914527|FG000|STARTED|Post-Treatment Follow-Up Period||265||
48681152|NCT03246087|102003219|FG002|COMPLETED|Crossover to Acupuncture||30||
48681153|NCT03246087|102003217|FG000|NOT COMPLETED|Crossover to Acupuncture||0||
48243718|NCT03151551|100914528|FG001|STARTED|Post-Treatment Follow-Up Period||258||
48243719|NCT03151551|100914527|FG000|COMPLETED|Post-Treatment Follow-Up Period||240||
48243720|NCT03151551|100914528|FG001|COMPLETED|Post-Treatment Follow-Up Period||230||
48243721|NCT03151551|100914527|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||25||
48243722|NCT03151551|100914528|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||28||
48243723|NCT00884793|100914529|FG000|STARTED|Overall Study||8||
48243724|NCT00884793|100914529|FG000|COMPLETED|Overall Study||7||
48243725|NCT00884793|100914529|FG000|NOT COMPLETED|Overall Study||1||
48243726|NCT03469258|100914530|FG000|STARTED|Overall Study||4||
48243727|NCT03469258|100914530|FG000|COMPLETED|Overall Study||0||
48243728|NCT03469258|100914530|FG000|NOT COMPLETED|Overall Study||4||
48243729|NCT00248794|100914531|FG000|STARTED|Overall Study||25||
48243730|NCT00248794|100914532|FG001|STARTED|Overall Study||24||
48243731|NCT00248794|100914533|FG002|STARTED|Overall Study||10||
48243732|NCT00248794|100914531|FG000|COMPLETED|Overall Study||19||
48243733|NCT00248794|100914532|FG001|COMPLETED|Overall Study||16||
48243734|NCT00248794|100914533|FG002|COMPLETED|Overall Study||7||
48243735|NCT00248794|100914531|FG000|NOT COMPLETED|Overall Study||6||
48243736|NCT00248794|100914532|FG001|NOT COMPLETED|Overall Study||8||
48243737|NCT00248794|100914533|FG002|NOT COMPLETED|Overall Study||3||
48243738|NCT00515112|100914534|FG000|STARTED|Overall Study||3||
48243739|NCT00515112|100914535|FG001|STARTED|Overall Study||3||
48243740|NCT00515112|100914534|FG000|COMPLETED|Overall Study||0||
48243741|NCT00515112|100914535|FG001|COMPLETED|Overall Study||0||
48243742|NCT00515112|100914534|FG000|NOT COMPLETED|Overall Study||3||
48243743|NCT00515112|100914535|FG001|NOT COMPLETED|Overall Study||3||
48243744|NCT02632747|100914536|FG000|STARTED|Treatment Period 1||16||
48681154|NCT03246087|102003218|FG001|NOT COMPLETED|Crossover to Acupuncture||0||
48681155|NCT03246087|102003219|FG002|NOT COMPLETED|Crossover to Acupuncture||9||
48681156|NCT03654274|102003220|FG000|STARTED|Overall Study||278||
48681157|NCT03654274|102003221|FG001|STARTED|Overall Study||247||
48681158|NCT03654274|102003222|FG002|STARTED|Overall Study||277||
48681159|NCT03654274|102003220|FG000|Received at Least 1 Dose of Study Drug|Overall Study||277||
48243745|NCT02632747|100914537|FG001|STARTED|Treatment Period 1||15||
48243746|NCT02632747|100914536|FG000|COMPLETED|Treatment Period 1||16||
48243747|NCT02632747|100914537|FG001|COMPLETED|Treatment Period 1||15||
48243748|NCT02632747|100914536|FG000|NOT COMPLETED|Treatment Period 1||0||
48243749|NCT02632747|100914537|FG001|NOT COMPLETED|Treatment Period 1||0||
48243750|NCT02632747|100914536|FG000|STARTED|Wash-out Period||16||
48243751|NCT02632747|100914537|FG001|STARTED|Wash-out Period||15||
48243752|NCT02632747|100914536|FG000|COMPLETED|Wash-out Period||15||
48243753|NCT02632747|100914537|FG001|COMPLETED|Wash-out Period||15||
48243754|NCT02632747|100914536|FG000|NOT COMPLETED|Wash-out Period||1||
48243755|NCT02632747|100914537|FG001|NOT COMPLETED|Wash-out Period||0||
48243756|NCT02632747|100914536|FG000|STARTED|Treatment Period 2||15||
48243757|NCT02632747|100914537|FG001|STARTED|Treatment Period 2||15||
48243758|NCT02632747|100914536|FG000|COMPLETED|Treatment Period 2||15||
48243759|NCT02632747|100914537|FG001|COMPLETED|Treatment Period 2||15||
48243760|NCT02632747|100914536|FG000|NOT COMPLETED|Treatment Period 2||0||
48243761|NCT02632747|100914537|FG001|NOT COMPLETED|Treatment Period 2||0||
48243762|NCT01585597|100914538|FG000|STARTED|Overall Study||20||
48243763|NCT01585597|100914538|FG000|COMPLETED|Overall Study||20||
48243764|NCT01585597|100914538|FG000|NOT COMPLETED|Overall Study||0||
48243765|NCT03500835|100914539|FG000|STARTED|Overall Study||54||
48243766|NCT03500835|100914540|FG001|STARTED|Overall Study||53||
48243767|NCT03500835|100914541|FG002|STARTED|Overall Study||54||
48681160|NCT03654274|102003221|FG001|Received at Least 1 Dose of Study Drug|Overall Study||247||
48681161|NCT03654274|102003222|FG002|Received at Least 1 Dose of Study Drug|Overall Study||275||
48681162|NCT03654274|102003220|FG000|COMPLETED|Overall Study||172||
48540601|NCT01982448|101658143|FG001|STARTED|Definitive Breast Surgery||67||
48681163|NCT03654274|102003221|FG001|COMPLETED|Overall Study||155||
48681164|NCT03654274|102003222|FG002|COMPLETED|Overall Study||174||
48681165|NCT03654274|102003220|FG000|NOT COMPLETED|Overall Study||106||
48540602|NCT01982448|101658142|FG000|Evaluable for Response by Homologous Recombination Deficiency (HRD)|Definitive Breast Surgery||56|Participants with baseline diagnostic tissue for HRD analysis.|
48540603|NCT01982448|101658143|FG001|Evaluable for Response by Homologous Recombination Deficiency (HRD)|Definitive Breast Surgery||48|Participants with baseline diagnostic tissue for HRD analysis.|
48540604|NCT01982448|101658142|FG000|COMPLETED|Definitive Breast Surgery||72||
48540605|NCT01982448|101658143|FG001|COMPLETED|Definitive Breast Surgery||67||
48540606|NCT01982448|101658142|FG000|NOT COMPLETED|Definitive Breast Surgery||0||
48540607|NCT01982448|101658143|FG001|NOT COMPLETED|Definitive Breast Surgery||0||
48540608|NCT01438996|101658144|FG000|STARTED|Overall Study||18||
48540609|NCT01438996|101658145|FG001|STARTED|Overall Study||13||
48540610|NCT01438996|101658146|FG002|STARTED|Overall Study||20||
48540611|NCT01438996|101658144|FG000|COMPLETED|Overall Study||14||
48681166|NCT03654274|102003221|FG001|NOT COMPLETED|Overall Study||92||
48681167|NCT03654274|102003222|FG002|NOT COMPLETED|Overall Study||103||
48681168|NCT00775268|102003223|FG000|STARTED|Baseline||9||
48681169|NCT00775268|102003224|FG001|STARTED|Baseline||22||
48243768|NCT03500835|100914539|FG000|COMPLETED|Overall Study||37||
48243769|NCT03500835|100914540|FG001|COMPLETED|Overall Study||23||
48243770|NCT03500835|100914541|FG002|COMPLETED|Overall Study||42||
48243771|NCT03500835|100914539|FG000|NOT COMPLETED|Overall Study||17||
48243772|NCT03500835|100914540|FG001|NOT COMPLETED|Overall Study||30||
48243773|NCT03500835|100914541|FG002|NOT COMPLETED|Overall Study||12||
48243774|NCT01636778|100914542|FG000|STARTED|Pre-Antiviral Treatment Period (Part 1)||45||
48243775|NCT01636778|100914543|FG001|STARTED|Pre-Antiviral Treatment Period (Part 1)||0||
48243776|NCT01636778|100914544|FG002|STARTED|Pre-Antiviral Treatment Period (Part 1)||0||
48243777|NCT01636778|100914542|FG000|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||41||
48243778|NCT01636778|100914543|FG001|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0||
48243779|NCT01636778|100914544|FG002|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0||
48243780|NCT01636778|100914542|FG000|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||4||
48243781|NCT01636778|100914543|FG001|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0||
48243782|NCT01636778|100914544|FG002|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0||
48243783|NCT01636778|100914542|FG000|STARTED|Antiviral Treatment Period (Part 2)||0||
48243784|NCT01636778|100914543|FG001|STARTED|Antiviral Treatment Period (Part 2)||41||
48243785|NCT01636778|100914544|FG002|STARTED|Antiviral Treatment Period (Part 2)||0||
48243786|NCT01636778|100914542|FG000|COMPLETED|Antiviral Treatment Period (Part 2)||0||
48243787|NCT01636778|100914543|FG001|COMPLETED|Antiviral Treatment Period (Part 2)||31||
48243788|NCT01636778|100914544|FG002|COMPLETED|Antiviral Treatment Period (Part 2)||0||
48243789|NCT01636778|100914542|FG000|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0||
48243790|NCT01636778|100914543|FG001|NOT COMPLETED|Antiviral Treatment Period (Part 2)||10||
48243791|NCT01636778|100914544|FG002|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0||
48243792|NCT01636778|100914542|FG000|STARTED|Follow-up Period After Part 2||0||
48243793|NCT01636778|100914543|FG001|STARTED|Follow-up Period After Part 2||0||
48243794|NCT01636778|100914544|FG002|STARTED|Follow-up Period After Part 2||41||
48243795|NCT01636778|100914542|FG000|COMPLETED|Follow-up Period After Part 2||0||
48243796|NCT01636778|100914543|FG001|COMPLETED|Follow-up Period After Part 2||0||
48243797|NCT01636778|100914544|FG002|COMPLETED|Follow-up Period After Part 2||37||
48243798|NCT01636778|100914542|FG000|NOT COMPLETED|Follow-up Period After Part 2||0||
48243799|NCT01636778|100914543|FG001|NOT COMPLETED|Follow-up Period After Part 2||0||
48243800|NCT01636778|100914544|FG002|NOT COMPLETED|Follow-up Period After Part 2||4||
48243801|NCT02713698|100914545|FG000|STARTED|Overall Study||20||
48243802|NCT02713698|100914546|FG001|STARTED|Overall Study||20||
48243803|NCT02713698|100914547|FG002|STARTED|Overall Study||20||
48243804|NCT02713698|100914545|FG000|COMPLETED|Overall Study||20||
48243805|NCT02713698|100914546|FG001|COMPLETED|Overall Study||20||
48243806|NCT02713698|100914547|FG002|COMPLETED|Overall Study||20||
48243807|NCT02713698|100914545|FG000|NOT COMPLETED|Overall Study||0||
48243808|NCT02713698|100914546|FG001|NOT COMPLETED|Overall Study||0||
48243809|NCT02713698|100914547|FG002|NOT COMPLETED|Overall Study||0||
48243810|NCT00938041|100914548|FG000|STARTED|Overall Study||32||
48243811|NCT00938041|100914548|FG000|COMPLETED|Overall Study||5||
48243812|NCT00938041|100914548|FG000|NOT COMPLETED|Overall Study||27||
48243813|NCT00304278|100914549|FG000|STARTED|Overall Study||21||
48243814|NCT00304278|100914549|FG000|COMPLETED|Overall Study||19||
48243815|NCT00304278|100914549|FG000|NOT COMPLETED|Overall Study||2||
48243816|NCT02014402|100914550|FG000|STARTED|Overall Study||31||
48681170|NCT00775268|102003223|FG000|COMPLETED|Baseline||8||
48681171|NCT00775268|102003224|FG001|COMPLETED|Baseline||21||
48681172|NCT00775268|102003223|FG000|NOT COMPLETED|Baseline||1||
48681173|NCT00775268|102003224|FG001|NOT COMPLETED|Baseline||1||
48681174|NCT00775268|102003223|FG000|STARTED|After 2 Cycles||8||
48681175|NCT00775268|102003224|FG001|STARTED|After 2 Cycles||0||
48681176|NCT00775268|102003223|FG000|COMPLETED|After 2 Cycles||7||
48681177|NCT00775268|102003224|FG001|COMPLETED|After 2 Cycles||0||
48681178|NCT00775268|102003223|FG000|NOT COMPLETED|After 2 Cycles||1||
48681179|NCT00775268|102003224|FG001|NOT COMPLETED|After 2 Cycles||0||
48681180|NCT00775268|102003223|FG000|STARTED|After Completion||7||
48681181|NCT00775268|102003224|FG001|STARTED|After Completion||0||
48681182|NCT00775268|102003223|FG000|COMPLETED|After Completion||6||
48681183|NCT00775268|102003224|FG001|COMPLETED|After Completion||0||
48681184|NCT00775268|102003223|FG000|NOT COMPLETED|After Completion||1||
48681185|NCT00775268|102003224|FG001|NOT COMPLETED|After Completion||0||
48681186|NCT03381287|102003225|FG000|STARTED|Overall Study||12||
48681187|NCT03381287|102003226|FG001|STARTED|Overall Study||12||
48681188|NCT03381287|102003227|FG002|STARTED|Overall Study||12||
48681189|NCT03381287|102003228|FG003|STARTED|Overall Study||14||
48681190|NCT03381287|102003225|FG000|COMPLETED|Overall Study||12||
48681191|NCT03381287|102003226|FG001|COMPLETED|Overall Study||11||
48681192|NCT03381287|102003227|FG002|COMPLETED|Overall Study||12||
48681193|NCT03381287|102003228|FG003|COMPLETED|Overall Study||12||
48681194|NCT03381287|102003225|FG000|NOT COMPLETED|Overall Study||0||
48681195|NCT03381287|102003226|FG001|NOT COMPLETED|Overall Study||1||
48681196|NCT03381287|102003227|FG002|NOT COMPLETED|Overall Study||0||
48681197|NCT03381287|102003228|FG003|NOT COMPLETED|Overall Study||2||
48681198|NCT00670930|102003229|FG000|STARTED|Overall Study||23||
48681199|NCT00670930|102003230|FG001|STARTED|Overall Study||13||
48681200|NCT00670930|102003229|FG000|Intent to Treat (ITT) Population|Overall Study||23||
48681201|NCT00670930|102003230|FG001|Intent to Treat (ITT) Population|Overall Study||12||
48681202|NCT00670930|102003229|FG000|COMPLETED|Overall Study||22||
48681203|NCT00670930|102003230|FG001|COMPLETED|Overall Study||12||
48681204|NCT00670930|102003229|FG000|NOT COMPLETED|Overall Study||1||
48681205|NCT00670930|102003230|FG001|NOT COMPLETED|Overall Study||1||
48681206|NCT03289533|102003231|FG000|STARTED|Overall Study||22||
48681207|NCT03289533|102003231|FG000|COMPLETED|Overall Study||0||
48681208|NCT03289533|102003231|FG000|NOT COMPLETED|Overall Study||22||
48681209|NCT02332187|102003232|FG000|STARTED|Overall Study||5||
48681210|NCT02332187|102003233|FG001|STARTED|Overall Study||10||
48681211|NCT02332187|102003232|FG000|COMPLETED|Overall Study||3||
48681212|NCT02332187|102003233|FG001|COMPLETED|Overall Study||7||
48681213|NCT02332187|102003232|FG000|NOT COMPLETED|Overall Study||2||
48681214|NCT02332187|102003233|FG001|NOT COMPLETED|Overall Study||3||
48681215|NCT01130337|102003234|FG000|STARTED|Overall Study||36||
48681216|NCT01130337|102003234|FG000|COMPLETED|Overall Study||22||
48681217|NCT01130337|102003234|FG000|NOT COMPLETED|Overall Study||14||
48681218|NCT03421886|102003235|FG000|STARTED|Overall Study||30||
48681219|NCT03421886|102003236|FG001|STARTED|Overall Study||15||
48681220|NCT03421886|102003235|FG000|COMPLETED|Overall Study||23||
48681221|NCT03421886|102003236|FG001|COMPLETED|Overall Study||13||
48681222|NCT03421886|102003235|FG000|NOT COMPLETED|Overall Study||7||
48681223|NCT03421886|102003236|FG001|NOT COMPLETED|Overall Study||2||
48681224|NCT03710889|102003237|FG000|STARTED|Overall Study||23||
48681225|NCT03710889|102003237|FG000|Received at Least 1 Dose of Study Drug|Overall Study||23|Safety Population|
48681226|NCT03710889|102003237|FG000|Bone-Biopsy Population|Overall Study||19|All enrolled participants who received an evaluable biopsy (defined as a biopsy sample that can be analyzed in the laboratory).|
48681227|NCT03710889|102003237|FG000|COMPLETED|Overall Study||20||
48681228|NCT03710889|102003237|FG000|NOT COMPLETED|Overall Study||3||
48681229|NCT02609425|102003238|FG000|STARTED|Overall Study||30||
48681230|NCT02609425|102003238|FG000|COMPLETED|Overall Study||30||
48681231|NCT02609425|102003238|FG000|NOT COMPLETED|Overall Study||0||
48681232|NCT02073162|102003239|FG000|STARTED|Overall Study||1499||
48681233|NCT02073162|102003240|FG001|STARTED|Overall Study||1501||
48681234|NCT02073162|102003239|FG000|COMPLETED|Overall Study||1493||
48681235|NCT02073162|102003240|FG001|COMPLETED|Overall Study||1490||
48681236|NCT02073162|102003239|FG000|NOT COMPLETED|Overall Study||6||
48681237|NCT02073162|102003240|FG001|NOT COMPLETED|Overall Study||11||
48681238|NCT03314935|102003241|FG000|STARTED|Phase 1||8||
48681239|NCT03314935|102003242|FG001|STARTED|Phase 1||6||
48681240|NCT03314935|102003243|FG002|STARTED|Phase 1||6||
48681241|NCT03314935|102003244|FG003|STARTED|Phase 1||7||
48681242|NCT03314935|102003245|FG004|STARTED|Phase 1||4||
48681243|NCT03314935|102003246|FG005|STARTED|Phase 1||4||
48243817|NCT02014402|100914551|FG001|STARTED|Overall Study||30||
48243818|NCT02014402|100914552|FG002|STARTED|Overall Study||35||
48243819|NCT02014402|100914553|FG003|STARTED|Overall Study||85||
48243820|NCT02014402|100914550|FG000|Human Thrombin|Overall Study||20||
48243821|NCT02014402|100914551|FG001|Human Thrombin|Overall Study||20||
48243822|NCT02014402|100914552|FG002|Human Thrombin|Overall Study||23||
48243823|NCT02014402|100914553|FG003|Human Thrombin|Overall Study||57||
48243824|NCT02014402|100914550|FG000|Bovine Thrombin|Overall Study||11||
48243825|NCT02014402|100914551|FG001|Bovine Thrombin|Overall Study||10||
48243826|NCT02014402|100914552|FG002|Bovine Thrombin|Overall Study||12||
48243827|NCT02014402|100914553|FG003|Bovine Thrombin|Overall Study||28||
48243828|NCT02014402|100914550|FG000|COMPLETED|Overall Study||29||
48243829|NCT02014402|100914551|FG001|COMPLETED|Overall Study||27||
48243830|NCT02014402|100914552|FG002|COMPLETED|Overall Study||32||
48243831|NCT02014402|100914553|FG003|COMPLETED|Overall Study||82||
48243832|NCT02014402|100914550|FG000|NOT COMPLETED|Overall Study||2||
48243833|NCT02014402|100914551|FG001|NOT COMPLETED|Overall Study||3||
48243834|NCT02014402|100914552|FG002|NOT COMPLETED|Overall Study||3||
48243835|NCT02014402|100914553|FG003|NOT COMPLETED|Overall Study||3||
48243836|NCT00850993|100914554|FG000|STARTED|Overall Study||17||
48243837|NCT00850993|100914555|FG001|STARTED|Overall Study||18||
48243838|NCT00850993|100914556|FG002|STARTED|Overall Study||8||
48243839|NCT00850993|100914557|FG003|STARTED|Overall Study||15||
48243840|NCT00850993|100914554|FG000|Safety|Overall Study||17||
48243841|NCT00850993|100914555|FG001|Safety|Overall Study||18||
48243842|NCT00850993|100914556|FG002|Safety|Overall Study||8||
48243843|NCT00850993|100914557|FG003|Safety|Overall Study||15||
48243844|NCT00850993|100914554|FG000|Intent-to-treat|Overall Study||17||
48243845|NCT00850993|100914555|FG001|Intent-to-treat|Overall Study||18||
48243846|NCT00850993|100914556|FG002|Intent-to-treat|Overall Study||8||
48243847|NCT00850993|100914557|FG003|Intent-to-treat|Overall Study||15||
48243848|NCT00850993|100914554|FG000|Received Phototherapy|Overall Study||3||
48243849|NCT00850993|100914555|FG001|Received Phototherapy|Overall Study||6||
48243850|NCT00850993|100914556|FG002|Received Phototherapy|Overall Study||2||
48243851|NCT00850993|100914557|FG003|Received Phototherapy|Overall Study||8||
48243852|NCT00850993|100914554|FG000|Per Protocol|Overall Study||10||
48243853|NCT00850993|100914555|FG001|Per Protocol|Overall Study||13||
48243854|NCT00850993|100914556|FG002|Per Protocol|Overall Study||5||
48243855|NCT00850993|100914557|FG003|Per Protocol|Overall Study||13||
48243856|NCT00850993|100914554|FG000|COMPLETED|Overall Study||16||
48243857|NCT00850993|100914555|FG001|COMPLETED|Overall Study||18||
48243858|NCT00850993|100914556|FG002|COMPLETED|Overall Study||8||
48243859|NCT00850993|100914557|FG003|COMPLETED|Overall Study||14||
48243860|NCT00850993|100914554|FG000|NOT COMPLETED|Overall Study||1||
48243861|NCT00850993|100914555|FG001|NOT COMPLETED|Overall Study||0||
48681244|NCT03314935|102003247|FG006|STARTED|Phase 1||7||
48681245|NCT03314935|102003248|FG007|STARTED|Phase 1||5||
48681246|NCT03314935|102003249|FG008|STARTED|Phase 1||7||
48243862|NCT00850993|100914556|FG002|NOT COMPLETED|Overall Study||0||
48243863|NCT00850993|100914557|FG003|NOT COMPLETED|Overall Study||1||
48243864|NCT03859622|100914558|FG000|STARTED|Overall Study||289||
48243865|NCT03859622|100914558|FG000|COMPLETED|Overall Study||289||
48243866|NCT03859622|100914558|FG000|NOT COMPLETED|Overall Study||0||
48243867|NCT04839289|100914559|FG000|STARTED|Overall Study||18||
48681247|NCT03314935|102003250|FG009|STARTED|Phase 1||0||
48681248|NCT03314935|102003251|FG010|STARTED|Phase 1||0||
48681249|NCT03314935|102003252|FG011|STARTED|Phase 1||0||
48681250|NCT03314935|102003253|FG012|STARTED|Phase 1||0||
48681251|NCT03314935|102003254|FG013|STARTED|Phase 1||0||
48681252|NCT03314935|102003255|FG014|STARTED|Phase 1||0||
48243868|NCT04839289|100914560|FG001|STARTED|Overall Study||9||
48243869|NCT04839289|100914559|FG000|COMPLETED|Overall Study||17||
48243870|NCT04839289|100914560|FG001|COMPLETED|Overall Study||9||
48243871|NCT04839289|100914559|FG000|NOT COMPLETED|Overall Study||1||
48243872|NCT04839289|100914560|FG001|NOT COMPLETED|Overall Study||0||
48243873|NCT03029611|100914561|FG000|STARTED|Overall Study||9||
48681253|NCT03314935|102003241|FG000|COMPLETED|Phase 1||0||
48681254|NCT03314935|102003242|FG001|COMPLETED|Phase 1||0||
48243874|NCT03029611|100914561|FG000|COMPLETED|Overall Study||9||
48243875|NCT03029611|100914561|FG000|NOT COMPLETED|Overall Study||0||
48681255|NCT03314935|102003243|FG002|COMPLETED|Phase 1||0||
48681256|NCT03314935|102003244|FG003|COMPLETED|Phase 1||0||
48681257|NCT03314935|102003245|FG004|COMPLETED|Phase 1||0||
48681258|NCT03314935|102003246|FG005|COMPLETED|Phase 1||0||
48243876|NCT02498418|100914562|FG000|STARTED|Overall Study||247||
48681259|NCT03314935|102003247|FG006|COMPLETED|Phase 1||0||
48243877|NCT02498418|100914563|FG001|STARTED|Overall Study||248||
48681260|NCT03314935|102003248|FG007|COMPLETED|Phase 1||0||
48681261|NCT03314935|102003249|FG008|COMPLETED|Phase 1||0||
48681262|NCT03314935|102003250|FG009|COMPLETED|Phase 1||0||
48681263|NCT03314935|102003251|FG010|COMPLETED|Phase 1||0||
48681264|NCT03314935|102003252|FG011|COMPLETED|Phase 1||0||
48243878|NCT02498418|100914564|FG002|STARTED|Overall Study||244||
48243879|NCT02498418|100914562|FG000|Safety Population|Overall Study||246|Received at least 1 dose of study drug.|
48243880|NCT02498418|100914563|FG001|Safety Population|Overall Study||247|Received at least 1 dose of study drug.|
48243881|NCT02498418|100914564|FG002|Safety Population|Overall Study||244|Received at least 1 dose of study drug.|
48243882|NCT02498418|100914562|FG000|Modified Intent-to-treat Population|Overall Study||183|Met inclusion/exclusion criteria, took ≥1 dose of study drug, provided efficacy and safety data.|
48243883|NCT02498418|100914563|FG001|Modified Intent-to-treat Population|Overall Study||186|Met inclusion/exclusion criteria, took ≥1 dose of study drug, provided efficacy and safety data.|
48243884|NCT02498418|100914564|FG002|Modified Intent-to-treat Population|Overall Study||180|Met inclusion/exclusion criteria, took ≥1 dose of study drug, provided efficacy and safety data.|
48243885|NCT02498418|100914562|FG000|Per-protocol Analysis Set|Overall Study||182|Met study criteria, completed Visit 3 within 24-72 hrs of last dose, had no major protocol violation|
48540612|NCT01438996|101658145|FG001|COMPLETED|Overall Study||12||
48243886|NCT02498418|100914563|FG001|Per-protocol Analysis Set|Overall Study||181|Met study criteria, completed Visit 3 within 24-72 hrs of last dose, had no major protocol violation|
48243887|NCT02498418|100914564|FG002|Per-protocol Analysis Set|Overall Study||176|Met study criteria, completed Visit 3 within 24-72 hrs of last dose, had no major protocol violation|
48243888|NCT02498418|100914562|FG000|COMPLETED|Overall Study||245||
48243889|NCT02498418|100914563|FG001|COMPLETED|Overall Study||246||
48243890|NCT02498418|100914564|FG002|COMPLETED|Overall Study||238||
48243891|NCT02498418|100914562|FG000|NOT COMPLETED|Overall Study||2||
48243892|NCT02498418|100914563|FG001|NOT COMPLETED|Overall Study||2||
48243893|NCT02498418|100914564|FG002|NOT COMPLETED|Overall Study||6||
48243894|NCT03605745|100914565|FG000|STARTED|Overall Study||47||
48243895|NCT03605745|100914565|FG000|2 Weeks|Overall Study||47||
48243896|NCT03605745|100914565|FG000|6 Weeks|Overall Study||47||
48243897|NCT03605745|100914565|FG000|3 Months|Overall Study||47||
48243898|NCT03605745|100914565|FG000|6 Months|Overall Study||47||
48243899|NCT03605745|100914565|FG000|12 Months|Overall Study||40||
48243900|NCT03605745|100914565|FG000|24 Months|Overall Study||1||
48243901|NCT03605745|100914565|FG000|COMPLETED|Overall Study||0||
48243902|NCT03605745|100914565|FG000|NOT COMPLETED|Overall Study||47||
48243903|NCT01257698|100914566|FG000|STARTED|Overall Study||12||
48243904|NCT01257698|100914567|FG001|STARTED|Overall Study||9||
48681265|NCT03314935|102003253|FG012|COMPLETED|Phase 1||0||
48681266|NCT03314935|102003254|FG013|COMPLETED|Phase 1||0||
48681267|NCT03314935|102003255|FG014|COMPLETED|Phase 1||0||
48681268|NCT03314935|102003241|FG000|NOT COMPLETED|Phase 1||8||
48681269|NCT03314935|102003242|FG001|NOT COMPLETED|Phase 1||6||
48681270|NCT03314935|102003243|FG002|NOT COMPLETED|Phase 1||6||
48681271|NCT03314935|102003244|FG003|NOT COMPLETED|Phase 1||7||
48681272|NCT03314935|102003245|FG004|NOT COMPLETED|Phase 1||4||
48681273|NCT03314935|102003246|FG005|NOT COMPLETED|Phase 1||4||
48681274|NCT03314935|102003247|FG006|NOT COMPLETED|Phase 1||7||
48681275|NCT03314935|102003248|FG007|NOT COMPLETED|Phase 1||5||
48681276|NCT03314935|102003249|FG008|NOT COMPLETED|Phase 1||7||
48681277|NCT03314935|102003250|FG009|NOT COMPLETED|Phase 1||0||
48681278|NCT03314935|102003251|FG010|NOT COMPLETED|Phase 1||0||
48681279|NCT03314935|102003252|FG011|NOT COMPLETED|Phase 1||0||
48681280|NCT03314935|102003253|FG012|NOT COMPLETED|Phase 1||0||
48681281|NCT03314935|102003254|FG013|NOT COMPLETED|Phase 1||0||
48681282|NCT03314935|102003255|FG014|NOT COMPLETED|Phase 1||0||
48681283|NCT03314935|102003241|FG000|STARTED|Phase 2||0||
48681284|NCT03314935|102003242|FG001|STARTED|Phase 2||0||
48681285|NCT03314935|102003243|FG002|STARTED|Phase 2||0||
48243905|NCT01257698|100914566|FG000|COMPLETED|Overall Study||8||
48243906|NCT01257698|100914567|FG001|COMPLETED|Overall Study||9||
48243907|NCT01257698|100914566|FG000|NOT COMPLETED|Overall Study||4||
48243908|NCT01257698|100914567|FG001|NOT COMPLETED|Overall Study||0||
48681286|NCT03314935|102003244|FG003|STARTED|Phase 2||0||
48243909|NCT01204775|100914568|FG000|STARTED|Overall Study||4||
48243910|NCT01204775|100914569|FG001|STARTED|Overall Study||4||
48243911|NCT01204775|100914568|FG000|Double-blind Treatment Period|Overall Study||4||
48081623|NCT03129100|100521629|FG016|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081624|NCT03129100|100521630|FG017|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081625|NCT03129100|100521631|FG018|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081626|NCT03129100|100521632|FG019|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081627|NCT03129100|100521633|FG020|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48081628|NCT03129100|100521634|FG021|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48243912|NCT01204775|100914569|FG001|Double-blind Treatment Period|Overall Study||4||
48243913|NCT01204775|100914568|FG000|COMPLETED|Overall Study||3||
48243914|NCT01204775|100914569|FG001|COMPLETED|Overall Study||3||
48243915|NCT01204775|100914568|FG000|NOT COMPLETED|Overall Study||1||
48243916|NCT01204775|100914569|FG001|NOT COMPLETED|Overall Study||1||
48243917|NCT03640754|100914570|FG000|STARTED|Overall Study||31||
48243918|NCT03640754|100914571|FG001|STARTED|Overall Study||30||
48243919|NCT03640754|100914570|FG000|COMPLETED|Overall Study||30||
48243920|NCT03640754|100914571|FG001|COMPLETED|Overall Study||29||
48243921|NCT03640754|100914570|FG000|NOT COMPLETED|Overall Study||1||
48243922|NCT03640754|100914571|FG001|NOT COMPLETED|Overall Study||1||
48243923|NCT01323309|100914572|FG000|STARTED|Overall Study||109||
48243924|NCT01323309|100914573|FG001|STARTED|Overall Study||108||
48243925|NCT01323309|100914574|FG002|STARTED|Overall Study||104||
48243926|NCT01323309|100914572|FG000|COMPLETED|Overall Study||70||
48243927|NCT01323309|100914573|FG001|COMPLETED|Overall Study||54||
48243928|NCT01323309|100914574|FG002|COMPLETED|Overall Study||53||
48243929|NCT01323309|100914572|FG000|NOT COMPLETED|Overall Study||39||
48243930|NCT01323309|100914573|FG001|NOT COMPLETED|Overall Study||54||
48243931|NCT01323309|100914574|FG002|NOT COMPLETED|Overall Study||51||
48243932|NCT04277442|100914575|FG000|STARTED|Overall Study||1||
48243933|NCT04277442|100914575|FG000|COMPLETED|Overall Study||1||
48243934|NCT04277442|100914575|FG000|NOT COMPLETED|Overall Study||0||
48243935|NCT01601821|100914576|FG000|STARTED|Overall Study||125||
48243936|NCT01601821|100914577|FG001|STARTED|Overall Study||120||
48243937|NCT01601821|100914576|FG000|COMPLETED|Overall Study||96||
48243938|NCT01601821|100914577|FG001|COMPLETED|Overall Study||91||
48243939|NCT01601821|100914576|FG000|NOT COMPLETED|Overall Study||29||
48243940|NCT01601821|100914577|FG001|NOT COMPLETED|Overall Study||29||
48243941|NCT02879448|100914578|FG000|STARTED|Overall Study||934||
48243942|NCT02879448|100914579|FG001|STARTED|Overall Study||944||
48243943|NCT02879448|100914578|FG000|COMPLETED|Overall Study||796||
48243944|NCT02879448|100914579|FG001|COMPLETED|Overall Study||742||
48243945|NCT02879448|100914578|FG000|NOT COMPLETED|Overall Study||138||
48243946|NCT02879448|100914579|FG001|NOT COMPLETED|Overall Study||202||
48243947|NCT00473512|100914580|FG000|STARTED|Period 1 (Phase 1)||3||
48243948|NCT00473512|100914581|FG001|STARTED|Period 1 (Phase 1)||3||
48243949|NCT00473512|100914582|FG002|STARTED|Period 1 (Phase 1)||3||
48243950|NCT00473512|100914583|FG003|STARTED|Period 1 (Phase 1)||42||
48243951|NCT00473512|100914584|FG004|STARTED|Period 1 (Phase 1)||3||
48243952|NCT00473512|100914580|FG000|COMPLETED|Period 1 (Phase 1)||2||
48243953|NCT00473512|100914581|FG001|COMPLETED|Period 1 (Phase 1)||2||
48243954|NCT00473512|100914582|FG002|COMPLETED|Period 1 (Phase 1)||3||
48243955|NCT00473512|100914583|FG003|COMPLETED|Period 1 (Phase 1)||25||
48243956|NCT00473512|100914584|FG004|COMPLETED|Period 1 (Phase 1)||2||
48243957|NCT00473512|100914580|FG000|NOT COMPLETED|Period 1 (Phase 1)||1||
48243958|NCT00473512|100914581|FG001|NOT COMPLETED|Period 1 (Phase 1)||1||
48243959|NCT00473512|100914582|FG002|NOT COMPLETED|Period 1 (Phase 1)||0||
48243960|NCT00473512|100914583|FG003|NOT COMPLETED|Period 1 (Phase 1)||17||
48243961|NCT00473512|100914584|FG004|NOT COMPLETED|Period 1 (Phase 1)||1||
48243962|NCT00473512|100914580|FG000|STARTED|Period 2 (Phase 2)||1||
48243963|NCT00473512|100914581|FG001|STARTED|Period 2 (Phase 2)||2||
48243964|NCT00473512|100914582|FG002|STARTED|Period 2 (Phase 2)||2||
48243965|NCT00473512|100914583|FG003|STARTED|Period 2 (Phase 2)||23||
48243966|NCT00473512|100914584|FG004|STARTED|Period 2 (Phase 2)||2||
48243967|NCT00473512|100914580|FG000|COMPLETED|Period 2 (Phase 2)||0||
48243968|NCT00473512|100914581|FG001|COMPLETED|Period 2 (Phase 2)||0||
48243969|NCT00473512|100914582|FG002|COMPLETED|Period 2 (Phase 2)||0||
48243970|NCT00473512|100914583|FG003|COMPLETED|Period 2 (Phase 2)||0||
48243971|NCT00473512|100914584|FG004|COMPLETED|Period 2 (Phase 2)||0||
48243972|NCT00473512|100914580|FG000|NOT COMPLETED|Period 2 (Phase 2)||1||
48243973|NCT00473512|100914581|FG001|NOT COMPLETED|Period 2 (Phase 2)||2||
48243974|NCT00473512|100914582|FG002|NOT COMPLETED|Period 2 (Phase 2)||2||
48243975|NCT00473512|100914583|FG003|NOT COMPLETED|Period 2 (Phase 2)||23||
48243976|NCT00473512|100914584|FG004|NOT COMPLETED|Period 2 (Phase 2)||2||
48243977|NCT02092285|100914585|FG000|STARTED|Induction Phase||205||
48243978|NCT02092285|100914585|FG000|COMPLETED|Induction Phase||170||
48243979|NCT02092285|100914585|FG000|NOT COMPLETED|Induction Phase||35||
48243980|NCT02092285|100914585|FG000|STARTED|Maintenance Phase & Follow-up||170||
48243981|NCT02092285|100914585|FG000|COMPLETED|Maintenance Phase & Follow-up||60||
48243982|NCT02092285|100914585|FG000|NOT COMPLETED|Maintenance Phase & Follow-up||110||
48243983|NCT00647699|100914586|FG000|STARTED|Overall Study||73||
48243984|NCT00647699|100914587|FG001|STARTED|Overall Study||74||
48243985|NCT00647699|100914586|FG000|COMPLETED|Overall Study||65||
48243986|NCT00647699|100914587|FG001|COMPLETED|Overall Study||62||
48243987|NCT00647699|100914586|FG000|NOT COMPLETED|Overall Study||8||
48243988|NCT00647699|100914587|FG001|NOT COMPLETED|Overall Study||12||
48243989|NCT00609245|100914588|FG000|STARTED|Overall Study||13||
48243990|NCT00609245|100914588|FG000|COMPLETED|Overall Study||12||
48243991|NCT00609245|100914588|FG000|NOT COMPLETED|Overall Study||1||
48243992|NCT00432445|100914589|FG000|STARTED|Overall Study||2||
48243993|NCT00432445|100914589|FG000|COMPLETED|Overall Study||2||
48243994|NCT00432445|100914589|FG000|NOT COMPLETED|Overall Study||0||
48243995|NCT00246129|100914590|FG000|STARTED|Overall Study||82||
48243996|NCT00246129|100914591|FG001|STARTED|Overall Study||41||
48243997|NCT00246129|100914590|FG000|COMPLETED|Overall Study||75||
48243998|NCT00246129|100914591|FG001|COMPLETED|Overall Study||39||
48243999|NCT00246129|100914590|FG000|NOT COMPLETED|Overall Study||7||
48244000|NCT00246129|100914591|FG001|NOT COMPLETED|Overall Study||2||
48244001|NCT01774929|100914592|FG000|STARTED|Overall Study||35||
48244002|NCT01774929|100914592|FG000|COMPLETED|Overall Study||32||
48244003|NCT01774929|100914592|FG000|NOT COMPLETED|Overall Study||3||
48244004|NCT00002540|100914593|FG000|STARTED|Overall Study||38345||
48244005|NCT00002540|100914594|FG001|STARTED|Overall Study||38340||
48244006|NCT00002540|100914593|FG000|COMPLETED|Overall Study||37544||
48244007|NCT00002540|100914594|FG001|COMPLETED|Overall Study||35876||
48244008|NCT00002540|100914593|FG000|NOT COMPLETED|Overall Study||801||
48244009|NCT00002540|100914594|FG001|NOT COMPLETED|Overall Study||2464||
48681287|NCT03314935|102003245|FG004|STARTED|Phase 2||0||
48681288|NCT03314935|102003246|FG005|STARTED|Phase 2||0||
48244010|NCT00762853|100914595|FG000|STARTED|First Treatment Period||10||
48244011|NCT00762853|100914596|FG001|STARTED|First Treatment Period||10||
48244012|NCT00762853|100914595|FG000|COMPLETED|First Treatment Period||10||
48244013|NCT00762853|100914596|FG001|COMPLETED|First Treatment Period||10||
48244014|NCT00762853|100914595|FG000|NOT COMPLETED|First Treatment Period||0||
48244015|NCT00762853|100914596|FG001|NOT COMPLETED|First Treatment Period||0||
48244016|NCT00762853|100914595|FG000|STARTED|1 Week Washout After Treatment 1||10||
48244017|NCT00762853|100914596|FG001|STARTED|1 Week Washout After Treatment 1||10||
48244018|NCT00762853|100914595|FG000|COMPLETED|1 Week Washout After Treatment 1||10||
48244019|NCT00762853|100914596|FG001|COMPLETED|1 Week Washout After Treatment 1||10||
48244020|NCT00762853|100914595|FG000|NOT COMPLETED|1 Week Washout After Treatment 1||0||
48244021|NCT00762853|100914596|FG001|NOT COMPLETED|1 Week Washout After Treatment 1||0||
48244022|NCT00762853|100914595|FG000|STARTED|Second Treatment Period||10||
48244023|NCT00762853|100914596|FG001|STARTED|Second Treatment Period||10||
48244024|NCT00762853|100914595|FG000|COMPLETED|Second Treatment Period||10||
48244025|NCT00762853|100914596|FG001|COMPLETED|Second Treatment Period||10||
48244026|NCT00762853|100914595|FG000|NOT COMPLETED|Second Treatment Period||0||
48244027|NCT00762853|100914596|FG001|NOT COMPLETED|Second Treatment Period||0||
48244028|NCT02815709|100914597|FG000|STARTED|Overall Study||82||
48244029|NCT02815709|100914598|FG001|STARTED|Overall Study||86||
48244030|NCT02815709|100914599|FG002|STARTED|Overall Study||82||
48244031|NCT02815709|100914600|FG003|STARTED|Overall Study||84||
48244032|NCT02815709|100914601|FG004|STARTED|Overall Study||84||
48244033|NCT02815709|100914597|FG000|Treated With Study Medication|Overall Study||76||
48244034|NCT02815709|100914598|FG001|Treated With Study Medication|Overall Study||79||
48244035|NCT02815709|100914599|FG002|Treated With Study Medication|Overall Study||79||
48244036|NCT02815709|100914600|FG003|Treated With Study Medication|Overall Study||79||
48244037|NCT02815709|100914601|FG004|Treated With Study Medication|Overall Study||76||
48244038|NCT02815709|100914597|FG000|COMPLETED|Overall Study||75||
48244039|NCT02815709|100914598|FG001|COMPLETED|Overall Study||78||
48244040|NCT02815709|100914599|FG002|COMPLETED|Overall Study||75||
48244041|NCT02815709|100914600|FG003|COMPLETED|Overall Study||76||
48244042|NCT02815709|100914601|FG004|COMPLETED|Overall Study||74||
48244043|NCT02815709|100914597|FG000|NOT COMPLETED|Overall Study||7||
48244044|NCT02815709|100914598|FG001|NOT COMPLETED|Overall Study||8||
48244045|NCT02815709|100914599|FG002|NOT COMPLETED|Overall Study||7||
48244046|NCT02815709|100914600|FG003|NOT COMPLETED|Overall Study||8||
48244047|NCT02815709|100914601|FG004|NOT COMPLETED|Overall Study||10||
48244048|NCT00464737|100914602|FG000|STARTED|Overall Study||82||
48244049|NCT00464737|100914603|FG001|STARTED|Overall Study||74||
48244050|NCT00464737|100914604|FG002|STARTED|Overall Study||74||
48244051|NCT00464737|100914602|FG000|COMPLETED|Overall Study||50||
48244052|NCT00464737|100914603|FG001|COMPLETED|Overall Study||42||
48244053|NCT00464737|100914604|FG002|COMPLETED|Overall Study||19||
48244054|NCT00464737|100914602|FG000|NOT COMPLETED|Overall Study||32||
48244055|NCT00464737|100914603|FG001|NOT COMPLETED|Overall Study||32||
48244056|NCT00464737|100914604|FG002|NOT COMPLETED|Overall Study||55||
48244057|NCT03079284|100914605|FG000|STARTED|Overall Study||10||
48244058|NCT03079284|100914605|FG000|COMPLETED|Overall Study||10||
48244059|NCT03079284|100914605|FG000|NOT COMPLETED|Overall Study||0||
48244060|NCT02916745|100914606|FG000|STARTED|Overall Study||5||
48244061|NCT02916745|100914606|FG000|COMPLETED|Overall Study||5||
48244062|NCT02916745|100914606|FG000|NOT COMPLETED|Overall Study||0||
48244063|NCT01064856|100914607|FG000|STARTED|Double-blind (DB) Period||84||
48244064|NCT01064856|100914608|FG001|STARTED|Double-blind (DB) Period||81||
48244065|NCT01064856|100914609|FG002|STARTED|Double-blind (DB) Period||0||
48244066|NCT01064856|100914610|FG003|STARTED|Double-blind (DB) Period||0||
48244067|NCT01064856|100914607|FG000|COMPLETED|Double-blind (DB) Period||82||
48244068|NCT01064856|100914608|FG001|COMPLETED|Double-blind (DB) Period||81||
48244069|NCT01064856|100914609|FG002|COMPLETED|Double-blind (DB) Period||0||
48244070|NCT01064856|100914610|FG003|COMPLETED|Double-blind (DB) Period||0||
48244071|NCT01064856|100914607|FG000|NOT COMPLETED|Double-blind (DB) Period||2||
48244072|NCT01064856|100914608|FG001|NOT COMPLETED|Double-blind (DB) Period||0||
48244073|NCT01064856|100914609|FG002|NOT COMPLETED|Double-blind (DB) Period||0||
48244074|NCT01064856|100914610|FG003|NOT COMPLETED|Double-blind (DB) Period||0||
48244075|NCT01064856|100914607|FG000|STARTED|Open-label (OL) Period||0||
48244076|NCT01064856|100914608|FG001|STARTED|Open-label (OL) Period||0||
48244077|NCT01064856|100914609|FG002|STARTED|Open-label (OL) Period||82||
48244078|NCT01064856|100914610|FG003|STARTED|Open-label (OL) Period||81||
48244079|NCT01064856|100914607|FG000|COMPLETED|Open-label (OL) Period||0||
48244080|NCT01064856|100914608|FG001|COMPLETED|Open-label (OL) Period||0||
48244081|NCT01064856|100914609|FG002|COMPLETED|Open-label (OL) Period||56||
48244082|NCT01064856|100914610|FG003|COMPLETED|Open-label (OL) Period||61||
48244083|NCT01064856|100914607|FG000|NOT COMPLETED|Open-label (OL) Period||0||
48244084|NCT01064856|100914608|FG001|NOT COMPLETED|Open-label (OL) Period||0||
48681289|NCT03314935|102003247|FG006|STARTED|Phase 2||0||
48244085|NCT01064856|100914609|FG002|NOT COMPLETED|Open-label (OL) Period||26||
48244086|NCT01064856|100914610|FG003|NOT COMPLETED|Open-label (OL) Period||20||
48681290|NCT03314935|102003248|FG007|STARTED|Phase 2||0||
48244087|NCT02188784|100914611|FG000|STARTED|Overall Study||111||
48244088|NCT02188784|100914612|FG001|STARTED|Overall Study||114||
48244089|NCT02188784|100914611|FG000|COMPLETED|Overall Study||102||
48244090|NCT02188784|100914612|FG001|COMPLETED|Overall Study||101||
48244091|NCT02188784|100914611|FG000|NOT COMPLETED|Overall Study||9||
48244092|NCT02188784|100914612|FG001|NOT COMPLETED|Overall Study||13||
48244093|NCT03196180|100914613|FG000|STARTED|Overall Study||13||
48244094|NCT03196180|100914613|FG000|COMPLETED|Overall Study||11||
48244095|NCT03196180|100914613|FG000|NOT COMPLETED|Overall Study||2||
48244096|NCT01107912|100914614|FG000|STARTED|Period 1||73||
48681291|NCT03314935|102003249|FG008|STARTED|Phase 2||0||
48681292|NCT03314935|102003250|FG009|STARTED|Phase 2||8||
48681293|NCT03314935|102003251|FG010|STARTED|Phase 2||33||
48681294|NCT03314935|102003252|FG011|STARTED|Phase 2||9||
48681295|NCT03314935|102003253|FG012|STARTED|Phase 2||11||
48681296|NCT03314935|102003254|FG013|STARTED|Phase 2||10||
48681297|NCT03314935|102003255|FG014|STARTED|Phase 2||24||
48681298|NCT03314935|102003241|FG000|COMPLETED|Phase 2||0||
48681299|NCT03314935|102003242|FG001|COMPLETED|Phase 2||0||
48681300|NCT03314935|102003243|FG002|COMPLETED|Phase 2||0||
48681301|NCT03314935|102003244|FG003|COMPLETED|Phase 2||0||
48681302|NCT03314935|102003245|FG004|COMPLETED|Phase 2||0||
48681303|NCT03314935|102003246|FG005|COMPLETED|Phase 2||0||
48681304|NCT03314935|102003247|FG006|COMPLETED|Phase 2||0||
48681305|NCT03314935|102003248|FG007|COMPLETED|Phase 2||0||
48681306|NCT03314935|102003249|FG008|COMPLETED|Phase 2||0||
48681307|NCT03314935|102003250|FG009|COMPLETED|Phase 2||0||
48681308|NCT03314935|102003251|FG010|COMPLETED|Phase 2||0||
48681309|NCT03314935|102003252|FG011|COMPLETED|Phase 2||0||
48681310|NCT03314935|102003253|FG012|COMPLETED|Phase 2||0||
48681311|NCT03314935|102003254|FG013|COMPLETED|Phase 2||0||
48681312|NCT03314935|102003255|FG014|COMPLETED|Phase 2||0||
48681313|NCT03314935|102003241|FG000|NOT COMPLETED|Phase 2||0||
48681314|NCT03314935|102003242|FG001|NOT COMPLETED|Phase 2||0||
48681315|NCT03314935|102003243|FG002|NOT COMPLETED|Phase 2||0||
48681316|NCT03314935|102003244|FG003|NOT COMPLETED|Phase 2||0||
48681317|NCT03314935|102003245|FG004|NOT COMPLETED|Phase 2||0||
48681318|NCT03314935|102003246|FG005|NOT COMPLETED|Phase 2||0||
48681319|NCT03314935|102003247|FG006|NOT COMPLETED|Phase 2||0||
48681320|NCT03314935|102003248|FG007|NOT COMPLETED|Phase 2||0||
48681321|NCT03314935|102003249|FG008|NOT COMPLETED|Phase 2||0||
48681322|NCT03314935|102003250|FG009|NOT COMPLETED|Phase 2||8||
48681323|NCT03314935|102003251|FG010|NOT COMPLETED|Phase 2||33||
48681324|NCT03314935|102003252|FG011|NOT COMPLETED|Phase 2||9||
48681325|NCT03314935|102003253|FG012|NOT COMPLETED|Phase 2||11||
48681326|NCT03314935|102003254|FG013|NOT COMPLETED|Phase 2||10||
48681327|NCT03314935|102003255|FG014|NOT COMPLETED|Phase 2||24||
48681328|NCT01424943|102003256|FG000|STARTED|Overall Study||25||
48681329|NCT01424943|102003257|FG001|STARTED|Overall Study||24||
48244097|NCT01107912|100914615|FG001|STARTED|Period 1||0||
48244098|NCT01107912|100914616|FG002|STARTED|Period 1||0||
48244099|NCT01107912|100914617|FG003|STARTED|Period 1||0||
48244100|NCT01107912|100914618|FG004|STARTED|Period 1||82||
48244101|NCT01107912|100914619|FG005|STARTED|Period 1||0||
48244102|NCT01107912|100914614|FG000|Received at Least 1 Dose of Study Drug|Period 1||73||
48244103|NCT01107912|100914615|FG001|Received at Least 1 Dose of Study Drug|Period 1||0||
48244104|NCT01107912|100914616|FG002|Received at Least 1 Dose of Study Drug|Period 1||0||
48244105|NCT01107912|100914617|FG003|Received at Least 1 Dose of Study Drug|Period 1||0||
48244106|NCT01107912|100914618|FG004|Received at Least 1 Dose of Study Drug|Period 1||82||
48244107|NCT01107912|100914619|FG005|Received at Least 1 Dose of Study Drug|Period 1||0||
48681330|NCT01424943|102003256|FG000|COMPLETED|Overall Study||12||
48681331|NCT01424943|102003257|FG001|COMPLETED|Overall Study||23||
48681332|NCT01424943|102003256|FG000|NOT COMPLETED|Overall Study||13||
48681333|NCT01424943|102003257|FG001|NOT COMPLETED|Overall Study||1||
48681334|NCT03848416|102003258|FG000|STARTED|Overall Study||33||
48681335|NCT03848416|102003259|FG001|STARTED|Overall Study||33||
48681336|NCT03848416|102003260|FG002|STARTED|Overall Study||33||
48681337|NCT03848416|102003258|FG000|Received at Least One Dose of Study Drug|Overall Study||33||
48681338|NCT03848416|102003259|FG001|Received at Least One Dose of Study Drug|Overall Study||33||
48681339|NCT03848416|102003260|FG002|Received at Least One Dose of Study Drug|Overall Study||33||
48681340|NCT03848416|102003258|FG000|COMPLETED|Overall Study||32||
48244108|NCT01107912|100914614|FG000|COMPLETED|Period 1||72||
48681341|NCT03848416|102003259|FG001|COMPLETED|Overall Study||33||
48681342|NCT03848416|102003260|FG002|COMPLETED|Overall Study||32||
48681343|NCT03848416|102003258|FG000|NOT COMPLETED|Overall Study||1||
48244109|NCT01107912|100914615|FG001|COMPLETED|Period 1||0||
48244110|NCT01107912|100914616|FG002|COMPLETED|Period 1||0||
48244111|NCT01107912|100914617|FG003|COMPLETED|Period 1||0||
48244112|NCT01107912|100914618|FG004|COMPLETED|Period 1||79||
48244113|NCT01107912|100914619|FG005|COMPLETED|Period 1||0||
48244114|NCT01107912|100914614|FG000|NOT COMPLETED|Period 1||1||
48244115|NCT01107912|100914615|FG001|NOT COMPLETED|Period 1||0||
48681344|NCT03848416|102003259|FG001|NOT COMPLETED|Overall Study||0||
48681345|NCT03848416|102003260|FG002|NOT COMPLETED|Overall Study||1||
48681346|NCT00939107|102003261|FG000|STARTED|Overall Study||175||
48681347|NCT00939107|102003262|FG001|STARTED|Overall Study||175||
48681348|NCT00939107|102003261|FG000|12 Months Follow-up|Overall Study||161||
48681349|NCT00939107|102003262|FG001|12 Months Follow-up|Overall Study||163||
48681350|NCT00939107|102003261|FG000|COMPLETED|Overall Study||161||
48681351|NCT00939107|102003262|FG001|COMPLETED|Overall Study||163||
48681352|NCT00939107|102003261|FG000|NOT COMPLETED|Overall Study||14||
48681353|NCT00939107|102003262|FG001|NOT COMPLETED|Overall Study||12||
48681354|NCT03443687|102003263|FG000|STARTED|Overall Study||27||
48681355|NCT03443687|102003264|FG001|STARTED|Overall Study||27||
48681356|NCT03443687|102003263|FG000|COMPLETED|Overall Study||22||
48681357|NCT03443687|102003264|FG001|COMPLETED|Overall Study||21||
48681358|NCT03443687|102003263|FG000|NOT COMPLETED|Overall Study||5||
48681359|NCT03443687|102003264|FG001|NOT COMPLETED|Overall Study||6||
48244116|NCT01107912|100914616|FG002|NOT COMPLETED|Period 1||0||
48244117|NCT01107912|100914617|FG003|NOT COMPLETED|Period 1||0||
48244118|NCT01107912|100914618|FG004|NOT COMPLETED|Period 1||3||
48244119|NCT01107912|100914619|FG005|NOT COMPLETED|Period 1||0||
48244120|NCT01107912|100914614|FG000|STARTED|Period 2||0||
48244121|NCT01107912|100914615|FG001|STARTED|Period 2||36||
48244122|NCT01107912|100914616|FG002|STARTED|Period 2||36||
48244123|NCT01107912|100914617|FG003|STARTED|Period 2||41||
48244124|NCT01107912|100914618|FG004|STARTED|Period 2||0||
48244125|NCT01107912|100914619|FG005|STARTED|Period 2||38||
48244126|NCT01107912|100914614|FG000|COMPLETED|Period 2||0||
48244127|NCT01107912|100914615|FG001|COMPLETED|Period 2||36||
48244128|NCT01107912|100914616|FG002|COMPLETED|Period 2||35||
48244129|NCT01107912|100914617|FG003|COMPLETED|Period 2||41||
48244130|NCT01107912|100914618|FG004|COMPLETED|Period 2||0||
48244131|NCT01107912|100914619|FG005|COMPLETED|Period 2||38||
48244132|NCT01107912|100914614|FG000|NOT COMPLETED|Period 2||0||
48244133|NCT01107912|100914615|FG001|NOT COMPLETED|Period 2||0||
48244134|NCT01107912|100914616|FG002|NOT COMPLETED|Period 2||1||
48244135|NCT01107912|100914617|FG003|NOT COMPLETED|Period 2||0||
48244136|NCT01107912|100914618|FG004|NOT COMPLETED|Period 2||0||
48244137|NCT01107912|100914619|FG005|NOT COMPLETED|Period 2||0||
48244138|NCT01107912|100914614|FG000|STARTED|Period 3||0||
48244139|NCT01107912|100914615|FG001|STARTED|Period 3||35||
48244140|NCT01107912|100914616|FG002|STARTED|Period 3||36||
48244141|NCT01107912|100914617|FG003|STARTED|Period 3||38||
48244142|NCT01107912|100914618|FG004|STARTED|Period 3||0||
48244143|NCT01107912|100914619|FG005|STARTED|Period 3||41||
48244144|NCT01107912|100914614|FG000|COMPLETED|Period 3||0||
48244145|NCT01107912|100914615|FG001|COMPLETED|Period 3||34||
48244146|NCT01107912|100914616|FG002|COMPLETED|Period 3||35||
48244147|NCT01107912|100914617|FG003|COMPLETED|Period 3||37||
48244148|NCT01107912|100914618|FG004|COMPLETED|Period 3||0||
48244149|NCT01107912|100914619|FG005|COMPLETED|Period 3||41||
48244150|NCT01107912|100914614|FG000|NOT COMPLETED|Period 3||0||
48244151|NCT01107912|100914615|FG001|NOT COMPLETED|Period 3||1||
48244152|NCT01107912|100914616|FG002|NOT COMPLETED|Period 3||1||
48244153|NCT01107912|100914617|FG003|NOT COMPLETED|Period 3||1||
48244154|NCT01107912|100914618|FG004|NOT COMPLETED|Period 3||0||
48244155|NCT01107912|100914619|FG005|NOT COMPLETED|Period 3||0||
48244156|NCT02473913|100914620|FG000|STARTED|Overall Study||11||
48244157|NCT02473913|100914621|FG001|STARTED|Overall Study||11||
48244158|NCT02473913|100914620|FG000|COMPLETED|Overall Study||8||
48244159|NCT02473913|100914621|FG001|COMPLETED|Overall Study||8||
48244160|NCT02473913|100914620|FG000|NOT COMPLETED|Overall Study||3||
48681360|NCT01446874|102003265|FG000|STARTED|Overall Study||20||
48681361|NCT01446874|102003266|FG001|STARTED|Overall Study||50||
48244161|NCT02473913|100914621|FG001|NOT COMPLETED|Overall Study||3||
48244162|NCT01622088|100914622|FG000|STARTED|Overall Study||616||
48244163|NCT01622088|100914622|FG000|COMPLETED|Overall Study||0||
48244164|NCT01622088|100914622|FG000|NOT COMPLETED|Overall Study||616||
48244165|NCT02100189|100914623|FG000|STARTED|Overall Study||50||
48244166|NCT02100189|100914623|FG000|COMPLETED|Overall Study||50||
48244167|NCT02100189|100914623|FG000|NOT COMPLETED|Overall Study||0||
48244168|NCT02023099|100914624|FG000|STARTED|Overall Study||215||
48681362|NCT01446874|102003267|FG002|STARTED|Overall Study||80||
48244169|NCT02023099|100914625|FG001|STARTED|Overall Study||106||
48244170|NCT02023099|100914626|FG002|STARTED|Overall Study||42||
48681363|NCT01446874|102003265|FG000|COMPLETED|Overall Study||18||
48244171|NCT02023099|100914624|FG000|COMPLETED|Overall Study||212||
48244172|NCT02023099|100914625|FG001|COMPLETED|Overall Study||106||
48244173|NCT02023099|100914626|FG002|COMPLETED|Overall Study||39||
48244174|NCT02023099|100914624|FG000|NOT COMPLETED|Overall Study||3||
48244175|NCT02023099|100914625|FG001|NOT COMPLETED|Overall Study||0||
48244176|NCT02023099|100914626|FG002|NOT COMPLETED|Overall Study||3||
48244177|NCT02067000|100914627|FG000|STARTED|Overall Study||217||
48244178|NCT02067000|100914627|FG000|COMPLETED|Overall Study||167||
48244179|NCT02067000|100914627|FG000|NOT COMPLETED|Overall Study||50||
48244180|NCT01634620|100914628|FG000|STARTED|Overall Study||200||
48244181|NCT01634620|100914628|FG000|COMPLETED|Overall Study||200||
48244182|NCT01634620|100914628|FG000|NOT COMPLETED|Overall Study||0||
48244183|NCT03569891|100914629|FG000|STARTED|Lead-in||67||
48244184|NCT03569891|100914629|FG000|COMPLETED|Lead-in||54||
48244185|NCT03569891|100914629|FG000|NOT COMPLETED|Lead-in||13||
48244186|NCT03569891|100914629|FG000|STARTED|AMT-061||54||
48244187|NCT03569891|100914629|FG000|COMPLETED|AMT-061||53||
48244188|NCT03569891|100914629|FG000|NOT COMPLETED|AMT-061||1||
48244189|NCT02889809|100914630|FG000|STARTED|Overall Study||239||
48244190|NCT02889809|100914631|FG001|STARTED|Overall Study||238||
48244191|NCT02889809|100914630|FG000|COMPLETED|Overall Study||196||
48244192|NCT02889809|100914631|FG001|COMPLETED|Overall Study||205||
48244193|NCT02889809|100914630|FG000|NOT COMPLETED|Overall Study||43||
48244194|NCT02889809|100914631|FG001|NOT COMPLETED|Overall Study||33||
48244195|NCT04320602|100914632|FG000|STARTED|Overall Study||18||
48244196|NCT04320602|100914632|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18||
48244197|NCT04320602|100914632|FG000|COMPLETED|Overall Study||18||
48244198|NCT04320602|100914632|FG000|NOT COMPLETED|Overall Study||0||
48244199|NCT02359552|100914633|FG000|STARTED|Overall Study||25||
48244200|NCT02359552|100914634|FG001|STARTED|Overall Study||25||
48244201|NCT02359552|100914633|FG000|COMPLETED|Overall Study||22||
48244202|NCT02359552|100914634|FG001|COMPLETED|Overall Study||21||
48244203|NCT02359552|100914633|FG000|NOT COMPLETED|Overall Study||3||
48244204|NCT02359552|100914634|FG001|NOT COMPLETED|Overall Study||4||
48244205|NCT00495612|100914635|FG000|STARTED|Overall Study||36||
48244206|NCT00495612|100914636|FG001|STARTED|Overall Study||33||
48244207|NCT00495612|100914635|FG000|COMPLETED|Overall Study||32||
48244208|NCT00495612|100914636|FG001|COMPLETED|Overall Study||33||
48244209|NCT00495612|100914635|FG000|NOT COMPLETED|Overall Study||4||
48244210|NCT00495612|100914636|FG001|NOT COMPLETED|Overall Study||0||
48244211|NCT02382913|100914637|FG000|STARTED|Overall Study||27||
48244212|NCT02382913|100914638|FG001|STARTED|Overall Study||36||
48244213|NCT02382913|100914639|FG002|STARTED|Overall Study||32||
48244214|NCT02382913|100914640|FG003|STARTED|Overall Study||27||
48244215|NCT02382913|100914641|FG004|STARTED|Overall Study||33||
48244216|NCT02382913|100914642|FG005|STARTED|Overall Study||30||
48681364|NCT01446874|102003266|FG001|COMPLETED|Overall Study||46||
48681365|NCT01446874|102003267|FG002|COMPLETED|Overall Study||62||
48681366|NCT01446874|102003265|FG000|NOT COMPLETED|Overall Study||2||
48681367|NCT01446874|102003266|FG001|NOT COMPLETED|Overall Study||4||
48681368|NCT01446874|102003267|FG002|NOT COMPLETED|Overall Study||18||
48681369|NCT01227785|102003268|FG000|STARTED|Overall Study||120||
48681370|NCT01227785|102003268|FG000|COMPLETED|Overall Study||108||
48681371|NCT01227785|102003268|FG000|NOT COMPLETED|Overall Study||12||
48244217|NCT02382913|100914643|FG006|STARTED|Overall Study||37||
48681372|NCT00560508|102003269|FG000|STARTED|12 Week Double-blind Period||56||
48681373|NCT00560508|102003270|FG001|STARTED|12 Week Double-blind Period||56||
48681374|NCT00560508|102003269|FG000|COMPLETED|12 Week Double-blind Period||51||
48681375|NCT00560508|102003270|FG001|COMPLETED|12 Week Double-blind Period||53||
48681376|NCT00560508|102003269|FG000|NOT COMPLETED|12 Week Double-blind Period||5||
48681377|NCT00560508|102003270|FG001|NOT COMPLETED|12 Week Double-blind Period||3||
48681378|NCT00560508|102003269|FG000|STARTED|52-week Open-label Period Pramipexole ER||51||
48681379|NCT00560508|102003270|FG001|STARTED|52-week Open-label Period Pramipexole ER||53||
48244218|NCT02382913|100914644|FG007|STARTED|Overall Study||30||
48244219|NCT02382913|100914645|FG008|STARTED|Overall Study||30||
48244220|NCT02382913|100914646|FG009|STARTED|Overall Study||33||
48244221|NCT02382913|100914637|FG000|COMPLETED|Overall Study||27||
48244222|NCT02382913|100914638|FG001|COMPLETED|Overall Study||36||
48244223|NCT02382913|100914639|FG002|COMPLETED|Overall Study||32||
48244224|NCT02382913|100914640|FG003|COMPLETED|Overall Study||27||
48244225|NCT02382913|100914641|FG004|COMPLETED|Overall Study||33||
48244226|NCT02382913|100914642|FG005|COMPLETED|Overall Study||30||
48244227|NCT02382913|100914643|FG006|COMPLETED|Overall Study||37||
48681380|NCT00560508|102003269|FG000|COMPLETED|52-week Open-label Period Pramipexole ER||43||
48244228|NCT02382913|100914644|FG007|COMPLETED|Overall Study||30||
48244229|NCT02382913|100914645|FG008|COMPLETED|Overall Study||30||
48244230|NCT02382913|100914646|FG009|COMPLETED|Overall Study||33||
48681381|NCT00560508|102003270|FG001|COMPLETED|52-week Open-label Period Pramipexole ER||42||
48681382|NCT00560508|102003269|FG000|NOT COMPLETED|52-week Open-label Period Pramipexole ER||8||
48244231|NCT02382913|100914637|FG000|NOT COMPLETED|Overall Study||0||
48244232|NCT02382913|100914638|FG001|NOT COMPLETED|Overall Study||0||
48244233|NCT02382913|100914639|FG002|NOT COMPLETED|Overall Study||0||
48244234|NCT02382913|100914640|FG003|NOT COMPLETED|Overall Study||0||
48244235|NCT02382913|100914641|FG004|NOT COMPLETED|Overall Study||0||
48244236|NCT02382913|100914642|FG005|NOT COMPLETED|Overall Study||0||
48244237|NCT02382913|100914643|FG006|NOT COMPLETED|Overall Study||0||
48244238|NCT02382913|100914644|FG007|NOT COMPLETED|Overall Study||0||
48244239|NCT02382913|100914645|FG008|NOT COMPLETED|Overall Study||0||
48244240|NCT02382913|100914646|FG009|NOT COMPLETED|Overall Study||0||
48244241|NCT00839306|100914647|FG000|STARTED|Overall Study||60||
48244242|NCT00839306|100914648|FG001|STARTED|Overall Study||177||
48244243|NCT00839306|100914647|FG000|COMPLETED|Overall Study||35||
48244244|NCT00839306|100914648|FG001|COMPLETED|Overall Study||134||
48244245|NCT00839306|100914647|FG000|NOT COMPLETED|Overall Study||25||
48244246|NCT00839306|100914648|FG001|NOT COMPLETED|Overall Study||43||
48244247|NCT01375777|100914649|FG000|STARTED|Overall Study||46||
48244248|NCT01375777|100914650|FG001|STARTED|Overall Study||45||
48244249|NCT01375777|100914651|FG002|STARTED|Overall Study||46||
48244250|NCT01375777|100914652|FG003|STARTED|Overall Study||45||
48244251|NCT01375777|100914653|FG004|STARTED|Overall Study||46||
48244252|NCT01375777|100914654|FG005|STARTED|Overall Study||45||
48244253|NCT01375777|100914655|FG006|STARTED|Overall Study||46||
48244254|NCT01375777|100914656|FG007|STARTED|Overall Study||46||
48244255|NCT01375777|100914657|FG008|STARTED|Overall Study||46||
48244256|NCT01375777|100914649|FG000|Received Treatment|Overall Study||45||
48244257|NCT01375777|100914650|FG001|Received Treatment|Overall Study||45||
48244258|NCT01375777|100914651|FG002|Received Treatment|Overall Study||45||
48244259|NCT01375777|100914652|FG003|Received Treatment|Overall Study||45||
48244260|NCT01375777|100914653|FG004|Received Treatment|Overall Study||46||
48244261|NCT01375777|100914654|FG005|Received Treatment|Overall Study||45||
48244262|NCT01375777|100914655|FG006|Received Treatment|Overall Study||45||
48244263|NCT01375777|100914656|FG007|Received Treatment|Overall Study||45||
48244264|NCT01375777|100914657|FG008|Received Treatment|Overall Study||45||
48244265|NCT01375777|100914649|FG000|COMPLETED|Overall Study||44||
48244266|NCT01375777|100914650|FG001|COMPLETED|Overall Study||42||
48244267|NCT01375777|100914651|FG002|COMPLETED|Overall Study||45||
48244268|NCT01375777|100914652|FG003|COMPLETED|Overall Study||45||
48244269|NCT01375777|100914653|FG004|COMPLETED|Overall Study||45||
48244270|NCT01375777|100914654|FG005|COMPLETED|Overall Study||44||
48244271|NCT01375777|100914655|FG006|COMPLETED|Overall Study||44||
48244272|NCT01375777|100914656|FG007|COMPLETED|Overall Study||44||
48244273|NCT01375777|100914657|FG008|COMPLETED|Overall Study||44||
48244274|NCT01375777|100914649|FG000|NOT COMPLETED|Overall Study||2||
48244275|NCT01375777|100914650|FG001|NOT COMPLETED|Overall Study||3||
48244276|NCT01375777|100914651|FG002|NOT COMPLETED|Overall Study||1||
48244277|NCT01375777|100914652|FG003|NOT COMPLETED|Overall Study||0||
48244278|NCT01375777|100914653|FG004|NOT COMPLETED|Overall Study||1||
48244279|NCT01375777|100914654|FG005|NOT COMPLETED|Overall Study||1||
48244280|NCT01375777|100914655|FG006|NOT COMPLETED|Overall Study||2||
48244281|NCT01375777|100914656|FG007|NOT COMPLETED|Overall Study||2||
48244282|NCT01375777|100914657|FG008|NOT COMPLETED|Overall Study||2||
48244283|NCT01125436|100914658|FG000|STARTED|Overall Study||31||
48244284|NCT01125436|100914659|FG001|STARTED|Overall Study||33||
48244285|NCT01125436|100914658|FG000|COMPLETED|Overall Study||19||
48244286|NCT01125436|100914659|FG001|COMPLETED|Overall Study||21||
48244287|NCT01125436|100914658|FG000|NOT COMPLETED|Overall Study||12||
48244288|NCT01125436|100914659|FG001|NOT COMPLETED|Overall Study||12||
48244289|NCT01818245|100914660|FG000|STARTED|Intervention A||30||
48244290|NCT01818245|100914661|FG001|STARTED|Intervention A||22||
48244291|NCT01818245|100914660|FG000|Received One Dose of Study Drug|Intervention A||30||
48244292|NCT01818245|100914661|FG001|Received One Dose of Study Drug|Intervention A||22||
48244293|NCT01818245|100914660|FG000|COMPLETED|Intervention A||30||
48244294|NCT01818245|100914661|FG001|COMPLETED|Intervention A||22||
48244295|NCT01818245|100914660|FG000|NOT COMPLETED|Intervention A||0||
48244296|NCT01818245|100914661|FG001|NOT COMPLETED|Intervention A||0||
48244297|NCT01818245|100914660|FG000|STARTED|Washout (16-28 Days)||30||
48244298|NCT01818245|100914661|FG001|STARTED|Washout (16-28 Days)||0||
48244299|NCT01818245|100914660|FG000|COMPLETED|Washout (16-28 Days)||30||
48244300|NCT01818245|100914661|FG001|COMPLETED|Washout (16-28 Days)||0||
48244301|NCT01818245|100914660|FG000|NOT COMPLETED|Washout (16-28 Days)||0||
48244302|NCT01818245|100914661|FG001|NOT COMPLETED|Washout (16-28 Days)||0||
48244303|NCT01818245|100914660|FG000|STARTED|Intervention B||30||
48244304|NCT01818245|100914661|FG001|STARTED|Intervention B||0||
48244305|NCT01818245|100914660|FG000|COMPLETED|Intervention B||30||
48244306|NCT01818245|100914661|FG001|COMPLETED|Intervention B||0||
48244307|NCT01818245|100914660|FG000|NOT COMPLETED|Intervention B||0||
48244308|NCT01818245|100914661|FG001|NOT COMPLETED|Intervention B||0||
48244309|NCT01818245|100914660|FG000|STARTED|Washout (16-28 Days)||30||
48244310|NCT01818245|100914661|FG001|STARTED|Washout (16-28 Days)||0||
48244311|NCT01818245|100914660|FG000|COMPLETED|Washout (16-28 Days)||30||
48244312|NCT01818245|100914661|FG001|COMPLETED|Washout (16-28 Days)||0||
48244313|NCT01818245|100914660|FG000|NOT COMPLETED|Washout (16-28 Days)||0||
48244314|NCT01818245|100914661|FG001|NOT COMPLETED|Washout (16-28 Days)||0||
48244315|NCT01818245|100914660|FG000|STARTED|Intervention C||30||
48244316|NCT01818245|100914661|FG001|STARTED|Intervention C||0||
48244317|NCT01818245|100914660|FG000|COMPLETED|Intervention C||30||
48244318|NCT01818245|100914661|FG001|COMPLETED|Intervention C||0||
48244319|NCT01818245|100914660|FG000|NOT COMPLETED|Intervention C||0||
48244320|NCT01818245|100914661|FG001|NOT COMPLETED|Intervention C||0||
48244321|NCT01061775|100914662|FG000|STARTED|Overall Study||19||
48244322|NCT01061775|100914662|FG000|COMPLETED|Overall Study||16||
48244323|NCT01061775|100914662|FG000|NOT COMPLETED|Overall Study||3||
48244324|NCT04453709|100914663|FG000|STARTED|Overall Study||116||
48244325|NCT04453709|100914664|FG001|STARTED|Overall Study||116||
48244326|NCT04453709|100914663|FG000|COMPLETED|Overall Study||116||
48244327|NCT04453709|100914664|FG001|COMPLETED|Overall Study||116||
48244328|NCT04453709|100914663|FG000|NOT COMPLETED|Overall Study||0||
48244329|NCT04453709|100914664|FG001|NOT COMPLETED|Overall Study||0||
48244330|NCT01189136|100914665|FG000|STARTED|Overall Study||42||
48244331|NCT01189136|100914666|FG001|STARTED|Overall Study||42||
48244332|NCT01189136|100914665|FG000|COMPLETED|Overall Study||42||
48244333|NCT01189136|100914666|FG001|COMPLETED|Overall Study||42||
48244334|NCT01189136|100914665|FG000|NOT COMPLETED|Overall Study||0||
48244335|NCT01189136|100914666|FG001|NOT COMPLETED|Overall Study||0||
48244336|NCT00714688|100914667|FG000|STARTED|Overall Study||97||
48244337|NCT00714688|100914668|FG001|STARTED|Overall Study||90||
48244338|NCT00714688|100914669|FG002|STARTED|Overall Study||92||
48244339|NCT00714688|100914667|FG000|COMPLETED|Overall Study||68||
48244340|NCT00714688|100914668|FG001|COMPLETED|Overall Study||55||
48244341|NCT00714688|100914669|FG002|COMPLETED|Overall Study||55||
48244342|NCT00714688|100914667|FG000|NOT COMPLETED|Overall Study||29||
48244343|NCT00714688|100914668|FG001|NOT COMPLETED|Overall Study||35||
48244344|NCT00714688|100914669|FG002|NOT COMPLETED|Overall Study||37||
48244345|NCT00702520|100917690|FG000|STARTED|Base Study P05788 - Assigned Treatment||25||
48244346|NCT00702520|100917691|FG001|STARTED|Base Study P05788 - Assigned Treatment||25||
48244347|NCT00702520|100917692|FG002|STARTED|Base Study P05788 - Assigned Treatment||0||
48244348|NCT00702520|100917693|FG003|STARTED|Base Study P05788 - Assigned Treatment||0||
48244349|NCT00702520|100917690|FG000|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||25||
48244350|NCT00702520|100917691|FG001|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||24||
48244351|NCT00702520|100917692|FG002|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0||
48244352|NCT00702520|100917693|FG003|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0||
48244353|NCT00702520|100917690|FG000|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||25||
48244354|NCT00702520|100917691|FG001|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||24||
48244355|NCT00702520|100917692|FG002|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0||
48244356|NCT00702520|100917693|FG003|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0||
48244357|NCT00702520|100917690|FG000|COMPLETED|Base Study P05788 - Assigned Treatment||25||
48244358|NCT00702520|100917691|FG001|COMPLETED|Base Study P05788 - Assigned Treatment||24||
48244359|NCT00702520|100917692|FG002|COMPLETED|Base Study P05788 - Assigned Treatment||0||
48244360|NCT00702520|100917693|FG003|COMPLETED|Base Study P05788 - Assigned Treatment||0||
48244361|NCT00702520|100917690|FG000|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0||
48244362|NCT00702520|100917691|FG001|NOT COMPLETED|Base Study P05788 - Assigned Treatment||1||
48244363|NCT00702520|100917692|FG002|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0||
48244364|NCT00702520|100917693|FG003|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0||
48244365|NCT00702520|100917690|FG000|STARTED|Base Study P05788 - Embryo Transfer||25||
48244366|NCT00702520|100917691|FG001|STARTED|Base Study P05788 - Embryo Transfer||24||
48244367|NCT00702520|100917692|FG002|STARTED|Base Study P05788 - Embryo Transfer||0||
48244368|NCT00702520|100917693|FG003|STARTED|Base Study P05788 - Embryo Transfer||0||
48244369|NCT00702520|100917690|FG000|Embryo Transfer|Base Study P05788 - Embryo Transfer||22||
48244370|NCT00702520|100917691|FG001|Embryo Transfer|Base Study P05788 - Embryo Transfer||18||
48540613|NCT01438996|101658146|FG002|COMPLETED|Overall Study||20||
48244371|NCT00702520|100917692|FG002|Embryo Transfer|Base Study P05788 - Embryo Transfer||0||
48244372|NCT00702520|100917693|FG003|Embryo Transfer|Base Study P05788 - Embryo Transfer||0||
48244373|NCT00702520|100917690|FG000|COMPLETED|Base Study P05788 - Embryo Transfer||22||
48244374|NCT00702520|100917691|FG001|COMPLETED|Base Study P05788 - Embryo Transfer||18||
48244375|NCT00702520|100917692|FG002|COMPLETED|Base Study P05788 - Embryo Transfer||0||
48244376|NCT00702520|100917693|FG003|COMPLETED|Base Study P05788 - Embryo Transfer||0||
48540614|NCT01438996|101658144|FG000|NOT COMPLETED|Overall Study||4||
48244377|NCT00702520|100917690|FG000|NOT COMPLETED|Base Study P05788 - Embryo Transfer||3||
48244378|NCT00702520|100917691|FG001|NOT COMPLETED|Base Study P05788 - Embryo Transfer||6||
48081629|NCT03129100|100521635|FG022|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
48244379|NCT00702520|100917692|FG002|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0||
48244380|NCT00702520|100917693|FG003|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0||
48081630|NCT03129100|100521636|FG023|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||3||
48081631|NCT03129100|100521637|FG024|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||25||
48244381|NCT00702520|100917690|FG000|STARTED|Base Study P05788 - Follow-Up||22||
48081632|NCT03129100|100521638|FG025|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||42||
48244382|NCT00702520|100917691|FG001|STARTED|Base Study P05788 - Follow-Up||18||
48244383|NCT00702520|100917692|FG002|STARTED|Base Study P05788 - Follow-Up||0||
48244384|NCT00702520|100917693|FG003|STARTED|Base Study P05788 - Follow-Up||0||
48244385|NCT00702520|100917690|FG000|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||7||
48244386|NCT00702520|100917691|FG001|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||8||
48244387|NCT00702520|100917692|FG002|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0||
48244388|NCT00702520|100917693|FG003|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0||
48244389|NCT00702520|100917690|FG000|COMPLETED|Base Study P05788 - Follow-Up||7||
48244390|NCT00702520|100917691|FG001|COMPLETED|Base Study P05788 - Follow-Up||8||
48244391|NCT00702520|100917692|FG002|COMPLETED|Base Study P05788 - Follow-Up||0||
48244392|NCT00702520|100917693|FG003|COMPLETED|Base Study P05788 - Follow-Up||0||
48244393|NCT00702520|100917690|FG000|NOT COMPLETED|Base Study P05788 - Follow-Up||15||
48244394|NCT00702520|100917691|FG001|NOT COMPLETED|Base Study P05788 - Follow-Up||10||
48244395|NCT00702520|100917692|FG002|NOT COMPLETED|Base Study P05788 - Follow-Up||0||
48681383|NCT00560508|102003270|FG001|NOT COMPLETED|52-week Open-label Period Pramipexole ER||11||
48681384|NCT02271529|102003271|FG000|STARTED|Overall Study||40||
48244396|NCT00702520|100917693|FG003|NOT COMPLETED|Base Study P05788 - Follow-Up||0||
48244397|NCT00702520|100917690|FG000|STARTED|Follow-up Study P05783||7||
48244398|NCT00702520|100917691|FG001|STARTED|Follow-up Study P05783||8||
48244399|NCT00702520|100917692|FG002|STARTED|Follow-up Study P05783||8||
48681385|NCT02271529|102003271|FG000|COMPLETED|Overall Study||39||
48681386|NCT02271529|102003271|FG000|NOT COMPLETED|Overall Study||1||
48681387|NCT02712996|102003272|FG000|STARTED|First Intervention (Study Days 1-42)||8||
48681388|NCT02712996|102003273|FG001|STARTED|First Intervention (Study Days 1-42)||9||
48681389|NCT02712996|102003272|FG000|COMPLETED|First Intervention (Study Days 1-42)||8||
48681390|NCT02712996|102003273|FG001|COMPLETED|First Intervention (Study Days 1-42)||9||
48681391|NCT02712996|102003272|FG000|NOT COMPLETED|First Intervention (Study Days 1-42)||0||
48681392|NCT02712996|102003273|FG001|NOT COMPLETED|First Intervention (Study Days 1-42)||0||
48681393|NCT02712996|102003272|FG000|STARTED|Second Intervention (Study Days 43-84)||8||
48681394|NCT02712996|102003273|FG001|STARTED|Second Intervention (Study Days 43-84)||9||
48681395|NCT02712996|102003272|FG000|COMPLETED|Second Intervention (Study Days 43-84)||8||
48681396|NCT02712996|102003273|FG001|COMPLETED|Second Intervention (Study Days 43-84)||8||
48681397|NCT02712996|102003272|FG000|NOT COMPLETED|Second Intervention (Study Days 43-84)||0||
48681398|NCT02712996|102003273|FG001|NOT COMPLETED|Second Intervention (Study Days 43-84)||1||
48681399|NCT03289143|102003274|FG000|STARTED|Overall Study||135||
48681400|NCT03289143|102003275|FG001|STARTED|Overall Study||94||
48681401|NCT03289143|102003276|FG002|STARTED|Overall Study||136||
48681402|NCT03289143|102003277|FG003|STARTED|Overall Study||92||
48681403|NCT03289143|102003274|FG000|COMPLETED|Overall Study||1||
48681404|NCT03289143|102003275|FG001|COMPLETED|Overall Study||0||
48681405|NCT03289143|102003276|FG002|COMPLETED|Overall Study||2||
48681406|NCT03289143|102003277|FG003|COMPLETED|Overall Study||0||
48681407|NCT03289143|102003274|FG000|NOT COMPLETED|Overall Study||134||
48681408|NCT03289143|102003275|FG001|NOT COMPLETED|Overall Study||94||
48681409|NCT03289143|102003276|FG002|NOT COMPLETED|Overall Study||134||
48681410|NCT03289143|102003277|FG003|NOT COMPLETED|Overall Study||92||
48681411|NCT01892371|102003278|FG000|STARTED|Overall Study||5||
48681412|NCT01892371|102003279|FG001|STARTED|Overall Study||1||
48681413|NCT01892371|102003280|FG002|STARTED|Overall Study||35||
48681414|NCT01892371|102003281|FG003|STARTED|Overall Study||32||
48681415|NCT01892371|102003278|FG000|COMPLETED|Overall Study||5||
48681416|NCT01892371|102003279|FG001|COMPLETED|Overall Study||1||
48681417|NCT01892371|102003280|FG002|COMPLETED|Overall Study||35||
48681418|NCT01892371|102003281|FG003|COMPLETED|Overall Study||32||
48681419|NCT01892371|102003278|FG000|NOT COMPLETED|Overall Study||0||
48681420|NCT01892371|102003279|FG001|NOT COMPLETED|Overall Study||0||
48681421|NCT01892371|102003280|FG002|NOT COMPLETED|Overall Study||0||
48681422|NCT01892371|102003281|FG003|NOT COMPLETED|Overall Study||0||
48244400|NCT00702520|100917693|FG003|STARTED|Follow-up Study P05783||11||
48244401|NCT00702520|100917690|FG000|COMPLETED|Follow-up Study P05783||7||
48244402|NCT00702520|100917691|FG001|COMPLETED|Follow-up Study P05783||8||
48244403|NCT00702520|100917692|FG002|COMPLETED|Follow-up Study P05783||8||
48681423|NCT00469833|102003282|FG000|STARTED|Overall Study||17||
48681424|NCT00469833|102003282|FG000|COMPLETED|Overall Study||15||
48681425|NCT00469833|102003282|FG000|NOT COMPLETED|Overall Study||2||
48681426|NCT01030822|102003283|FG000|STARTED|Overall Study||100||
48681427|NCT01030822|102003284|FG001|STARTED|Overall Study||95||
48681428|NCT01030822|102003285|FG002|STARTED|Overall Study||87||
48681429|NCT01030822|102003283|FG000|COMPLETED|Overall Study||69||
48681430|NCT01030822|102003284|FG001|COMPLETED|Overall Study||71||
48681431|NCT01030822|102003285|FG002|COMPLETED|Overall Study||61||
48681432|NCT01030822|102003283|FG000|NOT COMPLETED|Overall Study||31||
48244404|NCT00702520|100917693|FG003|COMPLETED|Follow-up Study P05783||11||
48681433|NCT01030822|102003284|FG001|NOT COMPLETED|Overall Study||24||
48244405|NCT00702520|100917690|FG000|NOT COMPLETED|Follow-up Study P05783||0||
48244406|NCT00702520|100917691|FG001|NOT COMPLETED|Follow-up Study P05783||0||
48244407|NCT00702520|100917692|FG002|NOT COMPLETED|Follow-up Study P05783||0||
48244408|NCT00702520|100917693|FG003|NOT COMPLETED|Follow-up Study P05783||0||
48681434|NCT01030822|102003285|FG002|NOT COMPLETED|Overall Study||26||
48681435|NCT00200967|102003286|FG000|STARTED|First Treatment Period||42||
48681436|NCT00200967|102003287|FG001|STARTED|First Treatment Period||45||
48681437|NCT00200967|102003286|FG000|First Treatment Period|First Treatment Period||42||
48681438|NCT00200967|102003287|FG001|First Treatment Period|First Treatment Period||45||
48681439|NCT00200967|102003286|FG000|COMPLETED|First Treatment Period||36||
48681440|NCT00200967|102003287|FG001|COMPLETED|First Treatment Period||44||
48681441|NCT00200967|102003286|FG000|NOT COMPLETED|First Treatment Period||6||
48681442|NCT00200967|102003287|FG001|NOT COMPLETED|First Treatment Period||1||
48681443|NCT00200967|102003286|FG000|STARTED|Wash-out Period||36||
48681444|NCT00200967|102003287|FG001|STARTED|Wash-out Period||44||
48681445|NCT00200967|102003286|FG000|COMPLETED|Wash-out Period||36||
48681446|NCT00200967|102003287|FG001|COMPLETED|Wash-out Period||43||
48681447|NCT00200967|102003286|FG000|NOT COMPLETED|Wash-out Period||0||
48681448|NCT00200967|102003287|FG001|NOT COMPLETED|Wash-out Period||1||
48681449|NCT00200967|102003286|FG000|STARTED|Second Treatment Period||36||
48681450|NCT00200967|102003287|FG001|STARTED|Second Treatment Period||43||
48681451|NCT00200967|102003286|FG000|COMPLETED|Second Treatment Period||35||
48681452|NCT00200967|102003287|FG001|COMPLETED|Second Treatment Period||41||
48681453|NCT00200967|102003286|FG000|NOT COMPLETED|Second Treatment Period||1||
48681454|NCT00200967|102003287|FG001|NOT COMPLETED|Second Treatment Period||2||
48681455|NCT00200967|102003286|FG000|STARTED|Run-out Period||35||
48681456|NCT00200967|102003287|FG001|STARTED|Run-out Period||41||
48681457|NCT00200967|102003286|FG000|COMPLETED|Run-out Period||34||
48681458|NCT00200967|102003287|FG001|COMPLETED|Run-out Period||41||
48681459|NCT00200967|102003286|FG000|NOT COMPLETED|Run-out Period||1||
48681460|NCT00200967|102003287|FG001|NOT COMPLETED|Run-out Period||0||
48681461|NCT03257358|102003288|FG000|STARTED|Overall Study||165||
48681462|NCT03257358|102003289|FG001|STARTED|Overall Study||217||
48681463|NCT03257358|102003288|FG000|Never Received Treatment|Overall Study||2||
48681464|NCT03257358|102003289|FG001|Never Received Treatment|Overall Study||0||
48681465|NCT03257358|102003288|FG000|COMPLETED|Overall Study||94||
48681466|NCT03257358|102003289|FG001|COMPLETED|Overall Study||183||
48681467|NCT03257358|102003288|FG000|NOT COMPLETED|Overall Study||71||
48681468|NCT03257358|102003289|FG001|NOT COMPLETED|Overall Study||34||
48681469|NCT01213082|102003290|FG000|STARTED|Overall Study||12||
48681470|NCT01213082|102003291|FG001|STARTED|Overall Study||11||
48681471|NCT01213082|102003292|FG002|STARTED|Overall Study||11||
48681472|NCT01213082|102003290|FG000|COMPLETED|Overall Study||6||
48681473|NCT01213082|102003291|FG001|COMPLETED|Overall Study||4||
48681474|NCT01213082|102003292|FG002|COMPLETED|Overall Study||6||
48681475|NCT01213082|102003290|FG000|NOT COMPLETED|Overall Study||6||
48681476|NCT01213082|102003291|FG001|NOT COMPLETED|Overall Study||7||
48681477|NCT01213082|102003292|FG002|NOT COMPLETED|Overall Study||5||
48681478|NCT03975153|102003293|FG000|STARTED|Overall Study||14||
48681479|NCT03975153|102003293|FG000|COMPLETED|Overall Study||12||
48681480|NCT03975153|102003293|FG000|NOT COMPLETED|Overall Study||2||
48681481|NCT03533660|102003294|FG000|STARTED|Overall Study||15||
48681482|NCT03533660|102003295|FG001|STARTED|Overall Study||18||
48681483|NCT03533660|102003294|FG000|COMPLETED|Overall Study||11||
48244409|NCT02339506|100917694|FG000|STARTED|Period 1 (Placebo or Cosyntropin)||12||
48244410|NCT02339506|100917695|FG001|STARTED|Period 1 (Placebo or Cosyntropin)||11||
48244411|NCT02339506|100917694|FG000|COMPLETED|Period 1 (Placebo or Cosyntropin)||12||
48244412|NCT02339506|100917695|FG001|COMPLETED|Period 1 (Placebo or Cosyntropin)||10||
48244413|NCT02339506|100917694|FG000|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||0||
48244414|NCT02339506|100917695|FG001|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||1||
48681484|NCT03533660|102003295|FG001|COMPLETED|Overall Study||10||
48681485|NCT03533660|102003294|FG000|NOT COMPLETED|Overall Study||4||
48681486|NCT03533660|102003295|FG001|NOT COMPLETED|Overall Study||8||
48681487|NCT00052910|102003296|FG000|STARTED|Overall Study||280||
48681488|NCT00052910|102003297|FG001|STARTED|Overall Study||266||
48681489|NCT00052910|102003296|FG000|COMPLETED|Overall Study||280||
48681490|NCT00052910|102003297|FG001|COMPLETED|Overall Study||266||
48681491|NCT00052910|102003296|FG000|NOT COMPLETED|Overall Study||0||
48681492|NCT00052910|102003297|FG001|NOT COMPLETED|Overall Study||0||
48681493|NCT00552071|102003298|FG000|STARTED|Overall Study||10||
48681494|NCT00552071|102003299|FG001|STARTED|Overall Study||11||
48681495|NCT00552071|102003298|FG000|COMPLETED|Overall Study||6||
48681496|NCT00552071|102003299|FG001|COMPLETED|Overall Study||9||
48681497|NCT00552071|102003298|FG000|NOT COMPLETED|Overall Study||4||
48681498|NCT00552071|102003299|FG001|NOT COMPLETED|Overall Study||2||
48681499|NCT01482195|102003300|FG000|STARTED|Overall Study||6||
48681500|NCT01482195|102003300|FG000|One Year Results|Overall Study||6||
48681501|NCT01482195|102003300|FG000|COMPLETED|Overall Study||6||
48681502|NCT01482195|102003300|FG000|NOT COMPLETED|Overall Study||0||
48681503|NCT03789292|102003301|FG000|STARTED|Treatment Period I (Week 0 to Week 26)||324||
48681504|NCT03789292|102003302|FG001|STARTED|Treatment Period I (Week 0 to Week 26)||324||
48244415|NCT02339506|100917694|FG000|STARTED|Washout (Period 2)||12||
48244416|NCT02339506|100917695|FG001|STARTED|Washout (Period 2)||10||
48244417|NCT02339506|100917694|FG000|COMPLETED|Washout (Period 2)||10||
48244418|NCT02339506|100917695|FG001|COMPLETED|Washout (Period 2)||10||
48244419|NCT02339506|100917694|FG000|NOT COMPLETED|Washout (Period 2)||2||
48244420|NCT02339506|100917695|FG001|NOT COMPLETED|Washout (Period 2)||0||
48244421|NCT02339506|100917694|FG000|STARTED|Period 3 (Placebo or Cosyntropin)||10||
48244422|NCT02339506|100917695|FG001|STARTED|Period 3 (Placebo or Cosyntropin)||10||
48540615|NCT01438996|101658145|FG001|NOT COMPLETED|Overall Study||1||
48244423|NCT02339506|100917694|FG000|COMPLETED|Period 3 (Placebo or Cosyntropin)||10||
48244424|NCT02339506|100917695|FG001|COMPLETED|Period 3 (Placebo or Cosyntropin)||10||
48244425|NCT02339506|100917694|FG000|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0||
48244426|NCT02339506|100917695|FG001|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0||
48244427|NCT02040532|100917696|FG000|STARTED|Overall Study||32||
48244428|NCT02040532|100917696|FG000|Received at Least One Dose of Medication|Overall Study||26||
48244429|NCT02040532|100917696|FG000|COMPLETED|Overall Study||20||
48244430|NCT02040532|100917696|FG000|NOT COMPLETED|Overall Study||12||
48244431|NCT00417989|100917697|FG000|STARTED|Overall Study||244||
48244432|NCT00417989|100917698|FG001|STARTED|Overall Study||241||
48244433|NCT00417989|100917697|FG000|COMPLETED|Overall Study||224||
48244434|NCT00417989|100917698|FG001|COMPLETED|Overall Study||219||
48244435|NCT00417989|100917697|FG000|NOT COMPLETED|Overall Study||20||
48244436|NCT00417989|100917698|FG001|NOT COMPLETED|Overall Study||22||
48244437|NCT04088500|100917699|FG000|STARTED|Overall Study||5||
48244438|NCT04088500|100917699|FG000|COMPLETED|Overall Study||0||
48244439|NCT04088500|100917699|FG000|NOT COMPLETED|Overall Study||5||
48244440|NCT02963922|100917700|FG000|STARTED|Overall Study||198||
48244441|NCT02963922|100917701|FG001|STARTED|Overall Study||198||
48244442|NCT02963922|100917700|FG000|COMPLETED|Overall Study||166||
48244443|NCT02963922|100917701|FG001|COMPLETED|Overall Study||168||
48244444|NCT02963922|100917700|FG000|NOT COMPLETED|Overall Study||32||
48244445|NCT02963922|100917701|FG001|NOT COMPLETED|Overall Study||30||
48244446|NCT03332589|100917702|FG000|STARTED|Overall Study||4||
48244447|NCT03332589|100917703|FG001|STARTED|Overall Study||0||
48244448|NCT03332589|100917704|FG002|STARTED|Overall Study||0||
48244449|NCT03332589|100917702|FG000|COMPLETED|Overall Study||0||
48244450|NCT03332589|100917703|FG001|COMPLETED|Overall Study||0||
48244451|NCT03332589|100917704|FG002|COMPLETED|Overall Study||0||
48681505|NCT03789292|102003303|FG002|STARTED|Treatment Period I (Week 0 to Week 26)||0||
48681506|NCT03789292|102003301|FG000|COMPLETED|Treatment Period I (Week 0 to Week 26)||303||
48681507|NCT03789292|102003302|FG001|COMPLETED|Treatment Period I (Week 0 to Week 26)||305||
48681508|NCT03789292|102003303|FG002|COMPLETED|Treatment Period I (Week 0 to Week 26)||0||
48681509|NCT03789292|102003301|FG000|NOT COMPLETED|Treatment Period I (Week 0 to Week 26)||21||
48681510|NCT03789292|102003302|FG001|NOT COMPLETED|Treatment Period I (Week 0 to Week 26)||19||
48681511|NCT03789292|102003303|FG002|NOT COMPLETED|Treatment Period I (Week 0 to Week 26)||0||
48681512|NCT03789292|102003301|FG000|STARTED|Treatment Period II (Week 26 to Week 52)||303||
48681513|NCT03789292|102003302|FG001|STARTED|Treatment Period II (Week 26 to Week 52)||153||
48681514|NCT03789292|102003303|FG002|STARTED|Treatment Period II (Week 26 to Week 52)||152||
48681515|NCT03789292|102003301|FG000|COMPLETED|Treatment Period II (Week 26 to Week 52)||287||
48681516|NCT03789292|102003302|FG001|COMPLETED|Treatment Period II (Week 26 to Week 52)||147||
48681517|NCT03789292|102003303|FG002|COMPLETED|Treatment Period II (Week 26 to Week 52)||143||
48681518|NCT03789292|102003301|FG000|NOT COMPLETED|Treatment Period II (Week 26 to Week 52)||16||
48681519|NCT03789292|102003302|FG001|NOT COMPLETED|Treatment Period II (Week 26 to Week 52)||6||
48681520|NCT03789292|102003303|FG002|NOT COMPLETED|Treatment Period II (Week 26 to Week 52)||9||
48244452|NCT03332589|100917702|FG000|NOT COMPLETED|Overall Study||4||
48244453|NCT03332589|100917703|FG001|NOT COMPLETED|Overall Study||0||
48244454|NCT03332589|100917704|FG002|NOT COMPLETED|Overall Study||0||
48244455|NCT03779334|100917705|FG000|STARTED|Overall Study||8||
48244456|NCT03779334|100917706|FG001|STARTED|Overall Study||13||
48244457|NCT03779334|100917707|FG002|STARTED|Overall Study||5||
48244458|NCT03779334|100917705|FG000|Primary Efficacy Population|Overall Study||5||
48244459|NCT03779334|100917706|FG001|Primary Efficacy Population|Overall Study||0||
48244460|NCT03779334|100917707|FG002|Primary Efficacy Population|Overall Study||0||
48244461|NCT03779334|100917705|FG000|COMPLETED|Overall Study||0||
48244462|NCT03779334|100917706|FG001|COMPLETED|Overall Study||0||
48244463|NCT03779334|100917707|FG002|COMPLETED|Overall Study||0||
48244464|NCT03779334|100917705|FG000|NOT COMPLETED|Overall Study||8||
48244465|NCT03779334|100917706|FG001|NOT COMPLETED|Overall Study||13||
48244466|NCT03779334|100917707|FG002|NOT COMPLETED|Overall Study||5||
48244467|NCT00360971|100917708|FG000|STARTED|Overall Study||10||
48244468|NCT00360971|100917709|FG001|STARTED|Overall Study||11||
48244469|NCT00360971|100917708|FG000|COMPLETED|Overall Study||10||
48244470|NCT00360971|100917709|FG001|COMPLETED|Overall Study||11||
48244471|NCT00360971|100917708|FG000|NOT COMPLETED|Overall Study||0||
48244472|NCT00360971|100917709|FG001|NOT COMPLETED|Overall Study||0||
48681521|NCT01102738|102003304|FG000|STARTED|Overall Study||369||
48244473|NCT01177228|100917710|FG000|STARTED|Overall Study||9||
48244474|NCT01177228|100917711|FG001|STARTED|Overall Study||13||
48244475|NCT01177228|100917712|FG002|STARTED|Overall Study||14||
48244476|NCT01177228|100917713|FG003|STARTED|Overall Study||11||
48244477|NCT01177228|100917710|FG000|Received Treatment|Overall Study||9||
48244478|NCT01177228|100917711|FG001|Received Treatment|Overall Study||12||
48244479|NCT01177228|100917712|FG002|Received Treatment|Overall Study||14||
48244480|NCT01177228|100917713|FG003|Received Treatment|Overall Study||11||
48244481|NCT01177228|100917710|FG000|COMPLETED|Overall Study||8||
48244482|NCT01177228|100917711|FG001|COMPLETED|Overall Study||11||
48244483|NCT01177228|100917712|FG002|COMPLETED|Overall Study||14||
48244484|NCT01177228|100917713|FG003|COMPLETED|Overall Study||11||
48244485|NCT01177228|100917710|FG000|NOT COMPLETED|Overall Study||1||
48244486|NCT01177228|100917711|FG001|NOT COMPLETED|Overall Study||2||
48244487|NCT01177228|100917712|FG002|NOT COMPLETED|Overall Study||0||
48244488|NCT01177228|100917713|FG003|NOT COMPLETED|Overall Study||0||
48244489|NCT00834483|100917714|FG000|STARTED|Overall Study||31||
48244490|NCT00834483|100917715|FG001|STARTED|Overall Study||29||
48244491|NCT00834483|100917714|FG000|COMPLETED|Overall Study||31||
48244492|NCT00834483|100917715|FG001|COMPLETED|Overall Study||29||
48244493|NCT00834483|100917714|FG000|NOT COMPLETED|Overall Study||0||
48244494|NCT00834483|100917715|FG001|NOT COMPLETED|Overall Study||0||
48244495|NCT04374253|100917716|FG000|STARTED|Overall Study||15||
48244496|NCT04374253|100917717|FG001|STARTED|Overall Study||696||
48244497|NCT04374253|100917718|FG002|STARTED|Overall Study||28||
48244498|NCT04374253|100917719|FG003|STARTED|Overall Study||643||
48294129|NCT02527343|101047539|FG003|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||7||
48294130|NCT02527343|101047540|FG004|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0||
48294131|NCT02527343|101047541|FG005|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0||
48244499|NCT04374253|100917716|FG000|Safety-evaluable (SE) Analysis Set|Overall Study||14|SE analysis set included all participants enrolled who received at least one dose of study drug in this study or in the OLE part of the parent studies (GRADUATE I or GRADUATE II). Six participants randomized to placebo arm during the double-blind treatment in the parent studies received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set.|
48244500|NCT04374253|100917717|FG001|Safety-evaluable (SE) Analysis Set|Overall Study||691|SE analysis set included all participants enrolled who received at least one dose of study drug in this study or in the OLE part of the parent studies (GRADUATE I or GRADUATE II). Six participants randomized to placebo arm during the double-blind treatment in the parent studies received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set.|
48244501|NCT04374253|100917718|FG002|Safety-evaluable (SE) Analysis Set|Overall Study||29|SE analysis set included all participants enrolled who received at least one dose of study drug in this study or in the OLE part of the parent studies (GRADUATE I or GRADUATE II). Six participants randomized to placebo arm during the double-blind treatment in the parent studies received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set.|
48244502|NCT04374253|100917719|FG003|Safety-evaluable (SE) Analysis Set|Overall Study||647|SE analysis set included all participants enrolled who received at least one dose of study drug in this study or in the OLE part of the parent studies (GRADUATE I or GRADUATE II). Six participants randomized to placebo arm during the double-blind treatment in the parent studies received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set.|
48244503|NCT04374253|100917716|FG000|Intent-to-Treat Analysis (ITT) Set|Overall Study||15|ITT analysis set included all enrolled participants who received at least one dose of study drug. Participants will be analyzed by the treatment they were randomized to in the parent studies (GRADUATE I or GRADUATE II).|
48244504|NCT04374253|100917717|FG001|Intent-to-Treat Analysis (ITT) Set|Overall Study||696|ITT analysis set included all enrolled participants who received at least one dose of study drug. Participants will be analyzed by the treatment they were randomized to in the parent studies (GRADUATE I or GRADUATE II).|
48244505|NCT04374253|100917718|FG002|Intent-to-Treat Analysis (ITT) Set|Overall Study||28|ITT analysis set included all enrolled participants who received at least one dose of study drug. Participants will be analyzed by the treatment they were randomized to in the parent studies (GRADUATE I or GRADUATE II).|
48244506|NCT04374253|100917719|FG003|Intent-to-Treat Analysis (ITT) Set|Overall Study||642|ITT analysis set included all enrolled participants who received at least one dose of study drug. Participants will be analyzed by the treatment they were randomized to in the parent studies (GRADUATE I or GRADUATE II).|
48244507|NCT04374253|100917716|FG000|Magnetic Resonance Imaging (MRI) SE (M-SE) Analysis Set|Overall Study||14|M-SE analysis set included all participants in the SE analysis set who had at least one post-baseline safety MRI scan.|
48244508|NCT04374253|100917717|FG001|Magnetic Resonance Imaging (MRI) SE (M-SE) Analysis Set|Overall Study||671|M-SE analysis set included all participants in the SE analysis set who had at least one post-baseline safety MRI scan.|
48244509|NCT04374253|100917718|FG002|Magnetic Resonance Imaging (MRI) SE (M-SE) Analysis Set|Overall Study||29|M-SE analysis set included all participants in the SE analysis set who had at least one post-baseline safety MRI scan.|
48244510|NCT04374253|100917719|FG003|Magnetic Resonance Imaging (MRI) SE (M-SE) Analysis Set|Overall Study||627|M-SE analysis set included all participants in the SE analysis set who had at least one post-baseline safety MRI scan.|
48244511|NCT04374253|100917716|FG000|COMPLETED|Overall Study||0||
48244512|NCT04374253|100917717|FG001|COMPLETED|Overall Study||0||
48244513|NCT04374253|100917718|FG002|COMPLETED|Overall Study||0||
48244514|NCT04374253|100917719|FG003|COMPLETED|Overall Study||0||
48244515|NCT04374253|100917716|FG000|NOT COMPLETED|Overall Study||15||
48244516|NCT04374253|100917717|FG001|NOT COMPLETED|Overall Study||696||
48244517|NCT04374253|100917718|FG002|NOT COMPLETED|Overall Study||28||
48244518|NCT04374253|100917719|FG003|NOT COMPLETED|Overall Study||643||
48244519|NCT05041439|100917720|FG000|STARTED|Overall Study||25||
48244520|NCT05041439|100917721|FG001|STARTED|Overall Study||25||
48244521|NCT05041439|100917720|FG000|COMPLETED|Overall Study||23||
48244522|NCT05041439|100917721|FG001|COMPLETED|Overall Study||24||
48244523|NCT05041439|100917720|FG000|NOT COMPLETED|Overall Study||2||
48244524|NCT05041439|100917721|FG001|NOT COMPLETED|Overall Study||1||
48244525|NCT04057937|100917722|FG000|STARTED|Placebo-controlled Phase||44||
48244526|NCT04057937|100917723|FG001|STARTED|Placebo-controlled Phase||46||
48244527|NCT04057937|100917722|FG000|COMPLETED|Placebo-controlled Phase||41||
48244528|NCT04057937|100917723|FG001|COMPLETED|Placebo-controlled Phase||46||
48244529|NCT04057937|100917722|FG000|NOT COMPLETED|Placebo-controlled Phase||3||
48244530|NCT04057937|100917723|FG001|NOT COMPLETED|Placebo-controlled Phase||0||
48244531|NCT04057937|100917722|FG000|STARTED|Active-treatment Phase||41||
48244532|NCT04057937|100917723|FG001|STARTED|Active-treatment Phase||46||
48244533|NCT04057937|100917722|FG000|COMPLETED|Active-treatment Phase||40||
48244534|NCT04057937|100917723|FG001|COMPLETED|Active-treatment Phase||44||
48244535|NCT04057937|100917722|FG000|NOT COMPLETED|Active-treatment Phase||1||
48244536|NCT04057937|100917723|FG001|NOT COMPLETED|Active-treatment Phase||2||
48244537|NCT00138645|100917724|FG000|STARTED|Overall Study||30||
48244538|NCT00138645|100917725|FG001|STARTED|Overall Study||30||
48244539|NCT00138645|100917724|FG000|COMPLETED|Overall Study||24||
48244540|NCT00138645|100917725|FG001|COMPLETED|Overall Study||23||
48244541|NCT00138645|100917724|FG000|NOT COMPLETED|Overall Study||6||
48244542|NCT00138645|100917725|FG001|NOT COMPLETED|Overall Study||7||
48244543|NCT03614923|100917726|FG000|STARTED|Overall Study||35||
48244544|NCT03614923|100917727|FG001|STARTED|Overall Study||35||
48244545|NCT03614923|100917728|FG002|STARTED|Overall Study||35||
48244546|NCT03614923|100917726|FG000|COMPLETED|Overall Study||30||
48244547|NCT03614923|100917727|FG001|COMPLETED|Overall Study||30||
48244548|NCT03614923|100917728|FG002|COMPLETED|Overall Study||30||
48244549|NCT03614923|100917726|FG000|NOT COMPLETED|Overall Study||5||
48244550|NCT03614923|100917727|FG001|NOT COMPLETED|Overall Study||5||
48244551|NCT03614923|100917728|FG002|NOT COMPLETED|Overall Study||5||
48244552|NCT00472056|100917729|FG000|STARTED|Overall Study||25||
48244553|NCT00472056|100917730|FG001|STARTED|Overall Study||19||
48244554|NCT00472056|100917731|FG002|STARTED|Overall Study||32||
48244555|NCT00472056|100917732|FG003|STARTED|Overall Study||17||
48244556|NCT00472056|100917729|FG000|COMPLETED|Overall Study||25||
48244557|NCT00472056|100917730|FG001|COMPLETED|Overall Study||19||
48244558|NCT00472056|100917731|FG002|COMPLETED|Overall Study||32||
48244559|NCT00472056|100917732|FG003|COMPLETED|Overall Study||17||
48244560|NCT00472056|100917729|FG000|NOT COMPLETED|Overall Study||0||
48244561|NCT00472056|100917730|FG001|NOT COMPLETED|Overall Study||0||
48244562|NCT00472056|100917731|FG002|NOT COMPLETED|Overall Study||0||
48244563|NCT00472056|100917732|FG003|NOT COMPLETED|Overall Study||0||
48244564|NCT01780584|100917733|FG000|STARTED|Overall Study||15||
48244565|NCT01780584|100917734|FG001|STARTED|Overall Study||15||
48244566|NCT01780584|100917735|FG002|STARTED|Overall Study||15||
48244567|NCT01780584|100917733|FG000|COMPLETED|Overall Study||14||
48244568|NCT01780584|100917734|FG001|COMPLETED|Overall Study||14||
48244569|NCT01780584|100917735|FG002|COMPLETED|Overall Study||13||
48244570|NCT01780584|100917733|FG000|NOT COMPLETED|Overall Study||1||
48244571|NCT01780584|100917734|FG001|NOT COMPLETED|Overall Study||1||
48681522|NCT01102738|102003304|FG000|COMPLETED|Overall Study||369||
48244572|NCT01780584|100917735|FG002|NOT COMPLETED|Overall Study||2||
48244573|NCT02971683|100917736|FG000|STARTED|Double-Blind (24 Weeks)||75|All participants who started the Double-Blind period were treated|
48244574|NCT02971683|100917737|FG001|STARTED|Double-Blind (24 Weeks)||73|All participants who started the Double-Blind period were treated|
48244575|NCT02971683|100917736|FG000|COMPLETED|Double-Blind (24 Weeks)||69|Completed Period|
48244576|NCT02971683|100917737|FG001|COMPLETED|Double-Blind (24 Weeks)||65|Completed Period|
48244577|NCT02971683|100917736|FG000|NOT COMPLETED|Double-Blind (24 Weeks)||6||
48244578|NCT02971683|100917737|FG001|NOT COMPLETED|Double-Blind (24 Weeks)||8||
48244579|NCT02971683|100917736|FG000|STARTED|Open-Label||69|All participants treated in the Open Label Period|
48244580|NCT02971683|100917737|FG001|STARTED|Open-Label||63|All participants treated in the Open Label Period|
48244581|NCT02971683|100917736|FG000|COMPLETED|Open-Label||65|Completed Period|
48244582|NCT02971683|100917737|FG001|COMPLETED|Open-Label||61|Completed Period|
48244583|NCT02971683|100917736|FG000|NOT COMPLETED|Open-Label||4||
48681523|NCT01102738|102003304|FG000|NOT COMPLETED|Overall Study||0||
48681524|NCT01308840|102003305|FG000|STARTED|Overall Study||31||
48681525|NCT01308840|102003305|FG000|COMPLETED|Overall Study||31||
48681526|NCT01308840|102003305|FG000|NOT COMPLETED|Overall Study||0||
48244584|NCT02971683|100917737|FG001|NOT COMPLETED|Open-Label||2||
48244585|NCT02971683|100917736|FG000|STARTED|Long-Term Open Label||25||
48244586|NCT02971683|100917737|FG001|STARTED|Long-Term Open Label||21||
48244587|NCT02971683|100917736|FG000|COMPLETED|Long-Term Open Label||1|Completed Period|
48244588|NCT02971683|100917737|FG001|COMPLETED|Long-Term Open Label||0|Completed Period|
48244589|NCT02971683|100917736|FG000|NOT COMPLETED|Long-Term Open Label||24||
48244590|NCT02971683|100917737|FG001|NOT COMPLETED|Long-Term Open Label||21||
48244591|NCT01901302|100917738|FG000|STARTED|Overall Study||31||
48244592|NCT01901302|100917739|FG001|STARTED|Overall Study||30||
48244593|NCT01901302|100917738|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31||
48244594|NCT01901302|100917739|FG001|Received at Least 1 Dose of Study Drug|Overall Study||30||
48244595|NCT01901302|100917738|FG000|COMPLETED|Overall Study||4||
48244596|NCT01901302|100917739|FG001|COMPLETED|Overall Study||7||
48244597|NCT01901302|100917738|FG000|NOT COMPLETED|Overall Study||27||
48244598|NCT01901302|100917739|FG001|NOT COMPLETED|Overall Study||23||
48681527|NCT00003869|102003306|FG000|STARTED|Overall Study||94||
48681528|NCT00003869|102003307|FG001|STARTED|Overall Study||92||
48681529|NCT00003869|102003306|FG000|COMPLETED|Overall Study||53||
48681530|NCT00003869|102003307|FG001|COMPLETED|Overall Study||80||
48681531|NCT00003869|102003306|FG000|NOT COMPLETED|Overall Study||41||
48081633|NCT00279591|100521639|FG000|STARTED|Overall Study||48||
48081634|NCT00279591|100521640|FG001|STARTED|Overall Study||46||
48081635|NCT00279591|100521639|FG000|COMPLETED|Overall Study||48||
48081636|NCT00279591|100521640|FG001|COMPLETED|Overall Study||46||
48081637|NCT00279591|100521639|FG000|NOT COMPLETED|Overall Study||0||
48081638|NCT00279591|100521640|FG001|NOT COMPLETED|Overall Study||0||
48081639|NCT04748120|100521641|FG000|STARTED|Overall Study||1||
48081640|NCT04748120|100521642|FG001|STARTED|Overall Study||1||
48081641|NCT04748120|100521641|FG000|COMPLETED|Overall Study||1||
48081642|NCT04748120|100521642|FG001|COMPLETED|Overall Study||1||
48081643|NCT04748120|100521641|FG000|NOT COMPLETED|Overall Study||0||
48081644|NCT04748120|100521642|FG001|NOT COMPLETED|Overall Study||0||
48081645|NCT03281577|100521643|FG000|STARTED|Overall Study||10||
48081646|NCT03281577|100521644|FG001|STARTED|Overall Study||10||
48681532|NCT00003869|102003307|FG001|NOT COMPLETED|Overall Study||12||
48681533|NCT01297283|102003308|FG000|STARTED|Overall Study||195||
48681534|NCT01297283|102003308|FG000|COMPLETED|Overall Study||176||
48244599|NCT01066897|100917740|FG000|STARTED|Overall Study||7||
48244600|NCT01066897|100917741|FG001|STARTED|Overall Study||9||
48244601|NCT01066897|100917740|FG000|COMPLETED|Overall Study||5||
48244602|NCT01066897|100917741|FG001|COMPLETED|Overall Study||9||
48244603|NCT01066897|100917740|FG000|NOT COMPLETED|Overall Study||2||
48244604|NCT01066897|100917741|FG001|NOT COMPLETED|Overall Study||0||
48244605|NCT01114217|100917742|FG000|STARTED|Overall Study||337||
48244606|NCT01114217|100917743|FG001|STARTED|Overall Study||297||
48244607|NCT01114217|100917742|FG000|Received at Least 1 Dose of Ferumoxytol|Overall Study||337||
48244608|NCT01114217|100917743|FG001|Received at Least 1 Dose of Ferumoxytol|Overall Study||0||
48244609|NCT01114217|100917742|FG000|COMPLETED|Overall Study||262|Completed Study is defined as had study drug and Week 5 visit.|
48244610|NCT01114217|100917743|FG001|COMPLETED|Overall Study||199|Completed Study is defined as had study drug and Week 5 visit.|
48244611|NCT01114217|100917742|FG000|NOT COMPLETED|Overall Study||75||
48244612|NCT01114217|100917743|FG001|NOT COMPLETED|Overall Study||98||
48244613|NCT01532830|100917744|FG000|STARTED|Overall Study||30||
48244614|NCT01532830|100917744|FG000|COMPLETED|Overall Study||26||
48244615|NCT01532830|100917744|FG000|NOT COMPLETED|Overall Study||4||
48244616|NCT05288504|100917745|FG000|STARTED|Overall Study||45||
48244617|NCT05288504|100917746|FG001|STARTED|Overall Study||46||
48244618|NCT05288504|100917745|FG000|Safety Analysis Set|Overall Study||45||
48244619|NCT05288504|100917746|FG001|Safety Analysis Set|Overall Study||45||
48244620|NCT05288504|100917745|FG000|Full Analysis Set|Overall Study||45||
48244621|NCT05288504|100917746|FG001|Full Analysis Set|Overall Study||45||
48244622|NCT05288504|100917745|FG000|Per Protocol Analysis Set|Overall Study||43||
48244623|NCT05288504|100917746|FG001|Per Protocol Analysis Set|Overall Study||41||
48244624|NCT05288504|100917745|FG000|PK Analysis Set|Overall Study||45||
48244625|NCT05288504|100917746|FG001|PK Analysis Set|Overall Study||0||
48244626|NCT05288504|100917745|FG000|COMPLETED|Overall Study||36||
48244627|NCT05288504|100917746|FG001|COMPLETED|Overall Study||32||
48244628|NCT05288504|100917745|FG000|NOT COMPLETED|Overall Study||9||
48244629|NCT05288504|100917746|FG001|NOT COMPLETED|Overall Study||14||
48244630|NCT03418701|100917747|FG000|STARTED|Phase 1: 6-mo CHW-implemented HSWL Progr||683||20
48244631|NCT03418701|100917748|FG001|STARTED|Phase 1: 6-mo CHW-implemented HSWL Progr||0||0
48681535|NCT01297283|102003308|FG000|NOT COMPLETED|Overall Study||19||
48681536|NCT00672594|102003309|FG000|STARTED|Overall Study||30||
48681537|NCT00672594|102003309|FG000|COMPLETED|Overall Study||27||
48681538|NCT00672594|102003309|FG000|NOT COMPLETED|Overall Study||3||
48681539|NCT01343888|102003310|FG000|STARTED|Overall Study||259||
48681540|NCT01343888|102003311|FG001|STARTED|Overall Study||261||
48244632|NCT03418701|100917749|FG002|STARTED|Phase 1: 6-mo CHW-implemented HSWL Progr||0||0
48244633|NCT03418701|100917747|FG000|COMPLETED|Phase 1: 6-mo CHW-implemented HSWL Progr||356||20
48244634|NCT03418701|100917748|FG001|COMPLETED|Phase 1: 6-mo CHW-implemented HSWL Progr||0||0
48244635|NCT03418701|100917749|FG002|COMPLETED|Phase 1: 6-mo CHW-implemented HSWL Progr||0||0
48244636|NCT03418701|100917747|FG000|NOT COMPLETED|Phase 1: 6-mo CHW-implemented HSWL Progr||327||0
48244637|NCT03418701|100917748|FG001|NOT COMPLETED|Phase 1: 6-mo CHW-implemented HSWL Progr||0||0
48244638|NCT03418701|100917749|FG002|NOT COMPLETED|Phase 1: 6-mo CHW-implemented HSWL Progr||0||0
48681541|NCT01343888|102003312|FG002|STARTED|Overall Study||132||
48681542|NCT01343888|102003310|FG000|COMPLETED|Overall Study||234||
48681543|NCT01343888|102003311|FG001|COMPLETED|Overall Study||222||
48681544|NCT01343888|102003312|FG002|COMPLETED|Overall Study||110||
48681545|NCT01343888|102003310|FG000|NOT COMPLETED|Overall Study||25||
48681546|NCT01343888|102003311|FG001|NOT COMPLETED|Overall Study||39||
48681547|NCT01343888|102003312|FG002|NOT COMPLETED|Overall Study||22||
48681548|NCT00444925|102006409|FG000|STARTED|Single-blind Placebo Run-In Period||2446||
48681549|NCT00444925|102006410|FG001|STARTED|Single-blind Placebo Run-In Period||0||
48681550|NCT00444925|102006411|FG002|STARTED|Single-blind Placebo Run-In Period||0||
48681551|NCT00444925|102006409|FG000|COMPLETED|Single-blind Placebo Run-In Period||1712||
48681552|NCT00444925|102006410|FG001|COMPLETED|Single-blind Placebo Run-In Period||0||
48681553|NCT00444925|102006411|FG002|COMPLETED|Single-blind Placebo Run-In Period||0||
48681554|NCT00444925|102006409|FG000|NOT COMPLETED|Single-blind Placebo Run-In Period||734||
48681555|NCT00444925|102006410|FG001|NOT COMPLETED|Single-blind Placebo Run-In Period||0||
48244639|NCT03418701|100917747|FG000|STARTED|Phase 2: 12-mo Weight Loss Maintenance||0||0
48244640|NCT03418701|100917748|FG001|STARTED|Phase 2: 12-mo Weight Loss Maintenance||183||10
48244641|NCT03418701|100917749|FG002|STARTED|Phase 2: 12-mo Weight Loss Maintenance||173||10
48244642|NCT03418701|100917747|FG000|COMPLETED|Phase 2: 12-mo Weight Loss Maintenance||0||0
48681556|NCT00444925|102006411|FG002|NOT COMPLETED|Single-blind Placebo Run-In Period||0||
48681557|NCT00444925|102006409|FG000|STARTED|Randomized to Double-blind Treatment||337||
48681558|NCT00444925|102006410|FG001|STARTED|Randomized to Double-blind Treatment||690||
48681559|NCT00444925|102006411|FG002|STARTED|Randomized to Double-blind Treatment||685||
48244643|NCT03418701|100917748|FG001|COMPLETED|Phase 2: 12-mo Weight Loss Maintenance||140||10
48244644|NCT03418701|100917749|FG002|COMPLETED|Phase 2: 12-mo Weight Loss Maintenance||131||10
48681560|NCT00444925|102006409|FG000|COMPLETED|Randomized to Double-blind Treatment||334||
48681561|NCT00444925|102006410|FG001|COMPLETED|Randomized to Double-blind Treatment||684||
48681562|NCT00444925|102006411|FG002|COMPLETED|Randomized to Double-blind Treatment||679||
48681563|NCT00444925|102006409|FG000|NOT COMPLETED|Randomized to Double-blind Treatment||3||
48244645|NCT03418701|100917747|FG000|NOT COMPLETED|Phase 2: 12-mo Weight Loss Maintenance||0||0
48244646|NCT03418701|100917748|FG001|NOT COMPLETED|Phase 2: 12-mo Weight Loss Maintenance||43||0
48244647|NCT03418701|100917749|FG002|NOT COMPLETED|Phase 2: 12-mo Weight Loss Maintenance||42||0
48244648|NCT03360071|100917750|FG000|STARTED|Overall Study||17||
48244649|NCT03360071|100917751|FG001|STARTED|Overall Study||14||
48244650|NCT03360071|100917750|FG000|COMPLETED|Overall Study||16||
48244651|NCT03360071|100917751|FG001|COMPLETED|Overall Study||14||
48244652|NCT03360071|100917750|FG000|NOT COMPLETED|Overall Study||1||
48244653|NCT03360071|100917751|FG001|NOT COMPLETED|Overall Study||0||
48244654|NCT02868788|100917752|FG000|STARTED|First Visit||5||
48244655|NCT02868788|100917753|FG001|STARTED|First Visit||5||
48244656|NCT02868788|100917752|FG000|COMPLETED|First Visit||5||
48244657|NCT02868788|100917753|FG001|COMPLETED|First Visit||5||
48244658|NCT02868788|100917752|FG000|NOT COMPLETED|First Visit||0||
48244659|NCT02868788|100917753|FG001|NOT COMPLETED|First Visit||0||
48244660|NCT02868788|100917752|FG000|STARTED|Second Visit (One Week Later)||5||
48244661|NCT02868788|100917753|FG001|STARTED|Second Visit (One Week Later)||5||
48244662|NCT02868788|100917752|FG000|COMPLETED|Second Visit (One Week Later)||5||
48244663|NCT02868788|100917753|FG001|COMPLETED|Second Visit (One Week Later)||5||
48244664|NCT02868788|100917752|FG000|NOT COMPLETED|Second Visit (One Week Later)||0||
48244665|NCT02868788|100917753|FG001|NOT COMPLETED|Second Visit (One Week Later)||0||
48244666|NCT00702234|100917754|FG000|STARTED|Base Study (NCT00696878)||682||
48244667|NCT00702234|100917755|FG001|STARTED|Base Study (NCT00696878)||0||
48244668|NCT00702234|100917754|FG000|COMPLETED|Base Study (NCT00696878)||178||
48244669|NCT00702234|100917755|FG001|COMPLETED|Base Study (NCT00696878)||0||
48244670|NCT00702234|100917754|FG000|NOT COMPLETED|Base Study (NCT00696878)||504||
48244671|NCT00702234|100917755|FG001|NOT COMPLETED|Base Study (NCT00696878)||0||
48244672|NCT00702234|100917754|FG000|STARTED|Follow-up Study: Expectant Mothers||268||
48244673|NCT00702234|100917755|FG001|STARTED|Follow-up Study: Expectant Mothers||0||
48244674|NCT00702234|100917754|FG000|COMPLETED|Follow-up Study: Expectant Mothers||246||
48244675|NCT00702234|100917755|FG001|COMPLETED|Follow-up Study: Expectant Mothers||0||
48244676|NCT00702234|100917754|FG000|NOT COMPLETED|Follow-up Study: Expectant Mothers||22||
48244677|NCT00702234|100917755|FG001|NOT COMPLETED|Follow-up Study: Expectant Mothers||0||
48540616|NCT01438996|101658146|FG002|NOT COMPLETED|Overall Study||0||
48244678|NCT00702234|100917754|FG000|STARTED|Follow-up Study: Fetuses/Infants||0||
48540617|NCT01125371|101658147|FG000|STARTED|Overall Study||146||
48540618|NCT01125371|101658148|FG001|STARTED|Overall Study||145||
48540619|NCT01125371|101658149|FG002|STARTED|Overall Study||148||
48540620|NCT01125371|101658147|FG000|3 Months Follow up|Overall Study||127||
48540621|NCT01125371|101658148|FG001|3 Months Follow up|Overall Study||131||
48540622|NCT01125371|101658149|FG002|3 Months Follow up|Overall Study||135||
48540623|NCT01125371|101658147|FG000|6 Months Follow up|Overall Study||125||
48540624|NCT01125371|101658148|FG001|6 Months Follow up|Overall Study||133||
48540625|NCT01125371|101658149|FG002|6 Months Follow up|Overall Study||131||
48540626|NCT01125371|101658147|FG000|12 Months Follow up|Overall Study||120||
48540627|NCT01125371|101658148|FG001|12 Months Follow up|Overall Study||130||
48540628|NCT01125371|101658149|FG002|12 Months Follow up|Overall Study||129||
48540629|NCT01125371|101658147|FG000|COMPLETED|Overall Study||120||
48540630|NCT01125371|101658148|FG001|COMPLETED|Overall Study||130||
48540631|NCT01125371|101658149|FG002|COMPLETED|Overall Study||129||
48540632|NCT01125371|101658147|FG000|NOT COMPLETED|Overall Study||26||
48540633|NCT01125371|101658148|FG001|NOT COMPLETED|Overall Study||15||
48540634|NCT01125371|101658149|FG002|NOT COMPLETED|Overall Study||19||
48540635|NCT01811316|101658150|FG000|STARTED|Overall Study||21||
48540636|NCT01811316|101658151|FG001|STARTED|Overall Study||22||
48540637|NCT01811316|101658152|FG002|STARTED|Overall Study||19||
48540638|NCT01811316|101658150|FG000|Visit 4 Weeks|Overall Study||19||
48244679|NCT00702234|100917755|FG001|STARTED|Follow-up Study: Fetuses/Infants||315||
48244680|NCT00702234|100917754|FG000|Live Born Infants|Follow-up Study: Fetuses/Infants||0||
48244681|NCT00702234|100917755|FG001|Live Born Infants|Follow-up Study: Fetuses/Infants||304||
48244682|NCT00702234|100917754|FG000|COMPLETED|Follow-up Study: Fetuses/Infants||0||
48244683|NCT00702234|100917755|FG001|COMPLETED|Follow-up Study: Fetuses/Infants||288||
48244684|NCT00702234|100917754|FG000|NOT COMPLETED|Follow-up Study: Fetuses/Infants||0||
48244685|NCT00702234|100917755|FG001|NOT COMPLETED|Follow-up Study: Fetuses/Infants||27||
48244686|NCT03320941|100917756|FG000|STARTED|Overall Study||19||
48540639|NCT01811316|101658151|FG001|Visit 4 Weeks|Overall Study||22||
48244687|NCT03320941|100917757|FG001|STARTED|Overall Study||19||
48244688|NCT03320941|100917758|FG002|STARTED|Overall Study||28||
48244689|NCT03320941|100917759|FG003|STARTED|Overall Study||31||
48244690|NCT03320941|100917760|FG004|STARTED|Overall Study||29||
48244691|NCT03320941|100917756|FG000|COMPLETED|Overall Study||19||
48244692|NCT03320941|100917757|FG001|COMPLETED|Overall Study||19||
48244693|NCT03320941|100917758|FG002|COMPLETED|Overall Study||28||
48244694|NCT03320941|100917759|FG003|COMPLETED|Overall Study||30||
48244695|NCT03320941|100917760|FG004|COMPLETED|Overall Study||29||
48244696|NCT03320941|100917756|FG000|NOT COMPLETED|Overall Study||0||
48244697|NCT03320941|100917757|FG001|NOT COMPLETED|Overall Study||0||
48244698|NCT03320941|100917758|FG002|NOT COMPLETED|Overall Study||0||
48244699|NCT03320941|100917759|FG003|NOT COMPLETED|Overall Study||1||
48244700|NCT03320941|100917760|FG004|NOT COMPLETED|Overall Study||0||
48244701|NCT03282071|100917761|FG000|STARTED|Overall Study||75||2
48244702|NCT03282071|100917762|FG001|STARTED|Overall Study||69||2
48244703|NCT03282071|100917761|FG000|COMPLETED|Overall Study||65||2
48681564|NCT00444925|102006410|FG001|NOT COMPLETED|Randomized to Double-blind Treatment||6||
48681565|NCT00444925|102006411|FG002|NOT COMPLETED|Randomized to Double-blind Treatment||6||
48244704|NCT03282071|100917762|FG001|COMPLETED|Overall Study||60||2
48244705|NCT03282071|100917761|FG000|NOT COMPLETED|Overall Study||10||0
48244706|NCT03282071|100917762|FG001|NOT COMPLETED|Overall Study||9||0
48681566|NCT00444925|102006409|FG000|STARTED|Double-blind Treatment Period||334||
48681567|NCT00444925|102006410|FG001|STARTED|Double-blind Treatment Period||684||
48681568|NCT00444925|102006411|FG002|STARTED|Double-blind Treatment Period||679||
48681569|NCT00444925|102006409|FG000|COMPLETED|Double-blind Treatment Period||304||
48681570|NCT00444925|102006410|FG001|COMPLETED|Double-blind Treatment Period||628||
48681571|NCT00444925|102006411|FG002|COMPLETED|Double-blind Treatment Period||598||
48681572|NCT00444925|102006409|FG000|NOT COMPLETED|Double-blind Treatment Period||30||
48681573|NCT00444925|102006410|FG001|NOT COMPLETED|Double-blind Treatment Period||56||
48681574|NCT00444925|102006411|FG002|NOT COMPLETED|Double-blind Treatment Period||81||
48681575|NCT01585402|102006412|FG000|STARTED|Overall Study||7||
48681576|NCT01585402|102006412|FG000|COMPLETED|Overall Study||7||
48681577|NCT01585402|102006412|FG000|NOT COMPLETED|Overall Study||0||
48681578|NCT01428219|102006413|FG000|STARTED|Overall Study||25||
48681579|NCT01428219|102006413|FG000|COMPLETED|Overall Study||22||
48681580|NCT01428219|102006413|FG000|NOT COMPLETED|Overall Study||3||
48681581|NCT03273907|102006414|FG000|STARTED|Overall Study||43||
48681582|NCT03273907|102006414|FG000|COMPLETED|Overall Study||34||
48681583|NCT03273907|102006414|FG000|NOT COMPLETED|Overall Study||9||
48681584|NCT02178800|102006415|FG000|STARTED|Overall Study||151||
48681585|NCT02178800|102006416|FG001|STARTED|Overall Study||48||
48681586|NCT02178800|102006415|FG000|COMPLETED|Overall Study||131||
48681587|NCT02178800|102006416|FG001|COMPLETED|Overall Study||42||
48681588|NCT02178800|102006415|FG000|NOT COMPLETED|Overall Study||20||
48681589|NCT02178800|102006416|FG001|NOT COMPLETED|Overall Study||6||
48681590|NCT00950651|102006417|FG000|STARTED|Overall Study||215||
48681591|NCT00950651|102006418|FG001|STARTED|Overall Study||216||
48681592|NCT00950651|102006417|FG000|COMPLETED|Overall Study||184||
48681593|NCT00950651|102006418|FG001|COMPLETED|Overall Study||181||
48681594|NCT00950651|102006417|FG000|NOT COMPLETED|Overall Study||31||
48681595|NCT00950651|102006418|FG001|NOT COMPLETED|Overall Study||35||
48681596|NCT00295646|102006419|FG000|STARTED|Overall Study||450||
48681597|NCT00295646|102006420|FG001|STARTED|Overall Study||450||
48681598|NCT00295646|102006421|FG002|STARTED|Overall Study||453||
48681599|NCT00295646|102006422|FG003|STARTED|Overall Study||450||
48681600|NCT00295646|102006419|FG000|COMPLETED|Overall Study||415||
48681601|NCT00295646|102006420|FG001|COMPLETED|Overall Study||409||
48681602|NCT00295646|102006421|FG002|COMPLETED|Overall Study||403||
48681603|NCT00295646|102006422|FG003|COMPLETED|Overall Study||405||
48681604|NCT00295646|102006419|FG000|NOT COMPLETED|Overall Study||35||
48244707|NCT01038128|100917763|FG000|STARTED|Overall Study||5||
48244708|NCT01038128|100917763|FG000|Baseline Visit|Overall Study||3||
48244709|NCT01038128|100917763|FG000|COMPLETED|Overall Study||1||
48681605|NCT00295646|102006420|FG001|NOT COMPLETED|Overall Study||41||
48681606|NCT00295646|102006421|FG002|NOT COMPLETED|Overall Study||50||
48681607|NCT00295646|102006422|FG003|NOT COMPLETED|Overall Study||45||
48681608|NCT03443635|102006423|FG000|STARTED|Overall Study||2616||
48681609|NCT03443635|102006424|FG001|STARTED|Overall Study||4576||
48681610|NCT03443635|102006423|FG000|COMPLETED|Overall Study||2127||
48681611|NCT03443635|102006424|FG001|COMPLETED|Overall Study||3720||
48681612|NCT03443635|102006423|FG000|NOT COMPLETED|Overall Study||489||
48681613|NCT03443635|102006424|FG001|NOT COMPLETED|Overall Study||856||
48681614|NCT02246010|102006425|FG000|STARTED|Overall Study||4||
48681615|NCT02246010|102006426|FG001|STARTED|Overall Study||2||
48681616|NCT02246010|102006425|FG000|COMPLETED|Overall Study||4||
48681617|NCT02246010|102006426|FG001|COMPLETED|Overall Study||2||
48681618|NCT02246010|102006425|FG000|NOT COMPLETED|Overall Study||0||
48681619|NCT02246010|102006426|FG001|NOT COMPLETED|Overall Study||0||
48681620|NCT01404650|102006427|FG000|STARTED|Overall Study||25||
48681621|NCT01404650|102006427|FG000|COMPLETED|Overall Study||25||
48681622|NCT01404650|102006427|FG000|NOT COMPLETED|Overall Study||0||
48681623|NCT04685213|102006428|FG000|STARTED|Overall Study||9||
48681624|NCT04685213|102006429|FG001|STARTED|Overall Study||10||
48681625|NCT04685213|102006428|FG000|COMPLETED|Overall Study||8||
48681626|NCT04685213|102006429|FG001|COMPLETED|Overall Study||8||
48681627|NCT04685213|102006428|FG000|NOT COMPLETED|Overall Study||1||
48681628|NCT04685213|102006429|FG001|NOT COMPLETED|Overall Study||2||
48681629|NCT02706925|102006430|FG000|STARTED|Overall Study||16||
48244710|NCT01038128|100917763|FG000|NOT COMPLETED|Overall Study||4||
48244711|NCT00203502|100917764|FG000|STARTED|Overall Study||40||
48244712|NCT00203502|100917764|FG000|COMPLETED|Overall Study||39||
48244713|NCT00203502|100917764|FG000|NOT COMPLETED|Overall Study||1||
48244714|NCT01129011|100917765|FG000|STARTED|Overall Study||210||
48244715|NCT01129011|100917766|FG001|STARTED|Overall Study||210||
48244716|NCT01129011|100917765|FG000|COMPLETED|Overall Study||151||
48681630|NCT02706925|102006431|FG001|STARTED|Overall Study||6||
48244717|NCT01129011|100917766|FG001|COMPLETED|Overall Study||153||
48244718|NCT01129011|100917765|FG000|NOT COMPLETED|Overall Study||59||
48244719|NCT01129011|100917766|FG001|NOT COMPLETED|Overall Study||57||
48244720|NCT00988429|100917767|FG000|STARTED|Overall Study||226||
48540640|NCT01811316|101658152|FG002|Visit 4 Weeks|Overall Study||19||
48540641|NCT01811316|101658150|FG000|Visit 12 Weeks|Overall Study||18||
48681631|NCT02706925|102006432|FG002|STARTED|Overall Study||6||
48681632|NCT02706925|102006433|FG003|STARTED|Overall Study||6||
48681633|NCT02706925|102006434|FG004|STARTED|Overall Study||6||
48681634|NCT02706925|102006435|FG005|STARTED|Overall Study||5||
48681635|NCT02706925|102006436|FG006|STARTED|Overall Study||6||
48681636|NCT02706925|102006437|FG007|STARTED|Overall Study||6||
48681637|NCT02706925|102006438|FG008|STARTED|Overall Study||6||
48540642|NCT01811316|101658151|FG001|Visit 12 Weeks|Overall Study||22||
48681638|NCT02706925|102006430|FG000|COMPLETED|Overall Study||16||
48681639|NCT02706925|102006431|FG001|COMPLETED|Overall Study||6||
48681640|NCT02706925|102006432|FG002|COMPLETED|Overall Study||6||
48681641|NCT02706925|102006433|FG003|COMPLETED|Overall Study||6||
48681642|NCT02706925|102006434|FG004|COMPLETED|Overall Study||6||
48681643|NCT02706925|102006435|FG005|COMPLETED|Overall Study||5||
48681644|NCT02706925|102006436|FG006|COMPLETED|Overall Study||6||
48681645|NCT02706925|102006437|FG007|COMPLETED|Overall Study||6||
48681646|NCT02706925|102006438|FG008|COMPLETED|Overall Study||6||
48681647|NCT02706925|102006430|FG000|NOT COMPLETED|Overall Study||0||
48681648|NCT02706925|102006431|FG001|NOT COMPLETED|Overall Study||0||
48681649|NCT02706925|102006432|FG002|NOT COMPLETED|Overall Study||0||
48540643|NCT01811316|101658152|FG002|Visit 12 Weeks|Overall Study||19||
48540644|NCT01811316|101658150|FG000|COMPLETED|Overall Study||18||
48540645|NCT01811316|101658151|FG001|COMPLETED|Overall Study||22||
48540646|NCT01811316|101658152|FG002|COMPLETED|Overall Study||19||
48540647|NCT01811316|101658150|FG000|NOT COMPLETED|Overall Study||3||
48540648|NCT01811316|101658151|FG001|NOT COMPLETED|Overall Study||0||
48540649|NCT01811316|101658152|FG002|NOT COMPLETED|Overall Study||0||
48540650|NCT01243112|101658153|FG000|STARTED|Overall Study||25||
48540651|NCT01243112|101658153|FG000|COMPLETED|Overall Study||25||
48540652|NCT01243112|101658153|FG000|NOT COMPLETED|Overall Study||0||
48540653|NCT01044264|101658154|FG000|STARTED|Overall Study||200||
48540654|NCT01044264|101658155|FG001|STARTED|Overall Study||202||
48540655|NCT01044264|101658156|FG002|STARTED|Overall Study||200||
48540656|NCT01044264|101658154|FG000|COMPLETED|Overall Study||110||
48540657|NCT01044264|101658155|FG001|COMPLETED|Overall Study||108||
48540658|NCT01044264|101658156|FG002|COMPLETED|Overall Study||108||
48540659|NCT01044264|101658154|FG000|NOT COMPLETED|Overall Study||90||
48540660|NCT01044264|101658155|FG001|NOT COMPLETED|Overall Study||94||
48540661|NCT01044264|101658156|FG002|NOT COMPLETED|Overall Study||92||
48540662|NCT00626392|101658157|FG000|STARTED|Run-in Period||45||
48540663|NCT00626392|101658158|FG001|STARTED|Run-in Period||44||
48540664|NCT00626392|101658159|FG002|STARTED|Run-in Period||44||
48540665|NCT00626392|101658160|FG003|STARTED|Run-in Period||44||
48540666|NCT00626392|101658161|FG004|STARTED|Run-in Period||45||
48540667|NCT00626392|101658162|FG005|STARTED|Run-in Period||45||
48540668|NCT00626392|101658157|FG000|COMPLETED|Run-in Period||44||
48540669|NCT00626392|101658158|FG001|COMPLETED|Run-in Period||43||
48540670|NCT00626392|101658159|FG002|COMPLETED|Run-in Period||41||
48540671|NCT00626392|101658160|FG003|COMPLETED|Run-in Period||43||
48540672|NCT00626392|101658161|FG004|COMPLETED|Run-in Period||41||
48540673|NCT00626392|101658162|FG005|COMPLETED|Run-in Period||44||
48540674|NCT00626392|101658157|FG000|NOT COMPLETED|Run-in Period||1||
48540675|NCT00626392|101658158|FG001|NOT COMPLETED|Run-in Period||1||
48540676|NCT00626392|101658159|FG002|NOT COMPLETED|Run-in Period||3||
48540677|NCT00626392|101658160|FG003|NOT COMPLETED|Run-in Period||1||
48540678|NCT00626392|101658161|FG004|NOT COMPLETED|Run-in Period||4||
48540679|NCT00626392|101658162|FG005|NOT COMPLETED|Run-in Period||1||
48540680|NCT00626392|101658157|FG000|STARTED|Coadministration Period||44||
48540681|NCT00626392|101658158|FG001|STARTED|Coadministration Period||43||
48540682|NCT00626392|101658159|FG002|STARTED|Coadministration Period||41||
48540683|NCT00626392|101658160|FG003|STARTED|Coadministration Period||43||
48540684|NCT00626392|101658161|FG004|STARTED|Coadministration Period||41||
48540685|NCT00626392|101658162|FG005|STARTED|Coadministration Period||44||
48540686|NCT00626392|101658157|FG000|COMPLETED|Coadministration Period||40||
48540687|NCT00626392|101658158|FG001|COMPLETED|Coadministration Period||38||
48681650|NCT02706925|102006433|FG003|NOT COMPLETED|Overall Study||0||
48681651|NCT02706925|102006434|FG004|NOT COMPLETED|Overall Study||0||
48681652|NCT02706925|102006435|FG005|NOT COMPLETED|Overall Study||0||
48244721|NCT00988429|100917768|FG001|STARTED|Overall Study||216||
48244722|NCT00988429|100917769|FG002|STARTED|Overall Study||211||
48244723|NCT00988429|100917767|FG000|Safety Population|Overall Study||224||
48244724|NCT00988429|100917768|FG001|Safety Population|Overall Study||216||
48244725|NCT00988429|100917769|FG002|Safety Population|Overall Study||210||
48081647|NCT03281577|100521645|FG002|STARTED|Overall Study||9||
48081648|NCT03281577|100521646|FG003|STARTED|Overall Study||7||
48081649|NCT03281577|100521643|FG000|COMPLETED|Overall Study||9||
48081650|NCT03281577|100521644|FG001|COMPLETED|Overall Study||10||
48081651|NCT03281577|100521645|FG002|COMPLETED|Overall Study||9||
48081652|NCT03281577|100521646|FG003|COMPLETED|Overall Study||6||
48081653|NCT03281577|100521643|FG000|NOT COMPLETED|Overall Study||1||
48081654|NCT03281577|100521644|FG001|NOT COMPLETED|Overall Study||0||
48081655|NCT03281577|100521645|FG002|NOT COMPLETED|Overall Study||0||
48081656|NCT03281577|100521646|FG003|NOT COMPLETED|Overall Study||1||
48081657|NCT01192516|100521647|FG000|STARTED|Overall Study||66||
48081658|NCT01192516|100521648|FG001|STARTED|Overall Study||66||
48081659|NCT01192516|100521649|FG002|STARTED|Overall Study||63||
48081660|NCT01192516|100521647|FG000|COMPLETED|Overall Study||46||
48081661|NCT01192516|100521648|FG001|COMPLETED|Overall Study||49||
48081662|NCT01192516|100521649|FG002|COMPLETED|Overall Study||55||
48081663|NCT01192516|100521647|FG000|NOT COMPLETED|Overall Study||20||
48081664|NCT01192516|100521648|FG001|NOT COMPLETED|Overall Study||17||
48081665|NCT01192516|100521649|FG002|NOT COMPLETED|Overall Study||8||
48081666|NCT00590005|100521650|FG000|STARTED|Overall Study||106||
48081667|NCT00590005|100521651|FG001|STARTED|Overall Study||119||
48081668|NCT00590005|100521650|FG000|COMPLETED|Overall Study||106||
48081669|NCT00590005|100521651|FG001|COMPLETED|Overall Study||119||
48081670|NCT00590005|100521650|FG000|NOT COMPLETED|Overall Study||0||
48081671|NCT00590005|100521651|FG001|NOT COMPLETED|Overall Study||0||
48081672|NCT05048784|100521652|FG000|STARTED|Period 1||66||
48081673|NCT05048784|100521653|FG001|STARTED|Period 1||66||
48081674|NCT05048784|100521654|FG002|STARTED|Period 1||6||
48081675|NCT05048784|100521655|FG003|STARTED|Period 1||7||
48081676|NCT05048784|100521652|FG000|Administered Treatment A|Period 1||66||
48081677|NCT05048784|100521653|FG001|Administered Treatment A|Period 1||0||
48081678|NCT05048784|100521654|FG002|Administered Treatment A|Period 1||6||
48081679|NCT05048784|100521655|FG003|Administered Treatment A|Period 1||0||
48081680|NCT05048784|100521652|FG000|Administered Treatment B|Period 1||0||
48081681|NCT05048784|100521653|FG001|Administered Treatment B|Period 1||66||
48244726|NCT00988429|100917767|FG000|Intention-to-treat (ITT) Population|Overall Study||220||
48081682|NCT05048784|100521654|FG002|Administered Treatment B|Period 1||0||
48081683|NCT05048784|100521655|FG003|Administered Treatment B|Period 1||7||
48081684|NCT05048784|100521652|FG000|COMPLETED|Period 1||63||
48081685|NCT05048784|100521653|FG001|COMPLETED|Period 1||65||
48081686|NCT05048784|100521654|FG002|COMPLETED|Period 1||6||
48081687|NCT05048784|100521655|FG003|COMPLETED|Period 1||7||
48081688|NCT05048784|100521652|FG000|NOT COMPLETED|Period 1||3||
48244727|NCT00988429|100917768|FG001|Intention-to-treat (ITT) Population|Overall Study||215||
48244728|NCT00988429|100917769|FG002|Intention-to-treat (ITT) Population|Overall Study||205||
48244729|NCT00988429|100917767|FG000|COMPLETED|Overall Study||189||
48244730|NCT00988429|100917768|FG001|COMPLETED|Overall Study||173||
48244731|NCT00988429|100917769|FG002|COMPLETED|Overall Study||142||
48244732|NCT00988429|100917767|FG000|NOT COMPLETED|Overall Study||37||
48081689|NCT05048784|100521653|FG001|NOT COMPLETED|Period 1||1||
48081690|NCT05048784|100521654|FG002|NOT COMPLETED|Period 1||0||
48081691|NCT05048784|100521655|FG003|NOT COMPLETED|Period 1||0||
48081692|NCT05048784|100521652|FG000|STARTED|Period 2||63||
48081693|NCT05048784|100521653|FG001|STARTED|Period 2||65||
48244733|NCT00988429|100917768|FG001|NOT COMPLETED|Overall Study||43||
48081694|NCT05048784|100521654|FG002|STARTED|Period 2||6||
48081695|NCT05048784|100521655|FG003|STARTED|Period 2||7||
48081696|NCT05048784|100521652|FG000|Administered Treatment A|Period 2||0||
48081697|NCT05048784|100521653|FG001|Administered Treatment A|Period 2||65||
48081698|NCT05048784|100521654|FG002|Administered Treatment A|Period 2||0||
48081699|NCT05048784|100521655|FG003|Administered Treatment A|Period 2||7||
48081700|NCT05048784|100521652|FG000|Administered Treatment B|Period 2||63||
48081701|NCT05048784|100521653|FG001|Administered Treatment B|Period 2||0||
48081702|NCT05048784|100521654|FG002|Administered Treatment B|Period 2||6||
48081703|NCT05048784|100521655|FG003|Administered Treatment B|Period 2||0||
48244734|NCT00988429|100917769|FG002|NOT COMPLETED|Overall Study||69||
48244735|NCT03651271|100917770|FG000|STARTED|Overall Study||7||
48244736|NCT03651271|100917771|FG001|STARTED|Overall Study||72||
48244737|NCT03651271|100917772|FG002|STARTED|Overall Study||1||
48244738|NCT03651271|100917773|FG003|STARTED|Overall Study||5||
48244739|NCT03651271|100917774|FG004|STARTED|Overall Study||15||
48244740|NCT03651271|100917770|FG000|COMPLETED|Overall Study||1||
48244741|NCT03651271|100917771|FG001|COMPLETED|Overall Study||13||
48244742|NCT03651271|100917772|FG002|COMPLETED|Overall Study||1||
48244743|NCT03651271|100917773|FG003|COMPLETED|Overall Study||1||
48244744|NCT03651271|100917774|FG004|COMPLETED|Overall Study||8||
48244745|NCT03651271|100917770|FG000|NOT COMPLETED|Overall Study||6||
48244746|NCT03651271|100917771|FG001|NOT COMPLETED|Overall Study||59||
48681653|NCT02706925|102006436|FG006|NOT COMPLETED|Overall Study||0||
48681654|NCT02706925|102006437|FG007|NOT COMPLETED|Overall Study||0||
48681655|NCT02706925|102006438|FG008|NOT COMPLETED|Overall Study||0||
48681656|NCT00421148|102006439|FG000|STARTED|Overall Study||2||
48681657|NCT00421148|102006440|FG001|STARTED|Overall Study||2||
48681658|NCT00421148|102006441|FG002|STARTED|Overall Study||2||
48681659|NCT00421148|102006442|FG003|STARTED|Overall Study||1||
48681660|NCT00421148|102006443|FG004|STARTED|Overall Study||1||
48681661|NCT00421148|102006444|FG005|STARTED|Overall Study||5||
48681662|NCT00421148|102006445|FG006|STARTED|Overall Study||6||
48681663|NCT00421148|102006446|FG007|STARTED|Overall Study||5||
48681664|NCT00421148|102006447|FG008|STARTED|Overall Study||5||
48681665|NCT00421148|102006448|FG009|STARTED|Overall Study||5||
48681666|NCT00421148|102006449|FG010|STARTED|Overall Study||6||
48681667|NCT00421148|102006450|FG011|STARTED|Overall Study||6||
48681668|NCT00421148|102006451|FG012|STARTED|Overall Study||6||
48681669|NCT00421148|102006452|FG013|STARTED|Overall Study||6||
48681670|NCT00421148|102006453|FG014|STARTED|Overall Study||6||
48681671|NCT00421148|102006454|FG015|STARTED|Overall Study||6||
48681672|NCT00421148|102006455|FG016|STARTED|Overall Study||6||
48681673|NCT00421148|102006456|FG017|STARTED|Overall Study||6||
48681674|NCT00421148|102006457|FG018|STARTED|Overall Study||6||
48681675|NCT00421148|102006458|FG019|STARTED|Overall Study||6||
48681676|NCT00421148|102006439|FG000|Treated|Overall Study||2||
48681677|NCT00421148|102006440|FG001|Treated|Overall Study||2||
48681678|NCT00421148|102006441|FG002|Treated|Overall Study||2||
48681679|NCT00421148|102006442|FG003|Treated|Overall Study||1||
48681680|NCT00421148|102006443|FG004|Treated|Overall Study||1||
48681681|NCT00421148|102006444|FG005|Treated|Overall Study||4||
48681682|NCT00421148|102006445|FG006|Treated|Overall Study||6||
48681683|NCT00421148|102006446|FG007|Treated|Overall Study||5||
48681684|NCT00421148|102006447|FG008|Treated|Overall Study||5||
48681685|NCT00421148|102006448|FG009|Treated|Overall Study||5||
48681686|NCT00421148|102006449|FG010|Treated|Overall Study||6||
48681687|NCT00421148|102006450|FG011|Treated|Overall Study||6||
48681688|NCT00421148|102006451|FG012|Treated|Overall Study||6||
48681689|NCT00421148|102006452|FG013|Treated|Overall Study||6||
48681690|NCT00421148|102006453|FG014|Treated|Overall Study||6||
48681691|NCT00421148|102006454|FG015|Treated|Overall Study||6||
48681692|NCT00421148|102006455|FG016|Treated|Overall Study||6||
48681693|NCT00421148|102006456|FG017|Treated|Overall Study||5||
48681694|NCT00421148|102006457|FG018|Treated|Overall Study||5||
48681695|NCT00421148|102006458|FG019|Treated|Overall Study||6||
48681696|NCT00421148|102006439|FG000|COMPLETED|Overall Study||2||
48681697|NCT00421148|102006440|FG001|COMPLETED|Overall Study||2||
48681698|NCT00421148|102006441|FG002|COMPLETED|Overall Study||2||
48681699|NCT00421148|102006442|FG003|COMPLETED|Overall Study||1||
48681700|NCT00421148|102006443|FG004|COMPLETED|Overall Study||1||
48681701|NCT00421148|102006444|FG005|COMPLETED|Overall Study||4||
48681702|NCT00421148|102006445|FG006|COMPLETED|Overall Study||6||
48681703|NCT00421148|102006446|FG007|COMPLETED|Overall Study||5||
48681704|NCT00421148|102006447|FG008|COMPLETED|Overall Study||5||
48244747|NCT03651271|100917772|FG002|NOT COMPLETED|Overall Study||0||
48681705|NCT00421148|102006448|FG009|COMPLETED|Overall Study||5||
48681706|NCT00421148|102006449|FG010|COMPLETED|Overall Study||6||
48681707|NCT00421148|102006450|FG011|COMPLETED|Overall Study||6||
48681708|NCT00421148|102006451|FG012|COMPLETED|Overall Study||6||
48681709|NCT00421148|102006452|FG013|COMPLETED|Overall Study||6||
48081704|NCT05048784|100521652|FG000|COMPLETED|Period 2||63||
48681710|NCT00421148|102006453|FG014|COMPLETED|Overall Study||6||
48081705|NCT05048784|100521653|FG001|COMPLETED|Period 2||64||
48081706|NCT05048784|100521654|FG002|COMPLETED|Period 2||6||
48081707|NCT05048784|100521655|FG003|COMPLETED|Period 2||7||
48081708|NCT05048784|100521652|FG000|NOT COMPLETED|Period 2||0||
48081709|NCT05048784|100521653|FG001|NOT COMPLETED|Period 2||1||
48081710|NCT05048784|100521654|FG002|NOT COMPLETED|Period 2||0||
48081711|NCT05048784|100521655|FG003|NOT COMPLETED|Period 2||0||
48081712|NCT05048784|100521652|FG000|STARTED|Period 3||0||
48081713|NCT05048784|100521653|FG001|STARTED|Period 3||0||
48081714|NCT05048784|100521654|FG002|STARTED|Period 3||6||
48081715|NCT05048784|100521655|FG003|STARTED|Period 3||7||
48081716|NCT05048784|100521652|FG000|Administered Treatment C|Period 3||0||
48081717|NCT05048784|100521653|FG001|Administered Treatment C|Period 3||0||
48081718|NCT05048784|100521654|FG002|Administered Treatment C|Period 3||6||
48081719|NCT05048784|100521655|FG003|Administered Treatment C|Period 3||7||
48081720|NCT05048784|100521652|FG000|COMPLETED|Period 3||0||
48081721|NCT05048784|100521653|FG001|COMPLETED|Period 3||0||
48081722|NCT05048784|100521654|FG002|COMPLETED|Period 3||6||
48081723|NCT05048784|100521655|FG003|COMPLETED|Period 3||7||
48081724|NCT05048784|100521652|FG000|NOT COMPLETED|Period 3||0||
48081725|NCT05048784|100521653|FG001|NOT COMPLETED|Period 3||0||
48081726|NCT05048784|100521654|FG002|NOT COMPLETED|Period 3||0||
48081727|NCT05048784|100521655|FG003|NOT COMPLETED|Period 3||0||
48081728|NCT03217175|100521656|FG000|STARTED|Overall Study||4||
48081729|NCT03217175|100521657|FG001|STARTED|Overall Study||1||
48081730|NCT03217175|100521656|FG000|COMPLETED|Overall Study||0||
48081731|NCT03217175|100521657|FG001|COMPLETED|Overall Study||0||
48081732|NCT03217175|100521656|FG000|NOT COMPLETED|Overall Study||4||
48081733|NCT03217175|100521657|FG001|NOT COMPLETED|Overall Study||1||
48081734|NCT02457260|100521658|FG000|STARTED|Overall Study||12||
48081735|NCT02457260|100521659|FG001|STARTED|Overall Study||7||
48081736|NCT02457260|100521660|FG002|STARTED|Overall Study||2||
48081737|NCT02457260|100521658|FG000|COMPLETED|Overall Study||10||
48081738|NCT02457260|100521659|FG001|COMPLETED|Overall Study||4||
48081739|NCT02457260|100521660|FG002|COMPLETED|Overall Study||1||
48081740|NCT02457260|100521658|FG000|NOT COMPLETED|Overall Study||2||
48540688|NCT00626392|101658159|FG002|COMPLETED|Coadministration Period||31||
48540689|NCT00626392|101658160|FG003|COMPLETED|Coadministration Period||36||
48540690|NCT00626392|101658161|FG004|COMPLETED|Coadministration Period||36||
48081741|NCT02457260|100521659|FG001|NOT COMPLETED|Overall Study||3||
48081742|NCT02457260|100521660|FG002|NOT COMPLETED|Overall Study||1||
48081743|NCT00187369|100521661|FG000|STARTED|Mothers||1398||
48081744|NCT00187369|100521662|FG001|STARTED|Mothers||1406||
48081745|NCT00187369|100521661|FG000|Included in the Study|Mothers||1393||
48081746|NCT00187369|100521662|FG001|Included in the Study|Mothers||1393||
48081747|NCT00187369|100521661|FG000|COMPLETED|Mothers||1392||
48081748|NCT00187369|100521662|FG001|COMPLETED|Mothers||1392||
48081749|NCT00187369|100521661|FG000|NOT COMPLETED|Mothers||6||
48081750|NCT00187369|100521662|FG001|NOT COMPLETED|Mothers||14||
48081751|NCT00187369|100521661|FG000|STARTED|Fetuses or Infants||2795||
48540691|NCT00626392|101658162|FG005|COMPLETED|Coadministration Period||38||
48540692|NCT00626392|101658157|FG000|NOT COMPLETED|Coadministration Period||4||
48540693|NCT00626392|101658158|FG001|NOT COMPLETED|Coadministration Period||5||
48540694|NCT00626392|101658159|FG002|NOT COMPLETED|Coadministration Period||10||
48081752|NCT00187369|100521662|FG001|STARTED|Fetuses or Infants||2812||
48081753|NCT00187369|100521661|FG000|Included in the Study|Fetuses or Infants||2785||
48081754|NCT00187369|100521662|FG001|Included in the Study|Fetuses or Infants||2786||
48081755|NCT00187369|100521661|FG000|COMPLETED|Fetuses or Infants||2783||
48540695|NCT00626392|101658160|FG003|NOT COMPLETED|Coadministration Period||7||
48081756|NCT00187369|100521662|FG001|COMPLETED|Fetuses or Infants||2782||
48081757|NCT00187369|100521661|FG000|NOT COMPLETED|Fetuses or Infants||12||
48081758|NCT00187369|100521662|FG001|NOT COMPLETED|Fetuses or Infants||30||
48244748|NCT03651271|100917773|FG003|NOT COMPLETED|Overall Study||4||
48244749|NCT03651271|100917774|FG004|NOT COMPLETED|Overall Study||7||
48244750|NCT00789399|100917775|FG000|STARTED|Overall Study||41||
48244751|NCT00789399|100917776|FG001|STARTED|Overall Study||37||
48244752|NCT00789399|100917775|FG000|COMPLETED|Overall Study||39||
48244753|NCT00789399|100917776|FG001|COMPLETED|Overall Study||37||
48244754|NCT00789399|100917775|FG000|NOT COMPLETED|Overall Study||2||
48244755|NCT00789399|100917776|FG001|NOT COMPLETED|Overall Study||0||
48244756|NCT02350127|100917777|FG000|STARTED|4-Month Assessment||44||
48244757|NCT02350127|100917778|FG001|STARTED|4-Month Assessment||44||
48244758|NCT02350127|100917777|FG000|Completed Baseline|4-Month Assessment||42||
48244759|NCT02350127|100917778|FG001|Completed Baseline|4-Month Assessment||43||
48244760|NCT02350127|100917777|FG000|COMPLETED|4-Month Assessment||33||
48244761|NCT02350127|100917778|FG001|COMPLETED|4-Month Assessment||35||
48244762|NCT02350127|100917777|FG000|NOT COMPLETED|4-Month Assessment||11||
48244763|NCT02350127|100917778|FG001|NOT COMPLETED|4-Month Assessment||9||
48244764|NCT02350127|100917777|FG000|STARTED|8-Month Assessment||33||
48244765|NCT02350127|100917778|FG001|STARTED|8-Month Assessment||35||
48244766|NCT02350127|100917777|FG000|COMPLETED|8-Month Assessment||27||
48244767|NCT02350127|100917778|FG001|COMPLETED|8-Month Assessment||26||
48244768|NCT02350127|100917777|FG000|NOT COMPLETED|8-Month Assessment||6||
48244769|NCT02350127|100917778|FG001|NOT COMPLETED|8-Month Assessment||9||
48244770|NCT03082196|100917779|FG000|STARTED|Overall Study||142||
48244771|NCT03082196|100917780|FG001|STARTED|Overall Study||142||
48244772|NCT03082196|100917779|FG000|COMPLETED|Overall Study||133||
48244773|NCT03082196|100917780|FG001|COMPLETED|Overall Study||129||
48244774|NCT03082196|100917779|FG000|NOT COMPLETED|Overall Study||9||
48244775|NCT03082196|100917780|FG001|NOT COMPLETED|Overall Study||13||
48244776|NCT02135419|100917781|FG000|STARTED|Overall Study||2227||
48244777|NCT02135419|100917782|FG001|STARTED|Overall Study||2219||
48244778|NCT02135419|100917781|FG000|COMPLETED|Overall Study||2071||
48081759|NCT02517567|100521663|FG000|STARTED|First Exposure (8 Hours)||6||
48081760|NCT02517567|100521664|FG001|STARTED|First Exposure (8 Hours)||8||
48081761|NCT02517567|100521665|FG002|STARTED|First Exposure (8 Hours)||7||
48081762|NCT02517567|100521666|FG003|STARTED|First Exposure (8 Hours)||8||
48081763|NCT02517567|100521663|FG000|COMPLETED|First Exposure (8 Hours)||6||
48081764|NCT02517567|100521664|FG001|COMPLETED|First Exposure (8 Hours)||8||
48081765|NCT02517567|100521665|FG002|COMPLETED|First Exposure (8 Hours)||7||
48081766|NCT02517567|100521666|FG003|COMPLETED|First Exposure (8 Hours)||8||
48244779|NCT02135419|100917782|FG001|COMPLETED|Overall Study||2080||
48081767|NCT02517567|100521663|FG000|NOT COMPLETED|First Exposure (8 Hours)||0||
48244780|NCT02135419|100917781|FG000|NOT COMPLETED|Overall Study||156||
48244781|NCT02135419|100917782|FG001|NOT COMPLETED|Overall Study||139||
48244782|NCT01855997|100917783|FG000|STARTED|Overall Study||1669||
48244783|NCT01855997|100917783|FG000|COMPLETED|Overall Study||1669||
48681711|NCT00421148|102006454|FG015|COMPLETED|Overall Study||6||
48681712|NCT00421148|102006455|FG016|COMPLETED|Overall Study||6||
48681713|NCT00421148|102006456|FG017|COMPLETED|Overall Study||4||
48081768|NCT02517567|100521664|FG001|NOT COMPLETED|First Exposure (8 Hours)||0||
48081769|NCT02517567|100521665|FG002|NOT COMPLETED|First Exposure (8 Hours)||0||
48081770|NCT02517567|100521666|FG003|NOT COMPLETED|First Exposure (8 Hours)||0||
48081771|NCT02517567|100521663|FG000|STARTED|Second Exposure (8 Hours)||6||
48081772|NCT02517567|100521664|FG001|STARTED|Second Exposure (8 Hours)||8||
48081773|NCT02517567|100521665|FG002|STARTED|Second Exposure (8 Hours)||7||
48081774|NCT02517567|100521666|FG003|STARTED|Second Exposure (8 Hours)||8||
48081775|NCT02517567|100521663|FG000|COMPLETED|Second Exposure (8 Hours)||6||
48081776|NCT02517567|100521664|FG001|COMPLETED|Second Exposure (8 Hours)||8||
48081777|NCT02517567|100521665|FG002|COMPLETED|Second Exposure (8 Hours)||7||
48081778|NCT02517567|100521666|FG003|COMPLETED|Second Exposure (8 Hours)||8||
48081779|NCT02517567|100521663|FG000|NOT COMPLETED|Second Exposure (8 Hours)||0||
48081780|NCT02517567|100521664|FG001|NOT COMPLETED|Second Exposure (8 Hours)||0||
48081781|NCT02517567|100521665|FG002|NOT COMPLETED|Second Exposure (8 Hours)||0||
48081782|NCT02517567|100521666|FG003|NOT COMPLETED|Second Exposure (8 Hours)||0||
48081783|NCT02517567|100521663|FG000|STARTED|Third Exposure (8 Hours)||6||
48081784|NCT02517567|100521664|FG001|STARTED|Third Exposure (8 Hours)||8||
48081785|NCT02517567|100521665|FG002|STARTED|Third Exposure (8 Hours)||7||
48081786|NCT02517567|100521666|FG003|STARTED|Third Exposure (8 Hours)||8||
48244784|NCT01855997|100917783|FG000|NOT COMPLETED|Overall Study||0||
48244785|NCT02136797|100917784|FG000|STARTED|Overall Study||77||
48244786|NCT02136797|100917784|FG000|COMPLETED|Overall Study||69||
48244787|NCT02136797|100917784|FG000|NOT COMPLETED|Overall Study||8||
48244788|NCT00145496|100917785|FG000|STARTED|Overall Study||244||
48244789|NCT00145496|100917786|FG001|STARTED|Overall Study||224||
48244790|NCT00145496|100917785|FG000|COMPLETED|Overall Study||121||
48244791|NCT00145496|100917786|FG001|COMPLETED|Overall Study||143||
48244792|NCT00145496|100917785|FG000|NOT COMPLETED|Overall Study||123||
48244793|NCT00145496|100917786|FG001|NOT COMPLETED|Overall Study||81||
48244794|NCT01721759|100917787|FG000|STARTED|Treatment Period||117|= Starting Treatment|
48244795|NCT01721759|100917787|FG000|COMPLETED|Treatment Period||0|= Continuing in the treatment period|
48244796|NCT01721759|100917787|FG000|NOT COMPLETED|Treatment Period||117||
48244797|NCT01721759|100917787|FG000|STARTED|End of Study Period||117||
48244798|NCT01721759|100917787|FG000|COMPLETED|End of Study Period||0|= continuing in the study|
48244799|NCT01721759|100917787|FG000|NOT COMPLETED|End of Study Period||117||
48244800|NCT04564027|100917788|FG000|STARTED|Overall Study||8||
48244801|NCT04564027|100917789|FG001|STARTED|Overall Study||30||
48244802|NCT04564027|100917790|FG002|STARTED|Overall Study||1||
48244803|NCT04564027|100917791|FG003|STARTED|Overall Study||15||
48681714|NCT00421148|102006457|FG018|COMPLETED|Overall Study||5||
48681715|NCT00421148|102006458|FG019|COMPLETED|Overall Study||6||
48681716|NCT00421148|102006439|FG000|NOT COMPLETED|Overall Study||0||
48681717|NCT00421148|102006440|FG001|NOT COMPLETED|Overall Study||0||
48681718|NCT00421148|102006441|FG002|NOT COMPLETED|Overall Study||0||
48681719|NCT00421148|102006442|FG003|NOT COMPLETED|Overall Study||0||
48681720|NCT00421148|102006443|FG004|NOT COMPLETED|Overall Study||0||
48081787|NCT02517567|100521663|FG000|COMPLETED|Third Exposure (8 Hours)||6||
48081788|NCT02517567|100521664|FG001|COMPLETED|Third Exposure (8 Hours)||8||
48081789|NCT02517567|100521665|FG002|COMPLETED|Third Exposure (8 Hours)||7||
48081790|NCT02517567|100521666|FG003|COMPLETED|Third Exposure (8 Hours)||8||
48081791|NCT02517567|100521663|FG000|NOT COMPLETED|Third Exposure (8 Hours)||0||
48081792|NCT02517567|100521664|FG001|NOT COMPLETED|Third Exposure (8 Hours)||0||
48081793|NCT02517567|100521665|FG002|NOT COMPLETED|Third Exposure (8 Hours)||0||
48081794|NCT02517567|100521666|FG003|NOT COMPLETED|Third Exposure (8 Hours)||0||
48081795|NCT02517567|100521663|FG000|STARTED|Fourth Exposure (8 Hours)||6||
48081796|NCT02517567|100521664|FG001|STARTED|Fourth Exposure (8 Hours)||8||
48081797|NCT02517567|100521665|FG002|STARTED|Fourth Exposure (8 Hours)||6||
48081798|NCT02517567|100521666|FG003|STARTED|Fourth Exposure (8 Hours)||8||
48081799|NCT02517567|100521663|FG000|COMPLETED|Fourth Exposure (8 Hours)||6||
48081800|NCT02517567|100521664|FG001|COMPLETED|Fourth Exposure (8 Hours)||8||
48081801|NCT02517567|100521665|FG002|COMPLETED|Fourth Exposure (8 Hours)||6||
48081802|NCT02517567|100521666|FG003|COMPLETED|Fourth Exposure (8 Hours)||8||
48081803|NCT02517567|100521663|FG000|NOT COMPLETED|Fourth Exposure (8 Hours)||0||
48081804|NCT02517567|100521664|FG001|NOT COMPLETED|Fourth Exposure (8 Hours)||0||
48081805|NCT02517567|100521665|FG002|NOT COMPLETED|Fourth Exposure (8 Hours)||0||
48081806|NCT02517567|100521666|FG003|NOT COMPLETED|Fourth Exposure (8 Hours)||0||
48081807|NCT00777608|100521667|FG000|STARTED|Overall Study||53||
48081808|NCT00777608|100521668|FG001|STARTED|Overall Study||53||
48081809|NCT00777608|100521667|FG000|COMPLETED|Overall Study||49||
48081810|NCT00777608|100521668|FG001|COMPLETED|Overall Study||47||
48081811|NCT00777608|100521667|FG000|NOT COMPLETED|Overall Study||4||
48244804|NCT04564027|100917788|FG000|COMPLETED|Overall Study||8||
48244805|NCT04564027|100917789|FG001|COMPLETED|Overall Study||27||
48244806|NCT04564027|100917790|FG002|COMPLETED|Overall Study||1||
48681721|NCT00421148|102006444|FG005|NOT COMPLETED|Overall Study||1||
48681722|NCT00421148|102006445|FG006|NOT COMPLETED|Overall Study||0||
48681723|NCT00421148|102006446|FG007|NOT COMPLETED|Overall Study||0||
48681724|NCT00421148|102006447|FG008|NOT COMPLETED|Overall Study||0||
48081812|NCT00777608|100521668|FG001|NOT COMPLETED|Overall Study||6||
48081813|NCT01294267|100521669|FG000|STARTED|Overall Study||20||
48081814|NCT01294267|100521669|FG000|COMPLETED|Overall Study||20||
48081815|NCT01294267|100521669|FG000|NOT COMPLETED|Overall Study||0||
48081816|NCT01063868|100521670|FG000|STARTED|Overall Study||35||
48081817|NCT01063868|100521671|FG001|STARTED|Overall Study||12||
48081818|NCT01063868|100521670|FG000|COMPLETED|Overall Study||0||
48081819|NCT01063868|100521671|FG001|COMPLETED|Overall Study||0||
48081820|NCT01063868|100521670|FG000|NOT COMPLETED|Overall Study||35||
48081821|NCT01063868|100521671|FG001|NOT COMPLETED|Overall Study||12||
48081822|NCT03170401|100521672|FG000|STARTED|Study Subject Enrollment||256||
48081823|NCT03170401|100521673|FG001|STARTED|Study Subject Enrollment||244||
48081824|NCT03170401|100521672|FG000|COMPLETED|Study Subject Enrollment||256||
48081825|NCT03170401|100521673|FG001|COMPLETED|Study Subject Enrollment||244||
48081826|NCT03170401|100521672|FG000|NOT COMPLETED|Study Subject Enrollment||0||
48081827|NCT03170401|100521673|FG001|NOT COMPLETED|Study Subject Enrollment||0||
48081828|NCT03170401|100521672|FG000|STARTED|Follow up and Data Analysis||256||
48244807|NCT04564027|100917791|FG003|COMPLETED|Overall Study||15||
48244808|NCT04564027|100917788|FG000|NOT COMPLETED|Overall Study||0||
48244809|NCT04564027|100917789|FG001|NOT COMPLETED|Overall Study||3||
48244810|NCT04564027|100917790|FG002|NOT COMPLETED|Overall Study||0||
48244811|NCT04564027|100917791|FG003|NOT COMPLETED|Overall Study||0||
48244812|NCT04393779|100917792|FG000|STARTED|Overall Study||26||
48244813|NCT04393779|100917792|FG000|COMPLETED|Overall Study||21||
48244814|NCT04393779|100917792|FG000|NOT COMPLETED|Overall Study||5||
48244815|NCT00747149|100917793|FG000|STARTED|Overall Study||154||
48244816|NCT00747149|100917794|FG001|STARTED|Overall Study||444||
48244817|NCT00747149|100917793|FG000|COMPLETED|Overall Study||153||
48244818|NCT00747149|100917794|FG001|COMPLETED|Overall Study||401||
48244819|NCT00747149|100917793|FG000|NOT COMPLETED|Overall Study||1||
48540696|NCT00626392|101658161|FG004|NOT COMPLETED|Coadministration Period||5||
48540697|NCT00626392|101658162|FG005|NOT COMPLETED|Coadministration Period||6||
48540698|NCT00206323|101658163|FG000|STARTED|Overall Study||14||
48540699|NCT00206323|101658164|FG001|STARTED|Overall Study||15||
48540700|NCT00206323|101658163|FG000|COMPLETED|Overall Study||8||
48681725|NCT00421148|102006448|FG009|NOT COMPLETED|Overall Study||0||
48540701|NCT00206323|101658164|FG001|COMPLETED|Overall Study||12||
48540702|NCT00206323|101658163|FG000|NOT COMPLETED|Overall Study||6||
48540703|NCT00206323|101658164|FG001|NOT COMPLETED|Overall Study||3||
48540704|NCT01464931|101658165|FG000|STARTED|Overall Study||16||
48540705|NCT01464931|101658166|FG001|STARTED|Overall Study||16||
48540706|NCT01464931|101658165|FG000|COMPLETED|Overall Study||15||
48681726|NCT00421148|102006449|FG010|NOT COMPLETED|Overall Study||0||
48081829|NCT03170401|100521673|FG001|STARTED|Follow up and Data Analysis||244||
48081830|NCT03170401|100521672|FG000|COMPLETED|Follow up and Data Analysis||256||
48540707|NCT01464931|101658166|FG001|COMPLETED|Overall Study||16||
48540708|NCT01464931|101658165|FG000|NOT COMPLETED|Overall Study||1||
48540709|NCT01464931|101658166|FG001|NOT COMPLETED|Overall Study||0||
48540710|NCT00464438|101658167|FG000|STARTED|Overall Study||85||
48540711|NCT00464438|101658168|FG001|STARTED|Overall Study||86||
48540712|NCT00464438|101658167|FG000|COMPLETED|Overall Study||83||
48540713|NCT00464438|101658168|FG001|COMPLETED|Overall Study||80||
48540714|NCT00464438|101658167|FG000|NOT COMPLETED|Overall Study||2||
48681727|NCT00421148|102006450|FG011|NOT COMPLETED|Overall Study||0||
48081831|NCT03170401|100521673|FG001|COMPLETED|Follow up and Data Analysis||244||
48081832|NCT03170401|100521672|FG000|NOT COMPLETED|Follow up and Data Analysis||0||
48540715|NCT00464438|101658168|FG001|NOT COMPLETED|Overall Study||6||
48540716|NCT00530218|101658169|FG000|STARTED|Overall Study||61||
48681728|NCT00421148|102006451|FG012|NOT COMPLETED|Overall Study||0||
48681729|NCT00421148|102006452|FG013|NOT COMPLETED|Overall Study||0||
48681730|NCT00421148|102006453|FG014|NOT COMPLETED|Overall Study||0||
48081833|NCT03170401|100521673|FG001|NOT COMPLETED|Follow up and Data Analysis||0||
48081834|NCT01397084|100521674|FG000|STARTED|Overall Study||108||
48081835|NCT01397084|100521674|FG000|COMPLETED|Overall Study||100||
48081836|NCT01397084|100521674|FG000|NOT COMPLETED|Overall Study||8||
48081837|NCT00105469|100521675|FG000|STARTED|Overall Study||365||
48081838|NCT00105469|100521676|FG001|STARTED|Overall Study||378||
48081839|NCT00105469|100521675|FG000|COMPLETED|Overall Study||343||
48081840|NCT00105469|100521676|FG001|COMPLETED|Overall Study||367||
48081841|NCT00105469|100521675|FG000|NOT COMPLETED|Overall Study||22||
48081842|NCT00105469|100521676|FG001|NOT COMPLETED|Overall Study||11||
48081843|NCT00127660|100521677|FG000|STARTED|Overall Study||153||
48081844|NCT00127660|100521678|FG001|STARTED|Overall Study||154||
48081845|NCT00127660|100521679|FG002|STARTED|Overall Study||148||
48244820|NCT00747149|100917794|FG001|NOT COMPLETED|Overall Study||43||
48244821|NCT00191984|100917795|FG000|STARTED|Overall Study||46||
48244822|NCT00191984|100917795|FG000|COMPLETED|Overall Study||7||
48681731|NCT00421148|102006454|FG015|NOT COMPLETED|Overall Study||0||
48681732|NCT00421148|102006455|FG016|NOT COMPLETED|Overall Study||0||
48244823|NCT00191984|100917795|FG000|NOT COMPLETED|Overall Study||39||
48244824|NCT01106586|100917796|FG000|STARTED|Overall Study||353||
48244825|NCT01106586|100917797|FG001|STARTED|Overall Study||355||
48244826|NCT01106586|100917796|FG000|COMPLETED|Overall Study||68||
48244827|NCT01106586|100917797|FG001|COMPLETED|Overall Study||70||
48244828|NCT01106586|100917796|FG000|NOT COMPLETED|Overall Study||285||
48244829|NCT01106586|100917797|FG001|NOT COMPLETED|Overall Study||285||
48244830|NCT02409732|100917798|FG000|STARTED|Overall Study||20||
48244831|NCT02409732|100917798|FG000|COMPLETED|Overall Study||14||
48081846|NCT00127660|100521680|FG003|STARTED|Overall Study||150||
48081847|NCT00127660|100521677|FG000|COMPLETED|Overall Study||150||
48081848|NCT00127660|100521678|FG001|COMPLETED|Overall Study||151||
48081849|NCT00127660|100521679|FG002|COMPLETED|Overall Study||143||
48081850|NCT00127660|100521680|FG003|COMPLETED|Overall Study||150||
48081851|NCT00127660|100521677|FG000|NOT COMPLETED|Overall Study||3||
48081852|NCT00127660|100521678|FG001|NOT COMPLETED|Overall Study||3||
48081853|NCT00127660|100521679|FG002|NOT COMPLETED|Overall Study||5||
48244832|NCT02409732|100917798|FG000|NOT COMPLETED|Overall Study||6||
48244833|NCT01314014|100917799|FG000|STARTED|Overall Study||22||
48244834|NCT01314014|100917799|FG000|COMPLETED|Overall Study||22||
48244835|NCT01314014|100917799|FG000|NOT COMPLETED|Overall Study||0||
48244836|NCT04593641|100917800|FG000|STARTED|Overall Study||5||
48244837|NCT04593641|100917801|FG001|STARTED|Overall Study||5||
48244838|NCT04593641|100917802|FG002|STARTED|Overall Study||5||
48244839|NCT04593641|100917803|FG003|STARTED|Overall Study||3||
48244840|NCT04593641|100917800|FG000|COMPLETED|Overall Study||4||
48244841|NCT04593641|100917801|FG001|COMPLETED|Overall Study||5||
48244842|NCT04593641|100917802|FG002|COMPLETED|Overall Study||5||
48244843|NCT04593641|100917803|FG003|COMPLETED|Overall Study||3||
48244844|NCT04593641|100917800|FG000|NOT COMPLETED|Overall Study||1||
48244845|NCT04593641|100917801|FG001|NOT COMPLETED|Overall Study||0||
48244846|NCT04593641|100917802|FG002|NOT COMPLETED|Overall Study||0||
48244847|NCT04593641|100917803|FG003|NOT COMPLETED|Overall Study||0||
48244848|NCT01239056|100917804|FG000|STARTED|Overall Study||20||
48244849|NCT01239056|100917804|FG000|COMPLETED|Overall Study||20||
48244850|NCT01239056|100917804|FG000|NOT COMPLETED|Overall Study||0||
48244851|NCT01114334|100917805|FG000|STARTED|Overall Study||88||
48244852|NCT01114334|100917806|FG001|STARTED|Overall Study||80||
48244853|NCT01114334|100917805|FG000|COMPLETED|Overall Study||67||
48244854|NCT01114334|100917806|FG001|COMPLETED|Overall Study||58||
48244855|NCT01114334|100917805|FG000|NOT COMPLETED|Overall Study||21||
48244856|NCT01114334|100917806|FG001|NOT COMPLETED|Overall Study||22||
48244857|NCT01448447|100917807|FG000|STARTED|Overall Study||20||
48244858|NCT01448447|100917808|FG001|STARTED|Overall Study||0||
48244859|NCT01448447|100917807|FG000|COMPLETED|Overall Study||20||
48244860|NCT01448447|100917808|FG001|COMPLETED|Overall Study||0||
48244861|NCT01448447|100917807|FG000|NOT COMPLETED|Overall Study||0||
48081854|NCT00127660|100521680|FG003|NOT COMPLETED|Overall Study||0||
48081855|NCT02007109|100521681|FG000|STARTED|Overall Study||193||
48244862|NCT01448447|100917808|FG001|NOT COMPLETED|Overall Study||0||
48244863|NCT01446042|100917809|FG000|STARTED|Overall Study||142||
48244864|NCT01446042|100917810|FG001|STARTED|Overall Study||86||
48244865|NCT01446042|100917811|FG002|STARTED|Overall Study||78||
48244866|NCT01446042|100917809|FG000|COMPLETED|Overall Study||122||
48244867|NCT01446042|100917810|FG001|COMPLETED|Overall Study||83||
48081856|NCT02007109|100521681|FG000|PACU Analysis|Overall Study||184||
48081857|NCT02007109|100521681|FG000|COMPLETED|Overall Study||82|Post-Discharge Analysis|
48081858|NCT02007109|100521681|FG000|NOT COMPLETED|Overall Study||111||
48081859|NCT00752232|100521682|FG000|STARTED|Overall Study||6||
48081860|NCT00752232|100521683|FG001|STARTED|Overall Study||6||
48081861|NCT00752232|100521684|FG002|STARTED|Overall Study||6||
48244868|NCT01446042|100917811|FG002|COMPLETED|Overall Study||69||
48244869|NCT01446042|100917809|FG000|NOT COMPLETED|Overall Study||20||
48244870|NCT01446042|100917810|FG001|NOT COMPLETED|Overall Study||3||
48244871|NCT01446042|100917811|FG002|NOT COMPLETED|Overall Study||9||
48244872|NCT01283971|100917812|FG000|STARTED|Overall Study||48||
48244873|NCT01283971|100917813|FG001|STARTED|Overall Study||48||
48244874|NCT01283971|100917812|FG000|Intent to Treat Population|Overall Study||46||
48081862|NCT00752232|100521685|FG003|STARTED|Overall Study||6||
48081863|NCT00752232|100521686|FG004|STARTED|Overall Study||6||
48081864|NCT00752232|100521687|FG005|STARTED|Overall Study||6||
48081865|NCT00752232|100521688|FG006|STARTED|Overall Study||4||
48081866|NCT00752232|100521682|FG000|COMPLETED|Overall Study||4||
48244875|NCT01283971|100917813|FG001|Intent to Treat Population|Overall Study||48||
48244876|NCT01283971|100917812|FG000|COMPLETED|Overall Study||33||
48244877|NCT01283971|100917813|FG001|COMPLETED|Overall Study||36||
48244878|NCT01283971|100917812|FG000|NOT COMPLETED|Overall Study||15||
48244879|NCT01283971|100917813|FG001|NOT COMPLETED|Overall Study||12||
48244880|NCT03490942|100917814|FG000|STARTED|Overall Study||15||
48244881|NCT03490942|100917815|FG001|STARTED|Overall Study||18||
48244882|NCT03490942|100917816|FG002|STARTED|Overall Study||16||
48244883|NCT03490942|100917814|FG000|COMPLETED|Overall Study||5||
48081867|NCT00752232|100521683|FG001|COMPLETED|Overall Study||6||
48081868|NCT00752232|100521684|FG002|COMPLETED|Overall Study||5||
48081869|NCT00752232|100521685|FG003|COMPLETED|Overall Study||5||
48244884|NCT03490942|100917815|FG001|COMPLETED|Overall Study||8||
48244885|NCT03490942|100917816|FG002|COMPLETED|Overall Study||9||
48244886|NCT03490942|100917814|FG000|NOT COMPLETED|Overall Study||10||
48244887|NCT03490942|100917815|FG001|NOT COMPLETED|Overall Study||10||
48244888|NCT03490942|100917816|FG002|NOT COMPLETED|Overall Study||7||
48244889|NCT02520414|100917817|FG000|STARTED|Overall Study||10||
48244890|NCT02520414|100917817|FG000|COMPLETED|Overall Study||10||
48244891|NCT02520414|100917817|FG000|NOT COMPLETED|Overall Study||0||
48244892|NCT01955720|100917818|FG000|STARTED|Overall Study||13||
48244893|NCT01955720|100917819|FG001|STARTED|Overall Study||13||
48244894|NCT01955720|100917820|FG002|STARTED|Overall Study||3||
48244895|NCT01955720|100917821|FG003|STARTED|Overall Study||3||
48244896|NCT01955720|100917822|FG004|STARTED|Overall Study||7||
48244897|NCT01955720|100917823|FG005|STARTED|Overall Study||7||
48244898|NCT01955720|100917818|FG000|Healthy Subjects Aged 45-64|Overall Study||3||
48244899|NCT01955720|100917819|FG001|Healthy Subjects Aged 45-64|Overall Study||3||
48244900|NCT01955720|100917820|FG002|Healthy Subjects Aged 45-64|Overall Study||3||
48244901|NCT01955720|100917821|FG003|Healthy Subjects Aged 45-64|Overall Study||3||
48244902|NCT01955720|100917822|FG004|Healthy Subjects Aged 45-64|Overall Study||0||
48244903|NCT01955720|100917823|FG005|Healthy Subjects Aged 45-64|Overall Study||0||
48244904|NCT01955720|100917818|FG000|Healthy Subjects Aged 65-80|Overall Study||4||
48244905|NCT01955720|100917819|FG001|Healthy Subjects Aged 65-80|Overall Study||4||
48244906|NCT01955720|100917820|FG002|Healthy Subjects Aged 65-80|Overall Study||0||
48244907|NCT01955720|100917821|FG003|Healthy Subjects Aged 65-80|Overall Study||0||
48244908|NCT01955720|100917822|FG004|Healthy Subjects Aged 65-80|Overall Study||4||
48244909|NCT01955720|100917823|FG005|Healthy Subjects Aged 65-80|Overall Study||4||
48244910|NCT01955720|100917818|FG000|Subjects With Mild Renal Impairment|Overall Study||3||
48244911|NCT01955720|100917819|FG001|Subjects With Mild Renal Impairment|Overall Study||3||
48244912|NCT01955720|100917820|FG002|Subjects With Mild Renal Impairment|Overall Study||0||
48244913|NCT01955720|100917821|FG003|Subjects With Mild Renal Impairment|Overall Study||0||
48244914|NCT01955720|100917822|FG004|Subjects With Mild Renal Impairment|Overall Study||3||
48244915|NCT01955720|100917823|FG005|Subjects With Mild Renal Impairment|Overall Study||3||
48244916|NCT01955720|100917818|FG000|Subjects With Moderate Renal Impairment|Overall Study||3||
48244917|NCT01955720|100917819|FG001|Subjects With Moderate Renal Impairment|Overall Study||3||
48244918|NCT01955720|100917820|FG002|Subjects With Moderate Renal Impairment|Overall Study||0||
48244919|NCT01955720|100917821|FG003|Subjects With Moderate Renal Impairment|Overall Study||0||
48244920|NCT01955720|100917822|FG004|Subjects With Moderate Renal Impairment|Overall Study||0||
48244921|NCT01955720|100917823|FG005|Subjects With Moderate Renal Impairment|Overall Study||0||
48244922|NCT01955720|100917818|FG000|COMPLETED|Overall Study||13||
48244923|NCT01955720|100917819|FG001|COMPLETED|Overall Study||13||
48244924|NCT01955720|100917820|FG002|COMPLETED|Overall Study||3||
48244925|NCT01955720|100917821|FG003|COMPLETED|Overall Study||3||
48244926|NCT01955720|100917822|FG004|COMPLETED|Overall Study||7||
48244927|NCT01955720|100917823|FG005|COMPLETED|Overall Study||7||
48244928|NCT01955720|100917818|FG000|NOT COMPLETED|Overall Study||0||
48244929|NCT01955720|100917819|FG001|NOT COMPLETED|Overall Study||0||
48244930|NCT01955720|100917820|FG002|NOT COMPLETED|Overall Study||0||
48244931|NCT01955720|100917821|FG003|NOT COMPLETED|Overall Study||0||
48244932|NCT01955720|100917822|FG004|NOT COMPLETED|Overall Study||0||
48244933|NCT01955720|100917823|FG005|NOT COMPLETED|Overall Study||0||
48244934|NCT01631825|100917824|FG000|STARTED|Overall Study||321||
48244935|NCT01631825|100917824|FG000|COMPLETED|Overall Study||256||
48244936|NCT01631825|100917824|FG000|NOT COMPLETED|Overall Study||65||
48244937|NCT01103271|100917825|FG000|STARTED|Overall Study||11||
48244938|NCT01103271|100917826|FG001|STARTED|Overall Study||9||
48244939|NCT01103271|100917825|FG000|COMPLETED|Overall Study||10||
48244940|NCT01103271|100917826|FG001|COMPLETED|Overall Study||5||
48244941|NCT01103271|100917825|FG000|NOT COMPLETED|Overall Study||1||
48244942|NCT01103271|100917826|FG001|NOT COMPLETED|Overall Study||4||
48244943|NCT05740371|100917827|FG000|STARTED|Overall Study||50||
48244944|NCT05740371|100917827|FG000|COMPLETED|Overall Study||49||
48244945|NCT05740371|100917827|FG000|NOT COMPLETED|Overall Study||1||
48244946|NCT01870999|100917828|FG000|STARTED|Overall Study||14||
48244947|NCT01870999|100917829|FG001|STARTED|Overall Study||16||
48244948|NCT01870999|100917830|FG002|STARTED|Overall Study||11||
48244949|NCT01870999|100917828|FG000|Safety Population; Received Study Drug|Overall Study||14||
48244950|NCT01870999|100917829|FG001|Safety Population; Received Study Drug|Overall Study||15||
48244951|NCT01870999|100917830|FG002|Safety Population; Received Study Drug|Overall Study||10||
48244952|NCT01870999|100917828|FG000|COMPLETED|Overall Study||10||
48244953|NCT01870999|100917829|FG001|COMPLETED|Overall Study||8||
48244954|NCT01870999|100917830|FG002|COMPLETED|Overall Study||4||
48244955|NCT01870999|100917828|FG000|NOT COMPLETED|Overall Study||4||
48244956|NCT01870999|100917829|FG001|NOT COMPLETED|Overall Study||8||
48244957|NCT01870999|100917830|FG002|NOT COMPLETED|Overall Study||7||
48244958|NCT02732899|100917831|FG000|STARTED|Overall Study||10||
48244959|NCT02732899|100917832|FG001|STARTED|Overall Study||10||
48244960|NCT02732899|100917831|FG000|COMPLETED|Overall Study||10||
48244961|NCT02732899|100917832|FG001|COMPLETED|Overall Study||10||
48244962|NCT02732899|100917831|FG000|NOT COMPLETED|Overall Study||0||
48244963|NCT02732899|100917832|FG001|NOT COMPLETED|Overall Study||0||
48244964|NCT01882088|100917833|FG000|STARTED|Overall Study||35||
48244965|NCT01882088|100917833|FG000|COMPLETED|Overall Study||30||
48540717|NCT00530218|101658169|FG000|COMPLETED|Overall Study||36||
48540718|NCT00530218|101658169|FG000|NOT COMPLETED|Overall Study||25||
48540719|NCT02462291|101662554|FG000|STARTED|Overall Study||82||
48540720|NCT02462291|101662555|FG001|STARTED|Overall Study||81||
48540721|NCT02462291|101662554|FG000|COMPLETED|Overall Study||77||
48540722|NCT02462291|101662555|FG001|COMPLETED|Overall Study||75||
48540723|NCT02462291|101662554|FG000|NOT COMPLETED|Overall Study||5||
48540724|NCT02462291|101662555|FG001|NOT COMPLETED|Overall Study||6||
48540725|NCT03196635|101662556|FG000|STARTED|Overall Study||31||
48540726|NCT03196635|101662556|FG000|COMPLETED|Overall Study||30||
48540727|NCT03196635|101662556|FG000|NOT COMPLETED|Overall Study||1||
48540728|NCT03490760|101662557|FG000|STARTED|Overall Study||9||
48681733|NCT00421148|102006456|FG017|NOT COMPLETED|Overall Study||2||
48681734|NCT00421148|102006457|FG018|NOT COMPLETED|Overall Study||1||
48681735|NCT00421148|102006458|FG019|NOT COMPLETED|Overall Study||0||
48681736|NCT03111316|102006459|FG000|STARTED|Overall Study||26||
48681737|NCT03111316|102006460|FG001|STARTED|Overall Study||24||
48681738|NCT03111316|102006461|FG002|STARTED|Overall Study||25||
48681739|NCT03111316|102006462|FG003|STARTED|Overall Study||25||
48681740|NCT03111316|102006459|FG000|COMPLETED|Overall Study||26||
48681741|NCT03111316|102006460|FG001|COMPLETED|Overall Study||24||
48681742|NCT03111316|102006461|FG002|COMPLETED|Overall Study||25||
48681743|NCT03111316|102006462|FG003|COMPLETED|Overall Study||25||
48681744|NCT03111316|102006459|FG000|NOT COMPLETED|Overall Study||0||
48681745|NCT03111316|102006460|FG001|NOT COMPLETED|Overall Study||0||
48681746|NCT03111316|102006461|FG002|NOT COMPLETED|Overall Study||0||
48244966|NCT01882088|100917833|FG000|NOT COMPLETED|Overall Study||5||
48244967|NCT02056873|100917834|FG000|STARTED|Continuous DBS||10||
48244968|NCT02056873|100917834|FG000|Qualify for Second Intervention at the End of First Intervention|Continuous DBS||10||
48244969|NCT02056873|100917834|FG000|COMPLETED|Continuous DBS||10||
48244970|NCT02056873|100917834|FG000|NOT COMPLETED|Continuous DBS||0||
48244971|NCT02056873|100917834|FG000|STARTED|Responsive DBS||8||
48244972|NCT02056873|100917834|FG000|COMPLETED|Responsive DBS||5||
48681747|NCT03111316|102006462|FG003|NOT COMPLETED|Overall Study||0||
48681748|NCT02213068|102006463|FG000|STARTED|Overall Study||9||
48681749|NCT02213068|102006464|FG001|STARTED|Overall Study||8||
48681750|NCT02213068|102006465|FG002|STARTED|Overall Study||10||
48681751|NCT02213068|102006463|FG000|COMPLETED|Overall Study||9||
48244973|NCT02056873|100917834|FG000|NOT COMPLETED|Responsive DBS||3||
48244974|NCT03912298|100917835|FG000|STARTED|Overall Study||7||
48244975|NCT03912298|100917835|FG000|COMPLETED|Overall Study||7||
48244976|NCT03912298|100917835|FG000|NOT COMPLETED|Overall Study||0||
48244977|NCT01951105|100917836|FG000|STARTED|Overall Study||11||
48244978|NCT01951105|100917837|FG001|STARTED|Overall Study||31||
48244979|NCT01951105|100917838|FG002|STARTED|Overall Study||30||
48244980|NCT01951105|100917836|FG000|Completed 12 Weeks Treatment|Overall Study||10||
48244981|NCT01951105|100917837|FG001|Completed 12 Weeks Treatment|Overall Study||24||
48244982|NCT01951105|100917838|FG002|Completed 12 Weeks Treatment|Overall Study||28||
48244983|NCT01951105|100917836|FG000|COMPLETED|Overall Study||10||
48244984|NCT01951105|100917837|FG001|COMPLETED|Overall Study||21||
48244985|NCT01951105|100917838|FG002|COMPLETED|Overall Study||28||
48681752|NCT02213068|102006464|FG001|COMPLETED|Overall Study||8||
48244986|NCT01951105|100917836|FG000|NOT COMPLETED|Overall Study||1||
48244987|NCT01951105|100917837|FG001|NOT COMPLETED|Overall Study||10||
48244988|NCT01951105|100917838|FG002|NOT COMPLETED|Overall Study||2||
48244989|NCT03154827|100917839|FG000|STARTED|Overall Study||1||
48244990|NCT03154827|100917839|FG000|COMPLETED|Overall Study||0||
48244991|NCT03154827|100917839|FG000|NOT COMPLETED|Overall Study||1||
48244992|NCT03816202|100917840|FG000|STARTED|Overall Study||100||
48244993|NCT03816202|100917840|FG000|COMPLETED|Overall Study||100||
48244994|NCT03816202|100917840|FG000|NOT COMPLETED|Overall Study||0||
48244995|NCT02811302|100917841|FG000|STARTED|Overall Study||1495||
48244996|NCT02811302|100917841|FG000|COMPLETED|Overall Study||1282||
48244997|NCT02811302|100917841|FG000|NOT COMPLETED|Overall Study||213||
48540729|NCT03490760|101662557|FG000|COMPLETED|Overall Study||7||
48540730|NCT03490760|101662557|FG000|NOT COMPLETED|Overall Study||2||
48540731|NCT02027428|101662558|FG000|STARTED|Induction||427||
48540732|NCT02027428|101662559|FG001|STARTED|Induction||0||
48244998|NCT00449033|100917842|FG000|STARTED|Treatment Period||452||
48244999|NCT00449033|100917843|FG001|STARTED|Treatment Period||452||
48245000|NCT00449033|100917842|FG000|Received Treatment|Treatment Period||452||
48245001|NCT00449033|100917843|FG001|Received Treatment|Treatment Period||449||
48245002|NCT00449033|100917842|FG000|COMPLETED|Treatment Period||0||
48245003|NCT00449033|100917843|FG001|COMPLETED|Treatment Period||0||
48681753|NCT02213068|102006465|FG002|COMPLETED|Overall Study||10||
48681754|NCT02213068|102006463|FG000|NOT COMPLETED|Overall Study||0||
48681755|NCT02213068|102006464|FG001|NOT COMPLETED|Overall Study||0||
48681756|NCT02213068|102006465|FG002|NOT COMPLETED|Overall Study||0||
48681757|NCT04581785|102006466|FG000|STARTED|Overall Study||2||
48681758|NCT04581785|102006467|FG001|STARTED|Overall Study||2||
48681759|NCT04581785|102006466|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2||
48681760|NCT04581785|102006467|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2||
48081870|NCT00752232|100521686|FG004|COMPLETED|Overall Study||3||
48081871|NCT00752232|100521687|FG005|COMPLETED|Overall Study||5||
48081872|NCT00752232|100521688|FG006|COMPLETED|Overall Study||4||
48081873|NCT00752232|100521682|FG000|NOT COMPLETED|Overall Study||2||
48245004|NCT00449033|100917842|FG000|NOT COMPLETED|Treatment Period||452||
48245005|NCT00449033|100917843|FG001|NOT COMPLETED|Treatment Period||452||
48245006|NCT00449033|100917842|FG000|STARTED|Follow-up Period||425||
48245007|NCT00449033|100917843|FG001|STARTED|Follow-up Period||434||
48245008|NCT00449033|100917842|FG000|COMPLETED|Follow-up Period||0||
48245009|NCT00449033|100917843|FG001|COMPLETED|Follow-up Period||0||
48245010|NCT00449033|100917842|FG000|NOT COMPLETED|Follow-up Period||425||
48245011|NCT00449033|100917843|FG001|NOT COMPLETED|Follow-up Period||434||
48245012|NCT02784535|100917844|FG000|STARTED|Overall Study||20||
48245013|NCT02784535|100917845|FG001|STARTED|Overall Study||20||
48245014|NCT02784535|100917844|FG000|COMPLETED|Overall Study||19||
48245015|NCT02784535|100917845|FG001|COMPLETED|Overall Study||18||
48245016|NCT02784535|100917844|FG000|NOT COMPLETED|Overall Study||1||
48081874|NCT00752232|100521683|FG001|NOT COMPLETED|Overall Study||0||
48081875|NCT00752232|100521684|FG002|NOT COMPLETED|Overall Study||1||
48081876|NCT00752232|100521685|FG003|NOT COMPLETED|Overall Study||1||
48081877|NCT00752232|100521686|FG004|NOT COMPLETED|Overall Study||3||
48081878|NCT00752232|100521687|FG005|NOT COMPLETED|Overall Study||1||
48081879|NCT00752232|100521688|FG006|NOT COMPLETED|Overall Study||0||
48081880|NCT02634320|100521689|FG000|STARTED|Overall Study||51||
48081881|NCT02634320|100521689|FG000|COMPLETED|Overall Study||35||
48081882|NCT02634320|100521689|FG000|NOT COMPLETED|Overall Study||16||
48081883|NCT02408315|100521690|FG000|STARTED|Overall Study||148||
48081884|NCT02408315|100521691|FG001|STARTED|Overall Study||152||
48081885|NCT02408315|100521690|FG000|COMPLETED|Overall Study||148||
48245017|NCT02784535|100917845|FG001|NOT COMPLETED|Overall Study||2||
48245018|NCT02854436|100917846|FG000|STARTED|Overall Study||289||
48245019|NCT02854436|100917846|FG000|Intent to Treat Participants (Breast Cancer Gene [BRCA] and Non-BRCA Participants)|Overall Study||223||
48245020|NCT02854436|100917846|FG000|COMPLETED|Overall Study||0||
48245021|NCT02854436|100917846|FG000|NOT COMPLETED|Overall Study||289||
48245022|NCT03169530|100917847|FG000|STARTED|Overall Study||15||
48081886|NCT02408315|100521691|FG001|COMPLETED|Overall Study||152||
48081887|NCT02408315|100521690|FG000|NOT COMPLETED|Overall Study||0||
48081888|NCT02408315|100521691|FG001|NOT COMPLETED|Overall Study||0||
48081889|NCT03143894|100521692|FG000|STARTED|First Intervention (5 Days)||3||
48081890|NCT03143894|100521693|FG001|STARTED|First Intervention (5 Days)||4||
48081891|NCT03143894|100521692|FG000|COMPLETED|First Intervention (5 Days)||3||
48081892|NCT03143894|100521693|FG001|COMPLETED|First Intervention (5 Days)||4||
48081893|NCT03143894|100521692|FG000|NOT COMPLETED|First Intervention (5 Days)||0||
48081894|NCT03143894|100521693|FG001|NOT COMPLETED|First Intervention (5 Days)||0||
48081895|NCT03143894|100521692|FG000|STARTED|Washout (4 Weeks)||3||
48081896|NCT03143894|100521693|FG001|STARTED|Washout (4 Weeks)||4||
48081897|NCT03143894|100521692|FG000|COMPLETED|Washout (4 Weeks)||3||
48245023|NCT03169530|100917848|FG001|STARTED|Overall Study||17||
48245024|NCT03169530|100917847|FG000|COMPLETED|Overall Study||0||
48245025|NCT03169530|100917848|FG001|COMPLETED|Overall Study||0||
48245026|NCT03169530|100917847|FG000|NOT COMPLETED|Overall Study||15||
48245027|NCT03169530|100917848|FG001|NOT COMPLETED|Overall Study||17||
48245028|NCT02101554|100917849|FG000|STARTED|Overall Study||6||
48245029|NCT02101554|100917850|FG001|STARTED|Overall Study||10||
48245030|NCT02101554|100917851|FG002|STARTED|Overall Study||3||
48245031|NCT02101554|100917849|FG000|COMPLETED|Overall Study||3||
48245032|NCT02101554|100917850|FG001|COMPLETED|Overall Study||5||
48245033|NCT02101554|100917851|FG002|COMPLETED|Overall Study||2||
48245034|NCT02101554|100917849|FG000|NOT COMPLETED|Overall Study||3||
48245035|NCT02101554|100917850|FG001|NOT COMPLETED|Overall Study||5||
48245036|NCT02101554|100917851|FG002|NOT COMPLETED|Overall Study||1||
48245037|NCT02946788|100917852|FG000|STARTED|Overall Study||8||
48245038|NCT02946788|100917853|FG001|STARTED|Overall Study||10||
48245039|NCT02946788|100917852|FG000|COMPLETED|Overall Study||8||
48245040|NCT02946788|100917853|FG001|COMPLETED|Overall Study||9||
48245041|NCT02946788|100917852|FG000|NOT COMPLETED|Overall Study||0||
48245042|NCT02946788|100917853|FG001|NOT COMPLETED|Overall Study||1||
48245043|NCT02065895|100917854|FG000|STARTED|Overall Study||1||
48245044|NCT02065895|100917855|FG001|STARTED|Overall Study||3||
48245045|NCT02065895|100917856|FG002|STARTED|Overall Study||1||
48245046|NCT02065895|100917857|FG003|STARTED|Overall Study||1||
48245047|NCT02065895|100917858|FG004|STARTED|Overall Study||1||
48245048|NCT02065895|100917859|FG005|STARTED|Overall Study||1||
48245049|NCT02065895|100917854|FG000|COMPLETED|Overall Study||0||
48245050|NCT02065895|100917855|FG001|COMPLETED|Overall Study||2||
48245051|NCT02065895|100917856|FG002|COMPLETED|Overall Study||1||
48245052|NCT02065895|100917857|FG003|COMPLETED|Overall Study||0||
48245053|NCT02065895|100917858|FG004|COMPLETED|Overall Study||1||
48245054|NCT02065895|100917859|FG005|COMPLETED|Overall Study||1||
48681761|NCT04581785|102006466|FG000|COMPLETED|Overall Study||2||
48081898|NCT03143894|100521693|FG001|COMPLETED|Washout (4 Weeks)||4||
48081899|NCT03143894|100521692|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
48081900|NCT03143894|100521693|FG001|NOT COMPLETED|Washout (4 Weeks)||0||
48081901|NCT03143894|100521692|FG000|STARTED|Second Intervention (5 Days)||3||
48081902|NCT03143894|100521693|FG001|STARTED|Second Intervention (5 Days)||4||
48081903|NCT03143894|100521692|FG000|COMPLETED|Second Intervention (5 Days)||3||
48081904|NCT03143894|100521693|FG001|COMPLETED|Second Intervention (5 Days)||3||
48081905|NCT03143894|100521692|FG000|NOT COMPLETED|Second Intervention (5 Days)||0||
48081906|NCT03143894|100521693|FG001|NOT COMPLETED|Second Intervention (5 Days)||1||
48081907|NCT00496054|100521694|FG000|STARTED|Overall Study||110||
48081908|NCT00496054|100521694|FG000|COMPLETED|Overall Study||102||
48081909|NCT00496054|100521694|FG000|NOT COMPLETED|Overall Study||8||
48081910|NCT03636061|100521695|FG000|STARTED|Overall Study||47||
48081911|NCT03636061|100521696|FG001|STARTED|Overall Study||48||
48081912|NCT03636061|100521697|FG002|STARTED|Overall Study||44||
48081913|NCT03636061|100521698|FG003|STARTED|Overall Study||43||
48081914|NCT03636061|100521695|FG000|COMPLETED|Overall Study||47||
48081915|NCT03636061|100521696|FG001|COMPLETED|Overall Study||46||
48081916|NCT03636061|100521697|FG002|COMPLETED|Overall Study||40||
48081917|NCT03636061|100521698|FG003|COMPLETED|Overall Study||43||
48081918|NCT03636061|100521695|FG000|NOT COMPLETED|Overall Study||0||
48081919|NCT03636061|100521696|FG001|NOT COMPLETED|Overall Study||2||
48081920|NCT03636061|100521697|FG002|NOT COMPLETED|Overall Study||4||
48081921|NCT03636061|100521698|FG003|NOT COMPLETED|Overall Study||0||
48081922|NCT04584645|100521699|FG000|STARTED|Overall Study||24570||
48081923|NCT04584645|100521700|FG001|STARTED|Overall Study||24568||
48081924|NCT04584645|100521699|FG000|COMPLETED|Overall Study||5575||
48081925|NCT04584645|100521700|FG001|COMPLETED|Overall Study||5662||
48081926|NCT04584645|100521699|FG000|NOT COMPLETED|Overall Study||18995||
48081927|NCT04584645|100521700|FG001|NOT COMPLETED|Overall Study||18906||
48081928|NCT02820753|100521701|FG000|STARTED|Baseline||256||
48081929|NCT02820753|100521702|FG001|STARTED|Baseline||421||
48081930|NCT02820753|100521701|FG000|COMPLETED|Baseline||256||
48081931|NCT02820753|100521702|FG001|COMPLETED|Baseline||421||
48081932|NCT02820753|100521701|FG000|NOT COMPLETED|Baseline||0||
48081933|NCT02820753|100521702|FG001|NOT COMPLETED|Baseline||0||
48081934|NCT02820753|100521701|FG000|STARTED|2 Month||256||
48081935|NCT02820753|100521702|FG001|STARTED|2 Month||421||
48245055|NCT02065895|100917854|FG000|NOT COMPLETED|Overall Study||1||
48245056|NCT02065895|100917855|FG001|NOT COMPLETED|Overall Study||1||
48245057|NCT02065895|100917856|FG002|NOT COMPLETED|Overall Study||0||
48245058|NCT02065895|100917857|FG003|NOT COMPLETED|Overall Study||1||
48245059|NCT02065895|100917858|FG004|NOT COMPLETED|Overall Study||0||
48245060|NCT02065895|100917859|FG005|NOT COMPLETED|Overall Study||0||
48245061|NCT01745380|100917860|FG000|STARTED|Overall Study||100||
48245062|NCT01745380|100917861|FG001|STARTED|Overall Study||50||
48245063|NCT01745380|100917860|FG000|COMPLETED|Overall Study||99||
48245064|NCT01745380|100917861|FG001|COMPLETED|Overall Study||49||
48245065|NCT01745380|100917860|FG000|NOT COMPLETED|Overall Study||1||
48245066|NCT01745380|100917861|FG001|NOT COMPLETED|Overall Study||1||
48245067|NCT03939793|100917862|FG000|STARTED|Overall Study||50||
48245068|NCT03939793|100917863|FG001|STARTED|Overall Study||50||
48245069|NCT03939793|100917864|FG002|STARTED|Overall Study||50||
48245070|NCT03939793|100917862|FG000|COMPLETED|Overall Study||40||
48245071|NCT03939793|100917863|FG001|COMPLETED|Overall Study||34||
48245072|NCT03939793|100917864|FG002|COMPLETED|Overall Study||28||
48245073|NCT03939793|100917862|FG000|NOT COMPLETED|Overall Study||10||
48245074|NCT03939793|100917863|FG001|NOT COMPLETED|Overall Study||16||
48245075|NCT03939793|100917864|FG002|NOT COMPLETED|Overall Study||22||
48245076|NCT01838499|100917865|FG000|STARTED|Overall Study||55||
48245077|NCT01838499|100917866|FG001|STARTED|Overall Study||54||
48245078|NCT01838499|100917865|FG000|COMPLETED|Overall Study||31||
48245079|NCT01838499|100917866|FG001|COMPLETED|Overall Study||37||
48245080|NCT01838499|100917865|FG000|NOT COMPLETED|Overall Study||24||
48245081|NCT01838499|100917866|FG001|NOT COMPLETED|Overall Study||17||
48245082|NCT03048058|100917867|FG000|STARTED|Overall Study||10||
48245083|NCT03048058|100917868|FG001|STARTED|Overall Study||10||
48245084|NCT03048058|100917867|FG000|COMPLETED|Overall Study||6||
48081936|NCT02820753|100521701|FG000|COMPLETED|2 Month||178||
48081937|NCT02820753|100521702|FG001|COMPLETED|2 Month||379||
48081938|NCT02820753|100521701|FG000|NOT COMPLETED|2 Month||78||
48081939|NCT02820753|100521702|FG001|NOT COMPLETED|2 Month||42||
48081940|NCT02820753|100521701|FG000|STARTED|6 Month||253||
48081941|NCT02820753|100521702|FG001|STARTED|6 Month||418||
48245085|NCT03048058|100917868|FG001|COMPLETED|Overall Study||6||
48245086|NCT03048058|100917867|FG000|NOT COMPLETED|Overall Study||4||
48081942|NCT02820753|100521701|FG000|COMPLETED|6 Month||150||
48245087|NCT03048058|100917868|FG001|NOT COMPLETED|Overall Study||4||
48245088|NCT00665392|100917869|FG000|STARTED|Overall Study||42||
48081943|NCT02820753|100521702|FG001|COMPLETED|6 Month||307||
48081944|NCT02820753|100521701|FG000|NOT COMPLETED|6 Month||103||
48081945|NCT02820753|100521702|FG001|NOT COMPLETED|6 Month||111||
48245089|NCT00665392|100917869|FG000|COMPLETED|Overall Study||41||
48245090|NCT00665392|100917869|FG000|NOT COMPLETED|Overall Study||1||
48245091|NCT01190228|100917870|FG000|STARTED|Overall Study||349||
48245092|NCT01190228|100917871|FG001|STARTED|Overall Study||46||
48081946|NCT01780636|100521703|FG000|STARTED|Overall Study||7||
48081947|NCT01780636|100521703|FG000|COMPLETED|Overall Study||7||
48081948|NCT01780636|100521703|FG000|NOT COMPLETED|Overall Study||0||
48081949|NCT03695250|100521704|FG000|STARTED|Overall Study||8||
48081950|NCT03695250|100521704|FG000|COMPLETED|Overall Study||8||
48081951|NCT03695250|100521704|FG000|NOT COMPLETED|Overall Study||0||
48081952|NCT00840450|100521705|FG000|STARTED|Overall Study||12||
48081953|NCT00840450|100521705|FG000|COMPLETED|Overall Study||9||
48081954|NCT00840450|100521705|FG000|NOT COMPLETED|Overall Study||3||
48081955|NCT00160693|100521706|FG000|STARTED|Overall Study||402||
48081956|NCT00160693|100521706|FG000|COMPLETED|Overall Study||167||
48081957|NCT00160693|100521706|FG000|NOT COMPLETED|Overall Study||235||
48081958|NCT00801632|100521707|FG000|STARTED|Overall Study||5||
48081959|NCT00801632|100521707|FG000|COMPLETED|Overall Study||4||
48081960|NCT00801632|100521707|FG000|NOT COMPLETED|Overall Study||1||
48081961|NCT01691781|100521708|FG000|STARTED|Overall Study||19||
48081962|NCT01691781|100521709|FG001|STARTED|Overall Study||22||
48081963|NCT01691781|100521708|FG000|COMPLETED|Overall Study||12||
48081964|NCT01691781|100521709|FG001|COMPLETED|Overall Study||15||
48081965|NCT01691781|100521708|FG000|NOT COMPLETED|Overall Study||7||
48081966|NCT01691781|100521709|FG001|NOT COMPLETED|Overall Study||7||
48081967|NCT02944968|100521710|FG000|STARTED|Overall Study||51|Enrolled subjects (under protocol v1.0 and v2.0).|
48245093|NCT01190228|100917872|FG002|STARTED|Overall Study||59||
48245094|NCT01190228|100917870|FG000|COMPLETED|Overall Study||344||
48081968|NCT02944968|100521710|FG000|COMPLETED|Overall Study||48|Evaluable subjects (under protocol v1.0 and v2.0) who completed the study.|
48081969|NCT02944968|100521710|FG000|NOT COMPLETED|Overall Study||3||
48081970|NCT01830972|100521711|FG000|STARTED|Part I||46||
48081971|NCT01830972|100521712|FG001|STARTED|Part I||0||
48081972|NCT01830972|100521711|FG000|COMPLETED|Part I||46||
48081973|NCT01830972|100521712|FG001|COMPLETED|Part I||0||
48081974|NCT01830972|100521711|FG000|NOT COMPLETED|Part I||0||
48081975|NCT01830972|100521712|FG001|NOT COMPLETED|Part I||0||
48081976|NCT01830972|100521711|FG000|STARTED|Part II||46||
48081977|NCT01830972|100521712|FG001|STARTED|Part II||13||
48081978|NCT01830972|100521711|FG000|COMPLETED|Part II||44||
48081979|NCT01830972|100521712|FG001|COMPLETED|Part II||11||
48081980|NCT01830972|100521711|FG000|NOT COMPLETED|Part II||2||
48081981|NCT01830972|100521712|FG001|NOT COMPLETED|Part II||2||
48081982|NCT01830972|100521711|FG000|STARTED|Part III||44||
48081983|NCT01830972|100521712|FG001|STARTED|Part III||11||
48081984|NCT01830972|100521711|FG000|COMPLETED|Part III||42||
48081985|NCT01830972|100521712|FG001|COMPLETED|Part III||11||
48081986|NCT01830972|100521711|FG000|NOT COMPLETED|Part III||2||
48081987|NCT01830972|100521712|FG001|NOT COMPLETED|Part III||0||
48081988|NCT01830972|100521711|FG000|STARTED|Part IV||42||
48081989|NCT01830972|100521712|FG001|STARTED|Part IV||11||
48081990|NCT01830972|100521711|FG000|COMPLETED|Part IV||39||
48081991|NCT01830972|100521712|FG001|COMPLETED|Part IV||10||
48081992|NCT01830972|100521711|FG000|NOT COMPLETED|Part IV||3||
48081993|NCT01830972|100521712|FG001|NOT COMPLETED|Part IV||1||
48081994|NCT02071914|100521713|FG000|STARTED|Overall Study||27||
48081995|NCT02071914|100521714|FG001|STARTED|Overall Study||27||
48081996|NCT02071914|100521715|FG002|STARTED|Overall Study||27||
48081997|NCT02071914|100521713|FG000|COMPLETED|Overall Study||27||
48081998|NCT02071914|100521714|FG001|COMPLETED|Overall Study||27||
48081999|NCT02071914|100521715|FG002|COMPLETED|Overall Study||27||
48082000|NCT02071914|100521713|FG000|NOT COMPLETED|Overall Study||0||
48082001|NCT02071914|100521714|FG001|NOT COMPLETED|Overall Study||0||
48082002|NCT02071914|100521715|FG002|NOT COMPLETED|Overall Study||0||
48082003|NCT02340975|100521716|FG000|STARTED|Overall Study||6||
48082004|NCT02340975|100521717|FG001|STARTED|Overall Study||27||
48082005|NCT02340975|100521718|FG002|STARTED|Overall Study||24||
48082006|NCT02340975|100521719|FG003|STARTED|Overall Study||12||
48082007|NCT02340975|100521720|FG004|STARTED|Overall Study||25||
48082008|NCT02340975|100521721|FG005|STARTED|Overall Study||19||
48082009|NCT02340975|100521716|FG000|COMPLETED|Overall Study||0||
48082010|NCT02340975|100521717|FG001|COMPLETED|Overall Study||0||
48082011|NCT02340975|100521718|FG002|COMPLETED|Overall Study||0||
48082012|NCT02340975|100521719|FG003|COMPLETED|Overall Study||0||
48082013|NCT02340975|100521720|FG004|COMPLETED|Overall Study||0||
48082014|NCT02340975|100521721|FG005|COMPLETED|Overall Study||0||
48082015|NCT02340975|100521716|FG000|NOT COMPLETED|Overall Study||6||
48082016|NCT02340975|100521717|FG001|NOT COMPLETED|Overall Study||27||
48082017|NCT02340975|100521718|FG002|NOT COMPLETED|Overall Study||24||
48082018|NCT02340975|100521719|FG003|NOT COMPLETED|Overall Study||12||
48245095|NCT01190228|100917871|FG001|COMPLETED|Overall Study||46||
48082019|NCT02340975|100521720|FG004|NOT COMPLETED|Overall Study||25||
48082020|NCT02340975|100521721|FG005|NOT COMPLETED|Overall Study||19||
48082021|NCT01804465|100521722|FG000|STARTED|Overall Study||24||
48082022|NCT01804465|100521723|FG001|STARTED|Overall Study||26||
48082023|NCT01804465|100521722|FG000|COMPLETED|Overall Study||24||
48082024|NCT01804465|100521723|FG001|COMPLETED|Overall Study||26||
48082025|NCT01804465|100521722|FG000|NOT COMPLETED|Overall Study||0||
48082026|NCT01804465|100521723|FG001|NOT COMPLETED|Overall Study||0||
48082027|NCT03428360|100521724|FG000|STARTED|Overall Study||130||
48082028|NCT03428360|100521724|FG000|COMPLETED|Overall Study||90||
48245096|NCT01190228|100917872|FG002|COMPLETED|Overall Study||59||
48245097|NCT01190228|100917870|FG000|NOT COMPLETED|Overall Study||5||
48245098|NCT01190228|100917871|FG001|NOT COMPLETED|Overall Study||0||
48245099|NCT01190228|100917872|FG002|NOT COMPLETED|Overall Study||0||
48082029|NCT03428360|100521724|FG000|NOT COMPLETED|Overall Study||40||
48082030|NCT01206660|100521725|FG000|STARTED|Overall Study||60||
48082031|NCT01206660|100521726|FG001|STARTED|Overall Study||60||
48082032|NCT01206660|100521725|FG000|COMPLETED|Overall Study||60||
48082033|NCT01206660|100521726|FG001|COMPLETED|Overall Study||60||
48082034|NCT01206660|100521725|FG000|NOT COMPLETED|Overall Study||0||
48082035|NCT01206660|100521726|FG001|NOT COMPLETED|Overall Study||0||
48082036|NCT03844646|100521727|FG000|STARTED|Overall Study||8||
48082037|NCT03844646|100521728|FG001|STARTED|Overall Study||4||
48082038|NCT03844646|100521727|FG000|COMPLETED|Overall Study||8||
48082039|NCT03844646|100521728|FG001|COMPLETED|Overall Study||4||
48082040|NCT03844646|100521727|FG000|NOT COMPLETED|Overall Study||0||
48082041|NCT03844646|100521728|FG001|NOT COMPLETED|Overall Study||0||
48082042|NCT03310021|100521729|FG000|STARTED|Overall Study||6||
48082043|NCT03310021|100521730|FG001|STARTED|Overall Study||3||
48082044|NCT03310021|100521731|FG002|STARTED|Overall Study||6||
48082045|NCT03310021|100521732|FG003|STARTED|Overall Study||3||
48082046|NCT03310021|100521733|FG004|STARTED|Overall Study||8||
48082047|NCT03310021|100521734|FG005|STARTED|Overall Study||4||
48082048|NCT03310021|100521735|FG006|STARTED|Overall Study||8||
48082049|NCT03310021|100521736|FG007|STARTED|Overall Study||4||
48082050|NCT03310021|100521737|FG008|STARTED|Overall Study||6||
48082051|NCT03310021|100521738|FG009|STARTED|Overall Study||3||
48082052|NCT03310021|100521739|FG010|STARTED|Overall Study||6||
48082053|NCT03310021|100521740|FG011|STARTED|Overall Study||3||
48082054|NCT03310021|100521741|FG012|STARTED|Overall Study||8||
48082055|NCT03310021|100521742|FG013|STARTED|Overall Study||4||
48082056|NCT03310021|100521743|FG014|STARTED|Overall Study||6||
48082057|NCT03310021|100521744|FG015|STARTED|Overall Study||3||
48082058|NCT03310021|100521745|FG016|STARTED|Overall Study||10||
48082059|NCT03310021|100521746|FG017|STARTED|Overall Study||5||
48082060|NCT03310021|100521747|FG018|STARTED|Overall Study||8||
48082061|NCT03310021|100521748|FG019|STARTED|Overall Study||3||
48082062|NCT03310021|100521729|FG000|COMPLETED|Overall Study||6||
48082063|NCT03310021|100521730|FG001|COMPLETED|Overall Study||3||
48082064|NCT03310021|100521731|FG002|COMPLETED|Overall Study||6||
48082065|NCT03310021|100521732|FG003|COMPLETED|Overall Study||3||
48082066|NCT03310021|100521733|FG004|COMPLETED|Overall Study||8||
48082067|NCT03310021|100521734|FG005|COMPLETED|Overall Study||4||
48082068|NCT03310021|100521735|FG006|COMPLETED|Overall Study||7||
48082069|NCT03310021|100521736|FG007|COMPLETED|Overall Study||4||
48082070|NCT03310021|100521737|FG008|COMPLETED|Overall Study||6||
48082071|NCT03310021|100521738|FG009|COMPLETED|Overall Study||3||
48082072|NCT03310021|100521739|FG010|COMPLETED|Overall Study||5||
48245100|NCT02794428|100917873|FG000|STARTED|6 Months (Primary End Point)||45||
48245101|NCT02794428|100917874|FG001|STARTED|6 Months (Primary End Point)||46||
48540733|NCT02027428|101662560|FG002|STARTED|Induction||0||
48082073|NCT03310021|100521740|FG011|COMPLETED|Overall Study||3||
48082074|NCT03310021|100521741|FG012|COMPLETED|Overall Study||8||
48082075|NCT03310021|100521742|FG013|COMPLETED|Overall Study||4||
48082076|NCT03310021|100521743|FG014|COMPLETED|Overall Study||6||
48082077|NCT03310021|100521744|FG015|COMPLETED|Overall Study||3||
48082078|NCT03310021|100521745|FG016|COMPLETED|Overall Study||10||
48082079|NCT03310021|100521746|FG017|COMPLETED|Overall Study||5||
48082080|NCT03310021|100521747|FG018|COMPLETED|Overall Study||8||
48082081|NCT03310021|100521748|FG019|COMPLETED|Overall Study||3||
48082082|NCT03310021|100521729|FG000|NOT COMPLETED|Overall Study||0||
48082083|NCT03310021|100521730|FG001|NOT COMPLETED|Overall Study||0||
48082084|NCT03310021|100521731|FG002|NOT COMPLETED|Overall Study||0||
48082085|NCT03310021|100521732|FG003|NOT COMPLETED|Overall Study||0||
48082086|NCT03310021|100521733|FG004|NOT COMPLETED|Overall Study||0||
48082087|NCT03310021|100521734|FG005|NOT COMPLETED|Overall Study||0||
48245102|NCT02794428|100917873|FG000|COMPLETED|6 Months (Primary End Point)||36||
48082088|NCT03310021|100521735|FG006|NOT COMPLETED|Overall Study||1||
48245103|NCT02794428|100917874|FG001|COMPLETED|6 Months (Primary End Point)||42||
48082089|NCT03310021|100521736|FG007|NOT COMPLETED|Overall Study||0||
48082090|NCT03310021|100521737|FG008|NOT COMPLETED|Overall Study||0||
48082091|NCT03310021|100521738|FG009|NOT COMPLETED|Overall Study||0||
48082092|NCT03310021|100521739|FG010|NOT COMPLETED|Overall Study||1||
48082093|NCT03310021|100521740|FG011|NOT COMPLETED|Overall Study||0||
48082094|NCT03310021|100521741|FG012|NOT COMPLETED|Overall Study||0||
48082095|NCT03310021|100521742|FG013|NOT COMPLETED|Overall Study||0||
48082096|NCT03310021|100521743|FG014|NOT COMPLETED|Overall Study||0||
48082097|NCT03310021|100521744|FG015|NOT COMPLETED|Overall Study||0||
48245104|NCT02794428|100917873|FG000|NOT COMPLETED|6 Months (Primary End Point)||9||
48245105|NCT02794428|100917874|FG001|NOT COMPLETED|6 Months (Primary End Point)||4||
48245106|NCT02794428|100917873|FG000|STARTED|18 Months (Secondary Endpoint)||36||
48245107|NCT02794428|100917874|FG001|STARTED|18 Months (Secondary Endpoint)||42||
48245108|NCT02794428|100917873|FG000|COMPLETED|18 Months (Secondary Endpoint)||31||
48245109|NCT02794428|100917874|FG001|COMPLETED|18 Months (Secondary Endpoint)||38||
48245110|NCT02794428|100917873|FG000|NOT COMPLETED|18 Months (Secondary Endpoint)||5||
48245111|NCT02794428|100917874|FG001|NOT COMPLETED|18 Months (Secondary Endpoint)||4||
48245112|NCT02794428|100917873|FG000|STARTED|24 Months (End of Study)||31||
48245113|NCT02794428|100917874|FG001|STARTED|24 Months (End of Study)||38||
48245114|NCT02794428|100917873|FG000|COMPLETED|24 Months (End of Study)||26||
48245115|NCT02794428|100917874|FG001|COMPLETED|24 Months (End of Study)||29||
48245116|NCT02794428|100917873|FG000|NOT COMPLETED|24 Months (End of Study)||5||
48245117|NCT02794428|100917874|FG001|NOT COMPLETED|24 Months (End of Study)||9||
48245118|NCT01767636|100917875|FG000|STARTED|Overall Study||38||
48245119|NCT01767636|100917875|FG000|COMPLETED|Overall Study||35||
48245120|NCT01767636|100917875|FG000|NOT COMPLETED|Overall Study||3||
48245121|NCT01357564|100917876|FG000|STARTED|Short-term (4-month) Follow up||154||
48245122|NCT01357564|100917877|FG001|STARTED|Short-term (4-month) Follow up||168||
48245123|NCT01357564|100917876|FG000|COMPLETED|Short-term (4-month) Follow up||106||
48245124|NCT01357564|100917877|FG001|COMPLETED|Short-term (4-month) Follow up||118||
48245125|NCT01357564|100917876|FG000|NOT COMPLETED|Short-term (4-month) Follow up||48||
48245126|NCT01357564|100917877|FG001|NOT COMPLETED|Short-term (4-month) Follow up||50||
48245127|NCT01357564|100917876|FG000|STARTED|Long-term (8-month) Follow-up||106||
48245128|NCT01357564|100917877|FG001|STARTED|Long-term (8-month) Follow-up||118||
48245129|NCT01357564|100917876|FG000|COMPLETED|Long-term (8-month) Follow-up||104||
48245130|NCT01357564|100917877|FG001|COMPLETED|Long-term (8-month) Follow-up||102||
48245131|NCT01357564|100917876|FG000|NOT COMPLETED|Long-term (8-month) Follow-up||2||
48245132|NCT01357564|100917877|FG001|NOT COMPLETED|Long-term (8-month) Follow-up||16||
48245133|NCT03624023|100917878|FG000|STARTED|Overall Study||10||
48245134|NCT03624023|100917878|FG000|COMPLETED|Overall Study||6||
48245135|NCT03624023|100917878|FG000|NOT COMPLETED|Overall Study||4||
48245136|NCT04371471|100917879|FG000|STARTED|Overall Study||91||
48245137|NCT04371471|100917879|FG000|COMPLETED|Overall Study||81||
48245138|NCT04371471|100917879|FG000|NOT COMPLETED|Overall Study||10||
48245139|NCT03997409|100917880|FG000|STARTED|Overall Study||14||
48245140|NCT03997409|100917881|FG001|STARTED|Overall Study||13||
48245141|NCT03997409|100917882|FG002|STARTED|Overall Study||12||
48082098|NCT03310021|100521745|FG016|NOT COMPLETED|Overall Study||0||
48082099|NCT03310021|100521746|FG017|NOT COMPLETED|Overall Study||0||
48082100|NCT03310021|100521747|FG018|NOT COMPLETED|Overall Study||0||
48082101|NCT03310021|100521748|FG019|NOT COMPLETED|Overall Study||0||
48082102|NCT02848651|100521749|FG000|STARTED|Overall Study||153||
48082103|NCT02848651|100521749|FG000|Received Treatment|Overall Study||152||
48245142|NCT03997409|100917880|FG000|COMPLETED|Overall Study||10||
48245143|NCT03997409|100917881|FG001|COMPLETED|Overall Study||12||
48245144|NCT03997409|100917882|FG002|COMPLETED|Overall Study||11||
48245145|NCT03997409|100917880|FG000|NOT COMPLETED|Overall Study||4||
48245146|NCT03997409|100917881|FG001|NOT COMPLETED|Overall Study||1||
48245147|NCT03997409|100917882|FG002|NOT COMPLETED|Overall Study||1||
48245148|NCT01527500|100917883|FG000|STARTED|Part A||99||
48245149|NCT01527500|100917884|FG001|STARTED|Part A||51||
48245150|NCT01527500|100917883|FG000|COMPLETED|Part A||69||
48245151|NCT01527500|100917884|FG001|COMPLETED|Part A||38||
48245152|NCT01527500|100917883|FG000|NOT COMPLETED|Part A||30||
48245153|NCT01527500|100917884|FG001|NOT COMPLETED|Part A||13||
48245154|NCT01527500|100917883|FG000|STARTED|Part B||7||
48245155|NCT01527500|100917884|FG001|STARTED|Part B||1||
48245156|NCT01527500|100917883|FG000|COMPLETED|Part B||6||
48082104|NCT02848651|100521749|FG000|COMPLETED|Overall Study||47||
48082105|NCT02848651|100521749|FG000|NOT COMPLETED|Overall Study||106||
48082106|NCT00576927|100521750|FG000|STARTED|Clinical Assessment||79||
48082107|NCT00576927|100521750|FG000|COMPLETED|Clinical Assessment||43||
48082108|NCT00576927|100521750|FG000|NOT COMPLETED|Clinical Assessment||36||
48245157|NCT01527500|100917884|FG001|COMPLETED|Part B||1||
48245158|NCT01527500|100917883|FG000|NOT COMPLETED|Part B||1||
48245159|NCT01527500|100917884|FG001|NOT COMPLETED|Part B||0||
48245160|NCT00946088|100917885|FG000|STARTED|Overall Study||4||
48082109|NCT00576927|100521750|FG000|STARTED|Baseline||43||
48082110|NCT00576927|100521750|FG000|COMPLETED|Baseline||30||
48082111|NCT00576927|100521750|FG000|NOT COMPLETED|Baseline||13||
48245161|NCT00946088|100917886|FG001|STARTED|Overall Study||3||
48245162|NCT00946088|100917885|FG000|COMPLETED|Overall Study||4||
48245163|NCT00946088|100917886|FG001|COMPLETED|Overall Study||2||
48245164|NCT00946088|100917885|FG000|NOT COMPLETED|Overall Study||0||
48245165|NCT00946088|100917886|FG001|NOT COMPLETED|Overall Study||1||
48245166|NCT01503515|100917887|FG000|STARTED|Overall Study||145||
48681762|NCT04581785|102006467|FG001|COMPLETED|Overall Study||2||
48681763|NCT04581785|102006466|FG000|NOT COMPLETED|Overall Study||0||
48681764|NCT04581785|102006467|FG001|NOT COMPLETED|Overall Study||0||
48681765|NCT01103440|102006468|FG000|STARTED|Overall Study||18||
48681766|NCT01103440|102006469|FG001|STARTED|Overall Study||18||
48681767|NCT01103440|102006468|FG000|COMPLETED|Overall Study||18||
48681768|NCT01103440|102006469|FG001|COMPLETED|Overall Study||18||
48681769|NCT01103440|102006468|FG000|NOT COMPLETED|Overall Study||0||
48681770|NCT01103440|102006469|FG001|NOT COMPLETED|Overall Study||0||
48681771|NCT00700622|102006470|FG000|STARTED|Overall Study||65||
48681772|NCT00700622|102006471|FG001|STARTED|Overall Study||65||
48681773|NCT00700622|102006470|FG000|COMPLETED|Overall Study||52||
48681774|NCT00700622|102006471|FG001|COMPLETED|Overall Study||60||
48245167|NCT01503515|100917888|FG001|STARTED|Overall Study||147||
48245168|NCT01503515|100917887|FG000|COMPLETED|Overall Study||124||
48245169|NCT01503515|100917888|FG001|COMPLETED|Overall Study||112||
48245170|NCT01503515|100917887|FG000|NOT COMPLETED|Overall Study||21||
48245171|NCT01503515|100917888|FG001|NOT COMPLETED|Overall Study||35||
48245172|NCT03015961|100917889|FG000|STARTED|Overall Study||18||
48245173|NCT03015961|100917890|FG001|STARTED|Overall Study||20||
48245174|NCT03015961|100917889|FG000|COMPLETED|Overall Study||18||
48245175|NCT03015961|100917890|FG001|COMPLETED|Overall Study||18||
48245176|NCT03015961|100917889|FG000|NOT COMPLETED|Overall Study||0||
48245177|NCT03015961|100917890|FG001|NOT COMPLETED|Overall Study||2||
48245178|NCT05066230|100917891|FG000|STARTED|Primary Study (Through Week 48)||128||
48245179|NCT05066230|100917892|FG001|STARTED|Primary Study (Through Week 48)||125||
48245180|NCT05066230|100917891|FG000|COMPLETED|Primary Study (Through Week 48)||120|Completed is defined as those who completed study through Week 48.|
48245181|NCT05066230|100917892|FG001|COMPLETED|Primary Study (Through Week 48)||115|Completed is defined as those who completed study through Week 48.|
48245182|NCT05066230|100917891|FG000|NOT COMPLETED|Primary Study (Through Week 48)||8||
48245183|NCT05066230|100917892|FG001|NOT COMPLETED|Primary Study (Through Week 48)||10||
48245184|NCT05066230|100917891|FG000|STARTED|After Week 48||120||
48245185|NCT05066230|100917892|FG001|STARTED|After Week 48||115||
48245186|NCT05066230|100917891|FG000|COMPLETED|After Week 48||0|The study was discontinued by the Sponsor after all patients completed the primary endpoint assessment at Week 48.|
48245187|NCT05066230|100917892|FG001|COMPLETED|After Week 48||0|The study was discontinued by the Sponsor after all patients completed the primary endpoint assessment at Week 48.|
48245188|NCT05066230|100917891|FG000|NOT COMPLETED|After Week 48||120||
48245189|NCT05066230|100917892|FG001|NOT COMPLETED|After Week 48||115||
48245190|NCT02542293|100917893|FG000|STARTED|Overall Study||474|Randomized in overall study|
48245191|NCT02542293|100917894|FG001|STARTED|Overall Study||479|Randomized in overall study|
48245192|NCT02542293|100917893|FG000|Randomized in Global Cohort|Overall Study||410||
48245193|NCT02542293|100917894|FG001|Randomized in Global Cohort|Overall Study||413||
48245194|NCT02542293|100917893|FG000|Received Treatment in Global Cohort|Overall Study||410||
48245195|NCT02542293|100917894|FG001|Received Treatment in Global Cohort|Overall Study||399||
48245196|NCT02542293|100917893|FG000|Randomized in China Cohort|Overall Study||78||
48245197|NCT02542293|100917894|FG001|Randomized in China Cohort|Overall Study||82||
48245198|NCT02542293|100917893|FG000|Received Treatment in China Cohort|Overall Study||77||
48245199|NCT02542293|100917894|FG001|Received Treatment in China Cohort|Overall Study||78||
48245200|NCT02542293|100917893|FG000|Included in Both Cohorts (Global and China)|Overall Study||14||
48245201|NCT02542293|100917894|FG001|Included in Both Cohorts (Global and China)|Overall Study||16||
48245202|NCT02542293|100917893|FG000|Ongoing in Study at DCO for Final Analysis in Global Cohort|Overall Study||75||
48245203|NCT02542293|100917894|FG001|Ongoing in Study at DCO for Final Analysis in Global Cohort|Overall Study||67||
48245204|NCT02542293|100917893|FG000|Ongoing in Study at DCO for Final Analysis in China Cohort|Overall Study||27||
48245205|NCT02542293|100917894|FG001|Ongoing in Study at DCO for Final Analysis in China Cohort|Overall Study||18||
48245206|NCT02542293|100917893|FG000|COMPLETED|Overall Study||99|Ongoing in overall study at DCO for final analysis.|
48245207|NCT02542293|100917894|FG001|COMPLETED|Overall Study||83|Ongoing in overall study at DCO for final analysis.|
48245208|NCT02542293|100917893|FG000|NOT COMPLETED|Overall Study||375||
48245209|NCT02542293|100917894|FG001|NOT COMPLETED|Overall Study||396||
48245210|NCT04890158|100917895|FG000|STARTED|Overall Study||1||
48245211|NCT04890158|100917896|FG001|STARTED|Overall Study||0||
48245212|NCT04890158|100917895|FG000|COMPLETED|Overall Study||1||
48245213|NCT04890158|100917896|FG001|COMPLETED|Overall Study||0||
48245214|NCT04890158|100917895|FG000|NOT COMPLETED|Overall Study||0||
48245215|NCT04890158|100917896|FG001|NOT COMPLETED|Overall Study||0||
48245216|NCT04288778|100917897|FG000|STARTED|Overall Study||276||
48245217|NCT04288778|100917897|FG000|Treated|Overall Study||274||
48245218|NCT04288778|100917897|FG000|COMPLETED|Overall Study||265||
48245219|NCT04288778|100917897|FG000|NOT COMPLETED|Overall Study||11||
48245220|NCT02625922|100917898|FG000|STARTED|Overall Study||14||
48245221|NCT02625922|100917899|FG001|STARTED|Overall Study||12||
48245222|NCT02625922|100917898|FG000|Completed Treatment Period 1|Overall Study||12||
48245223|NCT02625922|100917899|FG001|Completed Treatment Period 1|Overall Study||10||
48245224|NCT02625922|100917898|FG000|Completed Treatment Period 2|Overall Study||11||
48681775|NCT00700622|102006470|FG000|NOT COMPLETED|Overall Study||13||
48681776|NCT00700622|102006471|FG001|NOT COMPLETED|Overall Study||5||
48681777|NCT00441766|102006472|FG000|STARTED|Overall Study||53||
48681778|NCT00441766|102006473|FG001|STARTED|Overall Study||53||
48681779|NCT00441766|102006474|FG002|STARTED|Overall Study||53||
48681780|NCT00441766|102006475|FG003|STARTED|Overall Study||54||
48681781|NCT00441766|102006472|FG000|COMPLETED|Overall Study||39||
48681782|NCT00441766|102006473|FG001|COMPLETED|Overall Study||46||
48681783|NCT00441766|102006474|FG002|COMPLETED|Overall Study||44||
48681784|NCT00441766|102006475|FG003|COMPLETED|Overall Study||48||
48681785|NCT00441766|102006472|FG000|NOT COMPLETED|Overall Study||14||
48681786|NCT00441766|102006473|FG001|NOT COMPLETED|Overall Study||7||
48681787|NCT00441766|102006474|FG002|NOT COMPLETED|Overall Study||9||
48681788|NCT00441766|102006475|FG003|NOT COMPLETED|Overall Study||6||
48681789|NCT04201639|102006476|FG000|STARTED|Overall Study||32||
48681790|NCT04201639|102006476|FG000|COMPLETED|Overall Study||32||
48681791|NCT04201639|102006476|FG000|NOT COMPLETED|Overall Study||0||
48681792|NCT02848092|102006477|FG000|STARTED|1-month Post-training Follow-up||76||
48681793|NCT02848092|102006478|FG001|STARTED|1-month Post-training Follow-up||76||
48681794|NCT02848092|102006477|FG000|COMPLETED|1-month Post-training Follow-up||64||
48681795|NCT02848092|102006478|FG001|COMPLETED|1-month Post-training Follow-up||71||
48681796|NCT02848092|102006477|FG000|NOT COMPLETED|1-month Post-training Follow-up||12||
48681797|NCT02848092|102006478|FG001|NOT COMPLETED|1-month Post-training Follow-up||5||
48681798|NCT02848092|102006477|FG000|STARTED|6-month Post-training Follow-up||76|All randomized participants, irrespective of whether they completed the 1-month post-training follow-up, were recruited to complete the 6-month post-training follow-up.|
48681799|NCT02848092|102006478|FG001|STARTED|6-month Post-training Follow-up||76|All randomized participants, irrespective of whether they completed the 1-month post-training follow-up, were recruited to complete the 6-month post-training follow-up.|
48681800|NCT02848092|102006477|FG000|COMPLETED|6-month Post-training Follow-up||63||
48681801|NCT02848092|102006478|FG001|COMPLETED|6-month Post-training Follow-up||72||
48681802|NCT02848092|102006477|FG000|NOT COMPLETED|6-month Post-training Follow-up||13||
48681803|NCT02848092|102006478|FG001|NOT COMPLETED|6-month Post-training Follow-up||4||
48681804|NCT02848092|102006477|FG000|STARTED|12-month Naturalistic Driving||76|Note that this assessment point reflects 12-months of naturalistic driving beginning at the end of training and ending 1-year post-training.|
48681805|NCT02848092|102006478|FG001|STARTED|12-month Naturalistic Driving||76|Note that this assessment point reflects 12-months of naturalistic driving beginning at the end of training and ending 1-year post-training.|
48681806|NCT02848092|102006477|FG000|COMPLETED|12-month Naturalistic Driving||73||
48681807|NCT02848092|102006478|FG001|COMPLETED|12-month Naturalistic Driving||74||
48681808|NCT02848092|102006477|FG000|NOT COMPLETED|12-month Naturalistic Driving||3||
48681809|NCT02848092|102006478|FG001|NOT COMPLETED|12-month Naturalistic Driving||2||
48681810|NCT02625181|102006479|FG000|STARTED|Overall Study||1518|Baseline measurement period|
48245225|NCT02625922|100917899|FG001|Completed Treatment Period 2|Overall Study||8||
48245226|NCT02625922|100917898|FG000|COMPLETED|Overall Study||12||
48245227|NCT02625922|100917899|FG001|COMPLETED|Overall Study||10||
48245228|NCT02625922|100917898|FG000|NOT COMPLETED|Overall Study||2||
48245229|NCT02625922|100917899|FG001|NOT COMPLETED|Overall Study||2||
48245230|NCT02849509|100917900|FG000|STARTED|Overall Study||379||
48245231|NCT02849509|100917901|FG001|STARTED|Overall Study||591||
48245232|NCT02849509|100917902|FG002|STARTED|Overall Study||343||
48245233|NCT02849509|100917900|FG000|COMPLETED|Overall Study||289||
48245234|NCT02849509|100917901|FG001|COMPLETED|Overall Study||425||
48245235|NCT02849509|100917902|FG002|COMPLETED|Overall Study||258||
48245236|NCT02849509|100917900|FG000|NOT COMPLETED|Overall Study||90||
48245237|NCT02849509|100917901|FG001|NOT COMPLETED|Overall Study||166||
48245238|NCT02849509|100917902|FG002|NOT COMPLETED|Overall Study||85||
48245239|NCT03816332|100917903|FG000|STARTED|Nivolumab, Tacrolimus, and Prednisone||12||
48245240|NCT03816332|100917903|FG000|COMPLETED|Nivolumab, Tacrolimus, and Prednisone||8||
48245241|NCT03816332|100917903|FG000|NOT COMPLETED|Nivolumab, Tacrolimus, and Prednisone||4||
48681811|NCT02625181|102006480|FG001|STARTED|Overall Study||12809|Baseline measurement period|
48681812|NCT02625181|102006481|FG002|STARTED|Overall Study||12707|Baseline measurement period|
48681813|NCT02625181|102006479|FG000|COMPLETED|Overall Study||1518||
48681814|NCT02625181|102006480|FG001|COMPLETED|Overall Study||12809||
48681815|NCT02625181|102006481|FG002|COMPLETED|Overall Study||12707||
48245242|NCT03816332|100917903|FG000|STARTED|Nivolumab, Ipilimumab, Tacrolimus, Pred||6||
48245243|NCT03816332|100917903|FG000|COMPLETED|Nivolumab, Ipilimumab, Tacrolimus, Pred||6||
48245244|NCT03816332|100917903|FG000|NOT COMPLETED|Nivolumab, Ipilimumab, Tacrolimus, Pred||0||
48245245|NCT03050372|100917904|FG000|STARTED|Adaptation Night (Night #1 PSG)||6||
48245246|NCT03050372|100917905|FG001|STARTED|Adaptation Night (Night #1 PSG)||6||
48245247|NCT03050372|100917904|FG000|COMPLETED|Adaptation Night (Night #1 PSG)||5||
48245248|NCT03050372|100917905|FG001|COMPLETED|Adaptation Night (Night #1 PSG)||6||
48245249|NCT03050372|100917904|FG000|NOT COMPLETED|Adaptation Night (Night #1 PSG)||1||
48245250|NCT03050372|100917905|FG001|NOT COMPLETED|Adaptation Night (Night #1 PSG)||0||
48681816|NCT02625181|102006479|FG000|NOT COMPLETED|Overall Study||0||
48681817|NCT02625181|102006480|FG001|NOT COMPLETED|Overall Study||0||
48681818|NCT02625181|102006481|FG002|NOT COMPLETED|Overall Study||0||
48245251|NCT03050372|100917904|FG000|STARTED|First Intervention (Nights #2 and #3)||5||
48245252|NCT03050372|100917905|FG001|STARTED|First Intervention (Nights #2 and #3)||6||
48245253|NCT03050372|100917904|FG000|COMPLETED|First Intervention (Nights #2 and #3)||5||
48245254|NCT03050372|100917905|FG001|COMPLETED|First Intervention (Nights #2 and #3)||6||
48245255|NCT03050372|100917904|FG000|NOT COMPLETED|First Intervention (Nights #2 and #3)||0||
48245256|NCT03050372|100917905|FG001|NOT COMPLETED|First Intervention (Nights #2 and #3)||0||
48245257|NCT03050372|100917904|FG000|STARTED|Second Intervention (Nights #4 and #5)||5||
48245258|NCT03050372|100917905|FG001|STARTED|Second Intervention (Nights #4 and #5)||6||
48245259|NCT03050372|100917904|FG000|COMPLETED|Second Intervention (Nights #4 and #5)||5||
48245260|NCT03050372|100917905|FG001|COMPLETED|Second Intervention (Nights #4 and #5)||5||
48245261|NCT03050372|100917904|FG000|NOT COMPLETED|Second Intervention (Nights #4 and #5)||0||
48681819|NCT02026011|102006482|FG000|STARTED|Allocation 1 (First Set of Medication)||46||
48681820|NCT02026011|102006483|FG001|STARTED|Allocation 1 (First Set of Medication)||41||
48681821|NCT02026011|102006482|FG000|COMPLETED|Allocation 1 (First Set of Medication)||38||
48681822|NCT02026011|102006483|FG001|COMPLETED|Allocation 1 (First Set of Medication)||39||
48681823|NCT02026011|102006482|FG000|NOT COMPLETED|Allocation 1 (First Set of Medication)||8||
48681824|NCT02026011|102006483|FG001|NOT COMPLETED|Allocation 1 (First Set of Medication)||2||
48681825|NCT02026011|102006482|FG000|STARTED|Allocation 2 (Second Set of Medication)||38||
48681826|NCT02026011|102006483|FG001|STARTED|Allocation 2 (Second Set of Medication)||37||
48681827|NCT02026011|102006482|FG000|COMPLETED|Allocation 2 (Second Set of Medication)||37||
48245262|NCT03050372|100917905|FG001|NOT COMPLETED|Second Intervention (Nights #4 and #5)||1||
48245263|NCT03786783|100917906|FG000|STARTED|Overall Study||42||
48245264|NCT03786783|100917906|FG000|COMPLETED|Overall Study||22||
48245265|NCT03786783|100917906|FG000|NOT COMPLETED|Overall Study||20||
48245266|NCT00068718|100917907|FG000|STARTED|Overall Study||35||
48245267|NCT00068718|100917907|FG000|COMPLETED|Overall Study||35||
48245268|NCT00068718|100917907|FG000|NOT COMPLETED|Overall Study||0||
48245269|NCT04372186|100917908|FG000|STARTED|Overall Study||249||
48245270|NCT04372186|100917909|FG001|STARTED|Overall Study||128||
48681828|NCT02026011|102006483|FG001|COMPLETED|Allocation 2 (Second Set of Medication)||35||
48681829|NCT02026011|102006482|FG000|NOT COMPLETED|Allocation 2 (Second Set of Medication)||1||
48681830|NCT02026011|102006483|FG001|NOT COMPLETED|Allocation 2 (Second Set of Medication)||2||
48681831|NCT03328832|102006484|FG000|STARTED|Overall Study||35||
48681832|NCT03328832|102006485|FG001|STARTED|Overall Study||35||
48681833|NCT03328832|102006484|FG000|COMPLETED|Overall Study||35||
48681834|NCT03328832|102006485|FG001|COMPLETED|Overall Study||34||
48681835|NCT03328832|102006484|FG000|NOT COMPLETED|Overall Study||0||
48681836|NCT03328832|102006485|FG001|NOT COMPLETED|Overall Study||1||
48681837|NCT02802293|102006486|FG000|STARTED|Overall Study||1||
48681838|NCT02802293|102006487|FG001|STARTED|Overall Study||2||
48681839|NCT02802293|102006488|FG002|STARTED|Overall Study||3||
48681840|NCT02802293|102006486|FG000|COMPLETED|Overall Study||0||
48681841|NCT02802293|102006487|FG001|COMPLETED|Overall Study||1||
48681842|NCT02802293|102006488|FG002|COMPLETED|Overall Study||1||
48681843|NCT02802293|102006486|FG000|NOT COMPLETED|Overall Study||1||
48245271|NCT04372186|100917908|FG000|COMPLETED|Overall Study||225||
48245272|NCT04372186|100917909|FG001|COMPLETED|Overall Study||115||
48245273|NCT04372186|100917908|FG000|NOT COMPLETED|Overall Study||24||
48245274|NCT04372186|100917909|FG001|NOT COMPLETED|Overall Study||13||
48245275|NCT02567227|100917910|FG000|STARTED|9 Weeks||192||
48245276|NCT02567227|100917911|FG001|STARTED|9 Weeks||191||
48245277|NCT02567227|100917910|FG000|COMPLETED|9 Weeks||158||
48245278|NCT02567227|100917911|FG001|COMPLETED|9 Weeks||167||
48245279|NCT02567227|100917910|FG000|NOT COMPLETED|9 Weeks||34||
48245280|NCT02567227|100917911|FG001|NOT COMPLETED|9 Weeks||24||
48245281|NCT02567227|100917910|FG000|STARTED|6 Month||158||
48245282|NCT02567227|100917911|FG001|STARTED|6 Month||167||
48245283|NCT02567227|100917910|FG000|COMPLETED|6 Month||113||
48245284|NCT02567227|100917911|FG001|COMPLETED|6 Month||127||
48245285|NCT02567227|100917910|FG000|NOT COMPLETED|6 Month||45||
48245286|NCT02567227|100917911|FG001|NOT COMPLETED|6 Month||40||
48245287|NCT02567227|100917910|FG000|STARTED|12 Months||113||
48245288|NCT02567227|100917911|FG001|STARTED|12 Months||127||
48245289|NCT02567227|100917910|FG000|COMPLETED|12 Months||82||
48245290|NCT02567227|100917911|FG001|COMPLETED|12 Months||93||
48245291|NCT02567227|100917910|FG000|NOT COMPLETED|12 Months||31||
48245292|NCT02567227|100917911|FG001|NOT COMPLETED|12 Months||34||
48245293|NCT01154699|100917912|FG000|STARTED|First Intervention (4 Weeks)||13||
48245294|NCT01154699|100917913|FG001|STARTED|First Intervention (4 Weeks)||8||
48245295|NCT01154699|100917912|FG000|Subjects With Asthma Only|First Intervention (4 Weeks)||7|The number of subjects who had asthma but NOT OSA in each arm|
48245296|NCT01154699|100917913|FG001|Subjects With Asthma Only|First Intervention (4 Weeks)||6|The number of subjects who had asthma but NOT OSA in each arm|
48245297|NCT01154699|100917912|FG000|Subjects With Asthma + OSA|First Intervention (4 Weeks)||6|The number of subjects who had asthma and OSA in each arm|
48681844|NCT02802293|102006487|FG001|NOT COMPLETED|Overall Study||1||
48681845|NCT02802293|102006488|FG002|NOT COMPLETED|Overall Study||2||
48681846|NCT01058239|102006489|FG000|STARTED|Overall Study||7||
48245298|NCT01154699|100917913|FG001|Subjects With Asthma + OSA|First Intervention (4 Weeks)||2|The number of subjects who had asthma and OSA in each arm|
48681847|NCT01058239|102006489|FG000|COMPLETED|Overall Study||7||
48681848|NCT01058239|102006489|FG000|NOT COMPLETED|Overall Study||0||
48681849|NCT02764996|102006490|FG000|STARTED|Overall Study||26||
48681850|NCT02764996|102006490|FG000|COMPLETED|Overall Study||18||
48681851|NCT02764996|102006490|FG000|NOT COMPLETED|Overall Study||8||
48681852|NCT00436436|102006491|FG000|STARTED|Overall Study||12||
48245299|NCT01154699|100917912|FG000|COMPLETED|First Intervention (4 Weeks)||13||
48245300|NCT01154699|100917913|FG001|COMPLETED|First Intervention (4 Weeks)||8||
48245301|NCT01154699|100917912|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0||
48245302|NCT01154699|100917913|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0||
48681853|NCT00436436|102006491|FG000|COMPLETED|Overall Study||0||
48681854|NCT00436436|102006491|FG000|NOT COMPLETED|Overall Study||12||
48681855|NCT00962871|102006492|FG000|STARTED|Overall Study||6||
48681856|NCT00962871|102006493|FG001|STARTED|Overall Study||6||
48681857|NCT00962871|102006494|FG002|STARTED|Overall Study||12||
48681858|NCT00962871|102006495|FG003|STARTED|Overall Study||6||
48681859|NCT00962871|102006492|FG000|COMPLETED|Overall Study||6||
48681860|NCT00962871|102006493|FG001|COMPLETED|Overall Study||6||
48681861|NCT00962871|102006494|FG002|COMPLETED|Overall Study||12||
48681862|NCT00962871|102006495|FG003|COMPLETED|Overall Study||6||
48681863|NCT00962871|102006492|FG000|NOT COMPLETED|Overall Study||0||
48082112|NCT00576927|100521750|FG000|STARTED|Sleep Hygiene Behavioral Intervention||30||
48082113|NCT00576927|100521750|FG000|COMPLETED|Sleep Hygiene Behavioral Intervention||23||
48082114|NCT00576927|100521750|FG000|NOT COMPLETED|Sleep Hygiene Behavioral Intervention||7||
48082115|NCT00576927|100521750|FG000|STARTED|Sleep Hygiene With the Placebo||23||
48082116|NCT00576927|100521750|FG000|COMPLETED|Sleep Hygiene With the Placebo||22||
48082117|NCT00576927|100521750|FG000|NOT COMPLETED|Sleep Hygiene With the Placebo||1||
48082118|NCT00576927|100521750|FG000|STARTED|Sleep Hygiene With Study Drug||22||
48082119|NCT00576927|100521750|FG000|COMPLETED|Sleep Hygiene With Study Drug||22||
48082120|NCT00576927|100521750|FG000|NOT COMPLETED|Sleep Hygiene With Study Drug||0||
48082121|NCT00576927|100521750|FG000|STARTED|Randomization 1:1 Placebo or Active Drug||22||
48082122|NCT00576927|100521750|FG000|COMPLETED|Randomization 1:1 Placebo or Active Drug||22||
48082123|NCT00576927|100521750|FG000|NOT COMPLETED|Randomization 1:1 Placebo or Active Drug||0||
48082124|NCT01393704|100521751|FG000|STARTED|Overall Study||76||
48082125|NCT01393704|100521752|FG001|STARTED|Overall Study||76||
48082126|NCT01393704|100521751|FG000|COMPLETED|Overall Study||76||
48082127|NCT01393704|100521752|FG001|COMPLETED|Overall Study||76||
48082128|NCT01393704|100521751|FG000|NOT COMPLETED|Overall Study||0||
48082129|NCT01393704|100521752|FG001|NOT COMPLETED|Overall Study||0||
48082130|NCT00536198|100521753|FG000|STARTED|Overall Study||125||
48082131|NCT00536198|100521754|FG001|STARTED|Overall Study||127||
48082132|NCT00536198|100521753|FG000|Cycle 1|Overall Study||110||
48082133|NCT00536198|100521754|FG001|Cycle 1|Overall Study||123||
48082134|NCT00536198|100521753|FG000|Cycle 2|Overall Study||104||
48082135|NCT00536198|100521754|FG001|Cycle 2|Overall Study||112||
48082136|NCT00536198|100521753|FG000|Cycle 3|Overall Study||100||
48082137|NCT00536198|100521754|FG001|Cycle 3|Overall Study||101||
48245303|NCT01154699|100917912|FG000|STARTED|Washout Period (4 Weeks)||13||
48245304|NCT01154699|100917913|FG001|STARTED|Washout Period (4 Weeks)||8||
48245305|NCT01154699|100917912|FG000|Subjects With Asthma Only|Washout Period (4 Weeks)||7||
48245306|NCT01154699|100917913|FG001|Subjects With Asthma Only|Washout Period (4 Weeks)||6||
48681864|NCT00962871|102006493|FG001|NOT COMPLETED|Overall Study||0||
48681865|NCT00962871|102006494|FG002|NOT COMPLETED|Overall Study||0||
48681866|NCT00962871|102006495|FG003|NOT COMPLETED|Overall Study||0||
48681867|NCT01541865|102006496|FG000|STARTED|Overall Study||146||
48681868|NCT01541865|102006496|FG000|COMPLETED|Overall Study||124||
48681869|NCT01541865|102006496|FG000|NOT COMPLETED|Overall Study||22||
48681870|NCT01856322|102006497|FG000|STARTED|Overall Study||0||
48681871|NCT01856322|102006498|FG001|STARTED|Overall Study||0||
48681872|NCT01856322|102006499|FG002|STARTED|Overall Study||3||
48681873|NCT01856322|102006497|FG000|COMPLETED|Overall Study||0||
48681874|NCT01856322|102006498|FG001|COMPLETED|Overall Study||0||
48681875|NCT01856322|102006499|FG002|COMPLETED|Overall Study||0||
48681876|NCT01856322|102006497|FG000|NOT COMPLETED|Overall Study||0||
48681877|NCT01856322|102006498|FG001|NOT COMPLETED|Overall Study||0||
48681878|NCT01856322|102006499|FG002|NOT COMPLETED|Overall Study||3||
48681879|NCT00936663|102006500|FG000|STARTED|Overall Study||1||
48681880|NCT00936663|102006501|FG001|STARTED|Overall Study||2||
48082138|NCT00536198|100521753|FG000|Cycle 4|Overall Study||95||
48082139|NCT00536198|100521754|FG001|Cycle 4|Overall Study||98||
48681881|NCT00936663|102006500|FG000|COMPLETED|Overall Study||1||
48681882|NCT00936663|102006501|FG001|COMPLETED|Overall Study||2||
48681883|NCT00936663|102006500|FG000|NOT COMPLETED|Overall Study||0||
48681884|NCT00936663|102006501|FG001|NOT COMPLETED|Overall Study||0||
48681885|NCT02847169|102006502|FG000|STARTED|First Intervention (1 Week)||15||
48681886|NCT02847169|102006503|FG001|STARTED|First Intervention (1 Week)||15||
48681887|NCT02847169|102006502|FG000|COMPLETED|First Intervention (1 Week)||15||
48082140|NCT00536198|100521753|FG000|Cycle 5|Overall Study||88||
48245307|NCT01154699|100917912|FG000|Subjects With Asthma + OSA|Washout Period (4 Weeks)||6||
48245308|NCT01154699|100917913|FG001|Subjects With Asthma + OSA|Washout Period (4 Weeks)||2||
48681888|NCT02847169|102006503|FG001|COMPLETED|First Intervention (1 Week)||15||
48681889|NCT02847169|102006502|FG000|NOT COMPLETED|First Intervention (1 Week)||0||
48681890|NCT02847169|102006503|FG001|NOT COMPLETED|First Intervention (1 Week)||0||
48082141|NCT00536198|100521754|FG001|Cycle 5|Overall Study||85||
48681891|NCT02847169|102006502|FG000|STARTED|Second Intervention (1 Week)||15||
48681892|NCT02847169|102006503|FG001|STARTED|Second Intervention (1 Week)||15||
48082142|NCT00536198|100521753|FG000|Cycle 6|Overall Study||88||
48082143|NCT00536198|100521754|FG001|Cycle 6|Overall Study||88||
48082144|NCT00536198|100521753|FG000|COMPLETED|Overall Study||88||
48082145|NCT00536198|100521754|FG001|COMPLETED|Overall Study||88||
48082146|NCT00536198|100521753|FG000|NOT COMPLETED|Overall Study||37||
48082147|NCT00536198|100521754|FG001|NOT COMPLETED|Overall Study||39||
48082148|NCT00217594|100521755|FG000|STARTED|Overall Study||31||
48082149|NCT00217594|100521755|FG000|COMPLETED|Overall Study||31||
48082150|NCT00217594|100521755|FG000|NOT COMPLETED|Overall Study||0||
48082151|NCT02268084|100521756|FG000|STARTED|Overall Study||49||
48082152|NCT02268084|100521757|FG001|STARTED|Overall Study||47||
48082153|NCT02268084|100521756|FG000|COMPLETED|Overall Study||40||
48082154|NCT02268084|100521757|FG001|COMPLETED|Overall Study||40||
48082155|NCT02268084|100521756|FG000|NOT COMPLETED|Overall Study||9||
48082156|NCT02268084|100521757|FG001|NOT COMPLETED|Overall Study||7||
48082157|NCT01118221|100521758|FG000|STARTED|Overall Study||14||
48082158|NCT01118221|100521759|FG001|STARTED|Overall Study||11||
48082159|NCT01118221|100521758|FG000|COMPLETED|Overall Study||11||
48082160|NCT01118221|100521759|FG001|COMPLETED|Overall Study||10||
48082161|NCT01118221|100521758|FG000|NOT COMPLETED|Overall Study||3||
48082162|NCT01118221|100521759|FG001|NOT COMPLETED|Overall Study||1||
48082163|NCT04882540|100521760|FG000|STARTED|Overall Study||12||
48082164|NCT04882540|100521760|FG000|COMPLETED|Overall Study||12||
48082165|NCT04882540|100521760|FG000|NOT COMPLETED|Overall Study||0||
48082166|NCT02380677|100521761|FG000|STARTED|Overall Study||1||
48082167|NCT02380677|100521762|FG001|STARTED|Overall Study||1||
48082168|NCT02380677|100521763|FG002|STARTED|Overall Study||3||
48082169|NCT02380677|100521764|FG003|STARTED|Overall Study||3||
48082170|NCT02380677|100521765|FG004|STARTED|Overall Study||6||
48082171|NCT02380677|100521766|FG005|STARTED|Overall Study||6||
48082172|NCT02380677|100521767|FG006|STARTED|Overall Study||3||
48082173|NCT02380677|100521768|FG007|STARTED|Overall Study||4||
48082174|NCT02380677|100521769|FG008|STARTED|Overall Study||4||
48082175|NCT02380677|100521770|FG009|STARTED|Overall Study||2||
48082176|NCT02380677|100521771|FG010|STARTED|Overall Study||4||
48082177|NCT02380677|100521772|FG011|STARTED|Overall Study||5||
48082178|NCT02380677|100521761|FG000|COMPLETED|Overall Study||0||
48082179|NCT02380677|100521762|FG001|COMPLETED|Overall Study||0||
48082180|NCT02380677|100521763|FG002|COMPLETED|Overall Study||0||
48082181|NCT02380677|100521764|FG003|COMPLETED|Overall Study||0||
48082182|NCT02380677|100521765|FG004|COMPLETED|Overall Study||0||
48082183|NCT02380677|100521766|FG005|COMPLETED|Overall Study||0||
48082184|NCT02380677|100521767|FG006|COMPLETED|Overall Study||0||
48082185|NCT02380677|100521768|FG007|COMPLETED|Overall Study||0||
48082186|NCT02380677|100521769|FG008|COMPLETED|Overall Study||0||
48082187|NCT02380677|100521770|FG009|COMPLETED|Overall Study||0||
48082188|NCT02380677|100521771|FG010|COMPLETED|Overall Study||0||
48082189|NCT02380677|100521772|FG011|COMPLETED|Overall Study||0||
48082190|NCT02380677|100521761|FG000|NOT COMPLETED|Overall Study||1||
48082191|NCT02380677|100521762|FG001|NOT COMPLETED|Overall Study||1||
48082192|NCT02380677|100521763|FG002|NOT COMPLETED|Overall Study||3||
48082193|NCT02380677|100521764|FG003|NOT COMPLETED|Overall Study||3||
48082194|NCT02380677|100521765|FG004|NOT COMPLETED|Overall Study||6||
48082195|NCT02380677|100521766|FG005|NOT COMPLETED|Overall Study||6||
48082196|NCT02380677|100521767|FG006|NOT COMPLETED|Overall Study||3||
48082197|NCT02380677|100521768|FG007|NOT COMPLETED|Overall Study||4||
48082198|NCT02380677|100521769|FG008|NOT COMPLETED|Overall Study||4||
48082199|NCT02380677|100521770|FG009|NOT COMPLETED|Overall Study||2||
48082200|NCT02380677|100521771|FG010|NOT COMPLETED|Overall Study||4||
48082201|NCT02380677|100521772|FG011|NOT COMPLETED|Overall Study||5||
48082202|NCT00660023|100521773|FG000|STARTED|Overall Study||124||
48082203|NCT00660023|100521773|FG000|Treated|Overall Study||114||
48082204|NCT00660023|100521773|FG000|COMPLETED|Overall Study||95||
48082205|NCT00660023|100521773|FG000|NOT COMPLETED|Overall Study||29||
48082206|NCT00403234|100521774|FG000|STARTED|Overall Study||2||
48082207|NCT00403234|100521775|FG001|STARTED|Overall Study||3||
48082208|NCT00403234|100521776|FG002|STARTED|Overall Study||3||
48082209|NCT00403234|100521777|FG003|STARTED|Overall Study||2||
48082210|NCT00403234|100521774|FG000|COMPLETED|Overall Study||1||
48082211|NCT00403234|100521775|FG001|COMPLETED|Overall Study||2||
48082212|NCT00403234|100521776|FG002|COMPLETED|Overall Study||2||
48082213|NCT00403234|100521777|FG003|COMPLETED|Overall Study||2||
48082214|NCT00403234|100521774|FG000|NOT COMPLETED|Overall Study||1||
48082215|NCT00403234|100521775|FG001|NOT COMPLETED|Overall Study||1||
48082216|NCT00403234|100521776|FG002|NOT COMPLETED|Overall Study||1||
48082217|NCT00403234|100521777|FG003|NOT COMPLETED|Overall Study||0||
48082218|NCT01900704|100521778|FG000|STARTED|Overall Study||270||
48082219|NCT01900704|100521779|FG001|STARTED|Overall Study||270||
48082220|NCT01900704|100521780|FG002|STARTED|Overall Study||270||
48082221|NCT01900704|100521778|FG000|COMPLETED|Overall Study||229||
48082222|NCT01900704|100521779|FG001|COMPLETED|Overall Study||235||
48082223|NCT01900704|100521780|FG002|COMPLETED|Overall Study||237||
48082224|NCT01900704|100521778|FG000|NOT COMPLETED|Overall Study||41||
48082225|NCT01900704|100521779|FG001|NOT COMPLETED|Overall Study||35||
48082226|NCT01900704|100521780|FG002|NOT COMPLETED|Overall Study||33||
48082227|NCT00521014|100521781|FG000|STARTED|Overall Study||14||
48082228|NCT00521014|100521781|FG000|COMPLETED|Overall Study||13||
48082229|NCT00521014|100521781|FG000|NOT COMPLETED|Overall Study||1||
48082230|NCT02785432|100521782|FG000|STARTED|Overall Study||4||
48082231|NCT02785432|100521783|FG001|STARTED|Overall Study||7||
48082232|NCT02785432|100521782|FG000|COMPLETED|Overall Study||4||
48082233|NCT02785432|100521783|FG001|COMPLETED|Overall Study||7||
48082234|NCT02785432|100521782|FG000|NOT COMPLETED|Overall Study||0||
48082235|NCT02785432|100521783|FG001|NOT COMPLETED|Overall Study||0||
48082236|NCT02193867|100521784|FG000|STARTED|Overall Study||10||
48082237|NCT02193867|100521784|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||10|Full Analysis Set (FAS)|
48082238|NCT02193867|100521784|FG000|Completed 18 Months Of Treatment|Overall Study||8|Treatment was to be at least 18 months; participants could continue treatment for up to 3 years|
48082239|NCT02193867|100521784|FG000|COMPLETED|Overall Study||6|All participants continued to receive commercial therapy after study completion/Sponsor termination|
48082240|NCT02193867|100521784|FG000|NOT COMPLETED|Overall Study||4||
48082241|NCT01678911|100521785|FG000|STARTED|First Intervention||4||
48082242|NCT01678911|100521786|FG001|STARTED|First Intervention||1||
48082243|NCT01678911|100521785|FG000|Cross Over|First Intervention||4||
48082244|NCT01678911|100521786|FG001|Cross Over|First Intervention||1||
48082245|NCT01678911|100521785|FG000|COMPLETED|First Intervention||4||
48082246|NCT01678911|100521786|FG001|COMPLETED|First Intervention||1||
48082247|NCT01678911|100521785|FG000|NOT COMPLETED|First Intervention||0||
48082248|NCT01678911|100521786|FG001|NOT COMPLETED|First Intervention||0||
48082249|NCT01678911|100521785|FG000|STARTED|Second Intervention||4||
48082250|NCT01678911|100521786|FG001|STARTED|Second Intervention||1||
48082251|NCT01678911|100521785|FG000|COMPLETED|Second Intervention||2||
48082252|NCT01678911|100521786|FG001|COMPLETED|Second Intervention||1||
48082253|NCT01678911|100521785|FG000|NOT COMPLETED|Second Intervention||2||
48082254|NCT01678911|100521786|FG001|NOT COMPLETED|Second Intervention||0||
48082255|NCT00959764|100521787|FG000|STARTED|Overall Study||271||
48082256|NCT00959764|100521788|FG001|STARTED|Overall Study||185||
48082257|NCT00959764|100521789|FG002|STARTED|Overall Study||109||
48082258|NCT00959764|100521787|FG000|COMPLETED|Overall Study||176||
48082259|NCT00959764|100521788|FG001|COMPLETED|Overall Study||128||
48082260|NCT00959764|100521789|FG002|COMPLETED|Overall Study||73||
48082261|NCT00959764|100521787|FG000|NOT COMPLETED|Overall Study||95||
48082262|NCT00959764|100521788|FG001|NOT COMPLETED|Overall Study||57||
48082263|NCT00959764|100521789|FG002|NOT COMPLETED|Overall Study||36||
48082264|NCT00598832|100521790|FG000|STARTED|Overall Study||533||
48082265|NCT00598832|100521791|FG001|STARTED|Overall Study||542||
48082266|NCT00598832|100521790|FG000|COMPLETED|Overall Study||471||
48082267|NCT00598832|100521791|FG001|COMPLETED|Overall Study||460||
48082268|NCT00598832|100521790|FG000|NOT COMPLETED|Overall Study||62||
48082269|NCT00598832|100521791|FG001|NOT COMPLETED|Overall Study||82||
48245309|NCT01154699|100917912|FG000|COMPLETED|Washout Period (4 Weeks)||13||
48245310|NCT01154699|100917913|FG001|COMPLETED|Washout Period (4 Weeks)||8||
48245311|NCT01154699|100917912|FG000|NOT COMPLETED|Washout Period (4 Weeks)||0||
48245312|NCT01154699|100917913|FG001|NOT COMPLETED|Washout Period (4 Weeks)||0||
48245313|NCT01154699|100917912|FG000|STARTED|Second Intervention||13||
48245314|NCT01154699|100917913|FG001|STARTED|Second Intervention||8||
48245315|NCT01154699|100917912|FG000|Subjects With Asthma Only|Second Intervention||7||
48245316|NCT01154699|100917913|FG001|Subjects With Asthma Only|Second Intervention||6||
48245317|NCT01154699|100917912|FG000|Subjects With Asthma + OSA|Second Intervention||6||
48245318|NCT01154699|100917913|FG001|Subjects With Asthma + OSA|Second Intervention||2||
48245319|NCT01154699|100917912|FG000|COMPLETED|Second Intervention||13||
48245320|NCT01154699|100917913|FG001|COMPLETED|Second Intervention||8||
48245321|NCT01154699|100917912|FG000|NOT COMPLETED|Second Intervention||0||
48245322|NCT01154699|100917913|FG001|NOT COMPLETED|Second Intervention||0||
48245323|NCT00771238|100917914|FG000|STARTED|Overall Study||31||
48245324|NCT00771238|100917915|FG001|STARTED|Overall Study||21||
48245325|NCT00771238|100917914|FG000|COMPLETED|Overall Study||31||
48245326|NCT00771238|100917915|FG001|COMPLETED|Overall Study||21||
48245327|NCT00771238|100917914|FG000|NOT COMPLETED|Overall Study||0||
48245328|NCT00771238|100917915|FG001|NOT COMPLETED|Overall Study||0||
48245329|NCT00125619|100917916|FG000|STARTED|Overall Study||8||
48245330|NCT00125619|100917917|FG001|STARTED|Overall Study||8||
48245331|NCT00125619|100917916|FG000|COMPLETED|Overall Study||8||
48245332|NCT00125619|100917917|FG001|COMPLETED|Overall Study||8||
48245333|NCT00125619|100917916|FG000|NOT COMPLETED|Overall Study||0||
48245334|NCT00125619|100917917|FG001|NOT COMPLETED|Overall Study||0||
48245335|NCT02176018|100917918|FG000|STARTED|Overall Study||22||
48245336|NCT02176018|100917919|FG001|STARTED|Overall Study||23||
48245337|NCT02176018|100917918|FG000|COMPLETED|Overall Study||17||
48681893|NCT02847169|102006502|FG000|COMPLETED|Second Intervention (1 Week)||15||
48681894|NCT02847169|102006503|FG001|COMPLETED|Second Intervention (1 Week)||15||
48681895|NCT02847169|102006502|FG000|NOT COMPLETED|Second Intervention (1 Week)||0||
48681896|NCT02847169|102006503|FG001|NOT COMPLETED|Second Intervention (1 Week)||0||
48082270|NCT00886899|100521792|FG000|STARTED|Overall Study||147||
48082271|NCT00886899|100521792|FG000|COMPLETED|Overall Study||147||
48082272|NCT00886899|100521792|FG000|NOT COMPLETED|Overall Study||0||
48082273|NCT01684007|100521793|FG000|STARTED|Overall Study||53||
48082274|NCT01684007|100521794|FG001|STARTED|Overall Study||50||
48082275|NCT01684007|100521793|FG000|COMPLETED|Overall Study||53||
48082276|NCT01684007|100521794|FG001|COMPLETED|Overall Study||50||
48082277|NCT01684007|100521793|FG000|NOT COMPLETED|Overall Study||0||
48082278|NCT01684007|100521794|FG001|NOT COMPLETED|Overall Study||0||
48245338|NCT02176018|100917919|FG001|COMPLETED|Overall Study||17||
48245339|NCT02176018|100917918|FG000|NOT COMPLETED|Overall Study||5||
48245340|NCT02176018|100917919|FG001|NOT COMPLETED|Overall Study||6||
48245341|NCT00830284|100917920|FG000|STARTED|Overall Study||12||
48681897|NCT03210701|102006504|FG000|STARTED|Overall Study||123||
48681898|NCT03210701|102006504|FG000|COMPLETED|Overall Study||123||
48681899|NCT03210701|102006504|FG000|NOT COMPLETED|Overall Study||0||
48681900|NCT01061385|102006505|FG000|STARTED|Overall Study||21||
48245342|NCT00830284|100917920|FG000|COMPLETED|Overall Study||10||
48245343|NCT00830284|100917920|FG000|NOT COMPLETED|Overall Study||2||
48245344|NCT00244751|100917921|FG000|STARTED|Overall Study||88||
48245345|NCT00244751|100917922|FG001|STARTED|Overall Study||89||
48245346|NCT00244751|100917923|FG002|STARTED|Overall Study||88||
48245347|NCT00244751|100917921|FG000|COMPLETED|Overall Study||72||
48245348|NCT00244751|100917922|FG001|COMPLETED|Overall Study||74||
48245349|NCT00244751|100917923|FG002|COMPLETED|Overall Study||78||
48245350|NCT00244751|100917921|FG000|NOT COMPLETED|Overall Study||16||
48245351|NCT00244751|100917922|FG001|NOT COMPLETED|Overall Study||15||
48245352|NCT00244751|100917923|FG002|NOT COMPLETED|Overall Study||10||
48245353|NCT01799993|100917924|FG000|STARTED|Overall Study||362||
48245354|NCT01799993|100917925|FG001|STARTED|Overall Study||363||
48245355|NCT01799993|100917924|FG000|ITT Population|Overall Study||354||
48245356|NCT01799993|100917925|FG001|ITT Population|Overall Study||358||
48245357|NCT01799993|100917924|FG000|mITT Population|Overall Study||255||
48245358|NCT01799993|100917925|FG001|mITT Population|Overall Study||253||
48245359|NCT01799993|100917924|FG000|COMPLETED|Overall Study||229|Completed follow-up|
48245360|NCT01799993|100917925|FG001|COMPLETED|Overall Study||235|Completed follow-up|
48245361|NCT01799993|100917924|FG000|NOT COMPLETED|Overall Study||133||
48245362|NCT01799993|100917925|FG001|NOT COMPLETED|Overall Study||128||
48245363|NCT03794609|100917926|FG000|STARTED|Overall Study||315||
48245364|NCT03794609|100917926|FG000|COMPLETED|Overall Study||4||
48245365|NCT03794609|100917926|FG000|NOT COMPLETED|Overall Study||311||
48245366|NCT03302559|100917927|FG000|STARTED|Overall Study||29||
48245367|NCT03302559|100917927|FG000|COMPLETED|Overall Study||23||
48245368|NCT03302559|100917927|FG000|NOT COMPLETED|Overall Study||6||
48245369|NCT03873714|100917928|FG000|STARTED|Overall Study||14||
48245370|NCT03873714|100917928|FG000|Primary Outcome Completion|Overall Study||7||
48245371|NCT03873714|100917928|FG000|COMPLETED|Overall Study||7||
48245372|NCT03873714|100917928|FG000|NOT COMPLETED|Overall Study||7||
48245373|NCT04175834|100917929|FG000|STARTED|Overall Study||9||
48245374|NCT04175834|100917930|FG001|STARTED|Overall Study||10||
48245375|NCT04175834|100917929|FG000|COMPLETED|Overall Study||8||
48245376|NCT04175834|100917930|FG001|COMPLETED|Overall Study||10||
48245377|NCT04175834|100917929|FG000|NOT COMPLETED|Overall Study||1||
48245378|NCT04175834|100917930|FG001|NOT COMPLETED|Overall Study||0||
48245379|NCT01136733|100917931|FG000|STARTED|Phase 1b||7||
48245380|NCT01136733|100917932|FG001|STARTED|Phase 1b||11||
48245381|NCT01136733|100917933|FG002|STARTED|Phase 1b||2||
48245382|NCT01136733|100917934|FG003|STARTED|Phase 1b||0||
48245383|NCT01136733|100917935|FG004|STARTED|Phase 1b||0||
48245384|NCT01136733|100917936|FG005|STARTED|Phase 1b||0||
48245385|NCT01136733|100917937|FG006|STARTED|Phase 1b||0||
48245386|NCT01136733|100917931|FG000|COMPLETED|Phase 1b||6||
48245387|NCT01136733|100917932|FG001|COMPLETED|Phase 1b||6||
48245388|NCT01136733|100917933|FG002|COMPLETED|Phase 1b||0||
48245389|NCT01136733|100917934|FG003|COMPLETED|Phase 1b||0||
48245390|NCT01136733|100917935|FG004|COMPLETED|Phase 1b||0||
48245391|NCT01136733|100917936|FG005|COMPLETED|Phase 1b||0||
48245392|NCT01136733|100917937|FG006|COMPLETED|Phase 1b||0||
48245393|NCT01136733|100917931|FG000|NOT COMPLETED|Phase 1b||1||
48245394|NCT01136733|100917932|FG001|NOT COMPLETED|Phase 1b||5||
48245395|NCT01136733|100917933|FG002|NOT COMPLETED|Phase 1b||2||
48245396|NCT01136733|100917934|FG003|NOT COMPLETED|Phase 1b||0||
48245397|NCT01136733|100917935|FG004|NOT COMPLETED|Phase 1b||0||
48245398|NCT01136733|100917936|FG005|NOT COMPLETED|Phase 1b||0||
48082279|NCT00578812|100521795|FG000|STARTED|Overall Study||224||
48082280|NCT00578812|100521796|FG001|STARTED|Overall Study||192||
48082281|NCT00578812|100521795|FG000|COMPLETED|Overall Study||218||
48082282|NCT00578812|100521796|FG001|COMPLETED|Overall Study||185||
48082283|NCT00578812|100521795|FG000|NOT COMPLETED|Overall Study||6||
48245399|NCT01136733|100917937|FG006|NOT COMPLETED|Phase 1b||0||
48245400|NCT01136733|100917931|FG000|STARTED|Phase 2||0||
48245401|NCT01136733|100917932|FG001|STARTED|Phase 2||0||
48245402|NCT01136733|100917933|FG002|STARTED|Phase 2||0||
48245403|NCT01136733|100917934|FG003|STARTED|Phase 2||0||
48245404|NCT01136733|100917935|FG004|STARTED|Phase 2||51||
48082284|NCT00578812|100521796|FG001|NOT COMPLETED|Overall Study||7||
48082285|NCT01854710|100521797|FG000|STARTED|Overall Study||10||
48082286|NCT01854710|100521798|FG001|STARTED|Overall Study||10||
48082287|NCT01854710|100521799|FG002|STARTED|Overall Study||10||
48082288|NCT01854710|100521800|FG003|STARTED|Overall Study||10||
48082289|NCT01854710|100521801|FG004|STARTED|Overall Study||10||
48245405|NCT01136733|100917936|FG005|STARTED|Phase 2||52||
48245406|NCT01136733|100917937|FG006|STARTED|Phase 2||50||
48245407|NCT01136733|100917931|FG000|COMPLETED|Phase 2||0||
48245408|NCT01136733|100917932|FG001|COMPLETED|Phase 2||0||
48245409|NCT01136733|100917933|FG002|COMPLETED|Phase 2||0||
48245410|NCT01136733|100917934|FG003|COMPLETED|Phase 2||0||
48245411|NCT01136733|100917935|FG004|COMPLETED|Phase 2||0||
48245412|NCT01136733|100917936|FG005|COMPLETED|Phase 2||0||
48245413|NCT01136733|100917937|FG006|COMPLETED|Phase 2||0||
48245414|NCT01136733|100917931|FG000|NOT COMPLETED|Phase 2||0||
48245415|NCT01136733|100917932|FG001|NOT COMPLETED|Phase 2||0||
48245416|NCT01136733|100917933|FG002|NOT COMPLETED|Phase 2||0||
48245417|NCT01136733|100917934|FG003|NOT COMPLETED|Phase 2||0||
48245418|NCT01136733|100917935|FG004|NOT COMPLETED|Phase 2||51||
48245419|NCT01136733|100917936|FG005|NOT COMPLETED|Phase 2||52||
48245420|NCT01136733|100917937|FG006|NOT COMPLETED|Phase 2||50||
48245421|NCT03247985|100917938|FG000|STARTED|Overall Study||19||
48245422|NCT03247985|100917939|FG001|STARTED|Overall Study||19||
48245423|NCT03247985|100917938|FG000|COMPLETED|Overall Study||19||
48245424|NCT03247985|100917939|FG001|COMPLETED|Overall Study||19||
48245425|NCT03247985|100917938|FG000|NOT COMPLETED|Overall Study||0||
48245426|NCT03247985|100917939|FG001|NOT COMPLETED|Overall Study||0||
48245427|NCT02033499|100917940|FG000|STARTED|Overall Study||152||
48245428|NCT02033499|100917941|FG001|STARTED|Overall Study||150||
48245429|NCT02033499|100917942|FG002|STARTED|Overall Study||148||
48245430|NCT02033499|100917940|FG000|COMPLETED|Overall Study||147||
48245431|NCT02033499|100917941|FG001|COMPLETED|Overall Study||142||
48245432|NCT02033499|100917942|FG002|COMPLETED|Overall Study||139||
48245433|NCT02033499|100917940|FG000|NOT COMPLETED|Overall Study||5||
48245434|NCT02033499|100917941|FG001|NOT COMPLETED|Overall Study||8||
48082290|NCT01854710|100521802|FG005|STARTED|Overall Study||10||
48082291|NCT01854710|100521797|FG000|COMPLETED|Overall Study||6||
48082292|NCT01854710|100521798|FG001|COMPLETED|Overall Study||7||
48082293|NCT01854710|100521799|FG002|COMPLETED|Overall Study||8||
48082294|NCT01854710|100521800|FG003|COMPLETED|Overall Study||8||
48082295|NCT01854710|100521801|FG004|COMPLETED|Overall Study||8||
48082296|NCT01854710|100521802|FG005|COMPLETED|Overall Study||8||
48082297|NCT01854710|100521797|FG000|NOT COMPLETED|Overall Study||4||
48082298|NCT01854710|100521798|FG001|NOT COMPLETED|Overall Study||3||
48082299|NCT01854710|100521799|FG002|NOT COMPLETED|Overall Study||2||
48082300|NCT01854710|100521800|FG003|NOT COMPLETED|Overall Study||2||
48082301|NCT01854710|100521801|FG004|NOT COMPLETED|Overall Study||2||
48082302|NCT01854710|100521802|FG005|NOT COMPLETED|Overall Study||2||
48082303|NCT02370160|100521803|FG000|STARTED|Overall Study||9||
48082304|NCT02370160|100521804|FG001|STARTED|Overall Study||6||
48082305|NCT02370160|100521805|FG002|STARTED|Overall Study||3||
48082306|NCT02370160|100521803|FG000|COMPLETED|Overall Study||6||
48082307|NCT02370160|100521804|FG001|COMPLETED|Overall Study||2||
48082308|NCT02370160|100521805|FG002|COMPLETED|Overall Study||2||
48082309|NCT02370160|100521803|FG000|NOT COMPLETED|Overall Study||3||
48082310|NCT02370160|100521804|FG001|NOT COMPLETED|Overall Study||4||
48082311|NCT02370160|100521805|FG002|NOT COMPLETED|Overall Study||1||
48082312|NCT01804075|100521806|FG000|STARTED|Overall Study||15||
48082313|NCT01804075|100521807|FG001|STARTED|Overall Study||16||
48245435|NCT02033499|100917942|FG002|NOT COMPLETED|Overall Study||9||
48245436|NCT01443546|100917943|FG000|STARTED|Overall Study||9||
48245437|NCT01443546|100917944|FG001|STARTED|Overall Study||9||
48245438|NCT01443546|100917945|FG002|STARTED|Overall Study||8||
48245439|NCT01443546|100917943|FG000|COMPLETED|Overall Study||9||
48245440|NCT01443546|100917944|FG001|COMPLETED|Overall Study||9||
48245441|NCT01443546|100917945|FG002|COMPLETED|Overall Study||8||
48245442|NCT01443546|100917943|FG000|NOT COMPLETED|Overall Study||0||
48245443|NCT01443546|100917944|FG001|NOT COMPLETED|Overall Study||0||
48245444|NCT01443546|100917945|FG002|NOT COMPLETED|Overall Study||0||
48245445|NCT03915951|100917946|FG000|STARTED|Overall Study||59||
48245446|NCT03915951|100917947|FG001|STARTED|Overall Study||39||
48245447|NCT03915951|100917946|FG000|COMPLETED|Overall Study||0||
48082314|NCT01804075|100521806|FG000|COMPLETED|Overall Study||15||
48082315|NCT01804075|100521807|FG001|COMPLETED|Overall Study||16||
48082316|NCT01804075|100521806|FG000|NOT COMPLETED|Overall Study||0||
48082317|NCT01804075|100521807|FG001|NOT COMPLETED|Overall Study||0||
48082318|NCT00850564|100521808|FG000|STARTED|Overall Study||15||
48082319|NCT00850564|100521808|FG000|COMPLETED|Overall Study||13||
48082320|NCT00850564|100521808|FG000|NOT COMPLETED|Overall Study||2||
48082321|NCT00913497|100521809|FG000|STARTED|Overall Study||16||
48082322|NCT00913497|100521809|FG000|COMPLETED|Overall Study||13||
48082323|NCT00913497|100521809|FG000|NOT COMPLETED|Overall Study||3||
48082324|NCT00790023|100521810|FG000|STARTED|Overall Study||237||
48082325|NCT00790023|100521811|FG001|STARTED|Overall Study||235||
48082326|NCT00790023|100521812|FG002|STARTED|Overall Study||235||
48082327|NCT00790023|100521810|FG000|COMPLETED|Overall Study||226||
48082328|NCT00790023|100521811|FG001|COMPLETED|Overall Study||225||
48082329|NCT00790023|100521812|FG002|COMPLETED|Overall Study||214||
48082330|NCT00790023|100521810|FG000|NOT COMPLETED|Overall Study||11||
48082331|NCT00790023|100521811|FG001|NOT COMPLETED|Overall Study||10||
48082332|NCT00790023|100521812|FG002|NOT COMPLETED|Overall Study||21||
48082333|NCT01367002|100521813|FG000|STARTED|Overall Study||29||
48082334|NCT01367002|100521814|FG001|STARTED|Overall Study||32||
48082335|NCT01367002|100521813|FG000|Participants Receive Drug|Overall Study||28||
48082336|NCT01367002|100521814|FG001|Participants Receive Drug|Overall Study||32||
48082337|NCT01367002|100521813|FG000|Participants Evaluable for PFS|Overall Study||28|PFS= Progression Free Survival|
48082338|NCT01367002|100521814|FG001|Participants Evaluable for PFS|Overall Study||30|PFS= Progression Free Survival|
48082339|NCT01367002|100521813|FG000|COMPLETED|Overall Study||28||
48245448|NCT03915951|100917947|FG001|COMPLETED|Overall Study||0||
48245449|NCT03915951|100917946|FG000|NOT COMPLETED|Overall Study||59||
48245450|NCT03915951|100917947|FG001|NOT COMPLETED|Overall Study||39||
48082340|NCT01367002|100521814|FG001|COMPLETED|Overall Study||30||
48245451|NCT01846988|100917948|FG000|STARTED|APAP Pressurize Comparison (4-8 Weeks)||15||
48082341|NCT01367002|100521813|FG000|NOT COMPLETED|Overall Study||1||
48245452|NCT01846988|100917949|FG001|STARTED|APAP Pressurize Comparison (4-8 Weeks)||0||
48245453|NCT01846988|100917950|FG002|STARTED|APAP Pressurize Comparison (4-8 Weeks)||0||
48082342|NCT01367002|100521814|FG001|NOT COMPLETED|Overall Study||2||
48082343|NCT01427504|100521815|FG000|STARTED|Overall Study||4||
48082344|NCT01427504|100521816|FG001|STARTED|Overall Study||3||
48082345|NCT01427504|100521817|FG002|STARTED|Overall Study||4||
48082346|NCT01427504|100521818|FG003|STARTED|Overall Study||6||
48082347|NCT01427504|100521819|FG004|STARTED|Overall Study||3||
48082348|NCT01427504|100521820|FG005|STARTED|Overall Study||6||
48082349|NCT01427504|100521815|FG000|Received Boceprevir|Overall Study||4||
48082350|NCT01427504|100521816|FG001|Received Boceprevir|Overall Study||3||
48082351|NCT01427504|100521817|FG002|Received Boceprevir|Overall Study||3||
48082352|NCT01427504|100521818|FG003|Received Boceprevir|Overall Study||5||
48082353|NCT01427504|100521819|FG004|Received Boceprevir|Overall Study||2||
48082354|NCT01427504|100521820|FG005|Received Boceprevir|Overall Study||4||
48082355|NCT01427504|100521815|FG000|Received Etravirine|Overall Study||4||
48082356|NCT01427504|100521816|FG001|Received Etravirine|Overall Study||2||
48082357|NCT01427504|100521817|FG002|Received Etravirine|Overall Study||4||
48082358|NCT01427504|100521818|FG003|Received Etravirine|Overall Study||6||
48082359|NCT01427504|100521819|FG004|Received Etravirine|Overall Study||2||
48082360|NCT01427504|100521820|FG005|Received Etravirine|Overall Study||4||
48082361|NCT01427504|100521815|FG000|Received Combination|Overall Study||4||
48082362|NCT01427504|100521816|FG001|Received Combination|Overall Study||3||
48082363|NCT01427504|100521817|FG002|Received Combination|Overall Study||3||
48082364|NCT01427504|100521818|FG003|Received Combination|Overall Study||6||
48082365|NCT01427504|100521819|FG004|Received Combination|Overall Study||3||
48082366|NCT01427504|100521820|FG005|Received Combination|Overall Study||6||
48082367|NCT01427504|100521815|FG000|COMPLETED|Overall Study||4||
48082368|NCT01427504|100521816|FG001|COMPLETED|Overall Study||2||
48082369|NCT01427504|100521817|FG002|COMPLETED|Overall Study||3||
48082370|NCT01427504|100521818|FG003|COMPLETED|Overall Study||5||
48082371|NCT01427504|100521819|FG004|COMPLETED|Overall Study||2||
48082372|NCT01427504|100521820|FG005|COMPLETED|Overall Study||4||
48082373|NCT01427504|100521815|FG000|NOT COMPLETED|Overall Study||0||
48082374|NCT01427504|100521816|FG001|NOT COMPLETED|Overall Study||1||
48082375|NCT01427504|100521817|FG002|NOT COMPLETED|Overall Study||1||
48082376|NCT01427504|100521818|FG003|NOT COMPLETED|Overall Study||1||
48082377|NCT01427504|100521819|FG004|NOT COMPLETED|Overall Study||1||
48082378|NCT01427504|100521820|FG005|NOT COMPLETED|Overall Study||2||
48082379|NCT02601469|100521821|FG000|STARTED|Overall Study||25||
48082380|NCT02601469|100521822|FG001|STARTED|Overall Study||1||
48082381|NCT02601469|100521821|FG000|COMPLETED|Overall Study||24||
48082382|NCT02601469|100521822|FG001|COMPLETED|Overall Study||1||
48082383|NCT02601469|100521821|FG000|NOT COMPLETED|Overall Study||1||
48082384|NCT02601469|100521822|FG001|NOT COMPLETED|Overall Study||0||
48082385|NCT00587054|100521823|FG000|STARTED|Overall Study||129||
48245454|NCT01846988|100917948|FG000|COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||15||
48082386|NCT00587054|100521823|FG000|COMPLETED|Overall Study||120||
48082387|NCT00587054|100521823|FG000|NOT COMPLETED|Overall Study||9||
48082388|NCT05374434|100521824|FG000|STARTED|Overall Study||5||
48082389|NCT05374434|100521825|FG001|STARTED|Overall Study||5||
48082390|NCT05374434|100521824|FG000|COMPLETED|Overall Study||5||
48082391|NCT05374434|100521825|FG001|COMPLETED|Overall Study||5||
48082392|NCT05374434|100521824|FG000|NOT COMPLETED|Overall Study||0||
48082393|NCT05374434|100521825|FG001|NOT COMPLETED|Overall Study||0||
48082394|NCT01055171|100521826|FG000|STARTED|Overall Study||29||
48082395|NCT01055171|100521827|FG001|STARTED|Overall Study||28||
48082396|NCT01055171|100521826|FG000|Retrieval Completion|Overall Study||25||
48245455|NCT01846988|100917949|FG001|COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0||
48245456|NCT01846988|100917950|FG002|COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0||
48245457|NCT01846988|100917948|FG000|NOT COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0||
48245458|NCT01846988|100917949|FG001|NOT COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0||
48245459|NCT01846988|100917950|FG002|NOT COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0||
48245460|NCT01846988|100917948|FG000|STARTED|Intervention #1 - 4 Weeks||0||
48245461|NCT01846988|100917949|FG001|STARTED|Intervention #1 - 4 Weeks||5||
48245462|NCT01846988|100917950|FG002|STARTED|Intervention #1 - 4 Weeks||5||
48245463|NCT01846988|100917948|FG000|COMPLETED|Intervention #1 - 4 Weeks||0||
48245464|NCT01846988|100917949|FG001|COMPLETED|Intervention #1 - 4 Weeks||5||
48245465|NCT01846988|100917950|FG002|COMPLETED|Intervention #1 - 4 Weeks||5||
48245466|NCT01846988|100917948|FG000|NOT COMPLETED|Intervention #1 - 4 Weeks||0||
48245467|NCT01846988|100917949|FG001|NOT COMPLETED|Intervention #1 - 4 Weeks||0||
48245468|NCT01846988|100917950|FG002|NOT COMPLETED|Intervention #1 - 4 Weeks||0||
48245469|NCT01846988|100917948|FG000|STARTED|Intervention #2 - 4 Weeks||0||
48245470|NCT01846988|100917949|FG001|STARTED|Intervention #2 - 4 Weeks||5||
48245471|NCT01846988|100917950|FG002|STARTED|Intervention #2 - 4 Weeks||5||
48245472|NCT01846988|100917948|FG000|COMPLETED|Intervention #2 - 4 Weeks||0||
48245473|NCT01846988|100917949|FG001|COMPLETED|Intervention #2 - 4 Weeks||5||
48245474|NCT01846988|100917950|FG002|COMPLETED|Intervention #2 - 4 Weeks||5||
48245475|NCT01846988|100917948|FG000|NOT COMPLETED|Intervention #2 - 4 Weeks||0||
48245476|NCT01846988|100917949|FG001|NOT COMPLETED|Intervention #2 - 4 Weeks||0||
48082397|NCT01055171|100521827|FG001|Retrieval Completion|Overall Study||24||
48082398|NCT01055171|100521826|FG000|Test Procedure Completion|Overall Study||21||
48082399|NCT01055171|100521827|FG001|Test Procedure Completion|Overall Study||23||
48082400|NCT01055171|100521826|FG000|COMPLETED|Overall Study||18||
48082401|NCT01055171|100521827|FG001|COMPLETED|Overall Study||21||
48082402|NCT01055171|100521826|FG000|NOT COMPLETED|Overall Study||11||
48245477|NCT01846988|100917950|FG002|NOT COMPLETED|Intervention #2 - 4 Weeks||0||
48245478|NCT03866434|100917951|FG000|STARTED|Overall Study||20||
48245479|NCT03866434|100917951|FG000|COMPLETED|Overall Study||20||
48082403|NCT01055171|100521827|FG001|NOT COMPLETED|Overall Study||7||
48082404|NCT01365910|100521828|FG000|STARTED|Overall Study||30||
48082405|NCT01365910|100521828|FG000|COMPLETED|Overall Study||0||
48082406|NCT01365910|100521828|FG000|NOT COMPLETED|Overall Study||30||
48082407|NCT00439244|100521829|FG000|STARTED|Overall Study||137||
48082408|NCT00439244|100521830|FG001|STARTED|Overall Study||137||
48540734|NCT02027428|101662558|FG000|Received Study Drug|Induction||420||
48540735|NCT02027428|101662559|FG001|Received Study Drug|Induction||0||
48540736|NCT02027428|101662560|FG002|Received Study Drug|Induction||0||
48540737|NCT02027428|101662558|FG000|COMPLETED|Induction||202|Completed = participants who continued to maintenance period.|
48082409|NCT00439244|100521831|FG002|STARTED|Overall Study||138||
48082410|NCT00439244|100521829|FG000|Safety Population|Overall Study||137||
48082411|NCT00439244|100521830|FG001|Safety Population|Overall Study||137||
48082412|NCT00439244|100521831|FG002|Safety Population|Overall Study||137||
48245480|NCT03866434|100917951|FG000|NOT COMPLETED|Overall Study||0||
48245481|NCT03340766|100917952|FG000|STARTED|Overall Study||12||
48245482|NCT03340766|100917953|FG001|STARTED|Overall Study||10||
48245483|NCT03340766|100917954|FG002|STARTED|Overall Study||9||
48245484|NCT03340766|100917952|FG000|Received Blinatumomab|Overall Study||12||
48245485|NCT03340766|100917953|FG001|Received Blinatumomab|Overall Study||10||
48082413|NCT00439244|100521829|FG000|COMPLETED|Overall Study||126||
48082414|NCT00439244|100521830|FG001|COMPLETED|Overall Study||131||
48082415|NCT00439244|100521831|FG002|COMPLETED|Overall Study||131||
48082416|NCT00439244|100521829|FG000|NOT COMPLETED|Overall Study||11||
48082417|NCT00439244|100521830|FG001|NOT COMPLETED|Overall Study||6||
48082418|NCT00439244|100521831|FG002|NOT COMPLETED|Overall Study||7||
48082419|NCT04869644|100521832|FG000|STARTED|Assessed for Eligibility||114||
48082420|NCT04869644|100521832|FG000|Did Not Meet or Complete Inclusion Criteria|Assessed for Eligibility||35||
48082421|NCT04869644|100521832|FG000|Did Not Consent to Study|Assessed for Eligibility||30||
48082422|NCT04869644|100521832|FG000|COMPLETED|Assessed for Eligibility||49||
48082423|NCT04869644|100521832|FG000|NOT COMPLETED|Assessed for Eligibility||65||
48082424|NCT04869644|100521832|FG000|STARTED|Enrolled in Study||49||
48082425|NCT04869644|100521832|FG000|Withdrew From Study|Enrolled in Study||5||
48082426|NCT04869644|100521832|FG000|COMPLETED|Enrolled in Study||44||
48082427|NCT04869644|100521832|FG000|NOT COMPLETED|Enrolled in Study||5||
48082428|NCT04869644|100521832|FG000|STARTED|Baseline||44||
48082429|NCT04869644|100521832|FG000|Ineligible After Baseline|Baseline||8||
48082430|NCT04869644|100521832|FG000|Withdrew From Study|Baseline||2||
48082431|NCT04869644|100521832|FG000|COMPLETED|Baseline||34||
48082432|NCT04869644|100521832|FG000|NOT COMPLETED|Baseline||10||
48082433|NCT04869644|100521832|FG000|STARTED|Intervention||34||
48082434|NCT04869644|100521832|FG000|Discontinued Intervention|Intervention||2||
48082435|NCT04869644|100521832|FG000|COMPLETED|Intervention||32||
48082436|NCT04869644|100521832|FG000|NOT COMPLETED|Intervention||2||
48082437|NCT02480439|100521833|FG000|STARTED|Treatment Period 1||8||
48082438|NCT02480439|100521834|FG001|STARTED|Treatment Period 1||8||
48082439|NCT02480439|100521835|FG002|STARTED|Treatment Period 1||8||
48082440|NCT02480439|100521833|FG000|COMPLETED|Treatment Period 1||8||
48082441|NCT02480439|100521834|FG001|COMPLETED|Treatment Period 1||8||
48082442|NCT02480439|100521835|FG002|COMPLETED|Treatment Period 1||8||
48082443|NCT02480439|100521833|FG000|NOT COMPLETED|Treatment Period 1||0||
48245486|NCT03340766|100917954|FG002|Received Blinatumomab|Overall Study||9||
48245487|NCT03340766|100917952|FG000|Received Pembrolizumab|Overall Study||10||
48245488|NCT03340766|100917953|FG001|Received Pembrolizumab|Overall Study||7||
48245489|NCT03340766|100917954|FG002|Received Pembrolizumab|Overall Study||7||
48245490|NCT03340766|100917952|FG000|COMPLETED|Overall Study||4||
48245491|NCT03340766|100917953|FG001|COMPLETED|Overall Study||2||
48245492|NCT03340766|100917954|FG002|COMPLETED|Overall Study||1||
48245493|NCT03340766|100917952|FG000|NOT COMPLETED|Overall Study||8||
48245494|NCT03340766|100917953|FG001|NOT COMPLETED|Overall Study||8||
48245495|NCT03340766|100917954|FG002|NOT COMPLETED|Overall Study||8||
48245496|NCT01350102|100917955|FG000|STARTED|Overall Study||0||
48245497|NCT01350102|100917956|FG001|STARTED|Overall Study||1||
48245498|NCT01350102|100917957|FG002|STARTED|Overall Study||1||
48245499|NCT01350102|100917958|FG003|STARTED|Overall Study||0||
48245500|NCT01350102|100917955|FG000|COMPLETED|Overall Study||0||
48245501|NCT01350102|100917956|FG001|COMPLETED|Overall Study||1||
48245502|NCT01350102|100917957|FG002|COMPLETED|Overall Study||0||
48245503|NCT01350102|100917958|FG003|COMPLETED|Overall Study||0||
48245504|NCT01350102|100917955|FG000|NOT COMPLETED|Overall Study||0||
48082444|NCT02480439|100521834|FG001|NOT COMPLETED|Treatment Period 1||0||
48082445|NCT02480439|100521835|FG002|NOT COMPLETED|Treatment Period 1||0||
48082446|NCT02480439|100521833|FG000|STARTED|Treatment Period 2||8||
48082447|NCT02480439|100521834|FG001|STARTED|Treatment Period 2||7||
48082448|NCT02480439|100521835|FG002|STARTED|Treatment Period 2||8||
48245505|NCT01350102|100917956|FG001|NOT COMPLETED|Overall Study||0||
48245506|NCT01350102|100917957|FG002|NOT COMPLETED|Overall Study||1||
48245507|NCT01350102|100917958|FG003|NOT COMPLETED|Overall Study||0||
48082449|NCT02480439|100521833|FG000|COMPLETED|Treatment Period 2||8||
48082450|NCT02480439|100521834|FG001|COMPLETED|Treatment Period 2||7||
48082451|NCT02480439|100521835|FG002|COMPLETED|Treatment Period 2||8||
48082452|NCT02480439|100521833|FG000|NOT COMPLETED|Treatment Period 2||0||
48082453|NCT02480439|100521834|FG001|NOT COMPLETED|Treatment Period 2||0||
48082454|NCT02480439|100521835|FG002|NOT COMPLETED|Treatment Period 2||0||
48082455|NCT02480439|100521833|FG000|STARTED|Treatment Period 3||8||
48245508|NCT01757171|100917959|FG000|STARTED|Overall Study||61||
48082456|NCT02480439|100521834|FG001|STARTED|Treatment Period 3||7||
48082457|NCT02480439|100521835|FG002|STARTED|Treatment Period 3||7||
48082458|NCT02480439|100521833|FG000|COMPLETED|Treatment Period 3||8||
48082459|NCT02480439|100521834|FG001|COMPLETED|Treatment Period 3||7||
48082460|NCT02480439|100521835|FG002|COMPLETED|Treatment Period 3||7||
48082461|NCT02480439|100521833|FG000|NOT COMPLETED|Treatment Period 3||0||
48082462|NCT02480439|100521834|FG001|NOT COMPLETED|Treatment Period 3||0||
48082463|NCT02480439|100521835|FG002|NOT COMPLETED|Treatment Period 3||0||
48082464|NCT02804932|100521836|FG000|STARTED|Overall Study||20||
48082465|NCT02804932|100521837|FG001|STARTED|Overall Study||19||
48082466|NCT02804932|100521838|FG002|STARTED|Overall Study||15||
48082467|NCT02804932|100521836|FG000|COMPLETED|Overall Study||19||
48082468|NCT02804932|100521837|FG001|COMPLETED|Overall Study||18||
48082469|NCT02804932|100521838|FG002|COMPLETED|Overall Study||15||
48082470|NCT02804932|100521836|FG000|NOT COMPLETED|Overall Study||1||
48082471|NCT02804932|100521837|FG001|NOT COMPLETED|Overall Study||1||
48082472|NCT02804932|100521838|FG002|NOT COMPLETED|Overall Study||0||
48082473|NCT03032705|100521839|FG000|STARTED|Overall Study||51|"Each participant was analyzed for both groups therefore the total number of participants is equal to participants in both groups, not the sum of both groups which is 51.~Each participants contributed 2 randomly selected teeth for each study group therefore 1 participant contributing 2 study teeth in each case."|51
48082474|NCT03032705|100521840|FG001|STARTED|Overall Study||51|"Each participant was analyzed for both groups therefore the total number of participants is equal to participants in both groups, not the sum of both groups which is 51.~Each participants contributed 2 randomly selected teeth for each study group therefore 1 participant contributing 2 study teeth in each case."|51
48082475|NCT03032705|100521839|FG000|Completion of Restorations (V2)|Overall Study||45|45 participants total for both groups|45
48082476|NCT03032705|100521840|FG001|Completion of Restorations (V2)|Overall Study||45|45 participants total for both groups|45
48082477|NCT03032705|100521839|FG000|COMPLETED|Overall Study||29|Completion of 18 month follow up visit (Visit #5) 29 participants for SonicFill2 group 28 particiants for Filtek Supreme group|29
48082478|NCT03032705|100521840|FG001|COMPLETED|Overall Study||28|Completion of 18 month follow up visit (Visit #5) 29 participants for SonicFill2 group 28 particiants for Filtek Supreme group|28
48082479|NCT03032705|100521839|FG000|NOT COMPLETED|Overall Study||22||22
48082480|NCT03032705|100521840|FG001|NOT COMPLETED|Overall Study||23||23
48082481|NCT04502589|100521841|FG000|STARTED|Overall Study||2||
48082482|NCT04502589|100521842|FG001|STARTED|Overall Study||2||
48082483|NCT04502589|100521841|FG000|COMPLETED|Overall Study||1||
48082484|NCT04502589|100521842|FG001|COMPLETED|Overall Study||2||
48082485|NCT04502589|100521841|FG000|NOT COMPLETED|Overall Study||1||
48082486|NCT04502589|100521842|FG001|NOT COMPLETED|Overall Study||0||
48082487|NCT03766581|100521843|FG000|STARTED|Randomization||691||
48245509|NCT01757171|100917960|FG001|STARTED|Overall Study||24||
48245510|NCT01757171|100917959|FG000|COMPLETED|Overall Study||53||
48245511|NCT01757171|100917960|FG001|COMPLETED|Overall Study||23||
48245512|NCT01757171|100917959|FG000|NOT COMPLETED|Overall Study||8||
48540738|NCT02027428|101662559|FG001|COMPLETED|Induction||0|Completed = participants who continued to maintenance period.|
48082488|NCT03766581|100521844|FG001|STARTED|Randomization||328||
48082489|NCT03766581|100521845|FG002|STARTED|Randomization||318||
48082490|NCT03766581|100521846|FG003|STARTED|Randomization||328||
48082491|NCT03766581|100521847|FG004|STARTED|Randomization||310||
48082492|NCT03766581|100521848|FG005|STARTED|Randomization||351||
48082493|NCT03766581|100521849|FG006|STARTED|Randomization||22||
48082494|NCT03766581|100521850|FG007|STARTED|Randomization||18||
48082495|NCT03766581|100521843|FG000|COMPLETED|Randomization||682||
48082496|NCT03766581|100521844|FG001|COMPLETED|Randomization||324||
48082497|NCT03766581|100521845|FG002|COMPLETED|Randomization||313||
48082498|NCT03766581|100521846|FG003|COMPLETED|Randomization||325||
48082499|NCT03766581|100521847|FG004|COMPLETED|Randomization||306||
48082500|NCT03766581|100521848|FG005|COMPLETED|Randomization||345||
48082501|NCT03766581|100521849|FG006|COMPLETED|Randomization||22||
48245513|NCT01757171|100917960|FG001|NOT COMPLETED|Overall Study||1||
48245514|NCT03861078|100917961|FG000|STARTED|Overall Study||22||
48082502|NCT03766581|100521850|FG007|COMPLETED|Randomization||17||
48082503|NCT03766581|100521843|FG000|NOT COMPLETED|Randomization||9||
48082504|NCT03766581|100521844|FG001|NOT COMPLETED|Randomization||4||
48082505|NCT03766581|100521845|FG002|NOT COMPLETED|Randomization||5||
48082506|NCT03766581|100521846|FG003|NOT COMPLETED|Randomization||3||
48082507|NCT03766581|100521847|FG004|NOT COMPLETED|Randomization||4||
48082508|NCT03766581|100521848|FG005|NOT COMPLETED|Randomization||6||
48245515|NCT03861078|100917961|FG000|Session 1: Own Brand Cigarette Use|Overall Study||14||
48245516|NCT03861078|100917961|FG000|Session 2: ECIG 15 mg Nicotine, Sweetened|Overall Study||14||
48245517|NCT03861078|100917961|FG000|Session 3: ECIG Lab Session ECIG 15 mg Nicotine, Unsweetened|Overall Study||14||
48245518|NCT03861078|100917961|FG000|Session 4: ECIG Lab Session ECIG 0 mg Nicotine, Sweetened|Overall Study||14||
48245519|NCT03861078|100917961|FG000|Session 5: ECIG Lab Session ECIG 0 mg Nicotine, Unsweetened|Overall Study||14||
48245520|NCT03861078|100917961|FG000|COMPLETED|Overall Study||14||
48245521|NCT03861078|100917961|FG000|NOT COMPLETED|Overall Study||8||
48245522|NCT00212888|100917962|FG000|STARTED|Overall Study||19||
48245523|NCT00212888|100917963|FG001|STARTED|Overall Study||18||
48245524|NCT00212888|100917964|FG002|STARTED|Overall Study||15||
48245525|NCT00212888|100917962|FG000|COMPLETED|Overall Study||16||
48245526|NCT00212888|100917963|FG001|COMPLETED|Overall Study||18||
48245527|NCT00212888|100917964|FG002|COMPLETED|Overall Study||14||
48245528|NCT00212888|100917962|FG000|NOT COMPLETED|Overall Study||3||
48245529|NCT00212888|100917963|FG001|NOT COMPLETED|Overall Study||0||
48245530|NCT00212888|100917964|FG002|NOT COMPLETED|Overall Study||1||
48082509|NCT03766581|100521849|FG006|NOT COMPLETED|Randomization||0||
48681901|NCT01061385|102006506|FG001|STARTED|Overall Study||9||
48681902|NCT01061385|102006505|FG000|COMPLETED|Overall Study||20||
48681903|NCT01061385|102006506|FG001|COMPLETED|Overall Study||8||
48681904|NCT01061385|102006505|FG000|NOT COMPLETED|Overall Study||1||
48681905|NCT01061385|102006506|FG001|NOT COMPLETED|Overall Study||1||
48681906|NCT01492088|102006507|FG000|STARTED|Overall Study||3||
48681907|NCT01492088|102006508|FG001|STARTED|Overall Study||16||
48681908|NCT01492088|102006509|FG002|STARTED|Overall Study||17||
48082510|NCT03766581|100521850|FG007|NOT COMPLETED|Randomization||1||
48681909|NCT01492088|102006507|FG000|COMPLETED|Overall Study||0||
48681910|NCT01492088|102006508|FG001|COMPLETED|Overall Study||2||
48681911|NCT01492088|102006509|FG002|COMPLETED|Overall Study||3||
48681912|NCT01492088|102006507|FG000|NOT COMPLETED|Overall Study||3||
48681913|NCT01492088|102006508|FG001|NOT COMPLETED|Overall Study||14||
48681914|NCT01492088|102006509|FG002|NOT COMPLETED|Overall Study||14||
48681915|NCT00339040|102006510|FG000|STARTED|Stage I||96||
48681916|NCT00339040|102006511|FG001|STARTED|Stage I||30||
48681917|NCT00339040|102006510|FG000|Vaccination 1 at Week 0|Stage I||96||
48681918|NCT00339040|102006511|FG001|Vaccination 1 at Week 0|Stage I||30||
48681919|NCT00339040|102006510|FG000|Vaccination 2 at Week 8|Stage I||95||
48681920|NCT00339040|102006511|FG001|Vaccination 2 at Week 8|Stage I||30||
48681921|NCT00339040|102006510|FG000|Vaccination 3 at Week 24|Stage I||94||
48681922|NCT00339040|102006511|FG001|Vaccination 3 at Week 24|Stage I||30||
48681923|NCT00339040|102006510|FG000|COMPLETED|Stage I||94||
48681924|NCT00339040|102006511|FG001|COMPLETED|Stage I||29||
48681925|NCT00339040|102006510|FG000|NOT COMPLETED|Stage I||2||
48681926|NCT00339040|102006511|FG001|NOT COMPLETED|Stage I||1||
48681927|NCT00339040|102006510|FG000|STARTED|Stage II||94||
48681928|NCT00339040|102006511|FG001|STARTED|Stage II||29||
48681929|NCT00339040|102006510|FG000|Vaccination 4 at Week 96|Stage II||84||
48681930|NCT00339040|102006511|FG001|Vaccination 4 at Week 96|Stage II||29||
48681931|NCT00339040|102006510|FG000|Vaccination 5 at Week 104|Stage II||0||
48681932|NCT00339040|102006511|FG001|Vaccination 5 at Week 104|Stage II||28||
48681933|NCT00339040|102006510|FG000|Vaccination 6 at Week 120|Stage II||0||
48681934|NCT00339040|102006511|FG001|Vaccination 6 at Week 120|Stage II||27||
48681935|NCT00339040|102006510|FG000|COMPLETED|Stage II||84||
48681936|NCT00339040|102006511|FG001|COMPLETED|Stage II||27||
48681937|NCT00339040|102006510|FG000|NOT COMPLETED|Stage II||10||
48681938|NCT00339040|102006511|FG001|NOT COMPLETED|Stage II||2||
48681939|NCT01123148|102006512|FG000|STARTED|Overall Study||14||
48681940|NCT01123148|102006512|FG000|BCI Calibration >50% Accuracy|Overall Study||13||
48681941|NCT01123148|102006512|FG000|COMPLETED|Overall Study||12||
48681942|NCT01123148|102006512|FG000|NOT COMPLETED|Overall Study||2||
48681943|NCT01531998|102006513|FG000|STARTED|Overall Study||11||
48681944|NCT01531998|102006513|FG000|COMPLETED|Overall Study||8||
48681945|NCT01531998|102006513|FG000|NOT COMPLETED|Overall Study||3||
48681946|NCT04828707|102006514|FG000|STARTED|Overall Study||128||
48681947|NCT04828707|102006515|FG001|STARTED|Overall Study||120||
48681948|NCT04828707|102006514|FG000|COMPLETED|Overall Study||123||
48681949|NCT04828707|102006515|FG001|COMPLETED|Overall Study||117||
48681950|NCT04828707|102006514|FG000|NOT COMPLETED|Overall Study||5||
48681951|NCT04828707|102006515|FG001|NOT COMPLETED|Overall Study||3||
48681952|NCT02078752|102006516|FG000|STARTED|Overall Study||3||
48681953|NCT02078752|102006517|FG001|STARTED|Overall Study||13||
48082511|NCT03766581|100521843|FG000|STARTED|Treatment||682||
48082512|NCT03766581|100521844|FG001|STARTED|Treatment||325||
48681954|NCT02078752|102006518|FG002|STARTED|Overall Study||2||
48681955|NCT02078752|102006519|FG003|STARTED|Overall Study||7||
48681956|NCT02078752|102006520|FG004|STARTED|Overall Study||3||
48681957|NCT02078752|102006521|FG005|STARTED|Overall Study||9||
48082513|NCT03766581|100521845|FG002|STARTED|Treatment||313||
48681958|NCT02078752|102006522|FG006|STARTED|Overall Study||3||
48681959|NCT02078752|102006523|FG007|STARTED|Overall Study||6||
48681960|NCT02078752|102006524|FG008|STARTED|Overall Study||2||
48681961|NCT02078752|102006525|FG009|STARTED|Overall Study||12||
48681962|NCT02078752|102006516|FG000|COMPLETED|Overall Study||1||
48082514|NCT03766581|100521846|FG003|STARTED|Treatment||325||
48245531|NCT00975130|100917965|FG000|STARTED|Study Part 1||3366||
48245532|NCT00975130|100917966|FG001|STARTED|Study Part 1||0||
48245533|NCT00975130|100917967|FG002|STARTED|Study Part 1||0||
48245534|NCT00975130|100917965|FG000|COMPLETED|Study Part 1||3086||
48082515|NCT03766581|100521847|FG004|STARTED|Treatment||306||
48082516|NCT03766581|100521848|FG005|STARTED|Treatment||344||
48681963|NCT02078752|102006517|FG001|COMPLETED|Overall Study||6||
48681964|NCT02078752|102006518|FG002|COMPLETED|Overall Study||1||
48681965|NCT02078752|102006519|FG003|COMPLETED|Overall Study||5||
48681966|NCT02078752|102006520|FG004|COMPLETED|Overall Study||2||
48681967|NCT02078752|102006521|FG005|COMPLETED|Overall Study||5||
48681968|NCT02078752|102006522|FG006|COMPLETED|Overall Study||1||
48681969|NCT02078752|102006523|FG007|COMPLETED|Overall Study||3||
48681970|NCT02078752|102006524|FG008|COMPLETED|Overall Study||2||
48681971|NCT02078752|102006525|FG009|COMPLETED|Overall Study||2||
48681972|NCT02078752|102006516|FG000|NOT COMPLETED|Overall Study||2||
48681973|NCT02078752|102006517|FG001|NOT COMPLETED|Overall Study||7||
48245535|NCT00975130|100917966|FG001|COMPLETED|Study Part 1||0||
48245536|NCT00975130|100917967|FG002|COMPLETED|Study Part 1||0||
48245537|NCT00975130|100917965|FG000|NOT COMPLETED|Study Part 1||280||
48245538|NCT00975130|100917966|FG001|NOT COMPLETED|Study Part 1||0||
48245539|NCT00975130|100917967|FG002|NOT COMPLETED|Study Part 1||0||
48245540|NCT00975130|100917965|FG000|STARTED|Study Part 2||0||
48245541|NCT00975130|100917966|FG001|STARTED|Study Part 2||250||
48245542|NCT00975130|100917967|FG002|STARTED|Study Part 2||255||
48245543|NCT00975130|100917965|FG000|COMPLETED|Study Part 2||0||
48245544|NCT00975130|100917966|FG001|COMPLETED|Study Part 2||212||
48082517|NCT03766581|100521849|FG006|STARTED|Treatment||22||
48245545|NCT00975130|100917967|FG002|COMPLETED|Study Part 2||238||
48245546|NCT00975130|100917965|FG000|NOT COMPLETED|Study Part 2||0||
48245547|NCT00975130|100917966|FG001|NOT COMPLETED|Study Part 2||38||
48245548|NCT00975130|100917967|FG002|NOT COMPLETED|Study Part 2||17||
48245549|NCT01350388|100917968|FG000|STARTED|Overall Study||40||
48245550|NCT01350388|100917969|FG001|STARTED|Overall Study||40||
48245551|NCT01350388|100917968|FG000|COMPLETED|Overall Study||37||
48245552|NCT01350388|100917969|FG001|COMPLETED|Overall Study||39||
48245553|NCT01350388|100917968|FG000|NOT COMPLETED|Overall Study||3||
48245554|NCT01350388|100917969|FG001|NOT COMPLETED|Overall Study||1||
48245555|NCT01212952|100917970|FG000|STARTED|Overall Study||3||
48245556|NCT01212952|100917971|FG001|STARTED|Overall Study||6||
48245557|NCT01212952|100917972|FG002|STARTED|Overall Study||41||
48245558|NCT01212952|100917970|FG000|COMPLETED|Overall Study||3||
48245559|NCT01212952|100917971|FG001|COMPLETED|Overall Study||6||
48245560|NCT01212952|100917972|FG002|COMPLETED|Overall Study||41||
48245561|NCT01212952|100917970|FG000|NOT COMPLETED|Overall Study||0||
48245562|NCT01212952|100917971|FG001|NOT COMPLETED|Overall Study||0||
48245563|NCT01212952|100917972|FG002|NOT COMPLETED|Overall Study||0||
48245564|NCT01753323|100917973|FG000|STARTED|Overall Study||11||
48245565|NCT01753323|100917974|FG001|STARTED|Overall Study||10||
48245566|NCT01753323|100917975|FG002|STARTED|Overall Study||22||
48245567|NCT01753323|100917973|FG000|Pharmacodynamic (PD) Set|Overall Study||10||
48245568|NCT01753323|100917974|FG001|Pharmacodynamic (PD) Set|Overall Study||10||
48245569|NCT01753323|100917975|FG002|Pharmacodynamic (PD) Set|Overall Study||21||
48245570|NCT01753323|100917973|FG000|Pharmacokinetic(PK) Set|Overall Study||10||
48245571|NCT01753323|100917974|FG001|Pharmacokinetic(PK) Set|Overall Study||10||
48540739|NCT02027428|101662560|FG002|COMPLETED|Induction||0|Completed = participants who continued to maintenance period.|
48540740|NCT02027428|101662558|FG000|NOT COMPLETED|Induction||225||
48540741|NCT02027428|101662559|FG001|NOT COMPLETED|Induction||0||
48540742|NCT02027428|101662560|FG002|NOT COMPLETED|Induction||0||
48540743|NCT02027428|101662558|FG000|STARTED|Maintenance||0||
48540744|NCT02027428|101662559|FG001|STARTED|Maintenance||136||
48540745|NCT02027428|101662560|FG002|STARTED|Maintenance||66||
48540746|NCT02027428|101662558|FG000|COMPLETED|Maintenance||0|Completed = Participants who continued on treatment|
48540747|NCT02027428|101662559|FG001|COMPLETED|Maintenance||12|Completed = Participants who continued on treatment|
48540748|NCT02027428|101662560|FG002|COMPLETED|Maintenance||6|Completed = Participants who continued on treatment|
48540749|NCT02027428|101662558|FG000|NOT COMPLETED|Maintenance||0||
48540750|NCT02027428|101662559|FG001|NOT COMPLETED|Maintenance||124||
48540751|NCT02027428|101662560|FG002|NOT COMPLETED|Maintenance||60||
48540752|NCT02027428|101662558|FG000|STARTED|Survival Follow-up||0||
48681974|NCT02078752|102006518|FG002|NOT COMPLETED|Overall Study||1||
48681975|NCT02078752|102006519|FG003|NOT COMPLETED|Overall Study||2||
48082518|NCT03766581|100521850|FG007|STARTED|Treatment||17||
48245572|NCT01753323|100917975|FG002|Pharmacokinetic(PK) Set|Overall Study||21||
48245573|NCT01753323|100917973|FG000|Safety Set|Overall Study||11||
48245574|NCT01753323|100917974|FG001|Safety Set|Overall Study||10||
48540753|NCT02027428|101662559|FG001|STARTED|Survival Follow-up||117||
48245575|NCT01753323|100917975|FG002|Safety Set|Overall Study||22||
48245576|NCT01753323|100917973|FG000|Intent-to-treat Analysis Set|Overall Study||11||
48245577|NCT01753323|100917974|FG001|Intent-to-treat Analysis Set|Overall Study||10||
48245578|NCT01753323|100917975|FG002|Intent-to-treat Analysis Set|Overall Study||22||
48540754|NCT02027428|101662560|FG002|STARTED|Survival Follow-up||55||
48681976|NCT02078752|102006520|FG004|NOT COMPLETED|Overall Study||1||
48082519|NCT03766581|100521843|FG000|COMPLETED|Treatment||529||
48082520|NCT03766581|100521844|FG001|COMPLETED|Treatment||260||
48082521|NCT03766581|100521845|FG002|COMPLETED|Treatment||242||
48082522|NCT03766581|100521846|FG003|COMPLETED|Treatment||251||
48245579|NCT01753323|100917973|FG000|COMPLETED|Overall Study||10||
48245580|NCT01753323|100917974|FG001|COMPLETED|Overall Study||10||
48245581|NCT01753323|100917975|FG002|COMPLETED|Overall Study||13||
48245582|NCT01753323|100917973|FG000|NOT COMPLETED|Overall Study||1||
48245583|NCT01753323|100917974|FG001|NOT COMPLETED|Overall Study||0||
48245584|NCT01753323|100917975|FG002|NOT COMPLETED|Overall Study||9||
48245585|NCT00672100|100920845|FG000|STARTED|Overall Study||12||
48245586|NCT00672100|100920846|FG001|STARTED|Overall Study||12||
48245587|NCT00672100|100920847|FG002|STARTED|Overall Study||12||
48245588|NCT00672100|100920845|FG000|PACU (Within 8 Hours)|Overall Study||12||
48245589|NCT00672100|100920846|FG001|PACU (Within 8 Hours)|Overall Study||12||
48245590|NCT00672100|100920847|FG002|PACU (Within 8 Hours)|Overall Study||12||
48245591|NCT00672100|100920845|FG000|COMPLETED|Overall Study||12||
48245592|NCT00672100|100920846|FG001|COMPLETED|Overall Study||12||
48245593|NCT00672100|100920847|FG002|COMPLETED|Overall Study||12||
48245594|NCT00672100|100920845|FG000|NOT COMPLETED|Overall Study||0||
48245595|NCT00672100|100920846|FG001|NOT COMPLETED|Overall Study||0||
48245596|NCT00672100|100920847|FG002|NOT COMPLETED|Overall Study||0||
48245597|NCT01544309|100920848|FG000|STARTED|Overall Study||524||
48245598|NCT01544309|100920849|FG001|STARTED|Overall Study||525||
48245599|NCT01544309|100920848|FG000|COMPLETED|Overall Study||504||
48245600|NCT01544309|100920849|FG001|COMPLETED|Overall Study||514||
48245601|NCT01544309|100920848|FG000|NOT COMPLETED|Overall Study||20||
48245602|NCT01544309|100920849|FG001|NOT COMPLETED|Overall Study||11||
48245603|NCT03575572|100920850|FG000|STARTED|Overall Study||9|Started is defined here to mean first sample collected.|
48245604|NCT03575572|100920850|FG000|COMPLETED|Overall Study||5||
48245605|NCT03575572|100920850|FG000|NOT COMPLETED|Overall Study||4||
48245606|NCT01769352|100920851|FG000|STARTED|Overall Study||13||
48245607|NCT01769352|100920852|FG001|STARTED|Overall Study||12||
48245608|NCT01769352|100920853|FG002|STARTED|Overall Study||9||
48245609|NCT01769352|100920854|FG003|STARTED|Overall Study||8||
48245610|NCT01769352|100920851|FG000|COMPLETED|Overall Study||13||
48245611|NCT01769352|100920852|FG001|COMPLETED|Overall Study||12||
48245612|NCT01769352|100920853|FG002|COMPLETED|Overall Study||9||
48245613|NCT01769352|100920854|FG003|COMPLETED|Overall Study||8||
48245614|NCT01769352|100920851|FG000|NOT COMPLETED|Overall Study||0||
48245615|NCT01769352|100920852|FG001|NOT COMPLETED|Overall Study||0||
48245616|NCT01769352|100920853|FG002|NOT COMPLETED|Overall Study||0||
48245617|NCT01769352|100920854|FG003|NOT COMPLETED|Overall Study||0||
48245618|NCT03802513|100920855|FG000|STARTED|Overall Study||10||
48245619|NCT03802513|100920855|FG000|COMPLETED|Overall Study||9||
48245620|NCT03802513|100920855|FG000|NOT COMPLETED|Overall Study||1||
48245621|NCT03722485|100920856|FG000|STARTED|Overall Study||19||
48245622|NCT03722485|100920857|FG001|STARTED|Overall Study||25||
48245623|NCT03722485|100920856|FG000|COMPLETED|Overall Study||15||
48245624|NCT03722485|100920857|FG001|COMPLETED|Overall Study||18||
48245625|NCT03722485|100920856|FG000|NOT COMPLETED|Overall Study||4||
48245626|NCT03722485|100920857|FG001|NOT COMPLETED|Overall Study||7||
48245627|NCT02131155|100920858|FG000|STARTED|Overall Study||25||
48245628|NCT02131155|100920859|FG001|STARTED|Overall Study||11||
48245629|NCT02131155|100920858|FG000|COMPLETED|Overall Study||0||
48245630|NCT02131155|100920859|FG001|COMPLETED|Overall Study||0||
48245631|NCT02131155|100920858|FG000|NOT COMPLETED|Overall Study||25||
48245632|NCT02131155|100920859|FG001|NOT COMPLETED|Overall Study||11||
48245633|NCT03409276|100920860|FG000|STARTED|Overall Study||2||
48245634|NCT03409276|100920861|FG001|STARTED|Overall Study||10||
48245635|NCT03409276|100920862|FG002|STARTED|Overall Study||6||
48245636|NCT03409276|100920863|FG003|STARTED|Overall Study||21||
48540755|NCT02027428|101662558|FG000|COMPLETED|Survival Follow-up||0|Completed = Participants alive to end of study|
48592682|NCT01877382|101783154|FG004|COMPLETED|Dose Expansion||0||
48082523|NCT03766581|100521847|FG004|COMPLETED|Treatment||230||
48245637|NCT03409276|100920864|FG004|STARTED|Overall Study||21||
48082524|NCT03766581|100521848|FG005|COMPLETED|Treatment||240||
48082525|NCT03766581|100521849|FG006|COMPLETED|Treatment||15||
48082526|NCT03766581|100521850|FG007|COMPLETED|Treatment||14||
48082527|NCT03766581|100521843|FG000|NOT COMPLETED|Treatment||153||
48082528|NCT03766581|100521844|FG001|NOT COMPLETED|Treatment||65||
48082529|NCT03766581|100521845|FG002|NOT COMPLETED|Treatment||71||
48082530|NCT03766581|100521846|FG003|NOT COMPLETED|Treatment||74||
48082531|NCT03766581|100521847|FG004|NOT COMPLETED|Treatment||76||
48082532|NCT03766581|100521848|FG005|NOT COMPLETED|Treatment||104||
48082533|NCT03766581|100521849|FG006|NOT COMPLETED|Treatment||7||
48082534|NCT03766581|100521850|FG007|NOT COMPLETED|Treatment||3||
48245638|NCT03409276|100920860|FG000|Month 2.5 Immunogenicity Cohort|Overall Study||2||
48245639|NCT03409276|100920861|FG001|Month 2.5 Immunogenicity Cohort|Overall Study||10||
48245640|NCT03409276|100920862|FG002|Month 2.5 Immunogenicity Cohort|Overall Study||0||
48245641|NCT03409276|100920863|FG003|Month 2.5 Immunogenicity Cohort|Overall Study||0||
48245642|NCT03409276|100920864|FG004|Month 2.5 Immunogenicity Cohort|Overall Study||0||
48082535|NCT01606436|100521851|FG000|STARTED|Overall Study||14||
48082536|NCT01606436|100521852|FG001|STARTED|Overall Study||14||
48082537|NCT01606436|100521853|FG002|STARTED|Overall Study||14||
48082538|NCT01606436|100521854|FG003|STARTED|Overall Study||14||
48681977|NCT02078752|102006521|FG005|NOT COMPLETED|Overall Study||4||
48681978|NCT02078752|102006522|FG006|NOT COMPLETED|Overall Study||2||
48681979|NCT02078752|102006523|FG007|NOT COMPLETED|Overall Study||3||
48681980|NCT02078752|102006524|FG008|NOT COMPLETED|Overall Study||0||
48681981|NCT02078752|102006525|FG009|NOT COMPLETED|Overall Study||10||
48681982|NCT02504372|102006526|FG000|STARTED|Overall Study||590||
48681983|NCT02504372|102006527|FG001|STARTED|Overall Study||587||
48681984|NCT02504372|102006526|FG000|Treated|Overall Study||580||
48681985|NCT02504372|102006527|FG001|Treated|Overall Study||581||
48681986|NCT02504372|102006526|FG000|COMPLETED|Overall Study||0||
48681987|NCT02504372|102006527|FG001|COMPLETED|Overall Study||0||
48681988|NCT02504372|102006526|FG000|NOT COMPLETED|Overall Study||590||
48681989|NCT02504372|102006527|FG001|NOT COMPLETED|Overall Study||587||
48681990|NCT03141255|102006528|FG000|STARTED|Overall Study||10||
48681991|NCT03141255|102006529|FG001|STARTED|Overall Study||10||
48681992|NCT03141255|102006528|FG000|COMPLETED|Overall Study||10||
48681993|NCT03141255|102006529|FG001|COMPLETED|Overall Study||10||
48681994|NCT03141255|102006528|FG000|NOT COMPLETED|Overall Study||0||
48681995|NCT03141255|102006529|FG001|NOT COMPLETED|Overall Study||0||
48681996|NCT03688919|102006530|FG000|STARTED|Overall Study||41||
48681997|NCT03688919|102006531|FG001|STARTED|Overall Study||47||
48681998|NCT03688919|102006530|FG000|COMPLETED|Overall Study||38||
48681999|NCT03688919|102006531|FG001|COMPLETED|Overall Study||46||
48682000|NCT03688919|102006530|FG000|NOT COMPLETED|Overall Study||3||
48682001|NCT03688919|102006531|FG001|NOT COMPLETED|Overall Study||1||
48682002|NCT02746406|102006532|FG000|STARTED|Overall Study||5||
48682003|NCT02746406|102006532|FG000|COMPLETED|Overall Study||5||
48245643|NCT03409276|100920860|FG000|Month 8.5 Immunogenicity Cohort|Overall Study||0||
48245644|NCT03409276|100920861|FG001|Month 8.5 Immunogenicity Cohort|Overall Study||0||
48245645|NCT03409276|100920862|FG002|Month 8.5 Immunogenicity Cohort|Overall Study||6||
48245646|NCT03409276|100920863|FG003|Month 8.5 Immunogenicity Cohort|Overall Study||19||
48245647|NCT03409276|100920864|FG004|Month 8.5 Immunogenicity Cohort|Overall Study||16||
48245648|NCT03409276|100920860|FG000|COMPLETED|Overall Study||2||
48245649|NCT03409276|100920861|FG001|COMPLETED|Overall Study||10||
48245650|NCT03409276|100920862|FG002|COMPLETED|Overall Study||6||
48245651|NCT03409276|100920863|FG003|COMPLETED|Overall Study||19||
48245652|NCT03409276|100920864|FG004|COMPLETED|Overall Study||18||
48245653|NCT03409276|100920860|FG000|NOT COMPLETED|Overall Study||0||
48245654|NCT03409276|100920861|FG001|NOT COMPLETED|Overall Study||0||
48245655|NCT03409276|100920862|FG002|NOT COMPLETED|Overall Study||0||
48245656|NCT03409276|100920863|FG003|NOT COMPLETED|Overall Study||2||
48245657|NCT03409276|100920864|FG004|NOT COMPLETED|Overall Study||3||
48245658|NCT03735147|100920865|FG000|STARTED|Overall Study||12||
48245659|NCT03735147|100920865|FG000|COMPLETED|Overall Study||12||
48245660|NCT03735147|100920865|FG000|NOT COMPLETED|Overall Study||0||
48245661|NCT06091982|100920866|FG000|STARTED|Overall Study||302||
48245662|NCT06091982|100920867|FG001|STARTED|Overall Study||811||
48245663|NCT06091982|100920866|FG000|COMPLETED|Overall Study||302||
48245664|NCT06091982|100920867|FG001|COMPLETED|Overall Study||811||
48245665|NCT06091982|100920866|FG000|NOT COMPLETED|Overall Study||0||
48682004|NCT02746406|102006532|FG000|NOT COMPLETED|Overall Study||0||
48682005|NCT04568603|102006533|FG000|STARTED|Overall Study||14||
48682006|NCT04568603|102006533|FG000|Received ISL on Day 2|Overall Study||13||
48682007|NCT04568603|102006533|FG000|COMPLETED|Overall Study||13||
48682008|NCT04568603|102006533|FG000|NOT COMPLETED|Overall Study||1||
48682009|NCT01154452|102006534|FG000|STARTED|Phase Ib||6||
48682010|NCT01154452|102006535|FG001|STARTED|Phase Ib||4||
48682011|NCT01154452|102006536|FG002|STARTED|Phase Ib||0||
48682012|NCT01154452|102006537|FG003|STARTED|Phase Ib||0||
48682013|NCT01154452|102006534|FG000|COMPLETED|Phase Ib||3||
48682014|NCT01154452|102006535|FG001|COMPLETED|Phase Ib||3||
48682015|NCT01154452|102006536|FG002|COMPLETED|Phase Ib||0||
48682016|NCT01154452|102006537|FG003|COMPLETED|Phase Ib||0||
48682017|NCT01154452|102006534|FG000|NOT COMPLETED|Phase Ib||3||
48682018|NCT01154452|102006535|FG001|NOT COMPLETED|Phase Ib||1||
48682019|NCT01154452|102006536|FG002|NOT COMPLETED|Phase Ib||0||
48682020|NCT01154452|102006537|FG003|NOT COMPLETED|Phase Ib||0||
48682021|NCT01154452|102006534|FG000|STARTED|Phase II||0||
48245666|NCT06091982|100920867|FG001|NOT COMPLETED|Overall Study||0||
48245667|NCT00428441|100920868|FG000|STARTED|Overall Study||75||
48245668|NCT00428441|100920868|FG000|COMPLETED|Overall Study||74||
48245669|NCT00428441|100920868|FG000|NOT COMPLETED|Overall Study||1||
48082539|NCT01606436|100521855|FG004|STARTED|Overall Study||13||
48082540|NCT01606436|100521856|FG005|STARTED|Overall Study||14||
48682022|NCT01154452|102006535|FG001|STARTED|Phase II||0||
48682023|NCT01154452|102006536|FG002|STARTED|Phase II||35||
48682024|NCT01154452|102006537|FG003|STARTED|Phase II||33||
48682025|NCT01154452|102006534|FG000|COMPLETED|Phase II||0||
48082541|NCT01606436|100521851|FG000|Received First Intervention|Overall Study||14||
48245670|NCT00187135|100920869|FG000|STARTED|Visit One||30||
48245671|NCT00187135|100920870|FG001|STARTED|Visit One||28||
48245672|NCT00187135|100920871|FG002|STARTED|Visit One||25||
48245673|NCT00187135|100920872|FG003|STARTED|Visit One||26||
48245674|NCT00187135|100920873|FG004|STARTED|Visit One||25||
48245675|NCT00187135|100920874|FG005|STARTED|Visit One||28||
48082542|NCT01606436|100521852|FG001|Received First Intervention|Overall Study||14||
48245676|NCT00187135|100920869|FG000|COMPLETED|Visit One||26||
48682026|NCT01154452|102006535|FG001|COMPLETED|Phase II||0||
48682027|NCT01154452|102006536|FG002|COMPLETED|Phase II||30||
48682028|NCT01154452|102006537|FG003|COMPLETED|Phase II||27||
48682029|NCT01154452|102006534|FG000|NOT COMPLETED|Phase II||0||
48245677|NCT00187135|100920870|FG001|COMPLETED|Visit One||27||
48245678|NCT00187135|100920871|FG002|COMPLETED|Visit One||25||
48245679|NCT00187135|100920872|FG003|COMPLETED|Visit One||26||
48682030|NCT01154452|102006535|FG001|NOT COMPLETED|Phase II||0||
48682031|NCT01154452|102006536|FG002|NOT COMPLETED|Phase II||5||
48245680|NCT00187135|100920873|FG004|COMPLETED|Visit One||25||
48245681|NCT00187135|100920874|FG005|COMPLETED|Visit One||26||
48082543|NCT01606436|100521853|FG002|Received First Intervention|Overall Study||14||
48082544|NCT01606436|100521854|FG003|Received First Intervention|Overall Study||14||
48082545|NCT01606436|100521855|FG004|Received First Intervention|Overall Study||13||
48082546|NCT01606436|100521856|FG005|Received First Intervention|Overall Study||14||
48082547|NCT01606436|100521851|FG000|Received Second Intervention|Overall Study||14||
48082548|NCT01606436|100521852|FG001|Received Second Intervention|Overall Study||14||
48245682|NCT00187135|100920869|FG000|NOT COMPLETED|Visit One||4||
48245683|NCT00187135|100920870|FG001|NOT COMPLETED|Visit One||1||
48245684|NCT00187135|100920871|FG002|NOT COMPLETED|Visit One||0||
48245685|NCT00187135|100920872|FG003|NOT COMPLETED|Visit One||0||
48245686|NCT00187135|100920873|FG004|NOT COMPLETED|Visit One||0||
48245687|NCT00187135|100920874|FG005|NOT COMPLETED|Visit One||2||
48245688|NCT00187135|100920869|FG000|STARTED|Visit Two||26||
48245689|NCT00187135|100920870|FG001|STARTED|Visit Two||27||
48245690|NCT00187135|100920871|FG002|STARTED|Visit Two||25||
48245691|NCT00187135|100920872|FG003|STARTED|Visit Two||26||
48245692|NCT00187135|100920873|FG004|STARTED|Visit Two||25||
48245693|NCT00187135|100920874|FG005|STARTED|Visit Two||26||
48245694|NCT00187135|100920869|FG000|COMPLETED|Visit Two||21||
48245695|NCT00187135|100920870|FG001|COMPLETED|Visit Two||24||
48245696|NCT00187135|100920871|FG002|COMPLETED|Visit Two||23||
48245697|NCT00187135|100920872|FG003|COMPLETED|Visit Two||18||
48245698|NCT00187135|100920873|FG004|COMPLETED|Visit Two||19||
48245699|NCT00187135|100920874|FG005|COMPLETED|Visit Two||18||
48245700|NCT00187135|100920869|FG000|NOT COMPLETED|Visit Two||5||
48245701|NCT00187135|100920870|FG001|NOT COMPLETED|Visit Two||3||
48245702|NCT00187135|100920871|FG002|NOT COMPLETED|Visit Two||2||
48245703|NCT00187135|100920872|FG003|NOT COMPLETED|Visit Two||8||
48245704|NCT00187135|100920873|FG004|NOT COMPLETED|Visit Two||6||
48245705|NCT00187135|100920874|FG005|NOT COMPLETED|Visit Two||8||
48082549|NCT01606436|100521853|FG002|Received Second Intervention|Overall Study||14||
48082550|NCT01606436|100521854|FG003|Received Second Intervention|Overall Study||14||
48082551|NCT01606436|100521855|FG004|Received Second Intervention|Overall Study||12||
48082552|NCT01606436|100521856|FG005|Received Second Intervention|Overall Study||14||
48245706|NCT00187135|100920869|FG000|STARTED|Visit Three||21||
48245707|NCT00187135|100920870|FG001|STARTED|Visit Three||24||
48245708|NCT00187135|100920871|FG002|STARTED|Visit Three||23||
48540756|NCT02027428|101662559|FG001|COMPLETED|Survival Follow-up||38|Completed = Participants alive to end of study|
48540757|NCT02027428|101662560|FG002|COMPLETED|Survival Follow-up||9|Completed = Participants alive to end of study|
48540758|NCT02027428|101662558|FG000|NOT COMPLETED|Survival Follow-up||0||
48540759|NCT02027428|101662559|FG001|NOT COMPLETED|Survival Follow-up||79||
48540760|NCT02027428|101662560|FG002|NOT COMPLETED|Survival Follow-up||46||
48540761|NCT01357148|101662561|FG000|STARTED|Overall Study||143||
48540762|NCT01357148|101662561|FG000|COMPLETED|Overall Study||143||
48540763|NCT01357148|101662561|FG000|NOT COMPLETED|Overall Study||0||
48540764|NCT04893018|101662562|FG000|STARTED|Overall Study||6||
48540765|NCT04893018|101662563|FG001|STARTED|Overall Study||2||
48082553|NCT01606436|100521851|FG000|Received Third Intervention|Overall Study||14||
48082554|NCT01606436|100521852|FG001|Received Third Intervention|Overall Study||14||
48082555|NCT01606436|100521853|FG002|Received Third Intervention|Overall Study||12||
48082556|NCT01606436|100521854|FG003|Received Third Intervention|Overall Study||12||
48082557|NCT01606436|100521855|FG004|Received Third Intervention|Overall Study||12||
48082558|NCT01606436|100521856|FG005|Received Third Intervention|Overall Study||14||
48082559|NCT01606436|100521851|FG000|COMPLETED|Overall Study||14||
48082560|NCT01606436|100521852|FG001|COMPLETED|Overall Study||14||
48082561|NCT01606436|100521853|FG002|COMPLETED|Overall Study||12||
48082562|NCT01606436|100521854|FG003|COMPLETED|Overall Study||12||
48082563|NCT01606436|100521855|FG004|COMPLETED|Overall Study||12||
48082564|NCT01606436|100521856|FG005|COMPLETED|Overall Study||14||
48082565|NCT01606436|100521851|FG000|NOT COMPLETED|Overall Study||0||
48082566|NCT01606436|100521852|FG001|NOT COMPLETED|Overall Study||0||
48082567|NCT01606436|100521853|FG002|NOT COMPLETED|Overall Study||2||
48082568|NCT01606436|100521854|FG003|NOT COMPLETED|Overall Study||2||
48082569|NCT01606436|100521855|FG004|NOT COMPLETED|Overall Study||1||
48245709|NCT00187135|100920872|FG003|STARTED|Visit Three||18||
48245710|NCT00187135|100920873|FG004|STARTED|Visit Three||19||
48245711|NCT00187135|100920874|FG005|STARTED|Visit Three||18||
48245712|NCT00187135|100920869|FG000|COMPLETED|Visit Three||14||
48245713|NCT00187135|100920870|FG001|COMPLETED|Visit Three||17||
48245714|NCT00187135|100920871|FG002|COMPLETED|Visit Three||14||
48245715|NCT00187135|100920872|FG003|COMPLETED|Visit Three||9||
48082570|NCT01606436|100521856|FG005|NOT COMPLETED|Overall Study||0||
48082571|NCT02028065|100521857|FG000|STARTED|Randomization Through Start Treatment||76||
48082572|NCT02028065|100521858|FG001|STARTED|Randomization Through Start Treatment||154||
48245716|NCT00187135|100920873|FG004|COMPLETED|Visit Three||11||
48082573|NCT02028065|100521859|FG002|STARTED|Randomization Through Start Treatment||152||
48082574|NCT02028065|100521857|FG000|COMPLETED|Randomization Through Start Treatment||75||
48082575|NCT02028065|100521858|FG001|COMPLETED|Randomization Through Start Treatment||151||
48082576|NCT02028065|100521859|FG002|COMPLETED|Randomization Through Start Treatment||149||
48082577|NCT02028065|100521857|FG000|NOT COMPLETED|Randomization Through Start Treatment||1||
48082578|NCT02028065|100521858|FG001|NOT COMPLETED|Randomization Through Start Treatment||3||
48082579|NCT02028065|100521859|FG002|NOT COMPLETED|Randomization Through Start Treatment||3||
48082580|NCT02028065|100521857|FG000|STARTED|Treatment Through Study Completion||76||
48082581|NCT02028065|100521858|FG001|STARTED|Treatment Through Study Completion||151||
48082582|NCT02028065|100521859|FG002|STARTED|Treatment Through Study Completion||148||
48082583|NCT02028065|100521857|FG000|Received First Dose|Treatment Through Study Completion||76||
48082584|NCT02028065|100521858|FG001|Received First Dose|Treatment Through Study Completion||151||
48082585|NCT02028065|100521859|FG002|Received First Dose|Treatment Through Study Completion||148||
48082586|NCT02028065|100521857|FG000|Received Second Dose|Treatment Through Study Completion||69||
48245717|NCT00187135|100920874|FG005|COMPLETED|Visit Three||12||
48245718|NCT00187135|100920869|FG000|NOT COMPLETED|Visit Three||7||
48245719|NCT00187135|100920870|FG001|NOT COMPLETED|Visit Three||7||
48245720|NCT00187135|100920871|FG002|NOT COMPLETED|Visit Three||9||
48245721|NCT00187135|100920872|FG003|NOT COMPLETED|Visit Three||9||
48245722|NCT00187135|100920873|FG004|NOT COMPLETED|Visit Three||8||
48082587|NCT02028065|100521858|FG001|Received Second Dose|Treatment Through Study Completion||140||
48082588|NCT02028065|100521859|FG002|Received Second Dose|Treatment Through Study Completion||138||
48082589|NCT02028065|100521857|FG000|Received Third Dose|Treatment Through Study Completion||64||
48082590|NCT02028065|100521858|FG001|Received Third Dose|Treatment Through Study Completion||136||
48082591|NCT02028065|100521859|FG002|Received Third Dose|Treatment Through Study Completion||134||
48245723|NCT00187135|100920874|FG005|NOT COMPLETED|Visit Three||6||
48245724|NCT00168805|100920875|FG000|STARTED|Overall Study||679||
48245725|NCT00168805|100920876|FG001|STARTED|Overall Study||703||
48245726|NCT00168805|100920877|FG002|STARTED|Overall Study||694||
48245727|NCT00168805|100920875|FG000|COMPLETED|Overall Study||608||
48245728|NCT00168805|100920876|FG001|COMPLETED|Overall Study||625||
48245729|NCT00168805|100920877|FG002|COMPLETED|Overall Study||616||
48245730|NCT00168805|100920875|FG000|NOT COMPLETED|Overall Study||71||
48245731|NCT00168805|100920876|FG001|NOT COMPLETED|Overall Study||78||
48245732|NCT00168805|100920877|FG002|NOT COMPLETED|Overall Study||78||
48245733|NCT00168805|100920875|FG000|STARTED|Treatment||679||
48245734|NCT00168805|100920876|FG001|STARTED|Treatment||703||
48245735|NCT00168805|100920877|FG002|STARTED|Treatment||694||
48245736|NCT00168805|100920875|FG000|COMPLETED|Treatment||630||
48245737|NCT00168805|100920876|FG001|COMPLETED|Treatment||647||
48245738|NCT00168805|100920877|FG002|COMPLETED|Treatment||632||
48245739|NCT00168805|100920875|FG000|NOT COMPLETED|Treatment||49||
48245740|NCT00168805|100920876|FG001|NOT COMPLETED|Treatment||56||
48245741|NCT00168805|100920877|FG002|NOT COMPLETED|Treatment||62||
48082592|NCT02028065|100521857|FG000|COMPLETED|Treatment Through Study Completion||64||
48082593|NCT02028065|100521858|FG001|COMPLETED|Treatment Through Study Completion||136||
48082594|NCT02028065|100521859|FG002|COMPLETED|Treatment Through Study Completion||134||
48082595|NCT02028065|100521857|FG000|NOT COMPLETED|Treatment Through Study Completion||12||
48082596|NCT02028065|100521858|FG001|NOT COMPLETED|Treatment Through Study Completion||15||
48082597|NCT02028065|100521859|FG002|NOT COMPLETED|Treatment Through Study Completion||14||
48082598|NCT00601458|100521860|FG000|STARTED|Overall Study||36||
48082599|NCT00601458|100521861|FG001|STARTED|Overall Study||34||
48082600|NCT00601458|100521862|FG002|STARTED|Overall Study||30||
48082601|NCT00601458|100521860|FG000|COMPLETED|Overall Study||32||
48082602|NCT00601458|100521861|FG001|COMPLETED|Overall Study||29||
48082603|NCT00601458|100521862|FG002|COMPLETED|Overall Study||28||
48082604|NCT00601458|100521860|FG000|NOT COMPLETED|Overall Study||4||
48082605|NCT00601458|100521861|FG001|NOT COMPLETED|Overall Study||5||
48082606|NCT00601458|100521862|FG002|NOT COMPLETED|Overall Study||2||
48082607|NCT01144286|100521863|FG000|STARTED|Overall Study||57||
48082608|NCT01144286|100521864|FG001|STARTED|Overall Study||58||
48082609|NCT01144286|100521865|FG002|STARTED|Overall Study||58||
48082610|NCT01144286|100521866|FG003|STARTED|Overall Study||56||
48082611|NCT01144286|100521863|FG000|COMPLETED|Overall Study||57||
48082612|NCT01144286|100521864|FG001|COMPLETED|Overall Study||58||
48082613|NCT01144286|100521865|FG002|COMPLETED|Overall Study||58||
48082614|NCT01144286|100521866|FG003|COMPLETED|Overall Study||56||
48082615|NCT01144286|100521863|FG000|NOT COMPLETED|Overall Study||0||
48082616|NCT01144286|100521864|FG001|NOT COMPLETED|Overall Study||0||
48245742|NCT02392429|100920878|FG000|STARTED|Screening||102||
48245743|NCT02392429|100920878|FG000|COMPLETED|Screening||87||
48245744|NCT02392429|100920878|FG000|NOT COMPLETED|Screening||15||
48245745|NCT02392429|100920878|FG000|STARTED|Enrolled Participants||87||
48245746|NCT02392429|100920878|FG000|Optional Pre-treatment FLT PET/CT|Enrolled Participants||15||
48245747|NCT02392429|100920878|FG000|COMPLETED|Enrolled Participants||71||
48245748|NCT02392429|100920878|FG000|NOT COMPLETED|Enrolled Participants||16||
48245749|NCT02392429|100920878|FG000|STARTED|Evaluable||71||
48245750|NCT02392429|100920878|FG000|COMPLETED|Evaluable||61||
48245751|NCT02392429|100920878|FG000|NOT COMPLETED|Evaluable||10||
48245752|NCT02785900|100920879|FG000|STARTED|Overall Study||117||
48245753|NCT02785900|100920880|FG001|STARTED|Overall Study||123||
48245754|NCT02785900|100920879|FG000|COMPLETED|Overall Study||0||
48245755|NCT02785900|100920880|FG001|COMPLETED|Overall Study||0||
48245756|NCT02785900|100920879|FG000|NOT COMPLETED|Overall Study||117||
48540766|NCT04893018|101662562|FG000|COMPLETED|Overall Study||2||
48540767|NCT04893018|101662563|FG001|COMPLETED|Overall Study||0||
48540768|NCT04893018|101662562|FG000|NOT COMPLETED|Overall Study||4||
48540769|NCT04893018|101662563|FG001|NOT COMPLETED|Overall Study||2||
48082617|NCT01144286|100521865|FG002|NOT COMPLETED|Overall Study||0||
48082618|NCT01144286|100521866|FG003|NOT COMPLETED|Overall Study||0||
48082619|NCT01007812|100521867|FG000|STARTED|Period 1, One Week||25||
48082620|NCT01007812|100521868|FG001|STARTED|Period 1, One Week||25||
48540770|NCT00435812|101662564|FG000|STARTED|Overall Study||1820||
48245757|NCT02785900|100920880|FG001|NOT COMPLETED|Overall Study||123||
48245758|NCT00953199|100920881|FG000|STARTED|Overall Study||254||
48245759|NCT00953199|100920882|FG001|STARTED|Overall Study||252||
48245760|NCT00953199|100920881|FG000|COMPLETED|Overall Study||254||
48245761|NCT00953199|100920882|FG001|COMPLETED|Overall Study||252||
48245762|NCT00953199|100920881|FG000|NOT COMPLETED|Overall Study||0||
48245763|NCT00953199|100920882|FG001|NOT COMPLETED|Overall Study||0||
48245764|NCT03341312|100920883|FG000|STARTED|Period 1||9||
48245765|NCT03341312|100920884|FG001|STARTED|Period 1||10||
48245766|NCT03341312|100920885|FG002|STARTED|Period 1||9||
48245767|NCT03341312|100920886|FG003|STARTED|Period 1||8||
48245768|NCT03341312|100920883|FG000|Received at Least One Dose of Study Drug|Period 1||9||
48245769|NCT03341312|100920884|FG001|Received at Least One Dose of Study Drug|Period 1||10||
48245770|NCT03341312|100920885|FG002|Received at Least One Dose of Study Drug|Period 1||9||
48245771|NCT03341312|100920886|FG003|Received at Least One Dose of Study Drug|Period 1||8||
48245772|NCT03341312|100920883|FG000|COMPLETED|Period 1||9||
48245773|NCT03341312|100920884|FG001|COMPLETED|Period 1||9||
48245774|NCT03341312|100920885|FG002|COMPLETED|Period 1||9||
48245775|NCT03341312|100920886|FG003|COMPLETED|Period 1||8||
48082621|NCT01007812|100521867|FG000|COMPLETED|Period 1, One Week||24||
48082622|NCT01007812|100521868|FG001|COMPLETED|Period 1, One Week||24||
48082623|NCT01007812|100521867|FG000|NOT COMPLETED|Period 1, One Week||1||
48082624|NCT01007812|100521868|FG001|NOT COMPLETED|Period 1, One Week||1||
48082625|NCT01007812|100521867|FG000|STARTED|Period 2, One Week||24||
48082626|NCT01007812|100521868|FG001|STARTED|Period 2, One Week||24||
48082627|NCT01007812|100521867|FG000|COMPLETED|Period 2, One Week||24||
48082628|NCT01007812|100521868|FG001|COMPLETED|Period 2, One Week||24||
48082629|NCT01007812|100521867|FG000|NOT COMPLETED|Period 2, One Week||0||
48082630|NCT01007812|100521868|FG001|NOT COMPLETED|Period 2, One Week||0||
48082631|NCT01932112|100521869|FG000|STARTED|Overall Study||378||
48245776|NCT03341312|100920883|FG000|NOT COMPLETED|Period 1||0||
48245777|NCT03341312|100920884|FG001|NOT COMPLETED|Period 1||1||
48245778|NCT03341312|100920885|FG002|NOT COMPLETED|Period 1||0||
48245779|NCT03341312|100920886|FG003|NOT COMPLETED|Period 1||0||
48245780|NCT03341312|100920883|FG000|STARTED|Period 2||9||
48245781|NCT03341312|100920884|FG001|STARTED|Period 2||9||
48245782|NCT03341312|100920885|FG002|STARTED|Period 2||9||
48245783|NCT03341312|100920886|FG003|STARTED|Period 2||8||
48245784|NCT03341312|100920883|FG000|COMPLETED|Period 2||9||
48245785|NCT03341312|100920884|FG001|COMPLETED|Period 2||9||
48245786|NCT03341312|100920885|FG002|COMPLETED|Period 2||9||
48082632|NCT01932112|100521869|FG000|COMPLETED|Overall Study||378||
48082633|NCT01932112|100521869|FG000|NOT COMPLETED|Overall Study||0||
48082634|NCT02879305|100521870|FG000|STARTED|Overall Study||1487||
48082635|NCT02879305|100521871|FG001|STARTED|Overall Study||1477||
48082636|NCT02879305|100521870|FG000|COMPLETED|Overall Study||1370||
48082637|NCT02879305|100521871|FG001|COMPLETED|Overall Study||1366||
48082638|NCT02879305|100521870|FG000|NOT COMPLETED|Overall Study||117||
48082639|NCT02879305|100521871|FG001|NOT COMPLETED|Overall Study||111||
48082640|NCT02536196|100521872|FG000|STARTED|Overall Study||262||
48082641|NCT02536196|100521873|FG001|STARTED|Overall Study||121||
48082642|NCT02536196|100521874|FG002|STARTED|Overall Study||95||
48245787|NCT03341312|100920886|FG003|COMPLETED|Period 2||8||
48245788|NCT03341312|100920883|FG000|NOT COMPLETED|Period 2||0||
48540771|NCT00435812|101662565|FG001|STARTED|Overall Study||608||
48082643|NCT02536196|100521872|FG000|COMPLETED|Overall Study||233||
48082644|NCT02536196|100521873|FG001|COMPLETED|Overall Study||107||
48245789|NCT03341312|100920884|FG001|NOT COMPLETED|Period 2||0||
48540772|NCT00435812|101662564|FG000|COMPLETED|Overall Study||1757||
48540773|NCT00435812|101662565|FG001|COMPLETED|Overall Study||590||
48245790|NCT03341312|100920885|FG002|NOT COMPLETED|Period 2||0||
48245791|NCT03341312|100920886|FG003|NOT COMPLETED|Period 2||0||
48245792|NCT03341312|100920883|FG000|STARTED|Period 3||9||
48245793|NCT03341312|100920884|FG001|STARTED|Period 3||9||
48245794|NCT03341312|100920885|FG002|STARTED|Period 3||9||
48245795|NCT03341312|100920886|FG003|STARTED|Period 3||8||
48245796|NCT03341312|100920883|FG000|COMPLETED|Period 3||9||
48245797|NCT03341312|100920884|FG001|COMPLETED|Period 3||9||
48245798|NCT03341312|100920885|FG002|COMPLETED|Period 3||9||
48245799|NCT03341312|100920886|FG003|COMPLETED|Period 3||8||
48245800|NCT03341312|100920883|FG000|NOT COMPLETED|Period 3||0||
48245801|NCT03341312|100920884|FG001|NOT COMPLETED|Period 3||0||
48245802|NCT03341312|100920885|FG002|NOT COMPLETED|Period 3||0||
48245803|NCT03341312|100920886|FG003|NOT COMPLETED|Period 3||0||
48245804|NCT03341312|100920883|FG000|STARTED|Period 4||9||
48245805|NCT03341312|100920884|FG001|STARTED|Period 4||9||
48245806|NCT03341312|100920885|FG002|STARTED|Period 4||9||
48245807|NCT03341312|100920886|FG003|STARTED|Period 4||8||
48245808|NCT03341312|100920883|FG000|COMPLETED|Period 4||9||
48082645|NCT02536196|100521874|FG002|COMPLETED|Overall Study||95||
48082646|NCT02536196|100521872|FG000|NOT COMPLETED|Overall Study||29||
48082647|NCT02536196|100521873|FG001|NOT COMPLETED|Overall Study||14||
48082648|NCT02536196|100521874|FG002|NOT COMPLETED|Overall Study||0||
48082649|NCT00706823|100521875|FG000|STARTED|Overall Study||25||
48082650|NCT00706823|100521876|FG001|STARTED|Overall Study||25||
48082651|NCT00706823|100521875|FG000|COMPLETED|Overall Study||25||
48082652|NCT00706823|100521876|FG001|COMPLETED|Overall Study||25||
48082653|NCT00706823|100521875|FG000|NOT COMPLETED|Overall Study||0||
48245809|NCT03341312|100920884|FG001|COMPLETED|Period 4||9||
48245810|NCT03341312|100920885|FG002|COMPLETED|Period 4||9||
48245811|NCT03341312|100920886|FG003|COMPLETED|Period 4||8||
48245812|NCT03341312|100920883|FG000|NOT COMPLETED|Period 4||0||
48245813|NCT03341312|100920884|FG001|NOT COMPLETED|Period 4||0||
48245814|NCT03341312|100920885|FG002|NOT COMPLETED|Period 4||0||
48245815|NCT03341312|100920886|FG003|NOT COMPLETED|Period 4||0||
48245816|NCT00828542|100920887|FG000|STARTED|Overall Study||23||
48082654|NCT00706823|100521876|FG001|NOT COMPLETED|Overall Study||0||
48082655|NCT01217814|100521877|FG000|STARTED|Overall Study||4||
48082656|NCT01217814|100521878|FG001|STARTED|Overall Study||5||
48082657|NCT01217814|100521879|FG002|STARTED|Overall Study||7||
48082658|NCT01217814|100521877|FG000|COMPLETED|Overall Study||3||
48082659|NCT01217814|100521878|FG001|COMPLETED|Overall Study||4||
48082660|NCT01217814|100521879|FG002|COMPLETED|Overall Study||6||
48245817|NCT00828542|100920888|FG001|STARTED|Overall Study||23||
48245818|NCT00828542|100920887|FG000|COMPLETED|Overall Study||20||
48082661|NCT01217814|100521877|FG000|NOT COMPLETED|Overall Study||1||
48082662|NCT01217814|100521878|FG001|NOT COMPLETED|Overall Study||1||
48082663|NCT01217814|100521879|FG002|NOT COMPLETED|Overall Study||1||
48082664|NCT00036738|100521880|FG000|STARTED|Overall Study||28||
48082665|NCT00036738|100521880|FG000|COMPLETED|Overall Study||28||
48082666|NCT00036738|100521880|FG000|NOT COMPLETED|Overall Study||0||
48082667|NCT02925494|100521881|FG000|STARTED|Treatment Period||59||
48082668|NCT02925494|100521882|FG001|STARTED|Treatment Period||58||
48082669|NCT02925494|100521883|FG002|STARTED|Treatment Period||98||
48082670|NCT02925494|100521884|FG003|STARTED|Treatment Period||218||
48082671|NCT02925494|100521881|FG000|COMPLETED|Treatment Period||50||
48082672|NCT02925494|100521882|FG001|COMPLETED|Treatment Period||43||
48082673|NCT02925494|100521883|FG002|COMPLETED|Treatment Period||79||
48082674|NCT02925494|100521884|FG003|COMPLETED|Treatment Period||182||
48082675|NCT02925494|100521881|FG000|NOT COMPLETED|Treatment Period||9||
48082676|NCT02925494|100521882|FG001|NOT COMPLETED|Treatment Period||15||
48082677|NCT02925494|100521883|FG002|NOT COMPLETED|Treatment Period||19||
48082678|NCT02925494|100521884|FG003|NOT COMPLETED|Treatment Period||36||
48245819|NCT00828542|100920888|FG001|COMPLETED|Overall Study||20||
48245820|NCT00828542|100920887|FG000|NOT COMPLETED|Overall Study||3||
48245821|NCT00828542|100920888|FG001|NOT COMPLETED|Overall Study||3||
48245822|NCT01145547|100920889|FG000|STARTED|Overall Study||4||
48082679|NCT02925494|100521881|FG000|STARTED|Post-Treatment Follow-Up Period||54|Completed or prematurely discontinued the Treatment Period and entered the follow-up period.|
48082680|NCT02925494|100521882|FG001|STARTED|Post-Treatment Follow-Up Period||47|Completed or prematurely discontinued the Treatment Period and entered the follow-up period.|
48082681|NCT02925494|100521883|FG002|STARTED|Post-Treatment Follow-Up Period||88|Completed or prematurely discontinued the Treatment Period and entered the follow-up period.|
48082682|NCT02925494|100521884|FG003|STARTED|Post-Treatment Follow-Up Period||184|Completed or prematurely discontinued the Treatment Period and entered the follow-up period.|
48082683|NCT02925494|100521881|FG000|COMPLETED|Post-Treatment Follow-Up Period||40||
48082684|NCT02925494|100521882|FG001|COMPLETED|Post-Treatment Follow-Up Period||37||
48082685|NCT02925494|100521883|FG002|COMPLETED|Post-Treatment Follow-Up Period||64||
48082686|NCT02925494|100521884|FG003|COMPLETED|Post-Treatment Follow-Up Period||134||
48082687|NCT02925494|100521881|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||14||
48082688|NCT02925494|100521882|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||10||
48082689|NCT02925494|100521883|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||24||
48082690|NCT02925494|100521884|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period||50||
48082691|NCT04997161|100521885|FG000|STARTED|Overall Study||3||
48245823|NCT01145547|100920890|FG001|STARTED|Overall Study||3||
48082692|NCT04997161|100521885|FG000|Randomized|Overall Study||1|Randomized to receive SZC 5 g once daily orally until the end of Month 2 in addition to enhanced nutritional advice to consume fruit and vegetables.|
48082693|NCT04997161|100521885|FG000|COMPLETED|Overall Study||0||
48245824|NCT01145547|100920889|FG000|COMPLETED|Overall Study||4||
48245825|NCT01145547|100920890|FG001|COMPLETED|Overall Study||3||
48245826|NCT01145547|100920889|FG000|NOT COMPLETED|Overall Study||0||
48245827|NCT01145547|100920890|FG001|NOT COMPLETED|Overall Study||0||
48082694|NCT04997161|100521885|FG000|NOT COMPLETED|Overall Study||3||
48082695|NCT00230607|100521886|FG000|STARTED|Overall Study||7||
48082696|NCT00230607|100521886|FG000|COMPLETED|Overall Study||4||
48082697|NCT00230607|100521886|FG000|NOT COMPLETED|Overall Study||3||
48082698|NCT00650260|100521887|FG000|STARTED|Overall Study||21||
48082699|NCT00650260|100521888|FG001|STARTED|Overall Study||21||
48082700|NCT00650260|100521887|FG000|COMPLETED|Overall Study||21||
48082701|NCT00650260|100521888|FG001|COMPLETED|Overall Study||21||
48082702|NCT00650260|100521887|FG000|NOT COMPLETED|Overall Study||0||
48082703|NCT00650260|100521888|FG001|NOT COMPLETED|Overall Study||0||
48082704|NCT02503735|100521889|FG000|STARTED|Overall Study||10|10/14 consented patients started treatment with Sofosbuvir/Ledipasvir (4 screen failures)|
48082705|NCT02503735|100521889|FG000|SVR 12 (12week Post Treatment RNA Neg)|Overall Study||8||
48082706|NCT02503735|100521889|FG000|COMPLETED|Overall Study||10|All 10 subjects who initiated treatment completed treatment|
48082707|NCT02503735|100521889|FG000|NOT COMPLETED|Overall Study||0||
48082708|NCT01362205|100521890|FG000|STARTED|Overall Study||22||
48082709|NCT01362205|100521891|FG001|STARTED|Overall Study||27||
48082710|NCT01362205|100521890|FG000|COMPLETED|Overall Study||22||
48082711|NCT01362205|100521891|FG001|COMPLETED|Overall Study||27||
48082712|NCT01362205|100521890|FG000|NOT COMPLETED|Overall Study||0||
48082713|NCT01362205|100521891|FG001|NOT COMPLETED|Overall Study||0||
48082714|NCT00830362|100521892|FG000|STARTED|Overall Study||27||
48082715|NCT00830362|100521893|FG001|STARTED|Overall Study||24||
48082716|NCT00830362|100521892|FG000|Completed Sessions 1 and 2|Overall Study||26||
48082717|NCT00830362|100521893|FG001|Completed Sessions 1 and 2|Overall Study||24||
48082718|NCT00830362|100521892|FG000|COMPLETED|Overall Study||23||
48082719|NCT00830362|100521893|FG001|COMPLETED|Overall Study||20||
48082720|NCT00830362|100521892|FG000|NOT COMPLETED|Overall Study||4||
48082721|NCT00830362|100521893|FG001|NOT COMPLETED|Overall Study||4||
48082722|NCT02373852|100521894|FG000|STARTED|Overall Study||12||
48082723|NCT02373852|100521894|FG000|COMPLETED|Overall Study||11||
48082724|NCT02373852|100521894|FG000|NOT COMPLETED|Overall Study||1||
48082725|NCT00461045|100521895|FG000|STARTED|Overall Study||15||
48082726|NCT00461045|100521895|FG000|COMPLETED|Overall Study||15||
48082727|NCT00461045|100521895|FG000|NOT COMPLETED|Overall Study||0||
48082728|NCT00353262|100521896|FG000|STARTED|Overall Study||36||
48082729|NCT00353262|100521896|FG000|COMPLETED|Overall Study||7||
48082730|NCT00353262|100521896|FG000|NOT COMPLETED|Overall Study||29||
48082731|NCT00491075|100521897|FG000|STARTED|Overall Study||16||
48082732|NCT00491075|100521897|FG000|COMPLETED|Overall Study||14||
48082733|NCT00491075|100521897|FG000|NOT COMPLETED|Overall Study||2||
48082734|NCT01468012|100521898|FG000|STARTED|Overall Study||9||
48082735|NCT01468012|100521899|FG001|STARTED|Overall Study||10||
48082736|NCT01468012|100521900|FG002|STARTED|Overall Study||4||
48082737|NCT01468012|100521898|FG000|COMPLETED|Overall Study||7||
48082738|NCT01468012|100521899|FG001|COMPLETED|Overall Study||9||
48082739|NCT01468012|100521900|FG002|COMPLETED|Overall Study||0||
48082740|NCT01468012|100521898|FG000|NOT COMPLETED|Overall Study||2||
48082741|NCT01468012|100521899|FG001|NOT COMPLETED|Overall Study||1||
48082742|NCT01468012|100521900|FG002|NOT COMPLETED|Overall Study||4||
48082743|NCT03978520|100521901|FG000|STARTED|Overall Study||75||
48082744|NCT03978520|100521902|FG001|STARTED|Overall Study||68||
48082745|NCT03978520|100521903|FG002|STARTED|Overall Study||62||
48082746|NCT03978520|100521904|FG003|STARTED|Overall Study||69||
48082747|NCT03978520|100521905|FG004|STARTED|Overall Study||67||
48082748|NCT03978520|100521901|FG000|COMPLETED|Overall Study||52||
48082749|NCT03978520|100521902|FG001|COMPLETED|Overall Study||52||
48082750|NCT03978520|100521903|FG002|COMPLETED|Overall Study||51||
48082751|NCT03978520|100521904|FG003|COMPLETED|Overall Study||24||
48082752|NCT03978520|100521905|FG004|COMPLETED|Overall Study||29||
48082753|NCT03978520|100521901|FG000|NOT COMPLETED|Overall Study||23||
48082754|NCT03978520|100521902|FG001|NOT COMPLETED|Overall Study||16||
48082755|NCT03978520|100521903|FG002|NOT COMPLETED|Overall Study||11||
48082756|NCT03978520|100521904|FG003|NOT COMPLETED|Overall Study||45||
48082757|NCT03978520|100521905|FG004|NOT COMPLETED|Overall Study||38||
48082758|NCT00828347|100521906|FG000|STARTED|Overall Study||12||
48082759|NCT00828347|100521907|FG001|STARTED|Overall Study||11||
48082760|NCT00828347|100521906|FG000|COMPLETED|Overall Study||12||
48082761|NCT00828347|100521907|FG001|COMPLETED|Overall Study||11||
48082762|NCT00828347|100521906|FG000|NOT COMPLETED|Overall Study||0||
48082763|NCT00828347|100521907|FG001|NOT COMPLETED|Overall Study||0||
48082764|NCT00590720|100521908|FG000|STARTED|Overall Study||4||
48245828|NCT02030847|100920891|FG000|STARTED|Overall Study||42||
48245829|NCT02030847|100920891|FG000|COMPLETED|Overall Study||5||
48245830|NCT02030847|100920891|FG000|NOT COMPLETED|Overall Study||37||
48245831|NCT02965599|100920892|FG000|STARTED|Overall Study||2||
48245832|NCT02965599|100920893|FG001|STARTED|Overall Study||1||
48245833|NCT02965599|100920892|FG000|COMPLETED|Overall Study||1||
48245834|NCT02965599|100920893|FG001|COMPLETED|Overall Study||1||
48245835|NCT02965599|100920892|FG000|NOT COMPLETED|Overall Study||1||
48245836|NCT02965599|100920893|FG001|NOT COMPLETED|Overall Study||0||
48245837|NCT03436433|100920894|FG000|STARTED|Overall Study||1||
48245838|NCT03436433|100920895|FG001|STARTED|Overall Study||2||
48245839|NCT03436433|100920896|FG002|STARTED|Overall Study||1||
48245840|NCT03436433|100920894|FG000|COMPLETED|Overall Study||1||
48245841|NCT03436433|100920895|FG001|COMPLETED|Overall Study||2||
48245842|NCT03436433|100920896|FG002|COMPLETED|Overall Study||1||
48245843|NCT03436433|100920894|FG000|NOT COMPLETED|Overall Study||0||
48245844|NCT03436433|100920895|FG001|NOT COMPLETED|Overall Study||0||
48245845|NCT03436433|100920896|FG002|NOT COMPLETED|Overall Study||0||
48245846|NCT01374971|100920897|FG000|STARTED|Overall Study||12||
48245847|NCT01374971|100920897|FG000|COMPLETED|Overall Study||11||
48245848|NCT01374971|100920897|FG000|NOT COMPLETED|Overall Study||1||
48245849|NCT05399082|100920898|FG000|STARTED|First Intervention||15||
48245850|NCT05399082|100920899|FG001|STARTED|First Intervention||15||
48245851|NCT05399082|100920898|FG000|COMPLETED|First Intervention||15||
48245852|NCT05399082|100920899|FG001|COMPLETED|First Intervention||15||
48245853|NCT05399082|100920898|FG000|NOT COMPLETED|First Intervention||0||
48245854|NCT05399082|100920899|FG001|NOT COMPLETED|First Intervention||0||
48245855|NCT05399082|100920898|FG000|STARTED|Second Intervention||15||
48245856|NCT05399082|100920899|FG001|STARTED|Second Intervention||15||
48245857|NCT05399082|100920898|FG000|COMPLETED|Second Intervention||15||
48245858|NCT05399082|100920899|FG001|COMPLETED|Second Intervention||15||
48245859|NCT05399082|100920898|FG000|NOT COMPLETED|Second Intervention||0||
48245860|NCT05399082|100920899|FG001|NOT COMPLETED|Second Intervention||0||
48245861|NCT01109602|100920900|FG000|STARTED|Overall Study||14||
48245862|NCT01109602|100920901|FG001|STARTED|Overall Study||23||
48245863|NCT01109602|100920902|FG002|STARTED|Overall Study||10||
48245864|NCT01109602|100920900|FG000|COMPLETED|Overall Study||13||
48245865|NCT01109602|100920901|FG001|COMPLETED|Overall Study||21||
48245866|NCT01109602|100920902|FG002|COMPLETED|Overall Study||9||
48245867|NCT01109602|100920900|FG000|NOT COMPLETED|Overall Study||1||
48245868|NCT01109602|100920901|FG001|NOT COMPLETED|Overall Study||2||
48245869|NCT01109602|100920902|FG002|NOT COMPLETED|Overall Study||1||
48245870|NCT02943109|100920903|FG000|STARTED|Overall Study||1242||
48245871|NCT02943109|100920904|FG001|STARTED|Overall Study||470||
48245872|NCT02943109|100920905|FG002|STARTED|Overall Study||905||
48245873|NCT02943109|100920906|FG003|STARTED|Overall Study||275||
48245874|NCT02943109|100920903|FG000|COMPLETED|Overall Study||1242||
48245875|NCT02943109|100920904|FG001|COMPLETED|Overall Study||470||
48245876|NCT02943109|100920905|FG002|COMPLETED|Overall Study||905||
48245877|NCT02943109|100920906|FG003|COMPLETED|Overall Study||275||
48245878|NCT02943109|100920903|FG000|NOT COMPLETED|Overall Study||0||
48245879|NCT02943109|100920904|FG001|NOT COMPLETED|Overall Study||0||
48245880|NCT02943109|100920905|FG002|NOT COMPLETED|Overall Study||0||
48245881|NCT02943109|100920906|FG003|NOT COMPLETED|Overall Study||0||
48245882|NCT00724750|100920907|FG000|STARTED|Overall Study||45||
48245883|NCT00724750|100920908|FG001|STARTED|Overall Study||42||
48245884|NCT00724750|100920907|FG000|COMPLETED|Overall Study||45||
48245885|NCT00724750|100920908|FG001|COMPLETED|Overall Study||42||
48245886|NCT00724750|100920907|FG000|NOT COMPLETED|Overall Study||0||
48245887|NCT00724750|100920908|FG001|NOT COMPLETED|Overall Study||0||
48245888|NCT04089332|100920909|FG000|STARTED|Overall Study||23||
48245889|NCT04089332|100920909|FG000|Completed Cognitive Tests|Overall Study||13||
48245890|NCT04089332|100920909|FG000|Completed OGTT|Overall Study||17||
48245891|NCT04089332|100920909|FG000|Completed MRI Structural Visit|Overall Study||16||
48245892|NCT04089332|100920909|FG000|Completed With Data to Analyze|Overall Study||15||
48245893|NCT04089332|100920909|FG000|Participants With Data for Change in CBF|Overall Study||11||
48245894|NCT04089332|100920909|FG000|COMPLETED|Overall Study||15||
48245895|NCT04089332|100920909|FG000|NOT COMPLETED|Overall Study||8||
48245896|NCT02648282|100920910|FG000|STARTED|Overall Study||58||
48245897|NCT02648282|100920910|FG000|COMPLETED|Overall Study||58||
48245898|NCT02648282|100920910|FG000|NOT COMPLETED|Overall Study||0||
48245899|NCT02573883|100920911|FG000|STARTED|Six Month Follow Up||25||
48245900|NCT02573883|100920912|FG001|STARTED|Six Month Follow Up||27||
48245901|NCT02573883|100920913|FG002|STARTED|Six Month Follow Up||0||
48245902|NCT02573883|100920914|FG003|STARTED|Six Month Follow Up||0||
48245903|NCT02573883|100920911|FG000|COMPLETED|Six Month Follow Up||24||
48245904|NCT02573883|100920912|FG001|COMPLETED|Six Month Follow Up||27||
48245905|NCT02573883|100920913|FG002|COMPLETED|Six Month Follow Up||0||
48245906|NCT02573883|100920914|FG003|COMPLETED|Six Month Follow Up||0||
48245907|NCT02573883|100920911|FG000|NOT COMPLETED|Six Month Follow Up||1||
48245908|NCT02573883|100920912|FG001|NOT COMPLETED|Six Month Follow Up||0||
48245909|NCT02573883|100920913|FG002|NOT COMPLETED|Six Month Follow Up||0||
48245910|NCT02573883|100920914|FG003|NOT COMPLETED|Six Month Follow Up||0||
48245911|NCT02573883|100920911|FG000|STARTED|One Year Follow Up||13||
48245912|NCT02573883|100920912|FG001|STARTED|One Year Follow Up||17||
48245913|NCT02573883|100920913|FG002|STARTED|One Year Follow Up||11||
48245914|NCT02573883|100920914|FG003|STARTED|One Year Follow Up||10||
48245915|NCT02573883|100920911|FG000|COMPLETED|One Year Follow Up||11||
48245916|NCT02573883|100920912|FG001|COMPLETED|One Year Follow Up||16||
48245917|NCT02573883|100920913|FG002|COMPLETED|One Year Follow Up||11||
48245918|NCT02573883|100920914|FG003|COMPLETED|One Year Follow Up||10||
48245919|NCT02573883|100920911|FG000|NOT COMPLETED|One Year Follow Up||2||
48245920|NCT02573883|100920912|FG001|NOT COMPLETED|One Year Follow Up||1||
48245921|NCT02573883|100920913|FG002|NOT COMPLETED|One Year Follow Up||0||
48245922|NCT02573883|100920914|FG003|NOT COMPLETED|One Year Follow Up||0||
48245923|NCT01568021|100920915|FG000|STARTED|Overall Study||99||
48682032|NCT01154452|102006537|FG003|NOT COMPLETED|Phase II||6||
48682033|NCT00429182|102006538|FG000|STARTED|Overall Study||32||
48682034|NCT00429182|102006538|FG000|COMPLETED|Overall Study||25||
48682035|NCT00429182|102006538|FG000|NOT COMPLETED|Overall Study||7||
48682036|NCT02148588|102006539|FG000|STARTED|Overall Study||8||
48682037|NCT02148588|102006539|FG000|COMPLETED|Overall Study||8||
48682038|NCT02148588|102006539|FG000|NOT COMPLETED|Overall Study||0||
48682039|NCT03800030|102006540|FG000|STARTED|Baseline||4||
48682040|NCT03800030|102006541|FG001|STARTED|Baseline||4||
48682041|NCT03800030|102006542|FG002|STARTED|Baseline||4||
48682042|NCT03800030|102006543|FG003|STARTED|Baseline||6||
48682043|NCT03800030|102006544|FG004|STARTED|Baseline||4||
48245924|NCT01568021|100920915|FG000|COMPLETED|Overall Study||83||
48245925|NCT01568021|100920915|FG000|NOT COMPLETED|Overall Study||16||
48245926|NCT03845517|100920916|FG000|STARTED|Treatment Period (52 Weeks)||100||
48245927|NCT03845517|100920917|FG001|STARTED|Treatment Period (52 Weeks)||50||
48245928|NCT03845517|100920918|FG002|STARTED|Treatment Period (52 Weeks)||101||
48245929|NCT03845517|100920919|FG003|STARTED|Treatment Period (52 Weeks)||99||
48245930|NCT03845517|100920916|FG000|COMPLETED|Treatment Period (52 Weeks)||68||
48245931|NCT03845517|100920917|FG001|COMPLETED|Treatment Period (52 Weeks)||36||
48245932|NCT03845517|100920918|FG002|COMPLETED|Treatment Period (52 Weeks)||78||
48245933|NCT03845517|100920919|FG003|COMPLETED|Treatment Period (52 Weeks)||71||
48245934|NCT03845517|100920916|FG000|NOT COMPLETED|Treatment Period (52 Weeks)||32||
48245935|NCT03845517|100920917|FG001|NOT COMPLETED|Treatment Period (52 Weeks)||14||
48245936|NCT03845517|100920918|FG002|NOT COMPLETED|Treatment Period (52 Weeks)||23||
48245937|NCT03845517|100920919|FG003|NOT COMPLETED|Treatment Period (52 Weeks)||28||
48245938|NCT03845517|100920916|FG000|STARTED|Follow-up Period (4 Weeks)||100||
48245939|NCT03845517|100920917|FG001|STARTED|Follow-up Period (4 Weeks)||50||
48245940|NCT03845517|100920918|FG002|STARTED|Follow-up Period (4 Weeks)||101||
48245941|NCT03845517|100920919|FG003|STARTED|Follow-up Period (4 Weeks)||99||
48245942|NCT03845517|100920916|FG000|COMPLETED|Follow-up Period (4 Weeks)||89||
48245943|NCT03845517|100920917|FG001|COMPLETED|Follow-up Period (4 Weeks)||42||
48245944|NCT03845517|100920918|FG002|COMPLETED|Follow-up Period (4 Weeks)||89||
48245945|NCT03845517|100920919|FG003|COMPLETED|Follow-up Period (4 Weeks)||92||
48245946|NCT03845517|100920916|FG000|NOT COMPLETED|Follow-up Period (4 Weeks)||11||
48245947|NCT03845517|100920917|FG001|NOT COMPLETED|Follow-up Period (4 Weeks)||8||
48245948|NCT03845517|100920918|FG002|NOT COMPLETED|Follow-up Period (4 Weeks)||12||
48245949|NCT03845517|100920919|FG003|NOT COMPLETED|Follow-up Period (4 Weeks)||7||
48245950|NCT00957671|100920920|FG000|STARTED|Overall Study||15||
48245951|NCT00957671|100920920|FG000|COMPLETED|Overall Study||15||
48245952|NCT00957671|100920920|FG000|NOT COMPLETED|Overall Study||0||
48245953|NCT00274846|100920921|FG000|STARTED|Overall Study||21||
48245954|NCT00274846|100920921|FG000|COMPLETED|Overall Study||20||
48245955|NCT00274846|100920921|FG000|NOT COMPLETED|Overall Study||1||
48245956|NCT01209936|100920922|FG000|STARTED|Overall Study||245||
48245957|NCT01209936|100920923|FG001|STARTED|Overall Study||115||
48245958|NCT01209936|100920922|FG000|COMPLETED|Overall Study||245||
48245959|NCT01209936|100920923|FG001|COMPLETED|Overall Study||115||
48245960|NCT01209936|100920922|FG000|NOT COMPLETED|Overall Study||0||
48245961|NCT01209936|100920923|FG001|NOT COMPLETED|Overall Study||0||
48245962|NCT01379521|100920924|FG000|STARTED|Overall Study -Treatment Period||33||
48245963|NCT01379521|100920925|FG001|STARTED|Overall Study -Treatment Period||26||
48245964|NCT01379521|100920924|FG000|COMPLETED|Overall Study -Treatment Period||0||
48245965|NCT01379521|100920925|FG001|COMPLETED|Overall Study -Treatment Period||0||
48245966|NCT01379521|100920924|FG000|NOT COMPLETED|Overall Study -Treatment Period||33||
48245967|NCT01379521|100920925|FG001|NOT COMPLETED|Overall Study -Treatment Period||26||
48245968|NCT01379521|100920924|FG000|STARTED|Post-Treatment Evaluations||25||
48245969|NCT01379521|100920925|FG001|STARTED|Post-Treatment Evaluations||21||
48682044|NCT03800030|102006545|FG005|STARTED|Baseline||4||
48682045|NCT03800030|102006540|FG000|COMPLETED|Baseline||4||
48682046|NCT03800030|102006541|FG001|COMPLETED|Baseline||4||
48682047|NCT03800030|102006542|FG002|COMPLETED|Baseline||4||
48245970|NCT01379521|100920924|FG000|COMPLETED|Post-Treatment Evaluations||0||
48245971|NCT01379521|100920925|FG001|COMPLETED|Post-Treatment Evaluations||0||
48245972|NCT01379521|100920924|FG000|NOT COMPLETED|Post-Treatment Evaluations||25||
48245973|NCT01379521|100920925|FG001|NOT COMPLETED|Post-Treatment Evaluations||21||
48245974|NCT02490878|100920926|FG000|STARTED|Overall Study||10||
48245975|NCT02490878|100920927|FG001|STARTED|Overall Study||9||
48245976|NCT02490878|100920926|FG000|Eligible Participants|Overall Study||10||
48245977|NCT02490878|100920927|FG001|Eligible Participants|Overall Study||8||
48245978|NCT02490878|100920926|FG000|COMPLETED|Overall Study||10||
48245979|NCT02490878|100920927|FG001|COMPLETED|Overall Study||6||
48245980|NCT02490878|100920926|FG000|NOT COMPLETED|Overall Study||0||
48245981|NCT02490878|100920927|FG001|NOT COMPLETED|Overall Study||3||
48245982|NCT00924209|100920928|FG000|STARTED|Overall Study||7||
48082765|NCT00590720|100521909|FG001|STARTED|Overall Study||7||
48082766|NCT00590720|100521908|FG000|COMPLETED|Overall Study||3||
48082767|NCT00590720|100521909|FG001|COMPLETED|Overall Study||6||
48082768|NCT00590720|100521908|FG000|NOT COMPLETED|Overall Study||1||
48082769|NCT00590720|100521909|FG001|NOT COMPLETED|Overall Study||1||
48082770|NCT02840097|100521910|FG000|STARTED|Overall Study||9||
48082771|NCT02840097|100521911|FG001|STARTED|Overall Study||10||
48082772|NCT02840097|100521912|FG002|STARTED|Overall Study||12||
48082773|NCT02840097|100521910|FG000|COMPLETED|Overall Study||9||
48082774|NCT02840097|100521911|FG001|COMPLETED|Overall Study||10||
48082775|NCT02840097|100521912|FG002|COMPLETED|Overall Study||12||
48245983|NCT00924209|100920928|FG000|COMPLETED|Overall Study||7||
48245984|NCT00924209|100920928|FG000|NOT COMPLETED|Overall Study||0||
48245985|NCT03847389|100920929|FG000|STARTED|Overall Study||8||
48245986|NCT03847389|100920930|FG001|STARTED|Overall Study||0||
48245987|NCT03847389|100920931|FG002|STARTED|Overall Study||0||
48245988|NCT03847389|100920929|FG000|COMPLETED|Overall Study||8||
48245989|NCT03847389|100920930|FG001|COMPLETED|Overall Study||0||
48245990|NCT03847389|100920931|FG002|COMPLETED|Overall Study||0||
48245991|NCT03847389|100920929|FG000|NOT COMPLETED|Overall Study||0||
48245992|NCT03847389|100920930|FG001|NOT COMPLETED|Overall Study||0||
48245993|NCT03847389|100920931|FG002|NOT COMPLETED|Overall Study||0||
48245994|NCT00513461|100920932|FG000|STARTED|Overall Study||57||
48245995|NCT00513461|100920933|FG001|STARTED|Overall Study||53||
48245996|NCT00513461|100920932|FG000|COMPLETED|Overall Study||44||
48245997|NCT00513461|100920933|FG001|COMPLETED|Overall Study||43||
48245998|NCT00513461|100920932|FG000|NOT COMPLETED|Overall Study||13||
48245999|NCT00513461|100920933|FG001|NOT COMPLETED|Overall Study||10||
48246000|NCT00083122|100920934|FG000|STARTED|Overall Study||40||
48246001|NCT00083122|100920935|FG001|STARTED|Overall Study||5||
48082776|NCT02840097|100521910|FG000|NOT COMPLETED|Overall Study||0||
48082777|NCT02840097|100521911|FG001|NOT COMPLETED|Overall Study||0||
48082778|NCT02840097|100521912|FG002|NOT COMPLETED|Overall Study||0||
48082779|NCT01246401|100521913|FG000|STARTED|Overall Study||66||
48082780|NCT01246401|100521914|FG001|STARTED|Overall Study||27||
48082781|NCT01246401|100521913|FG000|COMPLETED|Overall Study||66||
48082782|NCT01246401|100521914|FG001|COMPLETED|Overall Study||27||
48082783|NCT01246401|100521913|FG000|NOT COMPLETED|Overall Study||0||
48082784|NCT01246401|100521914|FG001|NOT COMPLETED|Overall Study||0||
48082785|NCT02310568|100521915|FG000|STARTED|Stage 1 ( 4 Weeks)||15||
48082786|NCT02310568|100521916|FG001|STARTED|Stage 1 ( 4 Weeks)||15||
48082787|NCT02310568|100521917|FG002|STARTED|Stage 1 ( 4 Weeks)||15||
48082788|NCT02310568|100521918|FG003|STARTED|Stage 1 ( 4 Weeks)||24||
48082789|NCT02310568|100521919|FG004|STARTED|Stage 1 ( 4 Weeks)||21||
48082790|NCT02310568|100521915|FG000|COMPLETED|Stage 1 ( 4 Weeks)||12||
48082791|NCT02310568|100521916|FG001|COMPLETED|Stage 1 ( 4 Weeks)||13||
48082792|NCT02310568|100521917|FG002|COMPLETED|Stage 1 ( 4 Weeks)||14||
48082793|NCT02310568|100521918|FG003|COMPLETED|Stage 1 ( 4 Weeks)||22||
48082794|NCT02310568|100521919|FG004|COMPLETED|Stage 1 ( 4 Weeks)||20||
48082795|NCT02310568|100521915|FG000|NOT COMPLETED|Stage 1 ( 4 Weeks)||3||
48082796|NCT02310568|100521916|FG001|NOT COMPLETED|Stage 1 ( 4 Weeks)||2||
48246002|NCT00083122|100920934|FG000|COMPLETED|Overall Study||40||
48246003|NCT00083122|100920935|FG001|COMPLETED|Overall Study||5||
48246004|NCT00083122|100920934|FG000|NOT COMPLETED|Overall Study||0||
48246005|NCT00083122|100920935|FG001|NOT COMPLETED|Overall Study||0||
48246006|NCT01537120|100920936|FG000|STARTED|Enrolled||25||
48246007|NCT01537120|100920936|FG000|COMPLETED|Enrolled||25||
48246008|NCT01537120|100920936|FG000|NOT COMPLETED|Enrolled||0||
48246009|NCT01537120|100920936|FG000|STARTED|8 Weeks Washout||25||
48246010|NCT01537120|100920936|FG000|COMPLETED|8 Weeks Washout||24||
48082797|NCT02310568|100521917|FG002|NOT COMPLETED|Stage 1 ( 4 Weeks)||1||
48082798|NCT02310568|100521918|FG003|NOT COMPLETED|Stage 1 ( 4 Weeks)||2||
48082799|NCT02310568|100521919|FG004|NOT COMPLETED|Stage 1 ( 4 Weeks)||1||
48082800|NCT02310568|100521915|FG000|STARTED|Stage 2 (4 Weeks)||12||
48082801|NCT02310568|100521916|FG001|STARTED|Stage 2 (4 Weeks)||13||
48082802|NCT02310568|100521917|FG002|STARTED|Stage 2 (4 Weeks)||14||
48082803|NCT02310568|100521918|FG003|STARTED|Stage 2 (4 Weeks)||22||
48082804|NCT02310568|100521919|FG004|STARTED|Stage 2 (4 Weeks)||20||
48246011|NCT01537120|100920936|FG000|NOT COMPLETED|8 Weeks Washout||1||
48246012|NCT01537120|100920936|FG000|STARTED|3 Weeks Placebo||24||
48246013|NCT01537120|100920936|FG000|COMPLETED|3 Weeks Placebo||23||
48246014|NCT01537120|100920936|FG000|NOT COMPLETED|3 Weeks Placebo||1||
48246015|NCT01537120|100920936|FG000|STARTED|12 Weeks Vildagliptin||23||
48246016|NCT01537120|100920936|FG000|COMPLETED|12 Weeks Vildagliptin||23||
48246017|NCT01537120|100920936|FG000|NOT COMPLETED|12 Weeks Vildagliptin||0||
48246018|NCT01509040|100920937|FG000|STARTED|Overall Study||0||
48246019|NCT01509040|100920938|FG001|STARTED|Overall Study||2||
48246020|NCT01509040|100920939|FG002|STARTED|Overall Study||0||
48246021|NCT01509040|100920937|FG000|COMPLETED|Overall Study||0||
48246022|NCT01509040|100920938|FG001|COMPLETED|Overall Study||1||
48246023|NCT01509040|100920939|FG002|COMPLETED|Overall Study||0||
48246024|NCT01509040|100920937|FG000|NOT COMPLETED|Overall Study||0||
48246025|NCT01509040|100920938|FG001|NOT COMPLETED|Overall Study||1||
48246026|NCT01509040|100920939|FG002|NOT COMPLETED|Overall Study||0||
48246027|NCT00946998|100920940|FG000|STARTED|Overall Study||102||
48246028|NCT00946998|100920941|FG001|STARTED|Overall Study||99||
48246029|NCT00946998|100920940|FG000|Received Treatment as Randomized|Overall Study||102||
48246030|NCT00946998|100920941|FG001|Received Treatment as Randomized|Overall Study||99||
48246031|NCT00946998|100920940|FG000|COMPLETED|Overall Study||97||
48246032|NCT00946998|100920941|FG001|COMPLETED|Overall Study||96||
48246033|NCT00946998|100920940|FG000|NOT COMPLETED|Overall Study||5||
48082805|NCT02310568|100521915|FG000|COMPLETED|Stage 2 (4 Weeks)||11||
48082806|NCT02310568|100521916|FG001|COMPLETED|Stage 2 (4 Weeks)||12||
48082807|NCT02310568|100521917|FG002|COMPLETED|Stage 2 (4 Weeks)||13||
48082808|NCT02310568|100521918|FG003|COMPLETED|Stage 2 (4 Weeks)||17||
48082809|NCT02310568|100521919|FG004|COMPLETED|Stage 2 (4 Weeks)||19||
48082810|NCT02310568|100521915|FG000|NOT COMPLETED|Stage 2 (4 Weeks)||1||
48082811|NCT02310568|100521916|FG001|NOT COMPLETED|Stage 2 (4 Weeks)||1||
48082812|NCT02310568|100521917|FG002|NOT COMPLETED|Stage 2 (4 Weeks)||1||
48082813|NCT02310568|100521918|FG003|NOT COMPLETED|Stage 2 (4 Weeks)||5||
48082814|NCT02310568|100521919|FG004|NOT COMPLETED|Stage 2 (4 Weeks)||1||
48082815|NCT00923247|100521920|FG000|STARTED|Overall Study||21||
48082816|NCT00923247|100521921|FG001|STARTED|Overall Study||1||
48082817|NCT00923247|100521920|FG000|COMPLETED|Overall Study||21||
48082818|NCT00923247|100521921|FG001|COMPLETED|Overall Study||1||
48082819|NCT00923247|100521920|FG000|NOT COMPLETED|Overall Study||0||
48082820|NCT00923247|100521921|FG001|NOT COMPLETED|Overall Study||0||
48082821|NCT02101060|100521922|FG000|STARTED|Overall Study||17||
48082822|NCT02101060|100521923|FG001|STARTED|Overall Study||16||
48082823|NCT02101060|100521922|FG000|COMPLETED|Overall Study||12||
48082824|NCT02101060|100521923|FG001|COMPLETED|Overall Study||12||
48082825|NCT02101060|100521922|FG000|NOT COMPLETED|Overall Study||5||
48082826|NCT02101060|100521923|FG001|NOT COMPLETED|Overall Study||4||
48082827|NCT04936256|100521924|FG000|STARTED|Overall Study||31||
48082828|NCT04936256|100521924|FG000|COMPLETED|Overall Study||29||
48082829|NCT04936256|100521924|FG000|NOT COMPLETED|Overall Study||2||
48082830|NCT01083368|100521925|FG000|STARTED|Dose Escalation Weeks 1-4||0||
48082831|NCT01083368|100521926|FG001|STARTED|Dose Escalation Weeks 1-4||0||
48082832|NCT01083368|100521927|FG002|STARTED|Dose Escalation Weeks 1-4||4||
48082833|NCT01083368|100521928|FG003|STARTED|Dose Escalation Weeks 1-4||0||
48082834|NCT01083368|100521925|FG000|Disease Progression|Dose Escalation Weeks 1-4||0||
48082835|NCT01083368|100521926|FG001|Disease Progression|Dose Escalation Weeks 1-4||0||
48082836|NCT01083368|100521927|FG002|Disease Progression|Dose Escalation Weeks 1-4||1||
48082837|NCT01083368|100521928|FG003|Disease Progression|Dose Escalation Weeks 1-4||0||
48082838|NCT01083368|100521925|FG000|COMPLETED|Dose Escalation Weeks 1-4||0||
48082839|NCT01083368|100521926|FG001|COMPLETED|Dose Escalation Weeks 1-4||0||
48082840|NCT01083368|100521927|FG002|COMPLETED|Dose Escalation Weeks 1-4||4||
48082841|NCT01083368|100521928|FG003|COMPLETED|Dose Escalation Weeks 1-4||0||
48082842|NCT01083368|100521925|FG000|NOT COMPLETED|Dose Escalation Weeks 1-4||0||
48082843|NCT01083368|100521926|FG001|NOT COMPLETED|Dose Escalation Weeks 1-4||0||
48082844|NCT01083368|100521927|FG002|NOT COMPLETED|Dose Escalation Weeks 1-4||0||
48082845|NCT01083368|100521928|FG003|NOT COMPLETED|Dose Escalation Weeks 1-4||0||
48082846|NCT01083368|100521925|FG000|STARTED|Dose Escalation Weeks 5-9||0||
48082847|NCT01083368|100521926|FG001|STARTED|Dose Escalation Weeks 5-9||0||
48082848|NCT01083368|100521927|FG002|STARTED|Dose Escalation Weeks 5-9||1||
48082849|NCT01083368|100521928|FG003|STARTED|Dose Escalation Weeks 5-9||6||
48082850|NCT01083368|100521925|FG000|COMPLETED|Dose Escalation Weeks 5-9||0||
48082851|NCT01083368|100521926|FG001|COMPLETED|Dose Escalation Weeks 5-9||0||
48082852|NCT01083368|100521927|FG002|COMPLETED|Dose Escalation Weeks 5-9||1||
48082853|NCT01083368|100521928|FG003|COMPLETED|Dose Escalation Weeks 5-9||6||
48082854|NCT01083368|100521925|FG000|NOT COMPLETED|Dose Escalation Weeks 5-9||0||
48082855|NCT01083368|100521926|FG001|NOT COMPLETED|Dose Escalation Weeks 5-9||0||
48082856|NCT01083368|100521927|FG002|NOT COMPLETED|Dose Escalation Weeks 5-9||0||
48082857|NCT01083368|100521928|FG003|NOT COMPLETED|Dose Escalation Weeks 5-9||0||
48246034|NCT00946998|100920941|FG001|NOT COMPLETED|Overall Study||3||
48540774|NCT00435812|101662564|FG000|NOT COMPLETED|Overall Study||63||
48082858|NCT01083368|100521925|FG000|STARTED|Phase II - Efficacy/Safety||0||
48082859|NCT01083368|100521926|FG001|STARTED|Phase II - Efficacy/Safety||0||
48082860|NCT01083368|100521927|FG002|STARTED|Phase II - Efficacy/Safety||0||
48082861|NCT01083368|100521928|FG003|STARTED|Phase II - Efficacy/Safety||20||
48082862|NCT01083368|100521925|FG000|COMPLETED|Phase II - Efficacy/Safety||0||
48082863|NCT01083368|100521926|FG001|COMPLETED|Phase II - Efficacy/Safety||0||
48082864|NCT01083368|100521927|FG002|COMPLETED|Phase II - Efficacy/Safety||0||
48082865|NCT01083368|100521928|FG003|COMPLETED|Phase II - Efficacy/Safety||20||
48082866|NCT01083368|100521925|FG000|NOT COMPLETED|Phase II - Efficacy/Safety||0||
48082867|NCT01083368|100521926|FG001|NOT COMPLETED|Phase II - Efficacy/Safety||0||
48082868|NCT01083368|100521927|FG002|NOT COMPLETED|Phase II - Efficacy/Safety||0||
48082869|NCT01083368|100521928|FG003|NOT COMPLETED|Phase II - Efficacy/Safety||0||
48082870|NCT03948698|100525458|FG000|STARTED|Overall Study||4749072||
48082871|NCT03948698|100525458|FG000|COMPLETED|Overall Study||4749072||
48082872|NCT03948698|100525458|FG000|NOT COMPLETED|Overall Study||0||
48082873|NCT02599129|100525459|FG000|STARTED|Overall Study||7||
48082874|NCT02599129|100525460|FG001|STARTED|Overall Study||4||
48082875|NCT02599129|100525459|FG000|COMPLETED|Overall Study||2||
48082876|NCT02599129|100525460|FG001|COMPLETED|Overall Study||1||
48082877|NCT02599129|100525459|FG000|NOT COMPLETED|Overall Study||5||
48082878|NCT02599129|100525460|FG001|NOT COMPLETED|Overall Study||3||
48082879|NCT01064713|100525461|FG000|STARTED|Overall Study||13||
48082880|NCT01064713|100525462|FG001|STARTED|Overall Study||4||
48082881|NCT01064713|100525461|FG000|COMPLETED|Overall Study||13||
48082882|NCT01064713|100525462|FG001|COMPLETED|Overall Study||4||
48082883|NCT01064713|100525461|FG000|NOT COMPLETED|Overall Study||0||
48082884|NCT01064713|100525462|FG001|NOT COMPLETED|Overall Study||0||
48082885|NCT02812160|100525463|FG000|STARTED|Overall Study||187||
48082886|NCT02812160|100525464|FG001|STARTED|Overall Study||101||
48082887|NCT02812160|100525463|FG000|COMPLETED|Overall Study||187||
48082888|NCT02812160|100525464|FG001|COMPLETED|Overall Study||101||
48082889|NCT02812160|100525463|FG000|NOT COMPLETED|Overall Study||0||
48082890|NCT02812160|100525464|FG001|NOT COMPLETED|Overall Study||0||
48082891|NCT00621985|100525465|FG000|STARTED|Hydrocortisone Admission||5||
48082892|NCT00621985|100525465|FG000|COMPLETED|Hydrocortisone Admission||5||
48082893|NCT00621985|100525465|FG000|NOT COMPLETED|Hydrocortisone Admission||0||
48082894|NCT00621985|100525465|FG000|STARTED|Dexamethasone Admission||5||
48082895|NCT00621985|100525465|FG000|COMPLETED|Dexamethasone Admission||4||
48082896|NCT00621985|100525465|FG000|NOT COMPLETED|Dexamethasone Admission||1||
48082897|NCT02990910|100525466|FG000|STARTED|Overall Study||140|accorded with the inclusion criteria|
48082898|NCT02990910|100525467|FG001|STARTED|Overall Study||140|accorded with the inclusion criteria|
48082899|NCT02990910|100525466|FG000|COMPLETED|Overall Study||134|back to the wards|
48082900|NCT02990910|100525467|FG001|COMPLETED|Overall Study||130|back to the wards|
48082901|NCT02990910|100525466|FG000|NOT COMPLETED|Overall Study||6||
48082902|NCT02990910|100525467|FG001|NOT COMPLETED|Overall Study||10||
48082903|NCT03919799|100525468|FG000|STARTED|DB Period (28 Weeks)||12||
48082904|NCT03919799|100525469|FG001|STARTED|DB Period (28 Weeks)||12||
48082905|NCT03919799|100525470|FG002|STARTED|DB Period (28 Weeks)||12||
48082906|NCT03919799|100525471|FG003|STARTED|DB Period (28 Weeks)||0||
48082907|NCT03919799|100525472|FG004|STARTED|DB Period (28 Weeks)||0||
48082908|NCT03919799|100525468|FG000|Treated|DB Period (28 Weeks)||11||
48082909|NCT03919799|100525469|FG001|Treated|DB Period (28 Weeks)||12||
48082910|NCT03919799|100525470|FG002|Treated|DB Period (28 Weeks)||12||
48082911|NCT03919799|100525471|FG003|Treated|DB Period (28 Weeks)||0||
48082912|NCT03919799|100525472|FG004|Treated|DB Period (28 Weeks)||0||
48082913|NCT03919799|100525468|FG000|COMPLETED|DB Period (28 Weeks)||10||
48082914|NCT03919799|100525469|FG001|COMPLETED|DB Period (28 Weeks)||10||
48082915|NCT03919799|100525470|FG002|COMPLETED|DB Period (28 Weeks)||11||
48082916|NCT03919799|100525471|FG003|COMPLETED|DB Period (28 Weeks)||0||
48082917|NCT03919799|100525472|FG004|COMPLETED|DB Period (28 Weeks)||0||
48082918|NCT03919799|100525468|FG000|NOT COMPLETED|DB Period (28 Weeks)||2||
48082919|NCT03919799|100525469|FG001|NOT COMPLETED|DB Period (28 Weeks)||2||
48082920|NCT03919799|100525470|FG002|NOT COMPLETED|DB Period (28 Weeks)||1||
48082921|NCT03919799|100525471|FG003|NOT COMPLETED|DB Period (28 Weeks)||0||
48082922|NCT03919799|100525472|FG004|NOT COMPLETED|DB Period (28 Weeks)||0||
48082923|NCT03919799|100525468|FG000|STARTED|OLE Period (24 Weeks)||10||
48082924|NCT03919799|100525469|FG001|STARTED|OLE Period (24 Weeks)||10||
48082925|NCT03919799|100525470|FG002|STARTED|OLE Period (24 Weeks)||0||
48082926|NCT03919799|100525471|FG003|STARTED|OLE Period (24 Weeks)||5||
48082927|NCT03919799|100525472|FG004|STARTED|OLE Period (24 Weeks)||6||
48082928|NCT03919799|100525468|FG000|COMPLETED|OLE Period (24 Weeks)||10||
48082929|NCT03919799|100525469|FG001|COMPLETED|OLE Period (24 Weeks)||7||
48082930|NCT03919799|100525470|FG002|COMPLETED|OLE Period (24 Weeks)||0||
48082931|NCT03919799|100525471|FG003|COMPLETED|OLE Period (24 Weeks)||5||
48082932|NCT03919799|100525472|FG004|COMPLETED|OLE Period (24 Weeks)||6||
48082933|NCT03919799|100525468|FG000|NOT COMPLETED|OLE Period (24 Weeks)||0||
48082934|NCT03919799|100525469|FG001|NOT COMPLETED|OLE Period (24 Weeks)||3||
48082935|NCT03919799|100525470|FG002|NOT COMPLETED|OLE Period (24 Weeks)||0||
48082936|NCT03919799|100525471|FG003|NOT COMPLETED|OLE Period (24 Weeks)||0||
48082937|NCT03919799|100525472|FG004|NOT COMPLETED|OLE Period (24 Weeks)||0||
48082938|NCT03229278|100525473|FG000|STARTED|Overall Study||3||
48082939|NCT03229278|100525474|FG001|STARTED|Overall Study||6||
48082940|NCT03229278|100525475|FG002|STARTED|Overall Study||3||
48082941|NCT03229278|100525476|FG003|STARTED|Overall Study||2||
48082942|NCT03229278|100525473|FG000|COMPLETED|Overall Study||3||
48082943|NCT03229278|100525474|FG001|COMPLETED|Overall Study||6||
48082944|NCT03229278|100525475|FG002|COMPLETED|Overall Study||3||
48082945|NCT03229278|100525476|FG003|COMPLETED|Overall Study||2||
48082946|NCT03229278|100525473|FG000|NOT COMPLETED|Overall Study||0||
48082947|NCT03229278|100525474|FG001|NOT COMPLETED|Overall Study||0||
48082948|NCT03229278|100525475|FG002|NOT COMPLETED|Overall Study||0||
48082949|NCT03229278|100525476|FG003|NOT COMPLETED|Overall Study||0||
48082950|NCT01867424|100525477|FG000|STARTED|Overall Study||12||
48082951|NCT01867424|100525478|FG001|STARTED|Overall Study||12||
48082952|NCT01867424|100525477|FG000|COMPLETED|Overall Study||10||
48246035|NCT01403805|100920942|FG000|STARTED|Overall Study||94||
48082953|NCT01867424|100525478|FG001|COMPLETED|Overall Study||11||
48082954|NCT01867424|100525477|FG000|NOT COMPLETED|Overall Study||2||
48082955|NCT01867424|100525478|FG001|NOT COMPLETED|Overall Study||1||
48082956|NCT03694821|100525479|FG000|STARTED|Overall Study||4||
48082957|NCT03694821|100525480|FG001|STARTED|Overall Study||8||
48082958|NCT03694821|100525481|FG002|STARTED|Overall Study||6||
48082959|NCT03694821|100525479|FG000|COMPLETED|Overall Study||0||
48082960|NCT03694821|100525480|FG001|COMPLETED|Overall Study||0||
48082961|NCT03694821|100525481|FG002|COMPLETED|Overall Study||2||
48082962|NCT03694821|100525479|FG000|NOT COMPLETED|Overall Study||4||
48082963|NCT03694821|100525480|FG001|NOT COMPLETED|Overall Study||8||
48246036|NCT01403805|100920943|FG001|STARTED|Overall Study||105||
48246037|NCT01403805|100920942|FG000|Pneumonia Diagnosis|Overall Study||21||
48246038|NCT01403805|100920943|FG001|Pneumonia Diagnosis|Overall Study||2||
48246039|NCT01403805|100920942|FG000|COMPLETED|Overall Study||94||
48246040|NCT01403805|100920943|FG001|COMPLETED|Overall Study||98||
48246041|NCT01403805|100920942|FG000|NOT COMPLETED|Overall Study||0||
48246042|NCT01403805|100920943|FG001|NOT COMPLETED|Overall Study||7||
48246043|NCT02592486|100920944|FG000|STARTED|Overall Study||81||
48246044|NCT02592486|100920945|FG001|STARTED|Overall Study||81||
48246045|NCT02592486|100920944|FG000|COMPLETED|Overall Study||81||
48246046|NCT02592486|100920945|FG001|COMPLETED|Overall Study||76||
48246047|NCT02592486|100920944|FG000|NOT COMPLETED|Overall Study||0||
48246048|NCT02592486|100920945|FG001|NOT COMPLETED|Overall Study||5||
48246049|NCT01190449|100920946|FG000|STARTED|Overall Study||15||
48246050|NCT01190449|100920947|FG001|STARTED|Overall Study||36||
48082964|NCT03694821|100525481|FG002|NOT COMPLETED|Overall Study||4||
48082965|NCT03444961|100525482|FG000|STARTED|Overall Study||4||
48082966|NCT03444961|100525482|FG000|COMPLETED|Overall Study||4||
48082967|NCT03444961|100525482|FG000|NOT COMPLETED|Overall Study||0||
48082968|NCT03798483|100525483|FG000|STARTED|Overall Study||15||
48082969|NCT03798483|100525483|FG000|Returned All Follow-up Outcome Data|Overall Study||11||
48082970|NCT03798483|100525483|FG000|COMPLETED|Overall Study||13|Completed participants were participants that returned Lysholm Knee Scoring Scale data. 2 participants returned Lysholm Knee Scoring Scale outcome data only.|
48082971|NCT03798483|100525483|FG000|NOT COMPLETED|Overall Study||2||
48082972|NCT03648541|100525484|FG000|STARTED|Started From Parent Trial||57|Number of participants from parent trials who were enrolled into 1368-0017.|
48082973|NCT03648541|100525485|FG001|STARTED|Started From Parent Trial||22|Number of participants from parent trials who were enrolled into 1368-0017.|
48082974|NCT03648541|100525484|FG000|COMPLETED|Started From Parent Trial||57|Completed reflects the number of participants who either started re-induction period or maintenance period or both.|
48082975|NCT03648541|100525485|FG001|COMPLETED|Started From Parent Trial||22|Completed reflects the number of participants who either started re-induction period or maintenance period or both.|
48082976|NCT03648541|100525484|FG000|NOT COMPLETED|Started From Parent Trial||0||
48082977|NCT03648541|100525485|FG001|NOT COMPLETED|Started From Parent Trial||0||
48082978|NCT03648541|100525484|FG000|STARTED|Re-induction Period Only||57|Started re-induction treatment.|
48246051|NCT01190449|100920946|FG000|COMPLETED|Overall Study||15||
48246052|NCT01190449|100920947|FG001|COMPLETED|Overall Study||32||
48082979|NCT03648541|100525485|FG001|STARTED|Re-induction Period Only||0|Started re-induction treatment.|
48082980|NCT03648541|100525484|FG000|Switched to Maintenance Treatment|Re-induction Period Only||12||
48682048|NCT03800030|102006543|FG003|COMPLETED|Baseline||6||
48682049|NCT03800030|102006544|FG004|COMPLETED|Baseline||4||
48682050|NCT03800030|102006545|FG005|COMPLETED|Baseline||4||
48682051|NCT03800030|102006540|FG000|NOT COMPLETED|Baseline||0||
48246053|NCT01190449|100920946|FG000|NOT COMPLETED|Overall Study||0||
48246054|NCT01190449|100920947|FG001|NOT COMPLETED|Overall Study||4||
48246055|NCT00645099|100920948|FG000|STARTED|Overall Study||239||
48082981|NCT03648541|100525485|FG001|Switched to Maintenance Treatment|Re-induction Period Only||0||
48082982|NCT03648541|100525484|FG000|COMPLETED|Re-induction Period Only||49|Completed re-induction treatment.|
48082983|NCT03648541|100525485|FG001|COMPLETED|Re-induction Period Only||0|Completed re-induction treatment.|
48082984|NCT03648541|100525484|FG000|NOT COMPLETED|Re-induction Period Only||8||
48246056|NCT00645099|100920949|FG001|STARTED|Overall Study||220||
48246057|NCT00645099|100920948|FG000|COMPLETED|Overall Study||168||
48246058|NCT00645099|100920949|FG001|COMPLETED|Overall Study||178||
48246059|NCT00645099|100920948|FG000|NOT COMPLETED|Overall Study||71||
48246060|NCT00645099|100920949|FG001|NOT COMPLETED|Overall Study||42||
48246061|NCT03861429|100920950|FG000|STARTED|Overall Study||64||4
48246062|NCT03861429|100920951|FG001|STARTED|Overall Study||74||4
48246063|NCT03861429|100920950|FG000|Residents|Overall Study||17||4
48246064|NCT03861429|100920951|FG001|Residents|Overall Study||19||4
48246065|NCT03861429|100920950|FG000|Family|Overall Study||25||4
48682052|NCT03800030|102006541|FG001|NOT COMPLETED|Baseline||0||
48682053|NCT03800030|102006542|FG002|NOT COMPLETED|Baseline||0||
48682054|NCT03800030|102006543|FG003|NOT COMPLETED|Baseline||0||
48682055|NCT03800030|102006544|FG004|NOT COMPLETED|Baseline||0||
48682056|NCT03800030|102006545|FG005|NOT COMPLETED|Baseline||0||
48682057|NCT03800030|102006540|FG000|STARTED|Pre-Randomization Period (1 Week)||4||
48682058|NCT03800030|102006541|FG001|STARTED|Pre-Randomization Period (1 Week)||4||
48682059|NCT03800030|102006542|FG002|STARTED|Pre-Randomization Period (1 Week)||4||
48682060|NCT03800030|102006543|FG003|STARTED|Pre-Randomization Period (1 Week)||6||
48682061|NCT03800030|102006544|FG004|STARTED|Pre-Randomization Period (1 Week)||4||
48682062|NCT03800030|102006545|FG005|STARTED|Pre-Randomization Period (1 Week)||4||
48682063|NCT03800030|102006540|FG000|COMPLETED|Pre-Randomization Period (1 Week)||4||
48682064|NCT03800030|102006541|FG001|COMPLETED|Pre-Randomization Period (1 Week)||4||
48082985|NCT03648541|100525485|FG001|NOT COMPLETED|Re-induction Period Only||0||
48082986|NCT03648541|100525484|FG000|STARTED|Maintenance Period Only||0|Started maintenance treatment|
48082987|NCT03648541|100525485|FG001|STARTED|Maintenance Period Only||34|Started maintenance treatment|
48082988|NCT03648541|100525484|FG000|Participants From Parent Trial|Maintenance Period Only||0||
48082989|NCT03648541|100525485|FG001|Participants From Parent Trial|Maintenance Period Only||22||
48082990|NCT03648541|100525484|FG000|Participants From Re-induction Treatment|Maintenance Period Only||0||
48082991|NCT03648541|100525485|FG001|Participants From Re-induction Treatment|Maintenance Period Only||12||
48246066|NCT03861429|100920951|FG001|Family|Overall Study||25||4
48246067|NCT03861429|100920950|FG000|Staff|Overall Study||13||4
48246068|NCT03861429|100920951|FG001|Staff|Overall Study||25||4
48246069|NCT03861429|100920950|FG000|COMPLETED|Overall Study||55||4
48246070|NCT03861429|100920951|FG001|COMPLETED|Overall Study||69||4
48246071|NCT03861429|100920950|FG000|NOT COMPLETED|Overall Study||9||0
48246072|NCT03861429|100920951|FG001|NOT COMPLETED|Overall Study||5||0
48246073|NCT04468633|100920952|FG000|STARTED|Overall Study||37||37
48682065|NCT03800030|102006542|FG002|COMPLETED|Pre-Randomization Period (1 Week)||4||
48682066|NCT03800030|102006543|FG003|COMPLETED|Pre-Randomization Period (1 Week)||6||
48682067|NCT03800030|102006544|FG004|COMPLETED|Pre-Randomization Period (1 Week)||4||
48682068|NCT03800030|102006545|FG005|COMPLETED|Pre-Randomization Period (1 Week)||4||
48682069|NCT03800030|102006540|FG000|NOT COMPLETED|Pre-Randomization Period (1 Week)||0||
48246074|NCT04468633|100920953|FG001|STARTED|Overall Study||39||39
48682070|NCT03800030|102006541|FG001|NOT COMPLETED|Pre-Randomization Period (1 Week)||0||
48082992|NCT03648541|100525484|FG000|COMPLETED|Maintenance Period Only||0|Completed maintenance treatment|
48082993|NCT03648541|100525485|FG001|COMPLETED|Maintenance Period Only||0|Completed maintenance treatment|
48082994|NCT03648541|100525484|FG000|NOT COMPLETED|Maintenance Period Only||0||
48082995|NCT03648541|100525485|FG001|NOT COMPLETED|Maintenance Period Only||34||
48082996|NCT03250845|100525486|FG000|STARTED|Multigam 5% Infusion (Baseline)||30||
48082997|NCT03250845|100525486|FG000|COMPLETED|Multigam 5% Infusion (Baseline)||30||
48082998|NCT03250845|100525486|FG000|NOT COMPLETED|Multigam 5% Infusion (Baseline)||0||
48682071|NCT03800030|102006542|FG002|NOT COMPLETED|Pre-Randomization Period (1 Week)||0||
48682072|NCT03800030|102006543|FG003|NOT COMPLETED|Pre-Randomization Period (1 Week)||0||
48682073|NCT03800030|102006544|FG004|NOT COMPLETED|Pre-Randomization Period (1 Week)||0||
48682074|NCT03800030|102006545|FG005|NOT COMPLETED|Pre-Randomization Period (1 Week)||0||
48682075|NCT03800030|102006540|FG000|STARTED|First Intervention||4||
48682076|NCT03800030|102006541|FG001|STARTED|First Intervention||4||
48082999|NCT03250845|100525486|FG000|STARTED|Multigam 10% Infusion (3-4 Weeks Later)||30||
48083000|NCT03250845|100525486|FG000|COMPLETED|Multigam 10% Infusion (3-4 Weeks Later)||30||
48083001|NCT03250845|100525486|FG000|NOT COMPLETED|Multigam 10% Infusion (3-4 Weeks Later)||0||
48682077|NCT03800030|102006542|FG002|STARTED|First Intervention||4||
48682078|NCT03800030|102006543|FG003|STARTED|First Intervention||6||
48682079|NCT03800030|102006544|FG004|STARTED|First Intervention||4||
48682080|NCT03800030|102006545|FG005|STARTED|First Intervention||4||
48682081|NCT03800030|102006540|FG000|COMPLETED|First Intervention||4||
48682082|NCT03800030|102006541|FG001|COMPLETED|First Intervention||4||
48682083|NCT03800030|102006542|FG002|COMPLETED|First Intervention||4||
48682084|NCT03800030|102006543|FG003|COMPLETED|First Intervention||6||
48682085|NCT03800030|102006544|FG004|COMPLETED|First Intervention||4||
48682086|NCT03800030|102006545|FG005|COMPLETED|First Intervention||4||
48682087|NCT03800030|102006540|FG000|NOT COMPLETED|First Intervention||0||
48682088|NCT03800030|102006541|FG001|NOT COMPLETED|First Intervention||0||
48682089|NCT03800030|102006542|FG002|NOT COMPLETED|First Intervention||0||
48682090|NCT03800030|102006543|FG003|NOT COMPLETED|First Intervention||0||
48682091|NCT03800030|102006544|FG004|NOT COMPLETED|First Intervention||0||
48682092|NCT03800030|102006545|FG005|NOT COMPLETED|First Intervention||0||
48682093|NCT03800030|102006540|FG000|STARTED|First Washout (1 Week)||4||
48083002|NCT02651922|100525487|FG000|STARTED|Overall Study||156||
48682094|NCT03800030|102006541|FG001|STARTED|First Washout (1 Week)||4||
48682095|NCT03800030|102006542|FG002|STARTED|First Washout (1 Week)||4||
48682096|NCT03800030|102006543|FG003|STARTED|First Washout (1 Week)||6||
48682097|NCT03800030|102006544|FG004|STARTED|First Washout (1 Week)||4||
48682098|NCT03800030|102006545|FG005|STARTED|First Washout (1 Week)||4||
48682099|NCT03800030|102006540|FG000|COMPLETED|First Washout (1 Week)||4||
48682100|NCT03800030|102006541|FG001|COMPLETED|First Washout (1 Week)||4||
48083003|NCT02651922|100525487|FG000|COMPLETED|Overall Study||154||
48246075|NCT04468633|100920952|FG000|COMPLETED|Overall Study||33||33
48682101|NCT03800030|102006542|FG002|COMPLETED|First Washout (1 Week)||4||
48083004|NCT02651922|100525487|FG000|NOT COMPLETED|Overall Study||2||
48083005|NCT01966900|100525488|FG000|STARTED|Overall Study||8||
48083006|NCT01966900|100525489|FG001|STARTED|Overall Study||6||
48083007|NCT01966900|100525488|FG000|COMPLETED|Overall Study||6||
48682102|NCT03800030|102006543|FG003|COMPLETED|First Washout (1 Week)||6||
48682103|NCT03800030|102006544|FG004|COMPLETED|First Washout (1 Week)||4||
48682104|NCT03800030|102006545|FG005|COMPLETED|First Washout (1 Week)||4||
48083008|NCT01966900|100525489|FG001|COMPLETED|Overall Study||6||
48083009|NCT01966900|100525488|FG000|NOT COMPLETED|Overall Study||2||
48083010|NCT01966900|100525489|FG001|NOT COMPLETED|Overall Study||0||
48083011|NCT04488068|100525490|FG000|STARTED|Overall Study||12||
48083012|NCT04488068|100525491|FG001|STARTED|Overall Study||0||
48083013|NCT04488068|100525490|FG000|COMPLETED|Overall Study||9||
48083014|NCT04488068|100525491|FG001|COMPLETED|Overall Study||0||
48083015|NCT04488068|100525490|FG000|NOT COMPLETED|Overall Study||3||
48083016|NCT04488068|100525491|FG001|NOT COMPLETED|Overall Study||0||
48083017|NCT00663169|100525492|FG000|STARTED|Overall Study||3||
48083018|NCT00663169|100525493|FG001|STARTED|Overall Study||3||
48083019|NCT00663169|100525492|FG000|COMPLETED|Overall Study||3||
48083020|NCT00663169|100525493|FG001|COMPLETED|Overall Study||3||
48083021|NCT00663169|100525492|FG000|NOT COMPLETED|Overall Study||0||
48083022|NCT00663169|100525493|FG001|NOT COMPLETED|Overall Study||0||
48083023|NCT01354977|100525494|FG000|STARTED|Overall Study||12||
48246076|NCT04468633|100920953|FG001|COMPLETED|Overall Study||39||39
48246077|NCT04468633|100920952|FG000|NOT COMPLETED|Overall Study||4||4
48246078|NCT04468633|100920953|FG001|NOT COMPLETED|Overall Study||0||0
48246079|NCT00911183|100920954|FG000|STARTED|Overall Study||47||
48246080|NCT00911183|100920955|FG001|STARTED|Overall Study||20||
48246081|NCT00911183|100920954|FG000|COMPLETED|Overall Study||47||
48682105|NCT03800030|102006540|FG000|NOT COMPLETED|First Washout (1 Week)||0||
48682106|NCT03800030|102006541|FG001|NOT COMPLETED|First Washout (1 Week)||0||
48682107|NCT03800030|102006542|FG002|NOT COMPLETED|First Washout (1 Week)||0||
48682108|NCT03800030|102006543|FG003|NOT COMPLETED|First Washout (1 Week)||0||
48682109|NCT03800030|102006544|FG004|NOT COMPLETED|First Washout (1 Week)||0||
48682110|NCT03800030|102006545|FG005|NOT COMPLETED|First Washout (1 Week)||0||
48682111|NCT03800030|102006540|FG000|STARTED|Second Intervention||4||
48682112|NCT03800030|102006541|FG001|STARTED|Second Intervention||4||
48682113|NCT03800030|102006542|FG002|STARTED|Second Intervention||4||
48682114|NCT03800030|102006543|FG003|STARTED|Second Intervention||6||
48682115|NCT03800030|102006544|FG004|STARTED|Second Intervention||4||
48682116|NCT03800030|102006545|FG005|STARTED|Second Intervention||4||
48682117|NCT03800030|102006540|FG000|COMPLETED|Second Intervention||4||
48682118|NCT03800030|102006541|FG001|COMPLETED|Second Intervention||4||
48682119|NCT03800030|102006542|FG002|COMPLETED|Second Intervention||4||
48682120|NCT03800030|102006543|FG003|COMPLETED|Second Intervention||5||
48682121|NCT03800030|102006544|FG004|COMPLETED|Second Intervention||4||
48682122|NCT03800030|102006545|FG005|COMPLETED|Second Intervention||4||
48682123|NCT03800030|102006540|FG000|NOT COMPLETED|Second Intervention||0||
48682124|NCT03800030|102006541|FG001|NOT COMPLETED|Second Intervention||0||
48682125|NCT03800030|102006542|FG002|NOT COMPLETED|Second Intervention||0||
48682126|NCT03800030|102006543|FG003|NOT COMPLETED|Second Intervention||1||
48682127|NCT03800030|102006544|FG004|NOT COMPLETED|Second Intervention||0||
48682128|NCT03800030|102006545|FG005|NOT COMPLETED|Second Intervention||0||
48682129|NCT03800030|102006540|FG000|STARTED|Second Washout (1 Week)||4||
48682130|NCT03800030|102006541|FG001|STARTED|Second Washout (1 Week)||4||
48682131|NCT03800030|102006542|FG002|STARTED|Second Washout (1 Week)||4||
48682132|NCT03800030|102006543|FG003|STARTED|Second Washout (1 Week)||5||
48682133|NCT03800030|102006544|FG004|STARTED|Second Washout (1 Week)||4||
48682134|NCT03800030|102006545|FG005|STARTED|Second Washout (1 Week)||4||
48682135|NCT03800030|102006540|FG000|COMPLETED|Second Washout (1 Week)||4||
48682136|NCT03800030|102006541|FG001|COMPLETED|Second Washout (1 Week)||4||
48682137|NCT03800030|102006542|FG002|COMPLETED|Second Washout (1 Week)||4||
48682138|NCT03800030|102006543|FG003|COMPLETED|Second Washout (1 Week)||4||
48682139|NCT03800030|102006544|FG004|COMPLETED|Second Washout (1 Week)||4||
48682140|NCT03800030|102006545|FG005|COMPLETED|Second Washout (1 Week)||4||
48682141|NCT03800030|102006540|FG000|NOT COMPLETED|Second Washout (1 Week)||0||
48682142|NCT03800030|102006541|FG001|NOT COMPLETED|Second Washout (1 Week)||0||
48682143|NCT03800030|102006542|FG002|NOT COMPLETED|Second Washout (1 Week)||0||
48682144|NCT03800030|102006543|FG003|NOT COMPLETED|Second Washout (1 Week)||1||
48682145|NCT03800030|102006544|FG004|NOT COMPLETED|Second Washout (1 Week)||0||
48682146|NCT03800030|102006545|FG005|NOT COMPLETED|Second Washout (1 Week)||0||
48682147|NCT03800030|102006540|FG000|STARTED|Third Intervention||4||
48682148|NCT03800030|102006541|FG001|STARTED|Third Intervention||4||
48682149|NCT03800030|102006542|FG002|STARTED|Third Intervention||4||
48682150|NCT03800030|102006543|FG003|STARTED|Third Intervention||4||
48682151|NCT03800030|102006544|FG004|STARTED|Third Intervention||4||
48682152|NCT03800030|102006545|FG005|STARTED|Third Intervention||4||
48246082|NCT00911183|100920955|FG001|COMPLETED|Overall Study||20||
48246083|NCT00911183|100920954|FG000|NOT COMPLETED|Overall Study||0||
48246084|NCT00911183|100920955|FG001|NOT COMPLETED|Overall Study||0||
48246085|NCT01536535|100920956|FG000|STARTED|Overall Study||178||
48246086|NCT01536535|100920957|FG001|STARTED|Overall Study||250||
48246087|NCT01536535|100920956|FG000|COMPLETED|Overall Study||163||
48246088|NCT01536535|100920957|FG001|COMPLETED|Overall Study||237||
48246089|NCT01536535|100920956|FG000|NOT COMPLETED|Overall Study||15||
48246090|NCT01536535|100920957|FG001|NOT COMPLETED|Overall Study||13||
48246091|NCT00774306|100920958|FG000|STARTED|Overall Study||24||
48246092|NCT00774306|100920959|FG001|STARTED|Overall Study||5||
48682153|NCT03800030|102006540|FG000|COMPLETED|Third Intervention||4||
48682154|NCT03800030|102006541|FG001|COMPLETED|Third Intervention||4||
48682155|NCT03800030|102006542|FG002|COMPLETED|Third Intervention||4||
48682156|NCT03800030|102006543|FG003|COMPLETED|Third Intervention||4||
48682157|NCT03800030|102006544|FG004|COMPLETED|Third Intervention||4||
48682158|NCT03800030|102006545|FG005|COMPLETED|Third Intervention||4||
48682159|NCT03800030|102006540|FG000|NOT COMPLETED|Third Intervention||0||
48682160|NCT03800030|102006541|FG001|NOT COMPLETED|Third Intervention||0||
48682161|NCT03800030|102006542|FG002|NOT COMPLETED|Third Intervention||0||
48682162|NCT03800030|102006543|FG003|NOT COMPLETED|Third Intervention||0||
48682163|NCT03800030|102006544|FG004|NOT COMPLETED|Third Intervention||0||
48246093|NCT00774306|100920960|FG002|STARTED|Overall Study||16||
48246094|NCT00774306|100920961|FG003|STARTED|Overall Study||7||
48246095|NCT00774306|100920958|FG000|COMPLETED|Overall Study||6||
48246096|NCT00774306|100920959|FG001|COMPLETED|Overall Study||3||
48246097|NCT00774306|100920960|FG002|COMPLETED|Overall Study||8||
48682164|NCT03800030|102006545|FG005|NOT COMPLETED|Third Intervention||0||
48682165|NCT00648037|102006546|FG000|STARTED|Overall Study||26||
48083024|NCT01354977|100525495|FG001|STARTED|Overall Study||8||
48083025|NCT01354977|100525494|FG000|COMPLETED|Overall Study||12||
48083026|NCT01354977|100525495|FG001|COMPLETED|Overall Study||8||
48083027|NCT01354977|100525494|FG000|NOT COMPLETED|Overall Study||0||
48246098|NCT00774306|100920961|FG003|COMPLETED|Overall Study||2||
48682166|NCT00648037|102006546|FG000|COMPLETED|Overall Study||10||
48682167|NCT00648037|102006546|FG000|NOT COMPLETED|Overall Study||16||
48682168|NCT02132572|102006547|FG000|STARTED|Overall Study||201||
48682169|NCT02132572|102006547|FG000|COMPLETED|Overall Study||201||
48682170|NCT02132572|102006547|FG000|NOT COMPLETED|Overall Study||0||
48682171|NCT04834726|102006548|FG000|STARTED|Overall Study||472||
48682172|NCT04834726|102006549|FG001|STARTED|Overall Study||2393||
48682173|NCT04834726|102006550|FG002|STARTED|Overall Study||2389||
48682174|NCT04834726|102006551|FG003|STARTED|Overall Study||2392||
48682175|NCT04834726|102006552|FG004|STARTED|Overall Study||2385||
48682176|NCT04834726|102006553|FG005|STARTED|Overall Study||2380||
48682177|NCT04834726|102006554|FG006|STARTED|Overall Study||2382||
48682178|NCT04834726|102006555|FG007|STARTED|Overall Study||2383||
48682179|NCT04834726|102006556|FG008|STARTED|Overall Study||2378||
48682180|NCT04834726|102006548|FG000|COMPLETED|Overall Study||390||
48682181|NCT04834726|102006549|FG001|COMPLETED|Overall Study||1971||
48682182|NCT04834726|102006550|FG002|COMPLETED|Overall Study||1985||
48083028|NCT01354977|100525495|FG001|NOT COMPLETED|Overall Study||0||
48083029|NCT03761277|100525496|FG000|STARTED|Enrollment to Implant||93||
48682183|NCT04834726|102006551|FG003|COMPLETED|Overall Study||1977||
48682184|NCT04834726|102006552|FG004|COMPLETED|Overall Study||1957||
48682185|NCT04834726|102006553|FG005|COMPLETED|Overall Study||1918||
48682186|NCT04834726|102006554|FG006|COMPLETED|Overall Study||1935||
48682187|NCT04834726|102006555|FG007|COMPLETED|Overall Study||1934||
48682188|NCT04834726|102006556|FG008|COMPLETED|Overall Study||1978||
48682189|NCT04834726|102006548|FG000|NOT COMPLETED|Overall Study||82||
48682190|NCT04834726|102006549|FG001|NOT COMPLETED|Overall Study||422||
48682191|NCT04834726|102006550|FG002|NOT COMPLETED|Overall Study||404||
48682192|NCT04834726|102006551|FG003|NOT COMPLETED|Overall Study||415||
48682193|NCT04834726|102006552|FG004|NOT COMPLETED|Overall Study||428||
48682194|NCT04834726|102006553|FG005|NOT COMPLETED|Overall Study||462||
48083030|NCT03761277|100525496|FG000|Intrathecal Trial|Enrollment to Implant||72||
48083031|NCT03761277|100525496|FG000|COMPLETED|Enrollment to Implant||52||
48141211|NCT01260350|100670370|FG008|STARTED|Overall Study||25||
48141212|NCT01260350|100670371|FG009|STARTED|Overall Study||25||
48141213|NCT01260350|100670372|FG010|STARTED|Overall Study||10||
48141214|NCT01260350|100670373|FG011|STARTED|Overall Study||9||
48141215|NCT01260350|100670374|FG012|STARTED|Overall Study||25||
48141216|NCT01260350|100670375|FG013|STARTED|Overall Study||10||
48141217|NCT01260350|100670376|FG014|STARTED|Overall Study||25||
48141218|NCT01260350|100670377|FG015|STARTED|Overall Study||10||
48141219|NCT01260350|100670378|FG016|STARTED|Overall Study||9||
48141220|NCT01260350|100670379|FG017|STARTED|Overall Study||10||
48141221|NCT01260350|100670380|FG018|STARTED|Overall Study||0||
48141222|NCT01260350|100670381|FG019|STARTED|Overall Study||14||
48141223|NCT01260350|100670382|FG020|STARTED|Overall Study||25||
48141224|NCT01260350|100670383|FG021|STARTED|Overall Study||0||
48141225|NCT01260350|100670362|FG000|COMPLETED|Overall Study||10||
48141226|NCT01260350|100670363|FG001|COMPLETED|Overall Study||9||
48141227|NCT01260350|100670364|FG002|COMPLETED|Overall Study||10||
48141228|NCT01260350|100670365|FG003|COMPLETED|Overall Study||11||
48141229|NCT01260350|100670366|FG004|COMPLETED|Overall Study||10||
48141230|NCT01260350|100670367|FG005|COMPLETED|Overall Study||10||
48083032|NCT03761277|100525496|FG000|NOT COMPLETED|Enrollment to Implant||41||
48083033|NCT03761277|100525496|FG000|STARTED|Post-Implant to 6 Months||52||
48083034|NCT03761277|100525496|FG000|COMPLETED|Post-Implant to 6 Months||47||
48682195|NCT04834726|102006554|FG006|NOT COMPLETED|Overall Study||447||
48682196|NCT04834726|102006555|FG007|NOT COMPLETED|Overall Study||449||
48682197|NCT04834726|102006556|FG008|NOT COMPLETED|Overall Study||400||
48682198|NCT03192137|102006557|FG000|STARTED|Overall Study||173||
48682199|NCT03192137|102006558|FG001|STARTED|Overall Study||87||
48682200|NCT03192137|102006557|FG000|COMPLETED|Overall Study||123||
48682201|NCT03192137|102006558|FG001|COMPLETED|Overall Study||29||
48682202|NCT03192137|102006557|FG000|NOT COMPLETED|Overall Study||50||
48682203|NCT03192137|102006558|FG001|NOT COMPLETED|Overall Study||58||
48083035|NCT03761277|100525496|FG000|NOT COMPLETED|Post-Implant to 6 Months||5||
48083036|NCT03761277|100525496|FG000|STARTED|6 Months to 12 Months||47||
48083037|NCT03761277|100525496|FG000|COMPLETED|6 Months to 12 Months||19||
48083038|NCT03761277|100525496|FG000|NOT COMPLETED|6 Months to 12 Months||28||
48083039|NCT00660309|100525497|FG000|STARTED|Overall Study||23||
48083040|NCT00660309|100525498|FG001|STARTED|Overall Study||22||
48083041|NCT00660309|100525497|FG000|Treated With Aliskiren or Irbesartan|Overall Study||22||
48083042|NCT00660309|100525498|FG001|Treated With Aliskiren or Irbesartan|Overall Study||21||
48083043|NCT00660309|100525497|FG000|Pharmacodynamic Analysis Set|Overall Study||22||
48083044|NCT00660309|100525498|FG001|Pharmacodynamic Analysis Set|Overall Study||20||
48083045|NCT00660309|100525497|FG000|COMPLETED|Overall Study||21||
48083046|NCT00660309|100525498|FG001|COMPLETED|Overall Study||19||
48083047|NCT00660309|100525497|FG000|NOT COMPLETED|Overall Study||2||
48083048|NCT00660309|100525498|FG001|NOT COMPLETED|Overall Study||3||
48083049|NCT02495168|100525499|FG000|STARTED|Overall Study||504||
48083050|NCT02495168|100525500|FG001|STARTED|Overall Study||516||
48083051|NCT02495168|100525501|FG002|STARTED|Overall Study||127||
48083052|NCT02495168|100525499|FG000|Safety Population|Overall Study||501|Randomized participants who received at least 1 dose of study drug during Treatment Period|
48083053|NCT02495168|100525500|FG001|Safety Population|Overall Study||514|Randomized participants who received at least 1 dose of study drug during Treatment Period|
48083054|NCT02495168|100525501|FG002|Safety Population|Overall Study||126|Randomized participants who received at least 1 dose of study drug during Treatment Period|
48083055|NCT02495168|100525499|FG000|Modified Intent-to-Treat Population|Overall Study||468|Participants in Safety Population with no major inclusion/exclusion deviations, enrolled only once|
48083056|NCT02495168|100525500|FG001|Modified Intent-to-Treat Population|Overall Study||478|Participants in Safety Population with no major inclusion/exclusion deviations, enrolled only once|
48083057|NCT02495168|100525501|FG002|Modified Intent-to-Treat Population|Overall Study||111|Participants in Safety Population with no major inclusion/exclusion deviations, enrolled only once|
48083058|NCT02495168|100525499|FG000|Day1 Per-protocol Set (D1PPS) Population|Overall Study||437|mITT Population, no major protocol violations that impacted analysis of the Day 1 primary endpoint|
48083059|NCT02495168|100525500|FG001|Day1 Per-protocol Set (D1PPS) Population|Overall Study||437|mITT Population, no major protocol violations that impacted analysis of the Day 1 primary endpoint|
48083060|NCT02495168|100525501|FG002|Day1 Per-protocol Set (D1PPS) Population|Overall Study||99|mITT Population, no major protocol violations that impacted analysis of the Day 1 primary endpoint|
48083061|NCT02495168|100525499|FG000|Day 42 (D42PPS) Population|Overall Study||382|mITT Population, no major protocol violations that impacted analysis of the Day 42 primary endpoint|
48083062|NCT02495168|100525500|FG001|Day 42 (D42PPS) Population|Overall Study||383|mITT Population, no major protocol violations that impacted analysis of the Day 42 primary endpoint|
48083063|NCT02495168|100525501|FG002|Day 42 (D42PPS) Population|Overall Study||88|mITT Population, no major protocol violations that impacted analysis of the Day 42 primary endpoint|
48083064|NCT02495168|100525499|FG000|COMPLETED|Overall Study||466||
48083065|NCT02495168|100525500|FG001|COMPLETED|Overall Study||462||
48083066|NCT02495168|100525501|FG002|COMPLETED|Overall Study||110||
48083067|NCT02495168|100525499|FG000|NOT COMPLETED|Overall Study||38||
48083068|NCT02495168|100525500|FG001|NOT COMPLETED|Overall Study||54||
48083069|NCT02495168|100525501|FG002|NOT COMPLETED|Overall Study||17||
48083070|NCT02670837|100525502|FG000|STARTED|Overall Study||17||51
48083071|NCT02670837|100525503|FG001|STARTED|Overall Study||17||0
48083072|NCT02670837|100525504|FG002|STARTED|Overall Study||0||0
48083073|NCT02670837|100525502|FG000|COMPLETED|Overall Study||15||45
48083074|NCT02670837|100525503|FG001|COMPLETED|Overall Study||17||0
48083075|NCT02670837|100525504|FG002|COMPLETED|Overall Study||0||0
48083076|NCT02670837|100525502|FG000|NOT COMPLETED|Overall Study||2||6
48083077|NCT02670837|100525503|FG001|NOT COMPLETED|Overall Study||0||0
48083078|NCT02670837|100525504|FG002|NOT COMPLETED|Overall Study||0||0
48083079|NCT01484197|100525505|FG000|STARTED|Treatment Period 1||9||
48682204|NCT05501639|102006559|FG000|STARTED|Overall Study||633||
48682205|NCT05501639|102006560|FG001|STARTED|Overall Study||1266||
48682206|NCT05501639|102006559|FG000|COMPLETED|Overall Study||633||
48682207|NCT05501639|102006560|FG001|COMPLETED|Overall Study||1266||
48682208|NCT05501639|102006559|FG000|NOT COMPLETED|Overall Study||0||
48083080|NCT01484197|100525506|FG001|STARTED|Treatment Period 1||9||
48083081|NCT01484197|100525507|FG002|STARTED|Treatment Period 1||9||
48083082|NCT01484197|100525508|FG003|STARTED|Treatment Period 1||9||
48682209|NCT05501639|102006560|FG001|NOT COMPLETED|Overall Study||0||
48682210|NCT01904721|102006561|FG000|STARTED|Overall Study||13||
48682211|NCT01904721|102006562|FG001|STARTED|Overall Study||13||
48246099|NCT00774306|100920958|FG000|NOT COMPLETED|Overall Study||18||
48246100|NCT00774306|100920959|FG001|NOT COMPLETED|Overall Study||2||
48246101|NCT00774306|100920960|FG002|NOT COMPLETED|Overall Study||8||
48246102|NCT00774306|100920961|FG003|NOT COMPLETED|Overall Study||5||
48246103|NCT01697592|100920962|FG000|STARTED|Phase A (Up to 24 Weeks)||126||
48246104|NCT01697592|100920963|FG001|STARTED|Phase A (Up to 24 Weeks)||65||
48246105|NCT01697592|100920964|FG002|STARTED|Phase A (Up to 24 Weeks)||66||
48246106|NCT01697592|100920965|FG003|STARTED|Phase A (Up to 24 Weeks)||65||
48246107|NCT01697592|100920966|FG004|STARTED|Phase A (Up to 24 Weeks)||67||
48246108|NCT01697592|100920967|FG005|STARTED|Phase A (Up to 24 Weeks)||63||
48246109|NCT01697592|100920968|FG006|STARTED|Phase A (Up to 24 Weeks)||34||
48246110|NCT01697592|100920969|FG007|STARTED|Phase A (Up to 24 Weeks)||33||
48246111|NCT01697592|100920970|FG008|STARTED|Phase A (Up to 24 Weeks)||34||
48246112|NCT01697592|100920971|FG009|STARTED|Phase A (Up to 24 Weeks)||32||
48246113|NCT01697592|100920962|FG000|COMPLETED|Phase A (Up to 24 Weeks)||123||
48246114|NCT01697592|100920963|FG001|COMPLETED|Phase A (Up to 24 Weeks)||62||
48246115|NCT01697592|100920964|FG002|COMPLETED|Phase A (Up to 24 Weeks)||65||
48246116|NCT01697592|100920965|FG003|COMPLETED|Phase A (Up to 24 Weeks)||63||
48083083|NCT01484197|100525505|FG000|COMPLETED|Treatment Period 1||8||
48083084|NCT01484197|100525506|FG001|COMPLETED|Treatment Period 1||9||
48083085|NCT01484197|100525507|FG002|COMPLETED|Treatment Period 1||9||
48083086|NCT01484197|100525508|FG003|COMPLETED|Treatment Period 1||9||
48083087|NCT01484197|100525505|FG000|NOT COMPLETED|Treatment Period 1||1||
48083088|NCT01484197|100525506|FG001|NOT COMPLETED|Treatment Period 1||0||
48083089|NCT01484197|100525507|FG002|NOT COMPLETED|Treatment Period 1||0||
48083090|NCT01484197|100525508|FG003|NOT COMPLETED|Treatment Period 1||0||
48083091|NCT01484197|100525505|FG000|STARTED|Treatment Period 2||7||
48083092|NCT01484197|100525506|FG001|STARTED|Treatment Period 2||8||
48083093|NCT01484197|100525507|FG002|STARTED|Treatment Period 2||9||
48083094|NCT01484197|100525508|FG003|STARTED|Treatment Period 2||9||
48083095|NCT01484197|100525505|FG000|COMPLETED|Treatment Period 2||7||
48083096|NCT01484197|100525506|FG001|COMPLETED|Treatment Period 2||8||
48083097|NCT01484197|100525507|FG002|COMPLETED|Treatment Period 2||9||
48083098|NCT01484197|100525508|FG003|COMPLETED|Treatment Period 2||8||
48083099|NCT01484197|100525505|FG000|NOT COMPLETED|Treatment Period 2||0||
48083100|NCT01484197|100525506|FG001|NOT COMPLETED|Treatment Period 2||0||
48083101|NCT01484197|100525507|FG002|NOT COMPLETED|Treatment Period 2||0||
48083102|NCT01484197|100525508|FG003|NOT COMPLETED|Treatment Period 2||1||
48083103|NCT01484197|100525505|FG000|STARTED|Treatment Period 3||7||
48083104|NCT01484197|100525506|FG001|STARTED|Treatment Period 3||8||
48083105|NCT01484197|100525507|FG002|STARTED|Treatment Period 3||9||
48083106|NCT01484197|100525508|FG003|STARTED|Treatment Period 3||8||
48083107|NCT01484197|100525505|FG000|COMPLETED|Treatment Period 3||7||
48083108|NCT01484197|100525506|FG001|COMPLETED|Treatment Period 3||8||
48083109|NCT01484197|100525507|FG002|COMPLETED|Treatment Period 3||9||
48083110|NCT01484197|100525508|FG003|COMPLETED|Treatment Period 3||8||
48083111|NCT01484197|100525505|FG000|NOT COMPLETED|Treatment Period 3||0||
48246117|NCT01697592|100920966|FG004|COMPLETED|Phase A (Up to 24 Weeks)||67||
48246118|NCT01697592|100920967|FG005|COMPLETED|Phase A (Up to 24 Weeks)||62||
48246119|NCT01697592|100920968|FG006|COMPLETED|Phase A (Up to 24 Weeks)||32||
48246120|NCT01697592|100920969|FG007|COMPLETED|Phase A (Up to 24 Weeks)||33||
48246121|NCT01697592|100920970|FG008|COMPLETED|Phase A (Up to 24 Weeks)||34||
48246122|NCT01697592|100920971|FG009|COMPLETED|Phase A (Up to 24 Weeks)||30||
48246123|NCT01697592|100920962|FG000|NOT COMPLETED|Phase A (Up to 24 Weeks)||3||
48246124|NCT01697592|100920963|FG001|NOT COMPLETED|Phase A (Up to 24 Weeks)||3||
48246125|NCT01697592|100920964|FG002|NOT COMPLETED|Phase A (Up to 24 Weeks)||1||
48246126|NCT01697592|100920965|FG003|NOT COMPLETED|Phase A (Up to 24 Weeks)||2||
48246127|NCT01697592|100920966|FG004|NOT COMPLETED|Phase A (Up to 24 Weeks)||0||
48246128|NCT01697592|100920967|FG005|NOT COMPLETED|Phase A (Up to 24 Weeks)||1||
48083112|NCT01484197|100525506|FG001|NOT COMPLETED|Treatment Period 3||0||
48083113|NCT01484197|100525507|FG002|NOT COMPLETED|Treatment Period 3||0||
48246129|NCT01697592|100920968|FG006|NOT COMPLETED|Phase A (Up to 24 Weeks)||2||
48246130|NCT01697592|100920969|FG007|NOT COMPLETED|Phase A (Up to 24 Weeks)||0||
48246131|NCT01697592|100920970|FG008|NOT COMPLETED|Phase A (Up to 24 Weeks)||0||
48246132|NCT01697592|100920971|FG009|NOT COMPLETED|Phase A (Up to 24 Weeks)||2||
48246133|NCT01697592|100920962|FG000|STARTED|Phase B (Week 25 to Week 52)||123||
48246134|NCT01697592|100920963|FG001|STARTED|Phase B (Week 25 to Week 52)||62||
48246135|NCT01697592|100920964|FG002|STARTED|Phase B (Week 25 to Week 52)||65||
48246136|NCT01697592|100920965|FG003|STARTED|Phase B (Week 25 to Week 52)||63||
48246137|NCT01697592|100920966|FG004|STARTED|Phase B (Week 25 to Week 52)||67||
48246138|NCT01697592|100920967|FG005|STARTED|Phase B (Week 25 to Week 52)||62||
48083114|NCT01484197|100525508|FG003|NOT COMPLETED|Treatment Period 3||0||
48083115|NCT01484197|100525505|FG000|STARTED|Treatment Period 4||7||
48083116|NCT01484197|100525506|FG001|STARTED|Treatment Period 4||8||
48083117|NCT01484197|100525507|FG002|STARTED|Treatment Period 4||9||
48083118|NCT01484197|100525508|FG003|STARTED|Treatment Period 4||6||
48083119|NCT01484197|100525505|FG000|COMPLETED|Treatment Period 4||7||
48246139|NCT01697592|100920968|FG006|STARTED|Phase B (Week 25 to Week 52)||32||
48083120|NCT01484197|100525506|FG001|COMPLETED|Treatment Period 4||8||
48083121|NCT01484197|100525507|FG002|COMPLETED|Treatment Period 4||9||
48083122|NCT01484197|100525508|FG003|COMPLETED|Treatment Period 4||6||
48083123|NCT01484197|100525505|FG000|NOT COMPLETED|Treatment Period 4||0||
48083124|NCT01484197|100525506|FG001|NOT COMPLETED|Treatment Period 4||0||
48083125|NCT01484197|100525507|FG002|NOT COMPLETED|Treatment Period 4||0||
48083126|NCT01484197|100525508|FG003|NOT COMPLETED|Treatment Period 4||0||
48083127|NCT02233647|100525509|FG000|STARTED|Overall Study||11||
48083128|NCT02233647|100525509|FG000|0 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11||
48083129|NCT02233647|100525509|FG000|10 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11||
48246140|NCT01697592|100920969|FG007|STARTED|Phase B (Week 25 to Week 52)||33||
48246141|NCT01697592|100920970|FG008|STARTED|Phase B (Week 25 to Week 52)||34||
48246142|NCT01697592|100920971|FG009|STARTED|Phase B (Week 25 to Week 52)||30||
48246143|NCT01697592|100920962|FG000|COMPLETED|Phase B (Week 25 to Week 52)||118||
48246144|NCT01697592|100920963|FG001|COMPLETED|Phase B (Week 25 to Week 52)||61||
48246145|NCT01697592|100920964|FG002|COMPLETED|Phase B (Week 25 to Week 52)||64||
48083130|NCT02233647|100525509|FG000|20 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10||
48246146|NCT01697592|100920965|FG003|COMPLETED|Phase B (Week 25 to Week 52)||60||
48246147|NCT01697592|100920966|FG004|COMPLETED|Phase B (Week 25 to Week 52)||67||
48246148|NCT01697592|100920967|FG005|COMPLETED|Phase B (Week 25 to Week 52)||60||
48246149|NCT01697592|100920968|FG006|COMPLETED|Phase B (Week 25 to Week 52)||31||
48246150|NCT01697592|100920969|FG007|COMPLETED|Phase B (Week 25 to Week 52)||32||
48246151|NCT01697592|100920970|FG008|COMPLETED|Phase B (Week 25 to Week 52)||32||
48246152|NCT01697592|100920971|FG009|COMPLETED|Phase B (Week 25 to Week 52)||30||
48246153|NCT01697592|100920962|FG000|NOT COMPLETED|Phase B (Week 25 to Week 52)||5||
48246154|NCT01697592|100920963|FG001|NOT COMPLETED|Phase B (Week 25 to Week 52)||1||
48246155|NCT01697592|100920964|FG002|NOT COMPLETED|Phase B (Week 25 to Week 52)||1||
48246156|NCT01697592|100920965|FG003|NOT COMPLETED|Phase B (Week 25 to Week 52)||3||
48246157|NCT01697592|100920966|FG004|NOT COMPLETED|Phase B (Week 25 to Week 52)||0||
48246158|NCT01697592|100920967|FG005|NOT COMPLETED|Phase B (Week 25 to Week 52)||2||
48246159|NCT01697592|100920968|FG006|NOT COMPLETED|Phase B (Week 25 to Week 52)||1||
48246160|NCT01697592|100920969|FG007|NOT COMPLETED|Phase B (Week 25 to Week 52)||1||
48246161|NCT01697592|100920970|FG008|NOT COMPLETED|Phase B (Week 25 to Week 52)||2||
48246162|NCT01697592|100920971|FG009|NOT COMPLETED|Phase B (Week 25 to Week 52)||0||
48246163|NCT00871143|100920972|FG000|STARTED|Overall Study||21||
48246164|NCT00871143|100920973|FG001|STARTED|Overall Study||25||
48246165|NCT00871143|100920972|FG000|COMPLETED|Overall Study||21||
48246166|NCT00871143|100920973|FG001|COMPLETED|Overall Study||25||
48246167|NCT00871143|100920972|FG000|NOT COMPLETED|Overall Study||0||
48246168|NCT00871143|100920973|FG001|NOT COMPLETED|Overall Study||0||
48246169|NCT01103141|100920974|FG000|STARTED|Overall Study||67||
48246170|NCT01103141|100920975|FG001|STARTED|Overall Study||76||
48246171|NCT01103141|100920974|FG000|COMPLETED|Overall Study||65||
48246172|NCT01103141|100920975|FG001|COMPLETED|Overall Study||74||
48246173|NCT01103141|100920974|FG000|NOT COMPLETED|Overall Study||2||
48246174|NCT01103141|100920975|FG001|NOT COMPLETED|Overall Study||2||
48246175|NCT02181400|100920976|FG000|STARTED|Overall Study||7||
48246176|NCT02181400|100920977|FG001|STARTED|Overall Study||7||
48246177|NCT02181400|100920978|FG002|STARTED|Overall Study||7||
48246178|NCT02181400|100920976|FG000|COMPLETED|Overall Study||7||
48246179|NCT02181400|100920977|FG001|COMPLETED|Overall Study||7||
48246180|NCT02181400|100920978|FG002|COMPLETED|Overall Study||7||
48246181|NCT02181400|100920976|FG000|NOT COMPLETED|Overall Study||0||
48246182|NCT02181400|100920977|FG001|NOT COMPLETED|Overall Study||0||
48246183|NCT02181400|100920978|FG002|NOT COMPLETED|Overall Study||0||
48246184|NCT00443599|100920979|FG000|STARTED|Overall Study||496||
48246185|NCT00443599|100920980|FG001|STARTED|Overall Study||493||
48246186|NCT00443599|100920979|FG000|COMPLETED|Overall Study||490||
48246187|NCT00443599|100920980|FG001|COMPLETED|Overall Study||490||
48246188|NCT00443599|100920979|FG000|NOT COMPLETED|Overall Study||6||
48246189|NCT00443599|100920980|FG001|NOT COMPLETED|Overall Study||3||
48246190|NCT04694300|100920981|FG000|STARTED|Overall Study||15||
48246191|NCT04694300|100920982|FG001|STARTED|Overall Study||15||
48246192|NCT04694300|100920981|FG000|COMPLETED|Overall Study||15||
48246193|NCT04694300|100920982|FG001|COMPLETED|Overall Study||15||
48246194|NCT04694300|100920981|FG000|NOT COMPLETED|Overall Study||0||
48246195|NCT04694300|100920982|FG001|NOT COMPLETED|Overall Study||0||
48246196|NCT03036124|100920983|FG000|STARTED|Overall Study||2373||
48246197|NCT03036124|100920984|FG001|STARTED|Overall Study||2371||
48246198|NCT03036124|100920983|FG000|COMPLETED|Overall Study||2368||
48246199|NCT03036124|100920984|FG001|COMPLETED|Overall Study||2365||
48246200|NCT03036124|100920983|FG000|NOT COMPLETED|Overall Study||5||
48246201|NCT03036124|100920984|FG001|NOT COMPLETED|Overall Study||6||
48246202|NCT05756348|100920985|FG000|STARTED|Overall Study||42||84
48246203|NCT05756348|100920985|FG000|Received Marathon|Overall Study||42||42
48246204|NCT05756348|100920985|FG000|Received Cavilon|Overall Study||42||42
48246205|NCT05756348|100920985|FG000|COMPLETED|Overall Study||42||84
48246206|NCT05756348|100920985|FG000|NOT COMPLETED|Overall Study||0||0
48246207|NCT00316589|100920986|FG000|STARTED|Overall Study||88|Vaccinated|
48246208|NCT00316589|100920987|FG001|STARTED|Overall Study||352|Vaccinated|
48083131|NCT02233647|100525509|FG000|40 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10||
48246209|NCT00316589|100920988|FG002|STARTED|Overall Study||9|Vaccinated|
48246210|NCT00316589|100920989|FG003|STARTED|Overall Study||132|Vaccinated|
48246211|NCT00316589|100920986|FG000|COMPLETED|Overall Study||87|active study period|
48246212|NCT00316589|100920987|FG001|COMPLETED|Overall Study||328|active study period|
48246213|NCT00316589|100920988|FG002|COMPLETED|Overall Study||8|active study period|
48246214|NCT00316589|100920989|FG003|COMPLETED|Overall Study||127|active study period|
48246215|NCT00316589|100920986|FG000|NOT COMPLETED|Overall Study||1||
48246216|NCT00316589|100920987|FG001|NOT COMPLETED|Overall Study||24||
48246217|NCT00316589|100920988|FG002|NOT COMPLETED|Overall Study||1||
48246218|NCT00316589|100920989|FG003|NOT COMPLETED|Overall Study||5||
48246219|NCT04044352|100920990|FG000|STARTED|Overall Study||76||
48246220|NCT04044352|100920990|FG000|COMPLETED|Overall Study||65||
48246221|NCT04044352|100920990|FG000|NOT COMPLETED|Overall Study||11||
48246222|NCT02103816|100920991|FG000|STARTED|Overall Study||21||
48246223|NCT02103816|100920991|FG000|COMPLETED|Overall Study||13||
48246224|NCT02103816|100920991|FG000|NOT COMPLETED|Overall Study||8||
48246225|NCT05216952|100920992|FG000|STARTED|Overall Study||3||
48246226|NCT05216952|100920992|FG000|COMPLETED|Overall Study||3||
48246227|NCT05216952|100920992|FG000|NOT COMPLETED|Overall Study||0||
48540775|NCT00435812|101662565|FG001|NOT COMPLETED|Overall Study||18||
48083132|NCT02233647|100525509|FG000|80 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10||
48083133|NCT02233647|100525509|FG000|0 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10||
48083134|NCT02233647|100525509|FG000|10 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10||
48083135|NCT02233647|100525509|FG000|20 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10||
48083136|NCT02233647|100525509|FG000|40 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10||
48083137|NCT02233647|100525509|FG000|80 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10||
48083138|NCT02233647|100525509|FG000|0 mg Cocaine With 140 mg Phendimetrazine|Overall Study||10||
48083139|NCT02233647|100525509|FG000|10 mg Cocaine with140 mg Phendimetrazine|Overall Study||10||
48083140|NCT02233647|100525509|FG000|20 mg Cocaine with140 mg Phendimetrazine|Overall Study||10||
48083141|NCT02233647|100525509|FG000|40 mg Cocaine with140 mg Phendimetrazine|Overall Study||10||
48083142|NCT02233647|100525509|FG000|80 mg Cocaine with140 mg Phendimetrazine|Overall Study||10||
48083143|NCT02233647|100525509|FG000|0 mg Cocaine With 210 mg Phendimetrazine|Overall Study||10||
48083144|NCT02233647|100525509|FG000|10 mg Cocaine with210 mg Phendimetrazine|Overall Study||10||
48083145|NCT02233647|100525509|FG000|20 mg Cocaine with210 mg Phendimetrazine|Overall Study||10||
48083146|NCT02233647|100525509|FG000|40 mg Cocaine with210 mg Phendimetrazine|Overall Study||10||
48083147|NCT02233647|100525509|FG000|80 mg Cocaine with210 mg Phendimetrazine|Overall Study||10||
48083148|NCT02233647|100525509|FG000|COMPLETED|Overall Study||10||
48083149|NCT02233647|100525509|FG000|NOT COMPLETED|Overall Study||1||
48083150|NCT01897402|100525510|FG000|STARTED|Overall Study||265||
48083151|NCT01897402|100525511|FG001|STARTED|Overall Study||260||
48083152|NCT01897402|100525510|FG000|COMPLETED|Overall Study||246||
48083153|NCT01897402|100525511|FG001|COMPLETED|Overall Study||244||
48083154|NCT01897402|100525510|FG000|NOT COMPLETED|Overall Study||19||
48083155|NCT01897402|100525511|FG001|NOT COMPLETED|Overall Study||16||
48083156|NCT02612727|100525512|FG000|STARTED|Overall Study||87||
48083157|NCT02612727|100525513|FG001|STARTED|Overall Study||87||
48083158|NCT02612727|100525512|FG000|COMPLETED|Overall Study||82||
48083159|NCT02612727|100525513|FG001|COMPLETED|Overall Study||83||
48083160|NCT02612727|100525512|FG000|NOT COMPLETED|Overall Study||5||
48083161|NCT02612727|100525513|FG001|NOT COMPLETED|Overall Study||4||
48083162|NCT00727025|100525514|FG000|STARTED|Overall Study||74||
48083163|NCT00727025|100525514|FG000|COMPLETED|Overall Study||51||
48083164|NCT00727025|100525514|FG000|NOT COMPLETED|Overall Study||23||
48083165|NCT00739674|100525515|FG000|STARTED|Overall Study||535||
48246228|NCT01150500|100920993|FG000|STARTED|Overall Study||65||
48246229|NCT01150500|100920993|FG000|COMPLETED|Overall Study||0||
48246230|NCT01150500|100920993|FG000|NOT COMPLETED|Overall Study||65||
48246231|NCT03087851|100920994|FG000|STARTED|Overall Study||20||
48246232|NCT03087851|100920995|FG001|STARTED|Overall Study||20||
48246233|NCT03087851|100920996|FG002|STARTED|Overall Study||21||
48246234|NCT03087851|100920994|FG000|COMPLETED|Overall Study||20||
48246235|NCT03087851|100920995|FG001|COMPLETED|Overall Study||19||
48246236|NCT03087851|100920996|FG002|COMPLETED|Overall Study||19||
48246237|NCT03087851|100920994|FG000|NOT COMPLETED|Overall Study||0||
48246238|NCT03087851|100920995|FG001|NOT COMPLETED|Overall Study||1||
48246239|NCT03087851|100920996|FG002|NOT COMPLETED|Overall Study||2||
48246240|NCT04413149|100920997|FG000|STARTED|Overall Study||31||
48540776|NCT03287843|101662566|FG000|STARTED|Overall Study||175||
48540777|NCT03287843|101662567|FG001|STARTED|Overall Study||175||
48083166|NCT00739674|100525516|FG001|STARTED|Overall Study||457||
48083167|NCT00739674|100525515|FG000|Screening Failures|Overall Study||19||
48083168|NCT00739674|100525516|FG001|Screening Failures|Overall Study||17||
48083169|NCT00739674|100525515|FG000|Site 212 Removal|Overall Study||19||
48083170|NCT00739674|100525516|FG001|Site 212 Removal|Overall Study||13||
48083171|NCT00739674|100525515|FG000|No Follow-up Data|Overall Study||33||
48083172|NCT00739674|100525516|FG001|No Follow-up Data|Overall Study||18||
48141231|NCT01260350|100670368|FG006|COMPLETED|Overall Study||10||
48246241|NCT04413149|100920998|FG001|STARTED|Overall Study||49||
48246242|NCT04413149|100920997|FG000|COMPLETED|Overall Study||20||
48083173|NCT00739674|100525515|FG000|Dietician Consultation >30 Days|Overall Study||1||
48083174|NCT00739674|100525516|FG001|Dietician Consultation >30 Days|Overall Study||9||
48246243|NCT04413149|100920998|FG001|COMPLETED|Overall Study||44||
48083175|NCT00739674|100525515|FG000|Intent-to-treat (ITT) Population|Overall Study||463||
48083176|NCT00739674|100525516|FG001|Intent-to-treat (ITT) Population|Overall Study||400||
48083177|NCT00739674|100525515|FG000|COMPLETED|Overall Study||354||
48083178|NCT00739674|100525516|FG001|COMPLETED|Overall Study||335||
48083179|NCT00739674|100525515|FG000|NOT COMPLETED|Overall Study||181||
48083180|NCT00739674|100525516|FG001|NOT COMPLETED|Overall Study||122||
48083181|NCT02014597|100525517|FG000|STARTED|Overall Study||12||24
48083182|NCT02014597|100525518|FG001|STARTED|Overall Study||11||22
48083183|NCT02014597|100525517|FG000|COMPLETED|Overall Study||10||20
48083184|NCT02014597|100525518|FG001|COMPLETED|Overall Study||10||20
48083185|NCT02014597|100525517|FG000|NOT COMPLETED|Overall Study||2||4
48083186|NCT02014597|100525518|FG001|NOT COMPLETED|Overall Study||1||2
48083187|NCT04656691|100525519|FG000|STARTED|Overall Study||139||
48083188|NCT04656691|100525519|FG000|COMPLETED|Overall Study||138||
48083189|NCT04656691|100525519|FG000|NOT COMPLETED|Overall Study||1||
48083190|NCT01937559|100525520|FG000|STARTED|Overall Study||61||
48083191|NCT01937559|100525521|FG001|STARTED|Overall Study||61||
48083192|NCT01937559|100525522|FG002|STARTED|Overall Study||66||
48083193|NCT01937559|100525520|FG000|COMPLETED|Overall Study||50||
48083194|NCT01937559|100525521|FG001|COMPLETED|Overall Study||50||
48083195|NCT01937559|100525522|FG002|COMPLETED|Overall Study||66||
48083196|NCT01937559|100525520|FG000|NOT COMPLETED|Overall Study||11||
48083197|NCT01937559|100525521|FG001|NOT COMPLETED|Overall Study||11||
48083198|NCT01937559|100525522|FG002|NOT COMPLETED|Overall Study||0||
48083199|NCT01619982|100525523|FG000|STARTED|Overall Study||20||
48083200|NCT01619982|100525524|FG001|STARTED|Overall Study||12||
48083201|NCT01619982|100525523|FG000|COMPLETED|Overall Study||20||
48083202|NCT01619982|100525524|FG001|COMPLETED|Overall Study||12||
48083203|NCT01619982|100525523|FG000|NOT COMPLETED|Overall Study||0||
48083204|NCT01619982|100525524|FG001|NOT COMPLETED|Overall Study||0||
48083205|NCT00165776|100525525|FG000|STARTED|Overall Study||35||
48083206|NCT00165776|100525526|FG001|STARTED|Overall Study||34||
48083207|NCT00165776|100525527|FG002|STARTED|Overall Study||33||
48083208|NCT00165776|100525528|FG003|STARTED|Overall Study||31||
48083209|NCT00165776|100525525|FG000|COMPLETED|Overall Study||31||
48083210|NCT00165776|100525526|FG001|COMPLETED|Overall Study||33||
48083211|NCT00165776|100525527|FG002|COMPLETED|Overall Study||31||
48083212|NCT00165776|100525528|FG003|COMPLETED|Overall Study||29||
48083213|NCT00165776|100525525|FG000|NOT COMPLETED|Overall Study||4||
48083214|NCT00165776|100525526|FG001|NOT COMPLETED|Overall Study||1||
48083215|NCT00165776|100525527|FG002|NOT COMPLETED|Overall Study||2||
48083216|NCT00165776|100525528|FG003|NOT COMPLETED|Overall Study||2||
48083217|NCT00434330|100525529|FG000|STARTED|Overall Study||15||
48083218|NCT00434330|100525530|FG001|STARTED|Overall Study||15||
48083219|NCT00434330|100525531|FG002|STARTED|Overall Study||16||
48083220|NCT00434330|100525532|FG003|STARTED|Overall Study||15||
48083221|NCT00434330|100525533|FG004|STARTED|Overall Study||15||
48083222|NCT00434330|100525534|FG005|STARTED|Overall Study||15||
48083223|NCT00434330|100525529|FG000|COMPLETED|Overall Study||14||
48083224|NCT00434330|100525530|FG001|COMPLETED|Overall Study||15||
48083225|NCT00434330|100525531|FG002|COMPLETED|Overall Study||13||
48083226|NCT00434330|100525532|FG003|COMPLETED|Overall Study||13||
48083227|NCT00434330|100525533|FG004|COMPLETED|Overall Study||14||
48083228|NCT00434330|100525534|FG005|COMPLETED|Overall Study||14||
48083229|NCT00434330|100525529|FG000|NOT COMPLETED|Overall Study||1||
48083230|NCT00434330|100525530|FG001|NOT COMPLETED|Overall Study||0||
48083231|NCT00434330|100525531|FG002|NOT COMPLETED|Overall Study||3||
48083232|NCT00434330|100525532|FG003|NOT COMPLETED|Overall Study||2||
48083233|NCT00434330|100525533|FG004|NOT COMPLETED|Overall Study||1||
48083234|NCT00434330|100525534|FG005|NOT COMPLETED|Overall Study||1||
48083235|NCT00990236|100525535|FG000|STARTED|Overall Study||89||
48083236|NCT00990236|100525536|FG001|STARTED|Overall Study||96||
48083237|NCT00990236|100525535|FG000|COMPLETED|Overall Study||89||
48083238|NCT00990236|100525536|FG001|COMPLETED|Overall Study||96||
48083239|NCT00990236|100525535|FG000|NOT COMPLETED|Overall Study||0||
48083240|NCT00990236|100525536|FG001|NOT COMPLETED|Overall Study||0||
48083241|NCT01206608|100525537|FG000|STARTED|Overall Study||20||
48083242|NCT01206608|100525538|FG001|STARTED|Overall Study||20||
48083243|NCT01206608|100525537|FG000|COMPLETED|Overall Study||20||
48083244|NCT01206608|100525538|FG001|COMPLETED|Overall Study||20||
48083245|NCT01206608|100525537|FG000|NOT COMPLETED|Overall Study||0||
48083246|NCT01206608|100525538|FG001|NOT COMPLETED|Overall Study||0||
48083247|NCT02893514|100525539|FG000|STARTED|Overall Study||42||
48083248|NCT02893514|100525540|FG001|STARTED|Overall Study||37||
48083249|NCT02893514|100525539|FG000|COMPLETED|Overall Study||42||
48083250|NCT02893514|100525540|FG001|COMPLETED|Overall Study||37||
48083251|NCT02893514|100525539|FG000|NOT COMPLETED|Overall Study||0||
48083252|NCT02893514|100525540|FG001|NOT COMPLETED|Overall Study||0||
48083253|NCT01532414|100525541|FG000|STARTED|Overall Study||92||
48083254|NCT01532414|100525542|FG001|STARTED|Overall Study||21||
48083255|NCT01532414|100525543|FG002|STARTED|Overall Study||38||
48083256|NCT01532414|100525541|FG000|COMPLETED|Overall Study||85||
48246244|NCT04413149|100920997|FG000|NOT COMPLETED|Overall Study||11||
48246245|NCT04413149|100920998|FG001|NOT COMPLETED|Overall Study||5||
48246246|NCT04349124|100920999|FG000|STARTED|Overall Study||6||
48246247|NCT04349124|100921000|FG001|STARTED|Overall Study||6||
48246248|NCT04349124|100920999|FG000|COMPLETED|Overall Study||5||
48246249|NCT04349124|100921000|FG001|COMPLETED|Overall Study||5||
48246250|NCT04349124|100920999|FG000|NOT COMPLETED|Overall Study||1||
48246251|NCT04349124|100921000|FG001|NOT COMPLETED|Overall Study||1||
48246252|NCT01383616|100921001|FG000|STARTED|Overall Study||40||
48246253|NCT01383616|100921002|FG001|STARTED|Overall Study||44||
48246254|NCT01383616|100921001|FG000|COMPLETED|Overall Study||23||
48246255|NCT01383616|100921002|FG001|COMPLETED|Overall Study||21||
48246256|NCT01383616|100921001|FG000|NOT COMPLETED|Overall Study||17||
48246257|NCT01383616|100921002|FG001|NOT COMPLETED|Overall Study||23||
48246258|NCT00562484|100921003|FG000|STARTED|Overall Study||10033||
48246259|NCT00562484|100921004|FG001|STARTED|Overall Study||5011||
48246260|NCT00562484|100921003|FG000|COMPLETED|Overall Study||9827||
48246261|NCT00562484|100921004|FG001|COMPLETED|Overall Study||4907||
48246262|NCT00562484|100921003|FG000|NOT COMPLETED|Overall Study||206||
48246263|NCT00562484|100921004|FG001|NOT COMPLETED|Overall Study||104||
48246264|NCT01568112|100921005|FG000|STARTED|Overall Study||44||
48246265|NCT01568112|100921006|FG001|STARTED|Overall Study||44||
48246266|NCT01568112|100921007|FG002|STARTED|Overall Study||43||
48246267|NCT01568112|100921008|FG003|STARTED|Overall Study||42||
48246268|NCT01568112|100921005|FG000|COMPLETED|Overall Study||39||
48246269|NCT01568112|100921006|FG001|COMPLETED|Overall Study||36||
48246270|NCT01568112|100921007|FG002|COMPLETED|Overall Study||36||
48246271|NCT01568112|100921008|FG003|COMPLETED|Overall Study||30||
48246272|NCT01568112|100921005|FG000|NOT COMPLETED|Overall Study||5||
48246273|NCT01568112|100921006|FG001|NOT COMPLETED|Overall Study||8||
48246274|NCT01568112|100921007|FG002|NOT COMPLETED|Overall Study||7||
48246275|NCT01568112|100921008|FG003|NOT COMPLETED|Overall Study||12||
48246276|NCT00443755|100921009|FG000|STARTED|Overall Study||14||
48246277|NCT00443755|100921010|FG001|STARTED|Overall Study||14||
48246278|NCT00443755|100921009|FG000|COMPLETED|Overall Study||12||
48246279|NCT00443755|100921010|FG001|COMPLETED|Overall Study||13||
48246280|NCT00443755|100921009|FG000|NOT COMPLETED|Overall Study||2||
48246281|NCT00443755|100921010|FG001|NOT COMPLETED|Overall Study||1||
48246282|NCT02502487|100921011|FG000|STARTED|Overall Study||86||
48246283|NCT02502487|100921012|FG001|STARTED|Overall Study||86||
48246284|NCT02502487|100921013|FG002|STARTED|Overall Study||86||
48246285|NCT02502487|100921011|FG000|COMPLETED|Overall Study||86||
48246286|NCT02502487|100921012|FG001|COMPLETED|Overall Study||86||
48246287|NCT02502487|100921013|FG002|COMPLETED|Overall Study||86||
48246288|NCT02502487|100921011|FG000|NOT COMPLETED|Overall Study||0||
48246289|NCT02502487|100921012|FG001|NOT COMPLETED|Overall Study||0||
48246290|NCT02502487|100921013|FG002|NOT COMPLETED|Overall Study||0||
48246291|NCT01370564|100921014|FG000|STARTED|Overall Study||21||
48246292|NCT01370564|100921014|FG000|COMPLETED|Overall Study||21||
48246293|NCT01370564|100921014|FG000|NOT COMPLETED|Overall Study||0||
48083257|NCT01532414|100525542|FG001|COMPLETED|Overall Study||19||
48083258|NCT01532414|100525543|FG002|COMPLETED|Overall Study||35||
48083259|NCT01532414|100525541|FG000|NOT COMPLETED|Overall Study||7||
48083260|NCT01532414|100525542|FG001|NOT COMPLETED|Overall Study||2||
48246294|NCT02150109|100921015|FG000|STARTED|Overall Study||372||
48246295|NCT02150109|100921015|FG000|COMPLETED|Overall Study||372||
48083261|NCT01532414|100525543|FG002|NOT COMPLETED|Overall Study||3||
48246296|NCT02150109|100921015|FG000|NOT COMPLETED|Overall Study||0||
48246297|NCT00147745|100921016|FG000|STARTED|Overall Study||16||
48246298|NCT00147745|100921017|FG001|STARTED|Overall Study||14||
48083262|NCT00837811|100525544|FG000|STARTED|Overall Study||60||
48083263|NCT00837811|100525545|FG001|STARTED|Overall Study||121||
48083264|NCT00837811|100525546|FG002|STARTED|Overall Study||1||
48083265|NCT00837811|100525544|FG000|Received Any Amount of Study Drug|Overall Study||60||
48083266|NCT00837811|100525545|FG001|Received Any Amount of Study Drug|Overall Study||121||
48083267|NCT00837811|100525546|FG002|Received Any Amount of Study Drug|Overall Study||1||
48083268|NCT00837811|100525544|FG000|Had at Least 1 Efficacy Assessment|Overall Study||59||
48246299|NCT00147745|100921018|FG002|STARTED|Overall Study||6||
48246300|NCT00147745|100921016|FG000|COMPLETED|Overall Study||15||
48246301|NCT00147745|100921017|FG001|COMPLETED|Overall Study||14||
48246302|NCT00147745|100921018|FG002|COMPLETED|Overall Study||6||
48246303|NCT00147745|100921016|FG000|NOT COMPLETED|Overall Study||1||
48246304|NCT00147745|100921017|FG001|NOT COMPLETED|Overall Study||0||
48246305|NCT00147745|100921018|FG002|NOT COMPLETED|Overall Study||0||
48246306|NCT01896921|100921019|FG000|STARTED|Overall Study||7||
48083269|NCT00837811|100525545|FG001|Had at Least 1 Efficacy Assessment|Overall Study||121||
48246307|NCT01896921|100921019|FG000|COMPLETED|Overall Study||5||
48246308|NCT01896921|100921019|FG000|NOT COMPLETED|Overall Study||2||
48246309|NCT00092456|100921020|FG000|STARTED|Overall Study||226||
48246310|NCT00092456|100921021|FG001|STARTED|Overall Study||225||
48246311|NCT00092456|100921022|FG002|STARTED|Overall Study||229||
48246312|NCT00092456|100921023|FG003|STARTED|Overall Study||113||
48246313|NCT00092456|100921020|FG000|Vaccinated at Visit 1|Overall Study||226||
48246314|NCT00092456|100921021|FG001|Vaccinated at Visit 1|Overall Study||225||
48246315|NCT00092456|100921022|FG002|Vaccinated at Visit 1|Overall Study||229||
48246316|NCT00092456|100921023|FG003|Vaccinated at Visit 1|Overall Study||113||
48246317|NCT00092456|100921020|FG000|Vaccinated at Visit 2|Overall Study||208||
48246318|NCT00092456|100921021|FG001|Vaccinated at Visit 2|Overall Study||217||
48246319|NCT00092456|100921022|FG002|Vaccinated at Visit 2|Overall Study||210||
48246320|NCT00092456|100921023|FG003|Vaccinated at Visit 2|Overall Study||104||
48246321|NCT00092456|100921020|FG000|Vaccinated at Visit 3|Overall Study||202||
48246322|NCT00092456|100921021|FG001|Vaccinated at Visit 3|Overall Study||210||
48246323|NCT00092456|100921022|FG002|Vaccinated at Visit 3|Overall Study||200||
48246324|NCT00092456|100921023|FG003|Vaccinated at Visit 3|Overall Study||98||
48246325|NCT00092456|100921020|FG000|COMPLETED|Overall Study||201||
48246326|NCT00092456|100921021|FG001|COMPLETED|Overall Study||208||
48246327|NCT00092456|100921022|FG002|COMPLETED|Overall Study||200||
48246328|NCT00092456|100921023|FG003|COMPLETED|Overall Study||97||
48246329|NCT00092456|100921020|FG000|NOT COMPLETED|Overall Study||25||
48246330|NCT00092456|100921021|FG001|NOT COMPLETED|Overall Study||17||
48246331|NCT00092456|100921022|FG002|NOT COMPLETED|Overall Study||29||
48246332|NCT00092456|100921023|FG003|NOT COMPLETED|Overall Study||16||
48246333|NCT03029234|100921024|FG000|STARTED|Overall Study||126||
48246334|NCT03029234|100921024|FG000|Received Carfilzomib|Overall Study||123||
48246335|NCT03029234|100921024|FG000|COMPLETED|Overall Study||27||
48246336|NCT03029234|100921024|FG000|NOT COMPLETED|Overall Study||99||
48246337|NCT03326193|100921025|FG000|STARTED|Overall Study||105||
48246338|NCT03326193|100921025|FG000|COMPLETED|Overall Study||52||
48246339|NCT03326193|100921025|FG000|NOT COMPLETED|Overall Study||53||
48246340|NCT03785210|100921026|FG000|STARTED|Overall Study||6||
48246341|NCT03785210|100921027|FG001|STARTED|Overall Study||16||
48246342|NCT03785210|100921026|FG000|COMPLETED|Overall Study||5||
48246343|NCT03785210|100921027|FG001|COMPLETED|Overall Study||10||
48246344|NCT03785210|100921026|FG000|NOT COMPLETED|Overall Study||1||
48246345|NCT03785210|100921027|FG001|NOT COMPLETED|Overall Study||6||
48246346|NCT02368691|100921028|FG000|STARTED|Overall Study||32||
48246347|NCT02368691|100921028|FG000|COMPLETED|Overall Study||0||
48246348|NCT02368691|100921028|FG000|NOT COMPLETED|Overall Study||32||
48246349|NCT01193283|100921029|FG000|STARTED|Overall Study||22||
48246350|NCT01193283|100921029|FG000|COMPLETED|Overall Study||21||
48246351|NCT01193283|100921029|FG000|NOT COMPLETED|Overall Study||1||
48246352|NCT00749671|100921030|FG000|STARTED|Overall Study||11||
48246353|NCT00749671|100921031|FG001|STARTED|Overall Study||9||
48246354|NCT00749671|100921030|FG000|COMPLETED|Overall Study||11||
48246355|NCT00749671|100921031|FG001|COMPLETED|Overall Study||9||
48246356|NCT00749671|100921030|FG000|NOT COMPLETED|Overall Study||0||
48246357|NCT00749671|100921031|FG001|NOT COMPLETED|Overall Study||0||
48246358|NCT00762502|100921032|FG000|STARTED|Baseline to Month 3 (Period 1)||36||
48246359|NCT00762502|100921033|FG001|STARTED|Baseline to Month 3 (Period 1)||25||
48246360|NCT00762502|100921034|FG002|STARTED|Baseline to Month 3 (Period 1)||51||
48246361|NCT00762502|100921032|FG000|COMPLETED|Baseline to Month 3 (Period 1)||26||
48246362|NCT00762502|100921033|FG001|COMPLETED|Baseline to Month 3 (Period 1)||19||
48246363|NCT00762502|100921034|FG002|COMPLETED|Baseline to Month 3 (Period 1)||32||
48246364|NCT00762502|100921032|FG000|NOT COMPLETED|Baseline to Month 3 (Period 1)||10||
48246365|NCT00762502|100921033|FG001|NOT COMPLETED|Baseline to Month 3 (Period 1)||6||
48246366|NCT00762502|100921034|FG002|NOT COMPLETED|Baseline to Month 3 (Period 1)||19||
48246367|NCT00762502|100921032|FG000|STARTED|Month 3 to Month 6 (Period 2)||9||
48246368|NCT00762502|100921033|FG001|STARTED|Month 3 to Month 6 (Period 2)||5||
48246369|NCT00762502|100921034|FG002|STARTED|Month 3 to Month 6 (Period 2)||23||
48246370|NCT00762502|100921032|FG000|COMPLETED|Month 3 to Month 6 (Period 2)||9||
48246371|NCT00762502|100921033|FG001|COMPLETED|Month 3 to Month 6 (Period 2)||4||
48246372|NCT00762502|100921034|FG002|COMPLETED|Month 3 to Month 6 (Period 2)||23||
48246373|NCT00762502|100921032|FG000|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0||
48246374|NCT00762502|100921033|FG001|NOT COMPLETED|Month 3 to Month 6 (Period 2)||1||
48246375|NCT00762502|100921034|FG002|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0||
48246376|NCT05045638|100921035|FG000|STARTED|Overall Study||13||
48246377|NCT05045638|100921035|FG000|Received Rosuvastatin Alone|Overall Study||13||
48246378|NCT05045638|100921035|FG000|Received Rosuvastatin Coadministered With Sotorasib|Overall Study||13||
48246379|NCT05045638|100921035|FG000|COMPLETED|Overall Study||13||
48246380|NCT05045638|100921035|FG000|NOT COMPLETED|Overall Study||0||
48246381|NCT02744898|100921036|FG000|STARTED|Overall Study||23||
48246382|NCT02744898|100921036|FG000|COMPLETED|Overall Study||19||
48246383|NCT02744898|100921036|FG000|NOT COMPLETED|Overall Study||4||
48246384|NCT03184519|100921037|FG000|STARTED|Overall Study||156||
48246385|NCT03184519|100921037|FG000|COMPLETED|Overall Study||129||
48246386|NCT03184519|100921037|FG000|NOT COMPLETED|Overall Study||27||
48246387|NCT02507297|100921038|FG000|STARTED|Overall Study||16||
48246388|NCT02507297|100921039|FG001|STARTED|Overall Study||13||
48246389|NCT02507297|100921038|FG000|COMPLETED|Overall Study||15||
48246390|NCT02507297|100921039|FG001|COMPLETED|Overall Study||12||
48246391|NCT02507297|100921038|FG000|NOT COMPLETED|Overall Study||1||
48246392|NCT02507297|100921039|FG001|NOT COMPLETED|Overall Study||1||
48246393|NCT02488070|100921040|FG000|STARTED|Overall Study||10||
48246394|NCT02488070|100921040|FG000|COMPLETED|Overall Study||10||
48246395|NCT02488070|100921040|FG000|NOT COMPLETED|Overall Study||0||
48246396|NCT00762723|100921041|FG000|STARTED|Overall Study||5||
48246397|NCT00762723|100921042|FG001|STARTED|Overall Study||11||
48246398|NCT00762723|100921043|FG002|STARTED|Overall Study||3||
48246399|NCT00762723|100921041|FG000|COMPLETED|Overall Study||0||
48246400|NCT00762723|100921042|FG001|COMPLETED|Overall Study||6||
48246401|NCT00762723|100921043|FG002|COMPLETED|Overall Study||0||
48246402|NCT00762723|100921041|FG000|NOT COMPLETED|Overall Study||5||
48246403|NCT00762723|100921042|FG001|NOT COMPLETED|Overall Study||5||
48246404|NCT00762723|100921043|FG002|NOT COMPLETED|Overall Study||3||
48246405|NCT04385849|100921044|FG000|STARTED|Overall Study||1||
48246406|NCT04385849|100921045|FG001|STARTED|Overall Study||0||
48246407|NCT04385849|100921044|FG000|COMPLETED|Overall Study||0||
48246408|NCT04385849|100921045|FG001|COMPLETED|Overall Study||0||
48246409|NCT04385849|100921044|FG000|NOT COMPLETED|Overall Study||1||
48246410|NCT04385849|100921045|FG001|NOT COMPLETED|Overall Study||0||
48246411|NCT01513447|100921046|FG000|STARTED|Overall Study||3||
48246412|NCT01513447|100921047|FG001|STARTED|Overall Study||5||
48246413|NCT01513447|100921046|FG000|COMPLETED|Overall Study||3||
48246414|NCT01513447|100921047|FG001|COMPLETED|Overall Study||5||
48246415|NCT01513447|100921046|FG000|NOT COMPLETED|Overall Study||0||
48246416|NCT01513447|100921047|FG001|NOT COMPLETED|Overall Study||0||
48246417|NCT01032200|100921048|FG000|STARTED|Overall Study||26||
48246418|NCT01032200|100921049|FG001|STARTED|Overall Study||28||
48246419|NCT01032200|100921048|FG000|COMPLETED|Overall Study||22||
48246420|NCT01032200|100921049|FG001|COMPLETED|Overall Study||21||
48246421|NCT01032200|100921048|FG000|NOT COMPLETED|Overall Study||4||
48246422|NCT01032200|100921049|FG001|NOT COMPLETED|Overall Study||7||
48246423|NCT02556918|100921050|FG000|STARTED|Overall Study||100||
48246424|NCT02556918|100921051|FG001|STARTED|Overall Study||101||
48246425|NCT02556918|100921050|FG000|COMPLETED|Overall Study||91||
48246426|NCT02556918|100921051|FG001|COMPLETED|Overall Study||91||
48246427|NCT02556918|100921050|FG000|NOT COMPLETED|Overall Study||9||
48246428|NCT02556918|100921051|FG001|NOT COMPLETED|Overall Study||10||
48246429|NCT04523571|100921052|FG000|STARTED|Received 2 Doses||24||
48246430|NCT04523571|100921053|FG001|STARTED|Received 2 Doses||24||
48246431|NCT04523571|100921054|FG002|STARTED|Received 2 Doses||24||
48246432|NCT04523571|100921055|FG003|STARTED|Received 2 Doses||24||
48246433|NCT04523571|100921056|FG004|STARTED|Received 2 Doses||24||
48246434|NCT04523571|100921057|FG005|STARTED|Received 2 Doses||24||
48246435|NCT04523571|100921052|FG000|COMPLETED|Received 2 Doses||24||
48246436|NCT04523571|100921053|FG001|COMPLETED|Received 2 Doses||24||
48246437|NCT04523571|100921054|FG002|COMPLETED|Received 2 Doses||24||
48246438|NCT04523571|100921055|FG003|COMPLETED|Received 2 Doses||23||
48246439|NCT04523571|100921056|FG004|COMPLETED|Received 2 Doses||23||
48246440|NCT04523571|100921057|FG005|COMPLETED|Received 2 Doses||24||
48246441|NCT04523571|100921052|FG000|NOT COMPLETED|Received 2 Doses||0||
48246442|NCT04523571|100921053|FG001|NOT COMPLETED|Received 2 Doses||0||
48246443|NCT04523571|100921054|FG002|NOT COMPLETED|Received 2 Doses||0||
48246444|NCT04523571|100921055|FG003|NOT COMPLETED|Received 2 Doses||1||
48246445|NCT04523571|100921056|FG004|NOT COMPLETED|Received 2 Doses||1||
48246446|NCT04523571|100921057|FG005|NOT COMPLETED|Received 2 Doses||0||
48246447|NCT04523571|100921052|FG000|STARTED|Received 2 Doses and Completed Follow-up||24||
48246448|NCT04523571|100921053|FG001|STARTED|Received 2 Doses and Completed Follow-up||24||
48246449|NCT04523571|100921054|FG002|STARTED|Received 2 Doses and Completed Follow-up||24||
48246450|NCT04523571|100921055|FG003|STARTED|Received 2 Doses and Completed Follow-up||23||
48246451|NCT04523571|100921056|FG004|STARTED|Received 2 Doses and Completed Follow-up||23||
48246452|NCT04523571|100921057|FG005|STARTED|Received 2 Doses and Completed Follow-up||24||
48246453|NCT04523571|100921052|FG000|COMPLETED|Received 2 Doses and Completed Follow-up||23||
48246454|NCT04523571|100921053|FG001|COMPLETED|Received 2 Doses and Completed Follow-up||24||
48246455|NCT04523571|100921054|FG002|COMPLETED|Received 2 Doses and Completed Follow-up||23||
48246456|NCT04523571|100921055|FG003|COMPLETED|Received 2 Doses and Completed Follow-up||22||
48246457|NCT04523571|100921056|FG004|COMPLETED|Received 2 Doses and Completed Follow-up||22||
48246458|NCT04523571|100921057|FG005|COMPLETED|Received 2 Doses and Completed Follow-up||23||
48246459|NCT04523571|100921052|FG000|NOT COMPLETED|Received 2 Doses and Completed Follow-up||1||
48246460|NCT04523571|100921053|FG001|NOT COMPLETED|Received 2 Doses and Completed Follow-up||0||
48246461|NCT04523571|100921054|FG002|NOT COMPLETED|Received 2 Doses and Completed Follow-up||1||
48246462|NCT04523571|100921055|FG003|NOT COMPLETED|Received 2 Doses and Completed Follow-up||1||
48246463|NCT04523571|100921056|FG004|NOT COMPLETED|Received 2 Doses and Completed Follow-up||1||
48246464|NCT04523571|100921057|FG005|NOT COMPLETED|Received 2 Doses and Completed Follow-up||1||
48246465|NCT05400226|100921058|FG000|STARTED|Overall Study||40||
48246466|NCT05400226|100921058|FG000|Dosing|Overall Study||40||
48246467|NCT05400226|100921058|FG000|Surgery|Overall Study||40||
48246468|NCT05400226|100921058|FG000|COMPLETED|Overall Study||40||
48246469|NCT05400226|100921058|FG000|NOT COMPLETED|Overall Study||0||
48246470|NCT01502787|100921059|FG000|STARTED|Overall Study||11||
48246471|NCT01502787|100921060|FG001|STARTED|Overall Study||10||
48246472|NCT01502787|100921059|FG000|COMPLETED|Overall Study||11||
48246473|NCT01502787|100921060|FG001|COMPLETED|Overall Study||10||
48246474|NCT01502787|100921059|FG000|NOT COMPLETED|Overall Study||0||
48246475|NCT01502787|100921060|FG001|NOT COMPLETED|Overall Study||0||
48246476|NCT00084409|100921061|FG000|STARTED|Overall Study||75||
48246477|NCT00084409|100921062|FG001|STARTED|Overall Study||77||
48246478|NCT00084409|100921061|FG000|COMPLETED|Overall Study||60||
48246479|NCT00084409|100921062|FG001|COMPLETED|Overall Study||65||
48246480|NCT00084409|100921061|FG000|NOT COMPLETED|Overall Study||15||
48246481|NCT00084409|100921062|FG001|NOT COMPLETED|Overall Study||12||
48246482|NCT01074099|100921063|FG000|STARTED|Overall Study||2||
48246483|NCT01074099|100921064|FG001|STARTED|Overall Study||3||
48246484|NCT01074099|100921063|FG000|COMPLETED|Overall Study||2||
48246485|NCT01074099|100921064|FG001|COMPLETED|Overall Study||3||
48246486|NCT01074099|100921063|FG000|NOT COMPLETED|Overall Study||0||
48246487|NCT01074099|100921064|FG001|NOT COMPLETED|Overall Study||0||
48246488|NCT02029521|100921065|FG000|STARTED|Overall Study||24||
48246489|NCT02029521|100921066|FG001|STARTED|Overall Study||23||
48246490|NCT02029521|100921065|FG000|COMPLETED|Overall Study||22||
48246491|NCT02029521|100921066|FG001|COMPLETED|Overall Study||22||
48246492|NCT02029521|100921065|FG000|NOT COMPLETED|Overall Study||2||
48246493|NCT02029521|100921066|FG001|NOT COMPLETED|Overall Study||1||
48246494|NCT02133066|100921067|FG000|STARTED|Overall Study||64||
48246495|NCT02133066|100921068|FG001|STARTED|Overall Study||64||
48246496|NCT02133066|100921067|FG000|COMPLETED|Overall Study||64||
48246497|NCT02133066|100921068|FG001|COMPLETED|Overall Study||64||
48246498|NCT02133066|100921067|FG000|NOT COMPLETED|Overall Study||0||
48246499|NCT02133066|100921068|FG001|NOT COMPLETED|Overall Study||0||
48246500|NCT02711553|100921069|FG000|STARTED|Overall Study||106||
48246501|NCT02711553|100921070|FG001|STARTED|Overall Study||52||
48246502|NCT02711553|100921071|FG002|STARTED|Overall Study||102||
48246503|NCT02711553|100921072|FG003|STARTED|Overall Study||49||
48246504|NCT02711553|100921069|FG000|Received at Least 1 Dose of Study Drug|Overall Study||104||
48246505|NCT02711553|100921070|FG001|Received at Least 1 Dose of Study Drug|Overall Study||52||
48246506|NCT02711553|100921071|FG002|Received at Least 1 Dose of Study Drug|Overall Study||102||
48246507|NCT02711553|100921072|FG003|Received at Least 1 Dose of Study Drug|Overall Study||48||
48246508|NCT02711553|100921069|FG000|COMPLETED|Overall Study||100||
48246509|NCT02711553|100921070|FG001|COMPLETED|Overall Study||47||
48246510|NCT02711553|100921071|FG002|COMPLETED|Overall Study||92||
48246511|NCT02711553|100921072|FG003|COMPLETED|Overall Study||45||
48246512|NCT02711553|100921069|FG000|NOT COMPLETED|Overall Study||6||
48246513|NCT02711553|100921070|FG001|NOT COMPLETED|Overall Study||5||
48246514|NCT02711553|100921071|FG002|NOT COMPLETED|Overall Study||10||
48246515|NCT02711553|100921072|FG003|NOT COMPLETED|Overall Study||4||
48246516|NCT04783519|100921073|FG000|STARTED|Overall Study||49||
48246517|NCT04783519|100921074|FG001|STARTED|Overall Study||51||
48246518|NCT04783519|100921075|FG002|STARTED|Overall Study||50||
48246519|NCT04783519|100921073|FG000|COMPLETED|Overall Study||38||
48246520|NCT04783519|100921074|FG001|COMPLETED|Overall Study||37||
48246521|NCT04783519|100921075|FG002|COMPLETED|Overall Study||41||
48246522|NCT04783519|100921073|FG000|NOT COMPLETED|Overall Study||11||
48682212|NCT01904721|102006563|FG002|STARTED|Overall Study||12||
48682213|NCT01904721|102006564|FG003|STARTED|Overall Study||12||
48682214|NCT01904721|102006565|FG004|STARTED|Overall Study||65||
48246523|NCT04783519|100921074|FG001|NOT COMPLETED|Overall Study||14||
48682215|NCT01904721|102006566|FG005|STARTED|Overall Study||65||
48682216|NCT01904721|102006567|FG006|STARTED|Overall Study||64||
48682217|NCT01904721|102006561|FG000|COMPLETED|Overall Study||13||
48682218|NCT01904721|102006562|FG001|COMPLETED|Overall Study||13||
48682219|NCT01904721|102006563|FG002|COMPLETED|Overall Study||11||
48682220|NCT01904721|102006564|FG003|COMPLETED|Overall Study||11||
48083270|NCT00837811|100525546|FG002|Had at Least 1 Efficacy Assessment|Overall Study||1||
48083271|NCT00837811|100525544|FG000|Included in Efficacy Analyses|Overall Study||59||
48083272|NCT00837811|100525545|FG001|Included in Efficacy Analyses|Overall Study||120||
48083273|NCT00837811|100525546|FG002|Included in Efficacy Analyses|Overall Study||1||
48083274|NCT00837811|100525544|FG000|COMPLETED|Overall Study||53||
48083275|NCT00837811|100525545|FG001|COMPLETED|Overall Study||87||
48682221|NCT01904721|102006565|FG004|COMPLETED|Overall Study||57||
48682222|NCT01904721|102006566|FG005|COMPLETED|Overall Study||56||
48682223|NCT01904721|102006567|FG006|COMPLETED|Overall Study||57||
48682224|NCT01904721|102006561|FG000|NOT COMPLETED|Overall Study||0||
48682225|NCT01904721|102006562|FG001|NOT COMPLETED|Overall Study||0||
48682226|NCT01904721|102006563|FG002|NOT COMPLETED|Overall Study||1||
48682227|NCT01904721|102006564|FG003|NOT COMPLETED|Overall Study||1||
48682228|NCT01904721|102006565|FG004|NOT COMPLETED|Overall Study||8||
48682229|NCT01904721|102006566|FG005|NOT COMPLETED|Overall Study||9||
48682230|NCT01904721|102006567|FG006|NOT COMPLETED|Overall Study||7||
48682231|NCT00439335|102006568|FG000|STARTED|Overall Study||113||
48682232|NCT00439335|102006569|FG001|STARTED|Overall Study||114||
48682233|NCT00439335|102006568|FG000|COMPLETED|Overall Study||111||
48682234|NCT00439335|102006569|FG001|COMPLETED|Overall Study||114||
48682235|NCT00439335|102006568|FG000|NOT COMPLETED|Overall Study||2||
48083276|NCT00837811|100525546|FG002|COMPLETED|Overall Study||0||
48083277|NCT00837811|100525544|FG000|NOT COMPLETED|Overall Study||7||
48083278|NCT00837811|100525545|FG001|NOT COMPLETED|Overall Study||34||
48083279|NCT00837811|100525546|FG002|NOT COMPLETED|Overall Study||1||
48083280|NCT03808493|100525547|FG000|STARTED|Overall Study||12||
48083281|NCT03808493|100525548|FG001|STARTED|Overall Study||12||
48083282|NCT03808493|100525549|FG002|STARTED|Overall Study||12||
48682236|NCT00439335|102006569|FG001|NOT COMPLETED|Overall Study||0||
48682237|NCT00558636|102006570|FG000|STARTED|Treatment||47||
48682238|NCT00558636|102006571|FG001|STARTED|Treatment||44||
48682239|NCT00558636|102006570|FG000|Start of Maintenance Monotherapy|Treatment||2||
48682240|NCT00558636|102006571|FG001|Start of Maintenance Monotherapy|Treatment||2||
48682241|NCT00558636|102006570|FG000|COMPLETED|Treatment||0||
48083283|NCT03808493|100525550|FG003|STARTED|Overall Study||12||
48141232|NCT01260350|100670369|FG007|COMPLETED|Overall Study||25||
48141233|NCT01260350|100670370|FG008|COMPLETED|Overall Study||24||
48141234|NCT01260350|100670371|FG009|COMPLETED|Overall Study||25||
48141235|NCT01260350|100670372|FG010|COMPLETED|Overall Study||10||
48141236|NCT01260350|100670373|FG011|COMPLETED|Overall Study||9||
48141237|NCT01260350|100670374|FG012|COMPLETED|Overall Study||25||
48141238|NCT01260350|100670375|FG013|COMPLETED|Overall Study||10||
48141239|NCT01260350|100670376|FG014|COMPLETED|Overall Study||25||
48141240|NCT01260350|100670377|FG015|COMPLETED|Overall Study||10||
48141241|NCT01260350|100670378|FG016|COMPLETED|Overall Study||9||
48141242|NCT01260350|100670379|FG017|COMPLETED|Overall Study||9||
48141243|NCT01260350|100670380|FG018|COMPLETED|Overall Study||0||
48141244|NCT01260350|100670381|FG019|COMPLETED|Overall Study||14||
48141245|NCT01260350|100670382|FG020|COMPLETED|Overall Study||22||
48141246|NCT01260350|100670383|FG021|COMPLETED|Overall Study||0||
48141247|NCT01260350|100670362|FG000|NOT COMPLETED|Overall Study||0||
48141248|NCT01260350|100670363|FG001|NOT COMPLETED|Overall Study||0||
48141249|NCT01260350|100670364|FG002|NOT COMPLETED|Overall Study||0||
48141250|NCT01260350|100670365|FG003|NOT COMPLETED|Overall Study||0||
48141251|NCT01260350|100670366|FG004|NOT COMPLETED|Overall Study||0||
48141252|NCT01260350|100670367|FG005|NOT COMPLETED|Overall Study||0||
48141253|NCT01260350|100670368|FG006|NOT COMPLETED|Overall Study||0||
48141254|NCT01260350|100670369|FG007|NOT COMPLETED|Overall Study||0||
48141255|NCT01260350|100670370|FG008|NOT COMPLETED|Overall Study||1||
48141256|NCT01260350|100670371|FG009|NOT COMPLETED|Overall Study||0||
48141257|NCT01260350|100670372|FG010|NOT COMPLETED|Overall Study||0||
48141258|NCT01260350|100670373|FG011|NOT COMPLETED|Overall Study||0||
48141259|NCT01260350|100670374|FG012|NOT COMPLETED|Overall Study||0||
48141260|NCT01260350|100670375|FG013|NOT COMPLETED|Overall Study||0||
48141261|NCT01260350|100670376|FG014|NOT COMPLETED|Overall Study||0||
48141262|NCT01260350|100670377|FG015|NOT COMPLETED|Overall Study||0||
48141263|NCT01260350|100670378|FG016|NOT COMPLETED|Overall Study||0||
48141264|NCT01260350|100670379|FG017|NOT COMPLETED|Overall Study||1||
48682242|NCT00558636|102006571|FG001|COMPLETED|Treatment||0||
48682243|NCT00558636|102006570|FG000|NOT COMPLETED|Treatment||47||
48682244|NCT00558636|102006571|FG001|NOT COMPLETED|Treatment||44||
48682245|NCT00558636|102006570|FG000|STARTED|Follow-up||12||
48682246|NCT00558636|102006571|FG001|STARTED|Follow-up||7||
48682247|NCT00558636|102006570|FG000|COMPLETED|Follow-up||0||
48682248|NCT00558636|102006571|FG001|COMPLETED|Follow-up||0||
48682249|NCT00558636|102006570|FG000|NOT COMPLETED|Follow-up||12||
48682250|NCT00558636|102006571|FG001|NOT COMPLETED|Follow-up||7||
48682251|NCT00803361|102006572|FG000|STARTED|Overall Study||108||
48682252|NCT00803361|102006573|FG001|STARTED|Overall Study||102||
48083284|NCT03808493|100525547|FG000|COMPLETED|Overall Study||12|Here, completed means completion of all periods, that means Period 1, Washout period, and Period 2.|
48083285|NCT03808493|100525548|FG001|COMPLETED|Overall Study||12|Here, completed means completion of all periods, that means Period 1, Washout period, and Period 2.|
48083286|NCT03808493|100525549|FG002|COMPLETED|Overall Study||12|Here, completed means completion of all periods, that means Period 1, Washout period, and Period 2.|
48083287|NCT03808493|100525550|FG003|COMPLETED|Overall Study||12|Here, completed means completion of all periods, that means Period 1, Washout period, and Period 2.|
48083288|NCT03808493|100525547|FG000|NOT COMPLETED|Overall Study||0||
48083289|NCT03808493|100525548|FG001|NOT COMPLETED|Overall Study||0||
48083290|NCT03808493|100525549|FG002|NOT COMPLETED|Overall Study||0||
48083291|NCT03808493|100525550|FG003|NOT COMPLETED|Overall Study||0||
48083292|NCT00855920|100525551|FG000|STARTED|Overall Study||76||
48083293|NCT00855920|100525552|FG001|STARTED|Overall Study||74||
48083294|NCT00855920|100525553|FG002|STARTED|Overall Study||75||
48083295|NCT00855920|100525551|FG000|Safety Population|Overall Study||77||
48083296|NCT00855920|100525552|FG001|Safety Population|Overall Study||73||
48083297|NCT00855920|100525553|FG002|Safety Population|Overall Study||75||
48083298|NCT00855920|100525551|FG000|COMPLETED|Overall Study||68||
48083299|NCT00855920|100525552|FG001|COMPLETED|Overall Study||65||
48083300|NCT00855920|100525553|FG002|COMPLETED|Overall Study||64||
48083301|NCT00855920|100525551|FG000|NOT COMPLETED|Overall Study||8||
48682253|NCT00803361|102006572|FG000|COMPLETED|Overall Study||82||
48682254|NCT00803361|102006573|FG001|COMPLETED|Overall Study||74||
48682255|NCT00803361|102006572|FG000|NOT COMPLETED|Overall Study||26||
48682256|NCT00803361|102006573|FG001|NOT COMPLETED|Overall Study||28||
48682257|NCT00570713|102006574|FG000|STARTED|Overall Study||78||
48682258|NCT00570713|102006575|FG001|STARTED|Overall Study||77||
48682259|NCT00570713|102006574|FG000|COMPLETED|Overall Study||0||
48682260|NCT00570713|102006575|FG001|COMPLETED|Overall Study||0||
48682261|NCT00570713|102006574|FG000|NOT COMPLETED|Overall Study||78||
48682262|NCT00570713|102006575|FG001|NOT COMPLETED|Overall Study||77||
48682263|NCT01147393|102006576|FG000|STARTED|Dose Level 1||3||
48682264|NCT01147393|102006576|FG000|COMPLETED|Dose Level 1||1||
48682265|NCT01147393|102006576|FG000|NOT COMPLETED|Dose Level 1||2||
48682266|NCT01147393|102006576|FG000|STARTED|Dose Level -1||1||
48682267|NCT01147393|102006576|FG000|COMPLETED|Dose Level -1||0||
48682268|NCT01147393|102006576|FG000|NOT COMPLETED|Dose Level -1||1||
48682269|NCT02185534|102006577|FG000|STARTED|First Period||14||
48682270|NCT02185534|102006578|FG001|STARTED|First Period||14||
48682271|NCT02185534|102006579|FG002|STARTED|First Period||14||
48682272|NCT02185534|102006580|FG003|STARTED|First Period||14||
48682273|NCT02185534|102006581|FG004|STARTED|First Period||14||
48682274|NCT02185534|102006582|FG005|STARTED|First Period||14||
48682275|NCT02185534|102006577|FG000|COMPLETED|First Period||14||
48682276|NCT02185534|102006578|FG001|COMPLETED|First Period||14||
48083302|NCT00855920|100525552|FG001|NOT COMPLETED|Overall Study||9||
48083303|NCT00855920|100525553|FG002|NOT COMPLETED|Overall Study||11||
48682277|NCT02185534|102006579|FG002|COMPLETED|First Period||14||
48682278|NCT02185534|102006580|FG003|COMPLETED|First Period||13||
48682279|NCT02185534|102006581|FG004|COMPLETED|First Period||14||
48682280|NCT02185534|102006582|FG005|COMPLETED|First Period||14||
48083304|NCT05740644|100525554|FG000|STARTED|Overall Study||20||
48682281|NCT02185534|102006577|FG000|NOT COMPLETED|First Period||0||
48682282|NCT02185534|102006578|FG001|NOT COMPLETED|First Period||0||
48682283|NCT02185534|102006579|FG002|NOT COMPLETED|First Period||0||
48682284|NCT02185534|102006580|FG003|NOT COMPLETED|First Period||1||
48682285|NCT02185534|102006581|FG004|NOT COMPLETED|First Period||0||
48682286|NCT02185534|102006582|FG005|NOT COMPLETED|First Period||0||
48682287|NCT02185534|102006577|FG000|STARTED|First Washout Period||14||
48682288|NCT02185534|102006578|FG001|STARTED|First Washout Period||14||
48682289|NCT02185534|102006579|FG002|STARTED|First Washout Period||14||
48682290|NCT02185534|102006580|FG003|STARTED|First Washout Period||13||
48682291|NCT02185534|102006581|FG004|STARTED|First Washout Period||14||
48682292|NCT02185534|102006582|FG005|STARTED|First Washout Period||14||
48682293|NCT02185534|102006577|FG000|COMPLETED|First Washout Period||13||
48682294|NCT02185534|102006578|FG001|COMPLETED|First Washout Period||14||
48682295|NCT02185534|102006579|FG002|COMPLETED|First Washout Period||14||
48682296|NCT02185534|102006580|FG003|COMPLETED|First Washout Period||13||
48682297|NCT02185534|102006581|FG004|COMPLETED|First Washout Period||13||
48682298|NCT02185534|102006582|FG005|COMPLETED|First Washout Period||13||
48682299|NCT02185534|102006577|FG000|NOT COMPLETED|First Washout Period||1||
48682300|NCT02185534|102006578|FG001|NOT COMPLETED|First Washout Period||0||
48682301|NCT02185534|102006579|FG002|NOT COMPLETED|First Washout Period||0||
48682302|NCT02185534|102006580|FG003|NOT COMPLETED|First Washout Period||0||
48682303|NCT02185534|102006581|FG004|NOT COMPLETED|First Washout Period||1||
48682304|NCT02185534|102006582|FG005|NOT COMPLETED|First Washout Period||1||
48083305|NCT05740644|100525554|FG000|COMPLETED|Overall Study||20||
48083306|NCT05740644|100525554|FG000|NOT COMPLETED|Overall Study||0||
48083307|NCT00484874|100525555|FG000|STARTED|Overall Study||12||
48083308|NCT00484874|100525555|FG000|COMPLETED|Overall Study||12||
48083309|NCT00484874|100525555|FG000|NOT COMPLETED|Overall Study||0||
48083310|NCT02823431|100525556|FG000|STARTED|Overall Study||11||
48083311|NCT02823431|100525557|FG001|STARTED|Overall Study||12||
48083312|NCT02823431|100525556|FG000|COMPLETED|Overall Study||11||
48083313|NCT02823431|100525557|FG001|COMPLETED|Overall Study||12||
48083314|NCT02823431|100525556|FG000|NOT COMPLETED|Overall Study||0||
48246524|NCT04783519|100921075|FG002|NOT COMPLETED|Overall Study||9||
48682305|NCT02185534|102006577|FG000|STARTED|Second Period||13||
48682306|NCT02185534|102006578|FG001|STARTED|Second Period||14||
48682307|NCT02185534|102006579|FG002|STARTED|Second Period||14||
48682308|NCT02185534|102006580|FG003|STARTED|Second Period||13||
48682309|NCT02185534|102006581|FG004|STARTED|Second Period||13||
48083315|NCT02823431|100525557|FG001|NOT COMPLETED|Overall Study||0||
48246525|NCT01578278|100921076|FG000|STARTED|Overall Study||152||
48682310|NCT02185534|102006582|FG005|STARTED|Second Period||13||
48246526|NCT01578278|100921077|FG001|STARTED|Overall Study||152||
48246527|NCT01578278|100921078|FG002|STARTED|Overall Study||154||
48246528|NCT01578278|100921079|FG003|STARTED|Overall Study||148||
48682311|NCT02185534|102006577|FG000|COMPLETED|Second Period||13||
48682312|NCT02185534|102006578|FG001|COMPLETED|Second Period||14||
48682313|NCT02185534|102006579|FG002|COMPLETED|Second Period||14||
48682314|NCT02185534|102006580|FG003|COMPLETED|Second Period||13||
48682315|NCT02185534|102006581|FG004|COMPLETED|Second Period||13||
48682316|NCT02185534|102006582|FG005|COMPLETED|Second Period||13||
48682317|NCT02185534|102006577|FG000|NOT COMPLETED|Second Period||0||
48682318|NCT02185534|102006578|FG001|NOT COMPLETED|Second Period||0||
48682319|NCT02185534|102006579|FG002|NOT COMPLETED|Second Period||0||
48682320|NCT02185534|102006580|FG003|NOT COMPLETED|Second Period||0||
48682321|NCT02185534|102006581|FG004|NOT COMPLETED|Second Period||0||
48083316|NCT04343261|100525558|FG000|STARTED|Overall Study||48||
48246529|NCT01578278|100921076|FG000|COMPLETED|Overall Study||148||
48246530|NCT01578278|100921077|FG001|COMPLETED|Overall Study||150||
48246531|NCT01578278|100921078|FG002|COMPLETED|Overall Study||150||
48246532|NCT01578278|100921079|FG003|COMPLETED|Overall Study||139||
48682322|NCT02185534|102006582|FG005|NOT COMPLETED|Second Period||0||
48682323|NCT02185534|102006577|FG000|STARTED|Second Washout Period||13||
48682324|NCT02185534|102006578|FG001|STARTED|Second Washout Period||14||
48682325|NCT02185534|102006579|FG002|STARTED|Second Washout Period||14||
48682326|NCT02185534|102006580|FG003|STARTED|Second Washout Period||13||
48682327|NCT02185534|102006581|FG004|STARTED|Second Washout Period||13||
48682328|NCT02185534|102006582|FG005|STARTED|Second Washout Period||13||
48682329|NCT02185534|102006577|FG000|COMPLETED|Second Washout Period||13||
48682330|NCT02185534|102006578|FG001|COMPLETED|Second Washout Period||14||
48682331|NCT02185534|102006579|FG002|COMPLETED|Second Washout Period||14||
48083317|NCT04343261|100525558|FG000|COMPLETED|Overall Study||40||
48083318|NCT04343261|100525558|FG000|NOT COMPLETED|Overall Study||8||
48083319|NCT00806390|100525559|FG000|STARTED|Overall Study||7||
48083320|NCT00806390|100525560|FG001|STARTED|Overall Study||8||
48682332|NCT02185534|102006580|FG003|COMPLETED|Second Washout Period||13||
48682333|NCT02185534|102006581|FG004|COMPLETED|Second Washout Period||13||
48682334|NCT02185534|102006582|FG005|COMPLETED|Second Washout Period||13||
48682335|NCT02185534|102006577|FG000|NOT COMPLETED|Second Washout Period||0||
48083321|NCT00806390|100525559|FG000|COMPLETED|Overall Study||7||
48083322|NCT00806390|100525560|FG001|COMPLETED|Overall Study||8||
48083323|NCT00806390|100525559|FG000|NOT COMPLETED|Overall Study||0||
48083324|NCT00806390|100525560|FG001|NOT COMPLETED|Overall Study||0||
48083325|NCT02927431|100525561|FG000|STARTED|Overall Study||2||
48083326|NCT02927431|100525562|FG001|STARTED|Overall Study||4||
48083327|NCT02927431|100525563|FG002|STARTED|Overall Study||4||
48083328|NCT02927431|100525561|FG000|COMPLETED|Overall Study||2||
48083329|NCT02927431|100525562|FG001|COMPLETED|Overall Study||4||
48083330|NCT02927431|100525563|FG002|COMPLETED|Overall Study||3||
48083331|NCT02927431|100525561|FG000|NOT COMPLETED|Overall Study||0||
48083332|NCT02927431|100525562|FG001|NOT COMPLETED|Overall Study||0||
48083333|NCT02927431|100525563|FG002|NOT COMPLETED|Overall Study||1||
48083334|NCT01880840|100525564|FG000|STARTED|Overall Study||95||
48083335|NCT01880840|100525565|FG001|STARTED|Overall Study||96||
48083336|NCT01880840|100525564|FG000|COMPLETED|Overall Study||87||
48083337|NCT01880840|100525565|FG001|COMPLETED|Overall Study||91||
48083338|NCT01880840|100525564|FG000|NOT COMPLETED|Overall Study||8||
48083339|NCT01880840|100525565|FG001|NOT COMPLETED|Overall Study||5||
48083340|NCT00599924|100525566|FG000|STARTED|Overall Study||4||
48083341|NCT00599924|100525567|FG001|STARTED|Overall Study||9||
48083342|NCT00599924|100525568|FG002|STARTED|Overall Study||5||
48083343|NCT00599924|100525569|FG003|STARTED|Overall Study||12||
48083344|NCT00599924|100525570|FG004|STARTED|Overall Study||9||
48083345|NCT00599924|100525571|FG005|STARTED|Overall Study||6||
48083346|NCT00599924|100525572|FG006|STARTED|Overall Study||8||
48083347|NCT00599924|100525566|FG000|COMPLETED|Overall Study||1||
48083348|NCT00599924|100525567|FG001|COMPLETED|Overall Study||4||
48083349|NCT00599924|100525568|FG002|COMPLETED|Overall Study||3||
48083350|NCT00599924|100525569|FG003|COMPLETED|Overall Study||4||
48246533|NCT01578278|100921076|FG000|NOT COMPLETED|Overall Study||4||
48246534|NCT01578278|100921077|FG001|NOT COMPLETED|Overall Study||2||
48246535|NCT01578278|100921078|FG002|NOT COMPLETED|Overall Study||4||
48246536|NCT01578278|100921079|FG003|NOT COMPLETED|Overall Study||9||
48246537|NCT00734851|100921080|FG000|STARTED|Overall Study||34||
48246538|NCT00734851|100921080|FG000|COMPLETED|Overall Study||13||
48246539|NCT00734851|100921080|FG000|NOT COMPLETED|Overall Study||21||
48246540|NCT01369706|100921081|FG000|STARTED|Overall Study||388||
48246541|NCT01369706|100921081|FG000|COMPLETED|Overall Study||388||
48083351|NCT00599924|100525570|FG004|COMPLETED|Overall Study||3||
48083352|NCT00599924|100525571|FG005|COMPLETED|Overall Study||2||
48083353|NCT00599924|100525572|FG006|COMPLETED|Overall Study||3||
48083354|NCT00599924|100525566|FG000|NOT COMPLETED|Overall Study||3||
48083355|NCT00599924|100525567|FG001|NOT COMPLETED|Overall Study||5||
48083356|NCT00599924|100525568|FG002|NOT COMPLETED|Overall Study||2||
48083357|NCT00599924|100525569|FG003|NOT COMPLETED|Overall Study||8||
48083358|NCT00599924|100525570|FG004|NOT COMPLETED|Overall Study||6||
48083359|NCT00599924|100525571|FG005|NOT COMPLETED|Overall Study||4||
48083360|NCT00599924|100525572|FG006|NOT COMPLETED|Overall Study||5||
48083361|NCT01500694|100525573|FG000|STARTED|Overall Study||131||
48083362|NCT01500694|100525574|FG001|STARTED|Overall Study||83||
48083363|NCT01500694|100525573|FG000|COMPLETED|Overall Study||79||
48083364|NCT01500694|100525574|FG001|COMPLETED|Overall Study||54||
48083365|NCT01500694|100525573|FG000|NOT COMPLETED|Overall Study||52||
48246542|NCT01369706|100921081|FG000|NOT COMPLETED|Overall Study||0||
48083366|NCT01500694|100525574|FG001|NOT COMPLETED|Overall Study||29||
48083367|NCT00062374|100525575|FG000|STARTED|Overall Study||55||
48083368|NCT00062374|100525575|FG000|COMPLETED|Overall Study||43||
48083369|NCT00062374|100525575|FG000|NOT COMPLETED|Overall Study||12||
48083370|NCT01803204|100525576|FG000|STARTED|Overall Study||20||
48083371|NCT01803204|100525577|FG001|STARTED|Overall Study||20||
48083372|NCT01803204|100525576|FG000|COMPLETED|Overall Study||20||
48083373|NCT01803204|100525577|FG001|COMPLETED|Overall Study||20||
48083374|NCT01803204|100525576|FG000|NOT COMPLETED|Overall Study||0||
48083375|NCT01803204|100525577|FG001|NOT COMPLETED|Overall Study||0||
48083376|NCT01350414|100525578|FG000|STARTED|Overall Study||181||
48246543|NCT01026103|100921082|FG000|STARTED|Overall Study||30||
48246544|NCT01026103|100921082|FG000|Consented|Overall Study||30||
48246545|NCT01026103|100921082|FG000|COMPLETED|Overall Study||28||
48246546|NCT01026103|100921082|FG000|NOT COMPLETED|Overall Study||2||
48246547|NCT03110692|100921083|FG000|STARTED|Overall Study||679||
48246548|NCT03110692|100921084|FG001|STARTED|Overall Study||509||
48246549|NCT03110692|100921083|FG000|COMPLETED|Overall Study||679||
48083377|NCT01350414|100525578|FG000|Year 2|Overall Study||165||
48083378|NCT01350414|100525578|FG000|Year 3|Overall Study||162||
48083379|NCT01350414|100525578|FG000|Year 4|Overall Study||159||
48083380|NCT01350414|100525578|FG000|Year 5|Overall Study||162||
48083381|NCT01350414|100525578|FG000|COMPLETED|Overall Study||162||
48083382|NCT01350414|100525578|FG000|NOT COMPLETED|Overall Study||19||
48083383|NCT00595530|100525579|FG000|STARTED|Overall Study||3||
48083384|NCT00595530|100525579|FG000|COMPLETED|Overall Study||3||
48083385|NCT00595530|100525579|FG000|NOT COMPLETED|Overall Study||0||
48083386|NCT00786682|100525580|FG000|STARTED|Overall Study||11||
48083387|NCT00786682|100525580|FG000|COMPLETED|Overall Study||11||
48083388|NCT00786682|100525580|FG000|NOT COMPLETED|Overall Study||0||
48083389|NCT00208091|100525581|FG000|STARTED|Overall Study||16||
48083390|NCT00208091|100525581|FG000|COMPLETED|Overall Study||16||
48083391|NCT00208091|100525581|FG000|NOT COMPLETED|Overall Study||0||
48083392|NCT00333814|100525582|FG000|STARTED|Overall Study||76||
48083393|NCT00333814|100525583|FG001|STARTED|Overall Study||77||
48083394|NCT00333814|100525584|FG002|STARTED|Overall Study||76||
48083395|NCT00333814|100525582|FG000|COMPLETED|Overall Study||73||
48083396|NCT00333814|100525583|FG001|COMPLETED|Overall Study||73||
48083397|NCT00333814|100525584|FG002|COMPLETED|Overall Study||71||
48083398|NCT00333814|100525582|FG000|NOT COMPLETED|Overall Study||3||
48083399|NCT00333814|100525583|FG001|NOT COMPLETED|Overall Study||4||
48083400|NCT00333814|100525584|FG002|NOT COMPLETED|Overall Study||5||
48083401|NCT00705653|100525585|FG000|STARTED|Overall Study||46||
48083402|NCT00705653|100525585|FG000|COMPLETED|Overall Study||46||
48083403|NCT00705653|100525585|FG000|NOT COMPLETED|Overall Study||0||
48083404|NCT00897104|100525586|FG000|STARTED|Overall Study||418||
48083405|NCT00897104|100525587|FG001|STARTED|Overall Study||428||
48083406|NCT00897104|100525588|FG002|STARTED|Overall Study||87||
48083407|NCT00897104|100525586|FG000|Participants Treated|Overall Study||355||
48083408|NCT00897104|100525587|FG001|Participants Treated|Overall Study||357||
48083409|NCT00897104|100525588|FG002|Participants Treated|Overall Study||80||
48682336|NCT02185534|102006578|FG001|NOT COMPLETED|Second Washout Period||0||
48682337|NCT02185534|102006579|FG002|NOT COMPLETED|Second Washout Period||0||
48083410|NCT00897104|100525586|FG000|Participants Not Treated|Overall Study||63||
48083411|NCT00897104|100525587|FG001|Participants Not Treated|Overall Study||71||
48083412|NCT00897104|100525588|FG002|Participants Not Treated|Overall Study||7||
48083413|NCT00897104|100525586|FG000|COMPLETED|Overall Study||354||
48083414|NCT00897104|100525587|FG001|COMPLETED|Overall Study||357||
48083415|NCT00897104|100525588|FG002|COMPLETED|Overall Study||79||
48083416|NCT00897104|100525586|FG000|NOT COMPLETED|Overall Study||64||
48083417|NCT00897104|100525587|FG001|NOT COMPLETED|Overall Study||71||
48083418|NCT00897104|100525588|FG002|NOT COMPLETED|Overall Study||8||
48083419|NCT01191398|100525589|FG000|STARTED|Overall Study||17||
48083420|NCT01191398|100525590|FG001|STARTED|Overall Study||17||
48083421|NCT01191398|100525591|FG002|STARTED|Overall Study||18||
48083422|NCT01191398|100525589|FG000|COMPLETED|Overall Study||17||
48083423|NCT01191398|100525590|FG001|COMPLETED|Overall Study||17||
48083424|NCT01191398|100525591|FG002|COMPLETED|Overall Study||18||
48083425|NCT01191398|100525589|FG000|NOT COMPLETED|Overall Study||0||
48083426|NCT01191398|100525590|FG001|NOT COMPLETED|Overall Study||0||
48083427|NCT01191398|100525591|FG002|NOT COMPLETED|Overall Study||0||
48083428|NCT00482612|100525592|FG000|STARTED|In-treatment Period||137||
48083429|NCT00482612|100525593|FG001|STARTED|In-treatment Period||125||
48083430|NCT00482612|100525594|FG002|STARTED|In-treatment Period||129||
48083431|NCT00482612|100525595|FG003|STARTED|In-treatment Period||135||
48083432|NCT00482612|100525592|FG000|Treated|In-treatment Period||137||
48083433|NCT00482612|100525593|FG001|Treated|In-treatment Period||125||
48083434|NCT00482612|100525594|FG002|Treated|In-treatment Period||128||
48083435|NCT00482612|100525595|FG003|Treated|In-treatment Period||135||
48083436|NCT00482612|100525592|FG000|COMPLETED|In-treatment Period||137||
48083437|NCT00482612|100525593|FG001|COMPLETED|In-treatment Period||125||
48083438|NCT00482612|100525594|FG002|COMPLETED|In-treatment Period||128||
48083439|NCT00482612|100525595|FG003|COMPLETED|In-treatment Period||135||
48083440|NCT00482612|100525592|FG000|NOT COMPLETED|In-treatment Period||0||
48083441|NCT00482612|100525593|FG001|NOT COMPLETED|In-treatment Period||0||
48083442|NCT00482612|100525594|FG002|NOT COMPLETED|In-treatment Period||1||
48083443|NCT00482612|100525595|FG003|NOT COMPLETED|In-treatment Period||0||
48083444|NCT00482612|100525592|FG000|STARTED|Follow-up Period||137||
48083445|NCT00482612|100525593|FG001|STARTED|Follow-up Period||125||
48083446|NCT00482612|100525594|FG002|STARTED|Follow-up Period||128||
48083447|NCT00482612|100525595|FG003|STARTED|Follow-up Period||135||
48083448|NCT00482612|100525592|FG000|COMPLETED|Follow-up Period||123||
48083449|NCT00482612|100525593|FG001|COMPLETED|Follow-up Period||107||
48083450|NCT00482612|100525594|FG002|COMPLETED|Follow-up Period||106||
48083451|NCT00482612|100525595|FG003|COMPLETED|Follow-up Period||127||
48083452|NCT00482612|100525592|FG000|NOT COMPLETED|Follow-up Period||14||
48083453|NCT00482612|100525593|FG001|NOT COMPLETED|Follow-up Period||18||
48083454|NCT00482612|100525594|FG002|NOT COMPLETED|Follow-up Period||22||
48083455|NCT00482612|100525595|FG003|NOT COMPLETED|Follow-up Period||8||
48083456|NCT02496611|100525596|FG000|STARTED|Overall Study||33||
48083457|NCT02496611|100525597|FG001|STARTED|Overall Study||33||
48083458|NCT02496611|100525596|FG000|COMPLETED|Overall Study||26||
48083459|NCT02496611|100525597|FG001|COMPLETED|Overall Study||30||
48083460|NCT02496611|100525596|FG000|NOT COMPLETED|Overall Study||7||
48083461|NCT02496611|100525597|FG001|NOT COMPLETED|Overall Study||3||
48083462|NCT02270957|100525598|FG000|STARTED|Overall Study||31||
48083463|NCT02270957|100525599|FG001|STARTED|Overall Study||35||
48083464|NCT02270957|100525598|FG000|COMPLETED|Overall Study||27||
48083465|NCT02270957|100525599|FG001|COMPLETED|Overall Study||31||
48083466|NCT02270957|100525598|FG000|NOT COMPLETED|Overall Study||4||
48083467|NCT02270957|100525599|FG001|NOT COMPLETED|Overall Study||4||
48083468|NCT02573350|100525600|FG000|STARTED|Overall Study||137||
48083469|NCT02573350|100525601|FG001|STARTED|Overall Study||76||
48141265|NCT01260350|100670380|FG018|NOT COMPLETED|Overall Study||0||
48246550|NCT03110692|100921084|FG001|COMPLETED|Overall Study||509||
48246551|NCT03110692|100921083|FG000|NOT COMPLETED|Overall Study||0||
48246552|NCT03110692|100921084|FG001|NOT COMPLETED|Overall Study||0||
48246553|NCT00588341|100921085|FG000|STARTED|Overall Study||24||
48246554|NCT00588341|100921085|FG000|COMPLETED|Overall Study||19||
48246555|NCT00588341|100921085|FG000|NOT COMPLETED|Overall Study||5||
48246556|NCT00126555|100921086|FG000|STARTED|Overall Study||23||
48246557|NCT00126555|100921086|FG000|Stratum 1- Resectable|Overall Study||18||
48246558|NCT00126555|100921086|FG000|Stratum 2- Unresectable|Overall Study||4||
48246559|NCT00126555|100921086|FG000|COMPLETED|Overall Study||17||
48246560|NCT00126555|100921086|FG000|NOT COMPLETED|Overall Study||6||
48246561|NCT04374019|100921087|FG000|STARTED|Overall Study||1||
48246562|NCT04374019|100921088|FG001|STARTED|Overall Study||1||
48246563|NCT04374019|100921089|FG002|STARTED|Overall Study||6||
48246564|NCT04374019|100921090|FG003|STARTED|Overall Study||5||
48246565|NCT04374019|100921087|FG000|COMPLETED|Overall Study||1||
48246566|NCT04374019|100921088|FG001|COMPLETED|Overall Study||1||
48246567|NCT04374019|100921089|FG002|COMPLETED|Overall Study||5||
48246568|NCT04374019|100921090|FG003|COMPLETED|Overall Study||5||
48246569|NCT04374019|100921087|FG000|NOT COMPLETED|Overall Study||0||
48246570|NCT04374019|100921088|FG001|NOT COMPLETED|Overall Study||0||
48246571|NCT04374019|100921089|FG002|NOT COMPLETED|Overall Study||1||
48246572|NCT04374019|100921090|FG003|NOT COMPLETED|Overall Study||0||
48246573|NCT04194541|100921091|FG000|STARTED|Visit 0 (Baseline)||28||
48246574|NCT04194541|100921091|FG000|COMPLETED|Visit 0 (Baseline)||28||
48246575|NCT04194541|100921091|FG000|NOT COMPLETED|Visit 0 (Baseline)||0||
48246576|NCT04194541|100921091|FG000|STARTED|Day 1 Through 13||28||
48246577|NCT04194541|100921091|FG000|COMPLETED|Day 1 Through 13||19||
48246578|NCT04194541|100921091|FG000|NOT COMPLETED|Day 1 Through 13||9||
48246579|NCT04194541|100921091|FG000|STARTED|Visit 1 (Day 14)||19||
48246580|NCT04194541|100921091|FG000|COMPLETED|Visit 1 (Day 14)||19||
48246581|NCT04194541|100921091|FG000|NOT COMPLETED|Visit 1 (Day 14)||0||
48246582|NCT04194541|100921091|FG000|STARTED|Day 15 Through Week 6||19||
48246583|NCT04194541|100921091|FG000|COMPLETED|Day 15 Through Week 6||14||
48246584|NCT04194541|100921091|FG000|NOT COMPLETED|Day 15 Through Week 6||5||
48246585|NCT04194541|100921091|FG000|STARTED|Visit 2 (6 Weeks)||14||
48246586|NCT04194541|100921091|FG000|COMPLETED|Visit 2 (6 Weeks)||14||
48246587|NCT04194541|100921091|FG000|NOT COMPLETED|Visit 2 (6 Weeks)||0||
48246588|NCT00580047|100921092|FG000|STARTED|Overall Study||24||
48246589|NCT00580047|100921093|FG001|STARTED|Overall Study||23||
48246590|NCT00580047|100921094|FG002|STARTED|Overall Study||12||
48246591|NCT00580047|100921092|FG000|COMPLETED|Overall Study||21||
48246592|NCT00580047|100921093|FG001|COMPLETED|Overall Study||21||
48246593|NCT00580047|100921094|FG002|COMPLETED|Overall Study||10||
48246594|NCT00580047|100921092|FG000|NOT COMPLETED|Overall Study||3||
48246595|NCT00580047|100921093|FG001|NOT COMPLETED|Overall Study||2||
48246596|NCT00580047|100921094|FG002|NOT COMPLETED|Overall Study||2||
48246597|NCT01047306|100921095|FG000|STARTED|Overall Study||19||
48246598|NCT01047306|100921096|FG001|STARTED|Overall Study||6||
48246599|NCT01047306|100921095|FG000|Discontinued From the Study|Overall Study||3||
48246600|NCT01047306|100921096|FG001|Discontinued From the Study|Overall Study||0||
48246601|NCT01047306|100921095|FG000|COMPLETED|Overall Study||16||
48246602|NCT01047306|100921096|FG001|COMPLETED|Overall Study||6||
48246603|NCT01047306|100921095|FG000|NOT COMPLETED|Overall Study||3||
48246604|NCT01047306|100921096|FG001|NOT COMPLETED|Overall Study||0||
48246605|NCT01393314|100921097|FG000|STARTED|Overall Study||54||
48246606|NCT01393314|100921098|FG001|STARTED|Overall Study||45||
48246607|NCT01393314|100921097|FG000|COMPLETED|Overall Study||54||
48246608|NCT01393314|100921098|FG001|COMPLETED|Overall Study||45||
48246609|NCT01393314|100921097|FG000|NOT COMPLETED|Overall Study||0||
48246610|NCT01393314|100921098|FG001|NOT COMPLETED|Overall Study||0||
48246611|NCT03319719|100921099|FG000|STARTED|Overall Study||52||
48246612|NCT03319719|100921099|FG000|COMPLETED|Overall Study||51||
48246613|NCT03319719|100921099|FG000|NOT COMPLETED|Overall Study||1||
48246614|NCT02081196|100921100|FG000|STARTED|Overall Study||45|Forty-five participants were enrolled. Subjects had 1 flank treated and 1 untreated.|
48246615|NCT02081196|100921100|FG000|Untreated Control Flank|Overall Study||45|Each subject had one treated flank and one untreated flank.|
48246616|NCT02081196|100921100|FG000|COMPLETED|Overall Study||44||
48246617|NCT02081196|100921100|FG000|NOT COMPLETED|Overall Study||1||
48246618|NCT02333071|100921101|FG000|STARTED|Core Study||326||
48246619|NCT02333071|100921102|FG001|STARTED|Core Study||327||
48246620|NCT02333071|100921101|FG000|Received Intervention|Core Study||319||
48246621|NCT02333071|100921102|FG001|Received Intervention|Core Study||324||
48246622|NCT02333071|100921101|FG000|COMPLETED|Core Study||274||
48246623|NCT02333071|100921102|FG001|COMPLETED|Core Study||190||
48246624|NCT02333071|100921101|FG000|NOT COMPLETED|Core Study||52||
48246625|NCT02333071|100921102|FG001|NOT COMPLETED|Core Study||137||
48246626|NCT02333071|100921101|FG000|STARTED|Open Label Extension||239|"363/464 subjects who completed Core Study continued to this OLE Study (124 BMT-BMT and 239 PBO-BMT.~The OLE study was not reported."|
48246627|NCT02333071|100921102|FG001|STARTED|Open Label Extension||124|"363/464 subjects who completed Core Study continued to this OLE Study (124 BMT-BMT and 239 PBO-BMT.~The OLE study was not reported."|
48246628|NCT02333071|100921101|FG000|COMPLETED|Open Label Extension||95||
48246629|NCT02333071|100921102|FG001|COMPLETED|Open Label Extension||49||
48246630|NCT02333071|100921101|FG000|NOT COMPLETED|Open Label Extension||144||
48246631|NCT02333071|100921102|FG001|NOT COMPLETED|Open Label Extension||75||
48246632|NCT03049306|100921103|FG000|STARTED|First Intervention (1 Night)||11||
48246633|NCT03049306|100921104|FG001|STARTED|First Intervention (1 Night)||12||
48246634|NCT03049306|100921103|FG000|COMPLETED|First Intervention (1 Night)||10||
48246635|NCT03049306|100921104|FG001|COMPLETED|First Intervention (1 Night)||11||
48246636|NCT03049306|100921103|FG000|NOT COMPLETED|First Intervention (1 Night)||1||
48246637|NCT03049306|100921104|FG001|NOT COMPLETED|First Intervention (1 Night)||1||
48246638|NCT03049306|100921103|FG000|STARTED|Second Intervention (1 Night)||10||
48246639|NCT03049306|100921104|FG001|STARTED|Second Intervention (1 Night)||11||
48246640|NCT03049306|100921103|FG000|COMPLETED|Second Intervention (1 Night)||10||
48246641|NCT03049306|100921104|FG001|COMPLETED|Second Intervention (1 Night)||11||
48246642|NCT03049306|100921103|FG000|NOT COMPLETED|Second Intervention (1 Night)||0||
48246643|NCT03049306|100921104|FG001|NOT COMPLETED|Second Intervention (1 Night)||0||
48246644|NCT00228813|100921105|FG000|STARTED|Overall Study||8||
48246645|NCT00228813|100921105|FG000|COMPLETED|Overall Study||4||
48246646|NCT00228813|100921105|FG000|NOT COMPLETED|Overall Study||4||
48246647|NCT02814279|100921106|FG000|STARTED|Overall Study||21||
48682338|NCT02185534|102006580|FG003|NOT COMPLETED|Second Washout Period||0||
48682339|NCT02185534|102006581|FG004|NOT COMPLETED|Second Washout Period||0||
48682340|NCT02185534|102006582|FG005|NOT COMPLETED|Second Washout Period||0||
48682341|NCT02185534|102006577|FG000|STARTED|Third Period||13||
48682342|NCT02185534|102006578|FG001|STARTED|Third Period||14||
48682343|NCT02185534|102006579|FG002|STARTED|Third Period||14||
48682344|NCT02185534|102006580|FG003|STARTED|Third Period||13||
48682345|NCT02185534|102006581|FG004|STARTED|Third Period||13||
48682346|NCT02185534|102006582|FG005|STARTED|Third Period||13||
48682347|NCT02185534|102006577|FG000|COMPLETED|Third Period||13||
48682348|NCT02185534|102006578|FG001|COMPLETED|Third Period||14||
48682349|NCT02185534|102006579|FG002|COMPLETED|Third Period||14||
48682350|NCT02185534|102006580|FG003|COMPLETED|Third Period||13||
48682351|NCT02185534|102006581|FG004|COMPLETED|Third Period||13||
48682352|NCT02185534|102006582|FG005|COMPLETED|Third Period||13||
48682353|NCT02185534|102006577|FG000|NOT COMPLETED|Third Period||0||
48682354|NCT02185534|102006578|FG001|NOT COMPLETED|Third Period||0||
48682355|NCT02185534|102006579|FG002|NOT COMPLETED|Third Period||0||
48682356|NCT02185534|102006580|FG003|NOT COMPLETED|Third Period||0||
48682357|NCT02185534|102006581|FG004|NOT COMPLETED|Third Period||0||
48682358|NCT02185534|102006582|FG005|NOT COMPLETED|Third Period||0||
48682359|NCT00696124|102006583|FG000|STARTED|Overall Study||3||
48682360|NCT00696124|102006584|FG001|STARTED|Overall Study||3||
48682361|NCT00696124|102006585|FG002|STARTED|Overall Study||3||
48682362|NCT00696124|102006586|FG003|STARTED|Overall Study||3||
48682363|NCT00696124|102006583|FG000|COMPLETED|Overall Study||3||
48682364|NCT00696124|102006584|FG001|COMPLETED|Overall Study||3||
48682365|NCT00696124|102006585|FG002|COMPLETED|Overall Study||3||
48682366|NCT00696124|102006586|FG003|COMPLETED|Overall Study||3||
48682367|NCT00696124|102006583|FG000|NOT COMPLETED|Overall Study||0||
48682368|NCT00696124|102006584|FG001|NOT COMPLETED|Overall Study||0||
48682369|NCT00696124|102006585|FG002|NOT COMPLETED|Overall Study||0||
48682370|NCT00696124|102006586|FG003|NOT COMPLETED|Overall Study||0||
48682371|NCT01534481|102006587|FG000|STARTED|Overall Study||239||
48246648|NCT02814279|100921107|FG001|STARTED|Overall Study||21||
48682372|NCT01534481|102006588|FG001|STARTED|Overall Study||244||
48682373|NCT01534481|102006587|FG000|Complete Data for BSID III Cognitive Score at 22-26 Months|Overall Study||175||
48682374|NCT01534481|102006588|FG001|Complete Data for BSID III Cognitive Score at 22-26 Months|Overall Study||192||
48682375|NCT01534481|102006587|FG000|Died After Discharge|Overall Study||5||
48682376|NCT01534481|102006588|FG001|Died After Discharge|Overall Study||7||
48682377|NCT01534481|102006587|FG000|Died Before Discharge|Overall Study||24||
48246649|NCT02814279|100921106|FG000|COMPLETED|Overall Study||21||
48246650|NCT02814279|100921107|FG001|COMPLETED|Overall Study||21||
48246651|NCT02814279|100921106|FG000|NOT COMPLETED|Overall Study||0||
48682378|NCT01534481|102006588|FG001|Died Before Discharge|Overall Study||18||
48246652|NCT02814279|100921107|FG001|NOT COMPLETED|Overall Study||0||
48246653|NCT01808144|100921108|FG000|STARTED|Overall Study||97||
48246654|NCT01808144|100921109|FG001|STARTED|Overall Study||99||
48246655|NCT01808144|100921108|FG000|COMPLETED|Overall Study||57||
48246656|NCT01808144|100921109|FG001|COMPLETED|Overall Study||51||
48246657|NCT01808144|100921108|FG000|NOT COMPLETED|Overall Study||40||
48246658|NCT01808144|100921109|FG001|NOT COMPLETED|Overall Study||48||
48246659|NCT01090076|100921110|FG000|STARTED|Overall Study||12||
48246660|NCT01090076|100921111|FG001|STARTED|Overall Study||14||
48246661|NCT01090076|100921110|FG000|COMPLETED|Overall Study||11||
48246662|NCT01090076|100921111|FG001|COMPLETED|Overall Study||12||
48246663|NCT01090076|100921110|FG000|NOT COMPLETED|Overall Study||1||
48246664|NCT01090076|100921111|FG001|NOT COMPLETED|Overall Study||2||
48246665|NCT01313299|100921112|FG000|STARTED|Overall Study||81||
48246666|NCT01313299|100921113|FG001|STARTED|Overall Study||81||
48246667|NCT01313299|100921114|FG002|STARTED|Overall Study||81||
48246668|NCT01313299|100921112|FG000|COMPLETED|Overall Study||74||
48246669|NCT01313299|100921113|FG001|COMPLETED|Overall Study||78||
48246670|NCT01313299|100921114|FG002|COMPLETED|Overall Study||77||
48246671|NCT01313299|100921112|FG000|NOT COMPLETED|Overall Study||7||
48246672|NCT01313299|100921113|FG001|NOT COMPLETED|Overall Study||3||
48246673|NCT01313299|100921114|FG002|NOT COMPLETED|Overall Study||4||
48246674|NCT03924193|100921115|FG000|STARTED|Overall Study||47||
48246675|NCT03924193|100921116|FG001|STARTED|Overall Study||47||
48246676|NCT03924193|100921117|FG002|STARTED|Overall Study||47||
48246677|NCT03924193|100921115|FG000|COMPLETED|Overall Study||32||
48246678|NCT03924193|100921116|FG001|COMPLETED|Overall Study||37||
48246679|NCT03924193|100921117|FG002|COMPLETED|Overall Study||35||
48246680|NCT03924193|100921115|FG000|NOT COMPLETED|Overall Study||15||
48246681|NCT03924193|100921116|FG001|NOT COMPLETED|Overall Study||10||
48246682|NCT03924193|100921117|FG002|NOT COMPLETED|Overall Study||12||
48246683|NCT00500539|100921118|FG000|STARTED|Treatment Period (24 Weeks)||155||
48246684|NCT00500539|100921118|FG000|COMPLETED|Treatment Period (24 Weeks)||140||
48246685|NCT00500539|100921118|FG000|NOT COMPLETED|Treatment Period (24 Weeks)||15||
48246686|NCT00500539|100921118|FG000|STARTED|Follow-up Period (16 Weeks)||148||
48246687|NCT00500539|100921118|FG000|COMPLETED|Follow-up Period (16 Weeks)||136||
48246688|NCT00500539|100921118|FG000|NOT COMPLETED|Follow-up Period (16 Weeks)||12||
48246689|NCT00382408|100924052|FG000|STARTED|Overall Study||3031||
48246690|NCT00382408|100924053|FG001|STARTED|Overall Study||1009||
48246691|NCT00382408|100924052|FG000|COMPLETED|Overall Study||2887||
48246692|NCT00382408|100924053|FG001|COMPLETED|Overall Study||955||
48246693|NCT00382408|100924052|FG000|NOT COMPLETED|Overall Study||144||
48246694|NCT00382408|100924053|FG001|NOT COMPLETED|Overall Study||54||
48246695|NCT00349713|100924054|FG000|STARTED|Overall Study||20||
48246696|NCT00349713|100924055|FG001|STARTED|Overall Study||20||
48246697|NCT00349713|100924056|FG002|STARTED|Overall Study||20||
48246698|NCT00349713|100924054|FG000|COMPLETED|Overall Study||20||
48246699|NCT00349713|100924055|FG001|COMPLETED|Overall Study||20||
48246700|NCT00349713|100924056|FG002|COMPLETED|Overall Study||20||
48246701|NCT00349713|100924054|FG000|NOT COMPLETED|Overall Study||0||
48246702|NCT00349713|100924055|FG001|NOT COMPLETED|Overall Study||0||
48246703|NCT00349713|100924056|FG002|NOT COMPLETED|Overall Study||0||
48246704|NCT01372202|100924057|FG000|STARTED|Overall Study||13||
48246705|NCT01372202|100924058|FG001|STARTED|Overall Study||9||
48246706|NCT01372202|100924059|FG002|STARTED|Overall Study||9||
48246707|NCT01372202|100924057|FG000|COMPLETED|Overall Study||13||
48246708|NCT01372202|100924058|FG001|COMPLETED|Overall Study||9||
48246709|NCT01372202|100924059|FG002|COMPLETED|Overall Study||9||
48246710|NCT01372202|100924057|FG000|NOT COMPLETED|Overall Study||0||
48246711|NCT01372202|100924058|FG001|NOT COMPLETED|Overall Study||0||
48246712|NCT01372202|100924059|FG002|NOT COMPLETED|Overall Study||0||
48246713|NCT03149887|100924060|FG000|STARTED|Overall Study||27||
48246714|NCT03149887|100924061|FG001|STARTED|Overall Study||27||
48246715|NCT03149887|100924060|FG000|COMPLETED|Overall Study||27||
48246716|NCT03149887|100924061|FG001|COMPLETED|Overall Study||27||
48246717|NCT03149887|100924060|FG000|NOT COMPLETED|Overall Study||0||
48246718|NCT03149887|100924061|FG001|NOT COMPLETED|Overall Study||0||
48246719|NCT00910871|100924062|FG000|STARTED|Overall Study||233||
48246720|NCT00910871|100924062|FG000|COMPLETED|Overall Study||179||
48246721|NCT00910871|100924062|FG000|NOT COMPLETED|Overall Study||54||
48246722|NCT02775214|100924063|FG000|STARTED|Overall Study||30||
48246723|NCT02775214|100924064|FG001|STARTED|Overall Study||32||
48246724|NCT02775214|100924063|FG000|COMPLETED|Overall Study||28||
48246725|NCT02775214|100924064|FG001|COMPLETED|Overall Study||32||
48246726|NCT02775214|100924063|FG000|NOT COMPLETED|Overall Study||2||
48246727|NCT02775214|100924064|FG001|NOT COMPLETED|Overall Study||0||
48246728|NCT01554371|100924065|FG000|STARTED|Overall Study||3||
48246729|NCT01554371|100924066|FG001|STARTED|Overall Study||3||
48246730|NCT01554371|100924067|FG002|STARTED|Overall Study||38||
48246731|NCT01554371|100924065|FG000|COMPLETED|Overall Study||3||
48246732|NCT01554371|100924066|FG001|COMPLETED|Overall Study||3||
48246733|NCT01554371|100924067|FG002|COMPLETED|Overall Study||38||
48246734|NCT01554371|100924065|FG000|NOT COMPLETED|Overall Study||0||
48246735|NCT01554371|100924066|FG001|NOT COMPLETED|Overall Study||0||
48246736|NCT01554371|100924067|FG002|NOT COMPLETED|Overall Study||0||
48682379|NCT01534481|102006587|FG000|Survived to Discharge|Overall Study||215||
48682380|NCT01534481|102006588|FG001|Survived to Discharge|Overall Study||226||
48246737|NCT01475370|100924068|FG000|STARTED|Overall Study||3||
48246738|NCT01475370|100924069|FG001|STARTED|Overall Study||3||
48246739|NCT01475370|100924070|FG002|STARTED|Overall Study||3||
48682381|NCT01534481|102006587|FG000|COMPLETED|Overall Study||204|Death or BSID III cognitive score at 22-26 months|
48682382|NCT01534481|102006588|FG001|COMPLETED|Overall Study||217|Death or BSID III cognitive score at 22-26 months|
48682383|NCT01534481|102006587|FG000|NOT COMPLETED|Overall Study||35||
48682384|NCT01534481|102006588|FG001|NOT COMPLETED|Overall Study||27||
48682385|NCT01953211|102006589|FG000|STARTED|Overall Study||64||
48682386|NCT01953211|102006589|FG000|COMPLETED|Overall Study||64||
48682387|NCT01953211|102006589|FG000|NOT COMPLETED|Overall Study||0||
48682388|NCT02581891|102006590|FG000|STARTED|Overall Study||135|Randomized|
48682389|NCT02581891|102006591|FG001|STARTED|Overall Study||136|Randomized|
48682390|NCT02581891|102006590|FG000|Completed Treatment|Overall Study||120||
48682391|NCT02581891|102006591|FG001|Completed Treatment|Overall Study||117||
48682392|NCT02581891|102006590|FG000|COMPLETED|Overall Study||119|Completed Study|
48682393|NCT02581891|102006591|FG001|COMPLETED|Overall Study||117|Completed Study|
48682394|NCT02581891|102006590|FG000|NOT COMPLETED|Overall Study||16||
48682395|NCT02581891|102006591|FG001|NOT COMPLETED|Overall Study||19||
48682396|NCT00598819|102006592|FG000|STARTED|Overall Study||14||
48682397|NCT00598819|102006592|FG000|COMPLETED|Overall Study||14||
48682398|NCT00598819|102006592|FG000|NOT COMPLETED|Overall Study||0||
48682399|NCT04240886|102006593|FG000|STARTED|Treatment Phase||21||
48246740|NCT01475370|100924068|FG000|COMPLETED|Overall Study||0||
48246741|NCT01475370|100924069|FG001|COMPLETED|Overall Study||0||
48246742|NCT01475370|100924070|FG002|COMPLETED|Overall Study||0||
48246743|NCT01475370|100924068|FG000|NOT COMPLETED|Overall Study||3||
48246744|NCT01475370|100924069|FG001|NOT COMPLETED|Overall Study||3||
48246745|NCT01475370|100924070|FG002|NOT COMPLETED|Overall Study||3||
48246746|NCT02762500|100924071|FG000|STARTED|Overall Study||62||
48246747|NCT02762500|100924072|FG001|STARTED|Overall Study||62||
48246748|NCT02762500|100924071|FG000|COMPLETED|Overall Study||60||
48682400|NCT04240886|102006593|FG000|COMPLETED|Treatment Phase||11||
48682401|NCT04240886|102006593|FG000|NOT COMPLETED|Treatment Phase||10||
48682402|NCT04240886|102006593|FG000|STARTED|Follow-up Phase||17||
48682403|NCT04240886|102006593|FG000|COMPLETED|Follow-up Phase||13||
48083470|NCT02573350|100525600|FG000|Efficacy Analysis Population|Overall Study||132|Efficacy Analysis Population included all enrolled participants who had a baseline and a post-baseline measurement available for assessment of any efficacy endpoint.|
48083471|NCT02573350|100525601|FG001|Efficacy Analysis Population|Overall Study||73|Efficacy Analysis Population included all enrolled participants who had a baseline and a post-baseline measurement available for assessment of any efficacy endpoint.|
48141266|NCT01260350|100670381|FG019|NOT COMPLETED|Overall Study||0||
48141267|NCT01260350|100670382|FG020|NOT COMPLETED|Overall Study||3||
48141268|NCT01260350|100670383|FG021|NOT COMPLETED|Overall Study||0||
48141269|NCT02558010|100670384|FG000|STARTED|Overall Study||30||
48246749|NCT02762500|100924072|FG001|COMPLETED|Overall Study||59||
48246750|NCT02762500|100924071|FG000|NOT COMPLETED|Overall Study||2||
48246751|NCT02762500|100924072|FG001|NOT COMPLETED|Overall Study||3||
48246752|NCT03512288|100924073|FG000|STARTED|Overall Study||232||
48246753|NCT03512288|100924074|FG001|STARTED|Overall Study||228||
48246754|NCT03512288|100924073|FG000|Vaccination 1|Overall Study||231||
48246755|NCT03512288|100924074|FG001|Vaccination 1|Overall Study||227||
48246756|NCT03512288|100924073|FG000|Vaccination 2|Overall Study||222||
48246757|NCT03512288|100924074|FG001|Vaccination 2|Overall Study||213||
48246758|NCT03512288|100924073|FG000|Vaccination 3|Overall Study||210||
48682404|NCT04240886|102006593|FG000|NOT COMPLETED|Follow-up Phase||4||
48682405|NCT02521974|102006594|FG000|STARTED|Overall Study||50||
48682406|NCT02521974|102006595|FG001|STARTED|Overall Study||114||
48083472|NCT02573350|100525600|FG000|Safety Population|Overall Study||137|Safety Population included all participants treated with at least one dose of Delamanid in this study.|
48083473|NCT02573350|100525601|FG001|Safety Population|Overall Study||76|Safety Population included all participants treated with at least one dose of Delamanid in this study.|
48083474|NCT02573350|100525600|FG000|COMPLETED|Overall Study||121||
48083475|NCT02573350|100525601|FG001|COMPLETED|Overall Study||67||
48083476|NCT02573350|100525600|FG000|NOT COMPLETED|Overall Study||16||
48083477|NCT02573350|100525601|FG001|NOT COMPLETED|Overall Study||9||
48083478|NCT03555591|100525602|FG000|STARTED|Overall Study||3198||
48083479|NCT03555591|100525602|FG000|COMPLETED|Overall Study||3121||
48083480|NCT03555591|100525602|FG000|NOT COMPLETED|Overall Study||77||
48083481|NCT03487276|100525603|FG000|STARTED|Main Period (16 Weeks)||37||
48083482|NCT03487276|100525604|FG001|STARTED|Main Period (16 Weeks)||34||
48083483|NCT03487276|100525605|FG002|STARTED|Main Period (16 Weeks)||36||
48083484|NCT03487276|100525606|FG003|STARTED|Main Period (16 Weeks)||36||
48083485|NCT03487276|100525607|FG004|STARTED|Main Period (16 Weeks)||36||
48083486|NCT03487276|100525603|FG000|COMPLETED|Main Period (16 Weeks)||34||
48083487|NCT03487276|100525604|FG001|COMPLETED|Main Period (16 Weeks)||30||
48083488|NCT03487276|100525605|FG002|COMPLETED|Main Period (16 Weeks)||32||
48083489|NCT03487276|100525606|FG003|COMPLETED|Main Period (16 Weeks)||30||
48083490|NCT03487276|100525607|FG004|COMPLETED|Main Period (16 Weeks)||31||
48083491|NCT03487276|100525603|FG000|NOT COMPLETED|Main Period (16 Weeks)||3||
48083492|NCT03487276|100525604|FG001|NOT COMPLETED|Main Period (16 Weeks)||4||
48083493|NCT03487276|100525605|FG002|NOT COMPLETED|Main Period (16 Weeks)||4||
48083494|NCT03487276|100525606|FG003|NOT COMPLETED|Main Period (16 Weeks)||6||
48083495|NCT03487276|100525607|FG004|NOT COMPLETED|Main Period (16 Weeks)||5||
48083496|NCT03487276|100525603|FG000|STARTED|Extension Period (28 Weeks)||0||
48083497|NCT03487276|100525604|FG001|STARTED|Extension Period (28 Weeks)||0||
48083498|NCT03487276|100525605|FG002|STARTED|Extension Period (28 Weeks)||72||
48083499|NCT03487276|100525606|FG003|STARTED|Extension Period (28 Weeks)||84||
48083500|NCT03487276|100525607|FG004|STARTED|Extension Period (28 Weeks)||0||
48083501|NCT03487276|100525603|FG000|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0||
48083502|NCT03487276|100525604|FG001|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0||
48083503|NCT03487276|100525605|FG002|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||16||
48083504|NCT03487276|100525606|FG003|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||18||
48083505|NCT03487276|100525607|FG004|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0||
48083506|NCT03487276|100525603|FG000|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0||
48083507|NCT03487276|100525604|FG001|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0||
48083508|NCT03487276|100525605|FG002|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||12||
48083509|NCT03487276|100525606|FG003|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||18||
48083510|NCT03487276|100525607|FG004|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0||
48083511|NCT03487276|100525603|FG000|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0||
48083512|NCT03487276|100525604|FG001|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0||
48083513|NCT03487276|100525605|FG002|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||17||
48083514|NCT03487276|100525606|FG003|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||15||
48083515|NCT03487276|100525607|FG004|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0||
48083516|NCT03487276|100525603|FG000|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0||
48083517|NCT03487276|100525604|FG001|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0||
48083518|NCT03487276|100525605|FG002|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||12||
48083519|NCT03487276|100525606|FG003|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||18||
48083520|NCT03487276|100525607|FG004|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0||
48083521|NCT03487276|100525603|FG000|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0|One patient of Cohort 5 completed the Main Period as Non-Responder but was lost to follow-up afterwards and not treated in the Extension Period|
48083522|NCT03487276|100525604|FG001|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0|One patient of Cohort 5 completed the Main Period as Non-Responder but was lost to follow-up afterwards and not treated in the Extension Period|
48083523|NCT03487276|100525605|FG002|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||15|One patient of Cohort 5 completed the Main Period as Non-Responder but was lost to follow-up afterwards and not treated in the Extension Period|
48083524|NCT03487276|100525606|FG003|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||16|One patient of Cohort 5 completed the Main Period as Non-Responder but was lost to follow-up afterwards and not treated in the Extension Period|
48141270|NCT02558010|100670385|FG001|STARTED|Overall Study||28||
48141271|NCT02558010|100670384|FG000|COMPLETED|Overall Study||25||
48141272|NCT02558010|100670385|FG001|COMPLETED|Overall Study||22||
48083525|NCT03487276|100525607|FG004|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0|One patient of Cohort 5 completed the Main Period as Non-Responder but was lost to follow-up afterwards and not treated in the Extension Period|
48083526|NCT03487276|100525603|FG000|COMPLETED|Extension Period (28 Weeks)||0||
48083527|NCT03487276|100525604|FG001|COMPLETED|Extension Period (28 Weeks)||0||
48083528|NCT03487276|100525605|FG002|COMPLETED|Extension Period (28 Weeks)||67||
48083529|NCT03487276|100525606|FG003|COMPLETED|Extension Period (28 Weeks)||54||
48083530|NCT03487276|100525607|FG004|COMPLETED|Extension Period (28 Weeks)||0||
48083531|NCT03487276|100525603|FG000|NOT COMPLETED|Extension Period (28 Weeks)||0||
48083532|NCT03487276|100525604|FG001|NOT COMPLETED|Extension Period (28 Weeks)||0||
48083533|NCT03487276|100525605|FG002|NOT COMPLETED|Extension Period (28 Weeks)||5||
48083534|NCT03487276|100525606|FG003|NOT COMPLETED|Extension Period (28 Weeks)||30||
48083535|NCT03487276|100525607|FG004|NOT COMPLETED|Extension Period (28 Weeks)||0||
48083536|NCT02683161|100525608|FG000|STARTED|Overall Study||5||
48083537|NCT02683161|100525608|FG000|COMPLETED|Overall Study||5||
48083538|NCT02683161|100525608|FG000|NOT COMPLETED|Overall Study||0||
48083539|NCT00187486|100525609|FG000|STARTED|Overall Study||66||
48083540|NCT00187486|100525609|FG000|COMPLETED|Overall Study||65||
48083541|NCT00187486|100525609|FG000|NOT COMPLETED|Overall Study||1||
48083542|NCT00471068|100525610|FG000|STARTED|Overall Study||21||
48083543|NCT00471068|100525611|FG001|STARTED|Overall Study||25||
48083544|NCT00471068|100525610|FG000|COMPLETED|Overall Study||20||
48083545|NCT00471068|100525611|FG001|COMPLETED|Overall Study||24||
48083546|NCT00471068|100525610|FG000|NOT COMPLETED|Overall Study||1||
48083547|NCT00471068|100525611|FG001|NOT COMPLETED|Overall Study||1||
48083548|NCT04812964|100525612|FG000|STARTED|Overall Study||40||
48083549|NCT04812964|100525613|FG001|STARTED|Overall Study||47||
48083550|NCT04812964|100525612|FG000|COMPLETED|Overall Study||31||
48083551|NCT04812964|100525613|FG001|COMPLETED|Overall Study||27||
48083552|NCT04812964|100525612|FG000|NOT COMPLETED|Overall Study||9||
48083553|NCT04812964|100525613|FG001|NOT COMPLETED|Overall Study||20||
48083554|NCT01828281|100525614|FG000|STARTED|Overall Study||45||
48083555|NCT01828281|100525615|FG001|STARTED|Overall Study||45||
48083556|NCT01828281|100525614|FG000|COMPLETED|Overall Study||44||
48083557|NCT01828281|100525615|FG001|COMPLETED|Overall Study||45||
48083558|NCT01828281|100525614|FG000|NOT COMPLETED|Overall Study||1||
48083559|NCT01828281|100525615|FG001|NOT COMPLETED|Overall Study||0||
48083560|NCT02835820|100525616|FG000|STARTED|Overall Study||7||
48083561|NCT02835820|100525617|FG001|STARTED|Overall Study||10||
48083562|NCT02835820|100525616|FG000|Baseline Screen (OGTT)|Overall Study||7||
48083563|NCT02835820|100525617|FG001|Baseline Screen (OGTT)|Overall Study||7||
48083564|NCT02835820|100525616|FG000|COMPLETED|Overall Study||7||
48083565|NCT02835820|100525617|FG001|COMPLETED|Overall Study||7||
48083566|NCT02835820|100525616|FG000|NOT COMPLETED|Overall Study||0||
48083567|NCT02835820|100525617|FG001|NOT COMPLETED|Overall Study||3||
48083568|NCT01513473|100525618|FG000|STARTED|Main Trial (26 Weeks)||174||
48083569|NCT01513473|100525619|FG001|STARTED|Main Trial (26 Weeks)||176||
48083570|NCT01513473|100525618|FG000|Exposed|Main Trial (26 Weeks)||174||
48083571|NCT01513473|100525619|FG001|Exposed|Main Trial (26 Weeks)||175||
48083572|NCT01513473|100525618|FG000|COMPLETED|Main Trial (26 Weeks)||170||
48083573|NCT01513473|100525619|FG001|COMPLETED|Main Trial (26 Weeks)||165||
48083574|NCT01513473|100525618|FG000|NOT COMPLETED|Main Trial (26 Weeks)||4||
48083575|NCT01513473|100525619|FG001|NOT COMPLETED|Main Trial (26 Weeks)||11||
48083576|NCT01513473|100525618|FG000|STARTED|Extension Trial (26 Weeks)||152||
48083577|NCT01513473|100525619|FG001|STARTED|Extension Trial (26 Weeks)||128||
48083578|NCT01513473|100525618|FG000|COMPLETED|Extension Trial (26 Weeks)||151||
48083579|NCT01513473|100525619|FG001|COMPLETED|Extension Trial (26 Weeks)||122||
48083580|NCT01513473|100525618|FG000|NOT COMPLETED|Extension Trial (26 Weeks)||1||
48083581|NCT01513473|100525619|FG001|NOT COMPLETED|Extension Trial (26 Weeks)||6||
48083582|NCT05276401|100525620|FG000|STARTED|Overall Study||2||
48083583|NCT05276401|100525621|FG001|STARTED|Overall Study||1||
48083584|NCT05276401|100525622|FG002|STARTED|Overall Study||0||
48083585|NCT05276401|100525623|FG003|STARTED|Overall Study||0||
48083586|NCT05276401|100525620|FG000|COMPLETED|Overall Study||2||
48083587|NCT05276401|100525621|FG001|COMPLETED|Overall Study||1||
48083588|NCT05276401|100525622|FG002|COMPLETED|Overall Study||0||
48083589|NCT05276401|100525623|FG003|COMPLETED|Overall Study||0||
48083590|NCT05276401|100525620|FG000|NOT COMPLETED|Overall Study||0||
48083591|NCT05276401|100525621|FG001|NOT COMPLETED|Overall Study||0||
48083592|NCT05276401|100525622|FG002|NOT COMPLETED|Overall Study||0||
48083593|NCT05276401|100525623|FG003|NOT COMPLETED|Overall Study||0||
48083594|NCT04212650|100525624|FG000|STARTED|Overall Study||1||
48083595|NCT04212650|100525625|FG001|STARTED|Overall Study||0||
48083596|NCT04212650|100525624|FG000|COMPLETED|Overall Study||0||
48083597|NCT04212650|100525625|FG001|COMPLETED|Overall Study||0||
48083598|NCT04212650|100525624|FG000|NOT COMPLETED|Overall Study||1||
48083599|NCT04212650|100525625|FG001|NOT COMPLETED|Overall Study||0||
48083600|NCT04249583|100525626|FG000|STARTED|Overall Study||225||
48083601|NCT04249583|100525627|FG001|STARTED|Overall Study||75||
48083602|NCT04249583|100525626|FG000|COMPLETED|Overall Study||210||
48083603|NCT04249583|100525627|FG001|COMPLETED|Overall Study||66||
48083604|NCT04249583|100525626|FG000|NOT COMPLETED|Overall Study||15||
48083605|NCT04249583|100525627|FG001|NOT COMPLETED|Overall Study||9||
48083606|NCT03247530|100525628|FG000|STARTED|Overall Study||159|Number of subjects is based on the Safety Population (defined as subjects who were randomized and took at least one dose of study medication)|
48083607|NCT03247530|100525629|FG001|STARTED|Overall Study||154|Number of subjects is based on the Safety Population (defined as subjects who were randomized and took at least one dose of study medication)|
48083608|NCT03247530|100525630|FG002|STARTED|Overall Study||161|Number of subjects is based on the Safety Population (defined as subjects who were randomized and took at least one dose of study medication)|
48083609|NCT03247530|100525628|FG000|COMPLETED|Overall Study||132||
48083610|NCT03247530|100525629|FG001|COMPLETED|Overall Study||126||
48083611|NCT03247530|100525630|FG002|COMPLETED|Overall Study||141||
48083612|NCT03247530|100525628|FG000|NOT COMPLETED|Overall Study||27||
48083613|NCT03247530|100525629|FG001|NOT COMPLETED|Overall Study||28||
48083614|NCT03247530|100525630|FG002|NOT COMPLETED|Overall Study||20||
48083615|NCT03535844|100525631|FG000|STARTED|Overall Study||22||
48246759|NCT03512288|100924074|FG001|Vaccination 3|Overall Study||206||
48246760|NCT03512288|100924073|FG000|Vaccination 4|Overall Study||197||
48083616|NCT03535844|100525632|FG001|STARTED|Overall Study||19||
48083617|NCT03535844|100525631|FG000|COMPLETED|Overall Study||22||
48083618|NCT03535844|100525632|FG001|COMPLETED|Overall Study||18||
48083619|NCT03535844|100525631|FG000|NOT COMPLETED|Overall Study||0||
48083620|NCT03535844|100525632|FG001|NOT COMPLETED|Overall Study||1||
48083621|NCT00331682|100525633|FG000|STARTED|Overall Study||10||
48246761|NCT03512288|100924074|FG001|Vaccination 4|Overall Study||194||
48246762|NCT03512288|100924073|FG000|COMPLETED|Overall Study||191||
48246763|NCT03512288|100924074|FG001|COMPLETED|Overall Study||185||
48246764|NCT03512288|100924073|FG000|NOT COMPLETED|Overall Study||41||
48083622|NCT00331682|100525633|FG000|COMPLETED|Overall Study||9||
48083623|NCT00331682|100525633|FG000|NOT COMPLETED|Overall Study||1||
48083624|NCT05227027|100525634|FG000|STARTED|Overall Study||251||
48083625|NCT05227027|100525635|FG001|STARTED|Overall Study||249||
48083626|NCT05227027|100525634|FG000|COMPLETED|Overall Study||241||
48083627|NCT05227027|100525635|FG001|COMPLETED|Overall Study||238||
48083628|NCT05227027|100525634|FG000|NOT COMPLETED|Overall Study||10||
48083629|NCT05227027|100525635|FG001|NOT COMPLETED|Overall Study||11||
48083630|NCT02980601|100525636|FG000|STARTED|Overall Study||6||
48083631|NCT02980601|100525637|FG001|STARTED|Overall Study||4||
48083632|NCT02980601|100525636|FG000|COMPLETED|Overall Study||1||
48083633|NCT02980601|100525637|FG001|COMPLETED|Overall Study||1||
48083634|NCT02980601|100525636|FG000|NOT COMPLETED|Overall Study||5||
48083635|NCT02980601|100525637|FG001|NOT COMPLETED|Overall Study||3||
48083636|NCT01709162|100525638|FG000|STARTED|Overall Study||18||
48083637|NCT01709162|100525639|FG001|STARTED|Overall Study||5||
48083638|NCT01709162|100525638|FG000|Received Treatment|Overall Study||18||
48083639|NCT01709162|100525639|FG001|Received Treatment|Overall Study||4||
48083640|NCT01709162|100525638|FG000|Still Receiving Treatment|Overall Study||0||
48083641|NCT01709162|100525639|FG001|Still Receiving Treatment|Overall Study||0||
48083642|NCT01709162|100525638|FG000|COMPLETED|Overall Study||12||
48083643|NCT01709162|100525639|FG001|COMPLETED|Overall Study||0||
48083644|NCT01709162|100525638|FG000|NOT COMPLETED|Overall Study||6||
48083645|NCT01709162|100525639|FG001|NOT COMPLETED|Overall Study||5||
48246765|NCT03512288|100924074|FG001|NOT COMPLETED|Overall Study||43||
48246766|NCT05006703|100924075|FG000|STARTED|Overall Study||32||
48246767|NCT05006703|100924076|FG001|STARTED|Overall Study||32||
48083646|NCT03982368|100525640|FG000|STARTED|Overall Study||87||
48083647|NCT03982368|100525641|FG001|STARTED|Overall Study||86||
48083648|NCT03982368|100525642|FG002|STARTED|Overall Study||88||
48083649|NCT03982368|100525640|FG000|FAS Popuation|Overall Study||81|The FAS consisted of all patients randomized who took at least 1 dose of IMP and who had at least 1 postbaseline efficacy measurement for the primary endpoint. This analysis set was used for the primary efficacy analysis. Patients were analyzed according to the randomized treatment.|
48246768|NCT05006703|100924075|FG000|COMPLETED|Overall Study||18||
48083650|NCT03982368|100525641|FG001|FAS Popuation|Overall Study||82|The FAS consisted of all patients randomized who took at least 1 dose of IMP and who had at least 1 postbaseline efficacy measurement for the primary endpoint. This analysis set was used for the primary efficacy analysis. Patients were analyzed according to the randomized treatment.|
48083651|NCT03982368|100525642|FG002|FAS Popuation|Overall Study||84|The FAS consisted of all patients randomized who took at least 1 dose of IMP and who had at least 1 postbaseline efficacy measurement for the primary endpoint. This analysis set was used for the primary efficacy analysis. Patients were analyzed according to the randomized treatment.|
48083652|NCT03982368|100525640|FG000|PP Population|Overall Study||72|The PP set consisted of all patients in the FAS who fulfilled the study protocol requirements in terms of IMP intake and collection of primary efficacy data and had no major deviations that may have affected study results. This analysis set was used for supportive efficacy analysis.|
48083653|NCT03982368|100525641|FG001|PP Population|Overall Study||71|The PP set consisted of all patients in the FAS who fulfilled the study protocol requirements in terms of IMP intake and collection of primary efficacy data and had no major deviations that may have affected study results. This analysis set was used for supportive efficacy analysis.|
48083654|NCT03982368|100525642|FG002|PP Population|Overall Study||80|The PP set consisted of all patients in the FAS who fulfilled the study protocol requirements in terms of IMP intake and collection of primary efficacy data and had no major deviations that may have affected study results. This analysis set was used for supportive efficacy analysis.|
48083655|NCT03982368|100525640|FG000|COMPLETED|Overall Study||74||
48083656|NCT03982368|100525641|FG001|COMPLETED|Overall Study||79||
48083657|NCT03982368|100525642|FG002|COMPLETED|Overall Study||83||
48083658|NCT03982368|100525640|FG000|NOT COMPLETED|Overall Study||13||
48083659|NCT03982368|100525641|FG001|NOT COMPLETED|Overall Study||7||
48083660|NCT03982368|100525642|FG002|NOT COMPLETED|Overall Study||5||
48083661|NCT01575769|100525643|FG000|STARTED|Overall Study||41||
48083662|NCT01575769|100525643|FG000|COMPLETED|Overall Study||0||
48083663|NCT01575769|100525643|FG000|NOT COMPLETED|Overall Study||41||
48083664|NCT01462097|100525644|FG000|STARTED|Overall Study||49||
48083665|NCT01462097|100525645|FG001|STARTED|Overall Study||50||
48083666|NCT01462097|100525644|FG000|6 Month|Overall Study||35||
48083667|NCT01462097|100525645|FG001|6 Month|Overall Study||37||
48083668|NCT01462097|100525644|FG000|COMPLETED|Overall Study||30||
48083669|NCT01462097|100525645|FG001|COMPLETED|Overall Study||38||
48083670|NCT01462097|100525644|FG000|NOT COMPLETED|Overall Study||19||
48083671|NCT01462097|100525645|FG001|NOT COMPLETED|Overall Study||12||
48246769|NCT05006703|100924076|FG001|COMPLETED|Overall Study||27||
48246770|NCT05006703|100924075|FG000|NOT COMPLETED|Overall Study||14||
48246771|NCT05006703|100924076|FG001|NOT COMPLETED|Overall Study||5||
48246772|NCT01751451|100924077|FG000|STARTED|Overall Study||42||
48246773|NCT01751451|100924078|FG001|STARTED|Overall Study||40||
48246774|NCT01751451|100924079|FG002|STARTED|Overall Study||42||
48246775|NCT01751451|100924077|FG000|COMPLETED|Overall Study||42||
48246776|NCT01751451|100924078|FG001|COMPLETED|Overall Study||40||
48246777|NCT01751451|100924079|FG002|COMPLETED|Overall Study||42||
48246778|NCT01751451|100924077|FG000|NOT COMPLETED|Overall Study||0||
48246779|NCT01751451|100924078|FG001|NOT COMPLETED|Overall Study||0||
48246780|NCT01751451|100924079|FG002|NOT COMPLETED|Overall Study||0||
48246781|NCT01329419|100924080|FG000|STARTED|Overall Study||4393||
48246782|NCT01329419|100924080|FG000|COMPLETED|Overall Study||4158||
48246783|NCT01329419|100924080|FG000|NOT COMPLETED|Overall Study||235||
48246784|NCT02794441|100924081|FG000|STARTED|Overall Study||7||
48246785|NCT02794441|100924082|FG001|STARTED|Overall Study||5||
48246786|NCT02794441|100924081|FG000|COMPLETED|Overall Study||6||
48246787|NCT02794441|100924082|FG001|COMPLETED|Overall Study||5||
48246788|NCT02794441|100924081|FG000|NOT COMPLETED|Overall Study||1||
48246789|NCT02794441|100924082|FG001|NOT COMPLETED|Overall Study||0||
48246790|NCT01514864|100924083|FG000|STARTED|Overall Study||9||
48246791|NCT01514864|100924084|FG001|STARTED|Overall Study||5||
48246792|NCT01514864|100924083|FG000|COMPLETED|Overall Study||0||
48246793|NCT01514864|100924084|FG001|COMPLETED|Overall Study||0||
48246794|NCT01514864|100924083|FG000|NOT COMPLETED|Overall Study||9||
48246795|NCT01514864|100924084|FG001|NOT COMPLETED|Overall Study||5||
48246796|NCT01072396|100924085|FG000|STARTED|Period One||63||
48246797|NCT01072396|100924086|FG001|STARTED|Period One||63||
48246798|NCT01072396|100924085|FG000|COMPLETED|Period One||58||
48246799|NCT01072396|100924086|FG001|COMPLETED|Period One||61||
48246800|NCT01072396|100924085|FG000|NOT COMPLETED|Period One||5||
48246801|NCT01072396|100924086|FG001|NOT COMPLETED|Period One||2||
48246802|NCT01072396|100924085|FG000|STARTED|Washout Period||58||
48682407|NCT02521974|102006594|FG000|COMPLETED|Overall Study||47||
48682408|NCT02521974|102006595|FG001|COMPLETED|Overall Study||110||
48682409|NCT02521974|102006594|FG000|NOT COMPLETED|Overall Study||3||
48682410|NCT02521974|102006595|FG001|NOT COMPLETED|Overall Study||4||
48682411|NCT01595529|102006596|FG000|STARTED|Overall Study||348|Randomized.|
48246803|NCT01072396|100924086|FG001|STARTED|Washout Period||61||
48246804|NCT01072396|100924085|FG000|COMPLETED|Washout Period||58||
48246805|NCT01072396|100924086|FG001|COMPLETED|Washout Period||60||
48682412|NCT01595529|102006597|FG001|STARTED|Overall Study||345|Randomized.|
48682413|NCT01595529|102006596|FG000|Treated|Overall Study||337||
48682414|NCT01595529|102006597|FG001|Treated|Overall Study||340||
48682415|NCT01595529|102006596|FG000|Evaluated for Primary Endpoint, ITT|Overall Study||328|Participants taking at least one dose of treatment from Day 6-10, evaluated at or failed before TOC.|
48682416|NCT01595529|102006597|FG001|Evaluated for Primary Endpoint, ITT|Overall Study||336|Participants taking at least one dose of treatment from Day 6-10, evaluated at or failed before TOC.|
48682417|NCT01595529|102006596|FG000|ITT Without Treatment Failure|Overall Study||326|This group was used to evaluate recurrent infection.|
48682418|NCT01595529|102006597|FG001|ITT Without Treatment Failure|Overall Study||322|This group was used to evaluate recurrent infection.|
48682419|NCT01595529|102006596|FG000|ITT With Stool Sample at TOC|Overall Study||298|This group was used to evaluate colonization with antibiotic-resistant E. coli and K. pneumoniae.|
48682420|NCT01595529|102006597|FG001|ITT With Stool Sample at TOC|Overall Study||310|This group was used to evaluate colonization with antibiotic-resistant E. coli and K. pneumoniae.|
48682421|NCT01595529|102006596|FG000|Per-protocol, Completed 80% of Dose|Overall Study||308|Participants who completed more than 80% of the prescribed dose between Day 6 and Day 10.|
48682422|NCT01595529|102006597|FG001|Per-protocol, Completed 80% of Dose|Overall Study||314|Participants who completed more than 80% of the prescribed dose between Day 6 and Day 10.|
48682423|NCT01595529|102006596|FG000|Per-protocol Without Treatment Failure|Overall Study||306|This group was used to evaluate recurrent infection.|
48682424|NCT01595529|102006597|FG001|Per-protocol Without Treatment Failure|Overall Study||305|This group was used to evaluate recurrent infection.|
48682425|NCT01595529|102006596|FG000|Per-protocol With Stool Sample at TOC|Overall Study||280|This group was used to evaluate colonization with antibiotic-resistant E. coli and K. pneumoniae.|
48682426|NCT01595529|102006597|FG001|Per-protocol With Stool Sample at TOC|Overall Study||289|This group was used to evaluate colonization with antibiotic-resistant E. coli and K. pneumoniae.|
48682427|NCT01595529|102006596|FG000|Completed All Milestones|Overall Study||318||
48682428|NCT01595529|102006597|FG001|Completed All Milestones|Overall Study||318||
48682429|NCT01595529|102006596|FG000|COMPLETED|Overall Study||324|A subject could have completed the study without completing all appointments.|
48682430|NCT01595529|102006597|FG001|COMPLETED|Overall Study||325|A subject could have completed the study without completing all appointments.|
48682431|NCT01595529|102006596|FG000|NOT COMPLETED|Overall Study||24||
48682432|NCT01595529|102006597|FG001|NOT COMPLETED|Overall Study||20||
48682433|NCT01247064|102006598|FG000|STARTED|Overall Study||31||
48682434|NCT01247064|102006599|FG001|STARTED|Overall Study||31||
48682435|NCT01247064|102006598|FG000|COMPLETED|Overall Study||31||
48682436|NCT01247064|102006599|FG001|COMPLETED|Overall Study||31||
48682437|NCT01247064|102006598|FG000|NOT COMPLETED|Overall Study||0||
48682438|NCT01247064|102006599|FG001|NOT COMPLETED|Overall Study||0||
48682439|NCT03323853|102006600|FG000|STARTED|Overall Study||213||
48682440|NCT03323853|102006601|FG001|STARTED|Overall Study||238||
48682441|NCT03323853|102006600|FG000|COMPLETED|Overall Study||213||
48682442|NCT03323853|102006601|FG001|COMPLETED|Overall Study||238||
48682443|NCT03323853|102006600|FG000|NOT COMPLETED|Overall Study||0||
48682444|NCT03323853|102006601|FG001|NOT COMPLETED|Overall Study||0||
48682445|NCT01937520|102006602|FG000|STARTED|Overall Study||11||
48083672|NCT02155608|100525646|FG000|STARTED|1a: 4 Week Double Blind Sham Controlled||32||
48083673|NCT02155608|100525647|FG001|STARTED|1a: 4 Week Double Blind Sham Controlled||30||
48083674|NCT02155608|100525646|FG000|COMPLETED|1a: 4 Week Double Blind Sham Controlled||32||
48083675|NCT02155608|100525647|FG001|COMPLETED|1a: 4 Week Double Blind Sham Controlled||29||
48083676|NCT02155608|100525646|FG000|NOT COMPLETED|1a: 4 Week Double Blind Sham Controlled||0||
48083677|NCT02155608|100525647|FG001|NOT COMPLETED|1a: 4 Week Double Blind Sham Controlled||1||
48083678|NCT02155608|100525646|FG000|STARTED|1b: 1 Week Blinded Post Treatment||32||
48083679|NCT02155608|100525647|FG001|STARTED|1b: 1 Week Blinded Post Treatment||29||
48083680|NCT02155608|100525646|FG000|COMPLETED|1b: 1 Week Blinded Post Treatment||31||
48083681|NCT02155608|100525647|FG001|COMPLETED|1b: 1 Week Blinded Post Treatment||28||
48083682|NCT02155608|100525646|FG000|NOT COMPLETED|1b: 1 Week Blinded Post Treatment||1||
48083683|NCT02155608|100525647|FG001|NOT COMPLETED|1b: 1 Week Blinded Post Treatment||1||
48083684|NCT04026308|100525648|FG000|STARTED|Overall Study||14||
48083685|NCT04026308|100525649|FG001|STARTED|Overall Study||16||
48083686|NCT04026308|100525648|FG000|COMPLETED|Overall Study||14||
48083687|NCT04026308|100525649|FG001|COMPLETED|Overall Study||16||
48083688|NCT04026308|100525648|FG000|NOT COMPLETED|Overall Study||0||
48083689|NCT04026308|100525649|FG001|NOT COMPLETED|Overall Study||0||
48083690|NCT02647203|100525650|FG000|STARTED|12 Month Follow-up||173||
48083691|NCT02647203|100525651|FG001|STARTED|12 Month Follow-up||172||
48083692|NCT02647203|100525650|FG000|COMPLETED|12 Month Follow-up||148||
48083693|NCT02647203|100525651|FG001|COMPLETED|12 Month Follow-up||149||
48083694|NCT02647203|100525650|FG000|NOT COMPLETED|12 Month Follow-up||25||
48083695|NCT02647203|100525651|FG001|NOT COMPLETED|12 Month Follow-up||23||
48246806|NCT01072396|100924085|FG000|NOT COMPLETED|Washout Period||0||
48246807|NCT01072396|100924086|FG001|NOT COMPLETED|Washout Period||1||
48246808|NCT01072396|100924085|FG000|STARTED|Period Two||58||
48246809|NCT01072396|100924086|FG001|STARTED|Period Two||60||
48246810|NCT01072396|100924085|FG000|COMPLETED|Period Two||57||
48246811|NCT01072396|100924086|FG001|COMPLETED|Period Two||57||
48246812|NCT01072396|100924085|FG000|NOT COMPLETED|Period Two||1||
48246813|NCT01072396|100924086|FG001|NOT COMPLETED|Period Two||3||
48246814|NCT04620733|100924087|FG000|STARTED|Overall Study||65||
48246815|NCT04620733|100924088|FG001|STARTED|Overall Study||128||
48246816|NCT04620733|100924087|FG000|COMPLETED|Overall Study||57||
48246817|NCT04620733|100924088|FG001|COMPLETED|Overall Study||117||
48246818|NCT04620733|100924087|FG000|NOT COMPLETED|Overall Study||8||
48246819|NCT04620733|100924088|FG001|NOT COMPLETED|Overall Study||11||
48246820|NCT00312845|100924089|FG000|STARTED|Overall Study||336||
48246821|NCT00312845|100924090|FG001|STARTED|Overall Study||340||
48083696|NCT02647203|100525650|FG000|STARTED|24 Month Follow-up||148||
48083697|NCT02647203|100525651|FG001|STARTED|24 Month Follow-up||149||
48083698|NCT02647203|100525650|FG000|COMPLETED|24 Month Follow-up||142||
48083699|NCT02647203|100525651|FG001|COMPLETED|24 Month Follow-up||138||
48083700|NCT02647203|100525650|FG000|NOT COMPLETED|24 Month Follow-up||6||
48083701|NCT02647203|100525651|FG001|NOT COMPLETED|24 Month Follow-up||11||
48083702|NCT03672747|100525652|FG000|STARTED|Overall Study||22||
48083703|NCT03672747|100525653|FG001|STARTED|Overall Study||22||
48246822|NCT00312845|100924089|FG000|COMPLETED|Overall Study||237||
48246823|NCT00312845|100924090|FG001|COMPLETED|Overall Study||245||
48246824|NCT00312845|100924089|FG000|NOT COMPLETED|Overall Study||99||
48246825|NCT00312845|100924090|FG001|NOT COMPLETED|Overall Study||95||
48246826|NCT04748445|100924091|FG000|STARTED|Overall Study||9151||
48246827|NCT04748445|100924091|FG000|COMPLETED|Overall Study||8520||
48246828|NCT04748445|100924091|FG000|NOT COMPLETED|Overall Study||631||
48246829|NCT01093690|100924092|FG000|STARTED|Overall Study||83||
48246830|NCT01093690|100924093|FG001|STARTED|Overall Study||79||
48083704|NCT03672747|100525654|FG002|STARTED|Overall Study||22||
48083705|NCT03672747|100525655|FG003|STARTED|Overall Study||23||
48083706|NCT03672747|100525656|FG004|STARTED|Overall Study||22||
48083707|NCT03672747|100525657|FG005|STARTED|Overall Study||22||
48083708|NCT03672747|100525652|FG000|COMPLETED|Overall Study||21||
48083709|NCT03672747|100525653|FG001|COMPLETED|Overall Study||21||
48083710|NCT03672747|100525654|FG002|COMPLETED|Overall Study||20||
48083711|NCT03672747|100525655|FG003|COMPLETED|Overall Study||21||
48083712|NCT03672747|100525656|FG004|COMPLETED|Overall Study||20||
48083713|NCT03672747|100525657|FG005|COMPLETED|Overall Study||21||
48083714|NCT03672747|100525652|FG000|NOT COMPLETED|Overall Study||1||
48083715|NCT03672747|100525653|FG001|NOT COMPLETED|Overall Study||1||
48246831|NCT01093690|100924092|FG000|COMPLETED|Overall Study||83||
48083716|NCT03672747|100525654|FG002|NOT COMPLETED|Overall Study||2||
48083717|NCT03672747|100525655|FG003|NOT COMPLETED|Overall Study||2||
48083718|NCT03672747|100525656|FG004|NOT COMPLETED|Overall Study||2||
48083719|NCT03672747|100525657|FG005|NOT COMPLETED|Overall Study||1||
48083720|NCT00646776|100525658|FG000|STARTED|Overall Study||15||
48083721|NCT00646776|100525659|FG001|STARTED|Overall Study||18||
48083722|NCT00646776|100525658|FG000|COMPLETED|Overall Study||14||
48246832|NCT01093690|100924093|FG001|COMPLETED|Overall Study||79||
48246833|NCT01093690|100924092|FG000|NOT COMPLETED|Overall Study||0||
48246834|NCT01093690|100924093|FG001|NOT COMPLETED|Overall Study||0||
48246835|NCT03579680|100924094|FG000|STARTED|Overall Study||46||3
48246836|NCT03579680|100924095|FG001|STARTED|Overall Study||14||1
48540778|NCT03287843|101662566|FG000|Excluded|Overall Study||12||
48246837|NCT03579680|100924094|FG000|COMPLETED|Overall Study||46|One center was not able to fully operationalize the electronic health record (CPRS) intervention due to informatics, regulatory, and workforce delays.|2
48246838|NCT03579680|100924095|FG001|COMPLETED|Overall Study||14|One center was not able to fully operationalize the electronic health record (CPRS) intervention due to informatics, regulatory, and workforce delays.|1
48246839|NCT03579680|100924094|FG000|NOT COMPLETED|Overall Study||0||1
48246840|NCT03579680|100924095|FG001|NOT COMPLETED|Overall Study||0||0
48246841|NCT01012999|100924096|FG000|STARTED|Overall Study||16||
48246842|NCT01012999|100924096|FG000|COMPLETED|Overall Study||15||
48246843|NCT01012999|100924096|FG000|NOT COMPLETED|Overall Study||1||
48246844|NCT04896502|100924097|FG000|STARTED|Overall Study||13||
48246845|NCT04896502|100924098|FG001|STARTED|Overall Study||14||
48246846|NCT04896502|100924097|FG000|COMPLETED|Overall Study||3||
48246847|NCT04896502|100924098|FG001|COMPLETED|Overall Study||4||
48246848|NCT04896502|100924097|FG000|NOT COMPLETED|Overall Study||10||
48246849|NCT04896502|100924098|FG001|NOT COMPLETED|Overall Study||10||
48246850|NCT00265096|100924099|FG000|STARTED|Overall Study||113||
48246851|NCT00265096|100924100|FG001|STARTED|Overall Study||146||
48246852|NCT00265096|100924101|FG002|STARTED|Overall Study||146||
48246853|NCT00265096|100924099|FG000|COMPLETED|Overall Study||77||
48246854|NCT00265096|100924100|FG001|COMPLETED|Overall Study||95||
48246855|NCT00265096|100924101|FG002|COMPLETED|Overall Study||107||
48246856|NCT00265096|100924099|FG000|NOT COMPLETED|Overall Study||36||
48246857|NCT00265096|100924100|FG001|NOT COMPLETED|Overall Study||51||
48246858|NCT00265096|100924101|FG002|NOT COMPLETED|Overall Study||39||
48246859|NCT03777553|100924102|FG000|STARTED|Overall Study||9||
48246860|NCT03777553|100924102|FG000|COMPLETED|Overall Study||5||
48246861|NCT03777553|100924102|FG000|NOT COMPLETED|Overall Study||4||
48246862|NCT04990973|100924103|FG000|STARTED|First Intervention (4 Weeks)||2||
48246863|NCT04990973|100924104|FG001|STARTED|First Intervention (4 Weeks)||2||
48246864|NCT04990973|100924103|FG000|COMPLETED|First Intervention (4 Weeks)||2||
48246865|NCT04990973|100924104|FG001|COMPLETED|First Intervention (4 Weeks)||2||
48246866|NCT04990973|100924103|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0||
48246867|NCT04990973|100924104|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0||
48246868|NCT04990973|100924103|FG000|STARTED|Washout (4 Weeks)||2||
48246869|NCT04990973|100924104|FG001|STARTED|Washout (4 Weeks)||2||
48246870|NCT04990973|100924103|FG000|COMPLETED|Washout (4 Weeks)||2||
48246871|NCT04990973|100924104|FG001|COMPLETED|Washout (4 Weeks)||2||
48246872|NCT04990973|100924103|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
48246873|NCT04990973|100924104|FG001|NOT COMPLETED|Washout (4 Weeks)||0||
48246874|NCT04990973|100924103|FG000|STARTED|Second Intervention (4 Weeks)||2||
48246875|NCT04990973|100924104|FG001|STARTED|Second Intervention (4 Weeks)||2||
48246876|NCT04990973|100924103|FG000|COMPLETED|Second Intervention (4 Weeks)||2||
48246877|NCT04990973|100924104|FG001|COMPLETED|Second Intervention (4 Weeks)||2||
48246878|NCT04990973|100924103|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0||
48246879|NCT04990973|100924104|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0||
48246880|NCT01234675|100924105|FG000|STARTED|First Intervention (6 Weeks)||10||
48246881|NCT01234675|100924106|FG001|STARTED|First Intervention (6 Weeks)||9||
48246882|NCT01234675|100924105|FG000|COMPLETED|First Intervention (6 Weeks)||9||
48083723|NCT00646776|100525659|FG001|COMPLETED|Overall Study||5||
48083724|NCT00646776|100525658|FG000|NOT COMPLETED|Overall Study||1||
48083725|NCT00646776|100525659|FG001|NOT COMPLETED|Overall Study||13||
48083726|NCT03667924|100525660|FG000|STARTED|Baseline Completed||7||
48083727|NCT03667924|100525661|FG001|STARTED|Baseline Completed||33||
48083728|NCT03667924|100525662|FG002|STARTED|Baseline Completed||4||
48083729|NCT03667924|100525660|FG000|COMPLETED|Baseline Completed||7||
48083730|NCT03667924|100525661|FG001|COMPLETED|Baseline Completed||31||
48083731|NCT03667924|100525662|FG002|COMPLETED|Baseline Completed||4||
48083732|NCT03667924|100525660|FG000|NOT COMPLETED|Baseline Completed||0||
48083733|NCT03667924|100525661|FG001|NOT COMPLETED|Baseline Completed||2||
48083734|NCT03667924|100525662|FG002|NOT COMPLETED|Baseline Completed||0||
48083735|NCT03667924|100525660|FG000|STARTED|1-month Completed/Training (Volunteers)||7||
48083736|NCT03667924|100525661|FG001|STARTED|1-month Completed/Training (Volunteers)||31||
48083737|NCT03667924|100525662|FG002|STARTED|1-month Completed/Training (Volunteers)||4||
48083738|NCT03667924|100525660|FG000|COMPLETED|1-month Completed/Training (Volunteers)||6|"Please note: volunteers did not complete 1-month surveys as did clients and caregivers; instead, the numbers entered here reflect the milestone training completed"|
48083739|NCT03667924|100525661|FG001|COMPLETED|1-month Completed/Training (Volunteers)||15|"Please note: volunteers did not complete 1-month surveys as did clients and caregivers; instead, the numbers entered here reflect the milestone training completed"|
48083740|NCT03667924|100525662|FG002|COMPLETED|1-month Completed/Training (Volunteers)||3|"Please note: volunteers did not complete 1-month surveys as did clients and caregivers; instead, the numbers entered here reflect the milestone training completed"|
48083741|NCT03667924|100525660|FG000|NOT COMPLETED|1-month Completed/Training (Volunteers)||1||
48083742|NCT03667924|100525661|FG001|NOT COMPLETED|1-month Completed/Training (Volunteers)||16||
48083743|NCT03667924|100525662|FG002|NOT COMPLETED|1-month Completed/Training (Volunteers)||1||
48083744|NCT03667924|100525660|FG000|STARTED|3-month/Volunteers Who Enrolled Clients||6||
48083745|NCT03667924|100525661|FG001|STARTED|3-month/Volunteers Who Enrolled Clients||15||
48083746|NCT03667924|100525662|FG002|STARTED|3-month/Volunteers Who Enrolled Clients||3||
48083747|NCT03667924|100525660|FG000|COMPLETED|3-month/Volunteers Who Enrolled Clients||5||
48246883|NCT01234675|100924106|FG001|COMPLETED|First Intervention (6 Weeks)||8||
48246884|NCT01234675|100924105|FG000|NOT COMPLETED|First Intervention (6 Weeks)||1||
48246885|NCT01234675|100924106|FG001|NOT COMPLETED|First Intervention (6 Weeks)||1||
48246886|NCT01234675|100924105|FG000|STARTED|Second Intervention (6 Weeks)||9||
48246887|NCT01234675|100924106|FG001|STARTED|Second Intervention (6 Weeks)||8||
48246888|NCT01234675|100924105|FG000|COMPLETED|Second Intervention (6 Weeks)||7||
48246889|NCT01234675|100924106|FG001|COMPLETED|Second Intervention (6 Weeks)||8||
48246890|NCT01234675|100924105|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||2||
48246891|NCT01234675|100924106|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0||
48246892|NCT04054193|100924107|FG000|STARTED|Cycle 1||103||
48246893|NCT04054193|100924107|FG000|Treated (≥1 Dose)|Cycle 1||100||
48246894|NCT04054193|100924107|FG000|COMPLETED|Cycle 1||98||
48246895|NCT04054193|100924107|FG000|NOT COMPLETED|Cycle 1||5||
48246896|NCT04054193|100924107|FG000|STARTED|Cycles 2-3||69||
48246897|NCT04054193|100924107|FG000|COMPLETED|Cycles 2-3||48|Completed Cycles 2 and 3|
48246898|NCT04054193|100924107|FG000|NOT COMPLETED|Cycles 2-3||21||
48246899|NCT00574171|100924108|FG000|STARTED|Overall Study||29||
48246900|NCT00574171|100924108|FG000|COMPLETED|Overall Study||29||
48246901|NCT00574171|100924108|FG000|NOT COMPLETED|Overall Study||0||
48246902|NCT03897049|100924109|FG000|STARTED|Overall Study||275||
48246903|NCT03897049|100924110|FG001|STARTED|Overall Study||299||
48246904|NCT03897049|100924109|FG000|Completed 1st Follow-up|Overall Study||182||
48246905|NCT03897049|100924110|FG001|Completed 1st Follow-up|Overall Study||205||
48246906|NCT03897049|100924109|FG000|Completed 2nd Follow-up|Overall Study||173||
48246907|NCT03897049|100924110|FG001|Completed 2nd Follow-up|Overall Study||191||
48246908|NCT03897049|100924109|FG000|COMPLETED|Overall Study||177|Participants are marked as completed if they completed the third follow-up|
48246909|NCT03897049|100924110|FG001|COMPLETED|Overall Study||199|Participants are marked as completed if they completed the third follow-up|
48246910|NCT03897049|100924109|FG000|NOT COMPLETED|Overall Study||98||
48246911|NCT03897049|100924110|FG001|NOT COMPLETED|Overall Study||100||
48246912|NCT02617667|100924111|FG000|STARTED|Overall Study||51||
48246913|NCT02617667|100924112|FG001|STARTED|Overall Study||51||
48246914|NCT02617667|100924113|FG002|STARTED|Overall Study||52||
48246915|NCT02617667|100924114|FG003|STARTED|Overall Study||53||
48246916|NCT02617667|100924111|FG000|COMPLETED|Overall Study||50||
48246917|NCT02617667|100924112|FG001|COMPLETED|Overall Study||50||
48246918|NCT02617667|100924113|FG002|COMPLETED|Overall Study||48||
48246919|NCT02617667|100924114|FG003|COMPLETED|Overall Study||52||
48246920|NCT02617667|100924111|FG000|NOT COMPLETED|Overall Study||1||
48246921|NCT02617667|100924112|FG001|NOT COMPLETED|Overall Study||1||
48246922|NCT02617667|100924113|FG002|NOT COMPLETED|Overall Study||4||
48246923|NCT02617667|100924114|FG003|NOT COMPLETED|Overall Study||1||
48246924|NCT03039088|100924115|FG000|STARTED|Overall Study||192||
48246925|NCT03039088|100924116|FG001|STARTED|Overall Study||316||
48246926|NCT03039088|100924115|FG000|COMPLETED|Overall Study||192||
48246927|NCT03039088|100924116|FG001|COMPLETED|Overall Study||316||
48246928|NCT03039088|100924115|FG000|NOT COMPLETED|Overall Study||0||
48246929|NCT03039088|100924116|FG001|NOT COMPLETED|Overall Study||0||
48246930|NCT02876302|100924117|FG000|STARTED|Run-In Treatment Phase||11||
48246931|NCT02876302|100924118|FG001|STARTED|Run-In Treatment Phase||12||
48246932|NCT02876302|100924117|FG000|COMPLETED|Run-In Treatment Phase||11||
48246933|NCT02876302|100924118|FG001|COMPLETED|Run-In Treatment Phase||12||
48246934|NCT02876302|100924117|FG000|NOT COMPLETED|Run-In Treatment Phase||0||
48246935|NCT02876302|100924118|FG001|NOT COMPLETED|Run-In Treatment Phase||0||
48246936|NCT02876302|100924117|FG000|STARTED|Neoadjuvant Treatment Phase||11||
48246937|NCT02876302|100924118|FG001|STARTED|Neoadjuvant Treatment Phase||12||
48246938|NCT02876302|100924117|FG000|Treated With Neoadjuvant Paclitaxel Only|Neoadjuvant Treatment Phase||6||
48246939|NCT02876302|100924118|FG001|Treated With Neoadjuvant Paclitaxel Only|Neoadjuvant Treatment Phase||0||
48246940|NCT02876302|100924117|FG000|Treated With Neoadjuvant Ruxolitinib and Paclitaxel|Neoadjuvant Treatment Phase||5||
48246941|NCT02876302|100924118|FG001|Treated With Neoadjuvant Ruxolitinib and Paclitaxel|Neoadjuvant Treatment Phase||12||
48246942|NCT02876302|100924117|FG000|COMPLETED|Neoadjuvant Treatment Phase||11||
48246943|NCT02876302|100924118|FG001|COMPLETED|Neoadjuvant Treatment Phase||12||
48246944|NCT02876302|100924117|FG000|NOT COMPLETED|Neoadjuvant Treatment Phase||0||
48246945|NCT02876302|100924118|FG001|NOT COMPLETED|Neoadjuvant Treatment Phase||0||
48246946|NCT04318587|100924119|FG000|STARTED|Overall Study||40||
48246947|NCT04318587|100924119|FG000|COMPLETED|Overall Study||40||
48246948|NCT04318587|100924119|FG000|NOT COMPLETED|Overall Study||0||
48246949|NCT02754310|100924120|FG000|STARTED|Overall Study||42||
48246950|NCT02754310|100924121|FG001|STARTED|Overall Study||43||
48246951|NCT02754310|100924120|FG000|COMPLETED|Overall Study||42||
48246952|NCT02754310|100924121|FG001|COMPLETED|Overall Study||43||
48246953|NCT02754310|100924120|FG000|NOT COMPLETED|Overall Study||0||
48246954|NCT02754310|100924121|FG001|NOT COMPLETED|Overall Study||0||
48246955|NCT02273180|100924122|FG000|STARTED|Overall Study||253||
48246956|NCT02273180|100924123|FG001|STARTED|Overall Study||254||
48246957|NCT02273180|100924122|FG000|Treated|Overall Study||252||
48246958|NCT02273180|100924123|FG001|Treated|Overall Study||254||
48246959|NCT02273180|100924122|FG000|COMPLETED|Overall Study||226||
48246960|NCT02273180|100924123|FG001|COMPLETED|Overall Study||235||
48246961|NCT02273180|100924122|FG000|NOT COMPLETED|Overall Study||27||
48246962|NCT02273180|100924123|FG001|NOT COMPLETED|Overall Study||19||
48246963|NCT05244226|100924124|FG000|STARTED|Overall Study||21||
48246964|NCT05244226|100924125|FG001|STARTED|Overall Study||22||
48246965|NCT05244226|100924126|FG002|STARTED|Overall Study||23||
48246966|NCT05244226|100924124|FG000|COMPLETED|Overall Study||20||
48246967|NCT05244226|100924125|FG001|COMPLETED|Overall Study||20||
48246968|NCT05244226|100924126|FG002|COMPLETED|Overall Study||20||
48246969|NCT05244226|100924124|FG000|NOT COMPLETED|Overall Study||1||
48246970|NCT05244226|100924125|FG001|NOT COMPLETED|Overall Study||2||
48246971|NCT05244226|100924126|FG002|NOT COMPLETED|Overall Study||3||
48246972|NCT02093897|100924127|FG000|STARTED|Overall Study||84|A total of 5313 CSL627 infusions were administered to 84 subjects during the study.|
48246973|NCT02093897|100924127|FG000|COMPLETED|Overall Study||65|As planned, groups were closed and subjects discontinued when 25 subjects reached 50 EDs per group.|
48246974|NCT02093897|100924127|FG000|NOT COMPLETED|Overall Study||19||
48246975|NCT01694199|100924128|FG000|STARTED|Overall Study||71||
48246976|NCT01694199|100924129|FG001|STARTED|Overall Study||68||
48246977|NCT01694199|100924128|FG000|COMPLETED|Overall Study||71||
48246978|NCT01694199|100924129|FG001|COMPLETED|Overall Study||68||
48246979|NCT01694199|100924128|FG000|NOT COMPLETED|Overall Study||0||
48246980|NCT01694199|100924129|FG001|NOT COMPLETED|Overall Study||0||
48246981|NCT01838447|100924130|FG000|STARTED|Overall Study||22||
48246982|NCT01838447|100924131|FG001|STARTED|Overall Study||24||
48246983|NCT01838447|100924130|FG000|COMPLETED|Overall Study||20||
48246984|NCT01838447|100924131|FG001|COMPLETED|Overall Study||21||
48246985|NCT01838447|100924130|FG000|NOT COMPLETED|Overall Study||2||
48246986|NCT01838447|100924131|FG001|NOT COMPLETED|Overall Study||3||
48246987|NCT02025985|100924132|FG000|STARTED|Overall Study||25||
48246988|NCT02025985|100924133|FG001|STARTED|Overall Study||23||
48246989|NCT02025985|100924134|FG002|STARTED|Overall Study||25||
48246990|NCT02025985|100924135|FG003|STARTED|Overall Study||21||
48246991|NCT02025985|100924136|FG004|STARTED|Overall Study||20||
48682446|NCT01937520|102006603|FG001|STARTED|Overall Study||9||
48246992|NCT02025985|100924132|FG000|Modified Intent-to-treat(mITT)Population|Overall Study||23||
48246993|NCT02025985|100924133|FG001|Modified Intent-to-treat(mITT)Population|Overall Study||22||
48246994|NCT02025985|100924134|FG002|Modified Intent-to-treat(mITT)Population|Overall Study||25||
48246995|NCT02025985|100924135|FG003|Modified Intent-to-treat(mITT)Population|Overall Study||21||
48246996|NCT02025985|100924136|FG004|Modified Intent-to-treat(mITT)Population|Overall Study||20||
48246997|NCT02025985|100924132|FG000|COMPLETED|Overall Study||0||
48246998|NCT02025985|100924133|FG001|COMPLETED|Overall Study||0||
48246999|NCT02025985|100924134|FG002|COMPLETED|Overall Study||0||
48247000|NCT02025985|100924135|FG003|COMPLETED|Overall Study||0||
48247001|NCT02025985|100924136|FG004|COMPLETED|Overall Study||0||
48247002|NCT02025985|100924132|FG000|NOT COMPLETED|Overall Study||25||
48247003|NCT02025985|100924133|FG001|NOT COMPLETED|Overall Study||23||
48247004|NCT02025985|100924134|FG002|NOT COMPLETED|Overall Study||25||
48247005|NCT02025985|100924135|FG003|NOT COMPLETED|Overall Study||21||
48247006|NCT02025985|100924136|FG004|NOT COMPLETED|Overall Study||20||
48247007|NCT01286870|100924137|FG000|STARTED|Overall Study||11|September 22, 2008|
48247008|NCT01286870|100924137|FG000|COMPLETED|Overall Study||11|February 28, 2014|
48247009|NCT01286870|100924137|FG000|NOT COMPLETED|Overall Study||0||
48247010|NCT00489489|100924138|FG000|STARTED|Overall Study||41||
48247011|NCT00489489|100924139|FG001|STARTED|Overall Study||37||
48247012|NCT00489489|100924140|FG002|STARTED|Overall Study||40||
48247013|NCT00489489|100924138|FG000|Treated|Overall Study||41||
48247014|NCT00489489|100924139|FG001|Treated|Overall Study||36||
48247015|NCT00489489|100924140|FG002|Treated|Overall Study||39||
48247016|NCT00489489|100924138|FG000|COMPLETED|Overall Study||38||
48247017|NCT00489489|100924139|FG001|COMPLETED|Overall Study||32||
48247018|NCT00489489|100924140|FG002|COMPLETED|Overall Study||37||
48247019|NCT00489489|100924138|FG000|NOT COMPLETED|Overall Study||3||
48247020|NCT00489489|100924139|FG001|NOT COMPLETED|Overall Study||5||
48247021|NCT00489489|100924140|FG002|NOT COMPLETED|Overall Study||3||
48247022|NCT03195127|100924141|FG000|STARTED|Overall Study||15||
48247023|NCT03195127|100924142|FG001|STARTED|Overall Study||18||
48247024|NCT03195127|100924141|FG000|COMPLETED|Overall Study||15||
48247025|NCT03195127|100924142|FG001|COMPLETED|Overall Study||17||
48247026|NCT03195127|100924141|FG000|NOT COMPLETED|Overall Study||0||
48247027|NCT03195127|100924142|FG001|NOT COMPLETED|Overall Study||1||
48247028|NCT00990821|100924143|FG000|STARTED|Overall Study||14||
48247029|NCT00990821|100924144|FG001|STARTED|Overall Study||16||
48247030|NCT00990821|100924145|FG002|STARTED|Overall Study||14||
48247031|NCT00990821|100924146|FG003|STARTED|Overall Study||8||
48682447|NCT01937520|102006602|FG000|COMPLETED|Overall Study||11||
48247032|NCT00990821|100924147|FG004|STARTED|Overall Study||17||
48247033|NCT00990821|100924148|FG005|STARTED|Overall Study||17||
48247034|NCT00990821|100924149|FG006|STARTED|Overall Study||12||
48247035|NCT00990821|100924150|FG007|STARTED|Overall Study||14||
48247036|NCT00990821|100924151|FG008|STARTED|Overall Study||12||
48247037|NCT00990821|100924152|FG009|STARTED|Overall Study||14||
48247038|NCT00990821|100924153|FG010|STARTED|Overall Study||12||
48247039|NCT00990821|100924154|FG011|STARTED|Overall Study||14||
48682448|NCT01937520|102006603|FG001|COMPLETED|Overall Study||9||
48682449|NCT01937520|102006602|FG000|NOT COMPLETED|Overall Study||0||
48682450|NCT01937520|102006603|FG001|NOT COMPLETED|Overall Study||0||
48083748|NCT03667924|100525661|FG001|COMPLETED|3-month/Volunteers Who Enrolled Clients||5||
48083749|NCT03667924|100525662|FG002|COMPLETED|3-month/Volunteers Who Enrolled Clients||3||
48247040|NCT00990821|100924155|FG012|STARTED|Overall Study||12||
48247041|NCT00990821|100924156|FG013|STARTED|Overall Study||12||
48247042|NCT00990821|100924143|FG000|COMPLETED|Overall Study||14||
48247043|NCT00990821|100924144|FG001|COMPLETED|Overall Study||14||
48682451|NCT04500457|102006604|FG000|STARTED|Overall Study||39||
48682452|NCT04500457|102006605|FG001|STARTED|Overall Study||37||
48682453|NCT04500457|102006604|FG000|COMPLETED|Overall Study||36||
48682454|NCT04500457|102006605|FG001|COMPLETED|Overall Study||35||
48682455|NCT04500457|102006604|FG000|NOT COMPLETED|Overall Study||3||
48083750|NCT03667924|100525660|FG000|NOT COMPLETED|3-month/Volunteers Who Enrolled Clients||1||
48682456|NCT04500457|102006605|FG001|NOT COMPLETED|Overall Study||2||
48682457|NCT03661840|102006606|FG000|STARTED|Overall Study||28||
48682458|NCT03661840|102006607|FG001|STARTED|Overall Study||22||
48247044|NCT00990821|100924145|FG002|COMPLETED|Overall Study||14||
48247045|NCT00990821|100924146|FG003|COMPLETED|Overall Study||8||
48682459|NCT03661840|102006606|FG000|COMPLETED|Overall Study||28||
48682460|NCT03661840|102006607|FG001|COMPLETED|Overall Study||22||
48247046|NCT00990821|100924147|FG004|COMPLETED|Overall Study||14||
48247047|NCT00990821|100924148|FG005|COMPLETED|Overall Study||14||
48682461|NCT03661840|102006606|FG000|NOT COMPLETED|Overall Study||0||
48682462|NCT03661840|102006607|FG001|NOT COMPLETED|Overall Study||0||
48682463|NCT04819113|102006608|FG000|STARTED|Overall Study||149||
48682464|NCT04819113|102006608|FG000|Vaccination 1|Overall Study||147||
48682465|NCT04819113|102006608|FG000|Safety Population|Overall Study||145||
48682466|NCT04819113|102006608|FG000|Vaccination 2|Overall Study||143||
48083751|NCT03667924|100525661|FG001|NOT COMPLETED|3-month/Volunteers Who Enrolled Clients||10||
48247048|NCT00990821|100924149|FG006|COMPLETED|Overall Study||11||
48247049|NCT00990821|100924150|FG007|COMPLETED|Overall Study||14||
48682467|NCT04819113|102006608|FG000|COMPLETED|Overall Study||143||
48682468|NCT04819113|102006608|FG000|NOT COMPLETED|Overall Study||6||
48682469|NCT01186250|102006609|FG000|STARTED|Overall Study||9||
48682470|NCT01186250|102006610|FG001|STARTED|Overall Study||9||
48682471|NCT01186250|102006609|FG000|COMPLETED|Overall Study||8||
48682472|NCT01186250|102006610|FG001|COMPLETED|Overall Study||9||
48682473|NCT01186250|102006609|FG000|NOT COMPLETED|Overall Study||1||
48682474|NCT01186250|102006610|FG001|NOT COMPLETED|Overall Study||0||
48682475|NCT03734822|102006611|FG000|STARTED|Overall Study||47||
48682476|NCT03734822|102006611|FG000|COMPLETED|Overall Study||47||
48682477|NCT03734822|102006611|FG000|NOT COMPLETED|Overall Study||0||
48682478|NCT02808429|102006612|FG000|STARTED|Overall Study||5||
48682479|NCT02808429|102006613|FG001|STARTED|Overall Study||6||
48682480|NCT02808429|102006614|FG002|STARTED|Overall Study||5||
48682481|NCT02808429|102006612|FG000|COMPLETED|Overall Study||2||
48682482|NCT02808429|102006613|FG001|COMPLETED|Overall Study||5||
48682483|NCT02808429|102006614|FG002|COMPLETED|Overall Study||3||
48682484|NCT02808429|102006612|FG000|NOT COMPLETED|Overall Study||3||
48682485|NCT02808429|102006613|FG001|NOT COMPLETED|Overall Study||1||
48682486|NCT02808429|102006614|FG002|NOT COMPLETED|Overall Study||2||
48682487|NCT02043145|102006615|FG000|STARTED|Overall Study||55||
48682488|NCT02043145|102006616|FG001|STARTED|Overall Study||247||
48682489|NCT02043145|102006617|FG002|STARTED|Overall Study||425||
48682490|NCT02043145|102006615|FG000|COMPLETED|Overall Study||55||
48682491|NCT02043145|102006616|FG001|COMPLETED|Overall Study||247||
48682492|NCT02043145|102006617|FG002|COMPLETED|Overall Study||425||
48247050|NCT00990821|100924151|FG008|COMPLETED|Overall Study||12||
48247051|NCT00990821|100924152|FG009|COMPLETED|Overall Study||13||
48247052|NCT00990821|100924153|FG010|COMPLETED|Overall Study||9||
48247053|NCT00990821|100924154|FG011|COMPLETED|Overall Study||9||
48247054|NCT00990821|100924155|FG012|COMPLETED|Overall Study||10||
48247055|NCT00990821|100924156|FG013|COMPLETED|Overall Study||11||
48247056|NCT00990821|100924143|FG000|NOT COMPLETED|Overall Study||0||
48247057|NCT00990821|100924144|FG001|NOT COMPLETED|Overall Study||2||
48247058|NCT00990821|100924145|FG002|NOT COMPLETED|Overall Study||0||
48247059|NCT00990821|100924146|FG003|NOT COMPLETED|Overall Study||0||
48247060|NCT00990821|100924147|FG004|NOT COMPLETED|Overall Study||3||
48247061|NCT00990821|100924148|FG005|NOT COMPLETED|Overall Study||3||
48682493|NCT02043145|102006615|FG000|NOT COMPLETED|Overall Study||0||
48682494|NCT02043145|102006616|FG001|NOT COMPLETED|Overall Study||0||
48682495|NCT02043145|102006617|FG002|NOT COMPLETED|Overall Study||0||
48083752|NCT03667924|100525662|FG002|NOT COMPLETED|3-month/Volunteers Who Enrolled Clients||0||
48083753|NCT03667924|100525660|FG000|STARTED|Post-study Interview Completed||5||
48083754|NCT03667924|100525661|FG001|STARTED|Post-study Interview Completed||5||
48083755|NCT03667924|100525662|FG002|STARTED|Post-study Interview Completed||3||
48083756|NCT03667924|100525660|FG000|COMPLETED|Post-study Interview Completed||5||
48083757|NCT03667924|100525661|FG001|COMPLETED|Post-study Interview Completed||4||
48083758|NCT03667924|100525662|FG002|COMPLETED|Post-study Interview Completed||3||
48083759|NCT03667924|100525660|FG000|NOT COMPLETED|Post-study Interview Completed||0||
48083760|NCT03667924|100525661|FG001|NOT COMPLETED|Post-study Interview Completed||1||
48083761|NCT03667924|100525662|FG002|NOT COMPLETED|Post-study Interview Completed||0||
48083762|NCT01153347|100525663|FG000|STARTED|Overall Study||160||
48083763|NCT01153347|100525664|FG001|STARTED|Overall Study||160||
48083764|NCT01153347|100525665|FG002|STARTED|Overall Study||160||
48083765|NCT01153347|100525666|FG003|STARTED|Overall Study||161||
48083766|NCT01153347|100525663|FG000|Received Treatment|Overall Study||160||
48083767|NCT01153347|100525664|FG001|Received Treatment|Overall Study||158||
48083768|NCT01153347|100525665|FG002|Received Treatment|Overall Study||158||
48083769|NCT01153347|100525666|FG003|Received Treatment|Overall Study||160||
48083770|NCT01153347|100525663|FG000|COMPLETED|Overall Study||127||
48083771|NCT01153347|100525664|FG001|COMPLETED|Overall Study||116||
48083772|NCT01153347|100525665|FG002|COMPLETED|Overall Study||110||
48083773|NCT01153347|100525666|FG003|COMPLETED|Overall Study||129||
48083774|NCT01153347|100525663|FG000|NOT COMPLETED|Overall Study||33||
48083775|NCT01153347|100525664|FG001|NOT COMPLETED|Overall Study||44||
48083776|NCT01153347|100525665|FG002|NOT COMPLETED|Overall Study||50||
48083777|NCT01153347|100525666|FG003|NOT COMPLETED|Overall Study||32||
48083778|NCT03057431|100525667|FG000|STARTED|Overall Study||102||
48083779|NCT03057431|100525668|FG001|STARTED|Overall Study||105||
48083780|NCT03057431|100525669|FG002|STARTED|Overall Study||108||
48083781|NCT03057431|100525670|FG003|STARTED|Overall Study||101||
48083782|NCT03057431|100525667|FG000|COMPLETED|Overall Study||95||
48083783|NCT03057431|100525668|FG001|COMPLETED|Overall Study||102||
48083784|NCT03057431|100525669|FG002|COMPLETED|Overall Study||104||
48083785|NCT03057431|100525670|FG003|COMPLETED|Overall Study||92||
48083786|NCT03057431|100525667|FG000|NOT COMPLETED|Overall Study||7||
48083787|NCT03057431|100525668|FG001|NOT COMPLETED|Overall Study||3||
48083788|NCT03057431|100525669|FG002|NOT COMPLETED|Overall Study||4||
48083789|NCT03057431|100525670|FG003|NOT COMPLETED|Overall Study||9||
48083790|NCT04669600|100525671|FG000|STARTED|Overall Study||12||
48083791|NCT04669600|100525671|FG000|COMPLETED|Overall Study||5||
48083792|NCT04669600|100525671|FG000|NOT COMPLETED|Overall Study||7||
48083793|NCT04617509|100525672|FG000|STARTED|Period 1: Part 1 Formulation A||14||
48083794|NCT04617509|100525673|FG001|STARTED|Period 1: Part 1 Formulation A||0||
48083795|NCT04617509|100525674|FG002|STARTED|Period 1: Part 1 Formulation A||0||
48083796|NCT04617509|100525672|FG000|COMPLETED|Period 1: Part 1 Formulation A||14||
48247062|NCT00990821|100924149|FG006|NOT COMPLETED|Overall Study||1||
48247063|NCT00990821|100924150|FG007|NOT COMPLETED|Overall Study||0||
48247064|NCT00990821|100924151|FG008|NOT COMPLETED|Overall Study||0||
48247065|NCT00990821|100924152|FG009|NOT COMPLETED|Overall Study||1||
48247066|NCT00990821|100924153|FG010|NOT COMPLETED|Overall Study||3||
48247067|NCT00990821|100924154|FG011|NOT COMPLETED|Overall Study||5||
48247068|NCT00990821|100924155|FG012|NOT COMPLETED|Overall Study||2||
48247069|NCT00990821|100924156|FG013|NOT COMPLETED|Overall Study||1||
48247070|NCT01732627|100924157|FG000|STARTED|Overall Study||201|Randomized and vaccinated.|
48247071|NCT01732627|100924158|FG001|STARTED|Overall Study||100|Randomized and vaccinated.|
48682496|NCT01508910|102006618|FG000|STARTED|Randomization||57||
48540779|NCT03287843|101662567|FG001|Excluded|Overall Study||8||
48682497|NCT01508910|102006619|FG001|STARTED|Randomization||27||
48083797|NCT04617509|100525673|FG001|COMPLETED|Period 1: Part 1 Formulation A||0||
48083798|NCT04617509|100525674|FG002|COMPLETED|Period 1: Part 1 Formulation A||0||
48083799|NCT04617509|100525672|FG000|NOT COMPLETED|Period 1: Part 1 Formulation A||0||
48083800|NCT04617509|100525673|FG001|NOT COMPLETED|Period 1: Part 1 Formulation A||0||
48294132|NCT02527343|101047536|FG000|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0||
48083801|NCT04617509|100525674|FG002|NOT COMPLETED|Period 1: Part 1 Formulation A||0||
48083802|NCT04617509|100525672|FG000|STARTED|Period 2: Part 1 Formulation B||0||
48083803|NCT04617509|100525673|FG001|STARTED|Period 2: Part 1 Formulation B||14||
48083804|NCT04617509|100525674|FG002|STARTED|Period 2: Part 1 Formulation B||0||
48083805|NCT04617509|100525672|FG000|COMPLETED|Period 2: Part 1 Formulation B||0||
48083806|NCT04617509|100525673|FG001|COMPLETED|Period 2: Part 1 Formulation B||14||
48083807|NCT04617509|100525674|FG002|COMPLETED|Period 2: Part 1 Formulation B||0||
48083808|NCT04617509|100525672|FG000|NOT COMPLETED|Period 2: Part 1 Formulation B||0||
48083809|NCT04617509|100525673|FG001|NOT COMPLETED|Period 2: Part 1 Formulation B||0||
48083810|NCT04617509|100525674|FG002|NOT COMPLETED|Period 2: Part 1 Formulation B||0||
48083811|NCT04617509|100525672|FG000|STARTED|Period 3: Part 2 Formulation A Fed Cond.||0||
48083812|NCT04617509|100525673|FG001|STARTED|Period 3: Part 2 Formulation A Fed Cond.||0||
48083813|NCT04617509|100525674|FG002|STARTED|Period 3: Part 2 Formulation A Fed Cond.||14||
48083814|NCT04617509|100525672|FG000|COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0||
48083815|NCT04617509|100525673|FG001|COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0||
48083816|NCT04617509|100525674|FG002|COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||13||
48083817|NCT04617509|100525672|FG000|NOT COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0||
48083818|NCT04617509|100525673|FG001|NOT COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0||
48083819|NCT04617509|100525674|FG002|NOT COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||1||
48247072|NCT01732627|100924157|FG000|Safety Analysis Set (SafAS)|Overall Study||199|Participants who received at least 1 dose of study or control vaccine and had safety data available.|
48247073|NCT01732627|100924158|FG001|Safety Analysis Set (SafAS)|Overall Study||100|Participants who received at least 1 dose of study or control vaccine and had safety data available.|
48247074|NCT01732627|100924157|FG000|COMPLETED|Overall Study||200||
48247075|NCT01732627|100924158|FG001|COMPLETED|Overall Study||100||
48247076|NCT01732627|100924157|FG000|NOT COMPLETED|Overall Study||1||
48247077|NCT01732627|100924158|FG001|NOT COMPLETED|Overall Study||0||
48247078|NCT03899259|100924159|FG000|STARTED|Overall Study||156||
48247079|NCT03899259|100924160|FG001|STARTED|Overall Study||156||
48247080|NCT03899259|100924161|FG002|STARTED|Overall Study||234||
48682498|NCT01508910|102006620|FG002|STARTED|Randomization||28||
48682499|NCT01508910|102006621|FG003|STARTED|Randomization||0||
48682500|NCT01508910|102006618|FG000|COMPLETED|Randomization||57||
48682501|NCT01508910|102006619|FG001|COMPLETED|Randomization||27||
48682502|NCT01508910|102006620|FG002|COMPLETED|Randomization||28||
48682503|NCT01508910|102006621|FG003|COMPLETED|Randomization||0||
48682504|NCT01508910|102006618|FG000|NOT COMPLETED|Randomization||0||
48682505|NCT01508910|102006619|FG001|NOT COMPLETED|Randomization||0||
48682506|NCT01508910|102006620|FG002|NOT COMPLETED|Randomization||0||
48682507|NCT01508910|102006621|FG003|NOT COMPLETED|Randomization||0||
48682508|NCT01508910|102006618|FG000|STARTED|Treatment||50||
48682509|NCT01508910|102006619|FG001|STARTED|Treatment||28||
48682510|NCT01508910|102006620|FG002|STARTED|Treatment||28||
48682511|NCT01508910|102006621|FG003|STARTED|Treatment||6||
48682512|NCT01508910|102006618|FG000|COMPLETED|Treatment||48||
48682513|NCT01508910|102006619|FG001|COMPLETED|Treatment||24||
48682514|NCT01508910|102006620|FG002|COMPLETED|Treatment||18||
48682515|NCT01508910|102006621|FG003|COMPLETED|Treatment||3||
48682516|NCT01508910|102006618|FG000|NOT COMPLETED|Treatment||2||
48682517|NCT01508910|102006619|FG001|NOT COMPLETED|Treatment||4||
48682518|NCT01508910|102006620|FG002|NOT COMPLETED|Treatment||10||
48682519|NCT01508910|102006621|FG003|NOT COMPLETED|Treatment||3||
48682520|NCT03484429|102006622|FG000|STARTED|Overall Study||8||
48682521|NCT03484429|102006623|FG001|STARTED|Overall Study||8||
48682522|NCT03484429|102006622|FG000|Postamputation Week 1-4|Overall Study||8||
48682523|NCT03484429|102006623|FG001|Postamputation Week 1-4|Overall Study||8||
48682524|NCT03484429|102006622|FG000|Postamputation Week 5-8|Overall Study||5||
48682525|NCT03484429|102006623|FG001|Postamputation Week 5-8|Overall Study||8||
48682526|NCT03484429|102006622|FG000|Postamputation Month 3|Overall Study||5||
48682527|NCT03484429|102006623|FG001|Postamputation Month 3|Overall Study||7||
48682528|NCT03484429|102006622|FG000|COMPLETED|Overall Study||5||
48682529|NCT03484429|102006623|FG001|COMPLETED|Overall Study||8||
48682530|NCT03484429|102006622|FG000|NOT COMPLETED|Overall Study||3||
48682531|NCT03484429|102006623|FG001|NOT COMPLETED|Overall Study||0||
48083820|NCT02279420|100525675|FG000|STARTED|Overall Study||73||
48083821|NCT02279420|100525675|FG000|COMPLETED|Overall Study||50||
48083822|NCT02279420|100525675|FG000|NOT COMPLETED|Overall Study||23||
48083823|NCT01833520|100525676|FG000|STARTED|Overall Study||3||
48083824|NCT01833520|100525677|FG001|STARTED|Overall Study||3||
48083825|NCT01833520|100525678|FG002|STARTED|Overall Study||9||
48083826|NCT01833520|100525679|FG003|STARTED|Overall Study||3||
48083827|NCT01833520|100525676|FG000|COMPLETED|Overall Study||0||
48682532|NCT00600067|102006624|FG000|STARTED|Overall Study||55||
48682533|NCT00600067|102006625|FG001|STARTED|Overall Study||75||
48682534|NCT00600067|102006624|FG000|COMPLETED|Overall Study||52||
48682535|NCT00600067|102006625|FG001|COMPLETED|Overall Study||68||
48682536|NCT00600067|102006624|FG000|NOT COMPLETED|Overall Study||3||
48682537|NCT00600067|102006625|FG001|NOT COMPLETED|Overall Study||7||
48682538|NCT00806260|102006626|FG000|STARTED|Period 1 (1 Day)||15||
48682539|NCT00806260|102006627|FG001|STARTED|Period 1 (1 Day)||8||
48682540|NCT00806260|102006628|FG002|STARTED|Period 1 (1 Day)||8||
48682541|NCT00806260|102006629|FG003|STARTED|Period 1 (1 Day)||14||
48682542|NCT00806260|102006630|FG004|STARTED|Period 1 (1 Day)||18||
48682543|NCT00806260|102006631|FG005|STARTED|Period 1 (1 Day)||17||
48540780|NCT03287843|101662566|FG000|Lost to Follow up|Overall Study||3||
48540781|NCT03287843|101662567|FG001|Lost to Follow up|Overall Study||0||
48682544|NCT00806260|102006626|FG000|COMPLETED|Period 1 (1 Day)||15||
48083828|NCT01833520|100525677|FG001|COMPLETED|Overall Study||0||
48083829|NCT01833520|100525678|FG002|COMPLETED|Overall Study||1||
48083830|NCT01833520|100525679|FG003|COMPLETED|Overall Study||0||
48083831|NCT01833520|100525676|FG000|NOT COMPLETED|Overall Study||3||
48083832|NCT01833520|100525677|FG001|NOT COMPLETED|Overall Study||3||
48083833|NCT01833520|100525678|FG002|NOT COMPLETED|Overall Study||8||
48083834|NCT01833520|100525679|FG003|NOT COMPLETED|Overall Study||3||
48083835|NCT01949506|100525680|FG000|STARTED|Overall Study||9||
48540782|NCT03287843|101662566|FG000|COMPLETED|Overall Study||160||
48540783|NCT03287843|101662567|FG001|COMPLETED|Overall Study||167||
48540784|NCT03287843|101662566|FG000|NOT COMPLETED|Overall Study||15||
48540785|NCT03287843|101662567|FG001|NOT COMPLETED|Overall Study||8||
48540786|NCT00000620|101662568|FG000|STARTED|Overall Study||1178||
48540787|NCT00000620|101662569|FG001|STARTED|Overall Study||1193||
48540788|NCT00000620|101662570|FG002|STARTED|Overall Study||1374||
48540789|NCT00000620|101662571|FG003|STARTED|Overall Study||1383||
48540790|NCT00000620|101662572|FG004|STARTED|Overall Study||1184||
48540791|NCT00000620|101662573|FG005|STARTED|Overall Study||1178||
48540792|NCT00000620|101662574|FG006|STARTED|Overall Study||1391||
48682545|NCT00806260|102006627|FG001|COMPLETED|Period 1 (1 Day)||8||
48682546|NCT00806260|102006628|FG002|COMPLETED|Period 1 (1 Day)||8||
48682547|NCT00806260|102006629|FG003|COMPLETED|Period 1 (1 Day)||14||
48682548|NCT00806260|102006630|FG004|COMPLETED|Period 1 (1 Day)||15||
48682549|NCT00806260|102006631|FG005|COMPLETED|Period 1 (1 Day)||17||
48682550|NCT00806260|102006626|FG000|NOT COMPLETED|Period 1 (1 Day)||0||
48682551|NCT00806260|102006627|FG001|NOT COMPLETED|Period 1 (1 Day)||0||
48682552|NCT00806260|102006628|FG002|NOT COMPLETED|Period 1 (1 Day)||0||
48540793|NCT00000620|101662575|FG007|STARTED|Overall Study||1370||
48540794|NCT00000620|101662568|FG000|COMPLETED|Overall Study||1016||
48540795|NCT00000620|101662569|FG001|COMPLETED|Overall Study||1057||
48540796|NCT00000620|101662570|FG002|COMPLETED|Overall Study||1204||
48682553|NCT00806260|102006629|FG003|NOT COMPLETED|Period 1 (1 Day)||0||
48540797|NCT00000620|101662571|FG003|COMPLETED|Overall Study||1205||
48682554|NCT00806260|102006630|FG004|NOT COMPLETED|Period 1 (1 Day)||3||
48682555|NCT00806260|102006631|FG005|NOT COMPLETED|Period 1 (1 Day)||0||
48083836|NCT01949506|100525680|FG000|COMPLETED|Overall Study||8||
48083837|NCT01949506|100525680|FG000|NOT COMPLETED|Overall Study||1||
48540798|NCT00000620|101662572|FG004|COMPLETED|Overall Study||1049||
48540799|NCT00000620|101662573|FG005|COMPLETED|Overall Study||1026||
48540800|NCT00000620|101662574|FG006|COMPLETED|Overall Study||1242||
48247081|NCT03899259|100924159|FG000|Received at Least One Dose of Study Drug|Overall Study||155||
48247082|NCT03899259|100924160|FG001|Received at Least One Dose of Study Drug|Overall Study||156||
48247083|NCT03899259|100924161|FG002|Received at Least One Dose of Study Drug|Overall Study||234||
48247084|NCT03899259|100924159|FG000|COMPLETED|Overall Study||0||
48247085|NCT03899259|100924160|FG001|COMPLETED|Overall Study||0||
48247086|NCT03899259|100924161|FG002|COMPLETED|Overall Study||0||
48247087|NCT03899259|100924159|FG000|NOT COMPLETED|Overall Study||156||
48247088|NCT03899259|100924160|FG001|NOT COMPLETED|Overall Study||156||
48682556|NCT00806260|102006626|FG000|STARTED|Period 2||15||
48682557|NCT00806260|102006627|FG001|STARTED|Period 2||8||
48682558|NCT00806260|102006628|FG002|STARTED|Period 2||8||
48682559|NCT00806260|102006629|FG003|STARTED|Period 2||14||
48682560|NCT00806260|102006630|FG004|STARTED|Period 2||0||
48682561|NCT00806260|102006631|FG005|STARTED|Period 2||0||
48682562|NCT00806260|102006626|FG000|COMPLETED|Period 2||13||
48682563|NCT00806260|102006627|FG001|COMPLETED|Period 2||8||
48682564|NCT00806260|102006628|FG002|COMPLETED|Period 2||6||
48682565|NCT00806260|102006629|FG003|COMPLETED|Period 2||12||
48247089|NCT03899259|100924161|FG002|NOT COMPLETED|Overall Study||234||
48247090|NCT01540071|100924162|FG000|STARTED|Overall Study||38||
48247091|NCT01540071|100924162|FG000|COMPLETED|Overall Study||38||
48247092|NCT01540071|100924162|FG000|NOT COMPLETED|Overall Study||0||
48540801|NCT00000620|101662575|FG007|COMPLETED|Overall Study||1224||
48540802|NCT00000620|101662568|FG000|NOT COMPLETED|Overall Study||162||
48540803|NCT00000620|101662569|FG001|NOT COMPLETED|Overall Study||136||
48540804|NCT00000620|101662570|FG002|NOT COMPLETED|Overall Study||170||
48540805|NCT00000620|101662571|FG003|NOT COMPLETED|Overall Study||178||
48540806|NCT00000620|101662572|FG004|NOT COMPLETED|Overall Study||135||
48540807|NCT00000620|101662573|FG005|NOT COMPLETED|Overall Study||152||
48540808|NCT00000620|101662574|FG006|NOT COMPLETED|Overall Study||149||
48540809|NCT00000620|101662575|FG007|NOT COMPLETED|Overall Study||146||
48540810|NCT05339334|101662576|FG000|STARTED|Overall Study||14||
48540811|NCT05339334|101662576|FG000|COMPLETED|Overall Study||14||
48540812|NCT05339334|101662576|FG000|NOT COMPLETED|Overall Study||0||
48540813|NCT03437031|101662577|FG000|STARTED|Overall Study||19||
48540814|NCT03437031|101662578|FG001|STARTED|Overall Study||21||
48540815|NCT03437031|101662577|FG000|COMPLETED|Overall Study||19||
48682566|NCT00806260|102006630|FG004|COMPLETED|Period 2||0||
48682567|NCT00806260|102006631|FG005|COMPLETED|Period 2||0||
48682568|NCT00806260|102006626|FG000|NOT COMPLETED|Period 2||2||
48247093|NCT00655668|100924163|FG000|STARTED|Overall Study||54||
48247094|NCT00655668|100924163|FG000|COMPLETED|Overall Study||0||
48247095|NCT00655668|100924163|FG000|NOT COMPLETED|Overall Study||54||
48247096|NCT01643902|100924164|FG000|STARTED|Overall Study||20||
48247097|NCT01643902|100924164|FG000|COMPLETED|Overall Study||20||
48247098|NCT01643902|100924164|FG000|NOT COMPLETED|Overall Study||0||
48247099|NCT02270463|100924165|FG000|STARTED|Overall Study||3||
48540816|NCT03437031|101662578|FG001|COMPLETED|Overall Study||21||
48540817|NCT03437031|101662577|FG000|NOT COMPLETED|Overall Study||0||
48247100|NCT02270463|100924166|FG001|STARTED|Overall Study||3||
48247101|NCT02270463|100924167|FG002|STARTED|Overall Study||3||
48540818|NCT03437031|101662578|FG001|NOT COMPLETED|Overall Study||0||
48682569|NCT00806260|102006627|FG001|NOT COMPLETED|Period 2||0||
48682570|NCT00806260|102006628|FG002|NOT COMPLETED|Period 2||2||
48682571|NCT00806260|102006629|FG003|NOT COMPLETED|Period 2||2||
48682572|NCT00806260|102006630|FG004|NOT COMPLETED|Period 2||0||
48682573|NCT00806260|102006631|FG005|NOT COMPLETED|Period 2||0||
48682574|NCT00806260|102006626|FG000|STARTED|Period 3||13||
48682575|NCT00806260|102006627|FG001|STARTED|Period 3||8||
48682576|NCT00806260|102006628|FG002|STARTED|Period 3||6||
48682577|NCT00806260|102006629|FG003|STARTED|Period 3||12||
48682578|NCT00806260|102006630|FG004|STARTED|Period 3||0||
48682579|NCT00806260|102006631|FG005|STARTED|Period 3||0||
48682580|NCT00806260|102006626|FG000|COMPLETED|Period 3||12||
48682581|NCT00806260|102006627|FG001|COMPLETED|Period 3||7||
48682582|NCT00806260|102006628|FG002|COMPLETED|Period 3||5||
48682583|NCT00806260|102006629|FG003|COMPLETED|Period 3||12||
48682584|NCT00806260|102006630|FG004|COMPLETED|Period 3||0||
48682585|NCT00806260|102006631|FG005|COMPLETED|Period 3||0||
48682586|NCT00806260|102006626|FG000|NOT COMPLETED|Period 3||1||
48682587|NCT00806260|102006627|FG001|NOT COMPLETED|Period 3||1||
48682588|NCT00806260|102006628|FG002|NOT COMPLETED|Period 3||1||
48682589|NCT00806260|102006629|FG003|NOT COMPLETED|Period 3||0||
48682590|NCT00806260|102006630|FG004|NOT COMPLETED|Period 3||0||
48682591|NCT00806260|102006631|FG005|NOT COMPLETED|Period 3||0||
48682592|NCT03071861|102006632|FG000|STARTED|Overall Study||13||
48682593|NCT03071861|102006633|FG001|STARTED|Overall Study||15||
48682594|NCT03071861|102006632|FG000|COMPLETED|Overall Study||12||
48682595|NCT03071861|102006633|FG001|COMPLETED|Overall Study||14||
48682596|NCT03071861|102006632|FG000|NOT COMPLETED|Overall Study||1||
48682597|NCT03071861|102006633|FG001|NOT COMPLETED|Overall Study||1||
48682598|NCT00107276|102006634|FG000|STARTED|Overall Study||112||
48682599|NCT00107276|102006634|FG000|Eligible|Overall Study||96||
48682600|NCT00107276|102006634|FG000|COMPLETED|Overall Study||40||
48682601|NCT00107276|102006634|FG000|NOT COMPLETED|Overall Study||72||
48682602|NCT02471313|102006635|FG000|STARTED|Overall Study||3||
48682603|NCT02471313|102006635|FG000|COMPLETED|Overall Study||3||
48682604|NCT02471313|102006635|FG000|NOT COMPLETED|Overall Study||0||
48682605|NCT01273038|102006636|FG000|STARTED|First Intervention (14 Days)||10||
48682606|NCT01273038|102006637|FG001|STARTED|First Intervention (14 Days)||10||
48682607|NCT01273038|102006636|FG000|COMPLETED|First Intervention (14 Days)||10||
48682608|NCT01273038|102006637|FG001|COMPLETED|First Intervention (14 Days)||10||
48682609|NCT01273038|102006636|FG000|NOT COMPLETED|First Intervention (14 Days)||0||
48682610|NCT01273038|102006637|FG001|NOT COMPLETED|First Intervention (14 Days)||0||
48682611|NCT01273038|102006636|FG000|STARTED|Second Intervention (14 Days)||10||
48682612|NCT01273038|102006637|FG001|STARTED|Second Intervention (14 Days)||10||
48682613|NCT01273038|102006636|FG000|COMPLETED|Second Intervention (14 Days)||10||
48682614|NCT01273038|102006637|FG001|COMPLETED|Second Intervention (14 Days)||8||
48682615|NCT01273038|102006636|FG000|NOT COMPLETED|Second Intervention (14 Days)||0||
48682616|NCT01273038|102006637|FG001|NOT COMPLETED|Second Intervention (14 Days)||2||
48682617|NCT01312519|102006638|FG000|STARTED|Overall Study||26||
48682618|NCT01312519|102006639|FG001|STARTED|Overall Study||24||
48682619|NCT01312519|102006638|FG000|COMPLETED|Overall Study||26||
48682620|NCT01312519|102006639|FG001|COMPLETED|Overall Study||24||
48682621|NCT01312519|102006638|FG000|NOT COMPLETED|Overall Study||0||
48682622|NCT01312519|102006639|FG001|NOT COMPLETED|Overall Study||0||
48682623|NCT02954458|102006640|FG000|STARTED|Overall Study||7||
48682624|NCT02954458|102006641|FG001|STARTED|Overall Study||3||
48682625|NCT02954458|102006642|FG002|STARTED|Overall Study||1||
48682626|NCT02954458|102006643|FG003|STARTED|Overall Study||50||
48682627|NCT02954458|102006640|FG000|COMPLETED|Overall Study||6||
48682628|NCT02954458|102006641|FG001|COMPLETED|Overall Study||3||
48682629|NCT02954458|102006642|FG002|COMPLETED|Overall Study||0||
48682630|NCT02954458|102006643|FG003|COMPLETED|Overall Study||38||
48682631|NCT02954458|102006640|FG000|NOT COMPLETED|Overall Study||1||
48682632|NCT02954458|102006641|FG001|NOT COMPLETED|Overall Study||0||
48682633|NCT02954458|102006642|FG002|NOT COMPLETED|Overall Study||1||
48682634|NCT02954458|102006643|FG003|NOT COMPLETED|Overall Study||12||
48682635|NCT01119287|102006644|FG000|STARTED|Overall Study||26||
48682636|NCT01119287|102006645|FG001|STARTED|Overall Study||24||
48682637|NCT01119287|102006646|FG002|STARTED|Overall Study||26||
48682638|NCT01119287|102006647|FG003|STARTED|Overall Study||31||
48682639|NCT01119287|102006648|FG004|STARTED|Overall Study||31||
48682640|NCT01119287|102006649|FG005|STARTED|Overall Study||32||
48682641|NCT01119287|102006644|FG000|COMPLETED|Overall Study||26||
48682642|NCT01119287|102006645|FG001|COMPLETED|Overall Study||24||
48682643|NCT01119287|102006646|FG002|COMPLETED|Overall Study||24||
48682644|NCT01119287|102006647|FG003|COMPLETED|Overall Study||29||
48682645|NCT01119287|102006648|FG004|COMPLETED|Overall Study||30||
48682646|NCT01119287|102006649|FG005|COMPLETED|Overall Study||32||
48682647|NCT01119287|102006644|FG000|NOT COMPLETED|Overall Study||0||
48682648|NCT01119287|102006645|FG001|NOT COMPLETED|Overall Study||0||
48682649|NCT01119287|102006646|FG002|NOT COMPLETED|Overall Study||2||
48682650|NCT01119287|102006647|FG003|NOT COMPLETED|Overall Study||2||
48682651|NCT01119287|102006648|FG004|NOT COMPLETED|Overall Study||1||
48682652|NCT01119287|102006649|FG005|NOT COMPLETED|Overall Study||0||
48247102|NCT02270463|100924168|FG003|STARTED|Overall Study||7||
48247103|NCT02270463|100924165|FG000|COMPLETED|Overall Study||0||
48247104|NCT02270463|100924166|FG001|COMPLETED|Overall Study||0||
48247105|NCT02270463|100924167|FG002|COMPLETED|Overall Study||0||
48247106|NCT02270463|100924168|FG003|COMPLETED|Overall Study||0||
48247107|NCT02270463|100924165|FG000|NOT COMPLETED|Overall Study||3||
48247108|NCT02270463|100924166|FG001|NOT COMPLETED|Overall Study||3||
48247109|NCT02270463|100924167|FG002|NOT COMPLETED|Overall Study||3||
48247110|NCT02270463|100924168|FG003|NOT COMPLETED|Overall Study||7||
48247111|NCT00577096|100924169|FG000|STARTED|Short Term Participation||69||
48247112|NCT00577096|100924170|FG001|STARTED|Short Term Participation||66||
48247113|NCT00577096|100924169|FG000|COMPLETED|Short Term Participation||62||
48247114|NCT00577096|100924170|FG001|COMPLETED|Short Term Participation||58||
48247115|NCT00577096|100924169|FG000|NOT COMPLETED|Short Term Participation||7||
48247116|NCT00577096|100924170|FG001|NOT COMPLETED|Short Term Participation||8||
48682653|NCT00997984|102006650|FG000|STARTED|Overall Study||113||
48682654|NCT00997984|102006651|FG001|STARTED|Overall Study||113||
48682655|NCT00997984|102006652|FG002|STARTED|Overall Study||114||
48682656|NCT00997984|102006650|FG000|COMPLETED|Overall Study||76||
48682657|NCT00997984|102006651|FG001|COMPLETED|Overall Study||79||
48682658|NCT00997984|102006652|FG002|COMPLETED|Overall Study||88||
48682659|NCT00997984|102006650|FG000|NOT COMPLETED|Overall Study||37||
48682660|NCT00997984|102006651|FG001|NOT COMPLETED|Overall Study||34||
48682661|NCT00997984|102006652|FG002|NOT COMPLETED|Overall Study||26||
48682662|NCT03824392|102006653|FG000|STARTED|Overall Study||12||
48682663|NCT03824392|102006654|FG001|STARTED|Overall Study||8||
48682664|NCT03824392|102006655|FG002|STARTED|Overall Study||8||
48682665|NCT03824392|102006656|FG003|STARTED|Overall Study||9||
48682666|NCT03824392|102006653|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12||
48682667|NCT03824392|102006654|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8||
48682668|NCT03824392|102006655|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8||
48682669|NCT03824392|102006656|FG003|Received at Least 1 Dose of Study Drug|Overall Study||9||
48247117|NCT00577096|100924169|FG000|STARTED|Long Term Participation||34||
48247118|NCT00577096|100924170|FG001|STARTED|Long Term Participation||35||
48247119|NCT00577096|100924169|FG000|COMPLETED|Long Term Participation||34||
48247120|NCT00577096|100924170|FG001|COMPLETED|Long Term Participation||35||
48247121|NCT00577096|100924169|FG000|NOT COMPLETED|Long Term Participation||0||
48247122|NCT00577096|100924170|FG001|NOT COMPLETED|Long Term Participation||0||
48247123|NCT02640807|100924171|FG000|STARTED|Overall Study||9||
48247124|NCT02640807|100924172|FG001|STARTED|Overall Study||8||
48247125|NCT02640807|100924173|FG002|STARTED|Overall Study||10||
48247126|NCT02640807|100924171|FG000|COMPLETED|Overall Study||9||
48247127|NCT02640807|100924172|FG001|COMPLETED|Overall Study||8||
48247128|NCT02640807|100924173|FG002|COMPLETED|Overall Study||10||
48247129|NCT02640807|100924171|FG000|NOT COMPLETED|Overall Study||0||
48247130|NCT02640807|100924172|FG001|NOT COMPLETED|Overall Study||0||
48247131|NCT02640807|100924173|FG002|NOT COMPLETED|Overall Study||0||
48247132|NCT00006436|100924174|FG000|STARTED|Overall Study||68||
48247133|NCT00006436|100924174|FG000|COMPLETED|Overall Study||65||
48247134|NCT00006436|100924174|FG000|NOT COMPLETED|Overall Study||3||
48247135|NCT02382406|100924175|FG000|STARTED|Study Treatment||14||
48247136|NCT02382406|100924176|FG001|STARTED|Study Treatment||0||
48247137|NCT02382406|100924177|FG002|STARTED|Study Treatment||32||
48247138|NCT02382406|100924175|FG000|COMPLETED|Study Treatment||0||
48247139|NCT02382406|100924176|FG001|COMPLETED|Study Treatment||0||
48247140|NCT02382406|100924177|FG002|COMPLETED|Study Treatment||2||
48247141|NCT02382406|100924175|FG000|NOT COMPLETED|Study Treatment||14||
48247142|NCT02382406|100924176|FG001|NOT COMPLETED|Study Treatment||0||
48247143|NCT02382406|100924177|FG002|NOT COMPLETED|Study Treatment||30||
48247144|NCT02382406|100924175|FG000|STARTED|Follow up||14|Treatment and Follow up both are at different time period. Therefore, the number of subjects to start follow up is not equal to the number of subjects who have completed treatment.|
48247145|NCT02382406|100924176|FG001|STARTED|Follow up||0|Treatment and Follow up both are at different time period. Therefore, the number of subjects to start follow up is not equal to the number of subjects who have completed treatment.|
48247146|NCT02382406|100924177|FG002|STARTED|Follow up||32|Treatment and Follow up both are at different time period. Therefore, the number of subjects to start follow up is not equal to the number of subjects who have completed treatment.|
48247147|NCT02382406|100924175|FG000|COMPLETED|Follow up||0||
48682670|NCT03824392|102006653|FG000|COMPLETED|Overall Study||9||
48682671|NCT03824392|102006654|FG001|COMPLETED|Overall Study||6||
48682672|NCT03824392|102006655|FG002|COMPLETED|Overall Study||5||
48682673|NCT03824392|102006656|FG003|COMPLETED|Overall Study||8||
48682674|NCT03824392|102006653|FG000|NOT COMPLETED|Overall Study||3||
48682675|NCT03824392|102006654|FG001|NOT COMPLETED|Overall Study||2||
48682676|NCT03824392|102006655|FG002|NOT COMPLETED|Overall Study||3||
48682677|NCT03824392|102006656|FG003|NOT COMPLETED|Overall Study||1||
48682678|NCT02329743|102006657|FG000|STARTED|Overall Study||84||
48682679|NCT02329743|102006658|FG001|STARTED|Overall Study||87||
48682680|NCT02329743|102006659|FG002|STARTED|Overall Study||85||
48682681|NCT02329743|102006657|FG000|COMPLETED|Overall Study||78||
48682682|NCT02329743|102006658|FG001|COMPLETED|Overall Study||80||
48682683|NCT02329743|102006659|FG002|COMPLETED|Overall Study||77||
48682684|NCT02329743|102006657|FG000|NOT COMPLETED|Overall Study||6||
48682685|NCT02329743|102006658|FG001|NOT COMPLETED|Overall Study||7||
48682686|NCT02329743|102006659|FG002|NOT COMPLETED|Overall Study||8||
48682687|NCT01770743|102006660|FG000|STARTED|Overall Study||44||
48682688|NCT01770743|102006661|FG001|STARTED|Overall Study||34||
48682689|NCT01770743|102006662|FG002|STARTED|Overall Study||23||
48682690|NCT01770743|102006663|FG003|STARTED|Overall Study||44||
48682691|NCT01770743|102006664|FG004|STARTED|Overall Study||23||
48682692|NCT01770743|102006660|FG000|Treated|Overall Study||44||
48682693|NCT01770743|102006661|FG001|Treated|Overall Study||34||
48682694|NCT01770743|102006662|FG002|Treated|Overall Study||23||
48682695|NCT01770743|102006663|FG003|Treated|Overall Study||44||
48682696|NCT01770743|102006664|FG004|Treated|Overall Study||23||
48682697|NCT01770743|102006660|FG000|COMPLETED|Overall Study||42||
48682698|NCT01770743|102006661|FG001|COMPLETED|Overall Study||31||
48682699|NCT01770743|102006662|FG002|COMPLETED|Overall Study||22||
48682700|NCT01770743|102006663|FG003|COMPLETED|Overall Study||42||
48682701|NCT01770743|102006664|FG004|COMPLETED|Overall Study||21||
48682702|NCT01770743|102006660|FG000|NOT COMPLETED|Overall Study||2||
48682703|NCT01770743|102006661|FG001|NOT COMPLETED|Overall Study||3||
48682704|NCT01770743|102006662|FG002|NOT COMPLETED|Overall Study||1||
48682705|NCT01770743|102006663|FG003|NOT COMPLETED|Overall Study||2||
48682706|NCT01770743|102006664|FG004|NOT COMPLETED|Overall Study||2||
48682707|NCT01331681|102006665|FG000|STARTED|Overall Study||136||
48682708|NCT01331681|102006666|FG001|STARTED|Overall Study||135||
48682709|NCT01331681|102006667|FG002|STARTED|Overall Study||135||
48682710|NCT01331681|102006665|FG000|Participants Received Treatment|Overall Study||136||
48682711|NCT01331681|102006666|FG001|Participants Received Treatment|Overall Study||135||
48682712|NCT01331681|102006667|FG002|Participants Received Treatment|Overall Study||133||
48540819|NCT00384930|101662579|FG000|STARTED|Overall Study||212||
48540820|NCT00384930|101662580|FG001|STARTED|Overall Study||209||
48540821|NCT00384930|101662581|FG002|STARTED|Overall Study||212||
48540822|NCT00384930|101662582|FG003|STARTED|Overall Study||216||
48540823|NCT00384930|101662583|FG004|STARTED|Overall Study||209||
48540824|NCT00384930|101662579|FG000|Received Double-Blind Study Drug|Overall Study||211||
48540825|NCT00384930|101662580|FG001|Received Double-Blind Study Drug|Overall Study||208||
48540826|NCT00384930|101662581|FG002|Received Double-Blind Study Drug|Overall Study||212||
48540827|NCT00384930|101662582|FG003|Received Double-Blind Study Drug|Overall Study||216||
48540828|NCT00384930|101662583|FG004|Received Double-Blind Study Drug|Overall Study||209||
48540829|NCT00384930|101662579|FG000|COMPLETED|Overall Study||185||
48540830|NCT00384930|101662580|FG001|COMPLETED|Overall Study||182||
48540831|NCT00384930|101662581|FG002|COMPLETED|Overall Study||182||
48540832|NCT00384930|101662582|FG003|COMPLETED|Overall Study||175||
48540833|NCT00384930|101662583|FG004|COMPLETED|Overall Study||162||
48540834|NCT00384930|101662579|FG000|NOT COMPLETED|Overall Study||27||
48540835|NCT00384930|101662580|FG001|NOT COMPLETED|Overall Study||27||
48540836|NCT00384930|101662581|FG002|NOT COMPLETED|Overall Study||30||
48540837|NCT00384930|101662582|FG003|NOT COMPLETED|Overall Study||41||
48540838|NCT00384930|101662583|FG004|NOT COMPLETED|Overall Study||47||
48540839|NCT03496610|101662584|FG000|STARTED|Overall Study||24||
48540840|NCT03496610|101662585|FG001|STARTED|Overall Study||20||
48540841|NCT03496610|101662584|FG000|COMPLETED|Overall Study||19||
48540842|NCT03496610|101662585|FG001|COMPLETED|Overall Study||18||
48540843|NCT03496610|101662584|FG000|NOT COMPLETED|Overall Study||5||
48540844|NCT03496610|101662585|FG001|NOT COMPLETED|Overall Study||2||
48540845|NCT00086281|101662586|FG000|STARTED|Phase 1||11||
48682713|NCT01331681|102006665|FG000|Completed Week 52|Overall Study||125||
48682714|NCT01331681|102006666|FG001|Completed Week 52|Overall Study||121||
48682715|NCT01331681|102006667|FG002|Completed Week 52|Overall Study||115||
48682716|NCT01331681|102006665|FG000|Completed Week 100|Overall Study||115||
48540846|NCT00086281|101662587|FG001|STARTED|Phase 1||12||
48540847|NCT00086281|101662588|FG002|STARTED|Phase 1||8||
48540848|NCT00086281|101662589|FG003|STARTED|Phase 1||11||
48083838|NCT01846416|100525681|FG000|STARTED|Treatment Phase||31||
48083839|NCT01846416|100525682|FG001|STARTED|Treatment Phase||93||
48083840|NCT01846416|100525683|FG002|STARTED|Treatment Phase||13||
48083841|NCT01846416|100525681|FG000|COMPLETED|Treatment Phase||0||
48083842|NCT01846416|100525682|FG001|COMPLETED|Treatment Phase||0||
48083843|NCT01846416|100525683|FG002|COMPLETED|Treatment Phase||0||
48083844|NCT01846416|100525681|FG000|NOT COMPLETED|Treatment Phase||31||
48083845|NCT01846416|100525682|FG001|NOT COMPLETED|Treatment Phase||93||
48083846|NCT01846416|100525683|FG002|NOT COMPLETED|Treatment Phase||13||
48083847|NCT01846416|100525681|FG000|STARTED|Survival Follow-up||28||
48083848|NCT01846416|100525682|FG001|STARTED|Survival Follow-up||80||
48083849|NCT01846416|100525683|FG002|STARTED|Survival Follow-up||12||
48083850|NCT01846416|100525681|FG000|COMPLETED|Survival Follow-up||0||
48083851|NCT01846416|100525682|FG001|COMPLETED|Survival Follow-up||0||
48083852|NCT01846416|100525683|FG002|COMPLETED|Survival Follow-up||0||
48083853|NCT01846416|100525681|FG000|NOT COMPLETED|Survival Follow-up||28||
48083854|NCT01846416|100525682|FG001|NOT COMPLETED|Survival Follow-up||80||
48083855|NCT01846416|100525683|FG002|NOT COMPLETED|Survival Follow-up||12||
48083856|NCT00138203|100525684|FG000|STARTED|Overall Study||16||
48083857|NCT00138203|100525684|FG000|COMPLETED|Overall Study||16||
48083858|NCT00138203|100525684|FG000|NOT COMPLETED|Overall Study||0||
48083859|NCT02397278|100525685|FG000|STARTED|Overall Study||7||
48083860|NCT02397278|100525686|FG001|STARTED|Overall Study||8||
48083861|NCT02397278|100525685|FG000|COMPLETED|Overall Study||6||
48083862|NCT02397278|100525686|FG001|COMPLETED|Overall Study||5||
48083863|NCT02397278|100525685|FG000|NOT COMPLETED|Overall Study||1||
48083864|NCT02397278|100525686|FG001|NOT COMPLETED|Overall Study||3||
48083865|NCT03926169|100525687|FG000|STARTED|Period A||82|Randomized|
48083866|NCT03926169|100525688|FG001|STARTED|Period A||80|Randomized|
48083867|NCT03926169|100525689|FG002|STARTED|Period A||81|Randomized|
48083868|NCT03926169|100525687|FG000|Never Received Study Drug|Period A||0||
48083869|NCT03926169|100525688|FG001|Never Received Study Drug|Period A||0||
48083870|NCT03926169|100525689|FG002|Never Received Study Drug|Period A||1||
48083871|NCT03926169|100525687|FG000|COMPLETED|Period A||74|Completed Week 16|
48083872|NCT03926169|100525688|FG001|COMPLETED|Period A||70|Completed Week 16|
48083873|NCT03926169|100525689|FG002|COMPLETED|Period A||75|Completed Week 16|
48083874|NCT03926169|100525687|FG000|NOT COMPLETED|Period A||8||
48083875|NCT03926169|100525688|FG001|NOT COMPLETED|Period A||10||
48083876|NCT03926169|100525689|FG002|NOT COMPLETED|Period A||6||
48083877|NCT03926169|100525687|FG000|STARTED|Period B||74|Entered Period B|
48083878|NCT03926169|100525688|FG001|STARTED|Period B||70|Entered Period B|
48083879|NCT03926169|100525689|FG002|STARTED|Period B||75|Entered Period B|
48083880|NCT03926169|100525687|FG000|Entered Period B and Received Study Drug|Period B||74||
48083881|NCT03926169|100525688|FG001|Entered Period B and Received Study Drug|Period B||70||
48083882|NCT03926169|100525689|FG002|Entered Period B and Received Study Drug|Period B||74||
48083883|NCT03926169|100525687|FG000|COMPLETED|Period B||4|Completed study|
48083884|NCT03926169|100525688|FG001|COMPLETED|Period B||7|Completed study|
48083885|NCT03926169|100525689|FG002|COMPLETED|Period B||4|Completed study|
48083886|NCT03926169|100525687|FG000|NOT COMPLETED|Period B||70||
48083887|NCT03926169|100525688|FG001|NOT COMPLETED|Period B||63||
48083888|NCT03926169|100525689|FG002|NOT COMPLETED|Period B||71||
48083889|NCT02323113|100525690|FG000|STARTED|Overall Study||4||
48083890|NCT02323113|100525691|FG001|STARTED|Overall Study||7||
48083891|NCT02323113|100525692|FG002|STARTED|Overall Study||4||
48083892|NCT02323113|100525693|FG003|STARTED|Overall Study||5||
48083893|NCT02323113|100525694|FG004|STARTED|Overall Study||9||
48083894|NCT02323113|100525695|FG005|STARTED|Overall Study||8||
48083895|NCT02323113|100525696|FG006|STARTED|Overall Study||6||
48083896|NCT02323113|100525697|FG007|STARTED|Overall Study||0||
48083897|NCT02323113|100525690|FG000|COMPLETED|Overall Study||0||
48083898|NCT02323113|100525691|FG001|COMPLETED|Overall Study||0||
48083899|NCT02323113|100525692|FG002|COMPLETED|Overall Study||0||
48083900|NCT02323113|100525693|FG003|COMPLETED|Overall Study||0||
48083901|NCT02323113|100525694|FG004|COMPLETED|Overall Study||0||
48083902|NCT02323113|100525695|FG005|COMPLETED|Overall Study||0||
48083903|NCT02323113|100525696|FG006|COMPLETED|Overall Study||0||
48083904|NCT02323113|100525697|FG007|COMPLETED|Overall Study||0||
48083905|NCT02323113|100525690|FG000|NOT COMPLETED|Overall Study||4||
48083906|NCT02323113|100525691|FG001|NOT COMPLETED|Overall Study||7||
48083907|NCT02323113|100525692|FG002|NOT COMPLETED|Overall Study||4||
48083908|NCT02323113|100525693|FG003|NOT COMPLETED|Overall Study||5||
48083909|NCT02323113|100525694|FG004|NOT COMPLETED|Overall Study||9||
48083910|NCT02323113|100525695|FG005|NOT COMPLETED|Overall Study||8||
48083911|NCT02323113|100525696|FG006|NOT COMPLETED|Overall Study||6||
48083912|NCT02323113|100525697|FG007|NOT COMPLETED|Overall Study||0||
48083913|NCT02254252|100525698|FG000|STARTED|Overall Study||27||
48083914|NCT02254252|100525699|FG001|STARTED|Overall Study||27||
48083915|NCT02254252|100525698|FG000|COMPLETED|Overall Study||24||
48083916|NCT02254252|100525699|FG001|COMPLETED|Overall Study||25||
48083917|NCT02254252|100525698|FG000|NOT COMPLETED|Overall Study||3||
48083918|NCT02254252|100525699|FG001|NOT COMPLETED|Overall Study||2||
48083919|NCT03647033|100525700|FG000|STARTED|Overall Study||16||
48083920|NCT03647033|100525701|FG001|STARTED|Overall Study||16||
48083921|NCT03647033|100525700|FG000|COMPLETED|Overall Study||16||
48083922|NCT03647033|100525701|FG001|COMPLETED|Overall Study||16||
48083923|NCT03647033|100525700|FG000|NOT COMPLETED|Overall Study||0||
48083924|NCT03647033|100525701|FG001|NOT COMPLETED|Overall Study||0||
48083925|NCT00299975|100525702|FG000|STARTED|Overall Study||32||
48083926|NCT00299975|100525703|FG001|STARTED|Overall Study||32||
48083927|NCT00299975|100525704|FG002|STARTED|Overall Study||33||
48083928|NCT00299975|100525702|FG000|Received Allocated Intervention|Overall Study||32||
48083929|NCT00299975|100525703|FG001|Received Allocated Intervention|Overall Study||32||
48083930|NCT00299975|100525704|FG002|Received Allocated Intervention|Overall Study||32||
48083931|NCT00299975|100525702|FG000|COMPLETED|Overall Study||29||
48083932|NCT00299975|100525703|FG001|COMPLETED|Overall Study||31||
48083933|NCT00299975|100525704|FG002|COMPLETED|Overall Study||25||
48083934|NCT00299975|100525702|FG000|NOT COMPLETED|Overall Study||3||
48083935|NCT00299975|100525703|FG001|NOT COMPLETED|Overall Study||1||
48083936|NCT00299975|100525704|FG002|NOT COMPLETED|Overall Study||8||
48083937|NCT03098550|100525705|FG000|STARTED|Overall Study||41||
48083938|NCT03098550|100525706|FG001|STARTED|Overall Study||21||
48083939|NCT03098550|100525707|FG002|STARTED|Overall Study||43||
48083940|NCT03098550|100525705|FG000|COMPLETED|Overall Study||0||
48083941|NCT03098550|100525706|FG001|COMPLETED|Overall Study||1||
48083942|NCT03098550|100525707|FG002|COMPLETED|Overall Study||0||
48083943|NCT03098550|100525705|FG000|NOT COMPLETED|Overall Study||41||
48083944|NCT03098550|100525706|FG001|NOT COMPLETED|Overall Study||20||
48083945|NCT03098550|100525707|FG002|NOT COMPLETED|Overall Study||43||
48083946|NCT01673867|100525708|FG000|STARTED|Randomization||292|Started = Randomized|
48083947|NCT01673867|100525709|FG001|STARTED|Randomization||290|Started = Randomized|
48083948|NCT01673867|100525708|FG000|COMPLETED|Randomization||287|Completed = Received treatment|
48083949|NCT01673867|100525709|FG001|COMPLETED|Randomization||268|Completed = Received treatment|
48083950|NCT01673867|100525708|FG000|NOT COMPLETED|Randomization||5||
48083951|NCT01673867|100525709|FG001|NOT COMPLETED|Randomization||22||
48083952|NCT01673867|100525708|FG000|STARTED|Treatment||287|Started = Received treatment|
48083953|NCT01673867|100525709|FG001|STARTED|Treatment||268|Started = Received treatment|
48083954|NCT01673867|100525708|FG000|Participants Who Transitioned to Nivolumab 3 mg/kg|Treatment||0||
48083955|NCT01673867|100525709|FG001|Participants Who Transitioned to Nivolumab 3 mg/kg|Treatment||17||
48083956|NCT01673867|100525708|FG000|Participants Who Transitioned to Nivolumab 480 mg|Treatment||15||
48083957|NCT01673867|100525709|FG001|Participants Who Transitioned to Nivolumab 480 mg|Treatment||1||
48083958|NCT01673867|100525708|FG000|COMPLETED|Treatment||2|Completed = Completed treatment period|
48083959|NCT01673867|100525709|FG001|COMPLETED|Treatment||0|Completed = Completed treatment period|
48083960|NCT01673867|100525708|FG000|NOT COMPLETED|Treatment||285||
48083961|NCT01673867|100525709|FG001|NOT COMPLETED|Treatment||268||
48083962|NCT01874054|100525710|FG000|STARTED|Overall Study||55||
48083963|NCT01874054|100525710|FG000|Completed ≥2 Cycles of Combo Treatment|Overall Study||53||
48083964|NCT01874054|100525710|FG000|Completed 16 Cycles of BV Treatment|Overall Study||17||
48083965|NCT01874054|100525710|FG000|COMPLETED|Overall Study||0|No patients completed per protocol as there was no pre-defined follow-up period|
48083966|NCT01874054|100525710|FG000|NOT COMPLETED|Overall Study||55||
48083967|NCT02947997|100525711|FG000|STARTED|Overall Study||4||
48083968|NCT02947997|100525711|FG000|COMPLETED|Overall Study||4||
48083969|NCT02947997|100525711|FG000|NOT COMPLETED|Overall Study||0||
48083970|NCT01433991|100525712|FG000|STARTED|Pretreatment Phase (Single Agent Run-in)||5|30 participants enrolled in Pretreatment Phase (single agent run in period) and 28 went on to receive combination treatment in the Treatment Phase and 2 participants were discontinued after receiving only single-agent therapy in the Pretreatment Phase.|
48083971|NCT01433991|100525713|FG001|STARTED|Pretreatment Phase (Single Agent Run-in)||3|30 participants enrolled in Pretreatment Phase (single agent run in period) and 28 went on to receive combination treatment in the Treatment Phase and 2 participants were discontinued after receiving only single-agent therapy in the Pretreatment Phase.|
48083972|NCT01433991|100525714|FG002|STARTED|Pretreatment Phase (Single Agent Run-in)||14|30 participants enrolled in Pretreatment Phase (single agent run in period) and 28 went on to receive combination treatment in the Treatment Phase and 2 participants were discontinued after receiving only single-agent therapy in the Pretreatment Phase.|
48083973|NCT01433991|100525715|FG003|STARTED|Pretreatment Phase (Single Agent Run-in)||8|30 participants enrolled in Pretreatment Phase (single agent run in period) and 28 went on to receive combination treatment in the Treatment Phase and 2 participants were discontinued after receiving only single-agent therapy in the Pretreatment Phase.|
48083974|NCT01433991|100525712|FG000|COMPLETED|Pretreatment Phase (Single Agent Run-in)||3||
48083975|NCT01433991|100525713|FG001|COMPLETED|Pretreatment Phase (Single Agent Run-in)||3||
48083976|NCT01433991|100525714|FG002|COMPLETED|Pretreatment Phase (Single Agent Run-in)||14||
48083977|NCT01433991|100525715|FG003|COMPLETED|Pretreatment Phase (Single Agent Run-in)||8||
48083978|NCT01433991|100525712|FG000|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||2||
48083979|NCT01433991|100525713|FG001|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||0||
48083980|NCT01433991|100525714|FG002|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||0||
48083981|NCT01433991|100525715|FG003|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||0||
48083982|NCT01433991|100525712|FG000|STARTED|Treatment Phase (Combination Agent)||3||
48083983|NCT01433991|100525713|FG001|STARTED|Treatment Phase (Combination Agent)||3||
48083984|NCT01433991|100525714|FG002|STARTED|Treatment Phase (Combination Agent)||14||
48083985|NCT01433991|100525715|FG003|STARTED|Treatment Phase (Combination Agent)||8||
48083986|NCT01433991|100525712|FG000|COMPLETED|Treatment Phase (Combination Agent)||1||
48083987|NCT01433991|100525713|FG001|COMPLETED|Treatment Phase (Combination Agent)||2||
48083988|NCT01433991|100525714|FG002|COMPLETED|Treatment Phase (Combination Agent)||8||
48083989|NCT01433991|100525715|FG003|COMPLETED|Treatment Phase (Combination Agent)||2||
48083990|NCT01433991|100525712|FG000|NOT COMPLETED|Treatment Phase (Combination Agent)||2||
48083991|NCT01433991|100525713|FG001|NOT COMPLETED|Treatment Phase (Combination Agent)||1||
48083992|NCT01433991|100525714|FG002|NOT COMPLETED|Treatment Phase (Combination Agent)||6||
48083993|NCT01433991|100525715|FG003|NOT COMPLETED|Treatment Phase (Combination Agent)||6||
48083994|NCT04342897|100525716|FG000|STARTED|Overall Study||47||
48083995|NCT04342897|100525717|FG001|STARTED|Overall Study||48||
48083996|NCT04342897|100525716|FG000|Received at Least One Dose of Study Drug|Overall Study||47||
48083997|NCT04342897|100525717|FG001|Received at Least One Dose of Study Drug|Overall Study||48||
48083998|NCT04342897|100525716|FG000|COMPLETED|Overall Study||33||
48083999|NCT04342897|100525717|FG001|COMPLETED|Overall Study||36||
48084000|NCT04342897|100525716|FG000|NOT COMPLETED|Overall Study||14||
48084001|NCT04342897|100525717|FG001|NOT COMPLETED|Overall Study||12||
48084002|NCT02734940|100525718|FG000|STARTED|Overall Study||0||
48084003|NCT02734940|100525719|FG001|STARTED|Overall Study||0||
48084004|NCT02734940|100525718|FG000|COMPLETED|Overall Study||0||
48084005|NCT02734940|100525719|FG001|COMPLETED|Overall Study||0||
48084006|NCT02734940|100525718|FG000|NOT COMPLETED|Overall Study||0||
48084007|NCT02734940|100525719|FG001|NOT COMPLETED|Overall Study||0||
48084008|NCT01384760|100525720|FG000|STARTED|Overall Study||61||
48084009|NCT01384760|100525721|FG001|STARTED|Overall Study||43||
48084010|NCT01384760|100525720|FG000|Randomized|Overall Study||61||
48084011|NCT01384760|100525721|FG001|Randomized|Overall Study||43||
48084012|NCT01384760|100525720|FG000|COMPLETED|Overall Study||45||
48084013|NCT01384760|100525721|FG001|COMPLETED|Overall Study||37||
48084014|NCT01384760|100525720|FG000|NOT COMPLETED|Overall Study||16||
48084015|NCT01384760|100525721|FG001|NOT COMPLETED|Overall Study||6||
48084016|NCT03725098|100525722|FG000|STARTED|Overall Study||53|1 additional subject enrolled due to delay in reporting function of electronic database.|
48084017|NCT03725098|100525723|FG001|STARTED|Overall Study||52|1 additional subject enrolled due to delay in reporting function of electronic database.|
48084018|NCT03725098|100525722|FG000|COMPLETED|Overall Study||53||
48084019|NCT03725098|100525723|FG001|COMPLETED|Overall Study||52||
48084020|NCT03725098|100525722|FG000|NOT COMPLETED|Overall Study||0||
48084021|NCT03725098|100525723|FG001|NOT COMPLETED|Overall Study||0||
48084022|NCT02343627|100525724|FG000|STARTED|Overall Study||35||
48084023|NCT02343627|100525725|FG001|STARTED|Overall Study||12||
48084024|NCT02343627|100525724|FG000|COMPLETED|Overall Study||23||
48084025|NCT02343627|100525725|FG001|COMPLETED|Overall Study||11||
48084026|NCT02343627|100525724|FG000|NOT COMPLETED|Overall Study||12||
48084027|NCT02343627|100525725|FG001|NOT COMPLETED|Overall Study||1||
48084028|NCT02695498|100525726|FG000|STARTED|Overall Study||45||
48084029|NCT02695498|100525727|FG001|STARTED|Overall Study||44||
48084030|NCT02695498|100525726|FG000|COMPLETED|Overall Study||45||
48084031|NCT02695498|100525727|FG001|COMPLETED|Overall Study||44||
48084032|NCT02695498|100525726|FG000|NOT COMPLETED|Overall Study||0||
48084033|NCT02695498|100525727|FG001|NOT COMPLETED|Overall Study||0||
48084034|NCT00023764|100525728|FG000|STARTED|Overall Study||103||
48084035|NCT00023764|100525728|FG000|COMPLETED|Overall Study||89||
48084036|NCT00023764|100525728|FG000|NOT COMPLETED|Overall Study||14||
48084037|NCT00056316|100525729|FG000|STARTED|Overall Study||33||
48084038|NCT00056316|100525730|FG001|STARTED|Overall Study||41||
48084039|NCT00056316|100525729|FG000|COMPLETED|Overall Study||30||
48084040|NCT00056316|100525730|FG001|COMPLETED|Overall Study||38||
48084041|NCT00056316|100525729|FG000|NOT COMPLETED|Overall Study||3||
48084042|NCT00056316|100525730|FG001|NOT COMPLETED|Overall Study||3||
48084043|NCT04980040|100525731|FG000|STARTED|Overall Study||3623||
48540849|NCT00086281|101662590|FG004|STARTED|Phase 1||1||
48084044|NCT04980040|100525731|FG000|COMPLETED|Overall Study||3131||
48084045|NCT04980040|100525731|FG000|NOT COMPLETED|Overall Study||492||
48084046|NCT01548651|100525732|FG000|STARTED|Overall Study||4||
48084047|NCT01548651|100525733|FG001|STARTED|Overall Study||4||
48084048|NCT01548651|100525732|FG000|COMPLETED|Overall Study||3||
48084049|NCT01548651|100525733|FG001|COMPLETED|Overall Study||4||
48084050|NCT01548651|100525732|FG000|NOT COMPLETED|Overall Study||1||
48084051|NCT01548651|100525733|FG001|NOT COMPLETED|Overall Study||0||
48084052|NCT00824512|100525734|FG000|STARTED|Overall Study||11||
48084053|NCT00824512|100525735|FG001|STARTED|Overall Study||11||
48084054|NCT00824512|100525734|FG000|COMPLETED|Overall Study||11||
48084055|NCT00824512|100525735|FG001|COMPLETED|Overall Study||11||
48084056|NCT00824512|100525734|FG000|NOT COMPLETED|Overall Study||0||
48084057|NCT00824512|100525735|FG001|NOT COMPLETED|Overall Study||0||
48084058|NCT03779724|100525736|FG000|STARTED|Overall Study||25||
48084059|NCT03779724|100525737|FG001|STARTED|Overall Study||25||
48084060|NCT03779724|100525736|FG000|COMPLETED|Overall Study||19||
48084061|NCT03779724|100525737|FG001|COMPLETED|Overall Study||21||
48084062|NCT03779724|100525736|FG000|NOT COMPLETED|Overall Study||6||
48084063|NCT03779724|100525737|FG001|NOT COMPLETED|Overall Study||4||
48084064|NCT01025791|100525738|FG000|STARTED|Period 1||2||
48084065|NCT01025791|100525739|FG001|STARTED|Period 1||2||
48084066|NCT01025791|100525740|FG002|STARTED|Period 1||2||
48247148|NCT02382406|100924176|FG001|COMPLETED|Follow up||0||
48247149|NCT02382406|100924177|FG002|COMPLETED|Follow up||2||
48247150|NCT02382406|100924175|FG000|NOT COMPLETED|Follow up||14||
48247151|NCT02382406|100924176|FG001|NOT COMPLETED|Follow up||0||
48247152|NCT02382406|100924177|FG002|NOT COMPLETED|Follow up||30||
48247153|NCT00166361|100924178|FG000|STARTED|Overall Study||14||
48247154|NCT00166361|100924179|FG001|STARTED|Overall Study||10||
48247155|NCT00166361|100924178|FG000|COMPLETED|Overall Study||14||
48247156|NCT00166361|100924179|FG001|COMPLETED|Overall Study||10||
48247157|NCT00166361|100924178|FG000|NOT COMPLETED|Overall Study||0||
48247158|NCT00166361|100924179|FG001|NOT COMPLETED|Overall Study||0||
48247159|NCT02391545|100924180|FG000|STARTED|Overall Study||27||
48247160|NCT02391545|100924181|FG001|STARTED|Overall Study||28||
48247161|NCT02391545|100924180|FG000|COMPLETED|Overall Study||1||
48540850|NCT00086281|101662591|FG005|STARTED|Phase 1||3||
48540851|NCT00086281|101662592|FG006|STARTED|Phase 1||1||
48084067|NCT01025791|100525741|FG003|STARTED|Period 1||2||
48084068|NCT01025791|100525742|FG004|STARTED|Period 1||2||
48084069|NCT01025791|100525743|FG005|STARTED|Period 1||2||
48084070|NCT01025791|100525744|FG006|STARTED|Period 1||2||
48247162|NCT02391545|100924181|FG001|COMPLETED|Overall Study||0||
48247163|NCT02391545|100924180|FG000|NOT COMPLETED|Overall Study||26||
48247164|NCT02391545|100924181|FG001|NOT COMPLETED|Overall Study||28||
48247165|NCT00475787|100924182|FG000|STARTED|Overall Study||69||
48247166|NCT00475787|100924183|FG001|STARTED|Overall Study||67||
48247167|NCT00475787|100924182|FG000|COMPLETED|Overall Study||61||
48247168|NCT00475787|100924183|FG001|COMPLETED|Overall Study||60||
48247169|NCT00475787|100924182|FG000|NOT COMPLETED|Overall Study||8||
48247170|NCT00475787|100924183|FG001|NOT COMPLETED|Overall Study||7||
48247171|NCT00111839|100924184|FG000|STARTED|Overall Study||50||
48247172|NCT00111839|100924185|FG001|STARTED|Overall Study||51||
48540852|NCT00086281|101662593|FG007|STARTED|Phase 1||1||
48540853|NCT00086281|101662594|FG008|STARTED|Phase 1||2||
48540854|NCT00086281|101662595|FG009|STARTED|Phase 1||1||
48540855|NCT00086281|101662596|FG010|STARTED|Phase 1||3||
48540856|NCT00086281|101662597|FG011|STARTED|Phase 1||1||
48540857|NCT00086281|101662598|FG012|STARTED|Phase 1||1||
48540858|NCT00086281|101662599|FG013|STARTED|Phase 1||1||
48682717|NCT01331681|102006666|FG001|Completed Week 100|Overall Study||110||
48682718|NCT01331681|102006667|FG002|Completed Week 100|Overall Study||105||
48682719|NCT01331681|102006665|FG000|Completed Week 148|Overall Study||101||
48682720|NCT01331681|102006666|FG001|Completed Week 148|Overall Study||101||
48682721|NCT01331681|102006667|FG002|Completed Week 148|Overall Study||100||
48682722|NCT01331681|102006665|FG000|COMPLETED|Overall Study||101||
48084071|NCT01025791|100525745|FG007|STARTED|Period 1||2||
48084072|NCT01025791|100525746|FG008|STARTED|Period 1||2||
48247173|NCT00111839|100924186|FG002|STARTED|Overall Study||49||
48247174|NCT00111839|100924184|FG000|Treated|Overall Study||50||
48247175|NCT00111839|100924185|FG001|Treated|Overall Study||51||
48247176|NCT00111839|100924186|FG002|Treated|Overall Study||47||
48084073|NCT01025791|100525747|FG009|STARTED|Period 1||1||
48084074|NCT01025791|100525748|FG010|STARTED|Period 1||2||
48084075|NCT01025791|100525749|FG011|STARTED|Period 1||1||
48084076|NCT01025791|100525750|FG012|STARTED|Period 1||2||
48084077|NCT01025791|100525751|FG013|STARTED|Period 1||1||
48084078|NCT01025791|100525738|FG000|COMPLETED|Period 1||2||
48084079|NCT01025791|100525739|FG001|COMPLETED|Period 1||2||
48084080|NCT01025791|100525740|FG002|COMPLETED|Period 1||2||
48084081|NCT01025791|100525741|FG003|COMPLETED|Period 1||2||
48084082|NCT01025791|100525742|FG004|COMPLETED|Period 1||2||
48084083|NCT01025791|100525743|FG005|COMPLETED|Period 1||2||
48084084|NCT01025791|100525744|FG006|COMPLETED|Period 1||2||
48084085|NCT01025791|100525745|FG007|COMPLETED|Period 1||2||
48084086|NCT01025791|100525746|FG008|COMPLETED|Period 1||2||
48084087|NCT01025791|100525747|FG009|COMPLETED|Period 1||1||
48084088|NCT01025791|100525748|FG010|COMPLETED|Period 1||2||
48084089|NCT01025791|100525749|FG011|COMPLETED|Period 1||1||
48084090|NCT01025791|100525750|FG012|COMPLETED|Period 1||2||
48084091|NCT01025791|100525751|FG013|COMPLETED|Period 1||1||
48084092|NCT01025791|100525738|FG000|NOT COMPLETED|Period 1||0||
48084093|NCT01025791|100525739|FG001|NOT COMPLETED|Period 1||0||
48084094|NCT01025791|100525740|FG002|NOT COMPLETED|Period 1||0||
48084095|NCT01025791|100525741|FG003|NOT COMPLETED|Period 1||0||
48084096|NCT01025791|100525742|FG004|NOT COMPLETED|Period 1||0||
48247177|NCT00111839|100924184|FG000|COMPLETED|Overall Study||2||
48540859|NCT00086281|101662600|FG014|STARTED|Phase 1||3||
48540860|NCT00086281|101662586|FG000|COMPLETED|Phase 1||11||
48540861|NCT00086281|101662587|FG001|COMPLETED|Phase 1||12||
48247178|NCT00111839|100924185|FG001|COMPLETED|Overall Study||5||
48084097|NCT01025791|100525743|FG005|NOT COMPLETED|Period 1||0||
48084098|NCT01025791|100525744|FG006|NOT COMPLETED|Period 1||0||
48084099|NCT01025791|100525745|FG007|NOT COMPLETED|Period 1||0||
48084100|NCT01025791|100525746|FG008|NOT COMPLETED|Period 1||0||
48084101|NCT01025791|100525747|FG009|NOT COMPLETED|Period 1||0||
48084102|NCT01025791|100525748|FG010|NOT COMPLETED|Period 1||0||
48084103|NCT01025791|100525749|FG011|NOT COMPLETED|Period 1||0||
48084104|NCT01025791|100525750|FG012|NOT COMPLETED|Period 1||0||
48084105|NCT01025791|100525751|FG013|NOT COMPLETED|Period 1||0||
48247179|NCT00111839|100924186|FG002|COMPLETED|Overall Study||0||
48247180|NCT00111839|100924184|FG000|NOT COMPLETED|Overall Study||48||
48247181|NCT00111839|100924185|FG001|NOT COMPLETED|Overall Study||46||
48247182|NCT00111839|100924186|FG002|NOT COMPLETED|Overall Study||49||
48247183|NCT03314233|100924187|FG000|STARTED|Overall Study||21||
48247184|NCT03314233|100924187|FG000|COMPLETED|Overall Study||20||
48247185|NCT03314233|100924187|FG000|NOT COMPLETED|Overall Study||1||
48247186|NCT01959607|100924188|FG000|STARTED|Washout Period of 1 Day (Day 0)||22||
48247187|NCT01959607|100924189|FG001|STARTED|Washout Period of 1 Day (Day 0)||22||
48247188|NCT01959607|100924190|FG002|STARTED|Washout Period of 1 Day (Day 0)||9||
48247189|NCT01959607|100924191|FG003|STARTED|Washout Period of 1 Day (Day 0)||9||
48247190|NCT01959607|100924188|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22||
48247191|NCT01959607|100924189|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||22||
48247192|NCT01959607|100924190|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9||
48247193|NCT01959607|100924191|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9||
48247194|NCT01959607|100924188|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0||
48247195|NCT01959607|100924189|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0||
48247196|NCT01959607|100924190|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0||
48247197|NCT01959607|100924191|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0||
48247198|NCT01959607|100924188|FG000|STARTED|First Intervention (Day 1)||22||
48247199|NCT01959607|100924189|FG001|STARTED|First Intervention (Day 1)||22||
48247200|NCT01959607|100924190|FG002|STARTED|First Intervention (Day 1)||9||
48247201|NCT01959607|100924191|FG003|STARTED|First Intervention (Day 1)||9||
48247202|NCT01959607|100924188|FG000|COMPLETED|First Intervention (Day 1)||21||
48247203|NCT01959607|100924189|FG001|COMPLETED|First Intervention (Day 1)||21||
48247204|NCT01959607|100924190|FG002|COMPLETED|First Intervention (Day 1)||9||
48247205|NCT01959607|100924191|FG003|COMPLETED|First Intervention (Day 1)||9||
48247206|NCT01959607|100924188|FG000|NOT COMPLETED|First Intervention (Day 1)||1||
48247207|NCT01959607|100924189|FG001|NOT COMPLETED|First Intervention (Day 1)||1||
48247208|NCT01959607|100924190|FG002|NOT COMPLETED|First Intervention (Day 1)||0||
48247209|NCT01959607|100924191|FG003|NOT COMPLETED|First Intervention (Day 1)||0||
48247210|NCT01959607|100924188|FG000|STARTED|Washout Period of 1 Day (Day 2)||21||
48247211|NCT01959607|100924189|FG001|STARTED|Washout Period of 1 Day (Day 2)||21||
48247212|NCT01959607|100924190|FG002|STARTED|Washout Period of 1 Day (Day 2)||9||
48247213|NCT01959607|100924191|FG003|STARTED|Washout Period of 1 Day (Day 2)||9||
48247214|NCT01959607|100924188|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||21||
48247215|NCT01959607|100924189|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||21||
48247216|NCT01959607|100924190|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9||
48247217|NCT01959607|100924191|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||9||
48084106|NCT01025791|100525738|FG000|STARTED|Period 2||2||
48084107|NCT01025791|100525739|FG001|STARTED|Period 2||2||
48084108|NCT01025791|100525740|FG002|STARTED|Period 2||2||
48084109|NCT01025791|100525741|FG003|STARTED|Period 2||2||
48084110|NCT01025791|100525742|FG004|STARTED|Period 2||2||
48084111|NCT01025791|100525743|FG005|STARTED|Period 2||2||
48084112|NCT01025791|100525744|FG006|STARTED|Period 2||2||
48247218|NCT01959607|100924188|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
48247219|NCT01959607|100924189|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
48247220|NCT01959607|100924190|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
48247221|NCT01959607|100924191|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
48247222|NCT01959607|100924188|FG000|STARTED|Second Intervention (Day 3)||21||
48247223|NCT01959607|100924189|FG001|STARTED|Second Intervention (Day 3)||21||
48247224|NCT01959607|100924190|FG002|STARTED|Second Intervention (Day 3)||9||
48247225|NCT01959607|100924191|FG003|STARTED|Second Intervention (Day 3)||9||
48247226|NCT01959607|100924188|FG000|COMPLETED|Second Intervention (Day 3)||21||
48247227|NCT01959607|100924189|FG001|COMPLETED|Second Intervention (Day 3)||21||
48247228|NCT01959607|100924190|FG002|COMPLETED|Second Intervention (Day 3)||9||
48247229|NCT01959607|100924191|FG003|COMPLETED|Second Intervention (Day 3)||9||
48247230|NCT01959607|100924188|FG000|NOT COMPLETED|Second Intervention (Day 3)||0||
48247231|NCT01959607|100924189|FG001|NOT COMPLETED|Second Intervention (Day 3)||0||
48247232|NCT01959607|100924190|FG002|NOT COMPLETED|Second Intervention (Day 3)||0||
48247233|NCT01959607|100924191|FG003|NOT COMPLETED|Second Intervention (Day 3)||0||
48247234|NCT04491136|100924192|FG000|STARTED|Overall Study||201||
48247235|NCT04491136|100924192|FG000|Safety Set (SS)|Overall Study||201|all patients who received at least one dose of study treatment.|
48084113|NCT01025791|100525745|FG007|STARTED|Period 2||2||
48084114|NCT01025791|100525746|FG008|STARTED|Period 2||2||
48084115|NCT01025791|100525747|FG009|STARTED|Period 2||1||
48084116|NCT01025791|100525748|FG010|STARTED|Period 2||2||
48084117|NCT01025791|100525749|FG011|STARTED|Period 2||1||
48247236|NCT04491136|100924192|FG000|Efficacy Analysis Set (EAS)|Overall Study||140|Patients in the safety set who received at least one dose of ARNI and completed 12 months of treatment and follow-up or withdrew early after receiving at least one dose of ARNI.|
48247237|NCT04491136|100924192|FG000|COMPLETED|Overall Study||122||
48247238|NCT04491136|100924192|FG000|NOT COMPLETED|Overall Study||79||
48247239|NCT01298219|100924193|FG000|STARTED|Overall Study||219||
48247240|NCT01298219|100924194|FG001|STARTED|Overall Study||220||
48247241|NCT01298219|100924193|FG000|Intention to Treat (ITT)|Overall Study||219||
48247242|NCT01298219|100924194|FG001|Intention to Treat (ITT)|Overall Study||220||
48247243|NCT01298219|100924193|FG000|Safety Analysis Set|Overall Study||219||
48247244|NCT01298219|100924194|FG001|Safety Analysis Set|Overall Study||220||
48247245|NCT01298219|100924193|FG000|COMPLETED|Overall Study||169||
48247246|NCT01298219|100924194|FG001|COMPLETED|Overall Study||184||
48247247|NCT01298219|100924193|FG000|NOT COMPLETED|Overall Study||50||
48247248|NCT01298219|100924194|FG001|NOT COMPLETED|Overall Study||36||
48247249|NCT01730118|100924195|FG000|STARTED|Dose Escalation||6||
48247250|NCT01730118|100924196|FG001|STARTED|Dose Escalation||7||
48247251|NCT01730118|100924197|FG002|STARTED|Dose Escalation||6||
48247252|NCT01730118|100924198|FG003|STARTED|Dose Escalation||6||
48247253|NCT01730118|100924199|FG004|STARTED|Dose Escalation||0||
48247254|NCT01730118|100924200|FG005|STARTED|Dose Escalation||0||
48247255|NCT01730118|100924201|FG006|STARTED|Dose Escalation||2||
48247256|NCT01730118|100924195|FG000|COMPLETED|Dose Escalation||0||
48247257|NCT01730118|100924196|FG001|COMPLETED|Dose Escalation||0||
48247258|NCT01730118|100924197|FG002|COMPLETED|Dose Escalation||3||
48247259|NCT01730118|100924198|FG003|COMPLETED|Dose Escalation||0||
48247260|NCT01730118|100924199|FG004|COMPLETED|Dose Escalation||0||
48247261|NCT01730118|100924200|FG005|COMPLETED|Dose Escalation||0||
48247262|NCT01730118|100924201|FG006|COMPLETED|Dose Escalation||0||
48247263|NCT01730118|100924195|FG000|NOT COMPLETED|Dose Escalation||6||
48247264|NCT01730118|100924196|FG001|NOT COMPLETED|Dose Escalation||7||
48247265|NCT01730118|100924197|FG002|NOT COMPLETED|Dose Escalation||3||
48247266|NCT01730118|100924198|FG003|NOT COMPLETED|Dose Escalation||6||
48247267|NCT01730118|100924199|FG004|NOT COMPLETED|Dose Escalation||0||
48247268|NCT01730118|100924200|FG005|NOT COMPLETED|Dose Escalation||0||
48247269|NCT01730118|100924201|FG006|NOT COMPLETED|Dose Escalation||2||
48247270|NCT01730118|100924195|FG000|STARTED|Dose Expansion||0||
48247271|NCT01730118|100924196|FG001|STARTED|Dose Expansion||0||
48247272|NCT01730118|100924197|FG002|STARTED|Dose Expansion||0||
48247273|NCT01730118|100924198|FG003|STARTED|Dose Expansion||0||
48247274|NCT01730118|100924199|FG004|STARTED|Dose Expansion||3||
48247275|NCT01730118|100924200|FG005|STARTED|Dose Expansion||3||
48247276|NCT01730118|100924201|FG006|STARTED|Dose Expansion||0||
48247277|NCT01730118|100924195|FG000|COMPLETED|Dose Expansion||0||
48247278|NCT01730118|100924196|FG001|COMPLETED|Dose Expansion||0||
48247279|NCT01730118|100924197|FG002|COMPLETED|Dose Expansion||0||
48247280|NCT01730118|100924198|FG003|COMPLETED|Dose Expansion||0||
48247281|NCT01730118|100924199|FG004|COMPLETED|Dose Expansion||0||
48247282|NCT01730118|100924200|FG005|COMPLETED|Dose Expansion||0||
48247283|NCT01730118|100924201|FG006|COMPLETED|Dose Expansion||0||
48247284|NCT01730118|100924195|FG000|NOT COMPLETED|Dose Expansion||0||
48247285|NCT01730118|100924196|FG001|NOT COMPLETED|Dose Expansion||0||
48247286|NCT01730118|100924197|FG002|NOT COMPLETED|Dose Expansion||0||
48247287|NCT01730118|100924198|FG003|NOT COMPLETED|Dose Expansion||0||
48247288|NCT01730118|100924199|FG004|NOT COMPLETED|Dose Expansion||3||
48247289|NCT01730118|100924200|FG005|NOT COMPLETED|Dose Expansion||3||
48247290|NCT01730118|100924201|FG006|NOT COMPLETED|Dose Expansion||0||
48247291|NCT04688086|100924202|FG000|STARTED|Overall Study||687||
48247292|NCT04688086|100924202|FG000|COMPLETED|Overall Study||459||
48247293|NCT04688086|100924202|FG000|NOT COMPLETED|Overall Study||228||
48247294|NCT01679613|100924203|FG000|STARTED|Overall Study||4||
48247295|NCT01679613|100924204|FG001|STARTED|Overall Study||4||
48247296|NCT01679613|100924205|FG002|STARTED|Overall Study||13||
48247297|NCT01679613|100924206|FG003|STARTED|Overall Study||13||
48247298|NCT01679613|100924203|FG000|Received Nintedanib (Pilot)|Overall Study||4||
48247299|NCT01679613|100924204|FG001|Received Nintedanib (Pilot)|Overall Study||3||
48247300|NCT01679613|100924205|FG002|Received Nintedanib (Pilot)|Overall Study||0||
48247301|NCT01679613|100924206|FG003|Received Nintedanib (Pilot)|Overall Study||0||
48247302|NCT01679613|100924203|FG000|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||4||
48247303|NCT01679613|100924204|FG001|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||4||
48247304|NCT01679613|100924205|FG002|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0||
48247305|NCT01679613|100924206|FG003|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0||
48247306|NCT01679613|100924203|FG000|Received Nintedanib (Main)|Overall Study||0||
48247307|NCT01679613|100924204|FG001|Received Nintedanib (Main)|Overall Study||0||
48247308|NCT01679613|100924205|FG002|Received Nintedanib (Main)|Overall Study||13||
48247309|NCT01679613|100924206|FG003|Received Nintedanib (Main)|Overall Study||11||
48247310|NCT01679613|100924203|FG000|Received Nintedanib+Ketoconazole (Main)|Overall Study||0||
48247311|NCT01679613|100924204|FG001|Received Nintedanib+Ketoconazole (Main)|Overall Study||0||
48247312|NCT01679613|100924205|FG002|Received Nintedanib+Ketoconazole (Main)|Overall Study||13||
48247313|NCT01679613|100924206|FG003|Received Nintedanib+Ketoconazole (Main)|Overall Study||13||
48247314|NCT01679613|100924203|FG000|COMPLETED|Overall Study||4||
48247315|NCT01679613|100924204|FG001|COMPLETED|Overall Study||3||
48247316|NCT01679613|100924205|FG002|COMPLETED|Overall Study||11||
48247317|NCT01679613|100924206|FG003|COMPLETED|Overall Study||11||
48247318|NCT01679613|100924203|FG000|NOT COMPLETED|Overall Study||0||
48247319|NCT01679613|100924204|FG001|NOT COMPLETED|Overall Study||1||
48247320|NCT01679613|100924205|FG002|NOT COMPLETED|Overall Study||2||
48247321|NCT01679613|100924206|FG003|NOT COMPLETED|Overall Study||2||
48247322|NCT03390933|100924207|FG000|STARTED|Overall Study||16||
48247323|NCT03390933|100924207|FG000|COMPLETED|Overall Study||15||
48247324|NCT03390933|100924207|FG000|NOT COMPLETED|Overall Study||1||
48247325|NCT02032420|100924208|FG000|STARTED|Overall Study||18||
48247326|NCT02032420|100924209|FG001|STARTED|Overall Study||17||
48247327|NCT02032420|100924208|FG000|COMPLETED|Overall Study||18||
48247328|NCT02032420|100924209|FG001|COMPLETED|Overall Study||17||
48247329|NCT02032420|100924208|FG000|NOT COMPLETED|Overall Study||0||
48247330|NCT02032420|100924209|FG001|NOT COMPLETED|Overall Study||0||
48247331|NCT01287416|100924210|FG000|STARTED|Pre-post Training||48||
48247332|NCT01287416|100924211|FG001|STARTED|Pre-post Training||48||
48247333|NCT01287416|100924210|FG000|Training Workshop|Pre-post Training||31||
48247334|NCT01287416|100924211|FG001|Training Workshop|Pre-post Training||24||
48247335|NCT01287416|100924210|FG000|Post Training Questionnaire|Pre-post Training||26||
48247336|NCT01287416|100924211|FG001|Post Training Questionnaire|Pre-post Training||23||
48247337|NCT01287416|100924210|FG000|COMPLETED|Pre-post Training||26||
48247338|NCT01287416|100924211|FG001|COMPLETED|Pre-post Training||23||
48247339|NCT01287416|100924210|FG000|NOT COMPLETED|Pre-post Training||22||
48247340|NCT01287416|100924211|FG001|NOT COMPLETED|Pre-post Training||25||
48247341|NCT01287416|100924210|FG000|STARTED|6 Month Follow-up||31||
48247342|NCT01287416|100924211|FG001|STARTED|6 Month Follow-up||24||
48247343|NCT01287416|100924210|FG000|COMPLETED|6 Month Follow-up||28||
48247344|NCT01287416|100924211|FG001|COMPLETED|6 Month Follow-up||22||
48247345|NCT01287416|100924210|FG000|NOT COMPLETED|6 Month Follow-up||3||
48247346|NCT01287416|100924211|FG001|NOT COMPLETED|6 Month Follow-up||2||
48247347|NCT03410953|100924212|FG000|STARTED|Overall Study||67||
48247348|NCT03410953|100924212|FG000|COMPLETED|Overall Study||67||
48247349|NCT03410953|100924212|FG000|NOT COMPLETED|Overall Study||0||
48247350|NCT00705614|100924213|FG000|STARTED|Initial Intervention||1541||
48247351|NCT00705614|100924214|FG001|STARTED|Initial Intervention||1121||
48247352|NCT00705614|100924213|FG000|COMPLETED|Initial Intervention||1023||
48247353|NCT00705614|100924214|FG001|COMPLETED|Initial Intervention||800||
48247354|NCT00705614|100924213|FG000|NOT COMPLETED|Initial Intervention||518||
48247355|NCT00705614|100924214|FG001|NOT COMPLETED|Initial Intervention||321||
48247356|NCT00705614|100924213|FG000|STARTED|Switch to Remicade||0||
48247357|NCT00705614|100924214|FG001|STARTED|Switch to Remicade||298||
48247358|NCT00705614|100924213|FG000|COMPLETED|Switch to Remicade||0||
48247359|NCT00705614|100924214|FG001|COMPLETED|Switch to Remicade||249||
48247360|NCT00705614|100924213|FG000|NOT COMPLETED|Switch to Remicade||0||
48247361|NCT00705614|100924214|FG001|NOT COMPLETED|Switch to Remicade||49||
48247362|NCT01797822|100924215|FG000|STARTED|Overall Study||20||
48247363|NCT01797822|100924215|FG000|COMPLETED|Overall Study||20||
48247364|NCT01797822|100924215|FG000|NOT COMPLETED|Overall Study||0||
48247365|NCT02391116|100924216|FG000|STARTED|Treatment||67||
48247366|NCT02391116|100924216|FG000|Included in Per Protocol Set|Treatment||40||
48247367|NCT02391116|100924216|FG000|COMPLETED|Treatment||53||
48247368|NCT02391116|100924216|FG000|NOT COMPLETED|Treatment||14||
48247369|NCT02391116|100924216|FG000|STARTED|Safety Follow-up||56||
48247370|NCT02391116|100924216|FG000|COMPLETED|Safety Follow-up||43||
48247371|NCT02391116|100924216|FG000|NOT COMPLETED|Safety Follow-up||13||
48247372|NCT02391116|100924216|FG000|STARTED|Active Follow-up||9||
48247373|NCT02391116|100924216|FG000|COMPLETED|Active Follow-up||6||
48247374|NCT02391116|100924216|FG000|NOT COMPLETED|Active Follow-up||3||
48247375|NCT02391116|100924216|FG000|STARTED|Survival Follow-up||46||
48247376|NCT02391116|100924216|FG000|COMPLETED|Survival Follow-up||42||
48247377|NCT02391116|100924216|FG000|NOT COMPLETED|Survival Follow-up||4||
48247378|NCT04369664|100924217|FG000|STARTED|Overall Study||76||
48247379|NCT04369664|100924218|FG001|STARTED|Overall Study||75||
48247380|NCT04369664|100924217|FG000|COMPLETED|Overall Study||75||
48247381|NCT04369664|100924218|FG001|COMPLETED|Overall Study||75||
48247382|NCT04369664|100924217|FG000|NOT COMPLETED|Overall Study||1||
48247383|NCT04369664|100924218|FG001|NOT COMPLETED|Overall Study||0||
48247384|NCT01189370|100924219|FG000|STARTED|Dose Level 1||25||
48247385|NCT01189370|100924220|FG001|STARTED|Dose Level 1||0||
48247386|NCT01189370|100924221|FG002|STARTED|Dose Level 1||0||
48247387|NCT01189370|100924219|FG000|COMPLETED|Dose Level 1||16||
48247388|NCT01189370|100924220|FG001|COMPLETED|Dose Level 1||0||
48247389|NCT01189370|100924221|FG002|COMPLETED|Dose Level 1||0||
48247390|NCT01189370|100924219|FG000|NOT COMPLETED|Dose Level 1||9||
48247391|NCT01189370|100924220|FG001|NOT COMPLETED|Dose Level 1||0||
48247392|NCT01189370|100924221|FG002|NOT COMPLETED|Dose Level 1||0||
48247393|NCT01189370|100924219|FG000|STARTED|Dose Level 2||0||
48247394|NCT01189370|100924220|FG001|STARTED|Dose Level 2||16||
48247395|NCT01189370|100924221|FG002|STARTED|Dose Level 2||0||
48247396|NCT01189370|100924219|FG000|COMPLETED|Dose Level 2||0||
48247397|NCT01189370|100924220|FG001|COMPLETED|Dose Level 2||12||
48247398|NCT01189370|100924221|FG002|COMPLETED|Dose Level 2||0||
48247399|NCT01189370|100924219|FG000|NOT COMPLETED|Dose Level 2||0||
48247400|NCT01189370|100924220|FG001|NOT COMPLETED|Dose Level 2||4||
48682723|NCT01331681|102006666|FG001|COMPLETED|Overall Study||101||
48682724|NCT01331681|102006667|FG002|COMPLETED|Overall Study||100||
48682725|NCT01331681|102006665|FG000|NOT COMPLETED|Overall Study||35||
48682726|NCT01331681|102006666|FG001|NOT COMPLETED|Overall Study||34||
48682727|NCT01331681|102006667|FG002|NOT COMPLETED|Overall Study||35||
48682728|NCT01466491|102006668|FG000|STARTED|Overall Study||83||
48682729|NCT01466491|102006669|FG001|STARTED|Overall Study||83||
48247401|NCT01189370|100924221|FG002|NOT COMPLETED|Dose Level 2||0||
48247402|NCT01189370|100924219|FG000|STARTED|Dose Level 3||0||
48247403|NCT01189370|100924220|FG001|STARTED|Dose Level 3||0||
48247404|NCT01189370|100924221|FG002|STARTED|Dose Level 3||12||
48247405|NCT01189370|100924219|FG000|COMPLETED|Dose Level 3||0||
48247406|NCT01189370|100924220|FG001|COMPLETED|Dose Level 3||0||
48247407|NCT01189370|100924221|FG002|COMPLETED|Dose Level 3||6||
48247408|NCT01189370|100924219|FG000|NOT COMPLETED|Dose Level 3||0||
48247409|NCT01189370|100924220|FG001|NOT COMPLETED|Dose Level 3||0||
48247410|NCT01189370|100924221|FG002|NOT COMPLETED|Dose Level 3||6||
48247411|NCT04864236|100924222|FG000|STARTED|Overall Study||39||
48247412|NCT04864236|100924223|FG001|STARTED|Overall Study||40||
48247413|NCT04864236|100924222|FG000|COMPLETED|Overall Study||39||
48247414|NCT04864236|100924223|FG001|COMPLETED|Overall Study||40||
48247415|NCT04864236|100924222|FG000|NOT COMPLETED|Overall Study||0||
48247416|NCT04864236|100924223|FG001|NOT COMPLETED|Overall Study||0||
48247417|NCT00460577|100924224|FG000|STARTED|Overall Study||30||
48247418|NCT00460577|100924225|FG001|STARTED|Overall Study||30||
48247419|NCT00460577|100924224|FG000|COMPLETED|Overall Study||28||
48247420|NCT00460577|100924225|FG001|COMPLETED|Overall Study||24||
48247421|NCT00460577|100924224|FG000|NOT COMPLETED|Overall Study||2||
48247422|NCT00460577|100924225|FG001|NOT COMPLETED|Overall Study||6||
48247423|NCT01924806|100924226|FG000|STARTED|Overall Study||5||5
48247424|NCT01924806|100924227|FG001|STARTED|Overall Study||4||4
48247425|NCT01924806|100924226|FG000|COMPLETED|Overall Study||3||3
48247426|NCT01924806|100924227|FG001|COMPLETED|Overall Study||3||3
48247427|NCT01924806|100924226|FG000|NOT COMPLETED|Overall Study||2||2
48247428|NCT01924806|100924227|FG001|NOT COMPLETED|Overall Study||1||1
48247429|NCT02679079|100924228|FG000|STARTED|Overall Study||33||
48247430|NCT02679079|100924229|FG001|STARTED|Overall Study||32||
48247431|NCT02679079|100924230|FG002|STARTED|Overall Study||33||
48247432|NCT02679079|100924228|FG000|ITT Analysis Set|Overall Study||31|Intent-to-treat (ITT) analysis set included all randomized participants who received at least one dose of study drug, had postbaseline safety data, and had a baseline (Day -1) and at least one postrandomization Total Tic Score (TTS) value reported at a scheduled or mapped early termination (ET) visit during the 6 week treatment period.|
48247433|NCT02679079|100924229|FG001|ITT Analysis Set|Overall Study||32|Intent-to-treat (ITT) analysis set included all randomized participants who received at least one dose of study drug, had postbaseline safety data, and had a baseline (Day -1) and at least one postrandomization Total Tic Score (TTS) value reported at a scheduled or mapped early termination (ET) visit during the 6 week treatment period.|
48247434|NCT02679079|100924230|FG002|ITT Analysis Set|Overall Study||32|Intent-to-treat (ITT) analysis set included all randomized participants who received at least one dose of study drug, had postbaseline safety data, and had a baseline (Day -1) and at least one postrandomization Total Tic Score (TTS) value reported at a scheduled or mapped early termination (ET) visit during the 6 week treatment period.|
48247435|NCT02679079|100924228|FG000|COMPLETED|Overall Study||29||
48247436|NCT02679079|100924229|FG001|COMPLETED|Overall Study||30||
48247437|NCT02679079|100924230|FG002|COMPLETED|Overall Study||31||
48247438|NCT02679079|100924228|FG000|NOT COMPLETED|Overall Study||4||
48247439|NCT02679079|100924229|FG001|NOT COMPLETED|Overall Study||2||
48247440|NCT02679079|100924230|FG002|NOT COMPLETED|Overall Study||2||
48247441|NCT02581137|100924231|FG000|STARTED|Overall Study||26||
48247442|NCT02581137|100924231|FG000|COMPLETED|Overall Study||22||
48247443|NCT02581137|100924231|FG000|NOT COMPLETED|Overall Study||4||
48247444|NCT00759681|100924232|FG000|STARTED|Overall Study||107||
48247445|NCT00759681|100924233|FG001|STARTED|Overall Study||110||
48247446|NCT00759681|100924232|FG000|COMPLETED|Overall Study||97||
48247447|NCT00759681|100924233|FG001|COMPLETED|Overall Study||100||
48247448|NCT00759681|100924232|FG000|NOT COMPLETED|Overall Study||10||
48247449|NCT00759681|100924233|FG001|NOT COMPLETED|Overall Study||10||
48247450|NCT04088136|100924234|FG000|STARTED|Overall Study||35||
48247451|NCT04088136|100924235|FG001|STARTED|Overall Study||33||
48247452|NCT04088136|100924234|FG000|COMPLETED|Overall Study||30||
48247453|NCT04088136|100924235|FG001|COMPLETED|Overall Study||32||
48247454|NCT04088136|100924234|FG000|NOT COMPLETED|Overall Study||5||
48247455|NCT04088136|100924235|FG001|NOT COMPLETED|Overall Study||1||
48247456|NCT02389725|100924236|FG000|STARTED|Overall Study||59||
48247457|NCT02389725|100924237|FG001|STARTED|Overall Study||60||
48247458|NCT02389725|100924236|FG000|COMPLETED|Overall Study||59||
48682730|NCT01466491|102006670|FG002|STARTED|Overall Study||83||
48247459|NCT02389725|100924237|FG001|COMPLETED|Overall Study||60||
48247460|NCT02389725|100924236|FG000|NOT COMPLETED|Overall Study||0||
48247461|NCT02389725|100924237|FG001|NOT COMPLETED|Overall Study||0||
48247462|NCT01678898|100924238|FG000|STARTED|PB-102-F01||6||
48247463|NCT01678898|100924239|FG001|STARTED|PB-102-F01||8||
48247464|NCT01678898|100924240|FG002|STARTED|PB-102-F01||4||
48247465|NCT01678898|100924238|FG000|COMPLETED|PB-102-F01||6||
48247466|NCT01678898|100924239|FG001|COMPLETED|PB-102-F01||6||
48247467|NCT01678898|100924240|FG002|COMPLETED|PB-102-F01||4||
48247468|NCT01678898|100924238|FG000|NOT COMPLETED|PB-102-F01||0||
48247469|NCT01678898|100924239|FG001|NOT COMPLETED|PB-102-F01||2||
48247470|NCT01678898|100924240|FG002|NOT COMPLETED|PB-102-F01||0||
48247471|NCT01678898|100924238|FG000|STARTED|PB-102-F02||6||
48084118|NCT01025791|100525750|FG012|STARTED|Period 2||2||
48084119|NCT01025791|100525751|FG013|STARTED|Period 2||1||
48084120|NCT01025791|100525738|FG000|COMPLETED|Period 2||2||
48084121|NCT01025791|100525739|FG001|COMPLETED|Period 2||2||
48247472|NCT01678898|100924239|FG001|STARTED|PB-102-F02||6||
48247473|NCT01678898|100924240|FG002|STARTED|PB-102-F02||4||
48247474|NCT01678898|100924238|FG000|COMPLETED|PB-102-F02||6||
48247475|NCT01678898|100924239|FG001|COMPLETED|PB-102-F02||6||
48247476|NCT01678898|100924240|FG002|COMPLETED|PB-102-F02||4||
48084122|NCT01025791|100525740|FG002|COMPLETED|Period 2||2||
48084123|NCT01025791|100525741|FG003|COMPLETED|Period 2||2||
48084124|NCT01025791|100525742|FG004|COMPLETED|Period 2||2||
48084125|NCT01025791|100525743|FG005|COMPLETED|Period 2||2||
48084126|NCT01025791|100525744|FG006|COMPLETED|Period 2||2||
48084127|NCT01025791|100525745|FG007|COMPLETED|Period 2||2||
48084128|NCT01025791|100525746|FG008|COMPLETED|Period 2||2||
48084129|NCT01025791|100525747|FG009|COMPLETED|Period 2||1||
48084130|NCT01025791|100525748|FG010|COMPLETED|Period 2||2||
48084131|NCT01025791|100525749|FG011|COMPLETED|Period 2||1||
48084132|NCT01025791|100525750|FG012|COMPLETED|Period 2||2||
48084133|NCT01025791|100525751|FG013|COMPLETED|Period 2||1||
48084134|NCT01025791|100525738|FG000|NOT COMPLETED|Period 2||0||
48084135|NCT01025791|100525739|FG001|NOT COMPLETED|Period 2||0||
48084136|NCT01025791|100525740|FG002|NOT COMPLETED|Period 2||0||
48084137|NCT01025791|100525741|FG003|NOT COMPLETED|Period 2||0||
48084138|NCT01025791|100525742|FG004|NOT COMPLETED|Period 2||0||
48084139|NCT01025791|100525743|FG005|NOT COMPLETED|Period 2||0||
48084140|NCT01025791|100525744|FG006|NOT COMPLETED|Period 2||0||
48084141|NCT01025791|100525745|FG007|NOT COMPLETED|Period 2||0||
48084142|NCT01025791|100525746|FG008|NOT COMPLETED|Period 2||0||
48084143|NCT01025791|100525747|FG009|NOT COMPLETED|Period 2||0||
48084144|NCT01025791|100525748|FG010|NOT COMPLETED|Period 2||0||
48084145|NCT01025791|100525749|FG011|NOT COMPLETED|Period 2||0||
48247477|NCT01678898|100924238|FG000|NOT COMPLETED|PB-102-F02||0||
48247478|NCT01678898|100924239|FG001|NOT COMPLETED|PB-102-F02||0||
48247479|NCT01678898|100924240|FG002|NOT COMPLETED|PB-102-F02||0||
48247480|NCT03327051|100924241|FG000|STARTED|Overall Study||19||
48247481|NCT03327051|100924242|FG001|STARTED|Overall Study||20||
48247482|NCT03327051|100924241|FG000|Received Treatment|Overall Study||16||
48247483|NCT03327051|100924242|FG001|Received Treatment|Overall Study||16||
48247484|NCT03327051|100924241|FG000|Attended Visit 2 (Week 0)|Overall Study||15||
48247485|NCT03327051|100924242|FG001|Attended Visit 2 (Week 0)|Overall Study||15||
48247486|NCT03327051|100924241|FG000|COMPLETED|Overall Study||14||
48247487|NCT03327051|100924242|FG001|COMPLETED|Overall Study||15||
48247488|NCT03327051|100924241|FG000|NOT COMPLETED|Overall Study||5||
48084146|NCT01025791|100525750|FG012|NOT COMPLETED|Period 2||0||
48084147|NCT01025791|100525751|FG013|NOT COMPLETED|Period 2||0||
48084148|NCT01025791|100525738|FG000|STARTED|Period 3||2||
48084149|NCT01025791|100525739|FG001|STARTED|Period 3||2||
48084150|NCT01025791|100525740|FG002|STARTED|Period 3||2||
48084151|NCT01025791|100525741|FG003|STARTED|Period 3||2||
48247489|NCT03327051|100924242|FG001|NOT COMPLETED|Overall Study||5||
48247490|NCT01075100|100924243|FG000|STARTED|Overall Study||49||
48247491|NCT01075100|100924244|FG001|STARTED|Overall Study||54||
48247492|NCT01075100|100924243|FG000|COMPLETED|Overall Study||0||
48247493|NCT01075100|100924244|FG001|COMPLETED|Overall Study||1||
48247494|NCT01075100|100924243|FG000|NOT COMPLETED|Overall Study||49||
48247495|NCT01075100|100924244|FG001|NOT COMPLETED|Overall Study||53||
48247496|NCT02534129|100924245|FG000|STARTED|Overall Study||13||13
48247497|NCT02534129|100924246|FG001|STARTED|Overall Study||13||13
48247498|NCT02534129|100924245|FG000|COMPLETED|Overall Study||13||13
48247499|NCT02534129|100924246|FG001|COMPLETED|Overall Study||13||13
48247500|NCT02534129|100924245|FG000|NOT COMPLETED|Overall Study||0||0
48247501|NCT02534129|100924246|FG001|NOT COMPLETED|Overall Study||0||0
48247502|NCT03273283|100924247|FG000|STARTED|Overall Study||99||
48084152|NCT01025791|100525742|FG004|STARTED|Period 3||2||
48084153|NCT01025791|100525743|FG005|STARTED|Period 3||2||
48084154|NCT01025791|100525744|FG006|STARTED|Period 3||2||
48084155|NCT01025791|100525745|FG007|STARTED|Period 3||2||
48084156|NCT01025791|100525746|FG008|STARTED|Period 3||2||
48084157|NCT01025791|100525747|FG009|STARTED|Period 3||1||
48247503|NCT03273283|100924248|FG001|STARTED|Overall Study||101||
48084158|NCT01025791|100525748|FG010|STARTED|Period 3||2||
48084159|NCT01025791|100525749|FG011|STARTED|Period 3||1||
48084160|NCT01025791|100525750|FG012|STARTED|Period 3||2||
48084161|NCT01025791|100525751|FG013|STARTED|Period 3||1||
48084162|NCT01025791|100525738|FG000|COMPLETED|Period 3||2||
48084163|NCT01025791|100525739|FG001|COMPLETED|Period 3||2||
48084164|NCT01025791|100525740|FG002|COMPLETED|Period 3||2||
48084165|NCT01025791|100525741|FG003|COMPLETED|Period 3||2||
48084166|NCT01025791|100525742|FG004|COMPLETED|Period 3||2||
48084167|NCT01025791|100525743|FG005|COMPLETED|Period 3||2||
48084168|NCT01025791|100525744|FG006|COMPLETED|Period 3||2||
48084169|NCT01025791|100525745|FG007|COMPLETED|Period 3||2||
48084170|NCT01025791|100525746|FG008|COMPLETED|Period 3||2||
48084171|NCT01025791|100525747|FG009|COMPLETED|Period 3||1||
48084172|NCT01025791|100525748|FG010|COMPLETED|Period 3||2||
48084173|NCT01025791|100525749|FG011|COMPLETED|Period 3||1||
48084174|NCT01025791|100525750|FG012|COMPLETED|Period 3||2||
48084175|NCT01025791|100525751|FG013|COMPLETED|Period 3||1||
48084176|NCT01025791|100525738|FG000|NOT COMPLETED|Period 3||0||
48084177|NCT01025791|100525739|FG001|NOT COMPLETED|Period 3||0||
48084178|NCT01025791|100525740|FG002|NOT COMPLETED|Period 3||0||
48084179|NCT01025791|100525741|FG003|NOT COMPLETED|Period 3||0||
48084180|NCT01025791|100525742|FG004|NOT COMPLETED|Period 3||0||
48084181|NCT01025791|100525743|FG005|NOT COMPLETED|Period 3||0||
48084182|NCT01025791|100525744|FG006|NOT COMPLETED|Period 3||0||
48084183|NCT01025791|100525745|FG007|NOT COMPLETED|Period 3||0||
48084184|NCT01025791|100525746|FG008|NOT COMPLETED|Period 3||0||
48084185|NCT01025791|100525747|FG009|NOT COMPLETED|Period 3||0||
48084186|NCT01025791|100525748|FG010|NOT COMPLETED|Period 3||0||
48084187|NCT01025791|100525749|FG011|NOT COMPLETED|Period 3||0||
48084188|NCT01025791|100525750|FG012|NOT COMPLETED|Period 3||0||
48084189|NCT01025791|100525751|FG013|NOT COMPLETED|Period 3||0||
48084190|NCT01025791|100525738|FG000|STARTED|Period 4||2||
48084191|NCT01025791|100525739|FG001|STARTED|Period 4||2||
48084192|NCT01025791|100525740|FG002|STARTED|Period 4||2||
48084193|NCT01025791|100525741|FG003|STARTED|Period 4||2||
48084194|NCT01025791|100525742|FG004|STARTED|Period 4||2||
48084195|NCT01025791|100525743|FG005|STARTED|Period 4||2||
48084196|NCT01025791|100525744|FG006|STARTED|Period 4||2||
48084197|NCT01025791|100525745|FG007|STARTED|Period 4||2||
48084198|NCT01025791|100525746|FG008|STARTED|Period 4||2||
48084199|NCT01025791|100525747|FG009|STARTED|Period 4||1||
48084200|NCT01025791|100525748|FG010|STARTED|Period 4||2||
48084201|NCT01025791|100525749|FG011|STARTED|Period 4||1||
48084202|NCT01025791|100525750|FG012|STARTED|Period 4||2||
48084203|NCT01025791|100525751|FG013|STARTED|Period 4||1||
48084204|NCT01025791|100525738|FG000|COMPLETED|Period 4||2||
48084205|NCT01025791|100525739|FG001|COMPLETED|Period 4||2||
48084206|NCT01025791|100525740|FG002|COMPLETED|Period 4||2||
48084207|NCT01025791|100525741|FG003|COMPLETED|Period 4||2||
48084208|NCT01025791|100525742|FG004|COMPLETED|Period 4||2||
48084209|NCT01025791|100525743|FG005|COMPLETED|Period 4||2||
48084210|NCT01025791|100525744|FG006|COMPLETED|Period 4||2||
48084211|NCT01025791|100525745|FG007|COMPLETED|Period 4||2||
48084212|NCT01025791|100525746|FG008|COMPLETED|Period 4||2||
48084213|NCT01025791|100525747|FG009|COMPLETED|Period 4||1||
48084214|NCT01025791|100525748|FG010|COMPLETED|Period 4||2||
48084215|NCT01025791|100525749|FG011|COMPLETED|Period 4||1||
48084216|NCT01025791|100525750|FG012|COMPLETED|Period 4||2||
48084217|NCT01025791|100525751|FG013|COMPLETED|Period 4||1||
48084218|NCT01025791|100525738|FG000|NOT COMPLETED|Period 4||0||
48084219|NCT01025791|100525739|FG001|NOT COMPLETED|Period 4||0||
48084220|NCT01025791|100525740|FG002|NOT COMPLETED|Period 4||0||
48084221|NCT01025791|100525741|FG003|NOT COMPLETED|Period 4||0||
48084222|NCT01025791|100525742|FG004|NOT COMPLETED|Period 4||0||
48084223|NCT01025791|100525743|FG005|NOT COMPLETED|Period 4||0||
48084224|NCT01025791|100525744|FG006|NOT COMPLETED|Period 4||0||
48084225|NCT01025791|100525745|FG007|NOT COMPLETED|Period 4||0||
48084226|NCT01025791|100525746|FG008|NOT COMPLETED|Period 4||0||
48084227|NCT01025791|100525747|FG009|NOT COMPLETED|Period 4||0||
48084228|NCT01025791|100525748|FG010|NOT COMPLETED|Period 4||0||
48084229|NCT01025791|100525749|FG011|NOT COMPLETED|Period 4||0||
48084230|NCT01025791|100525750|FG012|NOT COMPLETED|Period 4||0||
48084231|NCT01025791|100525751|FG013|NOT COMPLETED|Period 4||0||
48084232|NCT01025791|100525738|FG000|STARTED|Period 5||2||
48084233|NCT01025791|100525739|FG001|STARTED|Period 5||2||
48084234|NCT01025791|100525740|FG002|STARTED|Period 5||2||
48084235|NCT01025791|100525741|FG003|STARTED|Period 5||2||
48084236|NCT01025791|100525742|FG004|STARTED|Period 5||0||
48084237|NCT01025791|100525743|FG005|STARTED|Period 5||0||
48084238|NCT01025791|100525744|FG006|STARTED|Period 5||0||
48084239|NCT01025791|100525745|FG007|STARTED|Period 5||0||
48084240|NCT01025791|100525746|FG008|STARTED|Period 5||0||
48084241|NCT01025791|100525747|FG009|STARTED|Period 5||0||
48084242|NCT01025791|100525748|FG010|STARTED|Period 5||0||
48084243|NCT01025791|100525749|FG011|STARTED|Period 5||0||
48084244|NCT01025791|100525750|FG012|STARTED|Period 5||0||
48084245|NCT01025791|100525751|FG013|STARTED|Period 5||0||
48084246|NCT01025791|100525738|FG000|COMPLETED|Period 5||2||
48084247|NCT01025791|100525739|FG001|COMPLETED|Period 5||2||
48084248|NCT01025791|100525740|FG002|COMPLETED|Period 5||2||
48084249|NCT01025791|100525741|FG003|COMPLETED|Period 5||2||
48084250|NCT01025791|100525742|FG004|COMPLETED|Period 5||0||
48084251|NCT01025791|100525743|FG005|COMPLETED|Period 5||0||
48084252|NCT01025791|100525744|FG006|COMPLETED|Period 5||0||
48084253|NCT01025791|100525745|FG007|COMPLETED|Period 5||0||
48084254|NCT01025791|100525746|FG008|COMPLETED|Period 5||0||
48084255|NCT01025791|100525747|FG009|COMPLETED|Period 5||0||
48084256|NCT01025791|100525748|FG010|COMPLETED|Period 5||0||
48084257|NCT01025791|100525749|FG011|COMPLETED|Period 5||0||
48084258|NCT01025791|100525750|FG012|COMPLETED|Period 5||0||
48084259|NCT01025791|100525751|FG013|COMPLETED|Period 5||0||
48084260|NCT01025791|100525738|FG000|NOT COMPLETED|Period 5||0||
48084261|NCT01025791|100525739|FG001|NOT COMPLETED|Period 5||0||
48084262|NCT01025791|100525740|FG002|NOT COMPLETED|Period 5||0||
48084263|NCT01025791|100525741|FG003|NOT COMPLETED|Period 5||0||
48084264|NCT01025791|100525742|FG004|NOT COMPLETED|Period 5||0||
48084265|NCT01025791|100525743|FG005|NOT COMPLETED|Period 5||0||
48084266|NCT01025791|100525744|FG006|NOT COMPLETED|Period 5||0||
48084267|NCT01025791|100525745|FG007|NOT COMPLETED|Period 5||0||
48084268|NCT01025791|100525746|FG008|NOT COMPLETED|Period 5||0||
48084269|NCT01025791|100525747|FG009|NOT COMPLETED|Period 5||0||
48084270|NCT01025791|100525748|FG010|NOT COMPLETED|Period 5||0||
48247504|NCT03273283|100924247|FG000|COMPLETED|Overall Study||72||
48247505|NCT03273283|100924248|FG001|COMPLETED|Overall Study||81||
48247506|NCT03273283|100924247|FG000|NOT COMPLETED|Overall Study||27||
48247507|NCT03273283|100924248|FG001|NOT COMPLETED|Overall Study||20||
48247508|NCT02660034|100924249|FG000|STARTED|Overall Study||12||
48247509|NCT02660034|100924250|FG001|STARTED|Overall Study||12||
48540862|NCT00086281|101662588|FG002|COMPLETED|Phase 1||8||
48540863|NCT00086281|101662589|FG003|COMPLETED|Phase 1||11||
48540864|NCT00086281|101662590|FG004|COMPLETED|Phase 1||1||
48084271|NCT01025791|100525749|FG011|NOT COMPLETED|Period 5||0||
48084272|NCT01025791|100525750|FG012|NOT COMPLETED|Period 5||0||
48084273|NCT01025791|100525751|FG013|NOT COMPLETED|Period 5||0||
48084274|NCT00911053|100525752|FG000|STARTED|Overall Study||0||
48084275|NCT00911053|100525753|FG001|STARTED|Overall Study||0||
48084276|NCT00911053|100525754|FG002|STARTED|Overall Study||0||
48084277|NCT00911053|100525755|FG003|STARTED|Overall Study||0||
48084278|NCT00911053|100525756|FG004|STARTED|Overall Study||0||
48084279|NCT00911053|100525752|FG000|COMPLETED|Overall Study||0||
48084280|NCT00911053|100525753|FG001|COMPLETED|Overall Study||0||
48084281|NCT00911053|100525754|FG002|COMPLETED|Overall Study||0||
48084282|NCT00911053|100525755|FG003|COMPLETED|Overall Study||0||
48084283|NCT00911053|100525756|FG004|COMPLETED|Overall Study||0||
48084284|NCT00911053|100525752|FG000|NOT COMPLETED|Overall Study||0||
48084285|NCT00911053|100525753|FG001|NOT COMPLETED|Overall Study||0||
48084286|NCT00911053|100525754|FG002|NOT COMPLETED|Overall Study||0||
48084287|NCT00911053|100525755|FG003|NOT COMPLETED|Overall Study||0||
48084288|NCT00911053|100525756|FG004|NOT COMPLETED|Overall Study||0||
48084289|NCT02088047|100525757|FG000|STARTED|Overall Study||3||
48084290|NCT02088047|100525758|FG001|STARTED|Overall Study||1||
48084291|NCT02088047|100525757|FG000|COMPLETED|Overall Study||2||
48084292|NCT02088047|100525758|FG001|COMPLETED|Overall Study||1||
48084293|NCT02088047|100525757|FG000|NOT COMPLETED|Overall Study||1||
48084294|NCT02088047|100525758|FG001|NOT COMPLETED|Overall Study||0||
48084295|NCT01927367|100525759|FG000|STARTED|Overall Study||597||
48084296|NCT01927367|100525760|FG001|STARTED|Overall Study||548||
48084297|NCT01927367|100525759|FG000|COMPLETED|Overall Study||590||
48084298|NCT01927367|100525760|FG001|COMPLETED|Overall Study||543||
48084299|NCT01927367|100525759|FG000|NOT COMPLETED|Overall Study||7||
48084300|NCT01927367|100525760|FG001|NOT COMPLETED|Overall Study||5||
48084301|NCT01654536|100525761|FG000|STARTED|Overall Study||368||
48084302|NCT01654536|100525762|FG001|STARTED|Overall Study||369||
48084303|NCT01654536|100525761|FG000|COMPLETED|Overall Study||324||
48084304|NCT01654536|100525762|FG001|COMPLETED|Overall Study||331||
48084305|NCT01654536|100525761|FG000|NOT COMPLETED|Overall Study||44||
48084306|NCT01654536|100525762|FG001|NOT COMPLETED|Overall Study||38||
48084307|NCT03902574|100525763|FG000|STARTED|Overall Study||7||
48084308|NCT03902574|100525764|FG001|STARTED|Overall Study||7||
48084309|NCT03902574|100525765|FG002|STARTED|Overall Study||7||
48084310|NCT03902574|100525763|FG000|COMPLETED|Overall Study||7||
48084311|NCT03902574|100525764|FG001|COMPLETED|Overall Study||7||
48084312|NCT03902574|100525765|FG002|COMPLETED|Overall Study||6||
48084313|NCT03902574|100525763|FG000|NOT COMPLETED|Overall Study||0||
48084314|NCT03902574|100525764|FG001|NOT COMPLETED|Overall Study||0||
48084315|NCT03902574|100525765|FG002|NOT COMPLETED|Overall Study||1||
48084316|NCT02299297|100525766|FG000|STARTED|Overall Study||12||
48540865|NCT00086281|101662591|FG005|COMPLETED|Phase 1||3||
48084317|NCT02299297|100525766|FG000|COMPLETED|Overall Study||11||
48084318|NCT02299297|100525766|FG000|NOT COMPLETED|Overall Study||1||
48084319|NCT01191801|100525767|FG000|STARTED|Overall Study||356||
48084320|NCT01191801|100525768|FG001|STARTED|Overall Study||355||
48084321|NCT01191801|100525767|FG000|COMPLETED|Overall Study||40||
48084322|NCT01191801|100525768|FG001|COMPLETED|Overall Study||18||
48084323|NCT01191801|100525767|FG000|NOT COMPLETED|Overall Study||316||
48084324|NCT01191801|100525768|FG001|NOT COMPLETED|Overall Study||337||
48084325|NCT02860169|100525769|FG000|STARTED|Part A||46|Part A recruited healthy participants for an online survey.|
48084326|NCT02860169|100525769|FG000|Healthy Participants|Part A||46||
48084327|NCT02860169|100525769|FG000|Participants With Cold and Flu|Part A||0||
48540866|NCT00086281|101662592|FG006|COMPLETED|Phase 1||1||
48540867|NCT00086281|101662593|FG007|COMPLETED|Phase 1||1||
48084328|NCT02860169|100525769|FG000|COMPLETED|Part A||35||
48084329|NCT02860169|100525769|FG000|NOT COMPLETED|Part A||11||
48084330|NCT02860169|100525769|FG000|STARTED|Part B||20|Part B separately recruited healthy (control) and cold and flu participants.|
48084331|NCT02860169|100525769|FG000|Healthy Participants|Part B||10||
48084332|NCT02860169|100525769|FG000|Participants With Cold and Flu|Part B||10||
48084333|NCT02860169|100525769|FG000|COMPLETED|Part B||9||
48084334|NCT02860169|100525769|FG000|NOT COMPLETED|Part B||11||
48084335|NCT02860169|100525769|FG000|STARTED|Part C||48|Part C separately recruited healthy (control) and cold and flu participants.|
48084336|NCT02860169|100525769|FG000|Healthy Participants|Part C||6||
48084337|NCT02860169|100525769|FG000|Participants With Cold and Flu|Part C||42||
48084338|NCT02860169|100525769|FG000|COMPLETED|Part C||47||
48084339|NCT02860169|100525769|FG000|NOT COMPLETED|Part C||1||
48084340|NCT01402544|100525770|FG000|STARTED|Overall Study||12||
48084341|NCT01402544|100525770|FG000|COMPLETED|Overall Study||6||
48084342|NCT01402544|100525770|FG000|NOT COMPLETED|Overall Study||6||
48084343|NCT00982878|100525771|FG000|STARTED|Overall Study||13||
48084344|NCT00982878|100525771|FG000|COMPLETED|Overall Study||12||
48084345|NCT00982878|100525771|FG000|NOT COMPLETED|Overall Study||1||
48084346|NCT01482884|100525772|FG000|STARTED|Overall Study||56||
48084347|NCT01482884|100525773|FG001|STARTED|Overall Study||55||
48084348|NCT01482884|100525772|FG000|COMPLETED|Overall Study||43||
48084349|NCT01482884|100525773|FG001|COMPLETED|Overall Study||37||
48084350|NCT01482884|100525772|FG000|NOT COMPLETED|Overall Study||13||
48084351|NCT01482884|100525773|FG001|NOT COMPLETED|Overall Study||18||
48084352|NCT02048891|100525774|FG000|STARTED|Overall Study||2||
48084353|NCT02048891|100525775|FG001|STARTED|Overall Study||1||
48084354|NCT02048891|100525774|FG000|COMPLETED|Overall Study||2||
48084355|NCT02048891|100525775|FG001|COMPLETED|Overall Study||1||
48084356|NCT02048891|100525774|FG000|NOT COMPLETED|Overall Study||0||
48084357|NCT02048891|100525775|FG001|NOT COMPLETED|Overall Study||0||
48084358|NCT02010775|100525776|FG000|STARTED|Overall Study||38||
48084359|NCT02010775|100525777|FG001|STARTED|Overall Study||38||
48084360|NCT02010775|100525778|FG002|STARTED|Overall Study||37||
48084361|NCT02010775|100525779|FG003|STARTED|Overall Study||37||
48084362|NCT02010775|100525780|FG004|STARTED|Overall Study||37||
48084363|NCT02010775|100525776|FG000|COMPLETED|Overall Study||33||
48084364|NCT02010775|100525777|FG001|COMPLETED|Overall Study||35||
48084365|NCT02010775|100525778|FG002|COMPLETED|Overall Study||34||
48247510|NCT02660034|100924251|FG002|STARTED|Overall Study||6||
48247511|NCT02660034|100924252|FG003|STARTED|Overall Study||13||
48247512|NCT02660034|100924253|FG004|STARTED|Overall Study||6||
48247513|NCT02660034|100924254|FG005|STARTED|Overall Study||23||
48247514|NCT02660034|100924255|FG006|STARTED|Overall Study||23||
48247515|NCT02660034|100924256|FG007|STARTED|Overall Study||19||
48682731|NCT01466491|102006671|FG003|STARTED|Overall Study||83||
48682732|NCT01466491|102006668|FG000|COMPLETED|Overall Study||83||
48682733|NCT01466491|102006669|FG001|COMPLETED|Overall Study||80||
48682734|NCT01466491|102006670|FG002|COMPLETED|Overall Study||80||
48682735|NCT01466491|102006671|FG003|COMPLETED|Overall Study||83||
48682736|NCT01466491|102006668|FG000|NOT COMPLETED|Overall Study||0||
48682737|NCT01466491|102006669|FG001|NOT COMPLETED|Overall Study||3||
48682738|NCT01466491|102006670|FG002|NOT COMPLETED|Overall Study||3||
48682739|NCT01466491|102006671|FG003|NOT COMPLETED|Overall Study||0||
48682740|NCT00533429|102006672|FG000|STARTED|Overall Study||20||
48682741|NCT00533429|102006673|FG001|STARTED|Overall Study||20||
48084366|NCT02010775|100525779|FG003|COMPLETED|Overall Study||34||
48084367|NCT02010775|100525780|FG004|COMPLETED|Overall Study||31||
48084368|NCT02010775|100525776|FG000|NOT COMPLETED|Overall Study||5||
48084369|NCT02010775|100525777|FG001|NOT COMPLETED|Overall Study||3||
48084370|NCT02010775|100525778|FG002|NOT COMPLETED|Overall Study||3||
48084371|NCT02010775|100525779|FG003|NOT COMPLETED|Overall Study||3||
48084372|NCT02010775|100525780|FG004|NOT COMPLETED|Overall Study||6||
48084373|NCT00618072|100525781|FG000|STARTED|Overall Study||16||
48084374|NCT00618072|100525782|FG001|STARTED|Overall Study||15||
48084375|NCT00618072|100525783|FG002|STARTED|Overall Study||15||
48084376|NCT00618072|100525781|FG000|COMPLETED|Overall Study||14||
48084377|NCT00618072|100525782|FG001|COMPLETED|Overall Study||14||
48084378|NCT00618072|100525783|FG002|COMPLETED|Overall Study||11||
48084379|NCT00618072|100525781|FG000|NOT COMPLETED|Overall Study||2||
48084380|NCT00618072|100525782|FG001|NOT COMPLETED|Overall Study||1||
48247516|NCT02660034|100924257|FG008|STARTED|Overall Study||20||
48247517|NCT02660034|100924258|FG009|STARTED|Overall Study||23||
48247518|NCT02660034|100924259|FG010|STARTED|Overall Study||20||
48247519|NCT02660034|100924260|FG011|STARTED|Overall Study||21||
48682742|NCT00533429|102006672|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20||
48682743|NCT00533429|102006673|FG001|Received at Least 1 Dose of Study Drug|Overall Study||20||
48682744|NCT00533429|102006672|FG000|Entered Maintenance|Overall Study||8||
48682745|NCT00533429|102006673|FG001|Entered Maintenance|Overall Study||10||
48084381|NCT00618072|100525783|FG002|NOT COMPLETED|Overall Study||4||
48084382|NCT02170298|100525784|FG000|STARTED|Overall Study||1||
48084383|NCT02170298|100525785|FG001|STARTED|Overall Study||5||
48084384|NCT02170298|100525784|FG000|COMPLETED|Overall Study||0||
48247520|NCT02660034|100924261|FG012|STARTED|Overall Study||21||
48247521|NCT02660034|100924262|FG013|STARTED|Overall Study||10||
48247522|NCT02660034|100924249|FG000|Received At Least 1 Dose of Study Drug(s)|Overall Study||12|Safety Analysis Set|
48247523|NCT02660034|100924250|FG001|Received At Least 1 Dose of Study Drug(s)|Overall Study||12|Safety Analysis Set|
48247524|NCT02660034|100924251|FG002|Received At Least 1 Dose of Study Drug(s)|Overall Study||6|Safety Analysis Set|
48247525|NCT02660034|100924252|FG003|Received At Least 1 Dose of Study Drug(s)|Overall Study||13|Safety Analysis Set|
48247526|NCT02660034|100924253|FG004|Received At Least 1 Dose of Study Drug(s)|Overall Study||6|Safety Analysis Set|
48247527|NCT02660034|100924254|FG005|Received At Least 1 Dose of Study Drug(s)|Overall Study||23|Safety Analysis Set|
48247528|NCT02660034|100924255|FG006|Received At Least 1 Dose of Study Drug(s)|Overall Study||23|Safety Analysis Set|
48247529|NCT02660034|100924256|FG007|Received At Least 1 Dose of Study Drug(s)|Overall Study||19|Safety Analysis Set|
48247530|NCT02660034|100924257|FG008|Received At Least 1 Dose of Study Drug(s)|Overall Study||20|Safety Analysis Set|
48247531|NCT02660034|100924258|FG009|Received At Least 1 Dose of Study Drug(s)|Overall Study||23|Safety Analysis Set|
48247532|NCT02660034|100924259|FG010|Received At Least 1 Dose of Study Drug(s)|Overall Study||20|Safety Analysis Set|
48247533|NCT02660034|100924260|FG011|Received At Least 1 Dose of Study Drug(s)|Overall Study||21|Safety Analysis Set|
48247534|NCT02660034|100924261|FG012|Received At Least 1 Dose of Study Drug(s)|Overall Study||21|Safety Analysis Set|
48247535|NCT02660034|100924262|FG013|Received At Least 1 Dose of Study Drug(s)|Overall Study||10|Safety Analysis Set|
48247536|NCT02660034|100924249|FG000|COMPLETED|Overall Study||0||
48247537|NCT02660034|100924250|FG001|COMPLETED|Overall Study||0||
48247538|NCT02660034|100924251|FG002|COMPLETED|Overall Study||0||
48247539|NCT02660034|100924252|FG003|COMPLETED|Overall Study||0||
48247540|NCT02660034|100924253|FG004|COMPLETED|Overall Study||0||
48247541|NCT02660034|100924254|FG005|COMPLETED|Overall Study||0||
48682746|NCT00533429|102006672|FG000|COMPLETED|Overall Study||1||
48682747|NCT00533429|102006673|FG001|COMPLETED|Overall Study||4||
48682748|NCT00533429|102006672|FG000|NOT COMPLETED|Overall Study||19||
48682749|NCT00533429|102006673|FG001|NOT COMPLETED|Overall Study||16||
48247542|NCT02660034|100924255|FG006|COMPLETED|Overall Study||0||
48247543|NCT02660034|100924256|FG007|COMPLETED|Overall Study||0||
48247544|NCT02660034|100924257|FG008|COMPLETED|Overall Study||0||
48247545|NCT02660034|100924258|FG009|COMPLETED|Overall Study||0||
48247546|NCT02660034|100924259|FG010|COMPLETED|Overall Study||0||
48247547|NCT02660034|100924260|FG011|COMPLETED|Overall Study||0||
48247548|NCT02660034|100924261|FG012|COMPLETED|Overall Study||0||
48247549|NCT02660034|100924262|FG013|COMPLETED|Overall Study||0||
48247550|NCT02660034|100924249|FG000|NOT COMPLETED|Overall Study||12||
48247551|NCT02660034|100924250|FG001|NOT COMPLETED|Overall Study||12||
48247552|NCT02660034|100924251|FG002|NOT COMPLETED|Overall Study||6||
48682750|NCT00290810|102006674|FG000|STARTED|Overall Study||12||
48682751|NCT00290810|102006674|FG000|COMPLETED|Overall Study||12||
48682752|NCT00290810|102006674|FG000|NOT COMPLETED|Overall Study||0||
48682753|NCT01436110|102006675|FG000|STARTED|Overall Study||116||
48682754|NCT01436110|102006676|FG001|STARTED|Overall Study||117||
48682755|NCT01436110|102006677|FG002|STARTED|Overall Study||118||
48084385|NCT02170298|100525785|FG001|COMPLETED|Overall Study||4||
48682756|NCT01436110|102006675|FG000|Intent-to-Treat Population|Overall Study||115||
48682757|NCT01436110|102006676|FG001|Intent-to-Treat Population|Overall Study||117||
48084386|NCT02170298|100525784|FG000|NOT COMPLETED|Overall Study||1||
48084387|NCT02170298|100525785|FG001|NOT COMPLETED|Overall Study||1||
48247553|NCT02660034|100924252|FG003|NOT COMPLETED|Overall Study||13||
48247554|NCT02660034|100924253|FG004|NOT COMPLETED|Overall Study||6||
48247555|NCT02660034|100924254|FG005|NOT COMPLETED|Overall Study||23||
48247556|NCT02660034|100924255|FG006|NOT COMPLETED|Overall Study||23||
48247557|NCT02660034|100924256|FG007|NOT COMPLETED|Overall Study||19||
48247558|NCT02660034|100924257|FG008|NOT COMPLETED|Overall Study||20||
48084388|NCT02811445|100528748|FG000|STARTED|Overall Study||18||
48084389|NCT02811445|100528749|FG001|STARTED|Overall Study||11||
48084390|NCT02811445|100528748|FG000|COMPLETED|Overall Study||18||
48084391|NCT02811445|100528749|FG001|COMPLETED|Overall Study||11||
48084392|NCT02811445|100528748|FG000|NOT COMPLETED|Overall Study||0||
48084393|NCT02811445|100528749|FG001|NOT COMPLETED|Overall Study||0||
48247559|NCT02660034|100924258|FG009|NOT COMPLETED|Overall Study||23||
48247560|NCT02660034|100924259|FG010|NOT COMPLETED|Overall Study||20||
48247561|NCT02660034|100924260|FG011|NOT COMPLETED|Overall Study||21||
48247562|NCT02660034|100924261|FG012|NOT COMPLETED|Overall Study||21||
48247563|NCT02660034|100924262|FG013|NOT COMPLETED|Overall Study||10||
48247564|NCT00728884|100924263|FG000|STARTED|Implant Placement Surgery||162||
48247565|NCT00728884|100924263|FG000|COMPLETED|Implant Placement Surgery||162||
48247566|NCT00728884|100924263|FG000|NOT COMPLETED|Implant Placement Surgery||0||
48247567|NCT00728884|100924263|FG000|STARTED|Permanent Prosthesis Placement||162||
48247568|NCT00728884|100924263|FG000|COMPLETED|Permanent Prosthesis Placement||149||
48247569|NCT00728884|100924263|FG000|NOT COMPLETED|Permanent Prosthesis Placement||13||
48247570|NCT00728884|100924263|FG000|STARTED|One Year Post Placement Follow-up||149||
48247571|NCT00728884|100924263|FG000|COMPLETED|One Year Post Placement Follow-up||145||
48247572|NCT00728884|100924263|FG000|NOT COMPLETED|One Year Post Placement Follow-up||4||
48247573|NCT00728884|100924263|FG000|STARTED|Two Year Post Placement Follow-up||145||
48247574|NCT00728884|100924263|FG000|COMPLETED|Two Year Post Placement Follow-up||145||
48247575|NCT00728884|100924263|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||0||
48247576|NCT05335005|100924264|FG000|STARTED|Overall Study||12||
48247577|NCT05335005|100924264|FG000|COMPLETED|Overall Study||11||
48247578|NCT05335005|100924264|FG000|NOT COMPLETED|Overall Study||1||
48247579|NCT02005029|100924265|FG000|STARTED|First Intervention (1 Day)||5||
48247580|NCT02005029|100924266|FG001|STARTED|First Intervention (1 Day)||5||
48247581|NCT02005029|100924265|FG000|COMPLETED|First Intervention (1 Day)||4||
48247582|NCT02005029|100924266|FG001|COMPLETED|First Intervention (1 Day)||5||
48084394|NCT02151591|100528750|FG000|STARTED|Overall Study||13||
48084395|NCT02151591|100528751|FG001|STARTED|Overall Study||13||
48084396|NCT02151591|100528750|FG000|COMPLETED|Overall Study||7||
48084397|NCT02151591|100528751|FG001|COMPLETED|Overall Study||10||
48084398|NCT02151591|100528750|FG000|NOT COMPLETED|Overall Study||6||
48247583|NCT02005029|100924265|FG000|NOT COMPLETED|First Intervention (1 Day)||1||
48247584|NCT02005029|100924266|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48247585|NCT02005029|100924265|FG000|STARTED|Washout (2 Weeks)||4||
48247586|NCT02005029|100924266|FG001|STARTED|Washout (2 Weeks)||5||
48084399|NCT02151591|100528751|FG001|NOT COMPLETED|Overall Study||3||
48084400|NCT01874132|100528752|FG000|STARTED|Overall Study||22||
48084401|NCT01874132|100528753|FG001|STARTED|Overall Study||22||
48247587|NCT02005029|100924265|FG000|COMPLETED|Washout (2 Weeks)||4||
48247588|NCT02005029|100924266|FG001|COMPLETED|Washout (2 Weeks)||5||
48084402|NCT01874132|100528754|FG002|STARTED|Overall Study||22||
48084403|NCT01874132|100528752|FG000|COMPLETED|Overall Study||18||
48084404|NCT01874132|100528753|FG001|COMPLETED|Overall Study||18||
48084405|NCT01874132|100528754|FG002|COMPLETED|Overall Study||19||
48084406|NCT01874132|100528752|FG000|NOT COMPLETED|Overall Study||4||
48084407|NCT01874132|100528753|FG001|NOT COMPLETED|Overall Study||4||
48084408|NCT01874132|100528754|FG002|NOT COMPLETED|Overall Study||3||
48084409|NCT01224431|100528755|FG000|STARTED|Overall Study||30||
48084410|NCT01224431|100528756|FG001|STARTED|Overall Study||30||
48247589|NCT02005029|100924265|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
48247590|NCT02005029|100924266|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
48247591|NCT02005029|100924265|FG000|STARTED|Second Intervention (1 Day)||4||
48247592|NCT02005029|100924266|FG001|STARTED|Second Intervention (1 Day)||5||
48247593|NCT02005029|100924265|FG000|COMPLETED|Second Intervention (1 Day)||4||
48247594|NCT02005029|100924266|FG001|COMPLETED|Second Intervention (1 Day)||5||
48247595|NCT02005029|100924265|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48247596|NCT02005029|100924266|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48247597|NCT00527514|100924267|FG000|STARTED|Weeks 1-3: Amlodipine (Aml) 5mg||185||
48247598|NCT00527514|100924267|FG000|COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg||184||
48084411|NCT01224431|100528755|FG000|COMPLETED|Overall Study||30||
48084412|NCT01224431|100528756|FG001|COMPLETED|Overall Study||25||
48084413|NCT01224431|100528755|FG000|NOT COMPLETED|Overall Study||0||
48084414|NCT01224431|100528756|FG001|NOT COMPLETED|Overall Study||5||
48084415|NCT03462082|100528757|FG000|STARTED|Study Phase (Randomized, Blinded Period)||3||
48084416|NCT03462082|100528758|FG001|STARTED|Study Phase (Randomized, Blinded Period)||4||
48084417|NCT03462082|100528759|FG002|STARTED|Study Phase (Randomized, Blinded Period)||4||
48084418|NCT03462082|100528760|FG003|STARTED|Study Phase (Randomized, Blinded Period)||3||
48084419|NCT03462082|100528761|FG004|STARTED|Study Phase (Randomized, Blinded Period)||3||
48084420|NCT03462082|100528762|FG005|STARTED|Study Phase (Randomized, Blinded Period)||5||
48084421|NCT03462082|100528763|FG006|STARTED|Study Phase (Randomized, Blinded Period)||0||
48084422|NCT03462082|100528764|FG007|STARTED|Study Phase (Randomized, Blinded Period)||0||
48084423|NCT03462082|100528757|FG000|COMPLETED|Study Phase (Randomized, Blinded Period)||3||
48084424|NCT03462082|100528758|FG001|COMPLETED|Study Phase (Randomized, Blinded Period)||4||
48084425|NCT03462082|100528759|FG002|COMPLETED|Study Phase (Randomized, Blinded Period)||4||
48084426|NCT03462082|100528760|FG003|COMPLETED|Study Phase (Randomized, Blinded Period)||3||
48084427|NCT03462082|100528761|FG004|COMPLETED|Study Phase (Randomized, Blinded Period)||3||
48084428|NCT03462082|100528762|FG005|COMPLETED|Study Phase (Randomized, Blinded Period)||5||
48084429|NCT03462082|100528763|FG006|COMPLETED|Study Phase (Randomized, Blinded Period)||0||
48084430|NCT03462082|100528764|FG007|COMPLETED|Study Phase (Randomized, Blinded Period)||0||
48084431|NCT03462082|100528757|FG000|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0||
48084432|NCT03462082|100528758|FG001|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0||
48084433|NCT03462082|100528759|FG002|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0||
48084434|NCT03462082|100528760|FG003|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0||
48084435|NCT03462082|100528761|FG004|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0||
48084436|NCT03462082|100528762|FG005|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0||
48084437|NCT03462082|100528763|FG006|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0||
48084438|NCT03462082|100528764|FG007|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0||
48084439|NCT03462082|100528757|FG000|STARTED|Open Label Phase||0||
48084440|NCT03462082|100528758|FG001|STARTED|Open Label Phase||0||
48084441|NCT03462082|100528759|FG002|STARTED|Open Label Phase||0||
48084442|NCT03462082|100528760|FG003|STARTED|Open Label Phase||0||
48084443|NCT03462082|100528761|FG004|STARTED|Open Label Phase||0||
48084444|NCT03462082|100528762|FG005|STARTED|Open Label Phase||0||
48084445|NCT03462082|100528763|FG006|STARTED|Open Label Phase||7||
48084446|NCT03462082|100528764|FG007|STARTED|Open Label Phase||10||
48084447|NCT03462082|100528757|FG000|COMPLETED|Open Label Phase||0||
48084448|NCT03462082|100528758|FG001|COMPLETED|Open Label Phase||0||
48084449|NCT03462082|100528759|FG002|COMPLETED|Open Label Phase||0||
48084450|NCT03462082|100528760|FG003|COMPLETED|Open Label Phase||0||
48084451|NCT03462082|100528761|FG004|COMPLETED|Open Label Phase||0||
48084452|NCT03462082|100528762|FG005|COMPLETED|Open Label Phase||0||
48084453|NCT03462082|100528763|FG006|COMPLETED|Open Label Phase||6||
48084454|NCT03462082|100528764|FG007|COMPLETED|Open Label Phase||8||
48084455|NCT03462082|100528757|FG000|NOT COMPLETED|Open Label Phase||0||
48084456|NCT03462082|100528758|FG001|NOT COMPLETED|Open Label Phase||0||
48084457|NCT03462082|100528759|FG002|NOT COMPLETED|Open Label Phase||0||
48084458|NCT03462082|100528760|FG003|NOT COMPLETED|Open Label Phase||0||
48084459|NCT03462082|100528761|FG004|NOT COMPLETED|Open Label Phase||0||
48084460|NCT03462082|100528762|FG005|NOT COMPLETED|Open Label Phase||0||
48084461|NCT03462082|100528763|FG006|NOT COMPLETED|Open Label Phase||1||
48084462|NCT03462082|100528764|FG007|NOT COMPLETED|Open Label Phase||2||
48084463|NCT03292588|100528765|FG000|STARTED|Overall Study||146||
48084464|NCT03292588|100528766|FG001|STARTED|Overall Study||144||
48084465|NCT03292588|100528765|FG000|COMPLETED|Overall Study||126||
48084466|NCT03292588|100528766|FG001|COMPLETED|Overall Study||122||
48084467|NCT03292588|100528765|FG000|NOT COMPLETED|Overall Study||20||
48084468|NCT03292588|100528766|FG001|NOT COMPLETED|Overall Study||22||
48084469|NCT02038023|100528767|FG000|STARTED|Overall Study||74||
48084470|NCT02038023|100528767|FG000|COMPLETED|Overall Study||73||
48084471|NCT02038023|100528767|FG000|NOT COMPLETED|Overall Study||1||
48540868|NCT00086281|101662594|FG008|COMPLETED|Phase 1||2||
48084472|NCT01658072|100528768|FG000|STARTED|Overall Study||45||
48084473|NCT01658072|100528769|FG001|STARTED|Overall Study||45||
48084474|NCT01658072|100528768|FG000|COMPLETED|Overall Study||41||
48084475|NCT01658072|100528769|FG001|COMPLETED|Overall Study||43||
48084476|NCT01658072|100528768|FG000|NOT COMPLETED|Overall Study||4||
48084477|NCT01658072|100528769|FG001|NOT COMPLETED|Overall Study||2||
48084478|NCT01129609|100528770|FG000|STARTED|Overall Study||20||
48084479|NCT01129609|100528770|FG000|COMPLETED|Overall Study||18||
48084480|NCT01129609|100528770|FG000|NOT COMPLETED|Overall Study||2||
48084481|NCT02132130|100528771|FG000|STARTED|Overall Study||3||
48084482|NCT02132130|100528772|FG001|STARTED|Overall Study||12||
48084483|NCT02132130|100528773|FG002|STARTED|Overall Study||4||
48084484|NCT02132130|100528774|FG003|STARTED|Overall Study||3||
48084485|NCT02132130|100528771|FG000|COMPLETED|Overall Study||3||
48084486|NCT02132130|100528772|FG001|COMPLETED|Overall Study||10||
48084487|NCT02132130|100528773|FG002|COMPLETED|Overall Study||4||
48084488|NCT02132130|100528774|FG003|COMPLETED|Overall Study||2||
48540869|NCT00086281|101662595|FG009|COMPLETED|Phase 1||0||
48084489|NCT02132130|100528771|FG000|NOT COMPLETED|Overall Study||0||
48084490|NCT02132130|100528772|FG001|NOT COMPLETED|Overall Study||2||
48084491|NCT02132130|100528773|FG002|NOT COMPLETED|Overall Study||0||
48084492|NCT02132130|100528774|FG003|NOT COMPLETED|Overall Study||1||
48084493|NCT00203996|100528775|FG000|STARTED|Overall Study||0||
48084494|NCT00203996|100528776|FG001|STARTED|Overall Study||0||
48084495|NCT00203996|100528777|FG002|STARTED|Overall Study||0||
48084496|NCT00203996|100528778|FG003|STARTED|Overall Study||19||
48084497|NCT00203996|100528779|FG004|STARTED|Overall Study||4||
48084498|NCT00203996|100528780|FG005|STARTED|Overall Study||3||
48084499|NCT00203996|100528781|FG006|STARTED|Overall Study||2||
48084500|NCT00203996|100528782|FG007|STARTED|Overall Study||4||
48084501|NCT00203996|100528783|FG008|STARTED|Overall Study||2||
48084502|NCT00203996|100528784|FG009|STARTED|Overall Study||3||
48084503|NCT00203996|100528775|FG000|Aim 3 Only: First Intervention|Overall Study||0||
48084504|NCT00203996|100528776|FG001|Aim 3 Only: First Intervention|Overall Study||0||
48084505|NCT00203996|100528777|FG002|Aim 3 Only: First Intervention|Overall Study||0||
48084506|NCT00203996|100528778|FG003|Aim 3 Only: First Intervention|Overall Study||0||
48084507|NCT00203996|100528779|FG004|Aim 3 Only: First Intervention|Overall Study||0||
48084508|NCT00203996|100528780|FG005|Aim 3 Only: First Intervention|Overall Study||3||
48084509|NCT00203996|100528781|FG006|Aim 3 Only: First Intervention|Overall Study||2||
48084510|NCT00203996|100528782|FG007|Aim 3 Only: First Intervention|Overall Study||4||
48540870|NCT00086281|101662596|FG010|COMPLETED|Phase 1||0||
48084511|NCT00203996|100528783|FG008|Aim 3 Only: First Intervention|Overall Study||2||
48084512|NCT00203996|100528784|FG009|Aim 3 Only: First Intervention|Overall Study||3||
48084513|NCT00203996|100528775|FG000|Aim 3 Only: Washout|Overall Study||0||
48084514|NCT00203996|100528776|FG001|Aim 3 Only: Washout|Overall Study||0||
48084515|NCT00203996|100528777|FG002|Aim 3 Only: Washout|Overall Study||0||
48084516|NCT00203996|100528778|FG003|Aim 3 Only: Washout|Overall Study||0||
48084517|NCT00203996|100528779|FG004|Aim 3 Only: Washout|Overall Study||0||
48084518|NCT00203996|100528780|FG005|Aim 3 Only: Washout|Overall Study||3||
48084519|NCT00203996|100528781|FG006|Aim 3 Only: Washout|Overall Study||2||
48084520|NCT00203996|100528782|FG007|Aim 3 Only: Washout|Overall Study||2||
48084521|NCT00203996|100528783|FG008|Aim 3 Only: Washout|Overall Study||2||
48084522|NCT00203996|100528784|FG009|Aim 3 Only: Washout|Overall Study||2||
48084523|NCT00203996|100528775|FG000|Aim 3 Only: Second Intervention|Overall Study||0||
48084524|NCT00203996|100528776|FG001|Aim 3 Only: Second Intervention|Overall Study||0||
48084525|NCT00203996|100528777|FG002|Aim 3 Only: Second Intervention|Overall Study||0||
48084526|NCT00203996|100528778|FG003|Aim 3 Only: Second Intervention|Overall Study||0||
48084527|NCT00203996|100528779|FG004|Aim 3 Only: Second Intervention|Overall Study||0||
48084528|NCT00203996|100528780|FG005|Aim 3 Only: Second Intervention|Overall Study||3||
48084529|NCT00203996|100528781|FG006|Aim 3 Only: Second Intervention|Overall Study||2||
48084530|NCT00203996|100528782|FG007|Aim 3 Only: Second Intervention|Overall Study||2||
48084531|NCT00203996|100528783|FG008|Aim 3 Only: Second Intervention|Overall Study||2||
48084532|NCT00203996|100528784|FG009|Aim 3 Only: Second Intervention|Overall Study||2||
48084533|NCT00203996|100528775|FG000|Aim 3 Only: Second Washout|Overall Study||0||
48084534|NCT00203996|100528776|FG001|Aim 3 Only: Second Washout|Overall Study||0||
48084535|NCT00203996|100528777|FG002|Aim 3 Only: Second Washout|Overall Study||0||
48084536|NCT00203996|100528778|FG003|Aim 3 Only: Second Washout|Overall Study||0||
48084537|NCT00203996|100528779|FG004|Aim 3 Only: Second Washout|Overall Study||0||
48084538|NCT00203996|100528780|FG005|Aim 3 Only: Second Washout|Overall Study||3||
48084539|NCT00203996|100528781|FG006|Aim 3 Only: Second Washout|Overall Study||2||
48084540|NCT00203996|100528782|FG007|Aim 3 Only: Second Washout|Overall Study||2||
48084541|NCT00203996|100528783|FG008|Aim 3 Only: Second Washout|Overall Study||2||
48084542|NCT00203996|100528784|FG009|Aim 3 Only: Second Washout|Overall Study||2||
48540871|NCT00086281|101662597|FG011|COMPLETED|Phase 1||0||
48540872|NCT00086281|101662598|FG012|COMPLETED|Phase 1||0||
48540873|NCT00086281|101662599|FG013|COMPLETED|Phase 1||0||
48540874|NCT00086281|101662600|FG014|COMPLETED|Phase 1||0||
48540875|NCT00086281|101662586|FG000|NOT COMPLETED|Phase 1||0||
48540876|NCT00086281|101662587|FG001|NOT COMPLETED|Phase 1||0||
48540877|NCT00086281|101662588|FG002|NOT COMPLETED|Phase 1||0||
48084543|NCT00203996|100528775|FG000|Aim 3 Only: Third Intervention|Overall Study||0||
48084544|NCT00203996|100528776|FG001|Aim 3 Only: Third Intervention|Overall Study||0||
48084545|NCT00203996|100528777|FG002|Aim 3 Only: Third Intervention|Overall Study||0||
48084546|NCT00203996|100528778|FG003|Aim 3 Only: Third Intervention|Overall Study||0||
48084547|NCT00203996|100528779|FG004|Aim 3 Only: Third Intervention|Overall Study||0||
48084548|NCT00203996|100528780|FG005|Aim 3 Only: Third Intervention|Overall Study||3||
48084549|NCT00203996|100528781|FG006|Aim 3 Only: Third Intervention|Overall Study||2||
48084550|NCT00203996|100528782|FG007|Aim 3 Only: Third Intervention|Overall Study||2||
48084551|NCT00203996|100528783|FG008|Aim 3 Only: Third Intervention|Overall Study||2||
48084552|NCT00203996|100528784|FG009|Aim 3 Only: Third Intervention|Overall Study||2||
48084553|NCT00203996|100528775|FG000|COMPLETED|Overall Study||0||
48084554|NCT00203996|100528776|FG001|COMPLETED|Overall Study||0||
48084555|NCT00203996|100528777|FG002|COMPLETED|Overall Study||0||
48540878|NCT00086281|101662589|FG003|NOT COMPLETED|Phase 1||0||
48540879|NCT00086281|101662590|FG004|NOT COMPLETED|Phase 1||0||
48540880|NCT00086281|101662591|FG005|NOT COMPLETED|Phase 1||0||
48084556|NCT00203996|100528778|FG003|COMPLETED|Overall Study||9||
48084557|NCT00203996|100528779|FG004|COMPLETED|Overall Study||3||
48084558|NCT00203996|100528780|FG005|COMPLETED|Overall Study||3||
48084559|NCT00203996|100528781|FG006|COMPLETED|Overall Study||2||
48084560|NCT00203996|100528782|FG007|COMPLETED|Overall Study||2||
48084561|NCT00203996|100528783|FG008|COMPLETED|Overall Study||2||
48084562|NCT00203996|100528784|FG009|COMPLETED|Overall Study||2||
48084563|NCT00203996|100528775|FG000|NOT COMPLETED|Overall Study||0||
48247599|NCT00527514|100924267|FG000|NOT COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg||1||
48247600|NCT00527514|100924267|FG000|STARTED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||180||
48247601|NCT00527514|100924267|FG000|COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||178||
48247602|NCT00527514|100924267|FG000|NOT COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||2||
48247603|NCT00527514|100924267|FG000|STARTED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||161||
48247604|NCT00527514|100924267|FG000|COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||158||
48247605|NCT00527514|100924267|FG000|NOT COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||3||
48247606|NCT00527514|100924267|FG000|STARTED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||134||
48247607|NCT00527514|100924267|FG000|COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||132||
48247608|NCT00527514|100924267|FG000|NOT COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||2||
48247609|NCT00702338|100924268|FG000|STARTED|Base Study (NCT00697255)||5||
48247610|NCT00702338|100924269|FG001|STARTED|Base Study (NCT00697255)||3||
48247611|NCT00702338|100924270|FG002|STARTED|Base Study (NCT00697255)||0||
48247612|NCT00702338|100924268|FG000|COMPLETED|Base Study (NCT00697255)||2||
48247613|NCT00702338|100924269|FG001|COMPLETED|Base Study (NCT00697255)||1||
48084564|NCT00203996|100528776|FG001|NOT COMPLETED|Overall Study||0||
48084565|NCT00203996|100528777|FG002|NOT COMPLETED|Overall Study||0||
48247614|NCT00702338|100924270|FG002|COMPLETED|Base Study (NCT00697255)||0||
48247615|NCT00702338|100924268|FG000|NOT COMPLETED|Base Study (NCT00697255)||3||
48084566|NCT00203996|100528778|FG003|NOT COMPLETED|Overall Study||10||
48084567|NCT00203996|100528779|FG004|NOT COMPLETED|Overall Study||1||
48084568|NCT00203996|100528780|FG005|NOT COMPLETED|Overall Study||0||
48084569|NCT00203996|100528781|FG006|NOT COMPLETED|Overall Study||0||
48084570|NCT00203996|100528782|FG007|NOT COMPLETED|Overall Study||2||
48084571|NCT00203996|100528783|FG008|NOT COMPLETED|Overall Study||0||
48084572|NCT00203996|100528784|FG009|NOT COMPLETED|Overall Study||1||
48084573|NCT04967443|100528785|FG000|STARTED|Screening||6||
48084574|NCT04967443|100528786|FG001|STARTED|Screening||6||
48084575|NCT04967443|100528787|FG002|STARTED|Screening||6||
48084576|NCT04967443|100528788|FG003|STARTED|Screening||6||
48084577|NCT04967443|100528789|FG004|STARTED|Screening||6||
48084578|NCT04967443|100528790|FG005|STARTED|Screening||6||
48084579|NCT04967443|100528791|FG006|STARTED|Screening||18||
48084580|NCT04967443|100528792|FG007|STARTED|Screening||18||
48084581|NCT04967443|100528785|FG000|COMPLETED|Screening||6||
48084582|NCT04967443|100528786|FG001|COMPLETED|Screening||6||
48084583|NCT04967443|100528787|FG002|COMPLETED|Screening||6||
48084584|NCT04967443|100528788|FG003|COMPLETED|Screening||6||
48084585|NCT04967443|100528789|FG004|COMPLETED|Screening||6||
48084586|NCT04967443|100528790|FG005|COMPLETED|Screening||6||
48084587|NCT04967443|100528791|FG006|COMPLETED|Screening||18||
48084588|NCT04967443|100528792|FG007|COMPLETED|Screening||18||
48084589|NCT04967443|100528785|FG000|NOT COMPLETED|Screening||0||
48084590|NCT04967443|100528786|FG001|NOT COMPLETED|Screening||0||
48084591|NCT04967443|100528787|FG002|NOT COMPLETED|Screening||0||
48084592|NCT04967443|100528788|FG003|NOT COMPLETED|Screening||0||
48084593|NCT04967443|100528789|FG004|NOT COMPLETED|Screening||0||
48084594|NCT04967443|100528790|FG005|NOT COMPLETED|Screening||0||
48084595|NCT04967443|100528791|FG006|NOT COMPLETED|Screening||0||
48084596|NCT04967443|100528792|FG007|NOT COMPLETED|Screening||0||
48084597|NCT04967443|100528785|FG000|STARTED|Open Label Treatment||6||
48084598|NCT04967443|100528786|FG001|STARTED|Open Label Treatment||6||
48084599|NCT04967443|100528787|FG002|STARTED|Open Label Treatment||6||
48084600|NCT04967443|100528788|FG003|STARTED|Open Label Treatment||6||
48084601|NCT04967443|100528789|FG004|STARTED|Open Label Treatment||6||
48084602|NCT04967443|100528790|FG005|STARTED|Open Label Treatment||6||
48084603|NCT04967443|100528791|FG006|STARTED|Open Label Treatment||18||
48084604|NCT04967443|100528792|FG007|STARTED|Open Label Treatment||18||
48084605|NCT04967443|100528785|FG000|COMPLETED|Open Label Treatment||5||
48084606|NCT04967443|100528786|FG001|COMPLETED|Open Label Treatment||5||
48084607|NCT04967443|100528787|FG002|COMPLETED|Open Label Treatment||5||
48084608|NCT04967443|100528788|FG003|COMPLETED|Open Label Treatment||5||
48084609|NCT04967443|100528789|FG004|COMPLETED|Open Label Treatment||6||
48084610|NCT04967443|100528790|FG005|COMPLETED|Open Label Treatment||5||
48084611|NCT04967443|100528791|FG006|COMPLETED|Open Label Treatment||16||
48084612|NCT04967443|100528792|FG007|COMPLETED|Open Label Treatment||15||
48084613|NCT04967443|100528785|FG000|NOT COMPLETED|Open Label Treatment||1||
48084614|NCT04967443|100528786|FG001|NOT COMPLETED|Open Label Treatment||1||
48084615|NCT04967443|100528787|FG002|NOT COMPLETED|Open Label Treatment||1||
48084616|NCT04967443|100528788|FG003|NOT COMPLETED|Open Label Treatment||1||
48084617|NCT04967443|100528789|FG004|NOT COMPLETED|Open Label Treatment||0||
48084618|NCT04967443|100528790|FG005|NOT COMPLETED|Open Label Treatment||1||
48084619|NCT04967443|100528791|FG006|NOT COMPLETED|Open Label Treatment||2||
48084620|NCT04967443|100528792|FG007|NOT COMPLETED|Open Label Treatment||3||
48084621|NCT04967443|100528785|FG000|STARTED|Follow-Up||6|Participants who entered the follow-up period is calculated as participants who had open-label treatments as follow-up occurred 28-35 days from last dose of study treatment administration.|
48084622|NCT04967443|100528786|FG001|STARTED|Follow-Up||6|Participants who entered the follow-up period is calculated as participants who had open-label treatments as follow-up occurred 28-35 days from last dose of study treatment administration.|
48084623|NCT04967443|100528787|FG002|STARTED|Follow-Up||6|Participants who entered the follow-up period is calculated as participants who had open-label treatments as follow-up occurred 28-35 days from last dose of study treatment administration.|
48084624|NCT04967443|100528788|FG003|STARTED|Follow-Up||6|Participants who entered the follow-up period is calculated as participants who had open-label treatments as follow-up occurred 28-35 days from last dose of study treatment administration.|
48084625|NCT04967443|100528789|FG004|STARTED|Follow-Up||6|Participants who entered the follow-up period is calculated as participants who had open-label treatments as follow-up occurred 28-35 days from last dose of study treatment administration.|
48084626|NCT04967443|100528790|FG005|STARTED|Follow-Up||6|Participants who entered the follow-up period is calculated as participants who had open-label treatments as follow-up occurred 28-35 days from last dose of study treatment administration.|
48084627|NCT04967443|100528791|FG006|STARTED|Follow-Up||18|Participants who entered the follow-up period is calculated as participants who had open-label treatments as follow-up occurred 28-35 days from last dose of study treatment administration.|
48084628|NCT04967443|100528792|FG007|STARTED|Follow-Up||18|Participants who entered the follow-up period is calculated as participants who had open-label treatments as follow-up occurred 28-35 days from last dose of study treatment administration.|
48084629|NCT04967443|100528785|FG000|COMPLETED|Follow-Up||5||
48084630|NCT04967443|100528786|FG001|COMPLETED|Follow-Up||5||
48084631|NCT04967443|100528787|FG002|COMPLETED|Follow-Up||5||
48084632|NCT04967443|100528788|FG003|COMPLETED|Follow-Up||4||
48084633|NCT04967443|100528789|FG004|COMPLETED|Follow-Up||6||
48084634|NCT04967443|100528790|FG005|COMPLETED|Follow-Up||5||
48084635|NCT04967443|100528791|FG006|COMPLETED|Follow-Up||16||
48540881|NCT00086281|101662592|FG006|NOT COMPLETED|Phase 1||0||
48084636|NCT04967443|100528792|FG007|COMPLETED|Follow-Up||15||
48084637|NCT04967443|100528785|FG000|NOT COMPLETED|Follow-Up||1||
48084638|NCT04967443|100528786|FG001|NOT COMPLETED|Follow-Up||1||
48084639|NCT04967443|100528787|FG002|NOT COMPLETED|Follow-Up||1||
48084640|NCT04967443|100528788|FG003|NOT COMPLETED|Follow-Up||2||
48084641|NCT04967443|100528789|FG004|NOT COMPLETED|Follow-Up||0||
48084642|NCT04967443|100528790|FG005|NOT COMPLETED|Follow-Up||1||
48084643|NCT04967443|100528791|FG006|NOT COMPLETED|Follow-Up||2||
48084644|NCT04967443|100528792|FG007|NOT COMPLETED|Follow-Up||3||
48084645|NCT00740831|100528793|FG000|STARTED|Overall Study||97||
48084646|NCT00740831|100528794|FG001|STARTED|Overall Study||103||
48084647|NCT00740831|100528795|FG002|STARTED|Overall Study||101||
48084648|NCT00740831|100528793|FG000|COMPLETED|Overall Study||93||
48084649|NCT00740831|100528794|FG001|COMPLETED|Overall Study||100||
48084650|NCT00740831|100528795|FG002|COMPLETED|Overall Study||95||
48084651|NCT00740831|100528793|FG000|NOT COMPLETED|Overall Study||4||
48084652|NCT00740831|100528794|FG001|NOT COMPLETED|Overall Study||3||
48084653|NCT00740831|100528795|FG002|NOT COMPLETED|Overall Study||6||
48084654|NCT00907777|100528796|FG000|STARTED|Overall Study||25||
48084655|NCT00907777|100528797|FG001|STARTED|Overall Study||27||
48084656|NCT00907777|100528796|FG000|COMPLETED|Overall Study||25||
48084657|NCT00907777|100528797|FG001|COMPLETED|Overall Study||26||
48084658|NCT00907777|100528796|FG000|NOT COMPLETED|Overall Study||0||
48084659|NCT00907777|100528797|FG001|NOT COMPLETED|Overall Study||1||
48084660|NCT02775162|100528798|FG000|STARTED|Overall Study||136||
48084661|NCT02775162|100528799|FG001|STARTED|Overall Study||131||
48084662|NCT02775162|100528798|FG000|COMPLETED|Overall Study||122||
48084663|NCT02775162|100528799|FG001|COMPLETED|Overall Study||121||
48084664|NCT02775162|100528798|FG000|NOT COMPLETED|Overall Study||14||
48084665|NCT02775162|100528799|FG001|NOT COMPLETED|Overall Study||10||
48084666|NCT02532972|100528800|FG000|STARTED|Overall Study||11||
48084667|NCT02532972|100528800|FG000|COMPLETED|Overall Study||10||
48084668|NCT02532972|100528800|FG000|NOT COMPLETED|Overall Study||1||
48084669|NCT00314093|100528801|FG000|STARTED|Overall Study||0||
48084670|NCT00314093|100528801|FG000|COMPLETED|Overall Study||0||
48084671|NCT00314093|100528801|FG000|NOT COMPLETED|Overall Study||0||
48084672|NCT00553644|100528802|FG000|STARTED|Overall Study||53||
48084673|NCT00553644|100528802|FG000|COMPLETED|Overall Study||25||
48084674|NCT00553644|100528802|FG000|NOT COMPLETED|Overall Study||28||
48084675|NCT00560859|100528803|FG000|STARTED|Overall Study||226||
48084676|NCT00560859|100528804|FG001|STARTED|Overall Study||227||
48084677|NCT00560859|100528803|FG000|COMPLETED|Overall Study||194||
48084678|NCT00560859|100528804|FG001|COMPLETED|Overall Study||203||
48084679|NCT00560859|100528803|FG000|NOT COMPLETED|Overall Study||32||
48084680|NCT00560859|100528804|FG001|NOT COMPLETED|Overall Study||24||
48084681|NCT00963547|100528805|FG000|STARTED|Overall Study||4||
48084682|NCT00963547|100528806|FG001|STARTED|Overall Study||11||
48084683|NCT00963547|100528807|FG002|STARTED|Overall Study||12||
48084684|NCT00963547|100528808|FG003|STARTED|Overall Study||6||
48084685|NCT00963547|100528809|FG004|STARTED|Overall Study||0||
48084686|NCT00963547|100528810|FG005|STARTED|Overall Study||0||
48084687|NCT00963547|100528811|FG006|STARTED|Overall Study||0||
48084688|NCT00963547|100528805|FG000|Treated|Overall Study||3||
48084689|NCT00963547|100528806|FG001|Treated|Overall Study||11||
48084690|NCT00963547|100528807|FG002|Treated|Overall Study||11||
48084691|NCT00963547|100528808|FG003|Treated|Overall Study||6||
48084692|NCT00963547|100528809|FG004|Treated|Overall Study||0||
48084693|NCT00963547|100528810|FG005|Treated|Overall Study||0||
48084694|NCT00963547|100528811|FG006|Treated|Overall Study||0||
48084695|NCT00963547|100528805|FG000|COMPLETED|Overall Study||0||
48084696|NCT00963547|100528806|FG001|COMPLETED|Overall Study||0||
48084697|NCT00963547|100528807|FG002|COMPLETED|Overall Study||0||
48084698|NCT00963547|100528808|FG003|COMPLETED|Overall Study||0||
48084699|NCT00963547|100528809|FG004|COMPLETED|Overall Study||0||
48084700|NCT00963547|100528810|FG005|COMPLETED|Overall Study||0||
48084701|NCT00963547|100528811|FG006|COMPLETED|Overall Study||0||
48084702|NCT00963547|100528805|FG000|NOT COMPLETED|Overall Study||4||
48084703|NCT00963547|100528806|FG001|NOT COMPLETED|Overall Study||11||
48084704|NCT00963547|100528807|FG002|NOT COMPLETED|Overall Study||12||
48084705|NCT00963547|100528808|FG003|NOT COMPLETED|Overall Study||6||
48084706|NCT00963547|100528809|FG004|NOT COMPLETED|Overall Study||0||
48084707|NCT00963547|100528810|FG005|NOT COMPLETED|Overall Study||0||
48084708|NCT00963547|100528811|FG006|NOT COMPLETED|Overall Study||0||
48084709|NCT01918085|100528812|FG000|STARTED|Test Period 1: Strata Strip||10||
48084710|NCT01918085|100528813|FG001|STARTED|Test Period 1: Strata Strip||12||
48084711|NCT01918085|100528812|FG000|COMPLETED|Test Period 1: Strata Strip||10||
48084712|NCT01918085|100528813|FG001|COMPLETED|Test Period 1: Strata Strip||11||
48084713|NCT01918085|100528812|FG000|NOT COMPLETED|Test Period 1: Strata Strip||0||
48084714|NCT01918085|100528813|FG001|NOT COMPLETED|Test Period 1: Strata Strip||1||
48084715|NCT01918085|100528812|FG000|STARTED|Test Period 1: Hydrocolloid Strip||10||
48084716|NCT01918085|100528813|FG001|STARTED|Test Period 1: Hydrocolloid Strip||11||
48084717|NCT01918085|100528812|FG000|COMPLETED|Test Period 1: Hydrocolloid Strip||10||
48084718|NCT01918085|100528813|FG001|COMPLETED|Test Period 1: Hydrocolloid Strip||11||
48084719|NCT01918085|100528812|FG000|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0||
48084720|NCT01918085|100528813|FG001|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0||
48084721|NCT01918085|100528812|FG000|STARTED|Test Period 2: Strata Strip||10||
48084722|NCT01918085|100528813|FG001|STARTED|Test Period 2: Strata Strip||11||
48084723|NCT01918085|100528812|FG000|COMPLETED|Test Period 2: Strata Strip||10||
48084724|NCT01918085|100528813|FG001|COMPLETED|Test Period 2: Strata Strip||11||
48084725|NCT01918085|100528812|FG000|NOT COMPLETED|Test Period 2: Strata Strip||0||
48084726|NCT01918085|100528813|FG001|NOT COMPLETED|Test Period 2: Strata Strip||0||
48084727|NCT01918085|100528812|FG000|STARTED|Test Period 2: Hydrocolloid Strip||10||
48084728|NCT01918085|100528813|FG001|STARTED|Test Period 2: Hydrocolloid Strip||11||
48084729|NCT01918085|100528812|FG000|COMPLETED|Test Period 2: Hydrocolloid Strip||10||
48084730|NCT01918085|100528813|FG001|COMPLETED|Test Period 2: Hydrocolloid Strip||11||
48084731|NCT01918085|100528812|FG000|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0||
48084732|NCT01918085|100528813|FG001|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0||
48084733|NCT00320411|100528814|FG000|STARTED|Overall Study||62||
48084734|NCT00320411|100528814|FG000|COMPLETED|Overall Study||58||
48084735|NCT00320411|100528814|FG000|NOT COMPLETED|Overall Study||4||
48084736|NCT03631472|100528815|FG000|STARTED|Overall Study||21||
48084737|NCT03631472|100528815|FG000|COMPLETED|Overall Study||21||
48084738|NCT03631472|100528815|FG000|NOT COMPLETED|Overall Study||0||
48084739|NCT02692703|100528816|FG000|STARTED|Overall Study||100||
48084740|NCT02692703|100528816|FG000|COMPLETED|Overall Study||98||
48084741|NCT02692703|100528816|FG000|NOT COMPLETED|Overall Study||2||
48084742|NCT00553514|100528817|FG000|STARTED|Overall Study||14||
48084743|NCT00553514|100528818|FG001|STARTED|Overall Study||14||
48084744|NCT00553514|100528819|FG002|STARTED|Overall Study||15||
48084745|NCT00553514|100528820|FG003|STARTED|Overall Study||13||
48084746|NCT00553514|100528821|FG004|STARTED|Overall Study||15||
48084747|NCT00553514|100528817|FG000|COMPLETED|Overall Study||6||
48084748|NCT00553514|100528818|FG001|COMPLETED|Overall Study||6||
48084749|NCT00553514|100528819|FG002|COMPLETED|Overall Study||9||
48084750|NCT00553514|100528820|FG003|COMPLETED|Overall Study||6||
48084751|NCT00553514|100528821|FG004|COMPLETED|Overall Study||8||
48084752|NCT00553514|100528817|FG000|NOT COMPLETED|Overall Study||8||
48084753|NCT00553514|100528818|FG001|NOT COMPLETED|Overall Study||8||
48084754|NCT00553514|100528819|FG002|NOT COMPLETED|Overall Study||6||
48084755|NCT00553514|100528820|FG003|NOT COMPLETED|Overall Study||7||
48084756|NCT00553514|100528821|FG004|NOT COMPLETED|Overall Study||7||
48084757|NCT04605484|100528822|FG000|STARTED|Overall Study||20||
48084758|NCT04605484|100528823|FG001|STARTED|Overall Study||22||
48084759|NCT04605484|100528824|FG002|STARTED|Overall Study||19||
48084760|NCT04605484|100528822|FG000|COMPLETED|Overall Study||20||
48084761|NCT04605484|100528823|FG001|COMPLETED|Overall Study||20||
48084762|NCT04605484|100528824|FG002|COMPLETED|Overall Study||18||
48084763|NCT04605484|100528822|FG000|NOT COMPLETED|Overall Study||0||
48247616|NCT00702338|100924269|FG001|NOT COMPLETED|Base Study (NCT00697255)||2||
48247617|NCT00702338|100924270|FG002|NOT COMPLETED|Base Study (NCT00697255)||0||
48247618|NCT00702338|100924268|FG000|STARTED|Follow-up Study: Expectant Mothers FU||0||
48247619|NCT00702338|100924269|FG001|STARTED|Follow-up Study: Expectant Mothers FU||1||
48247620|NCT00702338|100924270|FG002|STARTED|Follow-up Study: Expectant Mothers FU||0||
48247621|NCT00702338|100924268|FG000|COMPLETED|Follow-up Study: Expectant Mothers FU||0||
48247622|NCT00702338|100924269|FG001|COMPLETED|Follow-up Study: Expectant Mothers FU||0||
48084764|NCT04605484|100528823|FG001|NOT COMPLETED|Overall Study||2||
48084765|NCT04605484|100528824|FG002|NOT COMPLETED|Overall Study||1||
48084766|NCT01903187|100528825|FG000|STARTED|Procedure||2||
48084767|NCT01903187|100528826|FG001|STARTED|Procedure||2||
48084768|NCT01903187|100528825|FG000|COMPLETED|Procedure||2||
48084769|NCT01903187|100528826|FG001|COMPLETED|Procedure||2||
48084770|NCT01903187|100528825|FG000|NOT COMPLETED|Procedure||0||
48084771|NCT01903187|100528826|FG001|NOT COMPLETED|Procedure||0||
48084772|NCT01903187|100528825|FG000|STARTED|1 Month||2||
48084773|NCT01903187|100528826|FG001|STARTED|1 Month||2||
48084774|NCT01903187|100528825|FG000|COMPLETED|1 Month||2||
48084775|NCT01903187|100528826|FG001|COMPLETED|1 Month||2||
48084776|NCT01903187|100528825|FG000|NOT COMPLETED|1 Month||0||
48084777|NCT01903187|100528826|FG001|NOT COMPLETED|1 Month||0||
48084778|NCT01903187|100528825|FG000|STARTED|3 Month||2||
48084779|NCT01903187|100528826|FG001|STARTED|3 Month||0||
48084780|NCT01903187|100528825|FG000|COMPLETED|3 Month||2||
48084781|NCT01903187|100528826|FG001|COMPLETED|3 Month||0||
48084782|NCT01903187|100528825|FG000|NOT COMPLETED|3 Month||0||
48084783|NCT01903187|100528826|FG001|NOT COMPLETED|3 Month||0||
48084784|NCT01903187|100528825|FG000|STARTED|6 Month||2||
48084785|NCT01903187|100528826|FG001|STARTED|6 Month||0||
48084786|NCT01903187|100528825|FG000|COMPLETED|6 Month||2||
48084787|NCT01903187|100528826|FG001|COMPLETED|6 Month||0||
48084788|NCT01903187|100528825|FG000|NOT COMPLETED|6 Month||0||
48084789|NCT01903187|100528826|FG001|NOT COMPLETED|6 Month||0||
48084790|NCT01903187|100528825|FG000|STARTED|12 Month||2||
48084791|NCT01903187|100528826|FG001|STARTED|12 Month||0||
48084792|NCT01903187|100528825|FG000|COMPLETED|12 Month||2||
48084793|NCT01903187|100528826|FG001|COMPLETED|12 Month||0||
48084794|NCT01903187|100528825|FG000|NOT COMPLETED|12 Month||0||
48084795|NCT01903187|100528826|FG001|NOT COMPLETED|12 Month||0||
48084796|NCT00368355|100528827|FG000|STARTED|Overall Study||18||
48084797|NCT00368355|100528828|FG001|STARTED|Overall Study||28||
48084798|NCT00368355|100528827|FG000|COMPLETED|Overall Study||7||
48084799|NCT00368355|100528828|FG001|COMPLETED|Overall Study||11||
48084800|NCT00368355|100528827|FG000|NOT COMPLETED|Overall Study||11||
48084801|NCT00368355|100528828|FG001|NOT COMPLETED|Overall Study||17||
48084802|NCT00759031|100528829|FG000|STARTED|First Intervention (1 Day)||10||
48084803|NCT00759031|100528830|FG001|STARTED|First Intervention (1 Day)||9||
48084804|NCT00759031|100528829|FG000|COMPLETED|First Intervention (1 Day)||8||
48084805|NCT00759031|100528830|FG001|COMPLETED|First Intervention (1 Day)||8||
48084806|NCT00759031|100528829|FG000|NOT COMPLETED|First Intervention (1 Day)||2||
48084807|NCT00759031|100528830|FG001|NOT COMPLETED|First Intervention (1 Day)||1||
48084808|NCT00759031|100528829|FG000|STARTED|Washout After 1st Intervention (1 Week)||8||
48084809|NCT00759031|100528830|FG001|STARTED|Washout After 1st Intervention (1 Week)||8||
48084810|NCT00759031|100528829|FG000|COMPLETED|Washout After 1st Intervention (1 Week)||8||
48084811|NCT00759031|100528830|FG001|COMPLETED|Washout After 1st Intervention (1 Week)||8||
48084812|NCT00759031|100528829|FG000|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0||
48084813|NCT00759031|100528830|FG001|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0||
48084814|NCT00759031|100528829|FG000|STARTED|Second Intervention (1 Day)||8||
48084815|NCT00759031|100528830|FG001|STARTED|Second Intervention (1 Day)||8||
48084816|NCT00759031|100528829|FG000|COMPLETED|Second Intervention (1 Day)||8||
48084817|NCT00759031|100528830|FG001|COMPLETED|Second Intervention (1 Day)||8||
48084818|NCT00759031|100528829|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48084819|NCT00759031|100528830|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48084820|NCT03825315|100528831|FG000|STARTED|Overall Study||49||
48084821|NCT03825315|100528832|FG001|STARTED|Overall Study||54||
48084822|NCT03825315|100528833|FG002|STARTED|Overall Study||52||
48084823|NCT03825315|100528831|FG000|COMPLETED|Overall Study||42||
48084824|NCT03825315|100528832|FG001|COMPLETED|Overall Study||48||
48084825|NCT03825315|100528833|FG002|COMPLETED|Overall Study||46||
48084826|NCT03825315|100528831|FG000|NOT COMPLETED|Overall Study||7||
48084827|NCT03825315|100528832|FG001|NOT COMPLETED|Overall Study||6||
48084828|NCT03825315|100528833|FG002|NOT COMPLETED|Overall Study||6||
48084829|NCT02397785|100528834|FG000|STARTED|Overall Study||24||
48247623|NCT00702338|100924270|FG002|COMPLETED|Follow-up Study: Expectant Mothers FU||0||
48247624|NCT00702338|100924268|FG000|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0||
48247625|NCT00702338|100924269|FG001|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||1||
48084830|NCT02397785|100528835|FG001|STARTED|Overall Study||34||
48084831|NCT02397785|100528834|FG000|COMPLETED|Overall Study||22||
48084832|NCT02397785|100528835|FG001|COMPLETED|Overall Study||25||
48084833|NCT02397785|100528834|FG000|NOT COMPLETED|Overall Study||2||
48247626|NCT00702338|100924270|FG002|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0||
48247627|NCT00702338|100924268|FG000|STARTED|Follow-up Study: Infant FU||0||
48247628|NCT00702338|100924269|FG001|STARTED|Follow-up Study: Infant FU||0||
48247629|NCT00702338|100924270|FG002|STARTED|Follow-up Study: Infant FU||2||
48247630|NCT00702338|100924268|FG000|COMPLETED|Follow-up Study: Infant FU||0||
48247631|NCT00702338|100924269|FG001|COMPLETED|Follow-up Study: Infant FU||0||
48247632|NCT00702338|100924270|FG002|COMPLETED|Follow-up Study: Infant FU||0||
48247633|NCT00702338|100924268|FG000|NOT COMPLETED|Follow-up Study: Infant FU||0||
48540882|NCT00086281|101662593|FG007|NOT COMPLETED|Phase 1||0||
48084834|NCT02397785|100528835|FG001|NOT COMPLETED|Overall Study||9||
48084835|NCT00691015|100528836|FG000|STARTED|Overall Study||48||
48084836|NCT00691015|100528836|FG000|COMPLETED|Overall Study||47||
48084837|NCT00691015|100528836|FG000|NOT COMPLETED|Overall Study||1||
48247634|NCT00702338|100924269|FG001|NOT COMPLETED|Follow-up Study: Infant FU||0||
48247635|NCT00702338|100924270|FG002|NOT COMPLETED|Follow-up Study: Infant FU||2||
48247636|NCT00348283|100924271|FG000|STARTED|Induction||0||
48247637|NCT00348283|100924272|FG001|STARTED|Induction||135||
48247638|NCT00348283|100924271|FG000|COMPLETED|Induction||0||
48247639|NCT00348283|100924272|FG001|COMPLETED|Induction||129||
48247640|NCT00348283|100924271|FG000|NOT COMPLETED|Induction||0||
48084838|NCT00160251|100528837|FG000|STARTED|Prior to Amendment 2||15||
48084839|NCT00160251|100528838|FG001|STARTED|Prior to Amendment 2||34||
48084840|NCT00160251|100528839|FG002|STARTED|Prior to Amendment 2||48||
48084841|NCT00160251|100528840|FG003|STARTED|Prior to Amendment 2||49||
48084842|NCT00160251|100528841|FG004|STARTED|Prior to Amendment 2||49||
48084843|NCT00160251|100528842|FG005|STARTED|Prior to Amendment 2||97||
48084844|NCT00160251|100528843|FG006|STARTED|Prior to Amendment 2||65||
48084845|NCT00160251|100528844|FG007|STARTED|Prior to Amendment 2||0||
48084846|NCT00160251|100528837|FG000|COMPLETED|Prior to Amendment 2||6||
48084847|NCT00160251|100528838|FG001|COMPLETED|Prior to Amendment 2||28||
48084848|NCT00160251|100528839|FG002|COMPLETED|Prior to Amendment 2||4||
48084849|NCT00160251|100528840|FG003|COMPLETED|Prior to Amendment 2||9||
48084850|NCT00160251|100528841|FG004|COMPLETED|Prior to Amendment 2||21||
48084851|NCT00160251|100528842|FG005|COMPLETED|Prior to Amendment 2||14||
48084852|NCT00160251|100528843|FG006|COMPLETED|Prior to Amendment 2||61||
48084853|NCT00160251|100528844|FG007|COMPLETED|Prior to Amendment 2||0||
48084854|NCT00160251|100528837|FG000|NOT COMPLETED|Prior to Amendment 2||9||
48084855|NCT00160251|100528838|FG001|NOT COMPLETED|Prior to Amendment 2||6||
48084856|NCT00160251|100528839|FG002|NOT COMPLETED|Prior to Amendment 2||44||
48084857|NCT00160251|100528840|FG003|NOT COMPLETED|Prior to Amendment 2||40||
48084858|NCT00160251|100528841|FG004|NOT COMPLETED|Prior to Amendment 2||28||
48084859|NCT00160251|100528842|FG005|NOT COMPLETED|Prior to Amendment 2||83||
48084860|NCT00160251|100528843|FG006|NOT COMPLETED|Prior to Amendment 2||4||
48084861|NCT00160251|100528844|FG007|NOT COMPLETED|Prior to Amendment 2||0||
48084862|NCT00160251|100528837|FG000|STARTED|Post-amendment 2||0||
48084863|NCT00160251|100528838|FG001|STARTED|Post-amendment 2||0||
48084864|NCT00160251|100528839|FG002|STARTED|Post-amendment 2||0||
48084865|NCT00160251|100528840|FG003|STARTED|Post-amendment 2||0||
48084866|NCT00160251|100528841|FG004|STARTED|Post-amendment 2||0||
48084867|NCT00160251|100528842|FG005|STARTED|Post-amendment 2||0||
48084868|NCT00160251|100528843|FG006|STARTED|Post-amendment 2||0||
48084869|NCT00160251|100528844|FG007|STARTED|Post-amendment 2||143||
48084870|NCT00160251|100528837|FG000|COMPLETED|Post-amendment 2||0||
48084871|NCT00160251|100528838|FG001|COMPLETED|Post-amendment 2||0||
48084872|NCT00160251|100528839|FG002|COMPLETED|Post-amendment 2||0||
48084873|NCT00160251|100528840|FG003|COMPLETED|Post-amendment 2||0||
48084874|NCT00160251|100528841|FG004|COMPLETED|Post-amendment 2||0||
48084875|NCT00160251|100528842|FG005|COMPLETED|Post-amendment 2||0||
48084876|NCT00160251|100528843|FG006|COMPLETED|Post-amendment 2||0||
48084877|NCT00160251|100528844|FG007|COMPLETED|Post-amendment 2||88||
48084878|NCT00160251|100528837|FG000|NOT COMPLETED|Post-amendment 2||0||
48084879|NCT00160251|100528838|FG001|NOT COMPLETED|Post-amendment 2||0||
48084880|NCT00160251|100528839|FG002|NOT COMPLETED|Post-amendment 2||0||
48084881|NCT00160251|100528840|FG003|NOT COMPLETED|Post-amendment 2||0||
48084882|NCT00160251|100528841|FG004|NOT COMPLETED|Post-amendment 2||0||
48084883|NCT00160251|100528842|FG005|NOT COMPLETED|Post-amendment 2||0||
48084884|NCT00160251|100528843|FG006|NOT COMPLETED|Post-amendment 2||0||
48084885|NCT00160251|100528844|FG007|NOT COMPLETED|Post-amendment 2||55||
48084886|NCT01651195|100528845|FG000|STARTED|Overall Study||284||
48084887|NCT01651195|100528846|FG001|STARTED|Overall Study||284||
48084888|NCT01651195|100528847|FG002|STARTED|Overall Study||204||
48084889|NCT01651195|100528848|FG003|STARTED|Overall Study||211||
48084890|NCT01651195|100528845|FG000|COMPLETED|Overall Study||63||
48084891|NCT01651195|100528846|FG001|COMPLETED|Overall Study||73||
48084892|NCT01651195|100528847|FG002|COMPLETED|Overall Study||121||
48084893|NCT01651195|100528848|FG003|COMPLETED|Overall Study||103||
48084894|NCT01651195|100528845|FG000|NOT COMPLETED|Overall Study||221||
48084895|NCT01651195|100528846|FG001|NOT COMPLETED|Overall Study||211||
48247641|NCT00348283|100924272|FG001|NOT COMPLETED|Induction||6||
48247642|NCT00348283|100924271|FG000|STARTED|Double Blind||65||
48247643|NCT00348283|100924272|FG001|STARTED|Double Blind||64||
48247644|NCT00348283|100924271|FG000|COMPLETED|Double Blind||60||
48247645|NCT00348283|100924272|FG001|COMPLETED|Double Blind||54||
48247646|NCT00348283|100924271|FG000|NOT COMPLETED|Double Blind||5||
48247647|NCT00348283|100924272|FG001|NOT COMPLETED|Double Blind||10||
48247648|NCT00348283|100924271|FG000|STARTED|Open Label||0||
48247649|NCT00348283|100924272|FG001|STARTED|Open Label||100||
48247650|NCT00348283|100924271|FG000|COMPLETED|Open Label||0||
48247651|NCT00348283|100924272|FG001|COMPLETED|Open Label||66||
48247652|NCT00348283|100924271|FG000|NOT COMPLETED|Open Label||0||
48247653|NCT00348283|100924272|FG001|NOT COMPLETED|Open Label||34||
48084896|NCT01651195|100528847|FG002|NOT COMPLETED|Overall Study||83||
48084897|NCT01651195|100528848|FG003|NOT COMPLETED|Overall Study||108||
48084898|NCT03158116|100528849|FG000|STARTED|Overall Study||5||
48084899|NCT03158116|100528849|FG000|COMPLETED|Overall Study||5||
48084900|NCT03158116|100528849|FG000|NOT COMPLETED|Overall Study||0||
48084901|NCT02114814|100528850|FG000|STARTED|Overall Study||103||
48084902|NCT02114814|100528851|FG001|STARTED|Overall Study||83||
48084903|NCT02114814|100528850|FG000|COMPLETED|Overall Study||88||
48084904|NCT02114814|100528851|FG001|COMPLETED|Overall Study||74||
48247654|NCT01502371|100924273|FG000|STARTED|Overall Study||120||
48247655|NCT01502371|100924274|FG001|STARTED|Overall Study||113||
48247656|NCT01502371|100924275|FG002|STARTED|Overall Study||108||
48084905|NCT02114814|100528850|FG000|NOT COMPLETED|Overall Study||15||
48084906|NCT02114814|100528851|FG001|NOT COMPLETED|Overall Study||9||
48084907|NCT02617628|100528852|FG000|STARTED|Overall Study||74||
48084908|NCT02617628|100528853|FG001|STARTED|Overall Study||72||
48084909|NCT02617628|100528852|FG000|COMPLETED|Overall Study||12||
48084910|NCT02617628|100528853|FG001|COMPLETED|Overall Study||11||
48084911|NCT02617628|100528852|FG000|NOT COMPLETED|Overall Study||62||
48084912|NCT02617628|100528853|FG001|NOT COMPLETED|Overall Study||61||
48247657|NCT01502371|100924276|FG003|STARTED|Overall Study||125||
48247658|NCT01502371|100924277|FG004|STARTED|Overall Study||112||
48247659|NCT01502371|100924273|FG000|COMPLETED|Overall Study||79||
48084913|NCT01113983|100528854|FG000|STARTED|Overall Study||37||
48084914|NCT01113983|100528855|FG001|STARTED|Overall Study||27||
48084915|NCT01113983|100528854|FG000|COMPLETED|Overall Study||12||
48084916|NCT01113983|100528855|FG001|COMPLETED|Overall Study||10||
48084917|NCT01113983|100528854|FG000|NOT COMPLETED|Overall Study||25||
48084918|NCT01113983|100528855|FG001|NOT COMPLETED|Overall Study||17||
48084919|NCT00612690|100528856|FG000|STARTED|Overall Study||275||
48247660|NCT01502371|100924274|FG001|COMPLETED|Overall Study||81||
48247661|NCT01502371|100924275|FG002|COMPLETED|Overall Study||83||
48084920|NCT00612690|100528857|FG001|STARTED|Overall Study||207||
48084921|NCT00612690|100528856|FG000|COMPLETED|Overall Study||160||
48084922|NCT00612690|100528857|FG001|COMPLETED|Overall Study||89||
48084923|NCT00612690|100528856|FG000|NOT COMPLETED|Overall Study||115||
48084924|NCT00612690|100528857|FG001|NOT COMPLETED|Overall Study||118||
48084925|NCT02622321|100528858|FG000|STARTED|Overall Study||35||
48084926|NCT02622321|100528859|FG001|STARTED|Overall Study||18||
48084927|NCT02622321|100528860|FG002|STARTED|Overall Study||49||
48084928|NCT02622321|100528861|FG003|STARTED|Overall Study||11||
48084929|NCT02622321|100528858|FG000|Received at Least One Dose of Treatment|Overall Study||34|Safety Population|
48084930|NCT02622321|100528859|FG001|Received at Least One Dose of Treatment|Overall Study||18|Safety Population|
48084931|NCT02622321|100528860|FG002|Received at Least One Dose of Treatment|Overall Study||49|Safety Population|
48084932|NCT02622321|100528861|FG003|Received at Least One Dose of Treatment|Overall Study||11|Safety Population|
48084933|NCT02622321|100528858|FG000|Completed 24 Weeks in the Study|Overall Study||31||
48084934|NCT02622321|100528859|FG001|Completed 24 Weeks in the Study|Overall Study||18||
48084935|NCT02622321|100528860|FG002|Completed 24 Weeks in the Study|Overall Study||49||
48084936|NCT02622321|100528861|FG003|Completed 24 Weeks in the Study|Overall Study||11||
48084937|NCT02622321|100528858|FG000|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2||
48247662|NCT01502371|100924276|FG003|COMPLETED|Overall Study||88||
48247663|NCT01502371|100924277|FG004|COMPLETED|Overall Study||60||
48247664|NCT01502371|100924273|FG000|NOT COMPLETED|Overall Study||41||
48247665|NCT01502371|100924274|FG001|NOT COMPLETED|Overall Study||32||
48247666|NCT01502371|100924275|FG002|NOT COMPLETED|Overall Study||25||
48247667|NCT01502371|100924276|FG003|NOT COMPLETED|Overall Study||37||
48247668|NCT01502371|100924277|FG004|NOT COMPLETED|Overall Study||52||
48247669|NCT00678899|100924278|FG000|STARTED|Overall Study||50||
48247670|NCT00678899|100924278|FG000|COMPLETED|Overall Study||49||
48247671|NCT00678899|100924278|FG000|NOT COMPLETED|Overall Study||1||
48247672|NCT04883541|100924279|FG000|STARTED|Overall Study||46||
48247673|NCT04883541|100924280|FG001|STARTED|Overall Study||69||
48084938|NCT02622321|100528859|FG001|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0||
48084939|NCT02622321|100528860|FG002|Dose Up-Titrated to 3 mg/kg QW|Overall Study||3||
48084940|NCT02622321|100528861|FG003|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2||
48084941|NCT02622321|100528858|FG000|COMPLETED|Overall Study||32||
48084942|NCT02622321|100528859|FG001|COMPLETED|Overall Study||18||
48084943|NCT02622321|100528860|FG002|COMPLETED|Overall Study||48||
48247674|NCT04883541|100924279|FG000|COMPLETED|Overall Study||30||
48247675|NCT04883541|100924280|FG001|COMPLETED|Overall Study||60||
48247676|NCT04883541|100924279|FG000|NOT COMPLETED|Overall Study||16||
48247677|NCT04883541|100924280|FG001|NOT COMPLETED|Overall Study||9||
48247678|NCT00411463|100924281|FG000|STARTED|Overall Study||14||
48247679|NCT00411463|100924282|FG001|STARTED|Overall Study||11||
48247680|NCT00411463|100924281|FG000|COMPLETED|Overall Study||11||
48247681|NCT00411463|100924282|FG001|COMPLETED|Overall Study||8||
48247682|NCT00411463|100924281|FG000|NOT COMPLETED|Overall Study||3||
48247683|NCT00411463|100924282|FG001|NOT COMPLETED|Overall Study||3||
48247684|NCT01828476|100924283|FG000|STARTED|Overall Study||13||
48247685|NCT01828476|100924284|FG001|STARTED|Overall Study||0||
48247686|NCT01828476|100924283|FG000|COMPLETED|Overall Study||13||
48247687|NCT01828476|100924284|FG001|COMPLETED|Overall Study||0||
48247688|NCT01828476|100924283|FG000|NOT COMPLETED|Overall Study||0||
48247689|NCT01828476|100924284|FG001|NOT COMPLETED|Overall Study||0||
48247690|NCT02504502|100924285|FG000|STARTED|Routine Care vs. Enhanced Report||24||
48247691|NCT02504502|100924286|FG001|STARTED|Routine Care vs. Enhanced Report||28||
48247692|NCT02504502|100924285|FG000|COMPLETED|Routine Care vs. Enhanced Report||20||
48247693|NCT02504502|100924286|FG001|COMPLETED|Routine Care vs. Enhanced Report||21||
48247694|NCT02504502|100924285|FG000|NOT COMPLETED|Routine Care vs. Enhanced Report||4||
48247695|NCT02504502|100924286|FG001|NOT COMPLETED|Routine Care vs. Enhanced Report||7||
48247696|NCT02504502|100924285|FG000|STARTED|Crossover to Enhanced Report||20||
48247697|NCT02504502|100924286|FG001|STARTED|Crossover to Enhanced Report||0||
48247698|NCT02504502|100924285|FG000|COMPLETED|Crossover to Enhanced Report||15||
48247699|NCT02504502|100924286|FG001|COMPLETED|Crossover to Enhanced Report||0||
48247700|NCT02504502|100924285|FG000|NOT COMPLETED|Crossover to Enhanced Report||5||
48247701|NCT02504502|100924286|FG001|NOT COMPLETED|Crossover to Enhanced Report||0||
48247702|NCT01812837|100924287|FG000|STARTED|Overall Study||17||
48247703|NCT01812837|100924288|FG001|STARTED|Overall Study||17||
48247704|NCT01812837|100924289|FG002|STARTED|Overall Study||17||
48247705|NCT01812837|100924287|FG000|COMPLETED|Overall Study||15||
48247706|NCT01812837|100924288|FG001|COMPLETED|Overall Study||16||
48247707|NCT01812837|100924289|FG002|COMPLETED|Overall Study||17||
48247708|NCT01812837|100924287|FG000|NOT COMPLETED|Overall Study||2||
48247709|NCT01812837|100924288|FG001|NOT COMPLETED|Overall Study||1||
48247710|NCT01812837|100924289|FG002|NOT COMPLETED|Overall Study||0||
48084944|NCT02622321|100528861|FG003|COMPLETED|Overall Study||11||
48084945|NCT02622321|100528858|FG000|NOT COMPLETED|Overall Study||3||
48247711|NCT01369147|100924290|FG000|STARTED|Overall Study||3||
48247712|NCT01369147|100924291|FG001|STARTED|Overall Study||5||
48247713|NCT01369147|100924292|FG002|STARTED|Overall Study||4||
48247714|NCT01369147|100924290|FG000|COMPLETED|Overall Study||3||
48247715|NCT01369147|100924291|FG001|COMPLETED|Overall Study||4||
48247716|NCT01369147|100924292|FG002|COMPLETED|Overall Study||4||
48247717|NCT01369147|100924290|FG000|NOT COMPLETED|Overall Study||0||
48084946|NCT02622321|100528859|FG001|NOT COMPLETED|Overall Study||0||
48084947|NCT02622321|100528860|FG002|NOT COMPLETED|Overall Study||1||
48084948|NCT02622321|100528861|FG003|NOT COMPLETED|Overall Study||0||
48084949|NCT00600483|100528862|FG000|STARTED|Overall Study||753||
48084950|NCT00600483|100528863|FG001|STARTED|Overall Study||749||
48084951|NCT00600483|100528862|FG000|COMPLETED|Overall Study||717||
48084952|NCT00600483|100528863|FG001|COMPLETED|Overall Study||702||
48084953|NCT00600483|100528862|FG000|NOT COMPLETED|Overall Study||36||
48084954|NCT00600483|100528863|FG001|NOT COMPLETED|Overall Study||47||
48084955|NCT03501069|100528864|FG000|STARTED|Period A||2||
48084956|NCT03501069|100528865|FG001|STARTED|Period A||4||
48084957|NCT03501069|100528866|FG002|STARTED|Period A||2||
48247718|NCT01369147|100924291|FG001|NOT COMPLETED|Overall Study||1||
48247719|NCT01369147|100924292|FG002|NOT COMPLETED|Overall Study||0||
48247720|NCT00116584|100924293|FG000|STARTED|Overall Study||36||
48247721|NCT00116584|100924294|FG001|STARTED|Overall Study||36||
48247722|NCT00116584|100924293|FG000|COMPLETED|Overall Study||34||
48247723|NCT00116584|100924294|FG001|COMPLETED|Overall Study||35||
48247724|NCT00116584|100924293|FG000|NOT COMPLETED|Overall Study||2||
48247725|NCT00116584|100924294|FG001|NOT COMPLETED|Overall Study||1||
48247726|NCT00103116|100924295|FG000|STARTED|Overall Study||32||
48247727|NCT00103116|100924295|FG000|COMPLETED|Overall Study||32||
48247728|NCT00103116|100924295|FG000|NOT COMPLETED|Overall Study||0||
48247729|NCT02341599|100924296|FG000|STARTED|Overall Study||8||
48247730|NCT02341599|100924297|FG001|STARTED|Overall Study||8||
48247731|NCT02341599|100924298|FG002|STARTED|Overall Study||8||
48247732|NCT02341599|100924299|FG003|STARTED|Overall Study||8||
48540883|NCT00086281|101662594|FG008|NOT COMPLETED|Phase 1||0||
48084958|NCT03501069|100528867|FG003|STARTED|Period A||5||
48084959|NCT03501069|100528868|FG004|STARTED|Period A||1||
48084960|NCT03501069|100528869|FG005|STARTED|Period A||6||
48084961|NCT03501069|100528870|FG006|STARTED|Period A||6||
48084962|NCT03501069|100528871|FG007|STARTED|Period A||3||
48084963|NCT03501069|100528872|FG008|STARTED|Period A||3||
48084964|NCT03501069|100528864|FG000|COMPLETED|Period A||2||
48084965|NCT03501069|100528865|FG001|COMPLETED|Period A||4||
48084966|NCT03501069|100528866|FG002|COMPLETED|Period A||2||
48084967|NCT03501069|100528867|FG003|COMPLETED|Period A||5||
48084968|NCT03501069|100528868|FG004|COMPLETED|Period A||1||
48084969|NCT03501069|100528869|FG005|COMPLETED|Period A||6||
48084970|NCT03501069|100528870|FG006|COMPLETED|Period A||6||
48084971|NCT03501069|100528871|FG007|COMPLETED|Period A||3||
48084972|NCT03501069|100528872|FG008|COMPLETED|Period A||3||
48247733|NCT02341599|100924300|FG004|STARTED|Overall Study||8||
48247734|NCT02341599|100924296|FG000|COMPLETED|Overall Study||8||
48247735|NCT02341599|100924297|FG001|COMPLETED|Overall Study||8||
48247736|NCT02341599|100924298|FG002|COMPLETED|Overall Study||8||
48247737|NCT02341599|100924299|FG003|COMPLETED|Overall Study||8||
48247738|NCT02341599|100924300|FG004|COMPLETED|Overall Study||8||
48247739|NCT02341599|100924296|FG000|NOT COMPLETED|Overall Study||0||
48247740|NCT02341599|100924297|FG001|NOT COMPLETED|Overall Study||0||
48247741|NCT02341599|100924298|FG002|NOT COMPLETED|Overall Study||0||
48247742|NCT02341599|100924299|FG003|NOT COMPLETED|Overall Study||0||
48247743|NCT02341599|100924300|FG004|NOT COMPLETED|Overall Study||0||
48247744|NCT02706834|100924301|FG000|STARTED|Overall Study||3||
48247745|NCT02706834|100924302|FG001|STARTED|Overall Study||3||
48247746|NCT02706834|100924303|FG002|STARTED|Overall Study||3||
48247747|NCT02706834|100924304|FG003|STARTED|Overall Study||3||
48247748|NCT02706834|100924305|FG004|STARTED|Overall Study||3||
48247749|NCT02706834|100924306|FG005|STARTED|Overall Study||3||
48247750|NCT02706834|100924307|FG006|STARTED|Overall Study||3||
48247751|NCT02706834|100924308|FG007|STARTED|Overall Study||3||
48247752|NCT02706834|100924309|FG008|STARTED|Overall Study||4||
48247753|NCT02706834|100924310|FG009|STARTED|Overall Study||4||
48247754|NCT02706834|100924311|FG010|STARTED|Overall Study||4||
48247755|NCT02706834|100924301|FG000|COMPLETED|Overall Study||1||
48247756|NCT02706834|100924302|FG001|COMPLETED|Overall Study||2||
48247757|NCT02706834|100924303|FG002|COMPLETED|Overall Study||2||
48247758|NCT02706834|100924304|FG003|COMPLETED|Overall Study||3||
48247759|NCT02706834|100924305|FG004|COMPLETED|Overall Study||2||
48084973|NCT03501069|100528864|FG000|NOT COMPLETED|Period A||0||
48247760|NCT02706834|100924306|FG005|COMPLETED|Overall Study||3||
48247761|NCT02706834|100924307|FG006|COMPLETED|Overall Study||3||
48247762|NCT02706834|100924308|FG007|COMPLETED|Overall Study||3||
48247763|NCT02706834|100924309|FG008|COMPLETED|Overall Study||4||
48247764|NCT02706834|100924310|FG009|COMPLETED|Overall Study||3||
48247765|NCT02706834|100924311|FG010|COMPLETED|Overall Study||3||
48247766|NCT02706834|100924301|FG000|NOT COMPLETED|Overall Study||2||
48084974|NCT03501069|100528865|FG001|NOT COMPLETED|Period A||0||
48084975|NCT03501069|100528866|FG002|NOT COMPLETED|Period A||0||
48084976|NCT03501069|100528867|FG003|NOT COMPLETED|Period A||0||
48084977|NCT03501069|100528868|FG004|NOT COMPLETED|Period A||0||
48084978|NCT03501069|100528869|FG005|NOT COMPLETED|Period A||0||
48084979|NCT03501069|100528870|FG006|NOT COMPLETED|Period A||0||
48084980|NCT03501069|100528871|FG007|NOT COMPLETED|Period A||0||
48247767|NCT02706834|100924302|FG001|NOT COMPLETED|Overall Study||1||
48247768|NCT02706834|100924303|FG002|NOT COMPLETED|Overall Study||1||
48247769|NCT02706834|100924304|FG003|NOT COMPLETED|Overall Study||0||
48540884|NCT00086281|101662595|FG009|NOT COMPLETED|Phase 1||1||
48084981|NCT03501069|100528872|FG008|NOT COMPLETED|Period A||0||
48084982|NCT03501069|100528864|FG000|STARTED|Washout Period (at Least 14 Days)||2||
48084983|NCT03501069|100528865|FG001|STARTED|Washout Period (at Least 14 Days)||4||
48084984|NCT03501069|100528866|FG002|STARTED|Washout Period (at Least 14 Days)||2||
48084985|NCT03501069|100528867|FG003|STARTED|Washout Period (at Least 14 Days)||0||
48247770|NCT02706834|100924305|FG004|NOT COMPLETED|Overall Study||1||
48247771|NCT02706834|100924306|FG005|NOT COMPLETED|Overall Study||0||
48247772|NCT02706834|100924307|FG006|NOT COMPLETED|Overall Study||0||
48084986|NCT03501069|100528868|FG004|STARTED|Washout Period (at Least 14 Days)||0||
48247773|NCT02706834|100924308|FG007|NOT COMPLETED|Overall Study||0||
48247774|NCT02706834|100924309|FG008|NOT COMPLETED|Overall Study||0||
48247775|NCT02706834|100924310|FG009|NOT COMPLETED|Overall Study||1||
48247776|NCT02706834|100924311|FG010|NOT COMPLETED|Overall Study||1||
48375482|NCT03459131|101247647|FG001|STARTED|Period 2, Second 7 Days of Wear||8||
48375483|NCT03459131|101247646|FG000|COMPLETED|Period 2, Second 7 Days of Wear||7||
48375484|NCT03459131|101247647|FG001|COMPLETED|Period 2, Second 7 Days of Wear||8||
48375485|NCT03459131|101247646|FG000|NOT COMPLETED|Period 2, Second 7 Days of Wear||0||
48375486|NCT03459131|101247647|FG001|NOT COMPLETED|Period 2, Second 7 Days of Wear||0||
48247777|NCT01020487|100924312|FG000|STARTED|Part 1||12||
48247778|NCT01020487|100924313|FG001|STARTED|Part 1||0||
48247779|NCT01020487|100924314|FG002|STARTED|Part 1||0||
48247780|NCT01020487|100924312|FG000|COMPLETED|Part 1||12||
48247781|NCT01020487|100924313|FG001|COMPLETED|Part 1||0||
48247782|NCT01020487|100924314|FG002|COMPLETED|Part 1||0||
48247783|NCT01020487|100924312|FG000|NOT COMPLETED|Part 1||0||
48247784|NCT01020487|100924313|FG001|NOT COMPLETED|Part 1||0||
48247785|NCT01020487|100924314|FG002|NOT COMPLETED|Part 1||0||
48247786|NCT01020487|100924312|FG000|STARTED|Part 2 Double-blind Treatment Period||0||
48247787|NCT01020487|100924313|FG001|STARTED|Part 2 Double-blind Treatment Period||18||
48247788|NCT01020487|100924314|FG002|STARTED|Part 2 Double-blind Treatment Period||19||
48084987|NCT03501069|100528869|FG005|STARTED|Washout Period (at Least 14 Days)||0||
48084988|NCT03501069|100528870|FG006|STARTED|Washout Period (at Least 14 Days)||0||
48084989|NCT03501069|100528871|FG007|STARTED|Washout Period (at Least 14 Days)||0||
48084990|NCT03501069|100528872|FG008|STARTED|Washout Period (at Least 14 Days)||0||
48084991|NCT03501069|100528864|FG000|COMPLETED|Washout Period (at Least 14 Days)||2||
48084992|NCT03501069|100528865|FG001|COMPLETED|Washout Period (at Least 14 Days)||4||
48084993|NCT03501069|100528866|FG002|COMPLETED|Washout Period (at Least 14 Days)||2||
48247789|NCT01020487|100924312|FG000|Received Treatment|Part 2 Double-blind Treatment Period||0||
48247790|NCT01020487|100924313|FG001|Received Treatment|Part 2 Double-blind Treatment Period||18||
48247791|NCT01020487|100924314|FG002|Received Treatment|Part 2 Double-blind Treatment Period||18||
48247792|NCT01020487|100924312|FG000|COMPLETED|Part 2 Double-blind Treatment Period||0||
48247793|NCT01020487|100924313|FG001|COMPLETED|Part 2 Double-blind Treatment Period||16||
48247794|NCT01020487|100924314|FG002|COMPLETED|Part 2 Double-blind Treatment Period||13||
48247795|NCT01020487|100924312|FG000|NOT COMPLETED|Part 2 Double-blind Treatment Period||0||
48247796|NCT01020487|100924313|FG001|NOT COMPLETED|Part 2 Double-blind Treatment Period||2||
48247797|NCT01020487|100924314|FG002|NOT COMPLETED|Part 2 Double-blind Treatment Period||6||
48247798|NCT01020487|100924312|FG000|STARTED|Part 2 Open-label Period||0||
48247799|NCT01020487|100924313|FG001|STARTED|Part 2 Open-label Period||16||
48247800|NCT01020487|100924314|FG002|STARTED|Part 2 Open-label Period||13||
48247801|NCT01020487|100924312|FG000|COMPLETED|Part 2 Open-label Period||0||
48247802|NCT01020487|100924313|FG001|COMPLETED|Part 2 Open-label Period||12||
48247803|NCT01020487|100924314|FG002|COMPLETED|Part 2 Open-label Period||12||
48247804|NCT01020487|100924312|FG000|NOT COMPLETED|Part 2 Open-label Period||0||
48247805|NCT01020487|100924313|FG001|NOT COMPLETED|Part 2 Open-label Period||4||
48247806|NCT01020487|100924314|FG002|NOT COMPLETED|Part 2 Open-label Period||1||
48247807|NCT00776984|100924315|FG000|STARTED|Overall Study||234||
48247808|NCT00776984|100924316|FG001|STARTED|Overall Study||219||
48247809|NCT00776984|100924315|FG000|COMPLETED|Overall Study||203||
48247810|NCT00776984|100924316|FG001|COMPLETED|Overall Study||198||
48247811|NCT00776984|100924315|FG000|NOT COMPLETED|Overall Study||31||
48247812|NCT00776984|100924316|FG001|NOT COMPLETED|Overall Study||21||
48247813|NCT05294328|100924317|FG000|STARTED|Overall Study||22||
48247814|NCT05294328|100924318|FG001|STARTED|Overall Study||22||
48247815|NCT05294328|100924319|FG002|STARTED|Overall Study||24||
48247816|NCT05294328|100924317|FG000|COMPLETED|Overall Study||20||
48247817|NCT05294328|100924318|FG001|COMPLETED|Overall Study||18||
48247818|NCT05294328|100924319|FG002|COMPLETED|Overall Study||23||
48247819|NCT05294328|100924317|FG000|NOT COMPLETED|Overall Study||2||
48247820|NCT05294328|100924318|FG001|NOT COMPLETED|Overall Study||4||
48084994|NCT03501069|100528867|FG003|COMPLETED|Washout Period (at Least 14 Days)||0||
48247821|NCT05294328|100924319|FG002|NOT COMPLETED|Overall Study||1||
48247822|NCT01605435|100924320|FG000|STARTED|Overall Study||2||
48247823|NCT01605435|100924321|FG001|STARTED|Overall Study||3||
48247824|NCT01605435|100924320|FG000|COMPLETED|Overall Study||2||
48247825|NCT01605435|100924321|FG001|COMPLETED|Overall Study||3||
48247826|NCT01605435|100924320|FG000|NOT COMPLETED|Overall Study||0||
48247827|NCT01605435|100924321|FG001|NOT COMPLETED|Overall Study||0||
48247828|NCT03106337|100924322|FG000|STARTED|Overall Study||35||
48375487|NCT03350750|101247648|FG000|STARTED|Overall Study||9||
48247829|NCT03106337|100924322|FG000|COMPLETED|Overall Study||35||
48247830|NCT03106337|100924322|FG000|NOT COMPLETED|Overall Study||0||
48247831|NCT01887418|100924323|FG000|STARTED|Overall Study||15||
48247832|NCT01887418|100924324|FG001|STARTED|Overall Study||14||
48247833|NCT01887418|100924325|FG002|STARTED|Overall Study||10||
48247834|NCT01887418|100924323|FG000|COMPLETED|Overall Study||15||
48247835|NCT01887418|100924324|FG001|COMPLETED|Overall Study||14||
48247836|NCT01887418|100924325|FG002|COMPLETED|Overall Study||9||
48247837|NCT01887418|100924323|FG000|NOT COMPLETED|Overall Study||0||
48247838|NCT01887418|100924324|FG001|NOT COMPLETED|Overall Study||0||
48247839|NCT01887418|100924325|FG002|NOT COMPLETED|Overall Study||1||
48247840|NCT05012280|100924326|FG000|STARTED|Overall Study||137||
48247841|NCT05012280|100924327|FG001|STARTED|Overall Study||101||
48247842|NCT05012280|100924326|FG000|COMPLETED|Overall Study||137||
48247843|NCT05012280|100924327|FG001|COMPLETED|Overall Study||97||
48247844|NCT05012280|100924326|FG000|NOT COMPLETED|Overall Study||0||
48247845|NCT05012280|100924327|FG001|NOT COMPLETED|Overall Study||4||
48247846|NCT03219476|100924328|FG000|STARTED|Overall Study||37||
48247847|NCT03219476|100924328|FG000|COMPLETED|Overall Study||37||
48247848|NCT03219476|100924328|FG000|NOT COMPLETED|Overall Study||0||
48247849|NCT02864342|100924329|FG000|STARTED|Overall Study||70||
48247850|NCT02864342|100924330|FG001|STARTED|Overall Study||68||
48247851|NCT02864342|100924329|FG000|Full Analysis Set (FAS)|Overall Study||70|Subjects who took at least 1 inhalation of Symbicort during the treatment phase of the study.|
48247852|NCT02864342|100924330|FG001|Full Analysis Set (FAS)|Overall Study||67|Subjects who took at least 1 inhalation of Symbicort during the treatment phase of the study.|
48247853|NCT02864342|100924329|FG000|COMPLETED|Overall Study||55||
48247854|NCT02864342|100924330|FG001|COMPLETED|Overall Study||49||
48247855|NCT02864342|100924329|FG000|NOT COMPLETED|Overall Study||15||
48247856|NCT02864342|100924330|FG001|NOT COMPLETED|Overall Study||19||
48247857|NCT00612716|100924331|FG000|STARTED|Overall Study||6||
48247858|NCT00612716|100924331|FG000|COMPLETED|Overall Study||6||
48247859|NCT00612716|100924331|FG000|NOT COMPLETED|Overall Study||0||
48247860|NCT05562583|100924332|FG000|STARTED|Overall Study||15||
48084995|NCT03501069|100528868|FG004|COMPLETED|Washout Period (at Least 14 Days)||0||
48084996|NCT03501069|100528869|FG005|COMPLETED|Washout Period (at Least 14 Days)||0||
48084997|NCT03501069|100528870|FG006|COMPLETED|Washout Period (at Least 14 Days)||0||
48247861|NCT05562583|100924332|FG000|COMPLETED|Overall Study||10||
48247862|NCT05562583|100924332|FG000|NOT COMPLETED|Overall Study||5||
48247863|NCT03635775|100924333|FG000|STARTED|Overall Study||5||
48247864|NCT03635775|100924334|FG001|STARTED|Overall Study||0||
48247865|NCT03635775|100924335|FG002|STARTED|Overall Study||5||
48247866|NCT03635775|100924336|FG003|STARTED|Overall Study||10||
48247867|NCT03635775|100924333|FG000|COMPLETED|Overall Study||5||
48247868|NCT03635775|100924334|FG001|COMPLETED|Overall Study||0||
48247869|NCT03635775|100924335|FG002|COMPLETED|Overall Study||5||
48247870|NCT03635775|100924336|FG003|COMPLETED|Overall Study||9||
48247871|NCT03635775|100924333|FG000|NOT COMPLETED|Overall Study||0||
48247872|NCT03635775|100924334|FG001|NOT COMPLETED|Overall Study||0||
48247873|NCT03635775|100924335|FG002|NOT COMPLETED|Overall Study||0||
48247874|NCT03635775|100924336|FG003|NOT COMPLETED|Overall Study||1||
48247875|NCT00240097|100924337|FG000|STARTED|Part I||30||
48247876|NCT00240097|100924337|FG000|COMPLETED|Part I||26||
48247877|NCT00240097|100924337|FG000|NOT COMPLETED|Part I||4||
48247878|NCT00240097|100924337|FG000|STARTED|Part II||26||
48247879|NCT00240097|100924337|FG000|COMPLETED|Part II||3||
48247880|NCT00240097|100924337|FG000|NOT COMPLETED|Part II||23||
48247881|NCT05021757|100924338|FG000|STARTED|Overall Study||1212||
48247882|NCT05021757|100924338|FG000|COMPLETED|Overall Study||1212||
48247883|NCT05021757|100924338|FG000|NOT COMPLETED|Overall Study||0||
48247884|NCT04362176|100924339|FG000|STARTED|Overall Study||495||
48141273|NCT02558010|100670384|FG000|NOT COMPLETED|Overall Study||5||
48247885|NCT04362176|100924340|FG001|STARTED|Overall Study||479||
48247886|NCT04362176|100924339|FG000|COMPLETED|Overall Study||482||
48682758|NCT01436110|102006677|FG002|Intent-to-Treat Population|Overall Study||115||
48682759|NCT01436110|102006675|FG000|COMPLETED|Overall Study||77||
48682760|NCT01436110|102006676|FG001|COMPLETED|Overall Study||91||
48682761|NCT01436110|102006677|FG002|COMPLETED|Overall Study||95||
48682762|NCT01436110|102006675|FG000|NOT COMPLETED|Overall Study||39||
48682763|NCT01436110|102006676|FG001|NOT COMPLETED|Overall Study||26||
48682764|NCT01436110|102006677|FG002|NOT COMPLETED|Overall Study||23||
48682765|NCT00833027|102006678|FG000|STARTED|Overall Study||608||
48682766|NCT00833027|102006678|FG000|COMPLETED|Overall Study||397||
48682767|NCT00833027|102006678|FG000|NOT COMPLETED|Overall Study||211||
48682768|NCT00429143|102006679|FG000|STARTED|Overall Study||27||
48682769|NCT00429143|102006679|FG000|COMPLETED|Overall Study||27||
48682770|NCT00429143|102006679|FG000|NOT COMPLETED|Overall Study||0||
48682771|NCT00465972|102006680|FG000|STARTED|Overall Study||20||
48682772|NCT00465972|102006681|FG001|STARTED|Overall Study||24||
48682773|NCT00465972|102006680|FG000|COMPLETED|Overall Study||18||
48682774|NCT00465972|102006681|FG001|COMPLETED|Overall Study||23||
48682775|NCT00465972|102006680|FG000|NOT COMPLETED|Overall Study||2||
48682776|NCT00465972|102006681|FG001|NOT COMPLETED|Overall Study||1||
48682777|NCT04068948|102006682|FG000|STARTED|Overall Study||20||
48682778|NCT04068948|102006683|FG001|STARTED|Overall Study||17||
48682779|NCT04068948|102006682|FG000|COMPLETED|Overall Study||20||
48682780|NCT04068948|102006683|FG001|COMPLETED|Overall Study||17||
48682781|NCT04068948|102006682|FG000|NOT COMPLETED|Overall Study||0||
48682782|NCT04068948|102006683|FG001|NOT COMPLETED|Overall Study||0||
48682783|NCT01451749|102006684|FG000|STARTED|Overall Study||216||
48682784|NCT01451749|102006685|FG001|STARTED|Overall Study||108||
48682785|NCT01451749|102006684|FG000|COMPLETED|Overall Study||184||
48682786|NCT01451749|102006685|FG001|COMPLETED|Overall Study||94||
48682787|NCT01451749|102006684|FG000|NOT COMPLETED|Overall Study||32||
48682788|NCT01451749|102006685|FG001|NOT COMPLETED|Overall Study||14||
48682789|NCT03541499|102006686|FG000|STARTED|Overall Study||15||
48682790|NCT03541499|102006687|FG001|STARTED|Overall Study||15||
48682791|NCT03541499|102006688|FG002|STARTED|Overall Study||5||
48682792|NCT03541499|102006689|FG003|STARTED|Overall Study||15||
48682793|NCT03541499|102006686|FG000|COMPLETED|Overall Study||15||
48682794|NCT03541499|102006687|FG001|COMPLETED|Overall Study||15||
48682795|NCT03541499|102006688|FG002|COMPLETED|Overall Study||5||
48682796|NCT03541499|102006689|FG003|COMPLETED|Overall Study||15||
48682797|NCT03541499|102006686|FG000|NOT COMPLETED|Overall Study||0||
48682798|NCT03541499|102006687|FG001|NOT COMPLETED|Overall Study||0||
48682799|NCT03541499|102006688|FG002|NOT COMPLETED|Overall Study||0||
48682800|NCT03541499|102006689|FG003|NOT COMPLETED|Overall Study||0||
48682801|NCT00913510|102006690|FG000|STARTED|Overall Study||13||
48682802|NCT00913510|102006691|FG001|STARTED|Overall Study||7||
48682803|NCT00913510|102006690|FG000|COMPLETED|Overall Study||5||
48682804|NCT00913510|102006691|FG001|COMPLETED|Overall Study||3||
48682805|NCT00913510|102006690|FG000|NOT COMPLETED|Overall Study||8||
48682806|NCT00913510|102006691|FG001|NOT COMPLETED|Overall Study||4||
48682807|NCT01976299|102006692|FG000|STARTED|Overall Study||292|Subjects that signed consent and were randomized.|
48682808|NCT01976299|102006693|FG001|STARTED|Overall Study||286|Subjects that signed consent and were randomized.|
48682809|NCT01976299|102006692|FG000|Completed Procedure|Overall Study||283||
48682810|NCT01976299|102006693|FG001|Completed Procedure|Overall Study||284||
48682811|NCT01976299|102006692|FG000|COMPLETED|Overall Study||269||
48682812|NCT01976299|102006693|FG001|COMPLETED|Overall Study||280||
48682813|NCT01976299|102006692|FG000|NOT COMPLETED|Overall Study||23||
48682814|NCT01976299|102006693|FG001|NOT COMPLETED|Overall Study||6||
48682815|NCT02272946|102006694|FG000|STARTED|Overall Study||10||
48682816|NCT02272946|102006695|FG001|STARTED|Overall Study||25||
48682817|NCT02272946|102006696|FG002|STARTED|Overall Study||8||
48682818|NCT02272946|102006694|FG000|COMPLETED|Overall Study||10||
48682819|NCT02272946|102006695|FG001|COMPLETED|Overall Study||25||
48682820|NCT02272946|102006696|FG002|COMPLETED|Overall Study||8||
48682821|NCT02272946|102006694|FG000|NOT COMPLETED|Overall Study||0||
48682822|NCT02272946|102006695|FG001|NOT COMPLETED|Overall Study||0||
48682823|NCT02272946|102006696|FG002|NOT COMPLETED|Overall Study||0||
48682824|NCT00811720|102006697|FG000|STARTED|All Randomised Patients||298||
48682825|NCT00811720|102006698|FG001|STARTED|All Randomised Patients||306||
48682826|NCT00811720|102006697|FG000|COMPLETED|All Randomised Patients||296||
48682827|NCT00811720|102006698|FG001|COMPLETED|All Randomised Patients||302||
48682828|NCT00811720|102006697|FG000|NOT COMPLETED|All Randomised Patients||2||
48682829|NCT00811720|102006698|FG001|NOT COMPLETED|All Randomised Patients||4||
48682830|NCT00811720|102006697|FG000|STARTED|All Treated Patients||296||
48682831|NCT00811720|102006698|FG001|STARTED|All Treated Patients||302||
48682832|NCT00811720|102006697|FG000|COMPLETED|All Treated Patients||200||
48682833|NCT00811720|102006698|FG001|COMPLETED|All Treated Patients||138||
48682834|NCT00811720|102006697|FG000|NOT COMPLETED|All Treated Patients||96||
48682835|NCT00811720|102006698|FG001|NOT COMPLETED|All Treated Patients||164||
48682836|NCT02388880|102006699|FG000|STARTED|Overall Study||3||
48682837|NCT02388880|102006699|FG000|COMPLETED|Overall Study||3||
48682838|NCT02388880|102006699|FG000|NOT COMPLETED|Overall Study||0||
48682839|NCT00742625|102006700|FG000|STARTED|Remission Induction||95||
48682840|NCT00742625|102006700|FG000|COMPLETED|Remission Induction||41||
48682841|NCT00742625|102006700|FG000|NOT COMPLETED|Remission Induction||54||
48682842|NCT00742625|102006700|FG000|STARTED|Consolidation||41||
48682843|NCT00742625|102006700|FG000|COMPLETED|Consolidation||20||
48682844|NCT00742625|102006700|FG000|NOT COMPLETED|Consolidation||21||
48682845|NCT03116997|102006701|FG000|STARTED|Overall Study||100||
48682846|NCT03116997|102006702|FG001|STARTED|Overall Study||101||
48682847|NCT03116997|102006701|FG000|COMPLETED|Overall Study||100||
48682848|NCT03116997|102006702|FG001|COMPLETED|Overall Study||101||
48682849|NCT03116997|102006701|FG000|NOT COMPLETED|Overall Study||0||
48682850|NCT03116997|102006702|FG001|NOT COMPLETED|Overall Study||0||
48682851|NCT03068897|102006703|FG000|STARTED|Overall Study||80||
48682852|NCT03068897|102006704|FG001|STARTED|Overall Study||80||
48682853|NCT03068897|102006705|FG002|STARTED|Overall Study||80||
48682854|NCT03068897|102006706|FG003|STARTED|Overall Study||80||
48682855|NCT03068897|102006703|FG000|COMPLETED|Overall Study||76||
48682856|NCT03068897|102006704|FG001|COMPLETED|Overall Study||76||
48682857|NCT03068897|102006705|FG002|COMPLETED|Overall Study||79||
48682858|NCT03068897|102006706|FG003|COMPLETED|Overall Study||74||
48682859|NCT03068897|102006703|FG000|NOT COMPLETED|Overall Study||4||
48682860|NCT03068897|102006704|FG001|NOT COMPLETED|Overall Study||4||
48682861|NCT03068897|102006705|FG002|NOT COMPLETED|Overall Study||1||
48682862|NCT03068897|102006706|FG003|NOT COMPLETED|Overall Study||6||
48682863|NCT02126319|102006707|FG000|STARTED|Overall Study||61||
48682864|NCT02126319|102006708|FG001|STARTED|Overall Study||67||
48682865|NCT02126319|102006707|FG000|COMPLETED|Overall Study||40||
48682866|NCT02126319|102006708|FG001|COMPLETED|Overall Study||43||
48682867|NCT02126319|102006707|FG000|NOT COMPLETED|Overall Study||21||
48247887|NCT04362176|100924340|FG001|COMPLETED|Overall Study||465||
48247888|NCT04362176|100924339|FG000|NOT COMPLETED|Overall Study||13||
48247889|NCT04362176|100924340|FG001|NOT COMPLETED|Overall Study||14||
48247890|NCT02264353|100924341|FG000|STARTED|Overall Study||20||
48247891|NCT02264353|100924342|FG001|STARTED|Overall Study||24||
48247892|NCT02264353|100924341|FG000|COMPLETED|Overall Study||17||
48247893|NCT02264353|100924342|FG001|COMPLETED|Overall Study||24||
48247894|NCT02264353|100924341|FG000|NOT COMPLETED|Overall Study||3||
48084998|NCT03501069|100528871|FG007|COMPLETED|Washout Period (at Least 14 Days)||0||
48084999|NCT03501069|100528872|FG008|COMPLETED|Washout Period (at Least 14 Days)||0||
48085000|NCT03501069|100528864|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48085001|NCT03501069|100528865|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48085002|NCT03501069|100528866|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48085003|NCT03501069|100528867|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48085004|NCT03501069|100528868|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48085005|NCT03501069|100528869|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48085006|NCT03501069|100528870|FG006|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48085007|NCT03501069|100528871|FG007|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48085008|NCT03501069|100528872|FG008|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48085009|NCT03501069|100528864|FG000|STARTED|Period B||2||
48085010|NCT03501069|100528865|FG001|STARTED|Period B||4||
48085011|NCT03501069|100528866|FG002|STARTED|Period B||2||
48085012|NCT03501069|100528867|FG003|STARTED|Period B||0||
48085013|NCT03501069|100528868|FG004|STARTED|Period B||0||
48085014|NCT03501069|100528869|FG005|STARTED|Period B||0||
48085015|NCT03501069|100528870|FG006|STARTED|Period B||0||
48085016|NCT03501069|100528871|FG007|STARTED|Period B||0||
48085017|NCT03501069|100528872|FG008|STARTED|Period B||0||
48085018|NCT03501069|100528864|FG000|COMPLETED|Period B||2||
48247895|NCT02264353|100924342|FG001|NOT COMPLETED|Overall Study||0||
48247896|NCT00640042|100924343|FG000|STARTED|Enrollment||1570||
48247897|NCT00640042|100924343|FG000|COMPLETED|Enrollment||1487||
48247898|NCT00640042|100924343|FG000|NOT COMPLETED|Enrollment||83||
48085019|NCT03501069|100528865|FG001|COMPLETED|Period B||4||
48085020|NCT03501069|100528866|FG002|COMPLETED|Period B||2||
48085021|NCT03501069|100528867|FG003|COMPLETED|Period B||0||
48085022|NCT03501069|100528868|FG004|COMPLETED|Period B||0||
48085023|NCT03501069|100528869|FG005|COMPLETED|Period B||0||
48085024|NCT03501069|100528870|FG006|COMPLETED|Period B||0||
48085025|NCT03501069|100528871|FG007|COMPLETED|Period B||0||
48085026|NCT03501069|100528872|FG008|COMPLETED|Period B||0||
48085027|NCT03501069|100528864|FG000|NOT COMPLETED|Period B||0||
48085028|NCT03501069|100528865|FG001|NOT COMPLETED|Period B||0||
48085029|NCT03501069|100528866|FG002|NOT COMPLETED|Period B||0||
48085030|NCT03501069|100528867|FG003|NOT COMPLETED|Period B||0||
48085031|NCT03501069|100528868|FG004|NOT COMPLETED|Period B||0||
48247899|NCT00640042|100924343|FG000|STARTED|Treatment||1487||
48247900|NCT00640042|100924343|FG000|COMPLETED|Treatment||561||
48247901|NCT00640042|100924343|FG000|NOT COMPLETED|Treatment||926||
48247902|NCT01878253|100924344|FG000|STARTED|Overall Study||95||
48247903|NCT01878253|100924344|FG000|Pre-Operative|Overall Study||95||
48247904|NCT01878253|100924344|FG000|6 Weeks|Overall Study||95||
48085032|NCT03501069|100528869|FG005|NOT COMPLETED|Period B||0||
48085033|NCT03501069|100528870|FG006|NOT COMPLETED|Period B||0||
48085034|NCT03501069|100528871|FG007|NOT COMPLETED|Period B||0||
48085035|NCT03501069|100528872|FG008|NOT COMPLETED|Period B||0||
48085036|NCT01550302|100528873|FG000|STARTED|Overall Study||5||
48085037|NCT01550302|100528874|FG001|STARTED|Overall Study||5||
48085038|NCT01550302|100528873|FG000|COMPLETED|Overall Study||5||
48247905|NCT01878253|100924344|FG000|6 Months|Overall Study||90||
48247906|NCT01878253|100924344|FG000|1 Year|Overall Study||88||
48085039|NCT01550302|100528874|FG001|COMPLETED|Overall Study||5||
48085040|NCT01550302|100528873|FG000|NOT COMPLETED|Overall Study||0||
48085041|NCT01550302|100528874|FG001|NOT COMPLETED|Overall Study||0||
48247907|NCT01878253|100924344|FG000|2 Year|Overall Study||86||
48085042|NCT01985867|100528875|FG000|STARTED|Overall Study||48||
48085043|NCT01985867|100528876|FG001|STARTED|Overall Study||46||
48085044|NCT01985867|100528875|FG000|COMPLETED|Overall Study||41||
48085045|NCT01985867|100528876|FG001|COMPLETED|Overall Study||40||
48085046|NCT01985867|100528875|FG000|NOT COMPLETED|Overall Study||7||
48085047|NCT01985867|100528876|FG001|NOT COMPLETED|Overall Study||6||
48085048|NCT01340898|100528877|FG000|STARTED|Primary Phase||376||
48085049|NCT01340898|100528878|FG001|STARTED|Primary Phase||187||
48085050|NCT01340898|100528879|FG002|STARTED|Primary Phase||187||
48085051|NCT01340898|100528877|FG000|COMPLETED|Primary Phase||360||
48085052|NCT01340898|100528878|FG001|COMPLETED|Primary Phase||178||
48085053|NCT01340898|100528879|FG002|COMPLETED|Primary Phase||181||
48085054|NCT01340898|100528877|FG000|NOT COMPLETED|Primary Phase||16||
48085055|NCT01340898|100528878|FG001|NOT COMPLETED|Primary Phase||9||
48085056|NCT01340898|100528879|FG002|NOT COMPLETED|Primary Phase||6||
48085057|NCT01340898|100528877|FG000|STARTED|Booster Phase||342||
48085058|NCT01340898|100528878|FG001|STARTED|Booster Phase||166||
48085059|NCT01340898|100528879|FG002|STARTED|Booster Phase||170||
48085060|NCT01340898|100528877|FG000|COMPLETED|Booster Phase||332||
48085061|NCT01340898|100528878|FG001|COMPLETED|Booster Phase||164||
48085062|NCT01340898|100528879|FG002|COMPLETED|Booster Phase||163||
48085063|NCT01340898|100528877|FG000|NOT COMPLETED|Booster Phase||10||
48085064|NCT01340898|100528878|FG001|NOT COMPLETED|Booster Phase||2||
48085065|NCT01340898|100528879|FG002|NOT COMPLETED|Booster Phase||7||
48085066|NCT00563381|100528880|FG000|STARTED|Overall Study||3707||
48085067|NCT00563381|100528881|FG001|STARTED|Overall Study||3669||
48085068|NCT00563381|100528880|FG000|COMPLETED|Overall Study||3122||
48085069|NCT00563381|100528881|FG001|COMPLETED|Overall Study||3021||
48085070|NCT00563381|100528880|FG000|NOT COMPLETED|Overall Study||585||
48085071|NCT00563381|100528881|FG001|NOT COMPLETED|Overall Study||648||
48085072|NCT04016285|100528882|FG000|STARTED|Overall Study||36||
48085073|NCT04016285|100528883|FG001|STARTED|Overall Study||37||
48085074|NCT04016285|100528882|FG000|COMPLETED|Overall Study||29||
48085075|NCT04016285|100528883|FG001|COMPLETED|Overall Study||29||
48085076|NCT04016285|100528882|FG000|NOT COMPLETED|Overall Study||7||
48085077|NCT04016285|100528883|FG001|NOT COMPLETED|Overall Study||8||
48085078|NCT00940225|100528884|FG000|STARTED|Overall Study||171||
48085079|NCT00940225|100528885|FG001|STARTED|Overall Study||77||
48085080|NCT00940225|100528886|FG002|STARTED|Overall Study||60||
48085081|NCT00940225|100528887|FG003|STARTED|Overall Study||20||
48085082|NCT00940225|100528888|FG004|STARTED|Overall Study||21||
48085083|NCT00940225|100528889|FG005|STARTED|Overall Study||41||
48085084|NCT00940225|100528890|FG006|STARTED|Overall Study||21||
48085085|NCT00940225|100528891|FG007|STARTED|Overall Study||70||
48085086|NCT00940225|100528892|FG008|STARTED|Overall Study||45||
48247908|NCT01878253|100924344|FG000|COMPLETED|Overall Study||86||
48247909|NCT01878253|100924344|FG000|NOT COMPLETED|Overall Study||9||
48247910|NCT01946529|100924345|FG000|STARTED|End of Window Therapy (2 Courses)||1||
48247911|NCT01946529|100924346|FG001|STARTED|End of Window Therapy (2 Courses)||17||
48247912|NCT01946529|100924347|FG002|STARTED|End of Window Therapy (2 Courses)||6||
48247913|NCT01946529|100924345|FG000|COMPLETED|End of Window Therapy (2 Courses)||1||
48247914|NCT01946529|100924346|FG001|COMPLETED|End of Window Therapy (2 Courses)||16||
48247915|NCT01946529|100924347|FG002|COMPLETED|End of Window Therapy (2 Courses)||6||
48247916|NCT01946529|100924345|FG000|NOT COMPLETED|End of Window Therapy (2 Courses)||0||
48247917|NCT01946529|100924346|FG001|NOT COMPLETED|End of Window Therapy (2 Courses)||1||
48247918|NCT01946529|100924347|FG002|NOT COMPLETED|End of Window Therapy (2 Courses)||0||
48247919|NCT01946529|100924345|FG000|STARTED|Completion of All Therapy||1||
48085087|NCT00940225|100528893|FG009|STARTED|Overall Study||93||
48085088|NCT00940225|100528894|FG010|STARTED|Overall Study||51||
48085089|NCT00940225|100528895|FG011|STARTED|Overall Study||60||
48085090|NCT00940225|100528884|FG000|COMPLETED|Overall Study||156||
48085091|NCT00940225|100528885|FG001|COMPLETED|Overall Study||66||
48085092|NCT00940225|100528886|FG002|COMPLETED|Overall Study||47||
48085093|NCT00940225|100528887|FG003|COMPLETED|Overall Study||16||
48085094|NCT00940225|100528888|FG004|COMPLETED|Overall Study||19||
48085095|NCT00940225|100528889|FG005|COMPLETED|Overall Study||36||
48085096|NCT00940225|100528890|FG006|COMPLETED|Overall Study||20||
48085097|NCT00940225|100528891|FG007|COMPLETED|Overall Study||60||
48085098|NCT00940225|100528892|FG008|COMPLETED|Overall Study||41||
48085099|NCT00940225|100528893|FG009|COMPLETED|Overall Study||87||
48085100|NCT00940225|100528894|FG010|COMPLETED|Overall Study||48||
48085101|NCT00940225|100528895|FG011|COMPLETED|Overall Study||54||
48085102|NCT00940225|100528884|FG000|NOT COMPLETED|Overall Study||15||
48085103|NCT00940225|100528885|FG001|NOT COMPLETED|Overall Study||11||
48085104|NCT00940225|100528886|FG002|NOT COMPLETED|Overall Study||13||
48085105|NCT00940225|100528887|FG003|NOT COMPLETED|Overall Study||4||
48085106|NCT00940225|100528888|FG004|NOT COMPLETED|Overall Study||2||
48085107|NCT00940225|100528889|FG005|NOT COMPLETED|Overall Study||5||
48085108|NCT00940225|100528890|FG006|NOT COMPLETED|Overall Study||1||
48085109|NCT00940225|100528891|FG007|NOT COMPLETED|Overall Study||10||
48085110|NCT00940225|100528892|FG008|NOT COMPLETED|Overall Study||4||
48085111|NCT00940225|100528893|FG009|NOT COMPLETED|Overall Study||6||
48085112|NCT00940225|100528894|FG010|NOT COMPLETED|Overall Study||3||
48085113|NCT00940225|100528895|FG011|NOT COMPLETED|Overall Study||6||
48085114|NCT01217840|100528896|FG000|STARTED|Overall Study||20||
48085115|NCT01217840|100528897|FG001|STARTED|Overall Study||20||
48085116|NCT01217840|100528896|FG000|COMPLETED|Overall Study||14||
48085117|NCT01217840|100528897|FG001|COMPLETED|Overall Study||17||
48085118|NCT01217840|100528896|FG000|NOT COMPLETED|Overall Study||6||
48085119|NCT01217840|100528897|FG001|NOT COMPLETED|Overall Study||3||
48085120|NCT00276744|100528898|FG000|STARTED|PART A||240||
48085121|NCT00276744|100528898|FG000|COMPLETED|PART A||142||
48085122|NCT00276744|100528898|FG000|NOT COMPLETED|PART A||98||
48085123|NCT00276744|100528898|FG000|STARTED|PART B||0||
48085124|NCT00276744|100528898|FG000|COMPLETED|PART B||0||
48085125|NCT00276744|100528898|FG000|NOT COMPLETED|PART B||0||
48085126|NCT00688753|100528899|FG000|STARTED|Overall Study||92||
48085127|NCT00688753|100528899|FG000|COMPLETED|Overall Study||0||
48085128|NCT00688753|100528899|FG000|NOT COMPLETED|Overall Study||92||
48085129|NCT04221009|100528900|FG000|STARTED|Overall Study||17||
48085130|NCT04221009|100528900|FG000|COMPLETED|Overall Study||13||
48085131|NCT04221009|100528900|FG000|NOT COMPLETED|Overall Study||4||
48085132|NCT01336764|100528901|FG000|STARTED|Overall Study||12||
48085133|NCT01336764|100528902|FG001|STARTED|Overall Study||10||
48085134|NCT01336764|100528901|FG000|COMPLETED|Overall Study||7||
48085135|NCT01336764|100528902|FG001|COMPLETED|Overall Study||5||
48085136|NCT01336764|100528901|FG000|NOT COMPLETED|Overall Study||5||
48085137|NCT01336764|100528902|FG001|NOT COMPLETED|Overall Study||5||
48085138|NCT02966028|100528903|FG000|STARTED|Overall Study||92||
48085139|NCT02966028|100528904|FG001|STARTED|Overall Study||91||
48085140|NCT02966028|100528905|FG002|STARTED|Overall Study||91||
48085141|NCT02966028|100528903|FG000|COMPLETED|Overall Study||68||
48085142|NCT02966028|100528904|FG001|COMPLETED|Overall Study||57||
48085143|NCT02966028|100528905|FG002|COMPLETED|Overall Study||60||
48085144|NCT02966028|100528903|FG000|NOT COMPLETED|Overall Study||24||
48085145|NCT02966028|100528904|FG001|NOT COMPLETED|Overall Study||34||
48085146|NCT02966028|100528905|FG002|NOT COMPLETED|Overall Study||31||
48085147|NCT00848081|100528906|FG000|STARTED|Overall Study||160||
48085148|NCT00848081|100528907|FG001|STARTED|Overall Study||158||
48085149|NCT00848081|100528906|FG000|COMPLETED|Overall Study||140||
48085150|NCT00848081|100528907|FG001|COMPLETED|Overall Study||140||
48085151|NCT00848081|100528906|FG000|NOT COMPLETED|Overall Study||20||
48085152|NCT00848081|100528907|FG001|NOT COMPLETED|Overall Study||18||
48085153|NCT05131646|100528908|FG000|STARTED|Overall Study||3||
48085154|NCT05131646|100528909|FG001|STARTED|Overall Study||7||
48085155|NCT05131646|100528910|FG002|STARTED|Overall Study||5||
48085156|NCT05131646|100528908|FG000|Safety Population|Overall Study||3||
48085157|NCT05131646|100528909|FG001|Safety Population|Overall Study||7||
48085158|NCT05131646|100528910|FG002|Safety Population|Overall Study||5||
48085159|NCT05131646|100528908|FG000|COMPLETED|Overall Study||2||
48085160|NCT05131646|100528909|FG001|COMPLETED|Overall Study||7||
48085161|NCT05131646|100528910|FG002|COMPLETED|Overall Study||5||
48085162|NCT05131646|100528908|FG000|NOT COMPLETED|Overall Study||1||
48085163|NCT05131646|100528909|FG001|NOT COMPLETED|Overall Study||0||
48085164|NCT05131646|100528910|FG002|NOT COMPLETED|Overall Study||0||
48085165|NCT01919723|100528911|FG000|STARTED|Overall Study||35||
48085166|NCT01919723|100528912|FG001|STARTED|Overall Study||35||
48085167|NCT01919723|100528911|FG000|COMPLETED|Overall Study||33||
48085168|NCT01919723|100528912|FG001|COMPLETED|Overall Study||33||
48085169|NCT01919723|100528911|FG000|NOT COMPLETED|Overall Study||2||
48085170|NCT01919723|100528912|FG001|NOT COMPLETED|Overall Study||2||
48085171|NCT01958008|100528913|FG000|STARTED|Overall Study||21||
48085172|NCT01958008|100528914|FG001|STARTED|Overall Study||21||
48085173|NCT01958008|100528915|FG002|STARTED|Overall Study||21||
48085174|NCT01958008|100528916|FG003|STARTED|Overall Study||21||
48085175|NCT01958008|100528913|FG000|COMPLETED|Overall Study||20||
48085176|NCT01958008|100528914|FG001|COMPLETED|Overall Study||21||
48247920|NCT01946529|100924346|FG001|STARTED|Completion of All Therapy||16||
48247921|NCT01946529|100924347|FG002|STARTED|Completion of All Therapy||6||
48247922|NCT01946529|100924345|FG000|COMPLETED|Completion of All Therapy||0||
48247923|NCT01946529|100924346|FG001|COMPLETED|Completion of All Therapy||0||
48085177|NCT01958008|100528915|FG002|COMPLETED|Overall Study||20||
48085178|NCT01958008|100528916|FG003|COMPLETED|Overall Study||21||
48085179|NCT01958008|100528913|FG000|NOT COMPLETED|Overall Study||1||
48085180|NCT01958008|100528914|FG001|NOT COMPLETED|Overall Study||0||
48085181|NCT01958008|100528915|FG002|NOT COMPLETED|Overall Study||1||
48085182|NCT01958008|100528916|FG003|NOT COMPLETED|Overall Study||0||
48085183|NCT02509156|100528917|FG000|STARTED|Open-Label Lead-In Phase||6||
48247924|NCT01946529|100924347|FG002|COMPLETED|Completion of All Therapy||0||
48247925|NCT01946529|100924345|FG000|NOT COMPLETED|Completion of All Therapy||1||
48247926|NCT01946529|100924346|FG001|NOT COMPLETED|Completion of All Therapy||16||
48247927|NCT01946529|100924347|FG002|NOT COMPLETED|Completion of All Therapy||6||
48247928|NCT01024036|100924348|FG000|STARTED|Blinded Treatment||53||
48247929|NCT01024036|100924349|FG001|STARTED|Blinded Treatment||26||
48247930|NCT01024036|100924348|FG000|COMPLETED|Blinded Treatment||31||
48247931|NCT01024036|100924349|FG001|COMPLETED|Blinded Treatment||6||
48085184|NCT02509156|100528918|FG001|STARTED|Open-Label Lead-In Phase||0||
48085185|NCT02509156|100528917|FG000|COMPLETED|Open-Label Lead-In Phase||6||
48085186|NCT02509156|100528918|FG001|COMPLETED|Open-Label Lead-In Phase||0||
48085187|NCT02509156|100528917|FG000|NOT COMPLETED|Open-Label Lead-In Phase||0||
48247932|NCT01024036|100924348|FG000|NOT COMPLETED|Blinded Treatment||22||
48247933|NCT01024036|100924349|FG001|NOT COMPLETED|Blinded Treatment||20||
48247934|NCT01024036|100924348|FG000|STARTED|Unblinded Treatment||0||
48247935|NCT01024036|100924349|FG001|STARTED|Unblinded Treatment||13||
48247936|NCT01024036|100924348|FG000|COMPLETED|Unblinded Treatment||0||
48247937|NCT01024036|100924349|FG001|COMPLETED|Unblinded Treatment||10||
48247938|NCT01024036|100924348|FG000|NOT COMPLETED|Unblinded Treatment||0||
48247939|NCT01024036|100924349|FG001|NOT COMPLETED|Unblinded Treatment||3||
48247940|NCT01024036|100924348|FG000|STARTED|Follow-Up Period||14|Any participant who discontinued blinded/unblinded treatment could entered Follow-up period|
48247941|NCT01024036|100924349|FG001|STARTED|Follow-Up Period||6|Any participant who discontinued blinded/unblinded treatment could entered Follow-up period|
48247942|NCT01024036|100924348|FG000|COMPLETED|Follow-Up Period||9||
48247943|NCT01024036|100924349|FG001|COMPLETED|Follow-Up Period||3||
48247944|NCT01024036|100924348|FG000|NOT COMPLETED|Follow-Up Period||5||
48247945|NCT01024036|100924349|FG001|NOT COMPLETED|Follow-Up Period||3||
48247946|NCT02538471|100924350|FG000|STARTED|Overall Study||3||
48247947|NCT02538471|100924350|FG000|COMPLETED|Overall Study||1||
48247948|NCT02538471|100924350|FG000|NOT COMPLETED|Overall Study||2||
48247949|NCT03740737|100924351|FG000|STARTED|Overall Study||526|This trial assessed the efficacy and safety of FE 999049 in participants undergoing controlled ovarian stimulation (COS) for in-vitro fertilization (IVF) / intracytoplasmic sperm injection (ICSI) following a GnRH antagonist protocol. The trial was designed to capture the clinical efficacy of a single COS cycle in a more complete manner by following outcomes from both the fresh and subsequent cryopreserved cycles.|
48247950|NCT03740737|100924352|FG001|STARTED|Overall Study||53|This trial assessed the efficacy and safety of FE 999049 in participants undergoing controlled ovarian stimulation (COS) for in-vitro fertilization (IVF) / intracytoplasmic sperm injection (ICSI) following a GnRH antagonist protocol. The trial was designed to capture the clinical efficacy of a single COS cycle in a more complete manner by following outcomes from both the fresh and subsequent cryopreserved cycles.|
48247951|NCT03740737|100924351|FG000|mITT|Overall Study||525||
48085188|NCT02509156|100528918|FG001|NOT COMPLETED|Open-Label Lead-In Phase||0||
48085189|NCT02509156|100528917|FG000|STARTED|Randomized Phase||14||
48085190|NCT02509156|100528918|FG001|STARTED|Randomized Phase||17||
48247952|NCT03740737|100924352|FG001|mITT|Overall Study||53||
48247953|NCT03740737|100924351|FG000|COMPLETED|Overall Study||506||
48085191|NCT02509156|100528917|FG000|COMPLETED|Randomized Phase||12||
48085192|NCT02509156|100528918|FG001|COMPLETED|Randomized Phase||16||
48247954|NCT03740737|100924352|FG001|COMPLETED|Overall Study||52||
48247955|NCT03740737|100924351|FG000|NOT COMPLETED|Overall Study||20||
48247956|NCT03740737|100924352|FG001|NOT COMPLETED|Overall Study||1||
48085193|NCT02509156|100528917|FG000|NOT COMPLETED|Randomized Phase||2||
48085194|NCT02509156|100528918|FG001|NOT COMPLETED|Randomized Phase||1||
48085195|NCT03789318|100528919|FG000|STARTED|Overall Study||9||
48085196|NCT03789318|100528920|FG001|STARTED|Overall Study||9||
48085197|NCT03789318|100528921|FG002|STARTED|Overall Study||12||
48085198|NCT03789318|100528922|FG003|STARTED|Overall Study||12||
48085199|NCT03789318|100528923|FG004|STARTED|Overall Study||12||
48085200|NCT03789318|100528919|FG000|COMPLETED|Overall Study||9||
48085201|NCT03789318|100528920|FG001|COMPLETED|Overall Study||9||
48085202|NCT03789318|100528921|FG002|COMPLETED|Overall Study||9||
48085203|NCT03789318|100528922|FG003|COMPLETED|Overall Study||11||
48085204|NCT03789318|100528923|FG004|COMPLETED|Overall Study||12||
48085205|NCT03789318|100528919|FG000|NOT COMPLETED|Overall Study||0||
48085206|NCT03789318|100528920|FG001|NOT COMPLETED|Overall Study||0||
48085207|NCT03789318|100528921|FG002|NOT COMPLETED|Overall Study||3||
48085208|NCT03789318|100528922|FG003|NOT COMPLETED|Overall Study||1||
48085209|NCT03789318|100528923|FG004|NOT COMPLETED|Overall Study||0||
48085210|NCT01276353|100528924|FG000|STARTED|Double-blind||22||
48085211|NCT01276353|100528925|FG001|STARTED|Double-blind||23||
48085212|NCT01276353|100528924|FG000|COMPLETED|Double-blind||19||
48085213|NCT01276353|100528925|FG001|COMPLETED|Double-blind||23||
48085214|NCT01276353|100528924|FG000|NOT COMPLETED|Double-blind||3||
48085215|NCT01276353|100528925|FG001|NOT COMPLETED|Double-blind||0||
48085216|NCT01276353|100528924|FG000|STARTED|Extension||19||
48085217|NCT01276353|100528925|FG001|STARTED|Extension||23||
48085218|NCT01276353|100528924|FG000|COMPLETED|Extension||12||
48085219|NCT01276353|100528925|FG001|COMPLETED|Extension||14||
48085220|NCT01276353|100528924|FG000|NOT COMPLETED|Extension||7||
48085221|NCT01276353|100528925|FG001|NOT COMPLETED|Extension||9||
48085222|NCT02584673|100528926|FG000|STARTED|Overall Study||15||
48085223|NCT02584673|100528927|FG001|STARTED|Overall Study||15||
48085224|NCT02584673|100528926|FG000|COMPLETED|Overall Study||15||
48085225|NCT02584673|100528927|FG001|COMPLETED|Overall Study||15||
48085226|NCT02584673|100528926|FG000|NOT COMPLETED|Overall Study||0||
48085227|NCT02584673|100528927|FG001|NOT COMPLETED|Overall Study||0||
48085228|NCT04203238|100528928|FG000|STARTED|Overall Study||18||
48085229|NCT04203238|100528929|FG001|STARTED|Overall Study||18||
48085230|NCT04203238|100528928|FG000|COMPLETED|Overall Study||14||
48085231|NCT04203238|100528929|FG001|COMPLETED|Overall Study||17||
48085232|NCT04203238|100528928|FG000|NOT COMPLETED|Overall Study||4||
48085233|NCT04203238|100528929|FG001|NOT COMPLETED|Overall Study||1||
48085234|NCT02324569|100528930|FG000|STARTED|Overall Study||116||
48085235|NCT02324569|100528931|FG001|STARTED|Overall Study||124||
48085236|NCT02324569|100528930|FG000|COMPLETED|Overall Study||100||
48085237|NCT02324569|100528931|FG001|COMPLETED|Overall Study||103||
48085238|NCT02324569|100528930|FG000|NOT COMPLETED|Overall Study||16||
48085239|NCT02324569|100528931|FG001|NOT COMPLETED|Overall Study||21||
48085240|NCT03124875|100528932|FG000|STARTED|Overall Study||32||
48085241|NCT03124875|100528932|FG000|COMPLETED|Overall Study||32||
48085242|NCT03124875|100528932|FG000|NOT COMPLETED|Overall Study||0||
48085243|NCT02954237|100528933|FG000|STARTED|Overall Study||91||
48085244|NCT02954237|100528933|FG000|COMPLETED|Overall Study||48||
48085245|NCT02954237|100528933|FG000|NOT COMPLETED|Overall Study||43||
48085246|NCT04851314|100528934|FG000|STARTED|Overall Study||55||
48085247|NCT04851314|100528935|FG001|STARTED|Overall Study||55||
48085248|NCT04851314|100528934|FG000|COMPLETED|Overall Study||52||
48085249|NCT04851314|100528935|FG001|COMPLETED|Overall Study||51||
48085250|NCT04851314|100528934|FG000|NOT COMPLETED|Overall Study||3||
48085251|NCT04851314|100528935|FG001|NOT COMPLETED|Overall Study||4||
48085252|NCT01089062|100528936|FG000|STARTED|Visit 2 (Randomization)||4||
48085253|NCT01089062|100528937|FG001|STARTED|Visit 2 (Randomization)||4||
48085254|NCT01089062|100528938|FG002|STARTED|Visit 2 (Randomization)||4||
48085255|NCT01089062|100528939|FG003|STARTED|Visit 2 (Randomization)||4||
48085256|NCT01089062|100528940|FG004|STARTED|Visit 2 (Randomization)||4||
48085257|NCT01089062|100528941|FG005|STARTED|Visit 2 (Randomization)||4||
48085258|NCT01089062|100528936|FG000|COMPLETED|Visit 2 (Randomization)||3||
48085259|NCT01089062|100528937|FG001|COMPLETED|Visit 2 (Randomization)||3||
48085260|NCT01089062|100528938|FG002|COMPLETED|Visit 2 (Randomization)||3||
48085261|NCT01089062|100528939|FG003|COMPLETED|Visit 2 (Randomization)||4||
48085262|NCT01089062|100528940|FG004|COMPLETED|Visit 2 (Randomization)||3||
48085263|NCT01089062|100528941|FG005|COMPLETED|Visit 2 (Randomization)||3||
48085264|NCT01089062|100528936|FG000|NOT COMPLETED|Visit 2 (Randomization)||1||
48085265|NCT01089062|100528937|FG001|NOT COMPLETED|Visit 2 (Randomization)||1||
48085266|NCT01089062|100528938|FG002|NOT COMPLETED|Visit 2 (Randomization)||1||
48085267|NCT01089062|100528939|FG003|NOT COMPLETED|Visit 2 (Randomization)||0||
48085268|NCT01089062|100528940|FG004|NOT COMPLETED|Visit 2 (Randomization)||1||
48085269|NCT01089062|100528941|FG005|NOT COMPLETED|Visit 2 (Randomization)||1||
48085270|NCT01089062|100528936|FG000|STARTED|Visit 3||3||
48085271|NCT01089062|100528937|FG001|STARTED|Visit 3||3||
48085272|NCT01089062|100528938|FG002|STARTED|Visit 3||3||
48085273|NCT01089062|100528939|FG003|STARTED|Visit 3||4||
48085274|NCT01089062|100528940|FG004|STARTED|Visit 3||3||
48085275|NCT01089062|100528941|FG005|STARTED|Visit 3||3||
48085276|NCT01089062|100528936|FG000|COMPLETED|Visit 3||3||
48085277|NCT01089062|100528937|FG001|COMPLETED|Visit 3||3||
48085278|NCT01089062|100528938|FG002|COMPLETED|Visit 3||3||
48247957|NCT01862614|100924353|FG000|STARTED|First Appointment.||40||
48247958|NCT01862614|100924354|FG001|STARTED|First Appointment.||40||
48247959|NCT01862614|100924353|FG000|COMPLETED|First Appointment.||40||
48247960|NCT01862614|100924354|FG001|COMPLETED|First Appointment.||40||
48247961|NCT01862614|100924353|FG000|NOT COMPLETED|First Appointment.||0||
48085279|NCT01089062|100528939|FG003|COMPLETED|Visit 3||3||
48085280|NCT01089062|100528940|FG004|COMPLETED|Visit 3||3||
48085281|NCT01089062|100528941|FG005|COMPLETED|Visit 3||3||
48085282|NCT01089062|100528936|FG000|NOT COMPLETED|Visit 3||0||
48247962|NCT01862614|100924354|FG001|NOT COMPLETED|First Appointment.||0||
48247963|NCT01862614|100924353|FG000|STARTED|2 Week Washout Period.||40||
48247964|NCT01862614|100924354|FG001|STARTED|2 Week Washout Period.||40||
48247965|NCT01862614|100924353|FG000|COMPLETED|2 Week Washout Period.||40||
48247966|NCT01862614|100924354|FG001|COMPLETED|2 Week Washout Period.||40||
48247967|NCT01862614|100924353|FG000|NOT COMPLETED|2 Week Washout Period.||0||
48247968|NCT01862614|100924354|FG001|NOT COMPLETED|2 Week Washout Period.||0||
48247969|NCT01862614|100924353|FG000|STARTED|Second Appointment.||40|Received buffered articaine at second appointment.|
48247970|NCT01862614|100924354|FG001|STARTED|Second Appointment.||40|Received buffered articaine at second appointment.|
48247971|NCT01862614|100924353|FG000|COMPLETED|Second Appointment.||40||
48375488|NCT03350750|101247649|FG001|STARTED|Overall Study||9||
48375489|NCT03350750|101247648|FG000|4-month Follow-up (Randomized Evaluation)|Overall Study||8||
48375490|NCT03350750|101247649|FG001|4-month Follow-up (Randomized Evaluation)|Overall Study||8||
48682868|NCT02126319|102006708|FG001|NOT COMPLETED|Overall Study||24||
48247972|NCT01862614|100924354|FG001|COMPLETED|Second Appointment.||40||
48247973|NCT01862614|100924353|FG000|NOT COMPLETED|Second Appointment.||0||
48247974|NCT01862614|100924354|FG001|NOT COMPLETED|Second Appointment.||0||
48247975|NCT02186587|100924355|FG000|STARTED|Overall Study||28||
48247976|NCT02186587|100924356|FG001|STARTED|Overall Study||0||
48682869|NCT01440764|102006709|FG000|STARTED|Test Day 1||4||
48682870|NCT01440764|102006710|FG001|STARTED|Test Day 1||2||
48682871|NCT01440764|102006711|FG002|STARTED|Test Day 1||6||
48682872|NCT01440764|102006712|FG003|STARTED|Test Day 1||1||
48085283|NCT01089062|100528937|FG001|NOT COMPLETED|Visit 3||0||
48085284|NCT01089062|100528938|FG002|NOT COMPLETED|Visit 3||0||
48085285|NCT01089062|100528939|FG003|NOT COMPLETED|Visit 3||1||
48085286|NCT01089062|100528940|FG004|NOT COMPLETED|Visit 3||0||
48085287|NCT01089062|100528941|FG005|NOT COMPLETED|Visit 3||0||
48085288|NCT01089062|100528936|FG000|STARTED|Visit 4||3||
48247977|NCT02186587|100924355|FG000|COMPLETED|Overall Study||23||
48247978|NCT02186587|100924356|FG001|COMPLETED|Overall Study||0||
48247979|NCT02186587|100924355|FG000|NOT COMPLETED|Overall Study||5||
48247980|NCT02186587|100924356|FG001|NOT COMPLETED|Overall Study||0||
48247981|NCT01618227|100924357|FG000|STARTED|Overall Study||2||
48247982|NCT01618227|100924358|FG001|STARTED|Overall Study||2||
48247983|NCT01618227|100924357|FG000|COMPLETED|Overall Study||2||
48247984|NCT01618227|100924358|FG001|COMPLETED|Overall Study||0||
48247985|NCT01618227|100924357|FG000|NOT COMPLETED|Overall Study||0||
48247986|NCT01618227|100924358|FG001|NOT COMPLETED|Overall Study||2||
48247987|NCT00404547|100924359|FG000|STARTED|Overall Study||762||
48247988|NCT00404547|100924360|FG001|STARTED|Overall Study||359||
48247989|NCT00404547|100924359|FG000|COMPLETED|Overall Study||672||
48247990|NCT00404547|100924360|FG001|COMPLETED|Overall Study||334||
48247991|NCT00404547|100924359|FG000|NOT COMPLETED|Overall Study||90||
48247992|NCT00404547|100924360|FG001|NOT COMPLETED|Overall Study||25||
48247993|NCT01498445|100924361|FG000|STARTED|Overall Study||4||
48247994|NCT01498445|100924362|FG001|STARTED|Overall Study||3||
48247995|NCT01498445|100924363|FG002|STARTED|Overall Study||8||
48247996|NCT01498445|100924364|FG003|STARTED|Overall Study||8||
48247997|NCT01498445|100924365|FG004|STARTED|Overall Study||4||
48247998|NCT01498445|100924366|FG005|STARTED|Overall Study||5||
48085289|NCT01089062|100528937|FG001|STARTED|Visit 4||3||
48085290|NCT01089062|100528938|FG002|STARTED|Visit 4||3||
48085291|NCT01089062|100528939|FG003|STARTED|Visit 4||3||
48085292|NCT01089062|100528940|FG004|STARTED|Visit 4||3||
48085293|NCT01089062|100528941|FG005|STARTED|Visit 4||3||
48085294|NCT01089062|100528936|FG000|COMPLETED|Visit 4||3||
48085295|NCT01089062|100528937|FG001|COMPLETED|Visit 4||3||
48085296|NCT01089062|100528938|FG002|COMPLETED|Visit 4||3||
48085297|NCT01089062|100528939|FG003|COMPLETED|Visit 4||3||
48085298|NCT01089062|100528940|FG004|COMPLETED|Visit 4||3||
48085299|NCT01089062|100528941|FG005|COMPLETED|Visit 4||3||
48247999|NCT01498445|100924361|FG000|COMPLETED|Overall Study||4||
48248000|NCT01498445|100924362|FG001|COMPLETED|Overall Study||3||
48248001|NCT01498445|100924363|FG002|COMPLETED|Overall Study||7||
48248002|NCT01498445|100924364|FG003|COMPLETED|Overall Study||6||
48248003|NCT01498445|100924365|FG004|COMPLETED|Overall Study||3||
48085300|NCT01089062|100528936|FG000|NOT COMPLETED|Visit 4||0||
48085301|NCT01089062|100528937|FG001|NOT COMPLETED|Visit 4||0||
48085302|NCT01089062|100528938|FG002|NOT COMPLETED|Visit 4||0||
48248004|NCT01498445|100924366|FG005|COMPLETED|Overall Study||4||
48248005|NCT01498445|100924361|FG000|NOT COMPLETED|Overall Study||0||
48248006|NCT01498445|100924362|FG001|NOT COMPLETED|Overall Study||0||
48682873|NCT01440764|102006713|FG004|STARTED|Test Day 1||3||
48085303|NCT01089062|100528939|FG003|NOT COMPLETED|Visit 4||0||
48085304|NCT01089062|100528940|FG004|NOT COMPLETED|Visit 4||0||
48085305|NCT01089062|100528941|FG005|NOT COMPLETED|Visit 4||0||
48248007|NCT01498445|100924363|FG002|NOT COMPLETED|Overall Study||1||
48248008|NCT01498445|100924364|FG003|NOT COMPLETED|Overall Study||2||
48248009|NCT01498445|100924365|FG004|NOT COMPLETED|Overall Study||1||
48248010|NCT01498445|100924366|FG005|NOT COMPLETED|Overall Study||1||
48248011|NCT00113880|100924367|FG000|STARTED|Overall Study||63061||
48248012|NCT00113880|100924368|FG001|STARTED|Overall Study||71949||
48248013|NCT00113880|100924369|FG002|STARTED|Overall Study||62492||
48248014|NCT00113880|100924367|FG000|COMPLETED|Overall Study||63061||
48248015|NCT00113880|100924368|FG001|COMPLETED|Overall Study||71949||
48248016|NCT00113880|100924369|FG002|COMPLETED|Overall Study||62492||
48248017|NCT00113880|100924367|FG000|NOT COMPLETED|Overall Study||0||
48248018|NCT00113880|100924368|FG001|NOT COMPLETED|Overall Study||0||
48248019|NCT00113880|100924369|FG002|NOT COMPLETED|Overall Study||0||
48248020|NCT00377312|100924370|FG000|STARTED|Overall Study||6||
48248021|NCT00377312|100924371|FG001|STARTED|Overall Study||5||
48248022|NCT00377312|100924370|FG000|COMPLETED|Overall Study||5||
48248023|NCT00377312|100924371|FG001|COMPLETED|Overall Study||4||
48248024|NCT00377312|100924370|FG000|NOT COMPLETED|Overall Study||1||
48248025|NCT00377312|100924371|FG001|NOT COMPLETED|Overall Study||1||
48248026|NCT01126879|100927338|FG000|STARTED|Overall Study||8||
48248027|NCT01126879|100927339|FG001|STARTED|Overall Study||4||
48248028|NCT01126879|100927338|FG000|Started 3 Months of Genistein/Placebo|Overall Study||8||
48248029|NCT01126879|100927339|FG001|Started 3 Months of Genistein/Placebo|Overall Study||4||
48248030|NCT01126879|100927338|FG000|Prostatectomy or Radiation|Overall Study||8||
48248031|NCT01126879|100927339|FG001|Prostatectomy or Radiation|Overall Study||4||
48085306|NCT01089062|100528936|FG000|STARTED|Follow-up Visit (Final Visit)||3||
48085307|NCT01089062|100528937|FG001|STARTED|Follow-up Visit (Final Visit)||3||
48085308|NCT01089062|100528938|FG002|STARTED|Follow-up Visit (Final Visit)||3||
48248032|NCT01126879|100927338|FG000|Completed 3 Months Genistein/Placebo|Overall Study||4||
48248033|NCT01126879|100927339|FG001|Completed 3 Months Genistein/Placebo|Overall Study||2||
48248034|NCT01126879|100927338|FG000|COMPLETED|Overall Study||3||
48248035|NCT01126879|100927339|FG001|COMPLETED|Overall Study||2||
48248036|NCT01126879|100927338|FG000|NOT COMPLETED|Overall Study||5||
48248037|NCT01126879|100927339|FG001|NOT COMPLETED|Overall Study||2||
48248038|NCT00515281|100927340|FG000|STARTED|Overall Study||138||
48248039|NCT00515281|100927341|FG001|STARTED|Overall Study||135||
48248040|NCT00515281|100927340|FG000|COMPLETED|Overall Study||138||
48248041|NCT00515281|100927341|FG001|COMPLETED|Overall Study||135||
48248042|NCT00515281|100927340|FG000|NOT COMPLETED|Overall Study||0||
48248043|NCT00515281|100927341|FG001|NOT COMPLETED|Overall Study||0||
48248044|NCT05109117|100927342|FG000|STARTED|Overall Study||38||76
48248045|NCT05109117|100927342|FG000|Safety Population|Overall Study||37||74
48248046|NCT05109117|100927342|FG000|Test Product (CAP UnScented)|Overall Study||36||36
48248047|NCT05109117|100927342|FG000|Control (No Treatment)|Overall Study||36||36
48248048|NCT05109117|100927342|FG000|COMPLETED|Overall Study||36||72
48248049|NCT05109117|100927342|FG000|NOT COMPLETED|Overall Study||2||4
48248050|NCT02261285|100927343|FG000|STARTED|Overall Study||6||
48248051|NCT02261285|100927344|FG001|STARTED|Overall Study||6||
48248052|NCT02261285|100927345|FG002|STARTED|Overall Study||6||
48248053|NCT02261285|100927343|FG000|COMPLETED|Overall Study||6||
48248054|NCT02261285|100927344|FG001|COMPLETED|Overall Study||6||
48248055|NCT02261285|100927345|FG002|COMPLETED|Overall Study||5||
48248056|NCT02261285|100927343|FG000|NOT COMPLETED|Overall Study||0||
48248057|NCT02261285|100927344|FG001|NOT COMPLETED|Overall Study||0||
48248058|NCT02261285|100927345|FG002|NOT COMPLETED|Overall Study||1||
48248059|NCT04203199|100927346|FG000|STARTED|First Intervention Period||15||
48248060|NCT04203199|100927347|FG001|STARTED|First Intervention Period||16||
48248061|NCT04203199|100927346|FG000|COMPLETED|First Intervention Period||15||
48248062|NCT04203199|100927347|FG001|COMPLETED|First Intervention Period||15||
48540885|NCT00086281|101662596|FG010|NOT COMPLETED|Phase 1||3||
48540886|NCT00086281|101662597|FG011|NOT COMPLETED|Phase 1||1||
48540887|NCT00086281|101662598|FG012|NOT COMPLETED|Phase 1||1||
48540888|NCT00086281|101662599|FG013|NOT COMPLETED|Phase 1||1||
48540889|NCT00086281|101662600|FG014|NOT COMPLETED|Phase 1||3||
48540890|NCT00086281|101662586|FG000|STARTED|Phase 2||0||
48540891|NCT00086281|101662587|FG001|STARTED|Phase 2||0||
48248063|NCT04203199|100927346|FG000|NOT COMPLETED|First Intervention Period||0||
48248064|NCT04203199|100927347|FG001|NOT COMPLETED|First Intervention Period||1||
48248065|NCT04203199|100927346|FG000|STARTED|Second Intervention Period||15||
48248066|NCT04203199|100927347|FG001|STARTED|Second Intervention Period||15||
48248067|NCT04203199|100927346|FG000|COMPLETED|Second Intervention Period||14||
48248068|NCT04203199|100927347|FG001|COMPLETED|Second Intervention Period||15||
48248069|NCT04203199|100927346|FG000|NOT COMPLETED|Second Intervention Period||1||
48540892|NCT00086281|101662588|FG002|STARTED|Phase 2||0||
48540893|NCT00086281|101662589|FG003|STARTED|Phase 2||0||
48540894|NCT00086281|101662590|FG004|STARTED|Phase 2||0||
48540895|NCT00086281|101662591|FG005|STARTED|Phase 2||0||
48248070|NCT04203199|100927347|FG001|NOT COMPLETED|Second Intervention Period||0||
48248071|NCT02256488|100927348|FG000|STARTED|Overall Study||387||
48540896|NCT00086281|101662592|FG006|STARTED|Phase 2||0||
48540897|NCT00086281|101662593|FG007|STARTED|Phase 2||0||
48540898|NCT00086281|101662594|FG008|STARTED|Phase 2||0||
48248072|NCT02256488|100927349|FG001|STARTED|Overall Study||392||
48248073|NCT02256488|100927350|FG002|STARTED|Overall Study||392||
48248074|NCT02256488|100927351|FG003|STARTED|Overall Study||390||
48248075|NCT02256488|100927348|FG000|COMPLETED|Overall Study||379||
48248076|NCT02256488|100927349|FG001|COMPLETED|Overall Study||386||
48248077|NCT02256488|100927350|FG002|COMPLETED|Overall Study||382||
48248078|NCT02256488|100927351|FG003|COMPLETED|Overall Study||384||
48248079|NCT02256488|100927348|FG000|NOT COMPLETED|Overall Study||8||
48248080|NCT02256488|100927349|FG001|NOT COMPLETED|Overall Study||6||
48248081|NCT02256488|100927350|FG002|NOT COMPLETED|Overall Study||10||
48248082|NCT02256488|100927351|FG003|NOT COMPLETED|Overall Study||6||
48248083|NCT02499835|100927352|FG000|STARTED|Overall Study||13||
48248084|NCT02499835|100927353|FG001|STARTED|Overall Study||13||
48248085|NCT02499835|100927354|FG002|STARTED|Overall Study||20||
48248086|NCT02499835|100927355|FG003|STARTED|Overall Study||20||
48248087|NCT02499835|100927352|FG000|COMPLETED|Overall Study||10||
48248088|NCT02499835|100927353|FG001|COMPLETED|Overall Study||9||
48248089|NCT02499835|100927354|FG002|COMPLETED|Overall Study||2||
48248090|NCT02499835|100927355|FG003|COMPLETED|Overall Study||4||
48248091|NCT02499835|100927352|FG000|NOT COMPLETED|Overall Study||3||
48248092|NCT02499835|100927353|FG001|NOT COMPLETED|Overall Study||4||
48248093|NCT02499835|100927354|FG002|NOT COMPLETED|Overall Study||18||
48248094|NCT02499835|100927355|FG003|NOT COMPLETED|Overall Study||16||
48248095|NCT02604342|100927356|FG000|STARTED|Overall Study||79||
48248096|NCT02604342|100927357|FG001|STARTED|Overall Study||40||
48248097|NCT02604342|100927356|FG000|COMPLETED|Overall Study||36||
48248098|NCT02604342|100927357|FG001|COMPLETED|Overall Study||17||
48248099|NCT02604342|100927356|FG000|NOT COMPLETED|Overall Study||43||
48248100|NCT02604342|100927357|FG001|NOT COMPLETED|Overall Study||23||
48248101|NCT03325608|100927358|FG000|STARTED|Overall Study||320||
48248102|NCT03325608|100927359|FG001|STARTED|Overall Study||320||
48248103|NCT03325608|100927360|FG002|STARTED|Overall Study||322||
48085309|NCT01089062|100528939|FG003|STARTED|Follow-up Visit (Final Visit)||3||
48248104|NCT03325608|100927361|FG003|STARTED|Overall Study||322||
48248105|NCT03325608|100927358|FG000|COMPLETED|Overall Study||207||
48248106|NCT03325608|100927359|FG001|COMPLETED|Overall Study||207||
48248107|NCT03325608|100927360|FG002|COMPLETED|Overall Study||222||
48248108|NCT03325608|100927361|FG003|COMPLETED|Overall Study||222||
48248109|NCT03325608|100927358|FG000|NOT COMPLETED|Overall Study||113||
48248110|NCT03325608|100927359|FG001|NOT COMPLETED|Overall Study||113||
48248111|NCT03325608|100927360|FG002|NOT COMPLETED|Overall Study||100||
48248112|NCT03325608|100927361|FG003|NOT COMPLETED|Overall Study||100||
48248113|NCT01592383|100927362|FG000|STARTED|Overall Study||2||
48248114|NCT01592383|100927362|FG000|COMPLETED|Overall Study||1||
48248115|NCT01592383|100927362|FG000|NOT COMPLETED|Overall Study||1||
48248116|NCT01494298|100927363|FG000|STARTED|Overall Study||56||
48248117|NCT01494298|100927364|FG001|STARTED|Overall Study||55||
48248118|NCT01494298|100927363|FG000|COMPLETED|Overall Study||54||
48248119|NCT01494298|100927364|FG001|COMPLETED|Overall Study||47||
48248120|NCT01494298|100927363|FG000|NOT COMPLETED|Overall Study||2||
48248121|NCT01494298|100927364|FG001|NOT COMPLETED|Overall Study||8||
48085310|NCT01089062|100528940|FG004|STARTED|Follow-up Visit (Final Visit)||3||
48085311|NCT01089062|100528941|FG005|STARTED|Follow-up Visit (Final Visit)||3||
48085312|NCT01089062|100528936|FG000|COMPLETED|Follow-up Visit (Final Visit)||3||
48248122|NCT02642159|100927365|FG000|STARTED|Overall Study||276||
48248123|NCT02642159|100927366|FG001|STARTED|Overall Study||137||
48248124|NCT02642159|100927365|FG000|Treated (Safety Population)|Overall Study||275||
48248125|NCT02642159|100927366|FG001|Treated (Safety Population)|Overall Study||137||
48248126|NCT02642159|100927365|FG000|ITT Population|Overall Study||273||
48248127|NCT02642159|100927366|FG001|ITT Population|Overall Study||136||
48248128|NCT02642159|100927365|FG000|ITT: Intent to Prescribe Fenofibrate|Overall Study||47||
48248129|NCT02642159|100927366|FG001|ITT: Intent to Prescribe Fenofibrate|Overall Study||24||
48085313|NCT01089062|100528937|FG001|COMPLETED|Follow-up Visit (Final Visit)||3||
48085314|NCT01089062|100528938|FG002|COMPLETED|Follow-up Visit (Final Visit)||3||
48085315|NCT01089062|100528939|FG003|COMPLETED|Follow-up Visit (Final Visit)||3||
48085316|NCT01089062|100528940|FG004|COMPLETED|Follow-up Visit (Final Visit)||3||
48085317|NCT01089062|100528941|FG005|COMPLETED|Follow-up Visit (Final Visit)||3||
48085318|NCT01089062|100528936|FG000|NOT COMPLETED|Follow-up Visit (Final Visit)||0||
48085319|NCT01089062|100528937|FG001|NOT COMPLETED|Follow-up Visit (Final Visit)||0||
48248130|NCT02642159|100927365|FG000|COMPLETED|Overall Study||245|Completed = treatment completion|
48248131|NCT02642159|100927366|FG001|COMPLETED|Overall Study||129|Completed = treatment completion|
48248132|NCT02642159|100927365|FG000|NOT COMPLETED|Overall Study||31||
48248133|NCT02642159|100927366|FG001|NOT COMPLETED|Overall Study||8||
48248134|NCT00105521|100927367|FG000|STARTED|Overall Study||98||
48248135|NCT00105521|100927368|FG001|STARTED|Overall Study||101||
48248136|NCT00105521|100927369|FG002|STARTED|Overall Study||97||
48248137|NCT00105521|100927370|FG003|STARTED|Overall Study||102||
48248138|NCT00105521|100927367|FG000|COMPLETED|Overall Study||83||
48248139|NCT00105521|100927368|FG001|COMPLETED|Overall Study||90||
48248140|NCT00105521|100927369|FG002|COMPLETED|Overall Study||80||
48248141|NCT00105521|100927370|FG003|COMPLETED|Overall Study||85||
48248142|NCT00105521|100927367|FG000|NOT COMPLETED|Overall Study||15||
48540899|NCT00086281|101662595|FG009|STARTED|Phase 2||0||
48085320|NCT01089062|100528938|FG002|NOT COMPLETED|Follow-up Visit (Final Visit)||0||
48085321|NCT01089062|100528939|FG003|NOT COMPLETED|Follow-up Visit (Final Visit)||0||
48085322|NCT01089062|100528940|FG004|NOT COMPLETED|Follow-up Visit (Final Visit)||0||
48540900|NCT00086281|101662596|FG010|STARTED|Phase 2||0||
48540901|NCT00086281|101662597|FG011|STARTED|Phase 2||0||
48540902|NCT00086281|101662598|FG012|STARTED|Phase 2||23||
48540903|NCT00086281|101662599|FG013|STARTED|Phase 2||27||
48540904|NCT00086281|101662600|FG014|STARTED|Phase 2||0||
48540905|NCT00086281|101662586|FG000|COMPLETED|Phase 2||0||
48540906|NCT00086281|101662587|FG001|COMPLETED|Phase 2||0||
48540907|NCT00086281|101662588|FG002|COMPLETED|Phase 2||0||
48540908|NCT00086281|101662589|FG003|COMPLETED|Phase 2||0||
48540909|NCT00086281|101662590|FG004|COMPLETED|Phase 2||0||
48540910|NCT00086281|101662591|FG005|COMPLETED|Phase 2||0||
48540911|NCT00086281|101662592|FG006|COMPLETED|Phase 2||0||
48085323|NCT01089062|100528941|FG005|NOT COMPLETED|Follow-up Visit (Final Visit)||0||
48085324|NCT01664533|100528942|FG000|STARTED|Overall Study||57||
48085325|NCT01664533|100528942|FG000|COMPLETED|Overall Study||0||
48085326|NCT01664533|100528942|FG000|NOT COMPLETED|Overall Study||57||
48085327|NCT02970422|100528943|FG000|STARTED|Overall Study||200||
48085328|NCT02970422|100528943|FG000|COMPLETED|Overall Study||200||
48085329|NCT02970422|100528943|FG000|NOT COMPLETED|Overall Study||0||
48085330|NCT01850524|100528944|FG000|STARTED|Overall Study||354||
48085331|NCT01850524|100528945|FG001|STARTED|Overall Study||351||
48085332|NCT01850524|100528944|FG000|Intent-to-Treat (ITT) Population|Overall Study||354||
48085333|NCT01850524|100528945|FG001|Intent-to-Treat (ITT) Population|Overall Study||351||
48085334|NCT01850524|100528944|FG000|Safety Population|Overall Study||349|Includes all treated participants. Participants were analyzed as treated.|
48085335|NCT01850524|100528945|FG001|Safety Population|Overall Study||354|Includes all treated participants. Participants were analyzed as treated.|
48085336|NCT01850524|100528944|FG000|Participants Completed Study Treatment Per Protocol|Overall Study||283|Includes participants who completed treatment per protocol until disease progression or until discontinuation for unacceptable toxicity, withdrawal of consent, or death.|
48085337|NCT01850524|100528945|FG001|Participants Completed Study Treatment Per Protocol|Overall Study||284|Includes participants who completed treatment per protocol until disease progression or until discontinuation for unacceptable toxicity, withdrawal of consent, or death.|
48085338|NCT01850524|100528944|FG000|Per Protocol (PP) Population|Overall Study||293||
48085339|NCT01850524|100528945|FG001|Per Protocol (PP) Population|Overall Study||296||
48085340|NCT01850524|100528944|FG000|Participants With Exposure of ≥ 19 Cycles|Overall Study||189||
48085341|NCT01850524|100528945|FG001|Participants With Exposure of ≥ 19 Cycles|Overall Study||191||
48085342|NCT01850524|100528944|FG000|Response-evaluable Population|Overall Study||347|"Includes all participants in the ITT population who receive at least 1 dose of any study drug, have measurable disease at baseline, and at least~1 post baseline response assessment assessed by an Independent Review Committee (IRC)."|
48085343|NCT01850524|100528945|FG001|Response-evaluable Population|Overall Study||335|"Includes all participants in the ITT population who receive at least 1 dose of any study drug, have measurable disease at baseline, and at least~1 post baseline response assessment assessed by an Independent Review Committee (IRC)."|
48085344|NCT01850524|100528944|FG000|COMPLETED|Overall Study||183|Completed=who completed the study.|
48085345|NCT01850524|100528945|FG001|COMPLETED|Overall Study||178|Completed=who completed the study.|
48085346|NCT01850524|100528944|FG000|NOT COMPLETED|Overall Study||171||
48085347|NCT01850524|100528945|FG001|NOT COMPLETED|Overall Study||173||
48085348|NCT02034110|100528946|FG000|STARTED|Overall Study||36|All enrolled participants were included in the Intent-to-treat (ITT), All-treated subjects (ATS) and ITT/Evaluable populations|
48085349|NCT02034110|100528947|FG001|STARTED|Overall Study||43|All enrolled participants were included in the Intent-to-treat (ITT), All-treated subjects (ATS) and ITT/Evaluable populations|
48085350|NCT02034110|100528948|FG002|STARTED|Overall Study||1|All enrolled participants were included in the Intent-to-treat (ITT), All-treated subjects (ATS) and ITT/Evaluable populations|
48085351|NCT02034110|100528949|FG003|STARTED|Overall Study||13|All enrolled participants were included in the Intent-to-treat (ITT), All-treated subjects (ATS) and ITT/Evaluable populations|
48085352|NCT02034110|100528950|FG004|STARTED|Overall Study||45|All enrolled participants were included in the Intent-to-treat (ITT), All-treated subjects (ATS) and ITT/Evaluable populations|
48085353|NCT02034110|100528951|FG005|STARTED|Overall Study||3|All enrolled participants were included in the Intent-to-treat (ITT), All-treated subjects (ATS) and ITT/Evaluable populations|
48085354|NCT02034110|100528952|FG006|STARTED|Overall Study||55|All enrolled participants were included in the Intent-to-treat (ITT), All-treated subjects (ATS) and ITT/Evaluable populations|
48085355|NCT02034110|100528953|FG007|STARTED|Overall Study||10|All enrolled participants were included in the Intent-to-treat (ITT), All-treated subjects (ATS) and ITT/Evaluable populations|
48085356|NCT02034110|100528946|FG000|Primary Analysis Cohort|Overall Study||15||
48085357|NCT02034110|100528947|FG001|Primary Analysis Cohort|Overall Study||18||
48085358|NCT02034110|100528948|FG002|Primary Analysis Cohort|Overall Study||1||
48085359|NCT02034110|100528949|FG003|Primary Analysis Cohort|Overall Study||13||
48085360|NCT02034110|100528950|FG004|Primary Analysis Cohort|Overall Study||24||
48085361|NCT02034110|100528951|FG005|Primary Analysis Cohort|Overall Study||3||
48085362|NCT02034110|100528952|FG006|Primary Analysis Cohort|Overall Study||24||
48085363|NCT02034110|100528953|FG007|Primary Analysis Cohort|Overall Study||10||
48540912|NCT00086281|101662593|FG007|COMPLETED|Phase 2||0||
48540913|NCT00086281|101662594|FG008|COMPLETED|Phase 2||0||
48540914|NCT00086281|101662595|FG009|COMPLETED|Phase 2||0||
48540915|NCT00086281|101662596|FG010|COMPLETED|Phase 2||0||
48248143|NCT00105521|100927368|FG001|NOT COMPLETED|Overall Study||11||
48248144|NCT00105521|100927369|FG002|NOT COMPLETED|Overall Study||17||
48248145|NCT00105521|100927370|FG003|NOT COMPLETED|Overall Study||17||
48248146|NCT01898442|100927371|FG000|STARTED|Overall Study||17||
48248147|NCT01898442|100927372|FG001|STARTED|Overall Study||17||
48248148|NCT01898442|100927373|FG002|STARTED|Overall Study||18||
48248149|NCT01898442|100927371|FG000|COMPLETED|Overall Study||16||
48248150|NCT01898442|100927372|FG001|COMPLETED|Overall Study||15||
48248151|NCT01898442|100927373|FG002|COMPLETED|Overall Study||15||
48248152|NCT01898442|100927371|FG000|NOT COMPLETED|Overall Study||1||
48248153|NCT01898442|100927372|FG001|NOT COMPLETED|Overall Study||2||
48248154|NCT01898442|100927373|FG002|NOT COMPLETED|Overall Study||3||
48248155|NCT02544113|100927374|FG000|STARTED|Overall Study||55||
48248156|NCT02544113|100927375|FG001|STARTED|Overall Study||55||
48248157|NCT02544113|100927374|FG000|COMPLETED|Overall Study||52||
48248158|NCT02544113|100927375|FG001|COMPLETED|Overall Study||51||
48248159|NCT02544113|100927374|FG000|NOT COMPLETED|Overall Study||3||
48248160|NCT02544113|100927375|FG001|NOT COMPLETED|Overall Study||4||
48248161|NCT00907517|100927376|FG000|STARTED|Overall Study||3||
48248162|NCT00907517|100927377|FG001|STARTED|Overall Study||3||
48248163|NCT00907517|100927378|FG002|STARTED|Overall Study||6||
48248164|NCT00907517|100927379|FG003|STARTED|Overall Study||6||
48248165|NCT00907517|100927380|FG004|STARTED|Overall Study||6||
48248166|NCT00907517|100927376|FG000|COMPLETED|Overall Study||0||
48248167|NCT00907517|100927377|FG001|COMPLETED|Overall Study||0||
48248168|NCT00907517|100927378|FG002|COMPLETED|Overall Study||2||
48248169|NCT00907517|100927379|FG003|COMPLETED|Overall Study||2||
48248170|NCT00907517|100927380|FG004|COMPLETED|Overall Study||1||
48248171|NCT00907517|100927376|FG000|NOT COMPLETED|Overall Study||3||
48248172|NCT00907517|100927377|FG001|NOT COMPLETED|Overall Study||3||
48248173|NCT00907517|100927378|FG002|NOT COMPLETED|Overall Study||4||
48248174|NCT00907517|100927379|FG003|NOT COMPLETED|Overall Study||4||
48248175|NCT00907517|100927380|FG004|NOT COMPLETED|Overall Study||5||
48248176|NCT00744796|100927381|FG000|STARTED|Pre-operative||21||
48248177|NCT00744796|100927381|FG000|COMPLETED|Pre-operative||21||
48248178|NCT00744796|100927381|FG000|NOT COMPLETED|Pre-operative||0||
48682874|NCT01440764|102006714|FG005|STARTED|Test Day 1||5||
48682875|NCT01440764|102006715|FG006|STARTED|Test Day 1||3||
48682876|NCT01440764|102006709|FG000|COMPLETED|Test Day 1||4||
48682877|NCT01440764|102006710|FG001|COMPLETED|Test Day 1||2||
48682878|NCT01440764|102006711|FG002|COMPLETED|Test Day 1||6||
48682879|NCT01440764|102006712|FG003|COMPLETED|Test Day 1||1||
48682880|NCT01440764|102006713|FG004|COMPLETED|Test Day 1||3||
48682881|NCT01440764|102006714|FG005|COMPLETED|Test Day 1||5||
48682882|NCT01440764|102006715|FG006|COMPLETED|Test Day 1||3||
48682883|NCT01440764|102006709|FG000|NOT COMPLETED|Test Day 1||0||
48682884|NCT01440764|102006710|FG001|NOT COMPLETED|Test Day 1||0||
48682885|NCT01440764|102006711|FG002|NOT COMPLETED|Test Day 1||0||
48682886|NCT01440764|102006712|FG003|NOT COMPLETED|Test Day 1||0||
48682887|NCT01440764|102006713|FG004|NOT COMPLETED|Test Day 1||0||
48248179|NCT00744796|100927381|FG000|STARTED|Post-Operative Day 1||21||
48248180|NCT00744796|100927381|FG000|COMPLETED|Post-Operative Day 1||21||
48248181|NCT00744796|100927381|FG000|NOT COMPLETED|Post-Operative Day 1||0||
48248182|NCT00744796|100927381|FG000|STARTED|Post-Operative 3-6 Months||21||
48248183|NCT00744796|100927381|FG000|COMPLETED|Post-Operative 3-6 Months||21||
48248184|NCT00744796|100927381|FG000|NOT COMPLETED|Post-Operative 3-6 Months||0||
48248185|NCT00744796|100927381|FG000|STARTED|Post-Operative 6-9 Months||21||
48248186|NCT00744796|100927381|FG000|COMPLETED|Post-Operative 6-9 Months||9||
48248187|NCT00744796|100927381|FG000|NOT COMPLETED|Post-Operative 6-9 Months||12||
48248188|NCT00094497|100927382|FG000|STARTED|Overall Study||151||
48248189|NCT00094497|100927383|FG001|STARTED|Overall Study||153||
48248190|NCT00094497|100927382|FG000|Treated|Overall Study||148||
48248191|NCT00094497|100927383|FG001|Treated|Overall Study||149||
48248192|NCT00094497|100927382|FG000|Received Second Line Therapy|Overall Study||84||
48248193|NCT00094497|100927383|FG001|Received Second Line Therapy|Overall Study||101||
48248194|NCT00094497|100927382|FG000|COMPLETED|Overall Study||151||
48248195|NCT00094497|100927383|FG001|COMPLETED|Overall Study||153||
48248196|NCT00094497|100927382|FG000|NOT COMPLETED|Overall Study||0||
48248197|NCT00094497|100927383|FG001|NOT COMPLETED|Overall Study||0||
48248198|NCT01732926|100927384|FG000|STARTED|Overall Study||320||
48682888|NCT01440764|102006714|FG005|NOT COMPLETED|Test Day 1||0||
48682889|NCT01440764|102006715|FG006|NOT COMPLETED|Test Day 1||0||
48682890|NCT01440764|102006709|FG000|STARTED|Test Day 2||3||
48682891|NCT01440764|102006710|FG001|STARTED|Test Day 2||2||
48682892|NCT01440764|102006711|FG002|STARTED|Test Day 2||6||
48682893|NCT01440764|102006712|FG003|STARTED|Test Day 2||1||
48682894|NCT01440764|102006713|FG004|STARTED|Test Day 2||3||
48682895|NCT01440764|102006714|FG005|STARTED|Test Day 2||5||
48682896|NCT01440764|102006715|FG006|STARTED|Test Day 2||3||
48682897|NCT01440764|102006709|FG000|COMPLETED|Test Day 2||3||
48682898|NCT01440764|102006710|FG001|COMPLETED|Test Day 2||2||
48682899|NCT01440764|102006711|FG002|COMPLETED|Test Day 2||6||
48682900|NCT01440764|102006712|FG003|COMPLETED|Test Day 2||1||
48682901|NCT01440764|102006713|FG004|COMPLETED|Test Day 2||3||
48682902|NCT01440764|102006714|FG005|COMPLETED|Test Day 2||5||
48682903|NCT01440764|102006715|FG006|COMPLETED|Test Day 2||3||
48682904|NCT01440764|102006709|FG000|NOT COMPLETED|Test Day 2||0||
48682905|NCT01440764|102006710|FG001|NOT COMPLETED|Test Day 2||0||
48682906|NCT01440764|102006711|FG002|NOT COMPLETED|Test Day 2||0||
48682907|NCT01440764|102006712|FG003|NOT COMPLETED|Test Day 2||0||
48248199|NCT01732926|100927385|FG001|STARTED|Overall Study||155||
48248200|NCT01732926|100927384|FG000|COMPLETED|Overall Study||53|Completed = reached primary efficacy endpoint of progressive disease or death|
48248201|NCT01732926|100927385|FG001|COMPLETED|Overall Study||45|Completed = reached primary efficacy endpoint of progressive disease or death|
48248202|NCT01732926|100927384|FG000|NOT COMPLETED|Overall Study||267||
48248203|NCT01732926|100927385|FG001|NOT COMPLETED|Overall Study||110||
48248204|NCT01485991|100927386|FG000|STARTED|Overall Study||385||
48248205|NCT01485991|100927387|FG001|STARTED|Overall Study||386||
48248206|NCT01485991|100927386|FG000|Treated|Overall Study||379||
48248207|NCT01485991|100927387|FG001|Treated|Overall Study||384||
48248208|NCT01485991|100927386|FG000|COMPLETED|Overall Study||353||
48248209|NCT01485991|100927387|FG001|COMPLETED|Overall Study||350||
48248210|NCT01485991|100927386|FG000|NOT COMPLETED|Overall Study||32||
48248211|NCT01485991|100927387|FG001|NOT COMPLETED|Overall Study||36||
48248212|NCT00424177|100927388|FG000|STARTED|Cycle 1: Eltrombopag 50 mg Starting Dose||66||
48248213|NCT00424177|100927388|FG000|COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||55||
48248214|NCT00424177|100927388|FG000|NOT COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||11||
48248215|NCT00424177|100927388|FG000|STARTED|Cycle 2: Eltrombopag 50 or 75 mg||55||
48248216|NCT00424177|100927388|FG000|COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||51||
48248217|NCT00424177|100927388|FG000|NOT COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||4||
48248218|NCT00424177|100927388|FG000|STARTED|Cycle 3: Eltrombopag 50 or 75 mg||51||
48248219|NCT00424177|100927388|FG000|COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||48||
48248220|NCT00424177|100927388|FG000|NOT COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||3||
48248221|NCT00926952|100927389|FG000|STARTED|Overall Study||20||
48248222|NCT00926952|100927389|FG000|COMPLETED|Overall Study||20||
48248223|NCT00926952|100927389|FG000|NOT COMPLETED|Overall Study||0||
48248224|NCT00666835|100927390|FG000|STARTED|Overall Study||314||
48248225|NCT00666835|100927391|FG001|STARTED|Overall Study||164||
48248226|NCT00666835|100927390|FG000|COMPLETED|Overall Study||261||
48248227|NCT00666835|100927391|FG001|COMPLETED|Overall Study||142||
48248228|NCT00666835|100927390|FG000|NOT COMPLETED|Overall Study||53||
48248229|NCT00666835|100927391|FG001|NOT COMPLETED|Overall Study||22||
48248230|NCT01116440|100927392|FG000|STARTED|Treatment||11||
48248231|NCT01116440|100927393|FG001|STARTED|Treatment||16||
48248232|NCT01116440|100927392|FG000|COMPLETED|Treatment||8||
48248233|NCT01116440|100927393|FG001|COMPLETED|Treatment||9||
48248234|NCT01116440|100927392|FG000|NOT COMPLETED|Treatment||3||
48248235|NCT01116440|100927393|FG001|NOT COMPLETED|Treatment||7||
48248236|NCT01116440|100927392|FG000|STARTED|Withdrawal||8||
48248237|NCT01116440|100927393|FG001|STARTED|Withdrawal||9||
48248238|NCT01116440|100927392|FG000|COMPLETED|Withdrawal||8||
48248239|NCT01116440|100927393|FG001|COMPLETED|Withdrawal||7||
48248240|NCT01116440|100927392|FG000|NOT COMPLETED|Withdrawal||0||
48248241|NCT01116440|100927393|FG001|NOT COMPLETED|Withdrawal||2||
48248242|NCT01116440|100927392|FG000|STARTED|Follow-up||8||
48682908|NCT01440764|102006713|FG004|NOT COMPLETED|Test Day 2||0||
48248243|NCT01116440|100927393|FG001|STARTED|Follow-up||7||
48248244|NCT01116440|100927392|FG000|COMPLETED|Follow-up||8||
48248245|NCT01116440|100927393|FG001|COMPLETED|Follow-up||5||
48248246|NCT01116440|100927392|FG000|NOT COMPLETED|Follow-up||0||
48248247|NCT01116440|100927393|FG001|NOT COMPLETED|Follow-up||2||
48248248|NCT02878590|100927394|FG000|STARTED|Overall Study||12||
48248249|NCT02878590|100927394|FG000|COMPLETED|Overall Study||10||
48248250|NCT02878590|100927394|FG000|NOT COMPLETED|Overall Study||2||
48248251|NCT05177770|100927395|FG000|STARTED|Overall Study||16||
48248252|NCT05177770|100927395|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15|Safety Analysis Set|
48248253|NCT05177770|100927395|FG000|COMPLETED|Overall Study||10|Completion was defined as completing the safety follow up visit.|
48248254|NCT05177770|100927395|FG000|NOT COMPLETED|Overall Study||6||
48248255|NCT03078751|100927396|FG000|STARTED|Overall Study||26||
48248256|NCT03078751|100927397|FG001|STARTED|Overall Study||28||
48248257|NCT03078751|100927396|FG000|Untreated Participants|Overall Study||0||
48248258|NCT03078751|100927397|FG001|Untreated Participants|Overall Study||4||
48248259|NCT03078751|100927396|FG000|Safety Set|Overall Study||26||
48248260|NCT03078751|100927397|FG001|Safety Set|Overall Study||24||
48248261|NCT03078751|100927396|FG000|COMPLETED|Overall Study||13||
48248262|NCT03078751|100927397|FG001|COMPLETED|Overall Study||0||
48248263|NCT03078751|100927396|FG000|NOT COMPLETED|Overall Study||13||
48248264|NCT03078751|100927397|FG001|NOT COMPLETED|Overall Study||28||
48248265|NCT05878990|100927398|FG000|STARTED|Overall Study||22||
48248266|NCT05878990|100927398|FG000|COMPLETED|Overall Study||14||
48248267|NCT05878990|100927398|FG000|NOT COMPLETED|Overall Study||8||
48682909|NCT01440764|102006714|FG005|NOT COMPLETED|Test Day 2||0||
48682910|NCT01440764|102006715|FG006|NOT COMPLETED|Test Day 2||0||
48682911|NCT01440764|102006709|FG000|STARTED|Test Day 3||3||
48682912|NCT01440764|102006710|FG001|STARTED|Test Day 3||2||
48682913|NCT01440764|102006711|FG002|STARTED|Test Day 3||6||
48682914|NCT01440764|102006712|FG003|STARTED|Test Day 3||1||
48682915|NCT01440764|102006713|FG004|STARTED|Test Day 3||3||
48248268|NCT02212301|100927399|FG000|STARTED|Period 1||21||
48248269|NCT02212301|100927400|FG001|STARTED|Period 1||22||
48248270|NCT02212301|100927399|FG000|COMPLETED|Period 1||21||
48248271|NCT02212301|100927400|FG001|COMPLETED|Period 1||21||
48248272|NCT02212301|100927399|FG000|NOT COMPLETED|Period 1||0||
48248273|NCT02212301|100927400|FG001|NOT COMPLETED|Period 1||1||
48248274|NCT02212301|100927399|FG000|STARTED|Period 2||21||
48248275|NCT02212301|100927400|FG001|STARTED|Period 2||21||
48248276|NCT02212301|100927399|FG000|COMPLETED|Period 2||21||
48248277|NCT02212301|100927400|FG001|COMPLETED|Period 2||21||
48248278|NCT02212301|100927399|FG000|NOT COMPLETED|Period 2||0||
48248279|NCT02212301|100927400|FG001|NOT COMPLETED|Period 2||0||
48248280|NCT02364609|100927401|FG000|STARTED|Overall Study||6||
48248281|NCT02364609|100927402|FG001|STARTED|Overall Study||5||
48248282|NCT02364609|100927401|FG000|COMPLETED|Overall Study||6||
48248283|NCT02364609|100927402|FG001|COMPLETED|Overall Study||5||
48248284|NCT02364609|100927401|FG000|NOT COMPLETED|Overall Study||0||
48248285|NCT02364609|100927402|FG001|NOT COMPLETED|Overall Study||0||
48248286|NCT00253019|100927403|FG000|STARTED|Overall Study||111||
48248287|NCT00253019|100927404|FG001|STARTED|Overall Study||109||
48248288|NCT00253019|100927405|FG002|STARTED|Overall Study||101||
48248289|NCT00253019|100927403|FG000|COMPLETED|Overall Study||82||
48248290|NCT00253019|100927404|FG001|COMPLETED|Overall Study||78||
48248291|NCT00253019|100927405|FG002|COMPLETED|Overall Study||83||
48248292|NCT00253019|100927403|FG000|NOT COMPLETED|Overall Study||29||
48248293|NCT00253019|100927404|FG001|NOT COMPLETED|Overall Study||31||
48248294|NCT00253019|100927405|FG002|NOT COMPLETED|Overall Study||18||
48248295|NCT03045302|100927406|FG000|STARTED|Overall Study||4||
48248296|NCT03045302|100927406|FG000|COMPLETED|Overall Study||3||
48248297|NCT03045302|100927406|FG000|NOT COMPLETED|Overall Study||1||
48248298|NCT01158716|100927407|FG000|STARTED|Overall Study||48||
48248299|NCT01158716|100927408|FG001|STARTED|Overall Study||48||
48248300|NCT01158716|100927407|FG000|COMPLETED|Overall Study||47||
48248301|NCT01158716|100927408|FG001|COMPLETED|Overall Study||47||
48248302|NCT01158716|100927407|FG000|NOT COMPLETED|Overall Study||1||
48248303|NCT01158716|100927408|FG001|NOT COMPLETED|Overall Study||1||
48248304|NCT02123797|100927409|FG000|STARTED|Baseline Intervention||178||
48248305|NCT02123797|100927410|FG001|STARTED|Baseline Intervention||348||
48248306|NCT02123797|100927411|FG002|STARTED|Baseline Intervention||100||
48248307|NCT02123797|100927412|FG003|STARTED|Baseline Intervention||144||
48248308|NCT02123797|100927413|FG004|STARTED|Baseline Intervention||11||
48248309|NCT02123797|100927409|FG000|COMPLETED|Baseline Intervention||156||
48248310|NCT02123797|100927410|FG001|COMPLETED|Baseline Intervention||306||
48248311|NCT02123797|100927411|FG002|COMPLETED|Baseline Intervention||100||
48248312|NCT02123797|100927412|FG003|COMPLETED|Baseline Intervention||144||
48248313|NCT02123797|100927413|FG004|COMPLETED|Baseline Intervention||11||
48248314|NCT02123797|100927409|FG000|NOT COMPLETED|Baseline Intervention||22||
48248315|NCT02123797|100927410|FG001|NOT COMPLETED|Baseline Intervention||42||
48248316|NCT02123797|100927411|FG002|NOT COMPLETED|Baseline Intervention||0||
48248317|NCT02123797|100927412|FG003|NOT COMPLETED|Baseline Intervention||0||
48248318|NCT02123797|100927413|FG004|NOT COMPLETED|Baseline Intervention||0||
48248319|NCT02123797|100927409|FG000|STARTED|3-month Follow up (Cumulative Counts)||156||
48248320|NCT02123797|100927410|FG001|STARTED|3-month Follow up (Cumulative Counts)||306||
48248321|NCT02123797|100927411|FG002|STARTED|3-month Follow up (Cumulative Counts)||100||
48248322|NCT02123797|100927412|FG003|STARTED|3-month Follow up (Cumulative Counts)||144||
48248323|NCT02123797|100927413|FG004|STARTED|3-month Follow up (Cumulative Counts)||11||
48248324|NCT02123797|100927409|FG000|COMPLETED|3-month Follow up (Cumulative Counts)||99||
48248325|NCT02123797|100927410|FG001|COMPLETED|3-month Follow up (Cumulative Counts)||189||
48248326|NCT02123797|100927411|FG002|COMPLETED|3-month Follow up (Cumulative Counts)||50||
48248327|NCT02123797|100927412|FG003|COMPLETED|3-month Follow up (Cumulative Counts)||62||
48248328|NCT02123797|100927413|FG004|COMPLETED|3-month Follow up (Cumulative Counts)||8||
48248329|NCT02123797|100927409|FG000|NOT COMPLETED|3-month Follow up (Cumulative Counts)||57||
48248330|NCT02123797|100927410|FG001|NOT COMPLETED|3-month Follow up (Cumulative Counts)||117||
48248331|NCT02123797|100927411|FG002|NOT COMPLETED|3-month Follow up (Cumulative Counts)||50||
48248332|NCT02123797|100927412|FG003|NOT COMPLETED|3-month Follow up (Cumulative Counts)||82||
48248333|NCT02123797|100927413|FG004|NOT COMPLETED|3-month Follow up (Cumulative Counts)||3||
48248334|NCT02123797|100927409|FG000|STARTED|6-month Follow up (Cumulative Counts)||156|Participants were able to complete a 6 month survey, even if they did not complete a 3 month survey.|
48248335|NCT02123797|100927410|FG001|STARTED|6-month Follow up (Cumulative Counts)||306|Participants were able to complete a 6 month survey, even if they did not complete a 3 month survey.|
48248336|NCT02123797|100927411|FG002|STARTED|6-month Follow up (Cumulative Counts)||100|Participants were able to complete a 6 month survey, even if they did not complete a 3 month survey.|
48248337|NCT02123797|100927412|FG003|STARTED|6-month Follow up (Cumulative Counts)||144|Participants were able to complete a 6 month survey, even if they did not complete a 3 month survey.|
48248338|NCT02123797|100927413|FG004|STARTED|6-month Follow up (Cumulative Counts)||8|Participants were able to complete a 6 month survey, even if they did not complete a 3 month survey.|
48248339|NCT02123797|100927409|FG000|COMPLETED|6-month Follow up (Cumulative Counts)||101||
48248340|NCT02123797|100927410|FG001|COMPLETED|6-month Follow up (Cumulative Counts)||178||
48248341|NCT02123797|100927411|FG002|COMPLETED|6-month Follow up (Cumulative Counts)||34||
48248342|NCT02123797|100927412|FG003|COMPLETED|6-month Follow up (Cumulative Counts)||31||
48248343|NCT02123797|100927413|FG004|COMPLETED|6-month Follow up (Cumulative Counts)||5||
48248344|NCT02123797|100927409|FG000|NOT COMPLETED|6-month Follow up (Cumulative Counts)||55||
48248345|NCT02123797|100927410|FG001|NOT COMPLETED|6-month Follow up (Cumulative Counts)||128||
48248346|NCT02123797|100927411|FG002|NOT COMPLETED|6-month Follow up (Cumulative Counts)||66||
48248347|NCT02123797|100927412|FG003|NOT COMPLETED|6-month Follow up (Cumulative Counts)||113||
48248348|NCT02123797|100927413|FG004|NOT COMPLETED|6-month Follow up (Cumulative Counts)||3||
48248349|NCT03334747|100927414|FG000|STARTED|Treatment Phase||10|Randomized set (RAN)|
48248350|NCT03334747|100927415|FG001|STARTED|Treatment Phase||10|Randomized set (RAN)|
48085364|NCT02034110|100528946|FG000|Expansion Cohort|Overall Study||21||
48085365|NCT02034110|100528947|FG001|Expansion Cohort|Overall Study||25||
48085366|NCT02034110|100528948|FG002|Expansion Cohort|Overall Study||0||
48085367|NCT02034110|100528949|FG003|Expansion Cohort|Overall Study||0||
48085368|NCT02034110|100528950|FG004|Expansion Cohort|Overall Study||21||
48085369|NCT02034110|100528951|FG005|Expansion Cohort|Overall Study||0||
48248351|NCT03334747|100927416|FG002|STARTED|Treatment Phase||12|Randomized set (RAN)|
48248352|NCT03334747|100927417|FG003|STARTED|Treatment Phase||20|Randomized set (RAN)|
48248353|NCT03334747|100927418|FG004|STARTED|Treatment Phase||22|Randomized set (RAN)|
48248354|NCT03334747|100927419|FG005|STARTED|Treatment Phase||20|Randomized set (RAN)|
48248355|NCT03334747|100927420|FG006|STARTED|Treatment Phase||21|Randomized set (RAN)|
48248356|NCT03334747|100927421|FG007|STARTED|Treatment Phase||22|Randomized set (RAN)|
48248357|NCT03334747|100927422|FG008|STARTED|Treatment Phase||51|Randomized set (RAN)|
48248358|NCT03334747|100927414|FG000|COMPLETED|Treatment Phase||9||
48540916|NCT00086281|101662597|FG011|COMPLETED|Phase 2||0||
48540917|NCT00086281|101662598|FG012|COMPLETED|Phase 2||22||
48085370|NCT02034110|100528952|FG006|Expansion Cohort|Overall Study||31||
48085371|NCT02034110|100528953|FG007|Expansion Cohort|Overall Study||0||
48085372|NCT02034110|100528946|FG000|COMPLETED|Overall Study||24||
48248359|NCT03334747|100927415|FG001|COMPLETED|Treatment Phase||10||
48248360|NCT03334747|100927416|FG002|COMPLETED|Treatment Phase||12||
48248361|NCT03334747|100927417|FG003|COMPLETED|Treatment Phase||20||
48248362|NCT03334747|100927418|FG004|COMPLETED|Treatment Phase||21||
48540918|NCT00086281|101662599|FG013|COMPLETED|Phase 2||26||
48085373|NCT02034110|100528947|FG001|COMPLETED|Overall Study||34||
48085374|NCT02034110|100528948|FG002|COMPLETED|Overall Study||1||
48085375|NCT02034110|100528949|FG003|COMPLETED|Overall Study||4||
48085376|NCT02034110|100528950|FG004|COMPLETED|Overall Study||28||
48085377|NCT02034110|100528951|FG005|COMPLETED|Overall Study||3||
48540919|NCT00086281|101662600|FG014|COMPLETED|Phase 2||0||
48085378|NCT02034110|100528952|FG006|COMPLETED|Overall Study||8||
48085379|NCT02034110|100528953|FG007|COMPLETED|Overall Study||9||
48085380|NCT02034110|100528946|FG000|NOT COMPLETED|Overall Study||12||
48085381|NCT02034110|100528947|FG001|NOT COMPLETED|Overall Study||9||
48085382|NCT02034110|100528948|FG002|NOT COMPLETED|Overall Study||0||
48085383|NCT02034110|100528949|FG003|NOT COMPLETED|Overall Study||9||
48085384|NCT02034110|100528950|FG004|NOT COMPLETED|Overall Study||17||
48085385|NCT02034110|100528951|FG005|NOT COMPLETED|Overall Study||0||
48085386|NCT02034110|100528952|FG006|NOT COMPLETED|Overall Study||47||
48085387|NCT02034110|100528953|FG007|NOT COMPLETED|Overall Study||1||
48085388|NCT03530098|100528954|FG000|STARTED|Overall Study||939||
48085389|NCT03530098|100528955|FG001|STARTED|Overall Study||964||
48085390|NCT03530098|100528954|FG000|Ground-truth Labeled|Overall Study||741|Ground-truth labeled: exam was interpreted by a panel of 4 radiologists and their interpretations were averaged to determine a final label.|
48085391|NCT03530098|100528955|FG001|Ground-truth Labeled|Overall Study||794|Ground-truth labeled: exam was interpreted by a panel of 4 radiologists and their interpretations were averaged to determine a final label.|
48085392|NCT03530098|100528954|FG000|Primary Analysis Set|Overall Study||739|Primary analysis set: Participants with ground-truth labeled exam results and no bone deformity.|
48085393|NCT03530098|100528955|FG001|Primary Analysis Set|Overall Study||792|Primary analysis set: Participants with ground-truth labeled exam results and no bone deformity.|
48085394|NCT03530098|100528954|FG000|COMPLETED|Overall Study||939||
48085395|NCT03530098|100528955|FG001|COMPLETED|Overall Study||964||
48085396|NCT03530098|100528954|FG000|NOT COMPLETED|Overall Study||0||
48085397|NCT03530098|100528955|FG001|NOT COMPLETED|Overall Study||0||
48085398|NCT00387023|100528956|FG000|STARTED|Overall Study||12||
48085399|NCT00387023|100528956|FG000|COMPLETED|Overall Study||12||
48085400|NCT00387023|100528956|FG000|NOT COMPLETED|Overall Study||0||
48248363|NCT03334747|100927419|FG005|COMPLETED|Treatment Phase||19||
48248364|NCT03334747|100927420|FG006|COMPLETED|Treatment Phase||21||
48248365|NCT03334747|100927421|FG007|COMPLETED|Treatment Phase||22||
48248366|NCT03334747|100927422|FG008|COMPLETED|Treatment Phase||51||
48248367|NCT03334747|100927414|FG000|NOT COMPLETED|Treatment Phase||1||
48248368|NCT03334747|100927415|FG001|NOT COMPLETED|Treatment Phase||0||
48248369|NCT03334747|100927416|FG002|NOT COMPLETED|Treatment Phase||0||
48248370|NCT03334747|100927417|FG003|NOT COMPLETED|Treatment Phase||0||
48248371|NCT03334747|100927418|FG004|NOT COMPLETED|Treatment Phase||1||
48248372|NCT03334747|100927419|FG005|NOT COMPLETED|Treatment Phase||1||
48248373|NCT03334747|100927420|FG006|NOT COMPLETED|Treatment Phase||0||
48540920|NCT00086281|101662586|FG000|NOT COMPLETED|Phase 2||0||
48085401|NCT00964860|100528957|FG000|STARTED|Overall Study||30||
48085402|NCT00964860|100528958|FG001|STARTED|Overall Study||30||
48248374|NCT03334747|100927421|FG007|NOT COMPLETED|Treatment Phase||0||
48248375|NCT03334747|100927422|FG008|NOT COMPLETED|Treatment Phase||0||
48248376|NCT03334747|100927414|FG000|STARTED|Follow-Up Phase||9||
48248377|NCT03334747|100927415|FG001|STARTED|Follow-Up Phase||10||
48248378|NCT03334747|100927416|FG002|STARTED|Follow-Up Phase||12||
48248379|NCT03334747|100927417|FG003|STARTED|Follow-Up Phase||20||
48248380|NCT03334747|100927418|FG004|STARTED|Follow-Up Phase||21||
48248381|NCT03334747|100927419|FG005|STARTED|Follow-Up Phase||19||
48248382|NCT03334747|100927420|FG006|STARTED|Follow-Up Phase||21||
48248383|NCT03334747|100927421|FG007|STARTED|Follow-Up Phase||22||
48248384|NCT03334747|100927422|FG008|STARTED|Follow-Up Phase||51||
48248385|NCT03334747|100927414|FG000|COMPLETED|Follow-Up Phase||9||
48085403|NCT00964860|100528957|FG000|COMPLETED|Overall Study||30||
48085404|NCT00964860|100528958|FG001|COMPLETED|Overall Study||29||
48085405|NCT00964860|100528957|FG000|NOT COMPLETED|Overall Study||0||
48085406|NCT00964860|100528958|FG001|NOT COMPLETED|Overall Study||1||
48085407|NCT00171730|100528959|FG000|STARTED|Overall Study||30||
48085408|NCT00171730|100528959|FG000|COMPLETED|Overall Study||15||
48248386|NCT03334747|100927415|FG001|COMPLETED|Follow-Up Phase||10||
48248387|NCT03334747|100927416|FG002|COMPLETED|Follow-Up Phase||12||
48248388|NCT03334747|100927417|FG003|COMPLETED|Follow-Up Phase||20||
48248389|NCT03334747|100927418|FG004|COMPLETED|Follow-Up Phase||21||
48248390|NCT03334747|100927419|FG005|COMPLETED|Follow-Up Phase||19||
48248391|NCT03334747|100927420|FG006|COMPLETED|Follow-Up Phase||20||
48248392|NCT03334747|100927421|FG007|COMPLETED|Follow-Up Phase||22||
48248393|NCT03334747|100927422|FG008|COMPLETED|Follow-Up Phase||50||
48248394|NCT03334747|100927414|FG000|NOT COMPLETED|Follow-Up Phase||0||
48248395|NCT03334747|100927415|FG001|NOT COMPLETED|Follow-Up Phase||0||
48248396|NCT03334747|100927416|FG002|NOT COMPLETED|Follow-Up Phase||0||
48248397|NCT03334747|100927417|FG003|NOT COMPLETED|Follow-Up Phase||0||
48248398|NCT03334747|100927418|FG004|NOT COMPLETED|Follow-Up Phase||0||
48248399|NCT03334747|100927419|FG005|NOT COMPLETED|Follow-Up Phase||0||
48248400|NCT03334747|100927420|FG006|NOT COMPLETED|Follow-Up Phase||1||
48248401|NCT03334747|100927421|FG007|NOT COMPLETED|Follow-Up Phase||0||
48248402|NCT03334747|100927422|FG008|NOT COMPLETED|Follow-Up Phase||1||
48085409|NCT00171730|100528959|FG000|NOT COMPLETED|Overall Study||15||
48085410|NCT01906008|100528960|FG000|STARTED|Overall Study||59||
48085411|NCT01906008|100528961|FG001|STARTED|Overall Study||61||
48085412|NCT01906008|100528960|FG000|COMPLETED|Overall Study||32||
48085413|NCT01906008|100528961|FG001|COMPLETED|Overall Study||34||
48085414|NCT01906008|100528960|FG000|NOT COMPLETED|Overall Study||27||
48085415|NCT01906008|100528961|FG001|NOT COMPLETED|Overall Study||27||
48085416|NCT02418026|100528962|FG000|STARTED|Overall Study||44||
48085417|NCT02418026|100528963|FG001|STARTED|Overall Study||35||
48085418|NCT02418026|100528962|FG000|COMPLETED|Overall Study||44||
48085419|NCT02418026|100528963|FG001|COMPLETED|Overall Study||35||
48085420|NCT02418026|100528962|FG000|NOT COMPLETED|Overall Study||0||
48085421|NCT02418026|100528963|FG001|NOT COMPLETED|Overall Study||0||
48085422|NCT00673465|100528964|FG000|STARTED|Part 1/Period 1 (United States)||3||
48085423|NCT00673465|100528965|FG001|STARTED|Part 1/Period 1 (United States)||3||
48085424|NCT00673465|100528966|FG002|STARTED|Part 1/Period 1 (United States)||3||
48085425|NCT00673465|100528967|FG003|STARTED|Part 1/Period 1 (United States)||3||
48085426|NCT00673465|100528968|FG004|STARTED|Part 1/Period 1 (United States)||3||
48248403|NCT01271036|100927423|FG000|STARTED|Overall Study||62||
48248404|NCT01271036|100927424|FG001|STARTED|Overall Study||62||
48248405|NCT01271036|100927423|FG000|COMPLETED|Overall Study||62||
48248406|NCT01271036|100927424|FG001|COMPLETED|Overall Study||62||
48248407|NCT01271036|100927423|FG000|NOT COMPLETED|Overall Study||0||
48248408|NCT01271036|100927424|FG001|NOT COMPLETED|Overall Study||0||
48248409|NCT02229396|100927425|FG000|STARTED|Overall Study||233||
48248410|NCT02229396|100927426|FG001|STARTED|Overall Study||231||
48248411|NCT02229396|100927427|FG002|STARTED|Overall Study||231||
48248412|NCT02229396|100927425|FG000|Randomization Code Allocated|Overall Study||233||
48248413|NCT02229396|100927426|FG001|Randomization Code Allocated|Overall Study||231||
48248414|NCT02229396|100927427|FG002|Randomization Code Allocated|Overall Study||231||
48248415|NCT02229396|100927425|FG000|Safety Analysis Set|Overall Study||233||
48248416|NCT02229396|100927426|FG001|Safety Analysis Set|Overall Study||231||
48248417|NCT02229396|100927427|FG002|Safety Analysis Set|Overall Study||230||
48248418|NCT02229396|100927425|FG000|Intent-to-Treat (ITT) Analysis Set|Overall Study||230||
48248419|NCT02229396|100927426|FG001|Intent-to-Treat (ITT) Analysis Set|Overall Study||228||
48248420|NCT02229396|100927427|FG002|Intent-to-Treat (ITT) Analysis Set|Overall Study||227||
48248421|NCT02229396|100927425|FG000|Completed 28-Week Study Period|Overall Study||208||
48248422|NCT02229396|100927426|FG001|Completed 28-Week Study Period|Overall Study||202||
48248423|NCT02229396|100927427|FG002|Completed 28-Week Study Period|Overall Study||193||
48248424|NCT02229396|100927425|FG000|Completed 52-Week Study Period|Overall Study||194||
48248425|NCT02229396|100927426|FG001|Completed 52-Week Study Period|Overall Study||193||
48085427|NCT00673465|100528969|FG005|STARTED|Part 1/Period 1 (United States)||2||
48085428|NCT00673465|100528970|FG006|STARTED|Part 1/Period 1 (United States)||0||
48085429|NCT00673465|100528971|FG007|STARTED|Part 1/Period 1 (United States)||0||
48085430|NCT00673465|100528972|FG008|STARTED|Part 1/Period 1 (United States)||0||
48085431|NCT00673465|100528973|FG009|STARTED|Part 1/Period 1 (United States)||0||
48682916|NCT01440764|102006714|FG005|STARTED|Test Day 3||5||
48682917|NCT01440764|102006715|FG006|STARTED|Test Day 3||3||
48682918|NCT01440764|102006709|FG000|COMPLETED|Test Day 3||3||
48682919|NCT01440764|102006710|FG001|COMPLETED|Test Day 3||2||
48682920|NCT01440764|102006711|FG002|COMPLETED|Test Day 3||6||
48085432|NCT00673465|100528974|FG010|STARTED|Part 1/Period 1 (United States)||0||
48085433|NCT00673465|100528975|FG011|STARTED|Part 1/Period 1 (United States)||0||
48085434|NCT00673465|100528964|FG000|COMPLETED|Part 1/Period 1 (United States)||3||
48085435|NCT00673465|100528965|FG001|COMPLETED|Part 1/Period 1 (United States)||3||
48682921|NCT01440764|102006712|FG003|COMPLETED|Test Day 3||1||
48682922|NCT01440764|102006713|FG004|COMPLETED|Test Day 3||3||
48682923|NCT01440764|102006714|FG005|COMPLETED|Test Day 3||5||
48682924|NCT01440764|102006715|FG006|COMPLETED|Test Day 3||3||
48682925|NCT01440764|102006709|FG000|NOT COMPLETED|Test Day 3||0||
48682926|NCT01440764|102006710|FG001|NOT COMPLETED|Test Day 3||0||
48682927|NCT01440764|102006711|FG002|NOT COMPLETED|Test Day 3||0||
48682928|NCT01440764|102006712|FG003|NOT COMPLETED|Test Day 3||0||
48682929|NCT01440764|102006713|FG004|NOT COMPLETED|Test Day 3||0||
48682930|NCT01440764|102006714|FG005|NOT COMPLETED|Test Day 3||0||
48682931|NCT01440764|102006715|FG006|NOT COMPLETED|Test Day 3||0||
48682932|NCT02098304|102006716|FG000|STARTED|Overall Study||42||
48682933|NCT02098304|102006716|FG000|COMPLETED|Overall Study||42||
48682934|NCT02098304|102006716|FG000|NOT COMPLETED|Overall Study||0||
48682935|NCT01490918|102006717|FG000|STARTED|Overall Study||65||
48682936|NCT01490918|102006718|FG001|STARTED|Overall Study||66||
48682937|NCT01490918|102006719|FG002|STARTED|Overall Study||34||
48682938|NCT01490918|102006717|FG000|COMPLETED|Overall Study||52||
48682939|NCT01490918|102006718|FG001|COMPLETED|Overall Study||52||
48682940|NCT01490918|102006719|FG002|COMPLETED|Overall Study||22||
48682941|NCT01490918|102006717|FG000|NOT COMPLETED|Overall Study||13||
48682942|NCT01490918|102006718|FG001|NOT COMPLETED|Overall Study||14||
48682943|NCT01490918|102006719|FG002|NOT COMPLETED|Overall Study||12||
48682944|NCT01908140|102006720|FG000|STARTED|Overall Study||468||
48682945|NCT01908140|102006721|FG001|STARTED|Overall Study||465||
48682946|NCT01908140|102006720|FG000|COMPLETED|Overall Study||402||
48682947|NCT01908140|102006721|FG001|COMPLETED|Overall Study||386||
48085436|NCT00673465|100528966|FG002|COMPLETED|Part 1/Period 1 (United States)||3||
48085437|NCT00673465|100528967|FG003|COMPLETED|Part 1/Period 1 (United States)||3||
48085438|NCT00673465|100528968|FG004|COMPLETED|Part 1/Period 1 (United States)||2||
48085439|NCT00673465|100528969|FG005|COMPLETED|Part 1/Period 1 (United States)||1||
48085440|NCT00673465|100528970|FG006|COMPLETED|Part 1/Period 1 (United States)||0||
48085441|NCT00673465|100528971|FG007|COMPLETED|Part 1/Period 1 (United States)||0||
48085442|NCT00673465|100528972|FG008|COMPLETED|Part 1/Period 1 (United States)||0||
48085443|NCT00673465|100528973|FG009|COMPLETED|Part 1/Period 1 (United States)||0||
48682948|NCT01908140|102006720|FG000|NOT COMPLETED|Overall Study||66||
48682949|NCT01908140|102006721|FG001|NOT COMPLETED|Overall Study||79||
48682950|NCT00616642|102006722|FG000|STARTED|Overall Study||0||
48682951|NCT00616642|102006723|FG001|STARTED|Overall Study||1||
48682952|NCT00616642|102006722|FG000|COMPLETED|Overall Study||0||
48682953|NCT00616642|102006723|FG001|COMPLETED|Overall Study||0||
48682954|NCT00616642|102006722|FG000|NOT COMPLETED|Overall Study||0||
48682955|NCT00616642|102006723|FG001|NOT COMPLETED|Overall Study||1||
48682956|NCT03801928|102006724|FG000|STARTED|Overall Study||18||
48682957|NCT03801928|102006725|FG001|STARTED|Overall Study||21||
48682958|NCT03801928|102006726|FG002|STARTED|Overall Study||9||
48682959|NCT03801928|102006727|FG003|STARTED|Overall Study||21||
48682960|NCT03801928|102006728|FG004|STARTED|Overall Study||36||
48682961|NCT03801928|102006729|FG005|STARTED|Overall Study||10||
48682962|NCT03801928|102006724|FG000|COMPLETED|Overall Study||12||
48682963|NCT03801928|102006725|FG001|COMPLETED|Overall Study||18||
48682964|NCT03801928|102006726|FG002|COMPLETED|Overall Study||4||
48682965|NCT03801928|102006727|FG003|COMPLETED|Overall Study||13||
48682966|NCT03801928|102006728|FG004|COMPLETED|Overall Study||32||
48682967|NCT03801928|102006729|FG005|COMPLETED|Overall Study||5||
48682968|NCT03801928|102006724|FG000|NOT COMPLETED|Overall Study||6||
48682969|NCT03801928|102006725|FG001|NOT COMPLETED|Overall Study||3||
48682970|NCT03801928|102006726|FG002|NOT COMPLETED|Overall Study||5||
48682971|NCT03801928|102006727|FG003|NOT COMPLETED|Overall Study||8||
48682972|NCT03801928|102006728|FG004|NOT COMPLETED|Overall Study||4||
48682973|NCT03801928|102006729|FG005|NOT COMPLETED|Overall Study||5||
48682974|NCT01339936|102006730|FG000|STARTED|Overall Study||38||
48682975|NCT01339936|102006730|FG000|COMPLETED|Overall Study||36||
48682976|NCT01339936|102006730|FG000|NOT COMPLETED|Overall Study||2||
48682977|NCT04389866|102006731|FG000|STARTED|Overall Study||8||
48682978|NCT04389866|102006732|FG001|STARTED|Overall Study||8||
48682979|NCT04389866|102006731|FG000|COMPLETED|Overall Study||7||
48682980|NCT04389866|102006732|FG001|COMPLETED|Overall Study||7||
48682981|NCT04389866|102006731|FG000|NOT COMPLETED|Overall Study||1||
48682982|NCT04389866|102006732|FG001|NOT COMPLETED|Overall Study||1||
48682983|NCT04846231|102006733|FG000|STARTED|Overall Study||25||
48682984|NCT04846231|102006734|FG001|STARTED|Overall Study||25||
48682985|NCT04846231|102006735|FG002|STARTED|Overall Study||24||
48682986|NCT04846231|102006736|FG003|STARTED|Overall Study||25||
48682987|NCT04846231|102006737|FG004|STARTED|Overall Study||25||
48682988|NCT04846231|102006738|FG005|STARTED|Overall Study||25||
48085444|NCT00673465|100528974|FG010|COMPLETED|Part 1/Period 1 (United States)||0||
48085445|NCT00673465|100528975|FG011|COMPLETED|Part 1/Period 1 (United States)||0||
48085446|NCT00673465|100528964|FG000|NOT COMPLETED|Part 1/Period 1 (United States)||0||
48085447|NCT00673465|100528965|FG001|NOT COMPLETED|Part 1/Period 1 (United States)||0||
48085448|NCT00673465|100528966|FG002|NOT COMPLETED|Part 1/Period 1 (United States)||0||
48085449|NCT00673465|100528967|FG003|NOT COMPLETED|Part 1/Period 1 (United States)||0||
48248426|NCT02229396|100927427|FG002|Completed 52-Week Study Period|Overall Study||177||
48248427|NCT02229396|100927425|FG000|COMPLETED|Overall Study||155|Completed 104-Week Study Period|
48248428|NCT02229396|100927426|FG001|COMPLETED|Overall Study||154|Completed 104-Week Study Period|
48248429|NCT02229396|100927427|FG002|COMPLETED|Overall Study||136|Completed 104-Week Study Period|
48248430|NCT02229396|100927425|FG000|NOT COMPLETED|Overall Study||78||
48248431|NCT02229396|100927426|FG001|NOT COMPLETED|Overall Study||77||
48248432|NCT02229396|100927427|FG002|NOT COMPLETED|Overall Study||95||
48248433|NCT01703988|100927428|FG000|STARTED|Overall Study||8||
48248434|NCT01703988|100927429|FG001|STARTED|Overall Study||8||
48248435|NCT01703988|100927430|FG002|STARTED|Overall Study||9||
48248436|NCT01703988|100927431|FG003|STARTED|Overall Study||9||
48248437|NCT01703988|100927428|FG000|COMPLETED|Overall Study||8||
48248438|NCT01703988|100927429|FG001|COMPLETED|Overall Study||8||
48248439|NCT01703988|100927430|FG002|COMPLETED|Overall Study||9||
48248440|NCT01703988|100927431|FG003|COMPLETED|Overall Study||8||
48248441|NCT01703988|100927428|FG000|NOT COMPLETED|Overall Study||0||
48248442|NCT01703988|100927429|FG001|NOT COMPLETED|Overall Study||0||
48248443|NCT01703988|100927430|FG002|NOT COMPLETED|Overall Study||0||
48248444|NCT01703988|100927431|FG003|NOT COMPLETED|Overall Study||1||
48540921|NCT00086281|101662587|FG001|NOT COMPLETED|Phase 2||0||
48540922|NCT00086281|101662588|FG002|NOT COMPLETED|Phase 2||0||
48540923|NCT00086281|101662589|FG003|NOT COMPLETED|Phase 2||0||
48540924|NCT00086281|101662590|FG004|NOT COMPLETED|Phase 2||0||
48540925|NCT00086281|101662591|FG005|NOT COMPLETED|Phase 2||0||
48540926|NCT00086281|101662592|FG006|NOT COMPLETED|Phase 2||0||
48540927|NCT00086281|101662593|FG007|NOT COMPLETED|Phase 2||0||
48540928|NCT00086281|101662594|FG008|NOT COMPLETED|Phase 2||0||
48540929|NCT00086281|101662595|FG009|NOT COMPLETED|Phase 2||0||
48540930|NCT00086281|101662596|FG010|NOT COMPLETED|Phase 2||0||
48540931|NCT00086281|101662597|FG011|NOT COMPLETED|Phase 2||0||
48540932|NCT00086281|101662598|FG012|NOT COMPLETED|Phase 2||1||
48540933|NCT00086281|101662599|FG013|NOT COMPLETED|Phase 2||1||
48540934|NCT00086281|101662600|FG014|NOT COMPLETED|Phase 2||0||
48540935|NCT00627861|101662601|FG000|STARTED|Overall Study||1||
48540936|NCT00627861|101662601|FG000|COMPLETED|Overall Study||1||
48540937|NCT00627861|101662601|FG000|NOT COMPLETED|Overall Study||0||
48540938|NCT05204082|101662602|FG000|STARTED|Overall Study||84||
48540939|NCT05204082|101662603|FG001|STARTED|Overall Study||85||
48540940|NCT05204082|101662602|FG000|COMPLETED|Overall Study||84||
48540941|NCT05204082|101662603|FG001|COMPLETED|Overall Study||85||
48682989|NCT04846231|102006739|FG006|STARTED|Overall Study||25||
48682990|NCT04846231|102006740|FG007|STARTED|Overall Study||25||
48085450|NCT00673465|100528968|FG004|NOT COMPLETED|Part 1/Period 1 (United States)||1||
48085451|NCT00673465|100528969|FG005|NOT COMPLETED|Part 1/Period 1 (United States)||1||
48085452|NCT00673465|100528970|FG006|NOT COMPLETED|Part 1/Period 1 (United States)||0||
48248445|NCT02661490|100927432|FG000|STARTED|Overall Study||76||
48248446|NCT02661490|100927433|FG001|STARTED|Overall Study||74||
48248447|NCT02661490|100927434|FG002|STARTED|Overall Study||72||
48248448|NCT02661490|100927435|FG003|STARTED|Overall Study||72||
48248449|NCT02661490|100927436|FG004|STARTED|Overall Study||26||
48248450|NCT02661490|100927432|FG000|COMPLETED|Overall Study||73||
48085453|NCT00673465|100528971|FG007|NOT COMPLETED|Part 1/Period 1 (United States)||0||
48085454|NCT00673465|100528972|FG008|NOT COMPLETED|Part 1/Period 1 (United States)||0||
48085455|NCT00673465|100528973|FG009|NOT COMPLETED|Part 1/Period 1 (United States)||0||
48085456|NCT00673465|100528974|FG010|NOT COMPLETED|Part 1/Period 1 (United States)||0||
48085457|NCT00673465|100528975|FG011|NOT COMPLETED|Part 1/Period 1 (United States)||0||
48248451|NCT02661490|100927433|FG001|COMPLETED|Overall Study||72||
48248452|NCT02661490|100927434|FG002|COMPLETED|Overall Study||70||
48248453|NCT02661490|100927435|FG003|COMPLETED|Overall Study||71||
48248454|NCT02661490|100927436|FG004|COMPLETED|Overall Study||23||
48248455|NCT02661490|100927432|FG000|NOT COMPLETED|Overall Study||3||
48375491|NCT03350750|101247648|FG000|12-Month Follow-up (Entire Study)|Overall Study||8||
48248456|NCT02661490|100927433|FG001|NOT COMPLETED|Overall Study||2||
48248457|NCT02661490|100927434|FG002|NOT COMPLETED|Overall Study||2||
48248458|NCT02661490|100927435|FG003|NOT COMPLETED|Overall Study||1||
48248459|NCT02661490|100927436|FG004|NOT COMPLETED|Overall Study||3||
48248460|NCT04167085|100927437|FG000|STARTED|Baseline||13||
48248461|NCT04167085|100927438|FG001|STARTED|Baseline||13||
48375492|NCT03350750|101247649|FG001|12-Month Follow-up (Entire Study)|Overall Study||8||
48540942|NCT05204082|101662602|FG000|NOT COMPLETED|Overall Study||0||
48540943|NCT05204082|101662603|FG001|NOT COMPLETED|Overall Study||0||
48540944|NCT01520870|101662604|FG000|STARTED|Overall Study||49||
48540945|NCT01520870|101662604|FG000|COMPLETED|Overall Study||47||
48540946|NCT01520870|101662604|FG000|NOT COMPLETED|Overall Study||2||
48540947|NCT01900561|101662605|FG000|STARTED|Overall Study||278||
48682991|NCT04846231|102006733|FG000|COMPLETED|Overall Study||24||
48248462|NCT04167085|100927437|FG000|Day 1|Baseline||12||
48248463|NCT04167085|100927438|FG001|Day 1|Baseline||12||
48248464|NCT04167085|100927437|FG000|COMPLETED|Baseline||11||
48248465|NCT04167085|100927438|FG001|COMPLETED|Baseline||12||
48248466|NCT04167085|100927437|FG000|NOT COMPLETED|Baseline||2||
48248467|NCT04167085|100927438|FG001|NOT COMPLETED|Baseline||1||
48248468|NCT04167085|100927437|FG000|STARTED|First Intervention (2 Months)||11||
48248469|NCT04167085|100927438|FG001|STARTED|First Intervention (2 Months)||12||
48248470|NCT04167085|100927437|FG000|COMPLETED|First Intervention (2 Months)||11||
48248471|NCT04167085|100927438|FG001|COMPLETED|First Intervention (2 Months)||12||
48248472|NCT04167085|100927437|FG000|NOT COMPLETED|First Intervention (2 Months)||0||
48248473|NCT04167085|100927438|FG001|NOT COMPLETED|First Intervention (2 Months)||0||
48248474|NCT04167085|100927437|FG000|STARTED|Washout (1 Month)||11||
48248475|NCT04167085|100927438|FG001|STARTED|Washout (1 Month)||12||
48248476|NCT04167085|100927437|FG000|COMPLETED|Washout (1 Month)||10||
48248477|NCT04167085|100927438|FG001|COMPLETED|Washout (1 Month)||12||
48248478|NCT04167085|100927437|FG000|NOT COMPLETED|Washout (1 Month)||1||
48248479|NCT04167085|100927438|FG001|NOT COMPLETED|Washout (1 Month)||0||
48248480|NCT04167085|100927437|FG000|STARTED|Second Intervention (2 Months)||10||
48248481|NCT04167085|100927438|FG001|STARTED|Second Intervention (2 Months)||12||
48248482|NCT04167085|100927437|FG000|COMPLETED|Second Intervention (2 Months)||10||
48248483|NCT04167085|100927438|FG001|COMPLETED|Second Intervention (2 Months)||12||
48248484|NCT04167085|100927437|FG000|NOT COMPLETED|Second Intervention (2 Months)||0||
48248485|NCT04167085|100927438|FG001|NOT COMPLETED|Second Intervention (2 Months)||0||
48248486|NCT04167085|100927437|FG000|STARTED|Washout (1 Month)||10||
48248487|NCT04167085|100927438|FG001|STARTED|Washout (1 Month)||12||
48248488|NCT04167085|100927437|FG000|COMPLETED|Washout (1 Month)||10||
48248489|NCT04167085|100927438|FG001|COMPLETED|Washout (1 Month)||12||
48248490|NCT04167085|100927437|FG000|NOT COMPLETED|Washout (1 Month)||0||
48248491|NCT04167085|100927438|FG001|NOT COMPLETED|Washout (1 Month)||0||
48248492|NCT02515097|100927439|FG000|STARTED|Overall Study||142||
48248493|NCT02515097|100927440|FG001|STARTED|Overall Study||71||
48248494|NCT02515097|100927439|FG000|Intent-to-Treat (ITT) Population|Overall Study||142|Participants who were randomized and dispensed study drug.|
48248495|NCT02515097|100927440|FG001|Intent-to-Treat (ITT) Population|Overall Study||71|Participants who were randomized and dispensed study drug.|
48248496|NCT02515097|100927439|FG000|Safety Population|Overall Study||142|Randomized participants with ≥1 confirmed dose of study drug and ≥1 post-Baseline safety assessment.|
48248497|NCT02515097|100927440|FG001|Safety Population|Overall Study||70|Randomized participants with ≥1 confirmed dose of study drug and ≥1 post-Baseline safety assessment.|
48248498|NCT02515097|100927439|FG000|COMPLETED|Overall Study||135||
48248499|NCT02515097|100927440|FG001|COMPLETED|Overall Study||65||
48248500|NCT02515097|100927439|FG000|NOT COMPLETED|Overall Study||7||
48375493|NCT03350750|101247648|FG000|COMPLETED|Overall Study||8||
48682992|NCT04846231|102006734|FG001|COMPLETED|Overall Study||23||
48248501|NCT02515097|100927440|FG001|NOT COMPLETED|Overall Study||6||
48248502|NCT03303521|100927441|FG000|STARTED|Overall Study||97||
48248503|NCT03303521|100927442|FG001|STARTED|Overall Study||99||
48248504|NCT03303521|100927441|FG000|COMPLETED|Overall Study||92||
48248505|NCT03303521|100927442|FG001|COMPLETED|Overall Study||96||
48248506|NCT03303521|100927441|FG000|NOT COMPLETED|Overall Study||5||
48248507|NCT03303521|100927442|FG001|NOT COMPLETED|Overall Study||3||
48248508|NCT01906658|100927443|FG000|STARTED|Overall Study||11||
48248509|NCT01906658|100927444|FG001|STARTED|Overall Study||11||
48682993|NCT04846231|102006735|FG002|COMPLETED|Overall Study||22||
48682994|NCT04846231|102006736|FG003|COMPLETED|Overall Study||24||
48248510|NCT01906658|100927445|FG002|STARTED|Overall Study||10||
48248511|NCT01906658|100927446|FG003|STARTED|Overall Study||11||
48248512|NCT01906658|100927443|FG000|COMPLETED|Overall Study||9||
48248513|NCT01906658|100927444|FG001|COMPLETED|Overall Study||10||
48248514|NCT01906658|100927445|FG002|COMPLETED|Overall Study||7||
48248515|NCT01906658|100927446|FG003|COMPLETED|Overall Study||11||
48248516|NCT01906658|100927443|FG000|NOT COMPLETED|Overall Study||2||
48248517|NCT01906658|100927444|FG001|NOT COMPLETED|Overall Study||1||
48248518|NCT01906658|100927445|FG002|NOT COMPLETED|Overall Study||3||
48248519|NCT01906658|100927446|FG003|NOT COMPLETED|Overall Study||0||
48248520|NCT02598934|100927447|FG000|STARTED|Overall Study||154||
48248521|NCT02598934|100927448|FG001|STARTED|Overall Study||154||
48248522|NCT02598934|100927447|FG000|COMPLETED|Overall Study||135||
48248523|NCT02598934|100927448|FG001|COMPLETED|Overall Study||132||
48248524|NCT02598934|100927447|FG000|NOT COMPLETED|Overall Study||19||
48248525|NCT02598934|100927448|FG001|NOT COMPLETED|Overall Study||22||
48248526|NCT02161185|100927449|FG000|STARTED|Test Dose Phase||7||
48248527|NCT02161185|100927449|FG000|COMPLETED|Test Dose Phase||7||
48248528|NCT02161185|100927449|FG000|NOT COMPLETED|Test Dose Phase||0||
48248529|NCT02161185|100927449|FG000|STARTED|Treatment Phase||7|6 of the 7 participants who entered Treatment Phase treated at least one seizure cluster|
48248530|NCT02161185|100927449|FG000|COMPLETED|Treatment Phase||0|Study discontinued due to poor enrollment|
48248531|NCT02161185|100927449|FG000|NOT COMPLETED|Treatment Phase||7||
48682995|NCT04846231|102006737|FG004|COMPLETED|Overall Study||25||
48682996|NCT04846231|102006738|FG005|COMPLETED|Overall Study||25||
48682997|NCT04846231|102006739|FG006|COMPLETED|Overall Study||24||
48682998|NCT04846231|102006740|FG007|COMPLETED|Overall Study||23||
48682999|NCT04846231|102006733|FG000|NOT COMPLETED|Overall Study||1||
48683000|NCT04846231|102006734|FG001|NOT COMPLETED|Overall Study||2||
48683001|NCT04846231|102006735|FG002|NOT COMPLETED|Overall Study||2||
48683002|NCT04846231|102006736|FG003|NOT COMPLETED|Overall Study||1||
48683003|NCT04846231|102006737|FG004|NOT COMPLETED|Overall Study||0||
48683004|NCT04846231|102006738|FG005|NOT COMPLETED|Overall Study||0||
48683005|NCT04846231|102006739|FG006|NOT COMPLETED|Overall Study||1||
48683006|NCT04846231|102006740|FG007|NOT COMPLETED|Overall Study||2||
48683007|NCT01182298|102006741|FG000|STARTED|Overall Study||10||
48683008|NCT01182298|102006741|FG000|COMPLETED|Overall Study||4||
48248532|NCT01100268|100927450|FG000|STARTED|Overall Study||4||
48248533|NCT01100268|100927450|FG000|COMPLETED|Overall Study||4||
48248534|NCT01100268|100927450|FG000|NOT COMPLETED|Overall Study||0||
48248535|NCT00529555|100927451|FG000|STARTED|Overall Study||200||
48248536|NCT00529555|100927452|FG001|STARTED|Overall Study||202||
48248537|NCT00529555|100927453|FG002|STARTED|Overall Study||200||
48248538|NCT00529555|100927451|FG000|COMPLETED|Overall Study||171||
48248539|NCT00529555|100927452|FG001|COMPLETED|Overall Study||172||
48248540|NCT00529555|100927453|FG002|COMPLETED|Overall Study||174||
48248541|NCT00529555|100927451|FG000|NOT COMPLETED|Overall Study||29||
48248542|NCT00529555|100927452|FG001|NOT COMPLETED|Overall Study||30||
48248543|NCT00529555|100927453|FG002|NOT COMPLETED|Overall Study||26||
48248544|NCT02809677|100927454|FG000|STARTED|Overall Study||205||
48248545|NCT02809677|100927454|FG000|COMPLETED|Overall Study||197||
48248546|NCT02809677|100927454|FG000|NOT COMPLETED|Overall Study||8||
48248547|NCT00410423|100927455|FG000|STARTED|Phase 1 - Dose Level 1||3||
48248548|NCT00410423|100927456|FG001|STARTED|Phase 1 - Dose Level 1||0||
48248549|NCT00410423|100927457|FG002|STARTED|Phase 1 - Dose Level 1||0||
48248550|NCT00410423|100927458|FG003|STARTED|Phase 1 - Dose Level 1||0||
48248551|NCT00410423|100927455|FG000|COMPLETED|Phase 1 - Dose Level 1||3||
48248552|NCT00410423|100927456|FG001|COMPLETED|Phase 1 - Dose Level 1||0||
48248553|NCT00410423|100927457|FG002|COMPLETED|Phase 1 - Dose Level 1||0||
48248554|NCT00410423|100927458|FG003|COMPLETED|Phase 1 - Dose Level 1||0||
48683009|NCT01182298|102006741|FG000|NOT COMPLETED|Overall Study||6||
48683010|NCT00374595|102006742|FG000|STARTED|Overall Study||338||
48683011|NCT00374595|102006742|FG000|COMPLETED|Overall Study||268||
48683012|NCT00374595|102006742|FG000|NOT COMPLETED|Overall Study||70||
48683013|NCT04339413|102006743|FG000|STARTED|Overall Study||59||
48683014|NCT04339413|102006744|FG001|STARTED|Overall Study||57||
48248555|NCT00410423|100927455|FG000|NOT COMPLETED|Phase 1 - Dose Level 1||0||
48248556|NCT00410423|100927456|FG001|NOT COMPLETED|Phase 1 - Dose Level 1||0||
48248557|NCT00410423|100927457|FG002|NOT COMPLETED|Phase 1 - Dose Level 1||0||
48248558|NCT00410423|100927458|FG003|NOT COMPLETED|Phase 1 - Dose Level 1||0||
48248559|NCT00410423|100927455|FG000|STARTED|Phase 1 - Dose Level 2||0||
48248560|NCT00410423|100927456|FG001|STARTED|Phase 1 - Dose Level 2||5||
48248561|NCT00410423|100927457|FG002|STARTED|Phase 1 - Dose Level 2||0||
48248562|NCT00410423|100927458|FG003|STARTED|Phase 1 - Dose Level 2||0||
48248563|NCT00410423|100927455|FG000|COMPLETED|Phase 1 - Dose Level 2||0||
48248564|NCT00410423|100927456|FG001|COMPLETED|Phase 1 - Dose Level 2||5||
48248565|NCT00410423|100927457|FG002|COMPLETED|Phase 1 - Dose Level 2||0||
48248566|NCT00410423|100927458|FG003|COMPLETED|Phase 1 - Dose Level 2||0||
48248567|NCT00410423|100927455|FG000|NOT COMPLETED|Phase 1 - Dose Level 2||0||
48248568|NCT00410423|100927456|FG001|NOT COMPLETED|Phase 1 - Dose Level 2||0||
48248569|NCT00410423|100927457|FG002|NOT COMPLETED|Phase 1 - Dose Level 2||0||
48248570|NCT00410423|100927458|FG003|NOT COMPLETED|Phase 1 - Dose Level 2||0||
48248571|NCT00410423|100927455|FG000|STARTED|Phase 1 - Dose Level 3||0||
48248572|NCT00410423|100927456|FG001|STARTED|Phase 1 - Dose Level 3||0||
48248573|NCT00410423|100927457|FG002|STARTED|Phase 1 - Dose Level 3||3||
48248574|NCT00410423|100927458|FG003|STARTED|Phase 1 - Dose Level 3||0||
48248575|NCT00410423|100927455|FG000|COMPLETED|Phase 1 - Dose Level 3||0||
48248576|NCT00410423|100927456|FG001|COMPLETED|Phase 1 - Dose Level 3||0||
48248577|NCT00410423|100927457|FG002|COMPLETED|Phase 1 - Dose Level 3||3||
48248578|NCT00410423|100927458|FG003|COMPLETED|Phase 1 - Dose Level 3||0||
48248579|NCT00410423|100927455|FG000|NOT COMPLETED|Phase 1 - Dose Level 3||0||
48248580|NCT00410423|100927456|FG001|NOT COMPLETED|Phase 1 - Dose Level 3||0||
48248581|NCT00410423|100927457|FG002|NOT COMPLETED|Phase 1 - Dose Level 3||0||
48248582|NCT00410423|100927458|FG003|NOT COMPLETED|Phase 1 - Dose Level 3||0||
48248583|NCT00410423|100927455|FG000|STARTED|Phase 2||0||
48683015|NCT04339413|102006743|FG000|Safety Evaluable Population|Overall Study||59|Safety evaluable population included all the participants who received at least one dose of gantenerumab|
48683016|NCT04339413|102006744|FG001|Safety Evaluable Population|Overall Study||56|Safety evaluable population included all the participants who received at least one dose of gantenerumab|
48683017|NCT04339413|102006743|FG000|COMPLETED|Overall Study||1||
48683018|NCT04339413|102006744|FG001|COMPLETED|Overall Study||0||
48683019|NCT04339413|102006743|FG000|NOT COMPLETED|Overall Study||58||
48683020|NCT04339413|102006744|FG001|NOT COMPLETED|Overall Study||57||
48683021|NCT02580877|102006745|FG000|STARTED|Overall Study||45||
48683022|NCT02580877|102006746|FG001|STARTED|Overall Study||47||
48248584|NCT00410423|100927456|FG001|STARTED|Phase 2||0||
48248585|NCT00410423|100927457|FG002|STARTED|Phase 2||0||
48248586|NCT00410423|100927458|FG003|STARTED|Phase 2||44||
48248587|NCT00410423|100927455|FG000|COMPLETED|Phase 2||0||
48085458|NCT00673465|100528964|FG000|STARTED|Part 1/Period 2 (United States)||3||
48085459|NCT00673465|100528965|FG001|STARTED|Part 1/Period 2 (United States)||3||
48085460|NCT00673465|100528966|FG002|STARTED|Part 1/Period 2 (United States)||3||
48085461|NCT00673465|100528967|FG003|STARTED|Part 1/Period 2 (United States)||3||
48085462|NCT00673465|100528968|FG004|STARTED|Part 1/Period 2 (United States)||2||
48085463|NCT00673465|100528969|FG005|STARTED|Part 1/Period 2 (United States)||1||
48085464|NCT00673465|100528970|FG006|STARTED|Part 1/Period 2 (United States)||0||
48085465|NCT00673465|100528971|FG007|STARTED|Part 1/Period 2 (United States)||0||
48085466|NCT00673465|100528972|FG008|STARTED|Part 1/Period 2 (United States)||0||
48248588|NCT00410423|100927456|FG001|COMPLETED|Phase 2||0||
48248589|NCT00410423|100927457|FG002|COMPLETED|Phase 2||0||
48248590|NCT00410423|100927458|FG003|COMPLETED|Phase 2||44||
48248591|NCT00410423|100927455|FG000|NOT COMPLETED|Phase 2||0||
48248592|NCT00410423|100927456|FG001|NOT COMPLETED|Phase 2||0||
48248593|NCT00410423|100927457|FG002|NOT COMPLETED|Phase 2||0||
48248594|NCT00410423|100927458|FG003|NOT COMPLETED|Phase 2||0||
48248595|NCT00230971|100927459|FG000|STARTED|Randomization||235||
48248596|NCT00230971|100927460|FG001|STARTED|Randomization||238||
48248597|NCT00230971|100927459|FG000|COMPLETED|Randomization||232||
48248598|NCT00230971|100927460|FG001|COMPLETED|Randomization||235||
48248599|NCT00230971|100927459|FG000|NOT COMPLETED|Randomization||3||
48248600|NCT00230971|100927460|FG001|NOT COMPLETED|Randomization||3||
48248601|NCT00230971|100927459|FG000|STARTED|Baseline Participants||232||
48248602|NCT00230971|100927460|FG001|STARTED|Baseline Participants||235||
48248603|NCT00230971|100927459|FG000|COMPLETED|Baseline Participants||210||
48248604|NCT00230971|100927460|FG001|COMPLETED|Baseline Participants||216||
48248605|NCT00230971|100927459|FG000|NOT COMPLETED|Baseline Participants||22||
48248606|NCT00230971|100927460|FG001|NOT COMPLETED|Baseline Participants||19||
48248607|NCT01954771|100927461|FG000|STARTED|Overall Study||29||
48248608|NCT01954771|100927462|FG001|STARTED|Overall Study||32||
48085467|NCT00673465|100528973|FG009|STARTED|Part 1/Period 2 (United States)||0||
48085468|NCT00673465|100528974|FG010|STARTED|Part 1/Period 2 (United States)||0||
48085469|NCT00673465|100528975|FG011|STARTED|Part 1/Period 2 (United States)||0||
48085470|NCT00673465|100528964|FG000|COMPLETED|Part 1/Period 2 (United States)||3||
48085471|NCT00673465|100528965|FG001|COMPLETED|Part 1/Period 2 (United States)||3||
48248609|NCT01954771|100927463|FG002|STARTED|Overall Study||28||
48248610|NCT01954771|100927461|FG000|COMPLETED|Overall Study||22||
48248611|NCT01954771|100927462|FG001|COMPLETED|Overall Study||29||
48248612|NCT01954771|100927463|FG002|COMPLETED|Overall Study||25||
48248613|NCT01954771|100927461|FG000|NOT COMPLETED|Overall Study||7||
48248614|NCT01954771|100927462|FG001|NOT COMPLETED|Overall Study||3||
48248615|NCT01954771|100927463|FG002|NOT COMPLETED|Overall Study||3||
48248616|NCT03480919|100927464|FG000|STARTED|Overall Study||1||
48248617|NCT03480919|100927465|FG001|STARTED|Overall Study||2||
48248618|NCT03480919|100927466|FG002|STARTED|Overall Study||1||
48248619|NCT03480919|100927464|FG000|COMPLETED|Overall Study||1||
48248620|NCT03480919|100927465|FG001|COMPLETED|Overall Study||2||
48248621|NCT03480919|100927466|FG002|COMPLETED|Overall Study||1||
48248622|NCT03480919|100927464|FG000|NOT COMPLETED|Overall Study||0||
48248623|NCT03480919|100927465|FG001|NOT COMPLETED|Overall Study||0||
48248624|NCT03480919|100927466|FG002|NOT COMPLETED|Overall Study||0||
48248625|NCT04572997|100927467|FG000|STARTED|Overall Study||21||
48248626|NCT04572997|100927467|FG000|COMPLETED|Overall Study||20||
48248627|NCT04572997|100927467|FG000|NOT COMPLETED|Overall Study||1||
48248628|NCT01557699|100927468|FG000|STARTED|Overall Study||20||
48248629|NCT01557699|100927469|FG001|STARTED|Overall Study||20||
48248630|NCT01557699|100927470|FG002|STARTED|Overall Study||20||
48248631|NCT01557699|100927468|FG000|COMPLETED|Overall Study||20||
48248632|NCT01557699|100927469|FG001|COMPLETED|Overall Study||20||
48248633|NCT01557699|100927470|FG002|COMPLETED|Overall Study||20||
48248634|NCT01557699|100927468|FG000|NOT COMPLETED|Overall Study||0||
48248635|NCT01557699|100927469|FG001|NOT COMPLETED|Overall Study||0||
48248636|NCT01557699|100927470|FG002|NOT COMPLETED|Overall Study||0||
48248637|NCT01654445|100927471|FG000|STARTED|Overall Study||25||
48248638|NCT01654445|100927472|FG001|STARTED|Overall Study||25||
48248639|NCT01654445|100927471|FG000|COMPLETED|Overall Study||25||
48248640|NCT01654445|100927472|FG001|COMPLETED|Overall Study||25||
48248641|NCT01654445|100927471|FG000|NOT COMPLETED|Overall Study||0||
48248642|NCT01654445|100927472|FG001|NOT COMPLETED|Overall Study||0||
48248643|NCT03738397|100927473|FG000|STARTED|Overall Study||331||
48248644|NCT03738397|100927474|FG001|STARTED|Overall Study||342||
48248645|NCT03738397|100927473|FG000|COMPLETED|Overall Study||308||
48248646|NCT03738397|100927474|FG001|COMPLETED|Overall Study||312||
48085472|NCT00673465|100528966|FG002|COMPLETED|Part 1/Period 2 (United States)||3||
48085473|NCT00673465|100528967|FG003|COMPLETED|Part 1/Period 2 (United States)||3||
48085474|NCT00673465|100528968|FG004|COMPLETED|Part 1/Period 2 (United States)||1||
48085475|NCT00673465|100528969|FG005|COMPLETED|Part 1/Period 2 (United States)||1||
48085476|NCT00673465|100528970|FG006|COMPLETED|Part 1/Period 2 (United States)||0||
48085477|NCT00673465|100528971|FG007|COMPLETED|Part 1/Period 2 (United States)||0||
48085478|NCT00673465|100528972|FG008|COMPLETED|Part 1/Period 2 (United States)||0||
48085479|NCT00673465|100528973|FG009|COMPLETED|Part 1/Period 2 (United States)||0||
48085480|NCT00673465|100528974|FG010|COMPLETED|Part 1/Period 2 (United States)||0||
48085481|NCT00673465|100528975|FG011|COMPLETED|Part 1/Period 2 (United States)||0||
48085482|NCT00673465|100528964|FG000|NOT COMPLETED|Part 1/Period 2 (United States)||0||
48248647|NCT03738397|100927473|FG000|NOT COMPLETED|Overall Study||23||
48248648|NCT03738397|100927474|FG001|NOT COMPLETED|Overall Study||30||
48248649|NCT01770314|100927475|FG000|STARTED|Overall Study||86||
48248650|NCT01770314|100927476|FG001|STARTED|Overall Study||90||
48248651|NCT01770314|100927475|FG000|Contributed Data to Baseline|Overall Study||68||
48248652|NCT01770314|100927476|FG001|Contributed Data to Baseline|Overall Study||72||
48085483|NCT00673465|100528965|FG001|NOT COMPLETED|Part 1/Period 2 (United States)||0||
48248653|NCT01770314|100927475|FG000|Contributed Data to Post-test|Overall Study||65||
48085484|NCT00673465|100528966|FG002|NOT COMPLETED|Part 1/Period 2 (United States)||0||
48085485|NCT00673465|100528967|FG003|NOT COMPLETED|Part 1/Period 2 (United States)||0||
48248654|NCT01770314|100927476|FG001|Contributed Data to Post-test|Overall Study||67||
48248655|NCT01770314|100927475|FG000|Contributed Data to One-month Follow-up|Overall Study||61||
48248656|NCT01770314|100927476|FG001|Contributed Data to One-month Follow-up|Overall Study||66||
48248657|NCT01770314|100927475|FG000|COMPLETED|Overall Study||86||
48248658|NCT01770314|100927476|FG001|COMPLETED|Overall Study||90||
48248659|NCT01770314|100927475|FG000|NOT COMPLETED|Overall Study||0||
48248660|NCT01770314|100927476|FG001|NOT COMPLETED|Overall Study||0||
48248661|NCT01902381|100927477|FG000|STARTED|Overall Study||12||
48248662|NCT01902381|100927477|FG000|COMPLETED|Overall Study||11||
48248663|NCT01902381|100927477|FG000|NOT COMPLETED|Overall Study||1||
48248664|NCT02625571|100927478|FG000|STARTED|Overall Study||13||
48248665|NCT02625571|100927478|FG000|COMPLETED|Overall Study||10||
48248666|NCT02625571|100927478|FG000|NOT COMPLETED|Overall Study||3||
48248667|NCT01951261|100927479|FG000|STARTED|Overall Study||58||
48248668|NCT01951261|100927480|FG001|STARTED|Overall Study||58||
48248669|NCT01951261|100927479|FG000|Discontinued|Overall Study||9||
48248670|NCT01951261|100927480|FG001|Discontinued|Overall Study||6||
48248671|NCT01951261|100927479|FG000|COMPLETED|Overall Study||49||
48248672|NCT01951261|100927480|FG001|COMPLETED|Overall Study||52||
48248673|NCT01951261|100927479|FG000|NOT COMPLETED|Overall Study||9||
48248674|NCT01951261|100927480|FG001|NOT COMPLETED|Overall Study||6||
48248675|NCT04281875|100927481|FG000|STARTED|Overall Study||80||
48248676|NCT04281875|100927482|FG001|STARTED|Overall Study||80||
48248677|NCT04281875|100927481|FG000|COMPLETED|Overall Study||80||
48683023|NCT02580877|102006745|FG000|COMPLETED|Overall Study||44||
48683024|NCT02580877|102006746|FG001|COMPLETED|Overall Study||43||
48683025|NCT02580877|102006745|FG000|NOT COMPLETED|Overall Study||1||
48683026|NCT02580877|102006746|FG001|NOT COMPLETED|Overall Study||4||
48683027|NCT01881789|102006747|FG000|STARTED|Overall Study||3||
48683028|NCT01881789|102006748|FG001|STARTED|Overall Study||7||
48683029|NCT01881789|102006749|FG002|STARTED|Overall Study||3||
48683030|NCT01881789|102006750|FG003|STARTED|Overall Study||3||
48085486|NCT00673465|100528968|FG004|NOT COMPLETED|Part 1/Period 2 (United States)||1||
48085487|NCT00673465|100528969|FG005|NOT COMPLETED|Part 1/Period 2 (United States)||0||
48085488|NCT00673465|100528970|FG006|NOT COMPLETED|Part 1/Period 2 (United States)||0||
48085489|NCT00673465|100528971|FG007|NOT COMPLETED|Part 1/Period 2 (United States)||0||
48085490|NCT00673465|100528972|FG008|NOT COMPLETED|Part 1/Period 2 (United States)||0||
48085491|NCT00673465|100528973|FG009|NOT COMPLETED|Part 1/Period 2 (United States)||0||
48085492|NCT00673465|100528974|FG010|NOT COMPLETED|Part 1/Period 2 (United States)||0||
48085493|NCT00673465|100528975|FG011|NOT COMPLETED|Part 1/Period 2 (United States)||0||
48085494|NCT00673465|100528964|FG000|STARTED|Part 1/Period 3 (United States)||3||
48085495|NCT00673465|100528965|FG001|STARTED|Part 1/Period 3 (United States)||3||
48085496|NCT00673465|100528966|FG002|STARTED|Part 1/Period 3 (United States)||3||
48085497|NCT00673465|100528967|FG003|STARTED|Part 1/Period 3 (United States)||3||
48085498|NCT00673465|100528968|FG004|STARTED|Part 1/Period 3 (United States)||1||
48085499|NCT00673465|100528969|FG005|STARTED|Part 1/Period 3 (United States)||1||
48085500|NCT00673465|100528970|FG006|STARTED|Part 1/Period 3 (United States)||0||
48085501|NCT00673465|100528971|FG007|STARTED|Part 1/Period 3 (United States)||0||
48085502|NCT00673465|100528972|FG008|STARTED|Part 1/Period 3 (United States)||0||
48085503|NCT00673465|100528973|FG009|STARTED|Part 1/Period 3 (United States)||0||
48085504|NCT00673465|100528974|FG010|STARTED|Part 1/Period 3 (United States)||0||
48085505|NCT00673465|100528975|FG011|STARTED|Part 1/Period 3 (United States)||0||
48085506|NCT00673465|100528964|FG000|COMPLETED|Part 1/Period 3 (United States)||3||
48085507|NCT00673465|100528965|FG001|COMPLETED|Part 1/Period 3 (United States)||3||
48085508|NCT00673465|100528966|FG002|COMPLETED|Part 1/Period 3 (United States)||3||
48085509|NCT00673465|100528967|FG003|COMPLETED|Part 1/Period 3 (United States)||3||
48085510|NCT00673465|100528968|FG004|COMPLETED|Part 1/Period 3 (United States)||1||
48085511|NCT00673465|100528969|FG005|COMPLETED|Part 1/Period 3 (United States)||1||
48085512|NCT00673465|100528970|FG006|COMPLETED|Part 1/Period 3 (United States)||0||
48085513|NCT00673465|100528971|FG007|COMPLETED|Part 1/Period 3 (United States)||0||
48085514|NCT00673465|100528972|FG008|COMPLETED|Part 1/Period 3 (United States)||0||
48085515|NCT00673465|100528973|FG009|COMPLETED|Part 1/Period 3 (United States)||0||
48085516|NCT00673465|100528974|FG010|COMPLETED|Part 1/Period 3 (United States)||0||
48085517|NCT00673465|100528975|FG011|COMPLETED|Part 1/Period 3 (United States)||0||
48085518|NCT00673465|100528964|FG000|NOT COMPLETED|Part 1/Period 3 (United States)||0||
48085519|NCT00673465|100528965|FG001|NOT COMPLETED|Part 1/Period 3 (United States)||0||
48085520|NCT00673465|100528966|FG002|NOT COMPLETED|Part 1/Period 3 (United States)||0||
48085521|NCT00673465|100528967|FG003|NOT COMPLETED|Part 1/Period 3 (United States)||0||
48085522|NCT00673465|100528968|FG004|NOT COMPLETED|Part 1/Period 3 (United States)||0||
48085523|NCT00673465|100528969|FG005|NOT COMPLETED|Part 1/Period 3 (United States)||0||
48085524|NCT00673465|100528970|FG006|NOT COMPLETED|Part 1/Period 3 (United States)||0||
48085525|NCT00673465|100528971|FG007|NOT COMPLETED|Part 1/Period 3 (United States)||0||
48085526|NCT00673465|100528972|FG008|NOT COMPLETED|Part 1/Period 3 (United States)||0||
48085527|NCT00673465|100528973|FG009|NOT COMPLETED|Part 1/Period 3 (United States)||0||
48085528|NCT00673465|100528974|FG010|NOT COMPLETED|Part 1/Period 3 (United States)||0||
48248678|NCT04281875|100927482|FG001|COMPLETED|Overall Study||80||
48248679|NCT04281875|100927481|FG000|NOT COMPLETED|Overall Study||0||
48248680|NCT04281875|100927482|FG001|NOT COMPLETED|Overall Study||0||
48248681|NCT00985621|100927483|FG000|STARTED|Overall Study||142||
48248682|NCT00985621|100927484|FG001|STARTED|Overall Study||161||
48248683|NCT00985621|100927485|FG002|STARTED|Overall Study||152||
48248684|NCT00985621|100927486|FG003|STARTED|Overall Study||159||
48248685|NCT00985621|100927483|FG000|Treated|Overall Study||141||
48248686|NCT00985621|100927484|FG001|Treated|Overall Study||161||
48248687|NCT00985621|100927485|FG002|Treated|Overall Study||150||
48248688|NCT00985621|100927486|FG003|Treated|Overall Study||158||
48248689|NCT00985621|100927483|FG000|COMPLETED|Overall Study||28||
48248690|NCT00985621|100927484|FG001|COMPLETED|Overall Study||30||
48248691|NCT00985621|100927485|FG002|COMPLETED|Overall Study||29||
48248692|NCT00985621|100927486|FG003|COMPLETED|Overall Study||22||
48248693|NCT00985621|100927483|FG000|NOT COMPLETED|Overall Study||114||
48683031|NCT01881789|102006751|FG004|STARTED|Overall Study||2||
48085529|NCT00673465|100528975|FG011|NOT COMPLETED|Part 1/Period 3 (United States)||0||
48085530|NCT00673465|100528964|FG000|STARTED|Part 2 (India)||0||
48085531|NCT00673465|100528965|FG001|STARTED|Part 2 (India)||0||
48085532|NCT00673465|100528966|FG002|STARTED|Part 2 (India)||0||
48085533|NCT00673465|100528967|FG003|STARTED|Part 2 (India)||0||
48085534|NCT00673465|100528968|FG004|STARTED|Part 2 (India)||0||
48085535|NCT00673465|100528969|FG005|STARTED|Part 2 (India)||0||
48085536|NCT00673465|100528970|FG006|STARTED|Part 2 (India)||0||
48085537|NCT00673465|100528971|FG007|STARTED|Part 2 (India)||0||
48085538|NCT00673465|100528972|FG008|STARTED|Part 2 (India)||0||
48085539|NCT00673465|100528973|FG009|STARTED|Part 2 (India)||0||
48085540|NCT00673465|100528974|FG010|STARTED|Part 2 (India)||0||
48085541|NCT00673465|100528975|FG011|STARTED|Part 2 (India)||0||
48085542|NCT00673465|100528964|FG000|COMPLETED|Part 2 (India)||0||
48085543|NCT00673465|100528965|FG001|COMPLETED|Part 2 (India)||0||
48085544|NCT00673465|100528966|FG002|COMPLETED|Part 2 (India)||0||
48085545|NCT00673465|100528967|FG003|COMPLETED|Part 2 (India)||0||
48085546|NCT00673465|100528968|FG004|COMPLETED|Part 2 (India)||0||
48085547|NCT00673465|100528969|FG005|COMPLETED|Part 2 (India)||0||
48085548|NCT00673465|100528970|FG006|COMPLETED|Part 2 (India)||0||
48085549|NCT00673465|100528971|FG007|COMPLETED|Part 2 (India)||0||
48085550|NCT00673465|100528972|FG008|COMPLETED|Part 2 (India)||0||
48085551|NCT00673465|100528973|FG009|COMPLETED|Part 2 (India)||0||
48085552|NCT00673465|100528974|FG010|COMPLETED|Part 2 (India)||0||
48085553|NCT00673465|100528975|FG011|COMPLETED|Part 2 (India)||0||
48085554|NCT00673465|100528964|FG000|NOT COMPLETED|Part 2 (India)||0||
48085555|NCT00673465|100528965|FG001|NOT COMPLETED|Part 2 (India)||0||
48085556|NCT00673465|100528966|FG002|NOT COMPLETED|Part 2 (India)||0||
48085557|NCT00673465|100528967|FG003|NOT COMPLETED|Part 2 (India)||0||
48085558|NCT00673465|100528968|FG004|NOT COMPLETED|Part 2 (India)||0||
48085559|NCT00673465|100528969|FG005|NOT COMPLETED|Part 2 (India)||0||
48085560|NCT00673465|100528970|FG006|NOT COMPLETED|Part 2 (India)||0||
48085561|NCT00673465|100528971|FG007|NOT COMPLETED|Part 2 (India)||0||
48085562|NCT00673465|100528972|FG008|NOT COMPLETED|Part 2 (India)||0||
48683032|NCT01881789|102006752|FG005|STARTED|Overall Study||3||
48683033|NCT01881789|102006747|FG000|COMPLETED|Overall Study||0||
48085563|NCT00673465|100528973|FG009|NOT COMPLETED|Part 2 (India)||0||
48085564|NCT00673465|100528974|FG010|NOT COMPLETED|Part 2 (India)||0||
48085565|NCT00673465|100528975|FG011|NOT COMPLETED|Part 2 (India)||0||
48085566|NCT00651794|100528976|FG000|STARTED|Overall Study||36||
48085567|NCT00651794|100528977|FG001|STARTED|Overall Study||31||
48085568|NCT00651794|100528978|FG002|STARTED|Overall Study||31||
48085569|NCT00651794|100528976|FG000|COMPLETED|Overall Study||15||
48085570|NCT00651794|100528977|FG001|COMPLETED|Overall Study||9||
48085571|NCT00651794|100528978|FG002|COMPLETED|Overall Study||10||
48085572|NCT00651794|100528976|FG000|NOT COMPLETED|Overall Study||21||
48085573|NCT00651794|100528977|FG001|NOT COMPLETED|Overall Study||22||
48085574|NCT00651794|100528978|FG002|NOT COMPLETED|Overall Study||21||
48085575|NCT02727751|100528979|FG000|STARTED|Overall Study||312||
48085576|NCT02727751|100528979|FG000|COMPLETED|Overall Study||262||
48085577|NCT02727751|100528979|FG000|NOT COMPLETED|Overall Study||50||
48085578|NCT02573311|100528980|FG000|STARTED|Disposition for Part 1||1737||
48085579|NCT02573311|100528981|FG001|STARTED|Disposition for Part 1||364||
48085580|NCT02573311|100528980|FG000|COMPLETED|Disposition for Part 1||1730||
48085581|NCT02573311|100528981|FG001|COMPLETED|Disposition for Part 1||361||
48085582|NCT02573311|100528980|FG000|NOT COMPLETED|Disposition for Part 1||7||
48085583|NCT02573311|100528981|FG001|NOT COMPLETED|Disposition for Part 1||3||
48085584|NCT02573311|100528980|FG000|STARTED|Disposition for Part 2||964||
48085585|NCT02573311|100528981|FG001|STARTED|Disposition for Part 2||153||
48248694|NCT00985621|100927484|FG001|NOT COMPLETED|Overall Study||131||
48683034|NCT01881789|102006748|FG001|COMPLETED|Overall Study||0||
48683035|NCT01881789|102006749|FG002|COMPLETED|Overall Study||0||
48085586|NCT02573311|100528980|FG000|COMPLETED|Disposition for Part 2||754||
48248695|NCT00985621|100927485|FG002|NOT COMPLETED|Overall Study||123||
48248696|NCT00985621|100927486|FG003|NOT COMPLETED|Overall Study||137||
48248697|NCT03941769|100927487|FG000|STARTED|Overall Study||1||
48085587|NCT02573311|100528981|FG001|COMPLETED|Disposition for Part 2||127||
48085588|NCT02573311|100528980|FG000|NOT COMPLETED|Disposition for Part 2||210||
48085589|NCT02573311|100528981|FG001|NOT COMPLETED|Disposition for Part 2||26||
48085590|NCT03700671|100528982|FG000|STARTED|Overall Study||21||
48085591|NCT03700671|100528983|FG001|STARTED|Overall Study||21||
48085592|NCT03700671|100528982|FG000|COMPLETED|Overall Study||20||
48085593|NCT03700671|100528983|FG001|COMPLETED|Overall Study||19||
48085594|NCT03700671|100528982|FG000|NOT COMPLETED|Overall Study||1||
48248698|NCT03941769|100927487|FG000|COMPLETED|Overall Study||1||
48248699|NCT03941769|100927487|FG000|NOT COMPLETED|Overall Study||0||
48248700|NCT02998918|100927488|FG000|STARTED|Overall Study||11||
48248701|NCT02998918|100927489|FG001|STARTED|Overall Study||10||
48248702|NCT02998918|100927488|FG000|COMPLETED|Overall Study||10||
48683036|NCT01881789|102006750|FG003|COMPLETED|Overall Study||0||
48683037|NCT01881789|102006751|FG004|COMPLETED|Overall Study||0||
48085595|NCT03700671|100528983|FG001|NOT COMPLETED|Overall Study||2||
48085596|NCT01244425|100528984|FG000|STARTED|Overall Study||35||
48085597|NCT01244425|100528985|FG001|STARTED|Overall Study||35||
48683038|NCT01881789|102006752|FG005|COMPLETED|Overall Study||0||
48683039|NCT01881789|102006747|FG000|NOT COMPLETED|Overall Study||3||
48683040|NCT01881789|102006748|FG001|NOT COMPLETED|Overall Study||7||
48683041|NCT01881789|102006749|FG002|NOT COMPLETED|Overall Study||3||
48683042|NCT01881789|102006750|FG003|NOT COMPLETED|Overall Study||3||
48683043|NCT01881789|102006751|FG004|NOT COMPLETED|Overall Study||2||
48085598|NCT01244425|100528984|FG000|COMPLETED|Overall Study||32||
48085599|NCT01244425|100528985|FG001|COMPLETED|Overall Study||32||
48085600|NCT01244425|100528984|FG000|NOT COMPLETED|Overall Study||3||
48683044|NCT01881789|102006752|FG005|NOT COMPLETED|Overall Study||3||
48683045|NCT05160363|102009444|FG000|STARTED|Overall Study||15||
48683046|NCT05160363|102009445|FG001|STARTED|Overall Study||8||
48683047|NCT05160363|102009446|FG002|STARTED|Overall Study||8||
48683048|NCT05160363|102009447|FG003|STARTED|Overall Study||6||
48683049|NCT05160363|102009444|FG000|COMPLETED|Overall Study||15||
48683050|NCT05160363|102009445|FG001|COMPLETED|Overall Study||8||
48683051|NCT05160363|102009446|FG002|COMPLETED|Overall Study||8||
48683052|NCT05160363|102009447|FG003|COMPLETED|Overall Study||6||
48085601|NCT01244425|100528985|FG001|NOT COMPLETED|Overall Study||3||
48085602|NCT00284050|100528986|FG000|STARTED|Overall Study||51||
48085603|NCT00284050|100528987|FG001|STARTED|Overall Study||51||
48085604|NCT00284050|100528988|FG002|STARTED|Overall Study||49||
48085605|NCT00284050|100528986|FG000|COMPLETED|Overall Study||46||
48085606|NCT00284050|100528987|FG001|COMPLETED|Overall Study||46||
48085607|NCT00284050|100528988|FG002|COMPLETED|Overall Study||40||
48085608|NCT00284050|100528986|FG000|NOT COMPLETED|Overall Study||5||
48085609|NCT00284050|100528987|FG001|NOT COMPLETED|Overall Study||5||
48085610|NCT00284050|100528988|FG002|NOT COMPLETED|Overall Study||9||
48085611|NCT00811798|100528989|FG000|STARTED|Overall Study||92||
48085612|NCT00811798|100528989|FG000|COMPLETED|Overall Study||92||
48085613|NCT00811798|100528989|FG000|NOT COMPLETED|Overall Study||0||
48085614|NCT02376361|100528990|FG000|STARTED|Overall Study||229||
48085615|NCT02376361|100528991|FG001|STARTED|Overall Study||207||
48085616|NCT02376361|100528990|FG000|COMPLETED|Overall Study||58||
48085617|NCT02376361|100528991|FG001|COMPLETED|Overall Study||90||
48085618|NCT02376361|100528990|FG000|NOT COMPLETED|Overall Study||171||
48085619|NCT02376361|100528991|FG001|NOT COMPLETED|Overall Study||117||
48085620|NCT02468414|100528992|FG000|STARTED|Overall Study||3||
48085621|NCT02468414|100528993|FG001|STARTED|Overall Study||0||
48085622|NCT02468414|100528992|FG000|Successfully Screened|Overall Study||2||
48085623|NCT02468414|100528993|FG001|Successfully Screened|Overall Study||0||
48085624|NCT02468414|100528992|FG000|Harvesting|Overall Study||1||
48085625|NCT02468414|100528993|FG001|Harvesting|Overall Study||0||
48085626|NCT02468414|100528992|FG000|Implantation|Overall Study||1||
48085627|NCT02468414|100528993|FG001|Implantation|Overall Study||0||
48085628|NCT02468414|100528992|FG000|Safety Follow-up|Overall Study||0||
48085629|NCT02468414|100528993|FG001|Safety Follow-up|Overall Study||0||
48085630|NCT02468414|100528992|FG000|COMPLETED|Overall Study||0||
48085631|NCT02468414|100528993|FG001|COMPLETED|Overall Study||0||
48085632|NCT02468414|100528992|FG000|NOT COMPLETED|Overall Study||3||
48085633|NCT02468414|100528993|FG001|NOT COMPLETED|Overall Study||0||
48085634|NCT04567225|100528994|FG000|STARTED|Overall Study||39||
48085635|NCT04567225|100528995|FG001|STARTED|Overall Study||0||
48085636|NCT04567225|100528994|FG000|COMPLETED|Overall Study||0||
48085637|NCT04567225|100528995|FG001|COMPLETED|Overall Study||0||
48085638|NCT04567225|100528994|FG000|NOT COMPLETED|Overall Study||39||
48085639|NCT04567225|100528995|FG001|NOT COMPLETED|Overall Study||0||
48085640|NCT01291173|100528996|FG000|STARTED|Overall Study||64||
48085641|NCT01291173|100528997|FG001|STARTED|Overall Study||66||
48085642|NCT01291173|100528998|FG002|STARTED|Overall Study||65||
48085643|NCT01291173|100528999|FG003|STARTED|Overall Study||65||
48085644|NCT01291173|100528996|FG000|COMPLETED|Overall Study||47||
48085645|NCT01291173|100528997|FG001|COMPLETED|Overall Study||51||
48085646|NCT01291173|100528998|FG002|COMPLETED|Overall Study||52||
48085647|NCT01291173|100528999|FG003|COMPLETED|Overall Study||52||
48085648|NCT01291173|100528996|FG000|NOT COMPLETED|Overall Study||17||
48085649|NCT01291173|100528997|FG001|NOT COMPLETED|Overall Study||15||
48085650|NCT01291173|100528998|FG002|NOT COMPLETED|Overall Study||13||
48085651|NCT01291173|100528999|FG003|NOT COMPLETED|Overall Study||13||
48085652|NCT02269241|100529000|FG000|STARTED|Overall Study||1552||
48085653|NCT02269241|100529000|FG000|COMPLETED|Overall Study||352||
48085654|NCT02269241|100529000|FG000|NOT COMPLETED|Overall Study||1200||
48085655|NCT00692341|100529001|FG000|STARTED|Overall Study||8||
48085656|NCT00692341|100529002|FG001|STARTED|Overall Study||8||
48085657|NCT00692341|100529003|FG002|STARTED|Overall Study||8||
48085658|NCT00692341|100529001|FG000|COMPLETED|Overall Study||8||
48085659|NCT00692341|100529002|FG001|COMPLETED|Overall Study||8||
48085660|NCT00692341|100529003|FG002|COMPLETED|Overall Study||8||
48085661|NCT00692341|100529001|FG000|NOT COMPLETED|Overall Study||0||
48085662|NCT00692341|100529002|FG001|NOT COMPLETED|Overall Study||0||
48683053|NCT05160363|102009444|FG000|NOT COMPLETED|Overall Study||0||
48085663|NCT00692341|100529003|FG002|NOT COMPLETED|Overall Study||0||
48085664|NCT02254486|100529004|FG000|STARTED|Overall Study||311||
48683054|NCT05160363|102009445|FG001|NOT COMPLETED|Overall Study||0||
48683055|NCT05160363|102009446|FG002|NOT COMPLETED|Overall Study||0||
48683056|NCT05160363|102009447|FG003|NOT COMPLETED|Overall Study||0||
48683057|NCT02240121|102009448|FG000|STARTED|Overall Study||40||
48683058|NCT02240121|102009449|FG001|STARTED|Overall Study||40||
48683059|NCT02240121|102009448|FG000|COMPLETED|Overall Study||22||
48683060|NCT02240121|102009449|FG001|COMPLETED|Overall Study||20||
48683061|NCT02240121|102009448|FG000|NOT COMPLETED|Overall Study||18||
48683062|NCT02240121|102009449|FG001|NOT COMPLETED|Overall Study||20||
48683063|NCT03368196|102009450|FG000|STARTED|Overall Study||12||
48683064|NCT03368196|102009450|FG000|COMPLETED|Overall Study||12|Ongoing as of data cutoff 14 Sept 2018|
48683065|NCT03368196|102009450|FG000|NOT COMPLETED|Overall Study||0||
48683066|NCT00932035|102009451|FG000|STARTED|Overall Study||18||
48683067|NCT00932035|102009452|FG001|STARTED|Overall Study||21||
48683068|NCT00932035|102009451|FG000|COMPLETED|Overall Study||18||
48683069|NCT00932035|102009452|FG001|COMPLETED|Overall Study||21||
48085665|NCT02254486|100529005|FG001|STARTED|Overall Study||310||
48085666|NCT02254486|100529004|FG000|COMPLETED|Overall Study||261||
48085667|NCT02254486|100529005|FG001|COMPLETED|Overall Study||255||
48085668|NCT02254486|100529004|FG000|NOT COMPLETED|Overall Study||50||
48085669|NCT02254486|100529005|FG001|NOT COMPLETED|Overall Study||55||
48085670|NCT01535053|100529006|FG000|STARTED|Overall Study||29||
48085671|NCT01535053|100529007|FG001|STARTED|Overall Study||28||
48085672|NCT01535053|100529006|FG000|COMPLETED|Overall Study||28||
48085673|NCT01535053|100529007|FG001|COMPLETED|Overall Study||26||
48085674|NCT01535053|100529006|FG000|NOT COMPLETED|Overall Study||1||
48085675|NCT01535053|100529007|FG001|NOT COMPLETED|Overall Study||2||
48085676|NCT00793598|100529008|FG000|STARTED|Overall Study||1||
48085677|NCT00793598|100529009|FG001|STARTED|Overall Study||1||
48085678|NCT00793598|100529010|FG002|STARTED|Overall Study||1||
48085679|NCT00793598|100529011|FG003|STARTED|Overall Study||2||
48085680|NCT00793598|100529012|FG004|STARTED|Overall Study||8||
48085681|NCT00793598|100529013|FG005|STARTED|Overall Study||8||
48085682|NCT00793598|100529014|FG006|STARTED|Overall Study||4||
48085683|NCT00793598|100529015|FG007|STARTED|Overall Study||4||
48085684|NCT00793598|100529008|FG000|COMPLETED|Overall Study||1||
48085685|NCT00793598|100529009|FG001|COMPLETED|Overall Study||0||
48085686|NCT00793598|100529010|FG002|COMPLETED|Overall Study||1||
48085687|NCT00793598|100529011|FG003|COMPLETED|Overall Study||2||
48085688|NCT00793598|100529012|FG004|COMPLETED|Overall Study||8||
48085689|NCT00793598|100529013|FG005|COMPLETED|Overall Study||7||
48085690|NCT00793598|100529014|FG006|COMPLETED|Overall Study||4||
48085691|NCT00793598|100529015|FG007|COMPLETED|Overall Study||3||
48085692|NCT00793598|100529008|FG000|NOT COMPLETED|Overall Study||0||
48085693|NCT00793598|100529009|FG001|NOT COMPLETED|Overall Study||1||
48085694|NCT00793598|100529010|FG002|NOT COMPLETED|Overall Study||0||
48085695|NCT00793598|100529011|FG003|NOT COMPLETED|Overall Study||0||
48683070|NCT00932035|102009451|FG000|NOT COMPLETED|Overall Study||0||
48683071|NCT00932035|102009452|FG001|NOT COMPLETED|Overall Study||0||
48683072|NCT02625220|102009453|FG000|STARTED|Overall Study||170||
48683073|NCT02625220|102009453|FG000|COMPLETED|Overall Study||163||
48683074|NCT02625220|102009453|FG000|NOT COMPLETED|Overall Study||7||
48683075|NCT00570323|102009454|FG000|STARTED|Started Treatment After Randomization||36||
48683076|NCT00570323|102009455|FG001|STARTED|Started Treatment After Randomization||36||
48683077|NCT00570323|102009454|FG000|COMPLETED|Started Treatment After Randomization||34||
48683078|NCT00570323|102009455|FG001|COMPLETED|Started Treatment After Randomization||35||
48683079|NCT00570323|102009454|FG000|NOT COMPLETED|Started Treatment After Randomization||2||
48683080|NCT00570323|102009455|FG001|NOT COMPLETED|Started Treatment After Randomization||1||
48683081|NCT00570323|102009454|FG000|STARTED|Complete Study After Start||34||
48683082|NCT00570323|102009455|FG001|STARTED|Complete Study After Start||35||
48683083|NCT00570323|102009454|FG000|COMPLETED|Complete Study After Start||31||
48683084|NCT00570323|102009455|FG001|COMPLETED|Complete Study After Start||34||
48683085|NCT00570323|102009454|FG000|NOT COMPLETED|Complete Study After Start||3||
48683086|NCT00570323|102009455|FG001|NOT COMPLETED|Complete Study After Start||1||
48683087|NCT02311881|102009456|FG000|STARTED|Overall Study||235||
48683088|NCT02311881|102009457|FG001|STARTED|Overall Study||236||
48683089|NCT02311881|102009458|FG002|STARTED|Overall Study||237||
48683090|NCT02311881|102009456|FG000|Safety Population|Overall Study||234||
48683091|NCT02311881|102009457|FG001|Safety Population|Overall Study||236||
48683092|NCT02311881|102009458|FG002|Safety Population|Overall Study||237||
48683093|NCT02311881|102009456|FG000|COMPLETED|Overall Study||200||
48683094|NCT02311881|102009457|FG001|COMPLETED|Overall Study||193||
48085696|NCT00793598|100529012|FG004|NOT COMPLETED|Overall Study||0||
48085697|NCT00793598|100529013|FG005|NOT COMPLETED|Overall Study||1||
48683095|NCT02311881|102009458|FG002|COMPLETED|Overall Study||196||
48683096|NCT02311881|102009456|FG000|NOT COMPLETED|Overall Study||35||
48683097|NCT02311881|102009457|FG001|NOT COMPLETED|Overall Study||43||
48683098|NCT02311881|102009458|FG002|NOT COMPLETED|Overall Study||41||
48683099|NCT04179305|102009459|FG000|STARTED|Overall Study||19||
48085698|NCT00793598|100529014|FG006|NOT COMPLETED|Overall Study||0||
48085699|NCT00793598|100529015|FG007|NOT COMPLETED|Overall Study||1||
48683100|NCT04179305|102009460|FG001|STARTED|Overall Study||14||
48085700|NCT04648631|100529016|FG000|STARTED|Overall Study||15||
48085701|NCT04648631|100529016|FG000|COMPLETED|Overall Study||15||
48683101|NCT04179305|102009461|FG002|STARTED|Overall Study||2||
48248703|NCT02998918|100927489|FG001|COMPLETED|Overall Study||10||
48248704|NCT02998918|100927488|FG000|NOT COMPLETED|Overall Study||1||
48248705|NCT02998918|100927489|FG001|NOT COMPLETED|Overall Study||0||
48248706|NCT00509925|100927490|FG000|STARTED|Overall Study||12||
48248707|NCT00509925|100927491|FG001|STARTED|Overall Study||11||
48248708|NCT00509925|100927490|FG000|COMPLETED|Overall Study||12||
48248709|NCT00509925|100927491|FG001|COMPLETED|Overall Study||10||
48248710|NCT00509925|100927490|FG000|NOT COMPLETED|Overall Study||0||
48683102|NCT04179305|102009462|FG003|STARTED|Overall Study||2||
48683103|NCT04179305|102009459|FG000|Completed Patient Baseline Assessment|Overall Study||18||
48683104|NCT04179305|102009460|FG001|Completed Patient Baseline Assessment|Overall Study||13||
48683105|NCT04179305|102009461|FG002|Completed Patient Baseline Assessment|Overall Study||0||
48683106|NCT04179305|102009462|FG003|Completed Patient Baseline Assessment|Overall Study||0||
48683107|NCT04179305|102009459|FG000|Had Progression on Scan|Overall Study||13||
48683108|NCT04179305|102009460|FG001|Had Progression on Scan|Overall Study||12||
48683109|NCT04179305|102009461|FG002|Had Progression on Scan|Overall Study||0||
48683110|NCT04179305|102009462|FG003|Had Progression on Scan|Overall Study||0||
48683111|NCT04179305|102009459|FG000|Completed Post-scan Assessment|Overall Study||13||
48683112|NCT04179305|102009460|FG001|Completed Post-scan Assessment|Overall Study||11||
48683113|NCT04179305|102009461|FG002|Completed Post-scan Assessment|Overall Study||0||
48683114|NCT04179305|102009462|FG003|Completed Post-scan Assessment|Overall Study||0||
48683115|NCT04179305|102009459|FG000|Completed Physician Demographics Survey|Overall Study||0||
48683116|NCT04179305|102009460|FG001|Completed Physician Demographics Survey|Overall Study||0||
48683117|NCT04179305|102009461|FG002|Completed Physician Demographics Survey|Overall Study||2||
48683118|NCT04179305|102009462|FG003|Completed Physician Demographics Survey|Overall Study||2||
48683119|NCT04179305|102009459|FG000|Completed Physician Oncolo-GIST Quiz|Overall Study||0||
48683120|NCT04179305|102009460|FG001|Completed Physician Oncolo-GIST Quiz|Overall Study||0||
48683121|NCT04179305|102009461|FG002|Completed Physician Oncolo-GIST Quiz|Overall Study||2||
48683122|NCT04179305|102009462|FG003|Completed Physician Oncolo-GIST Quiz|Overall Study||0||
48683123|NCT04179305|102009459|FG000|Completed Physician Post-study Questionnaire|Overall Study||0||
48683124|NCT04179305|102009460|FG001|Completed Physician Post-study Questionnaire|Overall Study||0||
48683125|NCT04179305|102009461|FG002|Completed Physician Post-study Questionnaire|Overall Study||2||
48683126|NCT04179305|102009462|FG003|Completed Physician Post-study Questionnaire|Overall Study||2||
48683127|NCT04179305|102009459|FG000|COMPLETED|Overall Study||13||
48683128|NCT04179305|102009460|FG001|COMPLETED|Overall Study||11||
48683129|NCT04179305|102009461|FG002|COMPLETED|Overall Study||2||
48683130|NCT04179305|102009462|FG003|COMPLETED|Overall Study||2||
48683131|NCT04179305|102009459|FG000|NOT COMPLETED|Overall Study||6||
48683132|NCT04179305|102009460|FG001|NOT COMPLETED|Overall Study||3||
48683133|NCT04179305|102009461|FG002|NOT COMPLETED|Overall Study||0||
48683134|NCT04179305|102009462|FG003|NOT COMPLETED|Overall Study||0||
48683135|NCT00658541|102009463|FG000|STARTED|First Intervention||19||
48683136|NCT00658541|102009464|FG001|STARTED|First Intervention||19||
48683137|NCT00658541|102009463|FG000|COMPLETED|First Intervention||19||
48683138|NCT00658541|102009464|FG001|COMPLETED|First Intervention||19||
48683139|NCT00658541|102009463|FG000|NOT COMPLETED|First Intervention||0||
48683140|NCT00658541|102009464|FG001|NOT COMPLETED|First Intervention||0||
48683141|NCT00658541|102009463|FG000|STARTED|Washout Period of 7 Days||19||
48683142|NCT00658541|102009464|FG001|STARTED|Washout Period of 7 Days||19||
48683143|NCT00658541|102009463|FG000|COMPLETED|Washout Period of 7 Days||18||
48683144|NCT00658541|102009464|FG001|COMPLETED|Washout Period of 7 Days||17||
48683145|NCT00658541|102009463|FG000|NOT COMPLETED|Washout Period of 7 Days||1||
48683146|NCT00658541|102009464|FG001|NOT COMPLETED|Washout Period of 7 Days||2||
48683147|NCT00658541|102009463|FG000|STARTED|Second Intervention||18||
48683148|NCT00658541|102009464|FG001|STARTED|Second Intervention||17||
48683149|NCT00658541|102009463|FG000|COMPLETED|Second Intervention||18||
48683150|NCT00658541|102009464|FG001|COMPLETED|Second Intervention||17||
48683151|NCT00658541|102009463|FG000|NOT COMPLETED|Second Intervention||0||
48683152|NCT00658541|102009464|FG001|NOT COMPLETED|Second Intervention||0||
48683153|NCT01082081|102009465|FG000|STARTED|Overall Study||121||
48683154|NCT01082081|102009466|FG001|STARTED|Overall Study||119||
48683155|NCT01082081|102009467|FG002|STARTED|Overall Study||60||
48248711|NCT00509925|100927491|FG001|NOT COMPLETED|Overall Study||1||
48248712|NCT02581189|100927492|FG000|STARTED|Overall Study||534||
48248713|NCT02581189|100927492|FG000|COMPLETED|Overall Study||481||
48248714|NCT02581189|100927492|FG000|NOT COMPLETED|Overall Study||53||
48248715|NCT03643705|100927493|FG000|STARTED|Overall Study||149||
48248716|NCT03643705|100927494|FG001|STARTED|Overall Study||148||
48248717|NCT03643705|100927493|FG000|COMPLETED|Overall Study||114||
48248718|NCT03643705|100927494|FG001|COMPLETED|Overall Study||129||
48248719|NCT03643705|100927493|FG000|NOT COMPLETED|Overall Study||35||
48248720|NCT03643705|100927494|FG001|NOT COMPLETED|Overall Study||19||
48248721|NCT00317603|100927495|FG000|STARTED|Overall Study||15||
48248722|NCT00317603|100927495|FG000|Treated|Overall Study||12||
48248723|NCT00317603|100927495|FG000|COMPLETED|Overall Study||12||
48248724|NCT00317603|100927495|FG000|NOT COMPLETED|Overall Study||3||
48248725|NCT02329223|100927496|FG000|STARTED|Overall Study||73||
48683156|NCT01082081|102009465|FG000|COMPLETED|Overall Study||121||
48683157|NCT01082081|102009466|FG001|COMPLETED|Overall Study||118||
48683158|NCT01082081|102009467|FG002|COMPLETED|Overall Study||58||
48683159|NCT01082081|102009465|FG000|NOT COMPLETED|Overall Study||0||
48683160|NCT01082081|102009466|FG001|NOT COMPLETED|Overall Study||1||
48683161|NCT01082081|102009467|FG002|NOT COMPLETED|Overall Study||2||
48683162|NCT02941614|102009468|FG000|STARTED|Overall Study||744||
48085702|NCT04648631|100529016|FG000|NOT COMPLETED|Overall Study||0||
48085703|NCT04891874|100529017|FG000|STARTED|Overall Study||38||
48085704|NCT04891874|100529018|FG001|STARTED|Overall Study||38||
48085705|NCT04891874|100529017|FG000|COMPLETED|Overall Study||38||
48248726|NCT02329223|100927497|FG001|STARTED|Overall Study||71||
48248727|NCT02329223|100927498|FG002|STARTED|Overall Study||74||
48248728|NCT02329223|100927496|FG000|Full Analysis Set|Overall Study||73||
48248729|NCT02329223|100927497|FG001|Full Analysis Set|Overall Study||70||
48248730|NCT02329223|100927498|FG002|Full Analysis Set|Overall Study||74||
48248731|NCT02329223|100927496|FG000|Safety Set|Overall Study||73||
48248732|NCT02329223|100927497|FG001|Safety Set|Overall Study||71||
48248733|NCT02329223|100927498|FG002|Safety Set|Overall Study||74||
48248734|NCT02329223|100927496|FG000|COMPLETED|Overall Study||72||
48248735|NCT02329223|100927497|FG001|COMPLETED|Overall Study||68||
48248736|NCT02329223|100927498|FG002|COMPLETED|Overall Study||68||
48248737|NCT02329223|100927496|FG000|NOT COMPLETED|Overall Study||1||
48248738|NCT02329223|100927497|FG001|NOT COMPLETED|Overall Study||3||
48683163|NCT02941614|102009469|FG001|STARTED|Overall Study||692||
48683164|NCT02941614|102009468|FG000|COMPLETED|Overall Study||603||
48683165|NCT02941614|102009469|FG001|COMPLETED|Overall Study||446||
48683166|NCT02941614|102009468|FG000|NOT COMPLETED|Overall Study||141||
48683167|NCT02941614|102009469|FG001|NOT COMPLETED|Overall Study||246||
48683168|NCT04865289|102009470|FG000|STARTED|Overall Study||74||
48683169|NCT04865289|102009471|FG001|STARTED|Overall Study||56||
48085706|NCT04891874|100529018|FG001|COMPLETED|Overall Study||38||
48085707|NCT04891874|100529017|FG000|NOT COMPLETED|Overall Study||0||
48085708|NCT04891874|100529018|FG001|NOT COMPLETED|Overall Study||0||
48085709|NCT01414855|100529019|FG000|STARTED|Overall Study||100||
48085710|NCT01414855|100529019|FG000|COMPLETED|Overall Study||71||
48085711|NCT01414855|100529019|FG000|NOT COMPLETED|Overall Study||29||
48085712|NCT01634360|100529020|FG000|STARTED|Overall Study||49||
48085713|NCT01634360|100529021|FG001|STARTED|Overall Study||136||
48085714|NCT01634360|100529020|FG000|COMPLETED|Overall Study||0||
48085715|NCT01634360|100529021|FG001|COMPLETED|Overall Study||0||
48085716|NCT01634360|100529020|FG000|NOT COMPLETED|Overall Study||49||
48085717|NCT01634360|100529021|FG001|NOT COMPLETED|Overall Study||136||
48085718|NCT01204853|100529022|FG000|STARTED|Overall Study||2||
48085719|NCT01204853|100529022|FG000|COMPLETED|Overall Study||2||
48085720|NCT01204853|100529022|FG000|NOT COMPLETED|Overall Study||0||
48085721|NCT03875885|100529023|FG000|STARTED|Overall Study||18||
48085722|NCT03875885|100529024|FG001|STARTED|Overall Study||22||
48085723|NCT03875885|100529023|FG000|COMPLETED|Overall Study||18||
48085724|NCT03875885|100529024|FG001|COMPLETED|Overall Study||22||
48085725|NCT03875885|100529023|FG000|NOT COMPLETED|Overall Study||0||
48085726|NCT03875885|100529024|FG001|NOT COMPLETED|Overall Study||0||
48085727|NCT02033694|100529025|FG000|STARTED|Overall Study||1271||
48085728|NCT02033694|100529025|FG000|COMPLETED|Overall Study||1271||
48085729|NCT02033694|100529025|FG000|NOT COMPLETED|Overall Study||0||
48085730|NCT02551757|100529026|FG000|STARTED|Overall Study||20||
48085731|NCT02551757|100529027|FG001|STARTED|Overall Study||20||
48085732|NCT02551757|100529026|FG000|COMPLETED|Overall Study||13||
48085733|NCT02551757|100529027|FG001|COMPLETED|Overall Study||17||
48085734|NCT02551757|100529026|FG000|NOT COMPLETED|Overall Study||7||
48085735|NCT02551757|100529027|FG001|NOT COMPLETED|Overall Study||3||
48085736|NCT03020160|100529028|FG000|STARTED|Overall Study||7||
48248739|NCT02329223|100927498|FG002|NOT COMPLETED|Overall Study||6||
48248740|NCT03410108|100927499|FG000|STARTED|Overall Study||104||
48248741|NCT03410108|100927499|FG000|Safety Evaluation Lead-in Part|Overall Study||9|Safety Evaluation Lead-in Part included participants with or without prior ALK-TKI treatment. Although the protocol allowed both refractory and TKI-naive participants to enroll in the Safety Evaluation Lead-in Part, all enrolled participants had history of prior ALK-TKI and were thus included in the efficacy evaluation in All Refractory Participants Cohort.|
48248742|NCT03410108|100927499|FG000|Refractory Expansion Part: Main Cohort|Overall Study||47|Main Cohort of the Refractory Expansion Part includes participants who had previously received alectinib (as their only ALK inhibitor) or both crizotinib and alectinib.|
48683170|NCT04865289|102009470|FG000|Treated|Overall Study||73||
48085737|NCT03020160|100529029|FG001|STARTED|Overall Study||41||
48085738|NCT03020160|100529028|FG000|Completed 24 Weeks in the Study|Overall Study||7||
48085739|NCT03020160|100529029|FG001|Completed 24 Weeks in the Study|Overall Study||41||
48085740|NCT03020160|100529028|FG000|Emicizumab Dose Was Up-Titrated|Overall Study||0||
48085741|NCT03020160|100529029|FG001|Emicizumab Dose Was Up-Titrated|Overall Study||4||
48085742|NCT03020160|100529028|FG000|Opted for a Change in Emicizumab Dosing Regimen|Overall Study||0|Upon Implementation of Protocol Version 5|
48085743|NCT03020160|100529029|FG001|Opted for a Change in Emicizumab Dosing Regimen|Overall Study||1|Upon Implementation of Protocol Version 5|
48085744|NCT03020160|100529028|FG000|COMPLETED|Overall Study||6||
48085745|NCT03020160|100529029|FG001|COMPLETED|Overall Study||41||
48085746|NCT03020160|100529028|FG000|NOT COMPLETED|Overall Study||1||
48683171|NCT04865289|102009471|FG001|Treated|Overall Study||56||
48683172|NCT04865289|102009470|FG000|COMPLETED|Overall Study||0||
48683173|NCT04865289|102009471|FG001|COMPLETED|Overall Study||0||
48683174|NCT04865289|102009470|FG000|NOT COMPLETED|Overall Study||74||
48683175|NCT04865289|102009471|FG001|NOT COMPLETED|Overall Study||56||
48683176|NCT03046836|102009472|FG000|STARTED|Overall Study||100||
48683177|NCT03046836|102009473|FG001|STARTED|Overall Study||100||
48683178|NCT03046836|102009472|FG000|COMPLETED|Overall Study||100||
48683179|NCT03046836|102009473|FG001|COMPLETED|Overall Study||100||
48683180|NCT03046836|102009472|FG000|NOT COMPLETED|Overall Study||0||
48683181|NCT03046836|102009473|FG001|NOT COMPLETED|Overall Study||0||
48683182|NCT01787383|102009474|FG000|STARTED|Overall Study||101||
48683183|NCT01787383|102009475|FG001|STARTED|Overall Study||98||
48683184|NCT01787383|102009474|FG000|COMPLETED|Overall Study||92||
48085747|NCT03020160|100529029|FG001|NOT COMPLETED|Overall Study||0||
48085748|NCT02911753|100529030|FG000|STARTED|Overall Study||21||
48085749|NCT02911753|100529031|FG001|STARTED|Overall Study||19||
48085750|NCT02911753|100529032|FG002|STARTED|Overall Study||10||
48085751|NCT02911753|100529030|FG000|COMPLETED|Overall Study||18||
48085752|NCT02911753|100529031|FG001|COMPLETED|Overall Study||16||
48085753|NCT02911753|100529032|FG002|COMPLETED|Overall Study||10||
48085754|NCT02911753|100529030|FG000|NOT COMPLETED|Overall Study||3||
48085755|NCT02911753|100529031|FG001|NOT COMPLETED|Overall Study||3||
48683185|NCT01787383|102009475|FG001|COMPLETED|Overall Study||76||
48683186|NCT01787383|102009474|FG000|NOT COMPLETED|Overall Study||9||
48683187|NCT01787383|102009475|FG001|NOT COMPLETED|Overall Study||22||
48683188|NCT03063606|102009476|FG000|STARTED|Overall Study||18||
48683189|NCT03063606|102009477|FG001|STARTED|Overall Study||13||
48683190|NCT03063606|102009476|FG000|COMPLETED|Overall Study||16||
48683191|NCT03063606|102009477|FG001|COMPLETED|Overall Study||10||
48683192|NCT03063606|102009476|FG000|NOT COMPLETED|Overall Study||2||
48683193|NCT03063606|102009477|FG001|NOT COMPLETED|Overall Study||3||
48683194|NCT00756275|102009478|FG000|STARTED|Overall Study||60||
48085756|NCT02911753|100529032|FG002|NOT COMPLETED|Overall Study||0||
48085757|NCT02994979|100529033|FG000|STARTED|Overall Study||114||
48085758|NCT02994979|100529034|FG001|STARTED|Overall Study||105||
48085759|NCT02994979|100529033|FG000|COMPLETED|Overall Study||114||
48085760|NCT02994979|100529034|FG001|COMPLETED|Overall Study||105||
48085761|NCT02994979|100529033|FG000|NOT COMPLETED|Overall Study||0||
48085762|NCT02994979|100529034|FG001|NOT COMPLETED|Overall Study||0||
48085763|NCT00666029|100529035|FG000|STARTED|Overall Study||20||
48085764|NCT00666029|100529036|FG001|STARTED|Overall Study||20||
48085765|NCT00666029|100529035|FG000|COMPLETED|Overall Study||19||
48085766|NCT00666029|100529036|FG001|COMPLETED|Overall Study||20||
48085767|NCT00666029|100529035|FG000|NOT COMPLETED|Overall Study||1||
48085768|NCT00666029|100529036|FG001|NOT COMPLETED|Overall Study||0||
48085769|NCT01083576|100529037|FG000|STARTED|Overall Study||15||
48085770|NCT01083576|100529038|FG001|STARTED|Overall Study||15||
48085771|NCT01083576|100529037|FG000|COMPLETED|Overall Study||9||
48085772|NCT01083576|100529038|FG001|COMPLETED|Overall Study||14||
48085773|NCT01083576|100529037|FG000|NOT COMPLETED|Overall Study||6||
48085774|NCT01083576|100529038|FG001|NOT COMPLETED|Overall Study||1||
48248743|NCT03410108|100927499|FG000|Refractory Expansion Part: Sub-Cohort|Overall Study||16|Sub-Cohort of the Refractory Expansion Part included participants with all sequences of ALK inhibitors other than the Main Cohort, and up to 2 prior ALK inhibitor(s).|
48248744|NCT03410108|100927499|FG000|Refractory Expansion Part|Overall Study||63|Refractory Expansion Part included participants from the Main Cohort and Sub-Cohort.|
48683195|NCT00756275|102009479|FG001|STARTED|Overall Study||77||
48683196|NCT00756275|102009478|FG000|COMPLETED|Overall Study||31||
48683197|NCT00756275|102009479|FG001|COMPLETED|Overall Study||49||
48085775|NCT00592384|100529039|FG000|STARTED|Overall Study||64||
48085776|NCT00592384|100529040|FG001|STARTED|Overall Study||69||
48085777|NCT00592384|100529039|FG000|COMPLETED|Overall Study||59||
48085778|NCT00592384|100529040|FG001|COMPLETED|Overall Study||63||
48085779|NCT00592384|100529039|FG000|NOT COMPLETED|Overall Study||5||
48085780|NCT00592384|100529040|FG001|NOT COMPLETED|Overall Study||6||
48085781|NCT03198234|100529041|FG000|STARTED|Overall Study||3||
48085782|NCT03198234|100529042|FG001|STARTED|Overall Study||2||
48085783|NCT03198234|100529043|FG002|STARTED|Overall Study||0||
48085784|NCT03198234|100529041|FG000|COMPLETED|Overall Study||3||
48683198|NCT00756275|102009478|FG000|NOT COMPLETED|Overall Study||29||
48683199|NCT00756275|102009479|FG001|NOT COMPLETED|Overall Study||28||
48683200|NCT03073525|102009480|FG000|STARTED|Overall Study||3||
48085785|NCT03198234|100529042|FG001|COMPLETED|Overall Study||1||
48085786|NCT03198234|100529043|FG002|COMPLETED|Overall Study||0||
48085787|NCT03198234|100529041|FG000|NOT COMPLETED|Overall Study||0||
48085788|NCT03198234|100529042|FG001|NOT COMPLETED|Overall Study||1||
48683201|NCT03073525|102009481|FG001|STARTED|Overall Study||11||
48085789|NCT03198234|100529043|FG002|NOT COMPLETED|Overall Study||0||
48683202|NCT03073525|102009482|FG002|STARTED|Overall Study||10||
48710781|NCT01215110|102078017|FG001|STARTED|Overall Study||15||
48085790|NCT04988646|100529044|FG000|STARTED|1st Intervention||14||
48085791|NCT04988646|100529045|FG001|STARTED|1st Intervention||14||
48085792|NCT04988646|100529046|FG002|STARTED|1st Intervention||14||
48085793|NCT04988646|100529047|FG003|STARTED|1st Intervention||14||
48085794|NCT04988646|100529044|FG000|COMPLETED|1st Intervention||14||
48248745|NCT03410108|100927499|FG000|All Refractory Participants|Overall Study||72|All Refractory Participants included all participants from the Main Cohort and Sub-Cohort of the Refractory Expansion Part, and Safety Evaluation Lead-in Part.|
48085795|NCT04988646|100529045|FG001|COMPLETED|1st Intervention||14||
48085796|NCT04988646|100529046|FG002|COMPLETED|1st Intervention||14||
48085797|NCT04988646|100529047|FG003|COMPLETED|1st Intervention||14||
48085798|NCT04988646|100529044|FG000|NOT COMPLETED|1st Intervention||0||
48085799|NCT04988646|100529045|FG001|NOT COMPLETED|1st Intervention||0||
48085800|NCT04988646|100529046|FG002|NOT COMPLETED|1st Intervention||0||
48085801|NCT04988646|100529047|FG003|NOT COMPLETED|1st Intervention||0||
48085802|NCT04988646|100529044|FG000|STARTED|Washout >= One Week||14||
48085803|NCT04988646|100529045|FG001|STARTED|Washout >= One Week||14||
48085804|NCT04988646|100529046|FG002|STARTED|Washout >= One Week||14||
48085805|NCT04988646|100529047|FG003|STARTED|Washout >= One Week||14||
48085806|NCT04988646|100529044|FG000|COMPLETED|Washout >= One Week||14||
48085807|NCT04988646|100529045|FG001|COMPLETED|Washout >= One Week||14||
48085808|NCT04988646|100529046|FG002|COMPLETED|Washout >= One Week||14||
48085809|NCT04988646|100529047|FG003|COMPLETED|Washout >= One Week||14||
48085810|NCT04988646|100529044|FG000|NOT COMPLETED|Washout >= One Week||0||
48085811|NCT04988646|100529045|FG001|NOT COMPLETED|Washout >= One Week||0||
48085812|NCT04988646|100529046|FG002|NOT COMPLETED|Washout >= One Week||0||
48085813|NCT04988646|100529047|FG003|NOT COMPLETED|Washout >= One Week||0||
48085814|NCT04988646|100529044|FG000|STARTED|2nd Intervention||14||
48248746|NCT03410108|100927499|FG000|TKI-Naive Expansion Cohort|Overall Study||32|TKI-Naive Expansion Cohort included participants with no prior ALK-TKI treatment.|
48248747|NCT03410108|100927499|FG000|Completed|Overall Study||0|Completed = Participants who completed the treatment.|
48248748|NCT03410108|100927499|FG000|COMPLETED|Overall Study||0||
48085815|NCT04988646|100529045|FG001|STARTED|2nd Intervention||14||
48085816|NCT04988646|100529046|FG002|STARTED|2nd Intervention||14||
48085817|NCT04988646|100529047|FG003|STARTED|2nd Intervention||14||
48085818|NCT04988646|100529044|FG000|COMPLETED|2nd Intervention||13||
48085819|NCT04988646|100529045|FG001|COMPLETED|2nd Intervention||13||
48085820|NCT04988646|100529046|FG002|COMPLETED|2nd Intervention||14||
48085821|NCT04988646|100529047|FG003|COMPLETED|2nd Intervention||14||
48248749|NCT03410108|100927499|FG000|NOT COMPLETED|Overall Study||104||
48248750|NCT01572493|100927500|FG000|STARTED|Overall Study||4||
48248751|NCT01572493|100927501|FG001|STARTED|Overall Study||3||
48248752|NCT01572493|100927502|FG002|STARTED|Overall Study||3||
48248753|NCT01572493|100927503|FG003|STARTED|Overall Study||6||
48248754|NCT01572493|100927504|FG004|STARTED|Overall Study||9||
48248755|NCT01572493|100927505|FG005|STARTED|Overall Study||2||
48248756|NCT01572493|100927506|FG006|STARTED|Overall Study||4||
48248757|NCT01572493|100927507|FG007|STARTED|Overall Study||3||
48248758|NCT01572493|100927508|FG008|STARTED|Overall Study||4||
48085822|NCT04988646|100529044|FG000|NOT COMPLETED|2nd Intervention||1||
48085823|NCT04988646|100529045|FG001|NOT COMPLETED|2nd Intervention||1||
48085824|NCT04988646|100529046|FG002|NOT COMPLETED|2nd Intervention||0||
48085825|NCT04988646|100529047|FG003|NOT COMPLETED|2nd Intervention||0||
48085826|NCT03856164|100529048|FG000|STARTED|Overall Study||55||
48085827|NCT03856164|100529049|FG001|STARTED|Overall Study||55||
48085828|NCT03856164|100529048|FG000|COMPLETED|Overall Study||55||
48085829|NCT03856164|100529049|FG001|COMPLETED|Overall Study||55||
48085830|NCT03856164|100529048|FG000|NOT COMPLETED|Overall Study||0||
48085831|NCT03856164|100529049|FG001|NOT COMPLETED|Overall Study||0||
48085832|NCT03364023|100529050|FG000|STARTED|Overall Study||183||
48085833|NCT03364023|100529050|FG000|COMPLETED|Overall Study||166||
48085834|NCT03364023|100529050|FG000|NOT COMPLETED|Overall Study||17||
48085835|NCT01661621|100529051|FG000|STARTED|Overall Study||116||
48085836|NCT01661621|100529052|FG001|STARTED|Overall Study||279||
48085837|NCT01661621|100529051|FG000|COMPLETED|Overall Study||116||
48085838|NCT01661621|100529052|FG001|COMPLETED|Overall Study||279||
48085839|NCT01661621|100529051|FG000|NOT COMPLETED|Overall Study||0||
48085840|NCT01661621|100529052|FG001|NOT COMPLETED|Overall Study||0||
48085841|NCT03554746|100529053|FG000|STARTED|Overall Study||24||
48085842|NCT03554746|100529054|FG001|STARTED|Overall Study||24||
48085843|NCT03554746|100529053|FG000|COMPLETED|Overall Study||24||
48085844|NCT03554746|100529054|FG001|COMPLETED|Overall Study||24||
48085845|NCT03554746|100529053|FG000|NOT COMPLETED|Overall Study||0||
48085846|NCT03554746|100529054|FG001|NOT COMPLETED|Overall Study||0||
48085847|NCT01479517|100529055|FG000|STARTED|Overall Study||10||
48085848|NCT01479517|100529056|FG001|STARTED|Overall Study||10||
48085849|NCT01479517|100529057|FG002|STARTED|Overall Study||10||
48085850|NCT01479517|100529055|FG000|COMPLETED|Overall Study||10||
48085851|NCT01479517|100529056|FG001|COMPLETED|Overall Study||10||
48085852|NCT01479517|100529057|FG002|COMPLETED|Overall Study||10||
48085853|NCT01479517|100529055|FG000|NOT COMPLETED|Overall Study||0||
48085854|NCT01479517|100529056|FG001|NOT COMPLETED|Overall Study||0||
48085855|NCT01479517|100529057|FG002|NOT COMPLETED|Overall Study||0||
48085856|NCT02227758|100529058|FG000|STARTED|Overall Study||112||
48085857|NCT02227758|100529058|FG000|COMPLETED|Overall Study||45||
48085858|NCT02227758|100529058|FG000|NOT COMPLETED|Overall Study||67||
48085859|NCT02057406|100529059|FG000|STARTED|Overall Study||36||
48085860|NCT02057406|100529060|FG001|STARTED|Overall Study||36||
48085861|NCT02057406|100529061|FG002|STARTED|Overall Study||36||
48248759|NCT01572493|100927500|FG000|COMPLETED|Overall Study||3||
48248760|NCT01572493|100927501|FG001|COMPLETED|Overall Study||2||
48248761|NCT01572493|100927502|FG002|COMPLETED|Overall Study||1||
48248762|NCT01572493|100927503|FG003|COMPLETED|Overall Study||4||
48248763|NCT01572493|100927504|FG004|COMPLETED|Overall Study||7||
48248764|NCT01572493|100927505|FG005|COMPLETED|Overall Study||1||
48248765|NCT01572493|100927506|FG006|COMPLETED|Overall Study||1||
48248766|NCT01572493|100927507|FG007|COMPLETED|Overall Study||3||
48248767|NCT01572493|100927508|FG008|COMPLETED|Overall Study||2||
48248768|NCT01572493|100927500|FG000|NOT COMPLETED|Overall Study||1||
48248769|NCT01572493|100927501|FG001|NOT COMPLETED|Overall Study||1||
48248770|NCT01572493|100927502|FG002|NOT COMPLETED|Overall Study||2||
48248771|NCT01572493|100927503|FG003|NOT COMPLETED|Overall Study||2||
48248772|NCT01572493|100927504|FG004|NOT COMPLETED|Overall Study||2||
48248773|NCT01572493|100927505|FG005|NOT COMPLETED|Overall Study||1||
48248774|NCT01572493|100927506|FG006|NOT COMPLETED|Overall Study||3||
48248775|NCT01572493|100927507|FG007|NOT COMPLETED|Overall Study||0||
48248776|NCT01572493|100927508|FG008|NOT COMPLETED|Overall Study||2||
48248777|NCT01956071|100927509|FG000|STARTED|Overall Study||44||
48248778|NCT01956071|100927509|FG000|COMPLETED|Overall Study||44||
48248779|NCT01956071|100927509|FG000|NOT COMPLETED|Overall Study||0||
48248780|NCT03594266|100927510|FG000|STARTED|Overall Study||38||
48248781|NCT03594266|100927511|FG001|STARTED|Overall Study||39||
48248782|NCT03594266|100927510|FG000|COMPLETED|Overall Study||31||
48248783|NCT03594266|100927511|FG001|COMPLETED|Overall Study||34||
48248784|NCT03594266|100927510|FG000|NOT COMPLETED|Overall Study||7||
48248785|NCT03594266|100927511|FG001|NOT COMPLETED|Overall Study||5||
48248786|NCT00837096|100927512|FG000|STARTED|Overall Study||10||
48248787|NCT00837096|100927513|FG001|STARTED|Overall Study||9||
48248788|NCT00837096|100927512|FG000|COMPLETED|Overall Study||0||
48248789|NCT00837096|100927513|FG001|COMPLETED|Overall Study||0||
48248790|NCT00837096|100927512|FG000|NOT COMPLETED|Overall Study||10||
48248791|NCT00837096|100927513|FG001|NOT COMPLETED|Overall Study||9||
48248792|NCT03022045|100927514|FG000|STARTED|Overall Study||9||
48248793|NCT03022045|100927515|FG001|STARTED|Overall Study||8||
48248794|NCT03022045|100927514|FG000|COMPLETED|Overall Study||8|As of the interim analysis data cutoff (14 December 2018)|
48248795|NCT03022045|100927515|FG001|COMPLETED|Overall Study||6|As of the interim analysis data cutoff (14 December 2018)|
48248796|NCT03022045|100927514|FG000|NOT COMPLETED|Overall Study||1||
48248797|NCT03022045|100927515|FG001|NOT COMPLETED|Overall Study||2||
48248798|NCT00791102|100927516|FG000|STARTED|Period 1||10||
48248799|NCT00791102|100927517|FG001|STARTED|Period 1||10||
48248800|NCT00791102|100927516|FG000|COMPLETED|Period 1||10||
48248801|NCT00791102|100927517|FG001|COMPLETED|Period 1||10||
48248802|NCT00791102|100927516|FG000|NOT COMPLETED|Period 1||0||
48248803|NCT00791102|100927517|FG001|NOT COMPLETED|Period 1||0||
48248804|NCT00791102|100927516|FG000|STARTED|Washout Period of 2 Weeks||10||
48248805|NCT00791102|100927517|FG001|STARTED|Washout Period of 2 Weeks||10||
48248806|NCT00791102|100927516|FG000|COMPLETED|Washout Period of 2 Weeks||10||
48248807|NCT00791102|100927517|FG001|COMPLETED|Washout Period of 2 Weeks||10||
48248808|NCT00791102|100927516|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0||
48683203|NCT03073525|102009480|FG000|Part 3: Atezolizumab Alone|Overall Study||0|Part 3 did not apply to Participants who completed Part 1.|
48683204|NCT03073525|102009481|FG001|Part 3: Atezolizumab Alone|Overall Study||1|Part 3 did not apply to Participants who completed Part 1.|
48683205|NCT03073525|102009482|FG002|Part 3: Atezolizumab Alone|Overall Study||0|Part 3 did not apply to Participants who completed Part 1.|
48683206|NCT03073525|102009480|FG000|COMPLETED|Overall Study||3||
48683207|NCT03073525|102009481|FG001|COMPLETED|Overall Study||11||
48683208|NCT03073525|102009482|FG002|COMPLETED|Overall Study||7||
48683209|NCT03073525|102009480|FG000|NOT COMPLETED|Overall Study||0||
48683210|NCT03073525|102009481|FG001|NOT COMPLETED|Overall Study||0||
48683211|NCT03073525|102009482|FG002|NOT COMPLETED|Overall Study||3||
48248809|NCT00791102|100927517|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0||
48248810|NCT00791102|100927516|FG000|STARTED|Period 2||10||
48248811|NCT00791102|100927517|FG001|STARTED|Period 2||10||
48683212|NCT01152788|102009483|FG000|STARTED|Overall Study||32||
48683213|NCT01152788|102009484|FG001|STARTED|Overall Study||32||
48683214|NCT01152788|102009483|FG000|COMPLETED|Overall Study||32||
48683215|NCT01152788|102009484|FG001|COMPLETED|Overall Study||28||
48683216|NCT01152788|102009483|FG000|NOT COMPLETED|Overall Study||0||
48683217|NCT01152788|102009484|FG001|NOT COMPLETED|Overall Study||4||
48683218|NCT00443118|102009485|FG000|STARTED|Overall Study||515||
48683219|NCT00443118|102009486|FG001|STARTED|Overall Study||291||
48683220|NCT00443118|102009487|FG002|STARTED|Overall Study||226||
48683221|NCT00443118|102009485|FG000|COMPLETED|Overall Study||511||
48683222|NCT00443118|102009486|FG001|COMPLETED|Overall Study||290||
48683223|NCT00443118|102009487|FG002|COMPLETED|Overall Study||226||
48683224|NCT00443118|102009485|FG000|NOT COMPLETED|Overall Study||4||
48683225|NCT00443118|102009486|FG001|NOT COMPLETED|Overall Study||1||
48683226|NCT00443118|102009487|FG002|NOT COMPLETED|Overall Study||0||
48683227|NCT02651116|102009488|FG000|STARTED|Overall Study||68||
48683228|NCT02651116|102009489|FG001|STARTED|Overall Study||63||
48683229|NCT02651116|102009488|FG000|Treated|Overall Study||68||
48683230|NCT02651116|102009489|FG001|Treated|Overall Study||63||
48683231|NCT02651116|102009488|FG000|COMPLETED|Overall Study||67||
48683232|NCT02651116|102009489|FG001|COMPLETED|Overall Study||62||
48683233|NCT02651116|102009488|FG000|NOT COMPLETED|Overall Study||1||
48683234|NCT02651116|102009489|FG001|NOT COMPLETED|Overall Study||1||
48683235|NCT01055613|102009490|FG000|STARTED|Overall Study||200||
48683236|NCT01055613|102009491|FG001|STARTED|Overall Study||100||
48248812|NCT00791102|100927516|FG000|COMPLETED|Period 2||10||
48683237|NCT01055613|102009490|FG000|COMPLETED|Overall Study||191||
48683238|NCT01055613|102009491|FG001|COMPLETED|Overall Study||96||
48248813|NCT00791102|100927517|FG001|COMPLETED|Period 2||10||
48248814|NCT00791102|100927516|FG000|NOT COMPLETED|Period 2||0||
48248815|NCT00791102|100927517|FG001|NOT COMPLETED|Period 2||0||
48248816|NCT02186015|100927518|FG000|STARTED|Overall Study||11||
48248817|NCT02186015|100927519|FG001|STARTED|Overall Study||31||
48248818|NCT02186015|100927518|FG000|COMPLETED|Overall Study||10||
48248819|NCT02186015|100927519|FG001|COMPLETED|Overall Study||31||
48248820|NCT02186015|100927518|FG000|NOT COMPLETED|Overall Study||1||
48248821|NCT02186015|100927519|FG001|NOT COMPLETED|Overall Study||0||
48248822|NCT03721978|100927520|FG000|STARTED|Overall Study||134||
48248823|NCT03721978|100927521|FG001|STARTED|Overall Study||69||
48248824|NCT03721978|100927520|FG000|Intent-to-Treat (ITT) Population|Overall Study||134|ITT population included all participants who were randomized.|
48248825|NCT03721978|100927521|FG001|Intent-to-Treat (ITT) Population|Overall Study||69|ITT population included all participants who were randomized.|
48248826|NCT03721978|100927520|FG000|Baseline Biomarker-positive Participants for ITT|Overall Study||21|Baseline Biomarker-positive Participants for ITT included participants from ITT population who were biomarker positive as identified by microRNA (miRNA) profiling performed from peripheral blood.|
48248827|NCT03721978|100927521|FG001|Baseline Biomarker-positive Participants for ITT|Overall Study||4|Baseline Biomarker-positive Participants for ITT included participants from ITT population who were biomarker positive as identified by microRNA (miRNA) profiling performed from peripheral blood.|
48248828|NCT03721978|100927520|FG000|Safety Set|Overall Study||134|Safety set included all participants who received at least one dose of study treatment.|
48248829|NCT03721978|100927521|FG001|Safety Set|Overall Study||68|Safety set included all participants who received at least one dose of study treatment.|
48248830|NCT03721978|100927520|FG000|Modified ITT (mITT) Population|Overall Study||130|mITT population included all participants who received at least one dose of study treatment and who had an analysis endpoint of interest.|
48294133|NCT02527343|101047537|FG001|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0||
48294134|NCT02527343|101047538|FG002|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||1||
48683239|NCT01055613|102009490|FG000|NOT COMPLETED|Overall Study||9||
48683240|NCT01055613|102009491|FG001|NOT COMPLETED|Overall Study||4||
48683241|NCT03110029|102009492|FG000|STARTED|Overall Study||7||
48683242|NCT03110029|102009493|FG001|STARTED|Overall Study||6||
48683243|NCT03110029|102009492|FG000|COMPLETED|Overall Study||6||
48683244|NCT03110029|102009493|FG001|COMPLETED|Overall Study||5||
48683245|NCT03110029|102009492|FG000|NOT COMPLETED|Overall Study||1||
48683246|NCT03110029|102009493|FG001|NOT COMPLETED|Overall Study||1||
48683247|NCT01352286|102009494|FG000|STARTED|Overall Study||25||
48683248|NCT01352286|102009494|FG000|Received T-cells|Overall Study||25||
48683249|NCT01352286|102009494|FG000|COMPLETED|Overall Study||25||
48683250|NCT01352286|102009494|FG000|NOT COMPLETED|Overall Study||0||
48683251|NCT03417466|102009495|FG000|STARTED|Overall Study||66||
48683252|NCT03417466|102009495|FG000|COMPLETED|Overall Study||66||
48683253|NCT03417466|102009495|FG000|NOT COMPLETED|Overall Study||0||
48683254|NCT01016132|102009496|FG000|STARTED|Overall Study||152||
48683255|NCT01016132|102009496|FG000|COMPLETED|Overall Study||151||
48683256|NCT01016132|102009496|FG000|NOT COMPLETED|Overall Study||1||
48683257|NCT01562886|102009497|FG000|STARTED|Overall Study||14||
48683258|NCT01562886|102009497|FG000|COMPLETED|Overall Study||13||
48683259|NCT01562886|102009497|FG000|NOT COMPLETED|Overall Study||1||
48683260|NCT02852967|102009498|FG000|STARTED|Overall Study||23||
48683261|NCT02852967|102009499|FG001|STARTED|Overall Study||22||
48683262|NCT02852967|102009500|FG002|STARTED|Overall Study||21||
48683263|NCT02852967|102009501|FG003|STARTED|Overall Study||26||
48683264|NCT02852967|102009502|FG004|STARTED|Overall Study||18||
48683265|NCT02852967|102009498|FG000|Completed Period 1: Double-blind|Overall Study||14||
48683266|NCT02852967|102009499|FG001|Completed Period 1: Double-blind|Overall Study||15||
48683267|NCT02852967|102009500|FG002|Completed Period 1: Double-blind|Overall Study||17||
48683268|NCT02852967|102009501|FG003|Completed Period 1: Double-blind|Overall Study||16||
48683269|NCT02852967|102009502|FG004|Completed Period 1: Double-blind|Overall Study||10||
48683270|NCT02852967|102009498|FG000|Completed Period 2: Open-label|Overall Study||11||
48683271|NCT02852967|102009499|FG001|Completed Period 2: Open-label|Overall Study||8||
48683272|NCT02852967|102009500|FG002|Completed Period 2: Open-label|Overall Study||13||
48683273|NCT02852967|102009501|FG003|Completed Period 2: Open-label|Overall Study||11||
48683274|NCT02852967|102009502|FG004|Completed Period 2: Open-label|Overall Study||14||
48683275|NCT02852967|102009498|FG000|COMPLETED|Overall Study||9||
48683276|NCT02852967|102009499|FG001|COMPLETED|Overall Study||6||
48683277|NCT02852967|102009500|FG002|COMPLETED|Overall Study||9||
48683278|NCT02852967|102009501|FG003|COMPLETED|Overall Study||4||
48683279|NCT02852967|102009502|FG004|COMPLETED|Overall Study||2||
48683280|NCT02852967|102009498|FG000|NOT COMPLETED|Overall Study||14||
48683281|NCT02852967|102009499|FG001|NOT COMPLETED|Overall Study||16||
48683282|NCT02852967|102009500|FG002|NOT COMPLETED|Overall Study||12||
48683283|NCT02852967|102009501|FG003|NOT COMPLETED|Overall Study||22||
48683284|NCT02852967|102009502|FG004|NOT COMPLETED|Overall Study||16||
48683285|NCT03364231|102009503|FG000|STARTED|Overall Study||8||
48683286|NCT03364231|102009504|FG001|STARTED|Overall Study||13||
48683287|NCT03364231|102009503|FG000|Safety Population|Overall Study||8|Safety population included all enrolled participants who received at least one dose of study treatment.|
48683288|NCT03364231|102009504|FG001|Safety Population|Overall Study||13|Safety population included all enrolled participants who received at least one dose of study treatment.|
48248831|NCT03721978|100927521|FG001|Modified ITT (mITT) Population|Overall Study||68|mITT population included all participants who received at least one dose of study treatment and who had an analysis endpoint of interest.|
48248832|NCT03721978|100927520|FG000|COMPLETED|Overall Study||121||
48248833|NCT03721978|100927521|FG001|COMPLETED|Overall Study||64||
48248834|NCT03721978|100927520|FG000|NOT COMPLETED|Overall Study||13||
48248835|NCT03721978|100927521|FG001|NOT COMPLETED|Overall Study||5||
48248836|NCT03746483|100927522|FG000|STARTED|Overall Study||21||
48248837|NCT03746483|100927523|FG001|STARTED|Overall Study||20||
48683289|NCT03364231|102009503|FG000|Modified Intent-To-Treat (mITT)|Overall Study||8|mITT population included all participants who received at least one dose of study treatment and provided at least some post baseline efficacy assessment.|
48683290|NCT03364231|102009504|FG001|Modified Intent-To-Treat (mITT)|Overall Study||10|mITT population included all participants who received at least one dose of study treatment and provided at least some post baseline efficacy assessment.|
48683291|NCT03364231|102009503|FG000|COMPLETED|Overall Study||0||
48683292|NCT03364231|102009504|FG001|COMPLETED|Overall Study||0||
48683293|NCT03364231|102009503|FG000|NOT COMPLETED|Overall Study||8||
48683294|NCT03364231|102009504|FG001|NOT COMPLETED|Overall Study||13||
48085862|NCT02057406|100529059|FG000|COMPLETED|Overall Study||35||
48085863|NCT02057406|100529060|FG001|COMPLETED|Overall Study||33||
48085864|NCT02057406|100529061|FG002|COMPLETED|Overall Study||32||
48085865|NCT02057406|100529059|FG000|NOT COMPLETED|Overall Study||1||
48085866|NCT02057406|100529060|FG001|NOT COMPLETED|Overall Study||3||
48085867|NCT02057406|100529061|FG002|NOT COMPLETED|Overall Study||4||
48085868|NCT02602496|100529062|FG000|STARTED|Overall Study||15||
48085869|NCT02602496|100529063|FG001|STARTED|Overall Study||20||
48085870|NCT02602496|100529064|FG002|STARTED|Overall Study||17||
48085871|NCT02602496|100529062|FG000|COMPLETED|Overall Study||14||
48085872|NCT02602496|100529063|FG001|COMPLETED|Overall Study||18||
48085873|NCT02602496|100529064|FG002|COMPLETED|Overall Study||17||
48085874|NCT02602496|100529062|FG000|NOT COMPLETED|Overall Study||1||
48085875|NCT02602496|100529063|FG001|NOT COMPLETED|Overall Study||2||
48248838|NCT03746483|100927522|FG000|COMPLETED|Overall Study||15||
48248839|NCT03746483|100927523|FG001|COMPLETED|Overall Study||17||
48248840|NCT03746483|100927522|FG000|NOT COMPLETED|Overall Study||6||
48248841|NCT03746483|100927523|FG001|NOT COMPLETED|Overall Study||3||
48248842|NCT04414397|100927524|FG000|STARTED|Control Period||58||
48248843|NCT04414397|100927525|FG001|STARTED|Control Period||113||
48248844|NCT04414397|100927524|FG000|COMPLETED|Control Period||56||
48248845|NCT04414397|100927525|FG001|COMPLETED|Control Period||106||
48248846|NCT04414397|100927524|FG000|NOT COMPLETED|Control Period||2||
48683295|NCT01537315|102009505|FG000|STARTED|Overall Study||1||
48683296|NCT01537315|102009506|FG001|STARTED|Overall Study||7||
48683297|NCT01537315|102009505|FG000|COMPLETED|Overall Study||1||
48683298|NCT01537315|102009506|FG001|COMPLETED|Overall Study||7||
48683299|NCT01537315|102009505|FG000|NOT COMPLETED|Overall Study||0||
48683300|NCT01537315|102009506|FG001|NOT COMPLETED|Overall Study||0||
48683301|NCT00066690|102009507|FG000|STARTED|Overall Study||1021||
48085876|NCT02602496|100529064|FG002|NOT COMPLETED|Overall Study||0||
48085877|NCT02056340|100529065|FG000|STARTED|Overall Study||59||
48085878|NCT02056340|100529066|FG001|STARTED|Overall Study||57||
48085879|NCT02056340|100529065|FG000|COMPLETED|Overall Study||52||
48085880|NCT02056340|100529066|FG001|COMPLETED|Overall Study||46||
48085881|NCT02056340|100529065|FG000|NOT COMPLETED|Overall Study||7||
48085882|NCT02056340|100529066|FG001|NOT COMPLETED|Overall Study||11||
48085883|NCT02547649|100529067|FG000|STARTED|Overall Study||231|Randomized|
48085884|NCT02547649|100529068|FG001|STARTED|Overall Study||231|Randomized|
48085885|NCT02547649|100529069|FG002|STARTED|Overall Study||228|Randomized|
48085886|NCT02547649|100529067|FG000|Vaccinated|Overall Study||231||
48085887|NCT02547649|100529068|FG001|Vaccinated|Overall Study||231||
48085888|NCT02547649|100529069|FG002|Vaccinated|Overall Study||227||
48085889|NCT02547649|100529067|FG000|COMPLETED|Overall Study||228||
48085890|NCT02547649|100529068|FG001|COMPLETED|Overall Study||226||
48085891|NCT02547649|100529069|FG002|COMPLETED|Overall Study||224||
48085892|NCT02547649|100529067|FG000|NOT COMPLETED|Overall Study||3||
48085893|NCT02547649|100529068|FG001|NOT COMPLETED|Overall Study||5||
48085894|NCT02547649|100529069|FG002|NOT COMPLETED|Overall Study||4||
48085895|NCT03383198|100529070|FG000|STARTED|Overall Study||4||
48085896|NCT03383198|100529071|FG001|STARTED|Overall Study||1||
48248847|NCT04414397|100927525|FG001|NOT COMPLETED|Control Period||7||
48248848|NCT04414397|100927524|FG000|STARTED|Post-Control Period||53||
48248849|NCT04414397|100927525|FG001|STARTED|Post-Control Period||106||
48248850|NCT04414397|100927524|FG000|COMPLETED|Post-Control Period||46||
48248851|NCT04414397|100927525|FG001|COMPLETED|Post-Control Period||91||
48248852|NCT04414397|100927524|FG000|NOT COMPLETED|Post-Control Period||7||
48248853|NCT04414397|100927525|FG001|NOT COMPLETED|Post-Control Period||15||
48248854|NCT04414397|100927524|FG000|STARTED|Maintenance Treatment Period||0||
48248855|NCT04414397|100927525|FG001|STARTED|Maintenance Treatment Period||40||
48248856|NCT04414397|100927524|FG000|COMPLETED|Maintenance Treatment Period||0||
48248857|NCT04414397|100927525|FG001|COMPLETED|Maintenance Treatment Period||35||
48248858|NCT04414397|100927524|FG000|NOT COMPLETED|Maintenance Treatment Period||0||
48248859|NCT04414397|100927525|FG001|NOT COMPLETED|Maintenance Treatment Period||5||
48248860|NCT00550771|100927526|FG000|STARTED|Overall Study||121||
48248861|NCT00550771|100927527|FG001|STARTED|Overall Study||60||
48085897|NCT03383198|100529070|FG000|COMPLETED|Overall Study||4||
48683302|NCT00066690|102009508|FG001|STARTED|Overall Study||1024||
48085898|NCT03383198|100529071|FG001|COMPLETED|Overall Study||1||
48085899|NCT03383198|100529070|FG000|NOT COMPLETED|Overall Study||0||
48248862|NCT00550771|100927526|FG000|COMPLETED|Overall Study||104||
48248863|NCT00550771|100927527|FG001|COMPLETED|Overall Study||50||
48248864|NCT00550771|100927526|FG000|NOT COMPLETED|Overall Study||17||
48248865|NCT00550771|100927527|FG001|NOT COMPLETED|Overall Study||10||
48248866|NCT02864147|100927528|FG000|STARTED|Overall Study||45||
48248867|NCT02864147|100927529|FG001|STARTED|Overall Study||45||
48248868|NCT02864147|100927530|FG002|STARTED|Overall Study||43||
48248869|NCT02864147|100927528|FG000|Completed Treatment|Overall Study||45||
48248870|NCT02864147|100927529|FG001|Completed Treatment|Overall Study||45||
48248871|NCT02864147|100927530|FG002|Completed Treatment|Overall Study||43||
48248872|NCT02864147|100927528|FG000|Placed On Follow Up|Overall Study||29||
48248873|NCT02864147|100927529|FG001|Placed On Follow Up|Overall Study||35||
48248874|NCT02864147|100927530|FG002|Placed On Follow Up|Overall Study||28||
48248875|NCT02864147|100927528|FG000|COMPLETED|Overall Study||38||
48248876|NCT02864147|100927529|FG001|COMPLETED|Overall Study||38||
48248877|NCT02864147|100927530|FG002|COMPLETED|Overall Study||38||
48248878|NCT02864147|100927528|FG000|NOT COMPLETED|Overall Study||7||
48248879|NCT02864147|100927529|FG001|NOT COMPLETED|Overall Study||7||
48085900|NCT03383198|100529071|FG001|NOT COMPLETED|Overall Study||0||
48248880|NCT02864147|100927530|FG002|NOT COMPLETED|Overall Study||5||
48248881|NCT04585737|100927531|FG000|STARTED|Overall Study||149||
48248882|NCT04585737|100927532|FG001|STARTED|Overall Study||73||
48248883|NCT04585737|100927531|FG000|COMPLETED|Overall Study||133||
48248884|NCT04585737|100927532|FG001|COMPLETED|Overall Study||65||
48248885|NCT04585737|100927531|FG000|NOT COMPLETED|Overall Study||16||
48248886|NCT04585737|100927532|FG001|NOT COMPLETED|Overall Study||8||
48248887|NCT05065918|100927533|FG000|STARTED|Overall Study||92||
48248888|NCT05065918|100927534|FG001|STARTED|Overall Study||91||
48248889|NCT05065918|100927533|FG000|COMPLETED|Overall Study||91||
48248890|NCT05065918|100927534|FG001|COMPLETED|Overall Study||89||
48248891|NCT05065918|100927533|FG000|NOT COMPLETED|Overall Study||1||
48248892|NCT05065918|100927534|FG001|NOT COMPLETED|Overall Study||2||
48248893|NCT00130728|100927535|FG000|STARTED|Overall Study||319||
48248894|NCT00130728|100927536|FG001|STARTED|Overall Study||317||
48248895|NCT00130728|100927535|FG000|Received Study Drug (Safety Population)|Overall Study||313||
48248896|NCT00130728|100927536|FG001|Received Study Drug (Safety Population)|Overall Study||313||
48248897|NCT00130728|100927535|FG000|COMPLETED|Overall Study||57||
48248898|NCT00130728|100927536|FG001|COMPLETED|Overall Study||57||
48248899|NCT00130728|100927535|FG000|NOT COMPLETED|Overall Study||262||
48248900|NCT00130728|100927536|FG001|NOT COMPLETED|Overall Study||260||
48248901|NCT00935649|100927537|FG000|STARTED|Overall Study||139||
48248902|NCT00935649|100927537|FG000|COMPLETED|Overall Study||134||
48248903|NCT00935649|100927537|FG000|NOT COMPLETED|Overall Study||5||
48248904|NCT02250183|100927538|FG000|STARTED|Overall Study||21||
48248905|NCT02250183|100927538|FG000|COMPLETED|Overall Study||13||
48248906|NCT02250183|100927538|FG000|NOT COMPLETED|Overall Study||8||
48248907|NCT06247488|100927539|FG000|STARTED|First Intervention (1 Day)||10||
48248908|NCT06247488|100927540|FG001|STARTED|First Intervention (1 Day)||10||
48248909|NCT06247488|100927541|FG002|STARTED|First Intervention (1 Day)||11||
48248910|NCT06247488|100927542|FG003|STARTED|First Intervention (1 Day)||12||
48248911|NCT06247488|100927543|FG004|STARTED|First Intervention (1 Day)||10||
48248912|NCT06247488|100927544|FG005|STARTED|First Intervention (1 Day)||10||
48248913|NCT06247488|100927539|FG000|COMPLETED|First Intervention (1 Day)||10||
48248914|NCT06247488|100927540|FG001|COMPLETED|First Intervention (1 Day)||10||
48085901|NCT01925677|100529072|FG000|STARTED|Overall Study||3||
48085902|NCT01925677|100529072|FG000|COMPLETED|Overall Study||3||
48085903|NCT01925677|100529072|FG000|NOT COMPLETED|Overall Study||0||
48085904|NCT02471430|100529073|FG000|STARTED|Overall Study||4||
48085905|NCT02471430|100529074|FG001|STARTED|Overall Study||9||
48085906|NCT02471430|100529075|FG002|STARTED|Overall Study||4||
48248915|NCT06247488|100927541|FG002|COMPLETED|First Intervention (1 Day)||11||
48248916|NCT06247488|100927542|FG003|COMPLETED|First Intervention (1 Day)||12||
48248917|NCT06247488|100927543|FG004|COMPLETED|First Intervention (1 Day)||10||
48248918|NCT06247488|100927544|FG005|COMPLETED|First Intervention (1 Day)||10||
48248919|NCT06247488|100927539|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48248920|NCT06247488|100927540|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48248921|NCT06247488|100927541|FG002|NOT COMPLETED|First Intervention (1 Day)||0||
48248922|NCT06247488|100927542|FG003|NOT COMPLETED|First Intervention (1 Day)||0||
48248923|NCT06247488|100927543|FG004|NOT COMPLETED|First Intervention (1 Day)||0||
48248924|NCT06247488|100927544|FG005|NOT COMPLETED|First Intervention (1 Day)||0||
48248925|NCT06247488|100927539|FG000|STARTED|First Washout (3 Days)||10||
48248926|NCT06247488|100927540|FG001|STARTED|First Washout (3 Days)||10||
48248927|NCT06247488|100927541|FG002|STARTED|First Washout (3 Days)||11||
48248928|NCT06247488|100927542|FG003|STARTED|First Washout (3 Days)||12||
48248929|NCT06247488|100927543|FG004|STARTED|First Washout (3 Days)||10||
48248930|NCT06247488|100927544|FG005|STARTED|First Washout (3 Days)||10||
48248931|NCT06247488|100927539|FG000|COMPLETED|First Washout (3 Days)||10||
48085907|NCT02471430|100529073|FG000|COMPLETED|Overall Study||4||
48248932|NCT06247488|100927540|FG001|COMPLETED|First Washout (3 Days)||10||
48248933|NCT06247488|100927541|FG002|COMPLETED|First Washout (3 Days)||11||
48248934|NCT06247488|100927542|FG003|COMPLETED|First Washout (3 Days)||12||
48248935|NCT06247488|100927543|FG004|COMPLETED|First Washout (3 Days)||10||
48248936|NCT06247488|100927544|FG005|COMPLETED|First Washout (3 Days)||10||
48248937|NCT06247488|100927539|FG000|NOT COMPLETED|First Washout (3 Days)||0||
48248938|NCT06247488|100927540|FG001|NOT COMPLETED|First Washout (3 Days)||0||
48248939|NCT06247488|100927541|FG002|NOT COMPLETED|First Washout (3 Days)||0||
48248940|NCT06247488|100927542|FG003|NOT COMPLETED|First Washout (3 Days)||0||
48248941|NCT06247488|100927543|FG004|NOT COMPLETED|First Washout (3 Days)||0||
48248942|NCT06247488|100927544|FG005|NOT COMPLETED|First Washout (3 Days)||0||
48248943|NCT06247488|100927539|FG000|STARTED|Second Intervention (1 Day)||10||
48248944|NCT06247488|100927540|FG001|STARTED|Second Intervention (1 Day)||10||
48248945|NCT06247488|100927541|FG002|STARTED|Second Intervention (1 Day)||11||
48248946|NCT06247488|100927542|FG003|STARTED|Second Intervention (1 Day)||12||
48683303|NCT00066690|102009509|FG002|STARTED|Overall Study||1021||
48683304|NCT00066690|102009507|FG000|COMPLETED|Overall Study||423||
48683305|NCT00066690|102009508|FG001|COMPLETED|Overall Study||502||
48683306|NCT00066690|102009509|FG002|COMPLETED|Overall Study||457||
48683307|NCT00066690|102009507|FG000|NOT COMPLETED|Overall Study||598||
48085908|NCT02471430|100529074|FG001|COMPLETED|Overall Study||9||
48085909|NCT02471430|100529075|FG002|COMPLETED|Overall Study||4||
48085910|NCT02471430|100529073|FG000|NOT COMPLETED|Overall Study||0||
48085911|NCT02471430|100529074|FG001|NOT COMPLETED|Overall Study||0||
48085912|NCT02471430|100529075|FG002|NOT COMPLETED|Overall Study||0||
48085913|NCT00289471|100529076|FG000|STARTED|Overall Study||630||
48683308|NCT00066690|102009508|FG001|NOT COMPLETED|Overall Study||522||
48085914|NCT00289471|100529076|FG000|COMPLETED|Overall Study||630||
48085915|NCT00289471|100529076|FG000|NOT COMPLETED|Overall Study||0||
48085916|NCT03649750|100529077|FG000|STARTED|Period 1||12||
48248947|NCT06247488|100927543|FG004|STARTED|Second Intervention (1 Day)||10||
48248948|NCT06247488|100927544|FG005|STARTED|Second Intervention (1 Day)||10||
48248949|NCT06247488|100927539|FG000|COMPLETED|Second Intervention (1 Day)||10||
48248950|NCT06247488|100927540|FG001|COMPLETED|Second Intervention (1 Day)||10||
48248951|NCT06247488|100927541|FG002|COMPLETED|Second Intervention (1 Day)||11||
48248952|NCT06247488|100927542|FG003|COMPLETED|Second Intervention (1 Day)||12||
48248953|NCT06247488|100927543|FG004|COMPLETED|Second Intervention (1 Day)||10||
48248954|NCT06247488|100927544|FG005|COMPLETED|Second Intervention (1 Day)||10||
48248955|NCT06247488|100927539|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48248956|NCT06247488|100927540|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48683309|NCT00066690|102009509|FG002|NOT COMPLETED|Overall Study||564||
48248957|NCT06247488|100927541|FG002|NOT COMPLETED|Second Intervention (1 Day)||0||
48683310|NCT01265992|102009510|FG000|STARTED|Overall Study||50||
48683311|NCT01265992|102009510|FG000|Received Treatment|Overall Study||49||
48683312|NCT01265992|102009510|FG000|COMPLETED|Overall Study||41||
48683313|NCT01265992|102009510|FG000|NOT COMPLETED|Overall Study||9||
48683314|NCT00524121|102009511|FG000|STARTED|Overall Study||22||
48683315|NCT00524121|102009511|FG000|COMPLETED|Overall Study||3||
48683316|NCT00524121|102009511|FG000|NOT COMPLETED|Overall Study||19||
48683317|NCT01896687|102009512|FG000|STARTED|Overall Study||15||
48683318|NCT01896687|102009513|FG001|STARTED|Overall Study||15||
48683319|NCT01896687|102009512|FG000|COMPLETED|Overall Study||15||
48085917|NCT03649750|100529078|FG001|STARTED|Period 1||24||
48085918|NCT03649750|100529077|FG000|COMPLETED|Period 1||12||
48085919|NCT03649750|100529078|FG001|COMPLETED|Period 1||24||
48085920|NCT03649750|100529077|FG000|NOT COMPLETED|Period 1||0||
48085921|NCT03649750|100529078|FG001|NOT COMPLETED|Period 1||0||
48085922|NCT03649750|100529077|FG000|STARTED|Washout: 7 Days||12||
48085923|NCT03649750|100529078|FG001|STARTED|Washout: 7 Days||24||
48085924|NCT03649750|100529077|FG000|COMPLETED|Washout: 7 Days||12||
48085925|NCT03649750|100529078|FG001|COMPLETED|Washout: 7 Days||24||
48085926|NCT03649750|100529077|FG000|NOT COMPLETED|Washout: 7 Days||0||
48085927|NCT03649750|100529078|FG001|NOT COMPLETED|Washout: 7 Days||0||
48085928|NCT03649750|100529077|FG000|STARTED|Period 2||12||
48085929|NCT03649750|100529078|FG001|STARTED|Period 2||24||
48085930|NCT03649750|100529077|FG000|COMPLETED|Period 2||12||
48085931|NCT03649750|100529078|FG001|COMPLETED|Period 2||24||
48248958|NCT06247488|100927542|FG003|NOT COMPLETED|Second Intervention (1 Day)||0||
48248959|NCT06247488|100927543|FG004|NOT COMPLETED|Second Intervention (1 Day)||0||
48248960|NCT06247488|100927544|FG005|NOT COMPLETED|Second Intervention (1 Day)||0||
48248961|NCT06247488|100927539|FG000|STARTED|Washout From 2nd Dose (3 Days)||10||
48248962|NCT06247488|100927540|FG001|STARTED|Washout From 2nd Dose (3 Days)||10||
48248963|NCT06247488|100927541|FG002|STARTED|Washout From 2nd Dose (3 Days)||11||
48248964|NCT06247488|100927542|FG003|STARTED|Washout From 2nd Dose (3 Days)||12||
48248965|NCT06247488|100927543|FG004|STARTED|Washout From 2nd Dose (3 Days)||10||
48248966|NCT06247488|100927544|FG005|STARTED|Washout From 2nd Dose (3 Days)||10||
48248967|NCT06247488|100927539|FG000|COMPLETED|Washout From 2nd Dose (3 Days)||9||
48248968|NCT06247488|100927540|FG001|COMPLETED|Washout From 2nd Dose (3 Days)||10||
48085932|NCT03649750|100529077|FG000|NOT COMPLETED|Period 2||0||
48085933|NCT03649750|100529078|FG001|NOT COMPLETED|Period 2||0||
48683320|NCT01896687|102009513|FG001|COMPLETED|Overall Study||15||
48683321|NCT01896687|102009512|FG000|NOT COMPLETED|Overall Study||0||
48248969|NCT06247488|100927541|FG002|COMPLETED|Washout From 2nd Dose (3 Days)||11||
48248970|NCT06247488|100927542|FG003|COMPLETED|Washout From 2nd Dose (3 Days)||11||
48248971|NCT06247488|100927543|FG004|COMPLETED|Washout From 2nd Dose (3 Days)||10||
48248972|NCT06247488|100927544|FG005|COMPLETED|Washout From 2nd Dose (3 Days)||10||
48248973|NCT06247488|100927539|FG000|NOT COMPLETED|Washout From 2nd Dose (3 Days)||1||
48248974|NCT06247488|100927540|FG001|NOT COMPLETED|Washout From 2nd Dose (3 Days)||0||
48248975|NCT06247488|100927541|FG002|NOT COMPLETED|Washout From 2nd Dose (3 Days)||0||
48248976|NCT06247488|100927542|FG003|NOT COMPLETED|Washout From 2nd Dose (3 Days)||1||
48248977|NCT06247488|100927543|FG004|NOT COMPLETED|Washout From 2nd Dose (3 Days)||0||
48248978|NCT06247488|100927544|FG005|NOT COMPLETED|Washout From 2nd Dose (3 Days)||0||
48248979|NCT06247488|100927539|FG000|STARTED|Third Intervention (1 Day)||9||
48248980|NCT06247488|100927540|FG001|STARTED|Third Intervention (1 Day)||10||
48248981|NCT06247488|100927541|FG002|STARTED|Third Intervention (1 Day)||11||
48248982|NCT06247488|100927542|FG003|STARTED|Third Intervention (1 Day)||11||
48248983|NCT06247488|100927543|FG004|STARTED|Third Intervention (1 Day)||10||
48248984|NCT06247488|100927544|FG005|STARTED|Third Intervention (1 Day)||10||
48248985|NCT06247488|100927539|FG000|COMPLETED|Third Intervention (1 Day)||9||
48248986|NCT06247488|100927540|FG001|COMPLETED|Third Intervention (1 Day)||10||
48248987|NCT06247488|100927541|FG002|COMPLETED|Third Intervention (1 Day)||11||
48248988|NCT06247488|100927542|FG003|COMPLETED|Third Intervention (1 Day)||11||
48248989|NCT06247488|100927543|FG004|COMPLETED|Third Intervention (1 Day)||10||
48248990|NCT06247488|100927544|FG005|COMPLETED|Third Intervention (1 Day)||10||
48248991|NCT06247488|100927539|FG000|NOT COMPLETED|Third Intervention (1 Day)||0||
48248992|NCT06247488|100927540|FG001|NOT COMPLETED|Third Intervention (1 Day)||0||
48248993|NCT06247488|100927541|FG002|NOT COMPLETED|Third Intervention (1 Day)||0||
48248994|NCT06247488|100927542|FG003|NOT COMPLETED|Third Intervention (1 Day)||0||
48248995|NCT06247488|100927543|FG004|NOT COMPLETED|Third Intervention (1 Day)||0||
48248996|NCT06247488|100927544|FG005|NOT COMPLETED|Third Intervention (1 Day)||0||
48248997|NCT06247488|100927539|FG000|STARTED|Washout of Third Dose (3 Days)||9||
48248998|NCT06247488|100927540|FG001|STARTED|Washout of Third Dose (3 Days)||10||
48248999|NCT06247488|100927541|FG002|STARTED|Washout of Third Dose (3 Days)||11||
48249000|NCT06247488|100927542|FG003|STARTED|Washout of Third Dose (3 Days)||11||
48249001|NCT06247488|100927543|FG004|STARTED|Washout of Third Dose (3 Days)||10||
48249002|NCT06247488|100927544|FG005|STARTED|Washout of Third Dose (3 Days)||10||
48249003|NCT06247488|100927539|FG000|COMPLETED|Washout of Third Dose (3 Days)||8||
48249004|NCT06247488|100927540|FG001|COMPLETED|Washout of Third Dose (3 Days)||10||
48249005|NCT06247488|100927541|FG002|COMPLETED|Washout of Third Dose (3 Days)||11||
48249006|NCT06247488|100927542|FG003|COMPLETED|Washout of Third Dose (3 Days)||11||
48249007|NCT06247488|100927543|FG004|COMPLETED|Washout of Third Dose (3 Days)||10||
48249008|NCT06247488|100927544|FG005|COMPLETED|Washout of Third Dose (3 Days)||10||
48540948|NCT01900561|101662606|FG001|STARTED|Overall Study||278||
48540949|NCT01900561|101662605|FG000|COMPLETED|Overall Study||261||
48540950|NCT01900561|101662606|FG001|COMPLETED|Overall Study||269||
48540951|NCT01900561|101662605|FG000|NOT COMPLETED|Overall Study||17||
48540952|NCT01900561|101662606|FG001|NOT COMPLETED|Overall Study||9||
48540953|NCT04646005|101662607|FG000|STARTED|Overall Study||113||
48540954|NCT04646005|101662607|FG000|COMPLETED|Overall Study||0||
48540955|NCT04646005|101662607|FG000|NOT COMPLETED|Overall Study||113||
48540956|NCT02538965|101662608|FG000|STARTED|Treatment Period||17||
48540957|NCT02538965|101662608|FG000|COMPLETED|Treatment Period||0||
48540958|NCT02538965|101662608|FG000|NOT COMPLETED|Treatment Period||17||
48540959|NCT02538965|101662608|FG000|STARTED|Follow-Up Period||17||
48249009|NCT06247488|100927539|FG000|NOT COMPLETED|Washout of Third Dose (3 Days)||1||
48249010|NCT06247488|100927540|FG001|NOT COMPLETED|Washout of Third Dose (3 Days)||0||
48249011|NCT06247488|100927541|FG002|NOT COMPLETED|Washout of Third Dose (3 Days)||0||
48249012|NCT06247488|100927542|FG003|NOT COMPLETED|Washout of Third Dose (3 Days)||0||
48249013|NCT06247488|100927543|FG004|NOT COMPLETED|Washout of Third Dose (3 Days)||0||
48249014|NCT06247488|100927544|FG005|NOT COMPLETED|Washout of Third Dose (3 Days)||0||
48249015|NCT06247488|100927539|FG000|STARTED|Fourth Intervention (One Day)||8||
48249016|NCT06247488|100927540|FG001|STARTED|Fourth Intervention (One Day)||10||
48249017|NCT06247488|100927541|FG002|STARTED|Fourth Intervention (One Day)||11||
48540960|NCT02538965|101662608|FG000|COMPLETED|Follow-Up Period||0||
48540961|NCT02538965|101662608|FG000|NOT COMPLETED|Follow-Up Period||17||
48540962|NCT01582152|101662609|FG000|STARTED|Overall Study||6||
48540963|NCT01582152|101662610|FG001|STARTED|Overall Study||6||
48249018|NCT06247488|100927542|FG003|STARTED|Fourth Intervention (One Day)||11||
48249019|NCT06247488|100927543|FG004|STARTED|Fourth Intervention (One Day)||10||
48249020|NCT06247488|100927544|FG005|STARTED|Fourth Intervention (One Day)||10||
48249021|NCT06247488|100927539|FG000|COMPLETED|Fourth Intervention (One Day)||8||
48249022|NCT06247488|100927540|FG001|COMPLETED|Fourth Intervention (One Day)||10||
48249023|NCT06247488|100927541|FG002|COMPLETED|Fourth Intervention (One Day)||11||
48249024|NCT06247488|100927542|FG003|COMPLETED|Fourth Intervention (One Day)||11||
48540964|NCT01582152|101662609|FG000|COMPLETED|Overall Study||0||
48540965|NCT01582152|101662610|FG001|COMPLETED|Overall Study||0||
48540966|NCT01582152|101662609|FG000|NOT COMPLETED|Overall Study||6||
48540967|NCT01582152|101662610|FG001|NOT COMPLETED|Overall Study||6||
48540968|NCT04141930|101662611|FG000|STARTED|Overall Study||302||
48249025|NCT06247488|100927543|FG004|COMPLETED|Fourth Intervention (One Day)||10||
48249026|NCT06247488|100927544|FG005|COMPLETED|Fourth Intervention (One Day)||10||
48249027|NCT06247488|100927539|FG000|NOT COMPLETED|Fourth Intervention (One Day)||0||
48249028|NCT06247488|100927540|FG001|NOT COMPLETED|Fourth Intervention (One Day)||0||
48249029|NCT06247488|100927541|FG002|NOT COMPLETED|Fourth Intervention (One Day)||0||
48249030|NCT06247488|100927542|FG003|NOT COMPLETED|Fourth Intervention (One Day)||0||
48249031|NCT06247488|100927543|FG004|NOT COMPLETED|Fourth Intervention (One Day)||0||
48249032|NCT06247488|100927544|FG005|NOT COMPLETED|Fourth Intervention (One Day)||0||
48249033|NCT06247488|100927539|FG000|STARTED|Washout of Fourth Dose (3 Days)||8||
48249034|NCT06247488|100927540|FG001|STARTED|Washout of Fourth Dose (3 Days)||10||
48249035|NCT06247488|100927541|FG002|STARTED|Washout of Fourth Dose (3 Days)||11||
48249036|NCT06247488|100927542|FG003|STARTED|Washout of Fourth Dose (3 Days)||11||
48249037|NCT06247488|100927543|FG004|STARTED|Washout of Fourth Dose (3 Days)||10||
48249038|NCT06247488|100927544|FG005|STARTED|Washout of Fourth Dose (3 Days)||10||
48249039|NCT06247488|100927539|FG000|COMPLETED|Washout of Fourth Dose (3 Days)||8||
48249040|NCT06247488|100927540|FG001|COMPLETED|Washout of Fourth Dose (3 Days)||10||
48249041|NCT06247488|100927541|FG002|COMPLETED|Washout of Fourth Dose (3 Days)||11||
48249042|NCT06247488|100927542|FG003|COMPLETED|Washout of Fourth Dose (3 Days)||10||
48085934|NCT01044862|100529079|FG000|STARTED|Overall Study||299||
48085935|NCT01044862|100529080|FG001|STARTED|Overall Study||300||
48085936|NCT01044862|100529081|FG002|STARTED|Overall Study||301||
48085937|NCT01044862|100529079|FG000|COMPLETED|Overall Study||246||
48249043|NCT06247488|100927543|FG004|COMPLETED|Washout of Fourth Dose (3 Days)||10||
48249044|NCT06247488|100927544|FG005|COMPLETED|Washout of Fourth Dose (3 Days)||10||
48249045|NCT06247488|100927539|FG000|NOT COMPLETED|Washout of Fourth Dose (3 Days)||0||
48249046|NCT06247488|100927540|FG001|NOT COMPLETED|Washout of Fourth Dose (3 Days)||0||
48249047|NCT06247488|100927541|FG002|NOT COMPLETED|Washout of Fourth Dose (3 Days)||0||
48249048|NCT06247488|100927542|FG003|NOT COMPLETED|Washout of Fourth Dose (3 Days)||1||
48249049|NCT06247488|100927543|FG004|NOT COMPLETED|Washout of Fourth Dose (3 Days)||0||
48249050|NCT06247488|100927544|FG005|NOT COMPLETED|Washout of Fourth Dose (3 Days)||0||
48249051|NCT06247488|100927539|FG000|STARTED|Fifth Intervention (1 Day)||8||
48249052|NCT06247488|100927540|FG001|STARTED|Fifth Intervention (1 Day)||10||
48249053|NCT06247488|100927541|FG002|STARTED|Fifth Intervention (1 Day)||11||
48249054|NCT06247488|100927542|FG003|STARTED|Fifth Intervention (1 Day)||10||
48249055|NCT06247488|100927543|FG004|STARTED|Fifth Intervention (1 Day)||10||
48249056|NCT06247488|100927544|FG005|STARTED|Fifth Intervention (1 Day)||10||
48249057|NCT06247488|100927539|FG000|COMPLETED|Fifth Intervention (1 Day)||8||
48249058|NCT06247488|100927540|FG001|COMPLETED|Fifth Intervention (1 Day)||10||
48249059|NCT06247488|100927541|FG002|COMPLETED|Fifth Intervention (1 Day)||11||
48249060|NCT06247488|100927542|FG003|COMPLETED|Fifth Intervention (1 Day)||10||
48249061|NCT06247488|100927543|FG004|COMPLETED|Fifth Intervention (1 Day)||10||
48249062|NCT06247488|100927544|FG005|COMPLETED|Fifth Intervention (1 Day)||10||
48249063|NCT06247488|100927539|FG000|NOT COMPLETED|Fifth Intervention (1 Day)||0||
48249064|NCT06247488|100927540|FG001|NOT COMPLETED|Fifth Intervention (1 Day)||0||
48249065|NCT06247488|100927541|FG002|NOT COMPLETED|Fifth Intervention (1 Day)||0||
48249066|NCT06247488|100927542|FG003|NOT COMPLETED|Fifth Intervention (1 Day)||0||
48375494|NCT03350750|101247649|FG001|COMPLETED|Overall Study||8||
48683322|NCT01896687|102009513|FG001|NOT COMPLETED|Overall Study||0||
48683323|NCT01673646|102009514|FG000|STARTED|Overall Study||11||
48683324|NCT01673646|102009515|FG001|STARTED|Overall Study||11||
48683325|NCT01673646|102009516|FG002|STARTED|Overall Study||11||
48085938|NCT01044862|100529080|FG001|COMPLETED|Overall Study||251||
48085939|NCT01044862|100529081|FG002|COMPLETED|Overall Study||249||
48085940|NCT01044862|100529079|FG000|NOT COMPLETED|Overall Study||53||
48085941|NCT01044862|100529080|FG001|NOT COMPLETED|Overall Study||49||
48085942|NCT01044862|100529081|FG002|NOT COMPLETED|Overall Study||52||
48085943|NCT02465216|100529082|FG000|STARTED|Overall Study||15||
48085944|NCT02465216|100529083|FG001|STARTED|Overall Study||5||
48085945|NCT02465216|100529084|FG002|STARTED|Overall Study||14||
48085946|NCT02465216|100529085|FG003|STARTED|Overall Study||14||
48085947|NCT02465216|100529086|FG004|STARTED|Overall Study||12||
48085948|NCT02465216|100529082|FG000|COMPLETED|Overall Study||12||
48085949|NCT02465216|100529083|FG001|COMPLETED|Overall Study||5||
48085950|NCT02465216|100529084|FG002|COMPLETED|Overall Study||13||
48085951|NCT02465216|100529085|FG003|COMPLETED|Overall Study||12||
48249067|NCT06247488|100927543|FG004|NOT COMPLETED|Fifth Intervention (1 Day)||0||
48249068|NCT06247488|100927544|FG005|NOT COMPLETED|Fifth Intervention (1 Day)||0||
48249069|NCT06247488|100927539|FG000|STARTED|Washout of 5th Dose (3 Days)||8||
48249070|NCT06247488|100927540|FG001|STARTED|Washout of 5th Dose (3 Days)||10||
48249071|NCT06247488|100927541|FG002|STARTED|Washout of 5th Dose (3 Days)||11||
48683326|NCT01673646|102009514|FG000|Entered/Treated in Core Phase|Overall Study||11||
48085952|NCT02465216|100529086|FG004|COMPLETED|Overall Study||9||
48085953|NCT02465216|100529082|FG000|NOT COMPLETED|Overall Study||3||
48085954|NCT02465216|100529083|FG001|NOT COMPLETED|Overall Study||0||
48085955|NCT02465216|100529084|FG002|NOT COMPLETED|Overall Study||1||
48085956|NCT02465216|100529085|FG003|NOT COMPLETED|Overall Study||2||
48085957|NCT02465216|100529086|FG004|NOT COMPLETED|Overall Study||3||
48085958|NCT04983264|100529087|FG000|STARTED|Part A: Single Dose Period||6|6|
48249072|NCT06247488|100927542|FG003|STARTED|Washout of 5th Dose (3 Days)||10||
48249073|NCT06247488|100927543|FG004|STARTED|Washout of 5th Dose (3 Days)||10||
48249074|NCT06247488|100927544|FG005|STARTED|Washout of 5th Dose (3 Days)||10||
48249075|NCT06247488|100927539|FG000|COMPLETED|Washout of 5th Dose (3 Days)||8||
48249076|NCT06247488|100927540|FG001|COMPLETED|Washout of 5th Dose (3 Days)||9||
48249077|NCT06247488|100927541|FG002|COMPLETED|Washout of 5th Dose (3 Days)||10||
48249078|NCT06247488|100927542|FG003|COMPLETED|Washout of 5th Dose (3 Days)||10||
48249079|NCT06247488|100927543|FG004|COMPLETED|Washout of 5th Dose (3 Days)||10||
48249080|NCT06247488|100927544|FG005|COMPLETED|Washout of 5th Dose (3 Days)||7||
48249081|NCT06247488|100927539|FG000|NOT COMPLETED|Washout of 5th Dose (3 Days)||0||
48249082|NCT06247488|100927540|FG001|NOT COMPLETED|Washout of 5th Dose (3 Days)||1||
48249083|NCT06247488|100927541|FG002|NOT COMPLETED|Washout of 5th Dose (3 Days)||1||
48249084|NCT06247488|100927542|FG003|NOT COMPLETED|Washout of 5th Dose (3 Days)||0||
48249085|NCT06247488|100927543|FG004|NOT COMPLETED|Washout of 5th Dose (3 Days)||0||
48249086|NCT06247488|100927544|FG005|NOT COMPLETED|Washout of 5th Dose (3 Days)||3||
48249087|NCT06247488|100927539|FG000|STARTED|Sixth Intervention (1 Day)||8||
48249088|NCT06247488|100927540|FG001|STARTED|Sixth Intervention (1 Day)||9||
48249089|NCT06247488|100927541|FG002|STARTED|Sixth Intervention (1 Day)||10||
48249090|NCT06247488|100927542|FG003|STARTED|Sixth Intervention (1 Day)||10||
48249091|NCT06247488|100927543|FG004|STARTED|Sixth Intervention (1 Day)||10||
48249092|NCT06247488|100927544|FG005|STARTED|Sixth Intervention (1 Day)||7||
48249093|NCT06247488|100927539|FG000|COMPLETED|Sixth Intervention (1 Day)||8||
48249094|NCT06247488|100927540|FG001|COMPLETED|Sixth Intervention (1 Day)||9||
48249095|NCT06247488|100927541|FG002|COMPLETED|Sixth Intervention (1 Day)||10||
48249096|NCT06247488|100927542|FG003|COMPLETED|Sixth Intervention (1 Day)||10||
48249097|NCT06247488|100927543|FG004|COMPLETED|Sixth Intervention (1 Day)||10||
48249098|NCT06247488|100927544|FG005|COMPLETED|Sixth Intervention (1 Day)||7||
48249099|NCT06247488|100927539|FG000|NOT COMPLETED|Sixth Intervention (1 Day)||0||
48249100|NCT06247488|100927540|FG001|NOT COMPLETED|Sixth Intervention (1 Day)||0||
48249101|NCT06247488|100927541|FG002|NOT COMPLETED|Sixth Intervention (1 Day)||0||
48249102|NCT06247488|100927542|FG003|NOT COMPLETED|Sixth Intervention (1 Day)||0||
48085959|NCT04983264|100529088|FG001|STARTED|Part A: Single Dose Period||0|6|
48085960|NCT04983264|100529089|FG002|STARTED|Part A: Single Dose Period||0|6|
48085961|NCT04983264|100529087|FG000|COMPLETED|Part A: Single Dose Period||6|6|
48085962|NCT04983264|100529088|FG001|COMPLETED|Part A: Single Dose Period||0|6|
48249103|NCT06247488|100927543|FG004|NOT COMPLETED|Sixth Intervention (1 Day)||0||
48249104|NCT06247488|100927544|FG005|NOT COMPLETED|Sixth Intervention (1 Day)||0||
48249105|NCT05153499|100927545|FG000|STARTED|Overall Study||12||
48249106|NCT05153499|100927546|FG001|STARTED|Overall Study||7||
48249107|NCT05153499|100927545|FG000|COMPLETED|Overall Study||4||
48249108|NCT05153499|100927546|FG001|COMPLETED|Overall Study||2||
48249109|NCT05153499|100927545|FG000|NOT COMPLETED|Overall Study||8||
48249110|NCT05153499|100927546|FG001|NOT COMPLETED|Overall Study||5||
48249111|NCT01857362|100927547|FG000|STARTED|Overall Study||6||
48249112|NCT01857362|100927548|FG001|STARTED|Overall Study||6||
48249113|NCT01857362|100927547|FG000|COMPLETED|Overall Study||6||
48249114|NCT01857362|100927548|FG001|COMPLETED|Overall Study||6||
48249115|NCT01857362|100927547|FG000|NOT COMPLETED|Overall Study||0||
48249116|NCT01857362|100927548|FG001|NOT COMPLETED|Overall Study||0||
48249117|NCT02055053|100927549|FG000|STARTED|Overall Study||35||
48249118|NCT02055053|100927550|FG001|STARTED|Overall Study||35||
48683327|NCT01673646|102009515|FG001|Entered/Treated in Core Phase|Overall Study||11||
48683328|NCT01673646|102009516|FG002|Entered/Treated in Core Phase|Overall Study||11||
48085963|NCT04983264|100529089|FG002|COMPLETED|Part A: Single Dose Period||0|6|
48085964|NCT04983264|100529087|FG000|NOT COMPLETED|Part A: Single Dose Period||0||
48249119|NCT02055053|100927549|FG000|COMPLETED|Overall Study||35||
48249120|NCT02055053|100927550|FG001|COMPLETED|Overall Study||35||
48249121|NCT02055053|100927549|FG000|NOT COMPLETED|Overall Study||0||
48683329|NCT01673646|102009514|FG000|Completed Core Phase|Overall Study||9||
48683330|NCT01673646|102009515|FG001|Completed Core Phase|Overall Study||10||
48683331|NCT01673646|102009516|FG002|Completed Core Phase|Overall Study||10||
48085965|NCT04983264|100529088|FG001|NOT COMPLETED|Part A: Single Dose Period||0||
48085966|NCT04983264|100529089|FG002|NOT COMPLETED|Part A: Single Dose Period||0||
48085967|NCT04983264|100529087|FG000|STARTED|Part B: Multiple Dose Period||0||
48085968|NCT04983264|100529088|FG001|STARTED|Part B: Multiple Dose Period||6||
48085969|NCT04983264|100529089|FG002|STARTED|Part B: Multiple Dose Period||0||
48085970|NCT04983264|100529087|FG000|COMPLETED|Part B: Multiple Dose Period||0||
48085971|NCT04983264|100529088|FG001|COMPLETED|Part B: Multiple Dose Period||5||
48085972|NCT04983264|100529089|FG002|COMPLETED|Part B: Multiple Dose Period||0||
48085973|NCT04983264|100529087|FG000|NOT COMPLETED|Part B: Multiple Dose Period||0||
48085974|NCT04983264|100529088|FG001|NOT COMPLETED|Part B: Multiple Dose Period||1||
48085975|NCT04983264|100529089|FG002|NOT COMPLETED|Part B: Multiple Dose Period||0||
48085976|NCT04983264|100529087|FG000|STARTED|Part C: Extended Treatment Period||0||
48085977|NCT04983264|100529088|FG001|STARTED|Part C: Extended Treatment Period||0||
48085978|NCT04983264|100529089|FG002|STARTED|Part C: Extended Treatment Period||4||
48249122|NCT02055053|100927550|FG001|NOT COMPLETED|Overall Study||0||
48249123|NCT00413634|100927551|FG000|STARTED|Overall Study||12||
48249124|NCT00413634|100927552|FG001|STARTED|Overall Study||12||
48249125|NCT00413634|100927551|FG000|COMPLETED|Overall Study||12||
48249126|NCT00413634|100927552|FG001|COMPLETED|Overall Study||12||
48249127|NCT00413634|100927551|FG000|NOT COMPLETED|Overall Study||0||
48249128|NCT00413634|100927552|FG001|NOT COMPLETED|Overall Study||0||
48249129|NCT01040403|100927553|FG000|STARTED|Overall Study||233||
48249130|NCT01040403|100927553|FG000|Completed Olo 5|Overall Study||106||
48249131|NCT01040403|100927553|FG000|Completed T+O 1.25/5|Overall Study||105||
48249132|NCT01040403|100927553|FG000|Completed T+O 2.5/5|Overall Study||111||
48249133|NCT01040403|100927553|FG000|Completed T+O 5/5|Overall Study||106||
48249134|NCT01040403|100927553|FG000|Completed Olo 10|Overall Study||109||
48249135|NCT01040403|100927553|FG000|Completed T+O 1.25/10|Overall Study||106||
48249136|NCT01040403|100927553|FG000|Completed T+O 2.5/10|Overall Study||110||
48249137|NCT01040403|100927553|FG000|Completed T+O 5/10|Overall Study||107||
48249138|NCT01040403|100927553|FG000|COMPLETED|Overall Study||213||
48249139|NCT01040403|100927553|FG000|NOT COMPLETED|Overall Study||20||
48375495|NCT03350750|101247648|FG000|NOT COMPLETED|Overall Study||1||
48683332|NCT01673646|102009514|FG000|Entered Ext. Phase|Overall Study||7||
48683333|NCT01673646|102009515|FG001|Entered Ext. Phase|Overall Study||9||
48683334|NCT01673646|102009516|FG002|Entered Ext. Phase|Overall Study||9||
48683335|NCT01673646|102009514|FG000|Did Not Enter Ext. Phase|Overall Study||2||
48683336|NCT01673646|102009515|FG001|Did Not Enter Ext. Phase|Overall Study||1||
48683337|NCT01673646|102009516|FG002|Did Not Enter Ext. Phase|Overall Study||1||
48683338|NCT01673646|102009514|FG000|Treated Beyond 24 Months|Overall Study||7||
48085979|NCT04983264|100529087|FG000|COMPLETED|Part C: Extended Treatment Period||0||
48085980|NCT04983264|100529088|FG001|COMPLETED|Part C: Extended Treatment Period||0||
48085981|NCT04983264|100529089|FG002|COMPLETED|Part C: Extended Treatment Period||3||
48085982|NCT04983264|100529087|FG000|NOT COMPLETED|Part C: Extended Treatment Period||0||
48085983|NCT04983264|100529088|FG001|NOT COMPLETED|Part C: Extended Treatment Period||0||
48249140|NCT01880697|100927554|FG000|STARTED|Overall Study||63||
48249141|NCT01880697|100927555|FG001|STARTED|Overall Study||63||
48249142|NCT01880697|100927554|FG000|COMPLETED|Overall Study||63||
48249143|NCT01880697|100927555|FG001|COMPLETED|Overall Study||62||
48249144|NCT01880697|100927554|FG000|NOT COMPLETED|Overall Study||0||
48683339|NCT01673646|102009515|FG001|Treated Beyond 24 Months|Overall Study||8||
48683340|NCT01673646|102009516|FG002|Treated Beyond 24 Months|Overall Study||8||
48683341|NCT01673646|102009514|FG000|Discontinued Beyond 24 Months|Overall Study||0||
48683342|NCT01673646|102009515|FG001|Discontinued Beyond 24 Months|Overall Study||4||
48683343|NCT01673646|102009516|FG002|Discontinued Beyond 24 Months|Overall Study||1||
48683344|NCT01673646|102009514|FG000|COMPLETED|Overall Study||7||
48683345|NCT01673646|102009515|FG001|COMPLETED|Overall Study||4||
48683346|NCT01673646|102009516|FG002|COMPLETED|Overall Study||7||
48683347|NCT01673646|102009514|FG000|NOT COMPLETED|Overall Study||4||
48683348|NCT01673646|102009515|FG001|NOT COMPLETED|Overall Study||7||
48683349|NCT01673646|102009516|FG002|NOT COMPLETED|Overall Study||4||
48683350|NCT00889707|102009517|FG000|STARTED|Overall Study||61||
48683351|NCT00889707|102009518|FG001|STARTED|Overall Study||31||
48683352|NCT00889707|102009517|FG000|COMPLETED|Overall Study||54||
48683353|NCT00889707|102009518|FG001|COMPLETED|Overall Study||21||
48683354|NCT00889707|102009517|FG000|NOT COMPLETED|Overall Study||7||
48683355|NCT00889707|102009518|FG001|NOT COMPLETED|Overall Study||10||
48085984|NCT04983264|100529089|FG002|NOT COMPLETED|Part C: Extended Treatment Period||1||
48085985|NCT00965718|100529090|FG000|STARTED|Overall Study||20||
48085986|NCT00965718|100529090|FG000|COMPLETED|Overall Study||16||
48085987|NCT00965718|100529090|FG000|NOT COMPLETED|Overall Study||4||
48085988|NCT00938639|100533010|FG000|STARTED|Overall Study||120||
48085989|NCT00938639|100533011|FG001|STARTED|Overall Study||120||
48085990|NCT00938639|100533010|FG000|COMPLETED|Overall Study||117||
48249145|NCT01880697|100927555|FG001|NOT COMPLETED|Overall Study||1||
48249146|NCT00627523|100927556|FG000|STARTED|Overall Study||21||
48249147|NCT00627523|100927557|FG001|STARTED|Overall Study||22||
48249148|NCT00627523|100927556|FG000|COMPLETED|Overall Study||19||
48249149|NCT00627523|100927557|FG001|COMPLETED|Overall Study||20||
48249150|NCT00627523|100927556|FG000|NOT COMPLETED|Overall Study||2||
48249151|NCT00627523|100927557|FG001|NOT COMPLETED|Overall Study||2||
48249152|NCT01742949|100927558|FG000|STARTED|Overall Study||20||
48249153|NCT01742949|100927559|FG001|STARTED|Overall Study||20||
48249154|NCT01742949|100927558|FG000|COMPLETED|Overall Study||20||
48249155|NCT01742949|100927559|FG001|COMPLETED|Overall Study||20||
48249156|NCT01742949|100927558|FG000|NOT COMPLETED|Overall Study||0||
48249157|NCT01742949|100927559|FG001|NOT COMPLETED|Overall Study||0||
48249158|NCT03275402|100927560|FG000|STARTED|Overall Study||52||
48249159|NCT03275402|100927560|FG000|COMPLETED|Overall Study||13||
48375496|NCT03350750|101247649|FG001|NOT COMPLETED|Overall Study||1||
48375497|NCT03637699|101247650|FG000|STARTED|Overall Study||15||
48683356|NCT00833443|102009519|FG000|STARTED|Overall Study||41||
48683357|NCT00833443|102009520|FG001|STARTED|Overall Study||43||
48683358|NCT00833443|102009519|FG000|COMPLETED|Overall Study||21||
48683359|NCT00833443|102009520|FG001|COMPLETED|Overall Study||15||
48085991|NCT00938639|100533011|FG001|COMPLETED|Overall Study||116||
48249160|NCT03275402|100927560|FG000|NOT COMPLETED|Overall Study||39||
48249161|NCT03282799|100927561|FG000|STARTED|Overall Study||36||
48249162|NCT03282799|100927562|FG001|STARTED|Overall Study||36||
48249163|NCT03282799|100927561|FG000|COMPLETED|Overall Study||34||
48249164|NCT03282799|100927562|FG001|COMPLETED|Overall Study||36||
48249165|NCT03282799|100927561|FG000|NOT COMPLETED|Overall Study||2||
48249166|NCT03282799|100927562|FG001|NOT COMPLETED|Overall Study||0||
48249167|NCT02137239|100927563|FG000|STARTED|Overall Study||26||
48249168|NCT02137239|100927564|FG001|STARTED|Overall Study||32||
48249169|NCT02137239|100927563|FG000|COMPLETED|Overall Study||23||
48249170|NCT02137239|100927564|FG001|COMPLETED|Overall Study||26||
48249171|NCT02137239|100927563|FG000|NOT COMPLETED|Overall Study||3||
48249172|NCT02137239|100927564|FG001|NOT COMPLETED|Overall Study||6||
48249173|NCT03327571|100927565|FG000|STARTED|Group 1: cHL||1598||
48249174|NCT03327571|100927566|FG001|STARTED|Group 1: cHL||0||
48249175|NCT03327571|100927565|FG000|COMPLETED|Group 1: cHL||1598||
48249176|NCT03327571|100927566|FG001|COMPLETED|Group 1: cHL||0||
48683360|NCT00833443|102009519|FG000|NOT COMPLETED|Overall Study||20||
48683361|NCT00833443|102009520|FG001|NOT COMPLETED|Overall Study||28||
48683362|NCT01840943|102009521|FG000|STARTED|Overall Study||14||
48683363|NCT01840943|102009522|FG001|STARTED|Overall Study||12||
48683364|NCT01840943|102009521|FG000|COMPLETED|Overall Study||1||
48683365|NCT01840943|102009522|FG001|COMPLETED|Overall Study||0||
48683366|NCT01840943|102009521|FG000|NOT COMPLETED|Overall Study||13||
48683367|NCT01840943|102009522|FG001|NOT COMPLETED|Overall Study||12||
48249177|NCT03327571|100927565|FG000|NOT COMPLETED|Group 1: cHL||0||
48249178|NCT03327571|100927566|FG001|NOT COMPLETED|Group 1: cHL||0||
48375498|NCT03637699|101247651|FG001|STARTED|Overall Study||15||
48375499|NCT03637699|101247650|FG000|COMPLETED|Overall Study||14||
48375500|NCT03637699|101247651|FG001|COMPLETED|Overall Study||14||
48375501|NCT03637699|101247650|FG000|NOT COMPLETED|Overall Study||1||
48375502|NCT03637699|101247651|FG001|NOT COMPLETED|Overall Study||1||
48375503|NCT03691610|101247652|FG000|STARTED|Overall Study||380||
48375504|NCT03691610|101247653|FG001|STARTED|Overall Study||370||
48375505|NCT03691610|101247654|FG002|STARTED|Overall Study||96||
48375506|NCT03691610|101247655|FG003|STARTED|Overall Study||104||
48375507|NCT03691610|101247652|FG000|COMPLETED|Overall Study||298||
48375508|NCT03691610|101247653|FG001|COMPLETED|Overall Study||290||
48375509|NCT03691610|101247654|FG002|COMPLETED|Overall Study||83||
48375510|NCT03691610|101247655|FG003|COMPLETED|Overall Study||94||
48375511|NCT03691610|101247652|FG000|NOT COMPLETED|Overall Study||82||
48375512|NCT03691610|101247653|FG001|NOT COMPLETED|Overall Study||80||
48249179|NCT03327571|100927565|FG000|STARTED|Group 2: RRHL||0||
48249180|NCT03327571|100927566|FG001|STARTED|Group 2: RRHL||426||
48375513|NCT03691610|101247654|FG002|NOT COMPLETED|Overall Study||13||
48375514|NCT03691610|101247655|FG003|NOT COMPLETED|Overall Study||10||
48375515|NCT00615290|101247656|FG000|STARTED|Overall Study||42||
48375516|NCT00615290|101247656|FG000|COMPLETED|Overall Study||34||
48375517|NCT00615290|101247656|FG000|NOT COMPLETED|Overall Study||8||
48375518|NCT03294681|101247657|FG000|STARTED|Overall Study||153||
48375519|NCT03294681|101247657|FG000|COMPLETED|Overall Study||152||
48375520|NCT03294681|101247657|FG000|NOT COMPLETED|Overall Study||1||
48375521|NCT00127062|101247658|FG000|STARTED|First intervention_Oxford Street||31||
48375522|NCT00127062|101247659|FG001|STARTED|First intervention_Oxford Street||29||
48375523|NCT00127062|101247658|FG000|COMPLETED|First intervention_Oxford Street||31||
48375524|NCT00127062|101247659|FG001|COMPLETED|First intervention_Oxford Street||29||
48375525|NCT00127062|101247658|FG000|NOT COMPLETED|First intervention_Oxford Street||0||
48375526|NCT00127062|101247659|FG001|NOT COMPLETED|First intervention_Oxford Street||0||
48375527|NCT00127062|101247658|FG000|STARTED|Second intervention_Hyde Park||31||
48375528|NCT00127062|101247659|FG001|STARTED|Second intervention_Hyde Park||29||
48375529|NCT00127062|101247658|FG000|COMPLETED|Second intervention_Hyde Park||31||
48375530|NCT00127062|101247659|FG001|COMPLETED|Second intervention_Hyde Park||29||
48375531|NCT00127062|101247658|FG000|NOT COMPLETED|Second intervention_Hyde Park||0||
48375532|NCT00127062|101247659|FG001|NOT COMPLETED|Second intervention_Hyde Park||0||
48375533|NCT02856269|101247660|FG000|STARTED|Overall Study||25||
48683368|NCT02230189|102009523|FG000|STARTED|Overall Study||22||
48683369|NCT02230189|102009524|FG001|STARTED|Overall Study||2||
48683370|NCT02230189|102009525|FG002|STARTED|Overall Study||4||
48683371|NCT02230189|102009523|FG000|COMPLETED|Overall Study||17||
48249181|NCT03327571|100927565|FG000|Participants Were Counted in Both Groups|Group 2: RRHL||0||
48683372|NCT02230189|102009524|FG001|COMPLETED|Overall Study||2||
48683373|NCT02230189|102009525|FG002|COMPLETED|Overall Study||3||
48249182|NCT03327571|100927566|FG001|Participants Were Counted in Both Groups|Group 2: RRHL||321||
48249183|NCT03327571|100927565|FG000|COMPLETED|Group 2: RRHL||0||
48249184|NCT03327571|100927566|FG001|COMPLETED|Group 2: RRHL||426||
48375534|NCT02856269|101247661|FG001|STARTED|Overall Study||27||
48375535|NCT02856269|101247660|FG000|COMPLETED|Overall Study||24||
48375536|NCT02856269|101247661|FG001|COMPLETED|Overall Study||24||
48375537|NCT02856269|101247660|FG000|NOT COMPLETED|Overall Study||1||
48375538|NCT02856269|101247661|FG001|NOT COMPLETED|Overall Study||3||
48375539|NCT02112994|101247662|FG000|STARTED|Overall Study||6||
48375540|NCT02112994|101247663|FG001|STARTED|Overall Study||16||
48683374|NCT02230189|102009523|FG000|NOT COMPLETED|Overall Study||5||
48683375|NCT02230189|102009524|FG001|NOT COMPLETED|Overall Study||0||
48683376|NCT02230189|102009525|FG002|NOT COMPLETED|Overall Study||1||
48375541|NCT02112994|101247664|FG002|STARTED|Overall Study||9||
48375542|NCT02112994|101247662|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
48375543|NCT02112994|101247663|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16||
48375544|NCT02112994|101247664|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9||
48375545|NCT02112994|101247662|FG000|Received 0.35 mg/kg QOW|Overall Study||0||
48249185|NCT03327571|100927565|FG000|NOT COMPLETED|Group 2: RRHL||0||
48249186|NCT03327571|100927566|FG001|NOT COMPLETED|Group 2: RRHL||0||
48249187|NCT02847637|100927567|FG000|STARTED|Overall Study||18||
48249188|NCT02847637|100927568|FG001|STARTED|Overall Study||36||
48249189|NCT02847637|100927569|FG002|STARTED|Overall Study||35||
48249190|NCT02847637|100927570|FG003|STARTED|Overall Study||63||
48249191|NCT02847637|100927567|FG000|Completed First 24 Weeks of Treatment|Overall Study||16||
48249192|NCT02847637|100927568|FG001|Completed First 24 Weeks of Treatment|Overall Study||35||
48249193|NCT02847637|100927569|FG002|Completed First 24 Weeks of Treatment|Overall Study||34||
48375546|NCT02112994|101247663|FG001|Received 0.35 mg/kg QOW|Overall Study||0||
48375547|NCT02112994|101247664|FG002|Received 0.35 mg/kg QOW|Overall Study||1||
48375548|NCT02112994|101247662|FG000|Received 1 mg/kg QOW|Overall Study||6|All participants started the study at this dose.|
48375549|NCT02112994|101247663|FG001|Received 1 mg/kg QOW|Overall Study||16|All participants started the study at this dose.|
48375550|NCT02112994|101247664|FG002|Received 1 mg/kg QOW|Overall Study||9|All participants started the study at this dose.|
48375551|NCT02112994|101247662|FG000|Received 1 mg/kg QW|Overall Study||1||
48375552|NCT02112994|101247663|FG001|Received 1 mg/kg QW|Overall Study||1||
48375553|NCT02112994|101247664|FG002|Received 1 mg/kg QW|Overall Study||0||
48375554|NCT02112994|101247662|FG000|Received 3 mg/kg QOW|Overall Study||3||
48375555|NCT02112994|101247663|FG001|Received 3 mg/kg QOW|Overall Study||5||
48375556|NCT02112994|101247664|FG002|Received 3 mg/kg QOW|Overall Study||3||
48375557|NCT02112994|101247662|FG000|Received 3 mg/kg QW|Overall Study||2||
48375558|NCT02112994|101247663|FG001|Received 3 mg/kg QW|Overall Study||1||
48375559|NCT02112994|101247664|FG002|Received 3 mg/kg QW|Overall Study||1||
48375560|NCT02112994|101247662|FG000|Completed 96-week Treatment Period|Overall Study||6||
48375561|NCT02112994|101247663|FG001|Completed 96-week Treatment Period|Overall Study||14||
48375562|NCT02112994|101247664|FG002|Completed 96-week Treatment Period|Overall Study||8||
48375563|NCT02112994|101247662|FG000|COMPLETED|Overall Study||6|Participants who transitioned to commercial product are displayed as having completed the study.|
48375564|NCT02112994|101247663|FG001|COMPLETED|Overall Study||14|Participants who transitioned to commercial product are displayed as having completed the study.|
48375565|NCT02112994|101247664|FG002|COMPLETED|Overall Study||6|Participants who transitioned to commercial product are displayed as having completed the study.|
48375566|NCT02112994|101247662|FG000|NOT COMPLETED|Overall Study||0||
48375567|NCT02112994|101247663|FG001|NOT COMPLETED|Overall Study||2||
48375568|NCT02112994|101247664|FG002|NOT COMPLETED|Overall Study||3||
48375569|NCT04146467|101247665|FG000|STARTED|Overall Study||17||
48375570|NCT04146467|101247666|FG001|STARTED|Overall Study||65||
48375571|NCT04146467|101247665|FG000|COMPLETED|Overall Study||17||
48375572|NCT04146467|101247666|FG001|COMPLETED|Overall Study||62||
48375573|NCT04146467|101247665|FG000|NOT COMPLETED|Overall Study||0||
48375574|NCT04146467|101247666|FG001|NOT COMPLETED|Overall Study||3||
48375575|NCT00620321|101247667|FG000|STARTED|Overall Study||8||
48375576|NCT00620321|101247668|FG001|STARTED|Overall Study||16||
48375577|NCT00620321|101247667|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8||
48375578|NCT00620321|101247668|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16||
48375579|NCT00620321|101247667|FG000|COMPLETED|Overall Study||0||
48249194|NCT02847637|100927570|FG003|Completed First 24 Weeks of Treatment|Overall Study||63||
48249195|NCT02847637|100927567|FG000|Emicizumab Dose Was Up-Titrated|Overall Study||0||
48249196|NCT02847637|100927568|FG001|Emicizumab Dose Was Up-Titrated|Overall Study||1||
48249197|NCT02847637|100927569|FG002|Emicizumab Dose Was Up-Titrated|Overall Study||1||
48249198|NCT02847637|100927570|FG003|Emicizumab Dose Was Up-Titrated|Overall Study||7||
48249199|NCT02847637|100927567|FG000|Opted to Change Emicizumab Dosing Regimen|Overall Study||1|Upon Implementation of Protocol Version 4|
48249200|NCT02847637|100927568|FG001|Opted to Change Emicizumab Dosing Regimen|Overall Study||3|Upon Implementation of Protocol Version 4|
48249201|NCT02847637|100927569|FG002|Opted to Change Emicizumab Dosing Regimen|Overall Study||1|Upon Implementation of Protocol Version 4|
48249202|NCT02847637|100927570|FG003|Opted to Change Emicizumab Dosing Regimen|Overall Study||1|Upon Implementation of Protocol Version 4|
48249203|NCT02847637|100927567|FG000|COMPLETED|Overall Study||17||
48249204|NCT02847637|100927568|FG001|COMPLETED|Overall Study||34||
48249205|NCT02847637|100927569|FG002|COMPLETED|Overall Study||34||
48249206|NCT02847637|100927570|FG003|COMPLETED|Overall Study||63||
48249207|NCT02847637|100927567|FG000|NOT COMPLETED|Overall Study||1||
48249208|NCT02847637|100927568|FG001|NOT COMPLETED|Overall Study||2||
48249209|NCT02847637|100927569|FG002|NOT COMPLETED|Overall Study||1||
48249210|NCT02847637|100927570|FG003|NOT COMPLETED|Overall Study||0||
48249211|NCT04098497|100927571|FG000|STARTED|Overall Study||30||
48249212|NCT04098497|100927571|FG000|Initial Interview|Overall Study||30||
48249213|NCT04098497|100927571|FG000|Set Up Study App|Overall Study||29||
48249214|NCT04098497|100927571|FG000|Logged Symptoms Into Study App at Least Once|Overall Study||26|Participants who did not log symptoms into the app were never randomized to receive or not receive an intervention|
48249215|NCT04098497|100927571|FG000|Linked Fitbit to Study Database|Overall Study||27||
48249216|NCT04098497|100927571|FG000|Used Fitbit|Overall Study||24||
48249217|NCT04098497|100927571|FG000|Exit Interview|Overall Study||29|Participant who did not do the exit interview was not included in analysis of safety outcomes.|
48249218|NCT04098497|100927571|FG000|COMPLETED|Overall Study||30|All participants were included in the analysis of feasibility outcomes|
48249219|NCT04098497|100927571|FG000|NOT COMPLETED|Overall Study||0||
48249220|NCT04872101|100927572|FG000|STARTED|Overall Study||314||
48249221|NCT04872101|100927573|FG001|STARTED|Overall Study||159||
48249222|NCT04872101|100927572|FG000|COMPLETED|Overall Study||291||
48249223|NCT04872101|100927573|FG001|COMPLETED|Overall Study||122||
48249224|NCT04872101|100927572|FG000|NOT COMPLETED|Overall Study||23||
48249225|NCT04872101|100927573|FG001|NOT COMPLETED|Overall Study||37||
48249226|NCT00809783|100927574|FG000|STARTED|Overall Study||525||
48249227|NCT00809783|100927575|FG001|STARTED|Overall Study||832||
48249228|NCT00809783|100927576|FG002|STARTED|Overall Study||790||
48249229|NCT00809783|100927574|FG000|Treated|Overall Study||522||
48249230|NCT00809783|100927575|FG001|Treated|Overall Study||832||
48249231|NCT00809783|100927576|FG002|Treated|Overall Study||788||
48249232|NCT00809783|100927574|FG000|COMPLETED|Overall Study||0||
48249233|NCT00809783|100927575|FG001|COMPLETED|Overall Study||0||
48249234|NCT00809783|100927576|FG002|COMPLETED|Overall Study||0||
48249235|NCT00809783|100927574|FG000|NOT COMPLETED|Overall Study||525||
48249236|NCT00809783|100927575|FG001|NOT COMPLETED|Overall Study||832||
48249237|NCT00809783|100927576|FG002|NOT COMPLETED|Overall Study||790||
48249238|NCT04043806|100927577|FG000|STARTED|Overall Study||458||
48249239|NCT04043806|100927577|FG000|Safety Set|Overall Study||457||
48249240|NCT04043806|100927577|FG000|COMPLETED|Overall Study||412||
48249241|NCT04043806|100927577|FG000|NOT COMPLETED|Overall Study||46||
48249242|NCT01533181|100927578|FG000|STARTED|Overall Study||15||
48249243|NCT01533181|100927579|FG001|STARTED|Overall Study||29||
48249244|NCT01533181|100927578|FG000|COMPLETED|Overall Study||14||
48249245|NCT01533181|100927579|FG001|COMPLETED|Overall Study||28||
48249246|NCT01533181|100927578|FG000|NOT COMPLETED|Overall Study||1||
48249247|NCT01533181|100927579|FG001|NOT COMPLETED|Overall Study||1||
48249248|NCT03972137|100927580|FG000|STARTED|Overall Study||10||
48249249|NCT03972137|100927580|FG000|Enrolled|Overall Study||10||
48249250|NCT03972137|100927580|FG000|Treatment Completed|Overall Study||6||
48249251|NCT03972137|100927580|FG000|Follow-up Completed|Overall Study||4||
48249252|NCT03972137|100927580|FG000|COMPLETED|Overall Study||4||
48249253|NCT03972137|100927580|FG000|NOT COMPLETED|Overall Study||6||
48249254|NCT05012397|100927581|FG000|STARTED|Overall Study||40||
48249255|NCT05012397|100927581|FG000|COMPLETED|Overall Study||14||
48249256|NCT05012397|100927581|FG000|NOT COMPLETED|Overall Study||26||
48249257|NCT01093222|100927582|FG000|STARTED|Overall Study||40||
48249258|NCT01093222|100927582|FG000|Eligible and Began Protocol Therapy|Overall Study||34||
48249259|NCT01093222|100927582|FG000|COMPLETED|Overall Study||0||
48249260|NCT01093222|100927582|FG000|NOT COMPLETED|Overall Study||40||
48249261|NCT00557349|100927583|FG000|STARTED|Overall Study||22||
48249262|NCT00557349|100927584|FG001|STARTED|Overall Study||18||
48249263|NCT00557349|100927583|FG000|COMPLETED|Overall Study||17||
48249264|NCT00557349|100927584|FG001|COMPLETED|Overall Study||13||
48375580|NCT00620321|101247668|FG001|COMPLETED|Overall Study||0||
48375581|NCT00620321|101247667|FG000|NOT COMPLETED|Overall Study||8||
48249265|NCT00557349|100927583|FG000|NOT COMPLETED|Overall Study||5||
48249266|NCT00557349|100927584|FG001|NOT COMPLETED|Overall Study||5||
48249267|NCT02262364|100927585|FG000|STARTED|Study Enrollment||11||
48249268|NCT02262364|100927585|FG000|COMPLETED|Study Enrollment||11||
48249269|NCT02262364|100927585|FG000|NOT COMPLETED|Study Enrollment||0||
48249270|NCT02262364|100927585|FG000|STARTED|Blood Draw for Device Processing||11||
48249271|NCT02262364|100927585|FG000|COMPLETED|Blood Draw for Device Processing||10||
48249272|NCT02262364|100927585|FG000|NOT COMPLETED|Blood Draw for Device Processing||1||
48249273|NCT02262364|100927585|FG000|STARTED|Injection With APS||10||
48249274|NCT02262364|100927585|FG000|COMPLETED|Injection With APS||10||
48249275|NCT02262364|100927585|FG000|NOT COMPLETED|Injection With APS||0||
48249276|NCT02262364|100927585|FG000|STARTED|Follow-Up Through 12 Months||10||
48249277|NCT02262364|100927585|FG000|COMPLETED|Follow-Up Through 12 Months||10||
48249278|NCT02262364|100927585|FG000|NOT COMPLETED|Follow-Up Through 12 Months||0||
48249279|NCT03930238|100927586|FG000|STARTED|Overall Study||153||
48249280|NCT03930238|100927587|FG001|STARTED|Overall Study||123||
48249281|NCT03930238|100927586|FG000|Collected Any Fitbit Data During Baseline Period|Overall Study||152||
48249282|NCT03930238|100927587|FG001|Collected Any Fitbit Data During Baseline Period|Overall Study||114||
48249283|NCT03930238|100927586|FG000|COMPLETED|Overall Study||149||
48249284|NCT03930238|100927587|FG001|COMPLETED|Overall Study||102||
48249285|NCT03930238|100927586|FG000|NOT COMPLETED|Overall Study||4||
48249286|NCT03930238|100927587|FG001|NOT COMPLETED|Overall Study||21||
48249287|NCT00661466|100927588|FG000|STARTED|Overall Study||4||
48249288|NCT00661466|100927589|FG001|STARTED|Overall Study||3||
48249289|NCT00661466|100927588|FG000|COMPLETED|Overall Study||4||
48249290|NCT00661466|100927589|FG001|COMPLETED|Overall Study||3||
48249291|NCT00661466|100927588|FG000|NOT COMPLETED|Overall Study||0||
48249292|NCT00661466|100927589|FG001|NOT COMPLETED|Overall Study||0||
48249293|NCT02189122|100927590|FG000|STARTED|Overall Study||18||
48249294|NCT02189122|100927591|FG001|STARTED|Overall Study||18||
48375582|NCT00620321|101247668|FG001|NOT COMPLETED|Overall Study||16||
48249295|NCT02189122|100927590|FG000|COMPLETED|Overall Study||18||
48249296|NCT02189122|100927591|FG001|COMPLETED|Overall Study||18||
48249297|NCT02189122|100927590|FG000|NOT COMPLETED|Overall Study||0||
48249298|NCT02189122|100927591|FG001|NOT COMPLETED|Overall Study||0||
48249299|NCT00981578|100927592|FG000|STARTED|Overall Study||17||
48249300|NCT00981578|100927592|FG000|COMPLETED|Overall Study||14||
48249301|NCT00981578|100927592|FG000|NOT COMPLETED|Overall Study||3||
48249302|NCT02886234|100930852|FG000|STARTED|Overall Study||20||
48249303|NCT02886234|100930853|FG001|STARTED|Overall Study||24||
48249304|NCT02886234|100930852|FG000|COMPLETED|Overall Study||20||
48249305|NCT02886234|100930853|FG001|COMPLETED|Overall Study||22||
48249306|NCT02886234|100930852|FG000|NOT COMPLETED|Overall Study||0||
48249307|NCT02886234|100930853|FG001|NOT COMPLETED|Overall Study||2||
48249308|NCT03229356|100930854|FG000|STARTED|Phase 1 (Months 1-6)||0||4
48249309|NCT03229356|100930855|FG001|STARTED|Phase 1 (Months 1-6)||0||4
48249310|NCT03229356|100930856|FG002|STARTED|Phase 1 (Months 1-6)||0||7
48249311|NCT03229356|100930857|FG003|STARTED|Phase 1 (Months 1-6)||0||7
48249312|NCT03229356|100930854|FG000|COMPLETED|Phase 1 (Months 1-6)||0||4
48249313|NCT03229356|100930855|FG001|COMPLETED|Phase 1 (Months 1-6)||0||4
48249314|NCT03229356|100930856|FG002|COMPLETED|Phase 1 (Months 1-6)||0||7
48249315|NCT03229356|100930857|FG003|COMPLETED|Phase 1 (Months 1-6)||0||7
48249316|NCT03229356|100930854|FG000|NOT COMPLETED|Phase 1 (Months 1-6)||0||0
48249317|NCT03229356|100930855|FG001|NOT COMPLETED|Phase 1 (Months 1-6)||0||0
48249318|NCT03229356|100930856|FG002|NOT COMPLETED|Phase 1 (Months 1-6)||0||0
48249319|NCT03229356|100930857|FG003|NOT COMPLETED|Phase 1 (Months 1-6)||0||0
48249320|NCT03229356|100930854|FG000|STARTED|Phase 2 (Months 7-12)||0||4
48249321|NCT03229356|100930855|FG001|STARTED|Phase 2 (Months 7-12)||0||4
48249322|NCT03229356|100930856|FG002|STARTED|Phase 2 (Months 7-12)||0||7
48249323|NCT03229356|100930857|FG003|STARTED|Phase 2 (Months 7-12)||0||7
48249324|NCT03229356|100930854|FG000|COMPLETED|Phase 2 (Months 7-12)||0||4
48249325|NCT03229356|100930855|FG001|COMPLETED|Phase 2 (Months 7-12)||0||4
48249326|NCT03229356|100930856|FG002|COMPLETED|Phase 2 (Months 7-12)||0||7
48249327|NCT03229356|100930857|FG003|COMPLETED|Phase 2 (Months 7-12)||0||7
48249328|NCT03229356|100930854|FG000|NOT COMPLETED|Phase 2 (Months 7-12)||0||0
48249329|NCT03229356|100930855|FG001|NOT COMPLETED|Phase 2 (Months 7-12)||0||0
48249330|NCT03229356|100930856|FG002|NOT COMPLETED|Phase 2 (Months 7-12)||0||0
48249331|NCT03229356|100930857|FG003|NOT COMPLETED|Phase 2 (Months 7-12)||0||0
48249332|NCT01837719|100930858|FG000|STARTED|Period 1: Days 1-7 (Treatment A or B)||64||
48249333|NCT01837719|100930858|FG000|COMPLETED|Period 1: Days 1-7 (Treatment A or B)||64||
48249334|NCT01837719|100930858|FG000|NOT COMPLETED|Period 1: Days 1-7 (Treatment A or B)||0||
48249335|NCT01837719|100930858|FG000|STARTED|Period 2: Days 8-14 (Treatment B or A)||64||
48375583|NCT03165721|101247669|FG000|STARTED|Overall Study||7||
48249336|NCT01837719|100930858|FG000|COMPLETED|Period 2: Days 8-14 (Treatment B or A)||63||
48249337|NCT01837719|100930858|FG000|NOT COMPLETED|Period 2: Days 8-14 (Treatment B or A)||1||
48249338|NCT01837719|100930858|FG000|STARTED|Period 3: Days 15-21 (Treatment C or D)||63||
48249339|NCT01837719|100930858|FG000|COMPLETED|Period 3: Days 15-21 (Treatment C or D)||63||
48249340|NCT01837719|100930858|FG000|NOT COMPLETED|Period 3: Days 15-21 (Treatment C or D)||0||
48249341|NCT01837719|100930858|FG000|STARTED|Period 4: Days 22-28 (Treatment D or C)||63||
48249342|NCT01837719|100930858|FG000|COMPLETED|Period 4: Days 22-28 (Treatment D or C)||63||
48249343|NCT01837719|100930858|FG000|NOT COMPLETED|Period 4: Days 22-28 (Treatment D or C)||0||
48249344|NCT01837719|100930858|FG000|STARTED|Period 5: Days 29-31 (Treatment E)||31||
48249345|NCT01837719|100930858|FG000|COMPLETED|Period 5: Days 29-31 (Treatment E)||30||
48249346|NCT01837719|100930858|FG000|NOT COMPLETED|Period 5: Days 29-31 (Treatment E)||1||
48249347|NCT01894256|100930859|FG000|STARTED|Part A||15||
48249348|NCT01894256|100930860|FG001|STARTED|Part A||15||
48249349|NCT01894256|100930861|FG002|STARTED|Part A||14||
48249350|NCT01894256|100930859|FG000|COMPLETED|Part A||15||
48249351|NCT01894256|100930860|FG001|COMPLETED|Part A||14||
48249352|NCT01894256|100930861|FG002|COMPLETED|Part A||14||
48249353|NCT01894256|100930859|FG000|NOT COMPLETED|Part A||0||
48249354|NCT01894256|100930860|FG001|NOT COMPLETED|Part A||1||
48249355|NCT01894256|100930861|FG002|NOT COMPLETED|Part A||0||
48249356|NCT01894256|100930859|FG000|STARTED|Part B||15||
48249357|NCT01894256|100930860|FG001|STARTED|Part B||14||
48249358|NCT01894256|100930861|FG002|STARTED|Part B||14||
48249359|NCT01894256|100930859|FG000|COMPLETED|Part B||0||
48375584|NCT03165721|101247670|FG001|STARTED|Overall Study||1||
48375585|NCT03165721|101247671|FG002|STARTED|Overall Study||1||
48375586|NCT03165721|101247669|FG000|COMPLETED|Overall Study||3||
48249360|NCT01894256|100930860|FG001|COMPLETED|Part B||0||
48249361|NCT01894256|100930861|FG002|COMPLETED|Part B||0||
48249362|NCT01894256|100930859|FG000|NOT COMPLETED|Part B||15||
48249363|NCT01894256|100930860|FG001|NOT COMPLETED|Part B||14||
48249364|NCT01894256|100930861|FG002|NOT COMPLETED|Part B||14||
48249365|NCT00711555|100930862|FG000|STARTED|Overall Study||22||
48249366|NCT00711555|100930862|FG000|COMPLETED|Overall Study||19||
48249367|NCT00711555|100930862|FG000|NOT COMPLETED|Overall Study||3||
48375587|NCT03165721|101247670|FG001|COMPLETED|Overall Study||1||
48375588|NCT03165721|101247671|FG002|COMPLETED|Overall Study||1||
48249368|NCT05372913|100930863|FG000|STARTED|Overall Study||71||
48249369|NCT05372913|100930864|FG001|STARTED|Overall Study||70||
48249370|NCT05372913|100930863|FG000|COMPLETED|Overall Study||69||
48249371|NCT05372913|100930864|FG001|COMPLETED|Overall Study||65||
48249372|NCT05372913|100930863|FG000|NOT COMPLETED|Overall Study||2||
48249373|NCT05372913|100930864|FG001|NOT COMPLETED|Overall Study||5||
48249374|NCT02720198|100930865|FG000|STARTED|Overall Study||29||
48249375|NCT02720198|100930866|FG001|STARTED|Overall Study||31||
48249376|NCT02720198|100930865|FG000|COMPLETED|Overall Study||29||
48249377|NCT02720198|100930866|FG001|COMPLETED|Overall Study||30||
48249378|NCT02720198|100930865|FG000|NOT COMPLETED|Overall Study||0||
48249379|NCT02720198|100930866|FG001|NOT COMPLETED|Overall Study||1||
48249380|NCT01424189|100930867|FG000|STARTED|Overall Study||386||
48249381|NCT01424189|100930868|FG001|STARTED|Overall Study||188||
48249382|NCT01424189|100930867|FG000|COMPLETED|Overall Study||373||
48249383|NCT01424189|100930868|FG001|COMPLETED|Overall Study||182||
48249384|NCT01424189|100930867|FG000|NOT COMPLETED|Overall Study||13||
48249385|NCT01424189|100930868|FG001|NOT COMPLETED|Overall Study||6||
48249386|NCT03168425|100930869|FG000|STARTED|Overall Study||94||
48249387|NCT03168425|100930870|FG001|STARTED|Overall Study||96||
48249388|NCT03168425|100930869|FG000|COMPLETED|Overall Study||87||
48249389|NCT03168425|100930870|FG001|COMPLETED|Overall Study||85||
48249390|NCT03168425|100930869|FG000|NOT COMPLETED|Overall Study||7||
48249391|NCT03168425|100930870|FG001|NOT COMPLETED|Overall Study||11||
48249392|NCT02996097|100930871|FG000|STARTED|Overall Study||30||30
48249393|NCT02996097|100930872|FG001|STARTED|Overall Study||30||30
48249394|NCT02996097|100930871|FG000|Per Protocol Population|Overall Study||22||22
48249395|NCT02996097|100930872|FG001|Per Protocol Population|Overall Study||22||22
48249396|NCT02996097|100930871|FG000|COMPLETED|Overall Study||19||19
48375589|NCT03165721|101247669|FG000|NOT COMPLETED|Overall Study||4||
48375590|NCT03165721|101247670|FG001|NOT COMPLETED|Overall Study||0||
48375591|NCT03165721|101247671|FG002|NOT COMPLETED|Overall Study||0||
48375592|NCT02641236|101247672|FG000|STARTED|Overall Study||10||
48375593|NCT02641236|101247673|FG001|STARTED|Overall Study||10||
48375594|NCT02641236|101247674|FG002|STARTED|Overall Study||4||
48375595|NCT02641236|101247672|FG000|COMPLETED|Overall Study||5||
48375596|NCT02641236|101247673|FG001|COMPLETED|Overall Study||3||
48375597|NCT02641236|101247674|FG002|COMPLETED|Overall Study||4||
48375598|NCT02641236|101247672|FG000|NOT COMPLETED|Overall Study||5||
48249397|NCT02996097|100930872|FG001|COMPLETED|Overall Study||19||19
48249398|NCT02996097|100930871|FG000|NOT COMPLETED|Overall Study||11||11
48249399|NCT02996097|100930872|FG001|NOT COMPLETED|Overall Study||11||11
48249400|NCT01129115|100930873|FG000|STARTED|Overall Study||25||
48249401|NCT01129115|100930874|FG001|STARTED|Overall Study||25||
48249402|NCT01129115|100930875|FG002|STARTED|Overall Study||27||
48249403|NCT01129115|100930876|FG003|STARTED|Overall Study||24||
48249404|NCT01129115|100930873|FG000|COMPLETED|Overall Study||23||
48249405|NCT01129115|100930874|FG001|COMPLETED|Overall Study||18||
48375599|NCT02641236|101247673|FG001|NOT COMPLETED|Overall Study||7||
48375600|NCT02641236|101247674|FG002|NOT COMPLETED|Overall Study||0||
48375601|NCT00995345|101247675|FG000|STARTED|Overall Study||81||
48375602|NCT00995345|101247676|FG001|STARTED|Overall Study||81||
48375603|NCT00995345|101247677|FG002|STARTED|Overall Study||80||
48375604|NCT00995345|101247678|FG003|STARTED|Overall Study||81||
48375605|NCT00995345|101247679|FG004|STARTED|Overall Study||80||
48540969|NCT04141930|101662612|FG001|STARTED|Overall Study||179||
48540970|NCT04141930|101662611|FG000|COMPLETED|Overall Study||302||
48540971|NCT04141930|101662612|FG001|COMPLETED|Overall Study||179||
48540972|NCT04141930|101662611|FG000|NOT COMPLETED|Overall Study||0||
48540973|NCT04141930|101662612|FG001|NOT COMPLETED|Overall Study||0||
48540974|NCT01256944|101662613|FG000|STARTED|Overall Study||70||
48249406|NCT01129115|100930875|FG002|COMPLETED|Overall Study||21||
48249407|NCT01129115|100930876|FG003|COMPLETED|Overall Study||15||
48249408|NCT01129115|100930873|FG000|NOT COMPLETED|Overall Study||2||
48249409|NCT01129115|100930874|FG001|NOT COMPLETED|Overall Study||7||
48249410|NCT01129115|100930875|FG002|NOT COMPLETED|Overall Study||6||
48249411|NCT01129115|100930876|FG003|NOT COMPLETED|Overall Study||9||
48249412|NCT01797705|100930877|FG000|STARTED|Overall Study||33||
48249413|NCT01797705|100930877|FG000|COMPLETED|Overall Study||28||
48249414|NCT01797705|100930877|FG000|NOT COMPLETED|Overall Study||5||
48249415|NCT01363297|100930878|FG000|STARTED|Overall Study||3||
48249416|NCT01363297|100930879|FG001|STARTED|Overall Study||12||
48249417|NCT01363297|100930880|FG002|STARTED|Overall Study||9||
48249418|NCT01363297|100930881|FG003|STARTED|Overall Study||13||
48249419|NCT01363297|100930882|FG004|STARTED|Overall Study||35||
48249420|NCT01363297|100930878|FG000|COMPLETED|Overall Study||0||
48249421|NCT01363297|100930879|FG001|COMPLETED|Overall Study||6||
48249422|NCT01363297|100930880|FG002|COMPLETED|Overall Study||3||
48249423|NCT01363297|100930881|FG003|COMPLETED|Overall Study||3||
48249424|NCT01363297|100930882|FG004|COMPLETED|Overall Study||4||
48375606|NCT00995345|101247675|FG000|COMPLETED|Overall Study||70||
48375607|NCT00995345|101247676|FG001|COMPLETED|Overall Study||74||
48375608|NCT00995345|101247677|FG002|COMPLETED|Overall Study||73||
48375609|NCT00995345|101247678|FG003|COMPLETED|Overall Study||76||
48375610|NCT00995345|101247679|FG004|COMPLETED|Overall Study||75||
48540975|NCT01256944|101662614|FG001|STARTED|Overall Study||220||
48249425|NCT01363297|100930878|FG000|NOT COMPLETED|Overall Study||3||
48249426|NCT01363297|100930879|FG001|NOT COMPLETED|Overall Study||6||
48249427|NCT01363297|100930880|FG002|NOT COMPLETED|Overall Study||6||
48249428|NCT01363297|100930881|FG003|NOT COMPLETED|Overall Study||10||
48249429|NCT01363297|100930882|FG004|NOT COMPLETED|Overall Study||31||
48249430|NCT00694564|100930883|FG000|STARTED|Overall Study||8||
48249431|NCT00694564|100930883|FG000|COMPLETED|Overall Study||6||
48249432|NCT00694564|100930883|FG000|NOT COMPLETED|Overall Study||2||
48249433|NCT01276509|100930884|FG000|STARTED|Overall Study||66||
48249434|NCT01276509|100930885|FG001|STARTED|Overall Study||65||
48375611|NCT00995345|101247675|FG000|NOT COMPLETED|Overall Study||11||
48375612|NCT00995345|101247676|FG001|NOT COMPLETED|Overall Study||7||
48375613|NCT00995345|101247677|FG002|NOT COMPLETED|Overall Study||7||
48249435|NCT01276509|100930886|FG002|STARTED|Overall Study||68||
48249436|NCT01276509|100930887|FG003|STARTED|Overall Study||63||
48249437|NCT01276509|100930884|FG000|COMPLETED|Overall Study||53||
48249438|NCT01276509|100930885|FG001|COMPLETED|Overall Study||53||
48249439|NCT01276509|100930886|FG002|COMPLETED|Overall Study||63||
48249440|NCT01276509|100930887|FG003|COMPLETED|Overall Study||58||
48249441|NCT01276509|100930884|FG000|NOT COMPLETED|Overall Study||13||
48249442|NCT01276509|100930885|FG001|NOT COMPLETED|Overall Study||12||
48249443|NCT01276509|100930886|FG002|NOT COMPLETED|Overall Study||5||
48249444|NCT01276509|100930887|FG003|NOT COMPLETED|Overall Study||5||
48249445|NCT01960114|100930888|FG000|STARTED|Overall Study||134||
48249446|NCT01960114|100930889|FG001|STARTED|Overall Study||269||
48249447|NCT01960114|100930888|FG000|COMPLETED|Overall Study||133||
48249448|NCT01960114|100930889|FG001|COMPLETED|Overall Study||268||
48249449|NCT01960114|100930888|FG000|NOT COMPLETED|Overall Study||1||
48249450|NCT01960114|100930889|FG001|NOT COMPLETED|Overall Study||1||
48249451|NCT01184859|100930890|FG000|STARTED|Period 1: Single Dose||23||
48249452|NCT01184859|100930891|FG001|STARTED|Period 1: Single Dose||25||
48249453|NCT01184859|100930892|FG002|STARTED|Period 1: Single Dose||22||
48249454|NCT01184859|100930893|FG003|STARTED|Period 1: Single Dose||22||
48249455|NCT01184859|100930894|FG004|STARTED|Period 1: Single Dose||24||
48249456|NCT01184859|100930890|FG000|Full Analysis Set (FAS)|Period 1: Single Dose||23||
48249457|NCT01184859|100930891|FG001|Full Analysis Set (FAS)|Period 1: Single Dose||23||
48249458|NCT01184859|100930892|FG002|Full Analysis Set (FAS)|Period 1: Single Dose||22||
48249459|NCT01184859|100930893|FG003|Full Analysis Set (FAS)|Period 1: Single Dose||21||
48249460|NCT01184859|100930894|FG004|Full Analysis Set (FAS)|Period 1: Single Dose||24||
48249461|NCT01184859|100930890|FG000|Per Protocol (PP)|Period 1: Single Dose||23||
48249462|NCT01184859|100930891|FG001|Per Protocol (PP)|Period 1: Single Dose||23||
48249463|NCT01184859|100930892|FG002|Per Protocol (PP)|Period 1: Single Dose||22||
48249464|NCT01184859|100930893|FG003|Per Protocol (PP)|Period 1: Single Dose||21||
48249465|NCT01184859|100930894|FG004|Per Protocol (PP)|Period 1: Single Dose||23||
48249466|NCT01184859|100930890|FG000|COMPLETED|Period 1: Single Dose||23||
48249467|NCT01184859|100930891|FG001|COMPLETED|Period 1: Single Dose||23||
48249468|NCT01184859|100930892|FG002|COMPLETED|Period 1: Single Dose||22||
48249469|NCT01184859|100930893|FG003|COMPLETED|Period 1: Single Dose||22||
48249470|NCT01184859|100930894|FG004|COMPLETED|Period 1: Single Dose||23||
48249471|NCT01184859|100930890|FG000|NOT COMPLETED|Period 1: Single Dose||0||
48249472|NCT01184859|100930891|FG001|NOT COMPLETED|Period 1: Single Dose||2||
48249473|NCT01184859|100930892|FG002|NOT COMPLETED|Period 1: Single Dose||0||
48249474|NCT01184859|100930893|FG003|NOT COMPLETED|Period 1: Single Dose||0||
48249475|NCT01184859|100930894|FG004|NOT COMPLETED|Period 1: Single Dose||1||
48249476|NCT01184859|100930890|FG000|STARTED|Washout Period||23||
48249477|NCT01184859|100930891|FG001|STARTED|Washout Period||23||
48249478|NCT01184859|100930892|FG002|STARTED|Washout Period||22||
48249479|NCT01184859|100930893|FG003|STARTED|Washout Period||22||
48249480|NCT01184859|100930894|FG004|STARTED|Washout Period||23||
48249481|NCT01184859|100930890|FG000|COMPLETED|Washout Period||23||
48249482|NCT01184859|100930891|FG001|COMPLETED|Washout Period||23||
48249483|NCT01184859|100930892|FG002|COMPLETED|Washout Period||22||
48249484|NCT01184859|100930893|FG003|COMPLETED|Washout Period||22||
48249485|NCT01184859|100930894|FG004|COMPLETED|Washout Period||23||
48249486|NCT01184859|100930890|FG000|NOT COMPLETED|Washout Period||0||
48249487|NCT01184859|100930891|FG001|NOT COMPLETED|Washout Period||0||
48249488|NCT01184859|100930892|FG002|NOT COMPLETED|Washout Period||0||
48249489|NCT01184859|100930893|FG003|NOT COMPLETED|Washout Period||0||
48249490|NCT01184859|100930894|FG004|NOT COMPLETED|Washout Period||0||
48249491|NCT01184859|100930890|FG000|STARTED|Period 2: Daily Dose for 28 Days||23||
48249492|NCT01184859|100930891|FG001|STARTED|Period 2: Daily Dose for 28 Days||23||
48249493|NCT01184859|100930892|FG002|STARTED|Period 2: Daily Dose for 28 Days||22||
48249494|NCT01184859|100930893|FG003|STARTED|Period 2: Daily Dose for 28 Days||22||
48249495|NCT01184859|100930894|FG004|STARTED|Period 2: Daily Dose for 28 Days||23||
48249496|NCT01184859|100930890|FG000|COMPLETED|Period 2: Daily Dose for 28 Days||22||
48249497|NCT01184859|100930891|FG001|COMPLETED|Period 2: Daily Dose for 28 Days||23||
48249498|NCT01184859|100930892|FG002|COMPLETED|Period 2: Daily Dose for 28 Days||22||
48249499|NCT01184859|100930893|FG003|COMPLETED|Period 2: Daily Dose for 28 Days||22||
48249500|NCT01184859|100930894|FG004|COMPLETED|Period 2: Daily Dose for 28 Days||22||
48375614|NCT00995345|101247678|FG003|NOT COMPLETED|Overall Study||5||
48249501|NCT01184859|100930890|FG000|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1||
48249502|NCT01184859|100930891|FG001|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0||
48249503|NCT01184859|100930892|FG002|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0||
48249504|NCT01184859|100930893|FG003|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0||
48249505|NCT01184859|100930894|FG004|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1||
48249506|NCT04483791|100930895|FG000|STARTED|Overall Study||50||
48249507|NCT04483791|100930895|FG000|COMPLETED|Overall Study||49||
48249508|NCT04483791|100930895|FG000|NOT COMPLETED|Overall Study||1||
48249509|NCT01393613|100930896|FG000|STARTED|Overall Study||120||
48249510|NCT01393613|100930897|FG001|STARTED|Overall Study||186||
48249511|NCT01393613|100930898|FG002|STARTED|Overall Study||184||
48249512|NCT01393613|100930899|FG003|STARTED|Overall Study||184||
48249513|NCT01393613|100930896|FG000|COMPLETED|Overall Study||81||
48249514|NCT01393613|100930897|FG001|COMPLETED|Overall Study||129||
48249515|NCT01393613|100930898|FG002|COMPLETED|Overall Study||130||
48249516|NCT01393613|100930899|FG003|COMPLETED|Overall Study||118||
48249517|NCT01393613|100930896|FG000|NOT COMPLETED|Overall Study||39||
48249518|NCT01393613|100930897|FG001|NOT COMPLETED|Overall Study||57||
48249519|NCT01393613|100930898|FG002|NOT COMPLETED|Overall Study||54||
48249520|NCT01393613|100930899|FG003|NOT COMPLETED|Overall Study||66||
48249521|NCT03974100|100930900|FG000|STARTED|TP1 - Day 1 to Week 52||263||
48249522|NCT03974100|100930901|FG001|STARTED|TP1 - Day 1 to Week 52||264||
48249523|NCT03974100|100930902|FG002|STARTED|TP1 - Day 1 to Week 52||0||
48249524|NCT03974100|100930903|FG003|STARTED|TP1 - Day 1 to Week 52||0||
48249525|NCT03974100|100930904|FG004|STARTED|TP1 - Day 1 to Week 52||0||
48249526|NCT03974100|100930900|FG000|Per-Protocol Set (PPS)|TP1 - Day 1 to Week 52||233||
48249527|NCT03974100|100930901|FG001|Per-Protocol Set (PPS)|TP1 - Day 1 to Week 52||230||
48249528|NCT03974100|100930902|FG002|Per-Protocol Set (PPS)|TP1 - Day 1 to Week 52||0||
48249529|NCT03974100|100930903|FG003|Per-Protocol Set (PPS)|TP1 - Day 1 to Week 52||0||
48249530|NCT03974100|100930904|FG004|Per-Protocol Set (PPS)|TP1 - Day 1 to Week 52||0||
48249531|NCT03974100|100930900|FG000|TP1 Full Analysis Set (TP1 FAS)|TP1 - Day 1 to Week 52||255||
48249532|NCT03974100|100930901|FG001|TP1 Full Analysis Set (TP1 FAS)|TP1 - Day 1 to Week 52||257||
48249533|NCT03974100|100930902|FG002|TP1 Full Analysis Set (TP1 FAS)|TP1 - Day 1 to Week 52||0||
48249534|NCT03974100|100930903|FG003|TP1 Full Analysis Set (TP1 FAS)|TP1 - Day 1 to Week 52||0||
48249535|NCT03974100|100930904|FG004|TP1 Full Analysis Set (TP1 FAS)|TP1 - Day 1 to Week 52||0||
48249536|NCT03974100|100930900|FG000|Pharmacodynamic Analysis Set (PDS)|TP1 - Day 1 to Week 52||228||
48249537|NCT03974100|100930901|FG001|Pharmacodynamic Analysis Set (PDS)|TP1 - Day 1 to Week 52||213||
48249538|NCT03974100|100930902|FG002|Pharmacodynamic Analysis Set (PDS)|TP1 - Day 1 to Week 52||0||
48249539|NCT03974100|100930903|FG003|Pharmacodynamic Analysis Set (PDS)|TP1 - Day 1 to Week 52||0||
48249540|NCT03974100|100930904|FG004|Pharmacodynamic Analysis Set (PDS)|TP1 - Day 1 to Week 52||0||
48249541|NCT03974100|100930900|FG000|Pharmacokinetic Analysis Set (PKS)|TP1 - Day 1 to Week 52||260||
48249542|NCT03974100|100930901|FG001|Pharmacokinetic Analysis Set (PKS)|TP1 - Day 1 to Week 52||258||
48249543|NCT03974100|100930902|FG002|Pharmacokinetic Analysis Set (PKS)|TP1 - Day 1 to Week 52||0||
48249544|NCT03974100|100930903|FG003|Pharmacokinetic Analysis Set (PKS)|TP1 - Day 1 to Week 52||0||
48249545|NCT03974100|100930904|FG004|Pharmacokinetic Analysis Set (PKS)|TP1 - Day 1 to Week 52||0||
48249546|NCT03974100|100930900|FG000|TP1 Safety Analysis Set|TP1 - Day 1 to Week 52||263||
48249547|NCT03974100|100930901|FG001|TP1 Safety Analysis Set|TP1 - Day 1 to Week 52||264||
48249548|NCT03974100|100930902|FG002|TP1 Safety Analysis Set|TP1 - Day 1 to Week 52||0||
48249549|NCT03974100|100930903|FG003|TP1 Safety Analysis Set|TP1 - Day 1 to Week 52||0||
48249550|NCT03974100|100930904|FG004|TP1 Safety Analysis Set|TP1 - Day 1 to Week 52||0||
48249551|NCT03974100|100930900|FG000|COMPLETED|TP1 - Day 1 to Week 52||253||
48249552|NCT03974100|100930901|FG001|COMPLETED|TP1 - Day 1 to Week 52||249||
48375615|NCT00995345|101247679|FG004|NOT COMPLETED|Overall Study||5||
48375616|NCT01201798|101247680|FG000|STARTED|Overall Study||56||
48375617|NCT01201798|101247681|FG001|STARTED|Overall Study||54||
48375618|NCT01201798|101247680|FG000|COMPLETED|Overall Study||47||
48375619|NCT01201798|101247681|FG001|COMPLETED|Overall Study||39||
48375620|NCT01201798|101247680|FG000|NOT COMPLETED|Overall Study||9||
48375621|NCT01201798|101247681|FG001|NOT COMPLETED|Overall Study||15||
48375622|NCT00321100|101247682|FG000|STARTED|Overall Study||12||
48375623|NCT00321100|101247683|FG001|STARTED|Overall Study||11||
48375624|NCT00321100|101247682|FG000|COMPLETED|Overall Study||12||
48375625|NCT00321100|101247683|FG001|COMPLETED|Overall Study||11||
48375626|NCT00321100|101247682|FG000|NOT COMPLETED|Overall Study||0||
48375627|NCT00321100|101247683|FG001|NOT COMPLETED|Overall Study||0||
48375628|NCT02433379|101247684|FG000|STARTED|Overall Study||1173||
48375629|NCT02433379|101247684|FG000|COMPLETED|Overall Study||852||
48375630|NCT02433379|101247684|FG000|NOT COMPLETED|Overall Study||321||
48375631|NCT01774344|101247685|FG000|STARTED|Overall Study||194||
48375632|NCT01774344|101247686|FG001|STARTED|Overall Study||379||
48375633|NCT01774344|101247685|FG000|Treated|Overall Study||193||
48375634|NCT01774344|101247686|FG001|Treated|Overall Study||374||
48375635|NCT01774344|101247685|FG000|Entered Survival FU|Overall Study||145||
48375636|NCT01774344|101247686|FG001|Entered Survival FU|Overall Study||291||
48375637|NCT01774344|101247685|FG000|COMPLETED|Overall Study||132||
48375638|NCT01774344|101247686|FG001|COMPLETED|Overall Study||258||
48375639|NCT01774344|101247685|FG000|NOT COMPLETED|Overall Study||62||
48375640|NCT01774344|101247686|FG001|NOT COMPLETED|Overall Study||121||
48375641|NCT01515995|101247687|FG000|STARTED|Overall Study||25||
48375642|NCT01515995|101247688|FG001|STARTED|Overall Study||25||
48375643|NCT01515995|101247687|FG000|COMPLETED|Overall Study||22||
48375644|NCT01515995|101247688|FG001|COMPLETED|Overall Study||21||
48683377|NCT03420742|102009526|FG000|STARTED|Part A (Cycle 1)||24||
48683378|NCT03420742|102009526|FG000|COMPLETED|Part A (Cycle 1)||24||
48683379|NCT03420742|102009526|FG000|NOT COMPLETED|Part A (Cycle 1)||0||
48683380|NCT03420742|102009526|FG000|STARTED|Part B (Cycle 2 to Cycle 20)||22||
48683381|NCT03420742|102009526|FG000|COMPLETED|Part B (Cycle 2 to Cycle 20)||22||
48683382|NCT03420742|102009526|FG000|NOT COMPLETED|Part B (Cycle 2 to Cycle 20)||0||
48683383|NCT04154605|102009527|FG000|STARTED|Overall Study||68||
48249553|NCT03974100|100930902|FG002|COMPLETED|TP1 - Day 1 to Week 52||0||
48249554|NCT03974100|100930903|FG003|COMPLETED|TP1 - Day 1 to Week 52||0||
48249555|NCT03974100|100930904|FG004|COMPLETED|TP1 - Day 1 to Week 52||0||
48249556|NCT03974100|100930900|FG000|NOT COMPLETED|TP1 - Day 1 to Week 52||10||
48249557|NCT03974100|100930901|FG001|NOT COMPLETED|TP1 - Day 1 to Week 52||15||
48249558|NCT03974100|100930902|FG002|NOT COMPLETED|TP1 - Day 1 to Week 52||0||
48249559|NCT03974100|100930903|FG003|NOT COMPLETED|TP1 - Day 1 to Week 52||0||
48249560|NCT03974100|100930904|FG004|NOT COMPLETED|TP1 - Day 1 to Week 52||0||
48249561|NCT03974100|100930900|FG000|STARTED|TP2- Week 52 to Week 78||0||
48249562|NCT03974100|100930901|FG001|STARTED|TP2- Week 52 to Week 78||0||
48249563|NCT03974100|100930902|FG002|STARTED|TP2- Week 52 to Week 78||253||
48249564|NCT03974100|100930903|FG003|STARTED|TP2- Week 52 to Week 78||125||
48249565|NCT03974100|100930904|FG004|STARTED|TP2- Week 52 to Week 78||124||
48249566|NCT03974100|100930900|FG000|TP2 Full Analysis Set (TP2 FAS)|TP2- Week 52 to Week 78||0||
48249567|NCT03974100|100930901|FG001|TP2 Full Analysis Set (TP2 FAS)|TP2- Week 52 to Week 78||0||
48249568|NCT03974100|100930902|FG002|TP2 Full Analysis Set (TP2 FAS)|TP2- Week 52 to Week 78||253||
48249569|NCT03974100|100930903|FG003|TP2 Full Analysis Set (TP2 FAS)|TP2- Week 52 to Week 78||124||
48249570|NCT03974100|100930904|FG004|TP2 Full Analysis Set (TP2 FAS)|TP2- Week 52 to Week 78||124||
48249571|NCT03974100|100930900|FG000|TP2 Safety Analysis Set|TP2- Week 52 to Week 78||0||
48249572|NCT03974100|100930901|FG001|TP2 Safety Analysis Set|TP2- Week 52 to Week 78||0||
48249573|NCT03974100|100930902|FG002|TP2 Safety Analysis Set|TP2- Week 52 to Week 78||253||
48249574|NCT03974100|100930903|FG003|TP2 Safety Analysis Set|TP2- Week 52 to Week 78||125||
48249575|NCT03974100|100930904|FG004|TP2 Safety Analysis Set|TP2- Week 52 to Week 78||124||
48249576|NCT03974100|100930900|FG000|COMPLETED|TP2- Week 52 to Week 78||0||
48249577|NCT03974100|100930901|FG001|COMPLETED|TP2- Week 52 to Week 78||0||
48249578|NCT03974100|100930902|FG002|COMPLETED|TP2- Week 52 to Week 78||253||
48249579|NCT03974100|100930903|FG003|COMPLETED|TP2- Week 52 to Week 78||123||
48249580|NCT03974100|100930904|FG004|COMPLETED|TP2- Week 52 to Week 78||124||
48249581|NCT03974100|100930900|FG000|NOT COMPLETED|TP2- Week 52 to Week 78||0||
48249582|NCT03974100|100930901|FG001|NOT COMPLETED|TP2- Week 52 to Week 78||0||
48249583|NCT03974100|100930902|FG002|NOT COMPLETED|TP2- Week 52 to Week 78||0||
48249584|NCT03974100|100930903|FG003|NOT COMPLETED|TP2- Week 52 to Week 78||2||
48249585|NCT03974100|100930904|FG004|NOT COMPLETED|TP2- Week 52 to Week 78||0||
48249586|NCT05376787|100930905|FG000|STARTED|Overall Study||20||
48249587|NCT05376787|100930905|FG000|COMPLETED|Overall Study||20||
48249588|NCT05376787|100930905|FG000|NOT COMPLETED|Overall Study||0||
48249589|NCT01177137|100930906|FG000|STARTED|Overall Study||51||
48249590|NCT01177137|100930907|FG001|STARTED|Overall Study||51||
48249591|NCT01177137|100930908|FG002|STARTED|Overall Study||49||
48249592|NCT01177137|100930906|FG000|COMPLETED|Overall Study||41||
48249593|NCT01177137|100930907|FG001|COMPLETED|Overall Study||41||
48249594|NCT01177137|100930908|FG002|COMPLETED|Overall Study||47||
48249595|NCT01177137|100930906|FG000|NOT COMPLETED|Overall Study||10||
48249596|NCT01177137|100930907|FG001|NOT COMPLETED|Overall Study||10||
48375645|NCT01515995|101247687|FG000|NOT COMPLETED|Overall Study||3||
48375646|NCT01515995|101247688|FG001|NOT COMPLETED|Overall Study||4||
48683384|NCT04154605|102009528|FG001|STARTED|Overall Study||65||
48683385|NCT04154605|102009527|FG000|COMPLETED|Overall Study||65||
48249597|NCT01177137|100930908|FG002|NOT COMPLETED|Overall Study||2||
48249598|NCT01537900|100930909|FG000|STARTED|Overall Study||4||
48249599|NCT01537900|100930909|FG000|COMPLETED|Overall Study||4||
48375647|NCT02902172|101247689|FG000|STARTED|Overall Study||16||
48375648|NCT02902172|101247690|FG001|STARTED|Overall Study||20||
48375649|NCT02902172|101247689|FG000|COMPLETED|Overall Study||16||
48375650|NCT02902172|101247690|FG001|COMPLETED|Overall Study||20||
48249600|NCT01537900|100930909|FG000|NOT COMPLETED|Overall Study||0||
48249601|NCT02004132|100930910|FG000|STARTED|Overall Study||12||
48375651|NCT02902172|101247689|FG000|NOT COMPLETED|Overall Study||0||
48375652|NCT02902172|101247690|FG001|NOT COMPLETED|Overall Study||0||
48375653|NCT01252134|101247691|FG000|STARTED|Period 1, 8 Hours||3||
48375654|NCT01252134|101247692|FG001|STARTED|Period 1, 8 Hours||4||
48375655|NCT01252134|101247693|FG002|STARTED|Period 1, 8 Hours||3||
48249602|NCT02004132|100930910|FG000|Received Study Drug|Overall Study||12||
48249603|NCT02004132|100930910|FG000|COMPLETED|Overall Study||12||
48375656|NCT01252134|101247694|FG003|STARTED|Period 1, 8 Hours||5||
48375657|NCT01252134|101247695|FG004|STARTED|Period 1, 8 Hours||3||
48375658|NCT01252134|101247696|FG005|STARTED|Period 1, 8 Hours||4||
48683386|NCT04154605|102009528|FG001|COMPLETED|Overall Study||63||
48683387|NCT04154605|102009527|FG000|NOT COMPLETED|Overall Study||3||
48683388|NCT04154605|102009528|FG001|NOT COMPLETED|Overall Study||2||
48683389|NCT00894699|102009529|FG000|STARTED|Overall Study||21||
48683390|NCT00894699|102009530|FG001|STARTED|Overall Study||19||
48683391|NCT00894699|102009529|FG000|COMPLETED|Overall Study||21||
48683392|NCT00894699|102009530|FG001|COMPLETED|Overall Study||19||
48683393|NCT00894699|102009529|FG000|NOT COMPLETED|Overall Study||0||
48683394|NCT00894699|102009530|FG001|NOT COMPLETED|Overall Study||0||
48683395|NCT00928187|102009531|FG000|STARTED|Overall Study||152||
48249604|NCT02004132|100930910|FG000|NOT COMPLETED|Overall Study||0||
48249605|NCT01763346|100930911|FG000|STARTED|Overall Study||44||
48249606|NCT01763346|100930912|FG001|STARTED|Overall Study||44||
48249607|NCT01763346|100930911|FG000|Received Intervention|Overall Study||39||
48249608|NCT01763346|100930912|FG001|Received Intervention|Overall Study||38||
48249609|NCT01763346|100930911|FG000|COMPLETED|Overall Study||34||
48249610|NCT01763346|100930912|FG001|COMPLETED|Overall Study||36||
48249611|NCT01763346|100930911|FG000|NOT COMPLETED|Overall Study||10||
48249612|NCT01763346|100930912|FG001|NOT COMPLETED|Overall Study||8||
48249613|NCT01259440|100930913|FG000|STARTED|Overall Study||13||
48249614|NCT01259440|100930914|FG001|STARTED|Overall Study||10||
48249615|NCT01259440|100930913|FG000|COMPLETED|Overall Study||13||
48249616|NCT01259440|100930914|FG001|COMPLETED|Overall Study||10||
48249617|NCT01259440|100930913|FG000|NOT COMPLETED|Overall Study||0||
48249618|NCT01259440|100930914|FG001|NOT COMPLETED|Overall Study||0||
48249619|NCT03565640|100930915|FG000|STARTED|Overall Study||23||
48249620|NCT03565640|100930916|FG001|STARTED|Overall Study||24||
48249621|NCT03565640|100930915|FG000|COMPLETED|Overall Study||22||
48249622|NCT03565640|100930916|FG001|COMPLETED|Overall Study||21||
48249623|NCT03565640|100930915|FG000|NOT COMPLETED|Overall Study||1||
48249624|NCT03565640|100930916|FG001|NOT COMPLETED|Overall Study||3||
48375659|NCT01252134|101247691|FG000|COMPLETED|Period 1, 8 Hours||3||
48375660|NCT01252134|101247692|FG001|COMPLETED|Period 1, 8 Hours||3||
48375661|NCT01252134|101247693|FG002|COMPLETED|Period 1, 8 Hours||2||
48375662|NCT01252134|101247694|FG003|COMPLETED|Period 1, 8 Hours||5||
48375663|NCT01252134|101247695|FG004|COMPLETED|Period 1, 8 Hours||3||
48375664|NCT01252134|101247696|FG005|COMPLETED|Period 1, 8 Hours||4||
48375665|NCT01252134|101247691|FG000|NOT COMPLETED|Period 1, 8 Hours||0||
48375666|NCT01252134|101247692|FG001|NOT COMPLETED|Period 1, 8 Hours||1||
48375667|NCT01252134|101247693|FG002|NOT COMPLETED|Period 1, 8 Hours||1||
48375668|NCT01252134|101247694|FG003|NOT COMPLETED|Period 1, 8 Hours||0||
48540976|NCT01256944|101662613|FG000|COMPLETED|Overall Study||70||
48540977|NCT01256944|101662614|FG001|COMPLETED|Overall Study||220||
48540978|NCT01256944|101662613|FG000|NOT COMPLETED|Overall Study||0||
48540979|NCT01256944|101662614|FG001|NOT COMPLETED|Overall Study||0||
48540980|NCT03257865|101662615|FG000|STARTED|Overall Study||163||
48540981|NCT03257865|101662616|FG001|STARTED|Overall Study||170||
48540982|NCT03257865|101662615|FG000|Received at Least 1 Dose of Study Drug|Overall Study||162|Randomized participants who received at least 1 dose of study drug were analyzed for safety.|
48540983|NCT03257865|101662616|FG001|Received at Least 1 Dose of Study Drug|Overall Study||170|Randomized participants who received at least 1 dose of study drug were analyzed for safety.|
48540984|NCT03257865|101662615|FG000|COMPLETED|Overall Study||128||
48540985|NCT03257865|101662616|FG001|COMPLETED|Overall Study||135||
48540986|NCT03257865|101662615|FG000|NOT COMPLETED|Overall Study||35||
48540987|NCT03257865|101662616|FG001|NOT COMPLETED|Overall Study||35||
48540988|NCT01199016|101662617|FG000|STARTED|Overall Study||239||
48540989|NCT01199016|101662617|FG000|Treated|Overall Study||236||
48540990|NCT01199016|101662617|FG000|COMPLETED|Overall Study||162||
48540991|NCT01199016|101662617|FG000|NOT COMPLETED|Overall Study||77||
48540992|NCT03844386|101662618|FG000|STARTED|Overall Study||7||
48540993|NCT03844386|101662619|FG001|STARTED|Overall Study||7||
48540994|NCT03844386|101662620|FG002|STARTED|Overall Study||8||
48683396|NCT00928187|102009532|FG001|STARTED|Overall Study||147||
48683397|NCT00928187|102009533|FG002|STARTED|Overall Study||155||
48683398|NCT00928187|102009531|FG000|Analysed|Overall Study||152||
48249625|NCT04397614|100930917|FG000|STARTED|Overall Study||121||
48249626|NCT04397614|100930918|FG001|STARTED|Overall Study||7||
48249627|NCT04397614|100930917|FG000|COMPLETED|Overall Study||57||
48249628|NCT04397614|100930918|FG001|COMPLETED|Overall Study||4||
48249629|NCT04397614|100930917|FG000|NOT COMPLETED|Overall Study||64||
48249630|NCT04397614|100930918|FG001|NOT COMPLETED|Overall Study||3||
48375669|NCT01252134|101247695|FG004|NOT COMPLETED|Period 1, 8 Hours||0||
48375670|NCT01252134|101247696|FG005|NOT COMPLETED|Period 1, 8 Hours||0||
48375671|NCT01252134|101247691|FG000|STARTED|Period 2, 8 Hours||3||
48375672|NCT01252134|101247692|FG001|STARTED|Period 2, 8 Hours||3||
48375673|NCT01252134|101247693|FG002|STARTED|Period 2, 8 Hours||2||
48249631|NCT01260142|100930919|FG000|STARTED|Treatment Period 1||6||
48249632|NCT01260142|100930920|FG001|STARTED|Treatment Period 1||6||
48249633|NCT01260142|100930921|FG002|STARTED|Treatment Period 1||6||
48249634|NCT01260142|100930922|FG003|STARTED|Treatment Period 1||6||
48375674|NCT01252134|101247694|FG003|STARTED|Period 2, 8 Hours||5||
48375675|NCT01252134|101247695|FG004|STARTED|Period 2, 8 Hours||3||
48540995|NCT03844386|101662621|FG003|STARTED|Overall Study||4||
48540996|NCT03844386|101662618|FG000|Completed Day 28|Overall Study||7||
48683399|NCT00928187|102009532|FG001|Analysed|Overall Study||145||
48683400|NCT00928187|102009533|FG002|Analysed|Overall Study||154||
48085992|NCT00938639|100533010|FG000|NOT COMPLETED|Overall Study||3||
48085993|NCT00938639|100533011|FG001|NOT COMPLETED|Overall Study||4||
48085994|NCT00679302|100533012|FG000|STARTED|Overall Study||84||
48085995|NCT00679302|100533013|FG001|STARTED|Overall Study||77||
48085996|NCT00679302|100533012|FG000|COMPLETED|Overall Study||76||
48085997|NCT00679302|100533013|FG001|COMPLETED|Overall Study||73||
48085998|NCT00679302|100533012|FG000|NOT COMPLETED|Overall Study||8||
48085999|NCT00679302|100533013|FG001|NOT COMPLETED|Overall Study||4||
48086000|NCT02669433|100533014|FG000|STARTED|Overall Study||91||
48086001|NCT02669433|100533015|FG001|STARTED|Overall Study||89||
48086002|NCT02669433|100533016|FG002|STARTED|Overall Study||89||
48086003|NCT02669433|100533014|FG000|Safety Population|Overall Study||91|The Safety population included subjects who took at least 1 dose of double-blind study drug|
48086004|NCT02669433|100533015|FG001|Safety Population|Overall Study||89|The Safety population included subjects who took at least 1 dose of double-blind study drug|
48086005|NCT02669433|100533016|FG002|Safety Population|Overall Study||88|The Safety population included subjects who took at least 1 dose of double-blind study drug|
48086006|NCT02669433|100533014|FG000|Intent to Treat (ITT) Population|Overall Study||89|Subjects took at least 1 dose of double-blind study drug and had at least 1 post-baseline assessment|
48086007|NCT02669433|100533015|FG001|Intent to Treat (ITT) Population|Overall Study||89|Subjects took at least 1 dose of double-blind study drug and had at least 1 post-baseline assessment|
48086008|NCT02669433|100533016|FG002|Intent to Treat (ITT) Population|Overall Study||87|Subjects took at least 1 dose of double-blind study drug and had at least 1 post-baseline assessment|
48086009|NCT02669433|100533014|FG000|Per-Protocol Population|Overall Study||78|Subjects in the ITT population who had no major protocol violations|
48086010|NCT02669433|100533015|FG001|Per-Protocol Population|Overall Study||79|Subjects in the ITT population who had no major protocol violations|
48086011|NCT02669433|100533016|FG002|Per-Protocol Population|Overall Study||82|Subjects in the ITT population who had no major protocol violations|
48086012|NCT02669433|100533014|FG000|Completers Population|Overall Study||73|Subjects in the ITT population who completed the study|
48086013|NCT02669433|100533015|FG001|Completers Population|Overall Study||72|Subjects in the ITT population who completed the study|
48086014|NCT02669433|100533016|FG002|Completers Population|Overall Study||69|Subjects in the ITT population who completed the study|
48086015|NCT02669433|100533014|FG000|UPDRS Primary Population|Overall Study||87||
48086016|NCT02669433|100533015|FG001|UPDRS Primary Population|Overall Study||87||
48086017|NCT02669433|100533016|FG002|UPDRS Primary Population|Overall Study||84||
48086018|NCT02669433|100533014|FG000|COMPLETED|Overall Study||76|Subjects who completed every visit per protocol|
48086019|NCT02669433|100533015|FG001|COMPLETED|Overall Study||75|Subjects who completed every visit per protocol|
48086020|NCT02669433|100533016|FG002|COMPLETED|Overall Study||74|Subjects who completed every visit per protocol|
48086021|NCT02669433|100533014|FG000|NOT COMPLETED|Overall Study||15||
48086022|NCT02669433|100533015|FG001|NOT COMPLETED|Overall Study||14||
48086023|NCT02669433|100533016|FG002|NOT COMPLETED|Overall Study||15||
48086024|NCT01442493|100533017|FG000|STARTED|Overall Study||149||
48086025|NCT01442493|100533018|FG001|STARTED|Overall Study||151||
48086026|NCT01442493|100533017|FG000|COMPLETED|Overall Study||146||
48086027|NCT01442493|100533018|FG001|COMPLETED|Overall Study||149||
48086028|NCT01442493|100533017|FG000|NOT COMPLETED|Overall Study||3||
48086029|NCT01442493|100533018|FG001|NOT COMPLETED|Overall Study||2||
48086030|NCT03018704|100533019|FG000|STARTED|Overall Study||19||
48086031|NCT03018704|100533020|FG001|STARTED|Overall Study||18||
48086032|NCT03018704|100533019|FG000|COMPLETED|Overall Study||18||
48086033|NCT03018704|100533020|FG001|COMPLETED|Overall Study||17||
48086034|NCT03018704|100533019|FG000|NOT COMPLETED|Overall Study||1||
48086035|NCT03018704|100533020|FG001|NOT COMPLETED|Overall Study||1||
48086036|NCT01693653|100533021|FG000|STARTED|Overall Study||1||
48086037|NCT01693653|100533022|FG001|STARTED|Overall Study||0||
48086038|NCT01693653|100533021|FG000|COMPLETED|Overall Study||1||
48086039|NCT01693653|100533022|FG001|COMPLETED|Overall Study||0||
48086040|NCT01693653|100533021|FG000|NOT COMPLETED|Overall Study||0||
48086041|NCT01693653|100533022|FG001|NOT COMPLETED|Overall Study||0||
48086042|NCT01539694|100533023|FG000|STARTED|Overall Study||63||
48086043|NCT01539694|100533024|FG001|STARTED|Overall Study||63||
48086044|NCT01539694|100533023|FG000|COMPLETED|Overall Study||62||
48086045|NCT01539694|100533024|FG001|COMPLETED|Overall Study||62||
48086046|NCT01539694|100533023|FG000|NOT COMPLETED|Overall Study||1||
48086047|NCT01539694|100533024|FG001|NOT COMPLETED|Overall Study||1||
48086048|NCT02246660|100533025|FG000|STARTED|Overall Study||23||
48086049|NCT02246660|100533026|FG001|STARTED|Overall Study||21||
48249635|NCT01260142|100930923|FG004|STARTED|Treatment Period 1||6||
48249636|NCT01260142|100930924|FG005|STARTED|Treatment Period 1||6||
48249637|NCT01260142|100930919|FG000|COMPLETED|Treatment Period 1||5||
48249638|NCT01260142|100930920|FG001|COMPLETED|Treatment Period 1||5||
48249639|NCT01260142|100930921|FG002|COMPLETED|Treatment Period 1||6||
48249640|NCT01260142|100930922|FG003|COMPLETED|Treatment Period 1||6||
48249641|NCT01260142|100930923|FG004|COMPLETED|Treatment Period 1||4||
48249642|NCT01260142|100930924|FG005|COMPLETED|Treatment Period 1||3||
48249643|NCT01260142|100930919|FG000|NOT COMPLETED|Treatment Period 1||1||
48249644|NCT01260142|100930920|FG001|NOT COMPLETED|Treatment Period 1||1||
48249645|NCT01260142|100930921|FG002|NOT COMPLETED|Treatment Period 1||0||
48249646|NCT01260142|100930922|FG003|NOT COMPLETED|Treatment Period 1||0||
48249647|NCT01260142|100930923|FG004|NOT COMPLETED|Treatment Period 1||2||
48086050|NCT02246660|100533027|FG002|STARTED|Overall Study||22||
48683401|NCT00928187|102009531|FG000|COMPLETED|Overall Study||150||
48683402|NCT00928187|102009532|FG001|COMPLETED|Overall Study||141||
48086051|NCT02246660|100533025|FG000|COMPLETED|Overall Study||23||
48683403|NCT00928187|102009533|FG002|COMPLETED|Overall Study||150||
48683404|NCT00928187|102009531|FG000|NOT COMPLETED|Overall Study||2||
48683405|NCT00928187|102009532|FG001|NOT COMPLETED|Overall Study||6||
48683406|NCT00928187|102009533|FG002|NOT COMPLETED|Overall Study||5||
48683407|NCT01581684|102009534|FG000|STARTED|Overall Study||14||
48683408|NCT01581684|102009535|FG001|STARTED|Overall Study||6||
48683409|NCT01581684|102009536|FG002|STARTED|Overall Study||6||
48683410|NCT01581684|102009537|FG003|STARTED|Overall Study||6||
48683411|NCT01581684|102009538|FG004|STARTED|Overall Study||6||
48683412|NCT01581684|102009539|FG005|STARTED|Overall Study||6||
48683413|NCT01581684|102009540|FG006|STARTED|Overall Study||6||
48683414|NCT01581684|102009541|FG007|STARTED|Overall Study||6||
48683415|NCT01581684|102009542|FG008|STARTED|Overall Study||1||
48683416|NCT01581684|102009543|FG009|STARTED|Overall Study||5||
48683417|NCT01581684|102009534|FG000|COMPLETED|Overall Study||14||
48683418|NCT01581684|102009535|FG001|COMPLETED|Overall Study||6||
48683419|NCT01581684|102009536|FG002|COMPLETED|Overall Study||6||
48683420|NCT01581684|102009537|FG003|COMPLETED|Overall Study||6||
48683421|NCT01581684|102009538|FG004|COMPLETED|Overall Study||6||
48683422|NCT01581684|102009539|FG005|COMPLETED|Overall Study||6||
48683423|NCT01581684|102009540|FG006|COMPLETED|Overall Study||6||
48683424|NCT01581684|102009541|FG007|COMPLETED|Overall Study||6||
48683425|NCT01581684|102009542|FG008|COMPLETED|Overall Study||0||
48683426|NCT01581684|102009543|FG009|COMPLETED|Overall Study||5||
48683427|NCT01581684|102009534|FG000|NOT COMPLETED|Overall Study||0||
48683428|NCT01581684|102009535|FG001|NOT COMPLETED|Overall Study||0||
48683429|NCT01581684|102009536|FG002|NOT COMPLETED|Overall Study||0||
48683430|NCT01581684|102009537|FG003|NOT COMPLETED|Overall Study||0||
48683431|NCT01581684|102009538|FG004|NOT COMPLETED|Overall Study||0||
48683432|NCT01581684|102009539|FG005|NOT COMPLETED|Overall Study||0||
48683433|NCT01581684|102009540|FG006|NOT COMPLETED|Overall Study||0||
48683434|NCT01581684|102009541|FG007|NOT COMPLETED|Overall Study||0||
48683435|NCT01581684|102009542|FG008|NOT COMPLETED|Overall Study||1||
48683436|NCT01581684|102009543|FG009|NOT COMPLETED|Overall Study||0||
48683437|NCT02503085|102009544|FG000|STARTED|Period 1||7||
48086052|NCT02246660|100533026|FG001|COMPLETED|Overall Study||20||
48249648|NCT01260142|100930924|FG005|NOT COMPLETED|Treatment Period 1||3||
48249649|NCT01260142|100930919|FG000|STARTED|Treatment Period 2||5||
48249650|NCT01260142|100930920|FG001|STARTED|Treatment Period 2||5||
48249651|NCT01260142|100930921|FG002|STARTED|Treatment Period 2||6||
48249652|NCT01260142|100930922|FG003|STARTED|Treatment Period 2||6||
48249653|NCT01260142|100930923|FG004|STARTED|Treatment Period 2||4||
48249654|NCT01260142|100930924|FG005|STARTED|Treatment Period 2||3||
48249655|NCT01260142|100930919|FG000|COMPLETED|Treatment Period 2||5||
48249656|NCT01260142|100930920|FG001|COMPLETED|Treatment Period 2||5||
48249657|NCT01260142|100930921|FG002|COMPLETED|Treatment Period 2||6||
48249658|NCT01260142|100930922|FG003|COMPLETED|Treatment Period 2||6||
48249659|NCT01260142|100930923|FG004|COMPLETED|Treatment Period 2||4||
48249660|NCT01260142|100930924|FG005|COMPLETED|Treatment Period 2||3||
48249661|NCT01260142|100930919|FG000|NOT COMPLETED|Treatment Period 2||0||
48249662|NCT01260142|100930920|FG001|NOT COMPLETED|Treatment Period 2||0||
48249663|NCT01260142|100930921|FG002|NOT COMPLETED|Treatment Period 2||0||
48249664|NCT01260142|100930922|FG003|NOT COMPLETED|Treatment Period 2||0||
48249665|NCT01260142|100930923|FG004|NOT COMPLETED|Treatment Period 2||0||
48249666|NCT01260142|100930924|FG005|NOT COMPLETED|Treatment Period 2||0||
48249667|NCT00024102|100930925|FG000|STARTED|Overall Study||326||
48249668|NCT00024102|100930926|FG001|STARTED|Overall Study||307||
48249669|NCT00024102|100930925|FG000|COMPLETED|Overall Study||326||
48249670|NCT00024102|100930926|FG001|COMPLETED|Overall Study||307||
48249671|NCT00024102|100930925|FG000|NOT COMPLETED|Overall Study||0||
48249672|NCT00024102|100930926|FG001|NOT COMPLETED|Overall Study||0||
48249673|NCT00553605|100930927|FG000|STARTED|Overall Study||176||
48249674|NCT00553605|100930928|FG001|STARTED|Overall Study||164||
48249675|NCT00553605|100930927|FG000|Treated|Overall Study||174||
48249676|NCT00553605|100930928|FG001|Treated|Overall Study||164||
48249677|NCT00553605|100930927|FG000|COMPLETED|Overall Study||172||
48249678|NCT00553605|100930928|FG001|COMPLETED|Overall Study||161||
48249679|NCT00553605|100930927|FG000|NOT COMPLETED|Overall Study||4||
48683438|NCT02503085|102009545|FG001|STARTED|Period 1||7||
48683439|NCT02503085|102009546|FG002|STARTED|Period 1||7||
48683440|NCT02503085|102009547|FG003|STARTED|Period 1||7||
48683441|NCT02503085|102009544|FG000|COMPLETED|Period 1||7||
48249680|NCT00553605|100930928|FG001|NOT COMPLETED|Overall Study||3||
48249681|NCT04750577|100930929|FG000|STARTED|Overall Study||61|Randomised|
48249682|NCT04750577|100930930|FG001|STARTED|Overall Study||61|Randomised|
48249683|NCT04750577|100930931|FG002|STARTED|Overall Study||61|Randomised|
48249684|NCT04750577|100930932|FG003|STARTED|Overall Study||60|Randomised|
48683442|NCT02503085|102009545|FG001|COMPLETED|Period 1||7||
48683443|NCT02503085|102009546|FG002|COMPLETED|Period 1||7||
48683444|NCT02503085|102009547|FG003|COMPLETED|Period 1||7||
48683445|NCT02503085|102009544|FG000|NOT COMPLETED|Period 1||0||
48683446|NCT02503085|102009545|FG001|NOT COMPLETED|Period 1||0||
48683447|NCT02503085|102009546|FG002|NOT COMPLETED|Period 1||0||
48683448|NCT02503085|102009547|FG003|NOT COMPLETED|Period 1||0||
48683449|NCT02503085|102009544|FG000|STARTED|Period 1: Washout (3 to 7 Days)||7||
48683450|NCT02503085|102009545|FG001|STARTED|Period 1: Washout (3 to 7 Days)||7||
48683451|NCT02503085|102009546|FG002|STARTED|Period 1: Washout (3 to 7 Days)||7||
48683452|NCT02503085|102009547|FG003|STARTED|Period 1: Washout (3 to 7 Days)||7||
48086053|NCT02246660|100533027|FG002|COMPLETED|Overall Study||21||
48086054|NCT02246660|100533025|FG000|NOT COMPLETED|Overall Study||0||
48086055|NCT02246660|100533026|FG001|NOT COMPLETED|Overall Study||1||
48086056|NCT02246660|100533027|FG002|NOT COMPLETED|Overall Study||1||
48086057|NCT02433483|100533028|FG000|STARTED|Overall Study||2||
48086058|NCT02433483|100533028|FG000|COMPLETED|Overall Study||0||
48086059|NCT02433483|100533028|FG000|NOT COMPLETED|Overall Study||2||
48086060|NCT04899921|100533029|FG000|STARTED|Overall Study||0||
48086061|NCT04899921|100533030|FG001|STARTED|Overall Study||0||
48086062|NCT04899921|100533031|FG002|STARTED|Overall Study||0||
48086063|NCT04899921|100533029|FG000|COMPLETED|Overall Study||0|Terminated with 1 patient enrolled, no data due to patient privacy.|
48086064|NCT04899921|100533030|FG001|COMPLETED|Overall Study||0|Terminated with 1 patient enrolled, no data due to patient privacy.|
48086065|NCT04899921|100533031|FG002|COMPLETED|Overall Study||0|Terminated with 1 patient enrolled, no data due to patient privacy.|
48086066|NCT04899921|100533029|FG000|NOT COMPLETED|Overall Study||0||
48086067|NCT04899921|100533030|FG001|NOT COMPLETED|Overall Study||0||
48086068|NCT04899921|100533031|FG002|NOT COMPLETED|Overall Study||0||
48086069|NCT03975790|100533032|FG000|STARTED|Overall Study||337||
48086070|NCT03975790|100533033|FG001|STARTED|Overall Study||94||
48086071|NCT03975790|100533034|FG002|STARTED|Overall Study||48||
48086072|NCT03975790|100533032|FG000|COMPLETED|Overall Study||337||
48086073|NCT03975790|100533033|FG001|COMPLETED|Overall Study||94||
48086074|NCT03975790|100533034|FG002|COMPLETED|Overall Study||48||
48086075|NCT03975790|100533032|FG000|NOT COMPLETED|Overall Study||0||
48086076|NCT03975790|100533033|FG001|NOT COMPLETED|Overall Study||0||
48086077|NCT03975790|100533034|FG002|NOT COMPLETED|Overall Study||0||
48249685|NCT04750577|100930929|FG000|Treated|Overall Study||61||
48249686|NCT04750577|100930930|FG001|Treated|Overall Study||61||
48249687|NCT04750577|100930931|FG002|Treated|Overall Study||61||
48683453|NCT02503085|102009544|FG000|COMPLETED|Period 1: Washout (3 to 7 Days)||7||
48683454|NCT02503085|102009545|FG001|COMPLETED|Period 1: Washout (3 to 7 Days)||7||
48249688|NCT04750577|100930932|FG003|Treated|Overall Study||58||
48249689|NCT04750577|100930929|FG000|COMPLETED|Overall Study||55||
48683455|NCT02503085|102009546|FG002|COMPLETED|Period 1: Washout (3 to 7 Days)||7||
48683456|NCT02503085|102009547|FG003|COMPLETED|Period 1: Washout (3 to 7 Days)||7||
48683457|NCT02503085|102009544|FG000|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0||
48683458|NCT02503085|102009545|FG001|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0||
48683459|NCT02503085|102009546|FG002|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0||
48683460|NCT02503085|102009547|FG003|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0||
48683461|NCT02503085|102009544|FG000|STARTED|Period 2||7||
48683462|NCT02503085|102009545|FG001|STARTED|Period 2||7||
48683463|NCT02503085|102009546|FG002|STARTED|Period 2||7||
48683464|NCT02503085|102009547|FG003|STARTED|Period 2||7||
48683465|NCT02503085|102009544|FG000|COMPLETED|Period 2||7||
48683466|NCT02503085|102009545|FG001|COMPLETED|Period 2||7||
48683467|NCT02503085|102009546|FG002|COMPLETED|Period 2||7||
48683468|NCT02503085|102009547|FG003|COMPLETED|Period 2||7||
48683469|NCT02503085|102009544|FG000|NOT COMPLETED|Period 2||0||
48683470|NCT02503085|102009545|FG001|NOT COMPLETED|Period 2||0||
48683471|NCT02503085|102009546|FG002|NOT COMPLETED|Period 2||0||
48683472|NCT02503085|102009547|FG003|NOT COMPLETED|Period 2||0||
48683473|NCT02503085|102009544|FG000|STARTED|Period 2: Washout (3 to 7 Days)||7||
48683474|NCT02503085|102009545|FG001|STARTED|Period 2: Washout (3 to 7 Days)||7||
48683475|NCT02503085|102009546|FG002|STARTED|Period 2: Washout (3 to 7 Days)||7||
48683476|NCT02503085|102009547|FG003|STARTED|Period 2: Washout (3 to 7 Days)||7||
48683477|NCT02503085|102009544|FG000|COMPLETED|Period 2: Washout (3 to 7 Days)||6||
48683478|NCT02503085|102009545|FG001|COMPLETED|Period 2: Washout (3 to 7 Days)||7||
48683479|NCT02503085|102009546|FG002|COMPLETED|Period 2: Washout (3 to 7 Days)||6||
48683480|NCT02503085|102009547|FG003|COMPLETED|Period 2: Washout (3 to 7 Days)||7||
48683481|NCT02503085|102009544|FG000|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1||
48086078|NCT04532164|100533035|FG000|STARTED|Overall Study||137||
48086079|NCT04532164|100533035|FG000|Treated|Overall Study||132||
48086080|NCT04532164|100533035|FG000|COMPLETED|Overall Study||113||
48086081|NCT04532164|100533035|FG000|NOT COMPLETED|Overall Study||24||
48086082|NCT00684307|100533036|FG000|STARTED|Overall Study||164||
48086083|NCT00684307|100533037|FG001|STARTED|Overall Study||151||
48249690|NCT04750577|100930930|FG001|COMPLETED|Overall Study||46||
48086084|NCT00684307|100533038|FG002|STARTED|Overall Study||156||
48086085|NCT00684307|100533039|FG003|STARTED|Overall Study||160||
48086086|NCT00684307|100533040|FG004|STARTED|Overall Study||318||
48086087|NCT00684307|100533036|FG000|On Treatment Period Started|Overall Study||164||
48683482|NCT02503085|102009545|FG001|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0||
48683483|NCT02503085|102009546|FG002|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1||
48683484|NCT02503085|102009547|FG003|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0||
48086088|NCT00684307|100533037|FG001|On Treatment Period Started|Overall Study||151||
48086089|NCT00684307|100533038|FG002|On Treatment Period Started|Overall Study||156||
48086090|NCT00684307|100533039|FG003|On Treatment Period Started|Overall Study||160||
48086091|NCT00684307|100533040|FG004|On Treatment Period Started|Overall Study||318||
48086092|NCT00684307|100533036|FG000|On Treatment Period Completed|Overall Study||140||
48086093|NCT00684307|100533037|FG001|On Treatment Period Completed|Overall Study||129||
48086094|NCT00684307|100533038|FG002|On Treatment Period Completed|Overall Study||128||
48086095|NCT00684307|100533039|FG003|On Treatment Period Completed|Overall Study||128||
48086096|NCT00684307|100533040|FG004|On Treatment Period Completed|Overall Study||293||
48683485|NCT02503085|102009544|FG000|STARTED|Period 3||6||
48683486|NCT02503085|102009545|FG001|STARTED|Period 3||7||
48683487|NCT02503085|102009546|FG002|STARTED|Period 3||6||
48683488|NCT02503085|102009547|FG003|STARTED|Period 3||7||
48683489|NCT02503085|102009544|FG000|COMPLETED|Period 3||6||
48086097|NCT00684307|100533036|FG000|COMPLETED|Overall Study||140||
48086098|NCT00684307|100533037|FG001|COMPLETED|Overall Study||129||
48086099|NCT00684307|100533038|FG002|COMPLETED|Overall Study||128||
48086100|NCT00684307|100533039|FG003|COMPLETED|Overall Study||128||
48086101|NCT00684307|100533040|FG004|COMPLETED|Overall Study||293||
48086102|NCT00684307|100533036|FG000|NOT COMPLETED|Overall Study||24||
48086103|NCT00684307|100533037|FG001|NOT COMPLETED|Overall Study||22||
48086104|NCT00684307|100533038|FG002|NOT COMPLETED|Overall Study||28||
48086105|NCT00684307|100533039|FG003|NOT COMPLETED|Overall Study||32||
48086106|NCT00684307|100533040|FG004|NOT COMPLETED|Overall Study||25||
48086107|NCT03291054|100533041|FG000|STARTED|Overall Study||1||
48086108|NCT03291054|100533041|FG000|COMPLETED|Overall Study||1||
48086109|NCT03291054|100533041|FG000|NOT COMPLETED|Overall Study||0||
48086110|NCT03498300|100533042|FG000|STARTED|Overall Study||21||
48086111|NCT03498300|100533043|FG001|STARTED|Overall Study||21||
48086112|NCT03498300|100533042|FG000|COMPLETED|Overall Study||18||
48086113|NCT03498300|100533043|FG001|COMPLETED|Overall Study||13||
48086114|NCT03498300|100533042|FG000|NOT COMPLETED|Overall Study||3||
48086115|NCT03498300|100533043|FG001|NOT COMPLETED|Overall Study||8||
48086116|NCT04677374|100533044|FG000|STARTED|Overall Study||514|Healthcare Workers at the participating site who could participate in one or both of the interviews and/or surveys.|
48086117|NCT04677374|100533045|FG001|STARTED|Overall Study||731|Healthcare Workers at the participating site who could participate in one or both of the interviews and/or surveys.|
48086118|NCT04677374|100533046|FG002|STARTED|Overall Study||508|Healthcare Workers at the participating site who could participate in one or both of the interviews and/or surveys.|
48086119|NCT04677374|100533047|FG003|STARTED|Overall Study||477|Healthcare Workers at the participating site who could participate in one or both of the interviews and/or surveys.|
48086120|NCT04677374|100533048|FG004|STARTED|Overall Study||12|Healthcare Workers at the participating site who could participate in one or both of the interviews and/or surveys.|
48086121|NCT04677374|100533044|FG000|COMPLETED|Overall Study||514||
48086122|NCT04677374|100533045|FG001|COMPLETED|Overall Study||731||
48086123|NCT04677374|100533046|FG002|COMPLETED|Overall Study||508||
48086124|NCT04677374|100533047|FG003|COMPLETED|Overall Study||477||
48086125|NCT04677374|100533048|FG004|COMPLETED|Overall Study||12||
48086126|NCT04677374|100533044|FG000|NOT COMPLETED|Overall Study||0||
48086127|NCT04677374|100533045|FG001|NOT COMPLETED|Overall Study||0||
48086128|NCT04677374|100533046|FG002|NOT COMPLETED|Overall Study||0||
48086129|NCT04677374|100533047|FG003|NOT COMPLETED|Overall Study||0||
48086130|NCT04677374|100533048|FG004|NOT COMPLETED|Overall Study||0||
48086131|NCT04118166|100533049|FG000|STARTED|Overall Study||30||
48086132|NCT04118166|100533049|FG000|COMPLETED|Overall Study||29||
48086133|NCT04118166|100533049|FG000|NOT COMPLETED|Overall Study||1||
48086134|NCT01307007|100533050|FG000|STARTED|Overall Study||25||
48086135|NCT01307007|100533051|FG001|STARTED|Overall Study||30||
48086136|NCT01307007|100533050|FG000|COMPLETED|Overall Study||25||
48086137|NCT01307007|100533051|FG001|COMPLETED|Overall Study||30||
48086138|NCT01307007|100533050|FG000|NOT COMPLETED|Overall Study||0||
48086139|NCT01307007|100533051|FG001|NOT COMPLETED|Overall Study||0||
48086140|NCT02152696|100533052|FG000|STARTED|Overall Study||86||
48086141|NCT02152696|100533053|FG001|STARTED|Overall Study||87||
48086142|NCT02152696|100533054|FG002|STARTED|Overall Study||82||
48086143|NCT02152696|100533052|FG000|COMPLETED|Overall Study||86||
48086144|NCT02152696|100533053|FG001|COMPLETED|Overall Study||86||
48249691|NCT04750577|100930931|FG002|COMPLETED|Overall Study||47||
48249692|NCT04750577|100930932|FG003|COMPLETED|Overall Study||53||
48249693|NCT04750577|100930929|FG000|NOT COMPLETED|Overall Study||6||
48249694|NCT04750577|100930930|FG001|NOT COMPLETED|Overall Study||15||
48249695|NCT04750577|100930931|FG002|NOT COMPLETED|Overall Study||14||
48249696|NCT04750577|100930932|FG003|NOT COMPLETED|Overall Study||7||
48249697|NCT02930837|100930933|FG000|STARTED|Overall Study||120||
48249698|NCT02930837|100930933|FG000|COMPLETED|Overall Study||108||
48249699|NCT02930837|100930933|FG000|NOT COMPLETED|Overall Study||12||
48249700|NCT02815735|100930934|FG000|STARTED|First Intervention (4 Weeks)||36||
48249701|NCT02815735|100930935|FG001|STARTED|First Intervention (4 Weeks)||38||
48249702|NCT02815735|100930934|FG000|COMPLETED|First Intervention (4 Weeks)||34||
48249703|NCT02815735|100930935|FG001|COMPLETED|First Intervention (4 Weeks)||37||
48683490|NCT02503085|102009545|FG001|COMPLETED|Period 3||7||
48683491|NCT02503085|102009546|FG002|COMPLETED|Period 3||6||
48683492|NCT02503085|102009547|FG003|COMPLETED|Period 3||7||
48683493|NCT02503085|102009544|FG000|NOT COMPLETED|Period 3||0||
48683494|NCT02503085|102009545|FG001|NOT COMPLETED|Period 3||0||
48683495|NCT02503085|102009546|FG002|NOT COMPLETED|Period 3||0||
48683496|NCT02503085|102009547|FG003|NOT COMPLETED|Period 3||0||
48683497|NCT02503085|102009544|FG000|STARTED|Period 3: Washout (3 to 7 Days)||6||
48683498|NCT02503085|102009545|FG001|STARTED|Period 3: Washout (3 to 7 Days)||7||
48683499|NCT02503085|102009546|FG002|STARTED|Period 3: Washout (3 to 7 Days)||6||
48683500|NCT02503085|102009547|FG003|STARTED|Period 3: Washout (3 to 7 Days)||7||
48086145|NCT02152696|100533054|FG002|COMPLETED|Overall Study||81||
48086146|NCT02152696|100533052|FG000|NOT COMPLETED|Overall Study||0||
48086147|NCT02152696|100533053|FG001|NOT COMPLETED|Overall Study||1||
48086148|NCT02152696|100533054|FG002|NOT COMPLETED|Overall Study||1||
48086149|NCT01652703|100533055|FG000|STARTED|Overall Study||52||
48086150|NCT01652703|100533056|FG001|STARTED|Overall Study||51||
48086151|NCT01652703|100533057|FG002|STARTED|Overall Study||50||
48086152|NCT01652703|100533058|FG003|STARTED|Overall Study||52||
48086153|NCT01652703|100533059|FG004|STARTED|Overall Study||52||
48086154|NCT01652703|100533060|FG005|STARTED|Overall Study||53||
48086155|NCT01652703|100533055|FG000|Received Treatment|Overall Study||52||
48086156|NCT01652703|100533056|FG001|Received Treatment|Overall Study||50||
48375676|NCT01252134|101247696|FG005|STARTED|Period 2, 8 Hours||4||
48375677|NCT01252134|101247691|FG000|COMPLETED|Period 2, 8 Hours||3||
48375678|NCT01252134|101247692|FG001|COMPLETED|Period 2, 8 Hours||3||
48086157|NCT01652703|100533057|FG002|Received Treatment|Overall Study||49||
48086158|NCT01652703|100533058|FG003|Received Treatment|Overall Study||52||
48086159|NCT01652703|100533059|FG004|Received Treatment|Overall Study||51||
48086160|NCT01652703|100533060|FG005|Received Treatment|Overall Study||53||
48086161|NCT01652703|100533055|FG000|COMPLETED|Overall Study||52||
48086162|NCT01652703|100533056|FG001|COMPLETED|Overall Study||50||
48375679|NCT01252134|101247693|FG002|COMPLETED|Period 2, 8 Hours||2||
48375680|NCT01252134|101247694|FG003|COMPLETED|Period 2, 8 Hours||5||
48375681|NCT01252134|101247695|FG004|COMPLETED|Period 2, 8 Hours||3||
48375682|NCT01252134|101247696|FG005|COMPLETED|Period 2, 8 Hours||4||
48375683|NCT01252134|101247691|FG000|NOT COMPLETED|Period 2, 8 Hours||0||
48375684|NCT01252134|101247692|FG001|NOT COMPLETED|Period 2, 8 Hours||0||
48086163|NCT01652703|100533057|FG002|COMPLETED|Overall Study||47||
48086164|NCT01652703|100533058|FG003|COMPLETED|Overall Study||50||
48086165|NCT01652703|100533059|FG004|COMPLETED|Overall Study||51||
48086166|NCT01652703|100533060|FG005|COMPLETED|Overall Study||51||
48086167|NCT01652703|100533055|FG000|NOT COMPLETED|Overall Study||0||
48249704|NCT02815735|100930934|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2||
48375685|NCT01252134|101247693|FG002|NOT COMPLETED|Period 2, 8 Hours||0||
48375686|NCT01252134|101247694|FG003|NOT COMPLETED|Period 2, 8 Hours||0||
48375687|NCT01252134|101247695|FG004|NOT COMPLETED|Period 2, 8 Hours||0||
48375688|NCT01252134|101247696|FG005|NOT COMPLETED|Period 2, 8 Hours||0||
48375689|NCT01252134|101247691|FG000|STARTED|Period 3, 8 Hours||3||
48375690|NCT01252134|101247692|FG001|STARTED|Period 3, 8 Hours||3||
48375691|NCT01252134|101247693|FG002|STARTED|Period 3, 8 Hours||2||
48375692|NCT01252134|101247694|FG003|STARTED|Period 3, 8 Hours||5||
48683501|NCT02503085|102009544|FG000|COMPLETED|Period 3: Washout (3 to 7 Days)||6||
48683502|NCT02503085|102009545|FG001|COMPLETED|Period 3: Washout (3 to 7 Days)||7||
48683503|NCT02503085|102009546|FG002|COMPLETED|Period 3: Washout (3 to 7 Days)||6||
48683504|NCT02503085|102009547|FG003|COMPLETED|Period 3: Washout (3 to 7 Days)||7||
48249705|NCT02815735|100930935|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1||
48249706|NCT02815735|100930934|FG000|STARTED|Second Intervention (4 Weeks)||34||
48249707|NCT02815735|100930935|FG001|STARTED|Second Intervention (4 Weeks)||37||
48249708|NCT02815735|100930934|FG000|COMPLETED|Second Intervention (4 Weeks)||33||
48249709|NCT02815735|100930935|FG001|COMPLETED|Second Intervention (4 Weeks)||37||
48249710|NCT02815735|100930934|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1||
48249711|NCT02815735|100930935|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0||
48086168|NCT01652703|100533056|FG001|NOT COMPLETED|Overall Study||1||
48086169|NCT01652703|100533057|FG002|NOT COMPLETED|Overall Study||3||
48086170|NCT01652703|100533058|FG003|NOT COMPLETED|Overall Study||2||
48086171|NCT01652703|100533059|FG004|NOT COMPLETED|Overall Study||1||
48086172|NCT01652703|100533060|FG005|NOT COMPLETED|Overall Study||2||
48249712|NCT02920021|100930936|FG000|STARTED|Overall Study||15||
48249713|NCT02920021|100930937|FG001|STARTED|Overall Study||5||
48249714|NCT02920021|100930936|FG000|COMPLETED|Overall Study||15||
48249715|NCT02920021|100930937|FG001|COMPLETED|Overall Study||5||
48249716|NCT02920021|100930936|FG000|NOT COMPLETED|Overall Study||0||
48249717|NCT02920021|100930937|FG001|NOT COMPLETED|Overall Study||0||
48249718|NCT00385697|100930938|FG000|STARTED|Open-label Segment 1||38||
48249719|NCT00385697|100930939|FG001|STARTED|Open-label Segment 1||0||
48086173|NCT00583778|100533061|FG000|STARTED|Overall Study||74||
48086174|NCT00583778|100533062|FG001|STARTED|Overall Study||67||
48375693|NCT01252134|101247695|FG004|STARTED|Period 3, 8 Hours||3||
48375694|NCT01252134|101247696|FG005|STARTED|Period 3, 8 Hours||4||
48375695|NCT01252134|101247691|FG000|COMPLETED|Period 3, 8 Hours||3||
48375696|NCT01252134|101247692|FG001|COMPLETED|Period 3, 8 Hours||3||
48375697|NCT01252134|101247693|FG002|COMPLETED|Period 3, 8 Hours||2||
48683505|NCT02503085|102009544|FG000|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0||
48683506|NCT02503085|102009545|FG001|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0||
48249720|NCT00385697|100930940|FG002|STARTED|Open-label Segment 1||0||
48249721|NCT00385697|100930941|FG003|STARTED|Open-label Segment 1||0||
48249722|NCT00385697|100930942|FG004|STARTED|Open-label Segment 1||0||
48249723|NCT00385697|100930938|FG000|COMPLETED|Open-label Segment 1||35||
48249724|NCT00385697|100930939|FG001|COMPLETED|Open-label Segment 1||0||
48249725|NCT00385697|100930940|FG002|COMPLETED|Open-label Segment 1||0||
48249726|NCT00385697|100930941|FG003|COMPLETED|Open-label Segment 1||0||
48249727|NCT00385697|100930942|FG004|COMPLETED|Open-label Segment 1||0||
48249728|NCT00385697|100930938|FG000|NOT COMPLETED|Open-label Segment 1||3||
48249729|NCT00385697|100930939|FG001|NOT COMPLETED|Open-label Segment 1||0||
48249730|NCT00385697|100930940|FG002|NOT COMPLETED|Open-label Segment 1||0||
48249731|NCT00385697|100930941|FG003|NOT COMPLETED|Open-label Segment 1||0||
48249732|NCT00385697|100930942|FG004|NOT COMPLETED|Open-label Segment 1||0||
48249733|NCT00385697|100930938|FG000|STARTED|Double-blind Segment 2||0||
48249734|NCT00385697|100930939|FG001|STARTED|Double-blind Segment 2||209||
48249735|NCT00385697|100930940|FG002|STARTED|Double-blind Segment 2||102||
48249736|NCT00385697|100930941|FG003|STARTED|Double-blind Segment 2||106||
48249737|NCT00385697|100930942|FG004|STARTED|Double-blind Segment 2||99||
48249738|NCT00385697|100930938|FG000|Full Analysis Set (FAS) Population|Double-blind Segment 2||0|Randomized subjects that received any amount of study treatment, analyzed according to randomization.|
48249739|NCT00385697|100930939|FG001|Full Analysis Set (FAS) Population|Double-blind Segment 2||207|Randomized subjects that received any amount of study treatment, analyzed according to randomization.|
48249740|NCT00385697|100930940|FG002|Full Analysis Set (FAS) Population|Double-blind Segment 2||102|Randomized subjects that received any amount of study treatment, analyzed according to randomization.|
48249741|NCT00385697|100930941|FG003|Full Analysis Set (FAS) Population|Double-blind Segment 2||106|Randomized subjects that received any amount of study treatment, analyzed according to randomization.|
48249742|NCT00385697|100930942|FG004|Full Analysis Set (FAS) Population|Double-blind Segment 2||98|Randomized subjects that received any amount of study treatment, analyzed according to randomization.|
48249743|NCT00385697|100930938|FG000|Safety Population|Double-blind Segment 2||0|Randomized subjects that received any amount of study treatment, analyzed according to actual treatment received.|
48249744|NCT00385697|100930939|FG001|Safety Population|Double-blind Segment 2||207|Randomized subjects that received any amount of study treatment, analyzed according to actual treatment received.|
48249745|NCT00385697|100930940|FG002|Safety Population|Double-blind Segment 2||102|Randomized subjects that received any amount of study treatment, analyzed according to actual treatment received.|
48249746|NCT00385697|100930941|FG003|Safety Population|Double-blind Segment 2||106|Randomized subjects that received any amount of study treatment, analyzed according to actual treatment received.|
48249747|NCT00385697|100930942|FG004|Safety Population|Double-blind Segment 2||98|Randomized subjects that received any amount of study treatment, analyzed according to actual treatment received.|
48249748|NCT00385697|100930938|FG000|COMPLETED|Double-blind Segment 2||0||
48249749|NCT00385697|100930939|FG001|COMPLETED|Double-blind Segment 2||183||
48249750|NCT00385697|100930940|FG002|COMPLETED|Double-blind Segment 2||90||
48249751|NCT00385697|100930941|FG003|COMPLETED|Double-blind Segment 2||97||
48249752|NCT00385697|100930942|FG004|COMPLETED|Double-blind Segment 2||92||
48249753|NCT00385697|100930938|FG000|NOT COMPLETED|Double-blind Segment 2||0||
48249754|NCT00385697|100930939|FG001|NOT COMPLETED|Double-blind Segment 2||26||
48249755|NCT00385697|100930940|FG002|NOT COMPLETED|Double-blind Segment 2||12||
48249756|NCT00385697|100930941|FG003|NOT COMPLETED|Double-blind Segment 2||9||
48249757|NCT00385697|100930942|FG004|NOT COMPLETED|Double-blind Segment 2||7||
48249758|NCT00385697|100930938|FG000|STARTED|Long-term Follow up Segment 3||35||
48249759|NCT00385697|100930939|FG001|STARTED|Long-term Follow up Segment 3||183||
48249760|NCT00385697|100930940|FG002|STARTED|Long-term Follow up Segment 3||90||
48249761|NCT00385697|100930941|FG003|STARTED|Long-term Follow up Segment 3||97||
48249762|NCT00385697|100930942|FG004|STARTED|Long-term Follow up Segment 3||92||
48249763|NCT00385697|100930938|FG000|COMPLETED|Long-term Follow up Segment 3||35||
48249764|NCT00385697|100930939|FG001|COMPLETED|Long-term Follow up Segment 3||183||
48249765|NCT00385697|100930940|FG002|COMPLETED|Long-term Follow up Segment 3||90||
48249766|NCT00385697|100930941|FG003|COMPLETED|Long-term Follow up Segment 3||97||
48249767|NCT00385697|100930942|FG004|COMPLETED|Long-term Follow up Segment 3||92||
48249768|NCT00385697|100930938|FG000|NOT COMPLETED|Long-term Follow up Segment 3||0||
48249769|NCT00385697|100930939|FG001|NOT COMPLETED|Long-term Follow up Segment 3||0||
48249770|NCT00385697|100930940|FG002|NOT COMPLETED|Long-term Follow up Segment 3||0||
48249771|NCT00385697|100930941|FG003|NOT COMPLETED|Long-term Follow up Segment 3||0||
48249772|NCT00385697|100930942|FG004|NOT COMPLETED|Long-term Follow up Segment 3||0||
48249773|NCT00760877|100930943|FG000|STARTED|Overall Study||104||
48249774|NCT00760877|100930944|FG001|STARTED|Overall Study||103||
48249775|NCT00760877|100930943|FG000|Cross-over to Nilotinib|Overall Study||0||
48249776|NCT00760877|100930944|FG001|Cross-over to Nilotinib|Overall Study||46||
48249777|NCT00760877|100930943|FG000|Safety Set|Overall Study||101||
48249778|NCT00760877|100930944|FG001|Safety Set|Overall Study||103||
48249779|NCT00760877|100930943|FG000|COMPLETED|Overall Study||59||
48249780|NCT00760877|100930944|FG001|COMPLETED|Overall Study||77||
48249781|NCT00760877|100930943|FG000|NOT COMPLETED|Overall Study||45||
48249782|NCT00760877|100930944|FG001|NOT COMPLETED|Overall Study||26||
48249783|NCT03868735|100930945|FG000|STARTED|Overall Study||136||
48249784|NCT03868735|100930946|FG001|STARTED|Overall Study||136||
48249785|NCT03868735|100930945|FG000|COMPLETED|Overall Study||136||
48249786|NCT03868735|100930946|FG001|COMPLETED|Overall Study||136||
48249787|NCT03868735|100930945|FG000|NOT COMPLETED|Overall Study||0||
48249788|NCT03868735|100930946|FG001|NOT COMPLETED|Overall Study||0||
48249789|NCT01284634|100930947|FG000|STARTED|Overall Study||7||
48249790|NCT01284634|100930948|FG001|STARTED|Overall Study||6||
48249791|NCT01284634|100930949|FG002|STARTED|Overall Study||7||
48086175|NCT00583778|100533061|FG000|COMPLETED|Overall Study||74||
48086176|NCT00583778|100533062|FG001|COMPLETED|Overall Study||67||
48086177|NCT00583778|100533061|FG000|NOT COMPLETED|Overall Study||0||
48086178|NCT00583778|100533062|FG001|NOT COMPLETED|Overall Study||0||
48086179|NCT02548650|100533063|FG000|STARTED|Triple Therapy||30||
48086180|NCT02548650|100533064|FG001|STARTED|Triple Therapy||36||
48086181|NCT02548650|100533063|FG000|COMPLETED|Triple Therapy||29||
48086182|NCT02548650|100533064|FG001|COMPLETED|Triple Therapy||32||
48086183|NCT02548650|100533063|FG000|NOT COMPLETED|Triple Therapy||1||
48086184|NCT02548650|100533064|FG001|NOT COMPLETED|Triple Therapy||4||
48086185|NCT02548650|100533063|FG000|STARTED|Double Therapy||29||
48086186|NCT02548650|100533064|FG001|STARTED|Double Therapy||32||
48086187|NCT02548650|100533063|FG000|COMPLETED|Double Therapy||28||
48086188|NCT02548650|100533064|FG001|COMPLETED|Double Therapy||30||
48086189|NCT02548650|100533063|FG000|NOT COMPLETED|Double Therapy||1||
48086190|NCT02548650|100533064|FG001|NOT COMPLETED|Double Therapy||2||
48086191|NCT01025752|100533065|FG000|STARTED|Overall Study||62||
48086192|NCT01025752|100533066|FG001|STARTED|Overall Study||63||
48086193|NCT01025752|100533065|FG000|COMPLETED|Overall Study||54||
48086194|NCT01025752|100533066|FG001|COMPLETED|Overall Study||50||
48086195|NCT01025752|100533065|FG000|NOT COMPLETED|Overall Study||8||
48086196|NCT01025752|100533066|FG001|NOT COMPLETED|Overall Study||13||
48086197|NCT00759811|100533067|FG000|STARTED|Overall Study||25||
48086198|NCT00759811|100533068|FG001|STARTED|Overall Study||25||
48086199|NCT00759811|100533067|FG000|COMPLETED|Overall Study||23||
48086200|NCT00759811|100533068|FG001|COMPLETED|Overall Study||24||
48086201|NCT00759811|100533067|FG000|NOT COMPLETED|Overall Study||2||
48086202|NCT00759811|100533068|FG001|NOT COMPLETED|Overall Study||1||
48086203|NCT01508650|100533069|FG000|STARTED|Overall Study||12||
48086204|NCT01508650|100533070|FG001|STARTED|Overall Study||15||
48086205|NCT01508650|100533069|FG000|COMPLETED|Overall Study||12||
48086206|NCT01508650|100533070|FG001|COMPLETED|Overall Study||12||
48086207|NCT01508650|100533069|FG000|NOT COMPLETED|Overall Study||0||
48086208|NCT01508650|100533070|FG001|NOT COMPLETED|Overall Study||3||
48086209|NCT03576976|100533071|FG000|STARTED|Overall Study||27||
48086210|NCT03576976|100533072|FG001|STARTED|Overall Study||28||
48086211|NCT03576976|100533071|FG000|COMPLETED|Overall Study||18||
48086212|NCT03576976|100533072|FG001|COMPLETED|Overall Study||17||
48086213|NCT03576976|100533071|FG000|NOT COMPLETED|Overall Study||9||
48086214|NCT03576976|100533072|FG001|NOT COMPLETED|Overall Study||11||
48086215|NCT02013791|100533073|FG000|STARTED|Period 1||8||
48086216|NCT02013791|100533074|FG001|STARTED|Period 1||8||
48086217|NCT02013791|100533075|FG002|STARTED|Period 1||4||
48086218|NCT02013791|100533076|FG003|STARTED|Period 1||8||
48086219|NCT02013791|100533077|FG004|STARTED|Period 1||4||
48086220|NCT02013791|100533078|FG005|STARTED|Period 1||8||
48086221|NCT02013791|100533079|FG006|STARTED|Period 1||4||
48086222|NCT02013791|100533080|FG007|STARTED|Period 1||8||
48086223|NCT02013791|100533081|FG008|STARTED|Period 1||3||
48086224|NCT02013791|100533073|FG000|COMPLETED|Period 1||8||
48086225|NCT02013791|100533074|FG001|COMPLETED|Period 1||6||
48086226|NCT02013791|100533075|FG002|COMPLETED|Period 1||4||
48086227|NCT02013791|100533076|FG003|COMPLETED|Period 1||7||
48086228|NCT02013791|100533077|FG004|COMPLETED|Period 1||4||
48086229|NCT02013791|100533078|FG005|COMPLETED|Period 1||8||
48086230|NCT02013791|100533079|FG006|COMPLETED|Period 1||3||
48086231|NCT02013791|100533080|FG007|COMPLETED|Period 1||7||
48086232|NCT02013791|100533081|FG008|COMPLETED|Period 1||3||
48086233|NCT02013791|100533073|FG000|NOT COMPLETED|Period 1||0||
48086234|NCT02013791|100533074|FG001|NOT COMPLETED|Period 1||2||
48086235|NCT02013791|100533075|FG002|NOT COMPLETED|Period 1||0||
48086236|NCT02013791|100533076|FG003|NOT COMPLETED|Period 1||1||
48086237|NCT02013791|100533077|FG004|NOT COMPLETED|Period 1||0||
48086238|NCT02013791|100533078|FG005|NOT COMPLETED|Period 1||0||
48086239|NCT02013791|100533079|FG006|NOT COMPLETED|Period 1||1||
48249792|NCT01284634|100930950|FG003|STARTED|Overall Study||5||
48249793|NCT01284634|100930947|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7|Safety analysis set; analyzed as per actual treatment received.|
48249794|NCT01284634|100930948|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6|Safety analysis set; analyzed as per actual treatment received.|
48249795|NCT01284634|100930949|FG002|Received at Least 1 Dose of Study Drug|Overall Study||7|Safety analysis set; analyzed as per actual treatment received.|
48249796|NCT01284634|100930950|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5|Safety analysis set; analyzed as per actual treatment received.|
48249797|NCT01284634|100930947|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||7|Randomized and received at least one dose of study medication and had on-treatment efficacy data.|
48249798|NCT01284634|100930948|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||6|Randomized and received at least one dose of study medication and had on-treatment efficacy data.|
48249799|NCT01284634|100930949|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||7|Randomized and received at least one dose of study medication and had on-treatment efficacy data.|
48086240|NCT02013791|100533080|FG007|NOT COMPLETED|Period 1||1||
48249800|NCT01284634|100930950|FG003|Intent to Treat (ITT) Analysis Set|Overall Study||5|Randomized and received at least one dose of study medication and had on-treatment efficacy data.|
48249801|NCT01284634|100930947|FG000|COMPLETED|Overall Study||6||
48249802|NCT01284634|100930948|FG001|COMPLETED|Overall Study||6||
48249803|NCT01284634|100930949|FG002|COMPLETED|Overall Study||5||
48249804|NCT01284634|100930950|FG003|COMPLETED|Overall Study||4||
48249805|NCT01284634|100930947|FG000|NOT COMPLETED|Overall Study||1||
48683507|NCT02503085|102009546|FG002|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0||
48683508|NCT02503085|102009547|FG003|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0||
48086241|NCT02013791|100533081|FG008|NOT COMPLETED|Period 1||0||
48086242|NCT02013791|100533073|FG000|STARTED|Period 2||0||
48086243|NCT02013791|100533074|FG001|STARTED|Period 2||0||
48086244|NCT02013791|100533075|FG002|STARTED|Period 2||2||
48086245|NCT02013791|100533076|FG003|STARTED|Period 2||0||
48086246|NCT02013791|100533077|FG004|STARTED|Period 2||0||
48086247|NCT02013791|100533078|FG005|STARTED|Period 2||0||
48086248|NCT02013791|100533079|FG006|STARTED|Period 2||3||
48086249|NCT02013791|100533080|FG007|STARTED|Period 2||0||
48086250|NCT02013791|100533081|FG008|STARTED|Period 2||0||
48086251|NCT02013791|100533073|FG000|COMPLETED|Period 2||0||
48086252|NCT02013791|100533074|FG001|COMPLETED|Period 2||0||
48086253|NCT02013791|100533075|FG002|COMPLETED|Period 2||2||
48086254|NCT02013791|100533076|FG003|COMPLETED|Period 2||0||
48086255|NCT02013791|100533077|FG004|COMPLETED|Period 2||0||
48086256|NCT02013791|100533078|FG005|COMPLETED|Period 2||0||
48086257|NCT02013791|100533079|FG006|COMPLETED|Period 2||3||
48086258|NCT02013791|100533080|FG007|COMPLETED|Period 2||0||
48086259|NCT02013791|100533081|FG008|COMPLETED|Period 2||0||
48086260|NCT02013791|100533073|FG000|NOT COMPLETED|Period 2||0||
48086261|NCT02013791|100533074|FG001|NOT COMPLETED|Period 2||0||
48086262|NCT02013791|100533075|FG002|NOT COMPLETED|Period 2||0||
48086263|NCT02013791|100533076|FG003|NOT COMPLETED|Period 2||0||
48086264|NCT02013791|100533077|FG004|NOT COMPLETED|Period 2||0||
48086265|NCT02013791|100533078|FG005|NOT COMPLETED|Period 2||0||
48086266|NCT02013791|100533079|FG006|NOT COMPLETED|Period 2||0||
48086267|NCT02013791|100533080|FG007|NOT COMPLETED|Period 2||0||
48086268|NCT02013791|100533081|FG008|NOT COMPLETED|Period 2||0||
48086269|NCT03547687|100533082|FG000|STARTED|Overall Study||9||
48086270|NCT03547687|100533082|FG000|COMPLETED|Overall Study||7||
48086271|NCT03547687|100533082|FG000|NOT COMPLETED|Overall Study||2||
48086272|NCT00191789|100533083|FG000|STARTED|Overall Study||65||
48086273|NCT00191789|100533083|FG000|COMPLETED|Overall Study||40||
48086274|NCT00191789|100533083|FG000|NOT COMPLETED|Overall Study||25||
48086275|NCT03655691|100533084|FG000|STARTED|Overall Study||26||
48086276|NCT03655691|100533085|FG001|STARTED|Overall Study||26||
48086277|NCT03655691|100533086|FG002|STARTED|Overall Study||27||
48086278|NCT03655691|100533084|FG000|COMPLETED|Overall Study||24||
48086279|NCT03655691|100533085|FG001|COMPLETED|Overall Study||23||
48086280|NCT03655691|100533086|FG002|COMPLETED|Overall Study||24||
48086281|NCT03655691|100533084|FG000|NOT COMPLETED|Overall Study||2||
48086282|NCT03655691|100533085|FG001|NOT COMPLETED|Overall Study||3||
48086283|NCT03655691|100533086|FG002|NOT COMPLETED|Overall Study||3||
48086284|NCT03716024|100533087|FG000|STARTED|Overall Study||118||
48086285|NCT03716024|100533088|FG001|STARTED|Overall Study||116||
48086286|NCT03716024|100533087|FG000|COMPLETED|Overall Study||107||
48086287|NCT03716024|100533088|FG001|COMPLETED|Overall Study||98||
48086288|NCT03716024|100533087|FG000|NOT COMPLETED|Overall Study||11||
48086289|NCT03716024|100533088|FG001|NOT COMPLETED|Overall Study||18||
48086290|NCT01580618|100533089|FG000|STARTED|Overall Study||8||
48086291|NCT01580618|100533090|FG001|STARTED|Overall Study||12||
48086292|NCT01580618|100533089|FG000|COMPLETED|Overall Study||7||
48086293|NCT01580618|100533090|FG001|COMPLETED|Overall Study||12||
48086294|NCT01580618|100533089|FG000|NOT COMPLETED|Overall Study||1||
48086295|NCT01580618|100533090|FG001|NOT COMPLETED|Overall Study||0||
48249806|NCT01284634|100930948|FG001|NOT COMPLETED|Overall Study||0||
48249807|NCT01284634|100930949|FG002|NOT COMPLETED|Overall Study||2||
48249808|NCT01284634|100930950|FG003|NOT COMPLETED|Overall Study||1||
48249809|NCT05135156|100930951|FG000|STARTED|Overall Study||25||
48683509|NCT02503085|102009544|FG000|STARTED|Period 4||6||
48683510|NCT02503085|102009545|FG001|STARTED|Period 4||7||
48683511|NCT02503085|102009546|FG002|STARTED|Period 4||6||
48086296|NCT03052725|100533091|FG000|STARTED|Overall Study||194||
48086297|NCT03052725|100533092|FG001|STARTED|Overall Study||197||
48086298|NCT03052725|100533091|FG000|Safety Analysis Set|Overall Study||194|Enrolled and treated|
48086299|NCT03052725|100533092|FG001|Safety Analysis Set|Overall Study||196|Enrolled and treated|
48086300|NCT03052725|100533091|FG000|COMPLETED|Overall Study||46|Completed treatment; due to study termination, the end of study visit was not conducted.|
48086301|NCT03052725|100533092|FG001|COMPLETED|Overall Study||47|Completed treatment; due to study termination, the end of study visit was not conducted.|
48086302|NCT03052725|100533091|FG000|NOT COMPLETED|Overall Study||148||
48086303|NCT03052725|100533092|FG001|NOT COMPLETED|Overall Study||150||
48086304|NCT04061915|100533093|FG000|STARTED|Overall Study||161||
48249810|NCT05135156|100930952|FG001|STARTED|Overall Study||25||
48249811|NCT05135156|100930953|FG002|STARTED|Overall Study||2||
48249812|NCT05135156|100930951|FG000|COMPLETED|Overall Study||25||
48683512|NCT02503085|102009547|FG003|STARTED|Period 4||7||
48249813|NCT05135156|100930952|FG001|COMPLETED|Overall Study||25||
48249814|NCT05135156|100930953|FG002|COMPLETED|Overall Study||0||
48249815|NCT05135156|100930951|FG000|NOT COMPLETED|Overall Study||0||
48249816|NCT05135156|100930952|FG001|NOT COMPLETED|Overall Study||0||
48375698|NCT01252134|101247694|FG003|COMPLETED|Period 3, 8 Hours||5||
48375699|NCT01252134|101247695|FG004|COMPLETED|Period 3, 8 Hours||3||
48375700|NCT01252134|101247696|FG005|COMPLETED|Period 3, 8 Hours||4||
48375701|NCT01252134|101247691|FG000|NOT COMPLETED|Period 3, 8 Hours||0||
48375702|NCT01252134|101247692|FG001|NOT COMPLETED|Period 3, 8 Hours||0||
48086305|NCT04061915|100533094|FG001|STARTED|Overall Study||161||
48249817|NCT05135156|100930953|FG002|NOT COMPLETED|Overall Study||2||
48249818|NCT01203956|100930954|FG000|STARTED|First Two-week Period||15||
48249819|NCT01203956|100930955|FG001|STARTED|First Two-week Period||13||
48249820|NCT01203956|100930954|FG000|COMPLETED|First Two-week Period||15||
48249821|NCT01203956|100930955|FG001|COMPLETED|First Two-week Period||13||
48086306|NCT04061915|100533093|FG000|COMPLETED|Overall Study||161||
48086307|NCT04061915|100533094|FG001|COMPLETED|Overall Study||161||
48086308|NCT04061915|100533093|FG000|NOT COMPLETED|Overall Study||0||
48086309|NCT04061915|100533094|FG001|NOT COMPLETED|Overall Study||0||
48086310|NCT03171415|100533095|FG000|STARTED|Overall Study||6||
48086311|NCT03171415|100533096|FG001|STARTED|Overall Study||6||
48086312|NCT03171415|100533097|FG002|STARTED|Overall Study||6||
48086313|NCT03171415|100533098|FG003|STARTED|Overall Study||6||
48086314|NCT03171415|100533099|FG004|STARTED|Overall Study||9||
48086315|NCT03171415|100533095|FG000|COMPLETED|Overall Study||6||
48086316|NCT03171415|100533096|FG001|COMPLETED|Overall Study||6||
48086317|NCT03171415|100533097|FG002|COMPLETED|Overall Study||6||
48086318|NCT03171415|100533098|FG003|COMPLETED|Overall Study||6||
48086319|NCT03171415|100533099|FG004|COMPLETED|Overall Study||7||
48086320|NCT03171415|100533095|FG000|NOT COMPLETED|Overall Study||0||
48086321|NCT03171415|100533096|FG001|NOT COMPLETED|Overall Study||0||
48086322|NCT03171415|100533097|FG002|NOT COMPLETED|Overall Study||0||
48086323|NCT03171415|100533098|FG003|NOT COMPLETED|Overall Study||0||
48086324|NCT03171415|100533099|FG004|NOT COMPLETED|Overall Study||2||
48086325|NCT00602953|100533100|FG000|STARTED|Overall Study||15||
48086326|NCT00602953|100533101|FG001|STARTED|Overall Study||26||
48249822|NCT01203956|100930954|FG000|NOT COMPLETED|First Two-week Period||0||
48086327|NCT00602953|100533102|FG002|STARTED|Overall Study||47||
48086328|NCT00602953|100533103|FG003|STARTED|Overall Study||13||
48086329|NCT00602953|100533104|FG004|STARTED|Overall Study||0||
48086330|NCT00602953|100533100|FG000|COMPLETED|Overall Study||15||
48086331|NCT00602953|100533101|FG001|COMPLETED|Overall Study||26||
48086332|NCT00602953|100533102|FG002|COMPLETED|Overall Study||47||
48086333|NCT00602953|100533103|FG003|COMPLETED|Overall Study||13||
48086334|NCT00602953|100533104|FG004|COMPLETED|Overall Study||0||
48086335|NCT00602953|100533100|FG000|NOT COMPLETED|Overall Study||0||
48086336|NCT00602953|100533101|FG001|NOT COMPLETED|Overall Study||0||
48086337|NCT00602953|100533102|FG002|NOT COMPLETED|Overall Study||0||
48086338|NCT00602953|100533103|FG003|NOT COMPLETED|Overall Study||0||
48086339|NCT00602953|100533104|FG004|NOT COMPLETED|Overall Study||0||
48086340|NCT03483051|100533105|FG000|STARTED|First Treatment, Pre Crossover||2||
48086341|NCT03483051|100533106|FG001|STARTED|First Treatment, Pre Crossover||1||
48086342|NCT03483051|100533105|FG000|COMPLETED|First Treatment, Pre Crossover||2||
48086343|NCT03483051|100533106|FG001|COMPLETED|First Treatment, Pre Crossover||1||
48086344|NCT03483051|100533105|FG000|NOT COMPLETED|First Treatment, Pre Crossover||0||
48086345|NCT03483051|100533106|FG001|NOT COMPLETED|First Treatment, Pre Crossover||0||
48086346|NCT03483051|100533105|FG000|STARTED|Second Treatment, After Crossover||2||
48086347|NCT03483051|100533106|FG001|STARTED|Second Treatment, After Crossover||1||
48086348|NCT03483051|100533105|FG000|COMPLETED|Second Treatment, After Crossover||2||
48086349|NCT03483051|100533106|FG001|COMPLETED|Second Treatment, After Crossover||1||
48086350|NCT03483051|100533105|FG000|NOT COMPLETED|Second Treatment, After Crossover||0||
48086351|NCT03483051|100533106|FG001|NOT COMPLETED|Second Treatment, After Crossover||0||
48086352|NCT02603419|100533107|FG000|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6||
48086353|NCT02603419|100533108|FG001|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||7||
48086354|NCT02603419|100533109|FG002|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6||
48086355|NCT02603419|100533110|FG003|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6||
48086356|NCT02603419|100533111|FG004|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6||
48086357|NCT02603419|100533112|FG005|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||0||
48086358|NCT02603419|100533107|FG000|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6||
48086359|NCT02603419|100533108|FG001|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6||
48086360|NCT02603419|100533109|FG002|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6||
48086361|NCT02603419|100533110|FG003|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6||
48249823|NCT01203956|100930955|FG001|NOT COMPLETED|First Two-week Period||0||
48249824|NCT01203956|100930954|FG000|STARTED|Second Two-week Period||15||
48249825|NCT01203956|100930955|FG001|STARTED|Second Two-week Period||13||
48375703|NCT01252134|101247693|FG002|NOT COMPLETED|Period 3, 8 Hours||0||
48086362|NCT02603419|100533111|FG004|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6||
48086363|NCT02603419|100533112|FG005|Treated|Lead-in Phase:Maximum Exposure:123Weeks||0||
48086364|NCT02603419|100533107|FG000|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0||
48086365|NCT02603419|100533108|FG001|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0||
48086366|NCT02603419|100533109|FG002|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0||
48086367|NCT02603419|100533110|FG003|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0||
48086368|NCT02603419|100533111|FG004|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0||
48086369|NCT02603419|100533112|FG005|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0||
48086370|NCT02603419|100533107|FG000|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6||
48249826|NCT01203956|100930954|FG000|Attended Sleep Studies for 14 Nights|Second Two-week Period||15||
48249827|NCT01203956|100930955|FG001|Attended Sleep Studies for 14 Nights|Second Two-week Period||13||
48249828|NCT01203956|100930954|FG000|COMPLETED|Second Two-week Period||10||
48249829|NCT01203956|100930955|FG001|COMPLETED|Second Two-week Period||7||
48249830|NCT01203956|100930954|FG000|NOT COMPLETED|Second Two-week Period||5||
48249831|NCT01203956|100930955|FG001|NOT COMPLETED|Second Two-week Period||6||
48086371|NCT02603419|100533108|FG001|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||7||
48086372|NCT02603419|100533109|FG002|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6||
48086373|NCT02603419|100533110|FG003|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6||
48086374|NCT02603419|100533111|FG004|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6||
48086375|NCT02603419|100533112|FG005|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0||
48086376|NCT02603419|100533107|FG000|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0||
48375704|NCT01252134|101247694|FG003|NOT COMPLETED|Period 3, 8 Hours||0||
48249832|NCT01215032|100930956|FG000|STARTED|Overall Study||21||
48249833|NCT01215032|100930956|FG000|COMPLETED|Overall Study||1||
48249834|NCT01215032|100930956|FG000|NOT COMPLETED|Overall Study||20||
48086377|NCT02603419|100533108|FG001|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0||
48086378|NCT02603419|100533109|FG002|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0||
48086379|NCT02603419|100533110|FG003|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0||
48086380|NCT02603419|100533111|FG004|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0||
48086381|NCT02603419|100533112|FG005|STARTED|Expansion Phase:Maximum Exposure:48Weeks||3||
48249835|NCT01670188|100930957|FG000|STARTED|Overall Study||38||
48249836|NCT01670188|100930958|FG001|STARTED|Overall Study||40||
48249837|NCT01670188|100930957|FG000|COMPLETED|Overall Study||38||
48249838|NCT01670188|100930958|FG001|COMPLETED|Overall Study||39||
48086382|NCT02603419|100533107|FG000|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0||
48086383|NCT02603419|100533108|FG001|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0||
48249839|NCT01670188|100930957|FG000|NOT COMPLETED|Overall Study||0||
48249840|NCT01670188|100930958|FG001|NOT COMPLETED|Overall Study||1||
48375705|NCT01252134|101247695|FG004|NOT COMPLETED|Period 3, 8 Hours||0||
48375706|NCT01252134|101247696|FG005|NOT COMPLETED|Period 3, 8 Hours||0||
48375707|NCT01651052|101247697|FG000|STARTED|Overall Study||133||
48375708|NCT01651052|101247697|FG000|Study Valve Group|Overall Study||133||
48375709|NCT01651052|101247697|FG000|COMPLETED|Overall Study||107||
48086384|NCT02603419|100533109|FG002|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0||
48086385|NCT02603419|100533110|FG003|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0||
48086386|NCT02603419|100533111|FG004|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0||
48086387|NCT02603419|100533112|FG005|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0||
48086388|NCT02603419|100533107|FG000|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0||
48086389|NCT02603419|100533108|FG001|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0||
48086390|NCT02603419|100533109|FG002|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0||
48086391|NCT02603419|100533110|FG003|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0||
48086392|NCT02603419|100533111|FG004|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0||
48086393|NCT02603419|100533112|FG005|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||3||
48086394|NCT00680862|100533113|FG000|STARTED|Overall Study||25||
48086395|NCT00680862|100533113|FG000|COMPLETED|Overall Study||25||
48086396|NCT00680862|100533113|FG000|NOT COMPLETED|Overall Study||0||
48086397|NCT02373202|100533114|FG000|STARTED|Overall Study||15||
48086398|NCT02373202|100533115|FG001|STARTED|Overall Study||15||
48086399|NCT02373202|100533116|FG002|STARTED|Overall Study||30||
48086400|NCT02373202|100533117|FG003|STARTED|Overall Study||31||
48086401|NCT02373202|100533114|FG000|COMPLETED|Overall Study||13||
48086402|NCT02373202|100533115|FG001|COMPLETED|Overall Study||9||
48086403|NCT02373202|100533116|FG002|COMPLETED|Overall Study||27||
48086404|NCT02373202|100533117|FG003|COMPLETED|Overall Study||30||
48086405|NCT02373202|100533114|FG000|NOT COMPLETED|Overall Study||2||
48249841|NCT04151706|100930959|FG000|STARTED|Overall Study||7||
48249842|NCT04151706|100930959|FG000|COMPLETED|Overall Study||7||
48249843|NCT04151706|100930959|FG000|NOT COMPLETED|Overall Study||0||
48249844|NCT01093183|100930960|FG000|STARTED|Overall Study||19||
48249845|NCT01093183|100930961|FG001|STARTED|Overall Study||6||
48249846|NCT01093183|100930960|FG000|COMPLETED|Overall Study||18||
48249847|NCT01093183|100930961|FG001|COMPLETED|Overall Study||4||
48249848|NCT01093183|100930960|FG000|NOT COMPLETED|Overall Study||1||
48249849|NCT01093183|100930961|FG001|NOT COMPLETED|Overall Study||2||
48249850|NCT00510783|100930962|FG000|STARTED|Overall Study||82||
48249851|NCT00510783|100930963|FG001|STARTED|Overall Study||76||
48249852|NCT00510783|100930962|FG000|COMPLETED|Overall Study||51||
48249853|NCT00510783|100930963|FG001|COMPLETED|Overall Study||47||
48249854|NCT00510783|100930962|FG000|NOT COMPLETED|Overall Study||31||
48375710|NCT01651052|101247697|FG000|NOT COMPLETED|Overall Study||26||
48086406|NCT02373202|100533115|FG001|NOT COMPLETED|Overall Study||6||
48086407|NCT02373202|100533116|FG002|NOT COMPLETED|Overall Study||3||
48086408|NCT02373202|100533117|FG003|NOT COMPLETED|Overall Study||1||
48086409|NCT00530764|100533118|FG000|STARTED|Overall Study||90||
48086410|NCT00530764|100533119|FG001|STARTED|Overall Study||88||
48086411|NCT00530764|100533120|FG002|STARTED|Overall Study||91||
48086412|NCT00530764|100533121|FG003|STARTED|Overall Study||91||
48086413|NCT00530764|100533118|FG000|COMPLETED|Overall Study||59||
48086414|NCT00530764|100533119|FG001|COMPLETED|Overall Study||67||
48086415|NCT00530764|100533120|FG002|COMPLETED|Overall Study||71||
48086416|NCT00530764|100533121|FG003|COMPLETED|Overall Study||66||
48086417|NCT00530764|100533118|FG000|NOT COMPLETED|Overall Study||31||
48086418|NCT00530764|100533119|FG001|NOT COMPLETED|Overall Study||21||
48086419|NCT00530764|100533120|FG002|NOT COMPLETED|Overall Study||20||
48086420|NCT00530764|100533121|FG003|NOT COMPLETED|Overall Study||25||
48086421|NCT02016560|100533122|FG000|STARTED|Exploratory Phase||16||
48086422|NCT02016560|100533123|FG001|STARTED|Exploratory Phase||58||
48086423|NCT02016560|100533124|FG002|STARTED|Exploratory Phase||98||
48375711|NCT01212172|101247698|FG000|STARTED|Overall Study||10||
48086424|NCT02016560|100533125|FG003|STARTED|Exploratory Phase||51||
48086425|NCT02016560|100533126|FG004|STARTED|Exploratory Phase||0||
48086426|NCT02016560|100533127|FG005|STARTED|Exploratory Phase||0||
48086427|NCT02016560|100533122|FG000|COMPLETED|Exploratory Phase||16||
48086428|NCT02016560|100533123|FG001|COMPLETED|Exploratory Phase||54||
48086429|NCT02016560|100533124|FG002|COMPLETED|Exploratory Phase||62||
48086430|NCT02016560|100533125|FG003|COMPLETED|Exploratory Phase||35||
48375712|NCT01212172|101247699|FG001|STARTED|Overall Study||10||
48375713|NCT01212172|101247698|FG000|COMPLETED|Overall Study||9||
48375714|NCT01212172|101247699|FG001|COMPLETED|Overall Study||9||
48375715|NCT01212172|101247698|FG000|NOT COMPLETED|Overall Study||1||
48375716|NCT01212172|101247699|FG001|NOT COMPLETED|Overall Study||1||
48375717|NCT02227329|101247700|FG000|STARTED|Overall Study||18||
48375718|NCT02227329|101247701|FG001|STARTED|Overall Study||20||
48375719|NCT02227329|101247700|FG000|COMPLETED|Overall Study||18||
48375720|NCT02227329|101247701|FG001|COMPLETED|Overall Study||20||
48375721|NCT02227329|101247700|FG000|NOT COMPLETED|Overall Study||0||
48375722|NCT02227329|101247701|FG001|NOT COMPLETED|Overall Study||0||
48249855|NCT00510783|100930963|FG001|NOT COMPLETED|Overall Study||29||
48249856|NCT03042559|100930964|FG000|STARTED|Overall Study||22||
48249857|NCT03042559|100930965|FG001|STARTED|Overall Study||21||
48249858|NCT03042559|100930964|FG000|COMPLETED|Overall Study||21||
48249859|NCT03042559|100930965|FG001|COMPLETED|Overall Study||20||
48249860|NCT03042559|100930964|FG000|NOT COMPLETED|Overall Study||1||
48249861|NCT03042559|100930965|FG001|NOT COMPLETED|Overall Study||1||
48249862|NCT00802438|100930966|FG000|STARTED|Overall Study||38||
48249863|NCT00802438|100930966|FG000|COMPLETED|Overall Study||10||
48249864|NCT00802438|100930966|FG000|NOT COMPLETED|Overall Study||28||
48249865|NCT03193216|100930967|FG000|STARTED|Overall Study||24||
48249866|NCT03193216|100930968|FG001|STARTED|Overall Study||21||
48249867|NCT03193216|100930967|FG000|COMPLETED|Overall Study||14||
48249868|NCT03193216|100930968|FG001|COMPLETED|Overall Study||21||
48249869|NCT03193216|100930967|FG000|NOT COMPLETED|Overall Study||10||
48249870|NCT03193216|100930968|FG001|NOT COMPLETED|Overall Study||0||
48249871|NCT01675050|100930969|FG000|STARTED|Period One Treatment||2||
48249872|NCT01675050|100930970|FG001|STARTED|Period One Treatment||2||
48249873|NCT01675050|100930969|FG000|COMPLETED|Period One Treatment||1||
48249874|NCT01675050|100930970|FG001|COMPLETED|Period One Treatment||2||
48249875|NCT01675050|100930969|FG000|NOT COMPLETED|Period One Treatment||1||
48249876|NCT01675050|100930970|FG001|NOT COMPLETED|Period One Treatment||0||
48249877|NCT01675050|100930969|FG000|STARTED|Wash Out Period||1||
48249878|NCT01675050|100930970|FG001|STARTED|Wash Out Period||2||
48249879|NCT01675050|100930969|FG000|COMPLETED|Wash Out Period||1||
48249880|NCT01675050|100930970|FG001|COMPLETED|Wash Out Period||2||
48249881|NCT01675050|100930969|FG000|NOT COMPLETED|Wash Out Period||0||
48249882|NCT01675050|100930970|FG001|NOT COMPLETED|Wash Out Period||0||
48249883|NCT01675050|100930969|FG000|STARTED|Second Period Treatment||1||
48086431|NCT02016560|100533126|FG004|COMPLETED|Exploratory Phase||0||
48249884|NCT01675050|100930970|FG001|STARTED|Second Period Treatment||2||
48249885|NCT01675050|100930969|FG000|COMPLETED|Second Period Treatment||1||
48249886|NCT01675050|100930970|FG001|COMPLETED|Second Period Treatment||2||
48086432|NCT02016560|100533127|FG005|COMPLETED|Exploratory Phase||0||
48086433|NCT02016560|100533122|FG000|NOT COMPLETED|Exploratory Phase||0||
48086434|NCT02016560|100533123|FG001|NOT COMPLETED|Exploratory Phase||4||
48249887|NCT01675050|100930969|FG000|NOT COMPLETED|Second Period Treatment||0||
48086435|NCT02016560|100533124|FG002|NOT COMPLETED|Exploratory Phase||36||
48086436|NCT02016560|100533125|FG003|NOT COMPLETED|Exploratory Phase||16||
48086437|NCT02016560|100533126|FG004|NOT COMPLETED|Exploratory Phase||0||
48086438|NCT02016560|100533127|FG005|NOT COMPLETED|Exploratory Phase||0||
48375723|NCT00590018|101247702|FG000|STARTED|Overall Study||9||
48375724|NCT00590018|101247703|FG001|STARTED|Overall Study||9||
48375725|NCT00590018|101247702|FG000|COMPLETED|Overall Study||9||
48375726|NCT00590018|101247703|FG001|COMPLETED|Overall Study||9||
48375727|NCT00590018|101247702|FG000|NOT COMPLETED|Overall Study||0||
48375728|NCT00590018|101247703|FG001|NOT COMPLETED|Overall Study||0||
48249888|NCT01675050|100930970|FG001|NOT COMPLETED|Second Period Treatment||0||
48249889|NCT01879085|100930971|FG000|STARTED|Phase 1b||6||
48249890|NCT01879085|100930972|FG001|STARTED|Phase 1b||6||
48249891|NCT01879085|100930973|FG002|STARTED|Phase 1b||0||
48249892|NCT01879085|100930971|FG000|COMPLETED|Phase 1b||6||
48683513|NCT02503085|102009544|FG000|COMPLETED|Period 4||6||
48683514|NCT02503085|102009545|FG001|COMPLETED|Period 4||7||
48683515|NCT02503085|102009546|FG002|COMPLETED|Period 4||6||
48683516|NCT02503085|102009547|FG003|COMPLETED|Period 4||7||
48683517|NCT02503085|102009544|FG000|NOT COMPLETED|Period 4||0||
48086439|NCT02016560|100533122|FG000|STARTED|Confirmatory Phase||0||
48086440|NCT02016560|100533123|FG001|STARTED|Confirmatory Phase||0||
48086441|NCT02016560|100533124|FG002|STARTED|Confirmatory Phase||0||
48086442|NCT02016560|100533125|FG003|STARTED|Confirmatory Phase||0||
48086443|NCT02016560|100533126|FG004|STARTED|Confirmatory Phase||98||
48086444|NCT02016560|100533127|FG005|STARTED|Confirmatory Phase||62||
48086445|NCT02016560|100533122|FG000|COMPLETED|Confirmatory Phase||0||
48086446|NCT02016560|100533123|FG001|COMPLETED|Confirmatory Phase||0||
48086447|NCT02016560|100533124|FG002|COMPLETED|Confirmatory Phase||0||
48086448|NCT02016560|100533125|FG003|COMPLETED|Confirmatory Phase||0||
48086449|NCT02016560|100533126|FG004|COMPLETED|Confirmatory Phase||76||
48086450|NCT02016560|100533127|FG005|COMPLETED|Confirmatory Phase||35||
48249893|NCT01879085|100930972|FG001|COMPLETED|Phase 1b||6||
48249894|NCT01879085|100930973|FG002|COMPLETED|Phase 1b||0||
48249895|NCT01879085|100930971|FG000|NOT COMPLETED|Phase 1b||0||
48249896|NCT01879085|100930972|FG001|NOT COMPLETED|Phase 1b||0||
48249897|NCT01879085|100930973|FG002|NOT COMPLETED|Phase 1b||0||
48249898|NCT01879085|100930971|FG000|STARTED|Phase 2||6||
48086451|NCT02016560|100533122|FG000|NOT COMPLETED|Confirmatory Phase||0||
48249899|NCT01879085|100930972|FG001|STARTED|Phase 2||0||
48249900|NCT01879085|100930973|FG002|STARTED|Phase 2||25||
48249901|NCT01879085|100930971|FG000|COMPLETED|Phase 2||6||
48249902|NCT01879085|100930972|FG001|COMPLETED|Phase 2||0||
48249903|NCT01879085|100930973|FG002|COMPLETED|Phase 2||25||
48249904|NCT01879085|100930971|FG000|NOT COMPLETED|Phase 2||0||
48249905|NCT01879085|100930972|FG001|NOT COMPLETED|Phase 2||0||
48249906|NCT01879085|100930973|FG002|NOT COMPLETED|Phase 2||0||
48249907|NCT02162771|100930974|FG000|STARTED|Core Study Period (Part 2)||70||
48249908|NCT02162771|100930975|FG001|STARTED|Core Study Period (Part 2)||70||
48249909|NCT02162771|100930974|FG000|COMPLETED|Core Study Period (Part 2)||62||
48249910|NCT02162771|100930975|FG001|COMPLETED|Core Study Period (Part 2)||62||
48249911|NCT02162771|100930974|FG000|NOT COMPLETED|Core Study Period (Part 2)||8||
48249912|NCT02162771|100930975|FG001|NOT COMPLETED|Core Study Period (Part 2)||8||
48375729|NCT00376597|101247704|FG000|STARTED|Overall Study||253||
48375730|NCT00376597|101247705|FG001|STARTED|Overall Study||315||
48375731|NCT00376597|101247704|FG000|COMPLETED|Overall Study||242||
48375732|NCT00376597|101247705|FG001|COMPLETED|Overall Study||312||
48375733|NCT00376597|101247704|FG000|NOT COMPLETED|Overall Study||11||
48375734|NCT00376597|101247705|FG001|NOT COMPLETED|Overall Study||3||
48375735|NCT00137436|101247706|FG000|STARTED|Overall Study||55||
48086452|NCT02016560|100533123|FG001|NOT COMPLETED|Confirmatory Phase||0||
48249913|NCT02162771|100930974|FG000|STARTED|Maintenance Study Period (Part 2)||62||
48249914|NCT02162771|100930975|FG001|STARTED|Maintenance Study Period (Part 2)||60||
48375736|NCT00137436|101247706|FG000|COMPLETED|Overall Study||12||
48249915|NCT02162771|100930974|FG000|COMPLETED|Maintenance Study Period (Part 2)||46||
48249916|NCT02162771|100930975|FG001|COMPLETED|Maintenance Study Period (Part 2)||38||
48249917|NCT02162771|100930974|FG000|NOT COMPLETED|Maintenance Study Period (Part 2)||16||
48249918|NCT02162771|100930975|FG001|NOT COMPLETED|Maintenance Study Period (Part 2)||22||
48375737|NCT00137436|101247706|FG000|NOT COMPLETED|Overall Study||43||
48375738|NCT04657016|101247707|FG000|STARTED|Overall Study||292||
48375739|NCT04657016|101247708|FG001|STARTED|Overall Study||287||
48683518|NCT02503085|102009545|FG001|NOT COMPLETED|Period 4||0||
48683519|NCT02503085|102009546|FG002|NOT COMPLETED|Period 4||0||
48683520|NCT02503085|102009547|FG003|NOT COMPLETED|Period 4||0||
48683521|NCT04421404|102009548|FG000|STARTED|Overall Study||16||
48683522|NCT04421404|102009549|FG001|STARTED|Overall Study||18||
48086453|NCT02016560|100533124|FG002|NOT COMPLETED|Confirmatory Phase||0||
48086454|NCT02016560|100533125|FG003|NOT COMPLETED|Confirmatory Phase||0||
48086455|NCT02016560|100533126|FG004|NOT COMPLETED|Confirmatory Phase||22||
48086456|NCT02016560|100533127|FG005|NOT COMPLETED|Confirmatory Phase||27||
48086457|NCT03729960|100533128|FG000|STARTED|Overall Study||20||
48086458|NCT03729960|100533128|FG000|COMPLETED|Overall Study||20||
48086459|NCT03729960|100533128|FG000|NOT COMPLETED|Overall Study||0||
48086460|NCT01892293|100533129|FG000|STARTED|Overall Study||6||
48086461|NCT01892293|100533129|FG000|Received T-cell|Overall Study||2||
48249919|NCT05215418|100930976|FG000|STARTED|Overall Study||190||
48249920|NCT05215418|100930977|FG001|STARTED|Overall Study||191||
48249921|NCT05215418|100930978|FG002|STARTED|Overall Study||184||
48249922|NCT05215418|100930976|FG000|COMPLETED|Overall Study||156||
48249923|NCT05215418|100930977|FG001|COMPLETED|Overall Study||167||
48249924|NCT05215418|100930978|FG002|COMPLETED|Overall Study||164||
48249925|NCT05215418|100930976|FG000|NOT COMPLETED|Overall Study||34||
48249926|NCT05215418|100930977|FG001|NOT COMPLETED|Overall Study||24||
48249927|NCT05215418|100930978|FG002|NOT COMPLETED|Overall Study||20||
48249928|NCT00581009|100930979|FG000|STARTED|Overall Study||17||
48249929|NCT00581009|100930980|FG001|STARTED|Overall Study||32||
48249930|NCT00581009|100930979|FG000|Sample Recruitment|Overall Study||17||
48249931|NCT00581009|100930980|FG001|Sample Recruitment|Overall Study||32||
48249932|NCT00581009|100930979|FG000|COMPLETED|Overall Study||17||
48249933|NCT00581009|100930980|FG001|COMPLETED|Overall Study||32||
48249934|NCT00581009|100930979|FG000|NOT COMPLETED|Overall Study||0||
48249935|NCT00581009|100930980|FG001|NOT COMPLETED|Overall Study||0||
48249936|NCT00434577|100930981|FG000|STARTED|Months 0-3||164||
48249937|NCT00434577|100930982|FG001|STARTED|Months 0-3||166||
48683523|NCT04421404|102009548|FG000|COMPLETED|Overall Study||16|Completion of study defined as completing 29 day follow up (or died prior to day 29)|
48683524|NCT04421404|102009549|FG001|COMPLETED|Overall Study||18|Completion of study defined as completing 29 day follow up (or died prior to day 29)|
48683525|NCT04421404|102009548|FG000|NOT COMPLETED|Overall Study||0||
48683526|NCT04421404|102009549|FG001|NOT COMPLETED|Overall Study||0||
48683527|NCT02694601|102009550|FG000|STARTED|Overall Study||10||
48683528|NCT02694601|102009550|FG000|COMPLETED|Overall Study||10||
48683529|NCT02694601|102009550|FG000|NOT COMPLETED|Overall Study||0||
48683530|NCT00506779|102009551|FG000|STARTED|Overall Study||4||
48683531|NCT00506779|102009552|FG001|STARTED|Overall Study||6||
48683532|NCT00506779|102009553|FG002|STARTED|Overall Study||2||
48683533|NCT00506779|102009554|FG003|STARTED|Overall Study||5||
48683534|NCT00506779|102009551|FG000|COMPLETED|Overall Study||3||
48086462|NCT01892293|100533129|FG000|COMPLETED|Overall Study||2||
48086463|NCT01892293|100533129|FG000|NOT COMPLETED|Overall Study||4||
48249938|NCT00434577|100930983|FG002|STARTED|Months 0-3||165||
48249939|NCT00434577|100930984|FG003|STARTED|Months 0-3||165||
48683535|NCT00506779|102009552|FG001|COMPLETED|Overall Study||5||
48683536|NCT00506779|102009553|FG002|COMPLETED|Overall Study||0||
48086464|NCT02170051|100533130|FG000|STARTED|Overall Study||26||
48086465|NCT02170051|100533131|FG001|STARTED|Overall Study||29||
48249940|NCT00434577|100930985|FG004|STARTED|Months 0-3||54||
48249941|NCT00434577|100930981|FG000|COMPLETED|Months 0-3||161||
48249942|NCT00434577|100930982|FG001|COMPLETED|Months 0-3||164||
48249943|NCT00434577|100930983|FG002|COMPLETED|Months 0-3||161||
48249944|NCT00434577|100930984|FG003|COMPLETED|Months 0-3||164||
48249945|NCT00434577|100930985|FG004|COMPLETED|Months 0-3||51||
48249946|NCT00434577|100930981|FG000|NOT COMPLETED|Months 0-3||3||
48249947|NCT00434577|100930982|FG001|NOT COMPLETED|Months 0-3||2||
48249948|NCT00434577|100930983|FG002|NOT COMPLETED|Months 0-3||4||
48249949|NCT00434577|100930984|FG003|NOT COMPLETED|Months 0-3||1||
48249950|NCT00434577|100930985|FG004|NOT COMPLETED|Months 0-3||3||
48249951|NCT00434577|100930981|FG000|STARTED|Month 12||156||
48375740|NCT04657016|101247707|FG000|Received at Least One Dose of Study Drug|Overall Study||292||
48375741|NCT04657016|101247708|FG001|Received at Least One Dose of Study Drug|Overall Study||287||
48375742|NCT04657016|101247707|FG000|COMPLETED|Overall Study||227||
48375743|NCT04657016|101247708|FG001|COMPLETED|Overall Study||252||
48375744|NCT04657016|101247707|FG000|NOT COMPLETED|Overall Study||65||
48375745|NCT04657016|101247708|FG001|NOT COMPLETED|Overall Study||35||
48375746|NCT03726671|101247709|FG000|STARTED|First Intervention (2 Weeks)||27||
48375747|NCT03726671|101247710|FG001|STARTED|First Intervention (2 Weeks)||14||
48375748|NCT03726671|101247711|FG002|STARTED|First Intervention (2 Weeks)||14||
48375749|NCT03726671|101247712|FG003|STARTED|First Intervention (2 Weeks)||13||
48375750|NCT03726671|101247713|FG004|STARTED|First Intervention (2 Weeks)||24||
48375751|NCT03726671|101247714|FG005|STARTED|First Intervention (2 Weeks)||9||
48375752|NCT03726671|101247709|FG000|COMPLETED|First Intervention (2 Weeks)||20||
48375753|NCT03726671|101247710|FG001|COMPLETED|First Intervention (2 Weeks)||12||
48375754|NCT03726671|101247711|FG002|COMPLETED|First Intervention (2 Weeks)||12||
48375755|NCT03726671|101247712|FG003|COMPLETED|First Intervention (2 Weeks)||12||
48375756|NCT03726671|101247713|FG004|COMPLETED|First Intervention (2 Weeks)||19||
48375757|NCT03726671|101247714|FG005|COMPLETED|First Intervention (2 Weeks)||8||
48375758|NCT03726671|101247709|FG000|NOT COMPLETED|First Intervention (2 Weeks)||7||
48375759|NCT03726671|101247710|FG001|NOT COMPLETED|First Intervention (2 Weeks)||2||
48375760|NCT03726671|101247711|FG002|NOT COMPLETED|First Intervention (2 Weeks)||2||
48375761|NCT03726671|101247712|FG003|NOT COMPLETED|First Intervention (2 Weeks)||1||
48375762|NCT03726671|101247713|FG004|NOT COMPLETED|First Intervention (2 Weeks)||5||
48375763|NCT03726671|101247714|FG005|NOT COMPLETED|First Intervention (2 Weeks)||1||
48375764|NCT03726671|101247709|FG000|STARTED|Washout (>/= 2 Weeks)||20||
48375765|NCT03726671|101247710|FG001|STARTED|Washout (>/= 2 Weeks)||12||
48375766|NCT03726671|101247711|FG002|STARTED|Washout (>/= 2 Weeks)||12||
48375767|NCT03726671|101247712|FG003|STARTED|Washout (>/= 2 Weeks)||12||
48375768|NCT03726671|101247713|FG004|STARTED|Washout (>/= 2 Weeks)||19||
48375769|NCT03726671|101247714|FG005|STARTED|Washout (>/= 2 Weeks)||8||
48683537|NCT00506779|102009554|FG003|COMPLETED|Overall Study||4||
48683538|NCT00506779|102009551|FG000|NOT COMPLETED|Overall Study||1||
48683539|NCT00506779|102009552|FG001|NOT COMPLETED|Overall Study||1||
48683540|NCT00506779|102009553|FG002|NOT COMPLETED|Overall Study||2||
48683541|NCT00506779|102009554|FG003|NOT COMPLETED|Overall Study||1||
48683542|NCT03503396|102009555|FG000|STARTED|Overall Study||24||
48683543|NCT03503396|102009556|FG001|STARTED|Overall Study||24||
48249952|NCT00434577|100930982|FG001|STARTED|Month 12||159||
48375770|NCT03726671|101247709|FG000|COMPLETED|Washout (>/= 2 Weeks)||20||
48375771|NCT03726671|101247710|FG001|COMPLETED|Washout (>/= 2 Weeks)||12||
48375772|NCT03726671|101247711|FG002|COMPLETED|Washout (>/= 2 Weeks)||12||
48375773|NCT03726671|101247712|FG003|COMPLETED|Washout (>/= 2 Weeks)||12||
48375774|NCT03726671|101247713|FG004|COMPLETED|Washout (>/= 2 Weeks)||19||
48375775|NCT03726671|101247714|FG005|COMPLETED|Washout (>/= 2 Weeks)||8||
48375776|NCT03726671|101247709|FG000|NOT COMPLETED|Washout (>/= 2 Weeks)||0||
48375777|NCT03726671|101247710|FG001|NOT COMPLETED|Washout (>/= 2 Weeks)||0||
48375778|NCT03726671|101247711|FG002|NOT COMPLETED|Washout (>/= 2 Weeks)||0||
48375779|NCT03726671|101247712|FG003|NOT COMPLETED|Washout (>/= 2 Weeks)||0||
48375780|NCT03726671|101247713|FG004|NOT COMPLETED|Washout (>/= 2 Weeks)||0||
48375781|NCT03726671|101247714|FG005|NOT COMPLETED|Washout (>/= 2 Weeks)||0||
48375782|NCT03726671|101247709|FG000|STARTED|Second Intervention (2 Weeks)||20||
48375783|NCT03726671|101247710|FG001|STARTED|Second Intervention (2 Weeks)||12||
48683544|NCT03503396|102009555|FG000|COMPLETED|Overall Study||22||
48683545|NCT03503396|102009556|FG001|COMPLETED|Overall Study||24||
48683546|NCT03503396|102009555|FG000|NOT COMPLETED|Overall Study||2||
48683547|NCT03503396|102009556|FG001|NOT COMPLETED|Overall Study||0||
48683548|NCT01000506|102009557|FG000|STARTED|Overall Study||155||
48249953|NCT00434577|100930983|FG002|STARTED|Month 12||159||
48249954|NCT00434577|100930984|FG003|STARTED|Month 12||161||
48249955|NCT00434577|100930985|FG004|STARTED|Month 12||50||
48375784|NCT03726671|101247711|FG002|STARTED|Second Intervention (2 Weeks)||12||
48375785|NCT03726671|101247712|FG003|STARTED|Second Intervention (2 Weeks)||12||
48375786|NCT03726671|101247713|FG004|STARTED|Second Intervention (2 Weeks)||19||
48375787|NCT03726671|101247714|FG005|STARTED|Second Intervention (2 Weeks)||8||
48375788|NCT03726671|101247709|FG000|COMPLETED|Second Intervention (2 Weeks)||17||
48683549|NCT01000506|102009558|FG001|STARTED|Overall Study||153||
48086466|NCT02170051|100533130|FG000|Tested at Mid-point|Overall Study||13||
48086467|NCT02170051|100533131|FG001|Tested at Mid-point|Overall Study||18||
48086468|NCT02170051|100533130|FG000|Tested at Post-treatment|Overall Study||15||
48540997|NCT03844386|101662619|FG001|Completed Day 28|Overall Study||7||
48683550|NCT01000506|102009559|FG002|STARTED|Overall Study||152||
48683551|NCT01000506|102009560|FG003|STARTED|Overall Study||156||
48683552|NCT01000506|102009557|FG000|COMPLETED|Overall Study||127||
48683553|NCT01000506|102009558|FG001|COMPLETED|Overall Study||129||
48683554|NCT01000506|102009559|FG002|COMPLETED|Overall Study||131||
48683555|NCT01000506|102009560|FG003|COMPLETED|Overall Study||133||
48683556|NCT01000506|102009557|FG000|NOT COMPLETED|Overall Study||28||
48683557|NCT01000506|102009558|FG001|NOT COMPLETED|Overall Study||24||
48683558|NCT01000506|102009559|FG002|NOT COMPLETED|Overall Study||21||
48683559|NCT01000506|102009560|FG003|NOT COMPLETED|Overall Study||23||
48683560|NCT01206517|102009561|FG000|STARTED|Overall Study||6||
48683561|NCT01206517|102009562|FG001|STARTED|Overall Study||6||
48683562|NCT01206517|102009563|FG002|STARTED|Overall Study||6||
48683563|NCT01206517|102009564|FG003|STARTED|Overall Study||4||
48683564|NCT01206517|102009565|FG004|STARTED|Overall Study||4||
48683565|NCT01206517|102009566|FG005|STARTED|Overall Study||4||
48683566|NCT01206517|102009561|FG000|COMPLETED|Overall Study||6||
48683567|NCT01206517|102009562|FG001|COMPLETED|Overall Study||6||
48683568|NCT01206517|102009563|FG002|COMPLETED|Overall Study||4||
48683569|NCT01206517|102009564|FG003|COMPLETED|Overall Study||4||
48683570|NCT01206517|102009565|FG004|COMPLETED|Overall Study||3||
48683571|NCT01206517|102009566|FG005|COMPLETED|Overall Study||4||
48683572|NCT01206517|102009561|FG000|NOT COMPLETED|Overall Study||0||
48683573|NCT01206517|102009562|FG001|NOT COMPLETED|Overall Study||0||
48683574|NCT01206517|102009563|FG002|NOT COMPLETED|Overall Study||2||
48683575|NCT01206517|102009564|FG003|NOT COMPLETED|Overall Study||0||
48683576|NCT01206517|102009565|FG004|NOT COMPLETED|Overall Study||1||
48683577|NCT01206517|102009566|FG005|NOT COMPLETED|Overall Study||0||
48683578|NCT02015039|102009567|FG000|STARTED|Overall Study||6||
48683579|NCT02015039|102009568|FG001|STARTED|Overall Study||7||
48683580|NCT02015039|102009567|FG000|COMPLETED|Overall Study||6||
48683581|NCT02015039|102009568|FG001|COMPLETED|Overall Study||6||
48683582|NCT02015039|102009567|FG000|NOT COMPLETED|Overall Study||0||
48683583|NCT02015039|102009568|FG001|NOT COMPLETED|Overall Study||1||
48683584|NCT00473889|102009569|FG000|STARTED|Overall Study||126||
48683585|NCT00473889|102009570|FG001|STARTED|Overall Study||127||
48683586|NCT00473889|102009569|FG000|COMPLETED|Overall Study||43||
48683587|NCT00473889|102009570|FG001|COMPLETED|Overall Study||63||
48683588|NCT00473889|102009569|FG000|NOT COMPLETED|Overall Study||83||
48683589|NCT00473889|102009570|FG001|NOT COMPLETED|Overall Study||64||
48683590|NCT01313910|102009571|FG000|STARTED|Overall Study||8||
48683591|NCT01313910|102009571|FG000|COMPLETED|Overall Study||8||
48683592|NCT01313910|102009571|FG000|NOT COMPLETED|Overall Study||0||
48683593|NCT01603043|102009572|FG000|STARTED|Overall Study||7||
48683594|NCT01603043|102009573|FG001|STARTED|Overall Study||3||
48683595|NCT01603043|102009572|FG000|COMPLETED|Overall Study||0||
48683596|NCT01603043|102009573|FG001|COMPLETED|Overall Study||0||
48086469|NCT02170051|100533131|FG001|Tested at Post-treatment|Overall Study||16||
48540998|NCT03844386|101662620|FG002|Completed Day 28|Overall Study||8||
48540999|NCT03844386|101662621|FG003|Completed Day 28|Overall Study||3||
48541000|NCT03844386|101662618|FG000|COMPLETED|Overall Study||7||
48541001|NCT03844386|101662619|FG001|COMPLETED|Overall Study||7||
48541002|NCT03844386|101662620|FG002|COMPLETED|Overall Study||7||
48541003|NCT03844386|101662621|FG003|COMPLETED|Overall Study||3||
48541004|NCT03844386|101662618|FG000|NOT COMPLETED|Overall Study||0||
48541005|NCT03844386|101662619|FG001|NOT COMPLETED|Overall Study||0||
48683597|NCT01603043|102009572|FG000|NOT COMPLETED|Overall Study||7||
48683598|NCT01603043|102009573|FG001|NOT COMPLETED|Overall Study||3||
48683599|NCT03159468|102009574|FG000|STARTED|Overall Study||35||
48683600|NCT03159468|102009575|FG001|STARTED|Overall Study||35||
48683601|NCT03159468|102009576|FG002|STARTED|Overall Study||37||
48683602|NCT03159468|102009577|FG003|STARTED|Overall Study||34||
48683603|NCT03159468|102009578|FG004|STARTED|Overall Study||34||
48683604|NCT03159468|102009579|FG005|STARTED|Overall Study||34||
48683605|NCT03159468|102009574|FG000|COMPLETED|Overall Study||35||
48683606|NCT03159468|102009575|FG001|COMPLETED|Overall Study||35||
48683607|NCT03159468|102009576|FG002|COMPLETED|Overall Study||34||
48541006|NCT03844386|101662620|FG002|NOT COMPLETED|Overall Study||1||
48541007|NCT03844386|101662621|FG003|NOT COMPLETED|Overall Study||1||
48683608|NCT03159468|102009577|FG003|COMPLETED|Overall Study||34||
48086470|NCT02170051|100533130|FG000|COMPLETED|Overall Study||15|Tested at 6-month follow-up|
48086471|NCT02170051|100533131|FG001|COMPLETED|Overall Study||16|Tested at 6-month follow-up|
48086472|NCT02170051|100533130|FG000|NOT COMPLETED|Overall Study||11||
48086473|NCT02170051|100533131|FG001|NOT COMPLETED|Overall Study||13||
48086474|NCT01605877|100533132|FG000|STARTED|Overall Study||64||
48086475|NCT01605877|100533132|FG000|COMPLETED|Overall Study||63||
48086476|NCT01605877|100533132|FG000|NOT COMPLETED|Overall Study||1||
48086477|NCT02375113|100533133|FG000|STARTED|Overall Study||6|Twelve met the inclusion criteria and consented to take part in the study.|
48086478|NCT02375113|100533134|FG001|STARTED|Overall Study||6|Twelve met the inclusion criteria and consented to take part in the study.|
48086479|NCT02375113|100533133|FG000|COMPLETED|Overall Study||4||
48086480|NCT02375113|100533134|FG001|COMPLETED|Overall Study||4||
48086481|NCT02375113|100533133|FG000|NOT COMPLETED|Overall Study||2||
48086482|NCT02375113|100533134|FG001|NOT COMPLETED|Overall Study||2||
48086483|NCT02893878|100533135|FG000|STARTED|Overall Study||13861||
48086484|NCT02893878|100533136|FG001|STARTED|Overall Study||2295||
48086485|NCT02893878|100533137|FG002|STARTED|Overall Study||3178||
48086486|NCT02893878|100533135|FG000|COMPLETED|Overall Study||13861||
48086487|NCT02893878|100533136|FG001|COMPLETED|Overall Study||2295||
48086488|NCT02893878|100533137|FG002|COMPLETED|Overall Study||3178||
48375789|NCT03726671|101247710|FG001|COMPLETED|Second Intervention (2 Weeks)||12||
48375790|NCT03726671|101247711|FG002|COMPLETED|Second Intervention (2 Weeks)||12||
48375791|NCT03726671|101247712|FG003|COMPLETED|Second Intervention (2 Weeks)||11||
48375792|NCT03726671|101247713|FG004|COMPLETED|Second Intervention (2 Weeks)||18||
48375793|NCT03726671|101247714|FG005|COMPLETED|Second Intervention (2 Weeks)||8||
48086489|NCT02893878|100533135|FG000|NOT COMPLETED|Overall Study||0||
48086490|NCT02893878|100533136|FG001|NOT COMPLETED|Overall Study||0||
48086491|NCT02893878|100533137|FG002|NOT COMPLETED|Overall Study||0||
48086492|NCT00187876|100533138|FG000|STARTED|Overall Study||24||
48086493|NCT00187876|100533139|FG001|STARTED|Overall Study||43||
48375794|NCT03726671|101247709|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||3||
48375795|NCT03726671|101247710|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48375796|NCT03726671|101247711|FG002|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48375797|NCT03726671|101247712|FG003|NOT COMPLETED|Second Intervention (2 Weeks)||1||
48375798|NCT03726671|101247713|FG004|NOT COMPLETED|Second Intervention (2 Weeks)||1||
48375799|NCT03726671|101247714|FG005|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48375800|NCT03726671|101247709|FG000|STARTED|Washout (>/= 2 Weeks)||17||
48541008|NCT01352416|101662622|FG000|STARTED|Overall Study||4||
48541009|NCT01352416|101662623|FG001|STARTED|Overall Study||7||
48086494|NCT00187876|100533138|FG000|COMPLETED|Overall Study||24||
48086495|NCT00187876|100533139|FG001|COMPLETED|Overall Study||43||
48086496|NCT00187876|100533138|FG000|NOT COMPLETED|Overall Study||0||
48086497|NCT00187876|100533139|FG001|NOT COMPLETED|Overall Study||0||
48086498|NCT00859053|100533140|FG000|STARTED|Overall Study||6||
48086499|NCT00859053|100533141|FG001|STARTED|Overall Study||6||
48086500|NCT00859053|100533142|FG002|STARTED|Overall Study||6||
48086501|NCT00859053|100533143|FG003|STARTED|Overall Study||12||
48086502|NCT00859053|100533140|FG000|COMPLETED|Overall Study||6||
48086503|NCT00859053|100533141|FG001|COMPLETED|Overall Study||6||
48086504|NCT00859053|100533142|FG002|COMPLETED|Overall Study||6||
48086505|NCT00859053|100533143|FG003|COMPLETED|Overall Study||12||
48086506|NCT00859053|100533140|FG000|NOT COMPLETED|Overall Study||0||
48086507|NCT00859053|100533141|FG001|NOT COMPLETED|Overall Study||0||
48086508|NCT00859053|100533142|FG002|NOT COMPLETED|Overall Study||0||
48086509|NCT00859053|100533143|FG003|NOT COMPLETED|Overall Study||0||
48249956|NCT00434577|100930981|FG000|COMPLETED|Month 12||156||
48249957|NCT00434577|100930982|FG001|COMPLETED|Month 12||159||
48249958|NCT00434577|100930983|FG002|COMPLETED|Month 12||159||
48249959|NCT00434577|100930984|FG003|COMPLETED|Month 12||161||
48249960|NCT00434577|100930985|FG004|COMPLETED|Month 12||50||
48249961|NCT00434577|100930981|FG000|NOT COMPLETED|Month 12||0||
48249962|NCT00434577|100930982|FG001|NOT COMPLETED|Month 12||0||
48249963|NCT00434577|100930983|FG002|NOT COMPLETED|Month 12||0||
48249964|NCT00434577|100930984|FG003|NOT COMPLETED|Month 12||0||
48249965|NCT00434577|100930985|FG004|NOT COMPLETED|Month 12||0||
48249966|NCT00434577|100930981|FG000|STARTED|Month 24||150||
48249967|NCT00434577|100930982|FG001|STARTED|Month 24||155||
48249968|NCT00434577|100930983|FG002|STARTED|Month 24||154||
48249969|NCT00434577|100930984|FG003|STARTED|Month 24||157||
48249970|NCT00434577|100930985|FG004|STARTED|Month 24||49||
48249971|NCT00434577|100930981|FG000|COMPLETED|Month 24||150||
48249972|NCT00434577|100930982|FG001|COMPLETED|Month 24||155||
48249973|NCT00434577|100930983|FG002|COMPLETED|Month 24||154||
48249974|NCT00434577|100930984|FG003|COMPLETED|Month 24||157||
48249975|NCT00434577|100930985|FG004|COMPLETED|Month 24||49||
48249976|NCT00434577|100930981|FG000|NOT COMPLETED|Month 24||0||
48541010|NCT01352416|101662624|FG002|STARTED|Overall Study||2||
48541011|NCT01352416|101662625|FG003|STARTED|Overall Study||2||
48541012|NCT01352416|101662622|FG000|COMPLETED|Overall Study||3||
48541013|NCT01352416|101662623|FG001|COMPLETED|Overall Study||5||
48375801|NCT03726671|101247710|FG001|STARTED|Washout (>/= 2 Weeks)||12||
48541014|NCT01352416|101662624|FG002|COMPLETED|Overall Study||0||
48541015|NCT01352416|101662625|FG003|COMPLETED|Overall Study||1||
48086510|NCT01129960|100533144|FG000|STARTED|Overall Study||84||
48086511|NCT01129960|100533145|FG001|STARTED|Overall Study||83||
48086512|NCT01129960|100533146|FG002|STARTED|Overall Study||82||
48086513|NCT01129960|100533147|FG003|STARTED|Overall Study||83||
48086514|NCT01129960|100533144|FG000|Safety|Overall Study||84||
48086515|NCT01129960|100533145|FG001|Safety|Overall Study||83||
48086516|NCT01129960|100533146|FG002|Safety|Overall Study||83||
48086517|NCT01129960|100533147|FG003|Safety|Overall Study||82||
48375802|NCT03726671|101247711|FG002|STARTED|Washout (>/= 2 Weeks)||12||
48375803|NCT03726671|101247712|FG003|STARTED|Washout (>/= 2 Weeks)||11||
48375804|NCT03726671|101247713|FG004|STARTED|Washout (>/= 2 Weeks)||18||
48375805|NCT03726671|101247714|FG005|STARTED|Washout (>/= 2 Weeks)||8||
48375806|NCT03726671|101247709|FG000|COMPLETED|Washout (>/= 2 Weeks)||17||
48375807|NCT03726671|101247710|FG001|COMPLETED|Washout (>/= 2 Weeks)||12||
48375808|NCT03726671|101247711|FG002|COMPLETED|Washout (>/= 2 Weeks)||12||
48375809|NCT03726671|101247712|FG003|COMPLETED|Washout (>/= 2 Weeks)||11||
48375810|NCT03726671|101247713|FG004|COMPLETED|Washout (>/= 2 Weeks)||17||
48375811|NCT03726671|101247714|FG005|COMPLETED|Washout (>/= 2 Weeks)||8||
48375812|NCT03726671|101247709|FG000|NOT COMPLETED|Washout (>/= 2 Weeks)||0||
48375813|NCT03726671|101247710|FG001|NOT COMPLETED|Washout (>/= 2 Weeks)||0||
48375814|NCT03726671|101247711|FG002|NOT COMPLETED|Washout (>/= 2 Weeks)||0||
48375815|NCT03726671|101247712|FG003|NOT COMPLETED|Washout (>/= 2 Weeks)||0||
48375816|NCT03726671|101247713|FG004|NOT COMPLETED|Washout (>/= 2 Weeks)||1||
48375817|NCT03726671|101247714|FG005|NOT COMPLETED|Washout (>/= 2 Weeks)||0||
48375818|NCT03726671|101247709|FG000|STARTED|Third Intervention (2 Weeks)||17||
48375819|NCT03726671|101247710|FG001|STARTED|Third Intervention (2 Weeks)||12||
48375820|NCT03726671|101247711|FG002|STARTED|Third Intervention (2 Weeks)||12||
48375821|NCT03726671|101247712|FG003|STARTED|Third Intervention (2 Weeks)||11||
48375822|NCT03726671|101247713|FG004|STARTED|Third Intervention (2 Weeks)||17||
48375823|NCT03726671|101247714|FG005|STARTED|Third Intervention (2 Weeks)||8||
48375824|NCT03726671|101247709|FG000|COMPLETED|Third Intervention (2 Weeks)||17||
48375825|NCT03726671|101247710|FG001|COMPLETED|Third Intervention (2 Weeks)||11||
48375826|NCT03726671|101247711|FG002|COMPLETED|Third Intervention (2 Weeks)||12||
48375827|NCT03726671|101247712|FG003|COMPLETED|Third Intervention (2 Weeks)||11||
48375828|NCT03726671|101247713|FG004|COMPLETED|Third Intervention (2 Weeks)||17||
48375829|NCT03726671|101247714|FG005|COMPLETED|Third Intervention (2 Weeks)||8||
48375830|NCT03726671|101247709|FG000|NOT COMPLETED|Third Intervention (2 Weeks)||0||
48375831|NCT03726671|101247710|FG001|NOT COMPLETED|Third Intervention (2 Weeks)||1||
48375832|NCT03726671|101247711|FG002|NOT COMPLETED|Third Intervention (2 Weeks)||0||
48375833|NCT03726671|101247712|FG003|NOT COMPLETED|Third Intervention (2 Weeks)||0||
48375834|NCT03726671|101247713|FG004|NOT COMPLETED|Third Intervention (2 Weeks)||0||
48375835|NCT03726671|101247714|FG005|NOT COMPLETED|Third Intervention (2 Weeks)||0||
48375836|NCT01750398|101247715|FG000|STARTED|ADT Lead In Phase||33||
48375837|NCT01750398|101247715|FG000|COMPLETED|ADT Lead In Phase||29||
48375838|NCT01750398|101247715|FG000|NOT COMPLETED|ADT Lead In Phase||4||
48375839|NCT01750398|101247715|FG000|STARTED|Bipolar Androgen Thearpy Phase||29||
48375840|NCT01750398|101247715|FG000|COMPLETED|Bipolar Androgen Thearpy Phase||26||
48375841|NCT01750398|101247715|FG000|NOT COMPLETED|Bipolar Androgen Thearpy Phase||3||
48375842|NCT00904826|101247716|FG000|STARTED|Overall Study||14||
48086518|NCT01129960|100533144|FG000|Intent-to-Treat|Overall Study||84||
48086519|NCT01129960|100533145|FG001|Intent-to-Treat|Overall Study||83||
48086520|NCT01129960|100533146|FG002|Intent-to-Treat|Overall Study||82||
48086521|NCT01129960|100533147|FG003|Intent-to-Treat|Overall Study||83||
48086522|NCT01129960|100533144|FG000|Per-Protocol|Overall Study||34||
48086523|NCT01129960|100533145|FG001|Per-Protocol|Overall Study||52||
48375843|NCT00904826|101247716|FG000|COMPLETED|Overall Study||14||
48375844|NCT00904826|101247716|FG000|NOT COMPLETED|Overall Study||0||
48375845|NCT02915367|101247717|FG000|STARTED|Overall Study||173||
48086524|NCT01129960|100533146|FG002|Per-Protocol|Overall Study||49||
48086525|NCT01129960|100533147|FG003|Per-Protocol|Overall Study||55||
48375846|NCT02915367|101247718|FG001|STARTED|Overall Study||175||
48375847|NCT02915367|101247717|FG000|COMPLETED|Overall Study||136||
48375848|NCT02915367|101247718|FG001|COMPLETED|Overall Study||144||
48375849|NCT02915367|101247717|FG000|NOT COMPLETED|Overall Study||37||
48375850|NCT02915367|101247718|FG001|NOT COMPLETED|Overall Study||31||
48375851|NCT02410707|101247719|FG000|STARTED|Overall Study||43||
48375852|NCT02410707|101247719|FG000|COMPLETED|Overall Study||43||
48375853|NCT02410707|101247719|FG000|NOT COMPLETED|Overall Study||0||
48375854|NCT00912015|101247720|FG000|STARTED|Overall Study||141||
48375855|NCT00912015|101247721|FG001|STARTED|Overall Study||70||
48375856|NCT00912015|101247722|FG002|STARTED|Overall Study||25||
48375857|NCT00912015|101247723|FG003|STARTED|Overall Study||2||
48375858|NCT00912015|101247720|FG000|COMPLETED|Overall Study||125||
48375859|NCT00912015|101247721|FG001|COMPLETED|Overall Study||62||
48375860|NCT00912015|101247722|FG002|COMPLETED|Overall Study||22||
48375861|NCT00912015|101247723|FG003|COMPLETED|Overall Study||0||
48375862|NCT00912015|101247720|FG000|NOT COMPLETED|Overall Study||16||
48375863|NCT00912015|101247721|FG001|NOT COMPLETED|Overall Study||8||
48086526|NCT01129960|100533144|FG000|Full Analysis Set (FAS|Overall Study||71||
48086527|NCT01129960|100533145|FG001|Full Analysis Set (FAS|Overall Study||67||
48086528|NCT01129960|100533146|FG002|Full Analysis Set (FAS|Overall Study||68||
48086529|NCT01129960|100533147|FG003|Full Analysis Set (FAS|Overall Study||71||
48086530|NCT01129960|100533144|FG000|COMPLETED|Overall Study||54||
48086531|NCT01129960|100533145|FG001|COMPLETED|Overall Study||61||
48086532|NCT01129960|100533146|FG002|COMPLETED|Overall Study||56||
48086533|NCT01129960|100533147|FG003|COMPLETED|Overall Study||70||
48086534|NCT01129960|100533144|FG000|NOT COMPLETED|Overall Study||30||
48086535|NCT01129960|100533145|FG001|NOT COMPLETED|Overall Study||22||
48375864|NCT00912015|101247722|FG002|NOT COMPLETED|Overall Study||3||
48375865|NCT00912015|101247723|FG003|NOT COMPLETED|Overall Study||2||
48375866|NCT02918266|101247724|FG000|STARTED|Part 1||6||
48375867|NCT02918266|101247725|FG001|STARTED|Part 1||0||
48375868|NCT02918266|101247726|FG002|STARTED|Part 1||0||
48375869|NCT02918266|101247727|FG003|STARTED|Part 1||0||
48375870|NCT02918266|101247728|FG004|STARTED|Part 1||0||
48375871|NCT02918266|101247729|FG005|STARTED|Part 1||0||
48375872|NCT02918266|101247730|FG006|STARTED|Part 1||0||
48375873|NCT02918266|101247731|FG007|STARTED|Part 1||0||
48375874|NCT02918266|101247732|FG008|STARTED|Part 1||0||
48375875|NCT02918266|101247733|FG009|STARTED|Part 1||0||
48375876|NCT02918266|101247734|FG010|STARTED|Part 1||0||
48086536|NCT01129960|100533146|FG002|NOT COMPLETED|Overall Study||26||
48086537|NCT01129960|100533147|FG003|NOT COMPLETED|Overall Study||13||
48375877|NCT02918266|101247724|FG000|COMPLETED|Part 1||6||
48086538|NCT01414010|100533148|FG000|STARTED|Overall Study||8||
48375878|NCT02918266|101247725|FG001|COMPLETED|Part 1||0||
48375879|NCT02918266|101247726|FG002|COMPLETED|Part 1||0||
48375880|NCT02918266|101247727|FG003|COMPLETED|Part 1||0||
48375881|NCT02918266|101247728|FG004|COMPLETED|Part 1||0||
48375882|NCT02918266|101247729|FG005|COMPLETED|Part 1||0||
48375883|NCT02918266|101247730|FG006|COMPLETED|Part 1||0||
48375884|NCT02918266|101247731|FG007|COMPLETED|Part 1||0||
48375885|NCT02918266|101247732|FG008|COMPLETED|Part 1||0||
48375886|NCT02918266|101247733|FG009|COMPLETED|Part 1||0||
48683609|NCT03159468|102009578|FG004|COMPLETED|Overall Study||34||
48683610|NCT03159468|102009579|FG005|COMPLETED|Overall Study||34||
48683611|NCT03159468|102009574|FG000|NOT COMPLETED|Overall Study||0||
48683612|NCT03159468|102009575|FG001|NOT COMPLETED|Overall Study||0||
48683613|NCT03159468|102009576|FG002|NOT COMPLETED|Overall Study||3||
48683614|NCT03159468|102009577|FG003|NOT COMPLETED|Overall Study||0||
48683615|NCT03159468|102009578|FG004|NOT COMPLETED|Overall Study||0||
48683616|NCT03159468|102009579|FG005|NOT COMPLETED|Overall Study||0||
48683617|NCT01361217|102009580|FG000|STARTED|Overall Study||10||
48683618|NCT01361217|102009580|FG000|COMPLETED|Overall Study||10||
48683619|NCT01361217|102009580|FG000|NOT COMPLETED|Overall Study||0||
48683620|NCT02383862|102009581|FG000|STARTED|Baseline||151||
48683621|NCT02383862|102009582|FG001|STARTED|Baseline||149||
48683622|NCT02383862|102009581|FG000|COMPLETED|Baseline||151||
48683623|NCT02383862|102009582|FG001|COMPLETED|Baseline||149||
48249977|NCT00434577|100930982|FG001|NOT COMPLETED|Month 24||0||
48249978|NCT00434577|100930983|FG002|NOT COMPLETED|Month 24||0||
48249979|NCT00434577|100930984|FG003|NOT COMPLETED|Month 24||0||
48249980|NCT00434577|100930985|FG004|NOT COMPLETED|Month 24||0||
48249981|NCT00434577|100930981|FG000|STARTED|Month 36||147||
48249982|NCT00434577|100930982|FG001|STARTED|Month 36||147||
48249983|NCT00434577|100930983|FG002|STARTED|Month 36||150||
48249984|NCT00434577|100930984|FG003|STARTED|Month 36||155||
48249985|NCT00434577|100930985|FG004|STARTED|Month 36||47||
48249986|NCT00434577|100930981|FG000|COMPLETED|Month 36||147||
48249987|NCT00434577|100930982|FG001|COMPLETED|Month 36||147||
48249988|NCT00434577|100930983|FG002|COMPLETED|Month 36||150||
48249989|NCT00434577|100930984|FG003|COMPLETED|Month 36||155||
48683624|NCT02383862|102009581|FG000|NOT COMPLETED|Baseline||0||
48249990|NCT00434577|100930985|FG004|COMPLETED|Month 36||47||
48683625|NCT02383862|102009582|FG001|NOT COMPLETED|Baseline||0||
48375887|NCT02918266|101247734|FG010|COMPLETED|Part 1||0||
48375888|NCT02918266|101247724|FG000|NOT COMPLETED|Part 1||0||
48375889|NCT02918266|101247725|FG001|NOT COMPLETED|Part 1||0||
48375890|NCT02918266|101247726|FG002|NOT COMPLETED|Part 1||0||
48375891|NCT02918266|101247727|FG003|NOT COMPLETED|Part 1||0||
48375892|NCT02918266|101247728|FG004|NOT COMPLETED|Part 1||0||
48375893|NCT02918266|101247729|FG005|NOT COMPLETED|Part 1||0||
48375894|NCT02918266|101247730|FG006|NOT COMPLETED|Part 1||0||
48375895|NCT02918266|101247731|FG007|NOT COMPLETED|Part 1||0||
48375896|NCT02918266|101247732|FG008|NOT COMPLETED|Part 1||0||
48375897|NCT02918266|101247733|FG009|NOT COMPLETED|Part 1||0||
48375898|NCT02918266|101247734|FG010|NOT COMPLETED|Part 1||0||
48375899|NCT02918266|101247724|FG000|STARTED|Part 2: Intervention Period 1 (2 Days)||0||
48375900|NCT02918266|101247725|FG001|STARTED|Part 2: Intervention Period 1 (2 Days)||1||
48375901|NCT02918266|101247726|FG002|STARTED|Part 2: Intervention Period 1 (2 Days)||1||
48375902|NCT02918266|101247727|FG003|STARTED|Part 2: Intervention Period 1 (2 Days)||1||
48375903|NCT02918266|101247728|FG004|STARTED|Part 2: Intervention Period 1 (2 Days)||1||
48375904|NCT02918266|101247729|FG005|STARTED|Part 2: Intervention Period 1 (2 Days)||1||
48375905|NCT02918266|101247730|FG006|STARTED|Part 2: Intervention Period 1 (2 Days)||2||
48375906|NCT02918266|101247731|FG007|STARTED|Part 2: Intervention Period 1 (2 Days)||1||
48375907|NCT02918266|101247732|FG008|STARTED|Part 2: Intervention Period 1 (2 Days)||2||
48375908|NCT02918266|101247733|FG009|STARTED|Part 2: Intervention Period 1 (2 Days)||1||
48375909|NCT02918266|101247734|FG010|STARTED|Part 2: Intervention Period 1 (2 Days)||1||
48086539|NCT01414010|100533149|FG001|STARTED|Overall Study||8||
48086540|NCT01414010|100533150|FG002|STARTED|Overall Study||8||
48375910|NCT02918266|101247724|FG000|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0||
48375911|NCT02918266|101247725|FG001|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0||
48375912|NCT02918266|101247726|FG002|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0||
48375913|NCT02918266|101247727|FG003|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0||
48375914|NCT02918266|101247728|FG004|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0||
48375915|NCT02918266|101247729|FG005|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0||
48375916|NCT02918266|101247730|FG006|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0||
48375917|NCT02918266|101247731|FG007|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0||
48683626|NCT02383862|102009581|FG000|STARTED|3 Month Follow up||151||
48683627|NCT02383862|102009582|FG001|STARTED|3 Month Follow up||149||
48683628|NCT02383862|102009581|FG000|COMPLETED|3 Month Follow up||128||
48683629|NCT02383862|102009582|FG001|COMPLETED|3 Month Follow up||128||
48683630|NCT02383862|102009581|FG000|NOT COMPLETED|3 Month Follow up||23||
48683631|NCT02383862|102009582|FG001|NOT COMPLETED|3 Month Follow up||21||
48683632|NCT00680628|102009583|FG000|STARTED|Overall Study||43||
48683633|NCT00680628|102009584|FG001|STARTED|Overall Study||40||
48683634|NCT00680628|102009583|FG000|COMPLETED|Overall Study||43||
48683635|NCT00680628|102009584|FG001|COMPLETED|Overall Study||40||
48683636|NCT00680628|102009583|FG000|NOT COMPLETED|Overall Study||0||
48683637|NCT00680628|102009584|FG001|NOT COMPLETED|Overall Study||0||
48683638|NCT01791517|102009585|FG000|STARTED|Phase I: Period 1||19||
48683639|NCT01791517|102009586|FG001|STARTED|Phase I: Period 1||20||
48683640|NCT01791517|102009587|FG002|STARTED|Phase I: Period 1||20||
48683641|NCT01791517|102009588|FG003|STARTED|Phase I: Period 1||19||
48683642|NCT01791517|102009589|FG004|STARTED|Phase I: Period 1||20||
48683643|NCT01791517|102009590|FG005|STARTED|Phase I: Period 1||20||
48683644|NCT01791517|102009591|FG006|STARTED|Phase I: Period 1||20||
48086541|NCT01414010|100533151|FG003|STARTED|Overall Study||8||
48086542|NCT01414010|100533148|FG000|COMPLETED|Overall Study||6||
48375918|NCT02918266|101247732|FG008|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0||
48375919|NCT02918266|101247733|FG009|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0||
48375920|NCT02918266|101247734|FG010|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0||
48375921|NCT02918266|101247724|FG000|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||0||
48683645|NCT01791517|102009592|FG007|STARTED|Phase I: Period 1||20||
48683646|NCT01791517|102009593|FG008|STARTED|Phase I: Period 1||20||
48683647|NCT01791517|102009594|FG009|STARTED|Phase I: Period 1||20||
48086543|NCT01414010|100533149|FG001|COMPLETED|Overall Study||8||
48086544|NCT01414010|100533150|FG002|COMPLETED|Overall Study||8||
48086545|NCT01414010|100533151|FG003|COMPLETED|Overall Study||8||
48086546|NCT01414010|100533148|FG000|NOT COMPLETED|Overall Study||2||
48086547|NCT01414010|100533149|FG001|NOT COMPLETED|Overall Study||0||
48086548|NCT01414010|100533150|FG002|NOT COMPLETED|Overall Study||0||
48086549|NCT01414010|100533151|FG003|NOT COMPLETED|Overall Study||0||
48086550|NCT02547454|100533152|FG000|STARTED|Overall Study||393||
48086551|NCT02547454|100533152|FG000|COMPLETED|Overall Study||221||
48086552|NCT02547454|100533152|FG000|NOT COMPLETED|Overall Study||172||
48086553|NCT00720434|100533153|FG000|STARTED|Double-Blind Period (Week 1-4)||10||
48086554|NCT00720434|100533154|FG001|STARTED|Double-Blind Period (Week 1-4)||9||
48086555|NCT00720434|100533155|FG002|STARTED|Double-Blind Period (Week 1-4)||8||
48086556|NCT00720434|100533156|FG003|STARTED|Double-Blind Period (Week 1-4)||8||
48086557|NCT00720434|100533153|FG000|COMPLETED|Double-Blind Period (Week 1-4)||10||
48086558|NCT00720434|100533154|FG001|COMPLETED|Double-Blind Period (Week 1-4)||8||
48086559|NCT00720434|100533155|FG002|COMPLETED|Double-Blind Period (Week 1-4)||8||
48086560|NCT00720434|100533156|FG003|COMPLETED|Double-Blind Period (Week 1-4)||8||
48086561|NCT00720434|100533153|FG000|NOT COMPLETED|Double-Blind Period (Week 1-4)||0||
48086562|NCT00720434|100533154|FG001|NOT COMPLETED|Double-Blind Period (Week 1-4)||1||
48086563|NCT00720434|100533155|FG002|NOT COMPLETED|Double-Blind Period (Week 1-4)||0||
48086564|NCT00720434|100533156|FG003|NOT COMPLETED|Double-Blind Period (Week 1-4)||0||
48086565|NCT00720434|100533153|FG000|STARTED|Open-Label Period (Week 5-72)||10||
48375922|NCT02918266|101247725|FG001|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1||
48375923|NCT02918266|101247726|FG002|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1||
48375924|NCT02918266|101247727|FG003|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1||
48375925|NCT02918266|101247728|FG004|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1||
48375926|NCT02918266|101247729|FG005|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1||
48086566|NCT00720434|100533154|FG001|STARTED|Open-Label Period (Week 5-72)||8||
48086567|NCT00720434|100533155|FG002|STARTED|Open-Label Period (Week 5-72)||8||
48086568|NCT00720434|100533156|FG003|STARTED|Open-Label Period (Week 5-72)||8||
48086569|NCT00720434|100533153|FG000|COMPLETED|Open-Label Period (Week 5-72)||4||
48086570|NCT00720434|100533154|FG001|COMPLETED|Open-Label Period (Week 5-72)||5||
48086571|NCT00720434|100533155|FG002|COMPLETED|Open-Label Period (Week 5-72)||4||
48086572|NCT00720434|100533156|FG003|COMPLETED|Open-Label Period (Week 5-72)||4||
48086573|NCT00720434|100533153|FG000|NOT COMPLETED|Open-Label Period (Week 5-72)||6||
48086574|NCT00720434|100533154|FG001|NOT COMPLETED|Open-Label Period (Week 5-72)||3||
48086575|NCT00720434|100533155|FG002|NOT COMPLETED|Open-Label Period (Week 5-72)||4||
48086576|NCT00720434|100533156|FG003|NOT COMPLETED|Open-Label Period (Week 5-72)||4||
48086577|NCT02255604|100533157|FG000|STARTED|Overall Study||12||
48375927|NCT02918266|101247730|FG006|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||2||
48375928|NCT02918266|101247731|FG007|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1||
48375929|NCT02918266|101247732|FG008|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||2||
48375930|NCT02918266|101247733|FG009|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1||
48375931|NCT02918266|101247734|FG010|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1||
48375932|NCT02918266|101247724|FG000|STARTED|Part 2: Washout Period 1 (3 Weeks)||0||
48086578|NCT02255604|100533158|FG001|STARTED|Overall Study||12||
48086579|NCT02255604|100533159|FG002|STARTED|Overall Study||12||
48375933|NCT02918266|101247725|FG001|STARTED|Part 2: Washout Period 1 (3 Weeks)||0||
48375934|NCT02918266|101247726|FG002|STARTED|Part 2: Washout Period 1 (3 Weeks)||0||
48375935|NCT02918266|101247727|FG003|STARTED|Part 2: Washout Period 1 (3 Weeks)||0||
48375936|NCT02918266|101247728|FG004|STARTED|Part 2: Washout Period 1 (3 Weeks)||0||
48375937|NCT02918266|101247729|FG005|STARTED|Part 2: Washout Period 1 (3 Weeks)||0||
48086580|NCT02255604|100533157|FG000|COMPLETED|Overall Study||10||
48086581|NCT02255604|100533158|FG001|COMPLETED|Overall Study||11||
48086582|NCT02255604|100533159|FG002|COMPLETED|Overall Study||9||
48086583|NCT02255604|100533157|FG000|NOT COMPLETED|Overall Study||2||
48086584|NCT02255604|100533158|FG001|NOT COMPLETED|Overall Study||1||
48375938|NCT02918266|101247730|FG006|STARTED|Part 2: Washout Period 1 (3 Weeks)||0||
48375939|NCT02918266|101247731|FG007|STARTED|Part 2: Washout Period 1 (3 Weeks)||0||
48375940|NCT02918266|101247732|FG008|STARTED|Part 2: Washout Period 1 (3 Weeks)||0||
48375941|NCT02918266|101247733|FG009|STARTED|Part 2: Washout Period 1 (3 Weeks)||0||
48086585|NCT02255604|100533159|FG002|NOT COMPLETED|Overall Study||3||
48086586|NCT00144963|100533160|FG000|STARTED|Overall Study||36||
48086587|NCT00144963|100533160|FG000|COMPLETED|Overall Study||36||
48086588|NCT00144963|100533160|FG000|NOT COMPLETED|Overall Study||0||
48086589|NCT01995825|100533161|FG000|STARTED|Overall Study||18||
48086590|NCT01995825|100533162|FG001|STARTED|Overall Study||17||
48086591|NCT01995825|100533161|FG000|COMPLETED|Overall Study||17||
48086592|NCT01995825|100533162|FG001|COMPLETED|Overall Study||17||
48086593|NCT01995825|100533161|FG000|NOT COMPLETED|Overall Study||1||
48086594|NCT01995825|100533162|FG001|NOT COMPLETED|Overall Study||0||
48086595|NCT03782272|100533163|FG000|STARTED|Overall Study||6||
48375942|NCT02918266|101247734|FG010|STARTED|Part 2: Washout Period 1 (3 Weeks)||0||
48375943|NCT02918266|101247724|FG000|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
48375944|NCT02918266|101247725|FG001|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
48375945|NCT02918266|101247726|FG002|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
48375946|NCT02918266|101247727|FG003|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
48375947|NCT02918266|101247728|FG004|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
48375948|NCT02918266|101247729|FG005|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
48375949|NCT02918266|101247730|FG006|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
48375950|NCT02918266|101247731|FG007|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
48375951|NCT02918266|101247732|FG008|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
48375952|NCT02918266|101247733|FG009|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
48375953|NCT02918266|101247734|FG010|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
48375954|NCT02918266|101247724|FG000|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
48375955|NCT02918266|101247725|FG001|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
48375956|NCT02918266|101247726|FG002|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
48375957|NCT02918266|101247727|FG003|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
48375958|NCT02918266|101247728|FG004|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
48375959|NCT02918266|101247729|FG005|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
48375960|NCT02918266|101247730|FG006|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
48375961|NCT02918266|101247731|FG007|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
48375962|NCT02918266|101247732|FG008|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
48375963|NCT02918266|101247733|FG009|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
48375964|NCT02918266|101247734|FG010|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
48375965|NCT02918266|101247724|FG000|STARTED|Part 2: Intervention Period 2 (2 Days)||0||
48375966|NCT02918266|101247725|FG001|STARTED|Part 2: Intervention Period 2 (2 Days)||0||
48375967|NCT02918266|101247726|FG002|STARTED|Part 2: Intervention Period 2 (2 Days)||0||
48375968|NCT02918266|101247727|FG003|STARTED|Part 2: Intervention Period 2 (2 Days)||0||
48375969|NCT02918266|101247728|FG004|STARTED|Part 2: Intervention Period 2 (2 Days)||0||
48375970|NCT02918266|101247729|FG005|STARTED|Part 2: Intervention Period 2 (2 Days)||0||
48375971|NCT02918266|101247730|FG006|STARTED|Part 2: Intervention Period 2 (2 Days)||0||
48683648|NCT01791517|102009595|FG010|STARTED|Phase I: Period 1||18||
48086596|NCT03782272|100533164|FG001|STARTED|Overall Study||6||
48086597|NCT03782272|100533163|FG000|COMPLETED|Overall Study||6||
48086598|NCT03782272|100533164|FG001|COMPLETED|Overall Study||6||
48086599|NCT03782272|100533163|FG000|NOT COMPLETED|Overall Study||0||
48086600|NCT03782272|100533164|FG001|NOT COMPLETED|Overall Study||0||
48086601|NCT01366521|100533165|FG000|STARTED|Overall Study||21||
48086602|NCT01366521|100533166|FG001|STARTED|Overall Study||15||
48086603|NCT01366521|100533167|FG002|STARTED|Overall Study||23||
48086604|NCT01366521|100533168|FG003|STARTED|Overall Study||11||
48086605|NCT01366521|100533165|FG000|COMPLETED|Overall Study||20||
48086606|NCT01366521|100533166|FG001|COMPLETED|Overall Study||14||
48086607|NCT01366521|100533167|FG002|COMPLETED|Overall Study||21||
48249991|NCT00434577|100930981|FG000|NOT COMPLETED|Month 36||0||
48249992|NCT00434577|100930982|FG001|NOT COMPLETED|Month 36||0||
48249993|NCT00434577|100930983|FG002|NOT COMPLETED|Month 36||0||
48249994|NCT00434577|100930984|FG003|NOT COMPLETED|Month 36||0||
48249995|NCT00434577|100930985|FG004|NOT COMPLETED|Month 36||0||
48249996|NCT03811834|100930986|FG000|STARTED|Period 1 ( 7 Days)||7||
48249997|NCT03811834|100930986|FG000|COMPLETED|Period 1 ( 7 Days)||6||
48086608|NCT01366521|100533168|FG003|COMPLETED|Overall Study||11||
48086609|NCT01366521|100533165|FG000|NOT COMPLETED|Overall Study||1||
48086610|NCT01366521|100533166|FG001|NOT COMPLETED|Overall Study||1||
48249998|NCT03811834|100930986|FG000|NOT COMPLETED|Period 1 ( 7 Days)||1||
48249999|NCT03811834|100930986|FG000|STARTED|Washout Period (9 Days)||6||
48250000|NCT03811834|100930986|FG000|COMPLETED|Washout Period (9 Days)||6||
48250001|NCT03811834|100930986|FG000|NOT COMPLETED|Washout Period (9 Days)||0||
48250002|NCT03811834|100930986|FG000|STARTED|Period 2 (10 Days)||6||
48086611|NCT01366521|100533167|FG002|NOT COMPLETED|Overall Study||2||
48086612|NCT01366521|100533168|FG003|NOT COMPLETED|Overall Study||0||
48086613|NCT04876274|100533169|FG000|STARTED|Overall Study||91||
48086614|NCT04876274|100533170|FG001|STARTED|Overall Study||90||
48250003|NCT03811834|100930986|FG000|COMPLETED|Period 2 (10 Days)||6||
48086615|NCT04876274|100533169|FG000|COMPLETED|Overall Study||82||
48086616|NCT04876274|100533170|FG001|COMPLETED|Overall Study||78||
48086617|NCT04876274|100533169|FG000|NOT COMPLETED|Overall Study||9||
48086618|NCT04876274|100533170|FG001|NOT COMPLETED|Overall Study||12||
48086619|NCT01085591|100533171|FG000|STARTED|Overall Study||69||
48086620|NCT01085591|100533172|FG001|STARTED|Overall Study||71||
48086621|NCT01085591|100533173|FG002|STARTED|Overall Study||70||
48086622|NCT01085591|100533171|FG000|Received at Least 1 Dose of Study Drug|Overall Study||68||
48250004|NCT03811834|100930986|FG000|NOT COMPLETED|Period 2 (10 Days)||0||
48250005|NCT01688895|100930987|FG000|STARTED|Overall Study||150||
48250006|NCT01688895|100930987|FG000|COMPLETED|Overall Study||150||
48250007|NCT01688895|100930987|FG000|NOT COMPLETED|Overall Study||0||
48250008|NCT00902226|100930988|FG000|STARTED|Overall Study||30||
48250009|NCT00902226|100930988|FG000|COMPLETED|Overall Study||30||
48683649|NCT01791517|102009596|FG011|STARTED|Phase I: Period 1||20||
48683650|NCT01791517|102009585|FG000|COMPLETED|Phase I: Period 1||18||
48683651|NCT01791517|102009586|FG001|COMPLETED|Phase I: Period 1||18||
48683652|NCT01791517|102009587|FG002|COMPLETED|Phase I: Period 1||18||
48683653|NCT01791517|102009588|FG003|COMPLETED|Phase I: Period 1||17||
48683654|NCT01791517|102009589|FG004|COMPLETED|Phase I: Period 1||19||
48086623|NCT01085591|100533172|FG001|Received at Least 1 Dose of Study Drug|Overall Study||69||
48086624|NCT01085591|100533173|FG002|Received at Least 1 Dose of Study Drug|Overall Study||70||
48086625|NCT01085591|100533171|FG000|COMPLETED|Overall Study||66||
48086626|NCT01085591|100533172|FG001|COMPLETED|Overall Study||65||
48086627|NCT01085591|100533173|FG002|COMPLETED|Overall Study||63||
48250010|NCT00902226|100930988|FG000|NOT COMPLETED|Overall Study||0||
48250011|NCT04814992|100930989|FG000|STARTED|Overall Study||27||
48250012|NCT04814992|100930990|FG001|STARTED|Overall Study||27||
48250013|NCT04814992|100930989|FG000|COMPLETED|Overall Study||20||
48250014|NCT04814992|100930990|FG001|COMPLETED|Overall Study||20||
48250015|NCT04814992|100930989|FG000|NOT COMPLETED|Overall Study||7||
48250016|NCT04814992|100930990|FG001|NOT COMPLETED|Overall Study||7||
48250017|NCT01042145|100930991|FG000|STARTED|Overall Study||41||
48250018|NCT01042145|100930992|FG001|STARTED|Overall Study||46||
48250019|NCT01042145|100930991|FG000|COMPLETED|Overall Study||40||
48250020|NCT01042145|100930992|FG001|COMPLETED|Overall Study||45||
48683655|NCT01791517|102009590|FG005|COMPLETED|Phase I: Period 1||19||
48683656|NCT01791517|102009591|FG006|COMPLETED|Phase I: Period 1||19||
48683657|NCT01791517|102009592|FG007|COMPLETED|Phase I: Period 1||20||
48683658|NCT01791517|102009593|FG008|COMPLETED|Phase I: Period 1||19||
48683659|NCT01791517|102009594|FG009|COMPLETED|Phase I: Period 1||19||
48683660|NCT01791517|102009595|FG010|COMPLETED|Phase I: Period 1||18||
48683661|NCT01791517|102009596|FG011|COMPLETED|Phase I: Period 1||19||
48683662|NCT01791517|102009585|FG000|NOT COMPLETED|Phase I: Period 1||1||
48683663|NCT01791517|102009586|FG001|NOT COMPLETED|Phase I: Period 1||2||
48683664|NCT01791517|102009587|FG002|NOT COMPLETED|Phase I: Period 1||2||
48683665|NCT01791517|102009588|FG003|NOT COMPLETED|Phase I: Period 1||2||
48683666|NCT01791517|102009589|FG004|NOT COMPLETED|Phase I: Period 1||1||
48683667|NCT01791517|102009590|FG005|NOT COMPLETED|Phase I: Period 1||1||
48683668|NCT01791517|102009591|FG006|NOT COMPLETED|Phase I: Period 1||1||
48683669|NCT01791517|102009592|FG007|NOT COMPLETED|Phase I: Period 1||0||
48683670|NCT01791517|102009593|FG008|NOT COMPLETED|Phase I: Period 1||1||
48683671|NCT01791517|102009594|FG009|NOT COMPLETED|Phase I: Period 1||1||
48683672|NCT01791517|102009595|FG010|NOT COMPLETED|Phase I: Period 1||0||
48683673|NCT01791517|102009596|FG011|NOT COMPLETED|Phase I: Period 1||1||
48683674|NCT01791517|102009585|FG000|STARTED|Phase I: Period 2||18||
48683675|NCT01791517|102009586|FG001|STARTED|Phase I: Period 2||18||
48683676|NCT01791517|102009587|FG002|STARTED|Phase I: Period 2||18||
48683677|NCT01791517|102009588|FG003|STARTED|Phase I: Period 2||17||
48683678|NCT01791517|102009589|FG004|STARTED|Phase I: Period 2||19||
48683679|NCT01791517|102009590|FG005|STARTED|Phase I: Period 2||19||
48683680|NCT01791517|102009591|FG006|STARTED|Phase I: Period 2||19||
48086628|NCT01085591|100533171|FG000|NOT COMPLETED|Overall Study||3||
48086629|NCT01085591|100533172|FG001|NOT COMPLETED|Overall Study||6||
48250021|NCT01042145|100930991|FG000|NOT COMPLETED|Overall Study||1||
48250022|NCT01042145|100930992|FG001|NOT COMPLETED|Overall Study||1||
48250023|NCT02132598|100930993|FG000|STARTED|Overall Study||5||
48086630|NCT01085591|100533173|FG002|NOT COMPLETED|Overall Study||7||
48086631|NCT01339429|100533174|FG000|STARTED|Overall Study||41||
48086632|NCT01339429|100533174|FG000|COMPLETED|Overall Study||37||
48086633|NCT01339429|100533174|FG000|NOT COMPLETED|Overall Study||4||
48086634|NCT01593215|100533175|FG000|STARTED|Overall Study||25||
48086635|NCT01593215|100533176|FG001|STARTED|Overall Study||25||
48086636|NCT01593215|100533175|FG000|COMPLETED|Overall Study||24||
48086637|NCT01593215|100533176|FG001|COMPLETED|Overall Study||25||
48086638|NCT01593215|100533175|FG000|NOT COMPLETED|Overall Study||1||
48086639|NCT01593215|100533176|FG001|NOT COMPLETED|Overall Study||0||
48086640|NCT02536040|100533177|FG000|STARTED|Overall Study||30||
48086641|NCT02536040|100533178|FG001|STARTED|Overall Study||36||
48086642|NCT02536040|100533177|FG000|COMPLETED|Overall Study||29||
48086643|NCT02536040|100533178|FG001|COMPLETED|Overall Study||35||
48086644|NCT02536040|100533177|FG000|NOT COMPLETED|Overall Study||1||
48086645|NCT02536040|100533178|FG001|NOT COMPLETED|Overall Study||1||
48086646|NCT01053221|100533179|FG000|STARTED|Overall Study||5||
48086647|NCT01053221|100533180|FG001|STARTED|Overall Study||9||
48086648|NCT01053221|100533179|FG000|COMPLETED|Overall Study||0||
48086649|NCT01053221|100533180|FG001|COMPLETED|Overall Study||0||
48086650|NCT01053221|100533179|FG000|NOT COMPLETED|Overall Study||5||
48086651|NCT01053221|100533180|FG001|NOT COMPLETED|Overall Study||9||
48086652|NCT02501473|100533181|FG000|STARTED|Overall Study||3||
48086653|NCT02501473|100533182|FG001|STARTED|Overall Study||3||
48086654|NCT02501473|100533183|FG002|STARTED|Overall Study||13||
48086655|NCT02501473|100533184|FG003|STARTED|Overall Study||14||
48086656|NCT02501473|100533185|FG004|STARTED|Overall Study||4||
48375972|NCT02918266|101247731|FG007|STARTED|Part 2: Intervention Period 2 (2 Days)||0||
48375973|NCT02918266|101247732|FG008|STARTED|Part 2: Intervention Period 2 (2 Days)||0||
48375974|NCT02918266|101247733|FG009|STARTED|Part 2: Intervention Period 2 (2 Days)||0||
48375975|NCT02918266|101247734|FG010|STARTED|Part 2: Intervention Period 2 (2 Days)||0||
48375976|NCT02918266|101247724|FG000|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
48375977|NCT02918266|101247725|FG001|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
48375978|NCT02918266|101247726|FG002|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
48683681|NCT01791517|102009592|FG007|STARTED|Phase I: Period 2||20||
48683682|NCT01791517|102009593|FG008|STARTED|Phase I: Period 2||19||
48086657|NCT02501473|100533186|FG005|STARTED|Overall Study||14||
48086658|NCT02501473|100533187|FG006|STARTED|Overall Study||1||
48086659|NCT02501473|100533188|FG007|STARTED|Overall Study||0||
48086660|NCT02501473|100533181|FG000|Treated|Overall Study||3||
48086661|NCT02501473|100533182|FG001|Treated|Overall Study||3||
48086662|NCT02501473|100533183|FG002|Treated|Overall Study||13||
48086663|NCT02501473|100533184|FG003|Treated|Overall Study||13||
48086664|NCT02501473|100533185|FG004|Treated|Overall Study||4||
48086665|NCT02501473|100533186|FG005|Treated|Overall Study||14||
48086666|NCT02501473|100533187|FG006|Treated|Overall Study||1||
48086667|NCT02501473|100533188|FG007|Treated|Overall Study||0||
48086668|NCT02501473|100533181|FG000|COMPLETED|Overall Study||0||
48086669|NCT02501473|100533182|FG001|COMPLETED|Overall Study||0||
48086670|NCT02501473|100533183|FG002|COMPLETED|Overall Study||0||
48375979|NCT02918266|101247727|FG003|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
48375980|NCT02918266|101247728|FG004|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
48375981|NCT02918266|101247729|FG005|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
48375982|NCT02918266|101247730|FG006|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
48375983|NCT02918266|101247731|FG007|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
48375984|NCT02918266|101247732|FG008|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
48086671|NCT02501473|100533184|FG003|COMPLETED|Overall Study||0||
48086672|NCT02501473|100533185|FG004|COMPLETED|Overall Study||0||
48375985|NCT02918266|101247733|FG009|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
48375986|NCT02918266|101247734|FG010|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
48375987|NCT02918266|101247724|FG000|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
48683683|NCT01791517|102009594|FG009|STARTED|Phase I: Period 2||19||
48683684|NCT01791517|102009595|FG010|STARTED|Phase I: Period 2||18||
48683685|NCT01791517|102009596|FG011|STARTED|Phase I: Period 2||19||
48683686|NCT01791517|102009585|FG000|COMPLETED|Phase I: Period 2||17||
48683687|NCT01791517|102009586|FG001|COMPLETED|Phase I: Period 2||15||
48683688|NCT01791517|102009587|FG002|COMPLETED|Phase I: Period 2||16||
48683689|NCT01791517|102009588|FG003|COMPLETED|Phase I: Period 2||16||
48086673|NCT02501473|100533186|FG005|COMPLETED|Overall Study||0||
48086674|NCT02501473|100533187|FG006|COMPLETED|Overall Study||0||
48086675|NCT02501473|100533188|FG007|COMPLETED|Overall Study||0||
48086676|NCT02501473|100533181|FG000|NOT COMPLETED|Overall Study||3||
48086677|NCT02501473|100533182|FG001|NOT COMPLETED|Overall Study||3||
48086678|NCT02501473|100533183|FG002|NOT COMPLETED|Overall Study||13||
48086679|NCT02501473|100533184|FG003|NOT COMPLETED|Overall Study||14||
48086680|NCT02501473|100533185|FG004|NOT COMPLETED|Overall Study||4||
48086681|NCT02501473|100533186|FG005|NOT COMPLETED|Overall Study||14||
48086682|NCT02501473|100533187|FG006|NOT COMPLETED|Overall Study||1||
48086683|NCT02501473|100533188|FG007|NOT COMPLETED|Overall Study||0||
48086684|NCT03508921|100533189|FG000|STARTED|Overall Study||10||
48086685|NCT03508921|100533190|FG001|STARTED|Overall Study||12||
48086686|NCT03508921|100533189|FG000|COMPLETED|Overall Study||6||
48086687|NCT03508921|100533190|FG001|COMPLETED|Overall Study||11||
48086688|NCT03508921|100533189|FG000|NOT COMPLETED|Overall Study||4||
48086689|NCT03508921|100533190|FG001|NOT COMPLETED|Overall Study||1||
48086690|NCT04113304|100533191|FG000|STARTED|Overall Study||6||
48086691|NCT04113304|100533191|FG000|COMPLETED|Overall Study||6||
48086692|NCT04113304|100533191|FG000|NOT COMPLETED|Overall Study||0||
48086693|NCT02670083|100533192|FG000|STARTED|Overall Study||409||
48086694|NCT02670083|100533193|FG001|STARTED|Overall Study||404||
48086695|NCT02670083|100533192|FG000|COMPLETED|Overall Study||88||
48086696|NCT02670083|100533193|FG001|COMPLETED|Overall Study||85||
48086697|NCT02670083|100533192|FG000|NOT COMPLETED|Overall Study||321||
48086698|NCT02670083|100533193|FG001|NOT COMPLETED|Overall Study||319||
48086699|NCT00642941|100533194|FG000|STARTED|Overall Study||70||
48086700|NCT00642941|100533195|FG001|STARTED|Overall Study||54||
48086701|NCT00642941|100533196|FG002|STARTED|Overall Study||7||
48086702|NCT00642941|100533197|FG003|STARTED|Overall Study||40||
48086703|NCT00642941|100533198|FG004|STARTED|Overall Study||25||
48086704|NCT00642941|100533199|FG005|STARTED|Overall Study||41||
48086705|NCT00642941|100533200|FG006|STARTED|Overall Study||23||
48086706|NCT00642941|100533201|FG007|STARTED|Overall Study||14||
48086707|NCT00642941|100533202|FG008|STARTED|Overall Study||11||
48086708|NCT00642941|100533203|FG009|STARTED|Overall Study||9||
48086709|NCT00642941|100533204|FG010|STARTED|Overall Study||12||
48086710|NCT00642941|100533205|FG011|STARTED|Overall Study||11||
48086711|NCT00642941|100533194|FG000|COMPLETED|Overall Study||0||
48086712|NCT00642941|100533195|FG001|COMPLETED|Overall Study||0||
48375988|NCT02918266|101247725|FG001|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
48375989|NCT02918266|101247726|FG002|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
48375990|NCT02918266|101247727|FG003|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
48086713|NCT00642941|100533196|FG002|COMPLETED|Overall Study||0||
48086714|NCT00642941|100533197|FG003|COMPLETED|Overall Study||0||
48086715|NCT00642941|100533198|FG004|COMPLETED|Overall Study||0||
48086716|NCT00642941|100533199|FG005|COMPLETED|Overall Study||0||
48086717|NCT00642941|100533200|FG006|COMPLETED|Overall Study||0||
48086718|NCT00642941|100533201|FG007|COMPLETED|Overall Study||0||
48375991|NCT02918266|101247728|FG004|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
48375992|NCT02918266|101247729|FG005|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
48375993|NCT02918266|101247730|FG006|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
48375994|NCT02918266|101247731|FG007|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
48375995|NCT02918266|101247732|FG008|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
48375996|NCT02918266|101247733|FG009|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
48375997|NCT02918266|101247734|FG010|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
48683690|NCT01791517|102009589|FG004|COMPLETED|Phase I: Period 2||19||
48683691|NCT01791517|102009590|FG005|COMPLETED|Phase I: Period 2||18||
48683692|NCT01791517|102009591|FG006|COMPLETED|Phase I: Period 2||19||
48683693|NCT01791517|102009592|FG007|COMPLETED|Phase I: Period 2||20||
48683694|NCT01791517|102009593|FG008|COMPLETED|Phase I: Period 2||19||
48086719|NCT00642941|100533202|FG008|COMPLETED|Overall Study||0||
48086720|NCT00642941|100533203|FG009|COMPLETED|Overall Study||0||
48086721|NCT00642941|100533204|FG010|COMPLETED|Overall Study||0||
48086722|NCT00642941|100533205|FG011|COMPLETED|Overall Study||0||
48086723|NCT00642941|100533194|FG000|NOT COMPLETED|Overall Study||70||
48375998|NCT02918266|101247724|FG000|STARTED|Part 2: Washout Period 2 (3 Weeks)||0||
48375999|NCT02918266|101247725|FG001|STARTED|Part 2: Washout Period 2 (3 Weeks)||0||
48376000|NCT02918266|101247726|FG002|STARTED|Part 2: Washout Period 2 (3 Weeks)||0||
48376001|NCT02918266|101247727|FG003|STARTED|Part 2: Washout Period 2 (3 Weeks)||0||
48376002|NCT02918266|101247728|FG004|STARTED|Part 2: Washout Period 2 (3 Weeks)||0||
48376003|NCT02918266|101247729|FG005|STARTED|Part 2: Washout Period 2 (3 Weeks)||0||
48683695|NCT01791517|102009594|FG009|COMPLETED|Phase I: Period 2||18||
48683696|NCT01791517|102009595|FG010|COMPLETED|Phase I: Period 2||16||
48683697|NCT01791517|102009596|FG011|COMPLETED|Phase I: Period 2||19||
48683698|NCT01791517|102009585|FG000|NOT COMPLETED|Phase I: Period 2||1||
48086724|NCT00642941|100533195|FG001|NOT COMPLETED|Overall Study||54||
48683699|NCT01791517|102009586|FG001|NOT COMPLETED|Phase I: Period 2||3||
48086725|NCT00642941|100533196|FG002|NOT COMPLETED|Overall Study||7||
48086726|NCT00642941|100533197|FG003|NOT COMPLETED|Overall Study||40||
48086727|NCT00642941|100533198|FG004|NOT COMPLETED|Overall Study||25||
48086728|NCT00642941|100533199|FG005|NOT COMPLETED|Overall Study||41||
48086729|NCT00642941|100533200|FG006|NOT COMPLETED|Overall Study||23||
48086730|NCT00642941|100533201|FG007|NOT COMPLETED|Overall Study||14||
48086731|NCT00642941|100533202|FG008|NOT COMPLETED|Overall Study||11||
48086732|NCT00642941|100533203|FG009|NOT COMPLETED|Overall Study||9||
48086733|NCT00642941|100533204|FG010|NOT COMPLETED|Overall Study||12||
48376004|NCT02918266|101247730|FG006|STARTED|Part 2: Washout Period 2 (3 Weeks)||0||
48086734|NCT00642941|100533205|FG011|NOT COMPLETED|Overall Study||11||
48086735|NCT01442675|100533206|FG000|STARTED|Overall Study||834||
48086736|NCT01442675|100533206|FG000|Safety Analysis Set|Overall Study||831||
48086737|NCT01442675|100533206|FG000|Per-Protocol Analysis Set|Overall Study||781||
48086738|NCT01442675|100533206|FG000|COMPLETED|Overall Study||822||
48376005|NCT02918266|101247731|FG007|STARTED|Part 2: Washout Period 2 (3 Weeks)||0||
48376006|NCT02918266|101247732|FG008|STARTED|Part 2: Washout Period 2 (3 Weeks)||0||
48376007|NCT02918266|101247733|FG009|STARTED|Part 2: Washout Period 2 (3 Weeks)||0||
48376008|NCT02918266|101247734|FG010|STARTED|Part 2: Washout Period 2 (3 Weeks)||0||
48376009|NCT02918266|101247724|FG000|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
48376010|NCT02918266|101247725|FG001|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
48376011|NCT02918266|101247726|FG002|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
48376012|NCT02918266|101247727|FG003|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
48376013|NCT02918266|101247728|FG004|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
48376014|NCT02918266|101247729|FG005|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
48086739|NCT01442675|100533206|FG000|NOT COMPLETED|Overall Study||12||
48086740|NCT00071513|100533207|FG000|STARTED|Intervention Component||241||
48086741|NCT00071513|100533208|FG001|STARTED|Intervention Component||256||
48086742|NCT00071513|100533207|FG000|COMPLETED|Intervention Component||239||
48086743|NCT00071513|100533208|FG001|COMPLETED|Intervention Component||253||
48086744|NCT00071513|100533207|FG000|NOT COMPLETED|Intervention Component||2||
48086745|NCT00071513|100533208|FG001|NOT COMPLETED|Intervention Component||3||
48086746|NCT00071513|100533207|FG000|STARTED|Follow-up Assessment||239||
48086747|NCT00071513|100533208|FG001|STARTED|Follow-up Assessment||253||
48086748|NCT00071513|100533207|FG000|COMPLETED|Follow-up Assessment||233||
48086749|NCT00071513|100533208|FG001|COMPLETED|Follow-up Assessment||247||
48086750|NCT00071513|100533207|FG000|NOT COMPLETED|Follow-up Assessment||6||
48086751|NCT00071513|100533208|FG001|NOT COMPLETED|Follow-up Assessment||6||
48086752|NCT01543698|100533209|FG000|STARTED|Phase 1b||6||
48086753|NCT01543698|100533210|FG001|STARTED|Phase 1b||5||
48086754|NCT01543698|100533211|FG002|STARTED|Phase 1b||4||
48086755|NCT01543698|100533212|FG003|STARTED|Phase 1b||5||
48086756|NCT01543698|100533213|FG004|STARTED|Phase 1b||13||
48086757|NCT01543698|100533214|FG005|STARTED|Phase 1b||8||
48086758|NCT01543698|100533215|FG006|STARTED|Phase 1b||6||
48086759|NCT01543698|100533216|FG007|STARTED|Phase 1b||4||
48086760|NCT01543698|100533217|FG008|STARTED|Phase 1b||5||
48086761|NCT01543698|100533218|FG009|STARTED|Phase 1b||6||
48086762|NCT01543698|100533219|FG010|STARTED|Phase 1b||6||
48086763|NCT01543698|100533220|FG011|STARTED|Phase 1b||0||
48086764|NCT01543698|100533221|FG012|STARTED|Phase 1b||0||
48086765|NCT01543698|100533222|FG013|STARTED|Phase 1b||0||
48086766|NCT01543698|100533223|FG014|STARTED|Phase 1b||0||
48086767|NCT01543698|100533209|FG000|COMPLETED|Phase 1b||0||
48086768|NCT01543698|100533210|FG001|COMPLETED|Phase 1b||0||
48086769|NCT01543698|100533211|FG002|COMPLETED|Phase 1b||0||
48086770|NCT01543698|100533212|FG003|COMPLETED|Phase 1b||0||
48086771|NCT01543698|100533213|FG004|COMPLETED|Phase 1b||0||
48086772|NCT01543698|100533214|FG005|COMPLETED|Phase 1b||0||
48086773|NCT01543698|100533215|FG006|COMPLETED|Phase 1b||0||
48086774|NCT01543698|100533216|FG007|COMPLETED|Phase 1b||0||
48086775|NCT01543698|100533217|FG008|COMPLETED|Phase 1b||0||
48086776|NCT01543698|100533218|FG009|COMPLETED|Phase 1b||0||
48086777|NCT01543698|100533219|FG010|COMPLETED|Phase 1b||0||
48086778|NCT01543698|100533220|FG011|COMPLETED|Phase 1b||0||
48086779|NCT01543698|100533221|FG012|COMPLETED|Phase 1b||0||
48086780|NCT01543698|100533222|FG013|COMPLETED|Phase 1b||0||
48086781|NCT01543698|100533223|FG014|COMPLETED|Phase 1b||0||
48086782|NCT01543698|100533209|FG000|NOT COMPLETED|Phase 1b||6||
48086783|NCT01543698|100533210|FG001|NOT COMPLETED|Phase 1b||5||
48086784|NCT01543698|100533211|FG002|NOT COMPLETED|Phase 1b||4||
48086785|NCT01543698|100533212|FG003|NOT COMPLETED|Phase 1b||5||
48086786|NCT01543698|100533213|FG004|NOT COMPLETED|Phase 1b||13||
48086787|NCT01543698|100533214|FG005|NOT COMPLETED|Phase 1b||8||
48086788|NCT01543698|100533215|FG006|NOT COMPLETED|Phase 1b||6||
48086789|NCT01543698|100533216|FG007|NOT COMPLETED|Phase 1b||4||
48086790|NCT01543698|100533217|FG008|NOT COMPLETED|Phase 1b||5||
48086791|NCT01543698|100533218|FG009|NOT COMPLETED|Phase 1b||6||
48086792|NCT01543698|100533219|FG010|NOT COMPLETED|Phase 1b||6||
48086793|NCT01543698|100533220|FG011|NOT COMPLETED|Phase 1b||0||
48086794|NCT01543698|100533221|FG012|NOT COMPLETED|Phase 1b||0||
48376015|NCT02918266|101247730|FG006|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
48376016|NCT02918266|101247731|FG007|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
48086795|NCT01543698|100533222|FG013|NOT COMPLETED|Phase 1b||0||
48086796|NCT01543698|100533223|FG014|NOT COMPLETED|Phase 1b||0||
48086797|NCT01543698|100533209|FG000|STARTED|Phase 2||0||
48086798|NCT01543698|100533210|FG001|STARTED|Phase 2||0||
48086799|NCT01543698|100533211|FG002|STARTED|Phase 2||0||
48086800|NCT01543698|100533212|FG003|STARTED|Phase 2||0||
48086801|NCT01543698|100533213|FG004|STARTED|Phase 2||0||
48086802|NCT01543698|100533214|FG005|STARTED|Phase 2||0||
48086803|NCT01543698|100533215|FG006|STARTED|Phase 2||0||
48086804|NCT01543698|100533216|FG007|STARTED|Phase 2||0||
48086805|NCT01543698|100533217|FG008|STARTED|Phase 2||0||
48086806|NCT01543698|100533218|FG009|STARTED|Phase 2||0||
48086807|NCT01543698|100533219|FG010|STARTED|Phase 2||0||
48086808|NCT01543698|100533220|FG011|STARTED|Phase 2||11||
48086809|NCT01543698|100533221|FG012|STARTED|Phase 2||26||
48086810|NCT01543698|100533222|FG013|STARTED|Phase 2||42||
48086811|NCT01543698|100533223|FG014|STARTED|Phase 2||42||
48086812|NCT01543698|100533209|FG000|COMPLETED|Phase 2||0||
48250024|NCT02132598|100930993|FG000|COMPLETED|Overall Study||5||
48250025|NCT02132598|100930993|FG000|NOT COMPLETED|Overall Study||0||
48250026|NCT03180008|100930994|FG000|STARTED|Overall Study||210||
48250027|NCT03180008|100930995|FG001|STARTED|Overall Study||203||
48250028|NCT03180008|100930994|FG000|2-Month Follow-up|Overall Study||192||
48250029|NCT03180008|100930995|FG001|2-Month Follow-up|Overall Study||191||
48250030|NCT03180008|100930994|FG000|6-Month Follow-up|Overall Study||173||
48250031|NCT03180008|100930995|FG001|6-Month Follow-up|Overall Study||175||
48250032|NCT03180008|100930994|FG000|12-Month Follow-up|Overall Study||169||
48250033|NCT03180008|100930995|FG001|12-Month Follow-up|Overall Study||156||
48250034|NCT03180008|100930994|FG000|COMPLETED|Overall Study||182|18-Month Follow-up|
48250035|NCT03180008|100930995|FG001|COMPLETED|Overall Study||174|18-Month Follow-up|
48250036|NCT03180008|100930994|FG000|NOT COMPLETED|Overall Study||28||
48250037|NCT03180008|100930995|FG001|NOT COMPLETED|Overall Study||29||
48250038|NCT03690284|100930996|FG000|STARTED|Overall Study||25||
48250039|NCT03690284|100930997|FG001|STARTED|Overall Study||25||
48376017|NCT02918266|101247732|FG008|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
48376018|NCT02918266|101247733|FG009|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
48376019|NCT02918266|101247734|FG010|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
48086813|NCT01543698|100533210|FG001|COMPLETED|Phase 2||0||
48086814|NCT01543698|100533211|FG002|COMPLETED|Phase 2||0||
48086815|NCT01543698|100533212|FG003|COMPLETED|Phase 2||0||
48376020|NCT02918266|101247724|FG000|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
48376021|NCT02918266|101247725|FG001|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
48376022|NCT02918266|101247726|FG002|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
48376023|NCT02918266|101247727|FG003|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
48376024|NCT02918266|101247728|FG004|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
48376025|NCT02918266|101247729|FG005|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
48376026|NCT02918266|101247730|FG006|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
48376027|NCT02918266|101247731|FG007|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
48376028|NCT02918266|101247732|FG008|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
48376029|NCT02918266|101247733|FG009|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
48376030|NCT02918266|101247734|FG010|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
48376031|NCT02918266|101247724|FG000|STARTED|Part 2: Intervention Period 3 (2 Days)||0||
48376032|NCT02918266|101247725|FG001|STARTED|Part 2: Intervention Period 3 (2 Days)||0||
48086816|NCT01543698|100533213|FG004|COMPLETED|Phase 2||0||
48250040|NCT03690284|100930996|FG000|COMPLETED|Overall Study||25||
48250041|NCT03690284|100930997|FG001|COMPLETED|Overall Study||25||
48376033|NCT02918266|101247726|FG002|STARTED|Part 2: Intervention Period 3 (2 Days)||0||
48376034|NCT02918266|101247727|FG003|STARTED|Part 2: Intervention Period 3 (2 Days)||0||
48376035|NCT02918266|101247728|FG004|STARTED|Part 2: Intervention Period 3 (2 Days)||0||
48376036|NCT02918266|101247729|FG005|STARTED|Part 2: Intervention Period 3 (2 Days)||0||
48376037|NCT02918266|101247730|FG006|STARTED|Part 2: Intervention Period 3 (2 Days)||0||
48376038|NCT02918266|101247731|FG007|STARTED|Part 2: Intervention Period 3 (2 Days)||0||
48376039|NCT02918266|101247732|FG008|STARTED|Part 2: Intervention Period 3 (2 Days)||0||
48376040|NCT02918266|101247733|FG009|STARTED|Part 2: Intervention Period 3 (2 Days)||0||
48376041|NCT02918266|101247734|FG010|STARTED|Part 2: Intervention Period 3 (2 Days)||0||
48376042|NCT02918266|101247724|FG000|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
48376043|NCT02918266|101247725|FG001|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
48376044|NCT02918266|101247726|FG002|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
48376045|NCT02918266|101247727|FG003|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
48376046|NCT02918266|101247728|FG004|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
48376047|NCT02918266|101247729|FG005|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
48376048|NCT02918266|101247730|FG006|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
48376049|NCT02918266|101247731|FG007|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
48376050|NCT02918266|101247732|FG008|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
48376051|NCT02918266|101247733|FG009|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
48376052|NCT02918266|101247734|FG010|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
48376053|NCT02918266|101247724|FG000|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
48376054|NCT02918266|101247725|FG001|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
48376055|NCT02918266|101247726|FG002|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
48376056|NCT02918266|101247727|FG003|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
48376057|NCT02918266|101247728|FG004|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
48376058|NCT02918266|101247729|FG005|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
48376059|NCT02918266|101247730|FG006|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
48376060|NCT02918266|101247731|FG007|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
48376061|NCT02918266|101247732|FG008|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
48541016|NCT01352416|101662622|FG000|NOT COMPLETED|Overall Study||1||
48086817|NCT01543698|100533214|FG005|COMPLETED|Phase 2||0||
48086818|NCT01543698|100533215|FG006|COMPLETED|Phase 2||0||
48086819|NCT01543698|100533216|FG007|COMPLETED|Phase 2||0||
48250042|NCT03690284|100930996|FG000|NOT COMPLETED|Overall Study||0||
48250043|NCT03690284|100930997|FG001|NOT COMPLETED|Overall Study||0||
48250044|NCT01961921|100930998|FG000|STARTED|Overall Study||27||
48250045|NCT01961921|100930998|FG000|COMPLETED|Overall Study||25||
48683700|NCT01791517|102009587|FG002|NOT COMPLETED|Phase I: Period 2||2||
48376062|NCT02918266|101247733|FG009|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
48376063|NCT02918266|101247734|FG010|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
48376064|NCT02918266|101247724|FG000|STARTED|Part 2: Washout Period 3 (3 Weeks)||0||
48376065|NCT02918266|101247725|FG001|STARTED|Part 2: Washout Period 3 (3 Weeks)||0||
48376066|NCT02918266|101247726|FG002|STARTED|Part 2: Washout Period 3 (3 Weeks)||0||
48376067|NCT02918266|101247727|FG003|STARTED|Part 2: Washout Period 3 (3 Weeks)||0||
48376068|NCT02918266|101247728|FG004|STARTED|Part 2: Washout Period 3 (3 Weeks)||0||
48376069|NCT02918266|101247729|FG005|STARTED|Part 2: Washout Period 3 (3 Weeks)||0||
48541017|NCT01352416|101662623|FG001|NOT COMPLETED|Overall Study||2||
48683701|NCT01791517|102009588|FG003|NOT COMPLETED|Phase I: Period 2||1||
48086820|NCT01543698|100533217|FG008|COMPLETED|Phase 2||0||
48250046|NCT01961921|100930998|FG000|NOT COMPLETED|Overall Study||2||
48250047|NCT00396097|100930999|FG000|STARTED|Overall Study||114||
48250048|NCT00396097|100931000|FG001|STARTED|Overall Study||202||
48250049|NCT00396097|100930999|FG000|COMPLETED|Overall Study||88||
48250050|NCT00396097|100931000|FG001|COMPLETED|Overall Study||156||
48250051|NCT00396097|100930999|FG000|NOT COMPLETED|Overall Study||26||
48250052|NCT00396097|100931000|FG001|NOT COMPLETED|Overall Study||46||
48250053|NCT00651937|100931001|FG000|STARTED|Overall Study||39||
48250054|NCT00651937|100931002|FG001|STARTED|Overall Study||41||
48250055|NCT00651937|100931001|FG000|COMPLETED|Overall Study||35||
48250056|NCT00651937|100931002|FG001|COMPLETED|Overall Study||40||
48250057|NCT00651937|100931001|FG000|NOT COMPLETED|Overall Study||4||
48250058|NCT00651937|100931002|FG001|NOT COMPLETED|Overall Study||1||
48250059|NCT02621047|100931003|FG000|STARTED|Overall Study||8||
48250060|NCT02621047|100931004|FG001|STARTED|Overall Study||8||
48250061|NCT02621047|100931005|FG002|STARTED|Overall Study||12||
48250062|NCT02621047|100931003|FG000|COMPLETED|Overall Study||8||
48250063|NCT02621047|100931004|FG001|COMPLETED|Overall Study||8||
48250064|NCT02621047|100931005|FG002|COMPLETED|Overall Study||11||
48250065|NCT02621047|100931003|FG000|NOT COMPLETED|Overall Study||0||
48250066|NCT02621047|100931004|FG001|NOT COMPLETED|Overall Study||0||
48250067|NCT02621047|100931005|FG002|NOT COMPLETED|Overall Study||1||
48250068|NCT00372255|100931006|FG000|STARTED|Overall Study||110||
48250069|NCT00372255|100931007|FG001|STARTED|Overall Study||114||
48250070|NCT00372255|100931006|FG000|COMPLETED|Overall Study||108||
48250071|NCT00372255|100931007|FG001|COMPLETED|Overall Study||113||
48250072|NCT00372255|100931006|FG000|NOT COMPLETED|Overall Study||2||
48250073|NCT00372255|100931007|FG001|NOT COMPLETED|Overall Study||1||
48250074|NCT02435381|100931008|FG000|STARTED|Overall Study||5||
48250075|NCT02435381|100931009|FG001|STARTED|Overall Study||6||
48250076|NCT02435381|100931008|FG000|COMPLETED|Overall Study||3||
48250077|NCT02435381|100931009|FG001|COMPLETED|Overall Study||5||
48250078|NCT02435381|100931008|FG000|NOT COMPLETED|Overall Study||2||
48250079|NCT02435381|100931009|FG001|NOT COMPLETED|Overall Study||1||
48250080|NCT03790878|100931010|FG000|STARTED|Overall Study||26||
48250081|NCT03790878|100931011|FG001|STARTED|Overall Study||27||
48250082|NCT03790878|100931012|FG002|STARTED|Overall Study||27||
48250083|NCT03790878|100931010|FG000|COMPLETED|Overall Study||26||
48250084|NCT03790878|100931011|FG001|COMPLETED|Overall Study||27||
48250085|NCT03790878|100931012|FG002|COMPLETED|Overall Study||27||
48250086|NCT03790878|100931010|FG000|NOT COMPLETED|Overall Study||0||
48250087|NCT03790878|100931011|FG001|NOT COMPLETED|Overall Study||0||
48250088|NCT03790878|100931012|FG002|NOT COMPLETED|Overall Study||0||
48250089|NCT00514813|100931013|FG000|STARTED|Overall Study||15||
48250090|NCT00514813|100931014|FG001|STARTED|Overall Study||86||
48250091|NCT00514813|100931015|FG002|STARTED|Overall Study||47||
48250092|NCT00514813|100931016|FG003|STARTED|Overall Study||4||
48683702|NCT01791517|102009589|FG004|NOT COMPLETED|Phase I: Period 2||0||
48683703|NCT01791517|102009590|FG005|NOT COMPLETED|Phase I: Period 2||1||
48086821|NCT01543698|100533218|FG009|COMPLETED|Phase 2||0||
48086822|NCT01543698|100533219|FG010|COMPLETED|Phase 2||0||
48086823|NCT01543698|100533220|FG011|COMPLETED|Phase 2||0||
48086824|NCT01543698|100533221|FG012|COMPLETED|Phase 2||0||
48086825|NCT01543698|100533222|FG013|COMPLETED|Phase 2||0||
48250093|NCT00514813|100931013|FG000|COMPLETED|Overall Study||0||
48086826|NCT01543698|100533223|FG014|COMPLETED|Phase 2||0||
48086827|NCT01543698|100533209|FG000|NOT COMPLETED|Phase 2||0||
48086828|NCT01543698|100533210|FG001|NOT COMPLETED|Phase 2||0||
48086829|NCT01543698|100533211|FG002|NOT COMPLETED|Phase 2||0||
48086830|NCT01543698|100533212|FG003|NOT COMPLETED|Phase 2||0||
48086831|NCT01543698|100533213|FG004|NOT COMPLETED|Phase 2||0||
48086832|NCT01543698|100533214|FG005|NOT COMPLETED|Phase 2||0||
48250094|NCT00514813|100931014|FG001|COMPLETED|Overall Study||0||
48250095|NCT00514813|100931015|FG002|COMPLETED|Overall Study||0||
48250096|NCT00514813|100931016|FG003|COMPLETED|Overall Study||0||
48250097|NCT00514813|100931013|FG000|NOT COMPLETED|Overall Study||15||
48250098|NCT00514813|100931014|FG001|NOT COMPLETED|Overall Study||86||
48250099|NCT00514813|100931015|FG002|NOT COMPLETED|Overall Study||47||
48086833|NCT01543698|100533215|FG006|NOT COMPLETED|Phase 2||0||
48250100|NCT00514813|100931016|FG003|NOT COMPLETED|Overall Study||4||
48250101|NCT02254681|100931017|FG000|STARTED|Overall Study||6||
48250102|NCT02254681|100931017|FG000|COMPLETED|Overall Study||0||
48086834|NCT01543698|100533216|FG007|NOT COMPLETED|Phase 2||0||
48086835|NCT01543698|100533217|FG008|NOT COMPLETED|Phase 2||0||
48086836|NCT01543698|100533218|FG009|NOT COMPLETED|Phase 2||0||
48086837|NCT01543698|100533219|FG010|NOT COMPLETED|Phase 2||0||
48086838|NCT01543698|100533220|FG011|NOT COMPLETED|Phase 2||11||
48086839|NCT01543698|100533221|FG012|NOT COMPLETED|Phase 2||26||
48086840|NCT01543698|100533222|FG013|NOT COMPLETED|Phase 2||42||
48086841|NCT01543698|100533223|FG014|NOT COMPLETED|Phase 2||42||
48086842|NCT00603889|100533224|FG000|STARTED|Overall Study||12||
48086843|NCT00603889|100533224|FG000|COMPLETED|Overall Study||12||
48086844|NCT00603889|100533224|FG000|NOT COMPLETED|Overall Study||0||
48086845|NCT01648101|100533225|FG000|STARTED|Titration Phase (4 Weeks)||25||
48086846|NCT01648101|100533226|FG001|STARTED|Titration Phase (4 Weeks)||26||
48086847|NCT01648101|100533227|FG002|STARTED|Titration Phase (4 Weeks)||24||
48086848|NCT01648101|100533225|FG000|COMPLETED|Titration Phase (4 Weeks)||23||
48086849|NCT01648101|100533226|FG001|COMPLETED|Titration Phase (4 Weeks)||23||
48250103|NCT02254681|100931017|FG000|NOT COMPLETED|Overall Study||6||
48541018|NCT01352416|101662624|FG002|NOT COMPLETED|Overall Study||2||
48541019|NCT01352416|101662625|FG003|NOT COMPLETED|Overall Study||1||
48086850|NCT01648101|100533227|FG002|COMPLETED|Titration Phase (4 Weeks)||18||
48086851|NCT01648101|100533225|FG000|NOT COMPLETED|Titration Phase (4 Weeks)||2||
48086852|NCT01648101|100533226|FG001|NOT COMPLETED|Titration Phase (4 Weeks)||3||
48086853|NCT01648101|100533227|FG002|NOT COMPLETED|Titration Phase (4 Weeks)||6||
48086854|NCT01648101|100533225|FG000|STARTED|Maintenance Phase (12 Weeks)||23||
48086855|NCT01648101|100533226|FG001|STARTED|Maintenance Phase (12 Weeks)||23||
48086856|NCT01648101|100533227|FG002|STARTED|Maintenance Phase (12 Weeks)||18||
48086857|NCT01648101|100533225|FG000|COMPLETED|Maintenance Phase (12 Weeks)||20||
48250104|NCT00961298|100931018|FG000|STARTED|Two Week Placebo Run in||15||
48250105|NCT00961298|100931018|FG000|COMPLETED|Two Week Placebo Run in||14||
48250106|NCT00961298|100931018|FG000|NOT COMPLETED|Two Week Placebo Run in||1||
48250107|NCT00961298|100931018|FG000|STARTED|12 Weeks Duloxetine Treatment Phase||14||
48250108|NCT00961298|100931018|FG000|COMPLETED|12 Weeks Duloxetine Treatment Phase||11||
48250109|NCT00961298|100931018|FG000|NOT COMPLETED|12 Weeks Duloxetine Treatment Phase||3||
48250110|NCT01994538|100931019|FG000|STARTED|Overall Study||136|One subject consented but was not randomized due to a miscommunication with the research pharmacy|
48250111|NCT01994538|100931020|FG001|STARTED|Overall Study||136|One subject consented but was not randomized due to a miscommunication with the research pharmacy|
48250112|NCT01994538|100931019|FG000|COMPLETED|Overall Study||136|A second site (Houston VA) was added mid-study, and began enrolling 1/2018|
48250113|NCT01994538|100931020|FG001|COMPLETED|Overall Study||136|A second site (Houston VA) was added mid-study, and began enrolling 1/2018|
48250114|NCT01994538|100931019|FG000|NOT COMPLETED|Overall Study||0||
48250115|NCT01994538|100931020|FG001|NOT COMPLETED|Overall Study||0||
48250116|NCT02212197|100931021|FG000|STARTED|Overall Study||19||
48250117|NCT02212197|100931022|FG001|STARTED|Overall Study||15||
48250118|NCT02212197|100931023|FG002|STARTED|Overall Study||17||
48250119|NCT02212197|100931021|FG000|COMPLETED|Overall Study||18||
48250120|NCT02212197|100931022|FG001|COMPLETED|Overall Study||15||
48250121|NCT02212197|100931023|FG002|COMPLETED|Overall Study||17||
48250122|NCT02212197|100931021|FG000|NOT COMPLETED|Overall Study||1||
48250123|NCT02212197|100931022|FG001|NOT COMPLETED|Overall Study||0||
48250124|NCT02212197|100931023|FG002|NOT COMPLETED|Overall Study||0||
48250125|NCT01713998|100931024|FG000|STARTED|Overall Study||16||
48250126|NCT01713998|100931025|FG001|STARTED|Overall Study||15||
48250127|NCT01713998|100931026|FG002|STARTED|Overall Study||16||
48250128|NCT01713998|100931024|FG000|COMPLETED|Overall Study||13||
48250129|NCT01713998|100931025|FG001|COMPLETED|Overall Study||15||
48250130|NCT01713998|100931026|FG002|COMPLETED|Overall Study||14||
48250131|NCT01713998|100931024|FG000|NOT COMPLETED|Overall Study||3||
48250132|NCT01713998|100931025|FG001|NOT COMPLETED|Overall Study||0||
48250133|NCT01713998|100931026|FG002|NOT COMPLETED|Overall Study||2||
48250134|NCT04289714|100931027|FG000|STARTED|Overall Study||14||
48250135|NCT04289714|100931028|FG001|STARTED|Overall Study||11||
48250136|NCT04289714|100931029|FG002|STARTED|Overall Study||10||
48250137|NCT04289714|100931027|FG000|COMPLETED|Overall Study||8||
48250138|NCT04289714|100931028|FG001|COMPLETED|Overall Study||6||
48250139|NCT04289714|100931029|FG002|COMPLETED|Overall Study||4||
48250140|NCT04289714|100931027|FG000|NOT COMPLETED|Overall Study||6||
48250141|NCT04289714|100931028|FG001|NOT COMPLETED|Overall Study||5||
48250142|NCT04289714|100931029|FG002|NOT COMPLETED|Overall Study||6||
48250143|NCT03435614|100931030|FG000|STARTED|Overall Study||6||
48250144|NCT03435614|100931031|FG001|STARTED|Overall Study||23||
48250145|NCT03435614|100931030|FG000|COMPLETED|Overall Study||6||
48250146|NCT03435614|100931031|FG001|COMPLETED|Overall Study||23||
48250147|NCT03435614|100931030|FG000|NOT COMPLETED|Overall Study||0||
48250148|NCT03435614|100931031|FG001|NOT COMPLETED|Overall Study||0||
48250149|NCT00817336|100931032|FG000|STARTED|Overall Study||8||
48250150|NCT00817336|100931033|FG001|STARTED|Overall Study||8||
48250151|NCT00817336|100931032|FG000|COMPLETED|Overall Study||7||
48250152|NCT00817336|100931033|FG001|COMPLETED|Overall Study||7||
48250153|NCT00817336|100931032|FG000|NOT COMPLETED|Overall Study||1||
48250154|NCT00817336|100931033|FG001|NOT COMPLETED|Overall Study||1||
48250155|NCT03840200|100931034|FG000|STARTED|Overall Study||8||
48541020|NCT04616430|101662626|FG000|STARTED|Overall Study||30||
48683704|NCT01791517|102009591|FG006|NOT COMPLETED|Phase I: Period 2||0||
48683705|NCT01791517|102009592|FG007|NOT COMPLETED|Phase I: Period 2||0||
48683706|NCT01791517|102009593|FG008|NOT COMPLETED|Phase I: Period 2||0||
48683707|NCT01791517|102009594|FG009|NOT COMPLETED|Phase I: Period 2||1||
48683708|NCT01791517|102009595|FG010|NOT COMPLETED|Phase I: Period 2||2||
48683709|NCT01791517|102009596|FG011|NOT COMPLETED|Phase I: Period 2||0||
48683710|NCT01791517|102009585|FG000|STARTED|Phase I: Period 3||17||
48683711|NCT01791517|102009586|FG001|STARTED|Phase I: Period 3||15||
48683712|NCT01791517|102009587|FG002|STARTED|Phase I: Period 3||16||
48683713|NCT01791517|102009588|FG003|STARTED|Phase I: Period 3||16||
48683714|NCT01791517|102009589|FG004|STARTED|Phase I: Period 3||19||
48683715|NCT01791517|102009590|FG005|STARTED|Phase I: Period 3||18||
48683716|NCT01791517|102009591|FG006|STARTED|Phase I: Period 3||19||
48683717|NCT01791517|102009592|FG007|STARTED|Phase I: Period 3||20||
48086858|NCT01648101|100533226|FG001|COMPLETED|Maintenance Phase (12 Weeks)||20||
48086859|NCT01648101|100533227|FG002|COMPLETED|Maintenance Phase (12 Weeks)||12||
48086860|NCT01648101|100533225|FG000|NOT COMPLETED|Maintenance Phase (12 Weeks)||3||
48086861|NCT01648101|100533226|FG001|NOT COMPLETED|Maintenance Phase (12 Weeks)||3||
48086862|NCT01648101|100533227|FG002|NOT COMPLETED|Maintenance Phase (12 Weeks)||6||
48086863|NCT01648101|100533225|FG000|STARTED|Transition Phase (4 Weeks)||17||
48086864|NCT01648101|100533226|FG001|STARTED|Transition Phase (4 Weeks)||18||
48086865|NCT01648101|100533227|FG002|STARTED|Transition Phase (4 Weeks)||9||
48086866|NCT01648101|100533225|FG000|COMPLETED|Transition Phase (4 Weeks)||12||
48086867|NCT01648101|100533226|FG001|COMPLETED|Transition Phase (4 Weeks)||13||
48086868|NCT01648101|100533227|FG002|COMPLETED|Transition Phase (4 Weeks)||5||
48086869|NCT01648101|100533225|FG000|NOT COMPLETED|Transition Phase (4 Weeks)||5||
48086870|NCT01648101|100533226|FG001|NOT COMPLETED|Transition Phase (4 Weeks)||5||
48086871|NCT01648101|100533227|FG002|NOT COMPLETED|Transition Phase (4 Weeks)||4||
48086872|NCT01648101|100533225|FG000|STARTED|Taper/Follow-up Phase (4 Weeks)||1||
48086873|NCT01648101|100533226|FG001|STARTED|Taper/Follow-up Phase (4 Weeks)||2||
48086874|NCT01648101|100533227|FG002|STARTED|Taper/Follow-up Phase (4 Weeks)||3||
48086875|NCT01648101|100533225|FG000|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1||
48086876|NCT01648101|100533226|FG001|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1||
48086877|NCT01648101|100533227|FG002|COMPLETED|Taper/Follow-up Phase (4 Weeks)||3||
48086878|NCT01648101|100533225|FG000|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0||
48250156|NCT03840200|100931035|FG001|STARTED|Overall Study||6||
48086879|NCT01648101|100533226|FG001|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||1||
48086880|NCT01648101|100533227|FG002|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0||
48086881|NCT01660698|100533228|FG000|STARTED|Overall Study||10||
48086882|NCT01660698|100533229|FG001|STARTED|Overall Study||10||
48086883|NCT01660698|100533228|FG000|COMPLETED|Overall Study||10||
48086884|NCT01660698|100533229|FG001|COMPLETED|Overall Study||10||
48086885|NCT01660698|100533228|FG000|NOT COMPLETED|Overall Study||0||
48086886|NCT01660698|100533229|FG001|NOT COMPLETED|Overall Study||0||
48086887|NCT01871532|100533230|FG000|STARTED|Overall Study||12||
48086888|NCT01871532|100533231|FG001|STARTED|Overall Study||12||
48086889|NCT01871532|100533230|FG000|Subjects Received hCG Treatment|Overall Study||11||
48250157|NCT03840200|100931036|FG002|STARTED|Overall Study||7||
48250158|NCT03840200|100931037|FG003|STARTED|Overall Study||30||
48086890|NCT01871532|100533231|FG001|Subjects Received hCG Treatment|Overall Study||9||
48086891|NCT01871532|100533230|FG000|COMPLETED|Overall Study||11||
48086892|NCT01871532|100533231|FG001|COMPLETED|Overall Study||10||
48086893|NCT01871532|100533230|FG000|NOT COMPLETED|Overall Study||1||
48086894|NCT01871532|100533231|FG001|NOT COMPLETED|Overall Study||2||
48086895|NCT01899300|100533232|FG000|STARTED|Overall Study||1|Patients 1-10, stent indwell for 8 weeks +/- 7 days.|
48250159|NCT03840200|100931034|FG000|COMPLETED|Overall Study||0||
48250160|NCT03840200|100931035|FG001|COMPLETED|Overall Study||0||
48250161|NCT03840200|100931036|FG002|COMPLETED|Overall Study||0||
48250162|NCT03840200|100931037|FG003|COMPLETED|Overall Study||0||
48250163|NCT03840200|100931034|FG000|NOT COMPLETED|Overall Study||8||
48250164|NCT03840200|100931035|FG001|NOT COMPLETED|Overall Study||6||
48250165|NCT03840200|100931036|FG002|NOT COMPLETED|Overall Study||7||
48250166|NCT03840200|100931037|FG003|NOT COMPLETED|Overall Study||30||
48250167|NCT02656745|100931038|FG000|STARTED|Overall Study||416||
48250168|NCT02656745|100931038|FG000|COMPLETED|Overall Study||416||
48250169|NCT02656745|100931038|FG000|NOT COMPLETED|Overall Study||0||
48250170|NCT03617458|100931039|FG000|STARTED|Overall Study||18||
48250171|NCT03617458|100931040|FG001|STARTED|Overall Study||17||
48250172|NCT03617458|100931041|FG002|STARTED|Overall Study||19||
48250173|NCT03617458|100931042|FG003|STARTED|Overall Study||19||
48250174|NCT03617458|100931039|FG000|COMPLETED|Overall Study||15||
48250175|NCT03617458|100931040|FG001|COMPLETED|Overall Study||14||
48250176|NCT03617458|100931041|FG002|COMPLETED|Overall Study||18||
48250177|NCT03617458|100931042|FG003|COMPLETED|Overall Study||19||
48250178|NCT03617458|100931039|FG000|NOT COMPLETED|Overall Study||3||
48250179|NCT03617458|100931040|FG001|NOT COMPLETED|Overall Study||3||
48250180|NCT03617458|100931041|FG002|NOT COMPLETED|Overall Study||1||
48250181|NCT03617458|100931042|FG003|NOT COMPLETED|Overall Study||0||
48250182|NCT01990664|100931043|FG000|STARTED|Overall Study||102||
48250183|NCT01990664|100931044|FG001|STARTED|Overall Study||90||
48250184|NCT01990664|100931043|FG000|COMPLETED|Overall Study||95||
48086896|NCT01899300|100533233|FG001|STARTED|Overall Study||0|Patients 1-10, stent indwell for 8 weeks +/- 7 days.|
48086897|NCT01899300|100533232|FG000|COMPLETED|Overall Study||1||
48086898|NCT01899300|100533233|FG001|COMPLETED|Overall Study||0||
48086899|NCT01899300|100533232|FG000|NOT COMPLETED|Overall Study||0||
48086900|NCT01899300|100533233|FG001|NOT COMPLETED|Overall Study||0||
48086901|NCT05286281|100533234|FG000|STARTED|Overall Study||6||
48086902|NCT05286281|100533234|FG000|COMPLETED|Overall Study||6||
48086903|NCT05286281|100533234|FG000|NOT COMPLETED|Overall Study||0||
48086904|NCT03809117|100533235|FG000|STARTED|Overall Study||38||
48086905|NCT03809117|100533236|FG001|STARTED|Overall Study||36||
48086906|NCT03809117|100533235|FG000|COMPLETED|Overall Study||38||
48086907|NCT03809117|100533236|FG001|COMPLETED|Overall Study||36||
48086908|NCT03809117|100533235|FG000|NOT COMPLETED|Overall Study||0||
48086909|NCT03809117|100533236|FG001|NOT COMPLETED|Overall Study||0||
48086910|NCT03998189|100533237|FG000|STARTED|Overall Study||0||
48086911|NCT03998189|100533238|FG001|STARTED|Overall Study||1||
48086912|NCT03998189|100533237|FG000|COMPLETED|Overall Study||0||
48086913|NCT03998189|100533238|FG001|COMPLETED|Overall Study||0||
48086914|NCT03998189|100533237|FG000|NOT COMPLETED|Overall Study||0||
48086915|NCT03998189|100533238|FG001|NOT COMPLETED|Overall Study||1||
48086916|NCT02051608|100533239|FG000|STARTED|Part 1: Double Blind Treatment||195||
48086917|NCT02051608|100533240|FG001|STARTED|Part 1: Double Blind Treatment||192||
48086918|NCT02051608|100533241|FG002|STARTED|Part 1: Double Blind Treatment||0||
48086919|NCT02051608|100533242|FG003|STARTED|Part 1: Double Blind Treatment||0||
48086920|NCT02051608|100533239|FG000|COMPLETED|Part 1: Double Blind Treatment||134||
48086921|NCT02051608|100533240|FG001|COMPLETED|Part 1: Double Blind Treatment||136||
48086922|NCT02051608|100533241|FG002|COMPLETED|Part 1: Double Blind Treatment||0||
48086923|NCT02051608|100533242|FG003|COMPLETED|Part 1: Double Blind Treatment||0||
48250185|NCT01990664|100931044|FG001|COMPLETED|Overall Study||79||
48250186|NCT01990664|100931043|FG000|NOT COMPLETED|Overall Study||7||
48250187|NCT01990664|100931044|FG001|NOT COMPLETED|Overall Study||11||
48250188|NCT02207322|100931045|FG000|STARTED|Overall Study||79||
48250189|NCT02207322|100931046|FG001|STARTED|Overall Study||81||
48250190|NCT02207322|100931045|FG000|Week-2|Overall Study||77||
48250191|NCT02207322|100931046|FG001|Week-2|Overall Study||80||
48250192|NCT02207322|100931045|FG000|3-month|Overall Study||74||
48250193|NCT02207322|100931046|FG001|3-month|Overall Study||75||
48250194|NCT02207322|100931045|FG000|COMPLETED|Overall Study||70|6-month|
48250195|NCT02207322|100931046|FG001|COMPLETED|Overall Study||71|6-month|
48250196|NCT02207322|100931045|FG000|NOT COMPLETED|Overall Study||9||
48250197|NCT02207322|100931046|FG001|NOT COMPLETED|Overall Study||10||
48250198|NCT02223871|100931047|FG000|STARTED|Overall Study||8||
48250199|NCT02223871|100931047|FG000|COMPLETED|Overall Study||8||
48250200|NCT02223871|100931047|FG000|NOT COMPLETED|Overall Study||0||
48250201|NCT02747121|100931048|FG000|STARTED|Overall Study||3594||
48250202|NCT02747121|100931049|FG001|STARTED|Overall Study||3813||
48250203|NCT02747121|100931048|FG000|COMPLETED|Overall Study||3594||
48250204|NCT02747121|100931049|FG001|COMPLETED|Overall Study||3813||
48250205|NCT02747121|100931048|FG000|NOT COMPLETED|Overall Study||0||
48250206|NCT02747121|100931049|FG001|NOT COMPLETED|Overall Study||0||
48250207|NCT02083679|100931050|FG000|STARTED|Overall Study||3||
48250208|NCT02083679|100931051|FG001|STARTED|Overall Study||6||
48250209|NCT02083679|100931052|FG002|STARTED|Overall Study||3||
48250210|NCT02083679|100931053|FG003|STARTED|Overall Study||3||
48086924|NCT02051608|100533239|FG000|NOT COMPLETED|Part 1: Double Blind Treatment||61||
48086925|NCT02051608|100533240|FG001|NOT COMPLETED|Part 1: Double Blind Treatment||56||
48086926|NCT02051608|100533241|FG002|NOT COMPLETED|Part 1: Double Blind Treatment||0||
48086927|NCT02051608|100533242|FG003|NOT COMPLETED|Part 1: Double Blind Treatment||0||
48086928|NCT02051608|100533239|FG000|STARTED|Part 2: Open-label Extension||0||
48086929|NCT02051608|100533240|FG001|STARTED|Part 2: Open-label Extension||0||
48086930|NCT02051608|100533241|FG002|STARTED|Part 2: Open-label Extension||119||
48086931|NCT02051608|100533242|FG003|STARTED|Part 2: Open-label Extension||111||
48086932|NCT02051608|100533239|FG000|COMPLETED|Part 2: Open-label Extension||0||
48086933|NCT02051608|100533240|FG001|COMPLETED|Part 2: Open-label Extension||0||
48086934|NCT02051608|100533241|FG002|COMPLETED|Part 2: Open-label Extension||49||
48086935|NCT02051608|100533242|FG003|COMPLETED|Part 2: Open-label Extension||50||
48086936|NCT02051608|100533239|FG000|NOT COMPLETED|Part 2: Open-label Extension||0||
48086937|NCT02051608|100533240|FG001|NOT COMPLETED|Part 2: Open-label Extension||0||
48086938|NCT02051608|100533241|FG002|NOT COMPLETED|Part 2: Open-label Extension||70||
48086939|NCT02051608|100533242|FG003|NOT COMPLETED|Part 2: Open-label Extension||61||
48086940|NCT01112241|100533243|FG000|STARTED|Overall Study||17||
48086941|NCT01112241|100533243|FG000|COMPLETED|Overall Study||17||
48086942|NCT01112241|100533243|FG000|NOT COMPLETED|Overall Study||0||
48086943|NCT01411774|100533244|FG000|STARTED|Overall Study||72||
48086944|NCT01411774|100533245|FG001|STARTED|Overall Study||70||
48086945|NCT01411774|100533244|FG000|COMPLETED|Overall Study||72||
48250211|NCT02083679|100931050|FG000|COMPLETED|Overall Study||3||
48250212|NCT02083679|100931051|FG001|COMPLETED|Overall Study||6||
48250213|NCT02083679|100931052|FG002|COMPLETED|Overall Study||3||
48086946|NCT01411774|100533245|FG001|COMPLETED|Overall Study||67||
48250214|NCT02083679|100931053|FG003|COMPLETED|Overall Study||3||
48683718|NCT01791517|102009593|FG008|STARTED|Phase I: Period 3||19||
48086947|NCT01411774|100533244|FG000|NOT COMPLETED|Overall Study||0||
48086948|NCT01411774|100533245|FG001|NOT COMPLETED|Overall Study||3||
48086949|NCT01104493|100533246|FG000|STARTED|Overall Study||240||
48086950|NCT01104493|100533247|FG001|STARTED|Overall Study||60||
48086951|NCT01104493|100533246|FG000|COMPLETED|Overall Study||240||
48086952|NCT01104493|100533247|FG001|COMPLETED|Overall Study||58||
48086953|NCT01104493|100533246|FG000|NOT COMPLETED|Overall Study||0||
48086954|NCT01104493|100533247|FG001|NOT COMPLETED|Overall Study||2||
48086955|NCT00830596|100533248|FG000|STARTED|Overall Study||74||
48086956|NCT00830596|100533249|FG001|STARTED|Overall Study||74||
48086957|NCT00830596|100533250|FG002|STARTED|Overall Study||73||
48086958|NCT00830596|100533248|FG000|COMPLETED|Overall Study||72||
48086959|NCT00830596|100533249|FG001|COMPLETED|Overall Study||72||
48086960|NCT00830596|100533250|FG002|COMPLETED|Overall Study||67||
48086961|NCT00830596|100533248|FG000|NOT COMPLETED|Overall Study||2||
48086962|NCT00830596|100533249|FG001|NOT COMPLETED|Overall Study||2||
48086963|NCT00830596|100533250|FG002|NOT COMPLETED|Overall Study||6||
48086964|NCT02113592|100533251|FG000|STARTED|Overall Study||433||53
48086965|NCT02113592|100533252|FG001|STARTED|Overall Study||417||53
48086966|NCT02113592|100533251|FG000|COMPLETED|Overall Study||414||53
48086967|NCT02113592|100533252|FG001|COMPLETED|Overall Study||402||53
48086968|NCT02113592|100533251|FG000|NOT COMPLETED|Overall Study||19||0
48086969|NCT02113592|100533252|FG001|NOT COMPLETED|Overall Study||15||0
48086970|NCT02708121|100533253|FG000|STARTED|Overall Study||35||
48086971|NCT02708121|100533254|FG001|STARTED|Overall Study||31||
48086972|NCT02708121|100533253|FG000|Provided Acceptability Data|Overall Study||20|No. of participants who completed the post mobilization tool acceptability survey.|
48086973|NCT02708121|100533254|FG001|Provided Acceptability Data|Overall Study||0|No. of participants who completed the post mobilization tool acceptability survey.|
48086974|NCT02708121|100533253|FG000|Treatment Program Use Data Available|Overall Study||34|No. of participants in which the treatment program provided initiation data|
48086975|NCT02708121|100533254|FG001|Treatment Program Use Data Available|Overall Study||24|No. of participants in which the treatment program provided initiation data|
48086976|NCT02708121|100533253|FG000|6 Month In-Person Follow Up Data|Overall Study||22|No. of participants who attended the six month assessment follow up|
48086977|NCT02708121|100533254|FG001|6 Month In-Person Follow Up Data|Overall Study||19|No. of participants who attended the six month assessment follow up|
48086978|NCT02708121|100533253|FG000|6 Month Weight Data Via EHR|Overall Study||14|No. of participants in which their weight data at 6 month follow up was available via health record|
48086979|NCT02708121|100533254|FG001|6 Month Weight Data Via EHR|Overall Study||13|No. of participants in which their weight data at 6 month follow up was available via health record|
48086980|NCT02708121|100533253|FG000|COMPLETED|Overall Study||34|No. of participants who received allocated intervention|
48086981|NCT02708121|100533254|FG001|COMPLETED|Overall Study||26|No. of participants who received allocated intervention|
48086982|NCT02708121|100533253|FG000|NOT COMPLETED|Overall Study||1||
48086983|NCT02708121|100533254|FG001|NOT COMPLETED|Overall Study||5||
48086984|NCT00809276|100533255|FG000|STARTED|Overall Study||92||
48086985|NCT00809276|100533255|FG000|COMPLETED|Overall Study||92||
48086986|NCT00809276|100533255|FG000|NOT COMPLETED|Overall Study||0||
48086987|NCT02407704|100533256|FG000|STARTED|Overall Study||2||
48086988|NCT02407704|100533257|FG001|STARTED|Overall Study||3||
48086989|NCT02407704|100533258|FG002|STARTED|Overall Study||5||
48086990|NCT02407704|100533259|FG003|STARTED|Overall Study||5||
48086991|NCT02407704|100533256|FG000|COMPLETED|Overall Study||2||
48086992|NCT02407704|100533257|FG001|COMPLETED|Overall Study||3||
48086993|NCT02407704|100533258|FG002|COMPLETED|Overall Study||4||
48086994|NCT02407704|100533259|FG003|COMPLETED|Overall Study||2||
48086995|NCT02407704|100533256|FG000|NOT COMPLETED|Overall Study||0||
48086996|NCT02407704|100533257|FG001|NOT COMPLETED|Overall Study||0||
48086997|NCT02407704|100533258|FG002|NOT COMPLETED|Overall Study||1||
48086998|NCT02407704|100533259|FG003|NOT COMPLETED|Overall Study||3||
48086999|NCT04868890|100533260|FG000|STARTED|Overall Study||64||
48087000|NCT04868890|100533261|FG001|STARTED|Overall Study||65||
48087001|NCT04868890|100533260|FG000|COMPLETED|Overall Study||61||
48376070|NCT02918266|101247730|FG006|STARTED|Part 2: Washout Period 3 (3 Weeks)||0||
48376071|NCT02918266|101247731|FG007|STARTED|Part 2: Washout Period 3 (3 Weeks)||0||
48376072|NCT02918266|101247732|FG008|STARTED|Part 2: Washout Period 3 (3 Weeks)||0||
48376073|NCT02918266|101247733|FG009|STARTED|Part 2: Washout Period 3 (3 Weeks)||0||
48376074|NCT02918266|101247734|FG010|STARTED|Part 2: Washout Period 3 (3 Weeks)||0||
48376075|NCT02918266|101247724|FG000|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
48376076|NCT02918266|101247725|FG001|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
48376077|NCT02918266|101247726|FG002|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
48376078|NCT02918266|101247727|FG003|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
48376079|NCT02918266|101247728|FG004|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
48376080|NCT02918266|101247729|FG005|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
48376081|NCT02918266|101247730|FG006|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
48376082|NCT02918266|101247731|FG007|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
48541021|NCT04616430|101662627|FG001|STARTED|Overall Study||30||
48087002|NCT04868890|100533261|FG001|COMPLETED|Overall Study||59||
48087003|NCT04868890|100533260|FG000|NOT COMPLETED|Overall Study||3||
48683719|NCT01791517|102009594|FG009|STARTED|Phase I: Period 3||18||
48376083|NCT02918266|101247732|FG008|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
48376084|NCT02918266|101247733|FG009|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
48376085|NCT02918266|101247734|FG010|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
48376086|NCT02918266|101247724|FG000|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
48376087|NCT02918266|101247725|FG001|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
48376088|NCT02918266|101247726|FG002|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
48376089|NCT02918266|101247727|FG003|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
48376090|NCT02918266|101247728|FG004|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
48376091|NCT02918266|101247729|FG005|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
48376092|NCT02918266|101247730|FG006|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
48376093|NCT02918266|101247731|FG007|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
48376094|NCT02918266|101247732|FG008|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
48376095|NCT02918266|101247733|FG009|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
48376096|NCT02918266|101247734|FG010|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
48376097|NCT02918266|101247724|FG000|STARTED|Part 2: Intervention Period 4 (2 Days)||0||
48376098|NCT02918266|101247725|FG001|STARTED|Part 2: Intervention Period 4 (2 Days)||0||
48376099|NCT02918266|101247726|FG002|STARTED|Part 2: Intervention Period 4 (2 Days)||0||
48376100|NCT02918266|101247727|FG003|STARTED|Part 2: Intervention Period 4 (2 Days)||0||
48376101|NCT02918266|101247728|FG004|STARTED|Part 2: Intervention Period 4 (2 Days)||0||
48376102|NCT02918266|101247729|FG005|STARTED|Part 2: Intervention Period 4 (2 Days)||0||
48376103|NCT02918266|101247730|FG006|STARTED|Part 2: Intervention Period 4 (2 Days)||0||
48376104|NCT02918266|101247731|FG007|STARTED|Part 2: Intervention Period 4 (2 Days)||0||
48376105|NCT02918266|101247732|FG008|STARTED|Part 2: Intervention Period 4 (2 Days)||0||
48376106|NCT02918266|101247733|FG009|STARTED|Part 2: Intervention Period 4 (2 Days)||0||
48376107|NCT02918266|101247734|FG010|STARTED|Part 2: Intervention Period 4 (2 Days)||0||
48376108|NCT02918266|101247724|FG000|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
48376109|NCT02918266|101247725|FG001|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
48376110|NCT02918266|101247726|FG002|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
48376111|NCT02918266|101247727|FG003|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
48376112|NCT02918266|101247728|FG004|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
48376113|NCT02918266|101247729|FG005|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
48376114|NCT02918266|101247730|FG006|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
48376115|NCT02918266|101247731|FG007|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
48376116|NCT02918266|101247732|FG008|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
48376117|NCT02918266|101247733|FG009|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
48376118|NCT02918266|101247734|FG010|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
48376119|NCT02918266|101247724|FG000|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
48376120|NCT02918266|101247725|FG001|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
48376121|NCT02918266|101247726|FG002|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
48376122|NCT02918266|101247727|FG003|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
48376123|NCT02918266|101247728|FG004|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
48376124|NCT02918266|101247729|FG005|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
48376125|NCT02918266|101247730|FG006|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
48376126|NCT02918266|101247731|FG007|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
48376127|NCT02918266|101247732|FG008|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
48376128|NCT02918266|101247733|FG009|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
48376129|NCT02918266|101247734|FG010|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
48376130|NCT02918266|101247724|FG000|STARTED|Part 2: Washout Period 4 (3 Weeks)||0||
48376131|NCT02918266|101247725|FG001|STARTED|Part 2: Washout Period 4 (3 Weeks)||0||
48376132|NCT02918266|101247726|FG002|STARTED|Part 2: Washout Period 4 (3 Weeks)||0||
48376133|NCT02918266|101247727|FG003|STARTED|Part 2: Washout Period 4 (3 Weeks)||0||
48087004|NCT04868890|100533261|FG001|NOT COMPLETED|Overall Study||6||
48087005|NCT01401283|100533262|FG000|STARTED|Overall Study||89||
48376134|NCT02918266|101247728|FG004|STARTED|Part 2: Washout Period 4 (3 Weeks)||0||
48376135|NCT02918266|101247729|FG005|STARTED|Part 2: Washout Period 4 (3 Weeks)||0||
48087006|NCT01401283|100533263|FG001|STARTED|Overall Study||91||
48376136|NCT02918266|101247730|FG006|STARTED|Part 2: Washout Period 4 (3 Weeks)||0||
48376137|NCT02918266|101247731|FG007|STARTED|Part 2: Washout Period 4 (3 Weeks)||0||
48376138|NCT02918266|101247732|FG008|STARTED|Part 2: Washout Period 4 (3 Weeks)||0||
48376139|NCT02918266|101247733|FG009|STARTED|Part 2: Washout Period 4 (3 Weeks)||0||
48376140|NCT02918266|101247734|FG010|STARTED|Part 2: Washout Period 4 (3 Weeks)||0||
48376141|NCT02918266|101247724|FG000|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
48376142|NCT02918266|101247725|FG001|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
48376143|NCT02918266|101247726|FG002|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
48376144|NCT02918266|101247727|FG003|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
48376145|NCT02918266|101247728|FG004|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
48376146|NCT02918266|101247729|FG005|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
48376147|NCT02918266|101247730|FG006|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
48376148|NCT02918266|101247731|FG007|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
48376149|NCT02918266|101247732|FG008|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
48376150|NCT02918266|101247733|FG009|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
48376151|NCT02918266|101247734|FG010|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
48376152|NCT02918266|101247724|FG000|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
48376153|NCT02918266|101247725|FG001|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
48376154|NCT02918266|101247726|FG002|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
48376155|NCT02918266|101247727|FG003|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
48376156|NCT02918266|101247728|FG004|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
48376157|NCT02918266|101247729|FG005|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
48376158|NCT02918266|101247730|FG006|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
48376159|NCT02918266|101247731|FG007|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
48376160|NCT02918266|101247732|FG008|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
48376161|NCT02918266|101247733|FG009|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
48376162|NCT02918266|101247734|FG010|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
48376163|NCT02918266|101247724|FG000|STARTED|Part 2: Intervention Period 5 (2 Days)||0||
48376164|NCT02918266|101247725|FG001|STARTED|Part 2: Intervention Period 5 (2 Days)||0||
48376165|NCT02918266|101247726|FG002|STARTED|Part 2: Intervention Period 5 (2 Days)||0||
48376166|NCT02918266|101247727|FG003|STARTED|Part 2: Intervention Period 5 (2 Days)||0||
48376167|NCT02918266|101247728|FG004|STARTED|Part 2: Intervention Period 5 (2 Days)||0||
48376168|NCT02918266|101247729|FG005|STARTED|Part 2: Intervention Period 5 (2 Days)||0||
48376169|NCT02918266|101247730|FG006|STARTED|Part 2: Intervention Period 5 (2 Days)||0||
48376170|NCT02918266|101247731|FG007|STARTED|Part 2: Intervention Period 5 (2 Days)||0||
48376171|NCT02918266|101247732|FG008|STARTED|Part 2: Intervention Period 5 (2 Days)||0||
48376172|NCT02918266|101247733|FG009|STARTED|Part 2: Intervention Period 5 (2 Days)||0||
48376173|NCT02918266|101247734|FG010|STARTED|Part 2: Intervention Period 5 (2 Days)||0||
48087007|NCT01401283|100533262|FG000|COMPLETED|Overall Study||79||
48087008|NCT01401283|100533263|FG001|COMPLETED|Overall Study||81||
48087009|NCT01401283|100533262|FG000|NOT COMPLETED|Overall Study||10||
48376174|NCT02918266|101247724|FG000|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
48376175|NCT02918266|101247725|FG001|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
48376176|NCT02918266|101247726|FG002|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
48376177|NCT02918266|101247727|FG003|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
48376178|NCT02918266|101247728|FG004|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
48376179|NCT02918266|101247729|FG005|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
48376180|NCT02918266|101247730|FG006|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
48376181|NCT02918266|101247731|FG007|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
48376182|NCT02918266|101247732|FG008|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
48683720|NCT01791517|102009595|FG010|STARTED|Phase I: Period 3||16||
48087010|NCT01401283|100533263|FG001|NOT COMPLETED|Overall Study||10||
48087011|NCT01599234|100533264|FG000|STARTED|Overall Study||167||
48376183|NCT02918266|101247733|FG009|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
48376184|NCT02918266|101247734|FG010|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
48376185|NCT02918266|101247724|FG000|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
48376186|NCT02918266|101247725|FG001|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
48376187|NCT02918266|101247726|FG002|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
48376188|NCT02918266|101247727|FG003|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
48376189|NCT02918266|101247728|FG004|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
48376190|NCT02918266|101247729|FG005|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
48376191|NCT02918266|101247730|FG006|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
48376192|NCT02918266|101247731|FG007|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
48376193|NCT02918266|101247732|FG008|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
48376194|NCT02918266|101247733|FG009|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
48376195|NCT02918266|101247734|FG010|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
48376196|NCT00543569|101247735|FG000|STARTED|Overall Study||82||
48683721|NCT01791517|102009596|FG011|STARTED|Phase I: Period 3||19||
48683722|NCT01791517|102009585|FG000|COMPLETED|Phase I: Period 3||17||
48683723|NCT01791517|102009586|FG001|COMPLETED|Phase I: Period 3||14||
48087012|NCT01599234|100533265|FG001|STARTED|Overall Study||170||
48376197|NCT00543569|101247736|FG001|STARTED|Overall Study||80||
48376198|NCT00543569|101247737|FG002|STARTED|Overall Study||80||
48683724|NCT01791517|102009587|FG002|COMPLETED|Phase I: Period 3||16||
48683725|NCT01791517|102009588|FG003|COMPLETED|Phase I: Period 3||15||
48683726|NCT01791517|102009589|FG004|COMPLETED|Phase I: Period 3||18||
48683727|NCT01791517|102009590|FG005|COMPLETED|Phase I: Period 3||18||
48683728|NCT01791517|102009591|FG006|COMPLETED|Phase I: Period 3||19||
48376199|NCT00543569|101247738|FG003|STARTED|Overall Study||81||
48376200|NCT00543569|101247735|FG000|Received Treatment|Overall Study||79||
48376201|NCT00543569|101247736|FG001|Received Treatment|Overall Study||77||
48376202|NCT00543569|101247737|FG002|Received Treatment|Overall Study||75||
48250215|NCT02083679|100931050|FG000|NOT COMPLETED|Overall Study||0||
48250216|NCT02083679|100931051|FG001|NOT COMPLETED|Overall Study||0||
48250217|NCT02083679|100931052|FG002|NOT COMPLETED|Overall Study||0||
48250218|NCT02083679|100931053|FG003|NOT COMPLETED|Overall Study||0||
48250219|NCT00451555|100931054|FG000|STARTED|Overall Study||96||
48250220|NCT00451555|100931055|FG001|STARTED|Overall Study||60||
48250221|NCT00451555|100931054|FG000|Received at Least One Dose of Study Drug|Overall Study||94||
48250222|NCT00451555|100931055|FG001|Received at Least One Dose of Study Drug|Overall Study||58||
48250223|NCT00451555|100931054|FG000|Enzastaurin Twice Daily Dosing (BID)|Overall Study||39||
48250224|NCT00451555|100931055|FG001|Enzastaurin Twice Daily Dosing (BID)|Overall Study||0||
48250225|NCT00451555|100931054|FG000|Enzastaurin Once Daily Dosing (QD)|Overall Study||55||
48250226|NCT00451555|100931055|FG001|Enzastaurin Once Daily Dosing (QD)|Overall Study||0||
48250227|NCT00451555|100931054|FG000|Progressive Disease|Overall Study||75||
48250228|NCT00451555|100931055|FG001|Progressive Disease|Overall Study||54||
48250229|NCT00451555|100931054|FG000|Death|Overall Study||2||
48250230|NCT00451555|100931055|FG001|Death|Overall Study||0||
48250231|NCT00451555|100931054|FG000|COMPLETED|Overall Study||83||
48376203|NCT00543569|101247738|FG003|Received Treatment|Overall Study||78||
48683729|NCT01791517|102009592|FG007|COMPLETED|Phase I: Period 3||20||
48683730|NCT01791517|102009593|FG008|COMPLETED|Phase I: Period 3||19||
48250232|NCT00451555|100931055|FG001|COMPLETED|Overall Study||56||
48250233|NCT00451555|100931054|FG000|NOT COMPLETED|Overall Study||13||
48376204|NCT00543569|101247735|FG000|COMPLETED|Overall Study||70||
48683731|NCT01791517|102009594|FG009|COMPLETED|Phase I: Period 3||18||
48683732|NCT01791517|102009595|FG010|COMPLETED|Phase I: Period 3||16||
48683733|NCT01791517|102009596|FG011|COMPLETED|Phase I: Period 3||18||
48683734|NCT01791517|102009585|FG000|NOT COMPLETED|Phase I: Period 3||0||
48683735|NCT01791517|102009586|FG001|NOT COMPLETED|Phase I: Period 3||1||
48683736|NCT01791517|102009587|FG002|NOT COMPLETED|Phase I: Period 3||0||
48683737|NCT01791517|102009588|FG003|NOT COMPLETED|Phase I: Period 3||1||
48376205|NCT00543569|101247736|FG001|COMPLETED|Overall Study||72||
48376206|NCT00543569|101247737|FG002|COMPLETED|Overall Study||60||
48376207|NCT00543569|101247738|FG003|COMPLETED|Overall Study||72||
48376208|NCT00543569|101247735|FG000|NOT COMPLETED|Overall Study||12||
48376209|NCT00543569|101247736|FG001|NOT COMPLETED|Overall Study||8||
48376210|NCT00543569|101247737|FG002|NOT COMPLETED|Overall Study||20||
48376211|NCT00543569|101247738|FG003|NOT COMPLETED|Overall Study||9||
48376212|NCT03141086|101247739|FG000|STARTED|Overall Study||7||
48376213|NCT03141086|101247740|FG001|STARTED|Overall Study||17||
48376214|NCT03141086|101247739|FG000|COMPLETED|Overall Study||6||
48376215|NCT03141086|101247740|FG001|COMPLETED|Overall Study||12||
48376216|NCT03141086|101247739|FG000|NOT COMPLETED|Overall Study||1||
48376217|NCT03141086|101247740|FG001|NOT COMPLETED|Overall Study||5||
48541022|NCT04616430|101662628|FG002|STARTED|Overall Study||30||
48541023|NCT04616430|101662626|FG000|COMPLETED|Overall Study||23||
48541024|NCT04616430|101662627|FG001|COMPLETED|Overall Study||2||
48541025|NCT04616430|101662628|FG002|COMPLETED|Overall Study||0||
48541026|NCT04616430|101662626|FG000|NOT COMPLETED|Overall Study||7||
48541027|NCT04616430|101662627|FG001|NOT COMPLETED|Overall Study||28||
48541028|NCT04616430|101662628|FG002|NOT COMPLETED|Overall Study||30||
48541029|NCT02522715|101662629|FG000|STARTED|Overall Study||3||
48541030|NCT02522715|101662630|FG001|STARTED|Overall Study||33||
48541031|NCT02522715|101662629|FG000|COMPLETED|Overall Study||3||
48541032|NCT02522715|101662630|FG001|COMPLETED|Overall Study||33||
48541033|NCT02522715|101662629|FG000|NOT COMPLETED|Overall Study||0||
48541034|NCT02522715|101662630|FG001|NOT COMPLETED|Overall Study||0||
48541035|NCT01908907|101662631|FG000|STARTED|Overall Study||31||
48541036|NCT01908907|101662632|FG001|STARTED|Overall Study||29||
48541037|NCT01908907|101662631|FG000|COMPLETED|Overall Study||29||
48541038|NCT01908907|101662632|FG001|COMPLETED|Overall Study||29||
48541039|NCT01908907|101662631|FG000|NOT COMPLETED|Overall Study||2||
48541040|NCT01908907|101662632|FG001|NOT COMPLETED|Overall Study||0||
48541041|NCT00721227|101662633|FG000|STARTED|Overall Study||9||
48541042|NCT00721227|101662634|FG001|STARTED|Overall Study||6||
48541043|NCT00721227|101662633|FG000|COMPLETED|Overall Study||5||
48541044|NCT00721227|101662634|FG001|COMPLETED|Overall Study||6||
48541045|NCT00721227|101662633|FG000|NOT COMPLETED|Overall Study||4||
48541046|NCT00721227|101662634|FG001|NOT COMPLETED|Overall Study||0||
48541047|NCT00843635|101662635|FG000|STARTED|Overall Study||15||
48541048|NCT00843635|101662636|FG001|STARTED|Overall Study||15||
48541049|NCT00843635|101662637|FG002|STARTED|Overall Study||5||
48541050|NCT00843635|101662635|FG000|COMPLETED|Overall Study||13||
48541051|NCT00843635|101662636|FG001|COMPLETED|Overall Study||13||
48541052|NCT00843635|101662637|FG002|COMPLETED|Overall Study||5||
48541053|NCT00843635|101662635|FG000|NOT COMPLETED|Overall Study||2||
48541054|NCT00843635|101662636|FG001|NOT COMPLETED|Overall Study||2||
48541055|NCT00843635|101662637|FG002|NOT COMPLETED|Overall Study||0||
48541056|NCT04106661|101662638|FG000|STARTED|Overall Study||11||
48541057|NCT04106661|101662639|FG001|STARTED|Overall Study||6||
48541058|NCT04106661|101662638|FG000|COMPLETED|Overall Study||7||
48541059|NCT04106661|101662639|FG001|COMPLETED|Overall Study||5||
48541060|NCT04106661|101662638|FG000|NOT COMPLETED|Overall Study||4||
48541061|NCT04106661|101662639|FG001|NOT COMPLETED|Overall Study||1||
48541062|NCT03423186|101662640|FG000|STARTED|Overall Study||3||
48541063|NCT03423186|101662641|FG001|STARTED|Overall Study||3||
48541064|NCT03423186|101662640|FG000|COMPLETED|Overall Study||3||
48541065|NCT03423186|101662641|FG001|COMPLETED|Overall Study||3||
48541066|NCT03423186|101662640|FG000|NOT COMPLETED|Overall Study||0||
48541067|NCT03423186|101662641|FG001|NOT COMPLETED|Overall Study||0||
48541068|NCT01830790|101662642|FG000|STARTED|Overall Study||0||
48541069|NCT01830790|101662643|FG001|STARTED|Overall Study||10||
48541070|NCT01830790|101662642|FG000|COMPLETED|Overall Study||0||
48541071|NCT01830790|101662643|FG001|COMPLETED|Overall Study||10||
48541072|NCT01830790|101662642|FG000|NOT COMPLETED|Overall Study||0||
48541073|NCT01830790|101662643|FG001|NOT COMPLETED|Overall Study||0||
48541074|NCT01130597|101662644|FG000|STARTED|Overall Study||63||
48541075|NCT01130597|101662644|FG000|COMPLETED|Overall Study||56||
48541076|NCT01130597|101662644|FG000|NOT COMPLETED|Overall Study||7||
48541077|NCT03164538|101662645|FG000|STARTED|Overall Study||35||
48541078|NCT03164538|101662646|FG001|STARTED|Overall Study||35||
48541079|NCT03164538|101662645|FG000|COMPLETED|Overall Study||28||
48541080|NCT03164538|101662646|FG001|COMPLETED|Overall Study||29||
48541081|NCT03164538|101662645|FG000|NOT COMPLETED|Overall Study||7||
48541082|NCT03164538|101662646|FG001|NOT COMPLETED|Overall Study||6||
48541083|NCT02159079|101662647|FG000|STARTED|Overall Study||15||
48541084|NCT02159079|101662648|FG001|STARTED|Overall Study||15||
48541085|NCT02159079|101662647|FG000|COMPLETED|Overall Study||15||
48376218|NCT02044159|101247741|FG000|STARTED|Overall Study||27|Fifty-seven patients were randomized (86.4%, 57/66 approached for consent)|
48376219|NCT02044159|101247742|FG001|STARTED|Overall Study||30|Fifty-seven patients were randomized (86.4%, 57/66 approached for consent)|
48376220|NCT02044159|101247741|FG000|COMPLETED|Overall Study||23||
48376221|NCT02044159|101247742|FG001|COMPLETED|Overall Study||26||
48376222|NCT02044159|101247741|FG000|NOT COMPLETED|Overall Study||4||
48376223|NCT02044159|101247742|FG001|NOT COMPLETED|Overall Study||4||
48376224|NCT00771030|101247743|FG000|STARTED|Overall Study||6||
48376225|NCT00771030|101247744|FG001|STARTED|Overall Study||4||
48376226|NCT00771030|101247745|FG002|STARTED|Overall Study||6||
48376227|NCT00771030|101247746|FG003|STARTED|Overall Study||6||
48376228|NCT00771030|101247747|FG004|STARTED|Overall Study||6||
48376229|NCT00771030|101247748|FG005|STARTED|Overall Study||6||
48087013|NCT01599234|100533264|FG000|COMPLETED|Overall Study||150||
48087014|NCT01599234|100533265|FG001|COMPLETED|Overall Study||155||
48087015|NCT01599234|100533264|FG000|NOT COMPLETED|Overall Study||17||
48087016|NCT01599234|100533265|FG001|NOT COMPLETED|Overall Study||15||
48087017|NCT02663674|100533266|FG000|STARTED|Overall Study||33||
48087018|NCT02663674|100533267|FG001|STARTED|Overall Study||39||
48087019|NCT02663674|100533266|FG000|COMPLETED|Overall Study||26||
48087020|NCT02663674|100533267|FG001|COMPLETED|Overall Study||29||
48087021|NCT02663674|100533266|FG000|NOT COMPLETED|Overall Study||7||
48376230|NCT00771030|101247749|FG006|STARTED|Overall Study||6||
48376231|NCT00771030|101247743|FG000|Received Study Drug|Overall Study||6|Study drug refers to placebo or brodalumab|
48376232|NCT00771030|101247744|FG001|Received Study Drug|Overall Study||4|Study drug refers to placebo or brodalumab|
48376233|NCT00771030|101247745|FG002|Received Study Drug|Overall Study||6|Study drug refers to placebo or brodalumab|
48376234|NCT00771030|101247746|FG003|Received Study Drug|Overall Study||6|Study drug refers to placebo or brodalumab|
48376235|NCT00771030|101247747|FG004|Received Study Drug|Overall Study||6|Study drug refers to placebo or brodalumab|
48376236|NCT00771030|101247748|FG005|Received Study Drug|Overall Study||6|Study drug refers to placebo or brodalumab|
48683738|NCT01791517|102009589|FG004|NOT COMPLETED|Phase I: Period 3||1||
48683739|NCT01791517|102009590|FG005|NOT COMPLETED|Phase I: Period 3||0||
48683740|NCT01791517|102009591|FG006|NOT COMPLETED|Phase I: Period 3||0||
48683741|NCT01791517|102009592|FG007|NOT COMPLETED|Phase I: Period 3||0||
48683742|NCT01791517|102009593|FG008|NOT COMPLETED|Phase I: Period 3||0||
48683743|NCT01791517|102009594|FG009|NOT COMPLETED|Phase I: Period 3||0||
48683744|NCT01791517|102009595|FG010|NOT COMPLETED|Phase I: Period 3||0||
48683745|NCT01791517|102009596|FG011|NOT COMPLETED|Phase I: Period 3||1||
48683746|NCT01791517|102009585|FG000|STARTED|Phase I: Period 4||17||
48683747|NCT01791517|102009586|FG001|STARTED|Phase I: Period 4||14||
48683748|NCT01791517|102009587|FG002|STARTED|Phase I: Period 4||16||
48683749|NCT01791517|102009588|FG003|STARTED|Phase I: Period 4||15||
48683750|NCT01791517|102009589|FG004|STARTED|Phase I: Period 4||18||
48683751|NCT01791517|102009590|FG005|STARTED|Phase I: Period 4||18||
48683752|NCT01791517|102009591|FG006|STARTED|Phase I: Period 4||19||
48683753|NCT01791517|102009592|FG007|STARTED|Phase I: Period 4||20||
48683754|NCT01791517|102009593|FG008|STARTED|Phase I: Period 4||19||
48683755|NCT01791517|102009594|FG009|STARTED|Phase I: Period 4||18||
48683756|NCT01791517|102009595|FG010|STARTED|Phase I: Period 4||16||
48683757|NCT01791517|102009596|FG011|STARTED|Phase I: Period 4||18||
48683758|NCT01791517|102009585|FG000|COMPLETED|Phase I: Period 4||17||
48683759|NCT01791517|102009586|FG001|COMPLETED|Phase I: Period 4||14||
48683760|NCT01791517|102009587|FG002|COMPLETED|Phase I: Period 4||16||
48683761|NCT01791517|102009588|FG003|COMPLETED|Phase I: Period 4||15||
48087022|NCT02663674|100533267|FG001|NOT COMPLETED|Overall Study||10||
48683762|NCT01791517|102009589|FG004|COMPLETED|Phase I: Period 4||18||
48683763|NCT01791517|102009590|FG005|COMPLETED|Phase I: Period 4||18||
48683764|NCT01791517|102009591|FG006|COMPLETED|Phase I: Period 4||19||
48683765|NCT01791517|102009592|FG007|COMPLETED|Phase I: Period 4||20||
48087023|NCT03545165|100533268|FG000|STARTED|Overall Study||6||
48087024|NCT03545165|100533268|FG000|COMPLETED|Overall Study||6||
48087025|NCT03545165|100533268|FG000|NOT COMPLETED|Overall Study||0||
48087026|NCT00240162|100533269|FG000|STARTED|Overall Study||21||
48087027|NCT00240162|100533269|FG000|COMPLETED|Overall Study||21||
48087028|NCT00240162|100533269|FG000|NOT COMPLETED|Overall Study||0||
48087029|NCT00580606|100533270|FG000|STARTED|Double Blind (DB)||20||
48087030|NCT00580606|100533271|FG001|STARTED|Double Blind (DB)||20||
48087031|NCT00580606|100533270|FG000|Had Week 44 Oral Food Challenge|Double Blind (DB)||18||
48087032|NCT00580606|100533271|FG001|Had Week 44 Oral Food Challenge|Double Blind (DB)||19||
48683766|NCT01791517|102009593|FG008|COMPLETED|Phase I: Period 4||19||
48087033|NCT00580606|100533270|FG000|COMPLETED|Double Blind (DB)||20||
48087034|NCT00580606|100533271|FG001|COMPLETED|Double Blind (DB)||20||
48087035|NCT00580606|100533270|FG000|NOT COMPLETED|Double Blind (DB)||0||
48087036|NCT00580606|100533271|FG001|NOT COMPLETED|Double Blind (DB)||0||
48087037|NCT00580606|100533270|FG000|STARTED|Open Label (OL)||18||
48087038|NCT00580606|100533271|FG001|STARTED|Open Label (OL)||17||
48087039|NCT00580606|100533270|FG000|Had Week 44 Oral Food Challenge|Open Label (OL)||0||
48087040|NCT00580606|100533271|FG001|Had Week 44 Oral Food Challenge|Open Label (OL)||12||
48087041|NCT00580606|100533270|FG000|Had Week 68 Oral Food Challenge|Open Label (OL)||15||
48087042|NCT00580606|100533271|FG001|Had Week 68 Oral Food Challenge|Open Label (OL)||12||
48087043|NCT00580606|100533270|FG000|Had Week 116 Oral Food Challenge|Open Label (OL)||13||
48087044|NCT00580606|100533271|FG001|Had Week 116 Oral Food Challenge|Open Label (OL)||6||
48087045|NCT00580606|100533270|FG000|Had Week 164 Oral Food Challenge|Open Label (OL)||9||
48087046|NCT00580606|100533271|FG001|Had Week 164 Oral Food Challenge|Open Label (OL)||5||
48087047|NCT00580606|100533270|FG000|Had Week 172 Oral Food Challenge|Open Label (OL)||2||
48087048|NCT00580606|100533271|FG001|Had Week 172 Oral Food Challenge|Open Label (OL)||2||
48376237|NCT00771030|101247749|FG006|Received Study Drug|Overall Study||6|Study drug refers to placebo or brodalumab|
48376238|NCT00771030|101247743|FG000|COMPLETED|Overall Study||6||
48376239|NCT00771030|101247744|FG001|COMPLETED|Overall Study||3||
48376240|NCT00771030|101247745|FG002|COMPLETED|Overall Study||6||
48376241|NCT00771030|101247746|FG003|COMPLETED|Overall Study||6||
48376242|NCT00771030|101247747|FG004|COMPLETED|Overall Study||6||
48087049|NCT00580606|100533270|FG000|COMPLETED|Open Label (OL)||9||
48087050|NCT00580606|100533271|FG001|COMPLETED|Open Label (OL)||5||
48087051|NCT00580606|100533270|FG000|NOT COMPLETED|Open Label (OL)||9||
48087052|NCT00580606|100533271|FG001|NOT COMPLETED|Open Label (OL)||12||
48087053|NCT02585960|100533272|FG000|STARTED|PK/Safety Assessment Period||57||
48087054|NCT02585960|100533273|FG001|STARTED|PK/Safety Assessment Period||58||
48087055|NCT02585960|100533274|FG002|STARTED|PK/Safety Assessment Period||6||
48087056|NCT02585960|100533272|FG000|Completed 1st 6 Month Period|PK/Safety Assessment Period||57||
48087057|NCT02585960|100533273|FG001|Completed 1st 6 Month Period|PK/Safety Assessment Period||53||
48087058|NCT02585960|100533274|FG002|Completed 1st 6 Month Period|PK/Safety Assessment Period||0||
48087059|NCT02585960|100533272|FG000|Completed 2nd 6 Month Period|PK/Safety Assessment Period||52||
48087060|NCT02585960|100533273|FG001|Completed 2nd 6 Month Period|PK/Safety Assessment Period||48||
48087061|NCT02585960|100533274|FG002|Completed 2nd 6 Month Period|PK/Safety Assessment Period||0||
48087062|NCT02585960|100533272|FG000|COMPLETED|PK/Safety Assessment Period||52||
48087063|NCT02585960|100533273|FG001|COMPLETED|PK/Safety Assessment Period||48||
48087064|NCT02585960|100533274|FG002|COMPLETED|PK/Safety Assessment Period||0||
48087065|NCT02585960|100533272|FG000|NOT COMPLETED|PK/Safety Assessment Period||5||
48376243|NCT00771030|101247748|FG005|COMPLETED|Overall Study||6||
48376244|NCT00771030|101247749|FG006|COMPLETED|Overall Study||6||
48376245|NCT00771030|101247743|FG000|NOT COMPLETED|Overall Study||0||
48376246|NCT00771030|101247744|FG001|NOT COMPLETED|Overall Study||1||
48376247|NCT00771030|101247745|FG002|NOT COMPLETED|Overall Study||0||
48376248|NCT00771030|101247746|FG003|NOT COMPLETED|Overall Study||0||
48376249|NCT00771030|101247747|FG004|NOT COMPLETED|Overall Study||0||
48376250|NCT00771030|101247748|FG005|NOT COMPLETED|Overall Study||0||
48376251|NCT00771030|101247749|FG006|NOT COMPLETED|Overall Study||0||
48376252|NCT02651194|101247750|FG000|STARTED|Overall Study||104||
48376253|NCT02651194|101247750|FG000|COMPLETED|Overall Study||99||
48376254|NCT02651194|101247750|FG000|NOT COMPLETED|Overall Study||5||
48376255|NCT01745393|101247751|FG000|STARTED|Treatment to End-of-treatment Assessment||163||
48376256|NCT01745393|101247752|FG001|STARTED|Treatment to End-of-treatment Assessment||164||
48376257|NCT01745393|101247751|FG000|Received Treatment|Treatment to End-of-treatment Assessment||147||
48541086|NCT02159079|101662648|FG001|COMPLETED|Overall Study||15||
48087066|NCT02585960|100533273|FG001|NOT COMPLETED|PK/Safety Assessment Period||10||
48087067|NCT02585960|100533274|FG002|NOT COMPLETED|PK/Safety Assessment Period||6||
48087068|NCT02585960|100533272|FG000|STARTED|Prophylactic Treatment Period||52||
48087069|NCT02585960|100533273|FG001|STARTED|Prophylactic Treatment Period||48||
48087070|NCT02585960|100533274|FG002|STARTED|Prophylactic Treatment Period||0||
48087071|NCT02585960|100533272|FG000|COMPLETED|Prophylactic Treatment Period||52||
48087072|NCT02585960|100533273|FG001|COMPLETED|Prophylactic Treatment Period||43||
48087073|NCT02585960|100533274|FG002|COMPLETED|Prophylactic Treatment Period||0||
48087074|NCT02585960|100533272|FG000|NOT COMPLETED|Prophylactic Treatment Period||0||
48087075|NCT02585960|100533273|FG001|NOT COMPLETED|Prophylactic Treatment Period||5||
48087076|NCT02585960|100533274|FG002|NOT COMPLETED|Prophylactic Treatment Period||0||
48087077|NCT03305653|100533275|FG000|STARTED|Overall Study||21||
48087078|NCT03305653|100533275|FG000|COMPLETED|Overall Study||21||
48376258|NCT01745393|101247752|FG001|Received Treatment|Treatment to End-of-treatment Assessment||144||
48376259|NCT01745393|101247751|FG000|COMPLETED|Treatment to End-of-treatment Assessment||142|completed end-of-treatment assessments|
48376260|NCT01745393|101247752|FG001|COMPLETED|Treatment to End-of-treatment Assessment||156|completed end-of-treatment assessments|
48376261|NCT01745393|101247751|FG000|NOT COMPLETED|Treatment to End-of-treatment Assessment||21||
48376262|NCT01745393|101247752|FG001|NOT COMPLETED|Treatment to End-of-treatment Assessment||8||
48376263|NCT01745393|101247751|FG000|STARTED|12-month Follow-up||142||
48376264|NCT01745393|101247752|FG001|STARTED|12-month Follow-up||156||
48376265|NCT01745393|101247751|FG000|COMPLETED|12-month Follow-up||136||
48376266|NCT01745393|101247752|FG001|COMPLETED|12-month Follow-up||151||
48376267|NCT01745393|101247751|FG000|NOT COMPLETED|12-month Follow-up||6||
48376268|NCT01745393|101247752|FG001|NOT COMPLETED|12-month Follow-up||5||
48376269|NCT01871896|101247753|FG000|STARTED|Overall Study||24||
48376270|NCT01871896|101247753|FG000|Underwent Procedure|Overall Study||23||
48376271|NCT01871896|101247753|FG000|COMPLETED|Overall Study||23||
48376272|NCT01871896|101247753|FG000|NOT COMPLETED|Overall Study||1||
48376273|NCT00138034|101247754|FG000|STARTED|Overall Study||26||
48376274|NCT00138034|101247755|FG001|STARTED|Overall Study||23||
48376275|NCT00138034|101247754|FG000|COMPLETED|Overall Study||23||
48087079|NCT03305653|100533275|FG000|NOT COMPLETED|Overall Study||0||
48087080|NCT01315678|100533276|FG000|STARTED|Overall Study||148|Number of participants treated|
48087081|NCT01315678|100533277|FG001|STARTED|Overall Study||146|Number of participants treated|
48087082|NCT01315678|100533276|FG000|COMPLETED|Overall Study||134||
48087083|NCT01315678|100533277|FG001|COMPLETED|Overall Study||140||
48087084|NCT01315678|100533276|FG000|NOT COMPLETED|Overall Study||14||
48087085|NCT01315678|100533277|FG001|NOT COMPLETED|Overall Study||6||
48087086|NCT00546637|100533278|FG000|STARTED|Overall Study||474||
48087087|NCT00546637|100533279|FG001|STARTED|Overall Study||473||
48087088|NCT00546637|100533278|FG000|Received Treatment|Overall Study||471||
48087089|NCT00546637|100533279|FG001|Received Treatment|Overall Study||472||
48087090|NCT00546637|100533278|FG000|COMPLETED|Overall Study||401||
48087091|NCT00546637|100533279|FG001|COMPLETED|Overall Study||424||
48376276|NCT00138034|101247755|FG001|COMPLETED|Overall Study||20||
48376277|NCT00138034|101247754|FG000|NOT COMPLETED|Overall Study||3||
48376278|NCT00138034|101247755|FG001|NOT COMPLETED|Overall Study||3||
48376279|NCT00905307|101247756|FG000|STARTED|Overall Study||42||
48376280|NCT00905307|101247757|FG001|STARTED|Overall Study||89||
48376281|NCT00905307|101247758|FG002|STARTED|Overall Study||90||
48376282|NCT00905307|101247759|FG003|STARTED|Overall Study||93||
48087092|NCT00546637|100533278|FG000|NOT COMPLETED|Overall Study||73||
48087093|NCT00546637|100533279|FG001|NOT COMPLETED|Overall Study||49||
48087094|NCT01223001|100533280|FG000|STARTED|Overall Study||4||
48087095|NCT01223001|100533281|FG001|STARTED|Overall Study||4||
48087096|NCT01223001|100533280|FG000|COMPLETED|Overall Study||0||
48087097|NCT01223001|100533281|FG001|COMPLETED|Overall Study||0||
48087098|NCT01223001|100533280|FG000|NOT COMPLETED|Overall Study||4||
48087099|NCT01223001|100533281|FG001|NOT COMPLETED|Overall Study||4||
48087100|NCT01110434|100533282|FG000|STARTED|Overall Study||40||
48087101|NCT01110434|100533283|FG001|STARTED|Overall Study||26||
48087102|NCT01110434|100533282|FG000|COMPLETED|Overall Study||29||
48087103|NCT01110434|100533283|FG001|COMPLETED|Overall Study||20||
48087104|NCT01110434|100533282|FG000|NOT COMPLETED|Overall Study||11||
48087105|NCT01110434|100533283|FG001|NOT COMPLETED|Overall Study||6||
48087106|NCT01689701|100533284|FG000|STARTED|Overall Study||27||
48087107|NCT01689701|100533285|FG001|STARTED|Overall Study||27||
48087108|NCT01689701|100533284|FG000|COMPLETED|Overall Study||22||
48087109|NCT01689701|100533285|FG001|COMPLETED|Overall Study||21||
48376283|NCT00905307|101247760|FG004|STARTED|Overall Study||50||
48376284|NCT00905307|101247761|FG005|STARTED|Overall Study||95||
48376285|NCT00905307|101247756|FG000|COMPLETED|Overall Study||20||
48376286|NCT00905307|101247757|FG001|COMPLETED|Overall Study||52||
48376287|NCT00905307|101247758|FG002|COMPLETED|Overall Study||53||
48376288|NCT00905307|101247759|FG003|COMPLETED|Overall Study||56||
48087110|NCT01689701|100533284|FG000|NOT COMPLETED|Overall Study||5||
48087111|NCT01689701|100533285|FG001|NOT COMPLETED|Overall Study||6||
48087112|NCT03187197|100533286|FG000|STARTED|Overall Study||153|Started are Enrolled|
48087113|NCT03187197|100533287|FG001|STARTED|Overall Study||1097|Started are Enrolled|
48087114|NCT03187197|100533288|FG002|STARTED|Overall Study||55|Started are Enrolled|
48087115|NCT03187197|100533286|FG000|Started (Eligible Participants as FAS)|Overall Study||139||
48087116|NCT03187197|100533287|FG001|Started (Eligible Participants as FAS)|Overall Study||1052||
48087117|NCT03187197|100533288|FG002|Started (Eligible Participants as FAS)|Overall Study||54||
48087118|NCT03187197|100533286|FG000|COMPLETED|Overall Study||107||
48087119|NCT03187197|100533287|FG001|COMPLETED|Overall Study||704||
48087120|NCT03187197|100533288|FG002|COMPLETED|Overall Study||32||
48087121|NCT03187197|100533286|FG000|NOT COMPLETED|Overall Study||46||
48087122|NCT03187197|100533287|FG001|NOT COMPLETED|Overall Study||393||
48087123|NCT03187197|100533288|FG002|NOT COMPLETED|Overall Study||23||
48376289|NCT00905307|101247760|FG004|COMPLETED|Overall Study||34||
48376290|NCT00905307|101247761|FG005|COMPLETED|Overall Study||53||
48376291|NCT00905307|101247756|FG000|NOT COMPLETED|Overall Study||22||
48376292|NCT00905307|101247757|FG001|NOT COMPLETED|Overall Study||37||
48376293|NCT00905307|101247758|FG002|NOT COMPLETED|Overall Study||37||
48376294|NCT00905307|101247759|FG003|NOT COMPLETED|Overall Study||37||
48376295|NCT00905307|101247760|FG004|NOT COMPLETED|Overall Study||16||
48087124|NCT03291808|100533289|FG000|STARTED|Overall Study||43||
48087125|NCT03291808|100533289|FG000|COMPLETED|Overall Study||33||
48087126|NCT03291808|100533289|FG000|NOT COMPLETED|Overall Study||10||
48087127|NCT02239978|100533290|FG000|STARTED|Overall Study||30||
48087128|NCT02239978|100533291|FG001|STARTED|Overall Study||12||
48087129|NCT02239978|100533290|FG000|COMPLETED|Overall Study||28||
48087130|NCT02239978|100533291|FG001|COMPLETED|Overall Study||12||
48087131|NCT02239978|100533290|FG000|NOT COMPLETED|Overall Study||2||
48087132|NCT02239978|100533291|FG001|NOT COMPLETED|Overall Study||0||
48087133|NCT00667368|100533292|FG000|STARTED|Overall Study||682||
48087134|NCT00667368|100533293|FG001|STARTED|Overall Study||683||
48087135|NCT00667368|100533292|FG000|COMPLETED|Overall Study||482||
48376296|NCT00905307|101247761|FG005|NOT COMPLETED|Overall Study||42||
48376297|NCT02577406|101247762|FG000|STARTED|Randomized Period||158||
48683767|NCT01791517|102009594|FG009|COMPLETED|Phase I: Period 4||18||
48087136|NCT00667368|100533293|FG001|COMPLETED|Overall Study||511||
48087137|NCT00667368|100533292|FG000|NOT COMPLETED|Overall Study||200||
48087138|NCT00667368|100533293|FG001|NOT COMPLETED|Overall Study||172||
48087139|NCT00003479|100533294|FG000|STARTED|Overall Study||9||
48087140|NCT00003479|100533294|FG000|COMPLETED|Overall Study||6||
48087141|NCT00003479|100533294|FG000|NOT COMPLETED|Overall Study||3||
48087142|NCT01244724|100533295|FG000|STARTED|Overall Study||17||
48250234|NCT00451555|100931055|FG001|NOT COMPLETED|Overall Study||4||
48250235|NCT03322514|100931056|FG000|STARTED|Overall Study||6||
48250236|NCT03322514|100931057|FG001|STARTED|Overall Study||6||
48087143|NCT01244724|100533295|FG000|Week 2 Visit|Overall Study||15||
48250237|NCT03322514|100931056|FG000|COMPLETED|Overall Study||5||
48250238|NCT03322514|100931057|FG001|COMPLETED|Overall Study||5||
48250239|NCT03322514|100931056|FG000|NOT COMPLETED|Overall Study||1||
48250240|NCT03322514|100931057|FG001|NOT COMPLETED|Overall Study||1||
48250241|NCT04358068|100931058|FG000|STARTED|Overall Study||9|Indicates the number randomized to a given arm|
48250242|NCT04358068|100931059|FG001|STARTED|Overall Study||11|Indicates the number randomized to a given arm|
48250243|NCT04358068|100931058|FG000|COMPLETED|Overall Study||7||
48250244|NCT04358068|100931059|FG001|COMPLETED|Overall Study||9||
48250245|NCT04358068|100931058|FG000|NOT COMPLETED|Overall Study||2||
48250246|NCT04358068|100931059|FG001|NOT COMPLETED|Overall Study||2||
48250247|NCT02672514|100931060|FG000|STARTED|Overall Study||53||
48250248|NCT02672514|100931061|FG001|STARTED|Overall Study||51||
48250249|NCT02672514|100931060|FG000|COMPLETED|Overall Study||53||
48250250|NCT02672514|100931061|FG001|COMPLETED|Overall Study||51||
48250251|NCT02672514|100931060|FG000|NOT COMPLETED|Overall Study||0||
48250252|NCT02672514|100931061|FG001|NOT COMPLETED|Overall Study||0||
48250253|NCT01049984|100931062|FG000|STARTED|Overall Study||163||
48250254|NCT01049984|100931063|FG001|STARTED|Overall Study||165||
48250255|NCT01049984|100931062|FG000|Safety Population|Overall Study||162||
48250256|NCT01049984|100931063|FG001|Safety Population|Overall Study||164||
48250257|NCT01049984|100931062|FG000|Modified Intent-to-treat Pop|Overall Study||159||
48250258|NCT01049984|100931063|FG001|Modified Intent-to-treat Pop|Overall Study||162||
48250259|NCT01049984|100931062|FG000|COMPLETED|Overall Study||144||
48250260|NCT01049984|100931063|FG001|COMPLETED|Overall Study||146||
48250261|NCT01049984|100931062|FG000|NOT COMPLETED|Overall Study||19||
48250262|NCT01049984|100931063|FG001|NOT COMPLETED|Overall Study||19||
48250263|NCT00549042|100931064|FG000|STARTED|Conversion and Titration Phase||459||
48250264|NCT00549042|100931065|FG001|STARTED|Conversion and Titration Phase||0||
48250265|NCT00549042|100931064|FG000|COMPLETED|Conversion and Titration Phase||268||
48250266|NCT00549042|100931065|FG001|COMPLETED|Conversion and Titration Phase||0||
48250267|NCT00549042|100931064|FG000|NOT COMPLETED|Conversion and Titration Phase||191||
48250268|NCT00549042|100931065|FG001|NOT COMPLETED|Conversion and Titration Phase||0||
48250269|NCT00549042|100931064|FG000|STARTED|Double-blind Phase||134|Patients who completed titration and conversion were allowed in the double-blind phase.|
48250270|NCT00549042|100931065|FG001|STARTED|Double-blind Phase||134|Patients who completed titration and conversion were allowed in the double-blind phase.|
48250271|NCT00549042|100931064|FG000|COMPLETED|Double-blind Phase||66||
48250272|NCT00549042|100931065|FG001|COMPLETED|Double-blind Phase||44||
48250273|NCT00549042|100931064|FG000|NOT COMPLETED|Double-blind Phase||68||
48250274|NCT00549042|100931065|FG001|NOT COMPLETED|Double-blind Phase||90||
48250275|NCT01940523|100931066|FG000|STARTED|Overall Study||320||
48376298|NCT02577406|101247763|FG001|STARTED|Randomized Period||161||
48376299|NCT02577406|101247762|FG000|COMPLETED|Randomized Period||157|Continuing to treatment period|
48376300|NCT02577406|101247763|FG001|COMPLETED|Randomized Period||141|Continuing to treatment period|
48683768|NCT01791517|102009595|FG010|COMPLETED|Phase I: Period 4||16||
48683769|NCT01791517|102009596|FG011|COMPLETED|Phase I: Period 4||18||
48683770|NCT01791517|102009585|FG000|NOT COMPLETED|Phase I: Period 4||0||
48087144|NCT01244724|100533295|FG000|COMPLETED|Overall Study||9||
48087145|NCT01244724|100533295|FG000|NOT COMPLETED|Overall Study||8||
48376301|NCT02577406|101247762|FG000|NOT COMPLETED|Randomized Period||1||
48376302|NCT02577406|101247763|FG001|NOT COMPLETED|Randomized Period||20||
48683771|NCT01791517|102009586|FG001|NOT COMPLETED|Phase I: Period 4||0||
48087146|NCT02573857|100533296|FG000|STARTED|Overall Study||8||
48087147|NCT02573857|100533297|FG001|STARTED|Overall Study||8||
48683772|NCT01791517|102009587|FG002|NOT COMPLETED|Phase I: Period 4||0||
48683773|NCT01791517|102009588|FG003|NOT COMPLETED|Phase I: Period 4||0||
48683774|NCT01791517|102009589|FG004|NOT COMPLETED|Phase I: Period 4||0||
48683775|NCT01791517|102009590|FG005|NOT COMPLETED|Phase I: Period 4||0||
48683776|NCT01791517|102009591|FG006|NOT COMPLETED|Phase I: Period 4||0||
48683777|NCT01791517|102009592|FG007|NOT COMPLETED|Phase I: Period 4||0||
48087148|NCT02573857|100533296|FG000|COMPLETED|Overall Study||8||
48087149|NCT02573857|100533297|FG001|COMPLETED|Overall Study||8||
48087150|NCT02573857|100533296|FG000|NOT COMPLETED|Overall Study||0||
48087151|NCT02573857|100533297|FG001|NOT COMPLETED|Overall Study||0||
48087152|NCT02709785|100533298|FG000|STARTED|Overall Study||24||
48087153|NCT02709785|100533299|FG001|STARTED|Overall Study||28||
48376303|NCT02577406|101247762|FG000|STARTED|Treatment Period||157||
48376304|NCT02577406|101247763|FG001|STARTED|Treatment Period||141||
48376305|NCT02577406|101247762|FG000|COMPLETED|Treatment Period||10|Ongoing treatment|
48376306|NCT02577406|101247763|FG001|COMPLETED|Treatment Period||4|Ongoing treatment|
48683778|NCT01791517|102009593|FG008|NOT COMPLETED|Phase I: Period 4||0||
48087154|NCT02709785|100533300|FG002|STARTED|Overall Study||28||
48683779|NCT01791517|102009594|FG009|NOT COMPLETED|Phase I: Period 4||0||
48683780|NCT01791517|102009595|FG010|NOT COMPLETED|Phase I: Period 4||0||
48683781|NCT01791517|102009596|FG011|NOT COMPLETED|Phase I: Period 4||0||
48683782|NCT01791517|102009585|FG000|STARTED|Phase II||17||
48683783|NCT01791517|102009586|FG001|STARTED|Phase II||14||
48683784|NCT01791517|102009587|FG002|STARTED|Phase II||16||
48683785|NCT01791517|102009588|FG003|STARTED|Phase II||15||
48683786|NCT01791517|102009589|FG004|STARTED|Phase II||18||
48683787|NCT01791517|102009590|FG005|STARTED|Phase II||18||
48683788|NCT01791517|102009591|FG006|STARTED|Phase II||19||
48683789|NCT01791517|102009592|FG007|STARTED|Phase II||20||
48683790|NCT01791517|102009593|FG008|STARTED|Phase II||19||
48683791|NCT01791517|102009594|FG009|STARTED|Phase II||18||
48683792|NCT01791517|102009595|FG010|STARTED|Phase II||16||
48087155|NCT02709785|100533298|FG000|3 Weeks|Overall Study||23||
48087156|NCT02709785|100533299|FG001|3 Weeks|Overall Study||27||
48683793|NCT01791517|102009596|FG011|STARTED|Phase II||18||
48376307|NCT02577406|101247762|FG000|NOT COMPLETED|Treatment Period||147||
48376308|NCT02577406|101247763|FG001|NOT COMPLETED|Treatment Period||137||
48683794|NCT01791517|102009585|FG000|COMPLETED|Phase II||15||
48683795|NCT01791517|102009586|FG001|COMPLETED|Phase II||14||
48683796|NCT01791517|102009587|FG002|COMPLETED|Phase II||15||
48683797|NCT01791517|102009588|FG003|COMPLETED|Phase II||15||
48683798|NCT01791517|102009589|FG004|COMPLETED|Phase II||16||
48683799|NCT01791517|102009590|FG005|COMPLETED|Phase II||14||
48683800|NCT01791517|102009591|FG006|COMPLETED|Phase II||17||
48683801|NCT01791517|102009592|FG007|COMPLETED|Phase II||17||
48087157|NCT02709785|100533300|FG002|3 Weeks|Overall Study||27||
48087158|NCT02709785|100533298|FG000|6 Weeks|Overall Study||23||
48087159|NCT02709785|100533299|FG001|6 Weeks|Overall Study||26||
48087160|NCT02709785|100533300|FG002|6 Weeks|Overall Study||27||
48087161|NCT02709785|100533298|FG000|COMPLETED|Overall Study||23||
48087162|NCT02709785|100533299|FG001|COMPLETED|Overall Study||26||
48087163|NCT02709785|100533300|FG002|COMPLETED|Overall Study||27||
48087164|NCT02709785|100533298|FG000|NOT COMPLETED|Overall Study||1||
48087165|NCT02709785|100533299|FG001|NOT COMPLETED|Overall Study||2||
48087166|NCT02709785|100533300|FG002|NOT COMPLETED|Overall Study||1||
48087167|NCT01214629|100533301|FG000|STARTED|Overall Study||1||
48087168|NCT01214629|100533302|FG001|STARTED|Overall Study||1||
48087169|NCT01214629|100533303|FG002|STARTED|Overall Study||1||
48087170|NCT01214629|100533304|FG003|STARTED|Overall Study||3||
48087171|NCT01214629|100533305|FG004|STARTED|Overall Study||3||
48087172|NCT01214629|100533306|FG005|STARTED|Overall Study||13||
48087173|NCT01214629|100533307|FG006|STARTED|Overall Study||5||
48087174|NCT01214629|100533308|FG007|STARTED|Overall Study||3||
48087175|NCT01214629|100533309|FG008|STARTED|Overall Study||3||
48087176|NCT01214629|100533310|FG009|STARTED|Overall Study||18||
48087177|NCT01214629|100533311|FG010|STARTED|Overall Study||3||
48087178|NCT01214629|100533301|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1||
48087179|NCT01214629|100533302|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1||
48087180|NCT01214629|100533303|FG002|Received at Least 1 Dose of Study Drug|Overall Study||1||
48087181|NCT01214629|100533304|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3||
48087182|NCT01214629|100533305|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3||
48087183|NCT01214629|100533306|FG005|Received at Least 1 Dose of Study Drug|Overall Study||13||
48087184|NCT01214629|100533307|FG006|Received at Least 1 Dose of Study Drug|Overall Study||5||
48087185|NCT01214629|100533308|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3||
48087186|NCT01214629|100533309|FG008|Received at Least 1 Dose of Study Drug|Overall Study||3||
48087187|NCT01214629|100533310|FG009|Received at Least 1 Dose of Study Drug|Overall Study||18||
48087188|NCT01214629|100533311|FG010|Received at Least 1 Dose of Study Drug|Overall Study||3||
48087189|NCT01214629|100533301|FG000|COMPLETED|Overall Study||0||
48087190|NCT01214629|100533302|FG001|COMPLETED|Overall Study||0||
48087191|NCT01214629|100533303|FG002|COMPLETED|Overall Study||1||
48087192|NCT01214629|100533304|FG003|COMPLETED|Overall Study||1||
48087193|NCT01214629|100533305|FG004|COMPLETED|Overall Study||1||
48087194|NCT01214629|100533306|FG005|COMPLETED|Overall Study||9||
48087195|NCT01214629|100533307|FG006|COMPLETED|Overall Study||4||
48087196|NCT01214629|100533308|FG007|COMPLETED|Overall Study||2||
48376309|NCT03504774|101247764|FG000|STARTED|Overall Study||40||
48087197|NCT01214629|100533309|FG008|COMPLETED|Overall Study||2||
48087198|NCT01214629|100533310|FG009|COMPLETED|Overall Study||11||
48087199|NCT01214629|100533311|FG010|COMPLETED|Overall Study||1||
48087200|NCT01214629|100533301|FG000|NOT COMPLETED|Overall Study||1||
48087201|NCT01214629|100533302|FG001|NOT COMPLETED|Overall Study||1||
48087202|NCT01214629|100533303|FG002|NOT COMPLETED|Overall Study||0||
48087203|NCT01214629|100533304|FG003|NOT COMPLETED|Overall Study||2||
48087204|NCT01214629|100533305|FG004|NOT COMPLETED|Overall Study||2||
48087205|NCT01214629|100533306|FG005|NOT COMPLETED|Overall Study||4||
48087206|NCT01214629|100533307|FG006|NOT COMPLETED|Overall Study||1||
48087207|NCT01214629|100533308|FG007|NOT COMPLETED|Overall Study||1||
48087208|NCT01214629|100533309|FG008|NOT COMPLETED|Overall Study||1||
48087209|NCT01214629|100533310|FG009|NOT COMPLETED|Overall Study||7||
48087210|NCT01214629|100533311|FG010|NOT COMPLETED|Overall Study||2||
48087211|NCT01987505|100533312|FG000|STARTED|Overall Study||140||
48087212|NCT01987505|100533312|FG000|COMPLETED|Overall Study||106||
48087213|NCT01987505|100533312|FG000|NOT COMPLETED|Overall Study||34||
48087214|NCT02674529|100533313|FG000|STARTED|Overall Study||25||
48087215|NCT02674529|100533314|FG001|STARTED|Overall Study||29||
48087216|NCT02674529|100533313|FG000|COMPLETED|Overall Study||22||
48087217|NCT02674529|100533314|FG001|COMPLETED|Overall Study||24||
48087218|NCT02674529|100533313|FG000|NOT COMPLETED|Overall Study||3||
48087219|NCT02674529|100533314|FG001|NOT COMPLETED|Overall Study||5||
48376310|NCT03504774|101247765|FG001|STARTED|Overall Study||12||
48683802|NCT01791517|102009593|FG008|COMPLETED|Phase II||17||
48683803|NCT01791517|102009594|FG009|COMPLETED|Phase II||15||
48087220|NCT02032810|100533315|FG000|STARTED|Overall Study||6||
48087221|NCT02032810|100533316|FG001|STARTED|Overall Study||11||
48087222|NCT02032810|100533315|FG000|COMPLETED|Overall Study||6||
48087223|NCT02032810|100533316|FG001|COMPLETED|Overall Study||11||
48087224|NCT02032810|100533315|FG000|NOT COMPLETED|Overall Study||0||
48087225|NCT02032810|100533316|FG001|NOT COMPLETED|Overall Study||0||
48087226|NCT02728076|100533317|FG000|STARTED|Overall Study||39||
48087227|NCT02728076|100533317|FG000|COMPLETED|Overall Study||35||
48376311|NCT03504774|101247764|FG000|Enrolled for the Intention-to-Treat Analysis|Overall Study||40||
48683804|NCT01791517|102009595|FG010|COMPLETED|Phase II||15||
48087228|NCT02728076|100533317|FG000|NOT COMPLETED|Overall Study||4||
48087229|NCT00543140|100533318|FG000|STARTED|Overall Study||303||
48087230|NCT00543140|100533318|FG000|COMPLETED|Overall Study||231||
48087231|NCT00543140|100533318|FG000|NOT COMPLETED|Overall Study||72||
48087232|NCT04952402|100533319|FG000|STARTED|Overall Study||18||
48087233|NCT04952402|100533320|FG001|STARTED|Overall Study||25||
48087234|NCT04952402|100533319|FG000|Completed Two-dose Vaccine Series|Overall Study||18||
48087235|NCT04952402|100533320|FG001|Completed Two-dose Vaccine Series|Overall Study||25||
48087236|NCT04952402|100533319|FG000|COMPLETED|Overall Study||17||
48087237|NCT04952402|100533320|FG001|COMPLETED|Overall Study||21||
48087238|NCT04952402|100533319|FG000|NOT COMPLETED|Overall Study||1||
48087239|NCT04952402|100533320|FG001|NOT COMPLETED|Overall Study||4||
48087240|NCT01907815|100533321|FG000|STARTED|Overall Study||17||
48087241|NCT01907815|100533322|FG001|STARTED|Overall Study||7||
48087242|NCT01907815|100533321|FG000|COMPLETED|Overall Study||16||
48087243|NCT01907815|100533322|FG001|COMPLETED|Overall Study||7||
48087244|NCT01907815|100533321|FG000|NOT COMPLETED|Overall Study||1||
48087245|NCT01907815|100533322|FG001|NOT COMPLETED|Overall Study||0||
48087246|NCT00719134|100533323|FG000|STARTED|Overall Study||76||
48087247|NCT00719134|100533323|FG000|COMPLETED|Overall Study||66||
48087248|NCT00719134|100533323|FG000|NOT COMPLETED|Overall Study||10||
48087249|NCT05035550|100533324|FG000|STARTED|Overall Study||32||
48087250|NCT05035550|100533325|FG001|STARTED|Overall Study||32||
48087251|NCT05035550|100533324|FG000|COMPLETED|Overall Study||29||
48087252|NCT05035550|100533325|FG001|COMPLETED|Overall Study||32||
48087253|NCT05035550|100533324|FG000|NOT COMPLETED|Overall Study||3||
48087254|NCT05035550|100533325|FG001|NOT COMPLETED|Overall Study||0||
48087255|NCT01767155|100533326|FG000|STARTED|Overall Study||256|Intent-to-treat population (ITT)|
48087256|NCT01767155|100533327|FG001|STARTED|Overall Study||255|Intent-to-treat population (ITT)|
48087257|NCT01767155|100533326|FG000|Modified ITT (mITT)|Overall Study||252|Excluding patients allocated to a treatment but never treated|
48087258|NCT01767155|100533327|FG001|Modified ITT (mITT)|Overall Study||249|Excluding patients allocated to a treatment but never treated|
48087259|NCT01767155|100533326|FG000|Safety Population (SAF)|Overall Study||252||
48087260|NCT01767155|100533327|FG001|Safety Population (SAF)|Overall Study||249||
48087261|NCT01767155|100533326|FG000|COMPLETED|Overall Study||243|Per protocol (PP) population|
48087262|NCT01767155|100533327|FG001|COMPLETED|Overall Study||240|Per protocol (PP) population|
48087263|NCT01767155|100533326|FG000|NOT COMPLETED|Overall Study||13||
48250276|NCT01940523|100931067|FG001|STARTED|Overall Study||320||
48250277|NCT01940523|100931066|FG000|COMPLETED|Overall Study||320||
48250278|NCT01940523|100931067|FG001|COMPLETED|Overall Study||320||
48250279|NCT01940523|100931066|FG000|NOT COMPLETED|Overall Study||0||
48376312|NCT03504774|101247765|FG001|Enrolled for the Intention-to-Treat Analysis|Overall Study||12||
48376313|NCT03504774|101247764|FG000|Assigned to Build-up and Maintenance|Overall Study||40||
48541087|NCT02159079|101662647|FG000|NOT COMPLETED|Overall Study||0||
48250280|NCT01940523|100931067|FG001|NOT COMPLETED|Overall Study||0||
48250281|NCT02402465|100931068|FG000|STARTED|Overall Study||4||
48250282|NCT02402465|100931069|FG001|STARTED|Overall Study||4||
48250283|NCT02402465|100931070|FG002|STARTED|Overall Study||4||
48250284|NCT02402465|100931071|FG003|STARTED|Overall Study||4||
48250285|NCT02402465|100931072|FG004|STARTED|Overall Study||2||
48250286|NCT02402465|100931073|FG005|STARTED|Overall Study||4||
48250287|NCT02402465|100931068|FG000|COMPLETED|Overall Study||4||
48250288|NCT02402465|100931069|FG001|COMPLETED|Overall Study||3||
48250289|NCT02402465|100931070|FG002|COMPLETED|Overall Study||4||
48250290|NCT02402465|100931071|FG003|COMPLETED|Overall Study||4||
48250291|NCT02402465|100931072|FG004|COMPLETED|Overall Study||1||
48250292|NCT02402465|100931073|FG005|COMPLETED|Overall Study||3||
48250293|NCT02402465|100931068|FG000|NOT COMPLETED|Overall Study||0||
48250294|NCT02402465|100931069|FG001|NOT COMPLETED|Overall Study||1||
48250295|NCT02402465|100931070|FG002|NOT COMPLETED|Overall Study||0||
48250296|NCT02402465|100931071|FG003|NOT COMPLETED|Overall Study||0||
48250297|NCT02402465|100931072|FG004|NOT COMPLETED|Overall Study||1||
48250298|NCT02402465|100931073|FG005|NOT COMPLETED|Overall Study||1||
48250299|NCT00731588|100931074|FG000|STARTED|Overall Study||9||
48541088|NCT02159079|101662648|FG001|NOT COMPLETED|Overall Study||0||
48087264|NCT01767155|100533327|FG001|NOT COMPLETED|Overall Study||15||
48087265|NCT03266094|100533328|FG000|STARTED|Overall Study||60||
48087266|NCT03266094|100533328|FG000|COMPLETED|Overall Study||58||
48087267|NCT03266094|100533328|FG000|NOT COMPLETED|Overall Study||2||
48087268|NCT02552199|100533329|FG000|STARTED|Overall Study||17||
48087269|NCT02552199|100533330|FG001|STARTED|Overall Study||11||
48087270|NCT02552199|100533329|FG000|COMPLETED|Overall Study||17||
48087271|NCT02552199|100533330|FG001|COMPLETED|Overall Study||11||
48087272|NCT02552199|100533329|FG000|NOT COMPLETED|Overall Study||0||
48087273|NCT02552199|100533330|FG001|NOT COMPLETED|Overall Study||0||
48087274|NCT03107754|100533331|FG000|STARTED|Overall Study||48||
48250300|NCT00731588|100931075|FG001|STARTED|Overall Study||95||
48250301|NCT00731588|100931074|FG000|COMPLETED|Overall Study||9||
48250302|NCT00731588|100931075|FG001|COMPLETED|Overall Study||53||
48250303|NCT00731588|100931074|FG000|NOT COMPLETED|Overall Study||0||
48250304|NCT00731588|100931075|FG001|NOT COMPLETED|Overall Study||42||
48250305|NCT04236245|100931076|FG000|STARTED|Overall Study||25||
48376314|NCT03504774|101247765|FG001|Assigned to Build-up and Maintenance|Overall Study||12||
48376315|NCT03504774|101247764|FG000|Had Week 52 Desensitization DBPCFC|Overall Study||27||
48087275|NCT03107754|100533332|FG001|STARTED|Overall Study||50||
48087276|NCT03107754|100533331|FG000|COMPLETED|Overall Study||48||
48087277|NCT03107754|100533332|FG001|COMPLETED|Overall Study||50||
48087278|NCT03107754|100533331|FG000|NOT COMPLETED|Overall Study||0||
48087279|NCT03107754|100533332|FG001|NOT COMPLETED|Overall Study||0||
48087280|NCT02788357|100533333|FG000|STARTED|Overall Study||6||
48087281|NCT02788357|100533334|FG001|STARTED|Overall Study||6||
48087282|NCT02788357|100533333|FG000|COMPLETED|Overall Study||3||
48087283|NCT02788357|100533334|FG001|COMPLETED|Overall Study||6||
48087284|NCT02788357|100533333|FG000|NOT COMPLETED|Overall Study||3||
48087285|NCT02788357|100533334|FG001|NOT COMPLETED|Overall Study||0||
48087286|NCT00573469|100533335|FG000|STARTED|Overall Study||26||
48087287|NCT00573469|100533336|FG001|STARTED|Overall Study||25||
48087288|NCT00573469|100533337|FG002|STARTED|Overall Study||26||
48087289|NCT00573469|100533335|FG000|COMPLETED|Overall Study||20||
48087290|NCT00573469|100533336|FG001|COMPLETED|Overall Study||21||
48683805|NCT01791517|102009596|FG011|COMPLETED|Phase II||17||
48683806|NCT01791517|102009585|FG000|NOT COMPLETED|Phase II||2||
48683807|NCT01791517|102009586|FG001|NOT COMPLETED|Phase II||0||
48683808|NCT01791517|102009587|FG002|NOT COMPLETED|Phase II||1||
48683809|NCT01791517|102009588|FG003|NOT COMPLETED|Phase II||0||
48087291|NCT00573469|100533337|FG002|COMPLETED|Overall Study||22||
48087292|NCT00573469|100533335|FG000|NOT COMPLETED|Overall Study||6||
48087293|NCT00573469|100533336|FG001|NOT COMPLETED|Overall Study||4||
48087294|NCT00573469|100533337|FG002|NOT COMPLETED|Overall Study||4||
48087295|NCT03274440|100533338|FG000|STARTED|Overall Study||3||
48087296|NCT03274440|100533339|FG001|STARTED|Overall Study||2||
48376316|NCT03504774|101247765|FG001|Had Week 52 Desensitization DBPCFC|Overall Study||8||
48376317|NCT03504774|101247764|FG000|Had Week 58 Sustained Unresponsiveness DBPCFC|Overall Study||26||
48376318|NCT03504774|101247765|FG001|Had Week 58 Sustained Unresponsiveness DBPCFC|Overall Study||8||
48376319|NCT03504774|101247764|FG000|COMPLETED|Overall Study||26||
48376320|NCT03504774|101247765|FG001|COMPLETED|Overall Study||8||
48376321|NCT03504774|101247764|FG000|NOT COMPLETED|Overall Study||14||
48376322|NCT03504774|101247765|FG001|NOT COMPLETED|Overall Study||4||
48376323|NCT02836990|101247766|FG000|STARTED|Overall Study||50||
48683810|NCT01791517|102009589|FG004|NOT COMPLETED|Phase II||2||
48683811|NCT01791517|102009590|FG005|NOT COMPLETED|Phase II||4||
48087297|NCT03274440|100533340|FG002|STARTED|Overall Study||4||
48087298|NCT03274440|100533341|FG003|STARTED|Overall Study||1||
48087299|NCT03274440|100533342|FG004|STARTED|Overall Study||1||
48087300|NCT03274440|100533343|FG005|STARTED|Overall Study||3||
48087301|NCT03274440|100533338|FG000|COMPLETED|Overall Study||2||
48087302|NCT03274440|100533339|FG001|COMPLETED|Overall Study||2||
48087303|NCT03274440|100533340|FG002|COMPLETED|Overall Study||4||
48087304|NCT03274440|100533341|FG003|COMPLETED|Overall Study||0||
48087305|NCT03274440|100533342|FG004|COMPLETED|Overall Study||1||
48541089|NCT02695537|101662649|FG000|STARTED|Overall Study||89||
48087306|NCT03274440|100533343|FG005|COMPLETED|Overall Study||3||
48087307|NCT03274440|100533338|FG000|NOT COMPLETED|Overall Study||1||
48087308|NCT03274440|100533339|FG001|NOT COMPLETED|Overall Study||0||
48087309|NCT03274440|100533340|FG002|NOT COMPLETED|Overall Study||0||
48087310|NCT03274440|100533341|FG003|NOT COMPLETED|Overall Study||1||
48087311|NCT03274440|100533342|FG004|NOT COMPLETED|Overall Study||0||
48087312|NCT03274440|100533343|FG005|NOT COMPLETED|Overall Study||0||
48683812|NCT01791517|102009591|FG006|NOT COMPLETED|Phase II||2||
48683813|NCT01791517|102009592|FG007|NOT COMPLETED|Phase II||3||
48683814|NCT01791517|102009593|FG008|NOT COMPLETED|Phase II||2||
48683815|NCT01791517|102009594|FG009|NOT COMPLETED|Phase II||3||
48683816|NCT01791517|102009595|FG010|NOT COMPLETED|Phase II||1||
48683817|NCT01791517|102009596|FG011|NOT COMPLETED|Phase II||1||
48683818|NCT03386435|102009597|FG000|STARTED|Overall Study||80||
48683819|NCT03386435|102009598|FG001|STARTED|Overall Study||80||
48683820|NCT03386435|102009597|FG000|COMPLETED|Overall Study||75||
48683821|NCT03386435|102009598|FG001|COMPLETED|Overall Study||73||
48683822|NCT03386435|102009597|FG000|NOT COMPLETED|Overall Study||5||
48683823|NCT03386435|102009598|FG001|NOT COMPLETED|Overall Study||7||
48683824|NCT03758261|102009599|FG000|STARTED|Overall Study||17||
48683825|NCT03758261|102009600|FG001|STARTED|Overall Study||16||
48683826|NCT03758261|102009599|FG000|COMPLETED|Overall Study||15||
48683827|NCT03758261|102009600|FG001|COMPLETED|Overall Study||15||
48683828|NCT03758261|102009599|FG000|NOT COMPLETED|Overall Study||2||
48683829|NCT03758261|102009600|FG001|NOT COMPLETED|Overall Study||1||
48683830|NCT03129464|102009601|FG000|STARTED|Overall Study||28||
48683831|NCT03129464|102009602|FG001|STARTED|Overall Study||28||
48683832|NCT03129464|102009601|FG000|COMPLETED|Overall Study||28||
48683833|NCT03129464|102009602|FG001|COMPLETED|Overall Study||27||
48683834|NCT03129464|102009601|FG000|NOT COMPLETED|Overall Study||0||
48683835|NCT03129464|102009602|FG001|NOT COMPLETED|Overall Study||1||
48087313|NCT04160091|100533344|FG000|STARTED|Overall Study||7||
48087314|NCT04160091|100533345|FG001|STARTED|Overall Study||3||
48087315|NCT04160091|100533346|FG002|STARTED|Overall Study||5||
48087316|NCT04160091|100533347|FG003|STARTED|Overall Study||4||
48087317|NCT04160091|100533344|FG000|COMPLETED|Overall Study||0||
48087318|NCT04160091|100533345|FG001|COMPLETED|Overall Study||0||
48087319|NCT04160091|100533346|FG002|COMPLETED|Overall Study||0||
48376324|NCT02836990|101247767|FG001|STARTED|Overall Study||55||
48376325|NCT02836990|101247766|FG000|COMPLETED|Overall Study||50||
48376326|NCT02836990|101247767|FG001|COMPLETED|Overall Study||55||
48087320|NCT04160091|100533347|FG003|COMPLETED|Overall Study||0||
48087321|NCT04160091|100533344|FG000|NOT COMPLETED|Overall Study||7||
48087322|NCT04160091|100533345|FG001|NOT COMPLETED|Overall Study||3||
48087323|NCT04160091|100533346|FG002|NOT COMPLETED|Overall Study||5||
48087324|NCT04160091|100533347|FG003|NOT COMPLETED|Overall Study||4||
48087325|NCT00218465|100533348|FG000|STARTED|Overall Study||50||
48376327|NCT02836990|101247766|FG000|NOT COMPLETED|Overall Study||0||
48087326|NCT00218465|100533349|FG001|STARTED|Overall Study||48||
48087327|NCT00218465|100533348|FG000|COMPLETED|Overall Study||33||
48087328|NCT00218465|100533349|FG001|COMPLETED|Overall Study||30||
48087329|NCT00218465|100533348|FG000|NOT COMPLETED|Overall Study||17||
48376328|NCT02836990|101247767|FG001|NOT COMPLETED|Overall Study||0||
48376329|NCT00578864|101247768|FG000|STARTED|Overall Study||7||
48376330|NCT00578864|101247769|FG001|STARTED|Overall Study||6||
48376331|NCT00578864|101247768|FG000|COMPLETED|Overall Study||6||
48376332|NCT00578864|101247769|FG001|COMPLETED|Overall Study||6||
48376333|NCT00578864|101247768|FG000|NOT COMPLETED|Overall Study||1||
48087330|NCT00218465|100533349|FG001|NOT COMPLETED|Overall Study||18||
48087331|NCT00790855|100533350|FG000|STARTED|Overall Study||25||
48087332|NCT00790855|100533350|FG000|COMPLETED|Overall Study||25||
48087333|NCT00790855|100533350|FG000|NOT COMPLETED|Overall Study||0||
48087334|NCT01962207|100533351|FG000|STARTED|Persistence Phase (5 Years)||76||
48087335|NCT01962207|100533352|FG001|STARTED|Persistence Phase (5 Years)||23||
48087336|NCT01962207|100533353|FG002|STARTED|Persistence Phase (5 Years)||115||
48087337|NCT01962207|100533354|FG003|STARTED|Persistence Phase (5 Years)||29||
48087338|NCT01962207|100533351|FG000|COMPLETED|Persistence Phase (5 Years)||47||
48087339|NCT01962207|100533352|FG001|COMPLETED|Persistence Phase (5 Years)||10||
48087340|NCT01962207|100533353|FG002|COMPLETED|Persistence Phase (5 Years)||71||
48087341|NCT01962207|100533354|FG003|COMPLETED|Persistence Phase (5 Years)||17||
48087342|NCT01962207|100533351|FG000|NOT COMPLETED|Persistence Phase (5 Years)||29||
48087343|NCT01962207|100533352|FG001|NOT COMPLETED|Persistence Phase (5 Years)||13||
48376334|NCT00578864|101247769|FG001|NOT COMPLETED|Overall Study||0||
48376335|NCT03703375|101247770|FG000|STARTED|Pre-Randomization (Safety Run-In)||7||
48376336|NCT03703375|101247771|FG001|STARTED|Pre-Randomization (Safety Run-In)||0||
48376337|NCT03703375|101247772|FG002|STARTED|Pre-Randomization (Safety Run-In)||0||
48376338|NCT03703375|101247773|FG003|STARTED|Pre-Randomization (Safety Run-In)||0||
48376339|NCT03703375|101247770|FG000|COMPLETED|Pre-Randomization (Safety Run-In)||7||
48376340|NCT03703375|101247771|FG001|COMPLETED|Pre-Randomization (Safety Run-In)||0||
48376341|NCT03703375|101247772|FG002|COMPLETED|Pre-Randomization (Safety Run-In)||0||
48087344|NCT01962207|100533353|FG002|NOT COMPLETED|Persistence Phase (5 Years)||44||
48087345|NCT01962207|100533354|FG003|NOT COMPLETED|Persistence Phase (5 Years)||12||
48087346|NCT01962207|100533351|FG000|STARTED|Booster Phase (6 Months)||67||
48087347|NCT01962207|100533352|FG001|STARTED|Booster Phase (6 Months)||16||
48087348|NCT01962207|100533353|FG002|STARTED|Booster Phase (6 Months)||77||
48087349|NCT01962207|100533354|FG003|STARTED|Booster Phase (6 Months)||21||
48087350|NCT01962207|100533351|FG000|COMPLETED|Booster Phase (6 Months)||67||
48087351|NCT01962207|100533352|FG001|COMPLETED|Booster Phase (6 Months)||16||
48376342|NCT03703375|101247773|FG003|COMPLETED|Pre-Randomization (Safety Run-In)||0||
48376343|NCT03703375|101247770|FG000|NOT COMPLETED|Pre-Randomization (Safety Run-In)||0||
48376344|NCT03703375|101247771|FG001|NOT COMPLETED|Pre-Randomization (Safety Run-In)||0||
48376345|NCT03703375|101247772|FG002|NOT COMPLETED|Pre-Randomization (Safety Run-In)||0||
48087352|NCT01962207|100533353|FG002|COMPLETED|Booster Phase (6 Months)||77||
48087353|NCT01962207|100533354|FG003|COMPLETED|Booster Phase (6 Months)||21||
48087354|NCT01962207|100533351|FG000|NOT COMPLETED|Booster Phase (6 Months)||0||
48376346|NCT03703375|101247773|FG003|NOT COMPLETED|Pre-Randomization (Safety Run-In)||0||
48376347|NCT03703375|101247770|FG000|STARTED|Randomization Period||49||
48376348|NCT03703375|101247771|FG001|STARTED|Randomization Period||4||
48376349|NCT03703375|101247772|FG002|STARTED|Randomization Period||16||
48376350|NCT03703375|101247773|FG003|STARTED|Randomization Period||24||
48376351|NCT03703375|101247770|FG000|Safety Run-In|Randomization Period||7||
48087355|NCT01962207|100533352|FG001|NOT COMPLETED|Booster Phase (6 Months)||0||
48087356|NCT01962207|100533353|FG002|NOT COMPLETED|Booster Phase (6 Months)||0||
48087357|NCT01962207|100533354|FG003|NOT COMPLETED|Booster Phase (6 Months)||0||
48087358|NCT01417234|100533355|FG000|STARTED|Overall Study||30||
48087359|NCT01417234|100533355|FG000|COMPLETED|Overall Study||27||
48087360|NCT01417234|100533355|FG000|NOT COMPLETED|Overall Study||3||
48087361|NCT00211809|100537047|FG000|STARTED|Overall Study||17||
48376352|NCT03703375|101247771|FG001|Safety Run-In|Randomization Period||0||
48376353|NCT03703375|101247772|FG002|Safety Run-In|Randomization Period||0||
48376354|NCT03703375|101247773|FG003|Safety Run-In|Randomization Period||0||
48087362|NCT00211809|100537047|FG000|COMPLETED|Overall Study||11||
48087363|NCT00211809|100537047|FG000|NOT COMPLETED|Overall Study||6||
48087364|NCT02329730|100537048|FG000|STARTED|Overall Study||14||
48087365|NCT02329730|100537049|FG001|STARTED|Overall Study||14||
48087366|NCT02329730|100537050|FG002|STARTED|Overall Study||14||
48087367|NCT02329730|100537051|FG003|STARTED|Overall Study||14||
48087368|NCT02329730|100537052|FG004|STARTED|Overall Study||14||
48087369|NCT02329730|100537053|FG005|STARTED|Overall Study||14||
48087370|NCT02329730|100537054|FG006|STARTED|Overall Study||14||
48087371|NCT02329730|100537055|FG007|STARTED|Overall Study||14||
48087372|NCT02329730|100537056|FG008|STARTED|Overall Study||8||
48087373|NCT02329730|100537057|FG009|STARTED|Overall Study||8||
48087374|NCT02329730|100537058|FG010|STARTED|Overall Study||8||
48376355|NCT03703375|101247770|FG000|COMPLETED|Randomization Period||42|Completed = ongoing to treatment period|
48376356|NCT03703375|101247771|FG001|COMPLETED|Randomization Period||4|Completed = ongoing to treatment period|
48376357|NCT03703375|101247772|FG002|COMPLETED|Randomization Period||16|Completed = ongoing to treatment period|
48376358|NCT03703375|101247773|FG003|COMPLETED|Randomization Period||23|Completed = ongoing to treatment period|
48376359|NCT03703375|101247770|FG000|NOT COMPLETED|Randomization Period||7||
48376360|NCT03703375|101247771|FG001|NOT COMPLETED|Randomization Period||0||
48376361|NCT03703375|101247772|FG002|NOT COMPLETED|Randomization Period||0||
48376362|NCT03703375|101247773|FG003|NOT COMPLETED|Randomization Period||1||
48376363|NCT03703375|101247770|FG000|STARTED|Treatment Period||42||
48376364|NCT03703375|101247771|FG001|STARTED|Treatment Period||4||
48376365|NCT03703375|101247772|FG002|STARTED|Treatment Period||16||
48376366|NCT03703375|101247773|FG003|STARTED|Treatment Period||23||
48376367|NCT03703375|101247770|FG000|COMPLETED|Treatment Period||0|Completed=ongoing treatment|
48376368|NCT03703375|101247771|FG001|COMPLETED|Treatment Period||0|Completed=ongoing treatment|
48376369|NCT03703375|101247772|FG002|COMPLETED|Treatment Period||4|Completed=ongoing treatment|
48376370|NCT03703375|101247773|FG003|COMPLETED|Treatment Period||5|Completed=ongoing treatment|
48376371|NCT03703375|101247770|FG000|NOT COMPLETED|Treatment Period||42||
48376372|NCT03703375|101247771|FG001|NOT COMPLETED|Treatment Period||4||
48376373|NCT03703375|101247772|FG002|NOT COMPLETED|Treatment Period||12||
48376374|NCT03703375|101247773|FG003|NOT COMPLETED|Treatment Period||18||
48376375|NCT02615535|101247774|FG000|STARTED|Overall Study||14||
48376376|NCT02615535|101247775|FG001|STARTED|Overall Study||11||
48376377|NCT02615535|101247774|FG000|COMPLETED|Overall Study||10||
48376378|NCT02615535|101247775|FG001|COMPLETED|Overall Study||10||
48376379|NCT02615535|101247774|FG000|NOT COMPLETED|Overall Study||4||
48376380|NCT02615535|101247775|FG001|NOT COMPLETED|Overall Study||1||
48376381|NCT00305006|101247776|FG000|STARTED|Overall Study||22||
48376382|NCT00305006|101247777|FG001|STARTED|Overall Study||22||
48376383|NCT00305006|101247776|FG000|COMPLETED|Overall Study||21||
48376384|NCT00305006|101247777|FG001|COMPLETED|Overall Study||21||
48376385|NCT00305006|101247776|FG000|NOT COMPLETED|Overall Study||1||
48376386|NCT00305006|101247777|FG001|NOT COMPLETED|Overall Study||1||
48376387|NCT00101192|101247778|FG000|STARTED|Overall Study||76||
48376388|NCT00101192|101247778|FG000|COMPLETED|Overall Study||69||
48376389|NCT00101192|101247778|FG000|NOT COMPLETED|Overall Study||7||
48376390|NCT01423617|101251812|FG000|STARTED|Overall Study||46||
48376391|NCT01423617|101251813|FG001|STARTED|Overall Study||46||
48376392|NCT01423617|101251812|FG000|COMPLETED|Overall Study||46||
48376393|NCT01423617|101251813|FG001|COMPLETED|Overall Study||45||
48376394|NCT01423617|101251812|FG000|NOT COMPLETED|Overall Study||0||
48087375|NCT02329730|100537059|FG011|STARTED|Overall Study||8||
48087376|NCT02329730|100537048|FG000|COMPLETED|Overall Study||14||
48087377|NCT02329730|100537049|FG001|COMPLETED|Overall Study||14||
48087378|NCT02329730|100537050|FG002|COMPLETED|Overall Study||14||
48376395|NCT01423617|101251813|FG001|NOT COMPLETED|Overall Study||1||
48376396|NCT03086317|101251814|FG000|STARTED|Overall Study||10||
48683836|NCT03723980|102009603|FG000|STARTED|Overall Study||40||
48683837|NCT03723980|102009604|FG001|STARTED|Overall Study||40||
48683838|NCT03723980|102009603|FG000|COMPLETED|Overall Study||33||
48683839|NCT03723980|102009604|FG001|COMPLETED|Overall Study||35||
48683840|NCT03723980|102009603|FG000|NOT COMPLETED|Overall Study||7||
48683841|NCT03723980|102009604|FG001|NOT COMPLETED|Overall Study||5||
48376397|NCT03086317|101251815|FG001|STARTED|Overall Study||8||
48376398|NCT03086317|101251814|FG000|COMPLETED|Overall Study||10||
48376399|NCT03086317|101251815|FG001|COMPLETED|Overall Study||8||
48376400|NCT03086317|101251814|FG000|NOT COMPLETED|Overall Study||0||
48376401|NCT03086317|101251815|FG001|NOT COMPLETED|Overall Study||0||
48376402|NCT01005719|101251816|FG000|STARTED|Period 1||10||
48683842|NCT01059357|102009605|FG000|STARTED|Overall Study||58||
48683843|NCT01059357|102009605|FG000|COMPLETED|Overall Study||54||
48087379|NCT02329730|100537051|FG003|COMPLETED|Overall Study||14||
48087380|NCT02329730|100537052|FG004|COMPLETED|Overall Study||11||
48087381|NCT02329730|100537053|FG005|COMPLETED|Overall Study||12||
48087382|NCT02329730|100537054|FG006|COMPLETED|Overall Study||13||
48087383|NCT02329730|100537055|FG007|COMPLETED|Overall Study||13||
48376403|NCT01005719|101251817|FG001|STARTED|Period 1||10||
48376404|NCT01005719|101251818|FG002|STARTED|Period 1||10||
48376405|NCT01005719|101251819|FG003|STARTED|Period 1||11||
48376406|NCT01005719|101251820|FG004|STARTED|Period 1||11||
48376407|NCT01005719|101251821|FG005|STARTED|Period 1||11||
48376408|NCT01005719|101251816|FG000|COMPLETED|Period 1||10||
48376409|NCT01005719|101251817|FG001|COMPLETED|Period 1||10||
48376410|NCT01005719|101251818|FG002|COMPLETED|Period 1||10||
48376411|NCT01005719|101251819|FG003|COMPLETED|Period 1||10||
48087384|NCT02329730|100537056|FG008|COMPLETED|Overall Study||7||
48087385|NCT02329730|100537057|FG009|COMPLETED|Overall Study||7||
48087386|NCT02329730|100537058|FG010|COMPLETED|Overall Study||8||
48087387|NCT02329730|100537059|FG011|COMPLETED|Overall Study||8||
48087388|NCT02329730|100537048|FG000|NOT COMPLETED|Overall Study||0||
48087389|NCT02329730|100537049|FG001|NOT COMPLETED|Overall Study||0||
48087390|NCT02329730|100537050|FG002|NOT COMPLETED|Overall Study||0||
48087391|NCT02329730|100537051|FG003|NOT COMPLETED|Overall Study||0||
48376412|NCT01005719|101251820|FG004|COMPLETED|Period 1||11||
48376413|NCT01005719|101251821|FG005|COMPLETED|Period 1||10||
48376414|NCT01005719|101251816|FG000|NOT COMPLETED|Period 1||0||
48376415|NCT01005719|101251817|FG001|NOT COMPLETED|Period 1||0||
48376416|NCT01005719|101251818|FG002|NOT COMPLETED|Period 1||0||
48376417|NCT01005719|101251819|FG003|NOT COMPLETED|Period 1||1||
48376418|NCT01005719|101251820|FG004|NOT COMPLETED|Period 1||0||
48376419|NCT01005719|101251821|FG005|NOT COMPLETED|Period 1||1||
48376420|NCT01005719|101251816|FG000|STARTED|Period 2||10||
48376421|NCT01005719|101251817|FG001|STARTED|Period 2||10||
48376422|NCT01005719|101251818|FG002|STARTED|Period 2||10||
48376423|NCT01005719|101251819|FG003|STARTED|Period 2||10||
48376424|NCT01005719|101251820|FG004|STARTED|Period 2||11||
48376425|NCT01005719|101251821|FG005|STARTED|Period 2||10||
48376426|NCT01005719|101251816|FG000|COMPLETED|Period 2||10||
48376427|NCT01005719|101251817|FG001|COMPLETED|Period 2||10||
48376428|NCT01005719|101251818|FG002|COMPLETED|Period 2||10||
48376429|NCT01005719|101251819|FG003|COMPLETED|Period 2||10||
48376430|NCT01005719|101251820|FG004|COMPLETED|Period 2||10||
48376431|NCT01005719|101251821|FG005|COMPLETED|Period 2||9||
48376432|NCT01005719|101251816|FG000|NOT COMPLETED|Period 2||0||
48376433|NCT01005719|101251817|FG001|NOT COMPLETED|Period 2||0||
48376434|NCT01005719|101251818|FG002|NOT COMPLETED|Period 2||0||
48376435|NCT01005719|101251819|FG003|NOT COMPLETED|Period 2||0||
48376436|NCT01005719|101251820|FG004|NOT COMPLETED|Period 2||1||
48376437|NCT01005719|101251821|FG005|NOT COMPLETED|Period 2||1||
48376438|NCT01005719|101251816|FG000|STARTED|Period 3||10||
48376439|NCT01005719|101251817|FG001|STARTED|Period 3||10||
48376440|NCT01005719|101251818|FG002|STARTED|Period 3||10||
48376441|NCT01005719|101251819|FG003|STARTED|Period 3||10||
48376442|NCT01005719|101251820|FG004|STARTED|Period 3||10||
48376443|NCT01005719|101251821|FG005|STARTED|Period 3||9||
48376444|NCT01005719|101251816|FG000|COMPLETED|Period 3||10||
48376445|NCT01005719|101251817|FG001|COMPLETED|Period 3||10||
48376446|NCT01005719|101251818|FG002|COMPLETED|Period 3||10||
48376447|NCT01005719|101251819|FG003|COMPLETED|Period 3||10||
48376448|NCT01005719|101251820|FG004|COMPLETED|Period 3||10||
48376449|NCT01005719|101251821|FG005|COMPLETED|Period 3||9||
48376450|NCT01005719|101251816|FG000|NOT COMPLETED|Period 3||0||
48376451|NCT01005719|101251817|FG001|NOT COMPLETED|Period 3||0||
48376452|NCT01005719|101251818|FG002|NOT COMPLETED|Period 3||0||
48376453|NCT01005719|101251819|FG003|NOT COMPLETED|Period 3||0||
48376454|NCT01005719|101251820|FG004|NOT COMPLETED|Period 3||0||
48376455|NCT01005719|101251821|FG005|NOT COMPLETED|Period 3||0||
48376456|NCT01351766|101251822|FG000|STARTED|Overall Study||39||
48376457|NCT01351766|101251822|FG000|COMPLETED|Overall Study||36||
48376458|NCT01351766|101251822|FG000|NOT COMPLETED|Overall Study||3||
48376459|NCT01743963|101251823|FG000|STARTED|Overall Study||21||
48087392|NCT02329730|100537052|FG004|NOT COMPLETED|Overall Study||3||
48376460|NCT01743963|101251824|FG001|STARTED|Overall Study||17||
48376461|NCT01743963|101251823|FG000|COMPLETED|Overall Study||21||
48376462|NCT01743963|101251824|FG001|COMPLETED|Overall Study||17||
48376463|NCT01743963|101251823|FG000|NOT COMPLETED|Overall Study||0||
48376464|NCT01743963|101251824|FG001|NOT COMPLETED|Overall Study||0||
48376465|NCT02841787|101251825|FG000|STARTED|Overall Study||12||
48376466|NCT02841787|101251826|FG001|STARTED|Overall Study||23||
48376467|NCT02841787|101251827|FG002|STARTED|Overall Study||12||
48376468|NCT02841787|101251825|FG000|COMPLETED|Overall Study||9||
48376469|NCT02841787|101251826|FG001|COMPLETED|Overall Study||19||
48376470|NCT02841787|101251827|FG002|COMPLETED|Overall Study||12||
48376471|NCT02841787|101251825|FG000|NOT COMPLETED|Overall Study||3||
48376472|NCT02841787|101251826|FG001|NOT COMPLETED|Overall Study||4||
48376473|NCT02841787|101251827|FG002|NOT COMPLETED|Overall Study||0||
48087393|NCT02329730|100537053|FG005|NOT COMPLETED|Overall Study||2||
48087394|NCT02329730|100537054|FG006|NOT COMPLETED|Overall Study||1||
48376474|NCT01515306|101251828|FG000|STARTED|Overall Study||24||
48376475|NCT01515306|101251829|FG001|STARTED|Overall Study||16||
48376476|NCT01515306|101251828|FG000|Received at Least 1 Dose of Study Drug|Overall Study||24||
48376477|NCT01515306|101251829|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16||
48376478|NCT01515306|101251828|FG000|Cycle 1|Overall Study||24||
48376479|NCT01515306|101251829|FG001|Cycle 1|Overall Study||16||
48376480|NCT01515306|101251828|FG000|Cycle 2|Overall Study||21||
48376481|NCT01515306|101251829|FG001|Cycle 2|Overall Study||15||
48376482|NCT01515306|101251828|FG000|Drug-Drug Interaction Population|Overall Study||21||
48376483|NCT01515306|101251829|FG001|Drug-Drug Interaction Population|Overall Study||0||
48376484|NCT01515306|101251828|FG000|COMPLETED|Overall Study||0||
48376485|NCT01515306|101251829|FG001|COMPLETED|Overall Study||2||
48376486|NCT01515306|101251828|FG000|NOT COMPLETED|Overall Study||24||
48376487|NCT01515306|101251829|FG001|NOT COMPLETED|Overall Study||14||
48376488|NCT02528097|101251830|FG000|STARTED|Overall Study||1||
48376489|NCT02528097|101251831|FG001|STARTED|Overall Study||1||
48376490|NCT02528097|101251830|FG000|COMPLETED|Overall Study||1||
48376491|NCT02528097|101251831|FG001|COMPLETED|Overall Study||1||
48376492|NCT02528097|101251830|FG000|NOT COMPLETED|Overall Study||0||
48376493|NCT02528097|101251831|FG001|NOT COMPLETED|Overall Study||0||
48376494|NCT01341652|101251832|FG000|STARTED|Overall Study||49||
48376495|NCT01341652|101251833|FG001|STARTED|Overall Study||50||
48376496|NCT01341652|101251832|FG000|COMPLETED|Overall Study||49||
48376497|NCT01341652|101251833|FG001|COMPLETED|Overall Study||48||
48376498|NCT01341652|101251832|FG000|NOT COMPLETED|Overall Study||0||
48376499|NCT01341652|101251833|FG001|NOT COMPLETED|Overall Study||2||
48087395|NCT02329730|100537055|FG007|NOT COMPLETED|Overall Study||1||
48087396|NCT02329730|100537056|FG008|NOT COMPLETED|Overall Study||1||
48087397|NCT02329730|100537057|FG009|NOT COMPLETED|Overall Study||1||
48087398|NCT02329730|100537058|FG010|NOT COMPLETED|Overall Study||0||
48087399|NCT02329730|100537059|FG011|NOT COMPLETED|Overall Study||0||
48087400|NCT05255068|100537060|FG000|STARTED|Overall Study||94||
48087401|NCT05255068|100537061|FG001|STARTED|Overall Study||17||
48087402|NCT05255068|100537060|FG000|COMPLETED|Overall Study||94||
48087403|NCT05255068|100537061|FG001|COMPLETED|Overall Study||16||
48087404|NCT05255068|100537060|FG000|NOT COMPLETED|Overall Study||0||
48087405|NCT05255068|100537061|FG001|NOT COMPLETED|Overall Study||1||
48087406|NCT01438424|100537062|FG000|STARTED|Overall Study||1051||
48376500|NCT00810719|101251834|FG000|STARTED|Overall Study||30||
48376501|NCT00810719|101251834|FG000|COMPLETED|Overall Study||30||
48376502|NCT00810719|101251834|FG000|NOT COMPLETED|Overall Study||0||
48376503|NCT03491553|101251835|FG000|STARTED|Main Study (Up to Week 48)||9||
48376504|NCT03491553|101251836|FG001|STARTED|Main Study (Up to Week 48)||10||
48376505|NCT03491553|101251837|FG002|STARTED|Main Study (Up to Week 48)||10||
48376506|NCT03491553|101251838|FG003|STARTED|Main Study (Up to Week 48)||10||
48376507|NCT03491553|101251839|FG004|STARTED|Main Study (Up to Week 48)||5||
48376508|NCT03491553|101251840|FG005|STARTED|Main Study (Up to Week 48)||4||
48376509|NCT03491553|101251835|FG000|COMPLETED|Main Study (Up to Week 48)||8||
48683844|NCT01059357|102009605|FG000|NOT COMPLETED|Overall Study||4||
48683845|NCT00784368|102009606|FG000|STARTED|Overall Study||16||
48683846|NCT00784368|102009607|FG001|STARTED|Overall Study||16||
48683847|NCT00784368|102009608|FG002|STARTED|Overall Study||23||
48683848|NCT00784368|102009606|FG000|COMPLETED|Overall Study||8||
48087407|NCT01438424|100537062|FG000|COMPLETED|Overall Study||634||
48376510|NCT03491553|101251836|FG001|COMPLETED|Main Study (Up to Week 48)||9||
48376511|NCT03491553|101251837|FG002|COMPLETED|Main Study (Up to Week 48)||10||
48376512|NCT03491553|101251838|FG003|COMPLETED|Main Study (Up to Week 48)||9||
48376513|NCT03491553|101251839|FG004|COMPLETED|Main Study (Up to Week 48)||5||
48376514|NCT03491553|101251840|FG005|COMPLETED|Main Study (Up to Week 48)||4||
48376515|NCT03491553|101251835|FG000|NOT COMPLETED|Main Study (Up to Week 48)||1||
48376516|NCT03491553|101251836|FG001|NOT COMPLETED|Main Study (Up to Week 48)||1||
48087408|NCT01438424|100537062|FG000|NOT COMPLETED|Overall Study||417||
48087409|NCT03715764|100537063|FG000|STARTED|Baseline (Randomized (n=69)||35||
48087410|NCT03715764|100537064|FG001|STARTED|Baseline (Randomized (n=69)||34||
48376517|NCT03491553|101251837|FG002|NOT COMPLETED|Main Study (Up to Week 48)||0||
48376518|NCT03491553|101251838|FG003|NOT COMPLETED|Main Study (Up to Week 48)||1||
48376519|NCT03491553|101251839|FG004|NOT COMPLETED|Main Study (Up to Week 48)||0||
48376520|NCT03491553|101251840|FG005|NOT COMPLETED|Main Study (Up to Week 48)||0||
48376521|NCT03491553|101251835|FG000|STARTED|TFFU (Week 49 up to Additional 48 Weeks)||0||
48376522|NCT03491553|101251836|FG001|STARTED|TFFU (Week 49 up to Additional 48 Weeks)||1||
48376523|NCT03491553|101251837|FG002|STARTED|TFFU (Week 49 up to Additional 48 Weeks)||0||
48376524|NCT03491553|101251838|FG003|STARTED|TFFU (Week 49 up to Additional 48 Weeks)||0||
48376525|NCT03491553|101251839|FG004|STARTED|TFFU (Week 49 up to Additional 48 Weeks)||0||
48376526|NCT03491553|101251840|FG005|STARTED|TFFU (Week 49 up to Additional 48 Weeks)||0||
48376527|NCT03491553|101251835|FG000|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0||
48376528|NCT03491553|101251836|FG001|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||1||
48376529|NCT03491553|101251837|FG002|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0||
48376530|NCT03491553|101251838|FG003|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0||
48376531|NCT03491553|101251839|FG004|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0||
48376532|NCT03491553|101251840|FG005|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0||
48376533|NCT03491553|101251835|FG000|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0||
48376534|NCT03491553|101251836|FG001|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0||
48376535|NCT03491553|101251837|FG002|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0||
48376536|NCT03491553|101251838|FG003|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0||
48683849|NCT00784368|102009607|FG001|COMPLETED|Overall Study||5||
48683850|NCT00784368|102009608|FG002|COMPLETED|Overall Study||12||
48087411|NCT03715764|100537063|FG000|COMPLETED|Baseline (Randomized (n=69)||33||
48087412|NCT03715764|100537064|FG001|COMPLETED|Baseline (Randomized (n=69)||31||
48376537|NCT03491553|101251839|FG004|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0||
48376538|NCT03491553|101251840|FG005|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0||
48376539|NCT02546674|101251841|FG000|STARTED|Overall Study||171||
48376540|NCT02546674|101251841|FG000|COMPLETED|Overall Study||123||
48376541|NCT02546674|101251841|FG000|NOT COMPLETED|Overall Study||48||
48376542|NCT04836455|101251842|FG000|STARTED|Overall Study||504||
48376543|NCT04836455|101251843|FG001|STARTED|Overall Study||506||
48376544|NCT04836455|101251844|FG002|STARTED|Overall Study||504||
48376545|NCT04836455|101251845|FG003|STARTED|Overall Study||51||
48376546|NCT04836455|101251842|FG000|COMPLETED|Overall Study||445||
48376547|NCT04836455|101251843|FG001|COMPLETED|Overall Study||451||
48376548|NCT04836455|101251844|FG002|COMPLETED|Overall Study||450||
48376549|NCT04836455|101251845|FG003|COMPLETED|Overall Study||51||
48376550|NCT04836455|101251842|FG000|NOT COMPLETED|Overall Study||59||
48376551|NCT04836455|101251843|FG001|NOT COMPLETED|Overall Study||55||
48376552|NCT04836455|101251844|FG002|NOT COMPLETED|Overall Study||54||
48376553|NCT04836455|101251845|FG003|NOT COMPLETED|Overall Study||0||
48376554|NCT00964548|101251846|FG000|STARTED|Overall Study||5||
48376555|NCT00964548|101251847|FG001|STARTED|Overall Study||5||
48376556|NCT00964548|101251846|FG000|COMPLETED|Overall Study||5||
48376557|NCT00964548|101251847|FG001|COMPLETED|Overall Study||5||
48376558|NCT00964548|101251846|FG000|NOT COMPLETED|Overall Study||0||
48376559|NCT00964548|101251847|FG001|NOT COMPLETED|Overall Study||0||
48376560|NCT03017924|101251848|FG000|STARTED|Overall Study||12||
48376561|NCT03017924|101251849|FG001|STARTED|Overall Study||11||
48376562|NCT03017924|101251848|FG000|COMPLETED|Overall Study||10||
48376563|NCT03017924|101251849|FG001|COMPLETED|Overall Study||8||
48376564|NCT03017924|101251848|FG000|NOT COMPLETED|Overall Study||2||
48376565|NCT03017924|101251849|FG001|NOT COMPLETED|Overall Study||3||
48376566|NCT02278289|101251850|FG000|STARTED|Overall Study||30||
48376567|NCT02278289|101251851|FG001|STARTED|Overall Study||30||
48376568|NCT02278289|101251850|FG000|COMPLETED|Overall Study||24||
48376569|NCT02278289|101251851|FG001|COMPLETED|Overall Study||23||
48376570|NCT02278289|101251850|FG000|NOT COMPLETED|Overall Study||6||
48376571|NCT02278289|101251851|FG001|NOT COMPLETED|Overall Study||7||
48376572|NCT00256867|101251852|FG000|STARTED|Overall Study||47||
48376573|NCT00256867|101251853|FG001|STARTED|Overall Study||44||
48376574|NCT00256867|101251854|FG002|STARTED|Overall Study||45||
48376575|NCT00256867|101251855|FG003|STARTED|Overall Study||46||
48376576|NCT00256867|101251856|FG004|STARTED|Overall Study||48||
48376577|NCT00256867|101251857|FG005|STARTED|Overall Study||46||
48376578|NCT00256867|101251858|FG006|STARTED|Overall Study||46||
48376579|NCT00256867|101251859|FG007|STARTED|Overall Study||47||
48376580|NCT00256867|101251852|FG000|COMPLETED|Overall Study||45||
48376581|NCT00256867|101251853|FG001|COMPLETED|Overall Study||39||
48376582|NCT00256867|101251854|FG002|COMPLETED|Overall Study||40||
48376583|NCT00256867|101251855|FG003|COMPLETED|Overall Study||40||
48376584|NCT00256867|101251856|FG004|COMPLETED|Overall Study||41||
48376585|NCT00256867|101251857|FG005|COMPLETED|Overall Study||40||
48376586|NCT00256867|101251858|FG006|COMPLETED|Overall Study||41||
48376587|NCT00256867|101251859|FG007|COMPLETED|Overall Study||36||
48376588|NCT00256867|101251852|FG000|NOT COMPLETED|Overall Study||2||
48376589|NCT00256867|101251853|FG001|NOT COMPLETED|Overall Study||5||
48376590|NCT00256867|101251854|FG002|NOT COMPLETED|Overall Study||5||
48376591|NCT00256867|101251855|FG003|NOT COMPLETED|Overall Study||6||
48376592|NCT00256867|101251856|FG004|NOT COMPLETED|Overall Study||7||
48376593|NCT00256867|101251857|FG005|NOT COMPLETED|Overall Study||6||
48376594|NCT00256867|101251858|FG006|NOT COMPLETED|Overall Study||5||
48376595|NCT00256867|101251859|FG007|NOT COMPLETED|Overall Study||11||
48376596|NCT02408796|101251860|FG000|STARTED|Overall Study||39||
48376597|NCT02408796|101251860|FG000|COMPLETED|Overall Study||39||
48376598|NCT02408796|101251860|FG000|NOT COMPLETED|Overall Study||0||
48376599|NCT01496430|101251861|FG000|STARTED|Overall Study||35||
48376600|NCT01496430|101251862|FG001|STARTED|Overall Study||35||
48376601|NCT01496430|101251863|FG002|STARTED|Overall Study||35||
48376602|NCT01496430|101251861|FG000|COMPLETED|Overall Study||29||
48376603|NCT01496430|101251862|FG001|COMPLETED|Overall Study||30||
48376604|NCT01496430|101251863|FG002|COMPLETED|Overall Study||25||
48376605|NCT01496430|101251861|FG000|NOT COMPLETED|Overall Study||6||
48376606|NCT01496430|101251862|FG001|NOT COMPLETED|Overall Study||5||
48376607|NCT01496430|101251863|FG002|NOT COMPLETED|Overall Study||10||
48376608|NCT02896907|101251864|FG000|STARTED|Overall Study||8||
48376609|NCT02896907|101251864|FG000|COMPLETED|Overall Study||8||
48376610|NCT02896907|101251864|FG000|NOT COMPLETED|Overall Study||0||
48376611|NCT01627067|101251865|FG000|STARTED|Overall Study||23||
48376612|NCT01627067|101251865|FG000|COMPLETED|Overall Study||22||
48376613|NCT01627067|101251865|FG000|NOT COMPLETED|Overall Study||1||
48376614|NCT01996904|101251866|FG000|STARTED|Overall Study||139||
48376615|NCT01996904|101251867|FG001|STARTED|Overall Study||117||
48376616|NCT01996904|101251866|FG000|COMPLETED|Overall Study||101||
48376617|NCT01996904|101251867|FG001|COMPLETED|Overall Study||90||
48376618|NCT01996904|101251866|FG000|NOT COMPLETED|Overall Study||38||
48376619|NCT01996904|101251867|FG001|NOT COMPLETED|Overall Study||27||
48376620|NCT00675558|101251868|FG000|STARTED|Surgery||10||
48376621|NCT00675558|101251869|FG001|STARTED|Surgery||10||
48376622|NCT00675558|101251870|FG002|STARTED|Surgery||30||
48376623|NCT00675558|101251868|FG000|COMPLETED|Surgery||10||
48376624|NCT00675558|101251869|FG001|COMPLETED|Surgery||10||
48376625|NCT00675558|101251870|FG002|COMPLETED|Surgery||30||
48376626|NCT00675558|101251868|FG000|NOT COMPLETED|Surgery||0||
48376627|NCT00675558|101251869|FG001|NOT COMPLETED|Surgery||0||
48376628|NCT00675558|101251870|FG002|NOT COMPLETED|Surgery||0||
48376629|NCT00675558|101251868|FG000|STARTED|Second Operation||0||
48376630|NCT00675558|101251869|FG001|STARTED|Second Operation||0||
48376631|NCT00675558|101251870|FG002|STARTED|Second Operation||10||
48376632|NCT00675558|101251868|FG000|COMPLETED|Second Operation||0||
48376633|NCT00675558|101251869|FG001|COMPLETED|Second Operation||0||
48376634|NCT00675558|101251870|FG002|COMPLETED|Second Operation||10||
48376635|NCT00675558|101251868|FG000|NOT COMPLETED|Second Operation||0||
48376636|NCT00675558|101251869|FG001|NOT COMPLETED|Second Operation||0||
48087413|NCT03715764|100537063|FG000|NOT COMPLETED|Baseline (Randomized (n=69)||2||
48087414|NCT03715764|100537064|FG001|NOT COMPLETED|Baseline (Randomized (n=69)||3||
48087415|NCT03715764|100537063|FG000|STARTED|3 Month Follow-up||33||
48087416|NCT03715764|100537064|FG001|STARTED|3 Month Follow-up||31||
48087417|NCT03715764|100537063|FG000|COMPLETED|3 Month Follow-up||30||
48087418|NCT03715764|100537064|FG001|COMPLETED|3 Month Follow-up||28||
48087419|NCT03715764|100537063|FG000|NOT COMPLETED|3 Month Follow-up||3||
48087420|NCT03715764|100537064|FG001|NOT COMPLETED|3 Month Follow-up||3||
48087421|NCT03715764|100537063|FG000|STARTED|6 Month Follow-up||30||
48087422|NCT03715764|100537064|FG001|STARTED|6 Month Follow-up||28||
48087423|NCT03715764|100537063|FG000|COMPLETED|6 Month Follow-up||27||
48087424|NCT03715764|100537064|FG001|COMPLETED|6 Month Follow-up||28||
48087425|NCT03715764|100537063|FG000|NOT COMPLETED|6 Month Follow-up||3||
48087426|NCT03715764|100537064|FG001|NOT COMPLETED|6 Month Follow-up||0||
48087427|NCT03715764|100537063|FG000|STARTED|12 Month Follow-up||27||
48087428|NCT03715764|100537064|FG001|STARTED|12 Month Follow-up||28||
48087429|NCT03715764|100537063|FG000|COMPLETED|12 Month Follow-up||21||
48087430|NCT03715764|100537064|FG001|COMPLETED|12 Month Follow-up||23||
48087431|NCT03715764|100537063|FG000|NOT COMPLETED|12 Month Follow-up||6||
48376637|NCT00675558|101251870|FG002|NOT COMPLETED|Second Operation||0||
48376638|NCT01361009|101251871|FG000|STARTED|Overall Study||2017||
48376639|NCT01361009|101251871|FG000|COMPLETED|Overall Study||1901||
48376640|NCT01361009|101251871|FG000|NOT COMPLETED|Overall Study||116||
48376641|NCT01263691|101251872|FG000|STARTED|Overall Study||18||
48376642|NCT01263691|101251873|FG001|STARTED|Overall Study||18||
48376643|NCT01263691|101251874|FG002|STARTED|Overall Study||17||
48376644|NCT01263691|101251875|FG003|STARTED|Overall Study||19||
48376645|NCT01263691|101251876|FG004|STARTED|Overall Study||18||
48376646|NCT01263691|101251877|FG005|STARTED|Overall Study||15||
48376647|NCT01263691|101251872|FG000|COMPLETED|Overall Study||15||
48376648|NCT01263691|101251873|FG001|COMPLETED|Overall Study||18||
48376649|NCT01263691|101251874|FG002|COMPLETED|Overall Study||16||
48376650|NCT01263691|101251875|FG003|COMPLETED|Overall Study||18||
48376651|NCT01263691|101251876|FG004|COMPLETED|Overall Study||18||
48376652|NCT01263691|101251877|FG005|COMPLETED|Overall Study||15||
48376653|NCT01263691|101251872|FG000|NOT COMPLETED|Overall Study||3||
48376654|NCT01263691|101251873|FG001|NOT COMPLETED|Overall Study||0||
48376655|NCT01263691|101251874|FG002|NOT COMPLETED|Overall Study||1||
48376656|NCT01263691|101251875|FG003|NOT COMPLETED|Overall Study||1||
48376657|NCT01263691|101251876|FG004|NOT COMPLETED|Overall Study||0||
48376658|NCT01263691|101251877|FG005|NOT COMPLETED|Overall Study||0||
48376659|NCT03664193|101251878|FG000|STARTED|Overall Study||30||
48376660|NCT03664193|101251878|FG000|COMPLETED|Overall Study||30||
48376661|NCT03664193|101251878|FG000|NOT COMPLETED|Overall Study||0||
48376662|NCT00305643|101251879|FG000|STARTED|Overall Study||6||
48376663|NCT00305643|101251880|FG001|STARTED|Overall Study||5||
48376664|NCT00305643|101251879|FG000|COMPLETED|Overall Study||6||
48376665|NCT00305643|101251880|FG001|COMPLETED|Overall Study||5||
48376666|NCT00305643|101251879|FG000|NOT COMPLETED|Overall Study||0||
48376667|NCT00305643|101251880|FG001|NOT COMPLETED|Overall Study||0||
48376668|NCT01523808|101251881|FG000|STARTED|Overall Study||3||
48376669|NCT01523808|101251882|FG001|STARTED|Overall Study||3||
48376670|NCT01523808|101251883|FG002|STARTED|Overall Study||3||
48376671|NCT01523808|101251884|FG003|STARTED|Overall Study||3||
48376672|NCT01523808|101251881|FG000|COMPLETED|Overall Study||0||
48376673|NCT01523808|101251882|FG001|COMPLETED|Overall Study||3||
48087432|NCT03715764|100537064|FG001|NOT COMPLETED|12 Month Follow-up||5||
48087433|NCT02950025|100537065|FG000|STARTED|Overall Study||2||
48087434|NCT02950025|100537066|FG001|STARTED|Overall Study||3||
48087435|NCT02950025|100537065|FG000|COMPLETED|Overall Study||2||
48087436|NCT02950025|100537066|FG001|COMPLETED|Overall Study||3||
48087437|NCT02950025|100537065|FG000|NOT COMPLETED|Overall Study||0||
48087438|NCT02950025|100537066|FG001|NOT COMPLETED|Overall Study||0||
48087439|NCT02743871|100537067|FG000|STARTED|Overall Study||6||
48087440|NCT02743871|100537068|FG001|STARTED|Overall Study||6||
48087441|NCT02743871|100537069|FG002|STARTED|Overall Study||6||
48087442|NCT02743871|100537070|FG003|STARTED|Overall Study||3||
48376674|NCT01523808|101251883|FG002|COMPLETED|Overall Study||1||
48376675|NCT01523808|101251884|FG003|COMPLETED|Overall Study||0||
48376676|NCT01523808|101251881|FG000|NOT COMPLETED|Overall Study||3||
48376677|NCT01523808|101251882|FG001|NOT COMPLETED|Overall Study||0||
48683851|NCT00784368|102009606|FG000|NOT COMPLETED|Overall Study||8||
48683852|NCT00784368|102009607|FG001|NOT COMPLETED|Overall Study||11||
48683853|NCT00784368|102009608|FG002|NOT COMPLETED|Overall Study||11||
48683854|NCT02965989|102009609|FG000|STARTED|Overall Study||26||
48683855|NCT02965989|102009610|FG001|STARTED|Overall Study||22||
48683856|NCT02965989|102009609|FG000|COMPLETED|Overall Study||26||
48683857|NCT02965989|102009610|FG001|COMPLETED|Overall Study||22||
48250306|NCT04236245|100931076|FG000|COMPLETED|Overall Study||25||
48250307|NCT04236245|100931076|FG000|NOT COMPLETED|Overall Study||0||
48250308|NCT01514630|100931077|FG000|STARTED|Overall Study||14||
48250309|NCT01514630|100931077|FG000|COMPLETED|Overall Study||11||
48376678|NCT01523808|101251883|FG002|NOT COMPLETED|Overall Study||2||
48376679|NCT01523808|101251884|FG003|NOT COMPLETED|Overall Study||3||
48376680|NCT01687413|101251885|FG000|STARTED|Overall Study||27||
48376681|NCT01687413|101251886|FG001|STARTED|Overall Study||15||
48376682|NCT01687413|101251885|FG000|COMPLETED|Overall Study||26||
48376683|NCT01687413|101251886|FG001|COMPLETED|Overall Study||11||
48376684|NCT01687413|101251885|FG000|NOT COMPLETED|Overall Study||1||
48376685|NCT01687413|101251886|FG001|NOT COMPLETED|Overall Study||4||
48376686|NCT00403559|101251887|FG000|STARTED|Overall Study||56||
48376687|NCT00403559|101251888|FG001|STARTED|Overall Study||56||
48376688|NCT00403559|101251887|FG000|COMPLETED|Overall Study||52||
48376689|NCT00403559|101251888|FG001|COMPLETED|Overall Study||52||
48376690|NCT00403559|101251887|FG000|NOT COMPLETED|Overall Study||4||
48376691|NCT00403559|101251888|FG001|NOT COMPLETED|Overall Study||4||
48376692|NCT02410902|101251889|FG000|STARTED|Overall Study||92||
48376693|NCT02410902|101251890|FG001|STARTED|Overall Study||98||
48376694|NCT02410902|101251889|FG000|Randomized|Overall Study||92||
48376695|NCT02410902|101251890|FG001|Randomized|Overall Study||98||
48376696|NCT02410902|101251889|FG000|ITT|Overall Study||92||
48376697|NCT02410902|101251890|FG001|ITT|Overall Study||98||
48376698|NCT02410902|101251889|FG000|COMPLETED|Overall Study||71||
48376699|NCT02410902|101251890|FG001|COMPLETED|Overall Study||80||
48376700|NCT02410902|101251889|FG000|NOT COMPLETED|Overall Study||21||
48376701|NCT02410902|101251890|FG001|NOT COMPLETED|Overall Study||18||
48376702|NCT00962039|101251891|FG000|STARTED|Overall Study||40||
48376703|NCT00962039|101251892|FG001|STARTED|Overall Study||41||
48376704|NCT00962039|101251891|FG000|COMPLETED|Overall Study||35||
48376705|NCT00962039|101251892|FG001|COMPLETED|Overall Study||37||
48376706|NCT00962039|101251891|FG000|NOT COMPLETED|Overall Study||5||
48376707|NCT00962039|101251892|FG001|NOT COMPLETED|Overall Study||4||
48376708|NCT02750800|101251893|FG000|STARTED|Overall Study||412||
48376709|NCT02750800|101251893|FG000|COMPLETED|Overall Study||314||
48376710|NCT02750800|101251893|FG000|NOT COMPLETED|Overall Study||98||
48376711|NCT01675011|101251894|FG000|STARTED|Overall Study||3||
48376712|NCT01675011|101251895|FG001|STARTED|Overall Study||1||
48376713|NCT01675011|101251894|FG000|COMPLETED|Overall Study||0||
48376714|NCT01675011|101251895|FG001|COMPLETED|Overall Study||0||
48376715|NCT01675011|101251894|FG000|NOT COMPLETED|Overall Study||3||
48376716|NCT01675011|101251895|FG001|NOT COMPLETED|Overall Study||1||
48376717|NCT00538980|101251896|FG000|STARTED|Overall Study||10||
48376718|NCT00538980|101251896|FG000|COMPLETED|Overall Study||0||
48376719|NCT00538980|101251896|FG000|NOT COMPLETED|Overall Study||10||
48376720|NCT03456713|101251897|FG000|STARTED|Overall Study||18||
48376721|NCT03456713|101251898|FG001|STARTED|Overall Study||18||
48376722|NCT03456713|101251899|FG002|STARTED|Overall Study||18||
48376723|NCT03456713|101251900|FG003|STARTED|Overall Study||18||
48376724|NCT03456713|101251897|FG000|Received at Least One Dose of Study Drug|Overall Study||18||
48376725|NCT03456713|101251898|FG001|Received at Least One Dose of Study Drug|Overall Study||18||
48376726|NCT03456713|101251899|FG002|Received at Least One Dose of Study Drug|Overall Study||18||
48376727|NCT03456713|101251900|FG003|Received at Least One Dose of Study Drug|Overall Study||18||
48376728|NCT03456713|101251897|FG000|COMPLETED|Overall Study||17||
48376729|NCT03456713|101251898|FG001|COMPLETED|Overall Study||18||
48376730|NCT03456713|101251899|FG002|COMPLETED|Overall Study||18||
48376731|NCT03456713|101251900|FG003|COMPLETED|Overall Study||18||
48376732|NCT03456713|101251897|FG000|NOT COMPLETED|Overall Study||1||
48683858|NCT02965989|102009609|FG000|NOT COMPLETED|Overall Study||0||
48250310|NCT01514630|100931077|FG000|NOT COMPLETED|Overall Study||3||
48250311|NCT04225039|100931078|FG000|STARTED|Overall Study||18||
48250312|NCT04225039|100931079|FG001|STARTED|Overall Study||8||
48250313|NCT04225039|100931080|FG002|STARTED|Overall Study||8||
48250314|NCT04225039|100931081|FG003|STARTED|Overall Study||5||
48376733|NCT03456713|101251898|FG001|NOT COMPLETED|Overall Study||0||
48376734|NCT03456713|101251899|FG002|NOT COMPLETED|Overall Study||0||
48376735|NCT03456713|101251900|FG003|NOT COMPLETED|Overall Study||0||
48376736|NCT04799405|101251901|FG000|STARTED|Phase 1 - Acute Stimulation, Daily tDCS||5||
48376737|NCT04799405|101251901|FG000|COMPLETED|Phase 1 - Acute Stimulation, Daily tDCS||3||
48376738|NCT04799405|101251901|FG000|NOT COMPLETED|Phase 1 - Acute Stimulation, Daily tDCS||2||
48376739|NCT04799405|101251901|FG000|STARTED|Phase 2 - Tapered Stimulation Schedule||3||
48683859|NCT02965989|102009610|FG001|NOT COMPLETED|Overall Study||0||
48376740|NCT04799405|101251901|FG000|COMPLETED|Phase 2 - Tapered Stimulation Schedule||3||
48376741|NCT04799405|101251901|FG000|NOT COMPLETED|Phase 2 - Tapered Stimulation Schedule||0||
48376742|NCT04799405|101251901|FG000|STARTED|Phase 3 - Follow up Phase||3||
48376743|NCT04799405|101251901|FG000|COMPLETED|Phase 3 - Follow up Phase||3||
48376744|NCT04799405|101251901|FG000|NOT COMPLETED|Phase 3 - Follow up Phase||0||
48376745|NCT03059810|101251902|FG000|STARTED|Overall Study||63||
48376746|NCT03059810|101251902|FG000|COMPLETED|Overall Study||63||
48376747|NCT03059810|101251902|FG000|NOT COMPLETED|Overall Study||0||
48541090|NCT02695537|101662649|FG000|COMPLETED|Overall Study||51||
48541091|NCT02695537|101662649|FG000|NOT COMPLETED|Overall Study||38||
48541092|NCT02242045|101662650|FG000|STARTED|Overall Study||6||
48087443|NCT02743871|100537071|FG004|STARTED|Overall Study||4||
48087444|NCT02743871|100537072|FG005|STARTED|Overall Study||6||
48087445|NCT02743871|100537073|FG006|STARTED|Overall Study||6||
48087446|NCT02743871|100537074|FG007|STARTED|Overall Study||8||
48087447|NCT02743871|100537075|FG008|STARTED|Overall Study||2||
48087448|NCT02743871|100537076|FG009|STARTED|Overall Study||2||
48087449|NCT02743871|100537077|FG010|STARTED|Overall Study||11||
48087450|NCT02743871|100537078|FG011|STARTED|Overall Study||9||
48087451|NCT02743871|100537079|FG012|STARTED|Overall Study||20||
48087452|NCT02743871|100537080|FG013|STARTED|Overall Study||8||
48087453|NCT02743871|100537067|FG000|COMPLETED|Overall Study||5||
48087454|NCT02743871|100537068|FG001|COMPLETED|Overall Study||6||
48087455|NCT02743871|100537069|FG002|COMPLETED|Overall Study||6||
48087456|NCT02743871|100537070|FG003|COMPLETED|Overall Study||2||
48087457|NCT02743871|100537071|FG004|COMPLETED|Overall Study||4||
48087458|NCT02743871|100537072|FG005|COMPLETED|Overall Study||6||
48087459|NCT02743871|100537073|FG006|COMPLETED|Overall Study||5||
48087460|NCT02743871|100537074|FG007|COMPLETED|Overall Study||8||
48087461|NCT02743871|100537075|FG008|COMPLETED|Overall Study||2||
48087462|NCT02743871|100537076|FG009|COMPLETED|Overall Study||2||
48087463|NCT02743871|100537077|FG010|COMPLETED|Overall Study||10||
48087464|NCT02743871|100537078|FG011|COMPLETED|Overall Study||6||
48087465|NCT02743871|100537079|FG012|COMPLETED|Overall Study||5||
48087466|NCT02743871|100537080|FG013|COMPLETED|Overall Study||1||
48087467|NCT02743871|100537067|FG000|NOT COMPLETED|Overall Study||1||
48087468|NCT02743871|100537068|FG001|NOT COMPLETED|Overall Study||0||
48087469|NCT02743871|100537069|FG002|NOT COMPLETED|Overall Study||0||
48087470|NCT02743871|100537070|FG003|NOT COMPLETED|Overall Study||1||
48376748|NCT03007953|101251903|FG000|STARTED|Overall Study||73||
48376749|NCT03007953|101251904|FG001|STARTED|Overall Study||78||
48376750|NCT03007953|101251903|FG000|COMPLETED|Overall Study||57||
48376751|NCT03007953|101251904|FG001|COMPLETED|Overall Study||65||
48376752|NCT03007953|101251903|FG000|NOT COMPLETED|Overall Study||16||
48376753|NCT03007953|101251904|FG001|NOT COMPLETED|Overall Study||13||
48376754|NCT03650452|101251905|FG000|STARTED|Overall Study||70||
48376755|NCT03650452|101251906|FG001|STARTED|Overall Study||71||
48376756|NCT03650452|101251905|FG000|COMPLETED|Overall Study||60||
48376757|NCT03650452|101251906|FG001|COMPLETED|Overall Study||66||
48376758|NCT03650452|101251905|FG000|NOT COMPLETED|Overall Study||10||
48376759|NCT03650452|101251906|FG001|NOT COMPLETED|Overall Study||5||
48376760|NCT01994226|101251907|FG000|STARTED|Overall Study||199||
48376761|NCT01994226|101251908|FG001|STARTED|Overall Study||200||
48376762|NCT01994226|101251907|FG000|COMPLETED|Overall Study||180||
48376763|NCT01994226|101251908|FG001|COMPLETED|Overall Study||179||
48376764|NCT01994226|101251907|FG000|NOT COMPLETED|Overall Study||19||
48376765|NCT01994226|101251908|FG001|NOT COMPLETED|Overall Study||21||
48376766|NCT00125658|101251909|FG000|STARTED|Overall Study||8||
48376767|NCT00125658|101251910|FG001|STARTED|Overall Study||6||
48376768|NCT00125658|101251909|FG000|COMPLETED|Overall Study||8||
48376769|NCT00125658|101251910|FG001|COMPLETED|Overall Study||6||
48376770|NCT00125658|101251909|FG000|NOT COMPLETED|Overall Study||0||
48376771|NCT00125658|101251910|FG001|NOT COMPLETED|Overall Study||0||
48376772|NCT02874404|101251911|FG000|STARTED|Overall Study||13||
48541093|NCT02242045|101662650|FG000|COMPLETED|Overall Study||0||
48541094|NCT02242045|101662650|FG000|NOT COMPLETED|Overall Study||6||
48541095|NCT00819637|101662651|FG000|STARTED|Overall Study||2||
48541096|NCT00819637|101662652|FG001|STARTED|Overall Study||0||
48541097|NCT00819637|101662653|FG002|STARTED|Overall Study||0||
48541098|NCT00819637|101662651|FG000|COMPLETED|Overall Study||2||
48541099|NCT00819637|101662652|FG001|COMPLETED|Overall Study||0||
48541100|NCT00819637|101662653|FG002|COMPLETED|Overall Study||0||
48541101|NCT00819637|101662651|FG000|NOT COMPLETED|Overall Study||0||
48541102|NCT00819637|101662652|FG001|NOT COMPLETED|Overall Study||0||
48541103|NCT00819637|101662653|FG002|NOT COMPLETED|Overall Study||0||
48541104|NCT03316547|101662654|FG000|STARTED|Overall Study||39||
48541105|NCT03316547|101662655|FG001|STARTED|Overall Study||31||
48541106|NCT03316547|101662654|FG000|COMPLETED|Overall Study||21||
48087471|NCT02743871|100537071|FG004|NOT COMPLETED|Overall Study||0||
48376773|NCT02874404|101251911|FG000|COMPLETED|Overall Study||13||
48376774|NCT02874404|101251911|FG000|NOT COMPLETED|Overall Study||0||
48404085|NCT03689972|101321767|FG001|COMPLETED|Part 2:Run-in Period (Week73uptoWeek107)||0||
48541107|NCT03316547|101662655|FG001|COMPLETED|Overall Study||18||
48541108|NCT03316547|101662654|FG000|NOT COMPLETED|Overall Study||18||
48541109|NCT03316547|101662655|FG001|NOT COMPLETED|Overall Study||13||
48683860|NCT00427011|102009611|FG000|STARTED|Overall Study||25||
48683861|NCT00427011|102009611|FG000|COMPLETED|Overall Study||0||
48683862|NCT00427011|102009611|FG000|NOT COMPLETED|Overall Study||25||
48683863|NCT03306433|102009612|FG000|STARTED|Overall Study||16||
48683864|NCT03306433|102009612|FG000|UDMA-K18|Overall Study||12||
48683865|NCT03306433|102009612|FG000|Adhesive Control|Overall Study||12||
48541110|NCT03541980|101662656|FG000|STARTED|Overall Study||35||
48683866|NCT03306433|102009612|FG000|UDMA-control|Overall Study||9||
48683867|NCT03306433|102009612|FG000|COMPLETED|Overall Study||9||
48683868|NCT03306433|102009612|FG000|NOT COMPLETED|Overall Study||7||
48683869|NCT03175731|102009613|FG000|STARTED|Overall Study||53||
48683870|NCT03175731|102009614|FG001|STARTED|Overall Study||53||
48683871|NCT03175731|102009613|FG000|COMPLETED|Overall Study||46||
48683872|NCT03175731|102009614|FG001|COMPLETED|Overall Study||48||
48683873|NCT03175731|102009613|FG000|NOT COMPLETED|Overall Study||7||
48541111|NCT03541980|101662657|FG001|STARTED|Overall Study||36||
48541112|NCT03541980|101662656|FG000|COMPLETED|Overall Study||35||
48541113|NCT03541980|101662657|FG001|COMPLETED|Overall Study||36||
48683874|NCT03175731|102009614|FG001|NOT COMPLETED|Overall Study||5||
48683875|NCT00825994|102009615|FG000|STARTED|Overall Study||24||
48683876|NCT00825994|102009615|FG000|COMPLETED|Overall Study||19||
48683877|NCT00825994|102009615|FG000|NOT COMPLETED|Overall Study||5||
48683878|NCT00856323|102009616|FG000|STARTED|Overall Study||53||
48683879|NCT00856323|102009616|FG000|COMPLETED|Overall Study||51||
48683880|NCT00856323|102009616|FG000|NOT COMPLETED|Overall Study||2||
48087472|NCT02743871|100537072|FG005|NOT COMPLETED|Overall Study||0||
48087473|NCT02743871|100537073|FG006|NOT COMPLETED|Overall Study||1||
48087474|NCT02743871|100537074|FG007|NOT COMPLETED|Overall Study||0||
48087475|NCT02743871|100537075|FG008|NOT COMPLETED|Overall Study||0||
48087476|NCT02743871|100537076|FG009|NOT COMPLETED|Overall Study||0||
48087477|NCT02743871|100537077|FG010|NOT COMPLETED|Overall Study||1||
48541114|NCT03541980|101662656|FG000|NOT COMPLETED|Overall Study||0||
48541115|NCT03541980|101662657|FG001|NOT COMPLETED|Overall Study||0||
48541116|NCT01590277|101662658|FG000|STARTED|Overall Study||33||
48541117|NCT01590277|101662658|FG000|Active Ethanol and Placebo Iomazenil|Overall Study||31||
48541118|NCT01590277|101662658|FG000|Active Ethanol and Active Iomazenil|Overall Study||30||
48683881|NCT00753948|102009617|FG000|STARTED|Overall Study||9||
48683882|NCT00753948|102009618|FG001|STARTED|Overall Study||7||
48683883|NCT00753948|102009619|FG002|STARTED|Overall Study||7||
48087478|NCT02743871|100537078|FG011|NOT COMPLETED|Overall Study||3||
48087479|NCT02743871|100537079|FG012|NOT COMPLETED|Overall Study||15||
48087480|NCT02743871|100537080|FG013|NOT COMPLETED|Overall Study||7||
48087481|NCT00644995|100537081|FG000|STARTED|Overall Study||25||
48087482|NCT00644995|100537082|FG001|STARTED|Overall Study||27||
48087483|NCT00644995|100537081|FG000|Completed 4 Month Assessment|Overall Study||23||
48087484|NCT00644995|100537082|FG001|Completed 4 Month Assessment|Overall Study||24||
48087485|NCT00644995|100537081|FG000|COMPLETED|Overall Study||23||
48087486|NCT00644995|100537082|FG001|COMPLETED|Overall Study||23||
48250315|NCT04225039|100931078|FG000|COMPLETED|Overall Study||15||
48683884|NCT00753948|102009617|FG000|COMPLETED|Overall Study||9||
48087487|NCT00644995|100537081|FG000|NOT COMPLETED|Overall Study||2||
48087488|NCT00644995|100537082|FG001|NOT COMPLETED|Overall Study||4||
48087489|NCT00004978|100537083|FG000|STARTED|Overall Study||2090||
48087490|NCT00004978|100537084|FG001|STARTED|Overall Study||2060||
48087491|NCT00004978|100537083|FG000|COMPLETED|Overall Study||1846||
48087492|NCT00004978|100537084|FG001|COMPLETED|Overall Study||1790||
48087493|NCT00004978|100537083|FG000|NOT COMPLETED|Overall Study||244||
48087494|NCT00004978|100537084|FG001|NOT COMPLETED|Overall Study||270||
48087495|NCT02507505|100537085|FG000|STARTED|Overall Study||795||
48087496|NCT02507505|100537086|FG001|STARTED|Overall Study||805||
48087497|NCT02507505|100537085|FG000|COMPLETED|Overall Study||712||
48087498|NCT02507505|100537086|FG001|COMPLETED|Overall Study||733||
48087499|NCT02507505|100537085|FG000|NOT COMPLETED|Overall Study||83||
48250316|NCT04225039|100931079|FG001|COMPLETED|Overall Study||7||
48250317|NCT04225039|100931080|FG002|COMPLETED|Overall Study||8||
48592683|NCT01877382|101783155|FG005|COMPLETED|Dose Expansion||0||
48683885|NCT00753948|102009618|FG001|COMPLETED|Overall Study||7||
48683886|NCT00753948|102009619|FG002|COMPLETED|Overall Study||7||
48683887|NCT00753948|102009617|FG000|NOT COMPLETED|Overall Study||0||
48376775|NCT04321252|101251912|FG000|STARTED|Overall Study||6|All enrolled participants were included in the Randomized Set and in the Safety Analysis Set|
48376776|NCT04321252|101251913|FG001|STARTED|Overall Study||6|All enrolled participants were included in the Randomized Set and in the Safety Analysis Set|
48376777|NCT04321252|101251914|FG002|STARTED|Overall Study||6|All enrolled participants were included in the Randomized Set and in the Safety Analysis Set|
48376778|NCT04321252|101251915|FG003|STARTED|Overall Study||6|All enrolled participants were included in the Randomized Set and in the Safety Analysis Set|
48376779|NCT04321252|101251916|FG004|STARTED|Overall Study||6|All enrolled participants were included in the Randomized Set and in the Safety Analysis Set|
48376780|NCT04321252|101251917|FG005|STARTED|Overall Study||9|All enrolled participants were included in the Randomized Set and in the Safety Analysis Set|
48376781|NCT04321252|101251918|FG006|STARTED|Overall Study||6|All enrolled participants were included in the Randomized Set and in the Safety Analysis Set|
48376782|NCT04321252|101251919|FG007|STARTED|Overall Study||6|All enrolled participants were included in the Randomized Set and in the Safety Analysis Set|
48541119|NCT01590277|101662658|FG000|Placebo Ethanol and Active Iomazenil|Overall Study||32||
48683888|NCT00753948|102009618|FG001|NOT COMPLETED|Overall Study||0||
48087500|NCT02507505|100537086|FG001|NOT COMPLETED|Overall Study||72||
48087501|NCT03336853|100537087|FG000|STARTED|Overall Study||30||
48376783|NCT04321252|101251920|FG008|STARTED|Overall Study||6|All enrolled participants were included in the Randomized Set and in the Safety Analysis Set|
48376784|NCT04321252|101251912|FG000|PK Analysis Set|Overall Study||6|All KAE609-treated participants were included in the PK analysis set|
48376785|NCT04321252|101251913|FG001|PK Analysis Set|Overall Study||6|All KAE609-treated participants were included in the PK analysis set|
48376786|NCT04321252|101251914|FG002|PK Analysis Set|Overall Study||6|All KAE609-treated participants were included in the PK analysis set|
48376787|NCT04321252|101251915|FG003|PK Analysis Set|Overall Study||6|All KAE609-treated participants were included in the PK analysis set|
48541120|NCT01590277|101662658|FG000|Placebo Ethanol and Placebo Iomazenil|Overall Study||32||
48541121|NCT01590277|101662658|FG000|COMPLETED|Overall Study||26||
48541122|NCT01590277|101662658|FG000|NOT COMPLETED|Overall Study||7||
48541123|NCT00340678|101662659|FG000|STARTED|Overall Study||46||
48541124|NCT00340678|101662660|FG001|STARTED|Overall Study||46||
48541125|NCT00340678|101662661|FG002|STARTED|Overall Study||39||
48541126|NCT00340678|101662662|FG003|STARTED|Overall Study||39||
48541127|NCT00340678|101662659|FG000|COMPLETED|Overall Study||45||
48541128|NCT00340678|101662660|FG001|COMPLETED|Overall Study||46||
48541129|NCT00340678|101662661|FG002|COMPLETED|Overall Study||39||
48541130|NCT00340678|101662662|FG003|COMPLETED|Overall Study||39||
48541131|NCT00340678|101662659|FG000|NOT COMPLETED|Overall Study||1||
48541132|NCT00340678|101662660|FG001|NOT COMPLETED|Overall Study||0||
48541133|NCT00340678|101662661|FG002|NOT COMPLETED|Overall Study||0||
48541134|NCT00340678|101662662|FG003|NOT COMPLETED|Overall Study||0||
48541135|NCT03629080|101662663|FG000|STARTED|Overall Study||12||
48541136|NCT03629080|101662664|FG001|STARTED|Overall Study||5||
48541137|NCT03629080|101662665|FG002|STARTED|Overall Study||35||
48541138|NCT03629080|101662666|FG003|STARTED|Overall Study||17||
48541139|NCT03629080|101662667|FG004|STARTED|Overall Study||10||
48541140|NCT03629080|101662668|FG005|STARTED|Overall Study||4||
48541141|NCT03629080|101662663|FG000|COMPLETED|Overall Study||10||
48541142|NCT03629080|101662664|FG001|COMPLETED|Overall Study||4||
48541143|NCT03629080|101662665|FG002|COMPLETED|Overall Study||22||
48541144|NCT03629080|101662666|FG003|COMPLETED|Overall Study||16||
48541145|NCT03629080|101662667|FG004|COMPLETED|Overall Study||6||
48541146|NCT03629080|101662668|FG005|COMPLETED|Overall Study||3||
48541147|NCT03629080|101662663|FG000|NOT COMPLETED|Overall Study||2||
48541148|NCT03629080|101662664|FG001|NOT COMPLETED|Overall Study||1||
48683889|NCT00753948|102009619|FG002|NOT COMPLETED|Overall Study||0||
48683890|NCT01900067|102009620|FG000|STARTED|Overall Study||134||
48683891|NCT01900067|102009621|FG001|STARTED|Overall Study||137||
48683892|NCT01900067|102009620|FG000|COMPLETED|Overall Study||122||
48683893|NCT01900067|102009621|FG001|COMPLETED|Overall Study||124||
48683894|NCT01900067|102009620|FG000|NOT COMPLETED|Overall Study||12||
48683895|NCT01900067|102009621|FG001|NOT COMPLETED|Overall Study||13||
48683896|NCT00980148|102009622|FG000|STARTED|Overall Study||284||
48683897|NCT00980148|102009623|FG001|STARTED|Overall Study||283||
48087502|NCT03336853|100537088|FG001|STARTED|Overall Study||30||
48541149|NCT03629080|101662665|FG002|NOT COMPLETED|Overall Study||13||
48541150|NCT03629080|101662666|FG003|NOT COMPLETED|Overall Study||1||
48541151|NCT03629080|101662667|FG004|NOT COMPLETED|Overall Study||4||
48541152|NCT03629080|101662668|FG005|NOT COMPLETED|Overall Study||1||
48541153|NCT03149757|101662669|FG000|STARTED|Overall Study||103||
48541154|NCT03149757|101662670|FG001|STARTED|Overall Study||105||
48683898|NCT00980148|102009622|FG000|COMPLETED|Overall Study||155||
48683899|NCT00980148|102009623|FG001|COMPLETED|Overall Study||155||
48376788|NCT04321252|101251916|FG004|PK Analysis Set|Overall Study||6|All KAE609-treated participants were included in the PK analysis set|
48376789|NCT04321252|101251917|FG005|PK Analysis Set|Overall Study||0|All KAE609-treated participants were included in the PK analysis set|
48376790|NCT04321252|101251918|FG006|PK Analysis Set|Overall Study||6|All KAE609-treated participants were included in the PK analysis set|
48376791|NCT04321252|101251919|FG007|PK Analysis Set|Overall Study||6|All KAE609-treated participants were included in the PK analysis set|
48376792|NCT04321252|101251920|FG008|PK Analysis Set|Overall Study||0|All KAE609-treated participants were included in the PK analysis set|
48376793|NCT04321252|101251912|FG000|COMPLETED|Overall Study||6||
48376794|NCT04321252|101251913|FG001|COMPLETED|Overall Study||6||
48376795|NCT04321252|101251914|FG002|COMPLETED|Overall Study||6||
48376796|NCT04321252|101251915|FG003|COMPLETED|Overall Study||6||
48376797|NCT04321252|101251916|FG004|COMPLETED|Overall Study||6||
48376798|NCT04321252|101251917|FG005|COMPLETED|Overall Study||8||
48376799|NCT04321252|101251918|FG006|COMPLETED|Overall Study||6||
48376800|NCT04321252|101251919|FG007|COMPLETED|Overall Study||6||
48376801|NCT04321252|101251920|FG008|COMPLETED|Overall Study||6||
48376802|NCT04321252|101251912|FG000|NOT COMPLETED|Overall Study||0||
48376803|NCT04321252|101251913|FG001|NOT COMPLETED|Overall Study||0||
48376804|NCT04321252|101251914|FG002|NOT COMPLETED|Overall Study||0||
48376805|NCT04321252|101251915|FG003|NOT COMPLETED|Overall Study||0||
48376806|NCT04321252|101251916|FG004|NOT COMPLETED|Overall Study||0||
48376807|NCT04321252|101251917|FG005|NOT COMPLETED|Overall Study||1||
48376808|NCT04321252|101251918|FG006|NOT COMPLETED|Overall Study||0||
48376809|NCT04321252|101251919|FG007|NOT COMPLETED|Overall Study||0||
48376810|NCT04321252|101251920|FG008|NOT COMPLETED|Overall Study||0||
48376811|NCT01753076|101251921|FG000|STARTED|Overall Study||151||
48376812|NCT01753076|101251922|FG001|STARTED|Overall Study||152||
48376813|NCT01753076|101251921|FG000|COMPLETED|Overall Study||110||
48376814|NCT01753076|101251922|FG001|COMPLETED|Overall Study||106||
48376815|NCT01753076|101251921|FG000|NOT COMPLETED|Overall Study||41||
48376816|NCT01753076|101251922|FG001|NOT COMPLETED|Overall Study||46||
48376817|NCT01331239|101251923|FG000|STARTED|Part I: Core Study||12||
48376818|NCT01331239|101251924|FG001|STARTED|Part I: Core Study||0||
48376819|NCT01331239|101251925|FG002|STARTED|Part I: Core Study||0||
48376820|NCT01331239|101251923|FG000|COMPLETED|Part I: Core Study||12||
48376821|NCT01331239|101251924|FG001|COMPLETED|Part I: Core Study||0||
48376822|NCT01331239|101251925|FG002|COMPLETED|Part I: Core Study||0||
48376823|NCT01331239|101251923|FG000|NOT COMPLETED|Part I: Core Study||0||
48376824|NCT01331239|101251924|FG001|NOT COMPLETED|Part I: Core Study||0||
48376825|NCT01331239|101251925|FG002|NOT COMPLETED|Part I: Core Study||0||
48376826|NCT01331239|101251923|FG000|STARTED|Part II: Core Study||0||
48376827|NCT01331239|101251924|FG001|STARTED|Part II: Core Study||15||
48683900|NCT00980148|102009622|FG000|NOT COMPLETED|Overall Study||129||
48683901|NCT00980148|102009623|FG001|NOT COMPLETED|Overall Study||128||
48683902|NCT03886493|102009624|FG000|STARTED|Overall Study||7||
48683903|NCT03886493|102009624|FG000|COMPLETED|Overall Study||6||
48683904|NCT03886493|102009624|FG000|NOT COMPLETED|Overall Study||1||
48376828|NCT01331239|101251925|FG002|STARTED|Part II: Core Study||4||
48376829|NCT01331239|101251923|FG000|COMPLETED|Part II: Core Study||0||
48376830|NCT01331239|101251924|FG001|COMPLETED|Part II: Core Study||7||
48376831|NCT01331239|101251925|FG002|COMPLETED|Part II: Core Study||3||
48376832|NCT01331239|101251923|FG000|NOT COMPLETED|Part II: Core Study||0||
48376833|NCT01331239|101251924|FG001|NOT COMPLETED|Part II: Core Study||8||
48376834|NCT01331239|101251925|FG002|NOT COMPLETED|Part II: Core Study||1||
48376835|NCT00008138|101251926|FG000|STARTED|Neoadjuvant Chemotherapy||58||
48376836|NCT00008138|101251926|FG000|Eligible|Neoadjuvant Chemotherapy||58||
48376837|NCT00008138|101251926|FG000|COMPLETED|Neoadjuvant Chemotherapy||38||
48376838|NCT00008138|101251926|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||20||
48376839|NCT00008138|101251926|FG000|STARTED|Interval Debulking||38||
48376840|NCT00008138|101251926|FG000|Received Protocol Surgery|Interval Debulking||36||
48376841|NCT00008138|101251926|FG000|COMPLETED|Interval Debulking||36||
48376842|NCT00008138|101251926|FG000|NOT COMPLETED|Interval Debulking||2||
48376843|NCT00008138|101251926|FG000|STARTED|Post-Cytoreduction Chemotherapy||26||
48376844|NCT00008138|101251926|FG000|COMPLETED|Post-Cytoreduction Chemotherapy||18||
48376845|NCT00008138|101251926|FG000|NOT COMPLETED|Post-Cytoreduction Chemotherapy||8||
48376846|NCT00366548|101251927|FG000|STARTED|Infant Series||250||
48376847|NCT00366548|101251928|FG001|STARTED|Infant Series||250||
48683905|NCT00142792|102009625|FG000|STARTED|Overall Study||39||
48683906|NCT00142792|102009626|FG001|STARTED|Overall Study||41||
48683907|NCT00142792|102009627|FG002|STARTED|Overall Study||42||
48683908|NCT00142792|102009625|FG000|Completed Intervention|Overall Study||35||
48376848|NCT00366548|101251927|FG000|Vaccinated Dose 1|Infant Series||250||
48376849|NCT00366548|101251928|FG001|Vaccinated Dose 1|Infant Series||250||
48376850|NCT00366548|101251927|FG000|Vaccinated Dose 2|Infant Series||246||
48376851|NCT00366548|101251928|FG001|Vaccinated Dose 2|Infant Series||249||
48376852|NCT00366548|101251927|FG000|Vaccinated Dose 3|Infant Series||246||
48376853|NCT00366548|101251928|FG001|Vaccinated Dose 3|Infant Series||247||
48376854|NCT00366548|101251927|FG000|COMPLETED|Infant Series||246||
48376855|NCT00366548|101251928|FG001|COMPLETED|Infant Series||245||
48683909|NCT00142792|102009626|FG001|Completed Intervention|Overall Study||37||
48376856|NCT00366548|101251927|FG000|NOT COMPLETED|Infant Series||4||
48376857|NCT00366548|101251928|FG001|NOT COMPLETED|Infant Series||5||
48376858|NCT00366548|101251927|FG000|STARTED|After Infant Series||246||
48376859|NCT00366548|101251928|FG001|STARTED|After Infant Series||245||
48376860|NCT00366548|101251927|FG000|COMPLETED|After Infant Series||240||
48376861|NCT00366548|101251928|FG001|COMPLETED|After Infant Series||244||
48376862|NCT00366548|101251927|FG000|NOT COMPLETED|After Infant Series||6||
48376863|NCT00366548|101251928|FG001|NOT COMPLETED|After Infant Series||1||
48376864|NCT00366548|101251927|FG000|STARTED|Toddler Dose||240||
48376865|NCT00366548|101251928|FG001|STARTED|Toddler Dose||244||
48376866|NCT00366548|101251927|FG000|COMPLETED|Toddler Dose||240||
48376867|NCT00366548|101251928|FG001|COMPLETED|Toddler Dose||244||
48376868|NCT00366548|101251927|FG000|NOT COMPLETED|Toddler Dose||0||
48376869|NCT00366548|101251928|FG001|NOT COMPLETED|Toddler Dose||0||
48376870|NCT00611897|101251929|FG000|STARTED|Day 1: Initial Treatment||8||
48376871|NCT00611897|101251930|FG001|STARTED|Day 1: Initial Treatment||8||
48376872|NCT00611897|101251929|FG000|COMPLETED|Day 1: Initial Treatment||8||
48376873|NCT00611897|101251930|FG001|COMPLETED|Day 1: Initial Treatment||8||
48376874|NCT00611897|101251929|FG000|NOT COMPLETED|Day 1: Initial Treatment||0||
48376875|NCT00611897|101251930|FG001|NOT COMPLETED|Day 1: Initial Treatment||0||
48376876|NCT00611897|101251929|FG000|STARTED|Day 2: Crossover Treatment||8||
48376877|NCT00611897|101251930|FG001|STARTED|Day 2: Crossover Treatment||8||
48376878|NCT00611897|101251929|FG000|COMPLETED|Day 2: Crossover Treatment||8||
48376879|NCT00611897|101251930|FG001|COMPLETED|Day 2: Crossover Treatment||8||
48376880|NCT00611897|101251929|FG000|NOT COMPLETED|Day 2: Crossover Treatment||0||
48376881|NCT00611897|101251930|FG001|NOT COMPLETED|Day 2: Crossover Treatment||0||
48376882|NCT02935634|101251931|FG000|STARTED|Randomization||42||
48376883|NCT02935634|101251932|FG001|STARTED|Randomization||54||
48376884|NCT02935634|101251933|FG002|STARTED|Randomization||62||
48376885|NCT02935634|101251934|FG003|STARTED|Randomization||12||
48376886|NCT02935634|101251935|FG004|STARTED|Randomization||10||
48376887|NCT02935634|101251936|FG005|STARTED|Randomization||10||
48376888|NCT02935634|101251931|FG000|Randomized to Track 1|Randomization||23||
48376889|NCT02935634|101251932|FG001|Randomized to Track 1|Randomization||22||
48376890|NCT02935634|101251933|FG002|Randomized to Track 1|Randomization||38||
48376891|NCT02935634|101251934|FG003|Randomized to Track 1|Randomization||7||
48376892|NCT02935634|101251935|FG004|Randomized to Track 1|Randomization||8||
48376893|NCT02935634|101251936|FG005|Randomized to Track 1|Randomization||6||
48376894|NCT02935634|101251931|FG000|Randomized to Track 2|Randomization||19||
48376895|NCT02935634|101251932|FG001|Randomized to Track 2|Randomization||32||
48376896|NCT02935634|101251933|FG002|Randomized to Track 2|Randomization||24||
48376897|NCT02935634|101251934|FG003|Randomized to Track 2|Randomization||5||
48376898|NCT02935634|101251935|FG004|Randomized to Track 2|Randomization||2||
48376899|NCT02935634|101251936|FG005|Randomized to Track 2|Randomization||4||
48376900|NCT02935634|101251931|FG000|COMPLETED|Randomization||40||
48376901|NCT02935634|101251932|FG001|COMPLETED|Randomization||50||
48376902|NCT02935634|101251933|FG002|COMPLETED|Randomization||59||
48376903|NCT02935634|101251934|FG003|COMPLETED|Randomization||12||
48376904|NCT02935634|101251935|FG004|COMPLETED|Randomization||10||
48376905|NCT02935634|101251936|FG005|COMPLETED|Randomization||10||
48376906|NCT02935634|101251931|FG000|NOT COMPLETED|Randomization||2||
48376907|NCT02935634|101251932|FG001|NOT COMPLETED|Randomization||4||
48376908|NCT02935634|101251933|FG002|NOT COMPLETED|Randomization||3||
48376909|NCT02935634|101251934|FG003|NOT COMPLETED|Randomization||0||
48376910|NCT02935634|101251935|FG004|NOT COMPLETED|Randomization||0||
48376911|NCT02935634|101251936|FG005|NOT COMPLETED|Randomization||0||
48376912|NCT02935634|101251931|FG000|STARTED|Treatment: Track 1||23|Treatment naive participants|
48376913|NCT02935634|101251932|FG001|STARTED|Treatment: Track 1||20|Treatment naive participants|
48376914|NCT02935634|101251933|FG002|STARTED|Treatment: Track 1||38|Treatment naive participants|
48376915|NCT02935634|101251934|FG003|STARTED|Treatment: Track 1||7|Treatment naive participants|
48376916|NCT02935634|101251935|FG004|STARTED|Treatment: Track 1||8|Treatment naive participants|
48376917|NCT02935634|101251936|FG005|STARTED|Treatment: Track 1||6|Treatment naive participants|
48376918|NCT02935634|101251931|FG000|Re-Randomized to Track 2|Treatment: Track 1||2||
48376919|NCT02935634|101251932|FG001|Re-Randomized to Track 2|Treatment: Track 1||3||
48376920|NCT02935634|101251933|FG002|Re-Randomized to Track 2|Treatment: Track 1||3||
48376921|NCT02935634|101251934|FG003|Re-Randomized to Track 2|Treatment: Track 1||0||
48376922|NCT02935634|101251935|FG004|Re-Randomized to Track 2|Treatment: Track 1||0||
48376923|NCT02935634|101251936|FG005|Re-Randomized to Track 2|Treatment: Track 1||0||
48376924|NCT02935634|101251931|FG000|COMPLETED|Treatment: Track 1||1||
48376925|NCT02935634|101251932|FG001|COMPLETED|Treatment: Track 1||1||
48376926|NCT02935634|101251933|FG002|COMPLETED|Treatment: Track 1||1||
48376927|NCT02935634|101251934|FG003|COMPLETED|Treatment: Track 1||0||
48376928|NCT02935634|101251935|FG004|COMPLETED|Treatment: Track 1||0||
48376929|NCT02935634|101251936|FG005|COMPLETED|Treatment: Track 1||0||
48087503|NCT03336853|100537087|FG000|COMPLETED|Overall Study||30||
48087504|NCT03336853|100537088|FG001|COMPLETED|Overall Study||30||
48376930|NCT02935634|101251931|FG000|NOT COMPLETED|Treatment: Track 1||22||
48376931|NCT02935634|101251932|FG001|NOT COMPLETED|Treatment: Track 1||19||
48376932|NCT02935634|101251933|FG002|NOT COMPLETED|Treatment: Track 1||37||
48376933|NCT02935634|101251934|FG003|NOT COMPLETED|Treatment: Track 1||7||
48376934|NCT02935634|101251935|FG004|NOT COMPLETED|Treatment: Track 1||8||
48376935|NCT02935634|101251936|FG005|NOT COMPLETED|Treatment: Track 1||6||
48376936|NCT02935634|101251931|FG000|STARTED|Treatment: Track 2||23|Treatment experienced participants|
48376937|NCT02935634|101251932|FG001|STARTED|Treatment: Track 2||36|Treatment experienced participants|
48376938|NCT02935634|101251933|FG002|STARTED|Treatment: Track 2||22|Treatment experienced participants|
48376939|NCT02935634|101251934|FG003|STARTED|Treatment: Track 2||6|Treatment experienced participants|
48376940|NCT02935634|101251935|FG004|STARTED|Treatment: Track 2||2|Treatment experienced participants|
48376941|NCT02935634|101251936|FG005|STARTED|Treatment: Track 2||4|Treatment experienced participants|
48376942|NCT02935634|101251931|FG000|No Pre-Randomization|Treatment: Track 2||17||
48376943|NCT02935634|101251932|FG001|No Pre-Randomization|Treatment: Track 2||30||
48376944|NCT02935634|101251933|FG002|No Pre-Randomization|Treatment: Track 2||21||
48376945|NCT02935634|101251934|FG003|No Pre-Randomization|Treatment: Track 2||5||
48376946|NCT02935634|101251935|FG004|No Pre-Randomization|Treatment: Track 2||2||
48376947|NCT02935634|101251936|FG005|No Pre-Randomization|Treatment: Track 2||4||
48376948|NCT02935634|101251931|FG000|Re-Randomized From Track 1 Nivolumab + Relatlimab|Treatment: Track 2||1||
48376949|NCT02935634|101251932|FG001|Re-Randomized From Track 1 Nivolumab + Relatlimab|Treatment: Track 2||0||
48376950|NCT02935634|101251933|FG002|Re-Randomized From Track 1 Nivolumab + Relatlimab|Treatment: Track 2||1||
48376951|NCT02935634|101251934|FG003|Re-Randomized From Track 1 Nivolumab + Relatlimab|Treatment: Track 2||1||
48376952|NCT02935634|101251935|FG004|Re-Randomized From Track 1 Nivolumab + Relatlimab|Treatment: Track 2||0||
48376953|NCT02935634|101251936|FG005|Re-Randomized From Track 1 Nivolumab + Relatlimab|Treatment: Track 2||0||
48376954|NCT02935634|101251931|FG000|Re-Randomized From Track 1 Nivolumab + Ipilimumab|Treatment: Track 2||2||
48376955|NCT02935634|101251932|FG001|Re-Randomized From Track 1 Nivolumab + Ipilimumab|Treatment: Track 2||1||
48376956|NCT02935634|101251933|FG002|Re-Randomized From Track 1 Nivolumab + Ipilimumab|Treatment: Track 2||0||
48376957|NCT02935634|101251934|FG003|Re-Randomized From Track 1 Nivolumab + Ipilimumab|Treatment: Track 2||0||
48376958|NCT02935634|101251935|FG004|Re-Randomized From Track 1 Nivolumab + Ipilimumab|Treatment: Track 2||0||
48376959|NCT02935634|101251936|FG005|Re-Randomized From Track 1 Nivolumab + Ipilimumab|Treatment: Track 2||0||
48376960|NCT02935634|101251931|FG000|Re-Randomized From Track 2 Nivolumab + Relatlimab|Treatment: Track 2||0||
48541155|NCT03149757|101662669|FG000|COMPLETED|Overall Study||96||
48683910|NCT00142792|102009627|FG002|Completed Intervention|Overall Study||37||
48683911|NCT00142792|102009625|FG000|COMPLETED|Overall Study||27||
48683912|NCT00142792|102009626|FG001|COMPLETED|Overall Study||26||
48683913|NCT00142792|102009627|FG002|COMPLETED|Overall Study||30||
48683914|NCT00142792|102009625|FG000|NOT COMPLETED|Overall Study||12||
48683915|NCT00142792|102009626|FG001|NOT COMPLETED|Overall Study||15||
48683916|NCT00142792|102009627|FG002|NOT COMPLETED|Overall Study||12||
48683917|NCT01369199|102009628|FG000|STARTED|Overall Study||28||
48683918|NCT01369199|102009628|FG000|End of Treatment (EOT)|Overall Study||26||
48683919|NCT01369199|102009628|FG000|COMPLETED|Overall Study||25|End of follow-up|
48683920|NCT01369199|102009628|FG000|NOT COMPLETED|Overall Study||3||
48683921|NCT02359006|102009629|FG000|STARTED|Overall Study||14||
48683922|NCT02359006|102009630|FG001|STARTED|Overall Study||13||
48683923|NCT02359006|102009629|FG000|COMPLETED|Overall Study||10||
48087505|NCT03336853|100537087|FG000|NOT COMPLETED|Overall Study||0||
48087506|NCT03336853|100537088|FG001|NOT COMPLETED|Overall Study||0||
48087507|NCT02707991|100537089|FG000|STARTED|Overall Study||33||
48087508|NCT02707991|100537090|FG001|STARTED|Overall Study||35||
48087509|NCT02707991|100537089|FG000|Day 60 Data Collectio|Overall Study||32||
48087510|NCT02707991|100537090|FG001|Day 60 Data Collectio|Overall Study||34||
48087511|NCT02707991|100537089|FG000|Month 6 Data Collection|Overall Study||32||
48087512|NCT02707991|100537090|FG001|Month 6 Data Collection|Overall Study||34||
48087513|NCT02707991|100537089|FG000|COMPLETED|Overall Study||32||
48087514|NCT02707991|100537090|FG001|COMPLETED|Overall Study||34||
48087515|NCT02707991|100537089|FG000|NOT COMPLETED|Overall Study||1||
48087516|NCT02707991|100537090|FG001|NOT COMPLETED|Overall Study||1||
48087517|NCT00869349|100537091|FG000|STARTED|Overall Study||39||
48087518|NCT00869349|100537092|FG001|STARTED|Overall Study||40||
48087519|NCT00869349|100537091|FG000|COMPLETED|Overall Study||32||
48087520|NCT00869349|100537092|FG001|COMPLETED|Overall Study||36||
48087521|NCT00869349|100537091|FG000|NOT COMPLETED|Overall Study||7||
48087522|NCT00869349|100537092|FG001|NOT COMPLETED|Overall Study||4||
48087523|NCT03454893|100537093|FG000|STARTED|Overall Study||15||
48087524|NCT03454893|100537093|FG000|Safety Population|Overall Study||11||
48087525|NCT03454893|100537093|FG000|Infused Population|Overall Study||9||
48087526|NCT03454893|100537093|FG000|COMPLETED|Overall Study||6||
48087527|NCT03454893|100537093|FG000|NOT COMPLETED|Overall Study||9||
48087528|NCT00587639|100537094|FG000|STARTED|Overall Study||8||
48087529|NCT00587639|100537094|FG000|COMPLETED|Overall Study||7||
48087530|NCT00587639|100537094|FG000|NOT COMPLETED|Overall Study||1||
48087531|NCT02692716|100537095|FG000|STARTED|Overall Study||1591||
48087532|NCT02692716|100537096|FG001|STARTED|Overall Study||1592||
48087533|NCT02692716|100537095|FG000|Full Analysis Set (FAS)|Overall Study||1591||
48087534|NCT02692716|100537096|FG001|Full Analysis Set (FAS)|Overall Study||1592||
48087535|NCT02692716|100537095|FG000|Exposed|Overall Study||1591||
48087536|NCT02692716|100537096|FG001|Exposed|Overall Study||1591||
48087537|NCT02692716|100537095|FG000|COMPLETED|Overall Study||1586||
48087538|NCT02692716|100537096|FG001|COMPLETED|Overall Study||1586||
48087539|NCT02692716|100537095|FG000|NOT COMPLETED|Overall Study||5||
48087540|NCT02692716|100537096|FG001|NOT COMPLETED|Overall Study||6||
48087541|NCT01549860|100537097|FG000|STARTED|Overall Study||40||
48087542|NCT01549860|100537098|FG001|STARTED|Overall Study||41||
48087543|NCT01549860|100537097|FG000|COMPLETED|Overall Study||38||
48087544|NCT01549860|100537098|FG001|COMPLETED|Overall Study||40||
48087545|NCT01549860|100537097|FG000|NOT COMPLETED|Overall Study||2||
48087546|NCT01549860|100537098|FG001|NOT COMPLETED|Overall Study||1||
48087547|NCT02417701|100537099|FG000|STARTED|Overall Study||34||
48087548|NCT02417701|100537099|FG000|COMPLETED|Overall Study||34||
48087549|NCT02417701|100537099|FG000|NOT COMPLETED|Overall Study||0||
48087550|NCT01581931|100537100|FG000|STARTED|First Period||16||
48087551|NCT01581931|100537101|FG001|STARTED|First Period||16||
48087552|NCT01581931|100537100|FG000|COMPLETED|First Period||16||
48087553|NCT01581931|100537101|FG001|COMPLETED|First Period||16||
48087554|NCT01581931|100537100|FG000|NOT COMPLETED|First Period||0||
48087555|NCT01581931|100537101|FG001|NOT COMPLETED|First Period||0||
48087556|NCT01581931|100537100|FG000|STARTED|Washout||16||
48087557|NCT01581931|100537101|FG001|STARTED|Washout||16||
48087558|NCT01581931|100537100|FG000|COMPLETED|Washout||16||
48087559|NCT01581931|100537101|FG001|COMPLETED|Washout||15||
48087560|NCT01581931|100537100|FG000|NOT COMPLETED|Washout||0||
48087561|NCT01581931|100537101|FG001|NOT COMPLETED|Washout||1||
48087562|NCT01581931|100537100|FG000|STARTED|Second Period||16||
48087563|NCT01581931|100537101|FG001|STARTED|Second Period||15||
48087564|NCT01581931|100537100|FG000|COMPLETED|Second Period||16||
48087565|NCT01581931|100537101|FG001|COMPLETED|Second Period||15||
48087566|NCT01581931|100537100|FG000|NOT COMPLETED|Second Period||0||
48087567|NCT01581931|100537101|FG001|NOT COMPLETED|Second Period||0||
48087568|NCT01411228|100537102|FG000|STARTED|Overall Study||5||
48087569|NCT01411228|100537103|FG001|STARTED|Overall Study||5||
48087570|NCT01411228|100537104|FG002|STARTED|Overall Study||5||
48087571|NCT01411228|100537102|FG000|COMPLETED|Overall Study||4||
48087572|NCT01411228|100537103|FG001|COMPLETED|Overall Study||5||
48087573|NCT01411228|100537104|FG002|COMPLETED|Overall Study||4||
48087574|NCT01411228|100537102|FG000|NOT COMPLETED|Overall Study||1||
48087575|NCT01411228|100537103|FG001|NOT COMPLETED|Overall Study||0||
48087576|NCT01411228|100537104|FG002|NOT COMPLETED|Overall Study||1||
48087577|NCT00867009|100537105|FG000|STARTED|Induction Period||113||
48087578|NCT00867009|100537105|FG000|Received at Least 1 Dose of Study Drug|Induction Period||113||
48087579|NCT00867009|100537105|FG000|Protocol Qualified (PQ) Population|Induction Period||109||
48087580|NCT00867009|100537105|FG000|COMPLETED|Induction Period||51||
48087581|NCT00867009|100537105|FG000|NOT COMPLETED|Induction Period||62||
48087582|NCT00867009|100537105|FG000|STARTED|Maintenance Period||51||
48087583|NCT00867009|100537105|FG000|COMPLETED|Maintenance Period||47||
48087584|NCT00867009|100537105|FG000|NOT COMPLETED|Maintenance Period||4||
48087585|NCT00642460|100537106|FG000|STARTED|Part I: 12 Week Double-Blind||37||
48087586|NCT00642460|100537107|FG001|STARTED|Part I: 12 Week Double-Blind||38||
48087587|NCT00642460|100537108|FG002|STARTED|Part I: 12 Week Double-Blind||37||
48087588|NCT00642460|100537109|FG003|STARTED|Part I: 12 Week Double-Blind||0||
48087589|NCT00642460|100537110|FG004|STARTED|Part I: 12 Week Double-Blind||0||
48087590|NCT00642460|100537111|FG005|STARTED|Part I: 12 Week Double-Blind||0||
48141274|NCT02558010|100670385|FG001|NOT COMPLETED|Overall Study||6||
48087591|NCT00642460|100537106|FG000|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37||
48087592|NCT00642460|100537107|FG001|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||38||
48087593|NCT00642460|100537108|FG002|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37||
48087594|NCT00642460|100537109|FG003|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0||
48087595|NCT00642460|100537110|FG004|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0||
48087596|NCT00642460|100537111|FG005|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0||
48087597|NCT00642460|100537106|FG000|COMPLETED|Part I: 12 Week Double-Blind||36||
48087598|NCT00642460|100537107|FG001|COMPLETED|Part I: 12 Week Double-Blind||37||
48087599|NCT00642460|100537108|FG002|COMPLETED|Part I: 12 Week Double-Blind||36||
48087600|NCT00642460|100537109|FG003|COMPLETED|Part I: 12 Week Double-Blind||0||
48087601|NCT00642460|100537110|FG004|COMPLETED|Part I: 12 Week Double-Blind||0||
48087602|NCT00642460|100537111|FG005|COMPLETED|Part I: 12 Week Double-Blind||0||
48087603|NCT00642460|100537106|FG000|NOT COMPLETED|Part I: 12 Week Double-Blind||1||
48087604|NCT00642460|100537107|FG001|NOT COMPLETED|Part I: 12 Week Double-Blind||1||
48087605|NCT00642460|100537108|FG002|NOT COMPLETED|Part I: 12 Week Double-Blind||1||
48087606|NCT00642460|100537109|FG003|NOT COMPLETED|Part I: 12 Week Double-Blind||0||
48087607|NCT00642460|100537110|FG004|NOT COMPLETED|Part I: 12 Week Double-Blind||0||
48087608|NCT00642460|100537111|FG005|NOT COMPLETED|Part I: 12 Week Double-Blind||0||
48087609|NCT00642460|100537106|FG000|STARTED|Part II: Open-Label Up to Week 92||52||
48087610|NCT00642460|100537107|FG001|STARTED|Part II: Open-Label Up to Week 92||40||
48087611|NCT00642460|100537108|FG002|STARTED|Part II: Open-Label Up to Week 92||0||
48087612|NCT00642460|100537109|FG003|STARTED|Part II: Open-Label Up to Week 92||20||
48087613|NCT00642460|100537110|FG004|STARTED|Part II: Open-Label Up to Week 92||0||
48376961|NCT02935634|101251932|FG001|Re-Randomized From Track 2 Nivolumab + Relatlimab|Treatment: Track 2||2||
48376962|NCT02935634|101251933|FG002|Re-Randomized From Track 2 Nivolumab + Relatlimab|Treatment: Track 2||0||
48376963|NCT02935634|101251934|FG003|Re-Randomized From Track 2 Nivolumab + Relatlimab|Treatment: Track 2||0||
48376964|NCT02935634|101251935|FG004|Re-Randomized From Track 2 Nivolumab + Relatlimab|Treatment: Track 2||0||
48376965|NCT02935634|101251936|FG005|Re-Randomized From Track 2 Nivolumab + Relatlimab|Treatment: Track 2||0||
48087614|NCT00642460|100537111|FG005|STARTED|Part II: Open-Label Up to Week 92||0||
48087615|NCT00642460|100537106|FG000|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||52||
48087616|NCT00642460|100537107|FG001|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||40||
48087617|NCT00642460|100537108|FG002|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0||
48087618|NCT00642460|100537109|FG003|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||20||
48087619|NCT00642460|100537110|FG004|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0||
48683924|NCT02359006|102009630|FG001|COMPLETED|Overall Study||10||
48683925|NCT02359006|102009629|FG000|NOT COMPLETED|Overall Study||4||
48683926|NCT02359006|102009630|FG001|NOT COMPLETED|Overall Study||3||
48683927|NCT05243628|102009631|FG000|STARTED|Overall Study||13||
48087620|NCT00642460|100537111|FG005|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0||
48087621|NCT00642460|100537106|FG000|COMPLETED|Part II: Open-Label Up to Week 92||43||
48087622|NCT00642460|100537107|FG001|COMPLETED|Part II: Open-Label Up to Week 92||32||
48087623|NCT00642460|100537108|FG002|COMPLETED|Part II: Open-Label Up to Week 92||0||
48087624|NCT00642460|100537109|FG003|COMPLETED|Part II: Open-Label Up to Week 92||17||
48087625|NCT00642460|100537110|FG004|COMPLETED|Part II: Open-Label Up to Week 92||0||
48087626|NCT00642460|100537111|FG005|COMPLETED|Part II: Open-Label Up to Week 92||0||
48087627|NCT00642460|100537106|FG000|NOT COMPLETED|Part II: Open-Label Up to Week 92||9||
48087628|NCT00642460|100537107|FG001|NOT COMPLETED|Part II: Open-Label Up to Week 92||8||
48087629|NCT00642460|100537108|FG002|NOT COMPLETED|Part II: Open-Label Up to Week 92||0||
48087630|NCT00642460|100537109|FG003|NOT COMPLETED|Part II: Open-Label Up to Week 92||3||
48087631|NCT00642460|100537110|FG004|NOT COMPLETED|Part II: Open-Label Up to Week 92||0||
48087632|NCT00642460|100537111|FG005|NOT COMPLETED|Part II: Open-Label Up to Week 92||0||
48087633|NCT00642460|100537106|FG000|STARTED|Part III: Open-Label Up to Week 260||0||
48087634|NCT00642460|100537107|FG001|STARTED|Part III: Open-Label Up to Week 260||0||
48087635|NCT00642460|100537108|FG002|STARTED|Part III: Open-Label Up to Week 260||0||
48087636|NCT00642460|100537109|FG003|STARTED|Part III: Open-Label Up to Week 260||0||
48087637|NCT00642460|100537110|FG004|STARTED|Part III: Open-Label Up to Week 260||53||
48087638|NCT00642460|100537111|FG005|STARTED|Part III: Open-Label Up to Week 260||59||
48087639|NCT00642460|100537106|FG000|COMPLETED|Part III: Open-Label Up to Week 260||0||
48087640|NCT00642460|100537107|FG001|COMPLETED|Part III: Open-Label Up to Week 260||0||
48376966|NCT02935634|101251931|FG000|Re-Randomized From Track 2 Nivolumab + BMS986205|Treatment: Track 2||3||
48376967|NCT02935634|101251932|FG001|Re-Randomized From Track 2 Nivolumab + BMS986205|Treatment: Track 2||0||
48087641|NCT00642460|100537108|FG002|COMPLETED|Part III: Open-Label Up to Week 260||0||
48376968|NCT02935634|101251933|FG002|Re-Randomized From Track 2 Nivolumab + BMS986205|Treatment: Track 2||0||
48683928|NCT05243628|102009632|FG001|STARTED|Overall Study||10||
48087642|NCT00642460|100537109|FG003|COMPLETED|Part III: Open-Label Up to Week 260||0||
48087643|NCT00642460|100537110|FG004|COMPLETED|Part III: Open-Label Up to Week 260||28||
48376969|NCT02935634|101251934|FG003|Re-Randomized From Track 2 Nivolumab + BMS986205|Treatment: Track 2||0||
48683929|NCT05243628|102009633|FG002|STARTED|Overall Study||5||
48683930|NCT05243628|102009631|FG000|COMPLETED|Overall Study||9||
48376970|NCT02935634|101251935|FG004|Re-Randomized From Track 2 Nivolumab + BMS986205|Treatment: Track 2||0||
48250318|NCT04225039|100931081|FG003|COMPLETED|Overall Study||0||
48250319|NCT04225039|100931078|FG000|NOT COMPLETED|Overall Study||3||
48376971|NCT02935634|101251936|FG005|Re-Randomized From Track 2 Nivolumab + BMS986205|Treatment: Track 2||0||
48376972|NCT02935634|101251931|FG000|Previously Un-Treated But Re-Randomized|Treatment: Track 2||0||
48376973|NCT02935634|101251932|FG001|Previously Un-Treated But Re-Randomized|Treatment: Track 2||1||
48376974|NCT02935634|101251933|FG002|Previously Un-Treated But Re-Randomized|Treatment: Track 2||0||
48376975|NCT02935634|101251934|FG003|Previously Un-Treated But Re-Randomized|Treatment: Track 2||0||
48376976|NCT02935634|101251935|FG004|Previously Un-Treated But Re-Randomized|Treatment: Track 2||0||
48250320|NCT04225039|100931079|FG001|NOT COMPLETED|Overall Study||1||
48250321|NCT04225039|100931080|FG002|NOT COMPLETED|Overall Study||0||
48250322|NCT04225039|100931081|FG003|NOT COMPLETED|Overall Study||5||
48250323|NCT04491084|100931082|FG000|STARTED|Overall Study||2||
48250324|NCT04491084|100931083|FG001|STARTED|Overall Study||3||
48250325|NCT04491084|100931082|FG000|COMPLETED|Overall Study||2||
48250326|NCT04491084|100931083|FG001|COMPLETED|Overall Study||3||
48250327|NCT04491084|100931082|FG000|NOT COMPLETED|Overall Study||0||
48250328|NCT04491084|100931083|FG001|NOT COMPLETED|Overall Study||0||
48250329|NCT00006099|100931084|FG000|STARTED|Overall Study||1||
48250330|NCT00006099|100931085|FG001|STARTED|Overall Study||0||
48250331|NCT00006099|100931084|FG000|COMPLETED|Overall Study||1||
48250332|NCT00006099|100931085|FG001|COMPLETED|Overall Study||0||
48250333|NCT00006099|100931084|FG000|NOT COMPLETED|Overall Study||0||
48250334|NCT00006099|100931085|FG001|NOT COMPLETED|Overall Study||0||
48250335|NCT02720081|100931086|FG000|STARTED|Overall Study||72||
48250336|NCT02720081|100931087|FG001|STARTED|Overall Study||70||
48250337|NCT02720081|100931086|FG000|Treated|Overall Study||70||
48250338|NCT02720081|100931087|FG001|Treated|Overall Study||69||
48250339|NCT02720081|100931086|FG000|COMPLETED|Overall Study||68||
48250340|NCT02720081|100931087|FG001|COMPLETED|Overall Study||66||
48250341|NCT02720081|100931086|FG000|NOT COMPLETED|Overall Study||4||
48250342|NCT02720081|100931087|FG001|NOT COMPLETED|Overall Study||4||
48250343|NCT02068352|100931088|FG000|STARTED|Overall Study||41||
48250344|NCT02068352|100931089|FG001|STARTED|Overall Study||43||
48250345|NCT02068352|100931090|FG002|STARTED|Overall Study||37||
48250346|NCT02068352|100931088|FG000|COMPLETED|Overall Study||31||
48250347|NCT02068352|100931089|FG001|COMPLETED|Overall Study||35||
48250348|NCT02068352|100931090|FG002|COMPLETED|Overall Study||28||
48250349|NCT02068352|100931088|FG000|NOT COMPLETED|Overall Study||10||
48250350|NCT02068352|100931089|FG001|NOT COMPLETED|Overall Study||8||
48250351|NCT02068352|100931090|FG002|NOT COMPLETED|Overall Study||9||
48250352|NCT01183013|100931091|FG000|STARTED|Overall Study||131||
48250353|NCT01183013|100931092|FG001|STARTED|Overall Study||140||
48250354|NCT01183013|100931093|FG002|STARTED|Overall Study||138||
48250355|NCT01183013|100931094|FG003|STARTED|Overall Study||135||
48250356|NCT01183013|100931095|FG004|STARTED|Overall Study||126||
48250357|NCT01183013|100931096|FG005|STARTED|Overall Study||133||
48376977|NCT02935634|101251936|FG005|Previously Un-Treated But Re-Randomized|Treatment: Track 2||0||
48541156|NCT03149757|101662670|FG001|COMPLETED|Overall Study||100||
48541157|NCT03149757|101662669|FG000|NOT COMPLETED|Overall Study||7||
48250358|NCT01183013|100931097|FG006|STARTED|Overall Study||133||
48250359|NCT01183013|100931091|FG000|COMPLETED|Overall Study||86||
48250360|NCT01183013|100931092|FG001|COMPLETED|Overall Study||101||
48250361|NCT01183013|100931093|FG002|COMPLETED|Overall Study||97||
48250362|NCT01183013|100931094|FG003|COMPLETED|Overall Study||105||
48250363|NCT01183013|100931095|FG004|COMPLETED|Overall Study||90||
48250364|NCT01183013|100931096|FG005|COMPLETED|Overall Study||88||
48250365|NCT01183013|100931097|FG006|COMPLETED|Overall Study||96||
48250366|NCT01183013|100931091|FG000|NOT COMPLETED|Overall Study||45||
48250367|NCT01183013|100931092|FG001|NOT COMPLETED|Overall Study||39||
48250368|NCT01183013|100931093|FG002|NOT COMPLETED|Overall Study||41||
48250369|NCT01183013|100931094|FG003|NOT COMPLETED|Overall Study||30||
48250370|NCT01183013|100931095|FG004|NOT COMPLETED|Overall Study||36||
48250371|NCT01183013|100931096|FG005|NOT COMPLETED|Overall Study||45||
48250372|NCT01183013|100931097|FG006|NOT COMPLETED|Overall Study||37||
48250373|NCT01560585|100931098|FG000|STARTED|Overall Study||3||
48376978|NCT02935634|101251931|FG000|Re-Randomized From Track 2 Nivolumab + Ipilimumab|Treatment: Track 2||0||
48376979|NCT02935634|101251932|FG001|Re-Randomized From Track 2 Nivolumab + Ipilimumab|Treatment: Track 2||2||
48683931|NCT05243628|102009632|FG001|COMPLETED|Overall Study||10||
48683932|NCT05243628|102009633|FG002|COMPLETED|Overall Study||5||
48683933|NCT05243628|102009631|FG000|NOT COMPLETED|Overall Study||4||
48376980|NCT02935634|101251933|FG002|Re-Randomized From Track 2 Nivolumab + Ipilimumab|Treatment: Track 2||0||
48376981|NCT02935634|101251934|FG003|Re-Randomized From Track 2 Nivolumab + Ipilimumab|Treatment: Track 2||0||
48376982|NCT02935634|101251935|FG004|Re-Randomized From Track 2 Nivolumab + Ipilimumab|Treatment: Track 2||0||
48376983|NCT02935634|101251936|FG005|Re-Randomized From Track 2 Nivolumab + Ipilimumab|Treatment: Track 2||0||
48376984|NCT02935634|101251931|FG000|COMPLETED|Treatment: Track 2||1||
48376985|NCT02935634|101251932|FG001|COMPLETED|Treatment: Track 2||2||
48683934|NCT05243628|102009632|FG001|NOT COMPLETED|Overall Study||0||
48683935|NCT05243628|102009633|FG002|NOT COMPLETED|Overall Study||0||
48683936|NCT00856609|102009634|FG000|STARTED|Overall Study||41||
48376986|NCT02935634|101251933|FG002|COMPLETED|Treatment: Track 2||0||
48376987|NCT02935634|101251934|FG003|COMPLETED|Treatment: Track 2||1||
48376988|NCT02935634|101251935|FG004|COMPLETED|Treatment: Track 2||0||
48376989|NCT02935634|101251936|FG005|COMPLETED|Treatment: Track 2||0||
48376990|NCT02935634|101251931|FG000|NOT COMPLETED|Treatment: Track 2||22||
48376991|NCT02935634|101251932|FG001|NOT COMPLETED|Treatment: Track 2||34||
48376992|NCT02935634|101251933|FG002|NOT COMPLETED|Treatment: Track 2||22||
48376993|NCT02935634|101251934|FG003|NOT COMPLETED|Treatment: Track 2||5||
48376994|NCT02935634|101251935|FG004|NOT COMPLETED|Treatment: Track 2||2||
48376995|NCT02935634|101251936|FG005|NOT COMPLETED|Treatment: Track 2||4||
48376996|NCT02528500|101251937|FG000|STARTED|Overall Study||10||
48376997|NCT02528500|101251937|FG000|COMPLETED|Overall Study||10||
48376998|NCT02528500|101251937|FG000|NOT COMPLETED|Overall Study||0||
48376999|NCT02600325|101251938|FG000|STARTED|Overall Study||80||
48377000|NCT02600325|101251938|FG000|COMPLETED|Overall Study||80||
48377001|NCT02600325|101251938|FG000|NOT COMPLETED|Overall Study||0||
48377002|NCT00751530|101251939|FG000|STARTED|Overall Study||332||
48377003|NCT00751530|101251940|FG001|STARTED|Overall Study||110||
48377004|NCT00751530|101251939|FG000|COMPLETED|Overall Study||332||
48377005|NCT00751530|101251940|FG001|COMPLETED|Overall Study||110||
48377006|NCT00751530|101251939|FG000|NOT COMPLETED|Overall Study||0||
48377007|NCT00751530|101251940|FG001|NOT COMPLETED|Overall Study||0||
48377008|NCT00579124|101251941|FG000|STARTED|Overall Study||87||
48377009|NCT00579124|101251942|FG001|STARTED|Overall Study||6||
48377010|NCT00579124|101251941|FG000|COMPLETED|Overall Study||82||
48377011|NCT00579124|101251942|FG001|COMPLETED|Overall Study||6||
48683937|NCT00856609|102009635|FG001|STARTED|Overall Study||39||
48683938|NCT00856609|102009634|FG000|COMPLETED|Overall Study||40||
48683939|NCT00856609|102009635|FG001|COMPLETED|Overall Study||39||
48683940|NCT00856609|102009634|FG000|NOT COMPLETED|Overall Study||1||
48683941|NCT00856609|102009635|FG001|NOT COMPLETED|Overall Study||0||
48683942|NCT00548197|102009636|FG000|STARTED|Overall Study||18||
48683943|NCT00548197|102009637|FG001|STARTED|Overall Study||22||
48377012|NCT00579124|101251941|FG000|NOT COMPLETED|Overall Study||5||
48377013|NCT00579124|101251942|FG001|NOT COMPLETED|Overall Study||0||
48377014|NCT02108951|101251943|FG000|STARTED|Overall Study||20||
48377015|NCT02108951|101251943|FG000|COMPLETED|Overall Study||4||
48377016|NCT02108951|101251943|FG000|NOT COMPLETED|Overall Study||16||
48377017|NCT03448718|101251944|FG000|STARTED|Overall Study||19||
48377018|NCT03448718|101251944|FG000|COMPLETED|Overall Study||19||
48683944|NCT00548197|102009636|FG000|COMPLETED|Overall Study||18||
48683945|NCT00548197|102009637|FG001|COMPLETED|Overall Study||22||
48683946|NCT00548197|102009636|FG000|NOT COMPLETED|Overall Study||0||
48683947|NCT00548197|102009637|FG001|NOT COMPLETED|Overall Study||0||
48683948|NCT00811954|102009638|FG000|STARTED|Overall Study||605||
48087644|NCT00642460|100537111|FG005|COMPLETED|Part III: Open-Label Up to Week 260||38||
48087645|NCT00642460|100537106|FG000|NOT COMPLETED|Part III: Open-Label Up to Week 260||0||
48087646|NCT00642460|100537107|FG001|NOT COMPLETED|Part III: Open-Label Up to Week 260||0||
48087647|NCT00642460|100537108|FG002|NOT COMPLETED|Part III: Open-Label Up to Week 260||0||
48087648|NCT00642460|100537109|FG003|NOT COMPLETED|Part III: Open-Label Up to Week 260||0||
48087649|NCT00642460|100537110|FG004|NOT COMPLETED|Part III: Open-Label Up to Week 260||25||
48087650|NCT00642460|100537111|FG005|NOT COMPLETED|Part III: Open-Label Up to Week 260||21||
48087651|NCT01134783|100537112|FG000|STARTED|Overall Study||224||
48087652|NCT01134783|100537113|FG001|STARTED|Overall Study||217||
48087653|NCT01134783|100537112|FG000|COMPLETED|Overall Study||188||
48087654|NCT01134783|100537113|FG001|COMPLETED|Overall Study||180||
48087655|NCT01134783|100537112|FG000|NOT COMPLETED|Overall Study||36||
48087656|NCT01134783|100537113|FG001|NOT COMPLETED|Overall Study||37||
48087657|NCT02782780|100537114|FG000|STARTED|Overall Study||46||
48087658|NCT02782780|100537115|FG001|STARTED|Overall Study||39||
48087659|NCT02782780|100537114|FG000|COMPLETED|Overall Study||39||
48087660|NCT02782780|100537115|FG001|COMPLETED|Overall Study||32||
48087661|NCT02782780|100537114|FG000|NOT COMPLETED|Overall Study||7||
48087662|NCT02782780|100537115|FG001|NOT COMPLETED|Overall Study||7||
48087663|NCT00872534|100537116|FG000|STARTED|Overall Study||100||
48087664|NCT00872534|100537117|FG001|STARTED|Overall Study||104||
48087665|NCT00872534|100537116|FG000|COMPLETED|Overall Study||97||
48087666|NCT00872534|100537117|FG001|COMPLETED|Overall Study||101||
48087667|NCT00872534|100537116|FG000|NOT COMPLETED|Overall Study||3||
48087668|NCT00872534|100537117|FG001|NOT COMPLETED|Overall Study||3||
48087669|NCT04900220|100537118|FG000|STARTED|Overall Study||33||
48087670|NCT04900220|100537119|FG001|STARTED|Overall Study||33||
48087671|NCT04900220|100537118|FG000|COMPLETED|Overall Study||32||
48087672|NCT04900220|100537119|FG001|COMPLETED|Overall Study||32||
48087673|NCT04900220|100537118|FG000|NOT COMPLETED|Overall Study||1||
48087674|NCT04900220|100537119|FG001|NOT COMPLETED|Overall Study||1||
48087675|NCT01860651|100537120|FG000|STARTED|Overall Study||56||
48087676|NCT01860651|100537121|FG001|STARTED|Overall Study||47||
48087677|NCT01860651|100537120|FG000|COMPLETED|Overall Study||31||
48087678|NCT01860651|100537121|FG001|COMPLETED|Overall Study||39||
48087679|NCT01860651|100537120|FG000|NOT COMPLETED|Overall Study||25||
48087680|NCT01860651|100537121|FG001|NOT COMPLETED|Overall Study||8||
48087681|NCT02342327|100537122|FG000|STARTED|Overall Study||60||
48087682|NCT02342327|100537123|FG001|STARTED|Overall Study||62||
48087683|NCT02342327|100537122|FG000|Completed Quit Day Visit|Overall Study||54||
48087684|NCT02342327|100537123|FG001|Completed Quit Day Visit|Overall Study||53||
48087685|NCT02342327|100537122|FG000|COMPLETED|Overall Study||39||
48087686|NCT02342327|100537123|FG001|COMPLETED|Overall Study||40||
48087687|NCT02342327|100537122|FG000|NOT COMPLETED|Overall Study||21||
48087688|NCT02342327|100537123|FG001|NOT COMPLETED|Overall Study||22||
48087689|NCT01250834|100537124|FG000|STARTED|Overall Study||27||
48087690|NCT01250834|100537124|FG000|COMPLETED|Overall Study||27||
48087691|NCT01250834|100537124|FG000|NOT COMPLETED|Overall Study||0||
48087692|NCT00429273|100537125|FG000|STARTED|Overall Study||68||
48087693|NCT00429273|100537126|FG001|STARTED|Overall Study||69||
48087694|NCT00429273|100537127|FG002|STARTED|Overall Study||70||
48087695|NCT00429273|100537125|FG000|COMPLETED|Overall Study||60||
48087696|NCT00429273|100537126|FG001|COMPLETED|Overall Study||61||
48087697|NCT00429273|100537127|FG002|COMPLETED|Overall Study||61||
48087698|NCT00429273|100537125|FG000|NOT COMPLETED|Overall Study||8||
48087699|NCT00429273|100537126|FG001|NOT COMPLETED|Overall Study||8||
48087700|NCT00429273|100537127|FG002|NOT COMPLETED|Overall Study||9||
48087701|NCT03950167|100537128|FG000|STARTED|Overall Study||25||
48087702|NCT03950167|100537129|FG001|STARTED|Overall Study||25||
48087703|NCT03950167|100537128|FG000|COMPLETED|Overall Study||24||
48087704|NCT03950167|100537129|FG001|COMPLETED|Overall Study||22||
48087705|NCT03950167|100537128|FG000|NOT COMPLETED|Overall Study||1||
48087706|NCT03950167|100537129|FG001|NOT COMPLETED|Overall Study||3||
48683949|NCT00811954|102009639|FG001|STARTED|Overall Study||603||
48683950|NCT00811954|102009640|FG002|STARTED|Overall Study||601||
48683951|NCT00811954|102009638|FG000|COMPLETED|Overall Study||516||
48683952|NCT00811954|102009639|FG001|COMPLETED|Overall Study||531||
48683953|NCT00811954|102009640|FG002|COMPLETED|Overall Study||500||
48683954|NCT00811954|102009638|FG000|NOT COMPLETED|Overall Study||89||
48683955|NCT00811954|102009639|FG001|NOT COMPLETED|Overall Study||72||
48087707|NCT03510884|100537130|FG000|STARTED|Double-blind Period (up to Week 24)||25|Randomized and treated participants.|
48087708|NCT03510884|100537131|FG001|STARTED|Double-blind Period (up to Week 24)||49|Randomized and treated participants.|
48087709|NCT03510884|100537132|FG002|STARTED|Double-blind Period (up to Week 24)||27|Randomized and treated participants.|
48087710|NCT03510884|100537133|FG003|STARTED|Double-blind Period (up to Week 24)||52|Randomized and treated participants.|
48087711|NCT03510884|100537130|FG000|COMPLETED|Double-blind Period (up to Week 24)||25||
48087712|NCT03510884|100537131|FG001|COMPLETED|Double-blind Period (up to Week 24)||45||
48087713|NCT03510884|100537132|FG002|COMPLETED|Double-blind Period (up to Week 24)||26||
48087714|NCT03510884|100537133|FG003|COMPLETED|Double-blind Period (up to Week 24)||49||
48087715|NCT03510884|100537130|FG000|NOT COMPLETED|Double-blind Period (up to Week 24)||0||
48087716|NCT03510884|100537131|FG001|NOT COMPLETED|Double-blind Period (up to Week 24)||4||
48087717|NCT03510884|100537132|FG002|NOT COMPLETED|Double-blind Period (up to Week 24)||1||
48087718|NCT03510884|100537133|FG003|NOT COMPLETED|Double-blind Period (up to Week 24)||3||
48087719|NCT03510884|100537130|FG000|STARTED|Open Label Period (up to Week 104)||25|Post completion of DB treatment period, only eligible participants entered OL treatment period.|
48087720|NCT03510884|100537131|FG001|STARTED|Open Label Period (up to Week 104)||46|Post completion of DB treatment period, only eligible participants entered OL treatment period.|
48087721|NCT03510884|100537132|FG002|STARTED|Open Label Period (up to Week 104)||25|Post completion of DB treatment period, only eligible participants entered OL treatment period.|
48087722|NCT03510884|100537133|FG003|STARTED|Open Label Period (up to Week 104)||49|Post completion of DB treatment period, only eligible participants entered OL treatment period.|
48087723|NCT03510884|100537130|FG000|COMPLETED|Open Label Period (up to Week 104)||22||
48087724|NCT03510884|100537131|FG001|COMPLETED|Open Label Period (up to Week 104)||43||
48087725|NCT03510884|100537132|FG002|COMPLETED|Open Label Period (up to Week 104)||24||
48087726|NCT03510884|100537133|FG003|COMPLETED|Open Label Period (up to Week 104)||49||
48087727|NCT03510884|100537130|FG000|NOT COMPLETED|Open Label Period (up to Week 104)||3||
48087728|NCT03510884|100537131|FG001|NOT COMPLETED|Open Label Period (up to Week 104)||3||
48087729|NCT03510884|100537132|FG002|NOT COMPLETED|Open Label Period (up to Week 104)||1||
48087730|NCT03510884|100537133|FG003|NOT COMPLETED|Open Label Period (up to Week 104)||0||
48087731|NCT02846779|100537134|FG000|STARTED|Overall Study||2000||
48087732|NCT02846779|100537135|FG001|STARTED|Overall Study||2000||
48087733|NCT02846779|100537136|FG002|STARTED|Overall Study||2000||
48087734|NCT02846779|100537134|FG000|COMPLETED|Overall Study||1861||
48087735|NCT02846779|100537135|FG001|COMPLETED|Overall Study||1873||
48087736|NCT02846779|100537136|FG002|COMPLETED|Overall Study||1862||
48087737|NCT02846779|100537134|FG000|NOT COMPLETED|Overall Study||139||
48087738|NCT02846779|100537135|FG001|NOT COMPLETED|Overall Study||127||
48087739|NCT02846779|100537136|FG002|NOT COMPLETED|Overall Study||138||
48087740|NCT02402127|100537137|FG000|STARTED|First Wear Period (1 Day)||4||
48087741|NCT02402127|100537138|FG001|STARTED|First Wear Period (1 Day)||4||
48087742|NCT02402127|100537139|FG002|STARTED|First Wear Period (1 Day)||4||
48087743|NCT02402127|100537140|FG003|STARTED|First Wear Period (1 Day)||4||
48087744|NCT02402127|100537141|FG004|STARTED|First Wear Period (1 Day)||4||
48087745|NCT02402127|100537142|FG005|STARTED|First Wear Period (1 Day)||4||
48087746|NCT02402127|100537137|FG000|Randomized and Treated|First Wear Period (1 Day)||4||
48087747|NCT02402127|100537138|FG001|Randomized and Treated|First Wear Period (1 Day)||4||
48087748|NCT02402127|100537139|FG002|Randomized and Treated|First Wear Period (1 Day)||4||
48087749|NCT02402127|100537140|FG003|Randomized and Treated|First Wear Period (1 Day)||4||
48087750|NCT02402127|100537141|FG004|Randomized and Treated|First Wear Period (1 Day)||4||
48087751|NCT02402127|100537142|FG005|Randomized and Treated|First Wear Period (1 Day)||4||
48683956|NCT00811954|102009640|FG002|NOT COMPLETED|Overall Study||101||
48683957|NCT03019887|102009641|FG000|STARTED|Overall Study||139||
48683958|NCT03019887|102009641|FG000|COMPLETED|Overall Study||130||
48683959|NCT03019887|102009641|FG000|NOT COMPLETED|Overall Study||9||
48683960|NCT03372161|102009642|FG000|STARTED|Overall Study||202||
48683961|NCT03372161|102009643|FG001|STARTED|Overall Study||199||
48683962|NCT03372161|102009642|FG000|COMPLETED|Overall Study||193||
48683963|NCT03372161|102009643|FG001|COMPLETED|Overall Study||192||
48683964|NCT03372161|102009642|FG000|NOT COMPLETED|Overall Study||9||
48683965|NCT03372161|102009643|FG001|NOT COMPLETED|Overall Study||7||
48087752|NCT02402127|100537137|FG000|COMPLETED|First Wear Period (1 Day)||4||
48087753|NCT02402127|100537138|FG001|COMPLETED|First Wear Period (1 Day)||4||
48087754|NCT02402127|100537139|FG002|COMPLETED|First Wear Period (1 Day)||4||
48087755|NCT02402127|100537140|FG003|COMPLETED|First Wear Period (1 Day)||4||
48683966|NCT03154476|102009644|FG000|STARTED|Overall Study||10||
48683967|NCT03154476|102009645|FG001|STARTED|Overall Study||10||
48683968|NCT03154476|102009644|FG000|COMPLETED|Overall Study||6||
48683969|NCT03154476|102009645|FG001|COMPLETED|Overall Study||6||
48683970|NCT03154476|102009644|FG000|NOT COMPLETED|Overall Study||4||
48683971|NCT03154476|102009645|FG001|NOT COMPLETED|Overall Study||4||
48087756|NCT02402127|100537141|FG004|COMPLETED|First Wear Period (1 Day)||4||
48087757|NCT02402127|100537142|FG005|COMPLETED|First Wear Period (1 Day)||4||
48087758|NCT02402127|100537137|FG000|NOT COMPLETED|First Wear Period (1 Day)||0||
48087759|NCT02402127|100537138|FG001|NOT COMPLETED|First Wear Period (1 Day)||0||
48683972|NCT02131662|102009646|FG000|STARTED|Overall Study||62||
48683973|NCT02131662|102009647|FG001|STARTED|Overall Study||61||
48683974|NCT02131662|102009648|FG002|STARTED|Overall Study||63||
48377019|NCT03448718|101251944|FG000|NOT COMPLETED|Overall Study||0||
48377020|NCT00932152|101251945|FG000|STARTED|Overall Study||1||
48377021|NCT00932152|101251946|FG001|STARTED|Overall Study||2||
48683975|NCT02131662|102009649|FG003|STARTED|Overall Study||62||
48683976|NCT02131662|102009650|FG004|STARTED|Overall Study||61||
48683977|NCT02131662|102009646|FG000|Treated|Overall Study||60||
48683978|NCT02131662|102009647|FG001|Treated|Overall Study||61||
48683979|NCT02131662|102009648|FG002|Treated|Overall Study||61||
48683980|NCT02131662|102009649|FG003|Treated|Overall Study||60||
48377022|NCT00932152|101251945|FG000|COMPLETED|Overall Study||0||
48377023|NCT00932152|101251946|FG001|COMPLETED|Overall Study||0||
48377024|NCT00932152|101251945|FG000|NOT COMPLETED|Overall Study||1||
48377025|NCT00932152|101251946|FG001|NOT COMPLETED|Overall Study||2||
48377026|NCT03471767|101251947|FG000|STARTED|Overall Study||31||
48377027|NCT03471767|101251948|FG001|STARTED|Overall Study||27||
48377028|NCT03471767|101251947|FG000|COMPLETED|Overall Study||25||
48377029|NCT03471767|101251948|FG001|COMPLETED|Overall Study||23||
48377030|NCT03471767|101251947|FG000|NOT COMPLETED|Overall Study||6||
48377031|NCT03471767|101251948|FG001|NOT COMPLETED|Overall Study||4||
48377032|NCT03450369|101251949|FG000|STARTED|Overall Study||5||
48377033|NCT03450369|101251950|FG001|STARTED|Overall Study||5||
48377034|NCT03450369|101251949|FG000|COMPLETED|Overall Study||5||
48377035|NCT03450369|101251950|FG001|COMPLETED|Overall Study||5||
48377036|NCT03450369|101251949|FG000|NOT COMPLETED|Overall Study||0||
48377037|NCT03450369|101251950|FG001|NOT COMPLETED|Overall Study||0||
48377038|NCT03298412|101251951|FG000|STARTED|Run-in Period||10||
48377039|NCT03298412|101251951|FG000|COMPLETED|Run-in Period||1||
48377040|NCT03298412|101251951|FG000|NOT COMPLETED|Run-in Period||9||
48683981|NCT02131662|102009650|FG004|Treated|Overall Study||58||
48683982|NCT02131662|102009646|FG000|Completed Treatment|Overall Study||57||
48087760|NCT02402127|100537139|FG002|NOT COMPLETED|First Wear Period (1 Day)||0||
48087761|NCT02402127|100537140|FG003|NOT COMPLETED|First Wear Period (1 Day)||0||
48377041|NCT03298412|101251951|FG000|STARTED|Treatment Period||1||
48377042|NCT03298412|101251951|FG000|COMPLETED|Treatment Period||1||
48377043|NCT03298412|101251951|FG000|NOT COMPLETED|Treatment Period||0||
48377044|NCT00051558|101251952|FG000|STARTED|Overall Study||214||
48377045|NCT00051558|101251953|FG001|STARTED|Overall Study||214||
48377046|NCT00051558|101251952|FG000|COMPLETED|Overall Study||123||
48377047|NCT00051558|101251953|FG001|COMPLETED|Overall Study||118||
48377048|NCT00051558|101251952|FG000|NOT COMPLETED|Overall Study||91||
48377049|NCT00051558|101251953|FG001|NOT COMPLETED|Overall Study||96||
48377050|NCT02115815|101251954|FG000|STARTED|Overall Study||24||
48377051|NCT02115815|101251955|FG001|STARTED|Overall Study||20||
48377052|NCT02115815|101251956|FG002|STARTED|Overall Study||20||
48377053|NCT02115815|101251957|FG003|STARTED|Overall Study||20||
48377054|NCT02115815|101251958|FG004|STARTED|Overall Study||20||
48377055|NCT02115815|101251959|FG005|STARTED|Overall Study||22||
48377056|NCT02115815|101251960|FG006|STARTED|Overall Study||20||
48377057|NCT02115815|101251954|FG000|COMPLETED|Overall Study||22||
48377058|NCT02115815|101251955|FG001|COMPLETED|Overall Study||20||
48377059|NCT02115815|101251956|FG002|COMPLETED|Overall Study||20||
48377060|NCT02115815|101251957|FG003|COMPLETED|Overall Study||20||
48377061|NCT02115815|101251958|FG004|COMPLETED|Overall Study||20||
48377062|NCT02115815|101251959|FG005|COMPLETED|Overall Study||20||
48377063|NCT02115815|101251960|FG006|COMPLETED|Overall Study||20||
48683983|NCT02131662|102009647|FG001|Completed Treatment|Overall Study||60||
48683984|NCT02131662|102009648|FG002|Completed Treatment|Overall Study||61||
48377064|NCT02115815|101251954|FG000|NOT COMPLETED|Overall Study||2||
48377065|NCT02115815|101251955|FG001|NOT COMPLETED|Overall Study||0||
48377066|NCT02115815|101251956|FG002|NOT COMPLETED|Overall Study||0||
48377067|NCT02115815|101251957|FG003|NOT COMPLETED|Overall Study||0||
48377068|NCT02115815|101251958|FG004|NOT COMPLETED|Overall Study||0||
48377069|NCT02115815|101251959|FG005|NOT COMPLETED|Overall Study||2||
48377070|NCT02115815|101251960|FG006|NOT COMPLETED|Overall Study||0||
48683985|NCT02131662|102009649|FG003|Completed Treatment|Overall Study||56||
48087762|NCT02402127|100537141|FG004|NOT COMPLETED|First Wear Period (1 Day)||0||
48087763|NCT02402127|100537142|FG005|NOT COMPLETED|First Wear Period (1 Day)||0||
48377071|NCT01419275|101251961|FG000|STARTED|Overall Study||126||
48377072|NCT01419275|101251961|FG000|COMPLETED|Overall Study||126||
48087764|NCT02402127|100537137|FG000|STARTED|Second Wear Period (1 Day)||4||
48087765|NCT02402127|100537138|FG001|STARTED|Second Wear Period (1 Day)||4||
48087766|NCT02402127|100537139|FG002|STARTED|Second Wear Period (1 Day)||4||
48087767|NCT02402127|100537140|FG003|STARTED|Second Wear Period (1 Day)||4||
48377073|NCT01419275|101251961|FG000|NOT COMPLETED|Overall Study||0||
48377074|NCT01551758|101251962|FG000|STARTED|Overall Study||1403||
48377075|NCT01551758|101251963|FG001|STARTED|Overall Study||1396||
48683986|NCT02131662|102009650|FG004|Completed Treatment|Overall Study||52||
48377076|NCT01551758|101251962|FG000|COMPLETED|Overall Study||1309||
48377077|NCT01551758|101251963|FG001|COMPLETED|Overall Study||1291||
48377078|NCT01551758|101251962|FG000|NOT COMPLETED|Overall Study||94||
48377079|NCT01551758|101251963|FG001|NOT COMPLETED|Overall Study||105||
48377080|NCT01395368|101251964|FG000|STARTED|Overall Study||108||
48377081|NCT01395368|101251964|FG000|COMPLETED|Overall Study||92||
48377082|NCT01395368|101251964|FG000|NOT COMPLETED|Overall Study||16||
48377083|NCT01613014|101251965|FG000|STARTED|Overall Study||75||
48377084|NCT01613014|101251966|FG001|STARTED|Overall Study||75||
48377085|NCT01613014|101251965|FG000|COMPLETED|Overall Study||57||
48377086|NCT01613014|101251966|FG001|COMPLETED|Overall Study||63||
48377087|NCT01613014|101251965|FG000|NOT COMPLETED|Overall Study||18||
48377088|NCT01613014|101251966|FG001|NOT COMPLETED|Overall Study||12||
48377089|NCT02488759|101251967|FG000|STARTED|Overall Study||113|Started = treated|
48377090|NCT02488759|101251968|FG001|STARTED|Overall Study||195|Started = treated|
48377091|NCT02488759|101251969|FG002|STARTED|Overall Study||133|Started = treated|
48377092|NCT02488759|101251970|FG003|STARTED|Overall Study||8|Started = treated|
48377093|NCT02488759|101251971|FG004|STARTED|Overall Study||6|Started = treated|
48377094|NCT02488759|101251972|FG005|STARTED|Overall Study||123|Started = treated|
48377095|NCT02488759|101251967|FG000|COMPLETED|Overall Study||0|Completed = completed the treatment period|
48377096|NCT02488759|101251968|FG001|COMPLETED|Overall Study||0|Completed = completed the treatment period|
48377097|NCT02488759|101251969|FG002|COMPLETED|Overall Study||0|Completed = completed the treatment period|
48377098|NCT02488759|101251970|FG003|COMPLETED|Overall Study||0|Completed = completed the treatment period|
48377099|NCT02488759|101251971|FG004|COMPLETED|Overall Study||0|Completed = completed the treatment period|
48377100|NCT02488759|101251972|FG005|COMPLETED|Overall Study||116|Completed = completed the treatment period|
48377101|NCT02488759|101251967|FG000|NOT COMPLETED|Overall Study||113||
48377102|NCT02488759|101251968|FG001|NOT COMPLETED|Overall Study||195||
48377103|NCT02488759|101251969|FG002|NOT COMPLETED|Overall Study||133||
48377104|NCT02488759|101251970|FG003|NOT COMPLETED|Overall Study||8||
48377105|NCT02488759|101251971|FG004|NOT COMPLETED|Overall Study||6||
48683987|NCT02131662|102009646|FG000|Completed Follow-up|Overall Study||54||
48683988|NCT02131662|102009647|FG001|Completed Follow-up|Overall Study||47||
48683989|NCT02131662|102009648|FG002|Completed Follow-up|Overall Study||56||
48683990|NCT02131662|102009649|FG003|Completed Follow-up|Overall Study||42||
48087768|NCT02402127|100537141|FG004|STARTED|Second Wear Period (1 Day)||4||
48087769|NCT02402127|100537142|FG005|STARTED|Second Wear Period (1 Day)||4||
48683991|NCT02131662|102009650|FG004|Completed Follow-up|Overall Study||44||
48683992|NCT02131662|102009646|FG000|COMPLETED|Overall Study||54||
48087770|NCT02402127|100537137|FG000|COMPLETED|Second Wear Period (1 Day)||4||
48087771|NCT02402127|100537138|FG001|COMPLETED|Second Wear Period (1 Day)||4||
48087772|NCT02402127|100537139|FG002|COMPLETED|Second Wear Period (1 Day)||4||
48087773|NCT02402127|100537140|FG003|COMPLETED|Second Wear Period (1 Day)||4||
48087774|NCT02402127|100537141|FG004|COMPLETED|Second Wear Period (1 Day)||4||
48087775|NCT02402127|100537142|FG005|COMPLETED|Second Wear Period (1 Day)||4||
48377106|NCT02488759|101251972|FG005|NOT COMPLETED|Overall Study||7||
48377107|NCT02273752|101251973|FG000|STARTED|Overall Study||2||
48377108|NCT02273752|101251973|FG000|COMPLETED|Overall Study||0||
48377109|NCT02273752|101251973|FG000|NOT COMPLETED|Overall Study||2||
48377110|NCT04220489|101251974|FG000|STARTED|Overall Study||1||
48377111|NCT04220489|101251975|FG001|STARTED|Overall Study||0||
48377112|NCT04220489|101251974|FG000|COMPLETED|Overall Study||1||
48377113|NCT04220489|101251975|FG001|COMPLETED|Overall Study||0||
48377114|NCT04220489|101251974|FG000|NOT COMPLETED|Overall Study||0||
48377115|NCT04220489|101251975|FG001|NOT COMPLETED|Overall Study||0||
48377116|NCT04510194|101251976|FG000|STARTED|Overall Study||284||
48377117|NCT04510194|101251977|FG001|STARTED|Overall Study||295||
48377118|NCT04510194|101251978|FG002|STARTED|Overall Study||206||
48377119|NCT04510194|101251979|FG003|STARTED|Overall Study||159||
48377120|NCT04510194|101251980|FG004|STARTED|Overall Study||175||
48377121|NCT04510194|101251981|FG005|STARTED|Overall Study||204||
48377122|NCT04510194|101251976|FG000|COMPLETED|Overall Study||278||
48377123|NCT04510194|101251977|FG001|COMPLETED|Overall Study||291||
48377124|NCT04510194|101251978|FG002|COMPLETED|Overall Study||206||
48377125|NCT04510194|101251979|FG003|COMPLETED|Overall Study||156||
48377126|NCT04510194|101251980|FG004|COMPLETED|Overall Study||173||
48377127|NCT04510194|101251981|FG005|COMPLETED|Overall Study||201||
48377128|NCT04510194|101251976|FG000|NOT COMPLETED|Overall Study||6||
48377129|NCT04510194|101251977|FG001|NOT COMPLETED|Overall Study||4||
48377130|NCT04510194|101251978|FG002|NOT COMPLETED|Overall Study||0||
48377131|NCT04510194|101251979|FG003|NOT COMPLETED|Overall Study||3||
48377132|NCT04510194|101251980|FG004|NOT COMPLETED|Overall Study||2||
48087776|NCT02402127|100537137|FG000|NOT COMPLETED|Second Wear Period (1 Day)||0||
48377133|NCT04510194|101251981|FG005|NOT COMPLETED|Overall Study||3||
48377134|NCT01204658|101251982|FG000|STARTED|Primary Phase||146||
48377135|NCT01204658|101251983|FG001|STARTED|Primary Phase||142||
48377136|NCT01204658|101251984|FG002|STARTED|Primary Phase||145||
48377137|NCT01204658|101251985|FG003|STARTED|Primary Phase||142||
48377138|NCT01204658|101251982|FG000|COMPLETED|Primary Phase||146||
48377139|NCT01204658|101251983|FG001|COMPLETED|Primary Phase||142||
48377140|NCT01204658|101251984|FG002|COMPLETED|Primary Phase||144||
48377141|NCT01204658|101251985|FG003|COMPLETED|Primary Phase||142||
48377142|NCT01204658|101251982|FG000|NOT COMPLETED|Primary Phase||0||
48377143|NCT01204658|101251983|FG001|NOT COMPLETED|Primary Phase||0||
48377144|NCT01204658|101251984|FG002|NOT COMPLETED|Primary Phase||1||
48377145|NCT01204658|101251985|FG003|NOT COMPLETED|Primary Phase||0||
48377146|NCT01204658|101251982|FG000|STARTED|Booster Phase||144||
48377147|NCT01204658|101251983|FG001|STARTED|Booster Phase||140||
48377148|NCT01204658|101251984|FG002|STARTED|Booster Phase||140||
48377149|NCT01204658|101251985|FG003|STARTED|Booster Phase||140||
48377150|NCT01204658|101251982|FG000|COMPLETED|Booster Phase||144||
48377151|NCT01204658|101251983|FG001|COMPLETED|Booster Phase||140||
48377152|NCT01204658|101251984|FG002|COMPLETED|Booster Phase||140||
48377153|NCT01204658|101251985|FG003|COMPLETED|Booster Phase||140||
48377154|NCT01204658|101251982|FG000|NOT COMPLETED|Booster Phase||0||
48377155|NCT01204658|101251983|FG001|NOT COMPLETED|Booster Phase||0||
48683993|NCT02131662|102009647|FG001|COMPLETED|Overall Study||47||
48683994|NCT02131662|102009648|FG002|COMPLETED|Overall Study||56||
48250374|NCT01560585|100931098|FG000|Screened|Overall Study||3||
48250375|NCT01560585|100931098|FG000|COMPLETED|Overall Study||0||
48250376|NCT01560585|100931098|FG000|NOT COMPLETED|Overall Study||3||
48250377|NCT03132753|100931099|FG000|STARTED|Baseline - 6 Month Follow-Up||46||
48250378|NCT03132753|100931100|FG001|STARTED|Baseline - 6 Month Follow-Up||54||
48250379|NCT03132753|100931099|FG000|COMPLETED|Baseline - 6 Month Follow-Up||19||
48250380|NCT03132753|100931100|FG001|COMPLETED|Baseline - 6 Month Follow-Up||22||
48250381|NCT03132753|100931099|FG000|NOT COMPLETED|Baseline - 6 Month Follow-Up||27||
48250382|NCT03132753|100931100|FG001|NOT COMPLETED|Baseline - 6 Month Follow-Up||32||
48250383|NCT03132753|100931099|FG000|STARTED|6 Month Follow-Up - 12 Month Follow-Up||19||
48250384|NCT03132753|100931100|FG001|STARTED|6 Month Follow-Up - 12 Month Follow-Up||22||
48250385|NCT03132753|100931099|FG000|COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||13||
48250386|NCT03132753|100931100|FG001|COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||20||
48250387|NCT03132753|100931099|FG000|NOT COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||6||
48250388|NCT03132753|100931100|FG001|NOT COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||2||
48250389|NCT03192202|100931101|FG000|STARTED|Overall Study||3||
48250390|NCT03192202|100931102|FG001|STARTED|Overall Study||3||
48250391|NCT03192202|100931103|FG002|STARTED|Overall Study||3||
48250392|NCT03192202|100931104|FG003|STARTED|Overall Study||6||
48250393|NCT03192202|100931101|FG000|COMPLETED|Overall Study||3||
48250394|NCT03192202|100931102|FG001|COMPLETED|Overall Study||3||
48377156|NCT01204658|101251984|FG002|NOT COMPLETED|Booster Phase||0||
48377157|NCT01204658|101251985|FG003|NOT COMPLETED|Booster Phase||0||
48377158|NCT00937768|101251986|FG000|STARTED|Overall Study||8||
48377159|NCT00937768|101251987|FG001|STARTED|Overall Study||8||
48377160|NCT00937768|101251986|FG000|COMPLETED|Overall Study||0||
48377161|NCT00937768|101251987|FG001|COMPLETED|Overall Study||0||
48377162|NCT00937768|101251986|FG000|NOT COMPLETED|Overall Study||8||
48377163|NCT00937768|101251987|FG001|NOT COMPLETED|Overall Study||8||
48377164|NCT02509598|101251988|FG000|STARTED|Overall Study||24||
48377165|NCT02509598|101251988|FG000|COMPLETED|Overall Study||23||
48377166|NCT02509598|101251988|FG000|NOT COMPLETED|Overall Study||1||
48377167|NCT00525148|101251989|FG000|STARTED|Overall Study||23||
48377168|NCT00525148|101251990|FG001|STARTED|Overall Study||38||
48377169|NCT00525148|101251991|FG002|STARTED|Overall Study||7||
48377170|NCT00525148|101251992|FG003|STARTED|Overall Study||61||
48377171|NCT00525148|101251989|FG000|COMPLETED|Overall Study||0||
48377172|NCT00525148|101251990|FG001|COMPLETED|Overall Study||0||
48377173|NCT00525148|101251991|FG002|COMPLETED|Overall Study||0||
48377174|NCT00525148|101251992|FG003|COMPLETED|Overall Study||0||
48377175|NCT00525148|101251989|FG000|NOT COMPLETED|Overall Study||23||
48377176|NCT00525148|101251990|FG001|NOT COMPLETED|Overall Study||38||
48377177|NCT00525148|101251991|FG002|NOT COMPLETED|Overall Study||7||
48377178|NCT00525148|101251992|FG003|NOT COMPLETED|Overall Study||61||
48377179|NCT01683071|101251993|FG000|STARTED|Part 1||25||
48377180|NCT01683071|101251994|FG001|STARTED|Part 1||26||
48377181|NCT01683071|101251995|FG002|STARTED|Part 1||25||
48377182|NCT01683071|101251996|FG003|STARTED|Part 1||25||
48377183|NCT01683071|101251997|FG004|STARTED|Part 1||0||
48377184|NCT01683071|101251998|FG005|STARTED|Part 1||0||
48377185|NCT01683071|101251993|FG000|COMPLETED|Part 1||21||
48377186|NCT01683071|101251994|FG001|COMPLETED|Part 1||22||
48377187|NCT01683071|101251995|FG002|COMPLETED|Part 1||22||
48377188|NCT01683071|101251996|FG003|COMPLETED|Part 1||20||
48377189|NCT01683071|101251997|FG004|COMPLETED|Part 1||0||
48377190|NCT01683071|101251998|FG005|COMPLETED|Part 1||0||
48250395|NCT03192202|100931103|FG002|COMPLETED|Overall Study||3||
48250396|NCT03192202|100931104|FG003|COMPLETED|Overall Study||6||
48250397|NCT03192202|100931101|FG000|NOT COMPLETED|Overall Study||0||
48250398|NCT03192202|100931102|FG001|NOT COMPLETED|Overall Study||0||
48377191|NCT01683071|101251993|FG000|NOT COMPLETED|Part 1||4||
48377192|NCT01683071|101251994|FG001|NOT COMPLETED|Part 1||4||
48377193|NCT01683071|101251995|FG002|NOT COMPLETED|Part 1||3||
48087777|NCT02402127|100537138|FG001|NOT COMPLETED|Second Wear Period (1 Day)||0||
48087778|NCT02402127|100537139|FG002|NOT COMPLETED|Second Wear Period (1 Day)||0||
48250399|NCT03192202|100931103|FG002|NOT COMPLETED|Overall Study||0||
48250400|NCT03192202|100931104|FG003|NOT COMPLETED|Overall Study||0||
48250401|NCT01178281|100931105|FG000|STARTED|Overall Study||168||
48250402|NCT01178281|100931106|FG001|STARTED|Overall Study||84||
48250403|NCT01178281|100931107|FG002|STARTED|Overall Study||15||
48250404|NCT01178281|100931105|FG000|Received Study Drug|Overall Study||167||
48250405|NCT01178281|100931106|FG001|Received Study Drug|Overall Study||83||
48250406|NCT01178281|100931107|FG002|Received Study Drug|Overall Study||15||
48250407|NCT01178281|100931105|FG000|COMPLETED|Overall Study||168|Completed study, no longer in follow-up|
48250408|NCT01178281|100931106|FG001|COMPLETED|Overall Study||84|Completed study, no longer in follow-up|
48250409|NCT01178281|100931107|FG002|COMPLETED|Overall Study||15|Completed study, no longer in follow-up|
48250410|NCT01178281|100931105|FG000|NOT COMPLETED|Overall Study||0||
48250411|NCT01178281|100931106|FG001|NOT COMPLETED|Overall Study||0||
48250412|NCT01178281|100931107|FG002|NOT COMPLETED|Overall Study||0||
48250413|NCT00084747|100931108|FG000|STARTED|Overall Study||30||
48250414|NCT00084747|100931108|FG000|COMPLETED|Overall Study||17||
48250415|NCT00084747|100931108|FG000|NOT COMPLETED|Overall Study||13||
48250416|NCT01107353|100931109|FG000|STARTED|Overall Study||20||
48250417|NCT01107353|100931110|FG001|STARTED|Overall Study||20||
48250418|NCT01107353|100931109|FG000|COMPLETED|Overall Study||19||
48250419|NCT01107353|100931110|FG001|COMPLETED|Overall Study||20||
48250420|NCT01107353|100931109|FG000|NOT COMPLETED|Overall Study||1||
48250421|NCT01107353|100931110|FG001|NOT COMPLETED|Overall Study||0||
48250422|NCT03628456|100931111|FG000|STARTED|Overall Study||10||
48250423|NCT03628456|100931111|FG000|COMPLETED|Overall Study||10||
48250424|NCT03628456|100931111|FG000|NOT COMPLETED|Overall Study||0||
48250425|NCT02512861|100931112|FG000|STARTED|Overall Study||44||
48250426|NCT02512861|100931113|FG001|STARTED|Overall Study||49||
48250427|NCT02512861|100931112|FG000|COMPLETED|Overall Study||38||
48250428|NCT02512861|100931113|FG001|COMPLETED|Overall Study||40||
48250429|NCT02512861|100931112|FG000|NOT COMPLETED|Overall Study||6||
48250430|NCT02512861|100931113|FG001|NOT COMPLETED|Overall Study||9||
48250431|NCT02986659|100931114|FG000|STARTED|First Intervention Period||15||
48250432|NCT02986659|100931115|FG001|STARTED|First Intervention Period||15||
48250433|NCT02986659|100931114|FG000|COMPLETED|First Intervention Period||11||
48250434|NCT02986659|100931115|FG001|COMPLETED|First Intervention Period||13||
48250435|NCT02986659|100931114|FG000|NOT COMPLETED|First Intervention Period||4||
48250436|NCT02986659|100931115|FG001|NOT COMPLETED|First Intervention Period||2||
48250437|NCT02986659|100931114|FG000|STARTED|Second Intervention Period||11||
48250438|NCT02986659|100931115|FG001|STARTED|Second Intervention Period||13||
48250439|NCT02986659|100931114|FG000|COMPLETED|Second Intervention Period||11||
48250440|NCT02986659|100931115|FG001|COMPLETED|Second Intervention Period||7||
48250441|NCT02986659|100931114|FG000|NOT COMPLETED|Second Intervention Period||0||
48250442|NCT02986659|100931115|FG001|NOT COMPLETED|Second Intervention Period||6||
48250443|NCT04013932|100931116|FG000|STARTED|Overall Study||33||
48250444|NCT04013932|100931117|FG001|STARTED|Overall Study||33||
48250445|NCT04013932|100931116|FG000|COMPLETED|Overall Study||33||
48250446|NCT04013932|100931117|FG001|COMPLETED|Overall Study||28||
48250447|NCT04013932|100931116|FG000|NOT COMPLETED|Overall Study||0||
48250448|NCT04013932|100931117|FG001|NOT COMPLETED|Overall Study||5||
48250449|NCT02865135|100931118|FG000|STARTED|Overall Study||6||
48250450|NCT02865135|100931119|FG001|STARTED|Overall Study||3||
48250451|NCT02865135|100931120|FG002|STARTED|Overall Study||2||
48250452|NCT02865135|100931118|FG000|Evaluable for T Cell Analysis|Overall Study||6||
48250453|NCT02865135|100931119|FG001|Evaluable for T Cell Analysis|Overall Study||3||
48250454|NCT02865135|100931120|FG002|Evaluable for T Cell Analysis|Overall Study||0||
48250455|NCT02865135|100931118|FG000|COMPLETED|Overall Study||0||
48250456|NCT02865135|100931119|FG001|COMPLETED|Overall Study||0||
48250457|NCT02865135|100931120|FG002|COMPLETED|Overall Study||0||
48250458|NCT02865135|100931118|FG000|NOT COMPLETED|Overall Study||6||
48250459|NCT02865135|100931119|FG001|NOT COMPLETED|Overall Study||3||
48250460|NCT02865135|100931120|FG002|NOT COMPLETED|Overall Study||2||
48250461|NCT01002547|100931121|FG000|STARTED|Overall Study||32||
48250462|NCT01002547|100931122|FG001|STARTED|Overall Study||36||
48250463|NCT01002547|100931123|FG002|STARTED|Overall Study||37||
48250464|NCT01002547|100931121|FG000|COMPLETED|Overall Study||24||
48250465|NCT01002547|100931122|FG001|COMPLETED|Overall Study||33||
48087779|NCT02402127|100537140|FG003|NOT COMPLETED|Second Wear Period (1 Day)||0||
48250466|NCT01002547|100931123|FG002|COMPLETED|Overall Study||29||
48250467|NCT01002547|100931121|FG000|NOT COMPLETED|Overall Study||8||
48250468|NCT01002547|100931122|FG001|NOT COMPLETED|Overall Study||3||
48250469|NCT01002547|100931123|FG002|NOT COMPLETED|Overall Study||8||
48250470|NCT02995733|100931124|FG000|STARTED|Overall Study||609||
48250471|NCT02995733|100931125|FG001|STARTED|Overall Study||611||
48250472|NCT02995733|100931124|FG000|COMPLETED|Overall Study||542||
48250473|NCT02995733|100931125|FG001|COMPLETED|Overall Study||557||
48250474|NCT02995733|100931124|FG000|NOT COMPLETED|Overall Study||67||
48087780|NCT02402127|100537141|FG004|NOT COMPLETED|Second Wear Period (1 Day)||0||
48087781|NCT02402127|100537142|FG005|NOT COMPLETED|Second Wear Period (1 Day)||0||
48250475|NCT02995733|100931125|FG001|NOT COMPLETED|Overall Study||54||
48250476|NCT03416335|100931126|FG000|STARTED|Overall Study||3||
48250477|NCT03416335|100931127|FG001|STARTED|Overall Study||4||
48250478|NCT03416335|100931128|FG002|STARTED|Overall Study||5||
48250479|NCT03416335|100931129|FG003|STARTED|Overall Study||3||
48250480|NCT03416335|100931130|FG004|STARTED|Overall Study||4||
48250481|NCT03416335|100931131|FG005|STARTED|Overall Study||7||
48250482|NCT03416335|100931132|FG006|STARTED|Overall Study||1||
48250483|NCT03416335|100931133|FG007|STARTED|Overall Study||3||
48250484|NCT03416335|100931134|FG008|STARTED|Overall Study||3||
48250485|NCT03416335|100931135|FG009|STARTED|Overall Study||3||
48250486|NCT03416335|100931126|FG000|COMPLETED|Overall Study||3||
48250487|NCT03416335|100931127|FG001|COMPLETED|Overall Study||4||
48250488|NCT03416335|100931128|FG002|COMPLETED|Overall Study||5||
48250489|NCT03416335|100931129|FG003|COMPLETED|Overall Study||3||
48250490|NCT03416335|100931130|FG004|COMPLETED|Overall Study||4||
48250491|NCT03416335|100931131|FG005|COMPLETED|Overall Study||7||
48250492|NCT03416335|100931132|FG006|COMPLETED|Overall Study||1||
48250493|NCT03416335|100931133|FG007|COMPLETED|Overall Study||3||
48250494|NCT03416335|100931134|FG008|COMPLETED|Overall Study||3||
48250495|NCT03416335|100931135|FG009|COMPLETED|Overall Study||3||
48250496|NCT03416335|100931126|FG000|NOT COMPLETED|Overall Study||0||
48250497|NCT03416335|100931127|FG001|NOT COMPLETED|Overall Study||0||
48250498|NCT03416335|100931128|FG002|NOT COMPLETED|Overall Study||0||
48250499|NCT03416335|100931129|FG003|NOT COMPLETED|Overall Study||0||
48250500|NCT03416335|100931130|FG004|NOT COMPLETED|Overall Study||0||
48250501|NCT03416335|100931131|FG005|NOT COMPLETED|Overall Study||0||
48250502|NCT03416335|100931132|FG006|NOT COMPLETED|Overall Study||0||
48250503|NCT03416335|100931133|FG007|NOT COMPLETED|Overall Study||0||
48250504|NCT03416335|100931134|FG008|NOT COMPLETED|Overall Study||0||
48250505|NCT03416335|100931135|FG009|NOT COMPLETED|Overall Study||0||
48087782|NCT02402127|100537137|FG000|STARTED|Third Wear Period (1 Day)||4||
48087783|NCT02402127|100537138|FG001|STARTED|Third Wear Period (1 Day)||4||
48377194|NCT01683071|101251996|FG003|NOT COMPLETED|Part 1||5||
48377195|NCT01683071|101251997|FG004|NOT COMPLETED|Part 1||0||
48377196|NCT01683071|101251998|FG005|NOT COMPLETED|Part 1||0||
48377197|NCT01683071|101251993|FG000|STARTED|Part 2||0||
48377198|NCT01683071|101251994|FG001|STARTED|Part 2||0||
48377199|NCT01683071|101251995|FG002|STARTED|Part 2||0||
48377200|NCT01683071|101251996|FG003|STARTED|Part 2||0||
48087784|NCT02402127|100537139|FG002|STARTED|Third Wear Period (1 Day)||4||
48087785|NCT02402127|100537140|FG003|STARTED|Third Wear Period (1 Day)||4||
48087786|NCT02402127|100537141|FG004|STARTED|Third Wear Period (1 Day)||4||
48087787|NCT02402127|100537142|FG005|STARTED|Third Wear Period (1 Day)||4||
48087788|NCT02402127|100537137|FG000|COMPLETED|Third Wear Period (1 Day)||4||
48087789|NCT02402127|100537138|FG001|COMPLETED|Third Wear Period (1 Day)||4||
48087790|NCT02402127|100537139|FG002|COMPLETED|Third Wear Period (1 Day)||4||
48087791|NCT02402127|100537140|FG003|COMPLETED|Third Wear Period (1 Day)||4||
48087792|NCT02402127|100537141|FG004|COMPLETED|Third Wear Period (1 Day)||4||
48087793|NCT02402127|100537142|FG005|COMPLETED|Third Wear Period (1 Day)||4||
48087794|NCT02402127|100537137|FG000|NOT COMPLETED|Third Wear Period (1 Day)||0||
48087795|NCT02402127|100537138|FG001|NOT COMPLETED|Third Wear Period (1 Day)||0||
48087796|NCT02402127|100537139|FG002|NOT COMPLETED|Third Wear Period (1 Day)||0||
48087797|NCT02402127|100537140|FG003|NOT COMPLETED|Third Wear Period (1 Day)||0||
48087798|NCT02402127|100537141|FG004|NOT COMPLETED|Third Wear Period (1 Day)||0||
48087799|NCT02402127|100537142|FG005|NOT COMPLETED|Third Wear Period (1 Day)||0||
48087800|NCT02151253|100537143|FG000|STARTED|Overall Study||13||
48087801|NCT02151253|100537144|FG001|STARTED|Overall Study||15||
48087802|NCT02151253|100537143|FG000|COMPLETED|Overall Study||13||
48087803|NCT02151253|100537144|FG001|COMPLETED|Overall Study||15||
48087804|NCT02151253|100537143|FG000|NOT COMPLETED|Overall Study||0||
48087805|NCT02151253|100537144|FG001|NOT COMPLETED|Overall Study||0||
48087806|NCT00483223|100537145|FG000|STARTED|Overall Study||86||
48087807|NCT00483223|100537145|FG000|COMPLETED|Overall Study||86||
48250506|NCT02548754|100931136|FG000|STARTED|Overall Study||26||
48250507|NCT02548754|100931137|FG001|STARTED|Overall Study||27||
48377201|NCT01683071|101251997|FG004|STARTED|Part 2||99||
48377202|NCT01683071|101251998|FG005|STARTED|Part 2||97||
48377203|NCT01683071|101251993|FG000|COMPLETED|Part 2||0||
48377204|NCT01683071|101251994|FG001|COMPLETED|Part 2||0||
48377205|NCT01683071|101251995|FG002|COMPLETED|Part 2||0||
48377206|NCT01683071|101251996|FG003|COMPLETED|Part 2||0||
48087808|NCT00483223|100537145|FG000|NOT COMPLETED|Overall Study||0||
48087809|NCT04666051|100537146|FG000|STARTED|Overall Study||16||
48087810|NCT04666051|100537147|FG001|STARTED|Overall Study||16||
48087811|NCT04666051|100537146|FG000|COMPLETED|Overall Study||16||
48087812|NCT04666051|100537147|FG001|COMPLETED|Overall Study||16||
48087813|NCT04666051|100537146|FG000|NOT COMPLETED|Overall Study||0||
48250508|NCT02548754|100931136|FG000|COMPLETED|Overall Study||24||
48250509|NCT02548754|100931137|FG001|COMPLETED|Overall Study||23||
48377207|NCT01683071|101251997|FG004|COMPLETED|Part 2||82||
48250510|NCT02548754|100931136|FG000|NOT COMPLETED|Overall Study||2||
48250511|NCT02548754|100931137|FG001|NOT COMPLETED|Overall Study||4||
48377208|NCT01683071|101251998|FG005|COMPLETED|Part 2||82||
48377209|NCT01683071|101251993|FG000|NOT COMPLETED|Part 2||0||
48377210|NCT01683071|101251994|FG001|NOT COMPLETED|Part 2||0||
48377211|NCT01683071|101251995|FG002|NOT COMPLETED|Part 2||0||
48377212|NCT01683071|101251996|FG003|NOT COMPLETED|Part 2||0||
48377213|NCT01683071|101251997|FG004|NOT COMPLETED|Part 2||17||
48377214|NCT01683071|101251998|FG005|NOT COMPLETED|Part 2||15||
48377215|NCT01251276|101251999|FG000|STARTED|Overall Study||96||
48377216|NCT01251276|101252000|FG001|STARTED|Overall Study||108||
48377217|NCT01251276|101251999|FG000|Vaccinated|Overall Study||96||
48377218|NCT01251276|101252000|FG001|Vaccinated|Overall Study||108||
48377219|NCT01251276|101251999|FG000|COMPLETED|Overall Study||95||
48087814|NCT04666051|100537147|FG001|NOT COMPLETED|Overall Study||0||
48087815|NCT00085631|100537148|FG000|STARTED|Overall Study||13||
48087816|NCT00085631|100537149|FG001|STARTED|Overall Study||49||
48087817|NCT00085631|100537150|FG002|STARTED|Overall Study||39||
48087818|NCT00085631|100537148|FG000|COMPLETED|Overall Study||9||
48087819|NCT00085631|100537149|FG001|COMPLETED|Overall Study||38||
48087820|NCT00085631|100537150|FG002|COMPLETED|Overall Study||32||
48087821|NCT00085631|100537148|FG000|NOT COMPLETED|Overall Study||4||
48087822|NCT00085631|100537149|FG001|NOT COMPLETED|Overall Study||11||
48087823|NCT00085631|100537150|FG002|NOT COMPLETED|Overall Study||7||
48087824|NCT02743520|100537151|FG000|STARTED|Overall Study||86||
48087825|NCT02743520|100537151|FG000|COMPLETED|Overall Study||85||
48087826|NCT02743520|100537151|FG000|NOT COMPLETED|Overall Study||1||
48087827|NCT02518750|100537152|FG000|STARTED|Overall Study||3||
48087828|NCT02518750|100537152|FG000|COMPLETED|Overall Study||1||
48087829|NCT02518750|100537152|FG000|NOT COMPLETED|Overall Study||2||
48087830|NCT02533427|100537153|FG000|STARTED|Overall Study||15||
48087831|NCT02533427|100537153|FG000|COMPLETED|Overall Study||15||
48087832|NCT02533427|100537153|FG000|NOT COMPLETED|Overall Study||0||
48087833|NCT01574326|100537154|FG000|STARTED|Overall Study||51||
48087834|NCT01574326|100537155|FG001|STARTED|Overall Study||50||
48087835|NCT01574326|100537154|FG000|Treated|Overall Study||51||
48087836|NCT01574326|100537155|FG001|Treated|Overall Study||49||
48087837|NCT01574326|100537154|FG000|COMPLETED|Overall Study||35||
48087838|NCT01574326|100537155|FG001|COMPLETED|Overall Study||31||
48250512|NCT04491006|100931138|FG000|STARTED|Overall Study||24||
48250513|NCT04491006|100931139|FG001|STARTED|Overall Study||27||
48250514|NCT04491006|100931140|FG002|STARTED|Overall Study||26||
48250515|NCT04491006|100931138|FG000|COMPLETED|Overall Study||23||
48250516|NCT04491006|100931139|FG001|COMPLETED|Overall Study||24||
48250517|NCT04491006|100931140|FG002|COMPLETED|Overall Study||19||
48250518|NCT04491006|100931138|FG000|NOT COMPLETED|Overall Study||1||
48250519|NCT04491006|100931139|FG001|NOT COMPLETED|Overall Study||3||
48377220|NCT01251276|101252000|FG001|COMPLETED|Overall Study||107||
48377221|NCT01251276|101251999|FG000|NOT COMPLETED|Overall Study||1||
48377222|NCT01251276|101252000|FG001|NOT COMPLETED|Overall Study||1||
48377223|NCT01157416|101252001|FG000|STARTED|Overall Study||17||
48377224|NCT01157416|101252002|FG001|STARTED|Overall Study||16||
48377225|NCT01157416|101252001|FG000|COMPLETED|Overall Study||15||
48377226|NCT01157416|101252002|FG001|COMPLETED|Overall Study||16||
48541158|NCT03149757|101662670|FG001|NOT COMPLETED|Overall Study||5||
48541159|NCT00143247|101662671|FG000|STARTED|Overall Study||173||
48541160|NCT00143247|101662671|FG000|COMPLETED|Overall Study||17||
48541161|NCT00143247|101662671|FG000|NOT COMPLETED|Overall Study||156||
48541162|NCT01068262|101662672|FG000|STARTED|Overall Study||23||
48087839|NCT01574326|100537154|FG000|NOT COMPLETED|Overall Study||16||
48087840|NCT01574326|100537155|FG001|NOT COMPLETED|Overall Study||19||
48087841|NCT01386554|100537156|FG000|STARTED|Overall Study||4||
48087842|NCT01386554|100537157|FG001|STARTED|Overall Study||35||
48250520|NCT04491006|100931140|FG002|NOT COMPLETED|Overall Study||7||
48250521|NCT01189617|100931141|FG000|STARTED|Overall Study||35||
48250522|NCT01189617|100931142|FG001|STARTED|Overall Study||35||
48250523|NCT01189617|100931141|FG000|COMPLETED|Overall Study||35||
48250524|NCT01189617|100931142|FG001|COMPLETED|Overall Study||35||
48087843|NCT01386554|100537158|FG002|STARTED|Overall Study||21||
48087844|NCT01386554|100537156|FG000|COMPLETED|Overall Study||1||
48087845|NCT01386554|100537157|FG001|COMPLETED|Overall Study||26||
48087846|NCT01386554|100537158|FG002|COMPLETED|Overall Study||15||
48087847|NCT01386554|100537156|FG000|NOT COMPLETED|Overall Study||3||
48087848|NCT01386554|100537157|FG001|NOT COMPLETED|Overall Study||9||
48087849|NCT01386554|100537158|FG002|NOT COMPLETED|Overall Study||6||
48087850|NCT01342796|100537159|FG000|STARTED|Overall Study||43||
48087851|NCT01342796|100537160|FG001|STARTED|Overall Study||41||
48087852|NCT01342796|100537159|FG000|COMPLETED|Overall Study||40||
48087853|NCT01342796|100537160|FG001|COMPLETED|Overall Study||38||
48087854|NCT01342796|100537159|FG000|NOT COMPLETED|Overall Study||3||
48087855|NCT01342796|100537160|FG001|NOT COMPLETED|Overall Study||3||
48087856|NCT02345850|100537161|FG000|STARTED|Overall Study||114||
48377227|NCT01157416|101252001|FG000|NOT COMPLETED|Overall Study||2||
48377228|NCT01157416|101252002|FG001|NOT COMPLETED|Overall Study||0||
48377229|NCT05674344|101252003|FG000|STARTED|Overall Study||170||
48250525|NCT01189617|100931141|FG000|NOT COMPLETED|Overall Study||0||
48250526|NCT01189617|100931142|FG001|NOT COMPLETED|Overall Study||0||
48250527|NCT03455218|100931143|FG000|STARTED|Overall Study||18||
48377230|NCT05674344|101252003|FG000|COMPLETED|Overall Study||146||
48541163|NCT01068262|101662673|FG001|STARTED|Overall Study||9||
48683995|NCT02131662|102009649|FG003|COMPLETED|Overall Study||41||
48683996|NCT02131662|102009650|FG004|COMPLETED|Overall Study||43||
48683997|NCT02131662|102009646|FG000|NOT COMPLETED|Overall Study||8||
48683998|NCT02131662|102009647|FG001|NOT COMPLETED|Overall Study||14||
48683999|NCT02131662|102009648|FG002|NOT COMPLETED|Overall Study||7||
48684000|NCT02131662|102009649|FG003|NOT COMPLETED|Overall Study||21||
48684001|NCT02131662|102009650|FG004|NOT COMPLETED|Overall Study||18||
48684002|NCT02656836|102009651|FG000|STARTED|Overall Study||9||
48684003|NCT02656836|102009651|FG000|COMPLETED|Overall Study||6||
48684004|NCT02656836|102009651|FG000|NOT COMPLETED|Overall Study||3||
48684005|NCT00488514|102009652|FG000|STARTED|Overall Study||656||
48250528|NCT03455218|100931144|FG001|STARTED|Overall Study||22||
48250529|NCT03455218|100931143|FG000|COMPLETED|Overall Study||18||
48250530|NCT03455218|100931144|FG001|COMPLETED|Overall Study||22||
48250531|NCT03455218|100931143|FG000|NOT COMPLETED|Overall Study||0||
48250532|NCT03455218|100931144|FG001|NOT COMPLETED|Overall Study||0||
48250533|NCT00507429|100931145|FG000|STARTED|Treatment Phase||55||
48250534|NCT00507429|100931146|FG001|STARTED|Treatment Phase||25||
48250535|NCT00507429|100931145|FG000|COMPLETED|Treatment Phase||18||
48250536|NCT00507429|100931146|FG001|COMPLETED|Treatment Phase||7||
48250537|NCT00507429|100931145|FG000|NOT COMPLETED|Treatment Phase||37||
48250538|NCT00507429|100931146|FG001|NOT COMPLETED|Treatment Phase||18||
48250539|NCT00507429|100931145|FG000|STARTED|Maintenance Phase||16||
48250540|NCT00507429|100931146|FG001|STARTED|Maintenance Phase||0||
48250541|NCT00507429|100931145|FG000|COMPLETED|Maintenance Phase||2||
48250542|NCT00507429|100931146|FG001|COMPLETED|Maintenance Phase||0||
48250543|NCT00507429|100931145|FG000|NOT COMPLETED|Maintenance Phase||14||
48250544|NCT00507429|100931146|FG001|NOT COMPLETED|Maintenance Phase||0||
48250545|NCT00475735|100931147|FG000|STARTED|Treatment Period 1||14||
48250546|NCT00475735|100931148|FG001|STARTED|Treatment Period 1||13||
48250547|NCT00475735|100931149|FG002|STARTED|Treatment Period 1||7||
48250548|NCT00475735|100931150|FG003|STARTED|Treatment Period 1||7||
48250549|NCT00475735|100931151|FG004|STARTED|Treatment Period 1||16||
48250550|NCT00475735|100931152|FG005|STARTED|Treatment Period 1||15||
48250551|NCT00475735|100931147|FG000|COMPLETED|Treatment Period 1||10||
48250552|NCT00475735|100931148|FG001|COMPLETED|Treatment Period 1||11||
48250553|NCT00475735|100931149|FG002|COMPLETED|Treatment Period 1||7||
48250554|NCT00475735|100931150|FG003|COMPLETED|Treatment Period 1||5||
48250555|NCT00475735|100931151|FG004|COMPLETED|Treatment Period 1||14||
48250556|NCT00475735|100931152|FG005|COMPLETED|Treatment Period 1||12||
48250557|NCT00475735|100931147|FG000|NOT COMPLETED|Treatment Period 1||4||
48684006|NCT00488514|102009652|FG000|COMPLETED|Overall Study||363||
48684007|NCT00488514|102009652|FG000|NOT COMPLETED|Overall Study||293||
48684008|NCT01306643|102009653|FG000|STARTED|Overall Study||18||
48684009|NCT01306643|102009653|FG000|COMPLETED|Overall Study||5||
48684010|NCT01306643|102009653|FG000|NOT COMPLETED|Overall Study||13||
48684011|NCT00746187|102009654|FG000|STARTED|Overall Study||18||
48684012|NCT00746187|102009655|FG001|STARTED|Overall Study||18||
48684013|NCT00746187|102009654|FG000|COMPLETED|Overall Study||15||
48250558|NCT00475735|100931148|FG001|NOT COMPLETED|Treatment Period 1||2||
48684014|NCT00746187|102009655|FG001|COMPLETED|Overall Study||16||
48684015|NCT00746187|102009654|FG000|NOT COMPLETED|Overall Study||3||
48250559|NCT00475735|100931149|FG002|NOT COMPLETED|Treatment Period 1||0||
48250560|NCT00475735|100931150|FG003|NOT COMPLETED|Treatment Period 1||2||
48250561|NCT00475735|100931151|FG004|NOT COMPLETED|Treatment Period 1||2||
48250562|NCT00475735|100931152|FG005|NOT COMPLETED|Treatment Period 1||3||
48250563|NCT00475735|100931147|FG000|STARTED|Treatment Washout||10||
48250564|NCT00475735|100931148|FG001|STARTED|Treatment Washout||12||
48250565|NCT00475735|100931149|FG002|STARTED|Treatment Washout||7||
48250566|NCT00475735|100931150|FG003|STARTED|Treatment Washout||6||
48250567|NCT00475735|100931151|FG004|STARTED|Treatment Washout||16||
48250568|NCT00475735|100931152|FG005|STARTED|Treatment Washout||14||
48250569|NCT00475735|100931147|FG000|COMPLETED|Treatment Washout||10||
48250570|NCT00475735|100931148|FG001|COMPLETED|Treatment Washout||10||
48250571|NCT00475735|100931149|FG002|COMPLETED|Treatment Washout||7||
48250572|NCT00475735|100931150|FG003|COMPLETED|Treatment Washout||6||
48250573|NCT00475735|100931151|FG004|COMPLETED|Treatment Washout||16||
48250574|NCT00475735|100931152|FG005|COMPLETED|Treatment Washout||14||
48250575|NCT00475735|100931147|FG000|NOT COMPLETED|Treatment Washout||0||
48250576|NCT00475735|100931148|FG001|NOT COMPLETED|Treatment Washout||2||
48250577|NCT00475735|100931149|FG002|NOT COMPLETED|Treatment Washout||0||
48250578|NCT00475735|100931150|FG003|NOT COMPLETED|Treatment Washout||0||
48684016|NCT00746187|102009655|FG001|NOT COMPLETED|Overall Study||2||
48684017|NCT02524561|102009656|FG000|STARTED|Baseline: Pre-randomization Mammogram||168||
48684018|NCT02524561|102009657|FG001|STARTED|Baseline: Pre-randomization Mammogram||162||
48250579|NCT00475735|100931151|FG004|NOT COMPLETED|Treatment Washout||0||
48250580|NCT00475735|100931152|FG005|NOT COMPLETED|Treatment Washout||0||
48250581|NCT00475735|100931147|FG000|STARTED|Treatment Period 2||10||
48250582|NCT00475735|100931148|FG001|STARTED|Treatment Period 2||10||
48250583|NCT00475735|100931149|FG002|STARTED|Treatment Period 2||7||
48250584|NCT00475735|100931150|FG003|STARTED|Treatment Period 2||6||
48250585|NCT00475735|100931151|FG004|STARTED|Treatment Period 2||16||
48250586|NCT00475735|100931152|FG005|STARTED|Treatment Period 2||14||
48087857|NCT02345850|100537162|FG001|STARTED|Overall Study||114||
48087858|NCT02345850|100537163|FG002|STARTED|Overall Study||118||
48087859|NCT02345850|100537161|FG000|COMPLETED|Overall Study||101||
48087860|NCT02345850|100537162|FG001|COMPLETED|Overall Study||106||
48377231|NCT05674344|101252003|FG000|NOT COMPLETED|Overall Study||24||
48377232|NCT01189435|101252004|FG000|STARTED|Overall Study||2||
48377233|NCT01189435|101252004|FG000|COMPLETED|Overall Study||0||
48377234|NCT01189435|101252004|FG000|NOT COMPLETED|Overall Study||2||
48377235|NCT02130427|101252005|FG000|STARTED|Overall Study||74||
48684019|NCT02524561|102009658|FG002|STARTED|Baseline: Pre-randomization Mammogram||187||
48684020|NCT02524561|102009656|FG000|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||137||
48684021|NCT02524561|102009657|FG001|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||133||
48684022|NCT02524561|102009658|FG002|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||151||
48684023|NCT02524561|102009656|FG000|COMPLETED|Baseline: Pre-randomization Mammogram||168||
48684024|NCT02524561|102009657|FG001|COMPLETED|Baseline: Pre-randomization Mammogram||162||
48684025|NCT02524561|102009658|FG002|COMPLETED|Baseline: Pre-randomization Mammogram||187||
48684026|NCT02524561|102009656|FG000|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0||
48684027|NCT02524561|102009657|FG001|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0||
48684028|NCT02524561|102009658|FG002|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0||
48684029|NCT02524561|102009656|FG000|STARTED|Year 1: Post Randomization Mammograms||168||
48684030|NCT02524561|102009657|FG001|STARTED|Year 1: Post Randomization Mammograms||162||
48684031|NCT02524561|102009658|FG002|STARTED|Year 1: Post Randomization Mammograms||187||
48087861|NCT02345850|100537163|FG002|COMPLETED|Overall Study||112||
48377236|NCT02130427|101252005|FG000|COMPLETED|Overall Study||44||
48377237|NCT02130427|101252005|FG000|NOT COMPLETED|Overall Study||30||
48377238|NCT00882102|101252006|FG000|STARTED|Overall Study||40||
48377239|NCT00882102|101252006|FG000|COMPLETED|Overall Study||40||
48377240|NCT00882102|101252006|FG000|NOT COMPLETED|Overall Study||0||
48377241|NCT01788306|101252007|FG000|STARTED|Overall Study||125||
48377242|NCT01788306|101252008|FG001|STARTED|Overall Study||131||
48377243|NCT01788306|101252007|FG000|COMPLETED|Overall Study||115||
48377244|NCT01788306|101252008|FG001|COMPLETED|Overall Study||126||
48377245|NCT01788306|101252007|FG000|NOT COMPLETED|Overall Study||10||
48377246|NCT01788306|101252008|FG001|NOT COMPLETED|Overall Study||5||
48377247|NCT00360243|101252009|FG000|STARTED|Overall Study||337||
48377248|NCT00360243|101252010|FG001|STARTED|Overall Study||363||
48377249|NCT00360243|101252011|FG002|STARTED|Overall Study||336||
48377250|NCT00360243|101252012|FG003|STARTED|Overall Study||349||
48377251|NCT00360243|101252009|FG000|COMPLETED|Overall Study||235||
48377252|NCT00360243|101252010|FG001|COMPLETED|Overall Study||243||
48377253|NCT00360243|101252011|FG002|COMPLETED|Overall Study||180||
48377254|NCT00360243|101252012|FG003|COMPLETED|Overall Study||224||
48377255|NCT00360243|101252009|FG000|NOT COMPLETED|Overall Study||102||
48377256|NCT00360243|101252010|FG001|NOT COMPLETED|Overall Study||120||
48377257|NCT00360243|101252011|FG002|NOT COMPLETED|Overall Study||156||
48377258|NCT00360243|101252012|FG003|NOT COMPLETED|Overall Study||125||
48377259|NCT03628508|101252013|FG000|STARTED|Overall Study||40||
48087862|NCT02345850|100537161|FG000|NOT COMPLETED|Overall Study||13||
48087863|NCT02345850|100537162|FG001|NOT COMPLETED|Overall Study||8||
48377260|NCT03628508|101252013|FG000|COMPLETED|Overall Study||39||
48377261|NCT03628508|101252013|FG000|NOT COMPLETED|Overall Study||1||
48377262|NCT00665288|101252014|FG000|STARTED|Overall Study||220||
48377263|NCT00665288|101252015|FG001|STARTED|Overall Study||192||
48377264|NCT00665288|101252014|FG000|COMPLETED|Overall Study||220||
48377265|NCT00665288|101252015|FG001|COMPLETED|Overall Study||192||
48377266|NCT00665288|101252014|FG000|NOT COMPLETED|Overall Study||0||
48377267|NCT00665288|101252015|FG001|NOT COMPLETED|Overall Study||0||
48377268|NCT02985450|101252016|FG000|STARTED|Overall Study||82||
48684032|NCT02524561|102009656|FG000|Obtained Mammogam|Year 1: Post Randomization Mammograms||136||
48684033|NCT02524561|102009657|FG001|Obtained Mammogam|Year 1: Post Randomization Mammograms||123||
48684034|NCT02524561|102009658|FG002|Obtained Mammogam|Year 1: Post Randomization Mammograms||148||
48087864|NCT02345850|100537163|FG002|NOT COMPLETED|Overall Study||6||
48087865|NCT03266107|100537164|FG000|STARTED|Enrollment to Procedure||50||
48087866|NCT03266107|100537164|FG000|COMPLETED|Enrollment to Procedure||47||
48377269|NCT02985450|101252016|FG000|COMPLETED|Overall Study||75||
48377270|NCT02985450|101252016|FG000|NOT COMPLETED|Overall Study||7||
48377271|NCT03430245|101252017|FG000|STARTED|Overall Study||16||
48377272|NCT03430245|101252017|FG000|COMPLETED|Overall Study||9||
48377273|NCT03430245|101252017|FG000|NOT COMPLETED|Overall Study||7||
48377274|NCT03622593|101252018|FG000|STARTED|Overall Study||317|Intent-to-Treat (ITT) Population|
48377275|NCT03622593|101252019|FG001|STARTED|Overall Study||319|Intent-to-Treat (ITT) Population|
48377276|NCT03622593|101252020|FG002|STARTED|Overall Study||315|Intent-to-Treat (ITT) Population|
48377277|NCT03622593|101252018|FG000|Received at Least One Dose of Study Drug|Overall Study||317|Safety-Evaluable Population|
48377278|NCT03622593|101252019|FG001|Received at Least One Dose of Study Drug|Overall Study||319|Safety-Evaluable Population|
48377279|NCT03622593|101252020|FG002|Received at Least One Dose of Study Drug|Overall Study||314|Safety-Evaluable Population|
48377280|NCT03622593|101252018|FG000|Completed up to Week 56|Overall Study||298|Primary Completion Date Cutoff|
48684035|NCT02524561|102009656|FG000|COMPLETED|Year 1: Post Randomization Mammograms||168||
48087867|NCT03266107|100537164|FG000|NOT COMPLETED|Enrollment to Procedure||3||
48087868|NCT03266107|100537164|FG000|STARTED|3-Month Follow-up Visit||47||
48087869|NCT03266107|100537164|FG000|COMPLETED|3-Month Follow-up Visit||46||
48087870|NCT03266107|100537164|FG000|NOT COMPLETED|3-Month Follow-up Visit||1||
48377281|NCT03622593|101252019|FG001|Completed up to Week 56|Overall Study||312|Primary Completion Date Cutoff|
48377282|NCT03622593|101252020|FG002|Completed up to Week 56|Overall Study||299|Primary Completion Date Cutoff|
48377283|NCT03622593|101252018|FG000|COMPLETED|Overall Study||275||
48377284|NCT03622593|101252019|FG001|COMPLETED|Overall Study||288||
48377285|NCT03622593|101252020|FG002|COMPLETED|Overall Study||267||
48377286|NCT03622593|101252018|FG000|NOT COMPLETED|Overall Study||42||
48377287|NCT03622593|101252019|FG001|NOT COMPLETED|Overall Study||31||
48377288|NCT03622593|101252020|FG002|NOT COMPLETED|Overall Study||48||
48377289|NCT04030104|101252021|FG000|STARTED|Overall Study||480||
48377290|NCT04030104|101252021|FG000|COMPLETED|Overall Study||480||
48377291|NCT04030104|101252021|FG000|NOT COMPLETED|Overall Study||0||
48377292|NCT02683525|101252022|FG000|STARTED|Overall Study||37||
48377293|NCT02683525|101252022|FG000|COMPLETED|Overall Study||29||
48087871|NCT03266107|100537164|FG000|STARTED|12-Month Follow-up Visit||46||
48087872|NCT03266107|100537164|FG000|COMPLETED|12-Month Follow-up Visit||45||
48087873|NCT03266107|100537164|FG000|NOT COMPLETED|12-Month Follow-up Visit||1||
48087874|NCT00309387|100537165|FG000|STARTED|Overall Study||510||
48087875|NCT00309387|100537166|FG001|STARTED|Overall Study||510||
48087876|NCT00309387|100537165|FG000|COMPLETED|Overall Study||368||
48087877|NCT00309387|100537166|FG001|COMPLETED|Overall Study||351||
48087878|NCT00309387|100537165|FG000|NOT COMPLETED|Overall Study||142||
48087879|NCT00309387|100537166|FG001|NOT COMPLETED|Overall Study||159||
48087880|NCT01804296|100537167|FG000|STARTED|Overall Study||4||
48087881|NCT01804296|100537167|FG000|COMPLETED|Overall Study||4||
48087882|NCT01804296|100537167|FG000|NOT COMPLETED|Overall Study||0||
48087883|NCT01195415|100537168|FG000|STARTED|Overall Study||25||
48087884|NCT01195415|100537168|FG000|COMPLETED|Overall Study||23||
48377294|NCT02683525|101252022|FG000|NOT COMPLETED|Overall Study||8||
48377295|NCT01067508|101252023|FG000|STARTED|Overall Study||10||
48377296|NCT01067508|101252024|FG001|STARTED|Overall Study||9||
48377297|NCT01067508|101252023|FG000|COMPLETED|Overall Study||10||
48377298|NCT01067508|101252024|FG001|COMPLETED|Overall Study||7||
48377299|NCT01067508|101252023|FG000|NOT COMPLETED|Overall Study||0||
48377300|NCT01067508|101252024|FG001|NOT COMPLETED|Overall Study||2||
48377301|NCT02273050|101252025|FG000|STARTED|Overall Study||210||
48377302|NCT02273050|101252026|FG001|STARTED|Overall Study||216||
48087885|NCT01195415|100537168|FG000|NOT COMPLETED|Overall Study||2||
48087886|NCT00846430|100537169|FG000|STARTED|Overall Study||9||
48087887|NCT00846430|100537169|FG000|COMPLETED|Overall Study||9||
48087888|NCT00846430|100537169|FG000|NOT COMPLETED|Overall Study||0||
48087889|NCT05426902|100537170|FG000|STARTED|Overall Study||16||
48087890|NCT05426902|100537171|FG001|STARTED|Overall Study||49||
48087891|NCT05426902|100537172|FG002|STARTED|Overall Study||115||
48087892|NCT05426902|100537170|FG000|COMPLETED|Overall Study||16||
48087893|NCT05426902|100537171|FG001|COMPLETED|Overall Study||49||
48087894|NCT05426902|100537172|FG002|COMPLETED|Overall Study||115||
48087895|NCT05426902|100537170|FG000|NOT COMPLETED|Overall Study||0||
48087896|NCT05426902|100537171|FG001|NOT COMPLETED|Overall Study||0||
48087897|NCT05426902|100537172|FG002|NOT COMPLETED|Overall Study||0||
48087898|NCT00441883|100537173|FG000|STARTED|Overall Study||43||
48087899|NCT00441883|100537174|FG001|STARTED|Overall Study||32||
48087900|NCT00441883|100537175|FG002|STARTED|Overall Study||28||
48087901|NCT00441883|100537176|FG003|STARTED|Overall Study||28||
48087902|NCT00441883|100537177|FG004|STARTED|Overall Study||45||
48087903|NCT00441883|100537173|FG000|ITT Population|Overall Study||43|Participants randomized and at least 1 dose of study medication; by randomized treatment.|
48087904|NCT00441883|100537174|FG001|ITT Population|Overall Study||30|Participants randomized and at least 1 dose of study medication; by randomized treatment.|
48087905|NCT00441883|100537175|FG002|ITT Population|Overall Study||30|Participants randomized and at least 1 dose of study medication; by randomized treatment.|
48087906|NCT00441883|100537176|FG003|ITT Population|Overall Study||30|Participants randomized and at least 1 dose of study medication; by randomized treatment.|
48087907|NCT00441883|100537177|FG004|ITT Population|Overall Study||43|Participants randomized and at least 1 dose of study medication; by randomized treatment.|
48087908|NCT00441883|100537173|FG000|Per Protocol Population|Overall Study||38|Participant randomized with no major protocol violations; by treatment received.|
48087909|NCT00441883|100537174|FG001|Per Protocol Population|Overall Study||29|Participant randomized with no major protocol violations; by treatment received.|
48087910|NCT00441883|100537175|FG002|Per Protocol Population|Overall Study||25|Participant randomized with no major protocol violations; by treatment received.|
48087911|NCT00441883|100537176|FG003|Per Protocol Population|Overall Study||24|Participant randomized with no major protocol violations; by treatment received.|
48377303|NCT02273050|101252027|FG002|STARTED|Overall Study||214||
48377304|NCT02273050|101252025|FG000|COMPLETED|Overall Study||186||
48377305|NCT02273050|101252026|FG001|COMPLETED|Overall Study||194||
48377306|NCT02273050|101252027|FG002|COMPLETED|Overall Study||185||
48377307|NCT02273050|101252025|FG000|NOT COMPLETED|Overall Study||24||
48377308|NCT02273050|101252026|FG001|NOT COMPLETED|Overall Study||22||
48377309|NCT02273050|101252027|FG002|NOT COMPLETED|Overall Study||29||
48377310|NCT00862849|101252028|FG000|STARTED|Intervention 1||3||
48377311|NCT00862849|101252029|FG001|STARTED|Intervention 1||5||
48377312|NCT00862849|101252030|FG002|STARTED|Intervention 1||3||
48377313|NCT00862849|101252031|FG003|STARTED|Intervention 1||4||
48377314|NCT00862849|101252032|FG004|STARTED|Intervention 1||4||
48377315|NCT00862849|101252033|FG005|STARTED|Intervention 1||3||
48377316|NCT00862849|101252028|FG000|Received at Least One Dose of Study Drug|Intervention 1||3||
48377317|NCT00862849|101252029|FG001|Received at Least One Dose of Study Drug|Intervention 1||5||
48377318|NCT00862849|101252030|FG002|Received at Least One Dose of Study Drug|Intervention 1||3||
48377319|NCT00862849|101252031|FG003|Received at Least One Dose of Study Drug|Intervention 1||4||
48377320|NCT00862849|101252032|FG004|Received at Least One Dose of Study Drug|Intervention 1||4||
48377321|NCT00862849|101252033|FG005|Received at Least One Dose of Study Drug|Intervention 1||3||
48377322|NCT00862849|101252028|FG000|COMPLETED|Intervention 1||3||
48377323|NCT00862849|101252029|FG001|COMPLETED|Intervention 1||5||
48377324|NCT00862849|101252030|FG002|COMPLETED|Intervention 1||3||
48377325|NCT00862849|101252031|FG003|COMPLETED|Intervention 1||4||
48377326|NCT00862849|101252032|FG004|COMPLETED|Intervention 1||4||
48377327|NCT00862849|101252033|FG005|COMPLETED|Intervention 1||3||
48377328|NCT00862849|101252028|FG000|NOT COMPLETED|Intervention 1||0||
48377329|NCT00862849|101252029|FG001|NOT COMPLETED|Intervention 1||0||
48377330|NCT00862849|101252030|FG002|NOT COMPLETED|Intervention 1||0||
48377331|NCT00862849|101252031|FG003|NOT COMPLETED|Intervention 1||0||
48377332|NCT00862849|101252032|FG004|NOT COMPLETED|Intervention 1||0||
48377333|NCT00862849|101252033|FG005|NOT COMPLETED|Intervention 1||0||
48377334|NCT00862849|101252028|FG000|STARTED|Washout 1 (3 to 14 Days)||3||
48377335|NCT00862849|101252029|FG001|STARTED|Washout 1 (3 to 14 Days)||5||
48377336|NCT00862849|101252030|FG002|STARTED|Washout 1 (3 to 14 Days)||3||
48377337|NCT00862849|101252031|FG003|STARTED|Washout 1 (3 to 14 Days)||4||
48377338|NCT00862849|101252032|FG004|STARTED|Washout 1 (3 to 14 Days)||4||
48377339|NCT00862849|101252033|FG005|STARTED|Washout 1 (3 to 14 Days)||3||
48377340|NCT00862849|101252028|FG000|COMPLETED|Washout 1 (3 to 14 Days)||3||
48377341|NCT00862849|101252029|FG001|COMPLETED|Washout 1 (3 to 14 Days)||4||
48377342|NCT00862849|101252030|FG002|COMPLETED|Washout 1 (3 to 14 Days)||3||
48377343|NCT00862849|101252031|FG003|COMPLETED|Washout 1 (3 to 14 Days)||4||
48377344|NCT00862849|101252032|FG004|COMPLETED|Washout 1 (3 to 14 Days)||4||
48377345|NCT00862849|101252033|FG005|COMPLETED|Washout 1 (3 to 14 Days)||3||
48377346|NCT00862849|101252028|FG000|NOT COMPLETED|Washout 1 (3 to 14 Days)||0||
48377347|NCT00862849|101252029|FG001|NOT COMPLETED|Washout 1 (3 to 14 Days)||1||
48377348|NCT00862849|101252030|FG002|NOT COMPLETED|Washout 1 (3 to 14 Days)||0||
48377349|NCT00862849|101252031|FG003|NOT COMPLETED|Washout 1 (3 to 14 Days)||0||
48377350|NCT00862849|101252032|FG004|NOT COMPLETED|Washout 1 (3 to 14 Days)||0||
48377351|NCT00862849|101252033|FG005|NOT COMPLETED|Washout 1 (3 to 14 Days)||0||
48377352|NCT00862849|101252028|FG000|STARTED|Intervention 2||3||
48377353|NCT00862849|101252029|FG001|STARTED|Intervention 2||4||
48377354|NCT00862849|101252030|FG002|STARTED|Intervention 2||3||
48377355|NCT00862849|101252031|FG003|STARTED|Intervention 2||4||
48377356|NCT00862849|101252032|FG004|STARTED|Intervention 2||4||
48377357|NCT00862849|101252033|FG005|STARTED|Intervention 2||3||
48377358|NCT00862849|101252028|FG000|COMPLETED|Intervention 2||3||
48377359|NCT00862849|101252029|FG001|COMPLETED|Intervention 2||4||
48377360|NCT00862849|101252030|FG002|COMPLETED|Intervention 2||3||
48377361|NCT00862849|101252031|FG003|COMPLETED|Intervention 2||4||
48377362|NCT00862849|101252032|FG004|COMPLETED|Intervention 2||4||
48377363|NCT00862849|101252033|FG005|COMPLETED|Intervention 2||3||
48377364|NCT00862849|101252028|FG000|NOT COMPLETED|Intervention 2||0||
48377365|NCT00862849|101252029|FG001|NOT COMPLETED|Intervention 2||0||
48377366|NCT00862849|101252030|FG002|NOT COMPLETED|Intervention 2||0||
48377367|NCT00862849|101252031|FG003|NOT COMPLETED|Intervention 2||0||
48377368|NCT00862849|101252032|FG004|NOT COMPLETED|Intervention 2||0||
48377369|NCT00862849|101252033|FG005|NOT COMPLETED|Intervention 2||0||
48377370|NCT00862849|101252028|FG000|STARTED|Washout 2 (3 to 14 Days)||3||
48377371|NCT00862849|101252029|FG001|STARTED|Washout 2 (3 to 14 Days)||4||
48377372|NCT00862849|101252030|FG002|STARTED|Washout 2 (3 to 14 Days)||3||
48377373|NCT00862849|101252031|FG003|STARTED|Washout 2 (3 to 14 Days)||4||
48377374|NCT00862849|101252032|FG004|STARTED|Washout 2 (3 to 14 Days)||4||
48377375|NCT00862849|101252033|FG005|STARTED|Washout 2 (3 to 14 Days)||3||
48377376|NCT00862849|101252028|FG000|COMPLETED|Washout 2 (3 to 14 Days)||3||
48377377|NCT00862849|101252029|FG001|COMPLETED|Washout 2 (3 to 14 Days)||3||
48377378|NCT00862849|101252030|FG002|COMPLETED|Washout 2 (3 to 14 Days)||3||
48377379|NCT00862849|101252031|FG003|COMPLETED|Washout 2 (3 to 14 Days)||4||
48377380|NCT00862849|101252032|FG004|COMPLETED|Washout 2 (3 to 14 Days)||4||
48377381|NCT00862849|101252033|FG005|COMPLETED|Washout 2 (3 to 14 Days)||3||
48377382|NCT00862849|101252028|FG000|NOT COMPLETED|Washout 2 (3 to 14 Days)||0||
48377383|NCT00862849|101252029|FG001|NOT COMPLETED|Washout 2 (3 to 14 Days)||1||
48377384|NCT00862849|101252030|FG002|NOT COMPLETED|Washout 2 (3 to 14 Days)||0||
48377385|NCT00862849|101252031|FG003|NOT COMPLETED|Washout 2 (3 to 14 Days)||0||
48377386|NCT00862849|101252032|FG004|NOT COMPLETED|Washout 2 (3 to 14 Days)||0||
48377387|NCT00862849|101252033|FG005|NOT COMPLETED|Washout 2 (3 to 14 Days)||0||
48377388|NCT00862849|101252028|FG000|STARTED|Intervention 3||3||
48377389|NCT00862849|101252029|FG001|STARTED|Intervention 3||3||
48377390|NCT00862849|101252030|FG002|STARTED|Intervention 3||3||
48377391|NCT00862849|101252031|FG003|STARTED|Intervention 3||4||
48377392|NCT00862849|101252032|FG004|STARTED|Intervention 3||4||
48377393|NCT00862849|101252033|FG005|STARTED|Intervention 3||3||
48377394|NCT00862849|101252028|FG000|COMPLETED|Intervention 3||3||
48087912|NCT00441883|100537177|FG004|Per Protocol Population|Overall Study||38|Participant randomized with no major protocol violations; by treatment received.|
48087913|NCT00441883|100537173|FG000|Safety Population|Overall Study||43|Participants randomized with at least 1 dose of study medication; by treatment received.|
48087914|NCT00441883|100537174|FG001|Safety Population|Overall Study||32|Participants randomized with at least 1 dose of study medication; by treatment received.|
48087915|NCT00441883|100537175|FG002|Safety Population|Overall Study||28|Participants randomized with at least 1 dose of study medication; by treatment received.|
48087916|NCT00441883|100537176|FG003|Safety Population|Overall Study||28|Participants randomized with at least 1 dose of study medication; by treatment received.|
48087917|NCT00441883|100537177|FG004|Safety Population|Overall Study||45|Participants randomized with at least 1 dose of study medication; by treatment received.|
48087918|NCT00441883|100537173|FG000|COMPLETED|Overall Study||42||
48087919|NCT00441883|100537174|FG001|COMPLETED|Overall Study||32||
48377395|NCT00862849|101252029|FG001|COMPLETED|Intervention 3||3||
48377396|NCT00862849|101252030|FG002|COMPLETED|Intervention 3||3||
48377397|NCT00862849|101252031|FG003|COMPLETED|Intervention 3||4||
48377398|NCT00862849|101252032|FG004|COMPLETED|Intervention 3||4||
48377399|NCT00862849|101252033|FG005|COMPLETED|Intervention 3||3||
48377400|NCT00862849|101252028|FG000|NOT COMPLETED|Intervention 3||0||
48377401|NCT00862849|101252029|FG001|NOT COMPLETED|Intervention 3||0||
48377402|NCT00862849|101252030|FG002|NOT COMPLETED|Intervention 3||0||
48684036|NCT02524561|102009657|FG001|COMPLETED|Year 1: Post Randomization Mammograms||162||
48684037|NCT02524561|102009658|FG002|COMPLETED|Year 1: Post Randomization Mammograms||187||
48684038|NCT02524561|102009656|FG000|NOT COMPLETED|Year 1: Post Randomization Mammograms||0||
48684039|NCT02524561|102009657|FG001|NOT COMPLETED|Year 1: Post Randomization Mammograms||0||
48684040|NCT02524561|102009658|FG002|NOT COMPLETED|Year 1: Post Randomization Mammograms||0||
48377403|NCT00862849|101252031|FG003|NOT COMPLETED|Intervention 3||0||
48377404|NCT00862849|101252032|FG004|NOT COMPLETED|Intervention 3||0||
48377405|NCT00862849|101252033|FG005|NOT COMPLETED|Intervention 3||0||
48377406|NCT00862849|101252028|FG000|STARTED|Washout 3 (3 to 14 Days)||3||
48377407|NCT00862849|101252029|FG001|STARTED|Washout 3 (3 to 14 Days)||3||
48377408|NCT00862849|101252030|FG002|STARTED|Washout 3 (3 to 14 Days)||3||
48377409|NCT00862849|101252031|FG003|STARTED|Washout 3 (3 to 14 Days)||4||
48377410|NCT00862849|101252032|FG004|STARTED|Washout 3 (3 to 14 Days)||4||
48377411|NCT00862849|101252033|FG005|STARTED|Washout 3 (3 to 14 Days)||3||
48377412|NCT00862849|101252028|FG000|COMPLETED|Washout 3 (3 to 14 Days)||3||
48377413|NCT00862849|101252029|FG001|COMPLETED|Washout 3 (3 to 14 Days)||3||
48377414|NCT00862849|101252030|FG002|COMPLETED|Washout 3 (3 to 14 Days)||3||
48377415|NCT00862849|101252031|FG003|COMPLETED|Washout 3 (3 to 14 Days)||4||
48377416|NCT00862849|101252032|FG004|COMPLETED|Washout 3 (3 to 14 Days)||4||
48377417|NCT00862849|101252033|FG005|COMPLETED|Washout 3 (3 to 14 Days)||3||
48377418|NCT00862849|101252028|FG000|NOT COMPLETED|Washout 3 (3 to 14 Days)||0||
48377419|NCT00862849|101252029|FG001|NOT COMPLETED|Washout 3 (3 to 14 Days)||0||
48684041|NCT02524561|102009656|FG000|STARTED|Final: Year 3 or 4 Post-randomization||168||
48684042|NCT02524561|102009657|FG001|STARTED|Final: Year 3 or 4 Post-randomization||162||
48684043|NCT02524561|102009658|FG002|STARTED|Final: Year 3 or 4 Post-randomization||187||
48684044|NCT02524561|102009656|FG000|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||143||
48684045|NCT02524561|102009657|FG001|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||139||
48377420|NCT00862849|101252030|FG002|NOT COMPLETED|Washout 3 (3 to 14 Days)||0||
48684046|NCT02524561|102009658|FG002|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||151||
48684047|NCT02524561|102009656|FG000|COMPLETED|Final: Year 3 or 4 Post-randomization||168||
48684048|NCT02524561|102009657|FG001|COMPLETED|Final: Year 3 or 4 Post-randomization||162||
48087920|NCT00441883|100537175|FG002|COMPLETED|Overall Study||28||
48087921|NCT00441883|100537176|FG003|COMPLETED|Overall Study||28||
48087922|NCT00441883|100537177|FG004|COMPLETED|Overall Study||43||
48087923|NCT00441883|100537173|FG000|NOT COMPLETED|Overall Study||1||
48087924|NCT00441883|100537174|FG001|NOT COMPLETED|Overall Study||0||
48087925|NCT00441883|100537175|FG002|NOT COMPLETED|Overall Study||0||
48087926|NCT00441883|100537176|FG003|NOT COMPLETED|Overall Study||0||
48087927|NCT00441883|100537177|FG004|NOT COMPLETED|Overall Study||2||
48087928|NCT00696696|100537178|FG000|STARTED|Overall Study||44||
48087929|NCT00696696|100537178|FG000|COMPLETED|Overall Study||26||
48087930|NCT00696696|100537178|FG000|NOT COMPLETED|Overall Study||18||
48087931|NCT02606604|100537179|FG000|STARTED|Overall Study||8||
48087932|NCT02606604|100537180|FG001|STARTED|Overall Study||7||
48087933|NCT02606604|100537179|FG000|COMPLETED|Overall Study||7||
48377421|NCT00862849|101252031|FG003|NOT COMPLETED|Washout 3 (3 to 14 Days)||0||
48377422|NCT00862849|101252032|FG004|NOT COMPLETED|Washout 3 (3 to 14 Days)||0||
48377423|NCT00862849|101252033|FG005|NOT COMPLETED|Washout 3 (3 to 14 Days)||0||
48377424|NCT00862849|101252028|FG000|STARTED|Intervention 4||3||
48377425|NCT00862849|101252029|FG001|STARTED|Intervention 4||3||
48377426|NCT00862849|101252030|FG002|STARTED|Intervention 4||3||
48377427|NCT00862849|101252031|FG003|STARTED|Intervention 4||4||
48377428|NCT00862849|101252032|FG004|STARTED|Intervention 4||4||
48087934|NCT02606604|100537180|FG001|COMPLETED|Overall Study||7||
48087935|NCT02606604|100537179|FG000|NOT COMPLETED|Overall Study||1||
48087936|NCT02606604|100537180|FG001|NOT COMPLETED|Overall Study||0||
48087937|NCT03445650|100537181|FG000|STARTED|Overall Study||7||
48087938|NCT03445650|100537182|FG001|STARTED|Overall Study||4||
48087939|NCT03445650|100537181|FG000|COMPLETED|Overall Study||6||
48087940|NCT03445650|100537182|FG001|COMPLETED|Overall Study||3||
48684049|NCT02524561|102009658|FG002|COMPLETED|Final: Year 3 or 4 Post-randomization||187||
48684050|NCT02524561|102009656|FG000|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0||
48087941|NCT03445650|100537181|FG000|NOT COMPLETED|Overall Study||1||
48087942|NCT03445650|100537182|FG001|NOT COMPLETED|Overall Study||1||
48377429|NCT00862849|101252033|FG005|STARTED|Intervention 4||3||
48377430|NCT00862849|101252028|FG000|COMPLETED|Intervention 4||3||
48377431|NCT00862849|101252029|FG001|COMPLETED|Intervention 4||3||
48377432|NCT00862849|101252030|FG002|COMPLETED|Intervention 4||3||
48377433|NCT00862849|101252031|FG003|COMPLETED|Intervention 4||4||
48377434|NCT00862849|101252032|FG004|COMPLETED|Intervention 4||4||
48377435|NCT00862849|101252033|FG005|COMPLETED|Intervention 4||3||
48377436|NCT00862849|101252028|FG000|NOT COMPLETED|Intervention 4||0||
48377437|NCT00862849|101252029|FG001|NOT COMPLETED|Intervention 4||0||
48377438|NCT00862849|101252030|FG002|NOT COMPLETED|Intervention 4||0||
48377439|NCT00862849|101252031|FG003|NOT COMPLETED|Intervention 4||0||
48087943|NCT01396148|100537183|FG000|STARTED|Overall Study||6||
48087944|NCT01396148|100537183|FG000|COMPLETED|Overall Study||5||
48377440|NCT00862849|101252032|FG004|NOT COMPLETED|Intervention 4||0||
48377441|NCT00862849|101252033|FG005|NOT COMPLETED|Intervention 4||0||
48377442|NCT00862849|101252028|FG000|STARTED|Washout 4 (3 to 14 Days)||3||
48377443|NCT00862849|101252029|FG001|STARTED|Washout 4 (3 to 14 Days)||3||
48377444|NCT00862849|101252030|FG002|STARTED|Washout 4 (3 to 14 Days)||3||
48377445|NCT00862849|101252031|FG003|STARTED|Washout 4 (3 to 14 Days)||4||
48377446|NCT00862849|101252032|FG004|STARTED|Washout 4 (3 to 14 Days)||4||
48377447|NCT00862849|101252033|FG005|STARTED|Washout 4 (3 to 14 Days)||3||
48377448|NCT00862849|101252028|FG000|COMPLETED|Washout 4 (3 to 14 Days)||3||
48377449|NCT00862849|101252029|FG001|COMPLETED|Washout 4 (3 to 14 Days)||3||
48377450|NCT00862849|101252030|FG002|COMPLETED|Washout 4 (3 to 14 Days)||3||
48377451|NCT00862849|101252031|FG003|COMPLETED|Washout 4 (3 to 14 Days)||4||
48377452|NCT00862849|101252032|FG004|COMPLETED|Washout 4 (3 to 14 Days)||4||
48377453|NCT00862849|101252033|FG005|COMPLETED|Washout 4 (3 to 14 Days)||3||
48377454|NCT00862849|101252028|FG000|NOT COMPLETED|Washout 4 (3 to 14 Days)||0||
48377455|NCT00862849|101252029|FG001|NOT COMPLETED|Washout 4 (3 to 14 Days)||0||
48377456|NCT00862849|101252030|FG002|NOT COMPLETED|Washout 4 (3 to 14 Days)||0||
48377457|NCT00862849|101252031|FG003|NOT COMPLETED|Washout 4 (3 to 14 Days)||0||
48377458|NCT00862849|101252032|FG004|NOT COMPLETED|Washout 4 (3 to 14 Days)||0||
48377459|NCT00862849|101252033|FG005|NOT COMPLETED|Washout 4 (3 to 14 Days)||0||
48377460|NCT00862849|101252028|FG000|STARTED|Intervention 5||3||
48377461|NCT00862849|101252029|FG001|STARTED|Intervention 5||3||
48377462|NCT00862849|101252030|FG002|STARTED|Intervention 5||3||
48087945|NCT01396148|100537183|FG000|NOT COMPLETED|Overall Study||1||
48087946|NCT01737944|100537184|FG000|STARTED|Overall Study||9||
48087947|NCT01737944|100537185|FG001|STARTED|Overall Study||9||
48087948|NCT01737944|100537186|FG002|STARTED|Overall Study||9||
48087949|NCT01737944|100537187|FG003|STARTED|Overall Study||9||
48087950|NCT01737944|100537184|FG000|COMPLETED|Overall Study||9||
48087951|NCT01737944|100537185|FG001|COMPLETED|Overall Study||9||
48087952|NCT01737944|100537186|FG002|COMPLETED|Overall Study||9||
48087953|NCT01737944|100537187|FG003|COMPLETED|Overall Study||9||
48087954|NCT01737944|100537184|FG000|NOT COMPLETED|Overall Study||0||
48087955|NCT01737944|100537185|FG001|NOT COMPLETED|Overall Study||0||
48087956|NCT01737944|100537186|FG002|NOT COMPLETED|Overall Study||0||
48087957|NCT01737944|100537187|FG003|NOT COMPLETED|Overall Study||0||
48087958|NCT01619774|100537188|FG000|STARTED|Overall Study||23||
48087959|NCT01619774|100537188|FG000|COMPLETED|Overall Study||23||
48087960|NCT01619774|100537188|FG000|NOT COMPLETED|Overall Study||0||
48087961|NCT00733408|100537189|FG000|STARTED|Overall Study||59||
48087962|NCT00733408|100537189|FG000|COMPLETED|Overall Study||55||
48377463|NCT00862849|101252031|FG003|STARTED|Intervention 5||4||
48377464|NCT00862849|101252032|FG004|STARTED|Intervention 5||4||
48377465|NCT00862849|101252033|FG005|STARTED|Intervention 5||3||
48087963|NCT00733408|100537189|FG000|NOT COMPLETED|Overall Study||4||
48087964|NCT00147199|100537190|FG000|STARTED|Overall Study||115||
48377466|NCT00862849|101252028|FG000|COMPLETED|Intervention 5||3||
48377467|NCT00862849|101252029|FG001|COMPLETED|Intervention 5||3||
48377468|NCT00862849|101252030|FG002|COMPLETED|Intervention 5||3||
48377469|NCT00862849|101252031|FG003|COMPLETED|Intervention 5||4||
48377470|NCT00862849|101252032|FG004|COMPLETED|Intervention 5||4||
48377471|NCT00862849|101252033|FG005|COMPLETED|Intervention 5||3||
48377472|NCT00862849|101252028|FG000|NOT COMPLETED|Intervention 5||0||
48377473|NCT00862849|101252029|FG001|NOT COMPLETED|Intervention 5||0||
48377474|NCT00862849|101252030|FG002|NOT COMPLETED|Intervention 5||0||
48377475|NCT00862849|101252031|FG003|NOT COMPLETED|Intervention 5||0||
48377476|NCT00862849|101252032|FG004|NOT COMPLETED|Intervention 5||0||
48377477|NCT00862849|101252033|FG005|NOT COMPLETED|Intervention 5||0||
48377478|NCT00862849|101252028|FG000|STARTED|Washout 5 (3 to 14 Days)||3||
48377479|NCT00862849|101252029|FG001|STARTED|Washout 5 (3 to 14 Days)||3||
48377480|NCT00862849|101252030|FG002|STARTED|Washout 5 (3 to 14 Days)||3||
48377481|NCT00862849|101252031|FG003|STARTED|Washout 5 (3 to 14 Days)||4||
48377482|NCT00862849|101252032|FG004|STARTED|Washout 5 (3 to 14 Days)||4||
48377483|NCT00862849|101252033|FG005|STARTED|Washout 5 (3 to 14 Days)||3||
48377484|NCT00862849|101252028|FG000|COMPLETED|Washout 5 (3 to 14 Days)||3||
48377485|NCT00862849|101252029|FG001|COMPLETED|Washout 5 (3 to 14 Days)||3||
48377486|NCT00862849|101252030|FG002|COMPLETED|Washout 5 (3 to 14 Days)||3||
48377487|NCT00862849|101252031|FG003|COMPLETED|Washout 5 (3 to 14 Days)||4||
48377488|NCT00862849|101252032|FG004|COMPLETED|Washout 5 (3 to 14 Days)||4||
48377489|NCT00862849|101252033|FG005|COMPLETED|Washout 5 (3 to 14 Days)||3||
48377490|NCT00862849|101252028|FG000|NOT COMPLETED|Washout 5 (3 to 14 Days)||0||
48377491|NCT00862849|101252029|FG001|NOT COMPLETED|Washout 5 (3 to 14 Days)||0||
48377492|NCT00862849|101252030|FG002|NOT COMPLETED|Washout 5 (3 to 14 Days)||0||
48377493|NCT00862849|101252031|FG003|NOT COMPLETED|Washout 5 (3 to 14 Days)||0||
48377494|NCT00862849|101252032|FG004|NOT COMPLETED|Washout 5 (3 to 14 Days)||0||
48377495|NCT00862849|101252033|FG005|NOT COMPLETED|Washout 5 (3 to 14 Days)||0||
48377496|NCT00862849|101252028|FG000|STARTED|Intervention 6||3||
48377497|NCT00862849|101252029|FG001|STARTED|Intervention 6||3||
48377498|NCT00862849|101252030|FG002|STARTED|Intervention 6||3||
48377499|NCT00862849|101252031|FG003|STARTED|Intervention 6||4||
48377500|NCT00862849|101252032|FG004|STARTED|Intervention 6||4||
48377501|NCT00862849|101252033|FG005|STARTED|Intervention 6||3||
48377502|NCT00862849|101252028|FG000|COMPLETED|Intervention 6||3||
48377503|NCT00862849|101252029|FG001|COMPLETED|Intervention 6||3||
48377504|NCT00862849|101252030|FG002|COMPLETED|Intervention 6||3||
48377505|NCT00862849|101252031|FG003|COMPLETED|Intervention 6||4||
48377506|NCT00862849|101252032|FG004|COMPLETED|Intervention 6||4||
48377507|NCT00862849|101252033|FG005|COMPLETED|Intervention 6||3||
48377508|NCT00862849|101252028|FG000|NOT COMPLETED|Intervention 6||0||
48377509|NCT00862849|101252029|FG001|NOT COMPLETED|Intervention 6||0||
48377510|NCT00862849|101252030|FG002|NOT COMPLETED|Intervention 6||0||
48377511|NCT00862849|101252031|FG003|NOT COMPLETED|Intervention 6||0||
48377512|NCT00862849|101252032|FG004|NOT COMPLETED|Intervention 6||0||
48377513|NCT00862849|101252033|FG005|NOT COMPLETED|Intervention 6||0||
48377514|NCT00788775|101252034|FG000|STARTED|Overall Study||11||
48684051|NCT02524561|102009657|FG001|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0||
48684052|NCT02524561|102009658|FG002|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0||
48684053|NCT01122446|102009659|FG000|STARTED|Overall Study||25||
48377515|NCT00788775|101252035|FG001|STARTED|Overall Study||9||
48377516|NCT00788775|101252034|FG000|Treated|Overall Study||11||
48377517|NCT00788775|101252035|FG001|Treated|Overall Study||8||
48541164|NCT01068262|101662674|FG002|STARTED|Overall Study||10||
48541165|NCT01068262|101662675|FG003|STARTED|Overall Study||2||
48541166|NCT01068262|101662672|FG000|COMPLETED|Overall Study||20||
48541167|NCT01068262|101662673|FG001|COMPLETED|Overall Study||8||
48541168|NCT01068262|101662674|FG002|COMPLETED|Overall Study||9||
48541169|NCT01068262|101662675|FG003|COMPLETED|Overall Study||2||
48541170|NCT01068262|101662672|FG000|NOT COMPLETED|Overall Study||3||
48377518|NCT00788775|101252034|FG000|COMPLETED|Overall Study||1||
48541171|NCT01068262|101662673|FG001|NOT COMPLETED|Overall Study||1||
48541172|NCT01068262|101662674|FG002|NOT COMPLETED|Overall Study||1||
48541173|NCT01068262|101662675|FG003|NOT COMPLETED|Overall Study||0||
48541174|NCT04386616|101662676|FG000|STARTED|Overall Study||134||
48541175|NCT04386616|101662677|FG001|STARTED|Overall Study||130||
48684054|NCT01122446|102009660|FG001|STARTED|Overall Study||25||
48541176|NCT04386616|101662678|FG002|STARTED|Overall Study||132||
48541177|NCT04386616|101662676|FG000|Received at Least One Dose of Study Drug|Overall Study||134|Safety Population|
48541178|NCT04386616|101662677|FG001|Received at Least One Dose of Study Drug|Overall Study||130|Safety Population|
48541179|NCT04386616|101662678|FG002|Received at Least One Dose of Study Drug|Overall Study||132|Safety Population|
48541180|NCT04386616|101662676|FG000|Completed Both Doses of Study Drug at Day 15|Overall Study||31||
48541181|NCT04386616|101662677|FG001|Completed Both Doses of Study Drug at Day 15|Overall Study||27||
48541182|NCT04386616|101662678|FG002|Completed Both Doses of Study Drug at Day 15|Overall Study||25||
48541183|NCT04386616|101662676|FG000|COMPLETED|Overall Study||104||
48541184|NCT04386616|101662677|FG001|COMPLETED|Overall Study||95||
48541185|NCT04386616|101662678|FG002|COMPLETED|Overall Study||104||
48541186|NCT04386616|101662676|FG000|NOT COMPLETED|Overall Study||30||
48541187|NCT04386616|101662677|FG001|NOT COMPLETED|Overall Study||35||
48541188|NCT04386616|101662678|FG002|NOT COMPLETED|Overall Study||28||
48541189|NCT02068092|101662679|FG000|STARTED|Overall Study||51||
48541190|NCT02068092|101662679|FG000|COMPLETED|Overall Study||41||
48541191|NCT02068092|101662679|FG000|NOT COMPLETED|Overall Study||10||
48684055|NCT01122446|102009659|FG000|COMPLETED|Overall Study||25||
48377519|NCT00788775|101252035|FG001|COMPLETED|Overall Study||1||
48377520|NCT00788775|101252034|FG000|NOT COMPLETED|Overall Study||10||
48377521|NCT00788775|101252035|FG001|NOT COMPLETED|Overall Study||8||
48377522|NCT02569411|101252036|FG000|STARTED|Overall Study||65|Authors were contacted in either arm to share complete individual patient data during the study|
48541192|NCT00229723|101662680|FG000|STARTED|Concomitant Phase||60||
48684056|NCT01122446|102009660|FG001|COMPLETED|Overall Study||25||
48684057|NCT01122446|102009659|FG000|NOT COMPLETED|Overall Study||0||
48684058|NCT01122446|102009660|FG001|NOT COMPLETED|Overall Study||0||
48684059|NCT01763333|102009661|FG000|STARTED|Overall Study||6||
48684060|NCT01763333|102009662|FG001|STARTED|Overall Study||6||
48684061|NCT01763333|102009663|FG002|STARTED|Overall Study||6||
48684062|NCT01763333|102009664|FG003|STARTED|Overall Study||6||
48684063|NCT01763333|102009665|FG004|STARTED|Overall Study||4||
48684064|NCT01763333|102009666|FG005|STARTED|Overall Study||6||
48684065|NCT01763333|102009667|FG006|STARTED|Overall Study||5||
48684066|NCT01763333|102009668|FG007|STARTED|Overall Study||6||
48684067|NCT01763333|102009669|FG008|STARTED|Overall Study||5||
48684068|NCT01763333|102009670|FG009|STARTED|Overall Study||18||
48684069|NCT01763333|102009671|FG010|STARTED|Overall Study||3||
48684070|NCT01763333|102009672|FG011|STARTED|Overall Study||3||
48087965|NCT00147199|100537191|FG001|STARTED|Overall Study||120||
48087966|NCT00147199|100537190|FG000|COMPLETED|Overall Study||102||
48087967|NCT00147199|100537191|FG001|COMPLETED|Overall Study||110||
48087968|NCT00147199|100537190|FG000|NOT COMPLETED|Overall Study||13||
48087969|NCT00147199|100537191|FG001|NOT COMPLETED|Overall Study||10||
48250587|NCT00475735|100931147|FG000|COMPLETED|Treatment Period 2||10||
48250588|NCT00475735|100931148|FG001|COMPLETED|Treatment Period 2||9||
48250589|NCT00475735|100931149|FG002|COMPLETED|Treatment Period 2||7||
48250590|NCT00475735|100931150|FG003|COMPLETED|Treatment Period 2||4||
48684071|NCT01763333|102009673|FG012|STARTED|Overall Study||3||
48684072|NCT01763333|102009674|FG013|STARTED|Overall Study||3||
48684073|NCT01763333|102009661|FG000|COMPLETED|Overall Study||6||
48684074|NCT01763333|102009662|FG001|COMPLETED|Overall Study||6||
48684075|NCT01763333|102009663|FG002|COMPLETED|Overall Study||6||
48684076|NCT01763333|102009664|FG003|COMPLETED|Overall Study||6||
48684077|NCT01763333|102009665|FG004|COMPLETED|Overall Study||4||
48684078|NCT01763333|102009666|FG005|COMPLETED|Overall Study||6||
48684079|NCT01763333|102009667|FG006|COMPLETED|Overall Study||5||
48684080|NCT01763333|102009668|FG007|COMPLETED|Overall Study||6||
48684081|NCT01763333|102009669|FG008|COMPLETED|Overall Study||5||
48684082|NCT01763333|102009670|FG009|COMPLETED|Overall Study||18||
48684083|NCT01763333|102009671|FG010|COMPLETED|Overall Study||3||
48684084|NCT01763333|102009672|FG011|COMPLETED|Overall Study||3||
48684085|NCT01763333|102009673|FG012|COMPLETED|Overall Study||3||
48684086|NCT01763333|102009674|FG013|COMPLETED|Overall Study||3||
48684087|NCT01763333|102009661|FG000|NOT COMPLETED|Overall Study||0||
48684088|NCT01763333|102009662|FG001|NOT COMPLETED|Overall Study||0||
48684089|NCT01763333|102009663|FG002|NOT COMPLETED|Overall Study||0||
48684090|NCT01763333|102009664|FG003|NOT COMPLETED|Overall Study||0||
48684091|NCT01763333|102009665|FG004|NOT COMPLETED|Overall Study||0||
48684092|NCT01763333|102009666|FG005|NOT COMPLETED|Overall Study||0||
48684093|NCT01763333|102009667|FG006|NOT COMPLETED|Overall Study||0||
48684094|NCT01763333|102009668|FG007|NOT COMPLETED|Overall Study||0||
48684095|NCT01763333|102009669|FG008|NOT COMPLETED|Overall Study||0||
48684096|NCT01763333|102009670|FG009|NOT COMPLETED|Overall Study||0||
48684097|NCT01763333|102009671|FG010|NOT COMPLETED|Overall Study||0||
48684098|NCT01763333|102009672|FG011|NOT COMPLETED|Overall Study||0||
48684099|NCT01763333|102009673|FG012|NOT COMPLETED|Overall Study||0||
48684100|NCT01763333|102009674|FG013|NOT COMPLETED|Overall Study||0||
48684101|NCT04677543|102009675|FG000|STARTED|Overall Study||48||
48087970|NCT02927080|100537192|FG000|STARTED|Overall Study||6||
48087971|NCT02927080|100537193|FG001|STARTED|Overall Study||6||
48087972|NCT02927080|100537194|FG002|STARTED|Overall Study||6||
48087973|NCT02927080|100537195|FG003|STARTED|Overall Study||6||
48087974|NCT02927080|100537196|FG004|STARTED|Overall Study||7||
48087975|NCT02927080|100537197|FG005|STARTED|Overall Study||6||
48087976|NCT02927080|100537198|FG006|STARTED|Overall Study||15||
48087977|NCT02927080|100537199|FG007|STARTED|Overall Study||14||
48087978|NCT02927080|100537200|FG008|STARTED|Overall Study||15||
48087979|NCT02927080|100537201|FG009|STARTED|Overall Study||14||
48684102|NCT04677543|102009676|FG001|STARTED|Overall Study||51||
48684103|NCT04677543|102009675|FG000|COMPLETED|Overall Study||44||
48684104|NCT04677543|102009676|FG001|COMPLETED|Overall Study||48||
48684105|NCT04677543|102009675|FG000|NOT COMPLETED|Overall Study||4||
48141275|NCT04386096|100670386|FG000|STARTED|Overall Study||20||
48684106|NCT04677543|102009676|FG001|NOT COMPLETED|Overall Study||3||
48684107|NCT02921295|102009677|FG000|STARTED|Sidekicks||1||
48141276|NCT04386096|100670387|FG001|STARTED|Overall Study||20||
48141277|NCT04386096|100670386|FG000|COMPLETED|Overall Study||20||
48141278|NCT04386096|100670387|FG001|COMPLETED|Overall Study||20||
48141279|NCT04386096|100670386|FG000|NOT COMPLETED|Overall Study||0||
48141280|NCT04386096|100670387|FG001|NOT COMPLETED|Overall Study||0||
48141281|NCT02504073|100670388|FG000|STARTED|Overall Study||54||
48141282|NCT02504073|100670388|FG000|COMPLETED|Overall Study||54||
48141283|NCT02504073|100670388|FG000|NOT COMPLETED|Overall Study||0||
48141284|NCT04396834|100670389|FG000|STARTED|Overall Study||1||
48141285|NCT04396834|100670390|FG001|STARTED|Overall Study||1||
48141286|NCT04396834|100670389|FG000|COMPLETED|Overall Study||1||
48141287|NCT04396834|100670390|FG001|COMPLETED|Overall Study||1||
48087980|NCT02927080|100537192|FG000|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0|Patients who completed the double-blind (DB) treatment period continued into the open-label extension (OLE) period. Patients who received ACE-083 in the DB treatment period continued to receive the same dose of ACE-083 during the OLE period, and patients who received placebo during the DB treatment period were switched to receive ACE-083, 240 mg/muscle. In the OLE period, ACE-083 was administered bilaterally in either the TA or BB muscle once every 3 weeks for approximately 6 months (8 doses).|
48087981|NCT02927080|100537193|FG001|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0|Patients who completed the double-blind (DB) treatment period continued into the open-label extension (OLE) period. Patients who received ACE-083 in the DB treatment period continued to receive the same dose of ACE-083 during the OLE period, and patients who received placebo during the DB treatment period were switched to receive ACE-083, 240 mg/muscle. In the OLE period, ACE-083 was administered bilaterally in either the TA or BB muscle once every 3 weeks for approximately 6 months (8 doses).|
48087982|NCT02927080|100537194|FG002|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0|Patients who completed the double-blind (DB) treatment period continued into the open-label extension (OLE) period. Patients who received ACE-083 in the DB treatment period continued to receive the same dose of ACE-083 during the OLE period, and patients who received placebo during the DB treatment period were switched to receive ACE-083, 240 mg/muscle. In the OLE period, ACE-083 was administered bilaterally in either the TA or BB muscle once every 3 weeks for approximately 6 months (8 doses).|
48087983|NCT02927080|100537195|FG003|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0|Patients who completed the double-blind (DB) treatment period continued into the open-label extension (OLE) period. Patients who received ACE-083 in the DB treatment period continued to receive the same dose of ACE-083 during the OLE period, and patients who received placebo during the DB treatment period were switched to receive ACE-083, 240 mg/muscle. In the OLE period, ACE-083 was administered bilaterally in either the TA or BB muscle once every 3 weeks for approximately 6 months (8 doses).|
48087984|NCT02927080|100537196|FG004|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0|Patients who completed the double-blind (DB) treatment period continued into the open-label extension (OLE) period. Patients who received ACE-083 in the DB treatment period continued to receive the same dose of ACE-083 during the OLE period, and patients who received placebo during the DB treatment period were switched to receive ACE-083, 240 mg/muscle. In the OLE period, ACE-083 was administered bilaterally in either the TA or BB muscle once every 3 weeks for approximately 6 months (8 doses).|
48087985|NCT02927080|100537197|FG005|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0|Patients who completed the double-blind (DB) treatment period continued into the open-label extension (OLE) period. Patients who received ACE-083 in the DB treatment period continued to receive the same dose of ACE-083 during the OLE period, and patients who received placebo during the DB treatment period were switched to receive ACE-083, 240 mg/muscle. In the OLE period, ACE-083 was administered bilaterally in either the TA or BB muscle once every 3 weeks for approximately 6 months (8 doses).|
48087986|NCT02927080|100537198|FG006|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||14|Patients who completed the double-blind (DB) treatment period continued into the open-label extension (OLE) period. Patients who received ACE-083 in the DB treatment period continued to receive the same dose of ACE-083 during the OLE period, and patients who received placebo during the DB treatment period were switched to receive ACE-083, 240 mg/muscle. In the OLE period, ACE-083 was administered bilaterally in either the TA or BB muscle once every 3 weeks for approximately 6 months (8 doses).|
48141288|NCT04396834|100670389|FG000|NOT COMPLETED|Overall Study||0||
48377523|NCT02569411|101252037|FG001|STARTED|Overall Study||64|Authors were contacted in either arm to share complete individual patient data during the study|
48377524|NCT02569411|101252036|FG000|COMPLETED|Overall Study||0|None of the authors contacted in either arm shared complete individual patient data during the study|
48377525|NCT02569411|101252037|FG001|COMPLETED|Overall Study||0|None of the authors contacted in either arm shared complete individual patient data during the study|
48377526|NCT02569411|101252036|FG000|NOT COMPLETED|Overall Study||65||
48377527|NCT02569411|101252037|FG001|NOT COMPLETED|Overall Study||64||
48377528|NCT00882999|101252038|FG000|STARTED|Overall Study||35||
48377529|NCT00882999|101252039|FG001|STARTED|Overall Study||34||
48377530|NCT00882999|101252040|FG002|STARTED|Overall Study||34||
48377531|NCT00882999|101252041|FG003|STARTED|Overall Study||36||
48377532|NCT00882999|101252042|FG004|STARTED|Overall Study||36||
48377533|NCT00882999|101252043|FG005|STARTED|Overall Study||35||
48377534|NCT00882999|101252044|FG006|STARTED|Overall Study||35||
48377535|NCT00882999|101252038|FG000|Received Any Amount of Study Drug|Overall Study||35||
48377536|NCT00882999|101252039|FG001|Received Any Amount of Study Drug|Overall Study||34||
48377537|NCT00882999|101252040|FG002|Received Any Amount of Study Drug|Overall Study||34||
48377538|NCT00882999|101252041|FG003|Received Any Amount of Study Drug|Overall Study||36||
48377539|NCT00882999|101252042|FG004|Received Any Amount of Study Drug|Overall Study||36||
48377540|NCT00882999|101252043|FG005|Received Any Amount of Study Drug|Overall Study||35||
48377541|NCT00882999|101252044|FG006|Received Any Amount of Study Drug|Overall Study||35||
48377542|NCT00882999|101252038|FG000|Completed Study Treatment|Overall Study||29||
48377543|NCT00882999|101252039|FG001|Completed Study Treatment|Overall Study||29||
48377544|NCT00882999|101252040|FG002|Completed Study Treatment|Overall Study||31||
48377545|NCT00882999|101252041|FG003|Completed Study Treatment|Overall Study||33||
48377546|NCT00882999|101252042|FG004|Completed Study Treatment|Overall Study||29||
48377547|NCT00882999|101252043|FG005|Completed Study Treatment|Overall Study||30||
48377548|NCT00882999|101252044|FG006|Completed Study Treatment|Overall Study||31||
48377549|NCT00882999|101252038|FG000|COMPLETED|Overall Study||27||
48377550|NCT00882999|101252039|FG001|COMPLETED|Overall Study||26||
48377551|NCT00882999|101252040|FG002|COMPLETED|Overall Study||30||
48377552|NCT00882999|101252041|FG003|COMPLETED|Overall Study||31||
48377553|NCT00882999|101252042|FG004|COMPLETED|Overall Study||28||
48087987|NCT02927080|100537199|FG007|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||13|Patients who completed the double-blind (DB) treatment period continued into the open-label extension (OLE) period. Patients who received ACE-083 in the DB treatment period continued to receive the same dose of ACE-083 during the OLE period, and patients who received placebo during the DB treatment period were switched to receive ACE-083, 240 mg/muscle. In the OLE period, ACE-083 was administered bilaterally in either the TA or BB muscle once every 3 weeks for approximately 6 months (8 doses).|
48087988|NCT02927080|100537200|FG008|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||14|Patients who completed the double-blind (DB) treatment period continued into the open-label extension (OLE) period. Patients who received ACE-083 in the DB treatment period continued to receive the same dose of ACE-083 during the OLE period, and patients who received placebo during the DB treatment period were switched to receive ACE-083, 240 mg/muscle. In the OLE period, ACE-083 was administered bilaterally in either the TA or BB muscle once every 3 weeks for approximately 6 months (8 doses).|
48087989|NCT02927080|100537201|FG009|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||12|Patients who completed the double-blind (DB) treatment period continued into the open-label extension (OLE) period. Patients who received ACE-083 in the DB treatment period continued to receive the same dose of ACE-083 during the OLE period, and patients who received placebo during the DB treatment period were switched to receive ACE-083, 240 mg/muscle. In the OLE period, ACE-083 was administered bilaterally in either the TA or BB muscle once every 3 weeks for approximately 6 months (8 doses).|
48087990|NCT02927080|100537192|FG000|COMPLETED|Overall Study||6||
48087991|NCT02927080|100537193|FG001|COMPLETED|Overall Study||5||
48087992|NCT02927080|100537194|FG002|COMPLETED|Overall Study||6||
48087993|NCT02927080|100537195|FG003|COMPLETED|Overall Study||6||
48087994|NCT02927080|100537196|FG004|COMPLETED|Overall Study||6||
48087995|NCT02927080|100537197|FG005|COMPLETED|Overall Study||6||
48087996|NCT02927080|100537198|FG006|COMPLETED|Overall Study||7||
48087997|NCT02927080|100537199|FG007|COMPLETED|Overall Study||5||
48087998|NCT02927080|100537200|FG008|COMPLETED|Overall Study||12||
48087999|NCT02927080|100537201|FG009|COMPLETED|Overall Study||7||
48088000|NCT02927080|100537192|FG000|NOT COMPLETED|Overall Study||0||
48088001|NCT02927080|100537193|FG001|NOT COMPLETED|Overall Study||1||
48088002|NCT02927080|100537194|FG002|NOT COMPLETED|Overall Study||0||
48088003|NCT02927080|100537195|FG003|NOT COMPLETED|Overall Study||0||
48088004|NCT02927080|100537196|FG004|NOT COMPLETED|Overall Study||1||
48088005|NCT02927080|100537197|FG005|NOT COMPLETED|Overall Study||0||
48088006|NCT02927080|100537198|FG006|NOT COMPLETED|Overall Study||8||
48088007|NCT02927080|100537199|FG007|NOT COMPLETED|Overall Study||9||
48088008|NCT02927080|100537200|FG008|NOT COMPLETED|Overall Study||3||
48088009|NCT02927080|100537201|FG009|NOT COMPLETED|Overall Study||7||
48088010|NCT02260921|100537202|FG000|STARTED|Overall Study||121||
48088011|NCT02260921|100537203|FG001|STARTED|Overall Study||59||
48088012|NCT02260921|100537202|FG000|Per-Protocol Population|Overall Study||112||
48088013|NCT02260921|100537203|FG001|Per-Protocol Population|Overall Study||56||
48088014|NCT02260921|100537202|FG000|COMPLETED|Overall Study||107||
48088015|NCT02260921|100537203|FG001|COMPLETED|Overall Study||55||
48088016|NCT02260921|100537202|FG000|NOT COMPLETED|Overall Study||14||
48088017|NCT02260921|100537203|FG001|NOT COMPLETED|Overall Study||4||
48088018|NCT00903695|100537204|FG000|STARTED|Overall Study||8||
48250591|NCT00475735|100931151|FG004|COMPLETED|Treatment Period 2||15||
48088019|NCT00903695|100537205|FG001|STARTED|Overall Study||2||
48088020|NCT00903695|100537204|FG000|COMPLETED|Overall Study||6||
48088021|NCT00903695|100537205|FG001|COMPLETED|Overall Study||2||
48088022|NCT00903695|100537204|FG000|NOT COMPLETED|Overall Study||2||
48088023|NCT00903695|100537205|FG001|NOT COMPLETED|Overall Study||0||
48088024|NCT00684593|100537206|FG000|STARTED|Overall Study||21||
48088025|NCT00684593|100537207|FG001|STARTED|Overall Study||10||
48088026|NCT00684593|100537206|FG000|COMPLETED|Overall Study||21||
48088027|NCT00684593|100537207|FG001|COMPLETED|Overall Study||8||
48088028|NCT00684593|100537206|FG000|NOT COMPLETED|Overall Study||0||
48088029|NCT00684593|100537207|FG001|NOT COMPLETED|Overall Study||2||
48088030|NCT01120223|100537208|FG000|STARTED|Overall Study||78||
48088031|NCT01120223|100537208|FG000|COMPLETED|Overall Study||74||
48088032|NCT01120223|100537208|FG000|NOT COMPLETED|Overall Study||4||
48088033|NCT00379574|100537209|FG000|STARTED|Overall Study||49||
48088034|NCT00379574|100537209|FG000|COMPLETED|Overall Study||49||
48088035|NCT00379574|100537209|FG000|NOT COMPLETED|Overall Study||0||
48088036|NCT01077856|100537210|FG000|STARTED|Overall Study||22199||
48088037|NCT01077856|100537211|FG001|STARTED|Overall Study||16604||
48088038|NCT01077856|100537212|FG002|STARTED|Overall Study||15713||
48088039|NCT01077856|100537210|FG000|COMPLETED|Overall Study||22199||
48088040|NCT01077856|100537211|FG001|COMPLETED|Overall Study||16604||
48088041|NCT01077856|100537212|FG002|COMPLETED|Overall Study||15713||
48088042|NCT01077856|100537210|FG000|NOT COMPLETED|Overall Study||0||
48088043|NCT01077856|100537211|FG001|NOT COMPLETED|Overall Study||0||
48088044|NCT01077856|100537212|FG002|NOT COMPLETED|Overall Study||0||
48088045|NCT00429104|100537213|FG000|STARTED|Overall Study||18||
48088046|NCT00429104|100537213|FG000|COMPLETED|Overall Study||17||
48088047|NCT00429104|100537213|FG000|NOT COMPLETED|Overall Study||1||
48088048|NCT01074450|100537214|FG000|STARTED|First Intervention||12||
48088049|NCT01074450|100537215|FG001|STARTED|First Intervention||12||
48088050|NCT01074450|100537214|FG000|COMPLETED|First Intervention||12||
48088051|NCT01074450|100537215|FG001|COMPLETED|First Intervention||10||
48250592|NCT00475735|100931152|FG005|COMPLETED|Treatment Period 2||13||
48377554|NCT00882999|101252043|FG005|COMPLETED|Overall Study||28||
48377555|NCT00882999|101252044|FG006|COMPLETED|Overall Study||27||
48377556|NCT00882999|101252038|FG000|NOT COMPLETED|Overall Study||8||
48377557|NCT00882999|101252039|FG001|NOT COMPLETED|Overall Study||8||
48377558|NCT00882999|101252040|FG002|NOT COMPLETED|Overall Study||4||
48377559|NCT00882999|101252041|FG003|NOT COMPLETED|Overall Study||5||
48377560|NCT00882999|101252042|FG004|NOT COMPLETED|Overall Study||8||
48377561|NCT00882999|101252043|FG005|NOT COMPLETED|Overall Study||7||
48377562|NCT00882999|101252044|FG006|NOT COMPLETED|Overall Study||8||
48684108|NCT02921295|102009677|FG000|COMPLETED|Sidekicks||1||
48684109|NCT02921295|102009677|FG000|NOT COMPLETED|Sidekicks||0||
48684110|NCT02921295|102009677|FG000|STARTED|Conventional Prostheses||1||
48684111|NCT02921295|102009677|FG000|COMPLETED|Conventional Prostheses||1||
48684112|NCT02921295|102009677|FG000|NOT COMPLETED|Conventional Prostheses||0||
48684113|NCT01516632|102009678|FG000|STARTED|Overall Study||101||
48684114|NCT01516632|102009679|FG001|STARTED|Overall Study||63||
48684115|NCT01516632|102009678|FG000|COMPLETED|Overall Study||77||
48684116|NCT01516632|102009679|FG001|COMPLETED|Overall Study||48||
48684117|NCT01516632|102009678|FG000|NOT COMPLETED|Overall Study||24||
48684118|NCT01516632|102009679|FG001|NOT COMPLETED|Overall Study||15||
48684119|NCT01861665|102009680|FG000|STARTED|Overall Study||10||
48684120|NCT01861665|102009681|FG001|STARTED|Overall Study||17||
48684121|NCT01861665|102009680|FG000|COMPLETED|Overall Study||10||
48684122|NCT01861665|102009681|FG001|COMPLETED|Overall Study||17||
48088052|NCT01074450|100537214|FG000|NOT COMPLETED|First Intervention||0||
48088053|NCT01074450|100537215|FG001|NOT COMPLETED|First Intervention||2||
48088054|NCT01074450|100537214|FG000|STARTED|Washout of 7 Days||12||
48088055|NCT01074450|100537215|FG001|STARTED|Washout of 7 Days||10||
48088056|NCT01074450|100537214|FG000|COMPLETED|Washout of 7 Days||12||
48088057|NCT01074450|100537215|FG001|COMPLETED|Washout of 7 Days||10||
48088058|NCT01074450|100537214|FG000|NOT COMPLETED|Washout of 7 Days||0||
48088059|NCT01074450|100537215|FG001|NOT COMPLETED|Washout of 7 Days||0||
48088060|NCT01074450|100537214|FG000|STARTED|Second Intervention||12||
48088061|NCT01074450|100537215|FG001|STARTED|Second Intervention||10||
48088062|NCT01074450|100537214|FG000|COMPLETED|Second Intervention||11||
48088063|NCT01074450|100537215|FG001|COMPLETED|Second Intervention||9||
48088064|NCT01074450|100537214|FG000|NOT COMPLETED|Second Intervention||1||
48088065|NCT01074450|100537215|FG001|NOT COMPLETED|Second Intervention||1||
48088066|NCT03552198|100537216|FG000|STARTED|Overall Study||83||
48088067|NCT03552198|100537217|FG001|STARTED|Overall Study||84||
48088068|NCT03552198|100537218|FG002|STARTED|Overall Study||24||
48088069|NCT03552198|100537219|FG003|STARTED|Overall Study||34||
48088070|NCT03552198|100537216|FG000|Final Questionnaire 4 Weeks Follow-up|Overall Study||34||
48088071|NCT03552198|100537217|FG001|Final Questionnaire 4 Weeks Follow-up|Overall Study||29||
48088072|NCT03552198|100537218|FG002|Final Questionnaire 4 Weeks Follow-up|Overall Study||7||
48088073|NCT03552198|100537219|FG003|Final Questionnaire 4 Weeks Follow-up|Overall Study||12||
48088074|NCT03552198|100537216|FG000|COMPLETED|Overall Study||34||
48088075|NCT03552198|100537217|FG001|COMPLETED|Overall Study||29||
48088076|NCT03552198|100537218|FG002|COMPLETED|Overall Study||7||
48088077|NCT03552198|100537219|FG003|COMPLETED|Overall Study||12||
48088078|NCT03552198|100537216|FG000|NOT COMPLETED|Overall Study||49||
48088079|NCT03552198|100537217|FG001|NOT COMPLETED|Overall Study||55||
48088080|NCT03552198|100537218|FG002|NOT COMPLETED|Overall Study||17||
48088081|NCT03552198|100537219|FG003|NOT COMPLETED|Overall Study||22||
48088082|NCT02279173|100537220|FG000|STARTED|Overall Study||203||
48088083|NCT02279173|100537220|FG000|Received Treatment|Overall Study||203||
48088084|NCT02279173|100537220|FG000|Enrolled Under Protocol Supplement|Overall Study||79||
48088085|NCT02279173|100537220|FG000|COMPLETED|Overall Study||109||
48088086|NCT02279173|100537220|FG000|NOT COMPLETED|Overall Study||94||
48088087|NCT01426373|100537221|FG000|STARTED|Overall Study||165||
48088088|NCT01426373|100537221|FG000|COMPLETED|Overall Study||131||
48088089|NCT01426373|100537221|FG000|NOT COMPLETED|Overall Study||34||
48377563|NCT03799718|101252045|FG000|STARTED|Overall Study||20||54
48684123|NCT01861665|102009680|FG000|NOT COMPLETED|Overall Study||0||
48684124|NCT01861665|102009681|FG001|NOT COMPLETED|Overall Study||0||
48684125|NCT04749745|102009682|FG000|STARTED|Overall Study||5||
48377564|NCT03799718|101252045|FG000|COMPLETED|Overall Study||18||53
48684126|NCT04749745|102009683|FG001|STARTED|Overall Study||6||
48088090|NCT01713686|100537222|FG000|STARTED|Overall Study||125||
48088091|NCT01713686|100537222|FG000|COMPLETED|Overall Study||110||
48088092|NCT01713686|100537222|FG000|NOT COMPLETED|Overall Study||15||
48088093|NCT02483520|100537223|FG000|STARTED|Overall Study||92||
48088094|NCT02483520|100537224|FG001|STARTED|Overall Study||97||
48088095|NCT02483520|100537223|FG000|Caregivers|Overall Study||50||
48088096|NCT02483520|100537224|FG001|Caregivers|Overall Study||56||
48088097|NCT02483520|100537223|FG000|Persons With Dementia|Overall Study||42||
48088098|NCT02483520|100537224|FG001|Persons With Dementia|Overall Study||41||
48377565|NCT03799718|101252045|FG000|NOT COMPLETED|Overall Study||2||1
48377566|NCT01163253|101252046|FG000|STARTED|Overall Study||2281||
48088099|NCT02483520|100537223|FG000|COMPLETED|Overall Study||81||
48377567|NCT01163253|101252047|FG001|STARTED|Overall Study||586||
48377568|NCT01163253|101252046|FG000|COMPLETED|Overall Study||0||
48684127|NCT04749745|102009682|FG000|First Intervention|Overall Study||4||
48684128|NCT04749745|102009683|FG001|First Intervention|Overall Study||6||
48684129|NCT04749745|102009682|FG000|Washout|Overall Study||4|72 hours at least|
48684130|NCT04749745|102009683|FG001|Washout|Overall Study||6|72 hours at least|
48684131|NCT04749745|102009682|FG000|Second Intervention|Overall Study||4||
48684132|NCT04749745|102009683|FG001|Second Intervention|Overall Study||6||
48684133|NCT04749745|102009682|FG000|COMPLETED|Overall Study||4||
48088100|NCT02483520|100537224|FG001|COMPLETED|Overall Study||73||
48088101|NCT02483520|100537223|FG000|NOT COMPLETED|Overall Study||11||
48088102|NCT02483520|100537224|FG001|NOT COMPLETED|Overall Study||24||
48088103|NCT00489541|100537225|FG000|STARTED|12-Month Clinical Follow-up||224||
48088104|NCT00489541|100537226|FG001|STARTED|12-Month Clinical Follow-up||125||
48088105|NCT00489541|100537225|FG000|COMPLETED|12-Month Clinical Follow-up||215||
48088106|NCT00489541|100537226|FG001|COMPLETED|12-Month Clinical Follow-up||120||
48088107|NCT00489541|100537225|FG000|NOT COMPLETED|12-Month Clinical Follow-up||9||
48088108|NCT00489541|100537226|FG001|NOT COMPLETED|12-Month Clinical Follow-up||5||
48088109|NCT00489541|100537225|FG000|STARTED|9-Month Angiographic Follow-up||224||
48088110|NCT00489541|100537226|FG001|STARTED|9-Month Angiographic Follow-up||125||
48088111|NCT00489541|100537225|FG000|COMPLETED|9-Month Angiographic Follow-up||197||
48088112|NCT00489541|100537226|FG001|COMPLETED|9-Month Angiographic Follow-up||108||
48088113|NCT00489541|100537225|FG000|NOT COMPLETED|9-Month Angiographic Follow-up||27||
48088114|NCT00489541|100537226|FG001|NOT COMPLETED|9-Month Angiographic Follow-up||17||
48088115|NCT01980992|100537227|FG000|STARTED|52 Weeks Blinded Study Treatment||23||
48088116|NCT01980992|100537228|FG001|STARTED|52 Weeks Blinded Study Treatment||23||
48088117|NCT01980992|100537227|FG000|COMPLETED|52 Weeks Blinded Study Treatment||21||
48250593|NCT00475735|100931147|FG000|NOT COMPLETED|Treatment Period 2||0||
48250594|NCT00475735|100931148|FG001|NOT COMPLETED|Treatment Period 2||1||
48250595|NCT00475735|100931149|FG002|NOT COMPLETED|Treatment Period 2||0||
48250596|NCT00475735|100931150|FG003|NOT COMPLETED|Treatment Period 2||2||
48250597|NCT00475735|100931151|FG004|NOT COMPLETED|Treatment Period 2||1||
48250598|NCT00475735|100931152|FG005|NOT COMPLETED|Treatment Period 2||1||
48250599|NCT03083093|100931153|FG000|STARTED|Overall Study||50||
48250600|NCT03083093|100931154|FG001|STARTED|Overall Study||50||
48250601|NCT03083093|100931153|FG000|COMPLETED|Overall Study||50||
48250602|NCT03083093|100931154|FG001|COMPLETED|Overall Study||50||
48250603|NCT03083093|100931153|FG000|NOT COMPLETED|Overall Study||0||
48250604|NCT03083093|100931154|FG001|NOT COMPLETED|Overall Study||0||
48250605|NCT00282828|100931155|FG000|STARTED|Overall Study||63||
48250606|NCT00282828|100931156|FG001|STARTED|Overall Study||59||
48250607|NCT00282828|100931157|FG002|STARTED|Overall Study||59||
48088118|NCT01980992|100537228|FG001|COMPLETED|52 Weeks Blinded Study Treatment||19||
48088119|NCT01980992|100537227|FG000|NOT COMPLETED|52 Weeks Blinded Study Treatment||2||
48088120|NCT01980992|100537228|FG001|NOT COMPLETED|52 Weeks Blinded Study Treatment||4||
48088121|NCT01980992|100537227|FG000|STARTED|52 Weeks Open Label Active Wheat OIT||21||
48088122|NCT01980992|100537228|FG001|STARTED|52 Weeks Open Label Active Wheat OIT||19||
48088123|NCT01980992|100537227|FG000|COMPLETED|52 Weeks Open Label Active Wheat OIT||18||
48088124|NCT01980992|100537228|FG001|COMPLETED|52 Weeks Open Label Active Wheat OIT||18||
48088125|NCT01980992|100537227|FG000|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||3||
48088126|NCT01980992|100537228|FG001|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||1||
48088127|NCT01749514|100537229|FG000|STARTED|Overall Study||3||
48088128|NCT01749514|100537230|FG001|STARTED|Overall Study||3||
48088129|NCT01749514|100537231|FG002|STARTED|Overall Study||3||
48088130|NCT01749514|100537232|FG003|STARTED|Overall Study||6||
48088131|NCT01749514|100537233|FG004|STARTED|Overall Study||3||
48088132|NCT01749514|100537234|FG005|STARTED|Overall Study||6||
48088133|NCT01749514|100537235|FG006|STARTED|Overall Study||3||
48088134|NCT01749514|100537236|FG007|STARTED|Overall Study||89||
48250608|NCT00282828|100931155|FG000|COMPLETED|Overall Study||57||
48250609|NCT00282828|100931156|FG001|COMPLETED|Overall Study||47||
48250610|NCT00282828|100931157|FG002|COMPLETED|Overall Study||50||
48250611|NCT00282828|100931155|FG000|NOT COMPLETED|Overall Study||6||
48250612|NCT00282828|100931156|FG001|NOT COMPLETED|Overall Study||12||
48250613|NCT00282828|100931157|FG002|NOT COMPLETED|Overall Study||9||
48250614|NCT03371706|100931158|FG000|STARTED|Overall Study||56||
48250615|NCT03371706|100931159|FG001|STARTED|Overall Study||56||
48250616|NCT03371706|100931160|FG002|STARTED|Overall Study||39||
48250617|NCT03371706|100931161|FG003|STARTED|Overall Study||39||
48250618|NCT03371706|100931158|FG000|COMPLETED|Overall Study||50||
48250619|NCT03371706|100931159|FG001|COMPLETED|Overall Study||50||
48250620|NCT03371706|100931160|FG002|COMPLETED|Overall Study||39||
48250621|NCT03371706|100931161|FG003|COMPLETED|Overall Study||39||
48250622|NCT03371706|100931158|FG000|NOT COMPLETED|Overall Study||6||
48250623|NCT03371706|100931159|FG001|NOT COMPLETED|Overall Study||6||
48250624|NCT03371706|100931160|FG002|NOT COMPLETED|Overall Study||0||
48250625|NCT03371706|100931161|FG003|NOT COMPLETED|Overall Study||0||
48250626|NCT00497198|100931162|FG000|STARTED|Overall Study||92||
48250627|NCT00497198|100931163|FG001|STARTED|Overall Study||91||
48250628|NCT00497198|100931162|FG000|COMPLETED|Overall Study||87||
48250629|NCT00497198|100931163|FG001|COMPLETED|Overall Study||86||
48250630|NCT00497198|100931162|FG000|NOT COMPLETED|Overall Study||5||
48250631|NCT00497198|100931163|FG001|NOT COMPLETED|Overall Study||5||
48684134|NCT04749745|102009683|FG001|COMPLETED|Overall Study||6||
48377569|NCT01163253|101252047|FG001|COMPLETED|Overall Study||0||
48377570|NCT01163253|101252046|FG000|NOT COMPLETED|Overall Study||2281||
48377571|NCT01163253|101252047|FG001|NOT COMPLETED|Overall Study||586||
48377572|NCT01043185|101252048|FG000|STARTED|Period 1 - First Intervention||3||
48377573|NCT01043185|101252049|FG001|STARTED|Period 1 - First Intervention||2||
48377574|NCT01043185|101252050|FG002|STARTED|Period 1 - First Intervention||3||
48377575|NCT01043185|101252051|FG003|STARTED|Period 1 - First Intervention||2||
48377576|NCT01043185|101252052|FG004|STARTED|Period 1 - First Intervention||2||
48377577|NCT01043185|101252053|FG005|STARTED|Period 1 - First Intervention||3||
48377578|NCT01043185|101252054|FG006|STARTED|Period 1 - First Intervention||3||
48377579|NCT01043185|101252055|FG007|STARTED|Period 1 - First Intervention||3||
48377580|NCT01043185|101252056|FG008|STARTED|Period 1 - First Intervention||3||
48377581|NCT01043185|101252057|FG009|STARTED|Period 1 - First Intervention||3||
48377582|NCT01043185|101252048|FG000|COMPLETED|Period 1 - First Intervention||3||
48377583|NCT01043185|101252049|FG001|COMPLETED|Period 1 - First Intervention||2||
48377584|NCT01043185|101252050|FG002|COMPLETED|Period 1 - First Intervention||3||
48377585|NCT01043185|101252051|FG003|COMPLETED|Period 1 - First Intervention||2||
48377586|NCT01043185|101252052|FG004|COMPLETED|Period 1 - First Intervention||2||
48377587|NCT01043185|101252053|FG005|COMPLETED|Period 1 - First Intervention||3||
48377588|NCT01043185|101252054|FG006|COMPLETED|Period 1 - First Intervention||3||
48377589|NCT01043185|101252055|FG007|COMPLETED|Period 1 - First Intervention||3||
48377590|NCT01043185|101252056|FG008|COMPLETED|Period 1 - First Intervention||3||
48377591|NCT01043185|101252057|FG009|COMPLETED|Period 1 - First Intervention||3||
48377592|NCT01043185|101252048|FG000|NOT COMPLETED|Period 1 - First Intervention||0||
48377593|NCT01043185|101252049|FG001|NOT COMPLETED|Period 1 - First Intervention||0||
48377594|NCT01043185|101252050|FG002|NOT COMPLETED|Period 1 - First Intervention||0||
48377595|NCT01043185|101252051|FG003|NOT COMPLETED|Period 1 - First Intervention||0||
48377596|NCT01043185|101252052|FG004|NOT COMPLETED|Period 1 - First Intervention||0||
48377597|NCT01043185|101252053|FG005|NOT COMPLETED|Period 1 - First Intervention||0||
48377598|NCT01043185|101252054|FG006|NOT COMPLETED|Period 1 - First Intervention||0||
48377599|NCT01043185|101252055|FG007|NOT COMPLETED|Period 1 - First Intervention||0||
48377600|NCT01043185|101252056|FG008|NOT COMPLETED|Period 1 - First Intervention||0||
48377601|NCT01043185|101252057|FG009|NOT COMPLETED|Period 1 - First Intervention||0||
48377602|NCT01043185|101252048|FG000|STARTED|Period 2 - First Washout Period||3||
48377603|NCT01043185|101252049|FG001|STARTED|Period 2 - First Washout Period||2||
48377604|NCT01043185|101252050|FG002|STARTED|Period 2 - First Washout Period||3||
48377605|NCT01043185|101252051|FG003|STARTED|Period 2 - First Washout Period||2||
48377606|NCT01043185|101252052|FG004|STARTED|Period 2 - First Washout Period||2||
48377607|NCT01043185|101252053|FG005|STARTED|Period 2 - First Washout Period||3||
48377608|NCT01043185|101252054|FG006|STARTED|Period 2 - First Washout Period||3||
48377609|NCT01043185|101252055|FG007|STARTED|Period 2 - First Washout Period||3||
48377610|NCT01043185|101252056|FG008|STARTED|Period 2 - First Washout Period||3||
48377611|NCT01043185|101252057|FG009|STARTED|Period 2 - First Washout Period||3||
48377612|NCT01043185|101252048|FG000|COMPLETED|Period 2 - First Washout Period||3||
48377613|NCT01043185|101252049|FG001|COMPLETED|Period 2 - First Washout Period||2||
48377614|NCT01043185|101252050|FG002|COMPLETED|Period 2 - First Washout Period||3||
48377615|NCT01043185|101252051|FG003|COMPLETED|Period 2 - First Washout Period||2||
48377616|NCT01043185|101252052|FG004|COMPLETED|Period 2 - First Washout Period||2||
48377617|NCT01043185|101252053|FG005|COMPLETED|Period 2 - First Washout Period||3||
48377618|NCT01043185|101252054|FG006|COMPLETED|Period 2 - First Washout Period||3||
48377619|NCT01043185|101252055|FG007|COMPLETED|Period 2 - First Washout Period||3||
48377620|NCT01043185|101252056|FG008|COMPLETED|Period 2 - First Washout Period||3||
48377621|NCT01043185|101252057|FG009|COMPLETED|Period 2 - First Washout Period||3||
48377622|NCT01043185|101252048|FG000|NOT COMPLETED|Period 2 - First Washout Period||0||
48377623|NCT01043185|101252049|FG001|NOT COMPLETED|Period 2 - First Washout Period||0||
48377624|NCT01043185|101252050|FG002|NOT COMPLETED|Period 2 - First Washout Period||0||
48377625|NCT01043185|101252051|FG003|NOT COMPLETED|Period 2 - First Washout Period||0||
48377626|NCT01043185|101252052|FG004|NOT COMPLETED|Period 2 - First Washout Period||0||
48377627|NCT01043185|101252053|FG005|NOT COMPLETED|Period 2 - First Washout Period||0||
48377628|NCT01043185|101252054|FG006|NOT COMPLETED|Period 2 - First Washout Period||0||
48377629|NCT01043185|101252055|FG007|NOT COMPLETED|Period 2 - First Washout Period||0||
48377630|NCT01043185|101252056|FG008|NOT COMPLETED|Period 2 - First Washout Period||0||
48377631|NCT01043185|101252057|FG009|NOT COMPLETED|Period 2 - First Washout Period||0||
48377632|NCT01043185|101252048|FG000|STARTED|Period 3 - Second Intervention||3||
48377633|NCT01043185|101252049|FG001|STARTED|Period 3 - Second Intervention||2||
48377634|NCT01043185|101252050|FG002|STARTED|Period 3 - Second Intervention||3||
48377635|NCT01043185|101252051|FG003|STARTED|Period 3 - Second Intervention||2||
48377636|NCT01043185|101252052|FG004|STARTED|Period 3 - Second Intervention||2||
48377637|NCT01043185|101252053|FG005|STARTED|Period 3 - Second Intervention||3||
48377638|NCT01043185|101252054|FG006|STARTED|Period 3 - Second Intervention||3||
48377639|NCT01043185|101252055|FG007|STARTED|Period 3 - Second Intervention||3||
48377640|NCT01043185|101252056|FG008|STARTED|Period 3 - Second Intervention||3||
48377641|NCT01043185|101252057|FG009|STARTED|Period 3 - Second Intervention||3||
48377642|NCT01043185|101252048|FG000|COMPLETED|Period 3 - Second Intervention||3||
48377643|NCT01043185|101252049|FG001|COMPLETED|Period 3 - Second Intervention||2||
48377644|NCT01043185|101252050|FG002|COMPLETED|Period 3 - Second Intervention||3||
48377645|NCT01043185|101252051|FG003|COMPLETED|Period 3 - Second Intervention||2||
48377646|NCT01043185|101252052|FG004|COMPLETED|Period 3 - Second Intervention||2||
48377647|NCT01043185|101252053|FG005|COMPLETED|Period 3 - Second Intervention||3||
48377648|NCT01043185|101252054|FG006|COMPLETED|Period 3 - Second Intervention||3||
48377649|NCT01043185|101252055|FG007|COMPLETED|Period 3 - Second Intervention||3||
48377650|NCT01043185|101252056|FG008|COMPLETED|Period 3 - Second Intervention||3||
48377651|NCT01043185|101252057|FG009|COMPLETED|Period 3 - Second Intervention||3||
48377652|NCT01043185|101252048|FG000|NOT COMPLETED|Period 3 - Second Intervention||0||
48377653|NCT01043185|101252049|FG001|NOT COMPLETED|Period 3 - Second Intervention||0||
48377654|NCT01043185|101252050|FG002|NOT COMPLETED|Period 3 - Second Intervention||0||
48377655|NCT01043185|101252051|FG003|NOT COMPLETED|Period 3 - Second Intervention||0||
48377656|NCT01043185|101252052|FG004|NOT COMPLETED|Period 3 - Second Intervention||0||
48377657|NCT01043185|101252053|FG005|NOT COMPLETED|Period 3 - Second Intervention||0||
48377658|NCT01043185|101252054|FG006|NOT COMPLETED|Period 3 - Second Intervention||0||
48377659|NCT01043185|101252055|FG007|NOT COMPLETED|Period 3 - Second Intervention||0||
48377660|NCT01043185|101252056|FG008|NOT COMPLETED|Period 3 - Second Intervention||0||
48377661|NCT01043185|101252057|FG009|NOT COMPLETED|Period 3 - Second Intervention||0||
48377662|NCT01043185|101252048|FG000|STARTED|Period 4 - Second Washout Period||3||
48377663|NCT01043185|101252049|FG001|STARTED|Period 4 - Second Washout Period||2||
48377664|NCT01043185|101252050|FG002|STARTED|Period 4 - Second Washout Period||3||
48377665|NCT01043185|101252051|FG003|STARTED|Period 4 - Second Washout Period||2||
48377666|NCT01043185|101252052|FG004|STARTED|Period 4 - Second Washout Period||2||
48377667|NCT01043185|101252053|FG005|STARTED|Period 4 - Second Washout Period||3||
48377668|NCT01043185|101252054|FG006|STARTED|Period 4 - Second Washout Period||3||
48377669|NCT01043185|101252055|FG007|STARTED|Period 4 - Second Washout Period||3||
48541193|NCT00229723|101662681|FG001|STARTED|Concomitant Phase||24||
48377670|NCT01043185|101252056|FG008|STARTED|Period 4 - Second Washout Period||3||
48377671|NCT01043185|101252057|FG009|STARTED|Period 4 - Second Washout Period||3||
48377672|NCT01043185|101252048|FG000|COMPLETED|Period 4 - Second Washout Period||3||
48377673|NCT01043185|101252049|FG001|COMPLETED|Period 4 - Second Washout Period||2||
48377674|NCT01043185|101252050|FG002|COMPLETED|Period 4 - Second Washout Period||3||
48377675|NCT01043185|101252051|FG003|COMPLETED|Period 4 - Second Washout Period||2||
48377676|NCT01043185|101252052|FG004|COMPLETED|Period 4 - Second Washout Period||2||
48377677|NCT01043185|101252053|FG005|COMPLETED|Period 4 - Second Washout Period||3||
48377678|NCT01043185|101252054|FG006|COMPLETED|Period 4 - Second Washout Period||3||
48377679|NCT01043185|101252055|FG007|COMPLETED|Period 4 - Second Washout Period||3||
48377680|NCT01043185|101252056|FG008|COMPLETED|Period 4 - Second Washout Period||3||
48377681|NCT01043185|101252057|FG009|COMPLETED|Period 4 - Second Washout Period||3||
48377682|NCT01043185|101252048|FG000|NOT COMPLETED|Period 4 - Second Washout Period||0||
48377683|NCT01043185|101252049|FG001|NOT COMPLETED|Period 4 - Second Washout Period||0||
48377684|NCT01043185|101252050|FG002|NOT COMPLETED|Period 4 - Second Washout Period||0||
48377685|NCT01043185|101252051|FG003|NOT COMPLETED|Period 4 - Second Washout Period||0||
48377686|NCT01043185|101252052|FG004|NOT COMPLETED|Period 4 - Second Washout Period||0||
48377687|NCT01043185|101252053|FG005|NOT COMPLETED|Period 4 - Second Washout Period||0||
48377688|NCT01043185|101252054|FG006|NOT COMPLETED|Period 4 - Second Washout Period||0||
48377689|NCT01043185|101252055|FG007|NOT COMPLETED|Period 4 - Second Washout Period||0||
48377690|NCT01043185|101252056|FG008|NOT COMPLETED|Period 4 - Second Washout Period||0||
48377691|NCT01043185|101252057|FG009|NOT COMPLETED|Period 4 - Second Washout Period||0||
48377692|NCT01043185|101252048|FG000|STARTED|Period 5 - Third Intervention||3||
48377693|NCT01043185|101252049|FG001|STARTED|Period 5 - Third Intervention||2||
48377694|NCT01043185|101252050|FG002|STARTED|Period 5 - Third Intervention||3||
48377695|NCT01043185|101252051|FG003|STARTED|Period 5 - Third Intervention||2||
48377696|NCT01043185|101252052|FG004|STARTED|Period 5 - Third Intervention||2||
48377697|NCT01043185|101252053|FG005|STARTED|Period 5 - Third Intervention||3||
48377698|NCT01043185|101252054|FG006|STARTED|Period 5 - Third Intervention||3||
48377699|NCT01043185|101252055|FG007|STARTED|Period 5 - Third Intervention||3||
48377700|NCT01043185|101252056|FG008|STARTED|Period 5 - Third Intervention||3||
48541194|NCT00229723|101662682|FG002|STARTED|Concomitant Phase||31||
48541195|NCT00229723|101662683|FG003|STARTED|Concomitant Phase||31||
48541196|NCT00229723|101662684|FG004|STARTED|Concomitant Phase||24||
48541197|NCT00229723|101662685|FG005|STARTED|Concomitant Phase||34||
48377701|NCT01043185|101252057|FG009|STARTED|Period 5 - Third Intervention||3||
48377702|NCT01043185|101252048|FG000|COMPLETED|Period 5 - Third Intervention||3||
48377703|NCT01043185|101252049|FG001|COMPLETED|Period 5 - Third Intervention||2||
48377704|NCT01043185|101252050|FG002|COMPLETED|Period 5 - Third Intervention||3||
48377705|NCT01043185|101252051|FG003|COMPLETED|Period 5 - Third Intervention||2||
48377706|NCT01043185|101252052|FG004|COMPLETED|Period 5 - Third Intervention||2||
48377707|NCT01043185|101252053|FG005|COMPLETED|Period 5 - Third Intervention||3||
48377708|NCT01043185|101252054|FG006|COMPLETED|Period 5 - Third Intervention||3||
48377709|NCT01043185|101252055|FG007|COMPLETED|Period 5 - Third Intervention||3||
48377710|NCT01043185|101252056|FG008|COMPLETED|Period 5 - Third Intervention||3||
48377711|NCT01043185|101252057|FG009|COMPLETED|Period 5 - Third Intervention||3||
48377712|NCT01043185|101252048|FG000|NOT COMPLETED|Period 5 - Third Intervention||0||
48377713|NCT01043185|101252049|FG001|NOT COMPLETED|Period 5 - Third Intervention||0||
48377714|NCT01043185|101252050|FG002|NOT COMPLETED|Period 5 - Third Intervention||0||
48377715|NCT01043185|101252051|FG003|NOT COMPLETED|Period 5 - Third Intervention||0||
48377716|NCT01043185|101252052|FG004|NOT COMPLETED|Period 5 - Third Intervention||0||
48377717|NCT01043185|101252053|FG005|NOT COMPLETED|Period 5 - Third Intervention||0||
48377718|NCT01043185|101252054|FG006|NOT COMPLETED|Period 5 - Third Intervention||0||
48377719|NCT01043185|101252055|FG007|NOT COMPLETED|Period 5 - Third Intervention||0||
48377720|NCT01043185|101252056|FG008|NOT COMPLETED|Period 5 - Third Intervention||0||
48377721|NCT01043185|101252057|FG009|NOT COMPLETED|Period 5 - Third Intervention||0||
48377722|NCT01043185|101252048|FG000|STARTED|Period 6 - Third Washout Period||3||
48377723|NCT01043185|101252049|FG001|STARTED|Period 6 - Third Washout Period||2||
48377724|NCT01043185|101252050|FG002|STARTED|Period 6 - Third Washout Period||3||
48377725|NCT01043185|101252051|FG003|STARTED|Period 6 - Third Washout Period||2||
48377726|NCT01043185|101252052|FG004|STARTED|Period 6 - Third Washout Period||2||
48377727|NCT01043185|101252053|FG005|STARTED|Period 6 - Third Washout Period||3||
48377728|NCT01043185|101252054|FG006|STARTED|Period 6 - Third Washout Period||3||
48377729|NCT01043185|101252055|FG007|STARTED|Period 6 - Third Washout Period||3||
48377730|NCT01043185|101252056|FG008|STARTED|Period 6 - Third Washout Period||3||
48377731|NCT01043185|101252057|FG009|STARTED|Period 6 - Third Washout Period||3||
48377732|NCT01043185|101252048|FG000|COMPLETED|Period 6 - Third Washout Period||3||
48377733|NCT01043185|101252049|FG001|COMPLETED|Period 6 - Third Washout Period||2||
48377734|NCT01043185|101252050|FG002|COMPLETED|Period 6 - Third Washout Period||3||
48377735|NCT01043185|101252051|FG003|COMPLETED|Period 6 - Third Washout Period||2||
48377736|NCT01043185|101252052|FG004|COMPLETED|Period 6 - Third Washout Period||2||
48377737|NCT01043185|101252053|FG005|COMPLETED|Period 6 - Third Washout Period||3||
48377738|NCT01043185|101252054|FG006|COMPLETED|Period 6 - Third Washout Period||3||
48377739|NCT01043185|101252055|FG007|COMPLETED|Period 6 - Third Washout Period||3||
48377740|NCT01043185|101252056|FG008|COMPLETED|Period 6 - Third Washout Period||2||
48377741|NCT01043185|101252057|FG009|COMPLETED|Period 6 - Third Washout Period||3||
48377742|NCT01043185|101252048|FG000|NOT COMPLETED|Period 6 - Third Washout Period||0||
48377743|NCT01043185|101252049|FG001|NOT COMPLETED|Period 6 - Third Washout Period||0||
48377744|NCT01043185|101252050|FG002|NOT COMPLETED|Period 6 - Third Washout Period||0||
48377745|NCT01043185|101252051|FG003|NOT COMPLETED|Period 6 - Third Washout Period||0||
48377746|NCT01043185|101252052|FG004|NOT COMPLETED|Period 6 - Third Washout Period||0||
48377747|NCT01043185|101252053|FG005|NOT COMPLETED|Period 6 - Third Washout Period||0||
48377748|NCT01043185|101252054|FG006|NOT COMPLETED|Period 6 - Third Washout Period||0||
48377749|NCT01043185|101252055|FG007|NOT COMPLETED|Period 6 - Third Washout Period||0||
48377750|NCT01043185|101252056|FG008|NOT COMPLETED|Period 6 - Third Washout Period||1||
48377751|NCT01043185|101252057|FG009|NOT COMPLETED|Period 6 - Third Washout Period||0||
48377752|NCT01043185|101252048|FG000|STARTED|Period 7 - Fourth Intervention||3||
48377753|NCT01043185|101252049|FG001|STARTED|Period 7 - Fourth Intervention||2||
48377754|NCT01043185|101252050|FG002|STARTED|Period 7 - Fourth Intervention||3||
48377755|NCT01043185|101252051|FG003|STARTED|Period 7 - Fourth Intervention||2||
48377756|NCT01043185|101252052|FG004|STARTED|Period 7 - Fourth Intervention||2||
48377757|NCT01043185|101252053|FG005|STARTED|Period 7 - Fourth Intervention||3||
48377758|NCT01043185|101252054|FG006|STARTED|Period 7 - Fourth Intervention||3||
48377759|NCT01043185|101252055|FG007|STARTED|Period 7 - Fourth Intervention||3||
48377760|NCT01043185|101252056|FG008|STARTED|Period 7 - Fourth Intervention||2||
48377761|NCT01043185|101252057|FG009|STARTED|Period 7 - Fourth Intervention||3||
48377762|NCT01043185|101252048|FG000|COMPLETED|Period 7 - Fourth Intervention||3||
48377763|NCT01043185|101252049|FG001|COMPLETED|Period 7 - Fourth Intervention||2||
48377764|NCT01043185|101252050|FG002|COMPLETED|Period 7 - Fourth Intervention||3||
48377765|NCT01043185|101252051|FG003|COMPLETED|Period 7 - Fourth Intervention||2||
48377766|NCT01043185|101252052|FG004|COMPLETED|Period 7 - Fourth Intervention||2||
48377767|NCT01043185|101252053|FG005|COMPLETED|Period 7 - Fourth Intervention||3||
48377768|NCT01043185|101252054|FG006|COMPLETED|Period 7 - Fourth Intervention||3||
48377769|NCT01043185|101252055|FG007|COMPLETED|Period 7 - Fourth Intervention||3||
48377770|NCT01043185|101252056|FG008|COMPLETED|Period 7 - Fourth Intervention||2||
48377771|NCT01043185|101252057|FG009|COMPLETED|Period 7 - Fourth Intervention||3||
48377772|NCT01043185|101252048|FG000|NOT COMPLETED|Period 7 - Fourth Intervention||0||
48377773|NCT01043185|101252049|FG001|NOT COMPLETED|Period 7 - Fourth Intervention||0||
48541198|NCT00229723|101662686|FG006|STARTED|Concomitant Phase||22||
48377774|NCT01043185|101252050|FG002|NOT COMPLETED|Period 7 - Fourth Intervention||0||
48377775|NCT01043185|101252051|FG003|NOT COMPLETED|Period 7 - Fourth Intervention||0||
48377776|NCT01043185|101252052|FG004|NOT COMPLETED|Period 7 - Fourth Intervention||0||
48377777|NCT01043185|101252053|FG005|NOT COMPLETED|Period 7 - Fourth Intervention||0||
48377778|NCT01043185|101252054|FG006|NOT COMPLETED|Period 7 - Fourth Intervention||0||
48377779|NCT01043185|101252055|FG007|NOT COMPLETED|Period 7 - Fourth Intervention||0||
48377780|NCT01043185|101252056|FG008|NOT COMPLETED|Period 7 - Fourth Intervention||0||
48377781|NCT01043185|101252057|FG009|NOT COMPLETED|Period 7 - Fourth Intervention||0||
48377782|NCT01401010|101252058|FG000|STARTED|Overall Study||6||
48377783|NCT01401010|101252059|FG001|STARTED|Overall Study||6||
48377784|NCT01401010|101252058|FG000|COMPLETED|Overall Study||5||
48377785|NCT01401010|101252059|FG001|COMPLETED|Overall Study||6||
48377786|NCT01401010|101252058|FG000|NOT COMPLETED|Overall Study||1||
48377787|NCT01401010|101252059|FG001|NOT COMPLETED|Overall Study||0||
48377788|NCT03649321|101252060|FG000|STARTED|Overall Study||9||
48377789|NCT03649321|101252061|FG001|STARTED|Overall Study||0||
48377790|NCT03649321|101252060|FG000|COMPLETED|Overall Study||7||
48377791|NCT03649321|101252061|FG001|COMPLETED|Overall Study||0||
48377792|NCT03649321|101252060|FG000|NOT COMPLETED|Overall Study||2||
48377793|NCT03649321|101252061|FG001|NOT COMPLETED|Overall Study||0||
48377794|NCT00696657|101252062|FG000|STARTED|Overall Study||46|STARTED = Randomised.|
48377795|NCT00696657|101252063|FG001|STARTED|Overall Study||47|STARTED = Randomised.|
48377796|NCT00696657|101252064|FG002|STARTED|Overall Study||44|STARTED = Randomised.|
48377797|NCT00696657|101252065|FG003|STARTED|Overall Study||49|STARTED = Randomised.|
48377798|NCT00696657|101252066|FG004|STARTED|Overall Study||44|STARTED = Randomised.|
48377799|NCT00696657|101252067|FG005|STARTED|Overall Study||45|STARTED = Randomised.|
48377800|NCT00696657|101252068|FG006|STARTED|Overall Study||45|STARTED = Randomised.|
48377801|NCT00696657|101252069|FG007|STARTED|Overall Study||45|STARTED = Randomised.|
48377802|NCT00696657|101252070|FG008|STARTED|Overall Study||50|STARTED = Randomised.|
48377803|NCT00696657|101252062|FG000|EXPOSED|Overall Study||46||
48377804|NCT00696657|101252063|FG001|EXPOSED|Overall Study||47||
48377805|NCT00696657|101252064|FG002|EXPOSED|Overall Study||43||
48377806|NCT00696657|101252065|FG003|EXPOSED|Overall Study||48||
48377807|NCT00696657|101252066|FG004|EXPOSED|Overall Study||44||
48377808|NCT00696657|101252067|FG005|EXPOSED|Overall Study||43||
48377809|NCT00696657|101252068|FG006|EXPOSED|Overall Study||45||
48377810|NCT00696657|101252069|FG007|EXPOSED|Overall Study||45||
48377811|NCT00696657|101252070|FG008|EXPOSED|Overall Study||50||
48377812|NCT00696657|101252062|FG000|COMPLETED|Overall Study||45||
48377813|NCT00696657|101252063|FG001|COMPLETED|Overall Study||42||
48377814|NCT00696657|101252064|FG002|COMPLETED|Overall Study||36||
48377815|NCT00696657|101252065|FG003|COMPLETED|Overall Study||38||
48684135|NCT04749745|102009682|FG000|NOT COMPLETED|Overall Study||1||
48684136|NCT04749745|102009683|FG001|NOT COMPLETED|Overall Study||0||
48684137|NCT00955474|102009684|FG000|STARTED|Overall Study||12||
48684138|NCT00955474|102009685|FG001|STARTED|Overall Study||13||
48684139|NCT00955474|102009684|FG000|COMPLETED|Overall Study||5||
48684140|NCT00955474|102009685|FG001|COMPLETED|Overall Study||8||
48684141|NCT00955474|102009684|FG000|NOT COMPLETED|Overall Study||7||
48684142|NCT00955474|102009685|FG001|NOT COMPLETED|Overall Study||5||
48684143|NCT05173974|102009686|FG000|STARTED|Period 1 (Visit 2, 1 Day)||11||
48684144|NCT05173974|102009687|FG001|STARTED|Period 1 (Visit 2, 1 Day)||10||
48684145|NCT05173974|102009688|FG002|STARTED|Period 1 (Visit 2, 1 Day)||11||
48684146|NCT05173974|102009689|FG003|STARTED|Period 1 (Visit 2, 1 Day)||11||
48684147|NCT05173974|102009686|FG000|COMPLETED|Period 1 (Visit 2, 1 Day)||11||
48684148|NCT05173974|102009687|FG001|COMPLETED|Period 1 (Visit 2, 1 Day)||10||
48684149|NCT05173974|102009688|FG002|COMPLETED|Period 1 (Visit 2, 1 Day)||11||
48684150|NCT05173974|102009689|FG003|COMPLETED|Period 1 (Visit 2, 1 Day)||11||
48684151|NCT05173974|102009686|FG000|NOT COMPLETED|Period 1 (Visit 2, 1 Day)||0||
48684152|NCT05173974|102009687|FG001|NOT COMPLETED|Period 1 (Visit 2, 1 Day)||0||
48684153|NCT05173974|102009688|FG002|NOT COMPLETED|Period 1 (Visit 2, 1 Day)||0||
48684154|NCT05173974|102009689|FG003|NOT COMPLETED|Period 1 (Visit 2, 1 Day)||0||
48684155|NCT05173974|102009686|FG000|STARTED|Washout Period 1 (at Least 1 to 28 Days)||11||
48684156|NCT05173974|102009687|FG001|STARTED|Washout Period 1 (at Least 1 to 28 Days)||10||
48684157|NCT05173974|102009688|FG002|STARTED|Washout Period 1 (at Least 1 to 28 Days)||11||
48684158|NCT05173974|102009689|FG003|STARTED|Washout Period 1 (at Least 1 to 28 Days)||11||
48684159|NCT05173974|102009686|FG000|COMPLETED|Washout Period 1 (at Least 1 to 28 Days)||11||
48684160|NCT05173974|102009687|FG001|COMPLETED|Washout Period 1 (at Least 1 to 28 Days)||10||
48684161|NCT05173974|102009688|FG002|COMPLETED|Washout Period 1 (at Least 1 to 28 Days)||11||
48684162|NCT05173974|102009689|FG003|COMPLETED|Washout Period 1 (at Least 1 to 28 Days)||11||
48684163|NCT05173974|102009686|FG000|NOT COMPLETED|Washout Period 1 (at Least 1 to 28 Days)||0||
48088135|NCT01749514|100537229|FG000|COMPLETED|Overall Study||3||
48377816|NCT00696657|101252066|FG004|COMPLETED|Overall Study||34||
48684164|NCT05173974|102009687|FG001|NOT COMPLETED|Washout Period 1 (at Least 1 to 28 Days)||0||
48684165|NCT05173974|102009688|FG002|NOT COMPLETED|Washout Period 1 (at Least 1 to 28 Days)||0||
48684166|NCT05173974|102009689|FG003|NOT COMPLETED|Washout Period 1 (at Least 1 to 28 Days)||0||
48684167|NCT05173974|102009686|FG000|STARTED|Period 2 (Visit 3, 1 Day)||11||
48684168|NCT05173974|102009687|FG001|STARTED|Period 2 (Visit 3, 1 Day)||9||
48684169|NCT05173974|102009688|FG002|STARTED|Period 2 (Visit 3, 1 Day)||11||
48684170|NCT05173974|102009689|FG003|STARTED|Period 2 (Visit 3, 1 Day)||11||
48684171|NCT05173974|102009686|FG000|COMPLETED|Period 2 (Visit 3, 1 Day)||11||
48088136|NCT01749514|100537230|FG001|COMPLETED|Overall Study||3||
48377817|NCT00696657|101252067|FG005|COMPLETED|Overall Study||33||
48377818|NCT00696657|101252068|FG006|COMPLETED|Overall Study||30||
48377819|NCT00696657|101252069|FG007|COMPLETED|Overall Study||42||
48684172|NCT05173974|102009687|FG001|COMPLETED|Period 2 (Visit 3, 1 Day)||9||
48710782|NCT01215110|102078018|FG002|STARTED|Overall Study||15||
48377820|NCT00696657|101252070|FG008|COMPLETED|Overall Study||41||
48377821|NCT00696657|101252062|FG000|NOT COMPLETED|Overall Study||1||
48377822|NCT00696657|101252063|FG001|NOT COMPLETED|Overall Study||5||
48684173|NCT05173974|102009688|FG002|COMPLETED|Period 2 (Visit 3, 1 Day)||11||
48684174|NCT05173974|102009689|FG003|COMPLETED|Period 2 (Visit 3, 1 Day)||10||
48684175|NCT05173974|102009686|FG000|NOT COMPLETED|Period 2 (Visit 3, 1 Day)||0||
48377823|NCT00696657|101252064|FG002|NOT COMPLETED|Overall Study||8||
48377824|NCT00696657|101252065|FG003|NOT COMPLETED|Overall Study||11||
48377825|NCT00696657|101252066|FG004|NOT COMPLETED|Overall Study||10||
48377826|NCT00696657|101252067|FG005|NOT COMPLETED|Overall Study||12||
48377827|NCT00696657|101252068|FG006|NOT COMPLETED|Overall Study||15||
48377828|NCT00696657|101252069|FG007|NOT COMPLETED|Overall Study||3||
48377829|NCT00696657|101252070|FG008|NOT COMPLETED|Overall Study||9||
48377830|NCT02006667|101252071|FG000|STARTED|Overall Study||13||
48377831|NCT02006667|101252071|FG000|COMPLETED|Overall Study||7||
48377832|NCT02006667|101252071|FG000|NOT COMPLETED|Overall Study||6||
48377833|NCT02898207|101252072|FG000|STARTED|Dose Level 0||3||
48377834|NCT02898207|101252073|FG001|STARTED|Dose Level 0||0||
48684176|NCT05173974|102009687|FG001|NOT COMPLETED|Period 2 (Visit 3, 1 Day)||0||
48684177|NCT05173974|102009688|FG002|NOT COMPLETED|Period 2 (Visit 3, 1 Day)||0||
48684178|NCT05173974|102009689|FG003|NOT COMPLETED|Period 2 (Visit 3, 1 Day)||1||
48684179|NCT05173974|102009686|FG000|STARTED|Washout Period 2 (at Least 1 to 28 Days)||11||
48684180|NCT05173974|102009687|FG001|STARTED|Washout Period 2 (at Least 1 to 28 Days)||9||
48684181|NCT05173974|102009688|FG002|STARTED|Washout Period 2 (at Least 1 to 28 Days)||11||
48684182|NCT05173974|102009689|FG003|STARTED|Washout Period 2 (at Least 1 to 28 Days)||10||
48684183|NCT05173974|102009686|FG000|COMPLETED|Washout Period 2 (at Least 1 to 28 Days)||11||
48684184|NCT05173974|102009687|FG001|COMPLETED|Washout Period 2 (at Least 1 to 28 Days)||9||
48684185|NCT05173974|102009688|FG002|COMPLETED|Washout Period 2 (at Least 1 to 28 Days)||11||
48684186|NCT05173974|102009689|FG003|COMPLETED|Washout Period 2 (at Least 1 to 28 Days)||10||
48684187|NCT05173974|102009686|FG000|NOT COMPLETED|Washout Period 2 (at Least 1 to 28 Days)||0||
48684188|NCT05173974|102009687|FG001|NOT COMPLETED|Washout Period 2 (at Least 1 to 28 Days)||0||
48684189|NCT05173974|102009688|FG002|NOT COMPLETED|Washout Period 2 (at Least 1 to 28 Days)||0||
48684190|NCT05173974|102009689|FG003|NOT COMPLETED|Washout Period 2 (at Least 1 to 28 Days)||0||
48684191|NCT05173974|102009686|FG000|STARTED|Period 3 (Visit 4, 1 Day)||11||
48684192|NCT05173974|102009687|FG001|STARTED|Period 3 (Visit 4, 1 Day)||10||
48684193|NCT05173974|102009688|FG002|STARTED|Period 3 (Visit 4, 1 Day)||11||
48684194|NCT05173974|102009689|FG003|STARTED|Period 3 (Visit 4, 1 Day)||10||
48684195|NCT05173974|102009686|FG000|COMPLETED|Period 3 (Visit 4, 1 Day)||11||
48684196|NCT05173974|102009687|FG001|COMPLETED|Period 3 (Visit 4, 1 Day)||10||
48684197|NCT05173974|102009688|FG002|COMPLETED|Period 3 (Visit 4, 1 Day)||11||
48684198|NCT05173974|102009689|FG003|COMPLETED|Period 3 (Visit 4, 1 Day)||10||
48684199|NCT05173974|102009686|FG000|NOT COMPLETED|Period 3 (Visit 4, 1 Day)||0||
48684200|NCT05173974|102009687|FG001|NOT COMPLETED|Period 3 (Visit 4, 1 Day)||0||
48684201|NCT05173974|102009688|FG002|NOT COMPLETED|Period 3 (Visit 4, 1 Day)||0||
48684202|NCT05173974|102009689|FG003|NOT COMPLETED|Period 3 (Visit 4, 1 Day)||0||
48684203|NCT05173974|102009686|FG000|STARTED|Washout Period 3 (at Least 1 to 28 Days)||11||
48684204|NCT05173974|102009687|FG001|STARTED|Washout Period 3 (at Least 1 to 28 Days)||10||
48684205|NCT05173974|102009688|FG002|STARTED|Washout Period 3 (at Least 1 to 28 Days)||11||
48684206|NCT05173974|102009689|FG003|STARTED|Washout Period 3 (at Least 1 to 28 Days)||10||
48684207|NCT05173974|102009686|FG000|COMPLETED|Washout Period 3 (at Least 1 to 28 Days)||11||
48684208|NCT05173974|102009687|FG001|COMPLETED|Washout Period 3 (at Least 1 to 28 Days)||10||
48684209|NCT05173974|102009688|FG002|COMPLETED|Washout Period 3 (at Least 1 to 28 Days)||11||
48684210|NCT05173974|102009689|FG003|COMPLETED|Washout Period 3 (at Least 1 to 28 Days)||10||
48684211|NCT05173974|102009686|FG000|NOT COMPLETED|Washout Period 3 (at Least 1 to 28 Days)||0||
48377835|NCT02898207|101252074|FG002|STARTED|Dose Level 0||0||
48377836|NCT02898207|101252075|FG003|STARTED|Dose Level 0||0||
48377837|NCT02898207|101252076|FG004|STARTED|Dose Level 0||0||
48377838|NCT02898207|101252077|FG005|STARTED|Dose Level 0||0||
48684212|NCT05173974|102009687|FG001|NOT COMPLETED|Washout Period 3 (at Least 1 to 28 Days)||0||
48377839|NCT02898207|101252072|FG000|COMPLETED|Dose Level 0||3||
48377840|NCT02898207|101252073|FG001|COMPLETED|Dose Level 0||0||
48377841|NCT02898207|101252074|FG002|COMPLETED|Dose Level 0||0||
48377842|NCT02898207|101252075|FG003|COMPLETED|Dose Level 0||0||
48250632|NCT03568708|100931164|FG000|STARTED|Overall Study||9||
48088137|NCT01749514|100537231|FG002|COMPLETED|Overall Study||3||
48088138|NCT01749514|100537232|FG003|COMPLETED|Overall Study||6||
48088139|NCT01749514|100537233|FG004|COMPLETED|Overall Study||3||
48088140|NCT01749514|100537234|FG005|COMPLETED|Overall Study||5||
48088141|NCT01749514|100537235|FG006|COMPLETED|Overall Study||3||
48088142|NCT01749514|100537236|FG007|COMPLETED|Overall Study||82||
48088143|NCT01749514|100537229|FG000|NOT COMPLETED|Overall Study||0||
48088144|NCT01749514|100537230|FG001|NOT COMPLETED|Overall Study||0||
48088145|NCT01749514|100537231|FG002|NOT COMPLETED|Overall Study||0||
48088146|NCT01749514|100537232|FG003|NOT COMPLETED|Overall Study||0||
48088147|NCT01749514|100537233|FG004|NOT COMPLETED|Overall Study||0||
48088148|NCT01749514|100537234|FG005|NOT COMPLETED|Overall Study||1||
48088149|NCT01749514|100537235|FG006|NOT COMPLETED|Overall Study||0||
48088150|NCT01749514|100537236|FG007|NOT COMPLETED|Overall Study||7||
48088151|NCT01806545|100537237|FG000|STARTED|Overall Study||29||
48088152|NCT01806545|100537238|FG001|STARTED|Overall Study||35||
48088153|NCT01806545|100537237|FG000|COMPLETED|Overall Study||23||
48088154|NCT01806545|100537238|FG001|COMPLETED|Overall Study||30||
48088155|NCT01806545|100537237|FG000|NOT COMPLETED|Overall Study||6||
48088156|NCT01806545|100537238|FG001|NOT COMPLETED|Overall Study||5||
48088157|NCT00420927|100537239|FG000|STARTED|Period 1||515||
48088158|NCT00420927|100537240|FG001|STARTED|Period 1||517||
48088159|NCT00420927|100537241|FG002|STARTED|Period 1||0||
48088160|NCT00420927|100537242|FG003|STARTED|Period 1||0||
48088161|NCT00420927|100537243|FG004|STARTED|Period 1||0||
48088162|NCT00420927|100537244|FG005|STARTED|Period 1||0||
48088163|NCT00420927|100537245|FG006|STARTED|Period 1||0||
48088164|NCT00420927|100537239|FG000|COMPLETED|Period 1||466||
48088165|NCT00420927|100537240|FG001|COMPLETED|Period 1||460||
48088166|NCT00420927|100537241|FG002|COMPLETED|Period 1||0||
48088167|NCT00420927|100537242|FG003|COMPLETED|Period 1||0||
48088168|NCT00420927|100537243|FG004|COMPLETED|Period 1||0||
48088169|NCT00420927|100537244|FG005|COMPLETED|Period 1||0||
48088170|NCT00420927|100537245|FG006|COMPLETED|Period 1||0||
48088171|NCT00420927|100537239|FG000|NOT COMPLETED|Period 1||49||
48088172|NCT00420927|100537240|FG001|NOT COMPLETED|Period 1||57||
48088173|NCT00420927|100537241|FG002|NOT COMPLETED|Period 1||0||
48088174|NCT00420927|100537242|FG003|NOT COMPLETED|Period 1||0||
48088175|NCT00420927|100537243|FG004|NOT COMPLETED|Period 1||0||
48088176|NCT00420927|100537244|FG005|NOT COMPLETED|Period 1||0||
48088177|NCT00420927|100537245|FG006|NOT COMPLETED|Period 1||0||
48088178|NCT00420927|100537239|FG000|STARTED|Period 2||0||
48088179|NCT00420927|100537240|FG001|STARTED|Period 2||0||
48088180|NCT00420927|100537241|FG002|STARTED|Period 2||102||
48088181|NCT00420927|100537242|FG003|STARTED|Period 2||105||
48088182|NCT00420927|100537243|FG004|STARTED|Period 2||259||
48088183|NCT00420927|100537244|FG005|STARTED|Period 2||112||
48088184|NCT00420927|100537245|FG006|STARTED|Period 2||348||
48088185|NCT00420927|100537239|FG000|COMPLETED|Period 2||0||
48088186|NCT00420927|100537240|FG001|COMPLETED|Period 2||0||
48088187|NCT00420927|100537241|FG002|COMPLETED|Period 2||89||
48088188|NCT00420927|100537242|FG003|COMPLETED|Period 2||95||
48088189|NCT00420927|100537243|FG004|COMPLETED|Period 2||216||
48088190|NCT00420927|100537244|FG005|COMPLETED|Period 2||97||
48088191|NCT00420927|100537245|FG006|COMPLETED|Period 2||295||
48088192|NCT00420927|100537239|FG000|NOT COMPLETED|Period 2||0||
48088193|NCT00420927|100537240|FG001|NOT COMPLETED|Period 2||0||
48088194|NCT00420927|100537241|FG002|NOT COMPLETED|Period 2||13||
48088195|NCT00420927|100537242|FG003|NOT COMPLETED|Period 2||10||
48088196|NCT00420927|100537243|FG004|NOT COMPLETED|Period 2||43||
48088197|NCT00420927|100537244|FG005|NOT COMPLETED|Period 2||15||
48088198|NCT00420927|100537245|FG006|NOT COMPLETED|Period 2||53||
48088199|NCT00885105|100537246|FG000|STARTED|Overall Study||112||
48088200|NCT00885105|100537247|FG001|STARTED|Overall Study||130||
48088201|NCT00885105|100537246|FG000|COMPLETED|Overall Study||111||
48088202|NCT00885105|100537247|FG001|COMPLETED|Overall Study||120||
48088203|NCT00885105|100537246|FG000|NOT COMPLETED|Overall Study||1||
48250633|NCT03568708|100931165|FG001|STARTED|Overall Study||10||
48088204|NCT00885105|100537247|FG001|NOT COMPLETED|Overall Study||10||
48088205|NCT00715078|100537248|FG000|STARTED|Overall Study||41||
48088206|NCT00715078|100537249|FG001|STARTED|Overall Study||40||
48088207|NCT00715078|100537250|FG002|STARTED|Overall Study||41||
48088208|NCT00715078|100537248|FG000|Received ≥ 1 Study Infusion|Overall Study||40||
48088209|NCT00715078|100537249|FG001|Received ≥ 1 Study Infusion|Overall Study||40||
48250634|NCT03568708|100931164|FG000|COMPLETED|Overall Study||8||
48250635|NCT03568708|100931165|FG001|COMPLETED|Overall Study||8||
48088210|NCT00715078|100537250|FG002|Received ≥ 1 Study Infusion|Overall Study||39||
48088211|NCT00715078|100537248|FG000|Received ≥ 1 Leukapheresis|Overall Study||40||
48088212|NCT00715078|100537249|FG001|Received ≥ 1 Leukapheresis|Overall Study||40||
48088213|NCT00715078|100537250|FG002|Received ≥ 1 Leukapheresis|Overall Study||40||
48088214|NCT00715078|100537248|FG000|COMPLETED|Overall Study||11||
48088215|NCT00715078|100537249|FG001|COMPLETED|Overall Study||4||
48088216|NCT00715078|100537250|FG002|COMPLETED|Overall Study||3||
48088217|NCT00715078|100537248|FG000|NOT COMPLETED|Overall Study||30||
48088218|NCT00715078|100537249|FG001|NOT COMPLETED|Overall Study||36||
48250636|NCT03568708|100931164|FG000|NOT COMPLETED|Overall Study||1||
48250637|NCT03568708|100931165|FG001|NOT COMPLETED|Overall Study||2||
48088219|NCT00715078|100537250|FG002|NOT COMPLETED|Overall Study||38||
48250638|NCT00727259|100931166|FG000|STARTED|Overall Study||1995||
48250639|NCT00727259|100931166|FG000|COMPLETED|Overall Study||940||
48250640|NCT00727259|100931166|FG000|NOT COMPLETED|Overall Study||1055||
48250641|NCT03900715|100931167|FG000|STARTED|Overall Study||21||
48250642|NCT03900715|100931167|FG000|Efficacy Evaluable Population|Overall Study||19|"Participants who received at least one dose of luspatercept and had at least two hemoglobin assessments~≥ 8 weeks apart post-treatment."|
48250643|NCT03900715|100931167|FG000|COMPLETED|Overall Study||0||
48250644|NCT03900715|100931167|FG000|NOT COMPLETED|Overall Study||21||
48250645|NCT01685047|100931168|FG000|STARTED|Overall Study||481||
48250646|NCT01685047|100931168|FG000|COMPLETED|Overall Study||396||
48250647|NCT01685047|100931168|FG000|NOT COMPLETED|Overall Study||85||
48684213|NCT05173974|102009688|FG002|NOT COMPLETED|Washout Period 3 (at Least 1 to 28 Days)||0||
48088220|NCT00847704|100537251|FG000|STARTED|Overall Study||3||
48088221|NCT00847704|100537251|FG000|COMPLETED|Overall Study||2||
48088222|NCT00847704|100537251|FG000|NOT COMPLETED|Overall Study||1||
48088223|NCT03210376|100537252|FG000|STARTED|Overall Study||50||
48088224|NCT03210376|100537253|FG001|STARTED|Overall Study||50||
48088225|NCT03210376|100537252|FG000|COMPLETED|Overall Study||50||
48088226|NCT03210376|100537253|FG001|COMPLETED|Overall Study||50||
48088227|NCT03210376|100537252|FG000|NOT COMPLETED|Overall Study||0||
48088228|NCT03210376|100537253|FG001|NOT COMPLETED|Overall Study||0||
48088229|NCT00381095|100537254|FG000|STARTED|Overall Study||72||
48088230|NCT00381095|100537255|FG001|STARTED|Overall Study||80||
48088231|NCT00381095|100537254|FG000|COMPLETED|Overall Study||59||
48088232|NCT00381095|100537255|FG001|COMPLETED|Overall Study||59||
48088233|NCT00381095|100537254|FG000|NOT COMPLETED|Overall Study||13||
48088234|NCT00381095|100537255|FG001|NOT COMPLETED|Overall Study||21||
48088235|NCT02245308|100537256|FG000|STARTED|Overall Study||63||
48088236|NCT02245308|100537257|FG001|STARTED|Overall Study||64||
48088237|NCT02245308|100537256|FG000|COMPLETED|Overall Study||63||
48088238|NCT02245308|100537257|FG001|COMPLETED|Overall Study||64||
48088239|NCT02245308|100537256|FG000|NOT COMPLETED|Overall Study||0||
48088240|NCT02245308|100537257|FG001|NOT COMPLETED|Overall Study||0||
48088241|NCT01031069|100537258|FG000|STARTED|Overall Study||129||
48088242|NCT01031069|100537259|FG001|STARTED|Overall Study||128||
48088243|NCT01031069|100537260|FG002|STARTED|Overall Study||144||
48088244|NCT01031069|100537261|FG003|STARTED|Overall Study||145||
48250648|NCT04159805|100931169|FG000|STARTED|Overall Study||12||
48250649|NCT04159805|100931170|FG001|STARTED|Overall Study||12||
48250650|NCT04159805|100931171|FG002|STARTED|Overall Study||12||
48250651|NCT04159805|100931169|FG000|COMPLETED|Overall Study||12||
48250652|NCT04159805|100931170|FG001|COMPLETED|Overall Study||10||
48250653|NCT04159805|100931171|FG002|COMPLETED|Overall Study||10||
48250654|NCT04159805|100931169|FG000|NOT COMPLETED|Overall Study||0||
48250655|NCT04159805|100931170|FG001|NOT COMPLETED|Overall Study||2||
48250656|NCT04159805|100931171|FG002|NOT COMPLETED|Overall Study||2||
48250657|NCT00427297|100931172|FG000|STARTED|Overall Study||17||
48250658|NCT00427297|100931173|FG001|STARTED|Overall Study||17||
48250659|NCT00427297|100931172|FG000|COMPLETED|Overall Study||17||
48250660|NCT00427297|100931173|FG001|COMPLETED|Overall Study||17||
48250661|NCT00427297|100931172|FG000|NOT COMPLETED|Overall Study||0||
48250662|NCT00427297|100931173|FG001|NOT COMPLETED|Overall Study||0||
48250663|NCT02600897|100931174|FG000|STARTED|Overall Study||3||
48684214|NCT05173974|102009689|FG003|NOT COMPLETED|Washout Period 3 (at Least 1 to 28 Days)||0||
48684215|NCT05173974|102009686|FG000|STARTED|Period 4 (Visit 5, 1 Day)||11||
48088245|NCT01031069|100537258|FG000|COMPLETED|Overall Study||117||
48088246|NCT01031069|100537259|FG001|COMPLETED|Overall Study||117||
48250664|NCT02600897|100931175|FG001|STARTED|Overall Study||4||
48250665|NCT02600897|100931176|FG002|STARTED|Overall Study||3||
48250666|NCT02600897|100931177|FG003|STARTED|Overall Study||6||
48250667|NCT02600897|100931178|FG004|STARTED|Overall Study||3||
48250668|NCT02600897|100931179|FG005|STARTED|Overall Study||5||
48250669|NCT02600897|100931180|FG006|STARTED|Overall Study||10||
48250670|NCT02600897|100931181|FG007|STARTED|Overall Study||40||
48250671|NCT02600897|100931182|FG008|STARTED|Overall Study||40||
48250672|NCT02600897|100931174|FG000|Intent-to-Treat Population|Overall Study||3|The intent-to-treat (ITT) population included all participants enrolled in the study.|
48250673|NCT02600897|100931175|FG001|Intent-to-Treat Population|Overall Study||4|The intent-to-treat (ITT) population included all participants enrolled in the study.|
48250674|NCT02600897|100931176|FG002|Intent-to-Treat Population|Overall Study||3|The intent-to-treat (ITT) population included all participants enrolled in the study.|
48250675|NCT02600897|100931177|FG003|Intent-to-Treat Population|Overall Study||6|The intent-to-treat (ITT) population included all participants enrolled in the study.|
48088247|NCT01031069|100537260|FG002|COMPLETED|Overall Study||103||
48250676|NCT02600897|100931178|FG004|Intent-to-Treat Population|Overall Study||3|The intent-to-treat (ITT) population included all participants enrolled in the study.|
48377843|NCT02898207|101252076|FG004|COMPLETED|Dose Level 0||0||
48088248|NCT01031069|100537261|FG003|COMPLETED|Overall Study||111||
48088249|NCT01031069|100537258|FG000|NOT COMPLETED|Overall Study||12||
48088250|NCT01031069|100537259|FG001|NOT COMPLETED|Overall Study||11||
48088251|NCT01031069|100537260|FG002|NOT COMPLETED|Overall Study||41||
48088252|NCT01031069|100537261|FG003|NOT COMPLETED|Overall Study||34||
48088253|NCT03334448|100537262|FG000|STARTED|Period 1||12||
48088254|NCT03334448|100537263|FG001|STARTED|Period 1||12||
48088255|NCT03334448|100537264|FG002|STARTED|Period 1||13||
48088256|NCT03334448|100537265|FG003|STARTED|Period 1||12||
48088257|NCT03334448|100537262|FG000|Received at Least 1 Dose of Study Drug|Period 1||12||
48088258|NCT03334448|100537263|FG001|Received at Least 1 Dose of Study Drug|Period 1||12||
48088259|NCT03334448|100537264|FG002|Received at Least 1 Dose of Study Drug|Period 1||13||
48088260|NCT03334448|100537265|FG003|Received at Least 1 Dose of Study Drug|Period 1||12||
48088261|NCT03334448|100537262|FG000|COMPLETED|Period 1||12||
48684216|NCT05173974|102009687|FG001|STARTED|Period 4 (Visit 5, 1 Day)||10||
48684217|NCT05173974|102009688|FG002|STARTED|Period 4 (Visit 5, 1 Day)||11||
48250677|NCT02600897|100931179|FG005|Intent-to-Treat Population|Overall Study||5|The intent-to-treat (ITT) population included all participants enrolled in the study.|
48250678|NCT02600897|100931180|FG006|Intent-to-Treat Population|Overall Study||10|The intent-to-treat (ITT) population included all participants enrolled in the study.|
48250679|NCT02600897|100931181|FG007|Intent-to-Treat Population|Overall Study||40|The intent-to-treat (ITT) population included all participants enrolled in the study.|
48684218|NCT05173974|102009689|FG003|STARTED|Period 4 (Visit 5, 1 Day)||10||
48088262|NCT03334448|100537263|FG001|COMPLETED|Period 1||12||
48088263|NCT03334448|100537264|FG002|COMPLETED|Period 1||13||
48250680|NCT02600897|100931182|FG008|Intent-to-Treat Population|Overall Study||40|The intent-to-treat (ITT) population included all participants enrolled in the study.|
48250681|NCT02600897|100931174|FG000|Safety-evaluable Population|Overall Study||3|The safety-evaluable population included all participants who received at least one dose of any component of the combination.|
48250682|NCT02600897|100931175|FG001|Safety-evaluable Population|Overall Study||4|The safety-evaluable population included all participants who received at least one dose of any component of the combination.|
48250683|NCT02600897|100931176|FG002|Safety-evaluable Population|Overall Study||3|The safety-evaluable population included all participants who received at least one dose of any component of the combination.|
48250684|NCT02600897|100931177|FG003|Safety-evaluable Population|Overall Study||6|The safety-evaluable population included all participants who received at least one dose of any component of the combination.|
48250685|NCT02600897|100931178|FG004|Safety-evaluable Population|Overall Study||3|The safety-evaluable population included all participants who received at least one dose of any component of the combination.|
48250686|NCT02600897|100931179|FG005|Safety-evaluable Population|Overall Study||5|The safety-evaluable population included all participants who received at least one dose of any component of the combination.|
48250687|NCT02600897|100931180|FG006|Safety-evaluable Population|Overall Study||10|The safety-evaluable population included all participants who received at least one dose of any component of the combination.|
48250688|NCT02600897|100931181|FG007|Safety-evaluable Population|Overall Study||40|The safety-evaluable population included all participants who received at least one dose of any component of the combination.|
48250689|NCT02600897|100931182|FG008|Safety-evaluable Population|Overall Study||39|The safety-evaluable population included all participants who received at least one dose of any component of the combination.|
48250690|NCT02600897|100931174|FG000|Immunogenicity-evaluable Population|Overall Study||3|Immunogenicity population included all safety-evaluable participants with at least one ADA sample.|
48250691|NCT02600897|100931175|FG001|Immunogenicity-evaluable Population|Overall Study||4|Immunogenicity population included all safety-evaluable participants with at least one ADA sample.|
48250692|NCT02600897|100931176|FG002|Immunogenicity-evaluable Population|Overall Study||3|Immunogenicity population included all safety-evaluable participants with at least one ADA sample.|
48250693|NCT02600897|100931177|FG003|Immunogenicity-evaluable Population|Overall Study||6|Immunogenicity population included all safety-evaluable participants with at least one ADA sample.|
48250694|NCT02600897|100931178|FG004|Immunogenicity-evaluable Population|Overall Study||3|Immunogenicity population included all safety-evaluable participants with at least one ADA sample.|
48250695|NCT02600897|100931179|FG005|Immunogenicity-evaluable Population|Overall Study||5|Immunogenicity population included all safety-evaluable participants with at least one ADA sample.|
48250696|NCT02600897|100931180|FG006|Immunogenicity-evaluable Population|Overall Study||10|Immunogenicity population included all safety-evaluable participants with at least one ADA sample.|
48250697|NCT02600897|100931181|FG007|Immunogenicity-evaluable Population|Overall Study||39|Immunogenicity population included all safety-evaluable participants with at least one ADA sample.|
48250698|NCT02600897|100931182|FG008|Immunogenicity-evaluable Population|Overall Study||38|Immunogenicity population included all safety-evaluable participants with at least one ADA sample.|
48250699|NCT02600897|100931174|FG000|Pharmacokinetic-evaluable Population|Overall Study||3|The pharmacokinetic-evaluable population included all participants who received at least one dose of any component of the combination and who provided at least one suitable postdose PK sample.|
48250700|NCT02600897|100931175|FG001|Pharmacokinetic-evaluable Population|Overall Study||4|The pharmacokinetic-evaluable population included all participants who received at least one dose of any component of the combination and who provided at least one suitable postdose PK sample.|
48250701|NCT02600897|100931176|FG002|Pharmacokinetic-evaluable Population|Overall Study||3|The pharmacokinetic-evaluable population included all participants who received at least one dose of any component of the combination and who provided at least one suitable postdose PK sample.|
48294135|NCT02527343|101047539|FG003|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||2||
48684219|NCT05173974|102009686|FG000|COMPLETED|Period 4 (Visit 5, 1 Day)||11||
48684220|NCT05173974|102009687|FG001|COMPLETED|Period 4 (Visit 5, 1 Day)||9||
48684221|NCT05173974|102009688|FG002|COMPLETED|Period 4 (Visit 5, 1 Day)||11||
48088264|NCT03334448|100537265|FG003|COMPLETED|Period 1||12||
48088265|NCT03334448|100537262|FG000|NOT COMPLETED|Period 1||0||
48088266|NCT03334448|100537263|FG001|NOT COMPLETED|Period 1||0||
48088267|NCT03334448|100537264|FG002|NOT COMPLETED|Period 1||0||
48088268|NCT03334448|100537265|FG003|NOT COMPLETED|Period 1||0||
48088269|NCT03334448|100537262|FG000|STARTED|Washout||12||
48088270|NCT03334448|100537263|FG001|STARTED|Washout||12||
48088271|NCT03334448|100537264|FG002|STARTED|Washout||13||
48088272|NCT03334448|100537265|FG003|STARTED|Washout||12||
48088273|NCT03334448|100537262|FG000|COMPLETED|Washout||12||
48088274|NCT03334448|100537263|FG001|COMPLETED|Washout||12||
48088275|NCT03334448|100537264|FG002|COMPLETED|Washout||13||
48088276|NCT03334448|100537265|FG003|COMPLETED|Washout||12||
48088277|NCT03334448|100537262|FG000|NOT COMPLETED|Washout||0||
48088278|NCT03334448|100537263|FG001|NOT COMPLETED|Washout||0||
48088279|NCT03334448|100537264|FG002|NOT COMPLETED|Washout||0||
48088280|NCT03334448|100537265|FG003|NOT COMPLETED|Washout||0||
48088281|NCT03334448|100537262|FG000|STARTED|Period 2||12||
48088282|NCT03334448|100537263|FG001|STARTED|Period 2||12||
48088283|NCT03334448|100537264|FG002|STARTED|Period 2||13||
48088284|NCT03334448|100537265|FG003|STARTED|Period 2||12||
48088285|NCT03334448|100537262|FG000|Received at Least 1 Dose of Study Drug|Period 2||12||
48088286|NCT03334448|100537263|FG001|Received at Least 1 Dose of Study Drug|Period 2||12||
48088287|NCT03334448|100537264|FG002|Received at Least 1 Dose of Study Drug|Period 2||13||
48088288|NCT03334448|100537265|FG003|Received at Least 1 Dose of Study Drug|Period 2||12||
48088289|NCT03334448|100537262|FG000|COMPLETED|Period 2||12||
48088290|NCT03334448|100537263|FG001|COMPLETED|Period 2||12||
48088291|NCT03334448|100537264|FG002|COMPLETED|Period 2||13||
48088292|NCT03334448|100537265|FG003|COMPLETED|Period 2||12||
48088293|NCT03334448|100537262|FG000|NOT COMPLETED|Period 2||0||
48088294|NCT03334448|100537263|FG001|NOT COMPLETED|Period 2||0||
48088295|NCT03334448|100537264|FG002|NOT COMPLETED|Period 2||0||
48088296|NCT03334448|100537265|FG003|NOT COMPLETED|Period 2||0||
48088297|NCT03334448|100537262|FG000|STARTED|Washout||12||
48088298|NCT03334448|100537263|FG001|STARTED|Washout||12||
48088299|NCT03334448|100537264|FG002|STARTED|Washout||13||
48088300|NCT03334448|100537265|FG003|STARTED|Washout||12||
48088301|NCT03334448|100537262|FG000|COMPLETED|Washout||12||
48088302|NCT03334448|100537263|FG001|COMPLETED|Washout||11||
48088303|NCT03334448|100537264|FG002|COMPLETED|Washout||13||
48088304|NCT03334448|100537265|FG003|COMPLETED|Washout||12||
48088305|NCT03334448|100537262|FG000|NOT COMPLETED|Washout||0||
48088306|NCT03334448|100537263|FG001|NOT COMPLETED|Washout||1||
48088307|NCT03334448|100537264|FG002|NOT COMPLETED|Washout||0||
48088308|NCT03334448|100537265|FG003|NOT COMPLETED|Washout||0||
48088309|NCT03334448|100537262|FG000|STARTED|Period 3||12||
48088310|NCT03334448|100537263|FG001|STARTED|Period 3||11||
48088311|NCT03334448|100537264|FG002|STARTED|Period 3||13||
48088312|NCT03334448|100537265|FG003|STARTED|Period 3||12||
48088313|NCT03334448|100537262|FG000|Received at Least 1 Dose of Study Drug|Period 3||12||
48088314|NCT03334448|100537263|FG001|Received at Least 1 Dose of Study Drug|Period 3||11||
48088315|NCT03334448|100537264|FG002|Received at Least 1 Dose of Study Drug|Period 3||13||
48088316|NCT03334448|100537265|FG003|Received at Least 1 Dose of Study Drug|Period 3||12||
48088317|NCT03334448|100537262|FG000|COMPLETED|Period 3||12||
48088318|NCT03334448|100537263|FG001|COMPLETED|Period 3||11||
48088319|NCT03334448|100537264|FG002|COMPLETED|Period 3||13||
48088320|NCT03334448|100537265|FG003|COMPLETED|Period 3||12||
48088321|NCT03334448|100537262|FG000|NOT COMPLETED|Period 3||0||
48088322|NCT03334448|100537263|FG001|NOT COMPLETED|Period 3||0||
48088323|NCT03334448|100537264|FG002|NOT COMPLETED|Period 3||0||
48088324|NCT03334448|100537265|FG003|NOT COMPLETED|Period 3||0||
48088325|NCT03334448|100537262|FG000|STARTED|Washout||12||
48088326|NCT03334448|100537263|FG001|STARTED|Washout||11||
48088327|NCT03334448|100537264|FG002|STARTED|Washout||13||
48088328|NCT03334448|100537265|FG003|STARTED|Washout||12||
48088329|NCT03334448|100537262|FG000|COMPLETED|Washout||12||
48088330|NCT03334448|100537263|FG001|COMPLETED|Washout||11||
48088331|NCT03334448|100537264|FG002|COMPLETED|Washout||13||
48088332|NCT03334448|100537265|FG003|COMPLETED|Washout||11||
48088333|NCT03334448|100537262|FG000|NOT COMPLETED|Washout||0||
48088334|NCT03334448|100537263|FG001|NOT COMPLETED|Washout||0||
48088335|NCT03334448|100537264|FG002|NOT COMPLETED|Washout||0||
48088336|NCT03334448|100537265|FG003|NOT COMPLETED|Washout||1||
48088337|NCT03334448|100537262|FG000|STARTED|Period 4||12||
48088338|NCT03334448|100537263|FG001|STARTED|Period 4||11||
48088339|NCT03334448|100537264|FG002|STARTED|Period 4||13||
48088340|NCT03334448|100537265|FG003|STARTED|Period 4||11||
48088341|NCT03334448|100537262|FG000|Received at Least 1 Dose of Study Drug|Period 4||12||
48088342|NCT03334448|100537263|FG001|Received at Least 1 Dose of Study Drug|Period 4||11||
48088343|NCT03334448|100537264|FG002|Received at Least 1 Dose of Study Drug|Period 4||13||
48088344|NCT03334448|100537265|FG003|Received at Least 1 Dose of Study Drug|Period 4||11||
48088345|NCT03334448|100537262|FG000|COMPLETED|Period 4||12||
48088346|NCT03334448|100537263|FG001|COMPLETED|Period 4||11||
48088347|NCT03334448|100537264|FG002|COMPLETED|Period 4||13||
48088348|NCT03334448|100537265|FG003|COMPLETED|Period 4||11||
48088349|NCT03334448|100537262|FG000|NOT COMPLETED|Period 4||0||
48088350|NCT03334448|100537263|FG001|NOT COMPLETED|Period 4||0||
48088351|NCT03334448|100537264|FG002|NOT COMPLETED|Period 4||0||
48088352|NCT03334448|100537265|FG003|NOT COMPLETED|Period 4||0||
48088353|NCT00911820|100537266|FG000|STARTED|Overall Study||45||
48088354|NCT00911820|100537267|FG001|STARTED|Overall Study||43||
48088355|NCT00911820|100537266|FG000|Treated|Overall Study||44||
48088356|NCT00911820|100537267|FG001|Treated|Overall Study||41||
48088357|NCT00911820|100537266|FG000|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all patients were considered as 'Not Completed'.|
48088358|NCT00911820|100537267|FG001|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all patients were considered as 'Not Completed'.|
48088359|NCT00911820|100537266|FG000|NOT COMPLETED|Overall Study||45||
48088360|NCT00911820|100537267|FG001|NOT COMPLETED|Overall Study||43||
48088361|NCT03519932|100537268|FG000|STARTED|First Intervention||24||
48088362|NCT03519932|100537269|FG001|STARTED|First Intervention||25||
48088363|NCT03519932|100537268|FG000|COMPLETED|First Intervention||23||
48088364|NCT03519932|100537269|FG001|COMPLETED|First Intervention||22||
48088365|NCT03519932|100537268|FG000|NOT COMPLETED|First Intervention||1||
48088366|NCT03519932|100537269|FG001|NOT COMPLETED|First Intervention||3||
48088367|NCT03519932|100537268|FG000|STARTED|Second Intervention||22||
48088368|NCT03519932|100537269|FG001|STARTED|Second Intervention||23||
48088369|NCT03519932|100537268|FG000|COMPLETED|Second Intervention||22||
48088370|NCT03519932|100537269|FG001|COMPLETED|Second Intervention||23||
48088371|NCT03519932|100537268|FG000|NOT COMPLETED|Second Intervention||0||
48088372|NCT03519932|100537269|FG001|NOT COMPLETED|Second Intervention||0||
48088373|NCT02663232|100537270|FG000|STARTED|Overall Study||264||
48088374|NCT02663232|100537270|FG000|COMPLETED|Overall Study||264||
48250702|NCT02600897|100931177|FG003|Pharmacokinetic-evaluable Population|Overall Study||6|The pharmacokinetic-evaluable population included all participants who received at least one dose of any component of the combination and who provided at least one suitable postdose PK sample.|
48250703|NCT02600897|100931178|FG004|Pharmacokinetic-evaluable Population|Overall Study||3|The pharmacokinetic-evaluable population included all participants who received at least one dose of any component of the combination and who provided at least one suitable postdose PK sample.|
48250704|NCT02600897|100931179|FG005|Pharmacokinetic-evaluable Population|Overall Study||5|The pharmacokinetic-evaluable population included all participants who received at least one dose of any component of the combination and who provided at least one suitable postdose PK sample.|
48250705|NCT02600897|100931180|FG006|Pharmacokinetic-evaluable Population|Overall Study||10|The pharmacokinetic-evaluable population included all participants who received at least one dose of any component of the combination and who provided at least one suitable postdose PK sample.|
48377844|NCT02898207|101252077|FG005|COMPLETED|Dose Level 0||0||
48377845|NCT02898207|101252072|FG000|NOT COMPLETED|Dose Level 0||0||
48377846|NCT02898207|101252073|FG001|NOT COMPLETED|Dose Level 0||0||
48377847|NCT02898207|101252074|FG002|NOT COMPLETED|Dose Level 0||0||
48088375|NCT02663232|100537270|FG000|NOT COMPLETED|Overall Study||0||
48088376|NCT00459953|100537271|FG000|STARTED|Overall Study||72||
48088377|NCT00459953|100537272|FG001|STARTED|Overall Study||71||
48088378|NCT00459953|100537271|FG000|COMPLETED|Overall Study||71||
48088379|NCT00459953|100537272|FG001|COMPLETED|Overall Study||70||
48088380|NCT00459953|100537271|FG000|NOT COMPLETED|Overall Study||1||
48088381|NCT00459953|100537272|FG001|NOT COMPLETED|Overall Study||1||
48088382|NCT02899988|100537273|FG000|STARTED|Induction Period (16 Weeks)||52||
48088383|NCT02899988|100537274|FG001|STARTED|Induction Period (16 Weeks)||51||
48088384|NCT02899988|100537275|FG002|STARTED|Induction Period (16 Weeks)||51||
48088385|NCT02899988|100537276|FG003|STARTED|Induction Period (16 Weeks)||51||
48088386|NCT02899988|100537277|FG004|STARTED|Induction Period (16 Weeks)||0||
48088387|NCT02899988|100537278|FG005|STARTED|Induction Period (16 Weeks)||0||
48088388|NCT02899988|100537279|FG006|STARTED|Induction Period (16 Weeks)||0||
48088389|NCT02899988|100537280|FG007|STARTED|Induction Period (16 Weeks)||0||
48088390|NCT02899988|100537281|FG008|STARTED|Induction Period (16 Weeks)||0||
48088391|NCT02899988|100537282|FG009|STARTED|Induction Period (16 Weeks)||0||
48088392|NCT02899988|100537283|FG010|STARTED|Induction Period (16 Weeks)||0||
48088393|NCT02899988|100537273|FG000|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||52||
48088394|NCT02899988|100537274|FG001|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51||
48088395|NCT02899988|100537275|FG002|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51||
48088396|NCT02899988|100537276|FG003|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51||
48088397|NCT02899988|100537277|FG004|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
48088398|NCT02899988|100537278|FG005|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
48088399|NCT02899988|100537279|FG006|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
48088400|NCT02899988|100537280|FG007|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
48088401|NCT02899988|100537281|FG008|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
48088402|NCT02899988|100537282|FG009|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
48088403|NCT02899988|100537283|FG010|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
48088404|NCT02899988|100537273|FG000|COMPLETED|Induction Period (16 Weeks)||50||
48088405|NCT02899988|100537274|FG001|COMPLETED|Induction Period (16 Weeks)||49||
48088406|NCT02899988|100537275|FG002|COMPLETED|Induction Period (16 Weeks)||51||
48088407|NCT02899988|100537276|FG003|COMPLETED|Induction Period (16 Weeks)||49||
48088408|NCT02899988|100537277|FG004|COMPLETED|Induction Period (16 Weeks)||0||
48088409|NCT02899988|100537278|FG005|COMPLETED|Induction Period (16 Weeks)||0||
48088410|NCT02899988|100537279|FG006|COMPLETED|Induction Period (16 Weeks)||0||
48088411|NCT02899988|100537280|FG007|COMPLETED|Induction Period (16 Weeks)||0||
48377848|NCT02898207|101252075|FG003|NOT COMPLETED|Dose Level 0||0||
48377849|NCT02898207|101252076|FG004|NOT COMPLETED|Dose Level 0||0||
48088412|NCT02899988|100537281|FG008|COMPLETED|Induction Period (16 Weeks)||0||
48088413|NCT02899988|100537282|FG009|COMPLETED|Induction Period (16 Weeks)||0||
48088414|NCT02899988|100537283|FG010|COMPLETED|Induction Period (16 Weeks)||0||
48088415|NCT02899988|100537273|FG000|NOT COMPLETED|Induction Period (16 Weeks)||2||
48088416|NCT02899988|100537274|FG001|NOT COMPLETED|Induction Period (16 Weeks)||2||
48088417|NCT02899988|100537275|FG002|NOT COMPLETED|Induction Period (16 Weeks)||0||
48088418|NCT02899988|100537276|FG003|NOT COMPLETED|Induction Period (16 Weeks)||2||
48088419|NCT02899988|100537277|FG004|NOT COMPLETED|Induction Period (16 Weeks)||0||
48088420|NCT02899988|100537278|FG005|NOT COMPLETED|Induction Period (16 Weeks)||0||
48088421|NCT02899988|100537279|FG006|NOT COMPLETED|Induction Period (16 Weeks)||0||
48088422|NCT02899988|100537280|FG007|NOT COMPLETED|Induction Period (16 Weeks)||0||
48088423|NCT02899988|100537281|FG008|NOT COMPLETED|Induction Period (16 Weeks)||0||
48088424|NCT02899988|100537282|FG009|NOT COMPLETED|Induction Period (16 Weeks)||0||
48088425|NCT02899988|100537283|FG010|NOT COMPLETED|Induction Period (16 Weeks)||0||
48088426|NCT02899988|100537273|FG000|STARTED|Maintenance Period (88 Weeks)||0||
48088427|NCT02899988|100537274|FG001|STARTED|Maintenance Period (88 Weeks)||0||
48088428|NCT02899988|100537275|FG002|STARTED|Maintenance Period (88 Weeks)||0||
48088429|NCT02899988|100537276|FG003|STARTED|Maintenance Period (88 Weeks)||0||
48088430|NCT02899988|100537277|FG004|STARTED|Maintenance Period (88 Weeks)||15||
48088431|NCT02899988|100537278|FG005|STARTED|Maintenance Period (88 Weeks)||30||
48088432|NCT02899988|100537279|FG006|STARTED|Maintenance Period (88 Weeks)||34||
48088433|NCT02899988|100537280|FG007|STARTED|Maintenance Period (88 Weeks)||50||
48088434|NCT02899988|100537281|FG008|STARTED|Maintenance Period (88 Weeks)||34||
48088435|NCT02899988|100537282|FG009|STARTED|Maintenance Period (88 Weeks)||21||
48088436|NCT02899988|100537283|FG010|STARTED|Maintenance Period (88 Weeks)||15||
48088437|NCT02899988|100537273|FG000|Rescue Participants|Maintenance Period (88 Weeks)||0||
48088438|NCT02899988|100537274|FG001|Rescue Participants|Maintenance Period (88 Weeks)||0||
48088439|NCT02899988|100537275|FG002|Rescue Participants|Maintenance Period (88 Weeks)||0||
48088440|NCT02899988|100537276|FG003|Rescue Participants|Maintenance Period (88 Weeks)||10||
48088441|NCT02899988|100537277|FG004|Rescue Participants|Maintenance Period (88 Weeks)||0||
48088442|NCT02899988|100537278|FG005|Rescue Participants|Maintenance Period (88 Weeks)||0||
48088443|NCT02899988|100537279|FG006|Rescue Participants|Maintenance Period (88 Weeks)||0||
48377850|NCT02898207|101252077|FG005|NOT COMPLETED|Dose Level 0||0||
48377851|NCT02898207|101252072|FG000|STARTED|Dose Level 1||0||
48377852|NCT02898207|101252073|FG001|STARTED|Dose Level 1||4||
48377853|NCT02898207|101252074|FG002|STARTED|Dose Level 1||0||
48377854|NCT02898207|101252075|FG003|STARTED|Dose Level 1||0||
48088444|NCT02899988|100537280|FG007|Rescue Participants|Maintenance Period (88 Weeks)||0||
48088445|NCT02899988|100537281|FG008|Rescue Participants|Maintenance Period (88 Weeks)||0||
48088446|NCT02899988|100537282|FG009|Rescue Participants|Maintenance Period (88 Weeks)||0||
48088447|NCT02899988|100537283|FG010|Rescue Participants|Maintenance Period (88 Weeks)||0||
48088448|NCT02899988|100537273|FG000|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0||
48088449|NCT02899988|100537274|FG001|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0||
48088450|NCT02899988|100537275|FG002|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0||
48088451|NCT02899988|100537276|FG003|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||13||
48088452|NCT02899988|100537277|FG004|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||9||
48088453|NCT02899988|100537278|FG005|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||18||
48088454|NCT02899988|100537279|FG006|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||26||
48088455|NCT02899988|100537280|FG007|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||42||
48088456|NCT02899988|100537281|FG008|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||24||
48088457|NCT02899988|100537282|FG009|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||17||
48088458|NCT02899988|100537283|FG010|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0||
48088459|NCT02899988|100537273|FG000|COMPLETED|Maintenance Period (88 Weeks)||0||
48088460|NCT02899988|100537274|FG001|COMPLETED|Maintenance Period (88 Weeks)||0||
48088461|NCT02899988|100537275|FG002|COMPLETED|Maintenance Period (88 Weeks)||0||
48088462|NCT02899988|100537276|FG003|COMPLETED|Maintenance Period (88 Weeks)||0||
48088463|NCT02899988|100537277|FG004|COMPLETED|Maintenance Period (88 Weeks)||13||
48088464|NCT02899988|100537278|FG005|COMPLETED|Maintenance Period (88 Weeks)||27||
48088465|NCT02899988|100537279|FG006|COMPLETED|Maintenance Period (88 Weeks)||30||
48088466|NCT02899988|100537280|FG007|COMPLETED|Maintenance Period (88 Weeks)||45||
48088467|NCT02899988|100537281|FG008|COMPLETED|Maintenance Period (88 Weeks)||30||
48088468|NCT02899988|100537282|FG009|COMPLETED|Maintenance Period (88 Weeks)||19||
48088469|NCT02899988|100537283|FG010|COMPLETED|Maintenance Period (88 Weeks)||13||
48377855|NCT02898207|101252076|FG004|STARTED|Dose Level 1||0||
48377856|NCT02898207|101252077|FG005|STARTED|Dose Level 1||0||
48377857|NCT02898207|101252072|FG000|COMPLETED|Dose Level 1||0||
48377858|NCT02898207|101252073|FG001|COMPLETED|Dose Level 1||4||
48088470|NCT02899988|100537273|FG000|NOT COMPLETED|Maintenance Period (88 Weeks)||0||
48088471|NCT02899988|100537274|FG001|NOT COMPLETED|Maintenance Period (88 Weeks)||0||
48088472|NCT02899988|100537275|FG002|NOT COMPLETED|Maintenance Period (88 Weeks)||0||
48088473|NCT02899988|100537276|FG003|NOT COMPLETED|Maintenance Period (88 Weeks)||0||
48377859|NCT02898207|101252074|FG002|COMPLETED|Dose Level 1||0||
48377860|NCT02898207|101252075|FG003|COMPLETED|Dose Level 1||0||
48088474|NCT02899988|100537277|FG004|NOT COMPLETED|Maintenance Period (88 Weeks)||2||
48088475|NCT02899988|100537278|FG005|NOT COMPLETED|Maintenance Period (88 Weeks)||3||
48088476|NCT02899988|100537279|FG006|NOT COMPLETED|Maintenance Period (88 Weeks)||4||
48088477|NCT02899988|100537280|FG007|NOT COMPLETED|Maintenance Period (88 Weeks)||5||
48377861|NCT02898207|101252076|FG004|COMPLETED|Dose Level 1||0||
48377862|NCT02898207|101252077|FG005|COMPLETED|Dose Level 1||0||
48377863|NCT02898207|101252072|FG000|NOT COMPLETED|Dose Level 1||0||
48377864|NCT02898207|101252073|FG001|NOT COMPLETED|Dose Level 1||0||
48088478|NCT02899988|100537281|FG008|NOT COMPLETED|Maintenance Period (88 Weeks)||4||
48088479|NCT02899988|100537282|FG009|NOT COMPLETED|Maintenance Period (88 Weeks)||2||
48088480|NCT02899988|100537283|FG010|NOT COMPLETED|Maintenance Period (88 Weeks)||2||
48088481|NCT02899988|100537273|FG000|STARTED|Follow-Up (16 Weeks)||0||
48088482|NCT02899988|100537274|FG001|STARTED|Follow-Up (16 Weeks)||0||
48088483|NCT02899988|100537275|FG002|STARTED|Follow-Up (16 Weeks)||0||
48088484|NCT02899988|100537276|FG003|STARTED|Follow-Up (16 Weeks)||0||
48088485|NCT02899988|100537277|FG004|STARTED|Follow-Up (16 Weeks)||2||
48088486|NCT02899988|100537278|FG005|STARTED|Follow-Up (16 Weeks)||4||
48088487|NCT02899988|100537279|FG006|STARTED|Follow-Up (16 Weeks)||3||
48088488|NCT02899988|100537280|FG007|STARTED|Follow-Up (16 Weeks)||3||
48088489|NCT02899988|100537281|FG008|STARTED|Follow-Up (16 Weeks)||6||
48088490|NCT02899988|100537282|FG009|STARTED|Follow-Up (16 Weeks)||2||
48088491|NCT02899988|100537283|FG010|STARTED|Follow-Up (16 Weeks)||0||
48088492|NCT02899988|100537273|FG000|COMPLETED|Follow-Up (16 Weeks)||0||
48088493|NCT02899988|100537274|FG001|COMPLETED|Follow-Up (16 Weeks)||0||
48088494|NCT02899988|100537275|FG002|COMPLETED|Follow-Up (16 Weeks)||0||
48088495|NCT02899988|100537276|FG003|COMPLETED|Follow-Up (16 Weeks)||0||
48088496|NCT02899988|100537277|FG004|COMPLETED|Follow-Up (16 Weeks)||2||
48088497|NCT02899988|100537278|FG005|COMPLETED|Follow-Up (16 Weeks)||4||
48088498|NCT02899988|100537279|FG006|COMPLETED|Follow-Up (16 Weeks)||3||
48088499|NCT02899988|100537280|FG007|COMPLETED|Follow-Up (16 Weeks)||3||
48088500|NCT02899988|100537281|FG008|COMPLETED|Follow-Up (16 Weeks)||6||
48088501|NCT02899988|100537282|FG009|COMPLETED|Follow-Up (16 Weeks)||2||
48088502|NCT02899988|100537283|FG010|COMPLETED|Follow-Up (16 Weeks)||0||
48088503|NCT02899988|100537273|FG000|NOT COMPLETED|Follow-Up (16 Weeks)||0||
48088504|NCT02899988|100537274|FG001|NOT COMPLETED|Follow-Up (16 Weeks)||0||
48088505|NCT02899988|100537275|FG002|NOT COMPLETED|Follow-Up (16 Weeks)||0||
48088506|NCT02899988|100537276|FG003|NOT COMPLETED|Follow-Up (16 Weeks)||0||
48088507|NCT02899988|100537277|FG004|NOT COMPLETED|Follow-Up (16 Weeks)||0||
48088508|NCT02899988|100537278|FG005|NOT COMPLETED|Follow-Up (16 Weeks)||0||
48088509|NCT02899988|100537279|FG006|NOT COMPLETED|Follow-Up (16 Weeks)||0||
48088510|NCT02899988|100537280|FG007|NOT COMPLETED|Follow-Up (16 Weeks)||0||
48088511|NCT02899988|100537281|FG008|NOT COMPLETED|Follow-Up (16 Weeks)||0||
48088512|NCT02899988|100537282|FG009|NOT COMPLETED|Follow-Up (16 Weeks)||0||
48088513|NCT02899988|100537283|FG010|NOT COMPLETED|Follow-Up (16 Weeks)||0||
48377865|NCT02898207|101252074|FG002|NOT COMPLETED|Dose Level 1||0||
48377866|NCT02898207|101252075|FG003|NOT COMPLETED|Dose Level 1||0||
48377867|NCT02898207|101252076|FG004|NOT COMPLETED|Dose Level 1||0||
48377868|NCT02898207|101252077|FG005|NOT COMPLETED|Dose Level 1||0||
48377869|NCT02898207|101252072|FG000|STARTED|Dose Level 2||0||
48377870|NCT02898207|101252073|FG001|STARTED|Dose Level 2||0||
48377871|NCT02898207|101252074|FG002|STARTED|Dose Level 2||6||
48088514|NCT00573534|100537284|FG000|STARTED|Overall Study||8||
48088515|NCT00573534|100537284|FG000|COMPLETED|Overall Study||5||
48088516|NCT00573534|100537284|FG000|NOT COMPLETED|Overall Study||3||
48088517|NCT01463878|100537285|FG000|STARTED|Overall Study||9||
48088518|NCT01463878|100537286|FG001|STARTED|Overall Study||9||
48088519|NCT01463878|100537285|FG000|COMPLETED|Overall Study||7||
48088520|NCT01463878|100537286|FG001|COMPLETED|Overall Study||7||
48088521|NCT01463878|100537285|FG000|NOT COMPLETED|Overall Study||2||
48088522|NCT01463878|100537286|FG001|NOT COMPLETED|Overall Study||2||
48377872|NCT02898207|101252075|FG003|STARTED|Dose Level 2||0||
48377873|NCT02898207|101252076|FG004|STARTED|Dose Level 2||0||
48377874|NCT02898207|101252077|FG005|STARTED|Dose Level 2||0||
48088523|NCT02421315|100537287|FG000|STARTED|Overall Study||28||
48088524|NCT02421315|100537288|FG001|STARTED|Overall Study||27||
48088525|NCT02421315|100537287|FG000|COMPLETED|Overall Study||23||
48088526|NCT02421315|100537288|FG001|COMPLETED|Overall Study||15||
48088527|NCT02421315|100537287|FG000|NOT COMPLETED|Overall Study||5||
48088528|NCT02421315|100537288|FG001|NOT COMPLETED|Overall Study||12||
48088529|NCT01782495|100537289|FG000|STARTED|Overall Study||34||
48088530|NCT01782495|100537290|FG001|STARTED|Overall Study||27||
48377875|NCT02898207|101252072|FG000|COMPLETED|Dose Level 2||0||
48088531|NCT01782495|100537291|FG002|STARTED|Overall Study||13||
48377876|NCT02898207|101252073|FG001|COMPLETED|Dose Level 2||0||
48088532|NCT01782495|100537292|FG003|STARTED|Overall Study||4||
48088533|NCT01782495|100537293|FG004|STARTED|Overall Study||2||
48088534|NCT01782495|100537294|FG005|STARTED|Overall Study||22||
48088535|NCT01782495|100537295|FG006|STARTED|Overall Study||12||
48088536|NCT01782495|100537296|FG007|STARTED|Overall Study||9||
48377877|NCT02898207|101252074|FG002|COMPLETED|Dose Level 2||6||
48377878|NCT02898207|101252075|FG003|COMPLETED|Dose Level 2||0||
48377879|NCT02898207|101252076|FG004|COMPLETED|Dose Level 2||0||
48377880|NCT02898207|101252077|FG005|COMPLETED|Dose Level 2||0||
48377881|NCT02898207|101252072|FG000|NOT COMPLETED|Dose Level 2||0||
48377882|NCT02898207|101252073|FG001|NOT COMPLETED|Dose Level 2||0||
48377883|NCT02898207|101252074|FG002|NOT COMPLETED|Dose Level 2||0||
48377884|NCT02898207|101252075|FG003|NOT COMPLETED|Dose Level 2||0||
48377885|NCT02898207|101252076|FG004|NOT COMPLETED|Dose Level 2||0||
48377886|NCT02898207|101252077|FG005|NOT COMPLETED|Dose Level 2||0||
48377887|NCT02898207|101252072|FG000|STARTED|Dose Level 3||0||
48377888|NCT02898207|101252073|FG001|STARTED|Dose Level 3||0||
48377889|NCT02898207|101252074|FG002|STARTED|Dose Level 3||0||
48377890|NCT02898207|101252075|FG003|STARTED|Dose Level 3||7||
48377891|NCT02898207|101252076|FG004|STARTED|Dose Level 3||0||
48377892|NCT02898207|101252077|FG005|STARTED|Dose Level 3||0||
48377893|NCT02898207|101252072|FG000|COMPLETED|Dose Level 3||0||
48377894|NCT02898207|101252073|FG001|COMPLETED|Dose Level 3||0||
48377895|NCT02898207|101252074|FG002|COMPLETED|Dose Level 3||0||
48377896|NCT02898207|101252075|FG003|COMPLETED|Dose Level 3||7||
48377897|NCT02898207|101252076|FG004|COMPLETED|Dose Level 3||0||
48377898|NCT02898207|101252077|FG005|COMPLETED|Dose Level 3||0||
48377899|NCT02898207|101252072|FG000|NOT COMPLETED|Dose Level 3||0||
48377900|NCT02898207|101252073|FG001|NOT COMPLETED|Dose Level 3||0||
48377901|NCT02898207|101252074|FG002|NOT COMPLETED|Dose Level 3||0||
48377902|NCT02898207|101252075|FG003|NOT COMPLETED|Dose Level 3||0||
48377903|NCT02898207|101252076|FG004|NOT COMPLETED|Dose Level 3||0||
48377904|NCT02898207|101252077|FG005|NOT COMPLETED|Dose Level 3||0||
48377905|NCT02898207|101252072|FG000|STARTED|Dose Level 2a||0||
48377906|NCT02898207|101252073|FG001|STARTED|Dose Level 2a||0||
48377907|NCT02898207|101252074|FG002|STARTED|Dose Level 2a||0||
48377908|NCT02898207|101252075|FG003|STARTED|Dose Level 2a||0||
48377909|NCT02898207|101252076|FG004|STARTED|Dose Level 2a||3||
48377910|NCT02898207|101252077|FG005|STARTED|Dose Level 2a||0||
48377911|NCT02898207|101252072|FG000|COMPLETED|Dose Level 2a||0||
48377912|NCT02898207|101252073|FG001|COMPLETED|Dose Level 2a||0||
48377913|NCT02898207|101252074|FG002|COMPLETED|Dose Level 2a||0||
48377914|NCT02898207|101252075|FG003|COMPLETED|Dose Level 2a||0||
48377915|NCT02898207|101252076|FG004|COMPLETED|Dose Level 2a||3||
48377916|NCT02898207|101252077|FG005|COMPLETED|Dose Level 2a||0||
48377917|NCT02898207|101252072|FG000|NOT COMPLETED|Dose Level 2a||0||
48377918|NCT02898207|101252073|FG001|NOT COMPLETED|Dose Level 2a||0||
48377919|NCT02898207|101252074|FG002|NOT COMPLETED|Dose Level 2a||0||
48377920|NCT02898207|101252075|FG003|NOT COMPLETED|Dose Level 2a||0||
48377921|NCT02898207|101252076|FG004|NOT COMPLETED|Dose Level 2a||0||
48377922|NCT02898207|101252077|FG005|NOT COMPLETED|Dose Level 2a||0||
48377923|NCT02898207|101252072|FG000|STARTED|Dose Level 3a||0||
48377924|NCT02898207|101252073|FG001|STARTED|Dose Level 3a||0||
48377925|NCT02898207|101252074|FG002|STARTED|Dose Level 3a||0||
48377926|NCT02898207|101252075|FG003|STARTED|Dose Level 3a||0||
48377927|NCT02898207|101252076|FG004|STARTED|Dose Level 3a||0||
48377928|NCT02898207|101252077|FG005|STARTED|Dose Level 3a||5||
48377929|NCT02898207|101252072|FG000|COMPLETED|Dose Level 3a||0||
48377930|NCT02898207|101252073|FG001|COMPLETED|Dose Level 3a||0||
48377931|NCT02898207|101252074|FG002|COMPLETED|Dose Level 3a||0||
48377932|NCT02898207|101252075|FG003|COMPLETED|Dose Level 3a||0||
48377933|NCT02898207|101252076|FG004|COMPLETED|Dose Level 3a||0||
48377934|NCT02898207|101252077|FG005|COMPLETED|Dose Level 3a||5||
48377935|NCT02898207|101252072|FG000|NOT COMPLETED|Dose Level 3a||0||
48377936|NCT02898207|101252073|FG001|NOT COMPLETED|Dose Level 3a||0||
48377937|NCT02898207|101252074|FG002|NOT COMPLETED|Dose Level 3a||0||
48377938|NCT02898207|101252075|FG003|NOT COMPLETED|Dose Level 3a||0||
48377939|NCT02898207|101252076|FG004|NOT COMPLETED|Dose Level 3a||0||
48377940|NCT02898207|101252077|FG005|NOT COMPLETED|Dose Level 3a||0||
48377941|NCT01111539|101252078|FG000|STARTED|Phase B (Day 1 to Week 8)||211||
48377942|NCT01111539|101252079|FG001|STARTED|Phase B (Day 1 to Week 8)||0||
48377943|NCT01111539|101252080|FG002|STARTED|Phase B (Day 1 to Week 8)||0||
48377944|NCT01111539|101252081|FG003|STARTED|Phase B (Day 1 to Week 8)||0||
48377945|NCT01111539|101252082|FG004|STARTED|Phase B (Day 1 to Week 8)||0||
48377946|NCT01111539|101252078|FG000|COMPLETED|Phase B (Day 1 to Week 8)||129||
48377947|NCT01111539|101252079|FG001|COMPLETED|Phase B (Day 1 to Week 8)||0||
48377948|NCT01111539|101252080|FG002|COMPLETED|Phase B (Day 1 to Week 8)||0||
48377949|NCT01111539|101252081|FG003|COMPLETED|Phase B (Day 1 to Week 8)||0||
48377950|NCT01111539|101252082|FG004|COMPLETED|Phase B (Day 1 to Week 8)||0||
48377951|NCT01111539|101252078|FG000|NOT COMPLETED|Phase B (Day 1 to Week 8)||82||
48377952|NCT01111539|101252079|FG001|NOT COMPLETED|Phase B (Day 1 to Week 8)||0||
48377953|NCT01111539|101252080|FG002|NOT COMPLETED|Phase B (Day 1 to Week 8)||0||
48377954|NCT01111539|101252081|FG003|NOT COMPLETED|Phase B (Day 1 to Week 8)||0||
48377955|NCT01111539|101252082|FG004|NOT COMPLETED|Phase B (Day 1 to Week 8)||0||
48377956|NCT01111539|101252078|FG000|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||0||
48377957|NCT01111539|101252079|FG001|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||45||
48377958|NCT01111539|101252080|FG002|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||28||
48377959|NCT01111539|101252081|FG003|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||28||
48377960|NCT01111539|101252082|FG004|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||28||
48404069|NCT03689972|101321766|FG000|COMPLETED|Part 1 (Day 1 up to Week 72)||194|Completed denotes the participants that completed the study treatment.|
48377961|NCT01111539|101252078|FG000|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||0|ITT Sample included all participants in the Randomized Sample who received at least one dose of double-blind study medication and had at least one post-randomization efficacy evaluation.|
48377962|NCT01111539|101252079|FG001|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||45|ITT Sample included all participants in the Randomized Sample who received at least one dose of double-blind study medication and had at least one post-randomization efficacy evaluation.|
48377963|NCT01111539|101252080|FG002|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||28|ITT Sample included all participants in the Randomized Sample who received at least one dose of double-blind study medication and had at least one post-randomization efficacy evaluation.|
48377964|NCT01111539|101252081|FG003|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||27|ITT Sample included all participants in the Randomized Sample who received at least one dose of double-blind study medication and had at least one post-randomization efficacy evaluation.|
48377965|NCT01111539|101252082|FG004|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||28|ITT Sample included all participants in the Randomized Sample who received at least one dose of double-blind study medication and had at least one post-randomization efficacy evaluation.|
48377966|NCT01111539|101252078|FG000|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||0|Safety Sample included those randomized participants in Phase C who received at least one dose of double-blind study medication as indicated on the dosing record.|
48377967|NCT01111539|101252079|FG001|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||45|Safety Sample included those randomized participants in Phase C who received at least one dose of double-blind study medication as indicated on the dosing record.|
48377968|NCT01111539|101252080|FG002|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||28|Safety Sample included those randomized participants in Phase C who received at least one dose of double-blind study medication as indicated on the dosing record.|
48377969|NCT01111539|101252081|FG003|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||27|Safety Sample included those randomized participants in Phase C who received at least one dose of double-blind study medication as indicated on the dosing record.|
48377970|NCT01111539|101252082|FG004|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||28|Safety Sample included those randomized participants in Phase C who received at least one dose of double-blind study medication as indicated on the dosing record.|
48377971|NCT01111539|101252078|FG000|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0||
48377972|NCT01111539|101252079|FG001|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||38||
48377973|NCT01111539|101252080|FG002|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||22||
48377974|NCT01111539|101252081|FG003|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||20||
48377975|NCT01111539|101252082|FG004|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||18||
48377976|NCT01111539|101252078|FG000|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0||
48377977|NCT01111539|101252079|FG001|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||7||
48377978|NCT01111539|101252080|FG002|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||6||
48377979|NCT01111539|101252081|FG003|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||8||
48377980|NCT01111539|101252082|FG004|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||10||
48377981|NCT03136705|101252083|FG000|STARTED|Overall Study||9||
48377982|NCT03136705|101252084|FG001|STARTED|Overall Study||10||
48377983|NCT03136705|101252085|FG002|STARTED|Overall Study||10||
48377984|NCT03136705|101252086|FG003|STARTED|Overall Study||10||
48377985|NCT03136705|101252083|FG000|COMPLETED|Overall Study||9||
48377986|NCT03136705|101252084|FG001|COMPLETED|Overall Study||10||
48377987|NCT03136705|101252085|FG002|COMPLETED|Overall Study||10||
48377988|NCT03136705|101252086|FG003|COMPLETED|Overall Study||9||
48377989|NCT03136705|101252083|FG000|NOT COMPLETED|Overall Study||0||
48377990|NCT03136705|101252084|FG001|NOT COMPLETED|Overall Study||0||
48377991|NCT03136705|101252085|FG002|NOT COMPLETED|Overall Study||0||
48377992|NCT03136705|101252086|FG003|NOT COMPLETED|Overall Study||1||
48377993|NCT00385268|101252087|FG000|STARTED|Overall Study||34||
48377994|NCT00385268|101252088|FG001|STARTED|Overall Study||26||
48377995|NCT00385268|101252087|FG000|COMPLETED|Overall Study||18||
48377996|NCT00385268|101252088|FG001|COMPLETED|Overall Study||18||
48377997|NCT00385268|101252087|FG000|NOT COMPLETED|Overall Study||16||
48377998|NCT00385268|101252088|FG001|NOT COMPLETED|Overall Study||8||
48377999|NCT00400829|101252089|FG000|STARTED|Overall Study||66||
48378000|NCT00400829|101252089|FG000|COMPLETED|Overall Study||66||
48378001|NCT00400829|101252089|FG000|NOT COMPLETED|Overall Study||0||
48378002|NCT02969317|101252090|FG000|STARTED|Overall Study||12||
48378003|NCT02969317|101252090|FG000|COMPLETED|Overall Study||12||
48378004|NCT02969317|101252090|FG000|NOT COMPLETED|Overall Study||0||
48378005|NCT01016106|101252091|FG000|STARTED|Overall Study||17||
48378006|NCT01016106|101252092|FG001|STARTED|Overall Study||18||
48378007|NCT01016106|101252091|FG000|COMPLETED|Overall Study||17||
48378008|NCT01016106|101252092|FG001|COMPLETED|Overall Study||18||
48378009|NCT01016106|101252091|FG000|NOT COMPLETED|Overall Study||0||
48378010|NCT01016106|101252092|FG001|NOT COMPLETED|Overall Study||0||
48378011|NCT01672996|101252093|FG000|STARTED|Overall Study||30||
48378012|NCT01672996|101252094|FG001|STARTED|Overall Study||30||
48378013|NCT01672996|101252095|FG002|STARTED|Overall Study||6||
48378014|NCT01672996|101252093|FG000|COMPLETED|Overall Study||30||
48378015|NCT01672996|101252094|FG001|COMPLETED|Overall Study||30||
48378016|NCT01672996|101252095|FG002|COMPLETED|Overall Study||6||
48378017|NCT01672996|101252093|FG000|NOT COMPLETED|Overall Study||0||
48378018|NCT01672996|101252094|FG001|NOT COMPLETED|Overall Study||0||
48378019|NCT01672996|101252095|FG002|NOT COMPLETED|Overall Study||0||
48378020|NCT02855411|101252096|FG000|STARTED|Overall Study||35||
48541199|NCT00229723|101662680|FG000|COMPLETED|Concomitant Phase||50||
48378021|NCT02855411|101252096|FG000|Assigned to Study Treatment|Overall Study||0||
48378022|NCT02855411|101252096|FG000|COMPLETED|Overall Study||0||
48378023|NCT02855411|101252096|FG000|NOT COMPLETED|Overall Study||35||
48378024|NCT01850745|101252097|FG000|STARTED|Overall Study||147||
48378025|NCT01850745|101252098|FG001|STARTED|Overall Study||169||
48378026|NCT01850745|101252099|FG002|STARTED|Overall Study||131||
48378027|NCT01850745|101252097|FG000|COMPLETED|Overall Study||147||
48378028|NCT01850745|101252098|FG001|COMPLETED|Overall Study||169||
48378029|NCT01850745|101252099|FG002|COMPLETED|Overall Study||131||
48378030|NCT01850745|101252097|FG000|NOT COMPLETED|Overall Study||0||
48684222|NCT05173974|102009689|FG003|COMPLETED|Period 4 (Visit 5, 1 Day)||10||
48684223|NCT05173974|102009686|FG000|NOT COMPLETED|Period 4 (Visit 5, 1 Day)||0||
48684224|NCT05173974|102009687|FG001|NOT COMPLETED|Period 4 (Visit 5, 1 Day)||1||
48684225|NCT05173974|102009688|FG002|NOT COMPLETED|Period 4 (Visit 5, 1 Day)||0||
48684226|NCT05173974|102009689|FG003|NOT COMPLETED|Period 4 (Visit 5, 1 Day)||0||
48250706|NCT02600897|100931181|FG007|Pharmacokinetic-evaluable Population|Overall Study||40|The pharmacokinetic-evaluable population included all participants who received at least one dose of any component of the combination and who provided at least one suitable postdose PK sample.|
48250707|NCT02600897|100931182|FG008|Pharmacokinetic-evaluable Population|Overall Study||39|The pharmacokinetic-evaluable population included all participants who received at least one dose of any component of the combination and who provided at least one suitable postdose PK sample.|
48250708|NCT02600897|100931174|FG000|COMPLETED|Overall Study||1||
48250709|NCT02600897|100931175|FG001|COMPLETED|Overall Study||2||
48250710|NCT02600897|100931176|FG002|COMPLETED|Overall Study||2||
48250711|NCT02600897|100931177|FG003|COMPLETED|Overall Study||4||
48250712|NCT02600897|100931178|FG004|COMPLETED|Overall Study||0||
48250713|NCT02600897|100931179|FG005|COMPLETED|Overall Study||3||
48250714|NCT02600897|100931180|FG006|COMPLETED|Overall Study||0||
48250715|NCT02600897|100931181|FG007|COMPLETED|Overall Study||28||
48250716|NCT02600897|100931182|FG008|COMPLETED|Overall Study||17||
48250717|NCT02600897|100931174|FG000|NOT COMPLETED|Overall Study||2||
48250718|NCT02600897|100931175|FG001|NOT COMPLETED|Overall Study||2||
48250719|NCT02600897|100931176|FG002|NOT COMPLETED|Overall Study||1||
48250720|NCT02600897|100931177|FG003|NOT COMPLETED|Overall Study||2||
48250721|NCT02600897|100931178|FG004|NOT COMPLETED|Overall Study||3||
48250722|NCT02600897|100931179|FG005|NOT COMPLETED|Overall Study||2||
48250723|NCT02600897|100931180|FG006|NOT COMPLETED|Overall Study||10||
48378031|NCT01850745|101252098|FG001|NOT COMPLETED|Overall Study||0||
48378032|NCT01850745|101252099|FG002|NOT COMPLETED|Overall Study||0||
48378033|NCT01830543|101252100|FG000|STARTED|Overall Study||709||
48378034|NCT01830543|101252101|FG001|STARTED|Overall Study||709||
48378035|NCT01830543|101252102|FG002|STARTED|Overall Study||706||
48378036|NCT01830543|101252100|FG000|Treated|Overall Study||696||
48378037|NCT01830543|101252101|FG001|Treated|Overall Study||706||
48378038|NCT01830543|101252102|FG002|Treated|Overall Study||697||
48378039|NCT01830543|101252100|FG000|COMPLETED|Overall Study||550||
48378040|NCT01830543|101252101|FG001|COMPLETED|Overall Study||557||
48378041|NCT01830543|101252102|FG002|COMPLETED|Overall Study||492||
48378042|NCT01830543|101252100|FG000|NOT COMPLETED|Overall Study||159||
48378043|NCT01830543|101252101|FG001|NOT COMPLETED|Overall Study||152||
48684227|NCT00363311|102009690|FG000|STARTED|Overall Study||155||
48250724|NCT02600897|100931181|FG007|NOT COMPLETED|Overall Study||12||
48250725|NCT02600897|100931182|FG008|NOT COMPLETED|Overall Study||23||
48250726|NCT01341444|100931183|FG000|STARTED|Overall Study||31||
48250727|NCT01341444|100931184|FG001|STARTED|Overall Study||32||
48250728|NCT01341444|100931183|FG000|COMPLETED|Overall Study||26||
48684228|NCT00363311|102009691|FG001|STARTED|Overall Study||147||
48250729|NCT01341444|100931184|FG001|COMPLETED|Overall Study||29||
48250730|NCT01341444|100931183|FG000|NOT COMPLETED|Overall Study||5||
48250731|NCT01341444|100931184|FG001|NOT COMPLETED|Overall Study||3||
48250732|NCT01074437|100931185|FG000|STARTED|Overall Study||4||
48250733|NCT01074437|100931186|FG001|STARTED|Overall Study||5||
48250734|NCT01074437|100931185|FG000|COMPLETED|Overall Study||4||
48250735|NCT01074437|100931186|FG001|COMPLETED|Overall Study||5||
48250736|NCT01074437|100931185|FG000|NOT COMPLETED|Overall Study||0||
48250737|NCT01074437|100931186|FG001|NOT COMPLETED|Overall Study||0||
48250738|NCT00096681|100931187|FG000|STARTED|Overall Study||762||
48250739|NCT00096681|100931187|FG000|COMPLETED|Overall Study||762||
48378044|NCT01830543|101252102|FG002|NOT COMPLETED|Overall Study||214||
48378045|NCT02345252|101252103|FG000|STARTED|Double-Blind Phase||316||
48378046|NCT02345252|101252104|FG001|STARTED|Double-Blind Phase||316||
48378047|NCT02345252|101252103|FG000|COMPLETED|Double-Blind Phase||276||
48684229|NCT00363311|102009690|FG000|COMPLETED|Overall Study||79||
48684230|NCT00363311|102009691|FG001|COMPLETED|Overall Study||102||
48250740|NCT00096681|100931187|FG000|NOT COMPLETED|Overall Study||0||
48250741|NCT01747837|100931188|FG000|STARTED|Overall Study||25||
48250742|NCT01747837|100931189|FG001|STARTED|Overall Study||23||
48250743|NCT01747837|100931188|FG000|COMPLETED|Overall Study||16||
48250744|NCT01747837|100931189|FG001|COMPLETED|Overall Study||17||
48250745|NCT01747837|100931188|FG000|NOT COMPLETED|Overall Study||9||
48250746|NCT01747837|100931189|FG001|NOT COMPLETED|Overall Study||6||
48378048|NCT02345252|101252104|FG001|COMPLETED|Double-Blind Phase||267||
48378049|NCT02345252|101252103|FG000|NOT COMPLETED|Double-Blind Phase||40||
48378050|NCT02345252|101252104|FG001|NOT COMPLETED|Double-Blind Phase||49||
48250747|NCT02551692|100934151|FG000|STARTED|Overall Study||31||
48250748|NCT02551692|100934152|FG001|STARTED|Overall Study||27||
48250749|NCT02551692|100934153|FG002|STARTED|Overall Study||30||
48250750|NCT02551692|100934151|FG000|COMPLETED|Overall Study||30||
48378051|NCT02345252|101252103|FG000|STARTED|Open-Label Extension Phase||19||
48378052|NCT02345252|101252104|FG001|STARTED|Open-Label Extension Phase||17||
48378053|NCT02345252|101252103|FG000|COMPLETED|Open-Label Extension Phase||19||
48378054|NCT02345252|101252104|FG001|COMPLETED|Open-Label Extension Phase||17||
48378055|NCT02345252|101252103|FG000|NOT COMPLETED|Open-Label Extension Phase||0||
48378056|NCT02345252|101252104|FG001|NOT COMPLETED|Open-Label Extension Phase||0||
48378057|NCT00258427|101252105|FG000|STARTED|Overall Study||3||
48541200|NCT00229723|101662681|FG001|COMPLETED|Concomitant Phase||19||
48250751|NCT02551692|100934152|FG001|COMPLETED|Overall Study||26||
48250752|NCT02551692|100934153|FG002|COMPLETED|Overall Study||25||
48250753|NCT02551692|100934151|FG000|NOT COMPLETED|Overall Study||1||
48250754|NCT02551692|100934152|FG001|NOT COMPLETED|Overall Study||1||
48250755|NCT02551692|100934153|FG002|NOT COMPLETED|Overall Study||5||
48250756|NCT03461211|100934154|FG000|STARTED|Overall Study||37||
48250757|NCT03461211|100934155|FG001|STARTED|Overall Study||14||
48250758|NCT03461211|100934154|FG000|Proptosis Non-Responders in OPTIC|Overall Study||36||
48250759|NCT03461211|100934155|FG001|Proptosis Non-Responders in OPTIC|Overall Study||5||
48250760|NCT03461211|100934154|FG000|Relapsed During Follow-Up Period of OPTIC|Overall Study||1||
48250761|NCT03461211|100934155|FG001|Relapsed During Follow-Up Period of OPTIC|Overall Study||9||
48250762|NCT03461211|100934154|FG000|COMPLETED|Overall Study||36||
48250763|NCT03461211|100934155|FG001|COMPLETED|Overall Study||12||
48250764|NCT03461211|100934154|FG000|NOT COMPLETED|Overall Study||1||
48250765|NCT03461211|100934155|FG001|NOT COMPLETED|Overall Study||2||
48250766|NCT02657954|100934156|FG000|STARTED|Overall Study||39||
48250767|NCT02657954|100934157|FG001|STARTED|Overall Study||40||
48250768|NCT02657954|100934156|FG000|Received at Least One Session|Overall Study||34||
48250769|NCT02657954|100934157|FG001|Received at Least One Session|Overall Study||35||
48250770|NCT02657954|100934156|FG000|COMPLETED|Overall Study||20||
48250771|NCT02657954|100934157|FG001|COMPLETED|Overall Study||26||
48250772|NCT02657954|100934156|FG000|NOT COMPLETED|Overall Study||19||
48250773|NCT02657954|100934157|FG001|NOT COMPLETED|Overall Study||14||
48250774|NCT01530659|100934158|FG000|STARTED|Overall Study||22|22 total participants and 44 eyes|22
48250775|NCT01530659|100934159|FG001|STARTED|Overall Study||22|22 total participants and 44 eyes|22
48250776|NCT01530659|100934158|FG000|COMPLETED|Overall Study||22||22
48250777|NCT01530659|100934159|FG001|COMPLETED|Overall Study||22||22
48250778|NCT01530659|100934158|FG000|NOT COMPLETED|Overall Study||0||0
48250779|NCT01530659|100934159|FG001|NOT COMPLETED|Overall Study||0||0
48250780|NCT03036150|100934160|FG000|STARTED|Overall Study||2152||
48250781|NCT03036150|100934161|FG001|STARTED|Overall Study||2152||
48250782|NCT03036150|100934160|FG000|COMPLETED|Overall Study||2142||
48250783|NCT03036150|100934161|FG001|COMPLETED|Overall Study||2147||
48250784|NCT03036150|100934160|FG000|NOT COMPLETED|Overall Study||10||
48250785|NCT03036150|100934161|FG001|NOT COMPLETED|Overall Study||5||
48250786|NCT00509821|100934162|FG000|STARTED|Study Period 1 (Induction)||3||
48250787|NCT00509821|100934163|FG001|STARTED|Study Period 1 (Induction)||57||
48250788|NCT00509821|100934162|FG000|Received at Least 1 Dose of Study Drug|Study Period 1 (Induction)||3||
48250789|NCT00509821|100934163|FG001|Received at Least 1 Dose of Study Drug|Study Period 1 (Induction)||57||
48250790|NCT00509821|100934162|FG000|COMPLETED|Study Period 1 (Induction)||3||
48250791|NCT00509821|100934163|FG001|COMPLETED|Study Period 1 (Induction)||53||
48250792|NCT00509821|100934162|FG000|NOT COMPLETED|Study Period 1 (Induction)||0||
48250793|NCT00509821|100934163|FG001|NOT COMPLETED|Study Period 1 (Induction)||4||
48250794|NCT00509821|100934162|FG000|STARTED|Study Period 2 (Radiation)||3||
48250795|NCT00509821|100934163|FG001|STARTED|Study Period 2 (Radiation)||53||
48250796|NCT00509821|100934162|FG000|COMPLETED|Study Period 2 (Radiation)||3||
48250797|NCT00509821|100934163|FG001|COMPLETED|Study Period 2 (Radiation)||0||
48378058|NCT00258427|101252106|FG001|STARTED|Overall Study||8||
48378059|NCT00258427|101252107|FG002|STARTED|Overall Study||2||
48378060|NCT00258427|101252108|FG003|STARTED|Overall Study||1||
48378061|NCT00258427|101252105|FG000|COMPLETED|Overall Study||3||
48378062|NCT00258427|101252106|FG001|COMPLETED|Overall Study||8||
48378063|NCT00258427|101252107|FG002|COMPLETED|Overall Study||2||
48378064|NCT00258427|101252108|FG003|COMPLETED|Overall Study||1||
48378065|NCT00258427|101252105|FG000|NOT COMPLETED|Overall Study||0||
48378066|NCT00258427|101252106|FG001|NOT COMPLETED|Overall Study||0||
48378067|NCT00258427|101252107|FG002|NOT COMPLETED|Overall Study||0||
48378068|NCT00258427|101252108|FG003|NOT COMPLETED|Overall Study||0||
48541201|NCT00229723|101662682|FG002|COMPLETED|Concomitant Phase||25||
48541202|NCT00229723|101662683|FG003|COMPLETED|Concomitant Phase||26||
48541203|NCT00229723|101662684|FG004|COMPLETED|Concomitant Phase||22||
48541204|NCT00229723|101662685|FG005|COMPLETED|Concomitant Phase||31||
48541205|NCT00229723|101662686|FG006|COMPLETED|Concomitant Phase||19||
48541206|NCT00229723|101662680|FG000|NOT COMPLETED|Concomitant Phase||10||
48541207|NCT00229723|101662681|FG001|NOT COMPLETED|Concomitant Phase||5||
48541208|NCT00229723|101662682|FG002|NOT COMPLETED|Concomitant Phase||6||
48541209|NCT00229723|101662683|FG003|NOT COMPLETED|Concomitant Phase||5||
48250798|NCT00509821|100934162|FG000|NOT COMPLETED|Study Period 2 (Radiation)||0||
48250799|NCT00509821|100934163|FG001|NOT COMPLETED|Study Period 2 (Radiation)||53||
48250800|NCT00509821|100934162|FG000|STARTED|Study Period 3 (Maintenance)||3||
48250801|NCT00509821|100934163|FG001|STARTED|Study Period 3 (Maintenance)||49||
48250802|NCT00509821|100934162|FG000|COMPLETED|Study Period 3 (Maintenance)||3||
48250803|NCT00509821|100934163|FG001|COMPLETED|Study Period 3 (Maintenance)||0||
48250804|NCT00509821|100934162|FG000|NOT COMPLETED|Study Period 3 (Maintenance)||0||
48250805|NCT00509821|100934163|FG001|NOT COMPLETED|Study Period 3 (Maintenance)||49||
48250806|NCT00509821|100934162|FG000|STARTED|Study Period 4 (Follow Up)||2||
48250807|NCT00509821|100934163|FG001|STARTED|Study Period 4 (Follow Up)||50||
48250808|NCT00509821|100934162|FG000|COMPLETED|Study Period 4 (Follow Up)||2||
48250809|NCT00509821|100934163|FG001|COMPLETED|Study Period 4 (Follow Up)||50||
48250810|NCT00509821|100934162|FG000|NOT COMPLETED|Study Period 4 (Follow Up)||0||
48250811|NCT00509821|100934163|FG001|NOT COMPLETED|Study Period 4 (Follow Up)||0||
48250812|NCT01078584|100934164|FG000|STARTED|Overall Study||7993||
48250813|NCT01078584|100934164|FG000|Participants Conducted Visit 2 (3-month)|Overall Study||7125||
48541210|NCT00229723|101662684|FG004|NOT COMPLETED|Concomitant Phase||2||
48541211|NCT00229723|101662685|FG005|NOT COMPLETED|Concomitant Phase||3||
48541212|NCT00229723|101662686|FG006|NOT COMPLETED|Concomitant Phase||3||
48250814|NCT01078584|100934164|FG000|Participants Conducted Visit 3 (6-month)|Overall Study||5833||
48250815|NCT01078584|100934164|FG000|Participants Conducted Visit 4(12-month)|Overall Study||4983||
48250816|NCT01078584|100934164|FG000|COMPLETED|Overall Study||4983||
48250817|NCT01078584|100934164|FG000|NOT COMPLETED|Overall Study||3010||
48250818|NCT00255944|100934165|FG000|STARTED|Overall Study||1311||
48250819|NCT00255944|100934166|FG001|STARTED|Overall Study||1311||
48250820|NCT00255944|100934165|FG000|COMPLETED|Overall Study||514||
48250821|NCT00255944|100934166|FG001|COMPLETED|Overall Study||477||
48250822|NCT00255944|100934165|FG000|NOT COMPLETED|Overall Study||797||
48250823|NCT00255944|100934166|FG001|NOT COMPLETED|Overall Study||834||
48250824|NCT03799289|100934167|FG000|STARTED|Initial Weight Loss Program (Weeks 1-12)||30||
48250825|NCT03799289|100934168|FG001|STARTED|Initial Weight Loss Program (Weeks 1-12)||30||
48250826|NCT03799289|100934167|FG000|COMPLETED|Initial Weight Loss Program (Weeks 1-12)||24||
48250827|NCT03799289|100934168|FG001|COMPLETED|Initial Weight Loss Program (Weeks 1-12)||27||
48250828|NCT03799289|100934167|FG000|NOT COMPLETED|Initial Weight Loss Program (Weeks 1-12)||6||
48250829|NCT03799289|100934168|FG001|NOT COMPLETED|Initial Weight Loss Program (Weeks 1-12)||3||
48250830|NCT03799289|100934167|FG000|STARTED|Maintenance Intervention (Weeks 13-24)||24||
48250831|NCT03799289|100934168|FG001|STARTED|Maintenance Intervention (Weeks 13-24)||27||
48250832|NCT03799289|100934167|FG000|COMPLETED|Maintenance Intervention (Weeks 13-24)||24||
48250833|NCT03799289|100934168|FG001|COMPLETED|Maintenance Intervention (Weeks 13-24)||27||
48250834|NCT03799289|100934167|FG000|NOT COMPLETED|Maintenance Intervention (Weeks 13-24)||0||
48250835|NCT03799289|100934168|FG001|NOT COMPLETED|Maintenance Intervention (Weeks 13-24)||0||
48250836|NCT02166047|100934169|FG000|STARTED|Overall Study||16||
48250837|NCT02166047|100934170|FG001|STARTED|Overall Study||15||
48250838|NCT02166047|100934171|FG002|STARTED|Overall Study||16||
48250839|NCT02166047|100934172|FG003|STARTED|Overall Study||5||
48250840|NCT02166047|100934173|FG004|STARTED|Overall Study||18||
48250841|NCT02166047|100934174|FG005|STARTED|Overall Study||17||
48250842|NCT02166047|100934175|FG006|STARTED|Overall Study||17||
48250843|NCT02166047|100934176|FG007|STARTED|Overall Study||5||
48250844|NCT02166047|100934177|FG008|STARTED|Overall Study||16||
48250845|NCT02166047|100934178|FG009|STARTED|Overall Study||17||
48250846|NCT02166047|100934179|FG010|STARTED|Overall Study||14||
48250847|NCT02166047|100934180|FG011|STARTED|Overall Study||6||
48250848|NCT02166047|100934169|FG000|COMPLETED|Overall Study||16||
48250849|NCT02166047|100934170|FG001|COMPLETED|Overall Study||14||
48250850|NCT02166047|100934171|FG002|COMPLETED|Overall Study||14||
48250851|NCT02166047|100934172|FG003|COMPLETED|Overall Study||5||
48250852|NCT02166047|100934173|FG004|COMPLETED|Overall Study||17||
48250853|NCT02166047|100934174|FG005|COMPLETED|Overall Study||17||
48250854|NCT02166047|100934175|FG006|COMPLETED|Overall Study||15||
48250855|NCT02166047|100934176|FG007|COMPLETED|Overall Study||5||
48250856|NCT02166047|100934177|FG008|COMPLETED|Overall Study||16||
48250857|NCT02166047|100934178|FG009|COMPLETED|Overall Study||17||
48250858|NCT02166047|100934179|FG010|COMPLETED|Overall Study||12||
48250859|NCT02166047|100934180|FG011|COMPLETED|Overall Study||6||
48250860|NCT02166047|100934169|FG000|NOT COMPLETED|Overall Study||0||
48250861|NCT02166047|100934170|FG001|NOT COMPLETED|Overall Study||1||
48541213|NCT00229723|101662680|FG000|STARTED|Maintenance Phase||50||
48541214|NCT00229723|101662681|FG001|STARTED|Maintenance Phase||19||
48378069|NCT01163162|101252109|FG000|STARTED|Overall Study||16||
48378070|NCT01163162|101252109|FG000|COMPLETED|Overall Study||16||
48378071|NCT01163162|101252109|FG000|NOT COMPLETED|Overall Study||0||
48378072|NCT00116857|101252110|FG000|STARTED|Overall Study||62||
48378073|NCT00116857|101252111|FG001|STARTED|Overall Study||60||
48378074|NCT00116857|101252110|FG000|COMPLETED|Overall Study||59||
48378075|NCT00116857|101252111|FG001|COMPLETED|Overall Study||56||
48378076|NCT00116857|101252110|FG000|NOT COMPLETED|Overall Study||3||
48378077|NCT00116857|101252111|FG001|NOT COMPLETED|Overall Study||4||
48378078|NCT00711269|101252112|FG000|STARTED|Overall Study||131||
48378079|NCT00711269|101252113|FG001|STARTED|Overall Study||131||
48378080|NCT00711269|101252114|FG002|STARTED|Overall Study||133||
48378081|NCT00711269|101252115|FG003|STARTED|Overall Study||65||
48378082|NCT00711269|101252112|FG000|COMPLETED|Overall Study||87||
48378083|NCT00711269|101252113|FG001|COMPLETED|Overall Study||83||
48378084|NCT00711269|101252114|FG002|COMPLETED|Overall Study||83||
48378085|NCT00711269|101252115|FG003|COMPLETED|Overall Study||51||
48378086|NCT00711269|101252112|FG000|NOT COMPLETED|Overall Study||44||
48378087|NCT00711269|101252113|FG001|NOT COMPLETED|Overall Study||48||
48378088|NCT00711269|101252114|FG002|NOT COMPLETED|Overall Study||50||
48378089|NCT00711269|101252115|FG003|NOT COMPLETED|Overall Study||14||
48378090|NCT00195260|101252116|FG000|STARTED|Part 1: Dose Escalation||4||
48378091|NCT00195260|101252117|FG001|STARTED|Part 1: Dose Escalation||4||
48378092|NCT00195260|101252118|FG002|STARTED|Part 1: Dose Escalation||6||
48378093|NCT00195260|101252119|FG003|STARTED|Part 1: Dose Escalation||7||
48378094|NCT00195260|101252120|FG004|STARTED|Part 1: Dose Escalation||7||
48378095|NCT00195260|101252121|FG005|STARTED|Part 1: Dose Escalation||7||
48088537|NCT01782495|100537297|FG008|STARTED|Overall Study||3||
48088538|NCT01782495|100537298|FG009|STARTED|Overall Study||2||
48088539|NCT01782495|100537299|FG010|STARTED|Overall Study||1||
48088540|NCT01782495|100537289|FG000|COMPLETED|Overall Study||34||
48088541|NCT01782495|100537290|FG001|COMPLETED|Overall Study||26||
48088542|NCT01782495|100537291|FG002|COMPLETED|Overall Study||13||
48088543|NCT01782495|100537292|FG003|COMPLETED|Overall Study||4||
48088544|NCT01782495|100537293|FG004|COMPLETED|Overall Study||2||
48088545|NCT01782495|100537294|FG005|COMPLETED|Overall Study||22||
48088546|NCT01782495|100537295|FG006|COMPLETED|Overall Study||12||
48541215|NCT00229723|101662682|FG002|STARTED|Maintenance Phase||25||
48541216|NCT00229723|101662683|FG003|STARTED|Maintenance Phase||26||
48088547|NCT01782495|100537296|FG007|COMPLETED|Overall Study||6||
48088548|NCT01782495|100537297|FG008|COMPLETED|Overall Study||3||
48088549|NCT01782495|100537298|FG009|COMPLETED|Overall Study||2||
48088550|NCT01782495|100537299|FG010|COMPLETED|Overall Study||1||
48088551|NCT01782495|100537289|FG000|NOT COMPLETED|Overall Study||0||
48088552|NCT01782495|100537290|FG001|NOT COMPLETED|Overall Study||1||
48088553|NCT01782495|100537291|FG002|NOT COMPLETED|Overall Study||0||
48088554|NCT01782495|100537292|FG003|NOT COMPLETED|Overall Study||0||
48088555|NCT01782495|100537293|FG004|NOT COMPLETED|Overall Study||0||
48378096|NCT00195260|101252122|FG006|STARTED|Part 1: Dose Escalation||10||
48378097|NCT00195260|101252123|FG007|STARTED|Part 1: Dose Escalation||6||
48378098|NCT00195260|101252124|FG008|STARTED|Part 1: Dose Escalation||0||
48378099|NCT00195260|101252125|FG009|STARTED|Part 1: Dose Escalation||0||
48378100|NCT00195260|101252126|FG010|STARTED|Part 1: Dose Escalation||0||
48378101|NCT00195260|101252116|FG000|COMPLETED|Part 1: Dose Escalation||0||
48378102|NCT00195260|101252117|FG001|COMPLETED|Part 1: Dose Escalation||0||
48378103|NCT00195260|101252118|FG002|COMPLETED|Part 1: Dose Escalation||0||
48378104|NCT00195260|101252119|FG003|COMPLETED|Part 1: Dose Escalation||0||
48378105|NCT00195260|101252120|FG004|COMPLETED|Part 1: Dose Escalation||0||
48378106|NCT00195260|101252121|FG005|COMPLETED|Part 1: Dose Escalation||0||
48378107|NCT00195260|101252122|FG006|COMPLETED|Part 1: Dose Escalation||0||
48378108|NCT00195260|101252123|FG007|COMPLETED|Part 1: Dose Escalation||0||
48378109|NCT00195260|101252124|FG008|COMPLETED|Part 1: Dose Escalation||0||
48378110|NCT00195260|101252125|FG009|COMPLETED|Part 1: Dose Escalation||0||
48378111|NCT00195260|101252126|FG010|COMPLETED|Part 1: Dose Escalation||0||
48378112|NCT00195260|101252116|FG000|NOT COMPLETED|Part 1: Dose Escalation||4||
48378113|NCT00195260|101252117|FG001|NOT COMPLETED|Part 1: Dose Escalation||4||
48378114|NCT00195260|101252118|FG002|NOT COMPLETED|Part 1: Dose Escalation||6||
48378115|NCT00195260|101252119|FG003|NOT COMPLETED|Part 1: Dose Escalation||7||
48378116|NCT00195260|101252120|FG004|NOT COMPLETED|Part 1: Dose Escalation||7||
48378117|NCT00195260|101252121|FG005|NOT COMPLETED|Part 1: Dose Escalation||7||
48378118|NCT00195260|101252122|FG006|NOT COMPLETED|Part 1: Dose Escalation||10||
48378119|NCT00195260|101252123|FG007|NOT COMPLETED|Part 1: Dose Escalation||6||
48378120|NCT00195260|101252124|FG008|NOT COMPLETED|Part 1: Dose Escalation||0||
48378121|NCT00195260|101252125|FG009|NOT COMPLETED|Part 1: Dose Escalation||0||
48088556|NCT01782495|100537294|FG005|NOT COMPLETED|Overall Study||0||
48088557|NCT01782495|100537295|FG006|NOT COMPLETED|Overall Study||0||
48088558|NCT01782495|100537296|FG007|NOT COMPLETED|Overall Study||3||
48088559|NCT01782495|100537297|FG008|NOT COMPLETED|Overall Study||0||
48088560|NCT01782495|100537298|FG009|NOT COMPLETED|Overall Study||0||
48088561|NCT01782495|100537299|FG010|NOT COMPLETED|Overall Study||0||
48088562|NCT00088985|100537300|FG000|STARTED|Overall Study||7||
48088563|NCT00088985|100537300|FG000|COMPLETED|Overall Study||4||
48088564|NCT00088985|100537300|FG000|NOT COMPLETED|Overall Study||3||
48088565|NCT02000973|100537301|FG000|STARTED|Overall Study||20||
48088566|NCT02000973|100537302|FG001|STARTED|Overall Study||20||
48088567|NCT02000973|100537303|FG002|STARTED|Overall Study||20||
48088568|NCT02000973|100537304|FG003|STARTED|Overall Study||20||
48378122|NCT00195260|101252126|FG010|NOT COMPLETED|Part 1: Dose Escalation||0||
48378123|NCT00195260|101252116|FG000|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
48378124|NCT00195260|101252117|FG001|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
48378125|NCT00195260|101252118|FG002|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
48378126|NCT00195260|101252119|FG003|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
48378127|NCT00195260|101252120|FG004|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
48378128|NCT00195260|101252121|FG005|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
48378129|NCT00195260|101252122|FG006|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
48378130|NCT00195260|101252123|FG007|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
48378131|NCT00195260|101252124|FG008|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||37||
48378132|NCT00195260|101252125|FG009|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||38||
48378133|NCT00195260|101252126|FG010|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||25||
48378134|NCT00195260|101252116|FG000|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
48378135|NCT00195260|101252117|FG001|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
48378136|NCT00195260|101252118|FG002|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
48378137|NCT00195260|101252119|FG003|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
48378138|NCT00195260|101252120|FG004|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
48378139|NCT00195260|101252121|FG005|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
48378140|NCT00195260|101252122|FG006|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
48378141|NCT00195260|101252123|FG007|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
48378142|NCT00195260|101252124|FG008|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||4||
48378143|NCT00195260|101252125|FG009|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
48378144|NCT00195260|101252126|FG010|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||2||
48378145|NCT00195260|101252116|FG000|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
48378146|NCT00195260|101252117|FG001|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
48378147|NCT00195260|101252118|FG002|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
48378148|NCT00195260|101252119|FG003|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
48378149|NCT00195260|101252120|FG004|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
48378150|NCT00195260|101252121|FG005|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
48378151|NCT00195260|101252122|FG006|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
48378152|NCT00195260|101252123|FG007|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
48378153|NCT00195260|101252124|FG008|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||33||
48378154|NCT00195260|101252125|FG009|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||38||
48378155|NCT00195260|101252126|FG010|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||23||
48378156|NCT03509207|101252127|FG000|STARTED|Overall Study||3||
48378157|NCT03509207|101252127|FG000|COMPLETED|Overall Study||1||
48378158|NCT03509207|101252127|FG000|NOT COMPLETED|Overall Study||2||
48378159|NCT00782418|101252128|FG000|STARTED|Period 1 Procedure/Treatment Groups||3||
48378160|NCT00782418|101252129|FG001|STARTED|Period 1 Procedure/Treatment Groups||4||
48378161|NCT00782418|101252130|FG002|STARTED|Period 1 Procedure/Treatment Groups||4||
48378162|NCT00782418|101252131|FG003|STARTED|Period 1 Procedure/Treatment Groups||2||
48378163|NCT00782418|101252132|FG004|STARTED|Period 1 Procedure/Treatment Groups||5||
48378164|NCT00782418|101252133|FG005|STARTED|Period 1 Procedure/Treatment Groups||5||
48378165|NCT00782418|101252134|FG006|STARTED|Period 1 Procedure/Treatment Groups||4||
48378166|NCT00782418|101252128|FG000|COMPLETED|Period 1 Procedure/Treatment Groups||1||
48378167|NCT00782418|101252129|FG001|COMPLETED|Period 1 Procedure/Treatment Groups||4||
48378168|NCT00782418|101252130|FG002|COMPLETED|Period 1 Procedure/Treatment Groups||4||
48088569|NCT02000973|100537301|FG000|COMPLETED|Overall Study||20||
48088570|NCT02000973|100537302|FG001|COMPLETED|Overall Study||20||
48088571|NCT02000973|100537303|FG002|COMPLETED|Overall Study||20||
48088572|NCT02000973|100537304|FG003|COMPLETED|Overall Study||20||
48088573|NCT02000973|100537301|FG000|NOT COMPLETED|Overall Study||0||
48088574|NCT02000973|100537302|FG001|NOT COMPLETED|Overall Study||0||
48088575|NCT02000973|100537303|FG002|NOT COMPLETED|Overall Study||0||
48088576|NCT02000973|100537304|FG003|NOT COMPLETED|Overall Study||0||
48088577|NCT00001723|100537305|FG000|STARTED|Overall Study||100||
48088578|NCT00001723|100537306|FG001|STARTED|Overall Study||100||
48088579|NCT00001723|100537305|FG000|COMPLETED|Overall Study||87||
48088580|NCT00001723|100537306|FG001|COMPLETED|Overall Study||84||
48088581|NCT00001723|100537305|FG000|NOT COMPLETED|Overall Study||13||
48088582|NCT00001723|100537306|FG001|NOT COMPLETED|Overall Study||16||
48378169|NCT00782418|101252131|FG003|COMPLETED|Period 1 Procedure/Treatment Groups||2||
48378170|NCT00782418|101252132|FG004|COMPLETED|Period 1 Procedure/Treatment Groups||4||
48378171|NCT00782418|101252133|FG005|COMPLETED|Period 1 Procedure/Treatment Groups||4||
48378172|NCT00782418|101252134|FG006|COMPLETED|Period 1 Procedure/Treatment Groups||4||
48378173|NCT00782418|101252128|FG000|NOT COMPLETED|Period 1 Procedure/Treatment Groups||2||
48378174|NCT00782418|101252129|FG001|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0||
48378175|NCT00782418|101252130|FG002|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0||
48378176|NCT00782418|101252131|FG003|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0||
48378177|NCT00782418|101252132|FG004|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1||
48378178|NCT00782418|101252133|FG005|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1||
48378179|NCT00782418|101252134|FG006|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0||
48378180|NCT00782418|101252128|FG000|STARTED|Period 2 Procedure/Treatment Groups||3||
48378181|NCT00782418|101252129|FG001|STARTED|Period 2 Procedure/Treatment Groups||4||
48378182|NCT00782418|101252130|FG002|STARTED|Period 2 Procedure/Treatment Groups||4||
48378183|NCT00782418|101252131|FG003|STARTED|Period 2 Procedure/Treatment Groups||1||
48378184|NCT00782418|101252132|FG004|STARTED|Period 2 Procedure/Treatment Groups||3||
48541217|NCT00229723|101662684|FG004|STARTED|Maintenance Phase||22||
48541218|NCT00229723|101662685|FG005|STARTED|Maintenance Phase||31||
48088583|NCT03585504|100537307|FG000|STARTED|Overall Study||41||
48088584|NCT03585504|100537308|FG001|STARTED|Overall Study||40||
48088585|NCT03585504|100537307|FG000|COMPLETED|Overall Study||15||
48088586|NCT03585504|100537308|FG001|COMPLETED|Overall Study||11||
48088587|NCT03585504|100537307|FG000|NOT COMPLETED|Overall Study||26||
48088588|NCT03585504|100537308|FG001|NOT COMPLETED|Overall Study||29||
48088589|NCT03758274|100537309|FG000|STARTED|Overall Study||197||
48088590|NCT03758274|100537310|FG001|STARTED|Overall Study||203||
48088591|NCT03758274|100537309|FG000|COMPLETED|Overall Study||186||
48088592|NCT03758274|100537310|FG001|COMPLETED|Overall Study||190||
48088593|NCT03758274|100537309|FG000|NOT COMPLETED|Overall Study||11||
48378185|NCT00782418|101252133|FG005|STARTED|Period 2 Procedure/Treatment Groups||4||
48378186|NCT00782418|101252134|FG006|STARTED|Period 2 Procedure/Treatment Groups||4||
48378187|NCT00782418|101252128|FG000|COMPLETED|Period 2 Procedure/Treatment Groups||3||
48378188|NCT00782418|101252129|FG001|COMPLETED|Period 2 Procedure/Treatment Groups||4||
48378189|NCT00782418|101252130|FG002|COMPLETED|Period 2 Procedure/Treatment Groups||4||
48378190|NCT00782418|101252131|FG003|COMPLETED|Period 2 Procedure/Treatment Groups||1||
48378191|NCT00782418|101252132|FG004|COMPLETED|Period 2 Procedure/Treatment Groups||3||
48378192|NCT00782418|101252133|FG005|COMPLETED|Period 2 Procedure/Treatment Groups||4||
48378193|NCT00782418|101252134|FG006|COMPLETED|Period 2 Procedure/Treatment Groups||4||
48378194|NCT00782418|101252128|FG000|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0||
48378195|NCT00782418|101252129|FG001|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0||
48378196|NCT00782418|101252130|FG002|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0||
48378197|NCT00782418|101252131|FG003|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0||
48378198|NCT00782418|101252132|FG004|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0||
48378199|NCT00782418|101252133|FG005|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0||
48378200|NCT00782418|101252134|FG006|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0||
48378201|NCT00436566|101252135|FG000|STARTED|Overall Study||112||
48378202|NCT00436566|101252135|FG000|COMPLETED|Overall Study||109||
48378203|NCT00436566|101252135|FG000|NOT COMPLETED|Overall Study||3||
48378204|NCT01740440|101252136|FG000|STARTED|Overall Study||30||
48378205|NCT01740440|101252136|FG000|COMPLETED|Overall Study||27||
48378206|NCT01740440|101252136|FG000|NOT COMPLETED|Overall Study||3||
48378207|NCT03540134|101252137|FG000|STARTED|Overall Study||4||
48378208|NCT03540134|101252137|FG000|COMPLETED|Overall Study||4||
48378209|NCT03540134|101252137|FG000|NOT COMPLETED|Overall Study||0||
48378210|NCT00471445|101252138|FG000|STARTED|Overall Study||229||
48378211|NCT00471445|101252139|FG001|STARTED|Overall Study||233||
48378212|NCT00471445|101252138|FG000|COMPLETED|Overall Study||227||
48541219|NCT00229723|101662686|FG006|STARTED|Maintenance Phase||19||
48378213|NCT00471445|101252139|FG001|COMPLETED|Overall Study||231||
48541220|NCT00229723|101662680|FG000|COMPLETED|Maintenance Phase||25||
48541221|NCT00229723|101662681|FG001|COMPLETED|Maintenance Phase||5||
48541222|NCT00229723|101662682|FG002|COMPLETED|Maintenance Phase||16||
48541223|NCT00229723|101662683|FG003|COMPLETED|Maintenance Phase||9||
48541224|NCT00229723|101662684|FG004|COMPLETED|Maintenance Phase||7||
48541225|NCT00229723|101662685|FG005|COMPLETED|Maintenance Phase||12||
48541226|NCT00229723|101662686|FG006|COMPLETED|Maintenance Phase||9||
48541227|NCT00229723|101662680|FG000|NOT COMPLETED|Maintenance Phase||25||
48088594|NCT03758274|100537310|FG001|NOT COMPLETED|Overall Study||13||
48088595|NCT04208698|100537311|FG000|STARTED|Overall Study||2||
48088596|NCT04208698|100537312|FG001|STARTED|Overall Study||0||
48088597|NCT04208698|100537313|FG002|STARTED|Overall Study||0||
48088598|NCT04208698|100537314|FG003|STARTED|Overall Study||0||
48378214|NCT00471445|101252138|FG000|NOT COMPLETED|Overall Study||2||
48378215|NCT00471445|101252139|FG001|NOT COMPLETED|Overall Study||2||
48378216|NCT01810042|101252140|FG000|STARTED|Overall Study||49||
48378217|NCT01810042|101252140|FG000|COMPLETED|Overall Study||39||
48378218|NCT01810042|101252140|FG000|NOT COMPLETED|Overall Study||10||
48378219|NCT00777491|101252141|FG000|STARTED|Overall Study||35||
48378220|NCT00777491|101252142|FG001|STARTED|Overall Study||35||
48378221|NCT00777491|101252141|FG000|Eligible|Overall Study||33||
48378222|NCT00777491|101252142|FG001|Eligible|Overall Study||33||
48378223|NCT00777491|101252141|FG000|Has 3-year Efficacy Data|Overall Study||27|Eligible and has 3-year distant metastasis status|
48378224|NCT00777491|101252142|FG001|Has 3-year Efficacy Data|Overall Study||25|Eligible and has 3-year distant metastasis status|
48378225|NCT00777491|101252141|FG000|Started Induction Therapy|Overall Study||33|Eligible and started induction therapy|
48378226|NCT00777491|101252142|FG001|Started Induction Therapy|Overall Study||33|Eligible and started induction therapy|
48378227|NCT00777491|101252141|FG000|Started Consolidation Therapy|Overall Study||29|Eligible and started consolidation therapy|
48378228|NCT00777491|101252142|FG001|Started Consolidation Therapy|Overall Study||25|Eligible and started consolidation therapy|
48378229|NCT00777491|101252141|FG000|Started Adjuvant Therapy|Overall Study||32|Eligible and started adjuvant therapy|
48378230|NCT00777491|101252142|FG001|Started Adjuvant Therapy|Overall Study||31|Eligible and started adjuvant therapy|
48378231|NCT00777491|101252141|FG000|Has Adverse Event Data (Treatment)|Overall Study||33|Eligible and has adverse event data during treatment|
48378232|NCT00777491|101252142|FG001|Has Adverse Event Data (Treatment)|Overall Study||33|Eligible and has adverse event data during treatment|
48378233|NCT00777491|101252141|FG000|Has Adverse Event Data (Late)|Overall Study||32|Eligible and has adverse event data between end of treatment to 180 days after end of treatment|
48378234|NCT00777491|101252142|FG001|Has Adverse Event Data (Late)|Overall Study||31|Eligible and has adverse event data between end of treatment to 180 days after end of treatment|
48378235|NCT00777491|101252141|FG000|Has 3 Year AUASI Data|Overall Study||6|Eligible and has baseline and 3-year American Urological Association Symptom Index (AUASI) scores|
48378236|NCT00777491|101252142|FG001|Has 3 Year AUASI Data|Overall Study||6|Eligible and has baseline and 3-year American Urological Association Symptom Index (AUASI) scores|
48378237|NCT00777491|101252141|FG000|COMPLETED|Overall Study||33|Subjects contributing any data to analysis are considered to have completed the study|
48378238|NCT00777491|101252142|FG001|COMPLETED|Overall Study||33|Subjects contributing any data to analysis are considered to have completed the study|
48378239|NCT00777491|101252141|FG000|NOT COMPLETED|Overall Study||2||
48378240|NCT00777491|101252142|FG001|NOT COMPLETED|Overall Study||2||
48378241|NCT01226420|101252143|FG000|STARTED|Overall Study||6||
48378242|NCT01226420|101252143|FG000|COMPLETED|Overall Study||6||
48378243|NCT01226420|101252143|FG000|NOT COMPLETED|Overall Study||0||
48378244|NCT00753935|101252144|FG000|STARTED|Overall Study||45||
48378245|NCT00753935|101252145|FG001|STARTED|Overall Study||47||
48378246|NCT00753935|101252144|FG000|COMPLETED|Overall Study||45||
48378247|NCT00753935|101252145|FG001|COMPLETED|Overall Study||47||
48378248|NCT00753935|101252144|FG000|NOT COMPLETED|Overall Study||0||
48378249|NCT00753935|101252145|FG001|NOT COMPLETED|Overall Study||0||
48378250|NCT00660504|101252146|FG000|STARTED|Overall Study||149||
48378251|NCT00660504|101252147|FG001|STARTED|Overall Study||151||
48378252|NCT00660504|101252146|FG000|COMPLETED|Overall Study||149||
48378253|NCT00660504|101252147|FG001|COMPLETED|Overall Study||150||
48378254|NCT00660504|101252146|FG000|NOT COMPLETED|Overall Study||0||
48378255|NCT00660504|101252147|FG001|NOT COMPLETED|Overall Study||1||
48378256|NCT01735617|101252148|FG000|STARTED|Overall Study||16||
48378257|NCT01735617|101252148|FG000|COMPLETED|Overall Study||16||
48378258|NCT01735617|101252148|FG000|NOT COMPLETED|Overall Study||0||
48378259|NCT02491073|101252149|FG000|STARTED|Overall Study||37||
48378260|NCT02491073|101252150|FG001|STARTED|Overall Study||34||
48378261|NCT02491073|101252149|FG000|COMPLETED|Overall Study||36||
48378262|NCT02491073|101252150|FG001|COMPLETED|Overall Study||34||
48378263|NCT02491073|101252149|FG000|NOT COMPLETED|Overall Study||1||
48378264|NCT02491073|101252150|FG001|NOT COMPLETED|Overall Study||0||
48378265|NCT00879814|101252151|FG000|STARTED|Overall Study||12||
48378266|NCT00879814|101252152|FG001|STARTED|Overall Study||12||
48378267|NCT00879814|101252153|FG002|STARTED|Overall Study||12||
48378268|NCT00879814|101252154|FG003|STARTED|Overall Study||12||
48378269|NCT00879814|101252151|FG000|COMPLETED|Overall Study||8||
48378270|NCT00879814|101252152|FG001|COMPLETED|Overall Study||10||
48378271|NCT00879814|101252153|FG002|COMPLETED|Overall Study||9||
48378272|NCT00879814|101252154|FG003|COMPLETED|Overall Study||7||
48378273|NCT00879814|101252151|FG000|NOT COMPLETED|Overall Study||4||
48378274|NCT00879814|101252152|FG001|NOT COMPLETED|Overall Study||2||
48378275|NCT00879814|101252153|FG002|NOT COMPLETED|Overall Study||3||
48250862|NCT02166047|100934171|FG002|NOT COMPLETED|Overall Study||2||
48250863|NCT02166047|100934172|FG003|NOT COMPLETED|Overall Study||0||
48250864|NCT02166047|100934173|FG004|NOT COMPLETED|Overall Study||1||
48250865|NCT02166047|100934174|FG005|NOT COMPLETED|Overall Study||0||
48250866|NCT02166047|100934175|FG006|NOT COMPLETED|Overall Study||2||
48378276|NCT00879814|101252154|FG003|NOT COMPLETED|Overall Study||5||
48378277|NCT01260467|101252155|FG000|STARTED|Overall Study||4||
48378278|NCT01260467|101252155|FG000|COMPLETED|Overall Study||2||
48378279|NCT01260467|101252155|FG000|NOT COMPLETED|Overall Study||2||
48378280|NCT00547378|101255858|FG000|STARTED|Randomized Cohort||70||
48378281|NCT00547378|101255859|FG001|STARTED|Randomized Cohort||77||
48378282|NCT00547378|101255860|FG002|STARTED|Randomized Cohort||0||
48378283|NCT00547378|101255858|FG000|Month 3|Randomized Cohort||62||
48378284|NCT00547378|101255859|FG001|Month 3|Randomized Cohort||72||
48378285|NCT00547378|101255860|FG002|Month 3|Randomized Cohort||0||
48378286|NCT00547378|101255858|FG000|Month 6|Randomized Cohort||59||
48378287|NCT00547378|101255859|FG001|Month 6|Randomized Cohort||71||
48684231|NCT00363311|102009690|FG000|NOT COMPLETED|Overall Study||76||
48684232|NCT00363311|102009691|FG001|NOT COMPLETED|Overall Study||45||
48684233|NCT04872569|102009692|FG000|STARTED|Overall Study||23||
48684234|NCT04872569|102009692|FG000|COMPLETED|Overall Study||21||
48684235|NCT04872569|102009692|FG000|NOT COMPLETED|Overall Study||2||
48684236|NCT01456130|102009693|FG000|STARTED|Overall Study||67||
48684237|NCT01456130|102009693|FG000|COMPLETED|Overall Study||57||
48684238|NCT01456130|102009693|FG000|NOT COMPLETED|Overall Study||10||
48684239|NCT00284180|102009694|FG000|STARTED|Overall Study||11||
48684240|NCT00284180|102009695|FG001|STARTED|Overall Study||21||
48088599|NCT04208698|100537315|FG004|STARTED|Overall Study||0||
48088600|NCT04208698|100537311|FG000|COMPLETED|Overall Study||0||
48088601|NCT04208698|100537312|FG001|COMPLETED|Overall Study||0||
48250867|NCT02166047|100934176|FG007|NOT COMPLETED|Overall Study||0||
48250868|NCT02166047|100934177|FG008|NOT COMPLETED|Overall Study||0||
48250869|NCT02166047|100934178|FG009|NOT COMPLETED|Overall Study||0||
48378288|NCT00547378|101255860|FG002|Month 6|Randomized Cohort||0||
48378289|NCT00547378|101255858|FG000|COMPLETED|Randomized Cohort||59||
48378290|NCT00547378|101255859|FG001|COMPLETED|Randomized Cohort||71||
48378291|NCT00547378|101255860|FG002|COMPLETED|Randomized Cohort||0||
48378292|NCT00547378|101255858|FG000|NOT COMPLETED|Randomized Cohort||11||
48378293|NCT00547378|101255859|FG001|NOT COMPLETED|Randomized Cohort||6||
48378294|NCT00547378|101255860|FG002|NOT COMPLETED|Randomized Cohort||0||
48250870|NCT02166047|100934179|FG010|NOT COMPLETED|Overall Study||2||
48250871|NCT02166047|100934180|FG011|NOT COMPLETED|Overall Study||0||
48250872|NCT02312622|100934181|FG000|STARTED|Overall Study||12||
48250873|NCT02312622|100934182|FG001|STARTED|Overall Study||3||
48250874|NCT02312622|100934183|FG002|STARTED|Overall Study||12||
48250875|NCT02312622|100934181|FG000|COMPLETED|Overall Study||12||
48250876|NCT02312622|100934182|FG001|COMPLETED|Overall Study||3||
48250877|NCT02312622|100934183|FG002|COMPLETED|Overall Study||12||
48250878|NCT02312622|100934181|FG000|NOT COMPLETED|Overall Study||0||
48250879|NCT02312622|100934182|FG001|NOT COMPLETED|Overall Study||0||
48378295|NCT00547378|101255858|FG000|STARTED|All Implanted Cohort||51|Subjects went through test stimulation in each group; if successful, received a full system implant.|
48378296|NCT00547378|101255859|FG001|STARTED|All Implanted Cohort||40|Subjects went through test stimulation in each group; if successful, received a full system implant.|
48378297|NCT00547378|101255860|FG002|STARTED|All Implanted Cohort||181|Subjects went through test stimulation in each group; if successful, received a full system implant.|
48378298|NCT00547378|101255858|FG000|Month 3|All Implanted Cohort||51||
48378299|NCT00547378|101255859|FG001|Month 3|All Implanted Cohort||39||
48378300|NCT00547378|101255860|FG002|Month 3|All Implanted Cohort||178||
48378301|NCT00547378|101255858|FG000|Month 6|All Implanted Cohort||50||
48378302|NCT00547378|101255859|FG001|Month 6|All Implanted Cohort||36||
48378303|NCT00547378|101255860|FG002|Month 6|All Implanted Cohort||178||
48378304|NCT00547378|101255858|FG000|Month 12|All Implanted Cohort||48||
48378305|NCT00547378|101255859|FG001|Month 12|All Implanted Cohort||32||
48684241|NCT00284180|102009694|FG000|COMPLETED|Overall Study||11||
48684242|NCT00284180|102009695|FG001|COMPLETED|Overall Study||17||
48088602|NCT04208698|100537313|FG002|COMPLETED|Overall Study||0||
48250880|NCT02312622|100934183|FG002|NOT COMPLETED|Overall Study||0||
48250881|NCT03690921|100934184|FG000|STARTED|Overall Study||8||
48250882|NCT03690921|100934184|FG000|COMPLETED|Overall Study||8||
48250883|NCT03690921|100934184|FG000|NOT COMPLETED|Overall Study||0||
48250884|NCT02236598|100934185|FG000|STARTED|Overall Study||15||
48250885|NCT02236598|100934186|FG001|STARTED|Overall Study||14||
48250886|NCT02236598|100934185|FG000|COMPLETED|Overall Study||15||
48250887|NCT02236598|100934186|FG001|COMPLETED|Overall Study||12||
48250888|NCT02236598|100934185|FG000|NOT COMPLETED|Overall Study||0||
48684243|NCT00284180|102009694|FG000|NOT COMPLETED|Overall Study||0||
48684244|NCT00284180|102009695|FG001|NOT COMPLETED|Overall Study||4||
48088603|NCT04208698|100537314|FG003|COMPLETED|Overall Study||0||
48088604|NCT04208698|100537315|FG004|COMPLETED|Overall Study||0||
48088605|NCT04208698|100537311|FG000|NOT COMPLETED|Overall Study||2||
48088606|NCT04208698|100537312|FG001|NOT COMPLETED|Overall Study||0||
48250889|NCT02236598|100934186|FG001|NOT COMPLETED|Overall Study||2||
48250890|NCT02434523|100934187|FG000|STARTED|Overall Study||15||
48250891|NCT02434523|100934188|FG001|STARTED|Overall Study||15||
48250892|NCT02434523|100934187|FG000|COMPLETED|Overall Study||10||
48250893|NCT02434523|100934188|FG001|COMPLETED|Overall Study||9||
48250894|NCT02434523|100934187|FG000|NOT COMPLETED|Overall Study||5||
48250895|NCT02434523|100934188|FG001|NOT COMPLETED|Overall Study||6||
48250896|NCT01395914|100934189|FG000|STARTED|Overall Study||345||
48378306|NCT00547378|101255860|FG002|Month 12|All Implanted Cohort||175||
48378307|NCT00547378|101255858|FG000|Month 24|All Implanted Cohort||42||
48378308|NCT00547378|101255859|FG001|Month 24|All Implanted Cohort||30||
48378309|NCT00547378|101255860|FG002|Month 24|All Implanted Cohort||161||
48378310|NCT00547378|101255858|FG000|Month 36|All Implanted Cohort||42||
48378311|NCT00547378|101255859|FG001|Month 36|All Implanted Cohort||29||
48378312|NCT00547378|101255860|FG002|Month 36|All Implanted Cohort||146||
48378313|NCT00547378|101255858|FG000|Month 48|All Implanted Cohort||38||
48378314|NCT00547378|101255859|FG001|Month 48|All Implanted Cohort||27||
48378315|NCT00547378|101255860|FG002|Month 48|All Implanted Cohort||136||
48378316|NCT00547378|101255858|FG000|Month 60|All Implanted Cohort||36||
48378317|NCT00547378|101255859|FG001|Month 60|All Implanted Cohort||23||
48378318|NCT00547378|101255860|FG002|Month 60|All Implanted Cohort||114||
48378319|NCT00547378|101255858|FG000|COMPLETED|All Implanted Cohort||36||
48378320|NCT00547378|101255859|FG001|COMPLETED|All Implanted Cohort||22||
48378321|NCT00547378|101255860|FG002|COMPLETED|All Implanted Cohort||111||
48378322|NCT00547378|101255858|FG000|NOT COMPLETED|All Implanted Cohort||15||
48378323|NCT00547378|101255859|FG001|NOT COMPLETED|All Implanted Cohort||18||
48378324|NCT00547378|101255860|FG002|NOT COMPLETED|All Implanted Cohort||70||
48378325|NCT00645567|101255861|FG000|STARTED|Overall Study||5||
48250897|NCT01395914|100934190|FG001|STARTED|Overall Study||168||
48250898|NCT01395914|100934189|FG000|ITT Population|Overall Study||345||
48250899|NCT01395914|100934190|FG001|ITT Population|Overall Study||168||
48250900|NCT01395914|100934189|FG000|Safety Population|Overall Study||343||
48250901|NCT01395914|100934190|FG001|Safety Population|Overall Study||167||
48250902|NCT01395914|100934189|FG000|COMPLETED|Overall Study||273||
48250903|NCT01395914|100934190|FG001|COMPLETED|Overall Study||131||
48378326|NCT00645567|101255861|FG000|COMPLETED|Overall Study||4||
48088607|NCT04208698|100537313|FG002|NOT COMPLETED|Overall Study||0||
48088608|NCT04208698|100537314|FG003|NOT COMPLETED|Overall Study||0||
48088609|NCT04208698|100537315|FG004|NOT COMPLETED|Overall Study||0||
48088610|NCT03847233|100537316|FG000|STARTED|Index Procedure||31||
48088611|NCT03847233|100537316|FG000|COMPLETED|Index Procedure||31||
48088612|NCT03847233|100537316|FG000|NOT COMPLETED|Index Procedure||0||
48088613|NCT03847233|100537316|FG000|STARTED|6 Month After Index Procedure||31||
48088614|NCT03847233|100537316|FG000|COMPLETED|6 Month After Index Procedure||30||
48088615|NCT03847233|100537316|FG000|NOT COMPLETED|6 Month After Index Procedure||1||
48088616|NCT01955733|100537317|FG000|STARTED|Period 1||33||
48088617|NCT01955733|100537318|FG001|STARTED|Period 1||29||
48088618|NCT01955733|100537319|FG002|STARTED|Period 1||29||
48088619|NCT01955733|100537317|FG000|COMPLETED|Period 1||32||
48088620|NCT01955733|100537318|FG001|COMPLETED|Period 1||29||
48088621|NCT01955733|100537319|FG002|COMPLETED|Period 1||29||
48088622|NCT01955733|100537317|FG000|NOT COMPLETED|Period 1||1||
48088623|NCT01955733|100537318|FG001|NOT COMPLETED|Period 1||0||
48088624|NCT01955733|100537319|FG002|NOT COMPLETED|Period 1||0||
48088625|NCT01955733|100537317|FG000|STARTED|Period 2||32||
48088626|NCT01955733|100537318|FG001|STARTED|Period 2||29||
48088627|NCT01955733|100537319|FG002|STARTED|Period 2||29||
48088628|NCT01955733|100537317|FG000|COMPLETED|Period 2||20||
48088629|NCT01955733|100537318|FG001|COMPLETED|Period 2||10||
48088630|NCT01955733|100537319|FG002|COMPLETED|Period 2||8||
48088631|NCT01955733|100537317|FG000|NOT COMPLETED|Period 2||12||
48088632|NCT01955733|100537318|FG001|NOT COMPLETED|Period 2||19||
48088633|NCT01955733|100537319|FG002|NOT COMPLETED|Period 2||21||
48088634|NCT03915496|100537320|FG000|STARTED|Overall Study||16||
48088635|NCT03915496|100537321|FG001|STARTED|Overall Study||14||
48088636|NCT03915496|100537322|FG002|STARTED|Overall Study||16||
48088637|NCT03915496|100537320|FG000|COMPLETED|Overall Study||14||
48088638|NCT03915496|100537321|FG001|COMPLETED|Overall Study||13||
48088639|NCT03915496|100537322|FG002|COMPLETED|Overall Study||14||
48088640|NCT03915496|100537320|FG000|NOT COMPLETED|Overall Study||2||
48088641|NCT03915496|100537321|FG001|NOT COMPLETED|Overall Study||1||
48088642|NCT03915496|100537322|FG002|NOT COMPLETED|Overall Study||2||
48088643|NCT03049280|100537323|FG000|STARTED|Overall Study||33||
48088644|NCT03049280|100537323|FG000|COMPLETED|Overall Study||32||
48088645|NCT03049280|100537323|FG000|NOT COMPLETED|Overall Study||1||
48088646|NCT01524692|100537324|FG000|STARTED|Overall Study||35||
48088647|NCT01524692|100537324|FG000|COMPLETED|Overall Study||32||
48088648|NCT01524692|100537324|FG000|NOT COMPLETED|Overall Study||3||
48250904|NCT01395914|100934189|FG000|NOT COMPLETED|Overall Study||72||
48250905|NCT01395914|100934190|FG001|NOT COMPLETED|Overall Study||37||
48250906|NCT00984698|100934191|FG000|STARTED|Overall Study||21||
48250907|NCT00984698|100934192|FG001|STARTED|Overall Study||22||
48250908|NCT00984698|100934191|FG000|COMPLETED|Overall Study||18||
48088649|NCT00307294|100537325|FG000|STARTED|Overall Study||40||
48088650|NCT00307294|100537325|FG000|COMPLETED|Overall Study||39||
48088651|NCT00307294|100537325|FG000|NOT COMPLETED|Overall Study||1||
48088652|NCT04140292|100537326|FG000|STARTED|Overall Study||33||
48088653|NCT04140292|100537327|FG001|STARTED|Overall Study||42||
48088654|NCT04140292|100537326|FG000|COMPLETED|Overall Study||29||
48088655|NCT04140292|100537327|FG001|COMPLETED|Overall Study||26||
48088656|NCT04140292|100537326|FG000|NOT COMPLETED|Overall Study||4||
48088657|NCT04140292|100537327|FG001|NOT COMPLETED|Overall Study||16||
48088658|NCT00126568|100537328|FG000|STARTED|Overall Study||20||
48250909|NCT00984698|100934192|FG001|COMPLETED|Overall Study||14||
48250910|NCT00984698|100934191|FG000|NOT COMPLETED|Overall Study||3||
48250911|NCT00984698|100934192|FG001|NOT COMPLETED|Overall Study||8||
48250912|NCT02388932|100934193|FG000|STARTED|Overall Study||3||
48250913|NCT02388932|100934193|FG000|COMPLETED|Overall Study||2||
48250914|NCT02388932|100934193|FG000|NOT COMPLETED|Overall Study||1||
48250915|NCT01702519|100934194|FG000|STARTED|Period 1||20||
48250916|NCT01702519|100934195|FG001|STARTED|Period 1||20||
48250917|NCT01702519|100934194|FG000|COMPLETED|Period 1||20||
48250918|NCT01702519|100934195|FG001|COMPLETED|Period 1||20||
48250919|NCT01702519|100934194|FG000|NOT COMPLETED|Period 1||0||
48250920|NCT01702519|100934195|FG001|NOT COMPLETED|Period 1||0||
48250921|NCT01702519|100934194|FG000|STARTED|Washout Period||20||
48088659|NCT00126568|100537328|FG000|COMPLETED|Overall Study||18||
48088660|NCT00126568|100537328|FG000|NOT COMPLETED|Overall Study||2||
48088661|NCT01896544|100537329|FG000|STARTED|Overall Study||10||
48088662|NCT01896544|100537330|FG001|STARTED|Overall Study||10||
48088663|NCT01896544|100537331|FG002|STARTED|Overall Study||10||
48088664|NCT01896544|100537329|FG000|COMPLETED|Overall Study||10||
48088665|NCT01896544|100537330|FG001|COMPLETED|Overall Study||10||
48088666|NCT01896544|100537331|FG002|COMPLETED|Overall Study||10||
48088667|NCT01896544|100537329|FG000|NOT COMPLETED|Overall Study||0||
48088668|NCT01896544|100537330|FG001|NOT COMPLETED|Overall Study||0||
48250922|NCT01702519|100934195|FG001|STARTED|Washout Period||20||
48250923|NCT01702519|100934194|FG000|COMPLETED|Washout Period||19||
48250924|NCT01702519|100934195|FG001|COMPLETED|Washout Period||18||
48250925|NCT01702519|100934194|FG000|NOT COMPLETED|Washout Period||1||
48088669|NCT01896544|100537331|FG002|NOT COMPLETED|Overall Study||0||
48088670|NCT02056782|100537332|FG000|STARTED|Overall Study||12||
48088671|NCT02056782|100537332|FG000|COMPLETED|Overall Study||10||
48088672|NCT02056782|100537332|FG000|NOT COMPLETED|Overall Study||2||
48088673|NCT00883116|100537333|FG000|STARTED|Overall Study||248||
48088674|NCT00883116|100537334|FG001|STARTED|Overall Study||248||
48088675|NCT00883116|100537333|FG000|Received Treatment|Overall Study||248||
48088676|NCT00883116|100537334|FG001|Received Treatment|Overall Study||239||
48088677|NCT00883116|100537333|FG000|COMPLETED|Overall Study||39||
48088678|NCT00883116|100537334|FG001|COMPLETED|Overall Study||29||
48088679|NCT00883116|100537333|FG000|NOT COMPLETED|Overall Study||209||
48088680|NCT00883116|100537334|FG001|NOT COMPLETED|Overall Study||219||
48088681|NCT00371137|100537335|FG000|STARTED|Overall Study||183||
48088682|NCT00371137|100537336|FG001|STARTED|Overall Study||182||
48088683|NCT00371137|100537337|FG002|STARTED|Overall Study||183||
48088684|NCT00371137|100537335|FG000|Treated|Overall Study||183||
48088685|NCT00371137|100537336|FG001|Treated|Overall Study||182||
48088686|NCT00371137|100537337|FG002|Treated|Overall Study||182||
48088687|NCT00371137|100537335|FG000|COMPLETED|Overall Study||111||
48250926|NCT01702519|100934195|FG001|NOT COMPLETED|Washout Period||2||
48250927|NCT01702519|100934194|FG000|STARTED|Period 2||19||
48250928|NCT01702519|100934195|FG001|STARTED|Period 2||18||
48250929|NCT01702519|100934194|FG000|COMPLETED|Period 2||19||
48250930|NCT01702519|100934195|FG001|COMPLETED|Period 2||18||
48250931|NCT01702519|100934194|FG000|NOT COMPLETED|Period 2||0||
48250932|NCT01702519|100934195|FG001|NOT COMPLETED|Period 2||0||
48250933|NCT03675308|100934196|FG000|STARTED|Overall Study||481||
48250934|NCT03675308|100934197|FG001|STARTED|Overall Study||483||
48250935|NCT03675308|100934196|FG000|COMPLETED|Overall Study||467|Completed Period 1 study participation|
48250936|NCT03675308|100934197|FG001|COMPLETED|Overall Study||473|Completed Period 1 study participation|
48088688|NCT00371137|100537336|FG001|COMPLETED|Overall Study||119||
48088689|NCT00371137|100537337|FG002|COMPLETED|Overall Study||104||
48088690|NCT00371137|100537335|FG000|NOT COMPLETED|Overall Study||72||
48088691|NCT00371137|100537336|FG001|NOT COMPLETED|Overall Study||63||
48250937|NCT03675308|100934196|FG000|NOT COMPLETED|Overall Study||14||
48250938|NCT03675308|100934197|FG001|NOT COMPLETED|Overall Study||10||
48088692|NCT00371137|100537337|FG002|NOT COMPLETED|Overall Study||79||
48088693|NCT00674700|100537338|FG000|STARTED|Year 1||170||
48088694|NCT00674700|100537339|FG001|STARTED|Year 1||169||
48250939|NCT03015181|100934198|FG000|STARTED|Overall Study||4||
48250940|NCT03015181|100934199|FG001|STARTED|Overall Study||3||
48250941|NCT03015181|100934200|FG002|STARTED|Overall Study||3||
48250942|NCT03015181|100934201|FG003|STARTED|Overall Study||3||
48250943|NCT03015181|100934202|FG004|STARTED|Overall Study||3||
48250944|NCT03015181|100934203|FG005|STARTED|Overall Study||5||
48250945|NCT03015181|100934204|FG006|STARTED|Overall Study||5||
48250946|NCT03015181|100934198|FG000|Received VRC07-523LS Per Protocol|Overall Study||3||
48250947|NCT03015181|100934199|FG001|Received VRC07-523LS Per Protocol|Overall Study||3||
48250948|NCT03015181|100934200|FG002|Received VRC07-523LS Per Protocol|Overall Study||3||
48250949|NCT03015181|100934201|FG003|Received VRC07-523LS Per Protocol|Overall Study||3||
48250950|NCT03015181|100934202|FG004|Received VRC07-523LS Per Protocol|Overall Study||3||
48250951|NCT03015181|100934203|FG005|Received VRC07-523LS Per Protocol|Overall Study||4||
48250952|NCT03015181|100934204|FG006|Received VRC07-523LS Per Protocol|Overall Study||4||
48250953|NCT03015181|100934198|FG000|Discontinued VRC07-523LS Administrations|Overall Study||1||
48250954|NCT03015181|100934199|FG001|Discontinued VRC07-523LS Administrations|Overall Study||0||
48250955|NCT03015181|100934200|FG002|Discontinued VRC07-523LS Administrations|Overall Study||0||
48250956|NCT03015181|100934201|FG003|Discontinued VRC07-523LS Administrations|Overall Study||0||
48250957|NCT03015181|100934202|FG004|Discontinued VRC07-523LS Administrations|Overall Study||0||
48250958|NCT03015181|100934203|FG005|Discontinued VRC07-523LS Administrations|Overall Study||1||
48250959|NCT03015181|100934204|FG006|Discontinued VRC07-523LS Administrations|Overall Study||1||
48250960|NCT03015181|100934198|FG000|COMPLETED|Overall Study||3||
48250961|NCT03015181|100934199|FG001|COMPLETED|Overall Study||3||
48250962|NCT03015181|100934200|FG002|COMPLETED|Overall Study||3||
48684245|NCT01354223|102009696|FG000|STARTED|Overall Study||60||
48684246|NCT01354223|102009697|FG001|STARTED|Overall Study||30||
48684247|NCT01354223|102009696|FG000|COMPLETED|Overall Study||57||
48684248|NCT01354223|102009697|FG001|COMPLETED|Overall Study||29||
48684249|NCT01354223|102009696|FG000|NOT COMPLETED|Overall Study||3||
48684250|NCT01354223|102009697|FG001|NOT COMPLETED|Overall Study||1||
48684251|NCT02980107|102009698|FG000|STARTED|Overall Study||105||
48684252|NCT02980107|102009699|FG001|STARTED|Overall Study||107||
48684253|NCT02980107|102009698|FG000|COMPLETED|Overall Study||54||
48684254|NCT02980107|102009699|FG001|COMPLETED|Overall Study||45||
48684255|NCT02980107|102009698|FG000|NOT COMPLETED|Overall Study||51||
48684256|NCT02980107|102009699|FG001|NOT COMPLETED|Overall Study||62||
48684257|NCT01969539|102009700|FG000|STARTED|Overall Study||11||
48088695|NCT00674700|100537340|FG002|STARTED|Year 1||170||
48684258|NCT01969539|102009700|FG000|COMPLETED|Overall Study||11||
48088696|NCT00674700|100537338|FG000|COMPLETED|Year 1||139||
48088697|NCT00674700|100537339|FG001|COMPLETED|Year 1||135||
48088698|NCT00674700|100537340|FG002|COMPLETED|Year 1||153||
48088699|NCT00674700|100537338|FG000|NOT COMPLETED|Year 1||31||
48088700|NCT00674700|100537339|FG001|NOT COMPLETED|Year 1||34||
48088701|NCT00674700|100537340|FG002|NOT COMPLETED|Year 1||17||
48088702|NCT00674700|100537338|FG000|STARTED|Year 2 Follow-up Without Treatment||139||
48088703|NCT00674700|100537339|FG001|STARTED|Year 2 Follow-up Without Treatment||135||
48088704|NCT00674700|100537340|FG002|STARTED|Year 2 Follow-up Without Treatment||153||
48088705|NCT00674700|100537338|FG000|COMPLETED|Year 2 Follow-up Without Treatment||133||
48088706|NCT00674700|100537339|FG001|COMPLETED|Year 2 Follow-up Without Treatment||123||
48088707|NCT00674700|100537340|FG002|COMPLETED|Year 2 Follow-up Without Treatment||141||
48088708|NCT00674700|100537338|FG000|NOT COMPLETED|Year 2 Follow-up Without Treatment||6||
48088709|NCT00674700|100537339|FG001|NOT COMPLETED|Year 2 Follow-up Without Treatment||12||
48088710|NCT00674700|100537340|FG002|NOT COMPLETED|Year 2 Follow-up Without Treatment||12||
48088711|NCT00310791|100537341|FG000|STARTED|Overall Study||40||
48088712|NCT00310791|100537342|FG001|STARTED|Overall Study||40||
48088713|NCT00310791|100537341|FG000|COMPLETED|Overall Study||30||
48088714|NCT00310791|100537342|FG001|COMPLETED|Overall Study||30||
48684259|NCT01969539|102009700|FG000|NOT COMPLETED|Overall Study||0||
48684260|NCT00952705|102009701|FG000|STARTED|Overall Study||1202||
48684261|NCT00952705|102009702|FG001|STARTED|Overall Study||300||
48684262|NCT00952705|102009703|FG002|STARTED|Overall Study||298||
48684263|NCT00952705|102009701|FG000|COMPLETED|Overall Study||1169||
48684264|NCT00952705|102009702|FG001|COMPLETED|Overall Study||290||
48088715|NCT00310791|100537341|FG000|NOT COMPLETED|Overall Study||10||
48088716|NCT00310791|100537342|FG001|NOT COMPLETED|Overall Study||10||
48088717|NCT00936910|100537343|FG000|STARTED|Overall Study||13||
48088718|NCT00936910|100537343|FG000|COMPLETED|Overall Study||10||
48088719|NCT00936910|100537343|FG000|NOT COMPLETED|Overall Study||3||
48088720|NCT00884312|100537344|FG000|STARTED|Overall Study||9||
48088721|NCT00884312|100537345|FG001|STARTED|Overall Study||92||
48088722|NCT00884312|100537344|FG000|Received Treatment|Overall Study||9||
48088723|NCT00884312|100537345|FG001|Received Treatment|Overall Study||91||
48088724|NCT00884312|100537344|FG000|COMPLETED|Overall Study||7|Completed final visit|
48088725|NCT00884312|100537345|FG001|COMPLETED|Overall Study||67|Completed final visit|
48088726|NCT00884312|100537344|FG000|NOT COMPLETED|Overall Study||2||
48088727|NCT00884312|100537345|FG001|NOT COMPLETED|Overall Study||25||
48088728|NCT01741701|100537346|FG000|STARTED|Overall Study||18||
48088729|NCT01741701|100537347|FG001|STARTED|Overall Study||15||
48250963|NCT03015181|100934201|FG003|COMPLETED|Overall Study||3||
48250964|NCT03015181|100934202|FG004|COMPLETED|Overall Study||3||
48250965|NCT03015181|100934203|FG005|COMPLETED|Overall Study||4||
48250966|NCT03015181|100934204|FG006|COMPLETED|Overall Study||4||
48250967|NCT03015181|100934198|FG000|NOT COMPLETED|Overall Study||1||
48250968|NCT03015181|100934199|FG001|NOT COMPLETED|Overall Study||0||
48250969|NCT03015181|100934200|FG002|NOT COMPLETED|Overall Study||0||
48250970|NCT03015181|100934201|FG003|NOT COMPLETED|Overall Study||0||
48250971|NCT03015181|100934202|FG004|NOT COMPLETED|Overall Study||0||
48250972|NCT03015181|100934203|FG005|NOT COMPLETED|Overall Study||1||
48250973|NCT03015181|100934204|FG006|NOT COMPLETED|Overall Study||1||
48250974|NCT00991029|100934205|FG000|STARTED|Overall Study||2432||
48250975|NCT00991029|100934206|FG001|STARTED|Overall Study||2449||
48250976|NCT00991029|100934205|FG000|COMPLETED|Overall Study||2276||
48250977|NCT00991029|100934206|FG001|COMPLETED|Overall Study||2281||
48250978|NCT00991029|100934205|FG000|NOT COMPLETED|Overall Study||156||
48250979|NCT00991029|100934206|FG001|NOT COMPLETED|Overall Study||168||
48250980|NCT00932659|100934207|FG000|STARTED|Overall Study||8||
48250981|NCT00932659|100934207|FG000|COMPLETED|Overall Study||8||
48250982|NCT00932659|100934207|FG000|NOT COMPLETED|Overall Study||0||
48250983|NCT01732588|100934208|FG000|STARTED|First Intervention (7 Days)||4||
48250984|NCT01732588|100934209|FG001|STARTED|First Intervention (7 Days)||3||
48250985|NCT01732588|100934210|FG002|STARTED|First Intervention (7 Days)||4||
48250986|NCT01732588|100934208|FG000|COMPLETED|First Intervention (7 Days)||4||
48250987|NCT01732588|100934209|FG001|COMPLETED|First Intervention (7 Days)||2||
48684265|NCT00952705|102009703|FG002|COMPLETED|Overall Study||288||
48684266|NCT00952705|102009701|FG000|NOT COMPLETED|Overall Study||33||
48684267|NCT00952705|102009702|FG001|NOT COMPLETED|Overall Study||10||
48684268|NCT00952705|102009703|FG002|NOT COMPLETED|Overall Study||10||
48250988|NCT01732588|100934210|FG002|COMPLETED|First Intervention (7 Days)||4||
48250989|NCT01732588|100934208|FG000|NOT COMPLETED|First Intervention (7 Days)||0||
48250990|NCT01732588|100934209|FG001|NOT COMPLETED|First Intervention (7 Days)||1||
48250991|NCT01732588|100934210|FG002|NOT COMPLETED|First Intervention (7 Days)||0||
48250992|NCT01732588|100934208|FG000|STARTED|Second Intervention (7 Days)||4||
48250993|NCT01732588|100934209|FG001|STARTED|Second Intervention (7 Days)||2||
48684269|NCT04005586|102009704|FG000|STARTED|Overall Study||25||
48684270|NCT04005586|102009704|FG000|COMPLETED|Overall Study||25||
48684271|NCT04005586|102009704|FG000|NOT COMPLETED|Overall Study||0||
48684272|NCT01773954|102009705|FG000|STARTED|Overall Study||40||
48684273|NCT01773954|102009705|FG000|COMPLETED|Overall Study||31||
48684274|NCT01773954|102009705|FG000|NOT COMPLETED|Overall Study||9||
48250994|NCT01732588|100934210|FG002|STARTED|Second Intervention (7 Days)||4||
48250995|NCT01732588|100934208|FG000|COMPLETED|Second Intervention (7 Days)||4||
48250996|NCT01732588|100934209|FG001|COMPLETED|Second Intervention (7 Days)||2||
48250997|NCT01732588|100934210|FG002|COMPLETED|Second Intervention (7 Days)||4||
48250998|NCT01732588|100934208|FG000|NOT COMPLETED|Second Intervention (7 Days)||0||
48250999|NCT01732588|100934209|FG001|NOT COMPLETED|Second Intervention (7 Days)||0||
48251000|NCT01732588|100934210|FG002|NOT COMPLETED|Second Intervention (7 Days)||0||
48251001|NCT01732588|100934208|FG000|STARTED|Third Intervention (7 Days)||4||
48251002|NCT01732588|100934209|FG001|STARTED|Third Intervention (7 Days)||2||
48684275|NCT02131311|102009706|FG000|STARTED|Overall Study||90||
48684276|NCT02131311|102009706|FG000|COMPLETED|Overall Study||86||
48684277|NCT02131311|102009706|FG000|NOT COMPLETED|Overall Study||4||
48684278|NCT01126190|102009707|FG000|STARTED|Double-Blind Phase||151||
48684279|NCT01126190|102009708|FG001|STARTED|Double-Blind Phase||153||
48251003|NCT01732588|100934210|FG002|STARTED|Third Intervention (7 Days)||4||
48251004|NCT01732588|100934208|FG000|COMPLETED|Third Intervention (7 Days)||4||
48251005|NCT01732588|100934209|FG001|COMPLETED|Third Intervention (7 Days)||2||
48251006|NCT01732588|100934210|FG002|COMPLETED|Third Intervention (7 Days)||4||
48251007|NCT01732588|100934208|FG000|NOT COMPLETED|Third Intervention (7 Days)||0||
48251008|NCT01732588|100934209|FG001|NOT COMPLETED|Third Intervention (7 Days)||0||
48684280|NCT01126190|102009709|FG002|STARTED|Double-Blind Phase||0||
48684281|NCT01126190|102009707|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Phase||150||
48684282|NCT01126190|102009708|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Phase||153||
48684283|NCT01126190|102009709|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Phase||0||
48684284|NCT01126190|102009707|FG000|Completed Without a Major Protocol Deviation|Double-Blind Phase||148||
48251009|NCT01732588|100934210|FG002|NOT COMPLETED|Third Intervention (7 Days)||0||
48251010|NCT00875615|100934211|FG000|STARTED|Overall Study||11||
48251011|NCT00875615|100934211|FG000|COMPLETED|Overall Study||10||
48251012|NCT00875615|100934211|FG000|NOT COMPLETED|Overall Study||1||
48251013|NCT01772147|100934212|FG000|STARTED|Overall Study||201||
48251014|NCT01772147|100934213|FG001|STARTED|Overall Study||203||
48251015|NCT01772147|100934214|FG002|STARTED|Overall Study||202||
48251016|NCT01772147|100934212|FG000|COMPLETED|Overall Study||170||
48251017|NCT01772147|100934213|FG001|COMPLETED|Overall Study||178||
48251018|NCT01772147|100934214|FG002|COMPLETED|Overall Study||184||
48684285|NCT01126190|102009708|FG001|Completed Without a Major Protocol Deviation|Double-Blind Phase||150||
48684286|NCT01126190|102009709|FG002|Completed Without a Major Protocol Deviation|Double-Blind Phase||77||
48684287|NCT01126190|102009707|FG000|COMPLETED|Double-Blind Phase||145||
48378327|NCT00645567|101255861|FG000|NOT COMPLETED|Overall Study||1||
48378328|NCT02436577|101255862|FG000|STARTED|Overall Study||7||
48378329|NCT02436577|101255863|FG001|STARTED|Overall Study||7||
48378330|NCT02436577|101255864|FG002|STARTED|Overall Study||7||
48378331|NCT02436577|101255865|FG003|STARTED|Overall Study||7||
48378332|NCT02436577|101255866|FG004|STARTED|Overall Study||7||
48378333|NCT02436577|101255867|FG005|STARTED|Overall Study||7||
48378334|NCT02436577|101255862|FG000|COMPLETED|Overall Study||7||
48378335|NCT02436577|101255863|FG001|COMPLETED|Overall Study||6||
48378336|NCT02436577|101255864|FG002|COMPLETED|Overall Study||7||
48378337|NCT02436577|101255865|FG003|COMPLETED|Overall Study||7||
48378338|NCT02436577|101255866|FG004|COMPLETED|Overall Study||7||
48378339|NCT02436577|101255867|FG005|COMPLETED|Overall Study||7||
48378340|NCT02436577|101255862|FG000|NOT COMPLETED|Overall Study||0||
48378341|NCT02436577|101255863|FG001|NOT COMPLETED|Overall Study||1||
48378342|NCT02436577|101255864|FG002|NOT COMPLETED|Overall Study||0||
48378343|NCT02436577|101255865|FG003|NOT COMPLETED|Overall Study||0||
48378344|NCT02436577|101255866|FG004|NOT COMPLETED|Overall Study||0||
48378345|NCT02436577|101255867|FG005|NOT COMPLETED|Overall Study||0||
48378346|NCT00121992|101255868|FG000|STARTED|Overall Study||521||
48378347|NCT00121992|101255869|FG001|STARTED|Overall Study||539||
48378348|NCT00121992|101255868|FG000|Hormone-receptor Positive and HER2 Positive Status Subjects|Overall Study||28||
48378349|NCT00121992|101255869|FG001|Hormone-receptor Positive and HER2 Positive Status Subjects|Overall Study||30||
48378350|NCT00121992|101255868|FG000|Hormone-receptor Negative and HER2 Positive Status Subjects|Overall Study||24||
48378351|NCT00121992|101255869|FG001|Hormone-receptor Negative and HER2 Positive Status Subjects|Overall Study||22||
48378352|NCT00121992|101255868|FG000|Hormone-receptor Positive and HER2 Negative Status Subjects|Overall Study||209||
48378353|NCT00121992|101255869|FG001|Hormone-receptor Positive and HER2 Negative Status Subjects|Overall Study||220||
48378354|NCT00121992|101255868|FG000|Hormone-receptor Negative and HER2 Negative Status Subjects|Overall Study||92||
48378355|NCT00121992|101255869|FG001|Hormone-receptor Negative and HER2 Negative Status Subjects|Overall Study||103||
48378356|NCT00121992|101255868|FG000|COMPLETED|Overall Study||519||
48378357|NCT00121992|101255869|FG001|COMPLETED|Overall Study||528||
48378358|NCT00121992|101255868|FG000|NOT COMPLETED|Overall Study||2||
48378359|NCT00121992|101255869|FG001|NOT COMPLETED|Overall Study||11||
48378360|NCT00074412|101255870|FG000|STARTED|Overall Study||763||
48378361|NCT00074412|101255871|FG001|STARTED|Overall Study||759||
48378362|NCT00074412|101255870|FG000|Week 8 Visit|Overall Study||759||
48378363|NCT00074412|101255871|FG001|Week 8 Visit|Overall Study||759||
48378364|NCT00074412|101255870|FG000|Month 3 Visit|Overall Study||759||
48378365|NCT00074412|101255871|FG001|Month 3 Visit|Overall Study||755||
48378366|NCT00074412|101255870|FG000|Month 4 Visit|Overall Study||758||
48378367|NCT00074412|101255871|FG001|Month 4 Visit|Overall Study||752||
48378368|NCT00074412|101255870|FG000|Month 5 Visit|Overall Study||756||
48378369|NCT00074412|101255871|FG001|Month 5 Visit|Overall Study||750||
48378370|NCT00074412|101255870|FG000|Month 6 Visit|Overall Study||748||
48378371|NCT00074412|101255871|FG001|Month 6 Visit|Overall Study||748||
48378372|NCT00074412|101255870|FG000|Month 9 Visit|Overall Study||741||
48378373|NCT00074412|101255871|FG001|Month 9 Visit|Overall Study||741||
48378374|NCT00074412|101255870|FG000|Month 12 Visit|Overall Study||733||
48378375|NCT00074412|101255871|FG001|Month 12 Visit|Overall Study||735||
48378376|NCT00074412|101255870|FG000|COMPLETED|Overall Study||681||
48378377|NCT00074412|101255871|FG001|COMPLETED|Overall Study||675||
48378378|NCT00074412|101255870|FG000|NOT COMPLETED|Overall Study||82||
48378379|NCT00074412|101255871|FG001|NOT COMPLETED|Overall Study||84||
48378380|NCT00585923|101255872|FG000|STARTED|Overall Study||56||
48378381|NCT00585923|101255873|FG001|STARTED|Overall Study||59||
48378382|NCT00585923|101255872|FG000|COMPLETED|Overall Study||25||
48378383|NCT00585923|101255873|FG001|COMPLETED|Overall Study||26||
48378384|NCT00585923|101255872|FG000|NOT COMPLETED|Overall Study||31||
48378385|NCT00585923|101255873|FG001|NOT COMPLETED|Overall Study||33||
48378386|NCT03075176|101255874|FG000|STARTED|Overall Study||18||18
48378387|NCT03075176|101255875|FG001|STARTED|Overall Study||20||20
48378388|NCT03075176|101255876|FG002|STARTED|Overall Study||18||18
48378389|NCT03075176|101255877|FG003|STARTED|Overall Study||20||20
48378390|NCT03075176|101255874|FG000|COMPLETED|Overall Study||18||18
48378391|NCT03075176|101255875|FG001|COMPLETED|Overall Study||20||20
48378392|NCT03075176|101255876|FG002|COMPLETED|Overall Study||18||18
48378393|NCT03075176|101255877|FG003|COMPLETED|Overall Study||20||20
48378394|NCT03075176|101255874|FG000|NOT COMPLETED|Overall Study||0||0
48378395|NCT03075176|101255875|FG001|NOT COMPLETED|Overall Study||0||0
48378396|NCT03075176|101255876|FG002|NOT COMPLETED|Overall Study||0||0
48378397|NCT03075176|101255877|FG003|NOT COMPLETED|Overall Study||0||0
48378398|NCT02458690|101255878|FG000|STARTED|Overall Study||107||
48378399|NCT02458690|101255879|FG001|STARTED|Overall Study||109||
48378400|NCT02458690|101255878|FG000|COMPLETED|Overall Study||99||
48378401|NCT02458690|101255879|FG001|COMPLETED|Overall Study||100||
48378402|NCT02458690|101255878|FG000|NOT COMPLETED|Overall Study||8||
48378403|NCT02458690|101255879|FG001|NOT COMPLETED|Overall Study||9||
48378404|NCT04056455|101255880|FG000|STARTED|Overall Study||14||
48378405|NCT04056455|101255881|FG001|STARTED|Overall Study||12||
48378406|NCT04056455|101255880|FG000|Safety Analysis Set|Overall Study||14|Safety Analysis Set included all participants who received the dose of study drug.|
48378407|NCT04056455|101255881|FG001|Safety Analysis Set|Overall Study||12|Safety Analysis Set included all participants who received the dose of study drug.|
48378408|NCT04056455|101255880|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||13|PK Analysis Set included all participants who complied sufficiently with the protocol and displayed an evaluable PK profile.|
48378409|NCT04056455|101255881|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||12|PK Analysis Set included all participants who complied sufficiently with the protocol and displayed an evaluable PK profile.|
48378410|NCT04056455|101255880|FG000|COMPLETED|Overall Study||13||
48378411|NCT04056455|101255881|FG001|COMPLETED|Overall Study||12||
48378412|NCT04056455|101255880|FG000|NOT COMPLETED|Overall Study||1||
48378413|NCT04056455|101255881|FG001|NOT COMPLETED|Overall Study||0||
48378414|NCT02023164|101255882|FG000|STARTED|Treatment Period||16||
48378415|NCT02023164|101255883|FG001|STARTED|Treatment Period||17||
48378416|NCT02023164|101255882|FG000|COMPLETED|Treatment Period||16||
48378417|NCT02023164|101255883|FG001|COMPLETED|Treatment Period||17||
48378418|NCT02023164|101255882|FG000|NOT COMPLETED|Treatment Period||0||
48378419|NCT02023164|101255883|FG001|NOT COMPLETED|Treatment Period||0||
48378420|NCT02023164|101255882|FG000|STARTED|24-Hour Follow-Up||16||
48378421|NCT02023164|101255883|FG001|STARTED|24-Hour Follow-Up||17||
48378422|NCT02023164|101255882|FG000|COMPLETED|24-Hour Follow-Up||16||
48378423|NCT02023164|101255883|FG001|COMPLETED|24-Hour Follow-Up||15||
48378424|NCT02023164|101255882|FG000|NOT COMPLETED|24-Hour Follow-Up||0||
48378425|NCT02023164|101255883|FG001|NOT COMPLETED|24-Hour Follow-Up||2||
48378426|NCT03521687|101255884|FG000|STARTED|Overall Study||20||
48378427|NCT03521687|101255884|FG000|COMPLETED|Overall Study||15||
48378428|NCT03521687|101255884|FG000|NOT COMPLETED|Overall Study||5||
48378429|NCT01944969|101255885|FG000|STARTED|Overall Study||26||
48378430|NCT01944969|101255885|FG000|COMPLETED|Overall Study||0||
48378431|NCT01944969|101255885|FG000|NOT COMPLETED|Overall Study||26||
48378432|NCT01725152|101255886|FG000|STARTED|Treatment Period 1 (Week 1 to Week 6)||30||
48378433|NCT01725152|101255887|FG001|STARTED|Treatment Period 1 (Week 1 to Week 6)||29||
48378434|NCT01725152|101255886|FG000|COMPLETED|Treatment Period 1 (Week 1 to Week 6)||26||
48378435|NCT01725152|101255887|FG001|COMPLETED|Treatment Period 1 (Week 1 to Week 6)||29||
48378436|NCT01725152|101255886|FG000|NOT COMPLETED|Treatment Period 1 (Week 1 to Week 6)||4||
48378437|NCT01725152|101255887|FG001|NOT COMPLETED|Treatment Period 1 (Week 1 to Week 6)||0||
48378438|NCT01725152|101255886|FG000|STARTED|Washout Period (2 Weeks)||26||
48378439|NCT01725152|101255887|FG001|STARTED|Washout Period (2 Weeks)||29||
48378440|NCT01725152|101255886|FG000|COMPLETED|Washout Period (2 Weeks)||26||
48378441|NCT01725152|101255887|FG001|COMPLETED|Washout Period (2 Weeks)||29||
48378442|NCT01725152|101255886|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0||
48684288|NCT01126190|102009708|FG001|COMPLETED|Double-Blind Phase||138||
48684289|NCT01126190|102009709|FG002|COMPLETED|Double-Blind Phase||0||
48684290|NCT01126190|102009707|FG000|NOT COMPLETED|Double-Blind Phase||6||
48684291|NCT01126190|102009708|FG001|NOT COMPLETED|Double-Blind Phase||15||
48684292|NCT01126190|102009709|FG002|NOT COMPLETED|Double-Blind Phase||0||
48684293|NCT01126190|102009707|FG000|STARTED|Open-Label Phase||0||
48684294|NCT01126190|102009708|FG001|STARTED|Open-Label Phase||0||
48684295|NCT01126190|102009709|FG002|STARTED|Open-Label Phase||77||
48684296|NCT01126190|102009707|FG000|Received at Least 1 Dose of Study Drug|Open-Label Phase||0||
48684297|NCT01126190|102009708|FG001|Received at Least 1 Dose of Study Drug|Open-Label Phase||0||
48378443|NCT01725152|101255887|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0||
48378444|NCT01725152|101255886|FG000|STARTED|Treatment Period 2 (Week 8 to Week 14)||26||
48378445|NCT01725152|101255887|FG001|STARTED|Treatment Period 2 (Week 8 to Week 14)||29||
48378446|NCT01725152|101255886|FG000|COMPLETED|Treatment Period 2 (Week 8 to Week 14)||25||
48378447|NCT01725152|101255887|FG001|COMPLETED|Treatment Period 2 (Week 8 to Week 14)||26||
48378448|NCT01725152|101255886|FG000|NOT COMPLETED|Treatment Period 2 (Week 8 to Week 14)||1||
48378449|NCT01725152|101255887|FG001|NOT COMPLETED|Treatment Period 2 (Week 8 to Week 14)||3||
48378450|NCT00446446|101255888|FG000|STARTED|Overall Study||52||
48378451|NCT00446446|101255888|FG000|COMPLETED|Overall Study||28||
48378452|NCT00446446|101255888|FG000|NOT COMPLETED|Overall Study||24||
48378453|NCT03226223|101255889|FG000|STARTED|Overall Study||10||
48378454|NCT03226223|101255890|FG001|STARTED|Overall Study||8||
48378455|NCT03226223|101255889|FG000|COMPLETED|Overall Study||8||
48378456|NCT03226223|101255890|FG001|COMPLETED|Overall Study||6||
48378457|NCT03226223|101255889|FG000|NOT COMPLETED|Overall Study||2||
48684298|NCT01126190|102009709|FG002|Received at Least 1 Dose of Study Drug|Open-Label Phase||77||
48684299|NCT01126190|102009707|FG000|COMPLETED|Open-Label Phase||0||
48684300|NCT01126190|102009708|FG001|COMPLETED|Open-Label Phase||0||
48684301|NCT01126190|102009709|FG002|COMPLETED|Open-Label Phase||66||
48684302|NCT01126190|102009707|FG000|NOT COMPLETED|Open-Label Phase||0||
48378458|NCT03226223|101255890|FG001|NOT COMPLETED|Overall Study||2||
48378459|NCT01860534|101255891|FG000|STARTED|ROP #1||14||
48378460|NCT01860534|101255892|FG001|STARTED|ROP #1||14||
48378461|NCT01860534|101255891|FG000|COMPLETED|ROP #1||14||
48378462|NCT01860534|101255892|FG001|COMPLETED|ROP #1||13||
48378463|NCT01860534|101255891|FG000|NOT COMPLETED|ROP #1||0||
48684303|NCT01126190|102009708|FG001|NOT COMPLETED|Open-Label Phase||0||
48684304|NCT01126190|102009709|FG002|NOT COMPLETED|Open-Label Phase||11||
48378464|NCT01860534|101255892|FG001|NOT COMPLETED|ROP #1||1||
48378465|NCT01860534|101255891|FG000|STARTED|ROP #2||14||
48378466|NCT01860534|101255892|FG001|STARTED|ROP #2||13||
48251019|NCT01772147|100934212|FG000|NOT COMPLETED|Overall Study||31||
48251020|NCT01772147|100934213|FG001|NOT COMPLETED|Overall Study||25||
48251021|NCT01772147|100934214|FG002|NOT COMPLETED|Overall Study||18||
48251022|NCT00515697|100934215|FG000|STARTED|Overall Study||39||
48251023|NCT00515697|100934215|FG000|Received at Least 1 Dose of Study Drug|Overall Study||39||
48251024|NCT00515697|100934215|FG000|COMPLETED|Overall Study||39||
48251025|NCT00515697|100934215|FG000|NOT COMPLETED|Overall Study||0||
48251026|NCT02301364|100934216|FG000|STARTED|Overall Study||4||
48251027|NCT02301364|100934216|FG000|COMPLETED|Overall Study||4||
48378467|NCT01860534|101255891|FG000|COMPLETED|ROP #2||13||
48378468|NCT01860534|101255892|FG001|COMPLETED|ROP #2||13||
48378469|NCT01860534|101255891|FG000|NOT COMPLETED|ROP #2||1||
48378470|NCT01860534|101255892|FG001|NOT COMPLETED|ROP #2||0||
48378471|NCT01151579|101255893|FG000|STARTED|Overall Study||58||
48378472|NCT01151579|101255894|FG001|STARTED|Overall Study||31||
48378473|NCT01151579|101255893|FG000|COMPLETED|Overall Study||46||
48378474|NCT01151579|101255894|FG001|COMPLETED|Overall Study||24||
48684305|NCT01775553|102009710|FG000|STARTED|Overall Study||13||
48684306|NCT01775553|102009710|FG000|COMPLETED|Overall Study||0||
48684307|NCT01775553|102009710|FG000|NOT COMPLETED|Overall Study||13||
48684308|NCT00673231|102009711|FG000|STARTED|Overall Study||197||
48684309|NCT00673231|102009712|FG001|STARTED|Overall Study||202||
48684310|NCT00673231|102009713|FG002|STARTED|Overall Study||212||
48684311|NCT00673231|102009714|FG003|STARTED|Overall Study||196||
48251028|NCT02301364|100934216|FG000|NOT COMPLETED|Overall Study||0||
48251029|NCT01723514|100934217|FG000|STARTED|Overall Study||8||
48251030|NCT01723514|100934218|FG001|STARTED|Overall Study||6||
48251031|NCT01723514|100934219|FG002|STARTED|Overall Study||6||
48251032|NCT01723514|100934220|FG003|STARTED|Overall Study||6||
48251033|NCT01723514|100934221|FG004|STARTED|Overall Study||6||
48378475|NCT01151579|101255893|FG000|NOT COMPLETED|Overall Study||12||
48378476|NCT01151579|101255894|FG001|NOT COMPLETED|Overall Study||7||
48378477|NCT01737840|101255895|FG000|STARTED|Overall Study||35||
48378478|NCT01737840|101255896|FG001|STARTED|Overall Study||35||
48684312|NCT00673231|102009711|FG000|COMPLETED|Overall Study||168||
48684313|NCT00673231|102009712|FG001|COMPLETED|Overall Study||180||
48684314|NCT00673231|102009713|FG002|COMPLETED|Overall Study||186||
48684315|NCT00673231|102009714|FG003|COMPLETED|Overall Study||178||
48684316|NCT00673231|102009711|FG000|NOT COMPLETED|Overall Study||29||
48684317|NCT00673231|102009712|FG001|NOT COMPLETED|Overall Study||22||
48684318|NCT00673231|102009713|FG002|NOT COMPLETED|Overall Study||26||
48684319|NCT00673231|102009714|FG003|NOT COMPLETED|Overall Study||18||
48684320|NCT00645840|102009715|FG000|STARTED|Overall Study||15||
48684321|NCT00645840|102009715|FG000|COMPLETED|Overall Study||12||
48684322|NCT00645840|102009715|FG000|NOT COMPLETED|Overall Study||3||
48684323|NCT00363142|102009716|FG000|STARTED|Overall Study||140||
48684324|NCT00363142|102009717|FG001|STARTED|Overall Study||69||
48684325|NCT00363142|102009716|FG000|COMPLETED|Overall Study||133||
48684326|NCT00363142|102009717|FG001|COMPLETED|Overall Study||66||
48684327|NCT00363142|102009716|FG000|NOT COMPLETED|Overall Study||7||
48684328|NCT00363142|102009717|FG001|NOT COMPLETED|Overall Study||3||
48684329|NCT01133665|102009718|FG000|STARTED|Overall Study||42||
48684330|NCT01133665|102009718|FG000|COMPLETED|Overall Study||40||
48684331|NCT01133665|102009718|FG000|NOT COMPLETED|Overall Study||2||
48684332|NCT00971282|102009719|FG000|STARTED|Overall Study||30||
48684333|NCT00971282|102009719|FG000|COMPLETED|Overall Study||30||
48684334|NCT00971282|102009719|FG000|NOT COMPLETED|Overall Study||0||
48684335|NCT00362882|102009720|FG000|STARTED|Overall Study||40||
48684336|NCT00362882|102009721|FG001|STARTED|Overall Study||41||
48251034|NCT01723514|100934222|FG005|STARTED|Overall Study||4||
48251035|NCT01723514|100934223|FG006|STARTED|Overall Study||6||
48251036|NCT01723514|100934224|FG007|STARTED|Overall Study||6||
48251037|NCT01723514|100934217|FG000|COMPLETED|Overall Study||8||
48251038|NCT01723514|100934218|FG001|COMPLETED|Overall Study||6||
48251039|NCT01723514|100934219|FG002|COMPLETED|Overall Study||6||
48251040|NCT01723514|100934220|FG003|COMPLETED|Overall Study||6||
48251041|NCT01723514|100934221|FG004|COMPLETED|Overall Study||6||
48378479|NCT01737840|101255895|FG000|COMPLETED|Overall Study||33||
48378480|NCT01737840|101255896|FG001|COMPLETED|Overall Study||33||
48378481|NCT01737840|101255895|FG000|NOT COMPLETED|Overall Study||2||
48378482|NCT01737840|101255896|FG001|NOT COMPLETED|Overall Study||2||
48378483|NCT01987349|101255897|FG000|STARTED|Overall Study||6||
48378484|NCT01987349|101255898|FG001|STARTED|Overall Study||6||
48684337|NCT00362882|102009720|FG000|COMPLETED|Overall Study||40||
48684338|NCT00362882|102009721|FG001|COMPLETED|Overall Study||41||
48684339|NCT00362882|102009720|FG000|NOT COMPLETED|Overall Study||0||
48684340|NCT00362882|102009721|FG001|NOT COMPLETED|Overall Study||0||
48684341|NCT04828135|102009722|FG000|STARTED|Overall Study||18||
48088730|NCT01741701|100537346|FG000|COMPLETED|Overall Study||13||
48378485|NCT01987349|101255899|FG002|STARTED|Overall Study||8||
48378486|NCT01987349|101255900|FG003|STARTED|Overall Study||6||
48378487|NCT01987349|101255901|FG004|STARTED|Overall Study||6||
48378488|NCT01987349|101255902|FG005|STARTED|Overall Study||6||
48378489|NCT01987349|101255903|FG006|STARTED|Overall Study||10||
48378490|NCT01987349|101255904|FG007|STARTED|Overall Study||25||
48378491|NCT01987349|101255897|FG000|COMPLETED|Overall Study||6||
48378492|NCT01987349|101255898|FG001|COMPLETED|Overall Study||6||
48378493|NCT01987349|101255899|FG002|COMPLETED|Overall Study||8||
48378494|NCT01987349|101255900|FG003|COMPLETED|Overall Study||6||
48378495|NCT01987349|101255901|FG004|COMPLETED|Overall Study||6||
48378496|NCT01987349|101255902|FG005|COMPLETED|Overall Study||6||
48378497|NCT01987349|101255903|FG006|COMPLETED|Overall Study||10||
48378498|NCT01987349|101255904|FG007|COMPLETED|Overall Study||24||
48378499|NCT01987349|101255897|FG000|NOT COMPLETED|Overall Study||0||
48088731|NCT01741701|100537347|FG001|COMPLETED|Overall Study||13||
48088732|NCT01741701|100537346|FG000|NOT COMPLETED|Overall Study||5||
48088733|NCT01741701|100537347|FG001|NOT COMPLETED|Overall Study||2||
48088734|NCT00750204|100537348|FG000|STARTED|Overall Study||1||
48088735|NCT00750204|100537349|FG001|STARTED|Overall Study||1||
48088736|NCT00750204|100537348|FG000|COMPLETED|Overall Study||0||
48088737|NCT00750204|100537349|FG001|COMPLETED|Overall Study||0||
48088738|NCT00750204|100537348|FG000|NOT COMPLETED|Overall Study||1||
48088739|NCT00750204|100537349|FG001|NOT COMPLETED|Overall Study||1||
48088740|NCT02756689|100537350|FG000|STARTED|Overall Study||64||
48088741|NCT02756689|100537351|FG001|STARTED|Overall Study||65||
48088742|NCT02756689|100537350|FG000|COMPLETED|Overall Study||64||
48088743|NCT02756689|100537351|FG001|COMPLETED|Overall Study||65||
48088744|NCT02756689|100537350|FG000|NOT COMPLETED|Overall Study||0||
48088745|NCT02756689|100537351|FG001|NOT COMPLETED|Overall Study||0||
48088746|NCT02403154|100537352|FG000|STARTED|Overall Study||2||
48088747|NCT02403154|100537353|FG001|STARTED|Overall Study||0||
48088748|NCT02403154|100537354|FG002|STARTED|Overall Study||1||
48088749|NCT02403154|100537355|FG003|STARTED|Overall Study||1||
48088750|NCT02403154|100537352|FG000|COMPLETED|Overall Study||0||
48088751|NCT02403154|100537353|FG001|COMPLETED|Overall Study||0||
48088752|NCT02403154|100537354|FG002|COMPLETED|Overall Study||0||
48088753|NCT02403154|100537355|FG003|COMPLETED|Overall Study||0||
48088754|NCT02403154|100537352|FG000|NOT COMPLETED|Overall Study||2||
48088755|NCT02403154|100537353|FG001|NOT COMPLETED|Overall Study||0||
48088756|NCT02403154|100537354|FG002|NOT COMPLETED|Overall Study||1||
48088757|NCT02403154|100537355|FG003|NOT COMPLETED|Overall Study||1||
48088758|NCT01402492|100537356|FG000|STARTED|Overall Study||100||
48088759|NCT01402492|100537357|FG001|STARTED|Overall Study||100||
48088760|NCT01402492|100537358|FG002|STARTED|Overall Study||102||
48088761|NCT01402492|100537356|FG000|COMPLETED|Overall Study||79||
48088762|NCT01402492|100537357|FG001|COMPLETED|Overall Study||83||
48088763|NCT01402492|100537358|FG002|COMPLETED|Overall Study||86||
48088764|NCT01402492|100537356|FG000|NOT COMPLETED|Overall Study||21||
48088765|NCT01402492|100537357|FG001|NOT COMPLETED|Overall Study||17||
48088766|NCT01402492|100537358|FG002|NOT COMPLETED|Overall Study||16||
48088767|NCT03965962|100537359|FG000|STARTED|Overall Study||320||
48088768|NCT03965962|100537360|FG001|STARTED|Overall Study||107||
48088769|NCT03965962|100537361|FG002|STARTED|Overall Study||107||
48088770|NCT03965962|100537362|FG003|STARTED|Overall Study||106||
48088771|NCT03965962|100537359|FG000|Vaccination 1 (Day 0)|Overall Study||318||
48088772|NCT03965962|100537360|FG001|Vaccination 1 (Day 0)|Overall Study||107||
48088773|NCT03965962|100537361|FG002|Vaccination 1 (Day 0)|Overall Study||107||
48088774|NCT03965962|100537362|FG003|Vaccination 1 (Day 0)|Overall Study||106||
48088775|NCT03965962|100537359|FG000|Vaccination 2 (Day 3)|Overall Study||317||
48088776|NCT03965962|100537360|FG001|Vaccination 2 (Day 3)|Overall Study||104||
48088777|NCT03965962|100537361|FG002|Vaccination 2 (Day 3)|Overall Study||107||
48088778|NCT03965962|100537362|FG003|Vaccination 2 (Day 3)|Overall Study||106||
48088779|NCT03965962|100537359|FG000|Vaccination 3 (Day 7)|Overall Study||311||
48088780|NCT03965962|100537360|FG001|Vaccination 3 (Day 7)|Overall Study||103||
48088781|NCT03965962|100537361|FG002|Vaccination 3 (Day 7)|Overall Study||105||
48088782|NCT03965962|100537362|FG003|Vaccination 3 (Day 7)|Overall Study||105||
48088783|NCT03965962|100537359|FG000|Vaccination 4 (Day 14)|Overall Study||301||
48088784|NCT03965962|100537360|FG001|Vaccination 4 (Day 14)|Overall Study||101||
48088785|NCT03965962|100537361|FG002|Vaccination 4 (Day 14)|Overall Study||101||
48088786|NCT03965962|100537362|FG003|Vaccination 4 (Day 14)|Overall Study||103||
48088787|NCT03965962|100537359|FG000|Vaccination 5 (Day 28)|Overall Study||294||
48088788|NCT03965962|100537360|FG001|Vaccination 5 (Day 28)|Overall Study||98||
48378500|NCT01987349|101255898|FG001|NOT COMPLETED|Overall Study||0||
48378501|NCT01987349|101255899|FG002|NOT COMPLETED|Overall Study||0||
48378502|NCT01987349|101255900|FG003|NOT COMPLETED|Overall Study||0||
48378503|NCT01987349|101255901|FG004|NOT COMPLETED|Overall Study||0||
48378504|NCT01987349|101255902|FG005|NOT COMPLETED|Overall Study||0||
48378505|NCT01987349|101255903|FG006|NOT COMPLETED|Overall Study||0||
48378506|NCT01987349|101255904|FG007|NOT COMPLETED|Overall Study||1||
48378507|NCT00462020|101255905|FG000|STARTED|Overall Study||52||
48684342|NCT04828135|102009722|FG000|COMPLETED|Overall Study||13||
48684343|NCT04828135|102009722|FG000|NOT COMPLETED|Overall Study||5||
48684344|NCT01261975|102009723|FG000|STARTED|Overall Study||36||
48684345|NCT01261975|102009723|FG000|COMPLETED|Overall Study||35||
48684346|NCT01261975|102009723|FG000|NOT COMPLETED|Overall Study||1||
48251042|NCT01723514|100934222|FG005|COMPLETED|Overall Study||4||
48251043|NCT01723514|100934223|FG006|COMPLETED|Overall Study||6||
48251044|NCT01723514|100934224|FG007|COMPLETED|Overall Study||6||
48251045|NCT01723514|100934217|FG000|NOT COMPLETED|Overall Study||0||
48251046|NCT01723514|100934218|FG001|NOT COMPLETED|Overall Study||0||
48251047|NCT01723514|100934219|FG002|NOT COMPLETED|Overall Study||0||
48251048|NCT01723514|100934220|FG003|NOT COMPLETED|Overall Study||0||
48251049|NCT01723514|100934221|FG004|NOT COMPLETED|Overall Study||0||
48251050|NCT01723514|100934222|FG005|NOT COMPLETED|Overall Study||0||
48251051|NCT01723514|100934223|FG006|NOT COMPLETED|Overall Study||0||
48251052|NCT01723514|100934224|FG007|NOT COMPLETED|Overall Study||0||
48251053|NCT02394925|100934225|FG000|STARTED|Overall Study||108||
48251054|NCT02394925|100934225|FG000|COMPLETED|Overall Study||79||
48251055|NCT02394925|100934225|FG000|NOT COMPLETED|Overall Study||29||
48251056|NCT01201915|100934226|FG000|STARTED|Overall Study||24||
48251057|NCT01201915|100934227|FG001|STARTED|Overall Study||25||
48251058|NCT01201915|100934228|FG002|STARTED|Overall Study||25||
48251059|NCT01201915|100934226|FG000|COMPLETED|Overall Study||16||
48251060|NCT01201915|100934227|FG001|COMPLETED|Overall Study||14||
48251061|NCT01201915|100934228|FG002|COMPLETED|Overall Study||19||
48251062|NCT01201915|100934226|FG000|NOT COMPLETED|Overall Study||8||
48251063|NCT01201915|100934227|FG001|NOT COMPLETED|Overall Study||11||
48251064|NCT01201915|100934228|FG002|NOT COMPLETED|Overall Study||6||
48251065|NCT01828593|100934229|FG000|STARTED|Placebo-Controlled Phase||36||
48251066|NCT01828593|100934230|FG001|STARTED|Placebo-Controlled Phase||34||
48251067|NCT01828593|100934231|FG002|STARTED|Placebo-Controlled Phase||33||
48251068|NCT01828593|100934229|FG000|COMPLETED|Placebo-Controlled Phase||36||
48251069|NCT01828593|100934230|FG001|COMPLETED|Placebo-Controlled Phase||34||
48251070|NCT01828593|100934231|FG002|COMPLETED|Placebo-Controlled Phase||32||
48251071|NCT01828593|100934229|FG000|NOT COMPLETED|Placebo-Controlled Phase||0||
48251072|NCT01828593|100934230|FG001|NOT COMPLETED|Placebo-Controlled Phase||0||
48251073|NCT01828593|100934231|FG002|NOT COMPLETED|Placebo-Controlled Phase||1||
48251074|NCT01828593|100934229|FG000|STARTED|Placebo-Free Phase||0||
48251075|NCT01828593|100934230|FG001|STARTED|Placebo-Free Phase||55||
48251076|NCT01828593|100934231|FG002|STARTED|Placebo-Free Phase||47||
48251077|NCT01828593|100934229|FG000|COMPLETED|Placebo-Free Phase||0||
48251078|NCT01828593|100934230|FG001|COMPLETED|Placebo-Free Phase||49||
48251079|NCT01828593|100934231|FG002|COMPLETED|Placebo-Free Phase||41||
48251080|NCT01828593|100934229|FG000|NOT COMPLETED|Placebo-Free Phase||0||
48251081|NCT01828593|100934230|FG001|NOT COMPLETED|Placebo-Free Phase||6||
48251082|NCT01828593|100934231|FG002|NOT COMPLETED|Placebo-Free Phase||6||
48251083|NCT00644332|100934232|FG000|STARTED|Overall Study||171||
48251084|NCT00644332|100934232|FG000|COMPLETED|Overall Study||150||
48251085|NCT00644332|100934232|FG000|NOT COMPLETED|Overall Study||21||
48251086|NCT00702273|100934233|FG000|STARTED|Base Study P05787 (NCT00696800)||757||
48251087|NCT00702273|100934234|FG001|STARTED|Base Study P05787 (NCT00696800)||752||
48251088|NCT00702273|100934233|FG000|Treated|Base Study P05787 (NCT00696800)||756||
48251089|NCT00702273|100934234|FG001|Treated|Base Study P05787 (NCT00696800)||750||
48251090|NCT00702273|100934233|FG000|COMPLETED|Base Study P05787 (NCT00696800)||672||
48251091|NCT00702273|100934234|FG001|COMPLETED|Base Study P05787 (NCT00696800)||704||
48251092|NCT00702273|100934233|FG000|NOT COMPLETED|Base Study P05787 (NCT00696800)||85||
48251093|NCT00702273|100934234|FG001|NOT COMPLETED|Base Study P05787 (NCT00696800)||48||
48251094|NCT00702273|100934233|FG000|STARTED|Follow Up Study P05716 (NCT00702273)||168||
48251095|NCT00702273|100934234|FG001|STARTED|Follow Up Study P05716 (NCT00702273)||176||
48251096|NCT00702273|100934233|FG000|COMPLETED|Follow Up Study P05716 (NCT00702273)||148||
48251097|NCT00702273|100934234|FG001|COMPLETED|Follow Up Study P05716 (NCT00702273)||147||
48251098|NCT00702273|100934233|FG000|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||20||
48251099|NCT00702273|100934234|FG001|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||29||
48251100|NCT01157377|100934235|FG000|STARTED|Overall Study||23||
48251101|NCT01157377|100934236|FG001|STARTED|Overall Study||23||
48684347|NCT01736267|102009724|FG000|STARTED|Overall Study||3||
48684348|NCT01736267|102009724|FG000|COMPLETED|Overall Study||3||
48684349|NCT01736267|102009724|FG000|NOT COMPLETED|Overall Study||0||
48684350|NCT03089047|102009725|FG000|STARTED|Overall Study||2||
48684351|NCT03089047|102009726|FG001|STARTED|Overall Study||2||
48684352|NCT03089047|102009725|FG000|COMPLETED|Overall Study||1||
48251102|NCT01157377|100934237|FG002|STARTED|Overall Study||27||
48251103|NCT01157377|100934238|FG003|STARTED|Overall Study||15||
48251104|NCT01157377|100934239|FG004|STARTED|Overall Study||20||
48251105|NCT01157377|100934240|FG005|STARTED|Overall Study||19||
48251106|NCT01157377|100934241|FG006|STARTED|Overall Study||29||
48251107|NCT01157377|100934235|FG000|COMPLETED|Overall Study||21||
48684353|NCT03089047|102009726|FG001|COMPLETED|Overall Study||2||
48684354|NCT03089047|102009725|FG000|NOT COMPLETED|Overall Study||1||
48684355|NCT03089047|102009726|FG001|NOT COMPLETED|Overall Study||0||
48088789|NCT03965962|100537361|FG002|Vaccination 5 (Day 28)|Overall Study||97||
48251108|NCT01157377|100934236|FG001|COMPLETED|Overall Study||20||
48251109|NCT01157377|100934237|FG002|COMPLETED|Overall Study||26||
48251110|NCT01157377|100934238|FG003|COMPLETED|Overall Study||14||
48251111|NCT01157377|100934239|FG004|COMPLETED|Overall Study||18||
48251112|NCT01157377|100934240|FG005|COMPLETED|Overall Study||16||
48251113|NCT01157377|100934241|FG006|COMPLETED|Overall Study||27||
48251114|NCT01157377|100934235|FG000|NOT COMPLETED|Overall Study||2||
48251115|NCT01157377|100934236|FG001|NOT COMPLETED|Overall Study||3||
48251116|NCT01157377|100934237|FG002|NOT COMPLETED|Overall Study||1||
48251117|NCT01157377|100934238|FG003|NOT COMPLETED|Overall Study||1||
48251118|NCT01157377|100934239|FG004|NOT COMPLETED|Overall Study||2||
48251119|NCT01157377|100934240|FG005|NOT COMPLETED|Overall Study||3||
48251120|NCT01157377|100934241|FG006|NOT COMPLETED|Overall Study||2||
48251121|NCT02675998|100934242|FG000|STARTED|8-Week Treatment Period||74||
48251122|NCT02675998|100934243|FG001|STARTED|8-Week Treatment Period||73||
48251123|NCT02675998|100934244|FG002|STARTED|8-Week Treatment Period||72||
48251124|NCT02675998|100934245|FG003|STARTED|8-Week Treatment Period||0||
48251125|NCT02675998|100934242|FG000|COMPLETED|8-Week Treatment Period||57||
48251126|NCT02675998|100934243|FG001|COMPLETED|8-Week Treatment Period||54||
48251127|NCT02675998|100934244|FG002|COMPLETED|8-Week Treatment Period||53||
48251128|NCT02675998|100934245|FG003|COMPLETED|8-Week Treatment Period||0||
48251129|NCT02675998|100934242|FG000|NOT COMPLETED|8-Week Treatment Period||17||
48251130|NCT02675998|100934243|FG001|NOT COMPLETED|8-Week Treatment Period||19||
48251131|NCT02675998|100934244|FG002|NOT COMPLETED|8-Week Treatment Period||19||
48251132|NCT02675998|100934245|FG003|NOT COMPLETED|8-Week Treatment Period||0||
48251133|NCT02675998|100934242|FG000|STARTED|4-Week Randomized Withdrawal Period||25|The number of patients in combined tenapanor groups is less since half were re-randomized to Placebo|
48251134|NCT02675998|100934243|FG001|STARTED|4-Week Randomized Withdrawal Period||23|The number of patients in combined tenapanor groups is less since half were re-randomized to Placebo|
48251135|NCT02675998|100934244|FG002|STARTED|4-Week Randomized Withdrawal Period||34|The number of patients in combined tenapanor groups is less since half were re-randomized to Placebo|
48251136|NCT02675998|100934245|FG003|STARTED|4-Week Randomized Withdrawal Period||82|The number of patients in combined tenapanor groups is less since half were re-randomized to Placebo|
48251137|NCT02675998|100934242|FG000|COMPLETED|4-Week Randomized Withdrawal Period||24||
48251138|NCT02675998|100934243|FG001|COMPLETED|4-Week Randomized Withdrawal Period||22||
48251139|NCT02675998|100934244|FG002|COMPLETED|4-Week Randomized Withdrawal Period||32||
48251140|NCT02675998|100934245|FG003|COMPLETED|4-Week Randomized Withdrawal Period||74||
48251141|NCT02675998|100934242|FG000|NOT COMPLETED|4-Week Randomized Withdrawal Period||1||
48251142|NCT02675998|100934243|FG001|NOT COMPLETED|4-Week Randomized Withdrawal Period||1||
48251143|NCT02675998|100934244|FG002|NOT COMPLETED|4-Week Randomized Withdrawal Period||2||
48251144|NCT02675998|100934245|FG003|NOT COMPLETED|4-Week Randomized Withdrawal Period||8||
48251145|NCT02110225|100934246|FG000|STARTED|Overall Study||20||
48251146|NCT02110225|100934247|FG001|STARTED|Overall Study||20||
48251147|NCT02110225|100934248|FG002|STARTED|Overall Study||10||
48251148|NCT02110225|100934246|FG000|COMPLETED|Overall Study||20||
48251149|NCT02110225|100934247|FG001|COMPLETED|Overall Study||19||
48251150|NCT02110225|100934248|FG002|COMPLETED|Overall Study||10||
48251151|NCT02110225|100934246|FG000|NOT COMPLETED|Overall Study||0||
48251152|NCT02110225|100934247|FG001|NOT COMPLETED|Overall Study||1||
48251153|NCT02110225|100934248|FG002|NOT COMPLETED|Overall Study||0||
48251154|NCT00578318|100934249|FG000|STARTED|Overall Study||8||
48251155|NCT00578318|100934250|FG001|STARTED|Overall Study||8||
48251156|NCT00578318|100934249|FG000|COMPLETED|Overall Study||5||
48251157|NCT00578318|100934250|FG001|COMPLETED|Overall Study||8||
48251158|NCT00578318|100934249|FG000|NOT COMPLETED|Overall Study||3||
48251159|NCT00578318|100934250|FG001|NOT COMPLETED|Overall Study||0||
48251160|NCT02201771|100934251|FG000|STARTED|Overall Study||166||
48251161|NCT02201771|100934252|FG001|STARTED|Overall Study||168||
48251162|NCT02201771|100934253|FG002|STARTED|Overall Study||166||
48251163|NCT02201771|100934251|FG000|COMPLETED|Overall Study||153||
48251164|NCT02201771|100934252|FG001|COMPLETED|Overall Study||158||
48251165|NCT02201771|100934253|FG002|COMPLETED|Overall Study||156||
48251166|NCT02201771|100934251|FG000|NOT COMPLETED|Overall Study||13||
48251167|NCT02201771|100934252|FG001|NOT COMPLETED|Overall Study||10||
48088790|NCT03965962|100537362|FG003|Vaccination 5 (Day 28)|Overall Study||98||
48088791|NCT03965962|100537359|FG000|Safety Analysis Set (SafAS)|Overall Study||320|SafAS: Participant who received at least one dose of vaccine and were analyzed as per actual vaccination received.|
48088792|NCT03965962|100537360|FG001|Safety Analysis Set (SafAS)|Overall Study||107|SafAS: Participant who received at least one dose of vaccine and were analyzed as per actual vaccination received.|
48088793|NCT03965962|100537361|FG002|Safety Analysis Set (SafAS)|Overall Study||107|SafAS: Participant who received at least one dose of vaccine and were analyzed as per actual vaccination received.|
48088794|NCT03965962|100537362|FG003|Safety Analysis Set (SafAS)|Overall Study||104|SafAS: Participant who received at least one dose of vaccine and were analyzed as per actual vaccination received.|
48088795|NCT03965962|100537359|FG000|COMPLETED|Overall Study||295||
48088796|NCT03965962|100537360|FG001|COMPLETED|Overall Study||102||
48088797|NCT03965962|100537361|FG002|COMPLETED|Overall Study||97||
48088798|NCT03965962|100537362|FG003|COMPLETED|Overall Study||100||
48088799|NCT03965962|100537359|FG000|NOT COMPLETED|Overall Study||25||
48088800|NCT03965962|100537360|FG001|NOT COMPLETED|Overall Study||5||
48378508|NCT00462020|101255906|FG001|STARTED|Overall Study||50||
48378509|NCT00462020|101255905|FG000|COMPLETED|Overall Study||52||
48378510|NCT00462020|101255906|FG001|COMPLETED|Overall Study||50||
48378511|NCT00462020|101255905|FG000|NOT COMPLETED|Overall Study||0||
48378512|NCT00462020|101255906|FG001|NOT COMPLETED|Overall Study||0||
48378513|NCT01586156|101255907|FG000|STARTED|Overall Study||10||
48378514|NCT01586156|101255908|FG001|STARTED|Overall Study||10||
48378515|NCT01586156|101255909|FG002|STARTED|Overall Study||10||
48088801|NCT03965962|100537361|FG002|NOT COMPLETED|Overall Study||10||
48378516|NCT01586156|101255907|FG000|COMPLETED|Overall Study||10||
48378517|NCT01586156|101255908|FG001|COMPLETED|Overall Study||9||
48378518|NCT01586156|101255909|FG002|COMPLETED|Overall Study||10||
48378519|NCT01586156|101255907|FG000|NOT COMPLETED|Overall Study||0||
48378520|NCT01586156|101255908|FG001|NOT COMPLETED|Overall Study||1||
48378521|NCT01586156|101255909|FG002|NOT COMPLETED|Overall Study||0||
48378522|NCT02891798|101255910|FG000|STARTED|Overall Study||62||
48378523|NCT02891798|101255911|FG001|STARTED|Overall Study||16||
48378524|NCT02891798|101255910|FG000|COMPLETED|Overall Study||62||
48378525|NCT02891798|101255911|FG001|COMPLETED|Overall Study||16||
48378526|NCT02891798|101255910|FG000|NOT COMPLETED|Overall Study||0||
48378527|NCT02891798|101255911|FG001|NOT COMPLETED|Overall Study||0||
48378528|NCT01003080|101255912|FG000|STARTED|Overall Study||50||
48378529|NCT01003080|101255913|FG001|STARTED|Overall Study||61||
48378530|NCT01003080|101255912|FG000|COMPLETED|Overall Study||50||
48378531|NCT01003080|101255913|FG001|COMPLETED|Overall Study||61||
48378532|NCT01003080|101255912|FG000|NOT COMPLETED|Overall Study||0||
48378533|NCT01003080|101255913|FG001|NOT COMPLETED|Overall Study||0||
48684356|NCT00573391|102009727|FG000|STARTED|Overall Study||3||
48684357|NCT00573391|102009728|FG001|STARTED|Overall Study||2||
48684358|NCT00573391|102009727|FG000|COMPLETED|Overall Study||0||
48684359|NCT00573391|102009728|FG001|COMPLETED|Overall Study||0||
48684360|NCT00573391|102009727|FG000|NOT COMPLETED|Overall Study||3||
48684361|NCT00573391|102009728|FG001|NOT COMPLETED|Overall Study||2||
48684362|NCT04403919|102009729|FG000|STARTED|Overall Study||22||
48378534|NCT03813719|101255914|FG000|STARTED|Overall Study||250||
48378535|NCT03813719|101255914|FG000|COMPLETED|Overall Study||250||
48378536|NCT03813719|101255914|FG000|NOT COMPLETED|Overall Study||0||
48378537|NCT02104804|101255915|FG000|STARTED|Overall Study||234||
48378538|NCT02104804|101255916|FG001|STARTED|Overall Study||232||
48378539|NCT02104804|101255915|FG000|COMPLETED|Overall Study||218||
48378540|NCT02104804|101255916|FG001|COMPLETED|Overall Study||213||
48378541|NCT02104804|101255915|FG000|NOT COMPLETED|Overall Study||16||
48378542|NCT02104804|101255916|FG001|NOT COMPLETED|Overall Study||19||
48378543|NCT03806179|101255917|FG000|STARTED|Overall Study||4||
48378544|NCT03806179|101255918|FG001|STARTED|Overall Study||3||
48684363|NCT04403919|102009730|FG001|STARTED|Overall Study||30||
48684364|NCT04403919|102009731|FG002|STARTED|Overall Study||18||
48088802|NCT03965962|100537362|FG003|NOT COMPLETED|Overall Study||6||
48378545|NCT03806179|101255917|FG000|COMPLETED|Overall Study||4||
48378546|NCT03806179|101255918|FG001|COMPLETED|Overall Study||1||
48251168|NCT02201771|100934253|FG002|NOT COMPLETED|Overall Study||10||
48251169|NCT01059526|100934254|FG000|STARTED|Overall Study||41||
48251170|NCT01059526|100934255|FG001|STARTED|Overall Study||40||
48088803|NCT01753856|100537363|FG000|STARTED|Overall Study||33||
48088804|NCT01753856|100537364|FG001|STARTED|Overall Study||36||
48088805|NCT01753856|100537363|FG000|Received at Least 1 Dose of Study Drug|Overall Study||33||
48088806|NCT01753856|100537364|FG001|Received at Least 1 Dose of Study Drug|Overall Study||36||
48088807|NCT01753856|100537363|FG000|Completed 3-Month Bone Biopsy|Overall Study||31||
48088808|NCT01753856|100537364|FG001|Completed 3-Month Bone Biopsy|Overall Study||35||
48088809|NCT01753856|100537363|FG000|COMPLETED|Overall Study||30||
48251171|NCT01059526|100934254|FG000|Treated|Overall Study||21||
48251172|NCT01059526|100934255|FG001|Treated|Overall Study||23||
48251173|NCT01059526|100934254|FG000|COMPLETED|Overall Study||11||
48251174|NCT01059526|100934255|FG001|COMPLETED|Overall Study||18||
48251175|NCT01059526|100934254|FG000|NOT COMPLETED|Overall Study||30||
48251176|NCT01059526|100934255|FG001|NOT COMPLETED|Overall Study||22||
48251177|NCT00745121|100934256|FG000|STARTED|Overall Study||20||63
48251178|NCT00745121|100934257|FG001|STARTED|Overall Study||28||85
48251179|NCT00745121|100934256|FG000|COMPLETED|Overall Study||11||37
48251180|NCT00745121|100934257|FG001|COMPLETED|Overall Study||26||77
48251181|NCT00745121|100934256|FG000|NOT COMPLETED|Overall Study||9||26
48251182|NCT00745121|100934257|FG001|NOT COMPLETED|Overall Study||2||8
48251183|NCT00520403|100934258|FG000|STARTED|Bevacizumab + IFN/Vinblastine||25||
48251184|NCT00520403|100934258|FG000|COMPLETED|Bevacizumab + IFN/Vinblastine||7||
48251185|NCT00520403|100934258|FG000|NOT COMPLETED|Bevacizumab + IFN/Vinblastine||18||
48251186|NCT00520403|100934258|FG000|STARTED|Bevacizumab Monotherapy||2||
48251187|NCT00520403|100934258|FG000|COMPLETED|Bevacizumab Monotherapy||0||
48251188|NCT00520403|100934258|FG000|NOT COMPLETED|Bevacizumab Monotherapy||2||
48251189|NCT01997437|100934259|FG000|STARTED|Overall Study||6||
48251190|NCT01997437|100934259|FG000|COMPLETED|Overall Study||6||
48251191|NCT01997437|100934259|FG000|NOT COMPLETED|Overall Study||0||
48251192|NCT02253147|100934260|FG000|STARTED|Overall Study||118||
48251193|NCT02253147|100934260|FG000|N Patients at W24 (Primary Outcome)|Overall Study||88||
48088810|NCT01753856|100537364|FG001|COMPLETED|Overall Study||34||
48251194|NCT02253147|100934260|FG000|N Patients at W36|Overall Study||86||
48251195|NCT02253147|100934260|FG000|N Patients at W52|Overall Study||84||
48251196|NCT02253147|100934260|FG000|COMPLETED|Overall Study||71|N patients completed W64|
48251197|NCT02253147|100934260|FG000|NOT COMPLETED|Overall Study||47||
48251198|NCT01355471|100934261|FG000|STARTED|Overall Study||148||
48088811|NCT01753856|100537363|FG000|NOT COMPLETED|Overall Study||3||
48088812|NCT01753856|100537364|FG001|NOT COMPLETED|Overall Study||2||
48088813|NCT00540514|100537365|FG000|STARTED|Overall Study||521||
48088814|NCT00540514|100537366|FG001|STARTED|Overall Study||531||
48088815|NCT00540514|100537365|FG000|Treated|Overall Study||514||
48088816|NCT00540514|100537366|FG001|Treated|Overall Study||524||
48088817|NCT00540514|100537365|FG000|Biomarker Population|Overall Study||35||
48088818|NCT00540514|100537366|FG001|Biomarker Population|Overall Study||36||
48088819|NCT00540514|100537365|FG000|COMPLETED|Overall Study||275||
48088820|NCT00540514|100537366|FG001|COMPLETED|Overall Study||265||
48088821|NCT00540514|100537365|FG000|NOT COMPLETED|Overall Study||246||
48088822|NCT00540514|100537366|FG001|NOT COMPLETED|Overall Study||266||
48088823|NCT03944954|100537367|FG000|STARTED|Overall Study||58||
48088824|NCT03944954|100537368|FG001|STARTED|Overall Study||8||
48088825|NCT03944954|100537367|FG000|Training Session|Overall Study||24||
48088826|NCT03944954|100537368|FG001|Training Session|Overall Study||5||
48088827|NCT03944954|100537367|FG000|0mg Marinol Sham TMS|Overall Study||13||
48088828|NCT03944954|100537368|FG001|0mg Marinol Sham TMS|Overall Study||4||
48088829|NCT03944954|100537367|FG000|0mg Marinol Real TMS|Overall Study||14||
48088830|NCT03944954|100537368|FG001|0mg Marinol Real TMS|Overall Study||4||
48088831|NCT03944954|100537367|FG000|10mg Marinol Sham TMS|Overall Study||13||
48088832|NCT03944954|100537368|FG001|10mg Marinol Sham TMS|Overall Study||4||
48088833|NCT03944954|100537367|FG000|10mg Marinol Real TMS|Overall Study||12||
48088834|NCT03944954|100537368|FG001|10mg Marinol Real TMS|Overall Study||4||
48088835|NCT03944954|100537367|FG000|30mg Marinol Sham TMS|Overall Study||12||
48088836|NCT03944954|100537368|FG001|30mg Marinol Sham TMS|Overall Study||5||
48088837|NCT03944954|100537367|FG000|30mg Marinol Real TMS|Overall Study||12||
48088838|NCT03944954|100537368|FG001|30mg Marinol Real TMS|Overall Study||4||
48088839|NCT03944954|100537367|FG000|COMPLETED|Overall Study||11||
48088840|NCT03944954|100537368|FG001|COMPLETED|Overall Study||4||
48088841|NCT03944954|100537367|FG000|NOT COMPLETED|Overall Study||47||
48088842|NCT03944954|100537368|FG001|NOT COMPLETED|Overall Study||4||
48088843|NCT01092559|100537369|FG000|STARTED|Overall Study||10||
48088844|NCT01092559|100537369|FG000|COMPLETED|Overall Study||10||
48088845|NCT01092559|100537369|FG000|NOT COMPLETED|Overall Study||0||
48088846|NCT01338792|100537370|FG000|STARTED|Overall Study||47||
48088847|NCT01338792|100537370|FG000|COMPLETED|Overall Study||43||
48088848|NCT01338792|100537370|FG000|NOT COMPLETED|Overall Study||4||
48088849|NCT01879332|100537371|FG000|STARTED|Overall Study||6||
48088850|NCT01879332|100537372|FG001|STARTED|Overall Study||6||
48088851|NCT01879332|100537373|FG002|STARTED|Overall Study||4||
48088852|NCT01879332|100537371|FG000|COMPLETED|Overall Study||0||
48088853|NCT01879332|100537372|FG001|COMPLETED|Overall Study||0||
48088854|NCT01879332|100537373|FG002|COMPLETED|Overall Study||0||
48088855|NCT01879332|100537371|FG000|NOT COMPLETED|Overall Study||6||
48088856|NCT01879332|100537372|FG001|NOT COMPLETED|Overall Study||6||
48088857|NCT01879332|100537373|FG002|NOT COMPLETED|Overall Study||4||
48088858|NCT03128892|100537374|FG000|STARTED|Overall Study||34||
48088859|NCT03128892|100537374|FG000|COMPLETED|Overall Study||31||
48088860|NCT03128892|100537374|FG000|NOT COMPLETED|Overall Study||3||
48088861|NCT00545168|100537375|FG000|STARTED|Overall Study||203||
48088862|NCT00545168|100537376|FG001|STARTED|Overall Study||63||
48088863|NCT00545168|100537377|FG002|STARTED|Overall Study||214||
48088864|NCT00545168|100537375|FG000|COMPLETED|Overall Study||187||
48088865|NCT00545168|100537376|FG001|COMPLETED|Overall Study||58||
48088866|NCT00545168|100537377|FG002|COMPLETED|Overall Study||193||
48088867|NCT00545168|100537375|FG000|NOT COMPLETED|Overall Study||16||
48088868|NCT00545168|100537376|FG001|NOT COMPLETED|Overall Study||5||
48541228|NCT00229723|101662681|FG001|NOT COMPLETED|Maintenance Phase||14||
48088869|NCT00545168|100537377|FG002|NOT COMPLETED|Overall Study||21||
48088870|NCT02005445|100537378|FG000|STARTED|Overall Study||2||
48088871|NCT02005445|100537379|FG001|STARTED|Overall Study||2||
48088872|NCT02005445|100537378|FG000|COMPLETED|Overall Study||2||
48088873|NCT02005445|100537379|FG001|COMPLETED|Overall Study||1||
48088874|NCT02005445|100537378|FG000|NOT COMPLETED|Overall Study||0||
48088875|NCT02005445|100537379|FG001|NOT COMPLETED|Overall Study||1||
48088876|NCT04346537|100537380|FG000|STARTED|Overall Study||109||201
48541229|NCT00229723|101662682|FG002|NOT COMPLETED|Maintenance Phase||9||
48088877|NCT04346537|100537380|FG000|Implanted/Attempted With INGEVITY+ Lead|Overall Study||101||201
48088878|NCT04346537|100537380|FG000|COMPLETED|Overall Study||99||198
48088879|NCT04346537|100537380|FG000|NOT COMPLETED|Overall Study||10||3
48088880|NCT02959944|100537381|FG000|STARTED|Overall Study||95||
48088881|NCT02959944|100537382|FG001|STARTED|Overall Study||98||
48088882|NCT02959944|100537381|FG000|Received at Least 1 Dose of Study Drug|Overall Study||94||
48088883|NCT02959944|100537382|FG001|Received at Least 1 Dose of Study Drug|Overall Study||96||
48088884|NCT02959944|100537381|FG000|COMPLETED|Overall Study||95||
48088885|NCT02959944|100537382|FG001|COMPLETED|Overall Study||98||
48088886|NCT02959944|100537381|FG000|NOT COMPLETED|Overall Study||0||
48088887|NCT02959944|100537382|FG001|NOT COMPLETED|Overall Study||0||
48541230|NCT00229723|101662683|FG003|NOT COMPLETED|Maintenance Phase||17||
48088888|NCT02733991|100537383|FG000|STARTED|Overall Study||76||
48088889|NCT02733991|100537384|FG001|STARTED|Overall Study||77||
48541231|NCT00229723|101662684|FG004|NOT COMPLETED|Maintenance Phase||15||
48088890|NCT02733991|100537383|FG000|COMPLETED|Overall Study||75||
48088891|NCT02733991|100537384|FG001|COMPLETED|Overall Study||72||
48088892|NCT02733991|100537383|FG000|NOT COMPLETED|Overall Study||1||
48088893|NCT02733991|100537384|FG001|NOT COMPLETED|Overall Study||5||
48088894|NCT04501666|100537385|FG000|STARTED|Overall Study||190||
48088895|NCT04501666|100537386|FG001|STARTED|Overall Study||96||
48088896|NCT04501666|100537385|FG000|Treated|Overall Study||187||
48088897|NCT04501666|100537386|FG001|Treated|Overall Study||95||
48088898|NCT04501666|100537385|FG000|COMPLETED|Overall Study||166||
48088899|NCT04501666|100537386|FG001|COMPLETED|Overall Study||83||
48088900|NCT04501666|100537385|FG000|NOT COMPLETED|Overall Study||24||
48088901|NCT04501666|100537386|FG001|NOT COMPLETED|Overall Study||13||
48088902|NCT00005937|100537387|FG000|STARTED|Overall Study||42||
48088903|NCT00005937|100537387|FG000|COMPLETED|Overall Study||37||
48088904|NCT00005937|100537387|FG000|NOT COMPLETED|Overall Study||5||
48088905|NCT01979016|100537388|FG000|STARTED|Overall Study||27||
48088906|NCT01979016|100537389|FG001|STARTED|Overall Study||27||
48088907|NCT01979016|100537388|FG000|COMPLETED|Overall Study||25||
48088908|NCT01979016|100537389|FG001|COMPLETED|Overall Study||26||
48088909|NCT01979016|100537388|FG000|NOT COMPLETED|Overall Study||2||
48088910|NCT01979016|100537389|FG001|NOT COMPLETED|Overall Study||1||
48088911|NCT00737282|100537390|FG000|STARTED|Overall Study||175||
48088912|NCT00737282|100537390|FG000|COMPLETED|Overall Study||0||
48088913|NCT00737282|100537390|FG000|NOT COMPLETED|Overall Study||175||
48088914|NCT01714635|100537391|FG000|STARTED|Overall Study||147||
48088915|NCT01714635|100537392|FG001|STARTED|Overall Study||150||
48088916|NCT01714635|100537393|FG002|STARTED|Overall Study||148||
48088917|NCT01714635|100537391|FG000|COMPLETED|Overall Study||145||
48088918|NCT01714635|100537392|FG001|COMPLETED|Overall Study||150||
48088919|NCT01714635|100537393|FG002|COMPLETED|Overall Study||146||
48088920|NCT01714635|100537391|FG000|NOT COMPLETED|Overall Study||2||
48088921|NCT01714635|100537392|FG001|NOT COMPLETED|Overall Study||0||
48088922|NCT01714635|100537393|FG002|NOT COMPLETED|Overall Study||2||
48088923|NCT02450903|100537394|FG000|STARTED|Overall Study||20||
48088924|NCT02450903|100537394|FG000|Entered Post-treatment Effic. f/u Phase|Overall Study||4|Discontinued from treatment phase|
48088925|NCT02450903|100537394|FG000|Entered Survival Follow-up Phase|Overall Study||15|Discontinued from treatment phase|
48088926|NCT02450903|100537394|FG000|COMPLETED|Overall Study||0||
48088927|NCT02450903|100537394|FG000|NOT COMPLETED|Overall Study||20||
48088928|NCT00241280|100537395|FG000|STARTED|Overall Study||247||
48088929|NCT00241280|100537396|FG001|STARTED|Overall Study||254||
48088930|NCT00241280|100537395|FG000|COMPLETED|Overall Study||199||
48088931|NCT00241280|100537396|FG001|COMPLETED|Overall Study||186||
48088932|NCT00241280|100537395|FG000|NOT COMPLETED|Overall Study||48||
48088933|NCT00241280|100537396|FG001|NOT COMPLETED|Overall Study||68||
48088934|NCT03626623|100537397|FG000|STARTED|Overall Study||5||
48088935|NCT03626623|100537398|FG001|STARTED|Overall Study||10||
48088936|NCT03626623|100537397|FG000|COMPLETED|Overall Study||0||
48088937|NCT03626623|100537398|FG001|COMPLETED|Overall Study||0||
48088938|NCT03626623|100537397|FG000|NOT COMPLETED|Overall Study||5||
48088939|NCT03626623|100537398|FG001|NOT COMPLETED|Overall Study||10||
48088940|NCT01958320|100537399|FG000|STARTED|Overall Study||104||
48088941|NCT01958320|100537400|FG001|STARTED|Overall Study||98||
48088942|NCT01958320|100537399|FG000|COMPLETED|Overall Study||104||
48088943|NCT01958320|100537400|FG001|COMPLETED|Overall Study||98||
48088944|NCT01958320|100537399|FG000|NOT COMPLETED|Overall Study||0||
48088945|NCT01958320|100537400|FG001|NOT COMPLETED|Overall Study||0||
48088946|NCT01366209|100537401|FG000|STARTED|Overall Study||278||
48088947|NCT01366209|100537402|FG001|STARTED|Overall Study||277||
48088948|NCT01366209|100537401|FG000|COMPLETED|Overall Study||243||
48088949|NCT01366209|100537402|FG001|COMPLETED|Overall Study||241||
48088950|NCT01366209|100537401|FG000|NOT COMPLETED|Overall Study||35||
48088951|NCT01366209|100537402|FG001|NOT COMPLETED|Overall Study||36||
48088952|NCT02891850|100541049|FG000|STARTED|Overall Study||111|Treated|
48088953|NCT02891850|100541050|FG001|STARTED|Overall Study||114|Treated|
48088954|NCT02891850|100541049|FG000|COMPLETED|Overall Study||104||
48088955|NCT02891850|100541050|FG001|COMPLETED|Overall Study||107||
48088956|NCT02891850|100541049|FG000|NOT COMPLETED|Overall Study||7||
48088957|NCT02891850|100541050|FG001|NOT COMPLETED|Overall Study||7||
48088958|NCT01511315|100541051|FG000|STARTED|Overall Study||36||
48088959|NCT01511315|100541051|FG000|COMPLETED|Overall Study||32||
48088960|NCT01511315|100541051|FG000|NOT COMPLETED|Overall Study||4||
48088961|NCT03241342|100541052|FG000|STARTED|Overall Study||163||
48088962|NCT03241342|100541053|FG001|STARTED|Overall Study||163||
48088963|NCT03241342|100541054|FG002|STARTED|Overall Study||165||
48088964|NCT03241342|100541052|FG000|COMPLETED|Overall Study||141||
48088965|NCT03241342|100541053|FG001|COMPLETED|Overall Study||132||
48088966|NCT03241342|100541054|FG002|COMPLETED|Overall Study||138||
48088967|NCT03241342|100541052|FG000|NOT COMPLETED|Overall Study||22||
48088968|NCT03241342|100541053|FG001|NOT COMPLETED|Overall Study||31||
48088969|NCT03241342|100541054|FG002|NOT COMPLETED|Overall Study||27||
48088970|NCT01214811|100541055|FG000|STARTED|Overall Study||27||
48088971|NCT01214811|100541055|FG000|COMPLETED|Overall Study||24||
48088972|NCT01214811|100541055|FG000|NOT COMPLETED|Overall Study||3||
48088973|NCT03402386|100541056|FG000|STARTED|Overall Study||42||
48088974|NCT03402386|100541056|FG000|Correction Group|Overall Study||2||
48088975|NCT03402386|100541056|FG000|Conversion Group|Overall Study||40||
48088976|NCT03402386|100541056|FG000|COMPLETED|Overall Study||36||
48088977|NCT03402386|100541056|FG000|NOT COMPLETED|Overall Study||6||
48088978|NCT02064868|100541057|FG000|STARTED|Overall Study||1756|All Randomized Participants|
48088979|NCT02064868|100541058|FG001|STARTED|Overall Study||894|All Randomized Participants|
48088980|NCT02064868|100541057|FG000|Full Analysis Set|Overall Study||1756||
48088981|NCT02064868|100541058|FG001|Full Analysis Set|Overall Study||894||
48088982|NCT02064868|100541057|FG000|Safety Set|Overall Study||1729||
48088983|NCT02064868|100541058|FG001|Safety Set|Overall Study||894||
48088984|NCT02064868|100541057|FG000|Per Protocol Set|Overall Study||1155||
48088985|NCT02064868|100541058|FG001|Per Protocol Set|Overall Study||627||
48088986|NCT02064868|100541057|FG000|COMPLETED|Overall Study||1722||
48088987|NCT02064868|100541058|FG001|COMPLETED|Overall Study||881||
48088988|NCT02064868|100541057|FG000|NOT COMPLETED|Overall Study||34||
48088989|NCT02064868|100541058|FG001|NOT COMPLETED|Overall Study||13||
48088990|NCT01113801|100541059|FG000|STARTED|Overall Study||103||
48088991|NCT01113801|100541060|FG001|STARTED|Overall Study||105||
48088992|NCT01113801|100541061|FG002|STARTED|Overall Study||103||
48088993|NCT01113801|100541062|FG003|STARTED|Overall Study||106||
48088994|NCT01113801|100541059|FG000|Received at Least One Dose of Drug|Overall Study||103||
48088995|NCT01113801|100541060|FG001|Received at Least One Dose of Drug|Overall Study||105||
48088996|NCT01113801|100541061|FG002|Received at Least One Dose of Drug|Overall Study||103||
48088997|NCT01113801|100541062|FG003|Received at Least One Dose of Drug|Overall Study||105||
48088998|NCT01113801|100541059|FG000|COMPLETED|Overall Study||62||
48088999|NCT01113801|100541060|FG001|COMPLETED|Overall Study||65||
48089000|NCT01113801|100541061|FG002|COMPLETED|Overall Study||66||
48089001|NCT01113801|100541062|FG003|COMPLETED|Overall Study||65||
48089002|NCT01113801|100541059|FG000|NOT COMPLETED|Overall Study||41||
48089003|NCT01113801|100541060|FG001|NOT COMPLETED|Overall Study||40||
48089004|NCT01113801|100541061|FG002|NOT COMPLETED|Overall Study||37||
48089005|NCT01113801|100541062|FG003|NOT COMPLETED|Overall Study||41||
48089006|NCT03211416|100541063|FG000|STARTED|Overall Study||37||
48089007|NCT03211416|100541063|FG000|COMPLETED|Overall Study||27||
48089008|NCT03211416|100541063|FG000|NOT COMPLETED|Overall Study||10||
48089009|NCT01648205|100541064|FG000|STARTED|Placebo||25|ECG data were available at 1 months in 21 of 25 subjects: one subject withdrew from the study and second subject got pregnant and was withdrawn, two other subjects still participating in the study did not have ECGs done (which was a protocol violation).|
48089010|NCT01648205|100541064|FG000|COMPLETED|Placebo||21||
48089011|NCT01648205|100541064|FG000|NOT COMPLETED|Placebo||4||
48089012|NCT01648205|100541064|FG000|STARTED|Ranolazine||23|ECG data were available at 1 months in 21 of 25 subjects: one subject withdrew from the study and second subject got pregnant and was withdrawn, two other subjects still participating in the study did not have ECGs done (which was a protocol violation) but they still participated in the period 2. This is why period 2 was started by 23 patients.|
48089013|NCT01648205|100541064|FG000|COMPLETED|Ranolazine||18||
48089014|NCT01648205|100541064|FG000|NOT COMPLETED|Ranolazine||5||
48089015|NCT02289898|100541065|FG000|STARTED|Overall Study||68||
48089016|NCT02289898|100541066|FG001|STARTED|Overall Study||71||
48089017|NCT02289898|100541067|FG002|STARTED|Overall Study||65||
48089018|NCT02289898|100541065|FG000|COMPLETED|Overall Study||16||
48089019|NCT02289898|100541066|FG001|COMPLETED|Overall Study||18||
48089020|NCT02289898|100541067|FG002|COMPLETED|Overall Study||9||
48089021|NCT02289898|100541065|FG000|NOT COMPLETED|Overall Study||52||
48089022|NCT02289898|100541066|FG001|NOT COMPLETED|Overall Study||53||
48089023|NCT02289898|100541067|FG002|NOT COMPLETED|Overall Study||56||
48089024|NCT01585194|100541068|FG000|STARTED|Overall Study||39||
48089025|NCT01585194|100541068|FG000|COMPLETED|Overall Study||35||
48089026|NCT01585194|100541068|FG000|NOT COMPLETED|Overall Study||4||
48089027|NCT00603993|100541069|FG000|STARTED|Overall Study||88||
48089028|NCT00603993|100541069|FG000|COMPLETED|Overall Study||68||
48089029|NCT00603993|100541069|FG000|NOT COMPLETED|Overall Study||20||
48089030|NCT03070782|100541070|FG000|STARTED|Overall Study||48||
48089031|NCT03070782|100541071|FG001|STARTED|Overall Study||48||
48089032|NCT03070782|100541072|FG002|STARTED|Overall Study||47||
48089033|NCT03070782|100541073|FG003|STARTED|Overall Study||48||
48089034|NCT03070782|100541074|FG004|STARTED|Overall Study||48||
48089035|NCT03070782|100541075|FG005|STARTED|Overall Study||47||
48089036|NCT03070782|100541070|FG000|COMPLETED|Overall Study||41|Completed here refers to participants who completed study treatment.|
48089037|NCT03070782|100541071|FG001|COMPLETED|Overall Study||47|Completed here refers to participants who completed study treatment.|
48089038|NCT03070782|100541072|FG002|COMPLETED|Overall Study||43|Completed here refers to participants who completed study treatment.|
48089039|NCT03070782|100541073|FG003|COMPLETED|Overall Study||43|Completed here refers to participants who completed study treatment.|
48089040|NCT03070782|100541074|FG004|COMPLETED|Overall Study||36|Completed here refers to participants who completed study treatment.|
48089041|NCT03070782|100541075|FG005|COMPLETED|Overall Study||40|Completed here refers to participants who completed study treatment.|
48089042|NCT03070782|100541070|FG000|NOT COMPLETED|Overall Study||7||
48089043|NCT03070782|100541071|FG001|NOT COMPLETED|Overall Study||1||
48089044|NCT03070782|100541072|FG002|NOT COMPLETED|Overall Study||4||
48089045|NCT03070782|100541073|FG003|NOT COMPLETED|Overall Study||5||
48089046|NCT03070782|100541074|FG004|NOT COMPLETED|Overall Study||12||
48089047|NCT03070782|100541075|FG005|NOT COMPLETED|Overall Study||7||
48089048|NCT04232124|100541076|FG000|STARTED|Overall Study||30||
48089049|NCT04232124|100541076|FG000|COMPLETED|Overall Study||27||
48251199|NCT01355471|100934262|FG001|STARTED|Overall Study||145||
48251200|NCT01355471|100934261|FG000|COMPLETED|Overall Study||141||
48251201|NCT01355471|100934262|FG001|COMPLETED|Overall Study||142||
48251202|NCT01355471|100934261|FG000|NOT COMPLETED|Overall Study||7||
48251203|NCT01355471|100934262|FG001|NOT COMPLETED|Overall Study||3||
48251204|NCT00583050|100934263|FG000|STARTED|Overall Study||1366||
48251205|NCT00583050|100934263|FG000|COMPLETED|Overall Study||1366||
48251206|NCT00583050|100934263|FG000|NOT COMPLETED|Overall Study||0||
48251207|NCT00352053|100934264|FG000|STARTED|Double-Blind Phase (Through Week 48)||45||
48251208|NCT00352053|100934265|FG001|STARTED|Double-Blind Phase (Through Week 48)||42||
48251209|NCT00352053|100934264|FG000|COMPLETED|Double-Blind Phase (Through Week 48)||27||
48251210|NCT00352053|100934265|FG001|COMPLETED|Double-Blind Phase (Through Week 48)||29||
48251211|NCT00352053|100934264|FG000|NOT COMPLETED|Double-Blind Phase (Through Week 48)||18||
48251212|NCT00352053|100934265|FG001|NOT COMPLETED|Double-Blind Phase (Through Week 48)||13||
48251213|NCT00352053|100934264|FG000|STARTED|First Extension Phase (Weeks 48-144)||24||
48251214|NCT00352053|100934265|FG001|STARTED|First Extension Phase (Weeks 48-144)||36||
48251215|NCT00352053|100934264|FG000|COMPLETED|First Extension Phase (Weeks 48-144)||12||
48251216|NCT00352053|100934265|FG001|COMPLETED|First Extension Phase (Weeks 48-144)||19||
48251217|NCT00352053|100934264|FG000|NOT COMPLETED|First Extension Phase (Weeks 48-144)||12||
48251218|NCT00352053|100934265|FG001|NOT COMPLETED|First Extension Phase (Weeks 48-144)||17||
48251219|NCT00352053|100934264|FG000|STARTED|Second Extension Phase (Weeks 144-240)||9||
48251220|NCT00352053|100934265|FG001|STARTED|Second Extension Phase (Weeks 144-240)||14||
48251221|NCT00352053|100934264|FG000|COMPLETED|Second Extension Phase (Weeks 144-240)||4||
48251222|NCT00352053|100934265|FG001|COMPLETED|Second Extension Phase (Weeks 144-240)||9||
48251223|NCT00352053|100934264|FG000|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5||
48251224|NCT00352053|100934265|FG001|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5||
48251225|NCT00352053|100934264|FG000|STARTED|Third Extension Phase (Weeks 240-294)||1||
48251226|NCT00352053|100934265|FG001|STARTED|Third Extension Phase (Weeks 240-294)||4||
48251227|NCT00352053|100934264|FG000|COMPLETED|Third Extension Phase (Weeks 240-294)||0||
48251228|NCT00352053|100934265|FG001|COMPLETED|Third Extension Phase (Weeks 240-294)||2||
48251229|NCT00352053|100934264|FG000|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||1||
48251230|NCT00352053|100934265|FG001|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||2||
48378547|NCT03806179|101255917|FG000|NOT COMPLETED|Overall Study||0||
48378548|NCT03806179|101255918|FG001|NOT COMPLETED|Overall Study||2||
48684365|NCT04403919|102009732|FG003|STARTED|Overall Study||11||
48684366|NCT04403919|102009729|FG000|COMPLETED|Overall Study||22||
48684367|NCT04403919|102009730|FG001|COMPLETED|Overall Study||30||
48684368|NCT04403919|102009731|FG002|COMPLETED|Overall Study||18||
48684369|NCT04403919|102009732|FG003|COMPLETED|Overall Study||10||
48684370|NCT04403919|102009729|FG000|NOT COMPLETED|Overall Study||0||
48684371|NCT04403919|102009730|FG001|NOT COMPLETED|Overall Study||0||
48684372|NCT04403919|102009731|FG002|NOT COMPLETED|Overall Study||0||
48684373|NCT04403919|102009732|FG003|NOT COMPLETED|Overall Study||1||
48684374|NCT00038948|102009733|FG000|STARTED|Overall Study||555||
48684375|NCT00038948|102009734|FG001|STARTED|Overall Study||275||
48684376|NCT00038948|102009733|FG000|COMPLETED|Overall Study||386||
48684377|NCT00038948|102009734|FG001|COMPLETED|Overall Study||198||
48684378|NCT00038948|102009733|FG000|NOT COMPLETED|Overall Study||169||
48684379|NCT00038948|102009734|FG001|NOT COMPLETED|Overall Study||77||
48684380|NCT01023217|102009735|FG000|STARTED|Overall Study||45||
48684381|NCT01023217|102009736|FG001|STARTED|Overall Study||45||
48684382|NCT01023217|102009735|FG000|COMPLETED|Overall Study||44||
48684383|NCT01023217|102009736|FG001|COMPLETED|Overall Study||45||
48684384|NCT01023217|102009735|FG000|NOT COMPLETED|Overall Study||1||
48684385|NCT01023217|102009736|FG001|NOT COMPLETED|Overall Study||0||
48684386|NCT02457247|102009737|FG000|STARTED|Period 1||68||
48378549|NCT00745368|101255919|FG000|STARTED|Overall Study||19||
48378550|NCT00745368|101255919|FG000|COMPLETED|Overall Study||16||
48378551|NCT00745368|101255919|FG000|NOT COMPLETED|Overall Study||3||
48378552|NCT00986427|101255920|FG000|STARTED|Overall Study||12||
48684387|NCT02457247|102009738|FG001|STARTED|Period 1||70||
48684388|NCT02457247|102009739|FG002|STARTED|Period 1||68||
48684389|NCT02457247|102009740|FG003|STARTED|Period 1||70||
48684390|NCT02457247|102009737|FG000|COMPLETED|Period 1||66||
48684391|NCT02457247|102009738|FG001|COMPLETED|Period 1||68||
48378553|NCT00986427|101255921|FG001|STARTED|Overall Study||12||
48378554|NCT00986427|101255920|FG000|COMPLETED|Overall Study||8||
48378555|NCT00986427|101255921|FG001|COMPLETED|Overall Study||12||
48684392|NCT02457247|102009739|FG002|COMPLETED|Period 1||68||
48684393|NCT02457247|102009740|FG003|COMPLETED|Period 1||70||
48251231|NCT02777242|100934266|FG000|STARTED|Overall Study||65||
48251232|NCT02777242|100934266|FG000|COMPLETED|Overall Study||59||
48251233|NCT02777242|100934266|FG000|NOT COMPLETED|Overall Study||6||
48251234|NCT02515656|100934267|FG000|STARTED|Overall Study||326||
48251235|NCT02515656|100934268|FG001|STARTED|Overall Study||332||
48684394|NCT02457247|102009737|FG000|NOT COMPLETED|Period 1||2||
48684395|NCT02457247|102009738|FG001|NOT COMPLETED|Period 1||2||
48684396|NCT02457247|102009739|FG002|NOT COMPLETED|Period 1||0||
48684397|NCT02457247|102009740|FG003|NOT COMPLETED|Period 1||0||
48684398|NCT02457247|102009737|FG000|STARTED|Period 2||66||
48684399|NCT02457247|102009738|FG001|STARTED|Period 2||68||
48251236|NCT02515656|100934267|FG000|Full Analysis Set (FAS)|Overall Study||302||
48251237|NCT02515656|100934268|FG001|Full Analysis Set (FAS)|Overall Study||309||
48251238|NCT02515656|100934267|FG000|Per Protocol Set (PPS)|Overall Study||277||
48251239|NCT02515656|100934268|FG001|Per Protocol Set (PPS)|Overall Study||275||
48251240|NCT02515656|100934267|FG000|Safety Population|Overall Study||325||
48251241|NCT02515656|100934268|FG001|Safety Population|Overall Study||328||
48251242|NCT02515656|100934267|FG000|COMPLETED|Overall Study||270||
48251243|NCT02515656|100934268|FG001|COMPLETED|Overall Study||261||
48251244|NCT02515656|100934267|FG000|NOT COMPLETED|Overall Study||56||
48251245|NCT02515656|100934268|FG001|NOT COMPLETED|Overall Study||71||
48251246|NCT01329185|100934269|FG000|STARTED|Overall Study||10||
48251247|NCT01329185|100934270|FG001|STARTED|Overall Study||7||
48251248|NCT01329185|100934269|FG000|CMV Disease|Overall Study||1||
48251249|NCT01329185|100934270|FG001|CMV Disease|Overall Study||0||
48251250|NCT01329185|100934269|FG000|PTLD|Overall Study||1||
48251251|NCT01329185|100934270|FG001|PTLD|Overall Study||0||
48251252|NCT01329185|100934269|FG000|COMPLETED|Overall Study||10||
48251253|NCT01329185|100934270|FG001|COMPLETED|Overall Study||7||
48251254|NCT01329185|100934269|FG000|NOT COMPLETED|Overall Study||0||
48251255|NCT01329185|100934270|FG001|NOT COMPLETED|Overall Study||0||
48251256|NCT00647998|100934271|FG000|STARTED|Overall Study||9||
48251257|NCT00647998|100934272|FG001|STARTED|Overall Study||9||
48251258|NCT00647998|100934271|FG000|COMPLETED|Overall Study||9||
48251259|NCT00647998|100934272|FG001|COMPLETED|Overall Study||9||
48251260|NCT00647998|100934271|FG000|NOT COMPLETED|Overall Study||0||
48251261|NCT00647998|100934272|FG001|NOT COMPLETED|Overall Study||0||
48251262|NCT00729053|100934273|FG000|STARTED|Overall Study||23||
48251263|NCT00729053|100934274|FG001|STARTED|Overall Study||23||
48251264|NCT00729053|100934275|FG002|STARTED|Overall Study||23||
48251265|NCT00729053|100934276|FG003|STARTED|Overall Study||23||
48251266|NCT00729053|100934273|FG000|COMPLETED|Overall Study||23||
48251267|NCT00729053|100934274|FG001|COMPLETED|Overall Study||23||
48251268|NCT00729053|100934275|FG002|COMPLETED|Overall Study||23||
48251269|NCT00729053|100934276|FG003|COMPLETED|Overall Study||23||
48251270|NCT00729053|100934273|FG000|NOT COMPLETED|Overall Study||0||
48251271|NCT00729053|100934274|FG001|NOT COMPLETED|Overall Study||0||
48251272|NCT00729053|100934275|FG002|NOT COMPLETED|Overall Study||0||
48251273|NCT00729053|100934276|FG003|NOT COMPLETED|Overall Study||0||
48251274|NCT03723915|100934277|FG000|STARTED|Screening||17||
48251275|NCT03723915|100934277|FG000|COMPLETED|Screening||15||
48251276|NCT03723915|100934277|FG000|NOT COMPLETED|Screening||2||
48251277|NCT03723915|100934277|FG000|STARTED|On Treatment||15||
48251278|NCT03723915|100934277|FG000|Registered on Study|On Treatment||15||
48251279|NCT03723915|100934277|FG000|Received First Dose of Study Drugs|On Treatment||13||
48251280|NCT03723915|100934277|FG000|COMPLETED|On Treatment||13||
48251281|NCT03723915|100934277|FG000|NOT COMPLETED|On Treatment||2||
48251282|NCT03723915|100934277|FG000|STARTED|Survival Follow-up||13|Followed until progression (PD) or withdrawal of consent. At PD followed for survival until death.|
48251283|NCT03723915|100934277|FG000|COMPLETED|Survival Follow-up||13||
48251284|NCT03723915|100934277|FG000|NOT COMPLETED|Survival Follow-up||0||
48251285|NCT01191697|100934278|FG000|STARTED|Overall Study||37||
48251286|NCT01191697|100934278|FG000|Analyzed Popopulation|Overall Study||36||
48251287|NCT01191697|100934278|FG000|COMPLETED|Overall Study||0||
48378556|NCT00986427|101255920|FG000|NOT COMPLETED|Overall Study||4||
48378557|NCT00986427|101255921|FG001|NOT COMPLETED|Overall Study||0||
48378558|NCT01504854|101255922|FG000|STARTED|Overall Study||64||
48378559|NCT01504854|101255923|FG001|STARTED|Overall Study||55||
48378560|NCT01504854|101255922|FG000|COMPLETED|Overall Study||56||
48378561|NCT01504854|101255923|FG001|COMPLETED|Overall Study||48||
48378562|NCT01504854|101255922|FG000|NOT COMPLETED|Overall Study||8||
48378563|NCT01504854|101255923|FG001|NOT COMPLETED|Overall Study||7||
48378564|NCT00115804|101255924|FG000|STARTED|Overall Study||6||
48378565|NCT00115804|101255924|FG000|COMPLETED|Overall Study||4||
48378566|NCT00115804|101255924|FG000|NOT COMPLETED|Overall Study||2||
48378567|NCT01104584|101255925|FG000|STARTED|Overall Study||460||
48378568|NCT01104584|101255925|FG000|Received Treatment|Overall Study||439||
48378569|NCT01104584|101255925|FG000|Fulfilled Requirements of FAS Population|Overall Study||397||
48378570|NCT01104584|101255925|FG000|COMPLETED|Overall Study||437||
48378571|NCT01104584|101255925|FG000|NOT COMPLETED|Overall Study||23||
48684400|NCT02457247|102009739|FG002|STARTED|Period 2||68||
48251288|NCT01191697|100934278|FG000|NOT COMPLETED|Overall Study||37||
48251289|NCT03389451|100934279|FG000|STARTED|Overall Study||30||
48378572|NCT00242385|101255926|FG000|STARTED|Period 1||14||
48251290|NCT03389451|100934279|FG000|COMPLETED|Overall Study||30||
48251291|NCT03389451|100934279|FG000|NOT COMPLETED|Overall Study||0||
48251292|NCT01874665|100934280|FG000|STARTED|Overall Study||30||
48378573|NCT00242385|101255927|FG001|STARTED|Period 1||11||
48684401|NCT02457247|102009740|FG003|STARTED|Period 2||70||
48251293|NCT01874665|100934281|FG001|STARTED|Overall Study||15||
48251294|NCT01874665|100934280|FG000|COMPLETED|Overall Study||0||
48251295|NCT01874665|100934281|FG001|COMPLETED|Overall Study||0||
48251296|NCT01874665|100934280|FG000|NOT COMPLETED|Overall Study||30||
48251297|NCT01874665|100934281|FG001|NOT COMPLETED|Overall Study||15||
48378574|NCT00242385|101255926|FG000|COMPLETED|Period 1||14||
48378575|NCT00242385|101255927|FG001|COMPLETED|Period 1||11||
48251298|NCT00825734|100934282|FG000|STARTED|Phase I||4||
48251299|NCT00825734|100934283|FG001|STARTED|Phase I||3||
48251300|NCT00825734|100934284|FG002|STARTED|Phase I||3||
48251301|NCT00825734|100934282|FG000|COMPLETED|Phase I||0||
48251302|NCT00825734|100934283|FG001|COMPLETED|Phase I||0||
48251303|NCT00825734|100934284|FG002|COMPLETED|Phase I||3||
48251304|NCT00825734|100934282|FG000|NOT COMPLETED|Phase I||4||
48251305|NCT00825734|100934283|FG001|NOT COMPLETED|Phase I||3||
48251306|NCT00825734|100934284|FG002|NOT COMPLETED|Phase I||0||
48251307|NCT00825734|100934282|FG000|STARTED|Phase II||0||
48251308|NCT00825734|100934283|FG001|STARTED|Phase II||0||
48251309|NCT00825734|100934284|FG002|STARTED|Phase II||76||
48251310|NCT00825734|100934282|FG000|COMPLETED|Phase II||0||
48251311|NCT00825734|100934283|FG001|COMPLETED|Phase II||0||
48251312|NCT00825734|100934284|FG002|COMPLETED|Phase II||0||
48378576|NCT00242385|101255926|FG000|NOT COMPLETED|Period 1||0||
48378577|NCT00242385|101255927|FG001|NOT COMPLETED|Period 1||0||
48378578|NCT00242385|101255926|FG000|STARTED|Period 2||14||
48378579|NCT00242385|101255927|FG001|STARTED|Period 2||11||
48378580|NCT00242385|101255926|FG000|COMPLETED|Period 2||14||
48378581|NCT00242385|101255927|FG001|COMPLETED|Period 2||11||
48378582|NCT00242385|101255926|FG000|NOT COMPLETED|Period 2||0||
48378583|NCT00242385|101255927|FG001|NOT COMPLETED|Period 2||0||
48378584|NCT01773135|101255928|FG000|STARTED|Overall Study||262||
48378585|NCT01773135|101255928|FG000|COMPLETED|Overall Study||262||
48378586|NCT01773135|101255928|FG000|NOT COMPLETED|Overall Study||0||
48378587|NCT01525849|101255929|FG000|STARTED|Overall Study||76||
48378588|NCT01525849|101255930|FG001|STARTED|Overall Study||75||
48378589|NCT01525849|101255929|FG000|Treated|Overall Study||74||
48378590|NCT01525849|101255930|FG001|Treated|Overall Study||61||
48378591|NCT01525849|101255929|FG000|6-Months|Overall Study||73||
48378592|NCT01525849|101255930|FG001|6-Months|Overall Study||60||
48378593|NCT01525849|101255929|FG000|COMPLETED|Overall Study||71||
48378594|NCT01525849|101255930|FG001|COMPLETED|Overall Study||59||
48684402|NCT02457247|102009737|FG000|COMPLETED|Period 2||64||
48684403|NCT02457247|102009738|FG001|COMPLETED|Period 2||65||
48251313|NCT00825734|100934282|FG000|NOT COMPLETED|Phase II||0||
48378595|NCT01525849|101255929|FG000|NOT COMPLETED|Overall Study||5||
48378596|NCT01525849|101255930|FG001|NOT COMPLETED|Overall Study||16||
48378597|NCT00848549|101255931|FG000|STARTED|E2090-E044-310 (Base Study) Disposition||282||
48378598|NCT00848549|101255932|FG001|STARTED|E2090-E044-310 (Base Study) Disposition||301||
48378599|NCT00848549|101255931|FG000|COMPLETED|E2090-E044-310 (Base Study) Disposition||161||
48378600|NCT00848549|101255932|FG001|COMPLETED|E2090-E044-310 (Base Study) Disposition||192||
48378601|NCT00848549|101255931|FG000|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||121||
48378602|NCT00848549|101255932|FG001|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||109||
48378603|NCT00848549|101255931|FG000|STARTED|E2090-E044-310 (Base Study) Transition||161||
48378604|NCT00848549|101255932|FG001|STARTED|E2090-E044-310 (Base Study) Transition||192||
48378605|NCT00848549|101255931|FG000|COMPLETED|E2090-E044-310 (Base Study) Transition||137||
48378606|NCT00848549|101255932|FG001|COMPLETED|E2090-E044-310 (Base Study) Transition||158||
48378607|NCT00848549|101255931|FG000|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||24||
48378608|NCT00848549|101255932|FG001|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||34||
48378609|NCT00848549|101255931|FG000|STARTED|E2090-E044-314 (Extension Study)||137||
48378610|NCT00848549|101255932|FG001|STARTED|E2090-E044-314 (Extension Study)||158||
48378611|NCT00848549|101255931|FG000|COMPLETED|E2090-E044-314 (Extension Study)||120||
48378612|NCT00848549|101255932|FG001|COMPLETED|E2090-E044-314 (Extension Study)||134||
48378613|NCT00848549|101255931|FG000|NOT COMPLETED|E2090-E044-314 (Extension Study)||17||
48378614|NCT00848549|101255932|FG001|NOT COMPLETED|E2090-E044-314 (Extension Study)||24||
48378615|NCT02364947|101255933|FG000|STARTED|Overall Study||248||
48378616|NCT02364947|101255934|FG001|STARTED|Overall Study||184||
48378617|NCT02364947|101255935|FG002|STARTED|Overall Study||245||
48378618|NCT02364947|101255933|FG000|COMPLETED|Overall Study||189||
48378619|NCT02364947|101255934|FG001|COMPLETED|Overall Study||139||
48378620|NCT02364947|101255935|FG002|COMPLETED|Overall Study||219||
48378621|NCT02364947|101255933|FG000|NOT COMPLETED|Overall Study||59||
48684404|NCT02457247|102009739|FG002|COMPLETED|Period 2||68||
48684405|NCT02457247|102009740|FG003|COMPLETED|Period 2||70||
48251314|NCT00825734|100934283|FG001|NOT COMPLETED|Phase II||0||
48251315|NCT00825734|100934284|FG002|NOT COMPLETED|Phase II||76||
48251316|NCT00853021|100934285|FG000|STARTED|Overall Study||26||
48251317|NCT00853021|100934285|FG000|COMPLETED|Overall Study||21||
48251318|NCT00853021|100934285|FG000|NOT COMPLETED|Overall Study||5||
48251319|NCT01209286|100934286|FG000|STARTED|Overall Study||7||
48251320|NCT01209286|100934287|FG001|STARTED|Overall Study||23||
48251321|NCT01209286|100934288|FG002|STARTED|Overall Study||6||
48251322|NCT01209286|100934286|FG000|COMPLETED|Overall Study||2||
48251323|NCT01209286|100934287|FG001|COMPLETED|Overall Study||13||
48378622|NCT02364947|101255934|FG001|NOT COMPLETED|Overall Study||45||
48378623|NCT02364947|101255935|FG002|NOT COMPLETED|Overall Study||26||
48378624|NCT02280291|101255936|FG000|STARTED|Overall Study||25||
48684406|NCT02457247|102009737|FG000|NOT COMPLETED|Period 2||2||
48684407|NCT02457247|102009738|FG001|NOT COMPLETED|Period 2||3||
48684408|NCT02457247|102009739|FG002|NOT COMPLETED|Period 2||0||
48251324|NCT01209286|100934288|FG002|COMPLETED|Overall Study||3||
48251325|NCT01209286|100934286|FG000|NOT COMPLETED|Overall Study||5||
48378625|NCT02280291|101255937|FG001|STARTED|Overall Study||25||
48378626|NCT02280291|101255938|FG002|STARTED|Overall Study||24||
48378627|NCT02280291|101255939|FG003|STARTED|Overall Study||26||
48378628|NCT02280291|101255936|FG000|COMPLETED|Overall Study||21||
48378629|NCT02280291|101255937|FG001|COMPLETED|Overall Study||23||
48684409|NCT02457247|102009740|FG003|NOT COMPLETED|Period 2||0||
48684410|NCT02881775|102009741|FG000|STARTED|Baseline||11||
48684411|NCT02881775|102009742|FG001|STARTED|Baseline||9||
48684412|NCT02881775|102009741|FG000|COMPLETED|Baseline||11||
48251326|NCT01209286|100934287|FG001|NOT COMPLETED|Overall Study||10||
48251327|NCT01209286|100934288|FG002|NOT COMPLETED|Overall Study||3||
48251328|NCT03579433|100934289|FG000|STARTED|Overall Study||104||
48251329|NCT03579433|100934289|FG000|ORA With VerifEye+|Overall Study||96|Successful implantation|
48251330|NCT03579433|100934289|FG000|Barrett Calculator|Overall Study||102|Successful implantation|
48251331|NCT03579433|100934289|FG000|COMPLETED|Overall Study||98||
48251332|NCT03579433|100934289|FG000|NOT COMPLETED|Overall Study||6||
48251333|NCT01747629|100934290|FG000|STARTED|Overall Study||85||
48251334|NCT01747629|100934291|FG001|STARTED|Overall Study||75||
48251335|NCT01747629|100934290|FG000|Treated|Overall Study||84||
48251336|NCT01747629|100934291|FG001|Treated|Overall Study||75||
48251337|NCT01747629|100934290|FG000|COMPLETED|Overall Study||77||
48251338|NCT01747629|100934291|FG001|COMPLETED|Overall Study||69||
48251339|NCT01747629|100934290|FG000|NOT COMPLETED|Overall Study||8||
48251340|NCT01747629|100934291|FG001|NOT COMPLETED|Overall Study||6||
48251341|NCT00702546|100934292|FG000|STARTED|Base Study P05690 (NCT00702845)||268||
48251342|NCT00702546|100934293|FG001|STARTED|Base Study P05690 (NCT00702845)||128||
48251343|NCT00702546|100934292|FG000|COMPLETED|Base Study P05690 (NCT00702845)||246||
48251344|NCT00702546|100934293|FG001|COMPLETED|Base Study P05690 (NCT00702845)||121||
48251345|NCT00702546|100934292|FG000|NOT COMPLETED|Base Study P05690 (NCT00702845)||22||
48251346|NCT00702546|100934293|FG001|NOT COMPLETED|Base Study P05690 (NCT00702845)||7||
48251347|NCT00702546|100934292|FG000|STARTED|Follow Up Study P05711 (NCT00702546)||77||
48251348|NCT00702546|100934293|FG001|STARTED|Follow Up Study P05711 (NCT00702546)||25||
48251349|NCT00702546|100934292|FG000|COMPLETED|Follow Up Study P05711 (NCT00702546)||72||
48251350|NCT00702546|100934293|FG001|COMPLETED|Follow Up Study P05711 (NCT00702546)||24||
48251351|NCT00702546|100934292|FG000|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||5||
48251352|NCT00702546|100934293|FG001|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||1||
48251353|NCT03334695|100934294|FG000|STARTED|Overall Study||31||
48251354|NCT03334695|100934295|FG001|STARTED|Overall Study||32||
48251355|NCT03334695|100934294|FG000|COMPLETED|Overall Study||27||
48378630|NCT02280291|101255938|FG002|COMPLETED|Overall Study||21||
48378631|NCT02280291|101255939|FG003|COMPLETED|Overall Study||18||
48378632|NCT02280291|101255936|FG000|NOT COMPLETED|Overall Study||4||
48378633|NCT02280291|101255937|FG001|NOT COMPLETED|Overall Study||2||
48378634|NCT02280291|101255938|FG002|NOT COMPLETED|Overall Study||3||
48378635|NCT02280291|101255939|FG003|NOT COMPLETED|Overall Study||8||
48378636|NCT04131517|101255940|FG000|STARTED|Overall Study||7||
48378637|NCT04131517|101255941|FG001|STARTED|Overall Study||7||
48378638|NCT04131517|101255940|FG000|COMPLETED|Overall Study||7||
48378639|NCT04131517|101255941|FG001|COMPLETED|Overall Study||7||
48378640|NCT04131517|101255940|FG000|NOT COMPLETED|Overall Study||0||
48378641|NCT04131517|101255941|FG001|NOT COMPLETED|Overall Study||0||
48378642|NCT05291949|101255942|FG000|STARTED|Overall Study||70||
48378643|NCT05291949|101255942|FG000|COMPLETED|Overall Study||66||
48378644|NCT05291949|101255942|FG000|NOT COMPLETED|Overall Study||4||
48378645|NCT00458406|101255943|FG000|STARTED|Month 1||43||
48684413|NCT02881775|102009742|FG001|COMPLETED|Baseline||9||
48684414|NCT02881775|102009741|FG000|NOT COMPLETED|Baseline||0||
48684415|NCT02881775|102009742|FG001|NOT COMPLETED|Baseline||0||
48684416|NCT02881775|102009741|FG000|STARTED|First Intervention (1-hr Session)||9||
48684417|NCT02881775|102009742|FG001|STARTED|First Intervention (1-hr Session)||7||
48684418|NCT02881775|102009741|FG000|COMPLETED|First Intervention (1-hr Session)||9||
48684419|NCT02881775|102009742|FG001|COMPLETED|First Intervention (1-hr Session)||7||
48684420|NCT02881775|102009741|FG000|NOT COMPLETED|First Intervention (1-hr Session)||0||
48684421|NCT02881775|102009742|FG001|NOT COMPLETED|First Intervention (1-hr Session)||0||
48251356|NCT03334695|100934295|FG001|COMPLETED|Overall Study||26||
48251357|NCT03334695|100934294|FG000|NOT COMPLETED|Overall Study||4||
48251358|NCT03334695|100934295|FG001|NOT COMPLETED|Overall Study||6||
48251359|NCT03175198|100934296|FG000|STARTED|Overall Study||5565|CRF collected|
48251360|NCT03175198|100934296|FG000|Safety Set 1|Overall Study||5436||
48378646|NCT00458406|101255944|FG001|STARTED|Month 1||13||
48378647|NCT00458406|101255943|FG000|COMPLETED|Month 1||43||
48684422|NCT02881775|102009741|FG000|STARTED|Washout (1 Week)||9||
48684423|NCT02881775|102009742|FG001|STARTED|Washout (1 Week)||7||
48684424|NCT02881775|102009741|FG000|COMPLETED|Washout (1 Week)||9||
48684425|NCT02881775|102009742|FG001|COMPLETED|Washout (1 Week)||7||
48684426|NCT02881775|102009741|FG000|NOT COMPLETED|Washout (1 Week)||0||
48684427|NCT02881775|102009742|FG001|NOT COMPLETED|Washout (1 Week)||0||
48684428|NCT02881775|102009741|FG000|STARTED|Second Intervention (1-Hour Session)||9||
48251361|NCT03175198|100934296|FG000|COMPLETED|Overall Study||3238||
48251362|NCT03175198|100934296|FG000|NOT COMPLETED|Overall Study||2327||
48251363|NCT03041701|100934297|FG000|STARTED|Ph I: Dose Level 1 and 2 Dose Escalation||7||
48378648|NCT00458406|101255944|FG001|COMPLETED|Month 1||13||
48378649|NCT00458406|101255943|FG000|NOT COMPLETED|Month 1||0||
48378650|NCT00458406|101255944|FG001|NOT COMPLETED|Month 1||0||
48378651|NCT00458406|101255943|FG000|STARTED|Month 3||43||
48378652|NCT00458406|101255944|FG001|STARTED|Month 3||13||
48378653|NCT00458406|101255943|FG000|COMPLETED|Month 3||43||
48378654|NCT00458406|101255944|FG001|COMPLETED|Month 3||13||
48378655|NCT00458406|101255943|FG000|NOT COMPLETED|Month 3||0||
48378656|NCT00458406|101255944|FG001|NOT COMPLETED|Month 3||0||
48378657|NCT04387136|101255945|FG000|STARTED|Overall Study||26||
48378658|NCT04387136|101255946|FG001|STARTED|Overall Study||27||
48378659|NCT04387136|101255945|FG000|COMPLETED|Overall Study||25||
48378660|NCT04387136|101255946|FG001|COMPLETED|Overall Study||25||
48378661|NCT04387136|101255945|FG000|NOT COMPLETED|Overall Study||1||
48378662|NCT04387136|101255946|FG001|NOT COMPLETED|Overall Study||2||
48378663|NCT01025817|101255947|FG000|STARTED|Completed Study Medication||309||
48378664|NCT01025817|101255948|FG001|STARTED|Completed Study Medication||304||
48378665|NCT01025817|101255947|FG000|COMPLETED|Completed Study Medication||204||
48378666|NCT01025817|101255948|FG001|COMPLETED|Completed Study Medication||232||
48378667|NCT01025817|101255947|FG000|NOT COMPLETED|Completed Study Medication||105||
48378668|NCT01025817|101255948|FG001|NOT COMPLETED|Completed Study Medication||72||
48378669|NCT01025817|101255947|FG000|STARTED|Completed Study||309||
48089050|NCT04232124|100541076|FG000|NOT COMPLETED|Overall Study||3||
48089051|NCT03934931|100541077|FG000|STARTED|Overall Study||552||
48089052|NCT03934931|100541078|FG001|STARTED|Overall Study||552||
48378670|NCT01025817|101255948|FG001|STARTED|Completed Study||304||
48378671|NCT01025817|101255947|FG000|COMPLETED|Completed Study||293||
48378672|NCT01025817|101255948|FG001|COMPLETED|Completed Study||282||
48378673|NCT01025817|101255947|FG000|NOT COMPLETED|Completed Study||16||
48378674|NCT01025817|101255948|FG001|NOT COMPLETED|Completed Study||22||
48378675|NCT00632541|101255949|FG000|STARTED|Overall Study||18||
48378676|NCT00632541|101255949|FG000|COMPLETED|Overall Study||11||
48378677|NCT00632541|101255949|FG000|NOT COMPLETED|Overall Study||7||
48378678|NCT03699631|101255950|FG000|STARTED|Overall Study||29||
48378679|NCT03699631|101255950|FG000|COMPLETED|Overall Study||26||
48378680|NCT03699631|101255950|FG000|NOT COMPLETED|Overall Study||3||
48378681|NCT04863014|101255951|FG000|STARTED|Overall Study||10||
48378682|NCT04863014|101255952|FG001|STARTED|Overall Study||11||
48378683|NCT04863014|101255951|FG000|COMPLETED|Overall Study||7||
48378684|NCT04863014|101255952|FG001|COMPLETED|Overall Study||5||
48378685|NCT04863014|101255951|FG000|NOT COMPLETED|Overall Study||3||
48378686|NCT04863014|101255952|FG001|NOT COMPLETED|Overall Study||6||
48378687|NCT05209932|101255953|FG000|STARTED|Overall Study||140||
48378688|NCT05209932|101255954|FG001|STARTED|Overall Study||93||
48378689|NCT05209932|101255953|FG000|Completed All or Partial Units|Overall Study||57||
48378690|NCT05209932|101255954|FG001|Completed All or Partial Units|Overall Study||93||
48378691|NCT05209932|101255953|FG000|COMPLETED|Overall Study||140||
48378692|NCT05209932|101255954|FG001|COMPLETED|Overall Study||93||
48378693|NCT05209932|101255953|FG000|NOT COMPLETED|Overall Study||0||
48378694|NCT05209932|101255954|FG001|NOT COMPLETED|Overall Study||0||
48378695|NCT04263142|101255955|FG000|STARTED|Part 1 Period 1 (Day 1)||9||
48378696|NCT04263142|101255956|FG001|STARTED|Part 1 Period 1 (Day 1)||9||
48378697|NCT04263142|101255957|FG002|STARTED|Part 1 Period 1 (Day 1)||0||
48378698|NCT04263142|101255958|FG003|STARTED|Part 1 Period 1 (Day 1)||0||
48378699|NCT04263142|101255959|FG004|STARTED|Part 1 Period 1 (Day 1)||0||
48378700|NCT04263142|101255955|FG000|COMPLETED|Part 1 Period 1 (Day 1)||9||
48378701|NCT04263142|101255956|FG001|COMPLETED|Part 1 Period 1 (Day 1)||9||
48378702|NCT04263142|101255957|FG002|COMPLETED|Part 1 Period 1 (Day 1)||0||
48378703|NCT04263142|101255958|FG003|COMPLETED|Part 1 Period 1 (Day 1)||0||
48378704|NCT04263142|101255959|FG004|COMPLETED|Part 1 Period 1 (Day 1)||0||
48378705|NCT04263142|101255955|FG000|NOT COMPLETED|Part 1 Period 1 (Day 1)||0||
48378706|NCT04263142|101255956|FG001|NOT COMPLETED|Part 1 Period 1 (Day 1)||0||
48684429|NCT02881775|102009742|FG001|STARTED|Second Intervention (1-Hour Session)||7||
48684430|NCT02881775|102009741|FG000|COMPLETED|Second Intervention (1-Hour Session)||9||
48684431|NCT02881775|102009742|FG001|COMPLETED|Second Intervention (1-Hour Session)||7||
48684432|NCT02881775|102009741|FG000|NOT COMPLETED|Second Intervention (1-Hour Session)||0||
48684433|NCT02881775|102009742|FG001|NOT COMPLETED|Second Intervention (1-Hour Session)||0||
48684434|NCT01485796|102009743|FG000|STARTED|Period 1: Epoch 1 (Ramp-up)||37||
48684435|NCT01485796|102009743|FG000|Treated in Epoch 1|Period 1: Epoch 1 (Ramp-up)||37||
48684436|NCT01485796|102009743|FG000|COMPLETED|Period 1: Epoch 1 (Ramp-up)||36||
48378707|NCT04263142|101255957|FG002|NOT COMPLETED|Part 1 Period 1 (Day 1)||0||
48378708|NCT04263142|101255958|FG003|NOT COMPLETED|Part 1 Period 1 (Day 1)||0||
48378709|NCT04263142|101255959|FG004|NOT COMPLETED|Part 1 Period 1 (Day 1)||0||
48378710|NCT04263142|101255955|FG000|STARTED|Part 1 Period 2 (Up to Day 5)||9||
48378711|NCT04263142|101255956|FG001|STARTED|Part 1 Period 2 (Up to Day 5)||9||
48378712|NCT04263142|101255957|FG002|STARTED|Part 1 Period 2 (Up to Day 5)||0||
48378713|NCT04263142|101255958|FG003|STARTED|Part 1 Period 2 (Up to Day 5)||0||
48378714|NCT04263142|101255959|FG004|STARTED|Part 1 Period 2 (Up to Day 5)||0||
48378715|NCT04263142|101255955|FG000|COMPLETED|Part 1 Period 2 (Up to Day 5)||9||
48378716|NCT04263142|101255956|FG001|COMPLETED|Part 1 Period 2 (Up to Day 5)||9||
48378717|NCT04263142|101255957|FG002|COMPLETED|Part 1 Period 2 (Up to Day 5)||0||
48251364|NCT03041701|100934298|FG001|STARTED|Ph I: Dose Level 1 and 2 Dose Escalation||6||
48251365|NCT03041701|100934299|FG002|STARTED|Ph I: Dose Level 1 and 2 Dose Escalation||0||
48251366|NCT03041701|100934297|FG000|COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||6||
48251367|NCT03041701|100934298|FG001|COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||5||
48251368|NCT03041701|100934299|FG002|COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||0||
48251369|NCT03041701|100934297|FG000|NOT COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||1||
48251370|NCT03041701|100934298|FG001|NOT COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||1||
48251371|NCT03041701|100934299|FG002|NOT COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||0||
48251372|NCT03041701|100934297|FG000|STARTED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0||
48251373|NCT03041701|100934298|FG001|STARTED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0||
48251374|NCT03041701|100934299|FG002|STARTED|Ph 2:Dose Level 1 Maximum Tolerated Dose||1||
48251375|NCT03041701|100934297|FG000|COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0||
48251376|NCT03041701|100934298|FG001|COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0||
48251377|NCT03041701|100934299|FG002|COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0||
48251378|NCT03041701|100934297|FG000|NOT COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0||
48251379|NCT03041701|100934298|FG001|NOT COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0||
48251380|NCT03041701|100934299|FG002|NOT COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||1||
48251381|NCT03605368|100934300|FG000|STARTED|Overall Study||25||
48251382|NCT03605368|100934301|FG001|STARTED|Overall Study||25||
48251383|NCT03605368|100934302|FG002|STARTED|Overall Study||31||
48251384|NCT03605368|100934303|FG003|STARTED|Overall Study||31||
48251385|NCT03605368|100934300|FG000|COMPLETED|Overall Study||23||
48251386|NCT03605368|100934301|FG001|COMPLETED|Overall Study||24||
48251387|NCT03605368|100934302|FG002|COMPLETED|Overall Study||24||
48251388|NCT03605368|100934303|FG003|COMPLETED|Overall Study||26||
48251389|NCT03605368|100934300|FG000|NOT COMPLETED|Overall Study||2||
48251390|NCT03605368|100934301|FG001|NOT COMPLETED|Overall Study||1||
48251391|NCT03605368|100934302|FG002|NOT COMPLETED|Overall Study||7||
48251392|NCT03605368|100934303|FG003|NOT COMPLETED|Overall Study||5||
48251393|NCT01490359|100934304|FG000|STARTED|Overall Study||609||
48251394|NCT01490359|100934305|FG001|STARTED|Overall Study||572||
48251395|NCT01490359|100934304|FG000|Followed-up at 6 mo|Overall Study||558||
48251396|NCT01490359|100934305|FG001|Followed-up at 6 mo|Overall Study||535||
48251397|NCT01490359|100934304|FG000|Followed-up at 12 mo|Overall Study||569||
48251398|NCT01490359|100934305|FG001|Followed-up at 12 mo|Overall Study||537||
48251399|NCT01490359|100934304|FG000|COMPLETED|Overall Study||585||
48251400|NCT01490359|100934305|FG001|COMPLETED|Overall Study||555||
48251401|NCT01490359|100934304|FG000|NOT COMPLETED|Overall Study||24||
48251402|NCT01490359|100934305|FG001|NOT COMPLETED|Overall Study||17||
48251403|NCT05060237|100934306|FG000|STARTED|Overall Study||112||
48251404|NCT05060237|100934306|FG000|Treated on the Face|Overall Study||40||
48251405|NCT05060237|100934306|FG000|Treated on the Scalp|Overall Study||39||
48251406|NCT05060237|100934306|FG000|Treated on the Face and Scalp|Overall Study||21||
48251407|NCT05060237|100934306|FG000|COMPLETED|Overall Study||100||
48251408|NCT05060237|100934306|FG000|NOT COMPLETED|Overall Study||12||
48378718|NCT04263142|101255958|FG003|COMPLETED|Part 1 Period 2 (Up to Day 5)||0||
48378719|NCT04263142|101255959|FG004|COMPLETED|Part 1 Period 2 (Up to Day 5)||0||
48378720|NCT04263142|101255955|FG000|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0||
48378721|NCT04263142|101255956|FG001|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0||
48541232|NCT00229723|101662685|FG005|NOT COMPLETED|Maintenance Phase||19||
48541233|NCT00229723|101662686|FG006|NOT COMPLETED|Maintenance Phase||10||
48541234|NCT01753297|101662687|FG000|STARTED|Overall Study||117||
48251409|NCT02090998|100934307|FG000|STARTED|Overall Study||2||
48251410|NCT02090998|100934308|FG001|STARTED|Overall Study||8||
48251411|NCT02090998|100934307|FG000|COMPLETED|Overall Study||2||
48251412|NCT02090998|100934308|FG001|COMPLETED|Overall Study||8||
48251413|NCT02090998|100934307|FG000|NOT COMPLETED|Overall Study||0||
48251414|NCT02090998|100934308|FG001|NOT COMPLETED|Overall Study||0||
48251415|NCT00621946|100934309|FG000|STARTED|Overall Study||13||
48541235|NCT01753297|101662688|FG001|STARTED|Overall Study||109||
48541236|NCT01753297|101662687|FG000|Received Triptorelin Treatment|Overall Study||0||
48541237|NCT01753297|101662688|FG001|Received Triptorelin Treatment|Overall Study||105||
48541238|NCT01753297|101662687|FG000|COMPLETED|Overall Study||76|Completed study at Month 36 or completed Follow-up|
48541239|NCT01753297|101662688|FG001|COMPLETED|Overall Study||73|Completed study at Month 36 or completed Follow-up|
48251416|NCT00621946|100934310|FG001|STARTED|Overall Study||13||
48251417|NCT00621946|100934309|FG000|COMPLETED|Overall Study||13||
48251418|NCT00621946|100934310|FG001|COMPLETED|Overall Study||12||
48251419|NCT00621946|100934309|FG000|NOT COMPLETED|Overall Study||0||
48251420|NCT00621946|100934310|FG001|NOT COMPLETED|Overall Study||1||
48251421|NCT01020747|100934311|FG000|STARTED|Overall Study||20||
48251422|NCT01020747|100934311|FG000|COMPLETED|Overall Study||19||
48251423|NCT01020747|100934311|FG000|NOT COMPLETED|Overall Study||1||
48251424|NCT03220776|100934312|FG000|STARTED|Overall Study||9||
48251425|NCT03220776|100934313|FG001|STARTED|Overall Study||9||
48251426|NCT03220776|100934314|FG002|STARTED|Overall Study||9||
48251427|NCT03220776|100934315|FG003|STARTED|Overall Study||9||
48378722|NCT04263142|101255957|FG002|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0||
48378723|NCT04263142|101255958|FG003|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0||
48378724|NCT04263142|101255959|FG004|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0||
48378725|NCT04263142|101255955|FG000|STARTED|Part 2 Period 1 (Day 1)||0||
48378726|NCT04263142|101255956|FG001|STARTED|Part 2 Period 1 (Day 1)||0||
48378727|NCT04263142|101255957|FG002|STARTED|Part 2 Period 1 (Day 1)||7||
48251428|NCT03220776|100934316|FG004|STARTED|Overall Study||9||
48251429|NCT03220776|100934317|FG005|STARTED|Overall Study||9||
48251430|NCT03220776|100934312|FG000|COMPLETED|Overall Study||7||
48251431|NCT03220776|100934313|FG001|COMPLETED|Overall Study||8||
48251432|NCT03220776|100934314|FG002|COMPLETED|Overall Study||8||
48251433|NCT03220776|100934315|FG003|COMPLETED|Overall Study||5||
48251434|NCT03220776|100934316|FG004|COMPLETED|Overall Study||8||
48251435|NCT03220776|100934317|FG005|COMPLETED|Overall Study||7||
48251436|NCT03220776|100934312|FG000|NOT COMPLETED|Overall Study||2||
48251437|NCT03220776|100934313|FG001|NOT COMPLETED|Overall Study||1||
48251438|NCT03220776|100934314|FG002|NOT COMPLETED|Overall Study||1||
48251439|NCT03220776|100934315|FG003|NOT COMPLETED|Overall Study||4||
48251440|NCT03220776|100934316|FG004|NOT COMPLETED|Overall Study||1||
48251441|NCT03220776|100934317|FG005|NOT COMPLETED|Overall Study||2||
48251442|NCT00570921|100934318|FG000|STARTED|Overall Study||33||
48251443|NCT00570921|100934318|FG000|COMPLETED|Overall Study||31||
48251444|NCT00570921|100934318|FG000|NOT COMPLETED|Overall Study||2||
48251445|NCT02269917|100934319|FG000|STARTED|BL to EOE-Test and BL to Switch-Control||766||
48251446|NCT02269917|100934320|FG001|STARTED|BL to EOE-Test and BL to Switch-Control||383||
48251447|NCT02269917|100934321|FG002|STARTED|BL to EOE-Test and BL to Switch-Control||0||
48251448|NCT02269917|100934319|FG000|Treated|BL to EOE-Test and BL to Switch-Control||763||
48251449|NCT02269917|100934320|FG001|Treated|BL to EOE-Test and BL to Switch-Control||378||
48251450|NCT02269917|100934321|FG002|Treated|BL to EOE-Test and BL to Switch-Control||0||
48251451|NCT02269917|100934319|FG000|COMPLETED|BL to EOE-Test and BL to Switch-Control||649||
48251452|NCT02269917|100934320|FG001|COMPLETED|BL to EOE-Test and BL to Switch-Control||352||
48251453|NCT02269917|100934321|FG002|COMPLETED|BL to EOE-Test and BL to Switch-Control||0||
48251454|NCT02269917|100934319|FG000|NOT COMPLETED|BL to EOE-Test and BL to Switch-Control||117||
48251455|NCT02269917|100934320|FG001|NOT COMPLETED|BL to EOE-Test and BL to Switch-Control||31||
48251456|NCT02269917|100934321|FG002|NOT COMPLETED|BL to EOE-Test and BL to Switch-Control||0||
48251457|NCT02269917|100934319|FG000|STARTED|Switch to D/C/F/TAF (Until EOE)||0||
48251458|NCT02269917|100934320|FG001|STARTED|Switch to D/C/F/TAF (Until EOE)||0||
48251459|NCT02269917|100934321|FG002|STARTED|Switch to D/C/F/TAF (Until EOE)||352||
48251460|NCT02269917|100934319|FG000|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0||
48251461|NCT02269917|100934320|FG001|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0||
48251462|NCT02269917|100934321|FG002|COMPLETED|Switch to D/C/F/TAF (Until EOE)||314||
48251463|NCT02269917|100934319|FG000|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0||
48251464|NCT02269917|100934320|FG001|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0||
48251465|NCT02269917|100934321|FG002|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||38||
48251466|NCT00931918|100934322|FG000|STARTED|Overall Study||103||
48251467|NCT00931918|100934323|FG001|STARTED|Overall Study||103||
48251468|NCT00931918|100934322|FG000|Safety Population: Received Study Drug|Overall Study||100||
48251469|NCT00931918|100934323|FG001|Safety Population: Received Study Drug|Overall Study||101||
48251470|NCT00931918|100934322|FG000|COMPLETED|Overall Study||86||
48251471|NCT00931918|100934323|FG001|COMPLETED|Overall Study||86||
48251472|NCT00931918|100934322|FG000|NOT COMPLETED|Overall Study||17||
48251473|NCT00931918|100934323|FG001|NOT COMPLETED|Overall Study||17||
48251474|NCT02469077|100934324|FG000|STARTED|Pre Randomization - Pre Intervention||44|Order of preexercise intervention placebo/morphine/naloxone randomizedeach subject|
48251475|NCT02469077|100934325|FG001|STARTED|Pre Randomization - Pre Intervention||49|Order of preexercise intervention placebo/morphine/naloxone randomizedeach subject|
48251476|NCT02469077|100934324|FG000|Pre Intervention Placebo|Pre Randomization - Pre Intervention||44||
48251477|NCT02469077|100934325|FG001|Pre Intervention Placebo|Pre Randomization - Pre Intervention||49||
48251478|NCT02469077|100934324|FG000|Pre Intervention Morpine|Pre Randomization - Pre Intervention||44||
48251479|NCT02469077|100934325|FG001|Pre Intervention Morpine|Pre Randomization - Pre Intervention||49||
48378728|NCT04263142|101255958|FG003|STARTED|Part 2 Period 1 (Day 1)||7||
48378729|NCT04263142|101255959|FG004|STARTED|Part 2 Period 1 (Day 1)||7||
48378730|NCT04263142|101255955|FG000|COMPLETED|Part 2 Period 1 (Day 1)||0||
48378731|NCT04263142|101255956|FG001|COMPLETED|Part 2 Period 1 (Day 1)||0||
48378732|NCT04263142|101255957|FG002|COMPLETED|Part 2 Period 1 (Day 1)||7||
48378733|NCT04263142|101255958|FG003|COMPLETED|Part 2 Period 1 (Day 1)||7||
48378734|NCT04263142|101255959|FG004|COMPLETED|Part 2 Period 1 (Day 1)||6||
48251480|NCT02469077|100934324|FG000|Pre Intervention Naloxone|Pre Randomization - Pre Intervention||44||
48251481|NCT02469077|100934325|FG001|Pre Intervention Naloxone|Pre Randomization - Pre Intervention||49||
48251482|NCT02469077|100934324|FG000|COMPLETED|Pre Randomization - Pre Intervention||44||
48378735|NCT04263142|101255955|FG000|NOT COMPLETED|Part 2 Period 1 (Day 1)||0||
48378736|NCT04263142|101255956|FG001|NOT COMPLETED|Part 2 Period 1 (Day 1)||0||
48251483|NCT02469077|100934325|FG001|COMPLETED|Pre Randomization - Pre Intervention||49||
48251484|NCT02469077|100934324|FG000|NOT COMPLETED|Pre Randomization - Pre Intervention||0||
48378737|NCT04263142|101255957|FG002|NOT COMPLETED|Part 2 Period 1 (Day 1)||0||
48378738|NCT04263142|101255958|FG003|NOT COMPLETED|Part 2 Period 1 (Day 1)||0||
48251485|NCT02469077|100934325|FG001|NOT COMPLETED|Pre Randomization - Pre Intervention||0||
48251486|NCT02469077|100934324|FG000|STARTED|Post Randomization/Intervention Period||44||
48251487|NCT02469077|100934325|FG001|STARTED|Post Randomization/Intervention Period||49||
48251488|NCT02469077|100934324|FG000|COMPLETED|Post Randomization/Intervention Period||40||
48251489|NCT02469077|100934325|FG001|COMPLETED|Post Randomization/Intervention Period||45||
48251490|NCT02469077|100934324|FG000|NOT COMPLETED|Post Randomization/Intervention Period||4||
48251491|NCT02469077|100934325|FG001|NOT COMPLETED|Post Randomization/Intervention Period||4||
48251492|NCT02469077|100934324|FG000|STARTED|Post Intervention /Followup||40|Order ofpostexercise intervention assessmentwith placebo/morphine/naloxone randomized foreachsubject|
48684437|NCT01485796|102009743|FG000|NOT COMPLETED|Period 1: Epoch 1 (Ramp-up)||1||
48684438|NCT01485796|102009743|FG000|STARTED|Period 2: Epoch 2||36||
48684439|NCT01485796|102009743|FG000|Treated in Epoch 2|Period 2: Epoch 2||36||
48378739|NCT04263142|101255959|FG004|NOT COMPLETED|Part 2 Period 1 (Day 1)||1||
48378740|NCT04263142|101255955|FG000|STARTED|Part 2 Period 2 (Day 1)||0||
48378741|NCT04263142|101255956|FG001|STARTED|Part 2 Period 2 (Day 1)||0||
48684440|NCT01485796|102009743|FG000|COMPLETED|Period 2: Epoch 2||1||
48684441|NCT01485796|102009743|FG000|NOT COMPLETED|Period 2: Epoch 2||35||
48684442|NCT01485796|102009743|FG000|STARTED|Overall Trial (Incl. Safety Follow-up)||37||
48251493|NCT02469077|100934325|FG001|STARTED|Post Intervention /Followup||45|Order ofpostexercise intervention assessmentwith placebo/morphine/naloxone randomized foreachsubject|
48251494|NCT02469077|100934324|FG000|Post Intervention Placebo|Post Intervention /Followup||39||
48251495|NCT02469077|100934325|FG001|Post Intervention Placebo|Post Intervention /Followup||45||
48684443|NCT01485796|102009743|FG000|Treated in Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||37||
48684444|NCT01485796|102009743|FG000|Completed Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||36||
48684445|NCT01485796|102009743|FG000|Started Epoch 2|Overall Trial (Incl. Safety Follow-up)||36||
48684446|NCT01485796|102009743|FG000|Treated in Epoch 2|Overall Trial (Incl. Safety Follow-up)||36||
48251496|NCT02469077|100934324|FG000|Post Intervention Morphine|Post Intervention /Followup||40||
48251497|NCT02469077|100934325|FG001|Post Intervention Morphine|Post Intervention /Followup||45||
48251498|NCT02469077|100934324|FG000|Post Intervention Naloxone|Post Intervention /Followup||39||
48251499|NCT02469077|100934325|FG001|Post Intervention Naloxone|Post Intervention /Followup||44||
48251500|NCT02469077|100934324|FG000|COMPLETED|Post Intervention /Followup||38||
48251501|NCT02469077|100934325|FG001|COMPLETED|Post Intervention /Followup||44||
48251502|NCT02469077|100934324|FG000|NOT COMPLETED|Post Intervention /Followup||2||
48251503|NCT02469077|100934325|FG001|NOT COMPLETED|Post Intervention /Followup||1||
48251504|NCT01011049|100934326|FG000|STARTED|Overall Study||507||
48251505|NCT01011049|100934327|FG001|STARTED|Overall Study||252||
48251506|NCT01011049|100934328|FG002|STARTED|Overall Study||243||
48251507|NCT01011049|100934329|FG003|STARTED|Overall Study||246||
48251508|NCT01011049|100934326|FG000|COMPLETED|Overall Study||506||
48251509|NCT01011049|100934327|FG001|COMPLETED|Overall Study||250||
48251510|NCT01011049|100934328|FG002|COMPLETED|Overall Study||239||
48251511|NCT01011049|100934329|FG003|COMPLETED|Overall Study||246||
48251512|NCT01011049|100934326|FG000|NOT COMPLETED|Overall Study||1||
48251513|NCT01011049|100934327|FG001|NOT COMPLETED|Overall Study||2||
48251514|NCT01011049|100934328|FG002|NOT COMPLETED|Overall Study||4||
48251515|NCT01011049|100934329|FG003|NOT COMPLETED|Overall Study||0||
48251516|NCT01431950|100934330|FG000|STARTED|Overall Study||119||
48251517|NCT01431950|100934331|FG001|STARTED|Overall Study||119||
48251518|NCT01431950|100934330|FG000|COMPLETED|Overall Study||100||
48251519|NCT01431950|100934331|FG001|COMPLETED|Overall Study||104||
48251520|NCT01431950|100934330|FG000|NOT COMPLETED|Overall Study||19||
48251521|NCT01431950|100934331|FG001|NOT COMPLETED|Overall Study||15||
48251522|NCT01229527|100934332|FG000|STARTED|Overall Study||30||
48378742|NCT04263142|101255957|FG002|STARTED|Part 2 Period 2 (Day 1)||7||
48378743|NCT04263142|101255958|FG003|STARTED|Part 2 Period 2 (Day 1)||7||
48378744|NCT04263142|101255959|FG004|STARTED|Part 2 Period 2 (Day 1)||6||
48541240|NCT01753297|101662687|FG000|NOT COMPLETED|Overall Study||41||
48684447|NCT01485796|102009743|FG000|Completed Epoch 2|Overall Trial (Incl. Safety Follow-up)||1||
48684448|NCT01485796|102009743|FG000|Switch to Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||26||
48684449|NCT01485796|102009743|FG000|Completed Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||24||
48684450|NCT01485796|102009743|FG000|COMPLETED|Overall Trial (Incl. Safety Follow-up)||25||
48684451|NCT01485796|102009743|FG000|NOT COMPLETED|Overall Trial (Incl. Safety Follow-up)||12||
48684452|NCT02903823|102009744|FG000|STARTED|Overall Study||27||
48684453|NCT02903823|102009744|FG000|COMPLETED|Overall Study||20||
48684454|NCT02903823|102009744|FG000|NOT COMPLETED|Overall Study||7||
48684455|NCT01991483|102009745|FG000|STARTED|Dose Level: Placebo||7||
48684456|NCT01991483|102009746|FG001|STARTED|Dose Level: Placebo||0||
48684457|NCT01991483|102009747|FG002|STARTED|Dose Level: Placebo||0||
48684458|NCT01991483|102009748|FG003|STARTED|Dose Level: Placebo||0||
48684459|NCT01991483|102009745|FG000|Received at Least One Dose of Study Drug|Dose Level: Placebo||7||
48251523|NCT01229527|100934333|FG001|STARTED|Overall Study||30||
48251524|NCT01229527|100934334|FG002|STARTED|Overall Study||30||
48251525|NCT01229527|100934332|FG000|COMPLETED|Overall Study||30||
48251526|NCT01229527|100934333|FG001|COMPLETED|Overall Study||30||
48684460|NCT01991483|102009746|FG001|Received at Least One Dose of Study Drug|Dose Level: Placebo||0||
48684461|NCT01991483|102009747|FG002|Received at Least One Dose of Study Drug|Dose Level: Placebo||0||
48251527|NCT01229527|100934334|FG002|COMPLETED|Overall Study||30||
48684462|NCT01991483|102009748|FG003|Received at Least One Dose of Study Drug|Dose Level: Placebo||0||
48251528|NCT01229527|100934332|FG000|NOT COMPLETED|Overall Study||0||
48251529|NCT01229527|100934333|FG001|NOT COMPLETED|Overall Study||0||
48251530|NCT01229527|100934334|FG002|NOT COMPLETED|Overall Study||0||
48251531|NCT01318538|100934335|FG000|STARTED|Overall Study||52||
48251532|NCT01318538|100934336|FG001|STARTED|Overall Study||106||
48251533|NCT01318538|100934337|FG002|STARTED|Overall Study||8||
48251534|NCT01318538|100934335|FG000|COMPLETED|Overall Study||52||
48251535|NCT01318538|100934336|FG001|COMPLETED|Overall Study||106||
48251536|NCT01318538|100934337|FG002|COMPLETED|Overall Study||8||
48251537|NCT01318538|100934335|FG000|NOT COMPLETED|Overall Study||0||
48251538|NCT01318538|100934336|FG001|NOT COMPLETED|Overall Study||0||
48251539|NCT01318538|100934337|FG002|NOT COMPLETED|Overall Study||0||
48251540|NCT02795819|100934338|FG000|STARTED|Overall Study||0||
48251541|NCT02795819|100934339|FG001|STARTED|Overall Study||6||
48251542|NCT02795819|100934340|FG002|STARTED|Overall Study||0||
48251543|NCT02795819|100934341|FG003|STARTED|Overall Study||0||
48251544|NCT02795819|100934342|FG004|STARTED|Overall Study||0||
48251545|NCT02795819|100934343|FG005|STARTED|Overall Study||0||
48251546|NCT02795819|100934344|FG006|STARTED|Overall Study||0||
48251547|NCT02795819|100934338|FG000|COMPLETED|Overall Study||0||
48251548|NCT02795819|100934339|FG001|COMPLETED|Overall Study||6||
48251549|NCT02795819|100934340|FG002|COMPLETED|Overall Study||0||
48251550|NCT02795819|100934341|FG003|COMPLETED|Overall Study||0||
48251551|NCT02795819|100934342|FG004|COMPLETED|Overall Study||0||
48251552|NCT02795819|100934343|FG005|COMPLETED|Overall Study||0||
48251553|NCT02795819|100934344|FG006|COMPLETED|Overall Study||0||
48251554|NCT02795819|100934338|FG000|NOT COMPLETED|Overall Study||0||
48251555|NCT02795819|100934339|FG001|NOT COMPLETED|Overall Study||0||
48251556|NCT02795819|100934340|FG002|NOT COMPLETED|Overall Study||0||
48251557|NCT02795819|100934341|FG003|NOT COMPLETED|Overall Study||0||
48251558|NCT02795819|100934342|FG004|NOT COMPLETED|Overall Study||0||
48251559|NCT02795819|100934343|FG005|NOT COMPLETED|Overall Study||0||
48251560|NCT02795819|100934344|FG006|NOT COMPLETED|Overall Study||0||
48251561|NCT03280108|100934345|FG000|STARTED|Overall Study||129|Successful Implantation|
48251562|NCT03280108|100934346|FG001|STARTED|Overall Study||114|Successful Implantation|
48251563|NCT03280108|100934345|FG000|COMPLETED|Overall Study||127||
48251564|NCT03280108|100934346|FG001|COMPLETED|Overall Study||114||
48251565|NCT03280108|100934345|FG000|NOT COMPLETED|Overall Study||2||
48251566|NCT03280108|100934346|FG001|NOT COMPLETED|Overall Study||0||
48251567|NCT02143063|100934347|FG000|STARTED|Overall Study||61||
48251568|NCT02143063|100934348|FG001|STARTED|Overall Study||105||
48251569|NCT02143063|100934349|FG002|STARTED|Overall Study||108||
48251570|NCT02143063|100934347|FG000|COMPLETED|Overall Study||45||
48251571|NCT02143063|100934348|FG001|COMPLETED|Overall Study||75||
48251572|NCT02143063|100934349|FG002|COMPLETED|Overall Study||78||
48251573|NCT02143063|100934347|FG000|NOT COMPLETED|Overall Study||16||
48251574|NCT02143063|100934348|FG001|NOT COMPLETED|Overall Study||30||
48684463|NCT01991483|102009745|FG000|COMPLETED|Dose Level: Placebo||7||
48684464|NCT01991483|102009746|FG001|COMPLETED|Dose Level: Placebo||0||
48684465|NCT01991483|102009747|FG002|COMPLETED|Dose Level: Placebo||0||
48684466|NCT01991483|102009748|FG003|COMPLETED|Dose Level: Placebo||0||
48684467|NCT01991483|102009745|FG000|NOT COMPLETED|Dose Level: Placebo||0||
48684468|NCT01991483|102009746|FG001|NOT COMPLETED|Dose Level: Placebo||0||
48251575|NCT02143063|100934349|FG002|NOT COMPLETED|Overall Study||30||
48251576|NCT01613807|100934350|FG000|STARTED|Overall Study||20||
48251577|NCT01613807|100934351|FG001|STARTED|Overall Study||20||
48251578|NCT01613807|100934350|FG000|COMPLETED|Overall Study||20||
48251579|NCT01613807|100934351|FG001|COMPLETED|Overall Study||20||
48251580|NCT01613807|100934350|FG000|NOT COMPLETED|Overall Study||0||
48251581|NCT01613807|100934351|FG001|NOT COMPLETED|Overall Study||0||
48251582|NCT01388478|100934352|FG000|STARTED|Overall Study||20||
48251583|NCT01388478|100934352|FG000|COMPLETED|Overall Study||15||
48251584|NCT01388478|100934352|FG000|NOT COMPLETED|Overall Study||5||
48251585|NCT03028012|100934353|FG000|STARTED|Overall Study||4||
48251586|NCT03028012|100934354|FG001|STARTED|Overall Study||3||
48251587|NCT03028012|100934355|FG002|STARTED|Overall Study||3||
48251588|NCT03028012|100934353|FG000|COMPLETED|Overall Study||2||
48251589|NCT03028012|100934354|FG001|COMPLETED|Overall Study||0||
48251590|NCT03028012|100934355|FG002|COMPLETED|Overall Study||0||
48251591|NCT03028012|100934353|FG000|NOT COMPLETED|Overall Study||2||
48251592|NCT03028012|100934354|FG001|NOT COMPLETED|Overall Study||3||
48251593|NCT03028012|100934355|FG002|NOT COMPLETED|Overall Study||3||
48251594|NCT01370018|100934356|FG000|STARTED|Overall Study||4||
48251595|NCT01370018|100934356|FG000|COMPLETED|Overall Study||3||
48251596|NCT01370018|100934356|FG000|NOT COMPLETED|Overall Study||1||
48251597|NCT01349036|100934357|FG000|STARTED|Overall Study||14||
48251598|NCT01349036|100934358|FG001|STARTED|Overall Study||24||
48251599|NCT01349036|100934357|FG000|COMPLETED|Overall Study||0||
48251600|NCT01349036|100934358|FG001|COMPLETED|Overall Study||0||
48251601|NCT01349036|100934357|FG000|NOT COMPLETED|Overall Study||14||
48251602|NCT01349036|100934358|FG001|NOT COMPLETED|Overall Study||24||
48251603|NCT05324007|100934359|FG000|STARTED|Overall Study||43||
48684469|NCT01991483|102009747|FG002|NOT COMPLETED|Dose Level: Placebo||0||
48378745|NCT04263142|101255955|FG000|COMPLETED|Part 2 Period 2 (Day 1)||0||
48684470|NCT01991483|102009748|FG003|NOT COMPLETED|Dose Level: Placebo||0||
48089053|NCT03934931|100541079|FG002|STARTED|Overall Study||552||
48089054|NCT03934931|100541077|FG000|COMPLETED|Overall Study||551||
48089055|NCT03934931|100541078|FG001|COMPLETED|Overall Study||552||
48089056|NCT03934931|100541079|FG002|COMPLETED|Overall Study||552||
48089057|NCT03934931|100541077|FG000|NOT COMPLETED|Overall Study||1||
48378746|NCT04263142|101255956|FG001|COMPLETED|Part 2 Period 2 (Day 1)||0||
48378747|NCT04263142|101255957|FG002|COMPLETED|Part 2 Period 2 (Day 1)||7||
48378748|NCT04263142|101255958|FG003|COMPLETED|Part 2 Period 2 (Day 1)||7||
48378749|NCT04263142|101255959|FG004|COMPLETED|Part 2 Period 2 (Day 1)||5||
48378750|NCT04263142|101255955|FG000|NOT COMPLETED|Part 2 Period 2 (Day 1)||0||
48378751|NCT04263142|101255956|FG001|NOT COMPLETED|Part 2 Period 2 (Day 1)||0||
48378752|NCT04263142|101255957|FG002|NOT COMPLETED|Part 2 Period 2 (Day 1)||0||
48378753|NCT04263142|101255958|FG003|NOT COMPLETED|Part 2 Period 2 (Day 1)||0||
48378754|NCT04263142|101255959|FG004|NOT COMPLETED|Part 2 Period 2 (Day 1)||1||
48378755|NCT04263142|101255955|FG000|STARTED|Part 2 Period 3 (Up to Day 5)||0||
48378756|NCT04263142|101255956|FG001|STARTED|Part 2 Period 3 (Up to Day 5)||0||
48378757|NCT04263142|101255957|FG002|STARTED|Part 2 Period 3 (Up to Day 5)||7||
48378758|NCT04263142|101255958|FG003|STARTED|Part 2 Period 3 (Up to Day 5)||7||
48378759|NCT04263142|101255959|FG004|STARTED|Part 2 Period 3 (Up to Day 5)||5||
48378760|NCT04263142|101255955|FG000|COMPLETED|Part 2 Period 3 (Up to Day 5)||0||
48378761|NCT04263142|101255956|FG001|COMPLETED|Part 2 Period 3 (Up to Day 5)||0||
48378762|NCT04263142|101255957|FG002|COMPLETED|Part 2 Period 3 (Up to Day 5)||7||
48378763|NCT04263142|101255958|FG003|COMPLETED|Part 2 Period 3 (Up to Day 5)||7||
48378764|NCT04263142|101255959|FG004|COMPLETED|Part 2 Period 3 (Up to Day 5)||5||
48089058|NCT03934931|100541078|FG001|NOT COMPLETED|Overall Study||0||
48089059|NCT03934931|100541079|FG002|NOT COMPLETED|Overall Study||0||
48089060|NCT00118365|100541080|FG000|STARTED|Overall Study||191||
48089061|NCT00118365|100541081|FG001|STARTED|Overall Study||184||
48089062|NCT00118365|100541080|FG000|COMPLETED|Overall Study||132||
48089063|NCT00118365|100541081|FG001|COMPLETED|Overall Study||124||
48089064|NCT00118365|100541080|FG000|NOT COMPLETED|Overall Study||59||
48089065|NCT00118365|100541081|FG001|NOT COMPLETED|Overall Study||60||
48089066|NCT02515058|100541082|FG000|STARTED|Overall Study||21||
48089067|NCT02515058|100541083|FG001|STARTED|Overall Study||22||
48089068|NCT02515058|100541082|FG000|COMPLETED|Overall Study||18||
48089069|NCT02515058|100541083|FG001|COMPLETED|Overall Study||20||
48089070|NCT02515058|100541082|FG000|NOT COMPLETED|Overall Study||3||
48089071|NCT02515058|100541083|FG001|NOT COMPLETED|Overall Study||2||
48089072|NCT01485770|100541084|FG000|STARTED|First Intervention (2 Weeks)||17||
48089073|NCT01485770|100541085|FG001|STARTED|First Intervention (2 Weeks)||16||
48089074|NCT01485770|100541084|FG000|COMPLETED|First Intervention (2 Weeks)||17||
48089075|NCT01485770|100541085|FG001|COMPLETED|First Intervention (2 Weeks)||16||
48089076|NCT01485770|100541084|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0||
48089077|NCT01485770|100541085|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0||
48089078|NCT01485770|100541084|FG000|STARTED|Second Intervention (2 Weeks)||17||
48089079|NCT01485770|100541085|FG001|STARTED|Second Intervention (2 Weeks)||16||
48089080|NCT01485770|100541084|FG000|COMPLETED|Second Intervention (2 Weeks)||17||
48089081|NCT01485770|100541085|FG001|COMPLETED|Second Intervention (2 Weeks)||16||
48089082|NCT01485770|100541084|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48089083|NCT01485770|100541085|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48089084|NCT01029795|100541086|FG000|STARTED|Overall Study||16||
48089085|NCT01029795|100541087|FG001|STARTED|Overall Study||22||
48089086|NCT01029795|100541086|FG000|COMPLETED|Overall Study||0||
48089087|NCT01029795|100541087|FG001|COMPLETED|Overall Study||0||
48089088|NCT01029795|100541086|FG000|NOT COMPLETED|Overall Study||16||
48251604|NCT05324007|100934360|FG001|STARTED|Overall Study||43||
48251605|NCT05324007|100934361|FG002|STARTED|Overall Study||42||
48251606|NCT05324007|100934359|FG000|COMPLETED|Overall Study||30||
48251607|NCT05324007|100934360|FG001|COMPLETED|Overall Study||30||
48378765|NCT04263142|101255955|FG000|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0||
48684471|NCT01991483|102009745|FG000|STARTED|Dose Level 300 mg||0||
48684472|NCT01991483|102009746|FG001|STARTED|Dose Level 300 mg||6||
48684473|NCT01991483|102009747|FG002|STARTED|Dose Level 300 mg||0||
48089089|NCT01029795|100541087|FG001|NOT COMPLETED|Overall Study||22||
48089090|NCT02117648|100541088|FG000|STARTED|Abemaciclib Alone Period 1||26||
48089091|NCT02117648|100541088|FG000|Received at Least 1 Dose of Study Drug|Abemaciclib Alone Period 1||26||
48251608|NCT05324007|100934361|FG002|COMPLETED|Overall Study||30||
48251609|NCT05324007|100934359|FG000|NOT COMPLETED|Overall Study||13||
48251610|NCT05324007|100934360|FG001|NOT COMPLETED|Overall Study||13||
48251611|NCT05324007|100934361|FG002|NOT COMPLETED|Overall Study||12||
48251612|NCT00819013|100934362|FG000|STARTED|Overall Study||22||
48251613|NCT00819013|100934363|FG001|STARTED|Overall Study||23||
48378766|NCT04263142|101255956|FG001|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0||
48251614|NCT00819013|100934364|FG002|STARTED|Overall Study||21||
48684474|NCT01991483|102009748|FG003|STARTED|Dose Level 300 mg||0||
48684475|NCT01991483|102009745|FG000|Received at Least One Dose of Study Drug|Dose Level 300 mg||0||
48684476|NCT01991483|102009746|FG001|Received at Least One Dose of Study Drug|Dose Level 300 mg||6||
48378767|NCT04263142|101255957|FG002|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0||
48378768|NCT04263142|101255958|FG003|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0||
48684477|NCT01991483|102009747|FG002|Received at Least One Dose of Study Drug|Dose Level 300 mg||0||
48089092|NCT02117648|100541088|FG000|COMPLETED|Abemaciclib Alone Period 1||24||
48378769|NCT04263142|101255959|FG004|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0||
48378770|NCT02142894|101255960|FG000|STARTED|Overall Study||33||
48378771|NCT02142894|101255960|FG000|COMPLETED|Overall Study||25||
48378772|NCT02142894|101255960|FG000|NOT COMPLETED|Overall Study||8||
48378773|NCT02754830|101255961|FG000|STARTED|Overall Study||17||
48378774|NCT02754830|101255962|FG001|STARTED|Overall Study||6||
48378775|NCT02754830|101255963|FG002|STARTED|Overall Study||6||
48378776|NCT02754830|101255964|FG003|STARTED|Overall Study||6||
48378777|NCT02754830|101255965|FG004|STARTED|Overall Study||6||
48378778|NCT02754830|101255966|FG005|STARTED|Overall Study||6||
48378779|NCT02754830|101255967|FG006|STARTED|Overall Study||6||
48378780|NCT02754830|101255968|FG007|STARTED|Overall Study||6||
48378781|NCT02754830|101255969|FG008|STARTED|Overall Study||7||
48378782|NCT02754830|101255970|FG009|STARTED|Overall Study||6||
48378783|NCT02754830|101255961|FG000|COMPLETED|Overall Study||17||
48378784|NCT02754830|101255962|FG001|COMPLETED|Overall Study||6||
48541241|NCT01753297|101662688|FG001|NOT COMPLETED|Overall Study||36||
48541242|NCT00143390|101662689|FG000|STARTED|Overall Study||149||
48541243|NCT00143390|101662690|FG001|STARTED|Overall Study||149||
48541244|NCT00143390|101662689|FG000|COMPLETED|Overall Study||0||
48541245|NCT00143390|101662690|FG001|COMPLETED|Overall Study||0||
48541246|NCT00143390|101662689|FG000|NOT COMPLETED|Overall Study||149||
48541247|NCT00143390|101662690|FG001|NOT COMPLETED|Overall Study||149||
48541248|NCT03048552|101662691|FG000|STARTED|Overall Study||4||
48541249|NCT03048552|101662692|FG001|STARTED|Overall Study||18||
48541250|NCT03048552|101662693|FG002|STARTED|Overall Study||4||
48541251|NCT03048552|101662694|FG003|STARTED|Overall Study||15||
48089093|NCT02117648|100541088|FG000|NOT COMPLETED|Abemaciclib Alone Period 1||2||
48089094|NCT02117648|100541088|FG000|STARTED|Abemaciclib + Clarithromycin Period 2||24||
48089095|NCT02117648|100541088|FG000|Received at Least 1 Dose of Study Drug|Abemaciclib + Clarithromycin Period 2||21||
48089096|NCT02117648|100541088|FG000|COMPLETED|Abemaciclib + Clarithromycin Period 2||20||
48089097|NCT02117648|100541088|FG000|NOT COMPLETED|Abemaciclib + Clarithromycin Period 2||4||
48089098|NCT02117648|100541088|FG000|STARTED|Abemaciclib Safety-Extension Phase||20||
48089099|NCT02117648|100541088|FG000|COMPLETED|Abemaciclib Safety-Extension Phase||0||
48089100|NCT02117648|100541088|FG000|NOT COMPLETED|Abemaciclib Safety-Extension Phase||20||
48089101|NCT02049957|100541089|FG000|STARTED|Overall Study||6||
48089102|NCT02049957|100541090|FG001|STARTED|Overall Study||6||
48089103|NCT02049957|100541091|FG002|STARTED|Overall Study||3||
48089104|NCT02049957|100541092|FG003|STARTED|Overall Study||3||
48089105|NCT02049957|100541093|FG004|STARTED|Overall Study||6||
48089106|NCT02049957|100541094|FG005|STARTED|Overall Study||43||
48089107|NCT02049957|100541095|FG006|STARTED|Overall Study||8||
48089108|NCT02049957|100541096|FG007|STARTED|Overall Study||35||
48089109|NCT02049957|100541097|FG008|STARTED|Overall Study||8||
48089110|NCT02049957|100541089|FG000|COMPLETED|Overall Study||0|Completed=Completed Study Treatment|
48089111|NCT02049957|100541090|FG001|COMPLETED|Overall Study||0|Completed=Completed Study Treatment|
48378785|NCT02754830|101255963|FG002|COMPLETED|Overall Study||6||
48378786|NCT02754830|101255964|FG003|COMPLETED|Overall Study||6||
48378787|NCT02754830|101255965|FG004|COMPLETED|Overall Study||6||
48378788|NCT02754830|101255966|FG005|COMPLETED|Overall Study||6||
48378789|NCT02754830|101255967|FG006|COMPLETED|Overall Study||6||
48378790|NCT02754830|101255968|FG007|COMPLETED|Overall Study||6||
48378791|NCT02754830|101255969|FG008|COMPLETED|Overall Study||7||
48378792|NCT02754830|101255970|FG009|COMPLETED|Overall Study||6||
48378793|NCT02754830|101255961|FG000|NOT COMPLETED|Overall Study||0||
48378794|NCT02754830|101255962|FG001|NOT COMPLETED|Overall Study||0||
48378795|NCT02754830|101255963|FG002|NOT COMPLETED|Overall Study||0||
48378796|NCT02754830|101255964|FG003|NOT COMPLETED|Overall Study||0||
48541252|NCT03048552|101662691|FG000|COMPLETED|Overall Study||4||
48541253|NCT03048552|101662692|FG001|COMPLETED|Overall Study||18||
48541254|NCT03048552|101662693|FG002|COMPLETED|Overall Study||4||
48541255|NCT03048552|101662694|FG003|COMPLETED|Overall Study||15||
48541256|NCT03048552|101662691|FG000|NOT COMPLETED|Overall Study||0||
48541257|NCT03048552|101662692|FG001|NOT COMPLETED|Overall Study||0||
48541258|NCT03048552|101662693|FG002|NOT COMPLETED|Overall Study||0||
48541259|NCT03048552|101662694|FG003|NOT COMPLETED|Overall Study||0||
48541260|NCT03904264|101662695|FG000|STARTED|Overall Study||11||
48541261|NCT03904264|101662696|FG001|STARTED|Overall Study||54||
48541262|NCT03904264|101662695|FG000|COMPLETED|Overall Study||3||
48541263|NCT03904264|101662696|FG001|COMPLETED|Overall Study||17||
48541264|NCT03904264|101662695|FG000|NOT COMPLETED|Overall Study||8||
48378797|NCT02754830|101255965|FG004|NOT COMPLETED|Overall Study||0||
48541265|NCT03904264|101662696|FG001|NOT COMPLETED|Overall Study||37||
48541266|NCT03787134|101662697|FG000|STARTED|Overall Study||12||
48541267|NCT03787134|101662698|FG001|STARTED|Overall Study||30||
48541268|NCT03787134|101662699|FG002|STARTED|Overall Study||19||
48378798|NCT02754830|101255966|FG005|NOT COMPLETED|Overall Study||0||
48541269|NCT03787134|101662700|FG003|STARTED|Overall Study||28||
48684478|NCT01991483|102009748|FG003|Received at Least One Dose of Study Drug|Dose Level 300 mg||0||
48251615|NCT00819013|100934365|FG003|STARTED|Overall Study||21||
48251616|NCT00819013|100934362|FG000|COMPLETED|Overall Study||19||
48251617|NCT00819013|100934363|FG001|COMPLETED|Overall Study||22||
48251618|NCT00819013|100934364|FG002|COMPLETED|Overall Study||16||
48251619|NCT00819013|100934365|FG003|COMPLETED|Overall Study||17||
48251620|NCT00819013|100934362|FG000|NOT COMPLETED|Overall Study||3||
48251621|NCT00819013|100934363|FG001|NOT COMPLETED|Overall Study||1||
48251622|NCT00819013|100934364|FG002|NOT COMPLETED|Overall Study||5||
48251623|NCT00819013|100934365|FG003|NOT COMPLETED|Overall Study||4||
48251624|NCT02660112|100934366|FG000|STARTED|Overall Study||10||
48251625|NCT02660112|100934366|FG000|COMPLETED|Overall Study||10||
48251626|NCT02660112|100934366|FG000|NOT COMPLETED|Overall Study||0||
48251627|NCT01176435|100934367|FG000|STARTED|Overall Study||15||
48251628|NCT01176435|100934368|FG001|STARTED|Overall Study||15||
48251629|NCT01176435|100934369|FG002|STARTED|Overall Study||15||
48251630|NCT01176435|100934367|FG000|COMPLETED|Overall Study||15||
48251631|NCT01176435|100934368|FG001|COMPLETED|Overall Study||15||
48251632|NCT01176435|100934369|FG002|COMPLETED|Overall Study||15||
48251633|NCT01176435|100934367|FG000|NOT COMPLETED|Overall Study||0||
48251634|NCT01176435|100934368|FG001|NOT COMPLETED|Overall Study||0||
48251635|NCT01176435|100934369|FG002|NOT COMPLETED|Overall Study||0||
48251636|NCT02122549|100934370|FG000|STARTED|Overall Study||59||
48251637|NCT02122549|100934370|FG000|COMPLETED|Overall Study||59||
48251638|NCT02122549|100934370|FG000|NOT COMPLETED|Overall Study||0||
48251639|NCT01746108|100934371|FG000|STARTED|Overall Study||18||
48251640|NCT01746108|100934372|FG001|STARTED|Overall Study||28||
48251641|NCT01746108|100934373|FG002|STARTED|Overall Study||6||
48251642|NCT01746108|100934371|FG000|COMPLETED|Overall Study||18||
48251643|NCT01746108|100934372|FG001|COMPLETED|Overall Study||24||
48251644|NCT01746108|100934373|FG002|COMPLETED|Overall Study||6||
48251645|NCT01746108|100934371|FG000|NOT COMPLETED|Overall Study||0||
48251646|NCT01746108|100934372|FG001|NOT COMPLETED|Overall Study||4||
48251647|NCT01746108|100934373|FG002|NOT COMPLETED|Overall Study||0||
48251648|NCT01820637|100934374|FG000|STARTED|Overall Study||57||
48251649|NCT01820637|100934374|FG000|COMPLETED|Overall Study||54||
48251650|NCT01820637|100934374|FG000|NOT COMPLETED|Overall Study||3||
48251651|NCT00496834|100934375|FG000|STARTED|Overall Study||101||
48251652|NCT00496834|100934376|FG001|STARTED|Overall Study||100||
48251653|NCT00496834|100934375|FG000|COMPLETED|Overall Study||83||
48251654|NCT00496834|100934376|FG001|COMPLETED|Overall Study||87||
48251655|NCT00496834|100934375|FG000|NOT COMPLETED|Overall Study||18||
48251656|NCT00496834|100934376|FG001|NOT COMPLETED|Overall Study||13||
48251657|NCT04772313|100934377|FG000|STARTED|MTX Run-in Period||13||
48251658|NCT04772313|100934377|FG000|COMPLETED|MTX Run-in Period||11||
48251659|NCT04772313|100934377|FG000|NOT COMPLETED|MTX Run-in Period||2||
48251660|NCT04772313|100934377|FG000|STARTED|Pegloticase + MTX Treatment Period||11||
48251661|NCT04772313|100934377|FG000|COMPLETED|Pegloticase + MTX Treatment Period||5||
48251662|NCT04772313|100934377|FG000|NOT COMPLETED|Pegloticase + MTX Treatment Period||6||
48251663|NCT04772313|100934377|FG000|STARTED|Pegloticase + MTX Extension Period||1||
48251664|NCT04772313|100934377|FG000|COMPLETED|Pegloticase + MTX Extension Period||1||
48251665|NCT04772313|100934377|FG000|NOT COMPLETED|Pegloticase + MTX Extension Period||0||
48251666|NCT02287883|100934378|FG000|STARTED|Overall Study||1081||
48251667|NCT02287883|100934379|FG001|STARTED|Overall Study||1095||
48251668|NCT02287883|100934378|FG000|One-year Follow-up Survey|Overall Study||622||
48251669|NCT02287883|100934379|FG001|One-year Follow-up Survey|Overall Study||669||
48251670|NCT02287883|100934378|FG000|COMPLETED|Overall Study||622||
48251671|NCT02287883|100934379|FG001|COMPLETED|Overall Study||669||
48251672|NCT02287883|100934378|FG000|NOT COMPLETED|Overall Study||459||
48251673|NCT02287883|100934379|FG001|NOT COMPLETED|Overall Study||426||
48251674|NCT01123642|100934380|FG000|STARTED|Overall Study||345||
48251675|NCT01123642|100934380|FG000|COMPLETED|Overall Study||277||
48251676|NCT01123642|100934380|FG000|NOT COMPLETED|Overall Study||68||
48251677|NCT02041221|100934381|FG000|STARTED|Part 1||6||
48251678|NCT02041221|100934382|FG001|STARTED|Part 1||6||
48251679|NCT02041221|100934383|FG002|STARTED|Part 1||6||
48251680|NCT02041221|100934384|FG003|STARTED|Part 1||6||
48251681|NCT02041221|100934385|FG004|STARTED|Part 1||6||
48251682|NCT02041221|100934386|FG005|STARTED|Part 1||10||
48684479|NCT01991483|102009745|FG000|COMPLETED|Dose Level 300 mg||0||
48251683|NCT02041221|100934381|FG000|COMPLETED|Part 1||6||
48251684|NCT02041221|100934382|FG001|COMPLETED|Part 1||6||
48251685|NCT02041221|100934383|FG002|COMPLETED|Part 1||6||
48251686|NCT02041221|100934384|FG003|COMPLETED|Part 1||6||
48251687|NCT02041221|100934385|FG004|COMPLETED|Part 1||6||
48251688|NCT02041221|100934386|FG005|COMPLETED|Part 1||10||
48251689|NCT02041221|100934381|FG000|NOT COMPLETED|Part 1||0||
48251690|NCT02041221|100934382|FG001|NOT COMPLETED|Part 1||0||
48251691|NCT02041221|100934383|FG002|NOT COMPLETED|Part 1||0||
48251692|NCT02041221|100934384|FG003|NOT COMPLETED|Part 1||0||
48251693|NCT02041221|100934385|FG004|NOT COMPLETED|Part 1||0||
48251694|NCT02041221|100934386|FG005|NOT COMPLETED|Part 1||0||
48251695|NCT02041221|100934381|FG000|STARTED|Part 2||6||
48251696|NCT02041221|100934382|FG001|STARTED|Part 2||6||
48251697|NCT02041221|100934383|FG002|STARTED|Part 2||6||
48251698|NCT02041221|100934384|FG003|STARTED|Part 2||0||
48251699|NCT02041221|100934385|FG004|STARTED|Part 2||0||
48251700|NCT02041221|100934386|FG005|STARTED|Part 2||6||
48251701|NCT02041221|100934381|FG000|COMPLETED|Part 2||6||
48251702|NCT02041221|100934382|FG001|COMPLETED|Part 2||6||
48251703|NCT02041221|100934383|FG002|COMPLETED|Part 2||5||
48251704|NCT02041221|100934384|FG003|COMPLETED|Part 2||0||
48251705|NCT02041221|100934385|FG004|COMPLETED|Part 2||0||
48251706|NCT02041221|100934386|FG005|COMPLETED|Part 2||6||
48251707|NCT02041221|100934381|FG000|NOT COMPLETED|Part 2||0||
48251708|NCT02041221|100934382|FG001|NOT COMPLETED|Part 2||0||
48251709|NCT02041221|100934383|FG002|NOT COMPLETED|Part 2||1||
48251710|NCT02041221|100934384|FG003|NOT COMPLETED|Part 2||0||
48251711|NCT02041221|100934385|FG004|NOT COMPLETED|Part 2||0||
48251712|NCT02041221|100934386|FG005|NOT COMPLETED|Part 2||0||
48251713|NCT03503162|100934387|FG000|STARTED|Overall Study||95||
48251714|NCT03503162|100934387|FG000|COMPLETED|Overall Study||94||
48251715|NCT03503162|100934387|FG000|NOT COMPLETED|Overall Study||1||
48251716|NCT00922441|100934388|FG000|STARTED|Overall Study||30||
48251717|NCT00922441|100934389|FG001|STARTED|Overall Study||30||
48251718|NCT00922441|100934390|FG002|STARTED|Overall Study||32||
48251719|NCT00922441|100934388|FG000|COMPLETED|Overall Study||30||
48251720|NCT00922441|100934389|FG001|COMPLETED|Overall Study||30||
48251721|NCT00922441|100934390|FG002|COMPLETED|Overall Study||29||
48251722|NCT00922441|100934388|FG000|NOT COMPLETED|Overall Study||0||
48251723|NCT00922441|100934389|FG001|NOT COMPLETED|Overall Study||0||
48251724|NCT00922441|100934390|FG002|NOT COMPLETED|Overall Study||3||
48251725|NCT01705145|100934391|FG000|STARTED|Part A||9||
48251726|NCT01705145|100934391|FG000|COMPLETED|Part A||9||
48251727|NCT01705145|100934391|FG000|NOT COMPLETED|Part A||0||
48251728|NCT01705145|100934391|FG000|STARTED|Part B||34||
48251729|NCT01705145|100934391|FG000|COMPLETED|Part B||33||
48251730|NCT01705145|100934391|FG000|NOT COMPLETED|Part B||1||
48251731|NCT03067610|100934392|FG000|STARTED|Overall Study||72||
48251732|NCT03067610|100934392|FG000|COMPLETED|Overall Study||72||
48251733|NCT03067610|100934392|FG000|NOT COMPLETED|Overall Study||0||
48251734|NCT01978236|100934393|FG000|STARTED|Overall Study||6||
48251735|NCT01978236|100934393|FG000|COMPLETED|Overall Study||4||
48251736|NCT01978236|100934393|FG000|NOT COMPLETED|Overall Study||2||
48251737|NCT01251887|100934394|FG000|STARTED|Overall Study||18||
48251738|NCT01251887|100934395|FG001|STARTED|Overall Study||29||
48251739|NCT01251887|100934396|FG002|STARTED|Overall Study||18||
48251740|NCT01251887|100934394|FG000|COMPLETED|Overall Study||17||
48251741|NCT01251887|100934395|FG001|COMPLETED|Overall Study||26||
48251742|NCT01251887|100934396|FG002|COMPLETED|Overall Study||16||
48251743|NCT01251887|100934394|FG000|NOT COMPLETED|Overall Study||1||
48251744|NCT01251887|100934395|FG001|NOT COMPLETED|Overall Study||3||
48251745|NCT01251887|100934396|FG002|NOT COMPLETED|Overall Study||2||
48251746|NCT02383927|100934397|FG000|STARTED|Overall Study||13||
48251747|NCT02383927|100934398|FG001|STARTED|Overall Study||10||
48251748|NCT02383927|100934399|FG002|STARTED|Overall Study||30||
48251749|NCT02383927|100934400|FG003|STARTED|Overall Study||10||
48251750|NCT02383927|100934397|FG000|COMPLETED|Overall Study||0||
48251751|NCT02383927|100934398|FG001|COMPLETED|Overall Study||0||
48251752|NCT02383927|100934399|FG002|COMPLETED|Overall Study||0||
48251753|NCT02383927|100934400|FG003|COMPLETED|Overall Study||0||
48251754|NCT02383927|100934397|FG000|NOT COMPLETED|Overall Study||13||
48251755|NCT02383927|100934398|FG001|NOT COMPLETED|Overall Study||10||
48251756|NCT02383927|100934399|FG002|NOT COMPLETED|Overall Study||30||
48251757|NCT02383927|100934400|FG003|NOT COMPLETED|Overall Study||10||
48251758|NCT04441996|100934401|FG000|STARTED|Overall Study||10||
48251759|NCT04441996|100934402|FG001|STARTED|Overall Study||10||
48251760|NCT04441996|100934401|FG000|COMPLETED|Overall Study||10||
48251761|NCT04441996|100934402|FG001|COMPLETED|Overall Study||10||
48251762|NCT04441996|100934401|FG000|NOT COMPLETED|Overall Study||0||
48251763|NCT04441996|100934402|FG001|NOT COMPLETED|Overall Study||0||
48251764|NCT00866918|100934403|FG000|STARTED|Overall Study||69||
48251765|NCT00866918|100934404|FG001|STARTED|Overall Study||39||
48251766|NCT00866918|100934403|FG000|COMPLETED|Overall Study||53||
48251767|NCT00866918|100934404|FG001|COMPLETED|Overall Study||27||
48251768|NCT00866918|100934403|FG000|NOT COMPLETED|Overall Study||16||
48251769|NCT00866918|100934404|FG001|NOT COMPLETED|Overall Study||12||
48251770|NCT01431105|100934405|FG000|STARTED|Overall Study||34||
48251771|NCT01431105|100934405|FG000|COMPLETED|Overall Study||34||
48251772|NCT01431105|100934405|FG000|NOT COMPLETED|Overall Study||0||
48251773|NCT03821064|100934406|FG000|STARTED|Overall Study||11||
48251774|NCT03821064|100934406|FG000|COMPLETED|Overall Study||10||
48251775|NCT03821064|100934406|FG000|NOT COMPLETED|Overall Study||1||
48251776|NCT02024477|100934407|FG000|STARTED|Overall Study||21||
48251777|NCT02024477|100934408|FG001|STARTED|Overall Study||21||
48251778|NCT02024477|100934407|FG000|COMPLETED|Overall Study||21||
48251779|NCT02024477|100934408|FG001|COMPLETED|Overall Study||21||
48251780|NCT02024477|100934407|FG000|NOT COMPLETED|Overall Study||0||
48251781|NCT02024477|100934408|FG001|NOT COMPLETED|Overall Study||0||
48251782|NCT04270747|100934409|FG000|STARTED|Through Week 16||288||
48251783|NCT04270747|100934410|FG001|STARTED|Through Week 16||288||
48251784|NCT04270747|100934411|FG002|STARTED|Through Week 16||0||
48378799|NCT02754830|101255967|FG006|NOT COMPLETED|Overall Study||0||
48251785|NCT04270747|100934409|FG000|COMPLETED|Through Week 16||273|Completed through Week 16|
48251786|NCT04270747|100934410|FG001|COMPLETED|Through Week 16||270|Completed through Week 16|
48251787|NCT04270747|100934411|FG002|COMPLETED|Through Week 16||0|Completed through Week 16|
48251788|NCT04270747|100934409|FG000|NOT COMPLETED|Through Week 16||15||
48251789|NCT04270747|100934410|FG001|NOT COMPLETED|Through Week 16||18||
48251790|NCT04270747|100934411|FG002|NOT COMPLETED|Through Week 16||0||
48251791|NCT04270747|100934409|FG000|STARTED|Post Week 16||273||
48251792|NCT04270747|100934410|FG001|STARTED|Post Week 16||136||
48251793|NCT04270747|100934411|FG002|STARTED|Post Week 16||134||
48251794|NCT04270747|100934409|FG000|Received Treatment|Post Week 16||273||
48251795|NCT04270747|100934410|FG001|Received Treatment|Post Week 16||136||
48251796|NCT04270747|100934411|FG002|Received Treatment|Post Week 16||133||
48251797|NCT04270747|100934409|FG000|COMPLETED|Post Week 16||251||
48251798|NCT04270747|100934410|FG001|COMPLETED|Post Week 16||125||
48251799|NCT04270747|100934411|FG002|COMPLETED|Post Week 16||123||
48251800|NCT04270747|100934409|FG000|NOT COMPLETED|Post Week 16||22||
48684480|NCT01991483|102009746|FG001|COMPLETED|Dose Level 300 mg||6||
48684481|NCT01991483|102009747|FG002|COMPLETED|Dose Level 300 mg||0||
48684482|NCT01991483|102009748|FG003|COMPLETED|Dose Level 300 mg||0||
48684483|NCT01991483|102009745|FG000|NOT COMPLETED|Dose Level 300 mg||0||
48684484|NCT01991483|102009746|FG001|NOT COMPLETED|Dose Level 300 mg||0||
48684485|NCT01991483|102009747|FG002|NOT COMPLETED|Dose Level 300 mg||0||
48684486|NCT01991483|102009748|FG003|NOT COMPLETED|Dose Level 300 mg||0||
48251801|NCT04270747|100934410|FG001|NOT COMPLETED|Post Week 16||11||
48251802|NCT04270747|100934411|FG002|NOT COMPLETED|Post Week 16||11||
48251803|NCT02685007|100934412|FG000|STARTED|Overall Study||131||
48251804|NCT02685007|100934412|FG000|COMPLETED|Overall Study||131||
48251805|NCT02685007|100934412|FG000|NOT COMPLETED|Overall Study||0||
48251806|NCT02601105|100934413|FG000|STARTED|Placebo Cream; Centella Asiatica Bsln.||15||
48251807|NCT02601105|100934413|FG000|COMPLETED|Placebo Cream; Centella Asiatica Bsln.||15||
48251808|NCT02601105|100934413|FG000|NOT COMPLETED|Placebo Cream; Centella Asiatica Bsln.||0||
48251809|NCT02601105|100934413|FG000|STARTED|Placebo Cream; Centella Asiatica Week 6||15||
48251810|NCT02601105|100934413|FG000|COMPLETED|Placebo Cream; Centella Asiatica Week 6||15||
48251811|NCT02601105|100934413|FG000|NOT COMPLETED|Placebo Cream; Centella Asiatica Week 6||0||
48251812|NCT02601105|100934413|FG000|STARTED|Placebo Cream; Centella Asiatica Week 12||15||
48251813|NCT02601105|100934413|FG000|COMPLETED|Placebo Cream; Centella Asiatica Week 12||13||
48251814|NCT02601105|100934413|FG000|NOT COMPLETED|Placebo Cream; Centella Asiatica Week 12||2||
48251815|NCT02973477|100934414|FG000|STARTED|First Intervention||19||
48251816|NCT02973477|100934415|FG001|STARTED|First Intervention||26||
48251817|NCT02973477|100934414|FG000|COMPLETED|First Intervention||19||
48251818|NCT02973477|100934415|FG001|COMPLETED|First Intervention||24||
48251819|NCT02973477|100934414|FG000|NOT COMPLETED|First Intervention||0||
48251820|NCT02973477|100934415|FG001|NOT COMPLETED|First Intervention||2||
48251821|NCT02973477|100934414|FG000|STARTED|Washout||19||
48251822|NCT02973477|100934415|FG001|STARTED|Washout||24||
48251823|NCT02973477|100934414|FG000|COMPLETED|Washout||18||
48251824|NCT02973477|100934415|FG001|COMPLETED|Washout||24||
48684487|NCT01991483|102009745|FG000|STARTED|Dose Level 600 mg||0||
48684488|NCT01991483|102009746|FG001|STARTED|Dose Level 600 mg||0||
48684489|NCT01991483|102009747|FG002|STARTED|Dose Level 600 mg||11||
48684490|NCT01991483|102009748|FG003|STARTED|Dose Level 600 mg||0||
48684491|NCT01991483|102009745|FG000|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0||
48684492|NCT01991483|102009746|FG001|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0||
48684493|NCT01991483|102009747|FG002|Receive at Least One Dose of Study Drug|Dose Level 600 mg||11||
48684494|NCT01991483|102009748|FG003|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0||
48684495|NCT01991483|102009745|FG000|COMPLETED|Dose Level 600 mg||0||
48684496|NCT01991483|102009746|FG001|COMPLETED|Dose Level 600 mg||0||
48684497|NCT01991483|102009747|FG002|COMPLETED|Dose Level 600 mg||9||
48684498|NCT01991483|102009748|FG003|COMPLETED|Dose Level 600 mg||0||
48684499|NCT01991483|102009745|FG000|NOT COMPLETED|Dose Level 600 mg||0||
48684500|NCT01991483|102009746|FG001|NOT COMPLETED|Dose Level 600 mg||0||
48684501|NCT01991483|102009747|FG002|NOT COMPLETED|Dose Level 600 mg||2||
48251825|NCT02973477|100934414|FG000|NOT COMPLETED|Washout||1||
48251826|NCT02973477|100934415|FG001|NOT COMPLETED|Washout||0||
48251827|NCT02973477|100934414|FG000|STARTED|Second Intervention||18||
48251828|NCT02973477|100934415|FG001|STARTED|Second Intervention||24||
48251829|NCT02973477|100934414|FG000|COMPLETED|Second Intervention||17||
48251830|NCT02973477|100934415|FG001|COMPLETED|Second Intervention||24||
48251831|NCT02973477|100934414|FG000|NOT COMPLETED|Second Intervention||1||
48251832|NCT02973477|100934415|FG001|NOT COMPLETED|Second Intervention||0||
48251833|NCT00857233|100934416|FG000|STARTED|Overall Study||297||
48251834|NCT00857233|100934416|FG000|COMPLETED|Overall Study||242||
48251835|NCT00857233|100934416|FG000|NOT COMPLETED|Overall Study||55||
48251836|NCT00676897|100934417|FG000|STARTED|Overall Study||8||
48251837|NCT00676897|100934418|FG001|STARTED|Overall Study||10||
48251838|NCT00676897|100934417|FG000|COMPLETED|Overall Study||8||
48251839|NCT00676897|100934418|FG001|COMPLETED|Overall Study||10||
48251840|NCT00676897|100934417|FG000|NOT COMPLETED|Overall Study||0||
48251841|NCT00676897|100934418|FG001|NOT COMPLETED|Overall Study||0||
48251842|NCT03494985|100934419|FG000|STARTED|Overall Study||101||
48251843|NCT03494985|100934420|FG001|STARTED|Overall Study||98||
48251844|NCT03494985|100934421|FG002|STARTED|Overall Study||98||
48251845|NCT03494985|100934422|FG003|STARTED|Overall Study||99||
48251846|NCT03494985|100934419|FG000|COMPLETED|Overall Study||96||
48251847|NCT03494985|100934420|FG001|COMPLETED|Overall Study||92||
48251848|NCT03494985|100934421|FG002|COMPLETED|Overall Study||92||
48251849|NCT03494985|100934422|FG003|COMPLETED|Overall Study||94||
48251850|NCT03494985|100934419|FG000|NOT COMPLETED|Overall Study||5||
48251851|NCT03494985|100934420|FG001|NOT COMPLETED|Overall Study||6||
48251852|NCT03494985|100934421|FG002|NOT COMPLETED|Overall Study||6||
48251853|NCT03494985|100934422|FG003|NOT COMPLETED|Overall Study||5||
48251854|NCT01281917|100934423|FG000|STARTED|Overall Study||40||
48251855|NCT01281917|100934423|FG000|COMPLETED|Overall Study||39||
48251856|NCT01281917|100934423|FG000|NOT COMPLETED|Overall Study||1||
48251857|NCT00583115|100934424|FG000|STARTED|Overall Study||1||
48251858|NCT00583115|100934424|FG000|COMPLETED|Overall Study||0||
48251859|NCT00583115|100934424|FG000|NOT COMPLETED|Overall Study||1||
48251860|NCT02552810|100934425|FG000|STARTED|Overall Study||15||
48251861|NCT02552810|100934426|FG001|STARTED|Overall Study||15||
48251862|NCT02552810|100934425|FG000|COMPLETED|Overall Study||15||
48251863|NCT02552810|100934426|FG001|COMPLETED|Overall Study||15||
48251864|NCT02552810|100934425|FG000|NOT COMPLETED|Overall Study||0||
48251865|NCT02552810|100934426|FG001|NOT COMPLETED|Overall Study||0||
48251866|NCT03101033|100934427|FG000|STARTED|Overall Study||32||
48251867|NCT03101033|100934428|FG001|STARTED|Overall Study||60||
48251868|NCT03101033|100934427|FG000|COMPLETED|Overall Study||27||
48251869|NCT03101033|100934428|FG001|COMPLETED|Overall Study||51||
48251870|NCT03101033|100934427|FG000|NOT COMPLETED|Overall Study||5||
48251871|NCT03101033|100934428|FG001|NOT COMPLETED|Overall Study||9||
48251872|NCT02979613|100934429|FG000|STARTED|Double-Blind Phase||245||
48251873|NCT02979613|100934430|FG001|STARTED|Double-Blind Phase||245||
48251874|NCT02979613|100934429|FG000|COMPLETED|Double-Blind Phase||235||
48251875|NCT02979613|100934430|FG001|COMPLETED|Double-Blind Phase||237||
48251876|NCT02979613|100934429|FG000|NOT COMPLETED|Double-Blind Phase||10||
48251877|NCT02979613|100934430|FG001|NOT COMPLETED|Double-Blind Phase||8||
48684502|NCT01991483|102009748|FG003|NOT COMPLETED|Dose Level 600 mg||0||
48684503|NCT01991483|102009745|FG000|STARTED|Dose Level 1000 mg||0||
48684504|NCT01991483|102009746|FG001|STARTED|Dose Level 1000 mg||0||
48684505|NCT01991483|102009747|FG002|STARTED|Dose Level 1000 mg||0||
48251878|NCT02979613|100934429|FG000|STARTED|Open-Label Extension (OLE) Phase||235||
48251879|NCT02979613|100934430|FG001|STARTED|Open-Label Extension (OLE) Phase||237||
48251880|NCT02979613|100934429|FG000|COMPLETED|Open-Label Extension (OLE) Phase||232||
48251881|NCT02979613|100934430|FG001|COMPLETED|Open-Label Extension (OLE) Phase||231||
48251882|NCT02979613|100934429|FG000|NOT COMPLETED|Open-Label Extension (OLE) Phase||3||
48251883|NCT02979613|100934430|FG001|NOT COMPLETED|Open-Label Extension (OLE) Phase||6||
48251884|NCT00468858|100934431|FG000|STARTED|Overall Study||211||
48251885|NCT00468858|100934432|FG001|STARTED|Overall Study||212||
48251886|NCT00468858|100934433|FG002|STARTED|Overall Study||213||
48251887|NCT00468858|100934431|FG000|COMPLETED|Overall Study||202||
48251888|NCT00468858|100934432|FG001|COMPLETED|Overall Study||202||
48251889|NCT00468858|100934433|FG002|COMPLETED|Overall Study||199||
48251890|NCT00468858|100934431|FG000|NOT COMPLETED|Overall Study||9||
48251891|NCT00468858|100934432|FG001|NOT COMPLETED|Overall Study||10||
48251892|NCT00468858|100934433|FG002|NOT COMPLETED|Overall Study||14||
48251893|NCT03214250|100934434|FG000|STARTED|Overall Study||7||
48251894|NCT03214250|100934435|FG001|STARTED|Overall Study||7||
48251895|NCT03214250|100934436|FG002|STARTED|Overall Study||8||
48251896|NCT03214250|100934437|FG003|STARTED|Overall Study||8||
48251897|NCT03214250|100934438|FG004|STARTED|Overall Study||37||
48251898|NCT03214250|100934439|FG005|STARTED|Overall Study||31||
48251899|NCT03214250|100934440|FG006|STARTED|Overall Study||31||
48251900|NCT03214250|100934434|FG000|COMPLETED|Overall Study||0|"Per the protocol, completed status is defined as completing 5 years of survival follow-up from the time a patient has discontinued treatment."|
48251901|NCT03214250|100934435|FG001|COMPLETED|Overall Study||0|"Per the protocol, completed status is defined as completing 5 years of survival follow-up from the time a patient has discontinued treatment."|
48251902|NCT03214250|100934436|FG002|COMPLETED|Overall Study||0|"Per the protocol, completed status is defined as completing 5 years of survival follow-up from the time a patient has discontinued treatment."|
48251903|NCT03214250|100934437|FG003|COMPLETED|Overall Study||0|"Per the protocol, completed status is defined as completing 5 years of survival follow-up from the time a patient has discontinued treatment."|
48251904|NCT03214250|100934438|FG004|COMPLETED|Overall Study||0|"Per the protocol, completed status is defined as completing 5 years of survival follow-up from the time a patient has discontinued treatment."|
48251905|NCT03214250|100934439|FG005|COMPLETED|Overall Study||0|"Per the protocol, completed status is defined as completing 5 years of survival follow-up from the time a patient has discontinued treatment."|
48251906|NCT03214250|100934440|FG006|COMPLETED|Overall Study||0|"Per the protocol, completed status is defined as completing 5 years of survival follow-up from the time a patient has discontinued treatment."|
48684506|NCT01991483|102009748|FG003|STARTED|Dose Level 1000 mg||4||
48251907|NCT03214250|100934434|FG000|NOT COMPLETED|Overall Study||7||
48251908|NCT03214250|100934435|FG001|NOT COMPLETED|Overall Study||7||
48251909|NCT03214250|100934436|FG002|NOT COMPLETED|Overall Study||8||
48251910|NCT03214250|100934437|FG003|NOT COMPLETED|Overall Study||8||
48378800|NCT02754830|101255968|FG007|NOT COMPLETED|Overall Study||0||
48378801|NCT02754830|101255969|FG008|NOT COMPLETED|Overall Study||0||
48378802|NCT02754830|101255970|FG009|NOT COMPLETED|Overall Study||0||
48378803|NCT03282357|101255971|FG000|STARTED|Overall Study||181||
48378804|NCT03282357|101255971|FG000|Safety Evaluation Set|Overall Study||176||
48378805|NCT03282357|101255971|FG000|COMPLETED|Overall Study||164||
48378806|NCT03282357|101255971|FG000|NOT COMPLETED|Overall Study||17||
48378807|NCT04549597|101255972|FG000|STARTED|Overall Study||151||
48378808|NCT04549597|101255973|FG001|STARTED|Overall Study||152||
48378809|NCT04549597|101255974|FG002|STARTED|Overall Study||30||
48378810|NCT04549597|101255972|FG000|COMPLETED|Overall Study||127||
48378811|NCT04549597|101255973|FG001|COMPLETED|Overall Study||133||
48378812|NCT04549597|101255974|FG002|COMPLETED|Overall Study||25||
48378813|NCT04549597|101255972|FG000|NOT COMPLETED|Overall Study||24||
48378814|NCT04549597|101255973|FG001|NOT COMPLETED|Overall Study||19||
48378815|NCT04549597|101255974|FG002|NOT COMPLETED|Overall Study||5||
48378816|NCT03136185|101255975|FG000|STARTED|Overall Study||9||
48378817|NCT03136185|101255976|FG001|STARTED|Overall Study||3||
48378818|NCT03136185|101255977|FG002|STARTED|Overall Study||6||
48378819|NCT03136185|101255978|FG003|STARTED|Overall Study||8||
48378820|NCT03136185|101255979|FG004|STARTED|Overall Study||5||
48378821|NCT03136185|101255980|FG005|STARTED|Overall Study||11||
48378822|NCT03136185|101255981|FG006|STARTED|Overall Study||24||
48378823|NCT03136185|101255982|FG007|STARTED|Overall Study||11||
48378824|NCT03136185|101255983|FG008|STARTED|Overall Study||13||
48378825|NCT03136185|101255975|FG000|Treated|Overall Study||9||
48378826|NCT03136185|101255976|FG001|Treated|Overall Study||3||
48378827|NCT03136185|101255977|FG002|Treated|Overall Study||6||
48378828|NCT03136185|101255978|FG003|Treated|Overall Study||8||
48378829|NCT03136185|101255979|FG004|Treated|Overall Study||5||
48378830|NCT03136185|101255980|FG005|Treated|Overall Study||11||
48378831|NCT03136185|101255981|FG006|Treated|Overall Study||24||
48378832|NCT03136185|101255982|FG007|Treated|Overall Study||11||
48251911|NCT03214250|100934438|FG004|NOT COMPLETED|Overall Study||37||
48378833|NCT03136185|101255983|FG008|Treated|Overall Study||13||
48541270|NCT03787134|101662701|FG004|STARTED|Overall Study||25||
48541271|NCT03787134|101662702|FG005|STARTED|Overall Study||56||
48684507|NCT01991483|102009745|FG000|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0||
48684508|NCT01991483|102009746|FG001|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0||
48684509|NCT01991483|102009747|FG002|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0||
48251912|NCT03214250|100934439|FG005|NOT COMPLETED|Overall Study||31||
48251913|NCT03214250|100934440|FG006|NOT COMPLETED|Overall Study||31||
48251914|NCT03416621|100934441|FG000|STARTED|Overall Study||13||
48251915|NCT03416621|100934442|FG001|STARTED|Overall Study||12||
48251916|NCT03416621|100934443|FG002|STARTED|Overall Study||6||
48251917|NCT03416621|100934441|FG000|COMPLETED|Overall Study||13||
48251918|NCT03416621|100934442|FG001|COMPLETED|Overall Study||11||
48251919|NCT03416621|100934443|FG002|COMPLETED|Overall Study||1||
48251920|NCT03416621|100934441|FG000|NOT COMPLETED|Overall Study||0||
48251921|NCT03416621|100934442|FG001|NOT COMPLETED|Overall Study||1||
48251922|NCT03416621|100934443|FG002|NOT COMPLETED|Overall Study||5||
48541272|NCT03787134|101662703|FG006|STARTED|Overall Study||14||
48541273|NCT03787134|101662697|FG000|Outcome 1 - Behavioral Accuracy|Overall Study||12|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541274|NCT03787134|101662698|FG001|Outcome 1 - Behavioral Accuracy|Overall Study||30|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541275|NCT03787134|101662699|FG002|Outcome 1 - Behavioral Accuracy|Overall Study||19|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541276|NCT03787134|101662700|FG003|Outcome 1 - Behavioral Accuracy|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541277|NCT03787134|101662701|FG004|Outcome 1 - Behavioral Accuracy|Overall Study||25|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541278|NCT03787134|101662702|FG005|Outcome 1 - Behavioral Accuracy|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541279|NCT03787134|101662703|FG006|Outcome 1 - Behavioral Accuracy|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48684510|NCT01991483|102009748|FG003|Received at Least One Dose of Study Drug|Dose Level 1000 mg||4||
48684511|NCT01991483|102009745|FG000|COMPLETED|Dose Level 1000 mg||0||
48684512|NCT01991483|102009746|FG001|COMPLETED|Dose Level 1000 mg||0||
48251923|NCT00726388|100934444|FG000|STARTED|Overall Study||1050||
48251924|NCT00726388|100934444|FG000|Treated|Overall Study||971||
48378834|NCT03136185|101255975|FG000|Entered Additional Treatment Period (ATP)|Overall Study||6||
48378835|NCT03136185|101255976|FG001|Entered Additional Treatment Period (ATP)|Overall Study||2||
48378836|NCT03136185|101255977|FG002|Entered Additional Treatment Period (ATP)|Overall Study||3||
48378837|NCT03136185|101255978|FG003|Entered Additional Treatment Period (ATP)|Overall Study||3||
48378838|NCT03136185|101255979|FG004|Entered Additional Treatment Period (ATP)|Overall Study||1||
48251925|NCT00726388|100934444|FG000|COMPLETED|Overall Study||943||
48251926|NCT00726388|100934444|FG000|NOT COMPLETED|Overall Study||107||
48251927|NCT02845375|100934445|FG000|STARTED|Overall Study||13||
48251928|NCT02845375|100934446|FG001|STARTED|Overall Study||14||
48251929|NCT02845375|100934447|FG002|STARTED|Overall Study||13||
48251930|NCT02845375|100934445|FG000|COMPLETED|Overall Study||12||
48251931|NCT02845375|100934446|FG001|COMPLETED|Overall Study||12||
48251932|NCT02845375|100934447|FG002|COMPLETED|Overall Study||12||
48251933|NCT02845375|100934445|FG000|NOT COMPLETED|Overall Study||1||
48251934|NCT02845375|100934446|FG001|NOT COMPLETED|Overall Study||2||
48251935|NCT02845375|100934447|FG002|NOT COMPLETED|Overall Study||1||
48251936|NCT01136798|100934448|FG000|STARTED|Overall Study||10||
48251937|NCT01136798|100934449|FG001|STARTED|Overall Study||8||
48251938|NCT01136798|100934448|FG000|COMPLETED|Overall Study||10||
48251939|NCT01136798|100934449|FG001|COMPLETED|Overall Study||8||
48251940|NCT01136798|100934448|FG000|NOT COMPLETED|Overall Study||0||
48251941|NCT01136798|100934449|FG001|NOT COMPLETED|Overall Study||0||
48251942|NCT00858247|100936647|FG000|STARTED|Baseline Assessment||25||
48251943|NCT00858247|100936648|FG001|STARTED|Baseline Assessment||26||
48251944|NCT00858247|100936647|FG000|COMPLETED|Baseline Assessment||23||
48251945|NCT00858247|100936648|FG001|COMPLETED|Baseline Assessment||24||
48251946|NCT00858247|100936647|FG000|NOT COMPLETED|Baseline Assessment||2||
48251947|NCT00858247|100936648|FG001|NOT COMPLETED|Baseline Assessment||2||
48251948|NCT00858247|100936647|FG000|STARTED|Week 12 Follow-up||23||
48251949|NCT00858247|100936648|FG001|STARTED|Week 12 Follow-up||24||
48251950|NCT00858247|100936647|FG000|COMPLETED|Week 12 Follow-up||23||
48251951|NCT00858247|100936648|FG001|COMPLETED|Week 12 Follow-up||23||
48251952|NCT00858247|100936647|FG000|NOT COMPLETED|Week 12 Follow-up||0||
48684513|NCT01991483|102009747|FG002|COMPLETED|Dose Level 1000 mg||0||
48684514|NCT01991483|102009748|FG003|COMPLETED|Dose Level 1000 mg||3||
48684515|NCT01991483|102009745|FG000|NOT COMPLETED|Dose Level 1000 mg||0||
48684516|NCT01991483|102009746|FG001|NOT COMPLETED|Dose Level 1000 mg||0||
48684517|NCT01991483|102009747|FG002|NOT COMPLETED|Dose Level 1000 mg||0||
48684518|NCT01991483|102009748|FG003|NOT COMPLETED|Dose Level 1000 mg||1||
48684519|NCT04162470|102009749|FG000|STARTED|Overall Study||24||
48684520|NCT04162470|102009749|FG000|COMPLETED|Overall Study||0||
48684521|NCT04162470|102009749|FG000|NOT COMPLETED|Overall Study||24||
48684522|NCT03108521|102013040|FG000|STARTED|Overall Study||83||
48684523|NCT03108521|102013041|FG001|STARTED|Overall Study||36||
48684524|NCT03108521|102013040|FG000|COMPLETED|Overall Study||71||
48684525|NCT03108521|102013041|FG001|COMPLETED|Overall Study||36||
48684526|NCT03108521|102013040|FG000|NOT COMPLETED|Overall Study||12||
48684527|NCT03108521|102013041|FG001|NOT COMPLETED|Overall Study||0||
48684528|NCT00305448|102013042|FG000|STARTED|Overall Study||45||
48684529|NCT00305448|102013043|FG001|STARTED|Overall Study||51||
48684530|NCT00305448|102013044|FG002|STARTED|Overall Study||47||
48684531|NCT00305448|102013042|FG000|COMPLETED|Overall Study||14||
48251953|NCT00858247|100936648|FG001|NOT COMPLETED|Week 12 Follow-up||1||
48684532|NCT00305448|102013043|FG001|COMPLETED|Overall Study||17||
48684533|NCT00305448|102013044|FG002|COMPLETED|Overall Study||14||
48684534|NCT00305448|102013042|FG000|NOT COMPLETED|Overall Study||31||
48684535|NCT00305448|102013043|FG001|NOT COMPLETED|Overall Study||34||
48684536|NCT00305448|102013044|FG002|NOT COMPLETED|Overall Study||33||
48684537|NCT00415870|102013045|FG000|STARTED|Overall Study||32||
48251954|NCT00961896|100936649|FG000|STARTED|Overall Study||8||
48251955|NCT00961896|100936650|FG001|STARTED|Overall Study||3||
48251956|NCT00961896|100936651|FG002|STARTED|Overall Study||7||
48684538|NCT00415870|102013046|FG001|STARTED|Overall Study||33||
48251957|NCT00961896|100936649|FG000|COMPLETED|Overall Study||8||
48251958|NCT00961896|100936650|FG001|COMPLETED|Overall Study||3||
48251959|NCT00961896|100936651|FG002|COMPLETED|Overall Study||6||
48251960|NCT00961896|100936649|FG000|NOT COMPLETED|Overall Study||0||
48251961|NCT00961896|100936650|FG001|NOT COMPLETED|Overall Study||0||
48251962|NCT00961896|100936651|FG002|NOT COMPLETED|Overall Study||1||
48251963|NCT04148521|100936652|FG000|STARTED|Overall Study||534||
48684539|NCT00415870|102013045|FG000|COMPLETED|Overall Study||26||
48684540|NCT00415870|102013046|FG001|COMPLETED|Overall Study||26||
48251964|NCT04148521|100936653|FG001|STARTED|Overall Study||555||
48251965|NCT04148521|100936652|FG000|COMPLETED|Overall Study||534||
48251966|NCT04148521|100936653|FG001|COMPLETED|Overall Study||555||
48251967|NCT04148521|100936652|FG000|NOT COMPLETED|Overall Study||0||
48251968|NCT04148521|100936653|FG001|NOT COMPLETED|Overall Study||0||
48251969|NCT02024750|100936654|FG000|STARTED|Overall Study||106||
48251970|NCT02024750|100936655|FG001|STARTED|Overall Study||108||
48684541|NCT00415870|102013045|FG000|NOT COMPLETED|Overall Study||6||
48684542|NCT00415870|102013046|FG001|NOT COMPLETED|Overall Study||7||
48684543|NCT03402932|102013047|FG000|STARTED|Overall Study||13||
48684544|NCT03402932|102013048|FG001|STARTED|Overall Study||8||
48684545|NCT03402932|102013049|FG002|STARTED|Overall Study||8||
48684546|NCT03402932|102013050|FG003|STARTED|Overall Study||8||
48684547|NCT03402932|102013047|FG000|COMPLETED|Overall Study||13||
48684548|NCT03402932|102013048|FG001|COMPLETED|Overall Study||8||
48684549|NCT03402932|102013049|FG002|COMPLETED|Overall Study||8||
48684550|NCT03402932|102013050|FG003|COMPLETED|Overall Study||8||
48684551|NCT03402932|102013047|FG000|NOT COMPLETED|Overall Study||0||
48684552|NCT03402932|102013048|FG001|NOT COMPLETED|Overall Study||0||
48684553|NCT03402932|102013049|FG002|NOT COMPLETED|Overall Study||0||
48251971|NCT02024750|100936654|FG000|COMPLETED|Overall Study||104||
48251972|NCT02024750|100936655|FG001|COMPLETED|Overall Study||107||
48251973|NCT02024750|100936654|FG000|NOT COMPLETED|Overall Study||2||
48251974|NCT02024750|100936655|FG001|NOT COMPLETED|Overall Study||1||
48251975|NCT00001941|100936656|FG000|STARTED|Overall Study||3||
48251976|NCT00001941|100936657|FG001|STARTED|Overall Study||5||
48251977|NCT00001941|100936658|FG002|STARTED|Overall Study||3||
48251978|NCT00001941|100936659|FG003|STARTED|Overall Study||3||
48251979|NCT00001941|100936660|FG004|STARTED|Overall Study||20||
48251980|NCT00001941|100936656|FG000|COMPLETED|Overall Study||3||
48251981|NCT00001941|100936657|FG001|COMPLETED|Overall Study||5||
48251982|NCT00001941|100936658|FG002|COMPLETED|Overall Study||3||
48251983|NCT00001941|100936659|FG003|COMPLETED|Overall Study||3||
48251984|NCT00001941|100936660|FG004|COMPLETED|Overall Study||19||
48251985|NCT00001941|100936656|FG000|NOT COMPLETED|Overall Study||0||
48251986|NCT00001941|100936657|FG001|NOT COMPLETED|Overall Study||0||
48251987|NCT00001941|100936658|FG002|NOT COMPLETED|Overall Study||0||
48251988|NCT00001941|100936659|FG003|NOT COMPLETED|Overall Study||0||
48251989|NCT00001941|100936660|FG004|NOT COMPLETED|Overall Study||1||
48251990|NCT00069277|100936661|FG000|STARTED|Overall Study||21||
48251991|NCT00069277|100936661|FG000|COMPLETED|Overall Study||0||
48251992|NCT00069277|100936661|FG000|NOT COMPLETED|Overall Study||21||
48251993|NCT03226106|100936662|FG000|STARTED|Overall Study||46||
48251994|NCT03226106|100936663|FG001|STARTED|Overall Study||46||
48251995|NCT03226106|100936662|FG000|Week 8|Overall Study||43||
48251996|NCT03226106|100936663|FG001|Week 8|Overall Study||46||
48251997|NCT03226106|100936662|FG000|Week 14 (Intervention End)|Overall Study||43||
48251998|NCT03226106|100936663|FG001|Week 14 (Intervention End)|Overall Study||46||
48251999|NCT03226106|100936662|FG000|COMPLETED|Overall Study||41||
48252000|NCT03226106|100936663|FG001|COMPLETED|Overall Study||46||
48252001|NCT03226106|100936662|FG000|NOT COMPLETED|Overall Study||5||
48252002|NCT03226106|100936663|FG001|NOT COMPLETED|Overall Study||0||
48684554|NCT03402932|102013050|FG003|NOT COMPLETED|Overall Study||0||
48252003|NCT04355013|100936664|FG000|STARTED|Overall Study||48||
48252004|NCT04355013|100936664|FG000|COMPLETED|Overall Study||48||
48252005|NCT04355013|100936664|FG000|NOT COMPLETED|Overall Study||0||
48252006|NCT00125853|100936665|FG000|STARTED|Wash-out (4 Weeks)||27||
48252007|NCT00125853|100936666|FG001|STARTED|Wash-out (4 Weeks)||27||
48252008|NCT00125853|100936665|FG000|COMPLETED|Wash-out (4 Weeks)||27||
48252009|NCT00125853|100936666|FG001|COMPLETED|Wash-out (4 Weeks)||27||
48684555|NCT00925002|102013051|FG000|STARTED|Overall Study||38||
48684556|NCT00925002|102013052|FG001|STARTED|Overall Study||37||
48378839|NCT03136185|101255980|FG005|Entered Additional Treatment Period (ATP)|Overall Study||4||
48378840|NCT03136185|101255981|FG006|Entered Additional Treatment Period (ATP)|Overall Study||17||
48541280|NCT03787134|101662697|FG000|Outcome 2 - Reaction Time|Overall Study||12|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541281|NCT03787134|101662698|FG001|Outcome 2 - Reaction Time|Overall Study||30|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48089112|NCT02049957|100541091|FG002|COMPLETED|Overall Study||0|Completed=Completed Study Treatment|
48089113|NCT02049957|100541092|FG003|COMPLETED|Overall Study||0|Completed=Completed Study Treatment|
48089114|NCT02049957|100541093|FG004|COMPLETED|Overall Study||0|Completed=Completed Study Treatment|
48089115|NCT02049957|100541094|FG005|COMPLETED|Overall Study||0|Completed=Completed Study Treatment|
48089116|NCT02049957|100541095|FG006|COMPLETED|Overall Study||0|Completed=Completed Study Treatment|
48089117|NCT02049957|100541096|FG007|COMPLETED|Overall Study||0|Completed=Completed Study Treatment|
48089118|NCT02049957|100541097|FG008|COMPLETED|Overall Study||0|Completed=Completed Study Treatment|
48089119|NCT02049957|100541089|FG000|NOT COMPLETED|Overall Study||6||
48089120|NCT02049957|100541090|FG001|NOT COMPLETED|Overall Study||6||
48089121|NCT02049957|100541091|FG002|NOT COMPLETED|Overall Study||3||
48089122|NCT02049957|100541092|FG003|NOT COMPLETED|Overall Study||3||
48089123|NCT02049957|100541093|FG004|NOT COMPLETED|Overall Study||6||
48252010|NCT00125853|100936665|FG000|NOT COMPLETED|Wash-out (4 Weeks)||0||
48252011|NCT00125853|100936666|FG001|NOT COMPLETED|Wash-out (4 Weeks)||0||
48252012|NCT00125853|100936665|FG000|STARTED|First Intervention (8 Weeks)||27||
48252013|NCT00125853|100936666|FG001|STARTED|First Intervention (8 Weeks)||27||
48252014|NCT00125853|100936665|FG000|COMPLETED|First Intervention (8 Weeks)||27||
48252015|NCT00125853|100936666|FG001|COMPLETED|First Intervention (8 Weeks)||27||
48252016|NCT00125853|100936665|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0||
48252017|NCT00125853|100936666|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0||
48252018|NCT00125853|100936665|FG000|STARTED|Wash-out (4 Weeks)||27||
48252019|NCT00125853|100936666|FG001|STARTED|Wash-out (4 Weeks)||27||
48252020|NCT00125853|100936665|FG000|COMPLETED|Wash-out (4 Weeks)||24||
48252021|NCT00125853|100936666|FG001|COMPLETED|Wash-out (4 Weeks)||20||
48252022|NCT00125853|100936665|FG000|NOT COMPLETED|Wash-out (4 Weeks)||3||
48252023|NCT00125853|100936666|FG001|NOT COMPLETED|Wash-out (4 Weeks)||7||
48252024|NCT00125853|100936665|FG000|STARTED|Second Intervention (8 Weeks)||24||
48252025|NCT00125853|100936666|FG001|STARTED|Second Intervention (8 Weeks)||20||
48252026|NCT00125853|100936665|FG000|COMPLETED|Second Intervention (8 Weeks)||24||
48252027|NCT00125853|100936666|FG001|COMPLETED|Second Intervention (8 Weeks)||20||
48252028|NCT00125853|100936665|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0||
48378841|NCT03136185|101255982|FG007|Entered Additional Treatment Period (ATP)|Overall Study||5||
48378842|NCT03136185|101255983|FG008|Entered Additional Treatment Period (ATP)|Overall Study||9||
48378843|NCT03136185|101255975|FG000|Completed Initial Treatment Period (ITP)|Overall Study||7||
48541282|NCT03787134|101662699|FG002|Outcome 2 - Reaction Time|Overall Study||19|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541283|NCT03787134|101662700|FG003|Outcome 2 - Reaction Time|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541284|NCT03787134|101662701|FG004|Outcome 2 - Reaction Time|Overall Study||25|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541285|NCT03787134|101662702|FG005|Outcome 2 - Reaction Time|Overall Study||56|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541286|NCT03787134|101662703|FG006|Outcome 2 - Reaction Time|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541287|NCT03787134|101662697|FG000|Outcome 3 - Multivariate Pattern Classification of EEG|Overall Study||12|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48252029|NCT00125853|100936666|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0||
48252030|NCT04816708|100936667|FG000|STARTED|Overall Study||69||
48252031|NCT04816708|100936668|FG001|STARTED|Overall Study||33||
48541288|NCT03787134|101662698|FG001|Outcome 3 - Multivariate Pattern Classification of EEG|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541289|NCT03787134|101662699|FG002|Outcome 3 - Multivariate Pattern Classification of EEG|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541290|NCT03787134|101662700|FG003|Outcome 3 - Multivariate Pattern Classification of EEG|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541291|NCT03787134|101662701|FG004|Outcome 3 - Multivariate Pattern Classification of EEG|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48089124|NCT02049957|100541094|FG005|NOT COMPLETED|Overall Study||43||
48089125|NCT02049957|100541095|FG006|NOT COMPLETED|Overall Study||8||
48089126|NCT02049957|100541096|FG007|NOT COMPLETED|Overall Study||35||
48089127|NCT02049957|100541097|FG008|NOT COMPLETED|Overall Study||8||
48089128|NCT02935088|100541098|FG000|STARTED|Overall Study||2217|Subjects consented|
48089129|NCT02935088|100541098|FG000|COMPLETED|Overall Study||2115||
48089130|NCT02935088|100541098|FG000|NOT COMPLETED|Overall Study||102||
48089131|NCT00617773|100541099|FG000|STARTED|Overall Study||31||
48089132|NCT00617773|100541099|FG000|COMPLETED|Overall Study||7||
48089133|NCT00617773|100541099|FG000|NOT COMPLETED|Overall Study||24||
48089134|NCT02266225|100541100|FG000|STARTED|Overall Study||48||
48089135|NCT02266225|100541100|FG000|Enrolled in Intervention|Overall Study||44||
48089136|NCT02266225|100541100|FG000|COMPLETED|Overall Study||32||
48089137|NCT02266225|100541100|FG000|NOT COMPLETED|Overall Study||16||
48089138|NCT02205814|100541101|FG000|STARTED|Overall Study||110||
48089139|NCT02205814|100541102|FG001|STARTED|Overall Study||110||
48089140|NCT02205814|100541103|FG002|STARTED|Overall Study||108||
48089141|NCT02205814|100541104|FG003|STARTED|Overall Study||108||
48089142|NCT02205814|100541101|FG000|COMPLETED|Overall Study||108||
48089143|NCT02205814|100541102|FG001|COMPLETED|Overall Study||109||
48089144|NCT02205814|100541103|FG002|COMPLETED|Overall Study||103||
48089145|NCT02205814|100541104|FG003|COMPLETED|Overall Study||104||
48089146|NCT02205814|100541101|FG000|NOT COMPLETED|Overall Study||2||
48089147|NCT02205814|100541102|FG001|NOT COMPLETED|Overall Study||1||
48089148|NCT02205814|100541103|FG002|NOT COMPLETED|Overall Study||5||
48089149|NCT02205814|100541104|FG003|NOT COMPLETED|Overall Study||4||
48089150|NCT02167893|100541105|FG000|STARTED|Overall Study||11288||
48089151|NCT02167893|100541105|FG000|COMPLETED|Overall Study||11125||
48089152|NCT02167893|100541105|FG000|NOT COMPLETED|Overall Study||163||
48089153|NCT01322360|100541106|FG000|STARTED|Overall Study||50||
48089154|NCT01322360|100541106|FG000|COMPLETED|Overall Study||50||
48089155|NCT01322360|100541106|FG000|NOT COMPLETED|Overall Study||0||
48378844|NCT03136185|101255976|FG001|Completed Initial Treatment Period (ITP)|Overall Study||3||
48378845|NCT03136185|101255977|FG002|Completed Initial Treatment Period (ITP)|Overall Study||4||
48378846|NCT03136185|101255978|FG003|Completed Initial Treatment Period (ITP)|Overall Study||4||
48378847|NCT03136185|101255979|FG004|Completed Initial Treatment Period (ITP)|Overall Study||1||
48378848|NCT03136185|101255980|FG005|Completed Initial Treatment Period (ITP)|Overall Study||4||
48378849|NCT03136185|101255981|FG006|Completed Initial Treatment Period (ITP)|Overall Study||18||
48089156|NCT00038857|100541107|FG000|STARTED|Overall Study||29||
48089157|NCT00038857|100541107|FG000|COMPLETED|Overall Study||28||
48089158|NCT00038857|100541107|FG000|NOT COMPLETED|Overall Study||1||
48089159|NCT00512707|100541108|FG000|STARTED|Overall Study||70||
48089160|NCT00512707|100541109|FG001|STARTED|Overall Study||70||
48089161|NCT00512707|100541108|FG000|COMPLETED|Overall Study||60||
48089162|NCT00512707|100541109|FG001|COMPLETED|Overall Study||58||
48089163|NCT00512707|100541108|FG000|NOT COMPLETED|Overall Study||10||
48089164|NCT00512707|100541109|FG001|NOT COMPLETED|Overall Study||12||
48089165|NCT03223246|100541110|FG000|STARTED|48-72 Hours||83||
48089166|NCT03223246|100541111|FG001|STARTED|48-72 Hours||66||
48089167|NCT03223246|100541110|FG000|COMPLETED|48-72 Hours||62||
48089168|NCT03223246|100541111|FG001|COMPLETED|48-72 Hours||35||
48089169|NCT03223246|100541110|FG000|NOT COMPLETED|48-72 Hours||21||
48089170|NCT03223246|100541111|FG001|NOT COMPLETED|48-72 Hours||31||
48089171|NCT03223246|100541110|FG000|STARTED|5-7 Days||83|Note: participants were called at 5-7 days even if they could not be reached at 48-72 hours|
48089172|NCT03223246|100541111|FG001|STARTED|5-7 Days||66|Note: participants were called at 5-7 days even if they could not be reached at 48-72 hours|
48089173|NCT03223246|100541110|FG000|COMPLETED|5-7 Days||41||
48089174|NCT03223246|100541111|FG001|COMPLETED|5-7 Days||35||
48089175|NCT03223246|100541110|FG000|NOT COMPLETED|5-7 Days||42||
48089176|NCT03223246|100541111|FG001|NOT COMPLETED|5-7 Days||31||
48089177|NCT00662363|100541112|FG000|STARTED|Overall Study||32||
48252032|NCT04816708|100936667|FG000|COMPLETED|Overall Study||59||
48252033|NCT04816708|100936668|FG001|COMPLETED|Overall Study||29||
48252034|NCT04816708|100936667|FG000|NOT COMPLETED|Overall Study||10||
48252035|NCT04816708|100936668|FG001|NOT COMPLETED|Overall Study||4||
48252036|NCT01274559|100936669|FG000|STARTED|Overall Study||587||
48252037|NCT01274559|100936670|FG001|STARTED|Overall Study||586||
48252038|NCT01274559|100936669|FG000|Treated|Overall Study||572||
48252039|NCT01274559|100936670|FG001|Treated|Overall Study||572||
48252040|NCT01274559|100936669|FG000|COMPLETED|Overall Study||390||
48252041|NCT01274559|100936670|FG001|COMPLETED|Overall Study||441||
48252042|NCT01274559|100936669|FG000|NOT COMPLETED|Overall Study||197||
48252043|NCT01274559|100936670|FG001|NOT COMPLETED|Overall Study||145||
48252044|NCT00635570|100936671|FG000|STARTED|Overall Study||136||
48252045|NCT00635570|100936672|FG001|STARTED|Overall Study||137||
48252046|NCT00635570|100936671|FG000|COMPLETED|Overall Study||121||
48252047|NCT00635570|100936672|FG001|COMPLETED|Overall Study||126||
48252048|NCT00635570|100936671|FG000|NOT COMPLETED|Overall Study||15||
48252049|NCT00635570|100936672|FG001|NOT COMPLETED|Overall Study||11||
48252050|NCT00555997|100936673|FG000|STARTED|Phase 1 SPCD||29||
48252051|NCT00555997|100936674|FG001|STARTED|Phase 1 SPCD||91||
48252052|NCT00555997|100936675|FG002|STARTED|Phase 1 SPCD||0||
48252053|NCT00555997|100936676|FG003|STARTED|Phase 1 SPCD||0||
48252054|NCT00555997|100936673|FG000|COMPLETED|Phase 1 SPCD||17||
48252055|NCT00555997|100936674|FG001|COMPLETED|Phase 1 SPCD||76||
48252056|NCT00555997|100936675|FG002|COMPLETED|Phase 1 SPCD||0||
48252057|NCT00555997|100936676|FG003|COMPLETED|Phase 1 SPCD||0||
48252058|NCT00555997|100936673|FG000|NOT COMPLETED|Phase 1 SPCD||12||
48252059|NCT00555997|100936674|FG001|NOT COMPLETED|Phase 1 SPCD||15||
48252060|NCT00555997|100936675|FG002|NOT COMPLETED|Phase 1 SPCD||0||
48252061|NCT00555997|100936676|FG003|NOT COMPLETED|Phase 1 SPCD||0||
48252062|NCT00555997|100936673|FG000|STARTED|Phase 2 SPCD||0||
48252063|NCT00555997|100936674|FG001|STARTED|Phase 2 SPCD||0||
48252064|NCT00555997|100936675|FG002|STARTED|Phase 2 SPCD||38||
48252065|NCT00555997|100936676|FG003|STARTED|Phase 2 SPCD||25||
48252066|NCT00555997|100936673|FG000|COMPLETED|Phase 2 SPCD||0||
48252067|NCT00555997|100936674|FG001|COMPLETED|Phase 2 SPCD||0||
48252068|NCT00555997|100936675|FG002|COMPLETED|Phase 2 SPCD||31||
48252069|NCT00555997|100936676|FG003|COMPLETED|Phase 2 SPCD||22||
48252070|NCT00555997|100936673|FG000|NOT COMPLETED|Phase 2 SPCD||0||
48252071|NCT00555997|100936674|FG001|NOT COMPLETED|Phase 2 SPCD||0||
48252072|NCT00555997|100936675|FG002|NOT COMPLETED|Phase 2 SPCD||7||
48252073|NCT00555997|100936676|FG003|NOT COMPLETED|Phase 2 SPCD||3||
48252074|NCT01751165|100936677|FG000|STARTED|Overall Study||119||
48252075|NCT01751165|100936678|FG001|STARTED|Overall Study||119||
48252076|NCT01751165|100936679|FG002|STARTED|Overall Study||116||
48252077|NCT01751165|100936677|FG000|COMPLETED|Overall Study||117||
48252078|NCT01751165|100936678|FG001|COMPLETED|Overall Study||116||
48252079|NCT01751165|100936679|FG002|COMPLETED|Overall Study||113||
48252080|NCT01751165|100936677|FG000|NOT COMPLETED|Overall Study||2||
48252081|NCT01751165|100936678|FG001|NOT COMPLETED|Overall Study||3||
48252082|NCT01751165|100936679|FG002|NOT COMPLETED|Overall Study||3||
48252083|NCT00668785|100936680|FG000|STARTED|Overall Study||6||
48252084|NCT00668785|100936680|FG000|COMPLETED|Overall Study||6||
48252085|NCT00668785|100936680|FG000|NOT COMPLETED|Overall Study||0||
48252086|NCT00702650|100936681|FG000|STARTED|Overall Study||155||
48252087|NCT00702650|100936681|FG000|COMPLETED|Overall Study||135||
48252088|NCT00702650|100936681|FG000|NOT COMPLETED|Overall Study||20||
48252089|NCT00002597|100936682|FG000|STARTED|Overall Study||1013||
48252090|NCT00002597|100936683|FG001|STARTED|Overall Study||1015||
48252091|NCT00002597|100936682|FG000|COMPLETED|Overall Study||987||
48252092|NCT00002597|100936683|FG001|COMPLETED|Overall Study||992||
48252093|NCT00002597|100936682|FG000|NOT COMPLETED|Overall Study||26||
48252094|NCT00002597|100936683|FG001|NOT COMPLETED|Overall Study||23||
48252095|NCT02154477|100936684|FG000|STARTED|Overall Study||6||
48252096|NCT02154477|100936685|FG001|STARTED|Overall Study||8||
48252097|NCT02154477|100936684|FG000|COMPLETED|Overall Study||6||
48252098|NCT02154477|100936685|FG001|COMPLETED|Overall Study||8||
48252099|NCT02154477|100936684|FG000|NOT COMPLETED|Overall Study||0||
48252100|NCT02154477|100936685|FG001|NOT COMPLETED|Overall Study||0||
48252101|NCT03209050|100936686|FG000|STARTED|Overall Study||30||
48252102|NCT03209050|100936686|FG000|COMPLETED|Overall Study||27||
48252103|NCT03209050|100936686|FG000|NOT COMPLETED|Overall Study||3||
48252104|NCT02859558|100936687|FG000|STARTED|Step 1||49||
48252105|NCT02859558|100936688|FG001|STARTED|Step 1||79||
48252106|NCT02859558|100936689|FG002|STARTED|Step 1||60||
48252107|NCT02859558|100936690|FG003|STARTED|Step 1||4||
48252108|NCT02859558|100936691|FG004|STARTED|Step 1||3||
48252109|NCT02859558|100936687|FG000|Completed Week 48|Step 1||41||
48252110|NCT02859558|100936688|FG001|Completed Week 48|Step 1||68||
48252111|NCT02859558|100936689|FG002|Completed Week 48|Step 1||50||
48252112|NCT02859558|100936690|FG003|Completed Week 48|Step 1||0||
48252113|NCT02859558|100936691|FG004|Completed Week 48|Step 1||0||
48252114|NCT02859558|100936687|FG000|COMPLETED|Step 1||37||
48252115|NCT02859558|100936688|FG001|COMPLETED|Step 1||67||
48252116|NCT02859558|100936689|FG002|COMPLETED|Step 1||49||
48252117|NCT02859558|100936690|FG003|COMPLETED|Step 1||4||
48252118|NCT02859558|100936691|FG004|COMPLETED|Step 1||0||
48378850|NCT03136185|101255982|FG007|Completed Initial Treatment Period (ITP)|Overall Study||8||
48378851|NCT03136185|101255983|FG008|Completed Initial Treatment Period (ITP)|Overall Study||10||
48378852|NCT03136185|101255975|FG000|COMPLETED|Overall Study||1||
48378853|NCT03136185|101255976|FG001|COMPLETED|Overall Study||0||
48252119|NCT02859558|100936687|FG000|NOT COMPLETED|Step 1||12||
48252120|NCT02859558|100936688|FG001|NOT COMPLETED|Step 1||12||
48252121|NCT02859558|100936689|FG002|NOT COMPLETED|Step 1||11||
48252122|NCT02859558|100936690|FG003|NOT COMPLETED|Step 1||0||
48252123|NCT02859558|100936691|FG004|NOT COMPLETED|Step 1||3||
48252124|NCT02859558|100936687|FG000|STARTED|Step 2||25|Some participants who completed Step 1 will not or have not yet enrolled to Step 2. Step 2 follow-up is ongoing. Participant Flow Overview will be updated upon study completion. Summary tables are based on data through database freeze date (January 13, 2022) for this primary results submission.|
48252125|NCT02859558|100936688|FG001|STARTED|Step 2||39|Some participants who completed Step 1 will not or have not yet enrolled to Step 2. Step 2 follow-up is ongoing. Participant Flow Overview will be updated upon study completion. Summary tables are based on data through database freeze date (January 13, 2022) for this primary results submission.|
48252126|NCT02859558|100936689|FG002|STARTED|Step 2||21|Some participants who completed Step 1 will not or have not yet enrolled to Step 2. Step 2 follow-up is ongoing. Participant Flow Overview will be updated upon study completion. Summary tables are based on data through database freeze date (January 13, 2022) for this primary results submission.|
48252127|NCT02859558|100936690|FG003|STARTED|Step 2||0|Some participants who completed Step 1 will not or have not yet enrolled to Step 2. Step 2 follow-up is ongoing. Participant Flow Overview will be updated upon study completion. Summary tables are based on data through database freeze date (January 13, 2022) for this primary results submission.|
48252128|NCT02859558|100936691|FG004|STARTED|Step 2||0|Some participants who completed Step 1 will not or have not yet enrolled to Step 2. Step 2 follow-up is ongoing. Participant Flow Overview will be updated upon study completion. Summary tables are based on data through database freeze date (January 13, 2022) for this primary results submission.|
48252129|NCT02859558|100936687|FG000|COMPLETED|Step 2||0||
48252130|NCT02859558|100936688|FG001|COMPLETED|Step 2||0||
48252131|NCT02859558|100936689|FG002|COMPLETED|Step 2||0||
48252132|NCT02859558|100936690|FG003|COMPLETED|Step 2||0||
48252133|NCT02859558|100936691|FG004|COMPLETED|Step 2||0||
48252134|NCT02859558|100936687|FG000|NOT COMPLETED|Step 2||25||
48252135|NCT02859558|100936688|FG001|NOT COMPLETED|Step 2||39||
48252136|NCT02859558|100936689|FG002|NOT COMPLETED|Step 2||21||
48252137|NCT02859558|100936690|FG003|NOT COMPLETED|Step 2||0||
48252138|NCT02859558|100936691|FG004|NOT COMPLETED|Step 2||0||
48252139|NCT00439647|100936692|FG000|STARTED|Overall Study||588||
48252140|NCT00439647|100936693|FG001|STARTED|Overall Study||611||
48252141|NCT00439647|100936692|FG000|Modified Intent to Treat (mITT)|Overall Study||553||
48252142|NCT00439647|100936693|FG001|Modified Intent to Treat (mITT)|Overall Study||574||
48252143|NCT00439647|100936692|FG000|COMPLETED|Overall Study||530||
48252144|NCT00439647|100936693|FG001|COMPLETED|Overall Study||540||
48252145|NCT00439647|100936692|FG000|NOT COMPLETED|Overall Study||58||
48252146|NCT00439647|100936693|FG001|NOT COMPLETED|Overall Study||71||
48252147|NCT03357471|100936694|FG000|STARTED|Overall Study||35||
48252148|NCT03357471|100936695|FG001|STARTED|Overall Study||32||
48252149|NCT03357471|100936694|FG000|COMPLETED|Overall Study||33||
48252150|NCT03357471|100936695|FG001|COMPLETED|Overall Study||32||
48252151|NCT03357471|100936694|FG000|NOT COMPLETED|Overall Study||2||
48252152|NCT03357471|100936695|FG001|NOT COMPLETED|Overall Study||0||
48252153|NCT02176356|100936696|FG000|STARTED|Overall Study||116||
48252154|NCT02176356|100936696|FG000|Eligible and Received Treatment|Overall Study||100||
48252155|NCT02176356|100936696|FG000|COMPLETED|Overall Study||93||
48252156|NCT02176356|100936696|FG000|NOT COMPLETED|Overall Study||23||
48252157|NCT05896696|100936697|FG000|STARTED|Overall Study||81||
48252158|NCT05896696|100936697|FG000|COMPLETED|Overall Study||72||
48252159|NCT05896696|100936697|FG000|NOT COMPLETED|Overall Study||9||
48252160|NCT03891641|100936698|FG000|STARTED|Overall Study||10||
48252161|NCT03891641|100936699|FG001|STARTED|Overall Study||7||
48252162|NCT03891641|100936698|FG000|COMPLETED|Overall Study||8||
48252163|NCT03891641|100936699|FG001|COMPLETED|Overall Study||5||
48252164|NCT03891641|100936698|FG000|NOT COMPLETED|Overall Study||2||
48252165|NCT03891641|100936699|FG001|NOT COMPLETED|Overall Study||2||
48252166|NCT05694533|100936700|FG000|STARTED|Overall Study||20||
48252167|NCT05694533|100936700|FG000|COMPLETED|Overall Study||20||
48252168|NCT05694533|100936700|FG000|NOT COMPLETED|Overall Study||0||
48252169|NCT01508832|100936701|FG000|STARTED|Overall Study||6||
48252170|NCT01508832|100936702|FG001|STARTED|Overall Study||6||
48252171|NCT01508832|100936701|FG000|COMPLETED|Overall Study||6||
48252172|NCT01508832|100936702|FG001|COMPLETED|Overall Study||6||
48252173|NCT01508832|100936701|FG000|NOT COMPLETED|Overall Study||0||
48252174|NCT01508832|100936702|FG001|NOT COMPLETED|Overall Study||0||
48252175|NCT02396758|100936703|FG000|STARTED|Overall Study||38||
48252176|NCT02396758|100936704|FG001|STARTED|Overall Study||37||
48252177|NCT02396758|100936705|FG002|STARTED|Overall Study||38||
48252178|NCT02396758|100936706|FG003|STARTED|Overall Study||18||
48252179|NCT02396758|100936703|FG000|COMPLETED|Overall Study||26||
48252180|NCT02396758|100936704|FG001|COMPLETED|Overall Study||31||
48378854|NCT03136185|101255977|FG002|COMPLETED|Overall Study||0||
48378855|NCT03136185|101255978|FG003|COMPLETED|Overall Study||2||
48378856|NCT03136185|101255979|FG004|COMPLETED|Overall Study||0||
48378857|NCT03136185|101255980|FG005|COMPLETED|Overall Study||3||
48252181|NCT02396758|100936705|FG002|COMPLETED|Overall Study||34||
48252182|NCT02396758|100936706|FG003|COMPLETED|Overall Study||13||
48252183|NCT02396758|100936703|FG000|NOT COMPLETED|Overall Study||12||
48252184|NCT02396758|100936704|FG001|NOT COMPLETED|Overall Study||6||
48252185|NCT02396758|100936705|FG002|NOT COMPLETED|Overall Study||4||
48252186|NCT02396758|100936706|FG003|NOT COMPLETED|Overall Study||5||
48252187|NCT00925288|100936707|FG000|STARTED|Overall Study||100||
48252188|NCT00925288|100936708|FG001|STARTED|Overall Study||100||
48252189|NCT00925288|100936707|FG000|COMPLETED|Overall Study||91||
48252190|NCT00925288|100936708|FG001|COMPLETED|Overall Study||93||
48252191|NCT00925288|100936707|FG000|NOT COMPLETED|Overall Study||9||
48252192|NCT00925288|100936708|FG001|NOT COMPLETED|Overall Study||7||
48252193|NCT01951378|100936709|FG000|STARTED|Overall Study||23||
48252194|NCT01951378|100936710|FG001|STARTED|Overall Study||17||
48252195|NCT01951378|100936709|FG000|COMPLETED|Overall Study||0||
48252196|NCT01951378|100936710|FG001|COMPLETED|Overall Study||0||
48252197|NCT01951378|100936709|FG000|NOT COMPLETED|Overall Study||23||
48252198|NCT01951378|100936710|FG001|NOT COMPLETED|Overall Study||17||
48252199|NCT03681353|100936711|FG000|STARTED|Overall Study||25||
48378858|NCT03136185|101255981|FG006|COMPLETED|Overall Study||14||
48378859|NCT03136185|101255982|FG007|COMPLETED|Overall Study||5||
48378860|NCT03136185|101255983|FG008|COMPLETED|Overall Study||7||
48378861|NCT03136185|101255975|FG000|NOT COMPLETED|Overall Study||8||
48378862|NCT03136185|101255976|FG001|NOT COMPLETED|Overall Study||3||
48378863|NCT03136185|101255977|FG002|NOT COMPLETED|Overall Study||6||
48378864|NCT03136185|101255978|FG003|NOT COMPLETED|Overall Study||6||
48378865|NCT03136185|101255979|FG004|NOT COMPLETED|Overall Study||5||
48378866|NCT03136185|101255980|FG005|NOT COMPLETED|Overall Study||8||
48378867|NCT03136185|101255981|FG006|NOT COMPLETED|Overall Study||10||
48378868|NCT03136185|101255982|FG007|NOT COMPLETED|Overall Study||6||
48378869|NCT03136185|101255983|FG008|NOT COMPLETED|Overall Study||6||
48378870|NCT03392753|101255984|FG000|STARTED|Overall Study||83||
48378871|NCT03392753|101255985|FG001|STARTED|Overall Study||84||
48378872|NCT03392753|101255984|FG000|COMPLETED|Overall Study||47||
48378873|NCT03392753|101255985|FG001|COMPLETED|Overall Study||50||
48378874|NCT03392753|101255984|FG000|NOT COMPLETED|Overall Study||36||
48378875|NCT03392753|101255985|FG001|NOT COMPLETED|Overall Study||34||
48378876|NCT03796091|101255986|FG000|STARTED|Overall Study||60||
48252200|NCT03681353|100936711|FG000|COMPLETED|Overall Study||18||
48252201|NCT03681353|100936711|FG000|NOT COMPLETED|Overall Study||7||
48252202|NCT01780545|100936712|FG000|STARTED|Overall Study||99||
48252203|NCT01780545|100936713|FG001|STARTED|Overall Study||101||
48252204|NCT01780545|100936712|FG000|COMPLETED|Overall Study||95||
48252205|NCT01780545|100936713|FG001|COMPLETED|Overall Study||99||
48252206|NCT01780545|100936712|FG000|NOT COMPLETED|Overall Study||4||
48252207|NCT01780545|100936713|FG001|NOT COMPLETED|Overall Study||2||
48252208|NCT00332488|100936714|FG000|STARTED|Initial Treatment Phase (Weeks 0 - 12)||183||
48252209|NCT00332488|100936715|FG001|STARTED|Initial Treatment Phase (Weeks 0 - 12)||170||
48252210|NCT00332488|100936716|FG002|STARTED|Initial Treatment Phase (Weeks 0 - 12)||175||
48252211|NCT00332488|100936714|FG000|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||133||
48252212|NCT00332488|100936715|FG001|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||152||
48252213|NCT00332488|100936716|FG002|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||119||
48252214|NCT00332488|100936714|FG000|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||50||
48378877|NCT03796091|101255987|FG001|STARTED|Overall Study||60||
48378878|NCT03796091|101255988|FG002|STARTED|Overall Study||60||
48378879|NCT03796091|101255986|FG000|COMPLETED|Overall Study||40||
48378880|NCT03796091|101255987|FG001|COMPLETED|Overall Study||38||
48378881|NCT03796091|101255988|FG002|COMPLETED|Overall Study||45||
48378882|NCT03796091|101255986|FG000|NOT COMPLETED|Overall Study||20||
48378883|NCT03796091|101255987|FG001|NOT COMPLETED|Overall Study||22||
48252215|NCT00332488|100936715|FG001|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||18||
48252216|NCT00332488|100936716|FG002|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||56||
48252217|NCT00332488|100936714|FG000|STARTED|Transfer Treatment Phase (Weeks 12 - 24)||29||
48252218|NCT00332488|100936715|FG001|STARTED|Transfer Treatment Phase (Weeks 12 - 24)||72||
48378884|NCT03796091|101255988|FG002|NOT COMPLETED|Overall Study||15||
48378885|NCT01035255|101255989|FG000|STARTED|Overall Study||4209||
48378886|NCT01035255|101255990|FG001|STARTED|Overall Study||4233||
48378887|NCT01035255|101255989|FG000|GCP Violations|Overall Study||18||
48378888|NCT01035255|101255990|FG001|GCP Violations|Overall Study||19||
48378889|NCT01035255|101255989|FG000|Mis-randomized|Overall Study||4||
48378890|NCT01035255|101255990|FG001|Mis-randomized|Overall Study||2||
48378891|NCT01035255|101255989|FG000|Full Analysis Set (FAS)|Overall Study||4187||
48378892|NCT01035255|101255990|FG001|Full Analysis Set (FAS)|Overall Study||4212||
48378893|NCT01035255|101255989|FG000|COMPLETED|Overall Study||3468||
48378894|NCT01035255|101255990|FG001|COMPLETED|Overall Study||3371||
48378895|NCT01035255|101255989|FG000|NOT COMPLETED|Overall Study||741||
48378896|NCT01035255|101255990|FG001|NOT COMPLETED|Overall Study||862||
48378897|NCT03185455|101255991|FG000|STARTED|Overall Study||103||
48378898|NCT03185455|101255992|FG001|STARTED|Overall Study||103||
48378899|NCT03185455|101255991|FG000|COMPLETED|Overall Study||103||
48378900|NCT03185455|101255992|FG001|COMPLETED|Overall Study||103||
48378901|NCT03185455|101255991|FG000|NOT COMPLETED|Overall Study||0||
48378902|NCT03185455|101255992|FG001|NOT COMPLETED|Overall Study||0||
48378903|NCT01962714|101255993|FG000|STARTED|Overall Study||91||
48378904|NCT01962714|101255994|FG001|STARTED|Overall Study||93||
48378905|NCT01962714|101255993|FG000|Immediate Post-treatment Assessment|Overall Study||63||
48378906|NCT01962714|101255994|FG001|Immediate Post-treatment Assessment|Overall Study||57||
48378907|NCT01962714|101255993|FG000|3-month Follow-up|Overall Study||58||
48378908|NCT01962714|101255994|FG001|3-month Follow-up|Overall Study||56||
48378909|NCT01962714|101255993|FG000|COMPLETED|Overall Study||61||
48378910|NCT01962714|101255994|FG001|COMPLETED|Overall Study||60||
48378911|NCT01962714|101255993|FG000|NOT COMPLETED|Overall Study||30||
48378912|NCT01962714|101255994|FG001|NOT COMPLETED|Overall Study||33||
48378913|NCT03302416|101255995|FG000|STARTED|Overall Study||19||
48378914|NCT03302416|101255995|FG000|COMPLETED|Overall Study||19||
48378915|NCT03302416|101255995|FG000|NOT COMPLETED|Overall Study||0||
48378916|NCT00924352|101255996|FG000|STARTED|Overall Study||12||
48378917|NCT00924352|101255997|FG001|STARTED|Overall Study||44||
48378918|NCT00924352|101255996|FG000|COMPLETED|Overall Study||12||
48378919|NCT00924352|101255997|FG001|COMPLETED|Overall Study||44||
48378920|NCT00924352|101255996|FG000|NOT COMPLETED|Overall Study||0||
48378921|NCT00924352|101255997|FG001|NOT COMPLETED|Overall Study||0||
48378922|NCT00678587|101255998|FG000|STARTED|Overall Study||147||
48378923|NCT00678587|101255999|FG001|STARTED|Overall Study||145||
48378924|NCT00678587|101255998|FG000|COMPLETED|Overall Study||127||
48378925|NCT00678587|101255999|FG001|COMPLETED|Overall Study||127||
48378926|NCT00678587|101255998|FG000|NOT COMPLETED|Overall Study||20||
48378927|NCT00678587|101255999|FG001|NOT COMPLETED|Overall Study||18||
48378928|NCT04426825|101256000|FG000|STARTED|Overall Study||23||
48378929|NCT04426825|101256000|FG000|COMPLETED|Overall Study||0||
48378930|NCT04426825|101256000|FG000|NOT COMPLETED|Overall Study||23||
48378931|NCT03161938|101256001|FG000|STARTED|Overall Study||32||
48378932|NCT03161938|101256002|FG001|STARTED|Overall Study||32||
48089178|NCT00662363|100541113|FG001|STARTED|Overall Study||32||
48089179|NCT00662363|100541112|FG000|COMPLETED|Overall Study||21||
48089180|NCT00662363|100541113|FG001|COMPLETED|Overall Study||22||
48089181|NCT00662363|100541112|FG000|NOT COMPLETED|Overall Study||11||
48089182|NCT00662363|100541113|FG001|NOT COMPLETED|Overall Study||10||
48089183|NCT03684811|100541114|FG000|STARTED|Overall Study||26||
48089184|NCT03684811|100541115|FG001|STARTED|Overall Study||6||
48089185|NCT03684811|100541116|FG002|STARTED|Overall Study||8||
48089186|NCT03684811|100541117|FG003|STARTED|Overall Study||0||
48089187|NCT03684811|100541118|FG004|STARTED|Overall Study||23||
48089188|NCT03684811|100541119|FG005|STARTED|Overall Study||0||
48089189|NCT03684811|100541120|FG006|STARTED|Overall Study||24||
48089190|NCT03684811|100541121|FG007|STARTED|Overall Study||0||
48089191|NCT03684811|100541122|FG008|STARTED|Overall Study||6||
48089192|NCT03684811|100541114|FG000|COMPLETED|Overall Study||0||
48089193|NCT03684811|100541115|FG001|COMPLETED|Overall Study||0||
48089194|NCT03684811|100541116|FG002|COMPLETED|Overall Study||0||
48089195|NCT03684811|100541117|FG003|COMPLETED|Overall Study||0||
48252219|NCT00332488|100936716|FG002|STARTED|Transfer Treatment Phase (Weeks 12 - 24)||254||
48252220|NCT00332488|100936714|FG000|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||27||
48252221|NCT00332488|100936715|FG001|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||70||
48252222|NCT00332488|100936716|FG002|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||233||
48252223|NCT00332488|100936714|FG000|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||2||
48252224|NCT00332488|100936715|FG001|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||2||
48252225|NCT00332488|100936716|FG002|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||21||
48252226|NCT01750086|100936717|FG000|STARTED|Overall Study||13||
48378933|NCT03161938|101256001|FG000|COMPLETED|Overall Study||32||
48089196|NCT03684811|100541118|FG004|COMPLETED|Overall Study||0||
48089197|NCT03684811|100541119|FG005|COMPLETED|Overall Study||0||
48089198|NCT03684811|100541120|FG006|COMPLETED|Overall Study||0||
48089199|NCT03684811|100541121|FG007|COMPLETED|Overall Study||0||
48089200|NCT03684811|100541122|FG008|COMPLETED|Overall Study||0||
48089201|NCT03684811|100541114|FG000|NOT COMPLETED|Overall Study||26||
48089202|NCT03684811|100541115|FG001|NOT COMPLETED|Overall Study||6||
48089203|NCT03684811|100541116|FG002|NOT COMPLETED|Overall Study||8||
48089204|NCT03684811|100541117|FG003|NOT COMPLETED|Overall Study||0||
48089205|NCT03684811|100541118|FG004|NOT COMPLETED|Overall Study||23||
48089206|NCT03684811|100541119|FG005|NOT COMPLETED|Overall Study||0||
48089207|NCT03684811|100541120|FG006|NOT COMPLETED|Overall Study||24||
48089208|NCT03684811|100541121|FG007|NOT COMPLETED|Overall Study||0||
48089209|NCT03684811|100541122|FG008|NOT COMPLETED|Overall Study||6||
48378934|NCT03161938|101256002|FG001|COMPLETED|Overall Study||32||
48378935|NCT03161938|101256001|FG000|NOT COMPLETED|Overall Study||0||
48378936|NCT03161938|101256002|FG001|NOT COMPLETED|Overall Study||0||
48378937|NCT00502307|101256003|FG000|STARTED|Open Label Period (16 Weeks)||272||
48378938|NCT00502307|101256004|FG001|STARTED|Open Label Period (16 Weeks)||0||
48378939|NCT00502307|101256005|FG002|STARTED|Open Label Period (16 Weeks)||0||
48089210|NCT04973826|100541123|FG000|STARTED|Overall Study||12||
48089211|NCT04973826|100541123|FG000|COMPLETED|Overall Study||12||
48089212|NCT04973826|100541123|FG000|NOT COMPLETED|Overall Study||0||
48089213|NCT01124422|100541124|FG000|STARTED|4-Week Open-label Run-in Phase||338||
48089214|NCT01124422|100541125|FG001|STARTED|4-Week Open-label Run-in Phase||0||
48089215|NCT01124422|100541126|FG002|STARTED|4-Week Open-label Run-in Phase||0||
48089216|NCT01124422|100541124|FG000|COMPLETED|4-Week Open-label Run-in Phase||255||
48089217|NCT01124422|100541125|FG001|COMPLETED|4-Week Open-label Run-in Phase||0||
48089218|NCT01124422|100541126|FG002|COMPLETED|4-Week Open-label Run-in Phase||0||
48089219|NCT01124422|100541124|FG000|NOT COMPLETED|4-Week Open-label Run-in Phase||83||
48089220|NCT01124422|100541125|FG001|NOT COMPLETED|4-Week Open-label Run-in Phase||0||
48089221|NCT01124422|100541126|FG002|NOT COMPLETED|4-Week Open-label Run-in Phase||0||
48089222|NCT01124422|100541124|FG000|STARTED|4-Week Double-blind Treatment Phase||0||
48089223|NCT01124422|100541125|FG001|STARTED|4-Week Double-blind Treatment Phase||131||
48089224|NCT01124422|100541126|FG002|STARTED|4-Week Double-blind Treatment Phase||124||
48378940|NCT00502307|101256003|FG000|COMPLETED|Open Label Period (16 Weeks)||196||
48378941|NCT00502307|101256004|FG001|COMPLETED|Open Label Period (16 Weeks)||0||
48378942|NCT00502307|101256005|FG002|COMPLETED|Open Label Period (16 Weeks)||0||
48378943|NCT00502307|101256003|FG000|NOT COMPLETED|Open Label Period (16 Weeks)||76||
48378944|NCT00502307|101256004|FG001|NOT COMPLETED|Open Label Period (16 Weeks)||0||
48378945|NCT00502307|101256005|FG002|NOT COMPLETED|Open Label Period (16 Weeks)||0||
48378946|NCT00502307|101256003|FG000|STARTED|Double-Blind Period (12 Weeks)||0||
48378947|NCT00502307|101256004|FG001|STARTED|Double-Blind Period (12 Weeks)||61||
48378948|NCT00502307|101256005|FG002|STARTED|Double-Blind Period (12 Weeks)||57||
48378949|NCT00502307|101256003|FG000|COMPLETED|Double-Blind Period (12 Weeks)||0||
48089225|NCT01124422|100541124|FG000|COMPLETED|4-Week Double-blind Treatment Phase||0||
48089226|NCT01124422|100541125|FG001|COMPLETED|4-Week Double-blind Treatment Phase||120||
48089227|NCT01124422|100541126|FG002|COMPLETED|4-Week Double-blind Treatment Phase||115||
48089228|NCT01124422|100541124|FG000|NOT COMPLETED|4-Week Double-blind Treatment Phase||0||
48089229|NCT01124422|100541125|FG001|NOT COMPLETED|4-Week Double-blind Treatment Phase||11||
48089230|NCT01124422|100541126|FG002|NOT COMPLETED|4-Week Double-blind Treatment Phase||9||
48089231|NCT04007094|100541127|FG000|STARTED|Overall Study||21||58
48089232|NCT04007094|100541128|FG001|STARTED|Overall Study||21||58
48089233|NCT04007094|100541127|FG000|COMPLETED|Overall Study||20||55
48089234|NCT04007094|100541128|FG001|COMPLETED|Overall Study||20||55
48089235|NCT04007094|100541127|FG000|NOT COMPLETED|Overall Study||1||3
48089236|NCT04007094|100541128|FG001|NOT COMPLETED|Overall Study||1||3
48089237|NCT02989194|100541129|FG000|STARTED|Overall Study||50||
48089238|NCT02989194|100541130|FG001|STARTED|Overall Study||50||
48089239|NCT02989194|100541131|FG002|STARTED|Overall Study||50||
48089240|NCT02989194|100541129|FG000|COMPLETED|Overall Study||49||
48089241|NCT02989194|100541130|FG001|COMPLETED|Overall Study||48||
48089242|NCT02989194|100541131|FG002|COMPLETED|Overall Study||50||
48089243|NCT02989194|100541129|FG000|NOT COMPLETED|Overall Study||1||
48089244|NCT02989194|100541130|FG001|NOT COMPLETED|Overall Study||2||
48089245|NCT02989194|100541131|FG002|NOT COMPLETED|Overall Study||0||
48089246|NCT02514447|100541132|FG000|STARTED|Overall Study||29||
48089247|NCT02514447|100541133|FG001|STARTED|Overall Study||30||
48089248|NCT02514447|100541134|FG002|STARTED|Overall Study||32||
48089249|NCT02514447|100541135|FG003|STARTED|Overall Study||2||
48089250|NCT02514447|100541136|FG004|STARTED|Overall Study||3||
48089251|NCT02514447|100541137|FG005|STARTED|Overall Study||4||
48089252|NCT02514447|100541138|FG006|STARTED|Overall Study||8||
48089253|NCT02514447|100541139|FG007|STARTED|Overall Study||7||
48089254|NCT02514447|100541140|FG008|STARTED|Overall Study||8||
48089255|NCT02514447|100541132|FG000|COMPLETED|Overall Study||0||
48089256|NCT02514447|100541133|FG001|COMPLETED|Overall Study||0||
48089257|NCT02514447|100541134|FG002|COMPLETED|Overall Study||0||
48089258|NCT02514447|100541135|FG003|COMPLETED|Overall Study||0||
48089259|NCT02514447|100541136|FG004|COMPLETED|Overall Study||0||
48089260|NCT02514447|100541137|FG005|COMPLETED|Overall Study||0||
48089261|NCT02514447|100541138|FG006|COMPLETED|Overall Study||0||
48089262|NCT02514447|100541139|FG007|COMPLETED|Overall Study||0||
48089263|NCT02514447|100541140|FG008|COMPLETED|Overall Study||0||
48089264|NCT02514447|100541132|FG000|NOT COMPLETED|Overall Study||29||
48089265|NCT02514447|100541133|FG001|NOT COMPLETED|Overall Study||30||
48089266|NCT02514447|100541134|FG002|NOT COMPLETED|Overall Study||32||
48089267|NCT02514447|100541135|FG003|NOT COMPLETED|Overall Study||2||
48089268|NCT02514447|100541136|FG004|NOT COMPLETED|Overall Study||3||
48378950|NCT00502307|101256004|FG001|COMPLETED|Double-Blind Period (12 Weeks)||35||
48378951|NCT00502307|101256005|FG002|COMPLETED|Double-Blind Period (12 Weeks)||48||
48378952|NCT00502307|101256003|FG000|NOT COMPLETED|Double-Blind Period (12 Weeks)||0||
48592684|NCT01877382|101783156|FG006|COMPLETED|Dose Expansion||0||
48089269|NCT02514447|100541137|FG005|NOT COMPLETED|Overall Study||4||
48089270|NCT02514447|100541138|FG006|NOT COMPLETED|Overall Study||8||
48089271|NCT02514447|100541139|FG007|NOT COMPLETED|Overall Study||7||
48089272|NCT02514447|100541140|FG008|NOT COMPLETED|Overall Study||8||
48089273|NCT01285310|100541141|FG000|STARTED|Placebo Controlled Phase: Weeks 0-24||79||
48089274|NCT01285310|100541142|FG001|STARTED|Placebo Controlled Phase: Weeks 0-24||82||
48089275|NCT01285310|100541143|FG002|STARTED|Placebo Controlled Phase: Weeks 0-24||76||
48089276|NCT01285310|100541144|FG003|STARTED|Placebo Controlled Phase: Weeks 0-24||0||
48089277|NCT01285310|100541145|FG004|STARTED|Placebo Controlled Phase: Weeks 0-24||0||
48089278|NCT01285310|100541141|FG000|COMPLETED|Placebo Controlled Phase: Weeks 0-24||70||
48684557|NCT00925002|102013053|FG002|STARTED|Overall Study||18||
48684558|NCT00925002|102013051|FG000|Treated|Overall Study||38||
48684559|NCT00925002|102013052|FG001|Treated|Overall Study||37||
48252227|NCT01750086|100936718|FG001|STARTED|Overall Study||14||
48252228|NCT01750086|100936717|FG000|COMPLETED|Overall Study||12||
48252229|NCT01750086|100936718|FG001|COMPLETED|Overall Study||13||
48252230|NCT01750086|100936717|FG000|NOT COMPLETED|Overall Study||1||
48252231|NCT01750086|100936718|FG001|NOT COMPLETED|Overall Study||1||
48252232|NCT01885936|100936719|FG000|STARTED|Overall Study||8||
48252233|NCT01885936|100936720|FG001|STARTED|Overall Study||5||
48252234|NCT01885936|100936719|FG000|COMPLETED|Overall Study||7||
48252235|NCT01885936|100936720|FG001|COMPLETED|Overall Study||5||
48252236|NCT01885936|100936719|FG000|NOT COMPLETED|Overall Study||1||
48252237|NCT01885936|100936720|FG001|NOT COMPLETED|Overall Study||0||
48252238|NCT01704547|100936721|FG000|STARTED|Overall Study||25||
48252239|NCT01704547|100936721|FG000|COMPLETED|Overall Study||20||
48252240|NCT01704547|100936721|FG000|NOT COMPLETED|Overall Study||5||
48252241|NCT01219777|100936722|FG000|STARTED|Overall Study||9||
48252242|NCT01219777|100936722|FG000|COMPLETED|Overall Study||9||
48252243|NCT01219777|100936722|FG000|NOT COMPLETED|Overall Study||0||
48252244|NCT01180790|100936723|FG000|STARTED|Overall Study||16||
48252245|NCT01180790|100936724|FG001|STARTED|Overall Study||16||
48252246|NCT01180790|100936725|FG002|STARTED|Overall Study||17||
48252247|NCT01180790|100936726|FG003|STARTED|Overall Study||15||
48252248|NCT01180790|100936727|FG004|STARTED|Overall Study||19||
48252249|NCT01180790|100936728|FG005|STARTED|Overall Study||20||
48252250|NCT01180790|100936729|FG006|STARTED|Overall Study||19||
48252251|NCT01180790|100936723|FG000|COMPLETED|Overall Study||7||
48252252|NCT01180790|100936724|FG001|COMPLETED|Overall Study||11||
48252253|NCT01180790|100936725|FG002|COMPLETED|Overall Study||4||
48252254|NCT01180790|100936726|FG003|COMPLETED|Overall Study||6||
48252255|NCT01180790|100936727|FG004|COMPLETED|Overall Study||14||
48252256|NCT01180790|100936728|FG005|COMPLETED|Overall Study||13||
48252257|NCT01180790|100936729|FG006|COMPLETED|Overall Study||18||
48252258|NCT01180790|100936723|FG000|NOT COMPLETED|Overall Study||9||
48252259|NCT01180790|100936724|FG001|NOT COMPLETED|Overall Study||5||
48252260|NCT01180790|100936725|FG002|NOT COMPLETED|Overall Study||13||
48252261|NCT01180790|100936726|FG003|NOT COMPLETED|Overall Study||9||
48252262|NCT01180790|100936727|FG004|NOT COMPLETED|Overall Study||5||
48252263|NCT01180790|100936728|FG005|NOT COMPLETED|Overall Study||7||
48378953|NCT00502307|101256004|FG001|NOT COMPLETED|Double-Blind Period (12 Weeks)||26||
48378954|NCT00502307|101256005|FG002|NOT COMPLETED|Double-Blind Period (12 Weeks)||9||
48378955|NCT00502307|101256003|FG000|STARTED|Maintenance Period||148||
48378956|NCT00502307|101256004|FG001|STARTED|Maintenance Period||0||
48378957|NCT00502307|101256005|FG002|STARTED|Maintenance Period||0||
48378958|NCT00502307|101256003|FG000|COMPLETED|Maintenance Period||0||
48378959|NCT00502307|101256004|FG001|COMPLETED|Maintenance Period||0||
48378960|NCT00502307|101256005|FG002|COMPLETED|Maintenance Period||0||
48378961|NCT00502307|101256003|FG000|NOT COMPLETED|Maintenance Period||148||
48378962|NCT00502307|101256004|FG001|NOT COMPLETED|Maintenance Period||0||
48378963|NCT00502307|101256005|FG002|NOT COMPLETED|Maintenance Period||0||
48378964|NCT03054077|101256006|FG000|STARTED|Overall Study||12||
48378965|NCT03054077|101256007|FG001|STARTED|Overall Study||12||
48378966|NCT03054077|101256006|FG000|COMPLETED|Overall Study||12||
48378967|NCT03054077|101256007|FG001|COMPLETED|Overall Study||12||
48378968|NCT03054077|101256006|FG000|NOT COMPLETED|Overall Study||0||
48378969|NCT03054077|101256007|FG001|NOT COMPLETED|Overall Study||0||
48378970|NCT04460690|101256008|FG000|STARTED|Overall Study||93||
48378971|NCT04460690|101256008|FG000|Community Participants|Overall Study||83||
48378972|NCT04460690|101256008|FG000|Investigator Participants|Overall Study||10||
48684560|NCT00925002|102013053|FG002|Treated|Overall Study||18||
48252264|NCT01180790|100936729|FG006|NOT COMPLETED|Overall Study||1||
48252265|NCT00096109|100936730|FG000|STARTED|Overall Study||11||
48252266|NCT00096109|100936730|FG000|COMPLETED|Overall Study||11||
48252267|NCT00096109|100936730|FG000|NOT COMPLETED|Overall Study||0||
48252268|NCT01729923|100936731|FG000|STARTED|Overall Study||27||
48252269|NCT01729923|100936731|FG000|COMPLETED|Overall Study||0||
48252270|NCT01729923|100936731|FG000|NOT COMPLETED|Overall Study||27||
48378973|NCT04460690|101256008|FG000|COMPLETED|Overall Study||93||
48378974|NCT04460690|101256008|FG000|NOT COMPLETED|Overall Study||0||
48378975|NCT00306917|101256009|FG000|STARTED|Overall Study||121||
48378976|NCT00306917|101256010|FG001|STARTED|Overall Study||124||
48378977|NCT00306917|101256009|FG000|Postoperative to 6 Month Follow up|Overall Study||93||
48378978|NCT00306917|101256010|FG001|Postoperative to 6 Month Follow up|Overall Study||100||
48378979|NCT00306917|101256009|FG000|12 Month Follow|Overall Study||86||
48378980|NCT00306917|101256010|FG001|12 Month Follow|Overall Study||94||
48684561|NCT00925002|102013051|FG000|COMPLETED|Overall Study||32||
48252271|NCT01939405|100936732|FG000|STARTED|Overall Study||30||
48252272|NCT01939405|100936733|FG001|STARTED|Overall Study||30||
48252273|NCT01939405|100936732|FG000|COMPLETED|Overall Study||27||
48252274|NCT01939405|100936733|FG001|COMPLETED|Overall Study||28||
48252275|NCT01939405|100936732|FG000|NOT COMPLETED|Overall Study||3||
48252276|NCT01939405|100936733|FG001|NOT COMPLETED|Overall Study||2||
48252277|NCT02482935|100936734|FG000|STARTED|Period 1||15||
48089279|NCT01285310|100541142|FG001|COMPLETED|Placebo Controlled Phase: Weeks 0-24||67||
48089280|NCT01285310|100541143|FG002|COMPLETED|Placebo Controlled Phase: Weeks 0-24||61||
48089281|NCT01285310|100541144|FG003|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0||
48089282|NCT01285310|100541145|FG004|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0||
48252278|NCT02482935|100936735|FG001|STARTED|Period 1||15||
48252279|NCT02482935|100936734|FG000|Received Abemaciclib|Period 1||15||
48252280|NCT02482935|100936735|FG001|Received Abemaciclib|Period 1||15||
48252281|NCT02482935|100936734|FG000|Washout|Period 1||15||
48378981|NCT00306917|101256009|FG000|24 Month Follow up|Overall Study||60||
48378982|NCT00306917|101256010|FG001|24 Month Follow up|Overall Study||71||
48378983|NCT00306917|101256009|FG000|36 Month Follow up|Overall Study||56||
48378984|NCT00306917|101256010|FG001|36 Month Follow up|Overall Study||42||
48378985|NCT00306917|101256009|FG000|48 Month Follow up|Overall Study||29||
48378986|NCT00306917|101256010|FG001|48 Month Follow up|Overall Study||22||
48684562|NCT00925002|102013052|FG001|COMPLETED|Overall Study||28||
48684563|NCT00925002|102013053|FG002|COMPLETED|Overall Study||8||
48684564|NCT00925002|102013051|FG000|NOT COMPLETED|Overall Study||6||
48684565|NCT00925002|102013052|FG001|NOT COMPLETED|Overall Study||9||
48684566|NCT00925002|102013053|FG002|NOT COMPLETED|Overall Study||10||
48684567|NCT03460652|102013054|FG000|STARTED|Overall Study||282||
48684568|NCT03460652|102013054|FG000|Entered Treatment Phase|Overall Study||238|Treatment Phase Safety Population, which includes all enrolled subjects who received at least 1 dose of study medication and had at least 1 post-dose safety assessment in the Treatment Phase|
48684569|NCT03460652|102013054|FG000|COMPLETED|Overall Study||155||
48089283|NCT01285310|100541141|FG000|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||9||
48089284|NCT01285310|100541142|FG001|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15||
48089285|NCT01285310|100541143|FG002|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15||
48089286|NCT01285310|100541144|FG003|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0||
48089287|NCT01285310|100541145|FG004|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0||
48252282|NCT02482935|100936735|FG001|Washout|Period 1||15||
48252283|NCT02482935|100936734|FG000|COMPLETED|Period 1||14||
48252284|NCT02482935|100936735|FG001|COMPLETED|Period 1||15||
48252285|NCT02482935|100936734|FG000|NOT COMPLETED|Period 1||1||
48252286|NCT02482935|100936735|FG001|NOT COMPLETED|Period 1||0||
48252287|NCT02482935|100936734|FG000|STARTED|Period 2||14||
48252288|NCT02482935|100936735|FG001|STARTED|Period 2||15||
48252289|NCT02482935|100936734|FG000|Received Abemaciclib|Period 2||14||
48252290|NCT02482935|100936735|FG001|Received Abemaciclib|Period 2||15||
48252291|NCT02482935|100936734|FG000|Follow-up|Period 2||14||
48252292|NCT02482935|100936735|FG001|Follow-up|Period 2||15||
48252293|NCT02482935|100936734|FG000|COMPLETED|Period 2||14||
48252294|NCT02482935|100936735|FG001|COMPLETED|Period 2||15||
48252295|NCT02482935|100936734|FG000|NOT COMPLETED|Period 2||0||
48252296|NCT02482935|100936735|FG001|NOT COMPLETED|Period 2||0||
48252297|NCT01194271|100936736|FG000|STARTED|Overall Study||19||
48378987|NCT00306917|101256009|FG000|60 Month Follow up|Overall Study||13||
48378988|NCT00306917|101256010|FG001|60 Month Follow up|Overall Study||15||
48089288|NCT01285310|100541141|FG000|STARTED|Active Treatment Phase: Weeks 25-52||0||
48089289|NCT01285310|100541142|FG001|STARTED|Active Treatment Phase: Weeks 25-52||63||
48089290|NCT01285310|100541143|FG002|STARTED|Active Treatment Phase: Weeks 25-52||60||
48089291|NCT01285310|100541144|FG003|STARTED|Active Treatment Phase: Weeks 25-52||27||
48089292|NCT01285310|100541145|FG004|STARTED|Active Treatment Phase: Weeks 25-52||42||
48089293|NCT01285310|100541141|FG000|COMPLETED|Active Treatment Phase: Weeks 25-52||0||
48089294|NCT01285310|100541142|FG001|COMPLETED|Active Treatment Phase: Weeks 25-52||31||
48089295|NCT01285310|100541143|FG002|COMPLETED|Active Treatment Phase: Weeks 25-52||34||
48089296|NCT01285310|100541144|FG003|COMPLETED|Active Treatment Phase: Weeks 25-52||17||
48089297|NCT01285310|100541145|FG004|COMPLETED|Active Treatment Phase: Weeks 25-52||23||
48089298|NCT01285310|100541141|FG000|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||0||
48089299|NCT01285310|100541142|FG001|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||32||
48089300|NCT01285310|100541143|FG002|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||26||
48089301|NCT01285310|100541144|FG003|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||10||
48089302|NCT01285310|100541145|FG004|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||19||
48089303|NCT00456521|100541146|FG000|STARTED|Overall Study||591||
48089304|NCT00456521|100541147|FG001|STARTED|Overall Study||202||
48089305|NCT00456521|100541146|FG000|COMPLETED|Overall Study||342||
48089306|NCT00456521|100541147|FG001|COMPLETED|Overall Study||118||
48089307|NCT00456521|100541146|FG000|NOT COMPLETED|Overall Study||249||
48089308|NCT00456521|100541147|FG001|NOT COMPLETED|Overall Study||84||
48089309|NCT01218204|100541148|FG000|STARTED|Part A||6||
48089310|NCT01218204|100541149|FG001|STARTED|Part A||0||
48089311|NCT01218204|100541150|FG002|STARTED|Part A||0||
48089312|NCT01218204|100541151|FG003|STARTED|Part A||0||
48089313|NCT01218204|100541148|FG000|COMPLETED|Part A||6||
48089314|NCT01218204|100541149|FG001|COMPLETED|Part A||0||
48089315|NCT01218204|100541150|FG002|COMPLETED|Part A||0||
48089316|NCT01218204|100541151|FG003|COMPLETED|Part A||0||
48089317|NCT01218204|100541148|FG000|NOT COMPLETED|Part A||0||
48089318|NCT01218204|100541149|FG001|NOT COMPLETED|Part A||0||
48378989|NCT00306917|101256009|FG000|COMPLETED|Overall Study||13||
48378990|NCT00306917|101256010|FG001|COMPLETED|Overall Study||15||
48378991|NCT00306917|101256009|FG000|NOT COMPLETED|Overall Study||108||
48378992|NCT00306917|101256010|FG001|NOT COMPLETED|Overall Study||109||
48378993|NCT02808312|101256011|FG000|STARTED|Overall Study||10||
48378994|NCT02808312|101256012|FG001|STARTED|Overall Study||10||
48378995|NCT02808312|101256013|FG002|STARTED|Overall Study||17||
48378996|NCT02808312|101256014|FG003|STARTED|Overall Study||10||
48378997|NCT02808312|101256015|FG004|STARTED|Overall Study||10||
48378998|NCT02808312|101256011|FG000|COMPLETED|Overall Study||10||
48378999|NCT02808312|101256012|FG001|COMPLETED|Overall Study||10||
48379000|NCT02808312|101256013|FG002|COMPLETED|Overall Study||16||
48379001|NCT02808312|101256014|FG003|COMPLETED|Overall Study||10||
48379002|NCT02808312|101256015|FG004|COMPLETED|Overall Study||10||
48379003|NCT02808312|101256011|FG000|NOT COMPLETED|Overall Study||0||
48379004|NCT02808312|101256012|FG001|NOT COMPLETED|Overall Study||0||
48379005|NCT02808312|101256013|FG002|NOT COMPLETED|Overall Study||1||
48379006|NCT02808312|101256014|FG003|NOT COMPLETED|Overall Study||0||
48379007|NCT02808312|101256015|FG004|NOT COMPLETED|Overall Study||0||
48379008|NCT03463941|101256016|FG000|STARTED|Overall Study||80||
48379009|NCT03463941|101256016|FG000|COMPLETED|Overall Study||62||
48379010|NCT03463941|101256016|FG000|NOT COMPLETED|Overall Study||18||
48379011|NCT00701727|101256017|FG000|STARTED|First Treatment Period||16||
48379012|NCT00701727|101256018|FG001|STARTED|First Treatment Period||15||
48379013|NCT00701727|101256017|FG000|COMPLETED|First Treatment Period||15||
48379014|NCT00701727|101256018|FG001|COMPLETED|First Treatment Period||13||
48379015|NCT00701727|101256017|FG000|NOT COMPLETED|First Treatment Period||1||
48379016|NCT00701727|101256018|FG001|NOT COMPLETED|First Treatment Period||2||
48379017|NCT00701727|101256017|FG000|STARTED|Second Treatment Period||15||
48379018|NCT00701727|101256018|FG001|STARTED|Second Treatment Period||13||
48379019|NCT00701727|101256017|FG000|COMPLETED|Second Treatment Period||13||
48379020|NCT00701727|101256018|FG001|COMPLETED|Second Treatment Period||13||
48379021|NCT00701727|101256017|FG000|NOT COMPLETED|Second Treatment Period||2||
48379022|NCT00701727|101256018|FG001|NOT COMPLETED|Second Treatment Period||0||
48379023|NCT02149836|101256019|FG000|STARTED|Overall Study||18||
48379024|NCT02149836|101256019|FG000|COMPLETED|Overall Study||17||
48379025|NCT02149836|101256019|FG000|NOT COMPLETED|Overall Study||1||
48379026|NCT03591146|101256020|FG000|STARTED|TLC590 190mg and Naropin 150mg||12||
48379027|NCT03591146|101256021|FG001|STARTED|TLC590 190mg and Naropin 150mg||0||
48379028|NCT03591146|101256022|FG002|STARTED|TLC590 190mg and Naropin 150mg||0||
48379029|NCT03591146|101256023|FG003|STARTED|TLC590 190mg and Naropin 150mg||0||
48379030|NCT03591146|101256024|FG004|STARTED|TLC590 190mg and Naropin 150mg||4||
48379031|NCT03591146|101256020|FG000|COMPLETED|TLC590 190mg and Naropin 150mg||12||
48379032|NCT03591146|101256021|FG001|COMPLETED|TLC590 190mg and Naropin 150mg||0||
48379033|NCT03591146|101256022|FG002|COMPLETED|TLC590 190mg and Naropin 150mg||0||
48379034|NCT03591146|101256023|FG003|COMPLETED|TLC590 190mg and Naropin 150mg||0||
48379035|NCT03591146|101256024|FG004|COMPLETED|TLC590 190mg and Naropin 150mg||3||
48379036|NCT03591146|101256020|FG000|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0||
48379037|NCT03591146|101256021|FG001|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0||
48379038|NCT03591146|101256022|FG002|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0||
48379039|NCT03591146|101256023|FG003|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0||
48379040|NCT03591146|101256024|FG004|NOT COMPLETED|TLC590 190mg and Naropin 150mg||1||
48379041|NCT03591146|101256020|FG000|STARTED|TLC590 380mg and Naropin 150mg||0||
48379042|NCT03591146|101256021|FG001|STARTED|TLC590 380mg and Naropin 150mg||12||
48379043|NCT03591146|101256022|FG002|STARTED|TLC590 380mg and Naropin 150mg||0||
48379044|NCT03591146|101256023|FG003|STARTED|TLC590 380mg and Naropin 150mg||0||
48379045|NCT03591146|101256024|FG004|STARTED|TLC590 380mg and Naropin 150mg||5||
48379046|NCT03591146|101256020|FG000|COMPLETED|TLC590 380mg and Naropin 150mg||0||
48379047|NCT03591146|101256021|FG001|COMPLETED|TLC590 380mg and Naropin 150mg||11||
48379048|NCT03591146|101256022|FG002|COMPLETED|TLC590 380mg and Naropin 150mg||0||
48379049|NCT03591146|101256023|FG003|COMPLETED|TLC590 380mg and Naropin 150mg||0||
48379050|NCT03591146|101256024|FG004|COMPLETED|TLC590 380mg and Naropin 150mg||4||
48379051|NCT03591146|101256020|FG000|NOT COMPLETED|TLC590 380mg and Naropin 150mg||0||
48379052|NCT03591146|101256021|FG001|NOT COMPLETED|TLC590 380mg and Naropin 150mg||1||
48379053|NCT03591146|101256022|FG002|NOT COMPLETED|TLC590 380mg and Naropin 150mg||0||
48379054|NCT03591146|101256023|FG003|NOT COMPLETED|TLC590 380mg and Naropin 150mg||0||
48379055|NCT03591146|101256024|FG004|NOT COMPLETED|TLC590 380mg and Naropin 150mg||1||
48379056|NCT03591146|101256020|FG000|STARTED|TLC590 570mg and Naropin 150mg||0||
48379057|NCT03591146|101256021|FG001|STARTED|TLC590 570mg and Naropin 150mg||0||
48379058|NCT03591146|101256022|FG002|STARTED|TLC590 570mg and Naropin 150mg||12||
48379059|NCT03591146|101256023|FG003|STARTED|TLC590 570mg and Naropin 150mg||0||
48379060|NCT03591146|101256024|FG004|STARTED|TLC590 570mg and Naropin 150mg||4||
48379061|NCT03591146|101256020|FG000|COMPLETED|TLC590 570mg and Naropin 150mg||0||
48379062|NCT03591146|101256021|FG001|COMPLETED|TLC590 570mg and Naropin 150mg||0||
48379063|NCT03591146|101256022|FG002|COMPLETED|TLC590 570mg and Naropin 150mg||11||
48379064|NCT03591146|101256023|FG003|COMPLETED|TLC590 570mg and Naropin 150mg||0||
48379065|NCT03591146|101256024|FG004|COMPLETED|TLC590 570mg and Naropin 150mg||3||
48379066|NCT03591146|101256020|FG000|NOT COMPLETED|TLC590 570mg and Naropin 150mg||0||
48379067|NCT03591146|101256021|FG001|NOT COMPLETED|TLC590 570mg and Naropin 150mg||0||
48379068|NCT03591146|101256022|FG002|NOT COMPLETED|TLC590 570mg and Naropin 150mg||1||
48379069|NCT03591146|101256023|FG003|NOT COMPLETED|TLC590 570mg and Naropin 150mg||0||
48379070|NCT03591146|101256024|FG004|NOT COMPLETED|TLC590 570mg and Naropin 150mg||1||
48379071|NCT03591146|101256020|FG000|STARTED|TLC590 475mg and Naropin 150mg||0||
48379072|NCT03591146|101256021|FG001|STARTED|TLC590 475mg and Naropin 150mg||0||
48379073|NCT03591146|101256022|FG002|STARTED|TLC590 475mg and Naropin 150mg||0||
48379074|NCT03591146|101256023|FG003|STARTED|TLC590 475mg and Naropin 150mg||12||
48379075|NCT03591146|101256024|FG004|STARTED|TLC590 475mg and Naropin 150mg||4||
48379076|NCT03591146|101256020|FG000|COMPLETED|TLC590 475mg and Naropin 150mg||0||
48379077|NCT03591146|101256021|FG001|COMPLETED|TLC590 475mg and Naropin 150mg||0||
48379078|NCT03591146|101256022|FG002|COMPLETED|TLC590 475mg and Naropin 150mg||0||
48379079|NCT03591146|101256023|FG003|COMPLETED|TLC590 475mg and Naropin 150mg||12||
48379080|NCT03591146|101256024|FG004|COMPLETED|TLC590 475mg and Naropin 150mg||4||
48379081|NCT03591146|101256020|FG000|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0||
48379082|NCT03591146|101256021|FG001|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0||
48379083|NCT03591146|101256022|FG002|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0||
48379084|NCT03591146|101256023|FG003|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0||
48379085|NCT03591146|101256024|FG004|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0||
48379086|NCT03534063|101256025|FG000|STARTED|Overall Study||173||
48379087|NCT03534063|101256026|FG001|STARTED|Overall Study||87||
48379088|NCT03534063|101256025|FG000|COMPLETED|Overall Study||154||
48379089|NCT03534063|101256026|FG001|COMPLETED|Overall Study||80||
48379090|NCT03534063|101256025|FG000|NOT COMPLETED|Overall Study||19||
48379091|NCT03534063|101256026|FG001|NOT COMPLETED|Overall Study||7||
48379092|NCT01104558|101256027|FG000|STARTED|Overall Study||100||
48379093|NCT01104558|101256027|FG000|COMPLETED|Overall Study||83||
48379094|NCT01104558|101256027|FG000|NOT COMPLETED|Overall Study||17||
48379095|NCT00538824|101256028|FG000|STARTED|Overall Study||5||
48379096|NCT00538824|101256028|FG000|Progression of Disease|Overall Study||2||
48379097|NCT00538824|101256028|FG000|COMPLETED|Overall Study||5||
48379098|NCT00538824|101256028|FG000|NOT COMPLETED|Overall Study||0||
48379099|NCT01232894|101256029|FG000|STARTED|Overall Study||60||
48379100|NCT01232894|101256030|FG001|STARTED|Overall Study||30||
48379101|NCT01232894|101256029|FG000|Received Study Drug|Overall Study||59||
48379102|NCT01232894|101256030|FG001|Received Study Drug|Overall Study||28||
48379103|NCT01232894|101256029|FG000|COMPLETED|Overall Study||48||
48684570|NCT03460652|102013054|FG000|NOT COMPLETED|Overall Study||127||
48684571|NCT04231097|102013055|FG000|STARTED|Overall Study||8||
48684572|NCT04231097|102013055|FG000|COMPLETED|Overall Study||4||
48379104|NCT01232894|101256030|FG001|COMPLETED|Overall Study||22||
48379105|NCT01232894|101256029|FG000|NOT COMPLETED|Overall Study||12||
48379106|NCT01232894|101256030|FG001|NOT COMPLETED|Overall Study||8||
48379107|NCT03927508|101256031|FG000|STARTED|Overall Study||9||
48379108|NCT03927508|101256031|FG000|COMPLETED|Overall Study||9||
48379109|NCT03927508|101256031|FG000|NOT COMPLETED|Overall Study||0||
48379110|NCT02351258|101256032|FG000|STARTED|Intervention 1 (12 Months)||0||7
48379111|NCT02351258|101256033|FG001|STARTED|Intervention 1 (12 Months)||0||9
48379112|NCT02351258|101256032|FG000|COMPLETED|Intervention 1 (12 Months)||0||7
48379113|NCT02351258|101256033|FG001|COMPLETED|Intervention 1 (12 Months)||0||9
48379114|NCT02351258|101256032|FG000|NOT COMPLETED|Intervention 1 (12 Months)||0||0
48379115|NCT02351258|101256033|FG001|NOT COMPLETED|Intervention 1 (12 Months)||0||0
48379116|NCT02351258|101256032|FG000|STARTED|Washout (2-3 Months)||0||7
48379117|NCT02351258|101256033|FG001|STARTED|Washout (2-3 Months)||0||9
48379118|NCT02351258|101256032|FG000|COMPLETED|Washout (2-3 Months)||0||7
48379119|NCT02351258|101256033|FG001|COMPLETED|Washout (2-3 Months)||0||9
48379120|NCT02351258|101256032|FG000|NOT COMPLETED|Washout (2-3 Months)||0||0
48379121|NCT02351258|101256033|FG001|NOT COMPLETED|Washout (2-3 Months)||0||0
48379122|NCT02351258|101256032|FG000|STARTED|Intervention 2 (12 Months)||0||7
48379123|NCT02351258|101256033|FG001|STARTED|Intervention 2 (12 Months)||0||9
48684573|NCT04231097|102013055|FG000|NOT COMPLETED|Overall Study||4||
48684574|NCT03012334|102013056|FG000|STARTED|Period 1||9||
48684575|NCT03012334|102013057|FG001|STARTED|Period 1||9||
48089319|NCT01218204|100541150|FG002|NOT COMPLETED|Part A||0||
48089320|NCT01218204|100541151|FG003|NOT COMPLETED|Part A||0||
48089321|NCT01218204|100541148|FG000|STARTED|Part B Washout||0||
48089322|NCT01218204|100541149|FG001|STARTED|Part B Washout||281||
48089323|NCT01218204|100541150|FG002|STARTED|Part B Washout||0||
48089324|NCT01218204|100541151|FG003|STARTED|Part B Washout||0||
48089325|NCT01218204|100541148|FG000|COMPLETED|Part B Washout||0||
48089326|NCT01218204|100541149|FG001|COMPLETED|Part B Washout||136||
48089327|NCT01218204|100541150|FG002|COMPLETED|Part B Washout||0||
48089328|NCT01218204|100541151|FG003|COMPLETED|Part B Washout||0||
48379124|NCT02351258|101256032|FG000|COMPLETED|Intervention 2 (12 Months)||0||7
48379125|NCT02351258|101256033|FG001|COMPLETED|Intervention 2 (12 Months)||0||9
48379126|NCT02351258|101256032|FG000|NOT COMPLETED|Intervention 2 (12 Months)||0||0
48379127|NCT02351258|101256033|FG001|NOT COMPLETED|Intervention 2 (12 Months)||0||0
48379128|NCT04501679|101256034|FG000|STARTED|Overall Study||183||
48379129|NCT04501679|101256035|FG001|STARTED|Overall Study||91||
48379130|NCT04501679|101256034|FG000|Treated|Overall Study||183||
48089329|NCT01218204|100541148|FG000|NOT COMPLETED|Part B Washout||0||
48089330|NCT01218204|100541149|FG001|NOT COMPLETED|Part B Washout||145||
48089331|NCT01218204|100541150|FG002|NOT COMPLETED|Part B Washout||0||
48089332|NCT01218204|100541151|FG003|NOT COMPLETED|Part B Washout||0||
48089333|NCT01218204|100541148|FG000|STARTED|Part B Run-in||0||
48089334|NCT01218204|100541149|FG001|STARTED|Part B Run-in||0||
48089335|NCT01218204|100541150|FG002|STARTED|Part B Run-in||89||
48089336|NCT01218204|100541151|FG003|STARTED|Part B Run-in||0||
48379131|NCT04501679|101256035|FG001|Treated|Overall Study||91||
48541292|NCT03787134|101662702|FG005|Outcome 3 - Multivariate Pattern Classification of EEG|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541293|NCT03787134|101662703|FG006|Outcome 3 - Multivariate Pattern Classification of EEG|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48089337|NCT01218204|100541148|FG000|COMPLETED|Part B Run-in||0||
48089338|NCT01218204|100541149|FG001|COMPLETED|Part B Run-in||0||
48089339|NCT01218204|100541150|FG002|COMPLETED|Part B Run-in||83||
48089340|NCT01218204|100541151|FG003|COMPLETED|Part B Run-in||0||
48541294|NCT03787134|101662697|FG000|Outcome 4 - Component Loadings|Overall Study||12|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541295|NCT03787134|101662698|FG001|Outcome 4 - Component Loadings|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541296|NCT03787134|101662699|FG002|Outcome 4 - Component Loadings|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541297|NCT03787134|101662700|FG003|Outcome 4 - Component Loadings|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48684576|NCT03012334|102013058|FG002|STARTED|Period 1||9||
48089341|NCT01218204|100541148|FG000|NOT COMPLETED|Part B Run-in||0||
48089342|NCT01218204|100541149|FG001|NOT COMPLETED|Part B Run-in||0||
48089343|NCT01218204|100541150|FG002|NOT COMPLETED|Part B Run-in||6||
48089344|NCT01218204|100541151|FG003|NOT COMPLETED|Part B Run-in||0||
48089345|NCT01218204|100541148|FG000|STARTED|Part B Pooled Treatment Arm||0||
48089346|NCT01218204|100541149|FG001|STARTED|Part B Pooled Treatment Arm||0||
48089347|NCT01218204|100541150|FG002|STARTED|Part B Pooled Treatment Arm||0||
48089348|NCT01218204|100541151|FG003|STARTED|Part B Pooled Treatment Arm||130||
48089349|NCT01218204|100541148|FG000|COMPLETED|Part B Pooled Treatment Arm||0||
48089350|NCT01218204|100541149|FG001|COMPLETED|Part B Pooled Treatment Arm||0||
48089351|NCT01218204|100541150|FG002|COMPLETED|Part B Pooled Treatment Arm||0||
48089352|NCT01218204|100541151|FG003|COMPLETED|Part B Pooled Treatment Arm||127||
48089353|NCT01218204|100541148|FG000|NOT COMPLETED|Part B Pooled Treatment Arm||0||
48379132|NCT04501679|101256034|FG000|COMPLETED|Overall Study||174||
48379133|NCT04501679|101256035|FG001|COMPLETED|Overall Study||88||
48379134|NCT04501679|101256034|FG000|NOT COMPLETED|Overall Study||9||
48379135|NCT04501679|101256035|FG001|NOT COMPLETED|Overall Study||3||
48379136|NCT01259856|101256036|FG000|STARTED|Overall Study||82||
48379137|NCT01259856|101256037|FG001|STARTED|Overall Study||86||
48379138|NCT01259856|101256036|FG000|COMPLETED|Overall Study||13||
48379139|NCT01259856|101256037|FG001|COMPLETED|Overall Study||12||
48379140|NCT01259856|101256036|FG000|NOT COMPLETED|Overall Study||69||
48379141|NCT01259856|101256037|FG001|NOT COMPLETED|Overall Study||74||
48089354|NCT01218204|100541149|FG001|NOT COMPLETED|Part B Pooled Treatment Arm||0||
48089355|NCT01218204|100541150|FG002|NOT COMPLETED|Part B Pooled Treatment Arm||0||
48089356|NCT01218204|100541151|FG003|NOT COMPLETED|Part B Pooled Treatment Arm||3||
48089357|NCT02759471|100541152|FG000|STARTED|Overall Study||54||
48089358|NCT02759471|100541152|FG000|COMPLETED|Overall Study||52||
48379142|NCT01795898|101256038|FG000|STARTED|Overall Study||237||
48379143|NCT01795898|101256038|FG000|COMPLETED|Overall Study||177||
48379144|NCT01795898|101256038|FG000|NOT COMPLETED|Overall Study||60||
48379145|NCT02262039|101256039|FG000|STARTED|Overall Study||14||
48089359|NCT02759471|100541152|FG000|NOT COMPLETED|Overall Study||2||
48089360|NCT03156543|100541153|FG000|STARTED|Overall Study||9||
48379146|NCT02262039|101256040|FG001|STARTED|Overall Study||27||
48379147|NCT02262039|101256039|FG000|COMPLETED|Overall Study||14||
48089361|NCT03156543|100541154|FG001|STARTED|Overall Study||23||
48089362|NCT03156543|100541153|FG000|COMPLETED|Overall Study||8||
48089363|NCT03156543|100541154|FG001|COMPLETED|Overall Study||23||
48089364|NCT03156543|100541153|FG000|NOT COMPLETED|Overall Study||1||
48089365|NCT03156543|100541154|FG001|NOT COMPLETED|Overall Study||0||
48089366|NCT00511667|100541155|FG000|STARTED|Overall Study||52||
48089367|NCT00511667|100541156|FG001|STARTED|Overall Study||18||
48089368|NCT00511667|100541155|FG000|COMPLETED|Overall Study||40||
48089369|NCT00511667|100541156|FG001|COMPLETED|Overall Study||15||
48379148|NCT02262039|101256040|FG001|COMPLETED|Overall Study||27||
48379149|NCT02262039|101256039|FG000|NOT COMPLETED|Overall Study||0||
48379150|NCT02262039|101256040|FG001|NOT COMPLETED|Overall Study||0||
48379151|NCT02605447|101256041|FG000|STARTED|Overall Study||1487||
48379152|NCT02605447|101256041|FG000|COMPLETED|Overall Study||1385||
48379153|NCT02605447|101256041|FG000|NOT COMPLETED|Overall Study||102||
48379154|NCT03483506|101256042|FG000|STARTED|Overall Study||12|Started are treated|
48379155|NCT03483506|101256042|FG000|COMPLETED|Overall Study||12||
48379156|NCT03483506|101256042|FG000|NOT COMPLETED|Overall Study||0||
48379157|NCT05100316|101256043|FG000|STARTED|Overall Study||16||
48379158|NCT05100316|101256043|FG000|COMPLETED|Overall Study||16||
48379159|NCT05100316|101256043|FG000|NOT COMPLETED|Overall Study||0||
48089370|NCT00511667|100541155|FG000|NOT COMPLETED|Overall Study||12||
48089371|NCT00511667|100541156|FG001|NOT COMPLETED|Overall Study||3||
48089372|NCT01824394|100541157|FG000|STARTED|Overall Study||174|Patients who signed informed consent forms|
48379160|NCT00960934|101256044|FG000|STARTED|Overall Study||64||
48379161|NCT00960934|101256045|FG001|STARTED|Overall Study||63||
48379162|NCT00960934|101256046|FG002|STARTED|Overall Study||64||
48379163|NCT00960934|101256047|FG003|STARTED|Overall Study||64||
48379164|NCT00960934|101256048|FG004|STARTED|Overall Study||64||
48379165|NCT00960934|101256049|FG005|STARTED|Overall Study||64||
48379166|NCT00960934|101256044|FG000|Number Treated|Overall Study||64||
48379167|NCT00960934|101256045|FG001|Number Treated|Overall Study||62||
48379168|NCT00960934|101256046|FG002|Number Treated|Overall Study||64||
48379169|NCT00960934|101256047|FG003|Number Treated|Overall Study||64||
48379170|NCT00960934|101256048|FG004|Number Treated|Overall Study||63||
48379171|NCT00960934|101256049|FG005|Number Treated|Overall Study||63||
48379172|NCT00960934|101256044|FG000|COMPLETED|Overall Study||0||
48379173|NCT00960934|101256045|FG001|COMPLETED|Overall Study||0||
48379174|NCT00960934|101256046|FG002|COMPLETED|Overall Study||0||
48379175|NCT00960934|101256047|FG003|COMPLETED|Overall Study||0||
48379176|NCT00960934|101256048|FG004|COMPLETED|Overall Study||0||
48089373|NCT01824394|100541158|FG001|STARTED|Overall Study||169|Patients who signed informed consent forms|
48089374|NCT01824394|100541159|FG002|STARTED|Overall Study||125|Patients who signed informed consent forms|
48379177|NCT00960934|101256049|FG005|COMPLETED|Overall Study||0||
48379178|NCT00960934|101256044|FG000|NOT COMPLETED|Overall Study||64||
48379179|NCT00960934|101256045|FG001|NOT COMPLETED|Overall Study||63||
48379180|NCT00960934|101256046|FG002|NOT COMPLETED|Overall Study||64||
48379181|NCT00960934|101256047|FG003|NOT COMPLETED|Overall Study||64||
48379182|NCT00960934|101256048|FG004|NOT COMPLETED|Overall Study||64||
48379183|NCT00960934|101256049|FG005|NOT COMPLETED|Overall Study||64||
48379184|NCT01253044|101256050|FG000|STARTED|Overall Study||80||
48379185|NCT01253044|101256051|FG001|STARTED|Overall Study||80||
48379186|NCT01253044|101256050|FG000|COMPLETED|Overall Study||42||
48379187|NCT01253044|101256051|FG001|COMPLETED|Overall Study||51||
48379188|NCT01253044|101256050|FG000|NOT COMPLETED|Overall Study||38||
48379189|NCT01253044|101256051|FG001|NOT COMPLETED|Overall Study||29||
48379190|NCT02045212|101256052|FG000|STARTED|Overall Study||13||
48379191|NCT02045212|101256053|FG001|STARTED|Overall Study||9||
48379192|NCT02045212|101256052|FG000|COMPLETED|Overall Study||11||
48379193|NCT02045212|101256053|FG001|COMPLETED|Overall Study||8||
48379194|NCT02045212|101256052|FG000|NOT COMPLETED|Overall Study||2||
48379195|NCT02045212|101256053|FG001|NOT COMPLETED|Overall Study||1||
48379196|NCT01640925|101256054|FG000|STARTED|Overall Study||175||
48379197|NCT01640925|101256055|FG001|STARTED|Overall Study||175||
48379198|NCT01640925|101256054|FG000|COMPLETED|Overall Study||161||
48379199|NCT01640925|101256055|FG001|COMPLETED|Overall Study||164||
48379200|NCT01640925|101256054|FG000|NOT COMPLETED|Overall Study||14||
48379201|NCT01640925|101256055|FG001|NOT COMPLETED|Overall Study||11||
48379202|NCT01328249|101256056|FG000|STARTED|Overall Study||55||
48379203|NCT01328249|101256057|FG001|STARTED|Overall Study||26||
48379204|NCT01328249|101256056|FG000|COMPLETED|Overall Study||48||
48379205|NCT01328249|101256057|FG001|COMPLETED|Overall Study||23||
48379206|NCT01328249|101256056|FG000|NOT COMPLETED|Overall Study||7||
48379207|NCT01328249|101256057|FG001|NOT COMPLETED|Overall Study||3||
48379208|NCT02415439|101256058|FG000|STARTED|Overall Study||6||
48379209|NCT02415439|101256059|FG001|STARTED|Overall Study||6||
48089375|NCT01824394|100541157|FG000|Intent to Treat Population|Overall Study||151|Intent-to-Treat (ITT) population include randomized patients who have the ablation catheter inserted|
48379210|NCT02415439|101256060|FG002|STARTED|Overall Study||6||
48379211|NCT02415439|101256061|FG003|STARTED|Overall Study||6||
48089376|NCT01824394|100541158|FG001|Intent to Treat Population|Overall Study||149|Intent-to-Treat (ITT) population include randomized patients who have the ablation catheter inserted|
48089377|NCT01824394|100541159|FG002|Intent to Treat Population|Overall Study||0|Intent-to-Treat (ITT) population include randomized patients who have the ablation catheter inserted|
48089378|NCT01824394|100541157|FG000|Safety Population|Overall Study||151|Safety Population includes those patients who have the ablation catheter inserted|
48089379|NCT01824394|100541158|FG001|Safety Population|Overall Study||149|Safety Population includes those patients who have the ablation catheter inserted|
48089380|NCT01824394|100541159|FG002|Safety Population|Overall Study||104|Safety Population includes those patients who have the ablation catheter inserted|
48252298|NCT01194271|100936736|FG000|COMPLETED|Overall Study||16||
48252299|NCT01194271|100936736|FG000|NOT COMPLETED|Overall Study||3||
48252300|NCT01182181|100936737|FG000|STARTED|First Intervention||11||
48089381|NCT01824394|100541157|FG000|Per-Protocol Population|Overall Study||150|Includes ITT patients who have undergone RF ablation and are in compliance with study protocol|
48089382|NCT01824394|100541158|FG001|Per-Protocol Population|Overall Study||148|Includes ITT patients who have undergone RF ablation and are in compliance with study protocol|
48089383|NCT01824394|100541159|FG002|Per-Protocol Population|Overall Study||0|Includes ITT patients who have undergone RF ablation and are in compliance with study protocol|
48089384|NCT01824394|100541157|FG000|COMPLETED|Overall Study||55|All enrolled subjects who underwent insertion of the study catheter|
48089385|NCT01824394|100541158|FG001|COMPLETED|Overall Study||53|All enrolled subjects who underwent insertion of the study catheter|
48141289|NCT04396834|100670390|FG001|NOT COMPLETED|Overall Study||0||
48141290|NCT03182868|100670391|FG000|STARTED|Overall Study||12||
48141291|NCT03182868|100670392|FG001|STARTED|Overall Study||20||
48141292|NCT03182868|100670393|FG002|STARTED|Overall Study||21||
48141293|NCT03182868|100670394|FG003|STARTED|Overall Study||1||
48141294|NCT03182868|100670395|FG004|STARTED|Overall Study||24||
48141295|NCT03182868|100670391|FG000|COMPLETED|Overall Study||9||
48141296|NCT03182868|100670392|FG001|COMPLETED|Overall Study||20||
48141297|NCT03182868|100670393|FG002|COMPLETED|Overall Study||17||
48141298|NCT03182868|100670394|FG003|COMPLETED|Overall Study||0||
48141299|NCT03182868|100670395|FG004|COMPLETED|Overall Study||16||
48141300|NCT03182868|100670391|FG000|NOT COMPLETED|Overall Study||3||
48141301|NCT03182868|100670392|FG001|NOT COMPLETED|Overall Study||0||
48141302|NCT03182868|100670393|FG002|NOT COMPLETED|Overall Study||4||
48141303|NCT03182868|100670394|FG003|NOT COMPLETED|Overall Study||1||
48141304|NCT03182868|100670395|FG004|NOT COMPLETED|Overall Study||8||
48141305|NCT01475136|100670396|FG000|STARTED|Overall Study||7||
48141306|NCT01475136|100670397|FG001|STARTED|Overall Study||9||
48141307|NCT01475136|100670398|FG002|STARTED|Overall Study||9||
48141308|NCT01475136|100670399|FG003|STARTED|Overall Study||12||
48141309|NCT01475136|100670396|FG000|Received 1 Dose of Study Drug|Overall Study||7||
48141310|NCT01475136|100670397|FG001|Received 1 Dose of Study Drug|Overall Study||6||
48141311|NCT01475136|100670398|FG002|Received 1 Dose of Study Drug|Overall Study||6||
48141312|NCT01475136|100670399|FG003|Received 1 Dose of Study Drug|Overall Study||7||
48141313|NCT01475136|100670396|FG000|COMPLETED|Overall Study||6||
48141314|NCT01475136|100670397|FG001|COMPLETED|Overall Study||6||
48141315|NCT01475136|100670398|FG002|COMPLETED|Overall Study||6||
48141316|NCT01475136|100670399|FG003|COMPLETED|Overall Study||7||
48141317|NCT01475136|100670396|FG000|NOT COMPLETED|Overall Study||1||
48141318|NCT01475136|100670397|FG001|NOT COMPLETED|Overall Study||3||
48141319|NCT01475136|100670398|FG002|NOT COMPLETED|Overall Study||3||
48141320|NCT01475136|100670399|FG003|NOT COMPLETED|Overall Study||5||
48141321|NCT00000392|100670400|FG000|STARTED|Overall Study||106||
48141322|NCT00000392|100670401|FG001|STARTED|Overall Study||109||
48141323|NCT00000392|100670400|FG000|COMPLETED|Overall Study||66||
48141324|NCT00000392|100670401|FG001|COMPLETED|Overall Study||77||
48141325|NCT00000392|100670400|FG000|NOT COMPLETED|Overall Study||40||
48141326|NCT00000392|100670401|FG001|NOT COMPLETED|Overall Study||32||
48141327|NCT01512225|100670402|FG000|STARTED|Overall Study||45||
48141328|NCT01512225|100670403|FG001|STARTED|Overall Study||45||
48141329|NCT01512225|100670402|FG000|Provided Day 14 Volume|Overall Study||45||
48141330|NCT01512225|100670403|FG001|Provided Day 14 Volume|Overall Study||40||
48141331|NCT01512225|100670402|FG000|COMPLETED|Overall Study||45||
48141332|NCT01512225|100670403|FG001|COMPLETED|Overall Study||45||
48141333|NCT01512225|100670402|FG000|NOT COMPLETED|Overall Study||0||
48141334|NCT01512225|100670403|FG001|NOT COMPLETED|Overall Study||0||
48141335|NCT02270450|100670404|FG000|STARTED|Overall Study||24||
48141336|NCT02270450|100670405|FG001|STARTED|Overall Study||25||
48141337|NCT02270450|100670406|FG002|STARTED|Overall Study||58||
48141338|NCT02270450|100670407|FG003|STARTED|Overall Study||92||
48141339|NCT02270450|100670404|FG000|COMPLETED|Overall Study||1||
48141340|NCT02270450|100670405|FG001|COMPLETED|Overall Study||3||
48141341|NCT02270450|100670406|FG002|COMPLETED|Overall Study||18||
48141342|NCT02270450|100670407|FG003|COMPLETED|Overall Study||10||
48141343|NCT02270450|100670404|FG000|NOT COMPLETED|Overall Study||23||
48141344|NCT02270450|100670405|FG001|NOT COMPLETED|Overall Study||22||
48141345|NCT02270450|100670406|FG002|NOT COMPLETED|Overall Study||40||
48141346|NCT02270450|100670407|FG003|NOT COMPLETED|Overall Study||82||
48141347|NCT02137369|100670408|FG000|STARTED|Overall Study||49||
48252301|NCT01182181|100936738|FG001|STARTED|First Intervention||11||
48252302|NCT01182181|100936737|FG000|COMPLETED|First Intervention||10||
48252303|NCT01182181|100936738|FG001|COMPLETED|First Intervention||11||
48252304|NCT01182181|100936737|FG000|NOT COMPLETED|First Intervention||1||
48252305|NCT01182181|100936738|FG001|NOT COMPLETED|First Intervention||0||
48252306|NCT01182181|100936737|FG000|STARTED|Washout of 21 Days||10||
48252307|NCT01182181|100936738|FG001|STARTED|Washout of 21 Days||11||
48252308|NCT01182181|100936737|FG000|COMPLETED|Washout of 21 Days||10||
48252309|NCT01182181|100936738|FG001|COMPLETED|Washout of 21 Days||10||
48252310|NCT01182181|100936737|FG000|NOT COMPLETED|Washout of 21 Days||0||
48252311|NCT01182181|100936738|FG001|NOT COMPLETED|Washout of 21 Days||1||
48252312|NCT01182181|100936737|FG000|STARTED|Second Intervention||10||
48252313|NCT01182181|100936738|FG001|STARTED|Second Intervention||10||
48252314|NCT01182181|100936737|FG000|COMPLETED|Second Intervention||10||
48252315|NCT01182181|100936738|FG001|COMPLETED|Second Intervention||10||
48252316|NCT01182181|100936737|FG000|NOT COMPLETED|Second Intervention||0||
48252317|NCT01182181|100936738|FG001|NOT COMPLETED|Second Intervention||0||
48252318|NCT00097669|100936739|FG000|STARTED|Overall Study||4089||
48252319|NCT00097669|100936740|FG001|STARTED|Overall Study||4075||
48252320|NCT00097669|100936739|FG000|COMPLETED|Overall Study||4089||
48252321|NCT00097669|100936740|FG001|COMPLETED|Overall Study||4075||
48252322|NCT00097669|100936739|FG000|NOT COMPLETED|Overall Study||0||
48252323|NCT00097669|100936740|FG001|NOT COMPLETED|Overall Study||0||
48252324|NCT03065205|100936741|FG000|STARTED|Overall Study||65||
48252325|NCT03065205|100936741|FG000|COMPLETED|Overall Study||53||
48252326|NCT03065205|100936741|FG000|NOT COMPLETED|Overall Study||12||
48252327|NCT05600036|100936742|FG000|STARTED|Overall Study||36||
48252328|NCT05600036|100936743|FG001|STARTED|Overall Study||36||
48252329|NCT05600036|100936744|FG002|STARTED|Overall Study||39||
48252330|NCT05600036|100936745|FG003|STARTED|Overall Study||40||
48252331|NCT05600036|100936746|FG004|STARTED|Overall Study||39||
48252332|NCT05600036|100936747|FG005|STARTED|Overall Study||38||
48252333|NCT05600036|100936742|FG000|COMPLETED|Overall Study||36||
48252334|NCT05600036|100936743|FG001|COMPLETED|Overall Study||30||
48252335|NCT05600036|100936744|FG002|COMPLETED|Overall Study||33||
48252336|NCT05600036|100936745|FG003|COMPLETED|Overall Study||37||
48252337|NCT05600036|100936746|FG004|COMPLETED|Overall Study||35||
48252338|NCT05600036|100936747|FG005|COMPLETED|Overall Study||33||
48252339|NCT05600036|100936742|FG000|NOT COMPLETED|Overall Study||0||
48252340|NCT05600036|100936743|FG001|NOT COMPLETED|Overall Study||6||
48252341|NCT05600036|100936744|FG002|NOT COMPLETED|Overall Study||6||
48252342|NCT05600036|100936745|FG003|NOT COMPLETED|Overall Study||3||
48252343|NCT05600036|100936746|FG004|NOT COMPLETED|Overall Study||4||
48252344|NCT05600036|100936747|FG005|NOT COMPLETED|Overall Study||5||
48252345|NCT03226353|100936748|FG000|STARTED|Overall Study||77||
48252346|NCT03226353|100936748|FG000|Habitual Wearers of Proclear 1 Day|Overall Study||2||
48252347|NCT03226353|100936748|FG000|Other Habitual Lens Types|Overall Study||75||
48252348|NCT03226353|100936748|FG000|COMPLETED|Overall Study||71||
48252349|NCT03226353|100936748|FG000|NOT COMPLETED|Overall Study||6||
48252350|NCT04912700|100936749|FG000|STARTED|Overall Study||10880||
48252351|NCT04912700|100936750|FG001|STARTED|Overall Study||825||
48252352|NCT04912700|100936751|FG002|STARTED|Overall Study||129||
48252353|NCT04912700|100936749|FG000|COMPLETED|Overall Study||10880||
48252354|NCT04912700|100936750|FG001|COMPLETED|Overall Study||825||
48252355|NCT04912700|100936751|FG002|COMPLETED|Overall Study||129||
48252356|NCT04912700|100936749|FG000|NOT COMPLETED|Overall Study||0||
48252357|NCT04912700|100936750|FG001|NOT COMPLETED|Overall Study||0||
48252358|NCT04912700|100936751|FG002|NOT COMPLETED|Overall Study||0||
48252359|NCT02906696|100936752|FG000|STARTED|Overall Study||8||
48252360|NCT02906696|100936752|FG000|COMPLETED|Overall Study||8||
48252361|NCT02906696|100936752|FG000|NOT COMPLETED|Overall Study||0||
48252362|NCT00706914|100936753|FG000|STARTED|Overall Study||63||
48252363|NCT00706914|100936754|FG001|STARTED|Overall Study||62||
48252364|NCT00706914|100936755|FG002|STARTED|Overall Study||31||
48252365|NCT00706914|100936753|FG000|COMPLETED|Overall Study||57||
48252366|NCT00706914|100936754|FG001|COMPLETED|Overall Study||58||
48252367|NCT00706914|100936755|FG002|COMPLETED|Overall Study||30||
48252368|NCT00706914|100936753|FG000|NOT COMPLETED|Overall Study||6||
48252369|NCT00706914|100936754|FG001|NOT COMPLETED|Overall Study||4||
48252370|NCT00706914|100936755|FG002|NOT COMPLETED|Overall Study||1||
48252371|NCT01967719|100936756|FG000|STARTED|Washout Period of 1 Day (Day 0)||22||
48252372|NCT01967719|100936757|FG001|STARTED|Washout Period of 1 Day (Day 0)||22||
48252373|NCT01967719|100936758|FG002|STARTED|Washout Period of 1 Day (Day 0)||9||
48252374|NCT01967719|100936759|FG003|STARTED|Washout Period of 1 Day (Day 0)||9||
48252375|NCT01967719|100936756|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22||
48252376|NCT01967719|100936757|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||22||
48252377|NCT01967719|100936758|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9||
48252378|NCT01967719|100936759|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9||
48252379|NCT01967719|100936756|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0||
48252380|NCT01967719|100936757|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0||
48252381|NCT01967719|100936758|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0||
48252382|NCT01967719|100936759|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0||
48379212|NCT02415439|101256062|FG004|STARTED|Overall Study||6||
48379213|NCT02415439|101256063|FG005|STARTED|Overall Study||6||
48379214|NCT02415439|101256064|FG006|STARTED|Overall Study||6||
48379215|NCT02415439|101256065|FG007|STARTED|Overall Study||12||
48379216|NCT02415439|101256066|FG008|STARTED|Overall Study||6||
48379217|NCT02415439|101256067|FG009|STARTED|Overall Study||6||
48379218|NCT02415439|101256068|FG010|STARTED|Overall Study||6||
48379219|NCT02415439|101256069|FG011|STARTED|Overall Study||6||
48379220|NCT02415439|101256070|FG012|STARTED|Overall Study||8||
48379221|NCT02415439|101256058|FG000|COMPLETED|Overall Study||6||
48379222|NCT02415439|101256059|FG001|COMPLETED|Overall Study||6||
48379223|NCT02415439|101256060|FG002|COMPLETED|Overall Study||6||
48379224|NCT02415439|101256061|FG003|COMPLETED|Overall Study||6||
48379225|NCT02415439|101256062|FG004|COMPLETED|Overall Study||6||
48379226|NCT02415439|101256063|FG005|COMPLETED|Overall Study||6||
48379227|NCT02415439|101256064|FG006|COMPLETED|Overall Study||6||
48379228|NCT02415439|101256065|FG007|COMPLETED|Overall Study||12||
48379229|NCT02415439|101256066|FG008|COMPLETED|Overall Study||5||
48379230|NCT02415439|101256067|FG009|COMPLETED|Overall Study||6||
48379231|NCT02415439|101256068|FG010|COMPLETED|Overall Study||6||
48379232|NCT02415439|101256069|FG011|COMPLETED|Overall Study||6||
48379233|NCT02415439|101256070|FG012|COMPLETED|Overall Study||8||
48379234|NCT02415439|101256058|FG000|NOT COMPLETED|Overall Study||0||
48379235|NCT02415439|101256059|FG001|NOT COMPLETED|Overall Study||0||
48379236|NCT02415439|101256060|FG002|NOT COMPLETED|Overall Study||0||
48379237|NCT02415439|101256061|FG003|NOT COMPLETED|Overall Study||0||
48379238|NCT02415439|101256062|FG004|NOT COMPLETED|Overall Study||0||
48379239|NCT02415439|101256063|FG005|NOT COMPLETED|Overall Study||0||
48379240|NCT02415439|101256064|FG006|NOT COMPLETED|Overall Study||0||
48379241|NCT02415439|101256065|FG007|NOT COMPLETED|Overall Study||0||
48379242|NCT02415439|101256066|FG008|NOT COMPLETED|Overall Study||1||
48379243|NCT02415439|101256067|FG009|NOT COMPLETED|Overall Study||0||
48379244|NCT02415439|101256068|FG010|NOT COMPLETED|Overall Study||0||
48379245|NCT02415439|101256069|FG011|NOT COMPLETED|Overall Study||0||
48379246|NCT02415439|101256070|FG012|NOT COMPLETED|Overall Study||0||
48379247|NCT02597673|101256071|FG000|STARTED|Overall Study||34||
48379248|NCT02597673|101256072|FG001|STARTED|Overall Study||33||
48379249|NCT02597673|101256073|FG002|STARTED|Overall Study||33||
48379250|NCT02597673|101256074|FG003|STARTED|Overall Study||30||
48379251|NCT02597673|101256071|FG000|COMPLETED|Overall Study||31||
48379252|NCT02597673|101256072|FG001|COMPLETED|Overall Study||27||
48379253|NCT02597673|101256073|FG002|COMPLETED|Overall Study||28||
48379254|NCT02597673|101256074|FG003|COMPLETED|Overall Study||25||
48379255|NCT02597673|101256071|FG000|NOT COMPLETED|Overall Study||3||
48379256|NCT02597673|101256072|FG001|NOT COMPLETED|Overall Study||6||
48379257|NCT02597673|101256073|FG002|NOT COMPLETED|Overall Study||5||
48379258|NCT02597673|101256074|FG003|NOT COMPLETED|Overall Study||5||
48379259|NCT02728258|101256075|FG000|STARTED|Overall Study||11||
48379260|NCT02728258|101256075|FG000|COMPLETED|Overall Study||11||
48379261|NCT02728258|101256075|FG000|NOT COMPLETED|Overall Study||0||
48379262|NCT00028002|101256076|FG000|STARTED|Overall Study||63||
48379263|NCT00028002|101256076|FG000|COMPLETED|Overall Study||52||
48379264|NCT00028002|101256076|FG000|NOT COMPLETED|Overall Study||11||
48379265|NCT04539249|101256077|FG000|STARTED|Overall Study||50|Randomized|
48379266|NCT04539249|101256078|FG001|STARTED|Overall Study||50|Randomized|
48379267|NCT04539249|101256077|FG000|Allocation|Overall Study||50|Received allocated intervention|
48379268|NCT04539249|101256078|FG001|Allocation|Overall Study||50|Received allocated intervention|
48379269|NCT04539249|101256077|FG000|Intervention Per Protocol|Overall Study||49|Received allocated intervention per protocol|
48379270|NCT04539249|101256078|FG001|Intervention Per Protocol|Overall Study||50|Received allocated intervention per protocol|
48379271|NCT04539249|101256077|FG000|Intervention NOT Per Protocol|Overall Study||1|Did not receive allocated intervention per protocol|
48379272|NCT04539249|101256078|FG001|Intervention NOT Per Protocol|Overall Study||0|Did not receive allocated intervention per protocol|
48379273|NCT04539249|101256077|FG000|Analyzed|Overall Study||50||
48379274|NCT04539249|101256078|FG001|Analyzed|Overall Study||50||
48379275|NCT04539249|101256077|FG000|Excluded From Analysis|Overall Study||0||
48379276|NCT04539249|101256078|FG001|Excluded From Analysis|Overall Study||0||
48379277|NCT04539249|101256077|FG000|COMPLETED|Overall Study||50||
48379278|NCT04539249|101256078|FG001|COMPLETED|Overall Study||50||
48379279|NCT04539249|101256077|FG000|NOT COMPLETED|Overall Study||0||
48379280|NCT04539249|101256078|FG001|NOT COMPLETED|Overall Study||0||
48379281|NCT01276457|101256079|FG000|STARTED|Core Study||142||
48379282|NCT01276457|101256080|FG001|STARTED|Core Study||143||
48379283|NCT01276457|101256079|FG000|COMPLETED|Core Study||129||
48379284|NCT01276457|101256080|FG001|COMPLETED|Core Study||123||
48379285|NCT01276457|101256079|FG000|NOT COMPLETED|Core Study||13||
48379286|NCT01276457|101256080|FG001|NOT COMPLETED|Core Study||20||
48379287|NCT01276457|101256079|FG000|STARTED|Extension Study||111||
48379288|NCT01276457|101256080|FG001|STARTED|Extension Study||112||
48379289|NCT01276457|101256079|FG000|COMPLETED|Extension Study||105||
48379290|NCT01276457|101256080|FG001|COMPLETED|Extension Study||110||
48379291|NCT01276457|101256079|FG000|NOT COMPLETED|Extension Study||6||
48379292|NCT01276457|101256080|FG001|NOT COMPLETED|Extension Study||2||
48379293|NCT01293032|101256081|FG000|STARTED|Recurrence Score(RS)Assigned/Randomized||12||
48379294|NCT01293032|101256082|FG001|STARTED|Recurrence Score(RS)Assigned/Randomized||17||
48379295|NCT01293032|101256083|FG002|STARTED|Recurrence Score(RS)Assigned/Randomized||16||
48379296|NCT01293032|101256084|FG003|STARTED|Recurrence Score(RS)Assigned/Randomized||14||
48379297|NCT01293032|101256081|FG000|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||12||
48379298|NCT01293032|101256082|FG001|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||17||
48379299|NCT01293032|101256083|FG002|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||16||
48379300|NCT01293032|101256084|FG003|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||14||
48684577|NCT03012334|102013059|FG003|STARTED|Period 1||9||
48684578|NCT03012334|102013060|FG004|STARTED|Period 1||9||
48379301|NCT01293032|101256081|FG000|COMPLETED|Recurrence Score(RS)Assigned/Randomized||12||
48379302|NCT01293032|101256082|FG001|COMPLETED|Recurrence Score(RS)Assigned/Randomized||17||
48379303|NCT01293032|101256083|FG002|COMPLETED|Recurrence Score(RS)Assigned/Randomized||11||
48379304|NCT01293032|101256084|FG003|COMPLETED|Recurrence Score(RS)Assigned/Randomized||14||
48379305|NCT01293032|101256081|FG000|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0||
48379306|NCT01293032|101256082|FG001|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0||
48379307|NCT01293032|101256083|FG002|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||5||
48379308|NCT01293032|101256084|FG003|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0||
48379309|NCT01293032|101256081|FG000|STARTED|Treatment||12||
48379310|NCT01293032|101256082|FG001|STARTED|Treatment||19||
48379311|NCT01293032|101256083|FG002|STARTED|Treatment||11||
48379312|NCT01293032|101256084|FG003|STARTED|Treatment||14||
48379313|NCT01293032|101256081|FG000|COMPLETED|Treatment||10||
48379314|NCT01293032|101256082|FG001|COMPLETED|Treatment||14||
48379315|NCT01293032|101256083|FG002|COMPLETED|Treatment||10||
48379316|NCT01293032|101256084|FG003|COMPLETED|Treatment||13||
48379317|NCT01293032|101256081|FG000|NOT COMPLETED|Treatment||2||
48379318|NCT01293032|101256082|FG001|NOT COMPLETED|Treatment||5||
48379319|NCT01293032|101256083|FG002|NOT COMPLETED|Treatment||1||
48379320|NCT01293032|101256084|FG003|NOT COMPLETED|Treatment||1||
48379321|NCT01096849|101256085|FG000|STARTED|Overall Study||22||
48379322|NCT01096849|101256086|FG001|STARTED|Overall Study||76||
48379323|NCT01096849|101256087|FG002|STARTED|Overall Study||47||
48379324|NCT01096849|101256085|FG000|COMPLETED|Overall Study||20||
48379325|NCT01096849|101256086|FG001|COMPLETED|Overall Study||64||
48379326|NCT01096849|101256087|FG002|COMPLETED|Overall Study||41||
48379327|NCT01096849|101256085|FG000|NOT COMPLETED|Overall Study||2||
48379328|NCT01096849|101256086|FG001|NOT COMPLETED|Overall Study||12||
48379329|NCT01096849|101256087|FG002|NOT COMPLETED|Overall Study||6||
48379330|NCT02320695|101256088|FG000|STARTED|Overall Study||60||
48379331|NCT02320695|101256088|FG000|Saline|Overall Study||60||
48684579|NCT03012334|102013061|FG005|STARTED|Period 1||9||
48684580|NCT03012334|102013062|FG006|STARTED|Period 1||9||
48684581|NCT03012334|102013063|FG007|STARTED|Period 1||9||
48684582|NCT03012334|102013064|FG008|STARTED|Period 1||9||
48684583|NCT03012334|102013065|FG009|STARTED|Period 1||9||
48684584|NCT03012334|102013056|FG000|COMPLETED|Period 1||9||
48684585|NCT03012334|102013057|FG001|COMPLETED|Period 1||9||
48684586|NCT03012334|102013058|FG002|COMPLETED|Period 1||9||
48684587|NCT03012334|102013059|FG003|COMPLETED|Period 1||9||
48684588|NCT03012334|102013060|FG004|COMPLETED|Period 1||9||
48684589|NCT03012334|102013061|FG005|COMPLETED|Period 1||9||
48684590|NCT03012334|102013062|FG006|COMPLETED|Period 1||9||
48684591|NCT03012334|102013063|FG007|COMPLETED|Period 1||9||
48379332|NCT02320695|101256088|FG000|Alcohol|Overall Study||60||
48379333|NCT02320695|101256088|FG000|Pain Relieving Cream|Overall Study||59||
48379334|NCT02320695|101256088|FG000|Antibiotic/Pain Relieving Ointment|Overall Study||60||
48379335|NCT02320695|101256088|FG000|Original Ointment|Overall Study||60||
48379336|NCT02320695|101256088|FG000|Pain Relief Ointment|Overall Study||60||
48379337|NCT02320695|101256088|FG000|COMPLETED|Overall Study||60||
48379338|NCT02320695|101256088|FG000|NOT COMPLETED|Overall Study||0||
48684592|NCT03012334|102013064|FG008|COMPLETED|Period 1||9||
48684593|NCT03012334|102013065|FG009|COMPLETED|Period 1||8||
48684594|NCT03012334|102013056|FG000|NOT COMPLETED|Period 1||0||
48684595|NCT03012334|102013057|FG001|NOT COMPLETED|Period 1||0||
48684596|NCT03012334|102013058|FG002|NOT COMPLETED|Period 1||0||
48252383|NCT01967719|100936756|FG000|STARTED|First Intervention (Day 1)||22||
48684597|NCT03012334|102013059|FG003|NOT COMPLETED|Period 1||0||
48684598|NCT03012334|102013060|FG004|NOT COMPLETED|Period 1||0||
48684599|NCT03012334|102013061|FG005|NOT COMPLETED|Period 1||0||
48252384|NCT01967719|100936757|FG001|STARTED|First Intervention (Day 1)||22||
48252385|NCT01967719|100936758|FG002|STARTED|First Intervention (Day 1)||9||
48252386|NCT01967719|100936759|FG003|STARTED|First Intervention (Day 1)||9||
48252387|NCT01967719|100936756|FG000|COMPLETED|First Intervention (Day 1)||22||
48252388|NCT01967719|100936757|FG001|COMPLETED|First Intervention (Day 1)||21||
48252389|NCT01967719|100936758|FG002|COMPLETED|First Intervention (Day 1)||9||
48252390|NCT01967719|100936759|FG003|COMPLETED|First Intervention (Day 1)||8||
48252391|NCT01967719|100936756|FG000|NOT COMPLETED|First Intervention (Day 1)||0||
48252392|NCT01967719|100936757|FG001|NOT COMPLETED|First Intervention (Day 1)||1||
48252393|NCT01967719|100936758|FG002|NOT COMPLETED|First Intervention (Day 1)||0||
48252394|NCT01967719|100936759|FG003|NOT COMPLETED|First Intervention (Day 1)||1||
48252395|NCT01967719|100936756|FG000|STARTED|Washout Period of 1 Day (Day 2)||22||
48252396|NCT01967719|100936757|FG001|STARTED|Washout Period of 1 Day (Day 2)||21||
48252397|NCT01967719|100936758|FG002|STARTED|Washout Period of 1 Day (Day 2)||9||
48252398|NCT01967719|100936759|FG003|STARTED|Washout Period of 1 Day (Day 2)||8||
48252399|NCT01967719|100936756|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||22||
48252400|NCT01967719|100936757|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||21||
48252401|NCT01967719|100936758|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9||
48252402|NCT01967719|100936759|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||8||
48252403|NCT01967719|100936756|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
48252404|NCT01967719|100936757|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
48252405|NCT01967719|100936758|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
48252406|NCT01967719|100936759|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
48252407|NCT01967719|100936756|FG000|STARTED|Second Intervention (Day 3)||22||
48252408|NCT01967719|100936757|FG001|STARTED|Second Intervention (Day 3)||21||
48252409|NCT01967719|100936758|FG002|STARTED|Second Intervention (Day 3)||9||
48252410|NCT01967719|100936759|FG003|STARTED|Second Intervention (Day 3)||8||
48252411|NCT01967719|100936756|FG000|COMPLETED|Second Intervention (Day 3)||22||
48252412|NCT01967719|100936757|FG001|COMPLETED|Second Intervention (Day 3)||20||
48252413|NCT01967719|100936758|FG002|COMPLETED|Second Intervention (Day 3)||9||
48252414|NCT01967719|100936759|FG003|COMPLETED|Second Intervention (Day 3)||8||
48252415|NCT01967719|100936756|FG000|NOT COMPLETED|Second Intervention (Day 3)||0||
48252416|NCT01967719|100936757|FG001|NOT COMPLETED|Second Intervention (Day 3)||1||
48252417|NCT01967719|100936758|FG002|NOT COMPLETED|Second Intervention (Day 3)||0||
48252418|NCT01967719|100936759|FG003|NOT COMPLETED|Second Intervention (Day 3)||0||
48252419|NCT01701271|100936760|FG000|STARTED|Overall Study||20||
48684600|NCT03012334|102013062|FG006|NOT COMPLETED|Period 1||0||
48684601|NCT03012334|102013063|FG007|NOT COMPLETED|Period 1||0||
48684602|NCT03012334|102013064|FG008|NOT COMPLETED|Period 1||0||
48252420|NCT01701271|100936760|FG000|COMPLETED|Overall Study||20||
48252421|NCT01701271|100936760|FG000|NOT COMPLETED|Overall Study||0||
48252422|NCT01547247|100936761|FG000|STARTED|Overall Study||104||
48252423|NCT01547247|100936762|FG001|STARTED|Overall Study||104||
48252424|NCT01547247|100936761|FG000|COMPLETED|Overall Study||98||
48252425|NCT01547247|100936762|FG001|COMPLETED|Overall Study||98||
48252426|NCT01547247|100936761|FG000|NOT COMPLETED|Overall Study||6||
48252427|NCT01547247|100936762|FG001|NOT COMPLETED|Overall Study||6||
48252428|NCT01376050|100936763|FG000|STARTED|Overall Study||13||
48252429|NCT01376050|100936764|FG001|STARTED|Overall Study||11||
48252430|NCT01376050|100936763|FG000|COMPLETED|Overall Study||13||
48252431|NCT01376050|100936764|FG001|COMPLETED|Overall Study||11||
48252432|NCT01376050|100936763|FG000|NOT COMPLETED|Overall Study||0||
48252433|NCT01376050|100936764|FG001|NOT COMPLETED|Overall Study||0||
48252434|NCT00361842|100936765|FG000|STARTED|Overall Study||28||
48252435|NCT00361842|100936766|FG001|STARTED|Overall Study||35||
48252436|NCT00361842|100936765|FG000|COMPLETED|Overall Study||1||
48252437|NCT00361842|100936766|FG001|COMPLETED|Overall Study||1||
48252438|NCT00361842|100936765|FG000|NOT COMPLETED|Overall Study||27||
48252439|NCT00361842|100936766|FG001|NOT COMPLETED|Overall Study||34||
48252440|NCT00053352|100936767|FG000|STARTED|Overall Study||190||
48252441|NCT00053352|100936768|FG001|STARTED|Overall Study||112||
48252442|NCT00053352|100936767|FG000|COMPLETED|Overall Study||169||
48252443|NCT00053352|100936768|FG001|COMPLETED|Overall Study||102||
48684603|NCT03012334|102013065|FG009|NOT COMPLETED|Period 1||1||
48252444|NCT00053352|100936767|FG000|NOT COMPLETED|Overall Study||21||
48252445|NCT00053352|100936768|FG001|NOT COMPLETED|Overall Study||10||
48252446|NCT01182207|100936769|FG000|STARTED|First Intervention||18||
48252447|NCT01182207|100936770|FG001|STARTED|First Intervention||15||
48684604|NCT03012334|102013056|FG000|STARTED|Period 2||9||
48141348|NCT02137369|100670409|FG001|STARTED|Overall Study||11||
48252448|NCT01182207|100936769|FG000|COMPLETED|First Intervention||18||
48252449|NCT01182207|100936770|FG001|COMPLETED|First Intervention||14||
48252450|NCT01182207|100936769|FG000|NOT COMPLETED|First Intervention||0||
48252451|NCT01182207|100936770|FG001|NOT COMPLETED|First Intervention||1||
48252452|NCT01182207|100936769|FG000|STARTED|Washout of 28 Days||18||
48252453|NCT01182207|100936770|FG001|STARTED|Washout of 28 Days||14||
48252454|NCT01182207|100936769|FG000|COMPLETED|Washout of 28 Days||18||
48252455|NCT01182207|100936770|FG001|COMPLETED|Washout of 28 Days||14||
48252456|NCT01182207|100936769|FG000|NOT COMPLETED|Washout of 28 Days||0||
48252457|NCT01182207|100936770|FG001|NOT COMPLETED|Washout of 28 Days||0||
48252458|NCT01182207|100936769|FG000|STARTED|Second Intervention||18||
48252459|NCT01182207|100936770|FG001|STARTED|Second Intervention||14||
48252460|NCT01182207|100936769|FG000|COMPLETED|Second Intervention||17||
48252461|NCT01182207|100936770|FG001|COMPLETED|Second Intervention||14||
48252462|NCT01182207|100936769|FG000|NOT COMPLETED|Second Intervention||1||
48252463|NCT01182207|100936770|FG001|NOT COMPLETED|Second Intervention||0||
48252464|NCT03935932|100936771|FG000|STARTED|Overall Study||6||
48252465|NCT03935932|100936772|FG001|STARTED|Overall Study||6||
48252466|NCT03935932|100936771|FG000|COMPLETED|Overall Study||6||
48252467|NCT03935932|100936772|FG001|COMPLETED|Overall Study||6||
48252468|NCT03935932|100936771|FG000|NOT COMPLETED|Overall Study||0||
48252469|NCT03935932|100936772|FG001|NOT COMPLETED|Overall Study||0||
48252470|NCT01831726|100936773|FG000|STARTED|Overall Study||80||
48252471|NCT01831726|100936773|FG000|COMPLETED|Overall Study||0||
48252472|NCT01831726|100936773|FG000|NOT COMPLETED|Overall Study||80||
48252473|NCT01053897|100936774|FG000|STARTED|Overall Study||5||
48252474|NCT01053897|100936774|FG000|COMPLETED|Overall Study||5||
48252475|NCT01053897|100936774|FG000|NOT COMPLETED|Overall Study||0||
48252476|NCT01960348|100936775|FG000|STARTED|Overall Study||148||
48252477|NCT01960348|100936776|FG001|STARTED|Overall Study||77||
48252478|NCT01960348|100936775|FG000|COMPLETED|Overall Study||138|Participants who completed this study could enter the extension study NCT02510261 (ALN-TTR02-006)|
48252479|NCT01960348|100936776|FG001|COMPLETED|Overall Study||55|Participants who completed this study could enter the extension study NCT02510261 (ALN-TTR02-006)|
48252480|NCT01960348|100936775|FG000|NOT COMPLETED|Overall Study||10||
48252481|NCT01960348|100936776|FG001|NOT COMPLETED|Overall Study||22||
48252482|NCT00349388|100936777|FG000|STARTED|Overall Study||0||
48252483|NCT00349388|100936778|FG001|STARTED|Overall Study||1||
48252484|NCT00349388|100936777|FG000|COMPLETED|Overall Study||0||
48252485|NCT00349388|100936778|FG001|COMPLETED|Overall Study||1||
48252486|NCT00349388|100936777|FG000|NOT COMPLETED|Overall Study||0||
48252487|NCT00349388|100936778|FG001|NOT COMPLETED|Overall Study||0||
48252488|NCT01009762|100936779|FG000|STARTED|Overall Study||1||
48252489|NCT01009762|100936780|FG001|STARTED|Overall Study||10||
48252490|NCT01009762|100936779|FG000|Primary Outcome|Overall Study||0||
48252491|NCT01009762|100936780|FG001|Primary Outcome|Overall Study||0||
48252492|NCT01009762|100936779|FG000|COMPLETED|Overall Study||1||
48252493|NCT01009762|100936780|FG001|COMPLETED|Overall Study||10||
48252494|NCT01009762|100936779|FG000|NOT COMPLETED|Overall Study||0||
48252495|NCT01009762|100936780|FG001|NOT COMPLETED|Overall Study||0||
48252496|NCT01726517|100936781|FG000|STARTED|Overall Study||20||
48252497|NCT01726517|100936782|FG001|STARTED|Overall Study||21||
48252498|NCT01726517|100936783|FG002|STARTED|Overall Study||19||
48252499|NCT01726517|100936784|FG003|STARTED|Overall Study||19||
48252500|NCT01726517|100936785|FG004|STARTED|Overall Study||21||
48252501|NCT01726517|100936781|FG000|COMPLETED|Overall Study||20||
48252502|NCT01726517|100936782|FG001|COMPLETED|Overall Study||21||
48252503|NCT01726517|100936783|FG002|COMPLETED|Overall Study||18||
48252504|NCT01726517|100936784|FG003|COMPLETED|Overall Study||19||
48252505|NCT01726517|100936785|FG004|COMPLETED|Overall Study||21||
48252506|NCT01726517|100936781|FG000|NOT COMPLETED|Overall Study||0||
48252507|NCT01726517|100936782|FG001|NOT COMPLETED|Overall Study||0||
48252508|NCT01726517|100936783|FG002|NOT COMPLETED|Overall Study||1||
48252509|NCT01726517|100936784|FG003|NOT COMPLETED|Overall Study||0||
48252510|NCT01726517|100936785|FG004|NOT COMPLETED|Overall Study||0||
48684605|NCT03012334|102013057|FG001|STARTED|Period 2||9||
48252511|NCT02168478|100936786|FG000|STARTED|Overall Study||206||
48252512|NCT02168478|100936786|FG000|COMPLETED|Overall Study||202||
48252513|NCT02168478|100936786|FG000|NOT COMPLETED|Overall Study||4||
48252514|NCT01077622|100936787|FG000|STARTED|Overall Study||10||
48252515|NCT01077622|100936787|FG000|COMPLETED|Overall Study||7||
48252516|NCT01077622|100936787|FG000|NOT COMPLETED|Overall Study||3||
48252517|NCT01887990|100936788|FG000|STARTED|Overall Study||7||
48252518|NCT01887990|100936789|FG001|STARTED|Overall Study||7||
48252519|NCT01887990|100936790|FG002|STARTED|Overall Study||2||
48252520|NCT01887990|100936791|FG003|STARTED|Overall Study||2||
48252521|NCT01887990|100936788|FG000|COMPLETED|Overall Study||7||
48252522|NCT01887990|100936789|FG001|COMPLETED|Overall Study||7||
48684606|NCT03012334|102013058|FG002|STARTED|Period 2||9||
48684607|NCT03012334|102013059|FG003|STARTED|Period 2||9||
48684608|NCT03012334|102013060|FG004|STARTED|Period 2||9||
48684609|NCT03012334|102013061|FG005|STARTED|Period 2||9||
48684610|NCT03012334|102013062|FG006|STARTED|Period 2||9||
48684611|NCT03012334|102013063|FG007|STARTED|Period 2||9||
48684612|NCT03012334|102013064|FG008|STARTED|Period 2||9||
48684613|NCT03012334|102013065|FG009|STARTED|Period 2||8||
48252523|NCT01887990|100936790|FG002|COMPLETED|Overall Study||2||
48252524|NCT01887990|100936791|FG003|COMPLETED|Overall Study||2||
48252525|NCT01887990|100936788|FG000|NOT COMPLETED|Overall Study||0||
48252526|NCT01887990|100936789|FG001|NOT COMPLETED|Overall Study||0||
48252527|NCT01887990|100936790|FG002|NOT COMPLETED|Overall Study||0||
48252528|NCT01887990|100936791|FG003|NOT COMPLETED|Overall Study||0||
48252529|NCT03206476|100936792|FG000|STARTED|Overall Study||54||
48252530|NCT03206476|100936793|FG001|STARTED|Overall Study||53||
48252531|NCT03206476|100936792|FG000|Completed Short-term Evaluation (4 Months)|Overall Study||48||
48252532|NCT03206476|100936793|FG001|Completed Short-term Evaluation (4 Months)|Overall Study||40||
48252533|NCT03206476|100936792|FG000|COMPLETED|Overall Study||42|Completed medium-term evaluation (7 months)|
48252534|NCT03206476|100936793|FG001|COMPLETED|Overall Study||37|Completed medium-term evaluation (7 months)|
48252535|NCT03206476|100936792|FG000|NOT COMPLETED|Overall Study||12||
48252536|NCT03206476|100936793|FG001|NOT COMPLETED|Overall Study||16||
48252537|NCT00920699|100936794|FG000|STARTED|Overall Study||29||
48252538|NCT00920699|100936795|FG001|STARTED|Overall Study||30||
48252539|NCT00920699|100936796|FG002|STARTED|Overall Study||32||
48252540|NCT00920699|100936794|FG000|COMPLETED|Overall Study||27||
48252541|NCT00920699|100936795|FG001|COMPLETED|Overall Study||29||
48252542|NCT00920699|100936796|FG002|COMPLETED|Overall Study||28||
48252543|NCT00920699|100936794|FG000|NOT COMPLETED|Overall Study||2||
48252544|NCT00920699|100936795|FG001|NOT COMPLETED|Overall Study||1||
48252545|NCT00920699|100936796|FG002|NOT COMPLETED|Overall Study||4||
48252546|NCT01225159|100936797|FG000|STARTED|Overall Study||100||
48252547|NCT01225159|100936798|FG001|STARTED|Overall Study||100||
48252548|NCT01225159|100936797|FG000|COMPLETED|Overall Study||99||
48252549|NCT01225159|100936798|FG001|COMPLETED|Overall Study||100||
48252550|NCT01225159|100936797|FG000|NOT COMPLETED|Overall Study||1||
48252551|NCT01225159|100936798|FG001|NOT COMPLETED|Overall Study||0||
48252552|NCT04357964|100936799|FG000|STARTED|Overall Study||55||
48252553|NCT04357964|100936800|FG001|STARTED|Overall Study||82||
48684614|NCT03012334|102013056|FG000|COMPLETED|Period 2||9||
48684615|NCT03012334|102013057|FG001|COMPLETED|Period 2||8||
48684616|NCT03012334|102013058|FG002|COMPLETED|Period 2||8||
48684617|NCT03012334|102013059|FG003|COMPLETED|Period 2||9||
48252554|NCT04357964|100936799|FG000|COMPLETED|Overall Study||37|Number of participants analyzed|
48252555|NCT04357964|100936800|FG001|COMPLETED|Overall Study||81|Number of participants analyzed|
48252556|NCT04357964|100936799|FG000|NOT COMPLETED|Overall Study||18||
48252557|NCT04357964|100936800|FG001|NOT COMPLETED|Overall Study||1||
48252558|NCT01123512|100936801|FG000|STARTED|Overall Study||153||
48252559|NCT01123512|100936802|FG001|STARTED|Overall Study||147||
48252560|NCT01123512|100936801|FG000|COMPLETED|Overall Study||127||
48252561|NCT01123512|100936802|FG001|COMPLETED|Overall Study||126||
48252562|NCT01123512|100936801|FG000|NOT COMPLETED|Overall Study||26||
48252563|NCT01123512|100936802|FG001|NOT COMPLETED|Overall Study||21||
48252564|NCT00997932|100936803|FG000|STARTED|Overall Study||29||
48684618|NCT03012334|102013060|FG004|COMPLETED|Period 2||9||
48684619|NCT03012334|102013061|FG005|COMPLETED|Period 2||9||
48684620|NCT03012334|102013062|FG006|COMPLETED|Period 2||9||
48684621|NCT03012334|102013063|FG007|COMPLETED|Period 2||8||
48252565|NCT00997932|100936803|FG000|COMPLETED|Overall Study||27||
48252566|NCT00997932|100936803|FG000|NOT COMPLETED|Overall Study||2||
48379339|NCT00625365|101256089|FG000|STARTED|Overall Study||1060||
48379340|NCT00625365|101256089|FG000|COMPLETED|Overall Study||1053||
48379341|NCT00625365|101256089|FG000|NOT COMPLETED|Overall Study||7||
48379342|NCT03453151|101256090|FG000|STARTED|Overall Study||19||
48379343|NCT03453151|101256090|FG000|COMPLETED|Overall Study||15||
48379344|NCT03453151|101256090|FG000|NOT COMPLETED|Overall Study||4||
48379345|NCT00364845|101256091|FG000|STARTED|Overall Study||28||
48379346|NCT00364845|101256092|FG001|STARTED|Overall Study||23||
48379347|NCT00364845|101256091|FG000|COMPLETED|Overall Study||17||
48379348|NCT00364845|101256092|FG001|COMPLETED|Overall Study||12||
48379349|NCT00364845|101256091|FG000|NOT COMPLETED|Overall Study||11||
48379350|NCT00364845|101256092|FG001|NOT COMPLETED|Overall Study||11||
48684622|NCT03012334|102013064|FG008|COMPLETED|Period 2||9||
48684623|NCT03012334|102013065|FG009|COMPLETED|Period 2||8||
48684624|NCT03012334|102013056|FG000|NOT COMPLETED|Period 2||0||
48252567|NCT01145417|100936804|FG000|STARTED|Overall Study||108||
48252568|NCT01145417|100936805|FG001|STARTED|Overall Study||109||
48252569|NCT01145417|100936804|FG000|COMPLETED|Overall Study||67||
48252570|NCT01145417|100936805|FG001|COMPLETED|Overall Study||62||
48252571|NCT01145417|100936804|FG000|NOT COMPLETED|Overall Study||41||
48252572|NCT01145417|100936805|FG001|NOT COMPLETED|Overall Study||47||
48252573|NCT00899379|100936806|FG000|STARTED|Overall Study||95||
48252574|NCT00899379|100936807|FG001|STARTED|Overall Study||95||
48252575|NCT00899379|100936808|FG002|STARTED|Overall Study||95||
48252576|NCT00899379|100936809|FG003|STARTED|Overall Study||94||
48252577|NCT00899379|100936810|FG004|STARTED|Overall Study||94||
48252578|NCT00899379|100936806|FG000|Patients Treated|Overall Study||83||
48252579|NCT00899379|100936807|FG001|Patients Treated|Overall Study||82||
48684625|NCT03012334|102013057|FG001|NOT COMPLETED|Period 2||1||
48684626|NCT03012334|102013058|FG002|NOT COMPLETED|Period 2||1||
48684627|NCT03012334|102013059|FG003|NOT COMPLETED|Period 2||0||
48684628|NCT03012334|102013060|FG004|NOT COMPLETED|Period 2||0||
48684629|NCT03012334|102013061|FG005|NOT COMPLETED|Period 2||0||
48684630|NCT03012334|102013062|FG006|NOT COMPLETED|Period 2||0||
48684631|NCT03012334|102013063|FG007|NOT COMPLETED|Period 2||1||
48684632|NCT03012334|102013064|FG008|NOT COMPLETED|Period 2||0||
48684633|NCT03012334|102013065|FG009|NOT COMPLETED|Period 2||0||
48684634|NCT03012334|102013056|FG000|STARTED|Period 3||9||
48684635|NCT03012334|102013057|FG001|STARTED|Period 3||8||
48684636|NCT03012334|102013058|FG002|STARTED|Period 3||8||
48684637|NCT03012334|102013059|FG003|STARTED|Period 3||9||
48684638|NCT03012334|102013060|FG004|STARTED|Period 3||9||
48684639|NCT03012334|102013061|FG005|STARTED|Period 3||9||
48684640|NCT03012334|102013062|FG006|STARTED|Period 3||9||
48684641|NCT03012334|102013063|FG007|STARTED|Period 3||8||
48684642|NCT03012334|102013064|FG008|STARTED|Period 3||9||
48684643|NCT03012334|102013065|FG009|STARTED|Period 3||8||
48252580|NCT00899379|100936808|FG002|Patients Treated|Overall Study||84||
48252581|NCT00899379|100936809|FG003|Patients Treated|Overall Study||77||
48252582|NCT00899379|100936810|FG004|Patients Treated|Overall Study||81||
48252583|NCT00899379|100936806|FG000|Patients Not Treated|Overall Study||12||
48252584|NCT00899379|100936807|FG001|Patients Not Treated|Overall Study||13||
48252585|NCT00899379|100936808|FG002|Patients Not Treated|Overall Study||11||
48379351|NCT02653976|101256093|FG000|STARTED|Overall Study||65||
48379352|NCT02653976|101256093|FG000|COMPLETED|Overall Study||56||
48592685|NCT01877382|101783157|FG007|COMPLETED|Dose Expansion||0||
48252586|NCT00899379|100936809|FG003|Patients Not Treated|Overall Study||17||
48252587|NCT00899379|100936810|FG004|Patients Not Treated|Overall Study||13||
48379353|NCT02653976|101256093|FG000|NOT COMPLETED|Overall Study||9||
48379354|NCT02940626|101256094|FG000|STARTED|Overall Study||77|Population = Intent to treat (ITT)|
48684644|NCT03012334|102013056|FG000|COMPLETED|Period 3||9||
48684645|NCT03012334|102013057|FG001|COMPLETED|Period 3||8||
48684646|NCT03012334|102013058|FG002|COMPLETED|Period 3||8||
48684647|NCT03012334|102013059|FG003|COMPLETED|Period 3||9||
48684648|NCT03012334|102013060|FG004|COMPLETED|Period 3||9||
48684649|NCT03012334|102013061|FG005|COMPLETED|Period 3||9||
48684650|NCT03012334|102013062|FG006|COMPLETED|Period 3||9||
48684651|NCT03012334|102013063|FG007|COMPLETED|Period 3||8||
48684652|NCT03012334|102013064|FG008|COMPLETED|Period 3||9||
48379355|NCT02940626|101256095|FG001|STARTED|Overall Study||78|Population = Intent to treat (ITT)|
48379356|NCT02940626|101256094|FG000|Randomized Into Primary Prevention Study|Overall Study||77||
48684653|NCT03012334|102013065|FG009|COMPLETED|Period 3||8||
48684654|NCT03012334|102013056|FG000|NOT COMPLETED|Period 3||0||
48684655|NCT03012334|102013057|FG001|NOT COMPLETED|Period 3||0||
48684656|NCT03012334|102013058|FG002|NOT COMPLETED|Period 3||0||
48684657|NCT03012334|102013059|FG003|NOT COMPLETED|Period 3||0||
48684658|NCT03012334|102013060|FG004|NOT COMPLETED|Period 3||0||
48379357|NCT02940626|101256095|FG001|Randomized Into Primary Prevention Study|Overall Study||77||
48379358|NCT02940626|101256094|FG000|Randomized Into Treatment Sub-study|Overall Study||0|Single subject randomized/treated (placebo) in pneumonia treatment sub-study before trial terminated|
48379359|NCT02940626|101256095|FG001|Randomized Into Treatment Sub-study|Overall Study||1|Single subject randomized/treated (placebo) in pneumonia treatment sub-study before trial terminated|
48379360|NCT02940626|101256094|FG000|Received Study Treatment|Overall Study||77|Of the 77 subjects in the placebo arm, 76 were in primary prevention study, 1 in treatment sub-study|
48379361|NCT02940626|101256095|FG001|Received Study Treatment|Overall Study||77|Of the 77 subjects in the placebo arm, 76 were in primary prevention study, 1 in treatment sub-study|
48379362|NCT02940626|101256094|FG000|Completed Through Study Day 22|Overall Study||42||
48379363|NCT02940626|101256095|FG001|Completed Through Study Day 22|Overall Study||49||
48379364|NCT02940626|101256094|FG000|COMPLETED|Overall Study||30||
48379365|NCT02940626|101256095|FG001|COMPLETED|Overall Study||43||
48379366|NCT02940626|101256094|FG000|NOT COMPLETED|Overall Study||47||
48379367|NCT02940626|101256095|FG001|NOT COMPLETED|Overall Study||35||
48379368|NCT01976819|101256096|FG000|STARTED|Overall Study||16||
48684659|NCT03012334|102013061|FG005|NOT COMPLETED|Period 3||0||
48684660|NCT03012334|102013062|FG006|NOT COMPLETED|Period 3||0||
48684661|NCT03012334|102013063|FG007|NOT COMPLETED|Period 3||0||
48684662|NCT03012334|102013064|FG008|NOT COMPLETED|Period 3||0||
48684663|NCT03012334|102013065|FG009|NOT COMPLETED|Period 3||0||
48684664|NCT03012334|102013056|FG000|STARTED|Period 4||9||
48684665|NCT03012334|102013057|FG001|STARTED|Period 4||8||
48684666|NCT03012334|102013058|FG002|STARTED|Period 4||8||
48684667|NCT03012334|102013059|FG003|STARTED|Period 4||9||
48684668|NCT03012334|102013060|FG004|STARTED|Period 4||9||
48684669|NCT03012334|102013061|FG005|STARTED|Period 4||9||
48379369|NCT01976819|101256096|FG000|COMPLETED|Overall Study||11||
48379370|NCT01976819|101256096|FG000|NOT COMPLETED|Overall Study||5||
48379371|NCT02938585|101256097|FG000|STARTED|Overall Study||9||
48379372|NCT02938585|101256098|FG001|STARTED|Overall Study||33||
48379373|NCT02938585|101256099|FG002|STARTED|Overall Study||11||
48379374|NCT02938585|101256100|FG003|STARTED|Overall Study||15||
48379375|NCT02938585|101256097|FG000|Exposed to Prophylaxis Regimen|Overall Study||9|As participants were allowed to change regimen in EXT phase, some participants were exposed to both|
48379376|NCT02938585|101256098|FG001|Exposed to Prophylaxis Regimen|Overall Study||31|As participants were allowed to change regimen in EXT phase, some participants were exposed to both|
48379377|NCT02938585|101256099|FG002|Exposed to Prophylaxis Regimen|Overall Study||11|As participants were allowed to change regimen in EXT phase, some participants were exposed to both|
48379378|NCT02938585|101256100|FG003|Exposed to Prophylaxis Regimen|Overall Study||12|As participants were allowed to change regimen in EXT phase, some participants were exposed to both|
48684670|NCT03012334|102013062|FG006|STARTED|Period 4||9||
48684671|NCT03012334|102013063|FG007|STARTED|Period 4||8||
48684672|NCT03012334|102013064|FG008|STARTED|Period 4||9||
48684673|NCT03012334|102013065|FG009|STARTED|Period 4||8||
48684674|NCT03012334|102013056|FG000|COMPLETED|Period 4||9||
48684675|NCT03012334|102013057|FG001|COMPLETED|Period 4||8||
48089386|NCT01824394|100541159|FG002|COMPLETED|Overall Study||51|All enrolled subjects who underwent insertion of the study catheter|
48684676|NCT03012334|102013058|FG002|COMPLETED|Period 4||8||
48684677|NCT03012334|102013059|FG003|COMPLETED|Period 4||9||
48684678|NCT03012334|102013060|FG004|COMPLETED|Period 4||9||
48089387|NCT01824394|100541157|FG000|NOT COMPLETED|Overall Study||119||
48684679|NCT03012334|102013061|FG005|COMPLETED|Period 4||9||
48252588|NCT00899379|100936806|FG000|COMPLETED|Overall Study||61||
48252589|NCT00899379|100936807|FG001|COMPLETED|Overall Study||66||
48252590|NCT00899379|100936808|FG002|COMPLETED|Overall Study||66||
48252591|NCT00899379|100936809|FG003|COMPLETED|Overall Study||57||
48252592|NCT00899379|100936810|FG004|COMPLETED|Overall Study||63||
48252593|NCT00899379|100936806|FG000|NOT COMPLETED|Overall Study||34||
48252594|NCT00899379|100936807|FG001|NOT COMPLETED|Overall Study||29||
48252595|NCT00899379|100936808|FG002|NOT COMPLETED|Overall Study||29||
48252596|NCT00899379|100936809|FG003|NOT COMPLETED|Overall Study||37||
48252597|NCT00899379|100936810|FG004|NOT COMPLETED|Overall Study||31||
48379379|NCT02938585|101256097|FG000|Exposed to On-demand Regimen|Overall Study||1|As participants were allowed to change regimen in EXT phase, some participants were exposed to both|
48379380|NCT02938585|101256098|FG001|Exposed to On-demand Regimen|Overall Study||7|As participants were allowed to change regimen in EXT phase, some participants were exposed to both|
48379381|NCT02938585|101256099|FG002|Exposed to On-demand Regimen|Overall Study||1|As participants were allowed to change regimen in EXT phase, some participants were exposed to both|
48379382|NCT02938585|101256100|FG003|Exposed to On-demand Regimen|Overall Study||8|As participants were allowed to change regimen in EXT phase, some participants were exposed to both|
48379383|NCT02938585|101256097|FG000|COMPLETED|Overall Study||9||
48379384|NCT02938585|101256098|FG001|COMPLETED|Overall Study||32||
48379385|NCT02938585|101256099|FG002|COMPLETED|Overall Study||11||
48379386|NCT02938585|101256100|FG003|COMPLETED|Overall Study||10||
48379387|NCT02938585|101256097|FG000|NOT COMPLETED|Overall Study||0||
48379388|NCT02938585|101256098|FG001|NOT COMPLETED|Overall Study||1||
48379389|NCT02938585|101256099|FG002|NOT COMPLETED|Overall Study||0||
48379390|NCT02938585|101256100|FG003|NOT COMPLETED|Overall Study||5||
48541298|NCT03787134|101662701|FG004|Outcome 4 - Component Loadings|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541299|NCT03787134|101662702|FG005|Outcome 4 - Component Loadings|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541300|NCT03787134|101662703|FG006|Outcome 4 - Component Loadings|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541301|NCT03787134|101662697|FG000|Outcome 9 - Alpha Band Power|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541302|NCT03787134|101662698|FG001|Outcome 9 - Alpha Band Power|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541303|NCT03787134|101662699|FG002|Outcome 9 - Alpha Band Power|Overall Study||19|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541304|NCT03787134|101662700|FG003|Outcome 9 - Alpha Band Power|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541305|NCT03787134|101662701|FG004|Outcome 9 - Alpha Band Power|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541306|NCT03787134|101662702|FG005|Outcome 9 - Alpha Band Power|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541307|NCT03787134|101662703|FG006|Outcome 9 - Alpha Band Power|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541308|NCT03787134|101662697|FG000|Outcome 12 - Behavioral Accuracy (Mean Recall Error)|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541309|NCT03787134|101662698|FG001|Outcome 12 - Behavioral Accuracy (Mean Recall Error)|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541310|NCT03787134|101662699|FG002|Outcome 12 - Behavioral Accuracy (Mean Recall Error)|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48592686|NCT01877382|101783158|FG008|COMPLETED|Dose Expansion||0||
48592687|NCT01877382|101783159|FG009|COMPLETED|Dose Expansion||0||
48252598|NCT00506922|100936811|FG000|STARTED|Overall Study||37||
48252599|NCT00506922|100936812|FG001|STARTED|Overall Study||10||
48252600|NCT00506922|100936813|FG002|STARTED|Overall Study||29||
48252601|NCT00506922|100936814|FG003|STARTED|Overall Study||63||
48252602|NCT00506922|100936815|FG004|STARTED|Overall Study||11||
48252603|NCT00506922|100936811|FG000|COMPLETED|Overall Study||37||
48252604|NCT00506922|100936812|FG001|COMPLETED|Overall Study||10||
48252605|NCT00506922|100936813|FG002|COMPLETED|Overall Study||29||
48252606|NCT00506922|100936814|FG003|COMPLETED|Overall Study||61||
48252607|NCT00506922|100936815|FG004|COMPLETED|Overall Study||10||
48252608|NCT00506922|100936811|FG000|NOT COMPLETED|Overall Study||0||
48252609|NCT00506922|100936812|FG001|NOT COMPLETED|Overall Study||0||
48252610|NCT00506922|100936813|FG002|NOT COMPLETED|Overall Study||0||
48379391|NCT02330549|101256101|FG000|STARTED|Overall Study||20||
48252611|NCT00506922|100936814|FG003|NOT COMPLETED|Overall Study||2||
48252612|NCT00506922|100936815|FG004|NOT COMPLETED|Overall Study||1||
48252613|NCT02158247|100936816|FG000|STARTED|Overall Study||181||
48252614|NCT02158247|100936816|FG000|COMPLETED|Overall Study||176||
48252615|NCT02158247|100936816|FG000|NOT COMPLETED|Overall Study||5||
48252616|NCT02046941|100936817|FG000|STARTED|Overall Study||17||
48252617|NCT02046941|100936817|FG000|COMPLETED|Overall Study||10||
48252618|NCT02046941|100936817|FG000|NOT COMPLETED|Overall Study||7||
48684680|NCT03012334|102013062|FG006|COMPLETED|Period 4||8||
48684681|NCT03012334|102013063|FG007|COMPLETED|Period 4||8||
48684682|NCT03012334|102013064|FG008|COMPLETED|Period 4||8||
48684683|NCT03012334|102013065|FG009|COMPLETED|Period 4||8||
48684684|NCT03012334|102013056|FG000|NOT COMPLETED|Period 4||0||
48684685|NCT03012334|102013057|FG001|NOT COMPLETED|Period 4||0||
48684686|NCT03012334|102013058|FG002|NOT COMPLETED|Period 4||0||
48684687|NCT03012334|102013059|FG003|NOT COMPLETED|Period 4||0||
48684688|NCT03012334|102013060|FG004|NOT COMPLETED|Period 4||0||
48684689|NCT03012334|102013061|FG005|NOT COMPLETED|Period 4||0||
48684690|NCT03012334|102013062|FG006|NOT COMPLETED|Period 4||1||
48684691|NCT03012334|102013063|FG007|NOT COMPLETED|Period 4||0||
48089388|NCT01824394|100541158|FG001|NOT COMPLETED|Overall Study||116||
48089389|NCT01824394|100541159|FG002|NOT COMPLETED|Overall Study||74||
48089390|NCT04128267|100541160|FG000|STARTED|Overall Study||32||
48089391|NCT04128267|100541160|FG000|COMPLETED|Overall Study||17||
48089392|NCT04128267|100541160|FG000|NOT COMPLETED|Overall Study||15||
48089393|NCT00612924|100541161|FG000|STARTED|Overall Study||101||
48089394|NCT00612924|100541162|FG001|STARTED|Overall Study||94||
48089395|NCT00612924|100541161|FG000|COMPLETED|Overall Study||94||
48089396|NCT00612924|100541162|FG001|COMPLETED|Overall Study||85||
48089397|NCT00612924|100541161|FG000|NOT COMPLETED|Overall Study||7||
48089398|NCT00612924|100541162|FG001|NOT COMPLETED|Overall Study||9||
48089399|NCT00881712|100541163|FG000|STARTED|Overall Study||15||
48089400|NCT00881712|100541164|FG001|STARTED|Overall Study||0||
48089401|NCT00881712|100541165|FG002|STARTED|Overall Study||0||
48089402|NCT00881712|100541163|FG000|COMPLETED|Overall Study||13||
48089403|NCT00881712|100541164|FG001|COMPLETED|Overall Study||0||
48089404|NCT00881712|100541165|FG002|COMPLETED|Overall Study||0||
48089405|NCT00881712|100541163|FG000|NOT COMPLETED|Overall Study||2||
48089406|NCT00881712|100541164|FG001|NOT COMPLETED|Overall Study||0||
48089407|NCT00881712|100541165|FG002|NOT COMPLETED|Overall Study||0||
48089408|NCT02999854|100541166|FG000|STARTED|Active Study Phase (up to 18 Months)||32||
48089409|NCT02999854|100541167|FG001|STARTED|Active Study Phase (up to 18 Months)||31||
48089410|NCT02999854|100541166|FG000|COMPLETED|Active Study Phase (up to 18 Months)||8||
48089411|NCT02999854|100541167|FG001|COMPLETED|Active Study Phase (up to 18 Months)||22||
48089412|NCT02999854|100541166|FG000|NOT COMPLETED|Active Study Phase (up to 18 Months)||24||
48089413|NCT02999854|100541167|FG001|NOT COMPLETED|Active Study Phase (up to 18 Months)||9||
48089414|NCT02999854|100541166|FG000|STARTED|Long Term Safety FU (up to 24 Months)||8||
48089415|NCT02999854|100541167|FG001|STARTED|Long Term Safety FU (up to 24 Months)||22||
48089416|NCT02999854|100541166|FG000|COMPLETED|Long Term Safety FU (up to 24 Months)||5||
48089417|NCT02999854|100541167|FG001|COMPLETED|Long Term Safety FU (up to 24 Months)||19||
48089418|NCT02999854|100541166|FG000|NOT COMPLETED|Long Term Safety FU (up to 24 Months)||3||
48089419|NCT02999854|100541167|FG001|NOT COMPLETED|Long Term Safety FU (up to 24 Months)||3||
48089420|NCT00736723|100541168|FG000|STARTED|Overall Study||30||
48089421|NCT00736723|100541169|FG001|STARTED|Overall Study||21||
48089422|NCT00736723|100541168|FG000|COMPLETED|Overall Study||26||
48089423|NCT00736723|100541169|FG001|COMPLETED|Overall Study||18||
48089424|NCT00736723|100541168|FG000|NOT COMPLETED|Overall Study||4||
48089425|NCT00736723|100541169|FG001|NOT COMPLETED|Overall Study||3||
48089426|NCT04772755|100541170|FG000|STARTED|Overall Study||170||
48089427|NCT04772755|100541171|FG001|STARTED|Overall Study||168||
48089428|NCT04772755|100541170|FG000|COMPLETED|Overall Study||167||
48089429|NCT04772755|100541171|FG001|COMPLETED|Overall Study||165||
48089430|NCT04772755|100541170|FG000|NOT COMPLETED|Overall Study||3||
48089431|NCT04772755|100541171|FG001|NOT COMPLETED|Overall Study||3||
48089432|NCT00426855|100541172|FG000|STARTED|Overall Study||12||
48089433|NCT00426855|100541172|FG000|COMPLETED|Overall Study||12||
48089434|NCT00426855|100541172|FG000|NOT COMPLETED|Overall Study||0||
48089435|NCT01493570|100541173|FG000|STARTED|Overall Study||4||
48089436|NCT01493570|100541174|FG001|STARTED|Overall Study||4||
48089437|NCT01493570|100541175|FG002|STARTED|Overall Study||4||
48089438|NCT01493570|100541176|FG003|STARTED|Overall Study||4||
48089439|NCT01493570|100541177|FG004|STARTED|Overall Study||4||
48089440|NCT01493570|100541173|FG000|COMPLETED|Overall Study||4||
48089441|NCT01493570|100541174|FG001|COMPLETED|Overall Study||4||
48089442|NCT01493570|100541175|FG002|COMPLETED|Overall Study||4||
48089443|NCT01493570|100541176|FG003|COMPLETED|Overall Study||4||
48089444|NCT01493570|100541177|FG004|COMPLETED|Overall Study||4||
48089445|NCT01493570|100541173|FG000|NOT COMPLETED|Overall Study||0||
48089446|NCT01493570|100541174|FG001|NOT COMPLETED|Overall Study||0||
48089447|NCT01493570|100541175|FG002|NOT COMPLETED|Overall Study||0||
48089448|NCT01493570|100541176|FG003|NOT COMPLETED|Overall Study||0||
48089449|NCT01493570|100541177|FG004|NOT COMPLETED|Overall Study||0||
48089450|NCT00459667|100541178|FG000|STARTED|Overall Study||592||
48089451|NCT00459667|100541179|FG001|STARTED|Overall Study||647||
48252619|NCT00088452|100936818|FG000|STARTED|Overall Study||156||
48684692|NCT03012334|102013064|FG008|NOT COMPLETED|Period 4||1||
48684693|NCT03012334|102013065|FG009|NOT COMPLETED|Period 4||0||
48252620|NCT00088452|100936819|FG001|STARTED|Overall Study||149||
48252621|NCT00088452|100936820|FG002|STARTED|Overall Study||148||
48252622|NCT00088452|100936818|FG000|COMPLETED|Overall Study||155||
48252623|NCT00088452|100936819|FG001|COMPLETED|Overall Study||149||
48252624|NCT00088452|100936820|FG002|COMPLETED|Overall Study||147||
48252625|NCT00088452|100936818|FG000|NOT COMPLETED|Overall Study||1||
48252626|NCT00088452|100936819|FG001|NOT COMPLETED|Overall Study||0||
48252627|NCT00088452|100936820|FG002|NOT COMPLETED|Overall Study||1||
48252628|NCT02396953|100936821|FG000|STARTED|Overall Study||9||
48252629|NCT02396953|100936822|FG001|STARTED|Overall Study||9||
48252630|NCT02396953|100936823|FG002|STARTED|Overall Study||10||
48252631|NCT02396953|100936821|FG000|COMPLETED|Overall Study||5||
48252632|NCT02396953|100936822|FG001|COMPLETED|Overall Study||6||
48252633|NCT02396953|100936823|FG002|COMPLETED|Overall Study||7||
48252634|NCT02396953|100936821|FG000|NOT COMPLETED|Overall Study||4||
48252635|NCT02396953|100936822|FG001|NOT COMPLETED|Overall Study||3||
48684694|NCT03012334|102013056|FG000|STARTED|Period 5||9||
48684695|NCT03012334|102013057|FG001|STARTED|Period 5||8||
48089452|NCT00459667|100541180|FG002|STARTED|Overall Study||181||
48252636|NCT02396953|100936823|FG002|NOT COMPLETED|Overall Study||3||
48252637|NCT00695136|100936824|FG000|STARTED|Overall Study||7||
48252638|NCT00695136|100936824|FG000|COMPLETED|Overall Study||5||
48252639|NCT00695136|100936824|FG000|NOT COMPLETED|Overall Study||2||
48252640|NCT03807700|100936825|FG000|STARTED|Overall Study||60||
48252641|NCT03807700|100936826|FG001|STARTED|Overall Study||59||
48252642|NCT03807700|100936825|FG000|COMPLETED|Overall Study||58||
48252643|NCT03807700|100936826|FG001|COMPLETED|Overall Study||58||
48252644|NCT03807700|100936825|FG000|NOT COMPLETED|Overall Study||2||
48252645|NCT03807700|100936826|FG001|NOT COMPLETED|Overall Study||1||
48252646|NCT00498433|100936827|FG000|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10||
48252647|NCT00498433|100936828|FG001|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0||
48252648|NCT00498433|100936829|FG002|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0||
48252649|NCT00498433|100936827|FG000|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10||
48252650|NCT00498433|100936828|FG001|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0||
48252651|NCT00498433|100936829|FG002|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0||
48252652|NCT00498433|100936827|FG000|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0||
48252653|NCT00498433|100936828|FG001|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0||
48089453|NCT00459667|100541178|FG000|Study Medication Dispensed|Overall Study||586||
48089454|NCT00459667|100541179|FG001|Study Medication Dispensed|Overall Study||645||
48379392|NCT02330549|101256102|FG001|STARTED|Overall Study||25||
48379393|NCT02330549|101256101|FG000|COMPLETED|Overall Study||16||
48379394|NCT02330549|101256102|FG001|COMPLETED|Overall Study||24||
48379395|NCT02330549|101256101|FG000|NOT COMPLETED|Overall Study||4||
48379396|NCT02330549|101256102|FG001|NOT COMPLETED|Overall Study||1||
48379397|NCT03976531|101256103|FG000|STARTED|Overall Study||42||
48089455|NCT00459667|100541180|FG002|Study Medication Dispensed|Overall Study||180||
48089456|NCT00459667|100541178|FG000|Started Treatment|Overall Study||586||
48089457|NCT00459667|100541179|FG001|Started Treatment|Overall Study||644||
48089458|NCT00459667|100541180|FG002|Started Treatment|Overall Study||180||
48252654|NCT00498433|100936829|FG002|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0||
48252655|NCT00498433|100936827|FG000|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0||
48252656|NCT00498433|100936828|FG001|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||10||
48252657|NCT00498433|100936829|FG002|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0||
48252658|NCT00498433|100936827|FG000|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0||
48252659|NCT00498433|100936828|FG001|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||10||
48252660|NCT00498433|100936829|FG002|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0||
48252661|NCT00498433|100936827|FG000|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0||
48252662|NCT00498433|100936828|FG001|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0||
48252663|NCT00498433|100936829|FG002|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0||
48379398|NCT03976531|101256103|FG000|COMPLETED|Overall Study||42||
48379399|NCT03976531|101256103|FG000|NOT COMPLETED|Overall Study||0||
48379400|NCT00786032|101256104|FG000|STARTED|Overall Study||27||
48379401|NCT00786032|101256104|FG000|Independent Users|Overall Study||14||
48379402|NCT00786032|101256104|FG000|COMPLETED|Overall Study||3||
48379403|NCT00786032|101256104|FG000|NOT COMPLETED|Overall Study||24||
48379404|NCT01848054|101256105|FG000|STARTED|Induction Phase||155||
48379405|NCT01848054|101256106|FG001|STARTED|Induction Phase||155||
48379406|NCT01848054|101256105|FG000|COMPLETED|Induction Phase||132||
48379407|NCT01848054|101256106|FG001|COMPLETED|Induction Phase||147||
48379408|NCT01848054|101256105|FG000|NOT COMPLETED|Induction Phase||23||
48379409|NCT01848054|101256106|FG001|NOT COMPLETED|Induction Phase||8||
48541311|NCT03787134|101662700|FG003|Outcome 12 - Behavioral Accuracy (Mean Recall Error)|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48592688|NCT01877382|101783160|FG010|COMPLETED|Dose Expansion||0||
48592689|NCT01877382|101783161|FG011|COMPLETED|Dose Expansion||0||
48592690|NCT01877382|101783162|FG012|COMPLETED|Dose Expansion||0||
48379410|NCT01848054|101256105|FG000|STARTED|Stabilization/Maintenance||132||
48379411|NCT01848054|101256106|FG001|STARTED|Stabilization/Maintenance||147||
48379412|NCT01848054|101256105|FG000|COMPLETED|Stabilization/Maintenance||92||
48089459|NCT00459667|100541178|FG000|COMPLETED|Overall Study||554||
48089460|NCT00459667|100541179|FG001|COMPLETED|Overall Study||600||
48089461|NCT00459667|100541180|FG002|COMPLETED|Overall Study||161||
48089462|NCT00459667|100541178|FG000|NOT COMPLETED|Overall Study||38||
48089463|NCT00459667|100541179|FG001|NOT COMPLETED|Overall Study||47||
48089464|NCT00459667|100541180|FG002|NOT COMPLETED|Overall Study||20||
48089465|NCT00139399|100541181|FG000|STARTED|Overall Study||60||
48089466|NCT00139399|100541182|FG001|STARTED|Overall Study||82||
48089467|NCT00139399|100541181|FG000|COMPLETED|Overall Study||44||
48089468|NCT00139399|100541182|FG001|COMPLETED|Overall Study||59||
48089469|NCT00139399|100541181|FG000|NOT COMPLETED|Overall Study||16||
48089470|NCT00139399|100541182|FG001|NOT COMPLETED|Overall Study||23||
48089471|NCT00726661|100541183|FG000|STARTED|Overall Study||832||
48089472|NCT00726661|100541184|FG001|STARTED|Overall Study||435||
48089473|NCT00726661|100541183|FG000|COMPLETED|Overall Study||18||
48089474|NCT00726661|100541184|FG001|COMPLETED|Overall Study||17||
48089475|NCT00726661|100541183|FG000|NOT COMPLETED|Overall Study||814||
48089476|NCT00726661|100541184|FG001|NOT COMPLETED|Overall Study||418||
48089477|NCT01354951|100541185|FG000|STARTED|Overall Study||3||
48089478|NCT01354951|100541185|FG000|COMPLETED|Overall Study||1||
48089479|NCT01354951|100541185|FG000|NOT COMPLETED|Overall Study||2||
48089480|NCT03305822|100541186|FG000|STARTED|Period 1||20||
48089481|NCT03305822|100541187|FG001|STARTED|Period 1||18||
48089482|NCT03305822|100541186|FG000|Received at Least 1 Dose of Study Drug|Period 1||20||
48089483|NCT03305822|100541187|FG001|Received at Least 1 Dose of Study Drug|Period 1||18||
48089484|NCT03305822|100541186|FG000|COMPLETED|Period 1||20||
48089485|NCT03305822|100541187|FG001|COMPLETED|Period 1||18||
48089486|NCT03305822|100541186|FG000|NOT COMPLETED|Period 1||0||
48089487|NCT03305822|100541187|FG001|NOT COMPLETED|Period 1||0||
48089488|NCT03305822|100541186|FG000|STARTED|Washout||20||
48089489|NCT03305822|100541187|FG001|STARTED|Washout||18||
48089490|NCT03305822|100541186|FG000|COMPLETED|Washout||20||
48089491|NCT03305822|100541187|FG001|COMPLETED|Washout||18||
48089492|NCT03305822|100541186|FG000|NOT COMPLETED|Washout||0||
48684696|NCT03012334|102013058|FG002|STARTED|Period 5||8||
48684697|NCT03012334|102013059|FG003|STARTED|Period 5||9||
48684698|NCT03012334|102013060|FG004|STARTED|Period 5||9||
48684699|NCT03012334|102013061|FG005|STARTED|Period 5||9||
48684700|NCT03012334|102013062|FG006|STARTED|Period 5||8||
48684701|NCT03012334|102013063|FG007|STARTED|Period 5||8||
48684702|NCT03012334|102013064|FG008|STARTED|Period 5||8||
48684703|NCT03012334|102013065|FG009|STARTED|Period 5||8||
48684704|NCT03012334|102013056|FG000|COMPLETED|Period 5||9||
48684705|NCT03012334|102013057|FG001|COMPLETED|Period 5||8||
48684706|NCT03012334|102013058|FG002|COMPLETED|Period 5||8||
48684707|NCT03012334|102013059|FG003|COMPLETED|Period 5||9||
48684708|NCT03012334|102013060|FG004|COMPLETED|Period 5||9||
48684709|NCT03012334|102013061|FG005|COMPLETED|Period 5||9||
48684710|NCT03012334|102013062|FG006|COMPLETED|Period 5||8||
48684711|NCT03012334|102013063|FG007|COMPLETED|Period 5||8||
48684712|NCT03012334|102013064|FG008|COMPLETED|Period 5||8||
48684713|NCT03012334|102013065|FG009|COMPLETED|Period 5||8||
48684714|NCT03012334|102013056|FG000|NOT COMPLETED|Period 5||0||
48684715|NCT03012334|102013057|FG001|NOT COMPLETED|Period 5||0||
48684716|NCT03012334|102013058|FG002|NOT COMPLETED|Period 5||0||
48684717|NCT03012334|102013059|FG003|NOT COMPLETED|Period 5||0||
48684718|NCT03012334|102013060|FG004|NOT COMPLETED|Period 5||0||
48684719|NCT03012334|102013061|FG005|NOT COMPLETED|Period 5||0||
48684720|NCT03012334|102013062|FG006|NOT COMPLETED|Period 5||0||
48684721|NCT03012334|102013063|FG007|NOT COMPLETED|Period 5||0||
48684722|NCT03012334|102013064|FG008|NOT COMPLETED|Period 5||0||
48684723|NCT03012334|102013065|FG009|NOT COMPLETED|Period 5||0||
48684724|NCT00592631|102013066|FG000|STARTED|Overall Study||16||
48684725|NCT00592631|102013067|FG001|STARTED|Overall Study||11||
48684726|NCT00592631|102013066|FG000|COMPLETED|Overall Study||16||
48684727|NCT00592631|102013067|FG001|COMPLETED|Overall Study||9||
48684728|NCT00592631|102013066|FG000|NOT COMPLETED|Overall Study||0||
48089493|NCT03305822|100541187|FG001|NOT COMPLETED|Washout||0||
48089494|NCT03305822|100541186|FG000|STARTED|Period 2||20||
48379413|NCT01848054|101256106|FG001|COMPLETED|Stabilization/Maintenance||107||
48379414|NCT01848054|101256105|FG000|NOT COMPLETED|Stabilization/Maintenance||40||
48684729|NCT00592631|102013067|FG001|NOT COMPLETED|Overall Study||2||
48089495|NCT03305822|100541187|FG001|STARTED|Period 2||18||
48089496|NCT03305822|100541186|FG000|Received at Least 1 Dose of Study Drug|Period 2||20||
48089497|NCT03305822|100541187|FG001|Received at Least 1 Dose of Study Drug|Period 2||18||
48089498|NCT03305822|100541186|FG000|COMPLETED|Period 2||20||
48089499|NCT03305822|100541187|FG001|COMPLETED|Period 2||18||
48089500|NCT03305822|100541186|FG000|NOT COMPLETED|Period 2||0||
48089501|NCT03305822|100541187|FG001|NOT COMPLETED|Period 2||0||
48089502|NCT02625259|100541188|FG000|STARTED|First Intervention (Day 1)||11||
48684730|NCT00535769|102013068|FG000|STARTED|Overall Study||35||
48684731|NCT00535769|102013069|FG001|STARTED|Overall Study||35||
48684732|NCT00535769|102013068|FG000|COMPLETED|Overall Study||35||
48684733|NCT00535769|102013069|FG001|COMPLETED|Overall Study||35||
48684734|NCT00535769|102013068|FG000|NOT COMPLETED|Overall Study||0||
48684735|NCT00535769|102013069|FG001|NOT COMPLETED|Overall Study||0||
48684736|NCT01365793|102013070|FG000|STARTED|Overall Study||344||
48684737|NCT01365793|102013071|FG001|STARTED|Overall Study||351||
48684738|NCT01365793|102013072|FG002|STARTED|Overall Study||345||
48684739|NCT01365793|102013073|FG003|STARTED|Overall Study||349||
48684740|NCT01365793|102013070|FG000|COMPLETED|Overall Study||342||
48684741|NCT01365793|102013071|FG001|COMPLETED|Overall Study||344||
48684742|NCT01365793|102013072|FG002|COMPLETED|Overall Study||338||
48684743|NCT01365793|102013073|FG003|COMPLETED|Overall Study||347||
48684744|NCT01365793|102013070|FG000|NOT COMPLETED|Overall Study||2||
48684745|NCT01365793|102013071|FG001|NOT COMPLETED|Overall Study||7||
48684746|NCT01365793|102013072|FG002|NOT COMPLETED|Overall Study||7||
48684747|NCT01365793|102013073|FG003|NOT COMPLETED|Overall Study||2||
48684748|NCT01144143|102013074|FG000|STARTED|Overall Study||8||
48684749|NCT01144143|102013075|FG001|STARTED|Overall Study||4||
48684750|NCT01144143|102013076|FG002|STARTED|Overall Study||4||
48684751|NCT01144143|102013074|FG000|COMPLETED|Overall Study||8||
48684752|NCT01144143|102013075|FG001|COMPLETED|Overall Study||4||
48684753|NCT01144143|102013076|FG002|COMPLETED|Overall Study||4||
48684754|NCT01144143|102013074|FG000|NOT COMPLETED|Overall Study||0||
48684755|NCT01144143|102013075|FG001|NOT COMPLETED|Overall Study||0||
48684756|NCT01144143|102013076|FG002|NOT COMPLETED|Overall Study||0||
48684757|NCT01462929|102013077|FG000|STARTED|Overall Study||171||
48684758|NCT01462929|102013078|FG001|STARTED|Overall Study||158||
48684759|NCT01462929|102013079|FG002|STARTED|Overall Study||85||
48684760|NCT01462929|102013077|FG000|COMPLETED|Overall Study||166||
48684761|NCT01462929|102013078|FG001|COMPLETED|Overall Study||154||
48684762|NCT01462929|102013079|FG002|COMPLETED|Overall Study||80||
48684763|NCT01462929|102013077|FG000|NOT COMPLETED|Overall Study||5||
48684764|NCT01462929|102013078|FG001|NOT COMPLETED|Overall Study||4||
48684765|NCT01462929|102013079|FG002|NOT COMPLETED|Overall Study||5||
48684766|NCT00132301|102013080|FG000|STARTED|Overall Study||141||
48684767|NCT00132301|102013081|FG001|STARTED|Overall Study||157||
48684768|NCT00132301|102013080|FG000|COMPLETED|Overall Study||121|1 participant was excluded from all analysis by the DMC|
48684769|NCT00132301|102013081|FG001|COMPLETED|Overall Study||144|1 participant was excluded from all analysis by the DMC|
48684770|NCT00132301|102013080|FG000|NOT COMPLETED|Overall Study||20||
48684771|NCT00132301|102013081|FG001|NOT COMPLETED|Overall Study||13||
48684772|NCT02479880|102013082|FG000|STARTED|Overall Study||15||
48684773|NCT02479880|102013083|FG001|STARTED|Overall Study||15||
48684774|NCT02479880|102013082|FG000|COMPLETED|Overall Study||2||
48684775|NCT02479880|102013083|FG001|COMPLETED|Overall Study||2||
48684776|NCT02479880|102013082|FG000|NOT COMPLETED|Overall Study||13||
48684777|NCT02479880|102013083|FG001|NOT COMPLETED|Overall Study||13||
48684778|NCT03856359|102013084|FG000|STARTED|Overall Study||10||
48684779|NCT03856359|102013084|FG000|COMPLETED|Overall Study||9||
48684780|NCT03856359|102013084|FG000|NOT COMPLETED|Overall Study||1||
48684781|NCT01545765|102013085|FG000|STARTED|Overall Study||31||
48684782|NCT01545765|102013085|FG000|COMPLETED|Overall Study||31||
48684783|NCT01545765|102013085|FG000|NOT COMPLETED|Overall Study||0||
48684784|NCT02870985|102013086|FG000|STARTED|Overall Study||220||
48684785|NCT02870985|102013087|FG001|STARTED|Overall Study||220||
48684786|NCT02870985|102013086|FG000|COMPLETED|Overall Study||220||
48684787|NCT02870985|102013087|FG001|COMPLETED|Overall Study||220||
48252664|NCT00498433|100936827|FG000|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0||
48252665|NCT00498433|100936828|FG001|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0||
48252666|NCT00498433|100936829|FG002|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10||
48684788|NCT02870985|102013086|FG000|NOT COMPLETED|Overall Study||0||
48684789|NCT02870985|102013087|FG001|NOT COMPLETED|Overall Study||0||
48684790|NCT00413660|102013088|FG000|STARTED|Up To Week 12||71||
48684791|NCT00413660|102013089|FG001|STARTED|Up To Week 12||68||
48684792|NCT00413660|102013090|FG002|STARTED|Up To Week 12||71||
48252667|NCT00498433|100936827|FG000|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0||
48684793|NCT00413660|102013091|FG003|STARTED|Up To Week 12||75||
48684794|NCT00413660|102013092|FG004|STARTED|Up To Week 12||75||
48252668|NCT00498433|100936828|FG001|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0||
48252669|NCT00498433|100936829|FG002|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10||
48252670|NCT00498433|100936827|FG000|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0||
48252671|NCT00498433|100936828|FG001|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0||
48252672|NCT00498433|100936829|FG002|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0||
48684795|NCT00413660|102013093|FG005|STARTED|Up To Week 12||80||
48684796|NCT00413660|102013094|FG006|STARTED|Up To Week 12||69||
48684797|NCT00413660|102013095|FG007|STARTED|Up To Week 12||0||
48684798|NCT00413660|102013096|FG008|STARTED|Up To Week 12||0||
48684799|NCT00413660|102013097|FG009|STARTED|Up To Week 12||0||
48684800|NCT00413660|102013098|FG010|STARTED|Up To Week 12||0||
48684801|NCT00413660|102013088|FG000|Treated|Up To Week 12||70||
48684802|NCT00413660|102013089|FG001|Treated|Up To Week 12||68||
48684803|NCT00413660|102013090|FG002|Treated|Up To Week 12||71||
48684804|NCT00413660|102013091|FG003|Treated|Up To Week 12||74||
48684805|NCT00413660|102013092|FG004|Treated|Up To Week 12||75||
48684806|NCT00413660|102013093|FG005|Treated|Up To Week 12||80||
48684807|NCT00413660|102013094|FG006|Treated|Up To Week 12||69||
48684808|NCT00413660|102013095|FG007|Treated|Up To Week 12||0||
48684809|NCT00413660|102013096|FG008|Treated|Up To Week 12||0||
48684810|NCT00413660|102013097|FG009|Treated|Up To Week 12||0||
48684811|NCT00413660|102013098|FG010|Treated|Up To Week 12||0||
48684812|NCT00413660|102013088|FG000|COMPLETED|Up To Week 12||64||
48684813|NCT00413660|102013089|FG001|COMPLETED|Up To Week 12||61||
48684814|NCT00413660|102013090|FG002|COMPLETED|Up To Week 12||64||
48684815|NCT00413660|102013091|FG003|COMPLETED|Up To Week 12||67||
48684816|NCT00413660|102013092|FG004|COMPLETED|Up To Week 12||66||
48684817|NCT00413660|102013093|FG005|COMPLETED|Up To Week 12||70||
48684818|NCT00413660|102013094|FG006|COMPLETED|Up To Week 12||58||
48684819|NCT00413660|102013095|FG007|COMPLETED|Up To Week 12||0||
48684820|NCT00413660|102013096|FG008|COMPLETED|Up To Week 12||0||
48684821|NCT00413660|102013097|FG009|COMPLETED|Up To Week 12||0||
48684822|NCT00413660|102013098|FG010|COMPLETED|Up To Week 12||0||
48684823|NCT00413660|102013088|FG000|NOT COMPLETED|Up To Week 12||7||
48684824|NCT00413660|102013089|FG001|NOT COMPLETED|Up To Week 12||7||
48684825|NCT00413660|102013090|FG002|NOT COMPLETED|Up To Week 12||7||
48684826|NCT00413660|102013091|FG003|NOT COMPLETED|Up To Week 12||8||
48684827|NCT00413660|102013092|FG004|NOT COMPLETED|Up To Week 12||9||
48684828|NCT00413660|102013093|FG005|NOT COMPLETED|Up To Week 12||10||
48684829|NCT00413660|102013094|FG006|NOT COMPLETED|Up To Week 12||11||
48684830|NCT00413660|102013095|FG007|NOT COMPLETED|Up To Week 12||0||
48684831|NCT00413660|102013096|FG008|NOT COMPLETED|Up To Week 12||0||
48684832|NCT00413660|102013097|FG009|NOT COMPLETED|Up To Week 12||0||
48684833|NCT00413660|102013098|FG010|NOT COMPLETED|Up To Week 12||0||
48684834|NCT00413660|102013088|FG000|STARTED|Post Week 12||43||
48684835|NCT00413660|102013089|FG001|STARTED|Post Week 12||48||
48684836|NCT00413660|102013090|FG002|STARTED|Post Week 12||64||
48684837|NCT00413660|102013091|FG003|STARTED|Post Week 12||67||
48684838|NCT00413660|102013092|FG004|STARTED|Post Week 12||66||
48684839|NCT00413660|102013093|FG005|STARTED|Post Week 12||57||
48684840|NCT00413660|102013094|FG006|STARTED|Post Week 12||40||
48684841|NCT00413660|102013095|FG007|STARTED|Post Week 12||21||
48684842|NCT00413660|102013096|FG008|STARTED|Post Week 12||13||
48684843|NCT00413660|102013097|FG009|STARTED|Post Week 12||13||
48684844|NCT00413660|102013098|FG010|STARTED|Post Week 12||18||
48684845|NCT00413660|102013088|FG000|COMPLETED|Post Week 12||40||
48684846|NCT00413660|102013089|FG001|COMPLETED|Post Week 12||44||
48684847|NCT00413660|102013090|FG002|COMPLETED|Post Week 12||56||
48684848|NCT00413660|102013091|FG003|COMPLETED|Post Week 12||66||
48684849|NCT00413660|102013092|FG004|COMPLETED|Post Week 12||60||
48684850|NCT00413660|102013093|FG005|COMPLETED|Post Week 12||54||
48684851|NCT00413660|102013094|FG006|COMPLETED|Post Week 12||37||
48684852|NCT00413660|102013095|FG007|COMPLETED|Post Week 12||21||
48252673|NCT00498433|100936827|FG000|STARTED|Part 2: Placebo Run-in (2 Weeks)||36||
48252674|NCT00498433|100936828|FG001|STARTED|Part 2: Placebo Run-in (2 Weeks)||0||
48252675|NCT00498433|100936829|FG002|STARTED|Part 2: Placebo Run-in (2 Weeks)||0||
48252676|NCT00498433|100936827|FG000|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||16||
48252677|NCT00498433|100936828|FG001|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0||
48252678|NCT00498433|100936829|FG002|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0||
48252679|NCT00498433|100936827|FG000|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||20||
48252680|NCT00498433|100936828|FG001|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0||
48252681|NCT00498433|100936829|FG002|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0||
48252682|NCT00498433|100936827|FG000|STARTED|Part 2: Double Blind (12 Weeks)||0||
48252683|NCT00498433|100936828|FG001|STARTED|Part 2: Double Blind (12 Weeks)||8||
48252684|NCT00498433|100936829|FG002|STARTED|Part 2: Double Blind (12 Weeks)||8||
48684853|NCT00413660|102013096|FG008|COMPLETED|Post Week 12||13||
48684854|NCT00413660|102013097|FG009|COMPLETED|Post Week 12||12||
48684855|NCT00413660|102013098|FG010|COMPLETED|Post Week 12||17||
48684856|NCT00413660|102013088|FG000|NOT COMPLETED|Post Week 12||3||
48684857|NCT00413660|102013089|FG001|NOT COMPLETED|Post Week 12||4||
48684858|NCT00413660|102013090|FG002|NOT COMPLETED|Post Week 12||8||
48684859|NCT00413660|102013091|FG003|NOT COMPLETED|Post Week 12||1||
48684860|NCT00413660|102013092|FG004|NOT COMPLETED|Post Week 12||6||
48684861|NCT00413660|102013093|FG005|NOT COMPLETED|Post Week 12||3||
48684862|NCT00413660|102013094|FG006|NOT COMPLETED|Post Week 12||3||
48684863|NCT00413660|102013095|FG007|NOT COMPLETED|Post Week 12||0||
48684864|NCT00413660|102013096|FG008|NOT COMPLETED|Post Week 12||0||
48684865|NCT00413660|102013097|FG009|NOT COMPLETED|Post Week 12||1||
48684866|NCT00413660|102013098|FG010|NOT COMPLETED|Post Week 12||1||
48684867|NCT02607124|102013099|FG000|STARTED|Overall Study||10||
48684868|NCT02607124|102013099|FG000|COMPLETED|Overall Study||10||
48252685|NCT00498433|100936827|FG000|COMPLETED|Part 2: Double Blind (12 Weeks)||0||
48684869|NCT02607124|102013099|FG000|NOT COMPLETED|Overall Study||0||
48684870|NCT01465386|102013100|FG000|STARTED|Overall Study||6||
48684871|NCT01465386|102013100|FG000|COMPLETED|Overall Study||2||
48684872|NCT01465386|102013100|FG000|NOT COMPLETED|Overall Study||4||
48684873|NCT03693144|102013101|FG000|STARTED|Overall Study||7||
48684874|NCT03693144|102013102|FG001|STARTED|Overall Study||7||
48684875|NCT03693144|102013103|FG002|STARTED|Overall Study||5||
48684876|NCT03693144|102013101|FG000|COMPLETED|Overall Study||7|Completion = maintaining the app on their phone, or participating in an end-of-study interview, but as COVID shut down Fast Food Restaurants approximately four months after the first enrollment, no six-month data could be gathered from the app.|
48252686|NCT00498433|100936828|FG001|COMPLETED|Part 2: Double Blind (12 Weeks)||8||
48252687|NCT00498433|100936829|FG002|COMPLETED|Part 2: Double Blind (12 Weeks)||8||
48252688|NCT00498433|100936827|FG000|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0||
48252689|NCT00498433|100936828|FG001|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0||
48252690|NCT00498433|100936829|FG002|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0||
48252691|NCT01202409|100936830|FG000|STARTED|Overall Study||19||
48252692|NCT01202409|100936830|FG000|COMPLETED|Overall Study||11||
48252693|NCT01202409|100936830|FG000|NOT COMPLETED|Overall Study||8||
48252694|NCT03927222|100936831|FG000|STARTED|Overall Study||6||
48252695|NCT03927222|100936831|FG000|COMPLETED|Overall Study||0||
48252696|NCT03927222|100936831|FG000|NOT COMPLETED|Overall Study||6||
48252697|NCT00735462|100936832|FG000|STARTED|Overall Study||202||
48252698|NCT00735462|100936833|FG001|STARTED|Overall Study||204||
48252699|NCT00735462|100936834|FG002|STARTED|Overall Study||105||
48252700|NCT00735462|100936832|FG000|COMPLETED|Overall Study||139||
48252701|NCT00735462|100936833|FG001|COMPLETED|Overall Study||149||
48252702|NCT00735462|100936834|FG002|COMPLETED|Overall Study||77||
48252703|NCT00735462|100936832|FG000|NOT COMPLETED|Overall Study||63||
48252704|NCT00735462|100936833|FG001|NOT COMPLETED|Overall Study||55||
48252705|NCT00735462|100936834|FG002|NOT COMPLETED|Overall Study||28||
48252706|NCT00797511|100936835|FG000|STARTED|Overall Study||132||
48252707|NCT00797511|100936835|FG000|COMPLETED|Overall Study||131||
48252708|NCT00797511|100936835|FG000|NOT COMPLETED|Overall Study||1||
48252709|NCT02222337|100936836|FG000|STARTED|Overall Study||140||
48252710|NCT02222337|100936837|FG001|STARTED|Overall Study||132||
48252711|NCT02222337|100936836|FG000|COMPLETED|Overall Study||114||
48252712|NCT02222337|100936837|FG001|COMPLETED|Overall Study||108||
48252713|NCT02222337|100936836|FG000|NOT COMPLETED|Overall Study||26||
48252714|NCT02222337|100936837|FG001|NOT COMPLETED|Overall Study||24||
48252715|NCT04150341|100936838|FG000|STARTED|Overall Study||4||
48252716|NCT04150341|100936839|FG001|STARTED|Overall Study||4||
48252717|NCT04150341|100936840|FG002|STARTED|Overall Study||4||
48252718|NCT04150341|100936841|FG003|STARTED|Overall Study||4||
48252719|NCT04150341|100936842|FG004|STARTED|Overall Study||4||
48252720|NCT04150341|100936843|FG005|STARTED|Overall Study||4||
48252721|NCT04150341|100936838|FG000|COMPLETED|Overall Study||4||
48252722|NCT04150341|100936839|FG001|COMPLETED|Overall Study||4||
48252723|NCT04150341|100936840|FG002|COMPLETED|Overall Study||3||
48252724|NCT04150341|100936841|FG003|COMPLETED|Overall Study||4||
48252725|NCT04150341|100936842|FG004|COMPLETED|Overall Study||3||
48252726|NCT04150341|100936843|FG005|COMPLETED|Overall Study||4||
48252727|NCT04150341|100936838|FG000|NOT COMPLETED|Overall Study||0||
48252728|NCT04150341|100936839|FG001|NOT COMPLETED|Overall Study||0||
48379415|NCT01848054|101256106|FG001|NOT COMPLETED|Stabilization/Maintenance||40||
48379416|NCT02720016|101256107|FG000|STARTED|Overall Study||92||
48379417|NCT02720016|101256108|FG001|STARTED|Overall Study||92||
48379418|NCT02720016|101256109|FG002|STARTED|Overall Study||90||
48379419|NCT02720016|101256107|FG000|Y1|Overall Study||26|Number of enrollment in Year 1 of study (March 2017-December 2017)|
48379420|NCT02720016|101256108|FG001|Y1|Overall Study||26|Number of enrollment in Year 1 of study (March 2017-December 2017)|
48379421|NCT02720016|101256109|FG002|Y1|Overall Study||28|Number of enrollment in Year 1 of study (March 2017-December 2017)|
48379422|NCT02720016|101256107|FG000|Y2|Overall Study||34|Number of enrollment in Year 2 of study (2018)|
48379423|NCT02720016|101256108|FG001|Y2|Overall Study||32|Number of enrollment in Year 2 of study (2018)|
48379424|NCT02720016|101256109|FG002|Y2|Overall Study||34|Number of enrollment in Year 2 of study (2018)|
48379425|NCT02720016|101256107|FG000|Y3|Overall Study||28|Number of enrollment in Year 3 of study (2019)|
48379426|NCT02720016|101256108|FG001|Y3|Overall Study||30|Number of enrollment in Year 3 of study (2019)|
48379427|NCT02720016|101256109|FG002|Y3|Overall Study||24|Number of enrollment in Year 3 of study (2019)|
48710697|NCT00846040|102077994|FG001|STARTED|Washout: 2 Weeks to 10 Weeks||10||
48252729|NCT04150341|100936840|FG002|NOT COMPLETED|Overall Study||1||
48252730|NCT04150341|100936841|FG003|NOT COMPLETED|Overall Study||0||
48252731|NCT04150341|100936842|FG004|NOT COMPLETED|Overall Study||1||
48252732|NCT04150341|100936843|FG005|NOT COMPLETED|Overall Study||0||
48252733|NCT03772613|100936844|FG000|STARTED|Overall Study||61||
48252734|NCT03772613|100936845|FG001|STARTED|Overall Study||61||
48252735|NCT03772613|100936846|FG002|STARTED|Overall Study||58||
48710698|NCT00846040|102077995|FG002|STARTED|Washout: 2 Weeks to 10 Weeks||0||
48252736|NCT03772613|100936844|FG000|COMPLETED|Overall Study||61||
48252737|NCT03772613|100936845|FG001|COMPLETED|Overall Study||60||
48252738|NCT03772613|100936846|FG002|COMPLETED|Overall Study||57||
48252739|NCT03772613|100936844|FG000|NOT COMPLETED|Overall Study||0||
48252740|NCT03772613|100936845|FG001|NOT COMPLETED|Overall Study||1||
48252741|NCT03772613|100936846|FG002|NOT COMPLETED|Overall Study||1||
48252742|NCT03188536|100936847|FG000|STARTED|Overall Study||282||
48252743|NCT03188536|100936847|FG000|COMPLETED|Overall Study||276||
48252744|NCT03188536|100936847|FG000|NOT COMPLETED|Overall Study||6||
48252745|NCT00814632|100936848|FG000|STARTED|Overall Study||9||
48252746|NCT00814632|100936848|FG000|COMPLETED|Overall Study||7||
48252747|NCT00814632|100936848|FG000|NOT COMPLETED|Overall Study||2||
48252748|NCT01121913|100936849|FG000|STARTED|First Intervention Period||6||
48252749|NCT01121913|100936850|FG001|STARTED|First Intervention Period||6||
48252750|NCT01121913|100936851|FG002|STARTED|First Intervention Period||6||
48252751|NCT01121913|100936852|FG003|STARTED|First Intervention Period||6||
48252752|NCT01121913|100936849|FG000|COMPLETED|First Intervention Period||6||
48252753|NCT01121913|100936850|FG001|COMPLETED|First Intervention Period||6||
48252754|NCT01121913|100936851|FG002|COMPLETED|First Intervention Period||5||
48252755|NCT01121913|100936852|FG003|COMPLETED|First Intervention Period||6||
48252756|NCT01121913|100936849|FG000|NOT COMPLETED|First Intervention Period||0||
48252757|NCT01121913|100936850|FG001|NOT COMPLETED|First Intervention Period||0||
48252758|NCT01121913|100936851|FG002|NOT COMPLETED|First Intervention Period||1||
48252759|NCT01121913|100936852|FG003|NOT COMPLETED|First Intervention Period||0||
48252760|NCT01121913|100936849|FG000|STARTED|First Washout Period||6||
48252761|NCT01121913|100936850|FG001|STARTED|First Washout Period||6||
48252762|NCT01121913|100936851|FG002|STARTED|First Washout Period||5||
48252763|NCT01121913|100936852|FG003|STARTED|First Washout Period||6||
48252764|NCT01121913|100936849|FG000|COMPLETED|First Washout Period||5||
48252765|NCT01121913|100936850|FG001|COMPLETED|First Washout Period||6||
48252766|NCT01121913|100936851|FG002|COMPLETED|First Washout Period||5||
48252767|NCT01121913|100936852|FG003|COMPLETED|First Washout Period||6||
48252768|NCT01121913|100936849|FG000|NOT COMPLETED|First Washout Period||1||
48252769|NCT01121913|100936850|FG001|NOT COMPLETED|First Washout Period||0||
48252770|NCT01121913|100936851|FG002|NOT COMPLETED|First Washout Period||0||
48252771|NCT01121913|100936852|FG003|NOT COMPLETED|First Washout Period||0||
48252772|NCT01121913|100936849|FG000|STARTED|Second Intervention Period||5||
48252773|NCT01121913|100936850|FG001|STARTED|Second Intervention Period||6||
48252774|NCT01121913|100936851|FG002|STARTED|Second Intervention Period||5||
48252775|NCT01121913|100936852|FG003|STARTED|Second Intervention Period||6||
48252776|NCT01121913|100936849|FG000|COMPLETED|Second Intervention Period||5||
48252777|NCT01121913|100936850|FG001|COMPLETED|Second Intervention Period||6||
48252778|NCT01121913|100936851|FG002|COMPLETED|Second Intervention Period||4||
48252779|NCT01121913|100936852|FG003|COMPLETED|Second Intervention Period||6||
48252780|NCT01121913|100936849|FG000|NOT COMPLETED|Second Intervention Period||0||
48252781|NCT01121913|100936850|FG001|NOT COMPLETED|Second Intervention Period||0||
48252782|NCT01121913|100936851|FG002|NOT COMPLETED|Second Intervention Period||1||
48252783|NCT01121913|100936852|FG003|NOT COMPLETED|Second Intervention Period||0||
48252784|NCT01121913|100936849|FG000|STARTED|Second Washout Period||5||
48252785|NCT01121913|100936850|FG001|STARTED|Second Washout Period||6||
48252786|NCT01121913|100936851|FG002|STARTED|Second Washout Period||4||
48252787|NCT01121913|100936852|FG003|STARTED|Second Washout Period||6||
48252788|NCT01121913|100936849|FG000|COMPLETED|Second Washout Period||5||
48252789|NCT01121913|100936850|FG001|COMPLETED|Second Washout Period||6||
48252790|NCT01121913|100936851|FG002|COMPLETED|Second Washout Period||3||
48252791|NCT01121913|100936852|FG003|COMPLETED|Second Washout Period||6||
48252792|NCT01121913|100936849|FG000|NOT COMPLETED|Second Washout Period||0||
48252793|NCT01121913|100936850|FG001|NOT COMPLETED|Second Washout Period||0||
48252794|NCT01121913|100936851|FG002|NOT COMPLETED|Second Washout Period||1||
48252795|NCT01121913|100936852|FG003|NOT COMPLETED|Second Washout Period||0||
48252796|NCT01121913|100936849|FG000|STARTED|Third Intervention Period||5||
48252797|NCT01121913|100936850|FG001|STARTED|Third Intervention Period||6||
48252798|NCT01121913|100936851|FG002|STARTED|Third Intervention Period||3||
48252799|NCT01121913|100936852|FG003|STARTED|Third Intervention Period||6||
48379428|NCT02720016|101256107|FG000|Y4|Overall Study||4|Number of enrollment in Year 4 of study (January 2020-March 2020)|
48379429|NCT02720016|101256108|FG001|Y4|Overall Study||4|Number of enrollment in Year 4 of study (January 2020-March 2020)|
48379430|NCT02720016|101256109|FG002|Y4|Overall Study||4|Number of enrollment in Year 4 of study (January 2020-March 2020)|
48541312|NCT03787134|101662701|FG004|Outcome 12 - Behavioral Accuracy (Mean Recall Error)|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541313|NCT03787134|101662702|FG005|Outcome 12 - Behavioral Accuracy (Mean Recall Error)|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541314|NCT03787134|101662703|FG006|Outcome 12 - Behavioral Accuracy (Mean Recall Error)|Overall Study||14|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541315|NCT03787134|101662697|FG000|Outcome 17 - Amplitude of CDA|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541316|NCT03787134|101662698|FG001|Outcome 17 - Amplitude of CDA|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541317|NCT03787134|101662699|FG002|Outcome 17 - Amplitude of CDA|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541318|NCT03787134|101662700|FG003|Outcome 17 - Amplitude of CDA|Overall Study||28|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48592691|NCT01877382|101783163|FG013|COMPLETED|Dose Expansion||0||
48252800|NCT01121913|100936849|FG000|COMPLETED|Third Intervention Period||5||
48252801|NCT01121913|100936850|FG001|COMPLETED|Third Intervention Period||6||
48252802|NCT01121913|100936851|FG002|COMPLETED|Third Intervention Period||3||
48252803|NCT01121913|100936852|FG003|COMPLETED|Third Intervention Period||6||
48684877|NCT03693144|102013102|FG001|COMPLETED|Overall Study||5|Completion = maintaining the app on their phone, or participating in an end-of-study interview, but as COVID shut down Fast Food Restaurants approximately four months after the first enrollment, no six-month data could be gathered from the app.|
48684878|NCT03693144|102013103|FG002|COMPLETED|Overall Study||4|Completion = maintaining the app on their phone, or participating in an end-of-study interview, but as COVID shut down Fast Food Restaurants approximately four months after the first enrollment, no six-month data could be gathered from the app.|
48684879|NCT03693144|102013101|FG000|NOT COMPLETED|Overall Study||0||
48684880|NCT03693144|102013102|FG001|NOT COMPLETED|Overall Study||2||
48684881|NCT03693144|102013103|FG002|NOT COMPLETED|Overall Study||1||
48379431|NCT02720016|101256107|FG000|Veteran Total|Overall Study||46|Total number of veteran participants|
48684882|NCT02473471|102013104|FG000|STARTED|Overall Study||35||
48684883|NCT02473471|102013104|FG000|Received Allocated Intervention|Overall Study||33||
48684884|NCT02473471|102013104|FG000|Randomized Not Treated|Overall Study||2||
48684885|NCT02473471|102013104|FG000|COMPLETED|Overall Study||32||
48684886|NCT02473471|102013104|FG000|NOT COMPLETED|Overall Study||3||
48684887|NCT03082677|102013105|FG000|STARTED|Overall Study||20||
48684888|NCT03082677|102013105|FG000|COMPLETED|Overall Study||18||
48684889|NCT03082677|102013105|FG000|NOT COMPLETED|Overall Study||2||
48684890|NCT03281629|102013106|FG000|STARTED|Overall Study||18||
48684891|NCT03281629|102013107|FG001|STARTED|Overall Study||12||
48252804|NCT01121913|100936849|FG000|NOT COMPLETED|Third Intervention Period||0||
48252805|NCT01121913|100936850|FG001|NOT COMPLETED|Third Intervention Period||0||
48252806|NCT01121913|100936851|FG002|NOT COMPLETED|Third Intervention Period||0||
48379432|NCT02720016|101256108|FG001|Veteran Total|Overall Study||46|Total number of veteran participants|
48379433|NCT02720016|101256109|FG002|Veteran Total|Overall Study||45|Total number of veteran participants|
48379434|NCT02720016|101256107|FG000|Intimate Partner Total|Overall Study||46|Total number of intimate partners of veterans|
48379435|NCT02720016|101256108|FG001|Intimate Partner Total|Overall Study||46|Total number of intimate partners of veterans|
48379436|NCT02720016|101256109|FG002|Intimate Partner Total|Overall Study||45|Total number of intimate partners of veterans|
48379437|NCT02720016|101256107|FG000|COMPLETED|Overall Study||72||
48379438|NCT02720016|101256108|FG001|COMPLETED|Overall Study||72||
48379439|NCT02720016|101256109|FG002|COMPLETED|Overall Study||70||
48379440|NCT02720016|101256107|FG000|NOT COMPLETED|Overall Study||20||
48379441|NCT02720016|101256108|FG001|NOT COMPLETED|Overall Study||20||
48379442|NCT02720016|101256109|FG002|NOT COMPLETED|Overall Study||20||
48379443|NCT00568958|101256110|FG000|STARTED|Allocation||70||
48379444|NCT00568958|101256111|FG001|STARTED|Allocation||70||
48379445|NCT00568958|101256110|FG000|COMPLETED|Allocation||61||
48379446|NCT00568958|101256111|FG001|COMPLETED|Allocation||67||
48379447|NCT00568958|101256110|FG000|NOT COMPLETED|Allocation||9||
48379448|NCT00568958|101256111|FG001|NOT COMPLETED|Allocation||3||
48379449|NCT00568958|101256110|FG000|STARTED|Follow-Up||61||
48379450|NCT00568958|101256111|FG001|STARTED|Follow-Up||67||
48379451|NCT00568958|101256110|FG000|COMPLETED|Follow-Up||52||
48379452|NCT00568958|101256111|FG001|COMPLETED|Follow-Up||60||
48379453|NCT00568958|101256110|FG000|NOT COMPLETED|Follow-Up||9||
48379454|NCT00568958|101256111|FG001|NOT COMPLETED|Follow-Up||7||
48379455|NCT00418834|101256112|FG000|STARTED|Overall Study||526||
48379456|NCT00418834|101256113|FG001|STARTED|Overall Study||527||
48379457|NCT00418834|101256112|FG000|COMPLETED|Overall Study||503||
48379458|NCT00418834|101256113|FG001|COMPLETED|Overall Study||507||
48379459|NCT00418834|101256112|FG000|NOT COMPLETED|Overall Study||23||
48379460|NCT00418834|101256113|FG001|NOT COMPLETED|Overall Study||20||
48379461|NCT01151046|101256114|FG000|STARTED|Overall Study||59||
48379462|NCT01151046|101256115|FG001|STARTED|Overall Study||59||
48684892|NCT03281629|102013106|FG000|COMPLETED|Overall Study||16||
48684893|NCT03281629|102013107|FG001|COMPLETED|Overall Study||10||
48684894|NCT03281629|102013106|FG000|NOT COMPLETED|Overall Study||2||
48684895|NCT03281629|102013107|FG001|NOT COMPLETED|Overall Study||2||
48684896|NCT02315703|102013108|FG000|STARTED|Main Study (From Week 0 up to Week 96)||50||
48684897|NCT02315703|102013109|FG001|STARTED|Main Study (From Week 0 up to Week 96)||49||
48684898|NCT02315703|102013110|FG002|STARTED|Main Study (From Week 0 up to Week 96)||49||
48252807|NCT01121913|100936852|FG003|NOT COMPLETED|Third Intervention Period||0||
48252808|NCT01121913|100936849|FG000|STARTED|Third Washout Period||5||
48252809|NCT01121913|100936850|FG001|STARTED|Third Washout Period||6||
48252810|NCT01121913|100936851|FG002|STARTED|Third Washout Period||3||
48252811|NCT01121913|100936852|FG003|STARTED|Third Washout Period||6||
48252812|NCT01121913|100936849|FG000|COMPLETED|Third Washout Period||4||
48379463|NCT01151046|101256114|FG000|COMPLETED|Overall Study||56||
48684899|NCT02315703|102013111|FG003|STARTED|Main Study (From Week 0 up to Week 96)||48||
48684900|NCT02315703|102013112|FG004|STARTED|Main Study (From Week 0 up to Week 96)||49||
48684901|NCT02315703|102013113|FG005|STARTED|Main Study (From Week 0 up to Week 96)||49||
48684902|NCT02315703|102013114|FG006|STARTED|Main Study (From Week 0 up to Week 96)||50||
48684903|NCT02315703|102013115|FG007|STARTED|Main Study (From Week 0 up to Week 96)||49||
48379464|NCT01151046|101256115|FG001|COMPLETED|Overall Study||59||
48379465|NCT01151046|101256114|FG000|NOT COMPLETED|Overall Study||3||
48252813|NCT01121913|100936850|FG001|COMPLETED|Third Washout Period||6||
48379466|NCT01151046|101256115|FG001|NOT COMPLETED|Overall Study||0||
48379467|NCT00125190|101256116|FG000|STARTED|Overall Study||45||
48684904|NCT02315703|102013108|FG000|COMPLETED|Main Study (From Week 0 up to Week 96)||44||
48684905|NCT02315703|102013109|FG001|COMPLETED|Main Study (From Week 0 up to Week 96)||39||
48684906|NCT02315703|102013110|FG002|COMPLETED|Main Study (From Week 0 up to Week 96)||44||
48684907|NCT02315703|102013111|FG003|COMPLETED|Main Study (From Week 0 up to Week 96)||39||
48684908|NCT02315703|102013112|FG004|COMPLETED|Main Study (From Week 0 up to Week 96)||41||
48684909|NCT02315703|102013113|FG005|COMPLETED|Main Study (From Week 0 up to Week 96)||43||
48684910|NCT02315703|102013114|FG006|COMPLETED|Main Study (From Week 0 up to Week 96)||37||
48684911|NCT02315703|102013115|FG007|COMPLETED|Main Study (From Week 0 up to Week 96)||42||
48684912|NCT02315703|102013108|FG000|NOT COMPLETED|Main Study (From Week 0 up to Week 96)||6||
48684913|NCT02315703|102013109|FG001|NOT COMPLETED|Main Study (From Week 0 up to Week 96)||10||
48684914|NCT02315703|102013110|FG002|NOT COMPLETED|Main Study (From Week 0 up to Week 96)||5||
48684915|NCT02315703|102013111|FG003|NOT COMPLETED|Main Study (From Week 0 up to Week 96)||9||
48684916|NCT02315703|102013112|FG004|NOT COMPLETED|Main Study (From Week 0 up to Week 96)||8||
48684917|NCT02315703|102013113|FG005|NOT COMPLETED|Main Study (From Week 0 up to Week 96)||6||
48684918|NCT02315703|102013114|FG006|NOT COMPLETED|Main Study (From Week 0 up to Week 96)||13||
48684919|NCT02315703|102013115|FG007|NOT COMPLETED|Main Study (From Week 0 up to Week 96)||7||
48684920|NCT02315703|102013108|FG000|STARTED|LTE (After Week 96 up to Week 336)||31||
48684921|NCT02315703|102013109|FG001|STARTED|LTE (After Week 96 up to Week 336)||32||
48684922|NCT02315703|102013110|FG002|STARTED|LTE (After Week 96 up to Week 336)||0||
48684923|NCT02315703|102013111|FG003|STARTED|LTE (After Week 96 up to Week 336)||0||
48684924|NCT02315703|102013112|FG004|STARTED|LTE (After Week 96 up to Week 336)||0||
48684925|NCT02315703|102013113|FG005|STARTED|LTE (After Week 96 up to Week 336)||0||
48684926|NCT02315703|102013114|FG006|STARTED|LTE (After Week 96 up to Week 336)||0||
48684927|NCT02315703|102013115|FG007|STARTED|LTE (After Week 96 up to Week 336)||0||
48684928|NCT02315703|102013108|FG000|COMPLETED|LTE (After Week 96 up to Week 336)||29||
48252814|NCT01121913|100936851|FG002|COMPLETED|Third Washout Period||3||
48252815|NCT01121913|100936852|FG003|COMPLETED|Third Washout Period||6||
48252816|NCT01121913|100936849|FG000|NOT COMPLETED|Third Washout Period||1||
48252817|NCT01121913|100936850|FG001|NOT COMPLETED|Third Washout Period||0||
48252818|NCT01121913|100936851|FG002|NOT COMPLETED|Third Washout Period||0||
48252819|NCT01121913|100936852|FG003|NOT COMPLETED|Third Washout Period||0||
48252820|NCT01121913|100936849|FG000|STARTED|Fourth Intervention Period||4||
48252821|NCT01121913|100936850|FG001|STARTED|Fourth Intervention Period||6||
48252822|NCT01121913|100936851|FG002|STARTED|Fourth Intervention Period||3||
48252823|NCT01121913|100936852|FG003|STARTED|Fourth Intervention Period||6||
48252824|NCT01121913|100936849|FG000|COMPLETED|Fourth Intervention Period||4||
48252825|NCT01121913|100936850|FG001|COMPLETED|Fourth Intervention Period||6||
48252826|NCT01121913|100936851|FG002|COMPLETED|Fourth Intervention Period||3||
48252827|NCT01121913|100936852|FG003|COMPLETED|Fourth Intervention Period||6||
48252828|NCT01121913|100936849|FG000|NOT COMPLETED|Fourth Intervention Period||0||
48252829|NCT01121913|100936850|FG001|NOT COMPLETED|Fourth Intervention Period||0||
48252830|NCT01121913|100936851|FG002|NOT COMPLETED|Fourth Intervention Period||0||
48252831|NCT01121913|100936852|FG003|NOT COMPLETED|Fourth Intervention Period||0||
48252832|NCT00338988|100936853|FG000|STARTED|Overall Study||44||
48252833|NCT00338988|100936853|FG000|COMPLETED|Overall Study||43||
48252834|NCT00338988|100936853|FG000|NOT COMPLETED|Overall Study||1||
48252835|NCT05006417|100936854|FG000|STARTED|Overall Study||1||
48252836|NCT05006417|100936854|FG000|Baseline Measures|Overall Study||1||
48252837|NCT05006417|100936854|FG000|2 Months|Overall Study||0||
48252838|NCT05006417|100936854|FG000|4 Months|Overall Study||0||
48252839|NCT05006417|100936854|FG000|6 Months|Overall Study||0||
48252840|NCT05006417|100936854|FG000|COMPLETED|Overall Study||0||
48252841|NCT05006417|100936854|FG000|NOT COMPLETED|Overall Study||1||
48252842|NCT00815347|100936855|FG000|STARTED|Overall Study||11||
48252843|NCT00815347|100936855|FG000|COMPLETED|Overall Study||7||
48252844|NCT00815347|100936855|FG000|NOT COMPLETED|Overall Study||4||
48252845|NCT01612221|100936856|FG000|STARTED|Overall Study||50||
48252846|NCT01612221|100936857|FG001|STARTED|Overall Study||50||
48252847|NCT01612221|100936856|FG000|COMPLETED|Overall Study||50||
48252848|NCT01612221|100936857|FG001|COMPLETED|Overall Study||50||
48252849|NCT01612221|100936856|FG000|NOT COMPLETED|Overall Study||0||
48252850|NCT01612221|100936857|FG001|NOT COMPLETED|Overall Study||0||
48252851|NCT01208870|100936858|FG000|STARTED|Overall Study||46||
48252852|NCT01208870|100936859|FG001|STARTED|Overall Study||44||
48252853|NCT01208870|100936858|FG000|Pilot 1|Overall Study||20||
48252854|NCT01208870|100936859|FG001|Pilot 1|Overall Study||22||
48252855|NCT01208870|100936858|FG000|Pilot 2|Overall Study||26||
48252856|NCT01208870|100936859|FG001|Pilot 2|Overall Study||22||
48684929|NCT02315703|102013109|FG001|COMPLETED|LTE (After Week 96 up to Week 336)||27||
48684930|NCT02315703|102013110|FG002|COMPLETED|LTE (After Week 96 up to Week 336)||0||
48710783|NCT01215110|102078019|FG003|STARTED|Overall Study||15||
48252857|NCT01208870|100936858|FG000|COMPLETED|Overall Study||44||
48252858|NCT01208870|100936859|FG001|COMPLETED|Overall Study||36||
48252859|NCT01208870|100936858|FG000|NOT COMPLETED|Overall Study||2||
48252860|NCT01208870|100936859|FG001|NOT COMPLETED|Overall Study||8||
48252861|NCT00815919|100936860|FG000|STARTED|Overall Study||22||
48379468|NCT00125190|101256116|FG000|Completed 34 Weeks of Study|Overall Study||43||
48379469|NCT00125190|101256116|FG000|COMPLETED|Overall Study||30||
48379470|NCT00125190|101256116|FG000|NOT COMPLETED|Overall Study||15||
48684931|NCT02315703|102013111|FG003|COMPLETED|LTE (After Week 96 up to Week 336)||0||
48684932|NCT02315703|102013112|FG004|COMPLETED|LTE (After Week 96 up to Week 336)||0||
48684933|NCT02315703|102013113|FG005|COMPLETED|LTE (After Week 96 up to Week 336)||0||
48684934|NCT02315703|102013114|FG006|COMPLETED|LTE (After Week 96 up to Week 336)||0||
48684935|NCT02315703|102013115|FG007|COMPLETED|LTE (After Week 96 up to Week 336)||0||
48684936|NCT02315703|102013108|FG000|NOT COMPLETED|LTE (After Week 96 up to Week 336)||2||
48379471|NCT00906074|101256117|FG000|STARTED|Overall Study||90||
48379472|NCT00906074|101256118|FG001|STARTED|Overall Study||90||
48379473|NCT00906074|101256117|FG000|COMPLETED|Overall Study||90||
48379474|NCT00906074|101256118|FG001|COMPLETED|Overall Study||90||
48379475|NCT00906074|101256117|FG000|NOT COMPLETED|Overall Study||0||
48379476|NCT00906074|101256118|FG001|NOT COMPLETED|Overall Study||0||
48379477|NCT01208038|101256119|FG000|STARTED|Overall Study||22||
48379478|NCT01208038|101256119|FG000|COMPLETED|Overall Study||21||
48379479|NCT01208038|101256119|FG000|NOT COMPLETED|Overall Study||1||
48379480|NCT01533935|101256120|FG000|STARTED|Overall Study||58||
48379481|NCT01533935|101256121|FG001|STARTED|Overall Study||58||
48379482|NCT01533935|101256122|FG002|STARTED|Overall Study||58||
48379483|NCT01533935|101256123|FG003|STARTED|Overall Study||59||
48379484|NCT01533935|101256124|FG004|STARTED|Overall Study||58||
48379485|NCT01533935|101256120|FG000|Received Placebo|Overall Study||0||
48379486|NCT01533935|101256121|FG001|Received Placebo|Overall Study||47||
48379487|NCT01533935|101256122|FG002|Received Placebo|Overall Study||52||
48379488|NCT01533935|101256123|FG003|Received Placebo|Overall Study||57||
48379489|NCT01533935|101256124|FG004|Received Placebo|Overall Study||58||
48379490|NCT01533935|101256120|FG000|Received Olo 5|Overall Study||52||
48379491|NCT01533935|101256121|FG001|Received Olo 5|Overall Study||52||
48379492|NCT01533935|101256122|FG002|Received Olo 5|Overall Study||55||
48379493|NCT01533935|101256123|FG003|Received Olo 5|Overall Study||59||
48379494|NCT01533935|101256124|FG004|Received Olo 5|Overall Study||0||
48379495|NCT01533935|101256120|FG000|Received Tio 5|Overall Study||54||
48379496|NCT01533935|101256121|FG001|Received Tio 5|Overall Study||54||
48684937|NCT02315703|102013109|FG001|NOT COMPLETED|LTE (After Week 96 up to Week 336)||5||
48684938|NCT02315703|102013110|FG002|NOT COMPLETED|LTE (After Week 96 up to Week 336)||0||
48684939|NCT02315703|102013111|FG003|NOT COMPLETED|LTE (After Week 96 up to Week 336)||0||
48684940|NCT02315703|102013112|FG004|NOT COMPLETED|LTE (After Week 96 up to Week 336)||0||
48684941|NCT02315703|102013113|FG005|NOT COMPLETED|LTE (After Week 96 up to Week 336)||0||
48684942|NCT02315703|102013114|FG006|NOT COMPLETED|LTE (After Week 96 up to Week 336)||0||
48684943|NCT02315703|102013115|FG007|NOT COMPLETED|LTE (After Week 96 up to Week 336)||0||
48684944|NCT02175277|102013116|FG000|STARTED|Overall Study||9||
48684945|NCT02175277|102013116|FG000|COMPLETED|Overall Study||8||
48379497|NCT01533935|101256122|FG002|Received Tio 5|Overall Study||58||
48379498|NCT01533935|101256123|FG003|Received Tio 5|Overall Study||0||
48379499|NCT01533935|101256124|FG004|Received Tio 5|Overall Study||52||
48379500|NCT01533935|101256120|FG000|Received Tio+Olo 2.5/5|Overall Study||58||
48379501|NCT01533935|101256121|FG001|Received Tio+Olo 2.5/5|Overall Study||0||
48379502|NCT01533935|101256122|FG002|Received Tio+Olo 2.5/5|Overall Study||49||
48379503|NCT01533935|101256123|FG003|Received Tio+Olo 2.5/5|Overall Study||56||
48379504|NCT01533935|101256124|FG004|Received Tio+Olo 2.5/5|Overall Study||56||
48379505|NCT01533935|101256120|FG000|Received Tio+Olo 5/5|Overall Study||56||
48379506|NCT01533935|101256121|FG001|Received Tio+Olo 5/5|Overall Study||58||
48379507|NCT01533935|101256122|FG002|Received Tio+Olo 5/5|Overall Study||1||
48379508|NCT01533935|101256123|FG003|Received Tio+Olo 5/5|Overall Study||54||
48379509|NCT01533935|101256124|FG004|Received Tio+Olo 5/5|Overall Study||55||
48379510|NCT01533935|101256120|FG000|COMPLETED|Overall Study||52||
48379511|NCT01533935|101256121|FG001|COMPLETED|Overall Study||45||
48379512|NCT01533935|101256122|FG002|COMPLETED|Overall Study||50||
48379513|NCT01533935|101256123|FG003|COMPLETED|Overall Study||52||
48684946|NCT02175277|102013116|FG000|NOT COMPLETED|Overall Study||1||
48684947|NCT00118274|102013117|FG000|STARTED|Overall Study||41||
48684948|NCT00118274|102013118|FG001|STARTED|Overall Study||43||
48379514|NCT01533935|101256124|FG004|COMPLETED|Overall Study||50||
48379515|NCT01533935|101256120|FG000|NOT COMPLETED|Overall Study||6||
48379516|NCT01533935|101256121|FG001|NOT COMPLETED|Overall Study||13||
48379517|NCT01533935|101256122|FG002|NOT COMPLETED|Overall Study||8||
48379518|NCT01533935|101256123|FG003|NOT COMPLETED|Overall Study||7||
48379519|NCT01533935|101256124|FG004|NOT COMPLETED|Overall Study||8||
48379520|NCT02457182|101256125|FG000|STARTED|Overall Study||9||
48379521|NCT02457182|101256126|FG001|STARTED|Overall Study||11||
48379522|NCT02457182|101256125|FG000|COMPLETED|Overall Study||8||
48379523|NCT02457182|101256126|FG001|COMPLETED|Overall Study||11||
48379524|NCT02457182|101256125|FG000|NOT COMPLETED|Overall Study||1||
48379525|NCT02457182|101256126|FG001|NOT COMPLETED|Overall Study||0||
48684949|NCT00118274|102013119|FG002|STARTED|Overall Study||42||
48684950|NCT00118274|102013120|FG003|STARTED|Overall Study||44||
48252862|NCT00815919|100936860|FG000|COMPLETED|Overall Study||18||
48252863|NCT00815919|100936860|FG000|NOT COMPLETED|Overall Study||4||
48252864|NCT01212484|100936861|FG000|STARTED|Carbidopa Titration Period (4 Weeks)||6||
48252865|NCT01212484|100936862|FG001|STARTED|Carbidopa Titration Period (4 Weeks)||6||
48252866|NCT01212484|100936861|FG000|COMPLETED|Carbidopa Titration Period (4 Weeks)||5||
48252867|NCT01212484|100936862|FG001|COMPLETED|Carbidopa Titration Period (4 Weeks)||6||
48252868|NCT01212484|100936861|FG000|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||1||
48252869|NCT01212484|100936862|FG001|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||0||
48252870|NCT01212484|100936861|FG000|STARTED|First Intervention (4 Weeks)||5||
48252871|NCT01212484|100936862|FG001|STARTED|First Intervention (4 Weeks)||6||
48252872|NCT01212484|100936861|FG000|COMPLETED|First Intervention (4 Weeks)||5||
48252873|NCT01212484|100936862|FG001|COMPLETED|First Intervention (4 Weeks)||4||
48252874|NCT01212484|100936861|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0||
48252875|NCT01212484|100936862|FG001|NOT COMPLETED|First Intervention (4 Weeks)||2||
48252876|NCT01212484|100936861|FG000|STARTED|Second Intervention (4 Weeks)||5||
48252877|NCT01212484|100936862|FG001|STARTED|Second Intervention (4 Weeks)||4||
48252878|NCT01212484|100936861|FG000|COMPLETED|Second Intervention (4 Weeks)||5||
48252879|NCT01212484|100936862|FG001|COMPLETED|Second Intervention (4 Weeks)||3||
48252880|NCT01212484|100936861|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0||
48252881|NCT01212484|100936862|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1||
48252882|NCT00655083|100936863|FG000|STARTED|Overall Study||12||
48252883|NCT00655083|100936864|FG001|STARTED|Overall Study||8||
48252884|NCT00655083|100936863|FG000|COMPLETED|Overall Study||12||
48252885|NCT00655083|100936864|FG001|COMPLETED|Overall Study||8||
48252886|NCT00655083|100936863|FG000|NOT COMPLETED|Overall Study||0||
48252887|NCT00655083|100936864|FG001|NOT COMPLETED|Overall Study||0||
48252888|NCT00988117|100936865|FG000|STARTED|4.6 mg/24 Hours From Baseline to Week 4||15||
48252889|NCT00988117|100936865|FG000|COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||14||
48252890|NCT00988117|100936865|FG000|NOT COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||1||
48252891|NCT00988117|100936865|FG000|STARTED|9.5 mg/24 Hours From Week 4 to 12||14||
48252892|NCT00988117|100936865|FG000|COMPLETED|9.5 mg/24 Hours From Week 4 to 12||12||
48252893|NCT00988117|100936865|FG000|NOT COMPLETED|9.5 mg/24 Hours From Week 4 to 12||2||
48252894|NCT03124550|100936866|FG000|STARTED|Overall Study||18||
48252895|NCT03124550|100936866|FG000|COMPLETED|Overall Study||18||
48252896|NCT03124550|100936866|FG000|NOT COMPLETED|Overall Study||0||
48252897|NCT00676195|100936867|FG000|STARTED|Overall Study||24||
48252898|NCT00676195|100936867|FG000|COMPLETED|Overall Study||21||
48252899|NCT00676195|100936867|FG000|NOT COMPLETED|Overall Study||3||
48252900|NCT00193596|100936868|FG000|STARTED|Overall Study||93||
48252901|NCT00193596|100936869|FG001|STARTED|Overall Study||105||
48252902|NCT00193596|100936868|FG000|COMPLETED|Overall Study||37||
48252903|NCT00193596|100936869|FG001|COMPLETED|Overall Study||39||
48252904|NCT00193596|100936868|FG000|NOT COMPLETED|Overall Study||56||
48252905|NCT00193596|100936869|FG001|NOT COMPLETED|Overall Study||66||
48252906|NCT00297778|100936870|FG000|STARTED|Overall Study||152||
48252907|NCT00297778|100936871|FG001|STARTED|Overall Study||144||
48252908|NCT00297778|100936870|FG000|COMPLETED|Overall Study||133||
48252909|NCT00297778|100936871|FG001|COMPLETED|Overall Study||124||
48252910|NCT00297778|100936870|FG000|NOT COMPLETED|Overall Study||19||
48252911|NCT00297778|100936871|FG001|NOT COMPLETED|Overall Study||20||
48252912|NCT00979745|100936872|FG000|STARTED|Overall Study||38||
48252913|NCT00979745|100936873|FG001|STARTED|Overall Study||36||
48252914|NCT00979745|100936872|FG000|COMPLETED|Overall Study||34||
48252915|NCT00979745|100936873|FG001|COMPLETED|Overall Study||34||
48252916|NCT00979745|100936872|FG000|NOT COMPLETED|Overall Study||4||
48252917|NCT00979745|100936873|FG001|NOT COMPLETED|Overall Study||2||
48252918|NCT01091519|100936874|FG000|STARTED|Overall Study||346||
48252919|NCT01091519|100936875|FG001|STARTED|Overall Study||435||
48252920|NCT01091519|100936874|FG000|Treated|Overall Study||342||
48379526|NCT02370498|101256127|FG000|STARTED|Overall Study||296||
48379527|NCT02370498|101256128|FG001|STARTED|Overall Study||296||
48379528|NCT02370498|101256127|FG000|Treated|Overall Study||294||
48379529|NCT02370498|101256128|FG001|Treated|Overall Study||276||
48379530|NCT02370498|101256127|FG000|PD-L1 Positive Participants|Overall Study||196||
48379531|NCT02370498|101256128|FG001|PD-L1 Positive Participants|Overall Study||199||
48379532|NCT02370498|101256127|FG000|COMPLETED|Overall Study||0||
48379533|NCT02370498|101256128|FG001|COMPLETED|Overall Study||0||
48379534|NCT02370498|101256127|FG000|NOT COMPLETED|Overall Study||296||
48379535|NCT02370498|101256128|FG001|NOT COMPLETED|Overall Study||296||
48379536|NCT03105700|101256129|FG000|STARTED|Overall Study||15||
48379537|NCT03105700|101256129|FG000|COMPLETED|Overall Study||8||
48379538|NCT03105700|101256129|FG000|NOT COMPLETED|Overall Study||7||
48379539|NCT02520518|101256130|FG000|STARTED|Overall Study||3||
48379540|NCT02520518|101256131|FG001|STARTED|Overall Study||1||
48379541|NCT02520518|101256132|FG002|STARTED|Overall Study||3||
48379542|NCT02520518|101256133|FG003|STARTED|Overall Study||2||
48379543|NCT02520518|101256130|FG000|COMPLETED|Overall Study||3||
48379544|NCT02520518|101256131|FG001|COMPLETED|Overall Study||1||
48379545|NCT02520518|101256132|FG002|COMPLETED|Overall Study||1||
48379546|NCT02520518|101256133|FG003|COMPLETED|Overall Study||1||
48379547|NCT02520518|101256130|FG000|NOT COMPLETED|Overall Study||0||
48379548|NCT02520518|101256131|FG001|NOT COMPLETED|Overall Study||0||
48379549|NCT02520518|101256132|FG002|NOT COMPLETED|Overall Study||2||
48379550|NCT02520518|101256133|FG003|NOT COMPLETED|Overall Study||1||
48379551|NCT02366663|101256134|FG000|STARTED|Overall Study||2||
48379552|NCT02366663|101256135|FG001|STARTED|Overall Study||1||
48379553|NCT02366663|101256134|FG000|COMPLETED|Overall Study||2||
48379554|NCT02366663|101256135|FG001|COMPLETED|Overall Study||1||
48379555|NCT02366663|101256134|FG000|NOT COMPLETED|Overall Study||0||
48379556|NCT02366663|101256135|FG001|NOT COMPLETED|Overall Study||0||
48379557|NCT01702363|101256136|FG000|STARTED|Overall Study||131||
48379558|NCT01702363|101256136|FG000|COMPLETED|Overall Study||111||
48379559|NCT01702363|101256136|FG000|NOT COMPLETED|Overall Study||20||
48379560|NCT04179968|101256137|FG000|STARTED|Overall Study||20||
48379561|NCT04179968|101256137|FG000|COMPLETED|Overall Study||19||
48379562|NCT04179968|101256137|FG000|NOT COMPLETED|Overall Study||1||
48379563|NCT04715230|101256138|FG000|STARTED|Overall Study||8||
48379564|NCT04715230|101256139|FG001|STARTED|Overall Study||8||
48379565|NCT04715230|101256140|FG002|STARTED|Overall Study||4||
48379566|NCT04715230|101256138|FG000|COMPLETED|Overall Study||7||
48379567|NCT04715230|101256139|FG001|COMPLETED|Overall Study||3||
48379568|NCT04715230|101256140|FG002|COMPLETED|Overall Study||3||
48379569|NCT04715230|101256138|FG000|NOT COMPLETED|Overall Study||1||
48379570|NCT04715230|101256139|FG001|NOT COMPLETED|Overall Study||5||
48379571|NCT04715230|101256140|FG002|NOT COMPLETED|Overall Study||1||
48379572|NCT01511419|101256141|FG000|STARTED|Dose 1||30||
48379573|NCT01511419|101256142|FG001|STARTED|Dose 1||10||
48379574|NCT01511419|101256141|FG000|COMPLETED|Dose 1||30||
48379575|NCT01511419|101256142|FG001|COMPLETED|Dose 1||10||
48379576|NCT01511419|101256141|FG000|NOT COMPLETED|Dose 1||0||
48379577|NCT01511419|101256142|FG001|NOT COMPLETED|Dose 1||0||
48379578|NCT01511419|101256141|FG000|STARTED|Dose 2||30||
48379579|NCT01511419|101256142|FG001|STARTED|Dose 2||10||
48379580|NCT01511419|101256141|FG000|COMPLETED|Dose 2||29||
48379581|NCT01511419|101256142|FG001|COMPLETED|Dose 2||10||
48379582|NCT01511419|101256141|FG000|NOT COMPLETED|Dose 2||1||
48379583|NCT01511419|101256142|FG001|NOT COMPLETED|Dose 2||0||
48379584|NCT02121756|101256143|FG000|STARTED|Overall Study||21||
48379585|NCT02121756|101256144|FG001|STARTED|Overall Study||19||
48379586|NCT02121756|101256143|FG000|COMPLETED|Overall Study||15||
48379587|NCT02121756|101256144|FG001|COMPLETED|Overall Study||17||
48379588|NCT02121756|101256143|FG000|NOT COMPLETED|Overall Study||6||
48379589|NCT02121756|101256144|FG001|NOT COMPLETED|Overall Study||2||
48379590|NCT00712322|101256145|FG000|STARTED|Overall Study||12||
48379591|NCT00712322|101256146|FG001|STARTED|Overall Study||14||
48379592|NCT00712322|101256147|FG002|STARTED|Overall Study||9||
48379593|NCT00712322|101256145|FG000|COMPLETED|Overall Study||12||
48379594|NCT00712322|101256146|FG001|COMPLETED|Overall Study||13||
48379595|NCT00712322|101256147|FG002|COMPLETED|Overall Study||9||
48379596|NCT00712322|101256145|FG000|NOT COMPLETED|Overall Study||0||
48379597|NCT00712322|101256146|FG001|NOT COMPLETED|Overall Study||1||
48379598|NCT00712322|101256147|FG002|NOT COMPLETED|Overall Study||0||
48379599|NCT03009539|101256148|FG000|STARTED|Overall Study||225||
48379600|NCT03009539|101256149|FG001|STARTED|Overall Study||231||
48379601|NCT03009539|101256150|FG002|STARTED|Overall Study||225||
48379602|NCT03009539|101256151|FG003|STARTED|Overall Study||231||
48379603|NCT03009539|101256148|FG000|COMPLETED|Overall Study||93||
48379604|NCT03009539|101256149|FG001|COMPLETED|Overall Study||118||
48379605|NCT03009539|101256150|FG002|COMPLETED|Overall Study||93||
48379606|NCT03009539|101256151|FG003|COMPLETED|Overall Study||118||
48379607|NCT03009539|101256148|FG000|NOT COMPLETED|Overall Study||132||
48379608|NCT03009539|101256149|FG001|NOT COMPLETED|Overall Study||113||
48379609|NCT03009539|101256150|FG002|NOT COMPLETED|Overall Study||132||
48379610|NCT03009539|101256151|FG003|NOT COMPLETED|Overall Study||113||
48379611|NCT02125331|101256152|FG000|STARTED|Overall Study||58||
48379612|NCT02125331|101256153|FG001|STARTED|Overall Study||25||
48379613|NCT02125331|101256152|FG000|COMPLETED|Overall Study||53||
48379614|NCT02125331|101256153|FG001|COMPLETED|Overall Study||25||
48379615|NCT02125331|101256152|FG000|NOT COMPLETED|Overall Study||5||
48379616|NCT02125331|101256153|FG001|NOT COMPLETED|Overall Study||0||
48379617|NCT02953782|101256154|FG000|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||6||
48379618|NCT02953782|101256155|FG001|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||3||
48379619|NCT02953782|101256156|FG002|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||9||
48379620|NCT02953782|101256157|FG003|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||8||
48379621|NCT02953782|101256158|FG004|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||6||
48379622|NCT02953782|101256159|FG005|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||0||
48379623|NCT02953782|101256160|FG006|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||0||
48379624|NCT02953782|101256161|FG007|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||0||
48379625|NCT02953782|101256154|FG000|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0||
48379626|NCT02953782|101256155|FG001|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0||
48379627|NCT02953782|101256156|FG002|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0||
48379628|NCT02953782|101256157|FG003|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0||
48379629|NCT02953782|101256158|FG004|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0||
48379630|NCT02953782|101256159|FG005|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0||
48379631|NCT02953782|101256160|FG006|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0||
48379632|NCT02953782|101256161|FG007|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0||
48379633|NCT02953782|101256154|FG000|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||6||
48379634|NCT02953782|101256155|FG001|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||3||
48684951|NCT00118274|102013117|FG000|COMPLETED|Overall Study||21||
48684952|NCT00118274|102013118|FG001|COMPLETED|Overall Study||21||
48379635|NCT02953782|101256156|FG002|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||9||
48379636|NCT02953782|101256157|FG003|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||8||
48379637|NCT02953782|101256158|FG004|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||6||
48379638|NCT02953782|101256159|FG005|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0||
48379639|NCT02953782|101256160|FG006|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0||
48379640|NCT02953782|101256161|FG007|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0||
48379641|NCT02953782|101256154|FG000|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0||
48379642|NCT02953782|101256155|FG001|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0||
48379643|NCT02953782|101256156|FG002|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0||
48379644|NCT02953782|101256157|FG003|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0||
48379645|NCT02953782|101256158|FG004|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0||
48379646|NCT02953782|101256159|FG005|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||16||
48379647|NCT02953782|101256160|FG006|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||15||
48379648|NCT02953782|101256161|FG007|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||15||
48379649|NCT02953782|101256154|FG000|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0||
48379650|NCT02953782|101256155|FG001|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0||
48379651|NCT02953782|101256156|FG002|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0||
48379652|NCT02953782|101256157|FG003|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0||
48379653|NCT02953782|101256158|FG004|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0||
48379654|NCT02953782|101256159|FG005|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0||
48379655|NCT02953782|101256160|FG006|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0||
48379656|NCT02953782|101256161|FG007|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0||
48379657|NCT02953782|101256154|FG000|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0||
48379658|NCT02953782|101256155|FG001|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0||
48379659|NCT02953782|101256156|FG002|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0||
48379660|NCT02953782|101256157|FG003|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0||
48379661|NCT02953782|101256158|FG004|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0||
48379662|NCT02953782|101256159|FG005|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||16||
48379663|NCT02953782|101256160|FG006|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||15||
48379664|NCT02953782|101256161|FG007|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||15||
48379665|NCT03151148|101256162|FG000|STARTED|Overall Study||36||
48379666|NCT03151148|101256163|FG001|STARTED|Overall Study||18||
48379667|NCT03151148|101256162|FG000|COMPLETED|Overall Study||34||
48379668|NCT03151148|101256163|FG001|COMPLETED|Overall Study||18||
48379669|NCT03151148|101256162|FG000|NOT COMPLETED|Overall Study||2||
48541319|NCT03787134|101662701|FG004|Outcome 17 - Amplitude of CDA|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541320|NCT03787134|101662702|FG005|Outcome 17 - Amplitude of CDA|Overall Study||56|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541321|NCT03787134|101662703|FG006|Outcome 17 - Amplitude of CDA|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541322|NCT03787134|101662697|FG000|Outcome 18 - IEM|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541323|NCT03787134|101662698|FG001|Outcome 18 - IEM|Overall Study||30|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48379670|NCT03151148|101256163|FG001|NOT COMPLETED|Overall Study||0||
48379671|NCT00738543|101256164|FG000|STARTED|Povidone Iodine||48||
48379672|NCT00738543|101256164|FG000|COMPLETED|Povidone Iodine||48||
48379673|NCT00738543|101256164|FG000|NOT COMPLETED|Povidone Iodine||0||
48379674|NCT00738543|101256164|FG000|STARTED|Sodium Hypochlorite||48||
48379675|NCT00738543|101256164|FG000|COMPLETED|Sodium Hypochlorite||48||
48379676|NCT00738543|101256164|FG000|NOT COMPLETED|Sodium Hypochlorite||0||
48379677|NCT00738543|101256164|FG000|STARTED|Control||48||
48379678|NCT00738543|101256164|FG000|COMPLETED|Control||48||
48379679|NCT00738543|101256164|FG000|NOT COMPLETED|Control||0||
48379680|NCT01842308|101256165|FG000|STARTED|Overall Study||6||
48379681|NCT01842308|101256166|FG001|STARTED|Overall Study||3||
48379682|NCT01842308|101256167|FG002|STARTED|Overall Study||3||
48379683|NCT01842308|101256168|FG003|STARTED|Overall Study||2||
48379684|NCT01842308|101256169|FG004|STARTED|Overall Study||36||
48379685|NCT01842308|101256165|FG000|COMPLETED|Overall Study||6||
48379686|NCT01842308|101256166|FG001|COMPLETED|Overall Study||3||
48379687|NCT01842308|101256167|FG002|COMPLETED|Overall Study||3||
48379688|NCT01842308|101256168|FG003|COMPLETED|Overall Study||2||
48379689|NCT01842308|101256169|FG004|COMPLETED|Overall Study||35||
48379690|NCT01842308|101256165|FG000|NOT COMPLETED|Overall Study||0||
48379691|NCT01842308|101256166|FG001|NOT COMPLETED|Overall Study||0||
48379692|NCT01842308|101256167|FG002|NOT COMPLETED|Overall Study||0||
48379693|NCT01842308|101256168|FG003|NOT COMPLETED|Overall Study||0||
48379694|NCT01842308|101256169|FG004|NOT COMPLETED|Overall Study||1||
48252921|NCT01091519|100936875|FG001|Treated|Overall Study||431||
48252922|NCT01091519|100936874|FG000|COMPLETED|Overall Study||291||
48252923|NCT01091519|100936875|FG001|COMPLETED|Overall Study||362||
48252924|NCT01091519|100936874|FG000|NOT COMPLETED|Overall Study||55||
48252925|NCT01091519|100936875|FG001|NOT COMPLETED|Overall Study||73||
48252926|NCT03511378|100936876|FG000|STARTED|Overall Study||70||
48252927|NCT03511378|100936877|FG001|STARTED|Overall Study||68||
48252928|NCT03511378|100936876|FG000|COMPLETED|Overall Study||67||
48252929|NCT03511378|100936877|FG001|COMPLETED|Overall Study||66||
48252930|NCT03511378|100936876|FG000|NOT COMPLETED|Overall Study||3||
48252931|NCT03511378|100936877|FG001|NOT COMPLETED|Overall Study||2||
48252932|NCT01664897|100936878|FG000|STARTED|Overall Study||29||
48252933|NCT01664897|100936878|FG000|COMPLETED|Overall Study||29||
48252934|NCT01664897|100936878|FG000|NOT COMPLETED|Overall Study||0||
48252935|NCT02176837|100936879|FG000|STARTED|Overall Study||6||
48252936|NCT02176837|100936879|FG000|COMPLETED|Overall Study||0||
48252937|NCT02176837|100936879|FG000|NOT COMPLETED|Overall Study||6||
48252938|NCT01649297|100936880|FG000|STARTED|Overall Study||219||
48252939|NCT01649297|100936881|FG001|STARTED|Overall Study||218||
48252940|NCT01649297|100936882|FG002|STARTED|Overall Study||219||
48252941|NCT01649297|100936883|FG003|STARTED|Overall Study||220||
48252942|NCT01649297|100936884|FG004|STARTED|Overall Study||107||
48252943|NCT01649297|100936880|FG000|COMPLETED|Overall Study||205||
48252944|NCT01649297|100936881|FG001|COMPLETED|Overall Study||205||
48252945|NCT01649297|100936882|FG002|COMPLETED|Overall Study||202||
48252946|NCT01649297|100936883|FG003|COMPLETED|Overall Study||201||
48252947|NCT01649297|100936884|FG004|COMPLETED|Overall Study||103||
48252948|NCT01649297|100936880|FG000|NOT COMPLETED|Overall Study||14||
48252949|NCT01649297|100936881|FG001|NOT COMPLETED|Overall Study||13||
48252950|NCT01649297|100936882|FG002|NOT COMPLETED|Overall Study||17||
48252951|NCT01649297|100936883|FG003|NOT COMPLETED|Overall Study||19||
48252952|NCT01649297|100936884|FG004|NOT COMPLETED|Overall Study||4||
48252953|NCT01774019|100936885|FG000|STARTED|Overall Study||144||
48379695|NCT00471536|101256170|FG000|STARTED|Overall Study||19||
48379696|NCT00471536|101256170|FG000|COMPLETED|Overall Study||18||
48379697|NCT00471536|101256170|FG000|NOT COMPLETED|Overall Study||1||
48379698|NCT04494633|101258475|FG000|STARTED|Overall Study||35||
48379699|NCT04494633|101258476|FG001|STARTED|Overall Study||38||
48379700|NCT04494633|101258475|FG000|COMPLETED|Overall Study||29||
48379701|NCT04494633|101258476|FG001|COMPLETED|Overall Study||34||
48252954|NCT01774019|100936886|FG001|STARTED|Overall Study||140||
48252955|NCT01774019|100936885|FG000|COMPLETED|Overall Study||138||
48252956|NCT01774019|100936886|FG001|COMPLETED|Overall Study||136||
48252957|NCT01774019|100936885|FG000|NOT COMPLETED|Overall Study||6||
48252958|NCT01774019|100936886|FG001|NOT COMPLETED|Overall Study||4||
48252959|NCT01530477|100936887|FG000|STARTED|Overall Study||17||
48252960|NCT01530477|100936888|FG001|STARTED|Overall Study||12||
48252961|NCT01530477|100936889|FG002|STARTED|Overall Study||53||
48252962|NCT01530477|100936887|FG000|COMPLETED|Overall Study||17||
48252963|NCT01530477|100936888|FG001|COMPLETED|Overall Study||12||
48252964|NCT01530477|100936889|FG002|COMPLETED|Overall Study||53||
48252965|NCT01530477|100936887|FG000|NOT COMPLETED|Overall Study||0||
48252966|NCT01530477|100936888|FG001|NOT COMPLETED|Overall Study||0||
48252967|NCT01530477|100936889|FG002|NOT COMPLETED|Overall Study||0||
48252968|NCT00463580|100936890|FG000|STARTED|Overall Study||30||
48252969|NCT00463580|100936891|FG001|STARTED|Overall Study||30||
48252970|NCT00463580|100936890|FG000|COMPLETED|Overall Study||27||
48252971|NCT00463580|100936891|FG001|COMPLETED|Overall Study||28||
48252972|NCT00463580|100936890|FG000|NOT COMPLETED|Overall Study||3||
48379702|NCT04494633|101258475|FG000|NOT COMPLETED|Overall Study||6||
48379703|NCT04494633|101258476|FG001|NOT COMPLETED|Overall Study||4||
48379704|NCT00608530|101258477|FG000|STARTED|Study 1 Psychologist-delivered Treatment||33||
48379705|NCT00608530|101258478|FG001|STARTED|Study 1 Psychologist-delivered Treatment||33||
48379706|NCT00608530|101258479|FG002|STARTED|Study 1 Psychologist-delivered Treatment||0||
48379707|NCT00608530|101258480|FG003|STARTED|Study 1 Psychologist-delivered Treatment||0||
48379708|NCT00608530|101258477|FG000|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||28||
48379709|NCT00608530|101258478|FG001|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||31||
48379710|NCT00608530|101258479|FG002|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0||
48379711|NCT00608530|101258480|FG003|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0||
48379712|NCT00608530|101258477|FG000|COMPLETED|Study 1 Psychologist-delivered Treatment||22||
48379713|NCT00608530|101258478|FG001|COMPLETED|Study 1 Psychologist-delivered Treatment||28||
48379714|NCT00608530|101258479|FG002|COMPLETED|Study 1 Psychologist-delivered Treatment||0||
48379715|NCT00608530|101258480|FG003|COMPLETED|Study 1 Psychologist-delivered Treatment||0||
48379716|NCT00608530|101258477|FG000|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||11||
48379717|NCT00608530|101258478|FG001|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||5||
48379718|NCT00608530|101258479|FG002|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0||
48379719|NCT00608530|101258480|FG003|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0||
48379720|NCT00608530|101258477|FG000|STARTED|Study 2 Nurse-delivered Treatments||0||
48379721|NCT00608530|101258478|FG001|STARTED|Study 2 Nurse-delivered Treatments||0||
48379722|NCT00608530|101258479|FG002|STARTED|Study 2 Nurse-delivered Treatments||33||
48379723|NCT00608530|101258480|FG003|STARTED|Study 2 Nurse-delivered Treatments||34||
48379724|NCT00608530|101258477|FG000|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0||
48379725|NCT00608530|101258478|FG001|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0||
48379726|NCT00608530|101258479|FG002|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||30||
48252973|NCT00463580|100936891|FG001|NOT COMPLETED|Overall Study||2||
48252974|NCT02016690|100936892|FG000|STARTED|Overall Study||312||
48252975|NCT02016690|100936892|FG000|Treated|Overall Study||312||
48252976|NCT02016690|100936892|FG000|Safety Analysis Set (SAS)|Overall Study||304||
48252977|NCT02016690|100936892|FG000|COMPLETED|Overall Study||288||
48252978|NCT02016690|100936892|FG000|NOT COMPLETED|Overall Study||24||
48684953|NCT00118274|102013119|FG002|COMPLETED|Overall Study||25||
48252979|NCT03371485|100936893|FG000|STARTED|Main Trial (6 AST-VAC2 Vaccinations)||9||
48252980|NCT03371485|100936893|FG000|COMPLETED|Main Trial (6 AST-VAC2 Vaccinations)||8||
48252981|NCT03371485|100936893|FG000|NOT COMPLETED|Main Trial (6 AST-VAC2 Vaccinations)||1||
48252982|NCT03371485|100936893|FG000|STARTED|2-year Follow-up||8||
48252983|NCT03371485|100936893|FG000|COMPLETED|2-year Follow-up||3||
48252984|NCT03371485|100936893|FG000|NOT COMPLETED|2-year Follow-up||5||
48252985|NCT02172950|100936894|FG000|STARTED|Overall Study||222||
48252986|NCT02172950|100936895|FG001|STARTED|Overall Study||24||
48252987|NCT02172950|100936894|FG000|COMPLETED|Overall Study||197||
48252988|NCT02172950|100936895|FG001|COMPLETED|Overall Study||19||
48252989|NCT02172950|100936894|FG000|NOT COMPLETED|Overall Study||25||
48379727|NCT00608530|101258480|FG003|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||31||
48379728|NCT00608530|101258477|FG000|COMPLETED|Study 2 Nurse-delivered Treatments||0||
48379729|NCT00608530|101258478|FG001|COMPLETED|Study 2 Nurse-delivered Treatments||0||
48379730|NCT00608530|101258479|FG002|COMPLETED|Study 2 Nurse-delivered Treatments||21||
48379731|NCT00608530|101258480|FG003|COMPLETED|Study 2 Nurse-delivered Treatments||27||
48379732|NCT00608530|101258477|FG000|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0||
48379733|NCT00608530|101258478|FG001|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0||
48379734|NCT00608530|101258479|FG002|NOT COMPLETED|Study 2 Nurse-delivered Treatments||12||
48379735|NCT00608530|101258480|FG003|NOT COMPLETED|Study 2 Nurse-delivered Treatments||7||
48379736|NCT02024204|101258481|FG000|STARTED|Overall Study||49||
48379737|NCT02024204|101258482|FG001|STARTED|Overall Study||11||
48379738|NCT02024204|101258481|FG000|COMPLETED|Overall Study||49||
48379739|NCT02024204|101258482|FG001|COMPLETED|Overall Study||11||
48379740|NCT02024204|101258481|FG000|NOT COMPLETED|Overall Study||0||
48379741|NCT02024204|101258482|FG001|NOT COMPLETED|Overall Study||0||
48379742|NCT04737031|101258483|FG000|STARTED|Overall Study||490|Engaged patients (Intent-to-treat, ITT)|22
48252990|NCT02172950|100936895|FG001|NOT COMPLETED|Overall Study||5||
48252991|NCT00225277|100936896|FG000|STARTED|Overall Study||274||
48252992|NCT00225277|100936897|FG001|STARTED|Overall Study||273||
48252993|NCT00225277|100936896|FG000|COMPLETED|Overall Study||177||
48379743|NCT04737031|101258484|FG001|STARTED|Overall Study||506|Engaged patients (Intent-to-treat, ITT)|24
48379744|NCT04737031|101258485|FG002|STARTED|Overall Study||405|Engaged patients (Intent-to-treat, ITT)|19
48252994|NCT00225277|100936897|FG001|COMPLETED|Overall Study||178||
48252995|NCT00225277|100936896|FG000|NOT COMPLETED|Overall Study||97||
48252996|NCT00225277|100936897|FG001|NOT COMPLETED|Overall Study||95||
48252997|NCT02831998|100936898|FG000|STARTED|Overall Study||440||440
48252998|NCT02831998|100936898|FG000|ZP|Overall Study||400||400
48252999|NCT02831998|100936898|FG000|CP|Overall Study||400||400
48253000|NCT02831998|100936898|FG000|Vehicle|Overall Study||80||80
48253001|NCT02831998|100936898|FG000|COMPLETED|Overall Study||440||440
48253002|NCT02831998|100936898|FG000|NOT COMPLETED|Overall Study||0||0
48253003|NCT00014222|100936899|FG000|STARTED|Overall Study||701||
48253004|NCT00014222|100936900|FG001|STARTED|Overall Study||701||
48089503|NCT02625259|100541189|FG001|STARTED|First Intervention (Day 1)||9||
48089504|NCT02625259|100541190|FG002|STARTED|First Intervention (Day 1)||8||
48089505|NCT02625259|100541191|FG003|STARTED|First Intervention (Day 1)||10||
48089506|NCT02625259|100541192|FG004|STARTED|First Intervention (Day 1)||16||
48089507|NCT02625259|100541188|FG000|COMPLETED|First Intervention (Day 1)||9||
48089508|NCT02625259|100541189|FG001|COMPLETED|First Intervention (Day 1)||8||
48089509|NCT02625259|100541190|FG002|COMPLETED|First Intervention (Day 1)||7||
48089510|NCT02625259|100541191|FG003|COMPLETED|First Intervention (Day 1)||9||
48089511|NCT02625259|100541192|FG004|COMPLETED|First Intervention (Day 1)||16||
48089512|NCT02625259|100541188|FG000|NOT COMPLETED|First Intervention (Day 1)||2||
48089513|NCT02625259|100541189|FG001|NOT COMPLETED|First Intervention (Day 1)||1||
48089514|NCT02625259|100541190|FG002|NOT COMPLETED|First Intervention (Day 1)||1||
48089515|NCT02625259|100541191|FG003|NOT COMPLETED|First Intervention (Day 1)||1||
48089516|NCT02625259|100541192|FG004|NOT COMPLETED|First Intervention (Day 1)||0||
48089517|NCT02625259|100541188|FG000|STARTED|Washout (Day 2 to Day 14)||9||
48089518|NCT02625259|100541189|FG001|STARTED|Washout (Day 2 to Day 14)||8||
48089519|NCT02625259|100541190|FG002|STARTED|Washout (Day 2 to Day 14)||7||
48253005|NCT00014222|100936901|FG002|STARTED|Overall Study||702||
48253006|NCT00014222|100936899|FG000|COMPLETED|Overall Study||680|Only 2043 patients reported toxicity data.|
48253007|NCT00014222|100936900|FG001|COMPLETED|Overall Study||688|Only 2043 patients reported toxicity data.|
48253008|NCT00014222|100936901|FG002|COMPLETED|Overall Study||675|Only 2043 patients reported toxicity data.|
48253009|NCT00014222|100936899|FG000|NOT COMPLETED|Overall Study||21||
48253010|NCT00014222|100936900|FG001|NOT COMPLETED|Overall Study||13||
48253011|NCT00014222|100936901|FG002|NOT COMPLETED|Overall Study||27||
48253012|NCT00679549|100936902|FG000|STARTED|Overall Study||75||
48253013|NCT00679549|100936903|FG001|STARTED|Overall Study||75||
48253014|NCT00679549|100936902|FG000|COMPLETED|Overall Study||69||
48253015|NCT00679549|100936903|FG001|COMPLETED|Overall Study||66||
48253016|NCT00679549|100936902|FG000|NOT COMPLETED|Overall Study||6||
48541324|NCT03787134|101662699|FG002|Outcome 18 - IEM|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541325|NCT03787134|101662700|FG003|Outcome 18 - IEM|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48592692|NCT01877382|101783164|FG014|COMPLETED|Dose Expansion||0||
48592693|NCT01877382|101783150|FG000|NOT COMPLETED|Dose Expansion||0||
48253017|NCT00679549|100936903|FG001|NOT COMPLETED|Overall Study||9||
48253018|NCT01904019|100936904|FG000|STARTED|Pre-operative||95||100
48253019|NCT01904019|100936904|FG000|COMPLETED|Pre-operative||95||100
48253020|NCT01904019|100936904|FG000|NOT COMPLETED|Pre-operative||0||0
48089520|NCT02625259|100541191|FG003|STARTED|Washout (Day 2 to Day 14)||9||
48089521|NCT02625259|100541192|FG004|STARTED|Washout (Day 2 to Day 14)||0||
48089522|NCT02625259|100541188|FG000|COMPLETED|Washout (Day 2 to Day 14)||9||
48089523|NCT02625259|100541189|FG001|COMPLETED|Washout (Day 2 to Day 14)||8||
48089524|NCT02625259|100541190|FG002|COMPLETED|Washout (Day 2 to Day 14)||7||
48379745|NCT04737031|101258486|FG003|STARTED|Overall Study||745|Engaged patients (Intent-to-treat, ITT)|23
48379746|NCT04737031|101258483|FG000|COMPLETED|Overall Study||490|This was an ITT analysis. All engaged patients (2,146) were included in the analysis, even if they did not complete treatment.|22
48379747|NCT04737031|101258484|FG001|COMPLETED|Overall Study||475|This was an ITT analysis. All engaged patients (2,146) were included in the analysis, even if they did not complete treatment.|24
48379748|NCT04737031|101258485|FG002|COMPLETED|Overall Study||312|This was an ITT analysis. All engaged patients (2,146) were included in the analysis, even if they did not complete treatment.|19
48379749|NCT04737031|101258486|FG003|COMPLETED|Overall Study||518|This was an ITT analysis. All engaged patients (2,146) were included in the analysis, even if they did not complete treatment.|23
48379750|NCT04737031|101258483|FG000|NOT COMPLETED|Overall Study||0||0
48089525|NCT02625259|100541191|FG003|COMPLETED|Washout (Day 2 to Day 14)||9||
48089526|NCT02625259|100541192|FG004|COMPLETED|Washout (Day 2 to Day 14)||0||
48089527|NCT02625259|100541188|FG000|NOT COMPLETED|Washout (Day 2 to Day 14)||0||
48089528|NCT02625259|100541189|FG001|NOT COMPLETED|Washout (Day 2 to Day 14)||0||
48089529|NCT02625259|100541190|FG002|NOT COMPLETED|Washout (Day 2 to Day 14)||0||
48089530|NCT02625259|100541191|FG003|NOT COMPLETED|Washout (Day 2 to Day 14)||0||
48089531|NCT02625259|100541192|FG004|NOT COMPLETED|Washout (Day 2 to Day 14)||0||
48379751|NCT04737031|101258484|FG001|NOT COMPLETED|Overall Study||31||0
48379752|NCT04737031|101258485|FG002|NOT COMPLETED|Overall Study||93||0
48379753|NCT04737031|101258486|FG003|NOT COMPLETED|Overall Study||227||0
48379754|NCT00689819|101258487|FG000|STARTED|Overall Study||65||
48379755|NCT00689819|101258488|FG001|STARTED|Overall Study||58||
48379756|NCT00689819|101258487|FG000|COMPLETED|Overall Study||45||
48379757|NCT00689819|101258488|FG001|COMPLETED|Overall Study||43||
48379758|NCT00689819|101258487|FG000|NOT COMPLETED|Overall Study||20||
48379759|NCT00689819|101258488|FG001|NOT COMPLETED|Overall Study||15||
48379760|NCT03029650|101258489|FG000|STARTED|First Intervention (3 - 6 Days)||14||
48379761|NCT03029650|101258490|FG001|STARTED|First Intervention (3 - 6 Days)||12||
48379762|NCT03029650|101258489|FG000|COMPLETED|First Intervention (3 - 6 Days)||14||
48379763|NCT03029650|101258490|FG001|COMPLETED|First Intervention (3 - 6 Days)||12||
48379764|NCT03029650|101258489|FG000|NOT COMPLETED|First Intervention (3 - 6 Days)||0||
48379765|NCT03029650|101258490|FG001|NOT COMPLETED|First Intervention (3 - 6 Days)||0||
48379766|NCT03029650|101258489|FG000|STARTED|Washout (1 Week)||14||
48379767|NCT03029650|101258490|FG001|STARTED|Washout (1 Week)||12||
48379768|NCT03029650|101258489|FG000|COMPLETED|Washout (1 Week)||13||
48379769|NCT03029650|101258490|FG001|COMPLETED|Washout (1 Week)||10||
48379770|NCT03029650|101258489|FG000|NOT COMPLETED|Washout (1 Week)||1||
48379771|NCT03029650|101258490|FG001|NOT COMPLETED|Washout (1 Week)||2||
48379772|NCT03029650|101258489|FG000|STARTED|2nd Intervention (3 - 6 Days)||13||
48379773|NCT03029650|101258490|FG001|STARTED|2nd Intervention (3 - 6 Days)||10||
48379774|NCT03029650|101258489|FG000|COMPLETED|2nd Intervention (3 - 6 Days)||13||
48379775|NCT03029650|101258490|FG001|COMPLETED|2nd Intervention (3 - 6 Days)||10||
48379776|NCT03029650|101258489|FG000|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0||
48379777|NCT03029650|101258490|FG001|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0||
48379778|NCT01453569|101258491|FG000|STARTED|Overall Study||86||
48379779|NCT01453569|101258492|FG001|STARTED|Overall Study||84||
48379780|NCT01453569|101258493|FG002|STARTED|Overall Study||85||
48379781|NCT01453569|101258491|FG000|COMPLETED|Overall Study||75||
48379782|NCT01453569|101258492|FG001|COMPLETED|Overall Study||70||
48379783|NCT01453569|101258493|FG002|COMPLETED|Overall Study||78||
48379784|NCT01453569|101258491|FG000|NOT COMPLETED|Overall Study||11||
48379785|NCT01453569|101258492|FG001|NOT COMPLETED|Overall Study||14||
48379786|NCT01453569|101258493|FG002|NOT COMPLETED|Overall Study||7||
48379787|NCT01626352|101258494|FG000|STARTED|Overall Study||22||
48089532|NCT02625259|100541188|FG000|STARTED|Second Intervention (Day 15)||9||
48089533|NCT02625259|100541189|FG001|STARTED|Second Intervention (Day 15)||8||
48089534|NCT02625259|100541190|FG002|STARTED|Second Intervention (Day 15)||7||
48089535|NCT02625259|100541191|FG003|STARTED|Second Intervention (Day 15)||9||
48089536|NCT02625259|100541192|FG004|STARTED|Second Intervention (Day 15)||0||
48089537|NCT02625259|100541188|FG000|COMPLETED|Second Intervention (Day 15)||9||
48089538|NCT02625259|100541189|FG001|COMPLETED|Second Intervention (Day 15)||8||
48089539|NCT02625259|100541190|FG002|COMPLETED|Second Intervention (Day 15)||7||
48253021|NCT01904019|100936904|FG000|STARTED|1 Year Follow-up||95||100
48253022|NCT01904019|100936904|FG000|COMPLETED|1 Year Follow-up||86||91
48253023|NCT01904019|100936904|FG000|NOT COMPLETED|1 Year Follow-up||9||9
48253024|NCT01904019|100936904|FG000|STARTED|3 Year Follow-up||86||91
48253025|NCT01904019|100936904|FG000|COMPLETED|3 Year Follow-up||71||76
48253026|NCT01904019|100936904|FG000|NOT COMPLETED|3 Year Follow-up||15||15
48253027|NCT01904019|100936904|FG000|STARTED|5 Year Follow-up||71||76
48253028|NCT01904019|100936904|FG000|COMPLETED|5 Year Follow-up||65||69
48253029|NCT01904019|100936904|FG000|NOT COMPLETED|5 Year Follow-up||6||7
48089540|NCT02625259|100541191|FG003|COMPLETED|Second Intervention (Day 15)||9||
48089541|NCT02625259|100541192|FG004|COMPLETED|Second Intervention (Day 15)||0||
48089542|NCT02625259|100541188|FG000|NOT COMPLETED|Second Intervention (Day 15)||0||
48089543|NCT02625259|100541189|FG001|NOT COMPLETED|Second Intervention (Day 15)||0||
48089544|NCT02625259|100541190|FG002|NOT COMPLETED|Second Intervention (Day 15)||0||
48089545|NCT02625259|100541191|FG003|NOT COMPLETED|Second Intervention (Day 15)||0||
48089546|NCT02625259|100541192|FG004|NOT COMPLETED|Second Intervention (Day 15)||0||
48089547|NCT00936585|100541193|FG000|STARTED|Overall Study||2||
48089548|NCT00936585|100541193|FG000|COMPLETED|Overall Study||2||
48089549|NCT00936585|100541193|FG000|NOT COMPLETED|Overall Study||0||
48089550|NCT00290888|100541194|FG000|STARTED|Overall Study||41||
48089551|NCT00290888|100541195|FG001|STARTED|Overall Study||45||
48089552|NCT00290888|100541194|FG000|COMPLETED|Overall Study||38||
48089553|NCT00290888|100541195|FG001|COMPLETED|Overall Study||44||
48089554|NCT00290888|100541194|FG000|NOT COMPLETED|Overall Study||3||
48089555|NCT00290888|100541195|FG001|NOT COMPLETED|Overall Study||1||
48089556|NCT01949051|100541196|FG000|STARTED|Treatment Period 1 (7 Days)||13||
48089557|NCT01949051|100541197|FG001|STARTED|Treatment Period 1 (7 Days)||13||
48089558|NCT01949051|100541198|FG002|STARTED|Treatment Period 1 (7 Days)||13||
48089559|NCT01949051|100541199|FG003|STARTED|Treatment Period 1 (7 Days)||13||
48089560|NCT01949051|100541200|FG004|STARTED|Treatment Period 1 (7 Days)||13||
48253030|NCT02564718|100936905|FG000|STARTED|Overall Study||5||
48253031|NCT02564718|100936906|FG001|STARTED|Overall Study||5||
48253032|NCT02564718|100936905|FG000|COMPLETED|Overall Study||5||
48379788|NCT01626352|101258494|FG000|COMPLETED|Overall Study||12||
48379789|NCT01626352|101258494|FG000|NOT COMPLETED|Overall Study||10||
48379790|NCT01449682|101258495|FG000|STARTED|Overall Study||5||
48379791|NCT01449682|101258496|FG001|STARTED|Overall Study||5||
48379792|NCT01449682|101258495|FG000|COMPLETED|Overall Study||4||
48379793|NCT01449682|101258496|FG001|COMPLETED|Overall Study||4||
48379794|NCT01449682|101258495|FG000|NOT COMPLETED|Overall Study||1||
48253033|NCT02564718|100936906|FG001|COMPLETED|Overall Study||4||
48253034|NCT02564718|100936905|FG000|NOT COMPLETED|Overall Study||0||
48253035|NCT02564718|100936906|FG001|NOT COMPLETED|Overall Study||1||
48253036|NCT02097849|100936907|FG000|STARTED|Overall Study||33||
48253037|NCT02097849|100936908|FG001|STARTED|Overall Study||38||
48253038|NCT02097849|100936907|FG000|COMPLETED|Overall Study||33||
48379795|NCT01449682|101258496|FG001|NOT COMPLETED|Overall Study||1||
48379796|NCT03848221|101258497|FG000|STARTED|Overall Study||25||
48379797|NCT03848221|101258498|FG001|STARTED|Overall Study||24||
48379798|NCT03848221|101258499|FG002|STARTED|Overall Study||24||
48089561|NCT01949051|100541201|FG005|STARTED|Treatment Period 1 (7 Days)||13||
48089562|NCT01949051|100541196|FG000|COMPLETED|Treatment Period 1 (7 Days)||11||
48089563|NCT01949051|100541197|FG001|COMPLETED|Treatment Period 1 (7 Days)||13||
48379799|NCT03848221|101258497|FG000|COMPLETED|Overall Study||25||
48089564|NCT01949051|100541198|FG002|COMPLETED|Treatment Period 1 (7 Days)||13||
48089565|NCT01949051|100541199|FG003|COMPLETED|Treatment Period 1 (7 Days)||12||
48089566|NCT01949051|100541200|FG004|COMPLETED|Treatment Period 1 (7 Days)||13||
48379800|NCT03848221|101258498|FG001|COMPLETED|Overall Study||24||
48379801|NCT03848221|101258499|FG002|COMPLETED|Overall Study||24||
48379802|NCT03848221|101258497|FG000|NOT COMPLETED|Overall Study||0||
48379803|NCT03848221|101258498|FG001|NOT COMPLETED|Overall Study||0||
48379804|NCT03848221|101258499|FG002|NOT COMPLETED|Overall Study||0||
48379805|NCT02078713|101258500|FG000|STARTED|Overall Study||407||
48379806|NCT02078713|101258501|FG001|STARTED|Overall Study||351||
48379807|NCT02078713|101258502|FG002|STARTED|Overall Study||15||
48379808|NCT02078713|101258503|FG003|STARTED|Overall Study||13||
48379809|NCT02078713|101258500|FG000|COMPLETED|Overall Study||355||
48379810|NCT02078713|101258501|FG001|COMPLETED|Overall Study||290||
48379811|NCT02078713|101258502|FG002|COMPLETED|Overall Study||15||
48379812|NCT02078713|101258503|FG003|COMPLETED|Overall Study||13||
48379813|NCT02078713|101258500|FG000|NOT COMPLETED|Overall Study||52||
48379814|NCT02078713|101258501|FG001|NOT COMPLETED|Overall Study||61||
48379815|NCT02078713|101258502|FG002|NOT COMPLETED|Overall Study||0||
48379816|NCT02078713|101258503|FG003|NOT COMPLETED|Overall Study||0||
48379817|NCT03689504|101258504|FG000|STARTED|Overall Study||70||
48379818|NCT03689504|101258505|FG001|STARTED|Overall Study||70||
48379819|NCT03689504|101258504|FG000|COMPLETED|Overall Study||65||
48379820|NCT03689504|101258505|FG001|COMPLETED|Overall Study||70||
48379821|NCT03689504|101258504|FG000|NOT COMPLETED|Overall Study||5||
48379822|NCT03689504|101258505|FG001|NOT COMPLETED|Overall Study||0||
48379823|NCT01488318|101258506|FG000|STARTED|Overall Study||14||
48379824|NCT01488318|101258506|FG000|COMPLETED|Overall Study||14||
48684954|NCT00118274|102013120|FG003|COMPLETED|Overall Study||29||
48684955|NCT00118274|102013117|FG000|NOT COMPLETED|Overall Study||20||
48684956|NCT00118274|102013118|FG001|NOT COMPLETED|Overall Study||22||
48684957|NCT00118274|102013119|FG002|NOT COMPLETED|Overall Study||17||
48684958|NCT00118274|102013120|FG003|NOT COMPLETED|Overall Study||15||
48684959|NCT01151020|102013121|FG000|STARTED|Overall Study||110||
48684960|NCT01151020|102013121|FG000|30-day|Overall Study||110||
48684961|NCT01151020|102013121|FG000|COMPLETED|Overall Study||56||
48684962|NCT01151020|102013121|FG000|NOT COMPLETED|Overall Study||54||
48684963|NCT01907607|102013122|FG000|STARTED|Overall Study||29||
48684964|NCT01907607|102013122|FG000|COMPLETED|Overall Study||29||
48684965|NCT01907607|102013122|FG000|NOT COMPLETED|Overall Study||0||
48684966|NCT02969915|102013123|FG000|STARTED|Overall Study||1114||8
48684967|NCT02969915|102013124|FG001|STARTED|Overall Study||1200||8
48684968|NCT02969915|102013123|FG000|6-month Follow-up|Overall Study||901||8
48684969|NCT02969915|102013124|FG001|6-month Follow-up|Overall Study||968||8
48684970|NCT02969915|102013123|FG000|12-month Follow-up|Overall Study||826||8
48684971|NCT02969915|102013124|FG001|12-month Follow-up|Overall Study||885||8
48684972|NCT02969915|102013123|FG000|18-month Follow-up|Overall Study||778||8
48684973|NCT02969915|102013124|FG001|18-month Follow-up|Overall Study||824||8
48684974|NCT02969915|102013123|FG000|COMPLETED|Overall Study||421|24-month follow-up|8
48089567|NCT01949051|100541201|FG005|COMPLETED|Treatment Period 1 (7 Days)||13||
48089568|NCT01949051|100541196|FG000|NOT COMPLETED|Treatment Period 1 (7 Days)||2||
48684975|NCT02969915|102013124|FG001|COMPLETED|Overall Study||492|24-month follow-up|8
48684976|NCT02969915|102013123|FG000|NOT COMPLETED|Overall Study||693||0
48089569|NCT01949051|100541197|FG001|NOT COMPLETED|Treatment Period 1 (7 Days)||0||
48089570|NCT01949051|100541198|FG002|NOT COMPLETED|Treatment Period 1 (7 Days)||0||
48684977|NCT02969915|102013124|FG001|NOT COMPLETED|Overall Study||708||0
48684978|NCT02141672|102013125|FG000|STARTED|Overall Study||89||
48684979|NCT02141672|102013126|FG001|STARTED|Overall Study||88||
48684980|NCT02141672|102013127|FG002|STARTED|Overall Study||88||
48684981|NCT02141672|102013125|FG000|COMPLETED|Overall Study||73||
48684982|NCT02141672|102013126|FG001|COMPLETED|Overall Study||80||
48684983|NCT02141672|102013127|FG002|COMPLETED|Overall Study||70||
48684984|NCT02141672|102013125|FG000|NOT COMPLETED|Overall Study||16||
48379825|NCT01488318|101258506|FG000|NOT COMPLETED|Overall Study||0||
48379826|NCT02913222|101258507|FG000|STARTED|Overall Study||23||
48379827|NCT02913222|101258508|FG001|STARTED|Overall Study||23||
48379828|NCT02913222|101258507|FG000|COMPLETED|Overall Study||22||
48379829|NCT02913222|101258508|FG001|COMPLETED|Overall Study||21||
48379830|NCT02913222|101258507|FG000|NOT COMPLETED|Overall Study||1||
48379831|NCT02913222|101258508|FG001|NOT COMPLETED|Overall Study||2||
48379832|NCT00937560|101258509|FG000|STARTED|Initial Treatment||189||
48379833|NCT00937560|101258509|FG000|Received Treatment|Initial Treatment||189||
48379834|NCT00937560|101258509|FG000|COMPLETED|Initial Treatment||168||
48379835|NCT00937560|101258509|FG000|NOT COMPLETED|Initial Treatment||21||
48379836|NCT00937560|101258509|FG000|STARTED|Maintenance Treatment||168||
48379837|NCT00937560|101258509|FG000|COMPLETED|Maintenance Treatment||150||
48379838|NCT00937560|101258509|FG000|NOT COMPLETED|Maintenance Treatment||18||
48379839|NCT01269372|101258510|FG000|STARTED|Overall Study||30||
48379840|NCT01269372|101258510|FG000|COMPLETED|Overall Study||30||
48379841|NCT01269372|101258510|FG000|NOT COMPLETED|Overall Study||0||
48684985|NCT02141672|102013126|FG001|NOT COMPLETED|Overall Study||8||
48684986|NCT02141672|102013127|FG002|NOT COMPLETED|Overall Study||18||
48089571|NCT01949051|100541199|FG003|NOT COMPLETED|Treatment Period 1 (7 Days)||1||
48089572|NCT01949051|100541200|FG004|NOT COMPLETED|Treatment Period 1 (7 Days)||0||
48089573|NCT01949051|100541201|FG005|NOT COMPLETED|Treatment Period 1 (7 Days)||0||
48089574|NCT01949051|100541196|FG000|STARTED|Washout Period 1 (14 to 20 Days)||11||
48089575|NCT01949051|100541197|FG001|STARTED|Washout Period 1 (14 to 20 Days)||13||
48089576|NCT01949051|100541198|FG002|STARTED|Washout Period 1 (14 to 20 Days)||13||
48089577|NCT01949051|100541199|FG003|STARTED|Washout Period 1 (14 to 20 Days)||12||
48089578|NCT01949051|100541200|FG004|STARTED|Washout Period 1 (14 to 20 Days)||13||
48089579|NCT01949051|100541201|FG005|STARTED|Washout Period 1 (14 to 20 Days)||13||
48089580|NCT01949051|100541196|FG000|COMPLETED|Washout Period 1 (14 to 20 Days)||11||
48089581|NCT01949051|100541197|FG001|COMPLETED|Washout Period 1 (14 to 20 Days)||13||
48089582|NCT01949051|100541198|FG002|COMPLETED|Washout Period 1 (14 to 20 Days)||13||
48089583|NCT01949051|100541199|FG003|COMPLETED|Washout Period 1 (14 to 20 Days)||12||
48089584|NCT01949051|100541200|FG004|COMPLETED|Washout Period 1 (14 to 20 Days)||13||
48253039|NCT02097849|100936908|FG001|COMPLETED|Overall Study||38||
48253040|NCT02097849|100936907|FG000|NOT COMPLETED|Overall Study||0||
48253041|NCT02097849|100936908|FG001|NOT COMPLETED|Overall Study||0||
48253042|NCT01920178|100936909|FG000|STARTED|Overall Study||5||
48253043|NCT01920178|100936910|FG001|STARTED|Overall Study||2||
48379842|NCT01202227|101258511|FG000|STARTED|Overall Study||103||
48089585|NCT01949051|100541201|FG005|COMPLETED|Washout Period 1 (14 to 20 Days)||13||
48089586|NCT01949051|100541196|FG000|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0||
48089587|NCT01949051|100541197|FG001|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0||
48089588|NCT01949051|100541198|FG002|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0||
48089589|NCT01949051|100541199|FG003|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0||
48089590|NCT01949051|100541200|FG004|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0||
48089591|NCT01949051|100541201|FG005|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0||
48089592|NCT01949051|100541196|FG000|STARTED|Treatment Period 2 (7 Days)||11||
48089593|NCT01949051|100541197|FG001|STARTED|Treatment Period 2 (7 Days)||13||
48089594|NCT01949051|100541198|FG002|STARTED|Treatment Period 2 (7 Days)||13||
48089595|NCT01949051|100541199|FG003|STARTED|Treatment Period 2 (7 Days)||12||
48089596|NCT01949051|100541200|FG004|STARTED|Treatment Period 2 (7 Days)||13||
48089597|NCT01949051|100541201|FG005|STARTED|Treatment Period 2 (7 Days)||13||
48089598|NCT01949051|100541196|FG000|COMPLETED|Treatment Period 2 (7 Days)||11||
48089599|NCT01949051|100541197|FG001|COMPLETED|Treatment Period 2 (7 Days)||12||
48089600|NCT01949051|100541198|FG002|COMPLETED|Treatment Period 2 (7 Days)||12||
48089601|NCT01949051|100541199|FG003|COMPLETED|Treatment Period 2 (7 Days)||12||
48089602|NCT01949051|100541200|FG004|COMPLETED|Treatment Period 2 (7 Days)||13||
48089603|NCT01949051|100541201|FG005|COMPLETED|Treatment Period 2 (7 Days)||12||
48089604|NCT01949051|100541196|FG000|NOT COMPLETED|Treatment Period 2 (7 Days)||0||
48089605|NCT01949051|100541197|FG001|NOT COMPLETED|Treatment Period 2 (7 Days)||1||
48089606|NCT01949051|100541198|FG002|NOT COMPLETED|Treatment Period 2 (7 Days)||1||
48089607|NCT01949051|100541199|FG003|NOT COMPLETED|Treatment Period 2 (7 Days)||0||
48089608|NCT01949051|100541200|FG004|NOT COMPLETED|Treatment Period 2 (7 Days)||0||
48089609|NCT01949051|100541201|FG005|NOT COMPLETED|Treatment Period 2 (7 Days)||1||
48089610|NCT01949051|100541196|FG000|STARTED|Washout Period 2 (14 to 20 Days)||11||
48089611|NCT01949051|100541197|FG001|STARTED|Washout Period 2 (14 to 20 Days)||12||
48089612|NCT01949051|100541198|FG002|STARTED|Washout Period 2 (14 to 20 Days)||12||
48089613|NCT01949051|100541199|FG003|STARTED|Washout Period 2 (14 to 20 Days)||12||
48089614|NCT01949051|100541200|FG004|STARTED|Washout Period 2 (14 to 20 Days)||13||
48089615|NCT01949051|100541201|FG005|STARTED|Washout Period 2 (14 to 20 Days)||12||
48089616|NCT01949051|100541196|FG000|COMPLETED|Washout Period 2 (14 to 20 Days)||11||
48253044|NCT01920178|100936909|FG000|COMPLETED|Overall Study||3||
48253045|NCT01920178|100936910|FG001|COMPLETED|Overall Study||1||
48253046|NCT01920178|100936909|FG000|NOT COMPLETED|Overall Study||2||
48253047|NCT01920178|100936910|FG001|NOT COMPLETED|Overall Study||1||
48253048|NCT01435798|100936911|FG000|STARTED|Overall Study||26||
48253049|NCT01435798|100936911|FG000|0% MTD|Overall Study||25||
48253050|NCT01435798|100936911|FG000|25% MTD|Overall Study||26||
48253051|NCT01435798|100936911|FG000|50% MTD|Overall Study||25||
48253052|NCT01435798|100936911|FG000|100% MTD|Overall Study||25||
48253053|NCT01435798|100936911|FG000|COMPLETED|Overall Study||25||
48253054|NCT01435798|100936911|FG000|NOT COMPLETED|Overall Study||1||
48253055|NCT00363649|100936912|FG000|STARTED|Overall Study||18||
48253056|NCT00363649|100936913|FG001|STARTED|Overall Study||16||
48253057|NCT00363649|100936912|FG000|Crossed Over to Arm B|Overall Study||9||
48089617|NCT01949051|100541197|FG001|COMPLETED|Washout Period 2 (14 to 20 Days)||12||
48089618|NCT01949051|100541198|FG002|COMPLETED|Washout Period 2 (14 to 20 Days)||12||
48089619|NCT01949051|100541199|FG003|COMPLETED|Washout Period 2 (14 to 20 Days)||12||
48089620|NCT01949051|100541200|FG004|COMPLETED|Washout Period 2 (14 to 20 Days)||13||
48089621|NCT01949051|100541201|FG005|COMPLETED|Washout Period 2 (14 to 20 Days)||12||
48089622|NCT01949051|100541196|FG000|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0||
48089623|NCT01949051|100541197|FG001|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0||
48253058|NCT00363649|100936913|FG001|Crossed Over to Arm B|Overall Study||0||
48253059|NCT00363649|100936912|FG000|Crossed Over to Arm A|Overall Study||0||
48253060|NCT00363649|100936913|FG001|Crossed Over to Arm A|Overall Study||12||
48089624|NCT01949051|100541198|FG002|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0||
48089625|NCT01949051|100541199|FG003|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0||
48089626|NCT01949051|100541200|FG004|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0||
48089627|NCT01949051|100541201|FG005|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0||
48089628|NCT01949051|100541196|FG000|STARTED|Treatment Period 3 (7 Days)||11||
48089629|NCT01949051|100541197|FG001|STARTED|Treatment Period 3 (7 Days)||12||
48089630|NCT01949051|100541198|FG002|STARTED|Treatment Period 3 (7 Days)||12||
48089631|NCT01949051|100541199|FG003|STARTED|Treatment Period 3 (7 Days)||12||
48089632|NCT01949051|100541200|FG004|STARTED|Treatment Period 3 (7 Days)||13||
48089633|NCT01949051|100541201|FG005|STARTED|Treatment Period 3 (7 Days)||12||
48089634|NCT01949051|100541196|FG000|COMPLETED|Treatment Period 3 (7 Days)||11||
48089635|NCT01949051|100541197|FG001|COMPLETED|Treatment Period 3 (7 Days)||12||
48089636|NCT01949051|100541198|FG002|COMPLETED|Treatment Period 3 (7 Days)||12||
48089637|NCT01949051|100541199|FG003|COMPLETED|Treatment Period 3 (7 Days)||12||
48089638|NCT01949051|100541200|FG004|COMPLETED|Treatment Period 3 (7 Days)||13||
48089639|NCT01949051|100541201|FG005|COMPLETED|Treatment Period 3 (7 Days)||12||
48089640|NCT01949051|100541196|FG000|NOT COMPLETED|Treatment Period 3 (7 Days)||0||
48089641|NCT01949051|100541197|FG001|NOT COMPLETED|Treatment Period 3 (7 Days)||0||
48089642|NCT01949051|100541198|FG002|NOT COMPLETED|Treatment Period 3 (7 Days)||0||
48089643|NCT01949051|100541199|FG003|NOT COMPLETED|Treatment Period 3 (7 Days)||0||
48089644|NCT01949051|100541200|FG004|NOT COMPLETED|Treatment Period 3 (7 Days)||0||
48089645|NCT01949051|100541201|FG005|NOT COMPLETED|Treatment Period 3 (7 Days)||0||
48089646|NCT02664441|100541202|FG000|STARTED|Randomization||23||
48089647|NCT02664441|100541203|FG001|STARTED|Randomization||19||
48379843|NCT01202227|101258511|FG000|COMPLETED|Overall Study||84||
48379844|NCT01202227|101258511|FG000|NOT COMPLETED|Overall Study||19||
48379845|NCT00099359|101258512|FG000|STARTED|Overall Study||581||
48089648|NCT02664441|100541202|FG000|COMPLETED|Randomization||23||
48089649|NCT02664441|100541203|FG001|COMPLETED|Randomization||18||
48089650|NCT02664441|100541202|FG000|NOT COMPLETED|Randomization||0||
48379846|NCT00099359|101258513|FG001|STARTED|Overall Study||580||
48379847|NCT00099359|101258514|FG002|STARTED|Overall Study||574||
48379848|NCT00099359|101258512|FG000|COMPLETED|Overall Study||527||
48592694|NCT01877382|101783151|FG001|NOT COMPLETED|Dose Expansion||0||
48089651|NCT02664441|100541203|FG001|NOT COMPLETED|Randomization||1||
48089652|NCT02664441|100541202|FG000|STARTED|36-week Randomized Trial||23||
48089653|NCT02664441|100541203|FG001|STARTED|36-week Randomized Trial||18||
48089654|NCT02664441|100541202|FG000|COMPLETED|36-week Randomized Trial||20||
48089655|NCT02664441|100541203|FG001|COMPLETED|36-week Randomized Trial||15||
48089656|NCT02664441|100541202|FG000|NOT COMPLETED|36-week Randomized Trial||3||
48089657|NCT02664441|100541203|FG001|NOT COMPLETED|36-week Randomized Trial||3||
48089658|NCT02664441|100541202|FG000|STARTED|18-week Open Label Extension||20||
48089659|NCT02664441|100541203|FG001|STARTED|18-week Open Label Extension||15||
48089660|NCT02664441|100541202|FG000|COMPLETED|18-week Open Label Extension||17||
48089661|NCT02664441|100541203|FG001|COMPLETED|18-week Open Label Extension||14||
48089662|NCT02664441|100541202|FG000|NOT COMPLETED|18-week Open Label Extension||3||
48089663|NCT02664441|100541203|FG001|NOT COMPLETED|18-week Open Label Extension||1||
48089664|NCT00477971|100541204|FG000|STARTED|Overall Study||34||
48089665|NCT00477971|100541205|FG001|STARTED|Overall Study||55||
48089666|NCT00477971|100541204|FG000|COMPLETED|Overall Study||17||
48089667|NCT00477971|100541205|FG001|COMPLETED|Overall Study||49||
48089668|NCT00477971|100541204|FG000|NOT COMPLETED|Overall Study||17||
48089669|NCT00477971|100541205|FG001|NOT COMPLETED|Overall Study||6||
48089670|NCT01414114|100541206|FG000|STARTED|Overall Study||37||
48089671|NCT01414114|100541206|FG000|COMPLETED|Overall Study||32||
48089672|NCT01414114|100541206|FG000|NOT COMPLETED|Overall Study||5||
48089673|NCT01059799|100541207|FG000|STARTED|Overall Study||289||
48089674|NCT01059799|100541208|FG001|STARTED|Overall Study||146||
48089675|NCT01059799|100541207|FG000|Exposed|Overall Study||284||
48089676|NCT01059799|100541208|FG001|Exposed|Overall Study||146||
48089677|NCT01059799|100541207|FG000|COMPLETED|Overall Study||258||
48089678|NCT01059799|100541208|FG001|COMPLETED|Overall Study||136||
48089679|NCT01059799|100541207|FG000|NOT COMPLETED|Overall Study||31||
48089680|NCT01059799|100541208|FG001|NOT COMPLETED|Overall Study||10||
48089681|NCT03848650|100541209|FG000|STARTED|Overall Study||60||
48089682|NCT03848650|100541209|FG000|COMPLETED|Overall Study||60||
48089683|NCT03848650|100541209|FG000|NOT COMPLETED|Overall Study||0||
48089684|NCT00345345|100541210|FG000|STARTED|Overall Study||29||
48089685|NCT00345345|100541210|FG000|COMPLETED|Overall Study||27||
48089686|NCT00345345|100541210|FG000|NOT COMPLETED|Overall Study||2||
48089687|NCT03138889|100541211|FG000|STARTED|Overall Study||12||
48089688|NCT03138889|100541212|FG001|STARTED|Overall Study||23||
48379849|NCT00099359|101258513|FG001|COMPLETED|Overall Study||515||
48379850|NCT00099359|101258514|FG002|COMPLETED|Overall Study||506||
48379851|NCT00099359|101258512|FG000|NOT COMPLETED|Overall Study||54||
48089689|NCT03138889|100541213|FG002|STARTED|Overall Study||4||
48089690|NCT03138889|100541214|FG003|STARTED|Overall Study||7||
48089691|NCT03138889|100541215|FG004|STARTED|Overall Study||7||
48089692|NCT03138889|100541216|FG005|STARTED|Overall Study||75||
48089693|NCT03138889|100541217|FG006|STARTED|Overall Study||17||
48089694|NCT03138889|100541218|FG007|STARTED|Overall Study||17||
48089695|NCT03138889|100541211|FG000|COMPLETED|Overall Study||7||
48089696|NCT03138889|100541212|FG001|COMPLETED|Overall Study||18||
48089697|NCT03138889|100541213|FG002|COMPLETED|Overall Study||4||
48253061|NCT00363649|100936912|FG000|Did Not Cross Over|Overall Study||2||
48253062|NCT00363649|100936913|FG001|Did Not Cross Over|Overall Study||3||
48253063|NCT00363649|100936912|FG000|COMPLETED|Overall Study||11||
48253064|NCT00363649|100936913|FG001|COMPLETED|Overall Study||15||
48253065|NCT00363649|100936912|FG000|NOT COMPLETED|Overall Study||7||
48253066|NCT00363649|100936913|FG001|NOT COMPLETED|Overall Study||1||
48253067|NCT02299427|100936914|FG000|STARTED|Overall Study||35||
48253068|NCT02299427|100936915|FG001|STARTED|Overall Study||34||
48253069|NCT02299427|100936914|FG000|COMPLETED|Overall Study||12||
48253070|NCT02299427|100936915|FG001|COMPLETED|Overall Study||31||
48253071|NCT02299427|100936914|FG000|NOT COMPLETED|Overall Study||23||
48253072|NCT02299427|100936915|FG001|NOT COMPLETED|Overall Study||3||
48253073|NCT00594178|100936916|FG000|STARTED|Overall Study||17||
48253074|NCT00594178|100936916|FG000|COMPLETED|Overall Study||12||
48253075|NCT00594178|100936916|FG000|NOT COMPLETED|Overall Study||5||
48253076|NCT02316847|100936917|FG000|STARTED|Overall Study||9||
48253077|NCT02316847|100936918|FG001|STARTED|Overall Study||99||
48253078|NCT02316847|100936917|FG000|COMPLETED|Overall Study||0||
48253079|NCT02316847|100936918|FG001|COMPLETED|Overall Study||13||
48253080|NCT02316847|100936917|FG000|NOT COMPLETED|Overall Study||9||
48253081|NCT02316847|100936918|FG001|NOT COMPLETED|Overall Study||86||
48253082|NCT00474383|100936919|FG000|STARTED|Main Study||47||
48253083|NCT00474383|100936920|FG001|STARTED|Main Study||0||
48253084|NCT00474383|100936919|FG000|COMPLETED|Main Study||11||
48253085|NCT00474383|100936920|FG001|COMPLETED|Main Study||0||
48253086|NCT00474383|100936919|FG000|NOT COMPLETED|Main Study||36||
48253087|NCT00474383|100936920|FG001|NOT COMPLETED|Main Study||0||
48253088|NCT00474383|100936919|FG000|STARTED|Between Main Study and Extension||11||
48253089|NCT00474383|100936920|FG001|STARTED|Between Main Study and Extension||0||
48253090|NCT00474383|100936919|FG000|COMPLETED|Between Main Study and Extension||5||
48253091|NCT00474383|100936920|FG001|COMPLETED|Between Main Study and Extension||0||
48253092|NCT00474383|100936919|FG000|NOT COMPLETED|Between Main Study and Extension||6||
48253093|NCT00474383|100936920|FG001|NOT COMPLETED|Between Main Study and Extension||0||
48253094|NCT00474383|100936919|FG000|STARTED|Extension||0||
48253095|NCT00474383|100936920|FG001|STARTED|Extension||5||
48253096|NCT00474383|100936919|FG000|COMPLETED|Extension||0||
48253097|NCT00474383|100936920|FG001|COMPLETED|Extension||0||
48253098|NCT00474383|100936919|FG000|NOT COMPLETED|Extension||0||
48253099|NCT00474383|100936920|FG001|NOT COMPLETED|Extension||5||
48253100|NCT02025647|100936921|FG000|STARTED|Overall Study||139||
48253101|NCT02025647|100936921|FG000|Session 1 (Narrative Module)|Overall Study||139||
48253102|NCT02025647|100936921|FG000|Immediate Retest (Rating Module: 5 Min)|Overall Study||97||
48253103|NCT02025647|100936921|FG000|Session 2 (Narrative Module: 24-48 Hrs)|Overall Study||117||
48253104|NCT02025647|100936921|FG000|Session 3 (Rating Module: 30-45 Days)|Overall Study||76||
48253105|NCT02025647|100936921|FG000|COMPLETED|Overall Study||139||
48253106|NCT02025647|100936921|FG000|NOT COMPLETED|Overall Study||0||
48253107|NCT02413593|100936922|FG000|STARTED|Overall Study||111||
48253108|NCT02413593|100936922|FG000|COMPLETED|Overall Study||107||
48253109|NCT02413593|100936922|FG000|NOT COMPLETED|Overall Study||4||
48253110|NCT01572298|100936923|FG000|STARTED|Overall Study||14||
48253111|NCT01572298|100936924|FG001|STARTED|Overall Study||13||
48253112|NCT01572298|100936923|FG000|COMPLETED|Overall Study||12||
48253113|NCT01572298|100936924|FG001|COMPLETED|Overall Study||12||
48253114|NCT01572298|100936923|FG000|NOT COMPLETED|Overall Study||2||
48253115|NCT01572298|100936924|FG001|NOT COMPLETED|Overall Study||1||
48253116|NCT00575367|100936925|FG000|STARTED|Overall Study||19||
48253117|NCT00575367|100936926|FG001|STARTED|Overall Study||18||
48253118|NCT00575367|100936925|FG000|COMPLETED|Overall Study||19||
48253119|NCT00575367|100936926|FG001|COMPLETED|Overall Study||18||
48253120|NCT00575367|100936925|FG000|NOT COMPLETED|Overall Study||0||
48253121|NCT00575367|100936926|FG001|NOT COMPLETED|Overall Study||0||
48253122|NCT00337285|100939962|FG000|STARTED|Overall Study||349||
48253123|NCT00337285|100939962|FG000|COMPLETED|Overall Study||191||
48089698|NCT03138889|100541214|FG003|COMPLETED|Overall Study||5||
48089699|NCT03138889|100541215|FG004|COMPLETED|Overall Study||6||
48089700|NCT03138889|100541216|FG005|COMPLETED|Overall Study||72||
48089701|NCT03138889|100541217|FG006|COMPLETED|Overall Study||17||
48089702|NCT03138889|100541218|FG007|COMPLETED|Overall Study||16||
48089703|NCT03138889|100541211|FG000|NOT COMPLETED|Overall Study||5||
48089704|NCT03138889|100541212|FG001|NOT COMPLETED|Overall Study||5||
48253124|NCT00337285|100939962|FG000|NOT COMPLETED|Overall Study||158||
48253125|NCT03294941|100939963|FG000|STARTED|Overall Study||4||
48253126|NCT03294941|100939964|FG001|STARTED|Overall Study||13||
48253127|NCT03294941|100939963|FG000|COMPLETED|Overall Study||4||
48253128|NCT03294941|100939964|FG001|COMPLETED|Overall Study||11||
48089705|NCT03138889|100541213|FG002|NOT COMPLETED|Overall Study||0||
48089706|NCT03138889|100541214|FG003|NOT COMPLETED|Overall Study||2||
48089707|NCT03138889|100541215|FG004|NOT COMPLETED|Overall Study||1||
48253129|NCT03294941|100939963|FG000|NOT COMPLETED|Overall Study||0||
48253130|NCT03294941|100939964|FG001|NOT COMPLETED|Overall Study||2||
48253131|NCT01085812|100939965|FG000|STARTED|Open-Label Period||0||
48379852|NCT00099359|101258513|FG001|NOT COMPLETED|Overall Study||65||
48379853|NCT00099359|101258514|FG002|NOT COMPLETED|Overall Study||68||
48379854|NCT01606761|101258515|FG000|STARTED|Prior to Week 24||294||
48089708|NCT03138889|100541216|FG005|NOT COMPLETED|Overall Study||3||
48089709|NCT03138889|100541217|FG006|NOT COMPLETED|Overall Study||0||
48089710|NCT03138889|100541218|FG007|NOT COMPLETED|Overall Study||1||
48089711|NCT01500629|100541219|FG000|STARTED|Period 1 (Single Dose)||11||
48089712|NCT01500629|100541220|FG001|STARTED|Period 1 (Single Dose)||10||
48089713|NCT01500629|100541219|FG000|COMPLETED|Period 1 (Single Dose)||11||
48089714|NCT01500629|100541220|FG001|COMPLETED|Period 1 (Single Dose)||10||
48089715|NCT01500629|100541219|FG000|NOT COMPLETED|Period 1 (Single Dose)||0||
48089716|NCT01500629|100541220|FG001|NOT COMPLETED|Period 1 (Single Dose)||0||
48089717|NCT01500629|100541219|FG000|STARTED|Washout Period of 14 to 30 Days||11||
48089718|NCT01500629|100541220|FG001|STARTED|Washout Period of 14 to 30 Days||10||
48089719|NCT01500629|100541219|FG000|COMPLETED|Washout Period of 14 to 30 Days||10||
48089720|NCT01500629|100541220|FG001|COMPLETED|Washout Period of 14 to 30 Days||10||
48089721|NCT01500629|100541219|FG000|NOT COMPLETED|Washout Period of 14 to 30 Days||1||
48089722|NCT01500629|100541220|FG001|NOT COMPLETED|Washout Period of 14 to 30 Days||0||
48089723|NCT01500629|100541219|FG000|STARTED|Period 2 (Single Dose)||10||
48089724|NCT01500629|100541220|FG001|STARTED|Period 2 (Single Dose)||10||
48089725|NCT01500629|100541219|FG000|COMPLETED|Period 2 (Single Dose)||10||
48089726|NCT01500629|100541220|FG001|COMPLETED|Period 2 (Single Dose)||10||
48089727|NCT01500629|100541219|FG000|NOT COMPLETED|Period 2 (Single Dose)||0||
48089728|NCT01500629|100541220|FG001|NOT COMPLETED|Period 2 (Single Dose)||0||
48089729|NCT02387853|100541221|FG000|STARTED|Overall Study||106||
48089730|NCT02387853|100541221|FG000|COMPLETED|Overall Study||103||
48089731|NCT02387853|100541221|FG000|NOT COMPLETED|Overall Study||3||
48089732|NCT00706407|100541222|FG000|STARTED|Overall Study||42||
48089733|NCT00706407|100541222|FG000|COMPLETED|Overall Study||33||
48089734|NCT00706407|100541222|FG000|NOT COMPLETED|Overall Study||9||
48089735|NCT02642952|100541223|FG000|STARTED|Overall Study||21||
48379855|NCT01606761|101258516|FG001|STARTED|Prior to Week 24||292||
48379856|NCT01606761|101258517|FG002|STARTED|Prior to Week 24||292||
48379857|NCT01606761|101258518|FG003|STARTED|Prior to Week 24||0||
48379858|NCT01606761|101258519|FG004|STARTED|Prior to Week 24||0||
48379859|NCT01606761|101258515|FG000|Participants Re-randomized at Week 18|Prior to Week 24||94||
48379860|NCT01606761|101258516|FG001|Participants Re-randomized at Week 18|Prior to Week 24||0||
48379861|NCT01606761|101258517|FG002|Participants Re-randomized at Week 18|Prior to Week 24||0||
48379862|NCT01606761|101258518|FG003|Participants Re-randomized at Week 18|Prior to Week 24||0||
48379863|NCT01606761|101258519|FG004|Participants Re-randomized at Week 18|Prior to Week 24||0||
48379864|NCT01606761|101258515|FG000|COMPLETED|Prior to Week 24||252||
48379865|NCT01606761|101258516|FG001|COMPLETED|Prior to Week 24||237||
48379866|NCT01606761|101258517|FG002|COMPLETED|Prior to Week 24||245||
48379867|NCT01606761|101258518|FG003|COMPLETED|Prior to Week 24||0||
48379868|NCT01606761|101258519|FG004|COMPLETED|Prior to Week 24||0||
48379869|NCT01606761|101258515|FG000|NOT COMPLETED|Prior to Week 24||42||
48379870|NCT01606761|101258516|FG001|NOT COMPLETED|Prior to Week 24||55||
48379871|NCT01606761|101258517|FG002|NOT COMPLETED|Prior to Week 24||47||
48379872|NCT01606761|101258518|FG003|NOT COMPLETED|Prior to Week 24||0||
48379873|NCT01606761|101258519|FG004|NOT COMPLETED|Prior to Week 24||0||
48379874|NCT01606761|101258515|FG000|STARTED|Week 24 to Week 52||0||
48379875|NCT01606761|101258516|FG001|STARTED|Week 24 to Week 52||237||
48089736|NCT02642952|100541224|FG001|STARTED|Overall Study||30||
48089737|NCT02642952|100541223|FG000|COMPLETED|Overall Study||19||
48089738|NCT02642952|100541224|FG001|COMPLETED|Overall Study||25||
48089739|NCT02642952|100541223|FG000|NOT COMPLETED|Overall Study||2||
48089740|NCT02642952|100541224|FG001|NOT COMPLETED|Overall Study||5||
48089741|NCT00754624|100541225|FG000|STARTED|Overall Study||229||
48089742|NCT00754624|100541225|FG000|COMPLETED|Overall Study||160||
48089743|NCT00754624|100541225|FG000|NOT COMPLETED|Overall Study||69||
48089744|NCT02961751|100541226|FG000|STARTED|Overall Study||211||
48089745|NCT02961751|100541226|FG000|COMPLETED|Overall Study||196||
48089746|NCT02961751|100541226|FG000|NOT COMPLETED|Overall Study||15||
48089747|NCT00931762|100541227|FG000|STARTED|Overall Study||35||
48089748|NCT00931762|100541227|FG000|COMPLETED|Overall Study||0||
48089749|NCT00931762|100541227|FG000|NOT COMPLETED|Overall Study||35||
48089750|NCT00390858|100541228|FG000|STARTED|Overall Study||20||
48089751|NCT00390858|100541229|FG001|STARTED|Overall Study||20||
48089752|NCT00390858|100541228|FG000|Completed Core & Entered Extension Study|Overall Study||19||
48089753|NCT00390858|100541229|FG001|Completed Core & Entered Extension Study|Overall Study||20||
48089754|NCT00390858|100541228|FG000|COMPLETED|Overall Study||11||
48089755|NCT00390858|100541229|FG001|COMPLETED|Overall Study||13||
48089756|NCT00390858|100541228|FG000|NOT COMPLETED|Overall Study||9||
48379876|NCT01606761|101258517|FG002|STARTED|Week 24 to Week 52||245||
48379877|NCT01606761|101258518|FG003|STARTED|Week 24 to Week 52||126||
48379878|NCT01606761|101258519|FG004|STARTED|Week 24 to Week 52||126||
48379879|NCT01606761|101258515|FG000|Treated|Week 24 to Week 52||0||
48089757|NCT00390858|100541229|FG001|NOT COMPLETED|Overall Study||7||
48089758|NCT00877383|100541230|FG000|STARTED|Overall Study||572||
48089759|NCT00877383|100541231|FG001|STARTED|Overall Study||570||
48379880|NCT01606761|101258516|FG001|Treated|Week 24 to Week 52||237||
48379881|NCT01606761|101258517|FG002|Treated|Week 24 to Week 52||245||
48379882|NCT01606761|101258518|FG003|Treated|Week 24 to Week 52||124||
48089760|NCT00877383|100541230|FG000|COMPLETED|Overall Study||543||
48089761|NCT00877383|100541231|FG001|COMPLETED|Overall Study||533||
48379883|NCT01606761|101258519|FG004|Treated|Week 24 to Week 52||126||
48379884|NCT01606761|101258515|FG000|COMPLETED|Week 24 to Week 52||0||
48379885|NCT01606761|101258516|FG001|COMPLETED|Week 24 to Week 52||204||
48379886|NCT01606761|101258517|FG002|COMPLETED|Week 24 to Week 52||212||
48379887|NCT01606761|101258518|FG003|COMPLETED|Week 24 to Week 52||109||
48379888|NCT01606761|101258519|FG004|COMPLETED|Week 24 to Week 52||106||
48379889|NCT01606761|101258515|FG000|NOT COMPLETED|Week 24 to Week 52||0||
48379890|NCT01606761|101258516|FG001|NOT COMPLETED|Week 24 to Week 52||33||
48379891|NCT01606761|101258517|FG002|NOT COMPLETED|Week 24 to Week 52||33||
48379892|NCT01606761|101258518|FG003|NOT COMPLETED|Week 24 to Week 52||17||
48379893|NCT01606761|101258519|FG004|NOT COMPLETED|Week 24 to Week 52||20||
48379894|NCT01606761|101258515|FG000|STARTED|Safety Follow-up Period (Week 52-68)||28||
48379895|NCT01606761|101258516|FG001|STARTED|Safety Follow-up Period (Week 52-68)||65||
48379896|NCT01606761|101258517|FG002|STARTED|Safety Follow-up Period (Week 52-68)||62||
48379897|NCT01606761|101258518|FG003|STARTED|Safety Follow-up Period (Week 52-68)||9||
48379898|NCT01606761|101258519|FG004|STARTED|Safety Follow-up Period (Week 52-68)||19||
48379899|NCT01606761|101258515|FG000|Safety Population|Safety Follow-up Period (Week 52-68)||28||
48379900|NCT01606761|101258516|FG001|Safety Population|Safety Follow-up Period (Week 52-68)||65||
48379901|NCT01606761|101258517|FG002|Safety Population|Safety Follow-up Period (Week 52-68)||62||
48379902|NCT01606761|101258518|FG003|Safety Population|Safety Follow-up Period (Week 52-68)||7||
48379903|NCT01606761|101258519|FG004|Safety Population|Safety Follow-up Period (Week 52-68)||19||
48379904|NCT01606761|101258515|FG000|COMPLETED|Safety Follow-up Period (Week 52-68)||24||
48379905|NCT01606761|101258516|FG001|COMPLETED|Safety Follow-up Period (Week 52-68)||55||
48379906|NCT01606761|101258517|FG002|COMPLETED|Safety Follow-up Period (Week 52-68)||45||
48379907|NCT01606761|101258518|FG003|COMPLETED|Safety Follow-up Period (Week 52-68)||7||
48379908|NCT01606761|101258519|FG004|COMPLETED|Safety Follow-up Period (Week 52-68)||11||
48379909|NCT01606761|101258515|FG000|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||4||
48379910|NCT01606761|101258516|FG001|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||10||
48379911|NCT01606761|101258517|FG002|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||17||
48379912|NCT01606761|101258518|FG003|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||2||
48379913|NCT01606761|101258519|FG004|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||8||
48379914|NCT03442829|101258520|FG000|STARTED|Overall Study||27||
48379915|NCT03442829|101258521|FG001|STARTED|Overall Study||27||
48379916|NCT03442829|101258520|FG000|COMPLETED|Overall Study||23||
48379917|NCT03442829|101258521|FG001|COMPLETED|Overall Study||25||
48379918|NCT03442829|101258520|FG000|NOT COMPLETED|Overall Study||4||
48379919|NCT03442829|101258521|FG001|NOT COMPLETED|Overall Study||2||
48379920|NCT01051986|101258522|FG000|STARTED|Overall Study||112||
48379921|NCT01051986|101258523|FG001|STARTED|Overall Study||112||
48379922|NCT01051986|101258522|FG000|COMPLETED|Overall Study||107||
48379923|NCT01051986|101258523|FG001|COMPLETED|Overall Study||108||
48379924|NCT01051986|101258522|FG000|NOT COMPLETED|Overall Study||5||
48379925|NCT01051986|101258523|FG001|NOT COMPLETED|Overall Study||4||
48379926|NCT05216406|101258524|FG000|STARTED|Overall Study||39||
48379927|NCT05216406|101258525|FG001|STARTED|Overall Study||26||
48379928|NCT05216406|101258524|FG000|COMPLETED|Overall Study||31||
48379929|NCT05216406|101258525|FG001|COMPLETED|Overall Study||17||
48379930|NCT05216406|101258524|FG000|NOT COMPLETED|Overall Study||8||
48379931|NCT05216406|101258525|FG001|NOT COMPLETED|Overall Study||9||
48379932|NCT04937816|101258526|FG000|STARTED|Overall Study||2337|Randomised|
48379933|NCT04937816|101258527|FG001|STARTED|Overall Study||2347|Randomised|
48379934|NCT04937816|101258528|FG002|STARTED|Overall Study||2344|Randomised|
48379935|NCT04937816|101258529|FG003|STARTED|Overall Study||2991|Randomised|
48379936|NCT04937816|101258530|FG004|STARTED|Overall Study||2997|Randomised|
48379937|NCT04937816|101258531|FG005|STARTED|Overall Study||1867|Randomised|
48379938|NCT04937816|101258532|FG006|STARTED|Overall Study||1863|Randomised|
48089762|NCT00877383|100541230|FG000|NOT COMPLETED|Overall Study||29||
48089763|NCT00877383|100541231|FG001|NOT COMPLETED|Overall Study||37||
48379939|NCT04937816|101258526|FG000|Treated|Overall Study||2333||
48379940|NCT04937816|101258527|FG001|Treated|Overall Study||2345||
48379941|NCT04937816|101258528|FG002|Treated|Overall Study||2342||
48379942|NCT04937816|101258529|FG003|Treated|Overall Study||2989||
48379943|NCT04937816|101258530|FG004|Treated|Overall Study||2996||
48379944|NCT04937816|101258531|FG005|Treated|Overall Study||1863||
48379945|NCT04937816|101258532|FG006|Treated|Overall Study||1863||
48379946|NCT04937816|101258526|FG000|COMPLETED|Overall Study||1650||
48379947|NCT04937816|101258527|FG001|COMPLETED|Overall Study||1790||
48379948|NCT04937816|101258528|FG002|COMPLETED|Overall Study||1800||
48379949|NCT04937816|101258529|FG003|COMPLETED|Overall Study||2046||
48379950|NCT04937816|101258530|FG004|COMPLETED|Overall Study||2051||
48379951|NCT04937816|101258531|FG005|COMPLETED|Overall Study||1352||
48089764|NCT00113217|100541232|FG000|STARTED|Overall Study||50||
48089765|NCT00113217|100541232|FG000|COMPLETED|Overall Study||50||
48089766|NCT00113217|100541232|FG000|NOT COMPLETED|Overall Study||0||
48089767|NCT04474704|100541233|FG000|STARTED|Overall Study||21||
48379952|NCT04937816|101258532|FG006|COMPLETED|Overall Study||1381||
48379953|NCT04937816|101258526|FG000|NOT COMPLETED|Overall Study||687||
48379954|NCT04937816|101258527|FG001|NOT COMPLETED|Overall Study||557||
48379955|NCT04937816|101258528|FG002|NOT COMPLETED|Overall Study||544||
48089768|NCT04474704|100541234|FG001|STARTED|Overall Study||26||
48089769|NCT04474704|100541233|FG000|COMPLETED|Overall Study||21||
48089770|NCT04474704|100541234|FG001|COMPLETED|Overall Study||26||
48379956|NCT04937816|101258529|FG003|NOT COMPLETED|Overall Study||945||
48379957|NCT04937816|101258530|FG004|NOT COMPLETED|Overall Study||946||
48379958|NCT04937816|101258531|FG005|NOT COMPLETED|Overall Study||515||
48379959|NCT04937816|101258532|FG006|NOT COMPLETED|Overall Study||482||
48379960|NCT04507867|101258533|FG000|STARTED|Overall Study||40||
48379961|NCT04507867|101258534|FG001|STARTED|Overall Study||40||
48379962|NCT04507867|101258533|FG000|COMPLETED|Overall Study||33||
48379963|NCT04507867|101258534|FG001|COMPLETED|Overall Study||39||
48379964|NCT04507867|101258533|FG000|NOT COMPLETED|Overall Study||7||
48379965|NCT04507867|101258534|FG001|NOT COMPLETED|Overall Study||1||
48379966|NCT04664855|101258535|FG000|STARTED|Overall Study||23||
48379967|NCT04664855|101258536|FG001|STARTED|Overall Study||24||
48379968|NCT04664855|101258535|FG000|COMPLETED|Overall Study||23||
48379969|NCT04664855|101258536|FG001|COMPLETED|Overall Study||22||
48379970|NCT04664855|101258535|FG000|NOT COMPLETED|Overall Study||0||
48379971|NCT04664855|101258536|FG001|NOT COMPLETED|Overall Study||2||
48379972|NCT04574297|101258537|FG000|STARTED|Overall Study||180||
48379973|NCT04574297|101258538|FG001|STARTED|Overall Study||263||
48379974|NCT04574297|101258539|FG002|STARTED|Overall Study||230||
48379975|NCT04574297|101258540|FG003|STARTED|Overall Study||125||
48379976|NCT04574297|101258537|FG000|COMPLETED|Overall Study||180||
48379977|NCT04574297|101258538|FG001|COMPLETED|Overall Study||263||
48379978|NCT04574297|101258539|FG002|COMPLETED|Overall Study||230||
48379979|NCT04574297|101258540|FG003|COMPLETED|Overall Study||125||
48379980|NCT04574297|101258537|FG000|NOT COMPLETED|Overall Study||0||
48379981|NCT04574297|101258538|FG001|NOT COMPLETED|Overall Study||0||
48379982|NCT04574297|101258539|FG002|NOT COMPLETED|Overall Study||0||
48379983|NCT04574297|101258540|FG003|NOT COMPLETED|Overall Study||0||
48379984|NCT02768194|101258541|FG000|STARTED|Period 1||4||
48379985|NCT02768194|101258542|FG001|STARTED|Period 1||4||
48379986|NCT02768194|101258543|FG002|STARTED|Period 1||4||
48379987|NCT02768194|101258544|FG003|STARTED|Period 1||4||
48379988|NCT02768194|101258545|FG004|STARTED|Period 1||4||
48379989|NCT02768194|101258546|FG005|STARTED|Period 1||4||
48379990|NCT02768194|101258541|FG000|COMPLETED|Period 1||4||
48379991|NCT02768194|101258542|FG001|COMPLETED|Period 1||4||
48379992|NCT02768194|101258543|FG002|COMPLETED|Period 1||4||
48379993|NCT02768194|101258544|FG003|COMPLETED|Period 1||3||
48379994|NCT02768194|101258545|FG004|COMPLETED|Period 1||4||
48379995|NCT02768194|101258546|FG005|COMPLETED|Period 1||4||
48379996|NCT02768194|101258541|FG000|NOT COMPLETED|Period 1||0||
48379997|NCT02768194|101258542|FG001|NOT COMPLETED|Period 1||0||
48379998|NCT02768194|101258543|FG002|NOT COMPLETED|Period 1||0||
48379999|NCT02768194|101258544|FG003|NOT COMPLETED|Period 1||1||
48380000|NCT02768194|101258545|FG004|NOT COMPLETED|Period 1||0||
48380001|NCT02768194|101258546|FG005|NOT COMPLETED|Period 1||0||
48380002|NCT02768194|101258541|FG000|STARTED|Period 2||4||
48089771|NCT04474704|100541233|FG000|NOT COMPLETED|Overall Study||0||
48089772|NCT04474704|100541234|FG001|NOT COMPLETED|Overall Study||0||
48089773|NCT02825992|100541235|FG000|STARTED|Overall Study||129||
48089774|NCT02825992|100541235|FG000|COMPLETED|Overall Study||121||
48089775|NCT02825992|100541235|FG000|NOT COMPLETED|Overall Study||8||
48089776|NCT01457521|100541236|FG000|STARTED|Overall Study||123||
48089777|NCT01457521|100541237|FG001|STARTED|Overall Study||127||
48089778|NCT01457521|100541236|FG000|COMPLETED|Overall Study||111||
48089779|NCT01457521|100541237|FG001|COMPLETED|Overall Study||117||
48089780|NCT01457521|100541236|FG000|NOT COMPLETED|Overall Study||12||
48380003|NCT02768194|101258542|FG001|STARTED|Period 2||4||
48380004|NCT02768194|101258543|FG002|STARTED|Period 2||4||
48089781|NCT01457521|100541237|FG001|NOT COMPLETED|Overall Study||10||
48089782|NCT04147221|100541238|FG000|STARTED|Overall Study||9||
48089783|NCT04147221|100541238|FG000|COMPLETED|Overall Study||9||
48089784|NCT04147221|100541238|FG000|NOT COMPLETED|Overall Study||0||
48089785|NCT02196558|100541239|FG000|STARTED|Treatment Phase (12 Weeks)||12||
48380005|NCT02768194|101258544|FG003|STARTED|Period 2||3||
48380006|NCT02768194|101258545|FG004|STARTED|Period 2||4||
48380007|NCT02768194|101258546|FG005|STARTED|Period 2||4||
48380008|NCT02768194|101258541|FG000|COMPLETED|Period 2||3||
48380009|NCT02768194|101258542|FG001|COMPLETED|Period 2||4||
48380010|NCT02768194|101258543|FG002|COMPLETED|Period 2||4||
48380011|NCT02768194|101258544|FG003|COMPLETED|Period 2||3||
48380012|NCT02768194|101258545|FG004|COMPLETED|Period 2||4||
48380013|NCT02768194|101258546|FG005|COMPLETED|Period 2||4||
48380014|NCT02768194|101258541|FG000|NOT COMPLETED|Period 2||1||
48380015|NCT02768194|101258542|FG001|NOT COMPLETED|Period 2||0||
48380016|NCT02768194|101258543|FG002|NOT COMPLETED|Period 2||0||
48380017|NCT02768194|101258544|FG003|NOT COMPLETED|Period 2||0||
48380018|NCT02768194|101258545|FG004|NOT COMPLETED|Period 2||0||
48380019|NCT02768194|101258546|FG005|NOT COMPLETED|Period 2||0||
48380020|NCT02768194|101258541|FG000|STARTED|Period 3||3||
48380021|NCT02768194|101258542|FG001|STARTED|Period 3||4||
48380022|NCT02768194|101258543|FG002|STARTED|Period 3||4||
48380023|NCT02768194|101258544|FG003|STARTED|Period 3||3||
48684987|NCT02688192|102013128|FG000|STARTED|Overall Study||25||
48684988|NCT02688192|102013129|FG001|STARTED|Overall Study||24||
48684989|NCT02688192|102013128|FG000|COMPLETED|Overall Study||13||
48684990|NCT02688192|102013129|FG001|COMPLETED|Overall Study||19||
48089786|NCT02196558|100541240|FG001|STARTED|Treatment Phase (12 Weeks)||15||
48089787|NCT02196558|100541241|FG002|STARTED|Treatment Phase (12 Weeks)||10||
48380024|NCT02768194|101258545|FG004|STARTED|Period 3||4||
48380025|NCT02768194|101258546|FG005|STARTED|Period 3||4||
48380026|NCT02768194|101258541|FG000|COMPLETED|Period 3||3||
48380027|NCT02768194|101258542|FG001|COMPLETED|Period 3||3||
48380028|NCT02768194|101258543|FG002|COMPLETED|Period 3||4||
48380029|NCT02768194|101258544|FG003|COMPLETED|Period 3||3||
48089788|NCT02196558|100541239|FG000|COMPLETED|Treatment Phase (12 Weeks)||12||
48089789|NCT02196558|100541240|FG001|COMPLETED|Treatment Phase (12 Weeks)||12||
48089790|NCT02196558|100541241|FG002|COMPLETED|Treatment Phase (12 Weeks)||8||
48380030|NCT02768194|101258545|FG004|COMPLETED|Period 3||4||
48380031|NCT02768194|101258546|FG005|COMPLETED|Period 3||4||
48380032|NCT02768194|101258541|FG000|NOT COMPLETED|Period 3||0||
48380033|NCT02768194|101258542|FG001|NOT COMPLETED|Period 3||1||
48380034|NCT02768194|101258543|FG002|NOT COMPLETED|Period 3||0||
48380035|NCT02768194|101258544|FG003|NOT COMPLETED|Period 3||0||
48380036|NCT02768194|101258545|FG004|NOT COMPLETED|Period 3||0||
48380037|NCT02768194|101258546|FG005|NOT COMPLETED|Period 3||0||
48380038|NCT00748553|101258547|FG000|STARTED|Overall Study||16||
48380039|NCT00748553|101258548|FG001|STARTED|Overall Study||14||
48380040|NCT00748553|101258547|FG000|COMPLETED|Overall Study||13||
48380041|NCT00748553|101258548|FG001|COMPLETED|Overall Study||13||
48380042|NCT00748553|101258547|FG000|NOT COMPLETED|Overall Study||3||
48380043|NCT00748553|101258548|FG001|NOT COMPLETED|Overall Study||1||
48380044|NCT04633473|101258549|FG000|STARTED|Overall Study||43||
48380045|NCT04633473|101258549|FG000|COMPLETED|Overall Study||37||
48380046|NCT04633473|101258549|FG000|NOT COMPLETED|Overall Study||6||
48380047|NCT03609658|101258550|FG000|STARTED|Overall Study||379||
48380048|NCT03609658|101258551|FG001|STARTED|Overall Study||380||
48380049|NCT03609658|101258550|FG000|COMPLETED|Overall Study||379||
48380050|NCT03609658|101258551|FG001|COMPLETED|Overall Study||380||
48380051|NCT03609658|101258550|FG000|NOT COMPLETED|Overall Study||0||
48380052|NCT03609658|101258551|FG001|NOT COMPLETED|Overall Study||0||
48380053|NCT01727713|101258552|FG000|STARTED|Overall Study||110||
48380054|NCT01727713|101258552|FG000|COMPLETED|Overall Study||75||
48380055|NCT01727713|101258552|FG000|NOT COMPLETED|Overall Study||35||
48380056|NCT02175771|101258553|FG000|STARTED|Run-In Period (Pre-assignment)||758||
48380057|NCT02175771|101258554|FG001|STARTED|Run-In Period (Pre-assignment)||0||
48380058|NCT02175771|101258555|FG002|STARTED|Run-In Period (Pre-assignment)||0||
48380059|NCT02175771|101258556|FG003|STARTED|Run-In Period (Pre-assignment)||0||
48380060|NCT02175771|101258557|FG004|STARTED|Run-In Period (Pre-assignment)||0||
48380061|NCT02175771|101258558|FG005|STARTED|Run-In Period (Pre-assignment)||0||
48380062|NCT02175771|101258559|FG006|STARTED|Run-In Period (Pre-assignment)||0||
48684991|NCT02688192|102013128|FG000|NOT COMPLETED|Overall Study||12||
48089791|NCT02196558|100541239|FG000|NOT COMPLETED|Treatment Phase (12 Weeks)||0||
48089792|NCT02196558|100541240|FG001|NOT COMPLETED|Treatment Phase (12 Weeks)||3||
48380063|NCT02175771|101258560|FG007|STARTED|Run-In Period (Pre-assignment)||0||
48380064|NCT02175771|101258561|FG008|STARTED|Run-In Period (Pre-assignment)||0||
48380065|NCT02175771|101258553|FG000|COMPLETED|Run-In Period (Pre-assignment)||674||
48380066|NCT02175771|101258554|FG001|COMPLETED|Run-In Period (Pre-assignment)||0||
48380067|NCT02175771|101258555|FG002|COMPLETED|Run-In Period (Pre-assignment)||0||
48380068|NCT02175771|101258556|FG003|COMPLETED|Run-In Period (Pre-assignment)||0||
48684992|NCT02688192|102013129|FG001|NOT COMPLETED|Overall Study||5||
48684993|NCT00375674|102013130|FG000|STARTED|Overall Study||309||
48684994|NCT00375674|102013131|FG001|STARTED|Overall Study||306||
48684995|NCT00375674|102013130|FG000|Intent-to-Treat Population|Overall Study||309|All randomized participants, who received study drug/a different drug to which they were randomized|
48684996|NCT00375674|102013131|FG001|Intent-to-Treat Population|Overall Study||306|All randomized participants, who received study drug/a different drug to which they were randomized|
48710699|NCT00846040|102077993|FG000|COMPLETED|Washout: 2 Weeks to 10 Weeks||9||
48380069|NCT02175771|101258557|FG004|COMPLETED|Run-In Period (Pre-assignment)||0||
48380070|NCT02175771|101258558|FG005|COMPLETED|Run-In Period (Pre-assignment)||0||
48380071|NCT02175771|101258559|FG006|COMPLETED|Run-In Period (Pre-assignment)||0||
48380072|NCT02175771|101258560|FG007|COMPLETED|Run-In Period (Pre-assignment)||0||
48380073|NCT02175771|101258561|FG008|COMPLETED|Run-In Period (Pre-assignment)||0||
48380074|NCT02175771|101258553|FG000|NOT COMPLETED|Run-In Period (Pre-assignment)||84||
48380075|NCT02175771|101258554|FG001|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
48380076|NCT02175771|101258555|FG002|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
48380077|NCT02175771|101258556|FG003|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
48380078|NCT02175771|101258557|FG004|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
48380079|NCT02175771|101258558|FG005|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
48592695|NCT01877382|101783152|FG002|NOT COMPLETED|Dose Expansion||0||
48380080|NCT02175771|101258559|FG006|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
48380081|NCT02175771|101258560|FG007|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
48380082|NCT02175771|101258561|FG008|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
48380083|NCT02175771|101258553|FG000|STARTED|Treatment Period||0||
48380084|NCT02175771|101258554|FG001|STARTED|Treatment Period||127||
48380085|NCT02175771|101258555|FG002|STARTED|Treatment Period||42||
48380086|NCT02175771|101258556|FG003|STARTED|Treatment Period||126||
48380087|NCT02175771|101258557|FG004|STARTED|Treatment Period||41||
48380088|NCT02175771|101258558|FG005|STARTED|Treatment Period||120||
48380089|NCT02175771|101258559|FG006|STARTED|Treatment Period||41||
48380090|NCT02175771|101258560|FG007|STARTED|Treatment Period||133||
48380091|NCT02175771|101258561|FG008|STARTED|Treatment Period||44||
48380092|NCT02175771|101258553|FG000|COMPLETED|Treatment Period||0||
48380093|NCT02175771|101258554|FG001|COMPLETED|Treatment Period||111||
48380094|NCT02175771|101258555|FG002|COMPLETED|Treatment Period||35||
48380095|NCT02175771|101258556|FG003|COMPLETED|Treatment Period||113||
48380096|NCT02175771|101258557|FG004|COMPLETED|Treatment Period||36||
48380097|NCT02175771|101258558|FG005|COMPLETED|Treatment Period||110||
48380098|NCT02175771|101258559|FG006|COMPLETED|Treatment Period||36||
48380099|NCT02175771|101258560|FG007|COMPLETED|Treatment Period||116||
48380100|NCT02175771|101258561|FG008|COMPLETED|Treatment Period||38||
48380101|NCT02175771|101258553|FG000|NOT COMPLETED|Treatment Period||0||
48380102|NCT02175771|101258554|FG001|NOT COMPLETED|Treatment Period||16||
48380103|NCT02175771|101258555|FG002|NOT COMPLETED|Treatment Period||7||
48380104|NCT02175771|101258556|FG003|NOT COMPLETED|Treatment Period||13||
48380105|NCT02175771|101258557|FG004|NOT COMPLETED|Treatment Period||5||
48380106|NCT02175771|101258558|FG005|NOT COMPLETED|Treatment Period||10||
48380107|NCT02175771|101258559|FG006|NOT COMPLETED|Treatment Period||5||
48380108|NCT02175771|101258560|FG007|NOT COMPLETED|Treatment Period||17||
48380109|NCT02175771|101258561|FG008|NOT COMPLETED|Treatment Period||6||
48380110|NCT02073435|101258562|FG000|STARTED|Overall Study||81||
48380111|NCT02073435|101258563|FG001|STARTED|Overall Study||96||
48380112|NCT02073435|101258562|FG000|COMPLETED|Overall Study||81||
48380113|NCT02073435|101258563|FG001|COMPLETED|Overall Study||96||
48380114|NCT02073435|101258562|FG000|NOT COMPLETED|Overall Study||0||
48380115|NCT02073435|101258563|FG001|NOT COMPLETED|Overall Study||0||
48380116|NCT03150095|101258564|FG000|STARTED|Overall Study||30||
48380117|NCT03150095|101258565|FG001|STARTED|Overall Study||30||
48380118|NCT03150095|101258564|FG000|COMPLETED|Overall Study||21||
48380119|NCT03150095|101258565|FG001|COMPLETED|Overall Study||28||
48380120|NCT03150095|101258564|FG000|NOT COMPLETED|Overall Study||9||
48380121|NCT03150095|101258565|FG001|NOT COMPLETED|Overall Study||2||
48380122|NCT03364608|101258566|FG000|STARTED|Overall Study||86|ITT Analysis Set|
48380123|NCT03364608|101258566|FG000|Placebo MDI|Overall Study||82|(2 actuations)|
48380124|NCT03364608|101258566|FG000|AS MDI 90 µg|Overall Study||81|(2 actuations of 45 µg/actuation)|
48380125|NCT03364608|101258566|FG000|AS MDI 180 µg|Overall Study||81|(2 actuations of 90 µg/actuation)|
48380126|NCT03364608|101258566|FG000|Proventil 90 µg|Overall Study||82|(1 actuation of 90 µg/actuation)|
48380127|NCT03364608|101258566|FG000|Proventil 180 µg|Overall Study||79|(2 actuations of 90 µg/actuation)|
48380128|NCT03364608|101258566|FG000|COMPLETED|Overall Study||78||
48380129|NCT03364608|101258566|FG000|NOT COMPLETED|Overall Study||8||
48380130|NCT01628250|101258567|FG000|STARTED|Overall Study||49||
48380131|NCT01628250|101258568|FG001|STARTED|Overall Study||50||
48380132|NCT01628250|101258567|FG000|COMPLETED|Overall Study||49||
48380133|NCT01628250|101258568|FG001|COMPLETED|Overall Study||50||
48380134|NCT01628250|101258567|FG000|NOT COMPLETED|Overall Study||0||
48380135|NCT01628250|101258568|FG001|NOT COMPLETED|Overall Study||0||
48380136|NCT02324842|101258569|FG000|STARTED|Overall Study||15||
48380137|NCT02324842|101258570|FG001|STARTED|Overall Study||15||
48380138|NCT02324842|101258571|FG002|STARTED|Overall Study||15||
48380139|NCT02324842|101258569|FG000|COMPLETED|Overall Study||14||
48380140|NCT02324842|101258570|FG001|COMPLETED|Overall Study||14||
48380141|NCT02324842|101258571|FG002|COMPLETED|Overall Study||13||
48380142|NCT02324842|101258569|FG000|NOT COMPLETED|Overall Study||1||
48380143|NCT02324842|101258570|FG001|NOT COMPLETED|Overall Study||1||
48380144|NCT02324842|101258571|FG002|NOT COMPLETED|Overall Study||2||
48380145|NCT03288493|101258572|FG000|STARTED|Overall Study||69||
48380146|NCT03288493|101258573|FG001|STARTED|Overall Study||3||
48380147|NCT03288493|101258574|FG002|STARTED|Overall Study||1||
48380148|NCT03288493|101258575|FG003|STARTED|Overall Study||8||
48380149|NCT03288493|101258576|FG004|STARTED|Overall Study||5||
48380150|NCT03288493|101258577|FG005|STARTED|Overall Study||16||
48380151|NCT03288493|101258578|FG006|STARTED|Overall Study||3||
48380152|NCT03288493|101258572|FG000|COMPLETED|Overall Study||3|Completed Study is defined as a subject completing Post-Treatment Follow-up Visits to Month 24.|
48380153|NCT03288493|101258573|FG001|COMPLETED|Overall Study||0|Completed Study is defined as a subject completing Post-Treatment Follow-up Visits to Month 24.|
48380154|NCT03288493|101258574|FG002|COMPLETED|Overall Study||0|Completed Study is defined as a subject completing Post-Treatment Follow-up Visits to Month 24.|
48380155|NCT03288493|101258575|FG003|COMPLETED|Overall Study||0|Completed Study is defined as a subject completing Post-Treatment Follow-up Visits to Month 24.|
48380156|NCT03288493|101258576|FG004|COMPLETED|Overall Study||0|Completed Study is defined as a subject completing Post-Treatment Follow-up Visits to Month 24.|
48592696|NCT01877382|101783153|FG003|NOT COMPLETED|Dose Expansion||0||
48380157|NCT03288493|101258577|FG005|COMPLETED|Overall Study||0|Completed Study is defined as a subject completing Post-Treatment Follow-up Visits to Month 24.|
48380158|NCT03288493|101258578|FG006|COMPLETED|Overall Study||0|Completed Study is defined as a subject completing Post-Treatment Follow-up Visits to Month 24.|
48380159|NCT03288493|101258572|FG000|NOT COMPLETED|Overall Study||66||
48380160|NCT03288493|101258573|FG001|NOT COMPLETED|Overall Study||3||
48380161|NCT03288493|101258574|FG002|NOT COMPLETED|Overall Study||1||
48380162|NCT03288493|101258575|FG003|NOT COMPLETED|Overall Study||8||
48380163|NCT03288493|101258576|FG004|NOT COMPLETED|Overall Study||5||
48380164|NCT03288493|101258577|FG005|NOT COMPLETED|Overall Study||16||
48380165|NCT03288493|101258578|FG006|NOT COMPLETED|Overall Study||3||
48380166|NCT02279524|101258579|FG000|STARTED|Overall Study||98||
48380167|NCT02279524|101258580|FG001|STARTED|Overall Study||101||
48380168|NCT02279524|101258581|FG002|STARTED|Overall Study||48||
48380169|NCT02279524|101258579|FG000|COMPLETED|Overall Study||88||
48380170|NCT02279524|101258580|FG001|COMPLETED|Overall Study||90||
48380171|NCT02279524|101258581|FG002|COMPLETED|Overall Study||41||
48380172|NCT02279524|101258579|FG000|NOT COMPLETED|Overall Study||10||
48380173|NCT02279524|101258580|FG001|NOT COMPLETED|Overall Study||11||
48380174|NCT02279524|101258581|FG002|NOT COMPLETED|Overall Study||7||
48380175|NCT03888391|101258582|FG000|STARTED|Overall Study||18||
48380176|NCT03888391|101258582|FG000|COMPLETED|Overall Study||3||
48380177|NCT03888391|101258582|FG000|NOT COMPLETED|Overall Study||15||
48380178|NCT02775760|101258583|FG000|STARTED|Overall Study||17||
48380179|NCT02775760|101258584|FG001|STARTED|Overall Study||12||
48380180|NCT02775760|101258583|FG000|COMPLETED|Overall Study||12||
48380181|NCT02775760|101258584|FG001|COMPLETED|Overall Study||7||
48380182|NCT02775760|101258583|FG000|NOT COMPLETED|Overall Study||5||
48380183|NCT02775760|101258584|FG001|NOT COMPLETED|Overall Study||5||
48380184|NCT03050359|101258585|FG000|STARTED|Overall Study||265||
48380185|NCT03050359|101258586|FG001|STARTED|Overall Study||268||
48380186|NCT03050359|101258585|FG000|COMPLETED|Overall Study||248||
48380187|NCT03050359|101258586|FG001|COMPLETED|Overall Study||248||
48380188|NCT03050359|101258585|FG000|NOT COMPLETED|Overall Study||17||
48380189|NCT03050359|101258586|FG001|NOT COMPLETED|Overall Study||20||
48380190|NCT00414960|101258587|FG000|STARTED|Overall Study||25||
48380191|NCT00414960|101258588|FG001|STARTED|Overall Study||15||
48380192|NCT00414960|101258587|FG000|Received at Least One Dose of Study Drug|Overall Study||24||
48380193|NCT00414960|101258588|FG001|Received at Least One Dose of Study Drug|Overall Study||15||
48380194|NCT00414960|101258587|FG000|COMPLETED|Overall Study||18||
48380195|NCT00414960|101258588|FG001|COMPLETED|Overall Study||14||
48380196|NCT00414960|101258587|FG000|NOT COMPLETED|Overall Study||7||
48380197|NCT00414960|101258588|FG001|NOT COMPLETED|Overall Study||1||
48380198|NCT00335504|101258589|FG000|STARTED|Overall Study||22||
48380199|NCT00335504|101258590|FG001|STARTED|Overall Study||21||
48380200|NCT00335504|101258591|FG002|STARTED|Overall Study||20||
48380201|NCT00335504|101258592|FG003|STARTED|Overall Study||22||
48380202|NCT00335504|101258589|FG000|COMPLETED|Overall Study||22||
48380203|NCT00335504|101258590|FG001|COMPLETED|Overall Study||21||
48380204|NCT00335504|101258591|FG002|COMPLETED|Overall Study||20||
48380205|NCT00335504|101258592|FG003|COMPLETED|Overall Study||22||
48380206|NCT00335504|101258589|FG000|NOT COMPLETED|Overall Study||0||
48380207|NCT00335504|101258590|FG001|NOT COMPLETED|Overall Study||0||
48380208|NCT00335504|101258591|FG002|NOT COMPLETED|Overall Study||0||
48380209|NCT00335504|101258592|FG003|NOT COMPLETED|Overall Study||0||
48541326|NCT03787134|101662701|FG004|Outcome 18 - IEM|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541327|NCT03787134|101662702|FG005|Outcome 18 - IEM|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48541328|NCT03787134|101662703|FG006|Outcome 18 - IEM|Overall Study||0|Number of Participants who contributed data for outcome by experimental design, not all sub-studies were designed to collect data for all outcomes.|
48380210|NCT00304265|101258593|FG000|STARTED|Overall Study||117||
48380211|NCT00304265|101258594|FG001|STARTED|Overall Study||98||
48380212|NCT00304265|101258593|FG000|COMPLETED|Overall Study||117||
48380213|NCT00304265|101258594|FG001|COMPLETED|Overall Study||98||
48380214|NCT00304265|101258593|FG000|NOT COMPLETED|Overall Study||0||
48380215|NCT00304265|101258594|FG001|NOT COMPLETED|Overall Study||0||
48380216|NCT04191577|101258595|FG000|STARTED|Overall Study||44|Number of patients to be enrolled.|
48380217|NCT04191577|101258596|FG001|STARTED|Overall Study||45|Number of patients to be enrolled.|
48380218|NCT04191577|101258597|FG002|STARTED|Overall Study||47|Number of patients to be enrolled.|
48380219|NCT04191577|101258595|FG000|COMPLETED|Overall Study||41||
48380220|NCT04191577|101258596|FG001|COMPLETED|Overall Study||42||
48380221|NCT04191577|101258597|FG002|COMPLETED|Overall Study||44||
48380222|NCT04191577|101258595|FG000|NOT COMPLETED|Overall Study||3||
48380223|NCT04191577|101258596|FG001|NOT COMPLETED|Overall Study||3||
48380224|NCT04191577|101258597|FG002|NOT COMPLETED|Overall Study||3||
48380225|NCT02493426|101258598|FG000|STARTED|Overall Study||14||
48380226|NCT02493426|101258599|FG001|STARTED|Overall Study||13||
48380227|NCT02493426|101258598|FG000|COMPLETED|Overall Study||14||
48380228|NCT02493426|101258599|FG001|COMPLETED|Overall Study||12||
48380229|NCT02493426|101258598|FG000|NOT COMPLETED|Overall Study||0||
48380230|NCT02493426|101258599|FG001|NOT COMPLETED|Overall Study||1||
48253132|NCT01085812|100939966|FG001|STARTED|Open-Label Period||734||
48253133|NCT01085812|100939965|FG000|COMPLETED|Open-Label Period||0||
48253134|NCT01085812|100939966|FG001|COMPLETED|Open-Label Period||494||
48253135|NCT01085812|100939965|FG000|NOT COMPLETED|Open-Label Period||0||
48253136|NCT01085812|100939966|FG001|NOT COMPLETED|Open-Label Period||240||
48253137|NCT01085812|100939965|FG000|STARTED|Double-Blind Period||113||
48253138|NCT01085812|100939966|FG001|STARTED|Double-Blind Period||235||
48253139|NCT01085812|100939965|FG000|COMPLETED|Double-Blind Period||92||
48253140|NCT01085812|100939966|FG001|COMPLETED|Double-Blind Period||177||
48253141|NCT01085812|100939965|FG000|NOT COMPLETED|Double-Blind Period||21||
48253142|NCT01085812|100939966|FG001|NOT COMPLETED|Double-Blind Period||58||
48253143|NCT01085812|100939965|FG000|STARTED|Double-blind Intent-to-treat Population||112||
48253144|NCT01085812|100939966|FG001|STARTED|Double-blind Intent-to-treat Population||230||
48253145|NCT01085812|100939965|FG000|COMPLETED|Double-blind Intent-to-treat Population||92||
48253146|NCT01085812|100939966|FG001|COMPLETED|Double-blind Intent-to-treat Population||174||
48253147|NCT01085812|100939965|FG000|NOT COMPLETED|Double-blind Intent-to-treat Population||20||
48253148|NCT01085812|100939966|FG001|NOT COMPLETED|Double-blind Intent-to-treat Population||56||
48253149|NCT02246218|100939967|FG000|STARTED|Overall Study||10||
48253150|NCT02246218|100939968|FG001|STARTED|Overall Study||16||
48253151|NCT02246218|100939967|FG000|COMPLETED|Overall Study||6||
48253152|NCT02246218|100939968|FG001|COMPLETED|Overall Study||10||
48253153|NCT02246218|100939967|FG000|NOT COMPLETED|Overall Study||4||
48253154|NCT02246218|100939968|FG001|NOT COMPLETED|Overall Study||6||
48253155|NCT00239681|100939969|FG000|STARTED|Overall Study||8901||
48253156|NCT00239681|100939970|FG001|STARTED|Overall Study||8901||
48253157|NCT00239681|100939969|FG000|Randomized and Treated (Safety Pop)|Overall Study||8869||
48253158|NCT00239681|100939970|FG001|Randomized and Treated (Safety Pop)|Overall Study||8864||
48253159|NCT00239681|100939969|FG000|COMPLETED|Overall Study||8208||
48253160|NCT00239681|100939970|FG001|COMPLETED|Overall Study||8186||
48253161|NCT00239681|100939969|FG000|NOT COMPLETED|Overall Study||693||
48253162|NCT00239681|100939970|FG001|NOT COMPLETED|Overall Study||715||
48253163|NCT01878383|100939971|FG000|STARTED|Overall Study||50||
48253164|NCT01878383|100939972|FG001|STARTED|Overall Study||12500||
48253165|NCT01878383|100939971|FG000|COMPLETED|Overall Study||50||
48253166|NCT01878383|100939972|FG001|COMPLETED|Overall Study||11001||
48253167|NCT01878383|100939971|FG000|NOT COMPLETED|Overall Study||0||
48253168|NCT01878383|100939972|FG001|NOT COMPLETED|Overall Study||1499||
48253169|NCT02412111|100939973|FG000|STARTED|Ivacaftor Run-in Period (4 Weeks)||156||
48253170|NCT02412111|100939974|FG001|STARTED|Ivacaftor Run-in Period (4 Weeks)||0||
48253171|NCT02412111|100939975|FG002|STARTED|Ivacaftor Run-in Period (4 Weeks)||0||
48253172|NCT02412111|100939973|FG000|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||153||
48253173|NCT02412111|100939974|FG001|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0||
48253174|NCT02412111|100939975|FG002|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0||
48253175|NCT02412111|100939973|FG000|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||3||
48253176|NCT02412111|100939974|FG001|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0||
48253177|NCT02412111|100939975|FG002|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0||
48253178|NCT02412111|100939973|FG000|STARTED|Active Comparator Period (8 Weeks)||0|Two participants who completed the Run-in period did not enter the active comparator period.|
48253179|NCT02412111|100939974|FG001|STARTED|Active Comparator Period (8 Weeks)||76|Two participants who completed the Run-in period did not enter the active comparator period.|
48253180|NCT02412111|100939975|FG002|STARTED|Active Comparator Period (8 Weeks)||75|Two participants who completed the Run-in period did not enter the active comparator period.|
48253181|NCT02412111|100939973|FG000|Full Analysis Set|Active Comparator Period (8 Weeks)||0||
48253182|NCT02412111|100939974|FG001|Full Analysis Set|Active Comparator Period (8 Weeks)||76||
48253183|NCT02412111|100939975|FG002|Full Analysis Set|Active Comparator Period (8 Weeks)||74||
48253184|NCT02412111|100939973|FG000|COMPLETED|Active Comparator Period (8 Weeks)||0||
48253185|NCT02412111|100939974|FG001|COMPLETED|Active Comparator Period (8 Weeks)||75||
48253186|NCT02412111|100939975|FG002|COMPLETED|Active Comparator Period (8 Weeks)||69||
48253187|NCT02412111|100939973|FG000|NOT COMPLETED|Active Comparator Period (8 Weeks)||0||
48253188|NCT02412111|100939974|FG001|NOT COMPLETED|Active Comparator Period (8 Weeks)||1||
48253189|NCT02412111|100939975|FG002|NOT COMPLETED|Active Comparator Period (8 Weeks)||6||
48253190|NCT00582114|100939976|FG000|STARTED|Overall Study||100||
48253191|NCT00582114|100939977|FG001|STARTED|Overall Study||100||
48253192|NCT00582114|100939976|FG000|COMPLETED|Overall Study||58||
48253193|NCT00582114|100939977|FG001|COMPLETED|Overall Study||46||
48253194|NCT00582114|100939976|FG000|NOT COMPLETED|Overall Study||42||
48253195|NCT00582114|100939977|FG001|NOT COMPLETED|Overall Study||54||
48253196|NCT02725008|100939978|FG000|STARTED|Overall Study||46||
48253197|NCT02725008|100939979|FG001|STARTED|Overall Study||51||
48253198|NCT02725008|100939978|FG000|COMPLETED|Overall Study||37||
48253199|NCT02725008|100939979|FG001|COMPLETED|Overall Study||39||
48253200|NCT02725008|100939978|FG000|NOT COMPLETED|Overall Study||9||
48253201|NCT02725008|100939979|FG001|NOT COMPLETED|Overall Study||12||
48253202|NCT02427958|100939980|FG000|STARTED|Overall Study||307||
48253203|NCT02427958|100939980|FG000|COMPLETED|Overall Study||283||
48253204|NCT02427958|100939980|FG000|NOT COMPLETED|Overall Study||24||
48253205|NCT00690378|100939981|FG000|STARTED|Overall Study||69||
48253206|NCT00690378|100939982|FG001|STARTED|Overall Study||68||
48253207|NCT00690378|100939981|FG000|Treated|Overall Study||68||
48380231|NCT02096861|101258600|FG000|STARTED|Overall Study||56||
48380232|NCT02096861|101258601|FG001|STARTED|Overall Study||55||
48380233|NCT02096861|101258602|FG002|STARTED|Overall Study||54||
48380234|NCT02096861|101258603|FG003|STARTED|Overall Study||55||
48380235|NCT02096861|101258600|FG000|Drug Switching at Week 30|Overall Study||48||
48380236|NCT02096861|101258601|FG001|Drug Switching at Week 30|Overall Study||44||
48380237|NCT02096861|101258602|FG002|Drug Switching at Week 30|Overall Study||41||
48380238|NCT02096861|101258603|FG003|Drug Switching at Week 30|Overall Study||47||
48380239|NCT02096861|101258600|FG000|COMPLETED|Overall Study||44||
48380240|NCT02096861|101258601|FG001|COMPLETED|Overall Study||40||
48380241|NCT02096861|101258602|FG002|COMPLETED|Overall Study||37||
48380242|NCT02096861|101258603|FG003|COMPLETED|Overall Study||45||
48380243|NCT02096861|101258600|FG000|NOT COMPLETED|Overall Study||12||
48380244|NCT02096861|101258601|FG001|NOT COMPLETED|Overall Study||15||
48380245|NCT02096861|101258602|FG002|NOT COMPLETED|Overall Study||17||
48380246|NCT02096861|101258603|FG003|NOT COMPLETED|Overall Study||10||
48380247|NCT01781429|101258604|FG000|STARTED|Overall Study||1||
48380248|NCT01781429|101258605|FG001|STARTED|Overall Study||1||
48380249|NCT01781429|101258606|FG002|STARTED|Overall Study||1||
48380250|NCT01781429|101258607|FG003|STARTED|Overall Study||1||
48380251|NCT01781429|101258608|FG004|STARTED|Overall Study||1||
48380252|NCT01781429|101258609|FG005|STARTED|Overall Study||4||
48380253|NCT01781429|101258610|FG006|STARTED|Overall Study||7||
48380254|NCT01781429|101258611|FG007|STARTED|Overall Study||4||
48380255|NCT01781429|101258612|FG008|STARTED|Overall Study||7||
48380256|NCT01781429|101258613|FG009|STARTED|Overall Study||24||
48380257|NCT01781429|101258614|FG010|STARTED|Overall Study||18||
48380258|NCT01781429|101258615|FG011|STARTED|Overall Study||21||
48380259|NCT01781429|101258616|FG012|STARTED|Overall Study||22||
48380260|NCT01781429|101258617|FG013|STARTED|Overall Study||8||
48380261|NCT01781429|101258618|FG014|STARTED|Overall Study||16||
48380262|NCT01781429|101258619|FG015|STARTED|Overall Study||0||
48380263|NCT01781429|101258604|FG000|COMPLETED|Overall Study||0||
48380264|NCT01781429|101258605|FG001|COMPLETED|Overall Study||0||
48380265|NCT01781429|101258606|FG002|COMPLETED|Overall Study||0||
48380266|NCT01781429|101258607|FG003|COMPLETED|Overall Study||0||
48380267|NCT01781429|101258608|FG004|COMPLETED|Overall Study||0||
48380268|NCT01781429|101258609|FG005|COMPLETED|Overall Study||0||
48380269|NCT01781429|101258610|FG006|COMPLETED|Overall Study||0||
48380270|NCT01781429|101258611|FG007|COMPLETED|Overall Study||0||
48380271|NCT01781429|101258612|FG008|COMPLETED|Overall Study||0||
48380272|NCT01781429|101258613|FG009|COMPLETED|Overall Study||0||
48380273|NCT01781429|101258614|FG010|COMPLETED|Overall Study||0||
48380274|NCT01781429|101258615|FG011|COMPLETED|Overall Study||0||
48380275|NCT01781429|101258616|FG012|COMPLETED|Overall Study||0||
48380276|NCT01781429|101258617|FG013|COMPLETED|Overall Study||0||
48380277|NCT01781429|101258618|FG014|COMPLETED|Overall Study||0||
48380278|NCT01781429|101258619|FG015|COMPLETED|Overall Study||0||
48380279|NCT01781429|101258604|FG000|NOT COMPLETED|Overall Study||1||
48380280|NCT01781429|101258605|FG001|NOT COMPLETED|Overall Study||1||
48380281|NCT01781429|101258606|FG002|NOT COMPLETED|Overall Study||1||
48380282|NCT01781429|101258607|FG003|NOT COMPLETED|Overall Study||1||
48380283|NCT01781429|101258608|FG004|NOT COMPLETED|Overall Study||1||
48380284|NCT01781429|101258609|FG005|NOT COMPLETED|Overall Study||4||
48380285|NCT01781429|101258610|FG006|NOT COMPLETED|Overall Study||7||
48380286|NCT01781429|101258611|FG007|NOT COMPLETED|Overall Study||4||
48380287|NCT01781429|101258612|FG008|NOT COMPLETED|Overall Study||7||
48380288|NCT01781429|101258613|FG009|NOT COMPLETED|Overall Study||24||
48380289|NCT01781429|101258614|FG010|NOT COMPLETED|Overall Study||18||
48380290|NCT01781429|101258615|FG011|NOT COMPLETED|Overall Study||21||
48380291|NCT01781429|101258616|FG012|NOT COMPLETED|Overall Study||22||
48380292|NCT01781429|101258617|FG013|NOT COMPLETED|Overall Study||8||
48380293|NCT01781429|101258618|FG014|NOT COMPLETED|Overall Study||16||
48380294|NCT01781429|101258619|FG015|NOT COMPLETED|Overall Study||0||
48380295|NCT00859781|101258620|FG000|STARTED|Overall Study||38||
48380296|NCT00859781|101258621|FG001|STARTED|Overall Study||17||
48380297|NCT00859781|101258620|FG000|COMPLETED|Overall Study||38||
48380298|NCT00859781|101258621|FG001|COMPLETED|Overall Study||17||
48380299|NCT00859781|101258620|FG000|NOT COMPLETED|Overall Study||0||
48380300|NCT00859781|101258621|FG001|NOT COMPLETED|Overall Study||0||
48380301|NCT00798694|101258622|FG000|STARTED|Overall Study||30||
48380302|NCT00798694|101258623|FG001|STARTED|Overall Study||28||
48380303|NCT00798694|101258622|FG000|COMPLETED|Overall Study||28||
48380304|NCT00798694|101258623|FG001|COMPLETED|Overall Study||27||
48380305|NCT00798694|101258622|FG000|NOT COMPLETED|Overall Study||2||
48380306|NCT00798694|101258623|FG001|NOT COMPLETED|Overall Study||1||
48380307|NCT02635737|101258624|FG000|STARTED|Overall Study||29||
48380308|NCT02635737|101258624|FG000|COMPLETED|Overall Study||28||
48380309|NCT02635737|101258624|FG000|NOT COMPLETED|Overall Study||1||
48380310|NCT01603641|101258625|FG000|STARTED|Overall Study||370||
48380311|NCT01603641|101258625|FG000|Safety Population (Treated)|Overall Study||367||
48380312|NCT01603641|101258625|FG000|Modified Intent-to-treat Population|Overall Study||366||
48380313|NCT01603641|101258625|FG000|COMPLETED|Overall Study||335||
48380314|NCT01603641|101258625|FG000|NOT COMPLETED|Overall Study||35||
48380315|NCT02756650|101258626|FG000|STARTED|Overall Study||8||
48380316|NCT02756650|101258626|FG000|COMPLETED|Overall Study||6||
48380317|NCT02756650|101258626|FG000|NOT COMPLETED|Overall Study||2||
48380318|NCT00487084|101258627|FG000|STARTED|Overall Study||33||
48380319|NCT00487084|101258628|FG001|STARTED|Overall Study||33||
48380320|NCT00487084|101258629|FG002|STARTED|Overall Study||33||
48380321|NCT00487084|101258627|FG000|COMPLETED|Overall Study||29||
48380322|NCT00487084|101258628|FG001|COMPLETED|Overall Study||30||
48380323|NCT00487084|101258629|FG002|COMPLETED|Overall Study||28||
48380324|NCT00487084|101258627|FG000|NOT COMPLETED|Overall Study||4||
48380325|NCT00487084|101258628|FG001|NOT COMPLETED|Overall Study||3||
48380326|NCT00487084|101258629|FG002|NOT COMPLETED|Overall Study||5||
48380327|NCT04897841|101258630|FG000|STARTED|Overall Study||29||
48380328|NCT04897841|101258631|FG001|STARTED|Overall Study||31||
48380329|NCT04897841|101258630|FG000|COMPLETED|Overall Study||29||
48380330|NCT04897841|101258631|FG001|COMPLETED|Overall Study||31||
48380331|NCT04897841|101258630|FG000|NOT COMPLETED|Overall Study||0||
48380332|NCT04897841|101258631|FG001|NOT COMPLETED|Overall Study||0||
48380333|NCT00492856|101258632|FG000|STARTED|Induction||105||
48380334|NCT00492856|101258633|FG001|STARTED|Induction||0||
48380335|NCT00492856|101258634|FG002|STARTED|Induction||0||
48380336|NCT00492856|101258635|FG003|STARTED|Induction||0||
48380337|NCT00492856|101258632|FG000|COMPLETED|Induction||99||
48380338|NCT00492856|101258633|FG001|COMPLETED|Induction||0||
48380339|NCT00492856|101258634|FG002|COMPLETED|Induction||0||
48380340|NCT00492856|101258635|FG003|COMPLETED|Induction||0||
48380341|NCT00492856|101258632|FG000|NOT COMPLETED|Induction||6||
48380342|NCT00492856|101258633|FG001|NOT COMPLETED|Induction||0||
48380343|NCT00492856|101258634|FG002|NOT COMPLETED|Induction||0||
48380344|NCT00492856|101258635|FG003|NOT COMPLETED|Induction||0||
48380345|NCT00492856|101258632|FG000|STARTED|Consolidation||92||
48380346|NCT00492856|101258633|FG001|STARTED|Consolidation||0||
48380347|NCT00492856|101258634|FG002|STARTED|Consolidation||0||
48684997|NCT00375674|102013130|FG000|As-Treated Population|Overall Study||306|All participants, who received at least 1 dose of study drug according to actual study treatment|
48684998|NCT00375674|102013131|FG001|As-Treated Population|Overall Study||304|All participants, who received at least 1 dose of study drug according to actual study treatment|
48684999|NCT00375674|102013130|FG000|COMPLETED|Overall Study||165||
48089793|NCT02196558|100541241|FG002|NOT COMPLETED|Treatment Phase (12 Weeks)||2||
48380348|NCT00492856|101258635|FG003|STARTED|Consolidation||0||
48380349|NCT00492856|101258632|FG000|COMPLETED|Consolidation||83||
48380350|NCT00492856|101258633|FG001|COMPLETED|Consolidation||0||
48380351|NCT00492856|101258634|FG002|COMPLETED|Consolidation||0||
48380352|NCT00492856|101258635|FG003|COMPLETED|Consolidation||0||
48380353|NCT00492856|101258632|FG000|NOT COMPLETED|Consolidation||9||
48380354|NCT00492856|101258633|FG001|NOT COMPLETED|Consolidation||0||
48380355|NCT00492856|101258634|FG002|NOT COMPLETED|Consolidation||0||
48380356|NCT00492856|101258635|FG003|NOT COMPLETED|Consolidation||0||
48380357|NCT00492856|101258632|FG000|STARTED|Post-consolidation||0||
48380358|NCT00492856|101258633|FG001|STARTED|Post-consolidation||41||
48380359|NCT00492856|101258634|FG002|STARTED|Post-consolidation||27||
48685000|NCT00375674|102013131|FG001|COMPLETED|Overall Study||165||
48685001|NCT00375674|102013130|FG000|NOT COMPLETED|Overall Study||144||
48685002|NCT00375674|102013131|FG001|NOT COMPLETED|Overall Study||141||
48685003|NCT02393339|102013132|FG000|STARTED|Overall Study||58||
48685004|NCT02393339|102013133|FG001|STARTED|Overall Study||56||
48685005|NCT02393339|102013132|FG000|COMPLETED|Overall Study||51||
48685006|NCT02393339|102013133|FG001|COMPLETED|Overall Study||51||
48685007|NCT02393339|102013132|FG000|NOT COMPLETED|Overall Study||7||
48685008|NCT02393339|102013133|FG001|NOT COMPLETED|Overall Study||5||
48685009|NCT01509846|102013134|FG000|STARTED|Received Vaccination 1||5||
48685010|NCT01509846|102013135|FG001|STARTED|Received Vaccination 1||20||
48685011|NCT01509846|102013136|FG002|STARTED|Received Vaccination 1||20||
48685012|NCT01509846|102013137|FG003|STARTED|Received Vaccination 1||20||
48685013|NCT01509846|102013138|FG004|STARTED|Received Vaccination 1||17||
48380360|NCT00492856|101258635|FG003|STARTED|Post-consolidation||1||
48380361|NCT00492856|101258632|FG000|COMPLETED|Post-consolidation||0||
48380362|NCT00492856|101258633|FG001|COMPLETED|Post-consolidation||29||
48380363|NCT00492856|101258634|FG002|COMPLETED|Post-consolidation||0||
48380364|NCT00492856|101258635|FG003|COMPLETED|Post-consolidation||0||
48380365|NCT00492856|101258632|FG000|NOT COMPLETED|Post-consolidation||0||
48380366|NCT00492856|101258633|FG001|NOT COMPLETED|Post-consolidation||12||
48380367|NCT00492856|101258634|FG002|NOT COMPLETED|Post-consolidation||27||
48380368|NCT00492856|101258635|FG003|NOT COMPLETED|Post-consolidation||1||
48380369|NCT01525927|101258636|FG000|STARTED|Overall Study||0||
48380370|NCT01525927|101258636|FG000|COMPLETED|Overall Study||0||
48380371|NCT01525927|101258636|FG000|NOT COMPLETED|Overall Study||0||
48380372|NCT00216099|101258637|FG000|STARTED|Overall Study||49||
48380373|NCT00216099|101258637|FG000|Toxicity Analysis|Overall Study||49||
48380374|NCT00216099|101258637|FG000|Response Analysis|Overall Study||48||
48380375|NCT00216099|101258637|FG000|COMPLETED|Overall Study||48||
48380376|NCT00216099|101258637|FG000|NOT COMPLETED|Overall Study||1||
48380377|NCT00903032|101258638|FG000|STARTED|Overall Study||129||
48380378|NCT00903032|101258639|FG001|STARTED|Overall Study||124||
48380379|NCT00903032|101258638|FG000|COMPLETED|Overall Study||122||
48380380|NCT00903032|101258639|FG001|COMPLETED|Overall Study||119||
48380381|NCT00903032|101258638|FG000|NOT COMPLETED|Overall Study||7||
48380382|NCT00903032|101258639|FG001|NOT COMPLETED|Overall Study||5||
48380383|NCT00710034|101258640|FG000|STARTED|Completed 6 Weeks of Treatment||195||
48380384|NCT00710034|101258641|FG001|STARTED|Completed 6 Weeks of Treatment||196||
48380385|NCT00710034|101258640|FG000|COMPLETED|Completed 6 Weeks of Treatment||154||
48253208|NCT00690378|100939982|FG001|Treated|Overall Study||67||
48253209|NCT00690378|100939981|FG000|COMPLETED|Overall Study||49||
48253210|NCT00690378|100939982|FG001|COMPLETED|Overall Study||54||
48253211|NCT00690378|100939981|FG000|NOT COMPLETED|Overall Study||20||
48380386|NCT00710034|101258641|FG001|COMPLETED|Completed 6 Weeks of Treatment||149||
48380387|NCT00710034|101258640|FG000|NOT COMPLETED|Completed 6 Weeks of Treatment||41||
48685014|NCT01509846|102013134|FG000|COMPLETED|Received Vaccination 1||5||
48685015|NCT01509846|102013135|FG001|COMPLETED|Received Vaccination 1||20||
48685016|NCT01509846|102013136|FG002|COMPLETED|Received Vaccination 1||20||
48685017|NCT01509846|102013137|FG003|COMPLETED|Received Vaccination 1||20||
48685018|NCT01509846|102013138|FG004|COMPLETED|Received Vaccination 1||17||
48685019|NCT01509846|102013134|FG000|NOT COMPLETED|Received Vaccination 1||0||
48685020|NCT01509846|102013135|FG001|NOT COMPLETED|Received Vaccination 1||0||
48685021|NCT01509846|102013136|FG002|NOT COMPLETED|Received Vaccination 1||0||
48685022|NCT01509846|102013137|FG003|NOT COMPLETED|Received Vaccination 1||0||
48685023|NCT01509846|102013138|FG004|NOT COMPLETED|Received Vaccination 1||0||
48685024|NCT01509846|102013134|FG000|STARTED|Received Vaccination 2||5||
48685025|NCT01509846|102013135|FG001|STARTED|Received Vaccination 2||20||
48685026|NCT01509846|102013136|FG002|STARTED|Received Vaccination 2||20||
48685027|NCT01509846|102013137|FG003|STARTED|Received Vaccination 2||20||
48685028|NCT01509846|102013138|FG004|STARTED|Received Vaccination 2||17||
48685029|NCT01509846|102013134|FG000|COMPLETED|Received Vaccination 2||0||
48685030|NCT01509846|102013135|FG001|COMPLETED|Received Vaccination 2||20||
48253212|NCT00690378|100939982|FG001|NOT COMPLETED|Overall Study||14||
48380388|NCT00710034|101258641|FG001|NOT COMPLETED|Completed 6 Weeks of Treatment||47||
48685031|NCT01509846|102013136|FG002|COMPLETED|Received Vaccination 2||19||
48685032|NCT01509846|102013137|FG003|COMPLETED|Received Vaccination 2||20||
48685033|NCT01509846|102013138|FG004|COMPLETED|Received Vaccination 2||14||
48685034|NCT01509846|102013134|FG000|NOT COMPLETED|Received Vaccination 2||5||
48685035|NCT01509846|102013135|FG001|NOT COMPLETED|Received Vaccination 2||0||
48685036|NCT01509846|102013136|FG002|NOT COMPLETED|Received Vaccination 2||1||
48685037|NCT01509846|102013137|FG003|NOT COMPLETED|Received Vaccination 2||0||
48685038|NCT01509846|102013138|FG004|NOT COMPLETED|Received Vaccination 2||3||
48685039|NCT01509846|102013134|FG000|STARTED|Received Vaccination 3||0||
48685040|NCT01509846|102013135|FG001|STARTED|Received Vaccination 3||20||
48685041|NCT01509846|102013136|FG002|STARTED|Received Vaccination 3||19||
48685042|NCT01509846|102013137|FG003|STARTED|Received Vaccination 3||20||
48685043|NCT01509846|102013138|FG004|STARTED|Received Vaccination 3||14||
48685044|NCT01509846|102013134|FG000|COMPLETED|Received Vaccination 3||0||
48685045|NCT01509846|102013135|FG001|COMPLETED|Received Vaccination 3||19||
48685046|NCT01509846|102013136|FG002|COMPLETED|Received Vaccination 3||18||
48685047|NCT01509846|102013137|FG003|COMPLETED|Received Vaccination 3||19||
48685048|NCT01509846|102013138|FG004|COMPLETED|Received Vaccination 3||14||
48253213|NCT00806598|100939983|FG000|STARTED|Overall Study||48||
48253214|NCT00806598|100939983|FG000|COMPLETED|Overall Study||48||
48253215|NCT00806598|100939983|FG000|NOT COMPLETED|Overall Study||0||
48685049|NCT01509846|102013134|FG000|NOT COMPLETED|Received Vaccination 3||0||
48685050|NCT01509846|102013135|FG001|NOT COMPLETED|Received Vaccination 3||1||
48685051|NCT01509846|102013136|FG002|NOT COMPLETED|Received Vaccination 3||1||
48685052|NCT01509846|102013137|FG003|NOT COMPLETED|Received Vaccination 3||1||
48685053|NCT01509846|102013138|FG004|NOT COMPLETED|Received Vaccination 3||0||
48685054|NCT01737762|102013139|FG000|STARTED|Overall Study||77||
48685055|NCT01737762|102013140|FG001|STARTED|Overall Study||78||
48685056|NCT01737762|102013139|FG000|COMPLETED|Overall Study||57||
48685057|NCT01737762|102013140|FG001|COMPLETED|Overall Study||61||
48685058|NCT01737762|102013139|FG000|NOT COMPLETED|Overall Study||20||
48685059|NCT01737762|102013140|FG001|NOT COMPLETED|Overall Study||17||
48253216|NCT01484314|100939984|FG000|STARTED|Overall Study||1||
48253217|NCT01484314|100939984|FG000|COMPLETED|Overall Study||1||
48380389|NCT00710034|101258640|FG000|STARTED|Completed 12 Weeks of Treatment||154||
48253218|NCT01484314|100939984|FG000|NOT COMPLETED|Overall Study||0||
48380390|NCT00710034|101258641|FG001|STARTED|Completed 12 Weeks of Treatment||149||
48380391|NCT00710034|101258640|FG000|COMPLETED|Completed 12 Weeks of Treatment||141||
48541329|NCT03787134|101662697|FG000|COMPLETED|Overall Study||12||
48685060|NCT03751371|102013141|FG000|STARTED|Overall Study||23||
48685061|NCT03751371|102013142|FG001|STARTED|Overall Study||22||
48685062|NCT03751371|102013141|FG000|COMPLETED|Overall Study||20||
48685063|NCT03751371|102013142|FG001|COMPLETED|Overall Study||20||
48685064|NCT03751371|102013141|FG000|NOT COMPLETED|Overall Study||3||
48685065|NCT03751371|102013142|FG001|NOT COMPLETED|Overall Study||2||
48685066|NCT02621476|102013143|FG000|STARTED|Overall Study||31493||
48685067|NCT02621476|102013144|FG001|STARTED|Overall Study||31519||
48685068|NCT02621476|102013143|FG000|COMPLETED|Overall Study||26342||
48685069|NCT02621476|102013144|FG001|COMPLETED|Overall Study||26404||
48685070|NCT02621476|102013143|FG000|NOT COMPLETED|Overall Study||5151||
48685071|NCT02621476|102013144|FG001|NOT COMPLETED|Overall Study||5115||
48685072|NCT02379195|102013145|FG000|STARTED|Overall Study||12||
48685073|NCT02379195|102013145|FG000|COMPLETED|Overall Study||12||
48685074|NCT02379195|102013145|FG000|NOT COMPLETED|Overall Study||0||
48685075|NCT01187095|102013146|FG000|STARTED|Overall Study||153||
48685076|NCT01187095|102013147|FG001|STARTED|Overall Study||142||
48685077|NCT01187095|102013146|FG000|COMPLETED|Overall Study||108||
48685078|NCT01187095|102013147|FG001|COMPLETED|Overall Study||108||
48685079|NCT01187095|102013146|FG000|NOT COMPLETED|Overall Study||45||
48253219|NCT02975297|100939985|FG000|STARTED|Overall Study||41||
48253220|NCT02975297|100939986|FG001|STARTED|Overall Study||41||
48253221|NCT02975297|100939985|FG000|COMPLETED|Overall Study||34||
48253222|NCT02975297|100939986|FG001|COMPLETED|Overall Study||35||
48253223|NCT02975297|100939985|FG000|NOT COMPLETED|Overall Study||7||
48253224|NCT02975297|100939986|FG001|NOT COMPLETED|Overall Study||6||
48253225|NCT00720369|100939987|FG000|STARTED|Overall Study||11||
48253226|NCT00720369|100939988|FG001|STARTED|Overall Study||8||
48253227|NCT00720369|100939987|FG000|COMPLETED|Overall Study||10||
48253228|NCT00720369|100939988|FG001|COMPLETED|Overall Study||8||
48253229|NCT00720369|100939987|FG000|NOT COMPLETED|Overall Study||1||
48253230|NCT00720369|100939988|FG001|NOT COMPLETED|Overall Study||0||
48685080|NCT01187095|102013147|FG001|NOT COMPLETED|Overall Study||34||
48685081|NCT01714323|102013148|FG000|STARTED|Overall Study||677||
48685082|NCT01714323|102013149|FG001|STARTED|Overall Study||680||
48685083|NCT01714323|102013148|FG000|COMPLETED|Overall Study||513||
48685084|NCT01714323|102013149|FG001|COMPLETED|Overall Study||508||
48685085|NCT01714323|102013148|FG000|NOT COMPLETED|Overall Study||164||
48685086|NCT01714323|102013149|FG001|NOT COMPLETED|Overall Study||172||
48253231|NCT01837797|100939989|FG000|STARTED|Period 1||129||
48253232|NCT01837797|100939990|FG001|STARTED|Period 1||0||
48253233|NCT01837797|100939991|FG002|STARTED|Period 1||0||
48253234|NCT01837797|100939992|FG003|STARTED|Period 1||0||
48253235|NCT01837797|100939993|FG004|STARTED|Period 1||0||
48253236|NCT01837797|100939989|FG000|COMPLETED|Period 1||27||
48253237|NCT01837797|100939990|FG001|COMPLETED|Period 1||0||
48253238|NCT01837797|100939991|FG002|COMPLETED|Period 1||0||
48253239|NCT01837797|100939992|FG003|COMPLETED|Period 1||0||
48253240|NCT01837797|100939993|FG004|COMPLETED|Period 1||0||
48253241|NCT01837797|100939989|FG000|NOT COMPLETED|Period 1||102||
48253242|NCT01837797|100939990|FG001|NOT COMPLETED|Period 1||0||
48253243|NCT01837797|100939991|FG002|NOT COMPLETED|Period 1||0||
48253244|NCT01837797|100939992|FG003|NOT COMPLETED|Period 1||0||
48253245|NCT01837797|100939993|FG004|NOT COMPLETED|Period 1||0||
48253246|NCT01837797|100939989|FG000|STARTED|Period 2||0||
48685087|NCT01027650|102013150|FG000|STARTED|Overall Study||6||
48685088|NCT01027650|102013151|FG001|STARTED|Overall Study||6||
48685089|NCT01027650|102013152|FG002|STARTED|Overall Study||6||
48685090|NCT01027650|102013153|FG003|STARTED|Overall Study||3||
48685091|NCT01027650|102013154|FG004|STARTED|Overall Study||25||
48685092|NCT01027650|102013155|FG005|STARTED|Overall Study||26||
48685093|NCT01027650|102013156|FG006|STARTED|Overall Study||25||
48685094|NCT01027650|102013157|FG007|STARTED|Overall Study||24||
48685095|NCT01027650|102013150|FG000|COMPLETED|Overall Study||6||
48685096|NCT01027650|102013151|FG001|COMPLETED|Overall Study||6||
48685097|NCT01027650|102013152|FG002|COMPLETED|Overall Study||6||
48685098|NCT01027650|102013153|FG003|COMPLETED|Overall Study||3||
48685099|NCT01027650|102013154|FG004|COMPLETED|Overall Study||23||
48685100|NCT01027650|102013155|FG005|COMPLETED|Overall Study||24||
48685101|NCT01027650|102013156|FG006|COMPLETED|Overall Study||24||
48685102|NCT01027650|102013157|FG007|COMPLETED|Overall Study||24||
48685103|NCT01027650|102013150|FG000|NOT COMPLETED|Overall Study||0||
48685104|NCT01027650|102013151|FG001|NOT COMPLETED|Overall Study||0||
48685105|NCT01027650|102013152|FG002|NOT COMPLETED|Overall Study||0||
48685106|NCT01027650|102013153|FG003|NOT COMPLETED|Overall Study||0||
48685107|NCT01027650|102013154|FG004|NOT COMPLETED|Overall Study||2||
48685108|NCT01027650|102013155|FG005|NOT COMPLETED|Overall Study||2||
48685109|NCT01027650|102013156|FG006|NOT COMPLETED|Overall Study||1||
48685110|NCT01027650|102013157|FG007|NOT COMPLETED|Overall Study||0||
48685111|NCT04011592|102013158|FG000|STARTED|Overall Study||1||
48685112|NCT04011592|102013159|FG001|STARTED|Overall Study||0||
48685113|NCT04011592|102013158|FG000|COMPLETED|Overall Study||1||
48685114|NCT04011592|102013159|FG001|COMPLETED|Overall Study||0||
48253247|NCT01837797|100939990|FG001|STARTED|Period 2||6||
48253248|NCT01837797|100939991|FG002|STARTED|Period 2||3||
48253249|NCT01837797|100939992|FG003|STARTED|Period 2||6||
48253250|NCT01837797|100939993|FG004|STARTED|Period 2||0||
48253251|NCT01837797|100939989|FG000|COMPLETED|Period 2||0||
48253252|NCT01837797|100939990|FG001|COMPLETED|Period 2||1||
48253253|NCT01837797|100939991|FG002|COMPLETED|Period 2||1||
48253254|NCT01837797|100939992|FG003|COMPLETED|Period 2||1||
48685115|NCT04011592|102013158|FG000|NOT COMPLETED|Overall Study||0||
48685116|NCT04011592|102013159|FG001|NOT COMPLETED|Overall Study||0||
48685117|NCT01106157|102013160|FG000|STARTED|Overall Study||17||
48685118|NCT01106157|102013161|FG001|STARTED|Overall Study||8||
48685119|NCT01106157|102013160|FG000|COMPLETED|Overall Study||16||
48685120|NCT01106157|102013161|FG001|COMPLETED|Overall Study||8||
48685121|NCT01106157|102013160|FG000|NOT COMPLETED|Overall Study||1||
48685122|NCT01106157|102013161|FG001|NOT COMPLETED|Overall Study||0||
48685123|NCT01724216|102013162|FG000|STARTED|Overall Study||11||
48685124|NCT01724216|102013162|FG000|COMPLETED|Overall Study||10||
48685125|NCT01724216|102013162|FG000|NOT COMPLETED|Overall Study||1||
48685126|NCT00443703|102013163|FG000|STARTED|Overall Study||177||
48685127|NCT00443703|102013164|FG001|STARTED|Overall Study||175||
48685128|NCT00443703|102013163|FG000|Treated|Overall Study||174||
48380392|NCT00710034|101258641|FG001|COMPLETED|Completed 12 Weeks of Treatment||138||
48380393|NCT00710034|101258640|FG000|NOT COMPLETED|Completed 12 Weeks of Treatment||13||
48685129|NCT00443703|102013164|FG001|Treated|Overall Study||174||
48685130|NCT00443703|102013163|FG000|COMPLETED|Overall Study||149||
48685131|NCT00443703|102013164|FG001|COMPLETED|Overall Study||157||
48685132|NCT00443703|102013163|FG000|NOT COMPLETED|Overall Study||28||
48685133|NCT00443703|102013164|FG001|NOT COMPLETED|Overall Study||18||
48685134|NCT02953561|102013165|FG000|STARTED|Overall Study||19||
48685135|NCT02953561|102013165|FG000|COMPLETED|Overall Study||19||
48685136|NCT02953561|102013165|FG000|NOT COMPLETED|Overall Study||0||
48685137|NCT03519997|102013166|FG000|STARTED|Overall Study||35||
48685138|NCT03519997|102013166|FG000|COMPLETED|Overall Study||28||
48685139|NCT03519997|102013166|FG000|NOT COMPLETED|Overall Study||7||
48685140|NCT02967679|102013167|FG000|STARTED|Overall Study||15||
48685141|NCT02967679|102013167|FG000|COMPLETED|Overall Study||14||
48380394|NCT00710034|101258641|FG001|NOT COMPLETED|Completed 12 Weeks of Treatment||11||
48380395|NCT02239770|101258642|FG000|STARTED|Part 1||4||
48380396|NCT02239770|101258643|FG001|STARTED|Part 1||4||
48380397|NCT02239770|101258644|FG002|STARTED|Part 1||4||
48380398|NCT02239770|101258645|FG003|STARTED|Part 1||0||
48380399|NCT02239770|101258646|FG004|STARTED|Part 1||0||
48685142|NCT02967679|102013167|FG000|NOT COMPLETED|Overall Study||1||
48380400|NCT02239770|101258647|FG005|STARTED|Part 1||0||
48685143|NCT03599518|102013168|FG000|STARTED|Overall Study||5||
48685144|NCT03599518|102013169|FG001|STARTED|Overall Study||4||
48685145|NCT03599518|102013170|FG002|STARTED|Overall Study||6||
48685146|NCT03599518|102013171|FG003|STARTED|Overall Study||1||
48685147|NCT03599518|102013172|FG004|STARTED|Overall Study||4||
48685148|NCT03599518|102013168|FG000|COMPLETED|Overall Study||0||
48685149|NCT03599518|102013169|FG001|COMPLETED|Overall Study||0||
48685150|NCT03599518|102013170|FG002|COMPLETED|Overall Study||0||
48685151|NCT03599518|102013171|FG003|COMPLETED|Overall Study||0||
48685152|NCT03599518|102013172|FG004|COMPLETED|Overall Study||0||
48685153|NCT03599518|102013168|FG000|NOT COMPLETED|Overall Study||5||
48685154|NCT03599518|102013169|FG001|NOT COMPLETED|Overall Study||4||
48089794|NCT02196558|100541239|FG000|STARTED|Extension Phase (40 Weeks)||11||
48089795|NCT02196558|100541240|FG001|STARTED|Extension Phase (40 Weeks)||11||
48089796|NCT02196558|100541241|FG002|STARTED|Extension Phase (40 Weeks)||6||
48089797|NCT02196558|100541239|FG000|COMPLETED|Extension Phase (40 Weeks)||9||
48380401|NCT02239770|101258642|FG000|COMPLETED|Part 1||4||
48685155|NCT03599518|102013170|FG002|NOT COMPLETED|Overall Study||6||
48685156|NCT03599518|102013171|FG003|NOT COMPLETED|Overall Study||1||
48685157|NCT03599518|102013172|FG004|NOT COMPLETED|Overall Study||4||
48685158|NCT00992056|102013173|FG000|STARTED|Treatment Period 1 (6 Weeks)||12||
48685159|NCT00992056|102013174|FG001|STARTED|Treatment Period 1 (6 Weeks)||12||
48685160|NCT00992056|102013173|FG000|COMPLETED|Treatment Period 1 (6 Weeks)||11||
48685161|NCT00992056|102013174|FG001|COMPLETED|Treatment Period 1 (6 Weeks)||10||
48685162|NCT00992056|102013173|FG000|NOT COMPLETED|Treatment Period 1 (6 Weeks)||1||
48685163|NCT00992056|102013174|FG001|NOT COMPLETED|Treatment Period 1 (6 Weeks)||2||
48685164|NCT00992056|102013173|FG000|STARTED|Washout Period (2 Weeks)||11||
48685165|NCT00992056|102013174|FG001|STARTED|Washout Period (2 Weeks)||10||
48685166|NCT00992056|102013173|FG000|COMPLETED|Washout Period (2 Weeks)||10||
48685167|NCT00992056|102013174|FG001|COMPLETED|Washout Period (2 Weeks)||10||
48685168|NCT00992056|102013173|FG000|NOT COMPLETED|Washout Period (2 Weeks)||1||
48685169|NCT00992056|102013174|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0||
48685170|NCT00992056|102013173|FG000|STARTED|Treatment Period 2 (6 Weeks)||10||
48685171|NCT00992056|102013174|FG001|STARTED|Treatment Period 2 (6 Weeks)||10||
48685172|NCT00992056|102013173|FG000|COMPLETED|Treatment Period 2 (6 Weeks)||10||
48685173|NCT00992056|102013174|FG001|COMPLETED|Treatment Period 2 (6 Weeks)||10||
48685174|NCT00992056|102013173|FG000|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0||
48685175|NCT00992056|102013174|FG001|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0||
48089798|NCT02196558|100541240|FG001|COMPLETED|Extension Phase (40 Weeks)||8||
48380402|NCT02239770|101258643|FG001|COMPLETED|Part 1||4||
48380403|NCT02239770|101258644|FG002|COMPLETED|Part 1||4||
48685176|NCT02140970|102013175|FG000|STARTED|Overall Study||24||
48685177|NCT02140970|102013176|FG001|STARTED|Overall Study||25||
48253255|NCT01837797|100939993|FG004|COMPLETED|Period 2||0||
48253256|NCT01837797|100939989|FG000|NOT COMPLETED|Period 2||0||
48253257|NCT01837797|100939990|FG001|NOT COMPLETED|Period 2||5||
48253258|NCT01837797|100939991|FG002|NOT COMPLETED|Period 2||2||
48253259|NCT01837797|100939992|FG003|NOT COMPLETED|Period 2||5||
48253260|NCT01837797|100939993|FG004|NOT COMPLETED|Period 2||0||
48253261|NCT01837797|100939989|FG000|STARTED|Period 3||0||
48253262|NCT01837797|100939990|FG001|STARTED|Period 3||0||
48253263|NCT01837797|100939991|FG002|STARTED|Period 3||0||
48253264|NCT01837797|100939992|FG003|STARTED|Period 3||0||
48253265|NCT01837797|100939993|FG004|STARTED|Period 3||47||
48253266|NCT01837797|100939989|FG000|COMPLETED|Period 3||0||
48253267|NCT01837797|100939990|FG001|COMPLETED|Period 3||0||
48253268|NCT01837797|100939991|FG002|COMPLETED|Period 3||0||
48253269|NCT01837797|100939992|FG003|COMPLETED|Period 3||0||
48253270|NCT01837797|100939993|FG004|COMPLETED|Period 3||24||
48253271|NCT01837797|100939989|FG000|NOT COMPLETED|Period 3||0||
48253272|NCT01837797|100939990|FG001|NOT COMPLETED|Period 3||0||
48253273|NCT01837797|100939991|FG002|NOT COMPLETED|Period 3||0||
48253274|NCT01837797|100939992|FG003|NOT COMPLETED|Period 3||0||
48253275|NCT01837797|100939993|FG004|NOT COMPLETED|Period 3||23||
48253276|NCT00537329|100939994|FG000|STARTED|Overall Study||43||
48253277|NCT00537329|100939994|FG000|COMPLETED|Overall Study||17||
48253278|NCT00537329|100939994|FG000|NOT COMPLETED|Overall Study||26||
48253279|NCT02853305|100939995|FG000|STARTED|Overall Study||351||
48253280|NCT02853305|100939996|FG001|STARTED|Overall Study||307||
48253281|NCT02853305|100939997|FG002|STARTED|Overall Study||352||
48253282|NCT02853305|100939995|FG000|Received First Course of Pembrolizumab|Overall Study||349||
48253283|NCT02853305|100939996|FG001|Received First Course of Pembrolizumab|Overall Study||302||
48253284|NCT02853305|100939997|FG002|Received First Course of Pembrolizumab|Overall Study||342||
48380404|NCT02239770|101258645|FG003|COMPLETED|Part 1||0||
48089799|NCT02196558|100541241|FG002|COMPLETED|Extension Phase (40 Weeks)||5||
48089800|NCT02196558|100541239|FG000|NOT COMPLETED|Extension Phase (40 Weeks)||2||
48089801|NCT02196558|100541240|FG001|NOT COMPLETED|Extension Phase (40 Weeks)||3||
48089802|NCT02196558|100541241|FG002|NOT COMPLETED|Extension Phase (40 Weeks)||1||
48685178|NCT02140970|102013175|FG000|Received Intervention|Overall Study||23||
48685179|NCT02140970|102013176|FG001|Received Intervention|Overall Study||25||
48089803|NCT04294472|100541242|FG000|STARTED|Overall Study||8||
48089804|NCT04294472|100541243|FG001|STARTED|Overall Study||11||
48089805|NCT04294472|100541244|FG002|STARTED|Overall Study||11||
48089806|NCT04294472|100541242|FG000|COMPLETED|Overall Study||8||
48089807|NCT04294472|100541243|FG001|COMPLETED|Overall Study||9||
48089808|NCT04294472|100541244|FG002|COMPLETED|Overall Study||9||
48089809|NCT04294472|100541242|FG000|NOT COMPLETED|Overall Study||0||
48089810|NCT04294472|100541243|FG001|NOT COMPLETED|Overall Study||2||
48685180|NCT02140970|102013175|FG000|Analyzed|Overall Study||22||
48685181|NCT02140970|102013176|FG001|Analyzed|Overall Study||22||
48685182|NCT02140970|102013175|FG000|COMPLETED|Overall Study||22||
48685183|NCT02140970|102013176|FG001|COMPLETED|Overall Study||22||
48685184|NCT02140970|102013175|FG000|NOT COMPLETED|Overall Study||2||
48685185|NCT02140970|102013176|FG001|NOT COMPLETED|Overall Study||3||
48685186|NCT03369665|102013177|FG000|STARTED|Overall Study||482||
48685187|NCT03369665|102013177|FG000|Full Analysis Set (FAS)|Overall Study||482|Full Analysis Set (FAS) consisted of all participants from the Intent-to-treat (ITT \[ITT population included all participants classified as eligible\]) set treated with at least one dose of study medication.|
48685188|NCT03369665|102013177|FG000|Safety Analysis Set (SAS)|Overall Study||482|SAF consisted of all participants treated with at least one dose of study medication.|
48685189|NCT03369665|102013177|FG000|COMPLETED|Overall Study||452||
48685190|NCT03369665|102013177|FG000|NOT COMPLETED|Overall Study||30||
48089811|NCT04294472|100541244|FG002|NOT COMPLETED|Overall Study||2||
48089812|NCT00137046|100541245|FG000|STARTED|Overall Study||291||
48089813|NCT00137046|100541246|FG001|STARTED|Overall Study||291||
48089814|NCT00137046|100541245|FG000|Received Study Treatment|Overall Study||290||
48685191|NCT00414076|102013178|FG000|STARTED|Overall Study||4||
48685192|NCT00414076|102013179|FG001|STARTED|Overall Study||5||
48685193|NCT00414076|102013178|FG000|COMPLETED|Overall Study||1||
48685194|NCT00414076|102013179|FG001|COMPLETED|Overall Study||0||
48685195|NCT00414076|102013178|FG000|NOT COMPLETED|Overall Study||3||
48685196|NCT00414076|102013179|FG001|NOT COMPLETED|Overall Study||5||
48685197|NCT03188263|102013180|FG000|STARTED|Overall Study||10||
48685198|NCT03188263|102013181|FG001|STARTED|Overall Study||0||
48685199|NCT03188263|102013180|FG000|COMPLETED|Overall Study||6||
48685200|NCT03188263|102013181|FG001|COMPLETED|Overall Study||0||
48685201|NCT03188263|102013180|FG000|NOT COMPLETED|Overall Study||4||
48685202|NCT03188263|102013181|FG001|NOT COMPLETED|Overall Study||0||
48685203|NCT00401843|102013182|FG000|STARTED|Overall Study||21||
48685204|NCT00401843|102013183|FG001|STARTED|Overall Study||144||
48685205|NCT00401843|102013184|FG002|STARTED|Overall Study||142||
48685206|NCT00401843|102013182|FG000|Treated|Overall Study||21||
48685207|NCT00401843|102013183|FG001|Treated|Overall Study||142||
48685208|NCT00401843|102013184|FG002|Treated|Overall Study||139||
48685209|NCT00401843|102013182|FG000|COMPLETED|Overall Study||0||
48685210|NCT00401843|102013183|FG001|COMPLETED|Overall Study||0||
48685211|NCT00401843|102013184|FG002|COMPLETED|Overall Study||0||
48685212|NCT00401843|102013182|FG000|NOT COMPLETED|Overall Study||21||
48685213|NCT00401843|102013183|FG001|NOT COMPLETED|Overall Study||144||
48685214|NCT00401843|102013184|FG002|NOT COMPLETED|Overall Study||142||
48685215|NCT00589797|102013185|FG000|STARTED|Overall Study||264||
48685216|NCT00589797|102013186|FG001|STARTED|Overall Study||112||
48685217|NCT00589797|102013185|FG000|Baseline|Overall Study||218||
48685218|NCT00589797|102013186|FG001|Baseline|Overall Study||106||
48685219|NCT00589797|102013185|FG000|24 Months|Overall Study||191||
48685220|NCT00589797|102013186|FG001|24 Months|Overall Study||89||
48685221|NCT00589797|102013185|FG000|COMPLETED|Overall Study||191||
48685222|NCT00589797|102013186|FG001|COMPLETED|Overall Study||89||
48253285|NCT02853305|100939995|FG000|Received Second Course of Pembrolizumab|Overall Study||14||
48253286|NCT02853305|100939996|FG001|Received Second Course of Pembrolizumab|Overall Study||15||
48685223|NCT00589797|102013185|FG000|NOT COMPLETED|Overall Study||73||
48685224|NCT00589797|102013186|FG001|NOT COMPLETED|Overall Study||23||
48685225|NCT03759600|102013187|FG000|STARTED|Overall Study||20||
48685226|NCT03759600|102013187|FG000|COMPLETED|Overall Study||0||
48685227|NCT03759600|102013187|FG000|NOT COMPLETED|Overall Study||20||
48685228|NCT02537730|102013188|FG000|STARTED|First Intervention (7 Days)||17||
48685229|NCT02537730|102013189|FG001|STARTED|First Intervention (7 Days)||16||
48685230|NCT02537730|102013188|FG000|COMPLETED|First Intervention (7 Days)||17||
48685231|NCT02537730|102013189|FG001|COMPLETED|First Intervention (7 Days)||16||
48685232|NCT02537730|102013188|FG000|NOT COMPLETED|First Intervention (7 Days)||0||
48685233|NCT02537730|102013189|FG001|NOT COMPLETED|First Intervention (7 Days)||0||
48685234|NCT02537730|102013188|FG000|STARTED|Second Intervention (7 Days)||17||
48685235|NCT02537730|102013189|FG001|STARTED|Second Intervention (7 Days)||16||
48685236|NCT02537730|102013188|FG000|COMPLETED|Second Intervention (7 Days)||17||
48253287|NCT02853305|100939997|FG002|Received Second Course of Pembrolizumab|Overall Study||0||
48253288|NCT02853305|100939995|FG000|COMPLETED|Overall Study||0||
48253289|NCT02853305|100939996|FG001|COMPLETED|Overall Study||0||
48253290|NCT02853305|100939997|FG002|COMPLETED|Overall Study||0||
48253291|NCT02853305|100939995|FG000|NOT COMPLETED|Overall Study||351||
48253292|NCT02853305|100939996|FG001|NOT COMPLETED|Overall Study||307||
48253293|NCT02853305|100939997|FG002|NOT COMPLETED|Overall Study||352||
48253294|NCT00427778|100939998|FG000|STARTED|First Intervention (4 Weeks)||14||
48253295|NCT00427778|100939999|FG001|STARTED|First Intervention (4 Weeks)||15||
48253296|NCT00427778|100939998|FG000|COMPLETED|First Intervention (4 Weeks)||10||
48253297|NCT00427778|100939999|FG001|COMPLETED|First Intervention (4 Weeks)||14||
48253298|NCT00427778|100939998|FG000|NOT COMPLETED|First Intervention (4 Weeks)||4||
48253299|NCT00427778|100939999|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1||
48253300|NCT00427778|100939998|FG000|STARTED|Wash Out (2 Weeks)||10||
48253301|NCT00427778|100939999|FG001|STARTED|Wash Out (2 Weeks)||14||
48253302|NCT00427778|100939998|FG000|COMPLETED|Wash Out (2 Weeks)||10||
48253303|NCT00427778|100939999|FG001|COMPLETED|Wash Out (2 Weeks)||14||
48253304|NCT00427778|100939998|FG000|NOT COMPLETED|Wash Out (2 Weeks)||0||
48253305|NCT00427778|100939999|FG001|NOT COMPLETED|Wash Out (2 Weeks)||0||
48253306|NCT00427778|100939998|FG000|STARTED|Second Intervention (4 Weeks)||10||
48253307|NCT00427778|100939999|FG001|STARTED|Second Intervention (4 Weeks)||14||
48685237|NCT02537730|102013189|FG001|COMPLETED|Second Intervention (7 Days)||16||
48685238|NCT02537730|102013188|FG000|NOT COMPLETED|Second Intervention (7 Days)||0||
48685239|NCT02537730|102013189|FG001|NOT COMPLETED|Second Intervention (7 Days)||0||
48253308|NCT00427778|100939998|FG000|COMPLETED|Second Intervention (4 Weeks)||10||
48253309|NCT00427778|100939999|FG001|COMPLETED|Second Intervention (4 Weeks)||14||
48253310|NCT00427778|100939998|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0||
48253311|NCT00427778|100939999|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0||
48253312|NCT01220856|100940000|FG000|STARTED|Overall Study||6||
48253313|NCT01220856|100940001|FG001|STARTED|Overall Study||3||
48253314|NCT01220856|100940000|FG000|COMPLETED|Overall Study||2||
48253315|NCT01220856|100940001|FG001|COMPLETED|Overall Study||0||
48685240|NCT02224508|102013190|FG000|STARTED|Overall Study||935||
48685241|NCT02224508|102013191|FG001|STARTED|Overall Study||653||
48685242|NCT02224508|102013190|FG000|COMPLETED|Overall Study||935||
48685243|NCT02224508|102013191|FG001|COMPLETED|Overall Study||653||
48685244|NCT02224508|102013190|FG000|NOT COMPLETED|Overall Study||0||
48685245|NCT02224508|102013191|FG001|NOT COMPLETED|Overall Study||0||
48685246|NCT05384834|102013192|FG000|STARTED|Overall Study||60||
48685247|NCT05384834|102013192|FG000|COMPLETED|Overall Study||12||
48685248|NCT05384834|102013192|FG000|NOT COMPLETED|Overall Study||48||
48685249|NCT01665911|102013193|FG000|STARTED|Overall Study||28||
48685250|NCT01665911|102013193|FG000|0 mg Fluoride in 200 ml Milk|Overall Study||22||
48685251|NCT01665911|102013193|FG000|1.5 mg Sodium Fluoride in 100 ml Milk|Overall Study||23||
48685252|NCT01665911|102013193|FG000|1.5 mg Sodium Fluoride in 200 ml Milk|Overall Study||25||
48685253|NCT01665911|102013193|FG000|3.0 mg Sodium Fluoride in 100 ml Milk|Overall Study||22||
48685254|NCT01665911|102013193|FG000|3.0 mg Sodium Fluoride in 200 ml Milk|Overall Study||22||
48685255|NCT01665911|102013193|FG000|COMPLETED|Overall Study||22||
48685256|NCT01665911|102013193|FG000|NOT COMPLETED|Overall Study||6||
48685257|NCT00642707|102013194|FG000|STARTED|Overall Study||11||
48685258|NCT00642707|102013195|FG001|STARTED|Overall Study||11||
48685259|NCT00642707|102013196|FG002|STARTED|Overall Study||12||
48685260|NCT00642707|102013197|FG003|STARTED|Overall Study||10||
48685261|NCT00642707|102013194|FG000|COMPLETED|Overall Study||10||
48253316|NCT01220856|100940000|FG000|NOT COMPLETED|Overall Study||4||
48253317|NCT01220856|100940001|FG001|NOT COMPLETED|Overall Study||3||
48253318|NCT04458181|100940002|FG000|STARTED|Overall Study||42||
48253319|NCT04458181|100940003|FG001|STARTED|Overall Study||39||
48253320|NCT04458181|100940002|FG000|COMPLETED|Overall Study||22||
48253321|NCT04458181|100940003|FG001|COMPLETED|Overall Study||28||
48253322|NCT04458181|100940002|FG000|NOT COMPLETED|Overall Study||20||
48253323|NCT04458181|100940003|FG001|NOT COMPLETED|Overall Study||11||
48253324|NCT03713073|100940004|FG000|STARTED|Overall Study||19||38
48253325|NCT03713073|100940004|FG000|Allogenic Amnion Chorion Membrane|Overall Study||19||19
48253326|NCT03713073|100940004|FG000|Collagen Dressing|Overall Study||19||19
48253327|NCT03713073|100940004|FG000|COMPLETED|Overall Study||19||38
48253328|NCT03713073|100940004|FG000|NOT COMPLETED|Overall Study||0||0
48253329|NCT00710814|100940005|FG000|STARTED|Overall Study||15||
48253330|NCT00710814|100940006|FG001|STARTED|Overall Study||16||
48253331|NCT00710814|100940005|FG000|COMPLETED|Overall Study||14||
48253332|NCT00710814|100940006|FG001|COMPLETED|Overall Study||13||
48253333|NCT00710814|100940005|FG000|NOT COMPLETED|Overall Study||1||
48253334|NCT00710814|100940006|FG001|NOT COMPLETED|Overall Study||3||
48253335|NCT04626271|100940007|FG000|STARTED|Overall Study||250||546
48253336|NCT04626271|100940007|FG000|COMPLETED|Overall Study||250||546
48253337|NCT04626271|100940007|FG000|NOT COMPLETED|Overall Study||0||0
48253338|NCT03766373|100940008|FG000|STARTED|Overall Study||12||
48253339|NCT03766373|100940009|FG001|STARTED|Overall Study||12||
48253340|NCT03766373|100940008|FG000|COMPLETED|Overall Study||12||
48253341|NCT03766373|100940009|FG001|COMPLETED|Overall Study||12||
48253342|NCT03766373|100940008|FG000|NOT COMPLETED|Overall Study||0||
48685262|NCT00642707|102013195|FG001|COMPLETED|Overall Study||11||
48685263|NCT00642707|102013196|FG002|COMPLETED|Overall Study||12||
48685264|NCT00642707|102013197|FG003|COMPLETED|Overall Study||8||
48685265|NCT00642707|102013194|FG000|NOT COMPLETED|Overall Study||1||
48253343|NCT03766373|100940009|FG001|NOT COMPLETED|Overall Study||0||
48685266|NCT00642707|102013195|FG001|NOT COMPLETED|Overall Study||0||
48685267|NCT00642707|102013196|FG002|NOT COMPLETED|Overall Study||0||
48685268|NCT00642707|102013197|FG003|NOT COMPLETED|Overall Study||2||
48253344|NCT00853229|100940010|FG000|STARTED|Phase 1: Initial Intervention||8||
48253345|NCT00853229|100940011|FG001|STARTED|Phase 1: Initial Intervention||8||
48380405|NCT02239770|101258646|FG004|COMPLETED|Part 1||0||
48380406|NCT02239770|101258647|FG005|COMPLETED|Part 1||0||
48089815|NCT00137046|100541246|FG001|Received Study Treatment|Overall Study||290||
48089816|NCT00137046|100541245|FG000|COMPLETED|Overall Study||192||
48089817|NCT00137046|100541246|FG001|COMPLETED|Overall Study||198||
48089818|NCT00137046|100541245|FG000|NOT COMPLETED|Overall Study||99||
48089819|NCT00137046|100541246|FG001|NOT COMPLETED|Overall Study||93||
48089820|NCT01896531|100541247|FG000|STARTED|Overall Study||71||
48089821|NCT01896531|100541248|FG001|STARTED|Overall Study||82||
48089822|NCT01896531|100541247|FG000|Treated|Overall Study||70||
48089823|NCT01896531|100541248|FG001|Treated|Overall Study||82||
48089824|NCT01896531|100541247|FG000|COMPLETED|Overall Study||0||
48089825|NCT01896531|100541248|FG001|COMPLETED|Overall Study||0||
48089826|NCT01896531|100541247|FG000|NOT COMPLETED|Overall Study||71||
48089827|NCT01896531|100541248|FG001|NOT COMPLETED|Overall Study||82||
48380407|NCT02239770|101258642|FG000|NOT COMPLETED|Part 1||0||
48380408|NCT02239770|101258643|FG001|NOT COMPLETED|Part 1||0||
48685269|NCT00049257|102013198|FG000|STARTED|Carboplatin, Paclitaxel||58||
48685270|NCT00049257|102013198|FG000|COMPLETED|Carboplatin, Paclitaxel||45||
48685271|NCT00049257|102013198|FG000|NOT COMPLETED|Carboplatin, Paclitaxel||13||
48685272|NCT00049257|102013198|FG000|STARTED|Follow-up Period for Survival Status||45||
48685273|NCT00049257|102013198|FG000|COMPLETED|Follow-up Period for Survival Status||41||
48685274|NCT00049257|102013198|FG000|NOT COMPLETED|Follow-up Period for Survival Status||4||
48685275|NCT02918669|102013199|FG000|STARTED|Overall Study||12||
48685276|NCT02918669|102013199|FG000|COMPLETED|Overall Study||8||
48685277|NCT02918669|102013199|FG000|NOT COMPLETED|Overall Study||4||
48685278|NCT01718522|102013200|FG000|STARTED|Overall Study||75||
48685279|NCT01718522|102013200|FG000|COMPLETED|Overall Study||67||
48685280|NCT01718522|102013200|FG000|NOT COMPLETED|Overall Study||8||
48685281|NCT04342091|102013201|FG000|STARTED|Overall Study||6||
48685282|NCT04342091|102013201|FG000|COMPLETED|Overall Study||6||
48685283|NCT04342091|102013201|FG000|NOT COMPLETED|Overall Study||0||
48089828|NCT03867981|100541249|FG000|STARTED|Overall Study||150||
48685284|NCT02484443|102013202|FG000|STARTED|Overall Study||41||
48685285|NCT02484443|102013202|FG000|COMPLETED|Overall Study||9|Completion of planned therapy of Five Cycles and Disease Control Success (event-free for at least 12 months).|
48685286|NCT02484443|102013202|FG000|NOT COMPLETED|Overall Study||32||
48685287|NCT04571060|102013203|FG000|STARTED|Overall Study||703|Randomized|
48685288|NCT04571060|102013204|FG001|STARTED|Overall Study||702|Randomized|
48685289|NCT04571060|102013203|FG000|Treated|Overall Study||629||
48685290|NCT04571060|102013204|FG001|Treated|Overall Study||653||
48685291|NCT04571060|102013203|FG000|Efficacy Analysis Set Participants|Overall Study||623|Treated participants who were randomized only once, had a migraine of moderate or severe pain intensity at the time of dosing, were treated with study drug, and had post-dose efficacy data|
48685292|NCT04571060|102013204|FG001|Efficacy Analysis Set Participants|Overall Study||646|Treated participants who were randomized only once, had a migraine of moderate or severe pain intensity at the time of dosing, were treated with study drug, and had post-dose efficacy data|
48685293|NCT04571060|102013203|FG000|COMPLETED|Overall Study||622||
48685294|NCT04571060|102013204|FG001|COMPLETED|Overall Study||653||
48685295|NCT04571060|102013203|FG000|NOT COMPLETED|Overall Study||81||
48685296|NCT04571060|102013204|FG001|NOT COMPLETED|Overall Study||49||
48685297|NCT01277822|102013205|FG000|STARTED|Overall Study||168||
48685298|NCT01277822|102013206|FG001|STARTED|Overall Study||166||
48685299|NCT01277822|102013205|FG000|COMPLETED|Overall Study||153||
48685300|NCT01277822|102013206|FG001|COMPLETED|Overall Study||155||
48685301|NCT01277822|102013205|FG000|NOT COMPLETED|Overall Study||15||
48685302|NCT01277822|102013206|FG001|NOT COMPLETED|Overall Study||11||
48685303|NCT01664247|102013207|FG000|STARTED|Overall Study||174||
48685304|NCT01664247|102013208|FG001|STARTED|Overall Study||172||
48685305|NCT01664247|102013207|FG000|Exposed|Overall Study||173||
48685306|NCT01664247|102013208|FG001|Exposed|Overall Study||170||
48685307|NCT01664247|102013207|FG000|COMPLETED|Overall Study||160||
48685308|NCT01664247|102013208|FG001|COMPLETED|Overall Study||131||
48685309|NCT01664247|102013207|FG000|NOT COMPLETED|Overall Study||14||
48685310|NCT01664247|102013208|FG001|NOT COMPLETED|Overall Study||41||
48685311|NCT00972023|102013209|FG000|STARTED|Overall Study||1||
48685312|NCT00972023|102013209|FG000|COMPLETED|Overall Study||0||
48685313|NCT00972023|102013209|FG000|NOT COMPLETED|Overall Study||1||
48685314|NCT02168101|102013210|FG000|STARTED|Overall Study||3||
48685315|NCT02168101|102013211|FG001|STARTED|Overall Study||3||
48685316|NCT02168101|102013212|FG002|STARTED|Overall Study||3||
48380409|NCT02239770|101258644|FG002|NOT COMPLETED|Part 1||0||
48685317|NCT02168101|102013210|FG000|COMPLETED|Overall Study||1||
48685318|NCT02168101|102013211|FG001|COMPLETED|Overall Study||1||
48685319|NCT02168101|102013212|FG002|COMPLETED|Overall Study||2||
48685320|NCT02168101|102013210|FG000|NOT COMPLETED|Overall Study||2||
48685321|NCT02168101|102013211|FG001|NOT COMPLETED|Overall Study||2||
48380410|NCT02239770|101258645|FG003|NOT COMPLETED|Part 1||0||
48685322|NCT02168101|102013212|FG002|NOT COMPLETED|Overall Study||1||
48685323|NCT02015481|102013213|FG000|STARTED|Overall Study||25||
48685324|NCT02015481|102013213|FG000|COMPLETED|Overall Study||24||
48685325|NCT02015481|102013213|FG000|NOT COMPLETED|Overall Study||1||
48685326|NCT01558596|102013214|FG000|STARTED|Overall Study||104||
48685327|NCT01558596|102013215|FG001|STARTED|Overall Study||101||
48685328|NCT01558596|102013214|FG000|COMPLETED|Overall Study||101||
48685329|NCT01558596|102013215|FG001|COMPLETED|Overall Study||100||
48089829|NCT03867981|100541250|FG001|STARTED|Overall Study||150||
48089830|NCT03867981|100541251|FG002|STARTED|Overall Study||152||
48380411|NCT02239770|101258646|FG004|NOT COMPLETED|Part 1||0||
48380412|NCT02239770|101258647|FG005|NOT COMPLETED|Part 1||0||
48380413|NCT02239770|101258642|FG000|STARTED|Part 2||0||
48380414|NCT02239770|101258643|FG001|STARTED|Part 2||0||
48380415|NCT02239770|101258644|FG002|STARTED|Part 2||0||
48380416|NCT02239770|101258645|FG003|STARTED|Part 2||4||
48380417|NCT02239770|101258646|FG004|STARTED|Part 2||4||
48380418|NCT02239770|101258647|FG005|STARTED|Part 2||4||
48380419|NCT02239770|101258642|FG000|COMPLETED|Part 2||0||
48380420|NCT02239770|101258643|FG001|COMPLETED|Part 2||0||
48380421|NCT02239770|101258644|FG002|COMPLETED|Part 2||0||
48685330|NCT01558596|102013214|FG000|NOT COMPLETED|Overall Study||3||
48685331|NCT01558596|102013215|FG001|NOT COMPLETED|Overall Study||1||
48685332|NCT02685826|102013216|FG000|STARTED|Overall Study||25||
48685333|NCT02685826|102013217|FG001|STARTED|Overall Study||10||
48089831|NCT03867981|100541249|FG000|Reported Weight at 1 Month|Overall Study||143||
48089832|NCT03867981|100541250|FG001|Reported Weight at 1 Month|Overall Study||148||
48089833|NCT03867981|100541251|FG002|Reported Weight at 1 Month|Overall Study||146||
48089834|NCT03867981|100541249|FG000|Completed 4-month Assessment|Overall Study||134||
48089835|NCT03867981|100541250|FG001|Completed 4-month Assessment|Overall Study||135||
48089836|NCT03867981|100541251|FG002|Completed 4-month Assessment|Overall Study||126||
48089837|NCT03867981|100541249|FG000|COMPLETED|Overall Study||131||
48089838|NCT03867981|100541250|FG001|COMPLETED|Overall Study||131||
48089839|NCT03867981|100541251|FG002|COMPLETED|Overall Study||115||
48089840|NCT03867981|100541249|FG000|NOT COMPLETED|Overall Study||19||
48089841|NCT03867981|100541250|FG001|NOT COMPLETED|Overall Study||19||
48089842|NCT03867981|100541251|FG002|NOT COMPLETED|Overall Study||37||
48380422|NCT02239770|101258645|FG003|COMPLETED|Part 2||4||
48380423|NCT02239770|101258646|FG004|COMPLETED|Part 2||4||
48380424|NCT02239770|101258647|FG005|COMPLETED|Part 2||4||
48380425|NCT02239770|101258642|FG000|NOT COMPLETED|Part 2||0||
48380426|NCT02239770|101258643|FG001|NOT COMPLETED|Part 2||0||
48685334|NCT02685826|102013218|FG002|STARTED|Overall Study||21||
48685335|NCT02685826|102013216|FG000|COMPLETED|Overall Study||0|Completed treatment|
48685336|NCT02685826|102013217|FG001|COMPLETED|Overall Study||0|Completed treatment|
48685337|NCT02685826|102013218|FG002|COMPLETED|Overall Study||0|Completed treatment|
48685338|NCT02685826|102013216|FG000|NOT COMPLETED|Overall Study||25||
48685339|NCT02685826|102013217|FG001|NOT COMPLETED|Overall Study||10||
48685340|NCT02685826|102013218|FG002|NOT COMPLETED|Overall Study||21||
48685341|NCT00355030|102013219|FG000|STARTED|Study Period 1 Treatment||46||
48685342|NCT00355030|102013220|FG001|STARTED|Study Period 1 Treatment||45||
48685343|NCT00355030|102013219|FG000|Received At Least One Dose of Study Drug|Study Period 1 Treatment||45||
48710784|NCT01215110|102078020|FG004|STARTED|Overall Study||8||
48089843|NCT00616200|100541252|FG000|STARTED|Two Week Standard Diet||17||
48089844|NCT00616200|100541252|FG000|COMPLETED|Two Week Standard Diet||16||
48089845|NCT00616200|100541252|FG000|NOT COMPLETED|Two Week Standard Diet||1||
48089846|NCT00616200|100541252|FG000|STARTED|Four Week Very Low Carbohydrate Diet||16||
48089847|NCT00616200|100541252|FG000|COMPLETED|Four Week Very Low Carbohydrate Diet||13||
48089848|NCT00616200|100541252|FG000|NOT COMPLETED|Four Week Very Low Carbohydrate Diet||3||
48089849|NCT04840615|100541253|FG000|STARTED|Overall Study||0||
48089850|NCT04840615|100541254|FG001|STARTED|Overall Study||2||
48089851|NCT04840615|100541255|FG002|STARTED|Overall Study||0||
48089852|NCT04840615|100541253|FG000|COMPLETED|Overall Study||0||
48089853|NCT04840615|100541254|FG001|COMPLETED|Overall Study||0||
48089854|NCT04840615|100541255|FG002|COMPLETED|Overall Study||0||
48089855|NCT04840615|100541253|FG000|NOT COMPLETED|Overall Study||0||
48089856|NCT04840615|100541254|FG001|NOT COMPLETED|Overall Study||2||
48089857|NCT04840615|100541255|FG002|NOT COMPLETED|Overall Study||0||
48089858|NCT00875212|100541256|FG000|STARTED|Placebo Dentifrice||12||
48089859|NCT00875212|100541256|FG000|COMPLETED|Placebo Dentifrice||12||
48685344|NCT00355030|102013220|FG001|Received At Least One Dose of Study Drug|Study Period 1 Treatment||43||
48685345|NCT00355030|102013219|FG000|COMPLETED|Study Period 1 Treatment||1||
48685346|NCT00355030|102013220|FG001|COMPLETED|Study Period 1 Treatment||1||
48685347|NCT00355030|102013219|FG000|NOT COMPLETED|Study Period 1 Treatment||45||
48685348|NCT00355030|102013220|FG001|NOT COMPLETED|Study Period 1 Treatment||44||
48685349|NCT00355030|102013219|FG000|STARTED|Study Period 2 Long Term Follow-Up||20||
48685350|NCT00355030|102013220|FG001|STARTED|Study Period 2 Long Term Follow-Up||19||
48685351|NCT00355030|102013219|FG000|COMPLETED|Study Period 2 Long Term Follow-Up||19||
48685352|NCT00355030|102013220|FG001|COMPLETED|Study Period 2 Long Term Follow-Up||17||
48685353|NCT00355030|102013219|FG000|NOT COMPLETED|Study Period 2 Long Term Follow-Up||1||
48685354|NCT00355030|102013220|FG001|NOT COMPLETED|Study Period 2 Long Term Follow-Up||2||
48685355|NCT04563767|102013221|FG000|STARTED|Overall Study||4||
48685356|NCT04563767|102013221|FG000|COMPLETED|Overall Study||4||
48685357|NCT04563767|102013221|FG000|NOT COMPLETED|Overall Study||0||
48685358|NCT05219253|102013222|FG000|STARTED|Overall Study||143||
48685359|NCT05219253|102013223|FG001|STARTED|Overall Study||145||
48685360|NCT05219253|102013222|FG000|COMPLETED|Overall Study||142||
48685361|NCT05219253|102013223|FG001|COMPLETED|Overall Study||143||
48685362|NCT05219253|102013222|FG000|NOT COMPLETED|Overall Study||1||
48685363|NCT05219253|102013223|FG001|NOT COMPLETED|Overall Study||2||
48685364|NCT02251496|102013224|FG000|STARTED|Overall Study||19||
48685365|NCT02251496|102013225|FG001|STARTED|Overall Study||15||
48685366|NCT02251496|102013224|FG000|COMPLETED|Overall Study||14||
48685367|NCT02251496|102013225|FG001|COMPLETED|Overall Study||11||
48685368|NCT02251496|102013224|FG000|NOT COMPLETED|Overall Study||5||
48685369|NCT02251496|102013225|FG001|NOT COMPLETED|Overall Study||4||
48685370|NCT00480740|102013226|FG000|STARTED|Overall Study||26||
48685371|NCT00480740|102013227|FG001|STARTED|Overall Study||9||
48685372|NCT00480740|102013228|FG002|STARTED|Overall Study||6||
48685373|NCT00480740|102013226|FG000|COMPLETED|Overall Study||26||
48685374|NCT00480740|102013227|FG001|COMPLETED|Overall Study||9||
48685375|NCT00480740|102013228|FG002|COMPLETED|Overall Study||6||
48685376|NCT00480740|102013226|FG000|NOT COMPLETED|Overall Study||0||
48685377|NCT00480740|102013227|FG001|NOT COMPLETED|Overall Study||0||
48685378|NCT00480740|102013228|FG002|NOT COMPLETED|Overall Study||0||
48685379|NCT03579693|102013229|FG000|STARTED|First Intervention (6 Weeks)||4||
48089860|NCT00875212|100541256|FG000|NOT COMPLETED|Placebo Dentifrice||0||
48253346|NCT00853229|100940010|FG000|COMPLETED|Phase 1: Initial Intervention||0||
48685380|NCT03579693|102013230|FG001|STARTED|First Intervention (6 Weeks)||5||
48685381|NCT03579693|102013231|FG002|STARTED|First Intervention (6 Weeks)||5||
48685382|NCT03579693|102013232|FG003|STARTED|First Intervention (6 Weeks)||4||
48685383|NCT03579693|102013233|FG004|STARTED|First Intervention (6 Weeks)||4||
48685384|NCT03579693|102013234|FG005|STARTED|First Intervention (6 Weeks)||4||
48685385|NCT03579693|102013229|FG000|COMPLETED|First Intervention (6 Weeks)||4||
48685386|NCT03579693|102013230|FG001|COMPLETED|First Intervention (6 Weeks)||5||
48685387|NCT03579693|102013231|FG002|COMPLETED|First Intervention (6 Weeks)||5||
48089861|NCT00875212|100541256|FG000|STARTED|CaGP Only Dentifrice||12||
48089862|NCT00875212|100541256|FG000|COMPLETED|CaGP Only Dentifrice||12||
48089863|NCT00875212|100541256|FG000|NOT COMPLETED|CaGP Only Dentifrice||0||
48089864|NCT00875212|100541256|FG000|STARTED|Fluoride Only Dentifrice||12||
48089865|NCT00875212|100541256|FG000|COMPLETED|Fluoride Only Dentifrice||12||
48089866|NCT00875212|100541256|FG000|NOT COMPLETED|Fluoride Only Dentifrice||0||
48685388|NCT03579693|102013232|FG003|COMPLETED|First Intervention (6 Weeks)||4||
48685389|NCT03579693|102013233|FG004|COMPLETED|First Intervention (6 Weeks)||4||
48685390|NCT03579693|102013234|FG005|COMPLETED|First Intervention (6 Weeks)||3||
48685391|NCT03579693|102013229|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0||
48685392|NCT03579693|102013230|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0||
48685393|NCT03579693|102013231|FG002|NOT COMPLETED|First Intervention (6 Weeks)||0||
48089867|NCT00875212|100541256|FG000|STARTED|CaGP and Fluoride Dentifrice||12||
48089868|NCT00875212|100541256|FG000|COMPLETED|CaGP and Fluoride Dentifrice||12||
48089869|NCT00875212|100541256|FG000|NOT COMPLETED|CaGP and Fluoride Dentifrice||0||
48685394|NCT03579693|102013232|FG003|NOT COMPLETED|First Intervention (6 Weeks)||0||
48685395|NCT03579693|102013233|FG004|NOT COMPLETED|First Intervention (6 Weeks)||0||
48685396|NCT03579693|102013234|FG005|NOT COMPLETED|First Intervention (6 Weeks)||1||
48685397|NCT03579693|102013229|FG000|STARTED|Washout (1 Week)||4||
48685398|NCT03579693|102013230|FG001|STARTED|Washout (1 Week)||5||
48380427|NCT02239770|101258644|FG002|NOT COMPLETED|Part 2||0||
48380428|NCT02239770|101258645|FG003|NOT COMPLETED|Part 2||0||
48685399|NCT03579693|102013231|FG002|STARTED|Washout (1 Week)||5||
48685400|NCT03579693|102013232|FG003|STARTED|Washout (1 Week)||4||
48685401|NCT03579693|102013233|FG004|STARTED|Washout (1 Week)||4||
48685402|NCT03579693|102013234|FG005|STARTED|Washout (1 Week)||3||
48685403|NCT03579693|102013229|FG000|COMPLETED|Washout (1 Week)||4||
48685404|NCT03579693|102013230|FG001|COMPLETED|Washout (1 Week)||5||
48685405|NCT03579693|102013231|FG002|COMPLETED|Washout (1 Week)||5||
48685406|NCT03579693|102013232|FG003|COMPLETED|Washout (1 Week)||4||
48685407|NCT03579693|102013233|FG004|COMPLETED|Washout (1 Week)||4||
48685408|NCT03579693|102013234|FG005|COMPLETED|Washout (1 Week)||3||
48685409|NCT03579693|102013229|FG000|NOT COMPLETED|Washout (1 Week)||0||
48685410|NCT03579693|102013230|FG001|NOT COMPLETED|Washout (1 Week)||0||
48685411|NCT03579693|102013231|FG002|NOT COMPLETED|Washout (1 Week)||0||
48089870|NCT00609492|100541257|FG000|STARTED|Overall Study||44||
48685412|NCT03579693|102013232|FG003|NOT COMPLETED|Washout (1 Week)||0||
48685413|NCT03579693|102013233|FG004|NOT COMPLETED|Washout (1 Week)||0||
48089871|NCT00609492|100541258|FG001|STARTED|Overall Study||72||
48089872|NCT00609492|100541259|FG002|STARTED|Overall Study||129||
48089873|NCT00609492|100541257|FG000|COMPLETED|Overall Study||43||
48089874|NCT00609492|100541258|FG001|COMPLETED|Overall Study||69||
48089875|NCT00609492|100541259|FG002|COMPLETED|Overall Study||122||
48089876|NCT00609492|100541257|FG000|NOT COMPLETED|Overall Study||1||
48089877|NCT00609492|100541258|FG001|NOT COMPLETED|Overall Study||3||
48089878|NCT00609492|100541259|FG002|NOT COMPLETED|Overall Study||7||
48089879|NCT01829191|100541260|FG000|STARTED|Overall Study||63||
48089880|NCT01829191|100541261|FG001|STARTED|Overall Study||64||
48685414|NCT03579693|102013234|FG005|NOT COMPLETED|Washout (1 Week)||0||
48089881|NCT01829191|100541260|FG000|COMPLETED|Overall Study||56||
48089882|NCT01829191|100541261|FG001|COMPLETED|Overall Study||50||
48089883|NCT01829191|100541260|FG000|NOT COMPLETED|Overall Study||7||
48380429|NCT02239770|101258646|FG004|NOT COMPLETED|Part 2||0||
48685415|NCT03579693|102013229|FG000|STARTED|Second Intervention (6 Weeks)||4||
48685416|NCT03579693|102013230|FG001|STARTED|Second Intervention (6 Weeks)||5||
48380430|NCT02239770|101258647|FG005|NOT COMPLETED|Part 2||0||
48710785|NCT01215110|102078016|FG000|COMPLETED|Overall Study||15||
48685417|NCT03579693|102013231|FG002|STARTED|Second Intervention (6 Weeks)||5||
48685418|NCT03579693|102013232|FG003|STARTED|Second Intervention (6 Weeks)||4||
48685419|NCT03579693|102013233|FG004|STARTED|Second Intervention (6 Weeks)||4||
48685420|NCT03579693|102013234|FG005|STARTED|Second Intervention (6 Weeks)||3||
48685421|NCT03579693|102013229|FG000|COMPLETED|Second Intervention (6 Weeks)||4||
48685422|NCT03579693|102013230|FG001|COMPLETED|Second Intervention (6 Weeks)||4||
48685423|NCT03579693|102013231|FG002|COMPLETED|Second Intervention (6 Weeks)||5||
48685424|NCT03579693|102013232|FG003|COMPLETED|Second Intervention (6 Weeks)||4||
48685425|NCT03579693|102013233|FG004|COMPLETED|Second Intervention (6 Weeks)||4||
48685426|NCT03579693|102013234|FG005|COMPLETED|Second Intervention (6 Weeks)||3||
48685427|NCT03579693|102013229|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0||
48685428|NCT03579693|102013230|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||1||
48685429|NCT03579693|102013231|FG002|NOT COMPLETED|Second Intervention (6 Weeks)||0||
48685430|NCT03579693|102013232|FG003|NOT COMPLETED|Second Intervention (6 Weeks)||0||
48685431|NCT03579693|102013233|FG004|NOT COMPLETED|Second Intervention (6 Weeks)||0||
48685432|NCT03579693|102013234|FG005|NOT COMPLETED|Second Intervention (6 Weeks)||0||
48685433|NCT03579693|102013229|FG000|STARTED|Second Washout (1 Week)||4||
48685434|NCT03579693|102013230|FG001|STARTED|Second Washout (1 Week)||5||
48685435|NCT03579693|102013231|FG002|STARTED|Second Washout (1 Week)||5||
48685436|NCT03579693|102013232|FG003|STARTED|Second Washout (1 Week)||4||
48685437|NCT03579693|102013233|FG004|STARTED|Second Washout (1 Week)||4||
48685438|NCT03579693|102013234|FG005|STARTED|Second Washout (1 Week)||3||
48685439|NCT03579693|102013229|FG000|COMPLETED|Second Washout (1 Week)||4||
48685440|NCT03579693|102013230|FG001|COMPLETED|Second Washout (1 Week)||5||
48685441|NCT03579693|102013231|FG002|COMPLETED|Second Washout (1 Week)||5||
48685442|NCT03579693|102013232|FG003|COMPLETED|Second Washout (1 Week)||4||
48685443|NCT03579693|102013233|FG004|COMPLETED|Second Washout (1 Week)||4||
48685444|NCT03579693|102013234|FG005|COMPLETED|Second Washout (1 Week)||3||
48685445|NCT03579693|102013229|FG000|NOT COMPLETED|Second Washout (1 Week)||0||
48685446|NCT03579693|102013230|FG001|NOT COMPLETED|Second Washout (1 Week)||0||
48685447|NCT03579693|102013231|FG002|NOT COMPLETED|Second Washout (1 Week)||0||
48685448|NCT03579693|102013232|FG003|NOT COMPLETED|Second Washout (1 Week)||0||
48685449|NCT03579693|102013233|FG004|NOT COMPLETED|Second Washout (1 Week)||0||
48685450|NCT03579693|102013234|FG005|NOT COMPLETED|Second Washout (1 Week)||0||
48685451|NCT03579693|102013229|FG000|STARTED|Third Intervention (6 Weeks)||4||
48685452|NCT03579693|102013230|FG001|STARTED|Third Intervention (6 Weeks)||5||
48685453|NCT03579693|102013231|FG002|STARTED|Third Intervention (6 Weeks)||5||
48685454|NCT03579693|102013232|FG003|STARTED|Third Intervention (6 Weeks)||4||
48685455|NCT03579693|102013233|FG004|STARTED|Third Intervention (6 Weeks)||4||
48685456|NCT03579693|102013234|FG005|STARTED|Third Intervention (6 Weeks)||3||
48685457|NCT03579693|102013229|FG000|COMPLETED|Third Intervention (6 Weeks)||4||
48685458|NCT03579693|102013230|FG001|COMPLETED|Third Intervention (6 Weeks)||5||
48685459|NCT03579693|102013231|FG002|COMPLETED|Third Intervention (6 Weeks)||5||
48685460|NCT03579693|102013232|FG003|COMPLETED|Third Intervention (6 Weeks)||4||
48685461|NCT03579693|102013233|FG004|COMPLETED|Third Intervention (6 Weeks)||4||
48685462|NCT03579693|102013234|FG005|COMPLETED|Third Intervention (6 Weeks)||3||
48685463|NCT03579693|102013229|FG000|NOT COMPLETED|Third Intervention (6 Weeks)||0||
48685464|NCT03579693|102013230|FG001|NOT COMPLETED|Third Intervention (6 Weeks)||0||
48685465|NCT03579693|102013231|FG002|NOT COMPLETED|Third Intervention (6 Weeks)||0||
48685466|NCT03579693|102013232|FG003|NOT COMPLETED|Third Intervention (6 Weeks)||0||
48685467|NCT03579693|102013233|FG004|NOT COMPLETED|Third Intervention (6 Weeks)||0||
48685468|NCT03579693|102013234|FG005|NOT COMPLETED|Third Intervention (6 Weeks)||0||
48685469|NCT03341637|102013235|FG000|STARTED|Overall Study||100||
48685470|NCT03341637|102013236|FG001|STARTED|Overall Study||300||
48685471|NCT03341637|102013235|FG000|COMPLETED|Overall Study||95||
48685472|NCT03341637|102013236|FG001|COMPLETED|Overall Study||296||
48685473|NCT03341637|102013235|FG000|NOT COMPLETED|Overall Study||5||
48685474|NCT03341637|102013236|FG001|NOT COMPLETED|Overall Study||4||
48685475|NCT00553631|102013237|FG000|STARTED|Overall Study||17||
48685476|NCT00553631|102013238|FG001|STARTED|Overall Study||17||
48685477|NCT00553631|102013237|FG000|COMPLETED|Overall Study||16||
48685478|NCT00553631|102013238|FG001|COMPLETED|Overall Study||16||
48685479|NCT00553631|102013237|FG000|NOT COMPLETED|Overall Study||1||
48685480|NCT00553631|102013238|FG001|NOT COMPLETED|Overall Study||1||
48685481|NCT01408277|102013239|FG000|STARTED|Overall Study||28||
48685482|NCT01408277|102013240|FG001|STARTED|Overall Study||27||
48685483|NCT01408277|102013239|FG000|COMPLETED|Overall Study||20||
48685484|NCT01408277|102013240|FG001|COMPLETED|Overall Study||23||
48685485|NCT01408277|102013239|FG000|NOT COMPLETED|Overall Study||8||
48685486|NCT01408277|102013240|FG001|NOT COMPLETED|Overall Study||4||
48685487|NCT04232943|102013241|FG000|STARTED|Overall Study||32||
48685488|NCT04232943|102013242|FG001|STARTED|Overall Study||33||
48685489|NCT04232943|102013243|FG002|STARTED|Overall Study||22||
48685490|NCT04232943|102013241|FG000|Received Study Vaccination|Overall Study||30||
48685491|NCT04232943|102013242|FG001|Received Study Vaccination|Overall Study||30||
48685492|NCT04232943|102013243|FG002|Received Study Vaccination|Overall Study||20||
48685493|NCT04232943|102013241|FG000|Received bOPV Challenge on Day 29|Overall Study||29||
48685494|NCT04232943|102013242|FG001|Received bOPV Challenge on Day 29|Overall Study||30||
48685495|NCT04232943|102013243|FG002|Received bOPV Challenge on Day 29|Overall Study||20||
48685496|NCT04232943|102013241|FG000|COMPLETED|Overall Study||29||
48685497|NCT04232943|102013242|FG001|COMPLETED|Overall Study||29||
48685498|NCT04232943|102013243|FG002|COMPLETED|Overall Study||20||
48685499|NCT04232943|102013241|FG000|NOT COMPLETED|Overall Study||3||
48685500|NCT04232943|102013242|FG001|NOT COMPLETED|Overall Study||4||
48685501|NCT04232943|102013243|FG002|NOT COMPLETED|Overall Study||2||
48685502|NCT02389465|102013244|FG000|STARTED|Overall Study||30||
48685503|NCT02389465|102013245|FG001|STARTED|Overall Study||20||
48685504|NCT02389465|102013246|FG002|STARTED|Overall Study||29||
48685505|NCT02389465|102013247|FG003|STARTED|Overall Study||16||
48685506|NCT02389465|102013244|FG000|COMPLETED|Overall Study||29||
48685507|NCT02389465|102013245|FG001|COMPLETED|Overall Study||16||
48253347|NCT00853229|100940011|FG001|COMPLETED|Phase 1: Initial Intervention||0||
48253348|NCT00853229|100940010|FG000|NOT COMPLETED|Phase 1: Initial Intervention||8||
48253349|NCT00853229|100940011|FG001|NOT COMPLETED|Phase 1: Initial Intervention||8||
48253350|NCT00853229|100940010|FG000|STARTED|Phase 2: Cross Over||0||
48685508|NCT02389465|102013246|FG002|COMPLETED|Overall Study||24||
48685509|NCT02389465|102013247|FG003|COMPLETED|Overall Study||13||
48685510|NCT02389465|102013244|FG000|NOT COMPLETED|Overall Study||1||
48685511|NCT02389465|102013245|FG001|NOT COMPLETED|Overall Study||4||
48685512|NCT02389465|102013246|FG002|NOT COMPLETED|Overall Study||5||
48685513|NCT02389465|102013247|FG003|NOT COMPLETED|Overall Study||3||
48685514|NCT00437268|102013248|FG000|STARTED|Overall Study||13||
48685515|NCT00437268|102013249|FG001|STARTED|Overall Study||13||
48685516|NCT00437268|102013248|FG000|Received at Least 1 Dose of Study Drug|Overall Study||13||
48685517|NCT00437268|102013249|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13||
48685518|NCT00437268|102013248|FG000|Protocol Qualified (PQ) Participant|Overall Study||13||
48685519|NCT00437268|102013249|FG001|Protocol Qualified (PQ) Participant|Overall Study||12||
48685520|NCT00437268|102013248|FG000|COMPLETED|Overall Study||0||
48685521|NCT00437268|102013249|FG001|COMPLETED|Overall Study||0||
48685522|NCT00437268|102013248|FG000|NOT COMPLETED|Overall Study||13||
48685523|NCT00437268|102013249|FG001|NOT COMPLETED|Overall Study||13||
48685524|NCT04245709|102013250|FG000|STARTED|Overall Study||25||
48685525|NCT04245709|102013250|FG000|COMPLETED|Overall Study||11||
48685526|NCT04245709|102013250|FG000|NOT COMPLETED|Overall Study||14||
48685527|NCT00661830|102013251|FG000|STARTED|Overall Study||49||
48253351|NCT00853229|100940011|FG001|STARTED|Phase 2: Cross Over||0||
48253352|NCT00853229|100940010|FG000|COMPLETED|Phase 2: Cross Over||0||
48253353|NCT00853229|100940011|FG001|COMPLETED|Phase 2: Cross Over||0||
48253354|NCT00853229|100940010|FG000|NOT COMPLETED|Phase 2: Cross Over||0||
48253355|NCT00853229|100940011|FG001|NOT COMPLETED|Phase 2: Cross Over||0||
48253356|NCT03352882|100940012|FG000|STARTED|Overall Study||1||
48685528|NCT00661830|102013252|FG001|STARTED|Overall Study||48||
48685529|NCT00661830|102013251|FG000|COMPLETED|Overall Study||9||
48685530|NCT00661830|102013252|FG001|COMPLETED|Overall Study||6||
48685531|NCT00661830|102013251|FG000|NOT COMPLETED|Overall Study||40||
48685532|NCT00661830|102013252|FG001|NOT COMPLETED|Overall Study||42||
48685533|NCT00503425|102013253|FG000|STARTED|Overall Study||215||
48685534|NCT00503425|102013253|FG000|COMPLETED|Overall Study||161||
48685535|NCT00503425|102013253|FG000|NOT COMPLETED|Overall Study||54||
48685536|NCT02358993|102013254|FG000|STARTED|Overall Study||105||
48685537|NCT02358993|102013255|FG001|STARTED|Overall Study||96||
48685538|NCT02358993|102013254|FG000|COMPLETED|Overall Study||103||
48685539|NCT02358993|102013255|FG001|COMPLETED|Overall Study||94||
48685540|NCT02358993|102013254|FG000|NOT COMPLETED|Overall Study||2||
48685541|NCT02358993|102013255|FG001|NOT COMPLETED|Overall Study||2||
48685542|NCT00355368|102013256|FG000|STARTED|Overall Study||210||
48685543|NCT00355368|102013257|FG001|STARTED|Overall Study||210||
48685544|NCT00355368|102013256|FG000|COMPLETED|Overall Study||200||
48685545|NCT00355368|102013257|FG001|COMPLETED|Overall Study||201||
48685546|NCT00355368|102013256|FG000|NOT COMPLETED|Overall Study||10||
48685547|NCT00355368|102013257|FG001|NOT COMPLETED|Overall Study||9||
48253357|NCT03352882|100940012|FG000|COMPLETED|Overall Study||1||
48253358|NCT03352882|100940012|FG000|NOT COMPLETED|Overall Study||0||
48253359|NCT01880437|100940013|FG000|STARTED|Overall Study||15||
48253360|NCT01880437|100940014|FG001|STARTED|Overall Study||4||
48253361|NCT01880437|100940015|FG002|STARTED|Overall Study||19||
48253362|NCT01880437|100940013|FG000|COMPLETED|Overall Study||0||
48253363|NCT01880437|100940014|FG001|COMPLETED|Overall Study||0||
48253364|NCT01880437|100940015|FG002|COMPLETED|Overall Study||0||
48253365|NCT01880437|100940013|FG000|NOT COMPLETED|Overall Study||15||
48253366|NCT01880437|100940014|FG001|NOT COMPLETED|Overall Study||4||
48253367|NCT01880437|100940015|FG002|NOT COMPLETED|Overall Study||19||
48253368|NCT00519285|100940016|FG000|STARTED|Overall Study||612||
48253369|NCT00519285|100940017|FG001|STARTED|Overall Study||612||
48253370|NCT00519285|100940016|FG000|TREATED|Overall Study||604||
48253371|NCT00519285|100940017|FG001|TREATED|Overall Study||605||
48253372|NCT00519285|100940016|FG000|Still Treated at Cut-off Date|Overall Study||1||
48253373|NCT00519285|100940017|FG001|Still Treated at Cut-off Date|Overall Study||2||
48685548|NCT01963767|102013258|FG000|STARTED|Overall Study||58||
48685549|NCT01963767|102013259|FG001|STARTED|Overall Study||55||
48685550|NCT01963767|102013258|FG000|COMPLETED|Overall Study||52||
48685551|NCT01963767|102013259|FG001|COMPLETED|Overall Study||53||
48685552|NCT01963767|102013258|FG000|NOT COMPLETED|Overall Study||6||
48685553|NCT01963767|102013259|FG001|NOT COMPLETED|Overall Study||2||
48685554|NCT01194245|102013260|FG000|STARTED|Titration Period (4 to 6 Weeks)||135||
48685555|NCT01194245|102013261|FG001|STARTED|Titration Period (4 to 6 Weeks)||0||
48685556|NCT01194245|102013262|FG002|STARTED|Titration Period (4 to 6 Weeks)||0||
48685557|NCT01194245|102013263|FG003|STARTED|Titration Period (4 to 6 Weeks)||0||
48253374|NCT00519285|100940016|FG000|COMPLETED|Overall Study||0||
48253375|NCT00519285|100940017|FG001|COMPLETED|Overall Study||0||
48253376|NCT00519285|100940016|FG000|NOT COMPLETED|Overall Study||612||
48253377|NCT00519285|100940017|FG001|NOT COMPLETED|Overall Study||612||
48253378|NCT02514577|100940018|FG000|STARTED|Overall Study||143||
48380431|NCT01848899|101258648|FG000|STARTED|Overall Study||50||
48685558|NCT01194245|102013264|FG004|STARTED|Titration Period (4 to 6 Weeks)||0||
48685559|NCT01194245|102013260|FG000|COMPLETED|Titration Period (4 to 6 Weeks)||117||
48685560|NCT01194245|102013261|FG001|COMPLETED|Titration Period (4 to 6 Weeks)||0||
48380432|NCT01848899|101258649|FG001|STARTED|Overall Study||50||
48380433|NCT01848899|101258648|FG000|COMPLETED|Overall Study||50||
48685561|NCT01194245|102013262|FG002|COMPLETED|Titration Period (4 to 6 Weeks)||0||
48685562|NCT01194245|102013263|FG003|COMPLETED|Titration Period (4 to 6 Weeks)||0||
48253379|NCT02514577|100940019|FG001|STARTED|Overall Study||74||
48253380|NCT02514577|100940018|FG000|Intent-to-Treat (ITT) Population|Overall Study||143|Participants who were randomized and dispensed study drug.|
48253381|NCT02514577|100940019|FG001|Intent-to-Treat (ITT) Population|Overall Study||74|Participants who were randomized and dispensed study drug.|
48253382|NCT02514577|100940018|FG000|Safety Population|Overall Study||142|Randomized participants with ≥1 confirmed dose of study drug and ≥1 post-Baseline safety assessment.|
48253383|NCT02514577|100940019|FG001|Safety Population|Overall Study||72|Randomized participants with ≥1 confirmed dose of study drug and ≥1 post-Baseline safety assessment.|
48253384|NCT02514577|100940018|FG000|COMPLETED|Overall Study||129||
48253385|NCT02514577|100940019|FG001|COMPLETED|Overall Study||61||
48253386|NCT02514577|100940018|FG000|NOT COMPLETED|Overall Study||14||
48253387|NCT02514577|100940019|FG001|NOT COMPLETED|Overall Study||13||
48253388|NCT01722045|100940020|FG000|STARTED|Overall Study||154||
48253389|NCT01722045|100940020|FG000|COMPLETED|Overall Study||126||
48253390|NCT01722045|100940020|FG000|NOT COMPLETED|Overall Study||28||
48253391|NCT02668198|100940021|FG000|STARTED|Overall Study||230||
48253392|NCT02668198|100940021|FG000|COMPLETED|Overall Study||230||
48253393|NCT02668198|100940021|FG000|NOT COMPLETED|Overall Study||0||
48253394|NCT02647645|100940022|FG000|STARTED|Overall Study||11||
48253395|NCT02647645|100940023|FG001|STARTED|Overall Study||10||
48253396|NCT02647645|100940022|FG000|COMPLETED|Overall Study||9||
48253397|NCT02647645|100940023|FG001|COMPLETED|Overall Study||9||
48253398|NCT02647645|100940022|FG000|NOT COMPLETED|Overall Study||2||
48253399|NCT02647645|100940023|FG001|NOT COMPLETED|Overall Study||1||
48253400|NCT00948610|100940024|FG000|STARTED|Overall Study||10||
48253401|NCT00948610|100940025|FG001|STARTED|Overall Study||10||
48253402|NCT00948610|100940024|FG000|COMPLETED|Overall Study||9||
48253403|NCT00948610|100940025|FG001|COMPLETED|Overall Study||9||
48253404|NCT00948610|100940024|FG000|NOT COMPLETED|Overall Study||1||
48253405|NCT00948610|100940025|FG001|NOT COMPLETED|Overall Study||1||
48253406|NCT00766142|100940026|FG000|STARTED|Overall Study||18||
48253407|NCT00766142|100940026|FG000|COMPLETED|Overall Study||14||
48253408|NCT00766142|100940026|FG000|NOT COMPLETED|Overall Study||4||
48253409|NCT03187353|100940027|FG000|STARTED|First Intervention (6 Weeks)||36||
48253410|NCT03187353|100940028|FG001|STARTED|First Intervention (6 Weeks)||33||
48253411|NCT03187353|100940027|FG000|COMPLETED|First Intervention (6 Weeks)||33||
48253412|NCT03187353|100940028|FG001|COMPLETED|First Intervention (6 Weeks)||30||
48253413|NCT03187353|100940027|FG000|NOT COMPLETED|First Intervention (6 Weeks)||3||
48380434|NCT01848899|101258649|FG001|COMPLETED|Overall Study||50||
48380435|NCT01848899|101258648|FG000|NOT COMPLETED|Overall Study||0||
48685563|NCT01194245|102013264|FG004|COMPLETED|Titration Period (4 to 6 Weeks)||0||
48685564|NCT01194245|102013260|FG000|NOT COMPLETED|Titration Period (4 to 6 Weeks)||18||
48380436|NCT01848899|101258649|FG001|NOT COMPLETED|Overall Study||0||
48380437|NCT01981967|101258650|FG000|STARTED|Overall Study||6851||
48380438|NCT01981967|101258651|FG001|STARTED|Overall Study||3149||
48380439|NCT01981967|101258650|FG000|COMPLETED|Overall Study||6851||
48380440|NCT01981967|101258651|FG001|COMPLETED|Overall Study||3149||
48380441|NCT01981967|101258650|FG000|NOT COMPLETED|Overall Study||0||
48685565|NCT01194245|102013261|FG001|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0||
48685566|NCT01194245|102013262|FG002|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0||
48685567|NCT01194245|102013263|FG003|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0||
48685568|NCT01194245|102013264|FG004|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0||
48685569|NCT01194245|102013260|FG000|STARTED|Treatment Period 1 (Weeks 0 to 12)||0||
48685570|NCT01194245|102013261|FG001|STARTED|Treatment Period 1 (Weeks 0 to 12)||29||
48380442|NCT01981967|101258651|FG001|NOT COMPLETED|Overall Study||0||
48380443|NCT02939937|101258652|FG000|STARTED|Overall Study||21||
48380444|NCT02939937|101258653|FG001|STARTED|Overall Study||50||
48380445|NCT02939937|101258652|FG000|COMPLETED|Overall Study||15||
48380446|NCT02939937|101258653|FG001|COMPLETED|Overall Study||47||
48685571|NCT01194245|102013262|FG002|STARTED|Treatment Period 1 (Weeks 0 to 12)||28||
48685572|NCT01194245|102013263|FG003|STARTED|Treatment Period 1 (Weeks 0 to 12)||30||
48685573|NCT01194245|102013264|FG004|STARTED|Treatment Period 1 (Weeks 0 to 12)||30||
48685574|NCT01194245|102013260|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||0||
48685575|NCT01194245|102013261|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||29||
48685576|NCT01194245|102013262|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||28||
48253414|NCT03187353|100940028|FG001|NOT COMPLETED|First Intervention (6 Weeks)||3||
48253415|NCT03187353|100940027|FG000|STARTED|Washout (2 Weeks)||33||
48253416|NCT03187353|100940028|FG001|STARTED|Washout (2 Weeks)||30||
48253417|NCT03187353|100940027|FG000|COMPLETED|Washout (2 Weeks)||29||
48253418|NCT03187353|100940028|FG001|COMPLETED|Washout (2 Weeks)||29||
48253419|NCT03187353|100940027|FG000|NOT COMPLETED|Washout (2 Weeks)||4||
48253420|NCT03187353|100940028|FG001|NOT COMPLETED|Washout (2 Weeks)||1||
48253421|NCT03187353|100940027|FG000|STARTED|Second Intervention (6 Weeks)||29||
48253422|NCT03187353|100940028|FG001|STARTED|Second Intervention (6 Weeks)||29||
48253423|NCT03187353|100940027|FG000|COMPLETED|Second Intervention (6 Weeks)||28||
48253424|NCT03187353|100940028|FG001|COMPLETED|Second Intervention (6 Weeks)||29||
48253425|NCT03187353|100940027|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||1||
48253426|NCT03187353|100940028|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0||
48253427|NCT00118703|100940029|FG000|STARTED|Overall Study||173||
48253428|NCT00118703|100940030|FG001|STARTED|Overall Study||174||
48253429|NCT00118703|100940029|FG000|COMPLETED|Overall Study||168||
48253430|NCT00118703|100940030|FG001|COMPLETED|Overall Study||165||
48253431|NCT00118703|100940029|FG000|NOT COMPLETED|Overall Study||5||
48253432|NCT00118703|100940030|FG001|NOT COMPLETED|Overall Study||9||
48253433|NCT01121185|100940031|FG000|STARTED|Overall Study||7||
48253434|NCT01121185|100940032|FG001|STARTED|Overall Study||6||
48253435|NCT01121185|100940031|FG000|Infused|Overall Study||7||
48253436|NCT01121185|100940032|FG001|Infused|Overall Study||5||
48253437|NCT01121185|100940031|FG000|Transplanted|Overall Study||6||
48253438|NCT01121185|100940032|FG001|Transplanted|Overall Study||5||
48253439|NCT01121185|100940031|FG000|COMPLETED|Overall Study||6||
48253440|NCT01121185|100940032|FG001|COMPLETED|Overall Study||5||
48253441|NCT01121185|100940031|FG000|NOT COMPLETED|Overall Study||1||
48253442|NCT01121185|100940032|FG001|NOT COMPLETED|Overall Study||1||
48685577|NCT01194245|102013263|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30||
48685578|NCT01194245|102013264|FG004|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30||
48685579|NCT01194245|102013260|FG000|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0||
48685580|NCT01194245|102013261|FG001|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29||
48685581|NCT01194245|102013262|FG002|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||27||
48685582|NCT01194245|102013263|FG003|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29||
48685583|NCT01194245|102013264|FG004|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||28||
48685584|NCT01194245|102013260|FG000|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0||
48685585|NCT01194245|102013261|FG001|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0||
48685586|NCT01194245|102013262|FG002|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1||
48685587|NCT01194245|102013263|FG003|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1||
48685588|NCT01194245|102013264|FG004|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||2||
48253443|NCT00405912|100940033|FG000|STARTED|Overall Study||39||
48685589|NCT01194245|102013260|FG000|STARTED|Treatment Period 2 (Weeks 12 to 24)||0||
48685590|NCT01194245|102013261|FG001|STARTED|Treatment Period 2 (Weeks 12 to 24)||29||
48685591|NCT01194245|102013262|FG002|STARTED|Treatment Period 2 (Weeks 12 to 24)||27||
48685592|NCT01194245|102013263|FG003|STARTED|Treatment Period 2 (Weeks 12 to 24)||29||
48253444|NCT00405912|100940034|FG001|STARTED|Overall Study||40||
48253445|NCT00405912|100940035|FG002|STARTED|Overall Study||39||
48253446|NCT00405912|100940033|FG000|COMPLETED|Overall Study||23||
48253447|NCT00405912|100940034|FG001|COMPLETED|Overall Study||21||
48380447|NCT02939937|101258652|FG000|NOT COMPLETED|Overall Study||6||
48380448|NCT02939937|101258653|FG001|NOT COMPLETED|Overall Study||3||
48380449|NCT01767194|101258654|FG000|STARTED|Overall Study||19||
48380450|NCT01767194|101258655|FG001|STARTED|Overall Study||54||
48253448|NCT00405912|100940035|FG002|COMPLETED|Overall Study||23||
48253449|NCT00405912|100940033|FG000|NOT COMPLETED|Overall Study||16||
48253450|NCT00405912|100940034|FG001|NOT COMPLETED|Overall Study||19||
48253451|NCT00405912|100940035|FG002|NOT COMPLETED|Overall Study||16||
48253452|NCT02037256|100940036|FG000|STARTED|Overall Study||3||
48253453|NCT02037256|100940037|FG001|STARTED|Overall Study||20||
48253454|NCT02037256|100940036|FG000|COMPLETED|Overall Study||3|"1 withdrew consent prior to Velcade infusion~1 removed from protocol prior to Velcade infusioin~1 failed to comply with protocol requirement to come to transplant in 2 months"|
48253455|NCT02037256|100940037|FG001|COMPLETED|Overall Study||17|"1 withdrew consent prior to Velcade infusion~1 removed from protocol prior to Velcade infusioin~1 failed to comply with protocol requirement to come to transplant in 2 months"|
48253456|NCT02037256|100940036|FG000|NOT COMPLETED|Overall Study||0||
48253457|NCT02037256|100940037|FG001|NOT COMPLETED|Overall Study||3||
48253458|NCT04052997|100940038|FG000|STARTED|Overall Study||117||
48253459|NCT04052997|100940038|FG000|Discontinued From Study|Overall Study||117||
48253460|NCT04052997|100940038|FG000|COMPLETED|Overall Study||1||
48253461|NCT04052997|100940038|FG000|NOT COMPLETED|Overall Study||116||
48253462|NCT04599907|100940039|FG000|STARTED|Overall Study||10||
48253463|NCT04599907|100940040|FG001|STARTED|Overall Study||53||
48253464|NCT04599907|100940041|FG002|STARTED|Overall Study||57||
48253465|NCT04599907|100940039|FG000|COMPLETED|Overall Study||9||
48253466|NCT04599907|100940040|FG001|COMPLETED|Overall Study||45||
48253467|NCT04599907|100940041|FG002|COMPLETED|Overall Study||51||
48253468|NCT04599907|100940039|FG000|NOT COMPLETED|Overall Study||1||
48253469|NCT04599907|100940040|FG001|NOT COMPLETED|Overall Study||8||
48253470|NCT04599907|100940041|FG002|NOT COMPLETED|Overall Study||6||
48253471|NCT04588519|100940042|FG000|STARTED|Overall Study||8||
48253472|NCT04588519|100940042|FG000|COMPLETED|Overall Study||8||
48253473|NCT04588519|100940042|FG000|NOT COMPLETED|Overall Study||0||
48253474|NCT00546078|100940043|FG000|STARTED|Overall Study||65||
48253475|NCT00546078|100940044|FG001|STARTED|Overall Study||50||
48253476|NCT00546078|100940043|FG000|Month 18|Overall Study||61||
48253477|NCT00546078|100940044|FG001|Month 18|Overall Study||45||
48253478|NCT00546078|100940043|FG000|COMPLETED|Overall Study||61||
48253479|NCT00546078|100940044|FG001|COMPLETED|Overall Study||43||
48253480|NCT00546078|100940043|FG000|NOT COMPLETED|Overall Study||4||
48253481|NCT00546078|100940044|FG001|NOT COMPLETED|Overall Study||7||
48253482|NCT02629419|100940045|FG000|STARTED|Overall Study||4||
48253483|NCT02629419|100940045|FG000|COMPLETED|Overall Study||4||
48253484|NCT02629419|100940045|FG000|NOT COMPLETED|Overall Study||0||
48253485|NCT04970381|100940046|FG000|STARTED|Overall Study||75||
48253486|NCT04970381|100940046|FG000|COMPLETED|Overall Study||66||
48253487|NCT04970381|100940046|FG000|NOT COMPLETED|Overall Study||9||
48253488|NCT00511797|100940047|FG000|STARTED|Overall Study||62||
48253489|NCT00511797|100940048|FG001|STARTED|Overall Study||63||
48253490|NCT00511797|100940049|FG002|STARTED|Overall Study||62||
48253491|NCT00511797|100940050|FG003|STARTED|Overall Study||62||
48253492|NCT00511797|100940047|FG000|Subjects Dispensed Drugs|Overall Study||61||
48253493|NCT00511797|100940048|FG001|Subjects Dispensed Drugs|Overall Study||63||
48253494|NCT00511797|100940049|FG002|Subjects Dispensed Drugs|Overall Study||61||
48253495|NCT00511797|100940050|FG003|Subjects Dispensed Drugs|Overall Study||59||
48253496|NCT00511797|100940047|FG000|Subjects Received Treatment|Overall Study||61||
48253497|NCT00511797|100940048|FG001|Subjects Received Treatment|Overall Study||62||
48253498|NCT00511797|100940049|FG002|Subjects Received Treatment|Overall Study||61||
48253499|NCT00511797|100940050|FG003|Subjects Received Treatment|Overall Study||58||
48253500|NCT00511797|100940047|FG000|COMPLETED|Overall Study||55||
48253501|NCT00511797|100940048|FG001|COMPLETED|Overall Study||55||
48253502|NCT00511797|100940049|FG002|COMPLETED|Overall Study||51||
48253503|NCT00511797|100940050|FG003|COMPLETED|Overall Study||47||
48253504|NCT00511797|100940047|FG000|NOT COMPLETED|Overall Study||7||
48253505|NCT00511797|100940048|FG001|NOT COMPLETED|Overall Study||8||
48253506|NCT00511797|100940049|FG002|NOT COMPLETED|Overall Study||11||
48253507|NCT00511797|100940050|FG003|NOT COMPLETED|Overall Study||15||
48253508|NCT00740597|100940051|FG000|STARTED|Overall Study||1||
48253509|NCT00740597|100940051|FG000|COMPLETED|Overall Study||0||
48253510|NCT00740597|100940051|FG000|NOT COMPLETED|Overall Study||1||
48253511|NCT01525641|100940052|FG000|STARTED|Overall Study||615||
48253512|NCT01525641|100940052|FG000|COMPLETED|Overall Study||435||
48253513|NCT01525641|100940052|FG000|NOT COMPLETED|Overall Study||180||
48380451|NCT01767194|101258654|FG000|COMPLETED|Overall Study||1||
48380452|NCT01767194|101258655|FG001|COMPLETED|Overall Study||11||
48253514|NCT03722836|100940053|FG000|STARTED|Overall Study||708||
48253515|NCT03722836|100940053|FG000|COMPLETED|Overall Study||708||
48253516|NCT03722836|100940053|FG000|NOT COMPLETED|Overall Study||0||
48380453|NCT01767194|101258654|FG000|NOT COMPLETED|Overall Study||18||
48253517|NCT03772041|100940054|FG000|STARTED|Overall Study||149||
48253518|NCT03772041|100940055|FG001|STARTED|Overall Study||145||
48253519|NCT03772041|100940054|FG000|COMPLETED|Overall Study||135||
48253520|NCT03772041|100940055|FG001|COMPLETED|Overall Study||135||
48253521|NCT03772041|100940054|FG000|NOT COMPLETED|Overall Study||14||
48253522|NCT03772041|100940055|FG001|NOT COMPLETED|Overall Study||10||
48253523|NCT00488319|100940056|FG000|STARTED|Overall Study||39||
48253524|NCT00488319|100940057|FG001|STARTED|Overall Study||118||
48380454|NCT01767194|101258655|FG001|NOT COMPLETED|Overall Study||43||
48253525|NCT00488319|100940058|FG002|STARTED|Overall Study||243||
48253526|NCT00488319|100940056|FG000|COMPLETED|Overall Study||24||
48253527|NCT00488319|100940057|FG001|COMPLETED|Overall Study||75||
48253528|NCT00488319|100940058|FG002|COMPLETED|Overall Study||121||
48253529|NCT00488319|100940056|FG000|NOT COMPLETED|Overall Study||15||
48253530|NCT00488319|100940057|FG001|NOT COMPLETED|Overall Study||43||
48253531|NCT00488319|100940058|FG002|NOT COMPLETED|Overall Study||122||
48253532|NCT00953212|100940059|FG000|STARTED|Overall Study||76||
48253533|NCT00953212|100940060|FG001|STARTED|Overall Study||74||
48253534|NCT00953212|100940061|FG002|STARTED|Overall Study||78||
48253535|NCT00953212|100940062|FG003|STARTED|Overall Study||76||
48253536|NCT00953212|100940059|FG000|COMPLETED|Overall Study||76||
48253537|NCT00953212|100940060|FG001|COMPLETED|Overall Study||74||
48685593|NCT01194245|102013264|FG004|STARTED|Treatment Period 2 (Weeks 12 to 24)||28||
48685594|NCT01194245|102013260|FG000|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0||
48685595|NCT01194245|102013261|FG001|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29||
48253538|NCT00953212|100940061|FG002|COMPLETED|Overall Study||78||
48253539|NCT00953212|100940062|FG003|COMPLETED|Overall Study||76||
48253540|NCT00953212|100940059|FG000|NOT COMPLETED|Overall Study||0||
48253541|NCT00953212|100940060|FG001|NOT COMPLETED|Overall Study||0||
48253542|NCT00953212|100940061|FG002|NOT COMPLETED|Overall Study||0||
48253543|NCT00953212|100940062|FG003|NOT COMPLETED|Overall Study||0||
48253544|NCT02628964|100940063|FG000|STARTED|Overall Study||50||
48253545|NCT02628964|100940064|FG001|STARTED|Overall Study||50||
48253546|NCT02628964|100940063|FG000|COMPLETED|Overall Study||50||
48253547|NCT02628964|100940064|FG001|COMPLETED|Overall Study||49||
48253548|NCT02628964|100940063|FG000|NOT COMPLETED|Overall Study||0||
48253549|NCT02628964|100940064|FG001|NOT COMPLETED|Overall Study||1||
48253550|NCT02143310|100940065|FG000|STARTED|Overall Study||209||
48253551|NCT02143310|100940065|FG000|COMPLETED|Overall Study||102||
48253552|NCT02143310|100940065|FG000|NOT COMPLETED|Overall Study||107||
48253553|NCT00953862|100940066|FG000|STARTED|Overall Study||18||
48253554|NCT00953862|100940066|FG000|COMPLETED|Overall Study||12||
48253555|NCT00953862|100940066|FG000|NOT COMPLETED|Overall Study||6||
48253556|NCT00632931|100940067|FG000|STARTED|Part 1, Period 1||13||
48253557|NCT00632931|100940068|FG001|STARTED|Part 1, Period 1||12||
48253558|NCT00632931|100940069|FG002|STARTED|Part 1, Period 1||0||
48253559|NCT00632931|100940067|FG000|COMPLETED|Part 1, Period 1||11||
48253560|NCT00632931|100940068|FG001|COMPLETED|Part 1, Period 1||12||
48253561|NCT00632931|100940069|FG002|COMPLETED|Part 1, Period 1||0||
48253562|NCT00632931|100940067|FG000|NOT COMPLETED|Part 1, Period 1||2||
48253563|NCT00632931|100940068|FG001|NOT COMPLETED|Part 1, Period 1||0||
48253564|NCT00632931|100940069|FG002|NOT COMPLETED|Part 1, Period 1||0||
48253565|NCT00632931|100940067|FG000|STARTED|Part 1, Washout||11||
48253566|NCT00632931|100940068|FG001|STARTED|Part 1, Washout||12||
48253567|NCT00632931|100940069|FG002|STARTED|Part 1, Washout||0||
48253568|NCT00632931|100940067|FG000|COMPLETED|Part 1, Washout||11||
48253569|NCT00632931|100940068|FG001|COMPLETED|Part 1, Washout||12||
48253570|NCT00632931|100940069|FG002|COMPLETED|Part 1, Washout||0||
48253571|NCT00632931|100940067|FG000|NOT COMPLETED|Part 1, Washout||0||
48253572|NCT00632931|100940068|FG001|NOT COMPLETED|Part 1, Washout||0||
48253573|NCT00632931|100940069|FG002|NOT COMPLETED|Part 1, Washout||0||
48253574|NCT00632931|100940067|FG000|STARTED|Part 1, Period 2||11||
48253575|NCT00632931|100940068|FG001|STARTED|Part 1, Period 2||12||
48253576|NCT00632931|100940069|FG002|STARTED|Part 1, Period 2||0||
48253577|NCT00632931|100940067|FG000|COMPLETED|Part 1, Period 2||11||
48253578|NCT00632931|100940068|FG001|COMPLETED|Part 1, Period 2||12||
48253579|NCT00632931|100940069|FG002|COMPLETED|Part 1, Period 2||0||
48253580|NCT00632931|100940067|FG000|NOT COMPLETED|Part 1, Period 2||0||
48253581|NCT00632931|100940068|FG001|NOT COMPLETED|Part 1, Period 2||0||
48253582|NCT00632931|100940069|FG002|NOT COMPLETED|Part 1, Period 2||0||
48253583|NCT00632931|100940067|FG000|STARTED|Post-Part 1 Washout||12||
48685596|NCT01194245|102013262|FG002|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||27||
48710786|NCT01215110|102078017|FG001|COMPLETED|Overall Study||15||
48253584|NCT00632931|100940068|FG001|STARTED|Post-Part 1 Washout||12||
48253585|NCT00632931|100940069|FG002|STARTED|Post-Part 1 Washout||0||
48253586|NCT00632931|100940067|FG000|COMPLETED|Post-Part 1 Washout||12||
48253587|NCT00632931|100940068|FG001|COMPLETED|Post-Part 1 Washout||12||
48253588|NCT00632931|100940069|FG002|COMPLETED|Post-Part 1 Washout||0||
48253589|NCT00632931|100940067|FG000|NOT COMPLETED|Post-Part 1 Washout||0||
48253590|NCT00632931|100940068|FG001|NOT COMPLETED|Post-Part 1 Washout||0||
48253591|NCT00632931|100940069|FG002|NOT COMPLETED|Post-Part 1 Washout||0||
48253592|NCT00632931|100940067|FG000|STARTED|Part 2||0||
48253593|NCT00632931|100940068|FG001|STARTED|Part 2||0||
48253594|NCT00632931|100940069|FG002|STARTED|Part 2||24||
48253595|NCT00632931|100940067|FG000|COMPLETED|Part 2||0||
48253596|NCT00632931|100940068|FG001|COMPLETED|Part 2||0||
48253597|NCT00632931|100940069|FG002|COMPLETED|Part 2||0||
48253598|NCT00632931|100940067|FG000|NOT COMPLETED|Part 2||0||
48253599|NCT00632931|100940068|FG001|NOT COMPLETED|Part 2||0||
48253600|NCT00632931|100940069|FG002|NOT COMPLETED|Part 2||24||
48253601|NCT02151643|100940070|FG000|STARTED|Overall Study||26||
48253602|NCT02151643|100940071|FG001|STARTED|Overall Study||25||
48253603|NCT02151643|100940072|FG002|STARTED|Overall Study||25||
48253604|NCT02151643|100940073|FG003|STARTED|Overall Study||39||
48253605|NCT02151643|100940074|FG004|STARTED|Overall Study||38||
48253606|NCT02151643|100940070|FG000|COMPLETED|Overall Study||20||
48253607|NCT02151643|100940071|FG001|COMPLETED|Overall Study||21||
48253608|NCT02151643|100940072|FG002|COMPLETED|Overall Study||21||
48253609|NCT02151643|100940073|FG003|COMPLETED|Overall Study||32||
48253610|NCT02151643|100940074|FG004|COMPLETED|Overall Study||35||
48253611|NCT02151643|100940070|FG000|NOT COMPLETED|Overall Study||6||
48253612|NCT02151643|100940071|FG001|NOT COMPLETED|Overall Study||4||
48253613|NCT02151643|100940072|FG002|NOT COMPLETED|Overall Study||4||
48253614|NCT02151643|100940073|FG003|NOT COMPLETED|Overall Study||7||
48253615|NCT02151643|100940074|FG004|NOT COMPLETED|Overall Study||3||
48253616|NCT03398421|100940075|FG000|STARTED|Treatment Period 1 (Up to 6 Days)||20||
48253617|NCT03398421|100940076|FG001|STARTED|Treatment Period 1 (Up to 6 Days)||0||
48253618|NCT03398421|100940075|FG000|COMPLETED|Treatment Period 1 (Up to 6 Days)||20||
48253619|NCT03398421|100940076|FG001|COMPLETED|Treatment Period 1 (Up to 6 Days)||0||
48253620|NCT03398421|100940075|FG000|NOT COMPLETED|Treatment Period 1 (Up to 6 Days)||0||
48253621|NCT03398421|100940076|FG001|NOT COMPLETED|Treatment Period 1 (Up to 6 Days)||0||
48253622|NCT03398421|100940075|FG000|STARTED|Washout Period (Up to 14 Days)||20||
48253623|NCT03398421|100940076|FG001|STARTED|Washout Period (Up to 14 Days)||0||
48253624|NCT03398421|100940075|FG000|COMPLETED|Washout Period (Up to 14 Days)||20||
48253625|NCT03398421|100940076|FG001|COMPLETED|Washout Period (Up to 14 Days)||0||
48253626|NCT03398421|100940075|FG000|NOT COMPLETED|Washout Period (Up to 14 Days)||0||
48253627|NCT03398421|100940076|FG001|NOT COMPLETED|Washout Period (Up to 14 Days)||0||
48253628|NCT03398421|100940075|FG000|STARTED|Treatment Period 2 (Up to 11 Days)||0||
48253629|NCT03398421|100940076|FG001|STARTED|Treatment Period 2 (Up to 11 Days)||20||
48253630|NCT03398421|100940075|FG000|COMPLETED|Treatment Period 2 (Up to 11 Days)||0||
48253631|NCT03398421|100940076|FG001|COMPLETED|Treatment Period 2 (Up to 11 Days)||20||
48253632|NCT03398421|100940075|FG000|NOT COMPLETED|Treatment Period 2 (Up to 11 Days)||0||
48253633|NCT03398421|100940076|FG001|NOT COMPLETED|Treatment Period 2 (Up to 11 Days)||0||
48253634|NCT03972397|100940077|FG000|STARTED|Overall Study||10||
48253635|NCT03972397|100940078|FG001|STARTED|Overall Study||10||
48253636|NCT03972397|100940077|FG000|COMPLETED|Overall Study||10||
48253637|NCT03972397|100940078|FG001|COMPLETED|Overall Study||10||
48253638|NCT03972397|100940077|FG000|NOT COMPLETED|Overall Study||0||
48253639|NCT03972397|100940078|FG001|NOT COMPLETED|Overall Study||0||
48253640|NCT01818427|100940079|FG000|STARTED|Overall Study||239||
48253641|NCT01818427|100940080|FG001|STARTED|Overall Study||284||
48253642|NCT01818427|100940079|FG000|COMPLETED|Overall Study||230||
48253643|NCT01818427|100940080|FG001|COMPLETED|Overall Study||271||
48089884|NCT01829191|100541261|FG001|NOT COMPLETED|Overall Study||14||
48089885|NCT02728050|100541262|FG000|STARTED|Overall Study||6||
48089886|NCT02728050|100541263|FG001|STARTED|Overall Study||6||
48089887|NCT02728050|100541264|FG002|STARTED|Overall Study||11||
48089888|NCT02728050|100541265|FG003|STARTED|Overall Study||8||
48089889|NCT02728050|100541266|FG004|STARTED|Overall Study||9||
48089890|NCT02728050|100541267|FG005|STARTED|Overall Study||7||
48089891|NCT02728050|100541268|FG006|STARTED|Overall Study||37||
48089892|NCT02728050|100541262|FG000|COMPLETED|Overall Study||6||
48253644|NCT01818427|100940079|FG000|NOT COMPLETED|Overall Study||9||
48253645|NCT01818427|100940080|FG001|NOT COMPLETED|Overall Study||13||
48253646|NCT00496626|100940081|FG000|STARTED|Overall Study||302||
48253647|NCT00496626|100940082|FG001|STARTED|Overall Study||298||
48253648|NCT00496626|100940081|FG000|COMPLETED|Overall Study||296||
48253649|NCT00496626|100940082|FG001|COMPLETED|Overall Study||292||
48253650|NCT00496626|100940081|FG000|NOT COMPLETED|Overall Study||6||
48253651|NCT00496626|100940082|FG001|NOT COMPLETED|Overall Study||6||
48253652|NCT03463577|100940083|FG000|STARTED|Overall Study||16606||
48253653|NCT03463577|100940084|FG001|STARTED|Overall Study||16606||
48253654|NCT03463577|100940085|FG002|STARTED|Overall Study||65||
48253655|NCT03463577|100940086|FG003|STARTED|Overall Study||16350||
48253656|NCT03463577|100940087|FG004|STARTED|Overall Study||16088||
48253657|NCT03463577|100940088|FG005|STARTED|Overall Study||68||
48253658|NCT03463577|100940083|FG000|COMPLETED|Overall Study||16366||
48253659|NCT03463577|100940084|FG001|COMPLETED|Overall Study||16166||
48253660|NCT03463577|100940085|FG002|COMPLETED|Overall Study||65||
48253661|NCT03463577|100940086|FG003|COMPLETED|Overall Study||16335||
48253662|NCT03463577|100940087|FG004|COMPLETED|Overall Study||16071||
48253663|NCT03463577|100940088|FG005|COMPLETED|Overall Study||68||
48253664|NCT03463577|100940083|FG000|NOT COMPLETED|Overall Study||240||
48253665|NCT03463577|100940084|FG001|NOT COMPLETED|Overall Study||440||
48253666|NCT03463577|100940085|FG002|NOT COMPLETED|Overall Study||0||
48253667|NCT03463577|100940086|FG003|NOT COMPLETED|Overall Study||15||
48253668|NCT03463577|100940087|FG004|NOT COMPLETED|Overall Study||17||
48253669|NCT03463577|100940088|FG005|NOT COMPLETED|Overall Study||0||
48253670|NCT00566345|100940089|FG000|STARTED|Overall Study||1829||
48253671|NCT00566345|100940090|FG001|STARTED|Overall Study||1841||
48253672|NCT00566345|100940089|FG000|COMPLETED|Overall Study||1656||
48253673|NCT00566345|100940090|FG001|COMPLETED|Overall Study||1694||
48253674|NCT00566345|100940089|FG000|NOT COMPLETED|Overall Study||173||
48253675|NCT00566345|100940090|FG001|NOT COMPLETED|Overall Study||147||
48253676|NCT00523549|100940091|FG000|STARTED|Overall Study||114||
48253677|NCT00523549|100940092|FG001|STARTED|Overall Study||115||
48253678|NCT00523549|100940091|FG000|COMPLETED|Overall Study||95||
48253679|NCT00523549|100940092|FG001|COMPLETED|Overall Study||99||
48253680|NCT00523549|100940091|FG000|NOT COMPLETED|Overall Study||19||
48253681|NCT00523549|100940092|FG001|NOT COMPLETED|Overall Study||16||
48253682|NCT03822377|100940093|FG000|STARTED|Overall Study||65||
48253683|NCT03822377|100940094|FG001|STARTED|Overall Study||65||
48253684|NCT03822377|100940093|FG000|COMPLETED|Overall Study||65||
48253685|NCT03822377|100940094|FG001|COMPLETED|Overall Study||65||
48253686|NCT03822377|100940093|FG000|NOT COMPLETED|Overall Study||0||
48253687|NCT03822377|100940094|FG001|NOT COMPLETED|Overall Study||0||
48253688|NCT03719378|100940095|FG000|STARTED|Overall Study||75||
48253689|NCT03719378|100940096|FG001|STARTED|Overall Study||75||
48253690|NCT03719378|100940095|FG000|COMPLETED|Overall Study||65||
48253691|NCT03719378|100940096|FG001|COMPLETED|Overall Study||65||
48253692|NCT03719378|100940095|FG000|NOT COMPLETED|Overall Study||10||
48253693|NCT03719378|100940096|FG001|NOT COMPLETED|Overall Study||10||
48253694|NCT02356484|100940097|FG000|STARTED|Overall Study||138||
48253695|NCT02356484|100940097|FG000|COMPLETED|Overall Study||138||
48253696|NCT02356484|100940097|FG000|NOT COMPLETED|Overall Study||0||
48253697|NCT02705625|100940098|FG000|STARTED|Overall Study||82||
48253698|NCT02705625|100940099|FG001|STARTED|Overall Study||82||
48253699|NCT02705625|100940100|FG002|STARTED|Overall Study||80||
48685597|NCT01194245|102013263|FG003|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29||
48685598|NCT01194245|102013264|FG004|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||28||
48685599|NCT01194245|102013260|FG000|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0||
48253700|NCT02705625|100940098|FG000|COMPLETED|Overall Study||74||
48253701|NCT02705625|100940099|FG001|COMPLETED|Overall Study||72||
48253702|NCT02705625|100940100|FG002|COMPLETED|Overall Study||69||
48685600|NCT01194245|102013261|FG001|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0||
48685601|NCT01194245|102013262|FG002|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0||
48685602|NCT01194245|102013263|FG003|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0||
48253703|NCT02705625|100940098|FG000|NOT COMPLETED|Overall Study||8||
48253704|NCT02705625|100940099|FG001|NOT COMPLETED|Overall Study||10||
48253705|NCT02705625|100940100|FG002|NOT COMPLETED|Overall Study||11||
48253706|NCT02956278|100940101|FG000|STARTED|Overall Study||15||
48253707|NCT02956278|100940102|FG001|STARTED|Overall Study||9||
48253708|NCT02956278|100940103|FG002|STARTED|Overall Study||3||
48253709|NCT02956278|100940101|FG000|COMPLETED|Overall Study||9||
48253710|NCT02956278|100940102|FG001|COMPLETED|Overall Study||7||
48253711|NCT02956278|100940103|FG002|COMPLETED|Overall Study||3||
48253712|NCT02956278|100940101|FG000|NOT COMPLETED|Overall Study||6||
48253713|NCT02956278|100940102|FG001|NOT COMPLETED|Overall Study||2||
48253714|NCT02956278|100940103|FG002|NOT COMPLETED|Overall Study||0||
48253715|NCT04731142|100940104|FG000|STARTED|Overall Study||118||
48253716|NCT04731142|100940105|FG001|STARTED|Overall Study||117||
48253717|NCT04731142|100940104|FG000|COMPLETED|Overall Study||118||
48685603|NCT01194245|102013264|FG004|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0||
48685604|NCT03768089|102013265|FG000|STARTED|Part A||8||
48685605|NCT03768089|102013266|FG001|STARTED|Part A||5||
48685606|NCT03768089|102013267|FG002|STARTED|Part A||6||
48685607|NCT03768089|102013268|FG003|STARTED|Part A||6||
48685608|NCT03768089|102013269|FG004|STARTED|Part A||6||
48685609|NCT03768089|102013270|FG005|STARTED|Part A||6||
48685610|NCT03768089|102013271|FG006|STARTED|Part A||8||
48685611|NCT03768089|102013272|FG007|STARTED|Part A||0||
48685612|NCT03768089|102013273|FG008|STARTED|Part A||0||
48685613|NCT03768089|102013274|FG009|STARTED|Part A||0||
48685614|NCT03768089|102013275|FG010|STARTED|Part A||0||
48685615|NCT03768089|102013276|FG011|STARTED|Part A||0||
48685616|NCT03768089|102013277|FG012|STARTED|Part A||0||
48685617|NCT03768089|102013278|FG013|STARTED|Part A||0||
48685618|NCT03768089|102013279|FG014|STARTED|Part A||0||
48685619|NCT03768089|102013280|FG015|STARTED|Part A||0||
48685620|NCT03768089|102013281|FG016|STARTED|Part A||0||
48685621|NCT03768089|102013282|FG017|STARTED|Part A||0||
48685622|NCT03768089|102013265|FG000|Safety Set|Part A||8|Received at least 1 dose of study drug.|
48685623|NCT03768089|102013266|FG001|Safety Set|Part A||5|Received at least 1 dose of study drug.|
48253718|NCT04731142|100940105|FG001|COMPLETED|Overall Study||117||
48253719|NCT04731142|100940104|FG000|NOT COMPLETED|Overall Study||0||
48685624|NCT03768089|102013267|FG002|Safety Set|Part A||6|Received at least 1 dose of study drug.|
48685625|NCT03768089|102013268|FG003|Safety Set|Part A||6|Received at least 1 dose of study drug.|
48685626|NCT03768089|102013269|FG004|Safety Set|Part A||6|Received at least 1 dose of study drug.|
48685627|NCT03768089|102013270|FG005|Safety Set|Part A||6|Received at least 1 dose of study drug.|
48253720|NCT04731142|100940105|FG001|NOT COMPLETED|Overall Study||0||
48253721|NCT01665599|100940106|FG000|STARTED|Overall Study||180||
48253722|NCT01665599|100940106|FG000|COMPLETED|Overall Study||172||
48253723|NCT01665599|100940106|FG000|NOT COMPLETED|Overall Study||8||
48253724|NCT03459612|100940107|FG000|STARTED|Period 1||17||
48253725|NCT03459612|100940108|FG001|STARTED|Period 1||17||
48253726|NCT03459612|100940109|FG002|STARTED|Period 1||17||
48253727|NCT03459612|100940110|FG003|STARTED|Period 1||17||
48253728|NCT03459612|100940107|FG000|Received at Least 1 Dose of Study Drug|Period 1||17||
48685628|NCT03768089|102013271|FG006|Safety Set|Part A||8|Received at least 1 dose of study drug.|
48685629|NCT03768089|102013272|FG007|Safety Set|Part A||0|Received at least 1 dose of study drug.|
48685630|NCT03768089|102013273|FG008|Safety Set|Part A||0|Received at least 1 dose of study drug.|
48685631|NCT03768089|102013274|FG009|Safety Set|Part A||0|Received at least 1 dose of study drug.|
48685632|NCT03768089|102013275|FG010|Safety Set|Part A||0|Received at least 1 dose of study drug.|
48685633|NCT03768089|102013276|FG011|Safety Set|Part A||0|Received at least 1 dose of study drug.|
48685634|NCT03768089|102013277|FG012|Safety Set|Part A||0|Received at least 1 dose of study drug.|
48685635|NCT03768089|102013278|FG013|Safety Set|Part A||0|Received at least 1 dose of study drug.|
48685636|NCT03768089|102013279|FG014|Safety Set|Part A||0|Received at least 1 dose of study drug.|
48685637|NCT03768089|102013280|FG015|Safety Set|Part A||0|Received at least 1 dose of study drug.|
48685638|NCT03768089|102013281|FG016|Safety Set|Part A||0|Received at least 1 dose of study drug.|
48685639|NCT03768089|102013282|FG017|Safety Set|Part A||0|Received at least 1 dose of study drug.|
48685640|NCT03768089|102013265|FG000|COMPLETED|Part A||8||
48685641|NCT03768089|102013266|FG001|COMPLETED|Part A||5||
48685642|NCT03768089|102013267|FG002|COMPLETED|Part A||6||
48685643|NCT03768089|102013268|FG003|COMPLETED|Part A||6||
48685644|NCT03768089|102013269|FG004|COMPLETED|Part A||5||
48685645|NCT03768089|102013270|FG005|COMPLETED|Part A||6||
48685646|NCT03768089|102013271|FG006|COMPLETED|Part A||8||
48685647|NCT03768089|102013272|FG007|COMPLETED|Part A||0||
48685648|NCT03768089|102013273|FG008|COMPLETED|Part A||0||
48685649|NCT03768089|102013274|FG009|COMPLETED|Part A||0||
48685650|NCT03768089|102013275|FG010|COMPLETED|Part A||0||
48685651|NCT03768089|102013276|FG011|COMPLETED|Part A||0||
48685652|NCT03768089|102013277|FG012|COMPLETED|Part A||0||
48685653|NCT03768089|102013278|FG013|COMPLETED|Part A||0||
48685654|NCT03768089|102013279|FG014|COMPLETED|Part A||0||
48685655|NCT03768089|102013280|FG015|COMPLETED|Part A||0||
48685656|NCT03768089|102013281|FG016|COMPLETED|Part A||0||
48685657|NCT03768089|102013282|FG017|COMPLETED|Part A||0||
48685658|NCT03768089|102013265|FG000|NOT COMPLETED|Part A||0||
48685659|NCT03768089|102013266|FG001|NOT COMPLETED|Part A||0||
48685660|NCT03768089|102013267|FG002|NOT COMPLETED|Part A||0||
48685661|NCT03768089|102013268|FG003|NOT COMPLETED|Part A||0||
48685662|NCT03768089|102013269|FG004|NOT COMPLETED|Part A||1||
48685663|NCT03768089|102013270|FG005|NOT COMPLETED|Part A||0||
48685664|NCT03768089|102013271|FG006|NOT COMPLETED|Part A||0||
48685665|NCT03768089|102013272|FG007|NOT COMPLETED|Part A||0||
48685666|NCT03768089|102013273|FG008|NOT COMPLETED|Part A||0||
48685667|NCT03768089|102013274|FG009|NOT COMPLETED|Part A||0||
48685668|NCT03768089|102013275|FG010|NOT COMPLETED|Part A||0||
48685669|NCT03768089|102013276|FG011|NOT COMPLETED|Part A||0||
48253729|NCT03459612|100940108|FG001|Received at Least 1 Dose of Study Drug|Period 1||17||
48253730|NCT03459612|100940109|FG002|Received at Least 1 Dose of Study Drug|Period 1||17||
48253731|NCT03459612|100940110|FG003|Received at Least 1 Dose of Study Drug|Period 1||17||
48253732|NCT03459612|100940107|FG000|COMPLETED|Period 1||17||
48253733|NCT03459612|100940108|FG001|COMPLETED|Period 1||17||
48253734|NCT03459612|100940109|FG002|COMPLETED|Period 1||17||
48253735|NCT03459612|100940110|FG003|COMPLETED|Period 1||17||
48253736|NCT03459612|100940107|FG000|NOT COMPLETED|Period 1||0||
48253737|NCT03459612|100940108|FG001|NOT COMPLETED|Period 1||0||
48253738|NCT03459612|100940109|FG002|NOT COMPLETED|Period 1||0||
48253739|NCT03459612|100940110|FG003|NOT COMPLETED|Period 1||0||
48253740|NCT03459612|100940107|FG000|STARTED|Period 2||17||
48253741|NCT03459612|100940108|FG001|STARTED|Period 2||17||
48253742|NCT03459612|100940109|FG002|STARTED|Period 2||17||
48253743|NCT03459612|100940110|FG003|STARTED|Period 2||17||
48253744|NCT03459612|100940107|FG000|Received at Least 1 Dose of Study Drug|Period 2||17||
48253745|NCT03459612|100940108|FG001|Received at Least 1 Dose of Study Drug|Period 2||17||
48253746|NCT03459612|100940109|FG002|Received at Least 1 Dose of Study Drug|Period 2||17||
48253747|NCT03459612|100940110|FG003|Received at Least 1 Dose of Study Drug|Period 2||17||
48253748|NCT03459612|100940107|FG000|COMPLETED|Period 2||17||
48253749|NCT03459612|100940108|FG001|COMPLETED|Period 2||17||
48253750|NCT03459612|100940109|FG002|COMPLETED|Period 2||17||
48253751|NCT03459612|100940110|FG003|COMPLETED|Period 2||17||
48253752|NCT03459612|100940107|FG000|NOT COMPLETED|Period 2||0||
48253753|NCT03459612|100940108|FG001|NOT COMPLETED|Period 2||0||
48253754|NCT03459612|100940109|FG002|NOT COMPLETED|Period 2||0||
48253755|NCT03459612|100940110|FG003|NOT COMPLETED|Period 2||0||
48685670|NCT03768089|102013277|FG012|NOT COMPLETED|Part A||0||
48685671|NCT03768089|102013278|FG013|NOT COMPLETED|Part A||0||
48685672|NCT03768089|102013279|FG014|NOT COMPLETED|Part A||0||
48685673|NCT03768089|102013280|FG015|NOT COMPLETED|Part A||0||
48253756|NCT03459612|100940107|FG000|STARTED|Period 3||17||
48253757|NCT03459612|100940108|FG001|STARTED|Period 3||17||
48253758|NCT03459612|100940109|FG002|STARTED|Period 3||17||
48253759|NCT03459612|100940110|FG003|STARTED|Period 3||17||
48253760|NCT03459612|100940107|FG000|Received at Least 1 Dose of Study Drug|Period 3||17||
48380455|NCT02586233|101258656|FG000|STARTED|Overall Study||7||
48685674|NCT03768089|102013281|FG016|NOT COMPLETED|Part A||0||
48685675|NCT03768089|102013282|FG017|NOT COMPLETED|Part A||0||
48685676|NCT03768089|102013265|FG000|STARTED|Part B||0||
48685677|NCT03768089|102013266|FG001|STARTED|Part B||0||
48685678|NCT03768089|102013267|FG002|STARTED|Part B||0||
48685679|NCT03768089|102013268|FG003|STARTED|Part B||0||
48685680|NCT03768089|102013269|FG004|STARTED|Part B||0||
48685681|NCT03768089|102013270|FG005|STARTED|Part B||0||
48685682|NCT03768089|102013271|FG006|STARTED|Part B||0||
48685683|NCT03768089|102013272|FG007|STARTED|Part B||9||
48685684|NCT03768089|102013273|FG008|STARTED|Part B||6||
48685685|NCT03768089|102013274|FG009|STARTED|Part B||6||
48685686|NCT03768089|102013275|FG010|STARTED|Part B||6||
48685687|NCT03768089|102013276|FG011|STARTED|Part B||6||
48685688|NCT03768089|102013277|FG012|STARTED|Part B||0||
48685689|NCT03768089|102013278|FG013|STARTED|Part B||0||
48685690|NCT03768089|102013279|FG014|STARTED|Part B||0||
48685691|NCT03768089|102013280|FG015|STARTED|Part B||0||
48685692|NCT03768089|102013281|FG016|STARTED|Part B||0||
48685693|NCT03768089|102013282|FG017|STARTED|Part B||0||
48685694|NCT03768089|102013265|FG000|Safety Set|Part B||0|Received at least 1 dose of study drug.|
48685695|NCT03768089|102013266|FG001|Safety Set|Part B||0|Received at least 1 dose of study drug.|
48685696|NCT03768089|102013267|FG002|Safety Set|Part B||0|Received at least 1 dose of study drug.|
48685697|NCT03768089|102013268|FG003|Safety Set|Part B||0|Received at least 1 dose of study drug.|
48685698|NCT03768089|102013269|FG004|Safety Set|Part B||0|Received at least 1 dose of study drug.|
48685699|NCT03768089|102013270|FG005|Safety Set|Part B||0|Received at least 1 dose of study drug.|
48685700|NCT03768089|102013271|FG006|Safety Set|Part B||0|Received at least 1 dose of study drug.|
48685701|NCT03768089|102013272|FG007|Safety Set|Part B||9|Received at least 1 dose of study drug.|
48685702|NCT03768089|102013273|FG008|Safety Set|Part B||6|Received at least 1 dose of study drug.|
48685703|NCT03768089|102013274|FG009|Safety Set|Part B||6|Received at least 1 dose of study drug.|
48685704|NCT03768089|102013275|FG010|Safety Set|Part B||6|Received at least 1 dose of study drug.|
48685705|NCT03768089|102013276|FG011|Safety Set|Part B||6|Received at least 1 dose of study drug.|
48685706|NCT03768089|102013277|FG012|Safety Set|Part B||0|Received at least 1 dose of study drug.|
48685707|NCT03768089|102013278|FG013|Safety Set|Part B||0|Received at least 1 dose of study drug.|
48685708|NCT03768089|102013279|FG014|Safety Set|Part B||0|Received at least 1 dose of study drug.|
48685709|NCT03768089|102013280|FG015|Safety Set|Part B||0|Received at least 1 dose of study drug.|
48685710|NCT03768089|102013281|FG016|Safety Set|Part B||0|Received at least 1 dose of study drug.|
48685711|NCT03768089|102013282|FG017|Safety Set|Part B||0|Received at least 1 dose of study drug.|
48685712|NCT03768089|102013265|FG000|COMPLETED|Part B||0||
48685713|NCT03768089|102013266|FG001|COMPLETED|Part B||0||
48685714|NCT03768089|102013267|FG002|COMPLETED|Part B||0||
48685715|NCT03768089|102013268|FG003|COMPLETED|Part B||0||
48685716|NCT03768089|102013269|FG004|COMPLETED|Part B||0||
48685717|NCT03768089|102013270|FG005|COMPLETED|Part B||0||
48685718|NCT03768089|102013271|FG006|COMPLETED|Part B||0||
48685719|NCT03768089|102013272|FG007|COMPLETED|Part B||9||
48685720|NCT03768089|102013273|FG008|COMPLETED|Part B||6||
48685721|NCT03768089|102013274|FG009|COMPLETED|Part B||6||
48685722|NCT03768089|102013275|FG010|COMPLETED|Part B||6||
48685723|NCT03768089|102013276|FG011|COMPLETED|Part B||6||
48685724|NCT03768089|102013277|FG012|COMPLETED|Part B||0||
48685725|NCT03768089|102013278|FG013|COMPLETED|Part B||0||
48685726|NCT03768089|102013279|FG014|COMPLETED|Part B||0||
48089893|NCT02728050|100541263|FG001|COMPLETED|Overall Study||6||
48089894|NCT02728050|100541264|FG002|COMPLETED|Overall Study||11||
48089895|NCT02728050|100541265|FG003|COMPLETED|Overall Study||8||
48089896|NCT02728050|100541266|FG004|COMPLETED|Overall Study||9||
48089897|NCT02728050|100541267|FG005|COMPLETED|Overall Study||7||
48089898|NCT02728050|100541268|FG006|COMPLETED|Overall Study||37||
48089899|NCT02728050|100541262|FG000|NOT COMPLETED|Overall Study||0||
48089900|NCT02728050|100541263|FG001|NOT COMPLETED|Overall Study||0||
48089901|NCT02728050|100541264|FG002|NOT COMPLETED|Overall Study||0||
48089902|NCT02728050|100541265|FG003|NOT COMPLETED|Overall Study||0||
48089903|NCT02728050|100541266|FG004|NOT COMPLETED|Overall Study||0||
48089904|NCT02728050|100541267|FG005|NOT COMPLETED|Overall Study||0||
48685727|NCT03768089|102013280|FG015|COMPLETED|Part B||0||
48685728|NCT03768089|102013281|FG016|COMPLETED|Part B||0||
48685729|NCT03768089|102013282|FG017|COMPLETED|Part B||0||
48685730|NCT03768089|102013265|FG000|NOT COMPLETED|Part B||0||
48089905|NCT02728050|100541268|FG006|NOT COMPLETED|Overall Study||0||
48685731|NCT03768089|102013266|FG001|NOT COMPLETED|Part B||0||
48089906|NCT00865124|100541269|FG000|STARTED|Overall Study||27||
48253761|NCT03459612|100940108|FG001|Received at Least 1 Dose of Study Drug|Period 3||17||
48685732|NCT03768089|102013267|FG002|NOT COMPLETED|Part B||0||
48685733|NCT03768089|102013268|FG003|NOT COMPLETED|Part B||0||
48685734|NCT03768089|102013269|FG004|NOT COMPLETED|Part B||0||
48685735|NCT03768089|102013270|FG005|NOT COMPLETED|Part B||0||
48685736|NCT03768089|102013271|FG006|NOT COMPLETED|Part B||0||
48685737|NCT03768089|102013272|FG007|NOT COMPLETED|Part B||0||
48253762|NCT03459612|100940109|FG002|Received at Least 1 Dose of Study Drug|Period 3||17||
48253763|NCT03459612|100940110|FG003|Received at Least 1 Dose of Study Drug|Period 3||17||
48253764|NCT03459612|100940107|FG000|COMPLETED|Period 3||17||
48685738|NCT03768089|102013273|FG008|NOT COMPLETED|Part B||0||
48685739|NCT03768089|102013274|FG009|NOT COMPLETED|Part B||0||
48685740|NCT03768089|102013275|FG010|NOT COMPLETED|Part B||0||
48685741|NCT03768089|102013276|FG011|NOT COMPLETED|Part B||0||
48685742|NCT03768089|102013277|FG012|NOT COMPLETED|Part B||0||
48685743|NCT03768089|102013278|FG013|NOT COMPLETED|Part B||0||
48685744|NCT03768089|102013279|FG014|NOT COMPLETED|Part B||0||
48685745|NCT03768089|102013280|FG015|NOT COMPLETED|Part B||0||
48685746|NCT03768089|102013281|FG016|NOT COMPLETED|Part B||0||
48685747|NCT03768089|102013282|FG017|NOT COMPLETED|Part B||0||
48685748|NCT03768089|102013265|FG000|STARTED|Part C||0||
48685749|NCT03768089|102013266|FG001|STARTED|Part C||0||
48685750|NCT03768089|102013267|FG002|STARTED|Part C||0||
48685751|NCT03768089|102013268|FG003|STARTED|Part C||0||
48685752|NCT03768089|102013269|FG004|STARTED|Part C||0||
48685753|NCT03768089|102013270|FG005|STARTED|Part C||0||
48685754|NCT03768089|102013271|FG006|STARTED|Part C||0||
48253765|NCT03459612|100940108|FG001|COMPLETED|Period 3||17||
48253766|NCT03459612|100940109|FG002|COMPLETED|Period 3||17||
48253767|NCT03459612|100940110|FG003|COMPLETED|Period 3||17||
48253768|NCT03459612|100940107|FG000|NOT COMPLETED|Period 3||0||
48253769|NCT03459612|100940108|FG001|NOT COMPLETED|Period 3||0||
48089907|NCT00865124|100541270|FG001|STARTED|Overall Study||25||
48089908|NCT00865124|100541271|FG002|STARTED|Overall Study||17||
48089909|NCT00865124|100541269|FG000|COMPLETED|Overall Study||23||
48089910|NCT00865124|100541270|FG001|COMPLETED|Overall Study||24||
48089911|NCT00865124|100541271|FG002|COMPLETED|Overall Study||17||
48089912|NCT00865124|100541269|FG000|NOT COMPLETED|Overall Study||4||
48089913|NCT00865124|100541270|FG001|NOT COMPLETED|Overall Study||1||
48089914|NCT00865124|100541271|FG002|NOT COMPLETED|Overall Study||0||
48089915|NCT00760578|100541272|FG000|STARTED|Overall Study||22||
48089916|NCT00760578|100541273|FG001|STARTED|Overall Study||21||
48089917|NCT00760578|100541274|FG002|STARTED|Overall Study||21||
48089918|NCT00760578|100541275|FG003|STARTED|Overall Study||22||
48253770|NCT03459612|100940109|FG002|NOT COMPLETED|Period 3||0||
48253771|NCT03459612|100940110|FG003|NOT COMPLETED|Period 3||0||
48253772|NCT03459612|100940107|FG000|STARTED|Period 4||17||
48253773|NCT03459612|100940108|FG001|STARTED|Period 4||17||
48253774|NCT03459612|100940109|FG002|STARTED|Period 4||16||
48253775|NCT03459612|100940110|FG003|STARTED|Period 4||17||
48253776|NCT03459612|100940107|FG000|Received at Least 1 Dose of Study Drug|Period 4||17||
48253777|NCT03459612|100940108|FG001|Received at Least 1 Dose of Study Drug|Period 4||17||
48253778|NCT03459612|100940109|FG002|Received at Least 1 Dose of Study Drug|Period 4||16||
48253779|NCT03459612|100940110|FG003|Received at Least 1 Dose of Study Drug|Period 4||17||
48253780|NCT03459612|100940107|FG000|COMPLETED|Period 4||17||
48253781|NCT03459612|100940108|FG001|COMPLETED|Period 4||17||
48253782|NCT03459612|100940109|FG002|COMPLETED|Period 4||16||
48253783|NCT03459612|100940110|FG003|COMPLETED|Period 4||17||
48253784|NCT03459612|100940107|FG000|NOT COMPLETED|Period 4||0||
48253785|NCT03459612|100940108|FG001|NOT COMPLETED|Period 4||0||
48253786|NCT03459612|100940109|FG002|NOT COMPLETED|Period 4||0||
48253787|NCT03459612|100940110|FG003|NOT COMPLETED|Period 4||0||
48253788|NCT01612767|100940111|FG000|STARTED|Overall Study||329||
48685755|NCT03768089|102013272|FG007|STARTED|Part C||0||
48685756|NCT03768089|102013273|FG008|STARTED|Part C||0||
48685757|NCT03768089|102013274|FG009|STARTED|Part C||0||
48685758|NCT03768089|102013275|FG010|STARTED|Part C||0||
48685759|NCT03768089|102013276|FG011|STARTED|Part C||0||
48685760|NCT03768089|102013277|FG012|STARTED|Part C||6||
48685761|NCT03768089|102013278|FG013|STARTED|Part C||6||
48685762|NCT03768089|102013279|FG014|STARTED|Part C||8||
48253789|NCT01612767|100940111|FG000|COMPLETED|Overall Study||287||
48253790|NCT01612767|100940111|FG000|NOT COMPLETED|Overall Study||42||
48253791|NCT01084239|100940112|FG000|STARTED|Randomization - Index Hospitalization||501||
48253792|NCT01084239|100940113|FG001|STARTED|Randomization - Index Hospitalization||499||
48253793|NCT01084239|100940112|FG000|COMPLETED|Randomization - Index Hospitalization||501||
48685763|NCT03768089|102013280|FG015|STARTED|Part C||6||
48685764|NCT03768089|102013281|FG016|STARTED|Part C||0||
48685765|NCT03768089|102013282|FG017|STARTED|Part C||0||
48685766|NCT03768089|102013265|FG000|Safety Set|Part C||0|Received at least 1 dose of study drug.|
48141349|NCT02137369|100670408|FG000|COMPLETED|Overall Study||41||
48253794|NCT01084239|100940113|FG001|COMPLETED|Randomization - Index Hospitalization||499||
48253795|NCT01084239|100940112|FG000|NOT COMPLETED|Randomization - Index Hospitalization||0||
48685767|NCT03768089|102013266|FG001|Safety Set|Part C||0|Received at least 1 dose of study drug.|
48685768|NCT03768089|102013267|FG002|Safety Set|Part C||0|Received at least 1 dose of study drug.|
48710787|NCT01215110|102078018|FG002|COMPLETED|Overall Study||13||
48089919|NCT00760578|100541272|FG000|Entered Drug Treatment Period|Overall Study||21||
48089920|NCT00760578|100541273|FG001|Entered Drug Treatment Period|Overall Study||20||
48089921|NCT00760578|100541274|FG002|Entered Drug Treatment Period|Overall Study||19||
48089922|NCT00760578|100541275|FG003|Entered Drug Treatment Period|Overall Study||22||
48089923|NCT00760578|100541272|FG000|COMPLETED|Overall Study||19||
48089924|NCT00760578|100541273|FG001|COMPLETED|Overall Study||19||
48089925|NCT00760578|100541274|FG002|COMPLETED|Overall Study||16||
48089926|NCT00760578|100541275|FG003|COMPLETED|Overall Study||18||
48685769|NCT03768089|102013268|FG003|Safety Set|Part C||0|Received at least 1 dose of study drug.|
48685770|NCT03768089|102013269|FG004|Safety Set|Part C||0|Received at least 1 dose of study drug.|
48685771|NCT03768089|102013270|FG005|Safety Set|Part C||0|Received at least 1 dose of study drug.|
48685772|NCT03768089|102013271|FG006|Safety Set|Part C||0|Received at least 1 dose of study drug.|
48685773|NCT03768089|102013272|FG007|Safety Set|Part C||0|Received at least 1 dose of study drug.|
48685774|NCT03768089|102013273|FG008|Safety Set|Part C||0|Received at least 1 dose of study drug.|
48685775|NCT03768089|102013274|FG009|Safety Set|Part C||0|Received at least 1 dose of study drug.|
48685776|NCT03768089|102013275|FG010|Safety Set|Part C||0|Received at least 1 dose of study drug.|
48685777|NCT03768089|102013276|FG011|Safety Set|Part C||0|Received at least 1 dose of study drug.|
48685778|NCT03768089|102013277|FG012|Safety Set|Part C||6|Received at least 1 dose of study drug.|
48685779|NCT03768089|102013278|FG013|Safety Set|Part C||6|Received at least 1 dose of study drug.|
48685780|NCT03768089|102013279|FG014|Safety Set|Part C||7|Received at least 1 dose of study drug.|
48685781|NCT03768089|102013280|FG015|Safety Set|Part C||6|Received at least 1 dose of study drug.|
48685782|NCT03768089|102013281|FG016|Safety Set|Part C||0|Received at least 1 dose of study drug.|
48685783|NCT03768089|102013282|FG017|Safety Set|Part C||0|Received at least 1 dose of study drug.|
48685784|NCT03768089|102013265|FG000|COMPLETED|Part C||0||
48685785|NCT03768089|102013266|FG001|COMPLETED|Part C||0||
48685786|NCT03768089|102013267|FG002|COMPLETED|Part C||0||
48685787|NCT03768089|102013268|FG003|COMPLETED|Part C||0||
48685788|NCT03768089|102013269|FG004|COMPLETED|Part C||0||
48685789|NCT03768089|102013270|FG005|COMPLETED|Part C||0||
48685790|NCT03768089|102013271|FG006|COMPLETED|Part C||0||
48685791|NCT03768089|102013272|FG007|COMPLETED|Part C||0||
48685792|NCT03768089|102013273|FG008|COMPLETED|Part C||0||
48685793|NCT03768089|102013274|FG009|COMPLETED|Part C||0||
48685794|NCT03768089|102013275|FG010|COMPLETED|Part C||0||
48685795|NCT03768089|102013276|FG011|COMPLETED|Part C||0||
48685796|NCT03768089|102013277|FG012|COMPLETED|Part C||6||
48685797|NCT03768089|102013278|FG013|COMPLETED|Part C||6||
48685798|NCT03768089|102013279|FG014|COMPLETED|Part C||7||
48685799|NCT03768089|102013280|FG015|COMPLETED|Part C||6||
48253796|NCT01084239|100940113|FG001|NOT COMPLETED|Randomization - Index Hospitalization||0||
48253797|NCT01084239|100940112|FG000|STARTED|28-Day Follow-up||501||
48253798|NCT01084239|100940113|FG001|STARTED|28-Day Follow-up||499||
48253799|NCT01084239|100940112|FG000|COMPLETED|28-Day Follow-up||497||
48253800|NCT01084239|100940113|FG001|COMPLETED|28-Day Follow-up||490||
48253801|NCT01084239|100940112|FG000|NOT COMPLETED|28-Day Follow-up||4||
48253802|NCT01084239|100940113|FG001|NOT COMPLETED|28-Day Follow-up||9||
48253803|NCT01222078|100940114|FG000|STARTED|Overall Study||1||
48253804|NCT01222078|100940114|FG000|COMPLETED|Overall Study||0||
48253805|NCT01222078|100940114|FG000|NOT COMPLETED|Overall Study||1||
48253806|NCT03098797|100940115|FG000|STARTED|First Intervention (12 Weeks)||6||
48253807|NCT03098797|100940116|FG001|STARTED|First Intervention (12 Weeks)||6||
48380456|NCT02586233|101258657|FG001|STARTED|Overall Study||7||
48380457|NCT02586233|101258658|FG002|STARTED|Overall Study||13||
48380458|NCT02586233|101258659|FG003|STARTED|Overall Study||17||
48380459|NCT02586233|101258660|FG004|STARTED|Overall Study||18||
48380460|NCT02586233|101258661|FG005|STARTED|Overall Study||18||
48380461|NCT02586233|101258662|FG006|STARTED|Overall Study||26||
48380462|NCT02586233|101258656|FG000|COMPLETED|Overall Study||7||
48380463|NCT02586233|101258657|FG001|COMPLETED|Overall Study||5||
48380464|NCT02586233|101258658|FG002|COMPLETED|Overall Study||13||
48380465|NCT02586233|101258659|FG003|COMPLETED|Overall Study||17||
48380466|NCT02586233|101258660|FG004|COMPLETED|Overall Study||16||
48380467|NCT02586233|101258661|FG005|COMPLETED|Overall Study||16||
48380468|NCT02586233|101258662|FG006|COMPLETED|Overall Study||24||
48380469|NCT02586233|101258656|FG000|NOT COMPLETED|Overall Study||0||
48380470|NCT02586233|101258657|FG001|NOT COMPLETED|Overall Study||2||
48380471|NCT02586233|101258658|FG002|NOT COMPLETED|Overall Study||0||
48380472|NCT02586233|101258659|FG003|NOT COMPLETED|Overall Study||0||
48380473|NCT02586233|101258660|FG004|NOT COMPLETED|Overall Study||2||
48380474|NCT02586233|101258661|FG005|NOT COMPLETED|Overall Study||2||
48380475|NCT02586233|101258662|FG006|NOT COMPLETED|Overall Study||2||
48380476|NCT02065622|101258663|FG000|STARTED|Induction Study||379||
48380477|NCT02065622|101258664|FG001|STARTED|Induction Study||573||
48380478|NCT02065622|101258665|FG002|STARTED|Induction Study||0||
48380479|NCT02065622|101258666|FG003|STARTED|Induction Study||0||
48380480|NCT02065622|101258667|FG004|STARTED|Induction Study||0||
48380481|NCT02065622|101258663|FG000|Enrolled in Main Study|Induction Study||340||
48380482|NCT02065622|101258664|FG001|Enrolled in Main Study|Induction Study||512||
48380483|NCT02065622|101258665|FG002|Enrolled in Main Study|Induction Study||0||
48380484|NCT02065622|101258666|FG003|Enrolled in Main Study|Induction Study||0||
48380485|NCT02065622|101258667|FG004|Enrolled in Main Study|Induction Study||0||
48380486|NCT02065622|101258663|FG000|Enrolled in Japan Sub-Study|Induction Study||39||
48380487|NCT02065622|101258664|FG001|Enrolled in Japan Sub-Study|Induction Study||61||
48380488|NCT02065622|101258665|FG002|Enrolled in Japan Sub-Study|Induction Study||0||
48380489|NCT02065622|101258666|FG003|Enrolled in Japan Sub-Study|Induction Study||0||
48685800|NCT03768089|102013281|FG016|COMPLETED|Part C||0||
48685801|NCT03768089|102013282|FG017|COMPLETED|Part C||0||
48685802|NCT03768089|102013265|FG000|NOT COMPLETED|Part C||0||
48685803|NCT03768089|102013266|FG001|NOT COMPLETED|Part C||0||
48380490|NCT02065622|101258667|FG004|Enrolled in Japan Sub-Study|Induction Study||0||
48685804|NCT03768089|102013267|FG002|NOT COMPLETED|Part C||0||
48685805|NCT03768089|102013268|FG003|NOT COMPLETED|Part C||0||
48685806|NCT03768089|102013269|FG004|NOT COMPLETED|Part C||0||
48685807|NCT03768089|102013270|FG005|NOT COMPLETED|Part C||0||
48685808|NCT03768089|102013271|FG006|NOT COMPLETED|Part C||0||
48685809|NCT03768089|102013272|FG007|NOT COMPLETED|Part C||0||
48685810|NCT03768089|102013273|FG008|NOT COMPLETED|Part C||0||
48685811|NCT03768089|102013274|FG009|NOT COMPLETED|Part C||0||
48685812|NCT03768089|102013275|FG010|NOT COMPLETED|Part C||0||
48253808|NCT03098797|100940115|FG000|COMPLETED|First Intervention (12 Weeks)||6||
48685813|NCT03768089|102013276|FG011|NOT COMPLETED|Part C||0||
48685814|NCT03768089|102013277|FG012|NOT COMPLETED|Part C||0||
48253809|NCT03098797|100940116|FG001|COMPLETED|First Intervention (12 Weeks)||6||
48253810|NCT03098797|100940115|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0||
48380491|NCT02065622|101258663|FG000|COMPLETED|Induction Study||332||
48380492|NCT02065622|101258664|FG001|COMPLETED|Induction Study||514||
48380493|NCT02065622|101258665|FG002|COMPLETED|Induction Study||0||
48380494|NCT02065622|101258666|FG003|COMPLETED|Induction Study||0||
48380495|NCT02065622|101258667|FG004|COMPLETED|Induction Study||0||
48380496|NCT02065622|101258663|FG000|NOT COMPLETED|Induction Study||47||
48685815|NCT03768089|102013278|FG013|NOT COMPLETED|Part C||0||
48685816|NCT03768089|102013279|FG014|NOT COMPLETED|Part C||1||
48253811|NCT03098797|100940116|FG001|NOT COMPLETED|First Intervention (12 Weeks)||0||
48685817|NCT03768089|102013280|FG015|NOT COMPLETED|Part C||0||
48380497|NCT02065622|101258664|FG001|NOT COMPLETED|Induction Study||59||
48380498|NCT02065622|101258665|FG002|NOT COMPLETED|Induction Study||0||
48380499|NCT02065622|101258666|FG003|NOT COMPLETED|Induction Study||0||
48380500|NCT02065622|101258667|FG004|NOT COMPLETED|Induction Study||0||
48380501|NCT02065622|101258663|FG000|STARTED|Maintenance Study||0||
48380502|NCT02065622|101258664|FG001|STARTED|Maintenance Study||0||
48380503|NCT02065622|101258665|FG002|STARTED|Maintenance Study||345||
48380504|NCT02065622|101258666|FG003|STARTED|Maintenance Study||350||
48380505|NCT02065622|101258667|FG004|STARTED|Maintenance Study||151||
48380506|NCT02065622|101258663|FG000|COMPLETED|Maintenance Study||0||
48253812|NCT03098797|100940115|FG000|STARTED|Washout (4 Weeks)||6||
48253813|NCT03098797|100940116|FG001|STARTED|Washout (4 Weeks)||6||
48253814|NCT03098797|100940115|FG000|COMPLETED|Washout (4 Weeks)||6||
48253815|NCT03098797|100940116|FG001|COMPLETED|Washout (4 Weeks)||6||
48253816|NCT03098797|100940115|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
48253817|NCT03098797|100940116|FG001|NOT COMPLETED|Washout (4 Weeks)||0||
48253818|NCT03098797|100940115|FG000|STARTED|Second Intervention (12 Weeks)||6||
48253819|NCT03098797|100940116|FG001|STARTED|Second Intervention (12 Weeks)||6||
48253820|NCT03098797|100940115|FG000|COMPLETED|Second Intervention (12 Weeks)||6||
48253821|NCT03098797|100940116|FG001|COMPLETED|Second Intervention (12 Weeks)||6||
48253822|NCT03098797|100940115|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0||
48253823|NCT03098797|100940116|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0||
48253824|NCT03098797|100940115|FG000|STARTED|Part 2 Open Label Extension||5||
48253825|NCT03098797|100940116|FG001|STARTED|Part 2 Open Label Extension||5||
48253826|NCT03098797|100940115|FG000|Week 12|Part 2 Open Label Extension||5||
48253827|NCT03098797|100940116|FG001|Week 12|Part 2 Open Label Extension||5||
48253828|NCT03098797|100940115|FG000|Week 36|Part 2 Open Label Extension||3||
48253829|NCT03098797|100940116|FG001|Week 36|Part 2 Open Label Extension||5||
48253830|NCT03098797|100940115|FG000|Week 168|Part 2 Open Label Extension||3||
48253831|NCT03098797|100940116|FG001|Week 168|Part 2 Open Label Extension||5||
48253832|NCT03098797|100940115|FG000|COMPLETED|Part 2 Open Label Extension||3||
48253833|NCT03098797|100940116|FG001|COMPLETED|Part 2 Open Label Extension||5||
48253834|NCT03098797|100940115|FG000|NOT COMPLETED|Part 2 Open Label Extension||2||
48253835|NCT03098797|100940116|FG001|NOT COMPLETED|Part 2 Open Label Extension||0||
48253836|NCT00821119|100940117|FG000|STARTED|Overall Study||100||
48253837|NCT00821119|100940118|FG001|STARTED|Overall Study||100||
48253838|NCT00821119|100940117|FG000|COMPLETED|Overall Study||100||
48253839|NCT00821119|100940118|FG001|COMPLETED|Overall Study||100||
48253840|NCT00821119|100940117|FG000|NOT COMPLETED|Overall Study||0||
48253841|NCT00821119|100940118|FG001|NOT COMPLETED|Overall Study||0||
48253842|NCT04545476|100940119|FG000|STARTED|Overall Study||11||
48253843|NCT04545476|100940120|FG001|STARTED|Overall Study||10||
48253844|NCT04545476|100940121|FG002|STARTED|Overall Study||8||
48253845|NCT04545476|100940122|FG003|STARTED|Overall Study||8||
48253846|NCT04545476|100940119|FG000|COMPLETED|Overall Study||10||
48253847|NCT04545476|100940120|FG001|COMPLETED|Overall Study||9||
48253848|NCT04545476|100940121|FG002|COMPLETED|Overall Study||8||
48253849|NCT04545476|100940122|FG003|COMPLETED|Overall Study||8||
48253850|NCT04545476|100940119|FG000|NOT COMPLETED|Overall Study||1||
48253851|NCT04545476|100940120|FG001|NOT COMPLETED|Overall Study||1||
48253852|NCT04545476|100940121|FG002|NOT COMPLETED|Overall Study||0||
48253853|NCT04545476|100940122|FG003|NOT COMPLETED|Overall Study||0||
48253854|NCT01087814|100940123|FG000|STARTED|First Intervention (5 Days)||8||
48253855|NCT01087814|100940124|FG001|STARTED|First Intervention (5 Days)||7||
48253856|NCT01087814|100940123|FG000|COMPLETED|First Intervention (5 Days)||5||
48380507|NCT02065622|101258664|FG001|COMPLETED|Maintenance Study||0||
48380508|NCT02065622|101258665|FG002|COMPLETED|Maintenance Study||221||
48380509|NCT02065622|101258666|FG003|COMPLETED|Maintenance Study||246||
48380510|NCT02065622|101258667|FG004|COMPLETED|Maintenance Study||105||
48380511|NCT02065622|101258663|FG000|NOT COMPLETED|Maintenance Study||0||
48380512|NCT02065622|101258664|FG001|NOT COMPLETED|Maintenance Study||0||
48380513|NCT02065622|101258665|FG002|NOT COMPLETED|Maintenance Study||124||
48380514|NCT02065622|101258666|FG003|NOT COMPLETED|Maintenance Study||104||
48380515|NCT02065622|101258667|FG004|NOT COMPLETED|Maintenance Study||46||
48380516|NCT01709786|101258668|FG000|STARTED|Overall Study||88||
48380517|NCT01709786|101258668|FG000|COMPLETED|Overall Study||88||
48380518|NCT01709786|101258668|FG000|NOT COMPLETED|Overall Study||0||
48380519|NCT02010216|101258669|FG000|STARTED|Overall Study||23||
48380520|NCT02010216|101258669|FG000|COMPLETED|Overall Study||23||
48380521|NCT02010216|101258669|FG000|NOT COMPLETED|Overall Study||0||
48380522|NCT01982773|101258670|FG000|STARTED|Overall Study||58||
48380523|NCT01982773|101258671|FG001|STARTED|Overall Study||60||
48253857|NCT01087814|100940124|FG001|COMPLETED|First Intervention (5 Days)||6||
48253858|NCT01087814|100940123|FG000|NOT COMPLETED|First Intervention (5 Days)||3||
48380524|NCT01982773|101258670|FG000|COMPLETED|Overall Study||50||
48380525|NCT01982773|101258671|FG001|COMPLETED|Overall Study||56||
48380526|NCT01982773|101258670|FG000|NOT COMPLETED|Overall Study||8||
48380527|NCT01982773|101258671|FG001|NOT COMPLETED|Overall Study||4||
48380528|NCT03136367|101258672|FG000|STARTED|T1 Consultation||66||
48380529|NCT03136367|101258673|FG001|STARTED|T1 Consultation||248||
48253859|NCT01087814|100940124|FG001|NOT COMPLETED|First Intervention (5 Days)||1||
48253860|NCT01087814|100940123|FG000|STARTED|Second Intervention (5 Days)||5||
48253861|NCT01087814|100940124|FG001|STARTED|Second Intervention (5 Days)||6||
48253862|NCT01087814|100940123|FG000|COMPLETED|Second Intervention (5 Days)||4||
48253863|NCT01087814|100940124|FG001|COMPLETED|Second Intervention (5 Days)||6||
48253864|NCT01087814|100940123|FG000|NOT COMPLETED|Second Intervention (5 Days)||1||
48253865|NCT01087814|100940124|FG001|NOT COMPLETED|Second Intervention (5 Days)||0||
48253866|NCT01980524|100940125|FG000|STARTED|Study Day 1||4||
48253867|NCT01980524|100940126|FG001|STARTED|Study Day 1||4||
48253868|NCT01980524|100940125|FG000|COMPLETED|Study Day 1||4||
48253869|NCT01980524|100940126|FG001|COMPLETED|Study Day 1||4||
48253870|NCT01980524|100940125|FG000|NOT COMPLETED|Study Day 1||0||
48253871|NCT01980524|100940126|FG001|NOT COMPLETED|Study Day 1||0||
48253872|NCT01980524|100940125|FG000|STARTED|Washout (at Least 2 Weeks)||4||
48253873|NCT01980524|100940126|FG001|STARTED|Washout (at Least 2 Weeks)||4||
48253874|NCT01980524|100940125|FG000|COMPLETED|Washout (at Least 2 Weeks)||4||
48253875|NCT01980524|100940126|FG001|COMPLETED|Washout (at Least 2 Weeks)||4||
48253876|NCT01980524|100940125|FG000|NOT COMPLETED|Washout (at Least 2 Weeks)||0||
48253877|NCT01980524|100940126|FG001|NOT COMPLETED|Washout (at Least 2 Weeks)||0||
48685818|NCT03768089|102013281|FG016|NOT COMPLETED|Part C||0||
48685819|NCT03768089|102013282|FG017|NOT COMPLETED|Part C||0||
48685820|NCT03768089|102013265|FG000|STARTED|Part D||0||
48685821|NCT03768089|102013266|FG001|STARTED|Part D||0||
48685822|NCT03768089|102013267|FG002|STARTED|Part D||0||
48685823|NCT03768089|102013268|FG003|STARTED|Part D||0||
48253878|NCT01980524|100940125|FG000|STARTED|Study Day 2||4||
48253879|NCT01980524|100940126|FG001|STARTED|Study Day 2||4||
48253880|NCT01980524|100940125|FG000|COMPLETED|Study Day 2||4||
48253881|NCT01980524|100940126|FG001|COMPLETED|Study Day 2||4||
48253882|NCT01980524|100940125|FG000|NOT COMPLETED|Study Day 2||0||
48253883|NCT01980524|100940126|FG001|NOT COMPLETED|Study Day 2||0||
48253884|NCT00848393|100940127|FG000|STARTED|Overall Study||17||
48253885|NCT00848393|100940128|FG001|STARTED|Overall Study||16||
48253886|NCT00848393|100940129|FG002|STARTED|Overall Study||18||
48541330|NCT03787134|101662698|FG001|COMPLETED|Overall Study||30||
48541331|NCT03787134|101662699|FG002|COMPLETED|Overall Study||19||
48541332|NCT03787134|101662700|FG003|COMPLETED|Overall Study||28||
48685824|NCT03768089|102013269|FG004|STARTED|Part D||0||
48685825|NCT03768089|102013270|FG005|STARTED|Part D||0||
48685826|NCT03768089|102013271|FG006|STARTED|Part D||0||
48685827|NCT03768089|102013272|FG007|STARTED|Part D||0||
48685828|NCT03768089|102013273|FG008|STARTED|Part D||0||
48685829|NCT03768089|102013274|FG009|STARTED|Part D||0||
48685830|NCT03768089|102013275|FG010|STARTED|Part D||0||
48685831|NCT03768089|102013276|FG011|STARTED|Part D||0||
48685832|NCT03768089|102013277|FG012|STARTED|Part D||0||
48685833|NCT03768089|102013278|FG013|STARTED|Part D||0||
48253887|NCT00848393|100940127|FG000|COMPLETED|Overall Study||17||
48253888|NCT00848393|100940128|FG001|COMPLETED|Overall Study||16||
48253889|NCT00848393|100940129|FG002|COMPLETED|Overall Study||15||
48541333|NCT03787134|101662701|FG004|COMPLETED|Overall Study||25||
48541334|NCT03787134|101662702|FG005|COMPLETED|Overall Study||56||
48541335|NCT03787134|101662703|FG006|COMPLETED|Overall Study||14||
48541336|NCT03787134|101662697|FG000|NOT COMPLETED|Overall Study||0||
48541337|NCT03787134|101662698|FG001|NOT COMPLETED|Overall Study||0||
48541338|NCT03787134|101662699|FG002|NOT COMPLETED|Overall Study||0||
48685834|NCT03768089|102013279|FG014|STARTED|Part D||0||
48685835|NCT03768089|102013280|FG015|STARTED|Part D||0||
48685836|NCT03768089|102013281|FG016|STARTED|Part D||3||
48685837|NCT03768089|102013282|FG017|STARTED|Part D||9||
48685838|NCT03768089|102013265|FG000|Safety Set|Part D||0|Received at least 1 dose of study drug.|
48685839|NCT03768089|102013266|FG001|Safety Set|Part D||0|Received at least 1 dose of study drug.|
48685840|NCT03768089|102013267|FG002|Safety Set|Part D||0|Received at least 1 dose of study drug.|
48685841|NCT03768089|102013268|FG003|Safety Set|Part D||0|Received at least 1 dose of study drug.|
48685842|NCT03768089|102013269|FG004|Safety Set|Part D||0|Received at least 1 dose of study drug.|
48685843|NCT03768089|102013270|FG005|Safety Set|Part D||0|Received at least 1 dose of study drug.|
48685844|NCT03768089|102013271|FG006|Safety Set|Part D||0|Received at least 1 dose of study drug.|
48685845|NCT03768089|102013272|FG007|Safety Set|Part D||0|Received at least 1 dose of study drug.|
48685846|NCT03768089|102013273|FG008|Safety Set|Part D||0|Received at least 1 dose of study drug.|
48685847|NCT03768089|102013274|FG009|Safety Set|Part D||0|Received at least 1 dose of study drug.|
48685848|NCT03768089|102013275|FG010|Safety Set|Part D||0|Received at least 1 dose of study drug.|
48685849|NCT03768089|102013276|FG011|Safety Set|Part D||0|Received at least 1 dose of study drug.|
48685850|NCT03768089|102013277|FG012|Safety Set|Part D||0|Received at least 1 dose of study drug.|
48685851|NCT03768089|102013278|FG013|Safety Set|Part D||0|Received at least 1 dose of study drug.|
48685852|NCT03768089|102013279|FG014|Safety Set|Part D||0|Received at least 1 dose of study drug.|
48685853|NCT03768089|102013280|FG015|Safety Set|Part D||0|Received at least 1 dose of study drug.|
48685854|NCT03768089|102013281|FG016|Safety Set|Part D||3|Received at least 1 dose of study drug.|
48685855|NCT03768089|102013282|FG017|Safety Set|Part D||9|Received at least 1 dose of study drug.|
48685856|NCT03768089|102013265|FG000|COMPLETED|Part D||0||
48253890|NCT00848393|100940127|FG000|NOT COMPLETED|Overall Study||0||
48253891|NCT00848393|100940128|FG001|NOT COMPLETED|Overall Study||0||
48685857|NCT03768089|102013266|FG001|COMPLETED|Part D||0||
48253892|NCT00848393|100940129|FG002|NOT COMPLETED|Overall Study||3||
48253893|NCT00993798|100940130|FG000|STARTED|Overall Study||53||
48253894|NCT00993798|100940131|FG001|STARTED|Overall Study||25||
48253895|NCT00993798|100940132|FG002|STARTED|Overall Study||29||
48253896|NCT00993798|100940133|FG003|STARTED|Overall Study||0||
48253897|NCT00993798|100940134|FG004|STARTED|Overall Study||0||
48253898|NCT00993798|100940130|FG000|COMPLETED|Overall Study||53||
48253899|NCT00993798|100940131|FG001|COMPLETED|Overall Study||25||
48253900|NCT00993798|100940132|FG002|COMPLETED|Overall Study||29||
48253901|NCT00993798|100940133|FG003|COMPLETED|Overall Study||0||
48253902|NCT00993798|100940134|FG004|COMPLETED|Overall Study||0||
48253903|NCT00993798|100940130|FG000|NOT COMPLETED|Overall Study||0||
48253904|NCT00993798|100940131|FG001|NOT COMPLETED|Overall Study||0||
48253905|NCT00993798|100940132|FG002|NOT COMPLETED|Overall Study||0||
48253906|NCT00993798|100940133|FG003|NOT COMPLETED|Overall Study||0||
48380530|NCT03136367|101258674|FG002|STARTED|T1 Consultation||257||
48380531|NCT03136367|101258672|FG000|COMPLETED|T1 Consultation||64||
48380532|NCT03136367|101258673|FG001|COMPLETED|T1 Consultation||241||
48380533|NCT03136367|101258674|FG002|COMPLETED|T1 Consultation||256||
48380534|NCT03136367|101258672|FG000|NOT COMPLETED|T1 Consultation||2||
48380535|NCT03136367|101258673|FG001|NOT COMPLETED|T1 Consultation||7||
48380536|NCT03136367|101258674|FG002|NOT COMPLETED|T1 Consultation||1||
48380537|NCT03136367|101258672|FG000|STARTED|T2 Post-consultation||64||
48380538|NCT03136367|101258673|FG001|STARTED|T2 Post-consultation||241||
48380539|NCT03136367|101258674|FG002|STARTED|T2 Post-consultation||256||
48380540|NCT03136367|101258672|FG000|COMPLETED|T2 Post-consultation||61||
48380541|NCT03136367|101258673|FG001|COMPLETED|T2 Post-consultation||235||
48380542|NCT03136367|101258674|FG002|COMPLETED|T2 Post-consultation||225||
48380543|NCT03136367|101258672|FG000|NOT COMPLETED|T2 Post-consultation||3||
48380544|NCT03136367|101258673|FG001|NOT COMPLETED|T2 Post-consultation||6||
48380545|NCT03136367|101258674|FG002|NOT COMPLETED|T2 Post-consultation||31||
48380546|NCT03136367|101258672|FG000|STARTED|T3 1 Week After Surgery||61||
48253907|NCT00993798|100940134|FG004|NOT COMPLETED|Overall Study||0||
48253908|NCT01703845|100940135|FG000|STARTED|Overall Study||16||
48253909|NCT01703845|100940136|FG001|STARTED|Overall Study||16||
48253910|NCT01703845|100940135|FG000|COMPLETED|Overall Study||13||
48253911|NCT01703845|100940136|FG001|COMPLETED|Overall Study||16||
48253912|NCT01703845|100940135|FG000|NOT COMPLETED|Overall Study||3||
48253913|NCT01703845|100940136|FG001|NOT COMPLETED|Overall Study||0||
48253914|NCT02165397|100940137|FG000|STARTED|Overall Study||75||
48253915|NCT02165397|100940138|FG001|STARTED|Overall Study||75||
48380547|NCT03136367|101258673|FG001|STARTED|T3 1 Week After Surgery||235||
48380548|NCT03136367|101258674|FG002|STARTED|T3 1 Week After Surgery||225||
48380549|NCT03136367|101258672|FG000|COMPLETED|T3 1 Week After Surgery||51||
48380550|NCT03136367|101258673|FG001|COMPLETED|T3 1 Week After Surgery||203||
48380551|NCT03136367|101258674|FG002|COMPLETED|T3 1 Week After Surgery||194||
48380552|NCT03136367|101258672|FG000|NOT COMPLETED|T3 1 Week After Surgery||10||
48380553|NCT03136367|101258673|FG001|NOT COMPLETED|T3 1 Week After Surgery||32||
48380554|NCT03136367|101258674|FG002|NOT COMPLETED|T3 1 Week After Surgery||31||
48380555|NCT03136367|101258672|FG000|STARTED|T4 12 Weeks After Surgery||51||
48380556|NCT03136367|101258673|FG001|STARTED|T4 12 Weeks After Surgery||203||
48380557|NCT03136367|101258674|FG002|STARTED|T4 12 Weeks After Surgery||194||
48380558|NCT03136367|101258672|FG000|COMPLETED|T4 12 Weeks After Surgery||49||
48380559|NCT03136367|101258673|FG001|COMPLETED|T4 12 Weeks After Surgery||198||
48380560|NCT03136367|101258674|FG002|COMPLETED|T4 12 Weeks After Surgery||185||
48380561|NCT03136367|101258672|FG000|NOT COMPLETED|T4 12 Weeks After Surgery||2||
48380562|NCT03136367|101258673|FG001|NOT COMPLETED|T4 12 Weeks After Surgery||5||
48380563|NCT03136367|101258674|FG002|NOT COMPLETED|T4 12 Weeks After Surgery||9||
48380564|NCT03136367|101258672|FG000|STARTED|T5 1 Year After Surgery||49||
48380565|NCT03136367|101258673|FG001|STARTED|T5 1 Year After Surgery||198||
48380566|NCT03136367|101258674|FG002|STARTED|T5 1 Year After Surgery||185||
48380567|NCT03136367|101258672|FG000|COMPLETED|T5 1 Year After Surgery||13||
48380568|NCT03136367|101258673|FG001|COMPLETED|T5 1 Year After Surgery||62||
48380569|NCT03136367|101258674|FG002|COMPLETED|T5 1 Year After Surgery||56||
48380570|NCT03136367|101258672|FG000|NOT COMPLETED|T5 1 Year After Surgery||36||
48380571|NCT03136367|101258673|FG001|NOT COMPLETED|T5 1 Year After Surgery||136||
48380572|NCT03136367|101258674|FG002|NOT COMPLETED|T5 1 Year After Surgery||129||
48380573|NCT02078882|101258675|FG000|STARTED|Overall Study||16||
48380574|NCT02078882|101258675|FG000|COMPLETED|Overall Study||16||
48380575|NCT02078882|101258675|FG000|NOT COMPLETED|Overall Study||0||
48253916|NCT02165397|100940139|FG002|STARTED|Overall Study||31||
48253917|NCT02165397|100940137|FG000|COMPLETED|Overall Study||61|On-study until study termination by sponsor.|
48380576|NCT00793819|101258676|FG000|STARTED|Overall Study||111||
48380577|NCT00793819|101258677|FG001|STARTED|Overall Study||98||
48380578|NCT00793819|101258676|FG000|COMPLETED|Overall Study||97||
48380579|NCT00793819|101258677|FG001|COMPLETED|Overall Study||89||
48380580|NCT00793819|101258676|FG000|NOT COMPLETED|Overall Study||14||
48380581|NCT00793819|101258677|FG001|NOT COMPLETED|Overall Study||9||
48380582|NCT02106455|101258678|FG000|STARTED|Overall Study||315||
48380583|NCT02106455|101258678|FG000|COMPLETED|Overall Study||307||
48253918|NCT02165397|100940138|FG001|COMPLETED|Overall Study||56|On-study until study termination by sponsor.|
48380584|NCT02106455|101258678|FG000|NOT COMPLETED|Overall Study||8||
48380585|NCT03886701|101258679|FG000|STARTED|Period 1: Study Days 1-4||11|Healthy volunteers received oral DOR 100 mg twice daily alone|
48380586|NCT03886701|101258679|FG000|COMPLETED|Period 1: Study Days 1-4||11||
48380587|NCT03886701|101258679|FG000|NOT COMPLETED|Period 1: Study Days 1-4||0||
48380588|NCT03886701|101258679|FG000|STARTED|Period 2: Study Days 7-21||11|Healthy volunteers received oral DOR 100 mg twice daily together with once weekly RPT and INH|
48380589|NCT03886701|101258679|FG000|COMPLETED|Period 2: Study Days 7-21||11||
48380590|NCT03886701|101258679|FG000|NOT COMPLETED|Period 2: Study Days 7-21||0||
48380591|NCT00230100|101258680|FG000|STARTED|Overall Study||29||
48380592|NCT00230100|101258681|FG001|STARTED|Overall Study||17||
48380593|NCT00230100|101258680|FG000|COMPLETED|Overall Study||29||
48380594|NCT00230100|101258681|FG001|COMPLETED|Overall Study||17||
48380595|NCT00230100|101258680|FG000|NOT COMPLETED|Overall Study||0||
48380596|NCT00230100|101258681|FG001|NOT COMPLETED|Overall Study||0||
48380597|NCT00242580|101258682|FG000|STARTED|Overall Study||32||
48380598|NCT00242580|101258683|FG001|STARTED|Overall Study||41||
48380599|NCT00242580|101258684|FG002|STARTED|Overall Study||38||
48380600|NCT00242580|101258682|FG000|COMPLETED|Overall Study||22||
48380601|NCT00242580|101258683|FG001|COMPLETED|Overall Study||29||
48380602|NCT00242580|101258684|FG002|COMPLETED|Overall Study||24||
48380603|NCT00242580|101258682|FG000|NOT COMPLETED|Overall Study||10||
48089927|NCT00760578|100541272|FG000|NOT COMPLETED|Overall Study||3||
48253919|NCT02165397|100940139|FG002|COMPLETED|Overall Study||21|On-study until study termination by sponsor.|
48253920|NCT02165397|100940137|FG000|NOT COMPLETED|Overall Study||14||
48253921|NCT02165397|100940138|FG001|NOT COMPLETED|Overall Study||19||
48253922|NCT02165397|100940139|FG002|NOT COMPLETED|Overall Study||10||
48253923|NCT01246050|100940140|FG000|STARTED|Overall Study||6||
48253924|NCT01246050|100940141|FG001|STARTED|Overall Study||6||
48253925|NCT01246050|100940140|FG000|COMPLETED|Overall Study||6||
48253926|NCT01246050|100940141|FG001|COMPLETED|Overall Study||6||
48253927|NCT01246050|100940140|FG000|NOT COMPLETED|Overall Study||0||
48253928|NCT01246050|100940141|FG001|NOT COMPLETED|Overall Study||0||
48253929|NCT02624375|100940142|FG000|STARTED|Overall Study||10||
48253930|NCT02624375|100940142|FG000|COMPLETED|Overall Study||10||
48380604|NCT00242580|101258683|FG001|NOT COMPLETED|Overall Study||12||
48380605|NCT00242580|101258684|FG002|NOT COMPLETED|Overall Study||14||
48253931|NCT02624375|100940142|FG000|NOT COMPLETED|Overall Study||0||
48253932|NCT02971228|100940143|FG000|STARTED|Overall Study||1|Enrolled|
48253933|NCT02971228|100940144|FG001|STARTED|Overall Study||7|Enrolled|
48380606|NCT04504032|101258685|FG000|STARTED|Overall Study||246||
48380607|NCT04504032|101258686|FG001|STARTED|Overall Study||251||
48380608|NCT04504032|101258685|FG000|COMPLETED|Overall Study||210||
48380609|NCT04504032|101258686|FG001|COMPLETED|Overall Study||223||
48380610|NCT04504032|101258685|FG000|NOT COMPLETED|Overall Study||36||
48380611|NCT04504032|101258686|FG001|NOT COMPLETED|Overall Study||28||
48380612|NCT01432262|101258687|FG000|STARTED|Overall Study||162||
48380613|NCT01432262|101258688|FG001|STARTED|Overall Study||162||
48380614|NCT01432262|101258687|FG000|Vaccinated|Overall Study||162||
48380615|NCT01432262|101258688|FG001|Vaccinated|Overall Study||161||
48380616|NCT01432262|101258687|FG000|COMPLETED|Overall Study||160||
48380617|NCT01432262|101258688|FG001|COMPLETED|Overall Study||161||
48380618|NCT01432262|101258687|FG000|NOT COMPLETED|Overall Study||2||
48380619|NCT01432262|101258688|FG001|NOT COMPLETED|Overall Study||1||
48380620|NCT00975195|101258689|FG000|STARTED|Overall Study||1244||
48380621|NCT00975195|101258690|FG001|STARTED|Overall Study||1244||
48380622|NCT00975195|101258689|FG000|COMPLETED|Overall Study||1016||
48380623|NCT00975195|101258690|FG001|COMPLETED|Overall Study||1011||
48380624|NCT00975195|101258689|FG000|NOT COMPLETED|Overall Study||228||
48380625|NCT00975195|101258690|FG001|NOT COMPLETED|Overall Study||233||
48380626|NCT01628016|101258691|FG000|STARTED|Pretraining to Posttraining||27||
48380627|NCT01628016|101258692|FG001|STARTED|Pretraining to Posttraining||27||
48380628|NCT01628016|101258693|FG002|STARTED|Pretraining to Posttraining||23||
48380629|NCT01628016|101258691|FG000|COMPLETED|Pretraining to Posttraining||27||
48380630|NCT01628016|101258692|FG001|COMPLETED|Pretraining to Posttraining||27||
48380631|NCT01628016|101258693|FG002|COMPLETED|Pretraining to Posttraining||23||
48380632|NCT01628016|101258691|FG000|NOT COMPLETED|Pretraining to Posttraining||0||
48380633|NCT01628016|101258692|FG001|NOT COMPLETED|Pretraining to Posttraining||0||
48380634|NCT01628016|101258693|FG002|NOT COMPLETED|Pretraining to Posttraining||0||
48380635|NCT01628016|101258691|FG000|STARTED|Posttraining to 5 Follow-ups||27||
48380636|NCT01628016|101258692|FG001|STARTED|Posttraining to 5 Follow-ups||27||
48380637|NCT01628016|101258693|FG002|STARTED|Posttraining to 5 Follow-ups||23||
48380638|NCT01628016|101258691|FG000|COMPLETED|Posttraining to 5 Follow-ups||23||
48380639|NCT01628016|101258692|FG001|COMPLETED|Posttraining to 5 Follow-ups||20||
48380640|NCT01628016|101258693|FG002|COMPLETED|Posttraining to 5 Follow-ups||18||
48380641|NCT01628016|101258691|FG000|NOT COMPLETED|Posttraining to 5 Follow-ups||4||
48380642|NCT01628016|101258692|FG001|NOT COMPLETED|Posttraining to 5 Follow-ups||7||
48380643|NCT01628016|101258693|FG002|NOT COMPLETED|Posttraining to 5 Follow-ups||5||
48380644|NCT01778127|101258694|FG000|STARTED|Overall Study||33||
48380645|NCT01778127|101258695|FG001|STARTED|Overall Study||33||
48253934|NCT02971228|100940145|FG002|STARTED|Overall Study||5|Enrolled|
48253935|NCT02971228|100940146|FG003|STARTED|Overall Study||0|Enrolled|
48253936|NCT02971228|100940147|FG004|STARTED|Overall Study||0|Enrolled|
48253937|NCT02971228|100940143|FG000|Randomized and Treated|Overall Study||0||
48253938|NCT02971228|100940144|FG001|Randomized and Treated|Overall Study||7||
48253939|NCT02971228|100940145|FG002|Randomized and Treated|Overall Study||5||
48253940|NCT02971228|100940146|FG003|Randomized and Treated|Overall Study||0||
48253941|NCT02971228|100940147|FG004|Randomized and Treated|Overall Study||0||
48253942|NCT02971228|100940143|FG000|COMPLETED|Overall Study||0||
48253943|NCT02971228|100940144|FG001|COMPLETED|Overall Study||5||
48253944|NCT02971228|100940145|FG002|COMPLETED|Overall Study||5||
48253945|NCT02971228|100940146|FG003|COMPLETED|Overall Study||0||
48253946|NCT02971228|100940147|FG004|COMPLETED|Overall Study||0||
48253947|NCT02971228|100940143|FG000|NOT COMPLETED|Overall Study||1||
48253948|NCT02971228|100940144|FG001|NOT COMPLETED|Overall Study||2||
48253949|NCT02971228|100940145|FG002|NOT COMPLETED|Overall Study||0||
48253950|NCT02971228|100940146|FG003|NOT COMPLETED|Overall Study||0||
48253951|NCT02971228|100940147|FG004|NOT COMPLETED|Overall Study||0||
48253952|NCT00691678|100940148|FG000|STARTED|Overall Study||53||
48253953|NCT00691678|100940148|FG000|COMPLETED|Overall Study||37||
48253954|NCT00691678|100940148|FG000|NOT COMPLETED|Overall Study||16||
48253955|NCT03449134|100940149|FG000|STARTED|52-Week Treatment Period||244||
48253956|NCT03449134|100940150|FG001|STARTED|52-Week Treatment Period||244||
48253957|NCT03449134|100940151|FG002|STARTED|52-Week Treatment Period||244||
48253958|NCT03449134|100940149|FG000|Treated|52-Week Treatment Period||243||
48253959|NCT03449134|100940150|FG001|Treated|52-Week Treatment Period||244||
48253960|NCT03449134|100940151|FG002|Treated|52-Week Treatment Period||243||
48253961|NCT03449134|100940149|FG000|COMPLETED|52-Week Treatment Period||199||
48253962|NCT03449134|100940150|FG001|COMPLETED|52-Week Treatment Period||200||
48253963|NCT03449134|100940151|FG002|COMPLETED|52-Week Treatment Period||184||
48253964|NCT03449134|100940149|FG000|NOT COMPLETED|52-Week Treatment Period||45||
48253965|NCT03449134|100940150|FG001|NOT COMPLETED|52-Week Treatment Period||44||
48253966|NCT03449134|100940151|FG002|NOT COMPLETED|52-Week Treatment Period||60||
48253967|NCT03449134|100940149|FG000|STARTED|12-Week Off-Treatment Durability Period||10||
48253968|NCT03449134|100940150|FG001|STARTED|12-Week Off-Treatment Durability Period||18||
48253969|NCT03449134|100940151|FG002|STARTED|12-Week Off-Treatment Durability Period||13||
48253970|NCT03449134|100940149|FG000|COMPLETED|12-Week Off-Treatment Durability Period||10||
48253971|NCT03449134|100940150|FG001|COMPLETED|12-Week Off-Treatment Durability Period||18||
48253972|NCT03449134|100940151|FG002|COMPLETED|12-Week Off-Treatment Durability Period||13||
48253973|NCT03449134|100940149|FG000|NOT COMPLETED|12-Week Off-Treatment Durability Period||0||
48253974|NCT03449134|100940150|FG001|NOT COMPLETED|12-Week Off-Treatment Durability Period||0||
48253975|NCT03449134|100940151|FG002|NOT COMPLETED|12-Week Off-Treatment Durability Period||0||
48253976|NCT01037413|100940152|FG000|STARTED|Part A: Skin Testing||25||
48253977|NCT01037413|100940153|FG001|STARTED|Part A: Skin Testing||0||
48253978|NCT01037413|100940152|FG000|COMPLETED|Part A: Skin Testing||23||
48253979|NCT01037413|100940153|FG001|COMPLETED|Part A: Skin Testing||0||
48253980|NCT01037413|100940152|FG000|NOT COMPLETED|Part A: Skin Testing||2||
48253981|NCT01037413|100940153|FG001|NOT COMPLETED|Part A: Skin Testing||0||
48253982|NCT01037413|100940152|FG000|STARTED|Part B: Scar Revision||0||
48253983|NCT01037413|100940153|FG001|STARTED|Part B: Scar Revision||23||
48253984|NCT01037413|100940152|FG000|Treated|Part B: Scar Revision||0||
48253985|NCT01037413|100940153|FG001|Treated|Part B: Scar Revision||22||
48253986|NCT01037413|100940152|FG000|COMPLETED|Part B: Scar Revision||0||
48253987|NCT01037413|100940153|FG001|COMPLETED|Part B: Scar Revision||21||
48253988|NCT01037413|100940152|FG000|NOT COMPLETED|Part B: Scar Revision||0||
48253989|NCT01037413|100940153|FG001|NOT COMPLETED|Part B: Scar Revision||2||
48253990|NCT00275301|100940154|FG000|STARTED|Overall Study||19||
48253991|NCT00275301|100940154|FG000|COMPLETED|Overall Study||14||
48253992|NCT00275301|100940154|FG000|NOT COMPLETED|Overall Study||5||
48253993|NCT00619983|100940155|FG000|STARTED|Test Drug Alone||5||
48253994|NCT00619983|100940156|FG001|STARTED|Test Drug Alone||5||
48253995|NCT00619983|100940157|FG002|STARTED|Test Drug Alone||6||
48253996|NCT00619983|100940158|FG003|STARTED|Test Drug Alone||6||
48253997|NCT00619983|100940155|FG000|COMPLETED|Test Drug Alone||3||
48253998|NCT00619983|100940156|FG001|COMPLETED|Test Drug Alone||4||
48253999|NCT00619983|100940157|FG002|COMPLETED|Test Drug Alone||4||
48254000|NCT00619983|100940158|FG003|COMPLETED|Test Drug Alone||3||
48254001|NCT00619983|100940155|FG000|NOT COMPLETED|Test Drug Alone||2||
48254002|NCT00619983|100940156|FG001|NOT COMPLETED|Test Drug Alone||1||
48254003|NCT00619983|100940157|FG002|NOT COMPLETED|Test Drug Alone||2||
48254004|NCT00619983|100940158|FG003|NOT COMPLETED|Test Drug Alone||3||
48380646|NCT01778127|101258696|FG002|STARTED|Overall Study||32||
48254005|NCT00619983|100940155|FG000|STARTED|Test Drug Plus Gabapentin||3||
48254006|NCT00619983|100940156|FG001|STARTED|Test Drug Plus Gabapentin||4||
48254007|NCT00619983|100940157|FG002|STARTED|Test Drug Plus Gabapentin||4||
48254008|NCT00619983|100940158|FG003|STARTED|Test Drug Plus Gabapentin||3||
48254009|NCT00619983|100940155|FG000|COMPLETED|Test Drug Plus Gabapentin||3||
48254010|NCT00619983|100940156|FG001|COMPLETED|Test Drug Plus Gabapentin||4||
48254011|NCT00619983|100940157|FG002|COMPLETED|Test Drug Plus Gabapentin||4||
48254012|NCT00619983|100940158|FG003|COMPLETED|Test Drug Plus Gabapentin||3||
48254013|NCT00619983|100940155|FG000|NOT COMPLETED|Test Drug Plus Gabapentin||0||
48254014|NCT00619983|100940156|FG001|NOT COMPLETED|Test Drug Plus Gabapentin||0||
48254015|NCT00619983|100940157|FG002|NOT COMPLETED|Test Drug Plus Gabapentin||0||
48254016|NCT00619983|100940158|FG003|NOT COMPLETED|Test Drug Plus Gabapentin||0||
48254017|NCT00619983|100940155|FG000|STARTED|Gabapentin Alone||3||
48254018|NCT00619983|100940156|FG001|STARTED|Gabapentin Alone||4||
48254019|NCT00619983|100940157|FG002|STARTED|Gabapentin Alone||4||
48254020|NCT00619983|100940158|FG003|STARTED|Gabapentin Alone||3||
48254021|NCT00619983|100940155|FG000|COMPLETED|Gabapentin Alone||3||
48254022|NCT00619983|100940156|FG001|COMPLETED|Gabapentin Alone||4||
48254023|NCT00619983|100940157|FG002|COMPLETED|Gabapentin Alone||4||
48254024|NCT00619983|100940158|FG003|COMPLETED|Gabapentin Alone||3||
48089928|NCT00760578|100541273|FG001|NOT COMPLETED|Overall Study||2||
48089929|NCT00760578|100541274|FG002|NOT COMPLETED|Overall Study||5||
48089930|NCT00760578|100541275|FG003|NOT COMPLETED|Overall Study||4||
48089931|NCT00064844|100541276|FG000|STARTED|Overall Study||45||
48089932|NCT00064844|100541277|FG001|STARTED|Overall Study||51||
48089933|NCT00064844|100541276|FG000|2 Week Follow-up|Overall Study||45||
48089934|NCT00064844|100541277|FG001|2 Week Follow-up|Overall Study||51||
48089935|NCT00064844|100541276|FG000|3 Month Follow-up|Overall Study||40||
48089936|NCT00064844|100541277|FG001|3 Month Follow-up|Overall Study||47||
48089937|NCT00064844|100541276|FG000|6 Month Follow-up|Overall Study||39||
48254025|NCT00619983|100940155|FG000|NOT COMPLETED|Gabapentin Alone||0||
48254026|NCT00619983|100940156|FG001|NOT COMPLETED|Gabapentin Alone||0||
48254027|NCT00619983|100940157|FG002|NOT COMPLETED|Gabapentin Alone||0||
48254028|NCT00619983|100940158|FG003|NOT COMPLETED|Gabapentin Alone||0||
48254029|NCT00082641|100940159|FG000|STARTED|Overall Study||11||
48380647|NCT01778127|101258694|FG000|COMPLETED|Overall Study||25||
48380648|NCT01778127|101258695|FG001|COMPLETED|Overall Study||31||
48380649|NCT01778127|101258696|FG002|COMPLETED|Overall Study||26||
48380650|NCT01778127|101258694|FG000|NOT COMPLETED|Overall Study||8||
48089938|NCT00064844|100541277|FG001|6 Month Follow-up|Overall Study||40||
48089939|NCT00064844|100541276|FG000|12 Month Follow-up|Overall Study||37||
48089940|NCT00064844|100541277|FG001|12 Month Follow-up|Overall Study||32||
48089941|NCT00064844|100541276|FG000|COMPLETED|Overall Study||37||
48089942|NCT00064844|100541277|FG001|COMPLETED|Overall Study||32||
48089943|NCT00064844|100541276|FG000|NOT COMPLETED|Overall Study||8||
48089944|NCT00064844|100541277|FG001|NOT COMPLETED|Overall Study||19||
48089945|NCT04080297|100541278|FG000|STARTED|Overall Study||10||
48089946|NCT04080297|100541279|FG001|STARTED|Overall Study||11||
48089947|NCT04080297|100541278|FG000|COMPLETED|Overall Study||8||
48089948|NCT04080297|100541279|FG001|COMPLETED|Overall Study||8||
48089949|NCT04080297|100541278|FG000|NOT COMPLETED|Overall Study||2||
48089950|NCT04080297|100541279|FG001|NOT COMPLETED|Overall Study||3||
48089951|NCT02598076|100541280|FG000|STARTED|Overall Study||31||
48089952|NCT02598076|100541281|FG001|STARTED|Overall Study||29||
48089953|NCT02598076|100541280|FG000|COMPLETED|Overall Study||29||
48089954|NCT02598076|100541281|FG001|COMPLETED|Overall Study||26||
48089955|NCT02598076|100541280|FG000|NOT COMPLETED|Overall Study||2||
48089956|NCT02598076|100541281|FG001|NOT COMPLETED|Overall Study||3||
48089957|NCT01011634|100541282|FG000|STARTED|Overall Study||9||
48089958|NCT01011634|100541283|FG001|STARTED|Overall Study||9||
48089959|NCT01011634|100541282|FG000|COMPLETED|Overall Study||9||
48089960|NCT01011634|100541283|FG001|COMPLETED|Overall Study||8||
48089961|NCT01011634|100541282|FG000|NOT COMPLETED|Overall Study||0||
48089962|NCT01011634|100541283|FG001|NOT COMPLETED|Overall Study||1||
48089963|NCT02298803|100541284|FG000|STARTED|Overall Study||30||
48089964|NCT02298803|100541284|FG000|COMPLETED|Overall Study||30||
48089965|NCT02298803|100541284|FG000|NOT COMPLETED|Overall Study||0||
48089966|NCT03991715|100541285|FG000|STARTED|Overall Study||5||
48089967|NCT03991715|100541285|FG000|COMPLETED|Overall Study||5||
48089968|NCT03991715|100541285|FG000|NOT COMPLETED|Overall Study||0||
48089969|NCT00617123|100541286|FG000|STARTED|Referral Screening Period||137||
48089970|NCT00617123|100541287|FG001|STARTED|Referral Screening Period||121||
48089971|NCT00617123|100541286|FG000|COMPLETED|Referral Screening Period||98||
48089972|NCT00617123|100541287|FG001|COMPLETED|Referral Screening Period||95||
48254030|NCT00082641|100940160|FG001|STARTED|Overall Study||12||
48254031|NCT00082641|100940159|FG000|COMPLETED|Overall Study||11||
48254032|NCT00082641|100940160|FG001|COMPLETED|Overall Study||12||
48254033|NCT00082641|100940159|FG000|NOT COMPLETED|Overall Study||0||
48254034|NCT00082641|100940160|FG001|NOT COMPLETED|Overall Study||0||
48254035|NCT03697083|100940161|FG000|STARTED|Overall Study||262||
48254036|NCT03697083|100940162|FG001|STARTED|Overall Study||260||
48254037|NCT03697083|100940163|FG002|STARTED|Overall Study||255||
48254038|NCT03697083|100940161|FG000|COMPLETED|Overall Study||262||
48380651|NCT01778127|101258695|FG001|NOT COMPLETED|Overall Study||2||
48089973|NCT00617123|100541286|FG000|NOT COMPLETED|Referral Screening Period||39||
48089974|NCT00617123|100541287|FG001|NOT COMPLETED|Referral Screening Period||26||
48089975|NCT00617123|100541286|FG000|STARTED|Study Treatment Period||98||
48089976|NCT00617123|100541287|FG001|STARTED|Study Treatment Period||95||
48089977|NCT00617123|100541286|FG000|Treated|Study Treatment Period||97||
48089978|NCT00617123|100541287|FG001|Treated|Study Treatment Period||95||
48254039|NCT03697083|100940162|FG001|COMPLETED|Overall Study||250||
48089979|NCT00617123|100541286|FG000|COMPLETED|Study Treatment Period||81||
48089980|NCT00617123|100541287|FG001|COMPLETED|Study Treatment Period||79||
48089981|NCT00617123|100541286|FG000|NOT COMPLETED|Study Treatment Period||17||
48089982|NCT00617123|100541287|FG001|NOT COMPLETED|Study Treatment Period||16||
48089983|NCT00667004|100541288|FG000|STARTED|Overall Study||95||
48089984|NCT00667004|100541289|FG001|STARTED|Overall Study||88||
48089985|NCT00667004|100541288|FG000|COMPLETED|Overall Study||93||
48089986|NCT00667004|100541289|FG001|COMPLETED|Overall Study||85||
48089987|NCT00667004|100541288|FG000|NOT COMPLETED|Overall Study||2||
48089988|NCT00667004|100541289|FG001|NOT COMPLETED|Overall Study||3||
48254040|NCT03697083|100940163|FG002|COMPLETED|Overall Study||255||
48254041|NCT03697083|100940161|FG000|NOT COMPLETED|Overall Study||0||
48254042|NCT03697083|100940162|FG001|NOT COMPLETED|Overall Study||10||
48254043|NCT03697083|100940163|FG002|NOT COMPLETED|Overall Study||0||
48254044|NCT02633397|100940164|FG000|STARTED|Overall Study||66||
48254045|NCT02633397|100940165|FG001|STARTED|Overall Study||64||
48254046|NCT02633397|100940164|FG000|COMPLETED|Overall Study||50||
48685858|NCT03768089|102013267|FG002|COMPLETED|Part D||0||
48685859|NCT03768089|102013268|FG003|COMPLETED|Part D||0||
48685860|NCT03768089|102013269|FG004|COMPLETED|Part D||0||
48685861|NCT03768089|102013270|FG005|COMPLETED|Part D||0||
48254047|NCT02633397|100940165|FG001|COMPLETED|Overall Study||47||
48254048|NCT02633397|100940164|FG000|NOT COMPLETED|Overall Study||16||
48254049|NCT02633397|100940165|FG001|NOT COMPLETED|Overall Study||17||
48254050|NCT01891890|100940166|FG000|STARTED|Overall Study||24||
48254051|NCT01891890|100940167|FG001|STARTED|Overall Study||27||
48254052|NCT01891890|100940168|FG002|STARTED|Overall Study||21||
48254053|NCT01891890|100940166|FG000|COMPLETED|Overall Study||17||
48254054|NCT01891890|100940167|FG001|COMPLETED|Overall Study||24||
48254055|NCT01891890|100940168|FG002|COMPLETED|Overall Study||14||
48254056|NCT01891890|100940166|FG000|NOT COMPLETED|Overall Study||7||
48254057|NCT01891890|100940167|FG001|NOT COMPLETED|Overall Study||3||
48254058|NCT01891890|100940168|FG002|NOT COMPLETED|Overall Study||7||
48380652|NCT01778127|101258696|FG002|NOT COMPLETED|Overall Study||6||
48685862|NCT03768089|102013271|FG006|COMPLETED|Part D||0||
48089989|NCT00905151|100541290|FG000|STARTED|Overall Study||206||
48254059|NCT04124471|100940169|FG000|STARTED|Overall Study||42||
48254060|NCT04124471|100940169|FG000|COMPLETED|Overall Study||41||
48254061|NCT04124471|100940169|FG000|NOT COMPLETED|Overall Study||1||
48254062|NCT00374088|100940170|FG000|STARTED|Overall Study||10||
48254063|NCT00374088|100940171|FG001|STARTED|Overall Study||11||
48254064|NCT00374088|100940170|FG000|COMPLETED|Overall Study||9||
48254065|NCT00374088|100940171|FG001|COMPLETED|Overall Study||10||
48254066|NCT00374088|100940170|FG000|NOT COMPLETED|Overall Study||1||
48254067|NCT00374088|100940171|FG001|NOT COMPLETED|Overall Study||1||
48254068|NCT00143598|100940172|FG000|STARTED|Overall Study||410||
48254069|NCT00143598|100940173|FG001|STARTED|Overall Study||396||
48254070|NCT00143598|100940172|FG000|COMPLETED|Overall Study||318||
48380653|NCT03259490|101258697|FG000|STARTED|Period 1||15||
48685863|NCT03768089|102013272|FG007|COMPLETED|Part D||0||
48685864|NCT03768089|102013273|FG008|COMPLETED|Part D||0||
48685865|NCT03768089|102013274|FG009|COMPLETED|Part D||0||
48685866|NCT03768089|102013275|FG010|COMPLETED|Part D||0||
48685867|NCT03768089|102013276|FG011|COMPLETED|Part D||0||
48089990|NCT00905151|100541290|FG000|COMPLETED|Overall Study||200||
48089991|NCT00905151|100541290|FG000|NOT COMPLETED|Overall Study||6||
48089992|NCT02648178|100541291|FG000|STARTED|Overall Study||19||
48089993|NCT02648178|100541291|FG000|COMPLETED|Overall Study||10||
48254071|NCT00143598|100940173|FG001|COMPLETED|Overall Study||302||
48254072|NCT00143598|100940172|FG000|NOT COMPLETED|Overall Study||92||
48254073|NCT00143598|100940173|FG001|NOT COMPLETED|Overall Study||94||
48089994|NCT02648178|100541291|FG000|NOT COMPLETED|Overall Study||9||
48089995|NCT04533438|100541292|FG000|STARTED|Initial Enrollment||77||
48685868|NCT03768089|102013277|FG012|COMPLETED|Part D||0||
48685869|NCT03768089|102013278|FG013|COMPLETED|Part D||0||
48089996|NCT04533438|100541293|FG001|STARTED|Initial Enrollment||39||
48089997|NCT04533438|100541292|FG000|COMPLETED|Initial Enrollment||77||
48254074|NCT00258362|100940174|FG000|STARTED|Overall Study||41||
48254075|NCT00258362|100940174|FG000|COMPLETED|Overall Study||41||
48254076|NCT00258362|100940174|FG000|NOT COMPLETED|Overall Study||0||
48254077|NCT00487552|100940175|FG000|STARTED|Overall Study||18||
48254078|NCT00487552|100940175|FG000|COMPLETED|Overall Study||12||
48254079|NCT00487552|100940175|FG000|NOT COMPLETED|Overall Study||6||
48089998|NCT04533438|100541293|FG001|COMPLETED|Initial Enrollment||39||
48089999|NCT04533438|100541292|FG000|NOT COMPLETED|Initial Enrollment||0||
48090000|NCT04533438|100541293|FG001|NOT COMPLETED|Initial Enrollment||0||
48090001|NCT04533438|100541292|FG000|STARTED|Crossover Period||0|The Crossover Period does not apply to subjects that were randomized to Rhinaer Treatment Arm|
48090002|NCT04533438|100541293|FG001|STARTED|Crossover Period||39|The Crossover Period does not apply to subjects that were randomized to Rhinaer Treatment Arm|
48090003|NCT04533438|100541292|FG000|COMPLETED|Crossover Period||0||
48090004|NCT04533438|100541293|FG001|COMPLETED|Crossover Period||28||
48090005|NCT04533438|100541292|FG000|NOT COMPLETED|Crossover Period||0||
48090006|NCT04533438|100541293|FG001|NOT COMPLETED|Crossover Period||11||
48090007|NCT03546192|100541294|FG000|STARTED|Overall Study||60||
48090008|NCT03546192|100541295|FG001|STARTED|Overall Study||60||
48254080|NCT00460564|100940176|FG000|STARTED|Double-Blind Phase (12 Weeks)||51||
48254081|NCT00460564|100940177|FG001|STARTED|Double-Blind Phase (12 Weeks)||26||
48254082|NCT00460564|100940178|FG002|STARTED|Double-Blind Phase (12 Weeks)||21||
48254083|NCT00460564|100940179|FG003|STARTED|Double-Blind Phase (12 Weeks)||11||
48254084|NCT00460564|100940180|FG004|STARTED|Double-Blind Phase (12 Weeks)||0||
48254085|NCT00460564|100940181|FG005|STARTED|Double-Blind Phase (12 Weeks)||0||
48090009|NCT03546192|100541294|FG000|COMPLETED|Overall Study||60||
48090010|NCT03546192|100541295|FG001|COMPLETED|Overall Study||60||
48090011|NCT03546192|100541294|FG000|NOT COMPLETED|Overall Study||0||
48090012|NCT03546192|100541295|FG001|NOT COMPLETED|Overall Study||0||
48254086|NCT00460564|100940182|FG006|STARTED|Double-Blind Phase (12 Weeks)||0||
48254087|NCT00460564|100940183|FG007|STARTED|Double-Blind Phase (12 Weeks)||0||
48254088|NCT00460564|100940176|FG000|COMPLETED|Double-Blind Phase (12 Weeks)||47||
48254089|NCT00460564|100940177|FG001|COMPLETED|Double-Blind Phase (12 Weeks)||25||
48254090|NCT00460564|100940178|FG002|COMPLETED|Double-Blind Phase (12 Weeks)||21||
48254091|NCT00460564|100940179|FG003|COMPLETED|Double-Blind Phase (12 Weeks)||11||
48254092|NCT00460564|100940180|FG004|COMPLETED|Double-Blind Phase (12 Weeks)||0||
48254093|NCT00460564|100940181|FG005|COMPLETED|Double-Blind Phase (12 Weeks)||0||
48254094|NCT00460564|100940182|FG006|COMPLETED|Double-Blind Phase (12 Weeks)||0||
48254095|NCT00460564|100940183|FG007|COMPLETED|Double-Blind Phase (12 Weeks)||0||
48254096|NCT00460564|100940176|FG000|NOT COMPLETED|Double-Blind Phase (12 Weeks)||4||
48254097|NCT00460564|100940177|FG001|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1||
48254098|NCT00460564|100940178|FG002|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0||
48254099|NCT00460564|100940179|FG003|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0||
48254100|NCT00460564|100940180|FG004|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0||
48254101|NCT00460564|100940181|FG005|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0||
48254102|NCT00460564|100940182|FG006|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0||
48254103|NCT00460564|100940183|FG007|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0||
48254104|NCT00460564|100940176|FG000|STARTED|Open-Label Phase (36 Weeks)||0||
48254105|NCT00460564|100940177|FG001|STARTED|Open-Label Phase (36 Weeks)||0||
48090013|NCT02758899|100541296|FG000|STARTED|Overall Study||11||
48090014|NCT02758899|100541297|FG001|STARTED|Overall Study||10||
48090015|NCT02758899|100541296|FG000|COMPLETED|Overall Study||9||
48090016|NCT02758899|100541297|FG001|COMPLETED|Overall Study||9||
48090017|NCT02758899|100541296|FG000|NOT COMPLETED|Overall Study||2||
48090018|NCT02758899|100541297|FG001|NOT COMPLETED|Overall Study||1||
48090019|NCT00742001|100541298|FG000|STARTED|Overall Study||4||
48090020|NCT00742001|100541299|FG001|STARTED|Overall Study||4||
48090021|NCT00742001|100541300|FG002|STARTED|Overall Study||4||
48090022|NCT00742001|100541298|FG000|COMPLETED|Overall Study||4||
48090023|NCT00742001|100541299|FG001|COMPLETED|Overall Study||4||
48090024|NCT00742001|100541300|FG002|COMPLETED|Overall Study||3||
48090025|NCT00742001|100541298|FG000|NOT COMPLETED|Overall Study||0||
48090026|NCT00742001|100541299|FG001|NOT COMPLETED|Overall Study||0||
48090027|NCT00742001|100541300|FG002|NOT COMPLETED|Overall Study||1||
48090028|NCT01996982|100541301|FG000|STARTED|Overall Study||7||
48090029|NCT01996982|100541301|FG000|COMPLETED|Overall Study||0||
48090030|NCT01996982|100541301|FG000|NOT COMPLETED|Overall Study||7||
48090031|NCT00856284|100541302|FG000|STARTED|Overall Study||880||
48090032|NCT00856284|100541303|FG001|STARTED|Overall Study||885||
48090033|NCT00856284|100541304|FG002|STARTED|Overall Study||874||
48090034|NCT00856284|100541302|FG000|Received Study Drug|Overall Study||873||
48090035|NCT00856284|100541303|FG001|Received Study Drug|Overall Study||878||
48090036|NCT00856284|100541304|FG002|Received Study Drug|Overall Study||869||
48090037|NCT00856284|100541302|FG000|COMPLETED|Overall Study||472||
48090038|NCT00856284|100541303|FG001|COMPLETED|Overall Study||493||
48090039|NCT00856284|100541304|FG002|COMPLETED|Overall Study||427||
48090040|NCT00856284|100541302|FG000|NOT COMPLETED|Overall Study||408||
48090041|NCT00856284|100541303|FG001|NOT COMPLETED|Overall Study||392||
48090042|NCT00856284|100541304|FG002|NOT COMPLETED|Overall Study||447||
48254106|NCT00460564|100940178|FG002|STARTED|Open-Label Phase (36 Weeks)||0||
48254107|NCT00460564|100940179|FG003|STARTED|Open-Label Phase (36 Weeks)||0||
48254108|NCT00460564|100940180|FG004|STARTED|Open-Label Phase (36 Weeks)||47||
48254109|NCT00460564|100940181|FG005|STARTED|Open-Label Phase (36 Weeks)||25||
48254110|NCT00460564|100940182|FG006|STARTED|Open-Label Phase (36 Weeks)||21||
48254111|NCT00460564|100940183|FG007|STARTED|Open-Label Phase (36 Weeks)||11||
48254112|NCT00460564|100940176|FG000|COMPLETED|Open-Label Phase (36 Weeks)||0||
48254113|NCT00460564|100940177|FG001|COMPLETED|Open-Label Phase (36 Weeks)||0||
48254114|NCT00460564|100940178|FG002|COMPLETED|Open-Label Phase (36 Weeks)||0||
48254115|NCT00460564|100940179|FG003|COMPLETED|Open-Label Phase (36 Weeks)||0||
48254116|NCT00460564|100940180|FG004|COMPLETED|Open-Label Phase (36 Weeks)||38||
48254117|NCT00460564|100940181|FG005|COMPLETED|Open-Label Phase (36 Weeks)||19||
48254118|NCT00460564|100940182|FG006|COMPLETED|Open-Label Phase (36 Weeks)||19||
48254119|NCT00460564|100940183|FG007|COMPLETED|Open-Label Phase (36 Weeks)||11||
48254120|NCT00460564|100940176|FG000|NOT COMPLETED|Open-Label Phase (36 Weeks)||0||
48254121|NCT00460564|100940177|FG001|NOT COMPLETED|Open-Label Phase (36 Weeks)||0||
48254122|NCT00460564|100940178|FG002|NOT COMPLETED|Open-Label Phase (36 Weeks)||0||
48254123|NCT00460564|100940179|FG003|NOT COMPLETED|Open-Label Phase (36 Weeks)||0||
48254124|NCT00460564|100940180|FG004|NOT COMPLETED|Open-Label Phase (36 Weeks)||9||
48254125|NCT00460564|100940181|FG005|NOT COMPLETED|Open-Label Phase (36 Weeks)||6||
48254126|NCT00460564|100940182|FG006|NOT COMPLETED|Open-Label Phase (36 Weeks)||2||
48254127|NCT00460564|100940183|FG007|NOT COMPLETED|Open-Label Phase (36 Weeks)||0||
48254128|NCT02257918|100940184|FG000|STARTED|Overall Study||72||
48254129|NCT02257918|100940185|FG001|STARTED|Overall Study||67||
48254130|NCT02257918|100940186|FG002|STARTED|Overall Study||41||
48254131|NCT02257918|100940184|FG000|Test of Cure Visit|Overall Study||72||
48254132|NCT02257918|100940185|FG001|Test of Cure Visit|Overall Study||67||
48254133|NCT02257918|100940186|FG002|Test of Cure Visit|Overall Study||40||
48254134|NCT02257918|100940184|FG000|COMPLETED|Overall Study||68||
48380654|NCT03259490|101258698|FG001|STARTED|Period 1||15||
48380655|NCT03259490|101258697|FG000|COMPLETED|Period 1||15||
48380656|NCT03259490|101258698|FG001|COMPLETED|Period 1||14||
48380657|NCT03259490|101258697|FG000|NOT COMPLETED|Period 1||0||
48380658|NCT03259490|101258698|FG001|NOT COMPLETED|Period 1||1||
48380659|NCT03259490|101258697|FG000|STARTED|Period 2||15||
48380660|NCT03259490|101258698|FG001|STARTED|Period 2||14||
48380661|NCT03259490|101258697|FG000|COMPLETED|Period 2||14||
48380662|NCT03259490|101258698|FG001|COMPLETED|Period 2||14||
48380663|NCT03259490|101258697|FG000|NOT COMPLETED|Period 2||1||
48685870|NCT03768089|102013279|FG014|COMPLETED|Part D||0||
48685871|NCT03768089|102013280|FG015|COMPLETED|Part D||0||
48685872|NCT03768089|102013281|FG016|COMPLETED|Part D||3||
48685873|NCT03768089|102013282|FG017|COMPLETED|Part D||9||
48685874|NCT03768089|102013265|FG000|NOT COMPLETED|Part D||0||
48685875|NCT03768089|102013266|FG001|NOT COMPLETED|Part D||0||
48685876|NCT03768089|102013267|FG002|NOT COMPLETED|Part D||0||
48685877|NCT03768089|102013268|FG003|NOT COMPLETED|Part D||0||
48685878|NCT03768089|102013269|FG004|NOT COMPLETED|Part D||0||
48685879|NCT03768089|102013270|FG005|NOT COMPLETED|Part D||0||
48685880|NCT03768089|102013271|FG006|NOT COMPLETED|Part D||0||
48685881|NCT03768089|102013272|FG007|NOT COMPLETED|Part D||0||
48685882|NCT03768089|102013273|FG008|NOT COMPLETED|Part D||0||
48685883|NCT03768089|102013274|FG009|NOT COMPLETED|Part D||0||
48685884|NCT03768089|102013275|FG010|NOT COMPLETED|Part D||0||
48254135|NCT02257918|100940185|FG001|COMPLETED|Overall Study||66||
48254136|NCT02257918|100940186|FG002|COMPLETED|Overall Study||39||
48254137|NCT02257918|100940184|FG000|NOT COMPLETED|Overall Study||4||
48685885|NCT03768089|102013276|FG011|NOT COMPLETED|Part D||0||
48685886|NCT03768089|102013277|FG012|NOT COMPLETED|Part D||0||
48685887|NCT03768089|102013278|FG013|NOT COMPLETED|Part D||0||
48254138|NCT02257918|100940185|FG001|NOT COMPLETED|Overall Study||1||
48254139|NCT02257918|100940186|FG002|NOT COMPLETED|Overall Study||2||
48254140|NCT01845649|100940187|FG000|STARTED|Overall Study||273||
48380664|NCT03259490|101258698|FG001|NOT COMPLETED|Period 2||0||
48380665|NCT02492997|101258699|FG000|STARTED|Overall Study||21||
48685888|NCT03768089|102013279|FG014|NOT COMPLETED|Part D||0||
48685889|NCT03768089|102013280|FG015|NOT COMPLETED|Part D||0||
48685890|NCT03768089|102013281|FG016|NOT COMPLETED|Part D||0||
48685891|NCT03768089|102013282|FG017|NOT COMPLETED|Part D||0||
48380666|NCT02492997|101258700|FG001|STARTED|Overall Study||21||
48685892|NCT00251693|102013283|FG000|STARTED|Overall Study||680||
48685893|NCT00251693|102013284|FG001|STARTED|Overall Study||668||
48685894|NCT00251693|102013285|FG002|STARTED|Overall Study||690||
48685895|NCT00251693|102013283|FG000|COMPLETED|Overall Study||629||
48685896|NCT00251693|102013284|FG001|COMPLETED|Overall Study||624||
48685897|NCT00251693|102013285|FG002|COMPLETED|Overall Study||644||
48685898|NCT00251693|102013283|FG000|NOT COMPLETED|Overall Study||51||
48685899|NCT00251693|102013284|FG001|NOT COMPLETED|Overall Study||44||
48685900|NCT00251693|102013285|FG002|NOT COMPLETED|Overall Study||46||
48685901|NCT03432494|102013286|FG000|STARTED|Overall Study||12||
48685902|NCT03432494|102013286|FG000|COMPLETED|Overall Study||10||
48685903|NCT03432494|102013286|FG000|NOT COMPLETED|Overall Study||2||
48685904|NCT00310375|102013287|FG000|STARTED|Primary Reporting Phase||102||
48380667|NCT02492997|101258699|FG000|COMPLETED|Overall Study||19||
48380668|NCT02492997|101258700|FG001|COMPLETED|Overall Study||20||
48380669|NCT02492997|101258699|FG000|NOT COMPLETED|Overall Study||2||
48380670|NCT02492997|101258700|FG001|NOT COMPLETED|Overall Study||1||
48380671|NCT00947752|101258701|FG000|STARTED|7-Day Run-in Treatment Period||147||
48380672|NCT00947752|101258702|FG001|STARTED|7-Day Run-in Treatment Period||0||
48380673|NCT00947752|101258701|FG000|COMPLETED|7-Day Run-in Treatment Period||147||
48380674|NCT00947752|101258702|FG001|COMPLETED|7-Day Run-in Treatment Period||0||
48380675|NCT00947752|101258701|FG000|NOT COMPLETED|7-Day Run-in Treatment Period||0||
48380676|NCT00947752|101258702|FG001|NOT COMPLETED|7-Day Run-in Treatment Period||0||
48380677|NCT00947752|101258701|FG000|STARTED|1st 14-day Treatment Period||76||
48380678|NCT00947752|101258702|FG001|STARTED|1st 14-day Treatment Period||71||
48380679|NCT00947752|101258701|FG000|COMPLETED|1st 14-day Treatment Period||76||
48380680|NCT00947752|101258702|FG001|COMPLETED|1st 14-day Treatment Period||71||
48380681|NCT00947752|101258701|FG000|NOT COMPLETED|1st 14-day Treatment Period||0||
48380682|NCT00947752|101258702|FG001|NOT COMPLETED|1st 14-day Treatment Period||0||
48380683|NCT00947752|101258701|FG000|STARTED|Crossover to 2nd 14-day Treatment Period||71||
48380684|NCT00947752|101258702|FG001|STARTED|Crossover to 2nd 14-day Treatment Period||76||
48380685|NCT00947752|101258701|FG000|COMPLETED|Crossover to 2nd 14-day Treatment Period||71||
48380686|NCT00947752|101258702|FG001|COMPLETED|Crossover to 2nd 14-day Treatment Period||76||
48380687|NCT00947752|101258701|FG000|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0||
48380688|NCT00947752|101258702|FG001|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0||
48380689|NCT00677690|101258703|FG000|STARTED|Overall Study||42||
48380690|NCT00677690|101258704|FG001|STARTED|Overall Study||41||
48380691|NCT00677690|101258703|FG000|COMPLETED|Overall Study||42||
48380692|NCT00677690|101258704|FG001|COMPLETED|Overall Study||41||
48380693|NCT00677690|101258703|FG000|NOT COMPLETED|Overall Study||0||
48380694|NCT00677690|101258704|FG001|NOT COMPLETED|Overall Study||0||
48380695|NCT01072539|101258705|FG000|STARTED|Overall Study||3172||
48380696|NCT01072539|101258705|FG000|COMPLETED|Overall Study||3169||
48380697|NCT01072539|101258705|FG000|NOT COMPLETED|Overall Study||3||
48380698|NCT02625324|101258706|FG000|STARTED|30-Day Follow-up for Primary Endpoint||87||
48380699|NCT02625324|101258706|FG000|COMPLETED|30-Day Follow-up for Primary Endpoint||86||
48380700|NCT02625324|101258706|FG000|NOT COMPLETED|30-Day Follow-up for Primary Endpoint||1||
48380701|NCT02625324|101258706|FG000|STARTED|30-Day Follow-up for Secondary Endpoint||100||
48380702|NCT02625324|101258706|FG000|COMPLETED|30-Day Follow-up for Secondary Endpoint||99||
48380703|NCT02625324|101258706|FG000|NOT COMPLETED|30-Day Follow-up for Secondary Endpoint||1||
48380704|NCT02625324|101258706|FG000|STARTED|6-Month Follow-up Subject Accountability||99||
48380705|NCT02625324|101258706|FG000|COMPLETED|6-Month Follow-up Subject Accountability||91||
48380706|NCT02625324|101258706|FG000|NOT COMPLETED|6-Month Follow-up Subject Accountability||8||
48380707|NCT02625324|101258706|FG000|STARTED|12-Month Follow-up Secondary Endpoint||91||
48380708|NCT02625324|101258706|FG000|COMPLETED|12-Month Follow-up Secondary Endpoint||87||
48380709|NCT02625324|101258706|FG000|NOT COMPLETED|12-Month Follow-up Secondary Endpoint||4||
48380710|NCT02625324|101258706|FG000|STARTED|24-Month Follow-up Secondary Endpoint||87||
48685905|NCT00310375|102013288|FG001|STARTED|Primary Reporting Phase||79||
48685906|NCT00310375|102013289|FG002|STARTED|Primary Reporting Phase||0||
48685907|NCT00310375|102013287|FG000|COMPLETED|Primary Reporting Phase||11||
48685908|NCT00310375|102013288|FG001|COMPLETED|Primary Reporting Phase||11||
48685909|NCT00310375|102013289|FG002|COMPLETED|Primary Reporting Phase||0||
48685910|NCT00310375|102013287|FG000|NOT COMPLETED|Primary Reporting Phase||91||
48685911|NCT00310375|102013288|FG001|NOT COMPLETED|Primary Reporting Phase||68||
48685912|NCT00310375|102013289|FG002|NOT COMPLETED|Primary Reporting Phase||0||
48685913|NCT00310375|102013287|FG000|STARTED|Safety Follow-up Continuation Phase||0||
48380711|NCT02625324|101258706|FG000|COMPLETED|24-Month Follow-up Secondary Endpoint||52||
48380712|NCT02625324|101258706|FG000|NOT COMPLETED|24-Month Follow-up Secondary Endpoint||35||
48380713|NCT02625324|101258706|FG000|STARTED|36-Month Follow-up Secondary Endpoint||52||
48380714|NCT02625324|101258706|FG000|COMPLETED|36-Month Follow-up Secondary Endpoint||48||
48380715|NCT02625324|101258706|FG000|NOT COMPLETED|36-Month Follow-up Secondary Endpoint||4||
48380716|NCT02625324|101258706|FG000|STARTED|48-Month Follow-up Secondary Endpoint||48||
48380717|NCT02625324|101258706|FG000|COMPLETED|48-Month Follow-up Secondary Endpoint||42||
48380718|NCT02625324|101258706|FG000|NOT COMPLETED|48-Month Follow-up Secondary Endpoint||6||
48380719|NCT02625324|101258706|FG000|STARTED|60-Month Follow-up Secondary Endpoint||42||
48685914|NCT00310375|102013288|FG001|STARTED|Safety Follow-up Continuation Phase||0||
48685915|NCT00310375|102013289|FG002|STARTED|Safety Follow-up Continuation Phase||19||
48685916|NCT00310375|102013287|FG000|COMPLETED|Safety Follow-up Continuation Phase||0||
48685917|NCT00310375|102013288|FG001|COMPLETED|Safety Follow-up Continuation Phase||0||
48685918|NCT00310375|102013289|FG002|COMPLETED|Safety Follow-up Continuation Phase||18||
48685919|NCT00310375|102013287|FG000|NOT COMPLETED|Safety Follow-up Continuation Phase||0||
48685920|NCT00310375|102013288|FG001|NOT COMPLETED|Safety Follow-up Continuation Phase||0||
48685921|NCT00310375|102013289|FG002|NOT COMPLETED|Safety Follow-up Continuation Phase||1||
48685922|NCT03542019|102013290|FG000|STARTED|Overall Study||20||
48685923|NCT03542019|102013291|FG001|STARTED|Overall Study||20||
48685924|NCT03542019|102013292|FG002|STARTED|Overall Study||20||
48685925|NCT03542019|102013290|FG000|COMPLETED|Overall Study||19||
48685926|NCT03542019|102013291|FG001|COMPLETED|Overall Study||17||
48685927|NCT03542019|102013292|FG002|COMPLETED|Overall Study||19||
48685928|NCT03542019|102013290|FG000|NOT COMPLETED|Overall Study||1||
48685929|NCT03542019|102013291|FG001|NOT COMPLETED|Overall Study||3||
48685930|NCT03542019|102013292|FG002|NOT COMPLETED|Overall Study||1||
48685931|NCT01853462|102013293|FG000|STARTED|Overall Study||11||
48685932|NCT01853462|102013294|FG001|STARTED|Overall Study||11||
48685933|NCT01853462|102013293|FG000|COMPLETED|Overall Study||10||
48685934|NCT01853462|102013294|FG001|COMPLETED|Overall Study||10||
48685935|NCT01853462|102013293|FG000|NOT COMPLETED|Overall Study||1||
48685936|NCT01853462|102013294|FG001|NOT COMPLETED|Overall Study||1||
48685937|NCT00343564|102013295|FG000|STARTED|Overall Study||6||
48685938|NCT00343564|102013296|FG001|STARTED|Overall Study||7||
48685939|NCT00343564|102013297|FG002|STARTED|Overall Study||3||
48685940|NCT00343564|102013298|FG003|STARTED|Overall Study||7||
48685941|NCT00343564|102013299|FG004|STARTED|Overall Study||10||
48685942|NCT00343564|102013300|FG005|STARTED|Overall Study||9||
48685943|NCT00343564|102013301|FG006|STARTED|Overall Study||4||
48685944|NCT00343564|102013302|FG007|STARTED|Overall Study||3||
48685945|NCT00343564|102013303|FG008|STARTED|Overall Study||3||
48685946|NCT00343564|102013304|FG009|STARTED|Overall Study||8||
48685947|NCT00343564|102013305|FG010|STARTED|Overall Study||8||
48685948|NCT00343564|102013295|FG000|COMPLETED|Overall Study||6||
48685949|NCT00343564|102013296|FG001|COMPLETED|Overall Study||7||
48685950|NCT00343564|102013297|FG002|COMPLETED|Overall Study||3||
48380720|NCT02625324|101258706|FG000|COMPLETED|60-Month Follow-up Secondary Endpoint||36||
48380721|NCT02625324|101258706|FG000|NOT COMPLETED|60-Month Follow-up Secondary Endpoint||6||
48380722|NCT00736580|101258707|FG000|STARTED|Overall Study||117||
48380723|NCT00736580|101258708|FG001|STARTED|Overall Study||123||
48380724|NCT00736580|101258707|FG000|COMPLETED|Overall Study||117||
48380725|NCT00736580|101258708|FG001|COMPLETED|Overall Study||123||
48380726|NCT00736580|101258707|FG000|NOT COMPLETED|Overall Study||0||
48380727|NCT00736580|101258708|FG001|NOT COMPLETED|Overall Study||0||
48380728|NCT01826422|101258709|FG000|STARTED|Overall Study||18||
48380729|NCT01826422|101258710|FG001|STARTED|Overall Study||22||
48380730|NCT01826422|101258709|FG000|COMPLETED|Overall Study||17||
48380731|NCT01826422|101258710|FG001|COMPLETED|Overall Study||19||
48685951|NCT00343564|102013298|FG003|COMPLETED|Overall Study||7||
48685952|NCT00343564|102013299|FG004|COMPLETED|Overall Study||10||
48685953|NCT00343564|102013300|FG005|COMPLETED|Overall Study||9||
48685954|NCT00343564|102013301|FG006|COMPLETED|Overall Study||4||
48685955|NCT00343564|102013302|FG007|COMPLETED|Overall Study||3||
48685956|NCT00343564|102013303|FG008|COMPLETED|Overall Study||3||
48685957|NCT00343564|102013304|FG009|COMPLETED|Overall Study||8||
48685958|NCT00343564|102013305|FG010|COMPLETED|Overall Study||8||
48685959|NCT00343564|102013295|FG000|NOT COMPLETED|Overall Study||0||
48685960|NCT00343564|102013296|FG001|NOT COMPLETED|Overall Study||0||
48685961|NCT00343564|102013297|FG002|NOT COMPLETED|Overall Study||0||
48685962|NCT00343564|102013298|FG003|NOT COMPLETED|Overall Study||0||
48380732|NCT01826422|101258709|FG000|NOT COMPLETED|Overall Study||1||
48380733|NCT01826422|101258710|FG001|NOT COMPLETED|Overall Study||3||
48380734|NCT00555048|101258711|FG000|STARTED|Overall Study||1||
48380735|NCT00555048|101258711|FG000|COMPLETED|Overall Study||1||
48380736|NCT00555048|101258711|FG000|NOT COMPLETED|Overall Study||0||
48380737|NCT01113398|101258712|FG000|STARTED|Overall Study||36||
48685963|NCT00343564|102013299|FG004|NOT COMPLETED|Overall Study||0||
48685964|NCT00343564|102013300|FG005|NOT COMPLETED|Overall Study||0||
48685965|NCT00343564|102013301|FG006|NOT COMPLETED|Overall Study||0||
48685966|NCT00343564|102013302|FG007|NOT COMPLETED|Overall Study||0||
48685967|NCT00343564|102013303|FG008|NOT COMPLETED|Overall Study||0||
48685968|NCT00343564|102013304|FG009|NOT COMPLETED|Overall Study||0||
48685969|NCT00343564|102013305|FG010|NOT COMPLETED|Overall Study||0||
48685970|NCT00763256|102013306|FG000|STARTED|Overall Study||15||
48685971|NCT00763256|102013307|FG001|STARTED|Overall Study||18||
48685972|NCT00763256|102013306|FG000|COMPLETED|Overall Study||8||
48685973|NCT00763256|102013307|FG001|COMPLETED|Overall Study||8||
48685974|NCT00763256|102013306|FG000|NOT COMPLETED|Overall Study||7||
48685975|NCT00763256|102013307|FG001|NOT COMPLETED|Overall Study||10||
48380738|NCT01113398|101258712|FG000|COMPLETED|Overall Study||36||
48380739|NCT01113398|101258712|FG000|NOT COMPLETED|Overall Study||0||
48685976|NCT01964378|102013308|FG000|STARTED|Overall Study||66|All allocated participants|
48090043|NCT03338855|100541305|FG000|STARTED|Overall Study||12||
48090044|NCT03338855|100541306|FG001|STARTED|Overall Study||14||
48090045|NCT03338855|100541305|FG000|Received Treatment in Period 1|Overall Study||12||
48090046|NCT03338855|100541306|FG001|Received Treatment in Period 1|Overall Study||14||
48380740|NCT00444626|101258713|FG000|STARTED|Initial Treatment Period||140||
48380741|NCT00444626|101258713|FG000|COMPLETED|Initial Treatment Period||128||
48380742|NCT00444626|101258713|FG000|NOT COMPLETED|Initial Treatment Period||12||
48685977|NCT01964378|102013309|FG001|STARTED|Overall Study||66|All allocated participants|
48685978|NCT01964378|102013308|FG000|Participants Treated (Safety Set)|Overall Study||65||
48685979|NCT01964378|102013309|FG001|Participants Treated (Safety Set)|Overall Study||61||
48090047|NCT03338855|100541305|FG000|Received Treatment in Period 2|Overall Study||11||
48090048|NCT03338855|100541306|FG001|Received Treatment in Period 2|Overall Study||14||
48380743|NCT00444626|101258713|FG000|STARTED|Repeat Treatment Period||105||
48380744|NCT00444626|101258713|FG000|COMPLETED|Repeat Treatment Period||105||
48685980|NCT01964378|102013308|FG000|COMPLETED|Overall Study||41||
48685981|NCT01964378|102013309|FG001|COMPLETED|Overall Study||45||
48685982|NCT01964378|102013308|FG000|NOT COMPLETED|Overall Study||25||
48685983|NCT01964378|102013309|FG001|NOT COMPLETED|Overall Study||21||
48685984|NCT00120627|102013310|FG000|STARTED|Overall Study||71||
48685985|NCT00120627|102013311|FG001|STARTED|Overall Study||75||
48685986|NCT00120627|102013310|FG000|Began Interventions|Overall Study||69||
48380745|NCT00444626|101258713|FG000|NOT COMPLETED|Repeat Treatment Period||0||
48380746|NCT01700517|101258714|FG000|STARTED|Overall Study||40||
48380747|NCT01700517|101258715|FG001|STARTED|Overall Study||40||
48380748|NCT01700517|101258716|FG002|STARTED|Overall Study||40||
48380749|NCT01700517|101258714|FG000|COMPLETED|Overall Study||40||
48380750|NCT01700517|101258715|FG001|COMPLETED|Overall Study||40||
48380751|NCT01700517|101258716|FG002|COMPLETED|Overall Study||40||
48380752|NCT01700517|101258714|FG000|NOT COMPLETED|Overall Study||0||
48380753|NCT01700517|101258715|FG001|NOT COMPLETED|Overall Study||0||
48380754|NCT01700517|101258716|FG002|NOT COMPLETED|Overall Study||0||
48380755|NCT04167306|101258717|FG000|STARTED|Overall Study||97||
48380756|NCT04167306|101258718|FG001|STARTED|Overall Study||101||
48380757|NCT04167306|101258719|FG002|STARTED|Overall Study||93||
48380758|NCT04167306|101258720|FG003|STARTED|Overall Study||97||
48380759|NCT04167306|101258717|FG000|Correct Randomized , Received IMP|Overall Study||96|correctly randomized subjects that commenced study drug|
48380760|NCT04167306|101258718|FG001|Correct Randomized , Received IMP|Overall Study||100|correctly randomized subjects that commenced study drug|
48380761|NCT04167306|101258719|FG002|Correct Randomized , Received IMP|Overall Study||91|correctly randomized subjects that commenced study drug|
48380762|NCT04167306|101258720|FG003|Correct Randomized , Received IMP|Overall Study||97|correctly randomized subjects that commenced study drug|
48380763|NCT04167306|101258717|FG000|COMPLETED|Overall Study||76||
48380764|NCT04167306|101258718|FG001|COMPLETED|Overall Study||73||
48380765|NCT04167306|101258719|FG002|COMPLETED|Overall Study||67||
48380766|NCT04167306|101258720|FG003|COMPLETED|Overall Study||81||
48380767|NCT04167306|101258717|FG000|NOT COMPLETED|Overall Study||21||
48380768|NCT04167306|101258718|FG001|NOT COMPLETED|Overall Study||28||
48380769|NCT04167306|101258719|FG002|NOT COMPLETED|Overall Study||26||
48380770|NCT04167306|101258720|FG003|NOT COMPLETED|Overall Study||16||
48380771|NCT00296725|101258721|FG000|STARTED|Phase 1: Fluoxetine (1-12 Weeks)||17|Follow reviewers suggestion, added 2 periods to avoid double counting. Period 1 started with 17|
48380772|NCT00296725|101258721|FG000|COMPLETED|Phase 1: Fluoxetine (1-12 Weeks)||12||
48685987|NCT00120627|102013311|FG001|Began Interventions|Overall Study||73||
48685988|NCT00120627|102013310|FG000|Did Not Complete Post-tx Assessments|Overall Study||3||
48685989|NCT00120627|102013311|FG001|Did Not Complete Post-tx Assessments|Overall Study||3||
48685990|NCT00120627|102013310|FG000|COMPLETED|Overall Study||66||
48685991|NCT00120627|102013311|FG001|COMPLETED|Overall Study||70||
48685992|NCT00120627|102013310|FG000|NOT COMPLETED|Overall Study||5||
48685993|NCT00120627|102013311|FG001|NOT COMPLETED|Overall Study||5||
48685994|NCT03036852|102013312|FG000|STARTED|Overall Study||59||
48090049|NCT03338855|100541305|FG000|COMPLETED|Overall Study||11||
48090050|NCT03338855|100541306|FG001|COMPLETED|Overall Study||14||
48090051|NCT03338855|100541305|FG000|NOT COMPLETED|Overall Study||1||
48090052|NCT03338855|100541306|FG001|NOT COMPLETED|Overall Study||0||
48090053|NCT01314443|100541307|FG000|STARTED|Overall Study||18||
48090054|NCT01314443|100541308|FG001|STARTED|Overall Study||19||
48090055|NCT01314443|100541309|FG002|STARTED|Overall Study||15||
48090056|NCT01314443|100541310|FG003|STARTED|Overall Study||15||
48090057|NCT01314443|100541307|FG000|COMPLETED|Overall Study||14||
48090058|NCT01314443|100541308|FG001|COMPLETED|Overall Study||16||
48090059|NCT01314443|100541309|FG002|COMPLETED|Overall Study||13||
48090060|NCT01314443|100541310|FG003|COMPLETED|Overall Study||13||
48090061|NCT01314443|100541307|FG000|NOT COMPLETED|Overall Study||4||
48090062|NCT01314443|100541308|FG001|NOT COMPLETED|Overall Study||3||
48254141|NCT01845649|100940188|FG001|STARTED|Overall Study||277||
48254142|NCT01845649|100940187|FG000|Safety Population|Overall Study||271||
48254143|NCT01845649|100940188|FG001|Safety Population|Overall Study||277||
48254144|NCT01845649|100940187|FG000|Modified Intent-to-treat (mITT) Population|Overall Study||233||
48254145|NCT01845649|100940188|FG001|Modified Intent-to-treat (mITT) Population|Overall Study||239||
48254146|NCT01845649|100940187|FG000|COMPLETED|Overall Study||242||
48254147|NCT01845649|100940188|FG001|COMPLETED|Overall Study||255||
48254148|NCT01845649|100940187|FG000|NOT COMPLETED|Overall Study||31||
48254149|NCT01845649|100940188|FG001|NOT COMPLETED|Overall Study||22||
48254150|NCT03121612|100940189|FG000|STARTED|Overall Study||26||
48254151|NCT03121612|100940190|FG001|STARTED|Overall Study||25||
48254152|NCT03121612|100940189|FG000|COMPLETED|Overall Study||26||
48254153|NCT03121612|100940190|FG001|COMPLETED|Overall Study||25||
48254154|NCT03121612|100940189|FG000|NOT COMPLETED|Overall Study||0||
48254155|NCT03121612|100940190|FG001|NOT COMPLETED|Overall Study||0||
48254156|NCT01410084|100940191|FG000|STARTED|Overall Study||38||
48254157|NCT01410084|100940192|FG001|STARTED|Overall Study||30||
48254158|NCT01410084|100940191|FG000|COMPLETED|Overall Study||37||
48541339|NCT03787134|101662700|FG003|NOT COMPLETED|Overall Study||0||
48541340|NCT03787134|101662701|FG004|NOT COMPLETED|Overall Study||0||
48541341|NCT03787134|101662702|FG005|NOT COMPLETED|Overall Study||0||
48541342|NCT03787134|101662703|FG006|NOT COMPLETED|Overall Study||0||
48541343|NCT02687217|101662704|FG000|STARTED|Overall Study||30||
48541344|NCT02687217|101662705|FG001|STARTED|Overall Study||30||
48541345|NCT02687217|101662704|FG000|COMPLETED|Overall Study||30||
48541346|NCT02687217|101662705|FG001|COMPLETED|Overall Study||30||
48541347|NCT02687217|101662704|FG000|NOT COMPLETED|Overall Study||0||
48541348|NCT02687217|101662705|FG001|NOT COMPLETED|Overall Study||0||
48541349|NCT03417687|101662706|FG000|STARTED|Overall Study||18||
48685995|NCT03036852|102013312|FG000|COMPLETED|Overall Study||53||
48685996|NCT03036852|102013312|FG000|NOT COMPLETED|Overall Study||6||
48685997|NCT04466384|102013313|FG000|STARTED|First Phase||14||
48685998|NCT04466384|102013314|FG001|STARTED|First Phase||10||
48685999|NCT04466384|102013313|FG000|COMPLETED|First Phase||12||
48686000|NCT04466384|102013314|FG001|COMPLETED|First Phase||10||
48090063|NCT01314443|100541309|FG002|NOT COMPLETED|Overall Study||2||
48090064|NCT01314443|100541310|FG003|NOT COMPLETED|Overall Study||2||
48541350|NCT03417687|101662707|FG001|STARTED|Overall Study||20||
48541351|NCT03417687|101662706|FG000|Received 129Xe|Overall Study||14||
48541352|NCT03417687|101662707|FG001|Received 129Xe|Overall Study||20||
48541353|NCT03417687|101662706|FG000|Received 133Xe|Overall Study||13||
48541354|NCT03417687|101662707|FG001|Received 133Xe|Overall Study||20||
48090065|NCT00793403|100541311|FG000|STARTED|Overall Study||293||
48090066|NCT00793403|100541311|FG000|COMPLETED|Overall Study||220||
48090067|NCT00793403|100541311|FG000|NOT COMPLETED|Overall Study||73||
48090068|NCT02643082|100541312|FG000|STARTED|Period 1||10||
48090069|NCT02643082|100541313|FG001|STARTED|Period 1||10||
48090070|NCT02643082|100541312|FG000|COMPLETED|Period 1||9||
48090071|NCT02643082|100541313|FG001|COMPLETED|Period 1||10||
48090072|NCT02643082|100541312|FG000|NOT COMPLETED|Period 1||1||
48090073|NCT02643082|100541313|FG001|NOT COMPLETED|Period 1||0||
48090074|NCT02643082|100541312|FG000|STARTED|Washout||9||
48090075|NCT02643082|100541313|FG001|STARTED|Washout||10||
48090076|NCT02643082|100541312|FG000|COMPLETED|Washout||9||
48090077|NCT02643082|100541313|FG001|COMPLETED|Washout||10||
48090078|NCT02643082|100541312|FG000|NOT COMPLETED|Washout||0||
48090079|NCT02643082|100541313|FG001|NOT COMPLETED|Washout||0||
48090080|NCT02643082|100541312|FG000|STARTED|Period 2||9||
48090081|NCT02643082|100541313|FG001|STARTED|Period 2||10||
48090082|NCT02643082|100541312|FG000|COMPLETED|Period 2||9||
48090083|NCT02643082|100541313|FG001|COMPLETED|Period 2||10||
48090084|NCT02643082|100541312|FG000|NOT COMPLETED|Period 2||0||
48090085|NCT02643082|100541313|FG001|NOT COMPLETED|Period 2||0||
48254159|NCT01410084|100940192|FG001|COMPLETED|Overall Study||27||
48254160|NCT01410084|100940191|FG000|NOT COMPLETED|Overall Study||1||
48254161|NCT01410084|100940192|FG001|NOT COMPLETED|Overall Study||3||
48254162|NCT00618917|100940193|FG000|STARTED|Overall Study||4||
48541355|NCT03417687|101662706|FG000|COMPLETED|Overall Study||14||
48541356|NCT03417687|101662707|FG001|COMPLETED|Overall Study||20||
48541357|NCT03417687|101662706|FG000|NOT COMPLETED|Overall Study||4||
48541358|NCT03417687|101662707|FG001|NOT COMPLETED|Overall Study||0||
48686001|NCT04466384|102013313|FG000|NOT COMPLETED|First Phase||2||
48090086|NCT01698801|100541314|FG000|STARTED|Treatment Phase||26||
48090087|NCT01698801|100541314|FG000|COMPLETED|Treatment Phase||15||
48090088|NCT01698801|100541314|FG000|NOT COMPLETED|Treatment Phase||11||
48090089|NCT01698801|100541314|FG000|STARTED|Follow Up Phase||11||
48090090|NCT01698801|100541314|FG000|COMPLETED|Follow Up Phase||6||
48090091|NCT01698801|100541314|FG000|NOT COMPLETED|Follow Up Phase||5||
48090092|NCT01943292|100541315|FG000|STARTED|Overall Study||3||
48090093|NCT01943292|100541316|FG001|STARTED|Overall Study||3||
48090094|NCT01943292|100541317|FG002|STARTED|Overall Study||3||
48254163|NCT00618917|100940194|FG001|STARTED|Overall Study||3||
48254164|NCT00618917|100940195|FG002|STARTED|Overall Study||11||
48686002|NCT04466384|102013314|FG001|NOT COMPLETED|First Phase||0||
48686003|NCT04466384|102013313|FG000|STARTED|Cross Over Phase||14||
48686004|NCT04466384|102013314|FG001|STARTED|Cross Over Phase||10||
48686005|NCT04466384|102013313|FG000|COMPLETED|Cross Over Phase||13||
48686006|NCT04466384|102013314|FG001|COMPLETED|Cross Over Phase||9||
48686007|NCT04466384|102013313|FG000|NOT COMPLETED|Cross Over Phase||1||
48686008|NCT04466384|102013314|FG001|NOT COMPLETED|Cross Over Phase||1||
48686009|NCT02553928|102013315|FG000|STARTED|Overall Study||30||
48686010|NCT02553928|102013316|FG001|STARTED|Overall Study||32||
48686011|NCT02553928|102013315|FG000|COMPLETED|Overall Study||28||
48686012|NCT02553928|102013316|FG001|COMPLETED|Overall Study||29||
48686013|NCT02553928|102013315|FG000|NOT COMPLETED|Overall Study||2||
48686014|NCT02553928|102013316|FG001|NOT COMPLETED|Overall Study||3||
48686015|NCT02948582|102013317|FG000|STARTED|Treatment Period 1||7||
48254165|NCT00618917|100940193|FG000|COMPLETED|Overall Study||3||
48254166|NCT00618917|100940194|FG001|COMPLETED|Overall Study||3||
48254167|NCT00618917|100940195|FG002|COMPLETED|Overall Study||11||
48254168|NCT00618917|100940193|FG000|NOT COMPLETED|Overall Study||1||
48254169|NCT00618917|100940194|FG001|NOT COMPLETED|Overall Study||0||
48254170|NCT00618917|100940195|FG002|NOT COMPLETED|Overall Study||0||
48254171|NCT00264498|100940196|FG000|STARTED|Randomized Treatment||17||
48254172|NCT00264498|100940197|FG001|STARTED|Randomized Treatment||18||
48254173|NCT00264498|100940196|FG000|COMPLETED|Randomized Treatment||0||
48254174|NCT00264498|100940197|FG001|COMPLETED|Randomized Treatment||0||
48254175|NCT00264498|100940196|FG000|NOT COMPLETED|Randomized Treatment||17||
48254176|NCT00264498|100940197|FG001|NOT COMPLETED|Randomized Treatment||18||
48254177|NCT00264498|100940196|FG000|STARTED|Crossover Treatment||6||
48254178|NCT00264498|100940197|FG001|STARTED|Crossover Treatment||9||
48254179|NCT00264498|100940196|FG000|COMPLETED|Crossover Treatment||0||
48254180|NCT00264498|100940197|FG001|COMPLETED|Crossover Treatment||0||
48254181|NCT00264498|100940196|FG000|NOT COMPLETED|Crossover Treatment||6||
48254182|NCT00264498|100940197|FG001|NOT COMPLETED|Crossover Treatment||9||
48254183|NCT01797562|100940198|FG000|STARTED|Overall Study||116||
48254184|NCT01797562|100940198|FG000|COMPLETED|Overall Study||111||
48254185|NCT01797562|100940198|FG000|NOT COMPLETED|Overall Study||5||
48254186|NCT00420147|100940199|FG000|STARTED|Overall Study||19||
48254187|NCT00420147|100940200|FG001|STARTED|Overall Study||19||
48254188|NCT00420147|100940199|FG000|COMPLETED|Overall Study||19||
48254189|NCT00420147|100940200|FG001|COMPLETED|Overall Study||19||
48254190|NCT00420147|100940199|FG000|NOT COMPLETED|Overall Study||0||
48254191|NCT00420147|100940200|FG001|NOT COMPLETED|Overall Study||0||
48254192|NCT02381652|100940201|FG000|STARTED|Overall Study||94|Safety Population and Intent to Treat Population consisted of all enrolled subjects|
48254193|NCT02381652|100940202|FG001|STARTED|Overall Study||98|Safety Population and Intent to Treat Population consisted of all enrolled subjects|
48254194|NCT02381652|100940203|FG002|STARTED|Overall Study||50|Safety Population and Intent to Treat Population consisted of all enrolled subjects|
48254195|NCT02381652|100940201|FG000|COMPLETED|Overall Study||94||
48254196|NCT02381652|100940202|FG001|COMPLETED|Overall Study||98||
48254197|NCT02381652|100940203|FG002|COMPLETED|Overall Study||49||
48254198|NCT02381652|100940201|FG000|NOT COMPLETED|Overall Study||0||
48254199|NCT02381652|100940202|FG001|NOT COMPLETED|Overall Study||0||
48254200|NCT02381652|100940203|FG002|NOT COMPLETED|Overall Study||1||
48254201|NCT04269434|100940204|FG000|STARTED|Overall Study||506|First Participant First Visit (FPFV)|
48254202|NCT04269434|100940205|FG001|STARTED|Overall Study||508|First Participant First Visit (FPFV)|
48254203|NCT04269434|100940204|FG000|COMPLETED|Overall Study||439|Last Participant Last Visit (LPLV)|
48254204|NCT04269434|100940205|FG001|COMPLETED|Overall Study||440|Last Participant Last Visit (LPLV)|
48254205|NCT04269434|100940204|FG000|NOT COMPLETED|Overall Study||67||
48254206|NCT04269434|100940205|FG001|NOT COMPLETED|Overall Study||68||
48254207|NCT03443063|100940206|FG000|STARTED|Overall Study||8||
48686016|NCT02948582|102013318|FG001|STARTED|Treatment Period 1||7||
48686017|NCT02948582|102013319|FG002|STARTED|Treatment Period 1||7||
48686018|NCT02948582|102013320|FG003|STARTED|Treatment Period 1||7||
48686019|NCT02948582|102013321|FG004|STARTED|Treatment Period 1||7||
48686020|NCT02948582|102013322|FG005|STARTED|Treatment Period 1||7||
48686021|NCT02948582|102013317|FG000|COMPLETED|Treatment Period 1||7||
48686022|NCT02948582|102013318|FG001|COMPLETED|Treatment Period 1||7||
48686023|NCT02948582|102013319|FG002|COMPLETED|Treatment Period 1||7||
48686024|NCT02948582|102013320|FG003|COMPLETED|Treatment Period 1||7||
48686025|NCT02948582|102013321|FG004|COMPLETED|Treatment Period 1||7||
48686026|NCT02948582|102013322|FG005|COMPLETED|Treatment Period 1||7||
48686027|NCT02948582|102013317|FG000|NOT COMPLETED|Treatment Period 1||0||
48686028|NCT02948582|102013318|FG001|NOT COMPLETED|Treatment Period 1||0||
48686029|NCT02948582|102013319|FG002|NOT COMPLETED|Treatment Period 1||0||
48686030|NCT02948582|102013320|FG003|NOT COMPLETED|Treatment Period 1||0||
48686031|NCT02948582|102013321|FG004|NOT COMPLETED|Treatment Period 1||0||
48686032|NCT02948582|102013322|FG005|NOT COMPLETED|Treatment Period 1||0||
48686033|NCT02948582|102013317|FG000|STARTED|Washout Period 1||7||
48686034|NCT02948582|102013318|FG001|STARTED|Washout Period 1||7||
48254208|NCT03443063|100940207|FG001|STARTED|Overall Study||8||
48686035|NCT02948582|102013319|FG002|STARTED|Washout Period 1||7||
48686036|NCT02948582|102013320|FG003|STARTED|Washout Period 1||7||
48686037|NCT02948582|102013321|FG004|STARTED|Washout Period 1||7||
48686038|NCT02948582|102013322|FG005|STARTED|Washout Period 1||7||
48686039|NCT02948582|102013317|FG000|COMPLETED|Washout Period 1||7||
48686040|NCT02948582|102013318|FG001|COMPLETED|Washout Period 1||5||
48686041|NCT02948582|102013319|FG002|COMPLETED|Washout Period 1||7||
48686042|NCT02948582|102013320|FG003|COMPLETED|Washout Period 1||7||
48686043|NCT02948582|102013321|FG004|COMPLETED|Washout Period 1||7||
48686044|NCT02948582|102013322|FG005|COMPLETED|Washout Period 1||6||
48686045|NCT02948582|102013317|FG000|NOT COMPLETED|Washout Period 1||0||
48686046|NCT02948582|102013318|FG001|NOT COMPLETED|Washout Period 1||2||
48686047|NCT02948582|102013319|FG002|NOT COMPLETED|Washout Period 1||0||
48686048|NCT02948582|102013320|FG003|NOT COMPLETED|Washout Period 1||0||
48686049|NCT02948582|102013321|FG004|NOT COMPLETED|Washout Period 1||0||
48686050|NCT02948582|102013322|FG005|NOT COMPLETED|Washout Period 1||1||
48686051|NCT02948582|102013317|FG000|STARTED|Treatment Period 2||7||
48254209|NCT03443063|100940206|FG000|COMPLETED|Overall Study||8||
48254210|NCT03443063|100940207|FG001|COMPLETED|Overall Study||8||
48254211|NCT03443063|100940206|FG000|NOT COMPLETED|Overall Study||0||
48686052|NCT02948582|102013318|FG001|STARTED|Treatment Period 2||5||
48686053|NCT02948582|102013319|FG002|STARTED|Treatment Period 2||7||
48686054|NCT02948582|102013320|FG003|STARTED|Treatment Period 2||7||
48686055|NCT02948582|102013321|FG004|STARTED|Treatment Period 2||7||
48254212|NCT03443063|100940207|FG001|NOT COMPLETED|Overall Study||0||
48254213|NCT01223963|100940208|FG000|STARTED|Overall Study||93||
48254214|NCT01223963|100940208|FG000|COMPLETED|Overall Study||93||
48254215|NCT01223963|100940208|FG000|NOT COMPLETED|Overall Study||0||
48254216|NCT00874497|100940209|FG000|STARTED|Overall Study||51||
48254217|NCT00874497|100940210|FG001|STARTED|Overall Study||33||
48254218|NCT00874497|100940209|FG000|COMPLETED|Overall Study||23||
48254219|NCT00874497|100940210|FG001|COMPLETED|Overall Study||15||
48254220|NCT00874497|100940209|FG000|NOT COMPLETED|Overall Study||28||
48254221|NCT00874497|100940210|FG001|NOT COMPLETED|Overall Study||18||
48380773|NCT00296725|101258721|FG000|NOT COMPLETED|Phase 1: Fluoxetine (1-12 Weeks)||5||
48380774|NCT00296725|101258721|FG000|STARTED|Phase 2: Imipramine (1-6 Weeks)||8|8 participants available and eligible to participate in period 2|
48380775|NCT00296725|101258721|FG000|COMPLETED|Phase 2: Imipramine (1-6 Weeks)||7||
48380776|NCT00296725|101258721|FG000|NOT COMPLETED|Phase 2: Imipramine (1-6 Weeks)||1||
48380777|NCT01188564|101258722|FG000|STARTED|Double-blind Phase||44||
48380778|NCT01188564|101258723|FG001|STARTED|Double-blind Phase||31||
48380779|NCT01188564|101258722|FG000|COMPLETED|Double-blind Phase||43||
48380780|NCT01188564|101258723|FG001|COMPLETED|Double-blind Phase||31||
48380781|NCT01188564|101258722|FG000|NOT COMPLETED|Double-blind Phase||1||
48380782|NCT01188564|101258723|FG001|NOT COMPLETED|Double-blind Phase||0||
48380783|NCT01188564|101258722|FG000|STARTED|Open Label Phase||24||
48380784|NCT01188564|101258723|FG001|STARTED|Open Label Phase||20||
48380785|NCT01188564|101258722|FG000|COMPLETED|Open Label Phase||24||
48380786|NCT01188564|101258723|FG001|COMPLETED|Open Label Phase||20||
48380787|NCT01188564|101258722|FG000|NOT COMPLETED|Open Label Phase||0||
48380788|NCT01188564|101258723|FG001|NOT COMPLETED|Open Label Phase||0||
48686056|NCT02948582|102013322|FG005|STARTED|Treatment Period 2||6||
48686057|NCT02948582|102013317|FG000|COMPLETED|Treatment Period 2||7||
48686058|NCT02948582|102013318|FG001|COMPLETED|Treatment Period 2||5||
48686059|NCT02948582|102013319|FG002|COMPLETED|Treatment Period 2||7||
48686060|NCT02948582|102013320|FG003|COMPLETED|Treatment Period 2||7||
48686061|NCT02948582|102013321|FG004|COMPLETED|Treatment Period 2||7||
48686062|NCT02948582|102013322|FG005|COMPLETED|Treatment Period 2||6||
48686063|NCT02948582|102013317|FG000|NOT COMPLETED|Treatment Period 2||0||
48686064|NCT02948582|102013318|FG001|NOT COMPLETED|Treatment Period 2||0||
48686065|NCT02948582|102013319|FG002|NOT COMPLETED|Treatment Period 2||0||
48686066|NCT02948582|102013320|FG003|NOT COMPLETED|Treatment Period 2||0||
48686067|NCT02948582|102013321|FG004|NOT COMPLETED|Treatment Period 2||0||
48686068|NCT02948582|102013322|FG005|NOT COMPLETED|Treatment Period 2||0||
48686069|NCT02948582|102013317|FG000|STARTED|Washout Period 2||7||
48686070|NCT02948582|102013318|FG001|STARTED|Washout Period 2||5||
48686071|NCT02948582|102013319|FG002|STARTED|Washout Period 2||7||
48686072|NCT02948582|102013320|FG003|STARTED|Washout Period 2||7||
48686073|NCT02948582|102013321|FG004|STARTED|Washout Period 2||7||
48686074|NCT02948582|102013322|FG005|STARTED|Washout Period 2||6||
48686075|NCT02948582|102013317|FG000|COMPLETED|Washout Period 2||7||
48686076|NCT02948582|102013318|FG001|COMPLETED|Washout Period 2||4||
48686077|NCT02948582|102013319|FG002|COMPLETED|Washout Period 2||7||
48686078|NCT02948582|102013320|FG003|COMPLETED|Washout Period 2||6||
48686079|NCT02948582|102013321|FG004|COMPLETED|Washout Period 2||7||
48686080|NCT02948582|102013322|FG005|COMPLETED|Washout Period 2||6||
48686081|NCT02948582|102013317|FG000|NOT COMPLETED|Washout Period 2||0||
48686082|NCT02948582|102013318|FG001|NOT COMPLETED|Washout Period 2||1||
48254222|NCT00957996|100940211|FG000|STARTED|Overall Study||117||
48254223|NCT00957996|100940212|FG001|STARTED|Overall Study||117||
48380789|NCT01952730|101258724|FG000|STARTED|Overall Study||1||
48686083|NCT02948582|102013319|FG002|NOT COMPLETED|Washout Period 2||0||
48686084|NCT02948582|102013320|FG003|NOT COMPLETED|Washout Period 2||1||
48686085|NCT02948582|102013321|FG004|NOT COMPLETED|Washout Period 2||0||
48686086|NCT02948582|102013322|FG005|NOT COMPLETED|Washout Period 2||0||
48686087|NCT02948582|102013317|FG000|STARTED|Treatment Period 3||7||
48686088|NCT02948582|102013318|FG001|STARTED|Treatment Period 3||4||
48380790|NCT01952730|101258724|FG000|COMPLETED|Overall Study||0||
48380791|NCT01952730|101258724|FG000|NOT COMPLETED|Overall Study||1||
48380792|NCT00953043|101258725|FG000|STARTED|Overall Study||30||
48380793|NCT00953043|101258726|FG001|STARTED|Overall Study||30||
48380794|NCT00953043|101258725|FG000|COMPLETED|Overall Study||26||
48380795|NCT00953043|101258726|FG001|COMPLETED|Overall Study||28||
48380796|NCT00953043|101258725|FG000|NOT COMPLETED|Overall Study||4||
48380797|NCT00953043|101258726|FG001|NOT COMPLETED|Overall Study||2||
48380798|NCT00358917|101258727|FG000|STARTED|Overall Study||300||
48380799|NCT00358917|101258728|FG001|STARTED|Overall Study||299||
48380800|NCT00358917|101258727|FG000|COMPLETED|Overall Study||234||
48380801|NCT00358917|101258728|FG001|COMPLETED|Overall Study||230||
48380802|NCT00358917|101258727|FG000|NOT COMPLETED|Overall Study||66||
48380803|NCT00358917|101258728|FG001|NOT COMPLETED|Overall Study||69||
48380804|NCT01553916|101258729|FG000|STARTED|Overall Study||19||
48380805|NCT01553916|101258729|FG000|COMPLETED|Overall Study||16||
48380806|NCT01553916|101258729|FG000|NOT COMPLETED|Overall Study||3||
48380807|NCT01441115|101258730|FG000|STARTED|Overall Study||2||
48380808|NCT01441115|101258730|FG000|COMPLETED|Overall Study||1||
48380809|NCT01441115|101258730|FG000|NOT COMPLETED|Overall Study||1||
48380810|NCT01718509|101258731|FG000|STARTED|Overall Study||195||
48380811|NCT01718509|101258732|FG001|STARTED|Overall Study||195||
48380812|NCT01718509|101258731|FG000|COMPLETED|Overall Study||147||
48380813|NCT01718509|101258732|FG001|COMPLETED|Overall Study||147||
48380814|NCT01718509|101258731|FG000|NOT COMPLETED|Overall Study||48||
48380815|NCT01718509|101258732|FG001|NOT COMPLETED|Overall Study||48||
48380816|NCT01760941|101258733|FG000|STARTED|Overall Study||1||
48380817|NCT01760941|101258733|FG000|COMPLETED|Overall Study||1||
48380818|NCT01760941|101258733|FG000|NOT COMPLETED|Overall Study||0||
48380819|NCT00849121|101258734|FG000|STARTED|Overall Study||8||
48380820|NCT00849121|101258735|FG001|STARTED|Overall Study||9||
48380821|NCT00849121|101258734|FG000|COMPLETED|Overall Study||8||
48380822|NCT00849121|101258735|FG001|COMPLETED|Overall Study||9||
48380823|NCT00849121|101258734|FG000|NOT COMPLETED|Overall Study||0||
48380824|NCT00849121|101258735|FG001|NOT COMPLETED|Overall Study||0||
48380825|NCT00621855|101258736|FG000|STARTED|Overall Study||372||
48380826|NCT00621855|101258737|FG001|STARTED|Overall Study||371||
48380827|NCT00621855|101258738|FG002|STARTED|Overall Study||411||
48380828|NCT00621855|101258739|FG003|STARTED|Overall Study||351||
48380829|NCT00621855|101258740|FG004|STARTED|Overall Study||373||
48380830|NCT00621855|101258736|FG000|COMPLETED|Overall Study||296||
48380831|NCT00621855|101258737|FG001|COMPLETED|Overall Study||310||
48380832|NCT00621855|101258738|FG002|COMPLETED|Overall Study||330||
48380833|NCT00621855|101258739|FG003|COMPLETED|Overall Study||284||
48380834|NCT00621855|101258740|FG004|COMPLETED|Overall Study||318||
48380835|NCT00621855|101258736|FG000|NOT COMPLETED|Overall Study||76||
48380836|NCT00621855|101258737|FG001|NOT COMPLETED|Overall Study||61||
48380837|NCT00621855|101258738|FG002|NOT COMPLETED|Overall Study||81||
48380838|NCT00621855|101258739|FG003|NOT COMPLETED|Overall Study||67||
48380839|NCT00621855|101258740|FG004|NOT COMPLETED|Overall Study||55||
48380840|NCT02049749|101258741|FG000|STARTED|Overall Study||80||
48380841|NCT02049749|101258742|FG001|STARTED|Overall Study||160||
48380842|NCT02049749|101258741|FG000|COMPLETED|Overall Study||80||
48380843|NCT02049749|101258742|FG001|COMPLETED|Overall Study||160||
48380844|NCT02049749|101258741|FG000|NOT COMPLETED|Overall Study||0||
48380845|NCT02049749|101258742|FG001|NOT COMPLETED|Overall Study||0||
48380846|NCT01156597|101258743|FG000|STARTED|Overall Study||16||
48380847|NCT01156597|101258744|FG001|STARTED|Overall Study||14||
48380848|NCT01156597|101258743|FG000|COMPLETED|Overall Study||13||
48380849|NCT01156597|101258744|FG001|COMPLETED|Overall Study||13||
48380850|NCT01156597|101258743|FG000|NOT COMPLETED|Overall Study||3||
48380851|NCT01156597|101258744|FG001|NOT COMPLETED|Overall Study||1||
48380852|NCT03666858|101258745|FG000|STARTED|Cohort 1||216||
48380853|NCT03666858|101258746|FG001|STARTED|Cohort 1||0||
48380854|NCT03666858|101258745|FG000|COMPLETED|Cohort 1||215||
48380855|NCT03666858|101258746|FG001|COMPLETED|Cohort 1||0||
48380856|NCT03666858|101258745|FG000|NOT COMPLETED|Cohort 1||1||
48380857|NCT03666858|101258746|FG001|NOT COMPLETED|Cohort 1||0||
48380858|NCT03666858|101258745|FG000|STARTED|Cohort 2||0||
48380859|NCT03666858|101258746|FG001|STARTED|Cohort 2||138||
48380860|NCT03666858|101258745|FG000|COMPLETED|Cohort 2||0||
48380861|NCT03666858|101258746|FG001|COMPLETED|Cohort 2||137||
48380862|NCT03666858|101258745|FG000|NOT COMPLETED|Cohort 2||0||
48380863|NCT03666858|101258746|FG001|NOT COMPLETED|Cohort 2||1||
48380864|NCT03331666|101258747|FG000|STARTED|Overall Study||2||
48380865|NCT03331666|101258748|FG001|STARTED|Overall Study||2||
48380866|NCT03331666|101258747|FG000|COMPLETED|Overall Study||0||
48380867|NCT03331666|101258748|FG001|COMPLETED|Overall Study||0||
48380868|NCT03331666|101258747|FG000|NOT COMPLETED|Overall Study||2||
48380869|NCT03331666|101258748|FG001|NOT COMPLETED|Overall Study||2||
48380870|NCT00946530|101261495|FG000|STARTED|Overall Study||32||
48380871|NCT00946530|101261496|FG001|STARTED|Overall Study||27||
48380872|NCT00946530|101261497|FG002|STARTED|Overall Study||32||
48380873|NCT00946530|101261498|FG003|STARTED|Overall Study||27||
48380874|NCT00946530|101261495|FG000|COMPLETED|Overall Study||31||
48380875|NCT00946530|101261496|FG001|COMPLETED|Overall Study||23||
48380876|NCT00946530|101261497|FG002|COMPLETED|Overall Study||31||
48380877|NCT00946530|101261498|FG003|COMPLETED|Overall Study||23||
48380878|NCT00946530|101261495|FG000|NOT COMPLETED|Overall Study||1||
48380879|NCT00946530|101261496|FG001|NOT COMPLETED|Overall Study||4||
48380880|NCT00946530|101261497|FG002|NOT COMPLETED|Overall Study||1||
48380881|NCT00946530|101261498|FG003|NOT COMPLETED|Overall Study||4||
48380882|NCT00617409|101261499|FG000|STARTED|Overall Study||18||
48380883|NCT00617409|101261500|FG001|STARTED|Overall Study||20||
48380884|NCT00617409|101261501|FG002|STARTED|Overall Study||31||
48380885|NCT00617409|101261499|FG000|COMPLETED|Overall Study||2||
48380886|NCT00617409|101261500|FG001|COMPLETED|Overall Study||2||
48380887|NCT00617409|101261501|FG002|COMPLETED|Overall Study||4||
48380888|NCT00617409|101261499|FG000|NOT COMPLETED|Overall Study||16||
48380889|NCT00617409|101261500|FG001|NOT COMPLETED|Overall Study||18||
48380890|NCT00617409|101261501|FG002|NOT COMPLETED|Overall Study||27||
48380891|NCT02512068|101261502|FG000|STARTED|Overall Study||55||
48380892|NCT02512068|101261503|FG001|STARTED|Overall Study||52||
48380893|NCT02512068|101261502|FG000|COMPLETED|Overall Study||43||
48380894|NCT02512068|101261503|FG001|COMPLETED|Overall Study||39||
48380895|NCT02512068|101261502|FG000|NOT COMPLETED|Overall Study||12||
48380896|NCT02512068|101261503|FG001|NOT COMPLETED|Overall Study||13||
48380897|NCT05522673|101261504|FG000|STARTED|Overall Study||1||
48380898|NCT05522673|101261504|FG000|COMPLETED|Overall Study||1||
48380899|NCT05522673|101261504|FG000|NOT COMPLETED|Overall Study||0||
48380900|NCT01317667|101261505|FG000|STARTED|Overall Study||10||
48380901|NCT01317667|101261506|FG001|STARTED|Overall Study||10||
48380902|NCT01317667|101261507|FG002|STARTED|Overall Study||10||
48380903|NCT01317667|101261505|FG000|COMPLETED|Overall Study||10||
48380904|NCT01317667|101261506|FG001|COMPLETED|Overall Study||10||
48380905|NCT01317667|101261507|FG002|COMPLETED|Overall Study||10||
48380906|NCT01317667|101261505|FG000|NOT COMPLETED|Overall Study||0||
48380907|NCT01317667|101261506|FG001|NOT COMPLETED|Overall Study||0||
48380908|NCT01317667|101261507|FG002|NOT COMPLETED|Overall Study||0||
48380909|NCT02038218|101261508|FG000|STARTED|Overall Study||22|The aim of the project was that the drug was acceptable in patients with liver disease.|
48380910|NCT02038218|101261509|FG001|STARTED|Overall Study||7|The aim of the project was that the drug was acceptable in patients with liver disease.|
48380911|NCT02038218|101261508|FG000|COMPLETED|Overall Study||22|22 patients were treated|
48380912|NCT02038218|101261509|FG001|COMPLETED|Overall Study||7|22 patients were treated|
48380913|NCT02038218|101261508|FG000|NOT COMPLETED|Overall Study||0||
48380914|NCT02038218|101261509|FG001|NOT COMPLETED|Overall Study||0||
48380915|NCT03001310|101261510|FG000|STARTED|Overall Study||3||
48380916|NCT03001310|101261511|FG001|STARTED|Overall Study||12||
48380917|NCT03001310|101261512|FG002|STARTED|Overall Study||3||
48380918|NCT03001310|101261513|FG003|STARTED|Overall Study||5||
48380919|NCT03001310|101261510|FG000|COMPLETED|Overall Study||3||
48380920|NCT03001310|101261511|FG001|COMPLETED|Overall Study||12||
48380921|NCT03001310|101261512|FG002|COMPLETED|Overall Study||3||
48380922|NCT03001310|101261513|FG003|COMPLETED|Overall Study||5||
48380923|NCT03001310|101261510|FG000|NOT COMPLETED|Overall Study||0||
48380924|NCT03001310|101261511|FG001|NOT COMPLETED|Overall Study||0||
48380925|NCT03001310|101261512|FG002|NOT COMPLETED|Overall Study||0||
48380926|NCT03001310|101261513|FG003|NOT COMPLETED|Overall Study||0||
48380927|NCT03629041|101261514|FG000|STARTED|Visit 1||4||
48380928|NCT03629041|101261515|FG001|STARTED|Visit 1||4||
48380929|NCT03629041|101261516|FG002|STARTED|Visit 1||4||
48380930|NCT03629041|101261517|FG003|STARTED|Visit 1||4||
48380931|NCT03629041|101261514|FG000|COMPLETED|Visit 1||4||
48380932|NCT03629041|101261515|FG001|COMPLETED|Visit 1||4||
48380933|NCT03629041|101261516|FG002|COMPLETED|Visit 1||4||
48380934|NCT03629041|101261517|FG003|COMPLETED|Visit 1||4||
48380935|NCT03629041|101261514|FG000|NOT COMPLETED|Visit 1||0||
48380936|NCT03629041|101261515|FG001|NOT COMPLETED|Visit 1||0||
48380937|NCT03629041|101261516|FG002|NOT COMPLETED|Visit 1||0||
48380938|NCT03629041|101261517|FG003|NOT COMPLETED|Visit 1||0||
48380939|NCT03629041|101261514|FG000|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4||
48380940|NCT03629041|101261515|FG001|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4||
48380941|NCT03629041|101261516|FG002|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4||
48380942|NCT03629041|101261517|FG003|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4||
48380943|NCT03629041|101261514|FG000|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4||
48380944|NCT03629041|101261515|FG001|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||3||
48380945|NCT03629041|101261516|FG002|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4||
48380946|NCT03629041|101261517|FG003|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4||
48380947|NCT03629041|101261514|FG000|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0||
48380948|NCT03629041|101261515|FG001|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||1||
48380949|NCT03629041|101261516|FG002|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0||
48380950|NCT03629041|101261517|FG003|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0||
48380951|NCT01623531|101261518|FG000|STARTED|Overall Study||31||
48380952|NCT01623531|101261519|FG001|STARTED|Overall Study||31||
48380953|NCT01623531|101261518|FG000|COMPLETED|Overall Study||27||
48380954|NCT01623531|101261519|FG001|COMPLETED|Overall Study||29||
48380955|NCT01623531|101261518|FG000|NOT COMPLETED|Overall Study||4||
48380956|NCT01623531|101261519|FG001|NOT COMPLETED|Overall Study||2||
48380957|NCT01968954|101261520|FG000|STARTED|Overall Study||354||
48380958|NCT01968954|101261521|FG001|STARTED|Overall Study||357||
48380959|NCT01968954|101261520|FG000|Treated|Overall Study||353||
48380960|NCT01968954|101261521|FG001|Treated|Overall Study||356||
48380961|NCT01968954|101261520|FG000|COMPLETED|Overall Study||314||
48380962|NCT01968954|101261521|FG001|COMPLETED|Overall Study||314||
48380963|NCT01968954|101261520|FG000|NOT COMPLETED|Overall Study||40||
48380964|NCT01968954|101261521|FG001|NOT COMPLETED|Overall Study||43||
48380965|NCT02796391|101261522|FG000|STARTED|Overall Study||7||
48380966|NCT02796391|101261523|FG001|STARTED|Overall Study||8||
48380967|NCT02796391|101261524|FG002|STARTED|Overall Study||41||
48380968|NCT02796391|101261525|FG003|STARTED|Overall Study||32||
48380969|NCT02796391|101261526|FG004|STARTED|Overall Study||34||
48380970|NCT02796391|101261527|FG005|STARTED|Overall Study||40||
48380971|NCT02796391|101261522|FG000|COMPLETED|Overall Study||4||
48380972|NCT02796391|101261523|FG001|COMPLETED|Overall Study||5||
48380973|NCT02796391|101261524|FG002|COMPLETED|Overall Study||16||
48380974|NCT02796391|101261525|FG003|COMPLETED|Overall Study||14||
48380975|NCT02796391|101261526|FG004|COMPLETED|Overall Study||14||
48380976|NCT02796391|101261527|FG005|COMPLETED|Overall Study||20||
48380977|NCT02796391|101261522|FG000|NOT COMPLETED|Overall Study||3||
48380978|NCT02796391|101261523|FG001|NOT COMPLETED|Overall Study||3||
48380979|NCT02796391|101261524|FG002|NOT COMPLETED|Overall Study||25||
48380980|NCT02796391|101261525|FG003|NOT COMPLETED|Overall Study||18||
48380981|NCT02796391|101261526|FG004|NOT COMPLETED|Overall Study||20||
48380982|NCT02796391|101261527|FG005|NOT COMPLETED|Overall Study||20||
48380983|NCT00683475|101261528|FG000|STARTED|Overall Study||69||
48380984|NCT00683475|101261529|FG001|STARTED|Overall Study||69||
48380985|NCT00683475|101261528|FG000|Received Any Quantity of Study Drug|Overall Study||66||
48380986|NCT00683475|101261529|FG001|Received Any Quantity of Study Drug|Overall Study||66||
48380987|NCT00683475|101261528|FG000|COMPLETED|Overall Study||65||
48380988|NCT00683475|101261529|FG001|COMPLETED|Overall Study||66||
48380989|NCT00683475|101261528|FG000|NOT COMPLETED|Overall Study||4||
48380990|NCT00683475|101261529|FG001|NOT COMPLETED|Overall Study||3||
48380991|NCT05294211|101261530|FG000|STARTED|Overall Study||120||
48380992|NCT05294211|101261530|FG000|COMPLETED|Overall Study||80||
48380993|NCT05294211|101261530|FG000|NOT COMPLETED|Overall Study||40||
48380994|NCT02648724|101261531|FG000|STARTED|Overall Study||3||
48380995|NCT02648724|101261532|FG001|STARTED|Overall Study||3||
48380996|NCT02648724|101261533|FG002|STARTED|Overall Study||3||
48380997|NCT02648724|101261534|FG003|STARTED|Overall Study||3||
48380998|NCT02648724|101261535|FG004|STARTED|Overall Study||25||
48380999|NCT02648724|101261536|FG005|STARTED|Overall Study||8||
48381000|NCT02648724|101261537|FG006|STARTED|Overall Study||12||
48381001|NCT02648724|101261531|FG000|COMPLETED|Overall Study||0||
48381002|NCT02648724|101261532|FG001|COMPLETED|Overall Study||0||
48381003|NCT02648724|101261533|FG002|COMPLETED|Overall Study||0||
48381004|NCT02648724|101261534|FG003|COMPLETED|Overall Study||0||
48381005|NCT02648724|101261535|FG004|COMPLETED|Overall Study||0||
48381006|NCT02648724|101261536|FG005|COMPLETED|Overall Study||0||
48381007|NCT02648724|101261537|FG006|COMPLETED|Overall Study||0||
48381008|NCT02648724|101261531|FG000|NOT COMPLETED|Overall Study||3||
48381009|NCT02648724|101261532|FG001|NOT COMPLETED|Overall Study||3||
48381010|NCT02648724|101261533|FG002|NOT COMPLETED|Overall Study||3||
48381011|NCT02648724|101261534|FG003|NOT COMPLETED|Overall Study||3||
48381012|NCT02648724|101261535|FG004|NOT COMPLETED|Overall Study||25||
48381013|NCT02648724|101261536|FG005|NOT COMPLETED|Overall Study||8||
48381014|NCT02648724|101261537|FG006|NOT COMPLETED|Overall Study||12||
48381015|NCT03041909|101261538|FG000|STARTED|Overall Study||3||
48381016|NCT03041909|101261539|FG001|STARTED|Overall Study||1||
48381017|NCT03041909|101261540|FG002|STARTED|Overall Study||1||
48381018|NCT03041909|101261538|FG000|COMPLETED|Overall Study||3||
48381019|NCT03041909|101261539|FG001|COMPLETED|Overall Study||1||
48381020|NCT03041909|101261540|FG002|COMPLETED|Overall Study||1||
48381021|NCT03041909|101261538|FG000|NOT COMPLETED|Overall Study||0||
48381022|NCT03041909|101261539|FG001|NOT COMPLETED|Overall Study||0||
48381023|NCT03041909|101261540|FG002|NOT COMPLETED|Overall Study||0||
48381024|NCT00790738|101261541|FG000|STARTED|Overall Study||5||
48686089|NCT02948582|102013319|FG002|STARTED|Treatment Period 3||7||
48686090|NCT02948582|102013320|FG003|STARTED|Treatment Period 3||6||
48686091|NCT02948582|102013321|FG004|STARTED|Treatment Period 3||7||
48686092|NCT02948582|102013322|FG005|STARTED|Treatment Period 3||6||
48686093|NCT02948582|102013317|FG000|COMPLETED|Treatment Period 3||7||
48686094|NCT02948582|102013318|FG001|COMPLETED|Treatment Period 3||4||
48686095|NCT02948582|102013319|FG002|COMPLETED|Treatment Period 3||7||
48686096|NCT02948582|102013320|FG003|COMPLETED|Treatment Period 3||6||
48686097|NCT02948582|102013321|FG004|COMPLETED|Treatment Period 3||7||
48686098|NCT02948582|102013322|FG005|COMPLETED|Treatment Period 3||6||
48686099|NCT02948582|102013317|FG000|NOT COMPLETED|Treatment Period 3||0||
48686100|NCT02948582|102013318|FG001|NOT COMPLETED|Treatment Period 3||0||
48686101|NCT02948582|102013319|FG002|NOT COMPLETED|Treatment Period 3||0||
48686102|NCT02948582|102013320|FG003|NOT COMPLETED|Treatment Period 3||0||
48686103|NCT02948582|102013321|FG004|NOT COMPLETED|Treatment Period 3||0||
48686104|NCT02948582|102013322|FG005|NOT COMPLETED|Treatment Period 3||0||
48686105|NCT02948582|102013317|FG000|STARTED|Washout Period 3||7||
48686106|NCT02948582|102013318|FG001|STARTED|Washout Period 3||4||
48090095|NCT01943292|100541315|FG000|Completed Cycle 1|Overall Study||3||
48090096|NCT01943292|100541316|FG001|Completed Cycle 1|Overall Study||3||
48090097|NCT01943292|100541317|FG002|Completed Cycle 1|Overall Study||3||
48090098|NCT01943292|100541315|FG000|Completed Treatment|Overall Study||3||
48090099|NCT01943292|100541316|FG001|Completed Treatment|Overall Study||3||
48090100|NCT01943292|100541317|FG002|Completed Treatment|Overall Study||3||
48090101|NCT01943292|100541315|FG000|Completed Follow-Up|Overall Study||2||
48090102|NCT01943292|100541316|FG001|Completed Follow-Up|Overall Study||3||
48090103|NCT01943292|100541317|FG002|Completed Follow-Up|Overall Study||3||
48090104|NCT01943292|100541315|FG000|COMPLETED|Overall Study||2||
48090105|NCT01943292|100541316|FG001|COMPLETED|Overall Study||3||
48090106|NCT01943292|100541317|FG002|COMPLETED|Overall Study||3||
48090107|NCT01943292|100541315|FG000|NOT COMPLETED|Overall Study||1||
48090108|NCT01943292|100541316|FG001|NOT COMPLETED|Overall Study||0||
48090109|NCT01943292|100541317|FG002|NOT COMPLETED|Overall Study||0||
48254224|NCT00957996|100940211|FG000|COMPLETED|Overall Study||91||
48254225|NCT00957996|100940212|FG001|COMPLETED|Overall Study||89||
48254226|NCT00957996|100940211|FG000|NOT COMPLETED|Overall Study||26||
48254227|NCT00957996|100940212|FG001|NOT COMPLETED|Overall Study||28||
48254228|NCT01656486|100940213|FG000|STARTED|Overall Study||1||
48254229|NCT01656486|100940213|FG000|COMPLETED|Overall Study||1||
48254230|NCT01656486|100940213|FG000|NOT COMPLETED|Overall Study||0||
48254231|NCT00960505|100940214|FG000|STARTED|Overall Study||34||
48254232|NCT00960505|100940215|FG001|STARTED|Overall Study||35||
48254233|NCT00960505|100940216|FG002|STARTED|Overall Study||31||
48254234|NCT00960505|100940214|FG000|COMPLETED|Overall Study||21||
48254235|NCT00960505|100940215|FG001|COMPLETED|Overall Study||25||
48254236|NCT00960505|100940216|FG002|COMPLETED|Overall Study||23||
48254237|NCT00960505|100940214|FG000|NOT COMPLETED|Overall Study||13||
48254238|NCT00960505|100940215|FG001|NOT COMPLETED|Overall Study||10||
48254239|NCT00960505|100940216|FG002|NOT COMPLETED|Overall Study||8||
48254240|NCT00384865|100940217|FG000|STARTED|Overall Study||16||
48381025|NCT00790738|101261542|FG001|STARTED|Overall Study||6||
48381026|NCT00790738|101261541|FG000|COMPLETED|Overall Study||3||
48381027|NCT00790738|101261542|FG001|COMPLETED|Overall Study||3||
48381028|NCT00790738|101261541|FG000|NOT COMPLETED|Overall Study||2||
48686107|NCT02948582|102013319|FG002|STARTED|Washout Period 3||7||
48090110|NCT02064894|100541318|FG000|STARTED|Overall Study||99||
48090111|NCT02064894|100541319|FG001|STARTED|Overall Study||201||
48686108|NCT02948582|102013320|FG003|STARTED|Washout Period 3||6||
48090112|NCT02064894|100541320|FG002|STARTED|Overall Study||201||
48090113|NCT02064894|100541318|FG000|Available at T-60|Overall Study||91||
48254241|NCT00384865|100940218|FG001|STARTED|Overall Study||16||
48254242|NCT00384865|100940219|FG002|STARTED|Overall Study||16||
48254243|NCT00384865|100940220|FG003|STARTED|Overall Study||16||
48254244|NCT00384865|100940217|FG000|Completed Six Month Assessment|Overall Study||11||
48381029|NCT00790738|101261542|FG001|NOT COMPLETED|Overall Study||3||
48381030|NCT04019275|101261543|FG000|STARTED|Overall Study||30||
48381031|NCT04019275|101261543|FG000|COMPLETED|Overall Study||24||
48381032|NCT04019275|101261543|FG000|NOT COMPLETED|Overall Study||6||
48686109|NCT02948582|102013321|FG004|STARTED|Washout Period 3||7||
48090114|NCT02064894|100541319|FG001|Available at T-60|Overall Study||188||
48090115|NCT02064894|100541320|FG002|Available at T-60|Overall Study||177||
48090116|NCT02064894|100541318|FG000|Avalaible at T-90|Overall Study||74||
48090117|NCT02064894|100541319|FG001|Avalaible at T-90|Overall Study||134||
48090118|NCT02064894|100541320|FG002|Avalaible at T-90|Overall Study||129||
48090119|NCT02064894|100541318|FG000|COMPLETED|Overall Study||56|T-120|
48254245|NCT00384865|100940218|FG001|Completed Six Month Assessment|Overall Study||12||
48254246|NCT00384865|100940219|FG002|Completed Six Month Assessment|Overall Study||15||
48254247|NCT00384865|100940220|FG003|Completed Six Month Assessment|Overall Study||11||
48254248|NCT00384865|100940217|FG000|COMPLETED|Overall Study||16||
48254249|NCT00384865|100940218|FG001|COMPLETED|Overall Study||16||
48254250|NCT00384865|100940219|FG002|COMPLETED|Overall Study||16||
48254251|NCT00384865|100940220|FG003|COMPLETED|Overall Study||16||
48254252|NCT00384865|100940217|FG000|NOT COMPLETED|Overall Study||0||
48254253|NCT00384865|100940218|FG001|NOT COMPLETED|Overall Study||0||
48254254|NCT00384865|100940219|FG002|NOT COMPLETED|Overall Study||0||
48254255|NCT00384865|100940220|FG003|NOT COMPLETED|Overall Study||0||
48254256|NCT00812838|100940221|FG000|STARTED|Treatment Period of 16 Weeks||6||
48254257|NCT00812838|100940222|FG001|STARTED|Treatment Period of 16 Weeks||6||
48254258|NCT00812838|100940221|FG000|COMPLETED|Treatment Period of 16 Weeks||6||
48686110|NCT02948582|102013322|FG005|STARTED|Washout Period 3||6||
48686111|NCT02948582|102013317|FG000|COMPLETED|Washout Period 3||7||
48686112|NCT02948582|102013318|FG001|COMPLETED|Washout Period 3||4||
48686113|NCT02948582|102013319|FG002|COMPLETED|Washout Period 3||7||
48686114|NCT02948582|102013320|FG003|COMPLETED|Washout Period 3||6||
48686115|NCT02948582|102013321|FG004|COMPLETED|Washout Period 3||7||
48686116|NCT02948582|102013322|FG005|COMPLETED|Washout Period 3||6||
48686117|NCT02948582|102013317|FG000|NOT COMPLETED|Washout Period 3||0||
48686118|NCT02948582|102013318|FG001|NOT COMPLETED|Washout Period 3||0||
48686119|NCT02948582|102013319|FG002|NOT COMPLETED|Washout Period 3||0||
48686120|NCT02948582|102013320|FG003|NOT COMPLETED|Washout Period 3||0||
48686121|NCT02948582|102013321|FG004|NOT COMPLETED|Washout Period 3||0||
48686122|NCT02948582|102013322|FG005|NOT COMPLETED|Washout Period 3||0||
48686123|NCT02948582|102013317|FG000|STARTED|Treatment Period 4||7||
48686124|NCT02948582|102013318|FG001|STARTED|Treatment Period 4||4||
48686125|NCT02948582|102013319|FG002|STARTED|Treatment Period 4||7||
48686126|NCT02948582|102013320|FG003|STARTED|Treatment Period 4||6||
48686127|NCT02948582|102013321|FG004|STARTED|Treatment Period 4||7||
48686128|NCT02948582|102013322|FG005|STARTED|Treatment Period 4||6||
48686129|NCT02948582|102013317|FG000|COMPLETED|Treatment Period 4||7||
48686130|NCT02948582|102013318|FG001|COMPLETED|Treatment Period 4||4||
48686131|NCT02948582|102013319|FG002|COMPLETED|Treatment Period 4||7||
48686132|NCT02948582|102013320|FG003|COMPLETED|Treatment Period 4||6||
48686133|NCT02948582|102013321|FG004|COMPLETED|Treatment Period 4||7||
48686134|NCT02948582|102013322|FG005|COMPLETED|Treatment Period 4||6||
48686135|NCT02948582|102013317|FG000|NOT COMPLETED|Treatment Period 4||0||
48686136|NCT02948582|102013318|FG001|NOT COMPLETED|Treatment Period 4||0||
48686137|NCT02948582|102013319|FG002|NOT COMPLETED|Treatment Period 4||0||
48686138|NCT02948582|102013320|FG003|NOT COMPLETED|Treatment Period 4||0||
48686139|NCT02948582|102013321|FG004|NOT COMPLETED|Treatment Period 4||0||
48686140|NCT02948582|102013322|FG005|NOT COMPLETED|Treatment Period 4||0||
48686141|NCT02948582|102013317|FG000|STARTED|Washout Period 4||7||
48686142|NCT02948582|102013318|FG001|STARTED|Washout Period 4||4||
48686143|NCT02948582|102013319|FG002|STARTED|Washout Period 4||7||
48686144|NCT02948582|102013320|FG003|STARTED|Washout Period 4||6||
48686145|NCT02948582|102013321|FG004|STARTED|Washout Period 4||7||
48686146|NCT02948582|102013322|FG005|STARTED|Washout Period 4||6||
48686147|NCT02948582|102013317|FG000|COMPLETED|Washout Period 4||6||
48686148|NCT02948582|102013318|FG001|COMPLETED|Washout Period 4||4||
48686149|NCT02948582|102013319|FG002|COMPLETED|Washout Period 4||6||
48686150|NCT02948582|102013320|FG003|COMPLETED|Washout Period 4||6||
48686151|NCT02948582|102013321|FG004|COMPLETED|Washout Period 4||7||
48686152|NCT02948582|102013322|FG005|COMPLETED|Washout Period 4||6||
48686153|NCT02948582|102013317|FG000|NOT COMPLETED|Washout Period 4||1||
48686154|NCT02948582|102013318|FG001|NOT COMPLETED|Washout Period 4||0||
48686155|NCT02948582|102013319|FG002|NOT COMPLETED|Washout Period 4||1||
48686156|NCT02948582|102013320|FG003|NOT COMPLETED|Washout Period 4||0||
48686157|NCT02948582|102013321|FG004|NOT COMPLETED|Washout Period 4||0||
48686158|NCT02948582|102013322|FG005|NOT COMPLETED|Washout Period 4||0||
48686159|NCT02948582|102013317|FG000|STARTED|Treatment Period 5||6||
48686160|NCT02948582|102013318|FG001|STARTED|Treatment Period 5||4||
48686161|NCT02948582|102013319|FG002|STARTED|Treatment Period 5||6||
48254259|NCT00812838|100940222|FG001|COMPLETED|Treatment Period of 16 Weeks||6||
48686162|NCT02948582|102013320|FG003|STARTED|Treatment Period 5||6||
48686163|NCT02948582|102013321|FG004|STARTED|Treatment Period 5||7||
48686164|NCT02948582|102013322|FG005|STARTED|Treatment Period 5||6||
48686165|NCT02948582|102013317|FG000|COMPLETED|Treatment Period 5||6||
48686166|NCT02948582|102013318|FG001|COMPLETED|Treatment Period 5||4||
48686167|NCT02948582|102013319|FG002|COMPLETED|Treatment Period 5||6||
48686168|NCT02948582|102013320|FG003|COMPLETED|Treatment Period 5||6||
48686169|NCT02948582|102013321|FG004|COMPLETED|Treatment Period 5||7||
48254260|NCT00812838|100940221|FG000|NOT COMPLETED|Treatment Period of 16 Weeks||0||
48254261|NCT00812838|100940222|FG001|NOT COMPLETED|Treatment Period of 16 Weeks||0||
48686170|NCT02948582|102013322|FG005|COMPLETED|Treatment Period 5||6||
48686171|NCT02948582|102013317|FG000|NOT COMPLETED|Treatment Period 5||0||
48686172|NCT02948582|102013318|FG001|NOT COMPLETED|Treatment Period 5||0||
48381033|NCT03007485|101261544|FG000|STARTED|Overall Study||98||
48381034|NCT03007485|101261545|FG001|STARTED|Overall Study||111||
48381035|NCT03007485|101261544|FG000|COMPLETED|Overall Study||28||
48381036|NCT03007485|101261545|FG001|COMPLETED|Overall Study||57||
48381037|NCT03007485|101261544|FG000|NOT COMPLETED|Overall Study||70||
48381038|NCT03007485|101261545|FG001|NOT COMPLETED|Overall Study||54||
48381039|NCT04017442|101261546|FG000|STARTED|Overall Study||80||
48381040|NCT04017442|101261547|FG001|STARTED|Overall Study||80||
48381041|NCT04017442|101261546|FG000|COMPLETED|Overall Study||59||
48381042|NCT04017442|101261547|FG001|COMPLETED|Overall Study||58||
48381043|NCT04017442|101261546|FG000|NOT COMPLETED|Overall Study||21||
48381044|NCT04017442|101261547|FG001|NOT COMPLETED|Overall Study||22||
48381045|NCT01911845|101261548|FG000|STARTED|Overall Study||38||
48381046|NCT01911845|101261548|FG000|Completed Study Drug|Overall Study||37||
48381047|NCT01911845|101261548|FG000|COMPLETED|Overall Study||32||
48381048|NCT01911845|101261548|FG000|NOT COMPLETED|Overall Study||6||
48381049|NCT00077610|101261549|FG000|STARTED|Overall Study||223||
48381050|NCT00077610|101261550|FG001|STARTED|Overall Study||224||
48381051|NCT00077610|101261551|FG002|STARTED|Overall Study||226||
48381052|NCT00077610|101261549|FG000|Started Treatment|Overall Study||221||
48381053|NCT00077610|101261550|FG001|Started Treatment|Overall Study||220||
48381054|NCT00077610|101261551|FG002|Started Treatment|Overall Study||225||
48381055|NCT00077610|101261549|FG000|COMPLETED|Overall Study||169||
48381056|NCT00077610|101261550|FG001|COMPLETED|Overall Study||168||
48381057|NCT00077610|101261551|FG002|COMPLETED|Overall Study||180||
48381058|NCT00077610|101261549|FG000|NOT COMPLETED|Overall Study||54||
48381059|NCT00077610|101261550|FG001|NOT COMPLETED|Overall Study||56||
48381060|NCT00077610|101261551|FG002|NOT COMPLETED|Overall Study||46||
48381061|NCT00094887|101261552|FG000|STARTED|Overall Study||75||
48381062|NCT00094887|101261553|FG001|STARTED|Overall Study||75||
48381063|NCT00094887|101261552|FG000|Safety Population|Overall Study||75||
48381064|NCT00094887|101261553|FG001|Safety Population|Overall Study||75||
48381065|NCT00094887|101261552|FG000|Intent to Treat Population|Overall Study||75||
48381066|NCT00094887|101261553|FG001|Intent to Treat Population|Overall Study||75||
48381067|NCT00094887|101261552|FG000|Per Protocol Analysis Set|Overall Study||71||
48381068|NCT00094887|101261553|FG001|Per Protocol Analysis Set|Overall Study||71||
48381069|NCT00094887|101261552|FG000|Primary Efficacy Population|Overall Study||65||
48381070|NCT00094887|101261553|FG001|Primary Efficacy Population|Overall Study||64||
48381071|NCT00094887|101261552|FG000|COMPLETED|Overall Study||71||
48381072|NCT00094887|101261553|FG001|COMPLETED|Overall Study||71||
48381073|NCT00094887|101261552|FG000|NOT COMPLETED|Overall Study||4||
48381074|NCT00094887|101261553|FG001|NOT COMPLETED|Overall Study||4||
48381075|NCT03052842|101261554|FG000|STARTED|Overall Study||8||
48381076|NCT03052842|101261555|FG001|STARTED|Overall Study||8||
48381077|NCT03052842|101261556|FG002|STARTED|Overall Study||8||
48381078|NCT03052842|101261557|FG003|STARTED|Overall Study||6||
48381079|NCT03052842|101261554|FG000|COMPLETED|Overall Study||8||
48381080|NCT03052842|101261555|FG001|COMPLETED|Overall Study||8||
48381081|NCT03052842|101261556|FG002|COMPLETED|Overall Study||8||
48381082|NCT03052842|101261557|FG003|COMPLETED|Overall Study||6||
48381083|NCT03052842|101261554|FG000|NOT COMPLETED|Overall Study||0||
48381084|NCT03052842|101261555|FG001|NOT COMPLETED|Overall Study||0||
48381085|NCT03052842|101261556|FG002|NOT COMPLETED|Overall Study||0||
48381086|NCT03052842|101261557|FG003|NOT COMPLETED|Overall Study||0||
48381087|NCT03474406|101261558|FG000|STARTED|Overall Study||150||
48381088|NCT03474406|101261558|FG000|COMPLETED|Overall Study||72||
48381089|NCT03474406|101261558|FG000|NOT COMPLETED|Overall Study||78||
48381090|NCT02858154|101261559|FG000|STARTED|HFNC 3-4 Hours||9||
48381091|NCT02858154|101261559|FG000|COMPLETED|HFNC 3-4 Hours||9||
48381092|NCT02858154|101261559|FG000|NOT COMPLETED|HFNC 3-4 Hours||0||
48381093|NCT02858154|101261559|FG000|STARTED|Clinically Ordered PSG/Low Flow Oxygen||9||
48381094|NCT02858154|101261559|FG000|COMPLETED|Clinically Ordered PSG/Low Flow Oxygen||9||
48381095|NCT02858154|101261559|FG000|NOT COMPLETED|Clinically Ordered PSG/Low Flow Oxygen||0||
48090120|NCT02064894|100541319|FG001|COMPLETED|Overall Study||99|T-120|
48090121|NCT02064894|100541320|FG002|COMPLETED|Overall Study||86|T-120|
48090122|NCT02064894|100541318|FG000|NOT COMPLETED|Overall Study||43||
48686173|NCT02948582|102013319|FG002|NOT COMPLETED|Treatment Period 5||0||
48686174|NCT02948582|102013320|FG003|NOT COMPLETED|Treatment Period 5||0||
48686175|NCT02948582|102013321|FG004|NOT COMPLETED|Treatment Period 5||0||
48686176|NCT02948582|102013322|FG005|NOT COMPLETED|Treatment Period 5||0||
48686177|NCT02948582|102013317|FG000|STARTED|Washout Period 5||6||
48686178|NCT02948582|102013318|FG001|STARTED|Washout Period 5||4||
48686179|NCT02948582|102013319|FG002|STARTED|Washout Period 5||6||
48686180|NCT02948582|102013320|FG003|STARTED|Washout Period 5||6||
48686181|NCT02948582|102013321|FG004|STARTED|Washout Period 5||7||
48686182|NCT02948582|102013322|FG005|STARTED|Washout Period 5||6||
48686183|NCT02948582|102013317|FG000|COMPLETED|Washout Period 5||6||
48686184|NCT02948582|102013318|FG001|COMPLETED|Washout Period 5||4||
48686185|NCT02948582|102013319|FG002|COMPLETED|Washout Period 5||6||
48686186|NCT02948582|102013320|FG003|COMPLETED|Washout Period 5||6||
48686187|NCT02948582|102013321|FG004|COMPLETED|Washout Period 5||7||
48686188|NCT02948582|102013322|FG005|COMPLETED|Washout Period 5||6||
48686189|NCT02948582|102013317|FG000|NOT COMPLETED|Washout Period 5||0||
48686190|NCT02948582|102013318|FG001|NOT COMPLETED|Washout Period 5||0||
48686191|NCT02948582|102013319|FG002|NOT COMPLETED|Washout Period 5||0||
48686192|NCT02948582|102013320|FG003|NOT COMPLETED|Washout Period 5||0||
48686193|NCT02948582|102013321|FG004|NOT COMPLETED|Washout Period 5||0||
48686194|NCT02948582|102013322|FG005|NOT COMPLETED|Washout Period 5||0||
48686195|NCT02948582|102013317|FG000|STARTED|Treatment Period 6||6||
48686196|NCT02948582|102013318|FG001|STARTED|Treatment Period 6||4||
48686197|NCT02948582|102013319|FG002|STARTED|Treatment Period 6||6||
48686198|NCT02948582|102013320|FG003|STARTED|Treatment Period 6||6||
48686199|NCT02948582|102013321|FG004|STARTED|Treatment Period 6||7||
48686200|NCT02948582|102013322|FG005|STARTED|Treatment Period 6||6||
48686201|NCT02948582|102013317|FG000|COMPLETED|Treatment Period 6||6||
48686202|NCT02948582|102013318|FG001|COMPLETED|Treatment Period 6||4||
48686203|NCT02948582|102013319|FG002|COMPLETED|Treatment Period 6||6||
48686204|NCT02948582|102013320|FG003|COMPLETED|Treatment Period 6||6||
48686205|NCT02948582|102013321|FG004|COMPLETED|Treatment Period 6||7||
48686206|NCT02948582|102013322|FG005|COMPLETED|Treatment Period 6||6||
48686207|NCT02948582|102013317|FG000|NOT COMPLETED|Treatment Period 6||0||
48686208|NCT02948582|102013318|FG001|NOT COMPLETED|Treatment Period 6||0||
48686209|NCT02948582|102013319|FG002|NOT COMPLETED|Treatment Period 6||0||
48686210|NCT02948582|102013320|FG003|NOT COMPLETED|Treatment Period 6||0||
48686211|NCT02948582|102013321|FG004|NOT COMPLETED|Treatment Period 6||0||
48686212|NCT02948582|102013322|FG005|NOT COMPLETED|Treatment Period 6||0||
48686213|NCT02948582|102013317|FG000|STARTED|Wshout Period 6||6||
48686214|NCT02948582|102013318|FG001|STARTED|Wshout Period 6||4||
48294136|NCT02527343|101047540|FG004|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0||
48686215|NCT02948582|102013319|FG002|STARTED|Wshout Period 6||6||
48686216|NCT02948582|102013320|FG003|STARTED|Wshout Period 6||6||
48686217|NCT02948582|102013321|FG004|STARTED|Wshout Period 6||7||
48686218|NCT02948582|102013322|FG005|STARTED|Wshout Period 6||6||
48686219|NCT02948582|102013317|FG000|COMPLETED|Wshout Period 6||6||
48686220|NCT02948582|102013318|FG001|COMPLETED|Wshout Period 6||4||
48686221|NCT02948582|102013319|FG002|COMPLETED|Wshout Period 6||6||
48090123|NCT02064894|100541319|FG001|NOT COMPLETED|Overall Study||102||
48686222|NCT02948582|102013320|FG003|COMPLETED|Wshout Period 6||6||
48686223|NCT02948582|102013321|FG004|COMPLETED|Wshout Period 6||7||
48686224|NCT02948582|102013322|FG005|COMPLETED|Wshout Period 6||6||
48686225|NCT02948582|102013317|FG000|NOT COMPLETED|Wshout Period 6||0||
48686226|NCT02948582|102013318|FG001|NOT COMPLETED|Wshout Period 6||0||
48686227|NCT02948582|102013319|FG002|NOT COMPLETED|Wshout Period 6||0||
48686228|NCT02948582|102013320|FG003|NOT COMPLETED|Wshout Period 6||0||
48090124|NCT02064894|100541320|FG002|NOT COMPLETED|Overall Study||115||
48090125|NCT04285879|100541321|FG000|STARTED|Overall Study||33||
48090126|NCT04285879|100541322|FG001|STARTED|Overall Study||14||
48090127|NCT04285879|100541321|FG000|COMPLETED|Overall Study||16||
48090128|NCT04285879|100541322|FG001|COMPLETED|Overall Study||6||
48090129|NCT04285879|100541321|FG000|NOT COMPLETED|Overall Study||17||
48090130|NCT04285879|100541322|FG001|NOT COMPLETED|Overall Study||8||
48090131|NCT00592839|100541323|FG000|STARTED|Overall Study||53||
48090132|NCT00592839|100541324|FG001|STARTED|Overall Study||52||
48090133|NCT00592839|100541325|FG002|STARTED|Overall Study||52||
48090134|NCT00592839|100541323|FG000|COMPLETED|Overall Study||51||
48090135|NCT00592839|100541324|FG001|COMPLETED|Overall Study||48||
48090136|NCT00592839|100541325|FG002|COMPLETED|Overall Study||46||
48090137|NCT00592839|100541323|FG000|NOT COMPLETED|Overall Study||2||
48090138|NCT00592839|100541324|FG001|NOT COMPLETED|Overall Study||4||
48381096|NCT00579501|101261560|FG000|STARTED|Overall Study||29||
48381097|NCT00579501|101261560|FG000|COMPLETED|Overall Study||0||
48381098|NCT00579501|101261560|FG000|NOT COMPLETED|Overall Study||29||
48381099|NCT02723604|101261561|FG000|STARTED|Overall Study||25||
48381100|NCT02723604|101261561|FG000|COMPLETED|Overall Study||23||
48381101|NCT02723604|101261561|FG000|NOT COMPLETED|Overall Study||2||
48381102|NCT04058054|101261562|FG000|STARTED|Overall Study||22||22
48381103|NCT04058054|101261563|FG001|STARTED|Overall Study||22||22
48381104|NCT04058054|101261564|FG002|STARTED|Overall Study||22||22
48381105|NCT04058054|101261565|FG003|STARTED|Overall Study||22||22
48381106|NCT04058054|101261566|FG004|STARTED|Overall Study||22||22
48381107|NCT04058054|101261562|FG000|COMPLETED|Overall Study||22||22
48381108|NCT04058054|101261563|FG001|COMPLETED|Overall Study||22||22
48381109|NCT04058054|101261564|FG002|COMPLETED|Overall Study||22||22
48381110|NCT04058054|101261565|FG003|COMPLETED|Overall Study||22||22
48381111|NCT04058054|101261566|FG004|COMPLETED|Overall Study||22||22
48090139|NCT00592839|100541325|FG002|NOT COMPLETED|Overall Study||6||
48090140|NCT00518986|100541326|FG000|STARTED|Overall Study||125||
48381112|NCT04058054|101261562|FG000|NOT COMPLETED|Overall Study||0||0
48381113|NCT04058054|101261563|FG001|NOT COMPLETED|Overall Study||0||0
48381114|NCT04058054|101261564|FG002|NOT COMPLETED|Overall Study||0||0
48381115|NCT04058054|101261565|FG003|NOT COMPLETED|Overall Study||0||0
48381116|NCT04058054|101261566|FG004|NOT COMPLETED|Overall Study||0||0
48381117|NCT00363246|101261567|FG000|STARTED|Overall Study||766||
48381118|NCT00363246|101261567|FG000|COMPLETED|Overall Study||669||
48381119|NCT00363246|101261567|FG000|NOT COMPLETED|Overall Study||97||
48381120|NCT02504268|101261568|FG000|STARTED|Overall Study||451|= Started the Induction Period|
48381121|NCT02504268|101261569|FG001|STARTED|Overall Study||301|= Started the Induction Period|
48381122|NCT02504268|101261570|FG002|STARTED|Overall Study||242|= Started the Induction Period|
48686229|NCT02948582|102013321|FG004|NOT COMPLETED|Wshout Period 6||0||
48686230|NCT02948582|102013322|FG005|NOT COMPLETED|Wshout Period 6||0||
48686231|NCT00892008|102013323|FG000|STARTED|Overall Study||2278||
48686232|NCT00892008|102013323|FG000|COMPLETED|Overall Study||1713||
48686233|NCT00892008|102013323|FG000|NOT COMPLETED|Overall Study||565||
48090141|NCT00518986|100541327|FG001|STARTED|Overall Study||124||
48090142|NCT00518986|100541326|FG000|COMPLETED|Overall Study||99||
48381123|NCT02504268|101261571|FG003|STARTED|Overall Study||0|= Started the Induction Period|
48381124|NCT02504268|101261572|FG004|STARTED|Overall Study||0|= Started the Induction Period|
48381125|NCT02504268|101261573|FG005|STARTED|Overall Study||0|= Started the Induction Period|
48381126|NCT02504268|101261574|FG006|STARTED|Overall Study||0|= Started the Induction Period|
48381127|NCT02504268|101261575|FG007|STARTED|Overall Study||0|= Started the Induction Period|
48381128|NCT02504268|101261576|FG008|STARTED|Overall Study||0|= Started the Induction Period|
48381129|NCT02504268|101261568|FG000|Induction to Open Label|Overall Study||289|Number of participants who completed induction period and treated in Open Label Period|
48381130|NCT02504268|101261569|FG001|Induction to Open Label|Overall Study||196|Number of participants who completed induction period and treated in Open Label Period|
48381131|NCT02504268|101261570|FG002|Induction to Open Label|Overall Study||147|Number of participants who completed induction period and treated in Open Label Period|
48381132|NCT02504268|101261571|FG003|Induction to Open Label|Overall Study||0|Number of participants who completed induction period and treated in Open Label Period|
48541359|NCT04602546|101662708|FG000|STARTED|Overall Study||33||
48686234|NCT01435174|102013324|FG000|STARTED|Overall Study||17||
48686235|NCT01435174|102013324|FG000|COMPLETED|Overall Study||8||
48686236|NCT01435174|102013324|FG000|NOT COMPLETED|Overall Study||9||
48686237|NCT00129285|102013325|FG000|STARTED|Overall Study||65||
48686238|NCT00129285|102013326|FG001|STARTED|Overall Study||70||
48686239|NCT00129285|102013327|FG002|STARTED|Overall Study||75||
48686240|NCT00129285|102013325|FG000|COMPLETED|Overall Study||40||
48686241|NCT00129285|102013326|FG001|COMPLETED|Overall Study||43||
48686242|NCT00129285|102013327|FG002|COMPLETED|Overall Study||37||
48686243|NCT00129285|102013325|FG000|NOT COMPLETED|Overall Study||25||
48090143|NCT00518986|100541327|FG001|COMPLETED|Overall Study||98||
48090144|NCT00518986|100541326|FG000|NOT COMPLETED|Overall Study||26||
48090145|NCT00518986|100541327|FG001|NOT COMPLETED|Overall Study||26||
48090146|NCT00446290|100541328|FG000|STARTED|Overall Study||22||
48090147|NCT00446290|100541328|FG000|COMPLETED|Overall Study||22||
48090148|NCT00446290|100541328|FG000|NOT COMPLETED|Overall Study||0||
48090149|NCT00296374|100541329|FG000|STARTED|Overall Study||118||
48090150|NCT00296374|100541330|FG001|STARTED|Overall Study||124||
48090151|NCT00296374|100541331|FG002|STARTED|Overall Study||111||
48090152|NCT00296374|100541329|FG000|COMPLETED|Overall Study||93||
48090153|NCT00296374|100541330|FG001|COMPLETED|Overall Study||101||
48090154|NCT00296374|100541331|FG002|COMPLETED|Overall Study||82||
48090155|NCT00296374|100541329|FG000|NOT COMPLETED|Overall Study||25||
48090156|NCT00296374|100541330|FG001|NOT COMPLETED|Overall Study||23||
48090157|NCT00296374|100541331|FG002|NOT COMPLETED|Overall Study||29||
48090158|NCT00010374|100541332|FG000|STARTED|Overall Study||54||
48090159|NCT00010374|100541332|FG000|COMPLETED|Overall Study||53||
48090160|NCT00010374|100541332|FG000|NOT COMPLETED|Overall Study||1||
48090161|NCT00556712|100541333|FG000|STARTED|Overall Study||451||
48090162|NCT00556712|100541334|FG001|STARTED|Overall Study||438||
48090163|NCT00556712|100541333|FG000|COMPLETED|Overall Study||0||
48090164|NCT00556712|100541334|FG001|COMPLETED|Overall Study||0||
48090165|NCT00556712|100541333|FG000|NOT COMPLETED|Overall Study||451||
48090166|NCT00556712|100541334|FG001|NOT COMPLETED|Overall Study||438||
48090167|NCT01385202|100541335|FG000|STARTED|Overall Study||172||
48090168|NCT01385202|100541335|FG000|Study Catheter Inserted|Overall Study||161||
48090169|NCT01385202|100541335|FG000|Undergoing Ablation|Overall Study||160||
48090170|NCT01385202|100541335|FG000|COMPLETED|Overall Study||154||
48541360|NCT04602546|101662709|FG001|STARTED|Overall Study||29||
48541361|NCT04602546|101662710|FG002|STARTED|Overall Study||32||
48090171|NCT01385202|100541335|FG000|NOT COMPLETED|Overall Study||18||
48090172|NCT03227029|100541336|FG000|STARTED|Overall Study||26||
48090173|NCT03227029|100541337|FG001|STARTED|Overall Study||26||
48090174|NCT03227029|100541338|FG002|STARTED|Overall Study||13||
48090175|NCT03227029|100541336|FG000|Received Inoculation|Overall Study||26||
48090176|NCT03227029|100541337|FG001|Received Inoculation|Overall Study||25||
48090177|NCT03227029|100541338|FG002|Received Inoculation|Overall Study||12||
48090178|NCT03227029|100541336|FG000|COMPLETED|Overall Study||22||
48090179|NCT03227029|100541337|FG001|COMPLETED|Overall Study||22||
48090180|NCT03227029|100541338|FG002|COMPLETED|Overall Study||9||
48090181|NCT03227029|100541336|FG000|NOT COMPLETED|Overall Study||4||
48090182|NCT03227029|100541337|FG001|NOT COMPLETED|Overall Study||4||
48090183|NCT03227029|100541338|FG002|NOT COMPLETED|Overall Study||4||
48090184|NCT00923598|100541339|FG000|STARTED|Overall Study||23||
48090185|NCT00923598|100541340|FG001|STARTED|Overall Study||22||
48090186|NCT00923598|100541339|FG000|COMPLETED|Overall Study||19||
48090187|NCT00923598|100541340|FG001|COMPLETED|Overall Study||17||
48090188|NCT00923598|100541339|FG000|NOT COMPLETED|Overall Study||4||
48090189|NCT00923598|100541340|FG001|NOT COMPLETED|Overall Study||5||
48090190|NCT01948050|100541341|FG000|STARTED|Overall Study||16||
48090191|NCT01948050|100541342|FG001|STARTED|Overall Study||8||
48090192|NCT01948050|100541341|FG000|COMPLETED|Overall Study||16||
48090193|NCT01948050|100541342|FG001|COMPLETED|Overall Study||7||
48090194|NCT01948050|100541341|FG000|NOT COMPLETED|Overall Study||0||
48090195|NCT01948050|100541342|FG001|NOT COMPLETED|Overall Study||1||
48090196|NCT02485574|100541343|FG000|STARTED|Overall Study||69||
48090197|NCT02485574|100541343|FG000|COMPLETED|Overall Study||65||
48090198|NCT02485574|100541343|FG000|NOT COMPLETED|Overall Study||4||
48090199|NCT04570150|100541344|FG000|STARTED|Overall Study||45||
48090200|NCT04570150|100541345|FG001|STARTED|Overall Study||45||
48090201|NCT04570150|100541344|FG000|COMPLETED|Overall Study||45||
48090202|NCT04570150|100541345|FG001|COMPLETED|Overall Study||45||
48090203|NCT04570150|100541344|FG000|NOT COMPLETED|Overall Study||0||
48090204|NCT04570150|100541345|FG001|NOT COMPLETED|Overall Study||0||
48090205|NCT00110149|100541346|FG000|STARTED|Overall Study||12||
48090206|NCT00110149|100541346|FG000|Received Treatment|Overall Study||9||
48254262|NCT00812838|100940221|FG000|STARTED|Optional Crossover of 16 Weeks||0|Optional crossover did not apply to the experimental arm (ARM 1)|
48254263|NCT00812838|100940222|FG001|STARTED|Optional Crossover of 16 Weeks||4|Optional crossover did not apply to the experimental arm (ARM 1)|
48254264|NCT00812838|100940221|FG000|COMPLETED|Optional Crossover of 16 Weeks||0||
48254265|NCT00812838|100940222|FG001|COMPLETED|Optional Crossover of 16 Weeks||4||
48254266|NCT00812838|100940221|FG000|NOT COMPLETED|Optional Crossover of 16 Weeks||0||
48254267|NCT00812838|100940222|FG001|NOT COMPLETED|Optional Crossover of 16 Weeks||0||
48254268|NCT03269695|100940223|FG000|STARTED|Overall Study||10||
48254269|NCT03269695|100940224|FG001|STARTED|Overall Study||10||
48254270|NCT03269695|100940223|FG000|Treated|Overall Study||10||
48254271|NCT03269695|100940224|FG001|Treated|Overall Study||10||
48254272|NCT03269695|100940223|FG000|COMPLETED|Overall Study||8||
48254273|NCT03269695|100940224|FG001|COMPLETED|Overall Study||7||
48254274|NCT03269695|100940223|FG000|NOT COMPLETED|Overall Study||2||
48090207|NCT00110149|100541346|FG000|COMPLETED|Overall Study||9||
48090208|NCT00110149|100541346|FG000|NOT COMPLETED|Overall Study||3||
48254275|NCT03269695|100940224|FG001|NOT COMPLETED|Overall Study||3||
48090209|NCT01852110|100541347|FG000|STARTED|Overall Study||120||
48090210|NCT01852110|100541348|FG001|STARTED|Overall Study||120||
48090211|NCT01852110|100541349|FG002|STARTED|Overall Study||0||
48254276|NCT01589523|100940225|FG000|STARTED|Overall Study||5||
48254277|NCT01589523|100940225|FG000|COMPLETED|Overall Study||4||
48381133|NCT02504268|101261572|FG004|Induction to Open Label|Overall Study||0|Number of participants who completed induction period and treated in Open Label Period|
48686244|NCT00129285|102013326|FG001|NOT COMPLETED|Overall Study||27||
48686245|NCT00129285|102013327|FG002|NOT COMPLETED|Overall Study||38||
48381134|NCT02504268|101261573|FG005|Induction to Open Label|Overall Study||0|Number of participants who completed induction period and treated in Open Label Period|
48381135|NCT02504268|101261574|FG006|Induction to Open Label|Overall Study||0|Number of participants who completed induction period and treated in Open Label Period|
48381136|NCT02504268|101261575|FG007|Induction to Open Label|Overall Study||0|Number of participants who completed induction period and treated in Open Label Period|
48686246|NCT00937495|102013328|FG000|STARTED|Overall Study||16||
48686247|NCT00937495|102013328|FG000|COMPLETED|Overall Study||14||
48254278|NCT01589523|100940225|FG000|NOT COMPLETED|Overall Study||1||
48254279|NCT00792259|100940226|FG000|STARTED|Overall Study||15||
48254280|NCT00792259|100940227|FG001|STARTED|Overall Study||20||
48254281|NCT00792259|100940228|FG002|STARTED|Overall Study||13||
48254282|NCT00792259|100940226|FG000|COMPLETED|Overall Study||14||
48254283|NCT00792259|100940227|FG001|COMPLETED|Overall Study||20||
48254284|NCT00792259|100940228|FG002|COMPLETED|Overall Study||13||
48254285|NCT00792259|100940226|FG000|NOT COMPLETED|Overall Study||1||
48254286|NCT00792259|100940227|FG001|NOT COMPLETED|Overall Study||0||
48254287|NCT00792259|100940228|FG002|NOT COMPLETED|Overall Study||0||
48254288|NCT03730662|100940229|FG000|STARTED|Treatment Period (52 Weeks)||329||
48254289|NCT03730662|100940230|FG001|STARTED|Treatment Period (52 Weeks)||330||
48254290|NCT03730662|100940231|FG002|STARTED|Treatment Period (52 Weeks)||338||
48254291|NCT03730662|100940232|FG003|STARTED|Treatment Period (52 Weeks)||1005||
48254292|NCT03730662|100940229|FG000|Received at Least One Dose of Study Drug|Treatment Period (52 Weeks)||329||
48254293|NCT03730662|100940230|FG001|Received at Least One Dose of Study Drug|Treatment Period (52 Weeks)||328||
48254294|NCT03730662|100940231|FG002|Received at Least One Dose of Study Drug|Treatment Period (52 Weeks)||338||
48254295|NCT03730662|100940232|FG003|Received at Least One Dose of Study Drug|Treatment Period (52 Weeks)||1000||
48254296|NCT03730662|100940229|FG000|COMPLETED|Treatment Period (52 Weeks)||308||
48254297|NCT03730662|100940230|FG001|COMPLETED|Treatment Period (52 Weeks)||319||
48254298|NCT03730662|100940231|FG002|COMPLETED|Treatment Period (52 Weeks)||329||
48254299|NCT03730662|100940232|FG003|COMPLETED|Treatment Period (52 Weeks)||953||
48254300|NCT03730662|100940229|FG000|NOT COMPLETED|Treatment Period (52 Weeks)||21||
48254301|NCT03730662|100940230|FG001|NOT COMPLETED|Treatment Period (52 Weeks)||11||
48254302|NCT03730662|100940231|FG002|NOT COMPLETED|Treatment Period (52 Weeks)||9||
48254303|NCT03730662|100940232|FG003|NOT COMPLETED|Treatment Period (52 Weeks)||52||
48254304|NCT03730662|100940229|FG000|STARTED|Variable Treatment Period||308||
48254305|NCT03730662|100940230|FG001|STARTED|Variable Treatment Period||319||
48254306|NCT03730662|100940231|FG002|STARTED|Variable Treatment Period||329||
48254307|NCT03730662|100940232|FG003|STARTED|Variable Treatment Period||953||
48381137|NCT02504268|101261576|FG008|Induction to Open Label|Overall Study||0|Number of participants who completed induction period and treated in Open Label Period|
48381138|NCT02504268|101261568|FG000|Early Escaped to Open Label|Overall Study||10|Number of participants who early escaped and treated in open label period|
48541362|NCT04602546|101662711|FG003|STARTED|Overall Study||35||
48541363|NCT04602546|101662712|FG004|STARTED|Overall Study||33||
48541364|NCT04602546|101662708|FG000|COMPLETED|Overall Study||29||
48541365|NCT04602546|101662709|FG001|COMPLETED|Overall Study||27||
48541366|NCT04602546|101662710|FG002|COMPLETED|Overall Study||29||
48254308|NCT03730662|100940229|FG000|COMPLETED|Variable Treatment Period||294||
48254309|NCT03730662|100940230|FG001|COMPLETED|Variable Treatment Period||312||
48254310|NCT03730662|100940231|FG002|COMPLETED|Variable Treatment Period||313||
48254311|NCT03730662|100940232|FG003|COMPLETED|Variable Treatment Period||882||
48541367|NCT04602546|101662711|FG003|COMPLETED|Overall Study||28||
48541368|NCT04602546|101662712|FG004|COMPLETED|Overall Study||30||
48541369|NCT04602546|101662708|FG000|NOT COMPLETED|Overall Study||4||
48541370|NCT04602546|101662709|FG001|NOT COMPLETED|Overall Study||2||
48541371|NCT04602546|101662710|FG002|NOT COMPLETED|Overall Study||3||
48541372|NCT04602546|101662711|FG003|NOT COMPLETED|Overall Study||7||
48541373|NCT04602546|101662712|FG004|NOT COMPLETED|Overall Study||3||
48541374|NCT04867174|101662713|FG000|STARTED|Overall Study||136||
48541375|NCT04867174|101662714|FG001|STARTED|Overall Study||137||
48541376|NCT04867174|101662715|FG002|STARTED|Overall Study||29||
48541377|NCT04867174|101662716|FG003|STARTED|Overall Study||37||
48541378|NCT04867174|101662717|FG004|STARTED|Overall Study||32||
48541379|NCT04867174|101662718|FG005|STARTED|Overall Study||31||
48541380|NCT04867174|101662719|FG006|STARTED|Overall Study||43||
48541381|NCT04867174|101662720|FG007|STARTED|Overall Study||33||
48541382|NCT04867174|101662721|FG008|STARTED|Overall Study||39||
48541383|NCT04867174|101662722|FG009|STARTED|Overall Study||35||
48686248|NCT00937495|102013328|FG000|NOT COMPLETED|Overall Study||2||
48686249|NCT04011735|102013329|FG000|STARTED|Overall Study||133||
48686250|NCT04011735|102013330|FG001|STARTED|Overall Study||71||
48686251|NCT04011735|102013331|FG002|STARTED|Overall Study||56||
48254312|NCT03730662|100940229|FG000|NOT COMPLETED|Variable Treatment Period||14||
48254313|NCT03730662|100940230|FG001|NOT COMPLETED|Variable Treatment Period||7||
48254314|NCT03730662|100940231|FG002|NOT COMPLETED|Variable Treatment Period||16||
48254315|NCT03730662|100940232|FG003|NOT COMPLETED|Variable Treatment Period||71||
48686252|NCT04011735|102013329|FG000|COMPLETED|Overall Study||132||
48686253|NCT04011735|102013330|FG001|COMPLETED|Overall Study||70||
48686254|NCT04011735|102013331|FG002|COMPLETED|Overall Study||55||
48686255|NCT04011735|102013329|FG000|NOT COMPLETED|Overall Study||1||
48686256|NCT04011735|102013330|FG001|NOT COMPLETED|Overall Study||1||
48686257|NCT04011735|102013331|FG002|NOT COMPLETED|Overall Study||1||
48686258|NCT02041299|102013332|FG000|STARTED|Overall Study||152||
48686259|NCT02041299|102013333|FG001|STARTED|Overall Study||78||
48686260|NCT02041299|102013332|FG000|COMPLETED|Overall Study||106||
48686261|NCT02041299|102013333|FG001|COMPLETED|Overall Study||58||
48686262|NCT02041299|102013332|FG000|NOT COMPLETED|Overall Study||46||
48686263|NCT02041299|102013333|FG001|NOT COMPLETED|Overall Study||20||
48686264|NCT02949024|102013334|FG000|STARTED|Overall Study||10||
48381139|NCT02504268|101261569|FG001|Early Escaped to Open Label|Overall Study||21|Number of participants who early escaped and treated in open label period|
48381140|NCT02504268|101261570|FG002|Early Escaped to Open Label|Overall Study||8|Number of participants who early escaped and treated in open label period|
48381141|NCT02504268|101261571|FG003|Early Escaped to Open Label|Overall Study||0|Number of participants who early escaped and treated in open label period|
48381142|NCT02504268|101261572|FG004|Early Escaped to Open Label|Overall Study||0|Number of participants who early escaped and treated in open label period|
48381143|NCT02504268|101261573|FG005|Early Escaped to Open Label|Overall Study||0|Number of participants who early escaped and treated in open label period|
48381144|NCT02504268|101261574|FG006|Early Escaped to Open Label|Overall Study||0|Number of participants who early escaped and treated in open label period|
48381145|NCT02504268|101261575|FG007|Early Escaped to Open Label|Overall Study||0|Number of participants who early escaped and treated in open label period|
48381146|NCT02504268|101261576|FG008|Early Escaped to Open Label|Overall Study||0|Number of participants who early escaped and treated in open label period|
48381147|NCT02504268|101261568|FG000|Induction to De-Escalation|Overall Study||94|Number of participants who completed induction period and treated in de-escalation period|
48381148|NCT02504268|101261569|FG001|Induction to De-Escalation|Overall Study||37|Number of participants who completed induction period and treated in de-escalation period|
48381149|NCT02504268|101261570|FG002|Induction to De-Escalation|Overall Study||53|Number of participants who completed induction period and treated in de-escalation period|
48381150|NCT02504268|101261571|FG003|Induction to De-Escalation|Overall Study||0|Number of participants who completed induction period and treated in de-escalation period|
48381151|NCT02504268|101261572|FG004|Induction to De-Escalation|Overall Study||0|Number of participants who completed induction period and treated in de-escalation period|
48381152|NCT02504268|101261573|FG005|Induction to De-Escalation|Overall Study||0|Number of participants who completed induction period and treated in de-escalation period|
48381153|NCT02504268|101261574|FG006|Induction to De-Escalation|Overall Study||0|Number of participants who completed induction period and treated in de-escalation period|
48381154|NCT02504268|101261575|FG007|Induction to De-Escalation|Overall Study||0|Number of participants who completed induction period and treated in de-escalation period|
48381155|NCT02504268|101261576|FG008|Induction to De-Escalation|Overall Study||0|Number of participants who completed induction period and treated in de-escalation period|
48381156|NCT02504268|101261568|FG000|Randomized in De-Escalation Period|Overall Study||0|Participants after induction period randomized into De-Escalation|
48381157|NCT02504268|101261569|FG001|Randomized in De-Escalation Period|Overall Study||0|Participants after induction period randomized into De-Escalation|
48381158|NCT02504268|101261570|FG002|Randomized in De-Escalation Period|Overall Study||0|Participants after induction period randomized into De-Escalation|
48381159|NCT02504268|101261571|FG003|Randomized in De-Escalation Period|Overall Study||50|Participants after induction period randomized into De-Escalation|
48381160|NCT02504268|101261572|FG004|Randomized in De-Escalation Period|Overall Study||50|Participants after induction period randomized into De-Escalation|
48381161|NCT02504268|101261573|FG005|Randomized in De-Escalation Period|Overall Study||47|Participants after induction period randomized into De-Escalation|
48381162|NCT02504268|101261574|FG006|Randomized in De-Escalation Period|Overall Study||37|Participants after induction period randomized into De-Escalation|
48381163|NCT02504268|101261575|FG007|Randomized in De-Escalation Period|Overall Study||0|Participants after induction period randomized into De-Escalation|
48381164|NCT02504268|101261576|FG008|Randomized in De-Escalation Period|Overall Study||0|Participants after induction period randomized into De-Escalation|
48381165|NCT02504268|101261568|FG000|De-Escalation to Open Label Extension|Overall Study||0|Number of participants who completed De-escalation period and treated in Open Label Extension Period|
48381166|NCT02504268|101261569|FG001|De-Escalation to Open Label Extension|Overall Study||0|Number of participants who completed De-escalation period and treated in Open Label Extension Period|
48381167|NCT02504268|101261570|FG002|De-Escalation to Open Label Extension|Overall Study||0|Number of participants who completed De-escalation period and treated in Open Label Extension Period|
48686265|NCT02949024|102013335|FG001|STARTED|Overall Study||10||
48686266|NCT02949024|102013334|FG000|COMPLETED|Overall Study||10||
48686267|NCT02949024|102013335|FG001|COMPLETED|Overall Study||9||
48686268|NCT02949024|102013334|FG000|NOT COMPLETED|Overall Study||0||
48686269|NCT02949024|102013335|FG001|NOT COMPLETED|Overall Study||1||
48686270|NCT00410189|102013336|FG000|STARTED|Overall Study||54||
48686271|NCT00410189|102013336|FG000|COMPLETED|Overall Study||54||
48686272|NCT00410189|102013336|FG000|NOT COMPLETED|Overall Study||0||
48686273|NCT00755807|102013337|FG000|STARTED|Acute Phase||118||
48686274|NCT00755807|102013338|FG001|STARTED|Acute Phase||121||
48686275|NCT00755807|102013337|FG000|COMPLETED|Acute Phase||100||
48686276|NCT00755807|102013338|FG001|COMPLETED|Acute Phase||109||
48381168|NCT02504268|101261571|FG003|De-Escalation to Open Label Extension|Overall Study||36|Number of participants who completed De-escalation period and treated in Open Label Extension Period|
48381169|NCT02504268|101261572|FG004|De-Escalation to Open Label Extension|Overall Study||30|Number of participants who completed De-escalation period and treated in Open Label Extension Period|
48381170|NCT02504268|101261573|FG005|De-Escalation to Open Label Extension|Overall Study||32|Number of participants who completed De-escalation period and treated in Open Label Extension Period|
48381171|NCT02504268|101261574|FG006|De-Escalation to Open Label Extension|Overall Study||22|Number of participants who completed De-escalation period and treated in Open Label Extension Period|
48381172|NCT02504268|101261575|FG007|De-Escalation to Open Label Extension|Overall Study||0|Number of participants who completed De-escalation period and treated in Open Label Extension Period|
48381173|NCT02504268|101261576|FG008|De-Escalation to Open Label Extension|Overall Study||0|Number of participants who completed De-escalation period and treated in Open Label Extension Period|
48381174|NCT02504268|101261568|FG000|Early Escaped De-Escalation to Open Label Period|Overall Study||0|Number of participants who early escaped the De-Escalation Period and treated in the Open Label Period|
48381175|NCT02504268|101261569|FG001|Early Escaped De-Escalation to Open Label Period|Overall Study||0|Number of participants who early escaped the De-Escalation Period and treated in the Open Label Period|
48381176|NCT02504268|101261570|FG002|Early Escaped De-Escalation to Open Label Period|Overall Study||0|Number of participants who early escaped the De-Escalation Period and treated in the Open Label Period|
48381177|NCT02504268|101261571|FG003|Early Escaped De-Escalation to Open Label Period|Overall Study||2|Number of participants who early escaped the De-Escalation Period and treated in the Open Label Period|
48381178|NCT02504268|101261572|FG004|Early Escaped De-Escalation to Open Label Period|Overall Study||5|Number of participants who early escaped the De-Escalation Period and treated in the Open Label Period|
48381179|NCT02504268|101261573|FG005|Early Escaped De-Escalation to Open Label Period|Overall Study||4|Number of participants who early escaped the De-Escalation Period and treated in the Open Label Period|
48381180|NCT02504268|101261574|FG006|Early Escaped De-Escalation to Open Label Period|Overall Study||3|Number of participants who early escaped the De-Escalation Period and treated in the Open Label Period|
48090212|NCT01852110|100541350|FG003|STARTED|Overall Study||0||
48090213|NCT01852110|100541351|FG004|STARTED|Overall Study||0||
48090214|NCT01852110|100541352|FG005|STARTED|Overall Study||0||
48090215|NCT01852110|100541347|FG000|Treated|Overall Study||119||
48090216|NCT01852110|100541348|FG001|Treated|Overall Study||120||
48090217|NCT01852110|100541349|FG002|Treated|Overall Study||0||
48090218|NCT01852110|100541350|FG003|Treated|Overall Study||0||
48090219|NCT01852110|100541351|FG004|Treated|Overall Study||0||
48090220|NCT01852110|100541352|FG005|Treated|Overall Study||0||
48090221|NCT01852110|100541347|FG000|COMPLETED|Overall Study||70||
48090222|NCT01852110|100541348|FG001|COMPLETED|Overall Study||74||
48090223|NCT01852110|100541349|FG002|COMPLETED|Overall Study||0||
48090224|NCT01852110|100541350|FG003|COMPLETED|Overall Study||0||
48090225|NCT01852110|100541351|FG004|COMPLETED|Overall Study||0||
48090226|NCT01852110|100541352|FG005|COMPLETED|Overall Study||0||
48090227|NCT01852110|100541347|FG000|NOT COMPLETED|Overall Study||50||
48090228|NCT01852110|100541348|FG001|NOT COMPLETED|Overall Study||46||
48090229|NCT01852110|100541349|FG002|NOT COMPLETED|Overall Study||0||
48090230|NCT01852110|100541350|FG003|NOT COMPLETED|Overall Study||0||
48090231|NCT01852110|100541351|FG004|NOT COMPLETED|Overall Study||0||
48090232|NCT01852110|100541352|FG005|NOT COMPLETED|Overall Study||0||
48090233|NCT01957553|100541353|FG000|STARTED|Test Period 1 (21 +- 1 Days)||61||
48090234|NCT01957553|100541354|FG001|STARTED|Test Period 1 (21 +- 1 Days)||66||
48090235|NCT01957553|100541353|FG000|COMPLETED|Test Period 1 (21 +- 1 Days)||54||
48090236|NCT01957553|100541354|FG001|COMPLETED|Test Period 1 (21 +- 1 Days)||63||
48090237|NCT01957553|100541353|FG000|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||7||
48090238|NCT01957553|100541354|FG001|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||3||
48254316|NCT00730847|100940233|FG000|STARTED|Overall Study||596||
48254317|NCT00730847|100940233|FG000|COMPLETED|Overall Study||465||
48254318|NCT00730847|100940233|FG000|NOT COMPLETED|Overall Study||131||
48254319|NCT01066936|100940234|FG000|STARTED|Overall Study||20||20
48254320|NCT01066936|100940234|FG000|COMPLETED|Overall Study||10||10
48254321|NCT01066936|100940234|FG000|NOT COMPLETED|Overall Study||10||10
48254322|NCT01591655|100940235|FG000|STARTED|Overall Study||240||
48254323|NCT01591655|100940236|FG001|STARTED|Overall Study||120||
48254324|NCT01591655|100940235|FG000|COMPLETED|Overall Study||168||
48254325|NCT01591655|100940236|FG001|COMPLETED|Overall Study||57||
48254326|NCT01591655|100940235|FG000|NOT COMPLETED|Overall Study||72||
48254327|NCT01591655|100940236|FG001|NOT COMPLETED|Overall Study||63||
48254328|NCT00762645|100940237|FG000|STARTED|Overall Study||16||
48254329|NCT00762645|100940238|FG001|STARTED|Overall Study||14||
48254330|NCT00762645|100940237|FG000|COMPLETED|Overall Study||12||
48254331|NCT00762645|100940238|FG001|COMPLETED|Overall Study||12||
48254332|NCT00762645|100940237|FG000|NOT COMPLETED|Overall Study||4||
48254333|NCT00762645|100940238|FG001|NOT COMPLETED|Overall Study||2||
48254334|NCT01649505|100940239|FG000|STARTED|Overall Study||1||
48254335|NCT01649505|100940240|FG001|STARTED|Overall Study||1||
48090239|NCT01957553|100541353|FG000|STARTED|Test Period 2 (21 +- 1 Days)||54||
48090240|NCT01957553|100541354|FG001|STARTED|Test Period 2 (21 +- 1 Days)||63||
48090241|NCT01957553|100541353|FG000|COMPLETED|Test Period 2 (21 +- 1 Days)||51||
48254336|NCT01649505|100940239|FG000|COMPLETED|Overall Study||0||
48254337|NCT01649505|100940240|FG001|COMPLETED|Overall Study||0||
48381181|NCT02504268|101261575|FG007|Early Escaped De-Escalation to Open Label Period|Overall Study||0|Number of participants who early escaped the De-Escalation Period and treated in the Open Label Period|
48381182|NCT02504268|101261576|FG008|Early Escaped De-Escalation to Open Label Period|Overall Study||0|Number of participants who early escaped the De-Escalation Period and treated in the Open Label Period|
48381183|NCT02504268|101261568|FG000|Open Label and Open Label Extension Period|Overall Study||0|Participants who entered Open Label and Open Label Extension Periods|
48381184|NCT02504268|101261569|FG001|Open Label and Open Label Extension Period|Overall Study||0|Participants who entered Open Label and Open Label Extension Periods|
48381185|NCT02504268|101261570|FG002|Open Label and Open Label Extension Period|Overall Study||0|Participants who entered Open Label and Open Label Extension Periods|
48381186|NCT02504268|101261571|FG003|Open Label and Open Label Extension Period|Overall Study||0|Participants who entered Open Label and Open Label Extension Periods|
48381187|NCT02504268|101261572|FG004|Open Label and Open Label Extension Period|Overall Study||0|Participants who entered Open Label and Open Label Extension Periods|
48381188|NCT02504268|101261573|FG005|Open Label and Open Label Extension Period|Overall Study||0|Participants who entered Open Label and Open Label Extension Periods|
48381189|NCT02504268|101261574|FG006|Open Label and Open Label Extension Period|Overall Study||0|Participants who entered Open Label and Open Label Extension Periods|
48381190|NCT02504268|101261575|FG007|Open Label and Open Label Extension Period|Overall Study||685|Participants who entered Open Label and Open Label Extension Periods|
48381191|NCT02504268|101261576|FG008|Open Label and Open Label Extension Period|Overall Study||120|Participants who entered Open Label and Open Label Extension Periods|
48381192|NCT02504268|101261568|FG000|COMPLETED|Overall Study||388|Completed = Completed Induction Period|
48381193|NCT02504268|101261569|FG001|COMPLETED|Overall Study||233|Completed = Completed Induction Period|
48381194|NCT02504268|101261570|FG002|COMPLETED|Overall Study||201|Completed = Completed Induction Period|
48381195|NCT02504268|101261571|FG003|COMPLETED|Overall Study||0|Completed = Completed Induction Period|
48381196|NCT02504268|101261572|FG004|COMPLETED|Overall Study||0|Completed = Completed Induction Period|
48381197|NCT02504268|101261573|FG005|COMPLETED|Overall Study||0|Completed = Completed Induction Period|
48381198|NCT02504268|101261574|FG006|COMPLETED|Overall Study||0|Completed = Completed Induction Period|
48381199|NCT02504268|101261575|FG007|COMPLETED|Overall Study||0|Completed = Completed Induction Period|
48381200|NCT02504268|101261576|FG008|COMPLETED|Overall Study||0|Completed = Completed Induction Period|
48381201|NCT02504268|101261568|FG000|NOT COMPLETED|Overall Study||63||
48381202|NCT02504268|101261569|FG001|NOT COMPLETED|Overall Study||68||
48381203|NCT02504268|101261570|FG002|NOT COMPLETED|Overall Study||41||
48381204|NCT02504268|101261571|FG003|NOT COMPLETED|Overall Study||0||
48381205|NCT02504268|101261572|FG004|NOT COMPLETED|Overall Study||0||
48381206|NCT02504268|101261573|FG005|NOT COMPLETED|Overall Study||0||
48381207|NCT02504268|101261574|FG006|NOT COMPLETED|Overall Study||0||
48381208|NCT02504268|101261575|FG007|NOT COMPLETED|Overall Study||0||
48381209|NCT02504268|101261576|FG008|NOT COMPLETED|Overall Study||0||
48381210|NCT02223455|101261577|FG000|STARTED|Overall Study||0||19
48381211|NCT02223455|101261578|FG001|STARTED|Overall Study||0||19
48381212|NCT02223455|101261579|FG002|STARTED|Overall Study||0||20
48381213|NCT02223455|101261577|FG000|COMPLETED|Overall Study||0||19
48381214|NCT02223455|101261578|FG001|COMPLETED|Overall Study||0||19
48381215|NCT02223455|101261579|FG002|COMPLETED|Overall Study||0||20
48381216|NCT02223455|101261577|FG000|NOT COMPLETED|Overall Study||0||0
48381217|NCT02223455|101261578|FG001|NOT COMPLETED|Overall Study||0||0
48381218|NCT02223455|101261579|FG002|NOT COMPLETED|Overall Study||0||0
48381219|NCT00803010|101261580|FG000|STARTED|Overall Study||37||
48381220|NCT00803010|101261581|FG001|STARTED|Overall Study||37||
48381221|NCT00803010|101261580|FG000|COMPLETED|Overall Study||37||
48381222|NCT00803010|101261581|FG001|COMPLETED|Overall Study||37||
48381223|NCT00803010|101261580|FG000|NOT COMPLETED|Overall Study||0||
48381224|NCT00803010|101261581|FG001|NOT COMPLETED|Overall Study||0||
48381225|NCT01743872|101261582|FG000|STARTED|Overall Study||23||
48381226|NCT01743872|101261582|FG000|COMPLETED|Overall Study||23||
48381227|NCT01743872|101261582|FG000|NOT COMPLETED|Overall Study||0||
48381228|NCT01912716|101261583|FG000|STARTED|Overall Study||522||
48381229|NCT01912716|101261584|FG001|STARTED|Overall Study||515||
48381230|NCT01912716|101261583|FG000|Receipt of 2nd Dose|Overall Study||511||
48381231|NCT01912716|101261584|FG001|Receipt of 2nd Dose|Overall Study||503||
48381232|NCT01912716|101261583|FG000|5-day Follow-up|Overall Study||522||
48381233|NCT01912716|101261584|FG001|5-day Follow-up|Overall Study||515||
48381234|NCT01912716|101261583|FG000|3-day Follow-up|Overall Study||521||
48381235|NCT01912716|101261584|FG001|3-day Follow-up|Overall Study||513||
48381236|NCT01912716|101261583|FG000|COMPLETED|Overall Study||522||
48381237|NCT01912716|101261584|FG001|COMPLETED|Overall Study||515||
48381238|NCT01912716|101261583|FG000|NOT COMPLETED|Overall Study||0||
48381239|NCT01912716|101261584|FG001|NOT COMPLETED|Overall Study||0||
48381240|NCT04398199|101261585|FG000|STARTED|Overall Study||1||
48381241|NCT04398199|101261585|FG000|COMPLETED|Overall Study||1||
48381242|NCT04398199|101261585|FG000|NOT COMPLETED|Overall Study||0||
48381243|NCT02921919|101261586|FG000|STARTED|Overall Study||66||
48381244|NCT02921919|101261587|FG001|STARTED|Overall Study||52||
48381245|NCT02921919|101261586|FG000|Treated|Overall Study||66||
48381246|NCT02921919|101261587|FG001|Treated|Overall Study||52||
48381247|NCT02921919|101261586|FG000|COMPLETED|Overall Study||0||
48381248|NCT02921919|101261587|FG001|COMPLETED|Overall Study||0||
48541384|NCT04867174|101662723|FG010|STARTED|Overall Study||147||
48381249|NCT02921919|101261586|FG000|NOT COMPLETED|Overall Study||66||
48381250|NCT02921919|101261587|FG001|NOT COMPLETED|Overall Study||52||
48381251|NCT02076321|101261588|FG000|STARTED|Overall Study||51||
48381252|NCT02076321|101261589|FG001|STARTED|Overall Study||51||
48381253|NCT02076321|101261588|FG000|COMPLETED|Overall Study||46||
48381254|NCT02076321|101261589|FG001|COMPLETED|Overall Study||49||
48381255|NCT02076321|101261588|FG000|NOT COMPLETED|Overall Study||5||
48381256|NCT02076321|101261589|FG001|NOT COMPLETED|Overall Study||2||
48381257|NCT01592409|101261590|FG000|STARTED|Overall Study||67||
48381258|NCT01592409|101261591|FG001|STARTED|Overall Study||32||
48381259|NCT01592409|101261590|FG000|COMPLETED|Overall Study||67||
48381260|NCT01592409|101261591|FG001|COMPLETED|Overall Study||31||
48381261|NCT01592409|101261590|FG000|NOT COMPLETED|Overall Study||0||
48381262|NCT01592409|101261591|FG001|NOT COMPLETED|Overall Study||1||
48381263|NCT00819585|101261592|FG000|STARTED|Core Study||55||
48381264|NCT00819585|101261593|FG001|STARTED|Core Study||54||
48381265|NCT00819585|101261594|FG002|STARTED|Core Study||54||
48381266|NCT00819585|101261595|FG003|STARTED|Core Study||54||
48381267|NCT00819585|101261596|FG004|STARTED|Core Study||53||
48381268|NCT00819585|101261597|FG005|STARTED|Core Study||54||
48381269|NCT00819585|101261598|FG006|STARTED|Core Study||108||
48381270|NCT00819585|101261599|FG007|STARTED|Core Study||0||
48381271|NCT00819585|101261600|FG008|STARTED|Core Study||0||
48381272|NCT00819585|101261601|FG009|STARTED|Core Study||0||
48381273|NCT00819585|101261602|FG010|STARTED|Core Study||0||
48381274|NCT00819585|101261592|FG000|Received Study Medication|Core Study||55||
48381275|NCT00819585|101261593|FG001|Received Study Medication|Core Study||54||
48381276|NCT00819585|101261594|FG002|Received Study Medication|Core Study||54||
48381277|NCT00819585|101261595|FG003|Received Study Medication|Core Study||54||
48381278|NCT00819585|101261596|FG004|Received Study Medication|Core Study||53||
48381279|NCT00819585|101261597|FG005|Received Study Medication|Core Study||53||
48381280|NCT00819585|101261598|FG006|Received Study Medication|Core Study||108||
48381281|NCT00819585|101261599|FG007|Received Study Medication|Core Study||0||
48381282|NCT00819585|101261600|FG008|Received Study Medication|Core Study||0||
48381283|NCT00819585|101261601|FG009|Received Study Medication|Core Study||0||
48381284|NCT00819585|101261602|FG010|Received Study Medication|Core Study||0||
48381285|NCT00819585|101261592|FG000|COMPLETED|Core Study||49||
48381286|NCT00819585|101261593|FG001|COMPLETED|Core Study||48||
48381287|NCT00819585|101261594|FG002|COMPLETED|Core Study||48||
48381288|NCT00819585|101261595|FG003|COMPLETED|Core Study||49||
48381289|NCT00819585|101261596|FG004|COMPLETED|Core Study||50||
48381290|NCT00819585|101261597|FG005|COMPLETED|Core Study||52||
48381291|NCT00819585|101261598|FG006|COMPLETED|Core Study||95||
48381292|NCT00819585|101261599|FG007|COMPLETED|Core Study||0||
48381293|NCT00819585|101261600|FG008|COMPLETED|Core Study||0||
48381294|NCT00819585|101261601|FG009|COMPLETED|Core Study||0||
48381295|NCT00819585|101261602|FG010|COMPLETED|Core Study||0||
48381296|NCT00819585|101261592|FG000|NOT COMPLETED|Core Study||6||
48381297|NCT00819585|101261593|FG001|NOT COMPLETED|Core Study||6||
48381298|NCT00819585|101261594|FG002|NOT COMPLETED|Core Study||6||
48381299|NCT00819585|101261595|FG003|NOT COMPLETED|Core Study||5||
48381300|NCT00819585|101261596|FG004|NOT COMPLETED|Core Study||3||
48381301|NCT00819585|101261597|FG005|NOT COMPLETED|Core Study||2||
48381302|NCT00819585|101261598|FG006|NOT COMPLETED|Core Study||13||
48381303|NCT00819585|101261599|FG007|NOT COMPLETED|Core Study||0||
48381304|NCT00819585|101261600|FG008|NOT COMPLETED|Core Study||0||
48381305|NCT00819585|101261601|FG009|NOT COMPLETED|Core Study||0||
48686277|NCT00755807|102013337|FG000|NOT COMPLETED|Acute Phase||18||
48686278|NCT00755807|102013338|FG001|NOT COMPLETED|Acute Phase||12||
48686279|NCT00755807|102013337|FG000|STARTED|Open-label Extension Phase||100||
48686280|NCT00755807|102013338|FG001|STARTED|Open-label Extension Phase||109||
48686281|NCT00755807|102013337|FG000|COMPLETED|Open-label Extension Phase||82||
48381306|NCT00819585|101261602|FG010|NOT COMPLETED|Core Study||0||
48381307|NCT00819585|101261592|FG000|STARTED|Extension Study||0||
48381308|NCT00819585|101261593|FG001|STARTED|Extension Study||0||
48381309|NCT00819585|101261594|FG002|STARTED|Extension Study||0||
48381310|NCT00819585|101261595|FG003|STARTED|Extension Study||0||
48381311|NCT00819585|101261596|FG004|STARTED|Extension Study||0||
48381312|NCT00819585|101261597|FG005|STARTED|Extension Study||0||
48381313|NCT00819585|101261598|FG006|STARTED|Extension Study||0||
48381314|NCT00819585|101261599|FG007|STARTED|Extension Study||75||
48686282|NCT00755807|102013338|FG001|COMPLETED|Open-label Extension Phase||93||
48686283|NCT00755807|102013337|FG000|NOT COMPLETED|Open-label Extension Phase||18||
48686284|NCT00755807|102013338|FG001|NOT COMPLETED|Open-label Extension Phase||16||
48686285|NCT02336815|102013339|FG000|STARTED|Overall Study||79||
48686286|NCT02336815|102013340|FG001|STARTED|Overall Study||123||
48381315|NCT00819585|101261600|FG008|STARTED|Extension Study||181||
48381316|NCT00819585|101261601|FG009|STARTED|Extension Study||25||
48381317|NCT00819585|101261602|FG010|STARTED|Extension Study||60||
48381318|NCT00819585|101261592|FG000|COMPLETED|Extension Study||0||
48381319|NCT00819585|101261593|FG001|COMPLETED|Extension Study||0||
48381320|NCT00819585|101261594|FG002|COMPLETED|Extension Study||0||
48381321|NCT00819585|101261595|FG003|COMPLETED|Extension Study||0||
48381322|NCT00819585|101261596|FG004|COMPLETED|Extension Study||0||
48686287|NCT02336815|102013339|FG000|COMPLETED|Overall Study||0||
48381323|NCT00819585|101261597|FG005|COMPLETED|Extension Study||0||
48381324|NCT00819585|101261598|FG006|COMPLETED|Extension Study||0||
48381325|NCT00819585|101261599|FG007|COMPLETED|Extension Study||75||
48381326|NCT00819585|101261600|FG008|COMPLETED|Extension Study||173||
48381327|NCT00819585|101261601|FG009|COMPLETED|Extension Study||24||
48381328|NCT00819585|101261602|FG010|COMPLETED|Extension Study||58||
48381329|NCT00819585|101261592|FG000|NOT COMPLETED|Extension Study||0||
48381330|NCT00819585|101261593|FG001|NOT COMPLETED|Extension Study||0||
48381331|NCT00819585|101261594|FG002|NOT COMPLETED|Extension Study||0||
48381332|NCT00819585|101261595|FG003|NOT COMPLETED|Extension Study||0||
48381333|NCT00819585|101261596|FG004|NOT COMPLETED|Extension Study||0||
48381334|NCT00819585|101261597|FG005|NOT COMPLETED|Extension Study||0||
48381335|NCT00819585|101261598|FG006|NOT COMPLETED|Extension Study||0||
48381336|NCT00819585|101261599|FG007|NOT COMPLETED|Extension Study||0||
48686288|NCT02336815|102013340|FG001|COMPLETED|Overall Study||0||
48686289|NCT02336815|102013339|FG000|NOT COMPLETED|Overall Study||79||
48686290|NCT02336815|102013340|FG001|NOT COMPLETED|Overall Study||123||
48686291|NCT01107964|102013341|FG000|STARTED|Overall Study||13||
48686292|NCT01107964|102013342|FG001|STARTED|Overall Study||14||
48686293|NCT01107964|102013341|FG000|COMPLETED|Overall Study||12||
48686294|NCT01107964|102013342|FG001|COMPLETED|Overall Study||13||
48686295|NCT01107964|102013341|FG000|NOT COMPLETED|Overall Study||1||
48254338|NCT01649505|100940239|FG000|NOT COMPLETED|Overall Study||1||
48254339|NCT01649505|100940240|FG001|NOT COMPLETED|Overall Study||1||
48254340|NCT00654615|100940241|FG000|STARTED|Overall Study||30||
48254341|NCT00654615|100940242|FG001|STARTED|Overall Study||30||
48254342|NCT00654615|100940241|FG000|COMPLETED|Overall Study||22||
48254343|NCT00654615|100940242|FG001|COMPLETED|Overall Study||23||
48254344|NCT00654615|100940241|FG000|NOT COMPLETED|Overall Study||8||
48254345|NCT00654615|100940242|FG001|NOT COMPLETED|Overall Study||7||
48254346|NCT00197119|100940243|FG000|STARTED|Year 6||126||
48254347|NCT00197119|100940244|FG001|STARTED|Year 6||118||
48254348|NCT00197119|100940243|FG000|COMPLETED|Year 6||126||
48254349|NCT00197119|100940244|FG001|COMPLETED|Year 6||118||
48254350|NCT00197119|100940243|FG000|NOT COMPLETED|Year 6||0||
48254351|NCT00197119|100940244|FG001|NOT COMPLETED|Year 6||0||
48254352|NCT00197119|100940243|FG000|STARTED|Year 7||122||
48254353|NCT00197119|100940244|FG001|STARTED|Year 7||114||
48254354|NCT00197119|100940243|FG000|COMPLETED|Year 7||122||
48254355|NCT00197119|100940244|FG001|COMPLETED|Year 7||114||
48254356|NCT00197119|100940243|FG000|NOT COMPLETED|Year 7||0||
48254357|NCT00197119|100940244|FG001|NOT COMPLETED|Year 7||0||
48254358|NCT00197119|100940243|FG000|STARTED|Year 8||122||
48254359|NCT00197119|100940244|FG001|STARTED|Year 8||115||
48254360|NCT00197119|100940243|FG000|COMPLETED|Year 8||122||
48254361|NCT00197119|100940244|FG001|COMPLETED|Year 8||115||
48254362|NCT00197119|100940243|FG000|NOT COMPLETED|Year 8||0||
48254363|NCT00197119|100940244|FG001|NOT COMPLETED|Year 8||0||
48254364|NCT00197119|100940243|FG000|STARTED|Year 9||121||
48254365|NCT00197119|100940244|FG001|STARTED|Year 9||114||
48254366|NCT00197119|100940243|FG000|COMPLETED|Year 9||121||
48254367|NCT00197119|100940244|FG001|COMPLETED|Year 9||114||
48254368|NCT00197119|100940243|FG000|NOT COMPLETED|Year 9||0||
48254369|NCT00197119|100940244|FG001|NOT COMPLETED|Year 9||0||
48381337|NCT00819585|101261600|FG008|NOT COMPLETED|Extension Study||8||
48381338|NCT00819585|101261601|FG009|NOT COMPLETED|Extension Study||1||
48381339|NCT00819585|101261602|FG010|NOT COMPLETED|Extension Study||2||
48381340|NCT01029886|101261603|FG000|STARTED|Overall Study||461||
48381341|NCT01029886|101261604|FG001|STARTED|Overall Study||451||
48381342|NCT01029886|101261603|FG000|Intent to Treat (ITT)|Overall Study||461||
48381343|NCT01029886|101261604|FG001|Intent to Treat (ITT)|Overall Study||450||
48381344|NCT01029886|101261603|FG000|COMPLETED|Overall Study||400||
48686296|NCT01107964|102013342|FG001|NOT COMPLETED|Overall Study||1||
48686297|NCT01847092|102013343|FG000|STARTED|Overall Study||77||
48686298|NCT01847092|102013344|FG001|STARTED|Overall Study||77||
48686299|NCT01847092|102013343|FG000|COMPLETED|Overall Study||51||
48686300|NCT01847092|102013344|FG001|COMPLETED|Overall Study||66||
48686301|NCT01847092|102013343|FG000|NOT COMPLETED|Overall Study||26||
48686302|NCT01847092|102013344|FG001|NOT COMPLETED|Overall Study||11||
48254370|NCT00197119|100940243|FG000|STARTED|Year 10||120||
48254371|NCT00197119|100940244|FG001|STARTED|Year 10||108||
48254372|NCT00197119|100940243|FG000|COMPLETED|Year 10||120||
48254373|NCT00197119|100940244|FG001|COMPLETED|Year 10||108||
48254374|NCT00197119|100940243|FG000|NOT COMPLETED|Year 10||0||
48254375|NCT00197119|100940244|FG001|NOT COMPLETED|Year 10||0||
48686303|NCT03951610|102013345|FG000|STARTED|First Intervention||27||
48686304|NCT03951610|102013346|FG001|STARTED|First Intervention||25||
48686305|NCT03951610|102013345|FG000|COMPLETED|First Intervention||27||
48686306|NCT03951610|102013346|FG001|COMPLETED|First Intervention||25||
48381345|NCT01029886|101261604|FG001|COMPLETED|Overall Study||391||
48686307|NCT03951610|102013345|FG000|NOT COMPLETED|First Intervention||0||
48381346|NCT01029886|101261603|FG000|NOT COMPLETED|Overall Study||61||
48381347|NCT01029886|101261604|FG001|NOT COMPLETED|Overall Study||60||
48254376|NCT00383630|100940245|FG000|STARTED|Overall Study||1||
48254377|NCT00383630|100940245|FG000|COMPLETED|Overall Study||1||
48381348|NCT02431468|101261605|FG000|STARTED|Overall Study||46|Safety Analysis set|
48381349|NCT02431468|101261606|FG001|STARTED|Overall Study||47|Safety Analysis set|
48381350|NCT02431468|101261607|FG002|STARTED|Overall Study||48|Safety Analysis set|
48381351|NCT02431468|101261605|FG000|COMPLETED|Overall Study||38||
48381352|NCT02431468|101261606|FG001|COMPLETED|Overall Study||29||
48381353|NCT02431468|101261607|FG002|COMPLETED|Overall Study||39||
48381354|NCT02431468|101261605|FG000|NOT COMPLETED|Overall Study||8||
48381355|NCT02431468|101261606|FG001|NOT COMPLETED|Overall Study||18||
48381356|NCT02431468|101261607|FG002|NOT COMPLETED|Overall Study||9||
48381357|NCT02094872|101261608|FG000|STARTED|Overall Study||49||
48381358|NCT02094872|101261608|FG000|Received Biopsy|Overall Study||37||
48381359|NCT02094872|101261608|FG000|Received Tumor-board Recommendation|Overall Study||36||
48381360|NCT02094872|101261608|FG000|Received Targeted Therapy|Overall Study||20||
48381361|NCT02094872|101261608|FG000|Received Standard of Care|Overall Study||9||
48381362|NCT02094872|101261608|FG000|Patients Treated With MEK162|Overall Study||20|Total patients treated with MEK162 for final primary endpoint (following study redesign)|
48381363|NCT02094872|101261608|FG000|COMPLETED|Overall Study||20||
48381364|NCT02094872|101261608|FG000|NOT COMPLETED|Overall Study||29||
48381365|NCT01879176|101261609|FG000|STARTED|Overall Study||24||
48381366|NCT01879176|101261610|FG001|STARTED|Overall Study||22||
48381367|NCT01879176|101261609|FG000|COMPLETED|Overall Study||16||
48381368|NCT01879176|101261610|FG001|COMPLETED|Overall Study||16||
48381369|NCT01879176|101261609|FG000|NOT COMPLETED|Overall Study||8||
48381370|NCT01879176|101261610|FG001|NOT COMPLETED|Overall Study||6||
48381371|NCT04348591|101261611|FG000|STARTED|Imaging Session (120 Min)||29||
48381372|NCT04348591|101261612|FG001|STARTED|Imaging Session (120 Min)||30||
48381373|NCT04348591|101261611|FG000|COMPLETED|Imaging Session (120 Min)||27||
48254378|NCT00383630|100940245|FG000|NOT COMPLETED|Overall Study||0||
48254379|NCT02624869|100940246|FG000|STARTED|Overall Study||49||
48254380|NCT02624869|100940247|FG001|STARTED|Overall Study||101||
48254381|NCT02624869|100940248|FG002|STARTED|Overall Study||13||
48254382|NCT02624869|100940246|FG000|Received Study Drug|Overall Study||49||
48254383|NCT02624869|100940247|FG001|Received Study Drug|Overall Study||101||
48254384|NCT02624869|100940248|FG002|Received Study Drug|Overall Study||12||
48254385|NCT02624869|100940246|FG000|COMPLETED|Overall Study||48||
48254386|NCT02624869|100940247|FG001|COMPLETED|Overall Study||98||
48254387|NCT02624869|100940248|FG002|COMPLETED|Overall Study||11||
48254388|NCT02624869|100940246|FG000|NOT COMPLETED|Overall Study||1||
48254389|NCT02624869|100940247|FG001|NOT COMPLETED|Overall Study||3||
48254390|NCT02624869|100940248|FG002|NOT COMPLETED|Overall Study||2||
48254391|NCT01262118|100940249|FG000|STARTED|Baseline Assessment Period (3 Days)||36||
48254392|NCT01262118|100940250|FG001|STARTED|Baseline Assessment Period (3 Days)||33||
48254393|NCT01262118|100940249|FG000|COMPLETED|Baseline Assessment Period (3 Days)||36||
48254394|NCT01262118|100940250|FG001|COMPLETED|Baseline Assessment Period (3 Days)||33||
48254395|NCT01262118|100940249|FG000|NOT COMPLETED|Baseline Assessment Period (3 Days)||0||
48254396|NCT01262118|100940250|FG001|NOT COMPLETED|Baseline Assessment Period (3 Days)||0||
48254397|NCT01262118|100940249|FG000|STARTED|Treatment Period (6 Weeks)||36||
48254398|NCT01262118|100940250|FG001|STARTED|Treatment Period (6 Weeks)||0||
48254399|NCT01262118|100940249|FG000|COMPLETED|Treatment Period (6 Weeks)||36||
48254400|NCT01262118|100940250|FG001|COMPLETED|Treatment Period (6 Weeks)||0||
48254401|NCT01262118|100940249|FG000|NOT COMPLETED|Treatment Period (6 Weeks)||0||
48254402|NCT01262118|100940250|FG001|NOT COMPLETED|Treatment Period (6 Weeks)||0||
48254403|NCT00383747|100943685|FG000|STARTED|Visit 1||14||
48254404|NCT00383747|100943686|FG001|STARTED|Visit 1||14||
48254405|NCT00383747|100943687|FG002|STARTED|Visit 1||16||
48381374|NCT04348591|101261612|FG001|COMPLETED|Imaging Session (120 Min)||27||
48381375|NCT04348591|101261611|FG000|NOT COMPLETED|Imaging Session (120 Min)||2||
48381376|NCT04348591|101261612|FG001|NOT COMPLETED|Imaging Session (120 Min)||3||
48381377|NCT04348591|101261611|FG000|STARTED|CR Training (45 Min)||27||
48381378|NCT04348591|101261612|FG001|STARTED|CR Training (45 Min)||27||
48381379|NCT04348591|101261611|FG000|COMPLETED|CR Training (45 Min)||27||
48381380|NCT04348591|101261612|FG001|COMPLETED|CR Training (45 Min)||27||
48381381|NCT04348591|101261611|FG000|NOT COMPLETED|CR Training (45 Min)||0||
48254406|NCT00383747|100943688|FG003|STARTED|Visit 1||16||
48254407|NCT00383747|100943685|FG000|COMPLETED|Visit 1||14||
48254408|NCT00383747|100943686|FG001|COMPLETED|Visit 1||14||
48254409|NCT00383747|100943687|FG002|COMPLETED|Visit 1||16||
48254410|NCT00383747|100943688|FG003|COMPLETED|Visit 1||16||
48254411|NCT00383747|100943685|FG000|NOT COMPLETED|Visit 1||0||
48254412|NCT00383747|100943686|FG001|NOT COMPLETED|Visit 1||0||
48254413|NCT00383747|100943687|FG002|NOT COMPLETED|Visit 1||0||
48254414|NCT00383747|100943688|FG003|NOT COMPLETED|Visit 1||0||
48254415|NCT00383747|100943685|FG000|STARTED|Visit 2||14||
48381382|NCT04348591|101261612|FG001|NOT COMPLETED|CR Training (45 Min)||0||
48381383|NCT04348591|101261611|FG000|STARTED|Experimental Task (45 Min)||27||
48381384|NCT04348591|101261612|FG001|STARTED|Experimental Task (45 Min)||27||
48254416|NCT00383747|100943686|FG001|STARTED|Visit 2||14||
48254417|NCT00383747|100943687|FG002|STARTED|Visit 2||16||
48254418|NCT00383747|100943688|FG003|STARTED|Visit 2||16||
48254419|NCT00383747|100943685|FG000|COMPLETED|Visit 2||14||
48254420|NCT00383747|100943686|FG001|COMPLETED|Visit 2||14||
48254421|NCT00383747|100943687|FG002|COMPLETED|Visit 2||16||
48254422|NCT00383747|100943688|FG003|COMPLETED|Visit 2||16||
48254423|NCT00383747|100943685|FG000|NOT COMPLETED|Visit 2||0||
48254424|NCT00383747|100943686|FG001|NOT COMPLETED|Visit 2||0||
48254425|NCT00383747|100943687|FG002|NOT COMPLETED|Visit 2||0||
48254426|NCT00383747|100943688|FG003|NOT COMPLETED|Visit 2||0||
48254427|NCT02406495|100943689|FG000|STARTED|Overall Study||40||
48254428|NCT02406495|100943689|FG000|COMPLETED|Overall Study||40||
48254429|NCT02406495|100943689|FG000|NOT COMPLETED|Overall Study||0||
48254430|NCT00935259|100943690|FG000|STARTED|Period 1||16||
48254431|NCT00935259|100943691|FG001|STARTED|Period 1||15||
48254432|NCT00935259|100943690|FG000|COMPLETED|Period 1||15||
48254433|NCT00935259|100943691|FG001|COMPLETED|Period 1||14||
48254434|NCT00935259|100943690|FG000|NOT COMPLETED|Period 1||1||
48254435|NCT00935259|100943691|FG001|NOT COMPLETED|Period 1||1||
48254436|NCT00935259|100943690|FG000|STARTED|Period 2||15||
48254437|NCT00935259|100943691|FG001|STARTED|Period 2||14||
48254438|NCT00935259|100943690|FG000|COMPLETED|Period 2||15||
48254439|NCT00935259|100943691|FG001|COMPLETED|Period 2||14||
48254440|NCT00935259|100943690|FG000|NOT COMPLETED|Period 2||0||
48254441|NCT00935259|100943691|FG001|NOT COMPLETED|Period 2||0||
48254442|NCT00721214|100943692|FG000|STARTED|Overall Study||16||
48254443|NCT00721214|100943692|FG000|COMPLETED|Overall Study||12||
48254444|NCT00721214|100943692|FG000|NOT COMPLETED|Overall Study||4||
48254445|NCT00711997|100943693|FG000|STARTED|Overall Study||3||
48254446|NCT00711997|100943694|FG001|STARTED|Overall Study||6||
48254447|NCT00711997|100943693|FG000|COMPLETED|Overall Study||3||
48254448|NCT00711997|100943694|FG001|COMPLETED|Overall Study||6||
48254449|NCT00711997|100943693|FG000|NOT COMPLETED|Overall Study||0||
48254450|NCT00711997|100943694|FG001|NOT COMPLETED|Overall Study||0||
48254451|NCT05479747|100943695|FG000|STARTED|Overall Study||15||
48254452|NCT05479747|100943696|FG001|STARTED|Overall Study||15||
48254453|NCT05479747|100943697|FG002|STARTED|Overall Study||15||
48254454|NCT05479747|100943698|FG003|STARTED|Overall Study||15||
48254455|NCT05479747|100943695|FG000|COMPLETED|Overall Study||15||
48254456|NCT05479747|100943696|FG001|COMPLETED|Overall Study||15||
48254457|NCT05479747|100943697|FG002|COMPLETED|Overall Study||15||
48254458|NCT05479747|100943698|FG003|COMPLETED|Overall Study||15||
48254459|NCT05479747|100943695|FG000|NOT COMPLETED|Overall Study||0||
48254460|NCT05479747|100943696|FG001|NOT COMPLETED|Overall Study||0||
48254461|NCT05479747|100943697|FG002|NOT COMPLETED|Overall Study||0||
48254462|NCT05479747|100943698|FG003|NOT COMPLETED|Overall Study||0||
48254463|NCT03181282|100943699|FG000|STARTED|Overall Study||15||
48254464|NCT03181282|100943700|FG001|STARTED|Overall Study||14||
48254465|NCT03181282|100943699|FG000|COMPLETED|Overall Study||14||
48254466|NCT03181282|100943700|FG001|COMPLETED|Overall Study||14||
48254467|NCT03181282|100943699|FG000|NOT COMPLETED|Overall Study||1||
48254468|NCT03181282|100943700|FG001|NOT COMPLETED|Overall Study||0||
48254469|NCT03849768|100943701|FG000|STARTED|Overall Study||214||
48254470|NCT03849768|100943702|FG001|STARTED|Overall Study||215||
48254471|NCT03849768|100943701|FG000|COMPLETED|Overall Study||121||
48254472|NCT03849768|100943702|FG001|COMPLETED|Overall Study||181||
48254473|NCT03849768|100943701|FG000|NOT COMPLETED|Overall Study||93||
48254474|NCT03849768|100943702|FG001|NOT COMPLETED|Overall Study||34||
48254475|NCT02856490|100943703|FG000|STARTED|Overall Study||2||
48254476|NCT02856490|100943704|FG001|STARTED|Overall Study||2||
48254477|NCT02856490|100943705|FG002|STARTED|Overall Study||2||
48254478|NCT02856490|100943703|FG000|COMPLETED|Overall Study||2||
48254479|NCT02856490|100943704|FG001|COMPLETED|Overall Study||2||
48254480|NCT02856490|100943705|FG002|COMPLETED|Overall Study||2||
48254481|NCT02856490|100943703|FG000|NOT COMPLETED|Overall Study||0||
48254482|NCT02856490|100943704|FG001|NOT COMPLETED|Overall Study||0||
48254483|NCT02856490|100943705|FG002|NOT COMPLETED|Overall Study||0||
48254484|NCT01143883|100943706|FG000|STARTED|Overall Study||55||
48254485|NCT01143883|100943707|FG001|STARTED|Overall Study||55||
48254486|NCT01143883|100943706|FG000|COMPLETED|Overall Study||55||
48254487|NCT01143883|100943707|FG001|COMPLETED|Overall Study||55||
48254488|NCT01143883|100943706|FG000|NOT COMPLETED|Overall Study||0||
48254489|NCT01143883|100943707|FG001|NOT COMPLETED|Overall Study||0||
48254490|NCT02507687|100943708|FG000|STARTED|Overall Study||29||
48254491|NCT02507687|100943709|FG001|STARTED|Overall Study||28||
48254492|NCT02507687|100943710|FG002|STARTED|Overall Study||92||
48254493|NCT02507687|100943711|FG003|STARTED|Overall Study||91||
48254494|NCT02507687|100943708|FG000|Received Treatment|Overall Study||29|Participants are counted as treated if either eye received study treatment.|
48254495|NCT02507687|100943709|FG001|Received Treatment|Overall Study||27|Participants are counted as treated if either eye received study treatment.|
48254496|NCT02507687|100943710|FG002|Received Treatment|Overall Study||90|Participants are counted as treated if either eye received study treatment.|
48254497|NCT02507687|100943711|FG003|Received Treatment|Overall Study||90|Participants are counted as treated if either eye received study treatment.|
48254498|NCT02507687|100943708|FG000|COMPLETED|Overall Study||24||
48254499|NCT02507687|100943709|FG001|COMPLETED|Overall Study||22||
48254500|NCT02507687|100943710|FG002|COMPLETED|Overall Study||77||
48254501|NCT02507687|100943711|FG003|COMPLETED|Overall Study||78||
48254502|NCT02507687|100943708|FG000|NOT COMPLETED|Overall Study||5||
48254503|NCT02507687|100943709|FG001|NOT COMPLETED|Overall Study||6||
48254504|NCT02507687|100943710|FG002|NOT COMPLETED|Overall Study||15||
48254505|NCT02507687|100943711|FG003|NOT COMPLETED|Overall Study||13||
48254506|NCT00195442|100943712|FG000|STARTED|Overall Study||288||
48254507|NCT00195442|100943712|FG000|COMPLETED|Overall Study||152||
48254508|NCT00195442|100943712|FG000|NOT COMPLETED|Overall Study||136||
48254509|NCT00576823|100943713|FG000|STARTED|12-week Efficacy Phase||12||
48090242|NCT01957553|100541354|FG001|COMPLETED|Test Period 2 (21 +- 1 Days)||56||
48090243|NCT01957553|100541353|FG000|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||3||
48090244|NCT01957553|100541354|FG001|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||7||
48381385|NCT04348591|101261611|FG000|Completed Sham rTMS Experimental Condition|Experimental Task (45 Min)||26|Each participant listened to neutral, aversive, and misophonic trigger sounds that were personalized while receiving sham neurostimulation|
48381386|NCT04348591|101261612|FG001|Completed Sham rTMS Experimental Condition|Experimental Task (45 Min)||27|Each participant listened to neutral, aversive, and misophonic trigger sounds that were personalized while receiving sham neurostimulation|
48381387|NCT04348591|101261611|FG000|Completed HF rTMS Over the Right dlPFC Experimental Condition|Experimental Task (45 Min)||26|Each participant listened to neutral, aversive, and misophonic trigger sounds that were personalized while receiving high frequency neurostimulation over the right dlPFC|
48381388|NCT04348591|101261612|FG001|Completed HF rTMS Over the Right dlPFC Experimental Condition|Experimental Task (45 Min)||27|Each participant listened to neutral, aversive, and misophonic trigger sounds that were personalized while receiving high frequency neurostimulation over the right dlPFC|
48090245|NCT01824901|100541355|FG000|STARTED|Overall Study||2||
48381389|NCT04348591|101261611|FG000|Completed LF rTMS Over the Right mPFC Experimental Condition|Experimental Task (45 Min)||27|Each participant listened to neutral, aversive, and misophonic trigger sounds that were personalized while receiving low frequency neurostimulation over the right mPFC|
48381390|NCT04348591|101261612|FG001|Completed LF rTMS Over the Right mPFC Experimental Condition|Experimental Task (45 Min)||27|Each participant listened to neutral, aversive, and misophonic trigger sounds that were personalized while receiving low frequency neurostimulation over the right mPFC|
48381391|NCT04348591|101261611|FG000|COMPLETED|Experimental Task (45 Min)||27||
48381392|NCT04348591|101261612|FG001|COMPLETED|Experimental Task (45 Min)||27||
48381393|NCT04348591|101261611|FG000|NOT COMPLETED|Experimental Task (45 Min)||0||
48381394|NCT04348591|101261612|FG001|NOT COMPLETED|Experimental Task (45 Min)||0||
48381395|NCT02509494|101261613|FG000|STARTED|Overall Study||43||
48381396|NCT02509494|101261614|FG001|STARTED|Overall Study||298||
48381397|NCT02509494|101261615|FG002|STARTED|Overall Study||102||
48686308|NCT03951610|102013346|FG001|NOT COMPLETED|First Intervention||0||
48686309|NCT03951610|102013345|FG000|STARTED|Second Intervention||27||
48686310|NCT03951610|102013346|FG001|STARTED|Second Intervention||25||
48686311|NCT03951610|102013345|FG000|COMPLETED|Second Intervention||27||
48686312|NCT03951610|102013346|FG001|COMPLETED|Second Intervention||25||
48090246|NCT01824901|100541356|FG001|STARTED|Overall Study||0||
48090247|NCT01824901|100541357|FG002|STARTED|Overall Study||0||
48090248|NCT01824901|100541358|FG003|STARTED|Overall Study||0||
48090249|NCT01824901|100541355|FG000|COMPLETED|Overall Study||2||
48090250|NCT01824901|100541356|FG001|COMPLETED|Overall Study||0||
48090251|NCT01824901|100541357|FG002|COMPLETED|Overall Study||0||
48090252|NCT01824901|100541358|FG003|COMPLETED|Overall Study||0||
48090253|NCT01824901|100541355|FG000|NOT COMPLETED|Overall Study||0||
48090254|NCT01824901|100541356|FG001|NOT COMPLETED|Overall Study||0||
48090255|NCT01824901|100541357|FG002|NOT COMPLETED|Overall Study||0||
48090256|NCT01824901|100541358|FG003|NOT COMPLETED|Overall Study||0||
48090257|NCT01288469|100541359|FG000|STARTED|Overall Study||31||
48090258|NCT01288469|100541360|FG001|STARTED|Overall Study||31||
48090259|NCT01288469|100541361|FG002|STARTED|Overall Study||30||
48090260|NCT01288469|100541359|FG000|Treated|Overall Study||31||
48090261|NCT01288469|100541360|FG001|Treated|Overall Study||31||
48090262|NCT01288469|100541361|FG002|Treated|Overall Study||30||
48090263|NCT01288469|100541359|FG000|COMPLETED|Overall Study||24||
48090264|NCT01288469|100541360|FG001|COMPLETED|Overall Study||28||
48090265|NCT01288469|100541361|FG002|COMPLETED|Overall Study||28||
48090266|NCT01288469|100541359|FG000|NOT COMPLETED|Overall Study||7||
48090267|NCT01288469|100541360|FG001|NOT COMPLETED|Overall Study||3||
48090268|NCT01288469|100541361|FG002|NOT COMPLETED|Overall Study||2||
48090269|NCT00001596|100541362|FG000|STARTED|Overall Study||23||
48090270|NCT00001596|100541363|FG001|STARTED|Overall Study||12||
48090271|NCT00001596|100541362|FG000|COMPLETED|Overall Study||6||
48090272|NCT00001596|100541363|FG001|COMPLETED|Overall Study||2||
48090273|NCT00001596|100541362|FG000|NOT COMPLETED|Overall Study||17||
48090274|NCT00001596|100541363|FG001|NOT COMPLETED|Overall Study||10||
48090275|NCT01798004|100541364|FG000|STARTED|Overall Study||150||
48090276|NCT01798004|100541364|FG000|COMPLETED|Overall Study||63||
48090277|NCT01798004|100541364|FG000|NOT COMPLETED|Overall Study||87||
48090278|NCT00319644|100545503|FG000|STARTED|Overall Study||21||
48090279|NCT00319644|100545504|FG001|STARTED|Overall Study||16||
48090280|NCT00319644|100545503|FG000|COMPLETED|Overall Study||21||
48090281|NCT00319644|100545504|FG001|COMPLETED|Overall Study||16||
48090282|NCT00319644|100545503|FG000|NOT COMPLETED|Overall Study||0||
48254510|NCT00576823|100943714|FG001|STARTED|12-week Efficacy Phase||6||
48254511|NCT00576823|100943715|FG002|STARTED|12-week Efficacy Phase||7||
48254512|NCT00576823|100943713|FG000|COMPLETED|12-week Efficacy Phase||11||
48381398|NCT02509494|101261616|FG003|STARTED|Overall Study||143||
48381399|NCT02509494|101261617|FG004|STARTED|Overall Study||48||
48381400|NCT02509494|101261618|FG005|STARTED|Overall Study||144||
48381401|NCT02509494|101261619|FG006|STARTED|Overall Study||48||
48381402|NCT02509494|101261620|FG007|STARTED|Overall Study||144||
48381403|NCT02509494|101261621|FG008|STARTED|Overall Study||48||
48381404|NCT02509494|101261613|FG000|COMPLETED|Overall Study||28||
48381405|NCT02509494|101261614|FG001|COMPLETED|Overall Study||217||
48381406|NCT02509494|101261615|FG002|COMPLETED|Overall Study||64||
48381407|NCT02509494|101261616|FG003|COMPLETED|Overall Study||132||
48381408|NCT02509494|101261617|FG004|COMPLETED|Overall Study||43||
48381409|NCT02509494|101261618|FG005|COMPLETED|Overall Study||133||
48381410|NCT02509494|101261619|FG006|COMPLETED|Overall Study||45||
48381411|NCT02509494|101261620|FG007|COMPLETED|Overall Study||137||
48381412|NCT02509494|101261621|FG008|COMPLETED|Overall Study||46||
48381413|NCT02509494|101261613|FG000|NOT COMPLETED|Overall Study||15||
48381414|NCT02509494|101261614|FG001|NOT COMPLETED|Overall Study||81||
48381415|NCT02509494|101261615|FG002|NOT COMPLETED|Overall Study||38||
48381416|NCT02509494|101261616|FG003|NOT COMPLETED|Overall Study||11||
48381417|NCT02509494|101261617|FG004|NOT COMPLETED|Overall Study||5||
48381418|NCT02509494|101261618|FG005|NOT COMPLETED|Overall Study||11||
48381419|NCT02509494|101261619|FG006|NOT COMPLETED|Overall Study||3||
48381420|NCT02509494|101261620|FG007|NOT COMPLETED|Overall Study||7||
48381421|NCT02509494|101261621|FG008|NOT COMPLETED|Overall Study||2||
48381422|NCT00622869|101261622|FG000|STARTED|Overall Study||245||
48381423|NCT00622869|101261623|FG001|STARTED|Overall Study||231||
48090283|NCT00319644|100545504|FG001|NOT COMPLETED|Overall Study||0||
48090284|NCT04557371|100545505|FG000|STARTED|Overall Study||50||
48381424|NCT00622869|101261624|FG002|STARTED|Overall Study||243||
48381425|NCT00622869|101261622|FG000|COMPLETED|Overall Study||202||
48381426|NCT00622869|101261623|FG001|COMPLETED|Overall Study||174||
48381427|NCT00622869|101261624|FG002|COMPLETED|Overall Study||204||
48381428|NCT00622869|101261622|FG000|NOT COMPLETED|Overall Study||43||
48381429|NCT00622869|101261623|FG001|NOT COMPLETED|Overall Study||57||
48381430|NCT00622869|101261624|FG002|NOT COMPLETED|Overall Study||39||
48381431|NCT01262755|101261625|FG000|STARTED|Overall Study||450||
48381432|NCT01262755|101261625|FG000|COMPLETED|Overall Study||450||
48381433|NCT01262755|101261625|FG000|NOT COMPLETED|Overall Study||0||
48381434|NCT01647464|101261626|FG000|STARTED|Overall Study||10||
48381435|NCT01647464|101261626|FG000|COMPLETED|Overall Study||10||
48381436|NCT01647464|101261626|FG000|NOT COMPLETED|Overall Study||0||
48381437|NCT00138424|101261627|FG000|STARTED|Overall Study||9||
48381438|NCT00138424|101261628|FG001|STARTED|Overall Study||5||
48381439|NCT00138424|101261629|FG002|STARTED|Overall Study||5||
48381440|NCT00138424|101261630|FG003|STARTED|Overall Study||3||
48381441|NCT00138424|101261627|FG000|COMPLETED|Overall Study||9||
48686313|NCT03951610|102013345|FG000|NOT COMPLETED|Second Intervention||0||
48686314|NCT03951610|102013346|FG001|NOT COMPLETED|Second Intervention||0||
48686315|NCT02897115|102013347|FG000|STARTED|Overall Study||14||
48686316|NCT02897115|102013348|FG001|STARTED|Overall Study||8||
48686317|NCT02897115|102013347|FG000|COMPLETED|Overall Study||3||
48686318|NCT02897115|102013348|FG001|COMPLETED|Overall Study||0||
48686319|NCT02897115|102013347|FG000|NOT COMPLETED|Overall Study||11||
48686320|NCT02897115|102013348|FG001|NOT COMPLETED|Overall Study||8||
48686321|NCT02248766|102013349|FG000|STARTED|Overall Study||30||
48686322|NCT02248766|102013349|FG000|COMPLETED|Overall Study||30||
48686323|NCT02248766|102013349|FG000|NOT COMPLETED|Overall Study||0||
48686324|NCT01118780|102013350|FG000|STARTED|Overall Study||151||
48686325|NCT01118780|102013351|FG001|STARTED|Overall Study||140||
48090285|NCT04557371|100545506|FG001|STARTED|Overall Study||49||
48090286|NCT04557371|100545507|FG002|STARTED|Overall Study||51||
48090287|NCT04557371|100545505|FG000|COMPLETED|Overall Study||49||
48090288|NCT04557371|100545506|FG001|COMPLETED|Overall Study||47||
48090289|NCT04557371|100545507|FG002|COMPLETED|Overall Study||51||
48090290|NCT04557371|100545505|FG000|NOT COMPLETED|Overall Study||1||
48090291|NCT04557371|100545506|FG001|NOT COMPLETED|Overall Study||2||
48090292|NCT04557371|100545507|FG002|NOT COMPLETED|Overall Study||0||
48090293|NCT03506815|100545508|FG000|STARTED|Overall Study||52||
48090294|NCT03506815|100545509|FG001|STARTED|Overall Study||53||
48090295|NCT03506815|100545508|FG000|COMPLETED|Overall Study||37||
48090296|NCT03506815|100545509|FG001|COMPLETED|Overall Study||53||
48090297|NCT03506815|100545508|FG000|NOT COMPLETED|Overall Study||15||
48090298|NCT03506815|100545509|FG001|NOT COMPLETED|Overall Study||0||
48090299|NCT02532933|100545510|FG000|STARTED|Overall Study||22||
48090300|NCT02532933|100545511|FG001|STARTED|Overall Study||22||
48090301|NCT02532933|100545510|FG000|COMPLETED|Overall Study||16||
48090302|NCT02532933|100545511|FG001|COMPLETED|Overall Study||16||
48090303|NCT02532933|100545510|FG000|NOT COMPLETED|Overall Study||6||
48090304|NCT02532933|100545511|FG001|NOT COMPLETED|Overall Study||6||
48090305|NCT00779467|100545512|FG000|STARTED|Overall Study||53||
48090306|NCT00779467|100545513|FG001|STARTED|Overall Study||45||
48090307|NCT00779467|100545514|FG002|STARTED|Overall Study||48||
48090308|NCT00779467|100545515|FG003|STARTED|Overall Study||54||
48090309|NCT00779467|100545512|FG000|COMPLETED|Overall Study||38||
48090310|NCT00779467|100545513|FG001|COMPLETED|Overall Study||40||
48090311|NCT00779467|100545514|FG002|COMPLETED|Overall Study||38||
48090312|NCT00779467|100545515|FG003|COMPLETED|Overall Study||35||
48090313|NCT00779467|100545512|FG000|NOT COMPLETED|Overall Study||15||
48090314|NCT00779467|100545513|FG001|NOT COMPLETED|Overall Study||5||
48090315|NCT00779467|100545514|FG002|NOT COMPLETED|Overall Study||10||
48090316|NCT00779467|100545515|FG003|NOT COMPLETED|Overall Study||19||
48090317|NCT01781403|100545516|FG000|STARTED|Overall Study||2||
48090318|NCT01781403|100545517|FG001|STARTED|Overall Study||2||
48090319|NCT01781403|100545518|FG002|STARTED|Overall Study||18||
48090320|NCT01781403|100545516|FG000|COMPLETED|Overall Study||2||
48090321|NCT01781403|100545517|FG001|COMPLETED|Overall Study||2||
48090322|NCT01781403|100545518|FG002|COMPLETED|Overall Study||18||
48090323|NCT01781403|100545516|FG000|NOT COMPLETED|Overall Study||0||
48090324|NCT01781403|100545517|FG001|NOT COMPLETED|Overall Study||0||
48686326|NCT01118780|102013350|FG000|COMPLETED|Overall Study||115||
48686327|NCT01118780|102013351|FG001|COMPLETED|Overall Study||105||
48090325|NCT01781403|100545518|FG002|NOT COMPLETED|Overall Study||0||
48090326|NCT01694641|100545519|FG000|STARTED|Overall Study||80||
48090327|NCT01694641|100545520|FG001|STARTED|Overall Study||81||
48090328|NCT01694641|100545519|FG000|COMPLETED|Overall Study||68||
48381442|NCT00138424|101261628|FG001|COMPLETED|Overall Study||4||
48381443|NCT00138424|101261629|FG002|COMPLETED|Overall Study||5||
48381444|NCT00138424|101261630|FG003|COMPLETED|Overall Study||3||
48381445|NCT00138424|101261627|FG000|NOT COMPLETED|Overall Study||0||
48381446|NCT00138424|101261628|FG001|NOT COMPLETED|Overall Study||1||
48381447|NCT00138424|101261629|FG002|NOT COMPLETED|Overall Study||0||
48381448|NCT00138424|101261630|FG003|NOT COMPLETED|Overall Study||0||
48381449|NCT00165646|101261631|FG000|STARTED|Overall Study||93||
48381450|NCT00165646|101261632|FG001|STARTED|Overall Study||93||
48686328|NCT01118780|102013350|FG000|NOT COMPLETED|Overall Study||36||
48090329|NCT01694641|100545520|FG001|COMPLETED|Overall Study||71||
48090330|NCT01694641|100545519|FG000|NOT COMPLETED|Overall Study||12||
48090331|NCT01694641|100545520|FG001|NOT COMPLETED|Overall Study||10||
48090332|NCT00459108|100545521|FG000|STARTED|Overall Study||25||
48090333|NCT00459108|100545521|FG000|COMPLETED|Overall Study||14||
48090334|NCT00459108|100545521|FG000|NOT COMPLETED|Overall Study||11||
48090335|NCT01635101|100545522|FG000|STARTED|Overall Study||61||
48090336|NCT01635101|100545523|FG001|STARTED|Overall Study||67||
48090337|NCT01635101|100545524|FG002|STARTED|Overall Study||69||
48090338|NCT01635101|100545522|FG000|Safety Population|Overall Study||61||
48090339|NCT01635101|100545523|FG001|Safety Population|Overall Study||67||
48090340|NCT01635101|100545524|FG002|Safety Population|Overall Study||69||
48381451|NCT00165646|101261633|FG002|STARTED|Overall Study||102||
48381452|NCT00165646|101261631|FG000|COMPLETED|Overall Study||88||
48381453|NCT00165646|101261632|FG001|COMPLETED|Overall Study||88||
48381454|NCT00165646|101261633|FG002|COMPLETED|Overall Study||98||
48381455|NCT00165646|101261631|FG000|NOT COMPLETED|Overall Study||5||
48381456|NCT00165646|101261632|FG001|NOT COMPLETED|Overall Study||5||
48381457|NCT00165646|101261633|FG002|NOT COMPLETED|Overall Study||4||
48090341|NCT01635101|100545522|FG000|Modified Intent to Treat (mITT)|Overall Study||61||
48090342|NCT01635101|100545523|FG001|Modified Intent to Treat (mITT)|Overall Study||67||
48090343|NCT01635101|100545524|FG002|Modified Intent to Treat (mITT)|Overall Study||69||
48381458|NCT02607254|101261634|FG000|STARTED|Overall Study||3||
48090344|NCT01635101|100545522|FG000|Pharmacokinetics Evaluable Population|Overall Study||50||
48090345|NCT01635101|100545523|FG001|Pharmacokinetics Evaluable Population|Overall Study||59||
48090346|NCT01635101|100545524|FG002|Pharmacokinetics Evaluable Population|Overall Study||58||
48090347|NCT01635101|100545522|FG000|COMPLETED|Overall Study||52||
48090348|NCT01635101|100545523|FG001|COMPLETED|Overall Study||55||
48254513|NCT00576823|100943714|FG001|COMPLETED|12-week Efficacy Phase||6||
48254514|NCT00576823|100943715|FG002|COMPLETED|12-week Efficacy Phase||7||
48090349|NCT01635101|100545524|FG002|COMPLETED|Overall Study||52||
48090350|NCT01635101|100545522|FG000|NOT COMPLETED|Overall Study||9||
48090351|NCT01635101|100545523|FG001|NOT COMPLETED|Overall Study||12||
48090352|NCT01635101|100545524|FG002|NOT COMPLETED|Overall Study||17||
48090353|NCT01601626|100545525|FG000|STARTED|Overall Study||24||
48090354|NCT01601626|100545526|FG001|STARTED|Overall Study||24||
48090355|NCT01601626|100545527|FG002|STARTED|Overall Study||23||
48090356|NCT01601626|100545525|FG000|COMPLETED|Overall Study||21||
48090357|NCT01601626|100545526|FG001|COMPLETED|Overall Study||19||
48090358|NCT01601626|100545527|FG002|COMPLETED|Overall Study||21||
48090359|NCT01601626|100545525|FG000|NOT COMPLETED|Overall Study||3||
48090360|NCT01601626|100545526|FG001|NOT COMPLETED|Overall Study||5||
48090361|NCT01601626|100545527|FG002|NOT COMPLETED|Overall Study||2||
48090362|NCT02423577|100545528|FG000|STARTED|Overall Study||53||
48090363|NCT02423577|100545529|FG001|STARTED|Overall Study||26||
48090364|NCT02423577|100545528|FG000|COMPLETED|Overall Study||53||
48090365|NCT02423577|100545529|FG001|COMPLETED|Overall Study||26||
48090366|NCT02423577|100545528|FG000|NOT COMPLETED|Overall Study||0||
48090367|NCT02423577|100545529|FG001|NOT COMPLETED|Overall Study||0||
48090368|NCT00418314|100545530|FG000|STARTED|Overall Study||817||
48090369|NCT00418314|100545531|FG001|STARTED|Overall Study||830||
48090370|NCT00418314|100545530|FG000|COMPLETED|Overall Study||816||
48090371|NCT00418314|100545531|FG001|COMPLETED|Overall Study||828||
48090372|NCT00418314|100545530|FG000|NOT COMPLETED|Overall Study||1||
48090373|NCT00418314|100545531|FG001|NOT COMPLETED|Overall Study||2||
48090374|NCT01571427|100545532|FG000|STARTED|Overall Study||41||
48090375|NCT01571427|100545533|FG001|STARTED|Overall Study||42||
48090376|NCT01571427|100545532|FG000|COMPLETED|Overall Study||41||
48090377|NCT01571427|100545533|FG001|COMPLETED|Overall Study||42||
48090378|NCT01571427|100545532|FG000|NOT COMPLETED|Overall Study||0||
48090379|NCT01571427|100545533|FG001|NOT COMPLETED|Overall Study||0||
48090380|NCT04044716|100545534|FG000|STARTED|Overall Study||30||
48090381|NCT04044716|100545535|FG001|STARTED|Overall Study||30||
48090382|NCT04044716|100545536|FG002|STARTED|Overall Study||5||
48090383|NCT04044716|100545534|FG000|COMPLETED|Overall Study||27||
48090384|NCT04044716|100545535|FG001|COMPLETED|Overall Study||27||
48090385|NCT04044716|100545536|FG002|COMPLETED|Overall Study||5||
48090386|NCT04044716|100545534|FG000|NOT COMPLETED|Overall Study||3||
48090387|NCT04044716|100545535|FG001|NOT COMPLETED|Overall Study||3||
48090388|NCT04044716|100545536|FG002|NOT COMPLETED|Overall Study||0||
48254515|NCT00576823|100943713|FG000|NOT COMPLETED|12-week Efficacy Phase||1||
48254516|NCT00576823|100943714|FG001|NOT COMPLETED|12-week Efficacy Phase||0||
48254517|NCT00576823|100943715|FG002|NOT COMPLETED|12-week Efficacy Phase||0||
48254518|NCT00576823|100943713|FG000|STARTED|40-week Safety Extension Phase||11||
48254519|NCT00576823|100943714|FG001|STARTED|40-week Safety Extension Phase||6||
48090389|NCT03187262|100545537|FG000|STARTED|Induction||13||
48090390|NCT03187262|100545537|FG000|COMPLETED|Induction||7||
48090391|NCT03187262|100545537|FG000|NOT COMPLETED|Induction||6||
48090392|NCT03187262|100545537|FG000|STARTED|Consolidation||7||
48090393|NCT03187262|100545537|FG000|COMPLETED|Consolidation||2||
48090394|NCT03187262|100545537|FG000|NOT COMPLETED|Consolidation||5||
48090395|NCT03187262|100545537|FG000|STARTED|Maintenance||2||
48090396|NCT03187262|100545537|FG000|COMPLETED|Maintenance||2||
48381459|NCT02607254|101261635|FG001|STARTED|Overall Study||3||
48381460|NCT02607254|101261636|FG002|STARTED|Overall Study||5||
48381461|NCT02607254|101261634|FG000|COMPLETED|Overall Study||3||
48381462|NCT02607254|101261635|FG001|COMPLETED|Overall Study||3||
48381463|NCT02607254|101261636|FG002|COMPLETED|Overall Study||5||
48090397|NCT03187262|100545537|FG000|NOT COMPLETED|Maintenance||0||
48090398|NCT00919724|100545538|FG000|STARTED|Overall Study||45||
48090399|NCT00919724|100545539|FG001|STARTED|Overall Study||44||
48090400|NCT00919724|100545538|FG000|COMPLETED|Overall Study||45||
48090401|NCT00919724|100545539|FG001|COMPLETED|Overall Study||44||
48090402|NCT00919724|100545538|FG000|NOT COMPLETED|Overall Study||0||
48090403|NCT00919724|100545539|FG001|NOT COMPLETED|Overall Study||0||
48090404|NCT03457129|100545540|FG000|STARTED|Overall Study||10||
48090405|NCT03457129|100545541|FG001|STARTED|Overall Study||10||
48090406|NCT03457129|100545540|FG000|COMPLETED|Overall Study||7||
48090407|NCT03457129|100545541|FG001|COMPLETED|Overall Study||8||
48090408|NCT03457129|100545540|FG000|NOT COMPLETED|Overall Study||3||
48090409|NCT03457129|100545541|FG001|NOT COMPLETED|Overall Study||2||
48090410|NCT02282020|100545542|FG000|STARTED|Overall Study||178||
48090411|NCT02282020|100545543|FG001|STARTED|Overall Study||88||
48090412|NCT02282020|100545542|FG000|Received Treatment|Overall Study||178||
48090413|NCT02282020|100545543|FG001|Received Treatment|Overall Study||76||
48090414|NCT02282020|100545542|FG000|COMPLETED|Overall Study||19|Ongoing study treatment at time of analysis DCO: 16 April 2021|
48254520|NCT00576823|100943715|FG002|STARTED|40-week Safety Extension Phase||6||
48254521|NCT00576823|100943713|FG000|COMPLETED|40-week Safety Extension Phase||10||
48254522|NCT00576823|100943714|FG001|COMPLETED|40-week Safety Extension Phase||6||
48686329|NCT01118780|102013351|FG001|NOT COMPLETED|Overall Study||35||
48686330|NCT02973997|102013352|FG000|STARTED|Overall Study||30||
48686331|NCT02973997|102013353|FG001|STARTED|Overall Study||25||
48686332|NCT02973997|102013352|FG000|COMPLETED|Overall Study||8||
48686333|NCT02973997|102013353|FG001|COMPLETED|Overall Study||2||
48686334|NCT02973997|102013352|FG000|NOT COMPLETED|Overall Study||22||
48686335|NCT02973997|102013353|FG001|NOT COMPLETED|Overall Study||23||
48686336|NCT00924001|102013354|FG000|STARTED|Overall Study||1||
48686337|NCT00924001|102013354|FG000|COMPLETED|Overall Study||1||
48686338|NCT00924001|102013354|FG000|NOT COMPLETED|Overall Study||0||
48686339|NCT02163577|102013355|FG000|STARTED|Overall Study||26||
48686340|NCT02163577|102013356|FG001|STARTED|Overall Study||26||
48686341|NCT02163577|102013355|FG000|COMPLETED|Overall Study||26||
48686342|NCT02163577|102013356|FG001|COMPLETED|Overall Study||26||
48686343|NCT02163577|102013355|FG000|NOT COMPLETED|Overall Study||0||
48686344|NCT02163577|102013356|FG001|NOT COMPLETED|Overall Study||0||
48686345|NCT01890265|102013357|FG000|STARTED|Overall Study||50||
48686346|NCT01890265|102013358|FG001|STARTED|Overall Study||53||
48686347|NCT01890265|102013359|FG002|STARTED|Overall Study||24||
48686348|NCT01890265|102013360|FG003|STARTED|Overall Study||12||
48686349|NCT01890265|102013361|FG004|STARTED|Overall Study||15||
48686350|NCT01890265|102013362|FG005|STARTED|Overall Study||6||
48686351|NCT01890265|102013357|FG000|Safety Population|Overall Study||50|Population included randomized participants who received any amount of study medication.|
48686352|NCT01890265|102013358|FG001|Safety Population|Overall Study||53|Population included randomized participants who received any amount of study medication.|
48686353|NCT01890265|102013359|FG002|Safety Population|Overall Study||24|Population included randomized participants who received any amount of study medication.|
48686354|NCT01890265|102013360|FG003|Safety Population|Overall Study||12|Population included randomized participants who received any amount of study medication.|
48686355|NCT01890265|102013361|FG004|Safety Population|Overall Study||15|Population included randomized participants who received any amount of study medication.|
48686356|NCT01890265|102013362|FG005|Safety Population|Overall Study||6|Population included randomized participants who received any amount of study medication.|
48686357|NCT01890265|102013357|FG000|Intent-to-Treat (ITT) Population|Overall Study||50|Population included participants who were randomized and met all protocol eligibility criteria.|
48686358|NCT01890265|102013358|FG001|Intent-to-Treat (ITT) Population|Overall Study||51|Population included participants who were randomized and met all protocol eligibility criteria.|
48686359|NCT01890265|102013359|FG002|Intent-to-Treat (ITT) Population|Overall Study||24|Population included participants who were randomized and met all protocol eligibility criteria.|
48686360|NCT01890265|102013360|FG003|Intent-to-Treat (ITT) Population|Overall Study||12|Population included participants who were randomized and met all protocol eligibility criteria.|
48686361|NCT01890265|102013361|FG004|Intent-to-Treat (ITT) Population|Overall Study||15|Population included participants who were randomized and met all protocol eligibility criteria.|
48686362|NCT01890265|102013362|FG005|Intent-to-Treat (ITT) Population|Overall Study||6|Population included participants who were randomized and met all protocol eligibility criteria.|
48686363|NCT01890265|102013357|FG000|COMPLETED|Overall Study||40||
48686364|NCT01890265|102013358|FG001|COMPLETED|Overall Study||40||
48686365|NCT01890265|102013359|FG002|COMPLETED|Overall Study||20||
48090415|NCT02282020|100545543|FG001|COMPLETED|Overall Study||0|Ongoing study treatment at time of analysis DCO: 16 April 2021|
48090416|NCT02282020|100545542|FG000|NOT COMPLETED|Overall Study||159||
48090417|NCT02282020|100545543|FG001|NOT COMPLETED|Overall Study||88||
48090418|NCT02734238|100545544|FG000|STARTED|Overall Study||26||
48090419|NCT02734238|100545545|FG001|STARTED|Overall Study||24||
48090420|NCT02734238|100545544|FG000|COMPLETED|Overall Study||26||
48090421|NCT02734238|100545545|FG001|COMPLETED|Overall Study||24||
48090422|NCT02734238|100545544|FG000|NOT COMPLETED|Overall Study||0||
48090423|NCT02734238|100545545|FG001|NOT COMPLETED|Overall Study||0||
48090424|NCT01190878|100545546|FG000|STARTED|Overall Study||40||
48090425|NCT01190878|100545547|FG001|STARTED|Overall Study||45||
48090426|NCT01190878|100545548|FG002|STARTED|Overall Study||42||
48090427|NCT01190878|100545549|FG003|STARTED|Overall Study||42||
48090428|NCT01190878|100545546|FG000|COMPLETED|Overall Study||37||
48090429|NCT01190878|100545547|FG001|COMPLETED|Overall Study||42||
48090430|NCT01190878|100545548|FG002|COMPLETED|Overall Study||37||
48090431|NCT01190878|100545549|FG003|COMPLETED|Overall Study||22||
48090432|NCT01190878|100545546|FG000|NOT COMPLETED|Overall Study||3||
48254523|NCT00576823|100943715|FG002|COMPLETED|40-week Safety Extension Phase||6||
48686366|NCT01890265|102013360|FG003|COMPLETED|Overall Study||12||
48686367|NCT01890265|102013361|FG004|COMPLETED|Overall Study||13||
48686368|NCT01890265|102013362|FG005|COMPLETED|Overall Study||6||
48686369|NCT01890265|102013357|FG000|NOT COMPLETED|Overall Study||10||
48686370|NCT01890265|102013358|FG001|NOT COMPLETED|Overall Study||13||
48686371|NCT01890265|102013359|FG002|NOT COMPLETED|Overall Study||4||
48090433|NCT01190878|100545547|FG001|NOT COMPLETED|Overall Study||3||
48090434|NCT01190878|100545548|FG002|NOT COMPLETED|Overall Study||5||
48090435|NCT01190878|100545549|FG003|NOT COMPLETED|Overall Study||20||
48090436|NCT03327649|100545550|FG000|STARTED|Overall Study||26||
48090437|NCT03327649|100545551|FG001|STARTED|Overall Study||26||
48254524|NCT00576823|100943713|FG000|NOT COMPLETED|40-week Safety Extension Phase||1||
48254525|NCT00576823|100943714|FG001|NOT COMPLETED|40-week Safety Extension Phase||0||
48686372|NCT01890265|102013360|FG003|NOT COMPLETED|Overall Study||0||
48686373|NCT01890265|102013361|FG004|NOT COMPLETED|Overall Study||2||
48686374|NCT01890265|102013362|FG005|NOT COMPLETED|Overall Study||0||
48090438|NCT03327649|100545550|FG000|COMPLETED|Overall Study||24||
48090439|NCT03327649|100545551|FG001|COMPLETED|Overall Study||24||
48090440|NCT03327649|100545550|FG000|NOT COMPLETED|Overall Study||2||
48090441|NCT03327649|100545551|FG001|NOT COMPLETED|Overall Study||2||
48090442|NCT02470234|100545552|FG000|STARTED|Overall Study||5||
48254526|NCT00576823|100943715|FG002|NOT COMPLETED|40-week Safety Extension Phase||0||
48254527|NCT01101464|100943716|FG000|STARTED|Day 1 Through AM Dose of Day 5||4||
48254528|NCT01101464|100943717|FG001|STARTED|Day 1 Through AM Dose of Day 5||4||
48254529|NCT01101464|100943716|FG000|COMPLETED|Day 1 Through AM Dose of Day 5||4||
48254530|NCT01101464|100943717|FG001|COMPLETED|Day 1 Through AM Dose of Day 5||4||
48254531|NCT01101464|100943716|FG000|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0||
48254532|NCT01101464|100943717|FG001|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0||
48254533|NCT01101464|100943716|FG000|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4||
48254534|NCT01101464|100943717|FG001|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4||
48254535|NCT01101464|100943716|FG000|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4||
48254536|NCT01101464|100943717|FG001|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4||
48254537|NCT01101464|100943716|FG000|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0||
48254538|NCT01101464|100943717|FG001|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0||
48254539|NCT03544229|100943718|FG000|STARTED|Overall Study||73||
48254540|NCT03544229|100943719|FG001|STARTED|Overall Study||23||
48686375|NCT01042158|102013363|FG000|STARTED|Overall Study||25||
48686376|NCT01042158|102013363|FG000|COMPLETED|Overall Study||24||
48686377|NCT01042158|102013363|FG000|NOT COMPLETED|Overall Study||1||
48686378|NCT03135431|102013364|FG000|STARTED|Overall Study||20||
48686379|NCT03135431|102013365|FG001|STARTED|Overall Study||20||
48686380|NCT03135431|102013364|FG000|COMPLETED|Overall Study||18||
48686381|NCT03135431|102013365|FG001|COMPLETED|Overall Study||20||
48686382|NCT03135431|102013364|FG000|NOT COMPLETED|Overall Study||2||
48686383|NCT03135431|102013365|FG001|NOT COMPLETED|Overall Study||0||
48686384|NCT00972517|102016818|FG000|STARTED|Overall Study||31||
48686385|NCT00972517|102016819|FG001|STARTED|Overall Study||31||
48686386|NCT00972517|102016820|FG002|STARTED|Overall Study||60||
48686387|NCT00972517|102016821|FG003|STARTED|Overall Study||30||
48686388|NCT00972517|102016822|FG004|STARTED|Overall Study||34||
48686389|NCT00972517|102016823|FG005|STARTED|Overall Study||58||
48686390|NCT00972517|102016818|FG000|COMPLETED|Overall Study||31||
48686391|NCT00972517|102016819|FG001|COMPLETED|Overall Study||30||
48686392|NCT00972517|102016820|FG002|COMPLETED|Overall Study||60||
48686393|NCT00972517|102016821|FG003|COMPLETED|Overall Study||27||
48686394|NCT00972517|102016822|FG004|COMPLETED|Overall Study||33||
48686395|NCT00972517|102016823|FG005|COMPLETED|Overall Study||58||
48686396|NCT00972517|102016818|FG000|NOT COMPLETED|Overall Study||0||
48686397|NCT00972517|102016819|FG001|NOT COMPLETED|Overall Study||1||
48686398|NCT00972517|102016820|FG002|NOT COMPLETED|Overall Study||0||
48686399|NCT00972517|102016821|FG003|NOT COMPLETED|Overall Study||3||
48686400|NCT00972517|102016822|FG004|NOT COMPLETED|Overall Study||1||
48686401|NCT00972517|102016823|FG005|NOT COMPLETED|Overall Study||0||
48686402|NCT02781571|102016824|FG000|STARTED|Overall Study||79||
48686403|NCT02781571|102016824|FG000|COMPLETED|Overall Study||79||
48090443|NCT02470234|100545553|FG001|STARTED|Overall Study||3||
48090444|NCT02470234|100545554|FG002|STARTED|Overall Study||2||
48090445|NCT02470234|100545552|FG000|COMPLETED|Overall Study||5||
48254541|NCT03544229|100943720|FG002|STARTED|Overall Study||72||
48686404|NCT02781571|102016824|FG000|NOT COMPLETED|Overall Study||0||
48686405|NCT00648648|102016825|FG000|STARTED|Overall Study||3|Started = Randomized|
48686406|NCT00648648|102016826|FG001|STARTED|Overall Study||3|Started = Randomized|
48686407|NCT00648648|102016827|FG002|STARTED|Overall Study||3|Started = Randomized|
48686408|NCT00648648|102016828|FG003|STARTED|Overall Study||4|Started = Randomized|
48686409|NCT00648648|102016829|FG004|STARTED|Overall Study||9|Started = Randomized|
48686410|NCT00648648|102016830|FG005|STARTED|Overall Study||1|Started = Randomized|
48686411|NCT00648648|102016831|FG006|STARTED|Overall Study||10|Started = Randomized|
48090446|NCT02470234|100545553|FG001|COMPLETED|Overall Study||3||
48254542|NCT03544229|100943721|FG003|STARTED|Overall Study||74||
48254543|NCT03544229|100943718|FG000|COMPLETED|Overall Study||67||
48254544|NCT03544229|100943719|FG001|COMPLETED|Overall Study||21||
48254545|NCT03544229|100943720|FG002|COMPLETED|Overall Study||67||
48254546|NCT03544229|100943721|FG003|COMPLETED|Overall Study||72||
48254547|NCT03544229|100943718|FG000|NOT COMPLETED|Overall Study||6||
48254548|NCT03544229|100943719|FG001|NOT COMPLETED|Overall Study||2||
48254549|NCT03544229|100943720|FG002|NOT COMPLETED|Overall Study||5||
48254550|NCT03544229|100943721|FG003|NOT COMPLETED|Overall Study||2||
48686412|NCT00648648|102016832|FG007|STARTED|Overall Study||1|Started = Randomized|
48686413|NCT00648648|102016833|FG008|STARTED|Overall Study||3|Started = Randomized|
48686414|NCT00648648|102016834|FG009|STARTED|Overall Study||10|Started = Randomized|
48686415|NCT00648648|102016835|FG010|STARTED|Overall Study||6|Started = Randomized|
48090447|NCT02470234|100545554|FG002|COMPLETED|Overall Study||2||
48090448|NCT02470234|100545552|FG000|NOT COMPLETED|Overall Study||0||
48090449|NCT02470234|100545553|FG001|NOT COMPLETED|Overall Study||0||
48090450|NCT02470234|100545554|FG002|NOT COMPLETED|Overall Study||0||
48254551|NCT03311269|100943722|FG000|STARTED|Overall Study||10||
48254552|NCT03311269|100943723|FG001|STARTED|Overall Study||9||
48254553|NCT03311269|100943722|FG000|COMPLETED|Overall Study||10||
48254554|NCT03311269|100943723|FG001|COMPLETED|Overall Study||9||
48254555|NCT03311269|100943722|FG000|NOT COMPLETED|Overall Study||0||
48254556|NCT03311269|100943723|FG001|NOT COMPLETED|Overall Study||0||
48254557|NCT01530087|100943724|FG000|STARTED|Overall Study||3||
48254558|NCT01530087|100943724|FG000|COMPLETED|Overall Study||1||
48381464|NCT02607254|101261634|FG000|NOT COMPLETED|Overall Study||0||
48381465|NCT02607254|101261635|FG001|NOT COMPLETED|Overall Study||0||
48381466|NCT02607254|101261636|FG002|NOT COMPLETED|Overall Study||0||
48381467|NCT02012608|101261637|FG000|STARTED|Overall Study||7||
48090451|NCT02530554|100545555|FG000|STARTED|Overall Study||12|14 total participants,12 treated on all 4 sites \& 2 treated on 2 sites with both interventions.|12
48090452|NCT02530554|100545556|FG001|STARTED|Overall Study||14|14 total participants,12 treated on all 4 sites \& 2 treated on 2 sites with both interventions.|14
48090453|NCT02530554|100545557|FG002|STARTED|Overall Study||12|14 total participants,12 treated on all 4 sites \& 2 treated on 2 sites with both interventions.|12
48090454|NCT02530554|100545558|FG003|STARTED|Overall Study||14|14 total participants,12 treated on all 4 sites \& 2 treated on 2 sites with both interventions.|14
48090455|NCT02530554|100545555|FG000|COMPLETED|Overall Study||12||12
48090456|NCT02530554|100545556|FG001|COMPLETED|Overall Study||14||14
48090457|NCT02530554|100545557|FG002|COMPLETED|Overall Study||12||12
48090458|NCT02530554|100545558|FG003|COMPLETED|Overall Study||14||14
48090459|NCT02530554|100545555|FG000|NOT COMPLETED|Overall Study||0||0
48090460|NCT02530554|100545556|FG001|NOT COMPLETED|Overall Study||0||0
48090461|NCT02530554|100545557|FG002|NOT COMPLETED|Overall Study||0||0
48090462|NCT02530554|100545558|FG003|NOT COMPLETED|Overall Study||0||0
48090463|NCT00233103|100545559|FG000|STARTED|Overall Study||27||
48090464|NCT00233103|100545560|FG001|STARTED|Overall Study||25||
48090465|NCT00233103|100545559|FG000|COMPLETED|Overall Study||22||
48090466|NCT00233103|100545560|FG001|COMPLETED|Overall Study||19||
48090467|NCT00233103|100545559|FG000|NOT COMPLETED|Overall Study||5||
48090468|NCT00233103|100545560|FG001|NOT COMPLETED|Overall Study||6||
48090469|NCT00106392|100545561|FG000|STARTED|Overall Study||62||
48090470|NCT00106392|100545562|FG001|STARTED|Overall Study||69||
48090471|NCT00106392|100545561|FG000|Baseline Participants|Overall Study||59||
48090472|NCT00106392|100545562|FG001|Baseline Participants|Overall Study||65||
48090473|NCT00106392|100545561|FG000|Full Analysis Set (FAS)|Overall Study||53||
48090474|NCT00106392|100545562|FG001|Full Analysis Set (FAS)|Overall Study||61||
48090475|NCT00106392|100545561|FG000|COMPLETED|Overall Study||36||
48090476|NCT00106392|100545562|FG001|COMPLETED|Overall Study||42||
48090477|NCT00106392|100545561|FG000|NOT COMPLETED|Overall Study||26||
48090478|NCT00106392|100545562|FG001|NOT COMPLETED|Overall Study||27||
48090479|NCT03958955|100545563|FG000|STARTED|Overall Study||27||
48090480|NCT03958955|100545563|FG000|Lesions Treated With Delgocitinib Cream|Overall Study||27|All subjects had one target lesion treated with delgocitinib cream|
48090481|NCT03958955|100545563|FG000|Lesions Treated With Delgocitinib Cream Vehicle|Overall Study||27|All subjects had one target lesion treated with delgocitinib cream vehicle|
48090482|NCT03958955|100545563|FG000|COMPLETED|Overall Study||26||
48090483|NCT03958955|100545563|FG000|NOT COMPLETED|Overall Study||1||
48090484|NCT05392998|100545564|FG000|STARTED|Overall Study||30||
48090485|NCT05392998|100545564|FG000|COMPLETED|Overall Study||30||
48090486|NCT05392998|100545564|FG000|NOT COMPLETED|Overall Study||0||
48090487|NCT01519414|100545565|FG000|STARTED|Pre Cross-over||52||
48090488|NCT01519414|100545566|FG001|STARTED|Pre Cross-over||26||
48090489|NCT01519414|100545567|FG002|STARTED|Pre Cross-over||0||
48381468|NCT02012608|101261638|FG001|STARTED|Overall Study||7||
48381469|NCT02012608|101261637|FG000|COMPLETED|Overall Study||4||
48381470|NCT02012608|101261638|FG001|COMPLETED|Overall Study||7||
48381471|NCT02012608|101261637|FG000|NOT COMPLETED|Overall Study||3||
48090490|NCT01519414|100545565|FG000|COMPLETED|Pre Cross-over||52||
48090491|NCT01519414|100545566|FG001|COMPLETED|Pre Cross-over||26||
48090492|NCT01519414|100545567|FG002|COMPLETED|Pre Cross-over||0||
48090493|NCT01519414|100545565|FG000|NOT COMPLETED|Pre Cross-over||0||
48090494|NCT01519414|100545566|FG001|NOT COMPLETED|Pre Cross-over||0||
48090495|NCT01519414|100545567|FG002|NOT COMPLETED|Pre Cross-over||0||
48090496|NCT01519414|100545565|FG000|STARTED|Post Cross-over||52||
48090497|NCT01519414|100545566|FG001|STARTED|Post Cross-over||14||
48090498|NCT01519414|100545567|FG002|STARTED|Post Cross-over||12||
48090499|NCT01519414|100545565|FG000|COMPLETED|Post Cross-over||52||
48090500|NCT01519414|100545566|FG001|COMPLETED|Post Cross-over||14||
48090501|NCT01519414|100545567|FG002|COMPLETED|Post Cross-over||12||
48090502|NCT01519414|100545565|FG000|NOT COMPLETED|Post Cross-over||0||
48090503|NCT01519414|100545566|FG001|NOT COMPLETED|Post Cross-over||0||
48090504|NCT01519414|100545567|FG002|NOT COMPLETED|Post Cross-over||0||
48090505|NCT02267811|100545568|FG000|STARTED|Overall Study||16||
48254559|NCT01530087|100943724|FG000|NOT COMPLETED|Overall Study||2||
48254560|NCT02652390|100943725|FG000|STARTED|Overall Study||37||
48381472|NCT02012608|101261638|FG001|NOT COMPLETED|Overall Study||0||
48686416|NCT00648648|102016836|FG011|STARTED|Overall Study||13|Started = Randomized|
48686417|NCT00648648|102016837|FG012|STARTED|Overall Study||6|Started = Randomized|
48686418|NCT00648648|102016838|FG013|STARTED|Overall Study||5|Started = Randomized|
48686419|NCT00648648|102016839|FG014|STARTED|Overall Study||4|Started = Randomized|
48686420|NCT00648648|102016840|FG015|STARTED|Overall Study||11|Started = Randomized|
48686421|NCT00648648|102016841|FG016|STARTED|Overall Study||16|Started = Randomized|
48686422|NCT00648648|102016842|FG017|STARTED|Overall Study||6|Started = Randomized|
48686423|NCT00648648|102016843|FG018|STARTED|Overall Study||5|Started = Randomized|
48686424|NCT00648648|102016844|FG019|STARTED|Overall Study||7|Started = Randomized|
48686425|NCT00648648|102016845|FG020|STARTED|Overall Study||6|Started = Randomized|
48686426|NCT00648648|102016846|FG021|STARTED|Overall Study||10|Started = Randomized|
48686427|NCT00648648|102016847|FG022|STARTED|Overall Study||14|Started = Randomized|
48090506|NCT02267811|100545569|FG001|STARTED|Overall Study||17||
48090507|NCT02267811|100545568|FG000|COMPLETED|Overall Study||15||
48090508|NCT02267811|100545569|FG001|COMPLETED|Overall Study||15||
48254561|NCT02652390|100943726|FG001|STARTED|Overall Study||37||
48254562|NCT02652390|100943727|FG002|STARTED|Overall Study||37||
48254563|NCT02652390|100943725|FG000|COMPLETED|Overall Study||37||
48254564|NCT02652390|100943726|FG001|COMPLETED|Overall Study||37||
48254565|NCT02652390|100943727|FG002|COMPLETED|Overall Study||37||
48254566|NCT02652390|100943725|FG000|NOT COMPLETED|Overall Study||0||
48254567|NCT02652390|100943726|FG001|NOT COMPLETED|Overall Study||0||
48254568|NCT02652390|100943727|FG002|NOT COMPLETED|Overall Study||0||
48686428|NCT00648648|102016848|FG023|STARTED|Overall Study||4|Started = Randomized|
48686429|NCT00648648|102016849|FG024|STARTED|Overall Study||4|Started = Randomized|
48686430|NCT00648648|102016850|FG025|STARTED|Overall Study||4|Started = Randomized|
48686431|NCT00648648|102016851|FG026|STARTED|Overall Study||26|Started = Randomized|
48686432|NCT00648648|102016852|FG027|STARTED|Overall Study||12|Started = Randomized|
48090509|NCT02267811|100545568|FG000|NOT COMPLETED|Overall Study||1||
48090510|NCT02267811|100545569|FG001|NOT COMPLETED|Overall Study||2||
48090511|NCT02763189|100545570|FG000|STARTED|Overall Study||4||
48090512|NCT02763189|100545571|FG001|STARTED|Overall Study||4||
48090513|NCT02763189|100545570|FG000|COMPLETED|Overall Study||4||
48090514|NCT02763189|100545571|FG001|COMPLETED|Overall Study||2||
48090515|NCT02763189|100545570|FG000|NOT COMPLETED|Overall Study||0||
48090516|NCT02763189|100545571|FG001|NOT COMPLETED|Overall Study||2||
48090517|NCT00711711|100545572|FG000|STARTED|Overall Study||30||
48090518|NCT00711711|100545573|FG001|STARTED|Overall Study||30||
48090519|NCT00711711|100545572|FG000|Second Postsurgical Day|Overall Study||30||
48090520|NCT00711711|100545573|FG001|Second Postsurgical Day|Overall Study||30||
48090521|NCT00711711|100545572|FG000|Seventh Postsurgical Day|Overall Study||29||
48090522|NCT00711711|100545573|FG001|Seventh Postsurgical Day|Overall Study||27||
48090523|NCT00711711|100545572|FG000|COMPLETED|Overall Study||29||
48090524|NCT00711711|100545573|FG001|COMPLETED|Overall Study||24||
48090525|NCT00711711|100545572|FG000|NOT COMPLETED|Overall Study||1||
48090526|NCT00711711|100545573|FG001|NOT COMPLETED|Overall Study||6||
48090527|NCT02368431|100545574|FG000|STARTED|Overall Study||46||
48090528|NCT02368431|100545575|FG001|STARTED|Overall Study||46||
48254569|NCT04680637|100943728|FG000|STARTED|Overall Study||41||
48254570|NCT04680637|100943729|FG001|STARTED|Overall Study||35||
48254571|NCT04680637|100943730|FG002|STARTED|Overall Study||34||
48254572|NCT04680637|100943731|FG003|STARTED|Overall Study||58||
48254573|NCT04680637|100943728|FG000|Received Study Treatment|Overall Study||41||
48254574|NCT04680637|100943729|FG001|Received Study Treatment|Overall Study||35||
48254575|NCT04680637|100943730|FG002|Received Study Treatment|Overall Study||34||
48254576|NCT04680637|100943731|FG003|Received Study Treatment|Overall Study||58||
48254577|NCT04680637|100943728|FG000|COMPLETED|Overall Study||12||
48254578|NCT04680637|100943729|FG001|COMPLETED|Overall Study||9||
48254579|NCT04680637|100943730|FG002|COMPLETED|Overall Study||10||
48254580|NCT04680637|100943731|FG003|COMPLETED|Overall Study||10||
48254581|NCT04680637|100943728|FG000|NOT COMPLETED|Overall Study||29||
48254582|NCT04680637|100943729|FG001|NOT COMPLETED|Overall Study||26||
48254583|NCT04680637|100943730|FG002|NOT COMPLETED|Overall Study||24||
48686433|NCT00648648|102016825|FG000|Treated|Overall Study||3||
48254584|NCT04680637|100943731|FG003|NOT COMPLETED|Overall Study||48||
48254585|NCT00616577|100943732|FG000|STARTED|Overall Study||6||
48686434|NCT00648648|102016826|FG001|Treated|Overall Study||3||
48686435|NCT00648648|102016827|FG002|Treated|Overall Study||3||
48254586|NCT00616577|100943733|FG001|STARTED|Overall Study||9||
48254587|NCT00616577|100943734|FG002|STARTED|Overall Study||7||
48254588|NCT00616577|100943732|FG000|COMPLETED|Overall Study||6||
48090529|NCT02368431|100545574|FG000|COMPLETED|Overall Study||22||
48090530|NCT02368431|100545575|FG001|COMPLETED|Overall Study||27||
48090531|NCT02368431|100545574|FG000|NOT COMPLETED|Overall Study||24||
48090532|NCT02368431|100545575|FG001|NOT COMPLETED|Overall Study||19||
48254589|NCT00616577|100943733|FG001|COMPLETED|Overall Study||9||
48254590|NCT00616577|100943734|FG002|COMPLETED|Overall Study||7||
48254591|NCT00616577|100943732|FG000|NOT COMPLETED|Overall Study||0||
48254592|NCT00616577|100943733|FG001|NOT COMPLETED|Overall Study||0||
48254593|NCT00616577|100943734|FG002|NOT COMPLETED|Overall Study||0||
48254594|NCT03272711|100943735|FG000|STARTED|Overall Study||51||
48686436|NCT00648648|102016828|FG003|Treated|Overall Study||4||
48686437|NCT00648648|102016829|FG004|Treated|Overall Study||8||
48686438|NCT00648648|102016830|FG005|Treated|Overall Study||1||
48381473|NCT00916370|101261639|FG000|STARTED|Overall Study||401||
48381474|NCT00916370|101261640|FG001|STARTED|Overall Study||104||
48381475|NCT00916370|101261639|FG000|COMPLETED|Overall Study||396||
48381476|NCT00916370|101261640|FG001|COMPLETED|Overall Study||102||
48254595|NCT03272711|100943736|FG001|STARTED|Overall Study||49||
48254596|NCT03272711|100943735|FG000|COMPLETED|Overall Study||44||
48254597|NCT03272711|100943736|FG001|COMPLETED|Overall Study||41||
48254598|NCT03272711|100943735|FG000|NOT COMPLETED|Overall Study||7||
48381477|NCT00916370|101261639|FG000|NOT COMPLETED|Overall Study||5||
48381478|NCT00916370|101261640|FG001|NOT COMPLETED|Overall Study||2||
48381479|NCT01346371|101261641|FG000|STARTED|Overall Study||20||
48254599|NCT03272711|100943736|FG001|NOT COMPLETED|Overall Study||8||
48254600|NCT00999141|100943737|FG000|STARTED|Overall Study||75||
48254601|NCT00999141|100943737|FG000|COMPLETED|Overall Study||75||
48254602|NCT00999141|100943737|FG000|NOT COMPLETED|Overall Study||0||
48254603|NCT01226485|100943738|FG000|STARTED|Overall Study||3||
48254604|NCT01226485|100943739|FG001|STARTED|Overall Study||6||
48254605|NCT01226485|100943740|FG002|STARTED|Overall Study||3||
48254606|NCT01226485|100943741|FG003|STARTED|Overall Study||6||
48254607|NCT01226485|100943742|FG004|STARTED|Overall Study||7||
48254608|NCT01226485|100943743|FG005|STARTED|Overall Study||19||
48254609|NCT01226485|100943744|FG006|STARTED|Overall Study||40||
48254610|NCT01226485|100943738|FG000|Received at Least One Dose of Drug|Overall Study||3||
48254611|NCT01226485|100943739|FG001|Received at Least One Dose of Drug|Overall Study||6||
48254612|NCT01226485|100943740|FG002|Received at Least One Dose of Drug|Overall Study||3||
48254613|NCT01226485|100943741|FG003|Received at Least One Dose of Drug|Overall Study||6||
48254614|NCT01226485|100943742|FG004|Received at Least One Dose of Drug|Overall Study||7||
48254615|NCT01226485|100943743|FG005|Received at Least One Dose of Drug|Overall Study||19||
48254616|NCT01226485|100943744|FG006|Received at Least One Dose of Drug|Overall Study||40||
48254617|NCT01226485|100943738|FG000|COMPLETED|Overall Study||3||
48254618|NCT01226485|100943739|FG001|COMPLETED|Overall Study||6||
48254619|NCT01226485|100943740|FG002|COMPLETED|Overall Study||3||
48254620|NCT01226485|100943741|FG003|COMPLETED|Overall Study||6||
48254621|NCT01226485|100943742|FG004|COMPLETED|Overall Study||7||
48254622|NCT01226485|100943743|FG005|COMPLETED|Overall Study||19||
48254623|NCT01226485|100943744|FG006|COMPLETED|Overall Study||40||
48254624|NCT01226485|100943738|FG000|NOT COMPLETED|Overall Study||0||
48254625|NCT01226485|100943739|FG001|NOT COMPLETED|Overall Study||0||
48254626|NCT01226485|100943740|FG002|NOT COMPLETED|Overall Study||0||
48254627|NCT01226485|100943741|FG003|NOT COMPLETED|Overall Study||0||
48254628|NCT01226485|100943742|FG004|NOT COMPLETED|Overall Study||0||
48254629|NCT01226485|100943743|FG005|NOT COMPLETED|Overall Study||0||
48254630|NCT01226485|100943744|FG006|NOT COMPLETED|Overall Study||0||
48254631|NCT01379703|100943745|FG000|STARTED|Study Start Through 9 Months||66||
48254632|NCT01379703|100943746|FG001|STARTED|Study Start Through 9 Months||1206||
48254633|NCT01379703|100943747|FG002|STARTED|Study Start Through 9 Months||1016||
48381480|NCT01346371|101261642|FG001|STARTED|Overall Study||20||
48381481|NCT01346371|101261641|FG000|COMPLETED|Overall Study||18||
48381482|NCT01346371|101261642|FG001|COMPLETED|Overall Study||20||
48381483|NCT01346371|101261641|FG000|NOT COMPLETED|Overall Study||2||
48381484|NCT01346371|101261642|FG001|NOT COMPLETED|Overall Study||0||
48381485|NCT02554253|101261643|FG000|STARTED|Overall Study||26||
48381486|NCT02554253|101261644|FG001|STARTED|Overall Study||26||
48686439|NCT00648648|102016831|FG006|Treated|Overall Study||9||
48686440|NCT00648648|102016832|FG007|Treated|Overall Study||1||
48254634|NCT01379703|100943745|FG000|COMPLETED|Study Start Through 9 Months||62||
48254635|NCT01379703|100943746|FG001|COMPLETED|Study Start Through 9 Months||1084||
48254636|NCT01379703|100943747|FG002|COMPLETED|Study Start Through 9 Months||873||
48254637|NCT01379703|100943745|FG000|NOT COMPLETED|Study Start Through 9 Months||4||
48254638|NCT01379703|100943746|FG001|NOT COMPLETED|Study Start Through 9 Months||122||
48254639|NCT01379703|100943747|FG002|NOT COMPLETED|Study Start Through 9 Months||143||
48254640|NCT01379703|100943745|FG000|STARTED|9 Months Through 18 Months||0||
48254641|NCT01379703|100943746|FG001|STARTED|9 Months Through 18 Months||1084||
48254642|NCT01379703|100943747|FG002|STARTED|9 Months Through 18 Months||0||
48254643|NCT01379703|100943745|FG000|COMPLETED|9 Months Through 18 Months||0||
48254644|NCT01379703|100943746|FG001|COMPLETED|9 Months Through 18 Months||854||
48254645|NCT01379703|100943747|FG002|COMPLETED|9 Months Through 18 Months||0||
48254646|NCT01379703|100943745|FG000|NOT COMPLETED|9 Months Through 18 Months||0||
48254647|NCT01379703|100943746|FG001|NOT COMPLETED|9 Months Through 18 Months||230||
48254648|NCT01379703|100943747|FG002|NOT COMPLETED|9 Months Through 18 Months||0||
48254649|NCT02654132|100943748|FG000|STARTED|Pre-Treatment Period||60|Started = Randomized|
48254650|NCT02654132|100943749|FG001|STARTED|Pre-Treatment Period||57|Started = Randomized|
48254651|NCT02654132|100943748|FG000|COMPLETED|Pre-Treatment Period||60|Completed = Continued into Treatment Period|
48254652|NCT02654132|100943749|FG001|COMPLETED|Pre-Treatment Period||55|Completed = Continued into Treatment Period|
48381487|NCT02554253|101261643|FG000|COMPLETED|Overall Study||25||
48381488|NCT02554253|101261644|FG001|COMPLETED|Overall Study||24||
48381489|NCT02554253|101261643|FG000|NOT COMPLETED|Overall Study||1||
48254653|NCT02654132|100943748|FG000|NOT COMPLETED|Pre-Treatment Period||0||
48254654|NCT02654132|100943749|FG001|NOT COMPLETED|Pre-Treatment Period||2||
48254655|NCT02654132|100943748|FG000|STARTED|Treatment Period||60||
48254656|NCT02654132|100943749|FG001|STARTED|Treatment Period||55||
48254657|NCT02654132|100943748|FG000|COMPLETED|Treatment Period||0||
48254658|NCT02654132|100943749|FG001|COMPLETED|Treatment Period||0||
48254659|NCT02654132|100943748|FG000|NOT COMPLETED|Treatment Period||60||
48254660|NCT02654132|100943749|FG001|NOT COMPLETED|Treatment Period||55||
48254661|NCT05523219|100943750|FG000|STARTED|Overall Study||81||
48254662|NCT05523219|100943750|FG000|COMPLETED|Overall Study||73||
48254663|NCT05523219|100943750|FG000|NOT COMPLETED|Overall Study||8||
48254664|NCT01222533|100943751|FG000|STARTED|Overall Study||154||
48254665|NCT01222533|100943751|FG000|Received Placebo|Overall Study||147||
48254666|NCT01222533|100943751|FG000|Received Tio R1.25|Overall Study||147||
48381490|NCT02554253|101261644|FG001|NOT COMPLETED|Overall Study||2||
48381491|NCT00751114|101261645|FG000|STARTED|Overall Study||250||
48686441|NCT00648648|102016833|FG008|Treated|Overall Study||3||
48686442|NCT00648648|102016834|FG009|Treated|Overall Study||9||
48686443|NCT00648648|102016835|FG010|Treated|Overall Study||6||
48686444|NCT00648648|102016836|FG011|Treated|Overall Study||13||
48686445|NCT00648648|102016837|FG012|Treated|Overall Study||6||
48686446|NCT00648648|102016838|FG013|Treated|Overall Study||5||
48686447|NCT00648648|102016839|FG014|Treated|Overall Study||4||
48686448|NCT00648648|102016840|FG015|Treated|Overall Study||11||
48686449|NCT00648648|102016841|FG016|Treated|Overall Study||16||
48686450|NCT00648648|102016842|FG017|Treated|Overall Study||6||
48686451|NCT00648648|102016843|FG018|Treated|Overall Study||4||
48090533|NCT03055260|100545576|FG000|STARTED|Overall Study||8||
48090534|NCT03055260|100545577|FG001|STARTED|Overall Study||0||
48090535|NCT03055260|100545576|FG000|COMPLETED|Overall Study||7||
48090536|NCT03055260|100545577|FG001|COMPLETED|Overall Study||0||
48090537|NCT03055260|100545576|FG000|NOT COMPLETED|Overall Study||1||
48090538|NCT03055260|100545577|FG001|NOT COMPLETED|Overall Study||0||
48090539|NCT03709771|100545578|FG000|STARTED|Overall Study||0||
48090540|NCT03709771|100545579|FG001|STARTED|Overall Study||1||
48090541|NCT03709771|100545580|FG002|STARTED|Overall Study||1||
48090542|NCT03709771|100545581|FG003|STARTED|Overall Study||0||
48090543|NCT03709771|100545578|FG000|COMPLETED|Overall Study||0||
48090544|NCT03709771|100545579|FG001|COMPLETED|Overall Study||1||
48090545|NCT03709771|100545580|FG002|COMPLETED|Overall Study||0||
48090546|NCT03709771|100545581|FG003|COMPLETED|Overall Study||0||
48090547|NCT03709771|100545578|FG000|NOT COMPLETED|Overall Study||0||
48090548|NCT03709771|100545579|FG001|NOT COMPLETED|Overall Study||0||
48090549|NCT03709771|100545580|FG002|NOT COMPLETED|Overall Study||1||
48090550|NCT03709771|100545581|FG003|NOT COMPLETED|Overall Study||0||
48090551|NCT04059094|100545582|FG000|STARTED|Overall Study||18||
48090552|NCT04059094|100545583|FG001|STARTED|Overall Study||6||
48090553|NCT04059094|100545584|FG002|STARTED|Overall Study||5||
48090554|NCT04059094|100545585|FG003|STARTED|Overall Study||5||
48090555|NCT04059094|100545586|FG004|STARTED|Overall Study||18||
48090556|NCT04059094|100545582|FG000|COMPLETED|Overall Study||18||
48090557|NCT04059094|100545583|FG001|COMPLETED|Overall Study||4||
48090558|NCT04059094|100545584|FG002|COMPLETED|Overall Study||5||
48090559|NCT04059094|100545585|FG003|COMPLETED|Overall Study||5||
48090560|NCT04059094|100545586|FG004|COMPLETED|Overall Study||17||
48090561|NCT04059094|100545582|FG000|NOT COMPLETED|Overall Study||0||
48090562|NCT04059094|100545583|FG001|NOT COMPLETED|Overall Study||2||
48090563|NCT04059094|100545584|FG002|NOT COMPLETED|Overall Study||0||
48090564|NCT04059094|100545585|FG003|NOT COMPLETED|Overall Study||0||
48090565|NCT04059094|100545586|FG004|NOT COMPLETED|Overall Study||1||
48090566|NCT01438957|100545587|FG000|STARTED|Overall Study||22||
48090567|NCT01438957|100545588|FG001|STARTED|Overall Study||23||
48090568|NCT01438957|100545589|FG002|STARTED|Overall Study||24||
48090569|NCT01438957|100545590|FG003|STARTED|Overall Study||25||
48090570|NCT01438957|100545591|FG004|STARTED|Overall Study||25||
48090571|NCT01438957|100545587|FG000|COMPLETED|Overall Study||21||
48090572|NCT01438957|100545588|FG001|COMPLETED|Overall Study||22||
48254667|NCT01222533|100943751|FG000|Received Tio R2.5|Overall Study||145||
48254668|NCT01222533|100943751|FG000|Received Tio R5|Overall Study||150||
48254669|NCT01222533|100943751|FG000|Received Tio HH18|Overall Study||146||
48381492|NCT00751114|101261646|FG001|STARTED|Overall Study||265||
48686452|NCT00648648|102016844|FG019|Treated|Overall Study||7||
48686453|NCT00648648|102016845|FG020|Treated|Overall Study||6||
48686454|NCT00648648|102016846|FG021|Treated|Overall Study||10||
48686455|NCT00648648|102016847|FG022|Treated|Overall Study||14||
48686456|NCT00648648|102016848|FG023|Treated|Overall Study||4||
48686457|NCT00648648|102016849|FG024|Treated|Overall Study||4||
48686458|NCT00648648|102016850|FG025|Treated|Overall Study||4||
48686459|NCT00648648|102016851|FG026|Treated|Overall Study||26||
48686460|NCT00648648|102016852|FG027|Treated|Overall Study||12||
48090573|NCT01438957|100545589|FG002|COMPLETED|Overall Study||24||
48090574|NCT01438957|100545590|FG003|COMPLETED|Overall Study||24||
48090575|NCT01438957|100545591|FG004|COMPLETED|Overall Study||25||
48254670|NCT01222533|100943751|FG000|COMPLETED|Overall Study||140||
48381493|NCT00751114|101261645|FG000|TREATED = Safety Population|Overall Study||237||
48686461|NCT00648648|102016825|FG000|COMPLETED|Overall Study||3||
48254671|NCT01222533|100943751|FG000|NOT COMPLETED|Overall Study||14||
48254672|NCT01101997|100943752|FG000|STARTED|Overall Study||60||
48254673|NCT01101997|100943752|FG000|COMPLETED|Overall Study||58||
48254674|NCT01101997|100943752|FG000|NOT COMPLETED|Overall Study||2||
48254675|NCT05110014|100943753|FG000|STARTED|Overall Study||12239||
48254676|NCT05110014|100943754|FG001|STARTED|Overall Study||10787||
48254677|NCT05110014|100943753|FG000|COMPLETED|Overall Study||12239||
48254678|NCT05110014|100943754|FG001|COMPLETED|Overall Study||10787||
48254679|NCT05110014|100943753|FG000|NOT COMPLETED|Overall Study||0||
48254680|NCT05110014|100943754|FG001|NOT COMPLETED|Overall Study||0||
48254681|NCT01064882|100943755|FG000|STARTED|Overall Study||36||
48254682|NCT01064882|100943756|FG001|STARTED|Overall Study||34||
48254683|NCT01064882|100943757|FG002|STARTED|Overall Study||34||
48254684|NCT01064882|100943755|FG000|COMPLETED|Overall Study||34||
48254685|NCT01064882|100943756|FG001|COMPLETED|Overall Study||32||
48254686|NCT01064882|100943757|FG002|COMPLETED|Overall Study||32||
48254687|NCT01064882|100943755|FG000|NOT COMPLETED|Overall Study||2||
48254688|NCT01064882|100943756|FG001|NOT COMPLETED|Overall Study||2||
48254689|NCT01064882|100943757|FG002|NOT COMPLETED|Overall Study||2||
48254690|NCT03561597|100943758|FG000|STARTED|Overall Study||40||
48254691|NCT03561597|100943758|FG000|3 Month Follow up|Overall Study||21||
48254692|NCT03561597|100943758|FG000|COMPLETED|Overall Study||20||
48254693|NCT03561597|100943758|FG000|NOT COMPLETED|Overall Study||20||
48254694|NCT04522778|100943759|FG000|STARTED|Overall Study||12||
48254695|NCT04522778|100943760|FG001|STARTED|Overall Study||11||
48254696|NCT04522778|100943759|FG000|COMPLETED|Overall Study||11||
48254697|NCT04522778|100943760|FG001|COMPLETED|Overall Study||10||
48254698|NCT04522778|100943759|FG000|NOT COMPLETED|Overall Study||1||
48254699|NCT04522778|100943760|FG001|NOT COMPLETED|Overall Study||1||
48254700|NCT03432650|100943761|FG000|STARTED|Overall Study||48||
48254701|NCT03432650|100943762|FG001|STARTED|Overall Study||48||
48254702|NCT03432650|100943761|FG000|COMPLETED|Overall Study||48||
48254703|NCT03432650|100943762|FG001|COMPLETED|Overall Study||48||
48254704|NCT03432650|100943761|FG000|NOT COMPLETED|Overall Study||0||
48254705|NCT03432650|100943762|FG001|NOT COMPLETED|Overall Study||0||
48381494|NCT00751114|101261646|FG001|TREATED = Safety Population|Overall Study||264||
48381495|NCT00751114|101261645|FG000|mITT Population|Overall Study||227||
48381496|NCT00751114|101261646|FG001|mITT Population|Overall Study||253||
48381497|NCT00751114|101261645|FG000|COMPLETED|Overall Study||212||
48381498|NCT00751114|101261646|FG001|COMPLETED|Overall Study||233||
48381499|NCT00751114|101261645|FG000|NOT COMPLETED|Overall Study||38||
48381500|NCT00751114|101261646|FG001|NOT COMPLETED|Overall Study||32||
48381501|NCT01842607|101261647|FG000|STARTED|Overall Study||651||
48381502|NCT01842607|101261647|FG000|COMPLETED|Overall Study||585||
48381503|NCT01842607|101261647|FG000|NOT COMPLETED|Overall Study||66||
48381504|NCT00523614|101261648|FG000|STARTED|Overall Study||680||
48381505|NCT00523614|101261649|FG001|STARTED|Overall Study||2720||
48381506|NCT00523614|101261648|FG000|COMPLETED|Overall Study||680||
48381507|NCT00523614|101261649|FG001|COMPLETED|Overall Study||2720||
48381508|NCT00523614|101261648|FG000|NOT COMPLETED|Overall Study||0||
48381509|NCT00523614|101261649|FG001|NOT COMPLETED|Overall Study||0||
48381510|NCT03731364|101261650|FG000|STARTED|Overall Study||9||
48381511|NCT03731364|101261651|FG001|STARTED|Overall Study||9||
48381512|NCT03731364|101261652|FG002|STARTED|Overall Study||13||
48381513|NCT03731364|101261653|FG003|STARTED|Overall Study||13||
48381514|NCT03731364|101261654|FG004|STARTED|Overall Study||11||
48381515|NCT03731364|101261650|FG000|COMPLETED|Overall Study||9||
48381516|NCT03731364|101261651|FG001|COMPLETED|Overall Study||9||
48381517|NCT03731364|101261652|FG002|COMPLETED|Overall Study||12||
48381518|NCT03731364|101261653|FG003|COMPLETED|Overall Study||11||
48381519|NCT03731364|101261654|FG004|COMPLETED|Overall Study||10||
48381520|NCT03731364|101261650|FG000|NOT COMPLETED|Overall Study||0||
48381521|NCT03731364|101261651|FG001|NOT COMPLETED|Overall Study||0||
48381522|NCT03731364|101261652|FG002|NOT COMPLETED|Overall Study||1||
48381523|NCT03731364|101261653|FG003|NOT COMPLETED|Overall Study||2||
48381524|NCT03731364|101261654|FG004|NOT COMPLETED|Overall Study||1||
48381525|NCT00592852|101261655|FG000|STARTED|Overall Study||13||
48381526|NCT00592852|101261655|FG000|COMPLETED|Overall Study||7||
48381527|NCT00592852|101261655|FG000|NOT COMPLETED|Overall Study||6||
48381528|NCT00148733|101261656|FG000|STARTED|Overall Study||1314||
48254706|NCT02487251|100943763|FG000|STARTED|Overall Study||434|Sample sizes reflect parent-child dyads enrolled in each study arm. The sample size for dyads equals that number of parents and that number of children. Among those who started per arm: 434 parents/434 children (Phase 1 Usual Exposure); 65 parents/65 children (Phase 2 Mealtime Support Activities); 152 parents/152 children (Phase 2 Usual Exposure); 159 parents/159 children (Phase 2 Meal Delivery and Receipt of Cookware).|
48254707|NCT02487251|100943764|FG001|STARTED|Overall Study||65|Sample sizes reflect parent-child dyads enrolled in each study arm. The sample size for dyads equals that number of parents and that number of children. Among those who started per arm: 434 parents/434 children (Phase 1 Usual Exposure); 65 parents/65 children (Phase 2 Mealtime Support Activities); 152 parents/152 children (Phase 2 Usual Exposure); 159 parents/159 children (Phase 2 Meal Delivery and Receipt of Cookware).|
48294137|NCT02527343|101047541|FG005|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0||
48294138|NCT02527343|101047536|FG000|STARTED|OLE Period-Year 1: Week 53 to 104||0||
48381529|NCT00148733|101261657|FG001|STARTED|Overall Study||1314||
48381530|NCT00148733|101261656|FG000|COMPLETED|Overall Study||1300||
48381531|NCT00148733|101261657|FG001|COMPLETED|Overall Study||1299||
48381532|NCT00148733|101261656|FG000|NOT COMPLETED|Overall Study||14||
48381533|NCT00148733|101261657|FG001|NOT COMPLETED|Overall Study||15||
48381534|NCT02357849|101261658|FG000|STARTED|Overall Study||4||
48381535|NCT02357849|101261659|FG001|STARTED|Overall Study||5||
48381536|NCT02357849|101261658|FG000|COMPLETED|Overall Study||2||
48381537|NCT02357849|101261659|FG001|COMPLETED|Overall Study||2||
48381538|NCT02357849|101261658|FG000|NOT COMPLETED|Overall Study||2||
48381539|NCT02357849|101261659|FG001|NOT COMPLETED|Overall Study||3||
48381540|NCT00849251|101261660|FG000|STARTED|Overall Study||6||
48541385|NCT04867174|101662724|FG011|STARTED|Overall Study||122||
48541386|NCT04867174|101662725|FG012|STARTED|Overall Study||30||
48541387|NCT04867174|101662726|FG013|STARTED|Overall Study||31||
48541388|NCT04867174|101662727|FG014|STARTED|Overall Study||30||
48541389|NCT04867174|101662728|FG015|STARTED|Overall Study||23||
48541390|NCT04867174|101662729|FG016|STARTED|Overall Study||35||
48090576|NCT01438957|100545587|FG000|NOT COMPLETED|Overall Study||1||
48294139|NCT02527343|101047537|FG001|STARTED|OLE Period-Year 1: Week 53 to 104||0||
48541391|NCT04867174|101662730|FG017|STARTED|Overall Study||34||
48541392|NCT04867174|101662731|FG018|STARTED|Overall Study||34||
48541393|NCT04867174|101662732|FG019|STARTED|Overall Study||27||
48541394|NCT04867174|101662733|FG020|STARTED|Overall Study||113||
48541395|NCT04867174|101662734|FG021|STARTED|Overall Study||103||
48541396|NCT04867174|101662735|FG022|STARTED|Overall Study||27||
48541397|NCT04867174|101662736|FG023|STARTED|Overall Study||22||
48541398|NCT04867174|101662737|FG024|STARTED|Overall Study||30||
48541399|NCT04867174|101662738|FG025|STARTED|Overall Study||24||
48541400|NCT04867174|101662739|FG026|STARTED|Overall Study||33||
48541401|NCT04867174|101662740|FG027|STARTED|Overall Study||28||
48541402|NCT04867174|101662741|FG028|STARTED|Overall Study||17||
48541403|NCT04867174|101662742|FG029|STARTED|Overall Study||32||
48541404|NCT04867174|101662743|FG030|STARTED|Overall Study||117||
48541405|NCT04867174|101662744|FG031|STARTED|Overall Study||100||
48541406|NCT04867174|101662745|FG032|STARTED|Overall Study||20||
48541407|NCT04867174|101662746|FG033|STARTED|Overall Study||19||
48541408|NCT04867174|101662747|FG034|STARTED|Overall Study||28||
48541409|NCT04867174|101662748|FG035|STARTED|Overall Study||15||
48541410|NCT04867174|101662749|FG036|STARTED|Overall Study||22||
48541411|NCT04867174|101662750|FG037|STARTED|Overall Study||22||
48541412|NCT04867174|101662751|FG038|STARTED|Overall Study||24||
48541413|NCT04867174|101662752|FG039|STARTED|Overall Study||18||
48541414|NCT04867174|101662753|FG040|STARTED|Overall Study||112||
48541415|NCT04867174|101662754|FG041|STARTED|Overall Study||120||
48541416|NCT04867174|101662755|FG042|STARTED|Overall Study||28||
48541417|NCT04867174|101662756|FG043|STARTED|Overall Study||18||
48541418|NCT04867174|101662757|FG044|STARTED|Overall Study||26||
48541419|NCT04867174|101662758|FG045|STARTED|Overall Study||33||
48541420|NCT04867174|101662759|FG046|STARTED|Overall Study||21||
48541421|NCT04867174|101662760|FG047|STARTED|Overall Study||20||
48541422|NCT04867174|101662761|FG048|STARTED|Overall Study||21||
48541423|NCT04867174|101662762|FG049|STARTED|Overall Study||23||
48541424|NCT04867174|101662763|FG050|STARTED|Overall Study||104||
48541425|NCT04867174|101662764|FG051|STARTED|Overall Study||99||
48541426|NCT04867174|101662765|FG052|STARTED|Overall Study||28||
48541427|NCT04867174|101662766|FG053|STARTED|Overall Study||23||
48541428|NCT04867174|101662767|FG054|STARTED|Overall Study||27||
48541429|NCT04867174|101662768|FG055|STARTED|Overall Study||26||
48541430|NCT04867174|101662769|FG056|STARTED|Overall Study||19||
48541431|NCT04867174|101662770|FG057|STARTED|Overall Study||30||
48541432|NCT04867174|101662771|FG058|STARTED|Overall Study||20||
48541433|NCT04867174|101662772|FG059|STARTED|Overall Study||24||
48541434|NCT04867174|101662713|FG000|COMPLETED|Overall Study||136||
48381541|NCT00849251|101261661|FG001|STARTED|Overall Study||25||
48381542|NCT00849251|101261660|FG000|COMPLETED|Overall Study||5||
48381543|NCT00849251|101261661|FG001|COMPLETED|Overall Study||24||
48381544|NCT00849251|101261660|FG000|NOT COMPLETED|Overall Study||1||
48381545|NCT00849251|101261661|FG001|NOT COMPLETED|Overall Study||1||
48381546|NCT04580394|101261662|FG000|STARTED|First Intervention||60||
48381547|NCT04580394|101261662|FG000|75mg/2.5mg|First Intervention||16|Treatment A: Atomoxetine 75 mg and R-oxybutynin 2.5 mg|
48381548|NCT04580394|101261662|FG000|75mg and Placebo|First Intervention||14|Treatment B: Atomoxetine 75 mg and placebo|
48541435|NCT04867174|101662714|FG001|COMPLETED|Overall Study||137||
48541436|NCT04867174|101662715|FG002|COMPLETED|Overall Study||29||
48541437|NCT04867174|101662716|FG003|COMPLETED|Overall Study||37||
48541438|NCT04867174|101662717|FG004|COMPLETED|Overall Study||32||
48541439|NCT04867174|101662718|FG005|COMPLETED|Overall Study||31||
48541440|NCT04867174|101662719|FG006|COMPLETED|Overall Study||43||
48541441|NCT04867174|101662720|FG007|COMPLETED|Overall Study||33||
48541442|NCT04867174|101662721|FG008|COMPLETED|Overall Study||39||
48541443|NCT04867174|101662722|FG009|COMPLETED|Overall Study||35||
48541444|NCT04867174|101662723|FG010|COMPLETED|Overall Study||147||
48541445|NCT04867174|101662724|FG011|COMPLETED|Overall Study||122||
48541446|NCT04867174|101662725|FG012|COMPLETED|Overall Study||30||
48541447|NCT04867174|101662726|FG013|COMPLETED|Overall Study||31||
48541448|NCT04867174|101662727|FG014|COMPLETED|Overall Study||30||
48541449|NCT04867174|101662728|FG015|COMPLETED|Overall Study||23||
48541450|NCT04867174|101662729|FG016|COMPLETED|Overall Study||35||
48686462|NCT00648648|102016826|FG001|COMPLETED|Overall Study||3||
48686463|NCT00648648|102016827|FG002|COMPLETED|Overall Study||3||
48686464|NCT00648648|102016828|FG003|COMPLETED|Overall Study||0||
48686465|NCT00648648|102016829|FG004|COMPLETED|Overall Study||0||
48686466|NCT00648648|102016830|FG005|COMPLETED|Overall Study||0||
48686467|NCT00648648|102016831|FG006|COMPLETED|Overall Study||0||
48686468|NCT00648648|102016832|FG007|COMPLETED|Overall Study||0||
48686469|NCT00648648|102016833|FG008|COMPLETED|Overall Study||0||
48381549|NCT04580394|101261662|FG000|2.5mg and Placebo|First Intervention||15|Treatment C: R-oxybutynin 2.5 mg and placebo|
48381550|NCT04580394|101261662|FG000|Placebo and Placebo|First Intervention||15|Treatment D|
48381551|NCT04580394|101261662|FG000|COMPLETED|First Intervention||57||
48686470|NCT00648648|102016834|FG009|COMPLETED|Overall Study||0||
48686471|NCT00648648|102016835|FG010|COMPLETED|Overall Study||0||
48686472|NCT00648648|102016836|FG011|COMPLETED|Overall Study||0||
48686473|NCT00648648|102016837|FG012|COMPLETED|Overall Study||0||
48686474|NCT00648648|102016838|FG013|COMPLETED|Overall Study||0||
48686475|NCT00648648|102016839|FG014|COMPLETED|Overall Study||0||
48686476|NCT00648648|102016840|FG015|COMPLETED|Overall Study||0||
48686477|NCT00648648|102016841|FG016|COMPLETED|Overall Study||2||
48686478|NCT00648648|102016842|FG017|COMPLETED|Overall Study||0||
48686479|NCT00648648|102016843|FG018|COMPLETED|Overall Study||0||
48686480|NCT00648648|102016844|FG019|COMPLETED|Overall Study||0||
48686481|NCT00648648|102016845|FG020|COMPLETED|Overall Study||0||
48381552|NCT04580394|101261662|FG000|NOT COMPLETED|First Intervention||3||
48381553|NCT04580394|101261662|FG000|STARTED|Washout (One Week)||57||
48381554|NCT04580394|101261662|FG000|COMPLETED|Washout (One Week)||56||
48381555|NCT04580394|101261662|FG000|NOT COMPLETED|Washout (One Week)||1||
48381556|NCT04580394|101261662|FG000|STARTED|Second Intervention||56||
48381557|NCT04580394|101261662|FG000|75mg/2.5mg|Second Intervention||15|Treatment A: Atomoxetine 75 mg and R-oxybutynin 2.5 mg|
48381558|NCT04580394|101261662|FG000|75mg and Placebo|Second Intervention||15|Treatment B: Atomoxetine 75 mg and placebo|
48381559|NCT04580394|101261662|FG000|2.5mg and Placebo|Second Intervention||13|Treatment C: R-oxybutynin 2.5 mg and placebo|
48381560|NCT04580394|101261662|FG000|Placebo and Placebo|Second Intervention||14|Treatment D|
48381561|NCT04580394|101261662|FG000|COMPLETED|Second Intervention||56||
48381562|NCT04580394|101261662|FG000|NOT COMPLETED|Second Intervention||0||
48381563|NCT04580394|101261662|FG000|STARTED|Washout (One Week)||56||
48381564|NCT04580394|101261662|FG000|COMPLETED|Washout (One Week)||53||
48381565|NCT04580394|101261662|FG000|NOT COMPLETED|Washout (One Week)||3||
48381566|NCT04580394|101261662|FG000|STARTED|Third Intervention||53||
48381567|NCT04580394|101261662|FG000|75mg /2.5mg|Third Intervention||13|Treatment A: Atomoxetine 75 mg and R-oxybutynin 2.5 mg|
48381568|NCT04580394|101261662|FG000|75mg and Placebo|Third Intervention||13|Treatment B: Atomoxetine 75 mg and placebo|
48381569|NCT04580394|101261662|FG000|2.5mg and Placebo|Third Intervention||15|Treatment C: R-oxybutynin 2.5 mg and placebo|
48381570|NCT04580394|101261662|FG000|Placebo and Placebo|Third Intervention||14|Treatment D|
48381571|NCT04580394|101261662|FG000|COMPLETED|Third Intervention||51||
48381572|NCT04580394|101261662|FG000|NOT COMPLETED|Third Intervention||2||
48381573|NCT04580394|101261662|FG000|STARTED|Washout (One Week)||51||
48381574|NCT04580394|101261662|FG000|COMPLETED|Washout (One Week)||49||
48381575|NCT04580394|101261662|FG000|NOT COMPLETED|Washout (One Week)||2||
48381576|NCT04580394|101261662|FG000|STARTED|Fourth Intervention||49||
48381577|NCT04580394|101261662|FG000|75mg/2.5mg|Fourth Intervention||12|Treatment A: Atomoxetine 75 mg and R-oxybutynin 2.5 mg|
48381578|NCT04580394|101261662|FG000|75mg and Placebo|Fourth Intervention||12|Treatment B: Atomoxetine 75 mg and placebo|
48381579|NCT04580394|101261662|FG000|2.5mg and Placebo|Fourth Intervention||11|Treatment C: R-oxybutynin 2.5 mg and placebo|
48381580|NCT04580394|101261662|FG000|Placebo and Placebo|Fourth Intervention||14|Treatment D|
48381581|NCT04580394|101261662|FG000|COMPLETED|Fourth Intervention||49||
48381582|NCT04580394|101261662|FG000|NOT COMPLETED|Fourth Intervention||0||
48381583|NCT00127530|101261663|FG000|STARTED|Overall Study||72||
48381584|NCT00127530|101261664|FG001|STARTED|Overall Study||228||
48381585|NCT00127530|101261663|FG000|COMPLETED|Overall Study||71||
48381586|NCT00127530|101261664|FG001|COMPLETED|Overall Study||207||
48381587|NCT00127530|101261663|FG000|NOT COMPLETED|Overall Study||1||
48381588|NCT00127530|101261664|FG001|NOT COMPLETED|Overall Study||21||
48381589|NCT00311181|101261665|FG000|STARTED|Overall Study||217||
48686482|NCT00648648|102016846|FG021|COMPLETED|Overall Study||0||
48686483|NCT00648648|102016847|FG022|COMPLETED|Overall Study||0||
48686484|NCT00648648|102016848|FG023|COMPLETED|Overall Study||0||
48686485|NCT00648648|102016849|FG024|COMPLETED|Overall Study||0||
48686486|NCT00648648|102016850|FG025|COMPLETED|Overall Study||0||
48686487|NCT00648648|102016851|FG026|COMPLETED|Overall Study||0||
48686488|NCT00648648|102016852|FG027|COMPLETED|Overall Study||0||
48686489|NCT00648648|102016825|FG000|NOT COMPLETED|Overall Study||0||
48686490|NCT00648648|102016826|FG001|NOT COMPLETED|Overall Study||0||
48686491|NCT00648648|102016827|FG002|NOT COMPLETED|Overall Study||0||
48686492|NCT00648648|102016828|FG003|NOT COMPLETED|Overall Study||4||
48686493|NCT00648648|102016829|FG004|NOT COMPLETED|Overall Study||9||
48686494|NCT00648648|102016830|FG005|NOT COMPLETED|Overall Study||1||
48686495|NCT00648648|102016831|FG006|NOT COMPLETED|Overall Study||10||
48686496|NCT00648648|102016832|FG007|NOT COMPLETED|Overall Study||1||
48686497|NCT00648648|102016833|FG008|NOT COMPLETED|Overall Study||3||
48381590|NCT00311181|101261665|FG000|COMPLETED|Overall Study||121||
48686498|NCT00648648|102016834|FG009|NOT COMPLETED|Overall Study||10||
48686499|NCT00648648|102016835|FG010|NOT COMPLETED|Overall Study||6||
48686500|NCT00648648|102016836|FG011|NOT COMPLETED|Overall Study||13||
48686501|NCT00648648|102016837|FG012|NOT COMPLETED|Overall Study||6||
48686502|NCT00648648|102016838|FG013|NOT COMPLETED|Overall Study||5||
48686503|NCT00648648|102016839|FG014|NOT COMPLETED|Overall Study||4||
48686504|NCT00648648|102016840|FG015|NOT COMPLETED|Overall Study||11||
48686505|NCT00648648|102016841|FG016|NOT COMPLETED|Overall Study||14||
48686506|NCT00648648|102016842|FG017|NOT COMPLETED|Overall Study||6||
48686507|NCT00648648|102016843|FG018|NOT COMPLETED|Overall Study||5||
48686508|NCT00648648|102016844|FG019|NOT COMPLETED|Overall Study||7||
48686509|NCT00648648|102016845|FG020|NOT COMPLETED|Overall Study||6||
48686510|NCT00648648|102016846|FG021|NOT COMPLETED|Overall Study||10||
48686511|NCT00648648|102016847|FG022|NOT COMPLETED|Overall Study||14||
48686512|NCT00648648|102016848|FG023|NOT COMPLETED|Overall Study||4||
48686513|NCT00648648|102016849|FG024|NOT COMPLETED|Overall Study||4||
48686514|NCT00648648|102016850|FG025|NOT COMPLETED|Overall Study||4||
48686515|NCT00648648|102016851|FG026|NOT COMPLETED|Overall Study||26||
48254708|NCT02487251|100943765|FG002|STARTED|Overall Study||152|Sample sizes reflect parent-child dyads enrolled in each study arm. The sample size for dyads equals that number of parents and that number of children. Among those who started per arm: 434 parents/434 children (Phase 1 Usual Exposure); 65 parents/65 children (Phase 2 Mealtime Support Activities); 152 parents/152 children (Phase 2 Usual Exposure); 159 parents/159 children (Phase 2 Meal Delivery and Receipt of Cookware).|
48254709|NCT02487251|100943766|FG003|STARTED|Overall Study||159|Sample sizes reflect parent-child dyads enrolled in each study arm. The sample size for dyads equals that number of parents and that number of children. Among those who started per arm: 434 parents/434 children (Phase 1 Usual Exposure); 65 parents/65 children (Phase 2 Mealtime Support Activities); 152 parents/152 children (Phase 2 Usual Exposure); 159 parents/159 children (Phase 2 Meal Delivery and Receipt of Cookware).|
48254710|NCT02487251|100943763|FG000|COMPLETED|Overall Study||366|Sample sizes reflect parent-child dyads enrolled in each study arm. The sample size for dyads equals that number of parents and that number of children. Among those who completed per arm: 366 parents/366 children (Phase 1 Usual Exposure); 55 parents/55 children (Phase 2 Mealtime Support Activities); 125 parents/125 children (Phase 2 Usual Exposure); 134 parents/134 children (Phase 2 Meal Delivery and Receipt of Cookware).|
48254711|NCT02487251|100943764|FG001|COMPLETED|Overall Study||55|Sample sizes reflect parent-child dyads enrolled in each study arm. The sample size for dyads equals that number of parents and that number of children. Among those who completed per arm: 366 parents/366 children (Phase 1 Usual Exposure); 55 parents/55 children (Phase 2 Mealtime Support Activities); 125 parents/125 children (Phase 2 Usual Exposure); 134 parents/134 children (Phase 2 Meal Delivery and Receipt of Cookware).|
48254712|NCT02487251|100943765|FG002|COMPLETED|Overall Study||125|Sample sizes reflect parent-child dyads enrolled in each study arm. The sample size for dyads equals that number of parents and that number of children. Among those who completed per arm: 366 parents/366 children (Phase 1 Usual Exposure); 55 parents/55 children (Phase 2 Mealtime Support Activities); 125 parents/125 children (Phase 2 Usual Exposure); 134 parents/134 children (Phase 2 Meal Delivery and Receipt of Cookware).|
48294140|NCT02527343|101047538|FG002|STARTED|OLE Period-Year 1: Week 53 to 104||0||
48294141|NCT02527343|101047539|FG003|STARTED|OLE Period-Year 1: Week 53 to 104||0||
48381591|NCT00311181|101261665|FG000|NOT COMPLETED|Overall Study||96||
48381592|NCT02938052|101261666|FG000|STARTED|Overall Study||10||
48381593|NCT02938052|101261666|FG000|COMPLETED|Overall Study||10||
48381594|NCT02938052|101261666|FG000|NOT COMPLETED|Overall Study||0||
48381595|NCT03103906|101261667|FG000|STARTED|Overall Study||40||
48381596|NCT03103906|101261668|FG001|STARTED|Overall Study||42||
48381597|NCT03103906|101261667|FG000|COMPLETED|Overall Study||36||
48381598|NCT03103906|101261668|FG001|COMPLETED|Overall Study||39||
48381599|NCT03103906|101261667|FG000|NOT COMPLETED|Overall Study||4||
48381600|NCT03103906|101261668|FG001|NOT COMPLETED|Overall Study||3||
48381601|NCT01089582|101261669|FG000|STARTED|Overall Study||603||
48381602|NCT01089582|101261669|FG000|COMPLETED|Overall Study||573||
48381603|NCT01089582|101261669|FG000|NOT COMPLETED|Overall Study||30||
48381604|NCT01367301|101261670|FG000|STARTED|Overall Study||11||
48381605|NCT01367301|101261670|FG000|COMPLETED|Overall Study||11||
48381606|NCT01367301|101261670|FG000|NOT COMPLETED|Overall Study||0||
48381607|NCT02159469|101261671|FG000|STARTED|Overall Study||150||
48686516|NCT00648648|102016852|FG027|NOT COMPLETED|Overall Study||12||
48686517|NCT00361972|102016853|FG000|STARTED|Overall Study||8||
48686518|NCT00361972|102016854|FG001|STARTED|Overall Study||9||
48686519|NCT00361972|102016853|FG000|COMPLETED|Overall Study||8||
48686520|NCT00361972|102016854|FG001|COMPLETED|Overall Study||9||
48686521|NCT00361972|102016853|FG000|NOT COMPLETED|Overall Study||0||
48686522|NCT00361972|102016854|FG001|NOT COMPLETED|Overall Study||0||
48686523|NCT00628446|102016855|FG000|STARTED|Overall Study||45||
48686524|NCT00628446|102016855|FG000|COMPLETED|Overall Study||38||
48686525|NCT00628446|102016855|FG000|NOT COMPLETED|Overall Study||7||
48686526|NCT00344175|102016856|FG000|STARTED|Overall Study||121||
48686527|NCT00344175|102016857|FG001|STARTED|Overall Study||57||
48686528|NCT00344175|102016856|FG000|COMPLETED|Overall Study||109||
48686529|NCT00344175|102016857|FG001|COMPLETED|Overall Study||47||
48686530|NCT00344175|102016856|FG000|NOT COMPLETED|Overall Study||12||
48686531|NCT00344175|102016857|FG001|NOT COMPLETED|Overall Study||10||
48686532|NCT02530476|102016858|FG000|STARTED|Overall Study||4||
48686533|NCT02530476|102016859|FG001|STARTED|Overall Study||3||
48686534|NCT02530476|102016860|FG002|STARTED|Overall Study||7||
48254713|NCT02487251|100943766|FG003|COMPLETED|Overall Study||134|Sample sizes reflect parent-child dyads enrolled in each study arm. The sample size for dyads equals that number of parents and that number of children. Among those who completed per arm: 366 parents/366 children (Phase 1 Usual Exposure); 55 parents/55 children (Phase 2 Mealtime Support Activities); 125 parents/125 children (Phase 2 Usual Exposure); 134 parents/134 children (Phase 2 Meal Delivery and Receipt of Cookware).|
48254714|NCT02487251|100943763|FG000|NOT COMPLETED|Overall Study||68||
48254715|NCT02487251|100943764|FG001|NOT COMPLETED|Overall Study||10||
48254716|NCT02487251|100943765|FG002|NOT COMPLETED|Overall Study||27||
48254717|NCT02487251|100943766|FG003|NOT COMPLETED|Overall Study||25||
48254718|NCT00796614|100943767|FG000|STARTED|Overall Study||41||
48254719|NCT00796614|100943768|FG001|STARTED|Overall Study||40||
48254720|NCT00796614|100943769|FG002|STARTED|Overall Study||39||
48254721|NCT00796614|100943770|FG003|STARTED|Overall Study||41||
48254722|NCT00796614|100943767|FG000|Not Treated|Overall Study||0||
48254723|NCT00796614|100943768|FG001|Not Treated|Overall Study||0||
48254724|NCT00796614|100943769|FG002|Not Treated|Overall Study||1||
48254725|NCT00796614|100943770|FG003|Not Treated|Overall Study||0||
48254726|NCT00796614|100943767|FG000|COMPLETED|Overall Study||36||
48254727|NCT00796614|100943768|FG001|COMPLETED|Overall Study||36||
48254728|NCT00796614|100943769|FG002|COMPLETED|Overall Study||36||
48254729|NCT00796614|100943770|FG003|COMPLETED|Overall Study||40||
48254730|NCT00796614|100943767|FG000|NOT COMPLETED|Overall Study||5||
48254731|NCT00796614|100943768|FG001|NOT COMPLETED|Overall Study||4||
48254732|NCT00796614|100943769|FG002|NOT COMPLETED|Overall Study||3||
48254733|NCT00796614|100943770|FG003|NOT COMPLETED|Overall Study||1||
48254734|NCT02109107|100943771|FG000|STARTED|Overall Study||54||
48541451|NCT04867174|101662730|FG017|COMPLETED|Overall Study||34||
48090577|NCT01438957|100545588|FG001|NOT COMPLETED|Overall Study||1||
48254735|NCT02109107|100943771|FG000|COMPLETED|Overall Study||52||
48254736|NCT02109107|100943771|FG000|NOT COMPLETED|Overall Study||2||
48254737|NCT01231464|100943772|FG000|STARTED|Overall Study||182||
48254738|NCT01231464|100943773|FG001|STARTED|Overall Study||183||
48254739|NCT01231464|100943772|FG000|COMPLETED|Overall Study||177||
48254740|NCT01231464|100943773|FG001|COMPLETED|Overall Study||176||
48254741|NCT01231464|100943772|FG000|NOT COMPLETED|Overall Study||5||
48254742|NCT01231464|100943773|FG001|NOT COMPLETED|Overall Study||7||
48254743|NCT02959177|100943774|FG000|STARTED|Double-Blind Treatment Phase||115||
48254744|NCT02959177|100943775|FG001|STARTED|Double-Blind Treatment Phase||114||
48254745|NCT02959177|100943776|FG002|STARTED|Double-Blind Treatment Phase||230||
48254746|NCT02959177|100943774|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||115||
48254747|NCT02959177|100943775|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||114||
48254748|NCT02959177|100943776|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||230||
48254749|NCT02959177|100943774|FG000|COMPLETED|Double-Blind Treatment Phase||104||
48254750|NCT02959177|100943775|FG001|COMPLETED|Double-Blind Treatment Phase||111||
48254751|NCT02959177|100943776|FG002|COMPLETED|Double-Blind Treatment Phase||225||
48254752|NCT02959177|100943774|FG000|NOT COMPLETED|Double-Blind Treatment Phase||11||
48254753|NCT02959177|100943775|FG001|NOT COMPLETED|Double-Blind Treatment Phase||3||
48254754|NCT02959177|100943776|FG002|NOT COMPLETED|Double-Blind Treatment Phase||5||
48254755|NCT02959177|100943774|FG000|STARTED|Follow-up Post Treatment Phase||52|Entered Post Treatment Phase|
48254756|NCT02959177|100943775|FG001|STARTED|Follow-up Post Treatment Phase||52|Entered Post Treatment Phase|
48254757|NCT02959177|100943776|FG002|STARTED|Follow-up Post Treatment Phase||100|Entered Post Treatment Phase|
48254758|NCT02959177|100943774|FG000|COMPLETED|Follow-up Post Treatment Phase||51||
48541452|NCT04867174|101662731|FG018|COMPLETED|Overall Study||34||
48541453|NCT04867174|101662732|FG019|COMPLETED|Overall Study||27||
48541454|NCT04867174|101662733|FG020|COMPLETED|Overall Study||113||
48541455|NCT04867174|101662734|FG021|COMPLETED|Overall Study||103||
48541456|NCT04867174|101662735|FG022|COMPLETED|Overall Study||27||
48090578|NCT01438957|100545589|FG002|NOT COMPLETED|Overall Study||0||
48254759|NCT02959177|100943775|FG001|COMPLETED|Follow-up Post Treatment Phase||51||
48254760|NCT02959177|100943776|FG002|COMPLETED|Follow-up Post Treatment Phase||98||
48254761|NCT02959177|100943774|FG000|NOT COMPLETED|Follow-up Post Treatment Phase||1||
48254762|NCT02959177|100943775|FG001|NOT COMPLETED|Follow-up Post Treatment Phase||1||
48254763|NCT02959177|100943776|FG002|NOT COMPLETED|Follow-up Post Treatment Phase||2||
48254764|NCT02592707|100943777|FG000|STARTED|Overall Study||15||
48254765|NCT02592707|100943778|FG001|STARTED|Overall Study||6||
48254766|NCT02592707|100943779|FG002|STARTED|Overall Study||9||
48254767|NCT02592707|100943780|FG003|STARTED|Overall Study||10||
48254768|NCT02592707|100943777|FG000|COMPLETED|Overall Study||9|Completed LTFU period|
48254769|NCT02592707|100943778|FG001|COMPLETED|Overall Study||1|Completed LTFU period|
48254770|NCT02592707|100943779|FG002|COMPLETED|Overall Study||3|Completed LTFU period|
48254771|NCT02592707|100943780|FG003|COMPLETED|Overall Study||3|Completed LTFU period|
48254772|NCT02592707|100943777|FG000|NOT COMPLETED|Overall Study||6||
48254773|NCT02592707|100943778|FG001|NOT COMPLETED|Overall Study||5||
48254774|NCT02592707|100943779|FG002|NOT COMPLETED|Overall Study||6||
48254775|NCT02592707|100943780|FG003|NOT COMPLETED|Overall Study||7||
48254776|NCT01860807|100943781|FG000|STARTED|Overall Study||64||
48254777|NCT01860807|100943782|FG001|STARTED|Overall Study||61||
48541457|NCT04867174|101662736|FG023|COMPLETED|Overall Study||22||
48541458|NCT04867174|101662737|FG024|COMPLETED|Overall Study||30||
48254778|NCT01860807|100943781|FG000|COMPLETED|Overall Study||34||
48254779|NCT01860807|100943782|FG001|COMPLETED|Overall Study||32||
48254780|NCT01860807|100943781|FG000|NOT COMPLETED|Overall Study||30||
48254781|NCT01860807|100943782|FG001|NOT COMPLETED|Overall Study||29||
48254782|NCT01161628|100943783|FG000|STARTED|Overall Study||25||
48254783|NCT01161628|100943783|FG000|COMPLETED|Overall Study||17||
48254784|NCT01161628|100943783|FG000|NOT COMPLETED|Overall Study||8||
48686535|NCT02530476|102016861|FG003|STARTED|Overall Study||3||
48686536|NCT02530476|102016858|FG000|COMPLETED|Overall Study||4||
48686537|NCT02530476|102016859|FG001|COMPLETED|Overall Study||3||
48686538|NCT02530476|102016860|FG002|COMPLETED|Overall Study||7||
48686539|NCT02530476|102016861|FG003|COMPLETED|Overall Study||3||
48686540|NCT02530476|102016858|FG000|NOT COMPLETED|Overall Study||0||
48686541|NCT02530476|102016859|FG001|NOT COMPLETED|Overall Study||0||
48686542|NCT02530476|102016860|FG002|NOT COMPLETED|Overall Study||0||
48686543|NCT02530476|102016861|FG003|NOT COMPLETED|Overall Study||0||
48686544|NCT03745638|102016862|FG000|STARTED|Vehicle Control Period (Day 1 to Week 8)||126||
48686545|NCT03745638|102016863|FG001|STARTED|Vehicle Control Period (Day 1 to Week 8)||252||
48254785|NCT00816556|100943784|FG000|STARTED|Overall Study||20||
48254786|NCT00816556|100943785|FG001|STARTED|Overall Study||21||
48254787|NCT00816556|100943786|FG002|STARTED|Overall Study||22||
48254788|NCT00816556|100943784|FG000|COMPLETED|Overall Study||18||
48254789|NCT00816556|100943785|FG001|COMPLETED|Overall Study||19||
48254790|NCT00816556|100943786|FG002|COMPLETED|Overall Study||19||
48686546|NCT03745638|102016864|FG002|STARTED|Vehicle Control Period (Day 1 to Week 8)||253||
48686547|NCT03745638|102016865|FG003|STARTED|Vehicle Control Period (Day 1 to Week 8)||0||
48254791|NCT00816556|100943784|FG000|NOT COMPLETED|Overall Study||2||
48254792|NCT00816556|100943785|FG001|NOT COMPLETED|Overall Study||2||
48254793|NCT00816556|100943786|FG002|NOT COMPLETED|Overall Study||3||
48254794|NCT00560313|100943787|FG000|STARTED|Overall Study||54||
48254795|NCT00560313|100943787|FG000|COMPLETED|Overall Study||48||
48254796|NCT00560313|100943787|FG000|NOT COMPLETED|Overall Study||6||
48254797|NCT04811339|100943788|FG000|STARTED|Overall Study||19|19 patients received some BSS. 10 completed and 9 did not complete|
48254798|NCT04811339|100943789|FG001|STARTED|Overall Study||25|19 patients received some BSS. 10 completed and 9 did not complete|
48254799|NCT04811339|100943790|FG002|STARTED|Overall Study||0|19 patients received some BSS. 10 completed and 9 did not complete|
48254800|NCT04811339|100943788|FG000|Complete 3 Days of BSS|Overall Study||10|To complete BSS therapy, patients also needed to provide 3 days of saliva for SARS-CoV2 testing, record three days of bowel movements and record and score (between 0-3) 5 symptoms : cough, headache, fatigue, shortness of breath and anosmia ( loss of smell)|
48254801|NCT04811339|100943789|FG001|Complete 3 Days of BSS|Overall Study||0|To complete BSS therapy, patients also needed to provide 3 days of saliva for SARS-CoV2 testing, record three days of bowel movements and record and score (between 0-3) 5 symptoms : cough, headache, fatigue, shortness of breath and anosmia ( loss of smell)|
48254802|NCT04811339|100943790|FG002|Complete 3 Days of BSS|Overall Study||0|To complete BSS therapy, patients also needed to provide 3 days of saliva for SARS-CoV2 testing, record three days of bowel movements and record and score (between 0-3) 5 symptoms : cough, headache, fatigue, shortness of breath and anosmia ( loss of smell)|
48254803|NCT04811339|100943788|FG000|COMPLETED|Overall Study||10||
48254804|NCT04811339|100943789|FG001|COMPLETED|Overall Study||0||
48254805|NCT04811339|100943790|FG002|COMPLETED|Overall Study||0||
48254806|NCT04811339|100943788|FG000|NOT COMPLETED|Overall Study||9||
48254807|NCT04811339|100943789|FG001|NOT COMPLETED|Overall Study||25||
48254808|NCT04811339|100943790|FG002|NOT COMPLETED|Overall Study||0||
48254809|NCT02506881|100943791|FG000|STARTED|First Intervention (Day 1)||13||
48254810|NCT02506881|100943792|FG001|STARTED|First Intervention (Day 1)||12||
48254811|NCT02506881|100943793|FG002|STARTED|First Intervention (Day 1)||25||
48254812|NCT02506881|100943794|FG003|STARTED|First Intervention (Day 1)||24||
48254813|NCT02506881|100943791|FG000|COMPLETED|First Intervention (Day 1)||12||
48254814|NCT02506881|100943792|FG001|COMPLETED|First Intervention (Day 1)||12||
48254815|NCT02506881|100943793|FG002|COMPLETED|First Intervention (Day 1)||12||
48254816|NCT02506881|100943794|FG003|COMPLETED|First Intervention (Day 1)||12||
48254817|NCT02506881|100943791|FG000|NOT COMPLETED|First Intervention (Day 1)||1||
48254818|NCT02506881|100943792|FG001|NOT COMPLETED|First Intervention (Day 1)||0||
48254819|NCT02506881|100943793|FG002|NOT COMPLETED|First Intervention (Day 1)||13||
48254820|NCT02506881|100943794|FG003|NOT COMPLETED|First Intervention (Day 1)||12||
48254821|NCT02506881|100943791|FG000|STARTED|Washout (at Least 25 Days)||12||
48686548|NCT03745638|102016866|FG004|STARTED|Vehicle Control Period (Day 1 to Week 8)||0||
48254822|NCT02506881|100943792|FG001|STARTED|Washout (at Least 25 Days)||12||
48254823|NCT02506881|100943793|FG002|STARTED|Washout (at Least 25 Days)||12||
48254824|NCT02506881|100943794|FG003|STARTED|Washout (at Least 25 Days)||12||
48254825|NCT02506881|100943791|FG000|COMPLETED|Washout (at Least 25 Days)||12||
48254826|NCT02506881|100943792|FG001|COMPLETED|Washout (at Least 25 Days)||12||
48254827|NCT02506881|100943793|FG002|COMPLETED|Washout (at Least 25 Days)||12||
48254828|NCT02506881|100943794|FG003|COMPLETED|Washout (at Least 25 Days)||12||
48254829|NCT02506881|100943791|FG000|NOT COMPLETED|Washout (at Least 25 Days)||0||
48254830|NCT02506881|100943792|FG001|NOT COMPLETED|Washout (at Least 25 Days)||0||
48254831|NCT02506881|100943793|FG002|NOT COMPLETED|Washout (at Least 25 Days)||0||
48381608|NCT02159469|101261671|FG000|Completed 12 Week|Overall Study||137||
48686549|NCT03745638|102016867|FG005|STARTED|Vehicle Control Period (Day 1 to Week 8)||0||
48254832|NCT02506881|100943794|FG003|NOT COMPLETED|Washout (at Least 25 Days)||0||
48254833|NCT02506881|100943791|FG000|STARTED|Second Intervention (Day 1)||12||
48254834|NCT02506881|100943792|FG001|STARTED|Second Intervention (Day 1)||12||
48254835|NCT02506881|100943793|FG002|STARTED|Second Intervention (Day 1)||12||
48254836|NCT02506881|100943794|FG003|STARTED|Second Intervention (Day 1)||12||
48254837|NCT02506881|100943791|FG000|COMPLETED|Second Intervention (Day 1)||12||
48254838|NCT02506881|100943792|FG001|COMPLETED|Second Intervention (Day 1)||12||
48254839|NCT02506881|100943793|FG002|COMPLETED|Second Intervention (Day 1)||12||
48254840|NCT02506881|100943794|FG003|COMPLETED|Second Intervention (Day 1)||12||
48254841|NCT02506881|100943791|FG000|NOT COMPLETED|Second Intervention (Day 1)||0||
48254842|NCT02506881|100943792|FG001|NOT COMPLETED|Second Intervention (Day 1)||0||
48254843|NCT02506881|100943793|FG002|NOT COMPLETED|Second Intervention (Day 1)||0||
48254844|NCT02506881|100943794|FG003|NOT COMPLETED|Second Intervention (Day 1)||0||
48254845|NCT02101268|100943795|FG000|STARTED|Randomized Treatment Phase||104||
48254846|NCT02101268|100943796|FG001|STARTED|Randomized Treatment Phase||52||
48254847|NCT02101268|100943797|FG002|STARTED|Randomized Treatment Phase||0||
48254848|NCT02101268|100943798|FG003|STARTED|Randomized Treatment Phase||0||
48254849|NCT02101268|100943795|FG000|COMPLETED|Randomized Treatment Phase||77||
48254850|NCT02101268|100943796|FG001|COMPLETED|Randomized Treatment Phase||41||
48254851|NCT02101268|100943797|FG002|COMPLETED|Randomized Treatment Phase||0||
48254852|NCT02101268|100943798|FG003|COMPLETED|Randomized Treatment Phase||0||
48254853|NCT02101268|100943795|FG000|NOT COMPLETED|Randomized Treatment Phase||27||
48254854|NCT02101268|100943796|FG001|NOT COMPLETED|Randomized Treatment Phase||11||
48254855|NCT02101268|100943797|FG002|NOT COMPLETED|Randomized Treatment Phase||0||
48254856|NCT02101268|100943798|FG003|NOT COMPLETED|Randomized Treatment Phase||0||
48254857|NCT02101268|100943795|FG000|STARTED|Extended Treatment Phase||0||
48254858|NCT02101268|100943796|FG001|STARTED|Extended Treatment Phase||0||
48686550|NCT03745638|102016868|FG006|STARTED|Vehicle Control Period (Day 1 to Week 8)||0||
48686551|NCT03745638|102016862|FG000|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||95||
48686552|NCT03745638|102016863|FG001|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||222||
48686553|NCT03745638|102016864|FG002|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||225||
48686554|NCT03745638|102016865|FG003|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0||
48686555|NCT03745638|102016866|FG004|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0||
48686556|NCT03745638|102016867|FG005|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0||
48686557|NCT03745638|102016868|FG006|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0||
48686558|NCT03745638|102016862|FG000|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||31||
48686559|NCT03745638|102016863|FG001|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||30||
48686560|NCT03745638|102016864|FG002|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||28||
48686561|NCT03745638|102016865|FG003|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0||
48686562|NCT03745638|102016866|FG004|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0||
48686563|NCT03745638|102016867|FG005|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0||
48254859|NCT02101268|100943797|FG002|STARTED|Extended Treatment Phase||64||
48254860|NCT02101268|100943798|FG003|STARTED|Extended Treatment Phase||40||
48254861|NCT02101268|100943795|FG000|COMPLETED|Extended Treatment Phase||0||
48254862|NCT02101268|100943796|FG001|COMPLETED|Extended Treatment Phase||0||
48254863|NCT02101268|100943797|FG002|COMPLETED|Extended Treatment Phase||0||
48254864|NCT02101268|100943798|FG003|COMPLETED|Extended Treatment Phase||0||
48254865|NCT02101268|100943795|FG000|NOT COMPLETED|Extended Treatment Phase||0||
48254866|NCT02101268|100943796|FG001|NOT COMPLETED|Extended Treatment Phase||0||
48254867|NCT02101268|100943797|FG002|NOT COMPLETED|Extended Treatment Phase||64||
48254868|NCT02101268|100943798|FG003|NOT COMPLETED|Extended Treatment Phase||40||
48254869|NCT02330562|100943799|FG000|STARTED|Overall Study||6||
48254870|NCT02330562|100943800|FG001|STARTED|Overall Study||3||
48254871|NCT02330562|100943801|FG002|STARTED|Overall Study||27||
48254872|NCT02330562|100943802|FG003|STARTED|Overall Study||30||
48254873|NCT02330562|100943803|FG004|STARTED|Overall Study||31||
48254874|NCT02330562|100943804|FG005|STARTED|Overall Study||10||
48254875|NCT02330562|100943805|FG006|STARTED|Overall Study||1||
48254876|NCT02330562|100943806|FG007|STARTED|Overall Study||1||
48254877|NCT02330562|100943807|FG008|STARTED|Overall Study||1||
48254878|NCT02330562|100943808|FG009|STARTED|Overall Study||5||
48254879|NCT02330562|100943809|FG010|STARTED|Overall Study||6||
48254880|NCT02330562|100943799|FG000|COMPLETED|Overall Study||0||
48254881|NCT02330562|100943800|FG001|COMPLETED|Overall Study||0||
48686564|NCT03745638|102016868|FG006|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0||
48686565|NCT03745638|102016862|FG000|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0||
48254882|NCT02330562|100943801|FG002|COMPLETED|Overall Study||0||
48254883|NCT02330562|100943802|FG003|COMPLETED|Overall Study||0||
48254884|NCT02330562|100943803|FG004|COMPLETED|Overall Study||0||
48254885|NCT02330562|100943804|FG005|COMPLETED|Overall Study||0||
48254886|NCT02330562|100943805|FG006|COMPLETED|Overall Study||0||
48254887|NCT02330562|100943806|FG007|COMPLETED|Overall Study||0||
48254888|NCT02330562|100943807|FG008|COMPLETED|Overall Study||0||
48254889|NCT02330562|100943808|FG009|COMPLETED|Overall Study||0||
48254890|NCT02330562|100943809|FG010|COMPLETED|Overall Study||0||
48254891|NCT02330562|100943799|FG000|NOT COMPLETED|Overall Study||6||
48254892|NCT02330562|100943800|FG001|NOT COMPLETED|Overall Study||3||
48686566|NCT03745638|102016863|FG001|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0||
48686567|NCT03745638|102016864|FG002|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0||
48686568|NCT03745638|102016865|FG003|STARTED|Long-Term Safety Period (Weeks 8 to 52)||48||
48686569|NCT03745638|102016866|FG004|STARTED|Long-Term Safety Period (Weeks 8 to 52)||47||
48686570|NCT03745638|102016867|FG005|STARTED|Long-Term Safety Period (Weeks 8 to 52)||222||
48686571|NCT03745638|102016868|FG006|STARTED|Long-Term Safety Period (Weeks 8 to 52)||225||
48686572|NCT03745638|102016862|FG000|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0||
48686573|NCT03745638|102016863|FG001|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0||
48686574|NCT03745638|102016864|FG002|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0||
48686575|NCT03745638|102016865|FG003|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||37||
48686576|NCT03745638|102016866|FG004|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||38||
48686577|NCT03745638|102016867|FG005|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||176||
48686578|NCT03745638|102016868|FG006|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||174||
48686579|NCT03745638|102016862|FG000|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0||
48686580|NCT03745638|102016863|FG001|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0||
48686581|NCT03745638|102016864|FG002|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0||
48686582|NCT03745638|102016865|FG003|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||11||
48686583|NCT03745638|102016866|FG004|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||9||
48686584|NCT03745638|102016867|FG005|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||46||
48686585|NCT03745638|102016868|FG006|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||51||
48686586|NCT03346083|102016869|FG000|STARTED|Overall Study||3||
48686587|NCT03346083|102016870|FG001|STARTED|Overall Study||18||
48686588|NCT03346083|102016869|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||3||
48686589|NCT03346083|102016870|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||18||
48686590|NCT03346083|102016869|FG000|Evaluated Through Day 7 Follow-up|Overall Study||3||
48686591|NCT03346083|102016870|FG001|Evaluated Through Day 7 Follow-up|Overall Study||18||
48686592|NCT03346083|102016869|FG000|COMPLETED|Overall Study||3||
48686593|NCT03346083|102016870|FG001|COMPLETED|Overall Study||18||
48686594|NCT03346083|102016869|FG000|NOT COMPLETED|Overall Study||0||
48686595|NCT03346083|102016870|FG001|NOT COMPLETED|Overall Study||0||
48686596|NCT02100930|102016871|FG000|STARTED|Overall Study||69||
48686597|NCT02100930|102016871|FG000|COMPLETED|Overall Study||69||
48686598|NCT02100930|102016871|FG000|NOT COMPLETED|Overall Study||0||
48686599|NCT01444911|102016872|FG000|STARTED|Overall Study||16||
48686600|NCT01444911|102016873|FG001|STARTED|Overall Study||13||
48686601|NCT01444911|102016872|FG000|COMPLETED|Overall Study||8||
48686602|NCT01444911|102016873|FG001|COMPLETED|Overall Study||13||
48686603|NCT01444911|102016872|FG000|NOT COMPLETED|Overall Study||8||
48686604|NCT01444911|102016873|FG001|NOT COMPLETED|Overall Study||0||
48686605|NCT00996658|102016874|FG000|STARTED|Overall Study||92||
48686606|NCT00996658|102016875|FG001|STARTED|Overall Study||186||
48686607|NCT00996658|102016874|FG000|COMPLETED|Overall Study||76||
48686608|NCT00996658|102016875|FG001|COMPLETED|Overall Study||165||
48090579|NCT01438957|100545590|FG003|NOT COMPLETED|Overall Study||1||
48090580|NCT01438957|100545591|FG004|NOT COMPLETED|Overall Study||0||
48090581|NCT00748033|100545592|FG000|STARTED|Overall Study||12||
48090582|NCT00748033|100545593|FG001|STARTED|Overall Study||13||
48090583|NCT00748033|100545592|FG000|COMPLETED|Overall Study||12||
48090584|NCT00748033|100545593|FG001|COMPLETED|Overall Study||12||
48090585|NCT00748033|100545592|FG000|NOT COMPLETED|Overall Study||0||
48090586|NCT00748033|100545593|FG001|NOT COMPLETED|Overall Study||1||
48090587|NCT01710254|100545594|FG000|STARTED|Overall Study||30||
48090588|NCT01710254|100545594|FG000|COMPLETED|Overall Study||30||
48090589|NCT01710254|100545594|FG000|NOT COMPLETED|Overall Study||0||
48090590|NCT00386776|100545595|FG000|STARTED|Overall Study||40||
48090591|NCT00386776|100545595|FG000|COMPLETED|Overall Study||32||
48090592|NCT00386776|100545595|FG000|NOT COMPLETED|Overall Study||8||
48090593|NCT03068130|100545596|FG000|STARTED|Overall Study||261||
48090594|NCT03068130|100545596|FG000|COMPLETED|Overall Study||0||
48090595|NCT03068130|100545596|FG000|NOT COMPLETED|Overall Study||261||
48686609|NCT00996658|102016874|FG000|NOT COMPLETED|Overall Study||16||
48686610|NCT00996658|102016875|FG001|NOT COMPLETED|Overall Study||21||
48686611|NCT02709720|102016876|FG000|STARTED|Overall Study||68||
48686612|NCT02709720|102016876|FG000|COMPLETED|Overall Study||65||
48090596|NCT03836612|100545597|FG000|STARTED|Overall Study||19011||
48090597|NCT03836612|100545598|FG001|STARTED|Overall Study||76044||
48090598|NCT03836612|100545597|FG000|COMPLETED|Overall Study||19011||
48090599|NCT03836612|100545598|FG001|COMPLETED|Overall Study||76044||
48090600|NCT03836612|100545597|FG000|NOT COMPLETED|Overall Study||0||
48090601|NCT03836612|100545598|FG001|NOT COMPLETED|Overall Study||0||
48090602|NCT01750242|100545599|FG000|STARTED|Overall Study||23||
48090603|NCT01750242|100545599|FG000|Readable Images|Overall Study||20||
48090604|NCT01750242|100545599|FG000|COMPLETED|Overall Study||20||
48090605|NCT01750242|100545599|FG000|NOT COMPLETED|Overall Study||3||
48090606|NCT01706081|100545600|FG000|STARTED|Overall Study||40||
48686613|NCT02709720|102016876|FG000|NOT COMPLETED|Overall Study||3||
48686614|NCT03782064|102016877|FG000|STARTED|Overall Study||5|Enrolled and had Tumor and Dendritic Cells Collected|
48686615|NCT03782064|102016877|FG000|Initiated Treatment|Overall Study||2||
48686616|NCT03782064|102016877|FG000|COMPLETED|Overall Study||0||
48686617|NCT03782064|102016877|FG000|NOT COMPLETED|Overall Study||5||
48686618|NCT00130039|102016878|FG000|STARTED|Overall Study||232||
48686619|NCT00130039|102016879|FG001|STARTED|Overall Study||225||
48686620|NCT00130039|102016878|FG000|COMPLETED|Overall Study||202||
48686621|NCT00130039|102016879|FG001|COMPLETED|Overall Study||207||
48686622|NCT00130039|102016878|FG000|NOT COMPLETED|Overall Study||30||
48686623|NCT00130039|102016879|FG001|NOT COMPLETED|Overall Study||18||
48686624|NCT04704713|102016880|FG000|STARTED|Overall Study||15||
48686625|NCT04704713|102016881|FG001|STARTED|Overall Study||16||
48686626|NCT04704713|102016880|FG000|COMPLETED|Overall Study||11||
48686627|NCT04704713|102016881|FG001|COMPLETED|Overall Study||12||
48686628|NCT04704713|102016880|FG000|NOT COMPLETED|Overall Study||4||
48686629|NCT04704713|102016881|FG001|NOT COMPLETED|Overall Study||4||
48686630|NCT04971967|102016882|FG000|STARTED|Overall Study||81||
48686631|NCT04971967|102016883|FG001|STARTED|Overall Study||40||
48686632|NCT04971967|102016882|FG000|COMPLETED|Overall Study||75||
48686633|NCT04971967|102016883|FG001|COMPLETED|Overall Study||33||
48686634|NCT04971967|102016882|FG000|NOT COMPLETED|Overall Study||6||
48686635|NCT04971967|102016883|FG001|NOT COMPLETED|Overall Study||7||
48686636|NCT03500289|102016884|FG000|STARTED|Overall Study||12||
48254893|NCT02330562|100943801|FG002|NOT COMPLETED|Overall Study||27||
48254894|NCT02330562|100943802|FG003|NOT COMPLETED|Overall Study||30||
48254895|NCT02330562|100943803|FG004|NOT COMPLETED|Overall Study||31||
48254896|NCT02330562|100943804|FG005|NOT COMPLETED|Overall Study||10||
48254897|NCT02330562|100943805|FG006|NOT COMPLETED|Overall Study||1||
48254898|NCT02330562|100943806|FG007|NOT COMPLETED|Overall Study||1||
48254899|NCT02330562|100943807|FG008|NOT COMPLETED|Overall Study||1||
48254900|NCT02330562|100943808|FG009|NOT COMPLETED|Overall Study||5||
48254901|NCT02330562|100943809|FG010|NOT COMPLETED|Overall Study||6||
48254902|NCT01187407|100943810|FG000|STARTED|Confirmation (CF) Phase, 3 Weeks||1480||
48254903|NCT01187407|100943811|FG001|STARTED|Confirmation (CF) Phase, 3 Weeks||0||
48254904|NCT01187407|100943812|FG002|STARTED|Confirmation (CF) Phase, 3 Weeks||0||
48254905|NCT01187407|100943813|FG003|STARTED|Confirmation (CF) Phase, 3 Weeks||0||
48254906|NCT01187407|100943814|FG004|STARTED|Confirmation (CF) Phase, 3 Weeks||0||
48254907|NCT01187407|100943810|FG000|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||25||
48254908|NCT01187407|100943811|FG001|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0||
48254909|NCT01187407|100943812|FG002|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0||
48254910|NCT01187407|100943813|FG003|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0||
48254911|NCT01187407|100943814|FG004|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0||
48254912|NCT01187407|100943810|FG000|COMPLETED|Confirmation (CF) Phase, 3 Weeks||1390||
48254913|NCT01187407|100943811|FG001|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
48254914|NCT01187407|100943812|FG002|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
48254915|NCT01187407|100943813|FG003|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
48254916|NCT01187407|100943814|FG004|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
48254917|NCT01187407|100943810|FG000|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||90||
48254918|NCT01187407|100943811|FG001|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
48254919|NCT01187407|100943812|FG002|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
48254920|NCT01187407|100943813|FG003|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
48254921|NCT01187407|100943814|FG004|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
48254922|NCT01187407|100943810|FG000|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0||
48254923|NCT01187407|100943811|FG001|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||232||
48254924|NCT01187407|100943812|FG002|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||226||
48254925|NCT01187407|100943813|FG003|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231||
48254926|NCT01187407|100943814|FG004|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||701||
48254927|NCT01187407|100943810|FG000|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0||
48254928|NCT01187407|100943811|FG001|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||212||
48254929|NCT01187407|100943812|FG002|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||215||
48254930|NCT01187407|100943813|FG003|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||220||
48254931|NCT01187407|100943814|FG004|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||660||
48254932|NCT01187407|100943810|FG000|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0||
48254933|NCT01187407|100943811|FG001|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196||
48254934|NCT01187407|100943812|FG002|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||191||
48686637|NCT03500289|102016885|FG001|STARTED|Overall Study||6||
48686638|NCT03500289|102016884|FG000|COMPLETED|Overall Study||12||
48686639|NCT03500289|102016885|FG001|COMPLETED|Overall Study||6||
48686640|NCT03500289|102016884|FG000|NOT COMPLETED|Overall Study||0||
48686641|NCT03500289|102016885|FG001|NOT COMPLETED|Overall Study||0||
48686642|NCT03554018|102016886|FG000|STARTED|Overall Study||60||
48686643|NCT03554018|102016887|FG001|STARTED|Overall Study||60||
48686644|NCT03554018|102016886|FG000|COMPLETED|Overall Study||57||
48686645|NCT03554018|102016887|FG001|COMPLETED|Overall Study||53||
48686646|NCT03554018|102016886|FG000|NOT COMPLETED|Overall Study||3||
48686647|NCT03554018|102016887|FG001|NOT COMPLETED|Overall Study||7||
48686648|NCT01063348|102016888|FG000|STARTED|Overall Study||35||
48686649|NCT01063348|102016889|FG001|STARTED|Overall Study||31||
48381609|NCT02159469|101261671|FG000|COMPLETED|Overall Study||97||
48381610|NCT02159469|101261671|FG000|NOT COMPLETED|Overall Study||53||
48381611|NCT01998269|101261672|FG000|STARTED|Overall Study||193||
48381612|NCT01998269|101261672|FG000|COMPLETED|Overall Study||193||
48381613|NCT01998269|101261672|FG000|NOT COMPLETED|Overall Study||0||
48381614|NCT00302718|101261673|FG000|STARTED|Overall Study||20||
48381615|NCT00302718|101261674|FG001|STARTED|Overall Study||21||
48381616|NCT00302718|101261675|FG002|STARTED|Overall Study||21||
48381617|NCT00302718|101261676|FG003|STARTED|Overall Study||21||
48381618|NCT00302718|101261673|FG000|COMPLETED|Overall Study||19||
48686650|NCT01063348|102016888|FG000|COMPLETED|Overall Study||32||
48686651|NCT01063348|102016889|FG001|COMPLETED|Overall Study||21||
48686652|NCT01063348|102016888|FG000|NOT COMPLETED|Overall Study||3||
48686653|NCT01063348|102016889|FG001|NOT COMPLETED|Overall Study||10||
48686654|NCT03547908|102016890|FG000|STARTED|Overall Study||122||
48686655|NCT03547908|102016891|FG001|STARTED|Overall Study||122||
48686656|NCT03547908|102016890|FG000|COMPLETED|Overall Study||0||
48686657|NCT03547908|102016891|FG001|COMPLETED|Overall Study||0||
48686658|NCT03547908|102016890|FG000|NOT COMPLETED|Overall Study||122||
48090607|NCT01706081|100545601|FG001|STARTED|Overall Study||42||
48090608|NCT01706081|100545600|FG000|COMPLETED|Overall Study||40||
48686659|NCT03547908|102016891|FG001|NOT COMPLETED|Overall Study||122||
48686660|NCT00243191|102016892|FG000|STARTED|Overall Study||18||
48686661|NCT00243191|102016892|FG000|COMPLETED|Overall Study||18||
48686662|NCT00243191|102016892|FG000|NOT COMPLETED|Overall Study||0||
48090609|NCT01706081|100545601|FG001|COMPLETED|Overall Study||42||
48686663|NCT05110781|102016893|FG000|STARTED|Overall Study||1||
48686664|NCT05110781|102016893|FG000|COMPLETED|Overall Study||1||
48090610|NCT01706081|100545600|FG000|NOT COMPLETED|Overall Study||0||
48090611|NCT01706081|100545601|FG001|NOT COMPLETED|Overall Study||0||
48090612|NCT02634684|100545602|FG000|STARTED|Overall Study||19||
48090613|NCT02634684|100545603|FG001|STARTED|Overall Study||19||
48090614|NCT02634684|100545604|FG002|STARTED|Overall Study||21||
48686665|NCT05110781|102016893|FG000|NOT COMPLETED|Overall Study||0||
48686666|NCT00348946|102016894|FG000|STARTED|Overall Study||46||
48686667|NCT00348946|102016895|FG001|STARTED|Overall Study||47||
48686668|NCT00348946|102016894|FG000|COMPLETED|Overall Study||35||
48686669|NCT00348946|102016895|FG001|COMPLETED|Overall Study||35||
48686670|NCT00348946|102016894|FG000|NOT COMPLETED|Overall Study||11||
48686671|NCT00348946|102016895|FG001|NOT COMPLETED|Overall Study||12||
48090615|NCT02634684|100545605|FG003|STARTED|Overall Study||23||
48090616|NCT02634684|100545602|FG000|COMPLETED|Overall Study||19||
48090617|NCT02634684|100545603|FG001|COMPLETED|Overall Study||19||
48090618|NCT02634684|100545604|FG002|COMPLETED|Overall Study||21||
48090619|NCT02634684|100545605|FG003|COMPLETED|Overall Study||23||
48090620|NCT02634684|100545602|FG000|NOT COMPLETED|Overall Study||0||
48090621|NCT02634684|100545603|FG001|NOT COMPLETED|Overall Study||0||
48090622|NCT02634684|100545604|FG002|NOT COMPLETED|Overall Study||0||
48090623|NCT02634684|100545605|FG003|NOT COMPLETED|Overall Study||0||
48090624|NCT02733588|100545606|FG000|STARTED|Overall Study||7||
48090625|NCT02733588|100545606|FG000|COMPLETED|Overall Study||7||
48090626|NCT02733588|100545606|FG000|NOT COMPLETED|Overall Study||0||
48090627|NCT02744391|100545607|FG000|STARTED|Overall Study||47||
48090628|NCT02744391|100545607|FG000|COMPLETED|Overall Study||33||
48090629|NCT02744391|100545607|FG000|NOT COMPLETED|Overall Study||14||
48090630|NCT01170091|100545608|FG000|STARTED|Overall Study||651||
48090631|NCT01170091|100545608|FG000|COMPLETED|Overall Study||627||
48090632|NCT01170091|100545608|FG000|NOT COMPLETED|Overall Study||24||
48090633|NCT00975481|100545609|FG000|STARTED|First Intervention Period||6||
48090634|NCT00975481|100545610|FG001|STARTED|First Intervention Period||6||
48090635|NCT00975481|100545611|FG002|STARTED|First Intervention Period||6||
48090636|NCT00975481|100545612|FG003|STARTED|First Intervention Period||6||
48090637|NCT00975481|100545613|FG004|STARTED|First Intervention Period||6||
48090638|NCT00975481|100545614|FG005|STARTED|First Intervention Period||6||
48090639|NCT00975481|100545609|FG000|COMPLETED|First Intervention Period||6||
48090640|NCT00975481|100545610|FG001|COMPLETED|First Intervention Period||6||
48090641|NCT00975481|100545611|FG002|COMPLETED|First Intervention Period||6||
48090642|NCT00975481|100545612|FG003|COMPLETED|First Intervention Period||6||
48090643|NCT00975481|100545613|FG004|COMPLETED|First Intervention Period||6||
48090644|NCT00975481|100545614|FG005|COMPLETED|First Intervention Period||6||
48090645|NCT00975481|100545609|FG000|NOT COMPLETED|First Intervention Period||0||
48090646|NCT00975481|100545610|FG001|NOT COMPLETED|First Intervention Period||0||
48090647|NCT00975481|100545611|FG002|NOT COMPLETED|First Intervention Period||0||
48090648|NCT00975481|100545612|FG003|NOT COMPLETED|First Intervention Period||0||
48090649|NCT00975481|100545613|FG004|NOT COMPLETED|First Intervention Period||0||
48381619|NCT00302718|101261674|FG001|COMPLETED|Overall Study||20||
48381620|NCT00302718|101261675|FG002|COMPLETED|Overall Study||19||
48381621|NCT00302718|101261676|FG003|COMPLETED|Overall Study||19||
48381622|NCT00302718|101261673|FG000|NOT COMPLETED|Overall Study||1||
48686672|NCT03752203|102016896|FG000|STARTED|Overall Study||2||
48686673|NCT03752203|102016896|FG000|COMPLETED|Overall Study||2||
48686674|NCT03752203|102016896|FG000|NOT COMPLETED|Overall Study||0||
48686675|NCT02382991|102016897|FG000|STARTED|Overall Study||17||
48686676|NCT02382991|102016898|FG001|STARTED|Overall Study||18||
48090650|NCT00975481|100545614|FG005|NOT COMPLETED|First Intervention Period||0||
48090651|NCT00975481|100545609|FG000|STARTED|Washout Period (at Least 7 Days)||6||
48090652|NCT00975481|100545610|FG001|STARTED|Washout Period (at Least 7 Days)||6||
48090653|NCT00975481|100545611|FG002|STARTED|Washout Period (at Least 7 Days)||6||
48090654|NCT00975481|100545612|FG003|STARTED|Washout Period (at Least 7 Days)||6||
48686677|NCT02382991|102016897|FG000|COMPLETED|Overall Study||15||
48686678|NCT02382991|102016898|FG001|COMPLETED|Overall Study||15||
48686679|NCT02382991|102016897|FG000|NOT COMPLETED|Overall Study||2||
48686680|NCT02382991|102016898|FG001|NOT COMPLETED|Overall Study||3||
48686681|NCT01393899|102016899|FG000|STARTED|Overall Study||59||
48686682|NCT01393899|102016900|FG001|STARTED|Overall Study||60||
48686683|NCT01393899|102016901|FG002|STARTED|Overall Study||61||
48686684|NCT01393899|102016899|FG000|COMPLETED|Overall Study||27||
48686685|NCT01393899|102016900|FG001|COMPLETED|Overall Study||32||
48686686|NCT01393899|102016901|FG002|COMPLETED|Overall Study||38||
48686687|NCT01393899|102016899|FG000|NOT COMPLETED|Overall Study||32||
48686688|NCT01393899|102016900|FG001|NOT COMPLETED|Overall Study||28||
48686689|NCT01393899|102016901|FG002|NOT COMPLETED|Overall Study||23||
48686690|NCT03087604|102016902|FG000|STARTED|Overall Study||50||
48686691|NCT03087604|102016903|FG001|STARTED|Overall Study||50||
48686692|NCT03087604|102016902|FG000|COMPLETED|Overall Study||50||
48686693|NCT03087604|102016903|FG001|COMPLETED|Overall Study||50||
48686694|NCT03087604|102016902|FG000|NOT COMPLETED|Overall Study||0||
48686695|NCT03087604|102016903|FG001|NOT COMPLETED|Overall Study||0||
48686696|NCT00958477|102016904|FG000|STARTED|Overall Study||8||
48686697|NCT00958477|102016905|FG001|STARTED|Overall Study||6||
48686698|NCT00958477|102016906|FG002|STARTED|Overall Study||6||
48686699|NCT00958477|102016907|FG003|STARTED|Overall Study||6||
48686700|NCT00958477|102016904|FG000|COMPLETED|Overall Study||8||
48686701|NCT00958477|102016905|FG001|COMPLETED|Overall Study||6||
48686702|NCT00958477|102016906|FG002|COMPLETED|Overall Study||6||
48686703|NCT00958477|102016907|FG003|COMPLETED|Overall Study||6||
48686704|NCT00958477|102016904|FG000|NOT COMPLETED|Overall Study||0||
48686705|NCT00958477|102016905|FG001|NOT COMPLETED|Overall Study||0||
48686706|NCT00958477|102016906|FG002|NOT COMPLETED|Overall Study||0||
48686707|NCT00958477|102016907|FG003|NOT COMPLETED|Overall Study||0||
48686708|NCT01345929|102016908|FG000|STARTED|Overall Study||533||
48686709|NCT01345929|102016909|FG001|STARTED|Overall Study||535||
48686710|NCT01345929|102016908|FG000|COMPLETED|Overall Study||512||
48686711|NCT01345929|102016909|FG001|COMPLETED|Overall Study||516||
48686712|NCT01345929|102016908|FG000|NOT COMPLETED|Overall Study||21||
48686713|NCT01345929|102016909|FG001|NOT COMPLETED|Overall Study||19||
48686714|NCT02441101|102016910|FG000|STARTED|Overall Study||4||
48686715|NCT02441101|102016911|FG001|STARTED|Overall Study||2||
48686716|NCT02441101|102016910|FG000|COMPLETED|Overall Study||1||
48686717|NCT02441101|102016911|FG001|COMPLETED|Overall Study||2||
48686718|NCT02441101|102016910|FG000|NOT COMPLETED|Overall Study||3||
48686719|NCT02441101|102016911|FG001|NOT COMPLETED|Overall Study||0||
48686720|NCT00506454|102016912|FG000|STARTED|Overall Study||11||
48686721|NCT00506454|102016913|FG001|STARTED|Overall Study||11||
48686722|NCT00506454|102016912|FG000|COMPLETED|Overall Study||10||
48686723|NCT00506454|102016913|FG001|COMPLETED|Overall Study||10||
48686724|NCT00506454|102016912|FG000|NOT COMPLETED|Overall Study||1||
48686725|NCT00506454|102016913|FG001|NOT COMPLETED|Overall Study||1||
48686726|NCT00442416|102016914|FG000|STARTED|Overall Study||39||
48686727|NCT00442416|102016915|FG001|STARTED|Overall Study||41||
48686728|NCT00442416|102016914|FG000|COMPLETED|Overall Study||2||
48686729|NCT00442416|102016915|FG001|COMPLETED|Overall Study||2||
48686730|NCT00442416|102016914|FG000|NOT COMPLETED|Overall Study||37||
48686731|NCT00442416|102016915|FG001|NOT COMPLETED|Overall Study||39||
48686732|NCT01757301|102016916|FG000|STARTED|Overall Study||147||
48686733|NCT01757301|102016917|FG001|STARTED|Overall Study||147||
48686734|NCT01757301|102016916|FG000|COMPLETED|Overall Study||134||
48686735|NCT01757301|102016917|FG001|COMPLETED|Overall Study||133||
48686736|NCT01757301|102016916|FG000|NOT COMPLETED|Overall Study||13||
48686737|NCT01757301|102016917|FG001|NOT COMPLETED|Overall Study||14||
48686738|NCT01146613|102016918|FG000|STARTED|Overall Study||99||
48686739|NCT01146613|102016919|FG001|STARTED|Overall Study||101||
48686740|NCT01146613|102016918|FG000|COMPLETED|Overall Study||92||
48686741|NCT01146613|102016919|FG001|COMPLETED|Overall Study||89||
48686742|NCT01146613|102016918|FG000|NOT COMPLETED|Overall Study||7||
48686743|NCT01146613|102016919|FG001|NOT COMPLETED|Overall Study||12||
48686744|NCT01722994|102016920|FG000|STARTED|Overall Study||49||
48686745|NCT01722994|102016921|FG001|STARTED|Overall Study||48||
48686746|NCT01722994|102016920|FG000|COMPLETED|Overall Study||24||
48686747|NCT01722994|102016921|FG001|COMPLETED|Overall Study||31||
48686748|NCT01722994|102016920|FG000|NOT COMPLETED|Overall Study||25||
48686749|NCT01722994|102016921|FG001|NOT COMPLETED|Overall Study||17||
48686750|NCT00699413|102016922|FG000|STARTED|Overall Study||4||
48686751|NCT00699413|102016923|FG001|STARTED|Overall Study||4||
48686752|NCT00699413|102016922|FG000|COMPLETED|Overall Study||0||
48686753|NCT00699413|102016923|FG001|COMPLETED|Overall Study||0||
48686754|NCT00699413|102016922|FG000|NOT COMPLETED|Overall Study||4||
48686755|NCT00699413|102016923|FG001|NOT COMPLETED|Overall Study||4||
48686756|NCT03943290|102016924|FG000|STARTED|Overall Study||7||
48686757|NCT03943290|102016925|FG001|STARTED|Overall Study||1||
48686758|NCT03943290|102016926|FG002|STARTED|Overall Study||13||
48686759|NCT03943290|102016927|FG003|STARTED|Overall Study||6||
48686760|NCT03943290|102016928|FG004|STARTED|Overall Study||7||
48686761|NCT03943290|102016929|FG005|STARTED|Overall Study||6||
48686762|NCT03943290|102016930|FG006|STARTED|Overall Study||6||
48686763|NCT03943290|102016931|FG007|STARTED|Overall Study||8||
48686764|NCT03943290|102016932|FG008|STARTED|Overall Study||8||
48686765|NCT03943290|102016924|FG000|COMPLETED|Overall Study||0||
48686766|NCT03943290|102016925|FG001|COMPLETED|Overall Study||0||
48686767|NCT03943290|102016926|FG002|COMPLETED|Overall Study||0||
48686768|NCT03943290|102016927|FG003|COMPLETED|Overall Study||0||
48686769|NCT03943290|102016928|FG004|COMPLETED|Overall Study||0||
48686770|NCT03943290|102016929|FG005|COMPLETED|Overall Study||0||
48686771|NCT03943290|102016930|FG006|COMPLETED|Overall Study||0||
48686772|NCT03943290|102016931|FG007|COMPLETED|Overall Study||0||
48686773|NCT03943290|102016932|FG008|COMPLETED|Overall Study||0||
48686774|NCT03943290|102016924|FG000|NOT COMPLETED|Overall Study||7||
48686775|NCT03943290|102016925|FG001|NOT COMPLETED|Overall Study||1||
48686776|NCT03943290|102016926|FG002|NOT COMPLETED|Overall Study||13||
48686777|NCT03943290|102016927|FG003|NOT COMPLETED|Overall Study||6||
48686778|NCT03943290|102016928|FG004|NOT COMPLETED|Overall Study||7||
48686779|NCT03943290|102016929|FG005|NOT COMPLETED|Overall Study||6||
48686780|NCT03943290|102016930|FG006|NOT COMPLETED|Overall Study||6||
48686781|NCT03943290|102016931|FG007|NOT COMPLETED|Overall Study||8||
48686782|NCT03943290|102016932|FG008|NOT COMPLETED|Overall Study||8||
48686783|NCT00529243|102016933|FG000|STARTED|Overall Study||52||
48686784|NCT00529243|102016933|FG000|COMPLETED|Overall Study||49||
48686785|NCT00529243|102016933|FG000|NOT COMPLETED|Overall Study||3||
48686786|NCT00581048|102016934|FG000|STARTED|Overall Study||33||
48686787|NCT00581048|102016934|FG000|COMPLETED|Overall Study||33||
48686788|NCT00581048|102016934|FG000|NOT COMPLETED|Overall Study||0||
48686789|NCT03623698|102016935|FG000|STARTED|Overall Study||24||
48686790|NCT03623698|102016935|FG000|COMPLETED|Overall Study||24||
48686791|NCT03623698|102016935|FG000|NOT COMPLETED|Overall Study||0||
48686792|NCT02063984|102016936|FG000|STARTED|Overall Study||29||
48686793|NCT02063984|102016937|FG001|STARTED|Overall Study||30||
48686794|NCT02063984|102016936|FG000|COMPLETED|Overall Study||23||
48686795|NCT02063984|102016937|FG001|COMPLETED|Overall Study||25||
48686796|NCT02063984|102016936|FG000|NOT COMPLETED|Overall Study||6||
48686797|NCT02063984|102016937|FG001|NOT COMPLETED|Overall Study||5||
48686798|NCT00845481|102016938|FG000|STARTED|Overall Study||24||
48686799|NCT00845481|102016938|FG000|COMPLETED|Overall Study||24||
48686800|NCT00845481|102016938|FG000|NOT COMPLETED|Overall Study||0||
48686801|NCT03759639|102016939|FG000|STARTED|Treatment With IB1001||33||
48686802|NCT03759639|102016939|FG000|COMPLETED|Treatment With IB1001||31||
48686803|NCT03759639|102016939|FG000|NOT COMPLETED|Treatment With IB1001||2||
48686804|NCT03759639|102016939|FG000|STARTED|Post-Treatment Washout||31||
48686805|NCT03759639|102016939|FG000|COMPLETED|Post-Treatment Washout||31||
48686806|NCT03759639|102016939|FG000|NOT COMPLETED|Post-Treatment Washout||0||
48686807|NCT01747915|102016940|FG000|STARTED|Overall Study||75||
48686808|NCT01747915|102016941|FG001|STARTED|Overall Study||72||
48686809|NCT01747915|102016942|FG002|STARTED|Overall Study||72||
48686810|NCT01747915|102016940|FG000|COMPLETED|Overall Study||60||
48686811|NCT01747915|102016941|FG001|COMPLETED|Overall Study||61||
48686812|NCT01747915|102016942|FG002|COMPLETED|Overall Study||66||
48686813|NCT01747915|102016940|FG000|NOT COMPLETED|Overall Study||15||
48686814|NCT01747915|102016941|FG001|NOT COMPLETED|Overall Study||11||
48686815|NCT01747915|102016942|FG002|NOT COMPLETED|Overall Study||6||
48686816|NCT03666988|102016943|FG000|STARTED|Part 1 (Up to 28 Months)||3||
48686817|NCT03666988|102016944|FG001|STARTED|Part 1 (Up to 28 Months)||16||
48686818|NCT03666988|102016945|FG002|STARTED|Part 1 (Up to 28 Months)||12||
48686819|NCT03666988|102016946|FG003|STARTED|Part 1 (Up to 28 Months)||0||
48686820|NCT03666988|102016947|FG004|STARTED|Part 1 (Up to 28 Months)||0||
48686821|NCT03666988|102016948|FG005|STARTED|Part 1 (Up to 28 Months)||0||
48686822|NCT03666988|102016943|FG000|COMPLETED|Part 1 (Up to 28 Months)||0||
48686823|NCT03666988|102016944|FG001|COMPLETED|Part 1 (Up to 28 Months)||0||
48381623|NCT00302718|101261674|FG001|NOT COMPLETED|Overall Study||1||
48381624|NCT00302718|101261675|FG002|NOT COMPLETED|Overall Study||2||
48381625|NCT00302718|101261676|FG003|NOT COMPLETED|Overall Study||2||
48381626|NCT00539253|101261677|FG000|STARTED|Overall Study||45||
48381627|NCT00539253|101261677|FG000|COMPLETED|Overall Study||19||
48381628|NCT00539253|101261677|FG000|NOT COMPLETED|Overall Study||26||
48381629|NCT03615469|101261678|FG000|STARTED|Overall Study||7||
48381630|NCT03615469|101261679|FG001|STARTED|Overall Study||8||
48381631|NCT03615469|101261678|FG000|COMPLETED|Overall Study||4||
48381632|NCT03615469|101261679|FG001|COMPLETED|Overall Study||7||
48381633|NCT03615469|101261678|FG000|NOT COMPLETED|Overall Study||3||
48541459|NCT04867174|101662738|FG025|COMPLETED|Overall Study||24||
48381634|NCT03615469|101261679|FG001|NOT COMPLETED|Overall Study||1||
48381635|NCT01042613|101261680|FG000|STARTED|Overall Study||72||
48541460|NCT04867174|101662739|FG026|COMPLETED|Overall Study||33||
48541461|NCT04867174|101662740|FG027|COMPLETED|Overall Study||28||
48541462|NCT04867174|101662741|FG028|COMPLETED|Overall Study||17||
48541463|NCT04867174|101662742|FG029|COMPLETED|Overall Study||32||
48541464|NCT04867174|101662743|FG030|COMPLETED|Overall Study||117||
48541465|NCT04867174|101662744|FG031|COMPLETED|Overall Study||100||
48541466|NCT04867174|101662745|FG032|COMPLETED|Overall Study||20||
48541467|NCT04867174|101662746|FG033|COMPLETED|Overall Study||19||
48541468|NCT04867174|101662747|FG034|COMPLETED|Overall Study||28||
48541469|NCT04867174|101662748|FG035|COMPLETED|Overall Study||15||
48541470|NCT04867174|101662749|FG036|COMPLETED|Overall Study||22||
48541471|NCT04867174|101662750|FG037|COMPLETED|Overall Study||22||
48541472|NCT04867174|101662751|FG038|COMPLETED|Overall Study||24||
48541473|NCT04867174|101662752|FG039|COMPLETED|Overall Study||18||
48541474|NCT04867174|101662753|FG040|COMPLETED|Overall Study||112||
48541475|NCT04867174|101662754|FG041|COMPLETED|Overall Study||120||
48686824|NCT03666988|102016945|FG002|COMPLETED|Part 1 (Up to 28 Months)||0||
48541476|NCT04867174|101662755|FG042|COMPLETED|Overall Study||28||
48541477|NCT04867174|101662756|FG043|COMPLETED|Overall Study||18||
48541478|NCT04867174|101662757|FG044|COMPLETED|Overall Study||26||
48090655|NCT00975481|100545613|FG004|STARTED|Washout Period (at Least 7 Days)||6||
48090656|NCT00975481|100545614|FG005|STARTED|Washout Period (at Least 7 Days)||6||
48090657|NCT00975481|100545609|FG000|COMPLETED|Washout Period (at Least 7 Days)||6||
48090658|NCT00975481|100545610|FG001|COMPLETED|Washout Period (at Least 7 Days)||6||
48090659|NCT00975481|100545611|FG002|COMPLETED|Washout Period (at Least 7 Days)||6||
48090660|NCT00975481|100545612|FG003|COMPLETED|Washout Period (at Least 7 Days)||6||
48090661|NCT00975481|100545613|FG004|COMPLETED|Washout Period (at Least 7 Days)||6||
48090662|NCT00975481|100545614|FG005|COMPLETED|Washout Period (at Least 7 Days)||6||
48090663|NCT00975481|100545609|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48090664|NCT00975481|100545610|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48090665|NCT00975481|100545611|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48090666|NCT00975481|100545612|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48090667|NCT00975481|100545613|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48090668|NCT00975481|100545614|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48090669|NCT00975481|100545609|FG000|STARTED|Second Intervention Period||6||
48090670|NCT00975481|100545610|FG001|STARTED|Second Intervention Period||6||
48090671|NCT00975481|100545611|FG002|STARTED|Second Intervention Period||6||
48090672|NCT00975481|100545612|FG003|STARTED|Second Intervention Period||6||
48090673|NCT00975481|100545613|FG004|STARTED|Second Intervention Period||6||
48090674|NCT00975481|100545614|FG005|STARTED|Second Intervention Period||6||
48090675|NCT00975481|100545609|FG000|COMPLETED|Second Intervention Period||4||
48090676|NCT00975481|100545610|FG001|COMPLETED|Second Intervention Period||5||
48090677|NCT00975481|100545611|FG002|COMPLETED|Second Intervention Period||5||
48090678|NCT00975481|100545612|FG003|COMPLETED|Second Intervention Period||6||
48090679|NCT00975481|100545613|FG004|COMPLETED|Second Intervention Period||6||
48090680|NCT00975481|100545614|FG005|COMPLETED|Second Intervention Period||6||
48090681|NCT00975481|100545609|FG000|NOT COMPLETED|Second Intervention Period||2||
48090682|NCT00975481|100545610|FG001|NOT COMPLETED|Second Intervention Period||1||
48090683|NCT00975481|100545611|FG002|NOT COMPLETED|Second Intervention Period||1||
48090684|NCT00975481|100545612|FG003|NOT COMPLETED|Second Intervention Period||0||
48090685|NCT00975481|100545613|FG004|NOT COMPLETED|Second Intervention Period||0||
48090686|NCT00975481|100545614|FG005|NOT COMPLETED|Second Intervention Period||0||
48090687|NCT00975481|100545609|FG000|STARTED|Washout Period (at Least 7 Days)||4||
48090688|NCT00975481|100545610|FG001|STARTED|Washout Period (at Least 7 Days)||5||
48090689|NCT00975481|100545611|FG002|STARTED|Washout Period (at Least 7 Days)||5||
48090690|NCT00975481|100545612|FG003|STARTED|Washout Period (at Least 7 Days)||6||
48090691|NCT00975481|100545613|FG004|STARTED|Washout Period (at Least 7 Days)||6||
48090692|NCT00975481|100545614|FG005|STARTED|Washout Period (at Least 7 Days)||6||
48090693|NCT00975481|100545609|FG000|COMPLETED|Washout Period (at Least 7 Days)||4||
48090694|NCT00975481|100545610|FG001|COMPLETED|Washout Period (at Least 7 Days)||5||
48090695|NCT00975481|100545611|FG002|COMPLETED|Washout Period (at Least 7 Days)||5||
48090696|NCT00975481|100545612|FG003|COMPLETED|Washout Period (at Least 7 Days)||6||
48090697|NCT00975481|100545613|FG004|COMPLETED|Washout Period (at Least 7 Days)||6||
48090698|NCT00975481|100545614|FG005|COMPLETED|Washout Period (at Least 7 Days)||6||
48090699|NCT00975481|100545609|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48090700|NCT00975481|100545610|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48090701|NCT00975481|100545611|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48090702|NCT00975481|100545612|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48090703|NCT00975481|100545613|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48090704|NCT00975481|100545614|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48090705|NCT00975481|100545609|FG000|STARTED|Third Intervention Period||4||
48090706|NCT00975481|100545610|FG001|STARTED|Third Intervention Period||5||
48090707|NCT00975481|100545611|FG002|STARTED|Third Intervention Period||5||
48090708|NCT00975481|100545612|FG003|STARTED|Third Intervention Period||6||
48090709|NCT00975481|100545613|FG004|STARTED|Third Intervention Period||6||
48090710|NCT00975481|100545614|FG005|STARTED|Third Intervention Period||6||
48090711|NCT00975481|100545609|FG000|COMPLETED|Third Intervention Period||4||
48090712|NCT00975481|100545610|FG001|COMPLETED|Third Intervention Period||5||
48090713|NCT00975481|100545611|FG002|COMPLETED|Third Intervention Period||5||
48090714|NCT00975481|100545612|FG003|COMPLETED|Third Intervention Period||6||
48090715|NCT00975481|100545613|FG004|COMPLETED|Third Intervention Period||6||
48090716|NCT00975481|100545614|FG005|COMPLETED|Third Intervention Period||6||
48090717|NCT00975481|100545609|FG000|NOT COMPLETED|Third Intervention Period||0||
48090718|NCT00975481|100545610|FG001|NOT COMPLETED|Third Intervention Period||0||
48090719|NCT00975481|100545611|FG002|NOT COMPLETED|Third Intervention Period||0||
48090720|NCT00975481|100545612|FG003|NOT COMPLETED|Third Intervention Period||0||
48090721|NCT00975481|100545613|FG004|NOT COMPLETED|Third Intervention Period||0||
48090722|NCT00975481|100545614|FG005|NOT COMPLETED|Third Intervention Period||0||
48090723|NCT00975481|100545609|FG000|STARTED|Washout Period (at Least 7 Days)||4||
48090724|NCT00975481|100545610|FG001|STARTED|Washout Period (at Least 7 Days)||5||
48090725|NCT00975481|100545611|FG002|STARTED|Washout Period (at Least 7 Days)||5||
48090726|NCT00975481|100545612|FG003|STARTED|Washout Period (at Least 7 Days)||6||
48090727|NCT00975481|100545613|FG004|STARTED|Washout Period (at Least 7 Days)||6||
48090728|NCT00975481|100545614|FG005|STARTED|Washout Period (at Least 7 Days)||6||
48090729|NCT00975481|100545609|FG000|COMPLETED|Washout Period (at Least 7 Days)||4||
48381636|NCT01042613|101261681|FG001|STARTED|Overall Study||74||
48381637|NCT01042613|101261680|FG000|COMPLETED|Overall Study||72||
48381638|NCT01042613|101261681|FG001|COMPLETED|Overall Study||74||
48381639|NCT01042613|101261680|FG000|NOT COMPLETED|Overall Study||0||
48381640|NCT01042613|101261681|FG001|NOT COMPLETED|Overall Study||0||
48381641|NCT01429792|101261682|FG000|STARTED|Overall Study||1013||
48381642|NCT01429792|101261682|FG000|Genotype 1|Overall Study||687||
48381643|NCT01429792|101261682|FG000|Genotype 2 & 3|Overall Study||305||
48381644|NCT01429792|101261682|FG000|Genotype 4|Overall Study||5||
48381645|NCT01429792|101261682|FG000|COMPLETED|Overall Study||607||
48381646|NCT01429792|101261682|FG000|NOT COMPLETED|Overall Study||406||
48381647|NCT04365985|101261683|FG000|STARTED|Overall Study||9||
48381648|NCT04365985|101261684|FG001|STARTED|Overall Study||9||
48381649|NCT04365985|101261685|FG002|STARTED|Overall Study||52||
48381650|NCT04365985|101261683|FG000|COMPLETED|Overall Study||9||
48381651|NCT04365985|101261684|FG001|COMPLETED|Overall Study||9||
48381652|NCT04365985|101261685|FG002|COMPLETED|Overall Study||52||
48381653|NCT04365985|101261683|FG000|NOT COMPLETED|Overall Study||0||
48381654|NCT04365985|101261684|FG001|NOT COMPLETED|Overall Study||0||
48381655|NCT04365985|101261685|FG002|NOT COMPLETED|Overall Study||0||
48541479|NCT04867174|101662758|FG045|COMPLETED|Overall Study||33||
48541480|NCT04867174|101662759|FG046|COMPLETED|Overall Study||21||
48541481|NCT04867174|101662760|FG047|COMPLETED|Overall Study||20||
48541482|NCT04867174|101662761|FG048|COMPLETED|Overall Study||21||
48541483|NCT04867174|101662762|FG049|COMPLETED|Overall Study||23||
48541484|NCT04867174|101662763|FG050|COMPLETED|Overall Study||104||
48541485|NCT04867174|101662764|FG051|COMPLETED|Overall Study||99||
48541486|NCT04867174|101662765|FG052|COMPLETED|Overall Study||28||
48541487|NCT04867174|101662766|FG053|COMPLETED|Overall Study||23||
48541488|NCT04867174|101662767|FG054|COMPLETED|Overall Study||27||
48541489|NCT04867174|101662768|FG055|COMPLETED|Overall Study||26||
48381656|NCT00352755|101261686|FG000|STARTED|Overall Study||18||
48381657|NCT00352755|101261686|FG000|COMPLETED|Overall Study||16||
48381658|NCT00352755|101261686|FG000|NOT COMPLETED|Overall Study||2||
48381659|NCT01409031|101261687|FG000|STARTED|Overall Study||1||
48381660|NCT01409031|101261688|FG001|STARTED|Overall Study||2||
48381661|NCT01409031|101261687|FG000|COMPLETED|Overall Study||0||
48381662|NCT01409031|101261688|FG001|COMPLETED|Overall Study||2||
48381663|NCT01409031|101261687|FG000|NOT COMPLETED|Overall Study||1||
48381664|NCT01409031|101261688|FG001|NOT COMPLETED|Overall Study||0||
48381665|NCT01397552|101261689|FG000|STARTED|Overall Study||4||
48381666|NCT01397552|101261690|FG001|STARTED|Overall Study||4||
48381667|NCT01397552|101261689|FG000|COMPLETED|Overall Study||1||
48381668|NCT01397552|101261690|FG001|COMPLETED|Overall Study||3||
48381669|NCT01397552|101261689|FG000|NOT COMPLETED|Overall Study||3||
48541490|NCT04867174|101662769|FG056|COMPLETED|Overall Study||19||
48541491|NCT04867174|101662770|FG057|COMPLETED|Overall Study||30||
48141350|NCT02137369|100670409|FG001|COMPLETED|Overall Study||9||
48381670|NCT01397552|101261690|FG001|NOT COMPLETED|Overall Study||1||
48381671|NCT00948818|101261691|FG000|STARTED|Overall Study||397||
48381672|NCT00948818|101261692|FG001|STARTED|Overall Study||406||
48090730|NCT00975481|100545610|FG001|COMPLETED|Washout Period (at Least 7 Days)||5||
48090731|NCT00975481|100545611|FG002|COMPLETED|Washout Period (at Least 7 Days)||5||
48090732|NCT00975481|100545612|FG003|COMPLETED|Washout Period (at Least 7 Days)||6||
48090733|NCT00975481|100545613|FG004|COMPLETED|Washout Period (at Least 7 Days)||6||
48090734|NCT00975481|100545614|FG005|COMPLETED|Washout Period (at Least 7 Days)||6||
48090735|NCT00975481|100545609|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48090736|NCT00975481|100545610|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48090737|NCT00975481|100545611|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48090738|NCT00975481|100545612|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48381673|NCT00948818|101261691|FG000|COMPLETED|Overall Study||335||
48381674|NCT00948818|101261692|FG001|COMPLETED|Overall Study||312||
48381675|NCT00948818|101261691|FG000|NOT COMPLETED|Overall Study||62||
48686825|NCT03666988|102016946|FG003|COMPLETED|Part 1 (Up to 28 Months)||0||
48686826|NCT03666988|102016947|FG004|COMPLETED|Part 1 (Up to 28 Months)||0||
48686827|NCT03666988|102016948|FG005|COMPLETED|Part 1 (Up to 28 Months)||0||
48686828|NCT03666988|102016943|FG000|NOT COMPLETED|Part 1 (Up to 28 Months)||3||
48686829|NCT03666988|102016944|FG001|NOT COMPLETED|Part 1 (Up to 28 Months)||16||
48686830|NCT03666988|102016945|FG002|NOT COMPLETED|Part 1 (Up to 28 Months)||12||
48686831|NCT03666988|102016946|FG003|NOT COMPLETED|Part 1 (Up to 28 Months)||0||
48686832|NCT03666988|102016947|FG004|NOT COMPLETED|Part 1 (Up to 28 Months)||0||
48686833|NCT03666988|102016948|FG005|NOT COMPLETED|Part 1 (Up to 28 Months)||0||
48686834|NCT03666988|102016943|FG000|STARTED|Part 2 (Up to 48 Months)||0||
48686835|NCT03666988|102016944|FG001|STARTED|Part 2 (Up to 48 Months)||0||
48686836|NCT03666988|102016945|FG002|STARTED|Part 2 (Up to 48 Months)||0||
48686837|NCT03666988|102016946|FG003|STARTED|Part 2 (Up to 48 Months)||0||
48090739|NCT00975481|100545613|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48090740|NCT00975481|100545614|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48090741|NCT00975481|100545609|FG000|STARTED|Fourth Intervention Period||4||
48090742|NCT00975481|100545610|FG001|STARTED|Fourth Intervention Period||5||
48090743|NCT00975481|100545611|FG002|STARTED|Fourth Intervention Period||5||
48090744|NCT00975481|100545612|FG003|STARTED|Fourth Intervention Period||6||
48090745|NCT00975481|100545613|FG004|STARTED|Fourth Intervention Period||6||
48090746|NCT00975481|100545614|FG005|STARTED|Fourth Intervention Period||6||
48090747|NCT00975481|100545609|FG000|COMPLETED|Fourth Intervention Period||4||
48090748|NCT00975481|100545610|FG001|COMPLETED|Fourth Intervention Period||5||
48254935|NCT01187407|100943813|FG003|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||202||
48254936|NCT01187407|100943814|FG004|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||626||
48686838|NCT03666988|102016947|FG004|STARTED|Part 2 (Up to 48 Months)||0||
48686839|NCT03666988|102016948|FG005|STARTED|Part 2 (Up to 48 Months)||0||
48686840|NCT03666988|102016943|FG000|COMPLETED|Part 2 (Up to 48 Months)||0||
48686841|NCT03666988|102016944|FG001|COMPLETED|Part 2 (Up to 48 Months)||0||
48090749|NCT00975481|100545611|FG002|COMPLETED|Fourth Intervention Period||4||
48090750|NCT00975481|100545612|FG003|COMPLETED|Fourth Intervention Period||5||
48090751|NCT00975481|100545613|FG004|COMPLETED|Fourth Intervention Period||6||
48090752|NCT00975481|100545614|FG005|COMPLETED|Fourth Intervention Period||6||
48090753|NCT00975481|100545609|FG000|NOT COMPLETED|Fourth Intervention Period||0||
48090754|NCT00975481|100545610|FG001|NOT COMPLETED|Fourth Intervention Period||0||
48090755|NCT00975481|100545611|FG002|NOT COMPLETED|Fourth Intervention Period||1||
48090756|NCT00975481|100545612|FG003|NOT COMPLETED|Fourth Intervention Period||1||
48090757|NCT00975481|100545613|FG004|NOT COMPLETED|Fourth Intervention Period||0||
48141351|NCT02137369|100670408|FG000|NOT COMPLETED|Overall Study||8||
48141352|NCT02137369|100670409|FG001|NOT COMPLETED|Overall Study||2||
48141353|NCT01297062|100670410|FG000|STARTED|Overall Study||15||
48141354|NCT01297062|100670411|FG001|STARTED|Overall Study||14||
48141355|NCT01297062|100670412|FG002|STARTED|Overall Study||14||
48141356|NCT01297062|100670413|FG003|STARTED|Overall Study||14||
48141357|NCT01297062|100670414|FG004|STARTED|Overall Study||15||
48141358|NCT01297062|100670415|FG005|STARTED|Overall Study||14||
48141359|NCT01297062|100670416|FG006|STARTED|Overall Study||8||
48141360|NCT01297062|100670410|FG000|Intent to Treat (ITT)|Overall Study||15||
48141361|NCT01297062|100670411|FG001|Intent to Treat (ITT)|Overall Study||14||
48141362|NCT01297062|100670412|FG002|Intent to Treat (ITT)|Overall Study||14||
48141363|NCT01297062|100670413|FG003|Intent to Treat (ITT)|Overall Study||14||
48141364|NCT01297062|100670414|FG004|Intent to Treat (ITT)|Overall Study||15||
48141365|NCT01297062|100670415|FG005|Intent to Treat (ITT)|Overall Study||14||
48141366|NCT01297062|100670416|FG006|Intent to Treat (ITT)|Overall Study||0||
48141367|NCT01297062|100670410|FG000|Evaluable Population|Overall Study||11||
48141368|NCT01297062|100670411|FG001|Evaluable Population|Overall Study||12||
48141369|NCT01297062|100670412|FG002|Evaluable Population|Overall Study||12||
48141370|NCT01297062|100670413|FG003|Evaluable Population|Overall Study||13||
48141371|NCT01297062|100670414|FG004|Evaluable Population|Overall Study||13||
48141372|NCT01297062|100670415|FG005|Evaluable Population|Overall Study||13||
48141373|NCT01297062|100670416|FG006|Evaluable Population|Overall Study||0||
48141374|NCT01297062|100670410|FG000|COMPLETED|Overall Study||11||
48141375|NCT01297062|100670411|FG001|COMPLETED|Overall Study||13||
48141376|NCT01297062|100670412|FG002|COMPLETED|Overall Study||12||
48686842|NCT03666988|102016945|FG002|COMPLETED|Part 2 (Up to 48 Months)||0||
48686843|NCT03666988|102016946|FG003|COMPLETED|Part 2 (Up to 48 Months)||0||
48686844|NCT03666988|102016947|FG004|COMPLETED|Part 2 (Up to 48 Months)||0||
48686845|NCT03666988|102016948|FG005|COMPLETED|Part 2 (Up to 48 Months)||0||
48686846|NCT03666988|102016943|FG000|NOT COMPLETED|Part 2 (Up to 48 Months)||0||
48686847|NCT03666988|102016944|FG001|NOT COMPLETED|Part 2 (Up to 48 Months)||0||
48381676|NCT00948818|101261692|FG001|NOT COMPLETED|Overall Study||94||
48381677|NCT02082145|101261693|FG000|STARTED|Overall Study||5||
48090758|NCT00975481|100545614|FG005|NOT COMPLETED|Fourth Intervention Period||0||
48090759|NCT00975481|100545609|FG000|STARTED|Washout Period (at Least 7 Days)||4||
48381678|NCT02082145|101261694|FG001|STARTED|Overall Study||9||
48381679|NCT02082145|101261693|FG000|COMPLETED|Overall Study||5||
48381680|NCT02082145|101261694|FG001|COMPLETED|Overall Study||9||
48381681|NCT02082145|101261693|FG000|NOT COMPLETED|Overall Study||0||
48381682|NCT02082145|101261694|FG001|NOT COMPLETED|Overall Study||0||
48381683|NCT02295735|101261695|FG000|STARTED|Overall Study||238||
48381684|NCT02295735|101261696|FG001|STARTED|Overall Study||237||
48381685|NCT02295735|101261695|FG000|COMPLETED|Overall Study||212||
48381686|NCT02295735|101261696|FG001|COMPLETED|Overall Study||210||
48686848|NCT03666988|102016945|FG002|NOT COMPLETED|Part 2 (Up to 48 Months)||0||
48686849|NCT03666988|102016946|FG003|NOT COMPLETED|Part 2 (Up to 48 Months)||0||
48686850|NCT03666988|102016947|FG004|NOT COMPLETED|Part 2 (Up to 48 Months)||0||
48686851|NCT03666988|102016948|FG005|NOT COMPLETED|Part 2 (Up to 48 Months)||0||
48686852|NCT02808897|102016949|FG000|STARTED|Overall Study||249||
48686853|NCT02808897|102016950|FG001|STARTED|Overall Study||241||
48686854|NCT02808897|102016949|FG000|COMPLETED|Overall Study||240||
48686855|NCT02808897|102016950|FG001|COMPLETED|Overall Study||230||
48686856|NCT02808897|102016949|FG000|NOT COMPLETED|Overall Study||9||
48686857|NCT02808897|102016950|FG001|NOT COMPLETED|Overall Study||11||
48686858|NCT04774380|102016951|FG000|STARTED|Overall Study||152||
48686859|NCT04774380|102016951|FG000|COMPLETED|Overall Study||77|Patients who terminated study|
48686860|NCT04774380|102016951|FG000|NOT COMPLETED|Overall Study||75||
48686861|NCT00407602|102016952|FG000|STARTED|Overall Study||30||
48686862|NCT00407602|102016952|FG000|COMPLETED|Overall Study||23||
48254937|NCT01187407|100943810|FG000|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0||
48254938|NCT01187407|100943811|FG001|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||36||
48254939|NCT01187407|100943812|FG002|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35||
48381687|NCT02295735|101261695|FG000|NOT COMPLETED|Overall Study||26||
48381688|NCT02295735|101261696|FG001|NOT COMPLETED|Overall Study||27||
48381689|NCT05086289|101261697|FG000|STARTED|Overall Study||105||
48381690|NCT05086289|101261698|FG001|STARTED|Overall Study||54||
48381691|NCT05086289|101261697|FG000|Received at Least One Dose of Study Drug (Safety Population Week 1-4)|Overall Study||105||
48090760|NCT00975481|100545610|FG001|STARTED|Washout Period (at Least 7 Days)||5||
48090761|NCT00975481|100545611|FG002|STARTED|Washout Period (at Least 7 Days)||4||
48254940|NCT01187407|100943813|FG003|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||29||
48254941|NCT01187407|100943814|FG004|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||75||
48254942|NCT01125566|100943815|FG000|STARTED|Patients Before the Switch (26Apr2013)||339|Randomised|
48254943|NCT01125566|100943816|FG001|STARTED|Patients Before the Switch (26Apr2013)||169|Randomised|
48254944|NCT01125566|100943817|FG002|STARTED|Patients Before the Switch (26Apr2013)||0|Randomised|
48254945|NCT01125566|100943815|FG000|Treated|Patients Before the Switch (26Apr2013)||337||
48254946|NCT01125566|100943816|FG001|Treated|Patients Before the Switch (26Apr2013)||169||
48254947|NCT01125566|100943817|FG002|Treated|Patients Before the Switch (26Apr2013)||0||
48254948|NCT01125566|100943815|FG000|COMPLETED|Patients Before the Switch (26Apr2013)||74||
48254949|NCT01125566|100943816|FG001|COMPLETED|Patients Before the Switch (26Apr2013)||0||
48254950|NCT01125566|100943817|FG002|COMPLETED|Patients Before the Switch (26Apr2013)||0||
48254951|NCT01125566|100943815|FG000|NOT COMPLETED|Patients Before the Switch (26Apr2013)||265||
48254952|NCT01125566|100943816|FG001|NOT COMPLETED|Patients Before the Switch (26Apr2013)||169||
48254953|NCT01125566|100943817|FG002|NOT COMPLETED|Patients Before the Switch (26Apr2013)||0||
48254954|NCT01125566|100943815|FG000|STARTED|Patients Who Switched From AV to TV||0||
48381692|NCT05086289|101261698|FG001|Received at Least One Dose of Study Drug (Safety Population Week 1-4)|Overall Study||54||
48381693|NCT05086289|101261697|FG000|Safety Population Week 5-8|Overall Study||92|All participants who took at least 1 dose of study drug and who did not discontinue at or prior to week 4.|
48686863|NCT00407602|102016952|FG000|NOT COMPLETED|Overall Study||7||
48686864|NCT01029912|102016953|FG000|STARTED|Overall Study||14||
48686865|NCT01029912|102016954|FG001|STARTED|Overall Study||12||
48686866|NCT01029912|102016953|FG000|COMPLETED|Overall Study||12||
48090762|NCT00975481|100545612|FG003|STARTED|Washout Period (at Least 7 Days)||5||
48090763|NCT00975481|100545613|FG004|STARTED|Washout Period (at Least 7 Days)||6||
48090764|NCT00975481|100545614|FG005|STARTED|Washout Period (at Least 7 Days)||6||
48254955|NCT01125566|100943816|FG001|STARTED|Patients Who Switched From AV to TV||0||
48254956|NCT01125566|100943817|FG002|STARTED|Patients Who Switched From AV to TV||75||
48254957|NCT01125566|100943815|FG000|COMPLETED|Patients Who Switched From AV to TV||0||
48254958|NCT01125566|100943816|FG001|COMPLETED|Patients Who Switched From AV to TV||0||
48254959|NCT01125566|100943817|FG002|COMPLETED|Patients Who Switched From AV to TV||2||
48254960|NCT01125566|100943815|FG000|NOT COMPLETED|Patients Who Switched From AV to TV||0||
48254961|NCT01125566|100943816|FG001|NOT COMPLETED|Patients Who Switched From AV to TV||0||
48254962|NCT01125566|100943817|FG002|NOT COMPLETED|Patients Who Switched From AV to TV||73||
48254963|NCT01163955|100943818|FG000|STARTED|Overall Study||26||
48254964|NCT01163955|100943819|FG001|STARTED|Overall Study||30||
48254965|NCT01163955|100943818|FG000|COMPLETED|Overall Study||26||
48254966|NCT01163955|100943819|FG001|COMPLETED|Overall Study||26||
48254967|NCT01163955|100943818|FG000|NOT COMPLETED|Overall Study||0||
48254968|NCT01163955|100943819|FG001|NOT COMPLETED|Overall Study||4||
48254969|NCT02179853|100943820|FG000|STARTED|Overall Study||4||
48254970|NCT02179853|100943821|FG001|STARTED|Overall Study||3||
48254971|NCT02179853|100943822|FG002|STARTED|Overall Study||15||
48254972|NCT02179853|100943820|FG000|COMPLETED|Overall Study||4||
48254973|NCT02179853|100943821|FG001|COMPLETED|Overall Study||3||
48254974|NCT02179853|100943822|FG002|COMPLETED|Overall Study||15||
48254975|NCT02179853|100943820|FG000|NOT COMPLETED|Overall Study||0||
48254976|NCT02179853|100943821|FG001|NOT COMPLETED|Overall Study||0||
48254977|NCT02179853|100943822|FG002|NOT COMPLETED|Overall Study||0||
48254978|NCT01821729|100943823|FG000|STARTED|Overall Study||50||
48254979|NCT01821729|100943823|FG000|Received Chemoradiotherapy|Overall Study||45||
48254980|NCT01821729|100943823|FG000|Underwent Attempted Surgery|Overall Study||42||
48254981|NCT01821729|100943823|FG000|COMPLETED|Overall Study||49||
48254982|NCT01821729|100943823|FG000|NOT COMPLETED|Overall Study||1||
48254983|NCT01990313|100943824|FG000|STARTED|Overall Study||15||
48254984|NCT01990313|100943824|FG000|COMPLETED|Overall Study||14||
48254985|NCT01990313|100943824|FG000|NOT COMPLETED|Overall Study||1||
48254986|NCT01268098|100943825|FG000|STARTED|Overall Study||19||
48254987|NCT01268098|100943826|FG001|STARTED|Overall Study||23||
48254988|NCT01268098|100943825|FG000|COMPLETED|Overall Study||18||
48254989|NCT01268098|100943826|FG001|COMPLETED|Overall Study||23||
48254990|NCT01268098|100943825|FG000|NOT COMPLETED|Overall Study||1||
48254991|NCT01268098|100943826|FG001|NOT COMPLETED|Overall Study||0||
48254992|NCT00329550|100943827|FG000|STARTED|Overall Study||9||
48254993|NCT00329550|100943828|FG001|STARTED|Overall Study||15||
48254994|NCT00329550|100943829|FG002|STARTED|Overall Study||16||
48254995|NCT00329550|100943827|FG000|COMPLETED|Overall Study||5||
48254996|NCT00329550|100943828|FG001|COMPLETED|Overall Study||11||
48254997|NCT00329550|100943829|FG002|COMPLETED|Overall Study||12||
48254998|NCT00329550|100943827|FG000|NOT COMPLETED|Overall Study||4||
48254999|NCT00329550|100943828|FG001|NOT COMPLETED|Overall Study||4||
48255000|NCT00329550|100943829|FG002|NOT COMPLETED|Overall Study||4||
48255001|NCT00292981|100943830|FG000|STARTED|Overall Study||57||
48255002|NCT00292981|100943830|FG000|COMPLETED|Overall Study||18||
48255003|NCT00292981|100943830|FG000|NOT COMPLETED|Overall Study||39||
48255004|NCT02418845|100943831|FG000|STARTED|Overall Study||125||
48255005|NCT02418845|100943832|FG001|STARTED|Overall Study||64||
48255006|NCT02418845|100943831|FG000|COMPLETED|Overall Study||109||
48255007|NCT02418845|100943832|FG001|COMPLETED|Overall Study||52||
48255008|NCT02418845|100943831|FG000|NOT COMPLETED|Overall Study||16||
48255009|NCT02418845|100943832|FG001|NOT COMPLETED|Overall Study||12||
48255010|NCT03245463|100943833|FG000|STARTED|Overall Study||12||
48255011|NCT03245463|100943834|FG001|STARTED|Overall Study||12||
48255012|NCT03245463|100943833|FG000|COMPLETED|Overall Study||12||
48255013|NCT03245463|100943834|FG001|COMPLETED|Overall Study||12||
48255014|NCT03245463|100943833|FG000|NOT COMPLETED|Overall Study||0||
48255015|NCT03245463|100943834|FG001|NOT COMPLETED|Overall Study||0||
48255016|NCT01255761|100943835|FG000|STARTED|Overall Study||369||
48255017|NCT01255761|100943836|FG001|STARTED|Overall Study||367||
48255018|NCT01255761|100943835|FG000|COMPLETED|Overall Study||187||
48255019|NCT01255761|100943836|FG001|COMPLETED|Overall Study||192||
48255020|NCT01255761|100943835|FG000|NOT COMPLETED|Overall Study||182||
48255021|NCT01255761|100943836|FG001|NOT COMPLETED|Overall Study||175||
48255022|NCT02230306|100943837|FG000|STARTED|Overall Study||5||
48255023|NCT02230306|100943837|FG000|COMPLETED|Overall Study||4||
48255024|NCT02230306|100943837|FG000|NOT COMPLETED|Overall Study||1||
48255025|NCT01721746|100943838|FG000|STARTED|Pre-Treatment||272|Started = Randomized|
48255026|NCT01721746|100943839|FG001|STARTED|Pre-Treatment||133|Started = Randomized|
48255027|NCT01721746|100943838|FG000|COMPLETED|Pre-Treatment||268|Completed = Received Treatment|
48255028|NCT01721746|100943839|FG001|COMPLETED|Pre-Treatment||102|Completed = Received Treatment|
48255029|NCT01721746|100943838|FG000|NOT COMPLETED|Pre-Treatment||4||
48255030|NCT01721746|100943839|FG001|NOT COMPLETED|Pre-Treatment||31||
48255031|NCT01721746|100943838|FG000|STARTED|Treatment||268|Started = Received treatment|
48255032|NCT01721746|100943839|FG001|STARTED|Treatment||102|Started = Received treatment|
48255033|NCT01721746|100943838|FG000|COMPLETED|Treatment||0|Completed = Completed treatment|
48255034|NCT01721746|100943839|FG001|COMPLETED|Treatment||0|Completed = Completed treatment|
48255035|NCT01721746|100943838|FG000|NOT COMPLETED|Treatment||268||
48255036|NCT01721746|100943839|FG001|NOT COMPLETED|Treatment||102||
48255037|NCT02049515|100943840|FG000|STARTED|Overall Study||90||
48255038|NCT02049515|100943841|FG001|STARTED|Overall Study||9||
48255039|NCT02049515|100943840|FG000|Received at Least 1 Dose of Study Drug|Overall Study||90|All-treated analysis set: all participants who received any amount of study drug (IPI-145 or ofatumumab).|
48255040|NCT02049515|100943841|FG001|Received at Least 1 Dose of Study Drug|Overall Study||9|All-treated analysis set: all participants who received any amount of study drug (IPI-145 or ofatumumab).|
48255041|NCT02049515|100943840|FG000|COMPLETED|Overall Study||0||
48255042|NCT02049515|100943841|FG001|COMPLETED|Overall Study||3||
48255043|NCT02049515|100943840|FG000|NOT COMPLETED|Overall Study||90||
48255044|NCT02049515|100943841|FG001|NOT COMPLETED|Overall Study||6||
48255045|NCT00605566|100943842|FG000|STARTED|Overall Study||22||
48255046|NCT00605566|100943842|FG000|COMPLETED|Overall Study||19||
48255047|NCT00605566|100943842|FG000|NOT COMPLETED|Overall Study||3||
48255048|NCT04353817|100943843|FG000|STARTED|Overall Study||61||
48255049|NCT04353817|100943844|FG001|STARTED|Overall Study||60||
48255050|NCT04353817|100943843|FG000|COMPLETED|Overall Study||61||
48255051|NCT04353817|100943844|FG001|COMPLETED|Overall Study||59||
48381694|NCT05086289|101261698|FG001|Safety Population Week 5-8|Overall Study||50|All participants who took at least 1 dose of study drug and who did not discontinue at or prior to week 4.|
48381695|NCT05086289|101261697|FG000|COMPLETED|Overall Study||90||
48381696|NCT05086289|101261698|FG001|COMPLETED|Overall Study||49||
48381697|NCT05086289|101261697|FG000|NOT COMPLETED|Overall Study||15||
48381698|NCT05086289|101261698|FG001|NOT COMPLETED|Overall Study||5||
48255052|NCT04353817|100943843|FG000|NOT COMPLETED|Overall Study||0||
48255053|NCT04353817|100943844|FG001|NOT COMPLETED|Overall Study||1||
48255054|NCT04969224|100943845|FG000|STARTED|Overall Study||82||
48255055|NCT04969224|100943845|FG000|COMPLETED|Overall Study||80||
48255056|NCT04969224|100943845|FG000|NOT COMPLETED|Overall Study||2||
48255057|NCT01351337|100943846|FG000|STARTED|Overall Study||58||
48255058|NCT01351337|100943846|FG000|COMPLETED|Overall Study||58||
48255059|NCT01351337|100943846|FG000|NOT COMPLETED|Overall Study||0||
48255060|NCT03100864|100943847|FG000|STARTED|Overall Study||8||
48255061|NCT03100864|100943847|FG000|COMPLETED|Overall Study||8||
48255062|NCT03100864|100943847|FG000|NOT COMPLETED|Overall Study||0||
48255063|NCT03517111|100943848|FG000|STARTED|Enrolled||361||6
48255064|NCT03517111|100943849|FG001|STARTED|Enrolled||222||5
48255065|NCT03517111|100943850|FG002|STARTED|Enrolled||261||5
48255066|NCT03517111|100943848|FG000|Parents|Enrolled||215||6
48255067|NCT03517111|100943849|FG001|Parents|Enrolled||126||5
48255068|NCT03517111|100943850|FG002|Parents|Enrolled||153||5
48255069|NCT03517111|100943848|FG000|Youth|Enrolled||146||6
48255070|NCT03517111|100943849|FG001|Youth|Enrolled||96||5
48255071|NCT03517111|100943850|FG002|Youth|Enrolled||108||5
48255072|NCT03517111|100943848|FG000|COMPLETED|Enrolled||361||6
48255073|NCT03517111|100943849|FG001|COMPLETED|Enrolled||221||5
48255074|NCT03517111|100943850|FG002|COMPLETED|Enrolled||261||5
48255075|NCT03517111|100943848|FG000|NOT COMPLETED|Enrolled||0||0
48255076|NCT03517111|100943849|FG001|NOT COMPLETED|Enrolled||1||0
48255077|NCT03517111|100943850|FG002|NOT COMPLETED|Enrolled||0||0
48381699|NCT00434122|101261699|FG000|STARTED|Overall Study||42||
48381700|NCT00434122|101261700|FG001|STARTED|Overall Study||43||
48381701|NCT00434122|101261699|FG000|Intention-to-treat (ITT) Population|Overall Study||39||
48381702|NCT00434122|101261700|FG001|Intention-to-treat (ITT) Population|Overall Study||39||
48381703|NCT00434122|101261699|FG000|COMPLETED|Overall Study||36||
48381704|NCT00434122|101261700|FG001|COMPLETED|Overall Study||36||
48381705|NCT00434122|101261699|FG000|NOT COMPLETED|Overall Study||6||
48255078|NCT03517111|100943848|FG000|STARTED|T1 Survey (Week 0)||361||6
48255079|NCT03517111|100943849|FG001|STARTED|T1 Survey (Week 0)||221||5
48255080|NCT03517111|100943850|FG002|STARTED|T1 Survey (Week 0)||261||5
48255081|NCT03517111|100943848|FG000|Parents|T1 Survey (Week 0)||132||6
48255082|NCT03517111|100943849|FG001|Parents|T1 Survey (Week 0)||125||5
48255083|NCT03517111|100943850|FG002|Parents|T1 Survey (Week 0)||153||5
48255084|NCT03517111|100943848|FG000|Youth|T1 Survey (Week 0)||101||6
48255085|NCT03517111|100943849|FG001|Youth|T1 Survey (Week 0)||96||5
48255086|NCT03517111|100943850|FG002|Youth|T1 Survey (Week 0)||108||5
48255087|NCT03517111|100943848|FG000|COMPLETED|T1 Survey (Week 0)||361||6
48255088|NCT03517111|100943849|FG001|COMPLETED|T1 Survey (Week 0)||221||5
48255089|NCT03517111|100943850|FG002|COMPLETED|T1 Survey (Week 0)||261||5
48255090|NCT03517111|100943848|FG000|NOT COMPLETED|T1 Survey (Week 0)||0||0
48255091|NCT03517111|100943849|FG001|NOT COMPLETED|T1 Survey (Week 0)||0||0
48255092|NCT03517111|100943850|FG002|NOT COMPLETED|T1 Survey (Week 0)||0||0
48255093|NCT03517111|100943848|FG000|STARTED|T2 Survey (Week 10-12)||361||6
48255094|NCT03517111|100943849|FG001|STARTED|T2 Survey (Week 10-12)||221||5
48255095|NCT03517111|100943850|FG002|STARTED|T2 Survey (Week 10-12)||261||5
48381706|NCT00434122|101261700|FG001|NOT COMPLETED|Overall Study||7||
48381707|NCT02403830|101261701|FG000|STARTED|Visit 1||15||
48255096|NCT03517111|100943848|FG000|Parents|T2 Survey (Week 10-12)||132||6
48255097|NCT03517111|100943849|FG001|Parents|T2 Survey (Week 10-12)||71||5
48255098|NCT03517111|100943850|FG002|Parents|T2 Survey (Week 10-12)||98||5
48255099|NCT03517111|100943848|FG000|Youth|T2 Survey (Week 10-12)||101||6
48255100|NCT03517111|100943849|FG001|Youth|T2 Survey (Week 10-12)||57||5
48255101|NCT03517111|100943850|FG002|Youth|T2 Survey (Week 10-12)||76||5
48255102|NCT03517111|100943848|FG000|COMPLETED|T2 Survey (Week 10-12)||233||6
48255103|NCT03517111|100943849|FG001|COMPLETED|T2 Survey (Week 10-12)||128||5
48255104|NCT03517111|100943850|FG002|COMPLETED|T2 Survey (Week 10-12)||174||5
48255105|NCT03517111|100943848|FG000|NOT COMPLETED|T2 Survey (Week 10-12)||128||0
48255106|NCT03517111|100943849|FG001|NOT COMPLETED|T2 Survey (Week 10-12)||93||0
48255107|NCT03517111|100943850|FG002|NOT COMPLETED|T2 Survey (Week 10-12)||87||0
48090765|NCT00975481|100545609|FG000|COMPLETED|Washout Period (at Least 7 Days)||4||
48381708|NCT02403830|101261702|FG001|STARTED|Visit 1||15||
48381709|NCT02403830|101261701|FG000|COMPLETED|Visit 1||15||
48381710|NCT02403830|101261702|FG001|COMPLETED|Visit 1||15||
48381711|NCT02403830|101261701|FG000|NOT COMPLETED|Visit 1||0||
48381712|NCT02403830|101261702|FG001|NOT COMPLETED|Visit 1||0||
48381713|NCT02403830|101261701|FG000|STARTED|Visit 2||14||
48381714|NCT02403830|101261702|FG001|STARTED|Visit 2||15||
48381715|NCT02403830|101261701|FG000|COMPLETED|Visit 2||14||
48381716|NCT02403830|101261702|FG001|COMPLETED|Visit 2||15||
48381717|NCT02403830|101261701|FG000|NOT COMPLETED|Visit 2||0||
48381718|NCT02403830|101261702|FG001|NOT COMPLETED|Visit 2||0||
48381719|NCT00809458|101261703|FG000|STARTED|Overall Study||9||
48381720|NCT00809458|101261704|FG001|STARTED|Overall Study||6||
48381721|NCT00809458|101261703|FG000|COMPLETED|Overall Study||8||
48381722|NCT00809458|101261704|FG001|COMPLETED|Overall Study||5||
48381723|NCT00809458|101261703|FG000|NOT COMPLETED|Overall Study||1||
48381724|NCT00809458|101261704|FG001|NOT COMPLETED|Overall Study||1||
48381725|NCT01902953|101261705|FG000|STARTED|Overall Study||16||
48381726|NCT01902953|101261705|FG000|COMPLETED|Overall Study||16||
48381727|NCT01902953|101261705|FG000|NOT COMPLETED|Overall Study||0||
48381728|NCT01822691|101261706|FG000|STARTED|Overall Study||15||
48381729|NCT01822691|101261706|FG000|COMPLETED|Overall Study||13||
48381730|NCT01822691|101261706|FG000|NOT COMPLETED|Overall Study||2||
48381731|NCT03628417|101261707|FG000|STARTED|Overall Study||7|If the patient has more than six metastases, then one to four metastases were used for biopsy.|24
48381732|NCT03628417|101261708|FG001|STARTED|Overall Study||7|If the patient has more than six metastases, then one to four metastases were used for biopsy.|20
48381733|NCT03628417|101261707|FG000|Day 0|Overall Study||7|The treatment of the previously removed metastases (before and after treatment) were known.|21
48381734|NCT03628417|101261708|FG001|Day 0|Overall Study||7|The treatment of the previously removed metastases (before and after treatment) were known.|17
48381735|NCT03628417|101261707|FG000|Day 7|Overall Study||7||18
48090766|NCT00975481|100545610|FG001|COMPLETED|Washout Period (at Least 7 Days)||5||
48090767|NCT00975481|100545611|FG002|COMPLETED|Washout Period (at Least 7 Days)||4||
48090768|NCT00975481|100545612|FG003|COMPLETED|Washout Period (at Least 7 Days)||5||
48090769|NCT00975481|100545613|FG004|COMPLETED|Washout Period (at Least 7 Days)||6||
48090770|NCT00975481|100545614|FG005|COMPLETED|Washout Period (at Least 7 Days)||6||
48090771|NCT00975481|100545609|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48255108|NCT03517111|100943848|FG000|STARTED|T3 Survey (Weeks 24-26)||242|Some participants skipped T2 survey, but completed T3|6
48255109|NCT03517111|100943849|FG001|STARTED|T3 Survey (Weeks 24-26)||131|Some participants skipped T2 survey, but completed T3|5
48255110|NCT03517111|100943850|FG002|STARTED|T3 Survey (Weeks 24-26)||178|Some participants skipped T2 survey, but completed T3|5
48255111|NCT03517111|100943848|FG000|Parents|T3 Survey (Weeks 24-26)||119||6
48255112|NCT03517111|100943849|FG001|Parents|T3 Survey (Weeks 24-26)||70||5
48255113|NCT03517111|100943850|FG002|Parents|T3 Survey (Weeks 24-26)||92||5
48255114|NCT03517111|100943848|FG000|Youth|T3 Survey (Weeks 24-26)||96||6
48255115|NCT03517111|100943849|FG001|Youth|T3 Survey (Weeks 24-26)||55||5
48255116|NCT03517111|100943850|FG002|Youth|T3 Survey (Weeks 24-26)||71||5
48255117|NCT03517111|100943848|FG000|COMPLETED|T3 Survey (Weeks 24-26)||215||6
48255118|NCT03517111|100943849|FG001|COMPLETED|T3 Survey (Weeks 24-26)||125||5
48255119|NCT03517111|100943850|FG002|COMPLETED|T3 Survey (Weeks 24-26)||163||5
48255120|NCT03517111|100943848|FG000|NOT COMPLETED|T3 Survey (Weeks 24-26)||27||0
48255121|NCT03517111|100943849|FG001|NOT COMPLETED|T3 Survey (Weeks 24-26)||6||0
48255122|NCT03517111|100943850|FG002|NOT COMPLETED|T3 Survey (Weeks 24-26)||15||0
48255123|NCT02005393|100943851|FG000|STARTED|Overall Study||20||
48255124|NCT02005393|100943851|FG000|COMPLETED|Overall Study||20||
48255125|NCT02005393|100943851|FG000|NOT COMPLETED|Overall Study||0||
48255126|NCT02970305|100943852|FG000|STARTED|Overall Study||201||
48255127|NCT02970305|100943853|FG001|STARTED|Overall Study||202||
48255128|NCT02970305|100943852|FG000|COMPLETED|Overall Study||172||
48255129|NCT02970305|100943853|FG001|COMPLETED|Overall Study||174||
48255130|NCT02970305|100943852|FG000|NOT COMPLETED|Overall Study||29||
48255131|NCT02970305|100943853|FG001|NOT COMPLETED|Overall Study||28||
48255132|NCT04731675|100943854|FG000|STARTED|Overall Study||8||
48255133|NCT04731675|100943855|FG001|STARTED|Overall Study||3||
48255134|NCT04731675|100943854|FG000|COMPLETED|Overall Study||6||
48255135|NCT04731675|100943855|FG001|COMPLETED|Overall Study||3||
48255136|NCT04731675|100943854|FG000|NOT COMPLETED|Overall Study||2||
48255137|NCT04731675|100943855|FG001|NOT COMPLETED|Overall Study||0||
48381736|NCT03628417|101261708|FG001|Day 7|Overall Study||7||15
48381737|NCT03628417|101261707|FG000|Day 15|Overall Study||7||18
48381738|NCT03628417|101261708|FG001|Day 15|Overall Study||7||15
48090772|NCT00975481|100545610|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48090773|NCT00975481|100545611|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48090774|NCT00975481|100545612|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48255138|NCT00904722|100943856|FG000|STARTED|Overall Study||30||
48255139|NCT00904722|100943856|FG000|COMPLETED|Overall Study||29||
48255140|NCT00904722|100943856|FG000|NOT COMPLETED|Overall Study||1||
48255141|NCT00104637|100943857|FG000|STARTED|Period 1: ( TREATMENT: 4 Weeks)||6||
48255142|NCT00104637|100943858|FG001|STARTED|Period 1: ( TREATMENT: 4 Weeks)||4||
48255143|NCT00104637|100943857|FG000|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||5||
48255144|NCT00104637|100943858|FG001|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||4||
48255145|NCT00104637|100943857|FG000|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||1||
48255146|NCT00104637|100943858|FG001|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||0||
48255147|NCT00104637|100943857|FG000|STARTED|Period 2 (WASHOUT: 1 Week)||5||
48255148|NCT00104637|100943858|FG001|STARTED|Period 2 (WASHOUT: 1 Week)||4||
48255149|NCT00104637|100943857|FG000|COMPLETED|Period 2 (WASHOUT: 1 Week)||5||
48255150|NCT00104637|100943858|FG001|COMPLETED|Period 2 (WASHOUT: 1 Week)||4||
48255151|NCT00104637|100943857|FG000|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0||
48255152|NCT00104637|100943858|FG001|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0||
48255153|NCT00104637|100943857|FG000|STARTED|Period 3 ( TREATMENT: 4 Weeks)||5||
48255154|NCT00104637|100943858|FG001|STARTED|Period 3 ( TREATMENT: 4 Weeks)||4||
48255155|NCT00104637|100943857|FG000|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||5||
48255156|NCT00104637|100943858|FG001|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||4||
48255157|NCT00104637|100943857|FG000|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0||
48255158|NCT00104637|100943858|FG001|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0||
48255159|NCT00858507|100943859|FG000|STARTED|Overall Study||105||
48255160|NCT00858507|100943860|FG001|STARTED|Overall Study||116||
48255161|NCT00858507|100943859|FG000|COMPLETED|Overall Study||83||
48255162|NCT00858507|100943860|FG001|COMPLETED|Overall Study||101||
48255163|NCT00858507|100943859|FG000|NOT COMPLETED|Overall Study||22||
48255164|NCT00858507|100943860|FG001|NOT COMPLETED|Overall Study||15||
48255165|NCT00591591|100943861|FG000|STARTED|Overall Study||176||
48255166|NCT00591591|100943862|FG001|STARTED|Overall Study||133||
48255167|NCT00591591|100943861|FG000|COMPLETED|Overall Study||165||
48255168|NCT00591591|100943862|FG001|COMPLETED|Overall Study||94||
48255169|NCT00591591|100943861|FG000|NOT COMPLETED|Overall Study||11||
48255170|NCT00591591|100943862|FG001|NOT COMPLETED|Overall Study||39||
48255171|NCT01921114|100943863|FG000|STARTED|Overall Study||0||
48255172|NCT01921114|100943864|FG001|STARTED|Overall Study||0||
48255173|NCT01921114|100943863|FG000|COMPLETED|Overall Study||0||
48255174|NCT01921114|100943864|FG001|COMPLETED|Overall Study||0||
48255175|NCT01921114|100943863|FG000|NOT COMPLETED|Overall Study||0||
48255176|NCT01921114|100943864|FG001|NOT COMPLETED|Overall Study||0||
48255177|NCT02725528|100943865|FG000|STARTED|Overall Study||8||
48255178|NCT02725528|100943866|FG001|STARTED|Overall Study||14||
48255179|NCT02725528|100943865|FG000|COMPLETED|Overall Study||7||
48255180|NCT02725528|100943866|FG001|COMPLETED|Overall Study||9||
48255181|NCT02725528|100943865|FG000|NOT COMPLETED|Overall Study||1||
48255182|NCT02725528|100943866|FG001|NOT COMPLETED|Overall Study||5||
48255183|NCT01193218|100943867|FG000|STARTED|0-12 Weeks||109||
48255184|NCT01193218|100943868|FG001|STARTED|0-12 Weeks||0||
48255185|NCT01193218|100943869|FG002|STARTED|0-12 Weeks||110||
48255186|NCT01193218|100943870|FG003|STARTED|0-12 Weeks||0||
48255187|NCT01193218|100943871|FG004|STARTED|0-12 Weeks||109||
48255188|NCT01193218|100943872|FG005|STARTED|0-12 Weeks||109||
48255189|NCT01193218|100943873|FG006|STARTED|0-12 Weeks||110||
48255190|NCT01193218|100943874|FG007|STARTED|0-12 Weeks||0||
48255191|NCT01193218|100943867|FG000|COMPLETED|0-12 Weeks||100||
48255192|NCT01193218|100943868|FG001|COMPLETED|0-12 Weeks||0||
48255193|NCT01193218|100943869|FG002|COMPLETED|0-12 Weeks||107||
48255194|NCT01193218|100943870|FG003|COMPLETED|0-12 Weeks||0||
48255195|NCT01193218|100943871|FG004|COMPLETED|0-12 Weeks||108||
48255196|NCT01193218|100943872|FG005|COMPLETED|0-12 Weeks||106||
48255197|NCT01193218|100943873|FG006|COMPLETED|0-12 Weeks||107||
48255198|NCT01193218|100943874|FG007|COMPLETED|0-12 Weeks||0||
48255199|NCT01193218|100943867|FG000|NOT COMPLETED|0-12 Weeks||9||
48255200|NCT01193218|100943868|FG001|NOT COMPLETED|0-12 Weeks||0||
48255201|NCT01193218|100943869|FG002|NOT COMPLETED|0-12 Weeks||3||
48255202|NCT01193218|100943870|FG003|NOT COMPLETED|0-12 Weeks||0||
48255203|NCT01193218|100943871|FG004|NOT COMPLETED|0-12 Weeks||1||
48255204|NCT01193218|100943872|FG005|NOT COMPLETED|0-12 Weeks||3||
48255205|NCT01193218|100943873|FG006|NOT COMPLETED|0-12 Weeks||3||
48255206|NCT01193218|100943874|FG007|NOT COMPLETED|0-12 Weeks||0||
48255207|NCT01193218|100943867|FG000|STARTED|12-52 Weeks||50||
48255208|NCT01193218|100943868|FG001|STARTED|12-52 Weeks||50||
48255209|NCT01193218|100943869|FG002|STARTED|12-52 Weeks||54||
48255210|NCT01193218|100943870|FG003|STARTED|12-52 Weeks||53||
48255211|NCT01193218|100943871|FG004|STARTED|12-52 Weeks||108||
48255212|NCT01193218|100943872|FG005|STARTED|12-52 Weeks||106||
48255213|NCT01193218|100943873|FG006|STARTED|12-52 Weeks||54||
48255214|NCT01193218|100943874|FG007|STARTED|12-52 Weeks||53||
48255215|NCT01193218|100943867|FG000|COMPLETED|12-52 Weeks||45||
48255216|NCT01193218|100943868|FG001|COMPLETED|12-52 Weeks||50||
48255217|NCT01193218|100943869|FG002|COMPLETED|12-52 Weeks||50||
48255218|NCT01193218|100943870|FG003|COMPLETED|12-52 Weeks||50||
48255219|NCT01193218|100943871|FG004|COMPLETED|12-52 Weeks||104||
48255220|NCT01193218|100943872|FG005|COMPLETED|12-52 Weeks||101||
48255221|NCT01193218|100943873|FG006|COMPLETED|12-52 Weeks||51||
48255222|NCT01193218|100943874|FG007|COMPLETED|12-52 Weeks||49||
48381739|NCT03628417|101261707|FG000|Day 30|Overall Study||7||18
48381740|NCT03628417|101261708|FG001|Day 30|Overall Study||7||15
48381741|NCT03628417|101261707|FG000|Day 60|Overall Study||7||18
48381742|NCT03628417|101261708|FG001|Day 60|Overall Study||7||15
48381743|NCT03628417|101261707|FG000|Day 90|Overall Study||7||18
48381744|NCT03628417|101261708|FG001|Day 90|Overall Study||7||15
48381745|NCT03628417|101261707|FG000|Day 180|Overall Study||7|The randomization code was revealed for each patient. Biopsies were taken from both arms.|12
48381746|NCT03628417|101261708|FG001|Day 180|Overall Study||7|The randomization code was revealed for each patient. Biopsies were taken from both arms.|9
48381747|NCT03628417|101261707|FG000|COMPLETED|Overall Study||6|The patients were followed a year after treatment.|7
48381748|NCT03628417|101261708|FG001|COMPLETED|Overall Study||6|The patients were followed a year after treatment.|7
48381749|NCT03628417|101261707|FG000|NOT COMPLETED|Overall Study||1||17
48381750|NCT03628417|101261708|FG001|NOT COMPLETED|Overall Study||1||13
48381751|NCT04397718|101261709|FG000|STARTED|Overall Study||34||
48255223|NCT01193218|100943867|FG000|NOT COMPLETED|12-52 Weeks||5||
48255224|NCT01193218|100943868|FG001|NOT COMPLETED|12-52 Weeks||0||
48255225|NCT01193218|100943869|FG002|NOT COMPLETED|12-52 Weeks||4||
48255226|NCT01193218|100943870|FG003|NOT COMPLETED|12-52 Weeks||3||
48255227|NCT01193218|100943871|FG004|NOT COMPLETED|12-52 Weeks||4||
48255228|NCT01193218|100943872|FG005|NOT COMPLETED|12-52 Weeks||5||
48255229|NCT01193218|100943873|FG006|NOT COMPLETED|12-52 Weeks||3||
48255230|NCT01193218|100943874|FG007|NOT COMPLETED|12-52 Weeks||4||
48255231|NCT03082612|100943875|FG000|STARTED|Overall Study||17||
48255232|NCT03082612|100943876|FG001|STARTED|Overall Study||5||
48255233|NCT03082612|100943875|FG000|COMPLETED|Overall Study||15||
48255234|NCT03082612|100943876|FG001|COMPLETED|Overall Study||5||
48255235|NCT03082612|100943875|FG000|NOT COMPLETED|Overall Study||2||
48255236|NCT03082612|100943876|FG001|NOT COMPLETED|Overall Study||0||
48255237|NCT02918292|100943877|FG000|STARTED|Study Enrollment Prior to Transplant||32||
48255238|NCT02918292|100943877|FG000|COMPLETED|Study Enrollment Prior to Transplant||31||
48255239|NCT02918292|100943877|FG000|NOT COMPLETED|Study Enrollment Prior to Transplant||1||
48255240|NCT02918292|100943877|FG000|STARTED|Study Follow up After Transplant||31||
48255241|NCT02918292|100943877|FG000|COMPLETED|Study Follow up After Transplant||25||
48255242|NCT02918292|100943877|FG000|NOT COMPLETED|Study Follow up After Transplant||6||
48255243|NCT00087555|100943878|FG000|STARTED|Overall Study||66||
48255244|NCT00087555|100943879|FG001|STARTED|Overall Study||62||
48255245|NCT00087555|100943880|FG002|STARTED|Overall Study||67||
48255246|NCT00087555|100943878|FG000|Treated|Overall Study||65||
48255247|NCT00087555|100943879|FG001|Treated|Overall Study||60||
48255248|NCT00087555|100943880|FG002|Treated|Overall Study||67||
48255249|NCT00087555|100943878|FG000|COMPLETED|Overall Study||54||
48255250|NCT00087555|100943879|FG001|COMPLETED|Overall Study||51||
48255251|NCT00087555|100943880|FG002|COMPLETED|Overall Study||46||
48255252|NCT00087555|100943878|FG000|NOT COMPLETED|Overall Study||12||
48255253|NCT00087555|100943879|FG001|NOT COMPLETED|Overall Study||11||
48255254|NCT00087555|100943880|FG002|NOT COMPLETED|Overall Study||21||
48255255|NCT03475056|100943881|FG000|STARTED|Overall Study||20||
48255256|NCT03475056|100943882|FG001|STARTED|Overall Study||20||
48255257|NCT03475056|100943881|FG000|Received Product Administration|Overall Study||20||
48255258|NCT03475056|100943882|FG001|Received Product Administration|Overall Study||20||
48255259|NCT03475056|100943881|FG000|COMPLETED|Overall Study||20||
48255260|NCT03475056|100943882|FG001|COMPLETED|Overall Study||17||
48255261|NCT03475056|100943881|FG000|NOT COMPLETED|Overall Study||0||
48255262|NCT03475056|100943882|FG001|NOT COMPLETED|Overall Study||3||
48255263|NCT02175745|100943883|FG000|STARTED|Overall Study||2||
48255264|NCT02175745|100943883|FG000|COMPLETED|Overall Study||1||
48255265|NCT02175745|100943883|FG000|NOT COMPLETED|Overall Study||1||
48255266|NCT03440047|100943884|FG000|STARTED|Overall Study||355||
48255267|NCT03440047|100943884|FG000|COMPLETED|Overall Study||353||
48255268|NCT03440047|100943884|FG000|NOT COMPLETED|Overall Study||2||
48255269|NCT02503982|100943885|FG000|STARTED|Overall Study||13||
48255270|NCT02503982|100943885|FG000|COMPLETED|Overall Study||13||
48255271|NCT02503982|100943885|FG000|NOT COMPLETED|Overall Study||0||
48255272|NCT02138253|100943886|FG000|STARTED|Overall Study||41||
48255273|NCT02138253|100943887|FG001|STARTED|Overall Study||23||
48381752|NCT04397718|101261710|FG001|STARTED|Overall Study||62||
48255274|NCT02138253|100943886|FG000|COMPLETED|Overall Study||32||
48255275|NCT02138253|100943887|FG001|COMPLETED|Overall Study||19||
48255276|NCT02138253|100943886|FG000|NOT COMPLETED|Overall Study||9||
48255277|NCT02138253|100943887|FG001|NOT COMPLETED|Overall Study||4||
48255278|NCT01044901|100943888|FG000|STARTED|Overall Study||38||
48381753|NCT04397718|101261709|FG000|COMPLETED|Overall Study||27||
48381754|NCT04397718|101261710|FG001|COMPLETED|Overall Study||47||
48255279|NCT01044901|100943889|FG001|STARTED|Overall Study||13||
48255280|NCT01044901|100943888|FG000|COMPLETED|Overall Study||38||
48255281|NCT01044901|100943889|FG001|COMPLETED|Overall Study||13||
48255282|NCT01044901|100943888|FG000|NOT COMPLETED|Overall Study||0||
48255283|NCT01044901|100943889|FG001|NOT COMPLETED|Overall Study||0||
48255284|NCT00733226|100943890|FG000|STARTED|Overall Study||40||
48255285|NCT00733226|100943891|FG001|STARTED|Overall Study||40||
48255286|NCT00733226|100943890|FG000|COMPLETED|Overall Study||35||
48686867|NCT01029912|102016954|FG001|COMPLETED|Overall Study||12||
48686868|NCT01029912|102016953|FG000|NOT COMPLETED|Overall Study||2||
48686869|NCT01029912|102016954|FG001|NOT COMPLETED|Overall Study||0||
48686870|NCT02840253|102016955|FG000|STARTED|Overall Study||23||
48686871|NCT02840253|102016955|FG000|COMPLETED|Overall Study||19||
48686872|NCT02840253|102016955|FG000|NOT COMPLETED|Overall Study||4||
48686873|NCT00790582|102016956|FG000|STARTED|Overall Study||109||
48686874|NCT00790582|102016957|FG001|STARTED|Overall Study||249||
48686875|NCT00790582|102016956|FG000|COMPLETED|Overall Study||78||
48686876|NCT00790582|102016957|FG001|COMPLETED|Overall Study||162||
48686877|NCT00790582|102016956|FG000|NOT COMPLETED|Overall Study||31||
48686878|NCT00790582|102016957|FG001|NOT COMPLETED|Overall Study||87||
48686879|NCT01445613|102016958|FG000|STARTED|30-day Follow-up||1200||
48090775|NCT00975481|100545613|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48090776|NCT00975481|100545614|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48090777|NCT00975481|100545609|FG000|STARTED|Fifth Intervention Period||4||
48090778|NCT00975481|100545610|FG001|STARTED|Fifth Intervention Period||5||
48090779|NCT00975481|100545611|FG002|STARTED|Fifth Intervention Period||4||
48090780|NCT00975481|100545612|FG003|STARTED|Fifth Intervention Period||5||
48090781|NCT00975481|100545613|FG004|STARTED|Fifth Intervention Period||6||
48090782|NCT00975481|100545614|FG005|STARTED|Fifth Intervention Period||6||
48090783|NCT00975481|100545609|FG000|COMPLETED|Fifth Intervention Period||4||
48090784|NCT00975481|100545610|FG001|COMPLETED|Fifth Intervention Period||5||
48090785|NCT00975481|100545611|FG002|COMPLETED|Fifth Intervention Period||4||
48090786|NCT00975481|100545612|FG003|COMPLETED|Fifth Intervention Period||5||
48090787|NCT00975481|100545613|FG004|COMPLETED|Fifth Intervention Period||5||
48090788|NCT00975481|100545614|FG005|COMPLETED|Fifth Intervention Period||6||
48090789|NCT00975481|100545609|FG000|NOT COMPLETED|Fifth Intervention Period||0||
48090790|NCT00975481|100545610|FG001|NOT COMPLETED|Fifth Intervention Period||0||
48090791|NCT00975481|100545611|FG002|NOT COMPLETED|Fifth Intervention Period||0||
48090792|NCT00975481|100545612|FG003|NOT COMPLETED|Fifth Intervention Period||0||
48090793|NCT00975481|100545613|FG004|NOT COMPLETED|Fifth Intervention Period||1||
48090794|NCT00975481|100545614|FG005|NOT COMPLETED|Fifth Intervention Period||0||
48090795|NCT00975481|100545609|FG000|STARTED|Washout Period (at Least 7 Days)||4||
48090796|NCT00975481|100545610|FG001|STARTED|Washout Period (at Least 7 Days)||5||
48090797|NCT00975481|100545611|FG002|STARTED|Washout Period (at Least 7 Days)||4||
48090798|NCT00975481|100545612|FG003|STARTED|Washout Period (at Least 7 Days)||5||
48090799|NCT00975481|100545613|FG004|STARTED|Washout Period (at Least 7 Days)||5||
48090800|NCT00975481|100545614|FG005|STARTED|Washout Period (at Least 7 Days)||6||
48090801|NCT00975481|100545609|FG000|COMPLETED|Washout Period (at Least 7 Days)||4||
48090802|NCT00975481|100545610|FG001|COMPLETED|Washout Period (at Least 7 Days)||5||
48090803|NCT00975481|100545611|FG002|COMPLETED|Washout Period (at Least 7 Days)||4||
48090804|NCT00975481|100545612|FG003|COMPLETED|Washout Period (at Least 7 Days)||5||
48090805|NCT00975481|100545613|FG004|COMPLETED|Washout Period (at Least 7 Days)||5||
48090806|NCT00975481|100545614|FG005|COMPLETED|Washout Period (at Least 7 Days)||6||
48090807|NCT00975481|100545609|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48090808|NCT00975481|100545610|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48090809|NCT00975481|100545611|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48090810|NCT00975481|100545612|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48090811|NCT00975481|100545613|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48090812|NCT00975481|100545614|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48090813|NCT00975481|100545609|FG000|STARTED|Sixth Intervention Period||4||
48090814|NCT00975481|100545610|FG001|STARTED|Sixth Intervention Period||5||
48686880|NCT01445613|102016958|FG000|COMPLETED|30-day Follow-up||1165||
48686881|NCT01445613|102016958|FG000|NOT COMPLETED|30-day Follow-up||35||
48686882|NCT01445613|102016958|FG000|STARTED|1-year Follow-up||1165||
48686883|NCT01445613|102016958|FG000|COMPLETED|1-year Follow-up||1088||
48686884|NCT01445613|102016958|FG000|NOT COMPLETED|1-year Follow-up||77||
48686885|NCT01791491|102016959|FG000|STARTED|Overall Study||9||
48686886|NCT01791491|102016959|FG000|COMPLETED|Overall Study||9||
48686887|NCT01791491|102016959|FG000|NOT COMPLETED|Overall Study||0||
48686888|NCT03301779|102016960|FG000|STARTED|Overall Study||48||
48686889|NCT03301779|102016961|FG001|STARTED|Overall Study||52||
48686890|NCT03301779|102016960|FG000|COMPLETED|Overall Study||40||
48686891|NCT03301779|102016961|FG001|COMPLETED|Overall Study||45||
48090815|NCT00975481|100545611|FG002|STARTED|Sixth Intervention Period||4||
48090816|NCT00975481|100545612|FG003|STARTED|Sixth Intervention Period||5||
48090817|NCT00975481|100545613|FG004|STARTED|Sixth Intervention Period||5||
48090818|NCT00975481|100545614|FG005|STARTED|Sixth Intervention Period||6||
48090819|NCT00975481|100545609|FG000|COMPLETED|Sixth Intervention Period||4||
48090820|NCT00975481|100545610|FG001|COMPLETED|Sixth Intervention Period||5||
48090821|NCT00975481|100545611|FG002|COMPLETED|Sixth Intervention Period||4||
48255287|NCT00733226|100943891|FG001|COMPLETED|Overall Study||40||
48686892|NCT03301779|102016960|FG000|NOT COMPLETED|Overall Study||8||
48686893|NCT03301779|102016961|FG001|NOT COMPLETED|Overall Study||7||
48686894|NCT01284959|102016962|FG000|STARTED|Overall Study||11||
48686895|NCT01284959|102016963|FG001|STARTED|Overall Study||12||
48686896|NCT01284959|102016964|FG002|STARTED|Overall Study||11||
48686897|NCT01284959|102016962|FG000|COMPLETED|Overall Study||10||
48381755|NCT04397718|101261709|FG000|NOT COMPLETED|Overall Study||7||
48381756|NCT04397718|101261710|FG001|NOT COMPLETED|Overall Study||15||
48381757|NCT02237157|101261711|FG000|STARTED|Gemcitabine, Local Delivery (Dose 1)||20||
48381758|NCT02237157|101261712|FG001|STARTED|Gemcitabine, Local Delivery (Dose 1)||0||
48255288|NCT00733226|100943890|FG000|NOT COMPLETED|Overall Study||5||
48255289|NCT00733226|100943891|FG001|NOT COMPLETED|Overall Study||0||
48090822|NCT00975481|100545612|FG003|COMPLETED|Sixth Intervention Period||5||
48255290|NCT00644878|100943892|FG000|STARTED|Overall Study||18||
48255291|NCT00644878|100943892|FG000|COMPLETED|Overall Study||0||
48255292|NCT00644878|100943892|FG000|NOT COMPLETED|Overall Study||18||
48255293|NCT02517528|100943893|FG000|STARTED|Overall Study||104||
48255294|NCT02517528|100943893|FG000|COMPLETED|Overall Study||103||
48255295|NCT02517528|100943893|FG000|NOT COMPLETED|Overall Study||1||
48255296|NCT01172639|100943894|FG000|STARTED|Overall Study||98||
48255297|NCT01172639|100943895|FG001|STARTED|Overall Study||98||
48255298|NCT01172639|100943896|FG002|STARTED|Overall Study||93||
48255299|NCT01172639|100943897|FG003|STARTED|Overall Study||43||
48255300|NCT01172639|100943898|FG004|STARTED|Overall Study||47||
48255301|NCT01172639|100943894|FG000|Week 16|Overall Study||94||
48255302|NCT01172639|100943895|FG001|Week 16|Overall Study||96||
48255303|NCT01172639|100943896|FG002|Week 16|Overall Study||91||
48381759|NCT02237157|101261713|FG002|STARTED|Gemcitabine, Local Delivery (Dose 1)||0||
48381760|NCT02237157|101261714|FG003|STARTED|Gemcitabine, Local Delivery (Dose 1)||0||
48381761|NCT02237157|101261711|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||16||
48381762|NCT02237157|101261712|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0||
48381763|NCT02237157|101261713|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0||
48381764|NCT02237157|101261714|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0||
48381765|NCT02237157|101261711|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||4||
48381766|NCT02237157|101261712|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0||
48381767|NCT02237157|101261713|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0||
48381768|NCT02237157|101261714|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0||
48381769|NCT02237157|101261711|FG000|STARTED|Gemcitabine, Local Delivery (Dose 2)||0||
48381770|NCT02237157|101261712|FG001|STARTED|Gemcitabine, Local Delivery (Dose 2)||15||
48381771|NCT02237157|101261713|FG002|STARTED|Gemcitabine, Local Delivery (Dose 2)||0||
48381772|NCT02237157|101261714|FG003|STARTED|Gemcitabine, Local Delivery (Dose 2)||0||
48381773|NCT02237157|101261711|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0||
48381774|NCT02237157|101261712|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||15||
48381775|NCT02237157|101261713|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0||
48381776|NCT02237157|101261714|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0||
48381777|NCT02237157|101261711|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0||
48381778|NCT02237157|101261712|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0||
48381779|NCT02237157|101261713|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0||
48381780|NCT02237157|101261714|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0||
48381781|NCT02237157|101261711|FG000|STARTED|Gemcitabine, Local Delivery (Dose 3)||0||
48381782|NCT02237157|101261712|FG001|STARTED|Gemcitabine, Local Delivery (Dose 3)||0||
48381783|NCT02237157|101261713|FG002|STARTED|Gemcitabine, Local Delivery (Dose 3)||11||
48381784|NCT02237157|101261714|FG003|STARTED|Gemcitabine, Local Delivery (Dose 3)||0||
48381785|NCT02237157|101261711|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0||
48381786|NCT02237157|101261712|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0||
48381787|NCT02237157|101261713|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||11||
48381788|NCT02237157|101261714|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0||
48381789|NCT02237157|101261711|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0||
48255304|NCT01172639|100943897|FG003|Week 16|Overall Study||39||
48255305|NCT01172639|100943898|FG004|Week 16|Overall Study||47||
48255306|NCT01172639|100943894|FG000|Week 52|Overall Study||89||
48381790|NCT02237157|101261712|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0||
48381791|NCT02237157|101261713|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0||
48381792|NCT02237157|101261714|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0||
48381793|NCT02237157|101261711|FG000|STARTED|Gemcitabine, Local Delivery (Dose 4)||0||
48381794|NCT02237157|101261712|FG001|STARTED|Gemcitabine, Local Delivery (Dose 4)||0||
48381795|NCT02237157|101261713|FG002|STARTED|Gemcitabine, Local Delivery (Dose 4)||0||
48255307|NCT01172639|100943895|FG001|Week 52|Overall Study||89||
48255308|NCT01172639|100943896|FG002|Week 52|Overall Study||88||
48255309|NCT01172639|100943897|FG003|Week 52|Overall Study||38||
48255310|NCT01172639|100943898|FG004|Week 52|Overall Study||45||
48255311|NCT01172639|100943894|FG000|COMPLETED|Overall Study||85||
48255312|NCT01172639|100943895|FG001|COMPLETED|Overall Study||87||
48255313|NCT01172639|100943896|FG002|COMPLETED|Overall Study||77||
48255314|NCT01172639|100943897|FG003|COMPLETED|Overall Study||32||
48255315|NCT01172639|100943898|FG004|COMPLETED|Overall Study||41||
48255316|NCT01172639|100943894|FG000|NOT COMPLETED|Overall Study||13||
48255317|NCT01172639|100943895|FG001|NOT COMPLETED|Overall Study||11||
48255318|NCT01172639|100943896|FG002|NOT COMPLETED|Overall Study||16||
48255319|NCT01172639|100943897|FG003|NOT COMPLETED|Overall Study||11||
48255320|NCT01172639|100943898|FG004|NOT COMPLETED|Overall Study||6||
48255321|NCT01624298|100943899|FG000|STARTED|Overall Study||126||
48255322|NCT01624298|100943900|FG001|STARTED|Overall Study||131||
48255323|NCT01624298|100943899|FG000|COMPLETED|Overall Study||104||
48255324|NCT01624298|100943900|FG001|COMPLETED|Overall Study||106||
48255325|NCT01624298|100943899|FG000|NOT COMPLETED|Overall Study||22||
48255326|NCT01624298|100943900|FG001|NOT COMPLETED|Overall Study||25||
48255327|NCT01062971|100943901|FG000|STARTED|Overall Study||60||
48255328|NCT01062971|100943902|FG001|STARTED|Overall Study||63||
48255329|NCT01062971|100943901|FG000|COMPLETED|Overall Study||56||
48255330|NCT01062971|100943902|FG001|COMPLETED|Overall Study||56||
48686898|NCT01284959|102016963|FG001|COMPLETED|Overall Study||12||
48686899|NCT01284959|102016964|FG002|COMPLETED|Overall Study||10||
48686900|NCT01284959|102016962|FG000|NOT COMPLETED|Overall Study||1||
48686901|NCT01284959|102016963|FG001|NOT COMPLETED|Overall Study||0||
48686902|NCT01284959|102016964|FG002|NOT COMPLETED|Overall Study||1||
48686903|NCT00003631|102016965|FG000|STARTED|Overall Study||50||
48686904|NCT00003631|102016966|FG001|STARTED|Overall Study||44||
48686905|NCT00003631|102016967|FG002|STARTED|Overall Study||24||
48686906|NCT00003631|102016965|FG000|COMPLETED|Overall Study||47||
48255331|NCT01062971|100943901|FG000|NOT COMPLETED|Overall Study||4||
48686907|NCT00003631|102016966|FG001|COMPLETED|Overall Study||43||
48686908|NCT00003631|102016967|FG002|COMPLETED|Overall Study||15||
48686909|NCT00003631|102016965|FG000|NOT COMPLETED|Overall Study||3||
48686910|NCT00003631|102016966|FG001|NOT COMPLETED|Overall Study||1||
48686911|NCT00003631|102016967|FG002|NOT COMPLETED|Overall Study||9||
48686912|NCT01569815|102016968|FG000|STARTED|Overall Study||8||
48686913|NCT01569815|102016969|FG001|STARTED|Overall Study||8||
48686914|NCT01569815|102016970|FG002|STARTED|Overall Study||8||
48686915|NCT01569815|102016971|FG003|STARTED|Overall Study||8||
48686916|NCT01569815|102016968|FG000|COMPLETED|Overall Study||8||
48686917|NCT01569815|102016969|FG001|COMPLETED|Overall Study||8||
48686918|NCT01569815|102016970|FG002|COMPLETED|Overall Study||8||
48686919|NCT01569815|102016971|FG003|COMPLETED|Overall Study||8||
48686920|NCT01569815|102016968|FG000|NOT COMPLETED|Overall Study||0||
48686921|NCT01569815|102016969|FG001|NOT COMPLETED|Overall Study||0||
48686922|NCT01569815|102016970|FG002|NOT COMPLETED|Overall Study||0||
48686923|NCT01569815|102016971|FG003|NOT COMPLETED|Overall Study||0||
48686924|NCT00456625|102016972|FG000|STARTED|Overall Study||76||
48686925|NCT00456625|102016972|FG000|COMPLETED|Overall Study||76||
48686926|NCT00456625|102016972|FG000|NOT COMPLETED|Overall Study||0||
48255332|NCT01062971|100943902|FG001|NOT COMPLETED|Overall Study||7||
48255333|NCT00808899|100943903|FG000|STARTED|Overall Study||4||
48255334|NCT00808899|100943903|FG000|COMPLETED|Overall Study||0||
48255335|NCT00808899|100943903|FG000|NOT COMPLETED|Overall Study||4||
48255336|NCT01580995|100943904|FG000|STARTED|Overall Study||10||
48255337|NCT01580995|100943905|FG001|STARTED|Overall Study||9||
48255338|NCT01580995|100943904|FG000|COMPLETED|Overall Study||8||
48255339|NCT01580995|100943905|FG001|COMPLETED|Overall Study||7||
48255340|NCT01580995|100943904|FG000|NOT COMPLETED|Overall Study||2||
48686927|NCT00585637|102016973|FG000|STARTED|Baseline||81||
48686928|NCT00585637|102016974|FG001|STARTED|Baseline||81||
48686929|NCT00585637|102016975|FG002|STARTED|Baseline||83||
48686930|NCT00585637|102016976|FG003|STARTED|Baseline||83||
48686931|NCT00585637|102016973|FG000|COMPLETED|Baseline||81||
48686932|NCT00585637|102016974|FG001|COMPLETED|Baseline||81||
48686933|NCT00585637|102016975|FG002|COMPLETED|Baseline||83||
48686934|NCT00585637|102016976|FG003|COMPLETED|Baseline||83||
48686935|NCT00585637|102016973|FG000|NOT COMPLETED|Baseline||0||
48686936|NCT00585637|102016974|FG001|NOT COMPLETED|Baseline||0||
48686937|NCT00585637|102016975|FG002|NOT COMPLETED|Baseline||0||
48686938|NCT00585637|102016976|FG003|NOT COMPLETED|Baseline||0||
48686939|NCT00585637|102016973|FG000|STARTED|3-month Time Point||81||
48686940|NCT00585637|102016974|FG001|STARTED|3-month Time Point||81||
48686941|NCT00585637|102016975|FG002|STARTED|3-month Time Point||83||
48686942|NCT00585637|102016976|FG003|STARTED|3-month Time Point||83||
48686943|NCT00585637|102016973|FG000|COMPLETED|3-month Time Point||71||
48686944|NCT00585637|102016974|FG001|COMPLETED|3-month Time Point||67||
48255341|NCT01580995|100943905|FG001|NOT COMPLETED|Overall Study||2||
48686945|NCT00585637|102016975|FG002|COMPLETED|3-month Time Point||76||
48686946|NCT00585637|102016976|FG003|COMPLETED|3-month Time Point||78||
48686947|NCT00585637|102016973|FG000|NOT COMPLETED|3-month Time Point||10||
48255342|NCT01035047|100943906|FG000|STARTED|Overall Study||52||
48255343|NCT01035047|100943907|FG001|STARTED|Overall Study||53||
48255344|NCT01035047|100943906|FG000|COMPLETED|Overall Study||52||
48255345|NCT01035047|100943907|FG001|COMPLETED|Overall Study||53||
48255346|NCT01035047|100943906|FG000|NOT COMPLETED|Overall Study||0||
48686948|NCT00585637|102016974|FG001|NOT COMPLETED|3-month Time Point||14||
48686949|NCT00585637|102016975|FG002|NOT COMPLETED|3-month Time Point||7||
48090823|NCT00975481|100545613|FG004|COMPLETED|Sixth Intervention Period||5||
48090824|NCT00975481|100545614|FG005|COMPLETED|Sixth Intervention Period||6||
48090825|NCT00975481|100545609|FG000|NOT COMPLETED|Sixth Intervention Period||0||
48090826|NCT00975481|100545610|FG001|NOT COMPLETED|Sixth Intervention Period||0||
48381796|NCT02237157|101261714|FG003|STARTED|Gemcitabine, Local Delivery (Dose 4)||8||
48381797|NCT02237157|101261711|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0||
48381798|NCT02237157|101261712|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0||
48381799|NCT02237157|101261713|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0||
48381800|NCT02237157|101261714|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||8||
48381801|NCT02237157|101261711|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0||
48381802|NCT02237157|101261712|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0||
48381803|NCT02237157|101261713|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0||
48381804|NCT02237157|101261714|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0||
48381805|NCT04570657|101261715|FG000|STARTED|Overall Study||77||
48381806|NCT04570657|101261716|FG001|STARTED|Overall Study||77||
48381807|NCT04570657|101261717|FG002|STARTED|Overall Study||81||
48686950|NCT00585637|102016976|FG003|NOT COMPLETED|3-month Time Point||5||
48686951|NCT00585637|102016973|FG000|STARTED|6-month Time Point||81||
48686952|NCT00585637|102016974|FG001|STARTED|6-month Time Point||81||
48686953|NCT00585637|102016975|FG002|STARTED|6-month Time Point||83||
48686954|NCT00585637|102016976|FG003|STARTED|6-month Time Point||83||
48686955|NCT00585637|102016973|FG000|COMPLETED|6-month Time Point||75||
48686956|NCT00585637|102016974|FG001|COMPLETED|6-month Time Point||68||
48686957|NCT00585637|102016975|FG002|COMPLETED|6-month Time Point||72||
48686958|NCT00585637|102016976|FG003|COMPLETED|6-month Time Point||77||
48686959|NCT00585637|102016973|FG000|NOT COMPLETED|6-month Time Point||6||
48686960|NCT00585637|102016974|FG001|NOT COMPLETED|6-month Time Point||13||
48686961|NCT00585637|102016975|FG002|NOT COMPLETED|6-month Time Point||11||
48686962|NCT00585637|102016976|FG003|NOT COMPLETED|6-month Time Point||6||
48686963|NCT00943631|102016977|FG000|STARTED|Overall Study||202||
48686964|NCT00943631|102016978|FG001|STARTED|Overall Study||204||
48686965|NCT00943631|102016977|FG000|COMPLETED|Overall Study||198||
48686966|NCT00943631|102016978|FG001|COMPLETED|Overall Study||202||
48686967|NCT00943631|102016977|FG000|NOT COMPLETED|Overall Study||4||
48686968|NCT00943631|102016978|FG001|NOT COMPLETED|Overall Study||2||
48686969|NCT01684839|102016979|FG000|STARTED|Overall Study||9||
48686970|NCT01684839|102016979|FG000|COMPLETED|Overall Study||9||
48686971|NCT01684839|102016979|FG000|NOT COMPLETED|Overall Study||0||
48686972|NCT00252512|102016980|FG000|STARTED|Intervention||165||
48686973|NCT00252512|102016981|FG001|STARTED|Intervention||165||
48686974|NCT00252512|102016980|FG000|COMPLETED|Intervention||136||
48686975|NCT00252512|102016981|FG001|COMPLETED|Intervention||134||
48686976|NCT00252512|102016980|FG000|NOT COMPLETED|Intervention||29||
48686977|NCT00252512|102016981|FG001|NOT COMPLETED|Intervention||31||
48686978|NCT00252512|102016980|FG000|STARTED|Six Month Follow up||136||
48686979|NCT00252512|102016981|FG001|STARTED|Six Month Follow up||134||
48686980|NCT00252512|102016980|FG000|COMPLETED|Six Month Follow up||132||
48686981|NCT00252512|102016981|FG001|COMPLETED|Six Month Follow up||122||
48686982|NCT00252512|102016980|FG000|NOT COMPLETED|Six Month Follow up||4||
48686983|NCT00252512|102016981|FG001|NOT COMPLETED|Six Month Follow up||12||
48686984|NCT00252512|102016980|FG000|STARTED|12 Month Follow up||132||
48686985|NCT00252512|102016981|FG001|STARTED|12 Month Follow up||122||
48686986|NCT00252512|102016980|FG000|COMPLETED|12 Month Follow up||123||
48686987|NCT00252512|102016981|FG001|COMPLETED|12 Month Follow up||121||
48686988|NCT00252512|102016980|FG000|NOT COMPLETED|12 Month Follow up||9||
48686989|NCT00252512|102016981|FG001|NOT COMPLETED|12 Month Follow up||1||
48686990|NCT00114127|102016982|FG000|STARTED|Overall Study||13||
48686991|NCT00114127|102016983|FG001|STARTED|Overall Study||15||
48686992|NCT00114127|102016982|FG000|COMPLETED|Overall Study||9||
48381808|NCT04570657|101261715|FG000|Intent to Treat (ITT) Population|Overall Study||77||
48381809|NCT04570657|101261716|FG001|Intent to Treat (ITT) Population|Overall Study||77||
48541492|NCT04867174|101662771|FG058|COMPLETED|Overall Study||20||
48090827|NCT00975481|100545611|FG002|NOT COMPLETED|Sixth Intervention Period||0||
48686993|NCT00114127|102016983|FG001|COMPLETED|Overall Study||11||
48686994|NCT00114127|102016982|FG000|NOT COMPLETED|Overall Study||4||
48686995|NCT00114127|102016983|FG001|NOT COMPLETED|Overall Study||4||
48686996|NCT03531814|102016984|FG000|STARTED|Overall Study||12||
48686997|NCT03531814|102016985|FG001|STARTED|Overall Study||0||
48686998|NCT03531814|102016984|FG000|COMPLETED|Overall Study||12||
48686999|NCT03531814|102016985|FG001|COMPLETED|Overall Study||0||
48090828|NCT00975481|100545612|FG003|NOT COMPLETED|Sixth Intervention Period||0||
48090829|NCT00975481|100545613|FG004|NOT COMPLETED|Sixth Intervention Period||0||
48090830|NCT00975481|100545614|FG005|NOT COMPLETED|Sixth Intervention Period||0||
48090831|NCT02493621|100545615|FG000|STARTED|Overall Study||58||
48090832|NCT02493621|100545616|FG001|STARTED|Overall Study||58||
48090833|NCT02493621|100545615|FG000|COMPLETED|Overall Study||58||
48687000|NCT03531814|102016984|FG000|NOT COMPLETED|Overall Study||0||
48687001|NCT03531814|102016985|FG001|NOT COMPLETED|Overall Study||0||
48687002|NCT02544750|102016986|FG000|STARTED|Overall Study||124||
48687003|NCT02544750|102016987|FG001|STARTED|Overall Study||75||
48687004|NCT02544750|102016986|FG000|COMPLETED|Overall Study||22||
48687005|NCT02544750|102016987|FG001|COMPLETED|Overall Study||12||
48381810|NCT04570657|101261717|FG002|Intent to Treat (ITT) Population|Overall Study||81||
48381811|NCT04570657|101261715|FG000|As-treated Population|Overall Study||77||
48381812|NCT04570657|101261716|FG001|As-treated Population|Overall Study||77||
48381813|NCT04570657|101261717|FG002|As-treated Population|Overall Study||81||
48381814|NCT04570657|101261715|FG000|Pharmacokinetic (PK) Population|Overall Study||75||
48381815|NCT04570657|101261716|FG001|Pharmacokinetic (PK) Population|Overall Study||77||
48090834|NCT02493621|100545616|FG001|COMPLETED|Overall Study||58||
48090835|NCT02493621|100545615|FG000|NOT COMPLETED|Overall Study||0||
48090836|NCT02493621|100545616|FG001|NOT COMPLETED|Overall Study||0||
48090837|NCT02461563|100545617|FG000|STARTED|Overall Study||3||
48090838|NCT02461563|100545618|FG001|STARTED|Overall Study||3||
48090839|NCT02461563|100545619|FG002|STARTED|Overall Study||3||
48090840|NCT02461563|100545620|FG003|STARTED|Overall Study||3||
48090841|NCT02461563|100545617|FG000|COMPLETED|Overall Study||3||
48090842|NCT02461563|100545618|FG001|COMPLETED|Overall Study||3||
48090843|NCT02461563|100545619|FG002|COMPLETED|Overall Study||3||
48090844|NCT02461563|100545620|FG003|COMPLETED|Overall Study||3||
48090845|NCT02461563|100545617|FG000|NOT COMPLETED|Overall Study||0||
48090846|NCT02461563|100545618|FG001|NOT COMPLETED|Overall Study||0||
48090847|NCT02461563|100545619|FG002|NOT COMPLETED|Overall Study||0||
48090848|NCT02461563|100545620|FG003|NOT COMPLETED|Overall Study||0||
48090849|NCT01141907|100545621|FG000|STARTED|Overall Study||6||
48381816|NCT04570657|101261717|FG002|Pharmacokinetic (PK) Population|Overall Study||0||
48381817|NCT04570657|101261715|FG000|COMPLETED|Overall Study||76||
48687006|NCT02544750|102016986|FG000|NOT COMPLETED|Overall Study||102||
48687007|NCT02544750|102016987|FG001|NOT COMPLETED|Overall Study||63||
48687008|NCT00276406|102016988|FG000|STARTED|Overall Study||16||
48687009|NCT00276406|102016989|FG001|STARTED|Overall Study||14||
48687010|NCT00276406|102016988|FG000|COMPLETED|Overall Study||16||
48687011|NCT00276406|102016989|FG001|COMPLETED|Overall Study||14||
48381818|NCT04570657|101261716|FG001|COMPLETED|Overall Study||74||
48381819|NCT04570657|101261717|FG002|COMPLETED|Overall Study||77||
48381820|NCT04570657|101261715|FG000|NOT COMPLETED|Overall Study||1||
48381821|NCT04570657|101261716|FG001|NOT COMPLETED|Overall Study||3||
48381822|NCT04570657|101261717|FG002|NOT COMPLETED|Overall Study||4||
48381823|NCT00618449|101261718|FG000|STARTED|Overall Study||679||
48381824|NCT00618449|101261719|FG001|STARTED|Overall Study||668||
48381825|NCT00618449|101261718|FG000|1-month, Post-treatment|Overall Study||666||
48381826|NCT00618449|101261719|FG001|1-month, Post-treatment|Overall Study||656||
48381827|NCT00618449|101261718|FG000|1-year, Post-treatment|Overall Study||581||
48381828|NCT00618449|101261719|FG001|1-year, Post-treatment|Overall Study||558||
48687012|NCT00276406|102016988|FG000|NOT COMPLETED|Overall Study||0||
48687013|NCT00276406|102016989|FG001|NOT COMPLETED|Overall Study||0||
48687014|NCT00678288|102016990|FG000|STARTED|Overall Study||10||
48090850|NCT01141907|100545622|FG001|STARTED|Overall Study||5||
48090851|NCT01141907|100545621|FG000|COMPLETED|Overall Study||6||
48090852|NCT01141907|100545622|FG001|COMPLETED|Overall Study||5||
48090853|NCT01141907|100545621|FG000|NOT COMPLETED|Overall Study||0||
48090854|NCT01141907|100545622|FG001|NOT COMPLETED|Overall Study||0||
48090855|NCT02436889|100545623|FG000|STARTED|Overall Study||12||
48090856|NCT02436889|100545624|FG001|STARTED|Overall Study||11||
48381829|NCT00618449|101261718|FG000|COMPLETED|Overall Study||581||
48381830|NCT00618449|101261719|FG001|COMPLETED|Overall Study||558||
48381831|NCT00618449|101261718|FG000|NOT COMPLETED|Overall Study||98||
48687015|NCT00678288|102016991|FG001|STARTED|Overall Study||6||
48687016|NCT00678288|102016990|FG000|COMPLETED|Overall Study||0||
48687017|NCT00678288|102016991|FG001|COMPLETED|Overall Study||0||
48687018|NCT00678288|102016990|FG000|NOT COMPLETED|Overall Study||10||
48687019|NCT00678288|102016991|FG001|NOT COMPLETED|Overall Study||6||
48090857|NCT02436889|100545623|FG000|COMPLETED|Overall Study||11||
48090858|NCT02436889|100545624|FG001|COMPLETED|Overall Study||10||
48090859|NCT02436889|100545623|FG000|NOT COMPLETED|Overall Study||1||
48090860|NCT02436889|100545624|FG001|NOT COMPLETED|Overall Study||1||
48381832|NCT00618449|101261719|FG001|NOT COMPLETED|Overall Study||110||
48381833|NCT02669862|101261720|FG000|STARTED|Overall Study||33||
48381834|NCT02669862|101261721|FG001|STARTED|Overall Study||34||
48381835|NCT02669862|101261722|FG002|STARTED|Overall Study||31||
48381836|NCT02669862|101261720|FG000|COMPLETED|Overall Study||31|Patients completing visit 10 according to protocol|
48381837|NCT02669862|101261721|FG001|COMPLETED|Overall Study||29|Patients completing visit 10 according to protocol|
48381838|NCT02669862|101261722|FG002|COMPLETED|Overall Study||26|Patients completing visit 10 according to protocol|
48381839|NCT02669862|101261720|FG000|NOT COMPLETED|Overall Study||2||
48381840|NCT02669862|101261721|FG001|NOT COMPLETED|Overall Study||5||
48381841|NCT02669862|101261722|FG002|NOT COMPLETED|Overall Study||5||
48381842|NCT00654784|101261723|FG000|STARTED|Overall Study||13||
48381843|NCT00654784|101261724|FG001|STARTED|Overall Study||8||
48381844|NCT00654784|101261723|FG000|COMPLETED|Overall Study||13||
48381845|NCT00654784|101261724|FG001|COMPLETED|Overall Study||8||
48381846|NCT00654784|101261723|FG000|NOT COMPLETED|Overall Study||0||
48381847|NCT00654784|101261724|FG001|NOT COMPLETED|Overall Study||0||
48381848|NCT00723073|101261725|FG000|STARTED|Overall Study||149||
48381849|NCT00723073|101261726|FG001|STARTED|Overall Study||174||
48381850|NCT00723073|101261725|FG000|COMPLETED|Overall Study||149||
48381851|NCT00723073|101261726|FG001|COMPLETED|Overall Study||174||
48381852|NCT00723073|101261725|FG000|NOT COMPLETED|Overall Study||0||
48381853|NCT00723073|101261726|FG001|NOT COMPLETED|Overall Study||0||
48381854|NCT04032171|101261727|FG000|STARTED|Overall Study||1||
48381855|NCT04032171|101261728|FG001|STARTED|Overall Study||0||
48381856|NCT04032171|101261727|FG000|COMPLETED|Overall Study||0||
48381857|NCT04032171|101261728|FG001|COMPLETED|Overall Study||0||
48381858|NCT04032171|101261727|FG000|NOT COMPLETED|Overall Study||1||
48381859|NCT04032171|101261728|FG001|NOT COMPLETED|Overall Study||0||
48381860|NCT02034474|101261729|FG000|STARTED|Overall Study||19||
48381861|NCT02034474|101261730|FG001|STARTED|Overall Study||17||
48381862|NCT02034474|101261729|FG000|1 Dose|Overall Study||2||
48381863|NCT02034474|101261730|FG001|1 Dose|Overall Study||4||
48381864|NCT02034474|101261729|FG000|2 Doses|Overall Study||2||
48381865|NCT02034474|101261730|FG001|2 Doses|Overall Study||0||
48381866|NCT02034474|101261729|FG000|3 Doses|Overall Study||15||
48381867|NCT02034474|101261730|FG001|3 Doses|Overall Study||13||
48381868|NCT02034474|101261729|FG000|COMPLETED|Overall Study||15||
48381869|NCT02034474|101261730|FG001|COMPLETED|Overall Study||13||
48381870|NCT02034474|101261729|FG000|NOT COMPLETED|Overall Study||4||
48381871|NCT02034474|101261730|FG001|NOT COMPLETED|Overall Study||4||
48381872|NCT03497026|101261731|FG000|STARTED|Overall Study||4||
48381873|NCT03497026|101261731|FG000|COMPLETED|Overall Study||4||
48381874|NCT03497026|101261731|FG000|NOT COMPLETED|Overall Study||0||
48381875|NCT01317615|101261732|FG000|STARTED|Overall Study||49||
48381876|NCT01317615|101261732|FG000|COMPLETED|Overall Study||0||
48381877|NCT01317615|101261732|FG000|NOT COMPLETED|Overall Study||49||
48381878|NCT03550131|101261733|FG000|STARTED|Overall Study||162||
48381879|NCT03550131|101261734|FG001|STARTED|Overall Study||160||
48381880|NCT03550131|101261733|FG000|Baseline, CR|Overall Study||80||
48381881|NCT03550131|101261734|FG001|Baseline, CR|Overall Study||76||
48381882|NCT03550131|101261733|FG000|Baseline, CP|Overall Study||80||
48381883|NCT03550131|101261734|FG001|Baseline, CP|Overall Study||76||
48381884|NCT03550131|101261733|FG000|6 Week (Pre-Treatment), CR|Overall Study||70||
48381885|NCT03550131|101261734|FG001|6 Week (Pre-Treatment), CR|Overall Study||71||
48381886|NCT03550131|101261733|FG000|6 Week (Pre-Treatment), CP|Overall Study||70||
48381887|NCT03550131|101261734|FG001|6 Week (Pre-Treatment), CP|Overall Study||71||
48381888|NCT03550131|101261733|FG000|13 Week (Post-treatment), CR|Overall Study||57||
48381889|NCT03550131|101261734|FG001|13 Week (Post-treatment), CR|Overall Study||63||
48381890|NCT03550131|101261733|FG000|13 Week (Post-treatment), CP|Overall Study||57||
48541493|NCT04867174|101662772|FG059|COMPLETED|Overall Study||24||
48541494|NCT04867174|101662713|FG000|NOT COMPLETED|Overall Study||0||
48541495|NCT04867174|101662714|FG001|NOT COMPLETED|Overall Study||0||
48541496|NCT04867174|101662715|FG002|NOT COMPLETED|Overall Study||0||
48381891|NCT03550131|101261734|FG001|13 Week (Post-treatment), CP|Overall Study||63||
48381892|NCT03550131|101261733|FG000|30 Week Follow up, CR|Overall Study||53||
48381893|NCT03550131|101261734|FG001|30 Week Follow up, CR|Overall Study||61||
48381894|NCT03550131|101261733|FG000|30 Week Follow up, CP|Overall Study||53||
48381895|NCT03550131|101261734|FG001|30 Week Follow up, CP|Overall Study||61||
48381896|NCT03550131|101261733|FG000|13 Month Follow up, CR|Overall Study||48||
48381897|NCT03550131|101261734|FG001|13 Month Follow up, CR|Overall Study||49||
48381898|NCT03550131|101261733|FG000|13 Month Follow up, CP|Overall Study||48||
48381899|NCT03550131|101261734|FG001|13 Month Follow up, CP|Overall Study||49||
48381900|NCT03550131|101261733|FG000|COMPLETED|Overall Study||96||
48381901|NCT03550131|101261734|FG001|COMPLETED|Overall Study||98||
48381902|NCT03550131|101261733|FG000|NOT COMPLETED|Overall Study||66||
48381903|NCT03550131|101261734|FG001|NOT COMPLETED|Overall Study||62||
48381904|NCT03371160|101261735|FG000|STARTED|Overall Study||22||
48381905|NCT03371160|101261735|FG000|Completed Data Collection of Primary Endpoint|Overall Study||14||
48381906|NCT03371160|101261735|FG000|COMPLETED|Overall Study||14||
48541497|NCT04867174|101662716|FG003|NOT COMPLETED|Overall Study||0||
48541498|NCT04867174|101662717|FG004|NOT COMPLETED|Overall Study||0||
48381907|NCT03371160|101261735|FG000|NOT COMPLETED|Overall Study||8||
48381908|NCT02864940|101261736|FG000|STARTED|Overall Study||20||
48381909|NCT02864940|101261737|FG001|STARTED|Overall Study||18||
48381910|NCT02864940|101261736|FG000|COMPLETED|Overall Study||7||
48381911|NCT02864940|101261737|FG001|COMPLETED|Overall Study||7||
48381912|NCT02864940|101261736|FG000|NOT COMPLETED|Overall Study||13||
48381913|NCT02864940|101261737|FG001|NOT COMPLETED|Overall Study||11||
48381914|NCT00495495|101261738|FG000|STARTED|Overall Study||394||
48381915|NCT00495495|101261738|FG000|COMPLETED|Overall Study||295||
48381916|NCT00495495|101261738|FG000|NOT COMPLETED|Overall Study||99||
48381917|NCT01040208|101261739|FG000|STARTED|Overall Study||45||
48381918|NCT01040208|101261740|FG001|STARTED|Overall Study||28||
48381919|NCT01040208|101261741|FG002|STARTED|Overall Study||38||
48381920|NCT01040208|101261739|FG000|COMPLETED|Overall Study||39||
48381921|NCT01040208|101261740|FG001|COMPLETED|Overall Study||15||
48381922|NCT01040208|101261741|FG002|COMPLETED|Overall Study||35||
48381923|NCT01040208|101261739|FG000|NOT COMPLETED|Overall Study||6||
48381924|NCT01040208|101261740|FG001|NOT COMPLETED|Overall Study||13||
48381925|NCT01040208|101261741|FG002|NOT COMPLETED|Overall Study||3||
48381926|NCT03172520|101261742|FG000|STARTED|Overall Study||10||
48381927|NCT03172520|101261742|FG000|COMPLETED|Overall Study||0||
48381928|NCT03172520|101261742|FG000|NOT COMPLETED|Overall Study||10||
48381929|NCT00059215|101261743|FG000|STARTED|Overall Study||200||
48381930|NCT00059215|101261744|FG001|STARTED|Overall Study||200||
48381931|NCT00059215|101261745|FG002|STARTED|Overall Study||251||
48381932|NCT00059215|101261746|FG003|STARTED|Overall Study||254||
48381933|NCT00059215|101261743|FG000|COMPLETED|Overall Study||187||
48381934|NCT00059215|101261744|FG001|COMPLETED|Overall Study||186||
48381935|NCT00059215|101261745|FG002|COMPLETED|Overall Study||236||
48381936|NCT00059215|101261746|FG003|COMPLETED|Overall Study||239||
48381937|NCT00059215|101261743|FG000|NOT COMPLETED|Overall Study||13||
48381938|NCT00059215|101261744|FG001|NOT COMPLETED|Overall Study||14||
48381939|NCT00059215|101261745|FG002|NOT COMPLETED|Overall Study||15||
48381940|NCT00059215|101261746|FG003|NOT COMPLETED|Overall Study||15||
48381941|NCT03025217|101261747|FG000|STARTED|Overall Study||31||
48541499|NCT04867174|101662718|FG005|NOT COMPLETED|Overall Study||0||
48541500|NCT04867174|101662719|FG006|NOT COMPLETED|Overall Study||0||
48541501|NCT04867174|101662720|FG007|NOT COMPLETED|Overall Study||0||
48541502|NCT04867174|101662721|FG008|NOT COMPLETED|Overall Study||0||
48541503|NCT04867174|101662722|FG009|NOT COMPLETED|Overall Study||0||
48381942|NCT03025217|101261747|FG000|COMPLETED|Overall Study||27||
48541504|NCT04867174|101662723|FG010|NOT COMPLETED|Overall Study||0||
48541505|NCT04867174|101662724|FG011|NOT COMPLETED|Overall Study||0||
48541506|NCT04867174|101662725|FG012|NOT COMPLETED|Overall Study||0||
48541507|NCT04867174|101662726|FG013|NOT COMPLETED|Overall Study||0||
48541508|NCT04867174|101662727|FG014|NOT COMPLETED|Overall Study||0||
48541509|NCT04867174|101662728|FG015|NOT COMPLETED|Overall Study||0||
48541510|NCT04867174|101662729|FG016|NOT COMPLETED|Overall Study||0||
48541511|NCT04867174|101662730|FG017|NOT COMPLETED|Overall Study||0||
48541512|NCT04867174|101662731|FG018|NOT COMPLETED|Overall Study||0||
48541513|NCT04867174|101662732|FG019|NOT COMPLETED|Overall Study||0||
48541514|NCT04867174|101662733|FG020|NOT COMPLETED|Overall Study||0||
48687020|NCT01821326|102016992|FG000|STARTED|Overall Study||339||
48381943|NCT03025217|101261747|FG000|NOT COMPLETED|Overall Study||4||
48381944|NCT00756496|101261748|FG000|STARTED|Overall Study||442||
48381945|NCT00756496|101261748|FG000|COMPLETED|Overall Study||442||
48381946|NCT00756496|101261748|FG000|NOT COMPLETED|Overall Study||0||
48381947|NCT01019486|101261749|FG000|STARTED|Overall Study||5||
48381948|NCT01019486|101261750|FG001|STARTED|Overall Study||5||
48381949|NCT01019486|101261751|FG002|STARTED|Overall Study||16||
48381950|NCT01019486|101261749|FG000|COMPLETED|Overall Study||4||
48381951|NCT01019486|101261750|FG001|COMPLETED|Overall Study||4||
48381952|NCT01019486|101261751|FG002|COMPLETED|Overall Study||15||
48381953|NCT01019486|101261749|FG000|NOT COMPLETED|Overall Study||1||
48381954|NCT01019486|101261750|FG001|NOT COMPLETED|Overall Study||1||
48381955|NCT01019486|101261751|FG002|NOT COMPLETED|Overall Study||1||
48381956|NCT02338492|101261752|FG000|STARTED|Overall Study||81||
48381957|NCT02338492|101261752|FG000|Enrolled|Overall Study||81||
48381958|NCT02338492|101261752|FG000|Device Implanted|Overall Study||79||
48381959|NCT02338492|101261752|FG000|Treatment Failure|Overall Study||2||
48541515|NCT04867174|101662734|FG021|NOT COMPLETED|Overall Study||0||
48687021|NCT01821326|102016992|FG000|COMPLETED|Overall Study||339||
48687022|NCT01821326|102016992|FG000|NOT COMPLETED|Overall Study||0||
48381960|NCT02338492|101261752|FG000|COMPLETED|Overall Study||36||
48381961|NCT02338492|101261752|FG000|NOT COMPLETED|Overall Study||45||
48381962|NCT00074724|101261753|FG000|STARTED|Overall Study||0||
48381963|NCT00074724|101261754|FG001|STARTED|Overall Study||0||
48381964|NCT00074724|101261753|FG000|COMPLETED|Overall Study||0||
48381965|NCT00074724|101261754|FG001|COMPLETED|Overall Study||0||
48381966|NCT00074724|101261753|FG000|NOT COMPLETED|Overall Study||0||
48381967|NCT00074724|101261754|FG001|NOT COMPLETED|Overall Study||0||
48687023|NCT00837161|102016993|FG000|STARTED|Overall Study||11||
48381968|NCT01021852|101261755|FG000|STARTED|Treatment Period 1||40||
48381969|NCT01021852|101261756|FG001|STARTED|Treatment Period 1||40||
48381970|NCT01021852|101261757|FG002|STARTED|Treatment Period 1||41||
48381971|NCT01021852|101261758|FG003|STARTED|Treatment Period 1||40||
48381972|NCT01021852|101261759|FG004|STARTED|Treatment Period 1||42||
48687024|NCT00837161|102016993|FG000|COMPLETED|Overall Study||9||
48687025|NCT00837161|102016993|FG000|NOT COMPLETED|Overall Study||2||
48687026|NCT00375427|102016994|FG000|STARTED|Overall Study||209||
48090861|NCT00105482|100545625|FG000|STARTED|Overall Study||87||
48090862|NCT00105482|100545626|FG001|STARTED|Overall Study||85||
48090863|NCT00105482|100545625|FG000|COMPLETED|Overall Study||28||
48090864|NCT00105482|100545626|FG001|COMPLETED|Overall Study||30||
48090865|NCT00105482|100545625|FG000|NOT COMPLETED|Overall Study||59||
48090866|NCT00105482|100545626|FG001|NOT COMPLETED|Overall Study||55||
48090867|NCT02392247|100545627|FG000|STARTED|Overall Study||52||
48090868|NCT02392247|100545627|FG000|COMPLETED|Overall Study||50||
48090869|NCT02392247|100545627|FG000|NOT COMPLETED|Overall Study||2||
48090870|NCT03194321|100545628|FG000|STARTED|Overall Study||20||
48090871|NCT03194321|100545628|FG000|COMPLETED|Overall Study||17||
48090872|NCT03194321|100545628|FG000|NOT COMPLETED|Overall Study||3||
48090873|NCT01324999|100545629|FG000|STARTED|Overall Study||12||
48090874|NCT01324999|100545629|FG000|COMPLETED|Overall Study||7||
48090875|NCT01324999|100545629|FG000|NOT COMPLETED|Overall Study||5||
48090876|NCT02422511|100545630|FG000|STARTED|Overall Study||255|Start is the number of participants (including parents and their newborns) who were randomized. Parents were enrolled with their newborns and at least one parent had to complete a baseline survey to be randomized into the study and considered fully enrolled.|
48090877|NCT02422511|100545631|FG001|STARTED|Overall Study||128|Start is the number of participants (including parents and their newborns) who were randomized. Parents were enrolled with their newborns and at least one parent had to complete a baseline survey to be randomized into the study and considered fully enrolled.|
48090878|NCT02422511|100545632|FG002|STARTED|Overall Study||257|Start is the number of participants (including parents and their newborns) who were randomized. Parents were enrolled with their newborns and at least one parent had to complete a baseline survey to be randomized into the study and considered fully enrolled.|
48090879|NCT02422511|100545633|FG003|STARTED|Overall Study||129|Start is the number of participants (including parents and their newborns) who were randomized. Parents were enrolled with their newborns and at least one parent had to complete a baseline survey to be randomized into the study and considered fully enrolled.|
48090880|NCT02422511|100545634|FG004|STARTED|Overall Study||66|Start is the number of participants (including parents and their newborns) who were randomized. Parents were enrolled with their newborns and at least one parent had to complete a baseline survey to be randomized into the study and considered fully enrolled.|
48090881|NCT02422511|100545635|FG005|STARTED|Overall Study||33|Start is the number of participants (including parents and their newborns) who were randomized. Parents were enrolled with their newborns and at least one parent had to complete a baseline survey to be randomized into the study and considered fully enrolled.|
48090882|NCT02422511|100545636|FG006|STARTED|Overall Study||68|Start is the number of participants (including parents and their newborns) who were randomized. Parents were enrolled with their newborns and at least one parent had to complete a baseline survey to be randomized into the study and considered fully enrolled.|
48090883|NCT02422511|100545637|FG007|STARTED|Overall Study||34|Start is the number of participants (including parents and their newborns) who were randomized. Parents were enrolled with their newborns and at least one parent had to complete a baseline survey to be randomized into the study and considered fully enrolled.|
48090884|NCT02422511|100545630|FG000|Received Disclosure|Overall Study||158|Parents received disclosure for their newborns study results and responded to a post-disclosure survey. Either parent could complete or skip the survey.|
48090885|NCT02422511|100545631|FG001|Received Disclosure|Overall Study||79|Parents received disclosure for their newborns study results and responded to a post-disclosure survey. Either parent could complete or skip the survey.|
48090886|NCT02422511|100545632|FG002|Received Disclosure|Overall Study||194|Parents received disclosure for their newborns study results and responded to a post-disclosure survey. Either parent could complete or skip the survey.|
48090887|NCT02422511|100545633|FG003|Received Disclosure|Overall Study||97|Parents received disclosure for their newborns study results and responded to a post-disclosure survey. Either parent could complete or skip the survey.|
48090888|NCT02422511|100545634|FG004|Received Disclosure|Overall Study||43|Parents received disclosure for their newborns study results and responded to a post-disclosure survey. Either parent could complete or skip the survey.|
48141377|NCT01297062|100670413|FG003|COMPLETED|Overall Study||13||
48141378|NCT01297062|100670414|FG004|COMPLETED|Overall Study||13||
48381973|NCT01021852|101261760|FG005|STARTED|Treatment Period 1||41||
48381974|NCT01021852|101261761|FG006|STARTED|Treatment Period 1||41||
48381975|NCT01021852|101261762|FG007|STARTED|Treatment Period 1||41||
48381976|NCT01021852|101261755|FG000|Treated|Treatment Period 1||40||
48381977|NCT01021852|101261756|FG001|Treated|Treatment Period 1||40||
48381978|NCT01021852|101261757|FG002|Treated|Treatment Period 1||41||
48381979|NCT01021852|101261758|FG003|Treated|Treatment Period 1||38||
48381980|NCT01021852|101261759|FG004|Treated|Treatment Period 1||42||
48381981|NCT01021852|101261760|FG005|Treated|Treatment Period 1||41||
48381982|NCT01021852|101261761|FG006|Treated|Treatment Period 1||41||
48381983|NCT01021852|101261762|FG007|Treated|Treatment Period 1||41||
48381984|NCT01021852|101261755|FG000|COMPLETED|Treatment Period 1||37||
48687027|NCT00375427|102016995|FG001|STARTED|Overall Study||216||
48687028|NCT00375427|102016994|FG000|COMPLETED|Overall Study||149||
48687029|NCT00375427|102016995|FG001|COMPLETED|Overall Study||142||
48687030|NCT00375427|102016994|FG000|NOT COMPLETED|Overall Study||60||
48381985|NCT01021852|101261756|FG001|COMPLETED|Treatment Period 1||39||
48381986|NCT01021852|101261757|FG002|COMPLETED|Treatment Period 1||39||
48687031|NCT00375427|102016995|FG001|NOT COMPLETED|Overall Study||74||
48687032|NCT03604497|102016996|FG000|STARTED|Overall Study||437||
48687033|NCT03604497|102016996|FG000|COMPLETED|Overall Study||385||
48687034|NCT03604497|102016996|FG000|NOT COMPLETED|Overall Study||52||
48687035|NCT00730756|102016997|FG000|STARTED|Overall Study||49||
48687036|NCT00730756|102016998|FG001|STARTED|Overall Study||53||
48687037|NCT00730756|102016997|FG000|COMPLETED|Overall Study||45||
48687038|NCT00730756|102016998|FG001|COMPLETED|Overall Study||48||
48381987|NCT01021852|101261758|FG003|COMPLETED|Treatment Period 1||38||
48381988|NCT01021852|101261759|FG004|COMPLETED|Treatment Period 1||39||
48381989|NCT01021852|101261760|FG005|COMPLETED|Treatment Period 1||39||
48381990|NCT01021852|101261761|FG006|COMPLETED|Treatment Period 1||41||
48687039|NCT00730756|102016997|FG000|NOT COMPLETED|Overall Study||4||
48687040|NCT00730756|102016998|FG001|NOT COMPLETED|Overall Study||5||
48687041|NCT01285024|102016999|FG000|STARTED|Overall Study||49||
48687042|NCT01285024|102017000|FG001|STARTED|Overall Study||60||
48687043|NCT01285024|102016999|FG000|COMPLETED|Overall Study||49||
48687044|NCT01285024|102017000|FG001|COMPLETED|Overall Study||60||
48687045|NCT01285024|102016999|FG000|NOT COMPLETED|Overall Study||0||
48687046|NCT01285024|102017000|FG001|NOT COMPLETED|Overall Study||0||
48687047|NCT00803595|102017001|FG000|STARTED|Overall Study||337||
48687048|NCT00803595|102017002|FG001|STARTED|Overall Study||327||
48687049|NCT00803595|102017003|FG002|STARTED|Overall Study||338||
48687050|NCT00803595|102017001|FG000|COMPLETED|Overall Study||322||
48687051|NCT00803595|102017002|FG001|COMPLETED|Overall Study||319||
48687052|NCT00803595|102017003|FG002|COMPLETED|Overall Study||322||
48687053|NCT00803595|102017001|FG000|NOT COMPLETED|Overall Study||15||
48687054|NCT00803595|102017002|FG001|NOT COMPLETED|Overall Study||8||
48687055|NCT00803595|102017003|FG002|NOT COMPLETED|Overall Study||16||
48687056|NCT00041470|102017004|FG000|STARTED|Overall Study||38||
48687057|NCT00041470|102017004|FG000|COMPLETED|Overall Study||0||
48687058|NCT00041470|102017004|FG000|NOT COMPLETED|Overall Study||38||
48687059|NCT01396187|102017005|FG000|STARTED|Overall Study||8||
48687060|NCT01396187|102017006|FG001|STARTED|Overall Study||12||
48687061|NCT01396187|102017007|FG002|STARTED|Overall Study||10||
48687062|NCT01396187|102017008|FG003|STARTED|Overall Study||10||
48687063|NCT01396187|102017009|FG004|STARTED|Overall Study||10||
48687064|NCT01396187|102017005|FG000|COMPLETED|Overall Study||7||
48687065|NCT01396187|102017006|FG001|COMPLETED|Overall Study||9||
48381991|NCT01021852|101261762|FG007|COMPLETED|Treatment Period 1||40||
48381992|NCT01021852|101261755|FG000|NOT COMPLETED|Treatment Period 1||3||
48381993|NCT01021852|101261756|FG001|NOT COMPLETED|Treatment Period 1||1||
48381994|NCT01021852|101261757|FG002|NOT COMPLETED|Treatment Period 1||2||
48381995|NCT01021852|101261758|FG003|NOT COMPLETED|Treatment Period 1||2||
48381996|NCT01021852|101261759|FG004|NOT COMPLETED|Treatment Period 1||3||
48381997|NCT01021852|101261760|FG005|NOT COMPLETED|Treatment Period 1||2||
48381998|NCT01021852|101261761|FG006|NOT COMPLETED|Treatment Period 1||0||
48381999|NCT01021852|101261762|FG007|NOT COMPLETED|Treatment Period 1||1||
48382000|NCT01021852|101261755|FG000|STARTED|Washout Period-Placebo||37||
48382001|NCT01021852|101261756|FG001|STARTED|Washout Period-Placebo||39||
48382002|NCT01021852|101261757|FG002|STARTED|Washout Period-Placebo||39||
48541516|NCT04867174|101662735|FG022|NOT COMPLETED|Overall Study||0||
48541517|NCT04867174|101662736|FG023|NOT COMPLETED|Overall Study||0||
48541518|NCT04867174|101662737|FG024|NOT COMPLETED|Overall Study||0||
48541519|NCT04867174|101662738|FG025|NOT COMPLETED|Overall Study||0||
48541520|NCT04867174|101662739|FG026|NOT COMPLETED|Overall Study||0||
48541521|NCT04867174|101662740|FG027|NOT COMPLETED|Overall Study||0||
48541522|NCT04867174|101662741|FG028|NOT COMPLETED|Overall Study||0||
48541523|NCT04867174|101662742|FG029|NOT COMPLETED|Overall Study||0||
48541524|NCT04867174|101662743|FG030|NOT COMPLETED|Overall Study||0||
48541525|NCT04867174|101662744|FG031|NOT COMPLETED|Overall Study||0||
48541526|NCT04867174|101662745|FG032|NOT COMPLETED|Overall Study||0||
48541527|NCT04867174|101662746|FG033|NOT COMPLETED|Overall Study||0||
48541528|NCT04867174|101662747|FG034|NOT COMPLETED|Overall Study||0||
48541529|NCT04867174|101662748|FG035|NOT COMPLETED|Overall Study||0||
48541530|NCT04867174|101662749|FG036|NOT COMPLETED|Overall Study||0||
48541531|NCT04867174|101662750|FG037|NOT COMPLETED|Overall Study||0||
48541532|NCT04867174|101662751|FG038|NOT COMPLETED|Overall Study||0||
48541533|NCT04867174|101662752|FG039|NOT COMPLETED|Overall Study||0||
48541534|NCT04867174|101662753|FG040|NOT COMPLETED|Overall Study||0||
48687066|NCT01396187|102017007|FG002|COMPLETED|Overall Study||9||
48687067|NCT01396187|102017008|FG003|COMPLETED|Overall Study||10||
48382003|NCT01021852|101261758|FG003|STARTED|Washout Period-Placebo||38||
48382004|NCT01021852|101261759|FG004|STARTED|Washout Period-Placebo||40||
48541535|NCT04867174|101662754|FG041|NOT COMPLETED|Overall Study||0||
48541536|NCT04867174|101662755|FG042|NOT COMPLETED|Overall Study||0||
48541537|NCT04867174|101662756|FG043|NOT COMPLETED|Overall Study||0||
48687068|NCT01396187|102017009|FG004|COMPLETED|Overall Study||9||
48687069|NCT01396187|102017005|FG000|NOT COMPLETED|Overall Study||1||
48687070|NCT01396187|102017006|FG001|NOT COMPLETED|Overall Study||3||
48687071|NCT01396187|102017007|FG002|NOT COMPLETED|Overall Study||1||
48382005|NCT01021852|101261760|FG005|STARTED|Washout Period-Placebo||39||
48382006|NCT01021852|101261761|FG006|STARTED|Washout Period-Placebo||41||
48382007|NCT01021852|101261762|FG007|STARTED|Washout Period-Placebo||40||
48382008|NCT01021852|101261755|FG000|COMPLETED|Washout Period-Placebo||37||
48382009|NCT01021852|101261756|FG001|COMPLETED|Washout Period-Placebo||39||
48382010|NCT01021852|101261757|FG002|COMPLETED|Washout Period-Placebo||39||
48382011|NCT01021852|101261758|FG003|COMPLETED|Washout Period-Placebo||37||
48382012|NCT01021852|101261759|FG004|COMPLETED|Washout Period-Placebo||39||
48382013|NCT01021852|101261760|FG005|COMPLETED|Washout Period-Placebo||38||
48687072|NCT01396187|102017008|FG003|NOT COMPLETED|Overall Study||0||
48687073|NCT01396187|102017009|FG004|NOT COMPLETED|Overall Study||1||
48090889|NCT02422511|100545635|FG005|Received Disclosure|Overall Study||21|Parents received disclosure for their newborns study results and responded to a post-disclosure survey. Either parent could complete or skip the survey.|
48090890|NCT02422511|100545636|FG006|Received Disclosure|Overall Study||38|Parents received disclosure for their newborns study results and responded to a post-disclosure survey. Either parent could complete or skip the survey.|
48090891|NCT02422511|100545637|FG007|Received Disclosure|Overall Study||19|Parents received disclosure for their newborns study results and responded to a post-disclosure survey. Either parent could complete or skip the survey.|
48090892|NCT02422511|100545630|FG000|COMPLETED|Overall Study||143|Parents completed 10-month survey for their newborns. Either parent could complete or skip the survey.|
48090893|NCT02422511|100545631|FG001|COMPLETED|Overall Study||0|Parents completed 10-month survey for their newborns. Either parent could complete or skip the survey.|
48090894|NCT02422511|100545632|FG002|COMPLETED|Overall Study||168|Parents completed 10-month survey for their newborns. Either parent could complete or skip the survey.|
48090895|NCT02422511|100545633|FG003|COMPLETED|Overall Study||0|Parents completed 10-month survey for their newborns. Either parent could complete or skip the survey.|
48090896|NCT02422511|100545634|FG004|COMPLETED|Overall Study||39|Parents completed 10-month survey for their newborns. Either parent could complete or skip the survey.|
48090897|NCT02422511|100545635|FG005|COMPLETED|Overall Study||0|Parents completed 10-month survey for their newborns. Either parent could complete or skip the survey.|
48141379|NCT01297062|100670415|FG005|COMPLETED|Overall Study||13||
48382014|NCT01021852|101261761|FG006|COMPLETED|Washout Period-Placebo||40||
48382015|NCT01021852|101261762|FG007|COMPLETED|Washout Period-Placebo||40||
48382016|NCT01021852|101261755|FG000|NOT COMPLETED|Washout Period-Placebo||0||
48382017|NCT01021852|101261756|FG001|NOT COMPLETED|Washout Period-Placebo||0||
48382018|NCT01021852|101261757|FG002|NOT COMPLETED|Washout Period-Placebo||0||
48687074|NCT00347932|102017010|FG000|STARTED|Overall Study||475||
48687075|NCT00347932|102017011|FG001|STARTED|Overall Study||482||
48687076|NCT00347932|102017010|FG000|COMPLETED|Overall Study||444||
48687077|NCT00347932|102017011|FG001|COMPLETED|Overall Study||430||
48687078|NCT00347932|102017010|FG000|NOT COMPLETED|Overall Study||31||
48687079|NCT00347932|102017011|FG001|NOT COMPLETED|Overall Study||52||
48687080|NCT00286091|102017012|FG000|STARTED|Double-blind Treatment Phase||716||
48687081|NCT00286091|102017013|FG001|STARTED|Double-blind Treatment Phase||716||
48687082|NCT00286091|102017012|FG000|Received Treatment|Double-blind Treatment Phase||709||
48687083|NCT00286091|102017013|FG001|Received Treatment|Double-blind Treatment Phase||716||
48687084|NCT00286091|102017012|FG000|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase||164||
48687085|NCT00286091|102017013|FG001|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase||174||
48687086|NCT00286091|102017012|FG000|COMPLETED|Double-blind Treatment Phase||132||
48687087|NCT00286091|102017013|FG001|COMPLETED|Double-blind Treatment Phase||123||
48687088|NCT00286091|102017012|FG000|NOT COMPLETED|Double-blind Treatment Phase||584||
48687089|NCT00286091|102017013|FG001|NOT COMPLETED|Double-blind Treatment Phase||593||
48687090|NCT00286091|102017012|FG000|STARTED|Open-label Treatment Phase||110||
48382019|NCT01021852|101261758|FG003|NOT COMPLETED|Washout Period-Placebo||1||
48382020|NCT01021852|101261759|FG004|NOT COMPLETED|Washout Period-Placebo||1||
48687091|NCT00286091|102017013|FG001|STARTED|Open-label Treatment Phase||104||
48687092|NCT00286091|102017012|FG000|Received Treatment|Open-label Treatment Phase||109||
48687093|NCT00286091|102017013|FG001|Received Treatment|Open-label Treatment Phase||101||
48687094|NCT00286091|102017012|FG000|COMPLETED|Open-label Treatment Phase||33||
48090898|NCT02422511|100545636|FG006|COMPLETED|Overall Study||38|Parents completed 10-month survey for their newborns. Either parent could complete or skip the survey.|
48090899|NCT02422511|100545637|FG007|COMPLETED|Overall Study||0|Parents completed 10-month survey for their newborns. Either parent could complete or skip the survey.|
48090900|NCT02422511|100545630|FG000|NOT COMPLETED|Overall Study||112||
48090901|NCT02422511|100545631|FG001|NOT COMPLETED|Overall Study||128||
48090902|NCT02422511|100545632|FG002|NOT COMPLETED|Overall Study||89||
48090903|NCT02422511|100545633|FG003|NOT COMPLETED|Overall Study||129||
48090904|NCT02422511|100545634|FG004|NOT COMPLETED|Overall Study||27||
48090905|NCT02422511|100545635|FG005|NOT COMPLETED|Overall Study||33||
48541538|NCT04867174|101662757|FG044|NOT COMPLETED|Overall Study||0||
48541539|NCT04867174|101662758|FG045|NOT COMPLETED|Overall Study||0||
48541540|NCT04867174|101662759|FG046|NOT COMPLETED|Overall Study||0||
48090906|NCT02422511|100545636|FG006|NOT COMPLETED|Overall Study||30||
48090907|NCT02422511|100545637|FG007|NOT COMPLETED|Overall Study||34||
48090908|NCT01967121|100545638|FG000|STARTED|Overall Study||25||
48090909|NCT01967121|100545639|FG001|STARTED|Overall Study||25||
48090910|NCT01967121|100545640|FG002|STARTED|Overall Study||25||
48090911|NCT01967121|100545638|FG000|COMPLETED|Overall Study||25||
48090912|NCT01967121|100545639|FG001|COMPLETED|Overall Study||25||
48090913|NCT01967121|100545640|FG002|COMPLETED|Overall Study||25||
48090914|NCT01967121|100545638|FG000|NOT COMPLETED|Overall Study||0||
48090915|NCT01967121|100545639|FG001|NOT COMPLETED|Overall Study||0||
48090916|NCT01967121|100545640|FG002|NOT COMPLETED|Overall Study||0||
48090917|NCT02569723|100545641|FG000|STARTED|Overall Study||6||
48090918|NCT02569723|100545641|FG000|COMPLETED|Overall Study||6||
48090919|NCT02569723|100545641|FG000|NOT COMPLETED|Overall Study||0||
48090920|NCT03724084|100545642|FG000|STARTED|Overall Study||3||
48090921|NCT03724084|100545643|FG001|STARTED|Overall Study||3||
48090922|NCT03724084|100545642|FG000|COMPLETED|Overall Study||3||
48090923|NCT03724084|100545643|FG001|COMPLETED|Overall Study||3||
48090924|NCT03724084|100545642|FG000|NOT COMPLETED|Overall Study||0||
48090925|NCT03724084|100545643|FG001|NOT COMPLETED|Overall Study||0||
48090926|NCT04481750|100545644|FG000|STARTED|Period 1 (Fasted)||6||
48090927|NCT04481750|100545645|FG001|STARTED|Period 1 (Fasted)||6||
48090928|NCT04481750|100545646|FG002|STARTED|Period 1 (Fasted)||6||
48090929|NCT04481750|100545647|FG003|STARTED|Period 1 (Fasted)||6||
48090930|NCT04481750|100545648|FG004|STARTED|Period 1 (Fasted)||6||
48090931|NCT04481750|100545649|FG005|STARTED|Period 1 (Fasted)||6||
48090932|NCT04481750|100545650|FG006|STARTED|Period 1 (Fasted)||6||
48090933|NCT04481750|100545651|FG007|STARTED|Period 1 (Fasted)||14||
48090934|NCT04481750|100545652|FG008|STARTED|Period 1 (Fasted)||6||
48090935|NCT04481750|100545653|FG009|STARTED|Period 1 (Fasted)||6||
48090936|NCT04481750|100545654|FG010|STARTED|Period 1 (Fasted)||6||
48090937|NCT04481750|100545644|FG000|COMPLETED|Period 1 (Fasted)||6||
48090938|NCT04481750|100545645|FG001|COMPLETED|Period 1 (Fasted)||6||
48090939|NCT04481750|100545646|FG002|COMPLETED|Period 1 (Fasted)||5||
48090940|NCT04481750|100545647|FG003|COMPLETED|Period 1 (Fasted)||6||
48090941|NCT04481750|100545648|FG004|COMPLETED|Period 1 (Fasted)||6||
48090942|NCT04481750|100545649|FG005|COMPLETED|Period 1 (Fasted)||6||
48090943|NCT04481750|100545650|FG006|COMPLETED|Period 1 (Fasted)||6||
48090944|NCT04481750|100545651|FG007|COMPLETED|Period 1 (Fasted)||14||
48090945|NCT04481750|100545652|FG008|COMPLETED|Period 1 (Fasted)||6||
48090946|NCT04481750|100545653|FG009|COMPLETED|Period 1 (Fasted)||6||
48541541|NCT04867174|101662760|FG047|NOT COMPLETED|Overall Study||0||
48541542|NCT04867174|101662761|FG048|NOT COMPLETED|Overall Study||0||
48541543|NCT04867174|101662762|FG049|NOT COMPLETED|Overall Study||0||
48541544|NCT04867174|101662763|FG050|NOT COMPLETED|Overall Study||0||
48541545|NCT04867174|101662764|FG051|NOT COMPLETED|Overall Study||0||
48541546|NCT04867174|101662765|FG052|NOT COMPLETED|Overall Study||0||
48541547|NCT04867174|101662766|FG053|NOT COMPLETED|Overall Study||0||
48541548|NCT04867174|101662767|FG054|NOT COMPLETED|Overall Study||0||
48541549|NCT04867174|101662768|FG055|NOT COMPLETED|Overall Study||0||
48541550|NCT04867174|101662769|FG056|NOT COMPLETED|Overall Study||0||
48541551|NCT04867174|101662770|FG057|NOT COMPLETED|Overall Study||0||
48541552|NCT04867174|101662771|FG058|NOT COMPLETED|Overall Study||0||
48541553|NCT04867174|101662772|FG059|NOT COMPLETED|Overall Study||0||
48090947|NCT04481750|100545654|FG010|COMPLETED|Period 1 (Fasted)||6||
48090948|NCT04481750|100545644|FG000|NOT COMPLETED|Period 1 (Fasted)||0||
48090949|NCT04481750|100545645|FG001|NOT COMPLETED|Period 1 (Fasted)||0||
48090950|NCT04481750|100545646|FG002|NOT COMPLETED|Period 1 (Fasted)||1||
48090951|NCT04481750|100545647|FG003|NOT COMPLETED|Period 1 (Fasted)||0||
48090952|NCT04481750|100545648|FG004|NOT COMPLETED|Period 1 (Fasted)||0||
48090953|NCT04481750|100545649|FG005|NOT COMPLETED|Period 1 (Fasted)||0||
48090954|NCT04481750|100545650|FG006|NOT COMPLETED|Period 1 (Fasted)||0||
48541554|NCT00339144|101662773|FG000|STARTED|Overall Study||9||
48090955|NCT04481750|100545651|FG007|NOT COMPLETED|Period 1 (Fasted)||0||
48090956|NCT04481750|100545652|FG008|NOT COMPLETED|Period 1 (Fasted)||0||
48090957|NCT04481750|100545653|FG009|NOT COMPLETED|Period 1 (Fasted)||0||
48090958|NCT04481750|100545654|FG010|NOT COMPLETED|Period 1 (Fasted)||0||
48090959|NCT04481750|100545644|FG000|STARTED|Period 2 (After Meal)||0||
48090960|NCT04481750|100545645|FG001|STARTED|Period 2 (After Meal)||0||
48090961|NCT04481750|100545646|FG002|STARTED|Period 2 (After Meal)||5||
48090962|NCT04481750|100545647|FG003|STARTED|Period 2 (After Meal)||0||
48090963|NCT04481750|100545648|FG004|STARTED|Period 2 (After Meal)||0||
48090964|NCT04481750|100545649|FG005|STARTED|Period 2 (After Meal)||0||
48090965|NCT04481750|100545650|FG006|STARTED|Period 2 (After Meal)||0||
48090966|NCT04481750|100545651|FG007|STARTED|Period 2 (After Meal)||0||
48090967|NCT04481750|100545652|FG008|STARTED|Period 2 (After Meal)||0||
48090968|NCT04481750|100545653|FG009|STARTED|Period 2 (After Meal)||0||
48090969|NCT04481750|100545654|FG010|STARTED|Period 2 (After Meal)||0||
48090970|NCT04481750|100545644|FG000|COMPLETED|Period 2 (After Meal)||0||
48090971|NCT04481750|100545645|FG001|COMPLETED|Period 2 (After Meal)||0||
48090972|NCT04481750|100545646|FG002|COMPLETED|Period 2 (After Meal)||5||
48090973|NCT04481750|100545647|FG003|COMPLETED|Period 2 (After Meal)||0||
48090974|NCT04481750|100545648|FG004|COMPLETED|Period 2 (After Meal)||0||
48090975|NCT04481750|100545649|FG005|COMPLETED|Period 2 (After Meal)||0||
48090976|NCT04481750|100545650|FG006|COMPLETED|Period 2 (After Meal)||0||
48382021|NCT01021852|101261760|FG005|NOT COMPLETED|Washout Period-Placebo||1||
48090977|NCT04481750|100545651|FG007|COMPLETED|Period 2 (After Meal)||0||
48090978|NCT04481750|100545652|FG008|COMPLETED|Period 2 (After Meal)||0||
48090979|NCT04481750|100545653|FG009|COMPLETED|Period 2 (After Meal)||0||
48090980|NCT04481750|100545654|FG010|COMPLETED|Period 2 (After Meal)||0||
48687095|NCT00286091|102017013|FG001|COMPLETED|Open-label Treatment Phase||33||
48687096|NCT00286091|102017012|FG000|NOT COMPLETED|Open-label Treatment Phase||77||
48687097|NCT00286091|102017013|FG001|NOT COMPLETED|Open-label Treatment Phase||71||
48687098|NCT01881009|102017014|FG000|STARTED|Inpatient Safety Testing (22 Hours)||16||
48090981|NCT04481750|100545644|FG000|NOT COMPLETED|Period 2 (After Meal)||0||
48090982|NCT04481750|100545645|FG001|NOT COMPLETED|Period 2 (After Meal)||0||
48090983|NCT04481750|100545646|FG002|NOT COMPLETED|Period 2 (After Meal)||0||
48090984|NCT04481750|100545647|FG003|NOT COMPLETED|Period 2 (After Meal)||0||
48090985|NCT04481750|100545648|FG004|NOT COMPLETED|Period 2 (After Meal)||0||
48090986|NCT04481750|100545649|FG005|NOT COMPLETED|Period 2 (After Meal)||0||
48090987|NCT04481750|100545650|FG006|NOT COMPLETED|Period 2 (After Meal)||0||
48382022|NCT01021852|101261761|FG006|NOT COMPLETED|Washout Period-Placebo||1||
48382023|NCT01021852|101261762|FG007|NOT COMPLETED|Washout Period-Placebo||0||
48382024|NCT01021852|101261755|FG000|STARTED|Washout Period-No Drug||38||
48382025|NCT01021852|101261756|FG001|STARTED|Washout Period-No Drug||39||
48382026|NCT01021852|101261757|FG002|STARTED|Washout Period-No Drug||39||
48382027|NCT01021852|101261758|FG003|STARTED|Washout Period-No Drug||37||
48090988|NCT04481750|100545651|FG007|NOT COMPLETED|Period 2 (After Meal)||0||
48090989|NCT04481750|100545652|FG008|NOT COMPLETED|Period 2 (After Meal)||0||
48090990|NCT04481750|100545653|FG009|NOT COMPLETED|Period 2 (After Meal)||0||
48090991|NCT04481750|100545654|FG010|NOT COMPLETED|Period 2 (After Meal)||0||
48090992|NCT02880189|100545655|FG000|STARTED|Overall Study||21||
48090993|NCT02880189|100545655|FG000|COMPLETED|Overall Study||21||
48090994|NCT02880189|100545655|FG000|NOT COMPLETED|Overall Study||0||
48090995|NCT03628703|100545656|FG000|STARTED|Overall Study||10||
48382028|NCT01021852|101261759|FG004|STARTED|Washout Period-No Drug||39||
48382029|NCT01021852|101261760|FG005|STARTED|Washout Period-No Drug||39||
48382030|NCT01021852|101261761|FG006|STARTED|Washout Period-No Drug||40||
48382031|NCT01021852|101261762|FG007|STARTED|Washout Period-No Drug||40||
48382032|NCT01021852|101261755|FG000|COMPLETED|Washout Period-No Drug||37||
48382033|NCT01021852|101261756|FG001|COMPLETED|Washout Period-No Drug||39||
48382034|NCT01021852|101261757|FG002|COMPLETED|Washout Period-No Drug||39||
48382035|NCT01021852|101261758|FG003|COMPLETED|Washout Period-No Drug||37||
48382036|NCT01021852|101261759|FG004|COMPLETED|Washout Period-No Drug||39||
48382037|NCT01021852|101261760|FG005|COMPLETED|Washout Period-No Drug||38||
48382038|NCT01021852|101261761|FG006|COMPLETED|Washout Period-No Drug||40||
48382039|NCT01021852|101261762|FG007|COMPLETED|Washout Period-No Drug||40||
48382040|NCT01021852|101261755|FG000|NOT COMPLETED|Washout Period-No Drug||1||
48382041|NCT01021852|101261756|FG001|NOT COMPLETED|Washout Period-No Drug||0||
48382042|NCT01021852|101261757|FG002|NOT COMPLETED|Washout Period-No Drug||0||
48382043|NCT01021852|101261758|FG003|NOT COMPLETED|Washout Period-No Drug||0||
48382044|NCT01021852|101261759|FG004|NOT COMPLETED|Washout Period-No Drug||0||
48382045|NCT01021852|101261760|FG005|NOT COMPLETED|Washout Period-No Drug||1||
48382046|NCT01021852|101261761|FG006|NOT COMPLETED|Washout Period-No Drug||0||
48382047|NCT01021852|101261762|FG007|NOT COMPLETED|Washout Period-No Drug||0||
48687099|NCT01881009|102017015|FG001|STARTED|Inpatient Safety Testing (22 Hours)||0||
48687100|NCT01881009|102017014|FG000|COMPLETED|Inpatient Safety Testing (22 Hours)||16||
48090996|NCT03628703|100545656|FG000|COMPLETED|Overall Study||10||
48090997|NCT03628703|100545656|FG000|NOT COMPLETED|Overall Study||0||
48382048|NCT01021852|101261755|FG000|STARTED|Treatment Period 2||37||
48382049|NCT01021852|101261756|FG001|STARTED|Treatment Period 2||39||
48687101|NCT01881009|102017015|FG001|COMPLETED|Inpatient Safety Testing (22 Hours)||0||
48090998|NCT00759954|100545657|FG000|STARTED|Overall Study||18||
48090999|NCT00759954|100545658|FG001|STARTED|Overall Study||18||
48091000|NCT00759954|100545657|FG000|COMPLETED|Overall Study||16||
48382050|NCT01021852|101261757|FG002|STARTED|Treatment Period 2||39||
48382051|NCT01021852|101261758|FG003|STARTED|Treatment Period 2||37||
48382052|NCT01021852|101261759|FG004|STARTED|Treatment Period 2||39||
48091001|NCT00759954|100545658|FG001|COMPLETED|Overall Study||16||
48091002|NCT00759954|100545657|FG000|NOT COMPLETED|Overall Study||2||
48091003|NCT00759954|100545658|FG001|NOT COMPLETED|Overall Study||2||
48091004|NCT00996216|100545659|FG000|STARTED|Part 1 (Pre-Antiviral Treatment Phase)||27||
48091005|NCT00996216|100545659|FG000|COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||26||
48091006|NCT00996216|100545659|FG000|NOT COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||1||
48091007|NCT00996216|100545659|FG000|STARTED|Part 2 (Antiviral Treatment Phase)||25||
48091008|NCT00996216|100545659|FG000|COMPLETED|Part 2 (Antiviral Treatment Phase)||21||
48091009|NCT00996216|100545659|FG000|NOT COMPLETED|Part 2 (Antiviral Treatment Phase)||4||
48091010|NCT03277105|100545660|FG000|STARTED|Overall Study||259||
48091011|NCT03277105|100545661|FG001|STARTED|Overall Study||263||
48091012|NCT03277105|100545660|FG000|Treated (Safety Analysis Set)|Overall Study||258||
48091013|NCT03277105|100545661|FG001|Treated (Safety Analysis Set)|Overall Study||260||
48091014|NCT03277105|100545660|FG000|COMPLETED|Overall Study||0||
48091015|NCT03277105|100545661|FG001|COMPLETED|Overall Study||0||
48091016|NCT03277105|100545660|FG000|NOT COMPLETED|Overall Study||259||
48091017|NCT03277105|100545661|FG001|NOT COMPLETED|Overall Study||263||
48091018|NCT03348956|100545662|FG000|STARTED|Overall Study||7||
48091019|NCT03348956|100545662|FG000|Clinical, Electrophysiologic Metrics, and Neuropathy Scales|Overall Study||7||
48091020|NCT03348956|100545662|FG000|COMPLETED|Overall Study||3||
48091021|NCT03348956|100545662|FG000|NOT COMPLETED|Overall Study||4||
48091022|NCT00589563|100545663|FG000|STARTED|Overall Study||32||
48091023|NCT00589563|100545663|FG000|COMPLETED|Overall Study||32||
48091024|NCT00589563|100545663|FG000|NOT COMPLETED|Overall Study||0||
48091025|NCT02259582|100545664|FG000|STARTED|Overall Study||25||
48091026|NCT02259582|100545665|FG001|STARTED|Overall Study||28||
48091027|NCT02259582|100545666|FG002|STARTED|Overall Study||29||
48382053|NCT01021852|101261760|FG005|STARTED|Treatment Period 2||38||
48382054|NCT01021852|101261761|FG006|STARTED|Treatment Period 2||40||
48382055|NCT01021852|101261762|FG007|STARTED|Treatment Period 2||40||
48382056|NCT01021852|101261755|FG000|COMPLETED|Treatment Period 2||37||
48382057|NCT01021852|101261756|FG001|COMPLETED|Treatment Period 2||38||
48382058|NCT01021852|101261757|FG002|COMPLETED|Treatment Period 2||38||
48382059|NCT01021852|101261758|FG003|COMPLETED|Treatment Period 2||37||
48382060|NCT01021852|101261759|FG004|COMPLETED|Treatment Period 2||37||
48382061|NCT01021852|101261760|FG005|COMPLETED|Treatment Period 2||37||
48382062|NCT01021852|101261761|FG006|COMPLETED|Treatment Period 2||37||
48382063|NCT01021852|101261762|FG007|COMPLETED|Treatment Period 2||38||
48382064|NCT01021852|101261755|FG000|NOT COMPLETED|Treatment Period 2||0||
48382065|NCT01021852|101261756|FG001|NOT COMPLETED|Treatment Period 2||1||
48382066|NCT01021852|101261757|FG002|NOT COMPLETED|Treatment Period 2||1||
48382067|NCT01021852|101261758|FG003|NOT COMPLETED|Treatment Period 2||0||
48382068|NCT01021852|101261759|FG004|NOT COMPLETED|Treatment Period 2||2||
48382069|NCT01021852|101261760|FG005|NOT COMPLETED|Treatment Period 2||1||
48382070|NCT01021852|101261761|FG006|NOT COMPLETED|Treatment Period 2||3||
48382071|NCT01021852|101261762|FG007|NOT COMPLETED|Treatment Period 2||2||
48382072|NCT02344407|101261763|FG000|STARTED|Overall Study||500||
48382073|NCT02344407|101261764|FG001|STARTED|Overall Study||500||
48382074|NCT02344407|101261765|FG002|STARTED|Overall Study||500||
48382075|NCT02344407|101261763|FG000|COMPLETED|Overall Study||492||
48382076|NCT02344407|101261764|FG001|COMPLETED|Overall Study||491||
48382077|NCT02344407|101261765|FG002|COMPLETED|Overall Study||494||
48382078|NCT02344407|101261763|FG000|NOT COMPLETED|Overall Study||8||
48382079|NCT02344407|101261764|FG001|NOT COMPLETED|Overall Study||9||
48382080|NCT02344407|101261765|FG002|NOT COMPLETED|Overall Study||6||
48687102|NCT01881009|102017014|FG000|NOT COMPLETED|Inpatient Safety Testing (22 Hours)||0||
48687103|NCT01881009|102017015|FG001|NOT COMPLETED|Inpatient Safety Testing (22 Hours)||0||
48687104|NCT01881009|102017014|FG000|STARTED|Summer Camp Session (6 Days)||0||
48091028|NCT02259582|100545664|FG000|COMPLETED|Overall Study||9||
48091029|NCT02259582|100545665|FG001|COMPLETED|Overall Study||11||
48091030|NCT02259582|100545666|FG002|COMPLETED|Overall Study||8||
48382081|NCT00186056|101261766|FG000|STARTED|Overall Study||14||
48382082|NCT00186056|101261767|FG001|STARTED|Overall Study||17||
48382083|NCT00186056|101261766|FG000|COMPLETED|Overall Study||12||
48382084|NCT00186056|101261767|FG001|COMPLETED|Overall Study||16||
48091031|NCT02259582|100545664|FG000|NOT COMPLETED|Overall Study||16||
48091032|NCT02259582|100545665|FG001|NOT COMPLETED|Overall Study||17||
48382085|NCT00186056|101261766|FG000|NOT COMPLETED|Overall Study||2||
48382086|NCT00186056|101261767|FG001|NOT COMPLETED|Overall Study||1||
48382087|NCT01658579|101261768|FG000|STARTED|Treatment Period A||15||
48382088|NCT01658579|101261769|FG001|STARTED|Treatment Period A||15||
48382089|NCT01658579|101261770|FG002|STARTED|Treatment Period A||15||
48382090|NCT01658579|101261771|FG003|STARTED|Treatment Period A||14||
48382091|NCT01658579|101261768|FG000|COMPLETED|Treatment Period A||14||
48382092|NCT01658579|101261769|FG001|COMPLETED|Treatment Period A||15||
48382093|NCT01658579|101261770|FG002|COMPLETED|Treatment Period A||14||
48382094|NCT01658579|101261771|FG003|COMPLETED|Treatment Period A||13||
48382095|NCT01658579|101261768|FG000|NOT COMPLETED|Treatment Period A||1||
48382096|NCT01658579|101261769|FG001|NOT COMPLETED|Treatment Period A||0||
48382097|NCT01658579|101261770|FG002|NOT COMPLETED|Treatment Period A||1||
48382098|NCT01658579|101261771|FG003|NOT COMPLETED|Treatment Period A||1||
48091033|NCT02259582|100545666|FG002|NOT COMPLETED|Overall Study||21||
48091034|NCT03824912|100545667|FG000|STARTED|Overall Study||332||
48091035|NCT03824912|100545668|FG001|STARTED|Overall Study||335||
48091036|NCT03824912|100545669|FG002|STARTED|Overall Study||164||
48091037|NCT03824912|100545667|FG000|COMPLETED|Overall Study||192||
48091038|NCT03824912|100545668|FG001|COMPLETED|Overall Study||201||
48091039|NCT03824912|100545669|FG002|COMPLETED|Overall Study||96||
48091040|NCT03824912|100545667|FG000|NOT COMPLETED|Overall Study||140||
48091041|NCT03824912|100545668|FG001|NOT COMPLETED|Overall Study||134||
48091042|NCT03824912|100545669|FG002|NOT COMPLETED|Overall Study||68||
48091043|NCT02554812|100545670|FG000|STARTED|Overall Study||29||
48091044|NCT02554812|100545671|FG001|STARTED|Overall Study||28||
48091045|NCT02554812|100545672|FG002|STARTED|Overall Study||29||
48091046|NCT02554812|100545673|FG003|STARTED|Overall Study||28||
48091047|NCT02554812|100545674|FG004|STARTED|Overall Study||35||
48091048|NCT02554812|100545675|FG005|STARTED|Overall Study||21||
48091049|NCT02554812|100545676|FG006|STARTED|Overall Study||10||
48091050|NCT02554812|100545677|FG007|STARTED|Overall Study||21||
48255347|NCT01035047|100943907|FG001|NOT COMPLETED|Overall Study||0||
48255348|NCT00461123|100943908|FG000|STARTED|Overall Study||25||
48382099|NCT01658579|101261768|FG000|STARTED|Treatment Period B||14||
48687105|NCT01881009|102017015|FG001|STARTED|Summer Camp Session (6 Days)||22||
48687106|NCT01881009|102017014|FG000|COMPLETED|Summer Camp Session (6 Days)||0||
48687107|NCT01881009|102017015|FG001|COMPLETED|Summer Camp Session (6 Days)||21||
48091051|NCT02554812|100545678|FG008|STARTED|Overall Study||11||
48091052|NCT02554812|100545679|FG009|STARTED|Overall Study||11||
48091053|NCT02554812|100545680|FG010|STARTED|Overall Study||12||
48091054|NCT02554812|100545681|FG011|STARTED|Overall Study||12||
48091055|NCT02554812|100545682|FG012|STARTED|Overall Study||8||
48091056|NCT02554812|100545683|FG013|STARTED|Overall Study||14||
48091057|NCT02554812|100545684|FG014|STARTED|Overall Study||25||
48091058|NCT02554812|100545685|FG015|STARTED|Overall Study||10||
48091059|NCT02554812|100545686|FG016|STARTED|Overall Study||8||
48255349|NCT00461123|100943909|FG001|STARTED|Overall Study||25||
48255350|NCT00461123|100943908|FG000|COMPLETED|Overall Study||19||
48255351|NCT00461123|100943909|FG001|COMPLETED|Overall Study||19||
48255352|NCT00461123|100943908|FG000|NOT COMPLETED|Overall Study||6||
48255353|NCT00461123|100943909|FG001|NOT COMPLETED|Overall Study||6||
48255354|NCT00548847|100943910|FG000|STARTED|Overall Study||15||
48255355|NCT00548847|100943910|FG000|COMPLETED|Overall Study||8||
48687108|NCT01881009|102017014|FG000|NOT COMPLETED|Summer Camp Session (6 Days)||0||
48687109|NCT01881009|102017015|FG001|NOT COMPLETED|Summer Camp Session (6 Days)||1||
48687110|NCT02148263|102017016|FG000|STARTED|Overall Study||12||
48091060|NCT02554812|100545687|FG017|STARTED|Overall Study||6||
48255356|NCT00548847|100943910|FG000|NOT COMPLETED|Overall Study||7||
48255357|NCT02154347|100943911|FG000|STARTED|Double-blind Period||60||
48255358|NCT02154347|100943912|FG001|STARTED|Double-blind Period||118||
48255359|NCT02154347|100943911|FG000|COMPLETED|Double-blind Period||57||
48255360|NCT02154347|100943912|FG001|COMPLETED|Double-blind Period||114||
48255361|NCT02154347|100943911|FG000|NOT COMPLETED|Double-blind Period||3||
48255362|NCT02154347|100943912|FG001|NOT COMPLETED|Double-blind Period||4||
48255363|NCT02154347|100943911|FG000|STARTED|Open-label Period||57||
48255364|NCT02154347|100943912|FG001|STARTED|Open-label Period||113||
48255365|NCT02154347|100943911|FG000|COMPLETED|Open-label Period||50||
48255366|NCT02154347|100943912|FG001|COMPLETED|Open-label Period||88||
48255367|NCT02154347|100943911|FG000|NOT COMPLETED|Open-label Period||7||
48255368|NCT02154347|100943912|FG001|NOT COMPLETED|Open-label Period||25||
48255369|NCT02877732|100943913|FG000|STARTED|Overall Study||6||
48255370|NCT02877732|100943914|FG001|STARTED|Overall Study||6||
48255371|NCT02877732|100943913|FG000|COMPLETED|Overall Study||0||
48255372|NCT02877732|100943914|FG001|COMPLETED|Overall Study||0||
48255373|NCT02877732|100943913|FG000|NOT COMPLETED|Overall Study||6||
48255374|NCT02877732|100943914|FG001|NOT COMPLETED|Overall Study||6||
48255375|NCT02190552|100943915|FG000|STARTED|Overall Study||40||
48255376|NCT02190552|100943915|FG000|COMPLETED|Overall Study||36||
48255377|NCT02190552|100943915|FG000|NOT COMPLETED|Overall Study||4||
48255378|NCT01232569|100943916|FG000|STARTED|Double-blind Treatment Period||438||
48687111|NCT02148263|102017017|FG001|STARTED|Overall Study||13||
48091061|NCT02554812|100545688|FG018|STARTED|Overall Study||12||
48091062|NCT02554812|100545689|FG019|STARTED|Overall Study||12||
48091063|NCT02554812|100545690|FG020|STARTED|Overall Study||12||
48091064|NCT02554812|100545691|FG021|STARTED|Overall Study||12||
48255379|NCT01232569|100943917|FG001|STARTED|Double-blind Treatment Period||218||
48255380|NCT01232569|100943918|FG002|STARTED|Double-blind Treatment Period||0||
48255381|NCT01232569|100943919|FG003|STARTED|Double-blind Treatment Period||0||
48255382|NCT01232569|100943916|FG000|COMPLETED|Double-blind Treatment Period||410||
48255383|NCT01232569|100943917|FG001|COMPLETED|Double-blind Treatment Period||209||
48255384|NCT01232569|100943918|FG002|COMPLETED|Double-blind Treatment Period||0||
48255385|NCT01232569|100943919|FG003|COMPLETED|Double-blind Treatment Period||0||
48255386|NCT01232569|100943916|FG000|NOT COMPLETED|Double-blind Treatment Period||28||
48255387|NCT01232569|100943917|FG001|NOT COMPLETED|Double-blind Treatment Period||9||
48091065|NCT02554812|100545692|FG022|STARTED|Overall Study||12||
48091066|NCT02554812|100545693|FG023|STARTED|Overall Study||11||
48091067|NCT02554812|100545694|FG024|STARTED|Overall Study||6||
48091068|NCT02554812|100545695|FG025|STARTED|Overall Study||7||
48091069|NCT02554812|100545696|FG026|STARTED|Overall Study||7||
48091070|NCT02554812|100545670|FG000|Treated|Overall Study||29||
48091071|NCT02554812|100545671|FG001|Treated|Overall Study||27||
48091072|NCT02554812|100545672|FG002|Treated|Overall Study||29||
48091073|NCT02554812|100545673|FG003|Treated|Overall Study||28||
48091074|NCT02554812|100545674|FG004|Treated|Overall Study||35||
48091075|NCT02554812|100545675|FG005|Treated|Overall Study||21||
48091076|NCT02554812|100545676|FG006|Treated|Overall Study||10||
48091077|NCT02554812|100545677|FG007|Treated|Overall Study||21||
48091078|NCT02554812|100545678|FG008|Treated|Overall Study||11||
48091079|NCT02554812|100545679|FG009|Treated|Overall Study||11||
48091080|NCT02554812|100545680|FG010|Treated|Overall Study||12||
48091081|NCT02554812|100545681|FG011|Treated|Overall Study||12||
48091082|NCT02554812|100545682|FG012|Treated|Overall Study||8||
48091083|NCT02554812|100545683|FG013|Treated|Overall Study||14||
48091084|NCT02554812|100545684|FG014|Treated|Overall Study||25||
48091085|NCT02554812|100545685|FG015|Treated|Overall Study||10||
48091086|NCT02554812|100545686|FG016|Treated|Overall Study||8||
48091087|NCT02554812|100545687|FG017|Treated|Overall Study||6||
48091088|NCT02554812|100545688|FG018|Treated|Overall Study||12||
48091089|NCT02554812|100545689|FG019|Treated|Overall Study||12||
48091090|NCT02554812|100545690|FG020|Treated|Overall Study||12||
48091091|NCT02554812|100545691|FG021|Treated|Overall Study||12||
48091092|NCT02554812|100545692|FG022|Treated|Overall Study||12||
48091093|NCT02554812|100545693|FG023|Treated|Overall Study||11||
48091094|NCT02554812|100545694|FG024|Treated|Overall Study||6||
48091095|NCT02554812|100545695|FG025|Treated|Overall Study||7||
48091096|NCT02554812|100545696|FG026|Treated|Overall Study||7||
48091097|NCT02554812|100545670|FG000|COMPLETED|Overall Study||0||
48091098|NCT02554812|100545671|FG001|COMPLETED|Overall Study||0||
48091099|NCT02554812|100545672|FG002|COMPLETED|Overall Study||0||
48091100|NCT02554812|100545673|FG003|COMPLETED|Overall Study||0||
48091101|NCT02554812|100545674|FG004|COMPLETED|Overall Study||0||
48091102|NCT02554812|100545675|FG005|COMPLETED|Overall Study||0||
48091103|NCT02554812|100545676|FG006|COMPLETED|Overall Study||0||
48091104|NCT02554812|100545677|FG007|COMPLETED|Overall Study||0||
48091105|NCT02554812|100545678|FG008|COMPLETED|Overall Study||0||
48091106|NCT02554812|100545679|FG009|COMPLETED|Overall Study||0||
48091107|NCT02554812|100545680|FG010|COMPLETED|Overall Study||0||
48091108|NCT02554812|100545681|FG011|COMPLETED|Overall Study||0||
48091109|NCT02554812|100545682|FG012|COMPLETED|Overall Study||0||
48091110|NCT02554812|100545683|FG013|COMPLETED|Overall Study||0||
48091111|NCT02554812|100545684|FG014|COMPLETED|Overall Study||0||
48091112|NCT02554812|100545685|FG015|COMPLETED|Overall Study||0||
48091113|NCT02554812|100545686|FG016|COMPLETED|Overall Study||0||
48091114|NCT02554812|100545687|FG017|COMPLETED|Overall Study||0||
48091115|NCT02554812|100545688|FG018|COMPLETED|Overall Study||0||
48091116|NCT02554812|100545689|FG019|COMPLETED|Overall Study||0||
48091117|NCT02554812|100545690|FG020|COMPLETED|Overall Study||0||
48091118|NCT02554812|100545691|FG021|COMPLETED|Overall Study||0||
48091119|NCT02554812|100545692|FG022|COMPLETED|Overall Study||0||
48091120|NCT02554812|100545693|FG023|COMPLETED|Overall Study||0||
48091121|NCT02554812|100545694|FG024|COMPLETED|Overall Study||0||
48091122|NCT02554812|100545695|FG025|COMPLETED|Overall Study||0||
48091123|NCT02554812|100545696|FG026|COMPLETED|Overall Study||0||
48091124|NCT02554812|100545670|FG000|NOT COMPLETED|Overall Study||29||
48091125|NCT02554812|100545671|FG001|NOT COMPLETED|Overall Study||28||
48091126|NCT02554812|100545672|FG002|NOT COMPLETED|Overall Study||29||
48091127|NCT02554812|100545673|FG003|NOT COMPLETED|Overall Study||28||
48091128|NCT02554812|100545674|FG004|NOT COMPLETED|Overall Study||35||
48255388|NCT01232569|100943918|FG002|NOT COMPLETED|Double-blind Treatment Period||0||
48091129|NCT02554812|100545675|FG005|NOT COMPLETED|Overall Study||21||
48091130|NCT02554812|100545676|FG006|NOT COMPLETED|Overall Study||10||
48091131|NCT02554812|100545677|FG007|NOT COMPLETED|Overall Study||21||
48255389|NCT01232569|100943919|FG003|NOT COMPLETED|Double-blind Treatment Period||0||
48255390|NCT01232569|100943916|FG000|STARTED|Open-label Extension Period||0||
48255391|NCT01232569|100943917|FG001|STARTED|Open-label Extension Period||0||
48255392|NCT01232569|100943918|FG002|STARTED|Open-label Extension Period||230||
48255393|NCT01232569|100943919|FG003|STARTED|Open-label Extension Period||227||
48255394|NCT01232569|100943916|FG000|COMPLETED|Open-label Extension Period||0||
48255395|NCT01232569|100943917|FG001|COMPLETED|Open-label Extension Period||0||
48255396|NCT01232569|100943918|FG002|COMPLETED|Open-label Extension Period||203||
48255397|NCT01232569|100943919|FG003|COMPLETED|Open-label Extension Period||200||
48091132|NCT02554812|100545678|FG008|NOT COMPLETED|Overall Study||11||
48091133|NCT02554812|100545679|FG009|NOT COMPLETED|Overall Study||11||
48091134|NCT02554812|100545680|FG010|NOT COMPLETED|Overall Study||12||
48091135|NCT02554812|100545681|FG011|NOT COMPLETED|Overall Study||12||
48091136|NCT02554812|100545682|FG012|NOT COMPLETED|Overall Study||8||
48091137|NCT02554812|100545683|FG013|NOT COMPLETED|Overall Study||14||
48091138|NCT02554812|100545684|FG014|NOT COMPLETED|Overall Study||25||
48091139|NCT02554812|100545685|FG015|NOT COMPLETED|Overall Study||10||
48091140|NCT02554812|100545686|FG016|NOT COMPLETED|Overall Study||8||
48091141|NCT02554812|100545687|FG017|NOT COMPLETED|Overall Study||6||
48091142|NCT02554812|100545688|FG018|NOT COMPLETED|Overall Study||12||
48091143|NCT02554812|100545689|FG019|NOT COMPLETED|Overall Study||12||
48091144|NCT02554812|100545690|FG020|NOT COMPLETED|Overall Study||12||
48091145|NCT02554812|100545691|FG021|NOT COMPLETED|Overall Study||12||
48091146|NCT02554812|100545692|FG022|NOT COMPLETED|Overall Study||12||
48382100|NCT01658579|101261769|FG001|STARTED|Treatment Period B||15||
48091147|NCT02554812|100545693|FG023|NOT COMPLETED|Overall Study||11||
48382101|NCT01658579|101261770|FG002|STARTED|Treatment Period B||14||
48382102|NCT01658579|101261771|FG003|STARTED|Treatment Period B||13||
48382103|NCT01658579|101261768|FG000|COMPLETED|Treatment Period B||14||
48382104|NCT01658579|101261769|FG001|COMPLETED|Treatment Period B||15||
48382105|NCT01658579|101261770|FG002|COMPLETED|Treatment Period B||14||
48382106|NCT01658579|101261771|FG003|COMPLETED|Treatment Period B||12||
48382107|NCT01658579|101261768|FG000|NOT COMPLETED|Treatment Period B||0||
48382108|NCT01658579|101261769|FG001|NOT COMPLETED|Treatment Period B||0||
48382109|NCT01658579|101261770|FG002|NOT COMPLETED|Treatment Period B||0||
48382110|NCT01658579|101261771|FG003|NOT COMPLETED|Treatment Period B||1||
48382111|NCT05291598|101261772|FG000|STARTED|Overall Study||114||
48382112|NCT05291598|101261773|FG001|STARTED|Overall Study||109||
48382113|NCT05291598|101261772|FG000|COMPLETED|Overall Study||114||
48382114|NCT05291598|101261773|FG001|COMPLETED|Overall Study||109||
48382115|NCT05291598|101261772|FG000|NOT COMPLETED|Overall Study||0||
48382116|NCT05291598|101261773|FG001|NOT COMPLETED|Overall Study||0||
48382117|NCT00910429|101261774|FG000|STARTED|Overall Study||155||
48382118|NCT00910429|101261775|FG001|STARTED|Overall Study||82||
48382119|NCT00910429|101261774|FG000|COMPLETED|Overall Study||116||
48382120|NCT00910429|101261775|FG001|COMPLETED|Overall Study||61||
48382121|NCT00910429|101261774|FG000|NOT COMPLETED|Overall Study||39||
48382122|NCT00910429|101261775|FG001|NOT COMPLETED|Overall Study||21||
48382123|NCT03176277|101261776|FG000|STARTED|Part A Dose Escalation Study||10||
48382124|NCT03176277|101261777|FG001|STARTED|Part A Dose Escalation Study||3||
48382125|NCT03176277|101261778|FG002|STARTED|Part A Dose Escalation Study||7||
48382126|NCT03176277|101261779|FG003|STARTED|Part A Dose Escalation Study||0||
48382127|NCT03176277|101261776|FG000|COMPLETED|Part A Dose Escalation Study||0||
48382128|NCT03176277|101261777|FG001|COMPLETED|Part A Dose Escalation Study||0||
48382129|NCT03176277|101261778|FG002|COMPLETED|Part A Dose Escalation Study||0||
48382130|NCT03176277|101261779|FG003|COMPLETED|Part A Dose Escalation Study||0||
48382131|NCT03176277|101261776|FG000|NOT COMPLETED|Part A Dose Escalation Study||10||
48382132|NCT03176277|101261777|FG001|NOT COMPLETED|Part A Dose Escalation Study||3||
48382133|NCT03176277|101261778|FG002|NOT COMPLETED|Part A Dose Escalation Study||7||
48382134|NCT03176277|101261779|FG003|NOT COMPLETED|Part A Dose Escalation Study||0||
48382135|NCT03176277|101261776|FG000|STARTED|Part D ONO-7475 6mg + Venetoclax||0||
48382136|NCT03176277|101261777|FG001|STARTED|Part D ONO-7475 6mg + Venetoclax||0||
48382137|NCT03176277|101261778|FG002|STARTED|Part D ONO-7475 6mg + Venetoclax||0||
48382138|NCT03176277|101261779|FG003|STARTED|Part D ONO-7475 6mg + Venetoclax||22||
48382139|NCT03176277|101261776|FG000|COMPLETED|Part D ONO-7475 6mg + Venetoclax||0||
48382140|NCT03176277|101261777|FG001|COMPLETED|Part D ONO-7475 6mg + Venetoclax||0||
48382141|NCT03176277|101261778|FG002|COMPLETED|Part D ONO-7475 6mg + Venetoclax||0||
48382142|NCT03176277|101261779|FG003|COMPLETED|Part D ONO-7475 6mg + Venetoclax||22||
48382143|NCT03176277|101261776|FG000|NOT COMPLETED|Part D ONO-7475 6mg + Venetoclax||0||
48382144|NCT03176277|101261777|FG001|NOT COMPLETED|Part D ONO-7475 6mg + Venetoclax||0||
48382145|NCT03176277|101261778|FG002|NOT COMPLETED|Part D ONO-7475 6mg + Venetoclax||0||
48382146|NCT03176277|101261779|FG003|NOT COMPLETED|Part D ONO-7475 6mg + Venetoclax||0||
48382147|NCT01277341|101261780|FG000|STARTED|Overall Study||150||
48382148|NCT01277341|101261781|FG001|STARTED|Overall Study||150||
48382149|NCT01277341|101261782|FG002|STARTED|Overall Study||149||
48382150|NCT01277341|101261783|FG003|STARTED|Overall Study||152||
48382151|NCT01277341|101261780|FG000|COMPLETED|Overall Study||146||
48541555|NCT00339144|101662774|FG001|STARTED|Overall Study||3||
48541556|NCT00339144|101662775|FG002|STARTED|Overall Study||4||
48091148|NCT02554812|100545694|FG024|NOT COMPLETED|Overall Study||6||
48091149|NCT02554812|100545695|FG025|NOT COMPLETED|Overall Study||7||
48091150|NCT02554812|100545696|FG026|NOT COMPLETED|Overall Study||7||
48091151|NCT01891695|100545697|FG000|STARTED|Overall Study||1||
48091152|NCT01891695|100545697|FG000|COMPLETED|Overall Study||1||
48091153|NCT01891695|100545697|FG000|NOT COMPLETED|Overall Study||0||
48091154|NCT02446990|100545698|FG000|STARTED|Overall Study||9550||
48091155|NCT02446990|100545699|FG001|STARTED|Overall Study||9552||
48091156|NCT02446990|100545698|FG000|COMPLETED|Overall Study||8830||
48091157|NCT02446990|100545699|FG001|COMPLETED|Overall Study||8894||
48091158|NCT02446990|100545698|FG000|NOT COMPLETED|Overall Study||720||
48091159|NCT02446990|100545699|FG001|NOT COMPLETED|Overall Study||658||
48091160|NCT02887521|100545700|FG000|STARTED|Overall Study||4||
48091161|NCT02887521|100545701|FG001|STARTED|Overall Study||5||
48091162|NCT02887521|100545700|FG000|COMPLETED|Overall Study||4||
48091163|NCT02887521|100545701|FG001|COMPLETED|Overall Study||2||
48382152|NCT01277341|101261781|FG001|COMPLETED|Overall Study||145||
48382153|NCT01277341|101261782|FG002|COMPLETED|Overall Study||145||
48382154|NCT01277341|101261783|FG003|COMPLETED|Overall Study||146||
48541557|NCT00339144|101662773|FG000|COMPLETED|Overall Study||0||
48091164|NCT02887521|100545700|FG000|NOT COMPLETED|Overall Study||0||
48091165|NCT02887521|100545701|FG001|NOT COMPLETED|Overall Study||3||
48091166|NCT01370174|100545702|FG000|STARTED|Overall Study||25||
48091167|NCT01370174|100545703|FG001|STARTED|Overall Study||26||
48091168|NCT01370174|100545704|FG002|STARTED|Overall Study||25||
48091169|NCT01370174|100545705|FG003|STARTED|Overall Study||26||
48091170|NCT01370174|100545702|FG000|COMPLETED|Overall Study||18||
48091171|NCT01370174|100545703|FG001|COMPLETED|Overall Study||15||
48091172|NCT01370174|100545704|FG002|COMPLETED|Overall Study||13||
48091173|NCT01370174|100545705|FG003|COMPLETED|Overall Study||17||
48255398|NCT01232569|100943916|FG000|NOT COMPLETED|Open-label Extension Period||0||
48255399|NCT01232569|100943917|FG001|NOT COMPLETED|Open-label Extension Period||0||
48255400|NCT01232569|100943918|FG002|NOT COMPLETED|Open-label Extension Period||27||
48255401|NCT01232569|100943919|FG003|NOT COMPLETED|Open-label Extension Period||27||
48255402|NCT02108652|100943920|FG000|STARTED|Overall Study||310||
48255403|NCT02108652|100943920|FG000|COMPLETED|Overall Study||0||
48255404|NCT02108652|100943920|FG000|NOT COMPLETED|Overall Study||310||
48255405|NCT00217022|100943921|FG000|STARTED|Overall Study||12||
48255406|NCT00217022|100943922|FG001|STARTED|Overall Study||4||
48255407|NCT00217022|100943921|FG000|COMPLETED|Overall Study||11||
48255408|NCT00217022|100943922|FG001|COMPLETED|Overall Study||3||
48255409|NCT00217022|100943921|FG000|NOT COMPLETED|Overall Study||1||
48255410|NCT00217022|100943922|FG001|NOT COMPLETED|Overall Study||1||
48255411|NCT02171247|100943923|FG000|STARTED|Overall Study||16||
48382155|NCT01277341|101261780|FG000|NOT COMPLETED|Overall Study||4||
48382156|NCT01277341|101261781|FG001|NOT COMPLETED|Overall Study||5||
48255412|NCT02171247|100943924|FG001|STARTED|Overall Study||17||
48382157|NCT01277341|101261782|FG002|NOT COMPLETED|Overall Study||4||
48382158|NCT01277341|101261783|FG003|NOT COMPLETED|Overall Study||6||
48382159|NCT00448916|101261784|FG000|STARTED|Overall Study||16||
48382160|NCT00448916|101261785|FG001|STARTED|Overall Study||15||
48382161|NCT00448916|101261786|FG002|STARTED|Overall Study||12||
48382162|NCT00448916|101261787|FG003|STARTED|Overall Study||11||
48382163|NCT00448916|101261784|FG000|COMPLETED|Overall Study||9||
48382164|NCT00448916|101261785|FG001|COMPLETED|Overall Study||9||
48382165|NCT00448916|101261786|FG002|COMPLETED|Overall Study||6||
48382166|NCT00448916|101261787|FG003|COMPLETED|Overall Study||5||
48382167|NCT00448916|101261784|FG000|NOT COMPLETED|Overall Study||7||
48382168|NCT00448916|101261785|FG001|NOT COMPLETED|Overall Study||6||
48382169|NCT00448916|101261786|FG002|NOT COMPLETED|Overall Study||6||
48382170|NCT00448916|101261787|FG003|NOT COMPLETED|Overall Study||6||
48382171|NCT02391350|101261788|FG000|STARTED|Overall Study||110||
48382172|NCT02391350|101261789|FG001|STARTED|Overall Study||110||
48382173|NCT02391350|101261788|FG000|4-week Follow-up|Overall Study||106||
48382174|NCT02391350|101261789|FG001|4-week Follow-up|Overall Study||105||
48382175|NCT02391350|101261788|FG000|6-month Follow-up|Overall Study||100||
48255413|NCT02171247|100943923|FG000|COMPLETED|Overall Study||16||
48382176|NCT02391350|101261789|FG001|6-month Follow-up|Overall Study||96||
48382177|NCT02391350|101261788|FG000|COMPLETED|Overall Study||98|One-year follow-up|
48382178|NCT02391350|101261789|FG001|COMPLETED|Overall Study||93|One-year follow-up|
48382179|NCT02391350|101261788|FG000|NOT COMPLETED|Overall Study||12||
48382180|NCT02391350|101261789|FG001|NOT COMPLETED|Overall Study||17||
48382181|NCT00264849|101261790|FG000|STARTED|Overall Study||275||
48382182|NCT00264849|101261791|FG001|STARTED|Overall Study||131||
48382183|NCT00264849|101261790|FG000|COMPLETED|Overall Study||253||
48382184|NCT00264849|101261791|FG001|COMPLETED|Overall Study||106||
48382185|NCT00264849|101261790|FG000|NOT COMPLETED|Overall Study||22||
48382186|NCT00264849|101261791|FG001|NOT COMPLETED|Overall Study||25||
48091174|NCT01370174|100545702|FG000|NOT COMPLETED|Overall Study||7||
48091175|NCT01370174|100545703|FG001|NOT COMPLETED|Overall Study||11||
48091176|NCT01370174|100545704|FG002|NOT COMPLETED|Overall Study||12||
48091177|NCT01370174|100545705|FG003|NOT COMPLETED|Overall Study||9||
48091178|NCT00913003|100545706|FG000|STARTED|Overall Study||11||
48091179|NCT00913003|100545707|FG001|STARTED|Overall Study||11||
48091180|NCT00913003|100545706|FG000|COMPLETED|Overall Study||11||
48091181|NCT00913003|100545707|FG001|COMPLETED|Overall Study||11||
48091182|NCT00913003|100545706|FG000|NOT COMPLETED|Overall Study||0||
48091183|NCT00913003|100545707|FG001|NOT COMPLETED|Overall Study||0||
48091184|NCT01700725|100545708|FG000|STARTED|Overall Study||14||
48091185|NCT01700725|100545709|FG001|STARTED|Overall Study||14||
48091186|NCT01700725|100545710|FG002|STARTED|Overall Study||12||
48091187|NCT01700725|100545708|FG000|COMPLETED|Overall Study||14||
48091188|NCT01700725|100545709|FG001|COMPLETED|Overall Study||14||
48091189|NCT01700725|100545710|FG002|COMPLETED|Overall Study||12||
48382187|NCT00288860|101261792|FG000|STARTED|Overall Study||412||
48382188|NCT00288860|101261793|FG001|STARTED|Overall Study||425||
48382189|NCT00288860|101261792|FG000|Completed Intake Survey|Overall Study||408||
48382190|NCT00288860|101261793|FG001|Completed Intake Survey|Overall Study||417||
48382191|NCT00288860|101261792|FG000|Completed 4 Month fu Survey|Overall Study||275||
48091190|NCT01700725|100545708|FG000|NOT COMPLETED|Overall Study||0||
48255414|NCT02171247|100943924|FG001|COMPLETED|Overall Study||17||
48255415|NCT02171247|100943923|FG000|NOT COMPLETED|Overall Study||0||
48255416|NCT02171247|100943924|FG001|NOT COMPLETED|Overall Study||0||
48255417|NCT02736955|100943925|FG000|STARTED|Overall Study||36||
48382192|NCT00288860|101261793|FG001|Completed 4 Month fu Survey|Overall Study||299||
48382193|NCT00288860|101261792|FG000|Completed 12 Month fu Survey|Overall Study||257||
48382194|NCT00288860|101261793|FG001|Completed 12 Month fu Survey|Overall Study||281||
48382195|NCT00288860|101261792|FG000|COMPLETED|Overall Study||310||
48382196|NCT00288860|101261793|FG001|COMPLETED|Overall Study||328||
48382197|NCT00288860|101261792|FG000|NOT COMPLETED|Overall Study||102||
48382198|NCT00288860|101261793|FG001|NOT COMPLETED|Overall Study||97||
48382199|NCT04105244|101261794|FG000|STARTED|Overall Study||97||
48382200|NCT04105244|101261795|FG001|STARTED|Overall Study||100||
48382201|NCT04105244|101261794|FG000|COMPLETED|Overall Study||67||
48382202|NCT04105244|101261795|FG001|COMPLETED|Overall Study||62||
48382203|NCT04105244|101261794|FG000|NOT COMPLETED|Overall Study||30||
48382204|NCT04105244|101261795|FG001|NOT COMPLETED|Overall Study||38||
48382205|NCT02815293|101261796|FG000|STARTED|Overall Study||10||
48382206|NCT02815293|101261797|FG001|STARTED|Overall Study||8||
48382207|NCT02815293|101261798|FG002|STARTED|Overall Study||18||
48382208|NCT02815293|101261796|FG000|COMPLETED|Overall Study||0||
48382209|NCT02815293|101261797|FG001|COMPLETED|Overall Study||0||
48382210|NCT02815293|101261798|FG002|COMPLETED|Overall Study||0||
48382211|NCT02815293|101261796|FG000|NOT COMPLETED|Overall Study||10||
48382212|NCT02815293|101261797|FG001|NOT COMPLETED|Overall Study||8||
48382213|NCT02815293|101261798|FG002|NOT COMPLETED|Overall Study||18||
48382214|NCT00675103|101261799|FG000|STARTED|Overall Study||7||
48382215|NCT00675103|101261799|FG000|COMPLETED|Overall Study||4||
48382216|NCT00675103|101261799|FG000|NOT COMPLETED|Overall Study||3||
48382217|NCT00808249|101261800|FG000|STARTED|Overall Study||107||
48382218|NCT00808249|101261801|FG001|STARTED|Overall Study||106||
48382219|NCT00808249|101261802|FG002|STARTED|Overall Study||105||
48382220|NCT00808249|101261803|FG003|STARTED|Overall Study||106||
48382221|NCT00808249|101261800|FG000|COMPLETED|Overall Study||90||
48382222|NCT00808249|101261801|FG001|COMPLETED|Overall Study||91||
48382223|NCT00808249|101261802|FG002|COMPLETED|Overall Study||83||
48541558|NCT00339144|101662774|FG001|COMPLETED|Overall Study||0||
48382224|NCT00808249|101261803|FG003|COMPLETED|Overall Study||90||
48382225|NCT00808249|101261800|FG000|NOT COMPLETED|Overall Study||17||
48382226|NCT00808249|101261801|FG001|NOT COMPLETED|Overall Study||15||
48382227|NCT00808249|101261802|FG002|NOT COMPLETED|Overall Study||22||
48382228|NCT00808249|101261803|FG003|NOT COMPLETED|Overall Study||16||
48382229|NCT00370695|101261804|FG000|STARTED|Overall Study||15||
48382230|NCT00370695|101261804|FG000|12 Weeks Post-activation|Overall Study||2||
48382231|NCT00370695|101261804|FG000|COMPLETED|Overall Study||0||
48382232|NCT00370695|101261804|FG000|NOT COMPLETED|Overall Study||15||
48382233|NCT00426517|101261805|FG000|STARTED|Overall Study||7||
48382234|NCT00426517|101261806|FG001|STARTED|Overall Study||36||
48382235|NCT00426517|101261807|FG002|STARTED|Overall Study||3||
48382236|NCT00426517|101261808|FG003|STARTED|Overall Study||2||
48382237|NCT00426517|101261805|FG000|COMPLETED|Overall Study||7||
48382238|NCT00426517|101261806|FG001|COMPLETED|Overall Study||36||
48382239|NCT00426517|101261807|FG002|COMPLETED|Overall Study||3||
48382240|NCT00426517|101261808|FG003|COMPLETED|Overall Study||2||
48382241|NCT00426517|101261805|FG000|NOT COMPLETED|Overall Study||0||
48382242|NCT00426517|101261806|FG001|NOT COMPLETED|Overall Study||0||
48382243|NCT00426517|101261807|FG002|NOT COMPLETED|Overall Study||0||
48382244|NCT00426517|101261808|FG003|NOT COMPLETED|Overall Study||0||
48382245|NCT02397694|101261809|FG000|STARTED|Double-Blinded Phase||65||
48382246|NCT02397694|101261810|FG001|STARTED|Double-Blinded Phase||33||
48382247|NCT02397694|101261809|FG000|COMPLETED|Double-Blinded Phase||62||
48382248|NCT02397694|101261810|FG001|COMPLETED|Double-Blinded Phase||30||
48382249|NCT02397694|101261809|FG000|NOT COMPLETED|Double-Blinded Phase||3||
48382250|NCT02397694|101261810|FG001|NOT COMPLETED|Double-Blinded Phase||3||
48382251|NCT02397694|101261809|FG000|STARTED|Open Label Extension Phase||62||
48382252|NCT02397694|101261810|FG001|STARTED|Open Label Extension Phase||30||
48382253|NCT02397694|101261809|FG000|COMPLETED|Open Label Extension Phase||54||
48382254|NCT02397694|101261810|FG001|COMPLETED|Open Label Extension Phase||29||
48382255|NCT02397694|101261809|FG000|NOT COMPLETED|Open Label Extension Phase||8||
48382256|NCT02397694|101261810|FG001|NOT COMPLETED|Open Label Extension Phase||1||
48541559|NCT00339144|101662775|FG002|COMPLETED|Overall Study||0||
48541560|NCT00339144|101662773|FG000|NOT COMPLETED|Overall Study||9||
48382257|NCT00330863|101261811|FG000|STARTED|Overall Study||153||
48382258|NCT00330863|101261812|FG001|STARTED|Overall Study||152||
48382259|NCT00330863|101261811|FG000|COMPLETED|Overall Study||72||
48382260|NCT00330863|101261812|FG001|COMPLETED|Overall Study||72||
48382261|NCT00330863|101261811|FG000|NOT COMPLETED|Overall Study||81||
48382262|NCT00330863|101261812|FG001|NOT COMPLETED|Overall Study||80||
48382263|NCT01032993|101261813|FG000|STARTED|Overall Study||19||
48382264|NCT01032993|101261814|FG001|STARTED|Overall Study||20||
48382265|NCT01032993|101261813|FG000|COMPLETED|Overall Study||19||
48382266|NCT01032993|101261814|FG001|COMPLETED|Overall Study||20||
48382267|NCT01032993|101261813|FG000|NOT COMPLETED|Overall Study||0||
48382268|NCT01032993|101261814|FG001|NOT COMPLETED|Overall Study||0||
48382269|NCT03496467|101261815|FG000|STARTED|Overall Study||38||
48382270|NCT03496467|101261816|FG001|STARTED|Overall Study||18||
48382271|NCT03496467|101261815|FG000|COMPLETED|Overall Study||34||
48382272|NCT03496467|101261816|FG001|COMPLETED|Overall Study||14||
48382273|NCT03496467|101261815|FG000|NOT COMPLETED|Overall Study||4||
48382274|NCT03496467|101261816|FG001|NOT COMPLETED|Overall Study||4||
48382275|NCT00509496|101261817|FG000|STARTED|Overall Study||19||
48382276|NCT00509496|101261818|FG001|STARTED|Overall Study||2||
48382277|NCT00509496|101261817|FG000|COMPLETED|Overall Study||19||
48382278|NCT00509496|101261818|FG001|COMPLETED|Overall Study||2||
48382279|NCT00509496|101261817|FG000|NOT COMPLETED|Overall Study||0||
48382280|NCT00509496|101261818|FG001|NOT COMPLETED|Overall Study||0||
48382281|NCT01934894|101261819|FG000|STARTED|Overall Study||6||
48382282|NCT01934894|101261820|FG001|STARTED|Overall Study||5||
48382283|NCT01934894|101261819|FG000|COMPLETED|Overall Study||0||
48382284|NCT01934894|101261820|FG001|COMPLETED|Overall Study||0||
48382285|NCT01934894|101261819|FG000|NOT COMPLETED|Overall Study||6||
48382286|NCT01934894|101261820|FG001|NOT COMPLETED|Overall Study||5||
48382287|NCT02622724|101264976|FG000|STARTED|Overall Study||144|Subjects that received atleast 1 dose of study treatment|
48382288|NCT02622724|101264977|FG001|STARTED|Overall Study||152|Subjects that received atleast 1 dose of study treatment|
48382289|NCT02622724|101264976|FG000|Subjects Randomised|Overall Study||146||
48382290|NCT02622724|101264977|FG001|Subjects Randomised|Overall Study||155||
48687112|NCT02148263|102017016|FG000|COMPLETED|Overall Study||9||
48687113|NCT02148263|102017017|FG001|COMPLETED|Overall Study||11||
48687114|NCT02148263|102017016|FG000|NOT COMPLETED|Overall Study||3||
48687115|NCT02148263|102017017|FG001|NOT COMPLETED|Overall Study||2||
48687116|NCT01135992|102017018|FG000|STARTED|Overall Study||143||
48255418|NCT02736955|100943926|FG001|STARTED|Overall Study||117||
48255419|NCT02736955|100943927|FG002|STARTED|Overall Study||8||
48255420|NCT02736955|100943925|FG000|COMPLETED|Overall Study||29||
48255421|NCT02736955|100943926|FG001|COMPLETED|Overall Study||103||
48255422|NCT02736955|100943927|FG002|COMPLETED|Overall Study||6||
48255423|NCT02736955|100943925|FG000|NOT COMPLETED|Overall Study||7||
48255424|NCT02736955|100943926|FG001|NOT COMPLETED|Overall Study||14||
48255425|NCT02736955|100943927|FG002|NOT COMPLETED|Overall Study||2||
48255426|NCT00887198|100943928|FG000|STARTED|Randomized Period||546||
48255427|NCT00887198|100943929|FG001|STARTED|Randomized Period||542||
48255428|NCT00887198|100943930|FG002|STARTED|Randomized Period||0||
48255429|NCT00887198|100943928|FG000|Treated|Randomized Period||542||
48255430|NCT00887198|100943929|FG001|Treated|Randomized Period||540||
48382291|NCT02622724|101264976|FG000|Short-Term Follow-Up (Day 28)|Overall Study||105||
48382292|NCT02622724|101264977|FG001|Short-Term Follow-Up (Day 28)|Overall Study||115||
48382293|NCT02622724|101264976|FG000|Long-Term Follow-Up (Day 90)|Overall Study||96||
48382294|NCT02622724|101264977|FG001|Long-Term Follow-Up (Day 90)|Overall Study||101||
48382295|NCT02622724|101264976|FG000|Long-Term Follow-Up (Day 180)|Overall Study||73|The study was terminated early|
48382296|NCT02622724|101264977|FG001|Long-Term Follow-Up (Day 180)|Overall Study||74|The study was terminated early|
48382297|NCT02622724|101264976|FG000|COMPLETED|Overall Study||51|Extended Follow-Up (Day 360), but study was terminated early|
48382298|NCT02622724|101264977|FG001|COMPLETED|Overall Study||49|Extended Follow-Up (Day 360), but study was terminated early|
48382299|NCT02622724|101264976|FG000|NOT COMPLETED|Overall Study||93||
48382300|NCT02622724|101264977|FG001|NOT COMPLETED|Overall Study||103||
48687117|NCT01135992|102017018|FG000|Exposed|Overall Study||142||
48687118|NCT01135992|102017018|FG000|Full Analysis Set|Overall Study||129||
48382301|NCT00717366|101264978|FG000|STARTED|Core Study Period (20 Weeks)||16||
48382302|NCT00717366|101264979|FG001|STARTED|Core Study Period (20 Weeks)||48||
48687119|NCT01135992|102017018|FG000|COMPLETED|Overall Study||122||
48255431|NCT00887198|100943930|FG002|Treated|Randomized Period||0||
48255432|NCT00887198|100943928|FG000|COMPLETED|Randomized Period||0||
48255433|NCT00887198|100943929|FG001|COMPLETED|Randomized Period||0||
48255434|NCT00887198|100943930|FG002|COMPLETED|Randomized Period||0||
48382303|NCT00717366|101264978|FG000|COMPLETED|Core Study Period (20 Weeks)||12||
48382304|NCT00717366|101264979|FG001|COMPLETED|Core Study Period (20 Weeks)||35||
48382305|NCT00717366|101264978|FG000|NOT COMPLETED|Core Study Period (20 Weeks)||4||
48382306|NCT00717366|101264979|FG001|NOT COMPLETED|Core Study Period (20 Weeks)||13||
48382307|NCT00717366|101264978|FG000|STARTED|Extension Period (52 Weeks)||9||
48382308|NCT00717366|101264979|FG001|STARTED|Extension Period (52 Weeks)||28||
48382309|NCT00717366|101264978|FG000|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||8||
48382310|NCT00717366|101264979|FG001|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||28||
48382311|NCT00717366|101264978|FG000|COMPLETED|Extension Period (52 Weeks)||5||
48382312|NCT00717366|101264979|FG001|COMPLETED|Extension Period (52 Weeks)||12||
48382313|NCT00717366|101264978|FG000|NOT COMPLETED|Extension Period (52 Weeks)||4||
48382314|NCT00717366|101264979|FG001|NOT COMPLETED|Extension Period (52 Weeks)||16||
48382315|NCT02059213|101264980|FG000|STARTED|Overall Study||20||
48382316|NCT02059213|101264981|FG001|STARTED|Overall Study||42||
48382317|NCT02059213|101264980|FG000|Initiated Treatment|Overall Study||20||
48382318|NCT02059213|101264981|FG001|Initiated Treatment|Overall Study||40||
48382319|NCT02059213|101264980|FG000|COMPLETED|Overall Study||20||
48382320|NCT02059213|101264981|FG001|COMPLETED|Overall Study||40||
48382321|NCT02059213|101264980|FG000|NOT COMPLETED|Overall Study||0||
48382322|NCT02059213|101264981|FG001|NOT COMPLETED|Overall Study||2||
48382323|NCT03488914|101264982|FG000|STARTED|Overall Study||47||
48382324|NCT03488914|101264983|FG001|STARTED|Overall Study||39||
48382325|NCT03488914|101264982|FG000|COMPLETED|Overall Study||47||
48687120|NCT01135992|102017018|FG000|NOT COMPLETED|Overall Study||21||
48382326|NCT03488914|101264983|FG001|COMPLETED|Overall Study||39||
48382327|NCT03488914|101264982|FG000|NOT COMPLETED|Overall Study||0||
48382328|NCT03488914|101264983|FG001|NOT COMPLETED|Overall Study||0||
48382329|NCT03225716|101264984|FG000|STARTED|Overall Study||7||
48382330|NCT03225716|101264985|FG001|STARTED|Overall Study||3||
48382331|NCT03225716|101264986|FG002|STARTED|Overall Study||3||
48382332|NCT03225716|101264984|FG000|COMPLETED|Overall Study||2||
48382333|NCT03225716|101264985|FG001|COMPLETED|Overall Study||1||
48382334|NCT03225716|101264986|FG002|COMPLETED|Overall Study||0||
48382335|NCT03225716|101264984|FG000|NOT COMPLETED|Overall Study||5||
48382336|NCT03225716|101264985|FG001|NOT COMPLETED|Overall Study||2||
48382337|NCT03225716|101264986|FG002|NOT COMPLETED|Overall Study||3||
48382338|NCT02922634|101264987|FG000|STARTED|Overall Study||229||
48382339|NCT02922634|101264987|FG000|COMPLETED|Overall Study||219||
48382340|NCT02922634|101264987|FG000|NOT COMPLETED|Overall Study||10||
48382341|NCT03245723|101264988|FG000|STARTED|Overall Study||32||
48382342|NCT03245723|101264989|FG001|STARTED|Overall Study||18||
48382343|NCT03245723|101264988|FG000|COMPLETED|Overall Study||27||
48382344|NCT03245723|101264989|FG001|COMPLETED|Overall Study||17||
48382345|NCT03245723|101264988|FG000|NOT COMPLETED|Overall Study||5||
48382346|NCT03245723|101264989|FG001|NOT COMPLETED|Overall Study||1||
48382347|NCT00406783|101264990|FG000|STARTED|Overall Study||276||
48382348|NCT00406783|101264991|FG001|STARTED|Overall Study||271||
48382349|NCT00406783|101264990|FG000|COMPLETED|Overall Study||262||
48382350|NCT00406783|101264991|FG001|COMPLETED|Overall Study||256||
48382351|NCT00406783|101264990|FG000|NOT COMPLETED|Overall Study||14||
48382352|NCT00406783|101264991|FG001|NOT COMPLETED|Overall Study||15||
48382353|NCT01093755|101264992|FG000|STARTED|Overall Study||16||
48382354|NCT01093755|101264993|FG001|STARTED|Overall Study||14||
48382355|NCT01093755|101264992|FG000|COMPLETED|Overall Study||13||
48687121|NCT00705874|102017019|FG000|STARTED|Overall Study||12||
48382356|NCT01093755|101264993|FG001|COMPLETED|Overall Study||10||
48382357|NCT01093755|101264992|FG000|NOT COMPLETED|Overall Study||3||
48382358|NCT01093755|101264993|FG001|NOT COMPLETED|Overall Study||4||
48382359|NCT02561299|101264994|FG000|STARTED|Overall Study||32||
48382360|NCT02561299|101264995|FG001|STARTED|Overall Study||34||
48382361|NCT02561299|101264994|FG000|COMPLETED|Overall Study||27||
48382362|NCT02561299|101264995|FG001|COMPLETED|Overall Study||28||
48382363|NCT02561299|101264994|FG000|NOT COMPLETED|Overall Study||5||
48382364|NCT02561299|101264995|FG001|NOT COMPLETED|Overall Study||6||
48382365|NCT05439460|101264996|FG000|STARTED|First Intervention (Approx 5h on Study)||5||
48382366|NCT05439460|101264997|FG001|STARTED|First Intervention (Approx 5h on Study)||0||
48382367|NCT05439460|101264998|FG002|STARTED|First Intervention (Approx 5h on Study)||0||
48382368|NCT05439460|101264996|FG000|COMPLETED|First Intervention (Approx 5h on Study)||5||
48382369|NCT05439460|101264997|FG001|COMPLETED|First Intervention (Approx 5h on Study)||0||
48382370|NCT05439460|101264998|FG002|COMPLETED|First Intervention (Approx 5h on Study)||0||
48382371|NCT05439460|101264996|FG000|NOT COMPLETED|First Intervention (Approx 5h on Study)||0||
48541561|NCT00339144|101662774|FG001|NOT COMPLETED|Overall Study||3||
48541562|NCT00339144|101662775|FG002|NOT COMPLETED|Overall Study||4||
48541563|NCT04015908|101662776|FG000|STARTED|Overall Study||50||
48541564|NCT04015908|101662777|FG001|STARTED|Overall Study||50||
48687122|NCT00705874|102017020|FG001|STARTED|Overall Study||9||
48687123|NCT00705874|102017021|FG002|STARTED|Overall Study||34||
48382372|NCT05439460|101264997|FG001|NOT COMPLETED|First Intervention (Approx 5h on Study)||0||
48382373|NCT05439460|101264998|FG002|NOT COMPLETED|First Intervention (Approx 5h on Study)||0||
48382374|NCT05439460|101264996|FG000|STARTED|Second Intervention (Approx 5h on Study)||0||
48382375|NCT05439460|101264997|FG001|STARTED|Second Intervention (Approx 5h on Study)||5||
48382376|NCT05439460|101264998|FG002|STARTED|Second Intervention (Approx 5h on Study)||0||
48382377|NCT05439460|101264996|FG000|COMPLETED|Second Intervention (Approx 5h on Study)||0||
48382378|NCT05439460|101264997|FG001|COMPLETED|Second Intervention (Approx 5h on Study)||5||
48382379|NCT05439460|101264998|FG002|COMPLETED|Second Intervention (Approx 5h on Study)||0||
48382380|NCT05439460|101264996|FG000|NOT COMPLETED|Second Intervention (Approx 5h on Study)||0||
48382381|NCT05439460|101264997|FG001|NOT COMPLETED|Second Intervention (Approx 5h on Study)||0||
48382382|NCT05439460|101264998|FG002|NOT COMPLETED|Second Intervention (Approx 5h on Study)||0||
48382383|NCT05439460|101264996|FG000|STARTED|Third Intervention (Approx 5h on Study)||0||
48382384|NCT05439460|101264997|FG001|STARTED|Third Intervention (Approx 5h on Study)||0||
48382385|NCT05439460|101264998|FG002|STARTED|Third Intervention (Approx 5h on Study)||5||
48382386|NCT05439460|101264996|FG000|COMPLETED|Third Intervention (Approx 5h on Study)||0||
48382387|NCT05439460|101264997|FG001|COMPLETED|Third Intervention (Approx 5h on Study)||0||
48382388|NCT05439460|101264998|FG002|COMPLETED|Third Intervention (Approx 5h on Study)||5||
48382389|NCT05439460|101264996|FG000|NOT COMPLETED|Third Intervention (Approx 5h on Study)||0||
48382390|NCT05439460|101264997|FG001|NOT COMPLETED|Third Intervention (Approx 5h on Study)||0||
48382391|NCT05439460|101264998|FG002|NOT COMPLETED|Third Intervention (Approx 5h on Study)||0||
48382392|NCT03796182|101264999|FG000|STARTED|Period 1||6||
48382393|NCT03796182|101265000|FG001|STARTED|Period 1||6||
48382394|NCT03796182|101264999|FG000|COMPLETED|Period 1||6||
48687124|NCT00705874|102017022|FG003|STARTED|Overall Study||34||
48382395|NCT03796182|101265000|FG001|COMPLETED|Period 1||6||
48382396|NCT03796182|101264999|FG000|NOT COMPLETED|Period 1||0||
48382397|NCT03796182|101265000|FG001|NOT COMPLETED|Period 1||0||
48382398|NCT03796182|101264999|FG000|STARTED|Washout Period||6||
48382399|NCT03796182|101265000|FG001|STARTED|Washout Period||6||
48382400|NCT03796182|101264999|FG000|COMPLETED|Washout Period||6||
48382401|NCT03796182|101265000|FG001|COMPLETED|Washout Period||6||
48382402|NCT03796182|101264999|FG000|NOT COMPLETED|Washout Period||0||
48382403|NCT03796182|101265000|FG001|NOT COMPLETED|Washout Period||0||
48382404|NCT03796182|101264999|FG000|STARTED|Period 2||6||
48382405|NCT03796182|101265000|FG001|STARTED|Period 2||6||
48382406|NCT03796182|101264999|FG000|COMPLETED|Period 2||6||
48382407|NCT03796182|101265000|FG001|COMPLETED|Period 2||6||
48382408|NCT03796182|101264999|FG000|NOT COMPLETED|Period 2||0||
48382409|NCT03796182|101265000|FG001|NOT COMPLETED|Period 2||0||
48382410|NCT05554471|101265001|FG000|STARTED|Overall Study||177||
48382411|NCT05554471|101265002|FG001|STARTED|Overall Study||93||
48382412|NCT05554471|101265001|FG000|COMPLETED|Overall Study||173||
48382413|NCT05554471|101265002|FG001|COMPLETED|Overall Study||90||
48382414|NCT05554471|101265001|FG000|NOT COMPLETED|Overall Study||4||
48382415|NCT05554471|101265002|FG001|NOT COMPLETED|Overall Study||3||
48382416|NCT00006604|101265003|FG000|STARTED|Overall Study||6||
48382417|NCT00006604|101265004|FG001|STARTED|Overall Study||2||
48382418|NCT00006604|101265005|FG002|STARTED|Overall Study||5||
48382419|NCT00006604|101265006|FG003|STARTED|Overall Study||6||
48382420|NCT00006604|101265007|FG004|STARTED|Overall Study||5||
48382421|NCT00006604|101265008|FG005|STARTED|Overall Study||5||
48382422|NCT00006604|101265009|FG006|STARTED|Overall Study||21||
48382423|NCT00006604|101265010|FG007|STARTED|Overall Study||5||
48382424|NCT00006604|101265011|FG008|STARTED|Overall Study||5||
48382425|NCT00006604|101265012|FG009|STARTED|Overall Study||25||
48382426|NCT00006604|101265013|FG010|STARTED|Overall Study||21||
48382427|NCT00006604|101265014|FG011|STARTED|Overall Study||12||
48382428|NCT00006604|101265015|FG012|STARTED|Overall Study||26||
48382429|NCT00006604|101265016|FG013|STARTED|Overall Study||6||
48382430|NCT00006604|101265017|FG014|STARTED|Overall Study||24||
48382431|NCT00006604|101265018|FG015|STARTED|Overall Study||6||
48382432|NCT00006604|101265019|FG016|STARTED|Overall Study||15||
48382433|NCT00006604|101265003|FG000|COMPLETED|Overall Study||4||
48382434|NCT00006604|101265004|FG001|COMPLETED|Overall Study||2||
48382435|NCT00006604|101265005|FG002|COMPLETED|Overall Study||1||
48382436|NCT00006604|101265006|FG003|COMPLETED|Overall Study||1||
48382437|NCT00006604|101265007|FG004|COMPLETED|Overall Study||3||
48382438|NCT00006604|101265008|FG005|COMPLETED|Overall Study||2||
48382439|NCT00006604|101265009|FG006|COMPLETED|Overall Study||12||
48382440|NCT00006604|101265010|FG007|COMPLETED|Overall Study||2||
48382441|NCT00006604|101265011|FG008|COMPLETED|Overall Study||4||
48382442|NCT00006604|101265012|FG009|COMPLETED|Overall Study||6||
48382443|NCT00006604|101265013|FG010|COMPLETED|Overall Study||13||
48382444|NCT00006604|101265014|FG011|COMPLETED|Overall Study||6||
48382445|NCT00006604|101265015|FG012|COMPLETED|Overall Study||22||
48382446|NCT00006604|101265016|FG013|COMPLETED|Overall Study||0||
48382447|NCT00006604|101265017|FG014|COMPLETED|Overall Study||14||
48382448|NCT00006604|101265018|FG015|COMPLETED|Overall Study||1||
48382449|NCT00006604|101265019|FG016|COMPLETED|Overall Study||6||
48382450|NCT00006604|101265003|FG000|NOT COMPLETED|Overall Study||2||
48382451|NCT00006604|101265004|FG001|NOT COMPLETED|Overall Study||0||
48382452|NCT00006604|101265005|FG002|NOT COMPLETED|Overall Study||4||
48382453|NCT00006604|101265006|FG003|NOT COMPLETED|Overall Study||5||
48382454|NCT00006604|101265007|FG004|NOT COMPLETED|Overall Study||2||
48382455|NCT00006604|101265008|FG005|NOT COMPLETED|Overall Study||3||
48382456|NCT00006604|101265009|FG006|NOT COMPLETED|Overall Study||9||
48382457|NCT00006604|101265010|FG007|NOT COMPLETED|Overall Study||3||
48382458|NCT00006604|101265011|FG008|NOT COMPLETED|Overall Study||1||
48382459|NCT00006604|101265012|FG009|NOT COMPLETED|Overall Study||19||
48382460|NCT00006604|101265013|FG010|NOT COMPLETED|Overall Study||8||
48382461|NCT00006604|101265014|FG011|NOT COMPLETED|Overall Study||6||
48382462|NCT00006604|101265015|FG012|NOT COMPLETED|Overall Study||4||
48382463|NCT00006604|101265016|FG013|NOT COMPLETED|Overall Study||6||
48382464|NCT00006604|101265017|FG014|NOT COMPLETED|Overall Study||10||
48382465|NCT00006604|101265018|FG015|NOT COMPLETED|Overall Study||5||
48382466|NCT00006604|101265019|FG016|NOT COMPLETED|Overall Study||9||
48382467|NCT02156492|101265020|FG000|STARTED|Period 1||16||
48382468|NCT02156492|101265021|FG001|STARTED|Period 1||24||
48382469|NCT02156492|101265022|FG002|STARTED|Period 1||22||
48382470|NCT02156492|101265020|FG000|Received at Least One Dose of Study Drug|Period 1||16||
48382471|NCT02156492|101265021|FG001|Received at Least One Dose of Study Drug|Period 1||24||
48382472|NCT02156492|101265022|FG002|Received at Least One Dose of Study Drug|Period 1||22||
48382473|NCT02156492|101265020|FG000|COMPLETED|Period 1||16||
48382474|NCT02156492|101265021|FG001|COMPLETED|Period 1||23||
48382475|NCT02156492|101265022|FG002|COMPLETED|Period 1||22||
48382476|NCT02156492|101265020|FG000|NOT COMPLETED|Period 1||0||
48382477|NCT02156492|101265021|FG001|NOT COMPLETED|Period 1||1||
48382478|NCT02156492|101265022|FG002|NOT COMPLETED|Period 1||0||
48382479|NCT02156492|101265020|FG000|STARTED|Period 2||16||
48382480|NCT02156492|101265021|FG001|STARTED|Period 2||23||
48687125|NCT00705874|102017023|FG004|STARTED|Overall Study||48||
48255435|NCT00887198|100943928|FG000|NOT COMPLETED|Randomized Period||546||
48255436|NCT00887198|100943929|FG001|NOT COMPLETED|Randomized Period||542||
48255437|NCT00887198|100943930|FG002|NOT COMPLETED|Randomized Period||0||
48255438|NCT00887198|100943928|FG000|STARTED|Cross Over (Placebo to AA)||0||
48255439|NCT00887198|100943929|FG001|STARTED|Cross Over (Placebo to AA)||0||
48255440|NCT00887198|100943930|FG002|STARTED|Cross Over (Placebo to AA)||93||
48255441|NCT00887198|100943928|FG000|COMPLETED|Cross Over (Placebo to AA)||0||
48255442|NCT00887198|100943929|FG001|COMPLETED|Cross Over (Placebo to AA)||0||
48255443|NCT00887198|100943930|FG002|COMPLETED|Cross Over (Placebo to AA)||0||
48255444|NCT00887198|100943928|FG000|NOT COMPLETED|Cross Over (Placebo to AA)||0||
48255445|NCT00887198|100943929|FG001|NOT COMPLETED|Cross Over (Placebo to AA)||0||
48255446|NCT00887198|100943930|FG002|NOT COMPLETED|Cross Over (Placebo to AA)||93||
48255447|NCT01309243|100943931|FG000|STARTED|Randomized Phase Through Week 96||400||
48255448|NCT01309243|100943932|FG001|STARTED|Randomized Phase Through Week 96||399||
48255449|NCT01309243|100943931|FG000|Randomized and Treated|Randomized Phase Through Week 96||394||
48255450|NCT01309243|100943932|FG001|Randomized and Treated|Randomized Phase Through Week 96||392||
48255451|NCT01309243|100943931|FG000|COMPLETED|Randomized Phase Through Week 96||316||
48255452|NCT01309243|100943932|FG001|COMPLETED|Randomized Phase Through Week 96||290||
48255453|NCT01309243|100943931|FG000|NOT COMPLETED|Randomized Phase Through Week 96||84||
48255454|NCT01309243|100943932|FG001|NOT COMPLETED|Randomized Phase Through Week 96||109||
48255455|NCT01309243|100943931|FG000|STARTED|Extension Phase||40||
48255456|NCT01309243|100943932|FG001|STARTED|Extension Phase||117||
48255457|NCT01309243|100943931|FG000|COMPLETED|Extension Phase||34||
48255458|NCT01309243|100943932|FG001|COMPLETED|Extension Phase||117||
48255459|NCT01309243|100943931|FG000|NOT COMPLETED|Extension Phase||6||
48255460|NCT01309243|100943932|FG001|NOT COMPLETED|Extension Phase||0||
48255461|NCT00349622|100943933|FG000|STARTED|Overall Study||340||
48255462|NCT00349622|100943934|FG001|STARTED|Overall Study||173||
48255463|NCT00349622|100943933|FG000|COMPLETED|Overall Study||162||
48255464|NCT00349622|100943934|FG001|COMPLETED|Overall Study||77||
48255465|NCT00349622|100943933|FG000|NOT COMPLETED|Overall Study||178||
48255466|NCT00349622|100943934|FG001|NOT COMPLETED|Overall Study||96||
48255467|NCT02196168|100943935|FG000|STARTED|Overall Study||6||
48255468|NCT02196168|100943936|FG001|STARTED|Overall Study||0||
48255469|NCT02196168|100943935|FG000|COMPLETED|Overall Study||6||
48255470|NCT02196168|100943936|FG001|COMPLETED|Overall Study||0||
48255471|NCT02196168|100943935|FG000|NOT COMPLETED|Overall Study||0||
48255472|NCT02196168|100943936|FG001|NOT COMPLETED|Overall Study||0||
48255473|NCT02383407|100943937|FG000|STARTED|Overall Study||1||
48255474|NCT02383407|100943938|FG001|STARTED|Overall Study||2||
48255475|NCT02383407|100943937|FG000|COMPLETED|Overall Study||1||
48255476|NCT02383407|100943938|FG001|COMPLETED|Overall Study||2||
48255477|NCT02383407|100943937|FG000|NOT COMPLETED|Overall Study||0||
48255478|NCT02383407|100943938|FG001|NOT COMPLETED|Overall Study||0||
48687126|NCT00705874|102017024|FG005|STARTED|Overall Study||32||
48255479|NCT01917006|100943939|FG000|STARTED|Randomized-treatment Period||5||
48255480|NCT01917006|100943940|FG001|STARTED|Randomized-treatment Period||7||
48255481|NCT01917006|100943941|FG002|STARTED|Randomized-treatment Period||8||
48255482|NCT01917006|100943942|FG003|STARTED|Randomized-treatment Period||8||
48255483|NCT01917006|100943943|FG004|STARTED|Randomized-treatment Period||8||
48255484|NCT01917006|100943944|FG005|STARTED|Randomized-treatment Period||8||
48255485|NCT01917006|100943945|FG006|STARTED|Randomized-treatment Period||15||
48255486|NCT01917006|100943946|FG007|STARTED|Randomized-treatment Period||0||
48255487|NCT01917006|100943939|FG000|COMPLETED|Randomized-treatment Period||3||
48255488|NCT01917006|100943940|FG001|COMPLETED|Randomized-treatment Period||7||
48255489|NCT01917006|100943941|FG002|COMPLETED|Randomized-treatment Period||8||
48255490|NCT01917006|100943942|FG003|COMPLETED|Randomized-treatment Period||7||
48255491|NCT01917006|100943943|FG004|COMPLETED|Randomized-treatment Period||8||
48255492|NCT01917006|100943944|FG005|COMPLETED|Randomized-treatment Period||7||
48255493|NCT01917006|100943945|FG006|COMPLETED|Randomized-treatment Period||14||
48255494|NCT01917006|100943946|FG007|COMPLETED|Randomized-treatment Period||0||
48255495|NCT01917006|100943939|FG000|NOT COMPLETED|Randomized-treatment Period||2||
48255496|NCT01917006|100943940|FG001|NOT COMPLETED|Randomized-treatment Period||0||
48255497|NCT01917006|100943941|FG002|NOT COMPLETED|Randomized-treatment Period||0||
48255498|NCT01917006|100943942|FG003|NOT COMPLETED|Randomized-treatment Period||1||
48255499|NCT01917006|100943943|FG004|NOT COMPLETED|Randomized-treatment Period||0||
48255500|NCT01917006|100943944|FG005|NOT COMPLETED|Randomized-treatment Period||1||
48687127|NCT00705874|102017025|FG006|STARTED|Overall Study||3||
48687128|NCT00705874|102017019|FG000|COMPLETED|Overall Study||10||
48255501|NCT01917006|100943945|FG006|NOT COMPLETED|Randomized-treatment Period||1||
48255502|NCT01917006|100943946|FG007|NOT COMPLETED|Randomized-treatment Period||0||
48255503|NCT01917006|100943939|FG000|STARTED|Open-label Period||0||
48255504|NCT01917006|100943940|FG001|STARTED|Open-label Period||0||
48255505|NCT01917006|100943941|FG002|STARTED|Open-label Period||0||
48255506|NCT01917006|100943942|FG003|STARTED|Open-label Period||0||
48255507|NCT01917006|100943943|FG004|STARTED|Open-label Period||0||
48255508|NCT01917006|100943944|FG005|STARTED|Open-label Period||0||
48255509|NCT01917006|100943945|FG006|STARTED|Open-label Period||0||
48687129|NCT00705874|102017020|FG001|COMPLETED|Overall Study||8||
48255510|NCT01917006|100943946|FG007|STARTED|Open-label Period||8||
48255511|NCT01917006|100943939|FG000|COMPLETED|Open-label Period||0||
48255512|NCT01917006|100943940|FG001|COMPLETED|Open-label Period||0||
48255513|NCT01917006|100943941|FG002|COMPLETED|Open-label Period||0||
48255514|NCT01917006|100943942|FG003|COMPLETED|Open-label Period||0||
48255515|NCT01917006|100943943|FG004|COMPLETED|Open-label Period||0||
48255516|NCT01917006|100943944|FG005|COMPLETED|Open-label Period||0||
48255517|NCT01917006|100943945|FG006|COMPLETED|Open-label Period||0||
48255518|NCT01917006|100943946|FG007|COMPLETED|Open-label Period||6||
48255519|NCT01917006|100943939|FG000|NOT COMPLETED|Open-label Period||0||
48255520|NCT01917006|100943940|FG001|NOT COMPLETED|Open-label Period||0||
48255521|NCT01917006|100943941|FG002|NOT COMPLETED|Open-label Period||0||
48255522|NCT01917006|100943942|FG003|NOT COMPLETED|Open-label Period||0||
48255523|NCT01917006|100943943|FG004|NOT COMPLETED|Open-label Period||0||
48255524|NCT01917006|100943944|FG005|NOT COMPLETED|Open-label Period||0||
48255525|NCT01917006|100943945|FG006|NOT COMPLETED|Open-label Period||0||
48255526|NCT01917006|100943946|FG007|NOT COMPLETED|Open-label Period||2||
48255527|NCT01841112|100943947|FG000|STARTED|Single Dose Segment (Day 1)||16||
48255528|NCT01841112|100943948|FG001|STARTED|Single Dose Segment (Day 1)||12||
48255529|NCT01841112|100943949|FG002|STARTED|Single Dose Segment (Day 1)||12||
48382481|NCT02156492|101265022|FG002|STARTED|Period 2||22||
48382482|NCT02156492|101265020|FG000|COMPLETED|Period 2||16||
48382483|NCT02156492|101265021|FG001|COMPLETED|Period 2||23||
48382484|NCT02156492|101265022|FG002|COMPLETED|Period 2||22||
48687130|NCT00705874|102017021|FG002|COMPLETED|Overall Study||32||
48687131|NCT00705874|102017022|FG003|COMPLETED|Overall Study||33||
48687132|NCT00705874|102017023|FG004|COMPLETED|Overall Study||36||
48687133|NCT00705874|102017024|FG005|COMPLETED|Overall Study||28||
48687134|NCT00705874|102017025|FG006|COMPLETED|Overall Study||3||
48255530|NCT01841112|100943950|FG003|STARTED|Single Dose Segment (Day 1)||19||
48255531|NCT01841112|100943951|FG004|STARTED|Single Dose Segment (Day 1)||6||
48255532|NCT01841112|100943947|FG000|COMPLETED|Single Dose Segment (Day 1)||15||
48255533|NCT01841112|100943948|FG001|COMPLETED|Single Dose Segment (Day 1)||11||
48255534|NCT01841112|100943949|FG002|COMPLETED|Single Dose Segment (Day 1)||11||
48255535|NCT01841112|100943950|FG003|COMPLETED|Single Dose Segment (Day 1)||19||
48255536|NCT01841112|100943951|FG004|COMPLETED|Single Dose Segment (Day 1)||6||
48255537|NCT01841112|100943947|FG000|NOT COMPLETED|Single Dose Segment (Day 1)||1||
48255538|NCT01841112|100943948|FG001|NOT COMPLETED|Single Dose Segment (Day 1)||1||
48255539|NCT01841112|100943949|FG002|NOT COMPLETED|Single Dose Segment (Day 1)||1||
48255540|NCT01841112|100943950|FG003|NOT COMPLETED|Single Dose Segment (Day 1)||0||
48255541|NCT01841112|100943951|FG004|NOT COMPLETED|Single Dose Segment (Day 1)||0||
48255542|NCT01841112|100943947|FG000|STARTED|Washout (48 Hours)||0||
48255543|NCT01841112|100943948|FG001|STARTED|Washout (48 Hours)||0||
48255544|NCT01841112|100943949|FG002|STARTED|Washout (48 Hours)||0||
48382485|NCT02156492|101265020|FG000|NOT COMPLETED|Period 2||0||
48382486|NCT02156492|101265021|FG001|NOT COMPLETED|Period 2||0||
48382487|NCT02156492|101265022|FG002|NOT COMPLETED|Period 2||0||
48382488|NCT02156492|101265020|FG000|STARTED|Period 3||0||
48382489|NCT02156492|101265021|FG001|STARTED|Period 3||23||
48382490|NCT02156492|101265022|FG002|STARTED|Period 3||22||
48382491|NCT02156492|101265020|FG000|COMPLETED|Period 3||0||
48382492|NCT02156492|101265021|FG001|COMPLETED|Period 3||22||
48687135|NCT00705874|102017019|FG000|NOT COMPLETED|Overall Study||2||
48687136|NCT00705874|102017020|FG001|NOT COMPLETED|Overall Study||1||
48687137|NCT00705874|102017021|FG002|NOT COMPLETED|Overall Study||2||
48687138|NCT00705874|102017022|FG003|NOT COMPLETED|Overall Study||1||
48687139|NCT00705874|102017023|FG004|NOT COMPLETED|Overall Study||12||
48687140|NCT00705874|102017024|FG005|NOT COMPLETED|Overall Study||4||
48687141|NCT00705874|102017025|FG006|NOT COMPLETED|Overall Study||0||
48687142|NCT02628444|102017026|FG000|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||350|Randomized|
48687143|NCT02628444|102017027|FG001|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||348|Randomized|
48687144|NCT02628444|102017028|FG002|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||352|Randomized|
48687145|NCT02628444|102017029|FG003|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0|Randomized|
48687146|NCT02628444|102017030|FG004|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0|Randomized|
48687147|NCT02628444|102017031|FG005|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0|Randomized|
48687148|NCT02628444|102017032|FG006|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0|Randomized|
48687149|NCT02628444|102017033|FG007|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0|Randomized|
48687150|NCT02628444|102017034|FG008|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0|Randomized|
48687151|NCT02628444|102017026|FG000|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||348||
48687152|NCT02628444|102017027|FG001|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||348||
48687153|NCT02628444|102017028|FG002|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||352||
48687154|NCT02628444|102017029|FG003|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0||
48687155|NCT02628444|102017030|FG004|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0||
48255545|NCT01841112|100943950|FG003|STARTED|Washout (48 Hours)||0||
48255546|NCT01841112|100943951|FG004|STARTED|Washout (48 Hours)||6||
48382493|NCT02156492|101265022|FG002|COMPLETED|Period 3||22||
48255547|NCT01841112|100943947|FG000|COMPLETED|Washout (48 Hours)||0||
48255548|NCT01841112|100943948|FG001|COMPLETED|Washout (48 Hours)||0||
48255549|NCT01841112|100943949|FG002|COMPLETED|Washout (48 Hours)||0||
48255550|NCT01841112|100943950|FG003|COMPLETED|Washout (48 Hours)||0||
48255551|NCT01841112|100943951|FG004|COMPLETED|Washout (48 Hours)||6||
48255552|NCT01841112|100943947|FG000|NOT COMPLETED|Washout (48 Hours)||0||
48255553|NCT01841112|100943948|FG001|NOT COMPLETED|Washout (48 Hours)||0||
48255554|NCT01841112|100943949|FG002|NOT COMPLETED|Washout (48 Hours)||0||
48255555|NCT01841112|100943950|FG003|NOT COMPLETED|Washout (48 Hours)||0||
48255556|NCT01841112|100943951|FG004|NOT COMPLETED|Washout (48 Hours)||0||
48255557|NCT01841112|100943947|FG000|STARTED|Multiple Dose Segment (Days3-9)||0||
48255558|NCT01841112|100943948|FG001|STARTED|Multiple Dose Segment (Days3-9)||0||
48255559|NCT01841112|100943949|FG002|STARTED|Multiple Dose Segment (Days3-9)||0||
48255560|NCT01841112|100943950|FG003|STARTED|Multiple Dose Segment (Days3-9)||0||
48255561|NCT01841112|100943951|FG004|STARTED|Multiple Dose Segment (Days3-9)||6||
48255562|NCT01841112|100943947|FG000|COMPLETED|Multiple Dose Segment (Days3-9)||0||
48255563|NCT01841112|100943948|FG001|COMPLETED|Multiple Dose Segment (Days3-9)||0||
48255564|NCT01841112|100943949|FG002|COMPLETED|Multiple Dose Segment (Days3-9)||0||
48255565|NCT01841112|100943950|FG003|COMPLETED|Multiple Dose Segment (Days3-9)||0||
48091191|NCT01700725|100545709|FG001|NOT COMPLETED|Overall Study||0||
48091192|NCT01700725|100545710|FG002|NOT COMPLETED|Overall Study||0||
48091193|NCT01898611|100545711|FG000|STARTED|Overall Study||5||
48091194|NCT01898611|100545712|FG001|STARTED|Overall Study||11||
48091195|NCT01898611|100545711|FG000|COMPLETED|Overall Study||5||
48091196|NCT01898611|100545712|FG001|COMPLETED|Overall Study||10||
48091197|NCT01898611|100545711|FG000|NOT COMPLETED|Overall Study||0||
48091198|NCT01898611|100545712|FG001|NOT COMPLETED|Overall Study||1||
48091199|NCT02192814|100545713|FG000|STARTED|Overall Study||9||
48091200|NCT02192814|100545713|FG000|COMPLETED|Overall Study||9||
48091201|NCT02192814|100545713|FG000|NOT COMPLETED|Overall Study||0||
48091202|NCT01551082|100545714|FG000|STARTED|Overall Study||12||
48091203|NCT01551082|100545714|FG000|COMPLETED|Overall Study||12||
48091204|NCT01551082|100545714|FG000|NOT COMPLETED|Overall Study||0||
48091205|NCT02626520|100545715|FG000|STARTED|Overall Study||1||
48091206|NCT02626520|100545716|FG001|STARTED|Overall Study||10||
48091207|NCT02626520|100545715|FG000|COMPLETED|Overall Study||0||
48091208|NCT02626520|100545716|FG001|COMPLETED|Overall Study||0||
48091209|NCT02626520|100545715|FG000|NOT COMPLETED|Overall Study||1||
48091210|NCT02626520|100545716|FG001|NOT COMPLETED|Overall Study||10||
48091211|NCT01244906|100545717|FG000|STARTED|Overall Study||26||
48091212|NCT01244906|100545717|FG000|COMPLETED|Overall Study||18||
48091213|NCT01244906|100545717|FG000|NOT COMPLETED|Overall Study||8||
48091214|NCT03931291|100545718|FG000|STARTED|Overall Study||33||
48091215|NCT03931291|100545718|FG000|COMPLETED|Overall Study||33||
48091216|NCT03931291|100545718|FG000|NOT COMPLETED|Overall Study||0||
48091217|NCT02111850|100545719|FG000|STARTED|Phase 1 Dose Escalation||1||
48091218|NCT02111850|100545720|FG001|STARTED|Phase 1 Dose Escalation||1||
48091219|NCT02111850|100545721|FG002|STARTED|Phase 1 Dose Escalation||1||
48091220|NCT02111850|100545722|FG003|STARTED|Phase 1 Dose Escalation||1||
48091221|NCT02111850|100545723|FG004|STARTED|Phase 1 Dose Escalation||2||
48091222|NCT02111850|100545724|FG005|STARTED|Phase 1 Dose Escalation||1||
48091223|NCT02111850|100545725|FG006|STARTED|Phase 1 Dose Escalation||1||
48091224|NCT02111850|100545726|FG007|STARTED|Phase 1 Dose Escalation||1||
48091225|NCT02111850|100545727|FG008|STARTED|Phase 1 Dose Escalation||6||
48255566|NCT01841112|100943951|FG004|COMPLETED|Multiple Dose Segment (Days3-9)||6||
48255567|NCT01841112|100943947|FG000|NOT COMPLETED|Multiple Dose Segment (Days3-9)||0||
48255568|NCT01841112|100943948|FG001|NOT COMPLETED|Multiple Dose Segment (Days3-9)||0||
48091226|NCT02111850|100545728|FG009|STARTED|Phase 1 Dose Escalation||0||
48091227|NCT02111850|100545729|FG010|STARTED|Phase 1 Dose Escalation||0||
48091228|NCT02111850|100545719|FG000|COMPLETED|Phase 1 Dose Escalation||1||
48091229|NCT02111850|100545720|FG001|COMPLETED|Phase 1 Dose Escalation||1||
48091230|NCT02111850|100545721|FG002|COMPLETED|Phase 1 Dose Escalation||1||
48091231|NCT02111850|100545722|FG003|COMPLETED|Phase 1 Dose Escalation||1||
48091232|NCT02111850|100545723|FG004|COMPLETED|Phase 1 Dose Escalation||1||
48091233|NCT02111850|100545724|FG005|COMPLETED|Phase 1 Dose Escalation||1||
48091234|NCT02111850|100545725|FG006|COMPLETED|Phase 1 Dose Escalation||1||
48091235|NCT02111850|100545726|FG007|COMPLETED|Phase 1 Dose Escalation||1||
48091236|NCT02111850|100545727|FG008|COMPLETED|Phase 1 Dose Escalation||6||
48255569|NCT01841112|100943949|FG002|NOT COMPLETED|Multiple Dose Segment (Days3-9)||0||
48255570|NCT01841112|100943950|FG003|NOT COMPLETED|Multiple Dose Segment (Days3-9)||0||
48255571|NCT01841112|100943951|FG004|NOT COMPLETED|Multiple Dose Segment (Days3-9)||0||
48255572|NCT02204319|100943952|FG000|STARTED|Overall Study||10||
48255573|NCT02204319|100943952|FG000|COMPLETED|Overall Study||7||
48255574|NCT02204319|100943952|FG000|NOT COMPLETED|Overall Study||3||
48255575|NCT02282059|100943953|FG000|STARTED|Overall Study||82||
48255576|NCT02282059|100943954|FG001|STARTED|Overall Study||18||
48255577|NCT02282059|100943953|FG000|Treated|Overall Study||81|One participant (not taken sunitinib before) who had been assigned to the study treatment was not treated and therefore excluded from the study analysis.|
48255578|NCT02282059|100943954|FG001|Treated|Overall Study||18|One participant (not taken sunitinib before) who had been assigned to the study treatment was not treated and therefore excluded from the study analysis.|
48255579|NCT02282059|100943953|FG000|Discontinued|Overall Study||82|Discontinued participants included those who completed minimum 5-year follow-up since they have been assigned to the study treatment.|
48255580|NCT02282059|100943954|FG001|Discontinued|Overall Study||18|Discontinued participants included those who completed minimum 5-year follow-up since they have been assigned to the study treatment.|
48255581|NCT02282059|100943953|FG000|COMPLETED|Overall Study||0||
48255582|NCT02282059|100943954|FG001|COMPLETED|Overall Study||0||
48255583|NCT02282059|100943953|FG000|NOT COMPLETED|Overall Study||82||
48255584|NCT02282059|100943954|FG001|NOT COMPLETED|Overall Study||18||
48255585|NCT01009138|100943955|FG000|STARTED|Overall Study||106||
48255586|NCT01009138|100943956|FG001|STARTED|Overall Study||108||
48255587|NCT01009138|100943955|FG000|COMPLETED|Overall Study||93||
48255588|NCT01009138|100943956|FG001|COMPLETED|Overall Study||88||
48255589|NCT01009138|100943955|FG000|NOT COMPLETED|Overall Study||13||
48255590|NCT01009138|100943956|FG001|NOT COMPLETED|Overall Study||20||
48255591|NCT04517877|100943957|FG000|STARTED|Overall Study||82||
48255592|NCT04517877|100943958|FG001|STARTED|Overall Study||82||
48255593|NCT04517877|100943957|FG000|COMPLETED|Overall Study||63||
48255594|NCT04517877|100943958|FG001|COMPLETED|Overall Study||58||
48255595|NCT04517877|100943957|FG000|NOT COMPLETED|Overall Study||19||
48255596|NCT04517877|100943958|FG001|NOT COMPLETED|Overall Study||24||
48255597|NCT00677092|100943959|FG000|STARTED|Overall Study||12||
48255598|NCT00677092|100943959|FG000|Received Study Treatment|Overall Study||11||
48255599|NCT00677092|100943959|FG000|COMPLETED|Overall Study||6||
48255600|NCT00677092|100943959|FG000|NOT COMPLETED|Overall Study||6||
48255601|NCT02104505|100943960|FG000|STARTED|First Intervention (14 Days)||12||
48255602|NCT02104505|100943961|FG001|STARTED|First Intervention (14 Days)||11||
48255603|NCT02104505|100943960|FG000|COMPLETED|First Intervention (14 Days)||10||
48255604|NCT02104505|100943961|FG001|COMPLETED|First Intervention (14 Days)||8||
48255605|NCT02104505|100943960|FG000|NOT COMPLETED|First Intervention (14 Days)||2||
48255606|NCT02104505|100943961|FG001|NOT COMPLETED|First Intervention (14 Days)||3||
48255607|NCT02104505|100943960|FG000|STARTED|Washout (Minimum 3 Weeks)||10||
48255608|NCT02104505|100943961|FG001|STARTED|Washout (Minimum 3 Weeks)||8||
48255609|NCT02104505|100943960|FG000|COMPLETED|Washout (Minimum 3 Weeks)||10||
48255610|NCT02104505|100943961|FG001|COMPLETED|Washout (Minimum 3 Weeks)||8||
48255611|NCT02104505|100943960|FG000|NOT COMPLETED|Washout (Minimum 3 Weeks)||0||
48255612|NCT02104505|100943961|FG001|NOT COMPLETED|Washout (Minimum 3 Weeks)||0||
48255613|NCT02104505|100943960|FG000|STARTED|Second Intervention (14 Days)||10||
48255614|NCT02104505|100943961|FG001|STARTED|Second Intervention (14 Days)||8||
48255615|NCT02104505|100943960|FG000|COMPLETED|Second Intervention (14 Days)||8||
48255616|NCT02104505|100943961|FG001|COMPLETED|Second Intervention (14 Days)||7||
48255617|NCT02104505|100943960|FG000|NOT COMPLETED|Second Intervention (14 Days)||2||
48255618|NCT02104505|100943961|FG001|NOT COMPLETED|Second Intervention (14 Days)||1||
48255619|NCT03536702|100943962|FG000|STARTED|Overall Study||40||
48255620|NCT03536702|100943963|FG001|STARTED|Overall Study||20||
48255621|NCT03536702|100943962|FG000|COMPLETED|Overall Study||26|Competers are those who signed consent took baseline measures and at least one class|
48255622|NCT03536702|100943963|FG001|COMPLETED|Overall Study||8|Competers are those who signed consent took baseline measures and at least one class|
48255623|NCT03536702|100943962|FG000|NOT COMPLETED|Overall Study||14||
48255624|NCT03536702|100943963|FG001|NOT COMPLETED|Overall Study||12||
48255625|NCT01709123|100943964|FG000|STARTED|Overall Study||31||
48255626|NCT01709123|100943965|FG001|STARTED|Overall Study||31||
48255627|NCT01709123|100943964|FG000|COMPLETED|Overall Study||22||
48255628|NCT01709123|100943965|FG001|COMPLETED|Overall Study||22||
48255629|NCT01709123|100943964|FG000|NOT COMPLETED|Overall Study||9||
48255630|NCT01709123|100943965|FG001|NOT COMPLETED|Overall Study||9||
48255631|NCT00637247|100943966|FG000|STARTED|Overall Study||72||
48382494|NCT02156492|101265020|FG000|NOT COMPLETED|Period 3||0||
48382495|NCT02156492|101265021|FG001|NOT COMPLETED|Period 3||1||
48382496|NCT02156492|101265022|FG002|NOT COMPLETED|Period 3||0||
48382497|NCT03115476|101265023|FG000|STARTED|Main Trials (LP0084-119x)||407|Total number of subjects that started in Main Trials LP0084-1193, -1194, -1195, -1196 (LP0084-119x)|
48382498|NCT03115476|101265024|FG001|STARTED|Main Trials (LP0084-119x)||418|Total number of subjects that started in Main Trials LP0084-1193, -1194, -1195, -1196 (LP0084-119x)|
48382499|NCT03115476|101265025|FG002|STARTED|Main Trials (LP0084-119x)||409|Total number of subjects that started in Main Trials LP0084-1193, -1194, -1195, -1196 (LP0084-119x)|
48687156|NCT02628444|102017031|FG005|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0||
48687157|NCT02628444|102017032|FG006|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0||
48687158|NCT02628444|102017033|FG007|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0||
48687159|NCT02628444|102017034|FG008|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0||
48687160|NCT02628444|102017026|FG000|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||333|FAS population included participants who had received either at least 1 injection of CYD dengue vaccine or placebo; and had at least 1 blood sample drawn and valid post-vaccination serology results.|
48687161|NCT02628444|102017027|FG001|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||328|FAS population included participants who had received either at least 1 injection of CYD dengue vaccine or placebo; and had at least 1 blood sample drawn and valid post-vaccination serology results.|
48687162|NCT02628444|102017028|FG002|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||332|FAS population included participants who had received either at least 1 injection of CYD dengue vaccine or placebo; and had at least 1 blood sample drawn and valid post-vaccination serology results.|
48687163|NCT02628444|102017029|FG003|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0|FAS population included participants who had received either at least 1 injection of CYD dengue vaccine or placebo; and had at least 1 blood sample drawn and valid post-vaccination serology results.|
48710700|NCT00846040|102077994|FG001|COMPLETED|Washout: 2 Weeks to 10 Weeks||8||
48710701|NCT00846040|102077995|FG002|COMPLETED|Washout: 2 Weeks to 10 Weeks||0||
48255632|NCT00637247|100943967|FG001|STARTED|Overall Study||70||
48255633|NCT00637247|100943966|FG000|COMPLETED|Overall Study||72||
48255634|NCT00637247|100943967|FG001|COMPLETED|Overall Study||70||
48255635|NCT00637247|100943966|FG000|NOT COMPLETED|Overall Study||0||
48255636|NCT00637247|100943967|FG001|NOT COMPLETED|Overall Study||0||
48255637|NCT00092521|100943968|FG000|STARTED|Vaccination (Day 1 Through Month 7)||2723||
48255638|NCT00092521|100943969|FG001|STARTED|Vaccination (Day 1 Through Month 7)||304||
48255639|NCT00092521|100943970|FG002|STARTED|Vaccination (Day 1 Through Month 7)||2732||
48255640|NCT00092521|100943971|FG003|STARTED|Vaccination (Day 1 Through Month 7)||0||
48255641|NCT00092521|100943968|FG000|COMPLETED|Vaccination (Day 1 Through Month 7)||2583||
48382500|NCT03115476|101265023|FG000|COMPLETED|Main Trials (LP0084-119x)||407||
48382501|NCT03115476|101265024|FG001|COMPLETED|Main Trials (LP0084-119x)||418||
48382502|NCT03115476|101265025|FG002|COMPLETED|Main Trials (LP0084-119x)||409||
48382503|NCT03115476|101265023|FG000|NOT COMPLETED|Main Trials (LP0084-119x)||0||
48382504|NCT03115476|101265024|FG001|NOT COMPLETED|Main Trials (LP0084-119x)||0||
48382505|NCT03115476|101265025|FG002|NOT COMPLETED|Main Trials (LP0084-119x)||0||
48382506|NCT03115476|101265023|FG000|STARTED|LP0084-1369||191|"Number of subjects that continued into this extension trial LP0084-1369 from the Main trials"|
48382507|NCT03115476|101265024|FG001|STARTED|LP0084-1369||210|"Number of subjects that continued into this extension trial LP0084-1369 from the Main trials"|
48382508|NCT03115476|101265025|FG002|STARTED|LP0084-1369||162|"Number of subjects that continued into this extension trial LP0084-1369 from the Main trials"|
48382509|NCT03115476|101265023|FG000|COMPLETED|LP0084-1369||0||
48382510|NCT03115476|101265024|FG001|COMPLETED|LP0084-1369||0||
48382511|NCT03115476|101265025|FG002|COMPLETED|LP0084-1369||0||
48382512|NCT03115476|101265023|FG000|NOT COMPLETED|LP0084-1369||191||
48255642|NCT00092521|100943969|FG001|COMPLETED|Vaccination (Day 1 Through Month 7)||290||
48255643|NCT00092521|100943970|FG002|COMPLETED|Vaccination (Day 1 Through Month 7)||2586||
48255644|NCT00092521|100943971|FG003|COMPLETED|Vaccination (Day 1 Through Month 7)||0||
48255645|NCT00092521|100943968|FG000|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||140||
48255646|NCT00092521|100943969|FG001|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||14||
48255647|NCT00092521|100943970|FG002|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||146||
48255648|NCT00092521|100943971|FG003|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||0||
48255649|NCT00092521|100943968|FG000|STARTED|Follow-Up (After Month 7)||2599||
48255650|NCT00092521|100943969|FG001|STARTED|Follow-Up (After Month 7)||291||
48255651|NCT00092521|100943970|FG002|STARTED|Follow-Up (After Month 7)||2607||
48255652|NCT00092521|100943971|FG003|STARTED|Follow-Up (After Month 7)||0||
48255653|NCT00092521|100943968|FG000|COMPLETED|Follow-Up (After Month 7)||2353||
48255654|NCT00092521|100943969|FG001|COMPLETED|Follow-Up (After Month 7)||155||
48255655|NCT00092521|100943970|FG002|COMPLETED|Follow-Up (After Month 7)||1959||
48382513|NCT03115476|101265024|FG001|NOT COMPLETED|LP0084-1369||210||
48091237|NCT02111850|100545728|FG009|COMPLETED|Phase 1 Dose Escalation||0||
48091238|NCT02111850|100545729|FG010|COMPLETED|Phase 1 Dose Escalation||0||
48091239|NCT02111850|100545719|FG000|NOT COMPLETED|Phase 1 Dose Escalation||0||
48091240|NCT02111850|100545720|FG001|NOT COMPLETED|Phase 1 Dose Escalation||0||
48091241|NCT02111850|100545721|FG002|NOT COMPLETED|Phase 1 Dose Escalation||0||
48091242|NCT02111850|100545722|FG003|NOT COMPLETED|Phase 1 Dose Escalation||0||
48091243|NCT02111850|100545723|FG004|NOT COMPLETED|Phase 1 Dose Escalation||1||
48091244|NCT02111850|100545724|FG005|NOT COMPLETED|Phase 1 Dose Escalation||0||
48091245|NCT02111850|100545725|FG006|NOT COMPLETED|Phase 1 Dose Escalation||0||
48091246|NCT02111850|100545726|FG007|NOT COMPLETED|Phase 1 Dose Escalation||0||
48091247|NCT02111850|100545727|FG008|NOT COMPLETED|Phase 1 Dose Escalation||0||
48091248|NCT02111850|100545728|FG009|NOT COMPLETED|Phase 1 Dose Escalation||0||
48091249|NCT02111850|100545729|FG010|NOT COMPLETED|Phase 1 Dose Escalation||0||
48091250|NCT02111850|100545719|FG000|STARTED|Phase 2 Maximum Tolerated Dose||0||
48091251|NCT02111850|100545720|FG001|STARTED|Phase 2 Maximum Tolerated Dose||0||
48091252|NCT02111850|100545721|FG002|STARTED|Phase 2 Maximum Tolerated Dose||0||
48091253|NCT02111850|100545722|FG003|STARTED|Phase 2 Maximum Tolerated Dose||0||
48091254|NCT02111850|100545723|FG004|STARTED|Phase 2 Maximum Tolerated Dose||0||
48091255|NCT02111850|100545724|FG005|STARTED|Phase 2 Maximum Tolerated Dose||0||
48091256|NCT02111850|100545725|FG006|STARTED|Phase 2 Maximum Tolerated Dose||0||
48091257|NCT02111850|100545726|FG007|STARTED|Phase 2 Maximum Tolerated Dose||0||
48091258|NCT02111850|100545727|FG008|STARTED|Phase 2 Maximum Tolerated Dose||0||
48091259|NCT02111850|100545728|FG009|STARTED|Phase 2 Maximum Tolerated Dose||5||
48687164|NCT02628444|102017030|FG004|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0|FAS population included participants who had received either at least 1 injection of CYD dengue vaccine or placebo; and had at least 1 blood sample drawn and valid post-vaccination serology results.|
48687165|NCT02628444|102017031|FG005|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0|FAS population included participants who had received either at least 1 injection of CYD dengue vaccine or placebo; and had at least 1 blood sample drawn and valid post-vaccination serology results.|
48687166|NCT02628444|102017032|FG006|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0|FAS population included participants who had received either at least 1 injection of CYD dengue vaccine or placebo; and had at least 1 blood sample drawn and valid post-vaccination serology results.|
48687167|NCT02628444|102017033|FG007|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0|FAS population included participants who had received either at least 1 injection of CYD dengue vaccine or placebo; and had at least 1 blood sample drawn and valid post-vaccination serology results.|
48687168|NCT02628444|102017034|FG008|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0|FAS population included participants who had received either at least 1 injection of CYD dengue vaccine or placebo; and had at least 1 blood sample drawn and valid post-vaccination serology results.|
48687169|NCT02628444|102017026|FG000|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||314||
48687170|NCT02628444|102017027|FG001|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||309||
48687171|NCT02628444|102017028|FG002|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||310||
48382514|NCT03115476|101265025|FG002|NOT COMPLETED|LP0084-1369||162||
48382515|NCT01265420|101265026|FG000|STARTED|Overall Study||7||
48382516|NCT01265420|101265026|FG000|COMPLETED|Overall Study||6||
48382517|NCT01265420|101265026|FG000|NOT COMPLETED|Overall Study||1||
48382518|NCT00343291|101265027|FG000|STARTED|Overall Study||60||
48382519|NCT00343291|101265028|FG001|STARTED|Overall Study||61||
48382520|NCT00343291|101265027|FG000|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58||
48382521|NCT00343291|101265028|FG001|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58||
48382522|NCT00343291|101265027|FG000|COMPLETED|Overall Study||3||
48382523|NCT00343291|101265028|FG001|COMPLETED|Overall Study||5||
48382524|NCT00343291|101265027|FG000|NOT COMPLETED|Overall Study||57||
48382525|NCT00343291|101265028|FG001|NOT COMPLETED|Overall Study||56||
48382526|NCT03076190|101265029|FG000|STARTED|Overall Study||50||
48382527|NCT03076190|101265030|FG001|STARTED|Overall Study||77||
48382528|NCT03076190|101265029|FG000|COMPLETED|Overall Study||32||
48382529|NCT03076190|101265030|FG001|COMPLETED|Overall Study||36||
48091260|NCT02111850|100545729|FG010|STARTED|Phase 2 Maximum Tolerated Dose||1||
48091261|NCT02111850|100545719|FG000|COMPLETED|Phase 2 Maximum Tolerated Dose||0||
48091262|NCT02111850|100545720|FG001|COMPLETED|Phase 2 Maximum Tolerated Dose||0||
48091263|NCT02111850|100545721|FG002|COMPLETED|Phase 2 Maximum Tolerated Dose||0||
48091264|NCT02111850|100545722|FG003|COMPLETED|Phase 2 Maximum Tolerated Dose||0||
48091265|NCT02111850|100545723|FG004|COMPLETED|Phase 2 Maximum Tolerated Dose||0||
48091266|NCT02111850|100545724|FG005|COMPLETED|Phase 2 Maximum Tolerated Dose||0||
48091267|NCT02111850|100545725|FG006|COMPLETED|Phase 2 Maximum Tolerated Dose||0||
48091268|NCT02111850|100545726|FG007|COMPLETED|Phase 2 Maximum Tolerated Dose||0||
48091269|NCT02111850|100545727|FG008|COMPLETED|Phase 2 Maximum Tolerated Dose||0||
48255656|NCT00092521|100943971|FG003|COMPLETED|Follow-Up (After Month 7)||0||
48255657|NCT00092521|100943968|FG000|NOT COMPLETED|Follow-Up (After Month 7)||246||
48255658|NCT00092521|100943969|FG001|NOT COMPLETED|Follow-Up (After Month 7)||136||
48255659|NCT00092521|100943970|FG002|NOT COMPLETED|Follow-Up (After Month 7)||648||
48255660|NCT00092521|100943971|FG003|NOT COMPLETED|Follow-Up (After Month 7)||0||
48255661|NCT00092521|100943968|FG000|STARTED|Extension Study (Group 4)||0||
48255662|NCT00092521|100943969|FG001|STARTED|Extension Study (Group 4)||0||
48382530|NCT03076190|101265029|FG000|NOT COMPLETED|Overall Study||18||
48687172|NCT02628444|102017029|FG003|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0||
48382531|NCT03076190|101265030|FG001|NOT COMPLETED|Overall Study||41||
48382532|NCT00667251|101265031|FG000|STARTED|Overall Study||326||
48382533|NCT00667251|101265032|FG001|STARTED|Overall Study||326||
48382534|NCT00667251|101265031|FG000|Combination Rx|Overall Study||322||
48382535|NCT00667251|101265032|FG001|Combination Rx|Overall Study||325||
48382536|NCT00667251|101265031|FG000|Monotherapy|Overall Study||225||
48382537|NCT00667251|101265032|FG001|Monotherapy|Overall Study||232||
48382538|NCT00667251|101265031|FG000|Not Started|Overall Study||4||
48382539|NCT00667251|101265032|FG001|Not Started|Overall Study||1||
48382540|NCT00667251|101265031|FG000|COMPLETED|Overall Study||256||
48382541|NCT00667251|101265032|FG001|COMPLETED|Overall Study||231||
48382542|NCT00667251|101265031|FG000|NOT COMPLETED|Overall Study||70||
48382543|NCT00667251|101265032|FG001|NOT COMPLETED|Overall Study||95||
48382544|NCT01948388|101265033|FG000|STARTED|Overall Study||10||
48382545|NCT01948388|101265034|FG001|STARTED|Overall Study||10||
48382546|NCT01948388|101265033|FG000|COMPLETED|Overall Study||8||
48382547|NCT01948388|101265034|FG001|COMPLETED|Overall Study||9||
48382548|NCT01948388|101265033|FG000|NOT COMPLETED|Overall Study||2||
48687173|NCT02628444|102017030|FG004|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0||
48687174|NCT02628444|102017031|FG005|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0||
48687175|NCT02628444|102017032|FG006|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0||
48687176|NCT02628444|102017033|FG007|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0||
48687177|NCT02628444|102017034|FG008|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0||
48687178|NCT02628444|102017026|FG000|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||36||
48687179|NCT02628444|102017027|FG001|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||39||
48687180|NCT02628444|102017028|FG002|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||42||
48687181|NCT02628444|102017029|FG003|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0||
48687182|NCT02628444|102017030|FG004|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0||
48687183|NCT02628444|102017031|FG005|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0||
48687184|NCT02628444|102017032|FG006|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0||
48687185|NCT02628444|102017033|FG007|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0||
48687186|NCT02628444|102017034|FG008|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0||
48687187|NCT02628444|102017026|FG000|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||0|Started indicates the number of participants who were enrolled and randomized dengue seropositive subjects at baseline.|
48687188|NCT02628444|102017027|FG001|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||0|Started indicates the number of participants who were enrolled and randomized dengue seropositive subjects at baseline.|
48687189|NCT02628444|102017028|FG002|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||0|Started indicates the number of participants who were enrolled and randomized dengue seropositive subjects at baseline.|
48687190|NCT02628444|102017029|FG003|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||145|Started indicates the number of participants who were enrolled and randomized dengue seropositive subjects at baseline.|
48687191|NCT02628444|102017030|FG004|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||152|Started indicates the number of participants who were enrolled and randomized dengue seropositive subjects at baseline.|
48687192|NCT02628444|102017031|FG005|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||157|Started indicates the number of participants who were enrolled and randomized dengue seropositive subjects at baseline.|
48687193|NCT02628444|102017032|FG006|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||149|Started indicates the number of participants who were enrolled and randomized dengue seropositive subjects at baseline.|
48710702|NCT00846040|102077993|FG000|NOT COMPLETED|Washout: 2 Weeks to 10 Weeks||0||
48255663|NCT00092521|100943970|FG002|STARTED|Extension Study (Group 4)||0||
48255664|NCT00092521|100943971|FG003|STARTED|Extension Study (Group 4)||844||
48255665|NCT00092521|100943968|FG000|Initiated Extension Study|Extension Study (Group 4)||0||
48255666|NCT00092521|100943969|FG001|Initiated Extension Study|Extension Study (Group 4)||0||
48255667|NCT00092521|100943970|FG002|Initiated Extension Study|Extension Study (Group 4)||0||
48255668|NCT00092521|100943971|FG003|Initiated Extension Study|Extension Study (Group 4)||829||
48255669|NCT00092521|100943968|FG000|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0||
48255670|NCT00092521|100943969|FG001|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0||
48255671|NCT00092521|100943970|FG002|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0||
48255672|NCT00092521|100943971|FG003|Received >=1 Dose in Extension Study|Extension Study (Group 4)||801||
48382549|NCT01948388|101265034|FG001|NOT COMPLETED|Overall Study||1||
48382550|NCT01722487|101265035|FG000|STARTED|Overall Study||136||
48382551|NCT01722487|101265036|FG001|STARTED|Overall Study||133||
48255673|NCT00092521|100943968|FG000|COMPLETED|Extension Study (Group 4)||0||
48255674|NCT00092521|100943969|FG001|COMPLETED|Extension Study (Group 4)||0||
48255675|NCT00092521|100943970|FG002|COMPLETED|Extension Study (Group 4)||0||
48255676|NCT00092521|100943971|FG003|COMPLETED|Extension Study (Group 4)||635||
48255677|NCT00092521|100943968|FG000|NOT COMPLETED|Extension Study (Group 4)||0||
48255678|NCT00092521|100943969|FG001|NOT COMPLETED|Extension Study (Group 4)||0||
48255679|NCT00092521|100943970|FG002|NOT COMPLETED|Extension Study (Group 4)||0||
48255680|NCT00092521|100943971|FG003|NOT COMPLETED|Extension Study (Group 4)||209||
48255681|NCT01586975|100943972|FG000|STARTED|Overall Study||15||
48255682|NCT01586975|100943973|FG001|STARTED|Overall Study||32||
48382552|NCT01722487|101265035|FG000|COMPLETED|Overall Study||134||
48382553|NCT01722487|101265036|FG001|COMPLETED|Overall Study||126||
48687194|NCT02628444|102017033|FG007|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||152|Started indicates the number of participants who were enrolled and randomized dengue seropositive subjects at baseline.|
48687195|NCT02628444|102017034|FG008|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||151|Started indicates the number of participants who were enrolled and randomized dengue seropositive subjects at baseline.|
48687196|NCT02628444|102017026|FG000|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||0||
48687197|NCT02628444|102017027|FG001|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||0||
48687198|NCT02628444|102017028|FG002|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||0||
48687199|NCT02628444|102017029|FG003|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||55||
48687200|NCT02628444|102017030|FG004|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||59||
48687201|NCT02628444|102017031|FG005|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||62||
48687202|NCT02628444|102017032|FG006|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||53||
48687203|NCT02628444|102017033|FG007|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||56||
48687204|NCT02628444|102017034|FG008|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||53||
48687205|NCT02628444|102017026|FG000|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0||
48687206|NCT02628444|102017027|FG001|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0||
48687207|NCT02628444|102017028|FG002|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0||
48687208|NCT02628444|102017029|FG003|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||55||
48687209|NCT02628444|102017030|FG004|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||59||
48541565|NCT04015908|101662776|FG000|COMPLETED|Overall Study||50||
48687210|NCT02628444|102017031|FG005|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||62||
48687211|NCT02628444|102017032|FG006|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||53||
48687212|NCT02628444|102017033|FG007|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||54||
48091270|NCT02111850|100545728|FG009|COMPLETED|Phase 2 Maximum Tolerated Dose||5||
48091271|NCT02111850|100545729|FG010|COMPLETED|Phase 2 Maximum Tolerated Dose||1||
48091272|NCT02111850|100545719|FG000|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0||
48091273|NCT02111850|100545720|FG001|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0||
48091274|NCT02111850|100545721|FG002|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0||
48091275|NCT02111850|100545722|FG003|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0||
48091276|NCT02111850|100545723|FG004|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0||
48091277|NCT02111850|100545724|FG005|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0||
48091278|NCT02111850|100545725|FG006|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0||
48091279|NCT02111850|100545726|FG007|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0||
48091280|NCT02111850|100545727|FG008|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0||
48091281|NCT02111850|100545728|FG009|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0||
48091282|NCT02111850|100545729|FG010|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0||
48091283|NCT01150981|100545730|FG000|STARTED|Overall Study||20||
48091284|NCT01150981|100545731|FG001|STARTED|Overall Study||15||
48091285|NCT01150981|100545730|FG000|COMPLETED|Overall Study||16||
48091286|NCT01150981|100545731|FG001|COMPLETED|Overall Study||13||
48091287|NCT01150981|100545730|FG000|NOT COMPLETED|Overall Study||4||
48091288|NCT01150981|100545731|FG001|NOT COMPLETED|Overall Study||2||
48091289|NCT02335294|100545732|FG000|STARTED|Overall Study||39||
48091290|NCT02335294|100545733|FG001|STARTED|Overall Study||42||
48091291|NCT02335294|100545734|FG002|STARTED|Overall Study||19||
48091292|NCT02335294|100545735|FG003|STARTED|Overall Study||39||
48091293|NCT02335294|100545736|FG004|STARTED|Overall Study||41||
48091294|NCT02335294|100545737|FG005|STARTED|Overall Study||20||
48091295|NCT02335294|100545732|FG000|COMPLETED|Overall Study||36||
48091296|NCT02335294|100545733|FG001|COMPLETED|Overall Study||38||
48091297|NCT02335294|100545734|FG002|COMPLETED|Overall Study||18||
48091298|NCT02335294|100545735|FG003|COMPLETED|Overall Study||36||
48091299|NCT02335294|100545736|FG004|COMPLETED|Overall Study||39||
48091300|NCT02335294|100545737|FG005|COMPLETED|Overall Study||19||
48091301|NCT02335294|100545732|FG000|NOT COMPLETED|Overall Study||3||
48091302|NCT02335294|100545733|FG001|NOT COMPLETED|Overall Study||4||
48091303|NCT02335294|100545734|FG002|NOT COMPLETED|Overall Study||1||
48091304|NCT02335294|100545735|FG003|NOT COMPLETED|Overall Study||3||
48091305|NCT02335294|100545736|FG004|NOT COMPLETED|Overall Study||2||
48091306|NCT02335294|100545737|FG005|NOT COMPLETED|Overall Study||1||
48091307|NCT01320085|100545738|FG000|STARTED|Overall Study||41||
48091308|NCT01320085|100545739|FG001|STARTED|Overall Study||117||
48091309|NCT01320085|100545740|FG002|STARTED|Overall Study||25||
48091310|NCT01320085|100545738|FG000|COMPLETED|Overall Study||0||
48091311|NCT01320085|100545739|FG001|COMPLETED|Overall Study||0||
48091312|NCT01320085|100545740|FG002|COMPLETED|Overall Study||0||
48091313|NCT01320085|100545738|FG000|NOT COMPLETED|Overall Study||41||
48091314|NCT01320085|100545739|FG001|NOT COMPLETED|Overall Study||117||
48091315|NCT01320085|100545740|FG002|NOT COMPLETED|Overall Study||25||
48541566|NCT04015908|101662777|FG001|COMPLETED|Overall Study||49||
48091316|NCT02154490|100545741|FG000|STARTED|Overall Study||1864||
48091317|NCT02154490|100545741|FG000|COMPLETED|Overall Study||655||
48091318|NCT02154490|100545741|FG000|NOT COMPLETED|Overall Study||1209||
48091319|NCT01911689|100545742|FG000|STARTED|Overall Study||117||
48541567|NCT04015908|101662776|FG000|NOT COMPLETED|Overall Study||0||
48541568|NCT04015908|101662777|FG001|NOT COMPLETED|Overall Study||1||
48541569|NCT03332979|101662778|FG000|STARTED|Overall Study||150||
48091320|NCT01911689|100545743|FG001|STARTED|Overall Study||51||
48091321|NCT01911689|100545742|FG000|COMPLETED|Overall Study||117||
48091322|NCT01911689|100545743|FG001|COMPLETED|Overall Study||51||
48091323|NCT01911689|100545742|FG000|NOT COMPLETED|Overall Study||0||
48091324|NCT01911689|100545743|FG001|NOT COMPLETED|Overall Study||0||
48091325|NCT00619801|100545744|FG000|STARTED|Overall Study||59||
48091326|NCT00619801|100545745|FG001|STARTED|Overall Study||114||
48091327|NCT00619801|100545744|FG000|Safety Population|Overall Study||59||
48091328|NCT00619801|100545745|FG001|Safety Population|Overall Study||114||
48091329|NCT00619801|100545744|FG000|COMPLETED|Overall Study||58||
48091330|NCT00619801|100545745|FG001|COMPLETED|Overall Study||111||
48091331|NCT00619801|100545744|FG000|NOT COMPLETED|Overall Study||1||
48091332|NCT00619801|100545745|FG001|NOT COMPLETED|Overall Study||3||
48091333|NCT03336333|100545746|FG000|STARTED|Overall Study||238||
48091334|NCT03336333|100545747|FG001|STARTED|Overall Study||241||
48091335|NCT03336333|100545748|FG002|STARTED|Overall Study||111||
48091336|NCT03336333|100545746|FG000|Treated|Overall Study||227||
48091337|NCT03336333|100545747|FG001|Treated|Overall Study||240||
48541570|NCT03332979|101662778|FG000|COMPLETED|Overall Study||150||
48541571|NCT03332979|101662778|FG000|NOT COMPLETED|Overall Study||0||
48541572|NCT02593110|101662779|FG000|STARTED|Overall Study||30||
48541573|NCT02593110|101662780|FG001|STARTED|Overall Study||29||
48541574|NCT02593110|101662781|FG002|STARTED|Overall Study||28||
48541575|NCT02593110|101662782|FG003|STARTED|Overall Study||27||
48541576|NCT02593110|101662779|FG000|COMPLETED|Overall Study||30||
48687213|NCT02628444|102017034|FG008|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||52||
48687214|NCT02628444|102017026|FG000|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0||
48687215|NCT02628444|102017027|FG001|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0||
48687216|NCT02628444|102017028|FG002|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0||
48541577|NCT02593110|101662780|FG001|COMPLETED|Overall Study||26||
48541578|NCT02593110|101662781|FG002|COMPLETED|Overall Study||24||
48687217|NCT02628444|102017029|FG003|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||90||
48687218|NCT02628444|102017030|FG004|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||93||
48687219|NCT02628444|102017031|FG005|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||95||
48687220|NCT02628444|102017032|FG006|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||96||
48091338|NCT03336333|100545748|FG002|Treated|Overall Study||111||
48091339|NCT03336333|100545746|FG000|COMPLETED|Overall Study||0||
48091340|NCT03336333|100545747|FG001|COMPLETED|Overall Study||0||
48091341|NCT03336333|100545748|FG002|COMPLETED|Overall Study||0||
48091342|NCT03336333|100545746|FG000|NOT COMPLETED|Overall Study||238||
48091343|NCT03336333|100545747|FG001|NOT COMPLETED|Overall Study||241||
48091344|NCT03336333|100545748|FG002|NOT COMPLETED|Overall Study||111||
48091345|NCT03042533|100545749|FG000|STARTED|Overall Study||1||
48091346|NCT03042533|100545750|FG001|STARTED|Overall Study||4||
48091347|NCT03042533|100545751|FG002|STARTED|Overall Study||1||
48091348|NCT03042533|100545749|FG000|COMPLETED|Overall Study||0||
48091349|NCT03042533|100545750|FG001|COMPLETED|Overall Study||0||
48091350|NCT03042533|100545751|FG002|COMPLETED|Overall Study||0||
48091351|NCT03042533|100545749|FG000|NOT COMPLETED|Overall Study||1||
48091352|NCT03042533|100545750|FG001|NOT COMPLETED|Overall Study||4||
48091353|NCT03042533|100545751|FG002|NOT COMPLETED|Overall Study||1||
48091354|NCT03033511|100545752|FG000|STARTED|Overall Study||376||
48091355|NCT03033511|100545753|FG001|STARTED|Overall Study||372||
48091356|NCT03033511|100545752|FG000|COMPLETED|Overall Study||376||
48091357|NCT03033511|100545753|FG001|COMPLETED|Overall Study||372||
48091358|NCT03033511|100545752|FG000|NOT COMPLETED|Overall Study||0||
48091359|NCT03033511|100545753|FG001|NOT COMPLETED|Overall Study||0||
48091360|NCT01957644|100545754|FG000|STARTED|Overall Study||6||
48091361|NCT01957644|100545755|FG001|STARTED|Overall Study||6||
48091362|NCT01957644|100545756|FG002|STARTED|Overall Study||1||
48091363|NCT01957644|100545757|FG003|STARTED|Overall Study||2||
48091364|NCT01957644|100545758|FG004|STARTED|Overall Study||1||
48091365|NCT01957644|100545754|FG000|COMPLETED|Overall Study||0||
48091366|NCT01957644|100545755|FG001|COMPLETED|Overall Study||0||
48091367|NCT01957644|100545756|FG002|COMPLETED|Overall Study||0||
48091368|NCT01957644|100545757|FG003|COMPLETED|Overall Study||0||
48091369|NCT01957644|100545758|FG004|COMPLETED|Overall Study||0||
48091370|NCT01957644|100545754|FG000|NOT COMPLETED|Overall Study||6||
48091371|NCT01957644|100545755|FG001|NOT COMPLETED|Overall Study||6||
48091372|NCT01957644|100545756|FG002|NOT COMPLETED|Overall Study||1||
48091373|NCT01957644|100545757|FG003|NOT COMPLETED|Overall Study||2||
48091374|NCT01957644|100545758|FG004|NOT COMPLETED|Overall Study||1||
48541579|NCT02593110|101662782|FG003|COMPLETED|Overall Study||25||
48541580|NCT02593110|101662779|FG000|NOT COMPLETED|Overall Study||0||
48541581|NCT02593110|101662780|FG001|NOT COMPLETED|Overall Study||3||
48541582|NCT02593110|101662781|FG002|NOT COMPLETED|Overall Study||4||
48541583|NCT02593110|101662782|FG003|NOT COMPLETED|Overall Study||2||
48541584|NCT03750292|101662783|FG000|STARTED|First Intervention (Baseline to 8 Weeks)||5||
48541585|NCT03750292|101662784|FG001|STARTED|First Intervention (Baseline to 8 Weeks)||4||
48541586|NCT03750292|101662783|FG000|COMPLETED|First Intervention (Baseline to 8 Weeks)||5||
48592697|NCT01877382|101783154|FG004|NOT COMPLETED|Dose Expansion||0||
48091375|NCT01018186|100545759|FG000|STARTED|2-week Run-in Period||617||
48091376|NCT01018186|100545760|FG001|STARTED|2-week Run-in Period||0||
48091377|NCT01018186|100545761|FG002|STARTED|2-week Run-in Period||0||
48091378|NCT01018186|100545762|FG003|STARTED|2-week Run-in Period||0||
48091379|NCT01018186|100545759|FG000|COMPLETED|2-week Run-in Period||503||
48091380|NCT01018186|100545760|FG001|COMPLETED|2-week Run-in Period||0||
48091381|NCT01018186|100545761|FG002|COMPLETED|2-week Run-in Period||0||
48091382|NCT01018186|100545762|FG003|COMPLETED|2-week Run-in Period||0||
48091383|NCT01018186|100545759|FG000|NOT COMPLETED|2-week Run-in Period||114||
48091384|NCT01018186|100545760|FG001|NOT COMPLETED|2-week Run-in Period||0||
48091385|NCT01018186|100545761|FG002|NOT COMPLETED|2-week Run-in Period||0||
48091386|NCT01018186|100545762|FG003|NOT COMPLETED|2-week Run-in Period||0||
48091387|NCT01018186|100545759|FG000|STARTED|52-week Double-blind Treatment Period||0||
48091388|NCT01018186|100545760|FG001|STARTED|52-week Double-blind Treatment Period||201||
48687221|NCT02628444|102017033|FG007|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||98||
48687222|NCT02628444|102017034|FG008|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||99||
48687223|NCT02374060|102017035|FG000|STARTED|Overall Study||65||
48091389|NCT01018186|100545761|FG002|STARTED|52-week Double-blind Treatment Period||202||
48091390|NCT01018186|100545762|FG003|STARTED|52-week Double-blind Treatment Period||100||
48091391|NCT01018186|100545759|FG000|COMPLETED|52-week Double-blind Treatment Period||0||
48687224|NCT02374060|102017036|FG001|STARTED|Overall Study||63||
48687225|NCT02374060|102017037|FG002|STARTED|Overall Study||64||
48687226|NCT02374060|102017035|FG000|COMPLETED|Overall Study||63||
48687227|NCT02374060|102017036|FG001|COMPLETED|Overall Study||62||
48091392|NCT01018186|100545760|FG001|COMPLETED|52-week Double-blind Treatment Period||161||
48091393|NCT01018186|100545761|FG002|COMPLETED|52-week Double-blind Treatment Period||161||
48091394|NCT01018186|100545762|FG003|COMPLETED|52-week Double-blind Treatment Period||71||
48091395|NCT01018186|100545759|FG000|NOT COMPLETED|52-week Double-blind Treatment Period||0||
48091396|NCT01018186|100545760|FG001|NOT COMPLETED|52-week Double-blind Treatment Period||40||
48091397|NCT01018186|100545761|FG002|NOT COMPLETED|52-week Double-blind Treatment Period||41||
48091398|NCT01018186|100545762|FG003|NOT COMPLETED|52-week Double-blind Treatment Period||29||
48091399|NCT00142584|100545763|FG000|STARTED|Overall Study||252||
48091400|NCT00142584|100545764|FG001|STARTED|Overall Study||84||
48091401|NCT00142584|100545763|FG000|COMPLETED|Overall Study||108||
48091402|NCT00142584|100545764|FG001|COMPLETED|Overall Study||28||
48382554|NCT01722487|101265035|FG000|NOT COMPLETED|Overall Study||2||
48382555|NCT01722487|101265036|FG001|NOT COMPLETED|Overall Study||7||
48382556|NCT01069523|101265037|FG000|STARTED|Overall Study||13||
48382557|NCT01069523|101265038|FG001|STARTED|Overall Study||16||
48382558|NCT01069523|101265037|FG000|COMPLETED|Overall Study||9||
48382559|NCT01069523|101265038|FG001|COMPLETED|Overall Study||9||
48687228|NCT02374060|102017037|FG002|COMPLETED|Overall Study||61||
48687229|NCT02374060|102017035|FG000|NOT COMPLETED|Overall Study||2||
48687230|NCT02374060|102017036|FG001|NOT COMPLETED|Overall Study||1||
48687231|NCT02374060|102017037|FG002|NOT COMPLETED|Overall Study||3||
48687232|NCT00551031|102017038|FG000|STARTED|Overall Study||637||
48687233|NCT00551031|102017039|FG001|STARTED|Overall Study||636||
48091403|NCT00142584|100545763|FG000|NOT COMPLETED|Overall Study||144||
48091404|NCT00142584|100545764|FG001|NOT COMPLETED|Overall Study||56||
48091405|NCT01722071|100545765|FG000|STARTED|Overall Study||10||
48091406|NCT01722071|100545766|FG001|STARTED|Overall Study||10||
48091407|NCT01722071|100545765|FG000|COMPLETED|Overall Study||9||
48091408|NCT01722071|100545766|FG001|COMPLETED|Overall Study||10||
48382560|NCT01069523|101265037|FG000|NOT COMPLETED|Overall Study||4||
48382561|NCT01069523|101265038|FG001|NOT COMPLETED|Overall Study||7||
48382562|NCT01694420|101265039|FG000|STARTED|Overall Study||33||
48382563|NCT01694420|101265039|FG000|COMPLETED|Overall Study||30||
48382564|NCT01694420|101265039|FG000|NOT COMPLETED|Overall Study||3||
48382565|NCT00844649|101265040|FG000|STARTED|Overall Study||431||
48382566|NCT00844649|101265041|FG001|STARTED|Overall Study||430||
48382567|NCT00844649|101265040|FG000|Treated Population|Overall Study||421||
48382568|NCT00844649|101265041|FG001|Treated Population|Overall Study||402||
48541587|NCT03750292|101662784|FG001|COMPLETED|First Intervention (Baseline to 8 Weeks)||4||
48687234|NCT00551031|102017040|FG002|STARTED|Overall Study||319||
48091409|NCT01722071|100545765|FG000|NOT COMPLETED|Overall Study||1||
48091410|NCT01722071|100545766|FG001|NOT COMPLETED|Overall Study||0||
48091411|NCT00112593|100545767|FG000|STARTED|Overall Study||5||
48091412|NCT00112593|100545767|FG000|COMPLETED|Overall Study||5||
48091413|NCT00112593|100545767|FG000|NOT COMPLETED|Overall Study||0||
48091414|NCT01414075|100545768|FG000|STARTED|Overall Study||24|Safety population: all participants who received any dose of study drug.|
48091415|NCT01414075|100545769|FG001|STARTED|Overall Study||12|Safety population: all participants who received any dose of study drug.|
48091416|NCT01414075|100545770|FG002|STARTED|Overall Study||12|Safety population: all participants who received any dose of study drug.|
48382569|NCT00844649|101265040|FG000|COMPLETED|Overall Study||26||
48382570|NCT00844649|101265041|FG001|COMPLETED|Overall Study||12||
48382571|NCT00844649|101265040|FG000|NOT COMPLETED|Overall Study||405||
48382572|NCT00844649|101265041|FG001|NOT COMPLETED|Overall Study||418||
48541588|NCT03750292|101662783|FG000|NOT COMPLETED|First Intervention (Baseline to 8 Weeks)||0||
48687235|NCT00551031|102017041|FG003|STARTED|Overall Study||320||
48687236|NCT00551031|102017042|FG004|STARTED|Overall Study||186||
48382573|NCT01062074|101265042|FG000|STARTED|Overall Study||3605||
48382574|NCT01062074|101265042|FG000|COMPLETED|Overall Study||3605||
48382575|NCT01062074|101265042|FG000|NOT COMPLETED|Overall Study||0||
48382576|NCT05127421|101265043|FG000|STARTED|4-Week Double-Blind Period||23||
48382577|NCT05127421|101265044|FG001|STARTED|4-Week Double-Blind Period||54||
48382578|NCT05127421|101265045|FG002|STARTED|4-Week Double-Blind Period||0||
48382579|NCT05127421|101265046|FG003|STARTED|4-Week Double-Blind Period||0||
48382580|NCT05127421|101265043|FG000|COMPLETED|4-Week Double-Blind Period||18||
48382581|NCT05127421|101265044|FG001|COMPLETED|4-Week Double-Blind Period||48||
48382582|NCT05127421|101265045|FG002|COMPLETED|4-Week Double-Blind Period||0||
48382583|NCT05127421|101265046|FG003|COMPLETED|4-Week Double-Blind Period||0||
48382584|NCT05127421|101265043|FG000|NOT COMPLETED|4-Week Double-Blind Period||5||
48382585|NCT05127421|101265044|FG001|NOT COMPLETED|4-Week Double-Blind Period||6||
48382586|NCT05127421|101265045|FG002|NOT COMPLETED|4-Week Double-Blind Period||0||
48382587|NCT05127421|101265046|FG003|NOT COMPLETED|4-Week Double-Blind Period||0||
48382588|NCT05127421|101265043|FG000|STARTED|4-Week Open-Label Period||0||
48382589|NCT05127421|101265044|FG001|STARTED|4-Week Open-Label Period||0||
48382590|NCT05127421|101265045|FG002|STARTED|4-Week Open-Label Period||17||
48382591|NCT05127421|101265046|FG003|STARTED|4-Week Open-Label Period||47||
48255683|NCT01586975|100943974|FG002|STARTED|Overall Study||46||
48255684|NCT01586975|100943972|FG000|COMPLETED|Overall Study||15||
48255685|NCT01586975|100943973|FG001|COMPLETED|Overall Study||32||
48255686|NCT01586975|100943974|FG002|COMPLETED|Overall Study||46||
48255687|NCT01586975|100943972|FG000|NOT COMPLETED|Overall Study||0||
48255688|NCT01586975|100943973|FG001|NOT COMPLETED|Overall Study||0||
48255689|NCT01586975|100943974|FG002|NOT COMPLETED|Overall Study||0||
48255690|NCT03918447|100943975|FG000|STARTED|Overall Study||334||
48255691|NCT03918447|100943976|FG001|STARTED|Overall Study||333||
48255692|NCT03918447|100943975|FG000|Safety Analysis Set|Overall Study||335|Participants who received 1 dose of bardoxolone methyl were classified in the bardoxolone methyl group. Participants who received at least 1 dose of placebo and no dose of bardoxolone methyl were classified in the placebo group.|
48255693|NCT03918447|100943976|FG001|Safety Analysis Set|Overall Study||331|Participants who received 1 dose of bardoxolone methyl were classified in the bardoxolone methyl group. Participants who received at least 1 dose of placebo and no dose of bardoxolone methyl were classified in the placebo group.|
48255694|NCT03918447|100943975|FG000|COMPLETED|Overall Study||106||
48255695|NCT03918447|100943976|FG001|COMPLETED|Overall Study||112||
48255696|NCT03918447|100943975|FG000|NOT COMPLETED|Overall Study||228||
48255697|NCT03918447|100943976|FG001|NOT COMPLETED|Overall Study||221||
48255698|NCT03481556|100943977|FG000|STARTED|Overall Study||15||
48255699|NCT03481556|100943978|FG001|STARTED|Overall Study||8||
48255700|NCT03481556|100943979|FG002|STARTED|Overall Study||6||
48255701|NCT03481556|100943980|FG003|STARTED|Overall Study||27||
48255702|NCT03481556|100943977|FG000|COMPLETED|Overall Study||0||
48255703|NCT03481556|100943978|FG001|COMPLETED|Overall Study||1||
48255704|NCT03481556|100943979|FG002|COMPLETED|Overall Study||1||
48255705|NCT03481556|100943980|FG003|COMPLETED|Overall Study||2||
48255706|NCT03481556|100943977|FG000|NOT COMPLETED|Overall Study||15||
48255707|NCT03481556|100943978|FG001|NOT COMPLETED|Overall Study||7||
48255708|NCT03481556|100943979|FG002|NOT COMPLETED|Overall Study||5||
48255709|NCT03481556|100943980|FG003|NOT COMPLETED|Overall Study||25||
48255710|NCT02741713|100943981|FG000|STARTED|Overall Study||20||
48255711|NCT02741713|100943982|FG001|STARTED|Overall Study||20||
48255712|NCT02741713|100943981|FG000|COMPLETED|Overall Study||18||
48255713|NCT02741713|100943982|FG001|COMPLETED|Overall Study||19||
48255714|NCT02741713|100943981|FG000|NOT COMPLETED|Overall Study||2||
48255715|NCT02741713|100943982|FG001|NOT COMPLETED|Overall Study||1||
48255716|NCT01564953|100943983|FG000|STARTED|Overall Study||143||
48255717|NCT01564953|100943983|FG000|COMPLETED|Overall Study||143||
48255718|NCT01564953|100943983|FG000|NOT COMPLETED|Overall Study||0||
48255719|NCT03245762|100943984|FG000|STARTED|Overall Study||10||
48255720|NCT03245762|100943985|FG001|STARTED|Overall Study||5||
48255721|NCT03245762|100943984|FG000|COMPLETED|Overall Study||10||
48255722|NCT03245762|100943985|FG001|COMPLETED|Overall Study||5||
48255723|NCT03245762|100943984|FG000|NOT COMPLETED|Overall Study||0||
48255724|NCT03245762|100943985|FG001|NOT COMPLETED|Overall Study||0||
48255725|NCT00833898|100943986|FG000|STARTED|Overall Study||74||
48255726|NCT00833898|100943987|FG001|STARTED|Overall Study||74||
48255727|NCT00833898|100943986|FG000|Month 1 (Post Transplantation)|Overall Study||72||
48255728|NCT00833898|100943987|FG001|Month 1 (Post Transplantation)|Overall Study||74||
48255729|NCT00833898|100943986|FG000|Month 3 (Post Transplantation)|Overall Study||66||
48255730|NCT00833898|100943987|FG001|Month 3 (Post Transplantation)|Overall Study||64||
48255731|NCT00833898|100943986|FG000|Month 6 (Post Transplantation)|Overall Study||59||
48382592|NCT05127421|101265043|FG000|COMPLETED|4-Week Open-Label Period||0||
48382593|NCT05127421|101265044|FG001|COMPLETED|4-Week Open-Label Period||0||
48382594|NCT05127421|101265045|FG002|COMPLETED|4-Week Open-Label Period||16||
48382595|NCT05127421|101265046|FG003|COMPLETED|4-Week Open-Label Period||44||
48382596|NCT05127421|101265043|FG000|NOT COMPLETED|4-Week Open-Label Period||0||
48382597|NCT05127421|101265044|FG001|NOT COMPLETED|4-Week Open-Label Period||0||
48382598|NCT05127421|101265045|FG002|NOT COMPLETED|4-Week Open-Label Period||1||
48382599|NCT05127421|101265046|FG003|NOT COMPLETED|4-Week Open-Label Period||3||
48382600|NCT00077376|101265047|FG000|STARTED|Overall Study||61||
48382601|NCT00077376|101265047|FG000|Treated|Overall Study||59||
48382602|NCT00077376|101265047|FG000|HER2+ in Central Testing|Overall Study||39||
48382603|NCT00077376|101265047|FG000|COMPLETED|Overall Study||39||
48382604|NCT00077376|101265047|FG000|NOT COMPLETED|Overall Study||22||
48382605|NCT03180489|101265048|FG000|STARTED|Overall Study||33||
48382606|NCT03180489|101265049|FG001|STARTED|Overall Study||29||
48382607|NCT03180489|101265048|FG000|COMPLETED|Overall Study||25||
48382608|NCT03180489|101265049|FG001|COMPLETED|Overall Study||25||
48382609|NCT03180489|101265048|FG000|NOT COMPLETED|Overall Study||8||
48382610|NCT03180489|101265049|FG001|NOT COMPLETED|Overall Study||4||
48382611|NCT03499821|101265050|FG000|STARTED|Overall Study||35||70
48382612|NCT03499821|101265050|FG000|COMPLETED|Overall Study||34||68
48382613|NCT03499821|101265050|FG000|NOT COMPLETED|Overall Study||1||2
48382614|NCT01755195|101265051|FG000|STARTED|Overall Study||55||
48382615|NCT01755195|101265051|FG000|COMPLETED|Overall Study||42||
48382616|NCT01755195|101265051|FG000|NOT COMPLETED|Overall Study||13||
48382617|NCT01324622|101265052|FG000|STARTED|Overall Study||13||
48091417|NCT01414075|100545771|FG003|STARTED|Overall Study||12|Safety population: all participants who received any dose of study drug.|
48091418|NCT01414075|100545768|FG000|Efficacy Evaluable (EE) Population|Overall Study||23|All participants who received study treatment for 6 weeks or longer and had valid corresponding Hb measurements.|
48091419|NCT01414075|100545769|FG001|Efficacy Evaluable (EE) Population|Overall Study||12|All participants who received study treatment for 6 weeks or longer and had valid corresponding Hb measurements.|
48091420|NCT01414075|100545770|FG002|Efficacy Evaluable (EE) Population|Overall Study||10|All participants who received study treatment for 6 weeks or longer and had valid corresponding Hb measurements.|
48382618|NCT01324622|101265053|FG001|STARTED|Overall Study||11||
48382619|NCT01324622|101265052|FG000|COMPLETED|Overall Study||4||
48382620|NCT01324622|101265053|FG001|COMPLETED|Overall Study||4||
48255732|NCT00833898|100943987|FG001|Month 6 (Post Transplantation)|Overall Study||54||
48255733|NCT00833898|100943986|FG000|Month 12 (Post Transplantation)|Overall Study||50||
48382621|NCT01324622|101265052|FG000|NOT COMPLETED|Overall Study||9||
48382622|NCT01324622|101265053|FG001|NOT COMPLETED|Overall Study||7||
48382623|NCT00193219|101265054|FG000|STARTED|Overall Study||36||
48382624|NCT00193219|101265054|FG000|COMPLETED|Overall Study||6||
48382625|NCT00193219|101265054|FG000|NOT COMPLETED|Overall Study||30||
48382626|NCT01086150|101265055|FG000|STARTED|Overall Study||11||
48382627|NCT01086150|101265056|FG001|STARTED|Overall Study||27||
48382628|NCT01086150|101265057|FG002|STARTED|Overall Study||13||
48382629|NCT01086150|101265055|FG000|COMPLETED|Overall Study||11||
48382630|NCT01086150|101265056|FG001|COMPLETED|Overall Study||21||
48382631|NCT01086150|101265057|FG002|COMPLETED|Overall Study||12||
48382632|NCT01086150|101265055|FG000|NOT COMPLETED|Overall Study||0||
48382633|NCT01086150|101265056|FG001|NOT COMPLETED|Overall Study||6||
48382634|NCT01086150|101265057|FG002|NOT COMPLETED|Overall Study||1||
48382635|NCT00929734|101265058|FG000|STARTED|Overall Study||49||
48382636|NCT00929734|101265059|FG001|STARTED|Overall Study||50||
48382637|NCT00929734|101265058|FG000|COMPLETED|Overall Study||47||
48382638|NCT00929734|101265059|FG001|COMPLETED|Overall Study||47||
48382639|NCT00929734|101265058|FG000|NOT COMPLETED|Overall Study||2||
48382640|NCT00929734|101265059|FG001|NOT COMPLETED|Overall Study||3||
48382641|NCT01062568|101265060|FG000|STARTED|Overall Study||10||
48382642|NCT01062568|101265061|FG001|STARTED|Overall Study||40||
48382643|NCT01062568|101265060|FG000|COMPLETED|Overall Study||10||
48382644|NCT01062568|101265061|FG001|COMPLETED|Overall Study||40||
48382645|NCT01062568|101265060|FG000|NOT COMPLETED|Overall Study||0||
48382646|NCT01062568|101265061|FG001|NOT COMPLETED|Overall Study||0||
48382647|NCT00377611|101265062|FG000|STARTED|Overall Study||1047||
48382648|NCT00377611|101265063|FG001|STARTED|Overall Study||2007||
48382649|NCT00377611|101265062|FG000|COMPLETED|Overall Study||1025||
48382650|NCT00377611|101265063|FG001|COMPLETED|Overall Study||1974||
48382651|NCT00377611|101265062|FG000|NOT COMPLETED|Overall Study||22||
48382652|NCT00377611|101265063|FG001|NOT COMPLETED|Overall Study||33||
48382653|NCT04124536|101265064|FG000|STARTED|Overall Study||58||
48382654|NCT04124536|101265065|FG001|STARTED|Overall Study||58||
48382655|NCT04124536|101265066|FG002|STARTED|Overall Study||105||
48687237|NCT00551031|102017038|FG000|COMPLETED|Overall Study||635||
48687238|NCT00551031|102017039|FG001|COMPLETED|Overall Study||625||
48687239|NCT00551031|102017040|FG002|COMPLETED|Overall Study||317||
48687240|NCT00551031|102017041|FG003|COMPLETED|Overall Study||317||
48687241|NCT00551031|102017042|FG004|COMPLETED|Overall Study||185||
48687242|NCT00551031|102017038|FG000|NOT COMPLETED|Overall Study||2||
48687243|NCT00551031|102017039|FG001|NOT COMPLETED|Overall Study||11||
48687244|NCT00551031|102017040|FG002|NOT COMPLETED|Overall Study||2||
48687245|NCT00551031|102017041|FG003|NOT COMPLETED|Overall Study||3||
48687246|NCT00551031|102017042|FG004|NOT COMPLETED|Overall Study||1||
48687247|NCT02709577|102017043|FG000|STARTED|Overall Study||12||
48687248|NCT02709577|102017044|FG001|STARTED|Overall Study||13||
48687249|NCT02709577|102017045|FG002|STARTED|Overall Study||6||
48687250|NCT02709577|102017046|FG003|STARTED|Overall Study||5||
48687251|NCT02709577|102017043|FG000|COMPLETED|Overall Study||10||
48255734|NCT00833898|100943987|FG001|Month 12 (Post Transplantation)|Overall Study||50||
48255735|NCT00833898|100943986|FG000|COMPLETED|Overall Study||34||
48255736|NCT00833898|100943987|FG001|COMPLETED|Overall Study||38||
48255737|NCT00833898|100943986|FG000|NOT COMPLETED|Overall Study||40||
48255738|NCT00833898|100943987|FG001|NOT COMPLETED|Overall Study||36||
48255739|NCT01904136|100943988|FG000|STARTED|Overall Study||1||
48255740|NCT01904136|100943989|FG001|STARTED|Overall Study||2||
48255741|NCT01904136|100943990|FG002|STARTED|Overall Study||3||
48255742|NCT01904136|100943991|FG003|STARTED|Overall Study||3||
48255743|NCT01904136|100943992|FG004|STARTED|Overall Study||2||
48255744|NCT01904136|100943993|FG005|STARTED|Overall Study||3||
48255745|NCT01904136|100943994|FG006|STARTED|Overall Study||3||
48255746|NCT01904136|100943995|FG007|STARTED|Overall Study||10||
48255747|NCT01904136|100943996|FG008|STARTED|Overall Study||27||
48255748|NCT01904136|100943988|FG000|COMPLETED|Overall Study||1||
48255749|NCT01904136|100943989|FG001|COMPLETED|Overall Study||2||
48255750|NCT01904136|100943990|FG002|COMPLETED|Overall Study||3||
48255751|NCT01904136|100943991|FG003|COMPLETED|Overall Study||3||
48255752|NCT01904136|100943992|FG004|COMPLETED|Overall Study||2||
48255753|NCT01904136|100943993|FG005|COMPLETED|Overall Study||2||
48255754|NCT01904136|100943994|FG006|COMPLETED|Overall Study||3||
48687252|NCT02709577|102017044|FG001|COMPLETED|Overall Study||8||
48255755|NCT01904136|100943995|FG007|COMPLETED|Overall Study||10||
48382656|NCT04124536|101265067|FG003|STARTED|Overall Study||105||
48382657|NCT04124536|101265068|FG004|STARTED|Overall Study||15||
48382658|NCT04124536|101265064|FG000|COMPLETED|Overall Study||47||
48382659|NCT04124536|101265065|FG001|COMPLETED|Overall Study||53||
48382660|NCT04124536|101265066|FG002|COMPLETED|Overall Study||102||
48382661|NCT04124536|101265067|FG003|COMPLETED|Overall Study||98||
48255756|NCT01904136|100943996|FG008|COMPLETED|Overall Study||27||
48255757|NCT01904136|100943988|FG000|NOT COMPLETED|Overall Study||0||
48687253|NCT02709577|102017045|FG002|COMPLETED|Overall Study||4||
48382662|NCT04124536|101265068|FG004|COMPLETED|Overall Study||15||
48382663|NCT04124536|101265064|FG000|NOT COMPLETED|Overall Study||11||
48382664|NCT04124536|101265065|FG001|NOT COMPLETED|Overall Study||5||
48382665|NCT04124536|101265066|FG002|NOT COMPLETED|Overall Study||3||
48382666|NCT04124536|101265067|FG003|NOT COMPLETED|Overall Study||7||
48382667|NCT04124536|101265068|FG004|NOT COMPLETED|Overall Study||0||
48382668|NCT01115738|101265069|FG000|STARTED|Overall Study||110||
48382669|NCT01115738|101265070|FG001|STARTED|Overall Study||83||
48382670|NCT01115738|101265071|FG002|STARTED|Overall Study||89||
48382671|NCT01115738|101265069|FG000|Received Any Treatment|Overall Study||109||
48382672|NCT01115738|101265070|FG001|Received Any Treatment|Overall Study||79||
48382673|NCT01115738|101265071|FG002|Received Any Treatment|Overall Study||88||
48687254|NCT02709577|102017046|FG003|COMPLETED|Overall Study||5||
48687255|NCT02709577|102017043|FG000|NOT COMPLETED|Overall Study||2||
48687256|NCT02709577|102017044|FG001|NOT COMPLETED|Overall Study||5||
48687257|NCT02709577|102017045|FG002|NOT COMPLETED|Overall Study||2||
48687258|NCT02709577|102017046|FG003|NOT COMPLETED|Overall Study||0||
48687259|NCT04114071|102017047|FG000|STARTED|Overall Study||15||
48687260|NCT04114071|102017048|FG001|STARTED|Overall Study||15||
48687261|NCT04114071|102017047|FG000|COMPLETED|Overall Study||14||
48687262|NCT04114071|102017048|FG001|COMPLETED|Overall Study||15||
48687263|NCT04114071|102017047|FG000|NOT COMPLETED|Overall Study||1||
48091421|NCT01414075|100545771|FG003|Efficacy Evaluable (EE) Population|Overall Study||10|All participants who received study treatment for 6 weeks or longer and had valid corresponding Hb measurements.|
48091422|NCT01414075|100545768|FG000|COMPLETED|Overall Study||21||
48091423|NCT01414075|100545769|FG001|COMPLETED|Overall Study||12||
48091424|NCT01414075|100545770|FG002|COMPLETED|Overall Study||10||
48091425|NCT01414075|100545771|FG003|COMPLETED|Overall Study||10||
48091426|NCT01414075|100545768|FG000|NOT COMPLETED|Overall Study||3||
48091427|NCT01414075|100545769|FG001|NOT COMPLETED|Overall Study||0||
48091428|NCT01414075|100545770|FG002|NOT COMPLETED|Overall Study||2||
48091429|NCT01414075|100545771|FG003|NOT COMPLETED|Overall Study||2||
48091430|NCT00533845|100545772|FG000|STARTED|Overall Study||15||
48091431|NCT00533845|100545773|FG001|STARTED|Overall Study||15||
48091432|NCT00533845|100545772|FG000|COMPLETED|Overall Study||14||
48091433|NCT00533845|100545773|FG001|COMPLETED|Overall Study||15||
48091434|NCT00533845|100545772|FG000|NOT COMPLETED|Overall Study||1||
48091435|NCT00533845|100545773|FG001|NOT COMPLETED|Overall Study||0||
48091436|NCT01286012|100545774|FG000|STARTED|Overall Study||54||
48091437|NCT01286012|100545775|FG001|STARTED|Overall Study||54||
48091438|NCT01286012|100545774|FG000|COMPLETED|Overall Study||41||
48091439|NCT01286012|100545775|FG001|COMPLETED|Overall Study||40||
48091440|NCT01286012|100545774|FG000|NOT COMPLETED|Overall Study||13||
48091441|NCT01286012|100545775|FG001|NOT COMPLETED|Overall Study||14||
48091442|NCT01928524|100545776|FG000|STARTED|Overall Study||3||
48091443|NCT01928524|100545777|FG001|STARTED|Overall Study||3||
48091444|NCT01928524|100545778|FG002|STARTED|Overall Study||6||
48091445|NCT01928524|100545779|FG003|STARTED|Overall Study||6||
48091446|NCT01928524|100545780|FG004|STARTED|Overall Study||3||
48091447|NCT01928524|100545781|FG005|STARTED|Overall Study||8||
48091448|NCT01928524|100545782|FG006|STARTED|Overall Study||5||
48091449|NCT01928524|100545776|FG000|COMPLETED|Overall Study||3||
48091450|NCT01928524|100545777|FG001|COMPLETED|Overall Study||3||
48091451|NCT01928524|100545778|FG002|COMPLETED|Overall Study||6||
48382674|NCT01115738|101265069|FG000|Pharmacodynamic (PD) Population|Overall Study||52||
48382675|NCT01115738|101265070|FG001|Pharmacodynamic (PD) Population|Overall Study||47||
48382676|NCT01115738|101265071|FG002|Pharmacodynamic (PD) Population|Overall Study||50||
48382677|NCT01115738|101265069|FG000|COMPLETED|Overall Study||85||
48382678|NCT01115738|101265070|FG001|COMPLETED|Overall Study||62||
48382679|NCT01115738|101265071|FG002|COMPLETED|Overall Study||62||
48091452|NCT01928524|100545779|FG003|COMPLETED|Overall Study||6||
48091453|NCT01928524|100545780|FG004|COMPLETED|Overall Study||3||
48091454|NCT01928524|100545781|FG005|COMPLETED|Overall Study||8||
48091455|NCT01928524|100545782|FG006|COMPLETED|Overall Study||5||
48091456|NCT01928524|100545776|FG000|NOT COMPLETED|Overall Study||0||
48091457|NCT01928524|100545777|FG001|NOT COMPLETED|Overall Study||0||
48091458|NCT01928524|100545778|FG002|NOT COMPLETED|Overall Study||0||
48091459|NCT01928524|100545779|FG003|NOT COMPLETED|Overall Study||0||
48091460|NCT01928524|100545780|FG004|NOT COMPLETED|Overall Study||0||
48091461|NCT01928524|100545781|FG005|NOT COMPLETED|Overall Study||0||
48382680|NCT01115738|101265069|FG000|NOT COMPLETED|Overall Study||25||
48687264|NCT04114071|102017048|FG001|NOT COMPLETED|Overall Study||0||
48687265|NCT02454530|102017049|FG000|STARTED|Overall Study||552||
48687266|NCT02454530|102017050|FG001|STARTED|Overall Study||608||
48687267|NCT02454530|102017049|FG000|COMPLETED|Overall Study||482||
48687268|NCT02454530|102017050|FG001|COMPLETED|Overall Study||481||
48687269|NCT02454530|102017049|FG000|NOT COMPLETED|Overall Study||70||
48687270|NCT02454530|102017050|FG001|NOT COMPLETED|Overall Study||127||
48687271|NCT01994746|102017051|FG000|STARTED|First Visit||39||
48091462|NCT01928524|100545782|FG006|NOT COMPLETED|Overall Study||0||
48382681|NCT01115738|101265070|FG001|NOT COMPLETED|Overall Study||21||
48687272|NCT01994746|102017052|FG001|STARTED|First Visit||38||
48687273|NCT01994746|102017051|FG000|Received At Least 1 Dose|First Visit||39||
48710788|NCT01215110|102078019|FG003|COMPLETED|Overall Study||14||
48382682|NCT01115738|101265071|FG002|NOT COMPLETED|Overall Study||27||
48382683|NCT01973452|101265072|FG000|STARTED|Overall Study||165||
48382684|NCT01973452|101265073|FG001|STARTED|Overall Study||166||
48382685|NCT01973452|101265072|FG000|COMPLETED|Overall Study||148||
48382686|NCT01973452|101265073|FG001|COMPLETED|Overall Study||152||
48382687|NCT01973452|101265072|FG000|NOT COMPLETED|Overall Study||17||
48382688|NCT01973452|101265073|FG001|NOT COMPLETED|Overall Study||14||
48382689|NCT00848250|101265074|FG000|STARTED|Overall Study||11||
48382690|NCT00848250|101265075|FG001|STARTED|Overall Study||10||
48382691|NCT00848250|101265074|FG000|COMPLETED|Overall Study||11||
48382692|NCT00848250|101265075|FG001|COMPLETED|Overall Study||9||
48382693|NCT00848250|101265074|FG000|NOT COMPLETED|Overall Study||0||
48255758|NCT01904136|100943989|FG001|NOT COMPLETED|Overall Study||0||
48255759|NCT01904136|100943990|FG002|NOT COMPLETED|Overall Study||0||
48255760|NCT01904136|100943991|FG003|NOT COMPLETED|Overall Study||0||
48382694|NCT00848250|101265075|FG001|NOT COMPLETED|Overall Study||1||
48382695|NCT02163993|101265076|FG000|STARTED|Treatment Period||138||
48382696|NCT02163993|101265077|FG001|STARTED|Treatment Period||68||
48382697|NCT02163993|101265078|FG002|STARTED|Treatment Period||68||
48382698|NCT02163993|101265079|FG003|STARTED|Treatment Period||71||
48382699|NCT02163993|101265080|FG004|STARTED|Treatment Period||69||
48382700|NCT02163993|101265076|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||137||
48382701|NCT02163993|101265077|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||68||
48382702|NCT02163993|101265078|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||68||
48382703|NCT02163993|101265079|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||70||
48382704|NCT02163993|101265080|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||67||
48382705|NCT02163993|101265076|FG000|COMPLETED|Treatment Period||126||
48382706|NCT02163993|101265077|FG001|COMPLETED|Treatment Period||59||
48382707|NCT02163993|101265078|FG002|COMPLETED|Treatment Period||66||
48255761|NCT01904136|100943992|FG004|NOT COMPLETED|Overall Study||0||
48255762|NCT01904136|100943993|FG005|NOT COMPLETED|Overall Study||1||
48255763|NCT01904136|100943994|FG006|NOT COMPLETED|Overall Study||0||
48255764|NCT01904136|100943995|FG007|NOT COMPLETED|Overall Study||0||
48255765|NCT01904136|100943996|FG008|NOT COMPLETED|Overall Study||0||
48255766|NCT04531813|100943997|FG000|STARTED|Overall Study||32||
48255767|NCT04531813|100943997|FG000|Treated|Overall Study||31||
48255768|NCT04531813|100943997|FG000|COMPLETED|Overall Study||30||
48255769|NCT04531813|100943997|FG000|NOT COMPLETED|Overall Study||2||
48255770|NCT04525456|100943998|FG000|STARTED|Overall Study||20||
48255771|NCT04525456|100943998|FG000|COMPLETED|Overall Study||20||
48255772|NCT04525456|100943998|FG000|NOT COMPLETED|Overall Study||0||
48255773|NCT00321321|100943999|FG000|STARTED|Overall Study||12||
48255774|NCT00321321|100943999|FG000|COMPLETED|Overall Study||12||
48255775|NCT00321321|100943999|FG000|NOT COMPLETED|Overall Study||0||
48255776|NCT01167192|100944000|FG000|STARTED|Overall Study||10||
48255777|NCT01167192|100944000|FG000|COMPLETED|Overall Study||6||
48255778|NCT01167192|100944000|FG000|NOT COMPLETED|Overall Study||4||
48255779|NCT00233389|100944001|FG000|STARTED|Overall Study||154||
48255780|NCT00233389|100944002|FG001|STARTED|Overall Study||147||
48255781|NCT00233389|100944001|FG000|COMPLETED|Overall Study||136||
48255782|NCT00233389|100944002|FG001|COMPLETED|Overall Study||131||
48255783|NCT00233389|100944001|FG000|NOT COMPLETED|Overall Study||18||
48255784|NCT00233389|100944002|FG001|NOT COMPLETED|Overall Study||16||
48255785|NCT01313624|100947622|FG000|STARTED|Double-Blind Phase||134||
48255786|NCT01313624|100947623|FG001|STARTED|Double-Blind Phase||132||
48255787|NCT01313624|100947622|FG000|COMPLETED|Double-Blind Phase||96||
48255788|NCT01313624|100947623|FG001|COMPLETED|Double-Blind Phase||122||
48255789|NCT01313624|100947622|FG000|NOT COMPLETED|Double-Blind Phase||38||
48255790|NCT01313624|100947623|FG001|NOT COMPLETED|Double-Blind Phase||10||
48255791|NCT01313624|100947622|FG000|STARTED|Open-Label Phase||96||
48255792|NCT01313624|100947623|FG001|STARTED|Open-Label Phase||122||
48255793|NCT01313624|100947622|FG000|COMPLETED|Open-Label Phase||92||
48255794|NCT01313624|100947623|FG001|COMPLETED|Open-Label Phase||109||
48255795|NCT01313624|100947622|FG000|NOT COMPLETED|Open-Label Phase||4||
48255796|NCT01313624|100947623|FG001|NOT COMPLETED|Open-Label Phase||13||
48382708|NCT02163993|101265079|FG003|COMPLETED|Treatment Period||62||
48255797|NCT02447432|100947624|FG000|STARTED|Epoch 001||160||
48255798|NCT02447432|100947625|FG001|STARTED|Epoch 001||160||
48255799|NCT02447432|100947624|FG000|COMPLETED|Epoch 001||155||
48255800|NCT02447432|100947625|FG001|COMPLETED|Epoch 001||147||
48255801|NCT02447432|100947624|FG000|NOT COMPLETED|Epoch 001||5||
48382709|NCT02163993|101265080|FG004|COMPLETED|Treatment Period||62||
48382710|NCT02163993|101265076|FG000|NOT COMPLETED|Treatment Period||12||
48382711|NCT02163993|101265077|FG001|NOT COMPLETED|Treatment Period||9||
48382712|NCT02163993|101265078|FG002|NOT COMPLETED|Treatment Period||2||
48255802|NCT02447432|100947625|FG001|NOT COMPLETED|Epoch 001||13||
48255803|NCT02447432|100947624|FG000|STARTED|Epoch 002||152||
48255804|NCT02447432|100947625|FG001|STARTED|Epoch 002||145||
48255805|NCT02447432|100947624|FG000|COMPLETED|Epoch 002||152||
48255806|NCT02447432|100947625|FG001|COMPLETED|Epoch 002||145||
48255807|NCT02447432|100947624|FG000|NOT COMPLETED|Epoch 002||0||
48255808|NCT02447432|100947625|FG001|NOT COMPLETED|Epoch 002||0||
48255809|NCT03467698|100947626|FG000|STARTED|Overall Study||15||
48255810|NCT03467698|100947627|FG001|STARTED|Overall Study||15||
48382713|NCT02163993|101265079|FG003|NOT COMPLETED|Treatment Period||9||
48382714|NCT02163993|101265080|FG004|NOT COMPLETED|Treatment Period||7||
48382715|NCT02163993|101265076|FG000|STARTED|Post-treatment Period||125||
48382716|NCT02163993|101265077|FG001|STARTED|Post-treatment Period||61||
48382717|NCT02163993|101265078|FG002|STARTED|Post-treatment Period||66||
48382718|NCT02163993|101265079|FG003|STARTED|Post-treatment Period||63||
48382719|NCT02163993|101265080|FG004|STARTED|Post-treatment Period||65||
48382720|NCT02163993|101265076|FG000|COMPLETED|Post-treatment Period||121||
48382721|NCT02163993|101265077|FG001|COMPLETED|Post-treatment Period||55||
48091463|NCT02425046|100545783|FG000|STARTED|Overall Study||206||
48091464|NCT02425046|100545784|FG001|STARTED|Overall Study||210||
48091465|NCT02425046|100545785|FG002|STARTED|Overall Study||56||
48091466|NCT02425046|100545783|FG000|COMPLETED|Overall Study||138||
48091467|NCT02425046|100545784|FG001|COMPLETED|Overall Study||148||
48091468|NCT02425046|100545785|FG002|COMPLETED|Overall Study||0||
48382722|NCT02163993|101265078|FG002|COMPLETED|Post-treatment Period||62||
48382723|NCT02163993|101265079|FG003|COMPLETED|Post-treatment Period||61||
48382724|NCT02163993|101265080|FG004|COMPLETED|Post-treatment Period||62||
48091469|NCT02425046|100545783|FG000|NOT COMPLETED|Overall Study||68||
48091470|NCT02425046|100545784|FG001|NOT COMPLETED|Overall Study||62||
48091471|NCT02425046|100545785|FG002|NOT COMPLETED|Overall Study||56||
48091472|NCT01573572|100545786|FG000|STARTED|Overall Study||131||
48382725|NCT02163993|101265076|FG000|NOT COMPLETED|Post-treatment Period||4||
48382726|NCT02163993|101265077|FG001|NOT COMPLETED|Post-treatment Period||6||
48382727|NCT02163993|101265078|FG002|NOT COMPLETED|Post-treatment Period||4||
48541589|NCT03750292|101662784|FG001|NOT COMPLETED|First Intervention (Baseline to 8 Weeks)||0||
48091473|NCT01573572|100545786|FG000|COMPLETED|Overall Study||103||
48091474|NCT01573572|100545786|FG000|NOT COMPLETED|Overall Study||28||
48091475|NCT02326025|100545787|FG000|STARTED|Overall Study||25||
48091476|NCT02326025|100545788|FG001|STARTED|Overall Study||24||
48091477|NCT02326025|100545787|FG000|Received at Least 1 Dose of Study Drug|Overall Study||25||
48091478|NCT02326025|100545788|FG001|Received at Least 1 Dose of Study Drug|Overall Study||24||
48091479|NCT02326025|100545787|FG000|COMPLETED|Overall Study||20||
48091480|NCT02326025|100545788|FG001|COMPLETED|Overall Study||19||
48091481|NCT02326025|100545787|FG000|NOT COMPLETED|Overall Study||5||
48091482|NCT02326025|100545788|FG001|NOT COMPLETED|Overall Study||5||
48091483|NCT00040664|100545789|FG000|STARTED|Overall Study||69||
48091484|NCT00040664|100545790|FG001|STARTED|Overall Study||17||
48091485|NCT00040664|100545791|FG002|STARTED|Overall Study||17||
48091486|NCT00040664|100545792|FG003|STARTED|Overall Study||35||
48091487|NCT00040664|100545789|FG000|COMPLETED|Overall Study||16||
48091488|NCT00040664|100545790|FG001|COMPLETED|Overall Study||4||
48091489|NCT00040664|100545791|FG002|COMPLETED|Overall Study||4||
48091490|NCT00040664|100545792|FG003|COMPLETED|Overall Study||8||
48091491|NCT00040664|100545789|FG000|NOT COMPLETED|Overall Study||53||
48091492|NCT00040664|100545790|FG001|NOT COMPLETED|Overall Study||13||
48091493|NCT00040664|100545791|FG002|NOT COMPLETED|Overall Study||13||
48091494|NCT00040664|100545792|FG003|NOT COMPLETED|Overall Study||27||
48091495|NCT00450450|100545793|FG000|STARTED|Overall Study||13||
48091496|NCT00450450|100545794|FG001|STARTED|Overall Study||14||
48091497|NCT00450450|100545793|FG000|COMPLETED|Overall Study||8||
48382728|NCT02163993|101265079|FG003|NOT COMPLETED|Post-treatment Period||2||
48382729|NCT02163993|101265080|FG004|NOT COMPLETED|Post-treatment Period||3||
48091498|NCT00450450|100545794|FG001|COMPLETED|Overall Study||11||
48091499|NCT00450450|100545793|FG000|NOT COMPLETED|Overall Study||5||
48091500|NCT00450450|100545794|FG001|NOT COMPLETED|Overall Study||3||
48091501|NCT01881776|100545795|FG000|STARTED|Overall Study||24||
48091502|NCT01881776|100545796|FG001|STARTED|Overall Study||24||
48091503|NCT01881776|100545797|FG002|STARTED|Overall Study||22||
48091504|NCT01881776|100545795|FG000|COMPLETED|Overall Study||23||
48091505|NCT01881776|100545796|FG001|COMPLETED|Overall Study||20||
48091506|NCT01881776|100545797|FG002|COMPLETED|Overall Study||20||
48091507|NCT01881776|100545795|FG000|NOT COMPLETED|Overall Study||1||
48091508|NCT01881776|100545796|FG001|NOT COMPLETED|Overall Study||4||
48091509|NCT01881776|100545797|FG002|NOT COMPLETED|Overall Study||2||
48091510|NCT00467259|100545798|FG000|STARTED|Overall Study||251||
48091511|NCT00467259|100545799|FG001|STARTED|Overall Study||1020||
48091512|NCT00467259|100545798|FG000|ITT Population|Overall Study||251||
48091513|NCT00467259|100545799|FG001|ITT Population|Overall Study||1019||
48091514|NCT00467259|100545798|FG000|COMPLETED|Overall Study||176||
48091515|NCT00467259|100545799|FG001|COMPLETED|Overall Study||778||
48091516|NCT00467259|100545798|FG000|NOT COMPLETED|Overall Study||75||
48091517|NCT00467259|100545799|FG001|NOT COMPLETED|Overall Study||242||
48091518|NCT00734903|100545800|FG000|STARTED|Overall Study||33||
48091519|NCT00734903|100545801|FG001|STARTED|Overall Study||33||
48091520|NCT00734903|100545800|FG000|Completed End of Treatment Assessment|Overall Study||21||
48091521|NCT00734903|100545801|FG001|Completed End of Treatment Assessment|Overall Study||23||
48091522|NCT00734903|100545800|FG000|Completed 3-month Followup|Overall Study||14||
48091523|NCT00734903|100545801|FG001|Completed 3-month Followup|Overall Study||15||
48091524|NCT00734903|100545800|FG000|COMPLETED|Overall Study||30|Completion was defined, a priori, as completing at least 2 study assessments|
48141380|NCT01297062|100670416|FG006|COMPLETED|Overall Study||0||
48382730|NCT02559713|101265081|FG000|STARTED|Overall Study||11||
48255811|NCT03467698|100947626|FG000|COMPLETED|Overall Study||15||
48255812|NCT03467698|100947627|FG001|COMPLETED|Overall Study||15||
48255813|NCT03467698|100947626|FG000|NOT COMPLETED|Overall Study||0||
48255814|NCT03467698|100947627|FG001|NOT COMPLETED|Overall Study||0||
48255815|NCT01004185|100947628|FG000|STARTED|Overall Study||19||
48255816|NCT01004185|100947629|FG001|STARTED|Overall Study||20||
48382731|NCT02559713|101265081|FG000|Safety Set|Overall Study||11||
48382732|NCT02559713|101265081|FG000|Pharmacokinetic Set|Overall Study||11||
48382733|NCT02559713|101265081|FG000|COMPLETED|Overall Study||10||
48255817|NCT01004185|100947628|FG000|COMPLETED|Overall Study||10||
48382734|NCT02559713|101265081|FG000|NOT COMPLETED|Overall Study||1||
48382735|NCT00383721|101265082|FG000|STARTED|26-Week Double-Blind Treatment Period||225||
48382736|NCT00383721|101265083|FG001|STARTED|26-Week Double-Blind Treatment Period||239||
48382737|NCT00383721|101265084|FG002|STARTED|26-Week Double-Blind Treatment Period||253||
48382738|NCT00383721|101265085|FG003|STARTED|26-Week Double-Blind Treatment Period||243||
48382739|NCT00383721|101265086|FG004|STARTED|26-Week Double-Blind Treatment Period||236||
48382740|NCT00383721|101265082|FG000|COMPLETED|26-Week Double-Blind Treatment Period||190||
48255818|NCT01004185|100947629|FG001|COMPLETED|Overall Study||11||
48255819|NCT01004185|100947628|FG000|NOT COMPLETED|Overall Study||9||
48255820|NCT01004185|100947629|FG001|NOT COMPLETED|Overall Study||9||
48255821|NCT03756168|100947630|FG000|STARTED|Overall Study||30||
48255822|NCT03756168|100947630|FG000|Had at Least 1 Treatment|Overall Study||29||
48255823|NCT03756168|100947630|FG000|COMPLETED|Overall Study||27||
48255824|NCT03756168|100947630|FG000|NOT COMPLETED|Overall Study||3||
48255825|NCT00541671|100947631|FG000|STARTED|Overall Study||13||
48255826|NCT00541671|100947632|FG001|STARTED|Overall Study||12||
48255827|NCT00541671|100947631|FG000|COMPLETED|Overall Study||13||
48255828|NCT00541671|100947632|FG001|COMPLETED|Overall Study||12||
48255829|NCT00541671|100947631|FG000|NOT COMPLETED|Overall Study||0||
48255830|NCT00541671|100947632|FG001|NOT COMPLETED|Overall Study||0||
48255831|NCT04205955|100947633|FG000|STARTED|Overall Study||47||
48255832|NCT04205955|100947634|FG001|STARTED|Overall Study||48||
48255833|NCT04205955|100947633|FG000|COMPLETED|Overall Study||47||
48255834|NCT04205955|100947634|FG001|COMPLETED|Overall Study||48||
48255835|NCT04205955|100947633|FG000|NOT COMPLETED|Overall Study||0||
48255836|NCT04205955|100947634|FG001|NOT COMPLETED|Overall Study||0||
48255837|NCT01919398|100947635|FG000|STARTED|Overall Study||3||
48255838|NCT01919398|100947636|FG001|STARTED|Overall Study||3||
48255839|NCT01919398|100947637|FG002|STARTED|Overall Study||13||
48255840|NCT01919398|100947635|FG000|Received at Least One Dose of Study Drug|Overall Study||3||
48255841|NCT01919398|100947636|FG001|Received at Least One Dose of Study Drug|Overall Study||3||
48255842|NCT01919398|100947637|FG002|Received at Least One Dose of Study Drug|Overall Study||13||
48255843|NCT01919398|100947635|FG000|COMPLETED|Overall Study||3||
48255844|NCT01919398|100947636|FG001|COMPLETED|Overall Study||3||
48255845|NCT01919398|100947637|FG002|COMPLETED|Overall Study||9||
48255846|NCT01919398|100947635|FG000|NOT COMPLETED|Overall Study||0||
48255847|NCT01919398|100947636|FG001|NOT COMPLETED|Overall Study||0||
48255848|NCT01919398|100947637|FG002|NOT COMPLETED|Overall Study||4||
48255849|NCT02137499|100947638|FG000|STARTED|Overall Study||10||
48255850|NCT02137499|100947639|FG001|STARTED|Overall Study||10||
48255851|NCT02137499|100947640|FG002|STARTED|Overall Study||10||
48255852|NCT02137499|100947641|FG003|STARTED|Overall Study||10||
48255853|NCT02137499|100947638|FG000|COMPLETED|Overall Study||10||
48255854|NCT02137499|100947639|FG001|COMPLETED|Overall Study||10||
48255855|NCT02137499|100947640|FG002|COMPLETED|Overall Study||10||
48255856|NCT02137499|100947641|FG003|COMPLETED|Overall Study||10||
48255857|NCT02137499|100947638|FG000|NOT COMPLETED|Overall Study||0||
48255858|NCT02137499|100947639|FG001|NOT COMPLETED|Overall Study||0||
48255859|NCT02137499|100947640|FG002|NOT COMPLETED|Overall Study||0||
48255860|NCT02137499|100947641|FG003|NOT COMPLETED|Overall Study||0||
48382741|NCT00383721|101265083|FG001|COMPLETED|26-Week Double-Blind Treatment Period||202||
48382742|NCT00383721|101265084|FG002|COMPLETED|26-Week Double-Blind Treatment Period||202||
48382743|NCT00383721|101265085|FG003|COMPLETED|26-Week Double-Blind Treatment Period||193||
48382744|NCT00383721|101265086|FG004|COMPLETED|26-Week Double-Blind Treatment Period||169||
48255861|NCT00338949|100947642|FG000|STARTED|Subject Screening||36||
48255862|NCT00338949|100947643|FG001|STARTED|Subject Screening||41||
48255863|NCT00338949|100947642|FG000|COMPLETED|Subject Screening||25||
48255864|NCT00338949|100947643|FG001|COMPLETED|Subject Screening||30||
48255865|NCT00338949|100947642|FG000|NOT COMPLETED|Subject Screening||11||
48255866|NCT00338949|100947643|FG001|NOT COMPLETED|Subject Screening||11||
48255867|NCT00338949|100947642|FG000|STARTED|Randomization||25||
48255868|NCT00338949|100947643|FG001|STARTED|Randomization||30||
48255869|NCT00338949|100947642|FG000|COMPLETED|Randomization||24||
48255870|NCT00338949|100947643|FG001|COMPLETED|Randomization||25||
48255871|NCT00338949|100947642|FG000|NOT COMPLETED|Randomization||1||
48382745|NCT00383721|101265082|FG000|NOT COMPLETED|26-Week Double-Blind Treatment Period||35||
48255872|NCT00338949|100947643|FG001|NOT COMPLETED|Randomization||5||
48255873|NCT01817712|100947644|FG000|STARTED|Overall Study||271||
48255874|NCT01817712|100947645|FG001|STARTED|Overall Study||270||
48255875|NCT01817712|100947644|FG000|COMPLETED|Overall Study||250||
48255876|NCT01817712|100947645|FG001|COMPLETED|Overall Study||240||
48255877|NCT01817712|100947644|FG000|NOT COMPLETED|Overall Study||21||
48382746|NCT00383721|101265083|FG001|NOT COMPLETED|26-Week Double-Blind Treatment Period||37||
48382747|NCT00383721|101265084|FG002|NOT COMPLETED|26-Week Double-Blind Treatment Period||51||
48382748|NCT00383721|101265085|FG003|NOT COMPLETED|26-Week Double-Blind Treatment Period||50||
48382749|NCT00383721|101265086|FG004|NOT COMPLETED|26-Week Double-Blind Treatment Period||67||
48382750|NCT00383721|101265082|FG000|STARTED|26-Week Treatment Safety Extension||145||
48382751|NCT00383721|101265083|FG001|STARTED|26-Week Treatment Safety Extension||153||
48382752|NCT00383721|101265084|FG002|STARTED|26-Week Treatment Safety Extension||149||
48382753|NCT00383721|101265085|FG003|STARTED|26-Week Treatment Safety Extension||148||
48687274|NCT01994746|102017052|FG001|Received At Least 1 Dose|First Visit||38||
48687275|NCT01994746|102017051|FG000|COMPLETED|First Visit||39||
48091525|NCT00734903|100545801|FG001|COMPLETED|Overall Study||32|Completion was defined, a priori, as completing at least 2 study assessments|
48091526|NCT00734903|100545800|FG000|NOT COMPLETED|Overall Study||3||
48382754|NCT00383721|101265086|FG004|STARTED|26-Week Treatment Safety Extension||8||
48382755|NCT00383721|101265082|FG000|COMPLETED|26-Week Treatment Safety Extension||126||
48382756|NCT00383721|101265083|FG001|COMPLETED|26-Week Treatment Safety Extension||136||
48382757|NCT00383721|101265084|FG002|COMPLETED|26-Week Treatment Safety Extension||126||
48382758|NCT00383721|101265085|FG003|COMPLETED|26-Week Treatment Safety Extension||131||
48382759|NCT00383721|101265086|FG004|COMPLETED|26-Week Treatment Safety Extension||8||
48382760|NCT00383721|101265082|FG000|NOT COMPLETED|26-Week Treatment Safety Extension||19||
48382761|NCT00383721|101265083|FG001|NOT COMPLETED|26-Week Treatment Safety Extension||17||
48382762|NCT00383721|101265084|FG002|NOT COMPLETED|26-Week Treatment Safety Extension||23||
48382763|NCT00383721|101265085|FG003|NOT COMPLETED|26-Week Treatment Safety Extension||17||
48382764|NCT00383721|101265086|FG004|NOT COMPLETED|26-Week Treatment Safety Extension||0||
48382765|NCT04936724|101265087|FG000|STARTED|Overall Study||35||
48382766|NCT04936724|101265088|FG001|STARTED|Overall Study||35||
48382767|NCT04936724|101265087|FG000|COMPLETED|Overall Study||35||
48382768|NCT04936724|101265088|FG001|COMPLETED|Overall Study||35||
48382769|NCT04936724|101265087|FG000|NOT COMPLETED|Overall Study||0||
48382770|NCT04936724|101265088|FG001|NOT COMPLETED|Overall Study||0||
48382771|NCT01405313|101265089|FG000|STARTED|Overall Study||21||
48382772|NCT01405313|101265089|FG000|COMPLETED|Overall Study||21||
48382773|NCT01405313|101265089|FG000|NOT COMPLETED|Overall Study||0||
48382774|NCT00434512|101265090|FG000|STARTED|Overall Study||10||
48382775|NCT00434512|101265091|FG001|STARTED|Overall Study||10||
48382776|NCT00434512|101265092|FG002|STARTED|Overall Study||10||
48382777|NCT00434512|101265093|FG003|STARTED|Overall Study||50||
48382778|NCT00434512|101265094|FG004|STARTED|Overall Study||50||
48382779|NCT00434512|101265095|FG005|STARTED|Overall Study||50||
48382780|NCT00434512|101265090|FG000|COMPLETED|Overall Study||10||
48382781|NCT00434512|101265091|FG001|COMPLETED|Overall Study||9||
48091527|NCT00734903|100545801|FG001|NOT COMPLETED|Overall Study||1||
48091528|NCT00372112|100545802|FG000|STARTED|Overall Study||17||
48091529|NCT00372112|100545803|FG001|STARTED|Overall Study||16||
48091530|NCT00372112|100545804|FG002|STARTED|Overall Study||17||
48091531|NCT00372112|100545805|FG003|STARTED|Overall Study||18||
48091532|NCT00372112|100545802|FG000|COMPLETED|Overall Study||16||
48091533|NCT00372112|100545803|FG001|COMPLETED|Overall Study||15||
48091534|NCT00372112|100545804|FG002|COMPLETED|Overall Study||13||
48091535|NCT00372112|100545805|FG003|COMPLETED|Overall Study||14||
48091536|NCT00372112|100545802|FG000|NOT COMPLETED|Overall Study||1||
48091537|NCT00372112|100545803|FG001|NOT COMPLETED|Overall Study||1||
48382782|NCT00434512|101265092|FG002|COMPLETED|Overall Study||10||
48382783|NCT00434512|101265093|FG003|COMPLETED|Overall Study||49||
48382784|NCT00434512|101265094|FG004|COMPLETED|Overall Study||49||
48382785|NCT00434512|101265095|FG005|COMPLETED|Overall Study||49||
48382786|NCT00434512|101265090|FG000|NOT COMPLETED|Overall Study||0||
48382787|NCT00434512|101265091|FG001|NOT COMPLETED|Overall Study||1||
48382788|NCT00434512|101265092|FG002|NOT COMPLETED|Overall Study||0||
48382789|NCT00434512|101265093|FG003|NOT COMPLETED|Overall Study||1||
48382790|NCT00434512|101265094|FG004|NOT COMPLETED|Overall Study||1||
48091538|NCT00372112|100545804|FG002|NOT COMPLETED|Overall Study||4||
48091539|NCT00372112|100545805|FG003|NOT COMPLETED|Overall Study||4||
48091540|NCT00555321|100545806|FG000|STARTED|Treatment Phase up to 12-months||52||
48091541|NCT00555321|100545807|FG001|STARTED|Treatment Phase up to 12-months||51||
48091542|NCT00555321|100545808|FG002|STARTED|Treatment Phase up to 12-months||50||
48091543|NCT00555321|100545809|FG003|STARTED|Treatment Phase up to 12-months||53||
48382791|NCT00434512|101265095|FG005|NOT COMPLETED|Overall Study||1||
48382792|NCT01000727|101265096|FG000|STARTED|Overall Study||6522||
48382793|NCT01000727|101265097|FG001|STARTED|Overall Study||6504||
48382794|NCT01000727|101265096|FG000|COMPLETED|Overall Study||6347||
48382795|NCT01000727|101265097|FG001|COMPLETED|Overall Study||6328||
48382796|NCT01000727|101265096|FG000|NOT COMPLETED|Overall Study||175||
48382797|NCT01000727|101265097|FG001|NOT COMPLETED|Overall Study||176||
48382798|NCT00601796|101265098|FG000|STARTED|Overall Study||24||
48382799|NCT00601796|101265098|FG000|COMPLETED|Overall Study||24||
48382800|NCT00601796|101265098|FG000|NOT COMPLETED|Overall Study||0||
48382801|NCT00669916|101265099|FG000|STARTED|Overall Study||18||
48382802|NCT00669916|101265100|FG001|STARTED|Overall Study||18||
48382803|NCT00669916|101265099|FG000|COMPLETED|Overall Study||18||
48687276|NCT01994746|102017052|FG001|COMPLETED|First Visit||38||
48382804|NCT00669916|101265100|FG001|COMPLETED|Overall Study||18||
48382805|NCT00669916|101265099|FG000|NOT COMPLETED|Overall Study||0||
48382806|NCT00669916|101265100|FG001|NOT COMPLETED|Overall Study||0||
48255878|NCT01817712|100947645|FG001|NOT COMPLETED|Overall Study||30||
48255879|NCT03924947|100947646|FG000|STARTED|Part 1: Open Label Pre-Randomization||26||
48382807|NCT02193815|101265101|FG000|STARTED|Overall Study||15||
48382808|NCT02193815|101265101|FG000|COMPLETED|Overall Study||15||
48382809|NCT02193815|101265101|FG000|NOT COMPLETED|Overall Study||0||
48382810|NCT00262080|101265102|FG000|STARTED|Double Blind Treatment Period||36||
48255880|NCT03924947|100947647|FG001|STARTED|Part 1: Open Label Pre-Randomization||0||
48255881|NCT03924947|100947648|FG002|STARTED|Part 1: Open Label Pre-Randomization||0||
48255882|NCT03924947|100947649|FG003|STARTED|Part 1: Open Label Pre-Randomization||0||
48255883|NCT03924947|100947650|FG004|STARTED|Part 1: Open Label Pre-Randomization||0||
48255884|NCT03924947|100947651|FG005|STARTED|Part 1: Open Label Pre-Randomization||0||
48255885|NCT03924947|100947646|FG000|COMPLETED|Part 1: Open Label Pre-Randomization||26||
48255886|NCT03924947|100947647|FG001|COMPLETED|Part 1: Open Label Pre-Randomization||0||
48255887|NCT03924947|100947648|FG002|COMPLETED|Part 1: Open Label Pre-Randomization||0||
48382811|NCT00262080|101265103|FG001|STARTED|Double Blind Treatment Period||36||
48382812|NCT00262080|101265104|FG002|STARTED|Double Blind Treatment Period||0||
48382813|NCT00262080|101265102|FG000|COMPLETED|Double Blind Treatment Period||35||
48382814|NCT00262080|101265103|FG001|COMPLETED|Double Blind Treatment Period||36||
48382815|NCT00262080|101265104|FG002|COMPLETED|Double Blind Treatment Period||0||
48382816|NCT00262080|101265102|FG000|NOT COMPLETED|Double Blind Treatment Period||1||
48382817|NCT00262080|101265103|FG001|NOT COMPLETED|Double Blind Treatment Period||0||
48382818|NCT00262080|101265104|FG002|NOT COMPLETED|Double Blind Treatment Period||0||
48382819|NCT00262080|101265102|FG000|STARTED|Repeat Dose Treatment Period||22||
48255888|NCT03924947|100947649|FG003|COMPLETED|Part 1: Open Label Pre-Randomization||0||
48255889|NCT03924947|100947650|FG004|COMPLETED|Part 1: Open Label Pre-Randomization||0||
48255890|NCT03924947|100947651|FG005|COMPLETED|Part 1: Open Label Pre-Randomization||0||
48255891|NCT03924947|100947646|FG000|NOT COMPLETED|Part 1: Open Label Pre-Randomization||0||
48255892|NCT03924947|100947647|FG001|NOT COMPLETED|Part 1: Open Label Pre-Randomization||0||
48255893|NCT03924947|100947648|FG002|NOT COMPLETED|Part 1: Open Label Pre-Randomization||0||
48255894|NCT03924947|100947649|FG003|NOT COMPLETED|Part 1: Open Label Pre-Randomization||0||
48255895|NCT03924947|100947650|FG004|NOT COMPLETED|Part 1: Open Label Pre-Randomization||0||
48255896|NCT03924947|100947651|FG005|NOT COMPLETED|Part 1: Open Label Pre-Randomization||0||
48255897|NCT03924947|100947646|FG000|STARTED|Part 1: Double Blind Period 1||0||
48255898|NCT03924947|100947647|FG001|STARTED|Part 1: Double Blind Period 1||13||
48255899|NCT03924947|100947648|FG002|STARTED|Part 1: Double Blind Period 1||13||
48255900|NCT03924947|100947649|FG003|STARTED|Part 1: Double Blind Period 1||0||
48255901|NCT03924947|100947650|FG004|STARTED|Part 1: Double Blind Period 1||0||
48255902|NCT03924947|100947651|FG005|STARTED|Part 1: Double Blind Period 1||0||
48255903|NCT03924947|100947646|FG000|COMPLETED|Part 1: Double Blind Period 1||0||
48255904|NCT03924947|100947647|FG001|COMPLETED|Part 1: Double Blind Period 1||13||
48255905|NCT03924947|100947648|FG002|COMPLETED|Part 1: Double Blind Period 1||12||
48255906|NCT03924947|100947649|FG003|COMPLETED|Part 1: Double Blind Period 1||0||
48255907|NCT03924947|100947650|FG004|COMPLETED|Part 1: Double Blind Period 1||0||
48255908|NCT03924947|100947651|FG005|COMPLETED|Part 1: Double Blind Period 1||0||
48255909|NCT03924947|100947646|FG000|NOT COMPLETED|Part 1: Double Blind Period 1||0||
48255910|NCT03924947|100947647|FG001|NOT COMPLETED|Part 1: Double Blind Period 1||0||
48255911|NCT03924947|100947648|FG002|NOT COMPLETED|Part 1: Double Blind Period 1||1||
48255912|NCT03924947|100947649|FG003|NOT COMPLETED|Part 1: Double Blind Period 1||0||
48255913|NCT03924947|100947650|FG004|NOT COMPLETED|Part 1: Double Blind Period 1||0||
48255914|NCT03924947|100947651|FG005|NOT COMPLETED|Part 1: Double Blind Period 1||0||
48255915|NCT03924947|100947646|FG000|STARTED|Part 1: Double Blind Period 2||0||
48382820|NCT00262080|101265103|FG001|STARTED|Repeat Dose Treatment Period||26||
48382821|NCT00262080|101265104|FG002|STARTED|Repeat Dose Treatment Period||19||
48382822|NCT00262080|101265102|FG000|COMPLETED|Repeat Dose Treatment Period||18||
48382823|NCT00262080|101265103|FG001|COMPLETED|Repeat Dose Treatment Period||25||
48382824|NCT00262080|101265104|FG002|COMPLETED|Repeat Dose Treatment Period||14||
48382825|NCT00262080|101265102|FG000|NOT COMPLETED|Repeat Dose Treatment Period||4||
48382826|NCT00262080|101265103|FG001|NOT COMPLETED|Repeat Dose Treatment Period||1||
48382827|NCT00262080|101265104|FG002|NOT COMPLETED|Repeat Dose Treatment Period||5||
48382828|NCT03571256|101265105|FG000|STARTED|Overall Study||52|Intent-to-treat (ITT) analysis set: all randomized participants|
48382829|NCT03571256|101265106|FG001|STARTED|Overall Study||54|Intent-to-treat (ITT) analysis set: all randomized participants|
48382830|NCT03571256|101265107|FG002|STARTED|Overall Study||52|Intent-to-treat (ITT) analysis set: all randomized participants|
48382831|NCT03571256|101265105|FG000|Safety Analysis Set|Overall Study||52|Received at least 1 dose of study drug|
48382832|NCT03571256|101265106|FG001|Safety Analysis Set|Overall Study||54|Received at least 1 dose of study drug|
48382833|NCT03571256|101265107|FG002|Safety Analysis Set|Overall Study||51|Received at least 1 dose of study drug|
48382834|NCT03571256|101265105|FG000|Modified ITT (mITT) Analysis Set|Overall Study||49|Received at least 1 dose of study drug; had both baseline \& at least 1 postbaseline YGTSS assessment|
48382835|NCT03571256|101265106|FG001|Modified ITT (mITT) Analysis Set|Overall Study||53|Received at least 1 dose of study drug; had both baseline \& at least 1 postbaseline YGTSS assessment|
48382836|NCT03571256|101265107|FG002|Modified ITT (mITT) Analysis Set|Overall Study||51|Received at least 1 dose of study drug; had both baseline \& at least 1 postbaseline YGTSS assessment|
48382837|NCT03571256|101265105|FG000|COMPLETED|Overall Study||46||
48382838|NCT03571256|101265106|FG001|COMPLETED|Overall Study||51||
48382839|NCT03571256|101265107|FG002|COMPLETED|Overall Study||48||
48382840|NCT03571256|101265105|FG000|NOT COMPLETED|Overall Study||6||
48382841|NCT03571256|101265106|FG001|NOT COMPLETED|Overall Study||3||
48382842|NCT03571256|101265107|FG002|NOT COMPLETED|Overall Study||4||
48382843|NCT00356863|101265108|FG000|STARTED|Overall Study||504||
48382844|NCT00356863|101265109|FG001|STARTED|Overall Study||520||
48382845|NCT00356863|101265108|FG000|COMPLETED|Overall Study||412||
48382846|NCT00356863|101265109|FG001|COMPLETED|Overall Study||445||
48255916|NCT03924947|100947647|FG001|STARTED|Part 1: Double Blind Period 2||13||
48255917|NCT03924947|100947648|FG002|STARTED|Part 1: Double Blind Period 2||12||
48255918|NCT03924947|100947649|FG003|STARTED|Part 1: Double Blind Period 2||0||
48255919|NCT03924947|100947650|FG004|STARTED|Part 1: Double Blind Period 2||0||
48255920|NCT03924947|100947651|FG005|STARTED|Part 1: Double Blind Period 2||0||
48255921|NCT03924947|100947646|FG000|COMPLETED|Part 1: Double Blind Period 2||0||
48255922|NCT03924947|100947647|FG001|COMPLETED|Part 1: Double Blind Period 2||13||
48255923|NCT03924947|100947648|FG002|COMPLETED|Part 1: Double Blind Period 2||12||
48255924|NCT03924947|100947649|FG003|COMPLETED|Part 1: Double Blind Period 2||0||
48382847|NCT00356863|101265108|FG000|NOT COMPLETED|Overall Study||92||
48382848|NCT00356863|101265109|FG001|NOT COMPLETED|Overall Study||75||
48382849|NCT01363713|101265110|FG000|STARTED|Overall Study||130||
48382850|NCT01363713|101265110|FG000|ALLOCATED|Overall Study||130||
48382851|NCT01363713|101265110|FG000|COMPLETED|Overall Study||124||
48382852|NCT01363713|101265110|FG000|NOT COMPLETED|Overall Study||6||
48382853|NCT01953328|101265111|FG000|STARTED|Overall Study||49||
48382854|NCT01953328|101265112|FG001|STARTED|Overall Study||50||
48255925|NCT03924947|100947650|FG004|COMPLETED|Part 1: Double Blind Period 2||0||
48255926|NCT03924947|100947651|FG005|COMPLETED|Part 1: Double Blind Period 2||0||
48255927|NCT03924947|100947646|FG000|NOT COMPLETED|Part 1: Double Blind Period 2||0||
48255928|NCT03924947|100947647|FG001|NOT COMPLETED|Part 1: Double Blind Period 2||0||
48255929|NCT03924947|100947648|FG002|NOT COMPLETED|Part 1: Double Blind Period 2||0||
48255930|NCT03924947|100947649|FG003|NOT COMPLETED|Part 1: Double Blind Period 2||0||
48255931|NCT03924947|100947650|FG004|NOT COMPLETED|Part 1: Double Blind Period 2||0||
48255932|NCT03924947|100947651|FG005|NOT COMPLETED|Part 1: Double Blind Period 2||0||
48255933|NCT03924947|100947646|FG000|STARTED|Part 2: Open Label Pre-Randomization||0||
48255934|NCT03924947|100947647|FG001|STARTED|Part 2: Open Label Pre-Randomization||0||
48255935|NCT03924947|100947648|FG002|STARTED|Part 2: Open Label Pre-Randomization||0||
48255936|NCT03924947|100947649|FG003|STARTED|Part 2: Open Label Pre-Randomization||24||
48255937|NCT03924947|100947650|FG004|STARTED|Part 2: Open Label Pre-Randomization||0||
48255938|NCT03924947|100947651|FG005|STARTED|Part 2: Open Label Pre-Randomization||0||
48255939|NCT03924947|100947646|FG000|COMPLETED|Part 2: Open Label Pre-Randomization||0||
48255940|NCT03924947|100947647|FG001|COMPLETED|Part 2: Open Label Pre-Randomization||0||
48255941|NCT03924947|100947648|FG002|COMPLETED|Part 2: Open Label Pre-Randomization||0||
48255942|NCT03924947|100947649|FG003|COMPLETED|Part 2: Open Label Pre-Randomization||24||
48255943|NCT03924947|100947650|FG004|COMPLETED|Part 2: Open Label Pre-Randomization||0||
48687277|NCT01994746|102017051|FG000|NOT COMPLETED|First Visit||0||
48255944|NCT03924947|100947651|FG005|COMPLETED|Part 2: Open Label Pre-Randomization||0||
48255945|NCT03924947|100947646|FG000|NOT COMPLETED|Part 2: Open Label Pre-Randomization||0||
48255946|NCT03924947|100947647|FG001|NOT COMPLETED|Part 2: Open Label Pre-Randomization||0||
48255947|NCT03924947|100947648|FG002|NOT COMPLETED|Part 2: Open Label Pre-Randomization||0||
48255948|NCT03924947|100947649|FG003|NOT COMPLETED|Part 2: Open Label Pre-Randomization||0||
48255949|NCT03924947|100947650|FG004|NOT COMPLETED|Part 2: Open Label Pre-Randomization||0||
48255950|NCT03924947|100947651|FG005|NOT COMPLETED|Part 2: Open Label Pre-Randomization||0||
48382855|NCT01953328|101265113|FG002|STARTED|Overall Study||50||
48687278|NCT01994746|102017052|FG001|NOT COMPLETED|First Visit||0||
48255951|NCT03924947|100947646|FG000|STARTED|Part 2: Double Blind Period 1||0||
48255952|NCT03924947|100947647|FG001|STARTED|Part 2: Double Blind Period 1||0||
48382856|NCT01953328|101265114|FG003|STARTED|Overall Study||50||
48382857|NCT01953328|101265115|FG004|STARTED|Overall Study||52||
48382858|NCT01953328|101265116|FG005|STARTED|Overall Study||51||
48687279|NCT01994746|102017051|FG000|STARTED|Second Visit||38||
48255953|NCT03924947|100947648|FG002|STARTED|Part 2: Double Blind Period 1||0||
48255954|NCT03924947|100947649|FG003|STARTED|Part 2: Double Blind Period 1||0||
48382859|NCT01953328|101265117|FG006|STARTED|Overall Study||51||
48382860|NCT01953328|101265118|FG007|STARTED|Overall Study||51||
48382861|NCT01953328|101265111|FG000|Received Treatment|Overall Study||49||
48687280|NCT01994746|102017052|FG001|STARTED|Second Visit||38||
48382862|NCT01953328|101265112|FG001|Received Treatment|Overall Study||50||
48382863|NCT01953328|101265113|FG002|Received Treatment|Overall Study||50||
48382864|NCT01953328|101265114|FG003|Received Treatment|Overall Study||50||
48382865|NCT01953328|101265115|FG004|Received Treatment|Overall Study||52||
48382866|NCT01953328|101265116|FG005|Received Treatment|Overall Study||51||
48382867|NCT01953328|101265117|FG006|Received Treatment|Overall Study||51||
48382868|NCT01953328|101265118|FG007|Received Treatment|Overall Study||51||
48382869|NCT01953328|101265111|FG000|COMPLETED|Overall Study||49||
48382870|NCT01953328|101265112|FG001|COMPLETED|Overall Study||50||
48382871|NCT01953328|101265113|FG002|COMPLETED|Overall Study||50||
48382872|NCT01953328|101265114|FG003|COMPLETED|Overall Study||50||
48382873|NCT01953328|101265115|FG004|COMPLETED|Overall Study||50||
48382874|NCT01953328|101265116|FG005|COMPLETED|Overall Study||51||
48382875|NCT01953328|101265117|FG006|COMPLETED|Overall Study||51||
48382876|NCT01953328|101265118|FG007|COMPLETED|Overall Study||51||
48382877|NCT01953328|101265111|FG000|NOT COMPLETED|Overall Study||0||
48382878|NCT01953328|101265112|FG001|NOT COMPLETED|Overall Study||0||
48382879|NCT01953328|101265113|FG002|NOT COMPLETED|Overall Study||0||
48382880|NCT01953328|101265114|FG003|NOT COMPLETED|Overall Study||0||
48382881|NCT01953328|101265115|FG004|NOT COMPLETED|Overall Study||2||
48382882|NCT01953328|101265116|FG005|NOT COMPLETED|Overall Study||0||
48382883|NCT01953328|101265117|FG006|NOT COMPLETED|Overall Study||0||
48382884|NCT01953328|101265118|FG007|NOT COMPLETED|Overall Study||0||
48382885|NCT05138783|101265119|FG000|STARTED|First Wear Period, 8 -0/+3 Days||62||124
48382886|NCT05138783|101265120|FG001|STARTED|First Wear Period, 8 -0/+3 Days||64||128
48382887|NCT05138783|101265119|FG000|COMPLETED|First Wear Period, 8 -0/+3 Days||62||124
48382888|NCT05138783|101265120|FG001|COMPLETED|First Wear Period, 8 -0/+3 Days||64||128
48382889|NCT05138783|101265119|FG000|NOT COMPLETED|First Wear Period, 8 -0/+3 Days||0||0
48382890|NCT05138783|101265120|FG001|NOT COMPLETED|First Wear Period, 8 -0/+3 Days||0||0
48382891|NCT05138783|101265119|FG000|STARTED|Second Wear Period, 8 -0/+3 Days||62||124
48382892|NCT05138783|101265120|FG001|STARTED|Second Wear Period, 8 -0/+3 Days||64||128
48382893|NCT05138783|101265119|FG000|COMPLETED|Second Wear Period, 8 -0/+3 Days||62||124
48382894|NCT05138783|101265120|FG001|COMPLETED|Second Wear Period, 8 -0/+3 Days||64||128
48382895|NCT05138783|101265119|FG000|NOT COMPLETED|Second Wear Period, 8 -0/+3 Days||0||0
48382896|NCT05138783|101265120|FG001|NOT COMPLETED|Second Wear Period, 8 -0/+3 Days||0||0
48382897|NCT02055430|101265121|FG000|STARTED|Overall Study||45||
48382898|NCT02055430|101265122|FG001|STARTED|Overall Study||45||
48382899|NCT02055430|101265121|FG000|COMPLETED|Overall Study||45||
48382900|NCT02055430|101265122|FG001|COMPLETED|Overall Study||45||
48382901|NCT02055430|101265121|FG000|NOT COMPLETED|Overall Study||0||
48382902|NCT02055430|101265122|FG001|NOT COMPLETED|Overall Study||0||
48382903|NCT00442013|101265123|FG000|STARTED|Overall Study||157||
48382904|NCT00442013|101265124|FG001|STARTED|Overall Study||149||
48382905|NCT00442013|101265123|FG000|COMPLETED|Overall Study||131||
48382906|NCT00442013|101265124|FG001|COMPLETED|Overall Study||132||
48382907|NCT00442013|101265123|FG000|NOT COMPLETED|Overall Study||26||
48091544|NCT00555321|100545810|FG004|STARTED|Treatment Phase up to 12-months||54||
48382908|NCT00442013|101265124|FG001|NOT COMPLETED|Overall Study||17||
48382909|NCT00254293|101265125|FG000|STARTED|Short Term (12 Week) Randomized Dosing||7||
48382910|NCT00254293|101265126|FG001|STARTED|Short Term (12 Week) Randomized Dosing||4||
48382911|NCT00254293|101265127|FG002|STARTED|Short Term (12 Week) Randomized Dosing||29||
48687281|NCT01994746|102017051|FG000|Completed Both Dosing Visits|Second Visit||38||
48687282|NCT01994746|102017052|FG001|Completed Both Dosing Visits|Second Visit||38||
48687283|NCT01994746|102017051|FG000|COMPLETED|Second Visit||38||
48687284|NCT01994746|102017052|FG001|COMPLETED|Second Visit||38||
48382912|NCT00254293|101265128|FG003|STARTED|Short Term (12 Week) Randomized Dosing||6||
48382913|NCT00254293|101265129|FG004|STARTED|Short Term (12 Week) Randomized Dosing||5||
48382914|NCT00254293|101265130|FG005|STARTED|Short Term (12 Week) Randomized Dosing||17||
48382915|NCT00254293|101265131|FG006|STARTED|Short Term (12 Week) Randomized Dosing||0||
48382916|NCT00254293|101265125|FG000|COMPLETED|Short Term (12 Week) Randomized Dosing||7||
48382917|NCT00254293|101265126|FG001|COMPLETED|Short Term (12 Week) Randomized Dosing||3||
48382918|NCT00254293|101265127|FG002|COMPLETED|Short Term (12 Week) Randomized Dosing||26||
48382919|NCT00254293|101265128|FG003|COMPLETED|Short Term (12 Week) Randomized Dosing||5||
48382920|NCT00254293|101265129|FG004|COMPLETED|Short Term (12 Week) Randomized Dosing||5||
48382921|NCT00254293|101265130|FG005|COMPLETED|Short Term (12 Week) Randomized Dosing||17||
48382922|NCT00254293|101265131|FG006|COMPLETED|Short Term (12 Week) Randomized Dosing||0||
48382923|NCT00254293|101265125|FG000|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0||
48687285|NCT01994746|102017051|FG000|NOT COMPLETED|Second Visit||0||
48091545|NCT00555321|100545806|FG000|Received Transplant and Treated|Treatment Phase up to 12-months||50||
48091546|NCT00555321|100545807|FG001|Received Transplant and Treated|Treatment Phase up to 12-months||48||
48382924|NCT00254293|101265126|FG001|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1||
48382925|NCT00254293|101265127|FG002|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||3||
48382926|NCT00254293|101265128|FG003|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1||
48382927|NCT00254293|101265129|FG004|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0||
48382928|NCT00254293|101265130|FG005|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0||
48382929|NCT00254293|101265131|FG006|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0||
48382930|NCT00254293|101265125|FG000|STARTED|LTE Open Label Variable SC Dosing||11||
48382931|NCT00254293|101265126|FG001|STARTED|LTE Open Label Variable SC Dosing||0||
48382932|NCT00254293|101265127|FG002|STARTED|LTE Open Label Variable SC Dosing||42||
48382933|NCT00254293|101265128|FG003|STARTED|LTE Open Label Variable SC Dosing||0||
48382934|NCT00254293|101265129|FG004|STARTED|LTE Open Label Variable SC Dosing||10||
48382935|NCT00254293|101265130|FG005|STARTED|LTE Open Label Variable SC Dosing||0||
48382936|NCT00254293|101265131|FG006|STARTED|LTE Open Label Variable SC Dosing||0||
48382937|NCT00254293|101265125|FG000|COMPLETED|LTE Open Label Variable SC Dosing||8||
48382938|NCT00254293|101265126|FG001|COMPLETED|LTE Open Label Variable SC Dosing||0||
48382939|NCT00254293|101265127|FG002|COMPLETED|LTE Open Label Variable SC Dosing||32||
48382940|NCT00254293|101265128|FG003|COMPLETED|LTE Open Label Variable SC Dosing||0||
48382941|NCT00254293|101265129|FG004|COMPLETED|LTE Open Label Variable SC Dosing||8||
48382942|NCT00254293|101265130|FG005|COMPLETED|LTE Open Label Variable SC Dosing||0||
48382943|NCT00254293|101265131|FG006|COMPLETED|LTE Open Label Variable SC Dosing||0||
48382944|NCT00254293|101265125|FG000|NOT COMPLETED|LTE Open Label Variable SC Dosing||3||
48382945|NCT00254293|101265126|FG001|NOT COMPLETED|LTE Open Label Variable SC Dosing||0||
48255955|NCT03924947|100947650|FG004|STARTED|Part 2: Double Blind Period 1||11||
48255956|NCT03924947|100947651|FG005|STARTED|Part 2: Double Blind Period 1||12||
48255957|NCT03924947|100947646|FG000|COMPLETED|Part 2: Double Blind Period 1||0||
48255958|NCT03924947|100947647|FG001|COMPLETED|Part 2: Double Blind Period 1||0||
48255959|NCT03924947|100947648|FG002|COMPLETED|Part 2: Double Blind Period 1||0||
48255960|NCT03924947|100947649|FG003|COMPLETED|Part 2: Double Blind Period 1||0||
48255961|NCT03924947|100947650|FG004|COMPLETED|Part 2: Double Blind Period 1||11||
48255962|NCT03924947|100947651|FG005|COMPLETED|Part 2: Double Blind Period 1||12||
48255963|NCT03924947|100947646|FG000|NOT COMPLETED|Part 2: Double Blind Period 1||0||
48255964|NCT03924947|100947647|FG001|NOT COMPLETED|Part 2: Double Blind Period 1||0||
48255965|NCT03924947|100947648|FG002|NOT COMPLETED|Part 2: Double Blind Period 1||0||
48255966|NCT03924947|100947649|FG003|NOT COMPLETED|Part 2: Double Blind Period 1||0||
48255967|NCT03924947|100947650|FG004|NOT COMPLETED|Part 2: Double Blind Period 1||0||
48255968|NCT03924947|100947651|FG005|NOT COMPLETED|Part 2: Double Blind Period 1||0||
48255969|NCT03924947|100947646|FG000|STARTED|Part 2: Double Blind Period 2||0||
48255970|NCT03924947|100947647|FG001|STARTED|Part 2: Double Blind Period 2||0||
48255971|NCT03924947|100947648|FG002|STARTED|Part 2: Double Blind Period 2||0||
48255972|NCT03924947|100947649|FG003|STARTED|Part 2: Double Blind Period 2||0||
48255973|NCT03924947|100947650|FG004|STARTED|Part 2: Double Blind Period 2||11||
48255974|NCT03924947|100947651|FG005|STARTED|Part 2: Double Blind Period 2||12||
48255975|NCT03924947|100947646|FG000|COMPLETED|Part 2: Double Blind Period 2||0||
48255976|NCT03924947|100947647|FG001|COMPLETED|Part 2: Double Blind Period 2||0||
48255977|NCT03924947|100947648|FG002|COMPLETED|Part 2: Double Blind Period 2||0||
48255978|NCT03924947|100947649|FG003|COMPLETED|Part 2: Double Blind Period 2||0||
48255979|NCT03924947|100947650|FG004|COMPLETED|Part 2: Double Blind Period 2||11||
48091547|NCT00555321|100545808|FG002|Received Transplant and Treated|Treatment Phase up to 12-months||49||
48091548|NCT00555321|100545809|FG003|Received Transplant and Treated|Treatment Phase up to 12-months||53||
48091549|NCT00555321|100545810|FG004|Received Transplant and Treated|Treatment Phase up to 12-months||50||
48091550|NCT00555321|100545806|FG000|COMPLETED|Treatment Phase up to 12-months||31||
48091551|NCT00555321|100545807|FG001|COMPLETED|Treatment Phase up to 12-months||29||
48091552|NCT00555321|100545808|FG002|COMPLETED|Treatment Phase up to 12-months||26||
48091553|NCT00555321|100545809|FG003|COMPLETED|Treatment Phase up to 12-months||46||
48091554|NCT00555321|100545810|FG004|COMPLETED|Treatment Phase up to 12-months||32||
48091555|NCT00555321|100545806|FG000|NOT COMPLETED|Treatment Phase up to 12-months||21||
48091556|NCT00555321|100545807|FG001|NOT COMPLETED|Treatment Phase up to 12-months||22||
48091557|NCT00555321|100545808|FG002|NOT COMPLETED|Treatment Phase up to 12-months||24||
48091558|NCT00555321|100545809|FG003|NOT COMPLETED|Treatment Phase up to 12-months||7||
48091559|NCT00555321|100545810|FG004|NOT COMPLETED|Treatment Phase up to 12-months||22||
48091560|NCT00555321|100545806|FG000|STARTED|Long-term Extension Phase||30||
48091561|NCT00555321|100545807|FG001|STARTED|Long-term Extension Phase||27||
48091562|NCT00555321|100545808|FG002|STARTED|Long-term Extension Phase||24||
48091563|NCT00555321|100545809|FG003|STARTED|Long-term Extension Phase||38||
48091564|NCT00555321|100545810|FG004|STARTED|Long-term Extension Phase||26||
48091565|NCT00555321|100545806|FG000|COMPLETED|Long-term Extension Phase||0||
48091566|NCT00555321|100545807|FG001|COMPLETED|Long-term Extension Phase||0||
48091567|NCT00555321|100545808|FG002|COMPLETED|Long-term Extension Phase||0||
48091568|NCT00555321|100545809|FG003|COMPLETED|Long-term Extension Phase||0||
48091569|NCT00555321|100545810|FG004|COMPLETED|Long-term Extension Phase||0||
48091570|NCT00555321|100545806|FG000|NOT COMPLETED|Long-term Extension Phase||30||
48091571|NCT00555321|100545807|FG001|NOT COMPLETED|Long-term Extension Phase||27||
48091572|NCT00555321|100545808|FG002|NOT COMPLETED|Long-term Extension Phase||24||
48091573|NCT00555321|100545809|FG003|NOT COMPLETED|Long-term Extension Phase||38||
48091574|NCT00555321|100545810|FG004|NOT COMPLETED|Long-term Extension Phase||26||
48091575|NCT03804879|100545811|FG000|STARTED|Overall Study||41|All randomized participants.|
48091576|NCT03804879|100545812|FG001|STARTED|Overall Study||42|All randomized participants.|
48091577|NCT03804879|100545811|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||41|All randomized participants with at least one valid PK concentration measurement, who received LMB763 and no protocol deviations with relevant impact on PK data.|
48091578|NCT03804879|100545812|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||0|All randomized participants with at least one valid PK concentration measurement, who received LMB763 and no protocol deviations with relevant impact on PK data.|
48091579|NCT03804879|100545811|FG000|Pharmacodynamics (PD) Analysis Set|Overall Study||41|All randomized participants with no protocol deviations with relevant impact on PD data.|
48091580|NCT03804879|100545812|FG001|Pharmacodynamics (PD) Analysis Set|Overall Study||41|All randomized participants with no protocol deviations with relevant impact on PD data.|
48091581|NCT03804879|100545811|FG000|COMPLETED|Overall Study||25||
48091582|NCT03804879|100545812|FG001|COMPLETED|Overall Study||29||
48541590|NCT03750292|101662783|FG000|STARTED|Washout (3 Weeks)||5||
48541591|NCT03750292|101662784|FG001|STARTED|Washout (3 Weeks)||4||
48541592|NCT03750292|101662783|FG000|COMPLETED|Washout (3 Weeks)||5||
48687286|NCT01994746|102017052|FG001|NOT COMPLETED|Second Visit||0||
48687287|NCT02103127|102017053|FG000|STARTED|Overall Study||20||
48687288|NCT02103127|102017053|FG000|COMPLETED|Overall Study||17||
48687289|NCT02103127|102017053|FG000|NOT COMPLETED|Overall Study||3||
48091583|NCT03804879|100545811|FG000|NOT COMPLETED|Overall Study||16||
48091584|NCT03804879|100545812|FG001|NOT COMPLETED|Overall Study||13||
48091585|NCT00396591|100545813|FG000|STARTED|Overall Study||16||
48091586|NCT00396591|100545813|FG000|COMPLETED|Overall Study||0||
48091587|NCT00396591|100545813|FG000|NOT COMPLETED|Overall Study||16||
48091588|NCT01349803|100545814|FG000|STARTED|Overall Study||60||
48091589|NCT01349803|100545815|FG001|STARTED|Overall Study||58||
48091590|NCT01349803|100545816|FG002|STARTED|Overall Study||60||
48091591|NCT01349803|100545817|FG003|STARTED|Overall Study||59||
48091592|NCT01349803|100545814|FG000|COMPLETED|Overall Study||59||
48091593|NCT01349803|100545815|FG001|COMPLETED|Overall Study||57||
48091594|NCT01349803|100545816|FG002|COMPLETED|Overall Study||57||
48091595|NCT01349803|100545817|FG003|COMPLETED|Overall Study||57||
48091596|NCT01349803|100545814|FG000|NOT COMPLETED|Overall Study||1||
48091597|NCT01349803|100545815|FG001|NOT COMPLETED|Overall Study||1||
48091598|NCT01349803|100545816|FG002|NOT COMPLETED|Overall Study||3||
48091599|NCT01349803|100545817|FG003|NOT COMPLETED|Overall Study||2||
48091600|NCT00714389|100545818|FG000|STARTED|Overall Study||12||
48091601|NCT00714389|100545818|FG000|COMPLETED|Overall Study||12||
48091602|NCT00714389|100545818|FG000|NOT COMPLETED|Overall Study||0||
48091603|NCT02385045|100545819|FG000|STARTED|Overall Study||157||
48541593|NCT03750292|101662784|FG001|COMPLETED|Washout (3 Weeks)||4||
48687290|NCT03079531|102017054|FG000|STARTED|Overall Study||24||
48687291|NCT03079531|102017054|FG000|Attended ≥1 Post-baseline Visit|Overall Study||23||
48091604|NCT02385045|100545819|FG000|COMPLETED|Overall Study||153||
48091605|NCT02385045|100545819|FG000|NOT COMPLETED|Overall Study||4||
48091606|NCT00788151|100545820|FG000|STARTED|Overall Study||200||
48091607|NCT00788151|100545821|FG001|STARTED|Overall Study||100||
48091608|NCT00788151|100545820|FG000|Received Vaccination 1|Overall Study||199||
48091609|NCT00788151|100545821|FG001|Received Vaccination 1|Overall Study||99||
48091610|NCT00788151|100545820|FG000|Received Vaccination 2|Overall Study||188||
48091611|NCT00788151|100545821|FG001|Received Vaccination 2|Overall Study||92||
48091612|NCT00788151|100545820|FG000|Received Vaccination 3|Overall Study||186||
48091613|NCT00788151|100545821|FG001|Received Vaccination 3|Overall Study||90||
48091614|NCT00788151|100545820|FG000|COMPLETED|Overall Study||186||
48091615|NCT00788151|100545821|FG001|COMPLETED|Overall Study||90||
48091616|NCT00788151|100545820|FG000|NOT COMPLETED|Overall Study||14||
48091617|NCT00788151|100545821|FG001|NOT COMPLETED|Overall Study||10||
48091618|NCT01905657|100545822|FG000|STARTED|Overall Study||345||
48091619|NCT01905657|100545823|FG001|STARTED|Overall Study||346||
48091620|NCT01905657|100545824|FG002|STARTED|Overall Study||343||
48091621|NCT01905657|100545822|FG000|Treated|Overall Study||339||
48091622|NCT01905657|100545823|FG001|Treated|Overall Study||343||
48091623|NCT01905657|100545824|FG002|Treated|Overall Study||309||
48141381|NCT01297062|100670410|FG000|NOT COMPLETED|Overall Study||4||
48541594|NCT03750292|101662783|FG000|NOT COMPLETED|Washout (3 Weeks)||0||
48687292|NCT03079531|102017054|FG000|COMPLETED|Overall Study||17||
48255980|NCT03924947|100947651|FG005|COMPLETED|Part 2: Double Blind Period 2||11||
48255981|NCT03924947|100947646|FG000|NOT COMPLETED|Part 2: Double Blind Period 2||0||
48255982|NCT03924947|100947647|FG001|NOT COMPLETED|Part 2: Double Blind Period 2||0||
48255983|NCT03924947|100947648|FG002|NOT COMPLETED|Part 2: Double Blind Period 2||0||
48255984|NCT03924947|100947649|FG003|NOT COMPLETED|Part 2: Double Blind Period 2||0||
48255985|NCT03924947|100947650|FG004|NOT COMPLETED|Part 2: Double Blind Period 2||0||
48255986|NCT03924947|100947651|FG005|NOT COMPLETED|Part 2: Double Blind Period 2||1||
48255987|NCT01585441|100947652|FG000|STARTED|Overall Study||3||
48255988|NCT01585441|100947653|FG001|STARTED|Overall Study||3||
48255989|NCT01585441|100947652|FG000|Month 3|Overall Study||2||
48255990|NCT01585441|100947653|FG001|Month 3|Overall Study||3||
48255991|NCT01585441|100947652|FG000|Received Finasteride at Month 3|Overall Study||2||
48255992|NCT01585441|100947653|FG001|Received Finasteride at Month 3|Overall Study||2||
48255993|NCT01585441|100947652|FG000|Final Study Safety Visit|Overall Study||3||
48255994|NCT01585441|100947653|FG001|Final Study Safety Visit|Overall Study||2||
48382946|NCT00254293|101265127|FG002|NOT COMPLETED|LTE Open Label Variable SC Dosing||10||
48382947|NCT00254293|101265128|FG003|NOT COMPLETED|LTE Open Label Variable SC Dosing||0||
48382948|NCT00254293|101265129|FG004|NOT COMPLETED|LTE Open Label Variable SC Dosing||2||
48255995|NCT01585441|100947652|FG000|COMPLETED|Overall Study||3||
48255996|NCT01585441|100947653|FG001|COMPLETED|Overall Study||3||
48255997|NCT01585441|100947652|FG000|NOT COMPLETED|Overall Study||0||
48255998|NCT01585441|100947653|FG001|NOT COMPLETED|Overall Study||0||
48255999|NCT00634920|100947654|FG000|STARTED|Period 1 - Pre-Randomization||0||
48256000|NCT00634920|100947655|FG001|STARTED|Period 1 - Pre-Randomization||0||
48256001|NCT00634920|100947656|FG002|STARTED|Period 1 - Pre-Randomization||341||
48256002|NCT00634920|100947654|FG000|COMPLETED|Period 1 - Pre-Randomization||0||
48256003|NCT00634920|100947655|FG001|COMPLETED|Period 1 - Pre-Randomization||0||
48256004|NCT00634920|100947656|FG002|COMPLETED|Period 1 - Pre-Randomization||204||
48256005|NCT00634920|100947654|FG000|NOT COMPLETED|Period 1 - Pre-Randomization||0||
48256006|NCT00634920|100947655|FG001|NOT COMPLETED|Period 1 - Pre-Randomization||0||
48687293|NCT03079531|102017054|FG000|NOT COMPLETED|Overall Study||7||
48687294|NCT01580410|102017055|FG000|STARTED|Overall Study||68||
48687295|NCT01580410|102017056|FG001|STARTED|Overall Study||68||
48687296|NCT01580410|102017055|FG000|COMPLETED|Overall Study||57||
48382949|NCT00254293|101265130|FG005|NOT COMPLETED|LTE Open Label Variable SC Dosing||0||
48382950|NCT00254293|101265131|FG006|NOT COMPLETED|LTE Open Label Variable SC Dosing||0||
48382951|NCT00254293|101265125|FG000|STARTED|LTE Open Label Fixed Dosing||0||
48382952|NCT00254293|101265126|FG001|STARTED|LTE Open Label Fixed Dosing||0||
48382953|NCT00254293|101265127|FG002|STARTED|LTE Open Label Fixed Dosing||0||
48382954|NCT00254293|101265128|FG003|STARTED|LTE Open Label Fixed Dosing||0||
48382955|NCT00254293|101265129|FG004|STARTED|LTE Open Label Fixed Dosing||0||
48382956|NCT00254293|101265130|FG005|STARTED|LTE Open Label Fixed Dosing||0||
48382957|NCT00254293|101265131|FG006|STARTED|LTE Open Label Fixed Dosing||48||
48382958|NCT00254293|101265125|FG000|COMPLETED|LTE Open Label Fixed Dosing||0||
48382959|NCT00254293|101265126|FG001|COMPLETED|LTE Open Label Fixed Dosing||0||
48382960|NCT00254293|101265127|FG002|COMPLETED|LTE Open Label Fixed Dosing||0||
48382961|NCT00254293|101265128|FG003|COMPLETED|LTE Open Label Fixed Dosing||0||
48382962|NCT00254293|101265129|FG004|COMPLETED|LTE Open Label Fixed Dosing||0||
48382963|NCT00254293|101265130|FG005|COMPLETED|LTE Open Label Fixed Dosing||0||
48687297|NCT01580410|102017056|FG001|COMPLETED|Overall Study||60||
48687298|NCT01580410|102017055|FG000|NOT COMPLETED|Overall Study||11||
48687299|NCT01580410|102017056|FG001|NOT COMPLETED|Overall Study||8||
48256007|NCT00634920|100947656|FG002|NOT COMPLETED|Period 1 - Pre-Randomization||137||
48256008|NCT00634920|100947654|FG000|STARTED|Period 2 - Post-Randomization||104||
48256009|NCT00634920|100947655|FG001|STARTED|Period 2 - Post-Randomization||100||
48256010|NCT00634920|100947656|FG002|STARTED|Period 2 - Post-Randomization||0||
48256011|NCT00634920|100947654|FG000|Full Analysis Set (FAS)|Period 2 - Post-Randomization||92||
48256012|NCT00634920|100947655|FG001|Full Analysis Set (FAS)|Period 2 - Post-Randomization||90||
48256013|NCT00634920|100947656|FG002|Full Analysis Set (FAS)|Period 2 - Post-Randomization||0||
48256014|NCT00634920|100947654|FG000|COMPLETED|Period 2 - Post-Randomization||43||
48256015|NCT00634920|100947655|FG001|COMPLETED|Period 2 - Post-Randomization||68||
48256016|NCT00634920|100947656|FG002|COMPLETED|Period 2 - Post-Randomization||0||
48256017|NCT00634920|100947654|FG000|NOT COMPLETED|Period 2 - Post-Randomization||61||
48256018|NCT00634920|100947655|FG001|NOT COMPLETED|Period 2 - Post-Randomization||32||
48256019|NCT00634920|100947656|FG002|NOT COMPLETED|Period 2 - Post-Randomization||0||
48382964|NCT00254293|101265131|FG006|COMPLETED|LTE Open Label Fixed Dosing||35||
48382965|NCT00254293|101265125|FG000|NOT COMPLETED|LTE Open Label Fixed Dosing||0||
48687300|NCT02534883|102017057|FG000|STARTED|Overall Study||8||
48687301|NCT02534883|102017058|FG001|STARTED|Overall Study||3||
48687302|NCT02534883|102017057|FG000|COMPLETED|Overall Study||0||
48687303|NCT02534883|102017058|FG001|COMPLETED|Overall Study||0||
48687304|NCT02534883|102017057|FG000|NOT COMPLETED|Overall Study||8||
48687305|NCT02534883|102017058|FG001|NOT COMPLETED|Overall Study||3||
48687306|NCT02691416|102017059|FG000|STARTED|Overall Study||30||
48687307|NCT02691416|102017060|FG001|STARTED|Overall Study||30||
48256020|NCT00591409|100947657|FG000|STARTED|Overall Study||10||
48382966|NCT00254293|101265126|FG001|NOT COMPLETED|LTE Open Label Fixed Dosing||0||
48382967|NCT00254293|101265127|FG002|NOT COMPLETED|LTE Open Label Fixed Dosing||0||
48382968|NCT00254293|101265128|FG003|NOT COMPLETED|LTE Open Label Fixed Dosing||0||
48382969|NCT00254293|101265129|FG004|NOT COMPLETED|LTE Open Label Fixed Dosing||0||
48382970|NCT00254293|101265130|FG005|NOT COMPLETED|LTE Open Label Fixed Dosing||0||
48382971|NCT00254293|101265131|FG006|NOT COMPLETED|LTE Open Label Fixed Dosing||13||
48382972|NCT01617187|101265132|FG000|STARTED|Randomization Through Start Treatment||98||
48382973|NCT01617187|101265133|FG001|STARTED|Randomization Through Start Treatment||113||
48382974|NCT01617187|101265134|FG002|STARTED|Randomization Through Start Treatment||46||
48382975|NCT01617187|101265135|FG003|STARTED|Randomization Through Start Treatment||103||
48382976|NCT01617187|101265132|FG000|COMPLETED|Randomization Through Start Treatment||97||
48382977|NCT01617187|101265133|FG001|COMPLETED|Randomization Through Start Treatment||113||
48382978|NCT01617187|101265134|FG002|COMPLETED|Randomization Through Start Treatment||46||
48382979|NCT01617187|101265135|FG003|COMPLETED|Randomization Through Start Treatment||101||
48382980|NCT01617187|101265132|FG000|NOT COMPLETED|Randomization Through Start Treatment||1||
48382981|NCT01617187|101265133|FG001|NOT COMPLETED|Randomization Through Start Treatment||0||
48382982|NCT01617187|101265134|FG002|NOT COMPLETED|Randomization Through Start Treatment||0||
48382983|NCT01617187|101265135|FG003|NOT COMPLETED|Randomization Through Start Treatment||2||
48382984|NCT01617187|101265132|FG000|STARTED|Treatment Through Study Completion||97||
48382985|NCT01617187|101265133|FG001|STARTED|Treatment Through Study Completion||113||
48382986|NCT01617187|101265134|FG002|STARTED|Treatment Through Study Completion||46||
48382987|NCT01617187|101265135|FG003|STARTED|Treatment Through Study Completion||101||
48382988|NCT01617187|101265132|FG000|COMPLETED|Treatment Through Study Completion||86||
48382989|NCT01617187|101265133|FG001|COMPLETED|Treatment Through Study Completion||102||
48382990|NCT01617187|101265134|FG002|COMPLETED|Treatment Through Study Completion||41||
48382991|NCT01617187|101265135|FG003|COMPLETED|Treatment Through Study Completion||91||
48382992|NCT01617187|101265132|FG000|NOT COMPLETED|Treatment Through Study Completion||11||
48382993|NCT01617187|101265133|FG001|NOT COMPLETED|Treatment Through Study Completion||11||
48382994|NCT01617187|101265134|FG002|NOT COMPLETED|Treatment Through Study Completion||5||
48382995|NCT01617187|101265135|FG003|NOT COMPLETED|Treatment Through Study Completion||10||
48382996|NCT00393913|101265136|FG000|STARTED|Initial Assessment||144||
48382997|NCT00393913|101265136|FG000|COMPLETED|Initial Assessment||107||
48382998|NCT00393913|101265136|FG000|NOT COMPLETED|Initial Assessment||37||
48382999|NCT00393913|101265136|FG000|STARTED|CPAP||100||
48383000|NCT00393913|101265136|FG000|COMPLETED|CPAP||93||
48383001|NCT00393913|101265136|FG000|NOT COMPLETED|CPAP||7||
48383002|NCT00393913|101265136|FG000|STARTED|CPAP Withdrawal||42||
48383003|NCT00393913|101265136|FG000|CPAP Compliance|CPAP Withdrawal||42||
48383004|NCT00393913|101265136|FG000|COMPLETED|CPAP Withdrawal||42||
48383005|NCT00393913|101265136|FG000|NOT COMPLETED|CPAP Withdrawal||0||
48383006|NCT01357915|101265137|FG000|STARTED|Overall Study||30||
48383007|NCT01357915|101265138|FG001|STARTED|Overall Study||17||
48383008|NCT01357915|101265137|FG000|COMPLETED|Overall Study||27||
48383009|NCT01357915|101265138|FG001|COMPLETED|Overall Study||17||
48383010|NCT01357915|101265137|FG000|NOT COMPLETED|Overall Study||3||
48383011|NCT01357915|101265138|FG001|NOT COMPLETED|Overall Study||0||
48383012|NCT02702518|101265139|FG000|STARTED|Overall Study||29||
48383013|NCT02702518|101265140|FG001|STARTED|Overall Study||29||
48383014|NCT02702518|101265139|FG000|COMPLETED|Overall Study||26||
48383015|NCT02702518|101265140|FG001|COMPLETED|Overall Study||25||
48383016|NCT02702518|101265139|FG000|NOT COMPLETED|Overall Study||3||
48383017|NCT02702518|101265140|FG001|NOT COMPLETED|Overall Study||4||
48383018|NCT03150108|101265141|FG000|STARTED|Overall Study||12||
48383019|NCT03150108|101265142|FG001|STARTED|Overall Study||12||
48383020|NCT03150108|101265141|FG000|COMPLETED|Overall Study||12||
48383021|NCT03150108|101265142|FG001|COMPLETED|Overall Study||12||
48383022|NCT03150108|101265141|FG000|NOT COMPLETED|Overall Study||0||
48383023|NCT03150108|101265142|FG001|NOT COMPLETED|Overall Study||0||
48383024|NCT00734734|101265143|FG000|STARTED|Overall Study||64||
48383025|NCT00734734|101265143|FG000|COMPLETED|Overall Study||64||
48383026|NCT00734734|101265143|FG000|NOT COMPLETED|Overall Study||0||
48383027|NCT01202721|101265144|FG000|STARTED|Overall Study||18||
48383028|NCT01202721|101265145|FG001|STARTED|Overall Study||26||
48383029|NCT01202721|101265146|FG002|STARTED|Overall Study||14||
48383030|NCT01202721|101265147|FG003|STARTED|Overall Study||27||
48383031|NCT01202721|101265144|FG000|COMPLETED|Overall Study||18||
48383032|NCT01202721|101265145|FG001|COMPLETED|Overall Study||26||
48383033|NCT01202721|101265146|FG002|COMPLETED|Overall Study||14||
48383034|NCT01202721|101265147|FG003|COMPLETED|Overall Study||27||
48383035|NCT01202721|101265144|FG000|NOT COMPLETED|Overall Study||0||
48383036|NCT01202721|101265145|FG001|NOT COMPLETED|Overall Study||0||
48383037|NCT01202721|101265146|FG002|NOT COMPLETED|Overall Study||0||
48383038|NCT01202721|101265147|FG003|NOT COMPLETED|Overall Study||0||
48383039|NCT01996748|101265148|FG000|STARTED|Overall Study||66||
48383040|NCT01996748|101265149|FG001|STARTED|Overall Study||69||
48383041|NCT01996748|101265148|FG000|COMPLETED|Overall Study||58||
48383042|NCT01996748|101265149|FG001|COMPLETED|Overall Study||63||
48383043|NCT01996748|101265148|FG000|NOT COMPLETED|Overall Study||8||
48383044|NCT01996748|101265149|FG001|NOT COMPLETED|Overall Study||6||
48383045|NCT00547638|101265150|FG000|STARTED|Overall Study||143||
48383046|NCT00547638|101265151|FG001|STARTED|Overall Study||73||
48383047|NCT00547638|101265150|FG000|COMPLETED|Overall Study||119||
48383048|NCT00547638|101265151|FG001|COMPLETED|Overall Study||59||
48383049|NCT00547638|101265150|FG000|NOT COMPLETED|Overall Study||24||
48383050|NCT00547638|101265151|FG001|NOT COMPLETED|Overall Study||14||
48383051|NCT04191967|101265152|FG000|STARTED|Screening & Thermocoagulation (Ablation)||379||
48383052|NCT04191967|101265152|FG000|COMPLETED|Screening & Thermocoagulation (Ablation)||293||
48383053|NCT04191967|101265152|FG000|NOT COMPLETED|Screening & Thermocoagulation (Ablation)||86||
48383054|NCT04191967|101265152|FG000|STARTED|12 Month Follow-up||58||
48383055|NCT04191967|101265152|FG000|COMPLETED|12 Month Follow-up||54||
48383056|NCT04191967|101265152|FG000|NOT COMPLETED|12 Month Follow-up||4||
48383057|NCT01354353|101265153|FG000|STARTED|Overall Study||16||
48383058|NCT01354353|101265154|FG001|STARTED|Overall Study||12||
48383059|NCT01354353|101265155|FG002|STARTED|Overall Study||11||
48383060|NCT01354353|101265156|FG003|STARTED|Overall Study||12||
48383061|NCT01354353|101265157|FG004|STARTED|Overall Study||12||
48383062|NCT01354353|101265158|FG005|STARTED|Overall Study||12||
48383063|NCT01354353|101265153|FG000|Received at Least One Dose of Study Drug|Overall Study||16||
48383064|NCT01354353|101265154|FG001|Received at Least One Dose of Study Drug|Overall Study||11||
48383065|NCT01354353|101265155|FG002|Received at Least One Dose of Study Drug|Overall Study||10||
48383066|NCT01354353|101265156|FG003|Received at Least One Dose of Study Drug|Overall Study||11||
48383067|NCT01354353|101265157|FG004|Received at Least One Dose of Study Drug|Overall Study||11||
48383068|NCT01354353|101265158|FG005|Received at Least One Dose of Study Drug|Overall Study||11||
48383069|NCT01354353|101265153|FG000|COMPLETED|Overall Study||13||
48383070|NCT01354353|101265154|FG001|COMPLETED|Overall Study||11||
48256021|NCT00591409|100947658|FG001|STARTED|Overall Study||10||
48256022|NCT00591409|100947659|FG002|STARTED|Overall Study||10||
48256023|NCT00591409|100947660|FG003|STARTED|Overall Study||10||
48256024|NCT00591409|100947661|FG004|STARTED|Overall Study||10||
48256025|NCT00591409|100947662|FG005|STARTED|Overall Study||10||
48256026|NCT00591409|100947663|FG006|STARTED|Overall Study||10||
48256027|NCT00591409|100947664|FG007|STARTED|Overall Study||10||
48256028|NCT00591409|100947665|FG008|STARTED|Overall Study||9||
48256029|NCT00591409|100947666|FG009|STARTED|Overall Study||11||
48256030|NCT00591409|100947657|FG000|Treated|Overall Study||10||
48256031|NCT00591409|100947658|FG001|Treated|Overall Study||10||
48383071|NCT01354353|101265155|FG002|COMPLETED|Overall Study||9||
48383072|NCT01354353|101265156|FG003|COMPLETED|Overall Study||7||
48383073|NCT01354353|101265157|FG004|COMPLETED|Overall Study||11||
48383074|NCT01354353|101265158|FG005|COMPLETED|Overall Study||6||
48383075|NCT01354353|101265153|FG000|NOT COMPLETED|Overall Study||3||
48383076|NCT01354353|101265154|FG001|NOT COMPLETED|Overall Study||1||
48383077|NCT01354353|101265155|FG002|NOT COMPLETED|Overall Study||2||
48383078|NCT01354353|101265156|FG003|NOT COMPLETED|Overall Study||5||
48383079|NCT01354353|101265157|FG004|NOT COMPLETED|Overall Study||1||
48383080|NCT01354353|101265158|FG005|NOT COMPLETED|Overall Study||6||
48383081|NCT02695524|101265159|FG000|STARTED|Overall Study||30||
48383082|NCT02695524|101265160|FG001|STARTED|Overall Study||30||
48383083|NCT02695524|101265159|FG000|COMPLETED|Overall Study||27||
48383084|NCT02695524|101265160|FG001|COMPLETED|Overall Study||27||
48383085|NCT02695524|101265159|FG000|NOT COMPLETED|Overall Study||3||
48383086|NCT02695524|101265160|FG001|NOT COMPLETED|Overall Study||3||
48383087|NCT00574496|101265161|FG000|STARTED|Overall Study||25||
48383088|NCT00574496|101265161|FG000|COMPLETED|Overall Study||24||
48383089|NCT00574496|101265161|FG000|NOT COMPLETED|Overall Study||1||
48383090|NCT00831441|101265162|FG000|STARTED|Randomized||3687||
48383091|NCT00831441|101265163|FG001|STARTED|Randomized||3705||
48383092|NCT00831441|101265162|FG000|Treated|Randomized||3643||
48383093|NCT00831441|101265163|FG001|Treated|Randomized||3672||
48383094|NCT00831441|101265162|FG000|COMPLETED|Randomized||0||
48383095|NCT00831441|101265163|FG001|COMPLETED|Randomized||0||
48383096|NCT00831441|101265162|FG000|NOT COMPLETED|Randomized||3687||
48383097|NCT00831441|101265163|FG001|NOT COMPLETED|Randomized||3705||
48383098|NCT00831441|101265162|FG000|STARTED|Follow Up (30 Days)||3508||
48383099|NCT00831441|101265163|FG001|STARTED|Follow Up (30 Days)||3529||
48383100|NCT00831441|101265162|FG000|COMPLETED|Follow Up (30 Days)||3375||
48383101|NCT00831441|101265163|FG001|COMPLETED|Follow Up (30 Days)||3355||
48383102|NCT00831441|101265162|FG000|NOT COMPLETED|Follow Up (30 Days)||133||
48383103|NCT00831441|101265163|FG001|NOT COMPLETED|Follow Up (30 Days)||174||
48383104|NCT01586026|101265164|FG000|STARTED|Overall Study||350||
48383105|NCT01586026|101265165|FG001|STARTED|Overall Study||414||
48383106|NCT01586026|101265166|FG002|STARTED|Overall Study||271||
48383107|NCT01586026|101265164|FG000|COMPLETED|Overall Study||350||
48383108|NCT01586026|101265165|FG001|COMPLETED|Overall Study||414||
48383109|NCT01586026|101265166|FG002|COMPLETED|Overall Study||271||
48383110|NCT01586026|101265164|FG000|NOT COMPLETED|Overall Study||0||
48383111|NCT01586026|101265165|FG001|NOT COMPLETED|Overall Study||0||
48256032|NCT00591409|100947659|FG002|Treated|Overall Study||10||
48256033|NCT00591409|100947660|FG003|Treated|Overall Study||10||
48256034|NCT00591409|100947661|FG004|Treated|Overall Study||9||
48256035|NCT00591409|100947662|FG005|Treated|Overall Study||10||
48256036|NCT00591409|100947663|FG006|Treated|Overall Study||10||
48383112|NCT01586026|101265166|FG002|NOT COMPLETED|Overall Study||0||
48383113|NCT00082758|101265167|FG000|STARTED|Overall Study||15||
48383114|NCT00082758|101265168|FG001|STARTED|Overall Study||24||
48256037|NCT00591409|100947664|FG007|Treated|Overall Study||10||
48256038|NCT00591409|100947665|FG008|Treated|Overall Study||9||
48256039|NCT00591409|100947666|FG009|Treated|Overall Study||10||
48256040|NCT00591409|100947657|FG000|COMPLETED|Overall Study||10||
48256041|NCT00591409|100947658|FG001|COMPLETED|Overall Study||10||
48256042|NCT00591409|100947659|FG002|COMPLETED|Overall Study||10||
48256043|NCT00591409|100947660|FG003|COMPLETED|Overall Study||10||
48256044|NCT00591409|100947661|FG004|COMPLETED|Overall Study||9||
48256045|NCT00591409|100947662|FG005|COMPLETED|Overall Study||10||
48256046|NCT00591409|100947663|FG006|COMPLETED|Overall Study||10||
48256047|NCT00591409|100947664|FG007|COMPLETED|Overall Study||10||
48256048|NCT00591409|100947665|FG008|COMPLETED|Overall Study||9||
48256049|NCT00591409|100947666|FG009|COMPLETED|Overall Study||10||
48256050|NCT00591409|100947657|FG000|NOT COMPLETED|Overall Study||0||
48256051|NCT00591409|100947658|FG001|NOT COMPLETED|Overall Study||0||
48256052|NCT00591409|100947659|FG002|NOT COMPLETED|Overall Study||0||
48256053|NCT00591409|100947660|FG003|NOT COMPLETED|Overall Study||0||
48256054|NCT00591409|100947661|FG004|NOT COMPLETED|Overall Study||1||
48256055|NCT00591409|100947662|FG005|NOT COMPLETED|Overall Study||0||
48256056|NCT00591409|100947663|FG006|NOT COMPLETED|Overall Study||0||
48256057|NCT00591409|100947664|FG007|NOT COMPLETED|Overall Study||0||
48256058|NCT00591409|100947665|FG008|NOT COMPLETED|Overall Study||0||
48256059|NCT00591409|100947666|FG009|NOT COMPLETED|Overall Study||1||
48256060|NCT04068051|100947667|FG000|STARTED|Overall Study||706||
48256061|NCT04068051|100947667|FG000|COMPLETED|Overall Study||138||
48256062|NCT04068051|100947667|FG000|NOT COMPLETED|Overall Study||568||
48256063|NCT01101334|100947668|FG000|STARTED|Overall Study||45||
48256064|NCT01101334|100947669|FG001|STARTED|Overall Study||45||
48256065|NCT01101334|100947668|FG000|Received Study Treatment|Overall Study||44||
48256066|NCT01101334|100947669|FG001|Received Study Treatment|Overall Study||45||
48256067|NCT01101334|100947668|FG000|COMPLETED|Overall Study||0||
48256068|NCT01101334|100947669|FG001|COMPLETED|Overall Study||0||
48256069|NCT01101334|100947668|FG000|NOT COMPLETED|Overall Study||45||
48256070|NCT01101334|100947669|FG001|NOT COMPLETED|Overall Study||45||
48256071|NCT00543101|100947670|FG000|STARTED|Overall Study||12||
48256072|NCT00543101|100947671|FG001|STARTED|Overall Study||12||
48256073|NCT00543101|100947670|FG000|COMPLETED|Overall Study||12||
48256074|NCT00543101|100947671|FG001|COMPLETED|Overall Study||12||
48256075|NCT00543101|100947670|FG000|NOT COMPLETED|Overall Study||0||
48256076|NCT00543101|100947671|FG001|NOT COMPLETED|Overall Study||0||
48256077|NCT00115336|100947672|FG000|STARTED|Overall Study||6||
48256078|NCT00115336|100947673|FG001|STARTED|Overall Study||4||
48256079|NCT00115336|100947672|FG000|COMPLETED|Overall Study||6||
48256080|NCT00115336|100947673|FG001|COMPLETED|Overall Study||3||
48256081|NCT00115336|100947672|FG000|NOT COMPLETED|Overall Study||0||
48256082|NCT00115336|100947673|FG001|NOT COMPLETED|Overall Study||1||
48256083|NCT03023423|100947674|FG000|STARTED|Overall Study||7||
48256084|NCT03023423|100947675|FG001|STARTED|Overall Study||46||
48256085|NCT03023423|100947676|FG002|STARTED|Overall Study||46||
48256086|NCT03023423|100947674|FG000|Treated|Overall Study||7||
48256087|NCT03023423|100947675|FG001|Treated|Overall Study||44||
48256088|NCT03023423|100947676|FG002|Treated|Overall Study||44||
48256089|NCT03023423|100947674|FG000|Crossover From Atezo to Dara + Atezo|Overall Study||0||
48256090|NCT03023423|100947675|FG001|Crossover From Atezo to Dara + Atezo|Overall Study||8||
48256091|NCT03023423|100947676|FG002|Crossover From Atezo to Dara + Atezo|Overall Study||0||
48256092|NCT03023423|100947674|FG000|COMPLETED|Overall Study||0||
48256093|NCT03023423|100947675|FG001|COMPLETED|Overall Study||0||
48256094|NCT03023423|100947676|FG002|COMPLETED|Overall Study||0||
48256095|NCT03023423|100947674|FG000|NOT COMPLETED|Overall Study||7||
48256096|NCT03023423|100947675|FG001|NOT COMPLETED|Overall Study||46||
48383115|NCT00082758|101265169|FG002|STARTED|Overall Study||0||
48383116|NCT00082758|101265167|FG000|COMPLETED|Overall Study||0||
48383117|NCT00082758|101265168|FG001|COMPLETED|Overall Study||7||
48383118|NCT00082758|101265169|FG002|COMPLETED|Overall Study||0||
48383119|NCT00082758|101265167|FG000|NOT COMPLETED|Overall Study||15||
48383120|NCT00082758|101265168|FG001|NOT COMPLETED|Overall Study||17||
48383121|NCT00082758|101265169|FG002|NOT COMPLETED|Overall Study||0||
48256097|NCT03023423|100947676|FG002|NOT COMPLETED|Overall Study||46||
48256098|NCT01171183|100947677|FG000|STARTED|Residential Facility (Weeks 1-2)||15||
48256099|NCT01171183|100947678|FG001|STARTED|Residential Facility (Weeks 1-2)||16||
48256100|NCT01171183|100947677|FG000|COMPLETED|Residential Facility (Weeks 1-2)||13||
48256101|NCT01171183|100947678|FG001|COMPLETED|Residential Facility (Weeks 1-2)||10||
48256102|NCT01171183|100947677|FG000|NOT COMPLETED|Residential Facility (Weeks 1-2)||2||
48256103|NCT01171183|100947678|FG001|NOT COMPLETED|Residential Facility (Weeks 1-2)||6||
48256104|NCT01171183|100947677|FG000|STARTED|Outpatient Participation (Weeks 3-10)||12||
48383122|NCT02389712|101265170|FG000|STARTED|Overall Study||1||
48256105|NCT01171183|100947678|FG001|STARTED|Outpatient Participation (Weeks 3-10)||9||
48256106|NCT01171183|100947677|FG000|COMPLETED|Outpatient Participation (Weeks 3-10)||2||
48383123|NCT02389712|101265171|FG001|STARTED|Overall Study||1||
48383124|NCT02389712|101265170|FG000|COMPLETED|Overall Study||1||
48383125|NCT02389712|101265171|FG001|COMPLETED|Overall Study||1||
48383126|NCT02389712|101265170|FG000|NOT COMPLETED|Overall Study||0||
48383127|NCT02389712|101265171|FG001|NOT COMPLETED|Overall Study||0||
48383128|NCT01669811|101265172|FG000|STARTED|Overall Study||145||
48383129|NCT01669811|101265173|FG001|STARTED|Overall Study||142||
48383130|NCT01669811|101265172|FG000|COMPLETED|Overall Study||142||
48383131|NCT01669811|101265173|FG001|COMPLETED|Overall Study||131||
48383132|NCT01669811|101265172|FG000|NOT COMPLETED|Overall Study||3||
48383133|NCT01669811|101265173|FG001|NOT COMPLETED|Overall Study||11||
48383134|NCT02093234|101265174|FG000|STARTED|Overall Study||56||
48383135|NCT02093234|101265175|FG001|STARTED|Overall Study||56||
48256107|NCT01171183|100947678|FG001|COMPLETED|Outpatient Participation (Weeks 3-10)||4||
48256108|NCT01171183|100947677|FG000|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||10||
48256109|NCT01171183|100947678|FG001|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||5||
48256110|NCT01966978|100947679|FG000|STARTED|Overall Study||61||
48256111|NCT01966978|100947680|FG001|STARTED|Overall Study||59||
48256112|NCT01966978|100947679|FG000|COMPLETED|Overall Study||44||
48256113|NCT01966978|100947680|FG001|COMPLETED|Overall Study||46||
48256114|NCT01966978|100947679|FG000|NOT COMPLETED|Overall Study||17||
48256115|NCT01966978|100947680|FG001|NOT COMPLETED|Overall Study||13||
48256116|NCT01560871|100947681|FG000|STARTED|Overall Study||9||
48256117|NCT01560871|100947682|FG001|STARTED|Overall Study||7||
48256118|NCT01560871|100947681|FG000|COMPLETED|Overall Study||3||
48256119|NCT01560871|100947682|FG001|COMPLETED|Overall Study||5||
48256120|NCT01560871|100947681|FG000|NOT COMPLETED|Overall Study||6||
48256121|NCT01560871|100947682|FG001|NOT COMPLETED|Overall Study||2||
48256122|NCT02972242|100947683|FG000|STARTED|Overall Study||82||
48256123|NCT02972242|100947684|FG001|STARTED|Overall Study||93||
48256124|NCT02972242|100947683|FG000|COMPLETED|Overall Study||81||
48256125|NCT02972242|100947684|FG001|COMPLETED|Overall Study||93||
48256126|NCT02972242|100947683|FG000|NOT COMPLETED|Overall Study||1||
48256127|NCT02972242|100947684|FG001|NOT COMPLETED|Overall Study||0||
48256128|NCT01449747|100947685|FG000|STARTED|Overall Study||12||
48256129|NCT01449747|100947686|FG001|STARTED|Overall Study||12||
48256130|NCT01449747|100947685|FG000|COMPLETED|Overall Study||12||
48256131|NCT01449747|100947686|FG001|COMPLETED|Overall Study||12||
48256132|NCT01449747|100947685|FG000|NOT COMPLETED|Overall Study||0||
48256133|NCT01449747|100947686|FG001|NOT COMPLETED|Overall Study||0||
48256134|NCT02101983|100947687|FG000|STARTED|Overall Study||5||
48256135|NCT02101983|100947688|FG001|STARTED|Overall Study||6||
48256136|NCT02101983|100947687|FG000|COMPLETED|Overall Study||4||
48256137|NCT02101983|100947688|FG001|COMPLETED|Overall Study||6||
48383136|NCT02093234|101265176|FG002|STARTED|Overall Study||54||
48383137|NCT02093234|101265174|FG000|COMPLETED|Overall Study||53||
48383138|NCT02093234|101265175|FG001|COMPLETED|Overall Study||52||
48383139|NCT02093234|101265176|FG002|COMPLETED|Overall Study||50||
48383140|NCT02093234|101265174|FG000|NOT COMPLETED|Overall Study||3||
48383141|NCT02093234|101265175|FG001|NOT COMPLETED|Overall Study||4||
48383142|NCT02093234|101265176|FG002|NOT COMPLETED|Overall Study||4||
48383143|NCT03198754|101265177|FG000|STARTED|Overall Study||38||
48383144|NCT03198754|101265178|FG001|STARTED|Overall Study||35||
48383145|NCT03198754|101265177|FG000|COMPLETED|Overall Study||27||
48383146|NCT03198754|101265178|FG001|COMPLETED|Overall Study||27||
48383147|NCT03198754|101265177|FG000|NOT COMPLETED|Overall Study||11||
48383148|NCT03198754|101265178|FG001|NOT COMPLETED|Overall Study||8||
48383149|NCT01361919|101265179|FG000|STARTED|Overall Study||100||
48383150|NCT01361919|101265180|FG001|STARTED|Overall Study||100||
48383151|NCT01361919|101265181|FG002|STARTED|Overall Study||98||
48383152|NCT01361919|101265179|FG000|COMPLETED|Overall Study||90||
48383153|NCT01361919|101265180|FG001|COMPLETED|Overall Study||88||
48383154|NCT01361919|101265181|FG002|COMPLETED|Overall Study||88||
48383155|NCT01361919|101265179|FG000|NOT COMPLETED|Overall Study||10||
48383156|NCT01361919|101265180|FG001|NOT COMPLETED|Overall Study||12||
48383157|NCT01361919|101265181|FG002|NOT COMPLETED|Overall Study||10||
48383158|NCT00987623|101265182|FG000|STARTED|Overall Study||145||
48383159|NCT00987623|101265183|FG001|STARTED|Overall Study||154||
48383160|NCT00987623|101265182|FG000|COMPLETED|Overall Study||140||
48383161|NCT00987623|101265183|FG001|COMPLETED|Overall Study||151||
48383162|NCT00987623|101265182|FG000|NOT COMPLETED|Overall Study||5||
48383163|NCT00987623|101265183|FG001|NOT COMPLETED|Overall Study||3||
48383164|NCT03089216|101265184|FG000|STARTED|Overall Study||27||
48383165|NCT03089216|101265185|FG001|STARTED|Overall Study||27||
48256138|NCT02101983|100947687|FG000|NOT COMPLETED|Overall Study||1||
48256139|NCT02101983|100947688|FG001|NOT COMPLETED|Overall Study||0||
48256140|NCT04672798|100947689|FG000|STARTED|Overall Study||68||
48256141|NCT04672798|100947690|FG001|STARTED|Overall Study||33||
48256142|NCT04672798|100947689|FG000|COMPLETED|Overall Study||59||
48256143|NCT04672798|100947690|FG001|COMPLETED|Overall Study||31||
48383166|NCT03089216|101265186|FG002|STARTED|Overall Study||27||
48256144|NCT04672798|100947689|FG000|NOT COMPLETED|Overall Study||9||
48383167|NCT03089216|101265187|FG003|STARTED|Overall Study||27||
48383168|NCT03089216|101265184|FG000|COMPLETED|Overall Study||27||
48383169|NCT03089216|101265185|FG001|COMPLETED|Overall Study||27||
48256145|NCT04672798|100947690|FG001|NOT COMPLETED|Overall Study||2||
48256146|NCT00097708|100947691|FG000|STARTED|Overall Study||173||
48383170|NCT03089216|101265186|FG002|COMPLETED|Overall Study||27||
48383171|NCT03089216|101265187|FG003|COMPLETED|Overall Study||26||
48383172|NCT03089216|101265184|FG000|NOT COMPLETED|Overall Study||0||
48383173|NCT03089216|101265185|FG001|NOT COMPLETED|Overall Study||0||
48383174|NCT03089216|101265186|FG002|NOT COMPLETED|Overall Study||0||
48256147|NCT00097708|100947692|FG001|STARTED|Overall Study||176||
48256148|NCT00097708|100947693|FG002|STARTED|Overall Study||162||
48256149|NCT00097708|100947691|FG000|Intent-to-Treat (ITT)|Overall Study||165||
48256150|NCT00097708|100947692|FG001|Intent-to-Treat (ITT)|Overall Study||169||
48256151|NCT00097708|100947693|FG002|Intent-to-Treat (ITT)|Overall Study||149||
48256152|NCT00097708|100947691|FG000|Treated|Overall Study||171||
48256153|NCT00097708|100947692|FG001|Treated|Overall Study||176||
48256154|NCT00097708|100947693|FG002|Treated|Overall Study||160||
48256155|NCT00097708|100947691|FG000|COMPLETED|Overall Study||109||
48256156|NCT00097708|100947692|FG001|COMPLETED|Overall Study||120||
48256157|NCT00097708|100947693|FG002|COMPLETED|Overall Study||97||
48256158|NCT00097708|100947691|FG000|NOT COMPLETED|Overall Study||64||
48256159|NCT00097708|100947692|FG001|NOT COMPLETED|Overall Study||56||
48256160|NCT00097708|100947693|FG002|NOT COMPLETED|Overall Study||65||
48256161|NCT04438382|100947694|FG000|STARTED|Overall Study||0||
48256162|NCT04438382|100947695|FG001|STARTED|Overall Study||1||
48256163|NCT04438382|100947694|FG000|COMPLETED|Overall Study||0||
48256164|NCT04438382|100947695|FG001|COMPLETED|Overall Study||1||
48256165|NCT04438382|100947694|FG000|NOT COMPLETED|Overall Study||0||
48256166|NCT04438382|100947695|FG001|NOT COMPLETED|Overall Study||0||
48256167|NCT03700372|100947696|FG000|STARTED|Overall Study||7||
48256168|NCT03700372|100947696|FG000|COMPLETED|Overall Study||7||
48256169|NCT03700372|100947696|FG000|NOT COMPLETED|Overall Study||0||
48256170|NCT03845023|100947697|FG000|STARTED|Placebo Run-In Period (2 Nights)||36||
48256171|NCT03845023|100947698|FG001|STARTED|Placebo Run-In Period (2 Nights)||36||
48256172|NCT03845023|100947699|FG002|STARTED|Placebo Run-In Period (2 Nights)||34||
48256173|NCT03845023|100947700|FG003|STARTED|Placebo Run-In Period (2 Nights)||34||
48256174|NCT03845023|100947697|FG000|COMPLETED|Placebo Run-In Period (2 Nights)||36||
48256175|NCT03845023|100947698|FG001|COMPLETED|Placebo Run-In Period (2 Nights)||36||
48256176|NCT03845023|100947699|FG002|COMPLETED|Placebo Run-In Period (2 Nights)||34||
48256177|NCT03845023|100947700|FG003|COMPLETED|Placebo Run-In Period (2 Nights)||34||
48256178|NCT03845023|100947697|FG000|NOT COMPLETED|Placebo Run-In Period (2 Nights)||0||
48256179|NCT03845023|100947698|FG001|NOT COMPLETED|Placebo Run-In Period (2 Nights)||0||
48256180|NCT03845023|100947699|FG002|NOT COMPLETED|Placebo Run-In Period (2 Nights)||0||
48256181|NCT03845023|100947700|FG003|NOT COMPLETED|Placebo Run-In Period (2 Nights)||0||
48256182|NCT03845023|100947697|FG000|STARTED|Low Dose Run-In (3 Nights)||36||
48256183|NCT03845023|100947698|FG001|STARTED|Low Dose Run-In (3 Nights)||36||
48256184|NCT03845023|100947699|FG002|STARTED|Low Dose Run-In (3 Nights)||34||
48256185|NCT03845023|100947700|FG003|STARTED|Low Dose Run-In (3 Nights)||34||
48256186|NCT03845023|100947697|FG000|COMPLETED|Low Dose Run-In (3 Nights)||36||
48256187|NCT03845023|100947698|FG001|COMPLETED|Low Dose Run-In (3 Nights)||36||
48256188|NCT03845023|100947699|FG002|COMPLETED|Low Dose Run-In (3 Nights)||34||
48256189|NCT03845023|100947700|FG003|COMPLETED|Low Dose Run-In (3 Nights)||34||
48256190|NCT03845023|100947697|FG000|NOT COMPLETED|Low Dose Run-In (3 Nights)||0||
48256191|NCT03845023|100947698|FG001|NOT COMPLETED|Low Dose Run-In (3 Nights)||0||
48256192|NCT03845023|100947699|FG002|NOT COMPLETED|Low Dose Run-In (3 Nights)||0||
48256193|NCT03845023|100947700|FG003|NOT COMPLETED|Low Dose Run-In (3 Nights)||0||
48256194|NCT03845023|100947697|FG000|STARTED|Treatment Period (7 Nights)||36||
48256195|NCT03845023|100947698|FG001|STARTED|Treatment Period (7 Nights)||36||
48256196|NCT03845023|100947699|FG002|STARTED|Treatment Period (7 Nights)||34||
48256197|NCT03845023|100947700|FG003|STARTED|Treatment Period (7 Nights)||34||
48256198|NCT03845023|100947697|FG000|COMPLETED|Treatment Period (7 Nights)||36||
48256199|NCT03845023|100947698|FG001|COMPLETED|Treatment Period (7 Nights)||36||
48256200|NCT03845023|100947699|FG002|COMPLETED|Treatment Period (7 Nights)||34||
48256201|NCT03845023|100947700|FG003|COMPLETED|Treatment Period (7 Nights)||34||
48256202|NCT03845023|100947697|FG000|NOT COMPLETED|Treatment Period (7 Nights)||0||
48256203|NCT03845023|100947698|FG001|NOT COMPLETED|Treatment Period (7 Nights)||0||
48256204|NCT03845023|100947699|FG002|NOT COMPLETED|Treatment Period (7 Nights)||0||
48256205|NCT03845023|100947700|FG003|NOT COMPLETED|Treatment Period (7 Nights)||0||
48256206|NCT03845023|100947697|FG000|STARTED|Follow-Up (14 Days)||36||
48256207|NCT03845023|100947698|FG001|STARTED|Follow-Up (14 Days)||36||
48256208|NCT03845023|100947699|FG002|STARTED|Follow-Up (14 Days)||34||
48256209|NCT03845023|100947700|FG003|STARTED|Follow-Up (14 Days)||34||
48256210|NCT03845023|100947697|FG000|COMPLETED|Follow-Up (14 Days)||35||
48256211|NCT03845023|100947698|FG001|COMPLETED|Follow-Up (14 Days)||36||
48256212|NCT03845023|100947699|FG002|COMPLETED|Follow-Up (14 Days)||33||
48256213|NCT03845023|100947700|FG003|COMPLETED|Follow-Up (14 Days)||33||
48256214|NCT03845023|100947697|FG000|NOT COMPLETED|Follow-Up (14 Days)||1||
48256215|NCT03845023|100947698|FG001|NOT COMPLETED|Follow-Up (14 Days)||0||
48256216|NCT03845023|100947699|FG002|NOT COMPLETED|Follow-Up (14 Days)||1||
48256217|NCT03845023|100947700|FG003|NOT COMPLETED|Follow-Up (14 Days)||1||
48383175|NCT03089216|101265187|FG003|NOT COMPLETED|Overall Study||1||
48687308|NCT02691416|102017059|FG000|COMPLETED|Overall Study||30||
48687309|NCT02691416|102017060|FG001|COMPLETED|Overall Study||30||
48687310|NCT02691416|102017059|FG000|NOT COMPLETED|Overall Study||0||
48687311|NCT02691416|102017060|FG001|NOT COMPLETED|Overall Study||0||
48687312|NCT02567799|102017061|FG000|STARTED|Concurrent Chemoradiotherapy||7||
48687313|NCT02567799|102017062|FG001|STARTED|Concurrent Chemoradiotherapy||7||
48256218|NCT01316887|100947701|FG000|STARTED|Overall Study||109||
48256219|NCT01316887|100947702|FG001|STARTED|Overall Study||227||
48256220|NCT01316887|100947703|FG002|STARTED|Overall Study||226||
48256221|NCT01316887|100947701|FG000|COMPLETED|Overall Study||66||
48256222|NCT01316887|100947702|FG001|COMPLETED|Overall Study||133||
48256223|NCT01316887|100947703|FG002|COMPLETED|Overall Study||143||
48256224|NCT01316887|100947701|FG000|NOT COMPLETED|Overall Study||43||
48256225|NCT01316887|100947702|FG001|NOT COMPLETED|Overall Study||94||
48256226|NCT01316887|100947703|FG002|NOT COMPLETED|Overall Study||83||
48256227|NCT00713206|100947704|FG000|STARTED|Overall Study||65||158
48256228|NCT00713206|100947705|FG001|STARTED|Overall Study||57||140
48256229|NCT00713206|100947704|FG000|COMPLETED|Overall Study||60||152
48256230|NCT00713206|100947705|FG001|COMPLETED|Overall Study||53||131
48256231|NCT00713206|100947704|FG000|NOT COMPLETED|Overall Study||5||6
48256232|NCT00713206|100947705|FG001|NOT COMPLETED|Overall Study||4||9
48256233|NCT00510198|100947706|FG000|STARTED|Overall Study||59|3 subjects were exited prior to randomization for not meeting the inclusion /exclusion criteria.|
48256234|NCT00510198|100947707|FG001|STARTED|Overall Study||58|3 subjects were exited prior to randomization for not meeting the inclusion /exclusion criteria.|
48256235|NCT00510198|100947706|FG000|COMPLETED|Overall Study||54||
48256236|NCT00510198|100947707|FG001|COMPLETED|Overall Study||54||
48256237|NCT00510198|100947706|FG000|NOT COMPLETED|Overall Study||5||
48256238|NCT00510198|100947707|FG001|NOT COMPLETED|Overall Study||4||
48256239|NCT04458818|100947708|FG000|STARTED|Overall Study||39||
48256240|NCT04458818|100947708|FG000|COMPLETED|Overall Study||39||
48383176|NCT00039195|101265188|FG000|STARTED|Overall Study||98||
48383177|NCT00039195|101265188|FG000|COMPLETED|Overall Study||98||
48383178|NCT00039195|101265188|FG000|NOT COMPLETED|Overall Study||0||
48383179|NCT00190983|101265189|FG000|STARTED|Overall Study||29||
48383180|NCT00190983|101265189|FG000|COMPLETED|Overall Study||27||
48383181|NCT00190983|101265189|FG000|NOT COMPLETED|Overall Study||2||
48383182|NCT00853489|101265190|FG000|STARTED|Overall Study||16||
48383183|NCT00853489|101265191|FG001|STARTED|Overall Study||14||
48383184|NCT00853489|101265190|FG000|COMPLETED|Overall Study||11||
48383185|NCT00853489|101265191|FG001|COMPLETED|Overall Study||12||
48383186|NCT00853489|101265190|FG000|NOT COMPLETED|Overall Study||5||
48383187|NCT00853489|101265191|FG001|NOT COMPLETED|Overall Study||2||
48383188|NCT02152670|101265192|FG000|STARTED|Overall Study||1||
48687314|NCT02567799|102017063|FG002|STARTED|Concurrent Chemoradiotherapy||7||
48687315|NCT02567799|102017061|FG000|COMPLETED|Concurrent Chemoradiotherapy||6||
48687316|NCT02567799|102017062|FG001|COMPLETED|Concurrent Chemoradiotherapy||4||
48687317|NCT02567799|102017063|FG002|COMPLETED|Concurrent Chemoradiotherapy||6||
48687318|NCT02567799|102017061|FG000|NOT COMPLETED|Concurrent Chemoradiotherapy||1||
48687319|NCT02567799|102017062|FG001|NOT COMPLETED|Concurrent Chemoradiotherapy||3||
48687320|NCT02567799|102017063|FG002|NOT COMPLETED|Concurrent Chemoradiotherapy||1||
48687321|NCT02567799|102017061|FG000|STARTED|Follow-up||6||
48687322|NCT02567799|102017062|FG001|STARTED|Follow-up||4||
48687323|NCT02567799|102017063|FG002|STARTED|Follow-up||6||
48687324|NCT02567799|102017061|FG000|COMPLETED|Follow-up||4||
48687325|NCT02567799|102017062|FG001|COMPLETED|Follow-up||3||
48687326|NCT02567799|102017063|FG002|COMPLETED|Follow-up||2||
48687327|NCT02567799|102017061|FG000|NOT COMPLETED|Follow-up||2||
48687328|NCT02567799|102017062|FG001|NOT COMPLETED|Follow-up||1||
48687329|NCT02567799|102017063|FG002|NOT COMPLETED|Follow-up||4||
48687330|NCT03139032|102017064|FG000|STARTED|Overall Study||1||
48687331|NCT03139032|102017064|FG000|COMPLETED|Overall Study||1||
48687332|NCT03139032|102017064|FG000|NOT COMPLETED|Overall Study||0||
48687333|NCT02524145|102017065|FG000|STARTED|Overall Study||15||
48687334|NCT02524145|102017066|FG001|STARTED|Overall Study||15||
48687335|NCT02524145|102017067|FG002|STARTED|Overall Study||10||
48687336|NCT02524145|102017065|FG000|COMPLETED|Overall Study||13||
48687337|NCT02524145|102017066|FG001|COMPLETED|Overall Study||13||
48256241|NCT04458818|100947708|FG000|NOT COMPLETED|Overall Study||0||
48256242|NCT01200485|100947709|FG000|STARTED|Cycle 1: Rasburicase Alone Delivery||55||
48256243|NCT01200485|100947710|FG001|STARTED|Cycle 1: Rasburicase Alone Delivery||0||
48256244|NCT01200485|100947711|FG002|STARTED|Cycle 1: Rasburicase Alone Delivery||0||
48256245|NCT01200485|100947709|FG000|COMPLETED|Cycle 1: Rasburicase Alone Delivery||52||
48256246|NCT01200485|100947710|FG001|COMPLETED|Cycle 1: Rasburicase Alone Delivery||0||
48383189|NCT02152670|101265192|FG000|COMPLETED|Overall Study||1||
48383190|NCT02152670|101265192|FG000|NOT COMPLETED|Overall Study||0||
48383191|NCT00441441|101265193|FG000|STARTED|Overall Study||173||
48383192|NCT00441441|101265194|FG001|STARTED|Overall Study||177||
48541595|NCT03750292|101662784|FG001|NOT COMPLETED|Washout (3 Weeks)||0||
48687338|NCT02524145|102017067|FG002|COMPLETED|Overall Study||7||
48687339|NCT02524145|102017065|FG000|NOT COMPLETED|Overall Study||2||
48687340|NCT02524145|102017066|FG001|NOT COMPLETED|Overall Study||2||
48687341|NCT02524145|102017067|FG002|NOT COMPLETED|Overall Study||3||
48383193|NCT00441441|101265193|FG000|COMPLETED|Overall Study||162||
48383194|NCT00441441|101265194|FG001|COMPLETED|Overall Study||163||
48383195|NCT00441441|101265193|FG000|NOT COMPLETED|Overall Study||11||
48383196|NCT00441441|101265194|FG001|NOT COMPLETED|Overall Study||14||
48383197|NCT00421603|101265195|FG000|STARTED|Overall Study||39||
48383198|NCT00421603|101265196|FG001|STARTED|Overall Study||42||
48383199|NCT00421603|101265195|FG000|COMPLETED|Overall Study||28||
48687342|NCT03335150|102017068|FG000|STARTED|Overall Study||55||
48687343|NCT03335150|102017069|FG001|STARTED|Overall Study||55||
48256247|NCT01200485|100947711|FG002|COMPLETED|Cycle 1: Rasburicase Alone Delivery||0||
48256248|NCT01200485|100947709|FG000|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||3||
48687344|NCT03335150|102017068|FG000|Enrolled + Assigned Group|Overall Study||54||
48256249|NCT01200485|100947710|FG001|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||0||
48256250|NCT01200485|100947711|FG002|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||0||
48256251|NCT01200485|100947709|FG000|STARTED|Cycle 2: Randomization||0||
48256252|NCT01200485|100947710|FG001|STARTED|Cycle 2: Randomization||21||
48256253|NCT01200485|100947711|FG002|STARTED|Cycle 2: Randomization||25||
48256254|NCT01200485|100947709|FG000|COMPLETED|Cycle 2: Randomization||0||
48256255|NCT01200485|100947710|FG001|COMPLETED|Cycle 2: Randomization||21||
48256256|NCT01200485|100947711|FG002|COMPLETED|Cycle 2: Randomization||25||
48256257|NCT01200485|100947709|FG000|NOT COMPLETED|Cycle 2: Randomization||0||
48256258|NCT01200485|100947710|FG001|NOT COMPLETED|Cycle 2: Randomization||0||
48256259|NCT01200485|100947711|FG002|NOT COMPLETED|Cycle 2: Randomization||0||
48256260|NCT03305809|100947712|FG000|STARTED|Overall Study||86||
48256261|NCT03305809|100947713|FG001|STARTED|Overall Study||86||
48256262|NCT03305809|100947714|FG002|STARTED|Overall Study||85||
48256263|NCT03305809|100947715|FG003|STARTED|Overall Study||87||
48256264|NCT03305809|100947712|FG000|Received at Least One Dose of Study Drug|Overall Study||86||
48256265|NCT03305809|100947713|FG001|Received at Least One Dose of Study Drug|Overall Study||86||
48256266|NCT03305809|100947714|FG002|Received at Least One Dose of Study Drug|Overall Study||85||
48256267|NCT03305809|100947715|FG003|Received at Least One Dose of Study Drug|Overall Study||87||
48256268|NCT03305809|100947712|FG000|COMPLETED|Overall Study||79||
48256269|NCT03305809|100947713|FG001|COMPLETED|Overall Study||78||
48256270|NCT03305809|100947714|FG002|COMPLETED|Overall Study||66||
48256271|NCT03305809|100947715|FG003|COMPLETED|Overall Study||60||
48256272|NCT03305809|100947712|FG000|NOT COMPLETED|Overall Study||7||
48256273|NCT03305809|100947713|FG001|NOT COMPLETED|Overall Study||8||
48256274|NCT03305809|100947714|FG002|NOT COMPLETED|Overall Study||19||
48256275|NCT03305809|100947715|FG003|NOT COMPLETED|Overall Study||27||
48256276|NCT00846768|100947716|FG000|STARTED|Overall Study||11||
48256277|NCT00846768|100947717|FG001|STARTED|Overall Study||12||
48256278|NCT00846768|100947718|FG002|STARTED|Overall Study||12||
48256279|NCT00846768|100947719|FG003|STARTED|Overall Study||12||
48256280|NCT00846768|100947716|FG000|COMPLETED|Overall Study||11||
48256281|NCT00846768|100947717|FG001|COMPLETED|Overall Study||11||
48256282|NCT00846768|100947718|FG002|COMPLETED|Overall Study||12||
48256283|NCT00846768|100947719|FG003|COMPLETED|Overall Study||12||
48256284|NCT00846768|100947716|FG000|NOT COMPLETED|Overall Study||0||
48256285|NCT00846768|100947717|FG001|NOT COMPLETED|Overall Study||1||
48256286|NCT00846768|100947718|FG002|NOT COMPLETED|Overall Study||0||
48256287|NCT00846768|100947719|FG003|NOT COMPLETED|Overall Study||0||
48256288|NCT00025662|100947720|FG000|STARTED|Overall Study||25||
48256289|NCT00025662|100947720|FG000|COMPLETED|Overall Study||22||
48256290|NCT00025662|100947720|FG000|NOT COMPLETED|Overall Study||3||
48256291|NCT00727415|100947721|FG000|STARTED|Phase I||9||
48256292|NCT00727415|100947721|FG000|COMPLETED|Phase I||7||
48256293|NCT00727415|100947721|FG000|NOT COMPLETED|Phase I||2||
48256294|NCT00727415|100947721|FG000|STARTED|Phase II||33||
48256295|NCT00727415|100947721|FG000|COMPLETED|Phase II||33||
48256296|NCT00727415|100947721|FG000|NOT COMPLETED|Phase II||0||
48256297|NCT01263925|100947722|FG000|STARTED|Overall Study||276||
48256298|NCT01263925|100947723|FG001|STARTED|Overall Study||285||
48256299|NCT01263925|100947722|FG000|Full Analysis Set|Overall Study||269||
48256300|NCT01263925|100947723|FG001|Full Analysis Set|Overall Study||272||
48383200|NCT00421603|101265196|FG001|COMPLETED|Overall Study||30||
48256301|NCT01263925|100947722|FG000|COMPLETED|Overall Study||225||
48256302|NCT01263925|100947723|FG001|COMPLETED|Overall Study||233||
48256303|NCT01263925|100947722|FG000|NOT COMPLETED|Overall Study||51||
48256304|NCT01263925|100947723|FG001|NOT COMPLETED|Overall Study||52||
48687345|NCT03335150|102017069|FG001|Enrolled + Assigned Group|Overall Study||55||
48687346|NCT03335150|102017068|FG000|PRE Testing Session|Overall Study||53||
48256305|NCT01185171|100947724|FG000|STARTED|Induction Chemotherapy||59||
48256306|NCT01185171|100947724|FG000|COMPLETED|Induction Chemotherapy||57||
48256307|NCT01185171|100947724|FG000|NOT COMPLETED|Induction Chemotherapy||2||
48256308|NCT01185171|100947724|FG000|STARTED|Concurrent Chemo and Radiation Treatment||69||
48383201|NCT00421603|101265195|FG000|NOT COMPLETED|Overall Study||11||
48383202|NCT00421603|101265196|FG001|NOT COMPLETED|Overall Study||12||
48687347|NCT03335150|102017069|FG001|PRE Testing Session|Overall Study||55||
48256309|NCT01185171|100947724|FG000|COMPLETED|Concurrent Chemo and Radiation Treatment||66||
48256310|NCT01185171|100947724|FG000|NOT COMPLETED|Concurrent Chemo and Radiation Treatment||3||
48256311|NCT01185171|100947724|FG000|STARTED|Maintenance||60||
48687348|NCT03335150|102017068|FG000|Commenced Group|Overall Study||47||
48383203|NCT02235987|101265197|FG000|STARTED|Overall Study||20||
48383204|NCT02235987|101265197|FG000|Received Octreotide|Overall Study||20||
48383205|NCT02235987|101265197|FG000|Received 100 µg DG3173|Overall Study||20||
48383206|NCT02235987|101265197|FG000|Received 300 µg DG3173|Overall Study||20||
48383207|NCT02235987|101265197|FG000|Received 900 µg DG3173|Overall Study||19||
48383208|NCT02235987|101265197|FG000|Received 1800 µg DG3173|Overall Study||19||
48383209|NCT02235987|101265197|FG000|COMPLETED|Overall Study||19||
48383210|NCT02235987|101265197|FG000|NOT COMPLETED|Overall Study||1||
48383211|NCT03943953|101265198|FG000|STARTED|Trial of ITG 1||88||
48383212|NCT03943953|101265199|FG001|STARTED|Trial of ITG 1||9||
48383213|NCT03943953|101265198|FG000|COMPLETED|Trial of ITG 1||69||
48383214|NCT03943953|101265199|FG001|COMPLETED|Trial of ITG 1||8||
48383215|NCT03943953|101265198|FG000|NOT COMPLETED|Trial of ITG 1||19||
48383216|NCT03943953|101265199|FG001|NOT COMPLETED|Trial of ITG 1||1||
48383217|NCT03943953|101265198|FG000|STARTED|Trial of ITG 2||44||
48383218|NCT03943953|101265199|FG001|STARTED|Trial of ITG 2||0||
48383219|NCT03943953|101265198|FG000|COMPLETED|Trial of ITG 2||36||
48383220|NCT03943953|101265199|FG001|COMPLETED|Trial of ITG 2||0||
48383221|NCT03943953|101265198|FG000|NOT COMPLETED|Trial of ITG 2||8||
48383222|NCT03943953|101265199|FG001|NOT COMPLETED|Trial of ITG 2||0||
48383223|NCT03943953|101265198|FG000|STARTED|Trial of ITG 3||18||
48383224|NCT03943953|101265199|FG001|STARTED|Trial of ITG 3||0||
48383225|NCT03943953|101265198|FG000|COMPLETED|Trial of ITG 3||16||
48383226|NCT03943953|101265199|FG001|COMPLETED|Trial of ITG 3||0||
48383227|NCT03943953|101265198|FG000|NOT COMPLETED|Trial of ITG 3||2||
48383228|NCT03943953|101265199|FG001|NOT COMPLETED|Trial of ITG 3||0||
48383229|NCT03943953|101265198|FG000|STARTED|Trial of ITG 4||10||
48383230|NCT03943953|101265199|FG001|STARTED|Trial of ITG 4||0||
48383231|NCT03943953|101265198|FG000|COMPLETED|Trial of ITG 4||8||
48383232|NCT03943953|101265199|FG001|COMPLETED|Trial of ITG 4||0||
48383233|NCT03943953|101265198|FG000|NOT COMPLETED|Trial of ITG 4||2||
48383234|NCT03943953|101265199|FG001|NOT COMPLETED|Trial of ITG 4||0||
48383235|NCT03943953|101265198|FG000|STARTED|Trial of ITG 5||3||
48383236|NCT03943953|101265199|FG001|STARTED|Trial of ITG 5||0||
48383237|NCT03943953|101265198|FG000|COMPLETED|Trial of ITG 5||3||
48383238|NCT03943953|101265199|FG001|COMPLETED|Trial of ITG 5||0||
48383239|NCT03943953|101265198|FG000|NOT COMPLETED|Trial of ITG 5||0||
48383240|NCT03943953|101265199|FG001|NOT COMPLETED|Trial of ITG 5||0||
48383241|NCT01956240|101265200|FG000|STARTED|Overall Study||48||
48383242|NCT01956240|101265201|FG001|STARTED|Overall Study||49||
48383243|NCT01956240|101265200|FG000|COMPLETED|Overall Study||25||
48383244|NCT01956240|101265201|FG001|COMPLETED|Overall Study||25||
48383245|NCT01956240|101265200|FG000|NOT COMPLETED|Overall Study||23||
48383246|NCT01956240|101265201|FG001|NOT COMPLETED|Overall Study||24||
48383247|NCT00379197|101265202|FG000|STARTED|Overall Study||13||
48383248|NCT00379197|101265202|FG000|COMPLETED|Overall Study||8||
48383249|NCT00379197|101265202|FG000|NOT COMPLETED|Overall Study||5||
48383250|NCT02343276|101265203|FG000|STARTED|Overall Study||164||
48256312|NCT01185171|100947724|FG000|COMPLETED|Maintenance||48||
48256313|NCT01185171|100947724|FG000|NOT COMPLETED|Maintenance||12||
48256314|NCT00129649|100947725|FG000|STARTED|Overall Study||258||
48256315|NCT00129649|100947726|FG001|STARTED|Overall Study||246||
48256316|NCT00129649|100947725|FG000|COMPLETED|Overall Study||182||
48256317|NCT00129649|100947726|FG001|COMPLETED|Overall Study||181||
48256318|NCT00129649|100947725|FG000|NOT COMPLETED|Overall Study||76||
48383251|NCT02343276|101265204|FG001|STARTED|Overall Study||164||
48383252|NCT02343276|101265203|FG000|COMPLETED|Overall Study||164||
48383253|NCT02343276|101265204|FG001|COMPLETED|Overall Study||164||
48383254|NCT02343276|101265203|FG000|NOT COMPLETED|Overall Study||0||
48383255|NCT02343276|101265204|FG001|NOT COMPLETED|Overall Study||0||
48383256|NCT01393171|101265205|FG000|STARTED|Overall Study||36|Oct 2005|
48383257|NCT01393171|101265206|FG001|STARTED|Overall Study||32|Oct 2005|
48383258|NCT01393171|101265207|FG002|STARTED|Overall Study||31|Oct 2005|
48383259|NCT01393171|101265205|FG000|COMPLETED|Overall Study||28||
48383260|NCT01393171|101265206|FG001|COMPLETED|Overall Study||24||
48256319|NCT00129649|100947726|FG001|NOT COMPLETED|Overall Study||65||
48256320|NCT04035577|100947727|FG000|STARTED|Overall Study||21||
48256321|NCT04035577|100947727|FG000|COMPLETED|Overall Study||19||
48256322|NCT04035577|100947727|FG000|NOT COMPLETED|Overall Study||2||
48256323|NCT00611715|100947728|FG000|STARTED|Overall Study||42||
48383261|NCT01393171|101265207|FG002|COMPLETED|Overall Study||26||
48383262|NCT01393171|101265205|FG000|NOT COMPLETED|Overall Study||8||
48383263|NCT01393171|101265206|FG001|NOT COMPLETED|Overall Study||8||
48383264|NCT01393171|101265207|FG002|NOT COMPLETED|Overall Study||5||
48383265|NCT00642746|101265208|FG000|STARTED|Overall Study||10||
48383266|NCT00642746|101265209|FG001|STARTED|Overall Study||1||
48383267|NCT00642746|101265208|FG000|COMPLETED|Overall Study||9||
48256324|NCT00611715|100947729|FG001|STARTED|Overall Study||6||
48256325|NCT00611715|100947728|FG000|COMPLETED|Overall Study||1||
48383268|NCT00642746|101265209|FG001|COMPLETED|Overall Study||1||
48383269|NCT00642746|101265208|FG000|NOT COMPLETED|Overall Study||1||
48383270|NCT00642746|101265209|FG001|NOT COMPLETED|Overall Study||0||
48256326|NCT00611715|100947729|FG001|COMPLETED|Overall Study||0||
48256327|NCT00611715|100947728|FG000|NOT COMPLETED|Overall Study||41||
48256328|NCT00611715|100947729|FG001|NOT COMPLETED|Overall Study||6||
48256329|NCT00630552|100947730|FG000|STARTED|Overall Study||6||
48256330|NCT00630552|100947731|FG001|STARTED|Overall Study||7||
48256331|NCT00630552|100947732|FG002|STARTED|Overall Study||41||
48256332|NCT00630552|100947733|FG003|STARTED|Overall Study||42||
48256333|NCT00630552|100947734|FG004|STARTED|Overall Study||42||
48256334|NCT00630552|100947730|FG000|COMPLETED|Overall Study||1||
48256335|NCT00630552|100947731|FG001|COMPLETED|Overall Study||0||
48256336|NCT00630552|100947732|FG002|COMPLETED|Overall Study||4||
48256337|NCT00630552|100947733|FG003|COMPLETED|Overall Study||8||
48256338|NCT00630552|100947734|FG004|COMPLETED|Overall Study||3||
48256339|NCT00630552|100947730|FG000|NOT COMPLETED|Overall Study||5||
48256340|NCT00630552|100947731|FG001|NOT COMPLETED|Overall Study||7||
48256341|NCT00630552|100947732|FG002|NOT COMPLETED|Overall Study||37||
48256342|NCT00630552|100947733|FG003|NOT COMPLETED|Overall Study||34||
48256343|NCT00630552|100947734|FG004|NOT COMPLETED|Overall Study||39||
48256344|NCT00820664|100947735|FG000|STARTED|Overall Study||9||
48256345|NCT00820664|100947736|FG001|STARTED|Overall Study||11||
48256346|NCT00820664|100947737|FG002|STARTED|Overall Study||9||
48256347|NCT00820664|100947735|FG000|COMPLETED|Overall Study||9||
48256348|NCT00820664|100947736|FG001|COMPLETED|Overall Study||11||
48256349|NCT00820664|100947737|FG002|COMPLETED|Overall Study||9||
48256350|NCT00820664|100947735|FG000|NOT COMPLETED|Overall Study||0||
48256351|NCT00820664|100947736|FG001|NOT COMPLETED|Overall Study||0||
48256352|NCT00820664|100947737|FG002|NOT COMPLETED|Overall Study||0||
48256353|NCT02288364|100947738|FG000|STARTED|Overall Study||42||
48256354|NCT02288364|100947739|FG001|STARTED|Overall Study||44||
48256355|NCT02288364|100947738|FG000|COMPLETED|Overall Study||42||
48256356|NCT02288364|100947739|FG001|COMPLETED|Overall Study||44||
48256357|NCT02288364|100947738|FG000|NOT COMPLETED|Overall Study||0||
48256358|NCT02288364|100947739|FG001|NOT COMPLETED|Overall Study||0||
48256359|NCT02637856|100947740|FG000|STARTED|Main Study (Baseline to Week 100)||608||
48256360|NCT02637856|100947741|FG001|STARTED|Main Study (Baseline to Week 100)||0||
48256361|NCT02637856|100947740|FG000|COMPLETED|Main Study (Baseline to Week 100)||389||
48256362|NCT02637856|100947741|FG001|COMPLETED|Main Study (Baseline to Week 100)||0||
48256363|NCT02637856|100947740|FG000|NOT COMPLETED|Main Study (Baseline to Week 100)||219||
48383271|NCT00567541|101265210|FG000|STARTED|Overall Study||7||
48383272|NCT00567541|101265211|FG001|STARTED|Overall Study||9||
48256364|NCT02637856|100947741|FG001|NOT COMPLETED|Main Study (Baseline to Week 100)||0||
48256365|NCT02637856|100947740|FG000|STARTED|Sub-Study (Week 72 to Week 100)||0||
48256366|NCT02637856|100947741|FG001|STARTED|Sub-Study (Week 72 to Week 100)||129||
48256367|NCT02637856|100947740|FG000|COMPLETED|Sub-Study (Week 72 to Week 100)||0||
48256368|NCT02637856|100947741|FG001|COMPLETED|Sub-Study (Week 72 to Week 100)||125||
48256369|NCT02637856|100947740|FG000|NOT COMPLETED|Sub-Study (Week 72 to Week 100)||0||
48256370|NCT02637856|100947741|FG001|NOT COMPLETED|Sub-Study (Week 72 to Week 100)||4||
48256371|NCT03671239|100947742|FG000|STARTED|First Intervention (4 Weeks)||35||
48256372|NCT03671239|100947743|FG001|STARTED|First Intervention (4 Weeks)||36||
48256373|NCT03671239|100947744|FG002|STARTED|First Intervention (4 Weeks)||37||
48256374|NCT03671239|100947745|FG003|STARTED|First Intervention (4 Weeks)||36||
48256375|NCT03671239|100947746|FG004|STARTED|First Intervention (4 Weeks)||37||
48256376|NCT03671239|100947747|FG005|STARTED|First Intervention (4 Weeks)||36||
48256377|NCT03671239|100947742|FG000|COMPLETED|First Intervention (4 Weeks)||33||
48256378|NCT03671239|100947743|FG001|COMPLETED|First Intervention (4 Weeks)||33||
48256379|NCT03671239|100947744|FG002|COMPLETED|First Intervention (4 Weeks)||35||
48256380|NCT03671239|100947745|FG003|COMPLETED|First Intervention (4 Weeks)||35||
48256381|NCT03671239|100947746|FG004|COMPLETED|First Intervention (4 Weeks)||35||
48383273|NCT00567541|101265210|FG000|COMPLETED|Overall Study||7||
48383274|NCT00567541|101265211|FG001|COMPLETED|Overall Study||8||
48383275|NCT00567541|101265210|FG000|NOT COMPLETED|Overall Study||0||
48383276|NCT00567541|101265211|FG001|NOT COMPLETED|Overall Study||1||
48383277|NCT04587453|101265212|FG000|STARTED|Treatment Period (Week 0 to Week 16)||53||
48383278|NCT04587453|101265213|FG001|STARTED|Treatment Period (Week 0 to Week 16)||53||
48383279|NCT04587453|101265212|FG000|Full Analysis Set|Treatment Period (Week 0 to Week 16)||53|All participants randomised and exposed to IMP.|
48383280|NCT04587453|101265213|FG001|Full Analysis Set|Treatment Period (Week 0 to Week 16)||53|All participants randomised and exposed to IMP.|
48383281|NCT04587453|101265212|FG000|Safety Analysis Set|Treatment Period (Week 0 to Week 16)||53|All participants exposed to IMP.|
48383282|NCT04587453|101265213|FG001|Safety Analysis Set|Treatment Period (Week 0 to Week 16)||53|All participants exposed to IMP.|
48383283|NCT04587453|101265212|FG000|COMPLETED|Treatment Period (Week 0 to Week 16)||53|Participants attended the Week 16 visit (end of treatment visit).|
48383284|NCT04587453|101265213|FG001|COMPLETED|Treatment Period (Week 0 to Week 16)||52|Participants attended the Week 16 visit (end of treatment visit).|
48383285|NCT04587453|101265212|FG000|NOT COMPLETED|Treatment Period (Week 0 to Week 16)||0||
48383286|NCT04587453|101265213|FG001|NOT COMPLETED|Treatment Period (Week 0 to Week 16)||1||
48383287|NCT04587453|101265212|FG000|STARTED|Safety Follow-up (Week 16 to Week 20)||8|Date of last contact was after the date of exposure end.|
48256382|NCT03671239|100947747|FG005|COMPLETED|First Intervention (4 Weeks)||33||
48256383|NCT03671239|100947742|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2||
48256384|NCT03671239|100947743|FG001|NOT COMPLETED|First Intervention (4 Weeks)||3||
48256385|NCT03671239|100947744|FG002|NOT COMPLETED|First Intervention (4 Weeks)||2||
48256386|NCT03671239|100947745|FG003|NOT COMPLETED|First Intervention (4 Weeks)||1||
48256387|NCT03671239|100947746|FG004|NOT COMPLETED|First Intervention (4 Weeks)||2||
48256388|NCT03671239|100947747|FG005|NOT COMPLETED|First Intervention (4 Weeks)||3||
48256389|NCT03671239|100947742|FG000|STARTED|Washout (1 Week)||35||
48256390|NCT03671239|100947743|FG001|STARTED|Washout (1 Week)||36||
48256391|NCT03671239|100947744|FG002|STARTED|Washout (1 Week)||37||
48256392|NCT03671239|100947745|FG003|STARTED|Washout (1 Week)||36||
48256393|NCT03671239|100947746|FG004|STARTED|Washout (1 Week)||37||
48256394|NCT03671239|100947747|FG005|STARTED|Washout (1 Week)||36||
48256395|NCT03671239|100947742|FG000|COMPLETED|Washout (1 Week)||35||
48256396|NCT03671239|100947743|FG001|COMPLETED|Washout (1 Week)||36||
48256397|NCT03671239|100947744|FG002|COMPLETED|Washout (1 Week)||37||
48256398|NCT03671239|100947745|FG003|COMPLETED|Washout (1 Week)||36||
48256399|NCT03671239|100947746|FG004|COMPLETED|Washout (1 Week)||37||
48256400|NCT03671239|100947747|FG005|COMPLETED|Washout (1 Week)||36||
48256401|NCT03671239|100947742|FG000|NOT COMPLETED|Washout (1 Week)||0||
48256402|NCT03671239|100947743|FG001|NOT COMPLETED|Washout (1 Week)||0||
48256403|NCT03671239|100947744|FG002|NOT COMPLETED|Washout (1 Week)||0||
48256404|NCT03671239|100947745|FG003|NOT COMPLETED|Washout (1 Week)||0||
48256405|NCT03671239|100947746|FG004|NOT COMPLETED|Washout (1 Week)||0||
48256406|NCT03671239|100947747|FG005|NOT COMPLETED|Washout (1 Week)||0||
48256407|NCT03671239|100947742|FG000|STARTED|Second Intervetion (4 Weeks)||35||
48256408|NCT03671239|100947743|FG001|STARTED|Second Intervetion (4 Weeks)||36||
48256409|NCT03671239|100947744|FG002|STARTED|Second Intervetion (4 Weeks)||37||
48256410|NCT03671239|100947745|FG003|STARTED|Second Intervetion (4 Weeks)||36||
48256411|NCT03671239|100947746|FG004|STARTED|Second Intervetion (4 Weeks)||37||
48256412|NCT03671239|100947747|FG005|STARTED|Second Intervetion (4 Weeks)||36||
48256413|NCT03671239|100947742|FG000|COMPLETED|Second Intervetion (4 Weeks)||33||
48256414|NCT03671239|100947743|FG001|COMPLETED|Second Intervetion (4 Weeks)||33||
48256415|NCT03671239|100947744|FG002|COMPLETED|Second Intervetion (4 Weeks)||37||
48383288|NCT04587453|101265213|FG001|STARTED|Safety Follow-up (Week 16 to Week 20)||3|Date of last contact was after the date of exposure end.|
48383289|NCT04587453|101265212|FG000|Not Started|Safety Follow-up (Week 16 to Week 20)||45|Transferred to the long-term extension trial ECZTEND (LP0162-1337) instead of entering the safety follow-up period.|
48256416|NCT03671239|100947745|FG003|COMPLETED|Second Intervetion (4 Weeks)||34||
48256417|NCT03671239|100947746|FG004|COMPLETED|Second Intervetion (4 Weeks)||34||
48256418|NCT03671239|100947747|FG005|COMPLETED|Second Intervetion (4 Weeks)||35||
48256419|NCT03671239|100947742|FG000|NOT COMPLETED|Second Intervetion (4 Weeks)||2||
48256420|NCT03671239|100947743|FG001|NOT COMPLETED|Second Intervetion (4 Weeks)||3||
48256421|NCT03671239|100947744|FG002|NOT COMPLETED|Second Intervetion (4 Weeks)||0||
48256422|NCT03671239|100947745|FG003|NOT COMPLETED|Second Intervetion (4 Weeks)||2||
48256423|NCT03671239|100947746|FG004|NOT COMPLETED|Second Intervetion (4 Weeks)||3||
48256424|NCT03671239|100947747|FG005|NOT COMPLETED|Second Intervetion (4 Weeks)||1||
48256425|NCT03671239|100947742|FG000|STARTED|Washout (1 Week)||35||
48256426|NCT03671239|100947743|FG001|STARTED|Washout (1 Week)||36||
48256427|NCT03671239|100947744|FG002|STARTED|Washout (1 Week)||37||
48256428|NCT03671239|100947745|FG003|STARTED|Washout (1 Week)||36||
48256429|NCT03671239|100947746|FG004|STARTED|Washout (1 Week)||37||
48256430|NCT03671239|100947747|FG005|STARTED|Washout (1 Week)||36||
48256431|NCT03671239|100947742|FG000|COMPLETED|Washout (1 Week)||35||
48256432|NCT03671239|100947743|FG001|COMPLETED|Washout (1 Week)||36||
48256433|NCT03671239|100947744|FG002|COMPLETED|Washout (1 Week)||37||
48256434|NCT03671239|100947745|FG003|COMPLETED|Washout (1 Week)||36||
48256435|NCT03671239|100947746|FG004|COMPLETED|Washout (1 Week)||37||
48256436|NCT03671239|100947747|FG005|COMPLETED|Washout (1 Week)||36||
48256437|NCT03671239|100947742|FG000|NOT COMPLETED|Washout (1 Week)||0||
48256438|NCT03671239|100947743|FG001|NOT COMPLETED|Washout (1 Week)||0||
48256439|NCT03671239|100947744|FG002|NOT COMPLETED|Washout (1 Week)||0||
48256440|NCT03671239|100947745|FG003|NOT COMPLETED|Washout (1 Week)||0||
48256441|NCT03671239|100947746|FG004|NOT COMPLETED|Washout (1 Week)||0||
48256442|NCT03671239|100947747|FG005|NOT COMPLETED|Washout (1 Week)||0||
48256443|NCT03671239|100947742|FG000|STARTED|Third Intervention (4 Weeks)||35||
48256444|NCT03671239|100947743|FG001|STARTED|Third Intervention (4 Weeks)||36||
48256445|NCT03671239|100947744|FG002|STARTED|Third Intervention (4 Weeks)||37||
48256446|NCT03671239|100947745|FG003|STARTED|Third Intervention (4 Weeks)||36||
48256447|NCT03671239|100947746|FG004|STARTED|Third Intervention (4 Weeks)||37||
48256448|NCT03671239|100947747|FG005|STARTED|Third Intervention (4 Weeks)||36||
48256449|NCT03671239|100947742|FG000|COMPLETED|Third Intervention (4 Weeks)||33||
48256450|NCT03671239|100947743|FG001|COMPLETED|Third Intervention (4 Weeks)||35||
48256451|NCT03671239|100947744|FG002|COMPLETED|Third Intervention (4 Weeks)||35||
48256452|NCT03671239|100947745|FG003|COMPLETED|Third Intervention (4 Weeks)||34||
48256453|NCT03671239|100947746|FG004|COMPLETED|Third Intervention (4 Weeks)||36||
48256454|NCT03671239|100947747|FG005|COMPLETED|Third Intervention (4 Weeks)||34||
48256455|NCT03671239|100947742|FG000|NOT COMPLETED|Third Intervention (4 Weeks)||2||
48256456|NCT03671239|100947743|FG001|NOT COMPLETED|Third Intervention (4 Weeks)||1||
48256457|NCT03671239|100947744|FG002|NOT COMPLETED|Third Intervention (4 Weeks)||2||
48256458|NCT03671239|100947745|FG003|NOT COMPLETED|Third Intervention (4 Weeks)||2||
48383290|NCT04587453|101265213|FG001|Not Started|Safety Follow-up (Week 16 to Week 20)||49|Transferred to the long-term extension trial ECZTEND (LP0162-1337) instead of entering the safety follow-up period.|
48383291|NCT04587453|101265212|FG000|Safety Follow-up Analysis Set|Safety Follow-up (Week 16 to Week 20)||8|Date of last contact was after the date of exposure end.|
48383292|NCT04587453|101265213|FG001|Safety Follow-up Analysis Set|Safety Follow-up (Week 16 to Week 20)||4|Date of last contact was after the date of exposure end.|
48383293|NCT04587453|101265212|FG000|COMPLETED|Safety Follow-up (Week 16 to Week 20)||8|Completed the safety follow-up period with a safety follow-up visit.|
48383294|NCT04587453|101265213|FG001|COMPLETED|Safety Follow-up (Week 16 to Week 20)||3|Completed the safety follow-up period with a safety follow-up visit.|
48383295|NCT04587453|101265212|FG000|NOT COMPLETED|Safety Follow-up (Week 16 to Week 20)||0||
48383296|NCT04587453|101265213|FG001|NOT COMPLETED|Safety Follow-up (Week 16 to Week 20)||0||
48383297|NCT00734344|101265214|FG000|STARTED|Overall Study||9||
48383298|NCT00734344|101265215|FG001|STARTED|Overall Study||9||
48383299|NCT00734344|101265214|FG000|COMPLETED|Overall Study||9||
48383300|NCT00734344|101265215|FG001|COMPLETED|Overall Study||9||
48383301|NCT00734344|101265214|FG000|NOT COMPLETED|Overall Study||0||
48383302|NCT00734344|101265215|FG001|NOT COMPLETED|Overall Study||0||
48383303|NCT02365584|101265216|FG000|STARTED|Overall Study||21||
48383304|NCT02365584|101265217|FG001|STARTED|Overall Study||22||
48383305|NCT02365584|101265216|FG000|COMPLETED|Overall Study||9||
48383306|NCT02365584|101265217|FG001|COMPLETED|Overall Study||8||
48383307|NCT02365584|101265216|FG000|NOT COMPLETED|Overall Study||12||
48383308|NCT02365584|101265217|FG001|NOT COMPLETED|Overall Study||14||
48383309|NCT00301028|101265218|FG000|STARTED|Overall Study||47||
48383310|NCT00301028|101265218|FG000|COMPLETED|Overall Study||47||
48383311|NCT00301028|101265218|FG000|NOT COMPLETED|Overall Study||0||
48383312|NCT01709136|101265219|FG000|STARTED|Overall Study||3||
48383313|NCT01709136|101265219|FG000|COMPLETED|Overall Study||3||
48687349|NCT03335150|102017069|FG001|Commenced Group|Overall Study||52||
48687350|NCT03335150|102017068|FG000|POST Testing Session|Overall Study||45||
48687351|NCT03335150|102017069|FG001|POST Testing Session|Overall Study||50||
48687352|NCT03335150|102017068|FG000|COMPLETED|Overall Study||45||
48256459|NCT03671239|100947746|FG004|NOT COMPLETED|Third Intervention (4 Weeks)||1||
48256460|NCT03671239|100947747|FG005|NOT COMPLETED|Third Intervention (4 Weeks)||2||
48256461|NCT00827775|100947748|FG000|STARTED|Overall Study||25||
48256462|NCT00827775|100947749|FG001|STARTED|Overall Study||30||
48256463|NCT00827775|100947748|FG000|COMPLETED|Overall Study||25||
48256464|NCT00827775|100947749|FG001|COMPLETED|Overall Study||25||
48256465|NCT00827775|100947748|FG000|NOT COMPLETED|Overall Study||0||
48256466|NCT00827775|100947749|FG001|NOT COMPLETED|Overall Study||5||
48383314|NCT01709136|101265219|FG000|NOT COMPLETED|Overall Study||0||
48383315|NCT01364233|101265220|FG000|STARTED|Overall Study||10||
48687353|NCT03335150|102017069|FG001|COMPLETED|Overall Study||50||
48687354|NCT03335150|102017068|FG000|NOT COMPLETED|Overall Study||10||
48687355|NCT03335150|102017069|FG001|NOT COMPLETED|Overall Study||5||
48687356|NCT02168062|102017070|FG000|STARTED|Overall Study||23||
48687357|NCT02168062|102017071|FG001|STARTED|Overall Study||26||
48687358|NCT02168062|102017072|FG002|STARTED|Overall Study||8||
48687359|NCT02168062|102017070|FG000|COMPLETED|Overall Study||23||
48091624|NCT01905657|100545822|FG000|Received Second Course of Pembrolizumab|Overall Study||14||
48091625|NCT01905657|100545823|FG001|Received Second Course of Pembrolizumab|Overall Study||7||
48383316|NCT01364233|101265220|FG000|COMPLETED|Overall Study||9||
48383317|NCT01364233|101265220|FG000|NOT COMPLETED|Overall Study||1||
48687360|NCT02168062|102017071|FG001|COMPLETED|Overall Study||26||
48687361|NCT02168062|102017072|FG002|COMPLETED|Overall Study||8||
48091626|NCT01905657|100545824|FG002|Received Second Course of Pembrolizumab|Overall Study||0||
48687362|NCT02168062|102017070|FG000|NOT COMPLETED|Overall Study||0||
48687363|NCT02168062|102017071|FG001|NOT COMPLETED|Overall Study||0||
48687364|NCT02168062|102017072|FG002|NOT COMPLETED|Overall Study||0||
48687365|NCT01898286|102017073|FG000|STARTED|Overall Study||38||
48687366|NCT01898286|102017073|FG000|COMPLETED|Overall Study||35||
48091627|NCT01905657|100545822|FG000|Switched Over to Pembrolizumab|Overall Study||0||
48091628|NCT01905657|100545823|FG001|Switched Over to Pembrolizumab|Overall Study||0||
48091629|NCT01905657|100545824|FG002|Switched Over to Pembrolizumab|Overall Study||8||
48091630|NCT01905657|100545822|FG000|COMPLETED|Overall Study||142||
48091631|NCT01905657|100545823|FG001|COMPLETED|Overall Study||159||
48091632|NCT01905657|100545824|FG002|COMPLETED|Overall Study||143||
48091633|NCT01905657|100545822|FG000|NOT COMPLETED|Overall Study||203||
48091634|NCT01905657|100545823|FG001|NOT COMPLETED|Overall Study||187||
48091635|NCT01905657|100545824|FG002|NOT COMPLETED|Overall Study||200||
48091636|NCT01059825|100545825|FG000|STARTED|Enrolled, Run-in Period||0||
48091637|NCT01059825|100545826|FG001|STARTED|Enrolled, Run-in Period||0||
48091638|NCT01059825|100545827|FG002|STARTED|Enrolled, Run-in Period||0||
48091639|NCT01059825|100545828|FG003|STARTED|Enrolled, Run-in Period||0||
48091640|NCT01059825|100545829|FG004|STARTED|Enrolled, Run-in Period||0||
48091641|NCT01059825|100545830|FG005|STARTED|Enrolled, Run-in Period||0||
48091642|NCT01059825|100545831|FG006|STARTED|Enrolled, Run-in Period||375||
48091643|NCT01059825|100545825|FG000|COMPLETED|Enrolled, Run-in Period||0||
48091644|NCT01059825|100545826|FG001|COMPLETED|Enrolled, Run-in Period||0||
48091645|NCT01059825|100545827|FG002|COMPLETED|Enrolled, Run-in Period||0||
48091646|NCT01059825|100545828|FG003|COMPLETED|Enrolled, Run-in Period||0||
48091647|NCT01059825|100545829|FG004|COMPLETED|Enrolled, Run-in Period||0||
48383318|NCT02664532|101265221|FG000|STARTED|Overall Study||75||
48383319|NCT02664532|101265222|FG001|STARTED|Overall Study||75||
48383320|NCT02664532|101265221|FG000|COMPLETED|Overall Study||75||
48383321|NCT02664532|101265222|FG001|COMPLETED|Overall Study||75||
48383322|NCT02664532|101265221|FG000|NOT COMPLETED|Overall Study||0||
48687367|NCT01898286|102017073|FG000|NOT COMPLETED|Overall Study||3||
48687368|NCT01484652|102017074|FG000|STARTED|Overall Study||166||
48687369|NCT01484652|102017075|FG001|STARTED|Overall Study||163||
48687370|NCT01484652|102017074|FG000|COMPLETED|Overall Study||151||
48687371|NCT01484652|102017075|FG001|COMPLETED|Overall Study||142||
48687372|NCT01484652|102017074|FG000|NOT COMPLETED|Overall Study||15||
48687373|NCT01484652|102017075|FG001|NOT COMPLETED|Overall Study||21||
48687374|NCT00988156|102017076|FG000|STARTED|Overall Study||149||
48687375|NCT00988156|102017077|FG001|STARTED|Overall Study||155||
48091648|NCT01059825|100545830|FG005|COMPLETED|Enrolled, Run-in Period||0||
48091649|NCT01059825|100545831|FG006|COMPLETED|Enrolled, Run-in Period||328||
48091650|NCT01059825|100545825|FG000|NOT COMPLETED|Enrolled, Run-in Period||0||
48091651|NCT01059825|100545826|FG001|NOT COMPLETED|Enrolled, Run-in Period||0||
48091652|NCT01059825|100545827|FG002|NOT COMPLETED|Enrolled, Run-in Period||0||
48091653|NCT01059825|100545828|FG003|NOT COMPLETED|Enrolled, Run-in Period||0||
48091654|NCT01059825|100545829|FG004|NOT COMPLETED|Enrolled, Run-in Period||0||
48091655|NCT01059825|100545830|FG005|NOT COMPLETED|Enrolled, Run-in Period||0||
48091656|NCT01059825|100545831|FG006|NOT COMPLETED|Enrolled, Run-in Period||47||
48091657|NCT01059825|100545825|FG000|STARTED|Treatment Period||54||
48256467|NCT02742532|100947750|FG000|STARTED|Overall Study||31||
48687376|NCT00988156|102017076|FG000|Intention-to-Treat Set (ITT)|Overall Study||129||
48687377|NCT00988156|102017077|FG001|Intention-to-Treat Set (ITT)|Overall Study||134||
48687378|NCT00988156|102017076|FG000|Per Protocol Set (PP)|Overall Study||101||
48091658|NCT01059825|100545826|FG001|STARTED|Treatment Period||54||
48091659|NCT01059825|100545827|FG002|STARTED|Treatment Period||55||
48383323|NCT02664532|101265222|FG001|NOT COMPLETED|Overall Study||0||
48383324|NCT02855450|101265223|FG000|STARTED|Overall Study||40||
48383325|NCT02855450|101265224|FG001|STARTED|Overall Study||20||
48383326|NCT02855450|101265223|FG000|COMPLETED|Overall Study||35||
48383327|NCT02855450|101265224|FG001|COMPLETED|Overall Study||20||
48383328|NCT02855450|101265223|FG000|NOT COMPLETED|Overall Study||5||
48383329|NCT02855450|101265224|FG001|NOT COMPLETED|Overall Study||0||
48383330|NCT04866303|101265225|FG000|STARTED|Overall Study||136|Total randomized|
48383331|NCT04866303|101265226|FG001|STARTED|Overall Study||137|Total randomized|
48383332|NCT04866303|101265225|FG000|Withdrawal or Lost to Follow Up|Overall Study||4||
48383333|NCT04866303|101265226|FG001|Withdrawal or Lost to Follow Up|Overall Study||1||
48383334|NCT04866303|101265225|FG000|COMPLETED|Overall Study||132||
48687379|NCT00988156|102017077|FG001|Per Protocol Set (PP)|Overall Study||97||
48091660|NCT01059825|100545828|FG003|STARTED|Treatment Period||55||
48687380|NCT00988156|102017076|FG000|Safety Set|Overall Study||129||
48687381|NCT00988156|102017077|FG001|Safety Set|Overall Study||134||
48687382|NCT00988156|102017076|FG000|COMPLETED|Overall Study||132||
48687383|NCT00988156|102017077|FG001|COMPLETED|Overall Study||135||
48687384|NCT00988156|102017076|FG000|NOT COMPLETED|Overall Study||17||
48687385|NCT00988156|102017077|FG001|NOT COMPLETED|Overall Study||20||
48687386|NCT02094118|102017078|FG000|STARTED|Overall Study||85||
48687387|NCT02094118|102017079|FG001|STARTED|Overall Study||86||
48687388|NCT02094118|102017078|FG000|COMPLETED|Overall Study||73||
48687389|NCT02094118|102017079|FG001|COMPLETED|Overall Study||81||
48687390|NCT02094118|102017078|FG000|NOT COMPLETED|Overall Study||12||
48687391|NCT02094118|102017079|FG001|NOT COMPLETED|Overall Study||5||
48687392|NCT02517398|102017080|FG000|STARTED|Overall Study||3||
48687393|NCT02517398|102017081|FG001|STARTED|Overall Study||3||
48687394|NCT02517398|102017082|FG002|STARTED|Overall Study||4||
48687395|NCT02517398|102017083|FG003|STARTED|Overall Study||3||
48687396|NCT02517398|102017084|FG004|STARTED|Overall Study||6||
48091661|NCT01059825|100545829|FG004|STARTED|Treatment Period||55||
48091662|NCT01059825|100545830|FG005|STARTED|Treatment Period||55||
48091663|NCT01059825|100545831|FG006|STARTED|Treatment Period||0||
48091664|NCT01059825|100545825|FG000|COMPLETED|Treatment Period||44||
48091665|NCT01059825|100545826|FG001|COMPLETED|Treatment Period||50||
48091666|NCT01059825|100545827|FG002|COMPLETED|Treatment Period||49||
48091667|NCT01059825|100545828|FG003|COMPLETED|Treatment Period||44||
48091668|NCT01059825|100545829|FG004|COMPLETED|Treatment Period||47||
48091669|NCT01059825|100545830|FG005|COMPLETED|Treatment Period||52||
48091670|NCT01059825|100545831|FG006|COMPLETED|Treatment Period||0||
48091671|NCT01059825|100545825|FG000|NOT COMPLETED|Treatment Period||10||
48091672|NCT01059825|100545826|FG001|NOT COMPLETED|Treatment Period||4||
48091673|NCT01059825|100545827|FG002|NOT COMPLETED|Treatment Period||6||
48091674|NCT01059825|100545828|FG003|NOT COMPLETED|Treatment Period||11||
48091675|NCT01059825|100545829|FG004|NOT COMPLETED|Treatment Period||8||
48091676|NCT01059825|100545830|FG005|NOT COMPLETED|Treatment Period||3||
48091677|NCT01059825|100545831|FG006|NOT COMPLETED|Treatment Period||0||
48091678|NCT04867850|100545832|FG000|STARTED|Overall Study||1004|Oncologist-APP clusters were randomized to receive either the clinician nudge or usual care. Patients were individually randomized to receive the patient nudge or usual care. Combined, the clinician- and patient-directed nudges lead to four combinations of the presence or absence of nudges.|32
48091679|NCT04867850|100545833|FG001|STARTED|Overall Study||1179|Oncologist-APP clusters were randomized to receive either the clinician nudge or usual care. Patients were individually randomized to receive the patient nudge or usual care. Combined, the clinician- and patient-directed nudges lead to four combinations of the presence or absence of nudges.|33
48091680|NCT04867850|100545834|FG002|STARTED|Overall Study||997|Oncologist-APP clusters were randomized to receive either the clinician nudge or usual care. Patients were individually randomized to receive the patient nudge or usual care. Combined, the clinician- and patient-directed nudges lead to four combinations of the presence or absence of nudges.|0
48091681|NCT04867850|100545835|FG003|STARTED|Overall Study||1270|Oncologist-APP clusters were randomized to receive either the clinician nudge or usual care. Patients were individually randomized to receive the patient nudge or usual care. Combined, the clinician- and patient-directed nudges lead to four combinations of the presence or absence of nudges.|0
48091682|NCT04867850|100545832|FG000|COMPLETED|Overall Study||1004||29
48091683|NCT04867850|100545833|FG001|COMPLETED|Overall Study||1179||31
48091684|NCT04867850|100545834|FG002|COMPLETED|Overall Study||997||0
48091685|NCT04867850|100545835|FG003|COMPLETED|Overall Study||1270||0
48383335|NCT04866303|101265226|FG001|COMPLETED|Overall Study||136||
48687397|NCT02517398|102017085|FG005|STARTED|Overall Study||10||
48687398|NCT02517398|102017086|FG006|STARTED|Overall Study||7||
48687399|NCT02517398|102017087|FG007|STARTED|Overall Study||3||
48687400|NCT02517398|102017088|FG008|STARTED|Overall Study||6||
48687401|NCT02517398|102017089|FG009|STARTED|Overall Study||38||
48687402|NCT02517398|102017090|FG010|STARTED|Overall Study||68||
48687403|NCT02517398|102017091|FG011|STARTED|Overall Study||32||
48687404|NCT02517398|102017092|FG012|STARTED|Overall Study||83||
48687405|NCT02517398|102017093|FG013|STARTED|Overall Study||36||
48687406|NCT02517398|102017094|FG014|STARTED|Overall Study||30||
48687407|NCT02517398|102017095|FG015|STARTED|Overall Study||32||
48687408|NCT02517398|102017096|FG016|STARTED|Overall Study||33||
48091686|NCT04867850|100545832|FG000|NOT COMPLETED|Overall Study||0||3
48091687|NCT04867850|100545833|FG001|NOT COMPLETED|Overall Study||0||2
48091688|NCT04867850|100545834|FG002|NOT COMPLETED|Overall Study||0||0
48091689|NCT04867850|100545835|FG003|NOT COMPLETED|Overall Study||0||0
48091690|NCT04271605|100545836|FG000|STARTED|Overall Study||5|5 participants were enrolled and completed the baseline questionnaire and examination.|
48091691|NCT04271605|100545836|FG000|COMPLETED|Overall Study||0||
48091692|NCT04271605|100545836|FG000|NOT COMPLETED|Overall Study||5||
48091693|NCT00345254|100545837|FG000|STARTED|Overall Study||30||
48091694|NCT00345254|100545838|FG001|STARTED|Overall Study||30||
48091695|NCT00345254|100545837|FG000|COMPLETED|Overall Study||30||
48383336|NCT04866303|101265225|FG000|NOT COMPLETED|Overall Study||4||
48383337|NCT04866303|101265226|FG001|NOT COMPLETED|Overall Study||1||
48383338|NCT03956225|101265227|FG000|STARTED|Overall Study||119||238
48383339|NCT03956225|101265228|FG001|STARTED|Overall Study||117||234
48383340|NCT03956225|101265227|FG000|COMPLETED|Overall Study||114||228
48383341|NCT03956225|101265228|FG001|COMPLETED|Overall Study||113||226
48383342|NCT03956225|101265227|FG000|NOT COMPLETED|Overall Study||5||10
48383343|NCT03956225|101265228|FG001|NOT COMPLETED|Overall Study||4||8
48383344|NCT00681538|101265229|FG000|STARTED|Phase A- 4 Weeks Single Blind||572||
48383345|NCT00681538|101265230|FG001|STARTED|Phase A- 4 Weeks Single Blind||0||
48383346|NCT00681538|101265229|FG000|COMPLETED|Phase A- 4 Weeks Single Blind||538||
48383347|NCT00681538|101265230|FG001|COMPLETED|Phase A- 4 Weeks Single Blind||0||
48383348|NCT00681538|101265229|FG000|NOT COMPLETED|Phase A- 4 Weeks Single Blind||34||
48383349|NCT00681538|101265230|FG001|NOT COMPLETED|Phase A- 4 Weeks Single Blind||0||
48383350|NCT00681538|101265229|FG000|STARTED|Phase B- Responders;12 Week Double-blind||124||
48383351|NCT00681538|101265230|FG001|STARTED|Phase B- Responders;12 Week Double-blind||117||
48383352|NCT00681538|101265229|FG000|COMPLETED|Phase B- Responders;12 Week Double-blind||109||
48091696|NCT00345254|100545838|FG001|COMPLETED|Overall Study||30||
48091697|NCT00345254|100545837|FG000|NOT COMPLETED|Overall Study||0||
48091698|NCT00345254|100545838|FG001|NOT COMPLETED|Overall Study||0||
48256468|NCT02742532|100947751|FG001|STARTED|Overall Study||32||
48383353|NCT00681538|101265230|FG001|COMPLETED|Phase B- Responders;12 Week Double-blind||115||
48383354|NCT00681538|101265229|FG000|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||15||
48091699|NCT00844051|100545839|FG000|STARTED|Overall Study||2087||
48091700|NCT00844051|100545840|FG001|STARTED|Overall Study||2368||
48091701|NCT00844051|100545839|FG000|COMPLETED|Overall Study||2087||
48091702|NCT00844051|100545840|FG001|COMPLETED|Overall Study||2368||
48091703|NCT00844051|100545839|FG000|NOT COMPLETED|Overall Study||0||
48091704|NCT00844051|100545840|FG001|NOT COMPLETED|Overall Study||0||
48091705|NCT03562481|100545841|FG000|STARTED|First Intervention||12||
48091706|NCT03562481|100545842|FG001|STARTED|First Intervention||14||
48091707|NCT03562481|100545841|FG000|COMPLETED|First Intervention||11||
48091708|NCT03562481|100545842|FG001|COMPLETED|First Intervention||14||
48091709|NCT03562481|100545841|FG000|NOT COMPLETED|First Intervention||1||
48091710|NCT03562481|100545842|FG001|NOT COMPLETED|First Intervention||0||
48091711|NCT03562481|100545841|FG000|STARTED|Washout||11||
48091712|NCT03562481|100545842|FG001|STARTED|Washout||14||
48091713|NCT03562481|100545841|FG000|COMPLETED|Washout||11||
48091714|NCT03562481|100545842|FG001|COMPLETED|Washout||14||
48091715|NCT03562481|100545841|FG000|NOT COMPLETED|Washout||0||
48091716|NCT03562481|100545842|FG001|NOT COMPLETED|Washout||0||
48091717|NCT03562481|100545841|FG000|STARTED|Second Intervention||11||
48091718|NCT03562481|100545842|FG001|STARTED|Second Intervention||14||
48091719|NCT03562481|100545841|FG000|COMPLETED|Second Intervention||11||
48256469|NCT02742532|100947750|FG000|COMPLETED|Overall Study||28||
48256470|NCT02742532|100947751|FG001|COMPLETED|Overall Study||31||
48256471|NCT02742532|100947750|FG000|NOT COMPLETED|Overall Study||3||
48256472|NCT02742532|100947751|FG001|NOT COMPLETED|Overall Study||1||
48256473|NCT01093599|100947752|FG000|STARTED|Overall Study||91||
48256474|NCT01093599|100947753|FG001|STARTED|Overall Study||105||
48256475|NCT01093599|100947752|FG000|COMPLETED|Overall Study||59||
48256476|NCT01093599|100947753|FG001|COMPLETED|Overall Study||59||
48256477|NCT01093599|100947752|FG000|NOT COMPLETED|Overall Study||32||
48256478|NCT01093599|100947753|FG001|NOT COMPLETED|Overall Study||46||
48383355|NCT00681538|101265230|FG001|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||2||
48383356|NCT00707655|101265231|FG000|STARTED|Overall Study||3||
48383357|NCT00707655|101265232|FG001|STARTED|Overall Study||5||
48091720|NCT03562481|100545842|FG001|COMPLETED|Second Intervention||14||
48091721|NCT03562481|100545841|FG000|NOT COMPLETED|Second Intervention||0||
48091722|NCT03562481|100545842|FG001|NOT COMPLETED|Second Intervention||0||
48091723|NCT02496533|100545843|FG000|STARTED|Overall Study||105||
48091724|NCT02496533|100545844|FG001|STARTED|Overall Study||112||
48091725|NCT02496533|100545843|FG000|COMPLETED|Overall Study||102||
48091726|NCT02496533|100545844|FG001|COMPLETED|Overall Study||106||
48091727|NCT02496533|100545843|FG000|NOT COMPLETED|Overall Study||3||
48091728|NCT02496533|100545844|FG001|NOT COMPLETED|Overall Study||6||
48091729|NCT02700815|100545845|FG000|STARTED|Overall Study||75||
48091730|NCT02700815|100545846|FG001|STARTED|Overall Study||223||
48091731|NCT02700815|100545847|FG002|STARTED|Overall Study||223||
48091732|NCT02700815|100545848|FG003|STARTED|Overall Study||225||
48091733|NCT02700815|100545845|FG000|COMPLETED|Overall Study||74||
48091734|NCT02700815|100545846|FG001|COMPLETED|Overall Study||216||
48687409|NCT02517398|102017097|FG017|STARTED|Overall Study||35||
48687410|NCT02517398|102017098|FG018|STARTED|Overall Study||32||
48687411|NCT02517398|102017099|FG019|STARTED|Overall Study||15||
48687412|NCT02517398|102017100|FG020|STARTED|Overall Study||40||
48687413|NCT02517398|102017101|FG021|STARTED|Overall Study||40||
48687414|NCT02517398|102017102|FG022|STARTED|Overall Study||41||
48687415|NCT02517398|102017080|FG000|COMPLETED|Overall Study||1||
48687416|NCT02517398|102017081|FG001|COMPLETED|Overall Study||0||
48687417|NCT02517398|102017082|FG002|COMPLETED|Overall Study||0||
48687418|NCT02517398|102017083|FG003|COMPLETED|Overall Study||0||
48687419|NCT02517398|102017084|FG004|COMPLETED|Overall Study||3||
48383358|NCT00707655|101265231|FG000|COMPLETED|Overall Study||3||
48383359|NCT00707655|101265232|FG001|COMPLETED|Overall Study||3||
48383360|NCT00707655|101265231|FG000|NOT COMPLETED|Overall Study||0||
48383361|NCT00707655|101265232|FG001|NOT COMPLETED|Overall Study||2||
48383362|NCT02476357|101265233|FG000|STARTED|Overall Study||40||
48383363|NCT02476357|101265234|FG001|STARTED|Overall Study||40||
48383364|NCT02476357|101265233|FG000|COMPLETED|Overall Study||40||
48383365|NCT02476357|101265234|FG001|COMPLETED|Overall Study||40||
48383366|NCT02476357|101265233|FG000|NOT COMPLETED|Overall Study||0||
48383367|NCT02476357|101265234|FG001|NOT COMPLETED|Overall Study||0||
48383368|NCT00084929|101265235|FG000|STARTED|Overall Study||2600||
48687420|NCT02517398|102017085|FG005|COMPLETED|Overall Study||2||
48687421|NCT02517398|102017086|FG006|COMPLETED|Overall Study||3||
48687422|NCT02517398|102017087|FG007|COMPLETED|Overall Study||1||
48687423|NCT02517398|102017088|FG008|COMPLETED|Overall Study||0||
48687424|NCT02517398|102017089|FG009|COMPLETED|Overall Study||10||
48687425|NCT02517398|102017090|FG010|COMPLETED|Overall Study||8||
48687426|NCT02517398|102017091|FG011|COMPLETED|Overall Study||4||
48687427|NCT02517398|102017092|FG012|COMPLETED|Overall Study||3||
48687428|NCT02517398|102017093|FG013|COMPLETED|Overall Study||2||
48687429|NCT02517398|102017094|FG014|COMPLETED|Overall Study||1||
48687430|NCT02517398|102017095|FG015|COMPLETED|Overall Study||2||
48687431|NCT02517398|102017096|FG016|COMPLETED|Overall Study||2||
48687432|NCT02517398|102017097|FG017|COMPLETED|Overall Study||5||
48687433|NCT02517398|102017098|FG018|COMPLETED|Overall Study||6||
48687434|NCT02517398|102017099|FG019|COMPLETED|Overall Study||5||
48687435|NCT02517398|102017100|FG020|COMPLETED|Overall Study||4||
48687436|NCT02517398|102017101|FG021|COMPLETED|Overall Study||7||
48687437|NCT02517398|102017102|FG022|COMPLETED|Overall Study||18||
48687438|NCT02517398|102017080|FG000|NOT COMPLETED|Overall Study||2||
48383369|NCT00084929|101265235|FG000|COMPLETED|Overall Study||2531||
48687439|NCT02517398|102017081|FG001|NOT COMPLETED|Overall Study||3||
48687440|NCT02517398|102017082|FG002|NOT COMPLETED|Overall Study||4||
48687441|NCT02517398|102017083|FG003|NOT COMPLETED|Overall Study||3||
48687442|NCT02517398|102017084|FG004|NOT COMPLETED|Overall Study||3||
48687443|NCT02517398|102017085|FG005|NOT COMPLETED|Overall Study||8||
48687444|NCT02517398|102017086|FG006|NOT COMPLETED|Overall Study||4||
48687445|NCT02517398|102017087|FG007|NOT COMPLETED|Overall Study||2||
48687446|NCT02517398|102017088|FG008|NOT COMPLETED|Overall Study||6||
48687447|NCT02517398|102017089|FG009|NOT COMPLETED|Overall Study||28||
48687448|NCT02517398|102017090|FG010|NOT COMPLETED|Overall Study||60||
48256479|NCT01947153|100947754|FG000|STARTED|Test Period 1||18||
48256480|NCT01947153|100947755|FG001|STARTED|Test Period 1||18||
48256481|NCT01947153|100947754|FG000|COMPLETED|Test Period 1||18||
48256482|NCT01947153|100947755|FG001|COMPLETED|Test Period 1||18||
48256483|NCT01947153|100947754|FG000|NOT COMPLETED|Test Period 1||0||
48256484|NCT01947153|100947755|FG001|NOT COMPLETED|Test Period 1||0||
48256485|NCT01947153|100947754|FG000|STARTED|Test Period 2||18||
48256486|NCT01947153|100947755|FG001|STARTED|Test Period 2||18||
48256487|NCT01947153|100947754|FG000|COMPLETED|Test Period 2||18||
48687449|NCT02517398|102017091|FG011|NOT COMPLETED|Overall Study||28||
48687450|NCT02517398|102017092|FG012|NOT COMPLETED|Overall Study||80||
48687451|NCT02517398|102017093|FG013|NOT COMPLETED|Overall Study||34||
48687452|NCT02517398|102017094|FG014|NOT COMPLETED|Overall Study||29||
48687453|NCT02517398|102017095|FG015|NOT COMPLETED|Overall Study||30||
48687454|NCT02517398|102017096|FG016|NOT COMPLETED|Overall Study||31||
48687455|NCT02517398|102017097|FG017|NOT COMPLETED|Overall Study||30||
48687456|NCT02517398|102017098|FG018|NOT COMPLETED|Overall Study||26||
48687457|NCT02517398|102017099|FG019|NOT COMPLETED|Overall Study||10||
48687458|NCT02517398|102017100|FG020|NOT COMPLETED|Overall Study||36||
48687459|NCT02517398|102017101|FG021|NOT COMPLETED|Overall Study||33||
48687460|NCT02517398|102017102|FG022|NOT COMPLETED|Overall Study||23||
48687461|NCT02122146|102017103|FG000|STARTED|Part 1: Dose Escalation||2||
48687462|NCT02122146|102017104|FG001|STARTED|Part 1: Dose Escalation||2||
48687463|NCT02122146|102017105|FG002|STARTED|Part 1: Dose Escalation||4||
48687464|NCT02122146|102017106|FG003|STARTED|Part 1: Dose Escalation||4||
48256488|NCT01947153|100947755|FG001|COMPLETED|Test Period 2||18||
48256489|NCT01947153|100947754|FG000|NOT COMPLETED|Test Period 2||0||
48256490|NCT01947153|100947755|FG001|NOT COMPLETED|Test Period 2||0||
48256491|NCT00443898|100947756|FG000|STARTED|Overall Study||126||
48256492|NCT00443898|100947757|FG001|STARTED|Overall Study||128||
48256493|NCT00443898|100947758|FG002|STARTED|Overall Study||136||
48256494|NCT00443898|100947759|FG003|STARTED|Overall Study||128||
48256495|NCT00443898|100947756|FG000|COMPLETED|Overall Study||102||
48256496|NCT00443898|100947757|FG001|COMPLETED|Overall Study||103||
48256497|NCT00443898|100947758|FG002|COMPLETED|Overall Study||107||
48256498|NCT00443898|100947759|FG003|COMPLETED|Overall Study||110||
48256499|NCT00443898|100947756|FG000|NOT COMPLETED|Overall Study||24||
48687465|NCT02122146|102017107|FG004|STARTED|Part 1: Dose Escalation||4||
48687466|NCT02122146|102017108|FG005|STARTED|Part 1: Dose Escalation||6||
48687467|NCT02122146|102017109|FG006|STARTED|Part 1: Dose Escalation||1||
48687468|NCT02122146|102017110|FG007|STARTED|Part 1: Dose Escalation||8||
48256500|NCT00443898|100947757|FG001|NOT COMPLETED|Overall Study||25||
48256501|NCT00443898|100947758|FG002|NOT COMPLETED|Overall Study||29||
48256502|NCT00443898|100947759|FG003|NOT COMPLETED|Overall Study||18||
48256503|NCT01664923|100947760|FG000|STARTED|Period1:Double Blind Phase-29 Months||198||
48256504|NCT01664923|100947761|FG001|STARTED|Period1:Double Blind Phase-29 Months||198||
48256505|NCT01664923|100947760|FG000|Received Study Treatment|Period1:Double Blind Phase-29 Months||197||
48256506|NCT01664923|100947761|FG001|Received Study Treatment|Period1:Double Blind Phase-29 Months||198||
48256507|NCT01664923|100947760|FG000|COMPLETED|Period1:Double Blind Phase-29 Months||93||
48256508|NCT01664923|100947761|FG001|COMPLETED|Period1:Double Blind Phase-29 Months||38||
48256509|NCT01664923|100947760|FG000|NOT COMPLETED|Period1:Double Blind Phase-29 Months||105||
48256510|NCT01664923|100947761|FG001|NOT COMPLETED|Period1:Double Blind Phase-29 Months||160||
48256511|NCT01664923|100947760|FG000|STARTED|Period 2: Open-label Phase-36 Months||93||
48256512|NCT01664923|100947761|FG001|STARTED|Period 2: Open-label Phase-36 Months||38||
48256513|NCT01664923|100947760|FG000|Treated|Period 2: Open-label Phase-36 Months||93||
48256514|NCT01664923|100947761|FG001|Treated|Period 2: Open-label Phase-36 Months||37||
48256515|NCT01664923|100947760|FG000|COMPLETED|Period 2: Open-label Phase-36 Months||52||
48256516|NCT01664923|100947761|FG001|COMPLETED|Period 2: Open-label Phase-36 Months||15||
48256517|NCT01664923|100947760|FG000|NOT COMPLETED|Period 2: Open-label Phase-36 Months||41||
48256518|NCT01664923|100947761|FG001|NOT COMPLETED|Period 2: Open-label Phase-36 Months||23||
48256519|NCT01776008|100947762|FG000|STARTED|Overall Study||16||
48256520|NCT01776008|100947762|FG000|COMPLETED|Overall Study||14||
48256521|NCT01776008|100947762|FG000|NOT COMPLETED|Overall Study||2||
48256522|NCT03599622|100947763|FG000|STARTED|Pre-Treatment Period||60||
48687469|NCT02122146|102017103|FG000|COMPLETED|Part 1: Dose Escalation||1||
48687470|NCT02122146|102017104|FG001|COMPLETED|Part 1: Dose Escalation||1||
48687471|NCT02122146|102017105|FG002|COMPLETED|Part 1: Dose Escalation||2||
48687472|NCT02122146|102017106|FG003|COMPLETED|Part 1: Dose Escalation||3||
48687473|NCT02122146|102017107|FG004|COMPLETED|Part 1: Dose Escalation||3||
48687474|NCT02122146|102017108|FG005|COMPLETED|Part 1: Dose Escalation||5||
48687475|NCT02122146|102017109|FG006|COMPLETED|Part 1: Dose Escalation||0||
48687476|NCT02122146|102017110|FG007|COMPLETED|Part 1: Dose Escalation||6||
48687477|NCT02122146|102017103|FG000|NOT COMPLETED|Part 1: Dose Escalation||1||
48687478|NCT02122146|102017104|FG001|NOT COMPLETED|Part 1: Dose Escalation||1||
48687479|NCT02122146|102017105|FG002|NOT COMPLETED|Part 1: Dose Escalation||2||
48687480|NCT02122146|102017106|FG003|NOT COMPLETED|Part 1: Dose Escalation||1||
48687481|NCT02122146|102017107|FG004|NOT COMPLETED|Part 1: Dose Escalation||1||
48687482|NCT02122146|102017108|FG005|NOT COMPLETED|Part 1: Dose Escalation||1||
48687483|NCT02122146|102017109|FG006|NOT COMPLETED|Part 1: Dose Escalation||1||
48687484|NCT02122146|102017110|FG007|NOT COMPLETED|Part 1: Dose Escalation||2||
48687485|NCT02122146|102017103|FG000|STARTED|Part 2: Maximum Tolerated Dose||0||
48687486|NCT02122146|102017104|FG001|STARTED|Part 2: Maximum Tolerated Dose||0||
48687487|NCT02122146|102017105|FG002|STARTED|Part 2: Maximum Tolerated Dose||0||
48687488|NCT02122146|102017106|FG003|STARTED|Part 2: Maximum Tolerated Dose||0||
48687489|NCT02122146|102017107|FG004|STARTED|Part 2: Maximum Tolerated Dose||0||
48256523|NCT03599622|100947764|FG001|STARTED|Pre-Treatment Period||86||
48256524|NCT03599622|100947765|FG002|STARTED|Pre-Treatment Period||84||
48256525|NCT03599622|100947766|FG003|STARTED|Pre-Treatment Period||9||
48687490|NCT02122146|102017108|FG005|STARTED|Part 2: Maximum Tolerated Dose||0||
48256526|NCT03599622|100947763|FG000|COMPLETED|Pre-Treatment Period||59||
48256527|NCT03599622|100947764|FG001|COMPLETED|Pre-Treatment Period||84||
48256528|NCT03599622|100947765|FG002|COMPLETED|Pre-Treatment Period||83||
48256529|NCT03599622|100947766|FG003|COMPLETED|Pre-Treatment Period||9||
48256530|NCT03599622|100947763|FG000|NOT COMPLETED|Pre-Treatment Period||1||
48687491|NCT02122146|102017109|FG006|STARTED|Part 2: Maximum Tolerated Dose||0||
48687492|NCT02122146|102017110|FG007|STARTED|Part 2: Maximum Tolerated Dose||0||
48256531|NCT03599622|100947764|FG001|NOT COMPLETED|Pre-Treatment Period||2||
48687493|NCT02122146|102017103|FG000|COMPLETED|Part 2: Maximum Tolerated Dose||0||
48687494|NCT02122146|102017104|FG001|COMPLETED|Part 2: Maximum Tolerated Dose||0||
48687495|NCT02122146|102017105|FG002|COMPLETED|Part 2: Maximum Tolerated Dose||0||
48687496|NCT02122146|102017106|FG003|COMPLETED|Part 2: Maximum Tolerated Dose||0||
48687497|NCT02122146|102017107|FG004|COMPLETED|Part 2: Maximum Tolerated Dose||0||
48687498|NCT02122146|102017108|FG005|COMPLETED|Part 2: Maximum Tolerated Dose||0||
48687499|NCT02122146|102017109|FG006|COMPLETED|Part 2: Maximum Tolerated Dose||0||
48687500|NCT02122146|102017110|FG007|COMPLETED|Part 2: Maximum Tolerated Dose||0||
48687501|NCT02122146|102017103|FG000|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0||
48687502|NCT02122146|102017104|FG001|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0||
48687503|NCT02122146|102017105|FG002|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0||
48687504|NCT02122146|102017106|FG003|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0||
48687505|NCT02122146|102017107|FG004|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0||
48687506|NCT02122146|102017108|FG005|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0||
48687507|NCT02122146|102017109|FG006|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0||
48687508|NCT02122146|102017110|FG007|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0||
48687509|NCT02122146|102017103|FG000|STARTED|Part 3: Expansion||0||
48687510|NCT02122146|102017104|FG001|STARTED|Part 3: Expansion||0||
48687511|NCT02122146|102017105|FG002|STARTED|Part 3: Expansion||0||
48687512|NCT02122146|102017106|FG003|STARTED|Part 3: Expansion||0||
48687513|NCT02122146|102017107|FG004|STARTED|Part 3: Expansion||0||
48687514|NCT02122146|102017108|FG005|STARTED|Part 3: Expansion||0||
48256532|NCT03599622|100947765|FG002|NOT COMPLETED|Pre-Treatment Period||1||
48256533|NCT03599622|100947766|FG003|NOT COMPLETED|Pre-Treatment Period||0||
48256534|NCT03599622|100947763|FG000|STARTED|Treatment Period||59||
48256535|NCT03599622|100947764|FG001|STARTED|Treatment Period||84||
48256536|NCT03599622|100947765|FG002|STARTED|Treatment Period||83||
48256537|NCT03599622|100947766|FG003|STARTED|Treatment Period||9||
48256538|NCT03599622|100947763|FG000|COMPLETED|Treatment Period||13||
48256539|NCT03599622|100947764|FG001|COMPLETED|Treatment Period||14||
48256540|NCT03599622|100947765|FG002|COMPLETED|Treatment Period||14||
48256541|NCT03599622|100947766|FG003|COMPLETED|Treatment Period||4||
48687515|NCT02122146|102017109|FG006|STARTED|Part 3: Expansion||0||
48687516|NCT02122146|102017110|FG007|STARTED|Part 3: Expansion||0||
48687517|NCT02122146|102017103|FG000|COMPLETED|Part 3: Expansion||0||
48687518|NCT02122146|102017104|FG001|COMPLETED|Part 3: Expansion||0||
48687519|NCT02122146|102017105|FG002|COMPLETED|Part 3: Expansion||0||
48687520|NCT02122146|102017106|FG003|COMPLETED|Part 3: Expansion||0||
48687521|NCT02122146|102017107|FG004|COMPLETED|Part 3: Expansion||0||
48687522|NCT02122146|102017108|FG005|COMPLETED|Part 3: Expansion||0||
48687523|NCT02122146|102017109|FG006|COMPLETED|Part 3: Expansion||0||
48687524|NCT02122146|102017110|FG007|COMPLETED|Part 3: Expansion||0||
48256542|NCT03599622|100947763|FG000|NOT COMPLETED|Treatment Period||46||
48256543|NCT03599622|100947764|FG001|NOT COMPLETED|Treatment Period||70||
48256544|NCT03599622|100947765|FG002|NOT COMPLETED|Treatment Period||69||
48256545|NCT03599622|100947766|FG003|NOT COMPLETED|Treatment Period||5||
48256546|NCT02956122|100947767|FG000|STARTED|Overall Study||1||
48256547|NCT02956122|100947767|FG000|COMPLETED|Overall Study||1||
48256548|NCT02956122|100947767|FG000|NOT COMPLETED|Overall Study||0||
48256549|NCT02509312|100947768|FG000|STARTED|Overall Study||35||
48256550|NCT02509312|100947769|FG001|STARTED|Overall Study||35||
48256551|NCT02509312|100947768|FG000|Intraoperative Checkpoint|Overall Study||28|Checkpoint to confirm patients still meet inclusion and exclusion criteria.|
48256552|NCT02509312|100947769|FG001|Intraoperative Checkpoint|Overall Study||30|Checkpoint to confirm patients still meet inclusion and exclusion criteria.|
48256553|NCT02509312|100947768|FG000|COMPLETED|Overall Study||28||
48256554|NCT02509312|100947769|FG001|COMPLETED|Overall Study||30||
48256555|NCT02509312|100947768|FG000|NOT COMPLETED|Overall Study||7||
48256556|NCT02509312|100947769|FG001|NOT COMPLETED|Overall Study||5||
48256557|NCT00505414|100947770|FG000|STARTED|Titration Phase||0||
48256558|NCT00505414|100947771|FG001|STARTED|Titration Phase||0||
48256559|NCT00505414|100947772|FG002|STARTED|Titration Phase||0||
48256560|NCT00505414|100947773|FG003|STARTED|Titration Phase||62||
48256561|NCT00505414|100947774|FG004|STARTED|Titration Phase||31||
48256562|NCT00505414|100947770|FG000|COMPLETED|Titration Phase||0||
48256563|NCT00505414|100947771|FG001|COMPLETED|Titration Phase||0||
48256564|NCT00505414|100947772|FG002|COMPLETED|Titration Phase||0||
48687525|NCT02122146|102017103|FG000|NOT COMPLETED|Part 3: Expansion||0||
48687526|NCT02122146|102017104|FG001|NOT COMPLETED|Part 3: Expansion||0||
48687527|NCT02122146|102017105|FG002|NOT COMPLETED|Part 3: Expansion||0||
48687528|NCT02122146|102017106|FG003|NOT COMPLETED|Part 3: Expansion||0||
48687529|NCT02122146|102017107|FG004|NOT COMPLETED|Part 3: Expansion||0||
48687530|NCT02122146|102017108|FG005|NOT COMPLETED|Part 3: Expansion||0||
48687531|NCT02122146|102017109|FG006|NOT COMPLETED|Part 3: Expansion||0||
48256565|NCT00505414|100947773|FG003|COMPLETED|Titration Phase||32||
48256566|NCT00505414|100947774|FG004|COMPLETED|Titration Phase||19||
48256567|NCT00505414|100947770|FG000|NOT COMPLETED|Titration Phase||0||
48256568|NCT00505414|100947771|FG001|NOT COMPLETED|Titration Phase||0||
48256569|NCT00505414|100947772|FG002|NOT COMPLETED|Titration Phase||0||
48256570|NCT00505414|100947773|FG003|NOT COMPLETED|Titration Phase||30||
48256571|NCT00505414|100947774|FG004|NOT COMPLETED|Titration Phase||12||
48256572|NCT00505414|100947770|FG000|STARTED|Maintenance Phase||18||
48256573|NCT00505414|100947771|FG001|STARTED|Maintenance Phase||15||
48383370|NCT00084929|101265235|FG000|NOT COMPLETED|Overall Study||69||
48383371|NCT02902913|101265236|FG000|STARTED|Overall Study||9||
48383372|NCT02902913|101265236|FG000|First Intervention (1 Day)|Overall Study||9||
48383373|NCT02902913|101265236|FG000|Washout (7 Days)|Overall Study||9||
48383374|NCT02902913|101265236|FG000|Second Intervention (1 Day)|Overall Study||9||
48383375|NCT02902913|101265236|FG000|Washout (7 Days)|Overall Study||9||
48383376|NCT02902913|101265236|FG000|Third Intervention (1 Day)|Overall Study||9||
48383377|NCT02902913|101265236|FG000|Washout (7 Days)|Overall Study||9||
48383378|NCT02902913|101265236|FG000|Ibuprofen (400mg)|Overall Study||9||
48383379|NCT02902913|101265236|FG000|COMPLETED|Overall Study||9||
48383380|NCT02902913|101265236|FG000|NOT COMPLETED|Overall Study||0||
48383381|NCT02860845|101265237|FG000|STARTED|Overall Study||24||
48383382|NCT02860845|101265238|FG001|STARTED|Overall Study||24||
48383383|NCT02860845|101265237|FG000|Analyzed Patients|Overall Study||22||
48383384|NCT02860845|101265238|FG001|Analyzed Patients|Overall Study||23||
48383385|NCT02860845|101265237|FG000|COMPLETED|Overall Study||22||
48383386|NCT02860845|101265238|FG001|COMPLETED|Overall Study||23||
48383387|NCT02860845|101265237|FG000|NOT COMPLETED|Overall Study||2||
48383388|NCT02860845|101265238|FG001|NOT COMPLETED|Overall Study||1||
48383389|NCT01204255|101265239|FG000|STARTED|Overall Study||11||
48383390|NCT01204255|101265239|FG000|COMPLETED|Overall Study||10||
48383391|NCT01204255|101265239|FG000|NOT COMPLETED|Overall Study||1||
48383392|NCT02311309|101265240|FG000|STARTED|Overall Study||541||
48256574|NCT00505414|100947772|FG002|STARTED|Maintenance Phase||14||
48256575|NCT00505414|100947773|FG003|STARTED|Maintenance Phase||0||
48256576|NCT00505414|100947774|FG004|STARTED|Maintenance Phase||0||
48383393|NCT02311309|101265241|FG001|STARTED|Overall Study||35||
48383394|NCT02311309|101265242|FG002|STARTED|Overall Study||863||
48383395|NCT02311309|101265240|FG000|COMPLETED|Overall Study||541||
48383396|NCT02311309|101265241|FG001|COMPLETED|Overall Study||35||
48383397|NCT02311309|101265242|FG002|COMPLETED|Overall Study||863||
48383398|NCT02311309|101265240|FG000|NOT COMPLETED|Overall Study||0||
48383399|NCT02311309|101265241|FG001|NOT COMPLETED|Overall Study||0||
48383400|NCT02311309|101265242|FG002|NOT COMPLETED|Overall Study||0||
48383401|NCT00798655|101265243|FG000|STARTED|Overall Study||46||
48383402|NCT00798655|101265243|FG000|COMPLETED|Overall Study||44||
48383403|NCT00798655|101265243|FG000|NOT COMPLETED|Overall Study||2||
48383404|NCT04402008|101265244|FG000|STARTED|Overall Study||3||
48383405|NCT04402008|101265245|FG001|STARTED|Overall Study||3||
48256577|NCT00505414|100947770|FG000|Did Not Qualify for Maintenance Phase|Maintenance Phase||0||
48256578|NCT00505414|100947771|FG001|Did Not Qualify for Maintenance Phase|Maintenance Phase||0||
48256579|NCT00505414|100947772|FG002|Did Not Qualify for Maintenance Phase|Maintenance Phase||0||
48256580|NCT00505414|100947773|FG003|Did Not Qualify for Maintenance Phase|Maintenance Phase||3||
48256581|NCT00505414|100947774|FG004|Did Not Qualify for Maintenance Phase|Maintenance Phase||1||
48383406|NCT04402008|101265246|FG002|STARTED|Overall Study||3||
48256582|NCT00505414|100947770|FG000|COMPLETED|Maintenance Phase||12||
48256583|NCT00505414|100947771|FG001|COMPLETED|Maintenance Phase||10||
48383407|NCT04402008|101265247|FG003|STARTED|Overall Study||4||
48383408|NCT04402008|101265248|FG004|STARTED|Overall Study||6||
48383409|NCT04402008|101265249|FG005|STARTED|Overall Study||3||
48383410|NCT04402008|101265250|FG006|STARTED|Overall Study||20||
48383411|NCT04402008|101265244|FG000|COMPLETED|Overall Study||0||
48383412|NCT04402008|101265245|FG001|COMPLETED|Overall Study||0||
48383413|NCT04402008|101265246|FG002|COMPLETED|Overall Study||0||
48383414|NCT04402008|101265247|FG003|COMPLETED|Overall Study||0||
48383415|NCT04402008|101265248|FG004|COMPLETED|Overall Study||0||
48256584|NCT00505414|100947772|FG002|COMPLETED|Maintenance Phase||6||
48256585|NCT00505414|100947773|FG003|COMPLETED|Maintenance Phase||0||
48256586|NCT00505414|100947774|FG004|COMPLETED|Maintenance Phase||0||
48256587|NCT00505414|100947770|FG000|NOT COMPLETED|Maintenance Phase||6||
48256588|NCT00505414|100947771|FG001|NOT COMPLETED|Maintenance Phase||5||
48383416|NCT04402008|101265249|FG005|COMPLETED|Overall Study||0||
48383417|NCT04402008|101265250|FG006|COMPLETED|Overall Study||0||
48383418|NCT04402008|101265244|FG000|NOT COMPLETED|Overall Study||3||
48383419|NCT04402008|101265245|FG001|NOT COMPLETED|Overall Study||3||
48383420|NCT04402008|101265246|FG002|NOT COMPLETED|Overall Study||3||
48256589|NCT00505414|100947772|FG002|NOT COMPLETED|Maintenance Phase||8||
48383421|NCT04402008|101265247|FG003|NOT COMPLETED|Overall Study||4||
48383422|NCT04402008|101265248|FG004|NOT COMPLETED|Overall Study||6||
48383423|NCT04402008|101265249|FG005|NOT COMPLETED|Overall Study||3||
48383424|NCT04402008|101265250|FG006|NOT COMPLETED|Overall Study||20||
48383425|NCT02349789|101265251|FG000|STARTED|Overall Study||11||
48383426|NCT02349789|101265251|FG000|COMPLETED|Overall Study||9||
48383427|NCT02349789|101265251|FG000|NOT COMPLETED|Overall Study||2||
48383428|NCT00980980|101265252|FG000|STARTED|Overall Study||16||
48383429|NCT00980980|101265253|FG001|STARTED|Overall Study||14||
48383430|NCT00980980|101265254|FG002|STARTED|Overall Study||13||
48383431|NCT00980980|101265252|FG000|COMPLETED|Overall Study||16||
48383432|NCT00980980|101265253|FG001|COMPLETED|Overall Study||13||
48383433|NCT00980980|101265254|FG002|COMPLETED|Overall Study||13||
48687532|NCT02122146|102017110|FG007|NOT COMPLETED|Part 3: Expansion||0||
48687533|NCT04855240|102017111|FG000|STARTED|Overall Study||81||
48687534|NCT04855240|102017112|FG001|STARTED|Overall Study||78||
48687535|NCT04855240|102017113|FG002|STARTED|Overall Study||80||
48687536|NCT04855240|102017111|FG000|COMPLETED|Overall Study||77||
48383434|NCT00980980|101265252|FG000|NOT COMPLETED|Overall Study||0||
48383435|NCT00980980|101265253|FG001|NOT COMPLETED|Overall Study||1||
48383436|NCT00980980|101265254|FG002|NOT COMPLETED|Overall Study||0||
48383437|NCT01303380|101265255|FG000|STARTED|Overall Study||9||
48383438|NCT01303380|101265255|FG000|COMPLETED|Overall Study||8||
48383439|NCT01303380|101265255|FG000|NOT COMPLETED|Overall Study||1||
48383440|NCT02991937|101265256|FG000|STARTED|Overall Study||20||
48383441|NCT02991937|101265257|FG001|STARTED|Overall Study||19||
48383442|NCT02991937|101265256|FG000|COMPLETED|Overall Study||20||
48383443|NCT02991937|101265257|FG001|COMPLETED|Overall Study||19||
48383444|NCT02991937|101265256|FG000|NOT COMPLETED|Overall Study||0||
48383445|NCT02991937|101265257|FG001|NOT COMPLETED|Overall Study||0||
48383446|NCT04465396|101265258|FG000|STARTED|Treatment Period 1 (Day 1)||16||
48383447|NCT04465396|101265259|FG001|STARTED|Treatment Period 1 (Day 1)||16||
48383448|NCT04465396|101265260|FG002|STARTED|Treatment Period 1 (Day 1)||16||
48383449|NCT04465396|101265261|FG003|STARTED|Treatment Period 1 (Day 1)||16||
48383450|NCT04465396|101265258|FG000|COMPLETED|Treatment Period 1 (Day 1)||16||
48383451|NCT04465396|101265259|FG001|COMPLETED|Treatment Period 1 (Day 1)||16||
48383452|NCT04465396|101265260|FG002|COMPLETED|Treatment Period 1 (Day 1)||16||
48383453|NCT04465396|101265261|FG003|COMPLETED|Treatment Period 1 (Day 1)||16||
48383454|NCT04465396|101265258|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48383455|NCT04465396|101265259|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48383456|NCT04465396|101265260|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48383457|NCT04465396|101265261|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48383458|NCT04465396|101265258|FG000|STARTED|Washout Period (7 Days)||16||
48383459|NCT04465396|101265259|FG001|STARTED|Washout Period (7 Days)||16||
48383460|NCT04465396|101265260|FG002|STARTED|Washout Period (7 Days)||16||
48383461|NCT04465396|101265261|FG003|STARTED|Washout Period (7 Days)||16||
48383462|NCT04465396|101265258|FG000|COMPLETED|Washout Period (7 Days)||16||
48383463|NCT04465396|101265259|FG001|COMPLETED|Washout Period (7 Days)||16||
48383464|NCT04465396|101265260|FG002|COMPLETED|Washout Period (7 Days)||16||
48541596|NCT03750292|101662783|FG000|STARTED|Second Intervention (11 to 19 Weeks)||5||
48541597|NCT03750292|101662784|FG001|STARTED|Second Intervention (11 to 19 Weeks)||4||
48541598|NCT03750292|101662783|FG000|COMPLETED|Second Intervention (11 to 19 Weeks)||5||
48541599|NCT03750292|101662784|FG001|COMPLETED|Second Intervention (11 to 19 Weeks)||4||
48541600|NCT03750292|101662783|FG000|NOT COMPLETED|Second Intervention (11 to 19 Weeks)||0||
48541601|NCT03750292|101662784|FG001|NOT COMPLETED|Second Intervention (11 to 19 Weeks)||0||
48541602|NCT01885195|101662785|FG000|STARTED|Overall Study||110||
48541603|NCT01885195|101662785|FG000|COMPLETED|Overall Study||0||
48541604|NCT01885195|101662785|FG000|NOT COMPLETED|Overall Study||110||
48541605|NCT04040192|101662786|FG000|STARTED|Open Label Run-in Period (up to 8 Weeks)||497||
48541606|NCT04040192|101662787|FG001|STARTED|Open Label Run-in Period (up to 8 Weeks)||0||
48541607|NCT04040192|101662788|FG002|STARTED|Open Label Run-in Period (up to 8 Weeks)||0||
48541608|NCT04040192|101662786|FG000|COMPLETED|Open Label Run-in Period (up to 8 Weeks)||270||
48541609|NCT04040192|101662787|FG001|COMPLETED|Open Label Run-in Period (up to 8 Weeks)||0||
48541610|NCT04040192|101662788|FG002|COMPLETED|Open Label Run-in Period (up to 8 Weeks)||0||
48541611|NCT04040192|101662786|FG000|NOT COMPLETED|Open Label Run-in Period (up to 8 Weeks)||227||
48541612|NCT04040192|101662787|FG001|NOT COMPLETED|Open Label Run-in Period (up to 8 Weeks)||0||
48541613|NCT04040192|101662788|FG002|NOT COMPLETED|Open Label Run-in Period (up to 8 Weeks)||0||
48541614|NCT04040192|101662786|FG000|STARTED|Double Blind Period (up to 52 Weeks)||0||
48541615|NCT04040192|101662787|FG001|STARTED|Double Blind Period (up to 52 Weeks)||135||
48541616|NCT04040192|101662788|FG002|STARTED|Double Blind Period (up to 52 Weeks)||135||
48541617|NCT04040192|101662786|FG000|COMPLETED|Double Blind Period (up to 52 Weeks)||0||
48687537|NCT04855240|102017112|FG001|COMPLETED|Overall Study||73||
48687538|NCT04855240|102017113|FG002|COMPLETED|Overall Study||75||
48383465|NCT04465396|101265261|FG003|COMPLETED|Washout Period (7 Days)||16||
48383466|NCT04465396|101265258|FG000|NOT COMPLETED|Washout Period (7 Days)||0||
48383467|NCT04465396|101265259|FG001|NOT COMPLETED|Washout Period (7 Days)||0||
48256590|NCT00505414|100947773|FG003|NOT COMPLETED|Maintenance Phase||0||
48256591|NCT00505414|100947774|FG004|NOT COMPLETED|Maintenance Phase||0||
48256592|NCT00043186|100947775|FG000|STARTED|Overall Study||46||
48256593|NCT00043186|100947776|FG001|STARTED|Overall Study||44||
48383468|NCT04465396|101265260|FG002|NOT COMPLETED|Washout Period (7 Days)||0||
48256594|NCT00043186|100947777|FG002|STARTED|Overall Study||44||
48256595|NCT00043186|100947778|FG003|STARTED|Overall Study||41||
48256596|NCT00043186|100947779|FG004|STARTED|Overall Study||54||
48256597|NCT00043186|100947780|FG005|STARTED|Overall Study||47||
48256598|NCT00043186|100947781|FG006|STARTED|Overall Study||42||
48256599|NCT00043186|100947782|FG007|STARTED|Overall Study||47||
48256600|NCT00043186|100947783|FG008|STARTED|Overall Study||47||
48256601|NCT00043186|100947775|FG000|COMPLETED|Overall Study||29||
48256602|NCT00043186|100947776|FG001|COMPLETED|Overall Study||29||
48256603|NCT00043186|100947777|FG002|COMPLETED|Overall Study||24||
48256604|NCT00043186|100947778|FG003|COMPLETED|Overall Study||19||
48256605|NCT00043186|100947779|FG004|COMPLETED|Overall Study||36||
48256606|NCT00043186|100947780|FG005|COMPLETED|Overall Study||39||
48256607|NCT00043186|100947781|FG006|COMPLETED|Overall Study||25||
48256608|NCT00043186|100947782|FG007|COMPLETED|Overall Study||31||
48256609|NCT00043186|100947783|FG008|COMPLETED|Overall Study||30||
48256610|NCT00043186|100947775|FG000|NOT COMPLETED|Overall Study||17||
48256611|NCT00043186|100947776|FG001|NOT COMPLETED|Overall Study||15||
48256612|NCT00043186|100947777|FG002|NOT COMPLETED|Overall Study||20||
48256613|NCT00043186|100947778|FG003|NOT COMPLETED|Overall Study||22||
48256614|NCT00043186|100947779|FG004|NOT COMPLETED|Overall Study||18||
48256615|NCT00043186|100947780|FG005|NOT COMPLETED|Overall Study||8||
48256616|NCT00043186|100947781|FG006|NOT COMPLETED|Overall Study||17||
48256617|NCT00043186|100947782|FG007|NOT COMPLETED|Overall Study||16||
48256618|NCT00043186|100947783|FG008|NOT COMPLETED|Overall Study||17||
48256619|NCT00604188|100947784|FG000|STARTED|Overall Study||93||
48256620|NCT00604188|100947785|FG001|STARTED|Overall Study||95||
48256621|NCT00604188|100947784|FG000|COMPLETED|Overall Study||66||
48256622|NCT00604188|100947785|FG001|COMPLETED|Overall Study||70||
48256623|NCT00604188|100947784|FG000|NOT COMPLETED|Overall Study||27||
48256624|NCT00604188|100947785|FG001|NOT COMPLETED|Overall Study||25||
48256625|NCT01367444|100947786|FG000|STARTED|Overall Study||4||
48256626|NCT01367444|100947787|FG001|STARTED|Overall Study||4||
48256627|NCT01367444|100947788|FG002|STARTED|Overall Study||4||
48256628|NCT01367444|100947789|FG003|STARTED|Overall Study||4||
48256629|NCT01367444|100947790|FG004|STARTED|Overall Study||6||
48256630|NCT01367444|100947791|FG005|STARTED|Overall Study||4||
48256631|NCT01367444|100947792|FG006|STARTED|Overall Study||1||
48256632|NCT01367444|100947786|FG000|COMPLETED|Overall Study||4||
48256633|NCT01367444|100947787|FG001|COMPLETED|Overall Study||4||
48256634|NCT01367444|100947788|FG002|COMPLETED|Overall Study||4||
48256635|NCT01367444|100947789|FG003|COMPLETED|Overall Study||4||
48256636|NCT01367444|100947790|FG004|COMPLETED|Overall Study||6||
48256637|NCT01367444|100947791|FG005|COMPLETED|Overall Study||4||
48256638|NCT01367444|100947792|FG006|COMPLETED|Overall Study||1||
48256639|NCT01367444|100947786|FG000|NOT COMPLETED|Overall Study||0||
48256640|NCT01367444|100947787|FG001|NOT COMPLETED|Overall Study||0||
48256641|NCT01367444|100947788|FG002|NOT COMPLETED|Overall Study||0||
48256642|NCT01367444|100947789|FG003|NOT COMPLETED|Overall Study||0||
48256643|NCT01367444|100947790|FG004|NOT COMPLETED|Overall Study||0||
48256644|NCT01367444|100947791|FG005|NOT COMPLETED|Overall Study||0||
48256645|NCT01367444|100947792|FG006|NOT COMPLETED|Overall Study||0||
48256646|NCT03864341|100947793|FG000|STARTED|Overall Study||40||
48256647|NCT03864341|100947793|FG000|COMPLETED|Overall Study||39||
48256648|NCT03864341|100947793|FG000|NOT COMPLETED|Overall Study||1||
48256649|NCT05674292|100947794|FG000|STARTED|Overall Study||25||
48256650|NCT05674292|100947794|FG000|COMPLETED|Overall Study||25||
48256651|NCT05674292|100947794|FG000|NOT COMPLETED|Overall Study||0||
48383469|NCT04465396|101265261|FG003|NOT COMPLETED|Washout Period (7 Days)||0||
48383470|NCT04465396|101265258|FG000|STARTED|Treatment Period 2 (Day 1)||16||
48383471|NCT04465396|101265259|FG001|STARTED|Treatment Period 2 (Day 1)||16||
48383472|NCT04465396|101265260|FG002|STARTED|Treatment Period 2 (Day 1)||16||
48592698|NCT01877382|101783155|FG005|NOT COMPLETED|Dose Expansion||0||
48256652|NCT01836198|100947795|FG000|STARTED|Part A, Period 1||15||
48256653|NCT01836198|100947796|FG001|STARTED|Part A, Period 1||15||
48256654|NCT01836198|100947797|FG002|STARTED|Part A, Period 1||0||
48256655|NCT01836198|100947795|FG000|Received at Least 1 Dose of Study Drug|Part A, Period 1||15||
48256656|NCT01836198|100947796|FG001|Received at Least 1 Dose of Study Drug|Part A, Period 1||15||
48256657|NCT01836198|100947797|FG002|Received at Least 1 Dose of Study Drug|Part A, Period 1||0||
48256658|NCT01836198|100947795|FG000|COMPLETED|Part A, Period 1||15||
48256659|NCT01836198|100947796|FG001|COMPLETED|Part A, Period 1||15||
48256660|NCT01836198|100947797|FG002|COMPLETED|Part A, Period 1||0||
48256661|NCT01836198|100947795|FG000|NOT COMPLETED|Part A, Period 1||0||
48256662|NCT01836198|100947796|FG001|NOT COMPLETED|Part A, Period 1||0||
48256663|NCT01836198|100947797|FG002|NOT COMPLETED|Part A, Period 1||0||
48256664|NCT01836198|100947795|FG000|STARTED|Part A, Period 2||15||
48256665|NCT01836198|100947796|FG001|STARTED|Part A, Period 2||15||
48256666|NCT01836198|100947797|FG002|STARTED|Part A, Period 2||0||
48256667|NCT01836198|100947795|FG000|Completed Part A, Entered Part B|Part A, Period 2||6||
48383473|NCT04465396|101265261|FG003|STARTED|Treatment Period 2 (Day 1)||16||
48383474|NCT04465396|101265258|FG000|COMPLETED|Treatment Period 2 (Day 1)||16||
48383475|NCT04465396|101265259|FG001|COMPLETED|Treatment Period 2 (Day 1)||15||
48541618|NCT04040192|101662787|FG001|COMPLETED|Double Blind Period (up to 52 Weeks)||78||
48541619|NCT04040192|101662788|FG002|COMPLETED|Double Blind Period (up to 52 Weeks)||78||
48541620|NCT04040192|101662786|FG000|NOT COMPLETED|Double Blind Period (up to 52 Weeks)||0||
48541621|NCT04040192|101662787|FG001|NOT COMPLETED|Double Blind Period (up to 52 Weeks)||57||
48541622|NCT04040192|101662788|FG002|NOT COMPLETED|Double Blind Period (up to 52 Weeks)||57||
48541623|NCT03095638|101662789|FG000|STARTED|P1: Period 1 (4 Days)||7||
48541624|NCT03095638|101662790|FG001|STARTED|P1: Period 1 (4 Days)||7||
48091735|NCT02700815|100545847|FG002|COMPLETED|Overall Study||219||
48091736|NCT02700815|100545848|FG003|COMPLETED|Overall Study||218||
48091737|NCT02700815|100545845|FG000|NOT COMPLETED|Overall Study||1||
48091738|NCT02700815|100545846|FG001|NOT COMPLETED|Overall Study||7||
48091739|NCT02700815|100545847|FG002|NOT COMPLETED|Overall Study||4||
48091740|NCT02700815|100545848|FG003|NOT COMPLETED|Overall Study||7||
48091741|NCT00951808|100545849|FG000|STARTED|Overall Study||4||
48091742|NCT00951808|100545850|FG001|STARTED|Overall Study||6||
48091743|NCT00951808|100545851|FG002|STARTED|Overall Study||227||
48091744|NCT00951808|100545849|FG000|COMPLETED|Overall Study||4||
48091745|NCT00951808|100545850|FG001|COMPLETED|Overall Study||6||
48091746|NCT00951808|100545851|FG002|COMPLETED|Overall Study||223||
48091747|NCT00951808|100545849|FG000|NOT COMPLETED|Overall Study||0||
48091748|NCT00951808|100545850|FG001|NOT COMPLETED|Overall Study||0||
48091749|NCT00951808|100545851|FG002|NOT COMPLETED|Overall Study||4||
48091750|NCT01752907|100545852|FG000|STARTED|Overall Study||151||
48091751|NCT01752907|100545853|FG001|STARTED|Overall Study||153||
48091752|NCT01752907|100545852|FG000|Received Pegfilgrastim|Overall Study||149||
48091753|NCT01752907|100545853|FG001|Received Pegfilgrastim|Overall Study||151||
48091754|NCT01752907|100545852|FG000|COMPLETED|Overall Study||139||
48091755|NCT01752907|100545853|FG001|COMPLETED|Overall Study||133||
48091756|NCT01752907|100545852|FG000|NOT COMPLETED|Overall Study||12||
48091757|NCT01752907|100545853|FG001|NOT COMPLETED|Overall Study||20||
48091758|NCT01347008|100545854|FG000|STARTED|Overall Study||21||
48091759|NCT01347008|100545855|FG001|STARTED|Overall Study||20||
48091760|NCT01347008|100545854|FG000|COMPLETED|Overall Study||21||
48091761|NCT01347008|100545855|FG001|COMPLETED|Overall Study||20||
48091762|NCT01347008|100545854|FG000|NOT COMPLETED|Overall Study||0||
48091763|NCT01347008|100545855|FG001|NOT COMPLETED|Overall Study||0||
48091764|NCT02653391|100545856|FG000|STARTED|Overall Study||18||36
48383476|NCT04465396|101265260|FG002|COMPLETED|Treatment Period 2 (Day 1)||15||
48383477|NCT04465396|101265261|FG003|COMPLETED|Treatment Period 2 (Day 1)||16||
48383478|NCT04465396|101265258|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
48383479|NCT04465396|101265259|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||1||
48383480|NCT04465396|101265260|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||1||
48383481|NCT04465396|101265261|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
48383482|NCT04543955|101265262|FG000|STARTED|Overall Study||1||
48541625|NCT03095638|101662791|FG002|STARTED|P1: Period 1 (4 Days)||0||
48541626|NCT03095638|101662792|FG003|STARTED|P1: Period 1 (4 Days)||0||
48541627|NCT03095638|101662793|FG004|STARTED|P1: Period 1 (4 Days)||0||
48541628|NCT03095638|101662794|FG005|STARTED|P1: Period 1 (4 Days)||0||
48541629|NCT03095638|101662795|FG006|STARTED|P1: Period 1 (4 Days)||0||
48541630|NCT03095638|101662796|FG007|STARTED|P1: Period 1 (4 Days)||0||
48091765|NCT02653391|100545857|FG001|STARTED|Overall Study||3||6
48541631|NCT03095638|101662789|FG000|COMPLETED|P1: Period 1 (4 Days)||7||
48541632|NCT03095638|101662790|FG001|COMPLETED|P1: Period 1 (4 Days)||7||
48091766|NCT02653391|100545858|FG002|STARTED|Overall Study||1||2
48091767|NCT02653391|100545856|FG000|COMPLETED|Overall Study||16||32
48091768|NCT02653391|100545857|FG001|COMPLETED|Overall Study||1||2
48091769|NCT02653391|100545858|FG002|COMPLETED|Overall Study||1||2
48091770|NCT02653391|100545856|FG000|NOT COMPLETED|Overall Study||2||4
48091771|NCT02653391|100545857|FG001|NOT COMPLETED|Overall Study||2||4
48091772|NCT02653391|100545858|FG002|NOT COMPLETED|Overall Study||0||0
48091773|NCT01721330|100545859|FG000|STARTED|Overall Study||1||
48091774|NCT01721330|100545860|FG001|STARTED|Overall Study||2||
48091775|NCT01721330|100545859|FG000|COMPLETED|Overall Study||1||
48091776|NCT01721330|100545860|FG001|COMPLETED|Overall Study||1||
48091777|NCT01721330|100545859|FG000|NOT COMPLETED|Overall Study||0||
48091778|NCT01721330|100545860|FG001|NOT COMPLETED|Overall Study||1||
48091779|NCT00849810|100545861|FG000|STARTED|Overall Study||1||
48091780|NCT00849810|100545861|FG000|COMPLETED|Overall Study||1||
48091781|NCT00849810|100545861|FG000|NOT COMPLETED|Overall Study||0||
48091782|NCT02041286|100545862|FG000|STARTED|Overall Study||136||
48091783|NCT02041286|100545862|FG000|COMPLETED|Overall Study||135||
48091784|NCT02041286|100545862|FG000|NOT COMPLETED|Overall Study||1||
48091785|NCT00989014|100545863|FG000|STARTED|Overall Study||31||
48091786|NCT00989014|100545864|FG001|STARTED|Overall Study||31||
48091787|NCT00989014|100545865|FG002|STARTED|Overall Study||28||
48091788|NCT00989014|100545866|FG003|STARTED|Overall Study||32||
48091789|NCT00989014|100545863|FG000|COMPLETED|Overall Study||31||
48091790|NCT00989014|100545864|FG001|COMPLETED|Overall Study||31||
48091791|NCT00989014|100545865|FG002|COMPLETED|Overall Study||28||
48383483|NCT04543955|101265263|FG001|STARTED|Overall Study||0||
48383484|NCT04543955|101265262|FG000|COMPLETED|Overall Study||0||
48383485|NCT04543955|101265263|FG001|COMPLETED|Overall Study||0||
48383486|NCT04543955|101265262|FG000|NOT COMPLETED|Overall Study||1||
48383487|NCT04543955|101265263|FG001|NOT COMPLETED|Overall Study||0||
48687539|NCT04855240|102017111|FG000|NOT COMPLETED|Overall Study||4||
48687540|NCT04855240|102017112|FG001|NOT COMPLETED|Overall Study||5||
48687541|NCT04855240|102017113|FG002|NOT COMPLETED|Overall Study||5||
48687542|NCT00625586|102017114|FG000|STARTED|Overall Study||2||
48383488|NCT04311177|101265264|FG000|STARTED|Overall Study||58||
48383489|NCT04311177|101265265|FG001|STARTED|Overall Study||59||
48383490|NCT04311177|101265264|FG000|COMPLETED|Overall Study||50||
48383491|NCT04311177|101265265|FG001|COMPLETED|Overall Study||55||
48383492|NCT04311177|101265264|FG000|NOT COMPLETED|Overall Study||8||
48383493|NCT04311177|101265265|FG001|NOT COMPLETED|Overall Study||4||
48687543|NCT00625586|102017114|FG000|COMPLETED|Overall Study||0||
48687544|NCT00625586|102017114|FG000|NOT COMPLETED|Overall Study||2||
48687545|NCT00131352|102017115|FG000|STARTED|Initial Treatment Period||123||
48383494|NCT01348425|101265266|FG000|STARTED|Overall Study||31||
48383495|NCT01348425|101265267|FG001|STARTED|Overall Study||14||
48383496|NCT01348425|101265266|FG000|COMPLETED|Overall Study||30||
48383497|NCT01348425|101265267|FG001|COMPLETED|Overall Study||13||
48383498|NCT01348425|101265266|FG000|NOT COMPLETED|Overall Study||1||
48383499|NCT01348425|101265267|FG001|NOT COMPLETED|Overall Study||1||
48383500|NCT03580382|101265268|FG000|STARTED|Overall Study||0||
48383501|NCT03580382|101265269|FG001|STARTED|Overall Study||3||
48383502|NCT03580382|101265268|FG000|COMPLETED|Overall Study||0||
48383503|NCT03580382|101265269|FG001|COMPLETED|Overall Study||0||
48383504|NCT03580382|101265268|FG000|NOT COMPLETED|Overall Study||0||
48383505|NCT03580382|101265269|FG001|NOT COMPLETED|Overall Study||3||
48383506|NCT01980706|101265270|FG000|STARTED|Overall Study||40||
48383507|NCT01980706|101265271|FG001|STARTED|Overall Study||43||
48383508|NCT01980706|101265272|FG002|STARTED|Overall Study||37||
48383509|NCT01980706|101265270|FG000|COMPLETED|Overall Study||23||
48383510|NCT01980706|101265271|FG001|COMPLETED|Overall Study||26||
48383511|NCT01980706|101265272|FG002|COMPLETED|Overall Study||24||
48687546|NCT00131352|102017116|FG001|STARTED|Initial Treatment Period||130||
48687547|NCT00131352|102017115|FG000|Intent to Treat Population|Initial Treatment Period||124||
48687548|NCT00131352|102017116|FG001|Intent to Treat Population|Initial Treatment Period||129||
48687549|NCT00131352|102017115|FG000|COMPLETED|Initial Treatment Period||114||
48687550|NCT00131352|102017116|FG001|COMPLETED|Initial Treatment Period||118||
48687551|NCT00131352|102017115|FG000|NOT COMPLETED|Initial Treatment Period||9||
48687552|NCT00131352|102017116|FG001|NOT COMPLETED|Initial Treatment Period||12||
48687553|NCT00131352|102017115|FG000|STARTED|Repeat Treatment Period||160||
48687554|NCT00131352|102017116|FG001|STARTED|Repeat Treatment Period||0||
48687555|NCT00131352|102017115|FG000|COMPLETED|Repeat Treatment Period||158||
48687556|NCT00131352|102017116|FG001|COMPLETED|Repeat Treatment Period||0||
48687557|NCT00131352|102017115|FG000|NOT COMPLETED|Repeat Treatment Period||2||
48687558|NCT00131352|102017116|FG001|NOT COMPLETED|Repeat Treatment Period||0||
48687559|NCT03008070|102017117|FG000|STARTED|Overall Study||83||
48687560|NCT03008070|102017118|FG001|STARTED|Overall Study||83||
48383512|NCT01980706|101265270|FG000|NOT COMPLETED|Overall Study||17||
48383513|NCT01980706|101265271|FG001|NOT COMPLETED|Overall Study||17||
48383514|NCT01980706|101265272|FG002|NOT COMPLETED|Overall Study||13||
48383515|NCT02358369|101265273|FG000|STARTED|Pre-Randomization Washout Period||156||
48383516|NCT02358369|101265274|FG001|STARTED|Pre-Randomization Washout Period||0||
48383517|NCT02358369|101265275|FG002|STARTED|Pre-Randomization Washout Period||0||
48383518|NCT02358369|101265276|FG003|STARTED|Pre-Randomization Washout Period||0||
48383519|NCT02358369|101265277|FG004|STARTED|Pre-Randomization Washout Period||0||
48383520|NCT02358369|101265273|FG000|COMPLETED|Pre-Randomization Washout Period||121||
48383521|NCT02358369|101265274|FG001|COMPLETED|Pre-Randomization Washout Period||0||
48687561|NCT03008070|102017119|FG002|STARTED|Overall Study||81||
48687562|NCT03008070|102017117|FG000|COMPLETED|Overall Study||77||
48687563|NCT03008070|102017118|FG001|COMPLETED|Overall Study||77||
48687564|NCT03008070|102017119|FG002|COMPLETED|Overall Study||74||
48687565|NCT03008070|102017117|FG000|NOT COMPLETED|Overall Study||6||
48687566|NCT03008070|102017118|FG001|NOT COMPLETED|Overall Study||6||
48383522|NCT02358369|101265275|FG002|COMPLETED|Pre-Randomization Washout Period||0||
48383523|NCT02358369|101265276|FG003|COMPLETED|Pre-Randomization Washout Period||0||
48383524|NCT02358369|101265277|FG004|COMPLETED|Pre-Randomization Washout Period||0||
48383525|NCT02358369|101265273|FG000|NOT COMPLETED|Pre-Randomization Washout Period||35||
48383526|NCT02358369|101265274|FG001|NOT COMPLETED|Pre-Randomization Washout Period||0||
48383527|NCT02358369|101265275|FG002|NOT COMPLETED|Pre-Randomization Washout Period||0||
48383528|NCT02358369|101265276|FG003|NOT COMPLETED|Pre-Randomization Washout Period||0||
48383529|NCT02358369|101265277|FG004|NOT COMPLETED|Pre-Randomization Washout Period||0||
48383530|NCT02358369|101265273|FG000|STARTED|Treatment Period A/B||0||
48383531|NCT02358369|101265274|FG001|STARTED|Treatment Period A/B||40||
48383532|NCT02358369|101265275|FG002|STARTED|Treatment Period A/B||40||
48383533|NCT02358369|101265276|FG003|STARTED|Treatment Period A/B||41||
48383534|NCT02358369|101265277|FG004|STARTED|Treatment Period A/B||0||
48383535|NCT02358369|101265273|FG000|COMPLETED|Treatment Period A/B||0||
48383536|NCT02358369|101265274|FG001|COMPLETED|Treatment Period A/B||38||
48383537|NCT02358369|101265275|FG002|COMPLETED|Treatment Period A/B||38||
48383538|NCT02358369|101265276|FG003|COMPLETED|Treatment Period A/B||37||
48383539|NCT02358369|101265277|FG004|COMPLETED|Treatment Period A/B||0||
48383540|NCT02358369|101265273|FG000|NOT COMPLETED|Treatment Period A/B||0||
48383541|NCT02358369|101265274|FG001|NOT COMPLETED|Treatment Period A/B||2||
48383542|NCT02358369|101265275|FG002|NOT COMPLETED|Treatment Period A/B||2||
48383543|NCT02358369|101265276|FG003|NOT COMPLETED|Treatment Period A/B||4||
48383544|NCT02358369|101265277|FG004|NOT COMPLETED|Treatment Period A/B||0||
48383545|NCT02358369|101265273|FG000|STARTED|Treatment Period C||0||
48383546|NCT02358369|101265274|FG001|STARTED|Treatment Period C||0||
48383547|NCT02358369|101265275|FG002|STARTED|Treatment Period C||0||
48383548|NCT02358369|101265276|FG003|STARTED|Treatment Period C||0||
48383549|NCT02358369|101265277|FG004|STARTED|Treatment Period C||113||
48383550|NCT02358369|101265273|FG000|COMPLETED|Treatment Period C||0||
48383551|NCT02358369|101265274|FG001|COMPLETED|Treatment Period C||0||
48383552|NCT02358369|101265275|FG002|COMPLETED|Treatment Period C||0||
48383553|NCT02358369|101265276|FG003|COMPLETED|Treatment Period C||0||
48383554|NCT02358369|101265277|FG004|COMPLETED|Treatment Period C||106||
48383555|NCT02358369|101265273|FG000|NOT COMPLETED|Treatment Period C||0||
48383556|NCT02358369|101265274|FG001|NOT COMPLETED|Treatment Period C||0||
48383557|NCT02358369|101265275|FG002|NOT COMPLETED|Treatment Period C||0||
48383558|NCT02358369|101265276|FG003|NOT COMPLETED|Treatment Period C||0||
48383559|NCT02358369|101265277|FG004|NOT COMPLETED|Treatment Period C||7||
48383560|NCT02740504|101265278|FG000|STARTED|Overall Study||20||
48383561|NCT02740504|101265278|FG000|COMPLETED|Overall Study||20||
48383562|NCT02740504|101265278|FG000|NOT COMPLETED|Overall Study||0||
48383563|NCT02581111|101265279|FG000|STARTED|Overall Study||98||
48383564|NCT02581111|101265280|FG001|STARTED|Overall Study||101||
48383565|NCT02581111|101265279|FG000|COMPLETED|Overall Study||96||
48383566|NCT02581111|101265280|FG001|COMPLETED|Overall Study||94||
48383567|NCT02581111|101265279|FG000|NOT COMPLETED|Overall Study||2||
48383568|NCT02581111|101265280|FG001|NOT COMPLETED|Overall Study||7||
48383569|NCT00750555|101265281|FG000|STARTED|Overall Study||0||
48383570|NCT00750555|101265281|FG000|COMPLETED|Overall Study||0||
48383571|NCT00750555|101265281|FG000|NOT COMPLETED|Overall Study||0||
48383572|NCT00413062|101265282|FG000|STARTED|Overall Study||1666||
48383573|NCT00413062|101265283|FG001|STARTED|Overall Study||554||
48383574|NCT00413062|101265282|FG000|COMPLETED|Overall Study||988||
48383575|NCT00413062|101265283|FG001|COMPLETED|Overall Study||344||
48383576|NCT00413062|101265282|FG000|NOT COMPLETED|Overall Study||678||
48383577|NCT00413062|101265283|FG001|NOT COMPLETED|Overall Study||210||
48383578|NCT00650091|101265284|FG000|STARTED|Initial Study Design - Interim Analysis||81||
48383579|NCT00650091|101265285|FG001|STARTED|Initial Study Design - Interim Analysis||78||
48383580|NCT00650091|101265286|FG002|STARTED|Initial Study Design - Interim Analysis||77||
48383581|NCT00650091|101265284|FG000|COMPLETED|Initial Study Design - Interim Analysis||81||
48383582|NCT00650091|101265285|FG001|COMPLETED|Initial Study Design - Interim Analysis||78||
48383583|NCT00650091|101265286|FG002|COMPLETED|Initial Study Design - Interim Analysis||77||
48383584|NCT00650091|101265284|FG000|NOT COMPLETED|Initial Study Design - Interim Analysis||0||
48383585|NCT00650091|101265285|FG001|NOT COMPLETED|Initial Study Design - Interim Analysis||0||
48383586|NCT00650091|101265286|FG002|NOT COMPLETED|Initial Study Design - Interim Analysis||0||
48383587|NCT00650091|101265284|FG000|STARTED|Amended Study Design||133||
48383588|NCT00650091|101265285|FG001|STARTED|Amended Study Design||131||
48383589|NCT00650091|101265286|FG002|STARTED|Amended Study Design||0||
48383590|NCT00650091|101265284|FG000|COMPLETED|Amended Study Design||110||
48383591|NCT00650091|101265285|FG001|COMPLETED|Amended Study Design||111||
48383592|NCT00650091|101265286|FG002|COMPLETED|Amended Study Design||0||
48383593|NCT00650091|101265284|FG000|NOT COMPLETED|Amended Study Design||23||
48383594|NCT00650091|101265285|FG001|NOT COMPLETED|Amended Study Design||20||
48383595|NCT00650091|101265286|FG002|NOT COMPLETED|Amended Study Design||0||
48383596|NCT02486952|101265287|FG000|STARTED|Overall Study||154||
48383597|NCT02486952|101265287|FG000|Started Induction Therapy|Overall Study||151||
48383598|NCT02486952|101265287|FG000|COMPLETED|Overall Study||104||
48383599|NCT02486952|101265287|FG000|NOT COMPLETED|Overall Study||50||
48383600|NCT02176291|101265288|FG000|STARTED|Overall Study||20||
48383601|NCT02176291|101265289|FG001|STARTED|Overall Study||11||
48383602|NCT02176291|101265288|FG000|COMPLETED|Overall Study||15||
48383603|NCT02176291|101265289|FG001|COMPLETED|Overall Study||11||
48383604|NCT02176291|101265288|FG000|NOT COMPLETED|Overall Study||5||
48383605|NCT02176291|101265289|FG001|NOT COMPLETED|Overall Study||0||
48383606|NCT00574119|101265290|FG000|STARTED|Overall Study||16||
48383607|NCT00574119|101265290|FG000|COMPLETED|Overall Study||12||
48383608|NCT00574119|101265290|FG000|NOT COMPLETED|Overall Study||4||
48383609|NCT02432040|101265291|FG000|STARTED|Overall Study||14||
48383610|NCT02432040|101265292|FG001|STARTED|Overall Study||14||
48383611|NCT02432040|101265291|FG000|COMPLETED|Overall Study||6||
48383612|NCT02432040|101265292|FG001|COMPLETED|Overall Study||8||
48383613|NCT02432040|101265291|FG000|NOT COMPLETED|Overall Study||8||
48383614|NCT02432040|101265292|FG001|NOT COMPLETED|Overall Study||6||
48383615|NCT03522350|101265293|FG000|STARTED|Overall Study||18||115
48383616|NCT03522350|101265294|FG001|STARTED|Overall Study||18||116
48383617|NCT03522350|101265293|FG000|COMPLETED|Overall Study||18||115
48383618|NCT03522350|101265294|FG001|COMPLETED|Overall Study||18||116
48383619|NCT03522350|101265293|FG000|NOT COMPLETED|Overall Study||0||0
48383620|NCT03522350|101265294|FG001|NOT COMPLETED|Overall Study||0||0
48383621|NCT04511026|101265295|FG000|STARTED|Overall Study||6||
48383622|NCT04511026|101265295|FG000|COMPLETED|Overall Study||6||
48383623|NCT04511026|101265295|FG000|NOT COMPLETED|Overall Study||0||
48383624|NCT00315705|101265296|FG000|STARTED|Phase 1||25||
48383625|NCT00315705|101265296|FG000|COMPLETED|Phase 1||0||
48383626|NCT00315705|101265296|FG000|NOT COMPLETED|Phase 1||25||
48383627|NCT00315705|101265296|FG000|STARTED|Phase 2||25||
48383628|NCT00315705|101265296|FG000|COMPLETED|Phase 2||0||
48383629|NCT00315705|101265296|FG000|NOT COMPLETED|Phase 2||25||
48383630|NCT02780765|101265297|FG000|STARTED|Overall Study||30||
48383631|NCT02780765|101265298|FG001|STARTED|Overall Study||30||
48383632|NCT02780765|101265297|FG000|COMPLETED|Overall Study||30||
48383633|NCT02780765|101265298|FG001|COMPLETED|Overall Study||30||
48383634|NCT02780765|101265297|FG000|NOT COMPLETED|Overall Study||0||
48383635|NCT02780765|101265298|FG001|NOT COMPLETED|Overall Study||0||
48383636|NCT03364673|101265299|FG000|STARTED|Overall Study||29||
48383637|NCT03364673|101265299|FG000|COMPLETED|Overall Study||24||
48383638|NCT03364673|101265299|FG000|NOT COMPLETED|Overall Study||5||
48383639|NCT01714817|101269286|FG000|STARTED|Year 1 Period||203||
48383640|NCT01714817|101269287|FG001|STARTED|Year 1 Period||203||
48383641|NCT01714817|101269286|FG000|Treated|Year 1 Period||202||
48383642|NCT01714817|101269287|FG001|Treated|Year 1 Period||203||
48383643|NCT01714817|101269286|FG000|COMPLETED|Year 1 Period||155||
48383644|NCT01714817|101269287|FG001|COMPLETED|Year 1 Period||161||
48383645|NCT01714817|101269286|FG000|NOT COMPLETED|Year 1 Period||48||
48383646|NCT01714817|101269287|FG001|NOT COMPLETED|Year 1 Period||42||
48383647|NCT01714817|101269286|FG000|STARTED|Year 2 Period||155||
48383648|NCT01714817|101269287|FG001|STARTED|Year 2 Period||161||
48383649|NCT01714817|101269286|FG000|COMPLETED|Year 2 Period||129||
48383650|NCT01714817|101269287|FG001|COMPLETED|Year 2 Period||123||
48383651|NCT01714817|101269286|FG000|NOT COMPLETED|Year 2 Period||26||
48383652|NCT01714817|101269287|FG001|NOT COMPLETED|Year 2 Period||38||
48383653|NCT01714817|101269286|FG000|STARTED|Long-Term Extension (LTE) Period||129||
48383654|NCT01714817|101269287|FG001|STARTED|Long-Term Extension (LTE) Period||123||
48383655|NCT01714817|101269286|FG000|COMPLETED|Long-Term Extension (LTE) Period||62||
48383656|NCT01714817|101269287|FG001|COMPLETED|Long-Term Extension (LTE) Period||53||
48383657|NCT01714817|101269286|FG000|NOT COMPLETED|Long-Term Extension (LTE) Period||67||
48383658|NCT01714817|101269287|FG001|NOT COMPLETED|Long-Term Extension (LTE) Period||70||
48383659|NCT00973921|101269288|FG000|STARTED|Overall Study||40||
48383660|NCT00973921|101269288|FG000|COMPLETED|Overall Study||31||
48383661|NCT00973921|101269288|FG000|NOT COMPLETED|Overall Study||9||
48383662|NCT00797797|101269289|FG000|STARTED|Overall Study||178||
48383663|NCT00797797|101269290|FG001|STARTED|Overall Study||184||
48383664|NCT00797797|101269289|FG000|COMPLETED|Overall Study||123||
48091792|NCT00989014|100545866|FG003|COMPLETED|Overall Study||32||
48091793|NCT00989014|100545863|FG000|NOT COMPLETED|Overall Study||0||
48383665|NCT00797797|101269290|FG001|COMPLETED|Overall Study||141||
48383666|NCT00797797|101269289|FG000|NOT COMPLETED|Overall Study||55||
48383667|NCT00797797|101269290|FG001|NOT COMPLETED|Overall Study||43||
48383668|NCT01766817|101269291|FG000|STARTED|Overall Study||48||
48383669|NCT01766817|101269292|FG001|STARTED|Overall Study||48||
48383670|NCT01766817|101269293|FG002|STARTED|Overall Study||47||
48383671|NCT01766817|101269291|FG000|COMPLETED|Overall Study||37||
48383672|NCT01766817|101269292|FG001|COMPLETED|Overall Study||37||
48383673|NCT01766817|101269293|FG002|COMPLETED|Overall Study||34||
48383674|NCT01766817|101269291|FG000|NOT COMPLETED|Overall Study||11||
48383675|NCT01766817|101269292|FG001|NOT COMPLETED|Overall Study||11||
48091794|NCT00989014|100545864|FG001|NOT COMPLETED|Overall Study||0||
48091795|NCT00989014|100545865|FG002|NOT COMPLETED|Overall Study||0||
48383676|NCT01766817|101269293|FG002|NOT COMPLETED|Overall Study||13||
48383677|NCT02208024|101269294|FG000|STARTED|Overall Study||18||
48383678|NCT02208024|101269294|FG000|COMPLETED|Overall Study||17||
48383679|NCT02208024|101269294|FG000|NOT COMPLETED|Overall Study||1||
48383680|NCT01423773|101269295|FG000|STARTED|Period One, 2 Days||10||
48383681|NCT01423773|101269296|FG001|STARTED|Period One, 2 Days||10||
48383682|NCT01423773|101269295|FG000|COMPLETED|Period One, 2 Days||10||
48383683|NCT01423773|101269296|FG001|COMPLETED|Period One, 2 Days||10||
48383684|NCT01423773|101269295|FG000|NOT COMPLETED|Period One, 2 Days||0||
48383685|NCT01423773|101269296|FG001|NOT COMPLETED|Period One, 2 Days||0||
48383686|NCT01423773|101269295|FG000|STARTED|Period 2, 2 Days||10||
48091796|NCT00989014|100545866|FG003|NOT COMPLETED|Overall Study||0||
48091797|NCT02654483|100545867|FG000|STARTED|Double-blind||7||
48091798|NCT02654483|100545868|FG001|STARTED|Double-blind||7||
48091799|NCT02654483|100545867|FG000|COMPLETED|Double-blind||7||
48091800|NCT02654483|100545868|FG001|COMPLETED|Double-blind||7||
48091801|NCT02654483|100545867|FG000|NOT COMPLETED|Double-blind||0||
48383687|NCT01423773|101269296|FG001|STARTED|Period 2, 2 Days||10||
48383688|NCT01423773|101269295|FG000|COMPLETED|Period 2, 2 Days||10||
48383689|NCT01423773|101269296|FG001|COMPLETED|Period 2, 2 Days||10||
48383690|NCT01423773|101269295|FG000|NOT COMPLETED|Period 2, 2 Days||0||
48383691|NCT01423773|101269296|FG001|NOT COMPLETED|Period 2, 2 Days||0||
48383692|NCT03377244|101269297|FG000|STARTED|Baseline||19||
48383693|NCT03377244|101269298|FG001|STARTED|Baseline||14||
48383694|NCT03377244|101269299|FG002|STARTED|Baseline||69||
48383695|NCT03377244|101269297|FG000|COMPLETED|Baseline||19||
48383696|NCT03377244|101269298|FG001|COMPLETED|Baseline||14||
48383697|NCT03377244|101269299|FG002|COMPLETED|Baseline||69||
48383698|NCT03377244|101269297|FG000|NOT COMPLETED|Baseline||0||
48383699|NCT03377244|101269298|FG001|NOT COMPLETED|Baseline||0||
48383700|NCT03377244|101269299|FG002|NOT COMPLETED|Baseline||0||
48383701|NCT03377244|101269297|FG000|STARTED|6 Months Post-intervention||19||
48383702|NCT03377244|101269298|FG001|STARTED|6 Months Post-intervention||14||
48383703|NCT03377244|101269299|FG002|STARTED|6 Months Post-intervention||69||
48383704|NCT03377244|101269297|FG000|COMPLETED|6 Months Post-intervention||13||
48383705|NCT03377244|101269298|FG001|COMPLETED|6 Months Post-intervention||7||
48383706|NCT03377244|101269299|FG002|COMPLETED|6 Months Post-intervention||55||
48383707|NCT03377244|101269297|FG000|NOT COMPLETED|6 Months Post-intervention||6||
48383708|NCT03377244|101269298|FG001|NOT COMPLETED|6 Months Post-intervention||7||
48383709|NCT03377244|101269299|FG002|NOT COMPLETED|6 Months Post-intervention||14||
48383710|NCT00764478|101269300|FG000|STARTED|Overall Study||122||
48383711|NCT00764478|101269301|FG001|STARTED|Overall Study||119||
48383712|NCT00764478|101269302|FG002|STARTED|Overall Study||126||
48383713|NCT00764478|101269300|FG000|COMPLETED|Overall Study||107||
48383714|NCT00764478|101269301|FG001|COMPLETED|Overall Study||97||
48383715|NCT00764478|101269302|FG002|COMPLETED|Overall Study||118||
48383716|NCT00764478|101269300|FG000|NOT COMPLETED|Overall Study||15||
48383717|NCT00764478|101269301|FG001|NOT COMPLETED|Overall Study||22||
48256668|NCT01836198|100947796|FG001|Completed Part A, Entered Part B|Part A, Period 2||6||
48256669|NCT01836198|100947797|FG002|Completed Part A, Entered Part B|Part A, Period 2||0||
48256670|NCT01836198|100947795|FG000|COMPLETED|Part A, Period 2||15||
48256671|NCT01836198|100947796|FG001|COMPLETED|Part A, Period 2||14||
48256672|NCT01836198|100947797|FG002|COMPLETED|Part A, Period 2||0||
48256673|NCT01836198|100947795|FG000|NOT COMPLETED|Part A, Period 2||0||
48383718|NCT00764478|101269302|FG002|NOT COMPLETED|Overall Study||8||
48383719|NCT03448224|101269303|FG000|STARTED|Overall Study||28||
48383720|NCT03448224|101269304|FG001|STARTED|Overall Study||26||
48383721|NCT03448224|101269303|FG000|COMPLETED|Overall Study||27||
48383722|NCT03448224|101269304|FG001|COMPLETED|Overall Study||26||
48383723|NCT03448224|101269303|FG000|NOT COMPLETED|Overall Study||1||
48383724|NCT03448224|101269304|FG001|NOT COMPLETED|Overall Study||0||
48383725|NCT00280241|101269305|FG000|STARTED|Overall Study||65||
48383726|NCT00280241|101269305|FG000|COMPLETED|Overall Study||55||
48383727|NCT00280241|101269305|FG000|NOT COMPLETED|Overall Study||10||
48383728|NCT00838916|101269306|FG000|STARTED|Treatment Period (156 Weeks)||504||
48383729|NCT00838916|101269307|FG001|STARTED|Treatment Period (156 Weeks)||241||
48383730|NCT00838916|101269306|FG000|COMPLETED|Treatment Period (156 Weeks)||308||
48383731|NCT00838916|101269307|FG001|COMPLETED|Treatment Period (156 Weeks)||164||
48383732|NCT00838916|101269306|FG000|NOT COMPLETED|Treatment Period (156 Weeks)||196||
48383733|NCT00838916|101269307|FG001|NOT COMPLETED|Treatment Period (156 Weeks)||77||
48256674|NCT01836198|100947796|FG001|NOT COMPLETED|Part A, Period 2||1||
48256675|NCT01836198|100947797|FG002|NOT COMPLETED|Part A, Period 2||0||
48256676|NCT01836198|100947795|FG000|STARTED|Part B||0||
48256677|NCT01836198|100947796|FG001|STARTED|Part B||0||
48256678|NCT01836198|100947797|FG002|STARTED|Part B||12||
48256679|NCT01836198|100947795|FG000|Received at Least 1 Dose of Study Drug|Part B||0||
48383734|NCT00838916|101269306|FG000|STARTED|Follow-up Period (8 Weeks)||504||
48383735|NCT00838916|101269307|FG001|STARTED|Follow-up Period (8 Weeks)||241||
48383736|NCT00838916|101269306|FG000|COMPLETED|Follow-up Period (8 Weeks)||408||
48383737|NCT00838916|101269307|FG001|COMPLETED|Follow-up Period (8 Weeks)||190||
48383738|NCT00838916|101269306|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||96||
48383739|NCT00838916|101269307|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||51||
48383740|NCT04093258|101269308|FG000|STARTED|Period 1||21||
48383741|NCT04093258|101269309|FG001|STARTED|Period 1||20||
48383742|NCT04093258|101269308|FG000|COMPLETED|Period 1||21||
48383743|NCT04093258|101269309|FG001|COMPLETED|Period 1||20||
48383744|NCT04093258|101269308|FG000|NOT COMPLETED|Period 1||0||
48383745|NCT04093258|101269309|FG001|NOT COMPLETED|Period 1||0||
48383746|NCT04093258|101269308|FG000|STARTED|Period 2||21||
48383747|NCT04093258|101269309|FG001|STARTED|Period 2||20||
48383748|NCT04093258|101269308|FG000|COMPLETED|Period 2||20||
48383749|NCT04093258|101269309|FG001|COMPLETED|Period 2||20||
48383750|NCT04093258|101269308|FG000|NOT COMPLETED|Period 2||1||
48383751|NCT04093258|101269309|FG001|NOT COMPLETED|Period 2||0||
48383752|NCT00800865|101269310|FG000|STARTED|Overall Study||15||
48383753|NCT00800865|101269311|FG001|STARTED|Overall Study||16||
48383754|NCT00800865|101269310|FG000|COMPLETED|Overall Study||15||
48383755|NCT00800865|101269311|FG001|COMPLETED|Overall Study||16||
48383756|NCT00800865|101269310|FG000|NOT COMPLETED|Overall Study||0||
48383757|NCT00800865|101269311|FG001|NOT COMPLETED|Overall Study||0||
48383758|NCT01030458|101269312|FG000|STARTED|Overall Study||94||
48383759|NCT01030458|101269313|FG001|STARTED|Overall Study||89||
48383760|NCT01030458|101269312|FG000|COMPLETED|Overall Study||67||
48383761|NCT01030458|101269313|FG001|COMPLETED|Overall Study||57||
48383762|NCT01030458|101269312|FG000|NOT COMPLETED|Overall Study||27||
48383763|NCT01030458|101269313|FG001|NOT COMPLETED|Overall Study||32||
48383764|NCT01760993|101269314|FG000|STARTED|Overall Study||0||
48383765|NCT01760993|101269314|FG000|COMPLETED|Overall Study||0||
48383766|NCT01760993|101269314|FG000|NOT COMPLETED|Overall Study||0||
48383767|NCT02662985|101269315|FG000|STARTED|Treatment Period 1||83||
48383768|NCT02662985|101269316|FG001|STARTED|Treatment Period 1||83||
48383769|NCT02662985|101269315|FG000|COMPLETED|Treatment Period 1||82||
48383770|NCT02662985|101269316|FG001|COMPLETED|Treatment Period 1||79||
48383771|NCT02662985|101269315|FG000|NOT COMPLETED|Treatment Period 1||1||
48383772|NCT02662985|101269316|FG001|NOT COMPLETED|Treatment Period 1||4||
48383773|NCT02662985|101269315|FG000|STARTED|Treatment Period 2||82||
48383774|NCT02662985|101269316|FG001|STARTED|Treatment Period 2||79||
48383775|NCT02662985|101269315|FG000|COMPLETED|Treatment Period 2||81||
48383776|NCT02662985|101269316|FG001|COMPLETED|Treatment Period 2||78||
48383777|NCT02662985|101269315|FG000|NOT COMPLETED|Treatment Period 2||1||
48383778|NCT02662985|101269316|FG001|NOT COMPLETED|Treatment Period 2||1||
48383779|NCT02662985|101269315|FG000|STARTED|Treatment Period 3 (Extension Period)||81||
48383780|NCT02662985|101269316|FG001|STARTED|Treatment Period 3 (Extension Period)||78||
48383781|NCT02662985|101269315|FG000|COMPLETED|Treatment Period 3 (Extension Period)||75||
48383782|NCT02662985|101269316|FG001|COMPLETED|Treatment Period 3 (Extension Period)||69||
48383783|NCT02662985|101269315|FG000|NOT COMPLETED|Treatment Period 3 (Extension Period)||6||
48383784|NCT02662985|101269316|FG001|NOT COMPLETED|Treatment Period 3 (Extension Period)||9||
48383785|NCT03488251|101269317|FG000|STARTED|Part 1:Dose Escalation (Up to 168 Days)||8||
48383786|NCT03488251|101269318|FG001|STARTED|Part 1:Dose Escalation (Up to 168 Days)||0||
48383787|NCT03488251|101269319|FG002|STARTED|Part 1:Dose Escalation (Up to 168 Days)||0||
48383788|NCT03488251|101269320|FG003|STARTED|Part 1:Dose Escalation (Up to 168 Days)||0||
48383789|NCT03488251|101269317|FG000|COMPLETED|Part 1:Dose Escalation (Up to 168 Days)||0||
48383790|NCT03488251|101269318|FG001|COMPLETED|Part 1:Dose Escalation (Up to 168 Days)||0||
48383791|NCT03488251|101269319|FG002|COMPLETED|Part 1:Dose Escalation (Up to 168 Days)||0||
48383792|NCT03488251|101269320|FG003|COMPLETED|Part 1:Dose Escalation (Up to 168 Days)||0||
48383793|NCT03488251|101269317|FG000|NOT COMPLETED|Part 1:Dose Escalation (Up to 168 Days)||8||
48383794|NCT03488251|101269318|FG001|NOT COMPLETED|Part 1:Dose Escalation (Up to 168 Days)||0||
48383795|NCT03488251|101269319|FG002|NOT COMPLETED|Part 1:Dose Escalation (Up to 168 Days)||0||
48383796|NCT03488251|101269320|FG003|NOT COMPLETED|Part 1:Dose Escalation (Up to 168 Days)||0||
48383797|NCT03488251|101269317|FG000|STARTED|Part 2:Dose Expansion (Up to 168 Days)||0||
48383798|NCT03488251|101269318|FG001|STARTED|Part 2:Dose Expansion (Up to 168 Days)||0||
48383799|NCT03488251|101269319|FG002|STARTED|Part 2:Dose Expansion (Up to 168 Days)||0||
48383800|NCT03488251|101269320|FG003|STARTED|Part 2:Dose Expansion (Up to 168 Days)||0||
48383801|NCT03488251|101269317|FG000|COMPLETED|Part 2:Dose Expansion (Up to 168 Days)||0||
48383802|NCT03488251|101269318|FG001|COMPLETED|Part 2:Dose Expansion (Up to 168 Days)||0||
48383803|NCT03488251|101269319|FG002|COMPLETED|Part 2:Dose Expansion (Up to 168 Days)||0||
48383804|NCT03488251|101269320|FG003|COMPLETED|Part 2:Dose Expansion (Up to 168 Days)||0||
48383805|NCT03488251|101269317|FG000|NOT COMPLETED|Part 2:Dose Expansion (Up to 168 Days)||0||
48383806|NCT03488251|101269318|FG001|NOT COMPLETED|Part 2:Dose Expansion (Up to 168 Days)||0||
48383807|NCT03488251|101269319|FG002|NOT COMPLETED|Part 2:Dose Expansion (Up to 168 Days)||0||
48383808|NCT03488251|101269320|FG003|NOT COMPLETED|Part 2:Dose Expansion (Up to 168 Days)||0||
48383809|NCT00992784|101269321|FG000|STARTED|Overall Study||180||
48383810|NCT00992784|101269322|FG001|STARTED|Overall Study||104||
48383811|NCT00992784|101269323|FG002|STARTED|Overall Study||86||
48383812|NCT00992784|101269321|FG000|COMPLETED|Overall Study||177||
48383813|NCT00992784|101269322|FG001|COMPLETED|Overall Study||102||
48383814|NCT00992784|101269323|FG002|COMPLETED|Overall Study||85||
48383815|NCT00992784|101269321|FG000|NOT COMPLETED|Overall Study||3||
48383816|NCT00992784|101269322|FG001|NOT COMPLETED|Overall Study||2||
48383817|NCT00992784|101269323|FG002|NOT COMPLETED|Overall Study||1||
48383818|NCT01519284|101269324|FG000|STARTED|Overall Study||16||
48383819|NCT01519284|101269325|FG001|STARTED|Overall Study||16||
48383820|NCT01519284|101269326|FG002|STARTED|Overall Study||18||
48383821|NCT01519284|101269327|FG003|STARTED|Overall Study||16||
48383822|NCT01519284|101269328|FG004|STARTED|Overall Study||16||
48383823|NCT01519284|101269324|FG000|COMPLETED|Overall Study||16||
48383824|NCT01519284|101269325|FG001|COMPLETED|Overall Study||16||
48383825|NCT01519284|101269326|FG002|COMPLETED|Overall Study||16||
48383826|NCT01519284|101269327|FG003|COMPLETED|Overall Study||16||
48383827|NCT01519284|101269328|FG004|COMPLETED|Overall Study||16||
48383828|NCT01519284|101269324|FG000|NOT COMPLETED|Overall Study||0||
48383829|NCT01519284|101269325|FG001|NOT COMPLETED|Overall Study||0||
48383830|NCT01519284|101269326|FG002|NOT COMPLETED|Overall Study||2||
48383831|NCT01519284|101269327|FG003|NOT COMPLETED|Overall Study||0||
48383832|NCT01519284|101269328|FG004|NOT COMPLETED|Overall Study||0||
48383833|NCT03337152|101269329|FG000|STARTED|Overall Study||24||
48687567|NCT03008070|102017119|FG002|NOT COMPLETED|Overall Study||7||
48687568|NCT01947335|102017120|FG000|STARTED|Overall Study||42||
48687569|NCT01947335|102017121|FG001|STARTED|Overall Study||41||
48687570|NCT01947335|102017120|FG000|COMPLETED|Overall Study||42||
48687571|NCT01947335|102017121|FG001|COMPLETED|Overall Study||41||
48687572|NCT01947335|102017120|FG000|NOT COMPLETED|Overall Study||0||
48687573|NCT01947335|102017121|FG001|NOT COMPLETED|Overall Study||0||
48687574|NCT02735421|102017122|FG000|STARTED|Part A (Randomized): up to 24 Weeks||67||
48687575|NCT02735421|102017122|FG000|COMPLETED|Part A (Randomized): up to 24 Weeks||54||
48383834|NCT03337152|101269330|FG001|STARTED|Overall Study||24||
48383835|NCT03337152|101269329|FG000|COMPLETED|Overall Study||13||
48383836|NCT03337152|101269330|FG001|COMPLETED|Overall Study||13||
48687576|NCT02735421|102017122|FG000|NOT COMPLETED|Part A (Randomized): up to 24 Weeks||13||
48687577|NCT02735421|102017122|FG000|STARTED|Part 2 (Open Label): up to 48 Weeks||45||
48687578|NCT02735421|102017122|FG000|COMPLETED|Part 2 (Open Label): up to 48 Weeks||41||
48687579|NCT02735421|102017122|FG000|NOT COMPLETED|Part 2 (Open Label): up to 48 Weeks||4||
48687580|NCT00420381|102017123|FG000|STARTED|Overall Study||28||
48687581|NCT00420381|102017123|FG000|Received at Least One Dose of Study Drug|Overall Study||27||
48687582|NCT00420381|102017123|FG000|COMPLETED|Overall Study||27||
48687583|NCT00420381|102017123|FG000|NOT COMPLETED|Overall Study||1||
48687584|NCT03549338|102017124|FG000|STARTED|Overall Study||1||
48687585|NCT03549338|102017125|FG001|STARTED|Overall Study||1||
48687586|NCT03549338|102017126|FG002|STARTED|Overall Study||0||
48256680|NCT01836198|100947796|FG001|Received at Least 1 Dose of Study Drug|Part B||0||
48256681|NCT01836198|100947797|FG002|Received at Least 1 Dose of Study Drug|Part B||12||
48256682|NCT01836198|100947795|FG000|COMPLETED|Part B||0||
48256683|NCT01836198|100947796|FG001|COMPLETED|Part B||0||
48687587|NCT03549338|102017124|FG000|COMPLETED|Overall Study||0||
48687588|NCT03549338|102017125|FG001|COMPLETED|Overall Study||0||
48687589|NCT03549338|102017126|FG002|COMPLETED|Overall Study||0||
48687590|NCT03549338|102017124|FG000|NOT COMPLETED|Overall Study||1||
48687591|NCT03549338|102017125|FG001|NOT COMPLETED|Overall Study||1||
48687592|NCT03549338|102017126|FG002|NOT COMPLETED|Overall Study||0||
48687593|NCT02593903|102017127|FG000|STARTED|Overall Study||35||
48687594|NCT02593903|102017128|FG001|STARTED|Overall Study||32||
48687595|NCT02593903|102017127|FG000|COMPLETED|Overall Study||35||
48687596|NCT02593903|102017128|FG001|COMPLETED|Overall Study||31||
48687597|NCT02593903|102017127|FG000|NOT COMPLETED|Overall Study||0||
48687598|NCT02593903|102017128|FG001|NOT COMPLETED|Overall Study||1||
48687599|NCT02528942|102017129|FG000|STARTED|Overall Study||101||
48687600|NCT02528942|102017129|FG000|COMPLETED|Overall Study||67||
48687601|NCT02528942|102017129|FG000|NOT COMPLETED|Overall Study||34||
48687602|NCT04103112|102017130|FG000|STARTED|Overall Study||76||
48687603|NCT04103112|102017131|FG001|STARTED|Overall Study||76||
48687604|NCT04103112|102017130|FG000|COMPLETED|Overall Study||55||
48687605|NCT04103112|102017131|FG001|COMPLETED|Overall Study||56||
48256684|NCT01836198|100947797|FG002|COMPLETED|Part B||12||
48256685|NCT01836198|100947795|FG000|NOT COMPLETED|Part B||0||
48256686|NCT01836198|100947796|FG001|NOT COMPLETED|Part B||0||
48256687|NCT01836198|100947797|FG002|NOT COMPLETED|Part B||0||
48256688|NCT01086384|100947798|FG000|STARTED|2-week Run-in Period||2183||
48256689|NCT01086384|100947799|FG001|STARTED|2-week Run-in Period||0||
48256690|NCT01086384|100947800|FG002|STARTED|2-week Run-in Period||0||
48256691|NCT01086384|100947798|FG000|COMPLETED|2-week Run-in Period||2020||
48256692|NCT01086384|100947799|FG001|COMPLETED|2-week Run-in Period||0||
48256693|NCT01086384|100947800|FG002|COMPLETED|2-week Run-in Period||0||
48256694|NCT01086384|100947798|FG000|NOT COMPLETED|2-week Run-in Period||163||
48256695|NCT01086384|100947799|FG001|NOT COMPLETED|2-week Run-in Period||0||
48687606|NCT04103112|102017130|FG000|NOT COMPLETED|Overall Study||21||
48687607|NCT04103112|102017131|FG001|NOT COMPLETED|Overall Study||20||
48687608|NCT03020004|102017132|FG000|STARTED|Overall Study||70||
48687609|NCT03020004|102017132|FG000|COMPLETED|Overall Study||69||
48687610|NCT03020004|102017132|FG000|NOT COMPLETED|Overall Study||1||
48687611|NCT01244035|102017133|FG000|STARTED|Part 1: Period 1||5|This was a 3-period crossover study with a 4-day washout between treatment periods|
48687612|NCT01244035|102017134|FG001|STARTED|Part 1: Period 1||5|This was a 3-period crossover study with a 4-day washout between treatment periods|
48383837|NCT03337152|101269329|FG000|NOT COMPLETED|Overall Study||11||
48383838|NCT03337152|101269330|FG001|NOT COMPLETED|Overall Study||11||
48687613|NCT01244035|102017135|FG002|STARTED|Part 1: Period 1||6|This was a 3-period crossover study with a 4-day washout between treatment periods|
48256696|NCT01086384|100947800|FG002|NOT COMPLETED|2-week Run-in Period||0||
48256697|NCT01086384|100947798|FG000|STARTED|Treatment Period||0||
48383839|NCT03001843|101269331|FG000|STARTED|Overall Study||27||
48383840|NCT03001843|101269332|FG001|STARTED|Overall Study||27||
48383841|NCT03001843|101269331|FG000|COMPLETED|Overall Study||27||
48687614|NCT01244035|102017136|FG003|STARTED|Part 1: Period 1||5|This was a 3-period crossover study with a 4-day washout between treatment periods|
48710789|NCT01215110|102078020|FG004|COMPLETED|Overall Study||8||
48687615|NCT01244035|102017137|FG004|STARTED|Part 1: Period 1||5|This was a 3-period crossover study with a 4-day washout between treatment periods|
48687616|NCT01244035|102017138|FG005|STARTED|Part 1: Period 1||5|This was a 3-period crossover study with a 4-day washout between treatment periods|
48687617|NCT01244035|102017133|FG000|COMPLETED|Part 1: Period 1||4||
48687618|NCT01244035|102017134|FG001|COMPLETED|Part 1: Period 1||3||
48687619|NCT01244035|102017135|FG002|COMPLETED|Part 1: Period 1||4||
48687620|NCT01244035|102017136|FG003|COMPLETED|Part 1: Period 1||5||
48687621|NCT01244035|102017137|FG004|COMPLETED|Part 1: Period 1||4||
48687622|NCT01244035|102017138|FG005|COMPLETED|Part 1: Period 1||3||
48687623|NCT01244035|102017133|FG000|NOT COMPLETED|Part 1: Period 1||1||
48687624|NCT01244035|102017134|FG001|NOT COMPLETED|Part 1: Period 1||2||
48687625|NCT01244035|102017135|FG002|NOT COMPLETED|Part 1: Period 1||2||
48687626|NCT01244035|102017136|FG003|NOT COMPLETED|Part 1: Period 1||0||
48687627|NCT01244035|102017137|FG004|NOT COMPLETED|Part 1: Period 1||1||
48687628|NCT01244035|102017138|FG005|NOT COMPLETED|Part 1: Period 1||2||
48687629|NCT01244035|102017133|FG000|STARTED|Part 1: Period 2||4||
48687630|NCT01244035|102017134|FG001|STARTED|Part 1: Period 2||3||
48687631|NCT01244035|102017135|FG002|STARTED|Part 1: Period 2||4||
48687632|NCT01244035|102017136|FG003|STARTED|Part 1: Period 2||5||
48687633|NCT01244035|102017137|FG004|STARTED|Part 1: Period 2||4||
48091802|NCT02654483|100545868|FG001|NOT COMPLETED|Double-blind||0||
48256698|NCT01086384|100947799|FG001|STARTED|Treatment Period||1011||
48383842|NCT03001843|101269332|FG001|COMPLETED|Overall Study||27||
48383843|NCT03001843|101269331|FG000|NOT COMPLETED|Overall Study||0||
48541633|NCT03095638|101662791|FG002|COMPLETED|P1: Period 1 (4 Days)||0||
48541634|NCT03095638|101662792|FG003|COMPLETED|P1: Period 1 (4 Days)||0||
48687634|NCT01244035|102017138|FG005|STARTED|Part 1: Period 2||3||
48687635|NCT01244035|102017133|FG000|COMPLETED|Part 1: Period 2||4||
48687636|NCT01244035|102017134|FG001|COMPLETED|Part 1: Period 2||3||
48687637|NCT01244035|102017135|FG002|COMPLETED|Part 1: Period 2||3||
48687638|NCT01244035|102017136|FG003|COMPLETED|Part 1: Period 2||5||
48687639|NCT01244035|102017137|FG004|COMPLETED|Part 1: Period 2||4||
48687640|NCT01244035|102017138|FG005|COMPLETED|Part 1: Period 2||3||
48687641|NCT01244035|102017133|FG000|NOT COMPLETED|Part 1: Period 2||0||
48687642|NCT01244035|102017134|FG001|NOT COMPLETED|Part 1: Period 2||0||
48687643|NCT01244035|102017135|FG002|NOT COMPLETED|Part 1: Period 2||1||
48687644|NCT01244035|102017136|FG003|NOT COMPLETED|Part 1: Period 2||0||
48687645|NCT01244035|102017137|FG004|NOT COMPLETED|Part 1: Period 2||0||
48687646|NCT01244035|102017138|FG005|NOT COMPLETED|Part 1: Period 2||0||
48687647|NCT01244035|102017133|FG000|STARTED|Part 1: Period 3||4||
48687648|NCT01244035|102017134|FG001|STARTED|Part 1: Period 3||3||
48687649|NCT01244035|102017135|FG002|STARTED|Part 1: Period 3||3||
48687650|NCT01244035|102017136|FG003|STARTED|Part 1: Period 3||5||
48687651|NCT01244035|102017137|FG004|STARTED|Part 1: Period 3||4||
48687652|NCT01244035|102017138|FG005|STARTED|Part 1: Period 3||3||
48687653|NCT01244035|102017133|FG000|COMPLETED|Part 1: Period 3||4||
48541635|NCT03095638|101662793|FG004|COMPLETED|P1: Period 1 (4 Days)||0||
48541636|NCT03095638|101662794|FG005|COMPLETED|P1: Period 1 (4 Days)||0||
48541637|NCT03095638|101662795|FG006|COMPLETED|P1: Period 1 (4 Days)||0||
48541638|NCT03095638|101662796|FG007|COMPLETED|P1: Period 1 (4 Days)||0||
48541639|NCT03095638|101662789|FG000|NOT COMPLETED|P1: Period 1 (4 Days)||0||
48687654|NCT01244035|102017134|FG001|COMPLETED|Part 1: Period 3||2||
48687655|NCT01244035|102017135|FG002|COMPLETED|Part 1: Period 3||3||
48687656|NCT01244035|102017136|FG003|COMPLETED|Part 1: Period 3||5||
48687657|NCT01244035|102017137|FG004|COMPLETED|Part 1: Period 3||3||
48687658|NCT01244035|102017138|FG005|COMPLETED|Part 1: Period 3||2||
48687659|NCT01244035|102017133|FG000|NOT COMPLETED|Part 1: Period 3||0||
48687660|NCT01244035|102017134|FG001|NOT COMPLETED|Part 1: Period 3||1||
48687661|NCT01244035|102017135|FG002|NOT COMPLETED|Part 1: Period 3||0||
48687662|NCT01244035|102017136|FG003|NOT COMPLETED|Part 1: Period 3||0||
48687663|NCT01244035|102017137|FG004|NOT COMPLETED|Part 1: Period 3||1||
48687664|NCT01244035|102017138|FG005|NOT COMPLETED|Part 1: Period 3||1||
48687665|NCT02975804|102017139|FG000|STARTED|Overall Study||9||
48687666|NCT02975804|102017140|FG001|STARTED|Overall Study||9||
48687667|NCT02975804|102017139|FG000|COMPLETED|Overall Study||9||
48687668|NCT02975804|102017140|FG001|COMPLETED|Overall Study||9||
48687669|NCT02975804|102017139|FG000|NOT COMPLETED|Overall Study||0||
48687670|NCT02975804|102017140|FG001|NOT COMPLETED|Overall Study||0||
48687671|NCT01484496|102017141|FG000|STARTED|Period 1||280||
48256699|NCT01086384|100947800|FG002|STARTED|Treatment Period||1009||
48256700|NCT01086384|100947798|FG000|COMPLETED|Treatment Period||0||
48383844|NCT03001843|101269332|FG001|NOT COMPLETED|Overall Study||0||
48541640|NCT03095638|101662790|FG001|NOT COMPLETED|P1: Period 1 (4 Days)||0||
48541641|NCT03095638|101662791|FG002|NOT COMPLETED|P1: Period 1 (4 Days)||0||
48541642|NCT03095638|101662792|FG003|NOT COMPLETED|P1: Period 1 (4 Days)||0||
48687672|NCT01484496|102017142|FG001|STARTED|Period 1||556||
48687673|NCT01484496|102017143|FG002|STARTED|Period 1||0||
48687674|NCT01484496|102017144|FG003|STARTED|Period 1||0||
48687675|NCT01484496|102017141|FG000|COMPLETED|Period 1||214||
48687676|NCT01484496|102017142|FG001|COMPLETED|Period 1||463||
48687677|NCT01484496|102017143|FG002|COMPLETED|Period 1||0||
48383845|NCT00772382|101269333|FG000|STARTED|Overall Study||116||
48687678|NCT01484496|102017144|FG003|COMPLETED|Period 1||0||
48091803|NCT02654483|100545867|FG000|STARTED|Open-label||5|6 participants in total did not continue to the open-label period|
48091804|NCT02654483|100545868|FG001|STARTED|Open-label||3|6 participants in total did not continue to the open-label period|
48091805|NCT02654483|100545867|FG000|COMPLETED|Open-label||5||
48091806|NCT02654483|100545868|FG001|COMPLETED|Open-label||3||
48091807|NCT02654483|100545867|FG000|NOT COMPLETED|Open-label||0||
48091808|NCT02654483|100545868|FG001|NOT COMPLETED|Open-label||0||
48091809|NCT02417974|100545869|FG000|STARTED|Overall Study||15||
48091810|NCT02417974|100545870|FG001|STARTED|Overall Study||9||
48091811|NCT02417974|100545869|FG000|COMPLETED|Overall Study||15||
48091812|NCT02417974|100545870|FG001|COMPLETED|Overall Study||9||
48091813|NCT02417974|100545869|FG000|NOT COMPLETED|Overall Study||0||
48091814|NCT02417974|100545870|FG001|NOT COMPLETED|Overall Study||0||
48091815|NCT04326231|100545871|FG000|STARTED|Overall Study||10|10 subjects represents Child/Caregiver pair|
48091816|NCT04326231|100545871|FG000|COMPLETED|Overall Study||0|10 subjects represents Child/Caregiver pair|
48091817|NCT04326231|100545871|FG000|NOT COMPLETED|Overall Study||10||
48091818|NCT00927784|100545872|FG000|STARTED|Overall Study||8||
48091819|NCT00927784|100545873|FG001|STARTED|Overall Study||2||
48091820|NCT00927784|100545872|FG000|COMPLETED|Overall Study||6||
48091821|NCT00927784|100545873|FG001|COMPLETED|Overall Study||2||
48383846|NCT00772382|101269333|FG000|COMPLETED|Overall Study||61||
48383847|NCT00772382|101269333|FG000|NOT COMPLETED|Overall Study||55||
48383848|NCT00229203|101269334|FG000|STARTED|Overall Study||32||
48383849|NCT00229203|101269335|FG001|STARTED|Overall Study||19||
48383850|NCT00229203|101269334|FG000|COMPLETED|Overall Study||0||
48383851|NCT00229203|101269335|FG001|COMPLETED|Overall Study||0||
48383852|NCT00229203|101269334|FG000|NOT COMPLETED|Overall Study||32||
48383853|NCT00229203|101269335|FG001|NOT COMPLETED|Overall Study||19||
48383854|NCT00479557|101269336|FG000|STARTED|Overall Study||36||
48383855|NCT00479557|101269337|FG001|STARTED|Overall Study||61||
48091822|NCT00927784|100545872|FG000|NOT COMPLETED|Overall Study||2||
48091823|NCT00927784|100545873|FG001|NOT COMPLETED|Overall Study||0||
48091824|NCT01991067|100545874|FG000|STARTED|Overall Study||19||
48091825|NCT01991067|100545875|FG001|STARTED|Overall Study||15||
48091826|NCT01991067|100545874|FG000|COMPLETED|Overall Study||13||
48091827|NCT01991067|100545875|FG001|COMPLETED|Overall Study||10||
48091828|NCT01991067|100545874|FG000|NOT COMPLETED|Overall Study||6||
48091829|NCT01991067|100545875|FG001|NOT COMPLETED|Overall Study||5||
48091830|NCT00638378|100545876|FG000|STARTED|Overall Study||22||
48091831|NCT00638378|100545876|FG000|COMPLETED|Overall Study||0||
48091832|NCT00638378|100545876|FG000|NOT COMPLETED|Overall Study||22||
48091833|NCT03489720|100545877|FG000|STARTED|Overall Study||24||
48091834|NCT03489720|100545878|FG001|STARTED|Overall Study||22||
48091835|NCT03489720|100545877|FG000|COMPLETED|Overall Study||22||
48091836|NCT03489720|100545878|FG001|COMPLETED|Overall Study||22||
48091837|NCT03489720|100545877|FG000|NOT COMPLETED|Overall Study||2||
48091838|NCT03489720|100545878|FG001|NOT COMPLETED|Overall Study||0||
48091839|NCT04049123|100545879|FG000|STARTED|Period 1||5||
48091840|NCT04049123|100545880|FG001|STARTED|Period 1||5||
48091841|NCT04049123|100545881|FG002|STARTED|Period 1||5||
48091842|NCT04049123|100545879|FG000|Received at Least One Dose of Study Drug|Period 1||5||
48091843|NCT04049123|100545880|FG001|Received at Least One Dose of Study Drug|Period 1||5||
48091844|NCT04049123|100545881|FG002|Received at Least One Dose of Study Drug|Period 1||5||
48091845|NCT04049123|100545879|FG000|COMPLETED|Period 1||5||
48091846|NCT04049123|100545880|FG001|COMPLETED|Period 1||5||
48091847|NCT04049123|100545881|FG002|COMPLETED|Period 1||5||
48383856|NCT00479557|101269338|FG002|STARTED|Overall Study||40||
48383857|NCT00479557|101269339|FG003|STARTED|Overall Study||35||
48383858|NCT00479557|101269340|FG004|STARTED|Overall Study||12||
48383859|NCT00479557|101269341|FG005|STARTED|Overall Study||44||
48383860|NCT00479557|101269342|FG006|STARTED|Overall Study||17||
48383861|NCT00479557|101269336|FG000|Treated|Overall Study||36||
48383862|NCT00479557|101269337|FG001|Treated|Overall Study||60||
48383863|NCT00479557|101269338|FG002|Treated|Overall Study||40||
48091848|NCT04049123|100545879|FG000|NOT COMPLETED|Period 1||0||
48091849|NCT04049123|100545880|FG001|NOT COMPLETED|Period 1||0||
48091850|NCT04049123|100545881|FG002|NOT COMPLETED|Period 1||0||
48091851|NCT04049123|100545879|FG000|STARTED|Period 2||5||
48091852|NCT04049123|100545880|FG001|STARTED|Period 2||5||
48091853|NCT04049123|100545881|FG002|STARTED|Period 2||5||
48091854|NCT04049123|100545879|FG000|COMPLETED|Period 2||5||
48091855|NCT04049123|100545880|FG001|COMPLETED|Period 2||5||
48091856|NCT04049123|100545881|FG002|COMPLETED|Period 2||5||
48091857|NCT04049123|100545879|FG000|NOT COMPLETED|Period 2||0||
48091858|NCT04049123|100545880|FG001|NOT COMPLETED|Period 2||0||
48091859|NCT04049123|100545881|FG002|NOT COMPLETED|Period 2||0||
48091860|NCT04049123|100545879|FG000|STARTED|Period 3||5||
48383864|NCT00479557|101269339|FG003|Treated|Overall Study||35||
48091861|NCT04049123|100545880|FG001|STARTED|Period 3||5||
48091862|NCT04049123|100545881|FG002|STARTED|Period 3||5||
48091863|NCT04049123|100545879|FG000|COMPLETED|Period 3||5||
48091864|NCT04049123|100545880|FG001|COMPLETED|Period 3||5||
48091865|NCT04049123|100545881|FG002|COMPLETED|Period 3||5||
48091866|NCT04049123|100545879|FG000|NOT COMPLETED|Period 3||0||
48091867|NCT04049123|100545880|FG001|NOT COMPLETED|Period 3||0||
48091868|NCT04049123|100545881|FG002|NOT COMPLETED|Period 3||0||
48091869|NCT00166114|100545882|FG000|STARTED|Overall Study||21||
48091870|NCT00166114|100545883|FG001|STARTED|Overall Study||19||
48091871|NCT00166114|100545882|FG000|COMPLETED|Overall Study||7||
48091872|NCT00166114|100545883|FG001|COMPLETED|Overall Study||13||
48091873|NCT00166114|100545882|FG000|NOT COMPLETED|Overall Study||14||
48091874|NCT00166114|100545883|FG001|NOT COMPLETED|Overall Study||6||
48091875|NCT01183897|100545884|FG000|STARTED|Overall Study||31||
48091876|NCT01183897|100545884|FG000|COMPLETED|Overall Study||31||
48091877|NCT01183897|100545884|FG000|NOT COMPLETED|Overall Study||0||
48091878|NCT00176826|100548869|FG000|STARTED|Overall Study||22||
48091879|NCT00176826|100548869|FG000|COMPLETED|Overall Study||22||
48091880|NCT00176826|100548869|FG000|NOT COMPLETED|Overall Study||0||
48091881|NCT04216017|100548870|FG000|STARTED|Overall Study||5||
48091882|NCT04216017|100548871|FG001|STARTED|Overall Study||4||
48091883|NCT04216017|100548870|FG000|COMPLETED|Overall Study||4||
48091884|NCT04216017|100548871|FG001|COMPLETED|Overall Study||4||
48091885|NCT04216017|100548870|FG000|NOT COMPLETED|Overall Study||1||
48091886|NCT04216017|100548871|FG001|NOT COMPLETED|Overall Study||0||
48091887|NCT04814433|100548872|FG000|STARTED|Overall Study||12||
48091888|NCT04814433|100548873|FG001|STARTED|Overall Study||14||
48091889|NCT04814433|100548874|FG002|STARTED|Overall Study||9||
48091890|NCT04814433|100548875|FG003|STARTED|Overall Study||11||
48091891|NCT04814433|100548872|FG000|COMPLETED|Overall Study||8||
48091892|NCT04814433|100548873|FG001|COMPLETED|Overall Study||6||
48091893|NCT04814433|100548874|FG002|COMPLETED|Overall Study||5||
48091894|NCT04814433|100548875|FG003|COMPLETED|Overall Study||6||
48091895|NCT04814433|100548872|FG000|NOT COMPLETED|Overall Study||4||
48091896|NCT04814433|100548873|FG001|NOT COMPLETED|Overall Study||8||
48091897|NCT04814433|100548874|FG002|NOT COMPLETED|Overall Study||4||
48091898|NCT04814433|100548875|FG003|NOT COMPLETED|Overall Study||5||
48091899|NCT00278655|100548876|FG000|STARTED|Overall Study||21||
48091900|NCT00278655|100548876|FG000|COMPLETED|Overall Study||21||
48091901|NCT00278655|100548876|FG000|NOT COMPLETED|Overall Study||0||
48091902|NCT03021265|100548877|FG000|STARTED|Overall Study||676|Started are registered|
48091903|NCT03021265|100548877|FG000|COMPLETED|Overall Study||554||
48091904|NCT03021265|100548877|FG000|NOT COMPLETED|Overall Study||122||
48091905|NCT01148940|100548878|FG000|STARTED|Overall Study||7||
48091906|NCT01148940|100548879|FG001|STARTED|Overall Study||27||
48091907|NCT01148940|100548880|FG002|STARTED|Overall Study||0||
48091908|NCT01148940|100548878|FG000|COMPLETED|Overall Study||7||
48091909|NCT01148940|100548879|FG001|COMPLETED|Overall Study||27||
48091910|NCT01148940|100548880|FG002|COMPLETED|Overall Study||0||
48091911|NCT01148940|100548878|FG000|NOT COMPLETED|Overall Study||0||
48091912|NCT01148940|100548879|FG001|NOT COMPLETED|Overall Study||0||
48091913|NCT01148940|100548880|FG002|NOT COMPLETED|Overall Study||0||
48091914|NCT03141242|100548881|FG000|STARTED|Overall Study||55||
48091915|NCT03141242|100548882|FG001|STARTED|Overall Study||55||
48256701|NCT01086384|100947799|FG001|COMPLETED|Treatment Period||863||
48256702|NCT01086384|100947800|FG002|COMPLETED|Treatment Period||885||
48256703|NCT01086384|100947798|FG000|NOT COMPLETED|Treatment Period||0||
48091916|NCT03141242|100548881|FG000|Received Allocated Intervenion|Overall Study||44|Either attended group session or received mailed material, depending on arm|
48091917|NCT03141242|100548882|FG001|Received Allocated Intervenion|Overall Study||55|Either attended group session or received mailed material, depending on arm|
48091918|NCT03141242|100548881|FG000|6 Month Interview|Overall Study||51||
48091919|NCT03141242|100548882|FG001|6 Month Interview|Overall Study||49||
48091920|NCT03141242|100548881|FG000|COMPLETED|Overall Study||55|Received 12 month Chart Review|
48091921|NCT03141242|100548882|FG001|COMPLETED|Overall Study||55|Received 12 month Chart Review|
48091922|NCT03141242|100548881|FG000|NOT COMPLETED|Overall Study||0||
48091923|NCT03141242|100548882|FG001|NOT COMPLETED|Overall Study||0||
48091924|NCT01409564|100548883|FG000|STARTED|Overall Study||23||
48091925|NCT01409564|100548884|FG001|STARTED|Overall Study||23||
48091926|NCT01409564|100548883|FG000|COMPLETED|Overall Study||18||
48091927|NCT01409564|100548884|FG001|COMPLETED|Overall Study||18||
48091928|NCT01409564|100548883|FG000|NOT COMPLETED|Overall Study||5||
48091929|NCT01409564|100548884|FG001|NOT COMPLETED|Overall Study||5||
48091930|NCT01829230|100548885|FG000|STARTED|Overall Study||40||
48091931|NCT01829230|100548886|FG001|STARTED|Overall Study||42||
48091932|NCT01829230|100548885|FG000|COMPLETED|Overall Study||39||
48091933|NCT01829230|100548886|FG001|COMPLETED|Overall Study||38||
48091934|NCT01829230|100548885|FG000|NOT COMPLETED|Overall Study||1||
48091935|NCT01829230|100548886|FG001|NOT COMPLETED|Overall Study||4||
48091936|NCT02511184|100548887|FG000|STARTED|Overall Study||2||
48091937|NCT02511184|100548888|FG001|STARTED|Overall Study||7||
48091938|NCT02511184|100548887|FG000|COMPLETED|Overall Study||0||
48091939|NCT02511184|100548888|FG001|COMPLETED|Overall Study||0||
48091940|NCT02511184|100548887|FG000|NOT COMPLETED|Overall Study||2||
48091941|NCT02511184|100548888|FG001|NOT COMPLETED|Overall Study||7||
48091942|NCT02845453|100548889|FG000|STARTED|Overall Study||13||
48091943|NCT02845453|100548890|FG001|STARTED|Overall Study||11||
48091944|NCT02845453|100548889|FG000|Took One Dose of Study Medication|Overall Study||11||
48091945|NCT02845453|100548890|FG001|Took One Dose of Study Medication|Overall Study||10||
48091946|NCT02845453|100548889|FG000|Took One Week of Study Medication|Overall Study||10||
48091947|NCT02845453|100548890|FG001|Took One Week of Study Medication|Overall Study||9||
48091948|NCT02845453|100548889|FG000|COMPLETED|Overall Study||7||
48091949|NCT02845453|100548890|FG001|COMPLETED|Overall Study||6||
48091950|NCT02845453|100548889|FG000|NOT COMPLETED|Overall Study||6||
48091951|NCT02845453|100548890|FG001|NOT COMPLETED|Overall Study||5||
48091952|NCT03855280|100548891|FG000|STARTED|PK Phase||21||
48091953|NCT03855280|100548891|FG000|PK Phase|PK Phase||21||
48091954|NCT03855280|100548891|FG000|COMPLETED|PK Phase||21||
48091955|NCT03855280|100548891|FG000|NOT COMPLETED|PK Phase||0||
48091956|NCT03855280|100548891|FG000|STARTED|Treatment Phase||21||
48091957|NCT03855280|100548891|FG000|COMPLETED|Treatment Phase||19|21 subjects entered the Treatment Phase; 19 subjects completed the study (i.e., completion of PK assessments and a minimum of 50 ED).|
48091958|NCT03855280|100548891|FG000|NOT COMPLETED|Treatment Phase||2||
48091959|NCT03855280|100548891|FG000|STARTED|Continuation Phase||19||
48091960|NCT03855280|100548891|FG000|COMPLETED|Continuation Phase||16||
48091961|NCT03855280|100548891|FG000|NOT COMPLETED|Continuation Phase||3||
48091962|NCT03559257|100548892|FG000|STARTED|Double Blind Treatment Period||230||
48091963|NCT03559257|100548893|FG001|STARTED|Double Blind Treatment Period||233||
48091964|NCT03559257|100548892|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Period||230||
48091965|NCT03559257|100548893|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Period||232||
48091966|NCT03559257|100548892|FG000|COMPLETED|Double Blind Treatment Period||226||
48091967|NCT03559257|100548893|FG001|COMPLETED|Double Blind Treatment Period||225||
48091968|NCT03559257|100548892|FG000|NOT COMPLETED|Double Blind Treatment Period||4||
48091969|NCT03559257|100548893|FG001|NOT COMPLETED|Double Blind Treatment Period||8||
48091970|NCT03559257|100548892|FG000|STARTED|Open-label Treatment Period||225||
48091971|NCT03559257|100548893|FG001|STARTED|Open-label Treatment Period||224||
48091972|NCT03559257|100548892|FG000|COMPLETED|Open-label Treatment Period||215||
48091973|NCT03559257|100548893|FG001|COMPLETED|Open-label Treatment Period||217||
48091974|NCT03559257|100548892|FG000|NOT COMPLETED|Open-label Treatment Period||10||
48091975|NCT03559257|100548893|FG001|NOT COMPLETED|Open-label Treatment Period||7||
48091976|NCT03447990|100548894|FG000|STARTED|Overall Study||8|Started = Randomized and treated|
48091977|NCT03447990|100548895|FG001|STARTED|Overall Study||4|Started = Randomized and treated|
48091978|NCT03447990|100548896|FG002|STARTED|Overall Study||6|Started = Randomized and treated|
48091979|NCT03447990|100548897|FG003|STARTED|Overall Study||9|Started = Randomized and treated|
48091980|NCT03447990|100548898|FG004|STARTED|Overall Study||9|Started = Randomized and treated|
48091981|NCT03447990|100548899|FG005|STARTED|Overall Study||6|Started = Randomized and treated|
48091982|NCT03447990|100548900|FG006|STARTED|Overall Study||10|Started = Randomized and treated|
48256704|NCT01086384|100947799|FG001|NOT COMPLETED|Treatment Period||148||
48256705|NCT01086384|100947800|FG002|NOT COMPLETED|Treatment Period||124||
48256706|NCT02208037|100947801|FG000|STARTED|Overall Study||93||
48256707|NCT02208037|100947802|FG001|STARTED|Overall Study||93||
48256708|NCT02208037|100947803|FG002|STARTED|Overall Study||93||
48256709|NCT02208037|100947801|FG000|COMPLETED|Overall Study||89||
48256710|NCT02208037|100947802|FG001|COMPLETED|Overall Study||92||
48256711|NCT02208037|100947803|FG002|COMPLETED|Overall Study||92||
48256712|NCT02208037|100947801|FG000|NOT COMPLETED|Overall Study||4||
48256713|NCT02208037|100947802|FG001|NOT COMPLETED|Overall Study||1||
48256714|NCT02208037|100947803|FG002|NOT COMPLETED|Overall Study||1||
48592699|NCT01877382|101783156|FG006|NOT COMPLETED|Dose Expansion||0||
48091983|NCT03447990|100548894|FG000|Completed Blinded Treatment Period A|Overall Study||8|Blinded treatment period A planned in SAD Cohort 1 and 2|
48091984|NCT03447990|100548895|FG001|Completed Blinded Treatment Period A|Overall Study||4|Blinded treatment period A planned in SAD Cohort 1 and 2|
48091985|NCT03447990|100548896|FG002|Completed Blinded Treatment Period A|Overall Study||0|Blinded treatment period A planned in SAD Cohort 1 and 2|
48091986|NCT03447990|100548897|FG003|Completed Blinded Treatment Period A|Overall Study||0|Blinded treatment period A planned in SAD Cohort 1 and 2|
48091987|NCT03447990|100548898|FG004|Completed Blinded Treatment Period A|Overall Study||0|Blinded treatment period A planned in SAD Cohort 1 and 2|
48091988|NCT03447990|100548899|FG005|Completed Blinded Treatment Period A|Overall Study||0|Blinded treatment period A planned in SAD Cohort 1 and 2|
48091989|NCT03447990|100548900|FG006|Completed Blinded Treatment Period A|Overall Study||0|Blinded treatment period A planned in SAD Cohort 1 and 2|
48091990|NCT03447990|100548894|FG000|Completed Blinded Treatment Period B|Overall Study||8|Blinded treatment period B planned in SAD Cohort 1 and 2|
48091991|NCT03447990|100548895|FG001|Completed Blinded Treatment Period B|Overall Study||4|Blinded treatment period B planned in SAD Cohort 1 and 2|
48091992|NCT03447990|100548896|FG002|Completed Blinded Treatment Period B|Overall Study||0|Blinded treatment period B planned in SAD Cohort 1 and 2|
48091993|NCT03447990|100548897|FG003|Completed Blinded Treatment Period B|Overall Study||0|Blinded treatment period B planned in SAD Cohort 1 and 2|
48091994|NCT03447990|100548898|FG004|Completed Blinded Treatment Period B|Overall Study||0|Blinded treatment period B planned in SAD Cohort 1 and 2|
48091995|NCT03447990|100548899|FG005|Completed Blinded Treatment Period B|Overall Study||0|Blinded treatment period B planned in SAD Cohort 1 and 2|
48091996|NCT03447990|100548900|FG006|Completed Blinded Treatment Period B|Overall Study||0|Blinded treatment period B planned in SAD Cohort 1 and 2|
48091997|NCT03447990|100548894|FG000|Completed Blinded Treatment Period C|Overall Study||8|Blinded treatment period C planned in SAD Cohort 1 and 2|
48091998|NCT03447990|100548895|FG001|Completed Blinded Treatment Period C|Overall Study||4|Blinded treatment period C planned in SAD Cohort 1 and 2|
48091999|NCT03447990|100548896|FG002|Completed Blinded Treatment Period C|Overall Study||0|Blinded treatment period C planned in SAD Cohort 1 and 2|
48092000|NCT03447990|100548897|FG003|Completed Blinded Treatment Period C|Overall Study||0|Blinded treatment period C planned in SAD Cohort 1 and 2|
48092001|NCT03447990|100548898|FG004|Completed Blinded Treatment Period C|Overall Study||0|Blinded treatment period C planned in SAD Cohort 1 and 2|
48092002|NCT03447990|100548899|FG005|Completed Blinded Treatment Period C|Overall Study||0|Blinded treatment period C planned in SAD Cohort 1 and 2|
48256715|NCT01321723|100947804|FG000|STARTED|Overall Study||32||
48256716|NCT01321723|100947805|FG001|STARTED|Overall Study||33||
48256717|NCT01321723|100947806|FG002|STARTED|Overall Study||32||
48256718|NCT01321723|100947804|FG000|COMPLETED|Overall Study||27||
48256719|NCT01321723|100947805|FG001|COMPLETED|Overall Study||28||
48256720|NCT01321723|100947806|FG002|COMPLETED|Overall Study||28||
48256721|NCT01321723|100947804|FG000|NOT COMPLETED|Overall Study||5||
48256722|NCT01321723|100947805|FG001|NOT COMPLETED|Overall Study||5||
48256723|NCT01321723|100947806|FG002|NOT COMPLETED|Overall Study||4||
48256724|NCT00719212|100947807|FG000|STARTED|Overall Study||61||
48256725|NCT00719212|100947807|FG000|COMPLETED|Overall Study||17||
48256726|NCT00719212|100947807|FG000|NOT COMPLETED|Overall Study||44||
48256727|NCT05239598|100947808|FG000|STARTED|Phase I||21||
48256728|NCT05239598|100947809|FG001|STARTED|Phase I||19||
48687679|NCT01484496|102017141|FG000|NOT COMPLETED|Period 1||66||
48687680|NCT01484496|102017142|FG001|NOT COMPLETED|Period 1||93||
48687681|NCT01484496|102017143|FG002|NOT COMPLETED|Period 1||0||
48687682|NCT01484496|102017144|FG003|NOT COMPLETED|Period 1||0||
48256729|NCT05239598|100947808|FG000|COMPLETED|Phase I||21||
48256730|NCT05239598|100947809|FG001|COMPLETED|Phase I||19||
48256731|NCT05239598|100947808|FG000|NOT COMPLETED|Phase I||0||
48256732|NCT05239598|100947809|FG001|NOT COMPLETED|Phase I||0||
48256733|NCT05239598|100947808|FG000|STARTED|Phase II (Open Label)||37||
48256734|NCT05239598|100947809|FG001|STARTED|Phase II (Open Label)||0||
48256735|NCT05239598|100947808|FG000|COMPLETED|Phase II (Open Label)||35||
48256736|NCT05239598|100947809|FG001|COMPLETED|Phase II (Open Label)||0||
48383865|NCT00479557|101269340|FG004|Treated|Overall Study||12||
48383866|NCT00479557|101269341|FG005|Treated|Overall Study||44||
48383867|NCT00479557|101269342|FG006|Treated|Overall Study||17||
48383868|NCT00479557|101269336|FG000|COMPLETED|Overall Study||26||
48383869|NCT00479557|101269337|FG001|COMPLETED|Overall Study||51||
48383870|NCT00479557|101269338|FG002|COMPLETED|Overall Study||32||
48383871|NCT00479557|101269339|FG003|COMPLETED|Overall Study||30||
48383872|NCT00479557|101269340|FG004|COMPLETED|Overall Study||8||
48383873|NCT00479557|101269341|FG005|COMPLETED|Overall Study||31||
48383874|NCT00479557|101269342|FG006|COMPLETED|Overall Study||15||
48383875|NCT00479557|101269336|FG000|NOT COMPLETED|Overall Study||10||
48541643|NCT03095638|101662793|FG004|NOT COMPLETED|P1: Period 1 (4 Days)||0||
48541644|NCT03095638|101662794|FG005|NOT COMPLETED|P1: Period 1 (4 Days)||0||
48541645|NCT03095638|101662795|FG006|NOT COMPLETED|P1: Period 1 (4 Days)||0||
48541646|NCT03095638|101662796|FG007|NOT COMPLETED|P1: Period 1 (4 Days)||0||
48541647|NCT03095638|101662789|FG000|STARTED|P1: Period 1, Washout (7 [-4 Hours])||7||
48541648|NCT03095638|101662790|FG001|STARTED|P1: Period 1, Washout (7 [-4 Hours])||7||
48541649|NCT03095638|101662791|FG002|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0||
48541650|NCT03095638|101662792|FG003|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0||
48541651|NCT03095638|101662793|FG004|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0||
48541652|NCT03095638|101662794|FG005|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0||
48541653|NCT03095638|101662795|FG006|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0||
48541654|NCT03095638|101662796|FG007|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0||
48541655|NCT03095638|101662789|FG000|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||7||
48541656|NCT03095638|101662790|FG001|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||7||
48541657|NCT03095638|101662791|FG002|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0||
48541658|NCT03095638|101662792|FG003|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0||
48541659|NCT03095638|101662793|FG004|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0||
48541660|NCT03095638|101662794|FG005|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0||
48256737|NCT05239598|100947808|FG000|NOT COMPLETED|Phase II (Open Label)||2||
48256738|NCT05239598|100947809|FG001|NOT COMPLETED|Phase II (Open Label)||0||
48256739|NCT00661544|100947810|FG000|STARTED|Overall Study||48||
48256740|NCT00661544|100947810|FG000|COMPLETED|Overall Study||48||
48383876|NCT00479557|101269337|FG001|NOT COMPLETED|Overall Study||10||
48383877|NCT00479557|101269338|FG002|NOT COMPLETED|Overall Study||8||
48541661|NCT03095638|101662795|FG006|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0||
48687683|NCT01484496|102017141|FG000|STARTED|Period 2||0||
48256741|NCT00661544|100947810|FG000|NOT COMPLETED|Overall Study||0||
48256742|NCT00236184|100947811|FG000|STARTED|Overall Study||310||
48256743|NCT00236184|100947812|FG001|STARTED|Overall Study||319||
48256744|NCT00236184|100947811|FG000|COMPLETED|Overall Study||292||
48256745|NCT00236184|100947812|FG001|COMPLETED|Overall Study||308||
48256746|NCT00236184|100947811|FG000|NOT COMPLETED|Overall Study||18||
48256747|NCT00236184|100947812|FG001|NOT COMPLETED|Overall Study||11||
48256748|NCT02720185|100947813|FG000|STARTED|Overall Study||5||
48256749|NCT02720185|100947813|FG000|COMPLETED|Overall Study||4||
48256750|NCT02720185|100947813|FG000|NOT COMPLETED|Overall Study||1||
48256751|NCT01127321|100947814|FG000|STARTED|Overall Study||3||
48256752|NCT01127321|100947815|FG001|STARTED|Overall Study||1||
48256753|NCT01127321|100947816|FG002|STARTED|Overall Study||1||
48256754|NCT01127321|100947817|FG003|STARTED|Overall Study||7||
48256755|NCT01127321|100947818|FG004|STARTED|Overall Study||5||
48256756|NCT01127321|100947814|FG000|COMPLETED|Overall Study||3||
48256757|NCT01127321|100947815|FG001|COMPLETED|Overall Study||1||
48256758|NCT01127321|100947816|FG002|COMPLETED|Overall Study||1||
48256759|NCT01127321|100947817|FG003|COMPLETED|Overall Study||7||
48256760|NCT01127321|100947818|FG004|COMPLETED|Overall Study||5||
48256761|NCT01127321|100947814|FG000|NOT COMPLETED|Overall Study||0||
48256762|NCT01127321|100947815|FG001|NOT COMPLETED|Overall Study||0||
48256763|NCT01127321|100947816|FG002|NOT COMPLETED|Overall Study||0||
48256764|NCT01127321|100947817|FG003|NOT COMPLETED|Overall Study||0||
48256765|NCT01127321|100947818|FG004|NOT COMPLETED|Overall Study||0||
48256766|NCT05672771|100947819|FG000|STARTED|Overall Study||21||
48256767|NCT05672771|100947820|FG001|STARTED|Overall Study||25||
48256768|NCT05672771|100947821|FG002|STARTED|Overall Study||22||
48256769|NCT05672771|100947822|FG003|STARTED|Overall Study||22||
48256770|NCT05672771|100947819|FG000|COMPLETED|Overall Study||19||
48256771|NCT05672771|100947820|FG001|COMPLETED|Overall Study||22||
48256772|NCT05672771|100947821|FG002|COMPLETED|Overall Study||21||
48256773|NCT05672771|100947822|FG003|COMPLETED|Overall Study||18||
48687684|NCT01484496|102017142|FG001|STARTED|Period 2||0||
48687685|NCT01484496|102017143|FG002|STARTED|Period 2||206||
48687686|NCT01484496|102017144|FG003|STARTED|Period 2||456||
48687687|NCT01484496|102017141|FG000|COMPLETED|Period 2||0||
48687688|NCT01484496|102017142|FG001|COMPLETED|Period 2||0||
48687689|NCT01484496|102017143|FG002|COMPLETED|Period 2||191||
48687690|NCT01484496|102017144|FG003|COMPLETED|Period 2||434||
48092003|NCT03447990|100548900|FG006|Completed Blinded Treatment Period C|Overall Study||0|Blinded treatment period C planned in SAD Cohort 1 and 2|
48092004|NCT03447990|100548894|FG000|Completed Optional Open-Label Treatment Period D|Overall Study||6|Optional open-label treatment period D planned in SAD Cohort 1|
48092005|NCT03447990|100548895|FG001|Completed Optional Open-Label Treatment Period D|Overall Study||0|Optional open-label treatment period D planned in SAD Cohort 1|
48092006|NCT03447990|100548896|FG002|Completed Optional Open-Label Treatment Period D|Overall Study||0|Optional open-label treatment period D planned in SAD Cohort 1|
48092007|NCT03447990|100548897|FG003|Completed Optional Open-Label Treatment Period D|Overall Study||0|Optional open-label treatment period D planned in SAD Cohort 1|
48092008|NCT03447990|100548898|FG004|Completed Optional Open-Label Treatment Period D|Overall Study||0|Optional open-label treatment period D planned in SAD Cohort 1|
48141382|NCT01297062|100670411|FG001|NOT COMPLETED|Overall Study||1||
48256774|NCT05672771|100947819|FG000|NOT COMPLETED|Overall Study||2||
48256775|NCT05672771|100947820|FG001|NOT COMPLETED|Overall Study||3||
48256776|NCT05672771|100947821|FG002|NOT COMPLETED|Overall Study||1||
48687691|NCT01484496|102017141|FG000|NOT COMPLETED|Period 2||0||
48687692|NCT01484496|102017142|FG001|NOT COMPLETED|Period 2||0||
48687693|NCT01484496|102017143|FG002|NOT COMPLETED|Period 2||15||
48687694|NCT01484496|102017144|FG003|NOT COMPLETED|Period 2||22||
48687695|NCT00418093|102020032|FG000|STARTED|Overall Study||19||
48687696|NCT00418093|102020032|FG000|Completed Study|Overall Study||19||
48687697|NCT00418093|102020032|FG000|COMPLETED|Overall Study||19||
48687698|NCT00418093|102020032|FG000|NOT COMPLETED|Overall Study||0||
48687699|NCT01479764|102020033|FG000|STARTED|Randomized||76||
48687700|NCT01479764|102020034|FG001|STARTED|Randomized||78||
48687701|NCT01479764|102020033|FG000|COMPLETED|Randomized||74||
48687702|NCT01479764|102020034|FG001|COMPLETED|Randomized||77||
48687703|NCT01479764|102020033|FG000|NOT COMPLETED|Randomized||2||
48687704|NCT01479764|102020034|FG001|NOT COMPLETED|Randomized||1||
48687705|NCT01479764|102020033|FG000|STARTED|Treated||74||
48687706|NCT01479764|102020034|FG001|STARTED|Treated||77||
48687707|NCT01479764|102020033|FG000|COMPLETED|Treated||74||
48687708|NCT01479764|102020034|FG001|COMPLETED|Treated||75||
48256777|NCT05672771|100947822|FG003|NOT COMPLETED|Overall Study||4||
48256778|NCT00381888|100947823|FG000|STARTED|Overall Study||44||
48256779|NCT00381888|100947823|FG000|COMPLETED|Overall Study||27||
48256780|NCT00381888|100947823|FG000|NOT COMPLETED|Overall Study||17||
48256781|NCT00345800|100947824|FG000|STARTED|Overall Study||25||
48256782|NCT00345800|100947824|FG000|COMPLETED|Overall Study||25||
48256783|NCT00345800|100947824|FG000|NOT COMPLETED|Overall Study||0||
48256784|NCT00467298|100947825|FG000|STARTED|Overall Study||46||
48256785|NCT00467298|100947826|FG001|STARTED|Overall Study||44||
48256786|NCT00467298|100947825|FG000|COMPLETED|Overall Study||42||
48256787|NCT00467298|100947826|FG001|COMPLETED|Overall Study||38||
48687709|NCT01479764|102020033|FG000|NOT COMPLETED|Treated||0||
48687710|NCT01479764|102020034|FG001|NOT COMPLETED|Treated||2||
48383878|NCT00479557|101269339|FG003|NOT COMPLETED|Overall Study||5||
48383879|NCT00479557|101269340|FG004|NOT COMPLETED|Overall Study||4||
48383880|NCT00479557|101269341|FG005|NOT COMPLETED|Overall Study||13||
48383881|NCT00479557|101269342|FG006|NOT COMPLETED|Overall Study||2||
48383882|NCT03814590|101269343|FG000|STARTED|Overall Study||12||
48383883|NCT03814590|101269344|FG001|STARTED|Overall Study||12||
48383884|NCT03814590|101269345|FG002|STARTED|Overall Study||12||
48383885|NCT03814590|101269346|FG003|STARTED|Overall Study||12||
48383886|NCT03814590|101269347|FG004|STARTED|Overall Study||101||
48383887|NCT03814590|101269348|FG005|STARTED|Overall Study||97||
48383888|NCT03814590|101269349|FG006|STARTED|Overall Study||100||
48383889|NCT03814590|101269350|FG007|STARTED|Overall Study||101||
48383890|NCT03814590|101269351|FG008|STARTED|Overall Study||101||
48383891|NCT03814590|101269352|FG009|STARTED|Overall Study||100||
48383892|NCT03814590|101269353|FG010|STARTED|Overall Study||103||
48383893|NCT03814590|101269354|FG011|STARTED|Overall Study||100||
48383894|NCT03814590|101269355|FG012|STARTED|Overall Study||101||
48383895|NCT03814590|101269356|FG013|STARTED|Overall Study||101||
48383896|NCT03814590|101269343|FG000|COMPLETED|Overall Study||12||
48383897|NCT03814590|101269344|FG001|COMPLETED|Overall Study||10||
48687711|NCT00604552|102020035|FG000|STARTED|Overall Study||189||
48092009|NCT03447990|100548899|FG005|Completed Optional Open-Label Treatment Period D|Overall Study||0|Optional open-label treatment period D planned in SAD Cohort 1|
48092010|NCT03447990|100548900|FG006|Completed Optional Open-Label Treatment Period D|Overall Study||0|Optional open-label treatment period D planned in SAD Cohort 1|
48092011|NCT03447990|100548894|FG000|COMPLETED|Overall Study||8|Completed = completed treatment|
48092012|NCT03447990|100548895|FG001|COMPLETED|Overall Study||4|Completed = completed treatment|
48092013|NCT03447990|100548896|FG002|COMPLETED|Overall Study||6|Completed = completed treatment|
48092014|NCT03447990|100548897|FG003|COMPLETED|Overall Study||9|Completed = completed treatment|
48092015|NCT03447990|100548898|FG004|COMPLETED|Overall Study||9|Completed = completed treatment|
48383898|NCT03814590|101269345|FG002|COMPLETED|Overall Study||11||
48383899|NCT03814590|101269346|FG003|COMPLETED|Overall Study||12||
48383900|NCT03814590|101269347|FG004|COMPLETED|Overall Study||100||
48383901|NCT03814590|101269348|FG005|COMPLETED|Overall Study||92||
48383902|NCT03814590|101269349|FG006|COMPLETED|Overall Study||97||
48383903|NCT03814590|101269350|FG007|COMPLETED|Overall Study||95||
48687712|NCT00604552|102020036|FG001|STARTED|Overall Study||160||
48687713|NCT00604552|102020035|FG000|COMPLETED|Overall Study||189||
48687714|NCT00604552|102020036|FG001|COMPLETED|Overall Study||160||
48687715|NCT00604552|102020035|FG000|NOT COMPLETED|Overall Study||0||
48687716|NCT00604552|102020036|FG001|NOT COMPLETED|Overall Study||0||
48687717|NCT02477527|102020037|FG000|STARTED|Overall Study||27||
48687718|NCT02477527|102020037|FG000|COMPLETED|Overall Study||21||
48687719|NCT02477527|102020037|FG000|NOT COMPLETED|Overall Study||6||
48687720|NCT01941927|102020038|FG000|STARTED|Overall Study||10||
48687721|NCT01941927|102020039|FG001|STARTED|Overall Study||10||
48687722|NCT01941927|102020038|FG000|COMPLETED|Overall Study||10||
48687723|NCT01941927|102020039|FG001|COMPLETED|Overall Study||10||
48687724|NCT01941927|102020038|FG000|NOT COMPLETED|Overall Study||0||
48687725|NCT01941927|102020039|FG001|NOT COMPLETED|Overall Study||0||
48687726|NCT00628498|102020040|FG000|STARTED|Overall Study||1206||
48687727|NCT00628498|102020040|FG000|COMPLETED|Overall Study||1154||
48687728|NCT00628498|102020040|FG000|NOT COMPLETED|Overall Study||52||
48092016|NCT03447990|100548899|FG005|COMPLETED|Overall Study||6|Completed = completed treatment|
48092017|NCT03447990|100548900|FG006|COMPLETED|Overall Study||9|Completed = completed treatment|
48092018|NCT03447990|100548894|FG000|NOT COMPLETED|Overall Study||0||
48092019|NCT03447990|100548895|FG001|NOT COMPLETED|Overall Study||0||
48092020|NCT03447990|100548896|FG002|NOT COMPLETED|Overall Study||0||
48092021|NCT03447990|100548897|FG003|NOT COMPLETED|Overall Study||0||
48092022|NCT03447990|100548898|FG004|NOT COMPLETED|Overall Study||0||
48092023|NCT03447990|100548899|FG005|NOT COMPLETED|Overall Study||0||
48092024|NCT03447990|100548900|FG006|NOT COMPLETED|Overall Study||1||
48092025|NCT05620563|100548901|FG000|STARTED|Overall Study||98||
48092026|NCT05620563|100548902|FG001|STARTED|Overall Study||49||
48092027|NCT05620563|100548901|FG000|Received at Least One Dose of Study Drug|Overall Study||98||
48092028|NCT05620563|100548902|FG001|Received at Least One Dose of Study Drug|Overall Study||48||
48383904|NCT03814590|101269351|FG008|COMPLETED|Overall Study||101||
48383905|NCT03814590|101269352|FG009|COMPLETED|Overall Study||95||
48383906|NCT03814590|101269353|FG010|COMPLETED|Overall Study||100||
48383907|NCT03814590|101269354|FG011|COMPLETED|Overall Study||100||
48383908|NCT03814590|101269355|FG012|COMPLETED|Overall Study||97||
48687729|NCT00809926|102020041|FG000|STARTED|Overall Study||232||
48687730|NCT00809926|102020042|FG001|STARTED|Overall Study||219||
48687731|NCT00809926|102020041|FG000|COMPLETED|Overall Study||201||
48687732|NCT00809926|102020042|FG001|COMPLETED|Overall Study||196||
48092029|NCT05620563|100548901|FG000|COMPLETED|Overall Study||91||
48092030|NCT05620563|100548902|FG001|COMPLETED|Overall Study||40||
48383909|NCT03814590|101269356|FG013|COMPLETED|Overall Study||98||
48383910|NCT03814590|101269343|FG000|NOT COMPLETED|Overall Study||0||
48383911|NCT03814590|101269344|FG001|NOT COMPLETED|Overall Study||2||
48383912|NCT03814590|101269345|FG002|NOT COMPLETED|Overall Study||1||
48687733|NCT00809926|102020041|FG000|NOT COMPLETED|Overall Study||31||
48687734|NCT00809926|102020042|FG001|NOT COMPLETED|Overall Study||23||
48687735|NCT01977898|102020043|FG000|STARTED|Overall Study||28||
48687736|NCT01977898|102020044|FG001|STARTED|Overall Study||35||
48687737|NCT01977898|102020043|FG000|COMPLETED|Overall Study||27||
48687738|NCT01977898|102020044|FG001|COMPLETED|Overall Study||34||
48687739|NCT01977898|102020043|FG000|NOT COMPLETED|Overall Study||1||
48687740|NCT01977898|102020044|FG001|NOT COMPLETED|Overall Study||1||
48687741|NCT02931838|102020045|FG000|STARTED|Overall Study||45||
48687742|NCT02931838|102020046|FG001|STARTED|Overall Study||44||
48687743|NCT02931838|102020047|FG002|STARTED|Overall Study||44||
48687744|NCT02931838|102020048|FG003|STARTED|Overall Study||45||
48687745|NCT02931838|102020049|FG004|STARTED|Overall Study||45||
48687746|NCT02931838|102020050|FG005|STARTED|Overall Study||44||
48687747|NCT02931838|102020045|FG000|COMPLETED|Overall Study||31||
48687748|NCT02931838|102020046|FG001|COMPLETED|Overall Study||34||
48687749|NCT02931838|102020047|FG002|COMPLETED|Overall Study||36||
48687750|NCT02931838|102020048|FG003|COMPLETED|Overall Study||42||
48092031|NCT05620563|100548901|FG000|NOT COMPLETED|Overall Study||7||
48092032|NCT05620563|100548902|FG001|NOT COMPLETED|Overall Study||9||
48092033|NCT01214356|100548903|FG000|STARTED|Overall Study||27||
48092034|NCT01214356|100548904|FG001|STARTED|Overall Study||27||
48092035|NCT01214356|100548903|FG000|COMPLETED|Overall Study||10||
48092036|NCT01214356|100548904|FG001|COMPLETED|Overall Study||13||
48092037|NCT01214356|100548903|FG000|NOT COMPLETED|Overall Study||17||
48092038|NCT01214356|100548904|FG001|NOT COMPLETED|Overall Study||14||
48092039|NCT00911495|100548905|FG000|STARTED|Overall Study||15||
48092040|NCT00911495|100548905|FG000|COMPLETED|Overall Study||14||
48092041|NCT00911495|100548905|FG000|NOT COMPLETED|Overall Study||1||
48092042|NCT00705081|100548906|FG000|STARTED|Overall Study||255||
48092043|NCT00705081|100548907|FG001|STARTED|Overall Study||198||
48092044|NCT00705081|100548906|FG000|COMPLETED|Overall Study||255||
48092045|NCT00705081|100548907|FG001|COMPLETED|Overall Study||198||
48092046|NCT00705081|100548906|FG000|NOT COMPLETED|Overall Study||0||
48092047|NCT00705081|100548907|FG001|NOT COMPLETED|Overall Study||0||
48092048|NCT00680043|100548908|FG000|STARTED|Overall Study||39||
48092049|NCT00680043|100548909|FG001|STARTED|Overall Study||37||
48092050|NCT00680043|100548910|FG002|STARTED|Overall Study||38||
48092051|NCT00680043|100548908|FG000|COMPLETED|Overall Study||37||
48092052|NCT00680043|100548909|FG001|COMPLETED|Overall Study||36||
48092053|NCT00680043|100548910|FG002|COMPLETED|Overall Study||34||
48092054|NCT00680043|100548908|FG000|NOT COMPLETED|Overall Study||2||
48092055|NCT00680043|100548909|FG001|NOT COMPLETED|Overall Study||1||
48092056|NCT00680043|100548910|FG002|NOT COMPLETED|Overall Study||4||
48092057|NCT03235154|100548911|FG000|STARTED|Overall Study||11||
48092058|NCT03235154|100548911|FG000|Completed Epclusa. Treatment|Overall Study||8||
48092059|NCT03235154|100548911|FG000|12-wk Post-treatment HCV RNA Measured|Overall Study||7||
48256788|NCT00467298|100947825|FG000|NOT COMPLETED|Overall Study||4||
48256789|NCT00467298|100947826|FG001|NOT COMPLETED|Overall Study||6||
48256790|NCT00843115|100947827|FG000|STARTED|Overall Study||370||
48256791|NCT00843115|100947827|FG000|COMPLETED|Overall Study||304||
48256792|NCT00843115|100947827|FG000|NOT COMPLETED|Overall Study||66||
48256793|NCT01149876|100947828|FG000|STARTED|Overall Study||21||
48256794|NCT01149876|100947829|FG001|STARTED|Overall Study||20||
48256795|NCT01149876|100947830|FG002|STARTED|Overall Study||21||
48256796|NCT01149876|100947831|FG003|STARTED|Overall Study||18||
48256797|NCT01149876|100947828|FG000|COMPLETED|Overall Study||20||
48256798|NCT01149876|100947829|FG001|COMPLETED|Overall Study||20||
48256799|NCT01149876|100947830|FG002|COMPLETED|Overall Study||20||
48256800|NCT01149876|100947831|FG003|COMPLETED|Overall Study||18||
48256801|NCT01149876|100947828|FG000|NOT COMPLETED|Overall Study||1||
48256802|NCT01149876|100947829|FG001|NOT COMPLETED|Overall Study||0||
48687751|NCT02931838|102020049|FG004|COMPLETED|Overall Study||39||
48687752|NCT02931838|102020050|FG005|COMPLETED|Overall Study||42||
48687753|NCT02931838|102020045|FG000|NOT COMPLETED|Overall Study||14||
48687754|NCT02931838|102020046|FG001|NOT COMPLETED|Overall Study||10||
48092060|NCT03235154|100548911|FG000|COMPLETED|Overall Study||7||
48092061|NCT03235154|100548911|FG000|NOT COMPLETED|Overall Study||4||
48092062|NCT01751867|100548912|FG000|STARTED|Overall Study||36||
48092063|NCT01751867|100548913|FG001|STARTED|Overall Study||99||
48092064|NCT01751867|100548912|FG000|Treated|Overall Study||34||
48092065|NCT01751867|100548913|FG001|Treated|Overall Study||98||
48092066|NCT01751867|100548912|FG000|COMPLETED|Overall Study||0||
48092067|NCT01751867|100548913|FG001|COMPLETED|Overall Study||0||
48092068|NCT01751867|100548912|FG000|NOT COMPLETED|Overall Study||36||
48092069|NCT01751867|100548913|FG001|NOT COMPLETED|Overall Study||99||
48092070|NCT02738151|100548914|FG000|STARTED|Overall Study||466||
48092071|NCT02738151|100548915|FG001|STARTED|Overall Study||463||
48092072|NCT02738151|100548914|FG000|Treated|Overall Study||462||
48256803|NCT01149876|100947830|FG002|NOT COMPLETED|Overall Study||1||
48687755|NCT02931838|102020047|FG002|NOT COMPLETED|Overall Study||8||
48687756|NCT02931838|102020048|FG003|NOT COMPLETED|Overall Study||3||
48687757|NCT02931838|102020049|FG004|NOT COMPLETED|Overall Study||6||
48687758|NCT02931838|102020050|FG005|NOT COMPLETED|Overall Study||2||
48256804|NCT01149876|100947831|FG003|NOT COMPLETED|Overall Study||0||
48256805|NCT00241969|100947832|FG000|STARTED|Overall Study||36||
48256806|NCT00241969|100947833|FG001|STARTED|Overall Study||42||
48256807|NCT00241969|100947832|FG000|COMPLETED|Overall Study||36||
48256808|NCT00241969|100947833|FG001|COMPLETED|Overall Study||42||
48256809|NCT00241969|100947832|FG000|NOT COMPLETED|Overall Study||0||
48256810|NCT00241969|100947833|FG001|NOT COMPLETED|Overall Study||0||
48256811|NCT04191148|100947834|FG000|STARTED|Overall Study||24||
48256812|NCT04191148|100947835|FG001|STARTED|Overall Study||12||
48256813|NCT04191148|100947834|FG000|COMPLETED|Overall Study||22||
48256814|NCT04191148|100947835|FG001|COMPLETED|Overall Study||12||
48383913|NCT03814590|101269346|FG003|NOT COMPLETED|Overall Study||0||
48383914|NCT03814590|101269347|FG004|NOT COMPLETED|Overall Study||1||
48383915|NCT03814590|101269348|FG005|NOT COMPLETED|Overall Study||5||
48383916|NCT03814590|101269349|FG006|NOT COMPLETED|Overall Study||3||
48383917|NCT03814590|101269350|FG007|NOT COMPLETED|Overall Study||6||
48383918|NCT03814590|101269351|FG008|NOT COMPLETED|Overall Study||0||
48383919|NCT03814590|101269352|FG009|NOT COMPLETED|Overall Study||5||
48383920|NCT03814590|101269353|FG010|NOT COMPLETED|Overall Study||3||
48383921|NCT03814590|101269354|FG011|NOT COMPLETED|Overall Study||0||
48383922|NCT03814590|101269355|FG012|NOT COMPLETED|Overall Study||4||
48383923|NCT03814590|101269356|FG013|NOT COMPLETED|Overall Study||3||
48383924|NCT05027516|101269357|FG000|STARTED|Overall Study||22||
48383925|NCT05027516|101269358|FG001|STARTED|Overall Study||20||
48383926|NCT05027516|101269357|FG000|COMPLETED|Overall Study||22||
48383927|NCT05027516|101269358|FG001|COMPLETED|Overall Study||20||
48383928|NCT05027516|101269357|FG000|NOT COMPLETED|Overall Study||0||
48383929|NCT05027516|101269358|FG001|NOT COMPLETED|Overall Study||0||
48383930|NCT01170117|101269359|FG000|STARTED|Overall Study||77||
48383931|NCT01170117|101269360|FG001|STARTED|Overall Study||75||
48383932|NCT01170117|101269359|FG000|COMPLETED|Overall Study||47||
48383933|NCT01170117|101269360|FG001|COMPLETED|Overall Study||55||
48383934|NCT01170117|101269359|FG000|NOT COMPLETED|Overall Study||30||
48383935|NCT01170117|101269360|FG001|NOT COMPLETED|Overall Study||20||
48383936|NCT01895452|101269361|FG000|STARTED|Overall Study||65||
48383937|NCT01895452|101269362|FG001|STARTED|Overall Study||226||
48383938|NCT01895452|101269361|FG000|COMPLETED|Overall Study||61||
48383939|NCT01895452|101269362|FG001|COMPLETED|Overall Study||198||
48383940|NCT01895452|101269361|FG000|NOT COMPLETED|Overall Study||4||
48383941|NCT01895452|101269362|FG001|NOT COMPLETED|Overall Study||28||
48383942|NCT03137121|101269363|FG000|STARTED|Overall Study||15||
48383943|NCT03137121|101269364|FG001|STARTED|Overall Study||15||
48383944|NCT03137121|101269363|FG000|COMPLETED|Overall Study||15||
48383945|NCT03137121|101269364|FG001|COMPLETED|Overall Study||14||
48383946|NCT03137121|101269363|FG000|NOT COMPLETED|Overall Study||0||
48383947|NCT03137121|101269364|FG001|NOT COMPLETED|Overall Study||1||
48383948|NCT00004418|101269365|FG000|STARTED|Overall Study||126||
48256815|NCT04191148|100947834|FG000|NOT COMPLETED|Overall Study||2||
48256816|NCT04191148|100947835|FG001|NOT COMPLETED|Overall Study||0||
48256817|NCT00551135|100947836|FG000|STARTED|Overall Study||108||
48256818|NCT00551135|100947837|FG001|STARTED|Overall Study||106||
48256819|NCT00551135|100947838|FG002|STARTED|Overall Study||103||
48256820|NCT00551135|100947839|FG003|STARTED|Overall Study||108||
48256821|NCT00551135|100947836|FG000|COMPLETED|Overall Study||103||
48256822|NCT00551135|100947837|FG001|COMPLETED|Overall Study||104||
48383949|NCT00004418|101269365|FG000|COMPLETED|Overall Study||126||
48383950|NCT00004418|101269365|FG000|NOT COMPLETED|Overall Study||0||
48383951|NCT04253834|101269366|FG000|STARTED|Overall Study||10||
48383952|NCT04253834|101269367|FG001|STARTED|Overall Study||10||
48383953|NCT04253834|101269366|FG000|COMPLETED|Overall Study||10||
48383954|NCT04253834|101269367|FG001|COMPLETED|Overall Study||10||
48383955|NCT04253834|101269366|FG000|NOT COMPLETED|Overall Study||0||
48383956|NCT04253834|101269367|FG001|NOT COMPLETED|Overall Study||0||
48383957|NCT03060083|101269368|FG000|STARTED|Overall Study||39||
48383958|NCT03060083|101269369|FG001|STARTED|Overall Study||35||
48383959|NCT03060083|101269368|FG000|Attended End of Baseline Study Visit|Overall Study||36||
48383960|NCT03060083|101269369|FG001|Attended End of Baseline Study Visit|Overall Study||32||
48256823|NCT00551135|100947838|FG002|COMPLETED|Overall Study||98||
48256824|NCT00551135|100947839|FG003|COMPLETED|Overall Study||103||
48256825|NCT00551135|100947836|FG000|NOT COMPLETED|Overall Study||5||
48256826|NCT00551135|100947837|FG001|NOT COMPLETED|Overall Study||2||
48256827|NCT00551135|100947838|FG002|NOT COMPLETED|Overall Study||5||
48256828|NCT00551135|100947839|FG003|NOT COMPLETED|Overall Study||5||
48256829|NCT02072421|100947840|FG000|STARTED|Overall Study||2879||
48256830|NCT02072421|100947840|FG000|COMPLETED|Overall Study||2489||
48256831|NCT02072421|100947840|FG000|NOT COMPLETED|Overall Study||390||
48256832|NCT03035318|100947841|FG000|STARTED|Overall Study||24||
48256833|NCT03035318|100947842|FG001|STARTED|Overall Study||25||
48256834|NCT03035318|100947843|FG002|STARTED|Overall Study||25||
48256835|NCT03035318|100947844|FG003|STARTED|Overall Study||25||
48256836|NCT03035318|100947845|FG004|STARTED|Overall Study||27||
48256837|NCT03035318|100947841|FG000|COMPLETED|Overall Study||22||
48256838|NCT03035318|100947842|FG001|COMPLETED|Overall Study||21||
48256839|NCT03035318|100947843|FG002|COMPLETED|Overall Study||21||
48256840|NCT03035318|100947844|FG003|COMPLETED|Overall Study||23||
48256841|NCT03035318|100947845|FG004|COMPLETED|Overall Study||20||
48256842|NCT03035318|100947841|FG000|NOT COMPLETED|Overall Study||2||
48592700|NCT01877382|101783157|FG007|NOT COMPLETED|Dose Expansion||0||
48383961|NCT03060083|101269368|FG000|COMPLETED|Overall Study||31|Completion defined as attended the final study visit.|
48383962|NCT03060083|101269369|FG001|COMPLETED|Overall Study||27|Completion defined as attended the final study visit.|
48383963|NCT03060083|101269368|FG000|NOT COMPLETED|Overall Study||8||
48383964|NCT03060083|101269369|FG001|NOT COMPLETED|Overall Study||8||
48383965|NCT02935699|101269370|FG000|STARTED|Overall Study||127||
48383966|NCT02935699|101269371|FG001|STARTED|Overall Study||135||
48383967|NCT02935699|101269370|FG000|COMPLETED|Overall Study||127||
48383968|NCT02935699|101269371|FG001|COMPLETED|Overall Study||135||
48383969|NCT02935699|101269370|FG000|NOT COMPLETED|Overall Study||0||
48383970|NCT02935699|101269371|FG001|NOT COMPLETED|Overall Study||0||
48383971|NCT02207478|101269372|FG000|STARTED|Overall Study||40||
48383972|NCT02207478|101269373|FG001|STARTED|Overall Study||46||
48383973|NCT02207478|101269372|FG000|COMPLETED|Overall Study||40||
48383974|NCT02207478|101269373|FG001|COMPLETED|Overall Study||46||
48383975|NCT02207478|101269372|FG000|NOT COMPLETED|Overall Study||0||
48383976|NCT02207478|101269373|FG001|NOT COMPLETED|Overall Study||0||
48092073|NCT02738151|100548915|FG001|Treated|Overall Study||462||
48383977|NCT02278640|101269374|FG000|STARTED|Overall Study||40||
48383978|NCT02278640|101269374|FG000|COMPLETED|Overall Study||40||
48383979|NCT02278640|101269374|FG000|NOT COMPLETED|Overall Study||0||
48383980|NCT03521193|101269375|FG000|STARTED|Overall Study||78||
48383981|NCT03521193|101269376|FG001|STARTED|Overall Study||12||
48383982|NCT03521193|101269375|FG000|COMPLETED|Overall Study||62||
48383983|NCT03521193|101269376|FG001|COMPLETED|Overall Study||12||
48383984|NCT03521193|101269375|FG000|NOT COMPLETED|Overall Study||16||
48383985|NCT03521193|101269376|FG001|NOT COMPLETED|Overall Study||0||
48383986|NCT01969799|101269377|FG000|STARTED|Overall Study||71||
48383987|NCT01969799|101269378|FG001|STARTED|Overall Study||72||
48383988|NCT01969799|101269377|FG000|COMPLETED|Overall Study||54||
48383989|NCT01969799|101269378|FG001|COMPLETED|Overall Study||58||
48383990|NCT01969799|101269377|FG000|NOT COMPLETED|Overall Study||17||
48383991|NCT01969799|101269378|FG001|NOT COMPLETED|Overall Study||14||
48383992|NCT00305253|101269379|FG000|STARTED|Overall Study||432||
48383993|NCT00305253|101269380|FG001|STARTED|Overall Study||559||
48383994|NCT00305253|101269379|FG000|COMPLETED|Overall Study||432||
48383995|NCT00305253|101269380|FG001|COMPLETED|Overall Study||558||
48383996|NCT00305253|101269379|FG000|NOT COMPLETED|Overall Study||0||
48383997|NCT00305253|101269380|FG001|NOT COMPLETED|Overall Study||1||
48383998|NCT01887587|101269381|FG000|STARTED|Overall Study||5||
48383999|NCT01887587|101269381|FG000|COMPLETED|Overall Study||5||
48384000|NCT01887587|101269381|FG000|NOT COMPLETED|Overall Study||0||
48384001|NCT00511342|101269382|FG000|STARTED|Overall Study||56||
48384002|NCT00511342|101269383|FG001|STARTED|Overall Study||54||
48384003|NCT00511342|101269382|FG000|COMPLETED|Overall Study||43||
48384004|NCT00511342|101269383|FG001|COMPLETED|Overall Study||32||
48384005|NCT00511342|101269382|FG000|NOT COMPLETED|Overall Study||13||
48384006|NCT00511342|101269383|FG001|NOT COMPLETED|Overall Study||22||
48384007|NCT01114373|101269384|FG000|STARTED|Intervention 1 (4 Weeks)||21||
48384008|NCT01114373|101269385|FG001|STARTED|Intervention 1 (4 Weeks)||19||
48384009|NCT01114373|101269384|FG000|COMPLETED|Intervention 1 (4 Weeks)||18||
48384010|NCT01114373|101269385|FG001|COMPLETED|Intervention 1 (4 Weeks)||19||
48384011|NCT01114373|101269384|FG000|NOT COMPLETED|Intervention 1 (4 Weeks)||3||
48092074|NCT02738151|100548914|FG000|COMPLETED|Overall Study||443||
48092075|NCT02738151|100548915|FG001|COMPLETED|Overall Study||432||
48092076|NCT02738151|100548914|FG000|NOT COMPLETED|Overall Study||23||
48092077|NCT02738151|100548915|FG001|NOT COMPLETED|Overall Study||31||
48092078|NCT00529542|100548916|FG000|STARTED|Overall Study||9||
48384012|NCT01114373|101269385|FG001|NOT COMPLETED|Intervention 1 (4 Weeks)||0||
48384013|NCT01114373|101269384|FG000|STARTED|Intervention 2 (4 Weeks)||18||
48384014|NCT01114373|101269385|FG001|STARTED|Intervention 2 (4 Weeks)||19||
48384015|NCT01114373|101269384|FG000|COMPLETED|Intervention 2 (4 Weeks)||18||
48384016|NCT01114373|101269385|FG001|COMPLETED|Intervention 2 (4 Weeks)||18||
48384017|NCT01114373|101269384|FG000|NOT COMPLETED|Intervention 2 (4 Weeks)||0||
48384018|NCT01114373|101269385|FG001|NOT COMPLETED|Intervention 2 (4 Weeks)||1||
48384019|NCT03309787|101269386|FG000|STARTED|Overall Study||8||
48384020|NCT03309787|101269387|FG001|STARTED|Overall Study||20||
48384021|NCT03309787|101269388|FG002|STARTED|Overall Study||9||
48384022|NCT03309787|101269386|FG000|COMPLETED|Overall Study||6||
48384023|NCT03309787|101269387|FG001|COMPLETED|Overall Study||14||
48384024|NCT03309787|101269388|FG002|COMPLETED|Overall Study||7||
48384025|NCT03309787|101269386|FG000|NOT COMPLETED|Overall Study||2||
48384026|NCT03309787|101269387|FG001|NOT COMPLETED|Overall Study||6||
48384027|NCT03309787|101269388|FG002|NOT COMPLETED|Overall Study||2||
48384028|NCT03930641|101269389|FG000|STARTED|Overall Study||34||
48092079|NCT00529542|100548917|FG001|STARTED|Overall Study||11||
48092080|NCT00529542|100548916|FG000|COMPLETED|Overall Study||8||
48092081|NCT00529542|100548917|FG001|COMPLETED|Overall Study||10||
48384029|NCT03930641|101269389|FG000|COMPLETED|Overall Study||34||
48384030|NCT03930641|101269389|FG000|NOT COMPLETED|Overall Study||0||
48384031|NCT01124448|101269390|FG000|STARTED|Overall Study||25||
48384032|NCT01124448|101269391|FG001|STARTED|Overall Study||15||
48092082|NCT00529542|100548916|FG000|NOT COMPLETED|Overall Study||1||
48384033|NCT01124448|101269390|FG000|COMPLETED|Overall Study||23||
48384034|NCT01124448|101269391|FG001|COMPLETED|Overall Study||12||
48384035|NCT01124448|101269390|FG000|NOT COMPLETED|Overall Study||2||
48384036|NCT01124448|101269391|FG001|NOT COMPLETED|Overall Study||3||
48384037|NCT01885078|101269392|FG000|STARTED|Treatment Period||451||
48384038|NCT01885078|101269393|FG001|STARTED|Treatment Period||1091||
48384039|NCT01885078|101269394|FG002|STARTED|Treatment Period||180||
48384040|NCT01885078|101269395|FG003|STARTED|Treatment Period||403||
48384041|NCT01885078|101269396|FG004|STARTED|Treatment Period||117||
48384042|NCT01885078|101269397|FG005|STARTED|Treatment Period||331||
48384043|NCT01885078|101269398|FG006|STARTED|Treatment Period||221||
48384044|NCT01885078|101269399|FG007|STARTED|Treatment Period||83||
48384045|NCT01885078|101269400|FG008|STARTED|Treatment Period||0||
48384046|NCT01885078|101269401|FG009|STARTED|Treatment Period||0||
48384047|NCT01885078|101269392|FG000|Received at Least Once Dose of Study Drug|Treatment Period||451||
48384048|NCT01885078|101269393|FG001|Received at Least Once Dose of Study Drug|Treatment Period||1090||
48384049|NCT01885078|101269394|FG002|Received at Least Once Dose of Study Drug|Treatment Period||180||
48384050|NCT01885078|101269395|FG003|Received at Least Once Dose of Study Drug|Treatment Period||403||
48384051|NCT01885078|101269396|FG004|Received at Least Once Dose of Study Drug|Treatment Period||117||
48384052|NCT01885078|101269397|FG005|Received at Least Once Dose of Study Drug|Treatment Period||331||
48384053|NCT01885078|101269398|FG006|Received at Least Once Dose of Study Drug|Treatment Period||221||
48384054|NCT01885078|101269399|FG007|Received at Least Once Dose of Study Drug|Treatment Period||83||
48384055|NCT01885078|101269400|FG008|Received at Least Once Dose of Study Drug|Treatment Period||0||
48384056|NCT01885078|101269401|FG009|Received at Least Once Dose of Study Drug|Treatment Period||0||
48384057|NCT01885078|101269392|FG000|COMPLETED|Treatment Period||19||
48384058|NCT01885078|101269393|FG001|COMPLETED|Treatment Period||64||
48384059|NCT01885078|101269394|FG002|COMPLETED|Treatment Period||49||
48384060|NCT01885078|101269395|FG003|COMPLETED|Treatment Period||120||
48384061|NCT01885078|101269396|FG004|COMPLETED|Treatment Period||27||
48384062|NCT01885078|101269397|FG005|COMPLETED|Treatment Period||81||
48384063|NCT01885078|101269398|FG006|COMPLETED|Treatment Period||0||
48384064|NCT01885078|101269399|FG007|COMPLETED|Treatment Period||55||
48384065|NCT01885078|101269400|FG008|COMPLETED|Treatment Period||0||
48384066|NCT01885078|101269401|FG009|COMPLETED|Treatment Period||0||
48384067|NCT01885078|101269392|FG000|NOT COMPLETED|Treatment Period||432||
48384068|NCT01885078|101269393|FG001|NOT COMPLETED|Treatment Period||1027||
48384069|NCT01885078|101269394|FG002|NOT COMPLETED|Treatment Period||131||
48384070|NCT01885078|101269395|FG003|NOT COMPLETED|Treatment Period||283||
48384071|NCT01885078|101269396|FG004|NOT COMPLETED|Treatment Period||90||
48384072|NCT01885078|101269397|FG005|NOT COMPLETED|Treatment Period||250||
48384073|NCT01885078|101269398|FG006|NOT COMPLETED|Treatment Period||221||
48384074|NCT01885078|101269399|FG007|NOT COMPLETED|Treatment Period||28||
48384075|NCT01885078|101269400|FG008|NOT COMPLETED|Treatment Period||0||
48384076|NCT01885078|101269401|FG009|NOT COMPLETED|Treatment Period||0||
48384077|NCT01885078|101269392|FG000|STARTED|Step-down Period||0||
48384078|NCT01885078|101269393|FG001|STARTED|Step-down Period||0||
48384079|NCT01885078|101269394|FG002|STARTED|Step-down Period||0||
48384080|NCT01885078|101269395|FG003|STARTED|Step-down Period||0||
48384081|NCT01885078|101269396|FG004|STARTED|Step-down Period||0||
48384082|NCT01885078|101269397|FG005|STARTED|Step-down Period||0||
48384083|NCT01885078|101269398|FG006|STARTED|Step-down Period||0||
48384084|NCT01885078|101269399|FG007|STARTED|Step-down Period||0||
48384085|NCT01885078|101269400|FG008|STARTED|Step-down Period||592||
48384086|NCT01885078|101269401|FG009|STARTED|Step-down Period||594||
48384087|NCT01885078|101269392|FG000|Complete Through Week 96|Step-down Period||0||
48384088|NCT01885078|101269393|FG001|Complete Through Week 96|Step-down Period||0||
48384089|NCT01885078|101269394|FG002|Complete Through Week 96|Step-down Period||0||
48384090|NCT01885078|101269395|FG003|Complete Through Week 96|Step-down Period||0||
48384091|NCT01885078|101269396|FG004|Complete Through Week 96|Step-down Period||0||
48384092|NCT01885078|101269397|FG005|Complete Through Week 96|Step-down Period||0||
48384093|NCT01885078|101269398|FG006|Complete Through Week 96|Step-down Period||0||
48384094|NCT01885078|101269399|FG007|Complete Through Week 96|Step-down Period||0||
48384095|NCT01885078|101269400|FG008|Complete Through Week 96|Step-down Period||407||
48384096|NCT01885078|101269401|FG009|Complete Through Week 96|Step-down Period||455||
48384097|NCT01885078|101269392|FG000|COMPLETED|Step-down Period||0||
48384098|NCT01885078|101269393|FG001|COMPLETED|Step-down Period||0||
48384099|NCT01885078|101269394|FG002|COMPLETED|Step-down Period||0||
48384100|NCT01885078|101269395|FG003|COMPLETED|Step-down Period||0||
48384101|NCT01885078|101269396|FG004|COMPLETED|Step-down Period||0||
48384102|NCT01885078|101269397|FG005|COMPLETED|Step-down Period||0||
48384103|NCT01885078|101269398|FG006|COMPLETED|Step-down Period||0||
48384104|NCT01885078|101269399|FG007|COMPLETED|Step-down Period||0||
48384105|NCT01885078|101269400|FG008|COMPLETED|Step-down Period||523||
48384106|NCT01885078|101269401|FG009|COMPLETED|Step-down Period||533||
48384107|NCT01885078|101269392|FG000|NOT COMPLETED|Step-down Period||0||
48384108|NCT01885078|101269393|FG001|NOT COMPLETED|Step-down Period||0||
48384109|NCT01885078|101269394|FG002|NOT COMPLETED|Step-down Period||0||
48687759|NCT01962428|102020051|FG000|STARTED|Overall Study||139||
48687760|NCT01962428|102020052|FG001|STARTED|Overall Study||139||
48687761|NCT01962428|102020051|FG000|COMPLETED|Overall Study||129||
48256843|NCT03035318|100947842|FG001|NOT COMPLETED|Overall Study||4||
48256844|NCT03035318|100947843|FG002|NOT COMPLETED|Overall Study||4||
48256845|NCT03035318|100947844|FG003|NOT COMPLETED|Overall Study||2||
48256846|NCT03035318|100947845|FG004|NOT COMPLETED|Overall Study||7||
48256847|NCT01419977|100947846|FG000|STARTED|Overall Study||16||
48256848|NCT01419977|100947847|FG001|STARTED|Overall Study||13||
48256849|NCT01419977|100947846|FG000|COMPLETED|Overall Study||16||
48256850|NCT01419977|100947847|FG001|COMPLETED|Overall Study||13||
48256851|NCT01419977|100947846|FG000|NOT COMPLETED|Overall Study||0||
48256852|NCT01419977|100947847|FG001|NOT COMPLETED|Overall Study||0||
48256853|NCT04629443|100947848|FG000|STARTED|Overall Study||5||
48256854|NCT04629443|100947849|FG001|STARTED|Overall Study||7||
48256855|NCT04629443|100947850|FG002|STARTED|Overall Study||5||
48256856|NCT04629443|100947848|FG000|COMPLETED|Overall Study||0||
48256857|NCT04629443|100947849|FG001|COMPLETED|Overall Study||0||
48256858|NCT04629443|100947850|FG002|COMPLETED|Overall Study||0||
48256859|NCT04629443|100947848|FG000|NOT COMPLETED|Overall Study||5||
48256860|NCT04629443|100947849|FG001|NOT COMPLETED|Overall Study||7||
48256861|NCT04629443|100947850|FG002|NOT COMPLETED|Overall Study||5||
48256862|NCT02554383|100947851|FG000|STARTED|Overall Study||257|Randomized to the treatment group|
48256863|NCT02554383|100947852|FG001|STARTED|Overall Study||258|Randomized to the treatment group|
48256864|NCT02554383|100947851|FG000|COMPLETED|Overall Study||234|Parent completed \>=2 diaries Days 2-4 and \>= 3 diaries Days 5-11, where Day 1 is day of enrollment|
48256865|NCT02554383|100947852|FG001|COMPLETED|Overall Study||239|Parent completed \>=2 diaries Days 2-4 and \>= 3 diaries Days 5-11, where Day 1 is day of enrollment|
48256866|NCT02554383|100947851|FG000|NOT COMPLETED|Overall Study||23||
48256867|NCT02554383|100947852|FG001|NOT COMPLETED|Overall Study||19||
48256868|NCT02215954|100947853|FG000|STARTED|Overall Study||214||
48256869|NCT02215954|100947854|FG001|STARTED|Overall Study||212||
48256870|NCT02215954|100947855|FG002|STARTED|Overall Study||211||
48256871|NCT02215954|100947853|FG000|Intention-To-Treat (ITT) Analysis Set|Overall Study||214||
48256872|NCT02215954|100947854|FG001|Intention-To-Treat (ITT) Analysis Set|Overall Study||212||
48256873|NCT02215954|100947855|FG002|Intention-To-Treat (ITT) Analysis Set|Overall Study||211||
48256874|NCT02215954|100947853|FG000|Per Protocol (PP) Analysis Set|Overall Study||212||
48256875|NCT02215954|100947854|FG001|Per Protocol (PP) Analysis Set|Overall Study||208||
48256876|NCT02215954|100947855|FG002|Per Protocol (PP) Analysis Set|Overall Study||205||
48256877|NCT02215954|100947853|FG000|Safety Analysis Set|Overall Study||213||
48256878|NCT02215954|100947854|FG001|Safety Analysis Set|Overall Study||211||
48256879|NCT02215954|100947855|FG002|Safety Analysis Set|Overall Study||208||
48384110|NCT01885078|101269395|FG003|NOT COMPLETED|Step-down Period||0||
48384111|NCT01885078|101269396|FG004|NOT COMPLETED|Step-down Period||0||
48384112|NCT01885078|101269397|FG005|NOT COMPLETED|Step-down Period||0||
48384113|NCT01885078|101269398|FG006|NOT COMPLETED|Step-down Period||0||
48384114|NCT01885078|101269399|FG007|NOT COMPLETED|Step-down Period||0||
48384115|NCT01885078|101269400|FG008|NOT COMPLETED|Step-down Period||69||
48384116|NCT01885078|101269401|FG009|NOT COMPLETED|Step-down Period||61||
48384117|NCT00432094|101269402|FG000|STARTED|Overall Study||14||
48384118|NCT00432094|101269403|FG001|STARTED|Overall Study||9||
48384119|NCT00432094|101269402|FG000|COMPLETED|Overall Study||14||
48384120|NCT00432094|101269403|FG001|COMPLETED|Overall Study||9||
48384121|NCT00432094|101269402|FG000|NOT COMPLETED|Overall Study||0||
48384122|NCT00432094|101269403|FG001|NOT COMPLETED|Overall Study||0||
48384123|NCT01963208|101269404|FG000|STARTED|Treatment Phase 1 (Up to Week 14)||24||
48384124|NCT01963208|101269405|FG001|STARTED|Treatment Phase 1 (Up to Week 14)||22||
48384125|NCT01963208|101269406|FG002|STARTED|Treatment Phase 1 (Up to Week 14)||179||
48384126|NCT01963208|101269407|FG003|STARTED|Treatment Phase 1 (Up to Week 14)||180||
48384127|NCT01963208|101269408|FG004|STARTED|Treatment Phase 1 (Up to Week 14)||0||
48384128|NCT01963208|101269409|FG005|STARTED|Treatment Phase 1 (Up to Week 14)||0||
48384129|NCT01963208|101269404|FG000|COMPLETED|Treatment Phase 1 (Up to Week 14)||23||
48687762|NCT01962428|102020052|FG001|COMPLETED|Overall Study||133||
48256880|NCT02215954|100947853|FG000|COMPLETED|Overall Study||213||
48256881|NCT02215954|100947854|FG001|COMPLETED|Overall Study||211||
48256882|NCT02215954|100947855|FG002|COMPLETED|Overall Study||205||
48256883|NCT02215954|100947853|FG000|NOT COMPLETED|Overall Study||1||
48256884|NCT02215954|100947854|FG001|NOT COMPLETED|Overall Study||1||
48256885|NCT02215954|100947855|FG002|NOT COMPLETED|Overall Study||6||
48256886|NCT05146206|100947856|FG000|STARTED|Overall Study||98||
48256887|NCT05146206|100947857|FG001|STARTED|Overall Study||328||
48256888|NCT05146206|100947856|FG000|COMPLETED|Overall Study||98||
48256889|NCT05146206|100947857|FG001|COMPLETED|Overall Study||328||
48384130|NCT01963208|101269405|FG001|COMPLETED|Treatment Phase 1 (Up to Week 14)||19||
48384131|NCT01963208|101269406|FG002|COMPLETED|Treatment Phase 1 (Up to Week 14)||135||
48384132|NCT01963208|101269407|FG003|COMPLETED|Treatment Phase 1 (Up to Week 14)||154||
48384133|NCT01963208|101269408|FG004|COMPLETED|Treatment Phase 1 (Up to Week 14)||0||
48384134|NCT01963208|101269409|FG005|COMPLETED|Treatment Phase 1 (Up to Week 14)||0||
48384135|NCT01963208|101269404|FG000|NOT COMPLETED|Treatment Phase 1 (Up to Week 14)||1||
48384136|NCT01963208|101269405|FG001|NOT COMPLETED|Treatment Phase 1 (Up to Week 14)||3||
48384137|NCT01963208|101269406|FG002|NOT COMPLETED|Treatment Phase 1 (Up to Week 14)||44||
48384138|NCT01963208|101269407|FG003|NOT COMPLETED|Treatment Phase 1 (Up to Week 14)||26||
48384139|NCT01963208|101269408|FG004|NOT COMPLETED|Treatment Phase 1 (Up to Week 14)||0||
48384140|NCT01963208|101269409|FG005|NOT COMPLETED|Treatment Phase 1 (Up to Week 14)||0||
48384141|NCT01963208|101269404|FG000|STARTED|Treatment Phase 2 (Up to Week 68)||0||
48384142|NCT01963208|101269405|FG001|STARTED|Treatment Phase 2 (Up to Week 68)||0||
48384143|NCT01963208|101269406|FG002|STARTED|Treatment Phase 2 (Up to Week 68)||0||
48384144|NCT01963208|101269407|FG003|STARTED|Treatment Phase 2 (Up to Week 68)||0||
48384145|NCT01963208|101269408|FG004|STARTED|Treatment Phase 2 (Up to Week 68)||158||
48384146|NCT01963208|101269409|FG005|STARTED|Treatment Phase 2 (Up to Week 68)||173||
48384147|NCT01963208|101269404|FG000|COMPLETED|Treatment Phase 2 (Up to Week 68)||0||
48384148|NCT01963208|101269405|FG001|COMPLETED|Treatment Phase 2 (Up to Week 68)||0||
48384149|NCT01963208|101269406|FG002|COMPLETED|Treatment Phase 2 (Up to Week 68)||0||
48384150|NCT01963208|101269407|FG003|COMPLETED|Treatment Phase 2 (Up to Week 68)||0||
48384151|NCT01963208|101269408|FG004|COMPLETED|Treatment Phase 2 (Up to Week 68)||57||
48384152|NCT01963208|101269409|FG005|COMPLETED|Treatment Phase 2 (Up to Week 68)||44||
48384153|NCT01963208|101269404|FG000|NOT COMPLETED|Treatment Phase 2 (Up to Week 68)||0||
48384154|NCT01963208|101269405|FG001|NOT COMPLETED|Treatment Phase 2 (Up to Week 68)||0||
48384155|NCT01963208|101269406|FG002|NOT COMPLETED|Treatment Phase 2 (Up to Week 68)||0||
48384156|NCT01963208|101269407|FG003|NOT COMPLETED|Treatment Phase 2 (Up to Week 68)||0||
48384157|NCT01963208|101269408|FG004|NOT COMPLETED|Treatment Phase 2 (Up to Week 68)||101||
48384158|NCT01963208|101269409|FG005|NOT COMPLETED|Treatment Phase 2 (Up to Week 68)||129||
48384159|NCT03498287|101269410|FG000|STARTED|Overall Study||45||
48384160|NCT03498287|101269411|FG001|STARTED|Overall Study||43||
48384161|NCT03498287|101269410|FG000|COMPLETED|Overall Study||42||
48384162|NCT03498287|101269411|FG001|COMPLETED|Overall Study||38||
48384163|NCT03498287|101269410|FG000|NOT COMPLETED|Overall Study||3||
48384164|NCT03498287|101269411|FG001|NOT COMPLETED|Overall Study||5||
48384165|NCT00165841|101269412|FG000|STARTED|Overall Study||103||
48384166|NCT00165841|101269413|FG001|STARTED|Overall Study||97||
48384167|NCT00165841|101269412|FG000|COMPLETED|Overall Study||73||
48384168|NCT00165841|101269413|FG001|COMPLETED|Overall Study||35||
48384169|NCT00165841|101269412|FG000|NOT COMPLETED|Overall Study||30||
48384170|NCT00165841|101269413|FG001|NOT COMPLETED|Overall Study||62||
48384171|NCT00259740|101269414|FG000|STARTED|Overall Study||43||
48384172|NCT00259740|101269415|FG001|STARTED|Overall Study||53||
48384173|NCT00259740|101269414|FG000|Received Study Medication|Overall Study||42||
48384174|NCT00259740|101269415|FG001|Received Study Medication|Overall Study||53||
48384175|NCT00259740|101269414|FG000|COMPLETED|Overall Study||0||
48384176|NCT00259740|101269415|FG001|COMPLETED|Overall Study||0||
48384177|NCT00259740|101269414|FG000|NOT COMPLETED|Overall Study||43||
48384178|NCT00259740|101269415|FG001|NOT COMPLETED|Overall Study||53||
48384179|NCT03589885|101269416|FG000|STARTED|Treatment Period 1-Randomized Set||41||
48384180|NCT03589885|101269417|FG001|STARTED|Treatment Period 1-Randomized Set||41||
48384181|NCT03589885|101269418|FG002|STARTED|Treatment Period 1-Randomized Set||40||
48384182|NCT03589885|101269419|FG003|STARTED|Treatment Period 1-Randomized Set||0||
48384183|NCT03589885|101269420|FG004|STARTED|Treatment Period 1-Randomized Set||0||
48384184|NCT03589885|101269416|FG000|COMPLETED|Treatment Period 1-Randomized Set||41||
48384185|NCT03589885|101269417|FG001|COMPLETED|Treatment Period 1-Randomized Set||39||
48384186|NCT03589885|101269418|FG002|COMPLETED|Treatment Period 1-Randomized Set||37||
48384187|NCT03589885|101269419|FG003|COMPLETED|Treatment Period 1-Randomized Set||0||
48384188|NCT03589885|101269420|FG004|COMPLETED|Treatment Period 1-Randomized Set||0||
48384189|NCT03589885|101269416|FG000|NOT COMPLETED|Treatment Period 1-Randomized Set||0||
48384190|NCT03589885|101269417|FG001|NOT COMPLETED|Treatment Period 1-Randomized Set||2||
48384191|NCT03589885|101269418|FG002|NOT COMPLETED|Treatment Period 1-Randomized Set||3||
48384192|NCT03589885|101269419|FG003|NOT COMPLETED|Treatment Period 1-Randomized Set||0||
48384193|NCT03589885|101269420|FG004|NOT COMPLETED|Treatment Period 1-Randomized Set||0||
48384194|NCT03589885|101269416|FG000|STARTED|Treatment Period 2-Randomized Set||41||
48384195|NCT03589885|101269417|FG001|STARTED|Treatment Period 2-Randomized Set||39||
48384196|NCT03589885|101269418|FG002|STARTED|Treatment Period 2-Randomized Set||4||
48384197|NCT03589885|101269419|FG003|STARTED|Treatment Period 2-Randomized Set||16||
48384198|NCT03589885|101269420|FG004|STARTED|Treatment Period 2-Randomized Set||17||
48384199|NCT03589885|101269416|FG000|COMPLETED|Treatment Period 2-Randomized Set||40||
48384200|NCT03589885|101269417|FG001|COMPLETED|Treatment Period 2-Randomized Set||34||
48384201|NCT03589885|101269418|FG002|COMPLETED|Treatment Period 2-Randomized Set||3||
48384202|NCT03589885|101269419|FG003|COMPLETED|Treatment Period 2-Randomized Set||16||
48384203|NCT03589885|101269420|FG004|COMPLETED|Treatment Period 2-Randomized Set||16||
48592701|NCT01877382|101783158|FG008|NOT COMPLETED|Dose Expansion||0||
48384204|NCT03589885|101269416|FG000|NOT COMPLETED|Treatment Period 2-Randomized Set||1||
48384205|NCT03589885|101269417|FG001|NOT COMPLETED|Treatment Period 2-Randomized Set||5||
48384206|NCT03589885|101269418|FG002|NOT COMPLETED|Treatment Period 2-Randomized Set||1||
48687763|NCT01962428|102020051|FG000|NOT COMPLETED|Overall Study||10||
48687764|NCT01962428|102020052|FG001|NOT COMPLETED|Overall Study||6||
48687765|NCT00787241|102020053|FG000|STARTED|Overall Study||261||
48687766|NCT00787241|102020054|FG001|STARTED|Overall Study||143||
48687767|NCT00787241|102020055|FG002|STARTED|Overall Study||41||
48687768|NCT00787241|102020053|FG000|COMPLETED|Overall Study||261||
48687769|NCT00787241|102020054|FG001|COMPLETED|Overall Study||143||
48687770|NCT00787241|102020055|FG002|COMPLETED|Overall Study||41||
48687771|NCT00787241|102020053|FG000|NOT COMPLETED|Overall Study||0||
48687772|NCT00787241|102020054|FG001|NOT COMPLETED|Overall Study||0||
48687773|NCT00787241|102020055|FG002|NOT COMPLETED|Overall Study||0||
48687774|NCT02829996|102020056|FG000|STARTED|Overall Study||39||
48687775|NCT02829996|102020057|FG001|STARTED|Overall Study||39||
48687776|NCT02829996|102020058|FG002|STARTED|Overall Study||40||
48687777|NCT02829996|102020059|FG003|STARTED|Overall Study||41||
48687778|NCT02829996|102020060|FG004|STARTED|Overall Study||42||
48687779|NCT02829996|102020056|FG000|COMPLETED|Overall Study||38||
48687780|NCT02829996|102020057|FG001|COMPLETED|Overall Study||39||
48687781|NCT02829996|102020058|FG002|COMPLETED|Overall Study||40||
48687782|NCT02829996|102020059|FG003|COMPLETED|Overall Study||41||
48687783|NCT02829996|102020060|FG004|COMPLETED|Overall Study||42||
48687784|NCT02829996|102020056|FG000|NOT COMPLETED|Overall Study||1||
48687785|NCT02829996|102020057|FG001|NOT COMPLETED|Overall Study||0||
48687786|NCT02829996|102020058|FG002|NOT COMPLETED|Overall Study||0||
48687787|NCT02829996|102020059|FG003|NOT COMPLETED|Overall Study||0||
48687788|NCT02829996|102020060|FG004|NOT COMPLETED|Overall Study||0||
48687789|NCT04263766|102020061|FG000|STARTED|Overall Study||50||
48687790|NCT04263766|102020062|FG001|STARTED|Overall Study||26||
48687791|NCT04263766|102020061|FG000|COMPLETED|Overall Study||43||
48687792|NCT04263766|102020062|FG001|COMPLETED|Overall Study||19||
48687793|NCT04263766|102020061|FG000|NOT COMPLETED|Overall Study||7||
48687794|NCT04263766|102020062|FG001|NOT COMPLETED|Overall Study||7||
48687795|NCT00742170|102020063|FG000|STARTED|Overall Study||26||
48687796|NCT00742170|102020064|FG001|STARTED|Overall Study||29||
48687797|NCT00742170|102020063|FG000|COMPLETED|Overall Study||24||
48687798|NCT00742170|102020064|FG001|COMPLETED|Overall Study||24||
48687799|NCT00742170|102020063|FG000|NOT COMPLETED|Overall Study||2||
48687800|NCT00742170|102020064|FG001|NOT COMPLETED|Overall Study||5||
48256890|NCT05146206|100947856|FG000|NOT COMPLETED|Overall Study||0||
48256891|NCT05146206|100947857|FG001|NOT COMPLETED|Overall Study||0||
48256892|NCT03000348|100947858|FG000|STARTED|Overall Study||17||
48256893|NCT03000348|100947859|FG001|STARTED|Overall Study||11||
48256894|NCT03000348|100947860|FG002|STARTED|Overall Study||15||
48256895|NCT03000348|100947861|FG003|STARTED|Overall Study||15||
48256896|NCT03000348|100947862|FG004|STARTED|Overall Study||16||
48256897|NCT03000348|100947863|FG005|STARTED|Overall Study||15||
48256898|NCT03000348|100947858|FG000|Day 14 Treatment Period|Overall Study||17||
48384207|NCT03589885|101269419|FG003|NOT COMPLETED|Treatment Period 2-Randomized Set||0||
48384208|NCT03589885|101269420|FG004|NOT COMPLETED|Treatment Period 2-Randomized Set||1||
48384209|NCT03970395|101269421|FG000|STARTED|Overall Study||48||
48256899|NCT03000348|100947859|FG001|Day 14 Treatment Period|Overall Study||10||
48256900|NCT03000348|100947860|FG002|Day 14 Treatment Period|Overall Study||13||
48256901|NCT03000348|100947861|FG003|Day 14 Treatment Period|Overall Study||14||
48256902|NCT03000348|100947862|FG004|Day 14 Treatment Period|Overall Study||13||
48256903|NCT03000348|100947863|FG005|Day 14 Treatment Period|Overall Study||14||
48384210|NCT03970395|101269422|FG001|STARTED|Overall Study||48||
48256904|NCT03000348|100947858|FG000|COMPLETED|Overall Study||14||
48256905|NCT03000348|100947859|FG001|COMPLETED|Overall Study||7||
48256906|NCT03000348|100947860|FG002|COMPLETED|Overall Study||11||
48256907|NCT03000348|100947861|FG003|COMPLETED|Overall Study||12||
48256908|NCT03000348|100947862|FG004|COMPLETED|Overall Study||11||
48256909|NCT03000348|100947863|FG005|COMPLETED|Overall Study||13||
48256910|NCT03000348|100947858|FG000|NOT COMPLETED|Overall Study||3||
48256911|NCT03000348|100947859|FG001|NOT COMPLETED|Overall Study||4||
48256912|NCT03000348|100947860|FG002|NOT COMPLETED|Overall Study||4||
48256913|NCT03000348|100947861|FG003|NOT COMPLETED|Overall Study||3||
48256914|NCT03000348|100947862|FG004|NOT COMPLETED|Overall Study||5||
48687801|NCT02415244|102020065|FG000|STARTED|Overall Study||50||
48687802|NCT02415244|102020066|FG001|STARTED|Overall Study||25||
48687803|NCT02415244|102020065|FG000|COMPLETED|Overall Study||50||
48687804|NCT02415244|102020066|FG001|COMPLETED|Overall Study||25||
48687805|NCT02415244|102020065|FG000|NOT COMPLETED|Overall Study||0||
48687806|NCT02415244|102020066|FG001|NOT COMPLETED|Overall Study||0||
48687807|NCT03810014|102020067|FG000|STARTED|Overall Study||215||
48687808|NCT03810014|102020068|FG001|STARTED|Overall Study||204||
48687809|NCT03810014|102020069|FG002|STARTED|Overall Study||210||
48256915|NCT03000348|100947863|FG005|NOT COMPLETED|Overall Study||2||
48256916|NCT03318783|100947864|FG000|STARTED|Overall Study||10||
48256917|NCT03318783|100947865|FG001|STARTED|Overall Study||10||
48256918|NCT03318783|100947864|FG000|COMPLETED|Overall Study||10||
48687810|NCT03810014|102020070|FG003|STARTED|Overall Study||213||
48687811|NCT03810014|102020067|FG000|COMPLETED|Overall Study||213||
48687812|NCT03810014|102020068|FG001|COMPLETED|Overall Study||202||
48687813|NCT03810014|102020069|FG002|COMPLETED|Overall Study||210||
48687814|NCT03810014|102020070|FG003|COMPLETED|Overall Study||211||
48687815|NCT03810014|102020067|FG000|NOT COMPLETED|Overall Study||2||
48687816|NCT03810014|102020068|FG001|NOT COMPLETED|Overall Study||2||
48687817|NCT03810014|102020069|FG002|NOT COMPLETED|Overall Study||0||
48687818|NCT03810014|102020070|FG003|NOT COMPLETED|Overall Study||2||
48687819|NCT01575808|102020071|FG000|STARTED|Overall Study||103||
48687820|NCT01575808|102020072|FG001|STARTED|Overall Study||68||
48687821|NCT01575808|102020071|FG000|COMPLETED|Overall Study||100||
48687822|NCT01575808|102020072|FG001|COMPLETED|Overall Study||68||
48687823|NCT01575808|102020071|FG000|NOT COMPLETED|Overall Study||3||
48687824|NCT01575808|102020072|FG001|NOT COMPLETED|Overall Study||0||
48687825|NCT01162473|102020073|FG000|STARTED|Overall Study||8||
48687826|NCT01162473|102020074|FG001|STARTED|Overall Study||17||
48687827|NCT01162473|102020073|FG000|COMPLETED|Overall Study||6||
48687828|NCT01162473|102020074|FG001|COMPLETED|Overall Study||12||
48687829|NCT01162473|102020073|FG000|NOT COMPLETED|Overall Study||2||
48687830|NCT01162473|102020074|FG001|NOT COMPLETED|Overall Study||5||
48687831|NCT00690794|102020075|FG000|STARTED|Overall Study||363||
48687832|NCT00690794|102020076|FG001|STARTED|Overall Study||363||
48687833|NCT00690794|102020075|FG000|COMPLETED|Overall Study||342||
48687834|NCT00690794|102020076|FG001|COMPLETED|Overall Study||328||
48687835|NCT00690794|102020075|FG000|NOT COMPLETED|Overall Study||21||
48687836|NCT00690794|102020076|FG001|NOT COMPLETED|Overall Study||35||
48687837|NCT01198574|102020077|FG000|STARTED|Overall Study||98||
48687838|NCT01198574|102020078|FG001|STARTED|Overall Study||102||
48687839|NCT01198574|102020079|FG002|STARTED|Overall Study||100||
48687840|NCT01198574|102020080|FG003|STARTED|Overall Study||102||
48687841|NCT01198574|102020077|FG000|COMPLETED|Overall Study||94||
48687842|NCT01198574|102020078|FG001|COMPLETED|Overall Study||101||
48687843|NCT01198574|102020079|FG002|COMPLETED|Overall Study||99||
48687844|NCT01198574|102020080|FG003|COMPLETED|Overall Study||98||
48687845|NCT01198574|102020077|FG000|NOT COMPLETED|Overall Study||4||
48687846|NCT01198574|102020078|FG001|NOT COMPLETED|Overall Study||1||
48687847|NCT01198574|102020079|FG002|NOT COMPLETED|Overall Study||1||
48687848|NCT01198574|102020080|FG003|NOT COMPLETED|Overall Study||4||
48687849|NCT02099084|102020081|FG000|STARTED|First Intervention||4||
48687850|NCT02099084|102020082|FG001|STARTED|First Intervention||4||
48687851|NCT02099084|102020081|FG000|COMPLETED|First Intervention||4||
48687852|NCT02099084|102020082|FG001|COMPLETED|First Intervention||4||
48687853|NCT02099084|102020081|FG000|NOT COMPLETED|First Intervention||0||
48687854|NCT02099084|102020082|FG001|NOT COMPLETED|First Intervention||0||
48687855|NCT02099084|102020081|FG000|STARTED|Washout Period of 14 Days||4||
48687856|NCT02099084|102020082|FG001|STARTED|Washout Period of 14 Days||4||
48687857|NCT02099084|102020081|FG000|COMPLETED|Washout Period of 14 Days||4||
48687858|NCT02099084|102020082|FG001|COMPLETED|Washout Period of 14 Days||4||
48687859|NCT02099084|102020081|FG000|NOT COMPLETED|Washout Period of 14 Days||0||
48687860|NCT02099084|102020082|FG001|NOT COMPLETED|Washout Period of 14 Days||0||
48687861|NCT02099084|102020081|FG000|STARTED|Second Intervention||4||
48687862|NCT02099084|102020082|FG001|STARTED|Second Intervention||4||
48687863|NCT02099084|102020081|FG000|COMPLETED|Second Intervention||4||
48687864|NCT02099084|102020082|FG001|COMPLETED|Second Intervention||4||
48687865|NCT02099084|102020081|FG000|NOT COMPLETED|Second Intervention||0||
48687866|NCT02099084|102020082|FG001|NOT COMPLETED|Second Intervention||0||
48687867|NCT02776683|102020083|FG000|STARTED|Pre-switch Period||123|Only the BI 695502 arm was applicable for Period 1|
48687868|NCT02776683|102020084|FG001|STARTED|Pre-switch Period||0|Only the BI 695502 arm was applicable for Period 1|
48687869|NCT02776683|102020083|FG000|COMPLETED|Pre-switch Period||43||
48687870|NCT02776683|102020084|FG001|COMPLETED|Pre-switch Period||0||
48687871|NCT02776683|102020083|FG000|NOT COMPLETED|Pre-switch Period||80||
48687872|NCT02776683|102020084|FG001|NOT COMPLETED|Pre-switch Period||0||
48687873|NCT02776683|102020083|FG000|STARTED|Post-switch Period||0|Only the BI 695502 to Avastin arm was applicable to Period 2|
48687874|NCT02776683|102020084|FG001|STARTED|Post-switch Period||43|Only the BI 695502 to Avastin arm was applicable to Period 2|
48687875|NCT02776683|102020083|FG000|COMPLETED|Post-switch Period||0||
48687876|NCT02776683|102020084|FG001|COMPLETED|Post-switch Period||0||
48687877|NCT02776683|102020083|FG000|NOT COMPLETED|Post-switch Period||0||
48687878|NCT02776683|102020084|FG001|NOT COMPLETED|Post-switch Period||43||
48687879|NCT01176877|102020085|FG000|STARTED|Overall Study||40||
48687880|NCT01176877|102020085|FG000|COMPLETED|Overall Study||31||
48687881|NCT01176877|102020085|FG000|NOT COMPLETED|Overall Study||9||
48687882|NCT03886948|102020086|FG000|STARTED|Overall Study||11||
48687883|NCT03886948|102020087|FG001|STARTED|Overall Study||11||
48687884|NCT03886948|102020088|FG002|STARTED|Overall Study||11||
48687885|NCT03886948|102020089|FG003|STARTED|Overall Study||11||
48687886|NCT03886948|102020090|FG004|STARTED|Overall Study||11||
48687887|NCT03886948|102020091|FG005|STARTED|Overall Study||11||
48687888|NCT03886948|102020086|FG000|Received at Least One Dose of Study Drug|Overall Study||11||
48687889|NCT03886948|102020087|FG001|Received at Least One Dose of Study Drug|Overall Study||11||
48687890|NCT03886948|102020088|FG002|Received at Least One Dose of Study Drug|Overall Study||11||
48687891|NCT03886948|102020089|FG003|Received at Least One Dose of Study Drug|Overall Study||11||
48687892|NCT03886948|102020090|FG004|Received at Least One Dose of Study Drug|Overall Study||11||
48384211|NCT03970395|101269421|FG000|COMPLETED|Overall Study||41||
48384212|NCT03970395|101269422|FG001|COMPLETED|Overall Study||36||
48384213|NCT03970395|101269421|FG000|NOT COMPLETED|Overall Study||7||
48384214|NCT03970395|101269422|FG001|NOT COMPLETED|Overall Study||12||
48384215|NCT00064350|101269423|FG000|STARTED|Induction Treatment||59||
48384216|NCT00064350|101269424|FG001|STARTED|Induction Treatment||46||
48687893|NCT03886948|102020091|FG005|Received at Least One Dose of Study Drug|Overall Study||11||
48687894|NCT03886948|102020086|FG000|COMPLETED|Overall Study||11||
48687895|NCT03886948|102020087|FG001|COMPLETED|Overall Study||11||
48687896|NCT03886948|102020088|FG002|COMPLETED|Overall Study||11||
48687897|NCT03886948|102020089|FG003|COMPLETED|Overall Study||11||
48687898|NCT03886948|102020090|FG004|COMPLETED|Overall Study||11||
48687899|NCT03886948|102020091|FG005|COMPLETED|Overall Study||11||
48687900|NCT03886948|102020086|FG000|NOT COMPLETED|Overall Study||0||
48687901|NCT03886948|102020087|FG001|NOT COMPLETED|Overall Study||0||
48687902|NCT03886948|102020088|FG002|NOT COMPLETED|Overall Study||0||
48687903|NCT03886948|102020089|FG003|NOT COMPLETED|Overall Study||0||
48687904|NCT03886948|102020090|FG004|NOT COMPLETED|Overall Study||0||
48687905|NCT03886948|102020091|FG005|NOT COMPLETED|Overall Study||0||
48687906|NCT00049322|102020092|FG000|STARTED|Overall Study||15||
48687907|NCT00049322|102020093|FG001|STARTED|Overall Study||15||
48384217|NCT00064350|101269425|FG002|STARTED|Induction Treatment||237||
48384218|NCT00064350|101269423|FG000|Treated|Induction Treatment||59||
48384219|NCT00064350|101269424|FG001|Treated|Induction Treatment||46||
48384220|NCT00064350|101269425|FG002|Treated|Induction Treatment||228||
48384221|NCT00064350|101269423|FG000|Eligible and Treated|Induction Treatment||59||
48384222|NCT00064350|101269424|FG001|Eligible and Treated|Induction Treatment||46||
48384223|NCT00064350|101269425|FG002|Eligible and Treated|Induction Treatment||194||
48384224|NCT00064350|101269423|FG000|COMPLETED|Induction Treatment||51||
48384225|NCT00064350|101269424|FG001|COMPLETED|Induction Treatment||37||
48384226|NCT00064350|101269425|FG002|COMPLETED|Induction Treatment||1||
48384227|NCT00064350|101269423|FG000|NOT COMPLETED|Induction Treatment||8||
48384228|NCT00064350|101269424|FG001|NOT COMPLETED|Induction Treatment||9||
48384229|NCT00064350|101269425|FG002|NOT COMPLETED|Induction Treatment||236||
48384230|NCT00064350|101269423|FG000|STARTED|Randomization||59||
48384231|NCT00064350|101269424|FG001|STARTED|Randomization||46||
48384232|NCT00064350|101269425|FG002|STARTED|Randomization||0||
48384233|NCT00064350|101269423|FG000|Treated|Randomization||55||
48384234|NCT00064350|101269424|FG001|Treated|Randomization||40||
48384235|NCT00064350|101269425|FG002|Treated|Randomization||0||
48384236|NCT00064350|101269423|FG000|Eligible and Treated|Randomization||50||
48384237|NCT00064350|101269424|FG001|Eligible and Treated|Randomization||31||
48384238|NCT00064350|101269425|FG002|Eligible and Treated|Randomization||0||
48384239|NCT00064350|101269423|FG000|COMPLETED|Randomization||33||
48687908|NCT00049322|102020092|FG000|COMPLETED|Overall Study||14||
48687909|NCT00049322|102020093|FG001|COMPLETED|Overall Study||9||
48687910|NCT00049322|102020092|FG000|NOT COMPLETED|Overall Study||1||
48687911|NCT00049322|102020093|FG001|NOT COMPLETED|Overall Study||6||
48687912|NCT02462187|102020094|FG000|STARTED|Overall Study||13||
48687913|NCT02462187|102020095|FG001|STARTED|Overall Study||24||
48687914|NCT02462187|102020096|FG002|STARTED|Overall Study||14||
48687915|NCT02462187|102020097|FG003|STARTED|Overall Study||30||
48687916|NCT02462187|102020098|FG004|STARTED|Overall Study||23||
48687917|NCT02462187|102020099|FG005|STARTED|Overall Study||4||
48687918|NCT02462187|102020094|FG000|COMPLETED|Overall Study||8||
48687919|NCT02462187|102020095|FG001|COMPLETED|Overall Study||19||
48687920|NCT02462187|102020096|FG002|COMPLETED|Overall Study||9||
48687921|NCT02462187|102020097|FG003|COMPLETED|Overall Study||23||
48687922|NCT02462187|102020098|FG004|COMPLETED|Overall Study||16||
48687923|NCT02462187|102020099|FG005|COMPLETED|Overall Study||4||
48687924|NCT02462187|102020094|FG000|NOT COMPLETED|Overall Study||5||
48687925|NCT02462187|102020095|FG001|NOT COMPLETED|Overall Study||5||
48687926|NCT02462187|102020096|FG002|NOT COMPLETED|Overall Study||5||
48687927|NCT02462187|102020097|FG003|NOT COMPLETED|Overall Study||7||
48687928|NCT02462187|102020098|FG004|NOT COMPLETED|Overall Study||7||
48687929|NCT02462187|102020099|FG005|NOT COMPLETED|Overall Study||0||
48687930|NCT03338400|102020100|FG000|STARTED|Overall Study||25||
48687931|NCT03338400|102020101|FG001|STARTED|Overall Study||26||
48687932|NCT03338400|102020100|FG000|COMPLETED|Overall Study||24||
48687933|NCT03338400|102020101|FG001|COMPLETED|Overall Study||24||
48687934|NCT03338400|102020100|FG000|NOT COMPLETED|Overall Study||1||
48687935|NCT03338400|102020101|FG001|NOT COMPLETED|Overall Study||2||
48687936|NCT01531582|102020102|FG000|STARTED|Overall Study||25||
48687937|NCT01531582|102020102|FG000|COMPLETED|Overall Study||24||
48687938|NCT01531582|102020102|FG000|NOT COMPLETED|Overall Study||1||
48687939|NCT01072136|102020103|FG000|STARTED|Overall Study||44||
48687940|NCT01072136|102020104|FG001|STARTED|Overall Study||43||
48687941|NCT01072136|102020103|FG000|Met All Enrollment Criteria|Overall Study||30||
48710790|NCT01215110|102078016|FG000|NOT COMPLETED|Overall Study||0||
48687942|NCT01072136|102020104|FG001|Met All Enrollment Criteria|Overall Study||25||
48687943|NCT01072136|102020103|FG000|COMPLETED|Overall Study||21||
48687944|NCT01072136|102020104|FG001|COMPLETED|Overall Study||12||
48687945|NCT01072136|102020103|FG000|NOT COMPLETED|Overall Study||23||
48687946|NCT01072136|102020104|FG001|NOT COMPLETED|Overall Study||31||
48687947|NCT00856635|102020105|FG000|STARTED|Overall Study||22||
48687948|NCT00856635|102020106|FG001|STARTED|Overall Study||22||
48687949|NCT00856635|102020105|FG000|Received Study Drug|Overall Study||20||
48092083|NCT00529542|100548917|FG001|NOT COMPLETED|Overall Study||1||
48092084|NCT01974245|100548918|FG000|STARTED|Overall Study||27||
48092085|NCT01974245|100548919|FG001|STARTED|Overall Study||28||
48092086|NCT01974245|100548918|FG000|COMPLETED|Overall Study||18||
48092087|NCT01974245|100548919|FG001|COMPLETED|Overall Study||20||
48092088|NCT01974245|100548918|FG000|NOT COMPLETED|Overall Study||9||
48092089|NCT01974245|100548919|FG001|NOT COMPLETED|Overall Study||8||
48092090|NCT02671422|100548920|FG000|STARTED|Overall Study||260||
48092091|NCT02671422|100548920|FG000|Not Treated With Vargatef®|Overall Study||3||
48092092|NCT02671422|100548920|FG000|COMPLETED|Overall Study||0||
48092093|NCT02671422|100548920|FG000|NOT COMPLETED|Overall Study||260||
48092094|NCT01506479|100548921|FG000|STARTED|Overall Study||40||
48092095|NCT01506479|100548922|FG001|STARTED|Overall Study||43||
48687950|NCT00856635|102020106|FG001|Received Study Drug|Overall Study||20||
48687951|NCT00856635|102020105|FG000|COMPLETED|Overall Study||12||
48687952|NCT00856635|102020106|FG001|COMPLETED|Overall Study||14||
48687953|NCT00856635|102020105|FG000|NOT COMPLETED|Overall Study||10||
48687954|NCT00856635|102020106|FG001|NOT COMPLETED|Overall Study||8||
48687955|NCT03072043|102020107|FG000|STARTED|Overall Study||3||
48687956|NCT03072043|102020108|FG001|STARTED|Overall Study||3||
48687957|NCT03072043|102020109|FG002|STARTED|Overall Study||49||
48687958|NCT03072043|102020107|FG000|COMPLETED|Overall Study||3||
48687959|NCT03072043|102020108|FG001|COMPLETED|Overall Study||3||
48687960|NCT03072043|102020109|FG002|COMPLETED|Overall Study||40||
48687961|NCT03072043|102020107|FG000|NOT COMPLETED|Overall Study||0||
48687962|NCT03072043|102020108|FG001|NOT COMPLETED|Overall Study||0||
48687963|NCT03072043|102020109|FG002|NOT COMPLETED|Overall Study||9||
48687964|NCT01016067|102020110|FG000|STARTED|Overall Study||11||
48687965|NCT01016067|102020111|FG001|STARTED|Overall Study||12||
48687966|NCT01016067|102020110|FG000|COMPLETED|Overall Study||9||
48687967|NCT01016067|102020111|FG001|COMPLETED|Overall Study||8||
48687968|NCT01016067|102020110|FG000|NOT COMPLETED|Overall Study||2||
48687969|NCT01016067|102020111|FG001|NOT COMPLETED|Overall Study||4||
48687970|NCT00540592|102020112|FG000|STARTED|Overall Study||204||
48687971|NCT00540592|102020113|FG001|STARTED|Overall Study||202||
48687972|NCT00540592|102020114|FG002|STARTED|Overall Study||202||
48687973|NCT00540592|102020115|FG003|STARTED|Overall Study||202||
48687974|NCT00540592|102020116|FG004|STARTED|Overall Study||199||
48687975|NCT00540592|102020117|FG005|STARTED|Overall Study||198||
48687976|NCT00540592|102020118|FG006|STARTED|Overall Study||198||
48687977|NCT00540592|102020119|FG007|STARTED|Overall Study||199||
48687978|NCT00540592|102020120|FG008|STARTED|Overall Study||200||
48687979|NCT00540592|102020121|FG009|STARTED|Overall Study||203||
48092096|NCT01506479|100548923|FG002|STARTED|Overall Study||45||
48092097|NCT01506479|100548921|FG000|COMPLETED|Overall Study||37|Number of participants with 6 month follow-up.|
48092098|NCT01506479|100548922|FG001|COMPLETED|Overall Study||38|Number of participants with 6 month follow-up.|
48092099|NCT01506479|100548923|FG002|COMPLETED|Overall Study||42|Number of participants with 6 month follow-up.|
48687980|NCT00540592|102020112|FG000|Completed at Day 180|Overall Study||200||
48687981|NCT00540592|102020113|FG001|Completed at Day 180|Overall Study||201||
48687982|NCT00540592|102020114|FG002|Completed at Day 180|Overall Study||197||
48687983|NCT00540592|102020115|FG003|Completed at Day 180|Overall Study||197||
48687984|NCT00540592|102020116|FG004|Completed at Day 180|Overall Study||195||
48687985|NCT00540592|102020117|FG005|Completed at Day 180|Overall Study||198||
48687986|NCT00540592|102020118|FG006|Completed at Day 180|Overall Study||196||
48092100|NCT01506479|100548921|FG000|NOT COMPLETED|Overall Study||3||
48092101|NCT01506479|100548922|FG001|NOT COMPLETED|Overall Study||5||
48092102|NCT01506479|100548923|FG002|NOT COMPLETED|Overall Study||3||
48092103|NCT00909389|100548924|FG000|STARTED|Overall Study||4748||
48092104|NCT00909389|100548924|FG000|COMPLETED|Overall Study||4615||
48092105|NCT00909389|100548924|FG000|NOT COMPLETED|Overall Study||133||
48092106|NCT01084174|100548925|FG000|STARTED|Overall Study||10||
48092107|NCT01084174|100548926|FG001|STARTED|Overall Study||11||
48687987|NCT00540592|102020119|FG007|Completed at Day 180|Overall Study||193||
48687988|NCT00540592|102020120|FG008|Completed at Day 180|Overall Study||198||
48687989|NCT00540592|102020121|FG009|Completed at Day 180|Overall Study||189||
48687990|NCT00540592|102020112|FG000|COMPLETED|Overall Study||202||
48687991|NCT00540592|102020113|FG001|COMPLETED|Overall Study||201||
48687992|NCT00540592|102020114|FG002|COMPLETED|Overall Study||201||
48687993|NCT00540592|102020115|FG003|COMPLETED|Overall Study||201||
48687994|NCT00540592|102020116|FG004|COMPLETED|Overall Study||198||
48687995|NCT00540592|102020117|FG005|COMPLETED|Overall Study||198||
48687996|NCT00540592|102020118|FG006|COMPLETED|Overall Study||198||
48687997|NCT00540592|102020119|FG007|COMPLETED|Overall Study||198||
48687998|NCT00540592|102020120|FG008|COMPLETED|Overall Study||199||
48687999|NCT00540592|102020121|FG009|COMPLETED|Overall Study||201||
48688000|NCT00540592|102020112|FG000|NOT COMPLETED|Overall Study||2||
48688001|NCT00540592|102020113|FG001|NOT COMPLETED|Overall Study||1||
48688002|NCT00540592|102020114|FG002|NOT COMPLETED|Overall Study||1||
48092108|NCT01084174|100548925|FG000|COMPLETED|Overall Study||9||
48092109|NCT01084174|100548926|FG001|COMPLETED|Overall Study||7||
48092110|NCT01084174|100548925|FG000|NOT COMPLETED|Overall Study||1||
48092111|NCT01084174|100548926|FG001|NOT COMPLETED|Overall Study||4||
48092112|NCT02738450|100548927|FG000|STARTED|Overall Study||6||
48092113|NCT02738450|100548928|FG001|STARTED|Overall Study||6||
48092114|NCT02738450|100548929|FG002|STARTED|Overall Study||4||
48092115|NCT02738450|100548927|FG000|COMPLETED|Overall Study||6||
48092116|NCT02738450|100548928|FG001|COMPLETED|Overall Study||4||
48092117|NCT02738450|100548929|FG002|COMPLETED|Overall Study||4||
48092118|NCT02738450|100548927|FG000|NOT COMPLETED|Overall Study||0||
48092119|NCT02738450|100548928|FG001|NOT COMPLETED|Overall Study||2||
48092120|NCT02738450|100548929|FG002|NOT COMPLETED|Overall Study||0||
48092121|NCT00661622|100548930|FG000|STARTED|Overall Study||26||
48092122|NCT00661622|100548931|FG001|STARTED|Overall Study||27||
48092123|NCT00661622|100548930|FG000|COMPLETED|Overall Study||25||
48092124|NCT00661622|100548931|FG001|COMPLETED|Overall Study||27||
48092125|NCT00661622|100548930|FG000|NOT COMPLETED|Overall Study||1||
48092126|NCT00661622|100548931|FG001|NOT COMPLETED|Overall Study||0||
48092127|NCT02111772|100548932|FG000|STARTED|Overall Study||12||
48092128|NCT02111772|100548933|FG001|STARTED|Overall Study||14||
48092129|NCT02111772|100548932|FG000|COMPLETED|Overall Study||12||
48092130|NCT02111772|100548933|FG001|COMPLETED|Overall Study||14||
48092131|NCT02111772|100548932|FG000|NOT COMPLETED|Overall Study||0||
48092132|NCT02111772|100548933|FG001|NOT COMPLETED|Overall Study||0||
48092133|NCT03134989|100548934|FG000|STARTED|Overall Study||80||
48092134|NCT03134989|100548934|FG000|COMPLETED|Overall Study||80||
48092135|NCT03134989|100548934|FG000|NOT COMPLETED|Overall Study||0||
48092136|NCT02315170|100548935|FG000|STARTED|Overall Study||50|Each participant will have one eye randomly selected to receive Intraocular Injection Guide and the other eye will receive Standard Speculum.|50
48092137|NCT02315170|100548936|FG001|STARTED|Overall Study||50|Each participant will have one eye randomly selected to receive Intraocular Injection Guide and the other eye will receive Standard Speculum.|50
48092138|NCT02315170|100548935|FG000|COMPLETED|Overall Study||50||50
48092139|NCT02315170|100548936|FG001|COMPLETED|Overall Study||50||50
48092140|NCT02315170|100548935|FG000|NOT COMPLETED|Overall Study||0||0
48092141|NCT02315170|100548936|FG001|NOT COMPLETED|Overall Study||0||0
48092142|NCT01344161|100548937|FG000|STARTED|Overall Study||43||
48688003|NCT00540592|102020115|FG003|NOT COMPLETED|Overall Study||1||
48688004|NCT00540592|102020116|FG004|NOT COMPLETED|Overall Study||1||
48688005|NCT00540592|102020117|FG005|NOT COMPLETED|Overall Study||0||
48688006|NCT00540592|102020118|FG006|NOT COMPLETED|Overall Study||0||
48688007|NCT00540592|102020119|FG007|NOT COMPLETED|Overall Study||1||
48092143|NCT01344161|100548938|FG001|STARTED|Overall Study||42||
48092144|NCT01344161|100548937|FG000|COMPLETED|Overall Study||38||
48092145|NCT01344161|100548938|FG001|COMPLETED|Overall Study||39||
48092146|NCT01344161|100548937|FG000|NOT COMPLETED|Overall Study||5||
48092147|NCT01344161|100548938|FG001|NOT COMPLETED|Overall Study||3||
48092148|NCT02560584|100548939|FG000|STARTED|Overall Study||304||
48092149|NCT02560584|100548939|FG000|COMPLETED|Overall Study||304||
48092150|NCT02560584|100548939|FG000|NOT COMPLETED|Overall Study||0||
48092151|NCT00536601|100548940|FG000|STARTED|Overall Study||6||
48092152|NCT00536601|100548941|FG001|STARTED|Overall Study||21||
48092153|NCT00536601|100548942|FG002|STARTED|Overall Study||71||
48092154|NCT00536601|100548943|FG003|STARTED|Overall Study||65||
48092155|NCT00536601|100548944|FG004|STARTED|Overall Study||11||
48092156|NCT00536601|100548940|FG000|COMPLETED|Overall Study||6||
48092157|NCT00536601|100548941|FG001|COMPLETED|Overall Study||21||
48092158|NCT00536601|100548942|FG002|COMPLETED|Overall Study||71||
48092159|NCT00536601|100548943|FG003|COMPLETED|Overall Study||65||
48092160|NCT00536601|100548944|FG004|COMPLETED|Overall Study||11||
48092161|NCT00536601|100548940|FG000|NOT COMPLETED|Overall Study||0||
48092162|NCT00536601|100548941|FG001|NOT COMPLETED|Overall Study||0||
48092163|NCT00536601|100548942|FG002|NOT COMPLETED|Overall Study||0||
48092164|NCT00536601|100548943|FG003|NOT COMPLETED|Overall Study||0||
48092165|NCT00536601|100548944|FG004|NOT COMPLETED|Overall Study||0||
48688008|NCT00540592|102020120|FG008|NOT COMPLETED|Overall Study||1||
48688009|NCT00540592|102020121|FG009|NOT COMPLETED|Overall Study||2||
48092166|NCT00656474|100548945|FG000|STARTED|Overall Study||12||
48092167|NCT00656474|100548945|FG000|COMPLETED|Overall Study||11||
48092168|NCT00656474|100548945|FG000|NOT COMPLETED|Overall Study||1||
48092169|NCT01454947|100548946|FG000|STARTED|Overall Study||27||
48092170|NCT01454947|100548947|FG001|STARTED|Overall Study||42||
48092171|NCT01454947|100548948|FG002|STARTED|Overall Study||35||
48092172|NCT01454947|100548949|FG003|STARTED|Overall Study||20||
48092173|NCT01454947|100548950|FG004|STARTED|Overall Study||34||
48092174|NCT01454947|100548951|FG005|STARTED|Overall Study||35||
48092175|NCT01454947|100548952|FG006|STARTED|Overall Study||27||
48092176|NCT01454947|100548953|FG007|STARTED|Overall Study||28||
48092177|NCT01454947|100548946|FG000|COMPLETED|Overall Study||24||
48688010|NCT03456700|102020122|FG000|STARTED|Overall Study||22||
48092178|NCT01454947|100548947|FG001|COMPLETED|Overall Study||38||
48092179|NCT01454947|100548948|FG002|COMPLETED|Overall Study||32||
48688011|NCT03456700|102020122|FG000|COMPLETED|Overall Study||21||
48688012|NCT03456700|102020122|FG000|NOT COMPLETED|Overall Study||1||
48688013|NCT00912782|102020123|FG000|STARTED|Overall Study||27||
48688014|NCT00912782|102020124|FG001|STARTED|Overall Study||25||
48688015|NCT00912782|102020123|FG000|COMPLETED|Overall Study||24||
48688016|NCT00912782|102020124|FG001|COMPLETED|Overall Study||20||
48688017|NCT00912782|102020123|FG000|NOT COMPLETED|Overall Study||3||
48688018|NCT00912782|102020124|FG001|NOT COMPLETED|Overall Study||5||
48688019|NCT01399229|102020125|FG000|STARTED|Overall Study||20||
48688020|NCT01399229|102020126|FG001|STARTED|Overall Study||5||
48688021|NCT01399229|102020127|FG002|STARTED|Overall Study||5||
48688022|NCT01399229|102020125|FG000|COMPLETED|Overall Study||20||
48688023|NCT01399229|102020126|FG001|COMPLETED|Overall Study||5||
48688024|NCT01399229|102020127|FG002|COMPLETED|Overall Study||5||
48688025|NCT01399229|102020125|FG000|NOT COMPLETED|Overall Study||0||
48688026|NCT01399229|102020126|FG001|NOT COMPLETED|Overall Study||0||
48688027|NCT01399229|102020127|FG002|NOT COMPLETED|Overall Study||0||
48688028|NCT01558115|102020128|FG000|STARTED|Overall Study||8||
48688029|NCT01558115|102020128|FG000|COMPLETED|Overall Study||1||
48688030|NCT01558115|102020128|FG000|NOT COMPLETED|Overall Study||7||
48688031|NCT00881530|102020129|FG000|STARTED|Overall Study||106||
48688032|NCT00881530|102020130|FG001|STARTED|Overall Study||109||
48688033|NCT00881530|102020131|FG002|STARTED|Overall Study||56||
48688034|NCT00881530|102020132|FG003|STARTED|Overall Study||166||
48688035|NCT00881530|102020133|FG004|STARTED|Overall Study||166||
48688036|NCT00881530|102020134|FG005|STARTED|Overall Study||56||
48688037|NCT00881530|102020129|FG000|COMPLETED|Overall Study||92||
48688038|NCT00881530|102020130|FG001|COMPLETED|Overall Study||104||
48688039|NCT00881530|102020131|FG002|COMPLETED|Overall Study||51||
48688040|NCT00881530|102020132|FG003|COMPLETED|Overall Study||157||
48688041|NCT00881530|102020133|FG004|COMPLETED|Overall Study||152||
48688042|NCT00881530|102020134|FG005|COMPLETED|Overall Study||51||
48688043|NCT00881530|102020129|FG000|NOT COMPLETED|Overall Study||14||
48688044|NCT00881530|102020130|FG001|NOT COMPLETED|Overall Study||5||
48688045|NCT00881530|102020131|FG002|NOT COMPLETED|Overall Study||5||
48688046|NCT00881530|102020132|FG003|NOT COMPLETED|Overall Study||9||
48688047|NCT00881530|102020133|FG004|NOT COMPLETED|Overall Study||14||
48688048|NCT00881530|102020134|FG005|NOT COMPLETED|Overall Study||5||
48688049|NCT03122145|102020135|FG000|STARTED|Overall Study||37||
48688050|NCT03122145|102020136|FG001|STARTED|Overall Study||12||
48688051|NCT03122145|102020135|FG000|COMPLETED|Overall Study||34||
48688052|NCT03122145|102020136|FG001|COMPLETED|Overall Study||12||
48688053|NCT03122145|102020135|FG000|NOT COMPLETED|Overall Study||3||
48688054|NCT03122145|102020136|FG001|NOT COMPLETED|Overall Study||0||
48688055|NCT03889028|102020137|FG000|STARTED|Overall Study||144||144
48688056|NCT03889028|102020138|FG001|STARTED|Overall Study||422||422
48688057|NCT03889028|102020139|FG002|STARTED|Overall Study||312||312
48688058|NCT03889028|102020137|FG000|COMPLETED|Overall Study||144||144
48688059|NCT03889028|102020138|FG001|COMPLETED|Overall Study||422||422
48688060|NCT03889028|102020139|FG002|COMPLETED|Overall Study||312||312
48688061|NCT03889028|102020137|FG000|NOT COMPLETED|Overall Study||0||0
48688062|NCT03889028|102020138|FG001|NOT COMPLETED|Overall Study||0||0
48688063|NCT03889028|102020139|FG002|NOT COMPLETED|Overall Study||0||0
48688064|NCT02445014|102020140|FG000|STARTED|Overall Study||3||
48688065|NCT02445014|102020140|FG000|COMPLETED|Overall Study||3||
48688066|NCT02445014|102020140|FG000|NOT COMPLETED|Overall Study||0||
48688067|NCT02151786|102020141|FG000|STARTED|Overall Study||1120||
48688068|NCT02151786|102020141|FG000|COMPLETED|Overall Study||1084||
48688069|NCT02151786|102020141|FG000|NOT COMPLETED|Overall Study||36||
48688070|NCT02688270|102020142|FG000|STARTED|Overall Study||16||
48688071|NCT02688270|102020143|FG001|STARTED|Overall Study||16||
48688072|NCT02688270|102020144|FG002|STARTED|Overall Study||17||
48688073|NCT02688270|102020145|FG003|STARTED|Overall Study||16||
48092180|NCT01454947|100548949|FG003|COMPLETED|Overall Study||19||
48092181|NCT01454947|100548950|FG004|COMPLETED|Overall Study||33||
48688074|NCT02688270|102020142|FG000|COMPLETED|Overall Study||16||
48688075|NCT02688270|102020143|FG001|COMPLETED|Overall Study||16||
48092182|NCT01454947|100548951|FG005|COMPLETED|Overall Study||32||
48092183|NCT01454947|100548952|FG006|COMPLETED|Overall Study||26||
48688076|NCT02688270|102020144|FG002|COMPLETED|Overall Study||17||
48688077|NCT02688270|102020145|FG003|COMPLETED|Overall Study||16||
48688078|NCT02688270|102020142|FG000|NOT COMPLETED|Overall Study||0||
48688079|NCT02688270|102020143|FG001|NOT COMPLETED|Overall Study||0||
48688080|NCT02688270|102020144|FG002|NOT COMPLETED|Overall Study||0||
48688081|NCT02688270|102020145|FG003|NOT COMPLETED|Overall Study||0||
48688082|NCT01815424|102020146|FG000|STARTED|Week 0 to 16||90||
48688083|NCT01815424|102020147|FG001|STARTED|Week 0 to 16||88||
48688084|NCT01815424|102020148|FG002|STARTED|Week 0 to 16||88||
48688085|NCT01815424|102020149|FG003|STARTED|Week 0 to 16||0||
48688086|NCT01815424|102020150|FG004|STARTED|Week 0 to 16||0||
48688087|NCT01815424|102020146|FG000|COMPLETED|Week 0 to 16||83||
48688088|NCT01815424|102020147|FG001|COMPLETED|Week 0 to 16||84||
48688089|NCT01815424|102020148|FG002|COMPLETED|Week 0 to 16||77||
48688090|NCT01815424|102020149|FG003|COMPLETED|Week 0 to 16||0||
48688091|NCT01815424|102020150|FG004|COMPLETED|Week 0 to 16||0||
48688092|NCT01815424|102020146|FG000|NOT COMPLETED|Week 0 to 16||7||
48688093|NCT01815424|102020147|FG001|NOT COMPLETED|Week 0 to 16||4||
48688094|NCT01815424|102020148|FG002|NOT COMPLETED|Week 0 to 16||11||
48688095|NCT01815424|102020149|FG003|NOT COMPLETED|Week 0 to 16||0||
48688096|NCT01815424|102020150|FG004|NOT COMPLETED|Week 0 to 16||0||
48688097|NCT01815424|102020146|FG000|STARTED|Week 16 to 52||83||
48688098|NCT01815424|102020147|FG001|STARTED|Week 16 to 52||84||
48688099|NCT01815424|102020148|FG002|STARTED|Week 16 to 52||0||
48688100|NCT01815424|102020149|FG003|STARTED|Week 16 to 52||38||
48688101|NCT01815424|102020150|FG004|STARTED|Week 16 to 52||39||
48688102|NCT01815424|102020146|FG000|COMPLETED|Week 16 to 52||81||
48688103|NCT01815424|102020147|FG001|COMPLETED|Week 16 to 52||79||
48688104|NCT01815424|102020148|FG002|COMPLETED|Week 16 to 52||0||
48688105|NCT01815424|102020149|FG003|COMPLETED|Week 16 to 52||35||
48688106|NCT01815424|102020150|FG004|COMPLETED|Week 16 to 52||36||
48688107|NCT01815424|102020146|FG000|NOT COMPLETED|Week 16 to 52||2||
48688108|NCT01815424|102020147|FG001|NOT COMPLETED|Week 16 to 52||5||
48688109|NCT01815424|102020148|FG002|NOT COMPLETED|Week 16 to 52||0||
48688110|NCT01815424|102020149|FG003|NOT COMPLETED|Week 16 to 52||3||
48688111|NCT01815424|102020150|FG004|NOT COMPLETED|Week 16 to 52||3||
48688112|NCT01295944|102020151|FG000|STARTED|Overall Study||35||
48256919|NCT03318783|100947865|FG001|COMPLETED|Overall Study||8||
48256920|NCT03318783|100947864|FG000|NOT COMPLETED|Overall Study||0||
48256921|NCT03318783|100947865|FG001|NOT COMPLETED|Overall Study||2||
48256922|NCT01502306|100947866|FG000|STARTED|Overall Study||1004||
48256923|NCT01502306|100947867|FG001|STARTED|Overall Study||1405||
48256924|NCT01502306|100947868|FG002|STARTED|Overall Study||1407||
48256925|NCT01502306|100947866|FG000|COMPLETED|Overall Study||1004||
48256926|NCT01502306|100947867|FG001|COMPLETED|Overall Study||1405||
48256927|NCT01502306|100947868|FG002|COMPLETED|Overall Study||1407||
48688113|NCT01295944|102020151|FG000|COMPLETED|Overall Study||17||
48688114|NCT01295944|102020151|FG000|NOT COMPLETED|Overall Study||18||
48688115|NCT02110485|102020152|FG000|STARTED|Overall Study||98||
48688116|NCT02110485|102020153|FG001|STARTED|Overall Study||102||
48688117|NCT02110485|102020152|FG000|COMPLETED|Overall Study||91||
48256928|NCT01502306|100947866|FG000|NOT COMPLETED|Overall Study||0||
48256929|NCT01502306|100947867|FG001|NOT COMPLETED|Overall Study||0||
48256930|NCT01502306|100947868|FG002|NOT COMPLETED|Overall Study||0||
48256931|NCT00409409|100947869|FG000|STARTED|Overall Study||139||
48256932|NCT00409409|100947870|FG001|STARTED|Overall Study||139||
48256933|NCT00409409|100947869|FG000|COMPLETED|Overall Study||131||
48256934|NCT00409409|100947870|FG001|COMPLETED|Overall Study||135||
48256935|NCT00409409|100947869|FG000|NOT COMPLETED|Overall Study||8||
48256936|NCT00409409|100947870|FG001|NOT COMPLETED|Overall Study||4||
48256937|NCT02023905|100947871|FG000|STARTED|Overall Study||16||
48256938|NCT02023905|100947872|FG001|STARTED|Overall Study||2||
48256939|NCT02023905|100947873|FG002|STARTED|Overall Study||9||
48256940|NCT02023905|100947871|FG000|COMPLETED|Overall Study||16||
48256941|NCT02023905|100947872|FG001|COMPLETED|Overall Study||2||
48256942|NCT02023905|100947873|FG002|COMPLETED|Overall Study||9||
48688118|NCT02110485|102020153|FG001|COMPLETED|Overall Study||83||
48688119|NCT02110485|102020152|FG000|NOT COMPLETED|Overall Study||7||
48256943|NCT02023905|100947871|FG000|NOT COMPLETED|Overall Study||0||
48688120|NCT02110485|102020153|FG001|NOT COMPLETED|Overall Study||19||
48256944|NCT02023905|100947872|FG001|NOT COMPLETED|Overall Study||0||
48256945|NCT02023905|100947873|FG002|NOT COMPLETED|Overall Study||0||
48256946|NCT01584518|100947874|FG000|STARTED|Overall Study||25||
48256947|NCT01584518|100947875|FG001|STARTED|Overall Study||25||
48092184|NCT01454947|100548953|FG007|COMPLETED|Overall Study||23||
48092185|NCT01454947|100548946|FG000|NOT COMPLETED|Overall Study||3||
48092186|NCT01454947|100548947|FG001|NOT COMPLETED|Overall Study||4||
48092187|NCT01454947|100548948|FG002|NOT COMPLETED|Overall Study||3||
48092188|NCT01454947|100548949|FG003|NOT COMPLETED|Overall Study||1||
48092189|NCT01454947|100548950|FG004|NOT COMPLETED|Overall Study||1||
48092190|NCT01454947|100548951|FG005|NOT COMPLETED|Overall Study||3||
48092191|NCT01454947|100548952|FG006|NOT COMPLETED|Overall Study||1||
48092192|NCT01454947|100548953|FG007|NOT COMPLETED|Overall Study||5||
48092193|NCT00848367|100548954|FG000|STARTED|Overall Study||52||
48092194|NCT00848367|100548955|FG001|STARTED|Overall Study||50||
48092195|NCT00848367|100548954|FG000|COMPLETED|Overall Study||43||
48092196|NCT00848367|100548955|FG001|COMPLETED|Overall Study||41||
48092197|NCT00848367|100548954|FG000|NOT COMPLETED|Overall Study||9||
48092198|NCT00848367|100548955|FG001|NOT COMPLETED|Overall Study||9||
48092199|NCT02998840|100548956|FG000|STARTED|Overall Study||33||
48092200|NCT02998840|100548957|FG001|STARTED|Overall Study||33||
48092201|NCT02998840|100548958|FG002|STARTED|Overall Study||33||
48092202|NCT02998840|100548959|FG003|STARTED|Overall Study||33||
48092203|NCT02998840|100548956|FG000|COMPLETED|Overall Study||29||
48092204|NCT02998840|100548957|FG001|COMPLETED|Overall Study||30||
48092205|NCT02998840|100548958|FG002|COMPLETED|Overall Study||31||
48092206|NCT02998840|100548959|FG003|COMPLETED|Overall Study||28||
48092207|NCT02998840|100548956|FG000|NOT COMPLETED|Overall Study||4||
48092208|NCT02998840|100548957|FG001|NOT COMPLETED|Overall Study||3||
48092209|NCT02998840|100548958|FG002|NOT COMPLETED|Overall Study||2||
48092210|NCT02998840|100548959|FG003|NOT COMPLETED|Overall Study||5||
48092211|NCT02426892|100548960|FG000|STARTED|Overall Study||24||
48092212|NCT02426892|100548960|FG000|COMPLETED|Overall Study||4||
48092213|NCT02426892|100548960|FG000|NOT COMPLETED|Overall Study||20||
48092214|NCT00323115|100548961|FG000|STARTED|Vaccine Administration||11||
48092215|NCT00323115|100548961|FG000|COMPLETED|Vaccine Administration||10||
48092216|NCT00323115|100548961|FG000|NOT COMPLETED|Vaccine Administration||1||
48092217|NCT00323115|100548961|FG000|STARTED|Adjuvant Therapy & Survival Follow-Up||10||
48092218|NCT00323115|100548961|FG000|COMPLETED|Adjuvant Therapy & Survival Follow-Up||2||
48092219|NCT00323115|100548961|FG000|NOT COMPLETED|Adjuvant Therapy & Survival Follow-Up||8||
48092220|NCT02564042|100548962|FG000|STARTED|Overall Study||38||
48092221|NCT02564042|100548963|FG001|STARTED|Overall Study||38||
48092222|NCT02564042|100548964|FG002|STARTED|Overall Study||38||
48092223|NCT02564042|100548965|FG003|STARTED|Overall Study||38||
48092224|NCT02564042|100548966|FG004|STARTED|Overall Study||37||
48092225|NCT02564042|100548967|FG005|STARTED|Overall Study||38||
48092226|NCT02564042|100548962|FG000|COMPLETED|Overall Study||27||
48092227|NCT02564042|100548963|FG001|COMPLETED|Overall Study||30||
48092228|NCT02564042|100548964|FG002|COMPLETED|Overall Study||32||
48092229|NCT02564042|100548965|FG003|COMPLETED|Overall Study||35||
48092230|NCT02564042|100548966|FG004|COMPLETED|Overall Study||26||
48092231|NCT02564042|100548967|FG005|COMPLETED|Overall Study||24||
48092232|NCT02564042|100548962|FG000|NOT COMPLETED|Overall Study||11||
48092233|NCT02564042|100548963|FG001|NOT COMPLETED|Overall Study||8||
48092234|NCT02564042|100548964|FG002|NOT COMPLETED|Overall Study||6||
48092235|NCT02564042|100548965|FG003|NOT COMPLETED|Overall Study||3||
48092236|NCT02564042|100548966|FG004|NOT COMPLETED|Overall Study||11||
48092237|NCT02564042|100548967|FG005|NOT COMPLETED|Overall Study||14||
48092238|NCT02129725|100548968|FG000|STARTED|Overall Study||8||
48092239|NCT02129725|100548969|FG001|STARTED|Overall Study||7||
48092240|NCT02129725|100548968|FG000|COMPLETED|Overall Study||6||
48092241|NCT02129725|100548969|FG001|COMPLETED|Overall Study||4||
48256948|NCT01584518|100947874|FG000|COMPLETED|Overall Study||25||
48256949|NCT01584518|100947875|FG001|COMPLETED|Overall Study||25||
48688121|NCT00841412|102020154|FG000|STARTED|Overall Study||120||
48688122|NCT00841412|102020155|FG001|STARTED|Overall Study||80||
48092242|NCT02129725|100548968|FG000|NOT COMPLETED|Overall Study||2||
48256950|NCT01584518|100947874|FG000|NOT COMPLETED|Overall Study||0||
48256951|NCT01584518|100947875|FG001|NOT COMPLETED|Overall Study||0||
48092243|NCT02129725|100548969|FG001|NOT COMPLETED|Overall Study||3||
48092244|NCT03395886|100548970|FG000|STARTED|Overall Study||52||
48092245|NCT03395886|100548971|FG001|STARTED|Overall Study||38||
48092246|NCT03395886|100548970|FG000|COMPLETED|Overall Study||0||
48092247|NCT03395886|100548971|FG001|COMPLETED|Overall Study||0||
48092248|NCT03395886|100548970|FG000|NOT COMPLETED|Overall Study||52||
48092249|NCT03395886|100548971|FG001|NOT COMPLETED|Overall Study||38||
48092250|NCT01918761|100548972|FG000|STARTED|Overall Study||5||
48092251|NCT01918761|100548972|FG000|COMPLETED|Overall Study||5||
48092252|NCT01918761|100548972|FG000|NOT COMPLETED|Overall Study||0||
48092253|NCT02642614|100548973|FG000|STARTED|Overall Study||30||
48256952|NCT00371462|100947876|FG000|STARTED|Overall Study||35||
48688123|NCT00841412|102020154|FG000|COMPLETED|Overall Study||80||
48688124|NCT00841412|102020155|FG001|COMPLETED|Overall Study||50||
48092254|NCT02642614|100548974|FG001|STARTED|Overall Study||30||
48092255|NCT02642614|100548975|FG002|STARTED|Overall Study||30||
48092256|NCT02642614|100548976|FG003|STARTED|Overall Study||30||
48092257|NCT02642614|100548973|FG000|COMPLETED|Overall Study||27||
48384240|NCT00064350|101269424|FG001|COMPLETED|Randomization||28||
48384241|NCT00064350|101269425|FG002|COMPLETED|Randomization||0||
48384242|NCT00064350|101269423|FG000|NOT COMPLETED|Randomization||26||
48384243|NCT00064350|101269424|FG001|NOT COMPLETED|Randomization||18||
48384244|NCT00064350|101269425|FG002|NOT COMPLETED|Randomization||0||
48384245|NCT00064350|101269423|FG000|STARTED|Cross-Over||10||
48384246|NCT00064350|101269424|FG001|STARTED|Cross-Over||27||
48384247|NCT00064350|101269425|FG002|STARTED|Cross-Over||0||
48384248|NCT00064350|101269423|FG000|Treated|Cross-Over||9||
48384249|NCT00064350|101269424|FG001|Treated|Cross-Over||26||
48384250|NCT00064350|101269425|FG002|Treated|Cross-Over||0||
48384251|NCT00064350|101269423|FG000|Eligible and Treated|Cross-Over||7||
48384252|NCT00064350|101269424|FG001|Eligible and Treated|Cross-Over||21||
48384253|NCT00064350|101269425|FG002|Eligible and Treated|Cross-Over||0||
48384254|NCT00064350|101269423|FG000|COMPLETED|Cross-Over||4||
48384255|NCT00064350|101269424|FG001|COMPLETED|Cross-Over||13||
48384256|NCT00064350|101269425|FG002|COMPLETED|Cross-Over||0||
48092258|NCT02642614|100548974|FG001|COMPLETED|Overall Study||28||
48092259|NCT02642614|100548975|FG002|COMPLETED|Overall Study||28||
48092260|NCT02642614|100548976|FG003|COMPLETED|Overall Study||28||
48092261|NCT02642614|100548973|FG000|NOT COMPLETED|Overall Study||3||
48092262|NCT02642614|100548974|FG001|NOT COMPLETED|Overall Study||2||
48092263|NCT02642614|100548975|FG002|NOT COMPLETED|Overall Study||2||
48092264|NCT02642614|100548976|FG003|NOT COMPLETED|Overall Study||2||
48092265|NCT00632411|100548977|FG000|STARTED|Overall Study||649||
48092266|NCT00632411|100548978|FG001|STARTED|Overall Study||649||
48092267|NCT00632411|100548977|FG000|COMPLETED|Overall Study||489||
48092268|NCT00632411|100548978|FG001|COMPLETED|Overall Study||473||
48092269|NCT00632411|100548977|FG000|NOT COMPLETED|Overall Study||160||
48092270|NCT00632411|100548978|FG001|NOT COMPLETED|Overall Study||176||
48256953|NCT00371462|100947877|FG001|STARTED|Overall Study||35||
48092271|NCT04492618|100548979|FG000|STARTED|Overall Study||12||
48256954|NCT00371462|100947876|FG000|COMPLETED|Overall Study||27||
48256955|NCT00371462|100947877|FG001|COMPLETED|Overall Study||27||
48256956|NCT00371462|100947876|FG000|NOT COMPLETED|Overall Study||8||
48256957|NCT00371462|100947877|FG001|NOT COMPLETED|Overall Study||8||
48256958|NCT04081389|100947878|FG000|STARTED|Overall Study||1||
48256959|NCT04081389|100947879|FG001|STARTED|Overall Study||1||
48256960|NCT04081389|100947880|FG002|STARTED|Overall Study||4||
48256961|NCT04081389|100947881|FG003|STARTED|Overall Study||3||
48256962|NCT04081389|100947878|FG000|COMPLETED|Overall Study||1||
48256963|NCT04081389|100947879|FG001|COMPLETED|Overall Study||1||
48256964|NCT04081389|100947880|FG002|COMPLETED|Overall Study||3||
48256965|NCT04081389|100947881|FG003|COMPLETED|Overall Study||3||
48256966|NCT04081389|100947878|FG000|NOT COMPLETED|Overall Study||0||
48256967|NCT04081389|100947879|FG001|NOT COMPLETED|Overall Study||0||
48256968|NCT04081389|100947880|FG002|NOT COMPLETED|Overall Study||1||
48256969|NCT04081389|100947881|FG003|NOT COMPLETED|Overall Study||0||
48256970|NCT02650986|100947882|FG000|STARTED|Overall Study||3||
48256971|NCT02650986|100947883|FG001|STARTED|Overall Study||3||
48256972|NCT02650986|100947884|FG002|STARTED|Overall Study||3||
48256973|NCT02650986|100947885|FG003|STARTED|Overall Study||6||
48256974|NCT02650986|100947882|FG000|COMPLETED|Overall Study||3||
48256975|NCT02650986|100947883|FG001|COMPLETED|Overall Study||3||
48256976|NCT02650986|100947884|FG002|COMPLETED|Overall Study||3||
48256977|NCT02650986|100947885|FG003|COMPLETED|Overall Study||6||
48384257|NCT00064350|101269423|FG000|NOT COMPLETED|Cross-Over||6||
48384258|NCT00064350|101269424|FG001|NOT COMPLETED|Cross-Over||14||
48384259|NCT00064350|101269425|FG002|NOT COMPLETED|Cross-Over||0||
48384260|NCT04427917|101269426|FG000|STARTED|Overall Study||2||
48384261|NCT04427917|101269427|FG001|STARTED|Overall Study||6||
48384262|NCT04427917|101269426|FG000|COMPLETED|Overall Study||2||
48384263|NCT04427917|101269427|FG001|COMPLETED|Overall Study||6||
48384264|NCT04427917|101269426|FG000|NOT COMPLETED|Overall Study||0||
48384265|NCT04427917|101269427|FG001|NOT COMPLETED|Overall Study||0||
48384266|NCT00789958|101269428|FG000|STARTED|Overall Study||105||
48384267|NCT00789958|101269428|FG000|Eligible and Analyzable|Overall Study||79||
48384268|NCT00789958|101269428|FG000|COMPLETED|Overall Study||68||
48384269|NCT00789958|101269428|FG000|NOT COMPLETED|Overall Study||37||
48384270|NCT04550221|101269429|FG000|STARTED|Overall Study||32||
48384271|NCT04550221|101269430|FG001|STARTED|Overall Study||31||
48384272|NCT04550221|101269429|FG000|Month 1 Visit|Overall Study||29||
48384273|NCT04550221|101269430|FG001|Month 1 Visit|Overall Study||31||
48384274|NCT04550221|101269429|FG000|Month 3 Visit|Overall Study||29||
48384275|NCT04550221|101269430|FG001|Month 3 Visit|Overall Study||30||
48384276|NCT04550221|101269429|FG000|Month 6 Visit|Overall Study||27||
48384277|NCT04550221|101269430|FG001|Month 6 Visit|Overall Study||27||
48384278|NCT04550221|101269429|FG000|Exit Interviews|Overall Study||28||
48384279|NCT04550221|101269430|FG001|Exit Interviews|Overall Study||0||
48384280|NCT04550221|101269429|FG000|COMPLETED|Overall Study||27||
48384281|NCT04550221|101269430|FG001|COMPLETED|Overall Study||27||
48384282|NCT04550221|101269429|FG000|NOT COMPLETED|Overall Study||5||
48384283|NCT04550221|101269430|FG001|NOT COMPLETED|Overall Study||4||
48384284|NCT01098461|101269431|FG000|STARTED|Treatment Period (TP) (16 Weeks)||53||
48384285|NCT01098461|101269432|FG001|STARTED|Treatment Period (TP) (16 Weeks)||52||
48384286|NCT01098461|101269433|FG002|STARTED|Treatment Period (TP) (16 Weeks)||54||
48384287|NCT01098461|101269434|FG003|STARTED|Treatment Period (TP) (16 Weeks)||53||
48384288|NCT01098461|101269431|FG000|COMPLETED|Treatment Period (TP) (16 Weeks)||41||
48384289|NCT01098461|101269432|FG001|COMPLETED|Treatment Period (TP) (16 Weeks)||45||
48384290|NCT01098461|101269433|FG002|COMPLETED|Treatment Period (TP) (16 Weeks)||53||
48384291|NCT01098461|101269434|FG003|COMPLETED|Treatment Period (TP) (16 Weeks)||50||
48384292|NCT01098461|101269431|FG000|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||12||
48384293|NCT01098461|101269432|FG001|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||7||
48384294|NCT01098461|101269433|FG002|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||1||
48688125|NCT00841412|102020154|FG000|NOT COMPLETED|Overall Study||40||
48688126|NCT00841412|102020155|FG001|NOT COMPLETED|Overall Study||30||
48688127|NCT00730353|102020156|FG000|STARTED|Overall Study||28||
48688128|NCT00730353|102020156|FG000|COMPLETED|Overall Study||28||
48688129|NCT00730353|102020156|FG000|NOT COMPLETED|Overall Study||0||
48688130|NCT01869634|102020157|FG000|STARTED|Overall Study||20||
48688131|NCT01869634|102020158|FG001|STARTED|Overall Study||17||
48688132|NCT01869634|102020157|FG000|COMPLETED|Overall Study||18||
48688133|NCT01869634|102020158|FG001|COMPLETED|Overall Study||17||
48688134|NCT01869634|102020157|FG000|NOT COMPLETED|Overall Study||2||
48688135|NCT01869634|102020158|FG001|NOT COMPLETED|Overall Study||0||
48688136|NCT02725476|102020159|FG000|STARTED|Overall Study||15||
48688137|NCT02725476|102020160|FG001|STARTED|Overall Study||5||
48688138|NCT02725476|102020159|FG000|COMPLETED|Overall Study||12||
48688139|NCT02725476|102020160|FG001|COMPLETED|Overall Study||4||
48688140|NCT02725476|102020159|FG000|NOT COMPLETED|Overall Study||3||
48688141|NCT02725476|102020160|FG001|NOT COMPLETED|Overall Study||1||
48384295|NCT01098461|101269434|FG003|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||3||
48384296|NCT01098461|101269431|FG000|STARTED|Follow-up (FU) Period (8 Weeks)||52||
48384297|NCT01098461|101269432|FG001|STARTED|Follow-up (FU) Period (8 Weeks)||52||
48384298|NCT01098461|101269433|FG002|STARTED|Follow-up (FU) Period (8 Weeks)||53||
48384299|NCT01098461|101269434|FG003|STARTED|Follow-up (FU) Period (8 Weeks)||52||
48384300|NCT01098461|101269431|FG000|COMPLETED|Follow-up (FU) Period (8 Weeks)||52||
48384301|NCT01098461|101269432|FG001|COMPLETED|Follow-up (FU) Period (8 Weeks)||49||
48384302|NCT01098461|101269433|FG002|COMPLETED|Follow-up (FU) Period (8 Weeks)||52||
48384303|NCT01098461|101269434|FG003|COMPLETED|Follow-up (FU) Period (8 Weeks)||52||
48384304|NCT01098461|101269431|FG000|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0||
48384305|NCT01098461|101269432|FG001|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||3||
48384306|NCT01098461|101269433|FG002|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||1||
48384307|NCT01098461|101269434|FG003|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0||
48384308|NCT00976950|101269435|FG000|STARTED|Overall Study||42||
48384309|NCT00976950|101269435|FG000|COMPLETED|Overall Study||36||
48688142|NCT00258908|102020161|FG000|STARTED|Overall Study||112||
48688143|NCT00258908|102020161|FG000|COMPLETED|Overall Study||112||
48688144|NCT00258908|102020161|FG000|NOT COMPLETED|Overall Study||0||
48688145|NCT02549989|102020162|FG000|STARTED|Overall Study||28||
48688146|NCT02549989|102020162|FG000|COMPLETED|Overall Study||1||
48688147|NCT02549989|102020162|FG000|NOT COMPLETED|Overall Study||27||
48688148|NCT01618240|102020163|FG000|STARTED|Overall Study||30||
48688149|NCT01618240|102020163|FG000|COMPLETED|Overall Study||30||
48688150|NCT01618240|102020163|FG000|NOT COMPLETED|Overall Study||0||
48384310|NCT00976950|101269435|FG000|NOT COMPLETED|Overall Study||6||
48384311|NCT01819311|101269436|FG000|STARTED|Treatment Phase (4 Weeks)||33||
48384312|NCT01819311|101269437|FG001|STARTED|Treatment Phase (4 Weeks)||31||
48384313|NCT01819311|101269436|FG000|COMPLETED|Treatment Phase (4 Weeks)||31||
48384314|NCT01819311|101269437|FG001|COMPLETED|Treatment Phase (4 Weeks)||30||
48384315|NCT01819311|101269436|FG000|NOT COMPLETED|Treatment Phase (4 Weeks)||2||
48384316|NCT01819311|101269437|FG001|NOT COMPLETED|Treatment Phase (4 Weeks)||1||
48384317|NCT01819311|101269436|FG000|STARTED|Follow-up Phase (8 Weeks)||31||
48384318|NCT01819311|101269437|FG001|STARTED|Follow-up Phase (8 Weeks)||30||
48384319|NCT01819311|101269436|FG000|COMPLETED|Follow-up Phase (8 Weeks)||24||
48384320|NCT01819311|101269437|FG001|COMPLETED|Follow-up Phase (8 Weeks)||23||
48384321|NCT01819311|101269436|FG000|NOT COMPLETED|Follow-up Phase (8 Weeks)||7||
48384322|NCT01819311|101269437|FG001|NOT COMPLETED|Follow-up Phase (8 Weeks)||7||
48384323|NCT04863417|101269438|FG000|STARTED|Overall Study||4||
48384324|NCT04863417|101269439|FG001|STARTED|Overall Study||2||
48384325|NCT04863417|101269440|FG002|STARTED|Overall Study||4||
48384326|NCT04863417|101269441|FG003|STARTED|Overall Study||2||
48384327|NCT04863417|101269438|FG000|COMPLETED|Overall Study||4||
48384328|NCT04863417|101269439|FG001|COMPLETED|Overall Study||2||
48384329|NCT04863417|101269440|FG002|COMPLETED|Overall Study||4||
48384330|NCT04863417|101269441|FG003|COMPLETED|Overall Study||2||
48384331|NCT04863417|101269438|FG000|NOT COMPLETED|Overall Study||0||
48384332|NCT04863417|101269439|FG001|NOT COMPLETED|Overall Study||0||
48384333|NCT04863417|101269440|FG002|NOT COMPLETED|Overall Study||0||
48384334|NCT04863417|101269441|FG003|NOT COMPLETED|Overall Study||0||
48384335|NCT05590767|101269442|FG000|STARTED|Overall Study||40||
48384336|NCT05590767|101269442|FG000|COMPLETED|Overall Study||37||
48384337|NCT05590767|101269442|FG000|NOT COMPLETED|Overall Study||3||
48384338|NCT00946881|101269443|FG000|STARTED|First Treatment||30||
48384339|NCT00946881|101269443|FG000|COMPLETED|First Treatment||28||
48384340|NCT00946881|101269443|FG000|NOT COMPLETED|First Treatment||2||
48384341|NCT00946881|101269443|FG000|STARTED|Retreatment||8||
48384342|NCT00946881|101269443|FG000|COMPLETED|Retreatment||7||
48384343|NCT00946881|101269443|FG000|NOT COMPLETED|Retreatment||1||
48384344|NCT01575197|101269444|FG000|STARTED|Overall Study||152||
48384345|NCT01575197|101269445|FG001|STARTED|Overall Study||152||
48384346|NCT01575197|101269446|FG002|STARTED|Overall Study||152||
48688151|NCT03902392|102020164|FG000|STARTED|Overall Study||25||
48688152|NCT03902392|102020165|FG001|STARTED|Overall Study||25||
48688153|NCT03902392|102020164|FG000|COMPLETED|Overall Study||18||
48688154|NCT03902392|102020165|FG001|COMPLETED|Overall Study||18||
48688155|NCT03902392|102020164|FG000|NOT COMPLETED|Overall Study||7||
48688156|NCT03902392|102020165|FG001|NOT COMPLETED|Overall Study||7||
48688157|NCT01926444|102020166|FG000|STARTED|Overall Study||56||
48688158|NCT01926444|102020167|FG001|STARTED|Overall Study||52||
48688159|NCT01926444|102020168|FG002|STARTED|Overall Study||57||
48688160|NCT01926444|102020169|FG003|STARTED|Overall Study||103||
48688161|NCT01926444|102020166|FG000|COMPLETED|Overall Study||56||
48688162|NCT01926444|102020167|FG001|COMPLETED|Overall Study||52||
48256978|NCT02650986|100947882|FG000|NOT COMPLETED|Overall Study||0||
48256979|NCT02650986|100947883|FG001|NOT COMPLETED|Overall Study||0||
48256980|NCT02650986|100947884|FG002|NOT COMPLETED|Overall Study||0||
48256981|NCT02650986|100947885|FG003|NOT COMPLETED|Overall Study||0||
48256982|NCT03990298|100947886|FG000|STARTED|Overall Study||16||
48256983|NCT03990298|100947886|FG000|COMPLETED|Overall Study||16||
48256984|NCT03990298|100947886|FG000|NOT COMPLETED|Overall Study||0||
48384347|NCT01575197|101269444|FG000|COMPLETED|Overall Study||149||
48384348|NCT01575197|101269445|FG001|COMPLETED|Overall Study||143||
48384349|NCT01575197|101269446|FG002|COMPLETED|Overall Study||146||
48384350|NCT01575197|101269444|FG000|NOT COMPLETED|Overall Study||3||
48384351|NCT01575197|101269445|FG001|NOT COMPLETED|Overall Study||9||
48384352|NCT01575197|101269446|FG002|NOT COMPLETED|Overall Study||6||
48384353|NCT00668200|101269447|FG000|STARTED|Overall Study||80||
48384354|NCT00668200|101269447|FG000|Safety Population|Overall Study||81||
48384355|NCT00668200|101269447|FG000|Intent to Treat (ITT)|Overall Study||80||
48384356|NCT00668200|101269447|FG000|COMPLETED|Overall Study||77||
48384357|NCT00668200|101269447|FG000|NOT COMPLETED|Overall Study||3||
48256985|NCT00607997|100947887|FG000|STARTED|Overall Study||29||
48256986|NCT00607997|100947888|FG001|STARTED|Overall Study||35||
48256987|NCT00607997|100947889|FG002|STARTED|Overall Study||29||
48384358|NCT00258206|101269448|FG000|STARTED|Overall Study||21||
48384359|NCT00258206|101269448|FG000|COMPLETED|Overall Study||21||
48384360|NCT00258206|101269448|FG000|NOT COMPLETED|Overall Study||0||
48384361|NCT00643487|101269449|FG000|STARTED|Overall Study||8||
48384362|NCT00643487|101269449|FG000|COMPLETED|Overall Study||5||
48384363|NCT00643487|101269449|FG000|NOT COMPLETED|Overall Study||3||
48688163|NCT01926444|102020168|FG002|COMPLETED|Overall Study||53||
48688164|NCT01926444|102020169|FG003|COMPLETED|Overall Study||101||
48688165|NCT01926444|102020166|FG000|NOT COMPLETED|Overall Study||0||
48256988|NCT00607997|100947890|FG003|STARTED|Overall Study||20||
48384364|NCT04597619|101269450|FG000|STARTED|Overall Study||20||
48384365|NCT04597619|101269451|FG001|STARTED|Overall Study||10||
48384366|NCT04597619|101269450|FG000|COMPLETED|Overall Study||14||
48384367|NCT04597619|101269451|FG001|COMPLETED|Overall Study||6||
48384368|NCT04597619|101269450|FG000|NOT COMPLETED|Overall Study||6||
48384369|NCT04597619|101269451|FG001|NOT COMPLETED|Overall Study||4||
48384370|NCT00448760|101269452|FG000|STARTED|Overall Study||29||
48384371|NCT00448760|101269452|FG000|COMPLETED|Overall Study||26||
48384372|NCT00448760|101269452|FG000|NOT COMPLETED|Overall Study||3||
48384373|NCT00418964|101269453|FG000|STARTED|Overall Study||22||
48384374|NCT00418964|101269454|FG001|STARTED|Overall Study||20||
48384375|NCT00418964|101269455|FG002|STARTED|Overall Study||20||
48384376|NCT00418964|101269453|FG000|COMPLETED|Overall Study||21||
48384377|NCT00418964|101269454|FG001|COMPLETED|Overall Study||17||
48384378|NCT00418964|101269455|FG002|COMPLETED|Overall Study||14||
48384379|NCT00418964|101269453|FG000|NOT COMPLETED|Overall Study||1||
48384380|NCT00418964|101269454|FG001|NOT COMPLETED|Overall Study||3||
48384381|NCT00418964|101269455|FG002|NOT COMPLETED|Overall Study||6||
48384382|NCT00805545|101269456|FG000|STARTED|Overall Study||200||
48384383|NCT00805545|101269457|FG001|STARTED|Overall Study||200||
48384384|NCT00805545|101269456|FG000|COMPLETED|Overall Study||194||
48256989|NCT00607997|100947887|FG000|COMPLETED|Overall Study||2||
48256990|NCT00607997|100947888|FG001|COMPLETED|Overall Study||8||
48256991|NCT00607997|100947889|FG002|COMPLETED|Overall Study||5||
48256992|NCT00607997|100947890|FG003|COMPLETED|Overall Study||4||
48256993|NCT00607997|100947887|FG000|NOT COMPLETED|Overall Study||27||
48256994|NCT00607997|100947888|FG001|NOT COMPLETED|Overall Study||27||
48384385|NCT00805545|101269457|FG001|COMPLETED|Overall Study||197||
48384386|NCT00805545|101269456|FG000|NOT COMPLETED|Overall Study||6||
48384387|NCT00805545|101269457|FG001|NOT COMPLETED|Overall Study||3||
48384388|NCT00255086|101269458|FG000|STARTED|Overall Study||9||
48384389|NCT00255086|101269459|FG001|STARTED|Overall Study||8||
48384390|NCT00255086|101269458|FG000|COMPLETED|Overall Study||7||
48092272|NCT04492618|100548979|FG000|COMPLETED|Overall Study||11||
48092273|NCT04492618|100548979|FG000|NOT COMPLETED|Overall Study||1||
48092274|NCT00818662|100548980|FG000|STARTED|Overall Study||127||
48092275|NCT00818662|100548981|FG001|STARTED|Overall Study||135||
48092276|NCT00818662|100548982|FG002|STARTED|Overall Study||58||
48092277|NCT00818662|100548983|FG003|STARTED|Overall Study||63||
48256995|NCT00607997|100947889|FG002|NOT COMPLETED|Overall Study||24||
48256996|NCT00607997|100947890|FG003|NOT COMPLETED|Overall Study||16||
48384391|NCT00255086|101269459|FG001|COMPLETED|Overall Study||6||
48384392|NCT00255086|101269458|FG000|NOT COMPLETED|Overall Study||2||
48384393|NCT00255086|101269459|FG001|NOT COMPLETED|Overall Study||2||
48384394|NCT01740388|101269460|FG000|STARTED|Overall Study||64||
48384395|NCT01740388|101269461|FG001|STARTED|Overall Study||72||
48384396|NCT01740388|101269460|FG000|COMPLETED|Overall Study||18||
48384397|NCT01740388|101269461|FG001|COMPLETED|Overall Study||28||
48384398|NCT01740388|101269460|FG000|NOT COMPLETED|Overall Study||46||
48384399|NCT01740388|101269461|FG001|NOT COMPLETED|Overall Study||44||
48384400|NCT04124692|101269462|FG000|STARTED|Overall Study||52||
48384401|NCT04124692|101269463|FG001|STARTED|Overall Study||97||
48384402|NCT04124692|101269462|FG000|COMPLETED|Overall Study||46||
48384403|NCT04124692|101269463|FG001|COMPLETED|Overall Study||88||
48092278|NCT00818662|100548980|FG000|COMPLETED|Overall Study||104||
48092279|NCT00818662|100548981|FG001|COMPLETED|Overall Study||102||
48092280|NCT00818662|100548982|FG002|COMPLETED|Overall Study||49||
48092281|NCT00818662|100548983|FG003|COMPLETED|Overall Study||47||
48092282|NCT00818662|100548980|FG000|NOT COMPLETED|Overall Study||23||
48092283|NCT00818662|100548981|FG001|NOT COMPLETED|Overall Study||33||
48092284|NCT00818662|100548982|FG002|NOT COMPLETED|Overall Study||9||
48092285|NCT00818662|100548983|FG003|NOT COMPLETED|Overall Study||16||
48256997|NCT03022578|100947891|FG000|STARTED|Overall Study||4||
48256998|NCT03022578|100947891|FG000|COMPLETED|Overall Study||0||
48256999|NCT03022578|100947891|FG000|NOT COMPLETED|Overall Study||4||
48257000|NCT01227928|100947892|FG000|STARTED|Overall Study||72||
48257001|NCT01227928|100947893|FG001|STARTED|Overall Study||73||
48257002|NCT01227928|100947892|FG000|COMPLETED|Overall Study||50||
48257003|NCT01227928|100947893|FG001|COMPLETED|Overall Study||56||
48257004|NCT01227928|100947892|FG000|NOT COMPLETED|Overall Study||22||
48257005|NCT01227928|100947893|FG001|NOT COMPLETED|Overall Study||17||
48257006|NCT01402063|100947894|FG000|STARTED|Overall Study||42||
48257007|NCT01402063|100947895|FG001|STARTED|Overall Study||21||
48257008|NCT01402063|100947894|FG000|COMPLETED|Overall Study||39||
48257009|NCT01402063|100947895|FG001|COMPLETED|Overall Study||18||
48384404|NCT04124692|101269462|FG000|NOT COMPLETED|Overall Study||6||
48384405|NCT04124692|101269463|FG001|NOT COMPLETED|Overall Study||9||
48257010|NCT01402063|100947894|FG000|NOT COMPLETED|Overall Study||3||
48384406|NCT01185249|101269464|FG000|STARTED|Overall Study||66||
48384407|NCT01185249|101269464|FG000|COMPLETED|Overall Study||24||
48384408|NCT01185249|101269464|FG000|NOT COMPLETED|Overall Study||42||
48384409|NCT01022567|101269465|FG000|STARTED|Overall Study||273||
48092286|NCT01980914|100548984|FG000|STARTED|Overall Study||11||
48092287|NCT01980914|100548984|FG000|COMPLETED|Overall Study||11||
48092288|NCT01980914|100548984|FG000|NOT COMPLETED|Overall Study||0||
48257011|NCT01402063|100947895|FG001|NOT COMPLETED|Overall Study||3||
48384410|NCT01022567|101269466|FG001|STARTED|Overall Study||257||
48384411|NCT01022567|101269465|FG000|COMPLETED|Overall Study||272||
48384412|NCT01022567|101269466|FG001|COMPLETED|Overall Study||242||
48384413|NCT01022567|101269465|FG000|NOT COMPLETED|Overall Study||1||
48384414|NCT01022567|101269466|FG001|NOT COMPLETED|Overall Study||15||
48384415|NCT03641547|101269467|FG000|STARTED|Overall Study||3||
48384416|NCT03641547|101269468|FG001|STARTED|Overall Study||1||
48384417|NCT03641547|101269469|FG002|STARTED|Overall Study||1||
48384418|NCT03641547|101269470|FG003|STARTED|Overall Study||1||
48384419|NCT03641547|101269471|FG004|STARTED|Overall Study||1||
48384420|NCT03641547|101269472|FG005|STARTED|Overall Study||9||
48384421|NCT03641547|101269473|FG006|STARTED|Overall Study||5||
48384422|NCT03641547|101269474|FG007|STARTED|Overall Study||1||
48384423|NCT03641547|101269475|FG008|STARTED|Overall Study||9||
48384424|NCT03641547|101269476|FG009|STARTED|Overall Study||5||
48384425|NCT03641547|101269467|FG000|COMPLETED|Overall Study||3||
48384426|NCT03641547|101269468|FG001|COMPLETED|Overall Study||1||
48384427|NCT03641547|101269469|FG002|COMPLETED|Overall Study||1||
48384428|NCT03641547|101269470|FG003|COMPLETED|Overall Study||1||
48384429|NCT03641547|101269471|FG004|COMPLETED|Overall Study||1||
48384430|NCT03641547|101269472|FG005|COMPLETED|Overall Study||9||
48384431|NCT03641547|101269473|FG006|COMPLETED|Overall Study||2||
48384432|NCT03641547|101269474|FG007|COMPLETED|Overall Study||1||
48384433|NCT03641547|101269475|FG008|COMPLETED|Overall Study||4||
48384434|NCT03641547|101269476|FG009|COMPLETED|Overall Study||3||
48384435|NCT03641547|101269467|FG000|NOT COMPLETED|Overall Study||0||
48384436|NCT03641547|101269468|FG001|NOT COMPLETED|Overall Study||0||
48384437|NCT03641547|101269469|FG002|NOT COMPLETED|Overall Study||0||
48384438|NCT03641547|101269470|FG003|NOT COMPLETED|Overall Study||0||
48384439|NCT03641547|101269471|FG004|NOT COMPLETED|Overall Study||0||
48384440|NCT03641547|101269472|FG005|NOT COMPLETED|Overall Study||0||
48384441|NCT03641547|101269473|FG006|NOT COMPLETED|Overall Study||3||
48384442|NCT03641547|101269474|FG007|NOT COMPLETED|Overall Study||0||
48384443|NCT03641547|101269475|FG008|NOT COMPLETED|Overall Study||5||
48384444|NCT03641547|101269476|FG009|NOT COMPLETED|Overall Study||2||
48384445|NCT02429258|101269477|FG000|STARTED|Overall Study||50||
48384446|NCT02429258|101269478|FG001|STARTED|Overall Study||50||
48384447|NCT02429258|101269477|FG000|COMPLETED|Overall Study||48||
48688166|NCT01926444|102020167|FG001|NOT COMPLETED|Overall Study||0||
48688167|NCT01926444|102020168|FG002|NOT COMPLETED|Overall Study||4||
48688168|NCT01926444|102020169|FG003|NOT COMPLETED|Overall Study||2||
48688169|NCT04175340|102020170|FG000|STARTED|Overall Study||188||376
48092289|NCT03518073|100548985|FG000|STARTED|Overall Study||118||
48092290|NCT03518073|100548986|FG001|STARTED|Overall Study||126||
48092291|NCT03518073|100548987|FG002|STARTED|Overall Study||116||
48092292|NCT03518073|100548985|FG000|Received at Least One Dose of Study Drug|Overall Study||118||
48092293|NCT03518073|100548986|FG001|Received at Least One Dose of Study Drug|Overall Study||126||
48092294|NCT03518073|100548987|FG002|Received at Least One Dose of Study Drug|Overall Study||116||
48092295|NCT03518073|100548985|FG000|COMPLETED|Overall Study||74||
48092296|NCT03518073|100548986|FG001|COMPLETED|Overall Study||78||
48092297|NCT03518073|100548987|FG002|COMPLETED|Overall Study||70||
48092298|NCT03518073|100548985|FG000|NOT COMPLETED|Overall Study||44||
48092299|NCT03518073|100548986|FG001|NOT COMPLETED|Overall Study||48||
48092300|NCT03518073|100548987|FG002|NOT COMPLETED|Overall Study||46||
48092301|NCT02733367|100548988|FG000|STARTED|Overall Study||18||
48092302|NCT02733367|100548988|FG000|COMPLETED|Overall Study||12||
48092303|NCT02733367|100548988|FG000|NOT COMPLETED|Overall Study||6||
48092304|NCT00143403|100548989|FG000|STARTED|Overall Study||160||
48384448|NCT02429258|101269478|FG001|COMPLETED|Overall Study||49||
48384449|NCT02429258|101269477|FG000|NOT COMPLETED|Overall Study||2||
48384450|NCT02429258|101269478|FG001|NOT COMPLETED|Overall Study||1||
48384451|NCT01632735|101269479|FG000|STARTED|Overall Study||40||
48384452|NCT01632735|101269480|FG001|STARTED|Overall Study||40||
48384453|NCT01632735|101269479|FG000|COMPLETED|Overall Study||36||
48384454|NCT01632735|101269480|FG001|COMPLETED|Overall Study||37||
48384455|NCT01632735|101269479|FG000|NOT COMPLETED|Overall Study||4||
48384456|NCT01632735|101269480|FG001|NOT COMPLETED|Overall Study||3||
48092305|NCT00143403|100548990|FG001|STARTED|Overall Study||161||
48092306|NCT00143403|100548989|FG000|Treated|Overall Study||153||
48384457|NCT00630812|101269481|FG000|STARTED|Randomisation to First Dose||192||
48688170|NCT04175340|102020171|FG001|STARTED|Overall Study||181||362
48688171|NCT04175340|102020170|FG000|COMPLETED|Overall Study||188||376
48092307|NCT00143403|100548990|FG001|Treated|Overall Study||153||
48092308|NCT00143403|100548989|FG000|COMPLETED|Overall Study||125||
48092309|NCT00143403|100548990|FG001|COMPLETED|Overall Study||115||
48092310|NCT00143403|100548989|FG000|NOT COMPLETED|Overall Study||35||
48384458|NCT00630812|101269482|FG001|STARTED|Randomisation to First Dose||126||
48384459|NCT00630812|101269481|FG000|COMPLETED|Randomisation to First Dose||184||
48384460|NCT00630812|101269482|FG001|COMPLETED|Randomisation to First Dose||121||
48092311|NCT00143403|100548990|FG001|NOT COMPLETED|Overall Study||46||
48384461|NCT00630812|101269481|FG000|NOT COMPLETED|Randomisation to First Dose||8||
48384462|NCT00630812|101269482|FG001|NOT COMPLETED|Randomisation to First Dose||5||
48384463|NCT00630812|101269481|FG000|STARTED|Double Blind Treatment Period||184|Randomised and received first dose (mITT population). Patients not starting treatment are excluded|
48688172|NCT04175340|102020171|FG001|COMPLETED|Overall Study||181||362
48257012|NCT01161446|100947896|FG000|STARTED|Overall Study||116||
48257013|NCT01161446|100947897|FG001|STARTED|Overall Study||114||
48257014|NCT01161446|100947896|FG000|COMPLETED|Overall Study||98||
48257015|NCT01161446|100947897|FG001|COMPLETED|Overall Study||99||
48257016|NCT01161446|100947896|FG000|NOT COMPLETED|Overall Study||18||
48257017|NCT01161446|100947897|FG001|NOT COMPLETED|Overall Study||15||
48384464|NCT00630812|101269482|FG001|STARTED|Double Blind Treatment Period||121|Randomised and received first dose (mITT population). Patients not starting treatment are excluded|
48384465|NCT00630812|101269481|FG000|COMPLETED|Double Blind Treatment Period||153||
48384466|NCT00630812|101269482|FG001|COMPLETED|Double Blind Treatment Period||107||
48384467|NCT00630812|101269481|FG000|NOT COMPLETED|Double Blind Treatment Period||31||
48384468|NCT00630812|101269482|FG001|NOT COMPLETED|Double Blind Treatment Period||14||
48384469|NCT00638924|101269483|FG000|STARTED|Overall Study||40||
48384470|NCT00638924|101269483|FG000|2 Months|Overall Study||40||
48384471|NCT00638924|101269483|FG000|COMPLETED|Overall Study||40||
48384472|NCT00638924|101269483|FG000|NOT COMPLETED|Overall Study||0||
48384473|NCT00424528|101269484|FG000|STARTED|Overall Study||76||
48384474|NCT00424528|101269485|FG001|STARTED|Overall Study||80||
48384475|NCT00424528|101269486|FG002|STARTED|Overall Study||78||
48384476|NCT00424528|101269484|FG000|COMPLETED|Overall Study||71||
48384477|NCT00424528|101269485|FG001|COMPLETED|Overall Study||76||
48384478|NCT00424528|101269486|FG002|COMPLETED|Overall Study||74||
48384479|NCT00424528|101269484|FG000|NOT COMPLETED|Overall Study||5||
48384480|NCT00424528|101269485|FG001|NOT COMPLETED|Overall Study||4||
48384481|NCT00424528|101269486|FG002|NOT COMPLETED|Overall Study||4||
48384482|NCT00239837|101269487|FG000|STARTED|Overall Study||48||
48384483|NCT00239837|101269488|FG001|STARTED|Overall Study||52||
48384484|NCT00239837|101269487|FG000|6 Months|Overall Study||48||
48384485|NCT00239837|101269488|FG001|6 Months|Overall Study||50||
48384486|NCT00239837|101269487|FG000|COMPLETED|Overall Study||45||
48384487|NCT00239837|101269488|FG001|COMPLETED|Overall Study||45||
48384488|NCT00239837|101269487|FG000|NOT COMPLETED|Overall Study||3||
48384489|NCT00239837|101269488|FG001|NOT COMPLETED|Overall Study||7||
48384490|NCT00738374|101269489|FG000|STARTED|Induction Treatment Phase||97||
48257018|NCT00970320|100947898|FG000|STARTED|Overall Study||25||
48257019|NCT00970320|100947899|FG001|STARTED|Overall Study||24||
48257020|NCT00970320|100947900|FG002|STARTED|Overall Study||48||
48257021|NCT00970320|100947901|FG003|STARTED|Overall Study||50||
48257022|NCT00970320|100947902|FG004|STARTED|Overall Study||1571||
48384491|NCT00738374|101269490|FG001|STARTED|Induction Treatment Phase||0||
48384492|NCT00738374|101269491|FG002|STARTED|Induction Treatment Phase||0||
48384493|NCT00738374|101269492|FG003|STARTED|Induction Treatment Phase||0||
48384494|NCT00738374|101269489|FG000|COMPLETED|Induction Treatment Phase||73||
48384495|NCT00738374|101269490|FG001|COMPLETED|Induction Treatment Phase||0||
48384496|NCT00738374|101269491|FG002|COMPLETED|Induction Treatment Phase||0||
48384497|NCT00738374|101269492|FG003|COMPLETED|Induction Treatment Phase||0||
48384498|NCT00738374|101269489|FG000|NOT COMPLETED|Induction Treatment Phase||24||
48384499|NCT00738374|101269490|FG001|NOT COMPLETED|Induction Treatment Phase||0||
48384500|NCT00738374|101269491|FG002|NOT COMPLETED|Induction Treatment Phase||0||
48384501|NCT00738374|101269492|FG003|NOT COMPLETED|Induction Treatment Phase||0||
48384502|NCT00738374|101269489|FG000|STARTED|Maintenance Treatment/Observation Phase||0||
48384503|NCT00738374|101269490|FG001|STARTED|Maintenance Treatment/Observation Phase||7||
48384504|NCT00738374|101269491|FG002|STARTED|Maintenance Treatment/Observation Phase||34||
48384505|NCT00738374|101269492|FG003|STARTED|Maintenance Treatment/Observation Phase||32||
48384506|NCT00738374|101269489|FG000|COMPLETED|Maintenance Treatment/Observation Phase||0||
48384507|NCT00738374|101269490|FG001|COMPLETED|Maintenance Treatment/Observation Phase||0||
48384508|NCT00738374|101269491|FG002|COMPLETED|Maintenance Treatment/Observation Phase||27||
48384509|NCT00738374|101269492|FG003|COMPLETED|Maintenance Treatment/Observation Phase||20||
48384510|NCT00738374|101269489|FG000|NOT COMPLETED|Maintenance Treatment/Observation Phase||0||
48384511|NCT00738374|101269490|FG001|NOT COMPLETED|Maintenance Treatment/Observation Phase||7||
48384512|NCT00738374|101269491|FG002|NOT COMPLETED|Maintenance Treatment/Observation Phase||7||
48384513|NCT00738374|101269492|FG003|NOT COMPLETED|Maintenance Treatment/Observation Phase||12||
48384514|NCT01021813|101269493|FG000|STARTED|DB Treatment Phase||522||
48384515|NCT01021813|101269494|FG001|STARTED|DB Treatment Phase||259||
48384516|NCT01021813|101269495|FG002|STARTED|DB Treatment Phase||0||
48384517|NCT01021813|101269496|FG003|STARTED|DB Treatment Phase||0||
48384518|NCT01021813|101269497|FG004|STARTED|DB Treatment Phase||0||
48384519|NCT01021813|101269493|FG000|Treated|DB Treatment Phase||521||
48384520|NCT01021813|101269494|FG001|Treated|DB Treatment Phase||258||
48384521|NCT01021813|101269495|FG002|Treated|DB Treatment Phase||0||
48384522|NCT01021813|101269496|FG003|Treated|DB Treatment Phase||0||
48257023|NCT00970320|100947898|FG000|COMPLETED|Overall Study||25||
48257024|NCT00970320|100947899|FG001|COMPLETED|Overall Study||13||
48257025|NCT00970320|100947900|FG002|COMPLETED|Overall Study||35||
48257026|NCT00970320|100947901|FG003|COMPLETED|Overall Study||36||
48257027|NCT00970320|100947902|FG004|COMPLETED|Overall Study||1031||
48257028|NCT00970320|100947898|FG000|NOT COMPLETED|Overall Study||0||
48257029|NCT00970320|100947899|FG001|NOT COMPLETED|Overall Study||11||
48257030|NCT00970320|100947900|FG002|NOT COMPLETED|Overall Study||13||
48257031|NCT00970320|100947901|FG003|NOT COMPLETED|Overall Study||14||
48384523|NCT01021813|101269497|FG004|Treated|DB Treatment Phase||0||
48384524|NCT01021813|101269493|FG000|COMPLETED|DB Treatment Phase||322||
48384525|NCT01021813|101269494|FG001|COMPLETED|DB Treatment Phase||162||
48384526|NCT01021813|101269495|FG002|COMPLETED|DB Treatment Phase||0||
48384527|NCT01021813|101269496|FG003|COMPLETED|DB Treatment Phase||0||
48257032|NCT00970320|100947902|FG004|NOT COMPLETED|Overall Study||540||
48257033|NCT02634814|100947903|FG000|STARTED|Overall Study||32||
48257034|NCT02634814|100947904|FG001|STARTED|Overall Study||29||
48257035|NCT02634814|100947905|FG002|STARTED|Overall Study||29||
48257036|NCT02634814|100947903|FG000|COMPLETED|Overall Study||30||
48257037|NCT02634814|100947904|FG001|COMPLETED|Overall Study||23||
48384528|NCT01021813|101269497|FG004|COMPLETED|DB Treatment Phase||0||
48384529|NCT01021813|101269493|FG000|NOT COMPLETED|DB Treatment Phase||200||
48384530|NCT01021813|101269494|FG001|NOT COMPLETED|DB Treatment Phase||97||
48384531|NCT01021813|101269495|FG002|NOT COMPLETED|DB Treatment Phase||0||
48384532|NCT01021813|101269496|FG003|NOT COMPLETED|DB Treatment Phase||0||
48384533|NCT01021813|101269497|FG004|NOT COMPLETED|DB Treatment Phase||0||
48384534|NCT01021813|101269493|FG000|STARTED|DB Randomized Discontinuation Phase||0||
48384535|NCT01021813|101269494|FG001|STARTED|DB Randomized Discontinuation Phase||0||
48384536|NCT01021813|101269495|FG002|STARTED|DB Randomized Discontinuation Phase||156||
48384537|NCT01021813|101269496|FG003|STARTED|DB Randomized Discontinuation Phase||166||
48384538|NCT01021813|101269497|FG004|STARTED|DB Randomized Discontinuation Phase||162||
48384539|NCT01021813|101269493|FG000|COMPLETED|DB Randomized Discontinuation Phase||0||
48384540|NCT01021813|101269494|FG001|COMPLETED|DB Randomized Discontinuation Phase||0||
48384541|NCT01021813|101269495|FG002|COMPLETED|DB Randomized Discontinuation Phase||152||
48384542|NCT01021813|101269496|FG003|COMPLETED|DB Randomized Discontinuation Phase||161||
48384543|NCT01021813|101269497|FG004|COMPLETED|DB Randomized Discontinuation Phase||157||
48384544|NCT01021813|101269493|FG000|NOT COMPLETED|DB Randomized Discontinuation Phase||0||
48384545|NCT01021813|101269494|FG001|NOT COMPLETED|DB Randomized Discontinuation Phase||0||
48384546|NCT01021813|101269495|FG002|NOT COMPLETED|DB Randomized Discontinuation Phase||4||
48384547|NCT01021813|101269496|FG003|NOT COMPLETED|DB Randomized Discontinuation Phase||5||
48384548|NCT01021813|101269497|FG004|NOT COMPLETED|DB Randomized Discontinuation Phase||5||
48384549|NCT00503880|101269498|FG000|STARTED|Overall Study||2||
48384550|NCT00503880|101269499|FG001|STARTED|Overall Study||0||
48384551|NCT00503880|101269500|FG002|STARTED|Overall Study||0||
48384552|NCT00503880|101269501|FG003|STARTED|Overall Study||0||
48384553|NCT00503880|101269502|FG004|STARTED|Overall Study||0||
48384554|NCT00503880|101269498|FG000|COMPLETED|Overall Study||0||
48384555|NCT00503880|101269499|FG001|COMPLETED|Overall Study||0||
48384556|NCT00503880|101269500|FG002|COMPLETED|Overall Study||0||
48384557|NCT00503880|101269501|FG003|COMPLETED|Overall Study||0||
48384558|NCT00503880|101269502|FG004|COMPLETED|Overall Study||0||
48384559|NCT00503880|101269498|FG000|NOT COMPLETED|Overall Study||2||
48384560|NCT00503880|101269499|FG001|NOT COMPLETED|Overall Study||0||
48384561|NCT00503880|101269500|FG002|NOT COMPLETED|Overall Study||0||
48384562|NCT00503880|101269501|FG003|NOT COMPLETED|Overall Study||0||
48384563|NCT00503880|101269502|FG004|NOT COMPLETED|Overall Study||0||
48384564|NCT01536119|101269503|FG000|STARTED|Overall Study||214||
48384565|NCT01536119|101269504|FG001|STARTED|Overall Study||214||
48384566|NCT01536119|101269503|FG000|COMPLETED|Overall Study||197||
48384567|NCT01536119|101269504|FG001|COMPLETED|Overall Study||200||
48384568|NCT01536119|101269503|FG000|NOT COMPLETED|Overall Study||17||
48384569|NCT01536119|101269504|FG001|NOT COMPLETED|Overall Study||14||
48384570|NCT01322646|101269505|FG000|STARTED|Overall Study||86||
48384571|NCT01322646|101269506|FG001|STARTED|Overall Study||86||
48384572|NCT01322646|101269505|FG000|COMPLETED|Overall Study||83||
48384573|NCT01322646|101269506|FG001|COMPLETED|Overall Study||84||
48384574|NCT01322646|101269505|FG000|NOT COMPLETED|Overall Study||3||
48384575|NCT01322646|101269506|FG001|NOT COMPLETED|Overall Study||2||
48384576|NCT02006264|101269507|FG000|STARTED|Overall Study||15||
48384577|NCT02006264|101269508|FG001|STARTED|Overall Study||15||
48384578|NCT02006264|101269507|FG000|COMPLETED|Overall Study||14||
48384579|NCT02006264|101269508|FG001|COMPLETED|Overall Study||15||
48384580|NCT02006264|101269507|FG000|NOT COMPLETED|Overall Study||1||
48384581|NCT02006264|101269508|FG001|NOT COMPLETED|Overall Study||0||
48384582|NCT03482141|101269509|FG000|STARTED|Overall Study||316||
48384583|NCT03482141|101269509|FG000|COMPLETED|Overall Study||316||
48384584|NCT03482141|101269509|FG000|NOT COMPLETED|Overall Study||0||
48384585|NCT01088438|101269510|FG000|STARTED|Overall Study||94||
48384586|NCT01088438|101269511|FG001|STARTED|Overall Study||95||
48384587|NCT01088438|101269510|FG000|COMPLETED|Overall Study||65||
48384588|NCT01088438|101269511|FG001|COMPLETED|Overall Study||59||
48257038|NCT02634814|100947905|FG002|COMPLETED|Overall Study||29||
48257039|NCT02634814|100947903|FG000|NOT COMPLETED|Overall Study||2||
48257040|NCT02634814|100947904|FG001|NOT COMPLETED|Overall Study||6||
48257041|NCT02634814|100947905|FG002|NOT COMPLETED|Overall Study||0||
48257042|NCT04333147|100947906|FG000|STARTED|Overall Study||1456||
48257043|NCT04333147|100947907|FG001|STARTED|Overall Study||1459||
48257044|NCT04333147|100947906|FG000|COMPLETED|Overall Study||0||
48384589|NCT01088438|101269510|FG000|NOT COMPLETED|Overall Study||29||
48384590|NCT01088438|101269511|FG001|NOT COMPLETED|Overall Study||36||
48384591|NCT00171314|101269512|FG000|STARTED|Overall Study||263||
48384592|NCT00171314|101269513|FG001|STARTED|Overall Study||264||
48384593|NCT00171314|101269512|FG000|Safety Population|Overall Study||254||
48384594|NCT00171314|101269513|FG001|Safety Population|Overall Study||269||
48384595|NCT00171314|101269512|FG000|COMPLETED|Overall Study||172||
48384596|NCT00171314|101269513|FG001|COMPLETED|Overall Study||186||
48384597|NCT00171314|101269512|FG000|NOT COMPLETED|Overall Study||91||
48384598|NCT00171314|101269513|FG001|NOT COMPLETED|Overall Study||78||
48384599|NCT05250830|101269514|FG000|STARTED|Overall Study||67||
48384600|NCT05250830|101269515|FG001|STARTED|Overall Study||67||
48384601|NCT05250830|101269514|FG000|COMPLETED|Overall Study||67||
48384602|NCT05250830|101269515|FG001|COMPLETED|Overall Study||66||
48384603|NCT05250830|101269514|FG000|NOT COMPLETED|Overall Study||0||
48384604|NCT05250830|101269515|FG001|NOT COMPLETED|Overall Study||1||
48384605|NCT04777214|101269516|FG000|STARTED|Initial Randomization||5||
48384606|NCT04777214|101269517|FG001|STARTED|Initial Randomization||5||
48384607|NCT04777214|101269516|FG000|COMPLETED|Initial Randomization||5||
48384608|NCT04777214|101269517|FG001|COMPLETED|Initial Randomization||5||
48384609|NCT04777214|101269516|FG000|NOT COMPLETED|Initial Randomization||0||
48384610|NCT04777214|101269517|FG001|NOT COMPLETED|Initial Randomization||0||
48384611|NCT04777214|101269516|FG000|STARTED|Sham Crossover to Active TMS Arm||0|Only patients initially randomized to Sham arm continue on the crossover arm. Patients initially randomized to Active arm do not crossover to Sham arm|
48384612|NCT04777214|101269517|FG001|STARTED|Sham Crossover to Active TMS Arm||5|Only patients initially randomized to Sham arm continue on the crossover arm. Patients initially randomized to Active arm do not crossover to Sham arm|
48384613|NCT04777214|101269516|FG000|COMPLETED|Sham Crossover to Active TMS Arm||0||
48384614|NCT04777214|101269517|FG001|COMPLETED|Sham Crossover to Active TMS Arm||5||
48384615|NCT04777214|101269516|FG000|NOT COMPLETED|Sham Crossover to Active TMS Arm||0||
48384616|NCT04777214|101269517|FG001|NOT COMPLETED|Sham Crossover to Active TMS Arm||0||
48384617|NCT00747617|101269518|FG000|STARTED|Overall Study||13||
48384618|NCT00747617|101269519|FG001|STARTED|Overall Study||12||
48384619|NCT00747617|101269518|FG000|COMPLETED|Overall Study||10||
48384620|NCT00747617|101269519|FG001|COMPLETED|Overall Study||11||
48384621|NCT00747617|101269518|FG000|NOT COMPLETED|Overall Study||3||
48384622|NCT00747617|101269519|FG001|NOT COMPLETED|Overall Study||1||
48384623|NCT03987919|101269520|FG000|STARTED|Overall Study||471||
48384624|NCT03987919|101269521|FG001|STARTED|Overall Study||469||
48384625|NCT03987919|101269522|FG002|STARTED|Overall Study||470||
48384626|NCT03987919|101269523|FG003|STARTED|Overall Study||469||
48384627|NCT03987919|101269520|FG000|Received at Least One Dose of Study Drug|Overall Study||470||
48384628|NCT03987919|101269521|FG001|Received at Least One Dose of Study Drug|Overall Study||469||
48384629|NCT03987919|101269522|FG002|Received at Least One Dose of Study Drug|Overall Study||470||
48384630|NCT03987919|101269523|FG003|Received at Least One Dose of Study Drug|Overall Study||469||
48384631|NCT03987919|101269520|FG000|COMPLETED|Overall Study||452||
48384632|NCT03987919|101269521|FG001|COMPLETED|Overall Study||442||
48384633|NCT03987919|101269522|FG002|COMPLETED|Overall Study||446||
48384634|NCT03987919|101269523|FG003|COMPLETED|Overall Study||443||
48384635|NCT03987919|101269520|FG000|NOT COMPLETED|Overall Study||19||
48384636|NCT03987919|101269521|FG001|NOT COMPLETED|Overall Study||27||
48384637|NCT03987919|101269522|FG002|NOT COMPLETED|Overall Study||24||
48384638|NCT03987919|101269523|FG003|NOT COMPLETED|Overall Study||26||
48384639|NCT03558555|101269524|FG000|STARTED|Overall Study||58||
48384640|NCT03558555|101269525|FG001|STARTED|Overall Study||45||
48384641|NCT03558555|101269524|FG000|COMPLETED|Overall Study||56||
48384642|NCT03558555|101269525|FG001|COMPLETED|Overall Study||44||
48384643|NCT03558555|101269524|FG000|NOT COMPLETED|Overall Study||2||
48384644|NCT03558555|101269525|FG001|NOT COMPLETED|Overall Study||1||
48384645|NCT00218426|101269526|FG000|STARTED|Overall Study||102||
48384646|NCT00218426|101269527|FG001|STARTED|Overall Study||102||
48384647|NCT00218426|101269528|FG002|STARTED|Overall Study||102||
48384648|NCT00218426|101269526|FG000|COMPLETED|Overall Study||54||
48384649|NCT00218426|101269527|FG001|COMPLETED|Overall Study||16||
48384650|NCT00218426|101269528|FG002|COMPLETED|Overall Study||11||
48384651|NCT00218426|101269526|FG000|NOT COMPLETED|Overall Study||48||
48384652|NCT00218426|101269527|FG001|NOT COMPLETED|Overall Study||86||
48384653|NCT00218426|101269528|FG002|NOT COMPLETED|Overall Study||91||
48384654|NCT02927873|101269529|FG000|STARTED|Overall Study||11||
48384655|NCT02927873|101269530|FG001|STARTED|Overall Study||14||
48384656|NCT02927873|101269531|FG002|STARTED|Overall Study||18||
48384657|NCT02927873|101269532|FG003|STARTED|Overall Study||11||
48384658|NCT02927873|101269533|FG004|STARTED|Overall Study||11||
48384659|NCT02927873|101269534|FG005|STARTED|Overall Study||17||
48384660|NCT02927873|101269529|FG000|COMPLETED|Overall Study||9||
48384661|NCT02927873|101269530|FG001|COMPLETED|Overall Study||11||
48384662|NCT02927873|101269531|FG002|COMPLETED|Overall Study||18||
48384663|NCT02927873|101269532|FG003|COMPLETED|Overall Study||11||
48384664|NCT02927873|101269533|FG004|COMPLETED|Overall Study||11||
48384665|NCT02927873|101269534|FG005|COMPLETED|Overall Study||16||
48384666|NCT02927873|101269529|FG000|NOT COMPLETED|Overall Study||2||
48384667|NCT02927873|101269530|FG001|NOT COMPLETED|Overall Study||3||
48384668|NCT02927873|101269531|FG002|NOT COMPLETED|Overall Study||0||
48384669|NCT02927873|101269532|FG003|NOT COMPLETED|Overall Study||0||
48384670|NCT02927873|101269533|FG004|NOT COMPLETED|Overall Study||0||
48384671|NCT02927873|101269534|FG005|NOT COMPLETED|Overall Study||1||
48384672|NCT00501046|101269535|FG000|STARTED|Overall Study||508||
48384673|NCT00501046|101269536|FG001|STARTED|Overall Study||507||
48384674|NCT00501046|101269535|FG000|COMPLETED|Overall Study||238||
48384675|NCT00501046|101269536|FG001|COMPLETED|Overall Study||213||
48384676|NCT00501046|101269535|FG000|NOT COMPLETED|Overall Study||270||
48384677|NCT00501046|101269536|FG001|NOT COMPLETED|Overall Study||294||
48384678|NCT00473837|101269537|FG000|STARTED|Overall Study||50||
48384679|NCT00473837|101269538|FG001|STARTED|Overall Study||46||
48384680|NCT00473837|101269537|FG000|COMPLETED|Overall Study||49||
48384681|NCT00473837|101269538|FG001|COMPLETED|Overall Study||43||
48384682|NCT00473837|101269537|FG000|NOT COMPLETED|Overall Study||1||
48384683|NCT00473837|101269538|FG001|NOT COMPLETED|Overall Study||3||
48384684|NCT01948141|101269539|FG000|STARTED|Overall Study||6||
48384685|NCT01948141|101269539|FG000|COMPLETED|Overall Study||6||
48384686|NCT01948141|101269539|FG000|NOT COMPLETED|Overall Study||0||
48384687|NCT04895605|101269540|FG000|STARTED|Overall Study||19||
48384688|NCT04895605|101269541|FG001|STARTED|Overall Study||21||
48384689|NCT04895605|101269540|FG000|COMPLETED|Overall Study||19||
48384690|NCT04895605|101269541|FG001|COMPLETED|Overall Study||21||
48384691|NCT04895605|101269540|FG000|NOT COMPLETED|Overall Study||0||
48384692|NCT04895605|101269541|FG001|NOT COMPLETED|Overall Study||0||
48384693|NCT00762372|101269542|FG000|STARTED|Overall Study||111||
48384694|NCT00762372|101269543|FG001|STARTED|Overall Study||55||
48384695|NCT00762372|101269544|FG002|STARTED|Overall Study||50||
48384696|NCT00762372|101269542|FG000|COMPLETED|Overall Study||110||
48384697|NCT00762372|101269543|FG001|COMPLETED|Overall Study||55||
48384698|NCT00762372|101269544|FG002|COMPLETED|Overall Study||50||
48384699|NCT00762372|101269542|FG000|NOT COMPLETED|Overall Study||1||
48384700|NCT00762372|101269543|FG001|NOT COMPLETED|Overall Study||0||
48384701|NCT00762372|101269544|FG002|NOT COMPLETED|Overall Study||0||
48384702|NCT00878215|101269545|FG000|STARTED|Overall Study||21||
48384703|NCT00878215|101269546|FG001|STARTED|Overall Study||19||
48384704|NCT00878215|101269547|FG002|STARTED|Overall Study||0||
48384705|NCT00878215|101269548|FG003|STARTED|Overall Study||0||
48384706|NCT00878215|101269545|FG000|COMPLETED|Overall Study||21||
48384707|NCT00878215|101269546|FG001|COMPLETED|Overall Study||9||
48384708|NCT00878215|101269547|FG002|COMPLETED|Overall Study||0||
48384709|NCT00878215|101269548|FG003|COMPLETED|Overall Study||0||
48384710|NCT00878215|101269545|FG000|NOT COMPLETED|Overall Study||0||
48384711|NCT00878215|101269546|FG001|NOT COMPLETED|Overall Study||10||
48384712|NCT00878215|101269547|FG002|NOT COMPLETED|Overall Study||0||
48384713|NCT00878215|101269548|FG003|NOT COMPLETED|Overall Study||0||
48384714|NCT02785952|101269549|FG000|STARTED|Overall Study||125||
48384715|NCT02785952|101269550|FG001|STARTED|Overall Study||127||
48384716|NCT02785952|101269549|FG000|COMPLETED|Overall Study||0||
48384717|NCT02785952|101269550|FG001|COMPLETED|Overall Study||0||
48384718|NCT02785952|101269549|FG000|NOT COMPLETED|Overall Study||125||
48384719|NCT02785952|101269550|FG001|NOT COMPLETED|Overall Study||127||
48384720|NCT02568345|101269551|FG000|STARTED|Overall Study||31||
48384721|NCT02568345|101269551|FG000|Treated at 2.2 mg/kg|Overall Study||3||
48384722|NCT02568345|101269551|FG000|Treated at 2.4 mg/kg|Overall Study||25||
48384723|NCT02568345|101269551|FG000|Treated at 2.6 mg/kg|Overall Study||3||
48384724|NCT02568345|101269551|FG000|COMPLETED|Overall Study||31||
48384725|NCT02568345|101269551|FG000|NOT COMPLETED|Overall Study||0||
48384726|NCT00145249|101269552|FG000|STARTED|Overall Study||47||
48384727|NCT00145249|101269553|FG001|STARTED|Overall Study||48||
48384728|NCT00145249|101269554|FG002|STARTED|Overall Study||48||
48384729|NCT00145249|101269552|FG000|COMPLETED|Overall Study||36||
48384730|NCT00145249|101269553|FG001|COMPLETED|Overall Study||33||
48384731|NCT00145249|101269554|FG002|COMPLETED|Overall Study||31||
48384732|NCT00145249|101269552|FG000|NOT COMPLETED|Overall Study||11||
48384733|NCT00145249|101269553|FG001|NOT COMPLETED|Overall Study||15||
48384734|NCT00145249|101269554|FG002|NOT COMPLETED|Overall Study||17||
48384735|NCT01319110|101269555|FG000|STARTED|Overall Study||5||
48384736|NCT01319110|101269556|FG001|STARTED|Overall Study||5||
48384737|NCT01319110|101269555|FG000|COMPLETED|Overall Study||5||
48384738|NCT01319110|101269556|FG001|COMPLETED|Overall Study||5||
48384739|NCT01319110|101269555|FG000|NOT COMPLETED|Overall Study||0||
48384740|NCT01319110|101269556|FG001|NOT COMPLETED|Overall Study||0||
48384741|NCT02232087|101269557|FG000|STARTED|Overall Study||9||
48384742|NCT02232087|101269558|FG001|STARTED|Overall Study||10||
48384743|NCT02232087|101269559|FG002|STARTED|Overall Study||8||
48384744|NCT02232087|101269560|FG003|STARTED|Overall Study||8||
48384745|NCT02232087|101269561|FG004|STARTED|Overall Study||8||
48384746|NCT02232087|101269562|FG005|STARTED|Overall Study||9||
48384747|NCT02232087|101269557|FG000|COMPLETED|Overall Study||7||
48384748|NCT02232087|101269558|FG001|COMPLETED|Overall Study||8||
48384749|NCT02232087|101269559|FG002|COMPLETED|Overall Study||8||
48384750|NCT02232087|101269560|FG003|COMPLETED|Overall Study||7||
48384751|NCT02232087|101269561|FG004|COMPLETED|Overall Study||7||
48384752|NCT02232087|101269562|FG005|COMPLETED|Overall Study||6||
48384753|NCT02232087|101269557|FG000|NOT COMPLETED|Overall Study||2||
48384754|NCT02232087|101269558|FG001|NOT COMPLETED|Overall Study||2||
48384755|NCT02232087|101269559|FG002|NOT COMPLETED|Overall Study||0||
48384756|NCT02232087|101269560|FG003|NOT COMPLETED|Overall Study||1||
48384757|NCT02232087|101269561|FG004|NOT COMPLETED|Overall Study||1||
48384758|NCT02232087|101269562|FG005|NOT COMPLETED|Overall Study||3||
48384759|NCT02559206|101269563|FG000|STARTED|Overall Study||66|Randomized|
48384760|NCT02559206|101269564|FG001|STARTED|Overall Study||66|Randomized|
48384761|NCT02559206|101269565|FG002|STARTED|Overall Study||67|Randomized|
48384762|NCT02559206|101269566|FG003|STARTED|Overall Study||67|Randomized|
48384763|NCT02559206|101269567|FG004|STARTED|Overall Study||67|Randomized|
48384764|NCT02559206|101269568|FG005|STARTED|Overall Study||67|Randomized|
48384765|NCT02559206|101269569|FG006|STARTED|Overall Study||66|Randomized|
48384766|NCT02559206|101269570|FG007|STARTED|Overall Study||66|Randomized|
48384767|NCT02559206|101269563|FG000|COMPLETED|Overall Study||58||
48384768|NCT02559206|101269564|FG001|COMPLETED|Overall Study||54||
48384769|NCT02559206|101269565|FG002|COMPLETED|Overall Study||58||
48384770|NCT02559206|101269566|FG003|COMPLETED|Overall Study||53||
48384771|NCT02559206|101269567|FG004|COMPLETED|Overall Study||55||
48384772|NCT02559206|101269568|FG005|COMPLETED|Overall Study||53||
48384773|NCT02559206|101269569|FG006|COMPLETED|Overall Study||60||
48384774|NCT02559206|101269570|FG007|COMPLETED|Overall Study||57||
48384775|NCT02559206|101269563|FG000|NOT COMPLETED|Overall Study||8||
48384776|NCT02559206|101269564|FG001|NOT COMPLETED|Overall Study||12||
48384777|NCT02559206|101269565|FG002|NOT COMPLETED|Overall Study||9||
48384778|NCT02559206|101269566|FG003|NOT COMPLETED|Overall Study||14||
48384779|NCT02559206|101269567|FG004|NOT COMPLETED|Overall Study||12||
48384780|NCT02559206|101269568|FG005|NOT COMPLETED|Overall Study||14||
48384781|NCT02559206|101269569|FG006|NOT COMPLETED|Overall Study||6||
48384782|NCT02559206|101269570|FG007|NOT COMPLETED|Overall Study||9||
48384783|NCT00510224|101269571|FG000|STARTED|Overall Study||13||
48384784|NCT00510224|101269571|FG000|COMPLETED|Overall Study||10||
48384785|NCT00510224|101269571|FG000|NOT COMPLETED|Overall Study||3||
48384786|NCT01094730|101269572|FG000|STARTED|Period 1 (14 Days)||92||
48384787|NCT01094730|101269573|FG001|STARTED|Period 1 (14 Days)||88||
48384788|NCT01094730|101269572|FG000|COMPLETED|Period 1 (14 Days)||90||
48384789|NCT01094730|101269573|FG001|COMPLETED|Period 1 (14 Days)||86||
48384790|NCT01094730|101269572|FG000|NOT COMPLETED|Period 1 (14 Days)||2||
48384791|NCT01094730|101269573|FG001|NOT COMPLETED|Period 1 (14 Days)||2||
48384792|NCT01094730|101269572|FG000|STARTED|Period 2 (14 Days)||90||
48384793|NCT01094730|101269573|FG001|STARTED|Period 2 (14 Days)||86||
48384794|NCT01094730|101269572|FG000|COMPLETED|Period 2 (14 Days)||87||
48384795|NCT01094730|101269573|FG001|COMPLETED|Period 2 (14 Days)||84||
48384796|NCT01094730|101269572|FG000|NOT COMPLETED|Period 2 (14 Days)||3||
48384797|NCT01094730|101269573|FG001|NOT COMPLETED|Period 2 (14 Days)||2||
48384798|NCT00423085|101269574|FG000|STARTED|24-Week Double-Blind Treatment Phase||288||
48384799|NCT00423085|101269575|FG001|STARTED|24-Week Double-Blind Treatment Phase||284||
48384800|NCT00423085|101269576|FG002|STARTED|24-Week Double-Blind Treatment Phase||287||
48384801|NCT00423085|101269577|FG003|STARTED|24-Week Double-Blind Treatment Phase||0||
48384802|NCT00423085|101269574|FG000|COMPLETED|24-Week Double-Blind Treatment Phase||242||
48384803|NCT00423085|101269575|FG001|COMPLETED|24-Week Double-Blind Treatment Phase||220||
48384804|NCT00423085|101269576|FG002|COMPLETED|24-Week Double-Blind Treatment Phase||228||
48384805|NCT00423085|101269577|FG003|COMPLETED|24-Week Double-Blind Treatment Phase||0||
48384806|NCT00423085|101269574|FG000|NOT COMPLETED|24-Week Double-Blind Treatment Phase||46||
48384807|NCT00423085|101269575|FG001|NOT COMPLETED|24-Week Double-Blind Treatment Phase||64||
48384808|NCT00423085|101269576|FG002|NOT COMPLETED|24-Week Double-Blind Treatment Phase||59||
48384809|NCT00423085|101269577|FG003|NOT COMPLETED|24-Week Double-Blind Treatment Phase||0||
48384810|NCT00423085|101269574|FG000|STARTED|52-Week Open-Label Extension Phase||0||
48384811|NCT00423085|101269575|FG001|STARTED|52-Week Open-Label Extension Phase||0||
48384812|NCT00423085|101269576|FG002|STARTED|52-Week Open-Label Extension Phase||0||
48384813|NCT00423085|101269577|FG003|STARTED|52-Week Open-Label Extension Phase||637||
48384814|NCT00423085|101269574|FG000|COMPLETED|52-Week Open-Label Extension Phase||0||
48384815|NCT00423085|101269575|FG001|COMPLETED|52-Week Open-Label Extension Phase||0||
48092312|NCT02953314|100548991|FG000|STARTED|Overall Study||13||
48092313|NCT02953314|100548992|FG001|STARTED|Overall Study||70||
48092314|NCT02953314|100548991|FG000|COMPLETED|Overall Study||13||
48384816|NCT00423085|101269576|FG002|COMPLETED|52-Week Open-Label Extension Phase||0||
48384817|NCT00423085|101269577|FG003|COMPLETED|52-Week Open-Label Extension Phase||474||
48384818|NCT00423085|101269574|FG000|NOT COMPLETED|52-Week Open-Label Extension Phase||0||
48384819|NCT00423085|101269575|FG001|NOT COMPLETED|52-Week Open-Label Extension Phase||0||
48384820|NCT00423085|101269576|FG002|NOT COMPLETED|52-Week Open-Label Extension Phase||0||
48384821|NCT00423085|101269577|FG003|NOT COMPLETED|52-Week Open-Label Extension Phase||163||
48384822|NCT03141372|101269578|FG000|STARTED|Overall Study||42||
48384823|NCT03141372|101269579|FG001|STARTED|Overall Study||42||
48384824|NCT03141372|101269578|FG000|COMPLETED|Overall Study||42||
48384825|NCT03141372|101269579|FG001|COMPLETED|Overall Study||40||
48384826|NCT03141372|101269578|FG000|NOT COMPLETED|Overall Study||0||
48384827|NCT03141372|101269579|FG001|NOT COMPLETED|Overall Study||2||
48384828|NCT01182337|101269580|FG000|STARTED|Overall Study||22||
48384829|NCT01182337|101269581|FG001|STARTED|Overall Study||9||
48384830|NCT01182337|101269580|FG000|COMPLETED|Overall Study||19||
48384831|NCT01182337|101269581|FG001|COMPLETED|Overall Study||7||
48384832|NCT01182337|101269580|FG000|NOT COMPLETED|Overall Study||3||
48384833|NCT01182337|101269581|FG001|NOT COMPLETED|Overall Study||2||
48384834|NCT02932332|101269582|FG000|STARTED|Overall Study||5||
48384835|NCT02932332|101269583|FG001|STARTED|Overall Study||4||
48384836|NCT02932332|101269584|FG002|STARTED|Overall Study||5||
48384837|NCT02932332|101269585|FG003|STARTED|Overall Study||5||
48384838|NCT02932332|101269582|FG000|Intervention 1|Overall Study||4||
48384839|NCT02932332|101269583|FG001|Intervention 1|Overall Study||4||
48384840|NCT02932332|101269584|FG002|Intervention 1|Overall Study||5||
48384841|NCT02932332|101269585|FG003|Intervention 1|Overall Study||4||
48384842|NCT02932332|101269582|FG000|Intervention 2|Overall Study||4||
48384843|NCT02932332|101269583|FG001|Intervention 2|Overall Study||3||
48384844|NCT02932332|101269584|FG002|Intervention 2|Overall Study||4||
48384845|NCT02932332|101269585|FG003|Intervention 2|Overall Study||4||
48384846|NCT02932332|101269582|FG000|Intervention 3|Overall Study||3||
48384847|NCT02932332|101269583|FG001|Intervention 3|Overall Study||2||
48384848|NCT02932332|101269584|FG002|Intervention 3|Overall Study||4||
48384849|NCT02932332|101269585|FG003|Intervention 3|Overall Study||3||
48384850|NCT02932332|101269582|FG000|Intervention 4|Overall Study||3||
48384851|NCT02932332|101269583|FG001|Intervention 4|Overall Study||1||
48384852|NCT02932332|101269584|FG002|Intervention 4|Overall Study||4||
48384853|NCT02932332|101269585|FG003|Intervention 4|Overall Study||3||
48384854|NCT02932332|101269582|FG000|COMPLETED|Overall Study||3||
48384855|NCT02932332|101269583|FG001|COMPLETED|Overall Study||1||
48384856|NCT02932332|101269584|FG002|COMPLETED|Overall Study||4||
48384857|NCT02932332|101269585|FG003|COMPLETED|Overall Study||3||
48384858|NCT02932332|101269582|FG000|NOT COMPLETED|Overall Study||2||
48384859|NCT02932332|101269583|FG001|NOT COMPLETED|Overall Study||3||
48384860|NCT02932332|101269584|FG002|NOT COMPLETED|Overall Study||1||
48384861|NCT02932332|101269585|FG003|NOT COMPLETED|Overall Study||2||
48384862|NCT05254613|101269586|FG000|STARTED|Overall Study||6||
48384863|NCT05254613|101269587|FG001|STARTED|Overall Study||3||
48384864|NCT05254613|101269588|FG002|STARTED|Overall Study||3||
48384865|NCT05254613|101269586|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
48384866|NCT05254613|101269587|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3||
48384867|NCT05254613|101269588|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
48384868|NCT05254613|101269586|FG000|COMPLETED|Overall Study||6||
48384869|NCT05254613|101269587|FG001|COMPLETED|Overall Study||3||
48384870|NCT05254613|101269588|FG002|COMPLETED|Overall Study||2||
48384871|NCT05254613|101269586|FG000|NOT COMPLETED|Overall Study||0||
48384872|NCT05254613|101269587|FG001|NOT COMPLETED|Overall Study||0||
48384873|NCT05254613|101269588|FG002|NOT COMPLETED|Overall Study||1||
48384874|NCT01518244|101269589|FG000|STARTED|Overall Study||50||
48384875|NCT01518244|101269589|FG000|COMPLETED|Overall Study||47||
48384876|NCT01518244|101269589|FG000|NOT COMPLETED|Overall Study||3||
48384877|NCT00353496|101269590|FG000|STARTED|Overall Study||101||
48384878|NCT00353496|101269591|FG001|STARTED|Overall Study||103||
48384879|NCT00353496|101269590|FG000|COMPLETED|Overall Study||85||
48384880|NCT00353496|101269591|FG001|COMPLETED|Overall Study||86||
48384881|NCT00353496|101269590|FG000|NOT COMPLETED|Overall Study||16||
48384882|NCT00353496|101269591|FG001|NOT COMPLETED|Overall Study||17||
48384883|NCT01056341|101269592|FG000|STARTED|Overall Study||55||
48384884|NCT01056341|101269593|FG001|STARTED|Overall Study||99||
48384885|NCT01056341|101269594|FG002|STARTED|Overall Study||103||
48384886|NCT01056341|101269595|FG003|STARTED|Overall Study||101||
48384887|NCT01056341|101269596|FG004|STARTED|Overall Study||102||
48384888|NCT01056341|101269592|FG000|Interim Analysis|Overall Study||25||
48384889|NCT01056341|101269593|FG001|Interim Analysis|Overall Study||41||
48384890|NCT01056341|101269594|FG002|Interim Analysis|Overall Study||41||
48384891|NCT01056341|101269595|FG003|Interim Analysis|Overall Study||40||
48384892|NCT01056341|101269596|FG004|Interim Analysis|Overall Study||43||
48384893|NCT01056341|101269592|FG000|COMPLETED|Overall Study||19||
48384894|NCT01056341|101269593|FG001|COMPLETED|Overall Study||63||
48384895|NCT01056341|101269594|FG002|COMPLETED|Overall Study||88||
48384896|NCT01056341|101269595|FG003|COMPLETED|Overall Study||65||
48384897|NCT01056341|101269596|FG004|COMPLETED|Overall Study||88||
48384898|NCT01056341|101269592|FG000|NOT COMPLETED|Overall Study||36||
48384899|NCT01056341|101269593|FG001|NOT COMPLETED|Overall Study||36||
48384900|NCT01056341|101269594|FG002|NOT COMPLETED|Overall Study||15||
48384901|NCT01056341|101269595|FG003|NOT COMPLETED|Overall Study||36||
48384902|NCT01056341|101269596|FG004|NOT COMPLETED|Overall Study||14||
48384903|NCT00755846|101269597|FG000|STARTED|Overall Study||43||
48384904|NCT00755846|101269598|FG001|STARTED|Overall Study||44||
48384905|NCT00755846|101269599|FG002|STARTED|Overall Study||44||
48384906|NCT00755846|101269600|FG003|STARTED|Overall Study||45||
48384907|NCT00755846|101269601|FG004|STARTED|Overall Study||44||
48384908|NCT00755846|101269602|FG005|STARTED|Overall Study||45||
48384909|NCT00755846|101269597|FG000|COMPLETED|Overall Study||18||
48384910|NCT00755846|101269598|FG001|COMPLETED|Overall Study||27||
48384911|NCT00755846|101269599|FG002|COMPLETED|Overall Study||32||
48384912|NCT00755846|101269600|FG003|COMPLETED|Overall Study||32||
48384913|NCT00755846|101269601|FG004|COMPLETED|Overall Study||27||
48384914|NCT00755846|101269602|FG005|COMPLETED|Overall Study||31||
48384915|NCT00755846|101269597|FG000|NOT COMPLETED|Overall Study||25||
48384916|NCT00755846|101269598|FG001|NOT COMPLETED|Overall Study||17||
48384917|NCT00755846|101269599|FG002|NOT COMPLETED|Overall Study||12||
48384918|NCT00755846|101269600|FG003|NOT COMPLETED|Overall Study||13||
48384919|NCT00755846|101269601|FG004|NOT COMPLETED|Overall Study||17||
48384920|NCT00755846|101269602|FG005|NOT COMPLETED|Overall Study||14||
48384921|NCT01222572|101269603|FG000|STARTED|Overall Study||1||
48384922|NCT01222572|101269604|FG001|STARTED|Overall Study||0||
48384923|NCT01222572|101269605|FG002|STARTED|Overall Study||0||
48384924|NCT01222572|101269603|FG000|COMPLETED|Overall Study||1||
48384925|NCT01222572|101269604|FG001|COMPLETED|Overall Study||0||
48384926|NCT01222572|101269605|FG002|COMPLETED|Overall Study||0||
48384927|NCT01222572|101269603|FG000|NOT COMPLETED|Overall Study||0||
48384928|NCT01222572|101269604|FG001|NOT COMPLETED|Overall Study||0||
48384929|NCT01222572|101269605|FG002|NOT COMPLETED|Overall Study||0||
48384930|NCT00622544|101269606|FG000|STARTED|Overall Study||44||
48384931|NCT00622544|101269606|FG000|COMPLETED|Overall Study||35||
48384932|NCT00622544|101269606|FG000|NOT COMPLETED|Overall Study||9||
48384933|NCT02299141|101269607|FG000|STARTED|Overall Study||20||
48384934|NCT02299141|101269607|FG000|COMPLETED|Overall Study||20||
48384935|NCT02299141|101269607|FG000|NOT COMPLETED|Overall Study||0||
48384936|NCT01318512|101269608|FG000|STARTED|Titration Period (4 Months)||340||
48384937|NCT01318512|101269608|FG000|COMPLETED|Titration Period (4 Months)||340||
48384938|NCT01318512|101269608|FG000|NOT COMPLETED|Titration Period (4 Months)||0||
48384939|NCT01318512|101269608|FG000|STARTED|Maintenance Period (6 Months)||340||
48384940|NCT01318512|101269608|FG000|COMPLETED|Maintenance Period (6 Months)||329||
48384941|NCT01318512|101269608|FG000|NOT COMPLETED|Maintenance Period (6 Months)||11||
48384942|NCT01194804|101269609|FG000|STARTED|Overall Study||27||
48384943|NCT01194804|101269609|FG000|COMPLETED|Overall Study||26||
48384944|NCT01194804|101269609|FG000|NOT COMPLETED|Overall Study||1||
48384945|NCT00115765|101269610|FG000|STARTED|Overall Study||115||
48384946|NCT00115765|101269611|FG001|STARTED|Overall Study||413||
48384947|NCT00115765|101269612|FG002|STARTED|Overall Study||410||
48384948|NCT00115765|101269613|FG003|STARTED|Overall Study||115||
48384949|NCT00115765|101269610|FG000|COMPLETED|Overall Study||80||
48384950|NCT00115765|101269611|FG001|COMPLETED|Overall Study||313||
48384951|NCT00115765|101269612|FG002|COMPLETED|Overall Study||289||
48384952|NCT00115765|101269613|FG003|COMPLETED|Overall Study||84||
48384953|NCT00115765|101269610|FG000|NOT COMPLETED|Overall Study||35||
48384954|NCT00115765|101269611|FG001|NOT COMPLETED|Overall Study||100||
48384955|NCT00115765|101269612|FG002|NOT COMPLETED|Overall Study||121||
48384956|NCT00115765|101269613|FG003|NOT COMPLETED|Overall Study||31||
48384957|NCT01928485|101269614|FG000|STARTED|Overall Study||4||
48384958|NCT01928485|101269615|FG001|STARTED|Overall Study||2||
48384959|NCT01928485|101269614|FG000|COMPLETED|Overall Study||4||
48384960|NCT01928485|101269615|FG001|COMPLETED|Overall Study||1||
48384961|NCT01928485|101269614|FG000|NOT COMPLETED|Overall Study||0||
48384962|NCT01928485|101269615|FG001|NOT COMPLETED|Overall Study||1||
48384963|NCT03095521|101269616|FG000|STARTED|Overall Study||115|231 screened, 3 excluded (breach in incl. criteria (2) and no hematology analyses (1)|
48384964|NCT03095521|101269617|FG001|STARTED|Overall Study||113|231 screened, 3 excluded (breach in incl. criteria (2) and no hematology analyses (1)|
48384965|NCT03095521|101269616|FG000|Intent to Treat Population ITT|Overall Study||115||
48384966|NCT03095521|101269617|FG001|Intent to Treat Population ITT|Overall Study||113||
48384967|NCT03095521|101269616|FG000|Per Protocol Population PP|Overall Study||113||
48384968|NCT03095521|101269617|FG001|Per Protocol Population PP|Overall Study||107||
48384969|NCT03095521|101269616|FG000|Safety Population|Overall Study||115||
48384970|NCT03095521|101269617|FG001|Safety Population|Overall Study||113||
48384971|NCT03095521|101269616|FG000|COMPLETED|Overall Study||115||
48384972|NCT03095521|101269617|FG001|COMPLETED|Overall Study||111||
48384973|NCT03095521|101269616|FG000|NOT COMPLETED|Overall Study||0||
48384974|NCT03095521|101269617|FG001|NOT COMPLETED|Overall Study||2||
48384975|NCT02918409|101269618|FG000|STARTED|Overall Study||16||
48384976|NCT02918409|101269619|FG001|STARTED|Overall Study||10||
48384977|NCT02918409|101269620|FG002|STARTED|Overall Study||25||
48384978|NCT02918409|101269618|FG000|COMPLETED|Overall Study||15||
48384979|NCT02918409|101269619|FG001|COMPLETED|Overall Study||10||
48384980|NCT02918409|101269620|FG002|COMPLETED|Overall Study||24||
48384981|NCT02918409|101269618|FG000|NOT COMPLETED|Overall Study||1||
48384982|NCT02918409|101269619|FG001|NOT COMPLETED|Overall Study||0||
48384983|NCT02918409|101269620|FG002|NOT COMPLETED|Overall Study||1||
48384984|NCT01621672|101269621|FG000|STARTED|Overall Study||25||
48384985|NCT01621672|101269622|FG001|STARTED|Overall Study||17||
48384986|NCT01621672|101269621|FG000|COMPLETED|Overall Study||25||
48384987|NCT01621672|101269622|FG001|COMPLETED|Overall Study||17||
48384988|NCT01621672|101269621|FG000|NOT COMPLETED|Overall Study||0||
48384989|NCT01621672|101269622|FG001|NOT COMPLETED|Overall Study||0||
48384990|NCT01940510|101269623|FG000|STARTED|Overall Study||24||
48384991|NCT01940510|101269623|FG000|COMPLETED|Overall Study||24||
48384992|NCT01940510|101269623|FG000|NOT COMPLETED|Overall Study||0||
48384993|NCT01362946|101269624|FG000|STARTED|First Behavior Modification Block||24||
48384994|NCT01362946|101269625|FG001|STARTED|First Behavior Modification Block||24||
48384995|NCT01362946|101269624|FG000|COMPLETED|First Behavior Modification Block||24||
48384996|NCT01362946|101269625|FG001|COMPLETED|First Behavior Modification Block||24||
48384997|NCT01362946|101269624|FG000|NOT COMPLETED|First Behavior Modification Block||0||
48384998|NCT01362946|101269625|FG001|NOT COMPLETED|First Behavior Modification Block||0||
48384999|NCT01362946|101269624|FG000|STARTED|Second Behavior Modification Block||23||
48385000|NCT01362946|101269625|FG001|STARTED|Second Behavior Modification Block||24||
48385001|NCT01362946|101269624|FG000|COMPLETED|Second Behavior Modification Block||23||
48385002|NCT01362946|101269625|FG001|COMPLETED|Second Behavior Modification Block||24||
48385003|NCT01362946|101269624|FG000|NOT COMPLETED|Second Behavior Modification Block||0||
48385004|NCT01362946|101269625|FG001|NOT COMPLETED|Second Behavior Modification Block||0||
48385005|NCT01608724|101269626|FG000|STARTED|Overall Study||1423||
48385006|NCT01608724|101269626|FG000|Treated|Overall Study||1361||
48385007|NCT01608724|101269626|FG000|COMPLETED|Overall Study||1180||
48385008|NCT01608724|101269626|FG000|NOT COMPLETED|Overall Study||243||
48385009|NCT02130258|101269627|FG000|STARTED|Overall Study||9||
48385010|NCT02130258|101269628|FG001|STARTED|Overall Study||11||
48385011|NCT02130258|101269627|FG000|COMPLETED|Overall Study||9||
48385012|NCT02130258|101269628|FG001|COMPLETED|Overall Study||11||
48385013|NCT02130258|101269627|FG000|NOT COMPLETED|Overall Study||0||
48385014|NCT02130258|101269628|FG001|NOT COMPLETED|Overall Study||0||
48385015|NCT02821455|101269629|FG000|STARTED|Overall Study||19||
48385016|NCT02821455|101269629|FG000|COMPLETED|Overall Study||19||
48385017|NCT02821455|101269629|FG000|NOT COMPLETED|Overall Study||0||
48385018|NCT02363270|101269630|FG000|STARTED|Overall Study||24||
48385019|NCT02363270|101269631|FG001|STARTED|Overall Study||24||
48385020|NCT02363270|101269630|FG000|COMPLETED|Overall Study||24||
48385021|NCT02363270|101269631|FG001|COMPLETED|Overall Study||24||
48385022|NCT02363270|101269630|FG000|NOT COMPLETED|Overall Study||0||
48688173|NCT04175340|102020170|FG000|NOT COMPLETED|Overall Study||0||0
48688174|NCT04175340|102020171|FG001|NOT COMPLETED|Overall Study||0||0
48688175|NCT01816776|102020172|FG000|STARTED|Overall Study||73|Randomized|
48688176|NCT01816776|102020173|FG001|STARTED|Overall Study||78|Randomized|
48688177|NCT01816776|102020172|FG000|6 Month Primary Effectiveness Assessed|Overall Study||68||
48688178|NCT01816776|102020173|FG001|6 Month Primary Effectiveness Assessed|Overall Study||73||
48688179|NCT01816776|102020172|FG000|COMPLETED|Overall Study||60|Primary safety assessed through 12 months|
48688180|NCT01816776|102020173|FG001|COMPLETED|Overall Study||70|Primary safety assessed through 12 months|
48385023|NCT02363270|101269631|FG001|NOT COMPLETED|Overall Study||0||
48385024|NCT02170649|101269632|FG000|STARTED|Fasting Period||12||
48385025|NCT02170649|101269632|FG000|COMPLETED|Fasting Period||12||
48385026|NCT02170649|101269632|FG000|NOT COMPLETED|Fasting Period||0||
48385027|NCT02170649|101269632|FG000|STARTED|Fed Period||12||
48385028|NCT02170649|101269632|FG000|COMPLETED|Fed Period||12||
48385029|NCT02170649|101269632|FG000|NOT COMPLETED|Fed Period||0||
48385030|NCT00623467|101269633|FG000|STARTED|Overall Study||343||
48385031|NCT00623467|101269633|FG000|COMPLETED|Overall Study||336||
48385032|NCT00623467|101269633|FG000|NOT COMPLETED|Overall Study||7||
48385033|NCT04876599|101269634|FG000|STARTED|Overall Study||32||
48385034|NCT04876599|101269635|FG001|STARTED|Overall Study||32||
48385035|NCT04876599|101269634|FG000|Follow up Survey #1|Overall Study||31||
48385036|NCT04876599|101269635|FG001|Follow up Survey #1|Overall Study||31||
48385037|NCT04876599|101269634|FG000|Exit Interview|Overall Study||29||
48385038|NCT04876599|101269635|FG001|Exit Interview|Overall Study||30||
48385039|NCT04876599|101269634|FG000|Follow up Survey #2|Overall Study||29||
48385040|NCT04876599|101269635|FG001|Follow up Survey #2|Overall Study||29||
48385041|NCT04876599|101269634|FG000|COMPLETED|Overall Study||28||
48092315|NCT02953314|100548992|FG001|COMPLETED|Overall Study||67||
48092316|NCT02953314|100548991|FG000|NOT COMPLETED|Overall Study||0||
48092317|NCT02953314|100548992|FG001|NOT COMPLETED|Overall Study||3||
48092318|NCT00498602|100548993|FG000|STARTED|Overall Study||36||
48385042|NCT04876599|101269635|FG001|COMPLETED|Overall Study||29||
48385043|NCT04876599|101269634|FG000|NOT COMPLETED|Overall Study||4||
48385044|NCT04876599|101269635|FG001|NOT COMPLETED|Overall Study||3||
48385045|NCT02763072|101269636|FG000|STARTED|Overall Study||12||
48385046|NCT02763072|101269637|FG001|STARTED|Overall Study||12||
48385047|NCT02763072|101269636|FG000|COMPLETED|Overall Study||11||
48385048|NCT02763072|101269637|FG001|COMPLETED|Overall Study||12||
48385049|NCT02763072|101269636|FG000|NOT COMPLETED|Overall Study||1||
48385050|NCT02763072|101269637|FG001|NOT COMPLETED|Overall Study||0||
48385051|NCT01217190|101269638|FG000|STARTED|First Dosing||24||
48385052|NCT01217190|101269639|FG001|STARTED|First Dosing||24||
48385053|NCT01217190|101269638|FG000|COMPLETED|First Dosing||24||
48385054|NCT01217190|101269639|FG001|COMPLETED|First Dosing||24||
48385055|NCT01217190|101269638|FG000|NOT COMPLETED|First Dosing||0||
48688181|NCT01816776|102020172|FG000|NOT COMPLETED|Overall Study||13||
48688182|NCT01816776|102020173|FG001|NOT COMPLETED|Overall Study||8||
48688183|NCT02006108|102020174|FG000|STARTED|Overall Study||21||
48688184|NCT02006108|102020174|FG000|MR Imaging|Overall Study||19||
48688185|NCT02006108|102020174|FG000|COMPLETED|Overall Study||19||
48688186|NCT02006108|102020174|FG000|NOT COMPLETED|Overall Study||2||
48688187|NCT05079347|102020175|FG000|STARTED|Overall Study||418|418 people said they would be interested in receiving an HIV test from the healer|
48688188|NCT05079347|102020175|FG000|COMPLETED|Overall Study||418|418 people actually went through with the test and received their results|
48688189|NCT05079347|102020175|FG000|NOT COMPLETED|Overall Study||0||
48688190|NCT00078806|102020176|FG000|STARTED|Part 1A||19||
48688191|NCT00078806|102020177|FG001|STARTED|Part 1A||0||
48688192|NCT00078806|102020178|FG002|STARTED|Part 1A||0||
48688193|NCT00078806|102020179|FG003|STARTED|Part 1A||0||
48688194|NCT00078806|102020176|FG000|COMPLETED|Part 1A||9||
48688195|NCT00078806|102020177|FG001|COMPLETED|Part 1A||0||
48688196|NCT00078806|102020178|FG002|COMPLETED|Part 1A||0||
48688197|NCT00078806|102020179|FG003|COMPLETED|Part 1A||0||
48688198|NCT00078806|102020176|FG000|NOT COMPLETED|Part 1A||10||
48688199|NCT00078806|102020177|FG001|NOT COMPLETED|Part 1A||0||
48688200|NCT00078806|102020178|FG002|NOT COMPLETED|Part 1A||0||
48688201|NCT00078806|102020179|FG003|NOT COMPLETED|Part 1A||0||
48092319|NCT00498602|100548994|FG001|STARTED|Overall Study||61||
48092320|NCT00498602|100548995|FG002|STARTED|Overall Study||40||
48092321|NCT00498602|100548996|FG003|STARTED|Overall Study||35||
48092322|NCT00498602|100548997|FG004|STARTED|Overall Study||12||
48092323|NCT00498602|100548998|FG005|STARTED|Overall Study||44||
48092324|NCT00498602|100548999|FG006|STARTED|Overall Study||17||
48092325|NCT00498602|100548993|FG000|Treated|Overall Study||36||
48092326|NCT00498602|100548994|FG001|Treated|Overall Study||60||
48092327|NCT00498602|100548995|FG002|Treated|Overall Study||40||
48092328|NCT00498602|100548996|FG003|Treated|Overall Study||35||
48092329|NCT00498602|100548997|FG004|Treated|Overall Study||12||
48092330|NCT00498602|100548998|FG005|Treated|Overall Study||44||
48092331|NCT00498602|100548999|FG006|Treated|Overall Study||17||
48092332|NCT00498602|100548993|FG000|COMPLETED|Overall Study||26||
48092333|NCT00498602|100548994|FG001|COMPLETED|Overall Study||51||
48092334|NCT00498602|100548995|FG002|COMPLETED|Overall Study||32||
48688202|NCT00078806|102020176|FG000|STARTED|Part 1B||10||
48092335|NCT00498602|100548996|FG003|COMPLETED|Overall Study||30||
48092336|NCT00498602|100548997|FG004|COMPLETED|Overall Study||8||
48092337|NCT00498602|100548998|FG005|COMPLETED|Overall Study||31||
48092338|NCT00498602|100548999|FG006|COMPLETED|Overall Study||15||
48092339|NCT00498602|100548993|FG000|NOT COMPLETED|Overall Study||10||
48092340|NCT00498602|100548994|FG001|NOT COMPLETED|Overall Study||10||
48092341|NCT00498602|100548995|FG002|NOT COMPLETED|Overall Study||8||
48092342|NCT00498602|100548996|FG003|NOT COMPLETED|Overall Study||5||
48092343|NCT00498602|100548997|FG004|NOT COMPLETED|Overall Study||4||
48092344|NCT00498602|100548998|FG005|NOT COMPLETED|Overall Study||13||
48092345|NCT00498602|100548999|FG006|NOT COMPLETED|Overall Study||2||
48092346|NCT01850550|100549000|FG000|STARTED|Overall Study||40||
48092347|NCT01850550|100549001|FG001|STARTED|Overall Study||40||
48092348|NCT01850550|100549000|FG000|COMPLETED|Overall Study||40||
48385056|NCT01217190|101269639|FG001|NOT COMPLETED|First Dosing||0||
48385057|NCT01217190|101269638|FG000|STARTED|Second Dosing||24||
48385058|NCT01217190|101269639|FG001|STARTED|Second Dosing||24||
48385059|NCT01217190|101269638|FG000|COMPLETED|Second Dosing||24||
48385060|NCT01217190|101269639|FG001|COMPLETED|Second Dosing||22||
48385061|NCT01217190|101269638|FG000|NOT COMPLETED|Second Dosing||0||
48688203|NCT00078806|102020177|FG001|STARTED|Part 1B||0||
48688204|NCT00078806|102020178|FG002|STARTED|Part 1B||0||
48688205|NCT00078806|102020179|FG003|STARTED|Part 1B||0||
48688206|NCT00078806|102020176|FG000|COMPLETED|Part 1B||2||
48092349|NCT01850550|100549001|FG001|COMPLETED|Overall Study||37||
48092350|NCT01850550|100549000|FG000|NOT COMPLETED|Overall Study||0||
48385062|NCT01217190|101269639|FG001|NOT COMPLETED|Second Dosing||2||
48385063|NCT01875367|101269640|FG000|STARTED|Overall Study||81||
48688207|NCT00078806|102020177|FG001|COMPLETED|Part 1B||0||
48688208|NCT00078806|102020178|FG002|COMPLETED|Part 1B||0||
48688209|NCT00078806|102020179|FG003|COMPLETED|Part 1B||0||
48688210|NCT00078806|102020176|FG000|NOT COMPLETED|Part 1B||8||
48688211|NCT00078806|102020177|FG001|NOT COMPLETED|Part 1B||0||
48385064|NCT01875367|101269641|FG001|STARTED|Overall Study||85||
48385065|NCT01875367|101269640|FG000|COMPLETED|Overall Study||76||
48385066|NCT01875367|101269641|FG001|COMPLETED|Overall Study||83||
48385067|NCT01875367|101269640|FG000|NOT COMPLETED|Overall Study||5||
48385068|NCT01875367|101269641|FG001|NOT COMPLETED|Overall Study||2||
48385069|NCT01797965|101269642|FG000|STARTED|Overall Study||597||
48385070|NCT01797965|101269643|FG001|STARTED|Overall Study||607||
48385071|NCT01797965|101269644|FG002|STARTED|Overall Study||70||
48385072|NCT01797965|101269645|FG003|STARTED|Overall Study||227||
48385073|NCT01797965|101269642|FG000|COMPLETED|Overall Study||48||
48385074|NCT01797965|101269643|FG001|COMPLETED|Overall Study||38||
48385075|NCT01797965|101269644|FG002|COMPLETED|Overall Study||62||
48385076|NCT01797965|101269645|FG003|COMPLETED|Overall Study||154||
48385077|NCT01797965|101269642|FG000|NOT COMPLETED|Overall Study||549||
48385078|NCT01797965|101269643|FG001|NOT COMPLETED|Overall Study||569||
48385079|NCT01797965|101269644|FG002|NOT COMPLETED|Overall Study||8||
48385080|NCT01797965|101269645|FG003|NOT COMPLETED|Overall Study||73||
48385081|NCT02513784|101269646|FG000|STARTED|Overall Study||10||
48385082|NCT02513784|101269647|FG001|STARTED|Overall Study||10||
48385083|NCT02513784|101269646|FG000|COMPLETED|Overall Study||10||
48385084|NCT02513784|101269647|FG001|COMPLETED|Overall Study||10||
48385085|NCT02513784|101269646|FG000|NOT COMPLETED|Overall Study||0||
48385086|NCT02513784|101269647|FG001|NOT COMPLETED|Overall Study||0||
48385087|NCT05319080|101269648|FG000|STARTED|Overall Study||11||
48385088|NCT05319080|101269648|FG000|COMPLETED|Overall Study||5||
48385089|NCT05319080|101269648|FG000|NOT COMPLETED|Overall Study||6||
48385090|NCT02124707|101269649|FG000|STARTED|Overall Study||14||
48385091|NCT02124707|101269649|FG000|COMPLETED|Overall Study||7||
48385092|NCT02124707|101269649|FG000|NOT COMPLETED|Overall Study||7||
48385093|NCT01648452|101269650|FG000|STARTED|Overall Study||5||
48385094|NCT01648452|101269650|FG000|COMPLETED|Overall Study||5||
48385095|NCT01648452|101269650|FG000|NOT COMPLETED|Overall Study||0||
48385096|NCT00310388|101269651|FG000|STARTED|Primary Reporting Phase||376||
48385097|NCT00310388|101269652|FG001|STARTED|Primary Reporting Phase||0||
48385098|NCT00310388|101269651|FG000|COMPLETED|Primary Reporting Phase||30|Discontinued from Study and Switched to commercial product.|
48385099|NCT00310388|101269652|FG001|COMPLETED|Primary Reporting Phase||0|Discontinued from Study and Switched to commercial product.|
48385100|NCT00310388|101269651|FG000|NOT COMPLETED|Primary Reporting Phase||346||
48385101|NCT00310388|101269652|FG001|NOT COMPLETED|Primary Reporting Phase||0||
48385102|NCT00310388|101269651|FG000|STARTED|Safety Follow-up Continuation Phase||0||
48385103|NCT00310388|101269652|FG001|STARTED|Safety Follow-up Continuation Phase||26||
48385104|NCT00310388|101269651|FG000|COMPLETED|Safety Follow-up Continuation Phase||0||
48385105|NCT00310388|101269652|FG001|COMPLETED|Safety Follow-up Continuation Phase||13||
48385106|NCT00310388|101269651|FG000|NOT COMPLETED|Safety Follow-up Continuation Phase||0||
48385107|NCT00310388|101269652|FG001|NOT COMPLETED|Safety Follow-up Continuation Phase||13||
48385108|NCT01391819|101269653|FG000|STARTED|Overall Study||2116||
48385109|NCT01391819|101269653|FG000|COMPLETED|Overall Study||1714||
48385110|NCT01391819|101269653|FG000|NOT COMPLETED|Overall Study||402||
48385111|NCT00781599|101272717|FG000|STARTED|Overall Study||36||
48385112|NCT00781599|101272718|FG001|STARTED|Overall Study||36||
48385113|NCT00781599|101272717|FG000|COMPLETED|Overall Study||29||
48385114|NCT00781599|101272718|FG001|COMPLETED|Overall Study||32||
48385115|NCT00781599|101272717|FG000|NOT COMPLETED|Overall Study||7||
48385116|NCT00781599|101272718|FG001|NOT COMPLETED|Overall Study||4||
48385117|NCT01434641|101272719|FG000|STARTED|Overall Study||102||
48385118|NCT01434641|101272719|FG000|COMPLETED|Overall Study||102||
48385119|NCT01434641|101272719|FG000|NOT COMPLETED|Overall Study||0||
48385120|NCT01561560|101272720|FG000|STARTED|First Two Weeks of Wear||60||
48385121|NCT01561560|101272721|FG001|STARTED|First Two Weeks of Wear||61||
48385122|NCT01561560|101272720|FG000|COMPLETED|First Two Weeks of Wear||60||
48385123|NCT01561560|101272721|FG001|COMPLETED|First Two Weeks of Wear||59||
48385124|NCT01561560|101272720|FG000|NOT COMPLETED|First Two Weeks of Wear||0||
48385125|NCT01561560|101272721|FG001|NOT COMPLETED|First Two Weeks of Wear||2||
48385126|NCT01561560|101272720|FG000|STARTED|Second Two Weeks of Wear||60||
48385127|NCT01561560|101272721|FG001|STARTED|Second Two Weeks of Wear||59||
48385128|NCT01561560|101272720|FG000|COMPLETED|Second Two Weeks of Wear||60||
48385129|NCT01561560|101272721|FG001|COMPLETED|Second Two Weeks of Wear||58||
48385130|NCT01561560|101272720|FG000|NOT COMPLETED|Second Two Weeks of Wear||0||
48385131|NCT01561560|101272721|FG001|NOT COMPLETED|Second Two Weeks of Wear||1||
48385132|NCT00523341|101272722|FG000|STARTED|Overall Study||2207||
48385133|NCT00523341|101272723|FG001|STARTED|Overall Study||2343||
48385134|NCT00523341|101272722|FG000|Received Treatment|Overall Study||2206||
48385135|NCT00523341|101272723|FG001|Received Treatment|Overall Study||2343||
48385136|NCT00523341|101272722|FG000|COMPLETED|Overall Study||1283||
48385137|NCT00523341|101272723|FG001|COMPLETED|Overall Study||1343||
48688212|NCT00078806|102020178|FG002|NOT COMPLETED|Part 1B||0||
48688213|NCT00078806|102020179|FG003|NOT COMPLETED|Part 1B||0||
48385138|NCT00523341|101272722|FG000|NOT COMPLETED|Overall Study||924||
48385139|NCT00523341|101272723|FG001|NOT COMPLETED|Overall Study||1000||
48385140|NCT00494871|101272724|FG000|STARTED|Double-blind (DB) Treatment Period||640||
48385141|NCT00494871|101272725|FG001|STARTED|Double-blind (DB) Treatment Period||640||
48385142|NCT00494871|101272724|FG000|Started Treatment|Double-blind (DB) Treatment Period||639||
48385143|NCT00494871|101272725|FG001|Started Treatment|Double-blind (DB) Treatment Period||639||
48385144|NCT00494871|101272724|FG000|COMPLETED|Double-blind (DB) Treatment Period||480||
48385145|NCT00494871|101272725|FG001|COMPLETED|Double-blind (DB) Treatment Period||468||
48385146|NCT00494871|101272724|FG000|NOT COMPLETED|Double-blind (DB) Treatment Period||160||
48385147|NCT00494871|101272725|FG001|NOT COMPLETED|Double-blind (DB) Treatment Period||172||
48385148|NCT00494871|101272724|FG000|STARTED|Follow-up (FU) Period||639||
48385149|NCT00494871|101272725|FG001|STARTED|Follow-up (FU) Period||639||
48385150|NCT00494871|101272724|FG000|Entered FU and Valid for Safety|Follow-up (FU) Period||628||
48385151|NCT00494871|101272725|FG001|Entered FU and Valid for Safety|Follow-up (FU) Period||630||
48385152|NCT00494871|101272724|FG000|COMPLETED|Follow-up (FU) Period||610||
48385153|NCT00494871|101272725|FG001|COMPLETED|Follow-up (FU) Period||616||
48385154|NCT00494871|101272724|FG000|NOT COMPLETED|Follow-up (FU) Period||29||
48385155|NCT00494871|101272725|FG001|NOT COMPLETED|Follow-up (FU) Period||23||
48385156|NCT02681055|101272726|FG000|STARTED|Weeks 1-4||19||
48385157|NCT02681055|101272726|FG000|COMPLETED|Weeks 1-4||19||
48385158|NCT02681055|101272726|FG000|NOT COMPLETED|Weeks 1-4||0||
48385159|NCT02681055|101272726|FG000|STARTED|Weeks 5-12||19||
48385160|NCT02681055|101272726|FG000|COMPLETED|Weeks 5-12||18||
48385161|NCT02681055|101272726|FG000|NOT COMPLETED|Weeks 5-12||1||
48385162|NCT00438399|101272727|FG000|STARTED|Overall Study||38||
48385163|NCT00438399|101272728|FG001|STARTED|Overall Study||40||
48385164|NCT00438399|101272729|FG002|STARTED|Overall Study||35||
48385165|NCT00438399|101272730|FG003|STARTED|Overall Study||36||
48385166|NCT00438399|101272731|FG004|STARTED|Overall Study||33||
48385167|NCT00438399|101272732|FG005|STARTED|Overall Study||37||
48385168|NCT00438399|101272727|FG000|TREATED & ANALYZED|Overall Study||30||
48385169|NCT00438399|101272728|FG001|TREATED & ANALYZED|Overall Study||32||
48385170|NCT00438399|101272729|FG002|TREATED & ANALYZED|Overall Study||28||
48385171|NCT00438399|101272730|FG003|TREATED & ANALYZED|Overall Study||32||
48385172|NCT00438399|101272731|FG004|TREATED & ANALYZED|Overall Study||30||
48385173|NCT00438399|101272732|FG005|TREATED & ANALYZED|Overall Study||31||
48688214|NCT00078806|102020176|FG000|STARTED|Part 2||0||
48688215|NCT00078806|102020177|FG001|STARTED|Part 2||6||
48688216|NCT00078806|102020178|FG002|STARTED|Part 2||4||
48688217|NCT00078806|102020179|FG003|STARTED|Part 2||0||
48688218|NCT00078806|102020176|FG000|Received Study Drug|Part 2||0||
48688219|NCT00078806|102020177|FG001|Received Study Drug|Part 2||5||
48688220|NCT00078806|102020178|FG002|Received Study Drug|Part 2||4||
48688221|NCT00078806|102020179|FG003|Received Study Drug|Part 2||0||
48688222|NCT00078806|102020176|FG000|COMPLETED|Part 2||0||
48688223|NCT00078806|102020177|FG001|COMPLETED|Part 2||5||
48688224|NCT00078806|102020178|FG002|COMPLETED|Part 2||4||
48688225|NCT00078806|102020179|FG003|COMPLETED|Part 2||0||
48688226|NCT00078806|102020176|FG000|NOT COMPLETED|Part 2||0||
48092351|NCT01850550|100549001|FG001|NOT COMPLETED|Overall Study||3||
48092352|NCT01705652|100549002|FG000|STARTED|Overall Study||9||
48385174|NCT00438399|101272727|FG000|COMPLETED|Overall Study||30||
48385175|NCT00438399|101272728|FG001|COMPLETED|Overall Study||32||
48385176|NCT00438399|101272729|FG002|COMPLETED|Overall Study||28||
48385177|NCT00438399|101272730|FG003|COMPLETED|Overall Study||32||
48385178|NCT00438399|101272731|FG004|COMPLETED|Overall Study||30||
48385179|NCT00438399|101272732|FG005|COMPLETED|Overall Study||31||
48385180|NCT00438399|101272727|FG000|NOT COMPLETED|Overall Study||8||
48385181|NCT00438399|101272728|FG001|NOT COMPLETED|Overall Study||8||
48385182|NCT00438399|101272729|FG002|NOT COMPLETED|Overall Study||7||
48385183|NCT00438399|101272730|FG003|NOT COMPLETED|Overall Study||4||
48385184|NCT00438399|101272731|FG004|NOT COMPLETED|Overall Study||3||
48385185|NCT00438399|101272732|FG005|NOT COMPLETED|Overall Study||6||
48385186|NCT00817206|101272733|FG000|STARTED|Overall Study||163||
48385187|NCT00817206|101272734|FG001|STARTED|Overall Study||163||
48385188|NCT00817206|101272733|FG000|COMPLETED|Overall Study||142||
48385189|NCT00817206|101272734|FG001|COMPLETED|Overall Study||154||
48688227|NCT00078806|102020177|FG001|NOT COMPLETED|Part 2||1||
48688228|NCT00078806|102020178|FG002|NOT COMPLETED|Part 2||0||
48688229|NCT00078806|102020179|FG003|NOT COMPLETED|Part 2||0||
48092353|NCT01705652|100549003|FG001|STARTED|Overall Study||12||
48092354|NCT01705652|100549002|FG000|COMPLETED|Overall Study||6||
48385190|NCT00817206|101272733|FG000|NOT COMPLETED|Overall Study||21||
48688230|NCT00078806|102020176|FG000|STARTED|Part 3||0||
48092355|NCT01705652|100549003|FG001|COMPLETED|Overall Study||9||
48385191|NCT00817206|101272734|FG001|NOT COMPLETED|Overall Study||9||
48385192|NCT02781454|101272735|FG000|STARTED|Overall Study||8||
48385193|NCT02781454|101272736|FG001|STARTED|Overall Study||6||
48688231|NCT00078806|102020177|FG001|STARTED|Part 3||0||
48688232|NCT00078806|102020178|FG002|STARTED|Part 3||0||
48688233|NCT00078806|102020179|FG003|STARTED|Part 3||9||
48688234|NCT00078806|102020176|FG000|COMPLETED|Part 3||0||
48688235|NCT00078806|102020177|FG001|COMPLETED|Part 3||0||
48688236|NCT00078806|102020178|FG002|COMPLETED|Part 3||0||
48092356|NCT01705652|100549002|FG000|NOT COMPLETED|Overall Study||3||
48092357|NCT01705652|100549003|FG001|NOT COMPLETED|Overall Study||3||
48092358|NCT02865187|100549004|FG000|STARTED|Overall Study||33|Visit 1 - Enrollment|
48092359|NCT02865187|100549005|FG001|STARTED|Overall Study||14|Visit 1 - Enrollment|
48092360|NCT02865187|100549004|FG000|Visit 2 - at 3 Months|Overall Study||23||
48092361|NCT02865187|100549005|FG001|Visit 2 - at 3 Months|Overall Study||7||
48092362|NCT02865187|100549004|FG000|COMPLETED|Overall Study||20|Visit 3 - at 6 months|
48092363|NCT02865187|100549005|FG001|COMPLETED|Overall Study||7|Visit 3 - at 6 months|
48092364|NCT02865187|100549004|FG000|NOT COMPLETED|Overall Study||13||
48092365|NCT02865187|100549005|FG001|NOT COMPLETED|Overall Study||7||
48092366|NCT03965533|100549006|FG000|STARTED|Part A (112 Days)||2||
48092367|NCT03965533|100549007|FG001|STARTED|Part A (112 Days)||6||
48092368|NCT03965533|100549008|FG002|STARTED|Part A (112 Days)||2||
48092369|NCT03965533|100549009|FG003|STARTED|Part A (112 Days)||6||
48092370|NCT03965533|100549010|FG004|STARTED|Part A (112 Days)||0||
48385194|NCT02781454|101272737|FG002|STARTED|Overall Study||6||
48385195|NCT02781454|101272735|FG000|COMPLETED|Overall Study||8||
48385196|NCT02781454|101272736|FG001|COMPLETED|Overall Study||6||
48385197|NCT02781454|101272737|FG002|COMPLETED|Overall Study||5||
48385198|NCT02781454|101272735|FG000|NOT COMPLETED|Overall Study||0||
48385199|NCT02781454|101272736|FG001|NOT COMPLETED|Overall Study||0||
48385200|NCT02781454|101272737|FG002|NOT COMPLETED|Overall Study||1||
48385201|NCT02995330|101272738|FG000|STARTED|Overall Study||3||
48385202|NCT02995330|101272738|FG000|COMPLETED|Overall Study||3||
48385203|NCT02995330|101272738|FG000|NOT COMPLETED|Overall Study||0||
48688237|NCT00078806|102020179|FG003|COMPLETED|Part 3||9||
48688238|NCT00078806|102020176|FG000|NOT COMPLETED|Part 3||0||
48688239|NCT00078806|102020177|FG001|NOT COMPLETED|Part 3||0||
48688240|NCT00078806|102020178|FG002|NOT COMPLETED|Part 3||0||
48688241|NCT00078806|102020179|FG003|NOT COMPLETED|Part 3||0||
48688242|NCT01340664|102020180|FG000|STARTED|Overall Study||93||
48092371|NCT03965533|100549011|FG005|STARTED|Part A (112 Days)||0||
48092372|NCT03965533|100549012|FG006|STARTED|Part A (112 Days)||0||
48092373|NCT03965533|100549006|FG000|COMPLETED|Part A (112 Days)||2||
48092374|NCT03965533|100549007|FG001|COMPLETED|Part A (112 Days)||6||
48092375|NCT03965533|100549008|FG002|COMPLETED|Part A (112 Days)||2||
48092376|NCT03965533|100549009|FG003|COMPLETED|Part A (112 Days)||6||
48092377|NCT03965533|100549010|FG004|COMPLETED|Part A (112 Days)||0||
48092378|NCT03965533|100549011|FG005|COMPLETED|Part A (112 Days)||0||
48092379|NCT03965533|100549012|FG006|COMPLETED|Part A (112 Days)||0||
48385204|NCT00592553|101272739|FG000|STARTED|Overall Study||60||
48385205|NCT00592553|101272740|FG001|STARTED|Overall Study||57||
48385206|NCT00592553|101272741|FG002|STARTED|Overall Study||57||
48385207|NCT00592553|101272739|FG000|As-treated Population|Overall Study||60|All Randomized participants who received any study treatment.|
48385208|NCT00592553|101272740|FG001|As-treated Population|Overall Study||57|All Randomized participants who received any study treatment.|
48688243|NCT01340664|102020181|FG001|STARTED|Overall Study||93||
48092380|NCT03965533|100549006|FG000|NOT COMPLETED|Part A (112 Days)||0||
48092381|NCT03965533|100549007|FG001|NOT COMPLETED|Part A (112 Days)||0||
48092382|NCT03965533|100549008|FG002|NOT COMPLETED|Part A (112 Days)||0||
48092383|NCT03965533|100549009|FG003|NOT COMPLETED|Part A (112 Days)||0||
48092384|NCT03965533|100549010|FG004|NOT COMPLETED|Part A (112 Days)||0||
48092385|NCT03965533|100549011|FG005|NOT COMPLETED|Part A (112 Days)||0||
48092386|NCT03965533|100549012|FG006|NOT COMPLETED|Part A (112 Days)||0||
48092387|NCT03965533|100549006|FG000|STARTED|Part B (112 Days)||0||
48092388|NCT03965533|100549007|FG001|STARTED|Part B (112 Days)||0||
48092389|NCT03965533|100549008|FG002|STARTED|Part B (112 Days)||0||
48092390|NCT03965533|100549009|FG003|STARTED|Part B (112 Days)||0||
48092391|NCT03965533|100549010|FG004|STARTED|Part B (112 Days)||4||
48092392|NCT03965533|100549011|FG005|STARTED|Part B (112 Days)||8||
48092393|NCT03965533|100549012|FG006|STARTED|Part B (112 Days)||8||
48092394|NCT03965533|100549006|FG000|COMPLETED|Part B (112 Days)||0||
48092395|NCT03965533|100549007|FG001|COMPLETED|Part B (112 Days)||0||
48092396|NCT03965533|100549008|FG002|COMPLETED|Part B (112 Days)||0||
48092397|NCT03965533|100549009|FG003|COMPLETED|Part B (112 Days)||0||
48092398|NCT03965533|100549010|FG004|COMPLETED|Part B (112 Days)||4||
48092399|NCT03965533|100549011|FG005|COMPLETED|Part B (112 Days)||8||
48092400|NCT03965533|100549012|FG006|COMPLETED|Part B (112 Days)||8||
48092401|NCT03965533|100549006|FG000|NOT COMPLETED|Part B (112 Days)||0||
48092402|NCT03965533|100549007|FG001|NOT COMPLETED|Part B (112 Days)||0||
48092403|NCT03965533|100549008|FG002|NOT COMPLETED|Part B (112 Days)||0||
48688244|NCT01340664|102020182|FG002|STARTED|Overall Study||93||
48688245|NCT01340664|102020180|FG000|COMPLETED|Overall Study||86||
48092404|NCT03965533|100549009|FG003|NOT COMPLETED|Part B (112 Days)||0||
48092405|NCT03965533|100549010|FG004|NOT COMPLETED|Part B (112 Days)||0||
48385209|NCT00592553|101272741|FG002|As-treated Population|Overall Study||57|All Randomized participants who received any study treatment.|
48092406|NCT03965533|100549011|FG005|NOT COMPLETED|Part B (112 Days)||0||
48092407|NCT03965533|100549012|FG006|NOT COMPLETED|Part B (112 Days)||0||
48092408|NCT02289079|100549013|FG000|STARTED|Overall Study||30||
48092409|NCT02289079|100549014|FG001|STARTED|Overall Study||30||
48688246|NCT01340664|102020181|FG001|COMPLETED|Overall Study||85||
48688247|NCT01340664|102020182|FG002|COMPLETED|Overall Study||80||
48385210|NCT00592553|101272739|FG000|ITT Population|Overall Study||60|Received any study treatment; had a valid baseline, and at least 1 valid post-baseline 6MWD value.|
48385211|NCT00592553|101272740|FG001|ITT Population|Overall Study||57|Received any study treatment; had a valid baseline, and at least 1 valid post-baseline 6MWD value.|
48385212|NCT00592553|101272741|FG002|ITT Population|Overall Study||57|Received any study treatment; had a valid baseline, and at least 1 valid post-baseline 6MWD value.|
48688248|NCT01340664|102020180|FG000|NOT COMPLETED|Overall Study||7||
48688249|NCT01340664|102020181|FG001|NOT COMPLETED|Overall Study||8||
48092410|NCT02289079|100549013|FG000|COMPLETED|Overall Study||28||
48385213|NCT00592553|101272739|FG000|COMPLETED|Overall Study||59||
48385214|NCT00592553|101272740|FG001|COMPLETED|Overall Study||57||
48385215|NCT00592553|101272741|FG002|COMPLETED|Overall Study||57||
48385216|NCT00592553|101272739|FG000|NOT COMPLETED|Overall Study||1||
48385217|NCT00592553|101272740|FG001|NOT COMPLETED|Overall Study||0||
48385218|NCT00592553|101272741|FG002|NOT COMPLETED|Overall Study||0||
48541662|NCT03095638|101662796|FG007|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0||
48541663|NCT03095638|101662789|FG000|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0||
48541664|NCT03095638|101662790|FG001|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0||
48541665|NCT03095638|101662791|FG002|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0||
48541666|NCT03095638|101662792|FG003|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0||
48541667|NCT03095638|101662793|FG004|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0||
48541668|NCT03095638|101662794|FG005|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0||
48541669|NCT03095638|101662795|FG006|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0||
48541670|NCT03095638|101662796|FG007|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0||
48541671|NCT03095638|101662789|FG000|STARTED|P1: Period 2 (4 Days)||7||
48541672|NCT03095638|101662790|FG001|STARTED|P1: Period 2 (4 Days)||7||
48541673|NCT03095638|101662791|FG002|STARTED|P1: Period 2 (4 Days)||0||
48541674|NCT03095638|101662792|FG003|STARTED|P1: Period 2 (4 Days)||0||
48541675|NCT03095638|101662793|FG004|STARTED|P1: Period 2 (4 Days)||0||
48541676|NCT03095638|101662794|FG005|STARTED|P1: Period 2 (4 Days)||0||
48541677|NCT03095638|101662795|FG006|STARTED|P1: Period 2 (4 Days)||0||
48688250|NCT01340664|102020182|FG002|NOT COMPLETED|Overall Study||13||
48688251|NCT01119443|102020183|FG000|STARTED|Up-titration Period (10 Days)||14||
48688252|NCT01119443|102020184|FG001|STARTED|Up-titration Period (10 Days)||14||
48688253|NCT01119443|102020183|FG000|COMPLETED|Up-titration Period (10 Days)||14||
48688254|NCT01119443|102020184|FG001|COMPLETED|Up-titration Period (10 Days)||14||
48688255|NCT01119443|102020183|FG000|NOT COMPLETED|Up-titration Period (10 Days)||0||
48688256|NCT01119443|102020184|FG001|NOT COMPLETED|Up-titration Period (10 Days)||0||
48688257|NCT01119443|102020183|FG000|STARTED|Crossover Period 1 (5 Days)||14||
48688258|NCT01119443|102020184|FG001|STARTED|Crossover Period 1 (5 Days)||14||
48688259|NCT01119443|102020183|FG000|COMPLETED|Crossover Period 1 (5 Days)||14||
48688260|NCT01119443|102020184|FG001|COMPLETED|Crossover Period 1 (5 Days)||13||
48688261|NCT01119443|102020183|FG000|NOT COMPLETED|Crossover Period 1 (5 Days)||0||
48688262|NCT01119443|102020184|FG001|NOT COMPLETED|Crossover Period 1 (5 Days)||1||
48688263|NCT01119443|102020183|FG000|STARTED|Crossover Period 2 (5 Days)||14||
48688264|NCT01119443|102020184|FG001|STARTED|Crossover Period 2 (5 Days)||13||
48688265|NCT01119443|102020183|FG000|COMPLETED|Crossover Period 2 (5 Days)||14||
48688266|NCT01119443|102020184|FG001|COMPLETED|Crossover Period 2 (5 Days)||13||
48688267|NCT01119443|102020183|FG000|NOT COMPLETED|Crossover Period 2 (5 Days)||0||
48688268|NCT01119443|102020184|FG001|NOT COMPLETED|Crossover Period 2 (5 Days)||0||
48688269|NCT01119443|102020183|FG000|STARTED|Crossover Period 3 (5 Days)||14||
48688270|NCT01119443|102020184|FG001|STARTED|Crossover Period 3 (5 Days)||13||
48688271|NCT01119443|102020183|FG000|COMPLETED|Crossover Period 3 (5 Days)||14||
48688272|NCT01119443|102020184|FG001|COMPLETED|Crossover Period 3 (5 Days)||13||
48688273|NCT01119443|102020183|FG000|NOT COMPLETED|Crossover Period 3 (5 Days)||0||
48688274|NCT01119443|102020184|FG001|NOT COMPLETED|Crossover Period 3 (5 Days)||0||
48688275|NCT01119443|102020183|FG000|STARTED|Crossover Period 4 (5 Days)||14||
48688276|NCT01119443|102020184|FG001|STARTED|Crossover Period 4 (5 Days)||13||
48688277|NCT01119443|102020183|FG000|COMPLETED|Crossover Period 4 (5 Days)||14||
48688278|NCT01119443|102020184|FG001|COMPLETED|Crossover Period 4 (5 Days)||13||
48688279|NCT01119443|102020183|FG000|NOT COMPLETED|Crossover Period 4 (5 Days)||0||
48688280|NCT01119443|102020184|FG001|NOT COMPLETED|Crossover Period 4 (5 Days)||0||
48688281|NCT01119443|102020183|FG000|STARTED|Down-titration Period (1 Day)||14||
48688282|NCT01119443|102020184|FG001|STARTED|Down-titration Period (1 Day)||13||
48688283|NCT01119443|102020183|FG000|COMPLETED|Down-titration Period (1 Day)||14||
48688284|NCT01119443|102020184|FG001|COMPLETED|Down-titration Period (1 Day)||13||
48688285|NCT01119443|102020183|FG000|NOT COMPLETED|Down-titration Period (1 Day)||0||
48092411|NCT02289079|100549014|FG001|COMPLETED|Overall Study||29||
48092412|NCT02289079|100549013|FG000|NOT COMPLETED|Overall Study||2||
48092413|NCT02289079|100549014|FG001|NOT COMPLETED|Overall Study||1||
48092414|NCT02442869|100549015|FG000|STARTED|Overall Study||18||
48092415|NCT02442869|100549016|FG001|STARTED|Overall Study||29||
48092416|NCT02442869|100549017|FG002|STARTED|Overall Study||6||
48092417|NCT02442869|100549018|FG003|STARTED|Overall Study||2||
48092418|NCT02442869|100549019|FG004|STARTED|Overall Study||5||
48092419|NCT02442869|100549020|FG005|STARTED|Overall Study||2||
48092420|NCT02442869|100549015|FG000|COMPLETED|Overall Study||13||
48092421|NCT02442869|100549016|FG001|COMPLETED|Overall Study||20||
48092422|NCT02442869|100549017|FG002|COMPLETED|Overall Study||6||
48385219|NCT00575094|101272742|FG000|STARTED|Overall Study||9||
48385220|NCT00575094|101272742|FG000|COMPLETED|Overall Study||6||
48688286|NCT01119443|102020184|FG001|NOT COMPLETED|Down-titration Period (1 Day)||0||
48688287|NCT01119443|102020183|FG000|STARTED|End of Study (All Patients)||14||
48688288|NCT01119443|102020184|FG001|STARTED|End of Study (All Patients)||14||
48688289|NCT01119443|102020183|FG000|COMPLETED|End of Study (All Patients)||14||
48688290|NCT01119443|102020184|FG001|COMPLETED|End of Study (All Patients)||14||
48688291|NCT01119443|102020183|FG000|NOT COMPLETED|End of Study (All Patients)||0||
48688292|NCT01119443|102020184|FG001|NOT COMPLETED|End of Study (All Patients)||0||
48688293|NCT01212471|102020185|FG000|STARTED|Overall Study||141||
48688294|NCT01212471|102020186|FG001|STARTED|Overall Study||140||
48688295|NCT01212471|102020187|FG002|STARTED|Overall Study||139||
48688296|NCT01212471|102020185|FG000|COMPLETED|Overall Study||139||
48688297|NCT01212471|102020186|FG001|COMPLETED|Overall Study||137||
48688298|NCT01212471|102020187|FG002|COMPLETED|Overall Study||132||
48688299|NCT01212471|102020185|FG000|NOT COMPLETED|Overall Study||2||
48688300|NCT01212471|102020186|FG001|NOT COMPLETED|Overall Study||3||
48688301|NCT01212471|102020187|FG002|NOT COMPLETED|Overall Study||7||
48688302|NCT01635998|102020188|FG000|STARTED|Overall Study||28||
48688303|NCT01635998|102020189|FG001|STARTED|Overall Study||22||
48688304|NCT01635998|102020188|FG000|COMPLETED|Overall Study||24||
48688305|NCT01635998|102020189|FG001|COMPLETED|Overall Study||15||
48688306|NCT01635998|102020188|FG000|NOT COMPLETED|Overall Study||4||
48688307|NCT01635998|102020189|FG001|NOT COMPLETED|Overall Study||7||
48688308|NCT00161616|102020190|FG000|STARTED|Overall Study||139||
48688309|NCT00161616|102020191|FG001|STARTED|Overall Study||138||
48688310|NCT00161616|102020190|FG000|COMPLETED|Overall Study||113||
48688311|NCT00161616|102020191|FG001|COMPLETED|Overall Study||119||
48688312|NCT00161616|102020190|FG000|NOT COMPLETED|Overall Study||26||
48092423|NCT02442869|100549018|FG003|COMPLETED|Overall Study||1||
48092424|NCT02442869|100549019|FG004|COMPLETED|Overall Study||3||
48092425|NCT02442869|100549020|FG005|COMPLETED|Overall Study||2||
48092426|NCT02442869|100549015|FG000|NOT COMPLETED|Overall Study||5||
48092427|NCT02442869|100549016|FG001|NOT COMPLETED|Overall Study||9||
48092428|NCT02442869|100549017|FG002|NOT COMPLETED|Overall Study||0||
48092429|NCT02442869|100549018|FG003|NOT COMPLETED|Overall Study||1||
48092430|NCT02442869|100549019|FG004|NOT COMPLETED|Overall Study||2||
48092431|NCT02442869|100549020|FG005|NOT COMPLETED|Overall Study||0||
48092432|NCT00643682|100549021|FG000|STARTED|Overall Study||999||
48092433|NCT00643682|100549022|FG001|STARTED|Overall Study||1001||
48092434|NCT00643682|100549021|FG000|COMPLETED|Overall Study||477||
48092435|NCT00643682|100549022|FG001|COMPLETED|Overall Study||492||
48092436|NCT00643682|100549021|FG000|NOT COMPLETED|Overall Study||522||
48092437|NCT00643682|100549022|FG001|NOT COMPLETED|Overall Study||509||
48092438|NCT01166724|100549023|FG000|STARTED|Overall Study||7||
48092439|NCT01166724|100549024|FG001|STARTED|Overall Study||5||
48092440|NCT01166724|100549023|FG000|COMPLETED|Overall Study||0||
48385221|NCT00575094|101272742|FG000|NOT COMPLETED|Overall Study||3||
48385222|NCT03497429|101272743|FG000|STARTED|Overall Study||3||
48385223|NCT03497429|101272744|FG001|STARTED|Overall Study||6||
48688313|NCT00161616|102020191|FG001|NOT COMPLETED|Overall Study||19||
48688314|NCT01053507|102020192|FG000|STARTED|Overall Study||11||
48688315|NCT01053507|102020193|FG001|STARTED|Overall Study||12||
48688316|NCT01053507|102020192|FG000|COMPLETED|Overall Study||8||
48688317|NCT01053507|102020193|FG001|COMPLETED|Overall Study||11||
48688318|NCT01053507|102020192|FG000|NOT COMPLETED|Overall Study||3||
48688319|NCT01053507|102020193|FG001|NOT COMPLETED|Overall Study||1||
48092441|NCT01166724|100549024|FG001|COMPLETED|Overall Study||0||
48092442|NCT01166724|100549023|FG000|NOT COMPLETED|Overall Study||7||
48257045|NCT04333147|100947907|FG001|COMPLETED|Overall Study||0||
48688320|NCT02623205|102020194|FG000|STARTED|Overall Study||42||
48688321|NCT02623205|102020195|FG001|STARTED|Overall Study||43||
48688322|NCT02623205|102020194|FG000|COMPLETED|Overall Study||38||
48688323|NCT02623205|102020195|FG001|COMPLETED|Overall Study||40||
48688324|NCT02623205|102020194|FG000|NOT COMPLETED|Overall Study||4||
48688325|NCT02623205|102020195|FG001|NOT COMPLETED|Overall Study||3||
48688326|NCT01672879|102020196|FG000|STARTED|Blinded Phase (Up to 240 Weeks)||87||
48092443|NCT01166724|100549024|FG001|NOT COMPLETED|Overall Study||5||
48092444|NCT02268864|100549025|FG000|STARTED|Overall Study||17||
48092445|NCT02268864|100549026|FG001|STARTED|Overall Study||25||
48092446|NCT02268864|100549027|FG002|STARTED|Overall Study||64||
48092447|NCT02268864|100549025|FG000|COMPLETED|Overall Study||15||
48385224|NCT03497429|101272743|FG000|Started|Overall Study||3||
48385225|NCT03497429|101272744|FG001|Started|Overall Study||6||
48092448|NCT02268864|100549026|FG001|COMPLETED|Overall Study||24||
48092449|NCT02268864|100549027|FG002|COMPLETED|Overall Study||64||
48092450|NCT02268864|100549025|FG000|NOT COMPLETED|Overall Study||2||
48092451|NCT02268864|100549026|FG001|NOT COMPLETED|Overall Study||1||
48092452|NCT02268864|100549027|FG002|NOT COMPLETED|Overall Study||0||
48092453|NCT01189812|100549028|FG000|STARTED|Overall Study||40||
48092454|NCT01189812|100549029|FG001|STARTED|Overall Study||40||
48092455|NCT01189812|100549028|FG000|COMPLETED|Overall Study||32||
48092456|NCT01189812|100549029|FG001|COMPLETED|Overall Study||32||
48092457|NCT01189812|100549028|FG000|NOT COMPLETED|Overall Study||8||
48092458|NCT01189812|100549029|FG001|NOT COMPLETED|Overall Study||8||
48092459|NCT00799604|100549030|FG000|STARTED|Bolus 1 (Pre-anesthesia)||10||
48688327|NCT01672879|102020197|FG001|STARTED|Blinded Phase (Up to 240 Weeks)||86||
48688328|NCT01672879|102020198|FG002|STARTED|Blinded Phase (Up to 240 Weeks)||86||
48688329|NCT01672879|102020196|FG000|COMPLETED|Blinded Phase (Up to 240 Weeks)||0||
48092460|NCT00799604|100549031|FG001|STARTED|Bolus 1 (Pre-anesthesia)||10||
48092461|NCT00799604|100549032|FG002|STARTED|Bolus 1 (Pre-anesthesia)||10||
48092462|NCT00799604|100549030|FG000|COMPLETED|Bolus 1 (Pre-anesthesia)||10||
48092463|NCT00799604|100549031|FG001|COMPLETED|Bolus 1 (Pre-anesthesia)||10||
48092464|NCT00799604|100549032|FG002|COMPLETED|Bolus 1 (Pre-anesthesia)||10||
48092465|NCT00799604|100549030|FG000|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0||
48092466|NCT00799604|100549031|FG001|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0||
48092467|NCT00799604|100549032|FG002|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0||
48092468|NCT00799604|100549030|FG000|STARTED|Bolus 2 (With Anesthesia)||6||
48092469|NCT00799604|100549031|FG001|STARTED|Bolus 2 (With Anesthesia)||12||
48092470|NCT00799604|100549032|FG002|STARTED|Bolus 2 (With Anesthesia)||3||
48092471|NCT00799604|100549030|FG000|COMPLETED|Bolus 2 (With Anesthesia)||6||
48092472|NCT00799604|100549031|FG001|COMPLETED|Bolus 2 (With Anesthesia)||12||
48092473|NCT00799604|100549032|FG002|COMPLETED|Bolus 2 (With Anesthesia)||3||
48385226|NCT03497429|101272743|FG000|Completed|Overall Study||0||
48385227|NCT03497429|101272744|FG001|Completed|Overall Study||0||
48092474|NCT00799604|100549030|FG000|NOT COMPLETED|Bolus 2 (With Anesthesia)||0||
48092475|NCT00799604|100549031|FG001|NOT COMPLETED|Bolus 2 (With Anesthesia)||0||
48092476|NCT00799604|100549032|FG002|NOT COMPLETED|Bolus 2 (With Anesthesia)||0||
48092477|NCT00460408|100549033|FG000|STARTED|Overall Study||403||
48092478|NCT00460408|100549034|FG001|STARTED|Overall Study||16||
48092479|NCT00460408|100549035|FG002|STARTED|Overall Study||75||
48092480|NCT00460408|100549036|FG003|STARTED|Overall Study||7||
48092481|NCT00460408|100549033|FG000|COMPLETED|Overall Study||336||
48092482|NCT00460408|100549034|FG001|COMPLETED|Overall Study||13||
48092483|NCT00460408|100549035|FG002|COMPLETED|Overall Study||69||
48092484|NCT00460408|100549036|FG003|COMPLETED|Overall Study||7||
48092485|NCT00460408|100549033|FG000|NOT COMPLETED|Overall Study||67||
48092486|NCT00460408|100549034|FG001|NOT COMPLETED|Overall Study||3||
48092487|NCT00460408|100549035|FG002|NOT COMPLETED|Overall Study||6||
48092488|NCT00460408|100549036|FG003|NOT COMPLETED|Overall Study||0||
48385228|NCT03497429|101272743|FG000|COMPLETED|Overall Study||0||
48385229|NCT03497429|101272744|FG001|COMPLETED|Overall Study||0||
48385230|NCT03497429|101272743|FG000|NOT COMPLETED|Overall Study||3||
48385231|NCT03497429|101272744|FG001|NOT COMPLETED|Overall Study||6||
48385232|NCT01827930|101272745|FG000|STARTED|Overall Study||24||
48385233|NCT01827930|101272746|FG001|STARTED|Overall Study||25||
48385234|NCT01827930|101272747|FG002|STARTED|Overall Study||19||
48385235|NCT01827930|101272745|FG000|COMPLETED|Overall Study||24||
48385236|NCT01827930|101272746|FG001|COMPLETED|Overall Study||25||
48541678|NCT03095638|101662796|FG007|STARTED|P1: Period 2 (4 Days)||0||
48541679|NCT03095638|101662789|FG000|COMPLETED|P1: Period 2 (4 Days)||7||
48541680|NCT03095638|101662790|FG001|COMPLETED|P1: Period 2 (4 Days)||7||
48541681|NCT03095638|101662791|FG002|COMPLETED|P1: Period 2 (4 Days)||0||
48541682|NCT03095638|101662792|FG003|COMPLETED|P1: Period 2 (4 Days)||0||
48541683|NCT03095638|101662793|FG004|COMPLETED|P1: Period 2 (4 Days)||0||
48541684|NCT03095638|101662794|FG005|COMPLETED|P1: Period 2 (4 Days)||0||
48541685|NCT03095638|101662795|FG006|COMPLETED|P1: Period 2 (4 Days)||0||
48541686|NCT03095638|101662796|FG007|COMPLETED|P1: Period 2 (4 Days)||0||
48688330|NCT01672879|102020197|FG001|COMPLETED|Blinded Phase (Up to 240 Weeks)||0||
48688331|NCT01672879|102020198|FG002|COMPLETED|Blinded Phase (Up to 240 Weeks)||0||
48092489|NCT01614067|100549037|FG000|STARTED|Overall Study||15|Arm randomization assignment prior to starting clinical treatment cycle|
48092490|NCT01614067|100549038|FG001|STARTED|Overall Study||15|Arm randomization assignment prior to starting clinical treatment cycle|
48092491|NCT01614067|100549037|FG000|COMPLETED|Overall Study||0||
48092492|NCT01614067|100549038|FG001|COMPLETED|Overall Study||0||
48092493|NCT01614067|100549037|FG000|NOT COMPLETED|Overall Study||15||
48092494|NCT01614067|100549038|FG001|NOT COMPLETED|Overall Study||15||
48092495|NCT00416078|100549039|FG000|STARTED|Overall Study||29||
48385237|NCT01827930|101272747|FG002|COMPLETED|Overall Study||19||
48541687|NCT03095638|101662789|FG000|NOT COMPLETED|P1: Period 2 (4 Days)||0||
48541688|NCT03095638|101662790|FG001|NOT COMPLETED|P1: Period 2 (4 Days)||0||
48541689|NCT03095638|101662791|FG002|NOT COMPLETED|P1: Period 2 (4 Days)||0||
48541690|NCT03095638|101662792|FG003|NOT COMPLETED|P1: Period 2 (4 Days)||0||
48541691|NCT03095638|101662793|FG004|NOT COMPLETED|P1: Period 2 (4 Days)||0||
48541692|NCT03095638|101662794|FG005|NOT COMPLETED|P1: Period 2 (4 Days)||0||
48092496|NCT00416078|100549040|FG001|STARTED|Overall Study||24||
48092497|NCT00416078|100549039|FG000|COMPLETED|Overall Study||18||
48092498|NCT00416078|100549040|FG001|COMPLETED|Overall Study||16||
48092499|NCT00416078|100549039|FG000|NOT COMPLETED|Overall Study||11||
48092500|NCT00416078|100549040|FG001|NOT COMPLETED|Overall Study||8||
48092501|NCT00293254|100549041|FG000|STARTED|Primary Study - Double-Blind Week 0-48||232||
48092502|NCT00293254|100549042|FG001|STARTED|Primary Study - Double-Blind Week 0-48||119||
48092503|NCT00293254|100549041|FG000|Treated|Primary Study - Double-Blind Week 0-48||230||
48092504|NCT00293254|100549042|FG001|Treated|Primary Study - Double-Blind Week 0-48||119||
48092505|NCT00293254|100549041|FG000|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48||177||
48092506|NCT00293254|100549042|FG001|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48||55||
48092507|NCT00293254|100549041|FG000|COMPLETED|Primary Study - Double-Blind Week 0-48||177||
48092508|NCT00293254|100549042|FG001|COMPLETED|Primary Study - Double-Blind Week 0-48||55||
48092509|NCT00293254|100549041|FG000|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||55||
48092510|NCT00293254|100549042|FG001|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||64||
48092511|NCT00293254|100549041|FG000|STARTED|Extension - Double-Blind Week 49-156||177||
48688332|NCT01672879|102020196|FG000|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||87||
48688333|NCT01672879|102020197|FG001|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||86||
48688334|NCT01672879|102020198|FG002|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||86||
48092512|NCT00293254|100549042|FG001|STARTED|Extension - Double-Blind Week 49-156||54||
48092513|NCT00293254|100549041|FG000|COMPLETED|Extension - Double-Blind Week 49-156||120||
48385238|NCT01827930|101272745|FG000|NOT COMPLETED|Overall Study||0||
48688335|NCT01672879|102020196|FG000|STARTED|Open-Label Phase (Up to 240 Weeks)||15||
48688336|NCT01672879|102020197|FG001|STARTED|Open-Label Phase (Up to 240 Weeks)||17||
48688337|NCT01672879|102020198|FG002|STARTED|Open-Label Phase (Up to 240 Weeks)||8||
48688338|NCT01672879|102020196|FG000|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0||
48688339|NCT01672879|102020197|FG001|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0||
48688340|NCT01672879|102020198|FG002|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0||
48688341|NCT01672879|102020196|FG000|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||15||
48688342|NCT01672879|102020197|FG001|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||17||
48688343|NCT01672879|102020198|FG002|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||8||
48688344|NCT00451958|102020199|FG000|STARTED|CS21 (NCT00295750)||210||
48688345|NCT00451958|102020200|FG001|STARTED|CS21 (NCT00295750)||206||
48688346|NCT00451958|102020201|FG002|STARTED|CS21 (NCT00295750)||0||
48688347|NCT00451958|102020202|FG003|STARTED|CS21 (NCT00295750)||0||
48688348|NCT00451958|102020203|FG004|STARTED|CS21 (NCT00295750)||204||
48688349|NCT00451958|102020199|FG000|COMPLETED|CS21 (NCT00295750)||169||
48688350|NCT00451958|102020200|FG001|COMPLETED|CS21 (NCT00295750)||163||
48688351|NCT00451958|102020201|FG002|COMPLETED|CS21 (NCT00295750)||0||
48688352|NCT00451958|102020202|FG003|COMPLETED|CS21 (NCT00295750)||0||
48688353|NCT00451958|102020203|FG004|COMPLETED|CS21 (NCT00295750)||172||
48688354|NCT00451958|102020199|FG000|NOT COMPLETED|CS21 (NCT00295750)||41||
48688355|NCT00451958|102020200|FG001|NOT COMPLETED|CS21 (NCT00295750)||43||
48688356|NCT00451958|102020201|FG002|NOT COMPLETED|CS21 (NCT00295750)||0||
48688357|NCT00451958|102020202|FG003|NOT COMPLETED|CS21 (NCT00295750)||0||
48688358|NCT00451958|102020203|FG004|NOT COMPLETED|CS21 (NCT00295750)||32||
48688359|NCT00451958|102020199|FG000|STARTED|CS21A (NCT00451958)||125||
48688360|NCT00451958|102020200|FG001|STARTED|CS21A (NCT00451958)||126||
48688361|NCT00451958|102020201|FG002|STARTED|CS21A (NCT00451958)||69||
48688362|NCT00451958|102020202|FG003|STARTED|CS21A (NCT00451958)||66||
48688363|NCT00451958|102020203|FG004|STARTED|CS21A (NCT00451958)||0||
48688364|NCT00451958|102020199|FG000|COMPLETED|CS21A (NCT00451958)||60||
48688365|NCT00451958|102020200|FG001|COMPLETED|CS21A (NCT00451958)||49||
48688366|NCT00451958|102020201|FG002|COMPLETED|CS21A (NCT00451958)||27||
48688367|NCT00451958|102020202|FG003|COMPLETED|CS21A (NCT00451958)||27||
48688368|NCT00451958|102020203|FG004|COMPLETED|CS21A (NCT00451958)||0||
48688369|NCT00451958|102020199|FG000|NOT COMPLETED|CS21A (NCT00451958)||65||
48688370|NCT00451958|102020200|FG001|NOT COMPLETED|CS21A (NCT00451958)||77||
48092514|NCT00293254|100549042|FG001|COMPLETED|Extension - Double-Blind Week 49-156||25||
48092515|NCT00293254|100549041|FG000|NOT COMPLETED|Extension - Double-Blind Week 49-156||57||
48092516|NCT00293254|100549042|FG001|NOT COMPLETED|Extension - Double-Blind Week 49-156||29||
48092517|NCT00293254|100549041|FG000|STARTED|Extension - Open-Label Week 157-240||120||
48092518|NCT00293254|100549042|FG001|STARTED|Extension - Open-Label Week 157-240||19||
48092519|NCT00293254|100549041|FG000|COMPLETED|Extension - Open-Label Week 157-240||110||
48141383|NCT01297062|100670412|FG002|NOT COMPLETED|Overall Study||2||
48688371|NCT00451958|102020201|FG002|NOT COMPLETED|CS21A (NCT00451958)||42||
48688372|NCT00451958|102020202|FG003|NOT COMPLETED|CS21A (NCT00451958)||39||
48688373|NCT00451958|102020203|FG004|NOT COMPLETED|CS21A (NCT00451958)||0||
48688374|NCT00211172|102020204|FG000|STARTED|Overall Study||449||
48385239|NCT01827930|101272746|FG001|NOT COMPLETED|Overall Study||0||
48688375|NCT00211172|102020205|FG001|STARTED|Overall Study||458||
48688376|NCT00211172|102020204|FG000|COMPLETED|Overall Study||410||
48688377|NCT00211172|102020205|FG001|COMPLETED|Overall Study||426||
48688378|NCT00211172|102020204|FG000|NOT COMPLETED|Overall Study||39||
48688379|NCT00211172|102020205|FG001|NOT COMPLETED|Overall Study||32||
48688380|NCT03502915|102020206|FG000|STARTED|Overall Study||24||
48688381|NCT03502915|102020207|FG001|STARTED|Overall Study||24||
48688382|NCT03502915|102020206|FG000|COMPLETED|Overall Study||24||
48688383|NCT03502915|102020207|FG001|COMPLETED|Overall Study||24||
48385240|NCT01827930|101272747|FG002|NOT COMPLETED|Overall Study||0||
48385241|NCT01757405|101272748|FG000|STARTED|Overall Study||18||
48092520|NCT00293254|100549042|FG001|COMPLETED|Extension - Open-Label Week 157-240||18||
48688384|NCT03502915|102020206|FG000|NOT COMPLETED|Overall Study||0||
48688385|NCT03502915|102020207|FG001|NOT COMPLETED|Overall Study||0||
48688386|NCT03462641|102020208|FG000|STARTED|Visit 1||19||
48688387|NCT03462641|102020209|FG001|STARTED|Visit 1||11||
48092521|NCT00293254|100549041|FG000|NOT COMPLETED|Extension - Open-Label Week 157-240||10||
48092522|NCT00293254|100549042|FG001|NOT COMPLETED|Extension - Open-Label Week 157-240||1||
48092523|NCT00293254|100549041|FG000|STARTED|Open-Label Post Virologic Failure Phase||50||
48092524|NCT00293254|100549042|FG001|STARTED|Open-Label Post Virologic Failure Phase||64||
48092525|NCT00293254|100549041|FG000|COMPLETED|Open-Label Post Virologic Failure Phase||19||
48092526|NCT00293254|100549042|FG001|COMPLETED|Open-Label Post Virologic Failure Phase||37||
48092527|NCT00293254|100549041|FG000|NOT COMPLETED|Open-Label Post Virologic Failure Phase||31||
48092528|NCT00293254|100549042|FG001|NOT COMPLETED|Open-Label Post Virologic Failure Phase||27||
48385242|NCT01757405|101272749|FG001|STARTED|Overall Study||20||
48385243|NCT01757405|101272748|FG000|COMPLETED|Overall Study||17||
48385244|NCT01757405|101272749|FG001|COMPLETED|Overall Study||18||
48385245|NCT01757405|101272748|FG000|NOT COMPLETED|Overall Study||1||
48385246|NCT01757405|101272749|FG001|NOT COMPLETED|Overall Study||2||
48385247|NCT04900038|101272750|FG000|STARTED|Overall Study||22||
48385248|NCT04900038|101272751|FG001|STARTED|Overall Study||20||
48385249|NCT04900038|101272752|FG002|STARTED|Overall Study||22||
48385250|NCT04900038|101272753|FG003|STARTED|Overall Study||21||
48385251|NCT04900038|101272750|FG000|COMPLETED|Overall Study||2||
48385252|NCT04900038|101272751|FG001|COMPLETED|Overall Study||3||
48385253|NCT04900038|101272752|FG002|COMPLETED|Overall Study||2||
48385254|NCT04900038|101272753|FG003|COMPLETED|Overall Study||3||
48385255|NCT04900038|101272750|FG000|NOT COMPLETED|Overall Study||20||
48385256|NCT04900038|101272751|FG001|NOT COMPLETED|Overall Study||17||
48385257|NCT04900038|101272752|FG002|NOT COMPLETED|Overall Study||20||
48385258|NCT04900038|101272753|FG003|NOT COMPLETED|Overall Study||18||
48688388|NCT03462641|102020208|FG000|Actually Received Drug or Placebo|Visit 1||18||
48688389|NCT03462641|102020209|FG001|Actually Received Drug or Placebo|Visit 1||11||
48688390|NCT03462641|102020208|FG000|COMPLETED|Visit 1||18||
48688391|NCT03462641|102020209|FG001|COMPLETED|Visit 1||11||
48688392|NCT03462641|102020208|FG000|NOT COMPLETED|Visit 1||1||
48688393|NCT03462641|102020209|FG001|NOT COMPLETED|Visit 1||0||
48688394|NCT03462641|102020208|FG000|STARTED|Visit 2||18||
48688395|NCT03462641|102020209|FG001|STARTED|Visit 2||11||
48688396|NCT03462641|102020208|FG000|Actually Received Drug or Placebo|Visit 2||18||
48688397|NCT03462641|102020209|FG001|Actually Received Drug or Placebo|Visit 2||10||
48688398|NCT03462641|102020208|FG000|COMPLETED|Visit 2||18||
48688399|NCT03462641|102020209|FG001|COMPLETED|Visit 2||10||
48092529|NCT02557646|100549043|FG000|STARTED|Overall Study||693||
48385259|NCT00012012|101272754|FG000|STARTED|Overall Study||27||
48092530|NCT02557646|100549043|FG000|COMPLETED|Overall Study||417||
48092531|NCT02557646|100549043|FG000|NOT COMPLETED|Overall Study||276||
48092532|NCT02659631|100549044|FG000|STARTED|Overall Study||1|This study was terminated early and Part 2 was not initiated. The form only includes arms in Part 1.|
48092533|NCT02659631|100549045|FG001|STARTED|Overall Study||2|This study was terminated early and Part 2 was not initiated. The form only includes arms in Part 1.|
48092534|NCT02659631|100549046|FG002|STARTED|Overall Study||3|This study was terminated early and Part 2 was not initiated. The form only includes arms in Part 1.|
48092535|NCT02659631|100549047|FG003|STARTED|Overall Study||2|This study was terminated early and Part 2 was not initiated. The form only includes arms in Part 1.|
48092536|NCT02659631|100549048|FG004|STARTED|Overall Study||5|This study was terminated early and Part 2 was not initiated. The form only includes arms in Part 1.|
48092537|NCT02659631|100549049|FG005|STARTED|Overall Study||5|This study was terminated early and Part 2 was not initiated. The form only includes arms in Part 1.|
48092538|NCT02659631|100549050|FG006|STARTED|Overall Study||4|This study was terminated early and Part 2 was not initiated. The form only includes arms in Part 1.|
48092539|NCT02659631|100549051|FG007|STARTED|Overall Study||3|This study was terminated early and Part 2 was not initiated. The form only includes arms in Part 1.|
48092540|NCT02659631|100549052|FG008|STARTED|Overall Study||2|This study was terminated early and Part 2 was not initiated. The form only includes arms in Part 1.|
48092541|NCT02659631|100549053|FG009|STARTED|Overall Study||1|This study was terminated early and Part 2 was not initiated. The form only includes arms in Part 1.|
48092542|NCT02659631|100549044|FG000|COMPLETED|Overall Study||0||
48092543|NCT02659631|100549045|FG001|COMPLETED|Overall Study||0||
48385260|NCT00012012|101272755|FG001|STARTED|Overall Study||18||
48385261|NCT00012012|101272754|FG000|COMPLETED|Overall Study||26||
48385262|NCT00012012|101272755|FG001|COMPLETED|Overall Study||15||
48385263|NCT00012012|101272754|FG000|NOT COMPLETED|Overall Study||1||
48385264|NCT00012012|101272755|FG001|NOT COMPLETED|Overall Study||3||
48688400|NCT03462641|102020208|FG000|NOT COMPLETED|Visit 2||0||
48688401|NCT03462641|102020209|FG001|NOT COMPLETED|Visit 2||1||
48688402|NCT01119066|102020210|FG000|STARTED|Overall Study||132||1
48688403|NCT01119066|102020211|FG001|STARTED|Overall Study||227||0
48688404|NCT01119066|102020212|FG002|STARTED|Overall Study||52||1
48092544|NCT02659631|100549046|FG002|COMPLETED|Overall Study||0||
48092545|NCT02659631|100549047|FG003|COMPLETED|Overall Study||0||
48092546|NCT02659631|100549048|FG004|COMPLETED|Overall Study||0||
48092547|NCT02659631|100549049|FG005|COMPLETED|Overall Study||2||
48092548|NCT02659631|100549050|FG006|COMPLETED|Overall Study||3||
48092549|NCT02659631|100549051|FG007|COMPLETED|Overall Study||0||
48092550|NCT02659631|100549052|FG008|COMPLETED|Overall Study||0||
48092551|NCT02659631|100549053|FG009|COMPLETED|Overall Study||1||
48092552|NCT02659631|100549044|FG000|NOT COMPLETED|Overall Study||1||
48092553|NCT02659631|100549045|FG001|NOT COMPLETED|Overall Study||2||
48092554|NCT02659631|100549046|FG002|NOT COMPLETED|Overall Study||3||
48092555|NCT02659631|100549047|FG003|NOT COMPLETED|Overall Study||2||
48092556|NCT02659631|100549048|FG004|NOT COMPLETED|Overall Study||5||
48092557|NCT02659631|100549049|FG005|NOT COMPLETED|Overall Study||3||
48092558|NCT02659631|100549050|FG006|NOT COMPLETED|Overall Study||1||
48092559|NCT02659631|100549051|FG007|NOT COMPLETED|Overall Study||3||
48092560|NCT02659631|100549052|FG008|NOT COMPLETED|Overall Study||2||
48092561|NCT02659631|100549053|FG009|NOT COMPLETED|Overall Study||0||
48092562|NCT00464087|100549054|FG000|STARTED|Overall Study||49||
48092563|NCT00464087|100549055|FG001|STARTED|Overall Study||51||
48092564|NCT00464087|100549056|FG002|STARTED|Overall Study||29||
48092565|NCT00464087|100549054|FG000|COMPLETED|Overall Study||49||
48092566|NCT00464087|100549055|FG001|COMPLETED|Overall Study||51||
48092567|NCT00464087|100549056|FG002|COMPLETED|Overall Study||0||
48092568|NCT00464087|100549054|FG000|NOT COMPLETED|Overall Study||0||
48092569|NCT00464087|100549055|FG001|NOT COMPLETED|Overall Study||0||
48092570|NCT00464087|100549056|FG002|NOT COMPLETED|Overall Study||29||
48092571|NCT04626297|100549057|FG000|STARTED|Overall Study||127||
48092572|NCT04626297|100549058|FG001|STARTED|Overall Study||127||
48092573|NCT04626297|100549057|FG000|Received at Least 1 Dose of Study Drug|Overall Study||127||
48092574|NCT04626297|100549058|FG001|Received at Least 1 Dose of Study Drug|Overall Study||127||
48092575|NCT04626297|100549057|FG000|COMPLETED|Overall Study||88||
48092576|NCT04626297|100549058|FG001|COMPLETED|Overall Study||113||
48092577|NCT04626297|100549057|FG000|NOT COMPLETED|Overall Study||39||
48092578|NCT04626297|100549058|FG001|NOT COMPLETED|Overall Study||14||
48092579|NCT03315208|100549059|FG000|STARTED|Overall Study||29||
48092580|NCT03315208|100549060|FG001|STARTED|Overall Study||18||
48092581|NCT03315208|100549059|FG000|COMPLETED|Overall Study||16||
48092582|NCT03315208|100549060|FG001|COMPLETED|Overall Study||12||
48385265|NCT01706549|101272756|FG000|STARTED|Overall Study||16||
48385266|NCT01706549|101272756|FG000|COMPLETED|Overall Study||16||
48092583|NCT03315208|100549059|FG000|NOT COMPLETED|Overall Study||13||
48092584|NCT03315208|100549060|FG001|NOT COMPLETED|Overall Study||6||
48092585|NCT01196923|100549061|FG000|STARTED|Overall Study||20||
48092586|NCT01196923|100549061|FG000|COMPLETED|Overall Study||20||
48092587|NCT01196923|100549061|FG000|NOT COMPLETED|Overall Study||0||
48092588|NCT03358290|100549062|FG000|STARTED|Overall Study||2||
48092589|NCT03358290|100549063|FG001|STARTED|Overall Study||3||
48092590|NCT03358290|100549064|FG002|STARTED|Overall Study||3||
48092591|NCT03358290|100549065|FG003|STARTED|Overall Study||3||
48092592|NCT03358290|100549066|FG004|STARTED|Overall Study||2||
48092593|NCT03358290|100549062|FG000|COMPLETED|Overall Study||2||
48092594|NCT03358290|100549063|FG001|COMPLETED|Overall Study||2||
48092595|NCT03358290|100549064|FG002|COMPLETED|Overall Study||1||
48092596|NCT03358290|100549065|FG003|COMPLETED|Overall Study||1||
48092597|NCT03358290|100549066|FG004|COMPLETED|Overall Study||1||
48092598|NCT03358290|100549062|FG000|NOT COMPLETED|Overall Study||0||
48092599|NCT03358290|100549063|FG001|NOT COMPLETED|Overall Study||1||
48092600|NCT03358290|100549064|FG002|NOT COMPLETED|Overall Study||2||
48092601|NCT03358290|100549065|FG003|NOT COMPLETED|Overall Study||2||
48092602|NCT03358290|100549066|FG004|NOT COMPLETED|Overall Study||1||
48092603|NCT01986985|100549067|FG000|STARTED|Overall Study||58||
48092604|NCT01986985|100549067|FG000|COMPLETED|Overall Study||51||
48092605|NCT01986985|100549067|FG000|NOT COMPLETED|Overall Study||7||
48385267|NCT01706549|101272756|FG000|NOT COMPLETED|Overall Study||0||
48092606|NCT02452398|100549068|FG000|STARTED|Overall Study||79||
48092607|NCT02452398|100549068|FG000|COMPLETED|Overall Study||38||
48385268|NCT01519063|101272757|FG000|STARTED|Overall Study||26||
48385269|NCT01519063|101272758|FG001|STARTED|Overall Study||30||
48385270|NCT01519063|101272757|FG000|COMPLETED|Overall Study||19||
48385271|NCT01519063|101272758|FG001|COMPLETED|Overall Study||25||
48385272|NCT01519063|101272757|FG000|NOT COMPLETED|Overall Study||7||
48092608|NCT02452398|100549068|FG000|NOT COMPLETED|Overall Study||41||
48092609|NCT01563003|100549069|FG000|STARTED|Overall Study||16||
48092610|NCT01563003|100549070|FG001|STARTED|Overall Study||15||
48092611|NCT01563003|100549069|FG000|COMPLETED|Overall Study||16||
48092612|NCT01563003|100549070|FG001|COMPLETED|Overall Study||15||
48092613|NCT01563003|100549069|FG000|NOT COMPLETED|Overall Study||0||
48092614|NCT01563003|100549070|FG001|NOT COMPLETED|Overall Study||0||
48092615|NCT02328755|100549071|FG000|STARTED|Overall Study||3||
48092616|NCT02328755|100549072|FG001|STARTED|Overall Study||33||
48092617|NCT02328755|100549071|FG000|COMPLETED|Overall Study||0|Evaluable for the phase II primary endpoint of relapse at 6-months post-HCT|
48092618|NCT02328755|100549072|FG001|COMPLETED|Overall Study||31|Evaluable for the phase II primary endpoint of relapse at 6-months post-HCT|
48092619|NCT02328755|100549071|FG000|NOT COMPLETED|Overall Study||3||
48092620|NCT02328755|100549072|FG001|NOT COMPLETED|Overall Study||2||
48092621|NCT01961323|100549073|FG000|STARTED|Overall Study||70||
48092622|NCT01961323|100549073|FG000|COMPLETED|Overall Study||21||
48092623|NCT01961323|100549073|FG000|NOT COMPLETED|Overall Study||49||
48092624|NCT02107482|100549074|FG000|STARTED|Overall Study||21||
48092625|NCT02107482|100549074|FG000|COMPLETED|Overall Study||17||
48092626|NCT02107482|100549074|FG000|NOT COMPLETED|Overall Study||4||
48092627|NCT03036072|100549075|FG000|STARTED|Overall Study||12||
48092628|NCT03036072|100549076|FG001|STARTED|Overall Study||13||
48092629|NCT03036072|100549075|FG000|COMPLETED|Overall Study||12||
48092630|NCT03036072|100549076|FG001|COMPLETED|Overall Study||10||
48092631|NCT03036072|100549075|FG000|NOT COMPLETED|Overall Study||0||
48092632|NCT03036072|100549076|FG001|NOT COMPLETED|Overall Study||3||
48092633|NCT00770289|100549077|FG000|STARTED|Overall Study||851||
48092634|NCT00770289|100549077|FG000|COMPLETED|Overall Study||845||
48092635|NCT00770289|100549077|FG000|NOT COMPLETED|Overall Study||6||
48257046|NCT04333147|100947906|FG000|NOT COMPLETED|Overall Study||1456||
48257047|NCT04333147|100947907|FG001|NOT COMPLETED|Overall Study||1459||
48257048|NCT00569192|100947908|FG000|STARTED|Overall Study||111||
48257049|NCT00569192|100947909|FG001|STARTED|Overall Study||125||
48385273|NCT01519063|101272758|FG001|NOT COMPLETED|Overall Study||5||
48385274|NCT01583452|101272759|FG000|STARTED|Overall Study||21||
48385275|NCT01583452|101272760|FG001|STARTED|Overall Study||20||
48385276|NCT01583452|101272759|FG000|COMPLETED|Overall Study||21||
48385277|NCT01583452|101272760|FG001|COMPLETED|Overall Study||20||
48385278|NCT01583452|101272759|FG000|NOT COMPLETED|Overall Study||0||
48385279|NCT01583452|101272760|FG001|NOT COMPLETED|Overall Study||0||
48385280|NCT03379506|101272761|FG000|STARTED|Overall Study||22||
48385281|NCT03379506|101272762|FG001|STARTED|Overall Study||17||
48688405|NCT01119066|102020213|FG003|STARTED|Overall Study||11||0
48688406|NCT01119066|102020210|FG000|COMPLETED|Overall Study||125||1
48688407|NCT01119066|102020211|FG001|COMPLETED|Overall Study||213||0
48688408|NCT01119066|102020212|FG002|COMPLETED|Overall Study||52||1
48688409|NCT01119066|102020213|FG003|COMPLETED|Overall Study||11||0
48688410|NCT01119066|102020210|FG000|NOT COMPLETED|Overall Study||7||0
48092636|NCT04053023|100549078|FG000|STARTED|Part A: Period 1 (Day 1 to Day 19)||19||
48257050|NCT00569192|100947910|FG002|STARTED|Overall Study||124||
48257051|NCT00569192|100947908|FG000|COMPLETED|Overall Study||88||
48257052|NCT00569192|100947909|FG001|COMPLETED|Overall Study||105||
48257053|NCT00569192|100947910|FG002|COMPLETED|Overall Study||99||
48257054|NCT00569192|100947908|FG000|NOT COMPLETED|Overall Study||23||
48257055|NCT00569192|100947909|FG001|NOT COMPLETED|Overall Study||20||
48257056|NCT00569192|100947910|FG002|NOT COMPLETED|Overall Study||25||
48257057|NCT00585975|100947911|FG000|STARTED|Overall Study||277||
48257058|NCT00585975|100947912|FG001|STARTED|Overall Study||291||
48257059|NCT00585975|100947911|FG000|COMPLETED|Overall Study||262||
48257060|NCT00585975|100947912|FG001|COMPLETED|Overall Study||278||
48257061|NCT00585975|100947911|FG000|NOT COMPLETED|Overall Study||15||
48257062|NCT00585975|100947912|FG001|NOT COMPLETED|Overall Study||13||
48257063|NCT01340014|100947913|FG000|STARTED|Period 1, First 7 Days||55||
48257064|NCT01340014|100947914|FG001|STARTED|Period 1, First 7 Days||57||
48257065|NCT01340014|100947913|FG000|COMPLETED|Period 1, First 7 Days||53||
48257066|NCT01340014|100947914|FG001|COMPLETED|Period 1, First 7 Days||57||
48257067|NCT01340014|100947913|FG000|NOT COMPLETED|Period 1, First 7 Days||2||
48257068|NCT01340014|100947914|FG001|NOT COMPLETED|Period 1, First 7 Days||0||
48257069|NCT01340014|100947913|FG000|STARTED|Period 2, Second 7 Days||53||
48257070|NCT01340014|100947914|FG001|STARTED|Period 2, Second 7 Days||57||
48257071|NCT01340014|100947913|FG000|COMPLETED|Period 2, Second 7 Days||53||
48257072|NCT01340014|100947914|FG001|COMPLETED|Period 2, Second 7 Days||56||
48257073|NCT01340014|100947913|FG000|NOT COMPLETED|Period 2, Second 7 Days||0||
48257074|NCT01340014|100947914|FG001|NOT COMPLETED|Period 2, Second 7 Days||1||
48257075|NCT01324700|100947915|FG000|STARTED|Overall Study||22||
48257076|NCT01324700|100947916|FG001|STARTED|Overall Study||20||
48257077|NCT01324700|100947917|FG002|STARTED|Overall Study||49||
48257078|NCT01324700|100947918|FG003|STARTED|Overall Study||48||
48688411|NCT01119066|102020211|FG001|NOT COMPLETED|Overall Study||14||0
48092637|NCT04053023|100549079|FG001|STARTED|Part A: Period 1 (Day 1 to Day 19)||0||
48257079|NCT01324700|100947915|FG000|COMPLETED|Overall Study||13||
48257080|NCT01324700|100947916|FG001|COMPLETED|Overall Study||16||
48257081|NCT01324700|100947917|FG002|COMPLETED|Overall Study||33||
48257082|NCT01324700|100947918|FG003|COMPLETED|Overall Study||37||
48092638|NCT04053023|100549078|FG000|COMPLETED|Part A: Period 1 (Day 1 to Day 19)||19||
48257083|NCT01324700|100947915|FG000|NOT COMPLETED|Overall Study||9||
48257084|NCT01324700|100947916|FG001|NOT COMPLETED|Overall Study||4||
48257085|NCT01324700|100947917|FG002|NOT COMPLETED|Overall Study||16||
48257086|NCT01324700|100947918|FG003|NOT COMPLETED|Overall Study||11||
48385282|NCT03379506|101272763|FG002|STARTED|Overall Study||7||
48385283|NCT03379506|101272764|FG003|STARTED|Overall Study||11||
48385284|NCT03379506|101272761|FG000|COMPLETED|Overall Study||22||
48385285|NCT03379506|101272762|FG001|COMPLETED|Overall Study||17||
48385286|NCT03379506|101272763|FG002|COMPLETED|Overall Study||7||
48385287|NCT03379506|101272764|FG003|COMPLETED|Overall Study||11||
48385288|NCT03379506|101272761|FG000|NOT COMPLETED|Overall Study||0||
48257087|NCT01253447|100947919|FG000|STARTED|Overall Study||19||
48257088|NCT01253447|100947919|FG000|COMPLETED|Overall Study||17||
48257089|NCT01253447|100947919|FG000|NOT COMPLETED|Overall Study||2||
48257090|NCT01816685|100947920|FG000|STARTED|Overall Study||68||
48257091|NCT01816685|100947921|FG001|STARTED|Overall Study||67||
48257092|NCT01816685|100947920|FG000|COMPLETED|Overall Study||58||
48257093|NCT01816685|100947921|FG001|COMPLETED|Overall Study||56||
48257094|NCT01816685|100947920|FG000|NOT COMPLETED|Overall Study||10||
48257095|NCT01816685|100947921|FG001|NOT COMPLETED|Overall Study||11||
48257096|NCT02767609|100947922|FG000|STARTED|Overall Study||1||
48257097|NCT02767609|100947922|FG000|COMPLETED|Overall Study||1||
48257098|NCT02767609|100947922|FG000|NOT COMPLETED|Overall Study||0||
48257099|NCT01114139|100947923|FG000|STARTED|Overall Study||609||
48257100|NCT01114139|100947924|FG001|STARTED|Overall Study||203||
48257101|NCT01114139|100947923|FG000|Received at Least 1 Dose of Study Drug|Overall Study||608||
48257102|NCT01114139|100947924|FG001|Received at Least 1 Dose of Study Drug|Overall Study||200||
48257103|NCT01114139|100947923|FG000|COMPLETED|Overall Study||569|Completed is defined as had study drug and Week 5 visit.|
48257104|NCT01114139|100947924|FG001|COMPLETED|Overall Study||187|Completed is defined as had study drug and Week 5 visit.|
48257105|NCT01114139|100947923|FG000|NOT COMPLETED|Overall Study||40||
48257106|NCT01114139|100947924|FG001|NOT COMPLETED|Overall Study||16||
48257107|NCT00392704|100947925|FG000|STARTED|Neoadjuvant Chemotherapy||60||
48257108|NCT00392704|100947925|FG000|COMPLETED|Neoadjuvant Chemotherapy||54||
48257109|NCT00392704|100947925|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||6||
48257110|NCT00392704|100947925|FG000|STARTED|Combined Modality Therapy||54||
48257111|NCT00392704|100947925|FG000|COMPLETED|Combined Modality Therapy||49||
48257112|NCT00392704|100947925|FG000|NOT COMPLETED|Combined Modality Therapy||5||
48257113|NCT01726049|100947926|FG000|STARTED|Overall Study||26||
48257114|NCT01726049|100947927|FG001|STARTED|Overall Study||26||
48257115|NCT01726049|100947926|FG000|COMPLETED|Overall Study||21||
48257116|NCT01726049|100947927|FG001|COMPLETED|Overall Study||22||
48257117|NCT01726049|100947926|FG000|NOT COMPLETED|Overall Study||5||
48257118|NCT01726049|100947927|FG001|NOT COMPLETED|Overall Study||4||
48257119|NCT00937521|100947928|FG000|STARTED|Overall Study - Prior to Booster Dose||188||
48257120|NCT00937521|100947929|FG001|STARTED|Overall Study - Prior to Booster Dose||190||
48257121|NCT00937521|100947930|FG002|STARTED|Overall Study - Prior to Booster Dose||192||
48257122|NCT00937521|100947931|FG003|STARTED|Overall Study - Prior to Booster Dose||188||
48257123|NCT00937521|100947932|FG004|STARTED|Overall Study - Prior to Booster Dose||191||
48257124|NCT00937521|100947933|FG005|STARTED|Overall Study - Prior to Booster Dose||188||
48257125|NCT00937521|100947934|FG006|STARTED|Overall Study - Prior to Booster Dose||186||
48257126|NCT00937521|100947935|FG007|STARTED|Overall Study - Prior to Booster Dose||184||
48257127|NCT00937521|100947928|FG000|Premature Withdrawal|Overall Study - Prior to Booster Dose||3||
48257128|NCT00937521|100947929|FG001|Premature Withdrawal|Overall Study - Prior to Booster Dose||5||
48385289|NCT03379506|101272762|FG001|NOT COMPLETED|Overall Study||0||
48385290|NCT03379506|101272763|FG002|NOT COMPLETED|Overall Study||0||
48385291|NCT03379506|101272764|FG003|NOT COMPLETED|Overall Study||0||
48385292|NCT03712345|101272765|FG000|STARTED|Overall Study||6||
48385293|NCT03712345|101272766|FG001|STARTED|Overall Study||7||
48385294|NCT03712345|101272767|FG002|STARTED|Overall Study||7||
48385295|NCT03712345|101272765|FG000|COMPLETED|Overall Study||6||
48385296|NCT03712345|101272766|FG001|COMPLETED|Overall Study||7||
48385297|NCT03712345|101272767|FG002|COMPLETED|Overall Study||6||
48385298|NCT03712345|101272765|FG000|NOT COMPLETED|Overall Study||0||
48385299|NCT03712345|101272766|FG001|NOT COMPLETED|Overall Study||0||
48092639|NCT04053023|100549079|FG001|COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0||
48092640|NCT04053023|100549078|FG000|NOT COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0||
48092641|NCT04053023|100549079|FG001|NOT COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0||
48092642|NCT04053023|100549078|FG000|STARTED|Part A: Period 2 (Day 20 to Day 38)||19||
48092643|NCT04053023|100549079|FG001|STARTED|Part A: Period 2 (Day 20 to Day 38)||0||
48092644|NCT04053023|100549078|FG000|COMPLETED|Part A: Period 2 (Day 20 to Day 38)||18||
48092645|NCT04053023|100549079|FG001|COMPLETED|Part A: Period 2 (Day 20 to Day 38)||0||
48092646|NCT04053023|100549078|FG000|NOT COMPLETED|Part A: Period 2 (Day 20 to Day 38)||1||
48385300|NCT03712345|101272767|FG002|NOT COMPLETED|Overall Study||1||
48385301|NCT02405429|101272768|FG000|STARTED|Overall Study||49||
48385302|NCT02405429|101272768|FG000|COMPLETED|Overall Study||49||
48092647|NCT04053023|100549079|FG001|NOT COMPLETED|Part A: Period 2 (Day 20 to Day 38)||0||
48257129|NCT00937521|100947930|FG002|Premature Withdrawal|Overall Study - Prior to Booster Dose||6||
48257130|NCT00937521|100947931|FG003|Premature Withdrawal|Overall Study - Prior to Booster Dose||1||
48257131|NCT00937521|100947932|FG004|Premature Withdrawal|Overall Study - Prior to Booster Dose||3||
48257132|NCT00937521|100947933|FG005|Premature Withdrawal|Overall Study - Prior to Booster Dose||1||
48257133|NCT00937521|100947934|FG006|Premature Withdrawal|Overall Study - Prior to Booster Dose||5||
48257134|NCT00937521|100947935|FG007|Premature Withdrawal|Overall Study - Prior to Booster Dose||1||
48257135|NCT00937521|100947928|FG000|COMPLETED|Overall Study - Prior to Booster Dose||185||
48385303|NCT02405429|101272768|FG000|NOT COMPLETED|Overall Study||0||
48385304|NCT04831515|101272769|FG000|STARTED|First Intervention||24||
48385305|NCT04831515|101272770|FG001|STARTED|First Intervention||24||
48385306|NCT04831515|101272769|FG000|COMPLETED|First Intervention||24||
48385307|NCT04831515|101272770|FG001|COMPLETED|First Intervention||23||
48385308|NCT04831515|101272769|FG000|NOT COMPLETED|First Intervention||0||
48385309|NCT04831515|101272770|FG001|NOT COMPLETED|First Intervention||1||
48385310|NCT04831515|101272769|FG000|STARTED|Second Intervention||24||
48385311|NCT04831515|101272770|FG001|STARTED|Second Intervention||23||
48385312|NCT04831515|101272769|FG000|COMPLETED|Second Intervention||24||
48385313|NCT04831515|101272770|FG001|COMPLETED|Second Intervention||23||
48385314|NCT04831515|101272769|FG000|NOT COMPLETED|Second Intervention||0||
48385315|NCT04831515|101272770|FG001|NOT COMPLETED|Second Intervention||0||
48385316|NCT01315847|101272771|FG000|STARTED|Part I, Period 1||5||
48385317|NCT01315847|101272772|FG001|STARTED|Part I, Period 1||0||
48385318|NCT01315847|101272771|FG000|Received Telcagepant|Part I, Period 1||5||
48385319|NCT01315847|101272772|FG001|Received Telcagepant|Part I, Period 1||0||
48385320|NCT01315847|101272771|FG000|Received [11C]MK-4232|Part I, Period 1||5||
48385321|NCT01315847|101272772|FG001|Received [11C]MK-4232|Part I, Period 1||0||
48385322|NCT01315847|101272771|FG000|COMPLETED|Part I, Period 1||2||
48257136|NCT00937521|100947929|FG001|COMPLETED|Overall Study - Prior to Booster Dose||185||
48257137|NCT00937521|100947930|FG002|COMPLETED|Overall Study - Prior to Booster Dose||186||
48257138|NCT00937521|100947931|FG003|COMPLETED|Overall Study - Prior to Booster Dose||187||
48257139|NCT00937521|100947932|FG004|COMPLETED|Overall Study - Prior to Booster Dose||188||
48257140|NCT00937521|100947933|FG005|COMPLETED|Overall Study - Prior to Booster Dose||187||
48257141|NCT00937521|100947934|FG006|COMPLETED|Overall Study - Prior to Booster Dose||181||
48385323|NCT01315847|101272772|FG001|COMPLETED|Part I, Period 1||0||
48385324|NCT01315847|101272771|FG000|NOT COMPLETED|Part I, Period 1||3||
48385325|NCT01315847|101272772|FG001|NOT COMPLETED|Part I, Period 1||0||
48257142|NCT00937521|100947935|FG007|COMPLETED|Overall Study - Prior to Booster Dose||183||
48257143|NCT00937521|100947928|FG000|NOT COMPLETED|Overall Study - Prior to Booster Dose||3||
48257144|NCT00937521|100947929|FG001|NOT COMPLETED|Overall Study - Prior to Booster Dose||5||
48257145|NCT00937521|100947930|FG002|NOT COMPLETED|Overall Study - Prior to Booster Dose||6||
48257146|NCT00937521|100947931|FG003|NOT COMPLETED|Overall Study - Prior to Booster Dose||1||
48257147|NCT00937521|100947932|FG004|NOT COMPLETED|Overall Study - Prior to Booster Dose||3||
48257148|NCT00937521|100947933|FG005|NOT COMPLETED|Overall Study - Prior to Booster Dose||1||
48257149|NCT00937521|100947934|FG006|NOT COMPLETED|Overall Study - Prior to Booster Dose||5||
48257150|NCT00937521|100947935|FG007|NOT COMPLETED|Overall Study - Prior to Booster Dose||1||
48257151|NCT00937521|100947928|FG000|STARTED|Booster Phase||155||
48257152|NCT00937521|100947929|FG001|STARTED|Booster Phase||163||
48257153|NCT00937521|100947930|FG002|STARTED|Booster Phase||169||
48257154|NCT00937521|100947931|FG003|STARTED|Booster Phase||170||
48257155|NCT00937521|100947932|FG004|STARTED|Booster Phase||168||
48257156|NCT00937521|100947933|FG005|STARTED|Booster Phase||165||
48257157|NCT00937521|100947934|FG006|STARTED|Booster Phase||165||
48257158|NCT00937521|100947935|FG007|STARTED|Booster Phase||161||
48257159|NCT00937521|100947928|FG000|Premature Withdrawal|Booster Phase||3||
48257160|NCT00937521|100947929|FG001|Premature Withdrawal|Booster Phase||2||
48257161|NCT00937521|100947930|FG002|Premature Withdrawal|Booster Phase||5||
48257162|NCT00937521|100947931|FG003|Premature Withdrawal|Booster Phase||3||
48257163|NCT00937521|100947932|FG004|Premature Withdrawal|Booster Phase||5||
48257164|NCT00937521|100947933|FG005|Premature Withdrawal|Booster Phase||5||
48385326|NCT01315847|101272771|FG000|STARTED|Part I, Period 2||3||
48385327|NCT01315847|101272772|FG001|STARTED|Part I, Period 2||0||
48385328|NCT01315847|101272771|FG000|Received Telcagepant|Part I, Period 2||3||
48385329|NCT01315847|101272772|FG001|Received Telcagepant|Part I, Period 2||0||
48385330|NCT01315847|101272771|FG000|Received [11C]MK-4232|Part I, Period 2||3||
48385331|NCT01315847|101272772|FG001|Received [11C]MK-4232|Part I, Period 2||0||
48385332|NCT01315847|101272771|FG000|COMPLETED|Part I, Period 2||3||
48385333|NCT01315847|101272772|FG001|COMPLETED|Part I, Period 2||0||
48385334|NCT01315847|101272771|FG000|NOT COMPLETED|Part I, Period 2||0||
48385335|NCT01315847|101272772|FG001|NOT COMPLETED|Part I, Period 2||0||
48385336|NCT01315847|101272771|FG000|STARTED|Part III, Period 1||0||
48385337|NCT01315847|101272772|FG001|STARTED|Part III, Period 1||4||
48385338|NCT01315847|101272771|FG000|Received Telcagepant|Part III, Period 1||0||
48385339|NCT01315847|101272772|FG001|Received Telcagepant|Part III, Period 1||4||
48385340|NCT01315847|101272771|FG000|Received [11C]MK-4232|Part III, Period 1||0||
48385341|NCT01315847|101272772|FG001|Received [11C]MK-4232|Part III, Period 1||4||
48257165|NCT00937521|100947934|FG006|Premature Withdrawal|Booster Phase||5||
48257166|NCT00937521|100947935|FG007|Premature Withdrawal|Booster Phase||2||
48385342|NCT01315847|101272771|FG000|COMPLETED|Part III, Period 1||0||
48385343|NCT01315847|101272772|FG001|COMPLETED|Part III, Period 1||3||
48385344|NCT01315847|101272771|FG000|NOT COMPLETED|Part III, Period 1||0||
48385345|NCT01315847|101272772|FG001|NOT COMPLETED|Part III, Period 1||1||
48257167|NCT00937521|100947928|FG000|COMPLETED|Booster Phase||152||
48257168|NCT00937521|100947929|FG001|COMPLETED|Booster Phase||161||
48257169|NCT00937521|100947930|FG002|COMPLETED|Booster Phase||164||
48257170|NCT00937521|100947931|FG003|COMPLETED|Booster Phase||167||
48257171|NCT00937521|100947932|FG004|COMPLETED|Booster Phase||163||
48257172|NCT00937521|100947933|FG005|COMPLETED|Booster Phase||160||
48385346|NCT01315847|101272771|FG000|STARTED|Part III, Period 2||0||
48385347|NCT01315847|101272772|FG001|STARTED|Part III, Period 2||3||
48385348|NCT01315847|101272771|FG000|Received Telcagepant|Part III, Period 2||0||
48385349|NCT01315847|101272772|FG001|Received Telcagepant|Part III, Period 2||3||
48385350|NCT01315847|101272771|FG000|Received [11C]MK-4232|Part III, Period 2||0||
48385351|NCT01315847|101272772|FG001|Received [11C]MK-4232|Part III, Period 2||3||
48385352|NCT01315847|101272771|FG000|COMPLETED|Part III, Period 2||0||
48385353|NCT01315847|101272772|FG001|COMPLETED|Part III, Period 2||3||
48385354|NCT01315847|101272771|FG000|NOT COMPLETED|Part III, Period 2||0||
48385355|NCT01315847|101272772|FG001|NOT COMPLETED|Part III, Period 2||0||
48385356|NCT00868452|101272773|FG000|STARTED|Overall Study||183||
48385357|NCT00868452|101272774|FG001|STARTED|Overall Study||165||
48385358|NCT00868452|101272773|FG000|COMPLETED|Overall Study||143||
48385359|NCT00868452|101272774|FG001|COMPLETED|Overall Study||136||
48385360|NCT00868452|101272773|FG000|NOT COMPLETED|Overall Study||40||
48385361|NCT00868452|101272774|FG001|NOT COMPLETED|Overall Study||29||
48385362|NCT01295580|101272775|FG000|STARTED|Overall Study||174||
48385363|NCT01295580|101272776|FG001|STARTED|Overall Study||175||
48385364|NCT01295580|101272775|FG000|COMPLETED|Overall Study||164||
48385365|NCT01295580|101272776|FG001|COMPLETED|Overall Study||167||
48385366|NCT01295580|101272775|FG000|NOT COMPLETED|Overall Study||10||
48385367|NCT01295580|101272776|FG001|NOT COMPLETED|Overall Study||8||
48385368|NCT03539861|101272777|FG000|STARTED|Overall Study||2||
48385369|NCT03539861|101272777|FG000|COMPLETED|Overall Study||2||
48385370|NCT03539861|101272777|FG000|NOT COMPLETED|Overall Study||0||
48385371|NCT01999946|101272778|FG000|STARTED|Overall Study||61||
48385372|NCT01999946|101272779|FG001|STARTED|Overall Study||58||
48385373|NCT01999946|101272780|FG002|STARTED|Overall Study||79||
48385374|NCT01999946|101272778|FG000|COMPLETED|Overall Study||59||
48385375|NCT01999946|101272779|FG001|COMPLETED|Overall Study||56||
48385376|NCT01999946|101272780|FG002|COMPLETED|Overall Study||0||
48385377|NCT01999946|101272778|FG000|NOT COMPLETED|Overall Study||2||
48385378|NCT01999946|101272779|FG001|NOT COMPLETED|Overall Study||2||
48385379|NCT01999946|101272780|FG002|NOT COMPLETED|Overall Study||79||
48385380|NCT02807363|101272781|FG000|STARTED|Dosing Period||9||
48385381|NCT02807363|101272782|FG001|STARTED|Dosing Period||9||
48385382|NCT02807363|101272783|FG002|STARTED|Dosing Period||5||
48385383|NCT02807363|101272784|FG003|STARTED|Dosing Period||12||
48385384|NCT02807363|101272781|FG000|COMPLETED|Dosing Period||9||
48385385|NCT02807363|101272782|FG001|COMPLETED|Dosing Period||8||
48385386|NCT02807363|101272783|FG002|COMPLETED|Dosing Period||5||
48385387|NCT02807363|101272784|FG003|COMPLETED|Dosing Period||12||
48385388|NCT02807363|101272781|FG000|NOT COMPLETED|Dosing Period||0||
48385389|NCT02807363|101272782|FG001|NOT COMPLETED|Dosing Period||1||
48385390|NCT02807363|101272783|FG002|NOT COMPLETED|Dosing Period||0||
48385391|NCT02807363|101272784|FG003|NOT COMPLETED|Dosing Period||0||
48385392|NCT02807363|101272781|FG000|STARTED|Post- Dosing Period||9||
48385393|NCT02807363|101272782|FG001|STARTED|Post- Dosing Period||8||
48385394|NCT02807363|101272783|FG002|STARTED|Post- Dosing Period||5||
48385395|NCT02807363|101272784|FG003|STARTED|Post- Dosing Period||12||
48385396|NCT02807363|101272781|FG000|COMPLETED|Post- Dosing Period||9||
48385397|NCT02807363|101272782|FG001|COMPLETED|Post- Dosing Period||8||
48385398|NCT02807363|101272783|FG002|COMPLETED|Post- Dosing Period||5||
48385399|NCT02807363|101272784|FG003|COMPLETED|Post- Dosing Period||12||
48385400|NCT02807363|101272781|FG000|NOT COMPLETED|Post- Dosing Period||0||
48385401|NCT02807363|101272782|FG001|NOT COMPLETED|Post- Dosing Period||0||
48385402|NCT02807363|101272783|FG002|NOT COMPLETED|Post- Dosing Period||0||
48385403|NCT02807363|101272784|FG003|NOT COMPLETED|Post- Dosing Period||0||
48385404|NCT00756886|101272785|FG000|STARTED|Overall Study||41||
48385405|NCT00756886|101272786|FG001|STARTED|Overall Study||32||
48385406|NCT00756886|101272785|FG000|COMPLETED|Overall Study||30||
48385407|NCT00756886|101272786|FG001|COMPLETED|Overall Study||25||
48385408|NCT00756886|101272785|FG000|NOT COMPLETED|Overall Study||11||
48385409|NCT00756886|101272786|FG001|NOT COMPLETED|Overall Study||7||
48385410|NCT00913133|101272787|FG000|STARTED|Overall Study||516||
48385411|NCT00913133|101272787|FG000|COMPLETED|Overall Study||516||
48385412|NCT00913133|101272787|FG000|NOT COMPLETED|Overall Study||0||
48385413|NCT03446651|101272788|FG000|STARTED|Overall Study||22||
48385414|NCT03446651|101272789|FG001|STARTED|Overall Study||18||
48385415|NCT03446651|101272788|FG000|Participated in Open Label Portion|Overall Study||5||
48385416|NCT03446651|101272789|FG001|Participated in Open Label Portion|Overall Study||0||
48385417|NCT03446651|101272788|FG000|Completed 1st Visit|Overall Study||17||
48385418|NCT03446651|101272789|FG001|Completed 1st Visit|Overall Study||18||
48385419|NCT03446651|101272788|FG000|Completed Final Visit|Overall Study||13||
48385420|NCT03446651|101272789|FG001|Completed Final Visit|Overall Study||18||
48385421|NCT03446651|101272788|FG000|COMPLETED|Overall Study||13||
48385422|NCT03446651|101272789|FG001|COMPLETED|Overall Study||18||
48385423|NCT03446651|101272788|FG000|NOT COMPLETED|Overall Study||9||
48385424|NCT03446651|101272789|FG001|NOT COMPLETED|Overall Study||0||
48385425|NCT01555905|101272790|FG000|STARTED|Overall Study||17||
48385426|NCT01555905|101272790|FG000|COMPLETED|Overall Study||7||
48385427|NCT01555905|101272790|FG000|NOT COMPLETED|Overall Study||10||
48385428|NCT01568424|101272791|FG000|STARTED|Overall Study||25||
48385429|NCT01568424|101272791|FG000|COMPLETED|Overall Study||25||
48385430|NCT01568424|101272791|FG000|NOT COMPLETED|Overall Study||0||
48385431|NCT01313520|101272792|FG000|STARTED|Overall Study||30||
48385432|NCT01313520|101272793|FG001|STARTED|Overall Study||31||
48385433|NCT01313520|101272792|FG000|COMPLETED|Overall Study||30||
48385434|NCT01313520|101272793|FG001|COMPLETED|Overall Study||31||
48385435|NCT01313520|101272792|FG000|NOT COMPLETED|Overall Study||0||
48385436|NCT01313520|101272793|FG001|NOT COMPLETED|Overall Study||0||
48385437|NCT00238303|101272794|FG000|STARTED|Overall Study||68||
48385438|NCT00238303|101272795|FG001|STARTED|Overall Study||15||
48385439|NCT00238303|101272796|FG002|STARTED|Overall Study||20||
48385440|NCT00238303|101272794|FG000|COMPLETED|Overall Study||53||
48385441|NCT00238303|101272795|FG001|COMPLETED|Overall Study||13||
48385442|NCT00238303|101272796|FG002|COMPLETED|Overall Study||11||
48385443|NCT00238303|101272794|FG000|NOT COMPLETED|Overall Study||15||
48385444|NCT00238303|101272795|FG001|NOT COMPLETED|Overall Study||2||
48385445|NCT00238303|101272796|FG002|NOT COMPLETED|Overall Study||9||
48385446|NCT03544268|101272797|FG000|STARTED|Overall Study||5||
48385447|NCT03544268|101272798|FG001|STARTED|Overall Study||15||
48385448|NCT03544268|101272797|FG000|COMPLETED|Overall Study||3||
48385449|NCT03544268|101272798|FG001|COMPLETED|Overall Study||15||
48385450|NCT03544268|101272797|FG000|NOT COMPLETED|Overall Study||2||
48385451|NCT03544268|101272798|FG001|NOT COMPLETED|Overall Study||0||
48385452|NCT00847938|101272799|FG000|STARTED|Overall Study||16||
48385453|NCT00847938|101272800|FG001|STARTED|Overall Study||15||
48385454|NCT00847938|101272801|FG002|STARTED|Overall Study||16||
48385455|NCT00847938|101272802|FG003|STARTED|Overall Study||15||
48385456|NCT00847938|101272799|FG000|COMPLETED|Overall Study||16||
48385457|NCT00847938|101272800|FG001|COMPLETED|Overall Study||14||
48385458|NCT00847938|101272801|FG002|COMPLETED|Overall Study||15||
48385459|NCT00847938|101272802|FG003|COMPLETED|Overall Study||15||
48385460|NCT00847938|101272799|FG000|NOT COMPLETED|Overall Study||0||
48385461|NCT00847938|101272800|FG001|NOT COMPLETED|Overall Study||1||
48385462|NCT00847938|101272801|FG002|NOT COMPLETED|Overall Study||1||
48385463|NCT00847938|101272802|FG003|NOT COMPLETED|Overall Study||0||
48385464|NCT01549223|101272803|FG000|STARTED|Overall Study||30||
48385465|NCT01549223|101272804|FG001|STARTED|Overall Study||30||
48385466|NCT01549223|101272803|FG000|COMPLETED|Overall Study||30||
48385467|NCT01549223|101272804|FG001|COMPLETED|Overall Study||30||
48385468|NCT01549223|101272803|FG000|NOT COMPLETED|Overall Study||0||
48385469|NCT01549223|101272804|FG001|NOT COMPLETED|Overall Study||0||
48385470|NCT01206478|101272805|FG000|STARTED|Overall Study||9||
48385471|NCT01206478|101272806|FG001|STARTED|Overall Study||12||
48385472|NCT01206478|101272805|FG000|COMPLETED|Overall Study||7||
48385473|NCT01206478|101272806|FG001|COMPLETED|Overall Study||7||
48385474|NCT01206478|101272805|FG000|NOT COMPLETED|Overall Study||2||
48385475|NCT01206478|101272806|FG001|NOT COMPLETED|Overall Study||5||
48385476|NCT01479374|101272807|FG000|STARTED|Overall Study||66||
48385477|NCT01479374|101272808|FG001|STARTED|Overall Study||68||
48385478|NCT01479374|101272809|FG002|STARTED|Overall Study||68||
48385479|NCT01479374|101272807|FG000|COMPLETED|Overall Study||63||
48385480|NCT01479374|101272808|FG001|COMPLETED|Overall Study||60||
48385481|NCT01479374|101272809|FG002|COMPLETED|Overall Study||63||
48385482|NCT01479374|101272807|FG000|NOT COMPLETED|Overall Study||3||
48385483|NCT01479374|101272808|FG001|NOT COMPLETED|Overall Study||8||
48385484|NCT01479374|101272809|FG002|NOT COMPLETED|Overall Study||5||
48385485|NCT00634114|101272810|FG000|STARTED|Overall Study||188||
48385486|NCT00634114|101272811|FG001|STARTED|Overall Study||189||
48385487|NCT00634114|101272812|FG002|STARTED|Overall Study||187||
48385488|NCT00634114|101272810|FG000|COMPLETED|Overall Study||160||
48385489|NCT00634114|101272811|FG001|COMPLETED|Overall Study||154||
48385490|NCT00634114|101272812|FG002|COMPLETED|Overall Study||148||
48385491|NCT00634114|101272810|FG000|NOT COMPLETED|Overall Study||28||
48385492|NCT00634114|101272811|FG001|NOT COMPLETED|Overall Study||35||
48385493|NCT00634114|101272812|FG002|NOT COMPLETED|Overall Study||39||
48385494|NCT02979301|101272813|FG000|STARTED|Overall Study||11||
48385495|NCT02979301|101272814|FG001|STARTED|Overall Study||11||
48385496|NCT02979301|101272813|FG000|COMPLETED|Overall Study||10||
48385497|NCT02979301|101272814|FG001|COMPLETED|Overall Study||11||
48385498|NCT02979301|101272813|FG000|NOT COMPLETED|Overall Study||1||
48385499|NCT02979301|101272814|FG001|NOT COMPLETED|Overall Study||0||
48385500|NCT02056834|101272815|FG000|STARTED|Overall Study||36||
48385501|NCT02056834|101272815|FG000|6 Weeks|Overall Study||34||
48385502|NCT02056834|101272815|FG000|6 Months|Overall Study||31||
48385503|NCT02056834|101272815|FG000|COMPLETED|Overall Study||29||
48385504|NCT02056834|101272815|FG000|NOT COMPLETED|Overall Study||7||
48385505|NCT03583372|101272816|FG000|STARTED|Overall Study||92||
48385506|NCT03583372|101272817|FG001|STARTED|Overall Study||182||
48385507|NCT03583372|101272818|FG002|STARTED|Overall Study||91||
48385508|NCT03583372|101272819|FG003|STARTED|Overall Study||141||
48385509|NCT03583372|101272816|FG000|COMPLETED|Overall Study||79||
48385510|NCT03583372|101272817|FG001|COMPLETED|Overall Study||156||
48385511|NCT03583372|101272818|FG002|COMPLETED|Overall Study||72||
48385512|NCT03583372|101272819|FG003|COMPLETED|Overall Study||123||
48385513|NCT03583372|101272816|FG000|NOT COMPLETED|Overall Study||13||
48385514|NCT03583372|101272817|FG001|NOT COMPLETED|Overall Study||26||
48385515|NCT03583372|101272818|FG002|NOT COMPLETED|Overall Study||19||
48385516|NCT03583372|101272819|FG003|NOT COMPLETED|Overall Study||18||
48385517|NCT02190747|101272820|FG000|STARTED|Overall Study||21||
48385518|NCT02190747|101272821|FG001|STARTED|Overall Study||9||
48385519|NCT02190747|101272822|FG002|STARTED|Overall Study||10||
48385520|NCT02190747|101272820|FG000|COMPLETED|Overall Study||21||
48385521|NCT02190747|101272821|FG001|COMPLETED|Overall Study||9||
48385522|NCT02190747|101272822|FG002|COMPLETED|Overall Study||10||
48385523|NCT02190747|101272820|FG000|NOT COMPLETED|Overall Study||0||
48385524|NCT02190747|101272821|FG001|NOT COMPLETED|Overall Study||0||
48385525|NCT02190747|101272822|FG002|NOT COMPLETED|Overall Study||0||
48385526|NCT03722784|101272823|FG000|STARTED|Overall Study||58||116
48385527|NCT03722784|101272824|FG001|STARTED|Overall Study||30||60
48385528|NCT03722784|101272823|FG000|COMPLETED|Overall Study||56||112
48385529|NCT03722784|101272824|FG001|COMPLETED|Overall Study||28||56
48257173|NCT00937521|100947934|FG006|COMPLETED|Booster Phase||160||
48257174|NCT00937521|100947935|FG007|COMPLETED|Booster Phase||159||
48257175|NCT00937521|100947928|FG000|NOT COMPLETED|Booster Phase||3||
48257176|NCT00937521|100947929|FG001|NOT COMPLETED|Booster Phase||2||
48385530|NCT03722784|101272823|FG000|NOT COMPLETED|Overall Study||2||4
48385531|NCT03722784|101272824|FG001|NOT COMPLETED|Overall Study||2||4
48385532|NCT03296787|101272825|FG000|STARTED|Overall Study||8||
48385533|NCT03296787|101272826|FG001|STARTED|Overall Study||8||
48257177|NCT00937521|100947930|FG002|NOT COMPLETED|Booster Phase||5||
48257178|NCT00937521|100947931|FG003|NOT COMPLETED|Booster Phase||3||
48385534|NCT03296787|101272827|FG002|STARTED|Overall Study||9||
48385535|NCT03296787|101272828|FG003|STARTED|Overall Study||7||
48385536|NCT03296787|101272825|FG000|COMPLETED|Overall Study||8||
48385537|NCT03296787|101272826|FG001|COMPLETED|Overall Study||8||
48385538|NCT03296787|101272827|FG002|COMPLETED|Overall Study||9||
48385539|NCT03296787|101272828|FG003|COMPLETED|Overall Study||7||
48385540|NCT03296787|101272825|FG000|NOT COMPLETED|Overall Study||0||
48385541|NCT03296787|101272826|FG001|NOT COMPLETED|Overall Study||0||
48385542|NCT03296787|101272827|FG002|NOT COMPLETED|Overall Study||0||
48385543|NCT03296787|101272828|FG003|NOT COMPLETED|Overall Study||0||
48385544|NCT03730194|101272829|FG000|STARTED|First Stage Treatment||20||
48385545|NCT03730194|101272830|FG001|STARTED|First Stage Treatment||20||
48385546|NCT03730194|101272831|FG002|STARTED|First Stage Treatment||0||
48385547|NCT03730194|101272832|FG003|STARTED|First Stage Treatment||0||
48385548|NCT03730194|101272833|FG004|STARTED|First Stage Treatment||0||
48385549|NCT03730194|101272834|FG005|STARTED|First Stage Treatment||0||
48385550|NCT03730194|101272829|FG000|COMPLETED|First Stage Treatment||16|"This study utilizes a SMART Design.~1 participant from the Melatonin Only group withdrew from the study. 1 participant from the Bedtime Bank Only group withdrew from the study.~3 participants in the Melatonin Only group \& 3 participants in the Bedtime Bank Only group did not complete all study requirements (e.g., minimum actigraph days). These 6 participants remained in the pilot SMART study (did not want to withdraw), and repeated there assigned treatment in the Second Stage."|
48541693|NCT03095638|101662795|FG006|NOT COMPLETED|P1: Period 2 (4 Days)||0||
48541694|NCT03095638|101662796|FG007|NOT COMPLETED|P1: Period 2 (4 Days)||0||
48257179|NCT00937521|100947932|FG004|NOT COMPLETED|Booster Phase||5||
48257180|NCT00937521|100947933|FG005|NOT COMPLETED|Booster Phase||5||
48257181|NCT00937521|100947934|FG006|NOT COMPLETED|Booster Phase||5||
48257182|NCT00937521|100947935|FG007|NOT COMPLETED|Booster Phase||2||
48257183|NCT02028247|100947936|FG000|STARTED|Overall Study||77||
48257184|NCT02028247|100947937|FG001|STARTED|Overall Study||71||
48257185|NCT02028247|100947938|FG002|STARTED|Overall Study||19||
48257186|NCT02028247|100947936|FG000|COMPLETED|Overall Study||67||
48257187|NCT02028247|100947937|FG001|COMPLETED|Overall Study||59||
48257188|NCT02028247|100947938|FG002|COMPLETED|Overall Study||15||
48257189|NCT02028247|100947936|FG000|NOT COMPLETED|Overall Study||10||
48257190|NCT02028247|100947937|FG001|NOT COMPLETED|Overall Study||12||
48257191|NCT02028247|100947938|FG002|NOT COMPLETED|Overall Study||4||
48257192|NCT00552513|100947939|FG000|STARTED|Overall Study||1593||
48257193|NCT00552513|100947940|FG001|STARTED|Overall Study||1438||
48257194|NCT00552513|100947939|FG000|COMPLETED|Overall Study||1588||
48257195|NCT00552513|100947940|FG001|COMPLETED|Overall Study||1437||
48257196|NCT00552513|100947939|FG000|NOT COMPLETED|Overall Study||5||
48385551|NCT03730194|101272830|FG001|COMPLETED|First Stage Treatment||16|"This study utilizes a SMART Design.~1 participant from the Melatonin Only group withdrew from the study. 1 participant from the Bedtime Bank Only group withdrew from the study.~3 participants in the Melatonin Only group \& 3 participants in the Bedtime Bank Only group did not complete all study requirements (e.g., minimum actigraph days). These 6 participants remained in the pilot SMART study (did not want to withdraw), and repeated there assigned treatment in the Second Stage."|
48385552|NCT03730194|101272831|FG002|COMPLETED|First Stage Treatment||0|"This study utilizes a SMART Design.~1 participant from the Melatonin Only group withdrew from the study. 1 participant from the Bedtime Bank Only group withdrew from the study.~3 participants in the Melatonin Only group \& 3 participants in the Bedtime Bank Only group did not complete all study requirements (e.g., minimum actigraph days). These 6 participants remained in the pilot SMART study (did not want to withdraw), and repeated there assigned treatment in the Second Stage."|
48541695|NCT03095638|101662789|FG000|STARTED|P1: Period 2, Washout (7[-4 Hours])||7||
48257197|NCT00552513|100947940|FG001|NOT COMPLETED|Overall Study||1||
48257198|NCT00623363|100947941|FG000|STARTED|Overall Study||7||
48257199|NCT00623363|100947942|FG001|STARTED|Overall Study||20||
48257200|NCT00623363|100947941|FG000|COMPLETED|Overall Study||5||
48257201|NCT00623363|100947942|FG001|COMPLETED|Overall Study||18||
48257202|NCT00623363|100947941|FG000|NOT COMPLETED|Overall Study||2||
48385553|NCT03730194|101272832|FG003|COMPLETED|First Stage Treatment||0|"This study utilizes a SMART Design.~1 participant from the Melatonin Only group withdrew from the study. 1 participant from the Bedtime Bank Only group withdrew from the study.~3 participants in the Melatonin Only group \& 3 participants in the Bedtime Bank Only group did not complete all study requirements (e.g., minimum actigraph days). These 6 participants remained in the pilot SMART study (did not want to withdraw), and repeated there assigned treatment in the Second Stage."|
48385554|NCT03730194|101272833|FG004|COMPLETED|First Stage Treatment||0|"This study utilizes a SMART Design.~1 participant from the Melatonin Only group withdrew from the study. 1 participant from the Bedtime Bank Only group withdrew from the study.~3 participants in the Melatonin Only group \& 3 participants in the Bedtime Bank Only group did not complete all study requirements (e.g., minimum actigraph days). These 6 participants remained in the pilot SMART study (did not want to withdraw), and repeated there assigned treatment in the Second Stage."|
48385555|NCT03730194|101272834|FG005|COMPLETED|First Stage Treatment||0|"This study utilizes a SMART Design.~1 participant from the Melatonin Only group withdrew from the study. 1 participant from the Bedtime Bank Only group withdrew from the study.~3 participants in the Melatonin Only group \& 3 participants in the Bedtime Bank Only group did not complete all study requirements (e.g., minimum actigraph days). These 6 participants remained in the pilot SMART study (did not want to withdraw), and repeated there assigned treatment in the Second Stage."|
48385556|NCT03730194|101272829|FG000|NOT COMPLETED|First Stage Treatment||4||
48385557|NCT03730194|101272830|FG001|NOT COMPLETED|First Stage Treatment||4||
48385558|NCT03730194|101272831|FG002|NOT COMPLETED|First Stage Treatment||0||
48385559|NCT03730194|101272832|FG003|NOT COMPLETED|First Stage Treatment||0||
48385560|NCT03730194|101272833|FG004|NOT COMPLETED|First Stage Treatment||0||
48385561|NCT03730194|101272834|FG005|NOT COMPLETED|First Stage Treatment||0||
48385562|NCT03730194|101272829|FG000|STARTED|Second Stage Treatment||7||
48385563|NCT03730194|101272830|FG001|STARTED|Second Stage Treatment||5||
48385564|NCT03730194|101272831|FG002|STARTED|Second Stage Treatment||6||
48385565|NCT03730194|101272832|FG003|STARTED|Second Stage Treatment||6||
48385566|NCT03730194|101272833|FG004|STARTED|Second Stage Treatment||7||
48385567|NCT03730194|101272834|FG005|STARTED|Second Stage Treatment||7||
48385568|NCT03730194|101272829|FG000|COMPLETED|Second Stage Treatment||7||
48385569|NCT03730194|101272830|FG001|COMPLETED|Second Stage Treatment||5||
48385570|NCT03730194|101272831|FG002|COMPLETED|Second Stage Treatment||6||
48385571|NCT03730194|101272832|FG003|COMPLETED|Second Stage Treatment||6||
48385572|NCT03730194|101272833|FG004|COMPLETED|Second Stage Treatment||7||
48385573|NCT03730194|101272834|FG005|COMPLETED|Second Stage Treatment||7||
48385574|NCT03730194|101272829|FG000|NOT COMPLETED|Second Stage Treatment||0||
48385575|NCT03730194|101272830|FG001|NOT COMPLETED|Second Stage Treatment||0||
48385576|NCT03730194|101272831|FG002|NOT COMPLETED|Second Stage Treatment||0||
48385577|NCT03730194|101272832|FG003|NOT COMPLETED|Second Stage Treatment||0||
48385578|NCT03730194|101272833|FG004|NOT COMPLETED|Second Stage Treatment||0||
48385579|NCT03730194|101272834|FG005|NOT COMPLETED|Second Stage Treatment||0||
48385580|NCT04962503|101272835|FG000|STARTED|Overall Study||6||
48385581|NCT04962503|101272835|FG000|COMPLETED|Overall Study||5||
48385582|NCT04962503|101272835|FG000|NOT COMPLETED|Overall Study||1||
48688412|NCT01119066|102020212|FG002|NOT COMPLETED|Overall Study||0||0
48688413|NCT01119066|102020213|FG003|NOT COMPLETED|Overall Study||0||0
48688414|NCT01333722|102020214|FG000|STARTED|Overall Study||51||
48688415|NCT01333722|102020215|FG001|STARTED|Overall Study||49||
48688416|NCT01333722|102020214|FG000|COMPLETED|Overall Study||51||
48688417|NCT01333722|102020215|FG001|COMPLETED|Overall Study||46||
48385583|NCT03334396|101272836|FG000|STARTED|Overall Study||249||
48385584|NCT03334396|101272837|FG001|STARTED|Overall Study||127||
48385585|NCT03334396|101272838|FG002|STARTED|Overall Study||123||
48385586|NCT03334396|101272839|FG003|STARTED|Overall Study||125||
48385587|NCT03334396|101272840|FG004|STARTED|Overall Study||15||
48385588|NCT03334396|101272841|FG005|STARTED|Overall Study||5||
48385589|NCT03334396|101272842|FG006|STARTED|Overall Study||8||
48385590|NCT03334396|101272843|FG007|STARTED|Overall Study||8||
48385591|NCT03334396|101272836|FG000|Received at Least One Dose of Study Drug|Overall Study||249||
48385592|NCT03334396|101272837|FG001|Received at Least One Dose of Study Drug|Overall Study||127||
48385593|NCT03334396|101272838|FG002|Received at Least One Dose of Study Drug|Overall Study||123||
48385594|NCT03334396|101272839|FG003|Received at Least One Dose of Study Drug|Overall Study||125||
48385595|NCT03334396|101272840|FG004|Received at Least One Dose of Study Drug|Overall Study||15||
48385596|NCT03334396|101272841|FG005|Received at Least One Dose of Study Drug|Overall Study||5||
48385597|NCT03334396|101272842|FG006|Received at Least One Dose of Study Drug|Overall Study||8||
48385598|NCT03334396|101272843|FG007|Received at Least One Dose of Study Drug|Overall Study||8||
48385599|NCT03334396|101272836|FG000|COMPLETED|Overall Study||226||
48385600|NCT03334396|101272837|FG001|COMPLETED|Overall Study||116||
48385601|NCT03334396|101272838|FG002|COMPLETED|Overall Study||113||
48385602|NCT03334396|101272839|FG003|COMPLETED|Overall Study||120||
48385603|NCT03334396|101272840|FG004|COMPLETED|Overall Study||12||
48688418|NCT01333722|102020214|FG000|NOT COMPLETED|Overall Study||0||
48688419|NCT01333722|102020215|FG001|NOT COMPLETED|Overall Study||3||
48688420|NCT01664117|102020216|FG000|STARTED|Overall Study||209||
48688421|NCT01664117|102020216|FG000|COMPLETED|Overall Study||209||
48688422|NCT01664117|102020216|FG000|NOT COMPLETED|Overall Study||0||
48688423|NCT01804049|102020217|FG000|STARTED|Overall Study||43||
48688424|NCT01804049|102020218|FG001|STARTED|Overall Study||77||
48688425|NCT01804049|102020217|FG000|COMPLETED|Overall Study||32||
48385604|NCT03334396|101272841|FG005|COMPLETED|Overall Study||4||
48385605|NCT03334396|101272842|FG006|COMPLETED|Overall Study||5||
48385606|NCT03334396|101272843|FG007|COMPLETED|Overall Study||7||
48385607|NCT03334396|101272836|FG000|NOT COMPLETED|Overall Study||23||
48385608|NCT03334396|101272837|FG001|NOT COMPLETED|Overall Study||11||
48385609|NCT03334396|101272838|FG002|NOT COMPLETED|Overall Study||10||
48385610|NCT03334396|101272839|FG003|NOT COMPLETED|Overall Study||5||
48385611|NCT03334396|101272840|FG004|NOT COMPLETED|Overall Study||3||
48385612|NCT03334396|101272841|FG005|NOT COMPLETED|Overall Study||1||
48385613|NCT03334396|101272842|FG006|NOT COMPLETED|Overall Study||3||
48385614|NCT03334396|101272843|FG007|NOT COMPLETED|Overall Study||1||
48092648|NCT04053023|100549078|FG000|STARTED|Part B: Period 1 (Day 1 to Day 19)||0||
48092649|NCT04053023|100549079|FG001|STARTED|Part B: Period 1 (Day 1 to Day 19)||0||
48092650|NCT04053023|100549078|FG000|COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0||
48092651|NCT04053023|100549079|FG001|COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0||
48092652|NCT04053023|100549078|FG000|NOT COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0||
48092653|NCT04053023|100549079|FG001|NOT COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0||
48092654|NCT04053023|100549078|FG000|STARTED|Part B: Period 2 (Day 20 to Day 38)||0||
48257203|NCT00623363|100947942|FG001|NOT COMPLETED|Overall Study||2||
48257204|NCT02561078|100947943|FG000|STARTED|Overall Study||209||
48257205|NCT02561078|100947944|FG001|STARTED|Overall Study||211||
48257206|NCT02561078|100947943|FG000|Received at Least 1 Dose of Study Drug|Overall Study||208||
48257207|NCT02561078|100947944|FG001|Received at Least 1 Dose of Study Drug|Overall Study||210||
48257208|NCT02561078|100947943|FG000|COMPLETED|Overall Study||179||
48257209|NCT02561078|100947944|FG001|COMPLETED|Overall Study||186||
48257210|NCT02561078|100947943|FG000|NOT COMPLETED|Overall Study||30||
48257211|NCT02561078|100947944|FG001|NOT COMPLETED|Overall Study||25||
48257212|NCT01278615|100947945|FG000|STARTED|Overall Study||16||
48257213|NCT01278615|100947945|FG000|COMPLETED|Overall Study||14||
48257214|NCT01278615|100947945|FG000|NOT COMPLETED|Overall Study||2||
48257215|NCT01340300|100947946|FG000|STARTED|Overall Study||35||
48257216|NCT01340300|100947947|FG001|STARTED|Overall Study||35||
48257217|NCT01340300|100947948|FG002|STARTED|Overall Study||35||
48257218|NCT01340300|100947949|FG003|STARTED|Overall Study||34||
48257219|NCT01340300|100947946|FG000|Baseline Blood Sample|Overall Study||33||
48257220|NCT01340300|100947947|FG001|Baseline Blood Sample|Overall Study||34||
48257221|NCT01340300|100947948|FG002|Baseline Blood Sample|Overall Study||32||
48257222|NCT01340300|100947949|FG003|Baseline Blood Sample|Overall Study||29||
48257223|NCT01340300|100947946|FG000|Follow-up Blood Sample|Overall Study||25||
48257224|NCT01340300|100947947|FG001|Follow-up Blood Sample|Overall Study||26||
48257225|NCT01340300|100947948|FG002|Follow-up Blood Sample|Overall Study||19||
48257226|NCT01340300|100947949|FG003|Follow-up Blood Sample|Overall Study||18||
48257227|NCT01340300|100947946|FG000|COMPLETED|Overall Study||26|Complete treatment and required follow-ups|
48257228|NCT01340300|100947947|FG001|COMPLETED|Overall Study||26|Complete treatment and required follow-ups|
48257229|NCT01340300|100947948|FG002|COMPLETED|Overall Study||20|Complete treatment and required follow-ups|
48257230|NCT01340300|100947949|FG003|COMPLETED|Overall Study||20|Complete treatment and required follow-ups|
48257231|NCT01340300|100947946|FG000|NOT COMPLETED|Overall Study||9||
48257232|NCT01340300|100947947|FG001|NOT COMPLETED|Overall Study||9||
48257233|NCT01340300|100947948|FG002|NOT COMPLETED|Overall Study||15||
48257234|NCT01340300|100947949|FG003|NOT COMPLETED|Overall Study||14||
48257235|NCT00740870|100947950|FG000|STARTED|Overall Study||171||
48257236|NCT00740870|100947950|FG000|COMPLETED|Overall Study||150||
48257237|NCT00740870|100947950|FG000|NOT COMPLETED|Overall Study||21||
48257238|NCT00951171|100947951|FG000|STARTED|Overall Study||40||
48257239|NCT00951171|100947952|FG001|STARTED|Overall Study||55||
48257240|NCT00951171|100947951|FG000|Pregnancy|Overall Study||1||
48257241|NCT00951171|100947952|FG001|Pregnancy|Overall Study||7||
48257242|NCT00951171|100947951|FG000|COMPLETED|Overall Study||38||
48257243|NCT00951171|100947952|FG001|COMPLETED|Overall Study||55||
48257244|NCT00951171|100947951|FG000|NOT COMPLETED|Overall Study||2||
48257245|NCT00951171|100947952|FG001|NOT COMPLETED|Overall Study||0||
48257246|NCT01264887|100947953|FG000|STARTED|Overall Study||31||
48257247|NCT01264887|100947953|FG000|COMPLETED|Overall Study||0||
48257248|NCT01264887|100947953|FG000|NOT COMPLETED|Overall Study||31||
48385615|NCT02658994|101272844|FG000|STARTED|Enrollment||287||
48385616|NCT02658994|101272845|FG001|STARTED|Enrollment||283||
48385617|NCT02658994|101272846|FG002|STARTED|Enrollment||584||
48385618|NCT02658994|101272844|FG000|COMPLETED|Enrollment||287||
48385619|NCT02658994|101272845|FG001|COMPLETED|Enrollment||283||
48385620|NCT02658994|101272846|FG002|COMPLETED|Enrollment||584||
48092655|NCT04053023|100549079|FG001|STARTED|Part B: Period 2 (Day 20 to Day 38)||0||
48092656|NCT04053023|100549078|FG000|COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0||
48257249|NCT04486313|100947954|FG000|STARTED|Overall Study||472||
48257250|NCT04486313|100947955|FG001|STARTED|Overall Study||463||
48257251|NCT04486313|100947954|FG000|COMPLETED|Overall Study||453||
48257252|NCT04486313|100947955|FG001|COMPLETED|Overall Study||446||
48257253|NCT04486313|100947954|FG000|NOT COMPLETED|Overall Study||19||
48257254|NCT04486313|100947955|FG001|NOT COMPLETED|Overall Study||17||
48385621|NCT02658994|101272844|FG000|NOT COMPLETED|Enrollment||0||
48385622|NCT02658994|101272845|FG001|NOT COMPLETED|Enrollment||0||
48385623|NCT02658994|101272846|FG002|NOT COMPLETED|Enrollment||0||
48385624|NCT02658994|101272844|FG000|STARTED|3 Month Follow up||287||
48385625|NCT02658994|101272845|FG001|STARTED|3 Month Follow up||283||
48385626|NCT02658994|101272846|FG002|STARTED|3 Month Follow up||584||
48385627|NCT02658994|101272844|FG000|COMPLETED|3 Month Follow up||221||
48257255|NCT03638258|100947956|FG000|STARTED|Overall Study||109||
48257256|NCT03638258|100947957|FG001|STARTED|Overall Study||113||
48257257|NCT03638258|100947958|FG002|STARTED|Overall Study||109||
48257258|NCT03638258|100947956|FG000|COMPLETED|Overall Study||102||
48257259|NCT03638258|100947957|FG001|COMPLETED|Overall Study||104||
48257260|NCT03638258|100947958|FG002|COMPLETED|Overall Study||86||
48257261|NCT03638258|100947956|FG000|NOT COMPLETED|Overall Study||7||
48257262|NCT03638258|100947957|FG001|NOT COMPLETED|Overall Study||9||
48257263|NCT03638258|100947958|FG002|NOT COMPLETED|Overall Study||23||
48385628|NCT02658994|101272845|FG001|COMPLETED|3 Month Follow up||223||
48385629|NCT02658994|101272846|FG002|COMPLETED|3 Month Follow up||451||
48385630|NCT02658994|101272844|FG000|NOT COMPLETED|3 Month Follow up||66||
48385631|NCT02658994|101272845|FG001|NOT COMPLETED|3 Month Follow up||60||
48385632|NCT02658994|101272846|FG002|NOT COMPLETED|3 Month Follow up||133||
48385633|NCT02658994|101272844|FG000|STARTED|6 Month Follow up||287||
48385634|NCT02658994|101272845|FG001|STARTED|6 Month Follow up||283||
48385635|NCT02658994|101272846|FG002|STARTED|6 Month Follow up||584||
48385636|NCT02658994|101272844|FG000|COMPLETED|6 Month Follow up||228||
48385637|NCT02658994|101272845|FG001|COMPLETED|6 Month Follow up||230||
48385638|NCT02658994|101272846|FG002|COMPLETED|6 Month Follow up||471||
48385639|NCT02658994|101272844|FG000|NOT COMPLETED|6 Month Follow up||59||
48385640|NCT02658994|101272845|FG001|NOT COMPLETED|6 Month Follow up||53||
48385641|NCT02658994|101272846|FG002|NOT COMPLETED|6 Month Follow up||113||
48385642|NCT02658994|101272844|FG000|STARTED|12 Month Follow up||287||
48257264|NCT04765553|100947959|FG000|STARTED|Overall Study||6||
48257265|NCT04765553|100947960|FG001|STARTED|Overall Study||2||
48257266|NCT04765553|100947959|FG000|COMPLETED|Overall Study||6||
48257267|NCT04765553|100947960|FG001|COMPLETED|Overall Study||2||
48257268|NCT04765553|100947959|FG000|NOT COMPLETED|Overall Study||0||
48257269|NCT04765553|100947960|FG001|NOT COMPLETED|Overall Study||0||
48257270|NCT04706793|100947961|FG000|STARTED|Treatment||14||
48257271|NCT04706793|100947962|FG001|STARTED|Treatment||28||
48385643|NCT02658994|101272845|FG001|STARTED|12 Month Follow up||283||
48385644|NCT02658994|101272846|FG002|STARTED|12 Month Follow up||584||
48385645|NCT02658994|101272844|FG000|COMPLETED|12 Month Follow up||228||
48385646|NCT02658994|101272845|FG001|COMPLETED|12 Month Follow up||223||
48385647|NCT02658994|101272846|FG002|COMPLETED|12 Month Follow up||489||
48385648|NCT02658994|101272844|FG000|NOT COMPLETED|12 Month Follow up||59||
48385649|NCT02658994|101272845|FG001|NOT COMPLETED|12 Month Follow up||60||
48385650|NCT02658994|101272846|FG002|NOT COMPLETED|12 Month Follow up||95||
48257272|NCT04706793|100947961|FG000|COMPLETED|Treatment||4||
48257273|NCT04706793|100947962|FG001|COMPLETED|Treatment||18||
48257274|NCT04706793|100947961|FG000|NOT COMPLETED|Treatment||10||
48257275|NCT04706793|100947962|FG001|NOT COMPLETED|Treatment||10||
48257276|NCT04706793|100947961|FG000|STARTED|Follow-up||14||
48257277|NCT04706793|100947962|FG001|STARTED|Follow-up||28||
48257278|NCT04706793|100947961|FG000|COMPLETED|Follow-up||4||
48385651|NCT02658994|101272844|FG000|STARTED|24 Month Follow up||287||
48385652|NCT02658994|101272845|FG001|STARTED|24 Month Follow up||283||
48385653|NCT02658994|101272846|FG002|STARTED|24 Month Follow up||584||
48385654|NCT02658994|101272844|FG000|COMPLETED|24 Month Follow up||220||
48385655|NCT02658994|101272845|FG001|COMPLETED|24 Month Follow up||210||
48385656|NCT02658994|101272846|FG002|COMPLETED|24 Month Follow up||473||
48385657|NCT02658994|101272844|FG000|NOT COMPLETED|24 Month Follow up||67||
48385658|NCT02658994|101272845|FG001|NOT COMPLETED|24 Month Follow up||73||
48385659|NCT02658994|101272846|FG002|NOT COMPLETED|24 Month Follow up||111||
48385660|NCT02658994|101272844|FG000|STARTED|36 Month Follow up||287||
48385661|NCT02658994|101272845|FG001|STARTED|36 Month Follow up||283||
48385662|NCT02658994|101272846|FG002|STARTED|36 Month Follow up||584||
48385663|NCT02658994|101272844|FG000|COMPLETED|36 Month Follow up||216||
48257279|NCT04706793|100947962|FG001|COMPLETED|Follow-up||18||
48257280|NCT04706793|100947961|FG000|NOT COMPLETED|Follow-up||10||
48257281|NCT04706793|100947962|FG001|NOT COMPLETED|Follow-up||10||
48257282|NCT00983892|100947963|FG000|STARTED|Overall Study||66||
48257283|NCT00983892|100947964|FG001|STARTED|Overall Study||68||
48257284|NCT00983892|100947963|FG000|COMPLETED|Overall Study||56||
48257285|NCT00983892|100947964|FG001|COMPLETED|Overall Study||56||
48257286|NCT00983892|100947963|FG000|NOT COMPLETED|Overall Study||10||
48257287|NCT00983892|100947964|FG001|NOT COMPLETED|Overall Study||12||
48385664|NCT02658994|101272845|FG001|COMPLETED|36 Month Follow up||206||
48385665|NCT02658994|101272846|FG002|COMPLETED|36 Month Follow up||467||
48257288|NCT03991988|100947965|FG000|STARTED|Overall Study||16||
48385666|NCT02658994|101272844|FG000|NOT COMPLETED|36 Month Follow up||71||
48385667|NCT02658994|101272845|FG001|NOT COMPLETED|36 Month Follow up||77||
48385668|NCT02658994|101272846|FG002|NOT COMPLETED|36 Month Follow up||117||
48385669|NCT03337139|101272847|FG000|STARTED|Phase I||87||
48385670|NCT03337139|101272848|FG001|STARTED|Phase I||0||
48385671|NCT03337139|101272847|FG000|COMPLETED|Phase I||77||
48385672|NCT03337139|101272848|FG001|COMPLETED|Phase I||0||
48257289|NCT03991988|100947966|FG001|STARTED|Overall Study||16||
48385673|NCT03337139|101272847|FG000|NOT COMPLETED|Phase I||10||
48385674|NCT03337139|101272848|FG001|NOT COMPLETED|Phase I||0||
48385675|NCT03337139|101272847|FG000|STARTED|Phase II||38||
48385676|NCT03337139|101272848|FG001|STARTED|Phase II||39||
48385677|NCT03337139|101272847|FG000|26 Week Assessment|Phase II||34||
48385678|NCT03337139|101272848|FG001|26 Week Assessment|Phase II||37||
48385679|NCT03337139|101272847|FG000|COMPLETED|Phase II||33||
48385680|NCT03337139|101272848|FG001|COMPLETED|Phase II||36||
48385681|NCT03337139|101272847|FG000|NOT COMPLETED|Phase II||5||
48385682|NCT03337139|101272848|FG001|NOT COMPLETED|Phase II||3||
48385683|NCT03353753|101272849|FG000|STARTED|Overall Study||85||
48385684|NCT03353753|101272850|FG001|STARTED|Overall Study||44||
48385685|NCT03353753|101272849|FG000|COMPLETED|Overall Study||46|Completed patients of the double-blind period are those that have entered the open-label period, or discontinued treatment due to death or confirmed progressive disease by IRR as of the cutoff of May 31, 2019.|
48385686|NCT03353753|101272850|FG001|COMPLETED|Overall Study||35|Completed patients of the double-blind period are those that have entered the open-label period, or discontinued treatment due to death or confirmed progressive disease by IRR as of the cutoff of May 31, 2019.|
48385687|NCT03353753|101272849|FG000|NOT COMPLETED|Overall Study||39||
48385688|NCT03353753|101272850|FG001|NOT COMPLETED|Overall Study||9||
48385689|NCT00174785|101272851|FG000|STARTED|Overall Study||2301||
48385690|NCT00174785|101272852|FG001|STARTED|Overall Study||2327||
48385691|NCT00174785|101272851|FG000|COMPLETED|Overall Study||1605||
48385692|NCT00174785|101272852|FG001|COMPLETED|Overall Study||1611||
48385693|NCT00174785|101272851|FG000|NOT COMPLETED|Overall Study||696||
48385694|NCT00174785|101272852|FG001|NOT COMPLETED|Overall Study||716||
48385695|NCT00289185|101272853|FG000|STARTED|Overall Study||170||
48385696|NCT00289185|101272854|FG001|STARTED|Overall Study||170||
48385697|NCT00289185|101272853|FG000|COMPLETED|Overall Study||142||
48385698|NCT00289185|101272854|FG001|COMPLETED|Overall Study||144||
48385699|NCT00289185|101272853|FG000|NOT COMPLETED|Overall Study||28||
48385700|NCT00289185|101272854|FG001|NOT COMPLETED|Overall Study||26||
48385701|NCT02387372|101272855|FG000|STARTED|Overall Study||27||
48385702|NCT02387372|101272856|FG001|STARTED|Overall Study||10||
48688426|NCT01804049|102020218|FG001|COMPLETED|Overall Study||45||
48688427|NCT01804049|102020217|FG000|NOT COMPLETED|Overall Study||11||
48257290|NCT03991988|100947965|FG000|COMPLETED|Overall Study||14||
48257291|NCT03991988|100947966|FG001|COMPLETED|Overall Study||14||
48385703|NCT02387372|101272855|FG000|Treated|Overall Study||26||
48385704|NCT02387372|101272856|FG001|Treated|Overall Study||10||
48385705|NCT02387372|101272855|FG000|COMPLETED|Overall Study||26||
48257292|NCT03991988|100947965|FG000|NOT COMPLETED|Overall Study||2||
48257293|NCT03991988|100947966|FG001|NOT COMPLETED|Overall Study||2||
48257294|NCT00424554|100947967|FG000|STARTED|Overall Study||34||
48257295|NCT00424554|100947968|FG001|STARTED|Overall Study||6||
48257296|NCT00424554|100947967|FG000|COMPLETED|Overall Study||34||
48257297|NCT00424554|100947968|FG001|COMPLETED|Overall Study||6||
48257298|NCT00424554|100947967|FG000|NOT COMPLETED|Overall Study||0||
48257299|NCT00424554|100947968|FG001|NOT COMPLETED|Overall Study||0||
48257300|NCT02176382|100947969|FG000|STARTED|DATA-HD Study||39||
48257301|NCT02176382|100947970|FG001|STARTED|DATA-HD Study||37||
48257302|NCT02176382|100947969|FG000|COMPLETED|DATA-HD Study||31||
48257303|NCT02176382|100947970|FG001|COMPLETED|DATA-HD Study||29||
48257304|NCT02176382|100947969|FG000|NOT COMPLETED|DATA-HD Study||8||
48257305|NCT02176382|100947970|FG001|NOT COMPLETED|DATA-HD Study||8||
48257306|NCT02176382|100947969|FG000|STARTED|DATA-HD Extension||27|7 subjects completed DATA-HD but did not enroll in extension study.|
48257307|NCT02176382|100947970|FG001|STARTED|DATA-HD Extension||26|7 subjects completed DATA-HD but did not enroll in extension study.|
48257308|NCT02176382|100947969|FG000|COMPLETED|DATA-HD Extension||26||
48257309|NCT02176382|100947970|FG001|COMPLETED|DATA-HD Extension||26||
48257310|NCT02176382|100947969|FG000|NOT COMPLETED|DATA-HD Extension||1||
48257311|NCT02176382|100947970|FG001|NOT COMPLETED|DATA-HD Extension||0||
48257312|NCT02669407|100947971|FG000|STARTED|Overall Study||14||
48257313|NCT02669407|100947971|FG000|COMPLETED|Overall Study||11||
48385706|NCT02387372|101272856|FG001|COMPLETED|Overall Study||10||
48385707|NCT02387372|101272855|FG000|NOT COMPLETED|Overall Study||1||
48385708|NCT02387372|101272856|FG001|NOT COMPLETED|Overall Study||0||
48385709|NCT00589979|101272857|FG000|STARTED|Run-In Period||169||
48385710|NCT00589979|101272858|FG001|STARTED|Run-In Period||0||
48385711|NCT00589979|101272859|FG002|STARTED|Run-In Period||0||
48385712|NCT00589979|101272857|FG000|COMPLETED|Run-In Period||93||
48385713|NCT00589979|101272858|FG001|COMPLETED|Run-In Period||0||
48385714|NCT00589979|101272859|FG002|COMPLETED|Run-In Period||0||
48688428|NCT01804049|102020218|FG001|NOT COMPLETED|Overall Study||32||
48257314|NCT02669407|100947971|FG000|NOT COMPLETED|Overall Study||3||
48385715|NCT00589979|101272857|FG000|NOT COMPLETED|Run-In Period||76||
48385716|NCT00589979|101272858|FG001|NOT COMPLETED|Run-In Period||0||
48257315|NCT03589300|100947972|FG000|STARTED|Overall Study||125|125 participants (148 knees) proceeded with surgery and received the Persona TM Tibia implant (study device). There were 102 participants with surgery on one knee and 23 participants with surgery on both knees.|148
48385717|NCT00589979|101272859|FG002|NOT COMPLETED|Run-In Period||0||
48385718|NCT00589979|101272857|FG000|STARTED|Double-Blind Treatment Period 1||0||
48592702|NCT01877382|101783159|FG009|NOT COMPLETED|Dose Expansion||0||
48688429|NCT03896477|102020219|FG000|STARTED|Overall Study||220||
48257316|NCT03589300|100947972|FG000|COMPLETED|Overall Study||102|102 participants (120 knees) completed the 2 year follow-up physical exam.|120
48257317|NCT03589300|100947972|FG000|NOT COMPLETED|Overall Study||23||28
48257318|NCT05043883|100947973|FG000|STARTED|Overall Study||101||
48092657|NCT04053023|100549079|FG001|COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0||
48092658|NCT04053023|100549078|FG000|NOT COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0||
48092659|NCT04053023|100549079|FG001|NOT COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0||
48092660|NCT00330564|100549080|FG000|STARTED|Overall Study||15||
48092661|NCT00330564|100549080|FG000|COMPLETED|Overall Study||15||
48092662|NCT00330564|100549080|FG000|NOT COMPLETED|Overall Study||0||
48092663|NCT03406104|100549081|FG000|STARTED|Overall Study||62||
48092664|NCT03406104|100549081|FG000|COMPLETED|Overall Study||55||
48092665|NCT03406104|100549081|FG000|NOT COMPLETED|Overall Study||7||
48092666|NCT01830699|100549082|FG000|STARTED|Overall Study||13||
48092667|NCT01830699|100549083|FG001|STARTED|Overall Study||20||
48092668|NCT01830699|100549082|FG000|COMPLETED|Overall Study||13||
48257319|NCT05043883|100947973|FG000|COMPLETED|Overall Study||97||
48257320|NCT05043883|100947973|FG000|NOT COMPLETED|Overall Study||4||
48257321|NCT00917462|100947974|FG000|STARTED|Overall Study||35||
48257322|NCT00917462|100947974|FG000|COMPLETED|Overall Study||34||
48257323|NCT00917462|100947974|FG000|NOT COMPLETED|Overall Study||1||
48257324|NCT01461005|100947975|FG000|STARTED|Overall Study||1||
48257325|NCT01461005|100947975|FG000|COMPLETED|Overall Study||0||
48257326|NCT01461005|100947975|FG000|NOT COMPLETED|Overall Study||1||
48257327|NCT02916706|100947976|FG000|STARTED|Overall Study||127||
48257328|NCT02916706|100947977|FG001|STARTED|Overall Study||127||
48257329|NCT02916706|100947976|FG000|FAS|Overall Study||125||
48257330|NCT02916706|100947977|FG001|FAS|Overall Study||126||
48257331|NCT02916706|100947976|FG000|COMPLETED|Overall Study||112||
48257332|NCT02916706|100947977|FG001|COMPLETED|Overall Study||96||
48257333|NCT02916706|100947976|FG000|NOT COMPLETED|Overall Study||15||
48257334|NCT02916706|100947977|FG001|NOT COMPLETED|Overall Study||31||
48257335|NCT02194829|100947978|FG000|STARTED|Overall Study||2||
48257336|NCT02194829|100947979|FG001|STARTED|Overall Study||6||
48257337|NCT02194829|100947978|FG000|Received Protocol Therapy|Overall Study||2||
48257338|NCT02194829|100947979|FG001|Received Protocol Therapy|Overall Study||5||
48257339|NCT02194829|100947978|FG000|COMPLETED|Overall Study||0||
48257340|NCT02194829|100947979|FG001|COMPLETED|Overall Study||0||
48257341|NCT02194829|100947978|FG000|NOT COMPLETED|Overall Study||2||
48257342|NCT02194829|100947979|FG001|NOT COMPLETED|Overall Study||6||
48257343|NCT03245619|100947980|FG000|STARTED|Part A (Up to Day 22)||5||
48257344|NCT03245619|100947981|FG001|STARTED|Part A (Up to Day 22)||6||
48257345|NCT03245619|100947982|FG002|STARTED|Part A (Up to Day 22)||6||
48257346|NCT03245619|100947983|FG003|STARTED|Part A (Up to Day 22)||1||
48092669|NCT01830699|100549083|FG001|COMPLETED|Overall Study||20||
48092670|NCT01830699|100549082|FG000|NOT COMPLETED|Overall Study||0||
48092671|NCT01830699|100549083|FG001|NOT COMPLETED|Overall Study||0||
48092672|NCT00558025|100549084|FG000|STARTED|Overall Study||104||
48092673|NCT00558025|100549085|FG001|STARTED|Overall Study||52||
48092674|NCT00558025|100549084|FG000|COMPLETED|Overall Study||100||
48092675|NCT00558025|100549085|FG001|COMPLETED|Overall Study||49||
48092676|NCT00558025|100549084|FG000|NOT COMPLETED|Overall Study||4||
48092677|NCT00558025|100549085|FG001|NOT COMPLETED|Overall Study||3||
48092678|NCT02123745|100549086|FG000|STARTED|Overall Study||71||
48092679|NCT02123745|100549086|FG000|COMPLETED|Overall Study||71||
48092680|NCT02123745|100549086|FG000|NOT COMPLETED|Overall Study||0||
48257347|NCT03245619|100947984|FG004|STARTED|Part A (Up to Day 22)||0||
48257348|NCT03245619|100947985|FG005|STARTED|Part A (Up to Day 22)||0||
48257349|NCT03245619|100947986|FG006|STARTED|Part A (Up to Day 22)||0||
48257350|NCT03245619|100947987|FG007|STARTED|Part A (Up to Day 22)||0||
48257351|NCT03245619|100947988|FG008|STARTED|Part A (Up to Day 22)||0||
48257352|NCT03245619|100947989|FG009|STARTED|Part A (Up to Day 22)||0||
48257353|NCT03245619|100947990|FG010|STARTED|Part A (Up to Day 22)||0||
48257354|NCT03245619|100947991|FG011|STARTED|Part A (Up to Day 22)||0||
48257355|NCT03245619|100947992|FG012|STARTED|Part A (Up to Day 22)||0||
48257356|NCT03245619|100947993|FG013|STARTED|Part A (Up to Day 22)||0||
48257357|NCT03245619|100947994|FG014|STARTED|Part A (Up to Day 22)||0||
48092681|NCT01432886|100549087|FG000|STARTED|Overall Study||6||
48092682|NCT01432886|100549088|FG001|STARTED|Overall Study||6||
48092683|NCT01432886|100549087|FG000|COMPLETED|Overall Study||6||
48092684|NCT01432886|100549088|FG001|COMPLETED|Overall Study||6||
48092685|NCT01432886|100549087|FG000|NOT COMPLETED|Overall Study||0||
48092686|NCT01432886|100549088|FG001|NOT COMPLETED|Overall Study||0||
48092687|NCT01516424|100549089|FG000|STARTED|Overall Study||131||
48092688|NCT01516424|100549090|FG001|STARTED|Overall Study||136||
48092689|NCT01516424|100549089|FG000|COMPLETED|Overall Study||96||
48092690|NCT01516424|100549090|FG001|COMPLETED|Overall Study||114||
48092691|NCT01516424|100549089|FG000|NOT COMPLETED|Overall Study||35||
48092692|NCT01516424|100549090|FG001|NOT COMPLETED|Overall Study||22||
48092693|NCT00710710|100549091|FG000|STARTED|Overall Study||45||
48092694|NCT00710710|100549092|FG001|STARTED|Overall Study||44||
48092695|NCT00710710|100549091|FG000|Treated|Overall Study||43||
48092696|NCT00710710|100549092|FG001|Treated|Overall Study||43||
48257358|NCT03245619|100947995|FG015|STARTED|Part A (Up to Day 22)||0||
48092697|NCT00710710|100549091|FG000|COMPLETED|Overall Study||0||
48257359|NCT03245619|100947996|FG016|STARTED|Part A (Up to Day 22)||0||
48257360|NCT03245619|100947980|FG000|COMPLETED|Part A (Up to Day 22)||1||
48257361|NCT03245619|100947981|FG001|COMPLETED|Part A (Up to Day 22)||0||
48092698|NCT00710710|100549092|FG001|COMPLETED|Overall Study||0||
48092699|NCT00710710|100549091|FG000|NOT COMPLETED|Overall Study||45||
48092700|NCT00710710|100549092|FG001|NOT COMPLETED|Overall Study||44||
48092701|NCT02905331|100549093|FG000|STARTED|Placebo Controlled Period(Week[wk] 0-16)||16||
48092702|NCT02905331|100549094|FG001|STARTED|Placebo Controlled Period(Week[wk] 0-16)||62||
48092703|NCT02905331|100549095|FG002|STARTED|Placebo Controlled Period(Week[wk] 0-16)||0||
48092704|NCT02905331|100549093|FG000|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||13||
48092705|NCT02905331|100549094|FG001|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||61||
48688430|NCT03896477|102020220|FG001|STARTED|Overall Study||220||
48688431|NCT03896477|102020221|FG002|STARTED|Overall Study||220||
48688432|NCT03896477|102020219|FG000|Received First Vaccination|Overall Study||220||
48688433|NCT03896477|102020220|FG001|Received First Vaccination|Overall Study||220||
48688434|NCT03896477|102020221|FG002|Received First Vaccination|Overall Study||220||
48688435|NCT03896477|102020219|FG000|Received Second Vaccination|Overall Study||217||
48688436|NCT03896477|102020220|FG001|Received Second Vaccination|Overall Study||213||
48688437|NCT03896477|102020221|FG002|Received Second Vaccination|Overall Study||213||
48688438|NCT03896477|102020219|FG000|Received Booster Vaccination|Overall Study||208||
48688439|NCT03896477|102020220|FG001|Received Booster Vaccination|Overall Study||206||
48688440|NCT03896477|102020221|FG002|Received Booster Vaccination|Overall Study||206||
48092706|NCT02905331|100549095|FG002|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||0||
48092707|NCT02905331|100549093|FG000|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||3||
48092708|NCT02905331|100549094|FG001|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||1||
48092709|NCT02905331|100549095|FG002|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||0||
48092710|NCT02905331|100549093|FG000|STARTED|Active Treatment and Follow up (wk16-40)||0||
48092711|NCT02905331|100549094|FG001|STARTED|Active Treatment and Follow up (wk16-40)||61||
48092712|NCT02905331|100549095|FG002|STARTED|Active Treatment and Follow up (wk16-40)||13||
48092713|NCT02905331|100549093|FG000|COMPLETED|Active Treatment and Follow up (wk16-40)||0||
48092714|NCT02905331|100549094|FG001|COMPLETED|Active Treatment and Follow up (wk16-40)||53||
48092715|NCT02905331|100549095|FG002|COMPLETED|Active Treatment and Follow up (wk16-40)||13||
48092716|NCT02905331|100549093|FG000|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||0||
48092717|NCT02905331|100549094|FG001|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||8||
48092718|NCT02905331|100549095|FG002|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||0||
48092719|NCT03557151|100549096|FG000|STARTED|Randomization to 3 Months||74||
48092720|NCT03557151|100549097|FG001|STARTED|Randomization to 3 Months||134||
48092721|NCT03557151|100549096|FG000|Adolescent Participants|Randomization to 3 Months||37||
48092722|NCT03557151|100549097|FG001|Adolescent Participants|Randomization to 3 Months||67||
48092723|NCT03557151|100549096|FG000|Caregiver Participants|Randomization to 3 Months||37||
48092724|NCT03557151|100549097|FG001|Caregiver Participants|Randomization to 3 Months||67||
48092725|NCT03557151|100549096|FG000|COMPLETED|Randomization to 3 Months||72||
48092726|NCT03557151|100549097|FG001|COMPLETED|Randomization to 3 Months||132||
48092727|NCT03557151|100549096|FG000|NOT COMPLETED|Randomization to 3 Months||2||
48092728|NCT03557151|100549097|FG001|NOT COMPLETED|Randomization to 3 Months||2||
48092729|NCT03557151|100549096|FG000|STARTED|3 to 6 Months||72||
48257362|NCT03245619|100947982|FG002|COMPLETED|Part A (Up to Day 22)||0||
48257363|NCT03245619|100947983|FG003|COMPLETED|Part A (Up to Day 22)||1||
48257364|NCT03245619|100947984|FG004|COMPLETED|Part A (Up to Day 22)||0||
48257365|NCT03245619|100947985|FG005|COMPLETED|Part A (Up to Day 22)||0||
48257366|NCT03245619|100947986|FG006|COMPLETED|Part A (Up to Day 22)||0||
48257367|NCT03245619|100947987|FG007|COMPLETED|Part A (Up to Day 22)||0||
48688441|NCT03896477|102020219|FG000|COMPLETED|Overall Study||203||
48688442|NCT03896477|102020220|FG001|COMPLETED|Overall Study||200||
48688443|NCT03896477|102020221|FG002|COMPLETED|Overall Study||200||
48688444|NCT03896477|102020219|FG000|NOT COMPLETED|Overall Study||17||
48688445|NCT03896477|102020220|FG001|NOT COMPLETED|Overall Study||20||
48688446|NCT03896477|102020221|FG002|NOT COMPLETED|Overall Study||20||
48688447|NCT02970136|102020222|FG000|STARTED|Overall Study||377||
48688448|NCT02970136|102020223|FG001|STARTED|Overall Study||377||
48688449|NCT02970136|102020222|FG000|COMPLETED|Overall Study||297||
48688450|NCT02970136|102020223|FG001|COMPLETED|Overall Study||282||
48688451|NCT02970136|102020222|FG000|NOT COMPLETED|Overall Study||80||
48257368|NCT03245619|100947988|FG008|COMPLETED|Part A (Up to Day 22)||0||
48257369|NCT03245619|100947989|FG009|COMPLETED|Part A (Up to Day 22)||0||
48257370|NCT03245619|100947990|FG010|COMPLETED|Part A (Up to Day 22)||0||
48257371|NCT03245619|100947991|FG011|COMPLETED|Part A (Up to Day 22)||0||
48257372|NCT03245619|100947992|FG012|COMPLETED|Part A (Up to Day 22)||0||
48257373|NCT03245619|100947993|FG013|COMPLETED|Part A (Up to Day 22)||0||
48257374|NCT03245619|100947994|FG014|COMPLETED|Part A (Up to Day 22)||0||
48257375|NCT03245619|100947995|FG015|COMPLETED|Part A (Up to Day 22)||0||
48257376|NCT03245619|100947996|FG016|COMPLETED|Part A (Up to Day 22)||0||
48257377|NCT03245619|100947980|FG000|NOT COMPLETED|Part A (Up to Day 22)||4||
48688452|NCT02970136|102020223|FG001|NOT COMPLETED|Overall Study||95||
48688453|NCT02257242|102020224|FG000|STARTED|Overall Study||2||
48688454|NCT02257242|102020225|FG001|STARTED|Overall Study||1||
48257378|NCT03245619|100947981|FG001|NOT COMPLETED|Part A (Up to Day 22)||6||
48257379|NCT03245619|100947982|FG002|NOT COMPLETED|Part A (Up to Day 22)||6||
48257380|NCT03245619|100947983|FG003|NOT COMPLETED|Part A (Up to Day 22)||0||
48688455|NCT02257242|102020226|FG002|STARTED|Overall Study||1||
48688456|NCT02257242|102020227|FG003|STARTED|Overall Study||2||
48688457|NCT02257242|102020228|FG004|STARTED|Overall Study||1||
48688458|NCT02257242|102020229|FG005|STARTED|Overall Study||1||
48688459|NCT02257242|102020230|FG006|STARTED|Overall Study||1||
48688460|NCT02257242|102020231|FG007|STARTED|Overall Study||1||
48688461|NCT02257242|102020232|FG008|STARTED|Overall Study||1||
48688462|NCT02257242|102020224|FG000|COMPLETED|Overall Study||1||
48688463|NCT02257242|102020225|FG001|COMPLETED|Overall Study||1||
48688464|NCT02257242|102020226|FG002|COMPLETED|Overall Study||1||
48092730|NCT03557151|100549097|FG001|STARTED|3 to 6 Months||132||
48092731|NCT03557151|100549096|FG000|Adolescent Participants|3 to 6 Months||36||
48092732|NCT03557151|100549097|FG001|Adolescent Participants|3 to 6 Months||66||
48688465|NCT02257242|102020227|FG003|COMPLETED|Overall Study||2||
48688466|NCT02257242|102020228|FG004|COMPLETED|Overall Study||1||
48688467|NCT02257242|102020229|FG005|COMPLETED|Overall Study||1||
48688468|NCT02257242|102020230|FG006|COMPLETED|Overall Study||1||
48688469|NCT02257242|102020231|FG007|COMPLETED|Overall Study||1||
48688470|NCT02257242|102020232|FG008|COMPLETED|Overall Study||1||
48688471|NCT02257242|102020224|FG000|NOT COMPLETED|Overall Study||1||
48092733|NCT03557151|100549096|FG000|Caregiver Participants|3 to 6 Months||36||
48092734|NCT03557151|100549097|FG001|Caregiver Participants|3 to 6 Months||66||
48092735|NCT03557151|100549096|FG000|COMPLETED|3 to 6 Months||72||
48092736|NCT03557151|100549097|FG001|COMPLETED|3 to 6 Months||132||
48092737|NCT03557151|100549096|FG000|NOT COMPLETED|3 to 6 Months||0||
48092738|NCT03557151|100549097|FG001|NOT COMPLETED|3 to 6 Months||0||
48092739|NCT03557151|100549096|FG000|STARTED|6 to 9 Months||72||
48092740|NCT03557151|100549097|FG001|STARTED|6 to 9 Months||132||
48092741|NCT03557151|100549096|FG000|Adolescent Participants|6 to 9 Months||36||
48092742|NCT03557151|100549097|FG001|Adolescent Participants|6 to 9 Months||66||
48092743|NCT03557151|100549096|FG000|Caregiver Participants|6 to 9 Months||36||
48092744|NCT03557151|100549097|FG001|Caregiver Participants|6 to 9 Months||66||
48092745|NCT03557151|100549096|FG000|COMPLETED|6 to 9 Months||70||
48092746|NCT03557151|100549097|FG001|COMPLETED|6 to 9 Months||132||
48092747|NCT03557151|100549096|FG000|NOT COMPLETED|6 to 9 Months||2||
48092748|NCT03557151|100549097|FG001|NOT COMPLETED|6 to 9 Months||0||
48092749|NCT03557151|100549096|FG000|STARTED|9 to 12 Months (End of Study)||70||
48092750|NCT03557151|100549097|FG001|STARTED|9 to 12 Months (End of Study)||132||
48092751|NCT03557151|100549096|FG000|Adolescent Participants|9 to 12 Months (End of Study)||35||
48092752|NCT03557151|100549097|FG001|Adolescent Participants|9 to 12 Months (End of Study)||66||
48092753|NCT03557151|100549096|FG000|Caregiver Participants|9 to 12 Months (End of Study)||35||
48092754|NCT03557151|100549097|FG001|Caregiver Participants|9 to 12 Months (End of Study)||66||
48092755|NCT03557151|100549096|FG000|COMPLETED|9 to 12 Months (End of Study)||70||
48092756|NCT03557151|100549097|FG001|COMPLETED|9 to 12 Months (End of Study)||130||
48092757|NCT03557151|100549096|FG000|NOT COMPLETED|9 to 12 Months (End of Study)||0||
48092758|NCT03557151|100549097|FG001|NOT COMPLETED|9 to 12 Months (End of Study)||2||
48092759|NCT02309489|100549098|FG000|STARTED|Overall Study||583||
48092760|NCT02309489|100549099|FG001|STARTED|Overall Study||561||
48092761|NCT02309489|100549098|FG000|Follow-up at 3 Months Postpartum|Overall Study||560||
48092762|NCT02309489|100549099|FG001|Follow-up at 3 Months Postpartum|Overall Study||541||
48092763|NCT02309489|100549098|FG000|COMPLETED|Overall Study||568|Follow-up at 8 months postpartum|
48092764|NCT02309489|100549099|FG001|COMPLETED|Overall Study||547|Follow-up at 8 months postpartum|
48092765|NCT02309489|100549098|FG000|NOT COMPLETED|Overall Study||15||
48092766|NCT02309489|100549099|FG001|NOT COMPLETED|Overall Study||14||
48092767|NCT01711177|100549100|FG000|STARTED|Overall Study||10||
48092768|NCT01711177|100549101|FG001|STARTED|Overall Study||3||
48092769|NCT01711177|100549102|FG002|STARTED|Overall Study||3||
48092770|NCT01711177|100549100|FG000|COMPLETED|Overall Study||10||
48688472|NCT02257242|102020225|FG001|NOT COMPLETED|Overall Study||0||
48092771|NCT01711177|100549101|FG001|COMPLETED|Overall Study||3||
48092772|NCT01711177|100549102|FG002|COMPLETED|Overall Study||3||
48092773|NCT01711177|100549100|FG000|NOT COMPLETED|Overall Study||0||
48092774|NCT01711177|100549101|FG001|NOT COMPLETED|Overall Study||0||
48092775|NCT01711177|100549102|FG002|NOT COMPLETED|Overall Study||0||
48092776|NCT02299479|100549103|FG000|STARTED|Overall Study||20||
48092777|NCT02299479|100549103|FG000|COMPLETED|Overall Study||18||
48092778|NCT02299479|100549103|FG000|NOT COMPLETED|Overall Study||2||
48092779|NCT03108027|100549104|FG000|STARTED|Period 1||7||
48092780|NCT03108027|100549105|FG001|STARTED|Period 1||6||
48092781|NCT03108027|100549106|FG002|STARTED|Period 1||6||
48092782|NCT03108027|100549107|FG003|STARTED|Period 1||6||
48092783|NCT03108027|100549108|FG004|STARTED|Period 1||6||
48092784|NCT03108027|100549109|FG005|STARTED|Period 1||6||
48092785|NCT03108027|100549104|FG000|COMPLETED|Period 1||7||
48688473|NCT02257242|102020226|FG002|NOT COMPLETED|Overall Study||0||
48688474|NCT02257242|102020227|FG003|NOT COMPLETED|Overall Study||0||
48688475|NCT02257242|102020228|FG004|NOT COMPLETED|Overall Study||0||
48688476|NCT02257242|102020229|FG005|NOT COMPLETED|Overall Study||0||
48092786|NCT03108027|100549105|FG001|COMPLETED|Period 1||6||
48092787|NCT03108027|100549106|FG002|COMPLETED|Period 1||6||
48257381|NCT03245619|100947984|FG004|NOT COMPLETED|Part A (Up to Day 22)||0||
48257382|NCT03245619|100947985|FG005|NOT COMPLETED|Part A (Up to Day 22)||0||
48092788|NCT03108027|100549107|FG003|COMPLETED|Period 1||4||
48092789|NCT03108027|100549108|FG004|COMPLETED|Period 1||6||
48092790|NCT03108027|100549109|FG005|COMPLETED|Period 1||6||
48092791|NCT03108027|100549104|FG000|NOT COMPLETED|Period 1||0||
48092792|NCT03108027|100549105|FG001|NOT COMPLETED|Period 1||0||
48092793|NCT03108027|100549106|FG002|NOT COMPLETED|Period 1||0||
48092794|NCT03108027|100549107|FG003|NOT COMPLETED|Period 1||2||
48092795|NCT03108027|100549108|FG004|NOT COMPLETED|Period 1||0||
48092796|NCT03108027|100549109|FG005|NOT COMPLETED|Period 1||0||
48092797|NCT03108027|100549104|FG000|STARTED|Period 2||7||
48092798|NCT03108027|100549105|FG001|STARTED|Period 2||6||
48092799|NCT03108027|100549106|FG002|STARTED|Period 2||6||
48092800|NCT03108027|100549107|FG003|STARTED|Period 2||4||
48092801|NCT03108027|100549108|FG004|STARTED|Period 2||6||
48092802|NCT03108027|100549109|FG005|STARTED|Period 2||6||
48092803|NCT03108027|100549104|FG000|COMPLETED|Period 2||7||
48092804|NCT03108027|100549105|FG001|COMPLETED|Period 2||6||
48092805|NCT03108027|100549106|FG002|COMPLETED|Period 2||6||
48092806|NCT03108027|100549107|FG003|COMPLETED|Period 2||4||
48092807|NCT03108027|100549108|FG004|COMPLETED|Period 2||6||
48092808|NCT03108027|100549109|FG005|COMPLETED|Period 2||6||
48092809|NCT03108027|100549104|FG000|NOT COMPLETED|Period 2||0||
48092810|NCT03108027|100549105|FG001|NOT COMPLETED|Period 2||0||
48092811|NCT03108027|100549106|FG002|NOT COMPLETED|Period 2||0||
48092812|NCT03108027|100549107|FG003|NOT COMPLETED|Period 2||0||
48092813|NCT03108027|100549108|FG004|NOT COMPLETED|Period 2||0||
48092814|NCT03108027|100549109|FG005|NOT COMPLETED|Period 2||0||
48092815|NCT03108027|100549104|FG000|STARTED|Period 3||7||
48092816|NCT03108027|100549105|FG001|STARTED|Period 3||6||
48092817|NCT03108027|100549106|FG002|STARTED|Period 3||6||
48092818|NCT03108027|100549107|FG003|STARTED|Period 3||4||
48092819|NCT03108027|100549108|FG004|STARTED|Period 3||6||
48092820|NCT03108027|100549109|FG005|STARTED|Period 3||6||
48092821|NCT03108027|100549104|FG000|COMPLETED|Period 3||7||
48092822|NCT03108027|100549105|FG001|COMPLETED|Period 3||5||
48092823|NCT03108027|100549106|FG002|COMPLETED|Period 3||6||
48092824|NCT03108027|100549107|FG003|COMPLETED|Period 3||4||
48092825|NCT03108027|100549108|FG004|COMPLETED|Period 3||6||
48092826|NCT03108027|100549109|FG005|COMPLETED|Period 3||6||
48092827|NCT03108027|100549104|FG000|NOT COMPLETED|Period 3||0||
48092828|NCT03108027|100549105|FG001|NOT COMPLETED|Period 3||1||
48092829|NCT03108027|100549106|FG002|NOT COMPLETED|Period 3||0||
48092830|NCT03108027|100549107|FG003|NOT COMPLETED|Period 3||0||
48092831|NCT03108027|100549108|FG004|NOT COMPLETED|Period 3||0||
48092832|NCT03108027|100549109|FG005|NOT COMPLETED|Period 3||0||
48092833|NCT02288559|100549110|FG000|STARTED|Overall Study||10||
48092834|NCT02288559|100549111|FG001|STARTED|Overall Study||11||
48092835|NCT02288559|100549112|FG002|STARTED|Overall Study||46||
48092836|NCT02288559|100549113|FG003|STARTED|Overall Study||22||
48092837|NCT02288559|100549110|FG000|COMPLETED|Overall Study||9||
48092838|NCT02288559|100549111|FG001|COMPLETED|Overall Study||10||
48092839|NCT02288559|100549112|FG002|COMPLETED|Overall Study||35||
48092840|NCT02288559|100549113|FG003|COMPLETED|Overall Study||20||
48092841|NCT02288559|100549110|FG000|NOT COMPLETED|Overall Study||1||
48092842|NCT02288559|100549111|FG001|NOT COMPLETED|Overall Study||1||
48092843|NCT02288559|100549112|FG002|NOT COMPLETED|Overall Study||11||
48092844|NCT02288559|100549113|FG003|NOT COMPLETED|Overall Study||2||
48092845|NCT01267812|100549114|FG000|STARTED|Overall Study||23||
48092846|NCT01267812|100549114|FG000|COMPLETED|Overall Study||23||
48092847|NCT01267812|100549114|FG000|NOT COMPLETED|Overall Study||0||
48092848|NCT02986789|100549115|FG000|STARTED|Overall Study||43||
48092849|NCT02986789|100549116|FG001|STARTED|Overall Study||0||
48092850|NCT02986789|100549115|FG000|COMPLETED|Overall Study||43||
48092851|NCT02986789|100549116|FG001|COMPLETED|Overall Study||0||
48257383|NCT03245619|100947986|FG006|NOT COMPLETED|Part A (Up to Day 22)||0||
48257384|NCT03245619|100947987|FG007|NOT COMPLETED|Part A (Up to Day 22)||0||
48092852|NCT02986789|100549115|FG000|NOT COMPLETED|Overall Study||0||
48092853|NCT02986789|100549116|FG001|NOT COMPLETED|Overall Study||0||
48092854|NCT01327885|100549117|FG000|STARTED|Overall Study||228||
48092855|NCT01327885|100549118|FG001|STARTED|Overall Study||224||
48092856|NCT01327885|100549117|FG000|COMPLETED|Overall Study||0||
48092857|NCT01327885|100549118|FG001|COMPLETED|Overall Study||0||
48092858|NCT01327885|100549117|FG000|NOT COMPLETED|Overall Study||228||
48092859|NCT01327885|100549118|FG001|NOT COMPLETED|Overall Study||224||
48092860|NCT02200445|100549119|FG000|STARTED|Overall Study||4||
48092861|NCT02200445|100549120|FG001|STARTED|Overall Study||17||
48092862|NCT02200445|100549121|FG002|STARTED|Overall Study||5||
48092863|NCT02200445|100549119|FG000|COMPLETED|Overall Study||3||
48092864|NCT02200445|100549120|FG001|COMPLETED|Overall Study||13||
48092865|NCT02200445|100549121|FG002|COMPLETED|Overall Study||3||
48092866|NCT02200445|100549119|FG000|NOT COMPLETED|Overall Study||1||
48092867|NCT02200445|100549120|FG001|NOT COMPLETED|Overall Study||4||
48092868|NCT02200445|100549121|FG002|NOT COMPLETED|Overall Study||2||
48092869|NCT05584176|100549122|FG000|STARTED|Overall Study||298||
48092870|NCT05584176|100549123|FG001|STARTED|Overall Study||34||
48092871|NCT05584176|100549122|FG000|COMPLETED|Overall Study||298||
48092872|NCT05584176|100549123|FG001|COMPLETED|Overall Study||34||
48092873|NCT05584176|100549122|FG000|NOT COMPLETED|Overall Study||0||
48092874|NCT05584176|100549123|FG001|NOT COMPLETED|Overall Study||0||
48092875|NCT02157298|100549124|FG000|STARTED|Overall Study||123||
48092876|NCT02157298|100549125|FG001|STARTED|Overall Study||60||
48092877|NCT02157298|100549124|FG000|COMPLETED|Overall Study||119||
48092878|NCT02157298|100549125|FG001|COMPLETED|Overall Study||58||
48092879|NCT02157298|100549124|FG000|NOT COMPLETED|Overall Study||4||
48092880|NCT02157298|100549125|FG001|NOT COMPLETED|Overall Study||2||
48092881|NCT01064401|100549126|FG000|STARTED|Overall Study||922||
48257385|NCT03245619|100947988|FG008|NOT COMPLETED|Part A (Up to Day 22)||0||
48257386|NCT03245619|100947989|FG009|NOT COMPLETED|Part A (Up to Day 22)||0||
48257387|NCT03245619|100947990|FG010|NOT COMPLETED|Part A (Up to Day 22)||0||
48257388|NCT03245619|100947991|FG011|NOT COMPLETED|Part A (Up to Day 22)||0||
48257389|NCT03245619|100947992|FG012|NOT COMPLETED|Part A (Up to Day 22)||0||
48257390|NCT03245619|100947993|FG013|NOT COMPLETED|Part A (Up to Day 22)||0||
48092882|NCT01064401|100549127|FG001|STARTED|Overall Study||919||
48092883|NCT01064401|100549126|FG000|COMPLETED|Overall Study||694||
48092884|NCT01064401|100549127|FG001|COMPLETED|Overall Study||724||
48092885|NCT01064401|100549126|FG000|NOT COMPLETED|Overall Study||228||
48092886|NCT01064401|100549127|FG001|NOT COMPLETED|Overall Study||195||
48092887|NCT02730455|100549128|FG000|STARTED|Overall Study||94||
48092888|NCT02730455|100549129|FG001|STARTED|Overall Study||91||
48092889|NCT02730455|100549130|FG002|STARTED|Overall Study||92||
48092890|NCT02730455|100549128|FG000|Safety Population|Overall Study||91|Participants who had received any study treatment (including complete or incomplete infusion)|
48092891|NCT02730455|100549129|FG001|Safety Population|Overall Study||90|Participants who had received any study treatment (including complete or incomplete infusion)|
48092892|NCT02730455|100549130|FG002|Safety Population|Overall Study||89|Participants who had received any study treatment (including complete or incomplete infusion)|
48092893|NCT02730455|100549128|FG000|Participants Dosed|Overall Study||91||
48092894|NCT02730455|100549129|FG001|Participants Dosed|Overall Study||88||
48092895|NCT02730455|100549130|FG002|Participants Dosed|Overall Study||91||
48092896|NCT02730455|100549128|FG000|Who Received Total Volume of Study Drug|Overall Study||90||
48092897|NCT02730455|100549129|FG001|Who Received Total Volume of Study Drug|Overall Study||88||
48092898|NCT02730455|100549130|FG002|Who Received Total Volume of Study Drug|Overall Study||89||
48092899|NCT02730455|100549128|FG000|COMPLETED|Overall Study||81||
48092900|NCT02730455|100549129|FG001|COMPLETED|Overall Study||77||
48092901|NCT02730455|100549130|FG002|COMPLETED|Overall Study||81||
48092902|NCT02730455|100549128|FG000|NOT COMPLETED|Overall Study||13||
48092903|NCT02730455|100549129|FG001|NOT COMPLETED|Overall Study||14||
48092904|NCT02730455|100549130|FG002|NOT COMPLETED|Overall Study||11||
48092905|NCT00258882|100549131|FG000|STARTED|Adacel Recipients Historic Cohort Method||124139||
48092906|NCT00258882|100549132|FG001|STARTED|Adacel Recipients Historic Cohort Method||203154||
48257391|NCT03245619|100947994|FG014|NOT COMPLETED|Part A (Up to Day 22)||0||
48257392|NCT03245619|100947995|FG015|NOT COMPLETED|Part A (Up to Day 22)||0||
48257393|NCT03245619|100947996|FG016|NOT COMPLETED|Part A (Up to Day 22)||0||
48257394|NCT03245619|100947980|FG000|STARTED|Part B (Up to 34 Days)||0||
48385719|NCT00589979|101272858|FG001|STARTED|Double-Blind Treatment Period 1||50||
48385720|NCT00589979|101272859|FG002|STARTED|Double-Blind Treatment Period 1||43||
48385721|NCT00589979|101272857|FG000|COMPLETED|Double-Blind Treatment Period 1||0||
48385722|NCT00589979|101272858|FG001|COMPLETED|Double-Blind Treatment Period 1||48||
48385723|NCT00589979|101272859|FG002|COMPLETED|Double-Blind Treatment Period 1||41||
48385724|NCT00589979|101272857|FG000|NOT COMPLETED|Double-Blind Treatment Period 1||0||
48385725|NCT00589979|101272858|FG001|NOT COMPLETED|Double-Blind Treatment Period 1||2||
48385726|NCT00589979|101272859|FG002|NOT COMPLETED|Double-Blind Treatment Period 1||2||
48385727|NCT00589979|101272857|FG000|STARTED|Double-Blind Treatment Period 2||0||
48385728|NCT00589979|101272858|FG001|STARTED|Double-Blind Treatment Period 2||48||
48385729|NCT00589979|101272859|FG002|STARTED|Double-Blind Treatment Period 2||41||
48385730|NCT00589979|101272857|FG000|COMPLETED|Double-Blind Treatment Period 2||0||
48385731|NCT00589979|101272858|FG001|COMPLETED|Double-Blind Treatment Period 2||47||
48092907|NCT00258882|100549131|FG000|COMPLETED|Adacel Recipients Historic Cohort Method||124139||
48092908|NCT00258882|100549132|FG001|COMPLETED|Adacel Recipients Historic Cohort Method||203154||
48092909|NCT00258882|100549131|FG000|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0||
48092910|NCT00258882|100549132|FG001|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0||
48257395|NCT03245619|100947981|FG001|STARTED|Part B (Up to 34 Days)||0||
48257396|NCT03245619|100947982|FG002|STARTED|Part B (Up to 34 Days)||0||
48257397|NCT03245619|100947983|FG003|STARTED|Part B (Up to 34 Days)||0||
48257398|NCT03245619|100947984|FG004|STARTED|Part B (Up to 34 Days)||0||
48257399|NCT03245619|100947985|FG005|STARTED|Part B (Up to 34 Days)||0||
48385732|NCT00589979|101272859|FG002|COMPLETED|Double-Blind Treatment Period 2||39||
48385733|NCT00589979|101272857|FG000|NOT COMPLETED|Double-Blind Treatment Period 2||0||
48385734|NCT00589979|101272858|FG001|NOT COMPLETED|Double-Blind Treatment Period 2||1||
48385735|NCT00589979|101272859|FG002|NOT COMPLETED|Double-Blind Treatment Period 2||2||
48385736|NCT00589979|101272857|FG000|STARTED|Double-Blind Treatment Period 3||0||
48385737|NCT00589979|101272858|FG001|STARTED|Double-Blind Treatment Period 3||47||
48385738|NCT00589979|101272859|FG002|STARTED|Double-Blind Treatment Period 3||39||
48385739|NCT00589979|101272857|FG000|COMPLETED|Double-Blind Treatment Period 3||0||
48385740|NCT00589979|101272858|FG001|COMPLETED|Double-Blind Treatment Period 3||46||
48385741|NCT00589979|101272859|FG002|COMPLETED|Double-Blind Treatment Period 3||38||
48385742|NCT00589979|101272857|FG000|NOT COMPLETED|Double-Blind Treatment Period 3||0||
48385743|NCT00589979|101272858|FG001|NOT COMPLETED|Double-Blind Treatment Period 3||1||
48385744|NCT00589979|101272859|FG002|NOT COMPLETED|Double-Blind Treatment Period 3||1||
48385745|NCT01588353|101272860|FG000|STARTED|Step1||6||
48385746|NCT01588353|101272861|FG001|STARTED|Step1||0||
48385747|NCT01588353|101272862|FG002|STARTED|Step1||0||
48385748|NCT01588353|101272860|FG000|COMPLETED|Step1||6||
48385749|NCT01588353|101272861|FG001|COMPLETED|Step1||0||
48385750|NCT01588353|101272862|FG002|COMPLETED|Step1||0||
48385751|NCT01588353|101272860|FG000|NOT COMPLETED|Step1||0||
48257400|NCT03245619|100947986|FG006|STARTED|Part B (Up to 34 Days)||0||
48257401|NCT03245619|100947987|FG007|STARTED|Part B (Up to 34 Days)||0||
48257402|NCT03245619|100947988|FG008|STARTED|Part B (Up to 34 Days)||0||
48257403|NCT03245619|100947989|FG009|STARTED|Part B (Up to 34 Days)||0||
48257404|NCT03245619|100947990|FG010|STARTED|Part B (Up to 34 Days)||0||
48257405|NCT03245619|100947991|FG011|STARTED|Part B (Up to 34 Days)||0||
48257406|NCT03245619|100947992|FG012|STARTED|Part B (Up to 34 Days)||0||
48257407|NCT03245619|100947993|FG013|STARTED|Part B (Up to 34 Days)||0||
48257408|NCT03245619|100947994|FG014|STARTED|Part B (Up to 34 Days)||0||
48257409|NCT03245619|100947995|FG015|STARTED|Part B (Up to 34 Days)||0||
48257410|NCT03245619|100947996|FG016|STARTED|Part B (Up to 34 Days)||0||
48257411|NCT03245619|100947980|FG000|COMPLETED|Part B (Up to 34 Days)||0||
48385752|NCT01588353|101272861|FG001|NOT COMPLETED|Step1||0||
48385753|NCT01588353|101272862|FG002|NOT COMPLETED|Step1||0||
48385754|NCT01588353|101272860|FG000|STARTED|Step2||0||
48092911|NCT00258882|100549131|FG000|STARTED|Adacel Recipients-Risk Interval Method||124139||
48092912|NCT00258882|100549132|FG001|STARTED|Adacel Recipients-Risk Interval Method||0||
48092913|NCT00258882|100549131|FG000|COMPLETED|Adacel Recipients-Risk Interval Method||124139||
48092914|NCT00258882|100549132|FG001|COMPLETED|Adacel Recipients-Risk Interval Method||0||
48092915|NCT00258882|100549131|FG000|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0||
48092916|NCT00258882|100549132|FG001|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0||
48092917|NCT00258882|100549131|FG000|STARTED|Pregnancy Surveillance||225||
48092918|NCT00258882|100549132|FG001|STARTED|Pregnancy Surveillance||675||
48092919|NCT00258882|100549131|FG000|COMPLETED|Pregnancy Surveillance||225||
48092920|NCT00258882|100549132|FG001|COMPLETED|Pregnancy Surveillance||675||
48092921|NCT00258882|100549131|FG000|NOT COMPLETED|Pregnancy Surveillance||0||
48092922|NCT00258882|100549132|FG001|NOT COMPLETED|Pregnancy Surveillance||0||
48257412|NCT03245619|100947981|FG001|COMPLETED|Part B (Up to 34 Days)||0||
48257413|NCT03245619|100947982|FG002|COMPLETED|Part B (Up to 34 Days)||0||
48257414|NCT03245619|100947983|FG003|COMPLETED|Part B (Up to 34 Days)||0||
48257415|NCT03245619|100947984|FG004|COMPLETED|Part B (Up to 34 Days)||0||
48257416|NCT03245619|100947985|FG005|COMPLETED|Part B (Up to 34 Days)||0||
48257417|NCT03245619|100947986|FG006|COMPLETED|Part B (Up to 34 Days)||0||
48257418|NCT03245619|100947987|FG007|COMPLETED|Part B (Up to 34 Days)||0||
48257419|NCT03245619|100947988|FG008|COMPLETED|Part B (Up to 34 Days)||0||
48257420|NCT03245619|100947989|FG009|COMPLETED|Part B (Up to 34 Days)||0||
48385755|NCT01588353|101272861|FG001|STARTED|Step2||71||
48385756|NCT01588353|101272862|FG002|STARTED|Step2||0||
48385757|NCT01588353|101272860|FG000|COMPLETED|Step2||0||
48385758|NCT01588353|101272861|FG001|COMPLETED|Step2||70||
48385759|NCT01588353|101272862|FG002|COMPLETED|Step2||0||
48385760|NCT01588353|101272860|FG000|NOT COMPLETED|Step2||0||
48385761|NCT01588353|101272861|FG001|NOT COMPLETED|Step2||1||
48092923|NCT05020990|100549133|FG000|STARTED|Period 1 (One Week)||28||
48092924|NCT05020990|100549134|FG001|STARTED|Period 1 (One Week)||26||
48092925|NCT05020990|100549133|FG000|COMPLETED|Period 1 (One Week)||28||
48092926|NCT05020990|100549134|FG001|COMPLETED|Period 1 (One Week)||26||
48092927|NCT05020990|100549133|FG000|NOT COMPLETED|Period 1 (One Week)||0||
48257421|NCT03245619|100947990|FG010|COMPLETED|Part B (Up to 34 Days)||0||
48257422|NCT03245619|100947991|FG011|COMPLETED|Part B (Up to 34 Days)||0||
48257423|NCT03245619|100947992|FG012|COMPLETED|Part B (Up to 34 Days)||0||
48257424|NCT03245619|100947993|FG013|COMPLETED|Part B (Up to 34 Days)||0||
48257425|NCT03245619|100947994|FG014|COMPLETED|Part B (Up to 34 Days)||0||
48257426|NCT03245619|100947995|FG015|COMPLETED|Part B (Up to 34 Days)||0||
48385762|NCT01588353|101272862|FG002|NOT COMPLETED|Step2||0||
48092928|NCT05020990|100549134|FG001|NOT COMPLETED|Period 1 (One Week)||0||
48092929|NCT05020990|100549133|FG000|STARTED|Period 2 (One Week)||28||
48257427|NCT03245619|100947996|FG016|COMPLETED|Part B (Up to 34 Days)||0||
48385763|NCT01588353|101272860|FG000|STARTED|Step3||0||
48385764|NCT01588353|101272861|FG001|STARTED|Step3||0||
48385765|NCT01588353|101272862|FG002|STARTED|Step3||25||
48257428|NCT03245619|100947980|FG000|NOT COMPLETED|Part B (Up to 34 Days)||0||
48257429|NCT03245619|100947981|FG001|NOT COMPLETED|Part B (Up to 34 Days)||0||
48257430|NCT03245619|100947982|FG002|NOT COMPLETED|Part B (Up to 34 Days)||0||
48257431|NCT03245619|100947983|FG003|NOT COMPLETED|Part B (Up to 34 Days)||0||
48688477|NCT02257242|102020230|FG006|NOT COMPLETED|Overall Study||0||
48688478|NCT02257242|102020231|FG007|NOT COMPLETED|Overall Study||0||
48688479|NCT02257242|102020232|FG008|NOT COMPLETED|Overall Study||0||
48257432|NCT03245619|100947984|FG004|NOT COMPLETED|Part B (Up to 34 Days)||0||
48257433|NCT03245619|100947985|FG005|NOT COMPLETED|Part B (Up to 34 Days)||0||
48257434|NCT03245619|100947986|FG006|NOT COMPLETED|Part B (Up to 34 Days)||0||
48257435|NCT03245619|100947987|FG007|NOT COMPLETED|Part B (Up to 34 Days)||0||
48257436|NCT03245619|100947988|FG008|NOT COMPLETED|Part B (Up to 34 Days)||0||
48257437|NCT03245619|100947989|FG009|NOT COMPLETED|Part B (Up to 34 Days)||0||
48257438|NCT03245619|100947990|FG010|NOT COMPLETED|Part B (Up to 34 Days)||0||
48257439|NCT03245619|100947991|FG011|NOT COMPLETED|Part B (Up to 34 Days)||0||
48257440|NCT03245619|100947992|FG012|NOT COMPLETED|Part B (Up to 34 Days)||0||
48257441|NCT03245619|100947993|FG013|NOT COMPLETED|Part B (Up to 34 Days)||0||
48257442|NCT03245619|100947994|FG014|NOT COMPLETED|Part B (Up to 34 Days)||0||
48257443|NCT03245619|100947995|FG015|NOT COMPLETED|Part B (Up to 34 Days)||0||
48257444|NCT03245619|100947996|FG016|NOT COMPLETED|Part B (Up to 34 Days)||0||
48257445|NCT03245619|100947980|FG000|STARTED|Part C (Up to 34 Days)||0||
48688480|NCT01591408|102020233|FG000|STARTED|Overall Study||36||
48688481|NCT01591408|102020234|FG001|STARTED|Overall Study||32||
48688482|NCT01591408|102020233|FG000|COMPLETED|Overall Study||24||
48257446|NCT03245619|100947981|FG001|STARTED|Part C (Up to 34 Days)||0||
48257447|NCT03245619|100947982|FG002|STARTED|Part C (Up to 34 Days)||0||
48257448|NCT03245619|100947983|FG003|STARTED|Part C (Up to 34 Days)||0||
48257449|NCT03245619|100947984|FG004|STARTED|Part C (Up to 34 Days)||0||
48257450|NCT03245619|100947985|FG005|STARTED|Part C (Up to 34 Days)||0||
48257451|NCT03245619|100947986|FG006|STARTED|Part C (Up to 34 Days)||0||
48257452|NCT03245619|100947987|FG007|STARTED|Part C (Up to 34 Days)||0||
48257453|NCT03245619|100947988|FG008|STARTED|Part C (Up to 34 Days)||0||
48257454|NCT03245619|100947989|FG009|STARTED|Part C (Up to 34 Days)||0||
48257455|NCT03245619|100947990|FG010|STARTED|Part C (Up to 34 Days)||0||
48257456|NCT03245619|100947991|FG011|STARTED|Part C (Up to 34 Days)||0||
48257457|NCT03245619|100947992|FG012|STARTED|Part C (Up to 34 Days)||0||
48257458|NCT03245619|100947993|FG013|STARTED|Part C (Up to 34 Days)||0||
48257459|NCT03245619|100947994|FG014|STARTED|Part C (Up to 34 Days)||0||
48257460|NCT03245619|100947995|FG015|STARTED|Part C (Up to 34 Days)||0||
48257461|NCT03245619|100947996|FG016|STARTED|Part C (Up to 34 Days)||0||
48257462|NCT03245619|100947980|FG000|COMPLETED|Part C (Up to 34 Days)||0||
48257463|NCT03245619|100947981|FG001|COMPLETED|Part C (Up to 34 Days)||0||
48257464|NCT03245619|100947982|FG002|COMPLETED|Part C (Up to 34 Days)||0||
48257465|NCT03245619|100947983|FG003|COMPLETED|Part C (Up to 34 Days)||0||
48257466|NCT03245619|100947984|FG004|COMPLETED|Part C (Up to 34 Days)||0||
48257467|NCT03245619|100947985|FG005|COMPLETED|Part C (Up to 34 Days)||0||
48257468|NCT03245619|100947986|FG006|COMPLETED|Part C (Up to 34 Days)||0||
48257469|NCT03245619|100947987|FG007|COMPLETED|Part C (Up to 34 Days)||0||
48257470|NCT03245619|100947988|FG008|COMPLETED|Part C (Up to 34 Days)||0||
48257471|NCT03245619|100947989|FG009|COMPLETED|Part C (Up to 34 Days)||0||
48257472|NCT03245619|100947990|FG010|COMPLETED|Part C (Up to 34 Days)||0||
48257473|NCT03245619|100947991|FG011|COMPLETED|Part C (Up to 34 Days)||0||
48688483|NCT01591408|102020234|FG001|COMPLETED|Overall Study||24||
48688484|NCT01591408|102020233|FG000|NOT COMPLETED|Overall Study||12||
48688485|NCT01591408|102020234|FG001|NOT COMPLETED|Overall Study||8||
48688486|NCT00334737|102020235|FG000|STARTED|Hospital Phase||34||
48688487|NCT00334737|102020236|FG001|STARTED|Hospital Phase||34||
48688488|NCT00334737|102020237|FG002|STARTED|Hospital Phase||34||
48688489|NCT00334737|102020235|FG000|COMPLETED|Hospital Phase||32||
48257474|NCT03245619|100947992|FG012|COMPLETED|Part C (Up to 34 Days)||0||
48257475|NCT03245619|100947993|FG013|COMPLETED|Part C (Up to 34 Days)||0||
48257476|NCT03245619|100947994|FG014|COMPLETED|Part C (Up to 34 Days)||0||
48257477|NCT03245619|100947995|FG015|COMPLETED|Part C (Up to 34 Days)||0||
48257478|NCT03245619|100947996|FG016|COMPLETED|Part C (Up to 34 Days)||0||
48257479|NCT03245619|100947980|FG000|NOT COMPLETED|Part C (Up to 34 Days)||0||
48257480|NCT03245619|100947981|FG001|NOT COMPLETED|Part C (Up to 34 Days)||0||
48257481|NCT03245619|100947982|FG002|NOT COMPLETED|Part C (Up to 34 Days)||0||
48257482|NCT03245619|100947983|FG003|NOT COMPLETED|Part C (Up to 34 Days)||0||
48257483|NCT03245619|100947984|FG004|NOT COMPLETED|Part C (Up to 34 Days)||0||
48257484|NCT03245619|100947985|FG005|NOT COMPLETED|Part C (Up to 34 Days)||0||
48257485|NCT03245619|100947986|FG006|NOT COMPLETED|Part C (Up to 34 Days)||0||
48257486|NCT03245619|100947987|FG007|NOT COMPLETED|Part C (Up to 34 Days)||0||
48257487|NCT03245619|100947988|FG008|NOT COMPLETED|Part C (Up to 34 Days)||0||
48257488|NCT03245619|100947989|FG009|NOT COMPLETED|Part C (Up to 34 Days)||0||
48257489|NCT03245619|100947990|FG010|NOT COMPLETED|Part C (Up to 34 Days)||0||
48257490|NCT03245619|100947991|FG011|NOT COMPLETED|Part C (Up to 34 Days)||0||
48257491|NCT03245619|100947992|FG012|NOT COMPLETED|Part C (Up to 34 Days)||0||
48257492|NCT03245619|100947993|FG013|NOT COMPLETED|Part C (Up to 34 Days)||0||
48257493|NCT03245619|100947994|FG014|NOT COMPLETED|Part C (Up to 34 Days)||0||
48257494|NCT03245619|100947995|FG015|NOT COMPLETED|Part C (Up to 34 Days)||0||
48257495|NCT03245619|100947996|FG016|NOT COMPLETED|Part C (Up to 34 Days)||0||
48257496|NCT01004029|100951772|FG000|STARTED|Overall Study||578|ITT Population - intent to treat|
48257497|NCT01004029|100951773|FG001|STARTED|Overall Study||1130|ITT Population - intent to treat|
48257498|NCT01004029|100951772|FG000|Safety Population|Overall Study||578|Two subjects in the vehicle group were randomized to 17P but did not receive treatment with study medication.|
48257499|NCT01004029|100951773|FG001|Safety Population|Overall Study||1128|Two subjects in the vehicle group were randomized to 17P but did not receive treatment with study medication.|
48257500|NCT01004029|100951772|FG000|COMPLETED|Overall Study||530|PP Population - per-protocol|
48257501|NCT01004029|100951773|FG001|COMPLETED|Overall Study||1057|PP Population - per-protocol|
48257502|NCT01004029|100951772|FG000|NOT COMPLETED|Overall Study||48||
48257503|NCT01004029|100951773|FG001|NOT COMPLETED|Overall Study||73||
48257504|NCT04260464|100951774|FG000|STARTED|Overall Study||8||
48257505|NCT04260464|100951775|FG001|STARTED|Overall Study||7||
48257506|NCT04260464|100951776|FG002|STARTED|Overall Study||7||
48257507|NCT04260464|100951777|FG003|STARTED|Overall Study||8||
48257508|NCT04260464|100951774|FG000|COMPLETED|Overall Study||8||
48257509|NCT04260464|100951775|FG001|COMPLETED|Overall Study||7||
48257510|NCT04260464|100951776|FG002|COMPLETED|Overall Study||7||
48257511|NCT04260464|100951777|FG003|COMPLETED|Overall Study||8||
48257512|NCT04260464|100951774|FG000|NOT COMPLETED|Overall Study||0||
48257513|NCT04260464|100951775|FG001|NOT COMPLETED|Overall Study||0||
48257514|NCT04260464|100951776|FG002|NOT COMPLETED|Overall Study||0||
48257515|NCT04260464|100951777|FG003|NOT COMPLETED|Overall Study||0||
48257516|NCT00847132|100951778|FG000|STARTED|Overall Study||90||
48257517|NCT00847132|100951779|FG001|STARTED|Overall Study||85||
48257518|NCT00847132|100951778|FG000|COMPLETED|Overall Study||89||
48257519|NCT00847132|100951779|FG001|COMPLETED|Overall Study||84||
48257520|NCT00847132|100951778|FG000|NOT COMPLETED|Overall Study||1||
48257521|NCT00847132|100951779|FG001|NOT COMPLETED|Overall Study||1||
48257522|NCT04969276|100951780|FG000|STARTED|Overall Study||100||
48257523|NCT04969276|100951781|FG001|STARTED|Overall Study||101||
48257524|NCT04969276|100951782|FG002|STARTED|Overall Study||105||
48257525|NCT04969276|100951780|FG000|Safety Analysis Set (SafAS)|Overall Study||100|SafAS included all participants who had received the study vaccine(s) and were analyzed according to the vaccine they actually received and study intervention group.|
48257526|NCT04969276|100951781|FG001|Safety Analysis Set (SafAS)|Overall Study||92|SafAS included all participants who had received the study vaccine(s) and were analyzed according to the vaccine they actually received and study intervention group.|
48257527|NCT04969276|100951782|FG002|Safety Analysis Set (SafAS)|Overall Study||104|SafAS included all participants who had received the study vaccine(s) and were analyzed according to the vaccine they actually received and study intervention group.|
48257528|NCT04969276|100951780|FG000|COMPLETED|Overall Study||99||
48257529|NCT04969276|100951781|FG001|COMPLETED|Overall Study||89||
48257530|NCT04969276|100951782|FG002|COMPLETED|Overall Study||105||
48257531|NCT04969276|100951780|FG000|NOT COMPLETED|Overall Study||1||
48257532|NCT04969276|100951781|FG001|NOT COMPLETED|Overall Study||12||
48257533|NCT04969276|100951782|FG002|NOT COMPLETED|Overall Study||0||
48257534|NCT00867100|100951783|FG000|STARTED|Overall Study||5||
48257535|NCT00867100|100951784|FG001|STARTED|Overall Study||5||
48257536|NCT00867100|100951785|FG002|STARTED|Overall Study||8||
48257537|NCT00867100|100951786|FG003|STARTED|Overall Study||8||
48257538|NCT00867100|100951787|FG004|STARTED|Overall Study||14||
48257539|NCT00867100|100951788|FG005|STARTED|Overall Study||6||
48257540|NCT00867100|100951789|FG006|STARTED|Overall Study||7||
48257541|NCT00867100|100951790|FG007|STARTED|Overall Study||3||
48257542|NCT00867100|100951791|FG008|STARTED|Overall Study||6||
48257543|NCT00867100|100951792|FG009|STARTED|Overall Study||6||
48257544|NCT00867100|100951793|FG010|STARTED|Overall Study||4||
48257545|NCT00867100|100951794|FG011|STARTED|Overall Study||6||
48257546|NCT00867100|100951795|FG012|STARTED|Overall Study||6||
48257547|NCT00867100|100951783|FG000|COMPLETED|Overall Study||5||
48257548|NCT00867100|100951784|FG001|COMPLETED|Overall Study||4||
48257549|NCT00867100|100951785|FG002|COMPLETED|Overall Study||8||
48257550|NCT00867100|100951786|FG003|COMPLETED|Overall Study||8||
48257551|NCT00867100|100951787|FG004|COMPLETED|Overall Study||14||
48257552|NCT00867100|100951788|FG005|COMPLETED|Overall Study||6||
48257553|NCT00867100|100951789|FG006|COMPLETED|Overall Study||6||
48257554|NCT00867100|100951790|FG007|COMPLETED|Overall Study||3||
48257555|NCT00867100|100951791|FG008|COMPLETED|Overall Study||6||
48257556|NCT00867100|100951792|FG009|COMPLETED|Overall Study||6||
48257557|NCT00867100|100951793|FG010|COMPLETED|Overall Study||3||
48257558|NCT00867100|100951794|FG011|COMPLETED|Overall Study||6||
48257559|NCT00867100|100951795|FG012|COMPLETED|Overall Study||6||
48385766|NCT01588353|101272860|FG000|COMPLETED|Step3||0||
48385767|NCT01588353|101272861|FG001|COMPLETED|Step3||0||
48385768|NCT01588353|101272862|FG002|COMPLETED|Step3||23||
48385769|NCT01588353|101272860|FG000|NOT COMPLETED|Step3||0||
48385770|NCT01588353|101272861|FG001|NOT COMPLETED|Step3||0||
48385771|NCT01588353|101272862|FG002|NOT COMPLETED|Step3||2||
48385772|NCT01429077|101272863|FG000|STARTED|Overall Study||19||
48385773|NCT01429077|101272864|FG001|STARTED|Overall Study||17||
48385774|NCT01429077|101272863|FG000|Completed 6-week Intervention|Overall Study||19||
48385775|NCT01429077|101272864|FG001|Completed 6-week Intervention|Overall Study||17||
48385776|NCT01429077|101272863|FG000|COMPLETED|Overall Study||19||
48385777|NCT01429077|101272864|FG001|COMPLETED|Overall Study||14||
48385778|NCT01429077|101272863|FG000|NOT COMPLETED|Overall Study||0||
48385779|NCT01429077|101272864|FG001|NOT COMPLETED|Overall Study||3||
48688490|NCT00334737|102020236|FG001|COMPLETED|Hospital Phase||32||
48385780|NCT04348656|101272865|FG000|STARTED|Overall Study||627||
48385781|NCT04348656|101272866|FG001|STARTED|Overall Study||313||
48385782|NCT04348656|101272865|FG000|Baseline Population|Overall Study||625||
48257560|NCT00867100|100951783|FG000|NOT COMPLETED|Overall Study||0||
48257561|NCT00867100|100951784|FG001|NOT COMPLETED|Overall Study||1||
48385783|NCT04348656|101272866|FG001|Baseline Population|Overall Study||313||
48385784|NCT04348656|101272865|FG000|Intention to Treat Analysis|Overall Study||614||
48385785|NCT04348656|101272866|FG001|Intention to Treat Analysis|Overall Study||307||
48385786|NCT04348656|101272865|FG000|Per Protocol Analysis|Overall Study||548||
48385787|NCT04348656|101272866|FG001|Per Protocol Analysis|Overall Study||303||
48385788|NCT04348656|101272865|FG000|COMPLETED|Overall Study||614||
48385789|NCT04348656|101272866|FG001|COMPLETED|Overall Study||307||
48385790|NCT04348656|101272865|FG000|NOT COMPLETED|Overall Study||13||
48385791|NCT04348656|101272866|FG001|NOT COMPLETED|Overall Study||6||
48385792|NCT00895193|101272867|FG000|STARTED|Overall Study||25||
48385793|NCT00895193|101272868|FG001|STARTED|Overall Study||25||
48385794|NCT00895193|101272869|FG002|STARTED|Overall Study||25||
48385795|NCT00895193|101272870|FG003|STARTED|Overall Study||25||
48385796|NCT00895193|101272867|FG000|COMPLETED|Overall Study||25||
48385797|NCT00895193|101272868|FG001|COMPLETED|Overall Study||25||
48385798|NCT00895193|101272869|FG002|COMPLETED|Overall Study||25||
48385799|NCT00895193|101272870|FG003|COMPLETED|Overall Study||25||
48385800|NCT00895193|101272867|FG000|NOT COMPLETED|Overall Study||0||
48385801|NCT00895193|101272868|FG001|NOT COMPLETED|Overall Study||0||
48385802|NCT00895193|101272869|FG002|NOT COMPLETED|Overall Study||0||
48385803|NCT00895193|101272870|FG003|NOT COMPLETED|Overall Study||0||
48385804|NCT00748085|101272871|FG000|STARTED|Overall Study||5||
48385805|NCT00748085|101272871|FG000|COMPLETED|Overall Study||5||
48257562|NCT00867100|100951785|FG002|NOT COMPLETED|Overall Study||0||
48257563|NCT00867100|100951786|FG003|NOT COMPLETED|Overall Study||0||
48257564|NCT00867100|100951787|FG004|NOT COMPLETED|Overall Study||0||
48257565|NCT00867100|100951788|FG005|NOT COMPLETED|Overall Study||0||
48257566|NCT00867100|100951789|FG006|NOT COMPLETED|Overall Study||1||
48257567|NCT00867100|100951790|FG007|NOT COMPLETED|Overall Study||0||
48385806|NCT00748085|101272871|FG000|NOT COMPLETED|Overall Study||0||
48385807|NCT01927419|101272872|FG000|STARTED|Pre-Treatment Period||95||
48385808|NCT01927419|101272873|FG001|STARTED|Pre-Treatment Period||47||
48385809|NCT01927419|101272872|FG000|COMPLETED|Pre-Treatment Period||94||
48385810|NCT01927419|101272873|FG001|COMPLETED|Pre-Treatment Period||46||
48688491|NCT00334737|102020237|FG002|COMPLETED|Hospital Phase||30||
48688492|NCT00334737|102020235|FG000|NOT COMPLETED|Hospital Phase||2||
48385811|NCT01927419|101272872|FG000|NOT COMPLETED|Pre-Treatment Period||1||
48385812|NCT01927419|101272873|FG001|NOT COMPLETED|Pre-Treatment Period||1||
48385813|NCT01927419|101272872|FG000|STARTED|Treatment Period||94||
48385814|NCT01927419|101272873|FG001|STARTED|Treatment Period||46||
48688493|NCT00334737|102020236|FG001|NOT COMPLETED|Hospital Phase||2||
48688494|NCT00334737|102020237|FG002|NOT COMPLETED|Hospital Phase||4||
48257568|NCT00867100|100951791|FG008|NOT COMPLETED|Overall Study||0||
48257569|NCT00867100|100951792|FG009|NOT COMPLETED|Overall Study||0||
48257570|NCT00867100|100951793|FG010|NOT COMPLETED|Overall Study||1||
48257571|NCT00867100|100951794|FG011|NOT COMPLETED|Overall Study||0||
48257572|NCT00867100|100951795|FG012|NOT COMPLETED|Overall Study||0||
48257573|NCT01056263|100951796|FG000|STARTED|Overall Study||52||
48257574|NCT01056263|100951796|FG000|COMPLETED|Overall Study||0||
48257575|NCT01056263|100951796|FG000|NOT COMPLETED|Overall Study||52||
48385815|NCT01927419|101272872|FG000|COMPLETED|Treatment Period||0||
48385816|NCT01927419|101272873|FG001|COMPLETED|Treatment Period||0||
48688495|NCT00334737|102020235|FG000|STARTED|Follow up Phase||32||
48688496|NCT00334737|102020236|FG001|STARTED|Follow up Phase||32||
48688497|NCT00334737|102020237|FG002|STARTED|Follow up Phase||30||
48688498|NCT00334737|102020235|FG000|COMPLETED|Follow up Phase||27||
48688499|NCT00334737|102020236|FG001|COMPLETED|Follow up Phase||29||
48688500|NCT00334737|102020237|FG002|COMPLETED|Follow up Phase||24||
48688501|NCT00334737|102020235|FG000|NOT COMPLETED|Follow up Phase||5||
48688502|NCT00334737|102020236|FG001|NOT COMPLETED|Follow up Phase||3||
48688503|NCT00334737|102020237|FG002|NOT COMPLETED|Follow up Phase||6||
48688504|NCT02440139|102020238|FG000|STARTED|Overall Study||12|June 2015|324
48688505|NCT02440139|102020238|FG000|COMPLETED|Overall Study||12|August 2016|324
48688506|NCT02440139|102020238|FG000|NOT COMPLETED|Overall Study||0||0
48688507|NCT02820844|102020239|FG000|STARTED|Double-blinded (Up to 48 Weeks)||124||
48688508|NCT02820844|102020240|FG001|STARTED|Double-blinded (Up to 48 Weeks)||124||
48688509|NCT02820844|102020241|FG002|STARTED|Double-blinded (Up to 48 Weeks)||0||
48688510|NCT02820844|102020242|FG003|STARTED|Double-blinded (Up to 48 Weeks)||0||
48688511|NCT02820844|102020243|FG004|STARTED|Double-blinded (Up to 48 Weeks)||0||
48688512|NCT02820844|102020244|FG005|STARTED|Double-blinded (Up to 48 Weeks)||0||
48688513|NCT02820844|102020239|FG000|COMPLETED|Double-blinded (Up to 48 Weeks)||119||
48688514|NCT02820844|102020240|FG001|COMPLETED|Double-blinded (Up to 48 Weeks)||115||
48688515|NCT02820844|102020241|FG002|COMPLETED|Double-blinded (Up to 48 Weeks)||0||
48688516|NCT02820844|102020242|FG003|COMPLETED|Double-blinded (Up to 48 Weeks)||0||
48688517|NCT02820844|102020243|FG004|COMPLETED|Double-blinded (Up to 48 Weeks)||0||
48688518|NCT02820844|102020244|FG005|COMPLETED|Double-blinded (Up to 48 Weeks)||0||
48688519|NCT02820844|102020239|FG000|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||5||
48688520|NCT02820844|102020240|FG001|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||9||
48688521|NCT02820844|102020241|FG002|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0||
48688522|NCT02820844|102020242|FG003|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0||
48688523|NCT02820844|102020243|FG004|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0||
48257576|NCT01982786|100951797|FG000|STARTED|Overall Study||29||
48257577|NCT01982786|100951798|FG001|STARTED|Overall Study||28||
48257578|NCT01982786|100951797|FG000|COMPLETED|Overall Study||29||
48257579|NCT01982786|100951798|FG001|COMPLETED|Overall Study||28||
48688524|NCT02820844|102020244|FG005|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0||
48688525|NCT02820844|102020239|FG000|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0||
48688526|NCT02820844|102020240|FG001|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0||
48688527|NCT02820844|102020241|FG002|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||108||
48688528|NCT02820844|102020242|FG003|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||88||
48688529|NCT02820844|102020243|FG004|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0||
48688530|NCT02820844|102020244|FG005|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0||
48092930|NCT05020990|100549134|FG001|STARTED|Period 2 (One Week)||26||
48092931|NCT05020990|100549133|FG000|COMPLETED|Period 2 (One Week)||28||
48092932|NCT05020990|100549134|FG001|COMPLETED|Period 2 (One Week)||26||
48092933|NCT05020990|100549133|FG000|NOT COMPLETED|Period 2 (One Week)||0||
48092934|NCT05020990|100549134|FG001|NOT COMPLETED|Period 2 (One Week)||0||
48092935|NCT02348606|100549135|FG000|STARTED|Overall Study||58||
48092936|NCT02348606|100549136|FG001|STARTED|Overall Study||62||
48092937|NCT02348606|100549137|FG002|STARTED|Overall Study||117||
48092938|NCT02348606|100549138|FG003|STARTED|Overall Study||118||
48092939|NCT02348606|100549139|FG004|STARTED|Overall Study||119||
48092940|NCT02348606|100549135|FG000|COMPLETED|Overall Study||49||
48092941|NCT02348606|100549136|FG001|COMPLETED|Overall Study||54||
48092942|NCT02348606|100549137|FG002|COMPLETED|Overall Study||106||
48257580|NCT01982786|100951797|FG000|NOT COMPLETED|Overall Study||0||
48257581|NCT01982786|100951798|FG001|NOT COMPLETED|Overall Study||0||
48257582|NCT01644188|100951799|FG000|STARTED|Overall Study||479||
48092943|NCT02348606|100549138|FG003|COMPLETED|Overall Study||94||
48092944|NCT02348606|100549139|FG004|COMPLETED|Overall Study||101||
48257583|NCT01644188|100951800|FG001|STARTED|Overall Study||241||
48257584|NCT01644188|100951799|FG000|Treated|Overall Study||479||
48257585|NCT01644188|100951800|FG001|Treated|Overall Study||241||
48257586|NCT01644188|100951799|FG000|COMPLETED|Overall Study||357||
48092945|NCT02348606|100549135|FG000|NOT COMPLETED|Overall Study||9||
48092946|NCT02348606|100549136|FG001|NOT COMPLETED|Overall Study||8||
48092947|NCT02348606|100549137|FG002|NOT COMPLETED|Overall Study||11||
48092948|NCT02348606|100549138|FG003|NOT COMPLETED|Overall Study||24||
48257587|NCT01644188|100951800|FG001|COMPLETED|Overall Study||166||
48688531|NCT02820844|102020239|FG000|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0||
48688532|NCT02820844|102020240|FG001|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0||
48688533|NCT02820844|102020241|FG002|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||99||
48688534|NCT02820844|102020242|FG003|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||84||
48688535|NCT02820844|102020243|FG004|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0||
48688536|NCT02820844|102020244|FG005|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0||
48688537|NCT02820844|102020239|FG000|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0||
48688538|NCT02820844|102020240|FG001|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0||
48688539|NCT02820844|102020241|FG002|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||9||
48710791|NCT01215110|102078017|FG001|NOT COMPLETED|Overall Study||0||
48257588|NCT01644188|100951799|FG000|NOT COMPLETED|Overall Study||122||
48092949|NCT02348606|100549139|FG004|NOT COMPLETED|Overall Study||18||
48092950|NCT00006903|100549140|FG000|STARTED|Overall Study||10||
48092951|NCT00006903|100549141|FG001|STARTED|Overall Study||24||
48092952|NCT00006903|100549142|FG002|STARTED|Overall Study||33||
48385817|NCT01927419|101272872|FG000|NOT COMPLETED|Treatment Period||94||
48688540|NCT02820844|102020242|FG003|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||4||
48688541|NCT02820844|102020243|FG004|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0||
48688542|NCT02820844|102020244|FG005|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0||
48688543|NCT02820844|102020239|FG000|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0||
48688544|NCT02820844|102020240|FG001|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0||
48688545|NCT02820844|102020241|FG002|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0||
48688546|NCT02820844|102020242|FG003|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0||
48688547|NCT02820844|102020243|FG004|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||56||
48688548|NCT02820844|102020244|FG005|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||43||
48688549|NCT02820844|102020239|FG000|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0||
48688550|NCT02820844|102020240|FG001|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0||
48688551|NCT02820844|102020241|FG002|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0||
48688552|NCT02820844|102020242|FG003|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0||
48688553|NCT02820844|102020243|FG004|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||54||
48688554|NCT02820844|102020244|FG005|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||42||
48688555|NCT02820844|102020239|FG000|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0||
48688556|NCT02820844|102020240|FG001|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0||
48688557|NCT02820844|102020241|FG002|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0||
48688558|NCT02820844|102020242|FG003|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0||
48688559|NCT02820844|102020243|FG004|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||2||
48688560|NCT02820844|102020244|FG005|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||1||
48688561|NCT01569737|102020245|FG000|STARTED|Overall Study||98||
48688562|NCT01569737|102020245|FG000|COMPLETED|Overall Study||95||
48688563|NCT01569737|102020245|FG000|NOT COMPLETED|Overall Study||3||
48688564|NCT03497039|102020246|FG000|STARTED|Overall Study||30||
48688565|NCT03497039|102020247|FG001|STARTED|Overall Study||17||
48688566|NCT03497039|102020246|FG000|Treated|Overall Study||29||
48688567|NCT03497039|102020247|FG001|Treated|Overall Study||17||
48688568|NCT03497039|102020246|FG000|COMPLETED|Overall Study||29||
48688569|NCT03497039|102020247|FG001|COMPLETED|Overall Study||16||
48385818|NCT01927419|101272873|FG001|NOT COMPLETED|Treatment Period||46||
48385819|NCT01167582|101272874|FG000|STARTED|Overall Study||55||
48385820|NCT01167582|101272875|FG001|STARTED|Overall Study||55||
48385821|NCT01167582|101272874|FG000|COMPLETED|Overall Study||55||
48385822|NCT01167582|101272875|FG001|COMPLETED|Overall Study||54||
48385823|NCT01167582|101272874|FG000|NOT COMPLETED|Overall Study||0||
48688570|NCT03497039|102020246|FG000|NOT COMPLETED|Overall Study||1||
48688571|NCT03497039|102020247|FG001|NOT COMPLETED|Overall Study||1||
48092953|NCT00006903|100549140|FG000|COMPLETED|Overall Study||0||
48092954|NCT00006903|100549141|FG001|COMPLETED|Overall Study||20||
48092955|NCT00006903|100549142|FG002|COMPLETED|Overall Study||27||
48092956|NCT00006903|100549140|FG000|NOT COMPLETED|Overall Study||10||
48092957|NCT00006903|100549141|FG001|NOT COMPLETED|Overall Study||4||
48092958|NCT00006903|100549142|FG002|NOT COMPLETED|Overall Study||6||
48092959|NCT02736409|100549143|FG000|STARTED|Overall Study||23||
48092960|NCT02736409|100549144|FG001|STARTED|Overall Study||25||
48092961|NCT02736409|100549145|FG002|STARTED|Overall Study||106||
48092962|NCT02736409|100549146|FG003|STARTED|Overall Study||65||
48385824|NCT01167582|101272875|FG001|NOT COMPLETED|Overall Study||1||
48385825|NCT01935336|101272876|FG000|STARTED|Overall Study||6||
48385826|NCT01935336|101272877|FG001|STARTED|Overall Study||3||
48385827|NCT01935336|101272878|FG002|STARTED|Overall Study||47||
48385828|NCT01935336|101272879|FG003|STARTED|Overall Study||66||
48385829|NCT01935336|101272876|FG000|Started Treatment|Overall Study||1||
48688572|NCT01154335|102020248|FG000|STARTED|Overall Study||7||
48688573|NCT01154335|102020249|FG001|STARTED|Overall Study||6||
48688574|NCT01154335|102020250|FG002|STARTED|Overall Study||5||
48688575|NCT01154335|102020248|FG000|COMPLETED|Overall Study||0||
48688576|NCT01154335|102020249|FG001|COMPLETED|Overall Study||0||
48688577|NCT01154335|102020250|FG002|COMPLETED|Overall Study||0||
48688578|NCT01154335|102020248|FG000|NOT COMPLETED|Overall Study||7||
48688579|NCT01154335|102020249|FG001|NOT COMPLETED|Overall Study||6||
48688580|NCT01154335|102020250|FG002|NOT COMPLETED|Overall Study||5||
48092963|NCT02736409|100549143|FG000|COMPLETED|Overall Study||19||
48092964|NCT02736409|100549144|FG001|COMPLETED|Overall Study||22||
48092965|NCT02736409|100549145|FG002|COMPLETED|Overall Study||80||
48092966|NCT02736409|100549146|FG003|COMPLETED|Overall Study||53||
48092967|NCT02736409|100549143|FG000|NOT COMPLETED|Overall Study||4||
48092968|NCT02736409|100549144|FG001|NOT COMPLETED|Overall Study||3||
48385830|NCT01935336|101272877|FG001|Started Treatment|Overall Study||0||
48385831|NCT01935336|101272878|FG002|Started Treatment|Overall Study||3||
48092969|NCT02736409|100549145|FG002|NOT COMPLETED|Overall Study||26||
48385832|NCT01935336|101272879|FG003|Started Treatment|Overall Study||0||
48385833|NCT01935336|101272876|FG000|COMPLETED|Overall Study||0||
48257589|NCT01644188|100951800|FG001|NOT COMPLETED|Overall Study||75||
48257590|NCT00545571|100951801|FG000|STARTED|Overall Study||120||
48257591|NCT00545571|100951801|FG000|COMPLETED|Overall Study||53||
48257592|NCT00545571|100951801|FG000|NOT COMPLETED|Overall Study||67||
48257593|NCT03854019|100951802|FG000|STARTED|First Intervention (4 Weeks)||10||
48257594|NCT03854019|100951803|FG001|STARTED|First Intervention (4 Weeks)||10||
48257595|NCT03854019|100951802|FG000|COMPLETED|First Intervention (4 Weeks)||9||
48257596|NCT03854019|100951803|FG001|COMPLETED|First Intervention (4 Weeks)||9||
48257597|NCT03854019|100951802|FG000|NOT COMPLETED|First Intervention (4 Weeks)||1||
48257598|NCT03854019|100951803|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1||
48257599|NCT03854019|100951802|FG000|STARTED|Washout (1 Week)||9||
48257600|NCT03854019|100951803|FG001|STARTED|Washout (1 Week)||9||
48257601|NCT03854019|100951802|FG000|COMPLETED|Washout (1 Week)||9||
48257602|NCT03854019|100951803|FG001|COMPLETED|Washout (1 Week)||9||
48257603|NCT03854019|100951802|FG000|NOT COMPLETED|Washout (1 Week)||0||
48257604|NCT03854019|100951803|FG001|NOT COMPLETED|Washout (1 Week)||0||
48257605|NCT03854019|100951802|FG000|STARTED|Second Intervention (4 Weeks)||9||
48257606|NCT03854019|100951803|FG001|STARTED|Second Intervention (4 Weeks)||9||
48257607|NCT03854019|100951802|FG000|COMPLETED|Second Intervention (4 Weeks)||9||
48257608|NCT03854019|100951803|FG001|COMPLETED|Second Intervention (4 Weeks)||9||
48257609|NCT03854019|100951802|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0||
48257610|NCT03854019|100951803|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0||
48257611|NCT01690923|100951804|FG000|STARTED|Overall Study||10||
48257612|NCT01690923|100951805|FG001|STARTED|Overall Study||11||
48257613|NCT01690923|100951804|FG000|COMPLETED|Overall Study||10||
48257614|NCT01690923|100951805|FG001|COMPLETED|Overall Study||10||
48257615|NCT01690923|100951804|FG000|NOT COMPLETED|Overall Study||0||
48257616|NCT01690923|100951805|FG001|NOT COMPLETED|Overall Study||1||
48257617|NCT01743521|100951806|FG000|STARTED|Overall Study||7||
48257618|NCT01743521|100951807|FG001|STARTED|Overall Study||3||
48257619|NCT01743521|100951808|FG002|STARTED|Overall Study||2||
48257620|NCT01743521|100951809|FG003|STARTED|Overall Study||2||
48257621|NCT01743521|100951806|FG000|COMPLETED|Overall Study||7||
48257622|NCT01743521|100951807|FG001|COMPLETED|Overall Study||3||
48257623|NCT01743521|100951808|FG002|COMPLETED|Overall Study||2||
48257624|NCT01743521|100951809|FG003|COMPLETED|Overall Study||2||
48257625|NCT01743521|100951806|FG000|NOT COMPLETED|Overall Study||0||
48257626|NCT01743521|100951807|FG001|NOT COMPLETED|Overall Study||0||
48257627|NCT01743521|100951808|FG002|NOT COMPLETED|Overall Study||0||
48257628|NCT01743521|100951809|FG003|NOT COMPLETED|Overall Study||0||
48257629|NCT00526097|100951810|FG000|STARTED|Overall Study||121||
48257630|NCT00526097|100951811|FG001|STARTED|Overall Study||247||
48257631|NCT00526097|100951810|FG000|COMPLETED|Overall Study||106||
48257632|NCT00526097|100951811|FG001|COMPLETED|Overall Study||191||
48257633|NCT00526097|100951810|FG000|NOT COMPLETED|Overall Study||15||
48257634|NCT00526097|100951811|FG001|NOT COMPLETED|Overall Study||56||
48257635|NCT02438371|100951812|FG000|STARTED|Overall Study||24||
48257636|NCT02438371|100951813|FG001|STARTED|Overall Study||25||
48257637|NCT02438371|100951812|FG000|Received Intervention|Overall Study||24||
48257638|NCT02438371|100951813|FG001|Received Intervention|Overall Study||25||
48257639|NCT02438371|100951812|FG000|COMPLETED|Overall Study||20||
48257640|NCT02438371|100951813|FG001|COMPLETED|Overall Study||22||
48257641|NCT02438371|100951812|FG000|NOT COMPLETED|Overall Study||4||
48257642|NCT02438371|100951813|FG001|NOT COMPLETED|Overall Study||3||
48257643|NCT01947517|100951814|FG000|STARTED|Overall Study||26||
48257644|NCT01947517|100951815|FG001|STARTED|Overall Study||26||
48257645|NCT01947517|100951814|FG000|COMPLETED|Overall Study||25||
48257646|NCT01947517|100951815|FG001|COMPLETED|Overall Study||25||
48257647|NCT01947517|100951814|FG000|NOT COMPLETED|Overall Study||1||
48257648|NCT01947517|100951815|FG001|NOT COMPLETED|Overall Study||1||
48257649|NCT01305473|100951816|FG000|STARTED|Overall Study||90||
48257650|NCT01305473|100951816|FG000|COMPLETED|Overall Study||90||
48257651|NCT01305473|100951816|FG000|NOT COMPLETED|Overall Study||0||
48257652|NCT02716298|100951817|FG000|STARTED|First Intervention (1 Month)||25||
48257653|NCT02716298|100951818|FG001|STARTED|First Intervention (1 Month)||24||
48257654|NCT02716298|100951817|FG000|COMPLETED|First Intervention (1 Month)||24||
48257655|NCT02716298|100951818|FG001|COMPLETED|First Intervention (1 Month)||23||
48257656|NCT02716298|100951817|FG000|NOT COMPLETED|First Intervention (1 Month)||1||
48257657|NCT02716298|100951818|FG001|NOT COMPLETED|First Intervention (1 Month)||1||
48257658|NCT02716298|100951817|FG000|STARTED|Second Intervention (1 Month)||24||
48257659|NCT02716298|100951818|FG001|STARTED|Second Intervention (1 Month)||23||
48257660|NCT02716298|100951817|FG000|COMPLETED|Second Intervention (1 Month)||24||
48257661|NCT02716298|100951818|FG001|COMPLETED|Second Intervention (1 Month)||23||
48257662|NCT02716298|100951817|FG000|NOT COMPLETED|Second Intervention (1 Month)||0||
48257663|NCT02716298|100951818|FG001|NOT COMPLETED|Second Intervention (1 Month)||0||
48257664|NCT02575950|100951819|FG000|STARTED|Overall Study||3||
48257665|NCT02575950|100951820|FG001|STARTED|Overall Study||6||
48257666|NCT02575950|100951821|FG002|STARTED|Overall Study||6||
48257667|NCT02575950|100951822|FG003|STARTED|Overall Study||25||
48257668|NCT02575950|100951819|FG000|COMPLETED|Overall Study||3||
48257669|NCT02575950|100951820|FG001|COMPLETED|Overall Study||5||
48385834|NCT01935336|101272877|FG001|COMPLETED|Overall Study||0||
48385835|NCT01935336|101272878|FG002|COMPLETED|Overall Study||0||
48385836|NCT01935336|101272879|FG003|COMPLETED|Overall Study||0||
48385837|NCT01935336|101272876|FG000|NOT COMPLETED|Overall Study||6||
48385838|NCT01935336|101272877|FG001|NOT COMPLETED|Overall Study||3||
48385839|NCT01935336|101272878|FG002|NOT COMPLETED|Overall Study||47||
48385840|NCT01935336|101272879|FG003|NOT COMPLETED|Overall Study||66||
48385841|NCT00390416|101272880|FG000|STARTED|Overall Study||48||
48385842|NCT00390416|101272880|FG000|COMPLETED|Overall Study||44||
48385843|NCT00390416|101272880|FG000|NOT COMPLETED|Overall Study||4||
48385844|NCT03600714|101272881|FG000|STARTED|Overall Study||26||
48385845|NCT03600714|101272881|FG000|COMPLETED|Overall Study||25||
48385846|NCT03600714|101272881|FG000|NOT COMPLETED|Overall Study||1||
48385847|NCT04533815|101272882|FG000|STARTED|Overall Study||23||
48385848|NCT04533815|101272882|FG000|COMPLETED|Overall Study||16||
48385849|NCT04533815|101272882|FG000|NOT COMPLETED|Overall Study||7||
48385850|NCT01486784|101272883|FG000|STARTED|Overall Study||3||
48385851|NCT01486784|101272884|FG001|STARTED|Overall Study||7||
48385852|NCT01486784|101272885|FG002|STARTED|Overall Study||6||
48092970|NCT02736409|100549146|FG003|NOT COMPLETED|Overall Study||12||
48092971|NCT00531050|100549147|FG000|STARTED|Part 1: Period 1||4||
48092972|NCT00531050|100549148|FG001|STARTED|Part 1: Period 1||5||
48385853|NCT01486784|101272886|FG003|STARTED|Overall Study||1||
48385854|NCT01486784|101272887|FG004|STARTED|Overall Study||5||
48385855|NCT01486784|101272888|FG005|STARTED|Overall Study||5||
48385856|NCT01486784|101272883|FG000|Completed Cycle 1|Overall Study||2||
48385857|NCT01486784|101272884|FG001|Completed Cycle 1|Overall Study||6||
48385858|NCT01486784|101272885|FG002|Completed Cycle 1|Overall Study||3||
48385859|NCT01486784|101272886|FG003|Completed Cycle 1|Overall Study||1||
48385860|NCT01486784|101272887|FG004|Completed Cycle 1|Overall Study||3||
48385861|NCT01486784|101272888|FG005|Completed Cycle 1|Overall Study||2||
48385862|NCT01486784|101272883|FG000|Received Treatment|Overall Study||3|Number of subjects in each arm, who enrolled in study and received study treatment.|
48385863|NCT01486784|101272884|FG001|Received Treatment|Overall Study||7|Number of subjects in each arm, who enrolled in study and received study treatment.|
48385864|NCT01486784|101272885|FG002|Received Treatment|Overall Study||5|Number of subjects in each arm, who enrolled in study and received study treatment.|
48385865|NCT01486784|101272886|FG003|Received Treatment|Overall Study||1|Number of subjects in each arm, who enrolled in study and received study treatment.|
48385866|NCT01486784|101272887|FG004|Received Treatment|Overall Study||3|Number of subjects in each arm, who enrolled in study and received study treatment.|
48385867|NCT01486784|101272888|FG005|Received Treatment|Overall Study||2|Number of subjects in each arm, who enrolled in study and received study treatment.|
48385868|NCT01486784|101272883|FG000|COMPLETED|Overall Study||3||
48385869|NCT01486784|101272884|FG001|COMPLETED|Overall Study||7||
48385870|NCT01486784|101272885|FG002|COMPLETED|Overall Study||5||
48092973|NCT00531050|100549149|FG002|STARTED|Part 1: Period 1||4||
48092974|NCT00531050|100549150|FG003|STARTED|Part 1: Period 1||5||
48092975|NCT00531050|100549151|FG004|STARTED|Part 1: Period 1||4||
48092976|NCT00531050|100549152|FG005|STARTED|Part 1: Period 1||5||
48092977|NCT00531050|100549147|FG000|COMPLETED|Part 1: Period 1||4||
48092978|NCT00531050|100549148|FG001|COMPLETED|Part 1: Period 1||4||
48092979|NCT00531050|100549149|FG002|COMPLETED|Part 1: Period 1||4||
48092980|NCT00531050|100549150|FG003|COMPLETED|Part 1: Period 1||4||
48092981|NCT00531050|100549151|FG004|COMPLETED|Part 1: Period 1||4||
48092982|NCT00531050|100549152|FG005|COMPLETED|Part 1: Period 1||5||
48092983|NCT00531050|100549147|FG000|NOT COMPLETED|Part 1: Period 1||0||
48092984|NCT00531050|100549148|FG001|NOT COMPLETED|Part 1: Period 1||1||
48092985|NCT00531050|100549149|FG002|NOT COMPLETED|Part 1: Period 1||0||
48092986|NCT00531050|100549150|FG003|NOT COMPLETED|Part 1: Period 1||1||
48092987|NCT00531050|100549151|FG004|NOT COMPLETED|Part 1: Period 1||0||
48092988|NCT00531050|100549152|FG005|NOT COMPLETED|Part 1: Period 1||0||
48385871|NCT01486784|101272886|FG003|COMPLETED|Overall Study||1||
48385872|NCT01486784|101272887|FG004|COMPLETED|Overall Study||3||
48385873|NCT01486784|101272888|FG005|COMPLETED|Overall Study||2||
48385874|NCT01486784|101272883|FG000|NOT COMPLETED|Overall Study||0||
48385875|NCT01486784|101272884|FG001|NOT COMPLETED|Overall Study||0||
48385876|NCT01486784|101272885|FG002|NOT COMPLETED|Overall Study||1||
48385877|NCT01486784|101272886|FG003|NOT COMPLETED|Overall Study||0||
48385878|NCT01486784|101272887|FG004|NOT COMPLETED|Overall Study||2||
48385879|NCT01486784|101272888|FG005|NOT COMPLETED|Overall Study||3||
48385880|NCT00111917|101272889|FG000|STARTED|Overall Study||9||
48385881|NCT00111917|101272890|FG001|STARTED|Overall Study||4||
48385882|NCT00111917|101272889|FG000|COMPLETED|Overall Study||8||
48385883|NCT00111917|101272890|FG001|COMPLETED|Overall Study||3||
48385884|NCT00111917|101272889|FG000|NOT COMPLETED|Overall Study||1||
48385885|NCT00111917|101272890|FG001|NOT COMPLETED|Overall Study||1||
48385886|NCT04363437|101272891|FG000|STARTED|Overall Study||10||
48385887|NCT04363437|101272892|FG001|STARTED|Overall Study||11||
48385888|NCT04363437|101272891|FG000|COMPLETED|Overall Study||10||
48385889|NCT04363437|101272892|FG001|COMPLETED|Overall Study||11||
48385890|NCT04363437|101272891|FG000|NOT COMPLETED|Overall Study||0||
48092989|NCT00531050|100549147|FG000|STARTED|Part 1: Period 2||4||
48092990|NCT00531050|100549148|FG001|STARTED|Part 1: Period 2||4||
48092991|NCT00531050|100549149|FG002|STARTED|Part 1: Period 2||4||
48385891|NCT04363437|101272892|FG001|NOT COMPLETED|Overall Study||0||
48385892|NCT01413542|101272893|FG000|STARTED|Overall Study||6||
48385893|NCT01413542|101272894|FG001|STARTED|Overall Study||6||
48385894|NCT01413542|101272895|FG002|STARTED|Overall Study||9||
48688581|NCT01694433|102020251|FG000|STARTED|Overall Study||33||
48688582|NCT01694433|102020252|FG001|STARTED|Overall Study||33||
48688583|NCT01694433|102020251|FG000|Baseline Visit|Overall Study||33||
48688584|NCT01694433|102020252|FG001|Baseline Visit|Overall Study||32||
48688585|NCT01694433|102020251|FG000|COMPLETED|Overall Study||22||
48688586|NCT01694433|102020252|FG001|COMPLETED|Overall Study||29||
48688587|NCT01694433|102020251|FG000|NOT COMPLETED|Overall Study||11||
48688588|NCT01694433|102020252|FG001|NOT COMPLETED|Overall Study||4||
48688589|NCT01871545|102020253|FG000|STARTED|Overall Study||73||
48688590|NCT01871545|102020254|FG001|STARTED|Overall Study||11||
48688591|NCT01871545|102020253|FG000|COMPLETED|Overall Study||56||
48257670|NCT02575950|100951821|FG002|COMPLETED|Overall Study||6||
48257671|NCT02575950|100951822|FG003|COMPLETED|Overall Study||20||
48257672|NCT02575950|100951819|FG000|NOT COMPLETED|Overall Study||0||
48257673|NCT02575950|100951820|FG001|NOT COMPLETED|Overall Study||1||
48257674|NCT02575950|100951821|FG002|NOT COMPLETED|Overall Study||0||
48257675|NCT02575950|100951822|FG003|NOT COMPLETED|Overall Study||5||
48257676|NCT02541942|100951823|FG000|STARTED|Overall Study||19||
48385895|NCT01413542|101272896|FG003|STARTED|Overall Study||8||
48385896|NCT01413542|101272893|FG000|COMPLETED|Overall Study||5||
48385897|NCT01413542|101272894|FG001|COMPLETED|Overall Study||6||
48385898|NCT01413542|101272895|FG002|COMPLETED|Overall Study||6||
48385899|NCT01413542|101272896|FG003|COMPLETED|Overall Study||7||
48385900|NCT01413542|101272893|FG000|NOT COMPLETED|Overall Study||1||
48385901|NCT01413542|101272894|FG001|NOT COMPLETED|Overall Study||0||
48385902|NCT01413542|101272895|FG002|NOT COMPLETED|Overall Study||3||
48385903|NCT01413542|101272896|FG003|NOT COMPLETED|Overall Study||1||
48385904|NCT00884052|101272897|FG000|STARTED|Overall Study||6||
48257677|NCT02541942|100951823|FG000|COMPLETED|Overall Study||19||
48257678|NCT02541942|100951823|FG000|NOT COMPLETED|Overall Study||0||
48257679|NCT00726713|100951824|FG000|STARTED|Overall Study||106||
48257680|NCT00726713|100951825|FG001|STARTED|Overall Study||108||
48257681|NCT00726713|100951824|FG000|COMPLETED|Overall Study||99||
48257682|NCT00726713|100951825|FG001|COMPLETED|Overall Study||101||
48385905|NCT00884052|101272898|FG001|STARTED|Overall Study||12||
48385906|NCT00884052|101272897|FG000|COMPLETED|Overall Study||6||
48385907|NCT00884052|101272898|FG001|COMPLETED|Overall Study||12||
48385908|NCT00884052|101272897|FG000|NOT COMPLETED|Overall Study||0||
48385909|NCT00884052|101272898|FG001|NOT COMPLETED|Overall Study||0||
48385910|NCT02168933|101272899|FG000|STARTED|Overall Study||8||
48385911|NCT02168933|101272899|FG000|COMPLETED|Overall Study||7||
48688592|NCT01871545|102020254|FG001|COMPLETED|Overall Study||8||
48688593|NCT01871545|102020253|FG000|NOT COMPLETED|Overall Study||17||
48688594|NCT01871545|102020254|FG001|NOT COMPLETED|Overall Study||3||
48257683|NCT00726713|100951824|FG000|NOT COMPLETED|Overall Study||7||
48257684|NCT00726713|100951825|FG001|NOT COMPLETED|Overall Study||7||
48688595|NCT00921115|102020255|FG000|STARTED|Overall Study||42||
48257685|NCT00350298|100951826|FG000|STARTED|Overall Study||101||
48257686|NCT00350298|100951827|FG001|STARTED|Overall Study||99||
48257687|NCT00350298|100951826|FG000|COMPLETED|Overall Study||92||
48541696|NCT03095638|101662790|FG001|STARTED|P1: Period 2, Washout (7[-4 Hours])||7||
48257688|NCT00350298|100951827|FG001|COMPLETED|Overall Study||86||
48257689|NCT00350298|100951826|FG000|NOT COMPLETED|Overall Study||9||
48257690|NCT00350298|100951827|FG001|NOT COMPLETED|Overall Study||13||
48257691|NCT01588366|100951828|FG000|STARTED|Overall Study||2||
48257692|NCT01588366|100951829|FG001|STARTED|Overall Study||7||
48257693|NCT01588366|100951830|FG002|STARTED|Overall Study||2||
48385912|NCT02168933|101272899|FG000|NOT COMPLETED|Overall Study||1||
48385913|NCT00078559|101272900|FG000|STARTED|Overall Study||10||
48385914|NCT00078559|101272900|FG000|COMPLETED|Overall Study||10||
48385915|NCT00078559|101272900|FG000|NOT COMPLETED|Overall Study||0||
48688596|NCT00921115|102020255|FG000|COMPLETED|Overall Study||42||
48688597|NCT00921115|102020255|FG000|NOT COMPLETED|Overall Study||0||
48688598|NCT00553410|102020256|FG000|STARTED|Overall Study||2441||
48688599|NCT00553410|102020257|FG001|STARTED|Overall Study||2443||
48688600|NCT00553410|102020256|FG000|COMPLETED|Overall Study||2426||
48688601|NCT00553410|102020257|FG001|COMPLETED|Overall Study||2425||
48385916|NCT03837353|101272901|FG000|STARTED|Overall Study||3||
48385917|NCT03837353|101272902|FG001|STARTED|Overall Study||3||
48688602|NCT00553410|102020256|FG000|NOT COMPLETED|Overall Study||15||
48688603|NCT00553410|102020257|FG001|NOT COMPLETED|Overall Study||18||
48688604|NCT03974932|102020258|FG000|STARTED|Overall Study||66||
48688605|NCT03974932|102020259|FG001|STARTED|Overall Study||14||
48688606|NCT03974932|102020260|FG002|STARTED|Overall Study||16||
48688607|NCT03974932|102020261|FG003|STARTED|Overall Study||20||
48688608|NCT03974932|102020258|FG000|COMPLETED|Overall Study||66||
48688609|NCT03974932|102020259|FG001|COMPLETED|Overall Study||14||
48688610|NCT03974932|102020260|FG002|COMPLETED|Overall Study||16||
48688611|NCT03974932|102020261|FG003|COMPLETED|Overall Study||20||
48688612|NCT03974932|102020258|FG000|NOT COMPLETED|Overall Study||0||
48688613|NCT03974932|102020259|FG001|NOT COMPLETED|Overall Study||0||
48688614|NCT03974932|102020260|FG002|NOT COMPLETED|Overall Study||0||
48688615|NCT03974932|102020261|FG003|NOT COMPLETED|Overall Study||0||
48688616|NCT01206140|102020262|FG000|STARTED|Overall Study||35||
48688617|NCT01206140|102020263|FG001|STARTED|Overall Study||35||
48688618|NCT01206140|102020262|FG000|COMPLETED|Overall Study||34||
48688619|NCT01206140|102020263|FG001|COMPLETED|Overall Study||35||
48688620|NCT01206140|102020262|FG000|NOT COMPLETED|Overall Study||1||
48688621|NCT01206140|102020263|FG001|NOT COMPLETED|Overall Study||0||
48688622|NCT05010070|102020264|FG000|STARTED|Overall Study||11||
48688623|NCT05010070|102020264|FG000|COMPLETED|Overall Study||9||
48688624|NCT05010070|102020264|FG000|NOT COMPLETED|Overall Study||2||
48688625|NCT01696773|102020265|FG000|STARTED|Days 1-13, Washout||6||
48688626|NCT01696773|102020266|FG001|STARTED|Days 1-13, Washout||6||
48688627|NCT01696773|102020265|FG000|COMPLETED|Days 1-13, Washout||6||
48092992|NCT00531050|100549150|FG003|STARTED|Part 1: Period 2||4||
48092993|NCT00531050|100549151|FG004|STARTED|Part 1: Period 2||4||
48092994|NCT00531050|100549152|FG005|STARTED|Part 1: Period 2||5||
48092995|NCT00531050|100549147|FG000|COMPLETED|Part 1: Period 2||4||
48092996|NCT00531050|100549148|FG001|COMPLETED|Part 1: Period 2||4||
48092997|NCT00531050|100549149|FG002|COMPLETED|Part 1: Period 2||4||
48092998|NCT00531050|100549150|FG003|COMPLETED|Part 1: Period 2||4||
48257694|NCT01588366|100951831|FG003|STARTED|Overall Study||7||
48092999|NCT00531050|100549151|FG004|COMPLETED|Part 1: Period 2||4||
48093000|NCT00531050|100549152|FG005|COMPLETED|Part 1: Period 2||5||
48093001|NCT00531050|100549147|FG000|NOT COMPLETED|Part 1: Period 2||0||
48093002|NCT00531050|100549148|FG001|NOT COMPLETED|Part 1: Period 2||0||
48093003|NCT00531050|100549149|FG002|NOT COMPLETED|Part 1: Period 2||0||
48093004|NCT00531050|100549150|FG003|NOT COMPLETED|Part 1: Period 2||0||
48093005|NCT00531050|100549151|FG004|NOT COMPLETED|Part 1: Period 2||0||
48093006|NCT00531050|100549152|FG005|NOT COMPLETED|Part 1: Period 2||0||
48093007|NCT00531050|100549147|FG000|STARTED|Part 1: Period 3||4||
48257695|NCT01588366|100951832|FG004|STARTED|Overall Study||3||
48093008|NCT00531050|100549148|FG001|STARTED|Part 1: Period 3||4||
48093009|NCT00531050|100549149|FG002|STARTED|Part 1: Period 3||4||
48093010|NCT00531050|100549150|FG003|STARTED|Part 1: Period 3||4||
48093011|NCT00531050|100549151|FG004|STARTED|Part 1: Period 3||4||
48093012|NCT00531050|100549152|FG005|STARTED|Part 1: Period 3||5||
48093013|NCT00531050|100549147|FG000|COMPLETED|Part 1: Period 3||3||
48093014|NCT00531050|100549148|FG001|COMPLETED|Part 1: Period 3||4||
48093015|NCT00531050|100549149|FG002|COMPLETED|Part 1: Period 3||4||
48093016|NCT00531050|100549150|FG003|COMPLETED|Part 1: Period 3||4||
48093017|NCT00531050|100549151|FG004|COMPLETED|Part 1: Period 3||4||
48093018|NCT00531050|100549152|FG005|COMPLETED|Part 1: Period 3||5||
48257696|NCT01588366|100951833|FG005|STARTED|Overall Study||9||
48257697|NCT01588366|100951828|FG000|Received at Least One Dose of Study Drug|Overall Study||2||
48257698|NCT01588366|100951829|FG001|Received at Least One Dose of Study Drug|Overall Study||7||
48257699|NCT01588366|100951830|FG002|Received at Least One Dose of Study Drug|Overall Study||2||
48257700|NCT01588366|100951831|FG003|Received at Least One Dose of Study Drug|Overall Study||7||
48257701|NCT01588366|100951832|FG004|Received at Least One Dose of Study Drug|Overall Study||3||
48257702|NCT01588366|100951833|FG005|Received at Least One Dose of Study Drug|Overall Study||9||
48257703|NCT01588366|100951828|FG000|COMPLETED|Overall Study||2||
48688628|NCT01696773|102020266|FG001|COMPLETED|Days 1-13, Washout||6||
48688629|NCT01696773|102020265|FG000|NOT COMPLETED|Days 1-13, Washout||0||
48688630|NCT01696773|102020266|FG001|NOT COMPLETED|Days 1-13, Washout||0||
48093019|NCT00531050|100549147|FG000|NOT COMPLETED|Part 1: Period 3||1||
48093020|NCT00531050|100549148|FG001|NOT COMPLETED|Part 1: Period 3||0||
48093021|NCT00531050|100549149|FG002|NOT COMPLETED|Part 1: Period 3||0||
48093022|NCT00531050|100549150|FG003|NOT COMPLETED|Part 1: Period 3||0||
48093023|NCT00531050|100549151|FG004|NOT COMPLETED|Part 1: Period 3||0||
48093024|NCT00531050|100549152|FG005|NOT COMPLETED|Part 1: Period 3||0||
48093025|NCT00531050|100549147|FG000|STARTED|Part 2: Period 1||3||
48093026|NCT00531050|100549148|FG001|STARTED|Part 2: Period 1||4||
48093027|NCT00531050|100549149|FG002|STARTED|Part 2: Period 1||4||
48093028|NCT00531050|100549150|FG003|STARTED|Part 2: Period 1||4||
48093029|NCT00531050|100549151|FG004|STARTED|Part 2: Period 1||4||
48093030|NCT00531050|100549152|FG005|STARTED|Part 2: Period 1||5||
48257704|NCT01588366|100951829|FG001|COMPLETED|Overall Study||6||
48257705|NCT01588366|100951830|FG002|COMPLETED|Overall Study||2||
48093031|NCT00531050|100549147|FG000|COMPLETED|Part 2: Period 1||3||
48710792|NCT01215110|102078018|FG002|NOT COMPLETED|Overall Study||2||
48385918|NCT03837353|101272903|FG002|STARTED|Overall Study||2||
48385919|NCT03837353|101272904|FG003|STARTED|Overall Study||4||
48385920|NCT03837353|101272905|FG004|STARTED|Overall Study||3||
48385921|NCT03837353|101272906|FG005|STARTED|Overall Study||3||
48385922|NCT03837353|101272901|FG000|COMPLETED|Overall Study||3||
48385923|NCT03837353|101272902|FG001|COMPLETED|Overall Study||3||
48385924|NCT03837353|101272903|FG002|COMPLETED|Overall Study||2||
48385925|NCT03837353|101272904|FG003|COMPLETED|Overall Study||4||
48385926|NCT03837353|101272905|FG004|COMPLETED|Overall Study||3||
48385927|NCT03837353|101272906|FG005|COMPLETED|Overall Study||3||
48385928|NCT03837353|101272901|FG000|NOT COMPLETED|Overall Study||0||
48385929|NCT03837353|101272902|FG001|NOT COMPLETED|Overall Study||0||
48385930|NCT03837353|101272903|FG002|NOT COMPLETED|Overall Study||0||
48385931|NCT03837353|101272904|FG003|NOT COMPLETED|Overall Study||0||
48385932|NCT03837353|101272905|FG004|NOT COMPLETED|Overall Study||0||
48385933|NCT03837353|101272906|FG005|NOT COMPLETED|Overall Study||0||
48385934|NCT01653158|101272907|FG000|STARTED|Overall Study||3||
48385935|NCT01653158|101272908|FG001|STARTED|Overall Study||3||
48385936|NCT01653158|101272909|FG002|STARTED|Overall Study||3||
48385937|NCT01653158|101272910|FG003|STARTED|Overall Study||3||
48385938|NCT01653158|101272911|FG004|STARTED|Overall Study||3||
48385939|NCT01653158|101272912|FG005|STARTED|Overall Study||3||
48385940|NCT01653158|101272913|FG006|STARTED|Overall Study||9||
48385941|NCT01653158|101272914|FG007|STARTED|Overall Study||19||
48385942|NCT01653158|101272907|FG000|COMPLETED|Overall Study||2||
48688631|NCT01696773|102020265|FG000|STARTED|Day 14, First Intervention||6||
48688632|NCT01696773|102020266|FG001|STARTED|Day 14, First Intervention||6||
48688633|NCT01696773|102020265|FG000|COMPLETED|Day 14, First Intervention||6||
48688634|NCT01696773|102020266|FG001|COMPLETED|Day 14, First Intervention||6||
48688635|NCT01696773|102020265|FG000|NOT COMPLETED|Day 14, First Intervention||0||
48688636|NCT01696773|102020266|FG001|NOT COMPLETED|Day 14, First Intervention||0||
48688637|NCT01696773|102020265|FG000|STARTED|Days 15-27, Washout||6||
48688638|NCT01696773|102020266|FG001|STARTED|Days 15-27, Washout||6||
48385943|NCT01653158|101272908|FG001|COMPLETED|Overall Study||3||
48385944|NCT01653158|101272909|FG002|COMPLETED|Overall Study||3||
48385945|NCT01653158|101272910|FG003|COMPLETED|Overall Study||1||
48385946|NCT01653158|101272911|FG004|COMPLETED|Overall Study||2||
48385947|NCT01653158|101272912|FG005|COMPLETED|Overall Study||2||
48385948|NCT01653158|101272913|FG006|COMPLETED|Overall Study||7||
48385949|NCT01653158|101272914|FG007|COMPLETED|Overall Study||4||
48385950|NCT01653158|101272907|FG000|NOT COMPLETED|Overall Study||1||
48385951|NCT01653158|101272908|FG001|NOT COMPLETED|Overall Study||0||
48688639|NCT01696773|102020265|FG000|COMPLETED|Days 15-27, Washout||5||
48688640|NCT01696773|102020266|FG001|COMPLETED|Days 15-27, Washout||6||
48688641|NCT01696773|102020265|FG000|NOT COMPLETED|Days 15-27, Washout||1||
48688642|NCT01696773|102020266|FG001|NOT COMPLETED|Days 15-27, Washout||0||
48688643|NCT01696773|102020265|FG000|STARTED|Day 28, Second Intervention||5||
48688644|NCT01696773|102020266|FG001|STARTED|Day 28, Second Intervention||6||
48688645|NCT01696773|102020265|FG000|COMPLETED|Day 28, Second Intervention||5||
48385952|NCT01653158|101272909|FG002|NOT COMPLETED|Overall Study||0||
48385953|NCT01653158|101272910|FG003|NOT COMPLETED|Overall Study||2||
48385954|NCT01653158|101272911|FG004|NOT COMPLETED|Overall Study||1||
48385955|NCT01653158|101272912|FG005|NOT COMPLETED|Overall Study||1||
48385956|NCT01653158|101272913|FG006|NOT COMPLETED|Overall Study||2||
48385957|NCT01653158|101272914|FG007|NOT COMPLETED|Overall Study||15||
48385958|NCT03519516|101272915|FG000|STARTED|Overall Study||15||
48385959|NCT03519516|101272916|FG001|STARTED|Overall Study||15||
48385960|NCT03519516|101272915|FG000|COMPLETED|Overall Study||15||
48385961|NCT03519516|101272916|FG001|COMPLETED|Overall Study||14||
48385962|NCT03519516|101272915|FG000|NOT COMPLETED|Overall Study||0||
48385963|NCT03519516|101272916|FG001|NOT COMPLETED|Overall Study||1||
48385964|NCT02219087|101272917|FG000|STARTED|Overall Study||30||
48385965|NCT02219087|101272918|FG001|STARTED|Overall Study||30||
48385966|NCT02219087|101272917|FG000|COMPLETED|Overall Study||30||
48385967|NCT02219087|101272918|FG001|COMPLETED|Overall Study||29||
48385968|NCT02219087|101272917|FG000|NOT COMPLETED|Overall Study||0||
48385969|NCT02219087|101272918|FG001|NOT COMPLETED|Overall Study||1||
48385970|NCT00964158|101272919|FG000|STARTED|Overall Study||53||
48385971|NCT00964158|101272920|FG001|STARTED|Overall Study||57||
48385972|NCT00964158|101272921|FG002|STARTED|Overall Study||100||
48385973|NCT00964158|101272919|FG000|COMPLETED|Overall Study||53||
48385974|NCT00964158|101272920|FG001|COMPLETED|Overall Study||56||
48385975|NCT00964158|101272921|FG002|COMPLETED|Overall Study||92||
48385976|NCT00964158|101272919|FG000|NOT COMPLETED|Overall Study||0||
48385977|NCT00964158|101272920|FG001|NOT COMPLETED|Overall Study||1||
48688646|NCT01696773|102020266|FG001|COMPLETED|Day 28, Second Intervention||6||
48385978|NCT00964158|101272921|FG002|NOT COMPLETED|Overall Study||8||
48385979|NCT00941889|101272922|FG000|STARTED|Overall Study||17||
48385980|NCT00941889|101272923|FG001|STARTED|Overall Study||15||
48385981|NCT00941889|101272922|FG000|COMPLETED|Overall Study||5||
48385982|NCT00941889|101272923|FG001|COMPLETED|Overall Study||3||
48385983|NCT00941889|101272922|FG000|NOT COMPLETED|Overall Study||12||
48385984|NCT00941889|101272923|FG001|NOT COMPLETED|Overall Study||12||
48385985|NCT03247413|101272924|FG000|STARTED|Overall Study||63||126
48385986|NCT03247413|101272924|FG000|Received Dexamethasone (4 mg/ml) Intervention|Overall Study||63||126
48385987|NCT03247413|101272924|FG000|Received Placebo (1 mg Saline) Intervention|Overall Study||63||126
48385988|NCT03247413|101272924|FG000|COMPLETED|Overall Study||35||70
48385989|NCT03247413|101272924|FG000|NOT COMPLETED|Overall Study||28||56
48385990|NCT01681576|101272925|FG000|STARTED|Period 1||36||
48385991|NCT01681576|101272926|FG001|STARTED|Period 1||36||
48385992|NCT01681576|101272925|FG000|COMPLETED|Period 1||34||
48385993|NCT01681576|101272926|FG001|COMPLETED|Period 1||36||
48385994|NCT01681576|101272925|FG000|NOT COMPLETED|Period 1||2||
48385995|NCT01681576|101272926|FG001|NOT COMPLETED|Period 1||0||
48385996|NCT01681576|101272925|FG000|STARTED|Period 2||34||
48385997|NCT01681576|101272926|FG001|STARTED|Period 2||36||
48385998|NCT01681576|101272925|FG000|COMPLETED|Period 2||30||
48385999|NCT01681576|101272926|FG001|COMPLETED|Period 2||35||
48386000|NCT01681576|101272925|FG000|NOT COMPLETED|Period 2||4||
48386001|NCT01681576|101272926|FG001|NOT COMPLETED|Period 2||1||
48386002|NCT01106625|101272927|FG000|STARTED|Core Period: Baseline to Week 26||156||
48386003|NCT01106625|101272928|FG001|STARTED|Core Period: Baseline to Week 26||157||
48386004|NCT01106625|101272929|FG002|STARTED|Core Period: Baseline to Week 26||156||
48386005|NCT01106625|101272927|FG000|COMPLETED|Core Period: Baseline to Week 26||123||
48386006|NCT01106625|101272928|FG001|COMPLETED|Core Period: Baseline to Week 26||129||
48386007|NCT01106625|101272929|FG002|COMPLETED|Core Period: Baseline to Week 26||129||
48386008|NCT01106625|101272927|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||33||
48386009|NCT01106625|101272928|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||28||
48386010|NCT01106625|101272929|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||27||
48386011|NCT01106625|101272927|FG000|STARTED|Extension Period: Week 26 to Week 52||119||
48386012|NCT01106625|101272928|FG001|STARTED|Extension Period: Week 26 to Week 52||127||
48386013|NCT01106625|101272929|FG002|STARTED|Extension Period: Week 26 to Week 52||128||
48386014|NCT01106625|101272927|FG000|COMPLETED|Extension Period: Week 26 to Week 52||90||
48386015|NCT01106625|101272928|FG001|COMPLETED|Extension Period: Week 26 to Week 52||109||
48386016|NCT01106625|101272929|FG002|COMPLETED|Extension Period: Week 26 to Week 52||111||
48386017|NCT01106625|101272927|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||29||
48386018|NCT01106625|101272928|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||18||
48386019|NCT01106625|101272929|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||17||
48386020|NCT02947022|101272930|FG000|STARTED|Overall Study||1||
48688647|NCT01696773|102020265|FG000|NOT COMPLETED|Day 28, Second Intervention||0||
48386021|NCT02947022|101272930|FG000|COMPLETED|Overall Study||0||
48688648|NCT01696773|102020266|FG001|NOT COMPLETED|Day 28, Second Intervention||0||
48688649|NCT02103062|102020267|FG000|STARTED|Overall Study||18||
48688650|NCT02103062|102020268|FG001|STARTED|Overall Study||23||
48688651|NCT02103062|102020267|FG000|Safety Population|Overall Study||18||
48093032|NCT00531050|100549148|FG001|COMPLETED|Part 2: Period 1||4||
48386022|NCT02947022|101272930|FG000|NOT COMPLETED|Overall Study||1||
48386023|NCT01397448|101272931|FG000|STARTED|Overall Study||156||
48386024|NCT01397448|101272932|FG001|STARTED|Overall Study||157||
48386025|NCT01397448|101272933|FG002|STARTED|Overall Study||158||
48386026|NCT01397448|101272931|FG000|COMPLETED|Overall Study||138||
48386027|NCT01397448|101272932|FG001|COMPLETED|Overall Study||142||
48386028|NCT01397448|101272933|FG002|COMPLETED|Overall Study||140||
48386029|NCT01397448|101272931|FG000|NOT COMPLETED|Overall Study||18||
48386030|NCT01397448|101272932|FG001|NOT COMPLETED|Overall Study||15||
48386031|NCT01397448|101272933|FG002|NOT COMPLETED|Overall Study||18||
48386032|NCT02275767|101272934|FG000|STARTED|Overall Study||22||
48386033|NCT02275767|101272935|FG001|STARTED|Overall Study||22||
48386034|NCT02275767|101272936|FG002|STARTED|Overall Study||22||
48386035|NCT02275767|101272934|FG000|COMPLETED|Overall Study||20||
48386036|NCT02275767|101272935|FG001|COMPLETED|Overall Study||18||
48386037|NCT02275767|101272936|FG002|COMPLETED|Overall Study||19||
48386038|NCT02275767|101272934|FG000|NOT COMPLETED|Overall Study||2||
48386039|NCT02275767|101272935|FG001|NOT COMPLETED|Overall Study||4||
48386040|NCT02275767|101272936|FG002|NOT COMPLETED|Overall Study||3||
48386041|NCT00441103|101272937|FG000|STARTED|Overall Study||120||
48386042|NCT00441103|101272938|FG001|STARTED|Overall Study||60||
48386043|NCT00441103|101272937|FG000|COMPLETED|Overall Study||109||
48386044|NCT00441103|101272938|FG001|COMPLETED|Overall Study||56||
48386045|NCT00441103|101272937|FG000|NOT COMPLETED|Overall Study||11||
48386046|NCT00441103|101272938|FG001|NOT COMPLETED|Overall Study||4||
48386047|NCT04096326|101272939|FG000|STARTED|Overall Study||8||
48386048|NCT04096326|101272940|FG001|STARTED|Overall Study||32||
48386049|NCT04096326|101272941|FG002|STARTED|Overall Study||12||
48386050|NCT04096326|101272942|FG003|STARTED|Overall Study||28||
48386051|NCT04096326|101272943|FG004|STARTED|Overall Study||11||
48386052|NCT04096326|101272944|FG005|STARTED|Overall Study||27||
48386053|NCT04096326|101272945|FG006|STARTED|Overall Study||10||
48386054|NCT04096326|101272946|FG007|STARTED|Overall Study||30||
48386055|NCT04096326|101272947|FG008|STARTED|Overall Study||9||
48386056|NCT04096326|101272948|FG009|STARTED|Overall Study||31||
48386057|NCT04096326|101272939|FG000|COMPLETED|Overall Study||8||
48386058|NCT04096326|101272940|FG001|COMPLETED|Overall Study||31||
48386059|NCT04096326|101272941|FG002|COMPLETED|Overall Study||12||
48386060|NCT04096326|101272942|FG003|COMPLETED|Overall Study||28||
48386061|NCT04096326|101272943|FG004|COMPLETED|Overall Study||10||
48386062|NCT04096326|101272944|FG005|COMPLETED|Overall Study||22||
48386063|NCT04096326|101272945|FG006|COMPLETED|Overall Study||9||
48386064|NCT04096326|101272946|FG007|COMPLETED|Overall Study||30||
48386065|NCT04096326|101272947|FG008|COMPLETED|Overall Study||9||
48386066|NCT04096326|101272948|FG009|COMPLETED|Overall Study||31||
48386067|NCT04096326|101272939|FG000|NOT COMPLETED|Overall Study||0||
48386068|NCT04096326|101272940|FG001|NOT COMPLETED|Overall Study||1||
48386069|NCT04096326|101272941|FG002|NOT COMPLETED|Overall Study||0||
48257706|NCT01588366|100951831|FG003|COMPLETED|Overall Study||6||
48257707|NCT01588366|100951832|FG004|COMPLETED|Overall Study||3||
48257708|NCT01588366|100951833|FG005|COMPLETED|Overall Study||7||
48257709|NCT01588366|100951828|FG000|NOT COMPLETED|Overall Study||0||
48257710|NCT01588366|100951829|FG001|NOT COMPLETED|Overall Study||1||
48257711|NCT01588366|100951830|FG002|NOT COMPLETED|Overall Study||0||
48386070|NCT04096326|101272942|FG003|NOT COMPLETED|Overall Study||0||
48386071|NCT04096326|101272943|FG004|NOT COMPLETED|Overall Study||1||
48386072|NCT04096326|101272944|FG005|NOT COMPLETED|Overall Study||5||
48386073|NCT04096326|101272945|FG006|NOT COMPLETED|Overall Study||1||
48386074|NCT04096326|101272946|FG007|NOT COMPLETED|Overall Study||0||
48093033|NCT00531050|100549149|FG002|COMPLETED|Part 2: Period 1||4||
48093034|NCT00531050|100549150|FG003|COMPLETED|Part 2: Period 1||4||
48093035|NCT00531050|100549151|FG004|COMPLETED|Part 2: Period 1||4||
48093036|NCT00531050|100549152|FG005|COMPLETED|Part 2: Period 1||4||
48093037|NCT00531050|100549147|FG000|NOT COMPLETED|Part 2: Period 1||0||
48093038|NCT00531050|100549148|FG001|NOT COMPLETED|Part 2: Period 1||0||
48093039|NCT00531050|100549149|FG002|NOT COMPLETED|Part 2: Period 1||0||
48093040|NCT00531050|100549150|FG003|NOT COMPLETED|Part 2: Period 1||0||
48093041|NCT00531050|100549151|FG004|NOT COMPLETED|Part 2: Period 1||0||
48093042|NCT00531050|100549152|FG005|NOT COMPLETED|Part 2: Period 1||1||
48093043|NCT00531050|100549147|FG000|STARTED|Part 2: Period 2||3||
48093044|NCT00531050|100549148|FG001|STARTED|Part 2: Period 2||4||
48093045|NCT00531050|100549149|FG002|STARTED|Part 2: Period 2||4||
48093046|NCT00531050|100549150|FG003|STARTED|Part 2: Period 2||4||
48093047|NCT00531050|100549151|FG004|STARTED|Part 2: Period 2||4||
48386075|NCT04096326|101272947|FG008|NOT COMPLETED|Overall Study||0||
48688652|NCT02103062|102020268|FG001|Safety Population|Overall Study||23||
48688653|NCT02103062|102020267|FG000|Intent to Treat Population|Overall Study||17||
48386076|NCT04096326|101272948|FG009|NOT COMPLETED|Overall Study||0||
48386077|NCT03615911|101272949|FG000|STARTED|Overall Study||14||
48386078|NCT03615911|101272950|FG001|STARTED|Overall Study||12||
48386079|NCT03615911|101272949|FG000|Received Late Booster Immunization|Overall Study||3||
48386080|NCT03615911|101272950|FG001|Received Late Booster Immunization|Overall Study||7||
48688654|NCT02103062|102020268|FG001|Intent to Treat Population|Overall Study||20||
48688655|NCT02103062|102020267|FG000|COMPLETED|Overall Study||0||
48688656|NCT02103062|102020268|FG001|COMPLETED|Overall Study||0||
48093048|NCT00531050|100549152|FG005|STARTED|Part 2: Period 2||4||
48093049|NCT00531050|100549147|FG000|COMPLETED|Part 2: Period 2||3||
48093050|NCT00531050|100549148|FG001|COMPLETED|Part 2: Period 2||4||
48093051|NCT00531050|100549149|FG002|COMPLETED|Part 2: Period 2||4||
48093052|NCT00531050|100549150|FG003|COMPLETED|Part 2: Period 2||4||
48093053|NCT00531050|100549151|FG004|COMPLETED|Part 2: Period 2||4||
48093054|NCT00531050|100549152|FG005|COMPLETED|Part 2: Period 2||4||
48093055|NCT00531050|100549147|FG000|NOT COMPLETED|Part 2: Period 2||0||
48093056|NCT00531050|100549148|FG001|NOT COMPLETED|Part 2: Period 2||0||
48093057|NCT00531050|100549149|FG002|NOT COMPLETED|Part 2: Period 2||0||
48093058|NCT00531050|100549150|FG003|NOT COMPLETED|Part 2: Period 2||0||
48093059|NCT00531050|100549151|FG004|NOT COMPLETED|Part 2: Period 2||0||
48093060|NCT00531050|100549152|FG005|NOT COMPLETED|Part 2: Period 2||0||
48093061|NCT00531050|100549147|FG000|STARTED|Part 2: Period 3||3||
48257712|NCT01588366|100951831|FG003|NOT COMPLETED|Overall Study||1||
48257713|NCT01588366|100951832|FG004|NOT COMPLETED|Overall Study||0||
48257714|NCT01588366|100951833|FG005|NOT COMPLETED|Overall Study||2||
48257715|NCT02924350|100951834|FG000|STARTED|Overall Study||102||
48257716|NCT02924350|100951835|FG001|STARTED|Overall Study||102||
48257717|NCT02924350|100951834|FG000|COMPLETED|Overall Study||102||
48257718|NCT02924350|100951835|FG001|COMPLETED|Overall Study||100||
48386081|NCT03615911|101272949|FG000|COMPLETED|Overall Study||12||
48386082|NCT03615911|101272950|FG001|COMPLETED|Overall Study||11||
48386083|NCT03615911|101272949|FG000|NOT COMPLETED|Overall Study||2||
48386084|NCT03615911|101272950|FG001|NOT COMPLETED|Overall Study||1||
48093062|NCT00531050|100549148|FG001|STARTED|Part 2: Period 3||4||
48257719|NCT02924350|100951834|FG000|NOT COMPLETED|Overall Study||0||
48257720|NCT02924350|100951835|FG001|NOT COMPLETED|Overall Study||2||
48257721|NCT02647788|100951836|FG000|STARTED|Overall Study||70||
48257722|NCT02647788|100951837|FG001|STARTED|Overall Study||70||
48257723|NCT02647788|100951836|FG000|COMPLETED|Overall Study||54||
48386085|NCT01906866|101272951|FG000|STARTED|Overall Study||60||
48386086|NCT01906866|101272952|FG001|STARTED|Overall Study||65||
48093063|NCT00531050|100549149|FG002|STARTED|Part 2: Period 3||4||
48093064|NCT00531050|100549150|FG003|STARTED|Part 2: Period 3||4||
48093065|NCT00531050|100549151|FG004|STARTED|Part 2: Period 3||4||
48093066|NCT00531050|100549152|FG005|STARTED|Part 2: Period 3||4||
48386087|NCT01906866|101272951|FG000|COMPLETED|Overall Study||51||
48386088|NCT01906866|101272952|FG001|COMPLETED|Overall Study||44||
48386089|NCT01906866|101272951|FG000|NOT COMPLETED|Overall Study||9||
48386090|NCT01906866|101272952|FG001|NOT COMPLETED|Overall Study||21||
48386091|NCT03341923|101272953|FG000|STARTED|Period 1, First 14 Days of Wear||67||
48386092|NCT03341923|101272954|FG001|STARTED|Period 1, First 14 Days of Wear||67||
48386093|NCT03341923|101272953|FG000|COMPLETED|Period 1, First 14 Days of Wear||67||
48386094|NCT03341923|101272954|FG001|COMPLETED|Period 1, First 14 Days of Wear||67||
48386095|NCT03341923|101272953|FG000|NOT COMPLETED|Period 1, First 14 Days of Wear||0||
48386096|NCT03341923|101272954|FG001|NOT COMPLETED|Period 1, First 14 Days of Wear||0||
48688657|NCT02103062|102020267|FG000|NOT COMPLETED|Overall Study||18||
48688658|NCT02103062|102020268|FG001|NOT COMPLETED|Overall Study||23||
48688659|NCT02727816|102020269|FG000|STARTED|Overall Study||35||
48688660|NCT02727816|102020269|FG000|COMPLETED|Overall Study||35||
48688661|NCT02727816|102020269|FG000|NOT COMPLETED|Overall Study||0||
48386097|NCT03341923|101272953|FG000|STARTED|Period 2, Second 14 Days of Wear||67||
48386098|NCT03341923|101272954|FG001|STARTED|Period 2, Second 14 Days of Wear||66||
48386099|NCT03341923|101272953|FG000|COMPLETED|Period 2, Second 14 Days of Wear||67||
48386100|NCT03341923|101272954|FG001|COMPLETED|Period 2, Second 14 Days of Wear||65||
48386101|NCT03341923|101272953|FG000|NOT COMPLETED|Period 2, Second 14 Days of Wear||0||
48386102|NCT03341923|101272954|FG001|NOT COMPLETED|Period 2, Second 14 Days of Wear||1||
48386103|NCT00506948|101272955|FG000|STARTED|Overall Study||10||
48386104|NCT00506948|101272955|FG000|COMPLETED|Overall Study||0||
48386105|NCT00506948|101272955|FG000|NOT COMPLETED|Overall Study||10||
48386106|NCT01120379|101272956|FG000|STARTED|One Year Timepoint||5020||
48386107|NCT01120379|101272956|FG000|COMPLETED|One Year Timepoint||4742||
48386108|NCT01120379|101272956|FG000|NOT COMPLETED|One Year Timepoint||278||
48386109|NCT01120379|101272956|FG000|STARTED|Two Year Timepoint||4742||
48386110|NCT01120379|101272956|FG000|COMPLETED|Two Year Timepoint||4505||
48688662|NCT00292045|102020270|FG000|STARTED|Core Study (Through Week 13)||15||
48688663|NCT00292045|102020270|FG000|COMPLETED|Core Study (Through Week 13)||13|Completion of Cycle 1 (4 vaccinations given once every 3 weeks, for a total cycle length of 12 weeks) plus 3 weeks of follow-up|
48688664|NCT00292045|102020270|FG000|NOT COMPLETED|Core Study (Through Week 13)||2||
48688665|NCT00292045|102020270|FG000|STARTED|Extended Treatment Beyond Week 13||10||
48710703|NCT00846040|102077994|FG001|NOT COMPLETED|Washout: 2 Weeks to 10 Weeks||2||
48386111|NCT01120379|101272956|FG000|NOT COMPLETED|Two Year Timepoint||237||
48386112|NCT01120379|101272956|FG000|STARTED|Three Year Timepoint||4505||
48386113|NCT01120379|101272956|FG000|COMPLETED|Three Year Timepoint||4291||
48386114|NCT01120379|101272956|FG000|NOT COMPLETED|Three Year Timepoint||214||
48710704|NCT00846040|102077995|FG002|NOT COMPLETED|Washout: 2 Weeks to 10 Weeks||0||
48386115|NCT01120379|101272956|FG000|STARTED|Four Year Timepoint||4291||
48386116|NCT01120379|101272956|FG000|COMPLETED|Four Year Timepoint||3923||
48093067|NCT00531050|100549147|FG000|COMPLETED|Part 2: Period 3||2||
48093068|NCT00531050|100549148|FG001|COMPLETED|Part 2: Period 3||4||
48093069|NCT00531050|100549149|FG002|COMPLETED|Part 2: Period 3||4||
48688666|NCT00292045|102020270|FG000|COMPLETED|Extended Treatment Beyond Week 13||10|Completion of extended treatment was not defined; patients received between 1 and 4 vaccinations during extended treatment (in addition to the 4 vaccinations in the Core Study)|
48688667|NCT00292045|102020270|FG000|NOT COMPLETED|Extended Treatment Beyond Week 13||0||
48688668|NCT00400517|102020271|FG000|STARTED|Overall Study||28||
48688669|NCT00400517|102020271|FG000|COMPLETED|Overall Study||26||
48688670|NCT00400517|102020271|FG000|NOT COMPLETED|Overall Study||2||
48688671|NCT00703963|102020272|FG000|STARTED|Overall Study||100||
48688672|NCT00703963|102020273|FG001|STARTED|Overall Study||100||
48688673|NCT00703963|102020272|FG000|COMPLETED|Overall Study||93||
48093070|NCT00531050|100549150|FG003|COMPLETED|Part 2: Period 3||4||
48093071|NCT00531050|100549151|FG004|COMPLETED|Part 2: Period 3||4||
48093072|NCT00531050|100549152|FG005|COMPLETED|Part 2: Period 3||3||
48093073|NCT00531050|100549147|FG000|NOT COMPLETED|Part 2: Period 3||1||
48093074|NCT00531050|100549148|FG001|NOT COMPLETED|Part 2: Period 3||0||
48093075|NCT00531050|100549149|FG002|NOT COMPLETED|Part 2: Period 3||0||
48093076|NCT00531050|100549150|FG003|NOT COMPLETED|Part 2: Period 3||0||
48093077|NCT00531050|100549151|FG004|NOT COMPLETED|Part 2: Period 3||0||
48093078|NCT00531050|100549152|FG005|NOT COMPLETED|Part 2: Period 3||1||
48093079|NCT03454581|100549153|FG000|STARTED|Overall Study||18||
48093080|NCT03454581|100549154|FG001|STARTED|Overall Study||16||
48093081|NCT03454581|100549155|FG002|STARTED|Overall Study||17||
48093082|NCT03454581|100549153|FG000|COMPLETED|Overall Study||14||
48093083|NCT03454581|100549154|FG001|COMPLETED|Overall Study||13||
48093084|NCT03454581|100549155|FG002|COMPLETED|Overall Study||14||
48093085|NCT03454581|100549153|FG000|NOT COMPLETED|Overall Study||4||
48093086|NCT03454581|100549154|FG001|NOT COMPLETED|Overall Study||3||
48093087|NCT03454581|100549155|FG002|NOT COMPLETED|Overall Study||3||
48093088|NCT00330616|100549156|FG000|STARTED|Overall Study||35||
48093089|NCT00330616|100549156|FG000|COMPLETED|Overall Study||14||
48093090|NCT00330616|100549156|FG000|NOT COMPLETED|Overall Study||21||
48093091|NCT00224055|100551951|FG000|STARTED|Overall Study||44||
48093092|NCT00224055|100551952|FG001|STARTED|Overall Study||45||
48093093|NCT00224055|100551951|FG000|COMPLETED|Overall Study||29||
48257724|NCT02647788|100951837|FG001|COMPLETED|Overall Study||57||
48257725|NCT02647788|100951836|FG000|NOT COMPLETED|Overall Study||16||
48257726|NCT02647788|100951837|FG001|NOT COMPLETED|Overall Study||13||
48257727|NCT01653210|100951838|FG000|STARTED|Overall Study||15||
48257728|NCT01653210|100951838|FG000|COMPLETED|Overall Study||12||
48257729|NCT01653210|100951838|FG000|NOT COMPLETED|Overall Study||3||
48257730|NCT02367105|100951839|FG000|STARTED|Overall Study||41||
48257731|NCT02367105|100951840|FG001|STARTED|Overall Study||42||
48257732|NCT02367105|100951839|FG000|COMPLETED|Overall Study||36||
48257733|NCT02367105|100951840|FG001|COMPLETED|Overall Study||34||
48386117|NCT01120379|101272956|FG000|NOT COMPLETED|Four Year Timepoint||368||
48386118|NCT02092441|101272957|FG000|STARTED|Overall Study||37||
48386119|NCT02092441|101272958|FG001|STARTED|Overall Study||43||
48386120|NCT02092441|101272957|FG000|COMPLETED|Overall Study||37||
48386121|NCT02092441|101272958|FG001|COMPLETED|Overall Study||43||
48386122|NCT02092441|101272957|FG000|NOT COMPLETED|Overall Study||0||
48386123|NCT02092441|101272958|FG001|NOT COMPLETED|Overall Study||0||
48386124|NCT02530671|101272959|FG000|STARTED|Overall Study||55||
48688674|NCT00703963|102020273|FG001|COMPLETED|Overall Study||86||
48093094|NCT00224055|100551952|FG001|COMPLETED|Overall Study||31||
48093095|NCT00224055|100551951|FG000|NOT COMPLETED|Overall Study||15||
48257734|NCT02367105|100951839|FG000|NOT COMPLETED|Overall Study||5||
48257735|NCT02367105|100951840|FG001|NOT COMPLETED|Overall Study||8||
48257736|NCT03469492|100951841|FG000|STARTED|Overall Study||8||
48257737|NCT03469492|100951841|FG000|COMPLETED|Overall Study||8||
48541697|NCT03095638|101662791|FG002|STARTED|P1: Period 2, Washout (7[-4 Hours])||0||
48592703|NCT01877382|101783160|FG010|NOT COMPLETED|Dose Expansion||0||
48093096|NCT00224055|100551952|FG001|NOT COMPLETED|Overall Study||14||
48093097|NCT01748643|100551953|FG000|STARTED|Overall Study||30||
48093098|NCT01748643|100551954|FG001|STARTED|Overall Study||30||
48093099|NCT01748643|100551953|FG000|COMPLETED|Overall Study||30||
48093100|NCT01748643|100551954|FG001|COMPLETED|Overall Study||30||
48093101|NCT01748643|100551953|FG000|NOT COMPLETED|Overall Study||0||
48093102|NCT01748643|100551954|FG001|NOT COMPLETED|Overall Study||0||
48093103|NCT01169610|100551955|FG000|STARTED|Overall Study||1||
48093104|NCT01169610|100551955|FG000|COMPLETED|Overall Study||1||
48093105|NCT01169610|100551955|FG000|NOT COMPLETED|Overall Study||0||
48093106|NCT00513474|100551956|FG000|STARTED|Overall Study||25||
48093107|NCT00513474|100551957|FG001|STARTED|Overall Study||21||
48257738|NCT03469492|100951841|FG000|NOT COMPLETED|Overall Study||0||
48257739|NCT01795859|100951842|FG000|STARTED|Overall Study||45||
48257740|NCT01795859|100951843|FG001|STARTED|Overall Study||45||
48257741|NCT01795859|100951842|FG000|COMPLETED|Overall Study||44||
48688675|NCT00703963|102020272|FG000|NOT COMPLETED|Overall Study||7||
48093108|NCT00513474|100551956|FG000|Received Rasburicase Per Protocol|Overall Study||24||
48093109|NCT00513474|100551957|FG001|Received Rasburicase Per Protocol|Overall Study||0||
48386125|NCT02530671|101272960|FG001|STARTED|Overall Study||55||
48386126|NCT02530671|101272959|FG000|COMPLETED|Overall Study||52||
48386127|NCT02530671|101272960|FG001|COMPLETED|Overall Study||55||
48386128|NCT02530671|101272959|FG000|NOT COMPLETED|Overall Study||3||
48386129|NCT02530671|101272960|FG001|NOT COMPLETED|Overall Study||0||
48386130|NCT00423735|101272961|FG000|STARTED|Overall Study||29||
48386131|NCT00423735|101272962|FG001|STARTED|Overall Study||35||
48386132|NCT00423735|101272963|FG002|STARTED|Overall Study||0||
48386133|NCT00423735|101272961|FG000|COMPLETED|Overall Study||21||
48386134|NCT00423735|101272962|FG001|COMPLETED|Overall Study||29||
48386135|NCT00423735|101272963|FG002|COMPLETED|Overall Study||0||
48386136|NCT00423735|101272961|FG000|NOT COMPLETED|Overall Study||8||
48386137|NCT00423735|101272962|FG001|NOT COMPLETED|Overall Study||6||
48386138|NCT00423735|101272963|FG002|NOT COMPLETED|Overall Study||0||
48386139|NCT04410198|101272964|FG000|STARTED|Overall Study||203||
48386140|NCT04410198|101272964|FG000|Received at Least 1 Dose of Study Drug|Overall Study||203||
48386141|NCT04410198|101272964|FG000|Full Analysis Set|Overall Study||201|All enrolled participants who provided baseline Hb data and data for at least 1 postbaseline Hb time point.|
48386142|NCT04410198|101272964|FG000|COMPLETED|Overall Study||166||
48386143|NCT04410198|101272964|FG000|NOT COMPLETED|Overall Study||37||
48386144|NCT00980343|101272965|FG000|STARTED|Overall Study||21||
48386145|NCT00980343|101272966|FG001|STARTED|Overall Study||23||
48386146|NCT00980343|101272965|FG000|COMPLETED|Overall Study||20||
48386147|NCT00980343|101272966|FG001|COMPLETED|Overall Study||20||
48386148|NCT00980343|101272965|FG000|NOT COMPLETED|Overall Study||1||
48257742|NCT01795859|100951843|FG001|COMPLETED|Overall Study||43||
48257743|NCT01795859|100951842|FG000|NOT COMPLETED|Overall Study||1||
48257744|NCT01795859|100951843|FG001|NOT COMPLETED|Overall Study||2||
48257745|NCT02892201|100951844|FG000|STARTED|Overall Study||9||
48257746|NCT02892201|100951844|FG000|COMPLETED|Overall Study||9||
48257747|NCT02892201|100951844|FG000|NOT COMPLETED|Overall Study||0||
48386149|NCT00980343|101272966|FG001|NOT COMPLETED|Overall Study||3||
48093110|NCT00513474|100551956|FG000|COMPLETED|Overall Study||18||
48093111|NCT00513474|100551957|FG001|COMPLETED|Overall Study||12||
48093112|NCT00513474|100551956|FG000|NOT COMPLETED|Overall Study||7||
48093113|NCT00513474|100551957|FG001|NOT COMPLETED|Overall Study||9||
48093114|NCT03251079|100551958|FG000|STARTED|Overall Study||36||
48093115|NCT03251079|100551958|FG000|COMPLETED|Overall Study||35||
48093116|NCT03251079|100551958|FG000|NOT COMPLETED|Overall Study||1||
48093117|NCT00503009|100551959|FG000|STARTED|Overall Study||5||
48093118|NCT00503009|100551960|FG001|STARTED|Overall Study||5||
48093119|NCT00503009|100551961|FG002|STARTED|Overall Study||6||
48093120|NCT00503009|100551959|FG000|COMPLETED|Overall Study||4||
48093121|NCT00503009|100551960|FG001|COMPLETED|Overall Study||3||
48093122|NCT00503009|100551961|FG002|COMPLETED|Overall Study||3||
48093123|NCT00503009|100551959|FG000|NOT COMPLETED|Overall Study||1||
48093124|NCT00503009|100551960|FG001|NOT COMPLETED|Overall Study||2||
48093125|NCT00503009|100551961|FG002|NOT COMPLETED|Overall Study||3||
48093126|NCT04350788|100551962|FG000|STARTED|Overall Study||62||31
48093127|NCT04350788|100551963|FG001|STARTED|Overall Study||62||31
48093128|NCT04350788|100551962|FG000|COMPLETED|Overall Study||50||25
48093129|NCT04350788|100551963|FG001|COMPLETED|Overall Study||56||28
48093130|NCT04350788|100551962|FG000|NOT COMPLETED|Overall Study||12||6
48093131|NCT04350788|100551963|FG001|NOT COMPLETED|Overall Study||6||3
48093132|NCT04159025|100551964|FG000|STARTED|Overall Study||20||
48093133|NCT04159025|100551964|FG000|COMPLETED|Overall Study||20||
48093134|NCT04159025|100551964|FG000|NOT COMPLETED|Overall Study||0||
48093135|NCT02014844|100551965|FG000|STARTED|Overall Study||21||
48093136|NCT02014844|100551966|FG001|STARTED|Overall Study||7||
48093137|NCT02014844|100551965|FG000|COMPLETED|Overall Study||21|Completed defined as receiving at least one dose of study drug.|
48093138|NCT02014844|100551966|FG001|COMPLETED|Overall Study||7|Completed defined as receiving at least one dose of study drug.|
48093139|NCT02014844|100551965|FG000|NOT COMPLETED|Overall Study||0||
48386150|NCT02193828|101272967|FG000|STARTED|Overall Study||18||
48386151|NCT02193828|101272968|FG001|STARTED|Overall Study||18||
48093140|NCT02014844|100551966|FG001|NOT COMPLETED|Overall Study||0||
48093141|NCT01484873|100551967|FG000|STARTED|Overall Study||10||
48093142|NCT01484873|100551967|FG000|COMPLETED|Overall Study||8||
48093143|NCT01484873|100551967|FG000|NOT COMPLETED|Overall Study||2||
48093144|NCT00905554|100551968|FG000|STARTED|Overall Study||116||
48093145|NCT00905554|100551969|FG001|STARTED|Overall Study||114||
48093146|NCT00905554|100551968|FG000|COMPLETED|Overall Study||116||
48093147|NCT00905554|100551969|FG001|COMPLETED|Overall Study||114||
48093148|NCT00905554|100551968|FG000|NOT COMPLETED|Overall Study||0||
48386152|NCT02193828|101272969|FG002|STARTED|Overall Study||23||
48386153|NCT02193828|101272970|FG003|STARTED|Overall Study||17||
48386154|NCT02193828|101272967|FG000|COMPLETED|Overall Study||18||
48386155|NCT02193828|101272968|FG001|COMPLETED|Overall Study||18||
48386156|NCT02193828|101272969|FG002|COMPLETED|Overall Study||22||
48386157|NCT02193828|101272970|FG003|COMPLETED|Overall Study||16||
48386158|NCT02193828|101272967|FG000|NOT COMPLETED|Overall Study||0||
48093149|NCT00905554|100551969|FG001|NOT COMPLETED|Overall Study||0||
48257748|NCT02804399|100951845|FG000|STARTED|Period 1||12||
48257749|NCT02804399|100951846|FG001|STARTED|Period 1||0||
48257750|NCT02804399|100951845|FG000|COMPLETED|Period 1||12||
48257751|NCT02804399|100951846|FG001|COMPLETED|Period 1||0||
48093150|NCT03226392|100551970|FG000|STARTED|Overall Study||352||
48093151|NCT03226392|100551971|FG001|STARTED|Overall Study||352||
48093152|NCT03226392|100551970|FG000|FAS|Overall Study||352||
48093153|NCT03226392|100551971|FG001|FAS|Overall Study||350||
48093154|NCT03226392|100551970|FG000|COMPLETED|Overall Study||341||
48093155|NCT03226392|100551971|FG001|COMPLETED|Overall Study||344||
48093156|NCT03226392|100551970|FG000|NOT COMPLETED|Overall Study||11||
48093157|NCT03226392|100551971|FG001|NOT COMPLETED|Overall Study||8||
48093158|NCT03061331|100551972|FG000|STARTED|Treatment Period 1 (8 Weeks)||10||
48093159|NCT03061331|100551973|FG001|STARTED|Treatment Period 1 (8 Weeks)||10||
48093160|NCT03061331|100551972|FG000|COMPLETED|Treatment Period 1 (8 Weeks)||10||
48093161|NCT03061331|100551973|FG001|COMPLETED|Treatment Period 1 (8 Weeks)||10||
48093162|NCT03061331|100551972|FG000|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0||
48093163|NCT03061331|100551973|FG001|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0||
48257752|NCT02804399|100951845|FG000|NOT COMPLETED|Period 1||0||
48257753|NCT02804399|100951846|FG001|NOT COMPLETED|Period 1||0||
48257754|NCT02804399|100951845|FG000|STARTED|Washout Period at Least 10 Days||12||
48257755|NCT02804399|100951846|FG001|STARTED|Washout Period at Least 10 Days||0||
48257756|NCT02804399|100951845|FG000|COMPLETED|Washout Period at Least 10 Days||12||
48257757|NCT02804399|100951846|FG001|COMPLETED|Washout Period at Least 10 Days||0||
48257758|NCT02804399|100951845|FG000|NOT COMPLETED|Washout Period at Least 10 Days||0||
48257759|NCT02804399|100951846|FG001|NOT COMPLETED|Washout Period at Least 10 Days||0||
48386159|NCT02193828|101272968|FG001|NOT COMPLETED|Overall Study||0||
48386160|NCT02193828|101272969|FG002|NOT COMPLETED|Overall Study||1||
48386161|NCT02193828|101272970|FG003|NOT COMPLETED|Overall Study||1||
48386162|NCT03655717|101272971|FG000|STARTED|Overall Study||70||
48688676|NCT00703963|102020273|FG001|NOT COMPLETED|Overall Study||14||
48688677|NCT03350451|102020274|FG000|STARTED|Overall Study||13||
48688678|NCT03350451|102020275|FG001|STARTED|Overall Study||7||
48688679|NCT03350451|102020274|FG000|Safety Analysis Set|Overall Study||13|Safety analysis set included all participants who received any amount of study drug.|
48688680|NCT03350451|102020275|FG001|Safety Analysis Set|Overall Study||7|Safety analysis set included all participants who received any amount of study drug.|
48688681|NCT03350451|102020274|FG000|Pharmacodynamic Analysis Set|Overall Study||13|Pharmacodynamic (PD) analysis set included all participants who received any amount of study drug and who had at least 1 post-dose urine sample for PD.|
48688682|NCT03350451|102020275|FG001|Pharmacodynamic Analysis Set|Overall Study||7|Pharmacodynamic (PD) analysis set included all participants who received any amount of study drug and who had at least 1 post-dose urine sample for PD.|
48688683|NCT03350451|102020274|FG000|COMPLETED|Overall Study||13||
48688684|NCT03350451|102020275|FG001|COMPLETED|Overall Study||7||
48688685|NCT03350451|102020274|FG000|NOT COMPLETED|Overall Study||0||
48688686|NCT03350451|102020275|FG001|NOT COMPLETED|Overall Study||0||
48688687|NCT04721158|102020276|FG000|STARTED|Overall Study||41||
48688688|NCT04721158|102020276|FG000|COMPLETED|Overall Study||36||
48688689|NCT04721158|102020276|FG000|NOT COMPLETED|Overall Study||5||
48688690|NCT00326001|102020277|FG000|STARTED|Overall Study||236||
48688691|NCT00326001|102020278|FG001|STARTED|Overall Study||227||
48688692|NCT00326001|102020277|FG000|COMPLETED|Overall Study||229||
48688693|NCT00326001|102020278|FG001|COMPLETED|Overall Study||219||
48688694|NCT00326001|102020277|FG000|NOT COMPLETED|Overall Study||7||
48688695|NCT00326001|102020278|FG001|NOT COMPLETED|Overall Study||8||
48688696|NCT03009162|102020279|FG000|STARTED|Overall Study||8||
48688697|NCT03009162|102020280|FG001|STARTED|Overall Study||8||
48688698|NCT03009162|102020279|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8||
48688699|NCT03009162|102020280|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8||
48093164|NCT03061331|100551972|FG000|STARTED|Washout Period (8 Weeks)||10||
48093165|NCT03061331|100551973|FG001|STARTED|Washout Period (8 Weeks)||10||
48093166|NCT03061331|100551972|FG000|COMPLETED|Washout Period (8 Weeks)||8||
48093167|NCT03061331|100551973|FG001|COMPLETED|Washout Period (8 Weeks)||9||
48093168|NCT03061331|100551972|FG000|NOT COMPLETED|Washout Period (8 Weeks)||2||
48093169|NCT03061331|100551973|FG001|NOT COMPLETED|Washout Period (8 Weeks)||1||
48093170|NCT03061331|100551972|FG000|STARTED|Treatment Period 2 (8 Weeks)||8||
48093171|NCT03061331|100551973|FG001|STARTED|Treatment Period 2 (8 Weeks)||9||
48257760|NCT02804399|100951845|FG000|STARTED|Period 2||0||
48257761|NCT02804399|100951846|FG001|STARTED|Period 2||12||
48257762|NCT02804399|100951845|FG000|COMPLETED|Period 2||0||
48386163|NCT03655717|101272972|FG001|STARTED|Overall Study||68||
48386164|NCT03655717|101272973|FG002|STARTED|Overall Study||2||
48093172|NCT03061331|100551972|FG000|COMPLETED|Treatment Period 2 (8 Weeks)||8||
48093173|NCT03061331|100551973|FG001|COMPLETED|Treatment Period 2 (8 Weeks)||9||
48093174|NCT03061331|100551972|FG000|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0||
48093175|NCT03061331|100551973|FG001|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0||
48093176|NCT00232817|100551974|FG000|STARTED|Overall Study||12||
48093177|NCT00232817|100551975|FG001|STARTED|Overall Study||11||
48093178|NCT00232817|100551974|FG000|COMPLETED|Overall Study||10||
48093179|NCT00232817|100551975|FG001|COMPLETED|Overall Study||10||
48386165|NCT03655717|101272974|FG003|STARTED|Overall Study||1||
48386166|NCT03655717|101272975|FG004|STARTED|Overall Study||0||
48386167|NCT03655717|101272976|FG005|STARTED|Overall Study||3||
48386168|NCT03655717|101272977|FG006|STARTED|Overall Study||3||
48093180|NCT00232817|100551974|FG000|NOT COMPLETED|Overall Study||2||
48257763|NCT02804399|100951846|FG001|COMPLETED|Period 2||11||
48257764|NCT02804399|100951845|FG000|NOT COMPLETED|Period 2||0||
48257765|NCT02804399|100951846|FG001|NOT COMPLETED|Period 2||1||
48257766|NCT00661713|100951847|FG000|STARTED|Overall Study||128||
48257767|NCT00661713|100951848|FG001|STARTED|Overall Study||247||
48257768|NCT00661713|100951849|FG002|STARTED|Overall Study||128||
48257769|NCT00661713|100951850|FG003|STARTED|Overall Study||247||
48257770|NCT00661713|100951851|FG004|STARTED|Overall Study||127||
48257771|NCT00661713|100951852|FG005|STARTED|Overall Study||253||
48257772|NCT00661713|100951853|FG006|STARTED|Overall Study||373||
48257773|NCT00661713|100951854|FG007|STARTED|Overall Study||128||
48257774|NCT00661713|100951847|FG000|COMPLETED|Overall Study||112||
48257775|NCT00661713|100951848|FG001|COMPLETED|Overall Study||208||
48257776|NCT00661713|100951849|FG002|COMPLETED|Overall Study||111||
48257777|NCT00661713|100951850|FG003|COMPLETED|Overall Study||219||
48257778|NCT00661713|100951851|FG004|COMPLETED|Overall Study||107||
48257779|NCT00661713|100951852|FG005|COMPLETED|Overall Study||216||
48257780|NCT00661713|100951853|FG006|COMPLETED|Overall Study||309||
48257781|NCT00661713|100951854|FG007|COMPLETED|Overall Study||117||
48257782|NCT00661713|100951847|FG000|NOT COMPLETED|Overall Study||16||
48257783|NCT00661713|100951848|FG001|NOT COMPLETED|Overall Study||39||
48257784|NCT00661713|100951849|FG002|NOT COMPLETED|Overall Study||17||
48257785|NCT00661713|100951850|FG003|NOT COMPLETED|Overall Study||28||
48257786|NCT00661713|100951851|FG004|NOT COMPLETED|Overall Study||20||
48257787|NCT00661713|100951852|FG005|NOT COMPLETED|Overall Study||37||
48257788|NCT00661713|100951853|FG006|NOT COMPLETED|Overall Study||64||
48257789|NCT00661713|100951854|FG007|NOT COMPLETED|Overall Study||11||
48688700|NCT03009162|102020279|FG000|COMPLETED|Overall Study||8||
48688701|NCT03009162|102020280|FG001|COMPLETED|Overall Study||8||
48688702|NCT03009162|102020279|FG000|NOT COMPLETED|Overall Study||0||
48688703|NCT03009162|102020280|FG001|NOT COMPLETED|Overall Study||0||
48688704|NCT01527045|102020281|FG000|STARTED|Overall Study||30||
48688705|NCT01527045|102020282|FG001|STARTED|Overall Study||5||
48688706|NCT01527045|102020283|FG002|STARTED|Overall Study||12||
48688707|NCT01527045|102020281|FG000|COMPLETED|Overall Study||29||
48688708|NCT01527045|102020282|FG001|COMPLETED|Overall Study||5||
48688709|NCT01527045|102020283|FG002|COMPLETED|Overall Study||12||
48688710|NCT01527045|102020281|FG000|NOT COMPLETED|Overall Study||1||
48688711|NCT01527045|102020282|FG001|NOT COMPLETED|Overall Study||0||
48688712|NCT01527045|102020283|FG002|NOT COMPLETED|Overall Study||0||
48688713|NCT01170273|102020284|FG000|STARTED|Overall Study||64||
48688714|NCT01170273|102020285|FG001|STARTED|Overall Study||66||
48257790|NCT02085473|100951855|FG000|STARTED|Overall Study||15||
48257791|NCT02085473|100951856|FG001|STARTED|Overall Study||15||
48257792|NCT02085473|100951857|FG002|STARTED|Overall Study||15||
48257793|NCT02085473|100951858|FG003|STARTED|Overall Study||15||
48257794|NCT02085473|100951855|FG000|COMPLETED|Overall Study||15||
48257795|NCT02085473|100951856|FG001|COMPLETED|Overall Study||15||
48257796|NCT02085473|100951857|FG002|COMPLETED|Overall Study||15||
48257797|NCT02085473|100951858|FG003|COMPLETED|Overall Study||15||
48257798|NCT02085473|100951855|FG000|NOT COMPLETED|Overall Study||0||
48257799|NCT02085473|100951856|FG001|NOT COMPLETED|Overall Study||0||
48386169|NCT03655717|101272978|FG007|STARTED|Overall Study||3||
48386170|NCT03655717|101272979|FG008|STARTED|Overall Study||2||
48688715|NCT01170273|102020284|FG000|COMPLETED|Overall Study||56||
48688716|NCT01170273|102020285|FG001|COMPLETED|Overall Study||57||
48257800|NCT02085473|100951857|FG002|NOT COMPLETED|Overall Study||0||
48257801|NCT02085473|100951858|FG003|NOT COMPLETED|Overall Study||0||
48257802|NCT02840916|100951859|FG000|STARTED|Overall Study||33||
48257803|NCT02840916|100951860|FG001|STARTED|Overall Study||33||
48257804|NCT02840916|100951859|FG000|COMPLETED|Overall Study||32||
48257805|NCT02840916|100951860|FG001|COMPLETED|Overall Study||30||
48257806|NCT02840916|100951859|FG000|NOT COMPLETED|Overall Study||1||
48257807|NCT02840916|100951860|FG001|NOT COMPLETED|Overall Study||3||
48257808|NCT02973802|100951861|FG000|STARTED|Overall Study||12||
48257809|NCT02973802|100951861|FG000|COMPLETED|Overall Study||10||
48257810|NCT02973802|100951861|FG000|NOT COMPLETED|Overall Study||2||
48257811|NCT03009019|100951862|FG000|STARTED|Double-blind Period 1 (DB1)||316|Randomized|
48257812|NCT03009019|100951863|FG001|STARTED|Double-blind Period 1 (DB1)||315|Randomized|
48257813|NCT03009019|100951862|FG000|COMPLETED|Double-blind Period 1 (DB1)||280|Completed DB1|
48257814|NCT03009019|100951863|FG001|COMPLETED|Double-blind Period 1 (DB1)||264|Completed DB1|
48257815|NCT03009019|100951862|FG000|NOT COMPLETED|Double-blind Period 1 (DB1)||36||
48257816|NCT03009019|100951863|FG001|NOT COMPLETED|Double-blind Period 1 (DB1)||51||
48257817|NCT03009019|100951862|FG000|STARTED|Double-blind Period 2 (DB2)||272|Re-randomized for DB2|
48257818|NCT03009019|100951863|FG001|STARTED|Double-blind Period 2 (DB2)||273|Re-randomized for DB2|
48257819|NCT03009019|100951862|FG000|COMPLETED|Double-blind Period 2 (DB2)||251|Completed DB2|
48257820|NCT03009019|100951863|FG001|COMPLETED|Double-blind Period 2 (DB2)||253|Completed DB2|
48257821|NCT03009019|100951862|FG000|NOT COMPLETED|Double-blind Period 2 (DB2)||21||
48386171|NCT03655717|101272980|FG009|STARTED|Overall Study||1||
48386172|NCT03655717|101272981|FG010|STARTED|Overall Study||1||
48386173|NCT03655717|101272982|FG011|STARTED|Overall Study||3||
48386174|NCT03655717|101272983|FG012|STARTED|Overall Study||2||
48386175|NCT03655717|101272984|FG013|STARTED|Overall Study||3||
48386176|NCT03655717|101272985|FG014|STARTED|Overall Study||2||
48386177|NCT03655717|101272986|FG015|STARTED|Overall Study||2||
48093181|NCT00232817|100551975|FG001|NOT COMPLETED|Overall Study||1||
48093182|NCT02118012|100551976|FG000|STARTED|Overall Study||12||
48093183|NCT02118012|100551977|FG001|STARTED|Overall Study||12||
48093184|NCT02118012|100551976|FG000|Day 5|Overall Study||12||
48093185|NCT02118012|100551977|FG001|Day 5|Overall Study||11||
48093186|NCT02118012|100551976|FG000|Day 14|Overall Study||12||
48093187|NCT02118012|100551977|FG001|Day 14|Overall Study||10||
48093188|NCT02118012|100551976|FG000|COMPLETED|Overall Study||12||
48093189|NCT02118012|100551977|FG001|COMPLETED|Overall Study||10||
48093190|NCT02118012|100551976|FG000|NOT COMPLETED|Overall Study||0||
48093191|NCT02118012|100551977|FG001|NOT COMPLETED|Overall Study||2||
48093192|NCT02289690|100551978|FG000|STARTED|Overall Study||4||
48093193|NCT02289690|100551979|FG001|STARTED|Overall Study||3||
48093194|NCT02289690|100551980|FG002|STARTED|Overall Study||4||
48093195|NCT02289690|100551981|FG003|STARTED|Overall Study||3||
48093196|NCT02289690|100551982|FG004|STARTED|Overall Study||8||
48093197|NCT02289690|100551983|FG005|STARTED|Overall Study||14||
48093198|NCT02289690|100551984|FG006|STARTED|Overall Study||4||
48386178|NCT03655717|101272987|FG016|STARTED|Overall Study||2||
48386179|NCT03655717|101272988|FG017|STARTED|Overall Study||2||
48386180|NCT03655717|101272989|FG018|STARTED|Overall Study||3||
48386181|NCT03655717|101272990|FG019|STARTED|Overall Study||3||
48093199|NCT02289690|100551985|FG007|STARTED|Overall Study||61||
48093200|NCT02289690|100551986|FG008|STARTED|Overall Study||59||
48093201|NCT02289690|100551987|FG009|STARTED|Overall Study||61||
48093202|NCT02289690|100551978|FG000|Received Study Drug|Overall Study||4||
48093203|NCT02289690|100551979|FG001|Received Study Drug|Overall Study||3||
48093204|NCT02289690|100551980|FG002|Received Study Drug|Overall Study||4||
48093205|NCT02289690|100551981|FG003|Received Study Drug|Overall Study||3||
48257822|NCT03009019|100951863|FG001|NOT COMPLETED|Double-blind Period 2 (DB2)||20||
48257823|NCT04014790|100951864|FG000|STARTED|Overall Study||49||
48257824|NCT04014790|100951864|FG000|COMPLETED|Overall Study||43||
48257825|NCT04014790|100951864|FG000|NOT COMPLETED|Overall Study||6||
48688717|NCT01170273|102020284|FG000|NOT COMPLETED|Overall Study||8||
48688718|NCT01170273|102020285|FG001|NOT COMPLETED|Overall Study||9||
48688719|NCT03183063|102020286|FG000|STARTED|Overall Study||20||
48688720|NCT03183063|102020287|FG001|STARTED|Overall Study||4||
48688721|NCT03183063|102020288|FG002|STARTED|Overall Study||115||
48688722|NCT03183063|102020286|FG000|COMPLETED|Overall Study||15||
48688723|NCT03183063|102020287|FG001|COMPLETED|Overall Study||0||
48688724|NCT03183063|102020288|FG002|COMPLETED|Overall Study||111||
48688725|NCT03183063|102020286|FG000|NOT COMPLETED|Overall Study||5||
48093206|NCT02289690|100551982|FG004|Received Study Drug|Overall Study||8||
48093207|NCT02289690|100551983|FG005|Received Study Drug|Overall Study||14||
48093208|NCT02289690|100551984|FG006|Received Study Drug|Overall Study||4||
48093209|NCT02289690|100551985|FG007|Received Study Drug|Overall Study||60||
48093210|NCT02289690|100551986|FG008|Received Study Drug|Overall Study||58||
48093211|NCT02289690|100551987|FG009|Received Study Drug|Overall Study||60||
48093212|NCT02289690|100551978|FG000|COMPLETED|Overall Study||0|Completed indicates participants remaining on study.|
48093213|NCT02289690|100551979|FG001|COMPLETED|Overall Study||0|Completed indicates participants remaining on study.|
48093214|NCT02289690|100551980|FG002|COMPLETED|Overall Study||0|Completed indicates participants remaining on study.|
48093215|NCT02289690|100551981|FG003|COMPLETED|Overall Study||0|Completed indicates participants remaining on study.|
48093216|NCT02289690|100551982|FG004|COMPLETED|Overall Study||0|Completed indicates participants remaining on study.|
48093217|NCT02289690|100551983|FG005|COMPLETED|Overall Study||0|Completed indicates participants remaining on study.|
48093218|NCT02289690|100551984|FG006|COMPLETED|Overall Study||0|Completed indicates participants remaining on study.|
48093219|NCT02289690|100551985|FG007|COMPLETED|Overall Study||0|Completed indicates participants remaining on study.|
48093220|NCT02289690|100551986|FG008|COMPLETED|Overall Study||0|Completed indicates participants remaining on study.|
48093221|NCT02289690|100551987|FG009|COMPLETED|Overall Study||0|Completed indicates participants remaining on study.|
48093222|NCT02289690|100551978|FG000|NOT COMPLETED|Overall Study||4||
48093223|NCT02289690|100551979|FG001|NOT COMPLETED|Overall Study||3||
48093224|NCT02289690|100551980|FG002|NOT COMPLETED|Overall Study||4||
48093225|NCT02289690|100551981|FG003|NOT COMPLETED|Overall Study||3||
48093226|NCT02289690|100551982|FG004|NOT COMPLETED|Overall Study||8||
48093227|NCT02289690|100551983|FG005|NOT COMPLETED|Overall Study||14||
48093228|NCT02289690|100551984|FG006|NOT COMPLETED|Overall Study||4||
48093229|NCT02289690|100551985|FG007|NOT COMPLETED|Overall Study||61||
48093230|NCT02289690|100551986|FG008|NOT COMPLETED|Overall Study||59||
48093231|NCT02289690|100551987|FG009|NOT COMPLETED|Overall Study||61||
48093232|NCT04468204|100551988|FG000|STARTED|Overall Study||39||
48093233|NCT04468204|100551989|FG001|STARTED|Overall Study||13||
48093234|NCT04468204|100551988|FG000|COMPLETED|Overall Study||39||
48093235|NCT04468204|100551989|FG001|COMPLETED|Overall Study||13||
48093236|NCT04468204|100551988|FG000|NOT COMPLETED|Overall Study||0||
48093237|NCT04468204|100551989|FG001|NOT COMPLETED|Overall Study||0||
48093238|NCT03051607|100551990|FG000|STARTED|Overall Study||66||
48093239|NCT03051607|100551990|FG000|COMPLETED|Overall Study||0||
48093240|NCT03051607|100551990|FG000|NOT COMPLETED|Overall Study||66||
48093241|NCT00634166|100551991|FG000|STARTED|Overall Study||82||
48093242|NCT00634166|100551992|FG001|STARTED|Overall Study||138||
48093243|NCT00634166|100551991|FG000|COMPLETED|Overall Study||22||
48093244|NCT00634166|100551992|FG001|COMPLETED|Overall Study||78||
48093245|NCT00634166|100551991|FG000|NOT COMPLETED|Overall Study||60||
48093246|NCT00634166|100551992|FG001|NOT COMPLETED|Overall Study||60||
48093247|NCT03314753|100551993|FG000|STARTED|Overall Study||53||
48093248|NCT03314753|100551994|FG001|STARTED|Overall Study||36||
48093249|NCT03314753|100551993|FG000|COMPLETED|Overall Study||53||
48257826|NCT04947436|100951865|FG000|STARTED|Overall Study||7||
48257827|NCT04947436|100951866|FG001|STARTED|Overall Study||10||
48257828|NCT04947436|100951867|FG002|STARTED|Overall Study||11||
48257829|NCT04947436|100951865|FG000|COMPLETED|Overall Study||3||
48257830|NCT04947436|100951866|FG001|COMPLETED|Overall Study||2||
48257831|NCT04947436|100951867|FG002|COMPLETED|Overall Study||5||
48257832|NCT04947436|100951865|FG000|NOT COMPLETED|Overall Study||4||
48257833|NCT04947436|100951866|FG001|NOT COMPLETED|Overall Study||8||
48257834|NCT04947436|100951867|FG002|NOT COMPLETED|Overall Study||6||
48257835|NCT03248141|100951868|FG000|STARTED|Overall Study||11||
48688726|NCT03183063|102020287|FG001|NOT COMPLETED|Overall Study||4||
48688727|NCT03183063|102020288|FG002|NOT COMPLETED|Overall Study||4||
48093250|NCT03314753|100551994|FG001|COMPLETED|Overall Study||36||
48093251|NCT03314753|100551993|FG000|NOT COMPLETED|Overall Study||0||
48093252|NCT03314753|100551994|FG001|NOT COMPLETED|Overall Study||0||
48093253|NCT00799487|100551995|FG000|STARTED|Dose Adjustment Period||21||
48093254|NCT00799487|100551996|FG001|STARTED|Dose Adjustment Period||34||
48257836|NCT03248141|100951869|FG001|STARTED|Overall Study||0||
48688728|NCT02923531|102020289|FG000|STARTED|Overall Study||9||
48257837|NCT03248141|100951868|FG000|COMPLETED|Overall Study||11||
48257838|NCT03248141|100951869|FG001|COMPLETED|Overall Study||0||
48688729|NCT02923531|102020289|FG000|Received at Least 1 Dose of Study Medication|Overall Study||9||
48093255|NCT00799487|100551997|FG002|STARTED|Dose Adjustment Period||34||
48093256|NCT00799487|100551995|FG000|COMPLETED|Dose Adjustment Period||0||
48093257|NCT00799487|100551996|FG001|COMPLETED|Dose Adjustment Period||34||
48093258|NCT00799487|100551997|FG002|COMPLETED|Dose Adjustment Period||34||
48093259|NCT00799487|100551995|FG000|NOT COMPLETED|Dose Adjustment Period||21||
48093260|NCT00799487|100551996|FG001|NOT COMPLETED|Dose Adjustment Period||0||
48093261|NCT00799487|100551997|FG002|NOT COMPLETED|Dose Adjustment Period||0||
48093262|NCT00799487|100551995|FG000|STARTED|Double-Blind Assessment Period||0||
48093263|NCT00799487|100551996|FG001|STARTED|Double-Blind Assessment Period||34||
48093264|NCT00799487|100551997|FG002|STARTED|Double-Blind Assessment Period||34||
48093265|NCT00799487|100551995|FG000|COMPLETED|Double-Blind Assessment Period||0||
48093266|NCT00799487|100551996|FG001|COMPLETED|Double-Blind Assessment Period||33||
48093267|NCT00799487|100551997|FG002|COMPLETED|Double-Blind Assessment Period||32||
48257839|NCT03248141|100951868|FG000|NOT COMPLETED|Overall Study||0||
48257840|NCT03248141|100951869|FG001|NOT COMPLETED|Overall Study||0||
48257841|NCT03752242|100951870|FG000|STARTED|Overall Study||2||
48257842|NCT03752242|100951870|FG000|COMPLETED|Overall Study||2||
48257843|NCT03752242|100951870|FG000|NOT COMPLETED|Overall Study||0||
48257844|NCT02344173|100951871|FG000|STARTED|Enrollment||2035||
48257845|NCT02344173|100951871|FG000|COMPLETED|Enrollment||2035||
48257846|NCT02344173|100951871|FG000|NOT COMPLETED|Enrollment||0||
48257847|NCT02344173|100951871|FG000|STARTED|Procedure||2035||
48093268|NCT00799487|100551995|FG000|NOT COMPLETED|Double-Blind Assessment Period||0||
48093269|NCT00799487|100551996|FG001|NOT COMPLETED|Double-Blind Assessment Period||1||
48093270|NCT00799487|100551997|FG002|NOT COMPLETED|Double-Blind Assessment Period||2||
48093271|NCT03641651|100551998|FG000|STARTED|Overall Study||15||
48093272|NCT03641651|100551998|FG000|COMPLETED|Overall Study||14||
48093273|NCT03641651|100551998|FG000|NOT COMPLETED|Overall Study||1||
48093274|NCT03472469|100551999|FG000|STARTED|Overall Study||787||
48093275|NCT03472469|100552000|FG001|STARTED|Overall Study||774||
48093276|NCT03472469|100551999|FG000|COMPLETED|Overall Study||787||
48093277|NCT03472469|100552000|FG001|COMPLETED|Overall Study||774||
48093278|NCT03472469|100551999|FG000|NOT COMPLETED|Overall Study||0||
48093279|NCT03472469|100552000|FG001|NOT COMPLETED|Overall Study||0||
48093280|NCT02233309|100552001|FG000|STARTED|Overall Study||36||
48093281|NCT02233309|100552001|FG000|COMPLETED|Overall Study||31||
48093282|NCT02233309|100552001|FG000|NOT COMPLETED|Overall Study||5||
48093283|NCT01980875|100552002|FG000|STARTED|Overall Study||8||
48093284|NCT01980875|100552003|FG001|STARTED|Overall Study||25||
48093285|NCT01980875|100552004|FG002|STARTED|Overall Study||24||
48093286|NCT01980875|100552002|FG000|COMPLETED|Overall Study||0||
48093287|NCT01980875|100552003|FG001|COMPLETED|Overall Study||0||
48093288|NCT01980875|100552004|FG002|COMPLETED|Overall Study||0||
48093289|NCT01980875|100552002|FG000|NOT COMPLETED|Overall Study||8||
48093290|NCT01980875|100552003|FG001|NOT COMPLETED|Overall Study||25||
48093291|NCT01980875|100552004|FG002|NOT COMPLETED|Overall Study||24||
48093292|NCT03316131|100552005|FG000|STARTED|Treatment Period 1||18||
48093293|NCT03316131|100552006|FG001|STARTED|Treatment Period 1||18||
48093294|NCT03316131|100552005|FG000|COMPLETED|Treatment Period 1||18||
48093295|NCT03316131|100552006|FG001|COMPLETED|Treatment Period 1||18||
48093296|NCT03316131|100552005|FG000|NOT COMPLETED|Treatment Period 1||0||
48093297|NCT03316131|100552006|FG001|NOT COMPLETED|Treatment Period 1||0||
48093298|NCT03316131|100552005|FG000|STARTED|Treatment Period 2||18||
48093299|NCT03316131|100552006|FG001|STARTED|Treatment Period 2||18||
48093300|NCT03316131|100552005|FG000|COMPLETED|Treatment Period 2||17||
48093301|NCT03316131|100552006|FG001|COMPLETED|Treatment Period 2||18||
48093302|NCT03316131|100552005|FG000|NOT COMPLETED|Treatment Period 2||1||
48093303|NCT03316131|100552006|FG001|NOT COMPLETED|Treatment Period 2||0||
48093304|NCT01922089|100552007|FG000|STARTED|Overall Study||247||
48093305|NCT01922089|100552008|FG001|STARTED|Overall Study||251||
48093306|NCT01922089|100552007|FG000|Safety Set|Overall Study||246||
48093307|NCT01922089|100552008|FG001|Safety Set|Overall Study||251||
48093308|NCT01922089|100552007|FG000|COMPLETED|Overall Study||208||
48093309|NCT01922089|100552008|FG001|COMPLETED|Overall Study||221||
48093310|NCT01922089|100552007|FG000|NOT COMPLETED|Overall Study||39||
48093311|NCT01922089|100552008|FG001|NOT COMPLETED|Overall Study||30||
48093312|NCT00271609|100552009|FG000|STARTED|Overall Study||56||
48093313|NCT00271609|100552010|FG001|STARTED|Overall Study||32||
48093314|NCT00271609|100552009|FG000|COMPLETED|Overall Study||43||
48257848|NCT02344173|100951871|FG000|COMPLETED|Procedure||2028|Ablation procedure performed.|
48257849|NCT02344173|100951871|FG000|NOT COMPLETED|Procedure||7||
48093315|NCT00271609|100552010|FG001|COMPLETED|Overall Study||29||
48257850|NCT02344173|100951871|FG000|STARTED|12-month Visit||2028||
48093316|NCT00271609|100552009|FG000|NOT COMPLETED|Overall Study||13||
48093317|NCT00271609|100552010|FG001|NOT COMPLETED|Overall Study||3||
48093318|NCT00967798|100552011|FG000|STARTED|Overall Study||17||
48093319|NCT00967798|100552012|FG001|STARTED|Overall Study||16||
48093320|NCT00967798|100552011|FG000|COMPLETED|Overall Study||8||
48093321|NCT00967798|100552012|FG001|COMPLETED|Overall Study||13||
48093322|NCT00967798|100552011|FG000|NOT COMPLETED|Overall Study||9||
48093323|NCT00967798|100552012|FG001|NOT COMPLETED|Overall Study||3||
48257851|NCT02344173|100951871|FG000|COMPLETED|12-month Visit||1932||
48257852|NCT02344173|100951871|FG000|NOT COMPLETED|12-month Visit||96||
48093324|NCT00877058|100552013|FG000|STARTED|Overall Study||174||
48093325|NCT00877058|100552014|FG001|STARTED|Overall Study||171||
48093326|NCT00877058|100552015|FG002|STARTED|Overall Study||114||
48093327|NCT00877058|100552013|FG000|COMPLETED|Overall Study||137||
48093328|NCT00877058|100552014|FG001|COMPLETED|Overall Study||131||
48093329|NCT00877058|100552015|FG002|COMPLETED|Overall Study||75||
48257853|NCT00746785|100951872|FG000|STARTED|Overall Study||43||
48257854|NCT00746785|100951873|FG001|STARTED|Overall Study||46||
48257855|NCT00746785|100951874|FG002|STARTED|Overall Study||40||
48093330|NCT00877058|100552013|FG000|NOT COMPLETED|Overall Study||37||
48093331|NCT00877058|100552014|FG001|NOT COMPLETED|Overall Study||40||
48093332|NCT00877058|100552015|FG002|NOT COMPLETED|Overall Study||39||
48093333|NCT02769247|100552016|FG000|STARTED|Overall Study||40||
48093334|NCT02769247|100552017|FG001|STARTED|Overall Study||40||
48093335|NCT02769247|100552018|FG002|STARTED|Overall Study||40||
48093336|NCT02769247|100552019|FG003|STARTED|Overall Study||40||
48093337|NCT02769247|100552016|FG000|COMPLETED|Overall Study||38||
48257856|NCT00746785|100951872|FG000|COMPLETED|Overall Study||14||
48257857|NCT00746785|100951873|FG001|COMPLETED|Overall Study||21||
48257858|NCT00746785|100951874|FG002|COMPLETED|Overall Study||13||
48688730|NCT02923531|102020289|FG000|COMPLETED|Overall Study||0||
48688731|NCT02923531|102020289|FG000|NOT COMPLETED|Overall Study||9||
48688732|NCT01928290|102020290|FG000|STARTED|Overall Study||41||
48688733|NCT01928290|102020291|FG001|STARTED|Overall Study||26||
48688734|NCT01928290|102020290|FG000|COMPLETED|Overall Study||41||
48688735|NCT01928290|102020291|FG001|COMPLETED|Overall Study||26||
48688736|NCT01928290|102020290|FG000|NOT COMPLETED|Overall Study||0||
48688737|NCT01928290|102020291|FG001|NOT COMPLETED|Overall Study||0||
48688738|NCT00466947|102020292|FG000|STARTED|Primary Outcome Analysis Period||11875||
48688739|NCT00466947|102020293|FG001|STARTED|Primary Outcome Analysis Period||11863||
48688740|NCT00466947|102020292|FG000|Ongoing|Primary Outcome Analysis Period||11875||
48688741|NCT00466947|102020293|FG001|Ongoing|Primary Outcome Analysis Period||11863||
48688742|NCT00466947|102020292|FG000|COMPLETED|Primary Outcome Analysis Period||0||
48688743|NCT00466947|102020293|FG001|COMPLETED|Primary Outcome Analysis Period||0||
48688744|NCT00466947|102020292|FG000|NOT COMPLETED|Primary Outcome Analysis Period||11875||
48688745|NCT00466947|102020293|FG001|NOT COMPLETED|Primary Outcome Analysis Period||11863||
48688746|NCT00466947|102020292|FG000|STARTED|Study End Analysis Period||11798||
48688747|NCT00466947|102020293|FG001|STARTED|Study End Analysis Period||11799||
48688748|NCT00466947|102020292|FG000|COMPLETED|Study End Analysis Period||9302||
48688749|NCT00466947|102020293|FG001|COMPLETED|Study End Analysis Period||9265||
48688750|NCT00466947|102020292|FG000|NOT COMPLETED|Study End Analysis Period||2496||
48688751|NCT00466947|102020293|FG001|NOT COMPLETED|Study End Analysis Period||2534||
48688752|NCT02340169|102020294|FG000|STARTED|Overall Study||129||
48688753|NCT02340169|102020294|FG000|Cohort 1 12-17 Years of Age|Overall Study||84||
48688754|NCT02340169|102020294|FG000|Cohort 2 6 to 11 Years of Age|Overall Study||35||
48688755|NCT02340169|102020294|FG000|Cohort 3 2 to 5 Years of Age|Overall Study||10||
48093338|NCT02769247|100552017|FG001|COMPLETED|Overall Study||40||
48093339|NCT02769247|100552018|FG002|COMPLETED|Overall Study||39||
48093340|NCT02769247|100552019|FG003|COMPLETED|Overall Study||39||
48093341|NCT02769247|100552016|FG000|NOT COMPLETED|Overall Study||2||
48093342|NCT02769247|100552017|FG001|NOT COMPLETED|Overall Study||0||
48093343|NCT02769247|100552018|FG002|NOT COMPLETED|Overall Study||1||
48093344|NCT02769247|100552019|FG003|NOT COMPLETED|Overall Study||1||
48093345|NCT02658357|100552020|FG000|STARTED|Overall Study||0||
48093346|NCT02658357|100552021|FG001|STARTED|Overall Study||0||
48093347|NCT02658357|100552020|FG000|COMPLETED|Overall Study||0||
48093348|NCT02658357|100552021|FG001|COMPLETED|Overall Study||0||
48093349|NCT02658357|100552020|FG000|NOT COMPLETED|Overall Study||0||
48093350|NCT02658357|100552021|FG001|NOT COMPLETED|Overall Study||0||
48093351|NCT02902965|100552022|FG000|STARTED|Overall Study||74||
48093352|NCT02902965|100552022|FG000|COMPLETED|Overall Study||64||
48688756|NCT02340169|102020294|FG000|COMPLETED|Overall Study||106||
48688757|NCT02340169|102020294|FG000|NOT COMPLETED|Overall Study||23||
48688758|NCT00590122|102020295|FG000|STARTED|Overall Study||10||
48688759|NCT00590122|102020296|FG001|STARTED|Overall Study||10||
48688760|NCT00590122|102020295|FG000|COMPLETED|Overall Study||9||
48688761|NCT00590122|102020296|FG001|COMPLETED|Overall Study||10||
48688762|NCT00590122|102020295|FG000|NOT COMPLETED|Overall Study||1||
48688763|NCT00590122|102020296|FG001|NOT COMPLETED|Overall Study||0||
48688764|NCT02136004|102020297|FG000|STARTED|Overall Study||220||
48688765|NCT02136004|102020297|FG000|COMPLETED|Overall Study||219||
48688766|NCT02136004|102020297|FG000|NOT COMPLETED|Overall Study||1||
48688767|NCT00430989|102020298|FG000|STARTED|Overall Study||3543||
48688768|NCT00430989|102020299|FG001|STARTED|Overall Study||3569||
48688769|NCT00430989|102020298|FG000|COMPLETED|Overall Study||3483||
48688770|NCT00430989|102020299|FG001|COMPLETED|Overall Study||3509||
48688771|NCT00430989|102020298|FG000|NOT COMPLETED|Overall Study||60||
48688772|NCT00430989|102020299|FG001|NOT COMPLETED|Overall Study||60||
48093353|NCT02902965|100552022|FG000|NOT COMPLETED|Overall Study||10||
48093354|NCT01364207|100552023|FG000|STARTED|First Visit (~1.5-2 Hours)||54||
48093355|NCT01364207|100552024|FG001|STARTED|First Visit (~1.5-2 Hours)||58||
48093356|NCT01364207|100552023|FG000|COMPLETED|First Visit (~1.5-2 Hours)||54||
48093357|NCT01364207|100552024|FG001|COMPLETED|First Visit (~1.5-2 Hours)||58||
48257859|NCT00746785|100951872|FG000|NOT COMPLETED|Overall Study||29||
48257860|NCT00746785|100951873|FG001|NOT COMPLETED|Overall Study||25||
48257861|NCT00746785|100951874|FG002|NOT COMPLETED|Overall Study||27||
48257862|NCT00436956|100951875|FG000|STARTED|Overall Study||36||
48257863|NCT00436956|100951876|FG001|STARTED|Overall Study||23||
48257864|NCT00436956|100951875|FG000|COMPLETED|Overall Study||35||
48257865|NCT00436956|100951876|FG001|COMPLETED|Overall Study||23||
48257866|NCT00436956|100951875|FG000|NOT COMPLETED|Overall Study||1||
48257867|NCT00436956|100951876|FG001|NOT COMPLETED|Overall Study||0||
48257868|NCT01852032|100951877|FG000|STARTED|Overall Study||23||
48257869|NCT01852032|100951877|FG000|COMPLETED|Overall Study||23||
48257870|NCT01852032|100951877|FG000|NOT COMPLETED|Overall Study||0||
48257871|NCT02884492|100951878|FG000|STARTED|Overall Study||7||
48257872|NCT02884492|100951879|FG001|STARTED|Overall Study||10||
48257873|NCT02884492|100951878|FG000|COMPLETED|Overall Study||7||
48257874|NCT02884492|100951879|FG001|COMPLETED|Overall Study||10||
48257875|NCT02884492|100951878|FG000|NOT COMPLETED|Overall Study||0||
48257876|NCT02884492|100951879|FG001|NOT COMPLETED|Overall Study||0||
48257877|NCT02210208|100951880|FG000|STARTED|Period A (Graft Site)||25||
48257878|NCT02210208|100951880|FG000|COMPLETED|Period A (Graft Site)||23||
48257879|NCT02210208|100951880|FG000|NOT COMPLETED|Period A (Graft Site)||2||
48257880|NCT02210208|100951880|FG000|STARTED|Period B (Donor Site)||19||
48257881|NCT02210208|100951880|FG000|COMPLETED|Period B (Donor Site)||12||
48257882|NCT02210208|100951880|FG000|NOT COMPLETED|Period B (Donor Site)||7||
48257883|NCT01157351|100951881|FG000|STARTED|Overall Study||230||
48257884|NCT01157351|100951882|FG001|STARTED|Overall Study||220||
48257885|NCT01157351|100951881|FG000|Treated|Overall Study||226||
48257886|NCT01157351|100951882|FG001|Treated|Overall Study||218||
48257887|NCT01157351|100951881|FG000|COMPLETED|Overall Study||93||
48257888|NCT01157351|100951882|FG001|COMPLETED|Overall Study||88||
48257889|NCT01157351|100951881|FG000|NOT COMPLETED|Overall Study||137||
48257890|NCT01157351|100951882|FG001|NOT COMPLETED|Overall Study||132||
48257891|NCT01699698|100951883|FG000|STARTED|Overall Study||44||
48257892|NCT01699698|100951884|FG001|STARTED|Overall Study||61||
48257893|NCT01699698|100951883|FG000|COMPLETED|Overall Study||42||
48257894|NCT01699698|100951884|FG001|COMPLETED|Overall Study||56||
48257895|NCT01699698|100951883|FG000|NOT COMPLETED|Overall Study||2||
48257896|NCT01699698|100951884|FG001|NOT COMPLETED|Overall Study||5||
48257897|NCT04026399|100951885|FG000|STARTED|Overall Study||6||
48257898|NCT04026399|100951886|FG001|STARTED|Overall Study||6||
48257899|NCT04026399|100951885|FG000|COMPLETED|Overall Study||1||
48257900|NCT04026399|100951886|FG001|COMPLETED|Overall Study||3||
48257901|NCT04026399|100951885|FG000|NOT COMPLETED|Overall Study||5||
48257902|NCT04026399|100951886|FG001|NOT COMPLETED|Overall Study||3||
48257903|NCT03677245|100951887|FG000|STARTED|Overall Study||8||
48257904|NCT03677245|100951887|FG000|COMPLETED|Overall Study||8||
48257905|NCT03677245|100951887|FG000|NOT COMPLETED|Overall Study||0||
48257906|NCT00875277|100951888|FG000|STARTED|Overall Study||24||
48257907|NCT00875277|100951888|FG000|COMPLETED|Overall Study||24||
48257908|NCT00875277|100951888|FG000|NOT COMPLETED|Overall Study||0||
48257909|NCT01777126|100951889|FG000|STARTED|Overall Study||48||
48257910|NCT01777126|100951890|FG001|STARTED|Overall Study||46||
48257911|NCT01777126|100951889|FG000|COMPLETED|Overall Study||48||
48257912|NCT01777126|100951890|FG001|COMPLETED|Overall Study||46||
48257913|NCT01777126|100951889|FG000|NOT COMPLETED|Overall Study||0||
48257914|NCT01777126|100951890|FG001|NOT COMPLETED|Overall Study||0||
48257915|NCT03927690|100951891|FG000|STARTED|Overall Study||28||
48257916|NCT03927690|100951892|FG001|STARTED|Overall Study||30||
48257917|NCT03927690|100951893|FG002|STARTED|Overall Study||33||
48257918|NCT03927690|100951891|FG000|COMPLETED|Overall Study||21||
48257919|NCT03927690|100951892|FG001|COMPLETED|Overall Study||27||
48257920|NCT03927690|100951893|FG002|COMPLETED|Overall Study||31||
48257921|NCT03927690|100951891|FG000|NOT COMPLETED|Overall Study||7||
48257922|NCT03927690|100951892|FG001|NOT COMPLETED|Overall Study||3||
48257923|NCT03927690|100951893|FG002|NOT COMPLETED|Overall Study||2||
48257924|NCT00835510|100951894|FG000|STARTED|Overall Study||219||
48257925|NCT00835510|100951895|FG001|STARTED|Overall Study||221||
48257926|NCT00835510|100951896|FG002|STARTED|Overall Study||108||
48257927|NCT00835510|100951894|FG000|Positive Fungal Culture|Overall Study||149||
48257928|NCT00835510|100951895|FG001|Positive Fungal Culture|Overall Study||155||
48257929|NCT00835510|100951896|FG002|Positive Fungal Culture|Overall Study||71||
48257930|NCT00835510|100951894|FG000|COMPLETED|Overall Study||143||
48257931|NCT00835510|100951895|FG001|COMPLETED|Overall Study||152||
48257932|NCT00835510|100951896|FG002|COMPLETED|Overall Study||70||
48257933|NCT00835510|100951894|FG000|NOT COMPLETED|Overall Study||76||
48257934|NCT00835510|100951895|FG001|NOT COMPLETED|Overall Study||69||
48257935|NCT00835510|100951896|FG002|NOT COMPLETED|Overall Study||38||
48257936|NCT03296566|100951897|FG000|STARTED|Overall Study||145||
48257937|NCT03296566|100951898|FG001|STARTED|Overall Study||152||
48257938|NCT03296566|100951897|FG000|COMPLETED|Overall Study||126||
48257939|NCT03296566|100951898|FG001|COMPLETED|Overall Study||103||
48257940|NCT03296566|100951897|FG000|NOT COMPLETED|Overall Study||19||
48257941|NCT03296566|100951898|FG001|NOT COMPLETED|Overall Study||49||
48257942|NCT04582669|100951899|FG000|STARTED|Overall Study||3||
48257943|NCT04582669|100951900|FG001|STARTED|Overall Study||3||
48386182|NCT03655717|101272991|FG020|STARTED|Overall Study||2||
48386183|NCT03655717|101272992|FG021|STARTED|Overall Study||3||
48386184|NCT03655717|101272993|FG022|STARTED|Overall Study||2||
48386185|NCT03655717|101272994|FG023|STARTED|Overall Study||4||
48386186|NCT03655717|101272995|FG024|STARTED|Overall Study||1||
48386187|NCT03655717|101272996|FG025|STARTED|Overall Study||2||
48386188|NCT03655717|101272971|FG000|COMPLETED|Overall Study||60||
48386189|NCT03655717|101272972|FG001|COMPLETED|Overall Study||56||
48386190|NCT03655717|101272973|FG002|COMPLETED|Overall Study||1||
48386191|NCT03655717|101272974|FG003|COMPLETED|Overall Study||0||
48386192|NCT03655717|101272975|FG004|COMPLETED|Overall Study||0||
48386193|NCT03655717|101272976|FG005|COMPLETED|Overall Study||1||
48386194|NCT03655717|101272977|FG006|COMPLETED|Overall Study||0||
48386195|NCT03655717|101272978|FG007|COMPLETED|Overall Study||2||
48386196|NCT03655717|101272979|FG008|COMPLETED|Overall Study||0||
48386197|NCT03655717|101272980|FG009|COMPLETED|Overall Study||0||
48386198|NCT03655717|101272981|FG010|COMPLETED|Overall Study||1||
48386199|NCT03655717|101272982|FG011|COMPLETED|Overall Study||1||
48386200|NCT03655717|101272983|FG012|COMPLETED|Overall Study||2||
48386201|NCT03655717|101272984|FG013|COMPLETED|Overall Study||0||
48386202|NCT03655717|101272985|FG014|COMPLETED|Overall Study||2||
48386203|NCT03655717|101272986|FG015|COMPLETED|Overall Study||1||
48386204|NCT03655717|101272987|FG016|COMPLETED|Overall Study||2||
48386205|NCT03655717|101272988|FG017|COMPLETED|Overall Study||2||
48386206|NCT03655717|101272989|FG018|COMPLETED|Overall Study||2||
48386207|NCT03655717|101272990|FG019|COMPLETED|Overall Study||2||
48386208|NCT03655717|101272991|FG020|COMPLETED|Overall Study||2||
48257944|NCT04582669|100951901|FG002|STARTED|Overall Study||2||
48257945|NCT04582669|100951902|FG003|STARTED|Overall Study||3||
48386209|NCT03655717|101272992|FG021|COMPLETED|Overall Study||2||
48386210|NCT03655717|101272993|FG022|COMPLETED|Overall Study||0||
48386211|NCT03655717|101272994|FG023|COMPLETED|Overall Study||2||
48386212|NCT03655717|101272995|FG024|COMPLETED|Overall Study||0||
48386213|NCT03655717|101272996|FG025|COMPLETED|Overall Study||2||
48386214|NCT03655717|101272971|FG000|NOT COMPLETED|Overall Study||10||
48386215|NCT03655717|101272972|FG001|NOT COMPLETED|Overall Study||12||
48386216|NCT03655717|101272973|FG002|NOT COMPLETED|Overall Study||1||
48386217|NCT03655717|101272974|FG003|NOT COMPLETED|Overall Study||1||
48386218|NCT03655717|101272975|FG004|NOT COMPLETED|Overall Study||0||
48386219|NCT03655717|101272976|FG005|NOT COMPLETED|Overall Study||2||
48386220|NCT03655717|101272977|FG006|NOT COMPLETED|Overall Study||3||
48386221|NCT03655717|101272978|FG007|NOT COMPLETED|Overall Study||1||
48386222|NCT03655717|101272979|FG008|NOT COMPLETED|Overall Study||2||
48386223|NCT03655717|101272980|FG009|NOT COMPLETED|Overall Study||1||
48386224|NCT03655717|101272981|FG010|NOT COMPLETED|Overall Study||0||
48386225|NCT03655717|101272982|FG011|NOT COMPLETED|Overall Study||2||
48386226|NCT03655717|101272983|FG012|NOT COMPLETED|Overall Study||0||
48386227|NCT03655717|101272984|FG013|NOT COMPLETED|Overall Study||3||
48386228|NCT03655717|101272985|FG014|NOT COMPLETED|Overall Study||0||
48386229|NCT03655717|101272986|FG015|NOT COMPLETED|Overall Study||1||
48386230|NCT03655717|101272987|FG016|NOT COMPLETED|Overall Study||0||
48386231|NCT03655717|101272988|FG017|NOT COMPLETED|Overall Study||0||
48386232|NCT03655717|101272989|FG018|NOT COMPLETED|Overall Study||1||
48386233|NCT03655717|101272990|FG019|NOT COMPLETED|Overall Study||1||
48386234|NCT03655717|101272991|FG020|NOT COMPLETED|Overall Study||0||
48386235|NCT03655717|101272992|FG021|NOT COMPLETED|Overall Study||1||
48257946|NCT04582669|100951899|FG000|COMPLETED|Overall Study||2||
48386236|NCT03655717|101272993|FG022|NOT COMPLETED|Overall Study||2||
48386237|NCT03655717|101272994|FG023|NOT COMPLETED|Overall Study||2||
48386238|NCT03655717|101272995|FG024|NOT COMPLETED|Overall Study||1||
48386239|NCT03655717|101272996|FG025|NOT COMPLETED|Overall Study||0||
48257947|NCT04582669|100951900|FG001|COMPLETED|Overall Study||2||
48257948|NCT04582669|100951901|FG002|COMPLETED|Overall Study||0||
48257949|NCT04582669|100951902|FG003|COMPLETED|Overall Study||1||
48257950|NCT04582669|100951899|FG000|NOT COMPLETED|Overall Study||1||
48541698|NCT03095638|101662792|FG003|STARTED|P1: Period 2, Washout (7[-4 Hours])||0||
48257951|NCT04582669|100951900|FG001|NOT COMPLETED|Overall Study||1||
48386240|NCT01844830|101272997|FG000|STARTED|Overall Study||60||
48386241|NCT01844830|101272998|FG001|STARTED|Overall Study||30||
48386242|NCT01844830|101272997|FG000|100 µL Dose|Overall Study||16||
48386243|NCT01844830|101272998|FG001|100 µL Dose|Overall Study||8||
48386244|NCT01844830|101272997|FG000|200 µL Dose|Overall Study||24||
48386245|NCT01844830|101272998|FG001|200 µL Dose|Overall Study||12||
48386246|NCT01844830|101272997|FG000|400 µL Dose|Overall Study||20||
48386247|NCT01844830|101272998|FG001|400 µL Dose|Overall Study||10||
48386248|NCT01844830|101272997|FG000|COMPLETED|Overall Study||59|1 patient in the Kovacaine Mist 200 µL dose group did not finish the study.|
48386249|NCT01844830|101272998|FG001|COMPLETED|Overall Study||30|1 patient in the Kovacaine Mist 200 µL dose group did not finish the study.|
48386250|NCT01844830|101272997|FG000|NOT COMPLETED|Overall Study||1||
48386251|NCT01844830|101272998|FG001|NOT COMPLETED|Overall Study||0||
48257952|NCT04582669|100951901|FG002|NOT COMPLETED|Overall Study||2||
48257953|NCT04582669|100951902|FG003|NOT COMPLETED|Overall Study||2||
48257954|NCT01243411|100951903|FG000|STARTED|Overall Study||347||
48257955|NCT01243411|100951903|FG000|COMPLETED|Overall Study||306||
48257956|NCT01243411|100951903|FG000|NOT COMPLETED|Overall Study||41||
48257957|NCT00863798|100951904|FG000|STARTED|Overall Study||227||
48257958|NCT00863798|100951905|FG001|STARTED|Overall Study||228||
48688773|NCT00532129|102020300|FG000|STARTED|Treatment Period||100||
48688774|NCT00532129|102020300|FG000|COMPLETED|Treatment Period||51||
48688775|NCT00532129|102020300|FG000|NOT COMPLETED|Treatment Period||49||
48257959|NCT00863798|100951906|FG002|STARTED|Overall Study||227||
48257960|NCT00863798|100951904|FG000|Treated|Overall Study||223||
48257961|NCT00863798|100951905|FG001|Treated|Overall Study||226||
48257962|NCT00863798|100951906|FG002|Treated|Overall Study||224||
48257963|NCT00863798|100951904|FG000|COMPLETED|Overall Study||195||
48257964|NCT00863798|100951905|FG001|COMPLETED|Overall Study||198||
48257965|NCT00863798|100951906|FG002|COMPLETED|Overall Study||202||
48257966|NCT00863798|100951904|FG000|NOT COMPLETED|Overall Study||32||
48257967|NCT00863798|100951905|FG001|NOT COMPLETED|Overall Study||30||
48257968|NCT00863798|100951906|FG002|NOT COMPLETED|Overall Study||25||
48257969|NCT00156923|100951907|FG000|STARTED|Overall Study||56||
48386252|NCT03364335|101272999|FG000|STARTED|Overall Study||52||
48386253|NCT03364335|101273000|FG001|STARTED|Overall Study||51||
48386254|NCT03364335|101273001|FG002|STARTED|Overall Study||53||
48386255|NCT03364335|101273002|FG003|STARTED|Overall Study||50||
48386256|NCT03364335|101273003|FG004|STARTED|Overall Study||52||
48386257|NCT03364335|101272999|FG000|COMPLETED|Overall Study||42||
48257970|NCT00156923|100951908|FG001|STARTED|Overall Study||52||
48257971|NCT00156923|100951907|FG000|COMPLETED|Overall Study||22||
48257972|NCT00156923|100951908|FG001|COMPLETED|Overall Study||20||
48386258|NCT03364335|101273000|FG001|COMPLETED|Overall Study||40||
48386259|NCT03364335|101273001|FG002|COMPLETED|Overall Study||42||
48386260|NCT03364335|101273002|FG003|COMPLETED|Overall Study||37||
48386261|NCT03364335|101273003|FG004|COMPLETED|Overall Study||41||
48386262|NCT03364335|101272999|FG000|NOT COMPLETED|Overall Study||10||
48386263|NCT03364335|101273000|FG001|NOT COMPLETED|Overall Study||11||
48386264|NCT03364335|101273001|FG002|NOT COMPLETED|Overall Study||11||
48386265|NCT03364335|101273002|FG003|NOT COMPLETED|Overall Study||13||
48688776|NCT00532129|102020300|FG000|STARTED|Follow-up Period||98||
48688777|NCT00532129|102020300|FG000|COMPLETED|Follow-up Period||33||
48093358|NCT01364207|100552023|FG000|NOT COMPLETED|First Visit (~1.5-2 Hours)||0||
48257973|NCT00156923|100951907|FG000|NOT COMPLETED|Overall Study||34||
48257974|NCT00156923|100951908|FG001|NOT COMPLETED|Overall Study||32||
48257975|NCT03247738|100951909|FG000|STARTED|Overall Study||25||
48257976|NCT03247738|100951910|FG001|STARTED|Overall Study||25||
48257977|NCT03247738|100951909|FG000|COMPLETED|Overall Study||25||
48257978|NCT03247738|100951910|FG001|COMPLETED|Overall Study||25||
48257979|NCT03247738|100951909|FG000|NOT COMPLETED|Overall Study||0||
48257980|NCT03247738|100951910|FG001|NOT COMPLETED|Overall Study||0||
48257981|NCT02983877|100951911|FG000|STARTED|Overall Study||38||
48257982|NCT02983877|100951911|FG000|COMPLETED|Overall Study||38||
48257983|NCT02983877|100951911|FG000|NOT COMPLETED|Overall Study||0||
48257984|NCT01494545|100951912|FG000|STARTED|Overall Study||102||
48257985|NCT01494545|100951912|FG000|COMPLETED|Overall Study||92||
48257986|NCT01494545|100951912|FG000|NOT COMPLETED|Overall Study||10||
48257987|NCT00458393|100951913|FG000|STARTED|Overall Study||1251||
48257988|NCT00458393|100951914|FG001|STARTED|Overall Study||1248||
48257989|NCT00458393|100951913|FG000|COMPLETED|Overall Study||942||
48257990|NCT00458393|100951914|FG001|COMPLETED|Overall Study||953||
48257991|NCT00458393|100951913|FG000|NOT COMPLETED|Overall Study||309||
48257992|NCT00458393|100951914|FG001|NOT COMPLETED|Overall Study||295||
48257993|NCT01657877|100951915|FG000|STARTED|Overall Study||79||
48386266|NCT03364335|101273003|FG004|NOT COMPLETED|Overall Study||11||
48386267|NCT02157506|101273004|FG000|STARTED|Overall Study||12||
48688778|NCT00532129|102020300|FG000|NOT COMPLETED|Follow-up Period||65||
48688779|NCT01492426|102020301|FG000|STARTED|Treatment||402||
48688780|NCT01492426|102020302|FG001|STARTED|Treatment||200||
48688781|NCT01492426|102020301|FG000|COMPLETED|Treatment||319||
48688782|NCT01492426|102020302|FG001|COMPLETED|Treatment||160||
48093359|NCT01364207|100552024|FG001|NOT COMPLETED|First Visit (~1.5-2 Hours)||0||
48688783|NCT01492426|102020301|FG000|NOT COMPLETED|Treatment||83||
48688784|NCT01492426|102020302|FG001|NOT COMPLETED|Treatment||40||
48093360|NCT01364207|100552023|FG000|STARTED|Time Between Visits (2 Days to 4 Weeks)||54||
48257994|NCT01657877|100951915|FG000|Received 500ppm Fluoride as SMFP+ 0% CSP|Overall Study||70||
48257995|NCT01657877|100951915|FG000|Received 1500ppm Fluoride as SMFP+5% CSP|Overall Study||75||
48257996|NCT01657877|100951915|FG000|Received 0ppm Fluoride+ 5% CSP|Overall Study||71||
48257997|NCT01657877|100951915|FG000|Received 0ppm Fluoride+ 0% CSP|Overall Study||69||
48257998|NCT01657877|100951915|FG000|Received 1500ppm Fluoride as SMFP+0% CSP|Overall Study||71||
48257999|NCT01657877|100951915|FG000|COMPLETED|Overall Study||65||
48258000|NCT01657877|100951915|FG000|NOT COMPLETED|Overall Study||14||
48258001|NCT03119688|100951916|FG000|STARTED|Overall Study||48||
48258002|NCT03119688|100951916|FG000|COMPLETED|Overall Study||44||
48386268|NCT02157506|101273005|FG001|STARTED|Overall Study||6||
48386269|NCT02157506|101273006|FG002|STARTED|Overall Study||9||
48386270|NCT02157506|101273007|FG003|STARTED|Overall Study||12||
48386271|NCT02157506|101273008|FG004|STARTED|Overall Study||7||
48258003|NCT03119688|100951916|FG000|NOT COMPLETED|Overall Study||4||
48258004|NCT02209610|100951917|FG000|STARTED|Overall Study||16||
48258005|NCT02209610|100951918|FG001|STARTED|Overall Study||16||
48258006|NCT02209610|100951917|FG000|COMPLETED|Overall Study||16||
48258007|NCT02209610|100951918|FG001|COMPLETED|Overall Study||16||
48258008|NCT02209610|100951917|FG000|NOT COMPLETED|Overall Study||0||
48258009|NCT02209610|100951918|FG001|NOT COMPLETED|Overall Study||0||
48258010|NCT03765164|100951919|FG000|STARTED|Pre-intervention||78||
48258011|NCT03765164|100951920|FG001|STARTED|Pre-intervention||78||
48258012|NCT03765164|100951919|FG000|COMPLETED|Pre-intervention||73||
48258013|NCT03765164|100951920|FG001|COMPLETED|Pre-intervention||72||
48258014|NCT03765164|100951919|FG000|NOT COMPLETED|Pre-intervention||5||
48386272|NCT02157506|101273004|FG000|COMPLETED|Overall Study||12||
48386273|NCT02157506|101273005|FG001|COMPLETED|Overall Study||5||
48386274|NCT02157506|101273006|FG002|COMPLETED|Overall Study||8||
48386275|NCT02157506|101273007|FG003|COMPLETED|Overall Study||12||
48688785|NCT01492426|102020301|FG000|STARTED|Follow-Up||384||
48688786|NCT01492426|102020302|FG001|STARTED|Follow-Up||191||
48688787|NCT01492426|102020301|FG000|COMPLETED|Follow-Up||359||
48688788|NCT01492426|102020302|FG001|COMPLETED|Follow-Up||181||
48688789|NCT01492426|102020301|FG000|NOT COMPLETED|Follow-Up||25||
48688790|NCT01492426|102020302|FG001|NOT COMPLETED|Follow-Up||10||
48688791|NCT00745290|102020303|FG000|STARTED|Overall Study||123||
48688792|NCT00745290|102020304|FG001|STARTED|Overall Study||122||
48688793|NCT00745290|102020303|FG000|COMPLETED|Overall Study||123||
48688794|NCT00745290|102020304|FG001|COMPLETED|Overall Study||122||
48688795|NCT00745290|102020303|FG000|NOT COMPLETED|Overall Study||0||
48688796|NCT00745290|102020304|FG001|NOT COMPLETED|Overall Study||0||
48688797|NCT00778167|102020305|FG000|STARTED|Overall Study||6||
48688798|NCT00778167|102020306|FG001|STARTED|Overall Study||8||
48688799|NCT00778167|102020307|FG002|STARTED|Overall Study||4||
48688800|NCT00778167|102020305|FG000|COMPLETED|Overall Study||6||
48688801|NCT00778167|102020306|FG001|COMPLETED|Overall Study||8||
48688802|NCT00778167|102020307|FG002|COMPLETED|Overall Study||4||
48688803|NCT00778167|102020305|FG000|NOT COMPLETED|Overall Study||0||
48688804|NCT00778167|102020306|FG001|NOT COMPLETED|Overall Study||0||
48688805|NCT00778167|102020307|FG002|NOT COMPLETED|Overall Study||0||
48688806|NCT02025634|102020308|FG000|STARTED|Overall Study||65||
48688807|NCT02025634|102020309|FG001|STARTED|Overall Study||54||
48688808|NCT02025634|102020308|FG000|COMPLETED|Overall Study||65||
48258015|NCT03765164|100951920|FG001|NOT COMPLETED|Pre-intervention||6||
48258016|NCT03765164|100951919|FG000|STARTED|Post-intervention||73||
48258017|NCT03765164|100951920|FG001|STARTED|Post-intervention||72||
48258018|NCT03765164|100951919|FG000|COMPLETED|Post-intervention||0||
48258019|NCT03765164|100951920|FG001|COMPLETED|Post-intervention||0||
48258020|NCT03765164|100951919|FG000|NOT COMPLETED|Post-intervention||73||
48258021|NCT03765164|100951920|FG001|NOT COMPLETED|Post-intervention||72||
48258022|NCT02560389|100951921|FG000|STARTED|Overall Study||34||
48258023|NCT02560389|100951922|FG001|STARTED|Overall Study||28||
48258024|NCT02560389|100951923|FG002|STARTED|Overall Study||29||
48258025|NCT02560389|100951921|FG000|COMPLETED|Overall Study||33||
48258026|NCT02560389|100951922|FG001|COMPLETED|Overall Study||25||
48258027|NCT02560389|100951923|FG002|COMPLETED|Overall Study||27||
48258028|NCT02560389|100951921|FG000|NOT COMPLETED|Overall Study||1||
48258029|NCT02560389|100951922|FG001|NOT COMPLETED|Overall Study||3||
48258030|NCT02560389|100951923|FG002|NOT COMPLETED|Overall Study||2||
48258031|NCT02484547|100951924|FG000|STARTED|Placebo-Controlled Period||548||
48258032|NCT02484547|100951925|FG001|STARTED|Placebo-Controlled Period||543||
48258033|NCT02484547|100951926|FG002|STARTED|Placebo-Controlled Period||547||
48258034|NCT02484547|100951927|FG003|STARTED|Placebo-Controlled Period||0||
48258035|NCT02484547|100951928|FG004|STARTED|Placebo-Controlled Period||0||
48258036|NCT02484547|100951929|FG005|STARTED|Placebo-Controlled Period||0||
48688809|NCT02025634|102020309|FG001|COMPLETED|Overall Study||54||
48688810|NCT02025634|102020308|FG000|NOT COMPLETED|Overall Study||0||
48688811|NCT02025634|102020309|FG001|NOT COMPLETED|Overall Study||0||
48688812|NCT02375373|102020310|FG000|STARTED|Overall Study||12||
48688813|NCT02375373|102020310|FG000|COMPLETED|Overall Study||1||
48093361|NCT01364207|100552024|FG001|STARTED|Time Between Visits (2 Days to 4 Weeks)||58||
48258037|NCT02484547|100951930|FG006|STARTED|Placebo-Controlled Period||0||
48688814|NCT02375373|102020310|FG000|NOT COMPLETED|Overall Study||11||
48688815|NCT01945996|102020311|FG000|STARTED|Overall Study||22||
48688816|NCT01945996|102020312|FG001|STARTED|Overall Study||22||
48258038|NCT02484547|100951924|FG000|COMPLETED|Placebo-Controlled Period||288||
48258039|NCT02484547|100951925|FG001|COMPLETED|Placebo-Controlled Period||291||
48258040|NCT02484547|100951926|FG002|COMPLETED|Placebo-Controlled Period||295||
48386276|NCT02157506|101273008|FG004|COMPLETED|Overall Study||7||
48386277|NCT02157506|101273004|FG000|NOT COMPLETED|Overall Study||0||
48258041|NCT02484547|100951927|FG003|COMPLETED|Placebo-Controlled Period||0||
48258042|NCT02484547|100951928|FG004|COMPLETED|Placebo-Controlled Period||0||
48258043|NCT02484547|100951929|FG005|COMPLETED|Placebo-Controlled Period||0||
48386278|NCT02157506|101273005|FG001|NOT COMPLETED|Overall Study||1||
48386279|NCT02157506|101273006|FG002|NOT COMPLETED|Overall Study||1||
48386280|NCT02157506|101273007|FG003|NOT COMPLETED|Overall Study||0||
48386281|NCT02157506|101273008|FG004|NOT COMPLETED|Overall Study||0||
48688817|NCT01945996|102020311|FG000|COMPLETED|Overall Study||19||
48688818|NCT01945996|102020312|FG001|COMPLETED|Overall Study||17||
48688819|NCT01945996|102020311|FG000|NOT COMPLETED|Overall Study||3||
48688820|NCT01945996|102020312|FG001|NOT COMPLETED|Overall Study||5||
48688821|NCT01194219|102020313|FG000|STARTED|Placebo-Controlled Phase Weeks 0-16||562||
48688822|NCT01194219|102020314|FG001|STARTED|Placebo-Controlled Phase Weeks 0-16||282||
48688823|NCT01194219|102020315|FG002|STARTED|Placebo-Controlled Phase Weeks 0-16||0||
48688824|NCT01194219|102020316|FG003|STARTED|Placebo-Controlled Phase Weeks 0-16||0||
48688825|NCT01194219|102020317|FG004|STARTED|Placebo-Controlled Phase Weeks 0-16||0||
48688826|NCT01194219|102020318|FG005|STARTED|Placebo-Controlled Phase Weeks 0-16||0||
48688827|NCT01194219|102020319|FG006|STARTED|Placebo-Controlled Phase Weeks 0-16||0||
48688828|NCT01194219|102020320|FG007|STARTED|Placebo-Controlled Phase Weeks 0-16||0||
48093362|NCT01364207|100552023|FG000|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||52||
48093363|NCT01364207|100552024|FG001|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||54||
48093364|NCT01364207|100552023|FG000|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||2||
48093365|NCT01364207|100552024|FG001|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||4||
48093366|NCT01364207|100552023|FG000|STARTED|Second Visit (~1.5-2 Hours)||52||
48093367|NCT01364207|100552024|FG001|STARTED|Second Visit (~1.5-2 Hours)||54||
48093368|NCT01364207|100552023|FG000|COMPLETED|Second Visit (~1.5-2 Hours)||52||
48093369|NCT01364207|100552024|FG001|COMPLETED|Second Visit (~1.5-2 Hours)||54||
48093370|NCT01364207|100552023|FG000|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0||
48093371|NCT01364207|100552024|FG001|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0||
48093372|NCT01338493|100552025|FG000|STARTED|Enrolled||139||
48093373|NCT01338493|100552025|FG000|COMPLETED|Enrolled||134||
48093374|NCT01338493|100552025|FG000|NOT COMPLETED|Enrolled||5||
48093375|NCT01338493|100552025|FG000|STARTED|Implant||134||
48093376|NCT01338493|100552025|FG000|COMPLETED|Implant||134||
48093377|NCT01338493|100552025|FG000|NOT COMPLETED|Implant||0||
48093378|NCT01338493|100552025|FG000|STARTED|Discharge||134||
48093379|NCT01338493|100552025|FG000|COMPLETED|Discharge||132||
48093380|NCT01338493|100552025|FG000|NOT COMPLETED|Discharge||2||
48093381|NCT01338493|100552025|FG000|STARTED|6 Months Follow up||132||
48093382|NCT01338493|100552025|FG000|COMPLETED|6 Months Follow up||113||
48093383|NCT01338493|100552025|FG000|NOT COMPLETED|6 Months Follow up||19||
48093384|NCT01338493|100552025|FG000|STARTED|12 Months Follow up||113||
48093385|NCT01338493|100552025|FG000|COMPLETED|12 Months Follow up||104||
48093386|NCT01338493|100552025|FG000|NOT COMPLETED|12 Months Follow up||9||
48093387|NCT01338493|100552025|FG000|STARTED|24 Months Follow up||104||
48093388|NCT01338493|100552025|FG000|COMPLETED|24 Months Follow up||104||
48093389|NCT01338493|100552025|FG000|NOT COMPLETED|24 Months Follow up||0||
48093390|NCT03857243|100552026|FG000|STARTED|Overall Study||1||
48093391|NCT03857243|100552027|FG001|STARTED|Overall Study||1||
48093392|NCT03857243|100552026|FG000|COMPLETED|Overall Study||1||
48093393|NCT03857243|100552027|FG001|COMPLETED|Overall Study||1||
48093394|NCT03857243|100552026|FG000|NOT COMPLETED|Overall Study||0||
48688829|NCT01194219|102020321|FG008|STARTED|Placebo-Controlled Phase Weeks 0-16||0||
48093395|NCT03857243|100552027|FG001|NOT COMPLETED|Overall Study||0||
48093396|NCT04517253|100552028|FG000|STARTED|Overall Study||5||
48093397|NCT04517253|100552029|FG001|STARTED|Overall Study||2||
48093398|NCT04517253|100552030|FG002|STARTED|Overall Study||1||
48093399|NCT04517253|100552028|FG000|Received at Least One Dose of Study Drug|Overall Study||5||
48093400|NCT04517253|100552029|FG001|Received at Least One Dose of Study Drug|Overall Study||2||
48093401|NCT04517253|100552030|FG002|Received at Least One Dose of Study Drug|Overall Study||1||
48093402|NCT04517253|100552028|FG000|COMPLETED|Overall Study||4||
48093403|NCT04517253|100552029|FG001|COMPLETED|Overall Study||1||
48093404|NCT04517253|100552030|FG002|COMPLETED|Overall Study||1||
48093405|NCT04517253|100552028|FG000|NOT COMPLETED|Overall Study||1||
48093406|NCT04517253|100552029|FG001|NOT COMPLETED|Overall Study||1||
48688830|NCT01194219|102020322|FG009|STARTED|Placebo-Controlled Phase Weeks 0-16||0||
48688831|NCT01194219|102020313|FG000|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||560||
48688832|NCT01194219|102020314|FG001|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||282||
48688833|NCT01194219|102020315|FG002|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0||
48710793|NCT01215110|102078019|FG003|NOT COMPLETED|Overall Study||1||
48093407|NCT04517253|100552030|FG002|NOT COMPLETED|Overall Study||0||
48093408|NCT02066233|100552031|FG000|STARTED|EG Scan II (Day 1)||50||
48093409|NCT02066233|100552032|FG001|STARTED|EG Scan II (Day 1)||50||
48093410|NCT02066233|100552031|FG000|COMPLETED|EG Scan II (Day 1)||44||
48093411|NCT02066233|100552032|FG001|COMPLETED|EG Scan II (Day 1)||44||
48093412|NCT02066233|100552031|FG000|NOT COMPLETED|EG Scan II (Day 1)||6||
48093413|NCT02066233|100552032|FG001|NOT COMPLETED|EG Scan II (Day 1)||6||
48093414|NCT02066233|100552031|FG000|STARTED|Standard Endoscopy (Day 2)||44||
48093415|NCT02066233|100552032|FG001|STARTED|Standard Endoscopy (Day 2)||44||
48093416|NCT02066233|100552031|FG000|COMPLETED|Standard Endoscopy (Day 2)||44||
48093417|NCT02066233|100552032|FG001|COMPLETED|Standard Endoscopy (Day 2)||44||
48386282|NCT00594204|101273009|FG000|STARTED|Overall Study||394||
48386283|NCT00594204|101273010|FG001|STARTED|Overall Study||199||
48386284|NCT00594204|101273009|FG000|Received Treatment|Overall Study||390||
48258044|NCT02484547|100951930|FG006|COMPLETED|Placebo-Controlled Period||0||
48258045|NCT02484547|100951924|FG000|NOT COMPLETED|Placebo-Controlled Period||260||
48258046|NCT02484547|100951925|FG001|NOT COMPLETED|Placebo-Controlled Period||252||
48258047|NCT02484547|100951926|FG002|NOT COMPLETED|Placebo-Controlled Period||252||
48258048|NCT02484547|100951927|FG003|NOT COMPLETED|Placebo-Controlled Period||0||
48258049|NCT02484547|100951928|FG004|NOT COMPLETED|Placebo-Controlled Period||0||
48258050|NCT02484547|100951929|FG005|NOT COMPLETED|Placebo-Controlled Period||0||
48386285|NCT00594204|101273010|FG001|Received Treatment|Overall Study||198||
48386286|NCT00594204|101273009|FG000|COMPLETED|Overall Study||336||
48386287|NCT00594204|101273010|FG001|COMPLETED|Overall Study||154||
48386288|NCT00594204|101273009|FG000|NOT COMPLETED|Overall Study||58||
48688834|NCT01194219|102020316|FG003|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0||
48688835|NCT01194219|102020317|FG004|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0||
48688836|NCT01194219|102020318|FG005|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0||
48386289|NCT00594204|101273010|FG001|NOT COMPLETED|Overall Study||45||
48386290|NCT03004469|101273011|FG000|STARTED|Overall Study||189||
48386291|NCT03004469|101273012|FG001|STARTED|Overall Study||184||
48386292|NCT03004469|101273013|FG002|STARTED|Overall Study||85||
48386293|NCT03004469|101273011|FG000|COMPLETED|Overall Study||128||
48386294|NCT03004469|101273012|FG001|COMPLETED|Overall Study||135||
48386295|NCT03004469|101273013|FG002|COMPLETED|Overall Study||60||
48386296|NCT03004469|101273011|FG000|NOT COMPLETED|Overall Study||61||
48386297|NCT03004469|101273012|FG001|NOT COMPLETED|Overall Study||49||
48688837|NCT01194219|102020319|FG006|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0||
48688838|NCT01194219|102020320|FG007|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0||
48688839|NCT01194219|102020321|FG008|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0||
48688840|NCT01194219|102020322|FG009|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0||
48688841|NCT01194219|102020313|FG000|COMPLETED|Placebo-Controlled Phase Weeks 0-16||503||
48688842|NCT01194219|102020314|FG001|COMPLETED|Placebo-Controlled Phase Weeks 0-16||249||
48688843|NCT01194219|102020315|FG002|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0||
48688844|NCT01194219|102020316|FG003|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0||
48688845|NCT01194219|102020317|FG004|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0||
48688846|NCT01194219|102020318|FG005|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0||
48688847|NCT01194219|102020319|FG006|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0||
48688848|NCT01194219|102020320|FG007|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0||
48386298|NCT03004469|101273013|FG002|NOT COMPLETED|Overall Study||25||
48688849|NCT01194219|102020321|FG008|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0||
48688850|NCT01194219|102020322|FG009|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0||
48093418|NCT02066233|100552031|FG000|NOT COMPLETED|Standard Endoscopy (Day 2)||0||
48386299|NCT03452891|101273014|FG000|STARTED|Overall Study||25||
48386300|NCT03452891|101273015|FG001|STARTED|Overall Study||25||
48386301|NCT03452891|101273014|FG000|Subjects Enrolled|Overall Study||25||
48386302|NCT03452891|101273015|FG001|Subjects Enrolled|Overall Study||25||
48386303|NCT03452891|101273014|FG000|Subjects Completing Study|Overall Study||25||
48386304|NCT03452891|101273015|FG001|Subjects Completing Study|Overall Study||25||
48386305|NCT03452891|101273014|FG000|COMPLETED|Overall Study||25||
48688851|NCT01194219|102020313|FG000|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||59||
48688852|NCT01194219|102020314|FG001|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||33||
48688853|NCT01194219|102020315|FG002|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0||
48688854|NCT01194219|102020316|FG003|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0||
48688855|NCT01194219|102020317|FG004|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0||
48093419|NCT02066233|100552032|FG001|NOT COMPLETED|Standard Endoscopy (Day 2)||0||
48093420|NCT01026792|100552033|FG000|STARTED|Overall Study||38||
48093421|NCT01026792|100552033|FG000|COMPLETED|Overall Study||37||
48093422|NCT01026792|100552033|FG000|NOT COMPLETED|Overall Study||1||
48093423|NCT00708162|100552034|FG000|STARTED|Randomized Phase||361||
48093424|NCT00708162|100552035|FG001|STARTED|Randomized Phase||363||
48093425|NCT00708162|100552034|FG000|Randomized and Treated|Randomized Phase||354||
48258051|NCT02484547|100951930|FG006|NOT COMPLETED|Placebo-Controlled Period||0||
48258052|NCT02484547|100951924|FG000|STARTED|Long-Term Extension Period||0||
48688856|NCT01194219|102020318|FG005|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0||
48688857|NCT01194219|102020319|FG006|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0||
48688858|NCT01194219|102020320|FG007|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0||
48688859|NCT01194219|102020321|FG008|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0||
48688860|NCT01194219|102020322|FG009|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0||
48093426|NCT00708162|100552035|FG001|Randomized and Treated|Randomized Phase||358||
48258053|NCT02484547|100951925|FG001|STARTED|Long-Term Extension Period||0||
48258054|NCT02484547|100951926|FG002|STARTED|Long-Term Extension Period||0||
48258055|NCT02484547|100951927|FG003|STARTED|Long-Term Extension Period||131||
48386306|NCT03452891|101273015|FG001|COMPLETED|Overall Study||25||
48386307|NCT03452891|101273014|FG000|NOT COMPLETED|Overall Study||0||
48386308|NCT03452891|101273015|FG001|NOT COMPLETED|Overall Study||0||
48386309|NCT03303092|101273016|FG000|STARTED|Overall Study||121||
48386310|NCT03303092|101273017|FG001|STARTED|Overall Study||119||
48386311|NCT03303092|101273018|FG002|STARTED|Overall Study||117||
48386312|NCT03303092|101273016|FG000|COMPLETED|Overall Study||118||
48688861|NCT01194219|102020313|FG000|STARTED|Maintenance Phase Weeks16-32||0||
48688862|NCT01194219|102020314|FG001|STARTED|Maintenance Phase Weeks16-32||0||
48258056|NCT02484547|100951928|FG004|STARTED|Long-Term Extension Period||132||
48258057|NCT02484547|100951929|FG005|STARTED|Long-Term Extension Period||251||
48258058|NCT02484547|100951930|FG006|STARTED|Long-Term Extension Period||257||
48258059|NCT02484547|100951924|FG000|COMPLETED|Long-Term Extension Period||0||
48258060|NCT02484547|100951925|FG001|COMPLETED|Long-Term Extension Period||0||
48258061|NCT02484547|100951926|FG002|COMPLETED|Long-Term Extension Period||0||
48258062|NCT02484547|100951927|FG003|COMPLETED|Long-Term Extension Period||0||
48258063|NCT02484547|100951928|FG004|COMPLETED|Long-Term Extension Period||0||
48258064|NCT02484547|100951929|FG005|COMPLETED|Long-Term Extension Period||0||
48258065|NCT02484547|100951930|FG006|COMPLETED|Long-Term Extension Period||0||
48258066|NCT02484547|100951924|FG000|NOT COMPLETED|Long-Term Extension Period||0||
48258067|NCT02484547|100951925|FG001|NOT COMPLETED|Long-Term Extension Period||0||
48258068|NCT02484547|100951926|FG002|NOT COMPLETED|Long-Term Extension Period||0||
48258069|NCT02484547|100951927|FG003|NOT COMPLETED|Long-Term Extension Period||131||
48258070|NCT02484547|100951928|FG004|NOT COMPLETED|Long-Term Extension Period||132||
48258071|NCT02484547|100951929|FG005|NOT COMPLETED|Long-Term Extension Period||251||
48258072|NCT02484547|100951930|FG006|NOT COMPLETED|Long-Term Extension Period||257||
48258073|NCT03414047|100951931|FG000|STARTED|Overall Study||53||
48258074|NCT03414047|100951932|FG001|STARTED|Overall Study||46||
48258075|NCT03414047|100951933|FG002|STARTED|Overall Study||41||
48258076|NCT03414047|100951934|FG003|STARTED|Overall Study||29||
48258077|NCT03414047|100951931|FG000|Received at Least One Dose of Study Drug|Overall Study||53||
48258078|NCT03414047|100951932|FG001|Received at Least One Dose of Study Drug|Overall Study||46||
48688863|NCT01194219|102020315|FG002|STARTED|Maintenance Phase Weeks16-32||494||
48688864|NCT01194219|102020316|FG003|STARTED|Maintenance Phase Weeks16-32||245||
48688865|NCT01194219|102020317|FG004|STARTED|Maintenance Phase Weeks16-32||0||
48688866|NCT01194219|102020318|FG005|STARTED|Maintenance Phase Weeks16-32||0||
48688867|NCT01194219|102020319|FG006|STARTED|Maintenance Phase Weeks16-32||0||
48688868|NCT01194219|102020320|FG007|STARTED|Maintenance Phase Weeks16-32||0||
48688869|NCT01194219|102020321|FG008|STARTED|Maintenance Phase Weeks16-32||0||
48688870|NCT01194219|102020322|FG009|STARTED|Maintenance Phase Weeks16-32||0||
48688871|NCT01194219|102020313|FG000|Received Apremilast|Maintenance Phase Weeks16-32||0||
48258079|NCT03414047|100951933|FG002|Received at Least One Dose of Study Drug|Overall Study||41||
48258080|NCT03414047|100951934|FG003|Received at Least One Dose of Study Drug|Overall Study||29||
48258081|NCT03414047|100951931|FG000|COMPLETED|Overall Study||51||
48258082|NCT03414047|100951932|FG001|COMPLETED|Overall Study||46||
48258083|NCT03414047|100951933|FG002|COMPLETED|Overall Study||38||
48386313|NCT03303092|101273017|FG001|COMPLETED|Overall Study||113||
48688872|NCT01194219|102020314|FG001|Received Apremilast|Maintenance Phase Weeks16-32||0||
48688873|NCT01194219|102020315|FG002|Received Apremilast|Maintenance Phase Weeks16-32||493||
48688874|NCT01194219|102020316|FG003|Received Apremilast|Maintenance Phase Weeks16-32||244||
48688875|NCT01194219|102020317|FG004|Received Apremilast|Maintenance Phase Weeks16-32||0||
48688876|NCT01194219|102020318|FG005|Received Apremilast|Maintenance Phase Weeks16-32||0||
48258084|NCT03414047|100951934|FG003|COMPLETED|Overall Study||27||
48258085|NCT03414047|100951931|FG000|NOT COMPLETED|Overall Study||2||
48258086|NCT03414047|100951932|FG001|NOT COMPLETED|Overall Study||0||
48258087|NCT03414047|100951933|FG002|NOT COMPLETED|Overall Study||3||
48386314|NCT03303092|101273018|FG002|COMPLETED|Overall Study||112||
48386315|NCT03303092|101273016|FG000|NOT COMPLETED|Overall Study||3||
48386316|NCT03303092|101273017|FG001|NOT COMPLETED|Overall Study||6||
48386317|NCT03303092|101273018|FG002|NOT COMPLETED|Overall Study||5||
48386318|NCT00349752|101273019|FG000|STARTED|Overall Study||87||
48386319|NCT00349752|101273020|FG001|STARTED|Overall Study||87||
48386320|NCT00349752|101273019|FG000|COMPLETED|Overall Study||28||
48386321|NCT00349752|101273020|FG001|COMPLETED|Overall Study||23||
48386322|NCT00349752|101273019|FG000|NOT COMPLETED|Overall Study||59||
48386323|NCT00349752|101273020|FG001|NOT COMPLETED|Overall Study||64||
48386324|NCT00986310|101273021|FG000|STARTED|Overall Study||0||
48386325|NCT00986310|101273022|FG001|STARTED|Overall Study||0||
48386326|NCT00986310|101273021|FG000|COMPLETED|Overall Study||0||
48688877|NCT01194219|102020319|FG006|Received Apremilast|Maintenance Phase Weeks16-32||0||
48688878|NCT01194219|102020320|FG007|Received Apremilast|Maintenance Phase Weeks16-32||0||
48688879|NCT01194219|102020321|FG008|Received Apremilast|Maintenance Phase Weeks16-32||0||
48688880|NCT01194219|102020322|FG009|Received Apremilast|Maintenance Phase Weeks16-32||0||
48688881|NCT01194219|102020313|FG000|COMPLETED|Maintenance Phase Weeks16-32||0||
48688882|NCT01194219|102020314|FG001|COMPLETED|Maintenance Phase Weeks16-32||0||
48688883|NCT01194219|102020315|FG002|COMPLETED|Maintenance Phase Weeks16-32||424||
48688884|NCT01194219|102020316|FG003|COMPLETED|Maintenance Phase Weeks16-32||215||
48688885|NCT01194219|102020317|FG004|COMPLETED|Maintenance Phase Weeks16-32||0||
48688886|NCT01194219|102020318|FG005|COMPLETED|Maintenance Phase Weeks16-32||0||
48688887|NCT01194219|102020319|FG006|COMPLETED|Maintenance Phase Weeks16-32||0||
48688888|NCT01194219|102020320|FG007|COMPLETED|Maintenance Phase Weeks16-32||0||
48386327|NCT00986310|101273022|FG001|COMPLETED|Overall Study||0||
48386328|NCT00986310|101273021|FG000|NOT COMPLETED|Overall Study||0||
48688889|NCT01194219|102020321|FG008|COMPLETED|Maintenance Phase Weeks16-32||0||
48688890|NCT01194219|102020322|FG009|COMPLETED|Maintenance Phase Weeks16-32||0||
48688891|NCT01194219|102020313|FG000|NOT COMPLETED|Maintenance Phase Weeks16-32||0||
48688892|NCT01194219|102020314|FG001|NOT COMPLETED|Maintenance Phase Weeks16-32||0||
48688893|NCT01194219|102020315|FG002|NOT COMPLETED|Maintenance Phase Weeks16-32||70||
48386329|NCT00986310|101273022|FG001|NOT COMPLETED|Overall Study||0||
48386330|NCT02500602|101273023|FG000|STARTED|Treatment Phase||74||
48386331|NCT02500602|101273024|FG001|STARTED|Treatment Phase||70||
48386332|NCT02500602|101273023|FG000|COMPLETED|Treatment Phase||68||
48386333|NCT02500602|101273024|FG001|COMPLETED|Treatment Phase||69||
48386334|NCT02500602|101273023|FG000|NOT COMPLETED|Treatment Phase||6||
48386335|NCT02500602|101273024|FG001|NOT COMPLETED|Treatment Phase||1||
48386336|NCT02500602|101273023|FG000|STARTED|Follow Up Phase||68||
48386337|NCT02500602|101273024|FG001|STARTED|Follow Up Phase||69||
48386338|NCT02500602|101273023|FG000|COMPLETED|Follow Up Phase||53||
48386339|NCT02500602|101273024|FG001|COMPLETED|Follow Up Phase||47||
48386340|NCT02500602|101273023|FG000|NOT COMPLETED|Follow Up Phase||15||
48386341|NCT02500602|101273024|FG001|NOT COMPLETED|Follow Up Phase||22||
48386342|NCT01785810|101273025|FG000|STARTED|Overall Study||37||
48386343|NCT01785810|101273025|FG000|COMPLETED|Overall Study||29||
48386344|NCT01785810|101273025|FG000|NOT COMPLETED|Overall Study||8||
48386345|NCT00974051|101273026|FG000|STARTED|Overall Study||6||
48386346|NCT00974051|101273027|FG001|STARTED|Overall Study||4||
48386347|NCT00974051|101273028|FG002|STARTED|Overall Study||6||
48386348|NCT00974051|101273026|FG000|COMPLETED|Overall Study||6||
48386349|NCT00974051|101273027|FG001|COMPLETED|Overall Study||4||
48386350|NCT00974051|101273028|FG002|COMPLETED|Overall Study||6||
48386351|NCT00974051|101273026|FG000|NOT COMPLETED|Overall Study||0||
48386352|NCT00974051|101273027|FG001|NOT COMPLETED|Overall Study||0||
48386353|NCT00974051|101273028|FG002|NOT COMPLETED|Overall Study||0||
48386354|NCT01136668|101273029|FG000|STARTED|Overall Study||7||
48386355|NCT01136668|101273030|FG001|STARTED|Overall Study||6||
48386356|NCT01136668|101273029|FG000|COMPLETED|Overall Study||7||
48386357|NCT01136668|101273030|FG001|COMPLETED|Overall Study||6||
48386358|NCT01136668|101273029|FG000|NOT COMPLETED|Overall Study||0||
48386359|NCT01136668|101273030|FG001|NOT COMPLETED|Overall Study||0||
48386360|NCT02716194|101273031|FG000|STARTED|Period 1 - ADVATE||11||
48386361|NCT02716194|101273032|FG001|STARTED|Period 1 - ADVATE||16||
48386362|NCT02716194|101273033|FG002|STARTED|Period 1 - ADVATE||13||
48386363|NCT02716194|101273031|FG000|COMPLETED|Period 1 - ADVATE||10||
48386364|NCT02716194|101273032|FG001|COMPLETED|Period 1 - ADVATE||15||
48386365|NCT02716194|101273033|FG002|COMPLETED|Period 1 - ADVATE||13||
48386366|NCT02716194|101273031|FG000|NOT COMPLETED|Period 1 - ADVATE||1||
48386367|NCT02716194|101273032|FG001|NOT COMPLETED|Period 1 - ADVATE||1||
48386368|NCT02716194|101273033|FG002|NOT COMPLETED|Period 1 - ADVATE||0||
48386369|NCT02716194|101273031|FG000|STARTED|Period 2 - BAX 826||10||
48386370|NCT02716194|101273032|FG001|STARTED|Period 2 - BAX 826||15||
48386371|NCT02716194|101273033|FG002|STARTED|Period 2 - BAX 826||13||
48386372|NCT02716194|101273031|FG000|COMPLETED|Period 2 - BAX 826||10||
48386373|NCT02716194|101273032|FG001|COMPLETED|Period 2 - BAX 826||15||
48541699|NCT03095638|101662793|FG004|STARTED|P1: Period 2, Washout (7[-4 Hours])||0||
48541700|NCT03095638|101662794|FG005|STARTED|P1: Period 2, Washout (7[-4 Hours])||0||
48541701|NCT03095638|101662795|FG006|STARTED|P1: Period 2, Washout (7[-4 Hours])||0||
48541702|NCT03095638|101662796|FG007|STARTED|P1: Period 2, Washout (7[-4 Hours])||0||
48541703|NCT03095638|101662789|FG000|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||7||
48541704|NCT03095638|101662790|FG001|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||7||
48541705|NCT03095638|101662791|FG002|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0||
48541706|NCT03095638|101662792|FG003|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0||
48541707|NCT03095638|101662793|FG004|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0||
48541708|NCT03095638|101662794|FG005|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0||
48541709|NCT03095638|101662795|FG006|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0||
48541710|NCT03095638|101662796|FG007|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0||
48541711|NCT03095638|101662789|FG000|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0||
48541712|NCT03095638|101662790|FG001|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0||
48688894|NCT01194219|102020316|FG003|NOT COMPLETED|Maintenance Phase Weeks16-32||30||
48688895|NCT01194219|102020317|FG004|NOT COMPLETED|Maintenance Phase Weeks16-32||0||
48386374|NCT02716194|101273033|FG002|COMPLETED|Period 2 - BAX 826||13||
48386375|NCT02716194|101273031|FG000|NOT COMPLETED|Period 2 - BAX 826||0||
48386376|NCT02716194|101273032|FG001|NOT COMPLETED|Period 2 - BAX 826||0||
48386377|NCT02716194|101273033|FG002|NOT COMPLETED|Period 2 - BAX 826||0||
48386378|NCT02670330|101273034|FG000|STARTED|Overall Study||75||
48386379|NCT02670330|101273035|FG001|STARTED|Overall Study||77||
48386380|NCT02670330|101273034|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||75|Safety Population|
48386381|NCT02670330|101273035|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||77|Safety Population|
48386382|NCT02670330|101273034|FG000|COMPLETED|Overall Study||0||
48386383|NCT02670330|101273035|FG001|COMPLETED|Overall Study||0||
48386384|NCT02670330|101273034|FG000|NOT COMPLETED|Overall Study||75||
48386385|NCT02670330|101273035|FG001|NOT COMPLETED|Overall Study||77||
48386386|NCT00507416|101273036|FG000|STARTED|Overall Study||168||
48386387|NCT00507416|101273037|FG001|STARTED|Overall Study||167||
48386388|NCT00507416|101273038|FG002|STARTED|Overall Study||167||
48386389|NCT00507416|101273036|FG000|Treated (Safety Population)|Overall Study||165||
48386390|NCT00507416|101273037|FG001|Treated (Safety Population)|Overall Study||158||
48386391|NCT00507416|101273038|FG002|Treated (Safety Population)|Overall Study||163||
48386392|NCT00507416|101273036|FG000|Completed 8 Treatment Cycles|Overall Study||82||
48386393|NCT00507416|101273037|FG001|Completed 8 Treatment Cycles|Overall Study||60||
48386394|NCT00507416|101273038|FG002|Completed 8 Treatment Cycles|Overall Study||69||
48386395|NCT00507416|101273036|FG000|COMPLETED|Overall Study||50||
48386396|NCT00507416|101273037|FG001|COMPLETED|Overall Study||42||
48386397|NCT00507416|101273038|FG002|COMPLETED|Overall Study||53||
48386398|NCT00507416|101273036|FG000|NOT COMPLETED|Overall Study||118||
48386399|NCT00507416|101273037|FG001|NOT COMPLETED|Overall Study||125||
48386400|NCT00507416|101273038|FG002|NOT COMPLETED|Overall Study||114||
48386401|NCT01958125|101273039|FG000|STARTED|Overall Study||50||
48386402|NCT01958125|101273040|FG001|STARTED|Overall Study||52||
48386403|NCT01958125|101273039|FG000|COMPLETED|Overall Study||48||
48386404|NCT01958125|101273040|FG001|COMPLETED|Overall Study||44||
48386405|NCT01958125|101273039|FG000|NOT COMPLETED|Overall Study||2||
48386406|NCT01958125|101273040|FG001|NOT COMPLETED|Overall Study||8||
48386407|NCT01529385|101273041|FG000|STARTED|Overall Study||40||
48386408|NCT01529385|101273042|FG001|STARTED|Overall Study||40||
48386409|NCT01529385|101273041|FG000|Received Intervention|Overall Study||39||
48386410|NCT01529385|101273042|FG001|Received Intervention|Overall Study||40||
48386411|NCT01529385|101273041|FG000|COMPLETED|Overall Study||38||
48386412|NCT01529385|101273042|FG001|COMPLETED|Overall Study||39||
48386413|NCT01529385|101273041|FG000|NOT COMPLETED|Overall Study||2||
48386414|NCT01529385|101273042|FG001|NOT COMPLETED|Overall Study||1||
48386415|NCT03418051|101276567|FG000|STARTED|Overall Study||20||
48386416|NCT03418051|101276568|FG001|STARTED|Overall Study||20||
48386417|NCT03418051|101276569|FG002|STARTED|Overall Study||20||
48386418|NCT03418051|101276567|FG000|COMPLETED|Overall Study||14||
48386419|NCT03418051|101276568|FG001|COMPLETED|Overall Study||18||
48386420|NCT03418051|101276569|FG002|COMPLETED|Overall Study||17||
48386421|NCT03418051|101276567|FG000|NOT COMPLETED|Overall Study||6||
48386422|NCT03418051|101276568|FG001|NOT COMPLETED|Overall Study||2||
48386423|NCT03418051|101276569|FG002|NOT COMPLETED|Overall Study||3||
48386424|NCT02062463|101276570|FG000|STARTED|Crossover Stage 1||243||
48386425|NCT02062463|101276571|FG001|STARTED|Crossover Stage 1||242||
48386426|NCT02062463|101276572|FG002|STARTED|Crossover Stage 1||0||
48386427|NCT02062463|101276573|FG003|STARTED|Crossover Stage 1||0||
48386428|NCT02062463|101276570|FG000|Full Analysis Set|Crossover Stage 1||240|All randomized participants who completed assessments on both study devices (empty Turbohaler and empty Spiromax), permitting a paired analysis of results.|
48386429|NCT02062463|101276571|FG001|Full Analysis Set|Crossover Stage 1||241|All randomized participants who completed assessments on both study devices (empty Turbohaler and empty Spiromax), permitting a paired analysis of results.|
48386430|NCT02062463|101276572|FG002|Full Analysis Set|Crossover Stage 1||0|All randomized participants who completed assessments on both study devices (empty Turbohaler and empty Spiromax), permitting a paired analysis of results.|
48386431|NCT02062463|101276573|FG003|Full Analysis Set|Crossover Stage 1||0|All randomized participants who completed assessments on both study devices (empty Turbohaler and empty Spiromax), permitting a paired analysis of results.|
48386432|NCT02062463|101276570|FG000|COMPLETED|Crossover Stage 1||240||
48386433|NCT02062463|101276571|FG001|COMPLETED|Crossover Stage 1||241||
48386434|NCT02062463|101276572|FG002|COMPLETED|Crossover Stage 1||0||
48386435|NCT02062463|101276573|FG003|COMPLETED|Crossover Stage 1||0||
48386436|NCT02062463|101276570|FG000|NOT COMPLETED|Crossover Stage 1||3||
48386437|NCT02062463|101276571|FG001|NOT COMPLETED|Crossover Stage 1||1||
48386438|NCT02062463|101276572|FG002|NOT COMPLETED|Crossover Stage 1||0||
48386439|NCT02062463|101276573|FG003|NOT COMPLETED|Crossover Stage 1||0||
48386440|NCT02062463|101276570|FG000|STARTED|Stage 2||0||
48386441|NCT02062463|101276571|FG001|STARTED|Stage 2||0||
48386442|NCT02062463|101276572|FG002|STARTED|Stage 2||197||
48386443|NCT02062463|101276573|FG003|STARTED|Stage 2||197||
48386444|NCT02062463|101276570|FG000|Received at Least 1 Dose of Study Drug|Stage 2||0||
48386445|NCT02062463|101276571|FG001|Received at Least 1 Dose of Study Drug|Stage 2||0||
48386446|NCT02062463|101276572|FG002|Received at Least 1 Dose of Study Drug|Stage 2||197||
48386447|NCT02062463|101276573|FG003|Received at Least 1 Dose of Study Drug|Stage 2||197||
48404086|NCT03689972|101321768|FG002|COMPLETED|Part 2:Run-in Period (Week73uptoWeek107)||153||
48386448|NCT02062463|101276570|FG000|Full Analysis Set|Stage 2||0|All randomized participants who returned for assessment of maintenance of inhaler technique at Week 12, and who had at least 10 weeks (inclusive) of device use of the inhaler (treatment) to which they were randomly assigned.|
48386449|NCT02062463|101276571|FG001|Full Analysis Set|Stage 2||0|All randomized participants who returned for assessment of maintenance of inhaler technique at Week 12, and who had at least 10 weeks (inclusive) of device use of the inhaler (treatment) to which they were randomly assigned.|
48386450|NCT02062463|101276572|FG002|Full Analysis Set|Stage 2||151|All randomized participants who returned for assessment of maintenance of inhaler technique at Week 12, and who had at least 10 weeks (inclusive) of device use of the inhaler (treatment) to which they were randomly assigned.|
48386451|NCT02062463|101276573|FG003|Full Analysis Set|Stage 2||154|All randomized participants who returned for assessment of maintenance of inhaler technique at Week 12, and who had at least 10 weeks (inclusive) of device use of the inhaler (treatment) to which they were randomly assigned.|
48386452|NCT02062463|101276570|FG000|COMPLETED|Stage 2||0||
48093427|NCT00708162|100552034|FG000|COMPLETED|Randomized Phase||205||
48386453|NCT02062463|101276571|FG001|COMPLETED|Stage 2||0||
48386454|NCT02062463|101276572|FG002|COMPLETED|Stage 2||144||
48386455|NCT02062463|101276573|FG003|COMPLETED|Stage 2||141||
48386456|NCT02062463|101276570|FG000|NOT COMPLETED|Stage 2||0||
48386457|NCT02062463|101276571|FG001|NOT COMPLETED|Stage 2||0||
48386458|NCT02062463|101276572|FG002|NOT COMPLETED|Stage 2||53||
48386459|NCT02062463|101276573|FG003|NOT COMPLETED|Stage 2||56||
48386460|NCT01586806|101276574|FG000|STARTED|Overall Study||65||
48386461|NCT01586806|101276575|FG001|STARTED|Overall Study||65||
48386462|NCT01586806|101276576|FG002|STARTED|Overall Study||65||
48386463|NCT01586806|101276574|FG000|COMPLETED|Overall Study||62||
48386464|NCT01586806|101276575|FG001|COMPLETED|Overall Study||61||
48386465|NCT01586806|101276576|FG002|COMPLETED|Overall Study||63||
48386466|NCT01586806|101276574|FG000|NOT COMPLETED|Overall Study||3||
48386467|NCT01586806|101276575|FG001|NOT COMPLETED|Overall Study||4||
48386468|NCT01586806|101276576|FG002|NOT COMPLETED|Overall Study||2||
48386469|NCT03067129|101276577|FG000|STARTED|Overall Study||47||
48386470|NCT03067129|101276578|FG001|STARTED|Overall Study||29||
48386471|NCT03067129|101276579|FG002|STARTED|Overall Study||27||
48386472|NCT03067129|101276580|FG003|STARTED|Overall Study||24||
48386473|NCT03067129|101276577|FG000|Intense Pharmacokinetic Portion|Overall Study||14|Includes participants who provided IPK samples by age group|
48404087|NCT03689972|101321769|FG003|COMPLETED|Part 2:Run-in Period (Week73uptoWeek107)||0||
48093428|NCT00708162|100552035|FG001|COMPLETED|Randomized Phase||209||
48093429|NCT00708162|100552034|FG000|NOT COMPLETED|Randomized Phase||156||
48093430|NCT00708162|100552035|FG001|NOT COMPLETED|Randomized Phase||154||
48093431|NCT00708162|100552034|FG000|STARTED|Open-Label Phase||196||
48093432|NCT00708162|100552035|FG001|STARTED|Open-Label Phase||151||
48093433|NCT00708162|100552034|FG000|COMPLETED|Open-Label Phase||152||
48093434|NCT00708162|100552035|FG001|COMPLETED|Open-Label Phase||121||
48093435|NCT00708162|100552034|FG000|NOT COMPLETED|Open-Label Phase||44||
48093436|NCT00708162|100552035|FG001|NOT COMPLETED|Open-Label Phase||30||
48093437|NCT02785354|100552036|FG000|STARTED|Overall Study||27060||
48093438|NCT02785354|100552037|FG001|STARTED|Overall Study||31388||
48093439|NCT02785354|100552038|FG002|STARTED|Overall Study||44653||
48093440|NCT02785354|100552036|FG000|COMPLETED|Overall Study||27060||
48093441|NCT02785354|100552037|FG001|COMPLETED|Overall Study||31388||
48093442|NCT02785354|100552038|FG002|COMPLETED|Overall Study||44653||
48093443|NCT02785354|100552036|FG000|NOT COMPLETED|Overall Study||0||
48093444|NCT02785354|100552037|FG001|NOT COMPLETED|Overall Study||0||
48093445|NCT02785354|100552038|FG002|NOT COMPLETED|Overall Study||0||
48093446|NCT02070692|100552039|FG000|STARTED|Overall Study||28||
48093447|NCT02070692|100552040|FG001|STARTED|Overall Study||28||
48093448|NCT02070692|100552039|FG000|COMPLETED|Overall Study||18||
48093449|NCT02070692|100552040|FG001|COMPLETED|Overall Study||16||
48093450|NCT02070692|100552039|FG000|NOT COMPLETED|Overall Study||10||
48093451|NCT02070692|100552040|FG001|NOT COMPLETED|Overall Study||12||
48093452|NCT01252940|100552041|FG000|STARTED|Main Study Phase||321||
48093453|NCT01252940|100552042|FG001|STARTED|Main Study Phase||161||
48093454|NCT01252940|100552041|FG000|Completed 24 Weeks|Main Study Phase||0||
48258088|NCT03414047|100951934|FG003|NOT COMPLETED|Overall Study||2||
48258089|NCT03430050|100951935|FG000|STARTED|Overall Study||3||
48258090|NCT03430050|100951936|FG001|STARTED|Overall Study||5||
48258091|NCT03430050|100951935|FG000|COMPLETED|Overall Study||3||
48258092|NCT03430050|100951936|FG001|COMPLETED|Overall Study||5||
48258093|NCT03430050|100951935|FG000|NOT COMPLETED|Overall Study||0||
48258094|NCT03430050|100951936|FG001|NOT COMPLETED|Overall Study||0||
48258095|NCT01387815|100951937|FG000|STARTED|Overall Study||302|Participant flow shows intent to treat (ITT) population (595) vs. enrolled (662).|
48258096|NCT01387815|100951938|FG001|STARTED|Overall Study||293|Participant flow shows intent to treat (ITT) population (595) vs. enrolled (662).|
48258097|NCT01387815|100951937|FG000|COMPLETED|Overall Study||162||
48258098|NCT01387815|100951938|FG001|COMPLETED|Overall Study||189||
48258099|NCT01387815|100951937|FG000|NOT COMPLETED|Overall Study||140||
48258100|NCT01387815|100951938|FG001|NOT COMPLETED|Overall Study||104||
48258101|NCT00809341|100951939|FG000|STARTED|Overall Study||20||
48258102|NCT00809341|100951940|FG001|STARTED|Overall Study||5||
48258103|NCT00809341|100951939|FG000|COMPLETED|Overall Study||20||
48093455|NCT01252940|100552042|FG001|Completed 24 Weeks|Main Study Phase||153||
48093456|NCT01252940|100552041|FG000|COMPLETED|Main Study Phase||295||
48386474|NCT03067129|101276578|FG001|Intense Pharmacokinetic Portion|Overall Study||19|Includes participants who provided IPK samples by age group|
48386475|NCT03067129|101276579|FG002|Intense Pharmacokinetic Portion|Overall Study||18|Includes participants who provided IPK samples by age group|
48386476|NCT03067129|101276580|FG003|Intense Pharmacokinetic Portion|Overall Study||18|Includes participants who provided IPK samples by age group|
48386477|NCT03067129|101276577|FG000|COMPLETED|Overall Study||42||
48386478|NCT03067129|101276578|FG001|COMPLETED|Overall Study||24||
48386479|NCT03067129|101276579|FG002|COMPLETED|Overall Study||22||
48386480|NCT03067129|101276580|FG003|COMPLETED|Overall Study||18||
48386481|NCT03067129|101276577|FG000|NOT COMPLETED|Overall Study||5||
48386482|NCT03067129|101276578|FG001|NOT COMPLETED|Overall Study||5||
48386483|NCT03067129|101276579|FG002|NOT COMPLETED|Overall Study||5||
48386484|NCT03067129|101276580|FG003|NOT COMPLETED|Overall Study||6||
48386485|NCT05528770|101276581|FG000|STARTED|Overall Study||6||
48386486|NCT05528770|101276582|FG001|STARTED|Overall Study||5||
48386487|NCT05528770|101276581|FG000|COMPLETED|Overall Study||6||
48386488|NCT05528770|101276582|FG001|COMPLETED|Overall Study||5||
48386489|NCT05528770|101276581|FG000|NOT COMPLETED|Overall Study||0||
48386490|NCT05528770|101276582|FG001|NOT COMPLETED|Overall Study||0||
48386491|NCT00205699|101276583|FG000|STARTED|Overall Study||49||
48386492|NCT00205699|101276584|FG001|STARTED|Overall Study||46||
48386493|NCT00205699|101276585|FG002|STARTED|Overall Study||49||
48386494|NCT00205699|101276583|FG000|COMPLETED|Overall Study||46||
48386495|NCT00205699|101276584|FG001|COMPLETED|Overall Study||40||
48386496|NCT00205699|101276585|FG002|COMPLETED|Overall Study||43||
48386497|NCT00205699|101276583|FG000|NOT COMPLETED|Overall Study||3||
48386498|NCT00205699|101276584|FG001|NOT COMPLETED|Overall Study||6||
48386499|NCT00205699|101276585|FG002|NOT COMPLETED|Overall Study||6||
48386500|NCT00757484|101276586|FG000|STARTED|Overall Study||491||
48386501|NCT00757484|101276586|FG000|COMPLETED|Overall Study||491||
48386502|NCT00757484|101276586|FG000|NOT COMPLETED|Overall Study||0||
48386503|NCT00067470|101276587|FG000|STARTED|Overall Study||19||
48386504|NCT00067470|101276588|FG001|STARTED|Overall Study||20||
48386505|NCT00067470|101276587|FG000|COMPLETED|Overall Study||19||
48258104|NCT00809341|100951940|FG001|COMPLETED|Overall Study||4||
48258105|NCT00809341|100951939|FG000|NOT COMPLETED|Overall Study||0||
48258106|NCT00809341|100951940|FG001|NOT COMPLETED|Overall Study||1||
48258107|NCT00508274|100951941|FG000|STARTED|Overall Study||52||
48258108|NCT00508274|100951941|FG000|COMPLETED|Overall Study||2||
48258109|NCT00508274|100951941|FG000|NOT COMPLETED|Overall Study||50||
48258110|NCT00589836|100951942|FG000|STARTED|Overall Study||20||
48258111|NCT00589836|100951942|FG000|COMPLETED|Overall Study||20||
48258112|NCT00589836|100951942|FG000|NOT COMPLETED|Overall Study||0||
48258113|NCT03246347|100951943|FG000|STARTED|Overall Study||40||
48258114|NCT03246347|100951943|FG000|COMPLETED|Overall Study||17||
48258115|NCT03246347|100951943|FG000|NOT COMPLETED|Overall Study||23||
48258116|NCT03371823|100951944|FG000|STARTED|Overall Study||8||
48258117|NCT03371823|100951945|FG001|STARTED|Overall Study||0||
48258118|NCT03371823|100951944|FG000|COMPLETED|Overall Study||7||
48258119|NCT03371823|100951945|FG001|COMPLETED|Overall Study||0||
48258120|NCT03371823|100951944|FG000|NOT COMPLETED|Overall Study||1||
48258121|NCT03371823|100951945|FG001|NOT COMPLETED|Overall Study||0||
48258122|NCT00004445|100951946|FG000|STARTED|Overall Study||18||
48258123|NCT00004445|100951946|FG000|COMPLETED|Overall Study||15||
48258124|NCT00004445|100951946|FG000|NOT COMPLETED|Overall Study||3||
48258125|NCT01748045|100951947|FG000|STARTED|Overall Study||2||
48258126|NCT01748045|100951948|FG001|STARTED|Overall Study||1||
48258127|NCT01748045|100951947|FG000|COMPLETED|Overall Study||2||
48258128|NCT01748045|100951948|FG001|COMPLETED|Overall Study||1||
48258129|NCT01748045|100951947|FG000|NOT COMPLETED|Overall Study||0||
48258130|NCT01748045|100951948|FG001|NOT COMPLETED|Overall Study||0||
48258131|NCT02057575|100951949|FG000|STARTED|Overall Study||74||
48258132|NCT02057575|100951950|FG001|STARTED|Overall Study||73||
48258133|NCT02057575|100951951|FG002|STARTED|Overall Study||78||
48258134|NCT02057575|100951952|FG003|STARTED|Overall Study||73||
48258135|NCT02057575|100951949|FG000|COMPLETED|Overall Study||73||
48258136|NCT02057575|100951950|FG001|COMPLETED|Overall Study||69||
48258137|NCT02057575|100951951|FG002|COMPLETED|Overall Study||78||
48386506|NCT00067470|101276588|FG001|COMPLETED|Overall Study||19||
48386507|NCT00067470|101276587|FG000|NOT COMPLETED|Overall Study||0||
48386508|NCT00067470|101276588|FG001|NOT COMPLETED|Overall Study||1||
48386509|NCT04169061|101276589|FG000|STARTED|Overall Study||36||
48258138|NCT02057575|100951952|FG003|COMPLETED|Overall Study||72||
48258139|NCT02057575|100951949|FG000|NOT COMPLETED|Overall Study||1||
48386510|NCT04169061|101276589|FG000|Safety Population|Overall Study||36||
48386511|NCT04169061|101276589|FG000|Modified Intent to Treat (mITT) Population|Overall Study||34||
48386512|NCT04169061|101276589|FG000|COMPLETED|Overall Study||31||
48386513|NCT04169061|101276589|FG000|NOT COMPLETED|Overall Study||5||
48386514|NCT00192036|101276590|FG000|STARTED|Overall Study||49||
48386515|NCT00192036|101276590|FG000|COMPLETED|Overall Study||28||
48386516|NCT00192036|101276590|FG000|NOT COMPLETED|Overall Study||21||
48258140|NCT02057575|100951950|FG001|NOT COMPLETED|Overall Study||4||
48258141|NCT02057575|100951951|FG002|NOT COMPLETED|Overall Study||0||
48258142|NCT02057575|100951952|FG003|NOT COMPLETED|Overall Study||1||
48258143|NCT01850823|100951953|FG000|STARTED|Overall Study||175||
48386517|NCT02701192|101276591|FG000|STARTED|Overall Study||100||
48386518|NCT02701192|101276591|FG000|COMPLETED|Overall Study||94||
48386519|NCT02701192|101276591|FG000|NOT COMPLETED|Overall Study||6||
48386520|NCT01763866|101276592|FG000|STARTED|Overall Study||56||
48386521|NCT01763866|101276593|FG001|STARTED|Overall Study||55||
48386522|NCT01763866|101276594|FG002|STARTED|Overall Study||56||
48688896|NCT01194219|102020318|FG005|NOT COMPLETED|Maintenance Phase Weeks16-32||0||
48688897|NCT01194219|102020319|FG006|NOT COMPLETED|Maintenance Phase Weeks16-32||0||
48688898|NCT01194219|102020320|FG007|NOT COMPLETED|Maintenance Phase Weeks16-32||0||
48688899|NCT01194219|102020321|FG008|NOT COMPLETED|Maintenance Phase Weeks16-32||0||
48688900|NCT01194219|102020322|FG009|NOT COMPLETED|Maintenance Phase Weeks16-32||0||
48688901|NCT01194219|102020313|FG000|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0||
48688902|NCT01194219|102020314|FG001|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0||
48688903|NCT01194219|102020315|FG002|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0||
48688904|NCT01194219|102020316|FG003|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0||
48688905|NCT01194219|102020317|FG004|STARTED|Randomized Withdrawal Phase-Weeks 32-52||77||
48688906|NCT01194219|102020318|FG005|STARTED|Randomized Withdrawal Phase-Weeks 32-52||77||
48688907|NCT01194219|102020319|FG006|STARTED|Randomized Withdrawal Phase-Weeks 32-52||245||
48688908|NCT01194219|102020320|FG007|STARTED|Randomized Withdrawal Phase-Weeks 32-52||208||
48688909|NCT01194219|102020321|FG008|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0||
48688910|NCT01194219|102020322|FG009|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0||
48688911|NCT01194219|102020313|FG000|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0||
48688912|NCT01194219|102020314|FG001|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0||
48688913|NCT01194219|102020315|FG002|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0||
48688914|NCT01194219|102020316|FG003|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0||
48688915|NCT01194219|102020317|FG004|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0||
48688916|NCT01194219|102020318|FG005|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0||
48688917|NCT01194219|102020319|FG006|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||126||
48688918|NCT01194219|102020320|FG007|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||91||
48688919|NCT01194219|102020321|FG008|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0||
48688920|NCT01194219|102020322|FG009|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0||
48688921|NCT01194219|102020313|FG000|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0||
48688922|NCT01194219|102020314|FG001|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0||
48688923|NCT01194219|102020315|FG002|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0||
48688924|NCT01194219|102020316|FG003|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0||
48688925|NCT01194219|102020317|FG004|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||73||
48688926|NCT01194219|102020318|FG005|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||73||
48688927|NCT01194219|102020319|FG006|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||184||
48688928|NCT01194219|102020320|FG007|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||163||
48688929|NCT01194219|102020321|FG008|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0||
48688930|NCT01194219|102020322|FG009|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0||
48688931|NCT01194219|102020313|FG000|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0||
48688932|NCT01194219|102020314|FG001|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0||
48688933|NCT01194219|102020315|FG002|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0||
48688934|NCT01194219|102020316|FG003|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0||
48688935|NCT01194219|102020317|FG004|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4||
48688936|NCT01194219|102020318|FG005|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4||
48688937|NCT01194219|102020319|FG006|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||61||
48688938|NCT01194219|102020320|FG007|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||45||
48688939|NCT01194219|102020321|FG008|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0||
48688940|NCT01194219|102020322|FG009|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0||
48688941|NCT01194219|102020313|FG000|STARTED|Long-Term Extension Weeks 52 to 260||0||
48688942|NCT01194219|102020314|FG001|STARTED|Long-Term Extension Weeks 52 to 260||0||
48386523|NCT01763866|101276595|FG003|STARTED|Overall Study||55||
48386524|NCT01763866|101276596|FG004|STARTED|Overall Study||110||
48386525|NCT01763866|101276597|FG005|STARTED|Overall Study||110||
48386526|NCT01763866|101276598|FG006|STARTED|Overall Study||55||
48688943|NCT01194219|102020315|FG002|STARTED|Long-Term Extension Weeks 52 to 260||0||
48688944|NCT01194219|102020316|FG003|STARTED|Long-Term Extension Weeks 52 to 260||0||
48688945|NCT01194219|102020317|FG004|STARTED|Long-Term Extension Weeks 52 to 260||0||
48688946|NCT01194219|102020318|FG005|STARTED|Long-Term Extension Weeks 52 to 260||0||
48688947|NCT01194219|102020319|FG006|STARTED|Long-Term Extension Weeks 52 to 260||0||
48688948|NCT01194219|102020320|FG007|STARTED|Long-Term Extension Weeks 52 to 260||0||
48688949|NCT01194219|102020321|FG008|STARTED|Long-Term Extension Weeks 52 to 260||306||
48688950|NCT01194219|102020322|FG009|STARTED|Long-Term Extension Weeks 52 to 260||153||
48688951|NCT01194219|102020313|FG000|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0||
48688952|NCT01194219|102020314|FG001|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0||
48386527|NCT01763866|101276599|FG007|STARTED|Overall Study||55||
48386528|NCT01763866|101276600|FG008|STARTED|Overall Study||56||
48386529|NCT01763866|101276601|FG009|STARTED|Overall Study||54||
48386530|NCT01763866|101276602|FG010|STARTED|Overall Study||110||
48386531|NCT01763866|101276603|FG011|STARTED|Overall Study||110||
48688953|NCT01194219|102020315|FG002|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0||
48688954|NCT01194219|102020316|FG003|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0||
48688955|NCT01194219|102020317|FG004|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0||
48688956|NCT01194219|102020318|FG005|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0||
48688957|NCT01194219|102020319|FG006|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0||
48688958|NCT01194219|102020320|FG007|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0||
48688959|NCT01194219|102020321|FG008|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||304||
48688960|NCT01194219|102020322|FG009|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||153||
48688961|NCT01194219|102020313|FG000|COMPLETED|Long-Term Extension Weeks 52 to 260||0||
48093457|NCT01252940|100552042|FG001|COMPLETED|Main Study Phase||149||
48093458|NCT01252940|100552041|FG000|NOT COMPLETED|Main Study Phase||26||
48093459|NCT01252940|100552042|FG001|NOT COMPLETED|Main Study Phase||12||
48093460|NCT01252940|100552041|FG000|STARTED|Extension Phase||110||
48093461|NCT01252940|100552042|FG001|STARTED|Extension Phase||49||
48093462|NCT01252940|100552041|FG000|COMPLETED|Extension Phase||100||
48093463|NCT01252940|100552042|FG001|COMPLETED|Extension Phase||46||
48093464|NCT01252940|100552041|FG000|NOT COMPLETED|Extension Phase||10||
48093465|NCT01252940|100552042|FG001|NOT COMPLETED|Extension Phase||3||
48093466|NCT03254927|100552043|FG000|STARTED|Overall Study||30||
48093467|NCT03254927|100552043|FG000|COMPLETED|Overall Study||30||
48093468|NCT03254927|100552043|FG000|NOT COMPLETED|Overall Study||0||
48386532|NCT01763866|101276604|FG012|STARTED|Overall Study||58||
48386533|NCT01763866|101276605|FG013|STARTED|Overall Study||57||
48386534|NCT01763866|101276606|FG014|STARTED|Overall Study||114||
48386535|NCT01763866|101276607|FG015|STARTED|Overall Study||115||
48386536|NCT01763866|101276608|FG016|STARTED|Overall Study||56||
48386537|NCT01763866|101276609|FG017|STARTED|Overall Study||56||
48541713|NCT03095638|101662791|FG002|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0||
48541714|NCT03095638|101662792|FG003|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0||
48541715|NCT03095638|101662793|FG004|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0||
48541716|NCT03095638|101662794|FG005|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0||
48541717|NCT03095638|101662795|FG006|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0||
48541718|NCT03095638|101662796|FG007|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0||
48541719|NCT03095638|101662789|FG000|STARTED|P2: Period 1 (4 Days)||0||
48541720|NCT03095638|101662790|FG001|STARTED|P2: Period 1 (4 Days)||0||
48541721|NCT03095638|101662791|FG002|STARTED|P2: Period 1 (4 Days)||4||
48541722|NCT03095638|101662792|FG003|STARTED|P2: Period 1 (4 Days)||4||
48541723|NCT03095638|101662793|FG004|STARTED|P2: Period 1 (4 Days)||4||
48541724|NCT03095638|101662794|FG005|STARTED|P2: Period 1 (4 Days)||4||
48541725|NCT03095638|101662795|FG006|STARTED|P2: Period 1 (4 Days)||4||
48541726|NCT03095638|101662796|FG007|STARTED|P2: Period 1 (4 Days)||4||
48541727|NCT03095638|101662789|FG000|COMPLETED|P2: Period 1 (4 Days)||0||
48541728|NCT03095638|101662790|FG001|COMPLETED|P2: Period 1 (4 Days)||0||
48541729|NCT03095638|101662791|FG002|COMPLETED|P2: Period 1 (4 Days)||4||
48541730|NCT03095638|101662792|FG003|COMPLETED|P2: Period 1 (4 Days)||4||
48541731|NCT03095638|101662793|FG004|COMPLETED|P2: Period 1 (4 Days)||4||
48541732|NCT03095638|101662794|FG005|COMPLETED|P2: Period 1 (4 Days)||4||
48541733|NCT03095638|101662795|FG006|COMPLETED|P2: Period 1 (4 Days)||4||
48541734|NCT03095638|101662796|FG007|COMPLETED|P2: Period 1 (4 Days)||4||
48541735|NCT03095638|101662789|FG000|NOT COMPLETED|P2: Period 1 (4 Days)||0||
48541736|NCT03095638|101662790|FG001|NOT COMPLETED|P2: Period 1 (4 Days)||0||
48688962|NCT01194219|102020314|FG001|COMPLETED|Long-Term Extension Weeks 52 to 260||0||
48688963|NCT01194219|102020315|FG002|COMPLETED|Long-Term Extension Weeks 52 to 260||0||
48541737|NCT03095638|101662791|FG002|NOT COMPLETED|P2: Period 1 (4 Days)||0||
48541738|NCT03095638|101662792|FG003|NOT COMPLETED|P2: Period 1 (4 Days)||0||
48541739|NCT03095638|101662793|FG004|NOT COMPLETED|P2: Period 1 (4 Days)||0||
48688964|NCT01194219|102020316|FG003|COMPLETED|Long-Term Extension Weeks 52 to 260||0||
48093469|NCT01156311|100552044|FG000|STARTED|2-Month Monotherapy Period||59||
48093470|NCT01156311|100552045|FG001|STARTED|2-Month Monotherapy Period||49||
48093471|NCT01156311|100552046|FG002|STARTED|2-Month Monotherapy Period||0||
48093472|NCT01156311|100552047|FG003|STARTED|2-Month Monotherapy Period||0||
48093473|NCT01156311|100552044|FG000|COMPLETED|2-Month Monotherapy Period||57||
48093474|NCT01156311|100552045|FG001|COMPLETED|2-Month Monotherapy Period||47||
48093475|NCT01156311|100552046|FG002|COMPLETED|2-Month Monotherapy Period||0||
48093476|NCT01156311|100552047|FG003|COMPLETED|2-Month Monotherapy Period||0||
48093477|NCT01156311|100552044|FG000|NOT COMPLETED|2-Month Monotherapy Period||2||
48093478|NCT01156311|100552045|FG001|NOT COMPLETED|2-Month Monotherapy Period||2||
48093479|NCT01156311|100552046|FG002|NOT COMPLETED|2-Month Monotherapy Period||0||
48386538|NCT01763866|101276610|FG018|STARTED|Overall Study||111||
48386539|NCT01763866|101276611|FG019|STARTED|Overall Study||112||
48386540|NCT01763866|101276612|FG020|STARTED|Overall Study||56||
48541740|NCT03095638|101662794|FG005|NOT COMPLETED|P2: Period 1 (4 Days)||0||
48541741|NCT03095638|101662795|FG006|NOT COMPLETED|P2: Period 1 (4 Days)||0||
48093480|NCT01156311|100552047|FG003|NOT COMPLETED|2-Month Monotherapy Period||0||
48093481|NCT01156311|100552044|FG000|STARTED|6-month Add-on Therapy Period||0||
48093482|NCT01156311|100552045|FG001|STARTED|6-month Add-on Therapy Period||0||
48093483|NCT01156311|100552046|FG002|STARTED|6-month Add-on Therapy Period||57||
48093484|NCT01156311|100552047|FG003|STARTED|6-month Add-on Therapy Period||47||
48093485|NCT01156311|100552044|FG000|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0||
48093486|NCT01156311|100552045|FG001|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0||
48093487|NCT01156311|100552046|FG002|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||45||
48093488|NCT01156311|100552047|FG003|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||38||
48688965|NCT01194219|102020317|FG004|COMPLETED|Long-Term Extension Weeks 52 to 260||0||
48688966|NCT01194219|102020318|FG005|COMPLETED|Long-Term Extension Weeks 52 to 260||0||
48688967|NCT01194219|102020319|FG006|COMPLETED|Long-Term Extension Weeks 52 to 260||0||
48688968|NCT01194219|102020320|FG007|COMPLETED|Long-Term Extension Weeks 52 to 260||0||
48688969|NCT01194219|102020321|FG008|COMPLETED|Long-Term Extension Weeks 52 to 260||86||
48688970|NCT01194219|102020322|FG009|COMPLETED|Long-Term Extension Weeks 52 to 260||41||
48688971|NCT01194219|102020313|FG000|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0||
48688972|NCT01194219|102020314|FG001|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0||
48688973|NCT01194219|102020315|FG002|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0||
48688974|NCT01194219|102020316|FG003|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0||
48093489|NCT01156311|100552044|FG000|COMPLETED|6-month Add-on Therapy Period||0||
48093490|NCT01156311|100552045|FG001|COMPLETED|6-month Add-on Therapy Period||0||
48093491|NCT01156311|100552046|FG002|COMPLETED|6-month Add-on Therapy Period||45||
48093492|NCT01156311|100552047|FG003|COMPLETED|6-month Add-on Therapy Period||37||
48093493|NCT01156311|100552044|FG000|NOT COMPLETED|6-month Add-on Therapy Period||0||
48093494|NCT01156311|100552045|FG001|NOT COMPLETED|6-month Add-on Therapy Period||0||
48093495|NCT01156311|100552046|FG002|NOT COMPLETED|6-month Add-on Therapy Period||12||
48093496|NCT01156311|100552047|FG003|NOT COMPLETED|6-month Add-on Therapy Period||10||
48093497|NCT01313767|100552048|FG000|STARTED|Overall Study||98||
48093498|NCT01313767|100552049|FG001|STARTED|Overall Study||98||
48093499|NCT01313767|100552048|FG000|COMPLETED|Overall Study||91||
48093500|NCT01313767|100552049|FG001|COMPLETED|Overall Study||96||
48093501|NCT01313767|100552048|FG000|NOT COMPLETED|Overall Study||7||
48093502|NCT01313767|100552049|FG001|NOT COMPLETED|Overall Study||2||
48093503|NCT00449046|100552050|FG000|STARTED|Overall Study||40||
48093504|NCT00449046|100552050|FG000|COMPLETED|Overall Study||40||
48093505|NCT00449046|100552050|FG000|NOT COMPLETED|Overall Study||0||
48093506|NCT02715076|100552051|FG000|STARTED|Overall Study||48||
48093507|NCT02715076|100552052|FG001|STARTED|Overall Study||50||
48093508|NCT02715076|100552053|FG002|STARTED|Overall Study||49||
48093509|NCT02715076|100552054|FG003|STARTED|Overall Study||50||
48093510|NCT02715076|100552055|FG004|STARTED|Overall Study||47||
48093511|NCT02715076|100552056|FG005|STARTED|Overall Study||48||
48093512|NCT02715076|100552051|FG000|COMPLETED|Overall Study||48||
48093513|NCT02715076|100552052|FG001|COMPLETED|Overall Study||50||
48093514|NCT02715076|100552053|FG002|COMPLETED|Overall Study||49||
48093515|NCT02715076|100552054|FG003|COMPLETED|Overall Study||50||
48093516|NCT02715076|100552055|FG004|COMPLETED|Overall Study||47||
48093517|NCT02715076|100552056|FG005|COMPLETED|Overall Study||48||
48093518|NCT02715076|100552051|FG000|NOT COMPLETED|Overall Study||0||
48093519|NCT02715076|100552052|FG001|NOT COMPLETED|Overall Study||0||
48093520|NCT02715076|100552053|FG002|NOT COMPLETED|Overall Study||0||
48093521|NCT02715076|100552054|FG003|NOT COMPLETED|Overall Study||0||
48093522|NCT02715076|100552055|FG004|NOT COMPLETED|Overall Study||0||
48093523|NCT02715076|100552056|FG005|NOT COMPLETED|Overall Study||0||
48093524|NCT00157950|100552057|FG000|STARTED|Overall Study||117||
48093525|NCT00157950|100552058|FG001|STARTED|Overall Study||59||
48093526|NCT00157950|100552057|FG000|Vaccinated at Dose 1|Overall Study||117||
48093527|NCT00157950|100552058|FG001|Vaccinated at Dose 1|Overall Study||59||
48688975|NCT01194219|102020317|FG004|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0||
48688976|NCT01194219|102020318|FG005|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0||
48688977|NCT01194219|102020319|FG006|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0||
48688978|NCT01194219|102020320|FG007|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0||
48688979|NCT01194219|102020321|FG008|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||220||
48688980|NCT01194219|102020322|FG009|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||112||
48688981|NCT01642056|102020323|FG000|STARTED|First Intervention||10||
48688982|NCT01642056|102020324|FG001|STARTED|First Intervention||10||
48688983|NCT01642056|102020323|FG000|COMPLETED|First Intervention||9||
48688984|NCT01642056|102020324|FG001|COMPLETED|First Intervention||10||
48688985|NCT01642056|102020323|FG000|NOT COMPLETED|First Intervention||1||
48688986|NCT01642056|102020324|FG001|NOT COMPLETED|First Intervention||0||
48093528|NCT00157950|100552057|FG000|Vaccinated at Dose 2|Overall Study||117||
48093529|NCT00157950|100552058|FG001|Vaccinated at Dose 2|Overall Study||59||
48093530|NCT00157950|100552057|FG000|Vaccinated at Dose 3|Overall Study||116||
48093531|NCT00157950|100552058|FG001|Vaccinated at Dose 3|Overall Study||59||
48093532|NCT00157950|100552057|FG000|COMPLETED|Overall Study||116||
48093533|NCT00157950|100552058|FG001|COMPLETED|Overall Study||59||
48688987|NCT01642056|102020323|FG000|STARTED|Second Intervention||9||
48093534|NCT00157950|100552057|FG000|NOT COMPLETED|Overall Study||1||
48093535|NCT00157950|100552058|FG001|NOT COMPLETED|Overall Study||0||
48093536|NCT01119131|100552059|FG000|STARTED|Overall Study||10||
48093537|NCT01119131|100552060|FG001|STARTED|Overall Study||28||
48093538|NCT01119131|100552061|FG002|STARTED|Overall Study||30||
48093539|NCT01119131|100552059|FG000|COMPLETED|Overall Study||8||
48093540|NCT01119131|100552060|FG001|COMPLETED|Overall Study||27||
48093541|NCT01119131|100552061|FG002|COMPLETED|Overall Study||24||
48093542|NCT01119131|100552059|FG000|NOT COMPLETED|Overall Study||2||
48093543|NCT01119131|100552060|FG001|NOT COMPLETED|Overall Study||1||
48386541|NCT01763866|101276613|FG021|STARTED|Overall Study||55||
48386542|NCT01763866|101276614|FG022|STARTED|Overall Study||112||
48386543|NCT01763866|101276615|FG023|STARTED|Overall Study||115||
48386544|NCT01763866|101276592|FG000|Received Treatment|Overall Study||56||
48386545|NCT01763866|101276593|FG001|Received Treatment|Overall Study||55||
48688988|NCT01642056|102020324|FG001|STARTED|Second Intervention||10||
48688989|NCT01642056|102020323|FG000|COMPLETED|Second Intervention||8||
48688990|NCT01642056|102020324|FG001|COMPLETED|Second Intervention||8||
48688991|NCT01642056|102020323|FG000|NOT COMPLETED|Second Intervention||1||
48688992|NCT01642056|102020324|FG001|NOT COMPLETED|Second Intervention||2||
48688993|NCT03276728|102020325|FG000|STARTED|Overall Study||22||
48688994|NCT03276728|102020326|FG001|STARTED|Overall Study||66||
48688995|NCT03276728|102020327|FG002|STARTED|Overall Study||16||
48688996|NCT03276728|102020328|FG003|STARTED|Overall Study||50||
48386546|NCT01763866|101276594|FG002|Received Treatment|Overall Study||56||
48386547|NCT01763866|101276595|FG003|Received Treatment|Overall Study||55||
48386548|NCT01763866|101276596|FG004|Received Treatment|Overall Study||110||
48386549|NCT01763866|101276597|FG005|Received Treatment|Overall Study||110||
48386550|NCT01763866|101276598|FG006|Received Treatment|Overall Study||55||
48386551|NCT01763866|101276599|FG007|Received Treatment|Overall Study||55||
48386552|NCT01763866|101276600|FG008|Received Treatment|Overall Study||56||
48386553|NCT01763866|101276601|FG009|Received Treatment|Overall Study||54||
48386554|NCT01763866|101276602|FG010|Received Treatment|Overall Study||109||
48386555|NCT01763866|101276603|FG011|Received Treatment|Overall Study||110||
48688997|NCT03276728|102020329|FG004|STARTED|Overall Study||7||
48688998|NCT03276728|102020330|FG005|STARTED|Overall Study||1||
48688999|NCT03276728|102020331|FG006|STARTED|Overall Study||17||
48689000|NCT03276728|102020332|FG007|STARTED|Overall Study||3||
48689001|NCT03276728|102020325|FG000|Treated Participants|Overall Study||22||
48689002|NCT03276728|102020326|FG001|Treated Participants|Overall Study||66||
48093544|NCT01119131|100552061|FG002|NOT COMPLETED|Overall Study||6||
48093545|NCT00561080|100552062|FG000|STARTED|Vaccination Period (up to Month 4)||253||
48093546|NCT00561080|100552063|FG001|STARTED|Vaccination Period (up to Month 4)||255||
48093547|NCT00561080|100552064|FG002|STARTED|Vaccination Period (up to Month 4)||251||
48093548|NCT00561080|100552062|FG000|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||253||
48093549|NCT00561080|100552063|FG001|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||254||
48093550|NCT00561080|100552064|FG002|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||250||
48093551|NCT00561080|100552062|FG000|COMPLETED|Vaccination Period (up to Month 4)||250||
48093552|NCT00561080|100552063|FG001|COMPLETED|Vaccination Period (up to Month 4)||229||
48093553|NCT00561080|100552064|FG002|COMPLETED|Vaccination Period (up to Month 4)||225||
48093554|NCT00561080|100552062|FG000|NOT COMPLETED|Vaccination Period (up to Month 4)||3||
48093555|NCT00561080|100552063|FG001|NOT COMPLETED|Vaccination Period (up to Month 4)||26||
48093556|NCT00561080|100552064|FG002|NOT COMPLETED|Vaccination Period (up to Month 4)||26||
48093557|NCT00561080|100552062|FG000|STARTED|12-month Post Last Dose Follow-up||250||
48093558|NCT00561080|100552063|FG001|STARTED|12-month Post Last Dose Follow-up||229||
48093559|NCT00561080|100552064|FG002|STARTED|12-month Post Last Dose Follow-up||225||
48093560|NCT00561080|100552062|FG000|COMPLETED|12-month Post Last Dose Follow-up||243||
48093561|NCT00561080|100552063|FG001|COMPLETED|12-month Post Last Dose Follow-up||220||
48093562|NCT00561080|100552064|FG002|COMPLETED|12-month Post Last Dose Follow-up||215||
48258144|NCT01850823|100951954|FG001|STARTED|Overall Study||350||
48386556|NCT01763866|101276604|FG012|Received Treatment|Overall Study||58||
48386557|NCT01763866|101276605|FG013|Received Treatment|Overall Study||57||
48386558|NCT01763866|101276606|FG014|Received Treatment|Overall Study||113||
48689003|NCT03276728|102020327|FG002|Treated Participants|Overall Study||16||
48689004|NCT03276728|102020328|FG003|Treated Participants|Overall Study||50||
48689005|NCT03276728|102020329|FG004|Treated Participants|Overall Study||7||
48689006|NCT03276728|102020330|FG005|Treated Participants|Overall Study||1||
48689007|NCT03276728|102020331|FG006|Treated Participants|Overall Study||16||
48689008|NCT03276728|102020332|FG007|Treated Participants|Overall Study||3||
48689009|NCT03276728|102020325|FG000|COMPLETED|Overall Study||22||
48689010|NCT03276728|102020326|FG001|COMPLETED|Overall Study||66||
48093563|NCT00561080|100552062|FG000|NOT COMPLETED|12-month Post Last Dose Follow-up||7||
48093564|NCT00561080|100552063|FG001|NOT COMPLETED|12-month Post Last Dose Follow-up||9||
48386559|NCT01763866|101276607|FG015|Received Treatment|Overall Study||115||
48386560|NCT01763866|101276608|FG016|Received Treatment|Overall Study||56||
48386561|NCT01763866|101276609|FG017|Received Treatment|Overall Study||55||
48689011|NCT03276728|102020327|FG002|COMPLETED|Overall Study||14||
48689012|NCT03276728|102020328|FG003|COMPLETED|Overall Study||45||
48386562|NCT01763866|101276610|FG018|Received Treatment|Overall Study||111||
48386563|NCT01763866|101276611|FG019|Received Treatment|Overall Study||112||
48386564|NCT01763866|101276612|FG020|Received Treatment|Overall Study||56||
48386565|NCT01763866|101276613|FG021|Received Treatment|Overall Study||55||
48386566|NCT01763866|101276614|FG022|Received Treatment|Overall Study||112||
48386567|NCT01763866|101276615|FG023|Received Treatment|Overall Study||115||
48386568|NCT01763866|101276592|FG000|COMPLETED|Overall Study||54||
48386569|NCT01763866|101276593|FG001|COMPLETED|Overall Study||54||
48386570|NCT01763866|101276594|FG002|COMPLETED|Overall Study||51||
48386571|NCT01763866|101276595|FG003|COMPLETED|Overall Study||55||
48386572|NCT01763866|101276596|FG004|COMPLETED|Overall Study||108||
48386573|NCT01763866|101276597|FG005|COMPLETED|Overall Study||107||
48386574|NCT01763866|101276598|FG006|COMPLETED|Overall Study||48||
48386575|NCT01763866|101276599|FG007|COMPLETED|Overall Study||55||
48386576|NCT01763866|101276600|FG008|COMPLETED|Overall Study||53||
48386577|NCT01763866|101276601|FG009|COMPLETED|Overall Study||53||
48386578|NCT01763866|101276602|FG010|COMPLETED|Overall Study||102||
48386579|NCT01763866|101276603|FG011|COMPLETED|Overall Study||108||
48386580|NCT01763866|101276604|FG012|COMPLETED|Overall Study||54||
48386581|NCT01763866|101276605|FG013|COMPLETED|Overall Study||57||
48386582|NCT01763866|101276606|FG014|COMPLETED|Overall Study||102||
48386583|NCT01763866|101276607|FG015|COMPLETED|Overall Study||112||
48386584|NCT01763866|101276608|FG016|COMPLETED|Overall Study||55||
48386585|NCT01763866|101276609|FG017|COMPLETED|Overall Study||55||
48386586|NCT01763866|101276610|FG018|COMPLETED|Overall Study||105||
48386587|NCT01763866|101276611|FG019|COMPLETED|Overall Study||110||
48386588|NCT01763866|101276612|FG020|COMPLETED|Overall Study||52||
48386589|NCT01763866|101276613|FG021|COMPLETED|Overall Study||54||
48386590|NCT01763866|101276614|FG022|COMPLETED|Overall Study||109||
48386591|NCT01763866|101276615|FG023|COMPLETED|Overall Study||113||
48386592|NCT01763866|101276592|FG000|NOT COMPLETED|Overall Study||2||
48386593|NCT01763866|101276593|FG001|NOT COMPLETED|Overall Study||1||
48386594|NCT01763866|101276594|FG002|NOT COMPLETED|Overall Study||5||
48386595|NCT01763866|101276595|FG003|NOT COMPLETED|Overall Study||0||
48386596|NCT01763866|101276596|FG004|NOT COMPLETED|Overall Study||2||
48386597|NCT01763866|101276597|FG005|NOT COMPLETED|Overall Study||3||
48386598|NCT01763866|101276598|FG006|NOT COMPLETED|Overall Study||7||
48386599|NCT01763866|101276599|FG007|NOT COMPLETED|Overall Study||0||
48386600|NCT01763866|101276600|FG008|NOT COMPLETED|Overall Study||3||
48386601|NCT01763866|101276601|FG009|NOT COMPLETED|Overall Study||1||
48386602|NCT01763866|101276602|FG010|NOT COMPLETED|Overall Study||8||
48386603|NCT01763866|101276603|FG011|NOT COMPLETED|Overall Study||2||
48386604|NCT01763866|101276604|FG012|NOT COMPLETED|Overall Study||4||
48386605|NCT01763866|101276605|FG013|NOT COMPLETED|Overall Study||0||
48386606|NCT01763866|101276606|FG014|NOT COMPLETED|Overall Study||12||
48386607|NCT01763866|101276607|FG015|NOT COMPLETED|Overall Study||3||
48386608|NCT01763866|101276608|FG016|NOT COMPLETED|Overall Study||1||
48386609|NCT01763866|101276609|FG017|NOT COMPLETED|Overall Study||1||
48386610|NCT01763866|101276610|FG018|NOT COMPLETED|Overall Study||6||
48386611|NCT01763866|101276611|FG019|NOT COMPLETED|Overall Study||2||
48386612|NCT01763866|101276612|FG020|NOT COMPLETED|Overall Study||4||
48386613|NCT01763866|101276613|FG021|NOT COMPLETED|Overall Study||1||
48386614|NCT01763866|101276614|FG022|NOT COMPLETED|Overall Study||3||
48386615|NCT01763866|101276615|FG023|NOT COMPLETED|Overall Study||2||
48386616|NCT00599027|101276616|FG000|STARTED|Overall Study||26||
48386617|NCT00599027|101276617|FG001|STARTED|Overall Study||25||
48386618|NCT00599027|101276616|FG000|COMPLETED|Overall Study||25||
48386619|NCT00599027|101276617|FG001|COMPLETED|Overall Study||22||
48386620|NCT00599027|101276616|FG000|NOT COMPLETED|Overall Study||1||
48386621|NCT00599027|101276617|FG001|NOT COMPLETED|Overall Study||3||
48386622|NCT01861054|101276618|FG000|STARTED|Overall Study||18||
48386623|NCT01861054|101276619|FG001|STARTED|Overall Study||2||
48258145|NCT01850823|100951955|FG002|STARTED|Overall Study||355||
48258146|NCT01850823|100951953|FG000|COMPLETED|Overall Study||172||
48258147|NCT01850823|100951954|FG001|COMPLETED|Overall Study||347||
48689013|NCT03276728|102020329|FG004|COMPLETED|Overall Study||6||
48689014|NCT03276728|102020330|FG005|COMPLETED|Overall Study||1||
48689015|NCT03276728|102020331|FG006|COMPLETED|Overall Study||15||
48689016|NCT03276728|102020332|FG007|COMPLETED|Overall Study||2||
48689017|NCT03276728|102020325|FG000|NOT COMPLETED|Overall Study||0||
48689018|NCT03276728|102020326|FG001|NOT COMPLETED|Overall Study||0||
48689019|NCT03276728|102020327|FG002|NOT COMPLETED|Overall Study||2||
48689020|NCT03276728|102020328|FG003|NOT COMPLETED|Overall Study||5||
48689021|NCT03276728|102020329|FG004|NOT COMPLETED|Overall Study||1||
48689022|NCT03276728|102020330|FG005|NOT COMPLETED|Overall Study||0||
48689023|NCT03276728|102020331|FG006|NOT COMPLETED|Overall Study||2||
48689024|NCT03276728|102020332|FG007|NOT COMPLETED|Overall Study||1||
48689025|NCT03754556|102020333|FG000|STARTED|Overall Study||326658||
48689026|NCT03754556|102020333|FG000|COMPLETED|Overall Study||326658||
48689027|NCT03754556|102020333|FG000|NOT COMPLETED|Overall Study||0||
48689028|NCT04405999|102020334|FG000|STARTED|Overall Study||25||
48689029|NCT04405999|102020335|FG001|STARTED|Overall Study||25||
48689030|NCT04405999|102020334|FG000|COMPLETED|Overall Study||25||
48689031|NCT04405999|102020335|FG001|COMPLETED|Overall Study||25||
48689032|NCT04405999|102020334|FG000|NOT COMPLETED|Overall Study||0||
48689033|NCT04405999|102020335|FG001|NOT COMPLETED|Overall Study||0||
48689034|NCT03391986|102022597|FG000|STARTED|Overall Study||53||
48689035|NCT03391986|102022598|FG001|STARTED|Overall Study||50||
48689036|NCT03391986|102022599|FG002|STARTED|Overall Study||50||
48689037|NCT03391986|102022597|FG000|COMPLETED|Overall Study||53||
48689038|NCT03391986|102022598|FG001|COMPLETED|Overall Study||50||
48689039|NCT03391986|102022599|FG002|COMPLETED|Overall Study||50||
48689040|NCT03391986|102022597|FG000|NOT COMPLETED|Overall Study||0||
48689041|NCT03391986|102022598|FG001|NOT COMPLETED|Overall Study||0||
48689042|NCT03391986|102022599|FG002|NOT COMPLETED|Overall Study||0||
48689043|NCT02610972|102022600|FG000|STARTED|Overall Study||100||
48689044|NCT02610972|102022601|FG001|STARTED|Overall Study||50||
48689045|NCT02610972|102022600|FG000|COMPLETED|Overall Study||100||
48386624|NCT01861054|101276618|FG000|Safety Population|Overall Study||18||
48386625|NCT01861054|101276619|FG001|Safety Population|Overall Study||2||
48386626|NCT01861054|101276618|FG000|PK Population|Overall Study||4||
48689046|NCT02610972|102022601|FG001|COMPLETED|Overall Study||50||
48258148|NCT01850823|100951955|FG002|COMPLETED|Overall Study||345||
48386627|NCT01861054|101276619|FG001|PK Population|Overall Study||2||
48689047|NCT02610972|102022600|FG000|NOT COMPLETED|Overall Study||0||
48689048|NCT02610972|102022601|FG001|NOT COMPLETED|Overall Study||0||
48689049|NCT03181971|102022602|FG000|STARTED|Overall Study||690||9
48689050|NCT03181971|102022603|FG001|STARTED|Overall Study||594||9
48689051|NCT03181971|102022604|FG002|STARTED|Overall Study||13||0
48689052|NCT03181971|102022602|FG000|Students Who Started the Study|Overall Study||680||9
48689053|NCT03181971|102022603|FG001|Students Who Started the Study|Overall Study||582||9
48689054|NCT03181971|102022604|FG002|Students Who Started the Study|Overall Study||0||0
48689055|NCT03181971|102022602|FG000|Adults Who Started Study|Overall Study||10||9
48689056|NCT03181971|102022603|FG001|Adults Who Started Study|Overall Study||12||9
48689057|NCT03181971|102022604|FG002|Adults Who Started Study|Overall Study||13||0
48689058|NCT03181971|102022602|FG000|Students That Received Allocated Intervention / Participated in Allocated Control|Overall Study||677||9
48689059|NCT03181971|102022603|FG001|Students That Received Allocated Intervention / Participated in Allocated Control|Overall Study||572||9
48689060|NCT03181971|102022604|FG002|Students That Received Allocated Intervention / Participated in Allocated Control|Overall Study||0||0
48689061|NCT03181971|102022602|FG000|Students Who Completed the Study|Overall Study||548||9
48689062|NCT03181971|102022603|FG001|Students Who Completed the Study|Overall Study||510||9
48689063|NCT03181971|102022604|FG002|Students Who Completed the Study|Overall Study||0||0
48689064|NCT03181971|102022602|FG000|Adults Who Completed the Study|Overall Study||10||9
48689065|NCT03181971|102022603|FG001|Adults Who Completed the Study|Overall Study||12||9
48689066|NCT03181971|102022604|FG002|Adults Who Completed the Study|Overall Study||13||0
48689067|NCT03181971|102022602|FG000|COMPLETED|Overall Study||558||9
48689068|NCT03181971|102022603|FG001|COMPLETED|Overall Study||522||9
48258149|NCT01850823|100951953|FG000|NOT COMPLETED|Overall Study||3||
48386628|NCT01861054|101276618|FG000|COMPLETED|Overall Study||18||
48386629|NCT01861054|101276619|FG001|COMPLETED|Overall Study||2||
48386630|NCT01861054|101276618|FG000|NOT COMPLETED|Overall Study||0||
48258150|NCT01850823|100951954|FG001|NOT COMPLETED|Overall Study||3||
48258151|NCT01850823|100951955|FG002|NOT COMPLETED|Overall Study||10||
48386631|NCT01861054|101276619|FG001|NOT COMPLETED|Overall Study||0||
48258152|NCT02988349|100951956|FG000|STARTED|Overall Study||21||
48258153|NCT02988349|100951957|FG001|STARTED|Overall Study||21||
48386632|NCT01509872|101276620|FG000|STARTED|Overall Study||26||
48689069|NCT03181971|102022604|FG002|COMPLETED|Overall Study||13||0
48689070|NCT03181971|102022602|FG000|NOT COMPLETED|Overall Study||132||0
48689071|NCT03181971|102022603|FG001|NOT COMPLETED|Overall Study||72||0
48689072|NCT03181971|102022604|FG002|NOT COMPLETED|Overall Study||0||0
48093565|NCT00561080|100552064|FG002|NOT COMPLETED|12-month Post Last Dose Follow-up||10||
48093566|NCT00561080|100552062|FG000|STARTED|24-month Post Last Dose Follow-up||0||
48258154|NCT02988349|100951956|FG000|COMPLETED|Overall Study||21||
48258155|NCT02988349|100951957|FG001|COMPLETED|Overall Study||21||
48258156|NCT02988349|100951956|FG000|NOT COMPLETED|Overall Study||0||
48258157|NCT02988349|100951957|FG001|NOT COMPLETED|Overall Study||0||
48258158|NCT02569632|100951958|FG000|STARTED|Overall Study||18||
48258159|NCT02569632|100951958|FG000|COMPLETED|Overall Study||17||
48258160|NCT02569632|100951958|FG000|NOT COMPLETED|Overall Study||1||
48258161|NCT02062645|100951959|FG000|STARTED|Overall Study||115||
48258162|NCT02062645|100951959|FG000|COMPLETED|Overall Study||100||
48258163|NCT02062645|100951959|FG000|NOT COMPLETED|Overall Study||15||
48386633|NCT01509872|101276621|FG001|STARTED|Overall Study||24||
48386634|NCT01509872|101276620|FG000|Post-Intervention Assessment|Overall Study||26||
48386635|NCT01509872|101276621|FG001|Post-Intervention Assessment|Overall Study||24||
48386636|NCT01509872|101276620|FG000|COMPLETED|Overall Study||25||
48386637|NCT01509872|101276621|FG001|COMPLETED|Overall Study||24||
48386638|NCT01509872|101276620|FG000|NOT COMPLETED|Overall Study||1||
48689073|NCT03981744|102022605|FG000|STARTED|First Intervention (Prior to Week 24)||26||
48689074|NCT03981744|102022606|FG001|STARTED|First Intervention (Prior to Week 24)||25||
48689075|NCT03981744|102022607|FG002|STARTED|First Intervention (Prior to Week 24)||0||
48689076|NCT03981744|102022608|FG003|STARTED|First Intervention (Prior to Week 24)||0||
48689077|NCT03981744|102022605|FG000|COMPLETED|First Intervention (Prior to Week 24)||26||
48093567|NCT00561080|100552063|FG001|STARTED|24-month Post Last Dose Follow-up||0||
48093568|NCT00561080|100552064|FG002|STARTED|24-month Post Last Dose Follow-up||0||
48093569|NCT00561080|100552062|FG000|COMPLETED|24-month Post Last Dose Follow-up||0||
48093570|NCT00561080|100552063|FG001|COMPLETED|24-month Post Last Dose Follow-up||0||
48093571|NCT00561080|100552064|FG002|COMPLETED|24-month Post Last Dose Follow-up||0||
48093572|NCT00561080|100552062|FG000|NOT COMPLETED|24-month Post Last Dose Follow-up||0||
48093573|NCT00561080|100552063|FG001|NOT COMPLETED|24-month Post Last Dose Follow-up||0||
48093574|NCT00561080|100552064|FG002|NOT COMPLETED|24-month Post Last Dose Follow-up||0||
48093575|NCT00561080|100552062|FG000|STARTED|36 Month Post Last Dose Follow-up||0||
48093576|NCT00561080|100552063|FG001|STARTED|36 Month Post Last Dose Follow-up||0||
48093577|NCT00561080|100552064|FG002|STARTED|36 Month Post Last Dose Follow-up||0||
48093578|NCT00561080|100552062|FG000|COMPLETED|36 Month Post Last Dose Follow-up||0||
48093579|NCT00561080|100552063|FG001|COMPLETED|36 Month Post Last Dose Follow-up||0||
48093580|NCT00561080|100552064|FG002|COMPLETED|36 Month Post Last Dose Follow-up||0||
48093581|NCT00561080|100552062|FG000|NOT COMPLETED|36 Month Post Last Dose Follow-up||0||
48093582|NCT00561080|100552063|FG001|NOT COMPLETED|36 Month Post Last Dose Follow-up||0||
48093583|NCT00561080|100552064|FG002|NOT COMPLETED|36 Month Post Last Dose Follow-up||0||
48093584|NCT02255981|100552065|FG000|STARTED|Overall Study||33||64
48093585|NCT02255981|100552065|FG000|COMPLETED|Overall Study||29||56
48093586|NCT02255981|100552065|FG000|NOT COMPLETED|Overall Study||4||8
48093587|NCT01865539|100552066|FG000|STARTED|Overall Study||21||
48093588|NCT01865539|100552067|FG001|STARTED|Overall Study||30||
48093589|NCT01865539|100552066|FG000|COMPLETED|Overall Study||21||
48093590|NCT01865539|100552067|FG001|COMPLETED|Overall Study||30||
48093591|NCT01865539|100552066|FG000|NOT COMPLETED|Overall Study||0||
48093592|NCT01865539|100552067|FG001|NOT COMPLETED|Overall Study||0||
48093593|NCT01846507|100552068|FG000|STARTED|Overall Study||32||
48093594|NCT01846507|100552068|FG000|COMPLETED|Overall Study||25||
48093595|NCT01846507|100552068|FG000|NOT COMPLETED|Overall Study||7||
48093596|NCT00697203|100552069|FG000|STARTED|Overall Study||76||
48258164|NCT03018223|100951960|FG000|STARTED|Overall Study||32||
48093597|NCT00697203|100552070|FG001|STARTED|Overall Study||68||
48093598|NCT00697203|100552071|FG002|STARTED|Overall Study||74||
48093599|NCT00697203|100552072|FG003|STARTED|Overall Study||74||
48093600|NCT00697203|100552069|FG000|COMPLETED|Overall Study||67||
48093601|NCT00697203|100552070|FG001|COMPLETED|Overall Study||62||
48093602|NCT00697203|100552071|FG002|COMPLETED|Overall Study||66||
48258165|NCT03018223|100951960|FG000|COMPLETED|Overall Study||32||
48258166|NCT03018223|100951960|FG000|NOT COMPLETED|Overall Study||0||
48386639|NCT01509872|101276621|FG001|NOT COMPLETED|Overall Study||0||
48386640|NCT00750165|101276622|FG000|STARTED|Overall Study||32||
48386641|NCT00750165|101276622|FG000|COMPLETED|Overall Study||21||
48386642|NCT00750165|101276622|FG000|NOT COMPLETED|Overall Study||11||
48386643|NCT01236742|101276623|FG000|STARTED|Overall Study||18||
48386644|NCT01236742|101276624|FG001|STARTED|Overall Study||19||
48386645|NCT01236742|101276625|FG002|STARTED|Overall Study||16||
48258167|NCT00365547|100951961|FG000|STARTED|Overall Study||46||
48258168|NCT00365547|100951961|FG000|COMPLETED|Overall Study||43||
48386646|NCT01236742|101276623|FG000|COMPLETED|Overall Study||15||
48386647|NCT01236742|101276624|FG001|COMPLETED|Overall Study||16||
48258169|NCT00365547|100951961|FG000|NOT COMPLETED|Overall Study||3||
48258170|NCT03619889|100951962|FG000|STARTED|Overall Study||37||
48258171|NCT03619889|100951963|FG001|STARTED|Overall Study||37||
48258172|NCT03619889|100951962|FG000|COMPLETED|Overall Study||35||
48258173|NCT03619889|100951963|FG001|COMPLETED|Overall Study||37||
48258174|NCT03619889|100951962|FG000|NOT COMPLETED|Overall Study||2||
48258175|NCT03619889|100951963|FG001|NOT COMPLETED|Overall Study||0||
48258176|NCT03418493|100951964|FG000|STARTED|Overall Study||11||
48258177|NCT03418493|100951965|FG001|STARTED|Overall Study||3||
48258178|NCT03418493|100951966|FG002|STARTED|Overall Study||3||
48258179|NCT03418493|100951967|FG003|STARTED|Overall Study||6||
48258180|NCT03418493|100951968|FG004|STARTED|Overall Study||6||
48258181|NCT03418493|100951969|FG005|STARTED|Overall Study||6||
48258182|NCT03418493|100951970|FG006|STARTED|Overall Study||6||
48258183|NCT03418493|100951971|FG007|STARTED|Overall Study||6||
48258184|NCT03418493|100951972|FG008|STARTED|Overall Study||2||
48258185|NCT03418493|100951973|FG009|STARTED|Overall Study||6||
48258186|NCT03418493|100951974|FG010|STARTED|Overall Study||8||
48258187|NCT03418493|100951964|FG000|COMPLETED|Overall Study||10||
48258188|NCT03418493|100951965|FG001|COMPLETED|Overall Study||3||
48258189|NCT03418493|100951966|FG002|COMPLETED|Overall Study||3||
48258190|NCT03418493|100951967|FG003|COMPLETED|Overall Study||6||
48258191|NCT03418493|100951968|FG004|COMPLETED|Overall Study||6||
48258192|NCT03418493|100951969|FG005|COMPLETED|Overall Study||6||
48258193|NCT03418493|100951970|FG006|COMPLETED|Overall Study||6||
48258194|NCT03418493|100951971|FG007|COMPLETED|Overall Study||6||
48258195|NCT03418493|100951972|FG008|COMPLETED|Overall Study||2||
48258196|NCT03418493|100951973|FG009|COMPLETED|Overall Study||5||
48258197|NCT03418493|100951974|FG010|COMPLETED|Overall Study||8||
48258198|NCT03418493|100951964|FG000|NOT COMPLETED|Overall Study||1||
48258199|NCT03418493|100951965|FG001|NOT COMPLETED|Overall Study||0||
48258200|NCT03418493|100951966|FG002|NOT COMPLETED|Overall Study||0||
48258201|NCT03418493|100951967|FG003|NOT COMPLETED|Overall Study||0||
48258202|NCT03418493|100951968|FG004|NOT COMPLETED|Overall Study||0||
48258203|NCT03418493|100951969|FG005|NOT COMPLETED|Overall Study||0||
48258204|NCT03418493|100951970|FG006|NOT COMPLETED|Overall Study||0||
48258205|NCT03418493|100951971|FG007|NOT COMPLETED|Overall Study||0||
48258206|NCT03418493|100951972|FG008|NOT COMPLETED|Overall Study||0||
48258207|NCT03418493|100951973|FG009|NOT COMPLETED|Overall Study||1||
48258208|NCT03418493|100951974|FG010|NOT COMPLETED|Overall Study||0||
48258209|NCT03464383|100951975|FG000|STARTED|Overall Study||3||
48258210|NCT03464383|100951976|FG001|STARTED|Overall Study||3||
48258211|NCT03464383|100951977|FG002|STARTED|Overall Study||63||
48258212|NCT03464383|100951975|FG000|COMPLETED|Overall Study||2||
48258213|NCT03464383|100951976|FG001|COMPLETED|Overall Study||2||
48258214|NCT03464383|100951977|FG002|COMPLETED|Overall Study||63||
48258215|NCT03464383|100951975|FG000|NOT COMPLETED|Overall Study||1||
48258216|NCT03464383|100951976|FG001|NOT COMPLETED|Overall Study||1||
48386648|NCT01236742|101276625|FG002|COMPLETED|Overall Study||13||
48386649|NCT01236742|101276623|FG000|NOT COMPLETED|Overall Study||3||
48386650|NCT01236742|101276624|FG001|NOT COMPLETED|Overall Study||3||
48386651|NCT01236742|101276625|FG002|NOT COMPLETED|Overall Study||3||
48386652|NCT03162055|101276626|FG000|STARTED|Overall Study||559||
48386653|NCT03162055|101276627|FG001|STARTED|Overall Study||560||
48386654|NCT03162055|101276626|FG000|Received Treatment|Overall Study||557||
48386655|NCT03162055|101276627|FG001|Received Treatment|Overall Study||560||
48386656|NCT03162055|101276626|FG000|Safety Analysis Set|Overall Study||552||
48386657|NCT03162055|101276627|FG001|Safety Analysis Set|Overall Study||552||
48386658|NCT03162055|101276626|FG000|Full Analysis Set (FAS)|Overall Study||552||
48386659|NCT03162055|101276627|FG001|Full Analysis Set (FAS)|Overall Study||552||
48258217|NCT03464383|100951977|FG002|NOT COMPLETED|Overall Study||0||
48258218|NCT03634306|100951978|FG000|STARTED|Overall Study||15||
48258219|NCT03634306|100951979|FG001|STARTED|Overall Study||15||
48258220|NCT03634306|100951980|FG002|STARTED|Overall Study||5||
48258221|NCT03634306|100951978|FG000|COMPLETED|Overall Study||15||
48258222|NCT03634306|100951979|FG001|COMPLETED|Overall Study||15||
48258223|NCT03634306|100951980|FG002|COMPLETED|Overall Study||5||
48258224|NCT03634306|100951978|FG000|NOT COMPLETED|Overall Study||0||
48258225|NCT03634306|100951979|FG001|NOT COMPLETED|Overall Study||0||
48258226|NCT03634306|100951980|FG002|NOT COMPLETED|Overall Study||0||
48258227|NCT00469859|100951981|FG000|STARTED|Overall Study||6||
48258228|NCT00469859|100951982|FG001|STARTED|Overall Study||8||
48386660|NCT03162055|101276626|FG000|Per Protocol (PP) Analysis Set|Overall Study||506||
48386661|NCT03162055|101276627|FG001|Per Protocol (PP) Analysis Set|Overall Study||510||
48386662|NCT03162055|101276626|FG000|COMPLETED|Overall Study||497||
48258229|NCT00469859|100951981|FG000|COMPLETED|Overall Study||6||
48258230|NCT00469859|100951982|FG001|COMPLETED|Overall Study||6||
48258231|NCT00469859|100951981|FG000|NOT COMPLETED|Overall Study||0||
48258232|NCT00469859|100951982|FG001|NOT COMPLETED|Overall Study||2||
48258233|NCT00078728|100951983|FG000|STARTED|Overall Study||20||
48258234|NCT00078728|100951984|FG001|STARTED|Overall Study||20||
48258235|NCT00078728|100951983|FG000|COMPLETED|Overall Study||16||
48258236|NCT00078728|100951984|FG001|COMPLETED|Overall Study||17||
48258237|NCT00078728|100951983|FG000|NOT COMPLETED|Overall Study||4||
48258238|NCT00078728|100951984|FG001|NOT COMPLETED|Overall Study||3||
48258239|NCT00320398|100951985|FG000|STARTED|Overall Study||58||
48258240|NCT00320398|100951986|FG001|STARTED|Overall Study||56||
48258241|NCT00320398|100951985|FG000|COMPLETED|Overall Study||56||
48258242|NCT00320398|100951986|FG001|COMPLETED|Overall Study||52||
48258243|NCT00320398|100951985|FG000|NOT COMPLETED|Overall Study||2||
48258244|NCT00320398|100951986|FG001|NOT COMPLETED|Overall Study||4||
48258245|NCT04072445|100951987|FG000|STARTED|Overall Study||28||
48258246|NCT04072445|100951987|FG000|COMPLETED|Overall Study||27||
48258247|NCT04072445|100951987|FG000|NOT COMPLETED|Overall Study||1||
48258248|NCT00805285|100951988|FG000|STARTED|Overall Study||1||
48258249|NCT00805285|100951988|FG000|COMPLETED|Overall Study||0||
48258250|NCT00805285|100951988|FG000|NOT COMPLETED|Overall Study||1||
48258251|NCT00715117|100951989|FG000|STARTED|Overall Study||6||
48258252|NCT00715117|100951990|FG001|STARTED|Overall Study||6||
48258253|NCT00715117|100951989|FG000|Completion fo 8 Week Study|Overall Study||6||
48258254|NCT00715117|100951990|FG001|Completion fo 8 Week Study|Overall Study||6||
48258255|NCT00715117|100951989|FG000|COMPLETED|Overall Study||6||
48258256|NCT00715117|100951990|FG001|COMPLETED|Overall Study||5||
48258257|NCT00715117|100951989|FG000|NOT COMPLETED|Overall Study||0||
48258258|NCT00715117|100951990|FG001|NOT COMPLETED|Overall Study||1||
48258259|NCT01545557|100951991|FG000|STARTED|Overall Study||60||
48258260|NCT01545557|100951991|FG000|COMPLETED|Overall Study||60||
48258261|NCT01545557|100951991|FG000|NOT COMPLETED|Overall Study||0||
48258262|NCT02980705|100951992|FG000|STARTED|Overall Study||50||
48258263|NCT02980705|100951993|FG001|STARTED|Overall Study||51||
48258264|NCT02980705|100951992|FG000|COMPLETED|Overall Study||42||
48258265|NCT02980705|100951993|FG001|COMPLETED|Overall Study||40||
48258266|NCT02980705|100951992|FG000|NOT COMPLETED|Overall Study||8||
48258267|NCT02980705|100951993|FG001|NOT COMPLETED|Overall Study||11||
48258268|NCT00878553|100951994|FG000|STARTED|Sleep Study||67||
48258269|NCT00878553|100951995|FG001|STARTED|Sleep Study||0||
48258270|NCT00878553|100951996|FG002|STARTED|Sleep Study||0||
48258271|NCT00878553|100951997|FG003|STARTED|Sleep Study||0||
48386663|NCT03162055|101276627|FG001|COMPLETED|Overall Study||517||
48386664|NCT03162055|101276626|FG000|NOT COMPLETED|Overall Study||62||
48386665|NCT03162055|101276627|FG001|NOT COMPLETED|Overall Study||43||
48386666|NCT04368455|101276628|FG000|STARTED|Overall Study||97||
48386667|NCT04368455|101276629|FG001|STARTED|Overall Study||27||
48386668|NCT04368455|101276630|FG002|STARTED|Overall Study||37||
48386669|NCT04368455|101276628|FG000|COMPLETED|Overall Study||93||
48386670|NCT04368455|101276629|FG001|COMPLETED|Overall Study||27||
48386671|NCT04368455|101276630|FG002|COMPLETED|Overall Study||32||
48386672|NCT04368455|101276628|FG000|NOT COMPLETED|Overall Study||4||
48386673|NCT04368455|101276629|FG001|NOT COMPLETED|Overall Study||0||
48386674|NCT04368455|101276630|FG002|NOT COMPLETED|Overall Study||5||
48386675|NCT01206452|101276631|FG000|STARTED|Overall Study||30||
48386676|NCT01206452|101276632|FG001|STARTED|Overall Study||30||
48386677|NCT01206452|101276631|FG000|COMPLETED|Overall Study||30||
48386678|NCT01206452|101276632|FG001|COMPLETED|Overall Study||30||
48258272|NCT00878553|100951998|FG004|STARTED|Sleep Study||0||
48258273|NCT00878553|100951994|FG000|Number of Patients Receiving Placebo|Sleep Study||66||
48258274|NCT00878553|100951995|FG001|Number of Patients Receiving Placebo|Sleep Study||0||
48258275|NCT00878553|100951996|FG002|Number of Patients Receiving Placebo|Sleep Study||0||
48258276|NCT00878553|100951997|FG003|Number of Patients Receiving Placebo|Sleep Study||0||
48258277|NCT00878553|100951998|FG004|Number of Patients Receiving Placebo|Sleep Study||0||
48258278|NCT00878553|100951994|FG000|Number of Patients Receiving 10mg|Sleep Study||65||
48258279|NCT00878553|100951995|FG001|Number of Patients Receiving 10mg|Sleep Study||0||
48258280|NCT00878553|100951996|FG002|Number of Patients Receiving 10mg|Sleep Study||0||
48258281|NCT00878553|100951997|FG003|Number of Patients Receiving 10mg|Sleep Study||0||
48258282|NCT00878553|100951998|FG004|Number of Patients Receiving 10mg|Sleep Study||0||
48258283|NCT00878553|100951994|FG000|Number of Patients Receiving 15mg|Sleep Study||65||
48258284|NCT00878553|100951995|FG001|Number of Patients Receiving 15mg|Sleep Study||0||
48258285|NCT00878553|100951996|FG002|Number of Patients Receiving 15mg|Sleep Study||0||
48258286|NCT00878553|100951997|FG003|Number of Patients Receiving 15mg|Sleep Study||0||
48258287|NCT00878553|100951998|FG004|Number of Patients Receiving 15mg|Sleep Study||0||
48386679|NCT01206452|101276631|FG000|NOT COMPLETED|Overall Study||0||
48386680|NCT01206452|101276632|FG001|NOT COMPLETED|Overall Study||0||
48386681|NCT01148563|101276633|FG000|STARTED|Overall Study||69||
48386682|NCT01148563|101276634|FG001|STARTED|Overall Study||67||
48386683|NCT01148563|101276633|FG000|COMPLETED|Overall Study||40||
48386684|NCT01148563|101276634|FG001|COMPLETED|Overall Study||37||
48386685|NCT01148563|101276633|FG000|NOT COMPLETED|Overall Study||29||
48386686|NCT01148563|101276634|FG001|NOT COMPLETED|Overall Study||30||
48258288|NCT00878553|100951994|FG000|Number of Patients Receiving 20mg|Sleep Study||65||
48386687|NCT04511819|101276635|FG000|STARTED|Overall Study||26||
48386688|NCT04511819|101276636|FG001|STARTED|Overall Study||22||
48258289|NCT00878553|100951995|FG001|Number of Patients Receiving 20mg|Sleep Study||0||
48258290|NCT00878553|100951996|FG002|Number of Patients Receiving 20mg|Sleep Study||0||
48386689|NCT04511819|101276635|FG000|COMPLETED|Overall Study||20||
48386690|NCT04511819|101276636|FG001|COMPLETED|Overall Study||17||
48386691|NCT04511819|101276635|FG000|NOT COMPLETED|Overall Study||6||
48258291|NCT00878553|100951997|FG003|Number of Patients Receiving 20mg|Sleep Study||0||
48258292|NCT00878553|100951998|FG004|Number of Patients Receiving 20mg|Sleep Study||0||
48258293|NCT00878553|100951994|FG000|COMPLETED|Sleep Study||62||
48258294|NCT00878553|100951995|FG001|COMPLETED|Sleep Study||0||
48258295|NCT00878553|100951996|FG002|COMPLETED|Sleep Study||0||
48258296|NCT00878553|100951997|FG003|COMPLETED|Sleep Study||0||
48258297|NCT00878553|100951998|FG004|COMPLETED|Sleep Study||0||
48258298|NCT00878553|100951994|FG000|NOT COMPLETED|Sleep Study||5||
48258299|NCT00878553|100951995|FG001|NOT COMPLETED|Sleep Study||0||
48258300|NCT00878553|100951996|FG002|NOT COMPLETED|Sleep Study||0||
48258301|NCT00878553|100951997|FG003|NOT COMPLETED|Sleep Study||0||
48258302|NCT00878553|100951998|FG004|NOT COMPLETED|Sleep Study||0||
48258303|NCT00878553|100951994|FG000|STARTED|PK Study||0||
48258304|NCT00878553|100951995|FG001|STARTED|PK Study||16||
48258305|NCT00878553|100951996|FG002|STARTED|PK Study||17||
48258306|NCT00878553|100951997|FG003|STARTED|PK Study||14||
48258307|NCT00878553|100951998|FG004|STARTED|PK Study||15||
48258308|NCT00878553|100951994|FG000|COMPLETED|PK Study||0||
48258309|NCT00878553|100951995|FG001|COMPLETED|PK Study||16||
48258310|NCT00878553|100951996|FG002|COMPLETED|PK Study||17||
48258311|NCT00878553|100951997|FG003|COMPLETED|PK Study||13||
48258312|NCT00878553|100951998|FG004|COMPLETED|PK Study||15||
48258313|NCT00878553|100951994|FG000|NOT COMPLETED|PK Study||0||
48258314|NCT00878553|100951995|FG001|NOT COMPLETED|PK Study||0||
48258315|NCT00878553|100951996|FG002|NOT COMPLETED|PK Study||0||
48258316|NCT00878553|100951997|FG003|NOT COMPLETED|PK Study||1||
48258317|NCT00878553|100951998|FG004|NOT COMPLETED|PK Study||0||
48258318|NCT00926380|100951999|FG000|STARTED|Year 1||33||
48258319|NCT00926380|100952000|FG001|STARTED|Year 1||31||
48258320|NCT00926380|100952001|FG002|STARTED|Year 1||30||
48258321|NCT00926380|100951999|FG000|COMPLETED|Year 1||33||
48258322|NCT00926380|100952000|FG001|COMPLETED|Year 1||30||
48258323|NCT00926380|100952001|FG002|COMPLETED|Year 1||29||
48258324|NCT00926380|100951999|FG000|NOT COMPLETED|Year 1||0||
48258325|NCT00926380|100952000|FG001|NOT COMPLETED|Year 1||1||
48258326|NCT00926380|100952001|FG002|NOT COMPLETED|Year 1||1||
48258327|NCT00926380|100951999|FG000|STARTED|Year 2||33||
48258328|NCT00926380|100952000|FG001|STARTED|Year 2||30||
48258329|NCT00926380|100952001|FG002|STARTED|Year 2||29||
48258330|NCT00926380|100951999|FG000|COMPLETED|Year 2||31||
48258331|NCT00926380|100952000|FG001|COMPLETED|Year 2||28||
48258332|NCT00926380|100952001|FG002|COMPLETED|Year 2||24||
48258333|NCT00926380|100951999|FG000|NOT COMPLETED|Year 2||2||
48258334|NCT00926380|100952000|FG001|NOT COMPLETED|Year 2||2||
48258335|NCT00926380|100952001|FG002|NOT COMPLETED|Year 2||5||
48258336|NCT02806505|100952002|FG000|STARTED|Overall Study||38||
48258337|NCT02806505|100952003|FG001|STARTED|Overall Study||43||
48258338|NCT02806505|100952002|FG000|COMPLETED|Overall Study||28||
48258339|NCT02806505|100952003|FG001|COMPLETED|Overall Study||32||
48258340|NCT02806505|100952002|FG000|NOT COMPLETED|Overall Study||10||
48258341|NCT02806505|100952003|FG001|NOT COMPLETED|Overall Study||11||
48258342|NCT03367910|100952004|FG000|STARTED|Overall Study||1||
48258343|NCT03367910|100952004|FG000|COMPLETED|Overall Study||1||
48258344|NCT03367910|100952004|FG000|NOT COMPLETED|Overall Study||0||
48258345|NCT04131686|100952005|FG000|STARTED|Overall Study||146||6
48258346|NCT04131686|100952006|FG001|STARTED|Overall Study||148||6
48258347|NCT04131686|100952005|FG000|COMPLETED|Overall Study||138||6
48258348|NCT04131686|100952006|FG001|COMPLETED|Overall Study||143||6
48258349|NCT04131686|100952005|FG000|NOT COMPLETED|Overall Study||8||0
48258350|NCT04131686|100952006|FG001|NOT COMPLETED|Overall Study||5||0
48258351|NCT01006889|100952007|FG000|STARTED|Overall Study||20||
48258352|NCT01006889|100952007|FG000|COMPLETED|Overall Study||17||
48258353|NCT01006889|100952007|FG000|NOT COMPLETED|Overall Study||3||
48258354|NCT00665223|100952008|FG000|STARTED|Randomized Phase (26 Weeks)||144||
48258355|NCT00665223|100952009|FG001|STARTED|Randomized Phase (26 Weeks)||148||
48258356|NCT00665223|100952010|FG002|STARTED|Randomized Phase (26 Weeks)||145||
48258357|NCT00665223|100952008|FG000|Received at Least 1 Dose of Study Drug|Randomized Phase (26 Weeks)||144||
48258358|NCT00665223|100952009|FG001|Received at Least 1 Dose of Study Drug|Randomized Phase (26 Weeks)||148||
48592704|NCT01877382|101783161|FG011|NOT COMPLETED|Dose Expansion||0||
48258359|NCT00665223|100952010|FG002|Received at Least 1 Dose of Study Drug|Randomized Phase (26 Weeks)||145||
48258360|NCT00665223|100952008|FG000|COMPLETED|Randomized Phase (26 Weeks)||126||
48258361|NCT00665223|100952009|FG001|COMPLETED|Randomized Phase (26 Weeks)||136||
48258362|NCT00665223|100952010|FG002|COMPLETED|Randomized Phase (26 Weeks)||124||
48258363|NCT00665223|100952008|FG000|NOT COMPLETED|Randomized Phase (26 Weeks)||18||
48258364|NCT00665223|100952009|FG001|NOT COMPLETED|Randomized Phase (26 Weeks)||12||
48258365|NCT00665223|100952010|FG002|NOT COMPLETED|Randomized Phase (26 Weeks)||21||
48258366|NCT00665223|100952008|FG000|STARTED|Open-Label Period (26 Weeks)||113||
48258367|NCT00665223|100952009|FG001|STARTED|Open-Label Period (26 Weeks)||125||
48258368|NCT00665223|100952010|FG002|STARTED|Open-Label Period (26 Weeks)||115||
48258369|NCT00665223|100952008|FG000|COMPLETED|Open-Label Period (26 Weeks)||97||
48258370|NCT00665223|100952009|FG001|COMPLETED|Open-Label Period (26 Weeks)||108||
48258371|NCT00665223|100952010|FG002|COMPLETED|Open-Label Period (26 Weeks)||100||
48258372|NCT00665223|100952008|FG000|NOT COMPLETED|Open-Label Period (26 Weeks)||16||
48258373|NCT00665223|100952009|FG001|NOT COMPLETED|Open-Label Period (26 Weeks)||17||
48258374|NCT00665223|100952010|FG002|NOT COMPLETED|Open-Label Period (26 Weeks)||15||
48258375|NCT02416713|100952011|FG000|STARTED|Overall Study||8||
48258376|NCT02416713|100952012|FG001|STARTED|Overall Study||9||
48258377|NCT02416713|100952013|FG002|STARTED|Overall Study||8||
48258378|NCT02416713|100952014|FG003|STARTED|Overall Study||10||
48258379|NCT02416713|100952011|FG000|COMPLETED|Overall Study||8||
48258380|NCT02416713|100952012|FG001|COMPLETED|Overall Study||9||
48386692|NCT04511819|101276636|FG001|NOT COMPLETED|Overall Study||5||
48386693|NCT01767519|101276637|FG000|STARTED|Overall Study||145||
48386694|NCT01767519|101276638|FG001|STARTED|Overall Study||151||
48386695|NCT01767519|101276639|FG002|STARTED|Overall Study||60||
48386696|NCT01767519|101276637|FG000|COMPLETED|Overall Study||131||
48386697|NCT01767519|101276638|FG001|COMPLETED|Overall Study||138||
48386698|NCT01767519|101276639|FG002|COMPLETED|Overall Study||55||
48386699|NCT01767519|101276637|FG000|NOT COMPLETED|Overall Study||14||
48386700|NCT01767519|101276638|FG001|NOT COMPLETED|Overall Study||13||
48386701|NCT01767519|101276639|FG002|NOT COMPLETED|Overall Study||5||
48386702|NCT01594294|101276640|FG000|STARTED|Overall Study||39||
48386703|NCT01594294|101276641|FG001|STARTED|Overall Study||40||
48386704|NCT01594294|101276640|FG000|COMPLETED|Overall Study||36||
48386705|NCT01594294|101276641|FG001|COMPLETED|Overall Study||36||
48386706|NCT01594294|101276640|FG000|NOT COMPLETED|Overall Study||3||
48386707|NCT01594294|101276641|FG001|NOT COMPLETED|Overall Study||4||
48386708|NCT02769351|101276642|FG000|STARTED|Overall Study||46||
48386709|NCT02769351|101276642|FG000|COMPLETED|Overall Study||4||
48386710|NCT02769351|101276642|FG000|NOT COMPLETED|Overall Study||42||
48386711|NCT03019744|101276643|FG000|STARTED|Overall Study||38||
48386712|NCT03019744|101276644|FG001|STARTED|Overall Study||44||
48386713|NCT03019744|101276643|FG000|COMPLETED|Overall Study||32||
48386714|NCT03019744|101276644|FG001|COMPLETED|Overall Study||36||
48386715|NCT03019744|101276643|FG000|NOT COMPLETED|Overall Study||6||
48386716|NCT03019744|101276644|FG001|NOT COMPLETED|Overall Study||8||
48386717|NCT03695393|101276645|FG000|STARTED|Overall Study||67||
48386718|NCT03695393|101276646|FG001|STARTED|Overall Study||33||
48386719|NCT03695393|101276645|FG000|1-month|Overall Study||66||
48386720|NCT03695393|101276646|FG001|1-month|Overall Study||32||
48386721|NCT03695393|101276645|FG000|6-month|Overall Study||64||
48386722|NCT03695393|101276646|FG001|6-month|Overall Study||31||
48386723|NCT03695393|101276645|FG000|COMPLETED|Overall Study||64||
48386724|NCT03695393|101276646|FG001|COMPLETED|Overall Study||31||
48386725|NCT03695393|101276645|FG000|NOT COMPLETED|Overall Study||3||
48386726|NCT03695393|101276646|FG001|NOT COMPLETED|Overall Study||2||
48386727|NCT00131664|101276647|FG000|STARTED|First Period (First 6 Months)||136||
48386728|NCT00131664|101276648|FG001|STARTED|First Period (First 6 Months)||135||
48386729|NCT00131664|101276649|FG002|STARTED|First Period (First 6 Months)||120||
48386730|NCT00131664|101276650|FG003|STARTED|First Period (First 6 Months)||0||
48386731|NCT00131664|101276651|FG004|STARTED|First Period (First 6 Months)||0||
48386732|NCT00131664|101276652|FG005|STARTED|First Period (First 6 Months)||0||
48386733|NCT00131664|101276647|FG000|COMPLETED|First Period (First 6 Months)||111||
48386734|NCT00131664|101276648|FG001|COMPLETED|First Period (First 6 Months)||117||
48386735|NCT00131664|101276649|FG002|COMPLETED|First Period (First 6 Months)||104||
48386736|NCT00131664|101276650|FG003|COMPLETED|First Period (First 6 Months)||0||
48386737|NCT00131664|101276651|FG004|COMPLETED|First Period (First 6 Months)||0||
48386738|NCT00131664|101276652|FG005|COMPLETED|First Period (First 6 Months)||0||
48386739|NCT00131664|101276647|FG000|NOT COMPLETED|First Period (First 6 Months)||25||
48386740|NCT00131664|101276648|FG001|NOT COMPLETED|First Period (First 6 Months)||18||
48386741|NCT00131664|101276649|FG002|NOT COMPLETED|First Period (First 6 Months)||16||
48386742|NCT00131664|101276650|FG003|NOT COMPLETED|First Period (First 6 Months)||0||
48386743|NCT00131664|101276651|FG004|NOT COMPLETED|First Period (First 6 Months)||0||
48386744|NCT00131664|101276652|FG005|NOT COMPLETED|First Period (First 6 Months)||0||
48386745|NCT00131664|101276647|FG000|STARTED|Second Period (Additional Drug Added)||90||
48541742|NCT03095638|101662796|FG007|NOT COMPLETED|P2: Period 1 (4 Days)||0||
48258381|NCT02416713|100952013|FG002|COMPLETED|Overall Study||8||
48258382|NCT02416713|100952014|FG003|COMPLETED|Overall Study||10||
48258383|NCT02416713|100952011|FG000|NOT COMPLETED|Overall Study||0||
48258384|NCT02416713|100952012|FG001|NOT COMPLETED|Overall Study||0||
48258385|NCT02416713|100952013|FG002|NOT COMPLETED|Overall Study||0||
48258386|NCT02416713|100952014|FG003|NOT COMPLETED|Overall Study||0||
48258387|NCT02635386|100952015|FG000|STARTED|Overall Study||23||
48258388|NCT02635386|100952016|FG001|STARTED|Overall Study||23||
48386746|NCT00131664|101276648|FG001|STARTED|Second Period (Additional Drug Added)||101||
48258389|NCT02635386|100952017|FG002|STARTED|Overall Study||22||
48258390|NCT02635386|100952018|FG003|STARTED|Overall Study||26||
48386747|NCT00131664|101276649|FG002|STARTED|Second Period (Additional Drug Added)||79||
48386748|NCT00131664|101276650|FG003|STARTED|Second Period (Additional Drug Added)||21||
48386749|NCT00131664|101276651|FG004|STARTED|Second Period (Additional Drug Added)||16||
48386750|NCT00131664|101276652|FG005|STARTED|Second Period (Additional Drug Added)||25||
48386751|NCT00131664|101276647|FG000|COMPLETED|Second Period (Additional Drug Added)||81||
48386752|NCT00131664|101276648|FG001|COMPLETED|Second Period (Additional Drug Added)||97||
48386753|NCT00131664|101276649|FG002|COMPLETED|Second Period (Additional Drug Added)||76||
48386754|NCT00131664|101276650|FG003|COMPLETED|Second Period (Additional Drug Added)||19||
48386755|NCT00131664|101276651|FG004|COMPLETED|Second Period (Additional Drug Added)||15||
48386756|NCT00131664|101276652|FG005|COMPLETED|Second Period (Additional Drug Added)||22||
48386757|NCT00131664|101276647|FG000|NOT COMPLETED|Second Period (Additional Drug Added)||9||
48386758|NCT00131664|101276648|FG001|NOT COMPLETED|Second Period (Additional Drug Added)||4||
48386759|NCT00131664|101276649|FG002|NOT COMPLETED|Second Period (Additional Drug Added)||3||
48386760|NCT00131664|101276650|FG003|NOT COMPLETED|Second Period (Additional Drug Added)||2||
48386761|NCT00131664|101276651|FG004|NOT COMPLETED|Second Period (Additional Drug Added)||1||
48386762|NCT00131664|101276652|FG005|NOT COMPLETED|Second Period (Additional Drug Added)||3||
48386763|NCT01608490|101276653|FG000|STARTED|Overall Study||158||
48386764|NCT01608490|101276654|FG001|STARTED|Overall Study||157||
48386765|NCT01608490|101276653|FG000|COMPLETED|Overall Study||141||
48386766|NCT01608490|101276654|FG001|COMPLETED|Overall Study||142||
48386767|NCT01608490|101276653|FG000|NOT COMPLETED|Overall Study||17||
48386768|NCT01608490|101276654|FG001|NOT COMPLETED|Overall Study||15||
48386769|NCT01290445|101276655|FG000|STARTED|Overall Study||335||
48386770|NCT01290445|101276656|FG001|STARTED|Overall Study||78412||
48386771|NCT01290445|101276657|FG002|STARTED|Overall Study||806438||
48386772|NCT01290445|101276655|FG000|COMPLETED|Overall Study||335||
48386773|NCT01290445|101276656|FG001|COMPLETED|Overall Study||78412||
48386774|NCT01290445|101276657|FG002|COMPLETED|Overall Study||806438||
48386775|NCT01290445|101276655|FG000|NOT COMPLETED|Overall Study||0||
48386776|NCT01290445|101276656|FG001|NOT COMPLETED|Overall Study||0||
48386777|NCT01290445|101276657|FG002|NOT COMPLETED|Overall Study||0||
48386778|NCT01353144|101276658|FG000|STARTED|Overall Study||89||
48386779|NCT01353144|101276659|FG001|STARTED|Overall Study||89||
48386780|NCT01353144|101276658|FG000|COMPLETED|Overall Study||80||
48386781|NCT01353144|101276659|FG001|COMPLETED|Overall Study||81||
48386782|NCT01353144|101276658|FG000|NOT COMPLETED|Overall Study||9||
48386783|NCT01353144|101276659|FG001|NOT COMPLETED|Overall Study||8||
48386784|NCT01929473|101276660|FG000|STARTED|Overall Study||3830||
48386785|NCT01929473|101276660|FG000|365 Day|Overall Study||3589||
48386786|NCT01929473|101276660|FG000|COMPLETED|Overall Study||3243||
48386787|NCT01929473|101276660|FG000|NOT COMPLETED|Overall Study||587||
48386788|NCT03822871|101276661|FG000|STARTED|Overall Study||1||
48386789|NCT03822871|101276662|FG001|STARTED|Overall Study||1||
48386790|NCT03822871|101276663|FG002|STARTED|Overall Study||1||
48386791|NCT03822871|101276664|FG003|STARTED|Overall Study||3||
48386792|NCT03822871|101276665|FG004|STARTED|Overall Study||4||
48386793|NCT03822871|101276666|FG005|STARTED|Overall Study||3||
48386794|NCT03822871|101276667|FG006|STARTED|Overall Study||3||
48386795|NCT03822871|101276668|FG007|STARTED|Overall Study||1||
48386796|NCT03822871|101276661|FG000|COMPLETED|Overall Study||1||
48386797|NCT03822871|101276662|FG001|COMPLETED|Overall Study||1||
48386798|NCT03822871|101276663|FG002|COMPLETED|Overall Study||1||
48386799|NCT03822871|101276664|FG003|COMPLETED|Overall Study||3||
48386800|NCT03822871|101276665|FG004|COMPLETED|Overall Study||4||
48386801|NCT03822871|101276666|FG005|COMPLETED|Overall Study||3||
48386802|NCT03822871|101276667|FG006|COMPLETED|Overall Study||3||
48386803|NCT03822871|101276668|FG007|COMPLETED|Overall Study||1||
48386804|NCT03822871|101276661|FG000|NOT COMPLETED|Overall Study||0||
48386805|NCT03822871|101276662|FG001|NOT COMPLETED|Overall Study||0||
48386806|NCT03822871|101276663|FG002|NOT COMPLETED|Overall Study||0||
48386807|NCT03822871|101276664|FG003|NOT COMPLETED|Overall Study||0||
48386808|NCT03822871|101276665|FG004|NOT COMPLETED|Overall Study||0||
48689078|NCT03981744|102022606|FG001|COMPLETED|First Intervention (Prior to Week 24)||23||
48689079|NCT03981744|102022607|FG002|COMPLETED|First Intervention (Prior to Week 24)||0||
48689080|NCT03981744|102022608|FG003|COMPLETED|First Intervention (Prior to Week 24)||0||
48689081|NCT03981744|102022605|FG000|NOT COMPLETED|First Intervention (Prior to Week 24)||0||
48689082|NCT03981744|102022606|FG001|NOT COMPLETED|First Intervention (Prior to Week 24)||2||
48689083|NCT03981744|102022607|FG002|NOT COMPLETED|First Intervention (Prior to Week 24)||0||
48689084|NCT03981744|102022608|FG003|NOT COMPLETED|First Intervention (Prior to Week 24)||0||
48689085|NCT03981744|102022605|FG000|STARTED|Second Intervention (Week 24 to Week 72)||0||
48689086|NCT03981744|102022606|FG001|STARTED|Second Intervention (Week 24 to Week 72)||0||
48689087|NCT03981744|102022607|FG002|STARTED|Second Intervention (Week 24 to Week 72)||26||
48689088|NCT03981744|102022608|FG003|STARTED|Second Intervention (Week 24 to Week 72)||23||
48689089|NCT03981744|102022605|FG000|COMPLETED|Second Intervention (Week 24 to Week 72)||0||
48386809|NCT03822871|101276666|FG005|NOT COMPLETED|Overall Study||0||
48386810|NCT03822871|101276667|FG006|NOT COMPLETED|Overall Study||0||
48386811|NCT03822871|101276668|FG007|NOT COMPLETED|Overall Study||0||
48386812|NCT01360762|101276669|FG000|STARTED|Main Study Period (12-month Treatment)||74||
48386813|NCT01360762|101276669|FG000|COMPLETED|Main Study Period (12-month Treatment)||45||
48386814|NCT01360762|101276669|FG000|NOT COMPLETED|Main Study Period (12-month Treatment)||29||
48386815|NCT01360762|101276669|FG000|STARTED|Whole Study Period||74|Treatment period and extended treatment period and follow-up period|
48386816|NCT01360762|101276669|FG000|COMPLETED|Whole Study Period||38||
48386817|NCT01360762|101276669|FG000|NOT COMPLETED|Whole Study Period||36||
48386818|NCT00240539|101276670|FG000|STARTED|Overall Study||2||
48386819|NCT00240539|101276671|FG001|STARTED|Overall Study||2||
48386820|NCT00240539|101276672|FG002|STARTED|Overall Study||31||
48386821|NCT00240539|101276673|FG003|STARTED|Overall Study||1||
48386822|NCT00240539|101276670|FG000|COMPLETED|Overall Study||2||
48386823|NCT00240539|101276671|FG001|COMPLETED|Overall Study||2||
48386824|NCT00240539|101276672|FG002|COMPLETED|Overall Study||31||
48093603|NCT00697203|100552072|FG003|COMPLETED|Overall Study||67||
48093604|NCT00697203|100552069|FG000|NOT COMPLETED|Overall Study||9||
48093605|NCT00697203|100552070|FG001|NOT COMPLETED|Overall Study||6||
48093606|NCT00697203|100552071|FG002|NOT COMPLETED|Overall Study||8||
48093607|NCT00697203|100552072|FG003|NOT COMPLETED|Overall Study||7||
48093608|NCT01594125|100552073|FG000|STARTED|Overall Study||4||
48093609|NCT01594125|100552074|FG001|STARTED|Overall Study||12||
48093610|NCT01594125|100552075|FG002|STARTED|Overall Study||3||
48093611|NCT01594125|100552076|FG003|STARTED|Overall Study||4||
48093612|NCT01594125|100552077|FG004|STARTED|Overall Study||7||
48093613|NCT01594125|100552073|FG000|COMPLETED|Overall Study||0||
48093614|NCT01594125|100552074|FG001|COMPLETED|Overall Study||0||
48093615|NCT01594125|100552075|FG002|COMPLETED|Overall Study||0||
48093616|NCT01594125|100552076|FG003|COMPLETED|Overall Study||0||
48258391|NCT02635386|100952019|FG004|STARTED|Overall Study||25||
48093617|NCT01594125|100552077|FG004|COMPLETED|Overall Study||0||
48258392|NCT02635386|100952015|FG000|COMPLETED|Overall Study||20||
48258393|NCT02635386|100952016|FG001|COMPLETED|Overall Study||17||
48258394|NCT02635386|100952017|FG002|COMPLETED|Overall Study||20||
48258395|NCT02635386|100952018|FG003|COMPLETED|Overall Study||19||
48258396|NCT02635386|100952019|FG004|COMPLETED|Overall Study||16||
48258397|NCT02635386|100952015|FG000|NOT COMPLETED|Overall Study||3||
48258398|NCT02635386|100952016|FG001|NOT COMPLETED|Overall Study||6||
48258399|NCT02635386|100952017|FG002|NOT COMPLETED|Overall Study||2||
48258400|NCT02635386|100952018|FG003|NOT COMPLETED|Overall Study||7||
48258401|NCT02635386|100952019|FG004|NOT COMPLETED|Overall Study||9||
48258402|NCT00498615|100952020|FG000|STARTED|Fasudil 80mg||2||
48258403|NCT00498615|100952021|FG001|STARTED|Fasudil 80mg||4||
48258404|NCT00498615|100952022|FG002|STARTED|Fasudil 80mg||3||
48258405|NCT00498615|100952023|FG003|STARTED|Fasudil 80mg||2||
48258406|NCT00498615|100952024|FG004|STARTED|Fasudil 80mg||3||
48258407|NCT00498615|100952025|FG005|STARTED|Fasudil 80mg||3||
48258408|NCT00498615|100952020|FG000|COMPLETED|Fasudil 80mg||2||
48258409|NCT00498615|100952021|FG001|COMPLETED|Fasudil 80mg||4||
48258410|NCT00498615|100952022|FG002|COMPLETED|Fasudil 80mg||3||
48258411|NCT00498615|100952023|FG003|COMPLETED|Fasudil 80mg||2||
48258412|NCT00498615|100952024|FG004|COMPLETED|Fasudil 80mg||3||
48258413|NCT00498615|100952025|FG005|COMPLETED|Fasudil 80mg||3||
48258414|NCT00498615|100952020|FG000|NOT COMPLETED|Fasudil 80mg||0||
48258415|NCT00498615|100952021|FG001|NOT COMPLETED|Fasudil 80mg||0||
48258416|NCT00498615|100952022|FG002|NOT COMPLETED|Fasudil 80mg||0||
48258417|NCT00498615|100952023|FG003|NOT COMPLETED|Fasudil 80mg||0||
48258418|NCT00498615|100952024|FG004|NOT COMPLETED|Fasudil 80mg||0||
48258419|NCT00498615|100952025|FG005|NOT COMPLETED|Fasudil 80mg||0||
48258420|NCT00498615|100952020|FG000|STARTED|Fasudil 40mg||2||
48258421|NCT00498615|100952021|FG001|STARTED|Fasudil 40mg||4||
48258422|NCT00498615|100952022|FG002|STARTED|Fasudil 40mg||3||
48258423|NCT00498615|100952023|FG003|STARTED|Fasudil 40mg||2||
48258424|NCT00498615|100952024|FG004|STARTED|Fasudil 40mg||3||
48258425|NCT00498615|100952025|FG005|STARTED|Fasudil 40mg||3||
48258426|NCT00498615|100952020|FG000|COMPLETED|Fasudil 40mg||2||
48258427|NCT00498615|100952021|FG001|COMPLETED|Fasudil 40mg||4||
48258428|NCT00498615|100952022|FG002|COMPLETED|Fasudil 40mg||3||
48258429|NCT00498615|100952023|FG003|COMPLETED|Fasudil 40mg||2||
48258430|NCT00498615|100952024|FG004|COMPLETED|Fasudil 40mg||3||
48258431|NCT00498615|100952025|FG005|COMPLETED|Fasudil 40mg||3||
48258432|NCT00498615|100952020|FG000|NOT COMPLETED|Fasudil 40mg||0||
48258433|NCT00498615|100952021|FG001|NOT COMPLETED|Fasudil 40mg||0||
48258434|NCT00498615|100952022|FG002|NOT COMPLETED|Fasudil 40mg||0||
48258435|NCT00498615|100952023|FG003|NOT COMPLETED|Fasudil 40mg||0||
48258436|NCT00498615|100952024|FG004|NOT COMPLETED|Fasudil 40mg||0||
48258437|NCT00498615|100952025|FG005|NOT COMPLETED|Fasudil 40mg||0||
48258438|NCT00498615|100952020|FG000|STARTED|Placebo||2||
48258439|NCT00498615|100952021|FG001|STARTED|Placebo||4||
48258440|NCT00498615|100952022|FG002|STARTED|Placebo||3||
48258441|NCT00498615|100952023|FG003|STARTED|Placebo||2||
48258442|NCT00498615|100952024|FG004|STARTED|Placebo||3||
48258443|NCT00498615|100952025|FG005|STARTED|Placebo||3||
48258444|NCT00498615|100952020|FG000|COMPLETED|Placebo||2||
48258445|NCT00498615|100952021|FG001|COMPLETED|Placebo||4||
48258446|NCT00498615|100952022|FG002|COMPLETED|Placebo||3||
48258447|NCT00498615|100952023|FG003|COMPLETED|Placebo||2||
48258448|NCT00498615|100952024|FG004|COMPLETED|Placebo||3||
48258449|NCT00498615|100952025|FG005|COMPLETED|Placebo||3||
48258450|NCT00498615|100952020|FG000|NOT COMPLETED|Placebo||0||
48258451|NCT00498615|100952021|FG001|NOT COMPLETED|Placebo||0||
48258452|NCT00498615|100952022|FG002|NOT COMPLETED|Placebo||0||
48258453|NCT00498615|100952023|FG003|NOT COMPLETED|Placebo||0||
48258454|NCT00498615|100952024|FG004|NOT COMPLETED|Placebo||0||
48258455|NCT00498615|100952025|FG005|NOT COMPLETED|Placebo||0||
48258456|NCT03042299|100952026|FG000|STARTED|Intervention Period 1 (6 Days)||7||
48093618|NCT01594125|100552073|FG000|NOT COMPLETED|Overall Study||4||
48093619|NCT01594125|100552074|FG001|NOT COMPLETED|Overall Study||12||
48093620|NCT01594125|100552075|FG002|NOT COMPLETED|Overall Study||3||
48093621|NCT01594125|100552076|FG003|NOT COMPLETED|Overall Study||4||
48093622|NCT01594125|100552077|FG004|NOT COMPLETED|Overall Study||7||
48093623|NCT02237950|100552078|FG000|STARTED|Overall Study||295||
48093624|NCT02237950|100552079|FG001|STARTED|Overall Study||291||
48093625|NCT02237950|100552078|FG000|COMPLETED|Overall Study||247||
48093626|NCT02237950|100552079|FG001|COMPLETED|Overall Study||243||
48093627|NCT02237950|100552078|FG000|NOT COMPLETED|Overall Study||48||
48093628|NCT02237950|100552079|FG001|NOT COMPLETED|Overall Study||48||
48093629|NCT01712854|100552080|FG000|STARTED|Overall Study||9||
48093630|NCT01712854|100552080|FG000|COMPLETED|Overall Study||8||
48093631|NCT01712854|100552080|FG000|NOT COMPLETED|Overall Study||1||
48093632|NCT01590238|100552081|FG000|STARTED|Overall Study||15||
48093633|NCT01590238|100552081|FG000|COMPLETED|Overall Study||13||
48258457|NCT03042299|100952027|FG001|STARTED|Intervention Period 1 (6 Days)||7||
48258458|NCT03042299|100952026|FG000|COMPLETED|Intervention Period 1 (6 Days)||7||
48258459|NCT03042299|100952027|FG001|COMPLETED|Intervention Period 1 (6 Days)||7||
48258460|NCT03042299|100952026|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0||
48258461|NCT03042299|100952027|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0||
48258462|NCT03042299|100952026|FG000|STARTED|Washout Period (at Least 6 Days)||7||
48258463|NCT03042299|100952027|FG001|STARTED|Washout Period (at Least 6 Days)||7||
48258464|NCT03042299|100952026|FG000|COMPLETED|Washout Period (at Least 6 Days)||7||
48258465|NCT03042299|100952027|FG001|COMPLETED|Washout Period (at Least 6 Days)||7||
48258466|NCT03042299|100952026|FG000|NOT COMPLETED|Washout Period (at Least 6 Days)||0||
48258467|NCT03042299|100952027|FG001|NOT COMPLETED|Washout Period (at Least 6 Days)||0||
48258468|NCT03042299|100952026|FG000|STARTED|Intervention Period 2 (6 Days)||7||
48258469|NCT03042299|100952027|FG001|STARTED|Intervention Period 2 (6 Days)||7||
48258470|NCT03042299|100952026|FG000|COMPLETED|Intervention Period 2 (6 Days)||7||
48258471|NCT03042299|100952027|FG001|COMPLETED|Intervention Period 2 (6 Days)||7||
48258472|NCT03042299|100952026|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0||
48258473|NCT03042299|100952027|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0||
48258474|NCT03796208|100952028|FG000|STARTED|Overall Study||40||
48258475|NCT03796208|100952029|FG001|STARTED|Overall Study||38||
48258476|NCT03796208|100952028|FG000|COMPLETED|Overall Study||16||
48258477|NCT03796208|100952029|FG001|COMPLETED|Overall Study||16||
48258478|NCT03796208|100952028|FG000|NOT COMPLETED|Overall Study||24||
48258479|NCT03796208|100952029|FG001|NOT COMPLETED|Overall Study||22||
48258480|NCT00263575|100952030|FG000|STARTED|Titration Period||139||
48258481|NCT00263575|100952030|FG000|COMPLETED|Titration Period||96||
48258482|NCT00263575|100952030|FG000|NOT COMPLETED|Titration Period||43||
48258483|NCT00263575|100952030|FG000|STARTED|Maintence Period||96||
48258484|NCT00263575|100952030|FG000|COMPLETED|Maintence Period||19||
48258485|NCT00263575|100952030|FG000|NOT COMPLETED|Maintence Period||77||
48592705|NCT01877382|101783162|FG012|NOT COMPLETED|Dose Expansion||0||
48093634|NCT01590238|100552081|FG000|NOT COMPLETED|Overall Study||2||
48093635|NCT00849381|100552082|FG000|STARTED|Overall Study||1237||
48093636|NCT00849381|100552082|FG000|COMPLETED|Overall Study||1092||
48093637|NCT00849381|100552082|FG000|NOT COMPLETED|Overall Study||145||
48093638|NCT02677987|100552083|FG000|STARTED|Overall Study||23||
48093639|NCT02677987|100552084|FG001|STARTED|Overall Study||24||
48093640|NCT02677987|100552083|FG000|COMPLETED|Overall Study||19||
48093641|NCT02677987|100552084|FG001|COMPLETED|Overall Study||24||
48093642|NCT02677987|100552083|FG000|NOT COMPLETED|Overall Study||4||
48093643|NCT02677987|100552084|FG001|NOT COMPLETED|Overall Study||0||
48093644|NCT00937157|100552085|FG000|STARTED|Overall Study||12||
48093645|NCT00937157|100552085|FG000|COMPLETED|Overall Study||8||
48093646|NCT00937157|100552085|FG000|NOT COMPLETED|Overall Study||4||
48093647|NCT05517382|100552086|FG000|STARTED|Overall Study||31||
48093648|NCT05517382|100552087|FG001|STARTED|Overall Study||29||
48093649|NCT05517382|100552086|FG000|Completed Baseline Measures|Overall Study||31||
48093650|NCT05517382|100552087|FG001|Completed Baseline Measures|Overall Study||29||
48093651|NCT05517382|100552086|FG000|Completed 3 Month Follow up|Overall Study||31||
48093652|NCT05517382|100552087|FG001|Completed 3 Month Follow up|Overall Study||28||
48093653|NCT05517382|100552086|FG000|COMPLETED|Overall Study||31||
48093654|NCT05517382|100552087|FG001|COMPLETED|Overall Study||28||
48093655|NCT05517382|100552086|FG000|NOT COMPLETED|Overall Study||0||
48093656|NCT05517382|100552087|FG001|NOT COMPLETED|Overall Study||1||
48093657|NCT00461682|100552088|FG000|STARTED|Overall Study||1||
48093658|NCT00461682|100552088|FG000|COMPLETED|Overall Study||0||
48093659|NCT00461682|100552088|FG000|NOT COMPLETED|Overall Study||1||
48093660|NCT00022633|100552089|FG000|STARTED|Overall Study||55||
48093661|NCT00022633|100552090|FG001|STARTED|Overall Study||10||
48093662|NCT00022633|100552089|FG000|Eligible|Overall Study||51||
48093663|NCT00022633|100552090|FG001|Eligible|Overall Study||10||
48093664|NCT00022633|100552089|FG000|COMPLETED|Overall Study||23||
48093665|NCT00022633|100552090|FG001|COMPLETED|Overall Study||5||
48093666|NCT00022633|100552089|FG000|NOT COMPLETED|Overall Study||32||
48093667|NCT00022633|100552090|FG001|NOT COMPLETED|Overall Study||5||
48093668|NCT00982592|100552091|FG000|STARTED|Overall Study||64||
48258486|NCT00776659|100952031|FG000|STARTED|Overall Study||39||
48093669|NCT00982592|100552092|FG001|STARTED|Overall Study||60||
48093670|NCT00982592|100552091|FG000|Treatment Received|Overall Study||63||
48093671|NCT00982592|100552092|FG001|Treatment Received|Overall Study||52||
48093672|NCT00982592|100552091|FG000|COMPLETED|Overall Study||33||
48093673|NCT00982592|100552092|FG001|COMPLETED|Overall Study||27||
48093674|NCT00982592|100552091|FG000|NOT COMPLETED|Overall Study||31||
48093675|NCT00982592|100552092|FG001|NOT COMPLETED|Overall Study||33||
48093676|NCT01647282|100552093|FG000|STARTED|Overall Study||30||
48093677|NCT01647282|100552094|FG001|STARTED|Overall Study||30||
48093678|NCT01647282|100552093|FG000|COMPLETED|Overall Study||23||
48093679|NCT01647282|100552094|FG001|COMPLETED|Overall Study||25||
48093680|NCT01647282|100552093|FG000|NOT COMPLETED|Overall Study||7||
48093681|NCT01647282|100552094|FG001|NOT COMPLETED|Overall Study||5||
48093682|NCT01502423|100552095|FG000|STARTED|Overall Study||31||
48093683|NCT01502423|100552096|FG001|STARTED|Overall Study||30||
48093684|NCT01502423|100552095|FG000|COMPLETED|Overall Study||31||
48093685|NCT01502423|100552096|FG001|COMPLETED|Overall Study||29||
48093686|NCT01502423|100552095|FG000|NOT COMPLETED|Overall Study||0||
48093687|NCT01502423|100552096|FG001|NOT COMPLETED|Overall Study||1||
48093688|NCT00549302|100552097|FG000|STARTED|Double-Blind||63||
48093689|NCT00549302|100552098|FG001|STARTED|Double-Blind||294||
48093690|NCT00549302|100552099|FG002|STARTED|Double-Blind||0||
48258487|NCT00776659|100952031|FG000|COMPLETED|Overall Study||13||
48258488|NCT00776659|100952031|FG000|NOT COMPLETED|Overall Study||26||
48258489|NCT02835092|100952032|FG000|STARTED|Overall Study||66||
48258490|NCT02835092|100952033|FG001|STARTED|Overall Study||65||
48258491|NCT02835092|100952034|FG002|STARTED|Overall Study||67||
48258492|NCT02835092|100952032|FG000|COMPLETED|Overall Study||63||
48258493|NCT02835092|100952033|FG001|COMPLETED|Overall Study||57||
48258494|NCT02835092|100952034|FG002|COMPLETED|Overall Study||64||
48689090|NCT03981744|102022606|FG001|COMPLETED|Second Intervention (Week 24 to Week 72)||0||
48689091|NCT03981744|102022607|FG002|COMPLETED|Second Intervention (Week 24 to Week 72)||24||
48258495|NCT02835092|100952032|FG000|NOT COMPLETED|Overall Study||3||
48258496|NCT02835092|100952033|FG001|NOT COMPLETED|Overall Study||8||
48258497|NCT02835092|100952034|FG002|NOT COMPLETED|Overall Study||3||
48689092|NCT03981744|102022608|FG003|COMPLETED|Second Intervention (Week 24 to Week 72)||23||
48093691|NCT00549302|100552097|FG000|Received at Least One Dose of Study Drug|Double-Blind||63||
48093692|NCT00549302|100552098|FG001|Received at Least One Dose of Study Drug|Double-Blind||294||
48093693|NCT00549302|100552099|FG002|Received at Least One Dose of Study Drug|Double-Blind||0||
48093694|NCT00549302|100552097|FG000|COMPLETED|Double-Blind||52||
48093695|NCT00549302|100552098|FG001|COMPLETED|Double-Blind||241||
48093696|NCT00549302|100552099|FG002|COMPLETED|Double-Blind||0||
48093697|NCT00549302|100552097|FG000|NOT COMPLETED|Double-Blind||11||
48093698|NCT00549302|100552098|FG001|NOT COMPLETED|Double-Blind||53||
48093699|NCT00549302|100552099|FG002|NOT COMPLETED|Double-Blind||0||
48093700|NCT00549302|100552097|FG000|STARTED|Open-Label||0||
48093701|NCT00549302|100552098|FG001|STARTED|Open-Label||0||
48093702|NCT00549302|100552099|FG002|STARTED|Open-Label||286||
48093703|NCT00549302|100552097|FG000|COMPLETED|Open-Label||0||
48093704|NCT00549302|100552098|FG001|COMPLETED|Open-Label||0||
48093705|NCT00549302|100552099|FG002|COMPLETED|Open-Label||217||
48093706|NCT00549302|100552097|FG000|NOT COMPLETED|Open-Label||0||
48093707|NCT00549302|100552098|FG001|NOT COMPLETED|Open-Label||0||
48093708|NCT00549302|100552099|FG002|NOT COMPLETED|Open-Label||69||
48093709|NCT04690751|100552100|FG000|STARTED|Overall Study||4||
48093710|NCT04690751|100552101|FG001|STARTED|Overall Study||5||
48093711|NCT04690751|100552102|FG002|STARTED|Overall Study||5||
48093712|NCT04690751|100552103|FG003|STARTED|Overall Study||4||
48093713|NCT04690751|100552104|FG004|STARTED|Overall Study||6||
48093714|NCT04690751|100552105|FG005|STARTED|Overall Study||4||
48093715|NCT04690751|100552100|FG000|COMPLETED|Overall Study||4||
48093716|NCT04690751|100552101|FG001|COMPLETED|Overall Study||4||
48093717|NCT04690751|100552102|FG002|COMPLETED|Overall Study||4||
48093718|NCT04690751|100552103|FG003|COMPLETED|Overall Study||3||
48093719|NCT04690751|100552104|FG004|COMPLETED|Overall Study||3||
48093720|NCT04690751|100552105|FG005|COMPLETED|Overall Study||4||
48093721|NCT04690751|100552100|FG000|NOT COMPLETED|Overall Study||0||
48093722|NCT04690751|100552101|FG001|NOT COMPLETED|Overall Study||1||
48093723|NCT04690751|100552102|FG002|NOT COMPLETED|Overall Study||1||
48093724|NCT04690751|100552103|FG003|NOT COMPLETED|Overall Study||1||
48093725|NCT04690751|100552104|FG004|NOT COMPLETED|Overall Study||3||
48093726|NCT04690751|100552105|FG005|NOT COMPLETED|Overall Study||0||
48093727|NCT00065507|100552106|FG000|STARTED|Overall Study||100||
48093728|NCT00065507|100552107|FG001|STARTED|Overall Study||91||
48093729|NCT00065507|100552106|FG000|Treated (As-Randomized Population)|Overall Study||100||
48258498|NCT03995225|100952035|FG000|STARTED|Overall Study||155|Completed Zoom onboarding|
48093730|NCT00065507|100552107|FG001|Treated (As-Randomized Population)|Overall Study||91||
48093731|NCT00065507|100552106|FG000|Treated (As-Treated Population)|Overall Study||102||
48093732|NCT00065507|100552107|FG001|Treated (As-Treated Population)|Overall Study||89||
48093733|NCT00065507|100552106|FG000|Treated, Wk 48 (As-Treated Population)|Overall Study||102||
48258499|NCT03995225|100952035|FG000|Baseline Survey Completed|Overall Study||154||
48386825|NCT00240539|101276673|FG003|COMPLETED|Overall Study||1||
48093734|NCT00065507|100552107|FG001|Treated, Wk 48 (As-Treated Population)|Overall Study||89||
48093735|NCT00065507|100552106|FG000|Treated, 24-Week Follow-Up Population|Overall Study||25||
48093736|NCT00065507|100552107|FG001|Treated, 24-Week Follow-Up Population|Overall Study||28||
48093737|NCT00065507|100552106|FG000|COMPLETED|Overall Study||71||
48093738|NCT00065507|100552107|FG001|COMPLETED|Overall Study||62||
48093739|NCT00065507|100552106|FG000|NOT COMPLETED|Overall Study||29||
48093740|NCT00065507|100552107|FG001|NOT COMPLETED|Overall Study||29||
48093741|NCT01938378|100552108|FG000|STARTED|Overall Study||41||
48093742|NCT01938378|100552108|FG000|COMPLETED|Overall Study||41||
48093743|NCT01938378|100552108|FG000|NOT COMPLETED|Overall Study||0||
48093744|NCT03342690|100552109|FG000|STARTED|Overall Study||1164||
48093745|NCT03342690|100552109|FG000|COMPLETED|Overall Study||1139||
48386826|NCT00240539|101276670|FG000|NOT COMPLETED|Overall Study||0||
48386827|NCT00240539|101276671|FG001|NOT COMPLETED|Overall Study||0||
48386828|NCT00240539|101276672|FG002|NOT COMPLETED|Overall Study||0||
48386829|NCT00240539|101276673|FG003|NOT COMPLETED|Overall Study||0||
48386830|NCT00565058|101276674|FG000|STARTED|Overall Study||10||
48386831|NCT00565058|101276675|FG001|STARTED|Overall Study||15||
48386832|NCT00565058|101276674|FG000|COMPLETED|Overall Study||9||
48386833|NCT00565058|101276675|FG001|COMPLETED|Overall Study||15||
48386834|NCT00565058|101276674|FG000|NOT COMPLETED|Overall Study||1||
48386835|NCT00565058|101276675|FG001|NOT COMPLETED|Overall Study||0||
48386836|NCT01026389|101276676|FG000|STARTED|Overall Study||93||
48386837|NCT01026389|101276677|FG001|STARTED|Overall Study||93||
48386838|NCT01026389|101276676|FG000|COMPLETED|Overall Study||88||
48386839|NCT01026389|101276677|FG001|COMPLETED|Overall Study||88||
48386840|NCT01026389|101276676|FG000|NOT COMPLETED|Overall Study||5||
48386841|NCT01026389|101276677|FG001|NOT COMPLETED|Overall Study||5||
48386842|NCT00280150|101276678|FG000|STARTED|Overall Study||5||
48386843|NCT00280150|101276679|FG001|STARTED|Overall Study||5||
48386844|NCT00280150|101276680|FG002|STARTED|Overall Study||6||
48386845|NCT00280150|101276681|FG003|STARTED|Overall Study||30||
48386846|NCT00280150|101276678|FG000|Cohort Induction|Overall Study||5||
48386847|NCT00280150|101276679|FG001|Cohort Induction|Overall Study||5||
48386848|NCT00280150|101276680|FG002|Cohort Induction|Overall Study||6||
48386849|NCT00280150|101276681|FG003|Cohort Induction|Overall Study||30||
48541743|NCT03095638|101662789|FG000|STARTED|P2: Period 1, Washout (7[-4 Hours])||0||
48093746|NCT03342690|100552109|FG000|NOT COMPLETED|Overall Study||25||
48093747|NCT03045328|100552110|FG000|STARTED|Overall Study||22||
48093748|NCT03045328|100552110|FG000|COMPLETED|Overall Study||20||
48093749|NCT03045328|100552110|FG000|NOT COMPLETED|Overall Study||2||
48093750|NCT01349790|100552111|FG000|STARTED|Overall Study||40||
48093751|NCT01349790|100552111|FG000|COMPLETED|Overall Study||31||
48093752|NCT01349790|100552111|FG000|NOT COMPLETED|Overall Study||9||
48093753|NCT00671502|100552112|FG000|STARTED|Overall Study||281||
48093754|NCT00671502|100552113|FG001|STARTED|Overall Study||280||
48093755|NCT00671502|100552114|FG002|STARTED|Overall Study||279||
48541744|NCT03095638|101662790|FG001|STARTED|P2: Period 1, Washout (7[-4 Hours])||0||
48093756|NCT00671502|100552112|FG000|COMPLETED|Overall Study||242||
48093757|NCT00671502|100552113|FG001|COMPLETED|Overall Study||241||
48386850|NCT00280150|101276678|FG000|Consolidation Therapy|Overall Study||2||
48386851|NCT00280150|101276679|FG001|Consolidation Therapy|Overall Study||5||
48386852|NCT00280150|101276680|FG002|Consolidation Therapy|Overall Study||3||
48386853|NCT00280150|101276681|FG003|Consolidation Therapy|Overall Study||0||
48386854|NCT00280150|101276678|FG000|COMPLETED|Overall Study||2||
48386855|NCT00280150|101276679|FG001|COMPLETED|Overall Study||4||
48592706|NCT01877382|101783163|FG013|NOT COMPLETED|Dose Expansion||0||
48093758|NCT00671502|100552114|FG002|COMPLETED|Overall Study||252||
48093759|NCT00671502|100552112|FG000|NOT COMPLETED|Overall Study||39||
48093760|NCT00671502|100552113|FG001|NOT COMPLETED|Overall Study||39||
48093761|NCT00671502|100552114|FG002|NOT COMPLETED|Overall Study||27||
48093762|NCT01577329|100552115|FG000|STARTED|Overall Study||19||
48093763|NCT01577329|100552116|FG001|STARTED|Overall Study||22||
48093764|NCT01577329|100552115|FG000|COMPLETED|Overall Study||16||
48093765|NCT01577329|100552116|FG001|COMPLETED|Overall Study||22||
48093766|NCT01577329|100552115|FG000|NOT COMPLETED|Overall Study||3||
48093767|NCT01577329|100552116|FG001|NOT COMPLETED|Overall Study||0||
48093768|NCT00613938|100552117|FG000|STARTED|Overall Study||69||
48093769|NCT00613938|100552118|FG001|STARTED|Overall Study||275||
48093770|NCT00613938|100552119|FG002|STARTED|Overall Study||278||
48093771|NCT00613938|100552120|FG003|STARTED|Overall Study||279||
48093772|NCT00613938|100552117|FG000|COMPLETED|Overall Study||49||
48093773|NCT00613938|100552118|FG001|COMPLETED|Overall Study||247||
48093774|NCT00613938|100552119|FG002|COMPLETED|Overall Study||255||
48093775|NCT00613938|100552120|FG003|COMPLETED|Overall Study||253||
48093776|NCT00613938|100552117|FG000|NOT COMPLETED|Overall Study||20||
48093777|NCT00613938|100552118|FG001|NOT COMPLETED|Overall Study||28||
48093778|NCT00613938|100552119|FG002|NOT COMPLETED|Overall Study||23||
48093779|NCT00613938|100552120|FG003|NOT COMPLETED|Overall Study||26||
48093780|NCT01348347|100552121|FG000|STARTED|Overall Study||3||
48093781|NCT01348347|100552122|FG001|STARTED|Overall Study||6||
48093782|NCT01348347|100552123|FG002|STARTED|Overall Study||6||
48386856|NCT00280150|101276680|FG002|COMPLETED|Overall Study||1||
48386857|NCT00280150|101276681|FG003|COMPLETED|Overall Study||20||
48093783|NCT01348347|100552121|FG000|COMPLETED|Overall Study||0||
48093784|NCT01348347|100552122|FG001|COMPLETED|Overall Study||0||
48093785|NCT01348347|100552123|FG002|COMPLETED|Overall Study||0||
48093786|NCT01348347|100552121|FG000|NOT COMPLETED|Overall Study||3||
48093787|NCT01348347|100552122|FG001|NOT COMPLETED|Overall Study||6||
48093788|NCT01348347|100552123|FG002|NOT COMPLETED|Overall Study||6||
48093789|NCT00391274|100552124|FG000|STARTED|Overall Study||107||
48093790|NCT00391274|100552125|FG001|STARTED|Overall Study||104||
48093791|NCT00391274|100552124|FG000|Received at Least One Dose of Study Drug|Overall Study||106||
48093792|NCT00391274|100552125|FG001|Received at Least One Dose of Study Drug|Overall Study||102||
48093793|NCT00391274|100552124|FG000|COMPLETED|Overall Study||46||
48093794|NCT00391274|100552125|FG001|COMPLETED|Overall Study||47||
48093795|NCT00391274|100552124|FG000|NOT COMPLETED|Overall Study||61||
48093796|NCT00391274|100552125|FG001|NOT COMPLETED|Overall Study||57||
48093797|NCT00268996|100552126|FG000|STARTED|Overall Study||151||
48093798|NCT00268996|100552127|FG001|STARTED|Overall Study||172||
48093799|NCT00268996|100552126|FG000|COMPLETED|Overall Study||130||
48093800|NCT00268996|100552127|FG001|COMPLETED|Overall Study||152||
48093801|NCT00268996|100552126|FG000|NOT COMPLETED|Overall Study||21||
48093802|NCT00268996|100552127|FG001|NOT COMPLETED|Overall Study||20||
48093803|NCT03654651|100552128|FG000|STARTED|First Intervention (6 Weeks)||26||
48093804|NCT03654651|100552129|FG001|STARTED|First Intervention (6 Weeks)||25||
48093805|NCT03654651|100552128|FG000|COMPLETED|First Intervention (6 Weeks)||25||
48093806|NCT03654651|100552129|FG001|COMPLETED|First Intervention (6 Weeks)||25||
48093807|NCT03654651|100552128|FG000|NOT COMPLETED|First Intervention (6 Weeks)||1||
48093808|NCT03654651|100552129|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0||
48093809|NCT03654651|100552128|FG000|STARTED|Washout Period (2-weeks)||25||
48093810|NCT03654651|100552129|FG001|STARTED|Washout Period (2-weeks)||25||
48093811|NCT03654651|100552128|FG000|COMPLETED|Washout Period (2-weeks)||25||
48093812|NCT03654651|100552129|FG001|COMPLETED|Washout Period (2-weeks)||25||
48093813|NCT03654651|100552128|FG000|NOT COMPLETED|Washout Period (2-weeks)||0||
48093814|NCT03654651|100552129|FG001|NOT COMPLETED|Washout Period (2-weeks)||0||
48093815|NCT03654651|100552128|FG000|STARTED|Second Intervention (6 Weeks)||25||
48093816|NCT03654651|100552129|FG001|STARTED|Second Intervention (6 Weeks)||25||
48093817|NCT03654651|100552128|FG000|COMPLETED|Second Intervention (6 Weeks)||25||
48093818|NCT03654651|100552129|FG001|COMPLETED|Second Intervention (6 Weeks)||25||
48093819|NCT03654651|100552128|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0||
48093820|NCT03654651|100552129|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0||
48093821|NCT01953120|100552130|FG000|STARTED|Overall Study||20||
48093822|NCT01953120|100552130|FG000|COMPLETED|Overall Study||19||
48093823|NCT01953120|100552130|FG000|NOT COMPLETED|Overall Study||1||
48689093|NCT03981744|102022605|FG000|NOT COMPLETED|Second Intervention (Week 24 to Week 72)||0||
48689094|NCT03981744|102022606|FG001|NOT COMPLETED|Second Intervention (Week 24 to Week 72)||0||
48689095|NCT03981744|102022607|FG002|NOT COMPLETED|Second Intervention (Week 24 to Week 72)||2||
48689096|NCT03981744|102022608|FG003|NOT COMPLETED|Second Intervention (Week 24 to Week 72)||0||
48093824|NCT02335489|100552131|FG000|STARTED|Overall Study||10||
48093825|NCT02335489|100552131|FG000|Received Trial System|Overall Study||9||
48093826|NCT02335489|100552131|FG000|Receiving Permanent System|Overall Study||8||
48093827|NCT02335489|100552131|FG000|COMPLETED|Overall Study||0||
48093828|NCT02335489|100552131|FG000|NOT COMPLETED|Overall Study||10||
48093829|NCT01831544|100552132|FG000|STARTED|Overall Study||11||
48689097|NCT02413996|102022609|FG000|STARTED|Overall Study||44||
48689098|NCT02413996|102022610|FG001|STARTED|Overall Study||41||
48093830|NCT01831544|100552132|FG000|COMPLETED|Overall Study||8||
48093831|NCT01831544|100552132|FG000|NOT COMPLETED|Overall Study||3||
48093832|NCT03232801|100552133|FG000|STARTED|Overall Study||31||
48093833|NCT03232801|100552134|FG001|STARTED|Overall Study||30||
48093834|NCT03232801|100552133|FG000|Completed Baseline Survey|Overall Study||28||
48093835|NCT03232801|100552134|FG001|Completed Baseline Survey|Overall Study||27||
48093836|NCT03232801|100552133|FG000|Attended at Least One Session|Overall Study||18||
48093837|NCT03232801|100552134|FG001|Attended at Least One Session|Overall Study||23||
48093838|NCT03232801|100552133|FG000|Completed Week 7 Follow-up|Overall Study||15||
48093839|NCT03232801|100552134|FG001|Completed Week 7 Follow-up|Overall Study||22||
48093840|NCT03232801|100552133|FG000|Completed Week 12 Follow-up|Overall Study||15||
48093841|NCT03232801|100552134|FG001|Completed Week 12 Follow-up|Overall Study||18||
48093842|NCT03232801|100552133|FG000|COMPLETED|Overall Study||15||
48093843|NCT03232801|100552134|FG001|COMPLETED|Overall Study||18||
48093844|NCT03232801|100552133|FG000|NOT COMPLETED|Overall Study||16||
48093845|NCT03232801|100552134|FG001|NOT COMPLETED|Overall Study||12||
48093846|NCT01930747|100552135|FG000|STARTED|Overall Study||16||
48093847|NCT01930747|100552136|FG001|STARTED|Overall Study||14||
48093848|NCT01930747|100552137|FG002|STARTED|Overall Study||12||
48093849|NCT01930747|100552135|FG000|COMPLETED|Overall Study||16||
48093850|NCT01930747|100552136|FG001|COMPLETED|Overall Study||14||
48093851|NCT01930747|100552137|FG002|COMPLETED|Overall Study||12||
48093852|NCT01930747|100552135|FG000|NOT COMPLETED|Overall Study||0||
48093853|NCT01930747|100552136|FG001|NOT COMPLETED|Overall Study||0||
48093854|NCT01930747|100552137|FG002|NOT COMPLETED|Overall Study||0||
48093855|NCT01110707|100552138|FG000|STARTED|Overall Study||63||
48093856|NCT01110707|100552139|FG001|STARTED|Overall Study||68||
48093857|NCT01110707|100552138|FG000|COMPLETED|Overall Study||63||
48093858|NCT01110707|100552139|FG001|COMPLETED|Overall Study||65||
48093859|NCT01110707|100552138|FG000|NOT COMPLETED|Overall Study||0||
48093860|NCT01110707|100552139|FG001|NOT COMPLETED|Overall Study||3||
48093861|NCT00862745|100552140|FG000|STARTED|Randomized Control Trial||322||
48093862|NCT00862745|100552141|FG001|STARTED|Randomized Control Trial||323||
48093863|NCT00862745|100552140|FG000|COMPLETED|Randomized Control Trial||284||
48093864|NCT00862745|100552141|FG001|COMPLETED|Randomized Control Trial||284||
48093865|NCT00862745|100552140|FG000|NOT COMPLETED|Randomized Control Trial||38||
48093866|NCT00862745|100552141|FG001|NOT COMPLETED|Randomized Control Trial||39||
48093867|NCT00862745|100552140|FG000|STARTED|Open-label Follow-up||268||
48093868|NCT00862745|100552141|FG001|STARTED|Open-label Follow-up||274||
48093869|NCT00862745|100552140|FG000|COMPLETED|Open-label Follow-up||229||
48093870|NCT00862745|100552141|FG001|COMPLETED|Open-label Follow-up||225||
48093871|NCT00862745|100552140|FG000|NOT COMPLETED|Open-label Follow-up||39||
48093872|NCT00862745|100552141|FG001|NOT COMPLETED|Open-label Follow-up||49||
48093873|NCT03143569|100552142|FG000|STARTED|Overall Study||10||
48093874|NCT03143569|100552143|FG001|STARTED|Overall Study||10||
48093875|NCT03143569|100552142|FG000|COMPLETED|Overall Study||10||
48093876|NCT03143569|100552143|FG001|COMPLETED|Overall Study||8||
48093877|NCT03143569|100552142|FG000|NOT COMPLETED|Overall Study||0||
48093878|NCT03143569|100552143|FG001|NOT COMPLETED|Overall Study||2||
48093879|NCT04483011|100552144|FG000|STARTED|Intervention Period 1 (8 Days)||9||
48093880|NCT04483011|100552145|FG001|STARTED|Intervention Period 1 (8 Days)||9||
48093881|NCT04483011|100552144|FG000|COMPLETED|Intervention Period 1 (8 Days)||9||
48093882|NCT04483011|100552145|FG001|COMPLETED|Intervention Period 1 (8 Days)||9||
48093883|NCT04483011|100552144|FG000|NOT COMPLETED|Intervention Period 1 (8 Days)||0||
48093884|NCT04483011|100552145|FG001|NOT COMPLETED|Intervention Period 1 (8 Days)||0||
48093885|NCT04483011|100552144|FG000|STARTED|Washout (7 Days)||9||
48093886|NCT04483011|100552145|FG001|STARTED|Washout (7 Days)||9||
48093887|NCT04483011|100552144|FG000|COMPLETED|Washout (7 Days)||9||
48093888|NCT04483011|100552145|FG001|COMPLETED|Washout (7 Days)||8||
48093889|NCT04483011|100552144|FG000|NOT COMPLETED|Washout (7 Days)||0||
48093890|NCT04483011|100552145|FG001|NOT COMPLETED|Washout (7 Days)||1||
48093891|NCT04483011|100552144|FG000|STARTED|Intervention Period 2 (8 Days)||9||
48093892|NCT04483011|100552145|FG001|STARTED|Intervention Period 2 (8 Days)||8||
48093893|NCT04483011|100552144|FG000|COMPLETED|Intervention Period 2 (8 Days)||9||
48093894|NCT04483011|100552145|FG001|COMPLETED|Intervention Period 2 (8 Days)||8||
48093895|NCT04483011|100552144|FG000|NOT COMPLETED|Intervention Period 2 (8 Days)||0||
48093896|NCT04483011|100552145|FG001|NOT COMPLETED|Intervention Period 2 (8 Days)||0||
48093897|NCT00003644|100552146|FG000|STARTED|Overall Study||289||
48093898|NCT00003644|100552147|FG001|STARTED|Overall Study||282||
48093899|NCT00003644|100552146|FG000|COMPLETED|Overall Study||274||
48093900|NCT00003644|100552147|FG001|COMPLETED|Overall Study||268||
48093901|NCT00003644|100552146|FG000|NOT COMPLETED|Overall Study||15||
48093902|NCT00003644|100552147|FG001|NOT COMPLETED|Overall Study||14||
48093903|NCT01335581|100552148|FG000|STARTED|Overall Study||9||
48093904|NCT01335581|100552149|FG001|STARTED|Overall Study||9||
48093905|NCT01335581|100552148|FG000|COMPLETED|Overall Study||5||
48093906|NCT01335581|100552149|FG001|COMPLETED|Overall Study||3||
48093907|NCT01335581|100552148|FG000|NOT COMPLETED|Overall Study||4||
48093908|NCT01335581|100552149|FG001|NOT COMPLETED|Overall Study||6||
48093909|NCT01988857|100552150|FG000|STARTED|Overall Study||300||
48093910|NCT01988857|100552150|FG000|COMPLETED|Overall Study||300||
48093911|NCT01988857|100552150|FG000|NOT COMPLETED|Overall Study||0||
48093912|NCT00478569|100552151|FG000|STARTED|Overall Study||1170||
48093913|NCT00478569|100552151|FG000|COMPLETED|Overall Study||761||
48093914|NCT00478569|100552151|FG000|NOT COMPLETED|Overall Study||409||
48093915|NCT04311424|100552152|FG000|STARTED|Overall Study||6||
48093916|NCT04311424|100552152|FG000|COMPLETED|Overall Study||6||
48093917|NCT04311424|100552152|FG000|NOT COMPLETED|Overall Study||0||
48093918|NCT01743131|100552153|FG000|STARTED|Overall Study||73|Enrolled|
48093919|NCT01743131|100552154|FG001|STARTED|Overall Study||69|Enrolled|
48093920|NCT01743131|100552155|FG002|STARTED|Overall Study||43|Enrolled|
48093921|NCT01743131|100552156|FG003|STARTED|Overall Study||1|Enrolled|
48093922|NCT01743131|100552157|FG004|STARTED|Overall Study||127|Enrolled|
48093923|NCT01743131|100552153|FG000|Not Included in Analysis|Overall Study||0||
48093924|NCT01743131|100552154|FG001|Not Included in Analysis|Overall Study||0||
48093925|NCT01743131|100552155|FG002|Not Included in Analysis|Overall Study||0||
48093926|NCT01743131|100552156|FG003|Not Included in Analysis|Overall Study||1||
48093927|NCT01743131|100552157|FG004|Not Included in Analysis|Overall Study||0||
48093928|NCT01743131|100552153|FG000|COMPLETED|Overall Study||73|Received study intervention.|
48093929|NCT01743131|100552154|FG001|COMPLETED|Overall Study||69|Received study intervention.|
48093930|NCT01743131|100552155|FG002|COMPLETED|Overall Study||43|Received study intervention.|
48093931|NCT01743131|100552156|FG003|COMPLETED|Overall Study||1|Received study intervention.|
48093932|NCT01743131|100552157|FG004|COMPLETED|Overall Study||127|Received study intervention.|
48093933|NCT01743131|100552153|FG000|NOT COMPLETED|Overall Study||0||
48093934|NCT01743131|100552154|FG001|NOT COMPLETED|Overall Study||0||
48093935|NCT01743131|100552155|FG002|NOT COMPLETED|Overall Study||0||
48093936|NCT01743131|100552156|FG003|NOT COMPLETED|Overall Study||0||
48093937|NCT01743131|100552157|FG004|NOT COMPLETED|Overall Study||0||
48093938|NCT00998660|100552158|FG000|STARTED|Overall Study||100||
48093939|NCT00998660|100552158|FG000|Implanted|Overall Study||93||
48093940|NCT00998660|100552158|FG000|Month 3 Visit|Overall Study||87||
48093941|NCT00998660|100552158|FG000|COMPLETED|Overall Study||87||
48093942|NCT00998660|100552158|FG000|NOT COMPLETED|Overall Study||13||
48093943|NCT01059786|100552159|FG000|STARTED|Overall Study||6||
48093944|NCT01059786|100552160|FG001|STARTED|Overall Study||6||
48093945|NCT01059786|100552161|FG002|STARTED|Overall Study||28||
48093946|NCT01059786|100552162|FG003|STARTED|Overall Study||28||
48093947|NCT01059786|100552163|FG004|STARTED|Overall Study||1||
48093948|NCT01059786|100552159|FG000|COMPLETED|Overall Study||6||
48093949|NCT01059786|100552160|FG001|COMPLETED|Overall Study||6||
48093950|NCT01059786|100552161|FG002|COMPLETED|Overall Study||24||
48093951|NCT01059786|100552162|FG003|COMPLETED|Overall Study||27||
48093952|NCT01059786|100552163|FG004|COMPLETED|Overall Study||1||
48093953|NCT01059786|100552159|FG000|NOT COMPLETED|Overall Study||0||
48093954|NCT01059786|100552160|FG001|NOT COMPLETED|Overall Study||0||
48093955|NCT01059786|100552161|FG002|NOT COMPLETED|Overall Study||4||
48093956|NCT01059786|100552162|FG003|NOT COMPLETED|Overall Study||1||
48093957|NCT01059786|100552163|FG004|NOT COMPLETED|Overall Study||0||
48093958|NCT03761147|100552164|FG000|STARTED|Overall Study||32||
48093959|NCT03761147|100552165|FG001|STARTED|Overall Study||32||
48093960|NCT03761147|100552164|FG000|COMPLETED|Overall Study||25||
48093961|NCT03761147|100552165|FG001|COMPLETED|Overall Study||28||
48093962|NCT03761147|100552164|FG000|NOT COMPLETED|Overall Study||7||
48093963|NCT03761147|100552165|FG001|NOT COMPLETED|Overall Study||4||
48093964|NCT01946425|100552166|FG000|STARTED|Overall Study||30||
48093965|NCT01946425|100552167|FG001|STARTED|Overall Study||30||
48093966|NCT01946425|100552166|FG000|COMPLETED|Overall Study||28||
48093967|NCT01946425|100552167|FG001|COMPLETED|Overall Study||30||
48093968|NCT01946425|100552166|FG000|NOT COMPLETED|Overall Study||2||
48093969|NCT01946425|100552167|FG001|NOT COMPLETED|Overall Study||0||
48093970|NCT03267186|100552168|FG000|STARTED|Overall Study||8||
48093971|NCT03267186|100552168|FG000|COMPLETED|Overall Study||8||
48093972|NCT03267186|100552168|FG000|NOT COMPLETED|Overall Study||0||
48093973|NCT00449540|100552169|FG000|STARTED|Pretreatment Phase||267||
48093974|NCT00449540|100552170|FG001|STARTED|Pretreatment Phase||0||
48093975|NCT00449540|100552171|FG002|STARTED|Pretreatment Phase||0||
48093976|NCT00449540|100552169|FG000|COMPLETED|Pretreatment Phase||201||
48093977|NCT00449540|100552170|FG001|COMPLETED|Pretreatment Phase||0||
48093978|NCT00449540|100552171|FG002|COMPLETED|Pretreatment Phase||0||
48093979|NCT00449540|100552169|FG000|NOT COMPLETED|Pretreatment Phase||66||
48093980|NCT00449540|100552170|FG001|NOT COMPLETED|Pretreatment Phase||0||
48093981|NCT00449540|100552171|FG002|NOT COMPLETED|Pretreatment Phase||0||
48093982|NCT00449540|100552169|FG000|STARTED|Treatment Phase||0||
48093983|NCT00449540|100552170|FG001|STARTED|Treatment Phase||102||
48093984|NCT00449540|100552171|FG002|STARTED|Treatment Phase||99||
48093985|NCT00449540|100552169|FG000|COMPLETED|Treatment Phase||0||
48093986|NCT00449540|100552170|FG001|COMPLETED|Treatment Phase||82||
48093987|NCT00449540|100552171|FG002|COMPLETED|Treatment Phase||82||
48093988|NCT00449540|100552169|FG000|NOT COMPLETED|Treatment Phase||0||
48093989|NCT00449540|100552170|FG001|NOT COMPLETED|Treatment Phase||20||
48093990|NCT00449540|100552171|FG002|NOT COMPLETED|Treatment Phase||17||
48093991|NCT02743806|100552172|FG000|STARTED|Overall Study||331||
48093992|NCT02743806|100552172|FG000|COMPLETED|Overall Study||150||
48093993|NCT02743806|100552172|FG000|NOT COMPLETED|Overall Study||181||
48093994|NCT02377466|100552173|FG000|STARTED|Overall Study||13||
48093995|NCT02377466|100552174|FG001|STARTED|Overall Study||12||
48093996|NCT02377466|100552173|FG000|Treated|Overall Study||13||
48093997|NCT02377466|100552174|FG001|Treated|Overall Study||10||
48093998|NCT02377466|100552173|FG000|COMPLETED|Overall Study||13||
48093999|NCT02377466|100552174|FG001|COMPLETED|Overall Study||10||
48094000|NCT02377466|100552173|FG000|NOT COMPLETED|Overall Study||0||
48094001|NCT02377466|100552174|FG001|NOT COMPLETED|Overall Study||2||
48094002|NCT04200456|100552175|FG000|STARTED|Overall Study||12||
48094003|NCT04200456|100552176|FG001|STARTED|Overall Study||21||
48094004|NCT04200456|100552175|FG000|COMPLETED|Overall Study||9||
48094005|NCT04200456|100552176|FG001|COMPLETED|Overall Study||15||
48094006|NCT04200456|100552175|FG000|NOT COMPLETED|Overall Study||3||
48094007|NCT04200456|100552176|FG001|NOT COMPLETED|Overall Study||6||
48094008|NCT01529346|100552177|FG000|STARTED|Overall Study||55||
48094009|NCT01529346|100552178|FG001|STARTED|Overall Study||54||
48094010|NCT01529346|100552179|FG002|STARTED|Overall Study||54||
48094011|NCT01529346|100552180|FG003|STARTED|Overall Study||36||
48094012|NCT01529346|100552181|FG004|STARTED|Overall Study||36||
48094013|NCT01529346|100552177|FG000|COMPLETED|Overall Study||53||
48094014|NCT01529346|100552178|FG001|COMPLETED|Overall Study||53||
48094015|NCT01529346|100552179|FG002|COMPLETED|Overall Study||52||
48094016|NCT01529346|100552180|FG003|COMPLETED|Overall Study||36||
48094017|NCT01529346|100552181|FG004|COMPLETED|Overall Study||36||
48094018|NCT01529346|100552177|FG000|NOT COMPLETED|Overall Study||2||
48094019|NCT01529346|100552178|FG001|NOT COMPLETED|Overall Study||1||
48094020|NCT01529346|100552179|FG002|NOT COMPLETED|Overall Study||2||
48094021|NCT01529346|100552180|FG003|NOT COMPLETED|Overall Study||0||
48094022|NCT01529346|100552181|FG004|NOT COMPLETED|Overall Study||0||
48094023|NCT00531817|100552182|FG000|STARTED|Randomized||412||
48094024|NCT00531817|100552183|FG001|STARTED|Randomized||207||
48094025|NCT00531817|100552182|FG000|Received Study Drug in Core Study|Randomized||409||
48094026|NCT00531817|100552183|FG001|Received Study Drug in Core Study|Randomized||205||
48094027|NCT00531817|100552182|FG000|COMPLETED|Randomized||353||
48094028|NCT00531817|100552183|FG001|COMPLETED|Randomized||173||
48094029|NCT00531817|100552182|FG000|NOT COMPLETED|Randomized||59||
48094030|NCT00531817|100552183|FG001|NOT COMPLETED|Randomized||34||
48094031|NCT00531817|100552182|FG000|STARTED|Entered Extended Treatment Period||343||
48094032|NCT00531817|100552183|FG001|STARTED|Entered Extended Treatment Period||170||
48094033|NCT00531817|100552182|FG000|COMPLETED|Entered Extended Treatment Period||206||
48094034|NCT00531817|100552183|FG001|COMPLETED|Entered Extended Treatment Period||113||
48094035|NCT00531817|100552182|FG000|NOT COMPLETED|Entered Extended Treatment Period||137||
48094036|NCT00531817|100552183|FG001|NOT COMPLETED|Entered Extended Treatment Period||57||
48094037|NCT02069366|100552184|FG000|STARTED|Overall Study||13||
48094038|NCT02069366|100552185|FG001|STARTED|Overall Study||10||
48094039|NCT02069366|100552186|FG002|STARTED|Overall Study||18||
48094040|NCT02069366|100552187|FG003|STARTED|Overall Study||17||
48094041|NCT02069366|100552188|FG004|STARTED|Overall Study||14||
48094042|NCT02069366|100552189|FG005|STARTED|Overall Study||14||
48094043|NCT02069366|100552184|FG000|COMPLETED|Overall Study||12||
48094044|NCT02069366|100552185|FG001|COMPLETED|Overall Study||10||
48094045|NCT02069366|100552186|FG002|COMPLETED|Overall Study||15||
48094046|NCT02069366|100552187|FG003|COMPLETED|Overall Study||15||
48094047|NCT02069366|100552188|FG004|COMPLETED|Overall Study||14||
48094048|NCT02069366|100552189|FG005|COMPLETED|Overall Study||12||
48094049|NCT02069366|100552184|FG000|NOT COMPLETED|Overall Study||1||
48094050|NCT02069366|100552185|FG001|NOT COMPLETED|Overall Study||0||
48094051|NCT02069366|100552186|FG002|NOT COMPLETED|Overall Study||3||
48094052|NCT02069366|100552187|FG003|NOT COMPLETED|Overall Study||2||
48094053|NCT02069366|100552188|FG004|NOT COMPLETED|Overall Study||0||
48094054|NCT02069366|100552189|FG005|NOT COMPLETED|Overall Study||2||
48094055|NCT02404285|100552190|FG000|STARTED|Overall Study||33||
48094056|NCT02404285|100552191|FG001|STARTED|Overall Study||35||
48094057|NCT02404285|100552190|FG000|COMPLETED|Overall Study||31||
48094058|NCT02404285|100552191|FG001|COMPLETED|Overall Study||33||
48094059|NCT02404285|100552190|FG000|NOT COMPLETED|Overall Study||2||
48094060|NCT02404285|100552191|FG001|NOT COMPLETED|Overall Study||2||
48094061|NCT00528398|100552192|FG000|STARTED|Overall Study||111||
48094062|NCT00528398|100552192|FG000|COMPLETED|Overall Study||111||
48094063|NCT00528398|100552192|FG000|NOT COMPLETED|Overall Study||0||
48094064|NCT01230801|100552193|FG000|STARTED|Overall Study||3||
48094065|NCT01230801|100552194|FG001|STARTED|Overall Study||3||
48094066|NCT01230801|100552195|FG002|STARTED|Overall Study||16||
48094067|NCT01230801|100552193|FG000|COMPLETED|Overall Study||3||
48094068|NCT01230801|100552194|FG001|COMPLETED|Overall Study||3||
48094069|NCT01230801|100552195|FG002|COMPLETED|Overall Study||15||
48094070|NCT01230801|100552193|FG000|NOT COMPLETED|Overall Study||0||
48094071|NCT01230801|100552194|FG001|NOT COMPLETED|Overall Study||0||
48094072|NCT01230801|100552195|FG002|NOT COMPLETED|Overall Study||1||
48094073|NCT01472081|100552196|FG000|STARTED|Overall Study||7||
48094074|NCT01472081|100552197|FG001|STARTED|Overall Study||26||
48094075|NCT01472081|100552198|FG002|STARTED|Overall Study||20||
48094076|NCT01472081|100552199|FG003|STARTED|Overall Study||47||
48094077|NCT01472081|100552200|FG004|STARTED|Overall Study||47||
48094078|NCT01472081|100552201|FG005|STARTED|Overall Study||6||
48094079|NCT01472081|100552196|FG000|COMPLETED|Overall Study||0||
48094080|NCT01472081|100552197|FG001|COMPLETED|Overall Study||0||
48094081|NCT01472081|100552198|FG002|COMPLETED|Overall Study||0||
48094082|NCT01472081|100552199|FG003|COMPLETED|Overall Study||1||
48094083|NCT01472081|100552200|FG004|COMPLETED|Overall Study||0||
48094084|NCT01472081|100552201|FG005|COMPLETED|Overall Study||0||
48094085|NCT01472081|100552196|FG000|NOT COMPLETED|Overall Study||7||
48094086|NCT01472081|100552197|FG001|NOT COMPLETED|Overall Study||26||
48094087|NCT01472081|100552198|FG002|NOT COMPLETED|Overall Study||20||
48094088|NCT01472081|100552199|FG003|NOT COMPLETED|Overall Study||46||
48094089|NCT01472081|100552200|FG004|NOT COMPLETED|Overall Study||47||
48094090|NCT01472081|100552201|FG005|NOT COMPLETED|Overall Study||6||
48094091|NCT00524368|100552202|FG000|STARTED|Overall Study||294||
48094092|NCT00524368|100552203|FG001|STARTED|Overall Study||296||
48094093|NCT00524368|100552202|FG000|COMPLETED|Overall Study||253||
48386858|NCT00280150|101276678|FG000|NOT COMPLETED|Overall Study||3||
48386859|NCT00280150|101276679|FG001|NOT COMPLETED|Overall Study||1||
48094094|NCT00524368|100552203|FG001|COMPLETED|Overall Study||248||
48094095|NCT00524368|100552202|FG000|NOT COMPLETED|Overall Study||41||
48094096|NCT00524368|100552203|FG001|NOT COMPLETED|Overall Study||48||
48094097|NCT00541034|100552204|FG000|STARTED|Overall Study||49||
48094098|NCT00541034|100552204|FG000|COMPLETED|Overall Study||46||
48094099|NCT00541034|100552204|FG000|NOT COMPLETED|Overall Study||3||
48094100|NCT01585428|100552205|FG000|STARTED|Overall Study||18||
48094101|NCT01585428|100552206|FG001|STARTED|Overall Study||11||
48094102|NCT01585428|100552205|FG000|COMPLETED|Overall Study||17||
48094103|NCT01585428|100552206|FG001|COMPLETED|Overall Study||11||
48094104|NCT01585428|100552205|FG000|NOT COMPLETED|Overall Study||1||
48258500|NCT03995225|100952035|FG000|Smartband Worn for at Least 1 Day|Overall Study||115||
48094105|NCT01585428|100552206|FG001|NOT COMPLETED|Overall Study||0||
48094106|NCT02366845|100552207|FG000|STARTED|Overall Study||25||
48094107|NCT02366845|100552208|FG001|STARTED|Overall Study||25||
48094108|NCT02366845|100552207|FG000|COMPLETED|Overall Study||25||
48094109|NCT02366845|100552208|FG001|COMPLETED|Overall Study||25||
48094110|NCT02366845|100552207|FG000|NOT COMPLETED|Overall Study||0||
48094111|NCT02366845|100552208|FG001|NOT COMPLETED|Overall Study||0||
48094112|NCT04977583|100552209|FG000|STARTED|Overall Study||161||
48094113|NCT04977583|100552210|FG001|STARTED|Overall Study||160||
48258501|NCT03995225|100952035|FG000|Confirmed/Denied Smoking on Smartband|Overall Study||111||
48258502|NCT03995225|100952035|FG000|Received Mindful Smoking Exercise Triggered by Smoking|Overall Study||114||
48258503|NCT03995225|100952035|FG000|21-day Survey Completed|Overall Study||112||
48258504|NCT03995225|100952035|FG000|28-day Survey Completed|Overall Study||101||
48258505|NCT03995225|100952035|FG000|Primary Smoking Outcomes Reported at End of Treatment|Overall Study||96||
48258506|NCT03995225|100952035|FG000|End of Treatment Survey Completed|Overall Study||95||
48258507|NCT03995225|100952035|FG000|COMPLETED|Overall Study||115|Total number analyzed had to wear smartband for at least one day|
48258508|NCT03995225|100952035|FG000|NOT COMPLETED|Overall Study||40||
48258509|NCT02923193|100952036|FG000|STARTED|Overall Study||153||
48258510|NCT02923193|100952037|FG001|STARTED|Overall Study||153||
48258511|NCT02923193|100952036|FG000|COMPLETED|Overall Study||121||
48094114|NCT04977583|100552211|FG002|STARTED|Overall Study||158||
48094115|NCT04977583|100552209|FG000|8 Week Screen|Overall Study||143||
48094116|NCT04977583|100552210|FG001|8 Week Screen|Overall Study||141||
48094117|NCT04977583|100552211|FG002|8 Week Screen|Overall Study||133||
48094118|NCT04977583|100552209|FG000|6 Month Screen|Overall Study||135||
48094119|NCT04977583|100552210|FG001|6 Month Screen|Overall Study||133||
48094120|NCT04977583|100552211|FG002|6 Month Screen|Overall Study||138||
48094121|NCT04977583|100552209|FG000|COMPLETED|Overall Study||150||
48094122|NCT04977583|100552210|FG001|COMPLETED|Overall Study||154||
48094123|NCT04977583|100552211|FG002|COMPLETED|Overall Study||144||
48094124|NCT04977583|100552209|FG000|NOT COMPLETED|Overall Study||11||
48094125|NCT04977583|100552210|FG001|NOT COMPLETED|Overall Study||6||
48094126|NCT04977583|100552211|FG002|NOT COMPLETED|Overall Study||14||
48094127|NCT02452346|100552212|FG000|STARTED|Overall Study||12||
48094128|NCT02452346|100552212|FG000|COMPLETED|Overall Study||3||
48094129|NCT02452346|100552212|FG000|NOT COMPLETED|Overall Study||9||
48094130|NCT03828357|100552213|FG000|STARTED|Overall Study||15||
48094131|NCT03828357|100552214|FG001|STARTED|Overall Study||15||
48094132|NCT03828357|100552215|FG002|STARTED|Overall Study||15||
48094133|NCT03828357|100552216|FG003|STARTED|Overall Study||15||
48094134|NCT03828357|100552213|FG000|COMPLETED|Overall Study||14||
48094135|NCT03828357|100552214|FG001|COMPLETED|Overall Study||14||
48258512|NCT02923193|100952037|FG001|COMPLETED|Overall Study||121||
48258513|NCT02923193|100952036|FG000|NOT COMPLETED|Overall Study||32||
48258514|NCT02923193|100952037|FG001|NOT COMPLETED|Overall Study||32||
48258515|NCT03458728|100952038|FG000|STARTED|Overall Study||24||
48258516|NCT03458728|100952039|FG001|STARTED|Overall Study||7||
48386860|NCT00280150|101276680|FG002|NOT COMPLETED|Overall Study||5||
48094136|NCT03828357|100552215|FG002|COMPLETED|Overall Study||15||
48386861|NCT00280150|101276681|FG003|NOT COMPLETED|Overall Study||10||
48386862|NCT03300752|101276682|FG000|STARTED|Overall Study||40||
48386863|NCT03300752|101276683|FG001|STARTED|Overall Study||40||
48386864|NCT03300752|101276682|FG000|COMPLETED|Overall Study||38||
48386865|NCT03300752|101276683|FG001|COMPLETED|Overall Study||38||
48386866|NCT03300752|101276682|FG000|NOT COMPLETED|Overall Study||2||
48386867|NCT03300752|101276683|FG001|NOT COMPLETED|Overall Study||2||
48386868|NCT01764256|101276684|FG000|STARTED|Received All Vaccinations||12||
48386869|NCT01764256|101276685|FG001|STARTED|Received All Vaccinations||12||
48386870|NCT01764256|101276686|FG002|STARTED|Received All Vaccinations||12||
48386871|NCT01764256|101276687|FG003|STARTED|Received All Vaccinations||12||
48386872|NCT01764256|101276684|FG000|COMPLETED|Received All Vaccinations||10||
48386873|NCT01764256|101276685|FG001|COMPLETED|Received All Vaccinations||11||
48386874|NCT01764256|101276686|FG002|COMPLETED|Received All Vaccinations||11||
48386875|NCT01764256|101276687|FG003|COMPLETED|Received All Vaccinations||12||
48386876|NCT01764256|101276684|FG000|NOT COMPLETED|Received All Vaccinations||2||
48386877|NCT01764256|101276685|FG001|NOT COMPLETED|Received All Vaccinations||1||
48386878|NCT01764256|101276686|FG002|NOT COMPLETED|Received All Vaccinations||1||
48386879|NCT01764256|101276687|FG003|NOT COMPLETED|Received All Vaccinations||0||
48689099|NCT02413996|102022609|FG000|COMPLETED|Overall Study||35||
48689100|NCT02413996|102022610|FG001|COMPLETED|Overall Study||39||
48094137|NCT03828357|100552216|FG003|COMPLETED|Overall Study||12||
48094138|NCT03828357|100552213|FG000|NOT COMPLETED|Overall Study||1||
48094139|NCT03828357|100552214|FG001|NOT COMPLETED|Overall Study||1||
48094140|NCT03828357|100552215|FG002|NOT COMPLETED|Overall Study||0||
48094141|NCT03828357|100552216|FG003|NOT COMPLETED|Overall Study||3||
48094142|NCT00399360|100552217|FG000|STARTED|Overall Study||11||
48094143|NCT00399360|100552218|FG001|STARTED|Overall Study||11||
48094144|NCT00399360|100552219|FG002|STARTED|Overall Study||13||
48094145|NCT00399360|100552220|FG003|STARTED|Overall Study||15||
48094146|NCT00399360|100552217|FG000|COMPLETED|Overall Study||9||
48094147|NCT00399360|100552218|FG001|COMPLETED|Overall Study||8||
48094148|NCT00399360|100552219|FG002|COMPLETED|Overall Study||10||
48094149|NCT00399360|100552220|FG003|COMPLETED|Overall Study||9||
48094150|NCT00399360|100552217|FG000|NOT COMPLETED|Overall Study||2||
48094151|NCT00399360|100552218|FG001|NOT COMPLETED|Overall Study||3||
48094152|NCT00399360|100552219|FG002|NOT COMPLETED|Overall Study||3||
48094153|NCT00399360|100552220|FG003|NOT COMPLETED|Overall Study||6||
48094154|NCT00597545|100552221|FG000|STARTED|Overall Study||4||
48094155|NCT00597545|100552222|FG001|STARTED|Overall Study||6||
48094156|NCT00597545|100552221|FG000|COMPLETED|Overall Study||4||
48094157|NCT00597545|100552222|FG001|COMPLETED|Overall Study||6||
48258517|NCT03458728|100952038|FG000|Started Treatment|Overall Study||24||
48258518|NCT03458728|100952039|FG001|Started Treatment|Overall Study||7||
48258519|NCT03458728|100952038|FG000|Terminated Treatment|Overall Study||24||
48258520|NCT03458728|100952039|FG001|Terminated Treatment|Overall Study||7||
48258521|NCT03458728|100952038|FG000|COMPLETED|Overall Study||0||
48258522|NCT03458728|100952039|FG001|COMPLETED|Overall Study||0||
48386880|NCT01764256|101276684|FG000|STARTED|Completed Study||10||
48386881|NCT01764256|101276685|FG001|STARTED|Completed Study||11||
48386882|NCT01764256|101276686|FG002|STARTED|Completed Study||11||
48386883|NCT01764256|101276687|FG003|STARTED|Completed Study||12||
48386884|NCT01764256|101276684|FG000|COMPLETED|Completed Study||10||
48386885|NCT01764256|101276685|FG001|COMPLETED|Completed Study||11||
48094158|NCT00597545|100552221|FG000|NOT COMPLETED|Overall Study||0||
48094159|NCT00597545|100552222|FG001|NOT COMPLETED|Overall Study||0||
48094160|NCT00137423|100552223|FG000|STARTED|Overall Study||54||
48541745|NCT03095638|101662791|FG002|STARTED|P2: Period 1, Washout (7[-4 Hours])||4||
48094161|NCT00137423|100552224|FG001|STARTED|Overall Study||53||
48094162|NCT00137423|100552223|FG000|COMPLETED|Overall Study||15||
48094163|NCT00137423|100552224|FG001|COMPLETED|Overall Study||9||
48094164|NCT00137423|100552223|FG000|NOT COMPLETED|Overall Study||39||
48094165|NCT00137423|100552224|FG001|NOT COMPLETED|Overall Study||44||
48094166|NCT00103142|100552225|FG000|STARTED|Overall Study||36||
48258523|NCT03458728|100952038|FG000|NOT COMPLETED|Overall Study||24||
48258524|NCT03458728|100952039|FG001|NOT COMPLETED|Overall Study||7||
48258525|NCT01728623|100952040|FG000|STARTED|Overall Study||51||
48094167|NCT00103142|100552226|FG001|STARTED|Overall Study||37||
48094168|NCT00103142|100552225|FG000|COMPLETED|Overall Study||33||
48094169|NCT00103142|100552226|FG001|COMPLETED|Overall Study||36||
48094170|NCT00103142|100552225|FG000|NOT COMPLETED|Overall Study||3||
48094171|NCT00103142|100552226|FG001|NOT COMPLETED|Overall Study||1||
48094172|NCT00180414|100552227|FG000|STARTED|Overall Study||4||
48094173|NCT00180414|100552228|FG001|STARTED|Overall Study||4||
48386886|NCT01764256|101276686|FG002|COMPLETED|Completed Study||11||
48386887|NCT01764256|101276687|FG003|COMPLETED|Completed Study||11||
48386888|NCT01764256|101276684|FG000|NOT COMPLETED|Completed Study||0||
48386889|NCT01764256|101276685|FG001|NOT COMPLETED|Completed Study||0||
48386890|NCT01764256|101276686|FG002|NOT COMPLETED|Completed Study||0||
48386891|NCT01764256|101276687|FG003|NOT COMPLETED|Completed Study||1||
48386892|NCT01954251|101276688|FG000|STARTED|Overall Study||413||
48386893|NCT01954251|101276689|FG001|STARTED|Overall Study||415||
48386894|NCT01954251|101276688|FG000|COMPLETED|Overall Study||400||
48386895|NCT01954251|101276689|FG001|COMPLETED|Overall Study||396||
48386896|NCT01954251|101276688|FG000|NOT COMPLETED|Overall Study||13||
48094174|NCT00180414|100552227|FG000|COMPLETED|Overall Study||0||
48094175|NCT00180414|100552228|FG001|COMPLETED|Overall Study||0||
48094176|NCT00180414|100552227|FG000|NOT COMPLETED|Overall Study||4||
48094177|NCT00180414|100552228|FG001|NOT COMPLETED|Overall Study||4||
48094178|NCT01770379|100552229|FG000|STARTED|Overall Study||80||
48094179|NCT01770379|100552230|FG001|STARTED|Overall Study||81||
48386897|NCT01954251|101276689|FG001|NOT COMPLETED|Overall Study||19||
48386898|NCT00194025|101276690|FG000|STARTED|Overall Study||20||
48386899|NCT00194025|101276690|FG000|COMPLETED|Overall Study||15||
48386900|NCT00194025|101276690|FG000|NOT COMPLETED|Overall Study||5||
48386901|NCT02665364|101276691|FG000|STARTED|Overall Study||91||
48386902|NCT02665364|101276692|FG001|STARTED|Overall Study||93||
48386903|NCT02665364|101276691|FG000|COMPLETED|Overall Study||85||
48386904|NCT02665364|101276692|FG001|COMPLETED|Overall Study||84||
48386905|NCT02665364|101276691|FG000|NOT COMPLETED|Overall Study||6||
48386906|NCT02665364|101276692|FG001|NOT COMPLETED|Overall Study||9||
48386907|NCT00943488|101276693|FG000|STARTED|Overall Study||204||
48386908|NCT00943488|101276694|FG001|STARTED|Overall Study||204||
48386909|NCT00943488|101276693|FG000|COMPLETED|Overall Study||203||
48094180|NCT01770379|100552231|FG002|STARTED|Overall Study||81||
48094181|NCT01770379|100552229|FG000|COMPLETED|Overall Study||41||
48094182|NCT01770379|100552230|FG001|COMPLETED|Overall Study||37||
48094183|NCT01770379|100552231|FG002|COMPLETED|Overall Study||39||
48094184|NCT01770379|100552229|FG000|NOT COMPLETED|Overall Study||39||
48094185|NCT01770379|100552230|FG001|NOT COMPLETED|Overall Study||44||
48094186|NCT01770379|100552231|FG002|NOT COMPLETED|Overall Study||42||
48094187|NCT05286307|100552232|FG000|STARTED|Overall Study||52||
48094188|NCT05286307|100552233|FG001|STARTED|Overall Study||50||
48094189|NCT05286307|100552232|FG000|COMPLETED|Overall Study||24||
48094190|NCT05286307|100552233|FG001|COMPLETED|Overall Study||12||
48094191|NCT05286307|100552232|FG000|NOT COMPLETED|Overall Study||28||
48094192|NCT05286307|100552233|FG001|NOT COMPLETED|Overall Study||38||
48094193|NCT00869206|100552234|FG000|STARTED|Overall Study||911||
48094194|NCT00869206|100552235|FG001|STARTED|Overall Study||911||
48094195|NCT00869206|100552234|FG000|COMPLETED|Overall Study||882||
48094196|NCT00869206|100552235|FG001|COMPLETED|Overall Study||884||
48094197|NCT00869206|100552234|FG000|NOT COMPLETED|Overall Study||29||
48094198|NCT00869206|100552235|FG001|NOT COMPLETED|Overall Study||27||
48094199|NCT01313936|100552236|FG000|STARTED|Overall Study||6||
48094200|NCT01313936|100552237|FG001|STARTED|Overall Study||26||
48094201|NCT01313936|100552236|FG000|COMPLETED|Overall Study||6||
48094202|NCT01313936|100552237|FG001|COMPLETED|Overall Study||26||
48094203|NCT01313936|100552236|FG000|NOT COMPLETED|Overall Study||0||
48094204|NCT01313936|100552237|FG001|NOT COMPLETED|Overall Study||0||
48094205|NCT02611778|100552238|FG000|STARTED|Overall Study||238||
48094206|NCT02611778|100552239|FG001|STARTED|Overall Study||239||
48094207|NCT02611778|100552238|FG000|COMPLETED|Overall Study||226||
48386910|NCT00943488|101276694|FG001|COMPLETED|Overall Study||202||
48386911|NCT00943488|101276693|FG000|NOT COMPLETED|Overall Study||1||
48386912|NCT00943488|101276694|FG001|NOT COMPLETED|Overall Study||2||
48386913|NCT01305213|101276695|FG000|STARTED|Overall Study||53||
48094208|NCT02611778|100552239|FG001|COMPLETED|Overall Study||226||
48094209|NCT02611778|100552238|FG000|NOT COMPLETED|Overall Study||12||
48386914|NCT01305213|101276696|FG001|STARTED|Overall Study||54||
48386915|NCT01305213|101276695|FG000|COMPLETED|Overall Study||53||
48386916|NCT01305213|101276696|FG001|COMPLETED|Overall Study||54||
48386917|NCT01305213|101276695|FG000|NOT COMPLETED|Overall Study||0||
48386918|NCT01305213|101276696|FG001|NOT COMPLETED|Overall Study||0||
48094210|NCT02611778|100552239|FG001|NOT COMPLETED|Overall Study||13||
48094211|NCT00056407|100552240|FG000|STARTED|Overall Study||4126||
48094212|NCT00056407|100552241|FG001|STARTED|Overall Study||4105||
48094213|NCT00056407|100552240|FG000|COMPLETED|Overall Study||2915||
48094214|NCT00056407|100552241|FG001|COMPLETED|Overall Study||2912||
48094215|NCT00056407|100552240|FG000|NOT COMPLETED|Overall Study||1211||
48094216|NCT00056407|100552241|FG001|NOT COMPLETED|Overall Study||1193||
48141384|NCT01297062|100670413|FG003|NOT COMPLETED|Overall Study||1||
48386919|NCT02475395|101276697|FG000|STARTED|Overall Study||258||
48386920|NCT02475395|101276698|FG001|STARTED|Overall Study||14||
48258526|NCT01728623|100952040|FG000|DTC|Overall Study||25||
48386921|NCT02475395|101276697|FG000|COMPLETED|Overall Study||228||
48386922|NCT02475395|101276698|FG001|COMPLETED|Overall Study||11||
48386923|NCT02475395|101276697|FG000|NOT COMPLETED|Overall Study||30||
48386924|NCT02475395|101276698|FG001|NOT COMPLETED|Overall Study||3||
48386925|NCT01995136|101276699|FG000|STARTED|Overall Study||32||
48386926|NCT01995136|101276699|FG000|COMPLETED|Overall Study||31||
48386927|NCT01995136|101276699|FG000|NOT COMPLETED|Overall Study||1||
48386928|NCT01016691|101276700|FG000|STARTED|Overall Study||17||
48386929|NCT01016691|101276701|FG001|STARTED|Overall Study||12||
48386930|NCT01016691|101276702|FG002|STARTED|Overall Study||18||
48386931|NCT01016691|101276700|FG000|COMPLETED|Overall Study||17||
48386932|NCT01016691|101276701|FG001|COMPLETED|Overall Study||12||
48386933|NCT01016691|101276702|FG002|COMPLETED|Overall Study||18||
48386934|NCT01016691|101276700|FG000|NOT COMPLETED|Overall Study||0||
48386935|NCT01016691|101276701|FG001|NOT COMPLETED|Overall Study||0||
48386936|NCT01016691|101276702|FG002|NOT COMPLETED|Overall Study||0||
48386937|NCT01431144|101276703|FG000|STARTED|Overall Study||13||
48386938|NCT01431144|101276704|FG001|STARTED|Overall Study||14||
48386939|NCT01431144|101276703|FG000|COMPLETED|Overall Study||11||
48258527|NCT01728623|100952040|FG000|MTC|Overall Study||9||
48258528|NCT01728623|100952040|FG000|ATC|Overall Study||17||
48258529|NCT01728623|100952040|FG000|COMPLETED|Overall Study||23||
48258530|NCT01728623|100952040|FG000|NOT COMPLETED|Overall Study||28||
48386940|NCT01431144|101276704|FG001|COMPLETED|Overall Study||14||
48386941|NCT01431144|101276703|FG000|NOT COMPLETED|Overall Study||2||
48386942|NCT01431144|101276704|FG001|NOT COMPLETED|Overall Study||0||
48386943|NCT04603391|101276705|FG000|STARTED|First Intervention (4 Days)||8||
48386944|NCT04603391|101276706|FG001|STARTED|First Intervention (4 Days)||6||
48386945|NCT04603391|101276705|FG000|COMPLETED|First Intervention (4 Days)||6||
48258531|NCT00477464|100952041|FG000|STARTED|Overall Study||51||
48258532|NCT00477464|100952041|FG000|COMPLETED|Overall Study||0||
48258533|NCT00477464|100952041|FG000|NOT COMPLETED|Overall Study||51||
48258534|NCT02196077|100952042|FG000|STARTED|Overall Study||180||
48258535|NCT02196077|100952042|FG000|BFF MDI 320/9.6 μg|Overall Study||155||
48258536|NCT02196077|100952042|FG000|BFF MDI 160/9.6 μg|Overall Study||106||
48258537|NCT02196077|100952042|FG000|BFF MDI 80/9.6 μg|Overall Study||103||
48258538|NCT02196077|100952042|FG000|BD MDI 320 μg|Overall Study||108||
48258539|NCT02196077|100952042|FG000|FF MDI 9.6 μg|Overall Study||157||
48258540|NCT02196077|100952042|FG000|COMPLETED|Overall Study||133||
48258541|NCT02196077|100952042|FG000|NOT COMPLETED|Overall Study||47||
48258542|NCT00905359|100952043|FG000|STARTED|Overall Study||82||
48258543|NCT00905359|100952044|FG001|STARTED|Overall Study||81||
48386946|NCT04603391|101276706|FG001|COMPLETED|First Intervention (4 Days)||6||
48386947|NCT04603391|101276705|FG000|NOT COMPLETED|First Intervention (4 Days)||2||
48386948|NCT04603391|101276706|FG001|NOT COMPLETED|First Intervention (4 Days)||0||
48386949|NCT04603391|101276705|FG000|STARTED|Washout (Minimum 5 Days)||6||
48386950|NCT04603391|101276706|FG001|STARTED|Washout (Minimum 5 Days)||6||
48386951|NCT04603391|101276705|FG000|COMPLETED|Washout (Minimum 5 Days)||6||
48386952|NCT04603391|101276706|FG001|COMPLETED|Washout (Minimum 5 Days)||6||
48386953|NCT04603391|101276705|FG000|NOT COMPLETED|Washout (Minimum 5 Days)||0||
48386954|NCT04603391|101276706|FG001|NOT COMPLETED|Washout (Minimum 5 Days)||0||
48386955|NCT04603391|101276705|FG000|STARTED|Second Intervention (4 Days)||6||
48386956|NCT04603391|101276706|FG001|STARTED|Second Intervention (4 Days)||6||
48386957|NCT04603391|101276705|FG000|COMPLETED|Second Intervention (4 Days)||6||
48258544|NCT00905359|100952043|FG000|12 Months Follow up|Overall Study||68||
48258545|NCT00905359|100952044|FG001|12 Months Follow up|Overall Study||72||
48258546|NCT00905359|100952043|FG000|24 Months Follow up|Overall Study||58||
48258547|NCT00905359|100952044|FG001|24 Months Follow up|Overall Study||65||
48258548|NCT00905359|100952043|FG000|COMPLETED|Overall Study||58||
48258549|NCT00905359|100952044|FG001|COMPLETED|Overall Study||65||
48386958|NCT04603391|101276706|FG001|COMPLETED|Second Intervention (4 Days)||6||
48386959|NCT04603391|101276705|FG000|NOT COMPLETED|Second Intervention (4 Days)||0||
48386960|NCT04603391|101276706|FG001|NOT COMPLETED|Second Intervention (4 Days)||0||
48386961|NCT03543358|101276707|FG000|STARTED|Overall Study||3||
48386962|NCT03543358|101276708|FG001|STARTED|Overall Study||0||
48386963|NCT03543358|101276707|FG000|Received Treatment or Retreatment|Overall Study||0||
48386964|NCT03543358|101276708|FG001|Received Treatment or Retreatment|Overall Study||0||
48258550|NCT00905359|100952043|FG000|NOT COMPLETED|Overall Study||24||
48258551|NCT00905359|100952044|FG001|NOT COMPLETED|Overall Study||16||
48258552|NCT03712449|100952045|FG000|STARTED|Overall Study||13||
48258553|NCT03712449|100952046|FG001|STARTED|Overall Study||46||
48258554|NCT03712449|100952045|FG000|Full Analysis Population|Overall Study||13|Full Analysis Population included all participants who had met all eligibility criteria at the screening visit and received any product used as treatment in this study.|
48386965|NCT03543358|101276707|FG000|COMPLETED|Overall Study||0||
48386966|NCT03543358|101276708|FG001|COMPLETED|Overall Study||0||
48258555|NCT03712449|100952046|FG001|Full Analysis Population|Overall Study||45|Full Analysis Population included all participants who had met all eligibility criteria at the screening visit and received any product used as treatment in this study.|
48258556|NCT03712449|100952045|FG000|COMPLETED|Overall Study||13||
48258557|NCT03712449|100952046|FG001|COMPLETED|Overall Study||45||
48258558|NCT03712449|100952045|FG000|NOT COMPLETED|Overall Study||0||
48258559|NCT03712449|100952046|FG001|NOT COMPLETED|Overall Study||1||
48258560|NCT03004586|100952047|FG000|STARTED|Overall Study||31||200
48258561|NCT03004586|100952048|FG001|STARTED|Overall Study||30||200
48258562|NCT03004586|100952047|FG000|COMPLETED|Overall Study||31||200
48258563|NCT03004586|100952048|FG001|COMPLETED|Overall Study||30||200
48258564|NCT03004586|100952047|FG000|NOT COMPLETED|Overall Study||0||0
48258565|NCT03004586|100952048|FG001|NOT COMPLETED|Overall Study||0||0
48258566|NCT01438840|100952049|FG000|STARTED|Core Study||17||
48258567|NCT01438840|100952050|FG001|STARTED|Core Study||32||
48258568|NCT01438840|100952051|FG002|STARTED|Core Study||0||
48258569|NCT01438840|100952049|FG000|COMPLETED|Core Study||1||
48258570|NCT01438840|100952050|FG001|COMPLETED|Core Study||22||
48258571|NCT01438840|100952051|FG002|COMPLETED|Core Study||0||
48258572|NCT01438840|100952049|FG000|NOT COMPLETED|Core Study||16||
48258573|NCT01438840|100952050|FG001|NOT COMPLETED|Core Study||10||
48258574|NCT01438840|100952051|FG002|NOT COMPLETED|Core Study||0||
48258575|NCT01438840|100952049|FG000|STARTED|Extension Phase||0||
48258576|NCT01438840|100952050|FG001|STARTED|Extension Phase||0||
48258577|NCT01438840|100952051|FG002|STARTED|Extension Phase||39||
48258578|NCT01438840|100952049|FG000|COMPLETED|Extension Phase||0||
48258579|NCT01438840|100952050|FG001|COMPLETED|Extension Phase||0||
48258580|NCT01438840|100952051|FG002|COMPLETED|Extension Phase||29||
48258581|NCT01438840|100952049|FG000|NOT COMPLETED|Extension Phase||0||
48258582|NCT01438840|100952050|FG001|NOT COMPLETED|Extension Phase||0||
48258583|NCT01438840|100952051|FG002|NOT COMPLETED|Extension Phase||10||
48258584|NCT00741468|100952052|FG000|STARTED|Overall Study||18||
48258585|NCT00741468|100952052|FG000|COMPLETED|Overall Study||18||
48258586|NCT00741468|100952052|FG000|NOT COMPLETED|Overall Study||0||
48258587|NCT02826798|100952053|FG000|STARTED|Overall Study||25||
48258588|NCT02826798|100952054|FG001|STARTED|Overall Study||26||
48258589|NCT02826798|100952055|FG002|STARTED|Overall Study||26||
48258590|NCT02826798|100952056|FG003|STARTED|Overall Study||25||
48258591|NCT02826798|100952057|FG004|STARTED|Overall Study||26||
48258592|NCT02826798|100952053|FG000|COMPLETED|Overall Study||25||
48258593|NCT02826798|100952054|FG001|COMPLETED|Overall Study||25||
48258594|NCT02826798|100952055|FG002|COMPLETED|Overall Study||26||
48258595|NCT02826798|100952056|FG003|COMPLETED|Overall Study||24||
48258596|NCT02826798|100952057|FG004|COMPLETED|Overall Study||26||
48258597|NCT02826798|100952053|FG000|NOT COMPLETED|Overall Study||0||
48258598|NCT02826798|100952054|FG001|NOT COMPLETED|Overall Study||1||
48258599|NCT02826798|100952055|FG002|NOT COMPLETED|Overall Study||0||
48258600|NCT02826798|100952056|FG003|NOT COMPLETED|Overall Study||1||
48258601|NCT02826798|100952057|FG004|NOT COMPLETED|Overall Study||0||
48258602|NCT01983553|100952058|FG000|STARTED|Overall Study||2131||
48258603|NCT01983553|100952059|FG001|STARTED|Overall Study||1072||
48258604|NCT01983553|100952058|FG000|COMPLETED|Overall Study||2131||
48258605|NCT01983553|100952059|FG001|COMPLETED|Overall Study||1072||
48258606|NCT01983553|100952058|FG000|NOT COMPLETED|Overall Study||0||
48258607|NCT01983553|100952059|FG001|NOT COMPLETED|Overall Study||0||
48258608|NCT01930214|100952060|FG000|STARTED|Overall Study||100||
48258609|NCT01930214|100952061|FG001|STARTED|Overall Study||117||
48258610|NCT01930214|100952062|FG002|STARTED|Overall Study||133||
48258611|NCT01930214|100952060|FG000|COMPLETED|Overall Study||80||
48258612|NCT01930214|100952061|FG001|COMPLETED|Overall Study||96||
48258613|NCT01930214|100952062|FG002|COMPLETED|Overall Study||108||
48258614|NCT01930214|100952060|FG000|NOT COMPLETED|Overall Study||20||
48258615|NCT01930214|100952061|FG001|NOT COMPLETED|Overall Study||21||
48258616|NCT01930214|100952062|FG002|NOT COMPLETED|Overall Study||25||
48258617|NCT01124838|100952063|FG000|STARTED|Overall Study||130||
48258618|NCT01124838|100952064|FG001|STARTED|Overall Study||131||
48258619|NCT01124838|100952063|FG000|Enrolled in Main Study|Overall Study||114||
48258620|NCT01124838|100952064|FG001|Enrolled in Main Study|Overall Study||115||
48258621|NCT01124838|100952063|FG000|Enrolled in Japan Sub-study|Overall Study||16||
48258622|NCT01124838|100952064|FG001|Enrolled in Japan Sub-study|Overall Study||16||
48258623|NCT01124838|100952063|FG000|COMPLETED|Overall Study||112||
48258624|NCT01124838|100952064|FG001|COMPLETED|Overall Study||116||
48258625|NCT01124838|100952063|FG000|NOT COMPLETED|Overall Study||18||
48258626|NCT01124838|100952064|FG001|NOT COMPLETED|Overall Study||15||
48258627|NCT01036165|100952065|FG000|STARTED|Overall Study||103||
48258628|NCT01036165|100952065|FG000|COMPLETED|Overall Study||88||
48258629|NCT01036165|100952065|FG000|NOT COMPLETED|Overall Study||15||
48258630|NCT02353871|100952066|FG000|STARTED|Overall Study||125||
48258631|NCT02353871|100952067|FG001|STARTED|Overall Study||60||
48258632|NCT02353871|100952066|FG000|COMPLETED|Overall Study||122||
48258633|NCT02353871|100952067|FG001|COMPLETED|Overall Study||51||
48258634|NCT02353871|100952066|FG000|NOT COMPLETED|Overall Study||3||
48258635|NCT02353871|100952067|FG001|NOT COMPLETED|Overall Study||9||
48258636|NCT01540162|100952068|FG000|STARTED|Overall Study||30||
48258637|NCT01540162|100952069|FG001|STARTED|Overall Study||32||
48386967|NCT03543358|101276707|FG000|NOT COMPLETED|Overall Study||3||
48386968|NCT03543358|101276708|FG001|NOT COMPLETED|Overall Study||0||
48386969|NCT00326417|101276709|FG000|STARTED|Overall Study||14||
48386970|NCT00326417|101276710|FG001|STARTED|Overall Study||41||
48386971|NCT00326417|101276711|FG002|STARTED|Overall Study||39||
48386972|NCT00326417|101276712|FG003|STARTED|Overall Study||3||
48386973|NCT00326417|101276709|FG000|Phase I|Overall Study||6||
48386974|NCT00326417|101276710|FG001|Phase I|Overall Study||6||
48386975|NCT00326417|101276711|FG002|Phase I|Overall Study||6||
48386976|NCT00326417|101276712|FG003|Phase I|Overall Study||3||
48386977|NCT00326417|101276709|FG000|Phase II|Overall Study||8||
48386978|NCT00326417|101276710|FG001|Phase II|Overall Study||35||
48386979|NCT00326417|101276711|FG002|Phase II|Overall Study||33||
48386980|NCT00326417|101276712|FG003|Phase II|Overall Study||0||
48386981|NCT00326417|101276709|FG000|COMPLETED|Overall Study||0||
48386982|NCT00326417|101276710|FG001|COMPLETED|Overall Study||41||
48386983|NCT00326417|101276711|FG002|COMPLETED|Overall Study||38||
48386984|NCT00326417|101276712|FG003|COMPLETED|Overall Study||0||
48386985|NCT00326417|101276709|FG000|NOT COMPLETED|Overall Study||14||
48386986|NCT00326417|101276710|FG001|NOT COMPLETED|Overall Study||0||
48386987|NCT00326417|101276711|FG002|NOT COMPLETED|Overall Study||1||
48386988|NCT00326417|101276712|FG003|NOT COMPLETED|Overall Study||3||
48386989|NCT03303040|101276713|FG000|STARTED|Overall Study||25||
48386990|NCT03303040|101276713|FG000|COMPLETED|Overall Study||21||
48386991|NCT03303040|101276713|FG000|NOT COMPLETED|Overall Study||4||
48386992|NCT03454412|101276714|FG000|STARTED|Baseline Assesment||44||
48386993|NCT03454412|101276714|FG000|COMPLETED|Baseline Assesment||32||
48386994|NCT03454412|101276714|FG000|NOT COMPLETED|Baseline Assesment||12||
48386995|NCT03454412|101276714|FG000|STARTED|Treatment Course||32||
48386996|NCT03454412|101276714|FG000|COMPLETED|Treatment Course||32||
48386997|NCT03454412|101276714|FG000|NOT COMPLETED|Treatment Course||0||
48386998|NCT03454412|101276714|FG000|STARTED|Final Assesment||32||
48386999|NCT03454412|101276714|FG000|COMPLETED|Final Assesment||32||
48387000|NCT03454412|101276714|FG000|NOT COMPLETED|Final Assesment||0||
48387001|NCT02721251|101276715|FG000|STARTED|Overall Study||14||
48387002|NCT02721251|101276716|FG001|STARTED|Overall Study||16||
48387003|NCT02721251|101276717|FG002|STARTED|Overall Study||17||
48387004|NCT02721251|101276715|FG000|COMPLETED|Overall Study||4||
48387005|NCT02721251|101276716|FG001|COMPLETED|Overall Study||7||
48387006|NCT02721251|101276717|FG002|COMPLETED|Overall Study||6||
48387007|NCT02721251|101276715|FG000|NOT COMPLETED|Overall Study||10||
48387008|NCT02721251|101276716|FG001|NOT COMPLETED|Overall Study||9||
48387009|NCT02721251|101276717|FG002|NOT COMPLETED|Overall Study||11||
48387010|NCT01670656|101276718|FG000|STARTED|Overall Study||86||
48387011|NCT01670656|101276719|FG001|STARTED|Overall Study||91||
48387012|NCT01670656|101276720|FG002|STARTED|Overall Study||87||
48387013|NCT01670656|101276721|FG003|STARTED|Overall Study||85||
48387014|NCT01670656|101276722|FG004|STARTED|Overall Study||90||
48387015|NCT01670656|101276718|FG000|Treated|Overall Study||86||
48387016|NCT01670656|101276719|FG001|Treated|Overall Study||91||
48387017|NCT01670656|101276720|FG002|Treated|Overall Study||86||
48387018|NCT01670656|101276721|FG003|Treated|Overall Study||85||
48387019|NCT01670656|101276722|FG004|Treated|Overall Study||90||
48387020|NCT01670656|101276718|FG000|COMPLETED|Overall Study||83||
48387021|NCT01670656|101276719|FG001|COMPLETED|Overall Study||84||
48387022|NCT01670656|101276720|FG002|COMPLETED|Overall Study||79||
48387023|NCT01670656|101276721|FG003|COMPLETED|Overall Study||79||
48387024|NCT01670656|101276722|FG004|COMPLETED|Overall Study||79||
48387025|NCT01670656|101276718|FG000|NOT COMPLETED|Overall Study||3||
48387026|NCT01670656|101276719|FG001|NOT COMPLETED|Overall Study||7||
48387027|NCT01670656|101276720|FG002|NOT COMPLETED|Overall Study||8||
48387028|NCT01670656|101276721|FG003|NOT COMPLETED|Overall Study||6||
48387029|NCT01670656|101276722|FG004|NOT COMPLETED|Overall Study||11||
48387030|NCT05283863|101276723|FG000|STARTED|First Intervention (14 Days)||2||
48387031|NCT05283863|101276724|FG001|STARTED|First Intervention (14 Days)||2||
48387032|NCT05283863|101276723|FG000|COMPLETED|First Intervention (14 Days)||2||
48387033|NCT05283863|101276724|FG001|COMPLETED|First Intervention (14 Days)||2||
48387034|NCT05283863|101276723|FG000|NOT COMPLETED|First Intervention (14 Days)||0||
48387035|NCT05283863|101276724|FG001|NOT COMPLETED|First Intervention (14 Days)||0||
48387036|NCT05283863|101276723|FG000|STARTED|Washout (14 Days)||2||
48387037|NCT05283863|101276724|FG001|STARTED|Washout (14 Days)||2||
48387038|NCT05283863|101276723|FG000|COMPLETED|Washout (14 Days)||2||
48387039|NCT05283863|101276724|FG001|COMPLETED|Washout (14 Days)||2||
48387040|NCT05283863|101276723|FG000|NOT COMPLETED|Washout (14 Days)||0||
48387041|NCT05283863|101276724|FG001|NOT COMPLETED|Washout (14 Days)||0||
48387042|NCT05283863|101276723|FG000|STARTED|Second Intervention (14 Days)||2||
48387043|NCT05283863|101276724|FG001|STARTED|Second Intervention (14 Days)||2||
48387044|NCT05283863|101276723|FG000|COMPLETED|Second Intervention (14 Days)||2||
48387045|NCT05283863|101276724|FG001|COMPLETED|Second Intervention (14 Days)||2||
48387046|NCT05283863|101276723|FG000|NOT COMPLETED|Second Intervention (14 Days)||0||
48387047|NCT05283863|101276724|FG001|NOT COMPLETED|Second Intervention (14 Days)||0||
48387048|NCT02026206|101276725|FG000|STARTED|Overall Study||44||
48387049|NCT02026206|101276726|FG001|STARTED|Overall Study||44||
48387050|NCT02026206|101276725|FG000|COMPLETED|Overall Study||40||
48387051|NCT02026206|101276726|FG001|COMPLETED|Overall Study||36||
48387052|NCT02026206|101276725|FG000|NOT COMPLETED|Overall Study||4||
48387053|NCT02026206|101276726|FG001|NOT COMPLETED|Overall Study||8||
48387054|NCT01840228|101276727|FG000|STARTED|Overall Study||19||
48387055|NCT01840228|101276728|FG001|STARTED|Overall Study||19||
48387056|NCT01840228|101276727|FG000|COMPLETED|Overall Study||18||
48387057|NCT01840228|101276728|FG001|COMPLETED|Overall Study||18||
48387058|NCT01840228|101276727|FG000|NOT COMPLETED|Overall Study||1||
48387059|NCT01840228|101276728|FG001|NOT COMPLETED|Overall Study||1||
48387060|NCT00363051|101276729|FG000|STARTED|Overall Study||115||
48387061|NCT00363051|101276730|FG001|STARTED|Overall Study||45||
48387062|NCT00363051|101276729|FG000|COMPLETED|Overall Study||77||
48387063|NCT00363051|101276730|FG001|COMPLETED|Overall Study||23||
48387064|NCT00363051|101276729|FG000|NOT COMPLETED|Overall Study||38||
48387065|NCT00363051|101276730|FG001|NOT COMPLETED|Overall Study||22||
48387066|NCT01369212|101276731|FG000|STARTED|Overall Study||102||
48387067|NCT01369212|101276732|FG001|STARTED|Overall Study||99||
48387068|NCT01369212|101276731|FG000|COMPLETED|Overall Study||95||
48387069|NCT01369212|101276732|FG001|COMPLETED|Overall Study||92||
48387070|NCT01369212|101276731|FG000|NOT COMPLETED|Overall Study||7||
48387071|NCT01369212|101276732|FG001|NOT COMPLETED|Overall Study||7||
48387072|NCT00126581|101276733|FG000|STARTED|Overall Study||81||
48387073|NCT00126581|101276734|FG001|STARTED|Overall Study||100||
48387074|NCT00126581|101276733|FG000|COMPLETED|Overall Study||68||
48387075|NCT00126581|101276734|FG001|COMPLETED|Overall Study||80||
48387076|NCT00126581|101276733|FG000|NOT COMPLETED|Overall Study||13||
48387077|NCT00126581|101276734|FG001|NOT COMPLETED|Overall Study||20||
48387078|NCT01842841|101276735|FG000|STARTED|Overall Study||5||
48387079|NCT01842841|101276735|FG000|COMPLETED|Overall Study||5||
48387080|NCT01842841|101276735|FG000|NOT COMPLETED|Overall Study||0||
48387081|NCT00729326|101276736|FG000|STARTED|Overall Study||41||
48387082|NCT00729326|101276737|FG001|STARTED|Overall Study||42||
48387083|NCT00729326|101276736|FG000|COMPLETED|Overall Study||31||
48387084|NCT00729326|101276737|FG001|COMPLETED|Overall Study||33||
48387085|NCT00729326|101276736|FG000|NOT COMPLETED|Overall Study||10||
48387086|NCT00729326|101276737|FG001|NOT COMPLETED|Overall Study||9||
48387087|NCT03006471|101276738|FG000|STARTED|Overall Study||15||
48387088|NCT03006471|101276739|FG001|STARTED|Overall Study||15||
48387089|NCT03006471|101276738|FG000|COMPLETED|Overall Study||13||
48387090|NCT03006471|101276739|FG001|COMPLETED|Overall Study||13||
48387091|NCT03006471|101276738|FG000|NOT COMPLETED|Overall Study||2||
48387092|NCT03006471|101276739|FG001|NOT COMPLETED|Overall Study||2||
48387093|NCT01313208|101276740|FG000|STARTED|Double-blind Phase (Weeks 1 - 12)||104||
48387094|NCT01313208|101276741|FG001|STARTED|Double-blind Phase (Weeks 1 - 12)||106||
48387095|NCT01313208|101276740|FG000|COMPLETED|Double-blind Phase (Weeks 1 - 12)||98||
48387096|NCT01313208|101276741|FG001|COMPLETED|Double-blind Phase (Weeks 1 - 12)||101||
48387097|NCT01313208|101276740|FG000|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||6||
48387098|NCT01313208|101276741|FG001|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||5||
48387099|NCT01313208|101276740|FG000|STARTED|Open-label Phase (Weeks 13 - 24)||98||
48387100|NCT01313208|101276741|FG001|STARTED|Open-label Phase (Weeks 13 - 24)||101||
48387101|NCT01313208|101276740|FG000|COMPLETED|Open-label Phase (Weeks 13 - 24)||92||
48387102|NCT01313208|101276741|FG001|COMPLETED|Open-label Phase (Weeks 13 - 24)||98||
48387103|NCT01313208|101276740|FG000|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||6||
48387104|NCT01313208|101276741|FG001|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||3||
48387105|NCT02726113|101276742|FG000|STARTED|Total Enrollment||28||
48387106|NCT02726113|101276743|FG001|STARTED|Total Enrollment||22||
48387107|NCT02726113|101276742|FG000|COMPLETED|Total Enrollment||24||
48387108|NCT02726113|101276743|FG001|COMPLETED|Total Enrollment||19||
48387109|NCT02726113|101276742|FG000|NOT COMPLETED|Total Enrollment||4||
48387110|NCT02726113|101276743|FG001|NOT COMPLETED|Total Enrollment||3||
48387111|NCT02726113|101276742|FG000|STARTED|Genomic Analysis||19||
48387112|NCT02726113|101276743|FG001|STARTED|Genomic Analysis||14||
48387113|NCT02726113|101276742|FG000|COMPLETED|Genomic Analysis||15||
48387114|NCT02726113|101276743|FG001|COMPLETED|Genomic Analysis||12||
48689101|NCT02413996|102022609|FG000|NOT COMPLETED|Overall Study||9||
48689102|NCT02413996|102022610|FG001|NOT COMPLETED|Overall Study||2||
48689103|NCT00848237|102022611|FG000|STARTED|Overall Study||5521||
48689104|NCT00848237|102022611|FG000|COMPLETED|Overall Study||4982||
48689105|NCT00848237|102022611|FG000|NOT COMPLETED|Overall Study||539||
48689106|NCT06164691|102022612|FG000|STARTED|Overall Study||2||
48689107|NCT06164691|102022613|FG001|STARTED|Overall Study||0||
48689108|NCT06164691|102022614|FG002|STARTED|Overall Study||0||
48689109|NCT06164691|102022612|FG000|COMPLETED|Overall Study||0||
48689110|NCT06164691|102022613|FG001|COMPLETED|Overall Study||0||
48258638|NCT01540162|100952068|FG000|COMPLETED|Overall Study||30||
48258639|NCT01540162|100952069|FG001|COMPLETED|Overall Study||32||
48258640|NCT01540162|100952068|FG000|NOT COMPLETED|Overall Study||0||
48258641|NCT01540162|100952069|FG001|NOT COMPLETED|Overall Study||0||
48258642|NCT03774875|100952070|FG000|STARTED|Placebo-controlled Period (Week 1-16)||92||
48258643|NCT03774875|100952071|FG001|STARTED|Placebo-controlled Period (Week 1-16)||185||
48258644|NCT03774875|100952070|FG000|Received Study Drug|Placebo-controlled Period (Week 1-16)||91||
48258645|NCT03774875|100952071|FG001|Received Study Drug|Placebo-controlled Period (Week 1-16)||185||
48258646|NCT03774875|100952070|FG000|COMPLETED|Placebo-controlled Period (Week 1-16)||69||
48258647|NCT03774875|100952071|FG001|COMPLETED|Placebo-controlled Period (Week 1-16)||152||
48258648|NCT03774875|100952070|FG000|NOT COMPLETED|Placebo-controlled Period (Week 1-16)||23||
48258649|NCT03774875|100952071|FG001|NOT COMPLETED|Placebo-controlled Period (Week 1-16)||33||
48258650|NCT03774875|100952070|FG000|STARTED|Apremilast Extension Period (Week 16-52)||69||
48258651|NCT03774875|100952071|FG001|STARTED|Apremilast Extension Period (Week 16-52)||152||
48258652|NCT03774875|100952070|FG000|COMPLETED|Apremilast Extension Period (Week 16-52)||53||
48258653|NCT03774875|100952071|FG001|COMPLETED|Apremilast Extension Period (Week 16-52)||105||
48258654|NCT03774875|100952070|FG000|NOT COMPLETED|Apremilast Extension Period (Week 16-52)||16||
48258655|NCT03774875|100952071|FG001|NOT COMPLETED|Apremilast Extension Period (Week 16-52)||47||
48258656|NCT01427738|100952072|FG000|STARTED|Overall Study||110||
48258657|NCT01427738|100952073|FG001|STARTED|Overall Study||111||
48258658|NCT01427738|100952072|FG000|COMPLETED|Overall Study||91||
48258659|NCT01427738|100952073|FG001|COMPLETED|Overall Study||90||
48258660|NCT01427738|100952072|FG000|NOT COMPLETED|Overall Study||19||
48258661|NCT01427738|100952073|FG001|NOT COMPLETED|Overall Study||21||
48258662|NCT00397020|100952074|FG000|STARTED|Overall Study||14||
48258663|NCT00397020|100952075|FG001|STARTED|Overall Study||16||
48258664|NCT00397020|100952074|FG000|COMPLETED|Overall Study||13||
48258665|NCT00397020|100952075|FG001|COMPLETED|Overall Study||15||
48258666|NCT00397020|100952074|FG000|NOT COMPLETED|Overall Study||1||
48258667|NCT00397020|100952075|FG001|NOT COMPLETED|Overall Study||1||
48258668|NCT05127018|100952076|FG000|STARTED|the Average-dose Period||33|With the average-dose method, the dose was individualized according to the severity of anterior gingival exposure pretreatment.|
48258669|NCT05127018|100952076|FG000|COMPLETED|the Average-dose Period||33||
48258670|NCT05127018|100952076|FG000|NOT COMPLETED|the Average-dose Period||0||
48258671|NCT05127018|100952076|FG000|STARTED|the Higher-dose Method Period||33|With this method, patients were administered botulinum toxin type A after 8 months when the effect of the previous injection had vanished. The injection dose (U) per side was set as the absolute value of the preoperative anterior gingival exposure (mm).|
48258672|NCT05127018|100952076|FG000|COMPLETED|the Higher-dose Method Period||33||
48258673|NCT05127018|100952076|FG000|NOT COMPLETED|the Higher-dose Method Period||0||
48258674|NCT00665132|100952077|FG000|STARTED|Overall Study||10||
48258675|NCT00665132|100952077|FG000|COMPLETED|Overall Study||10||
48258676|NCT00665132|100952077|FG000|NOT COMPLETED|Overall Study||0||
48258677|NCT00356993|100952078|FG000|STARTED|Overall Study||6009||
48258678|NCT00356993|100952078|FG000|COMPLETED|Overall Study||2088||
48258679|NCT00356993|100952078|FG000|NOT COMPLETED|Overall Study||3921||
48258680|NCT01184898|100952079|FG000|STARTED|Overall Study||36||
48258681|NCT01184898|100952079|FG000|COMPLETED|Overall Study||36||
48258682|NCT01184898|100952079|FG000|NOT COMPLETED|Overall Study||0||
48258683|NCT04198948|100952080|FG000|STARTED|First Period||7||
48258684|NCT04198948|100952081|FG001|STARTED|First Period||8||
48258685|NCT04198948|100952080|FG000|COMPLETED|First Period||7||
48258686|NCT04198948|100952081|FG001|COMPLETED|First Period||8||
48387115|NCT02726113|101276742|FG000|NOT COMPLETED|Genomic Analysis||4||
48387116|NCT02726113|101276743|FG001|NOT COMPLETED|Genomic Analysis||2||
48387117|NCT01009983|101276744|FG000|STARTED|Overall Study||14||
48689111|NCT06164691|102022614|FG002|COMPLETED|Overall Study||0||
48689112|NCT06164691|102022612|FG000|NOT COMPLETED|Overall Study||2||
48689113|NCT06164691|102022613|FG001|NOT COMPLETED|Overall Study||0||
48689114|NCT06164691|102022614|FG002|NOT COMPLETED|Overall Study||0||
48689115|NCT01179984|102022615|FG000|STARTED|Overall Study||76||
48689116|NCT01179984|102022615|FG000|COMPLETED|Overall Study||58||
48689117|NCT01179984|102022615|FG000|NOT COMPLETED|Overall Study||18||
48689118|NCT00984594|102022616|FG000|STARTED|Overall Study||2||
48258687|NCT04198948|100952080|FG000|NOT COMPLETED|First Period||0||
48258688|NCT04198948|100952081|FG001|NOT COMPLETED|First Period||0||
48258689|NCT04198948|100952080|FG000|STARTED|Wash-out (10 Days)||7||
48258690|NCT04198948|100952081|FG001|STARTED|Wash-out (10 Days)||8||
48258691|NCT04198948|100952080|FG000|COMPLETED|Wash-out (10 Days)||7||
48387118|NCT01009983|101276744|FG000|COMPLETED|Overall Study||13||
48387119|NCT01009983|101276744|FG000|NOT COMPLETED|Overall Study||1||
48541746|NCT03095638|101662792|FG003|STARTED|P2: Period 1, Washout (7[-4 Hours])||4||
48541747|NCT03095638|101662793|FG004|STARTED|P2: Period 1, Washout (7[-4 Hours])||4||
48541748|NCT03095638|101662794|FG005|STARTED|P2: Period 1, Washout (7[-4 Hours])||4||
48541749|NCT03095638|101662795|FG006|STARTED|P2: Period 1, Washout (7[-4 Hours])||4||
48541750|NCT03095638|101662796|FG007|STARTED|P2: Period 1, Washout (7[-4 Hours])||4||
48689119|NCT00984594|102022617|FG001|STARTED|Overall Study||2||
48689120|NCT00984594|102022616|FG000|COMPLETED|Overall Study||1||
48258692|NCT04198948|100952081|FG001|COMPLETED|Wash-out (10 Days)||8||
48258693|NCT04198948|100952080|FG000|NOT COMPLETED|Wash-out (10 Days)||0||
48258694|NCT04198948|100952081|FG001|NOT COMPLETED|Wash-out (10 Days)||0||
48541751|NCT03095638|101662789|FG000|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0||
48541752|NCT03095638|101662790|FG001|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0||
48541753|NCT03095638|101662791|FG002|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4||
48541754|NCT03095638|101662792|FG003|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4||
48541755|NCT03095638|101662793|FG004|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4||
48541756|NCT03095638|101662794|FG005|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4||
48541757|NCT03095638|101662795|FG006|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4||
48541758|NCT03095638|101662796|FG007|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4||
48541759|NCT03095638|101662789|FG000|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0||
48541760|NCT03095638|101662790|FG001|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0||
48541761|NCT03095638|101662791|FG002|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0||
48541762|NCT03095638|101662792|FG003|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0||
48541763|NCT03095638|101662793|FG004|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0||
48541764|NCT03095638|101662794|FG005|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0||
48541765|NCT03095638|101662795|FG006|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0||
48541766|NCT03095638|101662796|FG007|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0||
48541767|NCT03095638|101662789|FG000|STARTED|P2: Period 2 (4 Days)||0||
48541768|NCT03095638|101662790|FG001|STARTED|P2: Period 2 (4 Days)||0||
48541769|NCT03095638|101662791|FG002|STARTED|P2: Period 2 (4 Days)||4||
48541770|NCT03095638|101662792|FG003|STARTED|P2: Period 2 (4 Days)||4||
48541771|NCT03095638|101662793|FG004|STARTED|P2: Period 2 (4 Days)||4||
48541772|NCT03095638|101662794|FG005|STARTED|P2: Period 2 (4 Days)||4||
48541773|NCT03095638|101662795|FG006|STARTED|P2: Period 2 (4 Days)||4||
48541774|NCT03095638|101662796|FG007|STARTED|P2: Period 2 (4 Days)||4||
48541775|NCT03095638|101662789|FG000|COMPLETED|P2: Period 2 (4 Days)||0||
48541776|NCT03095638|101662790|FG001|COMPLETED|P2: Period 2 (4 Days)||0||
48541777|NCT03095638|101662791|FG002|COMPLETED|P2: Period 2 (4 Days)||4||
48541778|NCT03095638|101662792|FG003|COMPLETED|P2: Period 2 (4 Days)||4||
48541779|NCT03095638|101662793|FG004|COMPLETED|P2: Period 2 (4 Days)||4||
48541780|NCT03095638|101662794|FG005|COMPLETED|P2: Period 2 (4 Days)||4||
48541781|NCT03095638|101662795|FG006|COMPLETED|P2: Period 2 (4 Days)||4||
48541782|NCT03095638|101662796|FG007|COMPLETED|P2: Period 2 (4 Days)||4||
48541783|NCT03095638|101662789|FG000|NOT COMPLETED|P2: Period 2 (4 Days)||0||
48541784|NCT03095638|101662790|FG001|NOT COMPLETED|P2: Period 2 (4 Days)||0||
48541785|NCT03095638|101662791|FG002|NOT COMPLETED|P2: Period 2 (4 Days)||0||
48541786|NCT03095638|101662792|FG003|NOT COMPLETED|P2: Period 2 (4 Days)||0||
48541787|NCT03095638|101662793|FG004|NOT COMPLETED|P2: Period 2 (4 Days)||0||
48541788|NCT03095638|101662794|FG005|NOT COMPLETED|P2: Period 2 (4 Days)||0||
48541789|NCT03095638|101662795|FG006|NOT COMPLETED|P2: Period 2 (4 Days)||0||
48541790|NCT03095638|101662796|FG007|NOT COMPLETED|P2: Period 2 (4 Days)||0||
48541791|NCT03095638|101662789|FG000|STARTED|P2: Period 2, Washout (7[-4 Hours])||0||
48541792|NCT03095638|101662790|FG001|STARTED|P2: Period 2, Washout (7[-4 Hours])||0||
48541793|NCT03095638|101662791|FG002|STARTED|P2: Period 2, Washout (7[-4 Hours])||4||
48541794|NCT03095638|101662792|FG003|STARTED|P2: Period 2, Washout (7[-4 Hours])||4||
48541795|NCT03095638|101662793|FG004|STARTED|P2: Period 2, Washout (7[-4 Hours])||4||
48592707|NCT01877382|101783164|FG014|NOT COMPLETED|Dose Expansion||20||
48689121|NCT00984594|102022617|FG001|COMPLETED|Overall Study||1||
48258695|NCT04198948|100952080|FG000|STARTED|Second Period||7||
48258696|NCT04198948|100952081|FG001|STARTED|Second Period||8||
48258697|NCT04198948|100952080|FG000|COMPLETED|Second Period||7||
48258698|NCT04198948|100952081|FG001|COMPLETED|Second Period||7||
48258699|NCT04198948|100952080|FG000|NOT COMPLETED|Second Period||0||
48258700|NCT04198948|100952081|FG001|NOT COMPLETED|Second Period||1||
48258701|NCT01114672|100952082|FG000|STARTED|Overall Study||25||
48258702|NCT01114672|100952083|FG001|STARTED|Overall Study||25||
48258703|NCT01114672|100952082|FG000|COMPLETED|Overall Study||21||
48258704|NCT01114672|100952083|FG001|COMPLETED|Overall Study||23||
48258705|NCT01114672|100952082|FG000|NOT COMPLETED|Overall Study||4||
48258706|NCT01114672|100952083|FG001|NOT COMPLETED|Overall Study||2||
48258707|NCT00468130|100952084|FG000|STARTED|Overall Study||7||
48258708|NCT00468130|100952085|FG001|STARTED|Overall Study||6||
48258709|NCT00468130|100952084|FG000|COMPLETED|Overall Study||5||
48258710|NCT00468130|100952085|FG001|COMPLETED|Overall Study||4||
48258711|NCT00468130|100952084|FG000|NOT COMPLETED|Overall Study||2||
48258712|NCT00468130|100952085|FG001|NOT COMPLETED|Overall Study||2||
48258713|NCT02832284|100952086|FG000|STARTED|Overall Study||23||
48387120|NCT01064076|101276745|FG000|STARTED|Overall Study||321||
48387121|NCT01064076|101276745|FG000|COMPLETED|Overall Study||303||
48387122|NCT01064076|101276745|FG000|NOT COMPLETED|Overall Study||18||
48387123|NCT02270684|101276746|FG000|STARTED|Overall Study||1||
48387124|NCT02270684|101276747|FG001|STARTED|Overall Study||3||
48387125|NCT02270684|101276746|FG000|COMPLETED|Overall Study||0||
48387126|NCT02270684|101276747|FG001|COMPLETED|Overall Study||0||
48387127|NCT02270684|101276746|FG000|NOT COMPLETED|Overall Study||1||
48387128|NCT02270684|101276747|FG001|NOT COMPLETED|Overall Study||3||
48387129|NCT03196193|101276748|FG000|STARTED|Overall Study||121||
48387130|NCT03196193|101276749|FG001|STARTED|Overall Study||119||
48387131|NCT03196193|101276748|FG000|COMPLETED|Overall Study||118||
48387132|NCT03196193|101276749|FG001|COMPLETED|Overall Study||119||
48387133|NCT03196193|101276748|FG000|NOT COMPLETED|Overall Study||3||
48387134|NCT03196193|101276749|FG001|NOT COMPLETED|Overall Study||0||
48387135|NCT02260648|101276750|FG000|STARTED|Overall Study||53||
48387136|NCT02260648|101276751|FG001|STARTED|Overall Study||46||
48387137|NCT02260648|101276752|FG002|STARTED|Overall Study||50||
48387138|NCT02260648|101276750|FG000|Received at Least One Dose of Study Drug|Overall Study||53||
48387139|NCT02260648|101276751|FG001|Received at Least One Dose of Study Drug|Overall Study||46||
48387140|NCT02260648|101276752|FG002|Received at Least One Dose of Study Drug|Overall Study||50||
48387141|NCT02260648|101276750|FG000|COMPLETED|Overall Study||35||
48387142|NCT02260648|101276751|FG001|COMPLETED|Overall Study||33||
48387143|NCT02260648|101276752|FG002|COMPLETED|Overall Study||42||
48387144|NCT02260648|101276750|FG000|NOT COMPLETED|Overall Study||18||
48387145|NCT02260648|101276751|FG001|NOT COMPLETED|Overall Study||13||
48387146|NCT02260648|101276752|FG002|NOT COMPLETED|Overall Study||8||
48387147|NCT00803543|101276753|FG000|STARTED|Overall Study||69||
48387148|NCT00803543|101276754|FG001|STARTED|Overall Study||34||
48387149|NCT00803543|101276753|FG000|COMPLETED|Overall Study||45||
48387150|NCT00803543|101276754|FG001|COMPLETED|Overall Study||22||
48387151|NCT00803543|101276753|FG000|NOT COMPLETED|Overall Study||24||
48387152|NCT00803543|101276754|FG001|NOT COMPLETED|Overall Study||12||
48387153|NCT04724733|101276755|FG000|STARTED|Overall Study||22||
48387154|NCT04724733|101276756|FG001|STARTED|Overall Study||22||
48387155|NCT04724733|101276757|FG002|STARTED|Overall Study||23||
48387156|NCT04724733|101276755|FG000|4 Weeks|Overall Study||22||
48387157|NCT04724733|101276756|FG001|4 Weeks|Overall Study||21||
48387158|NCT04724733|101276757|FG002|4 Weeks|Overall Study||23||
48387159|NCT04724733|101276755|FG000|COMPLETED|Overall Study||21||
48387160|NCT04724733|101276756|FG001|COMPLETED|Overall Study||21||
48387161|NCT04724733|101276757|FG002|COMPLETED|Overall Study||22||
48387162|NCT04724733|101276755|FG000|NOT COMPLETED|Overall Study||1||
48387163|NCT04724733|101276756|FG001|NOT COMPLETED|Overall Study||1||
48387164|NCT04724733|101276757|FG002|NOT COMPLETED|Overall Study||1||
48387165|NCT04914377|101276758|FG000|STARTED|Overall Study||29||
48387166|NCT04914377|101276759|FG001|STARTED|Overall Study||26||
48387167|NCT04914377|101276758|FG000|COMPLETED|Overall Study||29||
48387168|NCT04914377|101276759|FG001|COMPLETED|Overall Study||26||
48387169|NCT04914377|101276758|FG000|NOT COMPLETED|Overall Study||0||
48387170|NCT04914377|101276759|FG001|NOT COMPLETED|Overall Study||0||
48387171|NCT01582971|101276760|FG000|STARTED|Overall Study||128||
48387172|NCT01582971|101276761|FG001|STARTED|Overall Study||128||
48387173|NCT01582971|101276760|FG000|COMPLETED|Overall Study||89||
48387174|NCT01582971|101276761|FG001|COMPLETED|Overall Study||91||
48387175|NCT01582971|101276760|FG000|NOT COMPLETED|Overall Study||39||
48387176|NCT01582971|101276761|FG001|NOT COMPLETED|Overall Study||37||
48387177|NCT01374217|101276762|FG000|STARTED|Overall Study||13||
48387178|NCT01374217|101276762|FG000|COMPLETED|Overall Study||0||
48387179|NCT01374217|101276762|FG000|NOT COMPLETED|Overall Study||13||
48387180|NCT01054976|101276763|FG000|STARTED|Overall Study||92||
48387181|NCT01054976|101276763|FG000|COMPLETED|Overall Study||57||
48387182|NCT01054976|101276763|FG000|NOT COMPLETED|Overall Study||35||
48387183|NCT02659605|101276764|FG000|STARTED|Overall Study||40||
48387184|NCT02659605|101276765|FG001|STARTED|Overall Study||34||
48387185|NCT02659605|101276764|FG000|COMPLETED|Overall Study||31||
48387186|NCT02659605|101276765|FG001|COMPLETED|Overall Study||30||
48387187|NCT02659605|101276764|FG000|NOT COMPLETED|Overall Study||9||
48387188|NCT02659605|101276765|FG001|NOT COMPLETED|Overall Study||4||
48387189|NCT02310906|101276766|FG000|STARTED|Part 1: Double Blind Phase (12 Weeks)||4||
48387190|NCT02310906|101276767|FG001|STARTED|Part 1: Double Blind Phase (12 Weeks)||8||
48387191|NCT02310906|101276768|FG002|STARTED|Part 1: Double Blind Phase (12 Weeks)||0||
48387192|NCT02310906|101276769|FG003|STARTED|Part 1: Double Blind Phase (12 Weeks)||0||
48387193|NCT02310906|101276766|FG000|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0||
48387194|NCT02310906|101276767|FG001|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8||
48387195|NCT02310906|101276768|FG002|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0||
48387196|NCT02310906|101276769|FG003|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0||
48387197|NCT02310906|101276766|FG000|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0||
48387198|NCT02310906|101276767|FG001|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8||
48387199|NCT02310906|101276768|FG002|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0||
48387200|NCT02310906|101276769|FG003|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0||
48592708|NCT00176436|101783165|FG000|STARTED|Overall Study||20||
48387201|NCT02310906|101276766|FG000|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0||
48387202|NCT02310906|101276767|FG001|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8||
48387203|NCT02310906|101276768|FG002|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0||
48387204|NCT02310906|101276769|FG003|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0||
48258714|NCT02832284|100952086|FG000|COMPLETED|Overall Study||23||
48258715|NCT02832284|100952086|FG000|NOT COMPLETED|Overall Study||0||
48258716|NCT03305887|100952087|FG000|STARTED|Overall Study||91|First Patient In 2017.06.12|
48258717|NCT03305887|100952088|FG001|STARTED|Overall Study||93|First Patient In 2017.06.12|
48258718|NCT03305887|100952087|FG000|COMPLETED|Overall Study||80|Last Patient Out 2018.05.21|
48258719|NCT03305887|100952088|FG001|COMPLETED|Overall Study||83|Last Patient Out 2018.05.21|
48258720|NCT03305887|100952087|FG000|NOT COMPLETED|Overall Study||11||
48387205|NCT02310906|101276766|FG000|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0||
48387206|NCT02310906|101276767|FG001|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8||
48387207|NCT02310906|101276768|FG002|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0||
48387208|NCT02310906|101276769|FG003|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0||
48387209|NCT02310906|101276766|FG000|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||4||
48387210|NCT02310906|101276767|FG001|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||8||
48387211|NCT02310906|101276768|FG002|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0||
48387212|NCT02310906|101276769|FG003|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0||
48387213|NCT02310906|101276766|FG000|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0||
48387214|NCT02310906|101276767|FG001|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0||
48387215|NCT02310906|101276768|FG002|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0||
48387216|NCT02310906|101276769|FG003|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0||
48387217|NCT02310906|101276766|FG000|STARTED|Part 2: Open Label Phase (168 Weeks)||0||
48387218|NCT02310906|101276767|FG001|STARTED|Part 2: Open Label Phase (168 Weeks)||0||
48387219|NCT02310906|101276768|FG002|STARTED|Part 2: Open Label Phase (168 Weeks)||25||
48387220|NCT02310906|101276769|FG003|STARTED|Part 2: Open Label Phase (168 Weeks)||14||
48387221|NCT02310906|101276766|FG000|COMPLETED|Part 2: Open Label Phase (168 Weeks)||0||
48387222|NCT02310906|101276767|FG001|COMPLETED|Part 2: Open Label Phase (168 Weeks)||0||
48387223|NCT02310906|101276768|FG002|COMPLETED|Part 2: Open Label Phase (168 Weeks)||23||
48387224|NCT02310906|101276769|FG003|COMPLETED|Part 2: Open Label Phase (168 Weeks)||6||
48387225|NCT02310906|101276766|FG000|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||0||
48387226|NCT02310906|101276767|FG001|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||0||
48387227|NCT02310906|101276768|FG002|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||2||
48387228|NCT02310906|101276769|FG003|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||8||
48387229|NCT01354431|101276770|FG000|STARTED|Pre-Treatment Period||60||
48387230|NCT01354431|101276771|FG001|STARTED|Pre-Treatment Period||54||
48387231|NCT01354431|101276772|FG002|STARTED|Pre-Treatment Period||54||
48387232|NCT01354431|101276770|FG000|COMPLETED|Pre-Treatment Period||59|Completed = Moved to Treatment Period|
48387233|NCT01354431|101276771|FG001|COMPLETED|Pre-Treatment Period||54|Completed = Moved to Treatment Period|
48387234|NCT01354431|101276772|FG002|COMPLETED|Pre-Treatment Period||54|Completed = Moved to Treatment Period|
48387235|NCT01354431|101276770|FG000|NOT COMPLETED|Pre-Treatment Period||1||
48387236|NCT01354431|101276771|FG001|NOT COMPLETED|Pre-Treatment Period||0||
48387237|NCT01354431|101276772|FG002|NOT COMPLETED|Pre-Treatment Period||0||
48387238|NCT01354431|101276770|FG000|STARTED|Treatment Period||59||
48387239|NCT01354431|101276771|FG001|STARTED|Treatment Period||54||
48387240|NCT01354431|101276772|FG002|STARTED|Treatment Period||54||
48387241|NCT01354431|101276770|FG000|COMPLETED|Treatment Period||0||
48387242|NCT01354431|101276771|FG001|COMPLETED|Treatment Period||0||
48387243|NCT01354431|101276772|FG002|COMPLETED|Treatment Period||0||
48387244|NCT01354431|101276770|FG000|NOT COMPLETED|Treatment Period||59||
48387245|NCT01354431|101276771|FG001|NOT COMPLETED|Treatment Period||54||
48387246|NCT01354431|101276772|FG002|NOT COMPLETED|Treatment Period||54||
48387247|NCT00843843|101276773|FG000|STARTED|Overall Study||8||
48387248|NCT00843843|101276774|FG001|STARTED|Overall Study||8||
48387249|NCT00843843|101276773|FG000|COMPLETED|Overall Study||6||
48387250|NCT00843843|101276774|FG001|COMPLETED|Overall Study||6||
48387251|NCT00843843|101276773|FG000|NOT COMPLETED|Overall Study||2||
48258721|NCT03305887|100952088|FG001|NOT COMPLETED|Overall Study||10||
48258722|NCT01801982|100952089|FG000|STARTED|Overall Study||1||
48258723|NCT01801982|100952089|FG000|COMPLETED|Overall Study||0||
48387252|NCT00843843|101276774|FG001|NOT COMPLETED|Overall Study||2||
48387253|NCT01899677|101276775|FG000|STARTED|Overall Study||35||
48387254|NCT01899677|101276776|FG001|STARTED|Overall Study||35||
48387255|NCT01899677|101276775|FG000|COMPLETED|Overall Study||25||
48387256|NCT01899677|101276776|FG001|COMPLETED|Overall Study||28||
48387257|NCT01899677|101276775|FG000|NOT COMPLETED|Overall Study||10||
48387258|NCT01899677|101276776|FG001|NOT COMPLETED|Overall Study||7||
48387259|NCT01594333|101276777|FG000|STARTED|Overall Study||2391||
48387260|NCT01594333|101276778|FG001|STARTED|Overall Study||2395||
48387261|NCT01594333|101276777|FG000|COMPLETED|Overall Study||2230||
48258724|NCT01801982|100952089|FG000|NOT COMPLETED|Overall Study||1||
48387262|NCT01594333|101276778|FG001|COMPLETED|Overall Study||2244||
48387263|NCT01594333|101276777|FG000|NOT COMPLETED|Overall Study||161||
48387264|NCT01594333|101276778|FG001|NOT COMPLETED|Overall Study||151||
48258725|NCT02202109|100952090|FG000|STARTED|Overall Study||302||
48258726|NCT02202109|100952091|FG001|STARTED|Overall Study||300||
48258727|NCT02202109|100952090|FG000|COMPLETED|Overall Study||212||
48258728|NCT02202109|100952091|FG001|COMPLETED|Overall Study||213||
48258729|NCT02202109|100952090|FG000|NOT COMPLETED|Overall Study||90||
48258730|NCT02202109|100952091|FG001|NOT COMPLETED|Overall Study||87||
48258731|NCT01542398|100952092|FG000|STARTED|Overall Study||79||
48258732|NCT01542398|100952093|FG001|STARTED|Overall Study||80||
48258733|NCT01542398|100952092|FG000|Post-Intervention Assessment|Overall Study||78||
48258734|NCT01542398|100952093|FG001|Post-Intervention Assessment|Overall Study||80||
48258735|NCT01542398|100952092|FG000|COMPLETED|Overall Study||71||
48258736|NCT01542398|100952093|FG001|COMPLETED|Overall Study||67||
48258737|NCT01542398|100952092|FG000|NOT COMPLETED|Overall Study||8||
48258738|NCT01542398|100952093|FG001|NOT COMPLETED|Overall Study||13||
48258739|NCT02325830|100952094|FG000|STARTED|Overall Study||87||
48258740|NCT02325830|100952095|FG001|STARTED|Overall Study||33||
48258741|NCT02325830|100952094|FG000|COMPLETED|Overall Study||70||
48258742|NCT02325830|100952095|FG001|COMPLETED|Overall Study||24||
48258743|NCT02325830|100952094|FG000|NOT COMPLETED|Overall Study||17||
48258744|NCT02325830|100952095|FG001|NOT COMPLETED|Overall Study||9||
48258745|NCT00107978|100952096|FG000|STARTED|Overall Study||458||
48258746|NCT00107978|100952097|FG001|STARTED|Overall Study||481||
48258747|NCT00107978|100952096|FG000|COMPLETED|Overall Study||425||
48258748|NCT00107978|100952097|FG001|COMPLETED|Overall Study||431||
48258749|NCT00107978|100952096|FG000|NOT COMPLETED|Overall Study||33||
48258750|NCT00107978|100952097|FG001|NOT COMPLETED|Overall Study||50||
48258751|NCT00280683|100952098|FG000|STARTED|Overall Study||10||
48258752|NCT00280683|100952099|FG001|STARTED|Overall Study||10||
48258753|NCT00280683|100952098|FG000|COMPLETED|Overall Study||8||
48258754|NCT00280683|100952099|FG001|COMPLETED|Overall Study||7||
48258755|NCT00280683|100952098|FG000|NOT COMPLETED|Overall Study||2||
48258756|NCT00280683|100952099|FG001|NOT COMPLETED|Overall Study||3||
48258757|NCT00494026|100952100|FG000|STARTED|Overall Study||4||
48258758|NCT00494026|100952100|FG000|COMPLETED|Overall Study||0||
48258759|NCT00494026|100952100|FG000|NOT COMPLETED|Overall Study||4||
48258760|NCT00934700|100952101|FG000|STARTED|Overall Study||46||
48258761|NCT00934700|100952102|FG001|STARTED|Overall Study||46||
48258762|NCT00934700|100952101|FG000|COMPLETED|Overall Study||33||
48258763|NCT00934700|100952102|FG001|COMPLETED|Overall Study||34||
48258764|NCT00934700|100952101|FG000|NOT COMPLETED|Overall Study||13||
48258765|NCT00934700|100952102|FG001|NOT COMPLETED|Overall Study||12||
48258766|NCT00197106|100952103|FG000|STARTED|4-Week Run-In Period||257||
48258767|NCT00197106|100952104|FG001|STARTED|4-Week Run-In Period||0||
48258768|NCT00197106|100952105|FG002|STARTED|4-Week Run-In Period||0||
48258769|NCT00197106|100952103|FG000|COMPLETED|4-Week Run-In Period||158||
48258770|NCT00197106|100952104|FG001|COMPLETED|4-Week Run-In Period||0||
48258771|NCT00197106|100952105|FG002|COMPLETED|4-Week Run-In Period||0||
48258772|NCT00197106|100952103|FG000|NOT COMPLETED|4-Week Run-In Period||99||
48258773|NCT00197106|100952104|FG001|NOT COMPLETED|4-Week Run-In Period||0||
48258774|NCT00197106|100952105|FG002|NOT COMPLETED|4-Week Run-In Period||0||
48258775|NCT00197106|100952103|FG000|STARTED|Overall Treatment Period||0||
48258776|NCT00197106|100952104|FG001|STARTED|Overall Treatment Period||78||
48258777|NCT00197106|100952105|FG002|STARTED|Overall Treatment Period||80||
48258778|NCT00197106|100952103|FG000|COMPLETED|Overall Treatment Period||0||
48258779|NCT00197106|100952104|FG001|COMPLETED|Overall Treatment Period||77||
48258780|NCT00197106|100952105|FG002|COMPLETED|Overall Treatment Period||74||
48258781|NCT00197106|100952103|FG000|NOT COMPLETED|Overall Treatment Period||0||
48258782|NCT00197106|100952104|FG001|NOT COMPLETED|Overall Treatment Period||1||
48258783|NCT00197106|100952105|FG002|NOT COMPLETED|Overall Treatment Period||6||
48258784|NCT00704171|100954938|FG000|STARTED|Overall Study||62||
48258785|NCT00704171|100954939|FG001|STARTED|Overall Study||59||
48258786|NCT00704171|100954938|FG000|COMPLETED|Overall Study||61||
48258787|NCT00704171|100954939|FG001|COMPLETED|Overall Study||59||
48258788|NCT00704171|100954938|FG000|NOT COMPLETED|Overall Study||1||
48258789|NCT00704171|100954939|FG001|NOT COMPLETED|Overall Study||0||
48258790|NCT01482429|100954940|FG000|STARTED|Care Usual||0||
48258791|NCT01482429|100954941|FG001|STARTED|Care Usual||269||
48258792|NCT01482429|100954940|FG000|COMPLETED|Care Usual||0||
48258793|NCT01482429|100954941|FG001|COMPLETED|Care Usual||96||
48258794|NCT01482429|100954940|FG000|NOT COMPLETED|Care Usual||0||
48258795|NCT01482429|100954941|FG001|NOT COMPLETED|Care Usual||173||
48258796|NCT01482429|100954940|FG000|STARTED|Protocol||414||
48258797|NCT01482429|100954941|FG001|STARTED|Protocol||0||
48258798|NCT01482429|100954940|FG000|COMPLETED|Protocol||139||
48258799|NCT01482429|100954941|FG001|COMPLETED|Protocol||0||
48258800|NCT01482429|100954940|FG000|NOT COMPLETED|Protocol||275||
48258801|NCT01482429|100954941|FG001|NOT COMPLETED|Protocol||0||
48258802|NCT03201900|100954942|FG000|STARTED|Treatment Phase (Up to 62 Weeks)||91||
48258803|NCT03201900|100954942|FG000|Treated|Treatment Phase (Up to 62 Weeks)||89||
48258804|NCT03201900|100954942|FG000|COMPLETED|Treatment Phase (Up to 62 Weeks)||54||
48258805|NCT03201900|100954942|FG000|NOT COMPLETED|Treatment Phase (Up to 62 Weeks)||37||
48258806|NCT03201900|100954942|FG000|STARTED|Extension Phase (From Week 63 to 156)||46||
48258807|NCT03201900|100954942|FG000|COMPLETED|Extension Phase (From Week 63 to 156)||38||
48387265|NCT04009213|101276779|FG000|STARTED|Overall Study||142||
48387266|NCT04009213|101276780|FG001|STARTED|Overall Study||142||
48387267|NCT04009213|101276779|FG000|COMPLETED|Overall Study||132||
48387268|NCT04009213|101276780|FG001|COMPLETED|Overall Study||134||
48387269|NCT04009213|101276779|FG000|NOT COMPLETED|Overall Study||10||
48387270|NCT04009213|101276780|FG001|NOT COMPLETED|Overall Study||8||
48387271|NCT02227108|101276781|FG000|STARTED|Overall Study||32||
48387272|NCT02227108|101276781|FG000|Treated|Overall Study||30||
48387273|NCT02227108|101276781|FG000|COMPLETED|Overall Study||1||
48387274|NCT02227108|101276781|FG000|NOT COMPLETED|Overall Study||31||
48387275|NCT00997321|101276782|FG000|STARTED|Overall Study||50||
48387276|NCT00997321|101276783|FG001|STARTED|Overall Study||50||
48387277|NCT00997321|101276782|FG000|COMPLETED|Overall Study||50||
48387278|NCT00997321|101276783|FG001|COMPLETED|Overall Study||47||
48387279|NCT00997321|101276782|FG000|NOT COMPLETED|Overall Study||0||
48387280|NCT00997321|101276783|FG001|NOT COMPLETED|Overall Study||3||
48387281|NCT02247401|101276784|FG000|STARTED|Overall Study||100||
48387282|NCT02247401|101276785|FG001|STARTED|Overall Study||31||
48387283|NCT02247401|101276786|FG002|STARTED|Overall Study||29||
48387284|NCT02247401|101276784|FG000|COMPLETED|Overall Study||94||
48387285|NCT02247401|101276785|FG001|COMPLETED|Overall Study||29||
48387286|NCT02247401|101276786|FG002|COMPLETED|Overall Study||27||
48387287|NCT02247401|101276784|FG000|NOT COMPLETED|Overall Study||6||
48094217|NCT02485301|100552242|FG000|STARTED|Overall Study||1509|Out of 3024 subjects originally enrolled, only 3013 subjects received vaccination.|
48094218|NCT02485301|100552243|FG001|STARTED|Overall Study||1504|Out of 3024 subjects originally enrolled, only 3013 subjects received vaccination.|
48094219|NCT02485301|100552242|FG000|COMPLETED|Overall Study||1471||
48094220|NCT02485301|100552243|FG001|COMPLETED|Overall Study||1455||
48094221|NCT02485301|100552242|FG000|NOT COMPLETED|Overall Study||38||
48094222|NCT02485301|100552243|FG001|NOT COMPLETED|Overall Study||49||
48094223|NCT01361464|100552244|FG000|STARTED|Overall Study||21||
48094224|NCT01361464|100552244|FG000|COMPLETED|Overall Study||18||
48094225|NCT01361464|100552244|FG000|NOT COMPLETED|Overall Study||3||
48094226|NCT00969150|100556051|FG000|STARTED|Overall Study||182||
48094227|NCT00969150|100556052|FG001|STARTED|Overall Study||175||
48094228|NCT00969150|100556051|FG000|COMPLETED|Overall Study||149||
48094229|NCT00969150|100556052|FG001|COMPLETED|Overall Study||135||
48094230|NCT00969150|100556051|FG000|NOT COMPLETED|Overall Study||33||
48094231|NCT00969150|100556052|FG001|NOT COMPLETED|Overall Study||40||
48094232|NCT01702454|100556053|FG000|STARTED|Overall Study||241||
48094233|NCT01702454|100556054|FG001|STARTED|Overall Study||229||
48094234|NCT01702454|100556053|FG000|COMPLETED|Overall Study||238||
48094235|NCT01702454|100556054|FG001|COMPLETED|Overall Study||221||
48094236|NCT01702454|100556053|FG000|NOT COMPLETED|Overall Study||3||
48094237|NCT01702454|100556054|FG001|NOT COMPLETED|Overall Study||8||
48094238|NCT01341964|100556055|FG000|STARTED|Overall Study||152||
48094239|NCT01341964|100556056|FG001|STARTED|Overall Study||150||
48094240|NCT01341964|100556055|FG000|COMPLETED|Overall Study||152||
48094241|NCT01341964|100556056|FG001|COMPLETED|Overall Study||150||
48094242|NCT01341964|100556055|FG000|NOT COMPLETED|Overall Study||0||
48094243|NCT01341964|100556056|FG001|NOT COMPLETED|Overall Study||0||
48094244|NCT03168308|100556057|FG000|STARTED|Overall Study||48||
48094245|NCT03168308|100556058|FG001|STARTED|Overall Study||44||
48094246|NCT03168308|100556057|FG000|COMPLETED|Overall Study||48||
48094247|NCT03168308|100556058|FG001|COMPLETED|Overall Study||44||
48094248|NCT03168308|100556057|FG000|NOT COMPLETED|Overall Study||0||
48094249|NCT03168308|100556058|FG001|NOT COMPLETED|Overall Study||0||
48094250|NCT03194555|100556059|FG000|STARTED|Overall Study||6||
48094251|NCT03194555|100556060|FG001|STARTED|Overall Study||6||
48094252|NCT03194555|100556059|FG000|COMPLETED|Overall Study||6||
48094253|NCT03194555|100556060|FG001|COMPLETED|Overall Study||6||
48094254|NCT03194555|100556059|FG000|NOT COMPLETED|Overall Study||0||
48094255|NCT03194555|100556060|FG001|NOT COMPLETED|Overall Study||0||
48094256|NCT00362115|100556061|FG000|STARTED|Overall Study||65||
48094257|NCT00362115|100556062|FG001|STARTED|Overall Study||65||
48094258|NCT00362115|100556063|FG002|STARTED|Overall Study||64||
48387288|NCT02247401|101276785|FG001|NOT COMPLETED|Overall Study||2||
48387289|NCT02247401|101276786|FG002|NOT COMPLETED|Overall Study||2||
48387290|NCT01890512|101276787|FG000|STARTED|Overall Study||20||
48387291|NCT01890512|101276787|FG000|COMPLETED|Overall Study||17||
48387292|NCT01890512|101276787|FG000|NOT COMPLETED|Overall Study||3||
48387293|NCT01214317|101276788|FG000|STARTED|Overall Study||18||
48387294|NCT01214317|101276789|FG001|STARTED|Overall Study||22||
48387295|NCT01214317|101276788|FG000|COMPLETED|Overall Study||18||
48094259|NCT00362115|100556064|FG003|STARTED|Overall Study||63||
48094260|NCT00362115|100556065|FG004|STARTED|Overall Study||64||
48094261|NCT00362115|100556066|FG005|STARTED|Overall Study||64||
48387296|NCT01214317|101276789|FG001|COMPLETED|Overall Study||22||
48094262|NCT00362115|100556067|FG006|STARTED|Overall Study||64||
48387297|NCT01214317|101276788|FG000|NOT COMPLETED|Overall Study||0||
48387298|NCT01214317|101276789|FG001|NOT COMPLETED|Overall Study||0||
48387299|NCT01199055|101276790|FG000|STARTED|Overall Study||3||
48387300|NCT01199055|101276791|FG001|STARTED|Overall Study||4||
48094263|NCT00362115|100556061|FG000|COMPLETED|Overall Study||63||
48094264|NCT00362115|100556062|FG001|COMPLETED|Overall Study||59||
48258808|NCT03201900|100954942|FG000|NOT COMPLETED|Extension Phase (From Week 63 to 156)||8||
48258809|NCT02803593|100954943|FG000|STARTED|Overall Study||95||
48387301|NCT01199055|101276792|FG002|STARTED|Overall Study||9||
48387302|NCT01199055|101276790|FG000|COMPLETED|Overall Study||1||
48387303|NCT01199055|101276791|FG001|COMPLETED|Overall Study||1||
48387304|NCT01199055|101276792|FG002|COMPLETED|Overall Study||5||
48387305|NCT01199055|101276790|FG000|NOT COMPLETED|Overall Study||2||
48387306|NCT01199055|101276791|FG001|NOT COMPLETED|Overall Study||3||
48387307|NCT01199055|101276792|FG002|NOT COMPLETED|Overall Study||4||
48387308|NCT03219892|101276793|FG000|STARTED|Overall Study||20||
48387309|NCT03219892|101276794|FG001|STARTED|Overall Study||10||
48387310|NCT03219892|101276793|FG000|COMPLETED|Overall Study||20||
48387311|NCT03219892|101276794|FG001|COMPLETED|Overall Study||10||
48387312|NCT03219892|101276793|FG000|NOT COMPLETED|Overall Study||0||
48387313|NCT03219892|101276794|FG001|NOT COMPLETED|Overall Study||0||
48387314|NCT03101514|101276795|FG000|STARTED|Overall Study||53||
48387315|NCT03101514|101276795|FG000|COMPLETED|Overall Study||46||
48258810|NCT02803593|100954944|FG001|STARTED|Overall Study||104||
48258811|NCT02803593|100954943|FG000|Completed Month 1 Assessment|Overall Study||83||
48258812|NCT02803593|100954944|FG001|Completed Month 1 Assessment|Overall Study||76||
48258813|NCT02803593|100954943|FG000|COMPLETED|Overall Study||78|Completed the Month 3 assessment|
48258814|NCT02803593|100954944|FG001|COMPLETED|Overall Study||69|Completed the Month 3 assessment|
48258815|NCT02803593|100954943|FG000|NOT COMPLETED|Overall Study||17||
48387316|NCT03101514|101276795|FG000|NOT COMPLETED|Overall Study||7||
48387317|NCT01195363|101276796|FG000|STARTED|Overall Study||15||
48387318|NCT01195363|101276797|FG001|STARTED|Overall Study||13||
48387319|NCT01195363|101276796|FG000|COMPLETED|Overall Study||4||
48387320|NCT01195363|101276797|FG001|COMPLETED|Overall Study||4||
48258816|NCT02803593|100954944|FG001|NOT COMPLETED|Overall Study||35||
48258817|NCT00639769|100954945|FG000|STARTED|Overall Study||40||
48258818|NCT00639769|100954945|FG000|COMPLETED|Overall Study||0||
48258819|NCT00639769|100954945|FG000|NOT COMPLETED|Overall Study||40||
48258820|NCT03512197|100954946|FG000|STARTED|Overall Study||250|Randomized|
48258821|NCT03512197|100954947|FG001|STARTED|Overall Study||251|Randomized|
48258822|NCT03512197|100954946|FG000|Treated With Midostaurin/Placebo|Overall Study||245||
48258823|NCT03512197|100954947|FG001|Treated With Midostaurin/Placebo|Overall Study||249||
48258824|NCT03512197|100954946|FG000|Entered Induction Phase|Overall Study||250||
48258825|NCT03512197|100954947|FG001|Entered Induction Phase|Overall Study||251||
48258826|NCT03512197|100954946|FG000|Entered Consolidation Phase|Overall Study||120||
48258827|NCT03512197|100954947|FG001|Entered Consolidation Phase|Overall Study||129||
48258828|NCT03512197|100954946|FG000|Entered Post-Consolidation Phase|Overall Study||45||
48258829|NCT03512197|100954947|FG001|Entered Post-Consolidation Phase|Overall Study||27||
48689122|NCT00984594|102022616|FG000|NOT COMPLETED|Overall Study||1||
48689123|NCT00984594|102022617|FG001|NOT COMPLETED|Overall Study||1||
48689124|NCT00288886|102022618|FG000|STARTED|Overall Study||91||
48689125|NCT00288886|102022619|FG001|STARTED|Overall Study||92||
48689126|NCT00288886|102022618|FG000|3-month Follow Up|Overall Study||82||
48689127|NCT00288886|102022619|FG001|3-month Follow Up|Overall Study||85||
48689128|NCT00288886|102022618|FG000|6-month Follow Up|Overall Study||85||
48689129|NCT00288886|102022619|FG001|6-month Follow Up|Overall Study||84||
48689130|NCT00288886|102022618|FG000|12-month Follow Up|Overall Study||80||
48689131|NCT00288886|102022619|FG001|12-month Follow Up|Overall Study||81||
48689132|NCT00288886|102022618|FG000|COMPLETED|Overall Study||80||
48689133|NCT00288886|102022619|FG001|COMPLETED|Overall Study||81||
48689134|NCT00288886|102022618|FG000|NOT COMPLETED|Overall Study||11||
48689135|NCT00288886|102022619|FG001|NOT COMPLETED|Overall Study||11||
48258830|NCT03512197|100954946|FG000|COMPLETED|Overall Study||2|Completed entire study treatment as per protocol - defined as completion of induction, consolidation and post-consolidation treatment phases|
48258831|NCT03512197|100954947|FG001|COMPLETED|Overall Study||1|Completed entire study treatment as per protocol - defined as completion of induction, consolidation and post-consolidation treatment phases|
48258832|NCT03512197|100954946|FG000|NOT COMPLETED|Overall Study||248||
48387321|NCT01195363|101276796|FG000|NOT COMPLETED|Overall Study||11||
48387322|NCT01195363|101276797|FG001|NOT COMPLETED|Overall Study||9||
48387323|NCT02294318|101276798|FG000|STARTED|Overall Study||24||
48387324|NCT02294318|101276799|FG001|STARTED|Overall Study||23||
48387325|NCT02294318|101276798|FG000|COMPLETED|Overall Study||21||
48387326|NCT02294318|101276799|FG001|COMPLETED|Overall Study||21||
48387327|NCT02294318|101276798|FG000|NOT COMPLETED|Overall Study||3||
48387328|NCT02294318|101276799|FG001|NOT COMPLETED|Overall Study||2||
48387329|NCT02614287|101276800|FG000|STARTED|Open Label (OL) Treatment Phase||135||
48387330|NCT02614287|101276801|FG001|STARTED|Open Label (OL) Treatment Phase||135||
48387331|NCT02614287|101276800|FG000|Received at Least One Dose of Study Drug|Open Label (OL) Treatment Phase||135||
48689136|NCT02433496|102022620|FG000|STARTED|Overall Study||29990||4
48689137|NCT02433496|102022621|FG001|STARTED|Overall Study||13309||4
48258833|NCT03512197|100954947|FG001|NOT COMPLETED|Overall Study||250||
48258834|NCT01936324|100954948|FG000|STARTED|Overall Study||6||
48258835|NCT01936324|100954949|FG001|STARTED|Overall Study||53||
48258836|NCT01936324|100954950|FG002|STARTED|Overall Study||55||
48387332|NCT02614287|101276801|FG001|Received at Least One Dose of Study Drug|Open Label (OL) Treatment Phase||135||
48387333|NCT02614287|101276800|FG000|COMPLETED|Open Label (OL) Treatment Phase||97||
48258837|NCT01936324|100954948|FG000|COMPLETED|Overall Study||6||
48258838|NCT01936324|100954949|FG001|COMPLETED|Overall Study||47||
48258839|NCT01936324|100954950|FG002|COMPLETED|Overall Study||50||
48258840|NCT01936324|100954948|FG000|NOT COMPLETED|Overall Study||0||
48258841|NCT01936324|100954949|FG001|NOT COMPLETED|Overall Study||6||
48258842|NCT01936324|100954950|FG002|NOT COMPLETED|Overall Study||5||
48258843|NCT03297398|100954951|FG000|STARTED|Overall Study||36||
48258844|NCT03297398|100954952|FG001|STARTED|Overall Study||40||
48258845|NCT03297398|100954953|FG002|STARTED|Overall Study||38||
48258846|NCT03297398|100954951|FG000|COMPLETED|Overall Study||28||
48258847|NCT03297398|100954952|FG001|COMPLETED|Overall Study||23||
48258848|NCT03297398|100954953|FG002|COMPLETED|Overall Study||23||
48258849|NCT03297398|100954951|FG000|NOT COMPLETED|Overall Study||8||
48258850|NCT03297398|100954952|FG001|NOT COMPLETED|Overall Study||17||
48258851|NCT03297398|100954953|FG002|NOT COMPLETED|Overall Study||15||
48258852|NCT02281500|100954954|FG000|STARTED|Overall Study||22||
48258853|NCT02281500|100954954|FG000|COMPLETED|Overall Study||22||
48258854|NCT02281500|100954954|FG000|NOT COMPLETED|Overall Study||0||
48258855|NCT00796627|100954955|FG000|STARTED|Overall Study||10||
48258856|NCT00796627|100954956|FG001|STARTED|Overall Study||31||
48258857|NCT00796627|100954955|FG000|COMPLETED|Overall Study||10||
48258858|NCT00796627|100954956|FG001|COMPLETED|Overall Study||31||
48258859|NCT00796627|100954955|FG000|NOT COMPLETED|Overall Study||0||
48258860|NCT00796627|100954956|FG001|NOT COMPLETED|Overall Study||0||
48258861|NCT04016272|100954957|FG000|STARTED|Overall Study||61||
48541796|NCT03095638|101662794|FG005|STARTED|P2: Period 2, Washout (7[-4 Hours])||4||
48541797|NCT03095638|101662795|FG006|STARTED|P2: Period 2, Washout (7[-4 Hours])||4||
48541798|NCT03095638|101662796|FG007|STARTED|P2: Period 2, Washout (7[-4 Hours])||4||
48541799|NCT03095638|101662789|FG000|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0||
48541800|NCT03095638|101662790|FG001|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0||
48541801|NCT03095638|101662791|FG002|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4||
48541802|NCT03095638|101662792|FG003|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4||
48541803|NCT03095638|101662793|FG004|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4||
48541804|NCT03095638|101662794|FG005|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4||
48094265|NCT00362115|100556063|FG002|COMPLETED|Overall Study||57||
48541805|NCT03095638|101662795|FG006|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4||
48541806|NCT03095638|101662796|FG007|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4||
48689138|NCT02433496|102022622|FG002|STARTED|Overall Study||9833||3
48689139|NCT02433496|102022620|FG000|COMPLETED|Overall Study||29990||4
48689140|NCT02433496|102022621|FG001|COMPLETED|Overall Study||13309||4
48689141|NCT02433496|102022622|FG002|COMPLETED|Overall Study||9833||3
48689142|NCT02433496|102022620|FG000|NOT COMPLETED|Overall Study||0||0
48689143|NCT02433496|102022621|FG001|NOT COMPLETED|Overall Study||0||0
48689144|NCT02433496|102022622|FG002|NOT COMPLETED|Overall Study||0||0
48689145|NCT00709319|102022623|FG000|STARTED|Overall Study||87||
48689146|NCT00709319|102022623|FG000|COMPLETED|Overall Study||81||
48689147|NCT00709319|102022623|FG000|NOT COMPLETED|Overall Study||6||
48094266|NCT00362115|100556064|FG003|COMPLETED|Overall Study||59||
48258862|NCT04016272|100954958|FG001|STARTED|Overall Study||62||
48258863|NCT04016272|100954957|FG000|COMPLETED|Overall Study||60||
48094267|NCT00362115|100556065|FG004|COMPLETED|Overall Study||57||
48258864|NCT04016272|100954958|FG001|COMPLETED|Overall Study||60||
48258865|NCT04016272|100954957|FG000|NOT COMPLETED|Overall Study||1||
48258866|NCT04016272|100954958|FG001|NOT COMPLETED|Overall Study||2||
48258867|NCT01536197|100954959|FG000|STARTED|Overall Study||23||
48689148|NCT01805687|102022624|FG000|STARTED|Overall Study||25||
48689149|NCT01805687|102022624|FG000|COMPLETED|Overall Study||25||
48689150|NCT01805687|102022624|FG000|NOT COMPLETED|Overall Study||0||
48689151|NCT03472495|102022625|FG000|STARTED|Overall Study||9||
48094268|NCT00362115|100556066|FG005|COMPLETED|Overall Study||57||
48094269|NCT00362115|100556067|FG006|COMPLETED|Overall Study||52||
48094270|NCT00362115|100556061|FG000|NOT COMPLETED|Overall Study||2||
48094271|NCT00362115|100556062|FG001|NOT COMPLETED|Overall Study||6||
48258868|NCT01536197|100954960|FG001|STARTED|Overall Study||10||
48258869|NCT01536197|100954959|FG000|COMPLETED|Overall Study||23||
48258870|NCT01536197|100954960|FG001|COMPLETED|Overall Study||10||
48258871|NCT01536197|100954959|FG000|NOT COMPLETED|Overall Study||0||
48258872|NCT01536197|100954960|FG001|NOT COMPLETED|Overall Study||0||
48258873|NCT01013740|100954961|FG000|STARTED|Overall Study||37||
48258874|NCT01013740|100954962|FG001|STARTED|Overall Study||75||
48689152|NCT03472495|102022626|FG001|STARTED|Overall Study||10||
48689153|NCT03472495|102022625|FG000|COMPLETED|Overall Study||8||
48689154|NCT03472495|102022626|FG001|COMPLETED|Overall Study||6||
48689155|NCT03472495|102022625|FG000|NOT COMPLETED|Overall Study||1||
48689156|NCT03472495|102022626|FG001|NOT COMPLETED|Overall Study||4||
48689157|NCT04767061|102022627|FG000|STARTED|On or Off Beta Blockers Up to 6 Wks||5||
48258875|NCT01013740|100954961|FG000|Ongoing|Overall Study||0||
48258876|NCT01013740|100954962|FG001|Ongoing|Overall Study||0||
48258877|NCT01013740|100954961|FG000|COMPLETED|Overall Study||26||
48258878|NCT01013740|100954962|FG001|COMPLETED|Overall Study||56||
48689158|NCT04767061|102022628|FG001|STARTED|On or Off Beta Blockers Up to 6 Wks||4||
48689159|NCT04767061|102022627|FG000|COMPLETED|On or Off Beta Blockers Up to 6 Wks||5||
48689160|NCT04767061|102022628|FG001|COMPLETED|On or Off Beta Blockers Up to 6 Wks||4||
48689161|NCT04767061|102022627|FG000|NOT COMPLETED|On or Off Beta Blockers Up to 6 Wks||0||
48689162|NCT04767061|102022628|FG001|NOT COMPLETED|On or Off Beta Blockers Up to 6 Wks||0||
48689163|NCT04767061|102022627|FG000|STARTED|Down-titration/Up-titration Up to 6 Wks||5||
48689164|NCT04767061|102022628|FG001|STARTED|Down-titration/Up-titration Up to 6 Wks||4||
48689165|NCT04767061|102022627|FG000|COMPLETED|Down-titration/Up-titration Up to 6 Wks||5||
48689166|NCT04767061|102022628|FG001|COMPLETED|Down-titration/Up-titration Up to 6 Wks||4||
48689167|NCT04767061|102022627|FG000|NOT COMPLETED|Down-titration/Up-titration Up to 6 Wks||0||
48689168|NCT04767061|102022628|FG001|NOT COMPLETED|Down-titration/Up-titration Up to 6 Wks||0||
48689169|NCT04767061|102022627|FG000|STARTED|Up-titration/Down-titration Up to 6 Wks||0||
48689170|NCT04767061|102022628|FG001|STARTED|Up-titration/Down-titration Up to 6 Wks||2||
48689171|NCT04767061|102022627|FG000|COMPLETED|Up-titration/Down-titration Up to 6 Wks||0||
48689172|NCT04767061|102022628|FG001|COMPLETED|Up-titration/Down-titration Up to 6 Wks||2||
48094272|NCT00362115|100556063|FG002|NOT COMPLETED|Overall Study||7||
48094273|NCT00362115|100556064|FG003|NOT COMPLETED|Overall Study||4||
48258879|NCT01013740|100954961|FG000|NOT COMPLETED|Overall Study||11||
48258880|NCT01013740|100954962|FG001|NOT COMPLETED|Overall Study||19||
48094274|NCT00362115|100556065|FG004|NOT COMPLETED|Overall Study||7||
48094275|NCT00362115|100556066|FG005|NOT COMPLETED|Overall Study||7||
48258881|NCT01811498|100954963|FG000|STARTED|Overall Study||31||
48258882|NCT01811498|100954963|FG000|COMPLETED|Overall Study||23||
48258883|NCT01811498|100954963|FG000|NOT COMPLETED|Overall Study||8||
48258884|NCT00003477|100954964|FG000|STARTED|Overall Study||12||
48258885|NCT00003477|100954964|FG000|COMPLETED|Overall Study||8||
48258886|NCT00003477|100954964|FG000|NOT COMPLETED|Overall Study||4||
48258887|NCT02859064|100954965|FG000|STARTED|Overall Study||6||
48258888|NCT02859064|100954965|FG000|COMPLETED|Overall Study||0||
48258889|NCT02859064|100954965|FG000|NOT COMPLETED|Overall Study||6||
48258890|NCT03041298|100954966|FG000|STARTED|Overall Study||1537||
48258891|NCT03041298|100954966|FG000|COMPLETED|Overall Study||1537||
48258892|NCT03041298|100954966|FG000|NOT COMPLETED|Overall Study||0||
48258893|NCT01018732|100954967|FG000|STARTED|Overall Study||50||
48689173|NCT04767061|102022627|FG000|NOT COMPLETED|Up-titration/Down-titration Up to 6 Wks||0||
48689174|NCT04767061|102022628|FG001|NOT COMPLETED|Up-titration/Down-titration Up to 6 Wks||0||
48689175|NCT04767061|102022627|FG000|STARTED|Down-titration/Up-Titration Up to 6 Wks||0||
48689176|NCT04767061|102022628|FG001|STARTED|Down-titration/Up-Titration Up to 6 Wks||0||
48689177|NCT04767061|102022627|FG000|COMPLETED|Down-titration/Up-Titration Up to 6 Wks||0||
48689178|NCT04767061|102022628|FG001|COMPLETED|Down-titration/Up-Titration Up to 6 Wks||0||
48689179|NCT04767061|102022627|FG000|NOT COMPLETED|Down-titration/Up-Titration Up to 6 Wks||0||
48689180|NCT04767061|102022628|FG001|NOT COMPLETED|Down-titration/Up-Titration Up to 6 Wks||0||
48689181|NCT04767061|102022627|FG000|STARTED|Follow-up||5|After each of the subjects complete their intervention phase, they proceed to a follow-up phase, which lasts for 12 months.|
48689182|NCT04767061|102022628|FG001|STARTED|Follow-up||4|After each of the subjects complete their intervention phase, they proceed to a follow-up phase, which lasts for 12 months.|
48689183|NCT04767061|102022627|FG000|COMPLETED|Follow-up||5||
48689184|NCT04767061|102022628|FG001|COMPLETED|Follow-up||4||
48094276|NCT00362115|100556067|FG006|NOT COMPLETED|Overall Study||12||
48094277|NCT01905384|100556068|FG000|STARTED|Overall Study||3||
48094278|NCT01905384|100556069|FG001|STARTED|Overall Study||3||
48094279|NCT01905384|100556068|FG000|COMPLETED|Overall Study||3||
48094280|NCT01905384|100556069|FG001|COMPLETED|Overall Study||3||
48094281|NCT01905384|100556068|FG000|NOT COMPLETED|Overall Study||0||
48094282|NCT01905384|100556069|FG001|NOT COMPLETED|Overall Study||0||
48094283|NCT02904512|100556070|FG000|STARTED|Overall Study||9||
48258894|NCT01018732|100954968|FG001|STARTED|Overall Study||51||
48258895|NCT01018732|100954969|FG002|STARTED|Overall Study||54||
48258896|NCT01018732|100954967|FG000|COMPLETED|Overall Study||49||
48258897|NCT01018732|100954968|FG001|COMPLETED|Overall Study||49||
48258898|NCT01018732|100954969|FG002|COMPLETED|Overall Study||50||
48258899|NCT01018732|100954967|FG000|NOT COMPLETED|Overall Study||1||
48258900|NCT01018732|100954968|FG001|NOT COMPLETED|Overall Study||2||
48258901|NCT01018732|100954969|FG002|NOT COMPLETED|Overall Study||4||
48258902|NCT00469456|100954970|FG000|STARTED|Overall Study||129||
48258903|NCT00469456|100954971|FG001|STARTED|Overall Study||135||
48258904|NCT00469456|100954970|FG000|COMPLETED|Overall Study||120||
48258905|NCT00469456|100954971|FG001|COMPLETED|Overall Study||131||
48258906|NCT00469456|100954970|FG000|NOT COMPLETED|Overall Study||9||
48258907|NCT00469456|100954971|FG001|NOT COMPLETED|Overall Study||4||
48258908|NCT02872311|100954972|FG000|STARTED|Overall Study||59||
48258909|NCT02872311|100954973|FG001|STARTED|Overall Study||60||
48258910|NCT02872311|100954974|FG002|STARTED|Overall Study||20||
48258911|NCT02872311|100954975|FG003|STARTED|Overall Study||20||
48258912|NCT02872311|100954976|FG004|STARTED|Overall Study||20||
48258913|NCT02872311|100954972|FG000|COMPLETED|Overall Study||55||
48258914|NCT02872311|100954973|FG001|COMPLETED|Overall Study||58||
48258915|NCT02872311|100954974|FG002|COMPLETED|Overall Study||19||
48258916|NCT02872311|100954975|FG003|COMPLETED|Overall Study||20||
48258917|NCT02872311|100954976|FG004|COMPLETED|Overall Study||20||
48258918|NCT02872311|100954972|FG000|NOT COMPLETED|Overall Study||4||
48258919|NCT02872311|100954973|FG001|NOT COMPLETED|Overall Study||2||
48258920|NCT02872311|100954974|FG002|NOT COMPLETED|Overall Study||1||
48258921|NCT02872311|100954975|FG003|NOT COMPLETED|Overall Study||0||
48258922|NCT02872311|100954976|FG004|NOT COMPLETED|Overall Study||0||
48258923|NCT00478647|100954977|FG000|STARTED|Overall Study||40||
48258924|NCT00478647|100954977|FG000|COMPLETED|Overall Study||38||
48258925|NCT00478647|100954977|FG000|NOT COMPLETED|Overall Study||2||
48258926|NCT00510146|100954978|FG000|STARTED|Double-Blind Treatment||343||
48258927|NCT00510146|100954979|FG001|STARTED|Double-Blind Treatment||171||
48258928|NCT00510146|100954978|FG000|COMPLETED|Double-Blind Treatment||267||
48258929|NCT00510146|100954979|FG001|COMPLETED|Double-Blind Treatment||122||
48689185|NCT04767061|102022627|FG000|NOT COMPLETED|Follow-up||0||
48689186|NCT04767061|102022628|FG001|NOT COMPLETED|Follow-up||0||
48689187|NCT02151903|102022629|FG000|STARTED|Overall Study||3||
48689188|NCT02151903|102022630|FG001|STARTED|Overall Study||2||
48689189|NCT02151903|102022629|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
48689190|NCT02151903|102022630|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2||
48689191|NCT02151903|102022629|FG000|COMPLETED|Overall Study||0||
48094284|NCT02904512|100556071|FG001|STARTED|Overall Study||7||
48258930|NCT00510146|100954978|FG000|NOT COMPLETED|Double-Blind Treatment||76||
48258931|NCT00510146|100954979|FG001|NOT COMPLETED|Double-Blind Treatment||49||
48258932|NCT00510146|100954978|FG000|STARTED|Open-Label Treatment||267||
48258933|NCT00510146|100954979|FG001|STARTED|Open-Label Treatment||122||
48258934|NCT00510146|100954978|FG000|COMPLETED|Open-Label Treatment||196||
48094285|NCT02904512|100556070|FG000|COMPLETED|Overall Study||6||
48094286|NCT02904512|100556071|FG001|COMPLETED|Overall Study||7||
48094287|NCT02904512|100556070|FG000|NOT COMPLETED|Overall Study||3||
48094288|NCT02904512|100556071|FG001|NOT COMPLETED|Overall Study||0||
48094289|NCT05081011|100556072|FG000|STARTED|Overall Study||18||
48094290|NCT05081011|100556073|FG001|STARTED|Overall Study||21||
48094291|NCT05081011|100556072|FG000|Received Intervention as Randomized|Overall Study||16||
48094292|NCT05081011|100556073|FG001|Received Intervention as Randomized|Overall Study||16||
48094293|NCT05081011|100556072|FG000|COMPLETED|Overall Study||16||
48094294|NCT05081011|100556073|FG001|COMPLETED|Overall Study||16||
48094295|NCT05081011|100556072|FG000|NOT COMPLETED|Overall Study||2||
48094296|NCT05081011|100556073|FG001|NOT COMPLETED|Overall Study||5||
48094297|NCT04210310|100556074|FG000|STARTED|Overall Study||32||
48094298|NCT04210310|100556075|FG001|STARTED|Overall Study||1||
48094299|NCT04210310|100556074|FG000|COMPLETED|Overall Study||0||
48094300|NCT04210310|100556075|FG001|COMPLETED|Overall Study||0||
48094301|NCT04210310|100556074|FG000|NOT COMPLETED|Overall Study||32||
48094302|NCT04210310|100556075|FG001|NOT COMPLETED|Overall Study||1||
48094303|NCT02057198|100556076|FG000|STARTED|Overall Study||11||
48094304|NCT02057198|100556077|FG001|STARTED|Overall Study||11||
48094305|NCT02057198|100556078|FG002|STARTED|Overall Study||11||
48094306|NCT02057198|100556076|FG000|COMPLETED|Overall Study||11||
48094307|NCT02057198|100556077|FG001|COMPLETED|Overall Study||10||
48094308|NCT02057198|100556078|FG002|COMPLETED|Overall Study||10||
48094309|NCT02057198|100556076|FG000|NOT COMPLETED|Overall Study||0||
48094310|NCT02057198|100556077|FG001|NOT COMPLETED|Overall Study||1||
48094311|NCT02057198|100556078|FG002|NOT COMPLETED|Overall Study||1||
48094312|NCT01166178|100556079|FG000|STARTED|Overall Study||21||
48094313|NCT01166178|100556080|FG001|STARTED|Overall Study||8||
48094314|NCT01166178|100556079|FG000|COMPLETED|Overall Study||0||
48094315|NCT01166178|100556080|FG001|COMPLETED|Overall Study||0||
48094316|NCT01166178|100556079|FG000|NOT COMPLETED|Overall Study||21||
48094317|NCT01166178|100556080|FG001|NOT COMPLETED|Overall Study||8||
48094318|NCT01067456|100556081|FG000|STARTED|Overall Study||30||
48094319|NCT01067456|100556082|FG001|STARTED|Overall Study||29||
48094320|NCT01067456|100556081|FG000|COMPLETED|Overall Study||30||
48094321|NCT01067456|100556082|FG001|COMPLETED|Overall Study||29||
48094322|NCT01067456|100556081|FG000|NOT COMPLETED|Overall Study||0||
48094323|NCT01067456|100556082|FG001|NOT COMPLETED|Overall Study||0||
48094324|NCT05821842|100556083|FG000|STARTED|Overall Study||26||
48094325|NCT05821842|100556084|FG001|STARTED|Overall Study||26||
48094326|NCT05821842|100556083|FG000|COMPLETED|Overall Study||26||
48094327|NCT05821842|100556084|FG001|COMPLETED|Overall Study||26||
48094328|NCT05821842|100556083|FG000|NOT COMPLETED|Overall Study||0||
48094329|NCT05821842|100556084|FG001|NOT COMPLETED|Overall Study||0||
48094330|NCT03103919|100556085|FG000|STARTED|Overall Study||20||
48094331|NCT03103919|100556086|FG001|STARTED|Overall Study||19||
48094332|NCT03103919|100556085|FG000|COMPLETED|Overall Study||18||
48094333|NCT03103919|100556086|FG001|COMPLETED|Overall Study||17||
48094334|NCT03103919|100556085|FG000|NOT COMPLETED|Overall Study||2||
48094335|NCT03103919|100556086|FG001|NOT COMPLETED|Overall Study||2||
48094336|NCT00276159|100556087|FG000|STARTED|Overall Study||6||
48094337|NCT00276159|100556087|FG000|COMPLETED|Overall Study||0||
48094338|NCT00276159|100556087|FG000|NOT COMPLETED|Overall Study||6||
48094339|NCT01829516|100556088|FG000|STARTED|First Intervention||18||
48094340|NCT01829516|100556089|FG001|STARTED|First Intervention||14||
48094341|NCT01829516|100556088|FG000|COMPLETED|First Intervention||18||
48094342|NCT01829516|100556089|FG001|COMPLETED|First Intervention||14||
48387334|NCT02614287|101276801|FG001|COMPLETED|Open Label (OL) Treatment Phase||113||
48387335|NCT02614287|101276800|FG000|NOT COMPLETED|Open Label (OL) Treatment Phase||38||
48387336|NCT02614287|101276801|FG001|NOT COMPLETED|Open Label (OL) Treatment Phase||22||
48387337|NCT02614287|101276800|FG000|STARTED|Post Treatment Follow-up Phase||112||
48387338|NCT02614287|101276801|FG001|STARTED|Post Treatment Follow-up Phase||124||
48387339|NCT02614287|101276800|FG000|COMPLETED|Post Treatment Follow-up Phase||103||
48094343|NCT01829516|100556088|FG000|NOT COMPLETED|First Intervention||0||
48094344|NCT01829516|100556089|FG001|NOT COMPLETED|First Intervention||0||
48094345|NCT01829516|100556088|FG000|STARTED|Washout Period - 1 Week||18||
48094346|NCT01829516|100556089|FG001|STARTED|Washout Period - 1 Week||14||
48094347|NCT01829516|100556088|FG000|COMPLETED|Washout Period - 1 Week||18||
48387340|NCT02614287|101276801|FG001|COMPLETED|Post Treatment Follow-up Phase||119||
48094348|NCT01829516|100556089|FG001|COMPLETED|Washout Period - 1 Week||14||
48094349|NCT01829516|100556088|FG000|NOT COMPLETED|Washout Period - 1 Week||0||
48094350|NCT01829516|100556089|FG001|NOT COMPLETED|Washout Period - 1 Week||0||
48094351|NCT01829516|100556088|FG000|STARTED|2nd Intervention||18||
48094352|NCT01829516|100556089|FG001|STARTED|2nd Intervention||14||
48094353|NCT01829516|100556088|FG000|COMPLETED|2nd Intervention||18||
48094354|NCT01829516|100556089|FG001|COMPLETED|2nd Intervention||14||
48094355|NCT01829516|100556088|FG000|NOT COMPLETED|2nd Intervention||0||
48094356|NCT01829516|100556089|FG001|NOT COMPLETED|2nd Intervention||0||
48094357|NCT02772081|100556090|FG000|STARTED|Overall Study||20||
48094358|NCT02772081|100556091|FG001|STARTED|Overall Study||13||
48094359|NCT02772081|100556090|FG000|COMPLETED|Overall Study||18||
48094360|NCT02772081|100556091|FG001|COMPLETED|Overall Study||11||
48094361|NCT02772081|100556090|FG000|NOT COMPLETED|Overall Study||2||
48094362|NCT02772081|100556091|FG001|NOT COMPLETED|Overall Study||2||
48094363|NCT02781051|100556092|FG000|STARTED|Overall Study||16||
48387341|NCT02614287|101276800|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||9||
48387342|NCT02614287|101276801|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||5||
48387343|NCT00664209|101276802|FG000|STARTED|Motor Fluctuations Screen||13||
48387344|NCT00664209|101276802|FG000|COMPLETED|Motor Fluctuations Screen||6||
48387345|NCT00664209|101276802|FG000|NOT COMPLETED|Motor Fluctuations Screen||7||
48387346|NCT00664209|101276802|FG000|STARTED|Study Treatment Period||6||
48387347|NCT00664209|101276802|FG000|COMPLETED|Study Treatment Period||0||
48387348|NCT00664209|101276802|FG000|NOT COMPLETED|Study Treatment Period||6||
48387349|NCT01511107|101276803|FG000|STARTED|Overall Study||260||
48387350|NCT01511107|101276804|FG001|STARTED|Overall Study||260||
48387351|NCT01511107|101276803|FG000|COMPLETED|Overall Study||238||
48387352|NCT01511107|101276804|FG001|COMPLETED|Overall Study||219||
48387353|NCT01511107|101276803|FG000|NOT COMPLETED|Overall Study||22||
48387354|NCT01511107|101276804|FG001|NOT COMPLETED|Overall Study||41||
48387355|NCT00274768|101276805|FG000|STARTED|Overall Study||26||
48387356|NCT00274768|101276805|FG000|COMPLETED|Overall Study||26||
48387357|NCT00274768|101276805|FG000|NOT COMPLETED|Overall Study||0||
48387358|NCT01107405|101276806|FG000|STARTED|Overall Study||21||
48387359|NCT01107405|101276807|FG001|STARTED|Overall Study||20||
48387360|NCT01107405|101276808|FG002|STARTED|Overall Study||20||
48387361|NCT01107405|101276809|FG003|STARTED|Overall Study||20||
48387362|NCT01107405|101276810|FG004|STARTED|Overall Study||20||
48387363|NCT01107405|101276806|FG000|COMPLETED|Overall Study||19||
48387364|NCT01107405|101276807|FG001|COMPLETED|Overall Study||19||
48387365|NCT01107405|101276808|FG002|COMPLETED|Overall Study||18||
48387366|NCT01107405|101276809|FG003|COMPLETED|Overall Study||17||
48387367|NCT01107405|101276810|FG004|COMPLETED|Overall Study||17||
48387368|NCT01107405|101276806|FG000|NOT COMPLETED|Overall Study||2||
48387369|NCT01107405|101276807|FG001|NOT COMPLETED|Overall Study||1||
48387370|NCT01107405|101276808|FG002|NOT COMPLETED|Overall Study||2||
48387371|NCT01107405|101276809|FG003|NOT COMPLETED|Overall Study||3||
48387372|NCT01107405|101276810|FG004|NOT COMPLETED|Overall Study||3||
48387373|NCT00425477|101276811|FG000|STARTED|Overall Study||26||
48387374|NCT00425477|101276811|FG000|COMPLETED|Overall Study||13||
48387375|NCT00425477|101276811|FG000|NOT COMPLETED|Overall Study||13||
48387376|NCT01309841|101276812|FG000|STARTED|Overall Study||217||
48387377|NCT01309841|101276813|FG001|STARTED|Overall Study||218||
48387378|NCT01309841|101276814|FG002|STARTED|Overall Study||217||
48387379|NCT01309841|101276812|FG000|COMPLETED|Overall Study||178||
48387380|NCT01309841|101276813|FG001|COMPLETED|Overall Study||177||
48387381|NCT01309841|101276814|FG002|COMPLETED|Overall Study||180||
48387382|NCT01309841|101276812|FG000|NOT COMPLETED|Overall Study||39||
48387383|NCT01309841|101276813|FG001|NOT COMPLETED|Overall Study||41||
48387384|NCT01309841|101276814|FG002|NOT COMPLETED|Overall Study||37||
48387385|NCT01578785|101276815|FG000|STARTED|Overall Study||59||
48387386|NCT01578785|101276816|FG001|STARTED|Overall Study||119||
48387387|NCT01578785|101276815|FG000|COMPLETED|Overall Study||0||
48387388|NCT01578785|101276816|FG001|COMPLETED|Overall Study||0||
48387389|NCT01578785|101276815|FG000|NOT COMPLETED|Overall Study||59||
48387390|NCT01578785|101276816|FG001|NOT COMPLETED|Overall Study||119||
48387391|NCT01362686|101276817|FG000|STARTED|Overall Study||67||
48094364|NCT02781051|100556092|FG000|COMPLETED|Overall Study||14||
48094365|NCT02781051|100556092|FG000|NOT COMPLETED|Overall Study||2||
48094366|NCT01164956|100556093|FG000|STARTED|Overall Study||1||
48094367|NCT01164956|100556094|FG001|STARTED|Overall Study||1||
48387392|NCT01362686|101276818|FG001|STARTED|Overall Study||66||
48387393|NCT01362686|101276819|FG002|STARTED|Overall Study||63||
48387394|NCT01362686|101276817|FG000|COMPLETED|Overall Study||59||
48387395|NCT01362686|101276818|FG001|COMPLETED|Overall Study||54||
48387396|NCT01362686|101276819|FG002|COMPLETED|Overall Study||53||
48387397|NCT01362686|101276817|FG000|NOT COMPLETED|Overall Study||8||
48387398|NCT01362686|101276818|FG001|NOT COMPLETED|Overall Study||12||
48387399|NCT01362686|101276819|FG002|NOT COMPLETED|Overall Study||10||
48387400|NCT04354155|101276820|FG000|STARTED|Overall Study||40||
48387401|NCT04354155|101276820|FG000|COMPLETED|Overall Study||38||
48387402|NCT04354155|101276820|FG000|NOT COMPLETED|Overall Study||2||
48387403|NCT00699842|101276821|FG000|STARTED|Overall Study||3||
48387404|NCT00699842|101276822|FG001|STARTED|Overall Study||5||
48094368|NCT01164956|100556095|FG002|STARTED|Overall Study||1||
48094369|NCT01164956|100556093|FG000|Evaluable for pedsFACIT-F Score Change|Overall Study||0||
48387405|NCT00699842|101276823|FG002|STARTED|Overall Study||0||
48387406|NCT00699842|101276821|FG000|COMPLETED|Overall Study||3||
48094370|NCT01164956|100556094|FG001|Evaluable for pedsFACIT-F Score Change|Overall Study||1||
48094371|NCT01164956|100556095|FG002|Evaluable for pedsFACIT-F Score Change|Overall Study||0||
48094372|NCT01164956|100556093|FG000|COMPLETED|Overall Study||0||
48094373|NCT01164956|100556094|FG001|COMPLETED|Overall Study||1||
48094374|NCT01164956|100556095|FG002|COMPLETED|Overall Study||0||
48094375|NCT01164956|100556093|FG000|NOT COMPLETED|Overall Study||1||
48094376|NCT01164956|100556094|FG001|NOT COMPLETED|Overall Study||0||
48094377|NCT01164956|100556095|FG002|NOT COMPLETED|Overall Study||1||
48094378|NCT00473642|100556096|FG000|STARTED|Overall Study||10||
48094379|NCT00473642|100556097|FG001|STARTED|Overall Study||11||
48094380|NCT00473642|100556098|FG002|STARTED|Overall Study||10||
48094381|NCT00473642|100556096|FG000|COMPLETED|Overall Study||8||
48094382|NCT00473642|100556097|FG001|COMPLETED|Overall Study||10||
48094383|NCT00473642|100556098|FG002|COMPLETED|Overall Study||8||
48094384|NCT00473642|100556096|FG000|NOT COMPLETED|Overall Study||2||
48094385|NCT00473642|100556097|FG001|NOT COMPLETED|Overall Study||1||
48094386|NCT00473642|100556098|FG002|NOT COMPLETED|Overall Study||2||
48094387|NCT02320149|100556099|FG000|STARTED|Overall Study||483||
48094388|NCT02320149|100556100|FG001|STARTED|Overall Study||485||
48094389|NCT02320149|100556099|FG000|COMPLETED|Overall Study||420||
48094390|NCT02320149|100556100|FG001|COMPLETED|Overall Study||405||
48094391|NCT02320149|100556099|FG000|NOT COMPLETED|Overall Study||63||
48094392|NCT02320149|100556100|FG001|NOT COMPLETED|Overall Study||80||
48094393|NCT00589914|100556101|FG000|STARTED|Overall Study||606||
48094394|NCT00589914|100556102|FG001|STARTED|Overall Study||608||
48094395|NCT00589914|100556101|FG000|COMPLETED|Overall Study||456||
48094396|NCT00589914|100556102|FG001|COMPLETED|Overall Study||471||
48094397|NCT00589914|100556101|FG000|NOT COMPLETED|Overall Study||150||
48094398|NCT00589914|100556102|FG001|NOT COMPLETED|Overall Study||137||
48094399|NCT02746874|100556103|FG000|STARTED|Overall Study||35||
48094400|NCT02746874|100556104|FG001|STARTED|Overall Study||35||
48094401|NCT02746874|100556103|FG000|COMPLETED|Overall Study||35||
48094402|NCT02746874|100556104|FG001|COMPLETED|Overall Study||32||
48094403|NCT02746874|100556103|FG000|NOT COMPLETED|Overall Study||0||
48094404|NCT02746874|100556104|FG001|NOT COMPLETED|Overall Study||3||
48387407|NCT00699842|101276822|FG001|COMPLETED|Overall Study||4||
48387408|NCT00699842|101276823|FG002|COMPLETED|Overall Study||0||
48387409|NCT00699842|101276821|FG000|NOT COMPLETED|Overall Study||0||
48094405|NCT00202644|100556105|FG000|STARTED|Overall Study||76||
48094406|NCT00202644|100556106|FG001|STARTED|Overall Study||70||
48094407|NCT00202644|100556105|FG000|COMPLETED|Overall Study||41||
48094408|NCT00202644|100556106|FG001|COMPLETED|Overall Study||43||
48094409|NCT00202644|100556105|FG000|NOT COMPLETED|Overall Study||35||
48094410|NCT00202644|100556106|FG001|NOT COMPLETED|Overall Study||27||
48094411|NCT03010254|100556107|FG000|STARTED|Overall Study||159|All randomized subjects|
48094412|NCT03010254|100556108|FG001|STARTED|Overall Study||123|All randomized subjects|
48094413|NCT03010254|100556107|FG000|Attempted Implantation|Overall Study||156||
48094414|NCT03010254|100556108|FG001|Attempted Implantation|Overall Study||120||
48094415|NCT03010254|100556107|FG000|Successful Implantation|Overall Study||156||
48094416|NCT03010254|100556108|FG001|Successful Implantation|Overall Study||120||
48094417|NCT03010254|100556107|FG000|COMPLETED|Overall Study||152||
48387410|NCT00699842|101276822|FG001|NOT COMPLETED|Overall Study||1||
48387411|NCT00699842|101276823|FG002|NOT COMPLETED|Overall Study||0||
48387412|NCT03111550|101276824|FG000|STARTED|Overall Study||77||
48094418|NCT03010254|100556108|FG001|COMPLETED|Overall Study||118||
48094419|NCT03010254|100556107|FG000|NOT COMPLETED|Overall Study||7||
48094420|NCT03010254|100556108|FG001|NOT COMPLETED|Overall Study||5||
48094421|NCT03178773|100556109|FG000|STARTED|Overall Study||86||
48094422|NCT03178773|100556110|FG001|STARTED|Overall Study||80||
48094423|NCT03178773|100556109|FG000|3month Phone Follow up|Overall Study||49||
48094424|NCT03178773|100556110|FG001|3month Phone Follow up|Overall Study||51||
48387413|NCT03111550|101276825|FG001|STARTED|Overall Study||73||
48387414|NCT03111550|101276826|FG002|STARTED|Overall Study||79||
48387415|NCT03111550|101276824|FG000|COMPLETED|Overall Study||73||
48387416|NCT03111550|101276825|FG001|COMPLETED|Overall Study||71||
48387417|NCT03111550|101276826|FG002|COMPLETED|Overall Study||76||
48387418|NCT03111550|101276824|FG000|NOT COMPLETED|Overall Study||4||
48387419|NCT03111550|101276825|FG001|NOT COMPLETED|Overall Study||2||
48094425|NCT03178773|100556109|FG000|6month in Person Follow up|Overall Study||54||
48094426|NCT03178773|100556110|FG001|6month in Person Follow up|Overall Study||46||
48094427|NCT03178773|100556109|FG000|9month Follow up Phone|Overall Study||36||
48094428|NCT03178773|100556110|FG001|9month Follow up Phone|Overall Study||51||
48094429|NCT03178773|100556109|FG000|COMPLETED|Overall Study||47||
48094430|NCT03178773|100556110|FG001|COMPLETED|Overall Study||40||
48094431|NCT03178773|100556109|FG000|NOT COMPLETED|Overall Study||39||
48094432|NCT03178773|100556110|FG001|NOT COMPLETED|Overall Study||40||
48094433|NCT04493281|100556111|FG000|STARTED|Period 1||21||
48094434|NCT04493281|100556112|FG001|STARTED|Period 1||21||
48094435|NCT04493281|100556111|FG000|COMPLETED|Period 1||21||
48094436|NCT04493281|100556112|FG001|COMPLETED|Period 1||21||
48094437|NCT04493281|100556111|FG000|NOT COMPLETED|Period 1||0||
48094438|NCT04493281|100556112|FG001|NOT COMPLETED|Period 1||0||
48094439|NCT04493281|100556111|FG000|STARTED|Period 2||21||
48387420|NCT03111550|101276826|FG002|NOT COMPLETED|Overall Study||3||
48094440|NCT04493281|100556112|FG001|STARTED|Period 2||21||
48094441|NCT04493281|100556111|FG000|COMPLETED|Period 2||21||
48094442|NCT04493281|100556112|FG001|COMPLETED|Period 2||21||
48094443|NCT04493281|100556111|FG000|NOT COMPLETED|Period 2||0||
48387421|NCT03011450|101276827|FG000|STARTED|12-week Efficacy||311|One participant was randomized but not assigned to a treatment group per physician decision.|
48387422|NCT03011450|101276828|FG001|STARTED|12-week Efficacy||159|One participant was randomized but not assigned to a treatment group per physician decision.|
48387423|NCT03011450|101276827|FG000|COMPLETED|12-week Efficacy||299||
48387424|NCT03011450|101276828|FG001|COMPLETED|12-week Efficacy||159||
48387425|NCT03011450|101276827|FG000|NOT COMPLETED|12-week Efficacy||12||
48387426|NCT03011450|101276828|FG001|NOT COMPLETED|12-week Efficacy||0||
48387427|NCT03011450|101276827|FG000|STARTED|40-week Extension||292|Note that 12 participants (7 participants in the K-877 group and 5 participants in the placebo/fenofibrate group) withdrew after completing the 12-week Efficacy Period and did not start the 40-week Extension Period.|
48387428|NCT03011450|101276828|FG001|STARTED|40-week Extension||154|Note that 12 participants (7 participants in the K-877 group and 5 participants in the placebo/fenofibrate group) withdrew after completing the 12-week Efficacy Period and did not start the 40-week Extension Period.|
48387429|NCT03011450|101276827|FG000|COMPLETED|40-week Extension||275||
48387430|NCT03011450|101276828|FG001|COMPLETED|40-week Extension||146||
48387431|NCT03011450|101276827|FG000|NOT COMPLETED|40-week Extension||17||
48387432|NCT03011450|101276828|FG001|NOT COMPLETED|40-week Extension||8||
48387433|NCT02505542|101276829|FG000|STARTED|Part A: Open-Label Period||736||
48387434|NCT02505542|101276830|FG001|STARTED|Part A: Open-Label Period||0||
48387435|NCT02505542|101276831|FG002|STARTED|Part A: Open-Label Period||0||
48387436|NCT02505542|101276832|FG003|STARTED|Part A: Open-Label Period||0||
48387437|NCT02505542|101276829|FG000|COMPLETED|Part A: Open-Label Period||659||
48541807|NCT03095638|101662789|FG000|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0||
48094444|NCT04493281|100556112|FG001|NOT COMPLETED|Period 2||0||
48094445|NCT03480750|100556113|FG000|STARTED|Overall Study||3||
48258935|NCT00510146|100954979|FG001|COMPLETED|Open-Label Treatment||96||
48592709|NCT00176436|101783166|FG001|STARTED|Overall Study||17||
48094446|NCT03480750|100556114|FG001|STARTED|Overall Study||4||
48094447|NCT03480750|100556115|FG002|STARTED|Overall Study||3||
48094448|NCT03480750|100556116|FG003|STARTED|Overall Study||3||
48094449|NCT03480750|100556117|FG004|STARTED|Overall Study||3||
48094450|NCT03480750|100556118|FG005|STARTED|Overall Study||2||
48094451|NCT03480750|100556113|FG000|COMPLETED|Overall Study||3||
48094452|NCT03480750|100556114|FG001|COMPLETED|Overall Study||3||
48094453|NCT03480750|100556115|FG002|COMPLETED|Overall Study||3||
48094454|NCT03480750|100556116|FG003|COMPLETED|Overall Study||3||
48094455|NCT03480750|100556117|FG004|COMPLETED|Overall Study||3||
48094456|NCT03480750|100556118|FG005|COMPLETED|Overall Study||1||
48094457|NCT03480750|100556113|FG000|NOT COMPLETED|Overall Study||0||
48094458|NCT03480750|100556114|FG001|NOT COMPLETED|Overall Study||1||
48094459|NCT03480750|100556115|FG002|NOT COMPLETED|Overall Study||0||
48094460|NCT03480750|100556116|FG003|NOT COMPLETED|Overall Study||0||
48094461|NCT03480750|100556117|FG004|NOT COMPLETED|Overall Study||0||
48094462|NCT03480750|100556118|FG005|NOT COMPLETED|Overall Study||1||
48094463|NCT03635957|100556119|FG000|STARTED|Run-In Period||15||
48094464|NCT03635957|100556119|FG000|COMPLETED|Run-In Period||14||
48094465|NCT03635957|100556119|FG000|NOT COMPLETED|Run-In Period||1||
48094466|NCT03635957|100556119|FG000|STARTED|Pegloticase + IMM Period||14||
48094467|NCT03635957|100556119|FG000|Completed Study at 24 Weeks-Amendment 1|Pegloticase + IMM Period||1||
48094468|NCT03635957|100556119|FG000|Completed Study at 52 Weeks-Amendment 2|Pegloticase + IMM Period||10||
48258936|NCT00510146|100954978|FG000|NOT COMPLETED|Open-Label Treatment||71||
48258937|NCT00510146|100954979|FG001|NOT COMPLETED|Open-Label Treatment||26||
48258938|NCT03559829|100954980|FG000|STARTED|Overall Study||20||
48258939|NCT03559829|100954980|FG000|COMPLETED|Overall Study||20||
48258940|NCT03559829|100954980|FG000|NOT COMPLETED|Overall Study||0||
48258941|NCT00344032|100954981|FG000|STARTED|Overall Study||176||
48258942|NCT00344032|100954982|FG001|STARTED|Overall Study||178||
48258943|NCT00344032|100954981|FG000|COMPLETED|Overall Study||162||
48258944|NCT00344032|100954982|FG001|COMPLETED|Overall Study||168||
48258945|NCT00344032|100954981|FG000|NOT COMPLETED|Overall Study||14||
48258946|NCT00344032|100954982|FG001|NOT COMPLETED|Overall Study||10||
48094469|NCT03635957|100556119|FG000|Discontinued Study Treatment Early|Pegloticase + IMM Period||5||
48094470|NCT03635957|100556119|FG000|Had 3-Month Follow-up|Pegloticase + IMM Period||7||
48094471|NCT03635957|100556119|FG000|Had 6-Month Follow-up|Pegloticase + IMM Period||6||
48094472|NCT03635957|100556119|FG000|COMPLETED|Pegloticase + IMM Period||11|1 participant completed study under Amend. 1 at Week 24. Amend. 2 extended the study to 52 weeks.|
48094473|NCT03635957|100556119|FG000|NOT COMPLETED|Pegloticase + IMM Period||3||
48094474|NCT01686633|100556120|FG000|STARTED|Overall Study||347||
48094475|NCT01686633|100556121|FG001|STARTED|Overall Study||346||
48094476|NCT01686633|100556122|FG002|STARTED|Overall Study||346||
48094477|NCT01686633|100556120|FG000|COMPLETED|Overall Study||296||
48094478|NCT01686633|100556121|FG001|COMPLETED|Overall Study||314||
48094479|NCT01686633|100556122|FG002|COMPLETED|Overall Study||321||
48094480|NCT01686633|100556120|FG000|NOT COMPLETED|Overall Study||51||
48094481|NCT01686633|100556121|FG001|NOT COMPLETED|Overall Study||32||
48094482|NCT01686633|100556122|FG002|NOT COMPLETED|Overall Study||25||
48094483|NCT00422591|100556123|FG000|STARTED|Overall Study||175||
48094484|NCT00422591|100556123|FG000|COMPLETED|Overall Study||169||
48094485|NCT00422591|100556123|FG000|NOT COMPLETED|Overall Study||6||
48094486|NCT01408914|100556124|FG000|STARTED|Overall Study||60||
48094487|NCT01408914|100556125|FG001|STARTED|Overall Study||60||
48094488|NCT01408914|100556126|FG002|STARTED|Overall Study||60||
48094489|NCT01408914|100556124|FG000|COMPLETED|Overall Study||48||
48094490|NCT01408914|100556125|FG001|COMPLETED|Overall Study||48||
48094491|NCT01408914|100556126|FG002|COMPLETED|Overall Study||47||
48094492|NCT01408914|100556124|FG000|NOT COMPLETED|Overall Study||12||
48094493|NCT01408914|100556125|FG001|NOT COMPLETED|Overall Study||12||
48094494|NCT01408914|100556126|FG002|NOT COMPLETED|Overall Study||13||
48094495|NCT00492115|100556127|FG000|STARTED|Overall Study||19||
48094496|NCT00492115|100556128|FG001|STARTED|Overall Study||19||
48094497|NCT00492115|100556127|FG000|COMPLETED|Overall Study||16||
48094498|NCT00492115|100556128|FG001|COMPLETED|Overall Study||15||
48094499|NCT00492115|100556127|FG000|NOT COMPLETED|Overall Study||3||
48094500|NCT00492115|100556128|FG001|NOT COMPLETED|Overall Study||4||
48094501|NCT01082965|100556129|FG000|STARTED|Overall Study||10||
48094502|NCT01082965|100556130|FG001|STARTED|Overall Study||8||
48094503|NCT01082965|100556129|FG000|COMPLETED|Overall Study||9||
48258947|NCT02760485|100954983|FG000|STARTED|Phase 1||7||
48258948|NCT02760485|100954984|FG001|STARTED|Phase 1||7||
48258949|NCT02760485|100954985|FG002|STARTED|Phase 1||0||
48094504|NCT01082965|100556130|FG001|COMPLETED|Overall Study||6||
48094505|NCT01082965|100556129|FG000|NOT COMPLETED|Overall Study||1||
48094506|NCT01082965|100556130|FG001|NOT COMPLETED|Overall Study||2||
48094507|NCT01203046|100556131|FG000|STARTED|Overall Study||28||
48094508|NCT01203046|100556132|FG001|STARTED|Overall Study||28||
48094509|NCT01203046|100556131|FG000|COMPLETED|Overall Study||28||
48094510|NCT01203046|100556132|FG001|COMPLETED|Overall Study||28||
48094511|NCT01203046|100556131|FG000|NOT COMPLETED|Overall Study||0||
48094512|NCT01203046|100556132|FG001|NOT COMPLETED|Overall Study||0||
48094513|NCT00773292|100556133|FG000|STARTED|Pre-treatment 4 Weeks||7||
48094514|NCT00773292|100556133|FG000|COMPLETED|Pre-treatment 4 Weeks||7||
48094515|NCT00773292|100556133|FG000|NOT COMPLETED|Pre-treatment 4 Weeks||0||
48094516|NCT00773292|100556133|FG000|STARTED|Treatment 48 Weeks||7||
48094517|NCT00773292|100556133|FG000|COMPLETED|Treatment 48 Weeks||5||
48094518|NCT00773292|100556133|FG000|NOT COMPLETED|Treatment 48 Weeks||2||
48094519|NCT00773292|100556133|FG000|STARTED|Post Treatment 24 Weeks||7|Two patients discontinued the intervention but remained under follow up within the study|
48094520|NCT00773292|100556133|FG000|COMPLETED|Post Treatment 24 Weeks||7||
48094521|NCT00773292|100556133|FG000|NOT COMPLETED|Post Treatment 24 Weeks||0||
48094522|NCT02892760|100556134|FG000|STARTED|Overall Study||17||
48094523|NCT02892760|100556134|FG000|Received Intervention|Overall Study||15||
48094524|NCT02892760|100556134|FG000|COMPLETED|Overall Study||14||
48094525|NCT02892760|100556134|FG000|NOT COMPLETED|Overall Study||3||
48094526|NCT02345811|100556135|FG000|STARTED|First Intervention||17||
48689192|NCT02151903|102022630|FG001|COMPLETED|Overall Study||1||
48094527|NCT02345811|100556136|FG001|STARTED|First Intervention||17||
48094528|NCT02345811|100556135|FG000|COMPLETED|First Intervention||16||
48094529|NCT02345811|100556136|FG001|COMPLETED|First Intervention||16||
48094530|NCT02345811|100556135|FG000|NOT COMPLETED|First Intervention||1||
48094531|NCT02345811|100556136|FG001|NOT COMPLETED|First Intervention||1||
48094532|NCT02345811|100556135|FG000|STARTED|Second Intervention||16||
48094533|NCT02345811|100556136|FG001|STARTED|Second Intervention||16||
48094534|NCT02345811|100556135|FG000|COMPLETED|Second Intervention||16||
48094535|NCT02345811|100556136|FG001|COMPLETED|Second Intervention||16||
48094536|NCT02345811|100556135|FG000|NOT COMPLETED|Second Intervention||0||
48094537|NCT02345811|100556136|FG001|NOT COMPLETED|Second Intervention||0||
48094538|NCT00588848|100556137|FG000|STARTED|Overall Study||3||
48094539|NCT00588848|100556138|FG001|STARTED|Overall Study||8||
48094540|NCT00588848|100556137|FG000|COMPLETED|Overall Study||3||
48094541|NCT00588848|100556138|FG001|COMPLETED|Overall Study||5||
48094542|NCT00588848|100556137|FG000|NOT COMPLETED|Overall Study||0||
48094543|NCT00588848|100556138|FG001|NOT COMPLETED|Overall Study||3||
48094544|NCT02673489|100556139|FG000|STARTED|Treatment Period||54||
48094545|NCT02673489|100556140|FG001|STARTED|Treatment Period||24||
48094546|NCT02673489|100556139|FG000|COMPLETED|Treatment Period||49||
48094547|NCT02673489|100556140|FG001|COMPLETED|Treatment Period||21||
48094548|NCT02673489|100556139|FG000|NOT COMPLETED|Treatment Period||5||
48094549|NCT02673489|100556140|FG001|NOT COMPLETED|Treatment Period||3||
48094550|NCT02673489|100556139|FG000|STARTED|Follow Up Period||50||
48094551|NCT02673489|100556140|FG001|STARTED|Follow Up Period||23||
48094552|NCT02673489|100556139|FG000|COMPLETED|Follow Up Period||50|Completed Follow-Up Period|
48094553|NCT02673489|100556140|FG001|COMPLETED|Follow Up Period||21|Completed Follow-Up Period|
48094554|NCT02673489|100556139|FG000|NOT COMPLETED|Follow Up Period||0||
48094555|NCT02673489|100556140|FG001|NOT COMPLETED|Follow Up Period||2||
48094556|NCT00412854|100556141|FG000|STARTED|Overall Study||330||
48094557|NCT00412854|100556142|FG001|STARTED|Overall Study||330||
48094558|NCT00412854|100556141|FG000|COMPLETED|Overall Study||316||
48094559|NCT00412854|100556142|FG001|COMPLETED|Overall Study||314||
48094560|NCT00412854|100556141|FG000|NOT COMPLETED|Overall Study||14||
48094561|NCT00412854|100556142|FG001|NOT COMPLETED|Overall Study||16||
48094562|NCT00405587|100556143|FG000|STARTED|Overall Study||26||
48094563|NCT00405587|100556144|FG001|STARTED|Overall Study||30||
48094564|NCT00405587|100556145|FG002|STARTED|Overall Study||32||
48094565|NCT00405587|100556146|FG003|STARTED|Overall Study||21||
48094566|NCT00405587|100556143|FG000|COMPLETED|Overall Study||0||
48094567|NCT00405587|100556144|FG001|COMPLETED|Overall Study||2||
48094568|NCT00405587|100556145|FG002|COMPLETED|Overall Study||10||
48094569|NCT00405587|100556146|FG003|COMPLETED|Overall Study||1||
48541808|NCT03095638|101662790|FG001|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0||
48541809|NCT03095638|101662791|FG002|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0||
48689193|NCT02151903|102022629|FG000|NOT COMPLETED|Overall Study||3||
48094570|NCT00405587|100556143|FG000|NOT COMPLETED|Overall Study||26||
48258950|NCT02760485|100954983|FG000|COMPLETED|Phase 1||0||
48258951|NCT02760485|100954984|FG001|COMPLETED|Phase 1||0||
48258952|NCT02760485|100954985|FG002|COMPLETED|Phase 1||0||
48258953|NCT02760485|100954983|FG000|NOT COMPLETED|Phase 1||7||
48258954|NCT02760485|100954984|FG001|NOT COMPLETED|Phase 1||7||
48258955|NCT02760485|100954985|FG002|NOT COMPLETED|Phase 1||0||
48258956|NCT02760485|100954983|FG000|STARTED|Phase 2||0||
48258957|NCT02760485|100954984|FG001|STARTED|Phase 2||0||
48258958|NCT02760485|100954985|FG002|STARTED|Phase 2||19||
48258959|NCT02760485|100954983|FG000|COMPLETED|Phase 2||0||
48689194|NCT02151903|102022630|FG001|NOT COMPLETED|Overall Study||1||
48258960|NCT02760485|100954984|FG001|COMPLETED|Phase 2||0||
48258961|NCT02760485|100954985|FG002|COMPLETED|Phase 2||0||
48258962|NCT02760485|100954983|FG000|NOT COMPLETED|Phase 2||0||
48094571|NCT00405587|100556144|FG001|NOT COMPLETED|Overall Study||28||
48094572|NCT00405587|100556145|FG002|NOT COMPLETED|Overall Study||22||
48094573|NCT00405587|100556146|FG003|NOT COMPLETED|Overall Study||20||
48094574|NCT02062879|100556147|FG000|STARTED|Overall Study||10||
48094575|NCT02062879|100556148|FG001|STARTED|Overall Study||10||
48094576|NCT02062879|100556147|FG000|COMPLETED|Overall Study||6||
48094577|NCT02062879|100556148|FG001|COMPLETED|Overall Study||9||
48258963|NCT02760485|100954984|FG001|NOT COMPLETED|Phase 2||0||
48387438|NCT02505542|101276830|FG001|COMPLETED|Part A: Open-Label Period||0||
48387439|NCT02505542|101276831|FG002|COMPLETED|Part A: Open-Label Period||0||
48387440|NCT02505542|101276832|FG003|COMPLETED|Part A: Open-Label Period||0||
48387441|NCT02505542|101276829|FG000|NOT COMPLETED|Part A: Open-Label Period||77||
48387442|NCT02505542|101276830|FG001|NOT COMPLETED|Part A: Open-Label Period||0||
48387443|NCT02505542|101276831|FG002|NOT COMPLETED|Part A: Open-Label Period||0||
48387444|NCT02505542|101276832|FG003|NOT COMPLETED|Part A: Open-Label Period||0||
48387445|NCT02505542|101276829|FG000|STARTED|Completed Part A, Did Not Enter Part B||659||
48387446|NCT02505542|101276830|FG001|STARTED|Completed Part A, Did Not Enter Part B||0||
48387447|NCT02505542|101276831|FG002|STARTED|Completed Part A, Did Not Enter Part B||0||
48387448|NCT02505542|101276832|FG003|STARTED|Completed Part A, Did Not Enter Part B||0||
48387449|NCT02505542|101276829|FG000|COMPLETED|Completed Part A, Did Not Enter Part B||313||
48387450|NCT02505542|101276830|FG001|COMPLETED|Completed Part A, Did Not Enter Part B||0||
48258964|NCT02760485|100954985|FG002|NOT COMPLETED|Phase 2||19||
48258965|NCT02394665|100954986|FG000|STARTED|Overall Study||1||
48258966|NCT02394665|100954987|FG001|STARTED|Overall Study||0||
48258967|NCT02394665|100954988|FG002|STARTED|Overall Study||0||
48258968|NCT02394665|100954986|FG000|COMPLETED|Overall Study||0||
48258969|NCT02394665|100954987|FG001|COMPLETED|Overall Study||0||
48258970|NCT02394665|100954988|FG002|COMPLETED|Overall Study||0||
48258971|NCT02394665|100954986|FG000|NOT COMPLETED|Overall Study||1||
48258972|NCT02394665|100954987|FG001|NOT COMPLETED|Overall Study||0||
48258973|NCT02394665|100954988|FG002|NOT COMPLETED|Overall Study||0||
48258974|NCT03360110|100954989|FG000|STARTED|First Intervention||27||
48258975|NCT03360110|100954990|FG001|STARTED|First Intervention||26||
48258976|NCT03360110|100954989|FG000|COMPLETED|First Intervention||27||
48258977|NCT03360110|100954990|FG001|COMPLETED|First Intervention||26||
48258978|NCT03360110|100954989|FG000|NOT COMPLETED|First Intervention||0||
48258979|NCT03360110|100954990|FG001|NOT COMPLETED|First Intervention||0||
48258980|NCT03360110|100954989|FG000|STARTED|Second Intervention||27||
48258981|NCT03360110|100954990|FG001|STARTED|Second Intervention||26||
48258982|NCT03360110|100954989|FG000|COMPLETED|Second Intervention||27||
48258983|NCT03360110|100954990|FG001|COMPLETED|Second Intervention||26||
48258984|NCT03360110|100954989|FG000|NOT COMPLETED|Second Intervention||0||
48258985|NCT03360110|100954990|FG001|NOT COMPLETED|Second Intervention||0||
48258986|NCT02165826|100954991|FG000|STARTED|Main Treatment Period||441||
48258987|NCT02165826|100954992|FG001|STARTED|Main Treatment Period||439||
48258988|NCT02165826|100954993|FG002|STARTED|Main Treatment Period||443||
48258989|NCT02165826|100954991|FG000|Safety Analysis Set: Received Study Drug|Main Treatment Period||441||
48258990|NCT02165826|100954992|FG001|Safety Analysis Set: Received Study Drug|Main Treatment Period||437||
48258991|NCT02165826|100954993|FG002|Safety Analysis Set: Received Study Drug|Main Treatment Period||443||
48258992|NCT02165826|100954991|FG000|COMPLETED|Main Treatment Period||360||
48258993|NCT02165826|100954992|FG001|COMPLETED|Main Treatment Period||349||
48258994|NCT02165826|100954993|FG002|COMPLETED|Main Treatment Period||334||
48258995|NCT02165826|100954991|FG000|NOT COMPLETED|Main Treatment Period||81||
48258996|NCT02165826|100954992|FG001|NOT COMPLETED|Main Treatment Period||90||
48258997|NCT02165826|100954993|FG002|NOT COMPLETED|Main Treatment Period||109||
48258998|NCT02165826|100954991|FG000|STARTED|Down-Titration Period||27||
48258999|NCT02165826|100954992|FG001|STARTED|Down-Titration Period||39||
48259000|NCT02165826|100954993|FG002|STARTED|Down-Titration Period||38||
48387451|NCT02505542|101276831|FG002|COMPLETED|Completed Part A, Did Not Enter Part B||0||
48387452|NCT02505542|101276832|FG003|COMPLETED|Completed Part A, Did Not Enter Part B||0||
48387453|NCT02505542|101276829|FG000|NOT COMPLETED|Completed Part A, Did Not Enter Part B||346||
48387454|NCT02505542|101276830|FG001|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0||
48387455|NCT02505542|101276831|FG002|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0||
48387456|NCT02505542|101276832|FG003|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0||
48387457|NCT02505542|101276829|FG000|STARTED|Part B: Double-Blind Period||0||
48387458|NCT02505542|101276830|FG001|STARTED|Part B: Double-Blind Period||104||
48387459|NCT02505542|101276831|FG002|STARTED|Part B: Double-Blind Period||104||
48387460|NCT02505542|101276832|FG003|STARTED|Part B: Double-Blind Period||105||
48387461|NCT02505542|101276829|FG000|Started Escape Period|Part B: Double-Blind Period||0||
48387462|NCT02505542|101276830|FG001|Started Escape Period|Part B: Double-Blind Period||73||
48387463|NCT02505542|101276831|FG002|Started Escape Period|Part B: Double-Blind Period||7||
48387464|NCT02505542|101276832|FG003|Started Escape Period|Part B: Double-Blind Period||15||
48387465|NCT02505542|101276829|FG000|COMPLETED|Part B: Double-Blind Period||0||
48387466|NCT02505542|101276830|FG001|COMPLETED|Part B: Double-Blind Period||92||
48387467|NCT02505542|101276831|FG002|COMPLETED|Part B: Double-Blind Period||95||
48387468|NCT02505542|101276832|FG003|COMPLETED|Part B: Double-Blind Period||98||
48387469|NCT02505542|101276829|FG000|NOT COMPLETED|Part B: Double-Blind Period||0||
48387470|NCT02505542|101276830|FG001|NOT COMPLETED|Part B: Double-Blind Period||12||
48387471|NCT02505542|101276831|FG002|NOT COMPLETED|Part B: Double-Blind Period||9||
48387472|NCT02505542|101276832|FG003|NOT COMPLETED|Part B: Double-Blind Period||7||
48259001|NCT02165826|100954991|FG000|Safety Analysis Set: Received Study Drug|Down-Titration Period||27||
48259002|NCT02165826|100954992|FG001|Safety Analysis Set: Received Study Drug|Down-Titration Period||39||
48259003|NCT02165826|100954993|FG002|Safety Analysis Set: Received Study Drug|Down-Titration Period||38||
48259004|NCT02165826|100954991|FG000|COMPLETED|Down-Titration Period||20||
48259005|NCT02165826|100954992|FG001|COMPLETED|Down-Titration Period||28||
48259006|NCT02165826|100954993|FG002|COMPLETED|Down-Titration Period||31||
48259007|NCT02165826|100954991|FG000|NOT COMPLETED|Down-Titration Period||7||
48259008|NCT02165826|100954992|FG001|NOT COMPLETED|Down-Titration Period||11||
48259009|NCT02165826|100954993|FG002|NOT COMPLETED|Down-Titration Period||7||
48259010|NCT00708851|100954994|FG000|STARTED|Overall Study||12||
48259011|NCT00708851|100954994|FG000|COMPLETED|Overall Study||12||
48259012|NCT00708851|100954994|FG000|NOT COMPLETED|Overall Study||0||
48259013|NCT00675792|100954995|FG000|STARTED|Overall Study||51||
48259014|NCT00675792|100954996|FG001|STARTED|Overall Study||49||
48259015|NCT00675792|100954995|FG000|COMPLETED|Overall Study||51||
48259016|NCT00675792|100954996|FG001|COMPLETED|Overall Study||49||
48259017|NCT00675792|100954995|FG000|NOT COMPLETED|Overall Study||0||
48259018|NCT00675792|100954996|FG001|NOT COMPLETED|Overall Study||0||
48259019|NCT02019641|100954997|FG000|STARTED|10-Week Follow up||17||
48259020|NCT02019641|100954998|FG001|STARTED|10-Week Follow up||17||
48259021|NCT02019641|100954999|FG002|STARTED|10-Week Follow up||0||
48259022|NCT02019641|100954997|FG000|COMPLETED|10-Week Follow up||14||
48259023|NCT02019641|100954998|FG001|COMPLETED|10-Week Follow up||16||
48259024|NCT02019641|100954999|FG002|COMPLETED|10-Week Follow up||0||
48094578|NCT02062879|100556147|FG000|NOT COMPLETED|Overall Study||4||
48094579|NCT02062879|100556148|FG001|NOT COMPLETED|Overall Study||1||
48094580|NCT00827983|100556149|FG000|STARTED|Overall Study||339||
48094581|NCT00827983|100556150|FG001|STARTED|Overall Study||344||
48259025|NCT02019641|100954997|FG000|NOT COMPLETED|10-Week Follow up||3||
48259026|NCT02019641|100954998|FG001|NOT COMPLETED|10-Week Follow up||1||
48259027|NCT02019641|100954999|FG002|NOT COMPLETED|10-Week Follow up||0||
48259028|NCT02019641|100954997|FG000|STARTED|20-Week Follow up||0||
48259029|NCT02019641|100954998|FG001|STARTED|20-Week Follow up||0||
48259030|NCT02019641|100954999|FG002|STARTED|20-Week Follow up||15||
48259031|NCT02019641|100954997|FG000|COMPLETED|20-Week Follow up||0||
48259032|NCT02019641|100954998|FG001|COMPLETED|20-Week Follow up||0||
48259033|NCT02019641|100954999|FG002|COMPLETED|20-Week Follow up||14||
48259034|NCT02019641|100954997|FG000|NOT COMPLETED|20-Week Follow up||0||
48259035|NCT02019641|100954998|FG001|NOT COMPLETED|20-Week Follow up||0||
48259036|NCT02019641|100954999|FG002|NOT COMPLETED|20-Week Follow up||1||
48259037|NCT03277352|100955000|FG000|STARTED|Overall Study||10||
48259038|NCT03277352|100955000|FG000|COMPLETED|Overall Study||0||
48259039|NCT03277352|100955000|FG000|NOT COMPLETED|Overall Study||10||
48259040|NCT00839332|100955001|FG000|STARTED|Phase 1||50||
48259041|NCT00839332|100955002|FG001|STARTED|Phase 1||0||
48259042|NCT00839332|100955003|FG002|STARTED|Phase 1||0||
48259043|NCT00839332|100955001|FG000|Received at Least 1 Dose of Study Drug|Phase 1||50||
48259044|NCT00839332|100955002|FG001|Received at Least 1 Dose of Study Drug|Phase 1||0||
48259045|NCT00839332|100955003|FG002|Received at Least 1 Dose of Study Drug|Phase 1||0||
48259046|NCT00839332|100955001|FG000|COMPLETED|Phase 1||0||
48259047|NCT00839332|100955002|FG001|COMPLETED|Phase 1||0||
48259048|NCT00839332|100955003|FG002|COMPLETED|Phase 1||0||
48259049|NCT00839332|100955001|FG000|NOT COMPLETED|Phase 1||50||
48259050|NCT00839332|100955002|FG001|NOT COMPLETED|Phase 1||0||
48259051|NCT00839332|100955003|FG002|NOT COMPLETED|Phase 1||0||
48094582|NCT00827983|100556149|FG000|COMPLETED|Overall Study||321||
48094583|NCT00827983|100556150|FG001|COMPLETED|Overall Study||328||
48094584|NCT00827983|100556149|FG000|NOT COMPLETED|Overall Study||18||
48259052|NCT00839332|100955001|FG000|STARTED|Phase 2||0||
48259053|NCT00839332|100955002|FG001|STARTED|Phase 2||68||
48259054|NCT00839332|100955003|FG002|STARTED|Phase 2||39||
48259055|NCT00839332|100955001|FG000|Received at Least 1 Dose of Study Drug|Phase 2||0||
48259056|NCT00839332|100955002|FG001|Received at Least 1 Dose of Study Drug|Phase 2||65||
48259057|NCT00839332|100955003|FG002|Received at Least 1 Dose of Study Drug|Phase 2||34||
48259058|NCT00839332|100955001|FG000|COMPLETED|Phase 2||0||
48259059|NCT00839332|100955002|FG001|COMPLETED|Phase 2||0||
48259060|NCT00839332|100955003|FG002|COMPLETED|Phase 2||0||
48259061|NCT00839332|100955001|FG000|NOT COMPLETED|Phase 2||0||
48259062|NCT00839332|100955002|FG001|NOT COMPLETED|Phase 2||68||
48259063|NCT00839332|100955003|FG002|NOT COMPLETED|Phase 2||39||
48259064|NCT02330276|100955004|FG000|STARTED|Overall Study||4||
48259065|NCT02330276|100955005|FG001|STARTED|Overall Study||4||
48259066|NCT02330276|100955006|FG002|STARTED|Overall Study||4||
48259067|NCT02330276|100955004|FG000|COMPLETED|Overall Study||4||
48259068|NCT02330276|100955005|FG001|COMPLETED|Overall Study||4||
48259069|NCT02330276|100955006|FG002|COMPLETED|Overall Study||4||
48259070|NCT02330276|100955004|FG000|NOT COMPLETED|Overall Study||0||
48259071|NCT02330276|100955005|FG001|NOT COMPLETED|Overall Study||0||
48259072|NCT02330276|100955006|FG002|NOT COMPLETED|Overall Study||0||
48259073|NCT02775071|100955007|FG000|STARTED|Overall Study||300||
48259074|NCT02775071|100955007|FG000|COMPLETED|Overall Study||227||
48259075|NCT02775071|100955007|FG000|NOT COMPLETED|Overall Study||73||
48259076|NCT01470599|100955008|FG000|STARTED|Overall Study||62||
48259077|NCT01470599|100955009|FG001|STARTED|Overall Study||88||
48259078|NCT01470599|100955008|FG000|COMPLETED|Overall Study||43||
48259079|NCT01470599|100955009|FG001|COMPLETED|Overall Study||45||
48259080|NCT01470599|100955008|FG000|NOT COMPLETED|Overall Study||19||
48259081|NCT01470599|100955009|FG001|NOT COMPLETED|Overall Study||43||
48259082|NCT01973062|100955010|FG000|STARTED|Overall Study||1||
48259083|NCT01973062|100955010|FG000|COMPLETED|Overall Study||1||
48259084|NCT01973062|100955010|FG000|NOT COMPLETED|Overall Study||0||
48259085|NCT01169636|100955011|FG000|STARTED|Overall Study||3||
48259086|NCT01169636|100955012|FG001|STARTED|Overall Study||6||
48259087|NCT01169636|100955013|FG002|STARTED|Overall Study||20||
48259088|NCT01169636|100955014|FG003|STARTED|Overall Study||13||
48259089|NCT01169636|100955015|FG004|STARTED|Overall Study||14||
48259090|NCT01169636|100955011|FG000|COMPLETED|Overall Study||3||
48259091|NCT01169636|100955012|FG001|COMPLETED|Overall Study||6||
48259092|NCT01169636|100955013|FG002|COMPLETED|Overall Study||17||
48259093|NCT01169636|100955014|FG003|COMPLETED|Overall Study||12||
48259094|NCT01169636|100955015|FG004|COMPLETED|Overall Study||11||
48259095|NCT01169636|100955011|FG000|NOT COMPLETED|Overall Study||0||
48259096|NCT01169636|100955012|FG001|NOT COMPLETED|Overall Study||0||
48259097|NCT01169636|100955013|FG002|NOT COMPLETED|Overall Study||3||
48259098|NCT01169636|100955014|FG003|NOT COMPLETED|Overall Study||1||
48259099|NCT01169636|100955015|FG004|NOT COMPLETED|Overall Study||3||
48259100|NCT03842436|100955016|FG000|STARTED|Overall Study||16||
48259101|NCT03842436|100955016|FG000|COMPLETED|Overall Study||15||
48259102|NCT03842436|100955016|FG000|NOT COMPLETED|Overall Study||1||
48259103|NCT01078922|100955017|FG000|STARTED|Overall Study||11||
48259104|NCT01078922|100955017|FG000|COMPLETED|Overall Study||10||
48259105|NCT01078922|100955017|FG000|NOT COMPLETED|Overall Study||1||
48259106|NCT01642147|100955018|FG000|STARTED|Overall Study||30||
48259107|NCT01642147|100955019|FG001|STARTED|Overall Study||30||
48259108|NCT01642147|100955018|FG000|COMPLETED|Overall Study||30||
48259109|NCT01642147|100955019|FG001|COMPLETED|Overall Study||30||
48259110|NCT01642147|100955018|FG000|NOT COMPLETED|Overall Study||0||
48259111|NCT01642147|100955019|FG001|NOT COMPLETED|Overall Study||0||
48259112|NCT03434028|100955020|FG000|STARTED|Overall Study||782||
48259113|NCT03434028|100955021|FG001|STARTED|Overall Study||781||
48259114|NCT03434028|100955020|FG000|COMPLETED|Overall Study||782||
48259115|NCT03434028|100955021|FG001|COMPLETED|Overall Study||781||
48259116|NCT03434028|100955020|FG000|NOT COMPLETED|Overall Study||0||
48259117|NCT03434028|100955021|FG001|NOT COMPLETED|Overall Study||0||
48259118|NCT01710800|100955022|FG000|STARTED|Overall Study||63||
48259119|NCT01710800|100955022|FG000|Received PPI Intervention|Overall Study||44||
48259120|NCT01710800|100955022|FG000|Received Placebo Intervention|Overall Study||45||
48259121|NCT01710800|100955022|FG000|COMPLETED|Overall Study||41||
48259122|NCT01710800|100955022|FG000|NOT COMPLETED|Overall Study||22||
48259123|NCT00746356|100955023|FG000|STARTED|Overall Study||81||
48259124|NCT00746356|100955024|FG001|STARTED|Overall Study||47||
48259125|NCT00746356|100955023|FG000|COMPLETED|Overall Study||70||
48259126|NCT00746356|100955024|FG001|COMPLETED|Overall Study||40||
48259127|NCT00746356|100955023|FG000|NOT COMPLETED|Overall Study||11||
48259128|NCT00746356|100955024|FG001|NOT COMPLETED|Overall Study||7||
48259129|NCT00913068|100955025|FG000|STARTED|Overall Study||56||
48259130|NCT00913068|100955026|FG001|STARTED|Overall Study||54||
48259131|NCT00913068|100955025|FG000|COMPLETED|Overall Study||48||
48259132|NCT00913068|100955026|FG001|COMPLETED|Overall Study||46||
48259133|NCT00913068|100955025|FG000|NOT COMPLETED|Overall Study||8||
48259134|NCT00913068|100955026|FG001|NOT COMPLETED|Overall Study||8||
48259135|NCT04298099|100955027|FG000|STARTED|Overall Study||0||
48259136|NCT04298099|100955028|FG001|STARTED|Overall Study||4||
48259137|NCT04298099|100955027|FG000|COMPLETED|Overall Study||0||
48259138|NCT04298099|100955028|FG001|COMPLETED|Overall Study||4||
48259139|NCT04298099|100955027|FG000|NOT COMPLETED|Overall Study||0||
48259140|NCT04298099|100955028|FG001|NOT COMPLETED|Overall Study||0||
48259141|NCT00535938|100955029|FG000|STARTED|Overall Study||506||
48259142|NCT00535938|100955030|FG001|STARTED|Overall Study||866||
48259143|NCT00535938|100955029|FG000|COMPLETED|Overall Study||115||
48259144|NCT00535938|100955030|FG001|COMPLETED|Overall Study||404||
48259145|NCT00535938|100955029|FG000|NOT COMPLETED|Overall Study||391||
48259146|NCT00535938|100955030|FG001|NOT COMPLETED|Overall Study||462||
48387473|NCT00673894|101276833|FG000|STARTED|First Intervention 4 Weeks||8|First Intervention Duration 4 weeks|
48387474|NCT00673894|101276834|FG001|STARTED|First Intervention 4 Weeks||7|First Intervention Duration 4 weeks|
48387475|NCT00673894|101276833|FG000|COMPLETED|First Intervention 4 Weeks||6||
48387476|NCT00673894|101276834|FG001|COMPLETED|First Intervention 4 Weeks||7||
48387477|NCT00673894|101276833|FG000|NOT COMPLETED|First Intervention 4 Weeks||2||
48387478|NCT00673894|101276834|FG001|NOT COMPLETED|First Intervention 4 Weeks||0||
48387479|NCT00673894|101276833|FG000|STARTED|Washout 4-6 Weeks||6||
48387480|NCT00673894|101276834|FG001|STARTED|Washout 4-6 Weeks||7||
48387481|NCT00673894|101276833|FG000|COMPLETED|Washout 4-6 Weeks||6||
48387482|NCT00673894|101276834|FG001|COMPLETED|Washout 4-6 Weeks||7||
48387483|NCT00673894|101276833|FG000|NOT COMPLETED|Washout 4-6 Weeks||0||
48689195|NCT00690430|102022631|FG000|STARTED|Core Phase||53||
48689196|NCT00690430|102022632|FG001|STARTED|Core Phase||57||
48689197|NCT00690430|102022633|FG002|STARTED|Core Phase||0||
48689198|NCT00690430|102022631|FG000|COMPLETED|Core Phase||35||
48094585|NCT00827983|100556150|FG001|NOT COMPLETED|Overall Study||16||
48689199|NCT00690430|102022632|FG001|COMPLETED|Core Phase||34||
48689200|NCT00690430|102022633|FG002|COMPLETED|Core Phase||0||
48689201|NCT00690430|102022631|FG000|NOT COMPLETED|Core Phase||18||
48689202|NCT00690430|102022632|FG001|NOT COMPLETED|Core Phase||23||
48094586|NCT01762631|100556151|FG000|STARTED|Overall Study||53||
48094587|NCT01762631|100556152|FG001|STARTED|Overall Study||22||
48094588|NCT01762631|100556151|FG000|COMPLETED|Overall Study||53||
48094589|NCT01762631|100556152|FG001|COMPLETED|Overall Study||22||
48094590|NCT01762631|100556151|FG000|NOT COMPLETED|Overall Study||0||
48094591|NCT01762631|100556152|FG001|NOT COMPLETED|Overall Study||0||
48094592|NCT00003492|100556153|FG000|STARTED|Overall Study||9||
48094593|NCT00003492|100556153|FG000|COMPLETED|Overall Study||3||
48094594|NCT00003492|100556153|FG000|NOT COMPLETED|Overall Study||6||
48094595|NCT02335099|100556154|FG000|STARTED|Treatment||22||
48094596|NCT02335099|100556155|FG001|STARTED|Treatment||22||
48094597|NCT02335099|100556154|FG000|COMPLETED|Treatment||17||
48094598|NCT02335099|100556155|FG001|COMPLETED|Treatment||17||
48094599|NCT02335099|100556154|FG000|NOT COMPLETED|Treatment||5||
48094600|NCT02335099|100556155|FG001|NOT COMPLETED|Treatment||5||
48094601|NCT02335099|100556154|FG000|STARTED|Follow-up||17||
48094602|NCT02335099|100556155|FG001|STARTED|Follow-up||17||
48094603|NCT02335099|100556154|FG000|COMPLETED|Follow-up||17||
48094604|NCT02335099|100556155|FG001|COMPLETED|Follow-up||16||
48094605|NCT02335099|100556154|FG000|NOT COMPLETED|Follow-up||0||
48094606|NCT02335099|100556155|FG001|NOT COMPLETED|Follow-up||1||
48094607|NCT03649711|100556156|FG000|STARTED|Overall Study||26||
48094608|NCT03649711|100556157|FG001|STARTED|Overall Study||24||
48094609|NCT03649711|100556158|FG002|STARTED|Overall Study||26||
48094610|NCT03649711|100556156|FG000|COMPLETED|Overall Study||25||
48094611|NCT03649711|100556157|FG001|COMPLETED|Overall Study||23||
48094612|NCT03649711|100556158|FG002|COMPLETED|Overall Study||26||
48094613|NCT03649711|100556156|FG000|NOT COMPLETED|Overall Study||1||
48094614|NCT03649711|100556157|FG001|NOT COMPLETED|Overall Study||1||
48094615|NCT03649711|100556158|FG002|NOT COMPLETED|Overall Study||0||
48094616|NCT01111149|100556159|FG000|STARTED|Overall Study||9||
48094617|NCT01111149|100556160|FG001|STARTED|Overall Study||6||
48094618|NCT01111149|100556161|FG002|STARTED|Overall Study||9||
48094619|NCT01111149|100556159|FG000|COMPLETED|Overall Study||7||
48094620|NCT01111149|100556160|FG001|COMPLETED|Overall Study||5||
48094621|NCT01111149|100556161|FG002|COMPLETED|Overall Study||5||
48094622|NCT01111149|100556159|FG000|NOT COMPLETED|Overall Study||2||
48387484|NCT00673894|101276834|FG001|NOT COMPLETED|Washout 4-6 Weeks||0||
48387485|NCT00673894|101276833|FG000|STARTED|Second Intervention 4 Weeks||6||
48387486|NCT00673894|101276834|FG001|STARTED|Second Intervention 4 Weeks||7||
48387487|NCT00673894|101276833|FG000|COMPLETED|Second Intervention 4 Weeks||6||
48387488|NCT00673894|101276834|FG001|COMPLETED|Second Intervention 4 Weeks||7||
48387489|NCT00673894|101276833|FG000|NOT COMPLETED|Second Intervention 4 Weeks||0||
48541810|NCT03095638|101662792|FG003|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0||
48689203|NCT00690430|102022633|FG002|NOT COMPLETED|Core Phase||0||
48689204|NCT00690430|102022631|FG000|STARTED|Extension Phase||20||
48689205|NCT00690430|102022632|FG001|STARTED|Extension Phase||6||
48689206|NCT00690430|102022633|FG002|STARTED|Extension Phase||15||
48689207|NCT00690430|102022631|FG000|COMPLETED|Extension Phase||2||
48689208|NCT00690430|102022632|FG001|COMPLETED|Extension Phase||1||
48689209|NCT00690430|102022633|FG002|COMPLETED|Extension Phase||2||
48689210|NCT00690430|102022631|FG000|NOT COMPLETED|Extension Phase||18||
48094623|NCT01111149|100556160|FG001|NOT COMPLETED|Overall Study||1||
48094624|NCT01111149|100556161|FG002|NOT COMPLETED|Overall Study||4||
48094625|NCT01603459|100556162|FG000|STARTED|Overall Study||155||
48094626|NCT01603459|100556162|FG000|COMPLETED|Overall Study||137||
48094627|NCT01603459|100556162|FG000|NOT COMPLETED|Overall Study||18||
48094628|NCT01996709|100556163|FG000|STARTED|Overall Study||66||
48094629|NCT01996709|100556164|FG001|STARTED|Overall Study||68||
48094630|NCT01996709|100556163|FG000|COMPLETED|Overall Study||61||
48094631|NCT01996709|100556164|FG001|COMPLETED|Overall Study||67||
48094632|NCT01996709|100556163|FG000|NOT COMPLETED|Overall Study||5||
48094633|NCT01996709|100556164|FG001|NOT COMPLETED|Overall Study||1||
48094634|NCT01729754|100556165|FG000|STARTED|Part 1||20||
48094635|NCT01729754|100556166|FG001|STARTED|Part 1||184||
48094636|NCT01729754|100556167|FG002|STARTED|Part 1||110||
48094637|NCT01729754|100556168|FG003|STARTED|Part 1||18||
48094638|NCT01729754|100556169|FG004|STARTED|Part 1||21||
48094639|NCT01729754|100556170|FG005|STARTED|Part 1||268||
48094640|NCT01729754|100556171|FG006|STARTED|Part 1||14||
48259147|NCT04952701|100955031|FG000|STARTED|Control Lens||63||
48259148|NCT04952701|100955031|FG000|COMPLETED|Control Lens||59||
48259149|NCT04952701|100955031|FG000|NOT COMPLETED|Control Lens||4||
48259150|NCT04952701|100955031|FG000|STARTED|Test Lens||59||
48259151|NCT04952701|100955031|FG000|COMPLETED|Test Lens||58||
48259152|NCT04952701|100955031|FG000|NOT COMPLETED|Test Lens||1||
48259153|NCT01280604|100955032|FG000|STARTED|Overall Study||33||
48259154|NCT01280604|100955033|FG001|STARTED|Overall Study||33||
48259155|NCT01280604|100955032|FG000|Subjects Meeting All Inclusion Criteria|Overall Study||25||
48259156|NCT01280604|100955033|FG001|Subjects Meeting All Inclusion Criteria|Overall Study||29||
48259157|NCT01280604|100955032|FG000|COMPLETED|Overall Study||24||
48259158|NCT01280604|100955033|FG001|COMPLETED|Overall Study||28||
48259159|NCT01280604|100955032|FG000|NOT COMPLETED|Overall Study||9||
48259160|NCT01280604|100955033|FG001|NOT COMPLETED|Overall Study||5||
48259161|NCT03928392|100955034|FG000|STARTED|Overall Study||7||
48259162|NCT03928392|100955035|FG001|STARTED|Overall Study||8||
48259163|NCT03928392|100955034|FG000|COMPLETED|Overall Study||7||
48259164|NCT03928392|100955035|FG001|COMPLETED|Overall Study||8||
48259165|NCT03928392|100955034|FG000|NOT COMPLETED|Overall Study||0||
48259166|NCT03928392|100955035|FG001|NOT COMPLETED|Overall Study||0||
48259167|NCT03470545|100955036|FG000|STARTED|Overall Study||123||
48259168|NCT03470545|100955037|FG001|STARTED|Overall Study||128||
48259169|NCT03470545|100955036|FG000|COMPLETED|Overall Study||119||
48259170|NCT03470545|100955037|FG001|COMPLETED|Overall Study||125||
48259171|NCT03470545|100955036|FG000|NOT COMPLETED|Overall Study||4||
48094641|NCT01729754|100556172|FG007|STARTED|Part 1||72||
48094642|NCT01729754|100556173|FG008|STARTED|Part 1||70||
48259172|NCT03470545|100955037|FG001|NOT COMPLETED|Overall Study||3||
48259173|NCT00732992|100955038|FG000|STARTED|Overall Study||6||
48259174|NCT00732992|100955039|FG001|STARTED|Overall Study||6||
48259175|NCT00732992|100955038|FG000|COMPLETED|Overall Study||0||
48259176|NCT00732992|100955039|FG001|COMPLETED|Overall Study||0||
48259177|NCT00732992|100955038|FG000|NOT COMPLETED|Overall Study||6||
48094643|NCT01729754|100556174|FG009|STARTED|Part 1||313||
48094644|NCT01729754|100556165|FG000|COMPLETED|Part 1||6||
48094645|NCT01729754|100556166|FG001|COMPLETED|Part 1||184||
48259178|NCT00732992|100955039|FG001|NOT COMPLETED|Overall Study||6||
48259179|NCT02482610|100955040|FG000|STARTED|Overall Study||4||
48094646|NCT01729754|100556167|FG002|COMPLETED|Part 1||110||
48094647|NCT01729754|100556168|FG003|COMPLETED|Part 1||6||
48259180|NCT02482610|100955041|FG001|STARTED|Overall Study||5||
48259181|NCT02482610|100955042|FG002|STARTED|Overall Study||2||
48259182|NCT02482610|100955043|FG003|STARTED|Overall Study||3||
48387490|NCT00673894|101276834|FG001|NOT COMPLETED|Second Intervention 4 Weeks||0||
48387491|NCT05631548|101276835|FG000|STARTED|First Intervention (2 Sessions)||3||
48387492|NCT05631548|101276836|FG001|STARTED|First Intervention (2 Sessions)||3||
48387493|NCT05631548|101276835|FG000|Received Intervention|First Intervention (2 Sessions)||3||
48387494|NCT05631548|101276836|FG001|Received Intervention|First Intervention (2 Sessions)||2||
48387495|NCT05631548|101276835|FG000|COMPLETED|First Intervention (2 Sessions)||3||
48387496|NCT05631548|101276836|FG001|COMPLETED|First Intervention (2 Sessions)||2||
48387497|NCT05631548|101276835|FG000|NOT COMPLETED|First Intervention (2 Sessions)||0||
48094648|NCT01729754|100556169|FG004|COMPLETED|Part 1||21||
48094649|NCT01729754|100556170|FG005|COMPLETED|Part 1||268||
48094650|NCT01729754|100556171|FG006|COMPLETED|Part 1||0||
48094651|NCT01729754|100556172|FG007|COMPLETED|Part 1||72||
48094652|NCT01729754|100556173|FG008|COMPLETED|Part 1||70||
48094653|NCT01729754|100556174|FG009|COMPLETED|Part 1||289||
48094654|NCT01729754|100556165|FG000|NOT COMPLETED|Part 1||14||
48094655|NCT01729754|100556166|FG001|NOT COMPLETED|Part 1||0||
48094656|NCT01729754|100556167|FG002|NOT COMPLETED|Part 1||0||
48094657|NCT01729754|100556168|FG003|NOT COMPLETED|Part 1||12||
48094658|NCT01729754|100556169|FG004|NOT COMPLETED|Part 1||0||
48094659|NCT01729754|100556170|FG005|NOT COMPLETED|Part 1||0||
48094660|NCT01729754|100556171|FG006|NOT COMPLETED|Part 1||14||
48094661|NCT01729754|100556172|FG007|NOT COMPLETED|Part 1||0||
48094662|NCT01729754|100556173|FG008|NOT COMPLETED|Part 1||0||
48094663|NCT01729754|100556174|FG009|NOT COMPLETED|Part 1||24||
48094664|NCT01729754|100556165|FG000|STARTED|Part 2||6||
48094665|NCT01729754|100556166|FG001|STARTED|Part 2||184||
48094666|NCT01729754|100556167|FG002|STARTED|Part 2||110||
48094667|NCT01729754|100556168|FG003|STARTED|Part 2||5||
48094668|NCT01729754|100556169|FG004|STARTED|Part 2||21||
48094669|NCT01729754|100556170|FG005|STARTED|Part 2||268||
48094670|NCT01729754|100556171|FG006|STARTED|Part 2||0||
48094671|NCT01729754|100556172|FG007|STARTED|Part 2||72||
48094672|NCT01729754|100556173|FG008|STARTED|Part 2||70||
48094673|NCT01729754|100556174|FG009|STARTED|Part 2||289||
48094674|NCT01729754|100556165|FG000|COMPLETED|Part 2||0||
48094675|NCT01729754|100556166|FG001|COMPLETED|Part 2||184||
48094676|NCT01729754|100556167|FG002|COMPLETED|Part 2||110||
48094677|NCT01729754|100556168|FG003|COMPLETED|Part 2||0||
48094678|NCT01729754|100556169|FG004|COMPLETED|Part 2||21||
48094679|NCT01729754|100556170|FG005|COMPLETED|Part 2||268||
48094680|NCT01729754|100556171|FG006|COMPLETED|Part 2||0||
48094681|NCT01729754|100556172|FG007|COMPLETED|Part 2||69||
48094682|NCT01729754|100556173|FG008|COMPLETED|Part 2||66||
48094683|NCT01729754|100556174|FG009|COMPLETED|Part 2||277||
48094684|NCT01729754|100556165|FG000|NOT COMPLETED|Part 2||6||
48094685|NCT01729754|100556166|FG001|NOT COMPLETED|Part 2||0||
48094686|NCT01729754|100556167|FG002|NOT COMPLETED|Part 2||0||
48094687|NCT01729754|100556168|FG003|NOT COMPLETED|Part 2||5||
48094688|NCT01729754|100556169|FG004|NOT COMPLETED|Part 2||0||
48094689|NCT01729754|100556170|FG005|NOT COMPLETED|Part 2||0||
48094690|NCT01729754|100556171|FG006|NOT COMPLETED|Part 2||0||
48094691|NCT01729754|100556172|FG007|NOT COMPLETED|Part 2||3||
48259183|NCT02482610|100955044|FG004|STARTED|Overall Study||3||
48259184|NCT02482610|100955045|FG005|STARTED|Overall Study||5||
48259185|NCT02482610|100955040|FG000|COMPLETED|Overall Study||4||
48259186|NCT02482610|100955041|FG001|COMPLETED|Overall Study||5||
48259187|NCT02482610|100955042|FG002|COMPLETED|Overall Study||2||
48259188|NCT02482610|100955043|FG003|COMPLETED|Overall Study||3||
48259189|NCT02482610|100955044|FG004|COMPLETED|Overall Study||3||
48259190|NCT02482610|100955045|FG005|COMPLETED|Overall Study||5||
48259191|NCT02482610|100955040|FG000|NOT COMPLETED|Overall Study||0||
48259192|NCT02482610|100955041|FG001|NOT COMPLETED|Overall Study||0||
48259193|NCT02482610|100955042|FG002|NOT COMPLETED|Overall Study||0||
48259194|NCT02482610|100955043|FG003|NOT COMPLETED|Overall Study||0||
48387498|NCT05631548|101276836|FG001|NOT COMPLETED|First Intervention (2 Sessions)||1||
48387499|NCT05631548|101276835|FG000|STARTED|Second Interventions (2 Sessions)||3||
48387500|NCT05631548|101276836|FG001|STARTED|Second Interventions (2 Sessions)||2||
48259195|NCT02482610|100955044|FG004|NOT COMPLETED|Overall Study||0||
48259196|NCT02482610|100955045|FG005|NOT COMPLETED|Overall Study||0||
48259197|NCT03021551|100955046|FG000|STARTED|Overall Study||80||
48259198|NCT03021551|100955046|FG000|COMPLETED|Overall Study||77||
48259199|NCT03021551|100955046|FG000|NOT COMPLETED|Overall Study||3||
48094692|NCT01729754|100556173|FG008|NOT COMPLETED|Part 2||4||
48094693|NCT01729754|100556174|FG009|NOT COMPLETED|Part 2||12||
48094694|NCT01729754|100556165|FG000|STARTED|Part 3||0||
48094695|NCT01729754|100556166|FG001|STARTED|Part 3||170||
48094696|NCT01729754|100556167|FG002|STARTED|Part 3||110||
48094697|NCT01729754|100556168|FG003|STARTED|Part 3||0||
48094698|NCT01729754|100556169|FG004|STARTED|Part 3||21||
48094699|NCT01729754|100556170|FG005|STARTED|Part 3||237||
48094700|NCT01729754|100556171|FG006|STARTED|Part 3||0||
48094701|NCT01729754|100556172|FG007|STARTED|Part 3||69||
48259200|NCT03993457|100955047|FG000|STARTED|Overall Study||4||
48094702|NCT01729754|100556173|FG008|STARTED|Part 3||66||
48094703|NCT01729754|100556174|FG009|STARTED|Part 3||121||
48094704|NCT01729754|100556165|FG000|COMPLETED|Part 3||0||
48094705|NCT01729754|100556166|FG001|COMPLETED|Part 3||165||
48094706|NCT01729754|100556167|FG002|COMPLETED|Part 3||105||
48094707|NCT01729754|100556168|FG003|COMPLETED|Part 3||0||
48094708|NCT01729754|100556169|FG004|COMPLETED|Part 3||17||
48094709|NCT01729754|100556170|FG005|COMPLETED|Part 3||224||
48094710|NCT01729754|100556171|FG006|COMPLETED|Part 3||0||
48094711|NCT01729754|100556172|FG007|COMPLETED|Part 3||66||
48094712|NCT01729754|100556173|FG008|COMPLETED|Part 3||65||
48094713|NCT01729754|100556174|FG009|COMPLETED|Part 3||114||
48094714|NCT01729754|100556165|FG000|NOT COMPLETED|Part 3||0||
48094715|NCT01729754|100556166|FG001|NOT COMPLETED|Part 3||5||
48094716|NCT01729754|100556167|FG002|NOT COMPLETED|Part 3||5||
48094717|NCT01729754|100556168|FG003|NOT COMPLETED|Part 3||0||
48094718|NCT01729754|100556169|FG004|NOT COMPLETED|Part 3||4||
48094719|NCT01729754|100556170|FG005|NOT COMPLETED|Part 3||13||
48094720|NCT01729754|100556171|FG006|NOT COMPLETED|Part 3||0||
48094721|NCT01729754|100556172|FG007|NOT COMPLETED|Part 3||3||
48094722|NCT01729754|100556173|FG008|NOT COMPLETED|Part 3||1||
48259201|NCT03993457|100955048|FG001|STARTED|Overall Study||2||
48259202|NCT03993457|100955049|FG002|STARTED|Overall Study||1||
48259203|NCT03993457|100955050|FG003|STARTED|Overall Study||4||
48259204|NCT03993457|100955047|FG000|COMPLETED|Overall Study||4||
48259205|NCT03993457|100955048|FG001|COMPLETED|Overall Study||2||
48259206|NCT03993457|100955049|FG002|COMPLETED|Overall Study||1||
48259207|NCT03993457|100955050|FG003|COMPLETED|Overall Study||2||
48387501|NCT05631548|101276835|FG000|Received Intervention|Second Interventions (2 Sessions)||3||
48387502|NCT05631548|101276836|FG001|Received Intervention|Second Interventions (2 Sessions)||2||
48094723|NCT01729754|100556174|FG009|NOT COMPLETED|Part 3||7||
48094724|NCT02461355|100556175|FG000|STARTED|Overall Study||2||
48094725|NCT02461355|100556175|FG000|COMPLETED|Overall Study||2||
48094726|NCT02461355|100556175|FG000|NOT COMPLETED|Overall Study||0||
48094727|NCT00195676|100556176|FG000|STARTED|Period O - Open-label Treatment||1468||
48094728|NCT00195676|100556176|FG000|COMPLETED|Period O - Open-label Treatment||862||
48094729|NCT00195676|100556176|FG000|NOT COMPLETED|Period O - Open-label Treatment||606||
48094730|NCT00195676|100556176|FG000|STARTED|Period W (Withdrawal) - No Treatment||608||
48094731|NCT00195676|100556176|FG000|COMPLETED|Period W (Withdrawal) - No Treatment||0||
48094732|NCT00195676|100556176|FG000|NOT COMPLETED|Period W (Withdrawal) - No Treatment||608||
48094733|NCT00195676|100556176|FG000|STARTED|Period R - Retreatment 16 Weeks||525||
48094734|NCT00195676|100556176|FG000|COMPLETED|Period R - Retreatment 16 Weeks||490||
48094735|NCT00195676|100556176|FG000|NOT COMPLETED|Period R - Retreatment 16 Weeks||35||
48094736|NCT00535223|100556177|FG000|STARTED|Overall Study||41||
48094737|NCT00535223|100556178|FG001|STARTED|Overall Study||40||
48094738|NCT00535223|100556177|FG000|COMPLETED|Overall Study||37||
48094739|NCT00535223|100556178|FG001|COMPLETED|Overall Study||39||
48094740|NCT00535223|100556177|FG000|NOT COMPLETED|Overall Study||4||
48094741|NCT00535223|100556178|FG001|NOT COMPLETED|Overall Study||1||
48094742|NCT03735433|100556179|FG000|STARTED|Overall Study||76||
48094743|NCT03735433|100556180|FG001|STARTED|Overall Study||76||
48094744|NCT03735433|100556179|FG000|COMPLETED|Overall Study||0||
48094745|NCT03735433|100556180|FG001|COMPLETED|Overall Study||0||
48094746|NCT03735433|100556179|FG000|NOT COMPLETED|Overall Study||76||
48094747|NCT03735433|100556180|FG001|NOT COMPLETED|Overall Study||76||
48094748|NCT00553150|100556181|FG000|STARTED|Overall Study||6||
48094749|NCT00553150|100556182|FG001|STARTED|Overall Study||6||
48094750|NCT00553150|100556183|FG002|STARTED|Overall Study||6||
48094751|NCT00553150|100556184|FG003|STARTED|Overall Study||104||
48094752|NCT00553150|100556181|FG000|COMPLETED|Overall Study||6||
48259208|NCT03993457|100955047|FG000|NOT COMPLETED|Overall Study||0||
48259209|NCT03993457|100955048|FG001|NOT COMPLETED|Overall Study||0||
48259210|NCT03993457|100955049|FG002|NOT COMPLETED|Overall Study||0||
48259211|NCT03993457|100955050|FG003|NOT COMPLETED|Overall Study||2||
48259212|NCT01128114|100955051|FG000|STARTED|Overall Study||32||
48259213|NCT01128114|100955051|FG000|COMPLETED|Overall Study||24||
48387503|NCT05631548|101276835|FG000|COMPLETED|Second Interventions (2 Sessions)||3||
48592710|NCT00176436|101783165|FG000|COMPLETED|Overall Study||14||
48094753|NCT00553150|100556182|FG001|COMPLETED|Overall Study||6||
48094754|NCT00553150|100556183|FG002|COMPLETED|Overall Study||6||
48094755|NCT00553150|100556184|FG003|COMPLETED|Overall Study||100||
48094756|NCT00553150|100556181|FG000|NOT COMPLETED|Overall Study||0||
48094757|NCT00553150|100556182|FG001|NOT COMPLETED|Overall Study||0||
48094758|NCT00553150|100556183|FG002|NOT COMPLETED|Overall Study||0||
48094759|NCT00553150|100556184|FG003|NOT COMPLETED|Overall Study||4||
48094760|NCT04446377|100556185|FG000|STARTED|Overall Study||71||
48259214|NCT01128114|100955051|FG000|NOT COMPLETED|Overall Study||8||
48259215|NCT04522206|100955052|FG000|STARTED|Overall Study||44||
48259216|NCT04522206|100955052|FG000|COMPLETED|Overall Study||44||
48094761|NCT04446377|100556186|FG001|STARTED|Overall Study||71||
48094762|NCT04446377|100556185|FG000|COMPLETED|Overall Study||64||
48094763|NCT04446377|100556186|FG001|COMPLETED|Overall Study||66||
48094764|NCT04446377|100556185|FG000|NOT COMPLETED|Overall Study||7||
48259217|NCT04522206|100955052|FG000|NOT COMPLETED|Overall Study||0||
48259218|NCT01654068|100955053|FG000|STARTED|Overall Study||14||
48094765|NCT04446377|100556186|FG001|NOT COMPLETED|Overall Study||5||
48094766|NCT02188589|100556187|FG000|STARTED|Overall Study||30||
48094767|NCT02188589|100556187|FG000|6 Months|Overall Study||30||
48094768|NCT02188589|100556187|FG000|12 Months|Overall Study||30|Final follow-up under initial protocol.|
48094769|NCT02188589|100556187|FG000|24 Months|Overall Study||25|Extended follow-up protocol, participants signed additional consent for follow-up beyond 12 months.|
48094770|NCT02188589|100556187|FG000|COMPLETED|Overall Study||25||
48094771|NCT02188589|100556187|FG000|NOT COMPLETED|Overall Study||5||
48094772|NCT00732615|100556188|FG000|STARTED|Overall Study||40||
48689211|NCT00690430|102022632|FG001|NOT COMPLETED|Extension Phase||5||
48689212|NCT00690430|102022633|FG002|NOT COMPLETED|Extension Phase||13||
48689213|NCT01253369|102022634|FG000|STARTED|Overall Study||33||
48387504|NCT05631548|101276836|FG001|COMPLETED|Second Interventions (2 Sessions)||2||
48387505|NCT05631548|101276835|FG000|NOT COMPLETED|Second Interventions (2 Sessions)||0||
48387506|NCT05631548|101276836|FG001|NOT COMPLETED|Second Interventions (2 Sessions)||0||
48094773|NCT00732615|100556189|FG001|STARTED|Overall Study||84||
48094774|NCT00732615|100556188|FG000|COMPLETED|Overall Study||33||
48094775|NCT00732615|100556189|FG001|COMPLETED|Overall Study||79||
48094776|NCT00732615|100556188|FG000|NOT COMPLETED|Overall Study||7||
48094777|NCT00732615|100556189|FG001|NOT COMPLETED|Overall Study||5||
48094778|NCT03274414|100556190|FG000|STARTED|Overall Study||3||
48094779|NCT03274414|100556190|FG000|COMPLETED|Overall Study||3||
48094780|NCT03274414|100556190|FG000|NOT COMPLETED|Overall Study||0||
48094781|NCT01194479|100556191|FG000|STARTED|Overall Study||3||
48387507|NCT02120157|101276837|FG000|STARTED|Overall Study||32||
48387508|NCT02120157|101276837|FG000|Completed 180 Days|Overall Study||30||
48387509|NCT02120157|101276837|FG000|COMPLETED|Overall Study||24||
48387510|NCT02120157|101276837|FG000|NOT COMPLETED|Overall Study||8||
48387511|NCT03292952|101276838|FG000|STARTED|Open-Label Dose Optimization||155||
48094782|NCT01194479|100556192|FG001|STARTED|Overall Study||4||
48689214|NCT01253369|102022634|FG000|Evaluable|Overall Study||30||
48689215|NCT01253369|102022634|FG000|COMPLETED|Overall Study||0||
48094783|NCT01194479|100556193|FG002|STARTED|Overall Study||2||
48094784|NCT01194479|100556194|FG003|STARTED|Overall Study||5||
48094785|NCT01194479|100556191|FG000|Cross-over at Second Visit|Overall Study||3||
48387512|NCT03292952|101276839|FG001|STARTED|Open-Label Dose Optimization||0||
48094786|NCT01194479|100556192|FG001|Cross-over at Second Visit|Overall Study||4||
48094787|NCT01194479|100556193|FG002|Cross-over at Second Visit|Overall Study||2||
48094788|NCT01194479|100556194|FG003|Cross-over at Second Visit|Overall Study||5||
48387513|NCT03292952|101276840|FG002|STARTED|Open-Label Dose Optimization||0||
48387514|NCT03292952|101276838|FG000|COMPLETED|Open-Label Dose Optimization||150||
48689216|NCT01253369|102022634|FG000|NOT COMPLETED|Overall Study||33||
48689217|NCT05005273|102022635|FG000|STARTED|Overall Study||1||
48689218|NCT05005273|102022636|FG001|STARTED|Overall Study||0||
48689219|NCT05005273|102022635|FG000|COMPLETED|Overall Study||0||
48689220|NCT05005273|102022636|FG001|COMPLETED|Overall Study||0||
48094789|NCT01194479|100556191|FG000|COMPLETED|Overall Study||3||
48094790|NCT01194479|100556192|FG001|COMPLETED|Overall Study||4||
48094791|NCT01194479|100556193|FG002|COMPLETED|Overall Study||2||
48094792|NCT01194479|100556194|FG003|COMPLETED|Overall Study||5||
48689221|NCT05005273|102022635|FG000|NOT COMPLETED|Overall Study||1||
48094793|NCT01194479|100556191|FG000|NOT COMPLETED|Overall Study||0||
48094794|NCT01194479|100556192|FG001|NOT COMPLETED|Overall Study||0||
48094795|NCT01194479|100556193|FG002|NOT COMPLETED|Overall Study||0||
48094796|NCT01194479|100556194|FG003|NOT COMPLETED|Overall Study||0||
48094797|NCT03831347|100556195|FG000|STARTED|Overall Study||11||
48094798|NCT03831347|100556195|FG000|COMPLETED|Overall Study||9||
48094799|NCT03831347|100556195|FG000|NOT COMPLETED|Overall Study||2||
48094800|NCT00267046|100556196|FG000|STARTED|Overall Study||32||
48094801|NCT00267046|100556197|FG001|STARTED|Overall Study||16||
48094802|NCT00267046|100556196|FG000|COMPLETED|Overall Study||20||
48094803|NCT00267046|100556197|FG001|COMPLETED|Overall Study||5||
48094804|NCT00267046|100556196|FG000|NOT COMPLETED|Overall Study||12||
48094805|NCT00267046|100556197|FG001|NOT COMPLETED|Overall Study||11||
48094806|NCT00775645|100556198|FG000|STARTED|Overall Study||208||
48094807|NCT00775645|100556199|FG001|STARTED|Overall Study||201||
48094808|NCT00775645|100556198|FG000|COMPLETED|Overall Study||191||
48094809|NCT00775645|100556199|FG001|COMPLETED|Overall Study||181||
48094810|NCT00775645|100556198|FG000|NOT COMPLETED|Overall Study||17||
48094811|NCT00775645|100556199|FG001|NOT COMPLETED|Overall Study||20||
48094812|NCT02484729|100556200|FG000|STARTED|Overall Study||16||
48094813|NCT02484729|100556201|FG001|STARTED|Overall Study||6||
48094814|NCT02484729|100556202|FG002|STARTED|Overall Study||6||
48094815|NCT02484729|100556203|FG003|STARTED|Overall Study||6||
48094816|NCT02484729|100556204|FG004|STARTED|Overall Study||5||
48094817|NCT02484729|100556205|FG005|STARTED|Overall Study||6||
48094818|NCT02484729|100556206|FG006|STARTED|Overall Study||5||
48259219|NCT01654068|100955053|FG000|COMPLETED|Overall Study||14||
48094819|NCT02484729|100556207|FG007|STARTED|Overall Study||6||
48094820|NCT02484729|100556208|FG008|STARTED|Overall Study||6||
48094821|NCT02484729|100556209|FG009|STARTED|Overall Study||8||
48094822|NCT02484729|100556200|FG000|COMPLETED|Overall Study||16||
48094823|NCT02484729|100556201|FG001|COMPLETED|Overall Study||6||
48094824|NCT02484729|100556202|FG002|COMPLETED|Overall Study||6||
48094825|NCT02484729|100556203|FG003|COMPLETED|Overall Study||6||
48094826|NCT02484729|100556204|FG004|COMPLETED|Overall Study||5||
48094827|NCT02484729|100556205|FG005|COMPLETED|Overall Study||6||
48094828|NCT02484729|100556206|FG006|COMPLETED|Overall Study||5||
48094829|NCT02484729|100556207|FG007|COMPLETED|Overall Study||6||
48094830|NCT02484729|100556208|FG008|COMPLETED|Overall Study||6||
48094831|NCT02484729|100556209|FG009|COMPLETED|Overall Study||7||
48094832|NCT02484729|100556200|FG000|NOT COMPLETED|Overall Study||0||
48094833|NCT02484729|100556201|FG001|NOT COMPLETED|Overall Study||0||
48094834|NCT02484729|100556202|FG002|NOT COMPLETED|Overall Study||0||
48094835|NCT02484729|100556203|FG003|NOT COMPLETED|Overall Study||0||
48094836|NCT02484729|100556204|FG004|NOT COMPLETED|Overall Study||0||
48094837|NCT02484729|100556205|FG005|NOT COMPLETED|Overall Study||0||
48094838|NCT02484729|100556206|FG006|NOT COMPLETED|Overall Study||0||
48094839|NCT02484729|100556207|FG007|NOT COMPLETED|Overall Study||0||
48094840|NCT02484729|100556208|FG008|NOT COMPLETED|Overall Study||0||
48094841|NCT02484729|100556209|FG009|NOT COMPLETED|Overall Study||1||
48094842|NCT01549392|100556210|FG000|STARTED|Overall Study||3||
48259220|NCT01654068|100955053|FG000|NOT COMPLETED|Overall Study||0||
48259221|NCT02725567|100955054|FG000|STARTED|Part A (Up to 5 Days)||19||
48259222|NCT02725567|100955055|FG001|STARTED|Part A (Up to 5 Days)||0||
48259223|NCT02725567|100955054|FG000|COMPLETED|Part A (Up to 5 Days)||19||
48259224|NCT02725567|100955055|FG001|COMPLETED|Part A (Up to 5 Days)||0||
48259225|NCT02725567|100955054|FG000|NOT COMPLETED|Part A (Up to 5 Days)||0||
48259226|NCT02725567|100955055|FG001|NOT COMPLETED|Part A (Up to 5 Days)||0||
48259227|NCT02725567|100955054|FG000|STARTED|Part B + A/B ( Up to 24 Weeks)||0||
48259228|NCT02725567|100955055|FG001|STARTED|Part B + A/B ( Up to 24 Weeks)||43||
48259229|NCT02725567|100955054|FG000|COMPLETED|Part B + A/B ( Up to 24 Weeks)||0||
48259230|NCT02725567|100955055|FG001|COMPLETED|Part B + A/B ( Up to 24 Weeks)||40||
48259231|NCT02725567|100955054|FG000|NOT COMPLETED|Part B + A/B ( Up to 24 Weeks)||0||
48259232|NCT02725567|100955055|FG001|NOT COMPLETED|Part B + A/B ( Up to 24 Weeks)||3||
48259233|NCT03020069|100955056|FG000|STARTED|Overall Study||9||
48259234|NCT03020069|100955057|FG001|STARTED|Overall Study||4||
48259235|NCT03020069|100955056|FG000|COMPLETED|Overall Study||9||
48259236|NCT03020069|100955057|FG001|COMPLETED|Overall Study||3||
48259237|NCT03020069|100955056|FG000|NOT COMPLETED|Overall Study||0||
48094843|NCT01549392|100556211|FG001|STARTED|Overall Study||0||
48094844|NCT01549392|100556210|FG000|COMPLETED|Overall Study||2||
48094845|NCT01549392|100556211|FG001|COMPLETED|Overall Study||0||
48094846|NCT01549392|100556210|FG000|NOT COMPLETED|Overall Study||1||
48094847|NCT01549392|100556211|FG001|NOT COMPLETED|Overall Study||0||
48094848|NCT01499667|100556212|FG000|STARTED|Overall Study||50||
48094849|NCT01499667|100556213|FG001|STARTED|Overall Study||42||
48094850|NCT01499667|100556214|FG002|STARTED|Overall Study||50||
48094851|NCT01499667|100556212|FG000|Full Analysis Set (FAS)|Overall Study||49||
48094852|NCT01499667|100556213|FG001|Full Analysis Set (FAS)|Overall Study||42||
48094853|NCT01499667|100556214|FG002|Full Analysis Set (FAS)|Overall Study||50||
48094854|NCT01499667|100556212|FG000|Modified Full Analysis Set|Overall Study||41||
48094855|NCT01499667|100556213|FG001|Modified Full Analysis Set|Overall Study||29||
48259238|NCT03020069|100955057|FG001|NOT COMPLETED|Overall Study||1||
48094856|NCT01499667|100556214|FG002|Modified Full Analysis Set|Overall Study||39||
48094857|NCT01499667|100556212|FG000|COMPLETED|Overall Study||41||
48094858|NCT01499667|100556213|FG001|COMPLETED|Overall Study||31||
48094859|NCT01499667|100556214|FG002|COMPLETED|Overall Study||40||
48094860|NCT01499667|100556212|FG000|NOT COMPLETED|Overall Study||9||
48094861|NCT01499667|100556213|FG001|NOT COMPLETED|Overall Study||11||
48387515|NCT03292952|101276839|FG001|COMPLETED|Open-Label Dose Optimization||0||
48387516|NCT03292952|101276840|FG002|COMPLETED|Open-Label Dose Optimization||0||
48387517|NCT03292952|101276838|FG000|NOT COMPLETED|Open-Label Dose Optimization||5||
48387518|NCT03292952|101276839|FG001|NOT COMPLETED|Open-Label Dose Optimization||0||
48387519|NCT03292952|101276840|FG002|NOT COMPLETED|Open-Label Dose Optimization||0||
48387520|NCT03292952|101276838|FG000|STARTED|Double-Blind Treatment Phase||0||
48387521|NCT03292952|101276839|FG001|STARTED|Double-Blind Treatment Phase||74||
48387522|NCT03292952|101276840|FG002|STARTED|Double-Blind Treatment Phase||76||
48387523|NCT03292952|101276838|FG000|COMPLETED|Double-Blind Treatment Phase||0||
48387524|NCT03292952|101276839|FG001|COMPLETED|Double-Blind Treatment Phase||74||
48387525|NCT03292952|101276840|FG002|COMPLETED|Double-Blind Treatment Phase||75||
48387526|NCT03292952|101276838|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0||
48387527|NCT03292952|101276839|FG001|NOT COMPLETED|Double-Blind Treatment Phase||0||
48387528|NCT03292952|101276840|FG002|NOT COMPLETED|Double-Blind Treatment Phase||1||
48387529|NCT01401465|101276841|FG000|STARTED|Treatment Period 1||165||
48387530|NCT01401465|101276842|FG001|STARTED|Treatment Period 1||162||
48387531|NCT01401465|101276841|FG000|COMPLETED|Treatment Period 1||150||
48387532|NCT01401465|101276842|FG001|COMPLETED|Treatment Period 1||146||
48387533|NCT01401465|101276841|FG000|NOT COMPLETED|Treatment Period 1||15||
48387534|NCT01401465|101276842|FG001|NOT COMPLETED|Treatment Period 1||16||
48259239|NCT01017263|100955058|FG000|STARTED|Overall Study||14||
48259240|NCT01017263|100955058|FG000|COMPLETED|Overall Study||2||
48387535|NCT01401465|101276841|FG000|STARTED|Washout||150||
48387536|NCT01401465|101276842|FG001|STARTED|Washout||146||
48387537|NCT01401465|101276841|FG000|COMPLETED|Washout||150||
48387538|NCT01401465|101276842|FG001|COMPLETED|Washout||146||
48387539|NCT01401465|101276841|FG000|NOT COMPLETED|Washout||0||
48387540|NCT01401465|101276842|FG001|NOT COMPLETED|Washout||0||
48094862|NCT01499667|100556214|FG002|NOT COMPLETED|Overall Study||10||
48094863|NCT03630120|100556215|FG000|STARTED|Overall Study||2||
48094864|NCT03630120|100556216|FG001|STARTED|Overall Study||2||
48094865|NCT03630120|100556217|FG002|STARTED|Overall Study||1||
48094866|NCT03630120|100556218|FG003|STARTED|Overall Study||1||
48094867|NCT03630120|100556215|FG000|COMPLETED|Overall Study||2||
48094868|NCT03630120|100556216|FG001|COMPLETED|Overall Study||1||
48094869|NCT03630120|100556217|FG002|COMPLETED|Overall Study||0||
48094870|NCT03630120|100556218|FG003|COMPLETED|Overall Study||0||
48094871|NCT03630120|100556215|FG000|NOT COMPLETED|Overall Study||0||
48094872|NCT03630120|100556216|FG001|NOT COMPLETED|Overall Study||1||
48094873|NCT03630120|100556217|FG002|NOT COMPLETED|Overall Study||1||
48094874|NCT03630120|100556218|FG003|NOT COMPLETED|Overall Study||1||
48094875|NCT01928329|100556219|FG000|STARTED|Overall Study||40||
48094876|NCT01928329|100556220|FG001|STARTED|Overall Study||39||
48094877|NCT01928329|100556219|FG000|COMPLETED|Overall Study||28||
48094878|NCT01928329|100556220|FG001|COMPLETED|Overall Study||25||
48094879|NCT01928329|100556219|FG000|NOT COMPLETED|Overall Study||12||
48094880|NCT01928329|100556220|FG001|NOT COMPLETED|Overall Study||14||
48094881|NCT03087760|100556221|FG000|STARTED|Overall Study||22||
48094882|NCT03087760|100556221|FG000|COMPLETED|Overall Study||3||
48094883|NCT03087760|100556221|FG000|NOT COMPLETED|Overall Study||19||
48094884|NCT02153112|100556222|FG000|STARTED|Overall Study||61||
48094885|NCT02153112|100556223|FG001|STARTED|Overall Study||59||
48094886|NCT02153112|100556224|FG002|STARTED|Overall Study||61||
48094887|NCT02153112|100556225|FG003|STARTED|Overall Study||59||
48094888|NCT02153112|100556226|FG004|STARTED|Overall Study||60||
48094889|NCT02153112|100556227|FG005|STARTED|Overall Study||60||
48094890|NCT02153112|100556228|FG006|STARTED|Overall Study||60||
48094891|NCT02153112|100556229|FG007|STARTED|Overall Study||60||
48094892|NCT02153112|100556230|FG008|STARTED|Overall Study||180||
48094893|NCT02153112|100556231|FG009|STARTED|Overall Study||180||
48094894|NCT02153112|100556222|FG000|COMPLETED|Overall Study||57||
48094895|NCT02153112|100556223|FG001|COMPLETED|Overall Study||57||
48094896|NCT02153112|100556224|FG002|COMPLETED|Overall Study||58||
48259241|NCT01017263|100955058|FG000|NOT COMPLETED|Overall Study||12||
48259242|NCT00673127|100955059|FG000|STARTED|Overall Study||57||
48259243|NCT00673127|100955059|FG000|COMPLETED|Overall Study||57||
48259244|NCT00673127|100955059|FG000|NOT COMPLETED|Overall Study||0||
48259245|NCT03029819|100955060|FG000|STARTED|Overall Study||33||
48259246|NCT03029819|100955061|FG001|STARTED|Overall Study||39||
48259247|NCT03029819|100955060|FG000|COMPLETED|Overall Study||30||
48259248|NCT03029819|100955061|FG001|COMPLETED|Overall Study||33||
48259249|NCT03029819|100955060|FG000|NOT COMPLETED|Overall Study||3||
48259250|NCT03029819|100955061|FG001|NOT COMPLETED|Overall Study||6||
48259251|NCT01918371|100955062|FG000|STARTED|Overall Study||166||
48259252|NCT01918371|100955063|FG001|STARTED|Overall Study||157||
48259253|NCT01918371|100955062|FG000|Participants With Complete Data|Overall Study||165||
48259254|NCT01918371|100955063|FG001|Participants With Complete Data|Overall Study||156||
48094897|NCT02153112|100556225|FG003|COMPLETED|Overall Study||57||
48094898|NCT02153112|100556226|FG004|COMPLETED|Overall Study||57||
48094899|NCT02153112|100556227|FG005|COMPLETED|Overall Study||58||
48094900|NCT02153112|100556228|FG006|COMPLETED|Overall Study||52||
48094901|NCT02153112|100556229|FG007|COMPLETED|Overall Study||58||
48094902|NCT02153112|100556230|FG008|COMPLETED|Overall Study||165||
48094903|NCT02153112|100556231|FG009|COMPLETED|Overall Study||166||
48094904|NCT02153112|100556222|FG000|NOT COMPLETED|Overall Study||4||
48094905|NCT02153112|100556223|FG001|NOT COMPLETED|Overall Study||2||
48094906|NCT02153112|100556224|FG002|NOT COMPLETED|Overall Study||3||
48094907|NCT02153112|100556225|FG003|NOT COMPLETED|Overall Study||2||
48094908|NCT02153112|100556226|FG004|NOT COMPLETED|Overall Study||3||
48094909|NCT02153112|100556227|FG005|NOT COMPLETED|Overall Study||2||
48094910|NCT02153112|100556228|FG006|NOT COMPLETED|Overall Study||8||
48094911|NCT02153112|100556229|FG007|NOT COMPLETED|Overall Study||2||
48094912|NCT02153112|100556230|FG008|NOT COMPLETED|Overall Study||15||
48094913|NCT02153112|100556231|FG009|NOT COMPLETED|Overall Study||14||
48094914|NCT02150954|100556232|FG000|STARTED|Overall Study||58||
48094915|NCT02150954|100556233|FG001|STARTED|Overall Study||59||
48094916|NCT02150954|100556232|FG000|COMPLETED|Overall Study||57||
48541811|NCT03095638|101662793|FG004|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0||
48541812|NCT03095638|101662794|FG005|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0||
48094917|NCT02150954|100556233|FG001|COMPLETED|Overall Study||59||
48094918|NCT02150954|100556232|FG000|NOT COMPLETED|Overall Study||1||
48094919|NCT02150954|100556233|FG001|NOT COMPLETED|Overall Study||0||
48094920|NCT00826020|100556234|FG000|STARTED|Overall Study||72||
48094921|NCT00826020|100556234|FG000|COMPLETED|Overall Study||72||
48094922|NCT00826020|100556234|FG000|NOT COMPLETED|Overall Study||0||
48094923|NCT04273217|100556235|FG000|STARTED|Overall Study||6||
48094924|NCT04273217|100556236|FG001|STARTED|Overall Study||6||
48094925|NCT04273217|100556237|FG002|STARTED|Overall Study||6||
48094926|NCT04273217|100556238|FG003|STARTED|Overall Study||6||
48094927|NCT04273217|100556239|FG004|STARTED|Overall Study||7||
48094928|NCT04273217|100556240|FG005|STARTED|Overall Study||11||
48094929|NCT04273217|100556235|FG000|COMPLETED|Overall Study||5||
48094930|NCT04273217|100556236|FG001|COMPLETED|Overall Study||6||
48094931|NCT04273217|100556237|FG002|COMPLETED|Overall Study||5||
48094932|NCT04273217|100556238|FG003|COMPLETED|Overall Study||6||
48094933|NCT04273217|100556239|FG004|COMPLETED|Overall Study||6||
48094934|NCT04273217|100556240|FG005|COMPLETED|Overall Study||9||
48094935|NCT04273217|100556235|FG000|NOT COMPLETED|Overall Study||1||
48094936|NCT04273217|100556236|FG001|NOT COMPLETED|Overall Study||0||
48094937|NCT04273217|100556237|FG002|NOT COMPLETED|Overall Study||1||
48094938|NCT04273217|100556238|FG003|NOT COMPLETED|Overall Study||0||
48094939|NCT04273217|100556239|FG004|NOT COMPLETED|Overall Study||1||
48094940|NCT04273217|100556240|FG005|NOT COMPLETED|Overall Study||2||
48094941|NCT01270711|100556241|FG000|STARTED|Part 1: Compliance||7537||
48094942|NCT01270711|100556242|FG001|STARTED|Part 1: Compliance||6580||
48094943|NCT01270711|100556243|FG002|STARTED|Part 1: Compliance||326||
48094944|NCT01270711|100556244|FG003|STARTED|Part 1: Compliance||5486||
48094945|NCT01270711|100556245|FG004|STARTED|Part 1: Compliance||2024||
48094946|NCT01270711|100556246|FG005|STARTED|Part 1: Compliance||0||
48094947|NCT01270711|100556247|FG006|STARTED|Part 1: Compliance||0||
48094948|NCT01270711|100556248|FG007|STARTED|Part 1: Compliance||0||
48094949|NCT01270711|100556241|FG000|COMPLETED|Part 1: Compliance||7537||
48094950|NCT01270711|100556242|FG001|COMPLETED|Part 1: Compliance||6580||
48094951|NCT01270711|100556243|FG002|COMPLETED|Part 1: Compliance||326||
48094952|NCT01270711|100556244|FG003|COMPLETED|Part 1: Compliance||5486||
48094953|NCT01270711|100556245|FG004|COMPLETED|Part 1: Compliance||2024||
48094954|NCT01270711|100556246|FG005|COMPLETED|Part 1: Compliance||0||
48094955|NCT01270711|100556247|FG006|COMPLETED|Part 1: Compliance||0||
48094956|NCT01270711|100556248|FG007|COMPLETED|Part 1: Compliance||0||
48094957|NCT01270711|100556241|FG000|NOT COMPLETED|Part 1: Compliance||0||
48094958|NCT01270711|100556242|FG001|NOT COMPLETED|Part 1: Compliance||0||
48094959|NCT01270711|100556243|FG002|NOT COMPLETED|Part 1: Compliance||0||
48259255|NCT01918371|100955062|FG000|COMPLETED|Overall Study||165||
48541813|NCT03095638|101662795|FG006|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0||
48094960|NCT01270711|100556244|FG003|NOT COMPLETED|Part 1: Compliance||0||
48094961|NCT01270711|100556245|FG004|NOT COMPLETED|Part 1: Compliance||0||
48094962|NCT01270711|100556246|FG005|NOT COMPLETED|Part 1: Compliance||0||
48094963|NCT01270711|100556247|FG006|NOT COMPLETED|Part 1: Compliance||0||
48094964|NCT01270711|100556248|FG007|NOT COMPLETED|Part 1: Compliance||0||
48094965|NCT01270711|100556241|FG000|STARTED|Part 2: Effectiveness||0||
48094966|NCT01270711|100556242|FG001|STARTED|Part 2: Effectiveness||0||
48094967|NCT01270711|100556243|FG002|STARTED|Part 2: Effectiveness||0||
48094968|NCT01270711|100556244|FG003|STARTED|Part 2: Effectiveness||0||
48094969|NCT01270711|100556245|FG004|STARTED|Part 2: Effectiveness||0||
48094970|NCT01270711|100556246|FG005|STARTED|Part 2: Effectiveness||11||
48094971|NCT01270711|100556247|FG006|STARTED|Part 2: Effectiveness||2||
48094972|NCT01270711|100556248|FG007|STARTED|Part 2: Effectiveness||48||
48094973|NCT01270711|100556241|FG000|COMPLETED|Part 2: Effectiveness||0||
48094974|NCT01270711|100556242|FG001|COMPLETED|Part 2: Effectiveness||0||
48094975|NCT01270711|100556243|FG002|COMPLETED|Part 2: Effectiveness||0||
48094976|NCT01270711|100556244|FG003|COMPLETED|Part 2: Effectiveness||0||
48094977|NCT01270711|100556245|FG004|COMPLETED|Part 2: Effectiveness||0||
48094978|NCT01270711|100556246|FG005|COMPLETED|Part 2: Effectiveness||11||
48094979|NCT01270711|100556247|FG006|COMPLETED|Part 2: Effectiveness||2||
48094980|NCT01270711|100556248|FG007|COMPLETED|Part 2: Effectiveness||48||
48094981|NCT01270711|100556241|FG000|NOT COMPLETED|Part 2: Effectiveness||0||
48094982|NCT01270711|100556242|FG001|NOT COMPLETED|Part 2: Effectiveness||0||
48094983|NCT01270711|100556243|FG002|NOT COMPLETED|Part 2: Effectiveness||0||
48094984|NCT01270711|100556244|FG003|NOT COMPLETED|Part 2: Effectiveness||0||
48094985|NCT01270711|100556245|FG004|NOT COMPLETED|Part 2: Effectiveness||0||
48094986|NCT01270711|100556246|FG005|NOT COMPLETED|Part 2: Effectiveness||0||
48094987|NCT01270711|100556247|FG006|NOT COMPLETED|Part 2: Effectiveness||0||
48094988|NCT01270711|100556248|FG007|NOT COMPLETED|Part 2: Effectiveness||0||
48094989|NCT02535845|100556249|FG000|STARTED|Overall Study||7||
48094990|NCT02535845|100556250|FG001|STARTED|Overall Study||7||
48094991|NCT02535845|100556251|FG002|STARTED|Overall Study||4||
48094992|NCT02535845|100556252|FG003|STARTED|Overall Study||4||
48094993|NCT02535845|100556249|FG000|COMPLETED|Overall Study||7||
48094994|NCT02535845|100556250|FG001|COMPLETED|Overall Study||7||
48094995|NCT02535845|100556251|FG002|COMPLETED|Overall Study||4||
48094996|NCT02535845|100556252|FG003|COMPLETED|Overall Study||4||
48094997|NCT02535845|100556249|FG000|NOT COMPLETED|Overall Study||0||
48094998|NCT02535845|100556250|FG001|NOT COMPLETED|Overall Study||0||
48094999|NCT02535845|100556251|FG002|NOT COMPLETED|Overall Study||0||
48095000|NCT02535845|100556252|FG003|NOT COMPLETED|Overall Study||0||
48095001|NCT01892501|100556253|FG000|STARTED|Overall Study||75||
48095002|NCT01892501|100556253|FG000|Group A : Biopsy Surgically Possible|Overall Study||72|Eligible for surgical procedure : Patients with no major protocol violation or medical contraindication|
48095003|NCT01892501|100556253|FG000|Group B : Biopsy Not Surgically Possible|Overall Study||3|No eligible for surgical procedure : major protocol deviations or medical contraindication|
48095004|NCT01892501|100556253|FG000|COMPLETED|Overall Study||47||
48095005|NCT01892501|100556253|FG000|NOT COMPLETED|Overall Study||28||
48095006|NCT01998633|100556254|FG000|STARTED|Overall Study||47||
48095007|NCT01998633|100556254|FG000|COMPLETED|Overall Study||46||
48095008|NCT01998633|100556254|FG000|NOT COMPLETED|Overall Study||1||
48095009|NCT01572909|100556255|FG000|STARTED|Overall Study||152||
48095010|NCT01572909|100556256|FG001|STARTED|Overall Study||148||
48095011|NCT01572909|100556255|FG000|COMPLETED|Overall Study||120||
48095012|NCT01572909|100556256|FG001|COMPLETED|Overall Study||123||
48095013|NCT01572909|100556255|FG000|NOT COMPLETED|Overall Study||32||
48095014|NCT01572909|100556256|FG001|NOT COMPLETED|Overall Study||25||
48095015|NCT04741074|100556257|FG000|STARTED|Overall Study||7||
48095016|NCT04741074|100556258|FG001|STARTED|Overall Study||8||
48095017|NCT04741074|100556257|FG000|COMPLETED|Overall Study||5||
48095018|NCT04741074|100556258|FG001|COMPLETED|Overall Study||7||
48095019|NCT04741074|100556257|FG000|NOT COMPLETED|Overall Study||2||
48259256|NCT01918371|100955063|FG001|COMPLETED|Overall Study||156||
48259257|NCT01918371|100955062|FG000|NOT COMPLETED|Overall Study||1||
48259258|NCT01918371|100955063|FG001|NOT COMPLETED|Overall Study||1||
48259259|NCT01426113|100955064|FG000|STARTED|Overall Study||3||
48259260|NCT01426113|100955065|FG001|STARTED|Overall Study||3||
48259261|NCT01426113|100955064|FG000|COMPLETED|Overall Study||2||
48259262|NCT01426113|100955065|FG001|COMPLETED|Overall Study||1||
48259263|NCT01426113|100955064|FG000|NOT COMPLETED|Overall Study||1||
48259264|NCT01426113|100955065|FG001|NOT COMPLETED|Overall Study||2||
48259265|NCT00321685|100955066|FG000|STARTED|Overall Study||57||
48259266|NCT00321685|100955066|FG000|Eligible|Overall Study||55||
48259267|NCT00321685|100955066|FG000|Started Protocol Therapy|Overall Study||55||
48259268|NCT00321685|100955066|FG000|Eligible and Treated|Overall Study||53||
48259269|NCT00321685|100955066|FG000|COMPLETED|Overall Study||18||
48259270|NCT00321685|100955066|FG000|NOT COMPLETED|Overall Study||39||
48259271|NCT01547598|100955067|FG000|STARTED|Overall Study||67||
48259272|NCT01547598|100955068|FG001|STARTED|Overall Study||68||
48259273|NCT01547598|100955067|FG000|COMPLETED|Overall Study||61||
48259274|NCT01547598|100955068|FG001|COMPLETED|Overall Study||63||
48259275|NCT01547598|100955067|FG000|NOT COMPLETED|Overall Study||6||
48259276|NCT01547598|100955068|FG001|NOT COMPLETED|Overall Study||5||
48259277|NCT01527162|100955069|FG000|STARTED|Overall Study||6||
48259278|NCT01527162|100955070|FG001|STARTED|Overall Study||5||
48387541|NCT01401465|101276841|FG000|STARTED|Treatment Period 2||150||
48095020|NCT04741074|100556258|FG001|NOT COMPLETED|Overall Study||1||
48095021|NCT00597766|100556259|FG000|STARTED|Enrolled||9||
48095022|NCT00597766|100556260|FG001|STARTED|Enrolled||9||
48095023|NCT00597766|100556261|FG002|STARTED|Enrolled||10||
48095024|NCT00597766|100556259|FG000|COMPLETED|Enrolled||9||
48095025|NCT00597766|100556260|FG001|COMPLETED|Enrolled||9||
48095026|NCT00597766|100556261|FG002|COMPLETED|Enrolled||10||
48095027|NCT00597766|100556259|FG000|NOT COMPLETED|Enrolled||0||
48259279|NCT01527162|100955069|FG000|COMPLETED|Overall Study||6||
48259280|NCT01527162|100955070|FG001|COMPLETED|Overall Study||5||
48259281|NCT01527162|100955069|FG000|NOT COMPLETED|Overall Study||0||
48259282|NCT01527162|100955070|FG001|NOT COMPLETED|Overall Study||0||
48259283|NCT00311246|100955071|FG000|STARTED|Overall Study||11||
48259284|NCT00311246|100955071|FG000|COMPLETED|Overall Study||11||
48095028|NCT00597766|100556260|FG001|NOT COMPLETED|Enrolled||0||
48095029|NCT00597766|100556261|FG002|NOT COMPLETED|Enrolled||0||
48095030|NCT00597766|100556259|FG000|STARTED|Follow-up 1, Week 4||9||
48095031|NCT00597766|100556260|FG001|STARTED|Follow-up 1, Week 4||9||
48095032|NCT00597766|100556261|FG002|STARTED|Follow-up 1, Week 4||10||
48095033|NCT00597766|100556259|FG000|COMPLETED|Follow-up 1, Week 4||8||
48095034|NCT00597766|100556260|FG001|COMPLETED|Follow-up 1, Week 4||9||
48095035|NCT00597766|100556261|FG002|COMPLETED|Follow-up 1, Week 4||10||
48095036|NCT00597766|100556259|FG000|NOT COMPLETED|Follow-up 1, Week 4||1||
48095037|NCT00597766|100556260|FG001|NOT COMPLETED|Follow-up 1, Week 4||0||
48095038|NCT00597766|100556261|FG002|NOT COMPLETED|Follow-up 1, Week 4||0||
48095039|NCT00597766|100556259|FG000|STARTED|Follow-up 2, Week 8||8||
48095040|NCT00597766|100556260|FG001|STARTED|Follow-up 2, Week 8||9||
48095041|NCT00597766|100556261|FG002|STARTED|Follow-up 2, Week 8||10||
48095042|NCT00597766|100556259|FG000|COMPLETED|Follow-up 2, Week 8||8||
48095043|NCT00597766|100556260|FG001|COMPLETED|Follow-up 2, Week 8||9||
48095044|NCT00597766|100556261|FG002|COMPLETED|Follow-up 2, Week 8||9||
48095045|NCT00597766|100556259|FG000|NOT COMPLETED|Follow-up 2, Week 8||0||
48095046|NCT00597766|100556260|FG001|NOT COMPLETED|Follow-up 2, Week 8||0||
48095047|NCT00597766|100556261|FG002|NOT COMPLETED|Follow-up 2, Week 8||1||
48095048|NCT00597766|100556259|FG000|STARTED|Follow-up 3, Week 12||8||
48095049|NCT00597766|100556260|FG001|STARTED|Follow-up 3, Week 12||9||
48095050|NCT00597766|100556261|FG002|STARTED|Follow-up 3, Week 12||9||
48095051|NCT00597766|100556259|FG000|COMPLETED|Follow-up 3, Week 12||8||
48095052|NCT00597766|100556260|FG001|COMPLETED|Follow-up 3, Week 12||9||
48095053|NCT00597766|100556261|FG002|COMPLETED|Follow-up 3, Week 12||9||
48095054|NCT00597766|100556259|FG000|NOT COMPLETED|Follow-up 3, Week 12||0||
48095055|NCT00597766|100556260|FG001|NOT COMPLETED|Follow-up 3, Week 12||0||
48095056|NCT00597766|100556261|FG002|NOT COMPLETED|Follow-up 3, Week 12||0||
48095057|NCT06002347|100556262|FG000|STARTED|Overall Study||23||
48095058|NCT06002347|100556262|FG000|COMPLETED|Overall Study||20||
48095059|NCT06002347|100556262|FG000|NOT COMPLETED|Overall Study||3||
48095060|NCT00631566|100556263|FG000|STARTED|Overall Study||21||
48095061|NCT00631566|100556264|FG001|STARTED|Overall Study||28||
48095062|NCT00631566|100556265|FG002|STARTED|Overall Study||501||
48095063|NCT00631566|100556263|FG000|COMPLETED|Overall Study||19||
48095064|NCT00631566|100556264|FG001|COMPLETED|Overall Study||24||
48095065|NCT00631566|100556265|FG002|COMPLETED|Overall Study||501||
48095066|NCT00631566|100556263|FG000|NOT COMPLETED|Overall Study||2||
48095067|NCT00631566|100556264|FG001|NOT COMPLETED|Overall Study||4||
48095068|NCT00631566|100556265|FG002|NOT COMPLETED|Overall Study||0||
48095069|NCT03909295|100556266|FG000|STARTED|Overall Study||52||
48095070|NCT03909295|100556266|FG000|Safety Set (SAF)|Overall Study||52|All subjects who received at least one dose of study drug|
48095071|NCT03909295|100556266|FG000|COMPLETED|Overall Study||0||
48095072|NCT03909295|100556266|FG000|NOT COMPLETED|Overall Study||52||
48095073|NCT01641692|100556267|FG000|STARTED|Treatment Period 1||42||
48095074|NCT01641692|100556268|FG001|STARTED|Treatment Period 1||45||
48095075|NCT01641692|100556269|FG002|STARTED|Treatment Period 1||51||
48095076|NCT01641692|100556270|FG003|STARTED|Treatment Period 1||41||
48095077|NCT01641692|100556271|FG004|STARTED|Treatment Period 1||43||
48095078|NCT01641692|100556272|FG005|STARTED|Treatment Period 1||39||
48095079|NCT01641692|100556273|FG006|STARTED|Treatment Period 1||38||
48095080|NCT01641692|100556274|FG007|STARTED|Treatment Period 1||51||
48095081|NCT01641692|100556267|FG000|COMPLETED|Treatment Period 1||40||
48095082|NCT01641692|100556268|FG001|COMPLETED|Treatment Period 1||45||
48095083|NCT01641692|100556269|FG002|COMPLETED|Treatment Period 1||50||
48095084|NCT01641692|100556270|FG003|COMPLETED|Treatment Period 1||41||
48095085|NCT01641692|100556271|FG004|COMPLETED|Treatment Period 1||39||
48095086|NCT01641692|100556272|FG005|COMPLETED|Treatment Period 1||37||
48095087|NCT01641692|100556273|FG006|COMPLETED|Treatment Period 1||38||
48095088|NCT01641692|100556274|FG007|COMPLETED|Treatment Period 1||48||
48095089|NCT01641692|100556267|FG000|NOT COMPLETED|Treatment Period 1||2||
48095090|NCT01641692|100556268|FG001|NOT COMPLETED|Treatment Period 1||0||
48095091|NCT01641692|100556269|FG002|NOT COMPLETED|Treatment Period 1||1||
48095092|NCT01641692|100556270|FG003|NOT COMPLETED|Treatment Period 1||0||
48095093|NCT01641692|100556271|FG004|NOT COMPLETED|Treatment Period 1||4||
48095094|NCT01641692|100556272|FG005|NOT COMPLETED|Treatment Period 1||2||
48095095|NCT01641692|100556273|FG006|NOT COMPLETED|Treatment Period 1||0||
48095096|NCT01641692|100556274|FG007|NOT COMPLETED|Treatment Period 1||3||
48095097|NCT01641692|100556267|FG000|STARTED|Washout Period 1 (12-14 Days)||40||
48095098|NCT01641692|100556268|FG001|STARTED|Washout Period 1 (12-14 Days)||45||
48095099|NCT01641692|100556269|FG002|STARTED|Washout Period 1 (12-14 Days)||50||
48095100|NCT01641692|100556270|FG003|STARTED|Washout Period 1 (12-14 Days)||41||
48095101|NCT01641692|100556271|FG004|STARTED|Washout Period 1 (12-14 Days)||39||
48095102|NCT01641692|100556272|FG005|STARTED|Washout Period 1 (12-14 Days)||37||
48095103|NCT01641692|100556273|FG006|STARTED|Washout Period 1 (12-14 Days)||38||
48095104|NCT01641692|100556274|FG007|STARTED|Washout Period 1 (12-14 Days)||48||
48095105|NCT01641692|100556267|FG000|COMPLETED|Washout Period 1 (12-14 Days)||36||
48095106|NCT01641692|100556268|FG001|COMPLETED|Washout Period 1 (12-14 Days)||44||
48095107|NCT01641692|100556269|FG002|COMPLETED|Washout Period 1 (12-14 Days)||47||
48095108|NCT01641692|100556270|FG003|COMPLETED|Washout Period 1 (12-14 Days)||39||
48095109|NCT01641692|100556271|FG004|COMPLETED|Washout Period 1 (12-14 Days)||35||
48095110|NCT01641692|100556272|FG005|COMPLETED|Washout Period 1 (12-14 Days)||37||
48095111|NCT01641692|100556273|FG006|COMPLETED|Washout Period 1 (12-14 Days)||36||
48095112|NCT01641692|100556274|FG007|COMPLETED|Washout Period 1 (12-14 Days)||47||
48095113|NCT01641692|100556267|FG000|NOT COMPLETED|Washout Period 1 (12-14 Days)||4||
48095114|NCT01641692|100556268|FG001|NOT COMPLETED|Washout Period 1 (12-14 Days)||1||
48095115|NCT01641692|100556269|FG002|NOT COMPLETED|Washout Period 1 (12-14 Days)||3||
48095116|NCT01641692|100556270|FG003|NOT COMPLETED|Washout Period 1 (12-14 Days)||2||
48095117|NCT01641692|100556271|FG004|NOT COMPLETED|Washout Period 1 (12-14 Days)||4||
48095118|NCT01641692|100556272|FG005|NOT COMPLETED|Washout Period 1 (12-14 Days)||0||
48095119|NCT01641692|100556273|FG006|NOT COMPLETED|Washout Period 1 (12-14 Days)||2||
48095120|NCT01641692|100556274|FG007|NOT COMPLETED|Washout Period 1 (12-14 Days)||1||
48095121|NCT01641692|100556267|FG000|STARTED|Treatment Period 2||33||
48095122|NCT01641692|100556268|FG001|STARTED|Treatment Period 2||46||
48095123|NCT01641692|100556269|FG002|STARTED|Treatment Period 2||40||
48095124|NCT01641692|100556270|FG003|STARTED|Treatment Period 2||41||
48095125|NCT01641692|100556271|FG004|STARTED|Treatment Period 2||37||
48095126|NCT01641692|100556272|FG005|STARTED|Treatment Period 2||45||
48095127|NCT01641692|100556273|FG006|STARTED|Treatment Period 2||43||
48095128|NCT01641692|100556274|FG007|STARTED|Treatment Period 2||36||
48095129|NCT01641692|100556267|FG000|COMPLETED|Treatment Period 2||30||
48095130|NCT01641692|100556268|FG001|COMPLETED|Treatment Period 2||46||
48095131|NCT01641692|100556269|FG002|COMPLETED|Treatment Period 2||40||
48095132|NCT01641692|100556270|FG003|COMPLETED|Treatment Period 2||41||
48095133|NCT01641692|100556271|FG004|COMPLETED|Treatment Period 2||37||
48095134|NCT01641692|100556272|FG005|COMPLETED|Treatment Period 2||43||
48095135|NCT01641692|100556273|FG006|COMPLETED|Treatment Period 2||43||
48095136|NCT01641692|100556274|FG007|COMPLETED|Treatment Period 2||35||
48095137|NCT01641692|100556267|FG000|NOT COMPLETED|Treatment Period 2||3||
48095138|NCT01641692|100556268|FG001|NOT COMPLETED|Treatment Period 2||0||
48387542|NCT01401465|101276842|FG001|STARTED|Treatment Period 2||146||
48387543|NCT01401465|101276841|FG000|COMPLETED|Treatment Period 2||150||
48387544|NCT01401465|101276842|FG001|COMPLETED|Treatment Period 2||144||
48387545|NCT01401465|101276841|FG000|NOT COMPLETED|Treatment Period 2||0||
48095139|NCT01641692|100556269|FG002|NOT COMPLETED|Treatment Period 2||0||
48095140|NCT01641692|100556270|FG003|NOT COMPLETED|Treatment Period 2||0||
48095141|NCT01641692|100556271|FG004|NOT COMPLETED|Treatment Period 2||0||
48095142|NCT01641692|100556272|FG005|NOT COMPLETED|Treatment Period 2||2||
48095143|NCT01641692|100556273|FG006|NOT COMPLETED|Treatment Period 2||0||
48095144|NCT01641692|100556274|FG007|NOT COMPLETED|Treatment Period 2||1||
48095145|NCT01641692|100556267|FG000|STARTED|Washout Period 2 (12-14 Days)||30||
48095146|NCT01641692|100556268|FG001|STARTED|Washout Period 2 (12-14 Days)||46||
48095147|NCT01641692|100556269|FG002|STARTED|Washout Period 2 (12-14 Days)||40||
48095148|NCT01641692|100556270|FG003|STARTED|Washout Period 2 (12-14 Days)||41||
48095149|NCT01641692|100556271|FG004|STARTED|Washout Period 2 (12-14 Days)||37||
48095150|NCT01641692|100556272|FG005|STARTED|Washout Period 2 (12-14 Days)||43||
48095151|NCT01641692|100556273|FG006|STARTED|Washout Period 2 (12-14 Days)||43||
48095152|NCT01641692|100556274|FG007|STARTED|Washout Period 2 (12-14 Days)||35||
48095153|NCT01641692|100556267|FG000|COMPLETED|Washout Period 2 (12-14 Days)||30||
48095154|NCT01641692|100556268|FG001|COMPLETED|Washout Period 2 (12-14 Days)||46||
48095155|NCT01641692|100556269|FG002|COMPLETED|Washout Period 2 (12-14 Days)||39||
48095156|NCT01641692|100556270|FG003|COMPLETED|Washout Period 2 (12-14 Days)||41||
48095157|NCT01641692|100556271|FG004|COMPLETED|Washout Period 2 (12-14 Days)||34||
48095158|NCT01641692|100556272|FG005|COMPLETED|Washout Period 2 (12-14 Days)||42||
48095159|NCT01641692|100556273|FG006|COMPLETED|Washout Period 2 (12-14 Days)||42||
48387546|NCT01401465|101276842|FG001|NOT COMPLETED|Treatment Period 2||2||
48387547|NCT05101486|101276843|FG000|STARTED|Overall Study||251||
48387548|NCT05101486|101276844|FG001|STARTED|Overall Study||252||
48387549|NCT05101486|101276845|FG002|STARTED|Overall Study||252||
48387550|NCT05101486|101276843|FG000|Vaccinated (Full Analysis Set [FAS])|Overall Study||250||
48387551|NCT05101486|101276844|FG001|Vaccinated (Full Analysis Set [FAS])|Overall Study||251||
48387552|NCT05101486|101276845|FG002|Vaccinated (Full Analysis Set [FAS])|Overall Study||251||
48387553|NCT05101486|101276843|FG000|COMPLETED|Overall Study||231||
48387554|NCT05101486|101276844|FG001|COMPLETED|Overall Study||241||
48387555|NCT05101486|101276845|FG002|COMPLETED|Overall Study||228||
48387556|NCT05101486|101276843|FG000|NOT COMPLETED|Overall Study||20||
48387557|NCT05101486|101276844|FG001|NOT COMPLETED|Overall Study||11||
48541814|NCT03095638|101662796|FG007|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0||
48541815|NCT03095638|101662789|FG000|STARTED|P2: Period 3 (4 Days)||0||
48095160|NCT01641692|100556274|FG007|COMPLETED|Washout Period 2 (12-14 Days)||34||
48095161|NCT01641692|100556267|FG000|NOT COMPLETED|Washout Period 2 (12-14 Days)||0||
48095162|NCT01641692|100556268|FG001|NOT COMPLETED|Washout Period 2 (12-14 Days)||0||
48095163|NCT01641692|100556269|FG002|NOT COMPLETED|Washout Period 2 (12-14 Days)||1||
48095164|NCT01641692|100556270|FG003|NOT COMPLETED|Washout Period 2 (12-14 Days)||0||
48095165|NCT01641692|100556271|FG004|NOT COMPLETED|Washout Period 2 (12-14 Days)||3||
48387558|NCT05101486|101276845|FG002|NOT COMPLETED|Overall Study||24||
48259285|NCT00311246|100955071|FG000|NOT COMPLETED|Overall Study||0||
48259286|NCT00248534|100955072|FG000|STARTED|Overall Study||16||
48259287|NCT00248534|100955072|FG000|COMPLETED|Overall Study||16||
48259288|NCT00248534|100955072|FG000|NOT COMPLETED|Overall Study||0||
48259289|NCT01503164|100955073|FG000|STARTED|Overall Study||55||
48259290|NCT01503164|100955074|FG001|STARTED|Overall Study||56||
48259291|NCT01503164|100955073|FG000|COMPLETED|Overall Study||53||
48259292|NCT01503164|100955074|FG001|COMPLETED|Overall Study||55||
48259293|NCT01503164|100955073|FG000|NOT COMPLETED|Overall Study||2||
48259294|NCT01503164|100955074|FG001|NOT COMPLETED|Overall Study||1||
48387559|NCT03134313|101276846|FG000|STARTED|Overall Study||25||
48387560|NCT03134313|101276846|FG000|COMPLETED|Overall Study||25||
48387561|NCT03134313|101276846|FG000|NOT COMPLETED|Overall Study||0||
48387562|NCT02392494|101276847|FG000|STARTED|Overall Study||3||
48387563|NCT02392494|101276848|FG001|STARTED|Overall Study||3||
48387564|NCT02392494|101276849|FG002|STARTED|Overall Study||3||
48387565|NCT02392494|101276850|FG003|STARTED|Overall Study||0||
48387566|NCT02392494|101276847|FG000|COMPLETED|Overall Study||3||
48095166|NCT01641692|100556272|FG005|NOT COMPLETED|Washout Period 2 (12-14 Days)||1||
48095167|NCT01641692|100556273|FG006|NOT COMPLETED|Washout Period 2 (12-14 Days)||1||
48095168|NCT01641692|100556274|FG007|NOT COMPLETED|Washout Period 2 (12-14 Days)||1||
48259295|NCT02171130|100955075|FG000|STARTED|Overall Study||129||
48387567|NCT02392494|101276848|FG001|COMPLETED|Overall Study||3||
48387568|NCT02392494|101276849|FG002|COMPLETED|Overall Study||3||
48387569|NCT02392494|101276850|FG003|COMPLETED|Overall Study||0||
48387570|NCT02392494|101276847|FG000|NOT COMPLETED|Overall Study||0||
48387571|NCT02392494|101276848|FG001|NOT COMPLETED|Overall Study||0||
48387572|NCT02392494|101276849|FG002|NOT COMPLETED|Overall Study||0||
48387573|NCT02392494|101276850|FG003|NOT COMPLETED|Overall Study||0||
48689222|NCT05005273|102022636|FG001|NOT COMPLETED|Overall Study||0||
48689223|NCT00603941|102022637|FG000|STARTED|Overall Study||7||
48689224|NCT00603941|102022638|FG001|STARTED|Overall Study||10||
48689225|NCT00603941|102022639|FG002|STARTED|Overall Study||2||
48689226|NCT00603941|102022637|FG000|COMPLETED|Overall Study||0||
48259296|NCT02171130|100955075|FG000|Received at Least One Dose of Study Drug|Overall Study||87||
48259297|NCT02171130|100955075|FG000|Experienced Hypoglycemic Event|Overall Study||87||
48259298|NCT02171130|100955075|FG000|COMPLETED|Overall Study||101||
48259299|NCT02171130|100955075|FG000|NOT COMPLETED|Overall Study||28||
48259300|NCT01376297|100955076|FG000|STARTED|Overall Study||309||
48259301|NCT01376297|100955077|FG001|STARTED|Overall Study||104||
48259302|NCT01376297|100955076|FG000|COMPLETED|Overall Study||181||
48259303|NCT01376297|100955077|FG001|COMPLETED|Overall Study||55||
48259304|NCT01376297|100955076|FG000|NOT COMPLETED|Overall Study||128||
48259305|NCT01376297|100955077|FG001|NOT COMPLETED|Overall Study||49||
48259306|NCT01640171|100955078|FG000|STARTED|Overall Study||57||
48259307|NCT01640171|100955078|FG000|COMPLETED|Overall Study||57||
48259308|NCT01640171|100955078|FG000|NOT COMPLETED|Overall Study||0||
48259309|NCT02561806|100955079|FG000|STARTED|Induction Period||166||
48259310|NCT02561806|100955080|FG001|STARTED|Induction Period||136||
48259311|NCT02561806|100955079|FG000|Received At Least One Dose of Study Drug|Induction Period||166||
48259312|NCT02561806|100955080|FG001|Received At Least One Dose of Study Drug|Induction Period||135||
48259313|NCT02561806|100955079|FG000|COMPLETED|Induction Period||164||
48259314|NCT02561806|100955080|FG001|COMPLETED|Induction Period||131||
48387574|NCT01204697|101276851|FG000|STARTED|Overall Study||36||
48387575|NCT01204697|101276852|FG001|STARTED|Overall Study||38||
48387576|NCT01204697|101276851|FG000|Treated|Overall Study||36||
48387577|NCT01204697|101276852|FG001|Treated|Overall Study||37||
48387578|NCT01204697|101276851|FG000|COMPLETED|Overall Study||5||
48387579|NCT01204697|101276852|FG001|COMPLETED|Overall Study||2||
48387580|NCT01204697|101276851|FG000|NOT COMPLETED|Overall Study||31||
48387581|NCT01204697|101276852|FG001|NOT COMPLETED|Overall Study||36||
48387582|NCT02326467|101276853|FG000|STARTED|Overall Study||10||
48387583|NCT02326467|101276853|FG000|COMPLETED|Overall Study||9||
48387584|NCT02326467|101276853|FG000|NOT COMPLETED|Overall Study||1||
48387585|NCT02407041|101276854|FG000|STARTED|Overall Study||5||
48387586|NCT02407041|101276854|FG000|COMPLETED|Overall Study||5||
48387587|NCT02407041|101276854|FG000|NOT COMPLETED|Overall Study||0||
48387588|NCT02396342|101276855|FG000|STARTED|Overall Study||5||
48259315|NCT02561806|100955079|FG000|NOT COMPLETED|Induction Period||2||
48259316|NCT02561806|100955080|FG001|NOT COMPLETED|Induction Period||5||
48259317|NCT02561806|100955079|FG000|STARTED|Maintenance Period||164||
48259318|NCT02561806|100955080|FG001|STARTED|Maintenance Period||131||
48259319|NCT02561806|100955079|FG000|COMPLETED|Maintenance Period||151||
48259320|NCT02561806|100955080|FG001|COMPLETED|Maintenance Period||123||
48387589|NCT02396342|101276856|FG001|STARTED|Overall Study||5||
48689227|NCT00603941|102022638|FG001|COMPLETED|Overall Study||0||
48689228|NCT00603941|102022639|FG002|COMPLETED|Overall Study||0||
48689229|NCT00603941|102022637|FG000|NOT COMPLETED|Overall Study||7||
48259321|NCT02561806|100955079|FG000|NOT COMPLETED|Maintenance Period||13||
48259322|NCT02561806|100955080|FG001|NOT COMPLETED|Maintenance Period||8||
48387590|NCT02396342|101276855|FG000|COMPLETED|Overall Study||5||
48387591|NCT02396342|101276856|FG001|COMPLETED|Overall Study||5||
48387592|NCT02396342|101276855|FG000|NOT COMPLETED|Overall Study||0||
48689230|NCT00603941|102022638|FG001|NOT COMPLETED|Overall Study||10||
48387593|NCT02396342|101276856|FG001|NOT COMPLETED|Overall Study||0||
48387594|NCT00868166|101276857|FG000|STARTED|Overall Study||259||
48387595|NCT00868166|101276858|FG001|STARTED|Overall Study||253||
48387596|NCT00868166|101276857|FG000|COMPLETED|Overall Study||147||
48387597|NCT00868166|101276858|FG001|COMPLETED|Overall Study||139||
48387598|NCT00868166|101276857|FG000|NOT COMPLETED|Overall Study||112||
48387599|NCT00868166|101276858|FG001|NOT COMPLETED|Overall Study||114||
48387600|NCT03828149|101276859|FG000|STARTED|First Intervention (Single Dose)||9||
48387601|NCT03828149|101276860|FG001|STARTED|First Intervention (Single Dose)||8||
48387602|NCT03828149|101276859|FG000|COMPLETED|First Intervention (Single Dose)||9||
48387603|NCT03828149|101276860|FG001|COMPLETED|First Intervention (Single Dose)||8||
48387604|NCT03828149|101276859|FG000|NOT COMPLETED|First Intervention (Single Dose)||0||
48387605|NCT03828149|101276860|FG001|NOT COMPLETED|First Intervention (Single Dose)||0||
48387606|NCT03828149|101276859|FG000|STARTED|Washout (6 Days)||9||
48387607|NCT03828149|101276860|FG001|STARTED|Washout (6 Days)||8||
48387608|NCT03828149|101276859|FG000|COMPLETED|Washout (6 Days)||9||
48387609|NCT03828149|101276860|FG001|COMPLETED|Washout (6 Days)||8||
48387610|NCT03828149|101276859|FG000|NOT COMPLETED|Washout (6 Days)||0||
48387611|NCT03828149|101276860|FG001|NOT COMPLETED|Washout (6 Days)||0||
48387612|NCT03828149|101276859|FG000|STARTED|Second Intervention (Single Dose)||9||
48387613|NCT03828149|101276860|FG001|STARTED|Second Intervention (Single Dose)||8||
48387614|NCT03828149|101276859|FG000|COMPLETED|Second Intervention (Single Dose)||9||
48387615|NCT03828149|101276860|FG001|COMPLETED|Second Intervention (Single Dose)||8||
48387616|NCT03828149|101276859|FG000|NOT COMPLETED|Second Intervention (Single Dose)||0||
48689231|NCT00603941|102022639|FG002|NOT COMPLETED|Overall Study||2||
48689232|NCT01553292|102022640|FG000|STARTED|Overall Study||21||
48689233|NCT01553292|102022640|FG000|COMPLETED|Overall Study||21||
48689234|NCT01553292|102022640|FG000|NOT COMPLETED|Overall Study||0||
48689235|NCT04703192|102022641|FG000|STARTED|Overall Study||133||
48689236|NCT04703192|102022642|FG001|STARTED|Overall Study||22||
48689237|NCT04703192|102022641|FG000|COMPLETED|Overall Study||32|Completed = Participants with Ongoing Treatment. Not Completed = Participants who Discontinued Treatment|
48689238|NCT04703192|102022642|FG001|COMPLETED|Overall Study||2|Completed = Participants with Ongoing Treatment. Not Completed = Participants who Discontinued Treatment|
48689239|NCT04703192|102022641|FG000|NOT COMPLETED|Overall Study||101||
48387617|NCT03828149|101276860|FG001|NOT COMPLETED|Second Intervention (Single Dose)||0||
48387618|NCT02709083|101276861|FG000|STARTED|Overall Study||7||
48387619|NCT02709083|101276861|FG000|COMPLETED|Overall Study||0||
48387620|NCT02709083|101276861|FG000|NOT COMPLETED|Overall Study||7||
48387621|NCT04532918|101276862|FG000|STARTED|Overall Study||14||
48387622|NCT04532918|101276862|FG000|COMPLETED|Overall Study||14||
48387623|NCT04532918|101276862|FG000|NOT COMPLETED|Overall Study||0||
48387624|NCT01205451|101279375|FG000|STARTED|Overall Study||53||
48387625|NCT01205451|101279376|FG001|STARTED|Overall Study||56||
48387626|NCT01205451|101279375|FG000|COMPLETED|Overall Study||47||
48387627|NCT01205451|101279376|FG001|COMPLETED|Overall Study||46||
48387628|NCT01205451|101279375|FG000|NOT COMPLETED|Overall Study||6||
48387629|NCT01205451|101279376|FG001|NOT COMPLETED|Overall Study||10||
48387630|NCT02919683|101279377|FG000|STARTED|Pre-Surgery Intervention||15||
48689240|NCT04703192|102022642|FG001|NOT COMPLETED|Overall Study||20||
48387631|NCT02919683|101279378|FG001|STARTED|Pre-Surgery Intervention||15||
48387632|NCT02919683|101279377|FG000|COMPLETED|Pre-Surgery Intervention||15||
48387633|NCT02919683|101279378|FG001|COMPLETED|Pre-Surgery Intervention||15||
48387634|NCT02919683|101279377|FG000|NOT COMPLETED|Pre-Surgery Intervention||0||
48387635|NCT02919683|101279378|FG001|NOT COMPLETED|Pre-Surgery Intervention||0||
48387636|NCT02919683|101279377|FG000|STARTED|Post-Surgery Follow-Up||15||
48387637|NCT02919683|101279378|FG001|STARTED|Post-Surgery Follow-Up||15||
48387638|NCT02919683|101279377|FG000|COMPLETED|Post-Surgery Follow-Up||12||
48387639|NCT02919683|101279378|FG001|COMPLETED|Post-Surgery Follow-Up||13||
48387640|NCT02919683|101279377|FG000|NOT COMPLETED|Post-Surgery Follow-Up||3||
48387641|NCT02919683|101279378|FG001|NOT COMPLETED|Post-Surgery Follow-Up||2||
48387642|NCT02207556|101279379|FG000|STARTED|Overall Study||7||
48387643|NCT02207556|101279380|FG001|STARTED|Overall Study||25||
48387644|NCT02207556|101279379|FG000|COMPLETED|Overall Study||5||
48387645|NCT02207556|101279380|FG001|COMPLETED|Overall Study||20||
48387646|NCT02207556|101279379|FG000|NOT COMPLETED|Overall Study||2||
48387647|NCT02207556|101279380|FG001|NOT COMPLETED|Overall Study||5||
48387648|NCT00576251|101279381|FG000|STARTED|Overall Study||109||
48387649|NCT00576251|101279382|FG001|STARTED|Overall Study||112||
48387650|NCT00576251|101279381|FG000|COMPLETED|Overall Study||108||
48689241|NCT02749201|102022643|FG000|STARTED|Overall Study||10||
48689242|NCT02749201|102022643|FG000|COMPLETED|Overall Study||10||
48689243|NCT02749201|102022643|FG000|NOT COMPLETED|Overall Study||0||
48689244|NCT01976871|102022644|FG000|STARTED|Overall Study||21||
48689245|NCT01976871|102022644|FG000|COMPLETED|Overall Study||20||
48689246|NCT01976871|102022644|FG000|NOT COMPLETED|Overall Study||1||
48387651|NCT00576251|101279382|FG001|COMPLETED|Overall Study||111||
48387652|NCT00576251|101279381|FG000|NOT COMPLETED|Overall Study||1||
48387653|NCT00576251|101279382|FG001|NOT COMPLETED|Overall Study||1||
48387654|NCT03954444|101279383|FG000|STARTED|Overall Study||379||
48689247|NCT04918381|102022645|FG000|STARTED|Overall Study||30||37
48689248|NCT04918381|102022645|FG000|COMPLETED|Overall Study||30||37
48689249|NCT04918381|102022645|FG000|NOT COMPLETED|Overall Study||0||0
48259323|NCT02561806|100955079|FG000|STARTED|Post-Treatment Follow-up||157||
48259324|NCT02561806|100955080|FG001|STARTED|Post-Treatment Follow-up||60||
48259325|NCT02561806|100955079|FG000|COMPLETED|Post-Treatment Follow-up||155||
48259326|NCT02561806|100955080|FG001|COMPLETED|Post-Treatment Follow-up||59||
48259327|NCT02561806|100955079|FG000|NOT COMPLETED|Post-Treatment Follow-up||2||
48259328|NCT02561806|100955080|FG001|NOT COMPLETED|Post-Treatment Follow-up||1||
48259329|NCT02484664|100955081|FG000|STARTED|Overall Study||12||
48259330|NCT02484664|100955081|FG000|COMPLETED|Overall Study||9||
48259331|NCT02484664|100955081|FG000|NOT COMPLETED|Overall Study||3||
48259332|NCT00736125|100955082|FG000|STARTED|Overall Study||10||
48259333|NCT00736125|100955083|FG001|STARTED|Overall Study||10||
48259334|NCT00736125|100955082|FG000|COMPLETED|Overall Study||9||
48259335|NCT00736125|100955083|FG001|COMPLETED|Overall Study||8||
48259336|NCT00736125|100955082|FG000|NOT COMPLETED|Overall Study||1||
48259337|NCT00736125|100955083|FG001|NOT COMPLETED|Overall Study||2||
48259338|NCT01192776|100955084|FG000|STARTED|Overall Study||95||
48259339|NCT01192776|100955085|FG001|STARTED|Overall Study||90||
48259340|NCT01192776|100955086|FG002|STARTED|Overall Study||96||
48259341|NCT01192776|100955087|FG003|STARTED|Overall Study||83||
48259342|NCT01192776|100955084|FG000|Died Prior to Discharge|Overall Study||7||
48259343|NCT01192776|100955085|FG001|Died Prior to Discharge|Overall Study||13||
48259344|NCT01192776|100955086|FG002|Died Prior to Discharge|Overall Study||15||
48259345|NCT01192776|100955087|FG003|Died Prior to Discharge|Overall Study||14||
48259346|NCT01192776|100955084|FG000|Died After Discharge|Overall Study||1||
48259347|NCT01192776|100955085|FG001|Died After Discharge|Overall Study||2||
48259348|NCT01192776|100955086|FG002|Died After Discharge|Overall Study||3||
48259349|NCT01192776|100955087|FG003|Died After Discharge|Overall Study||1||
48259350|NCT01192776|100955084|FG000|COMPLETED|Overall Study||84||
48259351|NCT01192776|100955085|FG001|COMPLETED|Overall Study||69||
48259352|NCT01192776|100955086|FG002|COMPLETED|Overall Study||75||
48259353|NCT01192776|100955087|FG003|COMPLETED|Overall Study||63||
48259354|NCT01192776|100955084|FG000|NOT COMPLETED|Overall Study||11||
48259355|NCT01192776|100955085|FG001|NOT COMPLETED|Overall Study||21||
48259356|NCT01192776|100955086|FG002|NOT COMPLETED|Overall Study||21||
48259357|NCT01192776|100955087|FG003|NOT COMPLETED|Overall Study||20||
48259358|NCT00085566|100955088|FG000|STARTED|Overall Study||3||
48259359|NCT00085566|100955089|FG001|STARTED|Overall Study||3||
48259360|NCT00085566|100955090|FG002|STARTED|Overall Study||57||
48259361|NCT00085566|100955088|FG000|COMPLETED|Overall Study||3||
48259362|NCT00085566|100955089|FG001|COMPLETED|Overall Study||3||
48259363|NCT00085566|100955090|FG002|COMPLETED|Overall Study||43||
48259364|NCT00085566|100955088|FG000|NOT COMPLETED|Overall Study||0||
48259365|NCT00085566|100955089|FG001|NOT COMPLETED|Overall Study||0||
48259366|NCT00085566|100955090|FG002|NOT COMPLETED|Overall Study||14||
48259367|NCT01587118|100955091|FG000|STARTED|Overall Study||18||
48259368|NCT01587118|100955091|FG000|COMPLETED|Overall Study||11||
48259369|NCT01587118|100955091|FG000|NOT COMPLETED|Overall Study||7||
48259370|NCT00778921|100955092|FG000|STARTED|Overall Study||279||
48259371|NCT00778921|100955093|FG001|STARTED|Overall Study||285||
48259372|NCT00778921|100955094|FG002|STARTED|Overall Study||283||
48259373|NCT00778921|100955092|FG000|COMPLETED|Overall Study||261||
48259374|NCT00778921|100955093|FG001|COMPLETED|Overall Study||266||
48259375|NCT00778921|100955094|FG002|COMPLETED|Overall Study||255||
48259376|NCT00778921|100955092|FG000|NOT COMPLETED|Overall Study||18||
48259377|NCT00778921|100955093|FG001|NOT COMPLETED|Overall Study||19||
48259378|NCT00778921|100955094|FG002|NOT COMPLETED|Overall Study||28||
48689250|NCT03462758|102022646|FG000|STARTED|Overall Study||201||
48259379|NCT03845075|100955095|FG000|STARTED|Part 1 - DB||14||
48259380|NCT03845075|100955096|FG001|STARTED|Part 1 - DB||8||
48259381|NCT03845075|100955097|FG002|STARTED|Part 1 - DB||0||
48259382|NCT03845075|100955098|FG003|STARTED|Part 1 - DB||0||
48259383|NCT03845075|100955095|FG000|COMPLETED|Part 1 - DB||12||
48259384|NCT03845075|100955096|FG001|COMPLETED|Part 1 - DB||6||
48259385|NCT03845075|100955097|FG002|COMPLETED|Part 1 - DB||0||
48259386|NCT03845075|100955098|FG003|COMPLETED|Part 1 - DB||0||
48259387|NCT03845075|100955095|FG000|NOT COMPLETED|Part 1 - DB||2||
48259388|NCT03845075|100955096|FG001|NOT COMPLETED|Part 1 - DB||2||
48259389|NCT03845075|100955097|FG002|NOT COMPLETED|Part 1 - DB||0||
48259390|NCT03845075|100955098|FG003|NOT COMPLETED|Part 1 - DB||0||
48259391|NCT03845075|100955095|FG000|STARTED|Part 2 - OLE||0||
48259392|NCT03845075|100955096|FG001|STARTED|Part 2 - OLE||0||
48259393|NCT03845075|100955097|FG002|STARTED|Part 2 - OLE||12||
48259394|NCT03845075|100955098|FG003|STARTED|Part 2 - OLE||6||
48259395|NCT03845075|100955095|FG000|COMPLETED|Part 2 - OLE||0||
48689251|NCT03462758|102022647|FG001|STARTED|Overall Study||203||
48689252|NCT03462758|102022646|FG000|COMPLETED|Overall Study||145||
48387655|NCT03954444|101279384|FG001|STARTED|Overall Study||382||
48387656|NCT03954444|101279385|FG002|STARTED|Overall Study||344||
48387657|NCT03954444|101279383|FG000|COMPLETED|Overall Study||366||
48387658|NCT03954444|101279384|FG001|COMPLETED|Overall Study||366||
48387659|NCT03954444|101279385|FG002|COMPLETED|Overall Study||327||
48387660|NCT03954444|101279383|FG000|NOT COMPLETED|Overall Study||13||
48387661|NCT03954444|101279384|FG001|NOT COMPLETED|Overall Study||16||
48387662|NCT03954444|101279385|FG002|NOT COMPLETED|Overall Study||17||
48689253|NCT03462758|102022647|FG001|COMPLETED|Overall Study||149||
48689254|NCT03462758|102022646|FG000|NOT COMPLETED|Overall Study||56||
48689255|NCT03462758|102022647|FG001|NOT COMPLETED|Overall Study||54||
48689256|NCT01970241|102022648|FG000|STARTED|Overall Study||46||
48689257|NCT01970241|102022649|FG001|STARTED|Overall Study||39||
48259396|NCT03845075|100955096|FG001|COMPLETED|Part 2 - OLE||0||
48259397|NCT03845075|100955097|FG002|COMPLETED|Part 2 - OLE||12||
48259398|NCT03845075|100955098|FG003|COMPLETED|Part 2 - OLE||6||
48259399|NCT03845075|100955095|FG000|NOT COMPLETED|Part 2 - OLE||0||
48259400|NCT03845075|100955096|FG001|NOT COMPLETED|Part 2 - OLE||0||
48259401|NCT03845075|100955097|FG002|NOT COMPLETED|Part 2 - OLE||0||
48259402|NCT03845075|100955098|FG003|NOT COMPLETED|Part 2 - OLE||0||
48259403|NCT00723125|100955099|FG000|STARTED|Overall Study||33||
48259404|NCT00723125|100955100|FG001|STARTED|Overall Study||27||
48259405|NCT00723125|100955099|FG000|COMPLETED|Overall Study||15||
48259406|NCT00723125|100955100|FG001|COMPLETED|Overall Study||21||
48259407|NCT00723125|100955099|FG000|NOT COMPLETED|Overall Study||18||
48259408|NCT00723125|100955100|FG001|NOT COMPLETED|Overall Study||6||
48259409|NCT00381797|100955101|FG000|STARTED|Overall Study||18||
48259410|NCT00381797|100955102|FG001|STARTED|Overall Study||17||
48259411|NCT00381797|100955103|FG002|STARTED|Overall Study||10||
48259412|NCT00381797|100955104|FG003|STARTED|Overall Study||15||
48259413|NCT00381797|100955105|FG004|STARTED|Overall Study||37||
48259414|NCT00381797|100955101|FG000|COMPLETED|Overall Study||17||
48259415|NCT00381797|100955102|FG001|COMPLETED|Overall Study||16||
48387663|NCT01738737|101279386|FG000|STARTED|Overall Study||29||
48387664|NCT01738737|101279387|FG001|STARTED|Overall Study||29||
48387665|NCT01738737|101279388|FG002|STARTED|Overall Study||29||
48387666|NCT01738737|101279389|FG003|STARTED|Overall Study||29||
48387667|NCT01738737|101279390|FG004|STARTED|Overall Study||29||
48387668|NCT01738737|101279386|FG000|COMPLETED|Overall Study||25||
48387669|NCT01738737|101279387|FG001|COMPLETED|Overall Study||25||
48387670|NCT01738737|101279388|FG002|COMPLETED|Overall Study||25||
48689258|NCT01970241|102022648|FG000|COMPLETED|Overall Study||29||
48689259|NCT01970241|102022649|FG001|COMPLETED|Overall Study||31||
48689260|NCT01970241|102022648|FG000|NOT COMPLETED|Overall Study||17||
48689261|NCT01970241|102022649|FG001|NOT COMPLETED|Overall Study||8||
48095169|NCT01641692|100556267|FG000|STARTED|Treatment Period 3||43||
48095170|NCT01641692|100556268|FG001|STARTED|Treatment Period 3||33||
48095171|NCT01641692|100556269|FG002|STARTED|Treatment Period 3||38||
48095172|NCT01641692|100556270|FG003|STARTED|Treatment Period 3||42||
48095173|NCT01641692|100556271|FG004|STARTED|Treatment Period 3||40||
48095174|NCT01641692|100556272|FG005|STARTED|Treatment Period 3||39||
48095175|NCT01641692|100556273|FG006|STARTED|Treatment Period 3||35||
48095176|NCT01641692|100556274|FG007|STARTED|Treatment Period 3||38||
48095177|NCT01641692|100556267|FG000|COMPLETED|Treatment Period 3||43||
48095178|NCT01641692|100556268|FG001|COMPLETED|Treatment Period 3||32||
48095179|NCT01641692|100556269|FG002|COMPLETED|Treatment Period 3||37||
48095180|NCT01641692|100556270|FG003|COMPLETED|Treatment Period 3||42||
48095181|NCT01641692|100556271|FG004|COMPLETED|Treatment Period 3||40||
48095182|NCT01641692|100556272|FG005|COMPLETED|Treatment Period 3||39||
48095183|NCT01641692|100556273|FG006|COMPLETED|Treatment Period 3||33||
48095184|NCT01641692|100556274|FG007|COMPLETED|Treatment Period 3||38||
48095185|NCT01641692|100556267|FG000|NOT COMPLETED|Treatment Period 3||0||
48095186|NCT01641692|100556268|FG001|NOT COMPLETED|Treatment Period 3||1||
48095187|NCT01641692|100556269|FG002|NOT COMPLETED|Treatment Period 3||1||
48095188|NCT01641692|100556270|FG003|NOT COMPLETED|Treatment Period 3||0||
48259416|NCT00381797|100955103|FG002|COMPLETED|Overall Study||10||
48259417|NCT00381797|100955104|FG003|COMPLETED|Overall Study||14||
48259418|NCT00381797|100955105|FG004|COMPLETED|Overall Study||35||
48689262|NCT03674970|102022650|FG000|STARTED|Overall Study||15||
48689263|NCT03674970|102022651|FG001|STARTED|Overall Study||15||
48689264|NCT03674970|102022652|FG002|STARTED|Overall Study||15||
48689265|NCT03674970|102022650|FG000|COMPLETED|Overall Study||12||
48689266|NCT03674970|102022651|FG001|COMPLETED|Overall Study||8||
48689267|NCT03674970|102022652|FG002|COMPLETED|Overall Study||12||
48689268|NCT03674970|102022650|FG000|NOT COMPLETED|Overall Study||3||
48689269|NCT03674970|102022651|FG001|NOT COMPLETED|Overall Study||7||
48689270|NCT03674970|102022652|FG002|NOT COMPLETED|Overall Study||3||
48095189|NCT01641692|100556271|FG004|NOT COMPLETED|Treatment Period 3||0||
48095190|NCT01641692|100556272|FG005|NOT COMPLETED|Treatment Period 3||0||
48259419|NCT00381797|100955101|FG000|NOT COMPLETED|Overall Study||1||
48387671|NCT01738737|101279389|FG003|COMPLETED|Overall Study||25||
48387672|NCT01738737|101279390|FG004|COMPLETED|Overall Study||25||
48387673|NCT01738737|101279386|FG000|NOT COMPLETED|Overall Study||4||
48259420|NCT00381797|100955102|FG001|NOT COMPLETED|Overall Study||1||
48259421|NCT00381797|100955103|FG002|NOT COMPLETED|Overall Study||0||
48259422|NCT00381797|100955104|FG003|NOT COMPLETED|Overall Study||1||
48259423|NCT00381797|100955105|FG004|NOT COMPLETED|Overall Study||2||
48259424|NCT00832000|100955106|FG000|STARTED|Overall Study||29||
48259425|NCT00832000|100955107|FG001|STARTED|Overall Study||30||
48259426|NCT00832000|100955106|FG000|Crossed Over to Opposite Intervention|Overall Study||25||
48259427|NCT00832000|100955107|FG001|Crossed Over to Opposite Intervention|Overall Study||29||
48259428|NCT00832000|100955106|FG000|COMPLETED|Overall Study||23||
48259429|NCT00832000|100955107|FG001|COMPLETED|Overall Study||29||
48259430|NCT00832000|100955106|FG000|NOT COMPLETED|Overall Study||6||
48259431|NCT00832000|100955107|FG001|NOT COMPLETED|Overall Study||1||
48259432|NCT00983905|100955108|FG000|STARTED|Theophylline Alone||30||
48259433|NCT00983905|100955108|FG000|COMPLETED|Theophylline Alone||29||
48259434|NCT00983905|100955108|FG000|NOT COMPLETED|Theophylline Alone||1||
48259435|NCT00983905|100955108|FG000|STARTED|4 Day Washout Period||29||
48259436|NCT00983905|100955108|FG000|COMPLETED|4 Day Washout Period||29||
48259437|NCT00983905|100955108|FG000|NOT COMPLETED|4 Day Washout Period||0||
48259438|NCT00983905|100955108|FG000|STARTED|Colchicine Alone||29||
48259439|NCT00983905|100955108|FG000|COMPLETED|Colchicine Alone||27||
48259440|NCT00983905|100955108|FG000|NOT COMPLETED|Colchicine Alone||2||
48259441|NCT00983905|100955108|FG000|STARTED|Theophylline With Colchicine||27||
48259442|NCT00983905|100955108|FG000|COMPLETED|Theophylline With Colchicine||27||
48259443|NCT00983905|100955108|FG000|NOT COMPLETED|Theophylline With Colchicine||0||
48259444|NCT01006616|100955109|FG000|STARTED|Period 1 (6 Months)||152||
48259445|NCT01006616|100955110|FG001|STARTED|Period 1 (6 Months)||156||
48259446|NCT01006616|100955111|FG002|STARTED|Period 1 (6 Months)||153||
48259447|NCT01006616|100955112|FG003|STARTED|Period 1 (6 Months)||155||
48259448|NCT01006616|100955109|FG000|Treated|Period 1 (6 Months)||152||
48259449|NCT01006616|100955110|FG001|Treated|Period 1 (6 Months)||156||
48259450|NCT01006616|100955111|FG002|Treated|Period 1 (6 Months)||152||
48259451|NCT01006616|100955112|FG003|Treated|Period 1 (6 Months)||154||
48259452|NCT01006616|100955109|FG000|COMPLETED|Period 1 (6 Months)||126||
48259453|NCT01006616|100955110|FG001|COMPLETED|Period 1 (6 Months)||102||
48259454|NCT01006616|100955111|FG002|COMPLETED|Period 1 (6 Months)||102||
48259455|NCT01006616|100955112|FG003|COMPLETED|Period 1 (6 Months)||128||
48259456|NCT01006616|100955109|FG000|NOT COMPLETED|Period 1 (6 Months)||26||
48259457|NCT01006616|100955110|FG001|NOT COMPLETED|Period 1 (6 Months)||54||
48259458|NCT01006616|100955111|FG002|NOT COMPLETED|Period 1 (6 Months)||51||
48259459|NCT01006616|100955112|FG003|NOT COMPLETED|Period 1 (6 Months)||27||
48259460|NCT01006616|100955109|FG000|STARTED|Period 2 (18 Months)||75||
48259461|NCT01006616|100955110|FG001|STARTED|Period 2 (18 Months)||63||
48259462|NCT01006616|100955111|FG002|STARTED|Period 2 (18 Months)||55||
48259463|NCT01006616|100955112|FG003|STARTED|Period 2 (18 Months)||82||
48259464|NCT01006616|100955109|FG000|Treated|Period 2 (18 Months)||75||
48259465|NCT01006616|100955110|FG001|Treated|Period 2 (18 Months)||63||
48387674|NCT01738737|101279387|FG001|NOT COMPLETED|Overall Study||4||
48387675|NCT01738737|101279388|FG002|NOT COMPLETED|Overall Study||4||
48387676|NCT01738737|101279389|FG003|NOT COMPLETED|Overall Study||4||
48387677|NCT01738737|101279390|FG004|NOT COMPLETED|Overall Study||4||
48387678|NCT02180217|101279391|FG000|STARTED|Overall Study||36||
48387679|NCT02180217|101279392|FG001|STARTED|Overall Study||35||
48387680|NCT02180217|101279393|FG002|STARTED|Overall Study||66||
48259466|NCT01006616|100955111|FG002|Treated|Period 2 (18 Months)||55||
48259467|NCT01006616|100955112|FG003|Treated|Period 2 (18 Months)||82||
48259468|NCT01006616|100955109|FG000|COMPLETED|Period 2 (18 Months)||0||
48259469|NCT01006616|100955110|FG001|COMPLETED|Period 2 (18 Months)||0||
48259470|NCT01006616|100955111|FG002|COMPLETED|Period 2 (18 Months)||0||
48259471|NCT01006616|100955112|FG003|COMPLETED|Period 2 (18 Months)||0||
48259472|NCT01006616|100955109|FG000|NOT COMPLETED|Period 2 (18 Months)||75||
48259473|NCT01006616|100955110|FG001|NOT COMPLETED|Period 2 (18 Months)||63||
48259474|NCT01006616|100955111|FG002|NOT COMPLETED|Period 2 (18 Months)||55||
48259475|NCT01006616|100955112|FG003|NOT COMPLETED|Period 2 (18 Months)||82||
48259476|NCT03636373|100955113|FG000|STARTED|Overall Study||3||
48259477|NCT03636373|100955114|FG001|STARTED|Overall Study||2||
48259478|NCT03636373|100955113|FG000|COMPLETED|Overall Study||2||
48259479|NCT03636373|100955114|FG001|COMPLETED|Overall Study||2||
48259480|NCT03636373|100955113|FG000|NOT COMPLETED|Overall Study||1||
48387681|NCT02180217|101279391|FG000|Discontinued at/Prior to Week 12 (W12)|Overall Study||0||
48387682|NCT02180217|101279392|FG001|Discontinued at/Prior to Week 12 (W12)|Overall Study||0||
48387683|NCT02180217|101279393|FG002|Discontinued at/Prior to Week 12 (W12)|Overall Study||7||
48259481|NCT03636373|100955114|FG001|NOT COMPLETED|Overall Study||0||
48259482|NCT00490945|100955115|FG000|STARTED|Overall Study||8||
48259483|NCT00490945|100955116|FG001|STARTED|Overall Study||9||
48259484|NCT00490945|100955117|FG002|STARTED|Overall Study||8||
48259485|NCT00490945|100955118|FG003|STARTED|Overall Study||7||
48259486|NCT00490945|100955119|FG004|STARTED|Overall Study||7||
48259487|NCT00490945|100955115|FG000|COMPLETED|Overall Study||8||
48259488|NCT00490945|100955116|FG001|COMPLETED|Overall Study||8||
48387684|NCT02180217|101279391|FG000|Discont. at/Prior to W26 But After W12|Overall Study||0||
48259489|NCT00490945|100955117|FG002|COMPLETED|Overall Study||8||
48259490|NCT00490945|100955118|FG003|COMPLETED|Overall Study||7||
48259491|NCT00490945|100955119|FG004|COMPLETED|Overall Study||7||
48259492|NCT00490945|100955115|FG000|NOT COMPLETED|Overall Study||0||
48259493|NCT00490945|100955116|FG001|NOT COMPLETED|Overall Study||1||
48259494|NCT00490945|100955117|FG002|NOT COMPLETED|Overall Study||0||
48259495|NCT00490945|100955118|FG003|NOT COMPLETED|Overall Study||0||
48259496|NCT00490945|100955119|FG004|NOT COMPLETED|Overall Study||0||
48259497|NCT00992719|100955120|FG000|STARTED|Overall Study||28||
48259498|NCT00992719|100955121|FG001|STARTED|Overall Study||28||
48259499|NCT00992719|100955122|FG002|STARTED|Overall Study||28||
48387685|NCT02180217|101279392|FG001|Discont. at/Prior to W26 But After W12|Overall Study||0||
48387686|NCT02180217|101279393|FG002|Discont. at/Prior to W26 But After W12|Overall Study||12||
48387687|NCT02180217|101279391|FG000|Discontinued Prior to W48 But After W26|Overall Study||0||
48387688|NCT02180217|101279392|FG001|Discontinued Prior to W48 But After W26|Overall Study||2||
48387689|NCT02180217|101279393|FG002|Discontinued Prior to W48 But After W26|Overall Study||3||
48387690|NCT02180217|101279391|FG000|Completed Week 48 (Core Phase)|Overall Study||36||
48259500|NCT00992719|100955120|FG000|COMPLETED|Overall Study||27||
48259501|NCT00992719|100955121|FG001|COMPLETED|Overall Study||27||
48259502|NCT00992719|100955122|FG002|COMPLETED|Overall Study||28||
48387691|NCT02180217|101279392|FG001|Completed Week 48 (Core Phase)|Overall Study||33||
48387692|NCT02180217|101279393|FG002|Completed Week 48 (Core Phase)|Overall Study||44||
48387693|NCT02180217|101279391|FG000|Completed W48, Did Not Enter Ext. Phase|Overall Study||1||
48387694|NCT02180217|101279392|FG001|Completed W48, Did Not Enter Ext. Phase|Overall Study||3||
48387695|NCT02180217|101279393|FG002|Completed W48, Did Not Enter Ext. Phase|Overall Study||3||
48387696|NCT02180217|101279391|FG000|Completed W48, Entered Ext. Phase|Overall Study||35||
48387697|NCT02180217|101279392|FG001|Completed W48, Entered Ext. Phase|Overall Study||30||
48387698|NCT02180217|101279393|FG002|Completed W48, Entered Ext. Phase|Overall Study||41||
48387699|NCT02180217|101279391|FG000|Discontinued Extension Phase|Overall Study||12||
48387700|NCT02180217|101279392|FG001|Discontinued Extension Phase|Overall Study||6||
48387701|NCT02180217|101279393|FG002|Discontinued Extension Phase|Overall Study||16||
48387702|NCT02180217|101279391|FG000|Completed Ext. Phase|Overall Study||23||
48387703|NCT02180217|101279392|FG001|Completed Ext. Phase|Overall Study||24||
48387704|NCT02180217|101279393|FG002|Completed Ext. Phase|Overall Study||25||
48387705|NCT02180217|101279391|FG000|COMPLETED|Overall Study||24|Completed = Completed Core/Extension Phase|
48387706|NCT02180217|101279392|FG001|COMPLETED|Overall Study||27|Completed = Completed Core/Extension Phase|
48387707|NCT02180217|101279393|FG002|COMPLETED|Overall Study||28|Completed = Completed Core/Extension Phase|
48387708|NCT02180217|101279391|FG000|NOT COMPLETED|Overall Study||12||
48387709|NCT02180217|101279392|FG001|NOT COMPLETED|Overall Study||8||
48387710|NCT02180217|101279393|FG002|NOT COMPLETED|Overall Study||38||
48387711|NCT01464788|101279394|FG000|STARTED|Overall Study||30||
48387712|NCT01464788|101279395|FG001|STARTED|Overall Study||31||
48387713|NCT01464788|101279396|FG002|STARTED|Overall Study||29||
48387714|NCT01464788|101279394|FG000|COMPLETED|Overall Study||30||
48387715|NCT01464788|101279395|FG001|COMPLETED|Overall Study||29||
48387716|NCT01464788|101279396|FG002|COMPLETED|Overall Study||29||
48387717|NCT01464788|101279394|FG000|NOT COMPLETED|Overall Study||0||
48387718|NCT01464788|101279395|FG001|NOT COMPLETED|Overall Study||2||
48387719|NCT01464788|101279396|FG002|NOT COMPLETED|Overall Study||0||
48387720|NCT00765128|101279397|FG000|STARTED|Overall Study||8||
48387721|NCT00765128|101279398|FG001|STARTED|Overall Study||9||
48387722|NCT00765128|101279397|FG000|COMPLETED|Overall Study||8||
48387723|NCT00765128|101279398|FG001|COMPLETED|Overall Study||9||
48387724|NCT00765128|101279397|FG000|NOT COMPLETED|Overall Study||0||
48387725|NCT00765128|101279398|FG001|NOT COMPLETED|Overall Study||0||
48387726|NCT02585999|101279399|FG000|STARTED|Overall Study||28||
48387727|NCT02585999|101279399|FG000|COMPLETED|Overall Study||26||
48387728|NCT02585999|101279399|FG000|NOT COMPLETED|Overall Study||2||
48387729|NCT02618343|101279400|FG000|STARTED|Overall Study||28||
48387730|NCT02618343|101279401|FG001|STARTED|Overall Study||23||
48387731|NCT02618343|101279400|FG000|COMPLETED|Overall Study||28||
48259503|NCT00992719|100955120|FG000|NOT COMPLETED|Overall Study||1||
48259504|NCT00992719|100955121|FG001|NOT COMPLETED|Overall Study||1||
48259505|NCT00992719|100955122|FG002|NOT COMPLETED|Overall Study||0||
48259506|NCT02670122|100955123|FG000|STARTED|Overall Study||131||
48259507|NCT02670122|100955123|FG000|COMPLETED|Overall Study||127||
48259508|NCT02670122|100955123|FG000|NOT COMPLETED|Overall Study||4||
48259509|NCT01547117|100955124|FG000|STARTED|Overall Study||12||
48259510|NCT01547117|100955125|FG001|STARTED|Overall Study||5||
48259511|NCT01547117|100955126|FG002|STARTED|Overall Study||10||
48259512|NCT01547117|100955127|FG003|STARTED|Overall Study||11||
48259513|NCT01547117|100955124|FG000|Phase 1 Baseline Labs|Overall Study||12||
48259514|NCT01547117|100955125|FG001|Phase 1 Baseline Labs|Overall Study||4||
48259515|NCT01547117|100955126|FG002|Phase 1 Baseline Labs|Overall Study||8||
48259516|NCT01547117|100955127|FG003|Phase 1 Baseline Labs|Overall Study||7||
48259517|NCT01547117|100955124|FG000|Phase 1-150 mEq Sodium/Day|Overall Study||12||
48387732|NCT02618343|101279401|FG001|COMPLETED|Overall Study||23||
48387733|NCT02618343|101279400|FG000|NOT COMPLETED|Overall Study||0||
48387734|NCT02618343|101279401|FG001|NOT COMPLETED|Overall Study||0||
48387735|NCT00937794|101279402|FG000|STARTED|Overall Study||33||
48387736|NCT00937794|101279402|FG000|COMPLETED|Overall Study||33||
48387737|NCT00937794|101279402|FG000|NOT COMPLETED|Overall Study||0||
48387738|NCT03794752|101279403|FG000|STARTED|Overall Study||8||
48387739|NCT03794752|101279403|FG000|COMPLETED|Overall Study||8||
48387740|NCT03794752|101279403|FG000|NOT COMPLETED|Overall Study||0||
48387741|NCT00844285|101279404|FG000|STARTED|Overall Study||1131||
48387742|NCT00844285|101279405|FG001|STARTED|Overall Study||1666||
48387743|NCT00844285|101279406|FG002|STARTED|Overall Study||275||
48387744|NCT00844285|101279404|FG000|COMPLETED|Overall Study||42||
48387745|NCT00844285|101279405|FG001|COMPLETED|Overall Study||62||
48387746|NCT00844285|101279406|FG002|COMPLETED|Overall Study||3||
48387747|NCT00844285|101279404|FG000|NOT COMPLETED|Overall Study||1089||
48387748|NCT00844285|101279405|FG001|NOT COMPLETED|Overall Study||1604||
48387749|NCT00844285|101279406|FG002|NOT COMPLETED|Overall Study||272||
48387750|NCT00433446|101279407|FG000|STARTED|Overall Study||62||
48387751|NCT00433446|101279407|FG000|Eligible|Overall Study||53||
48387752|NCT00433446|101279407|FG000|Eligible and Began Protocol Therapy|Overall Study||53||
48387753|NCT00433446|101279407|FG000|COMPLETED|Overall Study||1||
48387754|NCT00433446|101279407|FG000|NOT COMPLETED|Overall Study||61||
48387755|NCT00862654|101279408|FG000|STARTED|Overall Study||82||
48387756|NCT00862654|101279409|FG001|STARTED|Overall Study||82||
48387757|NCT00862654|101279410|FG002|STARTED|Overall Study||82||
48387758|NCT00862654|101279411|FG003|STARTED|Overall Study||80||
48387759|NCT00862654|101279408|FG000|COMPLETED|Overall Study||76||
48387760|NCT00862654|101279409|FG001|COMPLETED|Overall Study||74||
48387761|NCT00862654|101279410|FG002|COMPLETED|Overall Study||76||
48387762|NCT00862654|101279411|FG003|COMPLETED|Overall Study||74||
48387763|NCT00862654|101279408|FG000|NOT COMPLETED|Overall Study||6||
48387764|NCT00862654|101279409|FG001|NOT COMPLETED|Overall Study||8||
48387765|NCT00862654|101279410|FG002|NOT COMPLETED|Overall Study||6||
48387766|NCT00862654|101279411|FG003|NOT COMPLETED|Overall Study||6||
48387767|NCT01409993|101279412|FG000|STARTED|Overall Study||25||
48387768|NCT01409993|101279413|FG001|STARTED|Overall Study||26||
48387769|NCT01409993|101279414|FG002|STARTED|Overall Study||14||
48387770|NCT01409993|101279415|FG003|STARTED|Overall Study||13||
48387771|NCT01409993|101279412|FG000|COMPLETED|Overall Study||21||
48387772|NCT01409993|101279413|FG001|COMPLETED|Overall Study||21||
48387773|NCT01409993|101279414|FG002|COMPLETED|Overall Study||11||
48387774|NCT01409993|101279415|FG003|COMPLETED|Overall Study||8||
48387775|NCT01409993|101279412|FG000|NOT COMPLETED|Overall Study||4||
48387776|NCT01409993|101279413|FG001|NOT COMPLETED|Overall Study||5||
48387777|NCT01409993|101279414|FG002|NOT COMPLETED|Overall Study||3||
48387778|NCT01409993|101279415|FG003|NOT COMPLETED|Overall Study||5||
48387779|NCT02188719|101279416|FG000|STARTED|Overall Study||6||
48387780|NCT02188719|101279417|FG001|STARTED|Overall Study||9||
48387781|NCT02188719|101279418|FG002|STARTED|Overall Study||0||
48387782|NCT02188719|101279419|FG003|STARTED|Overall Study||0||
48387783|NCT02188719|101279416|FG000|COMPLETED|Overall Study||6||
48095191|NCT01641692|100556273|FG006|NOT COMPLETED|Treatment Period 3||2||
48095192|NCT01641692|100556274|FG007|NOT COMPLETED|Treatment Period 3||0||
48095193|NCT01641692|100556267|FG000|STARTED|Washout Period 3 or Follow-up||43||
48095194|NCT01641692|100556268|FG001|STARTED|Washout Period 3 or Follow-up||32||
48095195|NCT01641692|100556269|FG002|STARTED|Washout Period 3 or Follow-up||37||
48387784|NCT02188719|101279417|FG001|COMPLETED|Overall Study||8||
48387785|NCT02188719|101279418|FG002|COMPLETED|Overall Study||0||
48387786|NCT02188719|101279419|FG003|COMPLETED|Overall Study||0||
48387787|NCT02188719|101279416|FG000|NOT COMPLETED|Overall Study||0||
48387788|NCT02188719|101279417|FG001|NOT COMPLETED|Overall Study||1||
48387789|NCT02188719|101279418|FG002|NOT COMPLETED|Overall Study||0||
48387790|NCT02188719|101279419|FG003|NOT COMPLETED|Overall Study||0||
48387791|NCT03328624|101279420|FG000|STARTED|Overall Study||36||
48387792|NCT03328624|101279420|FG000|COMPLETED|Overall Study||36||
48387793|NCT03328624|101279420|FG000|NOT COMPLETED|Overall Study||0||
48387794|NCT00426556|101279421|FG000|STARTED|Phase I - Core Phase||6||
48387795|NCT00426556|101279422|FG001|STARTED|Phase I - Core Phase||17||
48387796|NCT00426556|101279423|FG002|STARTED|Phase I - Core Phase||10||
48387797|NCT00426556|101279424|FG003|STARTED|Phase I - Core Phase||0||
48387798|NCT00426556|101279421|FG000|COMPLETED|Phase I - Core Phase||5||
48387799|NCT00426556|101279422|FG001|COMPLETED|Phase I - Core Phase||7||
48387800|NCT00426556|101279423|FG002|COMPLETED|Phase I - Core Phase||7||
48387801|NCT00426556|101279424|FG003|COMPLETED|Phase I - Core Phase||0||
48095196|NCT01641692|100556270|FG003|STARTED|Washout Period 3 or Follow-up||42||
48095197|NCT01641692|100556271|FG004|STARTED|Washout Period 3 or Follow-up||40||
48095198|NCT01641692|100556272|FG005|STARTED|Washout Period 3 or Follow-up||39||
48095199|NCT01641692|100556273|FG006|STARTED|Washout Period 3 or Follow-up||33||
48095200|NCT01641692|100556274|FG007|STARTED|Washout Period 3 or Follow-up||38||
48387802|NCT00426556|101279421|FG000|NOT COMPLETED|Phase I - Core Phase||1||
48387803|NCT00426556|101279422|FG001|NOT COMPLETED|Phase I - Core Phase||10||
48387804|NCT00426556|101279423|FG002|NOT COMPLETED|Phase I - Core Phase||3||
48387805|NCT00426556|101279424|FG003|NOT COMPLETED|Phase I - Core Phase||0||
48387806|NCT00426556|101279421|FG000|STARTED|Phase I - Extension Phase||5||
48387807|NCT00426556|101279422|FG001|STARTED|Phase I - Extension Phase||7||
48387808|NCT00426556|101279423|FG002|STARTED|Phase I - Extension Phase||7||
48387809|NCT00426556|101279424|FG003|STARTED|Phase I - Extension Phase||0||
48387810|NCT00426556|101279421|FG000|COMPLETED|Phase I - Extension Phase||0||
48387811|NCT00426556|101279422|FG001|COMPLETED|Phase I - Extension Phase||1||
48387812|NCT00426556|101279423|FG002|COMPLETED|Phase I - Extension Phase||0||
48387813|NCT00426556|101279424|FG003|COMPLETED|Phase I - Extension Phase||0||
48387814|NCT00426556|101279421|FG000|NOT COMPLETED|Phase I - Extension Phase||5||
48387815|NCT00426556|101279422|FG001|NOT COMPLETED|Phase I - Extension Phase||6||
48387816|NCT00426556|101279423|FG002|NOT COMPLETED|Phase I - Extension Phase||7||
48387817|NCT00426556|101279424|FG003|NOT COMPLETED|Phase I - Extension Phase||0||
48259518|NCT01547117|100955125|FG001|Phase 1-150 mEq Sodium/Day|Overall Study||4||
48259519|NCT01547117|100955126|FG002|Phase 1-150 mEq Sodium/Day|Overall Study||8||
48259520|NCT01547117|100955127|FG003|Phase 1-150 mEq Sodium/Day|Overall Study||7||
48259521|NCT01547117|100955124|FG000|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||12||
48259522|NCT01547117|100955125|FG001|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||4||
48259523|NCT01547117|100955126|FG002|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||8||
48259524|NCT01547117|100955127|FG003|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||7||
48259525|NCT01547117|100955124|FG000|Phase 1-finish|Overall Study||11||
48259526|NCT01547117|100955125|FG001|Phase 1-finish|Overall Study||2||
48259527|NCT01547117|100955126|FG002|Phase 1-finish|Overall Study||8||
48259528|NCT01547117|100955127|FG003|Phase 1-finish|Overall Study||6||
48259529|NCT01547117|100955124|FG000|Phase 2-150 mEq Sodium/Day|Overall Study||11||
48259530|NCT01547117|100955125|FG001|Phase 2-150 mEq Sodium/Day|Overall Study||2||
48259531|NCT01547117|100955126|FG002|Phase 2-150 mEq Sodium/Day|Overall Study||8||
48259532|NCT01547117|100955127|FG003|Phase 2-150 mEq Sodium/Day|Overall Study||6||
48259533|NCT01547117|100955124|FG000|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||11||
48259534|NCT01547117|100955125|FG001|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||2||
48259535|NCT01547117|100955126|FG002|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||8||
48259536|NCT01547117|100955127|FG003|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||6||
48259537|NCT01547117|100955124|FG000|Phase 2-finish|Overall Study||11||
48259538|NCT01547117|100955125|FG001|Phase 2-finish|Overall Study||2||
48259539|NCT01547117|100955126|FG002|Phase 2-finish|Overall Study||8||
48259540|NCT01547117|100955127|FG003|Phase 2-finish|Overall Study||6||
48259541|NCT01547117|100955124|FG000|COMPLETED|Overall Study||11||
48259542|NCT01547117|100955125|FG001|COMPLETED|Overall Study||2||
48259543|NCT01547117|100955126|FG002|COMPLETED|Overall Study||8||
48259544|NCT01547117|100955127|FG003|COMPLETED|Overall Study||6||
48259545|NCT01547117|100955124|FG000|NOT COMPLETED|Overall Study||1||
48259546|NCT01547117|100955125|FG001|NOT COMPLETED|Overall Study||3||
48259547|NCT01547117|100955126|FG002|NOT COMPLETED|Overall Study||2||
48259548|NCT01547117|100955127|FG003|NOT COMPLETED|Overall Study||5||
48259549|NCT00559377|100955128|FG000|STARTED|Overall Study||16||
48259550|NCT00559377|100955128|FG000|COMPLETED|Overall Study||7||
48259551|NCT00559377|100955128|FG000|NOT COMPLETED|Overall Study||9||
48259552|NCT00751634|100955129|FG000|STARTED|Overall Study||20||
48259553|NCT00751634|100955129|FG000|COMPLETED|Overall Study||20||
48259554|NCT00751634|100955129|FG000|NOT COMPLETED|Overall Study||0||
48259555|NCT02650466|100955130|FG000|STARTED|Overall Study||24||
48259556|NCT02650466|100955130|FG000|COMPLETED|Overall Study||17||
48387818|NCT00426556|101279421|FG000|STARTED|Phase II - Core Phase||0||
48387819|NCT00426556|101279422|FG001|STARTED|Phase II - Core Phase||0||
48387820|NCT00426556|101279423|FG002|STARTED|Phase II - Core Phase||0||
48387821|NCT00426556|101279424|FG003|STARTED|Phase II - Core Phase||55||
48387822|NCT00426556|101279421|FG000|COMPLETED|Phase II - Core Phase||0||
48259557|NCT02650466|100955130|FG000|NOT COMPLETED|Overall Study||7||
48259558|NCT03182998|100955131|FG000|STARTED|Overall Study||37||
48259559|NCT03182998|100955132|FG001|STARTED|Overall Study||33||
48259560|NCT03182998|100955133|FG002|STARTED|Overall Study||33||
48259561|NCT03182998|100955131|FG000|COMPLETED|Overall Study||36||
48259562|NCT03182998|100955132|FG001|COMPLETED|Overall Study||33||
48259563|NCT03182998|100955133|FG002|COMPLETED|Overall Study||33||
48259564|NCT03182998|100955131|FG000|NOT COMPLETED|Overall Study||1||
48259565|NCT03182998|100955132|FG001|NOT COMPLETED|Overall Study||0||
48259566|NCT03182998|100955133|FG002|NOT COMPLETED|Overall Study||0||
48259567|NCT01057251|100955134|FG000|STARTED|Overall Study||290||
48259568|NCT01057251|100955135|FG001|STARTED|Overall Study||143||
48259569|NCT01057251|100955134|FG000|COMPLETED|Overall Study||262||
48259570|NCT01057251|100955135|FG001|COMPLETED|Overall Study||114||
48259571|NCT01057251|100955134|FG000|NOT COMPLETED|Overall Study||28||
48259572|NCT01057251|100955135|FG001|NOT COMPLETED|Overall Study||29||
48259573|NCT02420041|100955136|FG000|STARTED|Overall Study||14||
48259574|NCT02420041|100955137|FG001|STARTED|Overall Study||14||
48259575|NCT02420041|100955136|FG000|COMPLETED|Overall Study||14||
48259576|NCT02420041|100955137|FG001|COMPLETED|Overall Study||14||
48259577|NCT02420041|100955136|FG000|NOT COMPLETED|Overall Study||0||
48259578|NCT02420041|100955137|FG001|NOT COMPLETED|Overall Study||0||
48259579|NCT01473745|100955138|FG000|STARTED|Overall Study||24||
48387823|NCT00426556|101279422|FG001|COMPLETED|Phase II - Core Phase||0||
48387824|NCT00426556|101279423|FG002|COMPLETED|Phase II - Core Phase||0||
48387825|NCT00426556|101279424|FG003|COMPLETED|Phase II - Core Phase||28||
48387826|NCT00426556|101279421|FG000|NOT COMPLETED|Phase II - Core Phase||0||
48095201|NCT01641692|100556267|FG000|COMPLETED|Washout Period 3 or Follow-up||42||
48095202|NCT01641692|100556268|FG001|COMPLETED|Washout Period 3 or Follow-up||32||
48095203|NCT01641692|100556269|FG002|COMPLETED|Washout Period 3 or Follow-up||36||
48095204|NCT01641692|100556270|FG003|COMPLETED|Washout Period 3 or Follow-up||41||
48095205|NCT01641692|100556271|FG004|COMPLETED|Washout Period 3 or Follow-up||40||
48095206|NCT01641692|100556272|FG005|COMPLETED|Washout Period 3 or Follow-up||37||
48259580|NCT01473745|100955139|FG001|STARTED|Overall Study||24||
48095207|NCT01641692|100556273|FG006|COMPLETED|Washout Period 3 or Follow-up||32||
48095208|NCT01641692|100556274|FG007|COMPLETED|Washout Period 3 or Follow-up||38||
48259581|NCT01473745|100955138|FG000|COMPLETED|Overall Study||24||
48259582|NCT01473745|100955139|FG001|COMPLETED|Overall Study||24||
48259583|NCT01473745|100955138|FG000|NOT COMPLETED|Overall Study||0||
48259584|NCT01473745|100955139|FG001|NOT COMPLETED|Overall Study||0||
48259585|NCT03569475|100955140|FG000|STARTED|Double-blind Treatment Period (8 Weeks)||164||
48259586|NCT03569475|100955141|FG001|STARTED|Double-blind Treatment Period (8 Weeks)||169||
48259587|NCT03569475|100955142|FG002|STARTED|Double-blind Treatment Period (8 Weeks)||168||
48259588|NCT03569475|100955140|FG000|Safety Population|Double-blind Treatment Period (8 Weeks)||160|Safety Population included all participants in the Randomized Population (all participants who underwent a Screening Visit, received a screening number, for whom informed consent was obtained, and who were randomized to a treatment group in the study) who received at least 1 dose of double-blind investigational product.|
48259589|NCT03569475|100955141|FG001|Safety Population|Double-blind Treatment Period (8 Weeks)||166|Safety Population included all participants in the Randomized Population (all participants who underwent a Screening Visit, received a screening number, for whom informed consent was obtained, and who were randomized to a treatment group in the study) who received at least 1 dose of double-blind investigational product.|
48259590|NCT03569475|100955142|FG002|Safety Population|Double-blind Treatment Period (8 Weeks)||166|Safety Population included all participants in the Randomized Population (all participants who underwent a Screening Visit, received a screening number, for whom informed consent was obtained, and who were randomized to a treatment group in the study) who received at least 1 dose of double-blind investigational product.|
48259591|NCT03569475|100955140|FG000|COMPLETED|Double-blind Treatment Period (8 Weeks)||146||
48259592|NCT03569475|100955141|FG001|COMPLETED|Double-blind Treatment Period (8 Weeks)||146||
48259593|NCT03569475|100955142|FG002|COMPLETED|Double-blind Treatment Period (8 Weeks)||144||
48259594|NCT03569475|100955140|FG000|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||18||
48259595|NCT03569475|100955141|FG001|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||23||
48259596|NCT03569475|100955142|FG002|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||24||
48259597|NCT03569475|100955140|FG000|STARTED|Double-blind Down-taper Period (1 Week)||140||
48259598|NCT03569475|100955141|FG001|STARTED|Double-blind Down-taper Period (1 Week)||141||
48259599|NCT03569475|100955142|FG002|STARTED|Double-blind Down-taper Period (1 Week)||140||
48259600|NCT03569475|100955140|FG000|COMPLETED|Double-blind Down-taper Period (1 Week)||140||
48259601|NCT03569475|100955141|FG001|COMPLETED|Double-blind Down-taper Period (1 Week)||139||
48259602|NCT03569475|100955142|FG002|COMPLETED|Double-blind Down-taper Period (1 Week)||138||
48259603|NCT03569475|100955140|FG000|NOT COMPLETED|Double-blind Down-taper Period (1 Week)||0||
48259604|NCT03569475|100955141|FG001|NOT COMPLETED|Double-blind Down-taper Period (1 Week)||2||
48259605|NCT03569475|100955142|FG002|NOT COMPLETED|Double-blind Down-taper Period (1 Week)||2||
48259606|NCT00719043|100955143|FG000|STARTED|Overall Study||120||
48259607|NCT00719043|100955144|FG001|STARTED|Overall Study||121||
48259608|NCT00719043|100955145|FG002|STARTED|Overall Study||119||
48387827|NCT00426556|101279422|FG001|NOT COMPLETED|Phase II - Core Phase||0||
48387828|NCT00426556|101279423|FG002|NOT COMPLETED|Phase II - Core Phase||0||
48387829|NCT00426556|101279424|FG003|NOT COMPLETED|Phase II - Core Phase||27||
48541816|NCT03095638|101662790|FG001|STARTED|P2: Period 3 (4 Days)||0||
48095209|NCT01641692|100556267|FG000|NOT COMPLETED|Washout Period 3 or Follow-up||1||
48095210|NCT01641692|100556268|FG001|NOT COMPLETED|Washout Period 3 or Follow-up||0||
48095211|NCT01641692|100556269|FG002|NOT COMPLETED|Washout Period 3 or Follow-up||1||
48095212|NCT01641692|100556270|FG003|NOT COMPLETED|Washout Period 3 or Follow-up||1||
48095213|NCT01641692|100556271|FG004|NOT COMPLETED|Washout Period 3 or Follow-up||0||
48095214|NCT01641692|100556272|FG005|NOT COMPLETED|Washout Period 3 or Follow-up||2||
48095215|NCT01641692|100556273|FG006|NOT COMPLETED|Washout Period 3 or Follow-up||1||
48095216|NCT01641692|100556274|FG007|NOT COMPLETED|Washout Period 3 or Follow-up||0||
48095217|NCT01103284|100556275|FG000|STARTED|Overall Study||236||
48095218|NCT01103284|100556276|FG001|STARTED|Overall Study||239||
48095219|NCT01103284|100556275|FG000|Treated|Overall Study||236||
48095220|NCT01103284|100556276|FG001|Treated|Overall Study||238||
48095221|NCT01103284|100556275|FG000|At Least One Post-baseline Visit (FAS)|Overall Study||233||
48095222|NCT01103284|100556276|FG001|At Least One Post-baseline Visit (FAS)|Overall Study||235||
48095223|NCT01103284|100556275|FG000|COMPLETED|Overall Study||194||
48095224|NCT01103284|100556276|FG001|COMPLETED|Overall Study||195||
48095225|NCT01103284|100556275|FG000|NOT COMPLETED|Overall Study||42||
48095226|NCT01103284|100556276|FG001|NOT COMPLETED|Overall Study||44||
48095227|NCT03721276|100556277|FG000|STARTED|Overall Study||30||
48095228|NCT03721276|100556278|FG001|STARTED|Overall Study||30||
48095229|NCT03721276|100556277|FG000|Three-month Pre-intervention|Overall Study||0||
48095230|NCT03721276|100556278|FG001|Three-month Pre-intervention|Overall Study||30||
48095231|NCT03721276|100556277|FG000|Immediate Pre-intervention|Overall Study||30||
48095232|NCT03721276|100556278|FG001|Immediate Pre-intervention|Overall Study||29||
48095233|NCT03721276|100556277|FG000|Post-intervention|Overall Study||25||
48095234|NCT03721276|100556278|FG001|Post-intervention|Overall Study||26||
48095235|NCT03721276|100556277|FG000|Three-month Follow-up (Post Intervention)|Overall Study||25||
48095236|NCT03721276|100556278|FG001|Three-month Follow-up (Post Intervention)|Overall Study||0||
48095237|NCT03721276|100556277|FG000|COMPLETED|Overall Study||25||
48541817|NCT03095638|101662791|FG002|STARTED|P2: Period 3 (4 Days)||4||
48541818|NCT03095638|101662792|FG003|STARTED|P2: Period 3 (4 Days)||4||
48541819|NCT03095638|101662793|FG004|STARTED|P2: Period 3 (4 Days)||4||
48541820|NCT03095638|101662794|FG005|STARTED|P2: Period 3 (4 Days)||4||
48541821|NCT03095638|101662795|FG006|STARTED|P2: Period 3 (4 Days)||4||
48541822|NCT03095638|101662796|FG007|STARTED|P2: Period 3 (4 Days)||4||
48541823|NCT03095638|101662789|FG000|COMPLETED|P2: Period 3 (4 Days)||0||
48541824|NCT03095638|101662790|FG001|COMPLETED|P2: Period 3 (4 Days)||0||
48541825|NCT03095638|101662791|FG002|COMPLETED|P2: Period 3 (4 Days)||4||
48541826|NCT03095638|101662792|FG003|COMPLETED|P2: Period 3 (4 Days)||4||
48541827|NCT03095638|101662793|FG004|COMPLETED|P2: Period 3 (4 Days)||4||
48541828|NCT03095638|101662794|FG005|COMPLETED|P2: Period 3 (4 Days)||4||
48541829|NCT03095638|101662795|FG006|COMPLETED|P2: Period 3 (4 Days)||4||
48541830|NCT03095638|101662796|FG007|COMPLETED|P2: Period 3 (4 Days)||4||
48541831|NCT03095638|101662789|FG000|NOT COMPLETED|P2: Period 3 (4 Days)||0||
48541832|NCT03095638|101662790|FG001|NOT COMPLETED|P2: Period 3 (4 Days)||0||
48541833|NCT03095638|101662791|FG002|NOT COMPLETED|P2: Period 3 (4 Days)||0||
48541834|NCT03095638|101662792|FG003|NOT COMPLETED|P2: Period 3 (4 Days)||0||
48541835|NCT03095638|101662793|FG004|NOT COMPLETED|P2: Period 3 (4 Days)||0||
48541836|NCT03095638|101662794|FG005|NOT COMPLETED|P2: Period 3 (4 Days)||0||
48541837|NCT03095638|101662795|FG006|NOT COMPLETED|P2: Period 3 (4 Days)||0||
48541838|NCT03095638|101662796|FG007|NOT COMPLETED|P2: Period 3 (4 Days)||0||
48541839|NCT03095638|101662789|FG000|STARTED|P2: Period 3, Washout (7[-4 Hours])||0||
48541840|NCT03095638|101662790|FG001|STARTED|P2: Period 3, Washout (7[-4 Hours])||0||
48541841|NCT03095638|101662791|FG002|STARTED|P2: Period 3, Washout (7[-4 Hours])||4||
48541842|NCT03095638|101662792|FG003|STARTED|P2: Period 3, Washout (7[-4 Hours])||4||
48541843|NCT03095638|101662793|FG004|STARTED|P2: Period 3, Washout (7[-4 Hours])||4||
48541844|NCT03095638|101662794|FG005|STARTED|P2: Period 3, Washout (7[-4 Hours])||4||
48541845|NCT03095638|101662795|FG006|STARTED|P2: Period 3, Washout (7[-4 Hours])||4||
48541846|NCT03095638|101662796|FG007|STARTED|P2: Period 3, Washout (7[-4 Hours])||4||
48541847|NCT03095638|101662789|FG000|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0||
48095238|NCT03721276|100556278|FG001|COMPLETED|Overall Study||26||
48095239|NCT03721276|100556277|FG000|NOT COMPLETED|Overall Study||5||
48095240|NCT03721276|100556278|FG001|NOT COMPLETED|Overall Study||4||
48095241|NCT04577118|100556279|FG000|STARTED|Overall Study||25||
48095242|NCT04577118|100556279|FG000|COMPLETED|Overall Study||21||
48095243|NCT04577118|100556279|FG000|NOT COMPLETED|Overall Study||4||
48095244|NCT02278263|100556280|FG000|STARTED|Overall Study||30||
48095245|NCT02278263|100556281|FG001|STARTED|Overall Study||60||
48095246|NCT02278263|100556282|FG002|STARTED|Overall Study||60||
48095247|NCT02278263|100556280|FG000|COMPLETED|Overall Study||23||
48095248|NCT02278263|100556281|FG001|COMPLETED|Overall Study||60||
48095249|NCT02278263|100556282|FG002|COMPLETED|Overall Study||51||
48095250|NCT02278263|100556280|FG000|NOT COMPLETED|Overall Study||7||
48095251|NCT02278263|100556281|FG001|NOT COMPLETED|Overall Study||0||
48095252|NCT02278263|100556282|FG002|NOT COMPLETED|Overall Study||9||
48095253|NCT00676455|100556283|FG000|STARTED|Overall Study||14||
48095254|NCT00676455|100556283|FG000|COMPLETED|Overall Study||14||
48095255|NCT00676455|100556283|FG000|NOT COMPLETED|Overall Study||0||
48095256|NCT00488345|100556284|FG000|STARTED|Overall Study||17||
48259609|NCT00719043|100955146|FG003|STARTED|Overall Study||119||
48259610|NCT00719043|100955147|FG004|STARTED|Overall Study||122||
48541848|NCT03095638|101662790|FG001|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0||
48541849|NCT03095638|101662791|FG002|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4||
48541850|NCT03095638|101662792|FG003|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4||
48541851|NCT03095638|101662793|FG004|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4||
48259611|NCT00719043|100955148|FG005|STARTED|Overall Study||120||
48095257|NCT00488345|100556285|FG001|STARTED|Overall Study||21||
48095258|NCT00488345|100556286|FG002|STARTED|Overall Study||20||
48095259|NCT00488345|100556284|FG000|COMPLETED|Overall Study||17||
48095260|NCT00488345|100556285|FG001|COMPLETED|Overall Study||17||
48095261|NCT00488345|100556286|FG002|COMPLETED|Overall Study||17||
48095262|NCT00488345|100556284|FG000|NOT COMPLETED|Overall Study||0||
48689271|NCT01059864|102022653|FG000|STARTED|Open-Label Run-In Phase||111||
48689272|NCT01059864|102022654|FG001|STARTED|Open-Label Run-In Phase||0||
48689273|NCT01059864|102022655|FG002|STARTED|Open-Label Run-In Phase||0||
48689274|NCT01059864|102022653|FG000|COMPLETED|Open-Label Run-In Phase||98||
48689275|NCT01059864|102022654|FG001|COMPLETED|Open-Label Run-In Phase||0||
48689276|NCT01059864|102022655|FG002|COMPLETED|Open-Label Run-In Phase||0||
48689277|NCT01059864|102022653|FG000|NOT COMPLETED|Open-Label Run-In Phase||13||
48689278|NCT01059864|102022654|FG001|NOT COMPLETED|Open-Label Run-In Phase||0||
48689279|NCT01059864|102022655|FG002|NOT COMPLETED|Open-Label Run-In Phase||0||
48689280|NCT01059864|102022653|FG000|STARTED|Double-Blind Treatment Phase||0||
48689281|NCT01059864|102022654|FG001|STARTED|Double-Blind Treatment Phase||50||
48689282|NCT01059864|102022655|FG002|STARTED|Double-Blind Treatment Phase||48||
48689283|NCT01059864|102022653|FG000|Treated|Double-Blind Treatment Phase||0||
48689284|NCT01059864|102022654|FG001|Treated|Double-Blind Treatment Phase||50||
48095263|NCT00488345|100556285|FG001|NOT COMPLETED|Overall Study||4||
48095264|NCT00488345|100556286|FG002|NOT COMPLETED|Overall Study||3||
48095265|NCT03194698|100556287|FG000|STARTED|Overall Study||10||
48095266|NCT03194698|100556288|FG001|STARTED|Overall Study||10||
48095267|NCT03194698|100556287|FG000|COMPLETED|Overall Study||10||
48095268|NCT03194698|100556288|FG001|COMPLETED|Overall Study||10||
48095269|NCT03194698|100556287|FG000|NOT COMPLETED|Overall Study||0||
48095270|NCT03194698|100556288|FG001|NOT COMPLETED|Overall Study||0||
48095271|NCT03263442|100556289|FG000|STARTED|Inpatient Phase||30||
48095272|NCT03263442|100556290|FG001|STARTED|Inpatient Phase||34||
48095273|NCT03263442|100556289|FG000|COMPLETED|Inpatient Phase||28||
48095274|NCT03263442|100556290|FG001|COMPLETED|Inpatient Phase||33||
48095275|NCT03263442|100556289|FG000|NOT COMPLETED|Inpatient Phase||2||
48095276|NCT03263442|100556290|FG001|NOT COMPLETED|Inpatient Phase||1||
48095277|NCT03263442|100556289|FG000|STARTED|1-month Follow-Up||28||
48095278|NCT03263442|100556290|FG001|STARTED|1-month Follow-Up||33||
48095279|NCT03263442|100556289|FG000|COMPLETED|1-month Follow-Up||27||
48095280|NCT03263442|100556290|FG001|COMPLETED|1-month Follow-Up||33||
48095281|NCT03263442|100556289|FG000|NOT COMPLETED|1-month Follow-Up||1||
48095282|NCT03263442|100556290|FG001|NOT COMPLETED|1-month Follow-Up||0||
48095283|NCT03263442|100556289|FG000|STARTED|3-month Follow-Up||27||
48095284|NCT03263442|100556290|FG001|STARTED|3-month Follow-Up||33||
48095285|NCT03263442|100556289|FG000|COMPLETED|3-month Follow-Up||26||
48095286|NCT03263442|100556290|FG001|COMPLETED|3-month Follow-Up||30||
48095287|NCT03263442|100556289|FG000|NOT COMPLETED|3-month Follow-Up||1||
48095288|NCT03263442|100556290|FG001|NOT COMPLETED|3-month Follow-Up||3||
48095289|NCT03263442|100556289|FG000|STARTED|6-month Follow-Up||26||
48095290|NCT03263442|100556290|FG001|STARTED|6-month Follow-Up||30||
48095291|NCT03263442|100556289|FG000|COMPLETED|6-month Follow-Up||24||
48095292|NCT03263442|100556290|FG001|COMPLETED|6-month Follow-Up||28||
48095293|NCT03263442|100556289|FG000|NOT COMPLETED|6-month Follow-Up||2||
48387830|NCT00426556|101279421|FG000|STARTED|Phase II - Extension Phase||0||
48387831|NCT00426556|101279422|FG001|STARTED|Phase II - Extension Phase||0||
48387832|NCT00426556|101279423|FG002|STARTED|Phase II - Extension Phase||0||
48387833|NCT00426556|101279424|FG003|STARTED|Phase II - Extension Phase||24||
48387834|NCT00426556|101279421|FG000|COMPLETED|Phase II - Extension Phase||0||
48387835|NCT00426556|101279422|FG001|COMPLETED|Phase II - Extension Phase||0||
48387836|NCT00426556|101279423|FG002|COMPLETED|Phase II - Extension Phase||0||
48387837|NCT00426556|101279424|FG003|COMPLETED|Phase II - Extension Phase||1||
48387838|NCT00426556|101279421|FG000|NOT COMPLETED|Phase II - Extension Phase||0||
48387839|NCT00426556|101279422|FG001|NOT COMPLETED|Phase II - Extension Phase||0||
48095294|NCT03263442|100556290|FG001|NOT COMPLETED|6-month Follow-Up||2||
48095295|NCT01909154|100556291|FG000|STARTED|Overall Study||12||
48095296|NCT01909154|100556291|FG000|COMPLETED|Overall Study||12||
48095297|NCT01909154|100556291|FG000|NOT COMPLETED|Overall Study||0||
48095298|NCT03527966|100556292|FG000|STARTED|Overall Study||3||
48095299|NCT03527966|100556293|FG001|STARTED|Overall Study||0||
48095300|NCT03527966|100556292|FG000|COMPLETED|Overall Study||0||
48095301|NCT03527966|100556293|FG001|COMPLETED|Overall Study||0||
48095302|NCT03527966|100556292|FG000|NOT COMPLETED|Overall Study||3||
48095303|NCT03527966|100556293|FG001|NOT COMPLETED|Overall Study||0||
48387840|NCT00426556|101279423|FG002|NOT COMPLETED|Phase II - Extension Phase||0||
48387841|NCT00426556|101279424|FG003|NOT COMPLETED|Phase II - Extension Phase||23||
48689285|NCT01059864|102022655|FG002|Treated|Double-Blind Treatment Phase||47||
48689286|NCT01059864|102022653|FG000|COMPLETED|Double-Blind Treatment Phase||0||
48689287|NCT01059864|102022654|FG001|COMPLETED|Double-Blind Treatment Phase||47||
48689288|NCT01059864|102022655|FG002|COMPLETED|Double-Blind Treatment Phase||45||
48689289|NCT01059864|102022653|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0||
48689290|NCT01059864|102022654|FG001|NOT COMPLETED|Double-Blind Treatment Phase||3||
48689291|NCT01059864|102022655|FG002|NOT COMPLETED|Double-Blind Treatment Phase||3||
48689292|NCT02548910|102022656|FG000|STARTED|Overall Study||31||
48689293|NCT02548910|102022657|FG001|STARTED|Overall Study||31||
48689294|NCT02548910|102022656|FG000|COMPLETED|Overall Study||31||
48689295|NCT02548910|102022657|FG001|COMPLETED|Overall Study||31||
48689296|NCT02548910|102022656|FG000|NOT COMPLETED|Overall Study||0||
48689297|NCT02548910|102022657|FG001|NOT COMPLETED|Overall Study||0||
48095304|NCT00411645|100556294|FG000|STARTED|Overall Study||227||
48095305|NCT00411645|100556295|FG001|STARTED|Overall Study||454||
48095306|NCT00411645|100556294|FG000|COMPLETED|Overall Study||146||
48095307|NCT00411645|100556295|FG001|COMPLETED|Overall Study||290||
48095308|NCT00411645|100556294|FG000|NOT COMPLETED|Overall Study||81||
48095309|NCT00411645|100556295|FG001|NOT COMPLETED|Overall Study||164||
48095310|NCT03182829|100556296|FG000|STARTED|Overall Study||467||
48095311|NCT03182829|100556297|FG001|STARTED|Overall Study||444||
48095312|NCT03182829|100556296|FG000|COMPLETED|Overall Study||451||
48095313|NCT03182829|100556297|FG001|COMPLETED|Overall Study||429||
48095314|NCT03182829|100556296|FG000|NOT COMPLETED|Overall Study||16||
48095315|NCT03182829|100556297|FG001|NOT COMPLETED|Overall Study||15||
48095316|NCT00810407|100556298|FG000|STARTED|Overall Study||594||
48095317|NCT00810407|100556298|FG000|COMPLETED|Overall Study||588||
48095318|NCT00810407|100556298|FG000|NOT COMPLETED|Overall Study||6||
48095319|NCT02566083|100556299|FG000|STARTED|Overall Study||214||
48095320|NCT02566083|100556300|FG001|STARTED|Overall Study||151||
48095321|NCT02566083|100556299|FG000|COMPLETED|Overall Study||198||
48095322|NCT02566083|100556300|FG001|COMPLETED|Overall Study||141||
48095323|NCT02566083|100556299|FG000|NOT COMPLETED|Overall Study||16||
48095324|NCT02566083|100556300|FG001|NOT COMPLETED|Overall Study||10||
48095325|NCT02172742|100556301|FG000|STARTED|Overall Study||7||
48095326|NCT02172742|100556302|FG001|STARTED|Overall Study||6||
48095327|NCT02172742|100556301|FG000|COMPLETED|Overall Study||6||
48095328|NCT02172742|100556302|FG001|COMPLETED|Overall Study||6||
48095329|NCT02172742|100556301|FG000|NOT COMPLETED|Overall Study||1||
48095330|NCT02172742|100556302|FG001|NOT COMPLETED|Overall Study||0||
48095331|NCT02810392|100556303|FG000|STARTED|Overall Study||9||
48095332|NCT02810392|100556304|FG001|STARTED|Overall Study||10||
48095333|NCT02810392|100556303|FG000|COMPLETED|Overall Study||8||
48095334|NCT02810392|100556304|FG001|COMPLETED|Overall Study||9||
48095335|NCT02810392|100556303|FG000|NOT COMPLETED|Overall Study||1||
48095336|NCT02810392|100556304|FG001|NOT COMPLETED|Overall Study||1||
48095337|NCT00453544|100556305|FG000|STARTED|Overall Study||62||
48095338|NCT00453544|100556306|FG001|STARTED|Overall Study||55||
48095339|NCT00453544|100556307|FG002|STARTED|Overall Study||68||
48095340|NCT00453544|100556308|FG003|STARTED|Overall Study||67||
48095341|NCT00453544|100556305|FG000|COMPLETED|Overall Study||60||
48095342|NCT00453544|100556306|FG001|COMPLETED|Overall Study||54||
48095343|NCT00453544|100556307|FG002|COMPLETED|Overall Study||68||
48095344|NCT00453544|100556308|FG003|COMPLETED|Overall Study||66||
48095345|NCT00453544|100556305|FG000|NOT COMPLETED|Overall Study||2||
48095346|NCT00453544|100556306|FG001|NOT COMPLETED|Overall Study||1||
48095347|NCT00453544|100556307|FG002|NOT COMPLETED|Overall Study||0||
48095348|NCT00453544|100556308|FG003|NOT COMPLETED|Overall Study||1||
48095349|NCT00040937|100556309|FG000|STARTED|Induction/PBSC Mobilization||147||
48095350|NCT00040937|100556309|FG000|COMPLETED|Induction/PBSC Mobilization||110||
48095351|NCT00040937|100556309|FG000|NOT COMPLETED|Induction/PBSC Mobilization||37||
48095352|NCT00040937|100556309|FG000|STARTED|Autologous PBSCT||108||
48095353|NCT00040937|100556309|FG000|COMPLETED|Autologous PBSCT||77||
48095354|NCT00040937|100556309|FG000|NOT COMPLETED|Autologous PBSCT||31||
48095355|NCT00040937|100556309|FG000|STARTED|Maintenance||76||
48095356|NCT00040937|100556309|FG000|COMPLETED|Maintenance||76||
48095357|NCT00040937|100556309|FG000|NOT COMPLETED|Maintenance||0||
48095358|NCT01867021|100556310|FG000|STARTED|Overall Study||1452||
48095359|NCT01867021|100556311|FG001|STARTED|Overall Study||1450||
48095360|NCT01867021|100556310|FG000|COMPLETED|Overall Study||1450||
48095361|NCT01867021|100556311|FG001|COMPLETED|Overall Study||1440||
48095362|NCT01867021|100556310|FG000|NOT COMPLETED|Overall Study||2||
48095363|NCT01867021|100556311|FG001|NOT COMPLETED|Overall Study||10||
48095364|NCT00475176|100556312|FG000|STARTED|Overall Study||24||
48095365|NCT00475176|100556312|FG000|COMPLETED|Overall Study||20||
48387842|NCT04150562|101279425|FG000|STARTED|Overall Study||2||
48387843|NCT04150562|101279426|FG001|STARTED|Overall Study||0||
48387844|NCT04150562|101279425|FG000|COMPLETED|Overall Study||2||
48689298|NCT02752490|102022658|FG000|STARTED|Overall Study||409||
48095366|NCT00475176|100556312|FG000|NOT COMPLETED|Overall Study||4||
48387845|NCT04150562|101279426|FG001|COMPLETED|Overall Study||0||
48387846|NCT04150562|101279425|FG000|NOT COMPLETED|Overall Study||0||
48095367|NCT01843751|100556313|FG000|STARTED|Overall Study||11||
48095368|NCT01843751|100556314|FG001|STARTED|Overall Study||10||
48095369|NCT01843751|100556313|FG000|COMPLETED|Overall Study||0||
48095370|NCT01843751|100556314|FG001|COMPLETED|Overall Study||3||
48095371|NCT01843751|100556313|FG000|NOT COMPLETED|Overall Study||11||
48095372|NCT01843751|100556314|FG001|NOT COMPLETED|Overall Study||7||
48095373|NCT03564145|100556315|FG000|STARTED|Overall Study||547||
48095374|NCT03564145|100556315|FG000|Received at Least 1 Dose of Study Drug|Overall Study||535||
48095375|NCT03564145|100556315|FG000|COMPLETED|Overall Study||323||
48095376|NCT03564145|100556315|FG000|NOT COMPLETED|Overall Study||224||
48095377|NCT01413191|100556316|FG000|STARTED|Overall Study||18||
48095378|NCT01413191|100556316|FG000|COMPLETED|Overall Study||7||
48095379|NCT01413191|100556316|FG000|NOT COMPLETED|Overall Study||11||
48095380|NCT02551731|100556317|FG000|STARTED|Overall Study||9||
48095381|NCT02551731|100556317|FG000|COMPLETED|Overall Study||7||
48095382|NCT02551731|100556317|FG000|NOT COMPLETED|Overall Study||2||
48387847|NCT04150562|101279426|FG001|NOT COMPLETED|Overall Study||0||
48095383|NCT00765375|100556318|FG000|STARTED|Overall Study||5||
48095384|NCT00765375|100556318|FG000|COMPLETED|Overall Study||5||
48095385|NCT00765375|100556318|FG000|NOT COMPLETED|Overall Study||0||
48095386|NCT01973166|100556319|FG000|STARTED|Overall Study||42||84
48095387|NCT01973166|100556319|FG000|Treatment With Cutera Investigational Picosecond Q-Switched Nd:YAG Laser|Overall Study||42||42
48095388|NCT01973166|100556319|FG000|Treatment With Comparator Nanosecond Q-switched Nd:YAG Laser|Overall Study||42||42
48095389|NCT01973166|100556319|FG000|COMPLETED|Overall Study||41||82
48095390|NCT01973166|100556319|FG000|NOT COMPLETED|Overall Study||1||2
48095391|NCT00708643|100556320|FG000|STARTED|Overall Study||40||
48095392|NCT00708643|100556321|FG001|STARTED|Overall Study||40||
48095393|NCT00708643|100556320|FG000|COMPLETED|Overall Study||40||
48095394|NCT00708643|100556321|FG001|COMPLETED|Overall Study||39||
48095395|NCT00708643|100556320|FG000|NOT COMPLETED|Overall Study||0||
48095396|NCT00708643|100556321|FG001|NOT COMPLETED|Overall Study||1||
48095397|NCT03414424|100556322|FG000|STARTED|Overall Study||15||
48095398|NCT03414424|100556323|FG001|STARTED|Overall Study||15||
48095399|NCT03414424|100556322|FG000|COMPLETED|Overall Study||15||
48095400|NCT03414424|100556323|FG001|COMPLETED|Overall Study||12||
48095401|NCT03414424|100556322|FG000|NOT COMPLETED|Overall Study||0||
48095402|NCT03414424|100556323|FG001|NOT COMPLETED|Overall Study||3||
48095403|NCT01411696|100556324|FG000|STARTED|Overall Study||289||
48095404|NCT01411696|100556324|FG000|COMPLETED|Overall Study||289||
48095405|NCT01411696|100556324|FG000|NOT COMPLETED|Overall Study||0||
48095406|NCT02829463|100556325|FG000|STARTED|Overall Study||59||
48095407|NCT02829463|100556326|FG001|STARTED|Overall Study||62||
48095408|NCT02829463|100556325|FG000|COMPLETED|Overall Study||59||
48095409|NCT02829463|100556326|FG001|COMPLETED|Overall Study||62||
48095410|NCT02829463|100556325|FG000|NOT COMPLETED|Overall Study||0||
48095411|NCT02829463|100556326|FG001|NOT COMPLETED|Overall Study||0||
48095412|NCT02393547|100556327|FG000|STARTED|Overall Study||20||
48095413|NCT02393547|100556327|FG000|COMPLETED|Overall Study||14||
48387848|NCT01559064|101279427|FG000|STARTED|Overall Study||16||
48387849|NCT01559064|101279428|FG001|STARTED|Overall Study||40||
48387850|NCT01559064|101279429|FG002|STARTED|Overall Study||59||
48387851|NCT01559064|101279427|FG000|COMPLETED|Overall Study||15||
48387852|NCT01559064|101279428|FG001|COMPLETED|Overall Study||39||
48387853|NCT01559064|101279429|FG002|COMPLETED|Overall Study||57||
48387854|NCT01559064|101279427|FG000|NOT COMPLETED|Overall Study||1||
48095414|NCT02393547|100556327|FG000|NOT COMPLETED|Overall Study||6||
48095415|NCT03352323|100556328|FG000|STARTED|Overall Study||50||
48095416|NCT03352323|100556328|FG000|COMPLETED|Overall Study||49||
48387855|NCT01559064|101279428|FG001|NOT COMPLETED|Overall Study||1||
48387856|NCT01559064|101279429|FG002|NOT COMPLETED|Overall Study||2||
48387857|NCT04176445|101279430|FG000|STARTED|Overall Study||12||
48387858|NCT04176445|101279431|FG001|STARTED|Overall Study||7||
48387859|NCT04176445|101279430|FG000|COMPLETED|Overall Study||12||
48387860|NCT04176445|101279431|FG001|COMPLETED|Overall Study||5||
48387861|NCT04176445|101279430|FG000|NOT COMPLETED|Overall Study||0||
48387862|NCT04176445|101279431|FG001|NOT COMPLETED|Overall Study||2||
48387863|NCT03222076|101279432|FG000|STARTED|Overall Study||13||
48095417|NCT03352323|100556328|FG000|NOT COMPLETED|Overall Study||1||
48095418|NCT01991457|100556329|FG000|STARTED|Overall Study||19||
48095419|NCT01991457|100556329|FG000|COMPLETED|Overall Study||19||
48095420|NCT01991457|100556329|FG000|NOT COMPLETED|Overall Study||0||
48095421|NCT02221284|100556330|FG000|STARTED|Overall Study||964||
48095422|NCT02221284|100556330|FG000|COMPLETED|Overall Study||903||
48095423|NCT02221284|100556330|FG000|NOT COMPLETED|Overall Study||61||
48095424|NCT01192282|100556331|FG000|STARTED|Overall Study||156||
48095425|NCT01192282|100556331|FG000|COMPLETED|Overall Study||156||
48095426|NCT01192282|100556331|FG000|NOT COMPLETED|Overall Study||0||
48095427|NCT04461015|100556332|FG000|STARTED|Overall Study||5||
48095428|NCT04461015|100556333|FG001|STARTED|Overall Study||7||
48259612|NCT00719043|100955149|FG006|STARTED|Overall Study||120||
48259613|NCT00719043|100955143|FG000|COMPLETED|Overall Study||88||
48259614|NCT00719043|100955144|FG001|COMPLETED|Overall Study||96||
48259615|NCT00719043|100955145|FG002|COMPLETED|Overall Study||99||
48259616|NCT00719043|100955146|FG003|COMPLETED|Overall Study||96||
48259617|NCT00719043|100955147|FG004|COMPLETED|Overall Study||95||
48259618|NCT00719043|100955148|FG005|COMPLETED|Overall Study||86||
48259619|NCT00719043|100955149|FG006|COMPLETED|Overall Study||92||
48259620|NCT00719043|100955143|FG000|NOT COMPLETED|Overall Study||32||
48259621|NCT00719043|100955144|FG001|NOT COMPLETED|Overall Study||25||
48259622|NCT00719043|100955145|FG002|NOT COMPLETED|Overall Study||20||
48259623|NCT00719043|100955146|FG003|NOT COMPLETED|Overall Study||23||
48259624|NCT00719043|100955147|FG004|NOT COMPLETED|Overall Study||27||
48387864|NCT03222076|101279433|FG001|STARTED|Overall Study||14||
48387865|NCT03222076|101279434|FG002|STARTED|Overall Study||0||
48387866|NCT03222076|101279432|FG000|COMPLETED|Overall Study||13||
48387867|NCT03222076|101279433|FG001|COMPLETED|Overall Study||14||
48387868|NCT03222076|101279434|FG002|COMPLETED|Overall Study||0||
48387869|NCT03222076|101279432|FG000|NOT COMPLETED|Overall Study||0||
48387870|NCT03222076|101279433|FG001|NOT COMPLETED|Overall Study||0||
48259625|NCT00719043|100955148|FG005|NOT COMPLETED|Overall Study||34||
48387871|NCT03222076|101279434|FG002|NOT COMPLETED|Overall Study||0||
48387872|NCT00698035|101279435|FG000|STARTED|Overall Study||39||
48387873|NCT00698035|101279436|FG001|STARTED|Overall Study||36||
48387874|NCT00698035|101279435|FG000|COMPLETED|Overall Study||35||
48387875|NCT00698035|101279436|FG001|COMPLETED|Overall Study||34||
48387876|NCT00698035|101279435|FG000|NOT COMPLETED|Overall Study||4||
48387877|NCT00698035|101279436|FG001|NOT COMPLETED|Overall Study||2||
48387878|NCT01770691|101279437|FG000|STARTED|Overall Study||7||
48387879|NCT01770691|101279437|FG000|COMPLETED|Overall Study||7||
48387880|NCT01770691|101279437|FG000|NOT COMPLETED|Overall Study||0||
48259626|NCT00719043|100955149|FG006|NOT COMPLETED|Overall Study||28||
48259627|NCT00573651|100955150|FG000|STARTED|Overall Study||43|one patient withdrew consent|
48259628|NCT00573651|100955150|FG000|COMPLETED|Overall Study||39|Any one who got a blood draw after the 3rd vaccine are considered completed as the primary outcome is available.|
48259629|NCT00573651|100955150|FG000|NOT COMPLETED|Overall Study||4||
48259630|NCT02363998|100955151|FG000|STARTED|Overall Study||286||
48387881|NCT01669642|101279438|FG000|STARTED|Overall Study||20||
48387882|NCT01669642|101279439|FG001|STARTED|Overall Study||20||
48387883|NCT01669642|101279440|FG002|STARTED|Overall Study||20||
48387884|NCT01669642|101279441|FG003|STARTED|Overall Study||21||
48387885|NCT01669642|101279442|FG004|STARTED|Overall Study||20||
48259631|NCT02363998|100955151|FG000|COMPLETED|Overall Study||168||
48259632|NCT02363998|100955151|FG000|NOT COMPLETED|Overall Study||118||
48259633|NCT01441583|100955152|FG000|STARTED|Overall Study||50||
48259634|NCT01441583|100955153|FG001|STARTED|Overall Study||50||
48689299|NCT02752490|102022659|FG001|STARTED|Overall Study||435||
48689300|NCT02752490|102022658|FG000|COMPLETED|Overall Study||409||
48689301|NCT02752490|102022659|FG001|COMPLETED|Overall Study||435||
48259635|NCT01441583|100955154|FG002|STARTED|Overall Study||36||
48259636|NCT01441583|100955152|FG000|COMPLETED|Overall Study||48||
48259637|NCT01441583|100955153|FG001|COMPLETED|Overall Study||49||
48259638|NCT01441583|100955154|FG002|COMPLETED|Overall Study||27||
48259639|NCT01441583|100955152|FG000|NOT COMPLETED|Overall Study||2||
48259640|NCT01441583|100955153|FG001|NOT COMPLETED|Overall Study||1||
48259641|NCT01441583|100955154|FG002|NOT COMPLETED|Overall Study||9||
48259642|NCT01182103|100955155|FG000|STARTED|Overall Study||48||
48259643|NCT01182103|100955156|FG001|STARTED|Overall Study||62||
48259644|NCT01182103|100955155|FG000|COMPLETED|Overall Study||48||
48259645|NCT01182103|100955156|FG001|COMPLETED|Overall Study||62||
48259646|NCT01182103|100955155|FG000|NOT COMPLETED|Overall Study||0||
48259647|NCT01182103|100955156|FG001|NOT COMPLETED|Overall Study||0||
48259648|NCT00568698|100955157|FG000|STARTED|Overall Study||29||
48259649|NCT00568698|100955157|FG000|COMPLETED|Overall Study||18||
48259650|NCT00568698|100955157|FG000|NOT COMPLETED|Overall Study||11||
48259651|NCT03954223|100955158|FG000|STARTED|Overall Study||15||
48259652|NCT03954223|100955159|FG001|STARTED|Overall Study||19||
48259653|NCT03954223|100955160|FG002|STARTED|Overall Study||16||
48259654|NCT03954223|100955158|FG000|COMPLETED|Overall Study||15||
48259655|NCT03954223|100955159|FG001|COMPLETED|Overall Study||19||
48259656|NCT03954223|100955160|FG002|COMPLETED|Overall Study||16||
48259657|NCT03954223|100955158|FG000|NOT COMPLETED|Overall Study||0||
48259658|NCT03954223|100955159|FG001|NOT COMPLETED|Overall Study||0||
48259659|NCT03954223|100955160|FG002|NOT COMPLETED|Overall Study||0||
48259660|NCT01407276|100955161|FG000|STARTED|Overall Study||6||
48259661|NCT01407276|100955162|FG001|STARTED|Overall Study||6||
48259662|NCT01407276|100955163|FG002|STARTED|Overall Study||6||
48259663|NCT01407276|100955164|FG003|STARTED|Overall Study||6||
48259664|NCT01407276|100955165|FG004|STARTED|Overall Study||6||
48259665|NCT01407276|100955166|FG005|STARTED|Overall Study||6||
48259666|NCT01407276|100955167|FG006|STARTED|Overall Study||6||
48259667|NCT01407276|100955168|FG007|STARTED|Overall Study||7||
48259668|NCT01407276|100955161|FG000|COMPLETED|Overall Study||6||
48259669|NCT01407276|100955162|FG001|COMPLETED|Overall Study||6||
48259670|NCT01407276|100955163|FG002|COMPLETED|Overall Study||6||
48259671|NCT01407276|100955164|FG003|COMPLETED|Overall Study||6||
48259672|NCT01407276|100955165|FG004|COMPLETED|Overall Study||6||
48259673|NCT01407276|100955166|FG005|COMPLETED|Overall Study||6||
48259674|NCT01407276|100955167|FG006|COMPLETED|Overall Study||6||
48259675|NCT01407276|100955168|FG007|COMPLETED|Overall Study||6||
48259676|NCT01407276|100955161|FG000|NOT COMPLETED|Overall Study||0||
48259677|NCT01407276|100955162|FG001|NOT COMPLETED|Overall Study||0||
48259678|NCT01407276|100955163|FG002|NOT COMPLETED|Overall Study||0||
48259679|NCT01407276|100955164|FG003|NOT COMPLETED|Overall Study||0||
48259680|NCT01407276|100955165|FG004|NOT COMPLETED|Overall Study||0||
48259681|NCT01407276|100955166|FG005|NOT COMPLETED|Overall Study||0||
48259682|NCT01407276|100955167|FG006|NOT COMPLETED|Overall Study||0||
48259683|NCT01407276|100955168|FG007|NOT COMPLETED|Overall Study||1||
48259684|NCT00912223|100955169|FG000|STARTED|Overall Study||65||
48689302|NCT02752490|102022658|FG000|NOT COMPLETED|Overall Study||0||
48259685|NCT00912223|100955169|FG000|COMPLETED|Overall Study||62||
48689303|NCT02752490|102022659|FG001|NOT COMPLETED|Overall Study||0||
48259686|NCT00912223|100955169|FG000|NOT COMPLETED|Overall Study||3||
48259687|NCT04354168|100955170|FG000|STARTED|Overall Study||160||
48259688|NCT04354168|100955170|FG000|COMPLETED|Overall Study||138||
48387886|NCT01669642|101279443|FG005|STARTED|Overall Study||10||
48387887|NCT01669642|101279438|FG000|COMPLETED|Overall Study||20||
48387888|NCT01669642|101279439|FG001|COMPLETED|Overall Study||20||
48387889|NCT01669642|101279440|FG002|COMPLETED|Overall Study||20||
48387890|NCT01669642|101279441|FG003|COMPLETED|Overall Study||20||
48689304|NCT03230318|102022660|FG000|STARTED|Overall Study||104||
48689305|NCT03230318|102022661|FG001|STARTED|Overall Study||44||
48689306|NCT03230318|102022660|FG000|COMPLETED|Overall Study||0||
48689307|NCT03230318|102022661|FG001|COMPLETED|Overall Study||0||
48689308|NCT03230318|102022660|FG000|NOT COMPLETED|Overall Study||104||
48689309|NCT03230318|102022661|FG001|NOT COMPLETED|Overall Study||44||
48689310|NCT03374358|102022662|FG000|STARTED|Overall Study||24||
48689311|NCT03374358|102022663|FG001|STARTED|Overall Study||21||
48689312|NCT03374358|102022662|FG000|COMPLETED|Overall Study||24||
48689313|NCT03374358|102022663|FG001|COMPLETED|Overall Study||19||
48689314|NCT03374358|102022662|FG000|NOT COMPLETED|Overall Study||0||
48689315|NCT03374358|102022663|FG001|NOT COMPLETED|Overall Study||2||
48689316|NCT00886769|102022664|FG000|STARTED|Overall Study||43||
48689317|NCT00886769|102022665|FG001|STARTED|Overall Study||41||
48689318|NCT00886769|102022664|FG000|COMPLETED|Overall Study||37||
48689319|NCT00886769|102022665|FG001|COMPLETED|Overall Study||4||
48689320|NCT00886769|102022664|FG000|NOT COMPLETED|Overall Study||6||
48689321|NCT00886769|102022665|FG001|NOT COMPLETED|Overall Study||37||
48689322|NCT01973231|102022666|FG000|STARTED|Overall Study||202||
48689323|NCT01973231|102022667|FG001|STARTED|Overall Study||202||
48689324|NCT01973231|102022666|FG000|COMPLETED|Overall Study||191||
48689325|NCT01973231|102022667|FG001|COMPLETED|Overall Study||190||
48689326|NCT01973231|102022666|FG000|NOT COMPLETED|Overall Study||11||
48689327|NCT01973231|102022667|FG001|NOT COMPLETED|Overall Study||12||
48689328|NCT00470262|102022668|FG000|STARTED|Overall Study||15||
48689329|NCT00470262|102022669|FG001|STARTED|Overall Study||12||
48689330|NCT00470262|102022668|FG000|COMPLETED|Overall Study||13||
48689331|NCT00470262|102022669|FG001|COMPLETED|Overall Study||12||
48689332|NCT00470262|102022668|FG000|NOT COMPLETED|Overall Study||2||
48689333|NCT00470262|102022669|FG001|NOT COMPLETED|Overall Study||0||
48689334|NCT02709512|102022670|FG000|STARTED|Phase 2||87||
48689335|NCT02709512|102022671|FG001|STARTED|Phase 2||89||
48689336|NCT02709512|102022670|FG000|COMPLETED|Phase 2||87||
48689337|NCT02709512|102022671|FG001|COMPLETED|Phase 2||89||
48689338|NCT02709512|102022670|FG000|NOT COMPLETED|Phase 2||0||
48689339|NCT02709512|102022671|FG001|NOT COMPLETED|Phase 2||0||
48689340|NCT02709512|102022670|FG000|STARTED|Phase 3||125||
48689341|NCT02709512|102022671|FG001|STARTED|Phase 3||124||
48689342|NCT02709512|102022670|FG000|COMPLETED|Phase 3||125||
48689343|NCT02709512|102022671|FG001|COMPLETED|Phase 3||124||
48689344|NCT02709512|102022670|FG000|NOT COMPLETED|Phase 3||0||
48689345|NCT02709512|102022671|FG001|NOT COMPLETED|Phase 3||0||
48689346|NCT01721486|102022672|FG000|STARTED|Overall Study||21||
48689347|NCT01721486|102022673|FG001|STARTED|Overall Study||20||
48689348|NCT01721486|102022672|FG000|COMPLETED|Overall Study||20||
48689349|NCT01721486|102022673|FG001|COMPLETED|Overall Study||19||
48689350|NCT01721486|102022672|FG000|NOT COMPLETED|Overall Study||1||
48689351|NCT01721486|102022673|FG001|NOT COMPLETED|Overall Study||1||
48689352|NCT04560686|102022674|FG000|STARTED|Overall Study||1||
48689353|NCT04560686|102022674|FG000|COMPLETED|Overall Study||1||
48689354|NCT04560686|102022674|FG000|NOT COMPLETED|Overall Study||0||
48689355|NCT00556439|102022675|FG000|STARTED|Study Entry to Week 12||49||
48689356|NCT00556439|102022676|FG001|STARTED|Study Entry to Week 12||0||
48689357|NCT00556439|102022677|FG002|STARTED|Study Entry to Week 12||34||
48689358|NCT00556439|102022678|FG003|STARTED|Study Entry to Week 12||0||
48259689|NCT04354168|100955170|FG000|NOT COMPLETED|Overall Study||22||
48387891|NCT01669642|101279442|FG004|COMPLETED|Overall Study||20||
48689359|NCT00556439|102022675|FG000|COMPLETED|Study Entry to Week 12||41||
48689360|NCT00556439|102022676|FG001|COMPLETED|Study Entry to Week 12||0||
48689361|NCT00556439|102022677|FG002|COMPLETED|Study Entry to Week 12||26||
48689362|NCT00556439|102022678|FG003|COMPLETED|Study Entry to Week 12||0||
48689363|NCT00556439|102022675|FG000|NOT COMPLETED|Study Entry to Week 12||8||
48689364|NCT00556439|102022676|FG001|NOT COMPLETED|Study Entry to Week 12||0||
48689365|NCT00556439|102022677|FG002|NOT COMPLETED|Study Entry to Week 12||8||
48689366|NCT00556439|102022678|FG003|NOT COMPLETED|Study Entry to Week 12||0||
48689367|NCT00556439|102022675|FG000|STARTED|After Week 12 (Randomized Study Period)||20||
48689368|NCT00556439|102022676|FG001|STARTED|After Week 12 (Randomized Study Period)||21||
48689369|NCT00556439|102022677|FG002|STARTED|After Week 12 (Randomized Study Period)||11||
48689370|NCT00556439|102022678|FG003|STARTED|After Week 12 (Randomized Study Period)||15||
48689371|NCT00556439|102022675|FG000|COMPLETED|After Week 12 (Randomized Study Period)||17||
48689372|NCT00556439|102022676|FG001|COMPLETED|After Week 12 (Randomized Study Period)||17||
48689373|NCT00556439|102022677|FG002|COMPLETED|After Week 12 (Randomized Study Period)||11||
48689374|NCT00556439|102022678|FG003|COMPLETED|After Week 12 (Randomized Study Period)||14||
48710794|NCT01215110|102078020|FG004|NOT COMPLETED|Overall Study||0||
48387892|NCT01669642|101279443|FG005|COMPLETED|Overall Study||0||
48387893|NCT01669642|101279438|FG000|NOT COMPLETED|Overall Study||0||
48387894|NCT01669642|101279439|FG001|NOT COMPLETED|Overall Study||0||
48387895|NCT01669642|101279440|FG002|NOT COMPLETED|Overall Study||0||
48387896|NCT01669642|101279441|FG003|NOT COMPLETED|Overall Study||1||
48387897|NCT01669642|101279442|FG004|NOT COMPLETED|Overall Study||0||
48387898|NCT01669642|101279443|FG005|NOT COMPLETED|Overall Study||10||
48387899|NCT02029495|101279444|FG000|STARTED|Overall Study||159||
48387900|NCT02029495|101279445|FG001|STARTED|Overall Study||158||
48387901|NCT02029495|101279446|FG002|STARTED|Overall Study||161||
48387902|NCT02029495|101279444|FG000|COMPLETED|Overall Study||158||
48387903|NCT02029495|101279445|FG001|COMPLETED|Overall Study||158||
48387904|NCT02029495|101279446|FG002|COMPLETED|Overall Study||159||
48387905|NCT02029495|101279444|FG000|NOT COMPLETED|Overall Study||1||
48387906|NCT02029495|101279445|FG001|NOT COMPLETED|Overall Study||0||
48387907|NCT02029495|101279446|FG002|NOT COMPLETED|Overall Study||2||
48387908|NCT01789346|101279447|FG000|STARTED|Overall Study||20||40
48387909|NCT01789346|101279447|FG000|Treatment With 532 nm KTP Laser|Overall Study||20||20
48387910|NCT01789346|101279447|FG000|Treatment With 595 nm PDL Laser|Overall Study||20||20
48387911|NCT01789346|101279447|FG000|COMPLETED|Overall Study||18||36
48387912|NCT01789346|101279447|FG000|NOT COMPLETED|Overall Study||2||4
48387913|NCT00793182|101279448|FG000|STARTED|Overall Study||2||
48387914|NCT00793182|101279449|FG001|STARTED|Overall Study||4||
48387915|NCT00793182|101279448|FG000|COMPLETED|Overall Study||2||
48387916|NCT00793182|101279449|FG001|COMPLETED|Overall Study||3||
48387917|NCT00793182|101279448|FG000|NOT COMPLETED|Overall Study||0||
48387918|NCT00793182|101279449|FG001|NOT COMPLETED|Overall Study||1||
48387919|NCT00178464|101279450|FG000|STARTED|Overall Study||11||
48387920|NCT00178464|101279450|FG000|COMPLETED|Overall Study||9||
48387921|NCT00178464|101279450|FG000|NOT COMPLETED|Overall Study||2||
48387922|NCT00488592|101279451|FG000|STARTED|Overall Study||10||
48387923|NCT00488592|101279451|FG000|COMPLETED|Overall Study||7||
48387924|NCT00488592|101279451|FG000|NOT COMPLETED|Overall Study||3||
48387925|NCT03428997|101279452|FG000|STARTED|Overall Study||24||
48387926|NCT03428997|101279452|FG000|COMPLETED|Overall Study||16||
48387927|NCT03428997|101279452|FG000|NOT COMPLETED|Overall Study||8||
48387928|NCT04218799|101279453|FG000|STARTED|Overall Study||7||
48387929|NCT04218799|101279453|FG000|COMPLETED|Overall Study||7||
48387930|NCT04218799|101279453|FG000|NOT COMPLETED|Overall Study||0||
48387931|NCT02682030|101279454|FG000|STARTED|Overall Study||1||
48387932|NCT02682030|101279455|FG001|STARTED|Overall Study||4||
48387933|NCT02682030|101279454|FG000|COMPLETED|Overall Study||0||
48387934|NCT02682030|101279455|FG001|COMPLETED|Overall Study||2||
48387935|NCT02682030|101279454|FG000|NOT COMPLETED|Overall Study||1||
48387936|NCT02682030|101279455|FG001|NOT COMPLETED|Overall Study||2||
48387937|NCT00111475|101279456|FG000|STARTED|Overall Study||4||
48387938|NCT00111475|101279457|FG001|STARTED|Overall Study||4||
48387939|NCT00111475|101279458|FG002|STARTED|Overall Study||4||
48387940|NCT00111475|101279459|FG003|STARTED|Overall Study||4||
48387941|NCT00111475|101279460|FG004|STARTED|Overall Study||4||
48387942|NCT00111475|101279461|FG005|STARTED|Overall Study||4||
48387943|NCT00111475|101279462|FG006|STARTED|Overall Study||4||
48387944|NCT00111475|101279463|FG007|STARTED|Overall Study||8||
48387945|NCT00111475|101279464|FG008|STARTED|Overall Study||8||
48387946|NCT00111475|101279465|FG009|STARTED|Overall Study||1||
48387947|NCT00111475|101279456|FG000|COMPLETED|Overall Study||4||
48387948|NCT00111475|101279457|FG001|COMPLETED|Overall Study||4||
48387949|NCT00111475|101279458|FG002|COMPLETED|Overall Study||4||
48387950|NCT00111475|101279459|FG003|COMPLETED|Overall Study||4||
48387951|NCT00111475|101279460|FG004|COMPLETED|Overall Study||4||
48387952|NCT00111475|101279461|FG005|COMPLETED|Overall Study||3||
48387953|NCT00111475|101279462|FG006|COMPLETED|Overall Study||4||
48387954|NCT00111475|101279463|FG007|COMPLETED|Overall Study||8||
48387955|NCT00111475|101279464|FG008|COMPLETED|Overall Study||8||
48387956|NCT00111475|101279465|FG009|COMPLETED|Overall Study||1||
48387957|NCT00111475|101279456|FG000|NOT COMPLETED|Overall Study||0||
48387958|NCT00111475|101279457|FG001|NOT COMPLETED|Overall Study||0||
48387959|NCT00111475|101279458|FG002|NOT COMPLETED|Overall Study||0||
48387960|NCT00111475|101279459|FG003|NOT COMPLETED|Overall Study||0||
48387961|NCT00111475|101279460|FG004|NOT COMPLETED|Overall Study||0||
48387962|NCT00111475|101279461|FG005|NOT COMPLETED|Overall Study||1||
48387963|NCT00111475|101279462|FG006|NOT COMPLETED|Overall Study||0||
48387964|NCT00111475|101279463|FG007|NOT COMPLETED|Overall Study||0||
48387965|NCT00111475|101279464|FG008|NOT COMPLETED|Overall Study||0||
48387966|NCT00111475|101279465|FG009|NOT COMPLETED|Overall Study||0||
48387967|NCT00664755|101279466|FG000|STARTED|Overall Study||67||
48387968|NCT00664755|101279467|FG001|STARTED|Overall Study||73||
48387969|NCT00664755|101279466|FG000|COMPLETED|Overall Study||67||
48387970|NCT00664755|101279467|FG001|COMPLETED|Overall Study||73||
48387971|NCT00664755|101279466|FG000|NOT COMPLETED|Overall Study||0||
48387972|NCT00664755|101279467|FG001|NOT COMPLETED|Overall Study||0||
48387973|NCT03224585|101279468|FG000|STARTED|Overall Study||2||
48387974|NCT03224585|101279469|FG001|STARTED|Overall Study||3||
48387975|NCT03224585|101279468|FG000|COMPLETED|Overall Study||2||
48387976|NCT03224585|101279469|FG001|COMPLETED|Overall Study||3||
48387977|NCT03224585|101279468|FG000|NOT COMPLETED|Overall Study||0||
48387978|NCT03224585|101279469|FG001|NOT COMPLETED|Overall Study||0||
48387979|NCT04656418|101279470|FG000|STARTED|Overall Study||39||
48387980|NCT04656418|101279471|FG001|STARTED|Overall Study||25||
48387981|NCT04656418|101279470|FG000|Intention-to-treat (ITT) Analysis Set|Overall Study||39|ITT analysis set included all the randomized participants who provided written informed consent and underwent study screening procedures.|
48387982|NCT04656418|101279471|FG001|Intention-to-treat (ITT) Analysis Set|Overall Study||25|ITT analysis set included all the randomized participants who provided written informed consent and underwent study screening procedures.|
48387983|NCT04656418|101279470|FG000|Safety Analysis Set|Overall Study||39|Safety analysis set included all the randomized participants who provided written informed consent, underwent study screening procedures and received at least 1 dose of the investigational product.|
48387984|NCT04656418|101279471|FG001|Safety Analysis Set|Overall Study||25|Safety analysis set included all the randomized participants who provided written informed consent, underwent study screening procedures and received at least 1 dose of the investigational product.|
48387985|NCT04656418|101279470|FG000|COMPLETED|Overall Study||38||
48387986|NCT04656418|101279471|FG001|COMPLETED|Overall Study||22||
48387987|NCT04656418|101279470|FG000|NOT COMPLETED|Overall Study||1||
48387988|NCT04656418|101279471|FG001|NOT COMPLETED|Overall Study||3||
48387989|NCT03123055|101279472|FG000|STARTED|Overall Study||28||
48387990|NCT03123055|101279472|FG000|COMPLETED|Overall Study||28||
48689375|NCT00556439|102022675|FG000|NOT COMPLETED|After Week 12 (Randomized Study Period)||3||
48689376|NCT00556439|102022676|FG001|NOT COMPLETED|After Week 12 (Randomized Study Period)||4||
48689377|NCT00556439|102022677|FG002|NOT COMPLETED|After Week 12 (Randomized Study Period)||0||
48689378|NCT00556439|102022678|FG003|NOT COMPLETED|After Week 12 (Randomized Study Period)||1||
48689379|NCT01766037|102022679|FG000|STARTED|Overall Study||111||
48689380|NCT01766037|102022680|FG001|STARTED|Overall Study||60||
48689381|NCT01766037|102022679|FG000|COMPLETED|Overall Study||82||
48689382|NCT01766037|102022680|FG001|COMPLETED|Overall Study||31||
48689383|NCT01766037|102022679|FG000|NOT COMPLETED|Overall Study||29||
48689384|NCT01766037|102022680|FG001|NOT COMPLETED|Overall Study||29||
48689385|NCT04194944|102022681|FG000|STARTED|Overall Study||159||
48689386|NCT04194944|102022682|FG001|STARTED|Overall Study||102||
48689387|NCT04194944|102022681|FG000|Received at Least One Dose of Study Drug|Overall Study||158||
48689388|NCT04194944|102022682|FG001|Received at Least One Dose of Study Drug|Overall Study||98||
48689389|NCT04194944|102022681|FG000|COMPLETED|Overall Study||61||
48689390|NCT04194944|102022682|FG001|COMPLETED|Overall Study||70||
48689391|NCT04194944|102022681|FG000|NOT COMPLETED|Overall Study||98||
48689392|NCT04194944|102022682|FG001|NOT COMPLETED|Overall Study||32||
48689393|NCT04684576|102022683|FG000|STARTED|Overall Study||12||
48689394|NCT04684576|102022684|FG001|STARTED|Overall Study||12||
48689395|NCT04684576|102022683|FG000|COMPLETED|Overall Study||12||
48689396|NCT04684576|102022684|FG001|COMPLETED|Overall Study||12||
48689397|NCT04684576|102022683|FG000|NOT COMPLETED|Overall Study||0||
48689398|NCT04684576|102022684|FG001|NOT COMPLETED|Overall Study||0||
48689399|NCT02628405|102022685|FG000|STARTED|Overall Study||30||
48689400|NCT02628405|102022685|FG000|COMPLETED|Overall Study||30||
48689401|NCT02628405|102022685|FG000|NOT COMPLETED|Overall Study||0||
48689402|NCT01144624|102022686|FG000|STARTED|Overall Study||7||
48689403|NCT01144624|102022687|FG001|STARTED|Overall Study||7||
48689404|NCT01144624|102022688|FG002|STARTED|Overall Study||6||
48689405|NCT01144624|102022686|FG000|Received Treatment|Overall Study||7||
48689406|NCT01144624|102022687|FG001|Received Treatment|Overall Study||7||
48387991|NCT03123055|101279472|FG000|NOT COMPLETED|Overall Study||0||
48387992|NCT03943888|101279473|FG000|STARTED|Overall Study||10||
48387993|NCT03943888|101279474|FG001|STARTED|Overall Study||10||
48689407|NCT01144624|102022688|FG002|Received Treatment|Overall Study||6||
48689408|NCT01144624|102022686|FG000|Completed Treatment|Overall Study||7||
48689409|NCT01144624|102022687|FG001|Completed Treatment|Overall Study||7||
48387994|NCT03943888|101279475|FG002|STARTED|Overall Study||10||
48387995|NCT03943888|101279476|FG003|STARTED|Overall Study||10||
48689410|NCT01144624|102022688|FG002|Completed Treatment|Overall Study||6||
48689411|NCT01144624|102022686|FG000|COMPLETED|Overall Study||7||
48689412|NCT01144624|102022687|FG001|COMPLETED|Overall Study||7||
48689413|NCT01144624|102022688|FG002|COMPLETED|Overall Study||6||
48689414|NCT01144624|102022686|FG000|NOT COMPLETED|Overall Study||0||
48689415|NCT01144624|102022687|FG001|NOT COMPLETED|Overall Study||0||
48689416|NCT01144624|102022688|FG002|NOT COMPLETED|Overall Study||0||
48689417|NCT03799952|102022689|FG000|STARTED|Overall Study||31||
48689418|NCT03799952|102022690|FG001|STARTED|Overall Study||31||
48689419|NCT03799952|102022689|FG000|COMPLETED|Overall Study||30||
48689420|NCT03799952|102022690|FG001|COMPLETED|Overall Study||29||
48689421|NCT03799952|102022689|FG000|NOT COMPLETED|Overall Study||1||
48689422|NCT03799952|102022690|FG001|NOT COMPLETED|Overall Study||2||
48689423|NCT04615624|102022691|FG000|STARTED|Overall Study||33||
48689424|NCT04615624|102022692|FG001|STARTED|Overall Study||32||
48689425|NCT04615624|102022691|FG000|COMPLETED|Overall Study||33||
48689426|NCT04615624|102022692|FG001|COMPLETED|Overall Study||32||
48689427|NCT04615624|102022691|FG000|NOT COMPLETED|Overall Study||0||
48689428|NCT04615624|102022692|FG001|NOT COMPLETED|Overall Study||0||
48689429|NCT02008942|102022693|FG000|STARTED|First Intervention||27||
48689430|NCT02008942|102022694|FG001|STARTED|First Intervention||30||
48387996|NCT03943888|101279473|FG000|COMPLETED|Overall Study||10||
48387997|NCT03943888|101279474|FG001|COMPLETED|Overall Study||10||
48387998|NCT03943888|101279475|FG002|COMPLETED|Overall Study||10||
48387999|NCT03943888|101279476|FG003|COMPLETED|Overall Study||10||
48388000|NCT03943888|101279473|FG000|NOT COMPLETED|Overall Study||0||
48388001|NCT03943888|101279474|FG001|NOT COMPLETED|Overall Study||0||
48388002|NCT03943888|101279475|FG002|NOT COMPLETED|Overall Study||0||
48388003|NCT03943888|101279476|FG003|NOT COMPLETED|Overall Study||0||
48388004|NCT04092816|101279477|FG000|STARTED|Overall Study||5||
48388005|NCT04092816|101279478|FG001|STARTED|Overall Study||5||
48388006|NCT04092816|101279477|FG000|COMPLETED|Overall Study||4||
48388007|NCT04092816|101279478|FG001|COMPLETED|Overall Study||3||
48388008|NCT04092816|101279477|FG000|NOT COMPLETED|Overall Study||1||
48388009|NCT04092816|101279478|FG001|NOT COMPLETED|Overall Study||2||
48388010|NCT03325556|101279479|FG000|STARTED|Open-label Period||392||
48388011|NCT03325556|101279480|FG001|STARTED|Open-label Period||0||
48388012|NCT03325556|101279481|FG002|STARTED|Open-label Period||0||
48388013|NCT03325556|101279479|FG000|COMPLETED|Open-label Period||217||
48388014|NCT03325556|101279480|FG001|COMPLETED|Open-label Period||0||
48388015|NCT03325556|101279481|FG002|COMPLETED|Open-label Period||0||
48388016|NCT03325556|101279479|FG000|NOT COMPLETED|Open-label Period||175||
48388017|NCT03325556|101279480|FG001|NOT COMPLETED|Open-label Period||0||
48388018|NCT03325556|101279481|FG002|NOT COMPLETED|Open-label Period||0||
48388019|NCT03325556|101279479|FG000|STARTED|Double-blind Period||0||
48388020|NCT03325556|101279480|FG001|STARTED|Double-blind Period||105||
48388021|NCT03325556|101279481|FG002|STARTED|Double-blind Period||112||
48388022|NCT03325556|101279479|FG000|COMPLETED|Double-blind Period||0||
48388023|NCT03325556|101279480|FG001|COMPLETED|Double-blind Period||44||
48388024|NCT03325556|101279481|FG002|COMPLETED|Double-blind Period||35||
48388025|NCT03325556|101279479|FG000|NOT COMPLETED|Double-blind Period||0||
48388026|NCT03325556|101279480|FG001|NOT COMPLETED|Double-blind Period||61||
48388027|NCT03325556|101279481|FG002|NOT COMPLETED|Double-blind Period||77||
48388028|NCT01825655|101279482|FG000|STARTED|Overall Study||0||
48388029|NCT01825655|101279483|FG001|STARTED|Overall Study||2||
48388030|NCT01825655|101279482|FG000|COMPLETED|Overall Study||0||
48388031|NCT01825655|101279483|FG001|COMPLETED|Overall Study||2||
48388032|NCT01825655|101279482|FG000|NOT COMPLETED|Overall Study||0||
48388033|NCT01825655|101279483|FG001|NOT COMPLETED|Overall Study||0||
48388034|NCT00600028|101279484|FG000|STARTED|First Intervention (12 Weeks)||13||
48388035|NCT00600028|101279485|FG001|STARTED|First Intervention (12 Weeks)||11||
48388036|NCT00600028|101279484|FG000|COMPLETED|First Intervention (12 Weeks)||12||
48388037|NCT00600028|101279485|FG001|COMPLETED|First Intervention (12 Weeks)||10||
48388038|NCT00600028|101279484|FG000|NOT COMPLETED|First Intervention (12 Weeks)||1||
48388039|NCT00600028|101279485|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1||
48388040|NCT00600028|101279484|FG000|STARTED|Second Intervention (12 Weeks)||12||
48388041|NCT00600028|101279485|FG001|STARTED|Second Intervention (12 Weeks)||10||
48388042|NCT00600028|101279484|FG000|COMPLETED|Second Intervention (12 Weeks)||12||
48388043|NCT00600028|101279485|FG001|COMPLETED|Second Intervention (12 Weeks)||8||
48388044|NCT00600028|101279484|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0||
48388045|NCT00600028|101279485|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||2||
48388046|NCT01736254|101279486|FG000|STARTED|Period 1 (Day 1)||24||
48388047|NCT01736254|101279486|FG000|Received at Least One Dose of Study Drug|Period 1 (Day 1)||24||
48388048|NCT01736254|101279486|FG000|COMPLETED|Period 1 (Day 1)||24||
48388049|NCT01736254|101279486|FG000|NOT COMPLETED|Period 1 (Day 1)||0||
48388050|NCT01736254|101279486|FG000|STARTED|Period 2 (Days 2 to 12)||24||
48388051|NCT01736254|101279486|FG000|COMPLETED|Period 2 (Days 2 to 12)||21||
48388052|NCT01736254|101279486|FG000|NOT COMPLETED|Period 2 (Days 2 to 12)||3||
48388053|NCT01736254|101279486|FG000|STARTED|Period 3 (Days 13 to 23)||21||
48388054|NCT01736254|101279486|FG000|COMPLETED|Period 3 (Days 13 to 23)||20||
48388055|NCT01736254|101279486|FG000|NOT COMPLETED|Period 3 (Days 13 to 23)||1||
48388056|NCT02581865|101279487|FG000|STARTED|Overall Study||40||
48388057|NCT02581865|101279488|FG001|STARTED|Overall Study||42||
48388058|NCT02581865|101279489|FG002|STARTED|Overall Study||42||
48388059|NCT02581865|101279487|FG000|COMPLETED|Overall Study||36||
48388060|NCT02581865|101279488|FG001|COMPLETED|Overall Study||35||
48388061|NCT02581865|101279489|FG002|COMPLETED|Overall Study||26||
48388062|NCT02581865|101279487|FG000|NOT COMPLETED|Overall Study||4||
48388063|NCT02581865|101279488|FG001|NOT COMPLETED|Overall Study||7||
48388064|NCT02581865|101279489|FG002|NOT COMPLETED|Overall Study||16||
48388065|NCT00039741|101279490|FG000|STARTED|Overall Study||66||
48388066|NCT00039741|101279491|FG001|STARTED|Overall Study||68||
48388067|NCT00039741|101279492|FG002|STARTED|Overall Study||65||
48388068|NCT00039741|101279493|FG003|STARTED|Overall Study||64||
48388069|NCT00039741|101279490|FG000|Death|Overall Study||0||
48388070|NCT00039741|101279491|FG001|Death|Overall Study||1||
48388071|NCT00039741|101279492|FG002|Death|Overall Study||0||
48388072|NCT00039741|101279493|FG003|Death|Overall Study||0||
48388073|NCT00039741|101279490|FG000|COMPLETED|Overall Study||51||
48388074|NCT00039741|101279491|FG001|COMPLETED|Overall Study||56||
48388075|NCT00039741|101279492|FG002|COMPLETED|Overall Study||54||
48388076|NCT00039741|101279493|FG003|COMPLETED|Overall Study||50||
48388077|NCT00039741|101279490|FG000|NOT COMPLETED|Overall Study||15||
48388078|NCT00039741|101279491|FG001|NOT COMPLETED|Overall Study||12||
48388079|NCT00039741|101279492|FG002|NOT COMPLETED|Overall Study||11||
48388080|NCT00039741|101279493|FG003|NOT COMPLETED|Overall Study||14||
48388081|NCT00413335|101279494|FG000|STARTED|Overall Study||12||
48388082|NCT00413335|101279495|FG001|STARTED|Overall Study||9||
48388083|NCT00413335|101279494|FG000|COMPLETED|Overall Study||12||
48388084|NCT00413335|101279495|FG001|COMPLETED|Overall Study||9||
48388085|NCT00413335|101279494|FG000|NOT COMPLETED|Overall Study||0||
48388086|NCT00413335|101279495|FG001|NOT COMPLETED|Overall Study||0||
48388087|NCT01610076|101279496|FG000|STARTED|Overall Study||103||
48388088|NCT01610076|101279497|FG001|STARTED|Overall Study||105||
48388089|NCT01610076|101279496|FG000|COMPLETED|Overall Study||100||
48388090|NCT01610076|101279497|FG001|COMPLETED|Overall Study||100||
48388091|NCT01610076|101279496|FG000|NOT COMPLETED|Overall Study||3||
48388092|NCT01610076|101279497|FG001|NOT COMPLETED|Overall Study||5||
48388093|NCT01589510|101279498|FG000|STARTED|Overall Study||419||
48388094|NCT01589510|101279498|FG000|COMPLETED|Overall Study||386||
48388095|NCT01589510|101279498|FG000|NOT COMPLETED|Overall Study||33||
48388096|NCT04404010|101279499|FG000|STARTED|Overall Study||10||
48388097|NCT04404010|101279500|FG001|STARTED|Overall Study||9||
48388098|NCT04404010|101279499|FG000|COMPLETED|Overall Study||9||
48388099|NCT04404010|101279500|FG001|COMPLETED|Overall Study||9||
48388100|NCT04404010|101279499|FG000|NOT COMPLETED|Overall Study||1||
48388101|NCT04404010|101279500|FG001|NOT COMPLETED|Overall Study||0||
48095429|NCT04461015|100556332|FG000|COMPLETED|Overall Study||5||
48095430|NCT04461015|100556333|FG001|COMPLETED|Overall Study||5||
48095431|NCT04461015|100556332|FG000|NOT COMPLETED|Overall Study||0||
48388102|NCT00293423|101279501|FG000|STARTED|Surgical Resection||28||
48388103|NCT00293423|101279502|FG001|STARTED|Surgical Resection||68||
48388104|NCT00293423|101279501|FG000|COMPLETED|Surgical Resection||12|All patients underwent aggressive resection with intra-operative collection of tissue to generate autologous vaccine. Only participants with adequate tissue collected to generate enough vaccine and whose vaccines passed quality control standards received the vaccine and constituted the intent-to-treat group|
48388105|NCT00293423|101279502|FG001|COMPLETED|Surgical Resection||41|All patients underwent aggressive resection with intra-operative collection of tissue to generate autologous vaccine. Only participants with adequate tissue collected to generate enough vaccine and whose vaccines passed quality control standards received the vaccine and constituted the intent-to-treat group|
48388106|NCT00293423|101279501|FG000|NOT COMPLETED|Surgical Resection||16||
48388107|NCT00293423|101279502|FG001|NOT COMPLETED|Surgical Resection||27||
48388108|NCT00293423|101279501|FG000|STARTED|Vaccination Treatment Period||12||
48388109|NCT00293423|101279502|FG001|STARTED|Vaccination Treatment Period||41||
48388110|NCT00293423|101279501|FG000|COMPLETED|Vaccination Treatment Period||12||
48388111|NCT00293423|101279502|FG001|COMPLETED|Vaccination Treatment Period||38||
48388112|NCT00293423|101279501|FG000|NOT COMPLETED|Vaccination Treatment Period||0||
48388113|NCT00293423|101279502|FG001|NOT COMPLETED|Vaccination Treatment Period||3||
48388114|NCT03741725|101279503|FG000|STARTED|Overall Study||101||10
48388115|NCT03741725|101279504|FG001|STARTED|Overall Study||100||10
48388116|NCT03741725|101279505|FG002|STARTED|Overall Study||100||10
48388117|NCT03741725|101279503|FG000|COMPLETED|Overall Study||101||10
48388118|NCT03741725|101279504|FG001|COMPLETED|Overall Study||100||10
48388119|NCT03741725|101279505|FG002|COMPLETED|Overall Study||100||10
48388120|NCT03741725|101279503|FG000|NOT COMPLETED|Overall Study||0||0
48388121|NCT03741725|101279504|FG001|NOT COMPLETED|Overall Study||0||0
48388122|NCT03741725|101279505|FG002|NOT COMPLETED|Overall Study||0||0
48388123|NCT01244191|101279506|FG000|STARTED|Overall Study||526||
48388124|NCT01244191|101279507|FG001|STARTED|Overall Study||522||
48388125|NCT01244191|101279506|FG000|Did Not Receive Treatment|Overall Study||6||
48388126|NCT01244191|101279507|FG001|Did Not Receive Treatment|Overall Study||5||
48388127|NCT01244191|101279506|FG000|COMPLETED|Overall Study||46||
48388128|NCT01244191|101279507|FG001|COMPLETED|Overall Study||24||
48388129|NCT01244191|101279506|FG000|NOT COMPLETED|Overall Study||480||
48388130|NCT01244191|101279507|FG001|NOT COMPLETED|Overall Study||498||
48388131|NCT01071096|101279508|FG000|STARTED|First Intervention (90 Days)||10||
48388132|NCT01071096|101279509|FG001|STARTED|First Intervention (90 Days)||10||
48388133|NCT01071096|101279508|FG000|COMPLETED|First Intervention (90 Days)||9||
48388134|NCT01071096|101279509|FG001|COMPLETED|First Intervention (90 Days)||10||
48388135|NCT01071096|101279508|FG000|NOT COMPLETED|First Intervention (90 Days)||1||
48388136|NCT01071096|101279509|FG001|NOT COMPLETED|First Intervention (90 Days)||0||
48388137|NCT01071096|101279508|FG000|STARTED|Washout Period (30 Days)||9||
48388138|NCT01071096|101279509|FG001|STARTED|Washout Period (30 Days)||10||
48388139|NCT01071096|101279508|FG000|COMPLETED|Washout Period (30 Days)||9||
48388140|NCT01071096|101279509|FG001|COMPLETED|Washout Period (30 Days)||10||
48388141|NCT01071096|101279508|FG000|NOT COMPLETED|Washout Period (30 Days)||0||
48388142|NCT01071096|101279509|FG001|NOT COMPLETED|Washout Period (30 Days)||0||
48388143|NCT01071096|101279508|FG000|STARTED|Second Intervention (90 Days)||9||
48388144|NCT01071096|101279509|FG001|STARTED|Second Intervention (90 Days)||10||
48388145|NCT01071096|101279508|FG000|COMPLETED|Second Intervention (90 Days)||9||
48388146|NCT01071096|101279509|FG001|COMPLETED|Second Intervention (90 Days)||10||
48388147|NCT01071096|101279508|FG000|NOT COMPLETED|Second Intervention (90 Days)||0||
48388148|NCT01071096|101279509|FG001|NOT COMPLETED|Second Intervention (90 Days)||0||
48388149|NCT00505895|101279510|FG000|STARTED|Overall Study||27||
48388150|NCT00505895|101279511|FG001|STARTED|Overall Study||23||
48388151|NCT00505895|101279510|FG000|COMPLETED|Overall Study||27||
48388152|NCT00505895|101279511|FG001|COMPLETED|Overall Study||23||
48388153|NCT00505895|101279510|FG000|NOT COMPLETED|Overall Study||0||
48388154|NCT00505895|101279511|FG001|NOT COMPLETED|Overall Study||0||
48388155|NCT00502320|101279512|FG000|STARTED|Overall Study||25||
48388156|NCT00502320|101279513|FG001|STARTED|Overall Study||25||
48388157|NCT00502320|101279512|FG000|Screening Visit|Overall Study||25||
48388158|NCT00502320|101279513|FG001|Screening Visit|Overall Study||24||
48388159|NCT00502320|101279512|FG000|COMPLETED|Overall Study||19||
48388160|NCT00502320|101279513|FG001|COMPLETED|Overall Study||18||
48388161|NCT00502320|101279512|FG000|NOT COMPLETED|Overall Study||6||
48388162|NCT00502320|101279513|FG001|NOT COMPLETED|Overall Study||7||
48388163|NCT02133742|101279514|FG000|STARTED|Period 1: Dose Finding Phase (6 Months)||11||
48388164|NCT02133742|101279514|FG000|COMPLETED|Period 1: Dose Finding Phase (6 Months)||11||
48388165|NCT02133742|101279514|FG000|NOT COMPLETED|Period 1: Dose Finding Phase (6 Months)||0||
48388166|NCT02133742|101279514|FG000|STARTED|Period 2:Dose Expansion Phase (1344days)||52||
48388167|NCT02133742|101279514|FG000|COMPLETED|Period 2:Dose Expansion Phase (1344days)||0||
48388168|NCT02133742|101279514|FG000|NOT COMPLETED|Period 2:Dose Expansion Phase (1344days)||52||
48388169|NCT02486211|101279515|FG000|STARTED|Overall Study||7||
48388170|NCT02486211|101279516|FG001|STARTED|Overall Study||7||
48541852|NCT03095638|101662794|FG005|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4||
48259690|NCT04962698|100955171|FG000|STARTED|Motor Imagery||19||
48259691|NCT04962698|100955172|FG001|STARTED|Motor Imagery||6||
48259692|NCT04962698|100955171|FG000|COMPLETED|Motor Imagery||18||
48259693|NCT04962698|100955172|FG001|COMPLETED|Motor Imagery||4||
48259694|NCT04962698|100955171|FG000|NOT COMPLETED|Motor Imagery||1||
48259695|NCT04962698|100955172|FG001|NOT COMPLETED|Motor Imagery||2||
48259696|NCT04962698|100955171|FG000|STARTED|Kinesthetic MI||19||
48259697|NCT04962698|100955172|FG001|STARTED|Kinesthetic MI||0||
48259698|NCT04962698|100955171|FG000|COMPLETED|Kinesthetic MI||18||
48259699|NCT04962698|100955172|FG001|COMPLETED|Kinesthetic MI||0||
48259700|NCT04962698|100955171|FG000|NOT COMPLETED|Kinesthetic MI||1||
48259701|NCT04962698|100955172|FG001|NOT COMPLETED|Kinesthetic MI||0||
48259702|NCT04962698|100955171|FG000|STARTED|Robotic-hand Interaction With MI||19||
48259703|NCT04962698|100955172|FG001|STARTED|Robotic-hand Interaction With MI||6||
48259704|NCT04962698|100955171|FG000|COMPLETED|Robotic-hand Interaction With MI||18||
48259705|NCT04962698|100955172|FG001|COMPLETED|Robotic-hand Interaction With MI||4||
48259706|NCT04962698|100955171|FG000|NOT COMPLETED|Robotic-hand Interaction With MI||1||
48259707|NCT04962698|100955172|FG001|NOT COMPLETED|Robotic-hand Interaction With MI||2||
48259708|NCT04962698|100955171|FG000|STARTED|Robotic-hand Interaction Without MI||19||
48259709|NCT04962698|100955172|FG001|STARTED|Robotic-hand Interaction Without MI||0||
48259710|NCT04962698|100955171|FG000|COMPLETED|Robotic-hand Interaction Without MI||18||
48259711|NCT04962698|100955172|FG001|COMPLETED|Robotic-hand Interaction Without MI||0||
48259712|NCT04962698|100955171|FG000|NOT COMPLETED|Robotic-hand Interaction Without MI||1||
48259713|NCT04962698|100955172|FG001|NOT COMPLETED|Robotic-hand Interaction Without MI||0||
48259714|NCT04962698|100955171|FG000|STARTED|Virtual-hand Interaction||19||
48259715|NCT04962698|100955172|FG001|STARTED|Virtual-hand Interaction||0||
48259716|NCT04962698|100955171|FG000|COMPLETED|Virtual-hand Interaction||18||
48259717|NCT04962698|100955172|FG001|COMPLETED|Virtual-hand Interaction||0||
48259718|NCT04962698|100955171|FG000|NOT COMPLETED|Virtual-hand Interaction||1||
48259719|NCT04962698|100955172|FG001|NOT COMPLETED|Virtual-hand Interaction||0||
48259720|NCT04962698|100955171|FG000|STARTED|Robotic Action Observation||19||
48259721|NCT04962698|100955172|FG001|STARTED|Robotic Action Observation||0||
48259722|NCT04962698|100955171|FG000|COMPLETED|Robotic Action Observation||18||
48259723|NCT04962698|100955172|FG001|COMPLETED|Robotic Action Observation||0||
48259724|NCT04962698|100955171|FG000|NOT COMPLETED|Robotic Action Observation||1||
48259725|NCT04962698|100955172|FG001|NOT COMPLETED|Robotic Action Observation||0||
48259726|NCT04962698|100955171|FG000|STARTED|Rest||19||
48259727|NCT04962698|100955172|FG001|STARTED|Rest||6||
48259728|NCT04962698|100955171|FG000|COMPLETED|Rest||18||
48259729|NCT04962698|100955172|FG001|COMPLETED|Rest||4||
48259730|NCT04962698|100955171|FG000|NOT COMPLETED|Rest||1||
48259731|NCT04962698|100955172|FG001|NOT COMPLETED|Rest||2||
48259732|NCT03856047|100955173|FG000|STARTED|Overall Study||101||
48259733|NCT03856047|100955174|FG001|STARTED|Overall Study||100||
48259734|NCT03856047|100955175|FG002|STARTED|Overall Study||102||
48259735|NCT03856047|100955176|FG003|STARTED|Overall Study||102||
48259736|NCT03856047|100955177|FG004|STARTED|Overall Study||101||
48259737|NCT03856047|100955178|FG005|STARTED|Overall Study||99||
48259738|NCT03856047|100955179|FG006|STARTED|Overall Study||101||
48259739|NCT03856047|100955173|FG000|Full Analysis Set|Overall Study||101||
48259740|NCT03856047|100955174|FG001|Full Analysis Set|Overall Study||100||
48259741|NCT03856047|100955175|FG002|Full Analysis Set|Overall Study||102||
48259742|NCT03856047|100955176|FG003|Full Analysis Set|Overall Study||102||
48259743|NCT03856047|100955177|FG004|Full Analysis Set|Overall Study||101||
48259744|NCT03856047|100955178|FG005|Full Analysis Set|Overall Study||99||
48259745|NCT03856047|100955179|FG006|Full Analysis Set|Overall Study||101||
48259746|NCT03856047|100955173|FG000|Safety Analysis Set|Overall Study||101||
48388171|NCT02486211|101279515|FG000|COMPLETED|Overall Study||6||
48388172|NCT02486211|101279516|FG001|COMPLETED|Overall Study||7||
48388173|NCT02486211|101279515|FG000|NOT COMPLETED|Overall Study||1||
48689431|NCT02008942|102022693|FG000|COMPLETED|First Intervention||27||
48689432|NCT02008942|102022694|FG001|COMPLETED|First Intervention||30||
48689433|NCT02008942|102022693|FG000|NOT COMPLETED|First Intervention||0||
48689434|NCT02008942|102022694|FG001|NOT COMPLETED|First Intervention||0||
48689435|NCT02008942|102022693|FG000|STARTED|Second Intervention||26||
48689436|NCT02008942|102022694|FG001|STARTED|Second Intervention||30||
48689437|NCT02008942|102022693|FG000|COMPLETED|Second Intervention||25||
48689438|NCT02008942|102022694|FG001|COMPLETED|Second Intervention||30||
48689439|NCT02008942|102022693|FG000|NOT COMPLETED|Second Intervention||1||
48689440|NCT02008942|102022694|FG001|NOT COMPLETED|Second Intervention||0||
48689441|NCT03083665|102022695|FG000|STARTED|Double-Blind Period||149||
48689442|NCT03083665|102022696|FG001|STARTED|Double-Blind Period||152||
48689443|NCT03083665|102022697|FG002|STARTED|Double-Blind Period||148||
48388174|NCT02486211|101279516|FG001|NOT COMPLETED|Overall Study||0||
48388175|NCT03287245|101279517|FG000|STARTED|Overall Study||15||
48388176|NCT03287245|101279518|FG001|STARTED|Overall Study||5||
48388177|NCT03287245|101279519|FG002|STARTED|Overall Study||6||
48388178|NCT03287245|101279520|FG003|STARTED|Overall Study||1||
48388179|NCT03287245|101279517|FG000|COMPLETED|Overall Study||0||
48388180|NCT03287245|101279518|FG001|COMPLETED|Overall Study||0||
48388181|NCT03287245|101279519|FG002|COMPLETED|Overall Study||0||
48388182|NCT03287245|101279520|FG003|COMPLETED|Overall Study||0||
48388183|NCT03287245|101279517|FG000|NOT COMPLETED|Overall Study||15||
48388184|NCT03287245|101279518|FG001|NOT COMPLETED|Overall Study||5||
48388185|NCT03287245|101279519|FG002|NOT COMPLETED|Overall Study||6||
48388186|NCT03287245|101279520|FG003|NOT COMPLETED|Overall Study||1||
48388187|NCT01705964|101279521|FG000|STARTED|Overall Study||25||
48388188|NCT01705964|101279522|FG001|STARTED|Overall Study||24||
48388189|NCT01705964|101279521|FG000|COMPLETED|Overall Study||25||
48388190|NCT01705964|101279522|FG001|COMPLETED|Overall Study||24||
48388191|NCT01705964|101279521|FG000|NOT COMPLETED|Overall Study||0||
48388192|NCT01705964|101279522|FG001|NOT COMPLETED|Overall Study||0||
48388193|NCT00676793|101279523|FG000|STARTED|Overall Study||32||
48388194|NCT00676793|101279523|FG000|COMPLETED|Overall Study||19||
48388195|NCT00676793|101279523|FG000|NOT COMPLETED|Overall Study||13||
48388196|NCT00318565|101279524|FG000|STARTED|Overall Study||291||
48388197|NCT00318565|101279524|FG000|COMPLETED|Overall Study||267||
48388198|NCT00318565|101279524|FG000|NOT COMPLETED|Overall Study||24||
48388199|NCT03495817|101279525|FG000|STARTED|26 Week Open Label||31||
48388200|NCT03495817|101279525|FG000|COMPLETED|26 Week Open Label||23||
48388201|NCT03495817|101279525|FG000|NOT COMPLETED|26 Week Open Label||8||
48388202|NCT03495817|101279525|FG000|STARTED|26 Week Extension||19|The 26-week extension was not required, and 4 patients elected to not start the extension.|
48388203|NCT03495817|101279525|FG000|COMPLETED|26 Week Extension||17||
48388204|NCT03495817|101279525|FG000|NOT COMPLETED|26 Week Extension||2||
48388205|NCT01830816|101279526|FG000|STARTED|Overall Study||20||
48388206|NCT01830816|101279527|FG001|STARTED|Overall Study||14||
48388207|NCT01830816|101279528|FG002|STARTED|Overall Study||7||
48388208|NCT01830816|101279526|FG000|Pharmacokinetic-Evaluable Population|Overall Study||18||
48388209|NCT01830816|101279527|FG001|Pharmacokinetic-Evaluable Population|Overall Study||14||
48388210|NCT01830816|101279528|FG002|Pharmacokinetic-Evaluable Population|Overall Study||6||
48388211|NCT01830816|101279526|FG000|COMPLETED|Overall Study||0||
48689444|NCT03083665|102022698|FG003|STARTED|Double-Blind Period||0||
48689445|NCT03083665|102022699|FG004|STARTED|Double-Blind Period||0||
48689446|NCT03083665|102022700|FG005|STARTED|Double-Blind Period||0||
48388212|NCT01830816|101279527|FG001|COMPLETED|Overall Study||0||
48388213|NCT01830816|101279528|FG002|COMPLETED|Overall Study||0||
48388214|NCT01830816|101279526|FG000|NOT COMPLETED|Overall Study||20||
48388215|NCT01830816|101279527|FG001|NOT COMPLETED|Overall Study||14||
48388216|NCT01830816|101279528|FG002|NOT COMPLETED|Overall Study||7||
48689447|NCT03083665|102022695|FG000|Started Treatment Period (12 Weeks)|Double-Blind Period||149||
48689448|NCT03083665|102022696|FG001|Started Treatment Period (12 Weeks)|Double-Blind Period||152||
48689449|NCT03083665|102022697|FG002|Started Treatment Period (12 Weeks)|Double-Blind Period||148||
48689450|NCT03083665|102022698|FG003|Started Treatment Period (12 Weeks)|Double-Blind Period||0||
48689451|NCT03083665|102022699|FG004|Started Treatment Period (12 Weeks)|Double-Blind Period||0||
48689452|NCT03083665|102022700|FG005|Started Treatment Period (12 Weeks)|Double-Blind Period||0||
48689453|NCT03083665|102022695|FG000|Started Down-Titration Period (4 Weeks)|Double-Blind Period||7||
48689454|NCT03083665|102022696|FG001|Started Down-Titration Period (4 Weeks)|Double-Blind Period||9||
48689455|NCT03083665|102022697|FG002|Started Down-Titration Period (4 Weeks)|Double-Blind Period||7||
48388217|NCT01811355|101279529|FG000|STARTED|First Dose||11||
48388218|NCT01811355|101279530|FG001|STARTED|First Dose||12||
48388219|NCT01811355|101279529|FG000|COMPLETED|First Dose||9||
48388220|NCT01811355|101279530|FG001|COMPLETED|First Dose||12||
48388221|NCT01811355|101279529|FG000|NOT COMPLETED|First Dose||2||
48689456|NCT03083665|102022698|FG003|Started Down-Titration Period (4 Weeks)|Double-Blind Period||0||
48689457|NCT03083665|102022699|FG004|Started Down-Titration Period (4 Weeks)|Double-Blind Period||0||
48689458|NCT03083665|102022700|FG005|Started Down-Titration Period (4 Weeks)|Double-Blind Period||0||
48388222|NCT01811355|101279530|FG001|NOT COMPLETED|First Dose||0||
48388223|NCT01811355|101279529|FG000|STARTED|Washout||9||
48388224|NCT01811355|101279530|FG001|STARTED|Washout||12||
48388225|NCT01811355|101279529|FG000|COMPLETED|Washout||9||
48388226|NCT01811355|101279530|FG001|COMPLETED|Washout||12||
48388227|NCT01811355|101279529|FG000|NOT COMPLETED|Washout||0||
48388228|NCT01811355|101279530|FG001|NOT COMPLETED|Washout||0||
48388229|NCT01811355|101279529|FG000|STARTED|Second Dose||9||
48388230|NCT01811355|101279530|FG001|STARTED|Second Dose||12||
48388231|NCT01811355|101279529|FG000|COMPLETED|Second Dose||9||
48388232|NCT01811355|101279530|FG001|COMPLETED|Second Dose||12||
48388233|NCT01811355|101279529|FG000|NOT COMPLETED|Second Dose||0||
48388234|NCT01811355|101279530|FG001|NOT COMPLETED|Second Dose||0||
48388235|NCT04034043|101279531|FG000|STARTED|Overall Study||68||
48388236|NCT04034043|101279531|FG000|COMPLETED|Overall Study||68||
48388237|NCT04034043|101279531|FG000|NOT COMPLETED|Overall Study||0||
48388238|NCT03235817|101279532|FG000|STARTED|Overall Study||13||
48388239|NCT03235817|101279533|FG001|STARTED|Overall Study||13||
48388240|NCT03235817|101279534|FG002|STARTED|Overall Study||13||
48388241|NCT03235817|101279532|FG000|COMPLETED|Overall Study||10||
48388242|NCT03235817|101279533|FG001|COMPLETED|Overall Study||12||
48388243|NCT03235817|101279534|FG002|COMPLETED|Overall Study||11||
48388244|NCT03235817|101279532|FG000|NOT COMPLETED|Overall Study||3||
48388245|NCT03235817|101279533|FG001|NOT COMPLETED|Overall Study||1||
48388246|NCT03235817|101279534|FG002|NOT COMPLETED|Overall Study||2||
48388247|NCT01396239|101279535|FG000|STARTED|Overall Study||4||
48388248|NCT01396239|101279536|FG001|STARTED|Overall Study||2||
48388249|NCT01396239|101279537|FG002|STARTED|Overall Study||4||
48388250|NCT01396239|101279538|FG003|STARTED|Overall Study||2||
48388251|NCT01396239|101279535|FG000|COMPLETED|Overall Study||4||
48388252|NCT01396239|101279536|FG001|COMPLETED|Overall Study||2||
48388253|NCT01396239|101279537|FG002|COMPLETED|Overall Study||4||
48388254|NCT01396239|101279538|FG003|COMPLETED|Overall Study||2||
48388255|NCT01396239|101279535|FG000|NOT COMPLETED|Overall Study||0||
48388256|NCT01396239|101279536|FG001|NOT COMPLETED|Overall Study||0||
48388257|NCT01396239|101279537|FG002|NOT COMPLETED|Overall Study||0||
48388258|NCT01396239|101279538|FG003|NOT COMPLETED|Overall Study||0||
48388259|NCT00789191|101279539|FG000|STARTED|Overall Study||111||
48259747|NCT03856047|100955174|FG001|Safety Analysis Set|Overall Study||100||
48259748|NCT03856047|100955175|FG002|Safety Analysis Set|Overall Study||102||
48259749|NCT03856047|100955176|FG003|Safety Analysis Set|Overall Study||102||
48259750|NCT03856047|100955177|FG004|Safety Analysis Set|Overall Study||101||
48259751|NCT03856047|100955178|FG005|Safety Analysis Set|Overall Study||99||
48259752|NCT03856047|100955179|FG006|Safety Analysis Set|Overall Study||101||
48259753|NCT03856047|100955173|FG000|COMPLETED|Overall Study||97||
48259754|NCT03856047|100955174|FG001|COMPLETED|Overall Study||97||
48259755|NCT03856047|100955175|FG002|COMPLETED|Overall Study||98||
48259756|NCT03856047|100955176|FG003|COMPLETED|Overall Study||101||
48259757|NCT03856047|100955177|FG004|COMPLETED|Overall Study||94||
48259758|NCT03856047|100955178|FG005|COMPLETED|Overall Study||95||
48259759|NCT03856047|100955179|FG006|COMPLETED|Overall Study||95||
48259760|NCT03856047|100955173|FG000|NOT COMPLETED|Overall Study||4||
48259761|NCT03856047|100955174|FG001|NOT COMPLETED|Overall Study||3||
48259762|NCT03856047|100955175|FG002|NOT COMPLETED|Overall Study||4||
48259763|NCT03856047|100955176|FG003|NOT COMPLETED|Overall Study||1||
48259764|NCT03856047|100955177|FG004|NOT COMPLETED|Overall Study||7||
48259765|NCT03856047|100955178|FG005|NOT COMPLETED|Overall Study||4||
48259766|NCT03856047|100955179|FG006|NOT COMPLETED|Overall Study||6||
48259767|NCT04698915|100955180|FG000|STARTED|Overall Study||84||
48259768|NCT04698915|100955181|FG001|STARTED|Overall Study||84||
48259769|NCT04698915|100955180|FG000|COMPLETED|Overall Study||0||
48259770|NCT04698915|100955181|FG001|COMPLETED|Overall Study||0||
48259771|NCT04698915|100955180|FG000|NOT COMPLETED|Overall Study||84||
48259772|NCT04698915|100955181|FG001|NOT COMPLETED|Overall Study||84||
48259773|NCT00826228|100955182|FG000|STARTED|Overall Study||12||
48259774|NCT00826228|100955182|FG000|COMPLETED|Overall Study||11||
48259775|NCT00826228|100955182|FG000|NOT COMPLETED|Overall Study||1||
48259776|NCT01743976|100955183|FG000|STARTED|Overall Study||2||
48388260|NCT00789191|101279540|FG001|STARTED|Overall Study||111||
48388261|NCT00789191|101279539|FG000|Exposed|Overall Study||107||
48388262|NCT00789191|101279540|FG001|Exposed|Overall Study||110||
48388263|NCT00789191|101279539|FG000|COMPLETED|Overall Study||97||
48388264|NCT00789191|101279540|FG001|COMPLETED|Overall Study||92||
48388265|NCT00789191|101279539|FG000|NOT COMPLETED|Overall Study||14||
48388266|NCT00789191|101279540|FG001|NOT COMPLETED|Overall Study||19||
48388267|NCT02853032|101279541|FG000|STARTED|Overall Study||60||
48388268|NCT02853032|101279542|FG001|STARTED|Overall Study||59||
48388269|NCT02853032|101279541|FG000|COMPLETED|Overall Study||51||
48259777|NCT01743976|100955184|FG001|STARTED|Overall Study||3||
48259778|NCT01743976|100955183|FG000|COMPLETED|Overall Study||2||
48259779|NCT01743976|100955184|FG001|COMPLETED|Overall Study||3||
48259780|NCT01743976|100955183|FG000|NOT COMPLETED|Overall Study||0||
48259781|NCT01743976|100955184|FG001|NOT COMPLETED|Overall Study||0||
48259782|NCT02658175|100955185|FG000|STARTED|Treatment Period: Weeks 1 to 52||51||
48259783|NCT02658175|100955186|FG001|STARTED|Treatment Period: Weeks 1 to 52||14||
48388270|NCT02853032|101279542|FG001|COMPLETED|Overall Study||56||
48388271|NCT02853032|101279541|FG000|NOT COMPLETED|Overall Study||9||
48388272|NCT02853032|101279542|FG001|NOT COMPLETED|Overall Study||3||
48388273|NCT02146248|101279543|FG000|STARTED|Overall Study||11||
48388274|NCT02146248|101279543|FG000|Enrolled|Overall Study||11||
48388275|NCT02146248|101279543|FG000|Uterine Sounding|Overall Study||11||
48388276|NCT02146248|101279543|FG000|HSG 1|Overall Study||10||
48388277|NCT02146248|101279543|FG000|HSG 2|Overall Study||10||
48388278|NCT02146248|101279543|FG000|HSG 3|Overall Study||9||
48388279|NCT02146248|101279543|FG000|HSG 4|Overall Study||7||
48388280|NCT02146248|101279543|FG000|HSG 5|Overall Study||1||
48388281|NCT02146248|101279543|FG000|COMPLETED|Overall Study||9||
48388282|NCT02146248|101279543|FG000|NOT COMPLETED|Overall Study||2||
48388283|NCT03833817|101279544|FG000|STARTED|Overall Study||14||
48388284|NCT03833817|101279545|FG001|STARTED|Overall Study||14||
48388285|NCT03833817|101279544|FG000|COMPLETED|Overall Study||8||
48388286|NCT03833817|101279545|FG001|COMPLETED|Overall Study||8||
48388287|NCT03833817|101279544|FG000|NOT COMPLETED|Overall Study||6||
48388288|NCT03833817|101279545|FG001|NOT COMPLETED|Overall Study||6||
48388289|NCT00995670|101279546|FG000|STARTED|Overall Study||26||
48388290|NCT00995670|101279547|FG001|STARTED|Overall Study||16||
48388291|NCT00995670|101279548|FG002|STARTED|Overall Study||17||
48388292|NCT00995670|101279546|FG000|COMPLETED|Overall Study||25||
48388293|NCT00995670|101279547|FG001|COMPLETED|Overall Study||16||
48388294|NCT00995670|101279548|FG002|COMPLETED|Overall Study||14||
48388295|NCT00995670|101279546|FG000|NOT COMPLETED|Overall Study||1||
48388296|NCT00995670|101279547|FG001|NOT COMPLETED|Overall Study||0||
48388297|NCT00995670|101279548|FG002|NOT COMPLETED|Overall Study||3||
48388298|NCT04585451|101279549|FG000|STARTED|Overall Study||280||
48388299|NCT04585451|101279550|FG001|STARTED|Overall Study||54||
48388300|NCT04585451|101279549|FG000|COMPLETED|Overall Study||254||
48388301|NCT04585451|101279550|FG001|COMPLETED|Overall Study||54||
48388302|NCT04585451|101279549|FG000|NOT COMPLETED|Overall Study||26||
48388303|NCT04585451|101279550|FG001|NOT COMPLETED|Overall Study||0||
48388304|NCT02921763|101279551|FG000|STARTED|Overall Study||60||
48388305|NCT02921763|101279551|FG000|COMPLETED|Overall Study||42||
48388306|NCT02921763|101279551|FG000|NOT COMPLETED|Overall Study||18||
48689459|NCT03083665|102022695|FG000|Started Study Drug-Free Period (2 Weeks)|Double-Blind Period||7||
48689460|NCT03083665|102022696|FG001|Started Study Drug-Free Period (2 Weeks)|Double-Blind Period||9||
48689461|NCT03083665|102022697|FG002|Started Study Drug-Free Period (2 Weeks)|Double-Blind Period||7||
48689462|NCT03083665|102022698|FG003|Started Study Drug-Free Period (2 Weeks)|Double-Blind Period||0||
48689463|NCT03083665|102022699|FG004|Started Study Drug-Free Period (2 Weeks)|Double-Blind Period||0||
48388307|NCT02287402|101279552|FG000|STARTED|Treatment Period||197||
48388308|NCT02287402|101279552|FG000|COMPLETED|Treatment Period||170||
48388309|NCT02287402|101279552|FG000|NOT COMPLETED|Treatment Period||27||
48388310|NCT02287402|101279552|FG000|STARTED|Follow-up||106||
48388311|NCT02287402|101279552|FG000|COMPLETED|Follow-up||103||
48388312|NCT02287402|101279552|FG000|NOT COMPLETED|Follow-up||3||
48388313|NCT00691093|101279553|FG000|STARTED|Overall Study||823||
48388314|NCT00691093|101279553|FG000|COMPLETED|Overall Study||816||
48388315|NCT00691093|101279553|FG000|NOT COMPLETED|Overall Study||7||
48388316|NCT00405821|101279554|FG000|STARTED|Overall Study||220||
48388317|NCT00405821|101279555|FG001|STARTED|Overall Study||220||
48388318|NCT00405821|101279554|FG000|COMPLETED|Overall Study||198||
48388319|NCT00405821|101279555|FG001|COMPLETED|Overall Study||198||
48388320|NCT00405821|101279554|FG000|NOT COMPLETED|Overall Study||22||
48388321|NCT00405821|101279555|FG001|NOT COMPLETED|Overall Study||22||
48388322|NCT02373241|101279556|FG000|STARTED|Overall Study||0||
48388323|NCT02373241|101279557|FG001|STARTED|Overall Study||1||
48388324|NCT02373241|101279556|FG000|COMPLETED|Overall Study||0||
48541853|NCT03095638|101662795|FG006|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4||
48689464|NCT03083665|102022700|FG005|Started Study Drug-Free Period (2 Weeks)|Double-Blind Period||0||
48689465|NCT03083665|102022695|FG000|Started Transition Period (2 Weeks)|Double-Blind Period||133||
48689466|NCT03083665|102022696|FG001|Started Transition Period (2 Weeks)|Double-Blind Period||139||
48689467|NCT03083665|102022697|FG002|Started Transition Period (2 Weeks)|Double-Blind Period||137||
48689468|NCT03083665|102022698|FG003|Started Transition Period (2 Weeks)|Double-Blind Period||0||
48710795|NCT01012921|102078021|FG000|STARTED|Overall Study||57||
48388325|NCT02373241|101279557|FG001|COMPLETED|Overall Study||1||
48388326|NCT02373241|101279556|FG000|NOT COMPLETED|Overall Study||0||
48388327|NCT02373241|101279557|FG001|NOT COMPLETED|Overall Study||0||
48388328|NCT00333619|101279558|FG000|STARTED|Overall Study||110||
48388329|NCT00333619|101279559|FG001|STARTED|Overall Study||109||
48388330|NCT00333619|101279558|FG000|Post-treatment|Overall Study||109||
48388331|NCT00333619|101279559|FG001|Post-treatment|Overall Study||109||
48388332|NCT00333619|101279558|FG000|3-month Follow-up|Overall Study||101||
48388333|NCT00333619|101279559|FG001|3-month Follow-up|Overall Study||105||
48388334|NCT00333619|101279558|FG000|COMPLETED|Overall Study||89||
48388335|NCT00333619|101279559|FG001|COMPLETED|Overall Study||99||
48388336|NCT00333619|101279558|FG000|NOT COMPLETED|Overall Study||21||
48388337|NCT00333619|101279559|FG001|NOT COMPLETED|Overall Study||10||
48388338|NCT00643604|101279560|FG000|STARTED|Overall Study||7||
48388339|NCT00643604|101279560|FG000|COMPLETED|Overall Study||6||
48388340|NCT00643604|101279560|FG000|NOT COMPLETED|Overall Study||1||
48388341|NCT00881361|101279561|FG000|STARTED|Overall Study||707||
48388342|NCT00881361|101279562|FG001|STARTED|Overall Study||47||
48388343|NCT00881361|101279563|FG002|STARTED|Overall Study||2||
48388344|NCT00881361|101279561|FG000|COMPLETED|Overall Study||663||
48388345|NCT00881361|101279562|FG001|COMPLETED|Overall Study||38||
48388346|NCT00881361|101279563|FG002|COMPLETED|Overall Study||0||
48388347|NCT00881361|101279561|FG000|NOT COMPLETED|Overall Study||44||
48388348|NCT00881361|101279562|FG001|NOT COMPLETED|Overall Study||9||
48388349|NCT00881361|101279563|FG002|NOT COMPLETED|Overall Study||2||
48388350|NCT03728140|101279564|FG000|STARTED|Overall Study||160||
48388351|NCT03728140|101279565|FG001|STARTED|Overall Study||175||
48388352|NCT03728140|101279564|FG000|COMPLETED|Overall Study||150||
48388353|NCT03728140|101279565|FG001|COMPLETED|Overall Study||168||
48388354|NCT03728140|101279564|FG000|NOT COMPLETED|Overall Study||10||
48388355|NCT03728140|101279565|FG001|NOT COMPLETED|Overall Study||7||
48388356|NCT04046341|101279566|FG000|STARTED|Overall Study||15||
48388357|NCT04046341|101279566|FG000|COMPLETED|Overall Study||12||
48388358|NCT04046341|101279566|FG000|NOT COMPLETED|Overall Study||3||
48388359|NCT00771173|101279567|FG000|STARTED|Overall Study||129||
48388360|NCT00771173|101279568|FG001|STARTED|Overall Study||129||
48388361|NCT00771173|101279567|FG000|COMPLETED|Overall Study||107||
48388362|NCT00771173|101279568|FG001|COMPLETED|Overall Study||112||
48388363|NCT00771173|101279567|FG000|NOT COMPLETED|Overall Study||22||
48388364|NCT00771173|101279568|FG001|NOT COMPLETED|Overall Study||17||
48388365|NCT02420223|101279569|FG000|STARTED|Overall Study||12||
48388366|NCT02420223|101279570|FG001|STARTED|Overall Study||13||
48388367|NCT02420223|101279569|FG000|COMPLETED|Overall Study||11||
48388368|NCT02420223|101279570|FG001|COMPLETED|Overall Study||11||
48388369|NCT02420223|101279569|FG000|NOT COMPLETED|Overall Study||1||
48388370|NCT02420223|101279570|FG001|NOT COMPLETED|Overall Study||2||
48388371|NCT03508661|101279571|FG000|STARTED|Overall Study||10||
48388372|NCT03508661|101279571|FG000|COMPLETED|Overall Study||10||
48388373|NCT03508661|101279571|FG000|NOT COMPLETED|Overall Study||0||
48388374|NCT01546285|101279572|FG000|STARTED|Overall Study||66||
48388375|NCT01546285|101279572|FG000|COMPLETED|Overall Study||66||
48388376|NCT01546285|101279572|FG000|NOT COMPLETED|Overall Study||0||
48388377|NCT01590394|101279573|FG000|STARTED|Overall Study||3||
48388378|NCT01590394|101279573|FG000|COMPLETED|Overall Study||3||
48388379|NCT01590394|101279573|FG000|NOT COMPLETED|Overall Study||0||
48388380|NCT03654755|101279574|FG000|STARTED|Overall Study||45||
48388381|NCT03654755|101279575|FG001|STARTED|Overall Study||41||
48388382|NCT03654755|101279576|FG002|STARTED|Overall Study||76||
48388383|NCT03654755|101279574|FG000|New Start of Treatment|Overall Study||9||
48388384|NCT03654755|101279575|FG001|New Start of Treatment|Overall Study||12||
48388385|NCT03654755|101279576|FG002|New Start of Treatment|Overall Study||15||
48388386|NCT03654755|101279574|FG000|Continued Treatment|Overall Study||36|Continued treatment from parent study|
48388387|NCT03654755|101279575|FG001|Continued Treatment|Overall Study||29|Continued treatment from parent study|
48388388|NCT03654755|101279576|FG002|Continued Treatment|Overall Study||61|Continued treatment from parent study|
48388389|NCT03654755|101279574|FG000|COMPLETED|Overall Study||0||
48388390|NCT03654755|101279575|FG001|COMPLETED|Overall Study||0||
48388391|NCT03654755|101279576|FG002|COMPLETED|Overall Study||0||
48388392|NCT03654755|101279574|FG000|NOT COMPLETED|Overall Study||45||
48388393|NCT03654755|101279575|FG001|NOT COMPLETED|Overall Study||41||
48388394|NCT03654755|101279576|FG002|NOT COMPLETED|Overall Study||76||
48388395|NCT00282568|101279577|FG000|STARTED|Pharmacokinetic Treatment Period||70||
48388396|NCT00282568|101279577|FG000|Received Tacrolimus|Pharmacokinetic Treatment Period||68||
48388397|NCT00282568|101279577|FG000|Received Tacrolimus MR|Pharmacokinetic Treatment Period||67||
48388398|NCT00282568|101279577|FG000|COMPLETED|Pharmacokinetic Treatment Period||67||
48388399|NCT00282568|101279577|FG000|NOT COMPLETED|Pharmacokinetic Treatment Period||3||
48689469|NCT03083665|102022699|FG004|Started Transition Period (2 Weeks)|Double-Blind Period||0||
48388400|NCT00282568|101279577|FG000|STARTED|Extended Treatment Period||66||
48388401|NCT00282568|101279577|FG000|COMPLETED|Extended Treatment Period||42||
48388402|NCT00282568|101279577|FG000|NOT COMPLETED|Extended Treatment Period||24||
48388403|NCT04111107|101279578|FG000|STARTED|Overall Study||45||
48388404|NCT04111107|101279578|FG000|COMPLETED|Overall Study||34||
48388405|NCT04111107|101279578|FG000|NOT COMPLETED|Overall Study||11||
48388406|NCT04247815|101279579|FG000|STARTED|Overall Study||16||
48689470|NCT03083665|102022700|FG005|Started Transition Period (2 Weeks)|Double-Blind Period||0||
48388407|NCT04247815|101279580|FG001|STARTED|Overall Study||3||
48388408|NCT04247815|101279579|FG000|COMPLETED|Overall Study||14||
48388409|NCT04247815|101279580|FG001|COMPLETED|Overall Study||2||
48689471|NCT03083665|102022695|FG000|COMPLETED|Double-Blind Period||138||
48095432|NCT04461015|100556333|FG001|NOT COMPLETED|Overall Study||2||
48689472|NCT03083665|102022696|FG001|COMPLETED|Double-Blind Period||147||
48388410|NCT04247815|101279579|FG000|NOT COMPLETED|Overall Study||2||
48388411|NCT04247815|101279580|FG001|NOT COMPLETED|Overall Study||1||
48388412|NCT01894477|101279581|FG000|STARTED|Overall Study||35||
48388413|NCT01894477|101279582|FG001|STARTED|Overall Study||67||
48388414|NCT01894477|101279581|FG000|COMPLETED|Overall Study||35||
48388415|NCT01894477|101279582|FG001|COMPLETED|Overall Study||65||
48388416|NCT01894477|101279581|FG000|NOT COMPLETED|Overall Study||0||
48388417|NCT01894477|101279582|FG001|NOT COMPLETED|Overall Study||2||
48388418|NCT03140423|101279583|FG000|STARTED|Overall Study||168301||68
48388419|NCT03140423|101279584|FG001|STARTED|Overall Study||185022||69
48388420|NCT03140423|101279583|FG000|COMPLETED|Overall Study||168301||66
48388421|NCT03140423|101279584|FG001|COMPLETED|Overall Study||185022||68
48388422|NCT03140423|101279583|FG000|NOT COMPLETED|Overall Study||0||2
48388423|NCT03140423|101279584|FG001|NOT COMPLETED|Overall Study||0||1
48388424|NCT00050986|101279585|FG000|STARTED|Overall Study||55||
48388425|NCT00050986|101279585|FG000|COMPLETED|Overall Study||53||
48388426|NCT00050986|101279585|FG000|NOT COMPLETED|Overall Study||2||
48388427|NCT02394808|101279586|FG000|STARTED|Period 1||25||
48388428|NCT02394808|101279587|FG001|STARTED|Period 1||29||
48388429|NCT02394808|101279586|FG000|COMPLETED|Period 1||25||
48388430|NCT02394808|101279587|FG001|COMPLETED|Period 1||28||
48388431|NCT02394808|101279586|FG000|NOT COMPLETED|Period 1||0||
48388432|NCT02394808|101279587|FG001|NOT COMPLETED|Period 1||1||
48388433|NCT02394808|101279586|FG000|STARTED|Period 2||25||
48388434|NCT02394808|101279587|FG001|STARTED|Period 2||28||
48388435|NCT02394808|101279586|FG000|COMPLETED|Period 2||24||
48388436|NCT02394808|101279587|FG001|COMPLETED|Period 2||28||
48388437|NCT02394808|101279586|FG000|NOT COMPLETED|Period 2||1||
48388438|NCT02394808|101279587|FG001|NOT COMPLETED|Period 2||0||
48388439|NCT00213980|101279588|FG000|STARTED|Overall Study||32||
48388440|NCT00213980|101279589|FG001|STARTED|Overall Study||36||
48388441|NCT00213980|101279588|FG000|COMPLETED|Overall Study||26||
48388442|NCT00213980|101279589|FG001|COMPLETED|Overall Study||29||
48388443|NCT00213980|101279588|FG000|NOT COMPLETED|Overall Study||6||
48388444|NCT00213980|101279589|FG001|NOT COMPLETED|Overall Study||7||
48388445|NCT03700736|101279590|FG000|STARTED|Overall Study||30|Intervention|
48388446|NCT03700736|101279591|FG001|STARTED|Overall Study||32|Intervention|
48388447|NCT03700736|101279590|FG000|COMPLETED|Overall Study||27||
48388448|NCT03700736|101279591|FG001|COMPLETED|Overall Study||25||
48388449|NCT03700736|101279590|FG000|NOT COMPLETED|Overall Study||3||
48388450|NCT03700736|101279591|FG001|NOT COMPLETED|Overall Study||7||
48388451|NCT01824693|101279592|FG000|STARTED|Overall Study||6||
48388452|NCT01824693|101279593|FG001|STARTED|Overall Study||9||
48388453|NCT01824693|101279594|FG002|STARTED|Overall Study||15||
48388454|NCT01824693|101279592|FG000|COMPLETED|Overall Study||5||
48388455|NCT01824693|101279593|FG001|COMPLETED|Overall Study||2||
48388456|NCT01824693|101279594|FG002|COMPLETED|Overall Study||0||
48388457|NCT01824693|101279592|FG000|NOT COMPLETED|Overall Study||1||
48095433|NCT00723892|100556334|FG000|STARTED|Overall Study||313||
48095434|NCT00723892|100556335|FG001|STARTED|Overall Study||255||
48095435|NCT00723892|100556334|FG000|COMPLETED|Overall Study||206||
48095436|NCT00723892|100556335|FG001|COMPLETED|Overall Study||168||
48095437|NCT00723892|100556334|FG000|NOT COMPLETED|Overall Study||107||
48095438|NCT00723892|100556335|FG001|NOT COMPLETED|Overall Study||87||
48095439|NCT01166763|100556336|FG000|STARTED|Overall Study||30||
48095440|NCT01166763|100556336|FG000|COMPLETED|Overall Study||27||
48095441|NCT01166763|100556336|FG000|NOT COMPLETED|Overall Study||3||
48095442|NCT00651573|100556337|FG000|STARTED|Overall Study||365||
48095443|NCT00651573|100556338|FG001|STARTED|Overall Study||357||
48095444|NCT00651573|100556337|FG000|COMPLETED|Overall Study||363||
48095445|NCT00651573|100556338|FG001|COMPLETED|Overall Study||354||
48095446|NCT00651573|100556337|FG000|NOT COMPLETED|Overall Study||2||
48095447|NCT00651573|100556338|FG001|NOT COMPLETED|Overall Study||3||
48095448|NCT03473808|100556339|FG000|STARTED|Overall Study||5||
48095449|NCT03473808|100556339|FG000|COMPLETED|Overall Study||4||
48388458|NCT01824693|101279593|FG001|NOT COMPLETED|Overall Study||7||
48388459|NCT01824693|101279594|FG002|NOT COMPLETED|Overall Study||15||
48388460|NCT03812588|101279595|FG000|STARTED|Overall Study||5||
48388461|NCT03812588|101279596|FG001|STARTED|Overall Study||7||
48388462|NCT03812588|101279597|FG002|STARTED|Overall Study||5||
48388463|NCT03812588|101279598|FG003|STARTED|Overall Study||8||
48388464|NCT03812588|101279595|FG000|COMPLETED|Overall Study||3||
48388465|NCT03812588|101279596|FG001|COMPLETED|Overall Study||5||
48388466|NCT03812588|101279597|FG002|COMPLETED|Overall Study||3||
48388467|NCT03812588|101279598|FG003|COMPLETED|Overall Study||8||
48388468|NCT03812588|101279595|FG000|NOT COMPLETED|Overall Study||2||
48388469|NCT03812588|101279596|FG001|NOT COMPLETED|Overall Study||2||
48388470|NCT03812588|101279597|FG002|NOT COMPLETED|Overall Study||2||
48388471|NCT03812588|101279598|FG003|NOT COMPLETED|Overall Study||0||
48388472|NCT02555657|101279599|FG000|STARTED|Overall Study||312||
48388473|NCT02555657|101279600|FG001|STARTED|Overall Study||310||
48095450|NCT03473808|100556339|FG000|NOT COMPLETED|Overall Study||1||
48388474|NCT02555657|101279599|FG000|Treated|Overall Study||309||
48388475|NCT02555657|101279600|FG001|Treated|Overall Study||292||
48388476|NCT02555657|101279599|FG000|COMPLETED|Overall Study||0||
48388477|NCT02555657|101279600|FG001|COMPLETED|Overall Study||0||
48388478|NCT02555657|101279599|FG000|NOT COMPLETED|Overall Study||312||
48388479|NCT02555657|101279600|FG001|NOT COMPLETED|Overall Study||310||
48388480|NCT01381718|101279601|FG000|STARTED|Overall Study||56||
48388481|NCT01381718|101279602|FG001|STARTED|Overall Study||56||
48388482|NCT01381718|101279601|FG000|COMPLETED|Overall Study||51||
48388483|NCT01381718|101279602|FG001|COMPLETED|Overall Study||43||
48095451|NCT04262232|100556340|FG000|STARTED|Overall Study||30||
48095452|NCT04262232|100556340|FG000|COMPLETED|Overall Study||30||
48095453|NCT04262232|100556340|FG000|NOT COMPLETED|Overall Study||0||
48095454|NCT02059057|100556341|FG000|STARTED|Overall Study||102||
48095455|NCT02059057|100556341|FG000|COMPLETED|Overall Study||87||
48095456|NCT02059057|100556341|FG000|NOT COMPLETED|Overall Study||15||
48095457|NCT00356369|100556342|FG000|STARTED|Active Phase||374||
48095458|NCT00356369|100556343|FG001|STARTED|Active Phase||126||
48095459|NCT00356369|100556342|FG000|COMPLETED|Active Phase||372||
48095460|NCT00356369|100556343|FG001|COMPLETED|Active Phase||125||
48095461|NCT00356369|100556342|FG000|NOT COMPLETED|Active Phase||2||
48095462|NCT00356369|100556343|FG001|NOT COMPLETED|Active Phase||1||
48095463|NCT00356369|100556342|FG000|STARTED|Year 1||364||
48095464|NCT00356369|100556343|FG001|STARTED|Year 1||121||
48095465|NCT00356369|100556342|FG000|COMPLETED|Year 1||364||
48095466|NCT00356369|100556343|FG001|COMPLETED|Year 1||121||
48095467|NCT00356369|100556342|FG000|NOT COMPLETED|Year 1||0||
48095468|NCT00356369|100556343|FG001|NOT COMPLETED|Year 1||0||
48095469|NCT00356369|100556342|FG000|STARTED|Year 2||354||
48095470|NCT00356369|100556343|FG001|STARTED|Year 2||117||
48095471|NCT00356369|100556342|FG000|COMPLETED|Year 2||354||
48095472|NCT00356369|100556343|FG001|COMPLETED|Year 2||117||
48095473|NCT00356369|100556342|FG000|NOT COMPLETED|Year 2||0||
48095474|NCT00356369|100556343|FG001|NOT COMPLETED|Year 2||0||
48095475|NCT00356369|100556342|FG000|STARTED|Year 3||344||
48095476|NCT00356369|100556343|FG001|STARTED|Year 3||116||
48095477|NCT00356369|100556342|FG000|COMPLETED|Year 3||344||
48095478|NCT00356369|100556343|FG001|COMPLETED|Year 3||116||
48095479|NCT00356369|100556342|FG000|NOT COMPLETED|Year 3||0||
48095480|NCT00356369|100556343|FG001|NOT COMPLETED|Year 3||0||
48095481|NCT00356369|100556342|FG000|STARTED|Year 4||317||
48095482|NCT00356369|100556343|FG001|STARTED|Year 4||109||
48095483|NCT00356369|100556342|FG000|COMPLETED|Year 4||317||
48095484|NCT00356369|100556343|FG001|COMPLETED|Year 4||109||
48095485|NCT00356369|100556342|FG000|NOT COMPLETED|Year 4||0||
48095486|NCT00356369|100556343|FG001|NOT COMPLETED|Year 4||0||
48095487|NCT00356369|100556342|FG000|STARTED|Year 5||299||
48095488|NCT00356369|100556343|FG001|STARTED|Year 5||105||
48095489|NCT00356369|100556342|FG000|COMPLETED|Year 5||299||
48095490|NCT00356369|100556343|FG001|COMPLETED|Year 5||105||
48095491|NCT00356369|100556342|FG000|NOT COMPLETED|Year 5||0||
48095492|NCT00356369|100556343|FG001|NOT COMPLETED|Year 5||0||
48095493|NCT04247581|100556344|FG000|STARTED|Overall Study||241||
48095494|NCT04247581|100556345|FG001|STARTED|Overall Study||305||
48095495|NCT04247581|100556344|FG000|COMPLETED|Overall Study||241||
48095496|NCT04247581|100556345|FG001|COMPLETED|Overall Study||293||
48095497|NCT04247581|100556344|FG000|NOT COMPLETED|Overall Study||0||
48095498|NCT04247581|100556345|FG001|NOT COMPLETED|Overall Study||12||
48095499|NCT02457910|100556346|FG000|STARTED|Overall Study||3||
48095500|NCT02457910|100556347|FG001|STARTED|Overall Study||5||
48095501|NCT02457910|100556348|FG002|STARTED|Overall Study||3||
48095502|NCT02457910|100556349|FG003|STARTED|Overall Study||2||
48095503|NCT02457910|100556350|FG004|STARTED|Overall Study||5||
48095504|NCT02457910|100556351|FG005|STARTED|Overall Study||12||
48095505|NCT02457910|100556346|FG000|COMPLETED|Overall Study||0||
48095506|NCT02457910|100556347|FG001|COMPLETED|Overall Study||0||
48095507|NCT02457910|100556348|FG002|COMPLETED|Overall Study||0||
48095508|NCT02457910|100556349|FG003|COMPLETED|Overall Study||0||
48095509|NCT02457910|100556350|FG004|COMPLETED|Overall Study||0||
48095510|NCT02457910|100556351|FG005|COMPLETED|Overall Study||1||
48095511|NCT02457910|100556346|FG000|NOT COMPLETED|Overall Study||3||
48095512|NCT02457910|100556347|FG001|NOT COMPLETED|Overall Study||5||
48095513|NCT02457910|100556348|FG002|NOT COMPLETED|Overall Study||3||
48095514|NCT02457910|100556349|FG003|NOT COMPLETED|Overall Study||2||
48095515|NCT02457910|100556350|FG004|NOT COMPLETED|Overall Study||5||
48095516|NCT02457910|100556351|FG005|NOT COMPLETED|Overall Study||11||
48095517|NCT03341533|100556352|FG000|STARTED|Overall Study||72||
48095518|NCT03341533|100556353|FG001|STARTED|Overall Study||70||
48095519|NCT03341533|100556352|FG000|COMPLETED|Overall Study||69||
48095520|NCT03341533|100556353|FG001|COMPLETED|Overall Study||68||
48095521|NCT03341533|100556352|FG000|NOT COMPLETED|Overall Study||3||
48095522|NCT03341533|100556353|FG001|NOT COMPLETED|Overall Study||2||
48095523|NCT01346839|100556354|FG000|STARTED|Overall Study||683||
48095524|NCT01346839|100556355|FG001|STARTED|Overall Study||573||
48095525|NCT01346839|100556354|FG000|COMPLETED|Overall Study||369||
48095526|NCT01346839|100556355|FG001|COMPLETED|Overall Study||364||
48095527|NCT01346839|100556354|FG000|NOT COMPLETED|Overall Study||314||
48095528|NCT01346839|100556355|FG001|NOT COMPLETED|Overall Study||209||
48095529|NCT02557698|100556356|FG000|STARTED|Overall Study||30||
48095530|NCT02557698|100556357|FG001|STARTED|Overall Study||30||
48095531|NCT02557698|100556356|FG000|COMPLETED|Overall Study||30||
48095532|NCT02557698|100556357|FG001|COMPLETED|Overall Study||30||
48095533|NCT02557698|100556356|FG000|NOT COMPLETED|Overall Study||0||
48095534|NCT02557698|100556357|FG001|NOT COMPLETED|Overall Study||0||
48095535|NCT00514540|100556358|FG000|STARTED|First-Line Chemo||113||
48095536|NCT00514540|100556358|FG000|COMPLETED|First-Line Chemo||105||
48095537|NCT00514540|100556358|FG000|NOT COMPLETED|First-Line Chemo||8||
48095538|NCT00514540|100556358|FG000|STARTED|Second-Line||105||
48095539|NCT00514540|100556358|FG000|COMPLETED|Second-Line||74||
48095540|NCT00514540|100556358|FG000|NOT COMPLETED|Second-Line||31||
48689473|NCT03083665|102022697|FG002|COMPLETED|Double-Blind Period||140||
48689474|NCT03083665|102022698|FG003|COMPLETED|Double-Blind Period||0||
48689475|NCT03083665|102022699|FG004|COMPLETED|Double-Blind Period||0||
48689476|NCT03083665|102022700|FG005|COMPLETED|Double-Blind Period||0||
48689477|NCT03083665|102022695|FG000|NOT COMPLETED|Double-Blind Period||11||
48689478|NCT03083665|102022696|FG001|NOT COMPLETED|Double-Blind Period||5||
48689479|NCT03083665|102022697|FG002|NOT COMPLETED|Double-Blind Period||8||
48689480|NCT03083665|102022698|FG003|NOT COMPLETED|Double-Blind Period||0||
48689481|NCT03083665|102022699|FG004|NOT COMPLETED|Double-Blind Period||0||
48689482|NCT03083665|102022700|FG005|NOT COMPLETED|Double-Blind Period||0||
48689483|NCT03083665|102022695|FG000|STARTED|Open-Label Temporary Period (OLTP)||0||
48689484|NCT03083665|102022696|FG001|STARTED|Open-Label Temporary Period (OLTP)||0||
48689485|NCT03083665|102022697|FG002|STARTED|Open-Label Temporary Period (OLTP)||0||
48689486|NCT03083665|102022698|FG003|STARTED|Open-Label Temporary Period (OLTP)||64||
48689487|NCT03083665|102022699|FG004|STARTED|Open-Label Temporary Period (OLTP)||68||
48689488|NCT03083665|102022700|FG005|STARTED|Open-Label Temporary Period (OLTP)||74||
48689489|NCT03083665|102022695|FG000|COMPLETED|Open-Label Temporary Period (OLTP)||0||
48689490|NCT03083665|102022696|FG001|COMPLETED|Open-Label Temporary Period (OLTP)||0||
48689491|NCT03083665|102022697|FG002|COMPLETED|Open-Label Temporary Period (OLTP)||0||
48095541|NCT00665847|100556359|FG000|STARTED|Overall Study||101||
48095542|NCT00665847|100556359|FG000|COMPLETED|Overall Study||76||
48095543|NCT00665847|100556359|FG000|NOT COMPLETED|Overall Study||25||
48095544|NCT00744627|100560207|FG000|STARTED|Overall Study||151||
48095545|NCT00744627|100560208|FG001|STARTED|Overall Study||150||
48095546|NCT00744627|100560207|FG000|Treated|Overall Study||150||
48095547|NCT00744627|100560208|FG001|Treated|Overall Study||150||
48095548|NCT00744627|100560207|FG000|COMPLETED|Overall Study||126||
48095549|NCT00744627|100560208|FG001|COMPLETED|Overall Study||128||
48095550|NCT00744627|100560207|FG000|NOT COMPLETED|Overall Study||25||
48095551|NCT00744627|100560208|FG001|NOT COMPLETED|Overall Study||22||
48095552|NCT02734979|100560209|FG000|STARTED|Overall Study||1||
48095553|NCT02734979|100560209|FG000|COMPLETED|Overall Study||1||
48095554|NCT02734979|100560209|FG000|NOT COMPLETED|Overall Study||0||
48095555|NCT00156533|100560210|FG000|STARTED|Overall Study||5||
48095556|NCT00156533|100560211|FG001|STARTED|Overall Study||5||
48095557|NCT00156533|100560212|FG002|STARTED|Overall Study||5||
48095558|NCT00156533|100560213|FG003|STARTED|Overall Study||5||
48095559|NCT00156533|100560210|FG000|COMPLETED|Overall Study||3||
48095560|NCT00156533|100560211|FG001|COMPLETED|Overall Study||3||
48095561|NCT00156533|100560212|FG002|COMPLETED|Overall Study||3||
48095562|NCT00156533|100560213|FG003|COMPLETED|Overall Study||3||
48095563|NCT00156533|100560210|FG000|NOT COMPLETED|Overall Study||2||
48095564|NCT00156533|100560211|FG001|NOT COMPLETED|Overall Study||2||
48095565|NCT00156533|100560212|FG002|NOT COMPLETED|Overall Study||2||
48095566|NCT00156533|100560213|FG003|NOT COMPLETED|Overall Study||2||
48095567|NCT01525550|100560214|FG000|STARTED|Overall Study||61||
48095568|NCT01525550|100560215|FG001|STARTED|Overall Study||45||
48095569|NCT01525550|100560214|FG000|COMPLETED|Overall Study||0||
48095570|NCT01525550|100560215|FG001|COMPLETED|Overall Study||0||
48095571|NCT01525550|100560214|FG000|NOT COMPLETED|Overall Study||61||
48095572|NCT01525550|100560215|FG001|NOT COMPLETED|Overall Study||45||
48689492|NCT03083665|102022698|FG003|COMPLETED|Open-Label Temporary Period (OLTP)||60||
48689493|NCT03083665|102022699|FG004|COMPLETED|Open-Label Temporary Period (OLTP)||67||
48689494|NCT03083665|102022700|FG005|COMPLETED|Open-Label Temporary Period (OLTP)||68||
48689495|NCT03083665|102022695|FG000|NOT COMPLETED|Open-Label Temporary Period (OLTP)||0||
48689496|NCT03083665|102022696|FG001|NOT COMPLETED|Open-Label Temporary Period (OLTP)||0||
48095573|NCT01214161|100560216|FG000|STARTED|Overall Study||100||
48095574|NCT01214161|100560217|FG001|STARTED|Overall Study||100||
48095575|NCT01214161|100560216|FG000|COMPLETED|Overall Study||100||
48095576|NCT01214161|100560217|FG001|COMPLETED|Overall Study||100||
48095577|NCT01214161|100560216|FG000|NOT COMPLETED|Overall Study||0||
48095578|NCT01214161|100560217|FG001|NOT COMPLETED|Overall Study||0||
48095579|NCT00390325|100560218|FG000|STARTED|Overall Study||5||
48095580|NCT00390325|100560219|FG001|STARTED|Overall Study||16||
48095581|NCT00390325|100560218|FG000|COMPLETED|Overall Study||5||
48095582|NCT00390325|100560219|FG001|COMPLETED|Overall Study||16||
48689497|NCT03083665|102022697|FG002|NOT COMPLETED|Open-Label Temporary Period (OLTP)||0||
48689498|NCT03083665|102022698|FG003|NOT COMPLETED|Open-Label Temporary Period (OLTP)||4||
48689499|NCT03083665|102022699|FG004|NOT COMPLETED|Open-Label Temporary Period (OLTP)||1||
48689500|NCT03083665|102022700|FG005|NOT COMPLETED|Open-Label Temporary Period (OLTP)||6||
48095583|NCT00390325|100560218|FG000|NOT COMPLETED|Overall Study||0||
48095584|NCT00390325|100560219|FG001|NOT COMPLETED|Overall Study||0||
48095585|NCT04351087|100560220|FG000|STARTED|Overall Study||36||
48095586|NCT04351087|100560221|FG001|STARTED|Overall Study||35||
48095587|NCT04351087|100560220|FG000|COMPLETED|Overall Study||23||
48095588|NCT04351087|100560221|FG001|COMPLETED|Overall Study||26||
48095589|NCT04351087|100560220|FG000|NOT COMPLETED|Overall Study||13||
48095590|NCT04351087|100560221|FG001|NOT COMPLETED|Overall Study||9||
48095591|NCT02703909|100560222|FG000|STARTED|Overall Study||36||
48095592|NCT02703909|100560223|FG001|STARTED|Overall Study||37||
48095593|NCT02703909|100560224|FG002|STARTED|Overall Study||36||
48095594|NCT02703909|100560225|FG003|STARTED|Overall Study||35||
48095595|NCT02703909|100560222|FG000|COMPLETED|Overall Study||36||
48095596|NCT02703909|100560223|FG001|COMPLETED|Overall Study||37||
48095597|NCT02703909|100560224|FG002|COMPLETED|Overall Study||36||
48095598|NCT02703909|100560225|FG003|COMPLETED|Overall Study||35||
48095599|NCT02703909|100560222|FG000|NOT COMPLETED|Overall Study||0||
48095600|NCT02703909|100560223|FG001|NOT COMPLETED|Overall Study||0||
48095601|NCT02703909|100560224|FG002|NOT COMPLETED|Overall Study||0||
48095602|NCT02703909|100560225|FG003|NOT COMPLETED|Overall Study||0||
48095603|NCT01909479|100560226|FG000|STARTED|From Baseline to Week 26||135||
48095604|NCT01909479|100560227|FG001|STARTED|From Baseline to Week 26||67||
48095605|NCT01909479|100560226|FG000|COMPLETED|From Baseline to Week 26||129||
48095606|NCT01909479|100560227|FG001|COMPLETED|From Baseline to Week 26||58||
48095607|NCT01909479|100560226|FG000|NOT COMPLETED|From Baseline to Week 26||6||
48095608|NCT01909479|100560227|FG001|NOT COMPLETED|From Baseline to Week 26||9||
48095609|NCT01909479|100560226|FG000|STARTED|26 - 52 Weeks||128|One patient withdrew consent after completing Period 1|
48095610|NCT01909479|100560227|FG001|STARTED|26 - 52 Weeks||58|One patient withdrew consent after completing Period 1|
48095611|NCT01909479|100560226|FG000|COMPLETED|26 - 52 Weeks||125||
48095612|NCT01909479|100560227|FG001|COMPLETED|26 - 52 Weeks||56||
48095613|NCT01909479|100560226|FG000|NOT COMPLETED|26 - 52 Weeks||3||
48095614|NCT01909479|100560227|FG001|NOT COMPLETED|26 - 52 Weeks||2||
48095615|NCT01909479|100560226|FG000|STARTED|52 Weeks to End of Study||111||
48095616|NCT01909479|100560227|FG001|STARTED|52 Weeks to End of Study||50||
48095617|NCT01909479|100560226|FG000|COMPLETED|52 Weeks to End of Study||83||
48095618|NCT01909479|100560227|FG001|COMPLETED|52 Weeks to End of Study||35||
48095619|NCT01909479|100560226|FG000|NOT COMPLETED|52 Weeks to End of Study||28||
48095620|NCT01909479|100560227|FG001|NOT COMPLETED|52 Weeks to End of Study||15||
48095621|NCT02402309|100560228|FG000|STARTED|Overall Study||6||
48095622|NCT02402309|100560229|FG001|STARTED|Overall Study||6||
48095623|NCT02402309|100560228|FG000|COMPLETED|Overall Study||6||
48095624|NCT02402309|100560229|FG001|COMPLETED|Overall Study||6||
48095625|NCT02402309|100560228|FG000|NOT COMPLETED|Overall Study||0||
48095626|NCT02402309|100560229|FG001|NOT COMPLETED|Overall Study||0||
48095627|NCT00519818|100560230|FG000|STARTED|Overall Study||14||
48095628|NCT00519818|100560230|FG000|COMPLETED|Overall Study||14||
48095629|NCT00519818|100560230|FG000|NOT COMPLETED|Overall Study||0||
48095630|NCT02653560|100560231|FG000|STARTED|KMgCit Phase||30||
48095631|NCT02653560|100560232|FG001|STARTED|KMgCit Phase||0||
48095632|NCT02653560|100560233|FG002|STARTED|KMgCit Phase||0||
48095633|NCT02653560|100560234|FG003|STARTED|KMgCit Phase||0||
48095634|NCT02653560|100560231|FG000|COMPLETED|KMgCit Phase||30||
48095635|NCT02653560|100560232|FG001|COMPLETED|KMgCit Phase||0||
48095636|NCT02653560|100560233|FG002|COMPLETED|KMgCit Phase||0||
48095637|NCT02653560|100560234|FG003|COMPLETED|KMgCit Phase||0||
48095638|NCT02653560|100560231|FG000|NOT COMPLETED|KMgCit Phase||0||
48095639|NCT02653560|100560232|FG001|NOT COMPLETED|KMgCit Phase||0||
48095640|NCT02653560|100560233|FG002|NOT COMPLETED|KMgCit Phase||0||
48259784|NCT02658175|100955187|FG002|STARTED|Treatment Period: Weeks 1 to 52||3||
48259785|NCT02658175|100955185|FG000|COMPLETED|Treatment Period: Weeks 1 to 52||36||
48259786|NCT02658175|100955186|FG001|COMPLETED|Treatment Period: Weeks 1 to 52||7||
48259787|NCT02658175|100955187|FG002|COMPLETED|Treatment Period: Weeks 1 to 52||3||
48259788|NCT02658175|100955185|FG000|NOT COMPLETED|Treatment Period: Weeks 1 to 52||15||
48259789|NCT02658175|100955186|FG001|NOT COMPLETED|Treatment Period: Weeks 1 to 52||7||
48259790|NCT02658175|100955187|FG002|NOT COMPLETED|Treatment Period: Weeks 1 to 52||0||
48259791|NCT02658175|100955185|FG000|STARTED|1st Extended Treatment: Weeks 53 to 104||36||
48259792|NCT02658175|100955186|FG001|STARTED|1st Extended Treatment: Weeks 53 to 104||7||
48259793|NCT02658175|100955187|FG002|STARTED|1st Extended Treatment: Weeks 53 to 104||3||
48259794|NCT02658175|100955185|FG000|COMPLETED|1st Extended Treatment: Weeks 53 to 104||15||
48259795|NCT02658175|100955186|FG001|COMPLETED|1st Extended Treatment: Weeks 53 to 104||5||
48095641|NCT02653560|100560234|FG003|NOT COMPLETED|KMgCit Phase||0||
48095642|NCT02653560|100560231|FG000|STARTED|K Citrate Phase||0||
48095643|NCT02653560|100560232|FG001|STARTED|K Citrate Phase||30||
48095644|NCT02653560|100560233|FG002|STARTED|K Citrate Phase||0||
48095645|NCT02653560|100560234|FG003|STARTED|K Citrate Phase||0||
48095646|NCT02653560|100560231|FG000|COMPLETED|K Citrate Phase||0||
48095647|NCT02653560|100560232|FG001|COMPLETED|K Citrate Phase||30||
48095648|NCT02653560|100560233|FG002|COMPLETED|K Citrate Phase||0||
48259796|NCT02658175|100955187|FG002|COMPLETED|1st Extended Treatment: Weeks 53 to 104||1||
48259797|NCT02658175|100955185|FG000|NOT COMPLETED|1st Extended Treatment: Weeks 53 to 104||21||
48259798|NCT02658175|100955186|FG001|NOT COMPLETED|1st Extended Treatment: Weeks 53 to 104||2||
48095649|NCT02653560|100560234|FG003|COMPLETED|K Citrate Phase||0||
48095650|NCT02653560|100560231|FG000|NOT COMPLETED|K Citrate Phase||0||
48095651|NCT02653560|100560232|FG001|NOT COMPLETED|K Citrate Phase||0||
48095652|NCT02653560|100560233|FG002|NOT COMPLETED|K Citrate Phase||0||
48095653|NCT02653560|100560234|FG003|NOT COMPLETED|K Citrate Phase||0||
48095654|NCT02653560|100560231|FG000|STARTED|KCl Phase||0||
48259799|NCT02658175|100955187|FG002|NOT COMPLETED|1st Extended Treatment: Weeks 53 to 104||2||
48388484|NCT01381718|101279601|FG000|NOT COMPLETED|Overall Study||5||
48095655|NCT02653560|100560232|FG001|STARTED|KCl Phase||0||
48095656|NCT02653560|100560233|FG002|STARTED|KCl Phase||30||
48095657|NCT02653560|100560234|FG003|STARTED|KCl Phase||0||
48095658|NCT02653560|100560231|FG000|COMPLETED|KCl Phase||0||
48095659|NCT02653560|100560232|FG001|COMPLETED|KCl Phase||0||
48095660|NCT02653560|100560233|FG002|COMPLETED|KCl Phase||30||
48095661|NCT02653560|100560234|FG003|COMPLETED|KCl Phase||0||
48095662|NCT02653560|100560231|FG000|NOT COMPLETED|KCl Phase||0||
48095663|NCT02653560|100560232|FG001|NOT COMPLETED|KCl Phase||0||
48095664|NCT02653560|100560233|FG002|NOT COMPLETED|KCl Phase||0||
48095665|NCT02653560|100560234|FG003|NOT COMPLETED|KCl Phase||0||
48095666|NCT02653560|100560231|FG000|STARTED|Placebo Phase||0||
48095667|NCT02653560|100560232|FG001|STARTED|Placebo Phase||0||
48095668|NCT02653560|100560233|FG002|STARTED|Placebo Phase||0||
48095669|NCT02653560|100560234|FG003|STARTED|Placebo Phase||30||
48095670|NCT02653560|100560231|FG000|COMPLETED|Placebo Phase||0||
48689501|NCT00579553|102022701|FG000|STARTED|Overall Study||82||
48689502|NCT00579553|102022702|FG001|STARTED|Overall Study||92||
48689503|NCT00579553|102022701|FG000|COMPLETED|Overall Study||66||
48095671|NCT02653560|100560232|FG001|COMPLETED|Placebo Phase||0||
48095672|NCT02653560|100560233|FG002|COMPLETED|Placebo Phase||0||
48095673|NCT02653560|100560234|FG003|COMPLETED|Placebo Phase||30||
48095674|NCT02653560|100560231|FG000|NOT COMPLETED|Placebo Phase||0||
48095675|NCT02653560|100560232|FG001|NOT COMPLETED|Placebo Phase||0||
48095676|NCT02653560|100560233|FG002|NOT COMPLETED|Placebo Phase||0||
48095677|NCT02653560|100560234|FG003|NOT COMPLETED|Placebo Phase||0||
48095678|NCT02946047|100560235|FG000|STARTED|Overall Study||4||
48095679|NCT02946047|100560236|FG001|STARTED|Overall Study||3||
48095680|NCT02946047|100560237|FG002|STARTED|Overall Study||3||
48095681|NCT02946047|100560238|FG003|STARTED|Overall Study||7||
48095682|NCT02946047|100560235|FG000|COMPLETED|Overall Study||3||
48095683|NCT02946047|100560236|FG001|COMPLETED|Overall Study||3||
48095684|NCT02946047|100560237|FG002|COMPLETED|Overall Study||3||
48095685|NCT02946047|100560238|FG003|COMPLETED|Overall Study||7||
48095686|NCT02946047|100560235|FG000|NOT COMPLETED|Overall Study||1||
48095687|NCT02946047|100560236|FG001|NOT COMPLETED|Overall Study||0||
48095688|NCT02946047|100560237|FG002|NOT COMPLETED|Overall Study||0||
48095689|NCT02946047|100560238|FG003|NOT COMPLETED|Overall Study||0||
48095690|NCT02728895|100560239|FG000|STARTED|Overall Study||3||
48095691|NCT02728895|100560240|FG001|STARTED|Overall Study||21||
48689504|NCT00579553|102022702|FG001|COMPLETED|Overall Study||79||
48689505|NCT00579553|102022701|FG000|NOT COMPLETED|Overall Study||16||
48689506|NCT00579553|102022702|FG001|NOT COMPLETED|Overall Study||13||
48689507|NCT03783962|102022703|FG000|STARTED|Overall Study||28||
48689508|NCT03783962|102022704|FG001|STARTED|Overall Study||28||
48689509|NCT03783962|102022703|FG000|COMPLETED|Overall Study||25||
48689510|NCT03783962|102022704|FG001|COMPLETED|Overall Study||21||
48689511|NCT03783962|102022703|FG000|NOT COMPLETED|Overall Study||3||
48689512|NCT03783962|102022704|FG001|NOT COMPLETED|Overall Study||7||
48689513|NCT01692743|102022705|FG000|STARTED|Overall Study||117||
48095692|NCT02728895|100560239|FG000|COMPLETED|Overall Study||2||
48095693|NCT02728895|100560240|FG001|COMPLETED|Overall Study||16||
48095694|NCT02728895|100560239|FG000|NOT COMPLETED|Overall Study||1||
48095695|NCT02728895|100560240|FG001|NOT COMPLETED|Overall Study||5||
48095696|NCT02448654|100560241|FG000|STARTED|Overall Study||19|Were eligible and completed the baseline assessments.|
48689514|NCT01692743|102022706|FG001|STARTED|Overall Study||116||
48689515|NCT01692743|102022707|FG002|STARTED|Overall Study||115||
48095697|NCT02448654|100560242|FG001|STARTED|Overall Study||17|Were eligible and completed the baseline assessments.|
48095698|NCT02448654|100560241|FG000|Started Pills (Tolcapone or Placebo)|Overall Study||17|Started the medication (tolcapone or placebo) portion of the trial.|
48095699|NCT02448654|100560242|FG001|Started Pills (Tolcapone or Placebo)|Overall Study||15|Started the medication (tolcapone or placebo) portion of the trial.|
48095700|NCT02448654|100560241|FG000|COMPLETED|Overall Study||16|Completed the medication (tolcapone or placebo) trial.|
48095701|NCT02448654|100560242|FG001|COMPLETED|Overall Study||13|Completed the medication (tolcapone or placebo) trial.|
48095702|NCT02448654|100560241|FG000|NOT COMPLETED|Overall Study||3||
48095703|NCT02448654|100560242|FG001|NOT COMPLETED|Overall Study||4||
48095704|NCT01172184|100560243|FG000|STARTED|Overall Study||111||
48095705|NCT01172184|100560243|FG000|COMPLETED|Overall Study||111||
48095706|NCT01172184|100560243|FG000|NOT COMPLETED|Overall Study||0||
48095707|NCT02864251|100560244|FG000|STARTED|Pre-Treatment||144|Started = Randomized|
48095708|NCT02864251|100560245|FG001|STARTED|Pre-Treatment||73|Started = Randomized|
48689516|NCT01692743|102022705|FG000|COMPLETED|Overall Study||90||
48095709|NCT02864251|100560246|FG002|STARTED|Pre-Treatment||150|Started = Randomized|
48095710|NCT02864251|100560244|FG000|COMPLETED|Pre-Treatment||141|Completed = Started Treatment|
48095711|NCT02864251|100560245|FG001|COMPLETED|Pre-Treatment||71|Completed = Started Treatment|
48095712|NCT02864251|100560246|FG002|COMPLETED|Pre-Treatment||143|Completed = Started Treatment|
48689517|NCT01692743|102022706|FG001|COMPLETED|Overall Study||81||
48689518|NCT01692743|102022707|FG002|COMPLETED|Overall Study||88||
48689519|NCT01692743|102022705|FG000|NOT COMPLETED|Overall Study||27||
48689520|NCT01692743|102022706|FG001|NOT COMPLETED|Overall Study||35||
48095713|NCT02864251|100560244|FG000|NOT COMPLETED|Pre-Treatment||3||
48095714|NCT02864251|100560245|FG001|NOT COMPLETED|Pre-Treatment||2||
48095715|NCT02864251|100560246|FG002|NOT COMPLETED|Pre-Treatment||7||
48095716|NCT02864251|100560244|FG000|STARTED|Treatment||141|Started Treatment|
48095717|NCT02864251|100560245|FG001|STARTED|Treatment||71|Started Treatment|
48095718|NCT02864251|100560246|FG002|STARTED|Treatment||143|Started Treatment|
48095719|NCT02864251|100560244|FG000|COMPLETED|Treatment||3|Completed Treatment|
48095720|NCT02864251|100560245|FG001|COMPLETED|Treatment||5|Completed Treatment|
48095721|NCT02864251|100560246|FG002|COMPLETED|Treatment||0|Completed Treatment|
48095722|NCT02864251|100560244|FG000|NOT COMPLETED|Treatment||138||
48095723|NCT02864251|100560245|FG001|NOT COMPLETED|Treatment||66||
48095724|NCT02864251|100560246|FG002|NOT COMPLETED|Treatment||143||
48095725|NCT02063854|100560247|FG000|STARTED|Overall Study||199||
48095726|NCT02063854|100560248|FG001|STARTED|Overall Study||66||
48095727|NCT02063854|100560249|FG002|STARTED|Overall Study||206||
48095728|NCT02063854|100560250|FG003|STARTED|Overall Study||68||
48095729|NCT02063854|100560251|FG004|STARTED|Overall Study||65||
48095730|NCT02063854|100560252|FG005|STARTED|Overall Study||201||
48095731|NCT02063854|100560253|FG006|STARTED|Overall Study||66||
48095732|NCT02063854|100560247|FG000|Full Analysis Set: Received Study Drug|Overall Study||199||
48095733|NCT02063854|100560248|FG001|Full Analysis Set: Received Study Drug|Overall Study||66||
48095734|NCT02063854|100560249|FG002|Full Analysis Set: Received Study Drug|Overall Study||206||
48388485|NCT01381718|101279602|FG001|NOT COMPLETED|Overall Study||13||
48388486|NCT03209440|101279603|FG000|STARTED|Step 1: Month 1-12||24||1
48388487|NCT03209440|101279604|FG001|STARTED|Step 1: Month 1-12||22||1
48388488|NCT03209440|101279605|FG002|STARTED|Step 1: Month 1-12||28||1
48388489|NCT03209440|101279606|FG003|STARTED|Step 1: Month 1-12||14||1
48388490|NCT03209440|101279607|FG004|STARTED|Step 1: Month 1-12||26||1
48388491|NCT03209440|101279608|FG005|STARTED|Step 1: Month 1-12||28||1
48388492|NCT03209440|101279603|FG000|COMPLETED|Step 1: Month 1-12||22||1
48388493|NCT03209440|101279604|FG001|COMPLETED|Step 1: Month 1-12||20||1
48388494|NCT03209440|101279605|FG002|COMPLETED|Step 1: Month 1-12||25||1
48388495|NCT03209440|101279606|FG003|COMPLETED|Step 1: Month 1-12||13||1
48689521|NCT01692743|102022707|FG002|NOT COMPLETED|Overall Study||27||
48689522|NCT00147017|102022708|FG000|STARTED|Overall Study||6||
48689523|NCT00147017|102022709|FG001|STARTED|Overall Study||7||
48689524|NCT00147017|102022710|FG002|STARTED|Overall Study||4||
48689525|NCT00147017|102022708|FG000|COMPLETED|Overall Study||6||
48689526|NCT00147017|102022709|FG001|COMPLETED|Overall Study||7||
48689527|NCT00147017|102022710|FG002|COMPLETED|Overall Study||4||
48689528|NCT00147017|102022708|FG000|NOT COMPLETED|Overall Study||0||
48689529|NCT00147017|102022709|FG001|NOT COMPLETED|Overall Study||0||
48689530|NCT00147017|102022710|FG002|NOT COMPLETED|Overall Study||0||
48689531|NCT02954887|102022711|FG000|STARTED|Overall Study||9||
48689532|NCT02954887|102022711|FG000|COMPLETED|Overall Study||2||
48689533|NCT02954887|102022711|FG000|NOT COMPLETED|Overall Study||7||
48095735|NCT02063854|100560250|FG003|Full Analysis Set: Received Study Drug|Overall Study||68||
48095736|NCT02063854|100560251|FG004|Full Analysis Set: Received Study Drug|Overall Study||65||
48095737|NCT02063854|100560252|FG005|Full Analysis Set: Received Study Drug|Overall Study||200||
48095738|NCT02063854|100560253|FG006|Full Analysis Set: Received Study Drug|Overall Study||66||
48095739|NCT02063854|100560247|FG000|COMPLETED|Overall Study||178||
48095740|NCT02063854|100560248|FG001|COMPLETED|Overall Study||54||
48095741|NCT02063854|100560249|FG002|COMPLETED|Overall Study||176||
48095742|NCT02063854|100560250|FG003|COMPLETED|Overall Study||58||
48095743|NCT02063854|100560251|FG004|COMPLETED|Overall Study||54||
48095744|NCT02063854|100560252|FG005|COMPLETED|Overall Study||170||
48095745|NCT02063854|100560253|FG006|COMPLETED|Overall Study||60||
48095746|NCT02063854|100560247|FG000|NOT COMPLETED|Overall Study||21||
48095747|NCT02063854|100560248|FG001|NOT COMPLETED|Overall Study||12||
48095748|NCT02063854|100560249|FG002|NOT COMPLETED|Overall Study||30||
48095749|NCT02063854|100560250|FG003|NOT COMPLETED|Overall Study||10||
48095750|NCT02063854|100560251|FG004|NOT COMPLETED|Overall Study||11||
48095751|NCT02063854|100560252|FG005|NOT COMPLETED|Overall Study||31||
48095752|NCT02063854|100560253|FG006|NOT COMPLETED|Overall Study||6||
48095753|NCT02066740|100560254|FG000|STARTED|Overall Study||34||
48388496|NCT03209440|101279607|FG004|COMPLETED|Step 1: Month 1-12||25||1
48388497|NCT03209440|101279608|FG005|COMPLETED|Step 1: Month 1-12||24||1
48388498|NCT03209440|101279603|FG000|NOT COMPLETED|Step 1: Month 1-12||2||0
48388499|NCT03209440|101279604|FG001|NOT COMPLETED|Step 1: Month 1-12||2||0
48388500|NCT03209440|101279605|FG002|NOT COMPLETED|Step 1: Month 1-12||3||0
48388501|NCT03209440|101279606|FG003|NOT COMPLETED|Step 1: Month 1-12||1||0
48388502|NCT03209440|101279607|FG004|NOT COMPLETED|Step 1: Month 1-12||1||0
48689534|NCT00383331|102022712|FG000|STARTED|Overall Study||10||
48689535|NCT00383331|102022713|FG001|STARTED|Overall Study||9||
48689536|NCT00383331|102022712|FG000|COMPLETED|Overall Study||10||
48689537|NCT00383331|102022713|FG001|COMPLETED|Overall Study||8||
48095754|NCT02066740|100560254|FG000|COMPLETED|Overall Study||32||
48095755|NCT02066740|100560254|FG000|NOT COMPLETED|Overall Study||2||
48095756|NCT01857232|100560255|FG000|STARTED|Overall Study||69||
48388503|NCT03209440|101279608|FG005|NOT COMPLETED|Step 1: Month 1-12||4||0
48388504|NCT03209440|101279603|FG000|STARTED|Step 2: Month 13-24||15||1
48388505|NCT03209440|101279604|FG001|STARTED|Step 2: Month 13-24||11||1
48388506|NCT03209440|101279605|FG002|STARTED|Step 2: Month 13-24||18||1
48388507|NCT03209440|101279606|FG003|STARTED|Step 2: Month 13-24||23||1
48388508|NCT03209440|101279607|FG004|STARTED|Step 2: Month 13-24||32||1
48388509|NCT03209440|101279608|FG005|STARTED|Step 2: Month 13-24||20||1
48388510|NCT03209440|101279603|FG000|COMPLETED|Step 2: Month 13-24||9||1
48388511|NCT03209440|101279604|FG001|COMPLETED|Step 2: Month 13-24||7||1
48388512|NCT03209440|101279605|FG002|COMPLETED|Step 2: Month 13-24||16||1
48388513|NCT03209440|101279606|FG003|COMPLETED|Step 2: Month 13-24||23||1
48388514|NCT03209440|101279607|FG004|COMPLETED|Step 2: Month 13-24||30||1
48388515|NCT03209440|101279608|FG005|COMPLETED|Step 2: Month 13-24||19||1
48388516|NCT03209440|101279603|FG000|NOT COMPLETED|Step 2: Month 13-24||6||0
48388517|NCT03209440|101279604|FG001|NOT COMPLETED|Step 2: Month 13-24||4||0
48388518|NCT03209440|101279605|FG002|NOT COMPLETED|Step 2: Month 13-24||2||0
48388519|NCT03209440|101279606|FG003|NOT COMPLETED|Step 2: Month 13-24||0||0
48388520|NCT03209440|101279607|FG004|NOT COMPLETED|Step 2: Month 13-24||2||0
48388521|NCT03209440|101279608|FG005|NOT COMPLETED|Step 2: Month 13-24||1||0
48689538|NCT00383331|102022712|FG000|NOT COMPLETED|Overall Study||0||
48689539|NCT00383331|102022713|FG001|NOT COMPLETED|Overall Study||1||
48689540|NCT00633087|102022714|FG000|STARTED|Overall Study||12||
48388522|NCT03209440|101279603|FG000|STARTED|Step 3: Month 25-36||18||1
48388523|NCT03209440|101279604|FG001|STARTED|Step 3: Month 25-36||13||1
48388524|NCT03209440|101279605|FG002|STARTED|Step 3: Month 25-36||24||1
48388525|NCT03209440|101279606|FG003|STARTED|Step 3: Month 25-36||11||1
48388526|NCT03209440|101279607|FG004|STARTED|Step 3: Month 25-36||13||1
48689541|NCT00633087|102022714|FG000|COMPLETED|Overall Study||12||
48689542|NCT00633087|102022714|FG000|NOT COMPLETED|Overall Study||0||
48689543|NCT02812238|102022715|FG000|STARTED|First Intervention||19||
48689544|NCT02812238|102022716|FG001|STARTED|First Intervention||19||
48689545|NCT02812238|102022715|FG000|COMPLETED|First Intervention||18||
48689546|NCT02812238|102022716|FG001|COMPLETED|First Intervention||19||
48689547|NCT02812238|102022715|FG000|NOT COMPLETED|First Intervention||1||
48095757|NCT01857232|100560256|FG001|STARTED|Overall Study||67||
48095758|NCT01857232|100560257|FG002|STARTED|Overall Study||67||
48095759|NCT01857232|100560258|FG003|STARTED|Overall Study||70||
48095760|NCT01857232|100560259|FG004|STARTED|Overall Study||69||
48095761|NCT01857232|100560255|FG000|Evaluable ITT|Overall Study||66||
48095762|NCT01857232|100560256|FG001|Evaluable ITT|Overall Study||66||
48095763|NCT01857232|100560257|FG002|Evaluable ITT|Overall Study||63||
48095764|NCT01857232|100560258|FG003|Evaluable ITT|Overall Study||68||
48095765|NCT01857232|100560259|FG004|Evaluable ITT|Overall Study||65||
48095766|NCT01857232|100560255|FG000|COMPLETED|Overall Study||61||
48095767|NCT01857232|100560256|FG001|COMPLETED|Overall Study||65||
48095768|NCT01857232|100560257|FG002|COMPLETED|Overall Study||63||
48095769|NCT01857232|100560258|FG003|COMPLETED|Overall Study||68||
48095770|NCT01857232|100560259|FG004|COMPLETED|Overall Study||63||
48095771|NCT01857232|100560255|FG000|NOT COMPLETED|Overall Study||8||
48095772|NCT01857232|100560256|FG001|NOT COMPLETED|Overall Study||2||
48095773|NCT01857232|100560257|FG002|NOT COMPLETED|Overall Study||4||
48095774|NCT01857232|100560258|FG003|NOT COMPLETED|Overall Study||2||
48259800|NCT02658175|100955185|FG000|STARTED|2nd Extended Treatment: Weeks 105 to156||1|Only those participants in France who continued into the 2nd extended treatment period.|
48259801|NCT02658175|100955186|FG001|STARTED|2nd Extended Treatment: Weeks 105 to156||0|Only those participants in France who continued into the 2nd extended treatment period.|
48259802|NCT02658175|100955187|FG002|STARTED|2nd Extended Treatment: Weeks 105 to156||1|Only those participants in France who continued into the 2nd extended treatment period.|
48259803|NCT02658175|100955185|FG000|COMPLETED|2nd Extended Treatment: Weeks 105 to156||0||
48259804|NCT02658175|100955186|FG001|COMPLETED|2nd Extended Treatment: Weeks 105 to156||0||
48259805|NCT02658175|100955187|FG002|COMPLETED|2nd Extended Treatment: Weeks 105 to156||0||
48259806|NCT02658175|100955185|FG000|NOT COMPLETED|2nd Extended Treatment: Weeks 105 to156||1||
48388527|NCT03209440|101279608|FG005|STARTED|Step 3: Month 25-36||14||1
48388528|NCT03209440|101279603|FG000|COMPLETED|Step 3: Month 25-36||11||1
48388529|NCT03209440|101279604|FG001|COMPLETED|Step 3: Month 25-36||4||1
48388530|NCT03209440|101279605|FG002|COMPLETED|Step 3: Month 25-36||14||1
48388531|NCT03209440|101279606|FG003|COMPLETED|Step 3: Month 25-36||10||1
48388532|NCT03209440|101279607|FG004|COMPLETED|Step 3: Month 25-36||12||1
48388533|NCT03209440|101279608|FG005|COMPLETED|Step 3: Month 25-36||14||1
48388534|NCT03209440|101279603|FG000|NOT COMPLETED|Step 3: Month 25-36||7||0
48388535|NCT03209440|101279604|FG001|NOT COMPLETED|Step 3: Month 25-36||9||0
48388536|NCT03209440|101279605|FG002|NOT COMPLETED|Step 3: Month 25-36||10||0
48388537|NCT03209440|101279606|FG003|NOT COMPLETED|Step 3: Month 25-36||1||0
48388538|NCT03209440|101279607|FG004|NOT COMPLETED|Step 3: Month 25-36||1||0
48388539|NCT03209440|101279608|FG005|NOT COMPLETED|Step 3: Month 25-36||0||0
48388540|NCT03209440|101279603|FG000|STARTED|Step 4: Month 37-48||65||1
48689548|NCT02812238|102022716|FG001|NOT COMPLETED|First Intervention||0||
48689549|NCT02812238|102022715|FG000|STARTED|Second Intervention||18||
48095775|NCT01857232|100560259|FG004|NOT COMPLETED|Overall Study||6||
48095776|NCT01408030|100560260|FG000|STARTED|Treatment Phase (on Drug)||29||
48095777|NCT01408030|100560261|FG001|STARTED|Treatment Phase (on Drug)||31||
48095778|NCT01408030|100560262|FG002|STARTED|Treatment Phase (on Drug)||33||
48689550|NCT02812238|102022716|FG001|STARTED|Second Intervention||19||
48689551|NCT02812238|102022715|FG000|COMPLETED|Second Intervention||18||
48259807|NCT02658175|100955186|FG001|NOT COMPLETED|2nd Extended Treatment: Weeks 105 to156||0||
48259808|NCT02658175|100955187|FG002|NOT COMPLETED|2nd Extended Treatment: Weeks 105 to156||1||
48294142|NCT02527343|101047540|FG004|STARTED|OLE Period-Year 1: Week 53 to 104||12||
48294143|NCT02527343|101047541|FG005|STARTED|OLE Period-Year 1: Week 53 to 104||12||
48388541|NCT03209440|101279604|FG001|STARTED|Step 4: Month 37-48||22||1
48388542|NCT03209440|101279605|FG002|STARTED|Step 4: Month 37-48||39||1
48388543|NCT03209440|101279606|FG003|STARTED|Step 4: Month 37-48||44||1
48388544|NCT03209440|101279607|FG004|STARTED|Step 4: Month 37-48||27||1
48388545|NCT03209440|101279608|FG005|STARTED|Step 4: Month 37-48||28||1
48388546|NCT03209440|101279603|FG000|COMPLETED|Step 4: Month 37-48||41||1
48388547|NCT03209440|101279604|FG001|COMPLETED|Step 4: Month 37-48||9||1
48388548|NCT03209440|101279605|FG002|COMPLETED|Step 4: Month 37-48||19||1
48388549|NCT03209440|101279606|FG003|COMPLETED|Step 4: Month 37-48||37||1
48388550|NCT03209440|101279607|FG004|COMPLETED|Step 4: Month 37-48||22||1
48388551|NCT03209440|101279608|FG005|COMPLETED|Step 4: Month 37-48||24||1
48388552|NCT03209440|101279603|FG000|NOT COMPLETED|Step 4: Month 37-48||24||0
48388553|NCT03209440|101279604|FG001|NOT COMPLETED|Step 4: Month 37-48||13||0
48388554|NCT03209440|101279605|FG002|NOT COMPLETED|Step 4: Month 37-48||20||0
48388555|NCT03209440|101279606|FG003|NOT COMPLETED|Step 4: Month 37-48||7||0
48388556|NCT03209440|101279607|FG004|NOT COMPLETED|Step 4: Month 37-48||5||0
48388557|NCT03209440|101279608|FG005|NOT COMPLETED|Step 4: Month 37-48||4||0
48388558|NCT02767856|101279609|FG000|STARTED|Overall Study||18||
48388559|NCT02767856|101279610|FG001|STARTED|Overall Study||14||
48388560|NCT02767856|101279609|FG000|COMPLETED|Overall Study||7||
48388561|NCT02767856|101279610|FG001|COMPLETED|Overall Study||12||
48388562|NCT02767856|101279609|FG000|NOT COMPLETED|Overall Study||11||
48388563|NCT02767856|101279610|FG001|NOT COMPLETED|Overall Study||2||
48388564|NCT00555906|101279611|FG000|STARTED|Phase 1||3||
48388565|NCT00555906|101279612|FG001|STARTED|Phase 1||6||
48388566|NCT00555906|101279613|FG002|STARTED|Phase 1||7||
48388567|NCT00555906|101279614|FG003|STARTED|Phase 1||5||
48388568|NCT00555906|101279615|FG004|STARTED|Phase 1||0||
48388569|NCT00555906|101279611|FG000|COMPLETED|Phase 1||0||
48388570|NCT00555906|101279612|FG001|COMPLETED|Phase 1||0||
48388571|NCT00555906|101279613|FG002|COMPLETED|Phase 1||0||
48388572|NCT00555906|101279614|FG003|COMPLETED|Phase 1||0||
48388573|NCT00555906|101279615|FG004|COMPLETED|Phase 1||0||
48388574|NCT00555906|101279611|FG000|NOT COMPLETED|Phase 1||3||
48388575|NCT00555906|101279612|FG001|NOT COMPLETED|Phase 1||6||
48388576|NCT00555906|101279613|FG002|NOT COMPLETED|Phase 1||7||
48388577|NCT00555906|101279614|FG003|NOT COMPLETED|Phase 1||5||
48388578|NCT00555906|101279615|FG004|NOT COMPLETED|Phase 1||0||
48388579|NCT00555906|101279611|FG000|STARTED|Phase 2||0||
48388580|NCT00555906|101279612|FG001|STARTED|Phase 2||0||
48388581|NCT00555906|101279613|FG002|STARTED|Phase 2||0||
48388582|NCT00555906|101279614|FG003|STARTED|Phase 2||0||
48388583|NCT00555906|101279615|FG004|STARTED|Phase 2||32||
48388584|NCT00555906|101279611|FG000|Treated|Phase 2||0||
48388585|NCT00555906|101279612|FG001|Treated|Phase 2||0||
48388586|NCT00555906|101279613|FG002|Treated|Phase 2||0||
48388587|NCT00555906|101279614|FG003|Treated|Phase 2||0||
48388588|NCT00555906|101279615|FG004|Treated|Phase 2||30||
48388589|NCT00555906|101279611|FG000|COMPLETED|Phase 2||0||
48388590|NCT00555906|101279612|FG001|COMPLETED|Phase 2||0||
48388591|NCT00555906|101279613|FG002|COMPLETED|Phase 2||0||
48541854|NCT03095638|101662796|FG007|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4||
48541855|NCT03095638|101662789|FG000|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0||
48541856|NCT03095638|101662790|FG001|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0||
48541857|NCT03095638|101662791|FG002|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0||
48541858|NCT03095638|101662792|FG003|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0||
48541859|NCT03095638|101662793|FG004|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0||
48541860|NCT03095638|101662794|FG005|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0||
48541861|NCT03095638|101662795|FG006|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0||
48541862|NCT03095638|101662796|FG007|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0||
48541863|NCT00682357|101662797|FG000|STARTED|Overall Study||10||
48541864|NCT00682357|101662798|FG001|STARTED|Overall Study||10||
48541865|NCT00682357|101662799|FG002|STARTED|Overall Study||5||
48541866|NCT00682357|101662797|FG000|COMPLETED|Overall Study||10||
48689552|NCT02812238|102022716|FG001|COMPLETED|Second Intervention||18||
48294144|NCT02527343|101047536|FG000|COMPLETED|OLE Period-Year 1: Week 53 to 104||0||
48294145|NCT02527343|101047537|FG001|COMPLETED|OLE Period-Year 1: Week 53 to 104||0||
48388592|NCT00555906|101279614|FG003|COMPLETED|Phase 2||0||
48388593|NCT00555906|101279615|FG004|COMPLETED|Phase 2||0||
48388594|NCT00555906|101279611|FG000|NOT COMPLETED|Phase 2||0||
48388595|NCT00555906|101279612|FG001|NOT COMPLETED|Phase 2||0||
48388596|NCT00555906|101279613|FG002|NOT COMPLETED|Phase 2||0||
48388597|NCT00555906|101279614|FG003|NOT COMPLETED|Phase 2||0||
48388598|NCT00555906|101279615|FG004|NOT COMPLETED|Phase 2||32||
48388599|NCT02115113|101279616|FG000|STARTED|Participants in Run-in Period||0||
48388600|NCT02115113|101279617|FG001|STARTED|Participants in Run-in Period||0||
48541867|NCT00682357|101662798|FG001|COMPLETED|Overall Study||10||
48541868|NCT00682357|101662799|FG002|COMPLETED|Overall Study||5||
48388601|NCT02115113|101279618|FG002|STARTED|Participants in Run-in Period||78||
48388602|NCT02115113|101279616|FG000|COMPLETED|Participants in Run-in Period||0||
48388603|NCT02115113|101279617|FG001|COMPLETED|Participants in Run-in Period||0||
48388604|NCT02115113|101279618|FG002|COMPLETED|Participants in Run-in Period||68||
48388605|NCT02115113|101279616|FG000|NOT COMPLETED|Participants in Run-in Period||0||
48388606|NCT02115113|101279617|FG001|NOT COMPLETED|Participants in Run-in Period||0||
48388607|NCT02115113|101279618|FG002|NOT COMPLETED|Participants in Run-in Period||10||
48388608|NCT02115113|101279616|FG000|STARTED|Participants Randomized||24||
48388609|NCT02115113|101279617|FG001|STARTED|Participants Randomized||26||
48388610|NCT02115113|101279618|FG002|STARTED|Participants Randomized||0||
48388611|NCT02115113|101279616|FG000|COMPLETED|Participants Randomized||22||
48388612|NCT02115113|101279617|FG001|COMPLETED|Participants Randomized||26||
48388613|NCT02115113|101279618|FG002|COMPLETED|Participants Randomized||0||
48388614|NCT02115113|101279616|FG000|NOT COMPLETED|Participants Randomized||2||
48388615|NCT02115113|101279617|FG001|NOT COMPLETED|Participants Randomized||0||
48388616|NCT02115113|101279618|FG002|NOT COMPLETED|Participants Randomized||0||
48388617|NCT02307838|101279619|FG000|STARTED|Overall Study||56||
48388618|NCT02307838|101279620|FG001|STARTED|Overall Study||64||
48388619|NCT02307838|101279621|FG002|STARTED|Overall Study||55||
48388620|NCT02307838|101279619|FG000|COMPLETED|Overall Study||56||
48388621|NCT02307838|101279620|FG001|COMPLETED|Overall Study||64||
48388622|NCT02307838|101279621|FG002|COMPLETED|Overall Study||55||
48388623|NCT02307838|101279619|FG000|NOT COMPLETED|Overall Study||0||
48388624|NCT02307838|101279620|FG001|NOT COMPLETED|Overall Study||0||
48388625|NCT02307838|101279621|FG002|NOT COMPLETED|Overall Study||0||
48388626|NCT04846348|101279622|FG000|STARTED|Overall Study||1||
48388627|NCT04846348|101279622|FG000|COMPLETED|Overall Study||1||
48388628|NCT04846348|101279622|FG000|NOT COMPLETED|Overall Study||0||
48388629|NCT03700970|101279623|FG000|STARTED|Overall Study||30||
48388630|NCT03700970|101279624|FG001|STARTED|Overall Study||30||
48388631|NCT03700970|101279623|FG000|COMPLETED|Overall Study||21||
48388632|NCT03700970|101279624|FG001|COMPLETED|Overall Study||19||
48388633|NCT03700970|101279623|FG000|NOT COMPLETED|Overall Study||9||
48388634|NCT03700970|101279624|FG001|NOT COMPLETED|Overall Study||11||
48388635|NCT01195831|101279625|FG000|STARTED|Overall Study||120||
48388636|NCT01195831|101279626|FG001|STARTED|Overall Study||124||
48388637|NCT01195831|101279625|FG000|COMPLETED|Overall Study||112||
48388638|NCT01195831|101279626|FG001|COMPLETED|Overall Study||114||
48388639|NCT01195831|101279625|FG000|NOT COMPLETED|Overall Study||8||
48388640|NCT01195831|101279626|FG001|NOT COMPLETED|Overall Study||10||
48388641|NCT02466412|101279627|FG000|STARTED|Washout Period of 1 Day (Day -1)||24||
48388642|NCT02466412|101279628|FG001|STARTED|Washout Period of 1 Day (Day -1)||24||
48388643|NCT02466412|101279627|FG000|COMPLETED|Washout Period of 1 Day (Day -1)||24||
48388644|NCT02466412|101279628|FG001|COMPLETED|Washout Period of 1 Day (Day -1)||24||
48388645|NCT02466412|101279627|FG000|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0||
48388646|NCT02466412|101279628|FG001|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0||
48388647|NCT02466412|101279627|FG000|STARTED|First Intervention (Day 1)||24||
48541869|NCT00682357|101662797|FG000|NOT COMPLETED|Overall Study||0||
48388648|NCT02466412|101279628|FG001|STARTED|First Intervention (Day 1)||24||
48388649|NCT02466412|101279627|FG000|COMPLETED|First Intervention (Day 1)||24||
48388650|NCT02466412|101279628|FG001|COMPLETED|First Intervention (Day 1)||24||
48388651|NCT02466412|101279627|FG000|NOT COMPLETED|First Intervention (Day 1)||0||
48388652|NCT02466412|101279628|FG001|NOT COMPLETED|First Intervention (Day 1)||0||
48388653|NCT02466412|101279627|FG000|STARTED|Washout Period of 1 Day (Day 2)||24||
48388654|NCT02466412|101279628|FG001|STARTED|Washout Period of 1 Day (Day 2)||24||
48388655|NCT02466412|101279627|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||24||
48388656|NCT02466412|101279628|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||24||
48388657|NCT02466412|101279627|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
48388658|NCT02466412|101279628|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
48388659|NCT02466412|101279627|FG000|STARTED|Second Intervention (Day 3)||24||
48388660|NCT02466412|101279628|FG001|STARTED|Second Intervention (Day 3)||24||
48388661|NCT02466412|101279627|FG000|COMPLETED|Second Intervention (Day 3)||24||
48388662|NCT02466412|101279628|FG001|COMPLETED|Second Intervention (Day 3)||24||
48388663|NCT02466412|101279627|FG000|NOT COMPLETED|Second Intervention (Day 3)||0||
48388664|NCT02466412|101279628|FG001|NOT COMPLETED|Second Intervention (Day 3)||0||
48388665|NCT01392053|101279629|FG000|STARTED|Overall Study||23||
48388666|NCT01392053|101279630|FG001|STARTED|Overall Study||23||
48388667|NCT01392053|101279629|FG000|COMPLETED|Overall Study||23||
48388668|NCT01392053|101279630|FG001|COMPLETED|Overall Study||23||
48388669|NCT01392053|101279629|FG000|NOT COMPLETED|Overall Study||0||
48388670|NCT01392053|101279630|FG001|NOT COMPLETED|Overall Study||0||
48388671|NCT01709981|101279631|FG000|STARTED|Overall Study||141||
48388672|NCT01709981|101279632|FG001|STARTED|Overall Study||139||
48388673|NCT01709981|101279631|FG000|COMPLETED|Overall Study||141||
48388674|NCT01709981|101279632|FG001|COMPLETED|Overall Study||139||
48388675|NCT01709981|101279631|FG000|NOT COMPLETED|Overall Study||0||
48689553|NCT02812238|102022715|FG000|NOT COMPLETED|Second Intervention||0||
48689554|NCT02812238|102022716|FG001|NOT COMPLETED|Second Intervention||1||
48689555|NCT01693250|102022717|FG000|STARTED|Overall Study||23||
48689556|NCT01693250|102022718|FG001|STARTED|Overall Study||17||
48689557|NCT01693250|102022717|FG000|COMPLETED|Overall Study||21||
48689558|NCT01693250|102022718|FG001|COMPLETED|Overall Study||15||
48689559|NCT01693250|102022717|FG000|NOT COMPLETED|Overall Study||2||
48689560|NCT01693250|102022718|FG001|NOT COMPLETED|Overall Study||2||
48689561|NCT00382265|102022719|FG000|STARTED|Overall Study||267||
48689562|NCT00382265|102022720|FG001|STARTED|Overall Study||245||
48689563|NCT00382265|102022719|FG000|COMPLETED|Overall Study||258||
48388676|NCT01709981|101279632|FG001|NOT COMPLETED|Overall Study||0||
48689564|NCT00382265|102022720|FG001|COMPLETED|Overall Study||239||
48689565|NCT00382265|102022719|FG000|NOT COMPLETED|Overall Study||9||
48388677|NCT01697267|101279633|FG000|STARTED|Overall Study||85||
48388678|NCT01697267|101279634|FG001|STARTED|Overall Study||85||
48388679|NCT01697267|101279633|FG000|Month 24|Overall Study||78||
48388680|NCT01697267|101279634|FG001|Month 24|Overall Study||78||
48388681|NCT01697267|101279633|FG000|COMPLETED|Overall Study||71||
48388682|NCT01697267|101279634|FG001|COMPLETED|Overall Study||70||
48388683|NCT01697267|101279633|FG000|NOT COMPLETED|Overall Study||14||
48388684|NCT01697267|101279634|FG001|NOT COMPLETED|Overall Study||15||
48388685|NCT05425719|101279635|FG000|STARTED|Overall Study||130||
48388686|NCT05425719|101279636|FG001|STARTED|Overall Study||119||
48388687|NCT05425719|101279635|FG000|COMPLETED|Overall Study||125||
48388688|NCT05425719|101279636|FG001|COMPLETED|Overall Study||118||
48388689|NCT05425719|101279635|FG000|NOT COMPLETED|Overall Study||5||
48388690|NCT05425719|101279636|FG001|NOT COMPLETED|Overall Study||1||
48388691|NCT02608229|101279637|FG000|STARTED|Overall Study||10||
48388692|NCT02608229|101279638|FG001|STARTED|Overall Study||8||
48388693|NCT02608229|101279637|FG000|600 mg BVD-523|Overall Study||10||
48388694|NCT02608229|101279638|FG001|600 mg BVD-523|Overall Study||2||
48388695|NCT02608229|101279637|FG000|450 mg BVD-523|Overall Study||0||
48388696|NCT02608229|101279638|FG001|450 mg BVD-523|Overall Study||6||
48388697|NCT02608229|101279637|FG000|COMPLETED|Overall Study||10||
48388698|NCT02608229|101279638|FG001|COMPLETED|Overall Study||8||
48388699|NCT02608229|101279637|FG000|NOT COMPLETED|Overall Study||0||
48388700|NCT02608229|101279638|FG001|NOT COMPLETED|Overall Study||0||
48388701|NCT01102218|101279639|FG000|STARTED|Overall Study||24||
48388702|NCT01102218|101279640|FG001|STARTED|Overall Study||24||
48388703|NCT01102218|101279639|FG000|COMPLETED|Overall Study||13||
48388704|NCT01102218|101279640|FG001|COMPLETED|Overall Study||14||
48388705|NCT01102218|101279639|FG000|NOT COMPLETED|Overall Study||11||
48388706|NCT01102218|101279640|FG001|NOT COMPLETED|Overall Study||10||
48388707|NCT03329599|101279641|FG000|STARTED|Overall Study||74||
48388708|NCT03329599|101279642|FG001|STARTED|Overall Study||74||
48388709|NCT03329599|101279641|FG000|COMPLETED|Overall Study||59||
48388710|NCT03329599|101279642|FG001|COMPLETED|Overall Study||64||
48388711|NCT03329599|101279641|FG000|NOT COMPLETED|Overall Study||15||
48388712|NCT03329599|101279642|FG001|NOT COMPLETED|Overall Study||10||
48388713|NCT01819506|101279643|FG000|STARTED|Overall Study||51||
48388714|NCT01819506|101279644|FG001|STARTED|Overall Study||52||
48388715|NCT01819506|101279643|FG000|COMPLETED|Overall Study||43||
48388716|NCT01819506|101279644|FG001|COMPLETED|Overall Study||47||
48388717|NCT01819506|101279643|FG000|NOT COMPLETED|Overall Study||8||
48388718|NCT01819506|101279644|FG001|NOT COMPLETED|Overall Study||5||
48388719|NCT03094832|101279645|FG000|STARTED|Overall Study||17||
48388720|NCT03094832|101279646|FG001|STARTED|Overall Study||22||
48388721|NCT03094832|101279647|FG002|STARTED|Overall Study||1||
48388722|NCT03094832|101279648|FG003|STARTED|Overall Study||8||
48388723|NCT03094832|101279649|FG004|STARTED|Overall Study||2||
48388724|NCT03094832|101279645|FG000|Treated|Overall Study||17||
48388725|NCT03094832|101279646|FG001|Treated|Overall Study||22||
48388726|NCT03094832|101279647|FG002|Treated|Overall Study||1||
48388727|NCT03094832|101279648|FG003|Treated|Overall Study||8||
48388728|NCT03094832|101279649|FG004|Treated|Overall Study||1||
48388729|NCT03094832|101279645|FG000|COMPLETED|Overall Study||2||
48388730|NCT03094832|101279646|FG001|COMPLETED|Overall Study||2||
48388731|NCT03094832|101279647|FG002|COMPLETED|Overall Study||0||
48541870|NCT00682357|101662798|FG001|NOT COMPLETED|Overall Study||0||
48541871|NCT00682357|101662799|FG002|NOT COMPLETED|Overall Study||0||
48541872|NCT02792699|101662800|FG000|STARTED|Overall Study||104||
48541873|NCT02792699|101662801|FG001|STARTED|Overall Study||104||
48541874|NCT02792699|101662802|FG002|STARTED|Overall Study||103||
48689566|NCT00382265|102022720|FG001|NOT COMPLETED|Overall Study||6||
48689567|NCT03542266|102022721|FG000|STARTED|Treatment Phase||21||
48689568|NCT03542266|102022721|FG000|COMPLETED|Treatment Phase||18||
48689569|NCT03542266|102022721|FG000|NOT COMPLETED|Treatment Phase||3||
48689570|NCT03542266|102022721|FG000|STARTED|Post-treatment Follow-up Phase||15||
48689571|NCT03542266|102022721|FG000|COMPLETED|Post-treatment Follow-up Phase||0||
48689572|NCT03542266|102022721|FG000|NOT COMPLETED|Post-treatment Follow-up Phase||15||
48541875|NCT02792699|101662800|FG000|Received First Infusion of First Dose|Overall Study||104|Day 1|
48541876|NCT02792699|101662801|FG001|Received First Infusion of First Dose|Overall Study||104|Day 1|
48541877|NCT02792699|101662802|FG002|Received First Infusion of First Dose|Overall Study||103|Day 1|
48689573|NCT02391311|102022722|FG000|STARTED|Overall Study||21||
48689574|NCT02391311|102022723|FG001|STARTED|Overall Study||21||
48388732|NCT03094832|101279648|FG003|COMPLETED|Overall Study||0||
48388733|NCT03094832|101279649|FG004|COMPLETED|Overall Study||0||
48388734|NCT03094832|101279645|FG000|NOT COMPLETED|Overall Study||15||
48388735|NCT03094832|101279646|FG001|NOT COMPLETED|Overall Study||20||
48388736|NCT03094832|101279647|FG002|NOT COMPLETED|Overall Study||1||
48388737|NCT03094832|101279648|FG003|NOT COMPLETED|Overall Study||8||
48388738|NCT03094832|101279649|FG004|NOT COMPLETED|Overall Study||2||
48388739|NCT03986190|101279650|FG000|STARTED|Overall Study||50||
48388740|NCT03986190|101279651|FG001|STARTED|Overall Study||50||
48388741|NCT03986190|101279650|FG000|Adolescents Started|Overall Study||25||
48388742|NCT03986190|101279651|FG001|Adolescents Started|Overall Study||25||
48388743|NCT03986190|101279650|FG000|Parents Started|Overall Study||25||
48095779|NCT01408030|100560263|FG003|STARTED|Treatment Phase (on Drug)||28||
48095780|NCT01408030|100560260|FG000|COMPLETED|Treatment Phase (on Drug)||26||
48095781|NCT01408030|100560261|FG001|COMPLETED|Treatment Phase (on Drug)||24||
48095782|NCT01408030|100560262|FG002|COMPLETED|Treatment Phase (on Drug)||32||
48095783|NCT01408030|100560263|FG003|COMPLETED|Treatment Phase (on Drug)||25||
48095784|NCT01408030|100560260|FG000|NOT COMPLETED|Treatment Phase (on Drug)||3||
48095785|NCT01408030|100560261|FG001|NOT COMPLETED|Treatment Phase (on Drug)||7||
48095786|NCT01408030|100560262|FG002|NOT COMPLETED|Treatment Phase (on Drug)||1||
48095787|NCT01408030|100560263|FG003|NOT COMPLETED|Treatment Phase (on Drug)||3||
48095788|NCT01408030|100560260|FG000|STARTED|Observation Phase (Off Drug)||26||
48095789|NCT01408030|100560261|FG001|STARTED|Observation Phase (Off Drug)||24||
48388744|NCT03986190|101279651|FG001|Parents Started|Overall Study||25||
48388745|NCT03986190|101279650|FG000|Adolescents Completed|Overall Study||19||
48388746|NCT03986190|101279651|FG001|Adolescents Completed|Overall Study||25||
48388747|NCT03986190|101279650|FG000|Parents Completed|Overall Study||19||
48388748|NCT03986190|101279651|FG001|Parents Completed|Overall Study||25||
48388749|NCT03986190|101279650|FG000|COMPLETED|Overall Study||38||
48388750|NCT03986190|101279651|FG001|COMPLETED|Overall Study||50||
48388751|NCT03986190|101279650|FG000|NOT COMPLETED|Overall Study||12||
48388752|NCT03986190|101279651|FG001|NOT COMPLETED|Overall Study||0||
48388753|NCT01700985|101279652|FG000|STARTED|Overall Study||23||
48388754|NCT01700985|101279653|FG001|STARTED|Overall Study||21||
48388755|NCT01700985|101279652|FG000|COMPLETED|Overall Study||23||
48388756|NCT01700985|101279653|FG001|COMPLETED|Overall Study||20||
48388757|NCT01700985|101279652|FG000|NOT COMPLETED|Overall Study||0||
48388758|NCT01700985|101279653|FG001|NOT COMPLETED|Overall Study||1||
48388759|NCT02702011|101279654|FG000|STARTED|Overall Study||11||
48388760|NCT02702011|101279655|FG001|STARTED|Overall Study||13||
48388761|NCT02702011|101279656|FG002|STARTED|Overall Study||12||
48388762|NCT02702011|101279657|FG003|STARTED|Overall Study||12||
48388763|NCT02702011|101279654|FG000|COMPLETED|Overall Study||11||
48388764|NCT02702011|101279655|FG001|COMPLETED|Overall Study||12||
48388765|NCT02702011|101279656|FG002|COMPLETED|Overall Study||12||
48388766|NCT02702011|101279657|FG003|COMPLETED|Overall Study||12||
48388767|NCT02702011|101279654|FG000|NOT COMPLETED|Overall Study||0||
48388768|NCT02702011|101279655|FG001|NOT COMPLETED|Overall Study||1||
48388769|NCT02702011|101279656|FG002|NOT COMPLETED|Overall Study||0||
48388770|NCT02702011|101279657|FG003|NOT COMPLETED|Overall Study||0||
48388771|NCT02574858|101279658|FG000|STARTED|Overall Study||25||
48388772|NCT02574858|101279658|FG000|COMPLETED|Overall Study||25||
48388773|NCT02574858|101279658|FG000|NOT COMPLETED|Overall Study||0||
48388774|NCT01802554|101279659|FG000|STARTED|Overall Study||51||
48388775|NCT01802554|101279660|FG001|STARTED|Overall Study||49||
48388776|NCT01802554|101279659|FG000|COMPLETED|Overall Study||43||
48388777|NCT01802554|101279660|FG001|COMPLETED|Overall Study||43||
48388778|NCT01802554|101279659|FG000|NOT COMPLETED|Overall Study||8||
48388779|NCT01802554|101279660|FG001|NOT COMPLETED|Overall Study||6||
48388780|NCT02038569|101279661|FG000|STARTED|Overall Study||107||
48388781|NCT02038569|101279661|FG000|COMPLETED|Overall Study||102||
48388782|NCT02038569|101279661|FG000|NOT COMPLETED|Overall Study||5||
48388783|NCT00936117|101279662|FG000|STARTED|Overall Study||20||
48388784|NCT00936117|101279662|FG000|COMPLETED|Overall Study||10||
48388785|NCT00936117|101279662|FG000|NOT COMPLETED|Overall Study||10||
48388786|NCT02168803|101279663|FG000|STARTED|Overall Study||30||
48388787|NCT02168803|101279664|FG001|STARTED|Overall Study||32||
48388788|NCT02168803|101279665|FG002|STARTED|Overall Study||39||
48388789|NCT02168803|101279663|FG000|Received at Least 1 Dose of Study Drug|Overall Study||30||
48388790|NCT02168803|101279664|FG001|Received at Least 1 Dose of Study Drug|Overall Study||32||
48388791|NCT02168803|101279665|FG002|Received at Least 1 Dose of Study Drug|Overall Study||39||
48388792|NCT02168803|101279663|FG000|COMPLETED|Overall Study||28||
48388793|NCT02168803|101279664|FG001|COMPLETED|Overall Study||29||
48388794|NCT02168803|101279665|FG002|COMPLETED|Overall Study||33||
48388795|NCT02168803|101279663|FG000|NOT COMPLETED|Overall Study||2||
48388796|NCT02168803|101279664|FG001|NOT COMPLETED|Overall Study||3||
48388797|NCT02168803|101279665|FG002|NOT COMPLETED|Overall Study||6||
48388798|NCT03444870|101279666|FG000|STARTED|Double-Blind Treatment (DBT) Period||486||
48388799|NCT03444870|101279667|FG001|STARTED|Double-Blind Treatment (DBT) Period||499||
48095790|NCT01408030|100560262|FG002|STARTED|Observation Phase (Off Drug)||32||
48388800|NCT03444870|101279668|FG002|STARTED|Double-Blind Treatment (DBT) Period||33||
48388801|NCT03444870|101279669|FG003|STARTED|Double-Blind Treatment (DBT) Period||35||
48388802|NCT03444870|101279670|FG004|STARTED|Double-Blind Treatment (DBT) Period||0||
48388803|NCT03444870|101279671|FG005|STARTED|Double-Blind Treatment (DBT) Period||0||
48388804|NCT03444870|101279666|FG000|Intent-to-treat (ITT) Analysis Set|Double-Blind Treatment (DBT) Period||485|ITT analysis set included all participants randomized during the global phase, who received at least one dose of study drug.|
48388805|NCT03444870|101279667|FG001|Intent-to-treat (ITT) Analysis Set|Double-Blind Treatment (DBT) Period||499|ITT analysis set included all participants randomized during the global phase, who received at least one dose of study drug.|
48388806|NCT03444870|101279668|FG002|Intent-to-treat (ITT) Analysis Set|Double-Blind Treatment (DBT) Period||0|ITT analysis set included all participants randomized during the global phase, who received at least one dose of study drug.|
48388807|NCT03444870|101279669|FG003|Intent-to-treat (ITT) Analysis Set|Double-Blind Treatment (DBT) Period||0|ITT analysis set included all participants randomized during the global phase, who received at least one dose of study drug.|
48388808|NCT03444870|101279670|FG004|Intent-to-treat (ITT) Analysis Set|Double-Blind Treatment (DBT) Period||0|ITT analysis set included all participants randomized during the global phase, who received at least one dose of study drug.|
48388809|NCT03444870|101279671|FG005|Intent-to-treat (ITT) Analysis Set|Double-Blind Treatment (DBT) Period||0|ITT analysis set included all participants randomized during the global phase, who received at least one dose of study drug.|
48388810|NCT03444870|101279666|FG000|Safety-evaluable (SE) Analysis Set|Double-Blind Treatment (DBT) Period||481|SE analysis set included all participants randomized during the global phase who received at least one dose of study drug. In the DBT period, 4 participants randomized to placebo arm received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set, of which 1 participant entered OLE period.|
48388811|NCT03444870|101279667|FG001|Safety-evaluable (SE) Analysis Set|Double-Blind Treatment (DBT) Period||503|SE analysis set included all participants randomized during the global phase who received at least one dose of study drug. In the DBT period, 4 participants randomized to placebo arm received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set, of which 1 participant entered OLE period.|
48404070|NCT03689972|101321767|FG001|COMPLETED|Part 1 (Day 1 up to Week 72)||202|Completed denotes the participants that completed the study treatment.|
48404071|NCT03689972|101321768|FG002|COMPLETED|Part 1 (Day 1 up to Week 72)||0|Completed denotes the participants that completed the study treatment.|
48541878|NCT02792699|101662800|FG000|Received Second Infusion of First Dose|Overall Study||102|Day 15 (week 2)|
48541879|NCT02792699|101662801|FG001|Received Second Infusion of First Dose|Overall Study||103|Day 15 (week 2)|
48541880|NCT02792699|101662802|FG002|Received Second Infusion of First Dose|Overall Study||99|Day 15 (week 2)|
48541881|NCT02792699|101662800|FG000|Received First Infusion of Second Dose|Overall Study||97|Week 24|
48541882|NCT02792699|101662801|FG001|Received First Infusion of Second Dose|Overall Study||99|Week 24|
48541883|NCT02792699|101662802|FG002|Received First Infusion of Second Dose|Overall Study||95|Week 24|
48541884|NCT02792699|101662800|FG000|Received Second Infusion of Second Dose|Overall Study||97|Week 26|
48541885|NCT02792699|101662801|FG001|Received Second Infusion of Second Dose|Overall Study||99|Week 26|
48541886|NCT02792699|101662802|FG002|Received Second Infusion of Second Dose|Overall Study||93|Week 26|
48541887|NCT02792699|101662800|FG000|COMPLETED|Overall Study||95||
48541888|NCT02792699|101662801|FG001|COMPLETED|Overall Study||94||
48541889|NCT02792699|101662802|FG002|COMPLETED|Overall Study||93||
48541890|NCT02792699|101662800|FG000|NOT COMPLETED|Overall Study||9||
48689575|NCT02391311|102022722|FG000|COMPLETED|Overall Study||18||
48689576|NCT02391311|102022723|FG001|COMPLETED|Overall Study||19||
48689577|NCT02391311|102022722|FG000|NOT COMPLETED|Overall Study||3||
48689578|NCT02391311|102022723|FG001|NOT COMPLETED|Overall Study||2||
48689579|NCT02364037|102022724|FG000|STARTED|Overall Study||502||
48689580|NCT02364037|102022725|FG001|STARTED|Overall Study||506||
48689581|NCT02364037|102022724|FG000|COMPLETED|Overall Study||458||
48689582|NCT02364037|102022725|FG001|COMPLETED|Overall Study||453||
48689583|NCT02364037|102022724|FG000|NOT COMPLETED|Overall Study||44||
48689584|NCT02364037|102022725|FG001|NOT COMPLETED|Overall Study||53||
48689585|NCT01232127|102022726|FG000|STARTED|Period 1: Days 1-10||25||
48689586|NCT01232127|102022727|FG001|STARTED|Period 1: Days 1-10||0||
48689587|NCT01232127|102022728|FG002|STARTED|Period 1: Days 1-10||0||
48541891|NCT02792699|101662801|FG001|NOT COMPLETED|Overall Study||10||
48541892|NCT02792699|101662802|FG002|NOT COMPLETED|Overall Study||10||
48541893|NCT00749892|101662803|FG000|STARTED|Overall Study||34||
48541894|NCT00749892|101662803|FG000|COMPLETED|Overall Study||31||
48541895|NCT00749892|101662803|FG000|NOT COMPLETED|Overall Study||3||
48541896|NCT02794870|101662804|FG000|STARTED|Overall Study||22||
48689588|NCT01232127|102022726|FG000|COMPLETED|Period 1: Days 1-10||24||
48689589|NCT01232127|102022727|FG001|COMPLETED|Period 1: Days 1-10||0||
48689590|NCT01232127|102022728|FG002|COMPLETED|Period 1: Days 1-10||0||
48689591|NCT01232127|102022726|FG000|NOT COMPLETED|Period 1: Days 1-10||1||
48689592|NCT01232127|102022727|FG001|NOT COMPLETED|Period 1: Days 1-10||0||
48689593|NCT01232127|102022728|FG002|NOT COMPLETED|Period 1: Days 1-10||0||
48689594|NCT01232127|102022726|FG000|STARTED|Period 2: Days 11-17||0||
48689595|NCT01232127|102022727|FG001|STARTED|Period 2: Days 11-17||24||
48689596|NCT01232127|102022728|FG002|STARTED|Period 2: Days 11-17||0||
48689597|NCT01232127|102022726|FG000|COMPLETED|Period 2: Days 11-17||0||
48388812|NCT03444870|101279668|FG002|Safety-evaluable (SE) Analysis Set|Double-Blind Treatment (DBT) Period||0|SE analysis set included all participants randomized during the global phase who received at least one dose of study drug. In the DBT period, 4 participants randomized to placebo arm received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set, of which 1 participant entered OLE period.|
48388813|NCT03444870|101279669|FG003|Safety-evaluable (SE) Analysis Set|Double-Blind Treatment (DBT) Period||0|SE analysis set included all participants randomized during the global phase who received at least one dose of study drug. In the DBT period, 4 participants randomized to placebo arm received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set, of which 1 participant entered OLE period.|
48388814|NCT03444870|101279670|FG004|Safety-evaluable (SE) Analysis Set|Double-Blind Treatment (DBT) Period||0|SE analysis set included all participants randomized during the global phase who received at least one dose of study drug. In the DBT period, 4 participants randomized to placebo arm received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set, of which 1 participant entered OLE period.|
48388815|NCT03444870|101279671|FG005|Safety-evaluable (SE) Analysis Set|Double-Blind Treatment (DBT) Period||0|SE analysis set included all participants randomized during the global phase who received at least one dose of study drug. In the DBT period, 4 participants randomized to placebo arm received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set, of which 1 participant entered OLE period.|
48388816|NCT03444870|101279666|FG000|ITT Analysis Set (China)|Double-Blind Treatment (DBT) Period||0|ITT analysis set (China) included all participants enrolled in China in the China extension phase who received at least one dose of study drug.|
48388817|NCT03444870|101279667|FG001|ITT Analysis Set (China)|Double-Blind Treatment (DBT) Period||0|ITT analysis set (China) included all participants enrolled in China in the China extension phase who received at least one dose of study drug.|
48388818|NCT03444870|101279668|FG002|ITT Analysis Set (China)|Double-Blind Treatment (DBT) Period||33|ITT analysis set (China) included all participants enrolled in China in the China extension phase who received at least one dose of study drug.|
48388819|NCT03444870|101279669|FG003|ITT Analysis Set (China)|Double-Blind Treatment (DBT) Period||35|ITT analysis set (China) included all participants enrolled in China in the China extension phase who received at least one dose of study drug.|
48388820|NCT03444870|101279670|FG004|ITT Analysis Set (China)|Double-Blind Treatment (DBT) Period||0|ITT analysis set (China) included all participants enrolled in China in the China extension phase who received at least one dose of study drug.|
48388821|NCT03444870|101279671|FG005|ITT Analysis Set (China)|Double-Blind Treatment (DBT) Period||0|ITT analysis set (China) included all participants enrolled in China in the China extension phase who received at least one dose of study drug.|
48388822|NCT03444870|101279666|FG000|SE Analysis Set (China)|Double-Blind Treatment (DBT) Period||0|SE analysis set (China) included all participants enrolled in China in the China extension phase who received at least one dose of study drug.|
48388823|NCT03444870|101279667|FG001|SE Analysis Set (China)|Double-Blind Treatment (DBT) Period||0|SE analysis set (China) included all participants enrolled in China in the China extension phase who received at least one dose of study drug.|
48388824|NCT03444870|101279668|FG002|SE Analysis Set (China)|Double-Blind Treatment (DBT) Period||33|SE analysis set (China) included all participants enrolled in China in the China extension phase who received at least one dose of study drug.|
48388825|NCT03444870|101279669|FG003|SE Analysis Set (China)|Double-Blind Treatment (DBT) Period||35|SE analysis set (China) included all participants enrolled in China in the China extension phase who received at least one dose of study drug.|
48388826|NCT03444870|101279670|FG004|SE Analysis Set (China)|Double-Blind Treatment (DBT) Period||0|SE analysis set (China) included all participants enrolled in China in the China extension phase who received at least one dose of study drug.|
48388827|NCT03444870|101279671|FG005|SE Analysis Set (China)|Double-Blind Treatment (DBT) Period||0|SE analysis set (China) included all participants enrolled in China in the China extension phase who received at least one dose of study drug.|
48388828|NCT03444870|101279666|FG000|Safety Magnetic Resonance Imaging (MRI)-Evaluable (SEMRI) Analysis Set|Double-Blind Treatment (DBT) Period||476|SEMRI analysis set included all participants in the SE analysis set who had at least one post-baseline safety MRI scan.|
48388829|NCT03444870|101279667|FG001|Safety Magnetic Resonance Imaging (MRI)-Evaluable (SEMRI) Analysis Set|Double-Blind Treatment (DBT) Period||497|SEMRI analysis set included all participants in the SE analysis set who had at least one post-baseline safety MRI scan.|
48388830|NCT03444870|101279668|FG002|Safety Magnetic Resonance Imaging (MRI)-Evaluable (SEMRI) Analysis Set|Double-Blind Treatment (DBT) Period||0|SEMRI analysis set included all participants in the SE analysis set who had at least one post-baseline safety MRI scan.|
48388831|NCT03444870|101279669|FG003|Safety Magnetic Resonance Imaging (MRI)-Evaluable (SEMRI) Analysis Set|Double-Blind Treatment (DBT) Period||0|SEMRI analysis set included all participants in the SE analysis set who had at least one post-baseline safety MRI scan.|
48388832|NCT03444870|101279670|FG004|Safety Magnetic Resonance Imaging (MRI)-Evaluable (SEMRI) Analysis Set|Double-Blind Treatment (DBT) Period||0|SEMRI analysis set included all participants in the SE analysis set who had at least one post-baseline safety MRI scan.|
48388833|NCT03444870|101279671|FG005|Safety Magnetic Resonance Imaging (MRI)-Evaluable (SEMRI) Analysis Set|Double-Blind Treatment (DBT) Period||0|SEMRI analysis set included all participants in the SE analysis set who had at least one post-baseline safety MRI scan.|
48388834|NCT03444870|101279666|FG000|COMPLETED|Double-Blind Treatment (DBT) Period||387||
48388835|NCT03444870|101279667|FG001|COMPLETED|Double-Blind Treatment (DBT) Period||375||
48388836|NCT03444870|101279668|FG002|COMPLETED|Double-Blind Treatment (DBT) Period||0||
48388837|NCT03444870|101279669|FG003|COMPLETED|Double-Blind Treatment (DBT) Period||0||
48388838|NCT03444870|101279670|FG004|COMPLETED|Double-Blind Treatment (DBT) Period||0||
48388839|NCT03444870|101279671|FG005|COMPLETED|Double-Blind Treatment (DBT) Period||0||
48541897|NCT02794870|101662805|FG001|STARTED|Overall Study||11||
48541898|NCT02794870|101662804|FG000|Received Inoculation|Overall Study||21||
48541899|NCT02794870|101662805|FG001|Received Inoculation|Overall Study||11||
48541900|NCT02794870|101662804|FG000|COMPLETED|Overall Study||20||
48388840|NCT03444870|101279666|FG000|NOT COMPLETED|Double-Blind Treatment (DBT) Period||99||
48388841|NCT03444870|101279667|FG001|NOT COMPLETED|Double-Blind Treatment (DBT) Period||124||
48388842|NCT03444870|101279668|FG002|NOT COMPLETED|Double-Blind Treatment (DBT) Period||33||
48388843|NCT03444870|101279669|FG003|NOT COMPLETED|Double-Blind Treatment (DBT) Period||35||
48388844|NCT03444870|101279670|FG004|NOT COMPLETED|Double-Blind Treatment (DBT) Period||0||
48388845|NCT03444870|101279671|FG005|NOT COMPLETED|Double-Blind Treatment (DBT) Period||0||
48388846|NCT03444870|101279666|FG000|STARTED|Open-Label Extension (OLE) Period||0||
48388847|NCT03444870|101279667|FG001|STARTED|Open-Label Extension (OLE) Period||0||
48388848|NCT03444870|101279668|FG002|STARTED|Open-Label Extension (OLE) Period||0||
48388849|NCT03444870|101279669|FG003|STARTED|Open-Label Extension (OLE) Period||0||
48689598|NCT01232127|102022727|FG001|COMPLETED|Period 2: Days 11-17||24||
48689599|NCT01232127|102022728|FG002|COMPLETED|Period 2: Days 11-17||0||
48689600|NCT01232127|102022726|FG000|NOT COMPLETED|Period 2: Days 11-17||0||
48689601|NCT01232127|102022727|FG001|NOT COMPLETED|Period 2: Days 11-17||0||
48689602|NCT01232127|102022728|FG002|NOT COMPLETED|Period 2: Days 11-17||0||
48689603|NCT01232127|102022726|FG000|STARTED|Period 3: Days 18-24||0||
48689604|NCT01232127|102022727|FG001|STARTED|Period 3: Days 18-24||0||
48689605|NCT01232127|102022728|FG002|STARTED|Period 3: Days 18-24||24||
48689606|NCT01232127|102022726|FG000|COMPLETED|Period 3: Days 18-24||0||
48689607|NCT01232127|102022727|FG001|COMPLETED|Period 3: Days 18-24||0||
48689608|NCT01232127|102022728|FG002|COMPLETED|Period 3: Days 18-24||24||
48689609|NCT01232127|102022726|FG000|NOT COMPLETED|Period 3: Days 18-24||0||
48689610|NCT01232127|102022727|FG001|NOT COMPLETED|Period 3: Days 18-24||0||
48689611|NCT01232127|102022728|FG002|NOT COMPLETED|Period 3: Days 18-24||0||
48689612|NCT00771927|102022729|FG000|STARTED|Overall Study||511||
48689613|NCT00771927|102022730|FG001|STARTED|Overall Study||493||
48689614|NCT00771927|102022729|FG000|COMPLETED|Overall Study||256||
48689615|NCT00771927|102022730|FG001|COMPLETED|Overall Study||256||
48689616|NCT00771927|102022729|FG000|NOT COMPLETED|Overall Study||255||
48689617|NCT00771927|102022730|FG001|NOT COMPLETED|Overall Study||237||
48689618|NCT00833469|102022731|FG000|STARTED|Overall Study||5||
48689619|NCT00833469|102022731|FG000|COMPLETED|Overall Study||3||
48689620|NCT00833469|102022731|FG000|NOT COMPLETED|Overall Study||2||
48689621|NCT00768261|102022732|FG000|STARTED|Overall Study||14||
48689622|NCT00768261|102022733|FG001|STARTED|Overall Study||18||
48689623|NCT00768261|102022734|FG002|STARTED|Overall Study||39||
48689624|NCT00768261|102022735|FG003|STARTED|Overall Study||56||
48689625|NCT00768261|102022732|FG000|COMPLETED|Overall Study||14||
48689626|NCT00768261|102022733|FG001|COMPLETED|Overall Study||18||
48689627|NCT00768261|102022734|FG002|COMPLETED|Overall Study||14||
48689628|NCT00768261|102022735|FG003|COMPLETED|Overall Study||56||
48689629|NCT00768261|102022732|FG000|NOT COMPLETED|Overall Study||0||
48689630|NCT00768261|102022733|FG001|NOT COMPLETED|Overall Study||0||
48689631|NCT00768261|102022734|FG002|NOT COMPLETED|Overall Study||25||
48689632|NCT00768261|102022735|FG003|NOT COMPLETED|Overall Study||0||
48689633|NCT00739310|102022736|FG000|STARTED|Overall Study||29||
48689634|NCT00739310|102022736|FG000|COMPLETED|Overall Study||22||
48689635|NCT00739310|102022736|FG000|NOT COMPLETED|Overall Study||7||
48689636|NCT02008149|102022737|FG000|STARTED|Overall Study||7||
48689637|NCT02008149|102022738|FG001|STARTED|Overall Study||1||
48689638|NCT02008149|102022739|FG002|STARTED|Overall Study||1||
48689639|NCT02008149|102022737|FG000|COMPLETED|Overall Study||4||
48689640|NCT02008149|102022738|FG001|COMPLETED|Overall Study||0||
48689641|NCT02008149|102022739|FG002|COMPLETED|Overall Study||1||
48689642|NCT02008149|102022737|FG000|NOT COMPLETED|Overall Study||3||
48689643|NCT02008149|102022738|FG001|NOT COMPLETED|Overall Study||1||
48689644|NCT02008149|102022739|FG002|NOT COMPLETED|Overall Study||0||
48689645|NCT00530634|102022740|FG000|STARTED|Overall Study||3||
48689646|NCT00530634|102022740|FG000|COMPLETED|Overall Study||3||
48689647|NCT00530634|102022740|FG000|NOT COMPLETED|Overall Study||0||
48689648|NCT01740258|102022741|FG000|STARTED|Overall Study||68||
48689649|NCT01740258|102022741|FG000|Entered Part A|Overall Study||68||
48689650|NCT01740258|102022741|FG000|Entered Part B|Overall Study||62||
48689651|NCT01740258|102022741|FG000|Entered Part C|Overall Study||20||
48689652|NCT01740258|102022741|FG000|Entered Part D|Overall Study||42||
48388850|NCT03444870|101279670|FG004|STARTED|Open-Label Extension (OLE) Period||10||
48388851|NCT03444870|101279671|FG005|STARTED|Open-Label Extension (OLE) Period||19||
48388852|NCT03444870|101279666|FG000|SE Analysis Set|Open-Label Extension (OLE) Period||0|SE analysis set included all participants randomized during the global phase who received at least one dose of study drug. In the DBT period, 4 participants randomized to placebo arm received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set, of which 1 participant entered OLE period.|
48404088|NCT03689972|101321770|FG004|COMPLETED|Part 2:Run-in Period (Week73uptoWeek107)||0||
48689653|NCT01740258|102022741|FG000|COMPLETED|Overall Study||68||
48689654|NCT01740258|102022741|FG000|NOT COMPLETED|Overall Study||0||
48689655|NCT04776161|102022742|FG000|STARTED|Overall Study||19||
48689656|NCT04776161|102022743|FG001|STARTED|Overall Study||21||
48689657|NCT04776161|102022744|FG002|STARTED|Overall Study||22||
48689658|NCT04776161|102022742|FG000|COMPLETED|Overall Study||17||
48689659|NCT04776161|102022743|FG001|COMPLETED|Overall Study||17||
48689660|NCT04776161|102022744|FG002|COMPLETED|Overall Study||18||
48689661|NCT04776161|102022742|FG000|NOT COMPLETED|Overall Study||2||
48689662|NCT04776161|102022743|FG001|NOT COMPLETED|Overall Study||4||
48689663|NCT04776161|102022744|FG002|NOT COMPLETED|Overall Study||4||
48689664|NCT01648023|102022745|FG000|STARTED|Overall Study||25||
48689665|NCT01648023|102022746|FG001|STARTED|Overall Study||24||
48689666|NCT01648023|102022745|FG000|COMPLETED|Overall Study||24||
48689667|NCT01648023|102022746|FG001|COMPLETED|Overall Study||22||
48689668|NCT01648023|102022745|FG000|NOT COMPLETED|Overall Study||1||
48689669|NCT01648023|102022746|FG001|NOT COMPLETED|Overall Study||2||
48689670|NCT02440204|102022747|FG000|STARTED|Overall Study||22||
48689671|NCT02440204|102022748|FG001|STARTED|Overall Study||24||
48259809|NCT04253119|100958788|FG000|STARTED|Overall Study||536||
48259810|NCT04253119|100958788|FG000|COMPLETED|Overall Study||536||
48259811|NCT04253119|100958788|FG000|NOT COMPLETED|Overall Study||0||
48259812|NCT00966979|100958789|FG000|STARTED|Overall Study||111||112
48259813|NCT00966979|100958789|FG000|COMPLETED|Overall Study||13||13
48259814|NCT00966979|100958789|FG000|NOT COMPLETED|Overall Study||98||99
48259815|NCT00224029|100958790|FG000|STARTED|Overall Study||24||
48259816|NCT00224029|100958790|FG000|COMPLETED|Overall Study||18||
48259817|NCT00224029|100958790|FG000|NOT COMPLETED|Overall Study||6||
48259818|NCT04752033|100958791|FG000|STARTED|Overall Study||2||
48259819|NCT04752033|100958792|FG001|STARTED|Overall Study||5||
48259820|NCT04752033|100958793|FG002|STARTED|Overall Study||4||
48388853|NCT03444870|101279667|FG001|SE Analysis Set|Open-Label Extension (OLE) Period||0|SE analysis set included all participants randomized during the global phase who received at least one dose of study drug. In the DBT period, 4 participants randomized to placebo arm received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set, of which 1 participant entered OLE period.|
48388854|NCT03444870|101279668|FG002|SE Analysis Set|Open-Label Extension (OLE) Period||0|SE analysis set included all participants randomized during the global phase who received at least one dose of study drug. In the DBT period, 4 participants randomized to placebo arm received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set, of which 1 participant entered OLE period.|
48388855|NCT03444870|101279669|FG003|SE Analysis Set|Open-Label Extension (OLE) Period||0|SE analysis set included all participants randomized during the global phase who received at least one dose of study drug. In the DBT period, 4 participants randomized to placebo arm received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set, of which 1 participant entered OLE period.|
48404072|NCT03689972|101321769|FG003|COMPLETED|Part 1 (Day 1 up to Week 72)||0|Completed denotes the participants that completed the study treatment.|
48404089|NCT03689972|101321766|FG000|NOT COMPLETED|Part 2:Run-in Period (Week73uptoWeek107)||0||
48541901|NCT02794870|101662805|FG001|COMPLETED|Overall Study||11||
48541902|NCT02794870|101662804|FG000|NOT COMPLETED|Overall Study||2||
48541903|NCT02794870|101662805|FG001|NOT COMPLETED|Overall Study||0||
48541904|NCT01866098|101662806|FG000|STARTED|Overall Study||51||
48541905|NCT01866098|101662807|FG001|STARTED|Overall Study||47||
48541906|NCT01866098|101662808|FG002|STARTED|Overall Study||46||
48541907|NCT01866098|101662806|FG000|COMPLETED|Overall Study||32||
48689672|NCT02440204|102022749|FG002|STARTED|Overall Study||22||
48689673|NCT02440204|102022747|FG000|COMPLETED|Overall Study||22||
48689674|NCT02440204|102022748|FG001|COMPLETED|Overall Study||24||
48259821|NCT04752033|100958794|FG003|STARTED|Overall Study||4||
48259822|NCT04752033|100958795|FG004|STARTED|Overall Study||4||
48259823|NCT04752033|100958796|FG005|STARTED|Overall Study||1||
48259824|NCT04752033|100958797|FG006|STARTED|Overall Study||4||
48259825|NCT04752033|100958798|FG007|STARTED|Overall Study||16||
48689675|NCT02440204|102022749|FG002|COMPLETED|Overall Study||22||
48259826|NCT04752033|100958799|FG008|STARTED|Overall Study||6||
48259827|NCT04752033|100958800|FG009|STARTED|Overall Study||10||
48259828|NCT04752033|100958801|FG010|STARTED|Overall Study||6||
48259829|NCT04752033|100958802|FG011|STARTED|Overall Study||2||
48259830|NCT04752033|100958803|FG012|STARTED|Overall Study||1||
48259831|NCT04752033|100958804|FG013|STARTED|Overall Study||3||
48259832|NCT04752033|100958805|FG014|STARTED|Overall Study||12||
48259833|NCT04752033|100958791|FG000|COMPLETED|Overall Study||2||
48259834|NCT04752033|100958792|FG001|COMPLETED|Overall Study||5||
48259835|NCT04752033|100958793|FG002|COMPLETED|Overall Study||4||
48259836|NCT04752033|100958794|FG003|COMPLETED|Overall Study||4||
48259837|NCT04752033|100958795|FG004|COMPLETED|Overall Study||4||
48259838|NCT04752033|100958796|FG005|COMPLETED|Overall Study||1||
48259839|NCT04752033|100958797|FG006|COMPLETED|Overall Study||4||
48259840|NCT04752033|100958798|FG007|COMPLETED|Overall Study||16||
48259841|NCT04752033|100958799|FG008|COMPLETED|Overall Study||6||
48259842|NCT04752033|100958800|FG009|COMPLETED|Overall Study||10||
48259843|NCT04752033|100958801|FG010|COMPLETED|Overall Study||6||
48259844|NCT04752033|100958802|FG011|COMPLETED|Overall Study||2||
48259845|NCT04752033|100958803|FG012|COMPLETED|Overall Study||1||
48259846|NCT04752033|100958804|FG013|COMPLETED|Overall Study||3||
48259847|NCT04752033|100958805|FG014|COMPLETED|Overall Study||12||
48259848|NCT04752033|100958791|FG000|NOT COMPLETED|Overall Study||0||
48259849|NCT04752033|100958792|FG001|NOT COMPLETED|Overall Study||0||
48259850|NCT04752033|100958793|FG002|NOT COMPLETED|Overall Study||0||
48259851|NCT04752033|100958794|FG003|NOT COMPLETED|Overall Study||0||
48259852|NCT04752033|100958795|FG004|NOT COMPLETED|Overall Study||0||
48259853|NCT04752033|100958796|FG005|NOT COMPLETED|Overall Study||0||
48259854|NCT04752033|100958797|FG006|NOT COMPLETED|Overall Study||0||
48259855|NCT04752033|100958798|FG007|NOT COMPLETED|Overall Study||0||
48689676|NCT02440204|102022747|FG000|NOT COMPLETED|Overall Study||0||
48689677|NCT02440204|102022748|FG001|NOT COMPLETED|Overall Study||0||
48259856|NCT04752033|100958799|FG008|NOT COMPLETED|Overall Study||0||
48259857|NCT04752033|100958800|FG009|NOT COMPLETED|Overall Study||0||
48259858|NCT04752033|100958801|FG010|NOT COMPLETED|Overall Study||0||
48259859|NCT04752033|100958802|FG011|NOT COMPLETED|Overall Study||0||
48259860|NCT04752033|100958803|FG012|NOT COMPLETED|Overall Study||0||
48259861|NCT04752033|100958804|FG013|NOT COMPLETED|Overall Study||0||
48388856|NCT03444870|101279670|FG004|SE Analysis Set|Open-Label Extension (OLE) Period||9|SE analysis set included all participants randomized during the global phase who received at least one dose of study drug. In the DBT period, 4 participants randomized to placebo arm received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set, of which 1 participant entered OLE period.|
48388857|NCT03444870|101279671|FG005|SE Analysis Set|Open-Label Extension (OLE) Period||20|SE analysis set included all participants randomized during the global phase who received at least one dose of study drug. In the DBT period, 4 participants randomized to placebo arm received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set, of which 1 participant entered OLE period.|
48388858|NCT03444870|101279666|FG000|COMPLETED|Open-Label Extension (OLE) Period||0||
48388859|NCT03444870|101279667|FG001|COMPLETED|Open-Label Extension (OLE) Period||0||
48388860|NCT03444870|101279668|FG002|COMPLETED|Open-Label Extension (OLE) Period||0||
48388861|NCT03444870|101279669|FG003|COMPLETED|Open-Label Extension (OLE) Period||0||
48388862|NCT03444870|101279670|FG004|COMPLETED|Open-Label Extension (OLE) Period||7||
48388863|NCT03444870|101279671|FG005|COMPLETED|Open-Label Extension (OLE) Period||17||
48259862|NCT04752033|100958805|FG014|NOT COMPLETED|Overall Study||0||
48259863|NCT01200498|100958806|FG000|STARTED|Overall Study||22||
48259864|NCT01200498|100958806|FG000|COMPLETED|Overall Study||22||
48259865|NCT01200498|100958806|FG000|NOT COMPLETED|Overall Study||0||
48259866|NCT03632083|100958807|FG000|STARTED|First Intervention||5||5
48259867|NCT03632083|100958808|FG001|STARTED|First Intervention||5||5
48259868|NCT03632083|100958809|FG002|STARTED|First Intervention||7||7
48388864|NCT03444870|101279666|FG000|NOT COMPLETED|Open-Label Extension (OLE) Period||0||
48388865|NCT03444870|101279667|FG001|NOT COMPLETED|Open-Label Extension (OLE) Period||0||
48388866|NCT03444870|101279668|FG002|NOT COMPLETED|Open-Label Extension (OLE) Period||0||
48388867|NCT03444870|101279669|FG003|NOT COMPLETED|Open-Label Extension (OLE) Period||0||
48388868|NCT03444870|101279670|FG004|NOT COMPLETED|Open-Label Extension (OLE) Period||3||
48388869|NCT03444870|101279671|FG005|NOT COMPLETED|Open-Label Extension (OLE) Period||2||
48388870|NCT00208494|101279672|FG000|STARTED|Overall Study||194||
48388871|NCT00208494|101279673|FG001|STARTED|Overall Study||196||
48388872|NCT00208494|101279672|FG000|COMPLETED|Overall Study||164||
48388873|NCT00208494|101279673|FG001|COMPLETED|Overall Study||162||
48388874|NCT00208494|101279672|FG000|NOT COMPLETED|Overall Study||30||
48541908|NCT01866098|101662807|FG001|COMPLETED|Overall Study||20||
48541909|NCT01866098|101662808|FG002|COMPLETED|Overall Study||25||
48541910|NCT01866098|101662806|FG000|NOT COMPLETED|Overall Study||19||
48541911|NCT01866098|101662807|FG001|NOT COMPLETED|Overall Study||27||
48541912|NCT01866098|101662808|FG002|NOT COMPLETED|Overall Study||21||
48541913|NCT04614948|101662809|FG000|STARTED|DB Phase (Day 1 up to 7.2 Months)||15708||
48541914|NCT04614948|101662810|FG001|STARTED|DB Phase (Day 1 up to 7.2 Months)||15592||
48541915|NCT04614948|101662811|FG002|STARTED|DB Phase (Day 1 up to 7.2 Months)||0||
48541916|NCT04614948|101662809|FG000|FAS Post-Dose 1 Population|DB Phase (Day 1 up to 7.2 Months)||15705|7 participants (3 in the Ad26 group, 4 in the placebo group) received a COVID-19 vaccination outside of the study prior to first study vaccination. These participants were excluded from post-dose 1 FAS.|
48689678|NCT02440204|102022749|FG002|NOT COMPLETED|Overall Study||0||
48689679|NCT00040742|102022750|FG000|STARTED|Overall Study||188||
48689680|NCT00040742|102022751|FG001|STARTED|Overall Study||183||
48259869|NCT03632083|100958810|FG003|STARTED|First Intervention||7||7
48259870|NCT03632083|100958811|FG004|STARTED|First Intervention||9||9
48259871|NCT03632083|100958812|FG005|STARTED|First Intervention||9||9
48259872|NCT03632083|100958813|FG006|STARTED|First Intervention||7||7
48259873|NCT03632083|100958814|FG007|STARTED|First Intervention||7||7
48259874|NCT03632083|100958807|FG000|COMPLETED|First Intervention||5||5
48259875|NCT03632083|100958808|FG001|COMPLETED|First Intervention||5||5
48259876|NCT03632083|100958809|FG002|COMPLETED|First Intervention||7||7
48259877|NCT03632083|100958810|FG003|COMPLETED|First Intervention||7||7
48259878|NCT03632083|100958811|FG004|COMPLETED|First Intervention||9||9
48259879|NCT03632083|100958812|FG005|COMPLETED|First Intervention||9||9
48259880|NCT03632083|100958813|FG006|COMPLETED|First Intervention||7||7
48259881|NCT03632083|100958814|FG007|COMPLETED|First Intervention||7||7
48259882|NCT03632083|100958807|FG000|NOT COMPLETED|First Intervention||0||0
48388875|NCT00208494|101279673|FG001|NOT COMPLETED|Overall Study||34||
48388876|NCT04428359|101279674|FG000|STARTED|Overall Study||33||
48388877|NCT04428359|101279675|FG001|STARTED|Overall Study||33||
48388878|NCT04428359|101279674|FG000|COMPLETED|Overall Study||31||
48388879|NCT04428359|101279675|FG001|COMPLETED|Overall Study||30||
48388880|NCT04428359|101279674|FG000|NOT COMPLETED|Overall Study||2||
48388881|NCT04428359|101279675|FG001|NOT COMPLETED|Overall Study||3||
48388882|NCT02379390|101279676|FG000|STARTED|Overall Study||4||
48388883|NCT02379390|101279677|FG001|STARTED|Overall Study||4||
48388884|NCT02379390|101279676|FG000|COMPLETED|Overall Study||2|Participant with Disease Progression were counted as completed.|
48388885|NCT02379390|101279677|FG001|COMPLETED|Overall Study||2|Participant with Disease Progression were counted as completed.|
48388886|NCT02379390|101279676|FG000|NOT COMPLETED|Overall Study||2||
48388887|NCT02379390|101279677|FG001|NOT COMPLETED|Overall Study||2||
48388888|NCT01921634|101283314|FG000|STARTED|Overall Study||300||
48388889|NCT01921634|101283314|FG000|COMPLETED|Overall Study||300||
48388890|NCT01921634|101283314|FG000|NOT COMPLETED|Overall Study||0||
48388891|NCT00795509|101283315|FG000|STARTED|Overall Study||374||
48388892|NCT00795509|101283315|FG000|COMPLETED|Overall Study||343||
48388893|NCT00795509|101283315|FG000|NOT COMPLETED|Overall Study||31||
48388894|NCT04929613|101283316|FG000|STARTED|Overall Study||30||
48388895|NCT04929613|101283316|FG000|COMPLETED|Overall Study||18||
48388896|NCT04929613|101283316|FG000|NOT COMPLETED|Overall Study||12||
48388897|NCT01868776|101283317|FG000|STARTED|Overall Study||50||
48388898|NCT01868776|101283318|FG001|STARTED|Overall Study||50||
48388899|NCT01868776|101283317|FG000|COMPLETED|Overall Study||50||
48388900|NCT01868776|101283318|FG001|COMPLETED|Overall Study||50||
48388901|NCT01868776|101283317|FG000|NOT COMPLETED|Overall Study||0||
48095791|NCT01408030|100560263|FG003|STARTED|Observation Phase (Off Drug)||25||
48095792|NCT01408030|100560260|FG000|COMPLETED|Observation Phase (Off Drug)||22||
48095793|NCT01408030|100560261|FG001|COMPLETED|Observation Phase (Off Drug)||18||
48095794|NCT01408030|100560262|FG002|COMPLETED|Observation Phase (Off Drug)||26||
48095795|NCT01408030|100560263|FG003|COMPLETED|Observation Phase (Off Drug)||21||
48095796|NCT01408030|100560260|FG000|NOT COMPLETED|Observation Phase (Off Drug)||4||
48095797|NCT01408030|100560261|FG001|NOT COMPLETED|Observation Phase (Off Drug)||6||
48095798|NCT01408030|100560262|FG002|NOT COMPLETED|Observation Phase (Off Drug)||6||
48388902|NCT01868776|101283318|FG001|NOT COMPLETED|Overall Study||0||
48388903|NCT02293902|101283319|FG000|STARTED|Double-Blind Period (Up to Week 24)||82||
48388904|NCT02293902|101283320|FG001|STARTED|Double-Blind Period (Up to Week 24)||81||
48388905|NCT02293902|101283321|FG002|STARTED|Double-Blind Period (Up to Week 24)||80||
48388906|NCT02293902|101283322|FG003|STARTED|Double-Blind Period (Up to Week 24)||0||
48388907|NCT02293902|101283323|FG004|STARTED|Double-Blind Period (Up to Week 24)||0||
48388908|NCT02293902|101283319|FG000|Treated|Double-Blind Period (Up to Week 24)||81||
48388909|NCT02293902|101283320|FG001|Treated|Double-Blind Period (Up to Week 24)||81||
48388910|NCT02293902|101283321|FG002|Treated|Double-Blind Period (Up to Week 24)||80||
48388911|NCT02293902|101283322|FG003|Treated|Double-Blind Period (Up to Week 24)||0||
48388912|NCT02293902|101283323|FG004|Treated|Double-Blind Period (Up to Week 24)||0||
48388913|NCT02293902|101283319|FG000|Rescued|Double-Blind Period (Up to Week 24)||44|Included both participants who completed and did not complete the study.|
48388914|NCT02293902|101283320|FG001|Rescued|Double-Blind Period (Up to Week 24)||6|Included both participants who completed and did not complete the study.|
48095799|NCT01408030|100560263|FG003|NOT COMPLETED|Observation Phase (Off Drug)||4||
48095800|NCT01430091|100560264|FG000|STARTED|Overall Study||18||
48095801|NCT01430091|100560264|FG000|COMPLETED|Overall Study||18||
48388915|NCT02293902|101283321|FG002|Rescued|Double-Blind Period (Up to Week 24)||8|Included both participants who completed and did not complete the study.|
48388916|NCT02293902|101283322|FG003|Rescued|Double-Blind Period (Up to Week 24)||0|Included both participants who completed and did not complete the study.|
48388917|NCT02293902|101283323|FG004|Rescued|Double-Blind Period (Up to Week 24)||0|Included both participants who completed and did not complete the study.|
48388918|NCT02293902|101283319|FG000|COMPLETED|Double-Blind Period (Up to Week 24)||71||
48388919|NCT02293902|101283320|FG001|COMPLETED|Double-Blind Period (Up to Week 24)||74||
48388920|NCT02293902|101283321|FG002|COMPLETED|Double-Blind Period (Up to Week 24)||70||
48388921|NCT02293902|101283322|FG003|COMPLETED|Double-Blind Period (Up to Week 24)||0||
48388922|NCT02293902|101283323|FG004|COMPLETED|Double-Blind Period (Up to Week 24)||0||
48388923|NCT02293902|101283319|FG000|NOT COMPLETED|Double-Blind Period (Up to Week 24)||11||
48388924|NCT02293902|101283320|FG001|NOT COMPLETED|Double-Blind Period (Up to Week 24)||7||
48388925|NCT02293902|101283321|FG002|NOT COMPLETED|Double-Blind Period (Up to Week 24)||10||
48388926|NCT02293902|101283322|FG003|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0||
48388927|NCT02293902|101283323|FG004|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0||
48095802|NCT01430091|100560264|FG000|NOT COMPLETED|Overall Study||0||
48095803|NCT03035708|100560265|FG000|STARTED|Overall Study||23||
48095804|NCT03035708|100560266|FG001|STARTED|Overall Study||24||
48095805|NCT03035708|100560265|FG000|COMPLETED|Overall Study||19||
48095806|NCT03035708|100560266|FG001|COMPLETED|Overall Study||13||
48388928|NCT02293902|101283319|FG000|STARTED|Single-Blind Period (Week 25 to Week 52)||0||
48388929|NCT02293902|101283320|FG001|STARTED|Single-Blind Period (Week 25 to Week 52)||74||
48388930|NCT02293902|101283321|FG002|STARTED|Single-Blind Period (Week 25 to Week 52)||70||
48388931|NCT02293902|101283322|FG003|STARTED|Single-Blind Period (Week 25 to Week 52)||34||
48388932|NCT02293902|101283323|FG004|STARTED|Single-Blind Period (Week 25 to Week 52)||37||
48388933|NCT02293902|101283319|FG000|COMPLETED|Single-Blind Period (Week 25 to Week 52)||0||
48388934|NCT02293902|101283320|FG001|COMPLETED|Single-Blind Period (Week 25 to Week 52)||66||
48388935|NCT02293902|101283321|FG002|COMPLETED|Single-Blind Period (Week 25 to Week 52)||68||
48388936|NCT02293902|101283322|FG003|COMPLETED|Single-Blind Period (Week 25 to Week 52)||33||
48388937|NCT02293902|101283323|FG004|COMPLETED|Single-Blind Period (Week 25 to Week 52)||31||
48592711|NCT00176436|101783166|FG001|COMPLETED|Overall Study||12||
48388938|NCT02293902|101283319|FG000|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||0||
48388939|NCT02293902|101283320|FG001|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||8||
48388940|NCT02293902|101283321|FG002|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||2||
48388941|NCT02293902|101283322|FG003|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||1||
48388942|NCT02293902|101283323|FG004|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||6||
48388943|NCT00570531|101283324|FG000|STARTED|Overall Study||6||
48388944|NCT00570531|101283324|FG000|COMPLETED|Overall Study||6||
48388945|NCT00570531|101283324|FG000|NOT COMPLETED|Overall Study||0||
48388946|NCT00779324|101283325|FG000|STARTED|Overall Study||82||
48388947|NCT00779324|101283326|FG001|STARTED|Overall Study||86||
48388948|NCT00779324|101283325|FG000|Completed 28-day Mid-point|Overall Study||80||
48388949|NCT00779324|101283326|FG001|Completed 28-day Mid-point|Overall Study||81||
48095807|NCT03035708|100560265|FG000|NOT COMPLETED|Overall Study||4||
48095808|NCT03035708|100560266|FG001|NOT COMPLETED|Overall Study||11||
48095809|NCT01333059|100560267|FG000|STARTED|Overall Study||14||
48095810|NCT01333059|100560268|FG001|STARTED|Overall Study||11||
48095811|NCT01333059|100560267|FG000|COMPLETED|Overall Study||8||
48095812|NCT01333059|100560268|FG001|COMPLETED|Overall Study||8||
48095813|NCT01333059|100560267|FG000|NOT COMPLETED|Overall Study||6||
48095814|NCT01333059|100560268|FG001|NOT COMPLETED|Overall Study||3||
48095815|NCT03312933|100560269|FG000|STARTED|Overall Study||100||
48259883|NCT03632083|100958808|FG001|NOT COMPLETED|First Intervention||0||0
48259884|NCT03632083|100958809|FG002|NOT COMPLETED|First Intervention||0||0
48259885|NCT03632083|100958810|FG003|NOT COMPLETED|First Intervention||0||0
48388950|NCT00779324|101283325|FG000|COMPLETED|Overall Study||75||
48388951|NCT00779324|101283326|FG001|COMPLETED|Overall Study||82||
48388952|NCT00779324|101283325|FG000|NOT COMPLETED|Overall Study||7||
48388953|NCT00779324|101283326|FG001|NOT COMPLETED|Overall Study||4||
48388954|NCT02565615|101283327|FG000|STARTED|Overall Study||291||
48388955|NCT02565615|101283328|FG001|STARTED|Overall Study||3080||
48388956|NCT02565615|101283329|FG002|STARTED|Overall Study||21||
48388957|NCT02565615|101283330|FG003|STARTED|Overall Study||101||
48388958|NCT02565615|101283331|FG004|STARTED|Overall Study||1622||
48388959|NCT02565615|101283327|FG000|Treated|Overall Study||291||
48388960|NCT02565615|101283328|FG001|Treated|Overall Study||3080||
48388961|NCT02565615|101283329|FG002|Treated|Overall Study||21||
48388962|NCT02565615|101283330|FG003|Treated|Overall Study||101||
48388963|NCT02565615|101283331|FG004|Treated|Overall Study||1055||
48388964|NCT02565615|101283327|FG000|COMPLETED|Overall Study||288||
48095816|NCT03312933|100560269|FG000|COMPLETED|Overall Study||46||
48095817|NCT03312933|100560269|FG000|NOT COMPLETED|Overall Study||54||
48095818|NCT00759863|100560270|FG000|STARTED|Overall Study||144||
48095819|NCT00759863|100560271|FG001|STARTED|Overall Study||98||
48095820|NCT00759863|100560270|FG000|COMPLETED|Overall Study||124||
48388965|NCT02565615|101283328|FG001|COMPLETED|Overall Study||3044||
48095821|NCT00759863|100560271|FG001|COMPLETED|Overall Study||80||
48095822|NCT00759863|100560270|FG000|NOT COMPLETED|Overall Study||20||
48095823|NCT00759863|100560271|FG001|NOT COMPLETED|Overall Study||18||
48095824|NCT02389088|100560272|FG000|STARTED|Overall Study - Phase I||9||
48095825|NCT02389088|100560272|FG000|COMPLETED|Overall Study - Phase I||9||
48095826|NCT02389088|100560272|FG000|NOT COMPLETED|Overall Study - Phase I||0||
48095827|NCT02389088|100560272|FG000|STARTED|Phase II - All Study Participants||9||
48095828|NCT02389088|100560272|FG000|COMPLETED|Phase II - All Study Participants||9||
48095829|NCT02389088|100560272|FG000|NOT COMPLETED|Phase II - All Study Participants||0||
48095830|NCT01471106|100560273|FG000|STARTED|Overall Study||12||
48095831|NCT01471106|100560274|FG001|STARTED|Overall Study||6||
48095832|NCT01471106|100560275|FG002|STARTED|Overall Study||6||
48095833|NCT01471106|100560273|FG000|COMPLETED|Overall Study||12||
48095834|NCT01471106|100560274|FG001|COMPLETED|Overall Study||6||
48095835|NCT01471106|100560275|FG002|COMPLETED|Overall Study||6||
48095836|NCT01471106|100560273|FG000|NOT COMPLETED|Overall Study||0||
48095837|NCT01471106|100560274|FG001|NOT COMPLETED|Overall Study||0||
48095838|NCT01471106|100560275|FG002|NOT COMPLETED|Overall Study||0||
48095839|NCT01356966|100560276|FG000|STARTED|Overall Study||18||
48095840|NCT01356966|100560277|FG001|STARTED|Overall Study||14||
48095841|NCT01356966|100560276|FG000|COMPLETED|Overall Study||16||
48095842|NCT01356966|100560277|FG001|COMPLETED|Overall Study||12||
48388966|NCT02565615|101283329|FG002|COMPLETED|Overall Study||21||
48388967|NCT02565615|101283330|FG003|COMPLETED|Overall Study||98||
48388968|NCT02565615|101283331|FG004|COMPLETED|Overall Study||21||
48388969|NCT02565615|101283327|FG000|NOT COMPLETED|Overall Study||3||
48388970|NCT02565615|101283328|FG001|NOT COMPLETED|Overall Study||36||
48388971|NCT02565615|101283329|FG002|NOT COMPLETED|Overall Study||0||
48388972|NCT02565615|101283330|FG003|NOT COMPLETED|Overall Study||3||
48388973|NCT02565615|101283331|FG004|NOT COMPLETED|Overall Study||1601||
48388974|NCT02616185|101283332|FG000|STARTED|Overall Study||3||
48388975|NCT02616185|101283333|FG001|STARTED|Overall Study||4||
48095843|NCT01356966|100560276|FG000|NOT COMPLETED|Overall Study||2||
48095844|NCT01356966|100560277|FG001|NOT COMPLETED|Overall Study||2||
48095845|NCT00249444|100560278|FG000|STARTED|Overall Study||42||
48095846|NCT00249444|100560279|FG001|STARTED|Overall Study||44||
48095847|NCT00249444|100560278|FG000|COMPLETED|Overall Study||30||
48095848|NCT00249444|100560279|FG001|COMPLETED|Overall Study||29||
48388976|NCT02616185|101283334|FG002|STARTED|Overall Study||6||
48388977|NCT02616185|101283335|FG003|STARTED|Overall Study||8||
48388978|NCT02616185|101283336|FG004|STARTED|Overall Study||14||
48388979|NCT02616185|101283337|FG005|STARTED|Overall Study||3||
48388980|NCT02616185|101283338|FG006|STARTED|Overall Study||20||
48095849|NCT00249444|100560278|FG000|NOT COMPLETED|Overall Study||12||
48095850|NCT00249444|100560279|FG001|NOT COMPLETED|Overall Study||15||
48095851|NCT01710033|100560280|FG000|STARTED|Stage 1||6||
48095852|NCT01710033|100560281|FG001|STARTED|Stage 1||6||
48095853|NCT01710033|100560282|FG002|STARTED|Stage 1||6||
48095854|NCT01710033|100560283|FG003|STARTED|Stage 1||6||
48095855|NCT01710033|100560284|FG004|STARTED|Stage 1||0||
48095856|NCT01710033|100560280|FG000|COMPLETED|Stage 1||6||
48095857|NCT01710033|100560281|FG001|COMPLETED|Stage 1||6||
48095858|NCT01710033|100560282|FG002|COMPLETED|Stage 1||6||
48095859|NCT01710033|100560283|FG003|COMPLETED|Stage 1||6||
48095860|NCT01710033|100560284|FG004|COMPLETED|Stage 1||0||
48095861|NCT01710033|100560280|FG000|NOT COMPLETED|Stage 1||0||
48095862|NCT01710033|100560281|FG001|NOT COMPLETED|Stage 1||0||
48095863|NCT01710033|100560282|FG002|NOT COMPLETED|Stage 1||0||
48259886|NCT03632083|100958811|FG004|NOT COMPLETED|First Intervention||0||0
48259887|NCT03632083|100958812|FG005|NOT COMPLETED|First Intervention||0||0
48259888|NCT03632083|100958813|FG006|NOT COMPLETED|First Intervention||0||0
48259889|NCT03632083|100958814|FG007|NOT COMPLETED|First Intervention||0||0
48259890|NCT03632083|100958807|FG000|STARTED|Second Intervention||5||5
48259891|NCT03632083|100958808|FG001|STARTED|Second Intervention||5||5
48259892|NCT03632083|100958809|FG002|STARTED|Second Intervention||7||7
48259893|NCT03632083|100958810|FG003|STARTED|Second Intervention||7||7
48259894|NCT03632083|100958811|FG004|STARTED|Second Intervention||9||9
48259895|NCT03632083|100958812|FG005|STARTED|Second Intervention||9||9
48259896|NCT03632083|100958813|FG006|STARTED|Second Intervention||7||7
48259897|NCT03632083|100958814|FG007|STARTED|Second Intervention||7||7
48259898|NCT03632083|100958807|FG000|COMPLETED|Second Intervention||5||5
48259899|NCT03632083|100958808|FG001|COMPLETED|Second Intervention||5||5
48259900|NCT03632083|100958809|FG002|COMPLETED|Second Intervention||7||7
48259901|NCT03632083|100958810|FG003|COMPLETED|Second Intervention||7||7
48259902|NCT03632083|100958811|FG004|COMPLETED|Second Intervention||9||9
48259903|NCT03632083|100958812|FG005|COMPLETED|Second Intervention||9||9
48259904|NCT03632083|100958813|FG006|COMPLETED|Second Intervention||7||7
48259905|NCT03632083|100958814|FG007|COMPLETED|Second Intervention||5||5
48259906|NCT03632083|100958807|FG000|NOT COMPLETED|Second Intervention||0||0
48259907|NCT03632083|100958808|FG001|NOT COMPLETED|Second Intervention||0||0
48259908|NCT03632083|100958809|FG002|NOT COMPLETED|Second Intervention||0||0
48259909|NCT03632083|100958810|FG003|NOT COMPLETED|Second Intervention||0||0
48259910|NCT03632083|100958811|FG004|NOT COMPLETED|Second Intervention||0||0
48259911|NCT03632083|100958812|FG005|NOT COMPLETED|Second Intervention||0||0
48259912|NCT03632083|100958813|FG006|NOT COMPLETED|Second Intervention||0||0
48259913|NCT03632083|100958814|FG007|NOT COMPLETED|Second Intervention||2||2
48259914|NCT01537185|100958815|FG000|STARTED|Overall Study||10||
48259915|NCT01537185|100958816|FG001|STARTED|Overall Study||12||
48259916|NCT01537185|100958817|FG002|STARTED|Overall Study||10||
48259917|NCT01537185|100958818|FG003|STARTED|Overall Study||10||
48259918|NCT01537185|100958815|FG000|COMPLETED|Overall Study||7||
48259919|NCT01537185|100958816|FG001|COMPLETED|Overall Study||6||
48259920|NCT01537185|100958817|FG002|COMPLETED|Overall Study||4||
48259921|NCT01537185|100958818|FG003|COMPLETED|Overall Study||8||
48259922|NCT01537185|100958815|FG000|NOT COMPLETED|Overall Study||3||
48388981|NCT02616185|101283339|FG007|STARTED|Overall Study||18||
48095864|NCT01710033|100560283|FG003|NOT COMPLETED|Stage 1||0||
48095865|NCT01710033|100560284|FG004|NOT COMPLETED|Stage 1||0||
48095866|NCT01710033|100560280|FG000|STARTED|Stage 2||0||
48095867|NCT01710033|100560281|FG001|STARTED|Stage 2||0||
48095868|NCT01710033|100560282|FG002|STARTED|Stage 2||0||
48095869|NCT01710033|100560283|FG003|STARTED|Stage 2||0||
48095870|NCT01710033|100560284|FG004|STARTED|Stage 2||4||
48095871|NCT01710033|100560280|FG000|COMPLETED|Stage 2||0||
48095872|NCT01710033|100560281|FG001|COMPLETED|Stage 2||0||
48095873|NCT01710033|100560282|FG002|COMPLETED|Stage 2||0||
48095874|NCT01710033|100560283|FG003|COMPLETED|Stage 2||0||
48095875|NCT01710033|100560284|FG004|COMPLETED|Stage 2||3||
48095876|NCT01710033|100560280|FG000|NOT COMPLETED|Stage 2||0||
48095877|NCT01710033|100560281|FG001|NOT COMPLETED|Stage 2||0||
48095878|NCT01710033|100560282|FG002|NOT COMPLETED|Stage 2||0||
48095879|NCT01710033|100560283|FG003|NOT COMPLETED|Stage 2||0||
48095880|NCT01710033|100560284|FG004|NOT COMPLETED|Stage 2||1||
48095881|NCT01669915|100560285|FG000|STARTED|Overall Study||844||
48095882|NCT01669915|100560286|FG001|STARTED|Overall Study||866||
48095883|NCT01669915|100560287|FG002|STARTED|Overall Study||855||
48095884|NCT01669915|100560288|FG003|STARTED|Overall Study||859||
48388982|NCT02616185|101283340|FG008|STARTED|Overall Study||15||
48388983|NCT02616185|101283332|FG000|COMPLETED|Overall Study||2||
48388984|NCT02616185|101283333|FG001|COMPLETED|Overall Study||3||
48095885|NCT01669915|100560285|FG000|COMPLETED|Overall Study||844||
48095886|NCT01669915|100560286|FG001|COMPLETED|Overall Study||866||
48095887|NCT01669915|100560287|FG002|COMPLETED|Overall Study||855||
48095888|NCT01669915|100560288|FG003|COMPLETED|Overall Study||859||
48095889|NCT01669915|100560285|FG000|NOT COMPLETED|Overall Study||0||
48095890|NCT01669915|100560286|FG001|NOT COMPLETED|Overall Study||0||
48095891|NCT01669915|100560287|FG002|NOT COMPLETED|Overall Study||0||
48095892|NCT01669915|100560288|FG003|NOT COMPLETED|Overall Study||0||
48388985|NCT02616185|101283334|FG002|COMPLETED|Overall Study||3||
48689681|NCT00040742|102022752|FG002|STARTED|Overall Study||187||
48095893|NCT01170754|100560289|FG000|STARTED|Overall Study||66||
48095894|NCT01170754|100560290|FG001|STARTED|Overall Study||70||
48095895|NCT01170754|100560289|FG000|COMPLETED|Overall Study||66||
48095896|NCT01170754|100560290|FG001|COMPLETED|Overall Study||70||
48095897|NCT01170754|100560289|FG000|NOT COMPLETED|Overall Study||0||
48095898|NCT01170754|100560290|FG001|NOT COMPLETED|Overall Study||0||
48095899|NCT00410046|100560291|FG000|STARTED|Overall Study||84||
48095900|NCT00410046|100560291|FG000|COMPLETED|Overall Study||79||
48095901|NCT00410046|100560291|FG000|NOT COMPLETED|Overall Study||5||
48095902|NCT01034462|100560292|FG000|STARTED|Overall Study||217||
48095903|NCT01034462|100560293|FG001|STARTED|Overall Study||217||
48095904|NCT01034462|100560292|FG000|COMPLETED|Overall Study||172||
48095905|NCT01034462|100560293|FG001|COMPLETED|Overall Study||163||
48095906|NCT01034462|100560292|FG000|NOT COMPLETED|Overall Study||45||
48095907|NCT01034462|100560293|FG001|NOT COMPLETED|Overall Study||54||
48095908|NCT02049307|100560294|FG000|STARTED|Overall Study||52||
48095909|NCT02049307|100560295|FG001|STARTED|Overall Study||56||
48095910|NCT02049307|100560294|FG000|COMPLETED|Overall Study||50||
48095911|NCT02049307|100560295|FG001|COMPLETED|Overall Study||55||
48095912|NCT02049307|100560294|FG000|NOT COMPLETED|Overall Study||2||
48095913|NCT02049307|100560295|FG001|NOT COMPLETED|Overall Study||1||
48095914|NCT02588833|100560296|FG000|STARTED|Part 1||3||
48388986|NCT02616185|101283335|FG003|COMPLETED|Overall Study||3||
48388987|NCT02616185|101283336|FG004|COMPLETED|Overall Study||5||
48689682|NCT00040742|102022753|FG003|STARTED|Overall Study||186||
48689683|NCT00040742|102022750|FG000|COMPLETED|Overall Study||149||
48689684|NCT00040742|102022751|FG001|COMPLETED|Overall Study||134||
48095915|NCT02588833|100560297|FG001|STARTED|Part 1||20||
48095916|NCT02588833|100560296|FG000|COMPLETED|Part 1||2||
48095917|NCT02588833|100560297|FG001|COMPLETED|Part 1||20||
48095918|NCT02588833|100560296|FG000|NOT COMPLETED|Part 1||1||
48095919|NCT02588833|100560297|FG001|NOT COMPLETED|Part 1||0||
48095920|NCT02588833|100560296|FG000|STARTED|Part 2A||0||
48095921|NCT02588833|100560297|FG001|STARTED|Part 2A||20||
48095922|NCT02588833|100560296|FG000|COMPLETED|Part 2A||0||
48095923|NCT02588833|100560297|FG001|COMPLETED|Part 2A||18||
48095924|NCT02588833|100560296|FG000|NOT COMPLETED|Part 2A||0||
48095925|NCT02588833|100560297|FG001|NOT COMPLETED|Part 2A||2||
48095926|NCT02588833|100560296|FG000|STARTED|Part 2B||0||
48095927|NCT02588833|100560297|FG001|STARTED|Part 2B||18||
48095928|NCT02588833|100560296|FG000|COMPLETED|Part 2B||0||
48095929|NCT02588833|100560297|FG001|COMPLETED|Part 2B||17||
48095930|NCT02588833|100560296|FG000|NOT COMPLETED|Part 2B||0||
48095931|NCT02588833|100560297|FG001|NOT COMPLETED|Part 2B||1||
48095932|NCT02588833|100560296|FG000|STARTED|Part 2C||0||
48095933|NCT02588833|100560297|FG001|STARTED|Part 2C||14||
48095934|NCT02588833|100560296|FG000|COMPLETED|Part 2C||0||
48095935|NCT02588833|100560297|FG001|COMPLETED|Part 2C||12||
48095936|NCT02588833|100560296|FG000|NOT COMPLETED|Part 2C||0||
48095937|NCT02588833|100560297|FG001|NOT COMPLETED|Part 2C||2||
48095938|NCT02588833|100560296|FG000|STARTED|Part 3 (Safety Follow-up)||3||
48095939|NCT02588833|100560297|FG001|STARTED|Part 3 (Safety Follow-up)||4||
48095940|NCT02588833|100560296|FG000|COMPLETED|Part 3 (Safety Follow-up)||3||
48095941|NCT02588833|100560297|FG001|COMPLETED|Part 3 (Safety Follow-up)||2||
48095942|NCT02588833|100560296|FG000|NOT COMPLETED|Part 3 (Safety Follow-up)||0||
48095943|NCT02588833|100560297|FG001|NOT COMPLETED|Part 3 (Safety Follow-up)||2||
48095944|NCT03742154|100560298|FG000|STARTED|Overall Study||50||
48095945|NCT03742154|100560299|FG001|STARTED|Overall Study||49||
48095946|NCT03742154|100560298|FG000|COMPLETED|Overall Study||50||
48095947|NCT03742154|100560299|FG001|COMPLETED|Overall Study||49||
48095948|NCT03742154|100560298|FG000|NOT COMPLETED|Overall Study||0||
48095949|NCT03742154|100560299|FG001|NOT COMPLETED|Overall Study||0||
48095950|NCT00075582|100560300|FG000|STARTED|Overall Study||305||
48095951|NCT00075582|100560301|FG001|STARTED|Overall Study||85||
48095952|NCT00075582|100560300|FG000|COMPLETED|Overall Study||255||
48095953|NCT00075582|100560301|FG001|COMPLETED|Overall Study||50||
48095954|NCT00075582|100560300|FG000|NOT COMPLETED|Overall Study||50||
48095955|NCT00075582|100560301|FG001|NOT COMPLETED|Overall Study||35||
48095956|NCT01685996|100560302|FG000|STARTED|Overall Study||34||
48095957|NCT01685996|100560303|FG001|STARTED|Overall Study||40||
48095958|NCT01685996|100560302|FG000|COMPLETED|Overall Study||18||
48095959|NCT01685996|100560303|FG001|COMPLETED|Overall Study||27||
48095960|NCT01685996|100560302|FG000|NOT COMPLETED|Overall Study||16||
48095961|NCT01685996|100560303|FG001|NOT COMPLETED|Overall Study||13||
48095962|NCT03078647|100560304|FG000|STARTED|Overall Study||17||
48095963|NCT03078647|100560305|FG001|STARTED|Overall Study||11||
48095964|NCT03078647|100560306|FG002|STARTED|Overall Study||3||
48095965|NCT03078647|100560304|FG000|COMPLETED|Overall Study||17||
48388988|NCT02616185|101283337|FG005|COMPLETED|Overall Study||2||
48388989|NCT02616185|101283338|FG006|COMPLETED|Overall Study||12||
48388990|NCT02616185|101283339|FG007|COMPLETED|Overall Study||5||
48095966|NCT03078647|100560305|FG001|COMPLETED|Overall Study||10||
48095967|NCT03078647|100560306|FG002|COMPLETED|Overall Study||3||
48095968|NCT03078647|100560304|FG000|NOT COMPLETED|Overall Study||0||
48095969|NCT03078647|100560305|FG001|NOT COMPLETED|Overall Study||1||
48095970|NCT03078647|100560306|FG002|NOT COMPLETED|Overall Study||0||
48095971|NCT03158051|100560307|FG000|STARTED|Overall Study||157||
48095972|NCT03158051|100560308|FG001|STARTED|Overall Study||159||
48095973|NCT03158051|100560307|FG000|Visit 3|Overall Study||100||
48095974|NCT03158051|100560308|FG001|Visit 3|Overall Study||104||
48095975|NCT03158051|100560307|FG000|Visit 4|Overall Study||100||
48095976|NCT03158051|100560308|FG001|Visit 4|Overall Study||104||
48095977|NCT03158051|100560307|FG000|Visit 5|Overall Study||86||
48095978|NCT03158051|100560308|FG001|Visit 5|Overall Study||90||
48095979|NCT03158051|100560307|FG000|Visit 6|Overall Study||86||
48388991|NCT02616185|101283340|FG008|COMPLETED|Overall Study||9||
48388992|NCT02616185|101283332|FG000|NOT COMPLETED|Overall Study||1||
48388993|NCT02616185|101283333|FG001|NOT COMPLETED|Overall Study||1||
48388994|NCT02616185|101283334|FG002|NOT COMPLETED|Overall Study||3||
48388995|NCT02616185|101283335|FG003|NOT COMPLETED|Overall Study||5||
48388996|NCT02616185|101283336|FG004|NOT COMPLETED|Overall Study||9||
48388997|NCT02616185|101283337|FG005|NOT COMPLETED|Overall Study||1||
48388998|NCT02616185|101283338|FG006|NOT COMPLETED|Overall Study||8||
48388999|NCT02616185|101283339|FG007|NOT COMPLETED|Overall Study||13||
48389000|NCT02616185|101283340|FG008|NOT COMPLETED|Overall Study||6||
48389001|NCT01230749|101283341|FG000|STARTED|Overall Study||22||
48389002|NCT01230749|101283342|FG001|STARTED|Overall Study||22||
48259923|NCT01537185|100958816|FG001|NOT COMPLETED|Overall Study||6||
48259924|NCT01537185|100958817|FG002|NOT COMPLETED|Overall Study||6||
48259925|NCT01537185|100958818|FG003|NOT COMPLETED|Overall Study||2||
48259926|NCT00996502|100958819|FG000|STARTED|Overall Study||4||
48389003|NCT01230749|101283343|FG002|STARTED|Overall Study||23||
48389004|NCT01230749|101283344|FG003|STARTED|Overall Study||22||
48389005|NCT01230749|101283341|FG000|COMPLETED|Overall Study||22||
48389006|NCT01230749|101283342|FG001|COMPLETED|Overall Study||20||
48389007|NCT01230749|101283343|FG002|COMPLETED|Overall Study||21||
48095980|NCT03158051|100560308|FG001|Visit 6|Overall Study||89||
48095981|NCT03158051|100560307|FG000|COMPLETED|Overall Study||86||
48095982|NCT03158051|100560308|FG001|COMPLETED|Overall Study||89||
48095983|NCT03158051|100560307|FG000|NOT COMPLETED|Overall Study||71||
48095984|NCT03158051|100560308|FG001|NOT COMPLETED|Overall Study||70||
48095985|NCT04585022|100560309|FG000|STARTED|Overall Study||39||
48095986|NCT04585022|100560310|FG001|STARTED|Overall Study||36||
48095987|NCT04585022|100560309|FG000|COMPLETED|Overall Study||33||
48095988|NCT04585022|100560310|FG001|COMPLETED|Overall Study||25||
48095989|NCT04585022|100560309|FG000|NOT COMPLETED|Overall Study||6||
48259927|NCT00996502|100958819|FG000|COMPLETED|Overall Study||4||
48259928|NCT00996502|100958819|FG000|NOT COMPLETED|Overall Study||0||
48259929|NCT04334278|100958820|FG000|STARTED|Overall Study||28||
48259930|NCT04334278|100958821|FG001|STARTED|Overall Study||23||
48259931|NCT04334278|100958820|FG000|COMPLETED|Overall Study||24||
48259932|NCT04334278|100958821|FG001|COMPLETED|Overall Study||18||
48259933|NCT04334278|100958820|FG000|NOT COMPLETED|Overall Study||4||
48259934|NCT04334278|100958821|FG001|NOT COMPLETED|Overall Study||5||
48259935|NCT02614690|100958822|FG000|STARTED|Overall Study||20||
48259936|NCT02614690|100958823|FG001|STARTED|Overall Study||20||
48095990|NCT04585022|100560310|FG001|NOT COMPLETED|Overall Study||11||
48095991|NCT02075658|100560311|FG000|STARTED|Overall Study||30||
48095992|NCT02075658|100560312|FG001|STARTED|Overall Study||30||
48095993|NCT02075658|100560311|FG000|COMPLETED|Overall Study||28||
48095994|NCT02075658|100560312|FG001|COMPLETED|Overall Study||28||
48095995|NCT02075658|100560311|FG000|NOT COMPLETED|Overall Study||2||
48095996|NCT02075658|100560312|FG001|NOT COMPLETED|Overall Study||2||
48095997|NCT03245008|100560313|FG000|STARTED|Overall Study||204||
48095998|NCT03245008|100560314|FG001|STARTED|Overall Study||203||
48095999|NCT03245008|100560315|FG002|STARTED|Overall Study||162||
48096000|NCT03245008|100560316|FG003|STARTED|Overall Study||28||
48096001|NCT03245008|100560317|FG004|STARTED|Overall Study||29||
48096002|NCT03245008|100560313|FG000|COMPLETED|Overall Study||164||
48096003|NCT03245008|100560314|FG001|COMPLETED|Overall Study||159||
48096004|NCT03245008|100560315|FG002|COMPLETED|Overall Study||132||
48096005|NCT03245008|100560316|FG003|COMPLETED|Overall Study||0||
48096006|NCT03245008|100560317|FG004|COMPLETED|Overall Study||0||
48096007|NCT03245008|100560313|FG000|NOT COMPLETED|Overall Study||40||
48096008|NCT03245008|100560314|FG001|NOT COMPLETED|Overall Study||44||
48096009|NCT03245008|100560315|FG002|NOT COMPLETED|Overall Study||30||
48096010|NCT03245008|100560316|FG003|NOT COMPLETED|Overall Study||28||
48389008|NCT01230749|101283344|FG003|COMPLETED|Overall Study||20||
48389009|NCT01230749|101283341|FG000|NOT COMPLETED|Overall Study||0||
48389010|NCT01230749|101283342|FG001|NOT COMPLETED|Overall Study||2||
48389011|NCT01230749|101283343|FG002|NOT COMPLETED|Overall Study||2||
48389012|NCT01230749|101283344|FG003|NOT COMPLETED|Overall Study||2||
48389013|NCT00617656|101283345|FG000|STARTED|Overall Study||190||
48389014|NCT00617656|101283346|FG001|STARTED|Overall Study||81||
48389015|NCT00617656|101283347|FG002|STARTED|Overall Study||62||
48096011|NCT03245008|100560317|FG004|NOT COMPLETED|Overall Study||29||
48096012|NCT03251508|100560318|FG000|STARTED|Peanut Oral Immunotherapy (Months 1-6)||15||
48096013|NCT03251508|100560318|FG000|COMPLETED|Peanut Oral Immunotherapy (Months 1-6)||11||
48096014|NCT03251508|100560318|FG000|NOT COMPLETED|Peanut Oral Immunotherapy (Months 1-6)||4||
48096015|NCT03251508|100560318|FG000|STARTED|Dietary Peanut (Months 7-12)||11||
48096016|NCT03251508|100560318|FG000|COMPLETED|Dietary Peanut (Months 7-12)||10||
48096017|NCT03251508|100560318|FG000|NOT COMPLETED|Dietary Peanut (Months 7-12)||1||
48096018|NCT01324388|100560319|FG000|STARTED|Part 1 of Study||23||
48096019|NCT01324388|100560320|FG001|STARTED|Part 1 of Study||8||
48096020|NCT01324388|100560321|FG002|STARTED|Part 1 of Study||0||
48096021|NCT01324388|100560322|FG003|STARTED|Part 1 of Study||0||
48096022|NCT01324388|100560319|FG000|Received at Least 1 Dose|Part 1 of Study||23||
48096023|NCT01324388|100560320|FG001|Received at Least 1 Dose|Part 1 of Study||8||
48096024|NCT01324388|100560321|FG002|Received at Least 1 Dose|Part 1 of Study||0||
48096025|NCT01324388|100560322|FG003|Received at Least 1 Dose|Part 1 of Study||0||
48096026|NCT01324388|100560319|FG000|COMPLETED|Part 1 of Study||19||
48096027|NCT01324388|100560320|FG001|COMPLETED|Part 1 of Study||6||
48096028|NCT01324388|100560321|FG002|COMPLETED|Part 1 of Study||0||
48096029|NCT01324388|100560322|FG003|COMPLETED|Part 1 of Study||0||
48096030|NCT01324388|100560319|FG000|NOT COMPLETED|Part 1 of Study||4||
48096031|NCT01324388|100560320|FG001|NOT COMPLETED|Part 1 of Study||2||
48096032|NCT01324388|100560321|FG002|NOT COMPLETED|Part 1 of Study||0||
48096033|NCT01324388|100560322|FG003|NOT COMPLETED|Part 1 of Study||0||
48096034|NCT01324388|100560319|FG000|STARTED|Part 2 of Study: First Intervention||0||
48096035|NCT01324388|100560320|FG001|STARTED|Part 2 of Study: First Intervention||0||
48096036|NCT01324388|100560321|FG002|STARTED|Part 2 of Study: First Intervention||10||
48096037|NCT01324388|100560322|FG003|STARTED|Part 2 of Study: First Intervention||10||
48096038|NCT01324388|100560319|FG000|COMPLETED|Part 2 of Study: First Intervention||0||
48096039|NCT01324388|100560320|FG001|COMPLETED|Part 2 of Study: First Intervention||0||
48096040|NCT01324388|100560321|FG002|COMPLETED|Part 2 of Study: First Intervention||10||
48096041|NCT01324388|100560322|FG003|COMPLETED|Part 2 of Study: First Intervention||9||
48389016|NCT00617656|101283348|FG003|STARTED|Overall Study||49||
48389017|NCT00617656|101283345|FG000|COMPLETED|Overall Study||142||
48389018|NCT00617656|101283346|FG001|COMPLETED|Overall Study||45||
48389019|NCT00617656|101283347|FG002|COMPLETED|Overall Study||49||
48389020|NCT00617656|101283348|FG003|COMPLETED|Overall Study||43||
48389021|NCT00617656|101283345|FG000|NOT COMPLETED|Overall Study||48||
48389022|NCT00617656|101283346|FG001|NOT COMPLETED|Overall Study||36||
48389023|NCT00617656|101283347|FG002|NOT COMPLETED|Overall Study||13||
48592712|NCT00176436|101783165|FG000|NOT COMPLETED|Overall Study||6||
48096042|NCT01324388|100560319|FG000|NOT COMPLETED|Part 2 of Study: First Intervention||0||
48096043|NCT01324388|100560320|FG001|NOT COMPLETED|Part 2 of Study: First Intervention||0||
48096044|NCT01324388|100560321|FG002|NOT COMPLETED|Part 2 of Study: First Intervention||0||
48096045|NCT01324388|100560322|FG003|NOT COMPLETED|Part 2 of Study: First Intervention||1||
48259937|NCT02614690|100958824|FG002|STARTED|Overall Study||20||
48259938|NCT02614690|100958822|FG000|COMPLETED|Overall Study||20||
48389024|NCT00617656|101283348|FG003|NOT COMPLETED|Overall Study||6||
48389025|NCT00493974|101283349|FG000|STARTED|Overall Study||60||
48389026|NCT00493974|101283350|FG001|STARTED|Overall Study||59||
48096046|NCT01324388|100560319|FG000|STARTED|Part 2: Washout of at Least 21 Days||0||
48096047|NCT01324388|100560320|FG001|STARTED|Part 2: Washout of at Least 21 Days||0||
48096048|NCT01324388|100560321|FG002|STARTED|Part 2: Washout of at Least 21 Days||10||
48096049|NCT01324388|100560322|FG003|STARTED|Part 2: Washout of at Least 21 Days||9||
48389027|NCT00493974|101283349|FG000|COMPLETED|Overall Study||47||
48389028|NCT00493974|101283350|FG001|COMPLETED|Overall Study||45||
48389029|NCT00493974|101283349|FG000|NOT COMPLETED|Overall Study||13||
48389030|NCT00493974|101283350|FG001|NOT COMPLETED|Overall Study||14||
48389031|NCT00971425|101283351|FG000|STARTED|Overall Study||72||
48389032|NCT00971425|101283352|FG001|STARTED|Overall Study||73||
48389033|NCT00971425|101283351|FG000|COMPLETED|Overall Study||71||
48389034|NCT00971425|101283352|FG001|COMPLETED|Overall Study||71||
48389035|NCT00971425|101283351|FG000|NOT COMPLETED|Overall Study||1||
48389036|NCT00971425|101283352|FG001|NOT COMPLETED|Overall Study||2||
48389037|NCT00593840|101283353|FG000|STARTED|Overall Study||73||
48389038|NCT00593840|101283353|FG000|COMPLETED|Overall Study||72||
48389039|NCT00593840|101283353|FG000|NOT COMPLETED|Overall Study||1||
48389040|NCT00131677|101283354|FG000|STARTED|Overall Study||201||
48389041|NCT00131677|101283355|FG001|STARTED|Overall Study||199||
48389042|NCT00131677|101283354|FG000|COMPLETED|Overall Study||171||
48389043|NCT00131677|101283355|FG001|COMPLETED|Overall Study||160||
48389044|NCT00131677|101283354|FG000|NOT COMPLETED|Overall Study||30||
48389045|NCT00131677|101283355|FG001|NOT COMPLETED|Overall Study||39||
48389046|NCT00003476|101283356|FG000|STARTED|Overall Study||8||
48389047|NCT00003476|101283356|FG000|COMPLETED|Overall Study||7||
48389048|NCT00003476|101283356|FG000|NOT COMPLETED|Overall Study||1||
48389049|NCT02173392|101283357|FG000|STARTED|Overall Study||73||
48389050|NCT02173392|101283358|FG001|STARTED|Overall Study||72||
48389051|NCT02173392|101283357|FG000|COMPLETED|Overall Study||59||
48389052|NCT02173392|101283358|FG001|COMPLETED|Overall Study||68||
48389053|NCT02173392|101283357|FG000|NOT COMPLETED|Overall Study||14||
48389054|NCT02173392|101283358|FG001|NOT COMPLETED|Overall Study||4||
48389055|NCT05137730|101283359|FG000|STARTED|Part I: Treatment Period 1 (1 Day)||42||
48389056|NCT05137730|101283360|FG001|STARTED|Part I: Treatment Period 1 (1 Day)||42||
48389057|NCT05137730|101283361|FG002|STARTED|Part I: Treatment Period 1 (1 Day)||0||
48389058|NCT05137730|101283362|FG003|STARTED|Part I: Treatment Period 1 (1 Day)||0||
48389059|NCT05137730|101283363|FG004|STARTED|Part I: Treatment Period 1 (1 Day)||0||
48389060|NCT05137730|101283364|FG005|STARTED|Part I: Treatment Period 1 (1 Day)||0||
48389061|NCT05137730|101283359|FG000|COMPLETED|Part I: Treatment Period 1 (1 Day)||42||
48389062|NCT05137730|101283360|FG001|COMPLETED|Part I: Treatment Period 1 (1 Day)||42||
48389063|NCT05137730|101283361|FG002|COMPLETED|Part I: Treatment Period 1 (1 Day)||0||
48389064|NCT05137730|101283362|FG003|COMPLETED|Part I: Treatment Period 1 (1 Day)||0||
48389065|NCT05137730|101283363|FG004|COMPLETED|Part I: Treatment Period 1 (1 Day)||0||
48389066|NCT05137730|101283364|FG005|COMPLETED|Part I: Treatment Period 1 (1 Day)||0||
48389067|NCT05137730|101283359|FG000|NOT COMPLETED|Part I: Treatment Period 1 (1 Day)||0||
48389068|NCT05137730|101283360|FG001|NOT COMPLETED|Part I: Treatment Period 1 (1 Day)||0||
48389069|NCT05137730|101283361|FG002|NOT COMPLETED|Part I: Treatment Period 1 (1 Day)||0||
48389070|NCT05137730|101283362|FG003|NOT COMPLETED|Part I: Treatment Period 1 (1 Day)||0||
48389071|NCT05137730|101283363|FG004|NOT COMPLETED|Part I: Treatment Period 1 (1 Day)||0||
48389072|NCT05137730|101283364|FG005|NOT COMPLETED|Part I: Treatment Period 1 (1 Day)||0||
48389073|NCT05137730|101283359|FG000|STARTED|Part I: Washout Period 1 (96 Hours)||42||
48096050|NCT01324388|100560319|FG000|COMPLETED|Part 2: Washout of at Least 21 Days||0||
48096051|NCT01324388|100560320|FG001|COMPLETED|Part 2: Washout of at Least 21 Days||0||
48096052|NCT01324388|100560321|FG002|COMPLETED|Part 2: Washout of at Least 21 Days||10||
48096053|NCT01324388|100560322|FG003|COMPLETED|Part 2: Washout of at Least 21 Days||9||
48096054|NCT01324388|100560319|FG000|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0||
48096055|NCT01324388|100560320|FG001|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0||
48096056|NCT01324388|100560321|FG002|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0||
48096057|NCT01324388|100560322|FG003|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0||
48096058|NCT01324388|100560319|FG000|STARTED|Part 2 of Study: Second Intervention||0||
48389074|NCT05137730|101283360|FG001|STARTED|Part I: Washout Period 1 (96 Hours)||42||
48389075|NCT05137730|101283361|FG002|STARTED|Part I: Washout Period 1 (96 Hours)||0||
48389076|NCT05137730|101283362|FG003|STARTED|Part I: Washout Period 1 (96 Hours)||0||
48389077|NCT05137730|101283363|FG004|STARTED|Part I: Washout Period 1 (96 Hours)||0||
48389078|NCT05137730|101283364|FG005|STARTED|Part I: Washout Period 1 (96 Hours)||0||
48389079|NCT05137730|101283359|FG000|COMPLETED|Part I: Washout Period 1 (96 Hours)||42||
48389080|NCT05137730|101283360|FG001|COMPLETED|Part I: Washout Period 1 (96 Hours)||42||
48096059|NCT01324388|100560320|FG001|STARTED|Part 2 of Study: Second Intervention||0||
48389081|NCT05137730|101283361|FG002|COMPLETED|Part I: Washout Period 1 (96 Hours)||0||
48389082|NCT05137730|101283362|FG003|COMPLETED|Part I: Washout Period 1 (96 Hours)||0||
48389083|NCT05137730|101283363|FG004|COMPLETED|Part I: Washout Period 1 (96 Hours)||0||
48389084|NCT05137730|101283364|FG005|COMPLETED|Part I: Washout Period 1 (96 Hours)||0||
48389085|NCT05137730|101283359|FG000|NOT COMPLETED|Part I: Washout Period 1 (96 Hours)||0||
48389086|NCT05137730|101283360|FG001|NOT COMPLETED|Part I: Washout Period 1 (96 Hours)||0||
48141385|NCT01297062|100670414|FG004|NOT COMPLETED|Overall Study||2||
48096060|NCT01324388|100560321|FG002|STARTED|Part 2 of Study: Second Intervention||10||
48096061|NCT01324388|100560322|FG003|STARTED|Part 2 of Study: Second Intervention||9||
48096062|NCT01324388|100560319|FG000|COMPLETED|Part 2 of Study: Second Intervention||0||
48096063|NCT01324388|100560320|FG001|COMPLETED|Part 2 of Study: Second Intervention||0||
48096064|NCT01324388|100560321|FG002|COMPLETED|Part 2 of Study: Second Intervention||9||
48096065|NCT01324388|100560322|FG003|COMPLETED|Part 2 of Study: Second Intervention||9||
48096066|NCT01324388|100560319|FG000|NOT COMPLETED|Part 2 of Study: Second Intervention||0||
48096067|NCT01324388|100560320|FG001|NOT COMPLETED|Part 2 of Study: Second Intervention||0||
48096068|NCT01324388|100560321|FG002|NOT COMPLETED|Part 2 of Study: Second Intervention||1||
48096069|NCT01324388|100560322|FG003|NOT COMPLETED|Part 2 of Study: Second Intervention||0||
48096070|NCT01782664|100560323|FG000|STARTED|Overall Study||14||
48096071|NCT01782664|100560324|FG001|STARTED|Overall Study||15||
48096072|NCT01782664|100560325|FG002|STARTED|Overall Study||16||
48096073|NCT01782664|100560326|FG003|STARTED|Overall Study||14||
48096074|NCT01782664|100560327|FG004|STARTED|Overall Study||6||
48096075|NCT01782664|100560328|FG005|STARTED|Overall Study||2||
48096076|NCT01782664|100560323|FG000|COMPLETED|Overall Study||8||
48096077|NCT01782664|100560324|FG001|COMPLETED|Overall Study||10||
48096078|NCT01782664|100560325|FG002|COMPLETED|Overall Study||12||
48096079|NCT01782664|100560326|FG003|COMPLETED|Overall Study||9||
48096080|NCT01782664|100560327|FG004|COMPLETED|Overall Study||6||
48096081|NCT01782664|100560328|FG005|COMPLETED|Overall Study||2||
48096082|NCT01782664|100560323|FG000|NOT COMPLETED|Overall Study||6||
48096083|NCT01782664|100560324|FG001|NOT COMPLETED|Overall Study||5||
48096084|NCT01782664|100560325|FG002|NOT COMPLETED|Overall Study||4||
48096085|NCT01782664|100560326|FG003|NOT COMPLETED|Overall Study||5||
48096086|NCT01782664|100560327|FG004|NOT COMPLETED|Overall Study||0||
48096087|NCT01782664|100560328|FG005|NOT COMPLETED|Overall Study||0||
48096088|NCT01566461|100560329|FG000|STARTED|IN.PACT SFA I Phase||99||
48096089|NCT01566461|100560330|FG001|STARTED|IN.PACT SFA I Phase||51||
48096090|NCT01566461|100560329|FG000|COMPLETED|IN.PACT SFA I Phase||88||
48096091|NCT01566461|100560330|FG001|COMPLETED|IN.PACT SFA I Phase||49||
48096092|NCT01566461|100560329|FG000|NOT COMPLETED|IN.PACT SFA I Phase||11||
48096093|NCT01566461|100560330|FG001|NOT COMPLETED|IN.PACT SFA I Phase||2||
48096094|NCT01566461|100560329|FG000|STARTED|IN.PACT SFA II Phase||121||
48096095|NCT01566461|100560330|FG001|STARTED|IN.PACT SFA II Phase||60||
48096096|NCT01566461|100560329|FG000|COMPLETED|IN.PACT SFA II Phase||109||
48096097|NCT01566461|100560330|FG001|COMPLETED|IN.PACT SFA II Phase||55||
48096098|NCT01566461|100560329|FG000|NOT COMPLETED|IN.PACT SFA II Phase||12||
48096099|NCT01566461|100560330|FG001|NOT COMPLETED|IN.PACT SFA II Phase||5||
48096100|NCT03261947|100560331|FG000|STARTED|Overall Study||12||
48096101|NCT03261947|100560332|FG001|STARTED|Overall Study||15||
48096102|NCT03261947|100560333|FG002|STARTED|Overall Study||35||
48096103|NCT03261947|100560334|FG003|STARTED|Overall Study||21||
48096104|NCT03261947|100560335|FG004|STARTED|Overall Study||18||
48096105|NCT03261947|100560331|FG000|COMPLETED|Overall Study||0||
48096106|NCT03261947|100560332|FG001|COMPLETED|Overall Study||2||
48096107|NCT03261947|100560333|FG002|COMPLETED|Overall Study||5||
48096108|NCT03261947|100560334|FG003|COMPLETED|Overall Study||0||
48096109|NCT03261947|100560335|FG004|COMPLETED|Overall Study||1||
48096110|NCT03261947|100560331|FG000|NOT COMPLETED|Overall Study||12||
48096111|NCT03261947|100560332|FG001|NOT COMPLETED|Overall Study||13||
48096112|NCT03261947|100560333|FG002|NOT COMPLETED|Overall Study||30||
48096113|NCT03261947|100560334|FG003|NOT COMPLETED|Overall Study||21||
48096114|NCT03261947|100560335|FG004|NOT COMPLETED|Overall Study||17||
48096115|NCT04779489|100560336|FG000|STARTED|Overall Study||1||
48096116|NCT04779489|100560336|FG000|COMPLETED|Overall Study||0||
48096117|NCT04779489|100560336|FG000|NOT COMPLETED|Overall Study||1||
48096118|NCT02140788|100560337|FG000|STARTED|Overall Study||0||
48096119|NCT02140788|100560338|FG001|STARTED|Overall Study||0||
48096120|NCT02140788|100560339|FG002|STARTED|Overall Study||0||
48096121|NCT02140788|100560340|FG003|STARTED|Overall Study||0||
48096122|NCT02140788|100560337|FG000|COMPLETED|Overall Study||0||
48096123|NCT02140788|100560338|FG001|COMPLETED|Overall Study||0||
48096124|NCT02140788|100560339|FG002|COMPLETED|Overall Study||0||
48096125|NCT02140788|100560340|FG003|COMPLETED|Overall Study||0||
48096126|NCT02140788|100560337|FG000|NOT COMPLETED|Overall Study||0||
48096127|NCT02140788|100560338|FG001|NOT COMPLETED|Overall Study||0||
48096128|NCT02140788|100560339|FG002|NOT COMPLETED|Overall Study||0||
48096129|NCT02140788|100560340|FG003|NOT COMPLETED|Overall Study||0||
48096130|NCT00614315|100560341|FG000|STARTED|Overall Study||30||
48096131|NCT00614315|100560341|FG000|COMPLETED|Overall Study||30||
48096132|NCT00614315|100560341|FG000|NOT COMPLETED|Overall Study||0||
48096133|NCT00289315|100560342|FG000|STARTED|Overall Study||713||
48096134|NCT00289315|100560343|FG001|STARTED|Overall Study||760||
48096135|NCT00289315|100560344|FG002|STARTED|Overall Study||587||
48096136|NCT00289315|100560342|FG000|COMPLETED|Overall Study||612||
48096137|NCT00289315|100560343|FG001|COMPLETED|Overall Study||638||
48096138|NCT00289315|100560344|FG002|COMPLETED|Overall Study||447||
48096139|NCT00289315|100560342|FG000|NOT COMPLETED|Overall Study||101||
48096140|NCT00289315|100560343|FG001|NOT COMPLETED|Overall Study||122||
48096141|NCT00289315|100560344|FG002|NOT COMPLETED|Overall Study||140||
48096142|NCT01881230|100560345|FG000|STARTED|Overall Study||61||
48096143|NCT01881230|100560346|FG001|STARTED|Overall Study||64||
48096144|NCT01881230|100560347|FG002|STARTED|Overall Study||66||
48096145|NCT01881230|100560345|FG000|Safety Population|Overall Study||60||
48096146|NCT01881230|100560346|FG001|Safety Population|Overall Study||64||
48096147|NCT01881230|100560347|FG002|Safety Population|Overall Study||64||
48096148|NCT01881230|100560345|FG000|Treatment Discontinued|Overall Study||60||
48096149|NCT01881230|100560346|FG001|Treatment Discontinued|Overall Study||64||
48096150|NCT01881230|100560347|FG002|Treatment Discontinued|Overall Study||64||
48096151|NCT01881230|100560345|FG000|COMPLETED|Overall Study||0||
48096152|NCT01881230|100560346|FG001|COMPLETED|Overall Study||0||
48096153|NCT01881230|100560347|FG002|COMPLETED|Overall Study||0||
48096154|NCT01881230|100560345|FG000|NOT COMPLETED|Overall Study||61||
48096155|NCT01881230|100560346|FG001|NOT COMPLETED|Overall Study||64||
48096156|NCT01881230|100560347|FG002|NOT COMPLETED|Overall Study||66||
48096157|NCT02154581|100560348|FG000|STARTED|Overall Study||21||
48096158|NCT02154581|100560349|FG001|STARTED|Overall Study||20||
48096159|NCT02154581|100560348|FG000|COMPLETED|Overall Study||14||
48096160|NCT02154581|100560349|FG001|COMPLETED|Overall Study||12||
48096161|NCT02154581|100560348|FG000|NOT COMPLETED|Overall Study||7||
48096162|NCT02154581|100560349|FG001|NOT COMPLETED|Overall Study||8||
48096163|NCT00842712|100560350|FG000|STARTED|Safety Run-in Part||3||
48389087|NCT05137730|101283361|FG002|NOT COMPLETED|Part I: Washout Period 1 (96 Hours)||0||
48389088|NCT05137730|101283362|FG003|NOT COMPLETED|Part I: Washout Period 1 (96 Hours)||0||
48389089|NCT05137730|101283363|FG004|NOT COMPLETED|Part I: Washout Period 1 (96 Hours)||0||
48389090|NCT05137730|101283364|FG005|NOT COMPLETED|Part I: Washout Period 1 (96 Hours)||0||
48389091|NCT05137730|101283359|FG000|STARTED|Part I: Treatment Period 2 (1 Day)||42||
48389092|NCT05137730|101283360|FG001|STARTED|Part I: Treatment Period 2 (1 Day)||42||
48389093|NCT05137730|101283361|FG002|STARTED|Part I: Treatment Period 2 (1 Day)||0||
48389094|NCT05137730|101283362|FG003|STARTED|Part I: Treatment Period 2 (1 Day)||0||
48389095|NCT05137730|101283363|FG004|STARTED|Part I: Treatment Period 2 (1 Day)||0||
48389096|NCT05137730|101283364|FG005|STARTED|Part I: Treatment Period 2 (1 Day)||0||
48096164|NCT00842712|100560351|FG001|STARTED|Safety Run-in Part||3||
48096165|NCT00842712|100560352|FG002|STARTED|Safety Run-in Part||3||
48096166|NCT00842712|100560353|FG003|STARTED|Safety Run-in Part||3||
48096167|NCT00842712|100560354|FG004|STARTED|Safety Run-in Part||0||
48096168|NCT00842712|100560355|FG005|STARTED|Safety Run-in Part||0||
48096169|NCT00842712|100560356|FG006|STARTED|Safety Run-in Part||0||
48096170|NCT00842712|100560350|FG000|COMPLETED|Safety Run-in Part||0||
48096171|NCT00842712|100560351|FG001|COMPLETED|Safety Run-in Part||1||
48096172|NCT00842712|100560352|FG002|COMPLETED|Safety Run-in Part||3||
48096173|NCT00842712|100560353|FG003|COMPLETED|Safety Run-in Part||2||
48096174|NCT00842712|100560354|FG004|COMPLETED|Safety Run-in Part||0||
48096175|NCT00842712|100560355|FG005|COMPLETED|Safety Run-in Part||0||
48096176|NCT00842712|100560356|FG006|COMPLETED|Safety Run-in Part||0||
48096177|NCT00842712|100560350|FG000|NOT COMPLETED|Safety Run-in Part||3||
48096178|NCT00842712|100560351|FG001|NOT COMPLETED|Safety Run-in Part||2||
48096179|NCT00842712|100560352|FG002|NOT COMPLETED|Safety Run-in Part||0||
48096180|NCT00842712|100560353|FG003|NOT COMPLETED|Safety Run-in Part||1||
48096181|NCT00842712|100560354|FG004|NOT COMPLETED|Safety Run-in Part||0||
48096182|NCT00842712|100560355|FG005|NOT COMPLETED|Safety Run-in Part||0||
48096183|NCT00842712|100560356|FG006|NOT COMPLETED|Safety Run-in Part||0||
48096184|NCT00842712|100560350|FG000|STARTED|Randomized Part||0||
48096185|NCT00842712|100560351|FG001|STARTED|Randomized Part||0||
48096186|NCT00842712|100560352|FG002|STARTED|Randomized Part||0||
48541917|NCT04614948|101662810|FG001|FAS Post-Dose 1 Population|DB Phase (Day 1 up to 7.2 Months)||15588|7 participants (3 in the Ad26 group, 4 in the placebo group) received a COVID-19 vaccination outside of the study prior to first study vaccination. These participants were excluded from post-dose 1 FAS.|
48541918|NCT04614948|101662811|FG002|FAS Post-Dose 1 Population|DB Phase (Day 1 up to 7.2 Months)||0|7 participants (3 in the Ad26 group, 4 in the placebo group) received a COVID-19 vaccination outside of the study prior to first study vaccination. These participants were excluded from post-dose 1 FAS.|
48096187|NCT00842712|100560353|FG003|STARTED|Randomized Part||0||
48096188|NCT00842712|100560354|FG004|STARTED|Randomized Part||85||
48096189|NCT00842712|100560355|FG005|STARTED|Randomized Part||51||
48096190|NCT00842712|100560356|FG006|STARTED|Randomized Part||84||
48096191|NCT00842712|100560350|FG000|Treated|Randomized Part||0||
48096192|NCT00842712|100560351|FG001|Treated|Randomized Part||0||
48096193|NCT00842712|100560352|FG002|Treated|Randomized Part||0||
48096194|NCT00842712|100560353|FG003|Treated|Randomized Part||0||
48096195|NCT00842712|100560354|FG004|Treated|Randomized Part||85||
48096196|NCT00842712|100560355|FG005|Treated|Randomized Part||50||
48389097|NCT05137730|101283359|FG000|COMPLETED|Part I: Treatment Period 2 (1 Day)||42||
48389098|NCT05137730|101283360|FG001|COMPLETED|Part I: Treatment Period 2 (1 Day)||42||
48389099|NCT05137730|101283361|FG002|COMPLETED|Part I: Treatment Period 2 (1 Day)||0||
48389100|NCT05137730|101283362|FG003|COMPLETED|Part I: Treatment Period 2 (1 Day)||0||
48096197|NCT00842712|100560356|FG006|Treated|Randomized Part||80||
48096198|NCT00842712|100560350|FG000|COMPLETED|Randomized Part||0||
48096199|NCT00842712|100560351|FG001|COMPLETED|Randomized Part||0||
48096200|NCT00842712|100560352|FG002|COMPLETED|Randomized Part||0||
48096201|NCT00842712|100560353|FG003|COMPLETED|Randomized Part||0||
48096202|NCT00842712|100560354|FG004|COMPLETED|Randomized Part||85||
48096203|NCT00842712|100560355|FG005|COMPLETED|Randomized Part||50||
48096204|NCT00842712|100560356|FG006|COMPLETED|Randomized Part||78||
48096205|NCT00842712|100560350|FG000|NOT COMPLETED|Randomized Part||0||
48096206|NCT00842712|100560351|FG001|NOT COMPLETED|Randomized Part||0||
48096207|NCT00842712|100560352|FG002|NOT COMPLETED|Randomized Part||0||
48096208|NCT00842712|100560353|FG003|NOT COMPLETED|Randomized Part||0||
48096209|NCT00842712|100560354|FG004|NOT COMPLETED|Randomized Part||0||
48096210|NCT00842712|100560355|FG005|NOT COMPLETED|Randomized Part||1||
48096211|NCT00842712|100560356|FG006|NOT COMPLETED|Randomized Part||6||
48096212|NCT00840294|100560357|FG000|STARTED|Overall Study||42||
48096213|NCT00840294|100560358|FG001|STARTED|Overall Study||43||
48096214|NCT00840294|100560357|FG000|COMPLETED|Overall Study||39||
48096215|NCT00840294|100560358|FG001|COMPLETED|Overall Study||38||
48096216|NCT00840294|100560357|FG000|NOT COMPLETED|Overall Study||3||
48096217|NCT00840294|100560358|FG001|NOT COMPLETED|Overall Study||5||
48096218|NCT00423150|100560359|FG000|STARTED|Overall Study||86||
48096219|NCT00423150|100560359|FG000|COMPLETED|Overall Study||0||
48096220|NCT00423150|100560359|FG000|NOT COMPLETED|Overall Study||86||
48096221|NCT03060447|100560360|FG000|STARTED|Overall Study||17||
48096222|NCT03060447|100560361|FG001|STARTED|Overall Study||8||
48096223|NCT03060447|100560360|FG000|COMPLETED|Overall Study||15||
48096224|NCT03060447|100560361|FG001|COMPLETED|Overall Study||8||
48096225|NCT03060447|100560360|FG000|NOT COMPLETED|Overall Study||2||
48096226|NCT03060447|100560361|FG001|NOT COMPLETED|Overall Study||0||
48259939|NCT02614690|100958823|FG001|COMPLETED|Overall Study||20||
48259940|NCT02614690|100958824|FG002|COMPLETED|Overall Study||20||
48259941|NCT02614690|100958822|FG000|NOT COMPLETED|Overall Study||0||
48259942|NCT02614690|100958823|FG001|NOT COMPLETED|Overall Study||0||
48259943|NCT02614690|100958824|FG002|NOT COMPLETED|Overall Study||0||
48259944|NCT04156399|100958825|FG000|STARTED|Overall Study||6||
48259945|NCT04156399|100958825|FG000|COMPLETED|Overall Study||2||
48259946|NCT04156399|100958825|FG000|NOT COMPLETED|Overall Study||4||
48259947|NCT00872001|100958826|FG000|STARTED|Overall Study||1536||
48259948|NCT00872001|100958827|FG001|STARTED|Overall Study||1544||
48259949|NCT00872001|100958826|FG000|COMPLETED|Overall Study||1400||
48259950|NCT00872001|100958827|FG001|COMPLETED|Overall Study||1413||
48259951|NCT00872001|100958826|FG000|NOT COMPLETED|Overall Study||136||
48259952|NCT00872001|100958827|FG001|NOT COMPLETED|Overall Study||131||
48259953|NCT04915131|100958828|FG000|STARTED|Overall Study||60||
48259954|NCT04915131|100958829|FG001|STARTED|Overall Study||61||
48259955|NCT04915131|100958828|FG000|Analysis Population|Overall Study||54||
48259956|NCT04915131|100958829|FG001|Analysis Population|Overall Study||56||
48259957|NCT04915131|100958828|FG000|COMPLETED|Overall Study||60||
48259958|NCT04915131|100958829|FG001|COMPLETED|Overall Study||61||
48259959|NCT04915131|100958828|FG000|NOT COMPLETED|Overall Study||0||
48259960|NCT04915131|100958829|FG001|NOT COMPLETED|Overall Study||0||
48259961|NCT01181609|100958830|FG000|STARTED|Overall Study||54||
48259962|NCT01181609|100958830|FG000|COMPLETED|Overall Study||1||
48259963|NCT01181609|100958830|FG000|NOT COMPLETED|Overall Study||53||
48259964|NCT02591862|100958831|FG000|STARTED|Overall Study||1||
48259965|NCT02591862|100958831|FG000|COMPLETED|Overall Study||1||
48259966|NCT02591862|100958831|FG000|NOT COMPLETED|Overall Study||0||
48259967|NCT01740154|100958832|FG000|STARTED|Overall Study||13||
48259968|NCT01740154|100958832|FG000|COMPLETED|Overall Study||12||
48259969|NCT01740154|100958832|FG000|NOT COMPLETED|Overall Study||1||
48259970|NCT02201901|100958833|FG000|STARTED|Overall Study||90||
48259971|NCT02201901|100958834|FG001|STARTED|Overall Study||88||
48096227|NCT02591147|100560362|FG000|STARTED|Overall Study||20||
48096228|NCT02591147|100560363|FG001|STARTED|Overall Study||21||
48096229|NCT02591147|100560362|FG000|COMPLETED|Overall Study||18||
48096230|NCT02591147|100560363|FG001|COMPLETED|Overall Study||16||
48096231|NCT02591147|100560362|FG000|NOT COMPLETED|Overall Study||2||
48096232|NCT02591147|100560363|FG001|NOT COMPLETED|Overall Study||5||
48096233|NCT03325075|100560364|FG000|STARTED|Part A: Dose Escalation (28 Days)||15||
48096234|NCT03325075|100560365|FG001|STARTED|Part A: Dose Escalation (28 Days)||15||
48096235|NCT03325075|100560366|FG002|STARTED|Part A: Dose Escalation (28 Days)||15||
48259972|NCT02201901|100958835|FG002|STARTED|Overall Study||90||
48259973|NCT02201901|100958833|FG000|COMPLETED|Overall Study||75||
48259974|NCT02201901|100958834|FG001|COMPLETED|Overall Study||79||
48259975|NCT02201901|100958835|FG002|COMPLETED|Overall Study||77||
48259976|NCT02201901|100958833|FG000|NOT COMPLETED|Overall Study||15||
48259977|NCT02201901|100958834|FG001|NOT COMPLETED|Overall Study||9||
48259978|NCT02201901|100958835|FG002|NOT COMPLETED|Overall Study||13||
48259979|NCT00550446|100958836|FG000|STARTED|Up To Week 12||54||
48259980|NCT00550446|100958837|FG001|STARTED|Up To Week 12||52||
48096236|NCT03325075|100560367|FG003|STARTED|Part A: Dose Escalation (28 Days)||15||
48096237|NCT03325075|100560364|FG000|Received Vaccination 1|Part A: Dose Escalation (28 Days)||15||
48141386|NCT01297062|100670415|FG005|NOT COMPLETED|Overall Study||1||
48259981|NCT00550446|100958838|FG002|STARTED|Up To Week 12||50||
48259982|NCT00550446|100958839|FG003|STARTED|Up To Week 12||61||
48259983|NCT00550446|100958840|FG004|STARTED|Up To Week 12||57||
48259984|NCT00550446|100958841|FG005|STARTED|Up To Week 12||53||
48259985|NCT00550446|100958842|FG006|STARTED|Up To Week 12||59||
48259986|NCT00550446|100958843|FG007|STARTED|Up To Week 12||0||
48096238|NCT03325075|100560365|FG001|Received Vaccination 1|Part A: Dose Escalation (28 Days)||15||
48096239|NCT03325075|100560366|FG002|Received Vaccination 1|Part A: Dose Escalation (28 Days)||15||
48096240|NCT03325075|100560367|FG003|Received Vaccination 1|Part A: Dose Escalation (28 Days)||15||
48096241|NCT03325075|100560364|FG000|Received Vaccination 2|Part A: Dose Escalation (28 Days)||15||
48096242|NCT03325075|100560365|FG001|Received Vaccination 2|Part A: Dose Escalation (28 Days)||14||
48096243|NCT03325075|100560366|FG002|Received Vaccination 2|Part A: Dose Escalation (28 Days)||14||
48096244|NCT03325075|100560367|FG003|Received Vaccination 2|Part A: Dose Escalation (28 Days)||15||
48096245|NCT03325075|100560364|FG000|COMPLETED|Part A: Dose Escalation (28 Days)||15||
48096246|NCT03325075|100560365|FG001|COMPLETED|Part A: Dose Escalation (28 Days)||15||
48096247|NCT03325075|100560366|FG002|COMPLETED|Part A: Dose Escalation (28 Days)||15||
48096248|NCT03325075|100560367|FG003|COMPLETED|Part A: Dose Escalation (28 Days)||15||
48096249|NCT03325075|100560364|FG000|NOT COMPLETED|Part A: Dose Escalation (28 Days)||0||
48096250|NCT03325075|100560365|FG001|NOT COMPLETED|Part A: Dose Escalation (28 Days)||0||
48096251|NCT03325075|100560366|FG002|NOT COMPLETED|Part A: Dose Escalation (28 Days)||0||
48096252|NCT03325075|100560367|FG003|NOT COMPLETED|Part A: Dose Escalation (28 Days)||0||
48096253|NCT03325075|100560364|FG000|STARTED|Part B: Follow-up (Up to 364 Days)||15||
48096254|NCT03325075|100560365|FG001|STARTED|Part B: Follow-up (Up to 364 Days)||15||
48096255|NCT03325075|100560366|FG002|STARTED|Part B: Follow-up (Up to 364 Days)||15||
48096256|NCT03325075|100560367|FG003|STARTED|Part B: Follow-up (Up to 364 Days)||15||
48096257|NCT03325075|100560364|FG000|COMPLETED|Part B: Follow-up (Up to 364 Days)||13||
48389101|NCT05137730|101283363|FG004|COMPLETED|Part I: Treatment Period 2 (1 Day)||0||
48389102|NCT05137730|101283364|FG005|COMPLETED|Part I: Treatment Period 2 (1 Day)||0||
48689685|NCT00040742|102022752|FG002|COMPLETED|Overall Study||141||
48689686|NCT00040742|102022753|FG003|COMPLETED|Overall Study||152||
48689687|NCT00040742|102022750|FG000|NOT COMPLETED|Overall Study||39||
48689688|NCT00040742|102022751|FG001|NOT COMPLETED|Overall Study||49||
48689689|NCT00040742|102022752|FG002|NOT COMPLETED|Overall Study||46||
48689690|NCT00040742|102022753|FG003|NOT COMPLETED|Overall Study||34||
48689691|NCT01643408|102022754|FG000|STARTED|Overall Study||30||
48689692|NCT01643408|102022754|FG000|COMPLETED|Overall Study||16||
48689693|NCT01643408|102022754|FG000|NOT COMPLETED|Overall Study||14||
48689694|NCT01102491|102022755|FG000|STARTED|Overall Study||71||
48689695|NCT01102491|102022756|FG001|STARTED|Overall Study||71||
48689696|NCT01102491|102022755|FG000|COMPLETED|Overall Study||60||
48689697|NCT01102491|102022756|FG001|COMPLETED|Overall Study||59||
48689698|NCT01102491|102022755|FG000|NOT COMPLETED|Overall Study||11||
48689699|NCT01102491|102022756|FG001|NOT COMPLETED|Overall Study||12||
48689700|NCT02100423|102022757|FG000|STARTED|Overall Study||35||
48689701|NCT02100423|102022757|FG000|COMPLETED|Overall Study||29||
48689702|NCT02100423|102022757|FG000|NOT COMPLETED|Overall Study||6||
48689703|NCT02779777|102022758|FG000|STARTED|Overall Study||14||
48689704|NCT02779777|102022759|FG001|STARTED|Overall Study||1||
48096258|NCT03325075|100560365|FG001|COMPLETED|Part B: Follow-up (Up to 364 Days)||13||
48096259|NCT03325075|100560366|FG002|COMPLETED|Part B: Follow-up (Up to 364 Days)||15||
48096260|NCT03325075|100560367|FG003|COMPLETED|Part B: Follow-up (Up to 364 Days)||13||
48096261|NCT03325075|100560364|FG000|NOT COMPLETED|Part B: Follow-up (Up to 364 Days)||2||
48096262|NCT03325075|100560365|FG001|NOT COMPLETED|Part B: Follow-up (Up to 364 Days)||2||
48096263|NCT03325075|100560366|FG002|NOT COMPLETED|Part B: Follow-up (Up to 364 Days)||0||
48096264|NCT03325075|100560367|FG003|NOT COMPLETED|Part B: Follow-up (Up to 364 Days)||2||
48096265|NCT01988103|100560368|FG000|STARTED|Placebo-Controlled Phase Week 0-16||84||
48096266|NCT01988103|100560369|FG001|STARTED|Placebo-Controlled Phase Week 0-16||85||
48096267|NCT01988103|100560370|FG002|STARTED|Placebo-Controlled Phase Week 0-16||85||
48096268|NCT01988103|100560371|FG003|STARTED|Placebo-Controlled Phase Week 0-16||0||
48096269|NCT01988103|100560372|FG004|STARTED|Placebo-Controlled Phase Week 0-16||0||
48096270|NCT01988103|100560368|FG000|COMPLETED|Placebo-Controlled Phase Week 0-16||72||
48096271|NCT01988103|100560369|FG001|COMPLETED|Placebo-Controlled Phase Week 0-16||69||
48096272|NCT01988103|100560370|FG002|COMPLETED|Placebo-Controlled Phase Week 0-16||76||
48096273|NCT01988103|100560371|FG003|COMPLETED|Placebo-Controlled Phase Week 0-16||0||
48096274|NCT01988103|100560372|FG004|COMPLETED|Placebo-Controlled Phase Week 0-16||0||
48096275|NCT01988103|100560368|FG000|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||12||
48096276|NCT01988103|100560369|FG001|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||16||
48096277|NCT01988103|100560370|FG002|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||9||
48096278|NCT01988103|100560371|FG003|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||0||
48096279|NCT01988103|100560372|FG004|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||0||
48096280|NCT01988103|100560368|FG000|STARTED|Active Treatment Phase (Weeks 16-68)||0||
48096281|NCT01988103|100560369|FG001|STARTED|Active Treatment Phase (Weeks 16-68)||69||
48096282|NCT01988103|100560370|FG002|STARTED|Active Treatment Phase (Weeks 16-68)||76||
48389103|NCT05137730|101283359|FG000|NOT COMPLETED|Part I: Treatment Period 2 (1 Day)||0||
48389104|NCT05137730|101283360|FG001|NOT COMPLETED|Part I: Treatment Period 2 (1 Day)||0||
48689705|NCT02779777|102022760|FG002|STARTED|Overall Study||1||
48689706|NCT02779777|102022758|FG000|COMPLETED|Overall Study||0||
48689707|NCT02779777|102022759|FG001|COMPLETED|Overall Study||0||
48689708|NCT02779777|102022760|FG002|COMPLETED|Overall Study||0||
48689709|NCT02779777|102022758|FG000|NOT COMPLETED|Overall Study||14||
48389105|NCT05137730|101283361|FG002|NOT COMPLETED|Part I: Treatment Period 2 (1 Day)||0||
48389106|NCT05137730|101283362|FG003|NOT COMPLETED|Part I: Treatment Period 2 (1 Day)||0||
48389107|NCT05137730|101283363|FG004|NOT COMPLETED|Part I: Treatment Period 2 (1 Day)||0||
48389108|NCT05137730|101283364|FG005|NOT COMPLETED|Part I: Treatment Period 2 (1 Day)||0||
48389109|NCT05137730|101283359|FG000|STARTED|Part II: Treatment Period 1 (1 Day)||0||
48389110|NCT05137730|101283360|FG001|STARTED|Part II: Treatment Period 1 (1 Day)||0||
48389111|NCT05137730|101283361|FG002|STARTED|Part II: Treatment Period 1 (1 Day)||3||
48389112|NCT05137730|101283362|FG003|STARTED|Part II: Treatment Period 1 (1 Day)||3||
48389113|NCT05137730|101283363|FG004|STARTED|Part II: Treatment Period 1 (1 Day)||3||
48389114|NCT05137730|101283364|FG005|STARTED|Part II: Treatment Period 1 (1 Day)||3||
48389115|NCT05137730|101283359|FG000|COMPLETED|Part II: Treatment Period 1 (1 Day)||0||
48259987|NCT00550446|100958844|FG008|STARTED|Up To Week 12||0||
48259988|NCT00550446|100958845|FG009|STARTED|Up To Week 12||0||
48259989|NCT00550446|100958846|FG010|STARTED|Up To Week 12||0||
48259990|NCT00550446|100958836|FG000|Treated|Up To Week 12||54||
48259991|NCT00550446|100958837|FG001|Treated|Up To Week 12||51||
48259992|NCT00550446|100958838|FG002|Treated|Up To Week 12||49||
48259993|NCT00550446|100958839|FG003|Treated|Up To Week 12||61||
48259994|NCT00550446|100958840|FG004|Treated|Up To Week 12||57||
48259995|NCT00550446|100958841|FG005|Treated|Up To Week 12||53||
48259996|NCT00550446|100958842|FG006|Treated|Up To Week 12||59||
48259997|NCT00550446|100958843|FG007|Treated|Up To Week 12||0||
48259998|NCT00550446|100958844|FG008|Treated|Up To Week 12||0||
48259999|NCT00550446|100958845|FG009|Treated|Up To Week 12||0||
48389116|NCT05137730|101283360|FG001|COMPLETED|Part II: Treatment Period 1 (1 Day)||0||
48389117|NCT05137730|101283361|FG002|COMPLETED|Part II: Treatment Period 1 (1 Day)||3||
48389118|NCT05137730|101283362|FG003|COMPLETED|Part II: Treatment Period 1 (1 Day)||3||
48389119|NCT05137730|101283363|FG004|COMPLETED|Part II: Treatment Period 1 (1 Day)||3||
48389120|NCT05137730|101283364|FG005|COMPLETED|Part II: Treatment Period 1 (1 Day)||3||
48389121|NCT05137730|101283359|FG000|NOT COMPLETED|Part II: Treatment Period 1 (1 Day)||0||
48389122|NCT05137730|101283360|FG001|NOT COMPLETED|Part II: Treatment Period 1 (1 Day)||0||
48260000|NCT00550446|100958846|FG010|Treated|Up To Week 12||0||
48260001|NCT00550446|100958836|FG000|COMPLETED|Up To Week 12||44||
48260002|NCT00550446|100958837|FG001|COMPLETED|Up To Week 12||47||
48260003|NCT00550446|100958838|FG002|COMPLETED|Up To Week 12||46||
48260004|NCT00550446|100958839|FG003|COMPLETED|Up To Week 12||58||
48260005|NCT00550446|100958840|FG004|COMPLETED|Up To Week 12||54||
48260006|NCT00550446|100958841|FG005|COMPLETED|Up To Week 12||45||
48260007|NCT00550446|100958842|FG006|COMPLETED|Up To Week 12||46||
48260008|NCT00550446|100958843|FG007|COMPLETED|Up To Week 12||0||
48260009|NCT00550446|100958844|FG008|COMPLETED|Up To Week 12||0||
48260010|NCT00550446|100958845|FG009|COMPLETED|Up To Week 12||0||
48260011|NCT00550446|100958846|FG010|COMPLETED|Up To Week 12||0||
48260012|NCT00550446|100958836|FG000|NOT COMPLETED|Up To Week 12||10||
48260013|NCT00550446|100958837|FG001|NOT COMPLETED|Up To Week 12||5||
48389123|NCT05137730|101283361|FG002|NOT COMPLETED|Part II: Treatment Period 1 (1 Day)||0||
48389124|NCT05137730|101283362|FG003|NOT COMPLETED|Part II: Treatment Period 1 (1 Day)||0||
48389125|NCT05137730|101283363|FG004|NOT COMPLETED|Part II: Treatment Period 1 (1 Day)||0||
48389126|NCT05137730|101283364|FG005|NOT COMPLETED|Part II: Treatment Period 1 (1 Day)||0||
48389127|NCT05137730|101283359|FG000|STARTED|Part II: Washout Period 1 (48 Hours)||0||
48389128|NCT05137730|101283360|FG001|STARTED|Part II: Washout Period 1 (48 Hours)||0||
48389129|NCT05137730|101283361|FG002|STARTED|Part II: Washout Period 1 (48 Hours)||3||
48389130|NCT05137730|101283362|FG003|STARTED|Part II: Washout Period 1 (48 Hours)||3||
48389131|NCT05137730|101283363|FG004|STARTED|Part II: Washout Period 1 (48 Hours)||3||
48389132|NCT05137730|101283364|FG005|STARTED|Part II: Washout Period 1 (48 Hours)||3||
48389133|NCT05137730|101283359|FG000|COMPLETED|Part II: Washout Period 1 (48 Hours)||0||
48389134|NCT05137730|101283360|FG001|COMPLETED|Part II: Washout Period 1 (48 Hours)||0||
48389135|NCT05137730|101283361|FG002|COMPLETED|Part II: Washout Period 1 (48 Hours)||3||
48389136|NCT05137730|101283362|FG003|COMPLETED|Part II: Washout Period 1 (48 Hours)||3||
48389137|NCT05137730|101283363|FG004|COMPLETED|Part II: Washout Period 1 (48 Hours)||3||
48389138|NCT05137730|101283364|FG005|COMPLETED|Part II: Washout Period 1 (48 Hours)||3||
48389139|NCT05137730|101283359|FG000|NOT COMPLETED|Part II: Washout Period 1 (48 Hours)||0||
48389140|NCT05137730|101283360|FG001|NOT COMPLETED|Part II: Washout Period 1 (48 Hours)||0||
48389141|NCT05137730|101283361|FG002|NOT COMPLETED|Part II: Washout Period 1 (48 Hours)||0||
48389142|NCT05137730|101283362|FG003|NOT COMPLETED|Part II: Washout Period 1 (48 Hours)||0||
48260014|NCT00550446|100958838|FG002|NOT COMPLETED|Up To Week 12||4||
48260015|NCT00550446|100958839|FG003|NOT COMPLETED|Up To Week 12||3||
48260016|NCT00550446|100958840|FG004|NOT COMPLETED|Up To Week 12||3||
48260017|NCT00550446|100958841|FG005|NOT COMPLETED|Up To Week 12||8||
48260018|NCT00550446|100958842|FG006|NOT COMPLETED|Up To Week 12||13||
48260019|NCT00550446|100958843|FG007|NOT COMPLETED|Up To Week 12||0||
48260020|NCT00550446|100958844|FG008|NOT COMPLETED|Up To Week 12||0||
48389143|NCT05137730|101283363|FG004|NOT COMPLETED|Part II: Washout Period 1 (48 Hours)||0||
48389144|NCT05137730|101283364|FG005|NOT COMPLETED|Part II: Washout Period 1 (48 Hours)||0||
48389145|NCT05137730|101283359|FG000|STARTED|Part II: Treatment Period 2 (1 Day)||0||
48389146|NCT05137730|101283360|FG001|STARTED|Part II: Treatment Period 2 (1 Day)||0||
48389147|NCT05137730|101283361|FG002|STARTED|Part II: Treatment Period 2 (1 Day)||3||
48389148|NCT05137730|101283362|FG003|STARTED|Part II: Treatment Period 2 (1 Day)||3||
48389149|NCT05137730|101283363|FG004|STARTED|Part II: Treatment Period 2 (1 Day)||3||
48389150|NCT05137730|101283364|FG005|STARTED|Part II: Treatment Period 2 (1 Day)||3||
48389151|NCT05137730|101283359|FG000|COMPLETED|Part II: Treatment Period 2 (1 Day)||0||
48389152|NCT05137730|101283360|FG001|COMPLETED|Part II: Treatment Period 2 (1 Day)||0||
48389153|NCT05137730|101283361|FG002|COMPLETED|Part II: Treatment Period 2 (1 Day)||3||
48389154|NCT05137730|101283362|FG003|COMPLETED|Part II: Treatment Period 2 (1 Day)||3||
48389155|NCT05137730|101283363|FG004|COMPLETED|Part II: Treatment Period 2 (1 Day)||3||
48389156|NCT05137730|101283364|FG005|COMPLETED|Part II: Treatment Period 2 (1 Day)||3||
48389157|NCT05137730|101283359|FG000|NOT COMPLETED|Part II: Treatment Period 2 (1 Day)||0||
48389158|NCT05137730|101283360|FG001|NOT COMPLETED|Part II: Treatment Period 2 (1 Day)||0||
48389159|NCT05137730|101283361|FG002|NOT COMPLETED|Part II: Treatment Period 2 (1 Day)||0||
48389160|NCT05137730|101283362|FG003|NOT COMPLETED|Part II: Treatment Period 2 (1 Day)||0||
48096283|NCT01988103|100560371|FG003|STARTED|Active Treatment Phase (Weeks 16-68)||36||
48096284|NCT01988103|100560372|FG004|STARTED|Active Treatment Phase (Weeks 16-68)||35||
48096285|NCT01988103|100560368|FG000|COMPLETED|Active Treatment Phase (Weeks 16-68)||0||
48096286|NCT01988103|100560369|FG001|COMPLETED|Active Treatment Phase (Weeks 16-68)||56||
48096287|NCT01988103|100560370|FG002|COMPLETED|Active Treatment Phase (Weeks 16-68)||65||
48096288|NCT01988103|100560371|FG003|COMPLETED|Active Treatment Phase (Weeks 16-68)||33||
48096289|NCT01988103|100560372|FG004|COMPLETED|Active Treatment Phase (Weeks 16-68)||30||
48096290|NCT01988103|100560368|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||0||
48096291|NCT01988103|100560369|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||13||
48389161|NCT05137730|101283363|FG004|NOT COMPLETED|Part II: Treatment Period 2 (1 Day)||0||
48389162|NCT05137730|101283364|FG005|NOT COMPLETED|Part II: Treatment Period 2 (1 Day)||0||
48389163|NCT05137730|101283359|FG000|STARTED|Part II: Washout Period 2 (48 Hours)||0||
48389164|NCT05137730|101283360|FG001|STARTED|Part II: Washout Period 2 (48 Hours)||0||
48389165|NCT05137730|101283361|FG002|STARTED|Part II: Washout Period 2 (48 Hours)||3||
48389166|NCT05137730|101283362|FG003|STARTED|Part II: Washout Period 2 (48 Hours)||3||
48389167|NCT05137730|101283363|FG004|STARTED|Part II: Washout Period 2 (48 Hours)||3||
48389168|NCT05137730|101283364|FG005|STARTED|Part II: Washout Period 2 (48 Hours)||3||
48389169|NCT05137730|101283359|FG000|COMPLETED|Part II: Washout Period 2 (48 Hours)||0||
48389170|NCT05137730|101283360|FG001|COMPLETED|Part II: Washout Period 2 (48 Hours)||0||
48389171|NCT05137730|101283361|FG002|COMPLETED|Part II: Washout Period 2 (48 Hours)||3||
48389172|NCT05137730|101283362|FG003|COMPLETED|Part II: Washout Period 2 (48 Hours)||3||
48389173|NCT05137730|101283363|FG004|COMPLETED|Part II: Washout Period 2 (48 Hours)||3||
48389174|NCT05137730|101283364|FG005|COMPLETED|Part II: Washout Period 2 (48 Hours)||3||
48389175|NCT05137730|101283359|FG000|NOT COMPLETED|Part II: Washout Period 2 (48 Hours)||0||
48096292|NCT01988103|100560370|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||11||
48096293|NCT01988103|100560371|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||3||
48096294|NCT01988103|100560372|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||5||
48096295|NCT01988103|100560368|FG000|STARTED|Observational Follow-up Phase||12||
48096296|NCT01988103|100560369|FG001|STARTED|Observational Follow-up Phase||82||
48096297|NCT01988103|100560370|FG002|STARTED|Observational Follow-up Phase||83||
48096298|NCT01988103|100560371|FG003|STARTED|Observational Follow-up Phase||36||
48096299|NCT01988103|100560372|FG004|STARTED|Observational Follow-up Phase||33||
48096300|NCT01988103|100560368|FG000|COMPLETED|Observational Follow-up Phase||12||
48096301|NCT01988103|100560369|FG001|COMPLETED|Observational Follow-up Phase||79||
48096302|NCT01988103|100560370|FG002|COMPLETED|Observational Follow-up Phase||82||
48096303|NCT01988103|100560371|FG003|COMPLETED|Observational Follow-up Phase||36||
48096304|NCT01988103|100560372|FG004|COMPLETED|Observational Follow-up Phase||33||
48096305|NCT01988103|100560368|FG000|NOT COMPLETED|Observational Follow-up Phase||0||
48096306|NCT01988103|100560369|FG001|NOT COMPLETED|Observational Follow-up Phase||3||
48096307|NCT01988103|100560370|FG002|NOT COMPLETED|Observational Follow-up Phase||1||
48096308|NCT01988103|100560371|FG003|NOT COMPLETED|Observational Follow-up Phase||0||
48096309|NCT01988103|100560372|FG004|NOT COMPLETED|Observational Follow-up Phase||0||
48096310|NCT00730912|100560373|FG000|STARTED|Overall Study||53||
48096311|NCT00730912|100560374|FG001|STARTED|Overall Study||104||
48096312|NCT00730912|100560375|FG002|STARTED|Overall Study||104||
48096313|NCT00730912|100560373|FG000|COMPLETED|Overall Study||53||
48096314|NCT00730912|100560374|FG001|COMPLETED|Overall Study||104||
48096315|NCT00730912|100560375|FG002|COMPLETED|Overall Study||103||
48096316|NCT00730912|100560373|FG000|NOT COMPLETED|Overall Study||0||
48096317|NCT00730912|100560374|FG001|NOT COMPLETED|Overall Study||0||
48096318|NCT00730912|100560375|FG002|NOT COMPLETED|Overall Study||1||
48389176|NCT05137730|101283360|FG001|NOT COMPLETED|Part II: Washout Period 2 (48 Hours)||0||
48389177|NCT05137730|101283361|FG002|NOT COMPLETED|Part II: Washout Period 2 (48 Hours)||0||
48389178|NCT05137730|101283362|FG003|NOT COMPLETED|Part II: Washout Period 2 (48 Hours)||0||
48389179|NCT05137730|101283363|FG004|NOT COMPLETED|Part II: Washout Period 2 (48 Hours)||0||
48389180|NCT05137730|101283364|FG005|NOT COMPLETED|Part II: Washout Period 2 (48 Hours)||0||
48096319|NCT00487747|100560376|FG000|STARTED|Overall Study||18||
48096320|NCT00487747|100560376|FG000|COMPLETED|Overall Study||7||
48096321|NCT00487747|100560376|FG000|NOT COMPLETED|Overall Study||11||
48096322|NCT00082355|100560377|FG000|STARTED|Initial Results of Thrombolytic Therapy||30||
48096323|NCT00082355|100560377|FG000|COMPLETED|Initial Results of Thrombolytic Therapy||28||
48096324|NCT00082355|100560377|FG000|NOT COMPLETED|Initial Results of Thrombolytic Therapy||2||
48389181|NCT05137730|101283359|FG000|STARTED|Part II: Treatment Period 3 (1 Day)||0||
48389182|NCT05137730|101283360|FG001|STARTED|Part II: Treatment Period 3 (1 Day)||0||
48389183|NCT05137730|101283361|FG002|STARTED|Part II: Treatment Period 3 (1 Day)||3||
48389184|NCT05137730|101283362|FG003|STARTED|Part II: Treatment Period 3 (1 Day)||3||
48389185|NCT05137730|101283363|FG004|STARTED|Part II: Treatment Period 3 (1 Day)||3||
48389186|NCT05137730|101283364|FG005|STARTED|Part II: Treatment Period 3 (1 Day)||3||
48096325|NCT00082355|100560377|FG000|STARTED|5 Year Recurrent Thromboembolism Rate||28||
48096326|NCT00082355|100560377|FG000|COMPLETED|5 Year Recurrent Thromboembolism Rate||0||
48096327|NCT00082355|100560377|FG000|NOT COMPLETED|5 Year Recurrent Thromboembolism Rate||28||
48096328|NCT01207765|100560378|FG000|STARTED|Overall Study||8||
48096329|NCT01207765|100560378|FG000|COMPLETED|Overall Study||8||
48096330|NCT01207765|100560378|FG000|NOT COMPLETED|Overall Study||0||
48096331|NCT00350636|100560379|FG000|STARTED|Overall Study||389||
48096332|NCT00350636|100560380|FG001|STARTED|Overall Study||400||
48096333|NCT00350636|100560379|FG000|COMPLETED|Overall Study||346||
48096334|NCT00350636|100560380|FG001|COMPLETED|Overall Study||355||
48689710|NCT02779777|102022759|FG001|NOT COMPLETED|Overall Study||1||
48689711|NCT02779777|102022760|FG002|NOT COMPLETED|Overall Study||1||
48096335|NCT00350636|100560379|FG000|NOT COMPLETED|Overall Study||43||
48096336|NCT00350636|100560380|FG001|NOT COMPLETED|Overall Study||45||
48096337|NCT02631850|100560381|FG000|STARTED|Treatment Period||41||
48096338|NCT02631850|100560382|FG001|STARTED|Treatment Period||44||
48096339|NCT02631850|100560383|FG002|STARTED|Treatment Period||45||
48096340|NCT02631850|100560384|FG003|STARTED|Treatment Period||38||
48096341|NCT02631850|100560381|FG000|COMPLETED|Treatment Period||38||
48096342|NCT02631850|100560382|FG001|COMPLETED|Treatment Period||38||
48096343|NCT02631850|100560383|FG002|COMPLETED|Treatment Period||41||
48096344|NCT02631850|100560384|FG003|COMPLETED|Treatment Period||33||
48096345|NCT02631850|100560381|FG000|NOT COMPLETED|Treatment Period||3||
48096346|NCT02631850|100560382|FG001|NOT COMPLETED|Treatment Period||6||
48096347|NCT02631850|100560383|FG002|NOT COMPLETED|Treatment Period||4||
48096348|NCT02631850|100560384|FG003|NOT COMPLETED|Treatment Period||5||
48096349|NCT02631850|100560381|FG000|STARTED|6 Month Follow up||38||
48096350|NCT02631850|100560382|FG001|STARTED|6 Month Follow up||38||
48096351|NCT02631850|100560383|FG002|STARTED|6 Month Follow up||41||
48096352|NCT02631850|100560384|FG003|STARTED|6 Month Follow up||33||
48096353|NCT02631850|100560381|FG000|COMPLETED|6 Month Follow up||31||
48389187|NCT05137730|101283359|FG000|COMPLETED|Part II: Treatment Period 3 (1 Day)||0||
48389188|NCT05137730|101283360|FG001|COMPLETED|Part II: Treatment Period 3 (1 Day)||0||
48389189|NCT05137730|101283361|FG002|COMPLETED|Part II: Treatment Period 3 (1 Day)||3||
48389190|NCT05137730|101283362|FG003|COMPLETED|Part II: Treatment Period 3 (1 Day)||3||
48389191|NCT05137730|101283363|FG004|COMPLETED|Part II: Treatment Period 3 (1 Day)||3||
48389192|NCT05137730|101283364|FG005|COMPLETED|Part II: Treatment Period 3 (1 Day)||3||
48541919|NCT04614948|101662809|FG000|Non-FAS Post-Dose 1 Population|DB Phase (Day 1 up to 7.2 Months)||3|Participants who received a COVID-19 vaccination outside of the study prior to first study vaccination.|
48096354|NCT02631850|100560382|FG001|COMPLETED|6 Month Follow up||25||
48096355|NCT02631850|100560383|FG002|COMPLETED|6 Month Follow up||35||
48096356|NCT02631850|100560384|FG003|COMPLETED|6 Month Follow up||22||
48096357|NCT02631850|100560381|FG000|NOT COMPLETED|6 Month Follow up||7||
48096358|NCT02631850|100560382|FG001|NOT COMPLETED|6 Month Follow up||13||
48096359|NCT02631850|100560383|FG002|NOT COMPLETED|6 Month Follow up||6||
48389193|NCT05137730|101283359|FG000|NOT COMPLETED|Part II: Treatment Period 3 (1 Day)||0||
48389194|NCT05137730|101283360|FG001|NOT COMPLETED|Part II: Treatment Period 3 (1 Day)||0||
48389195|NCT05137730|101283361|FG002|NOT COMPLETED|Part II: Treatment Period 3 (1 Day)||0||
48541920|NCT04614948|101662810|FG001|Non-FAS Post-Dose 1 Population|DB Phase (Day 1 up to 7.2 Months)||4|Participants who received a COVID-19 vaccination outside of the study prior to first study vaccination.|
48541921|NCT04614948|101662811|FG002|Non-FAS Post-Dose 1 Population|DB Phase (Day 1 up to 7.2 Months)||0|Participants who received a COVID-19 vaccination outside of the study prior to first study vaccination.|
48541922|NCT04614948|101662809|FG000|FAS Post-Dose 1 Safety Subset (Subset of FAS)|DB Phase (Day 1 up to 7.2 Months)||3015||
48541923|NCT04614948|101662810|FG001|FAS Post-Dose 1 Safety Subset (Subset of FAS)|DB Phase (Day 1 up to 7.2 Months)||3052||
48541924|NCT04614948|101662811|FG002|FAS Post-Dose 1 Safety Subset (Subset of FAS)|DB Phase (Day 1 up to 7.2 Months)||0||
48541925|NCT04614948|101662809|FG000|Non-FAS Post-Dose 1 Safety Subset (Subset of FAS)|DB Phase (Day 1 up to 7.2 Months)||1||
48689712|NCT03326063|102022761|FG000|STARTED|Overall Study||18||
48096360|NCT02631850|100560384|FG003|NOT COMPLETED|6 Month Follow up||11||
48096361|NCT00768300|100560385|FG000|STARTED|Overall Study||330||
48096362|NCT00768300|100560386|FG001|STARTED|Overall Study||164||
48096363|NCT00768300|100560385|FG000|Randomized and Treated|Overall Study||329||
48096364|NCT00768300|100560386|FG001|Randomized and Treated|Overall Study||163||
48096365|NCT00768300|100560385|FG000|COMPLETED|Overall Study||1||
48096366|NCT00768300|100560386|FG001|COMPLETED|Overall Study||1||
48096367|NCT00768300|100560385|FG000|NOT COMPLETED|Overall Study||329||
48541926|NCT04614948|101662810|FG001|Non-FAS Post-Dose 1 Safety Subset (Subset of FAS)|DB Phase (Day 1 up to 7.2 Months)||0||
48541927|NCT04614948|101662811|FG002|Non-FAS Post-Dose 1 Safety Subset (Subset of FAS)|DB Phase (Day 1 up to 7.2 Months)||0||
48541928|NCT04614948|101662809|FG000|COMPLETED|DB Phase (Day 1 up to 7.2 Months)||15007||
48541929|NCT04614948|101662810|FG001|COMPLETED|DB Phase (Day 1 up to 7.2 Months)||13834||
48541930|NCT04614948|101662811|FG002|COMPLETED|DB Phase (Day 1 up to 7.2 Months)||0||
48541931|NCT04614948|101662809|FG000|NOT COMPLETED|DB Phase (Day 1 up to 7.2 Months)||701||
48541932|NCT04614948|101662810|FG001|NOT COMPLETED|DB Phase (Day 1 up to 7.2 Months)||1758||
48541933|NCT04614948|101662811|FG002|NOT COMPLETED|DB Phase (Day 1 up to 7.2 Months)||0||
48541934|NCT04614948|101662809|FG000|STARTED|DB + Open-label Phase (2 Years 6 Months)||0||
48541935|NCT04614948|101662810|FG001|STARTED|DB + Open-label Phase (2 Years 6 Months)||0||
48541936|NCT04614948|101662811|FG002|STARTED|DB + Open-label Phase (2 Years 6 Months)||31705||
48541937|NCT04614948|101662809|FG000|COMPLETED|DB + Open-label Phase (2 Years 6 Months)||0||
48541938|NCT04614948|101662810|FG001|COMPLETED|DB + Open-label Phase (2 Years 6 Months)||0||
48260021|NCT00550446|100958845|FG009|NOT COMPLETED|Up To Week 12||0||
48260022|NCT00550446|100958846|FG010|NOT COMPLETED|Up To Week 12||0||
48260023|NCT00550446|100958836|FG000|STARTED|Post Week 12||27||
48260024|NCT00550446|100958837|FG001|STARTED|Post Week 12||30||
48260025|NCT00550446|100958838|FG002|STARTED|Post Week 12||46||
48260026|NCT00550446|100958839|FG003|STARTED|Post Week 12||58||
48260027|NCT00550446|100958840|FG004|STARTED|Post Week 12||54||
48260028|NCT00550446|100958841|FG005|STARTED|Post Week 12||1||
48260029|NCT00550446|100958842|FG006|STARTED|Post Week 12||21||
48260030|NCT00550446|100958843|FG007|STARTED|Post Week 12||17||
48260031|NCT00550446|100958844|FG008|STARTED|Post Week 12||17||
48260032|NCT00550446|100958845|FG009|STARTED|Post Week 12||44||
48260033|NCT00550446|100958846|FG010|STARTED|Post Week 12||25||
48260034|NCT00550446|100958836|FG000|COMPLETED|Post Week 12||24||
48260035|NCT00550446|100958837|FG001|COMPLETED|Post Week 12||28||
48541939|NCT04614948|101662811|FG002|COMPLETED|DB + Open-label Phase (2 Years 6 Months)||21018||
48541940|NCT04614948|101662809|FG000|NOT COMPLETED|DB + Open-label Phase (2 Years 6 Months)||0||
48541941|NCT04614948|101662810|FG001|NOT COMPLETED|DB + Open-label Phase (2 Years 6 Months)||0||
48541942|NCT04614948|101662811|FG002|NOT COMPLETED|DB + Open-label Phase (2 Years 6 Months)||10687||
48541943|NCT00191165|101662812|FG000|STARTED|Overall Study||14||
48541944|NCT00191165|101662813|FG001|STARTED|Overall Study||13||
48541945|NCT00191165|101662812|FG000|COMPLETED|Overall Study||12||
48541946|NCT00191165|101662813|FG001|COMPLETED|Overall Study||11||
48541947|NCT00191165|101662812|FG000|NOT COMPLETED|Overall Study||2||
48541948|NCT00191165|101662813|FG001|NOT COMPLETED|Overall Study||2||
48541949|NCT02430038|101662814|FG000|STARTED|Overall Study||119||
48541950|NCT02430038|101662815|FG001|STARTED|Overall Study||195||
48541951|NCT02430038|101662816|FG002|STARTED|Overall Study||270||
48541952|NCT02430038|101662814|FG000|Minimum Recruitment|Overall Study||42||
48541953|NCT02430038|101662815|FG001|Minimum Recruitment|Overall Study||100||
48541954|NCT02430038|101662816|FG002|Minimum Recruitment|Overall Study||270||
48541955|NCT02430038|101662814|FG000|COMPLETED|Overall Study||119|119 women recruited|
48541956|NCT02430038|101662815|FG001|COMPLETED|Overall Study||195|119 women recruited|
48541957|NCT02430038|101662816|FG002|COMPLETED|Overall Study||269|119 women recruited|
48541958|NCT02430038|101662814|FG000|NOT COMPLETED|Overall Study||0||
48541959|NCT02430038|101662815|FG001|NOT COMPLETED|Overall Study||0||
48541960|NCT02430038|101662816|FG002|NOT COMPLETED|Overall Study||1||
48541961|NCT03020537|101662817|FG000|STARTED|Overall Study||1||
48541962|NCT03020537|101662818|FG001|STARTED|Overall Study||7||
48541963|NCT03020537|101662817|FG000|COMPLETED|Overall Study||1||
48541964|NCT03020537|101662818|FG001|COMPLETED|Overall Study||7||
48541965|NCT03020537|101662817|FG000|NOT COMPLETED|Overall Study||0||
48541966|NCT03020537|101662818|FG001|NOT COMPLETED|Overall Study||0||
48541967|NCT00636389|101662819|FG000|STARTED|Period 1 - 1 Week||7||
48541968|NCT00636389|101662820|FG001|STARTED|Period 1 - 1 Week||5||
48541969|NCT00636389|101662819|FG000|COMPLETED|Period 1 - 1 Week||7||
48541970|NCT00636389|101662820|FG001|COMPLETED|Period 1 - 1 Week||5||
48541971|NCT00636389|101662819|FG000|NOT COMPLETED|Period 1 - 1 Week||0||
48541972|NCT00636389|101662820|FG001|NOT COMPLETED|Period 1 - 1 Week||0||
48541973|NCT00636389|101662819|FG000|STARTED|Period 2 - 1 Week||7||
48541974|NCT00636389|101662820|FG001|STARTED|Period 2 - 1 Week||5||
48541975|NCT00636389|101662819|FG000|COMPLETED|Period 2 - 1 Week||7||
48541976|NCT00636389|101662820|FG001|COMPLETED|Period 2 - 1 Week||5||
48260036|NCT00550446|100958838|FG002|COMPLETED|Post Week 12||43||
48541977|NCT00636389|101662819|FG000|NOT COMPLETED|Period 2 - 1 Week||0||
48541978|NCT00636389|101662820|FG001|NOT COMPLETED|Period 2 - 1 Week||0||
48541979|NCT01531439|101662821|FG000|STARTED|Overall Study||41||
48541980|NCT01531439|101662822|FG001|STARTED|Overall Study||43||
48541981|NCT01531439|101662821|FG000|COMPLETED|Overall Study||37||
48260037|NCT00550446|100958839|FG003|COMPLETED|Post Week 12||55||
48260038|NCT00550446|100958840|FG004|COMPLETED|Post Week 12||52||
48260039|NCT00550446|100958841|FG005|COMPLETED|Post Week 12||0||
48260040|NCT00550446|100958842|FG006|COMPLETED|Post Week 12||19||
48260041|NCT00550446|100958843|FG007|COMPLETED|Post Week 12||16||
48260042|NCT00550446|100958844|FG008|COMPLETED|Post Week 12||15||
48260043|NCT00550446|100958845|FG009|COMPLETED|Post Week 12||37||
48260044|NCT00550446|100958846|FG010|COMPLETED|Post Week 12||24||
48096368|NCT00768300|100560386|FG001|NOT COMPLETED|Overall Study||163||
48096369|NCT03566823|100560387|FG000|STARTED|Overall Study||6||
48096370|NCT03566823|100560388|FG001|STARTED|Overall Study||15||
48389196|NCT05137730|101283362|FG003|NOT COMPLETED|Part II: Treatment Period 3 (1 Day)||0||
48389197|NCT05137730|101283363|FG004|NOT COMPLETED|Part II: Treatment Period 3 (1 Day)||0||
48389198|NCT05137730|101283364|FG005|NOT COMPLETED|Part II: Treatment Period 3 (1 Day)||0||
48389199|NCT05137730|101283359|FG000|STARTED|Part II: Washout Period 3 (48 Hours)||0||
48389200|NCT05137730|101283360|FG001|STARTED|Part II: Washout Period 3 (48 Hours)||0||
48389201|NCT05137730|101283361|FG002|STARTED|Part II: Washout Period 3 (48 Hours)||3||
48389202|NCT05137730|101283362|FG003|STARTED|Part II: Washout Period 3 (48 Hours)||3||
48389203|NCT05137730|101283363|FG004|STARTED|Part II: Washout Period 3 (48 Hours)||3||
48389204|NCT05137730|101283364|FG005|STARTED|Part II: Washout Period 3 (48 Hours)||3||
48389205|NCT05137730|101283359|FG000|COMPLETED|Part II: Washout Period 3 (48 Hours)||0||
48389206|NCT05137730|101283360|FG001|COMPLETED|Part II: Washout Period 3 (48 Hours)||0||
48389207|NCT05137730|101283361|FG002|COMPLETED|Part II: Washout Period 3 (48 Hours)||3||
48389208|NCT05137730|101283362|FG003|COMPLETED|Part II: Washout Period 3 (48 Hours)||3||
48389209|NCT05137730|101283363|FG004|COMPLETED|Part II: Washout Period 3 (48 Hours)||3||
48389210|NCT05137730|101283364|FG005|COMPLETED|Part II: Washout Period 3 (48 Hours)||3||
48389211|NCT05137730|101283359|FG000|NOT COMPLETED|Part II: Washout Period 3 (48 Hours)||0||
48389212|NCT05137730|101283360|FG001|NOT COMPLETED|Part II: Washout Period 3 (48 Hours)||0||
48389213|NCT05137730|101283361|FG002|NOT COMPLETED|Part II: Washout Period 3 (48 Hours)||0||
48389214|NCT05137730|101283362|FG003|NOT COMPLETED|Part II: Washout Period 3 (48 Hours)||0||
48389215|NCT05137730|101283363|FG004|NOT COMPLETED|Part II: Washout Period 3 (48 Hours)||0||
48389216|NCT05137730|101283364|FG005|NOT COMPLETED|Part II: Washout Period 3 (48 Hours)||0||
48389217|NCT05137730|101283359|FG000|STARTED|Part II: Treatment Period 4 (1 Day)||0||
48389218|NCT05137730|101283360|FG001|STARTED|Part II: Treatment Period 4 (1 Day)||0||
48389219|NCT05137730|101283361|FG002|STARTED|Part II: Treatment Period 4 (1 Day)||3||
48389220|NCT05137730|101283362|FG003|STARTED|Part II: Treatment Period 4 (1 Day)||3||
48389221|NCT05137730|101283363|FG004|STARTED|Part II: Treatment Period 4 (1 Day)||3||
48389222|NCT05137730|101283364|FG005|STARTED|Part II: Treatment Period 4 (1 Day)||3||
48389223|NCT05137730|101283359|FG000|COMPLETED|Part II: Treatment Period 4 (1 Day)||0||
48389224|NCT05137730|101283360|FG001|COMPLETED|Part II: Treatment Period 4 (1 Day)||0||
48389225|NCT05137730|101283361|FG002|COMPLETED|Part II: Treatment Period 4 (1 Day)||3||
48389226|NCT05137730|101283362|FG003|COMPLETED|Part II: Treatment Period 4 (1 Day)||3||
48389227|NCT05137730|101283363|FG004|COMPLETED|Part II: Treatment Period 4 (1 Day)||3||
48389228|NCT05137730|101283364|FG005|COMPLETED|Part II: Treatment Period 4 (1 Day)||3||
48389229|NCT05137730|101283359|FG000|NOT COMPLETED|Part II: Treatment Period 4 (1 Day)||0||
48389230|NCT05137730|101283360|FG001|NOT COMPLETED|Part II: Treatment Period 4 (1 Day)||0||
48389231|NCT05137730|101283361|FG002|NOT COMPLETED|Part II: Treatment Period 4 (1 Day)||0||
48389232|NCT05137730|101283362|FG003|NOT COMPLETED|Part II: Treatment Period 4 (1 Day)||0||
48389233|NCT05137730|101283363|FG004|NOT COMPLETED|Part II: Treatment Period 4 (1 Day)||0||
48389234|NCT05137730|101283364|FG005|NOT COMPLETED|Part II: Treatment Period 4 (1 Day)||0||
48389235|NCT02325687|101283365|FG000|STARTED|Overall Study||16|1/19/2015|
48389236|NCT02325687|101283366|FG001|STARTED|Overall Study||15|1/19/2015|
48389237|NCT02325687|101283367|FG002|STARTED|Overall Study||19|1/19/2015|
48389238|NCT02325687|101283365|FG000|COMPLETED|Overall Study||12|11/15/16|
48389239|NCT02325687|101283366|FG001|COMPLETED|Overall Study||12|11/15/16|
48389240|NCT02325687|101283367|FG002|COMPLETED|Overall Study||13|11/15/16|
48389241|NCT02325687|101283365|FG000|NOT COMPLETED|Overall Study||4||
48389242|NCT02325687|101283366|FG001|NOT COMPLETED|Overall Study||3||
48389243|NCT02325687|101283367|FG002|NOT COMPLETED|Overall Study||6||
48389244|NCT03623334|101283368|FG000|STARTED|Overall Study||15||
48389245|NCT03623334|101283369|FG001|STARTED|Overall Study||21||
48389246|NCT03623334|101283370|FG002|STARTED|Overall Study||19||
48389247|NCT03623334|101283368|FG000|COMPLETED|Overall Study||15||
48389248|NCT03623334|101283369|FG001|COMPLETED|Overall Study||21||
48389249|NCT03623334|101283370|FG002|COMPLETED|Overall Study||19||
48389250|NCT03623334|101283368|FG000|NOT COMPLETED|Overall Study||0||
48389251|NCT03623334|101283369|FG001|NOT COMPLETED|Overall Study||0||
48389252|NCT03623334|101283370|FG002|NOT COMPLETED|Overall Study||0||
48389253|NCT05055570|101283371|FG000|STARTED|Overall Study||25||
48389254|NCT05055570|101283372|FG001|STARTED|Overall Study||63||
48389255|NCT05055570|101283371|FG000|COMPLETED|Overall Study||25||
48389256|NCT05055570|101283372|FG001|COMPLETED|Overall Study||63||
48096371|NCT03566823|100560389|FG002|STARTED|Overall Study||13||
48096372|NCT03566823|100560387|FG000|COMPLETED|Overall Study||4||
48541982|NCT01531439|101662822|FG001|COMPLETED|Overall Study||42||
48096373|NCT03566823|100560388|FG001|COMPLETED|Overall Study||12||
48389257|NCT05055570|101283371|FG000|NOT COMPLETED|Overall Study||0||
48389258|NCT05055570|101283372|FG001|NOT COMPLETED|Overall Study||0||
48389259|NCT00642018|101283373|FG000|STARTED|Overall Study||52||
48389260|NCT00642018|101283374|FG001|STARTED|Overall Study||102||
48389261|NCT00642018|101283373|FG000|Received at Least One Dose of Study Drug|Overall Study||51||
48389262|NCT00642018|101283374|FG001|Received at Least One Dose of Study Drug|Overall Study||98||
48096374|NCT03566823|100560389|FG002|COMPLETED|Overall Study||11||
48389263|NCT00642018|101283373|FG000|COMPLETED|Overall Study||24||
48389264|NCT00642018|101283374|FG001|COMPLETED|Overall Study||23||
48389265|NCT00642018|101283373|FG000|NOT COMPLETED|Overall Study||28||
48389266|NCT00642018|101283374|FG001|NOT COMPLETED|Overall Study||79||
48389267|NCT04682353|101283375|FG000|STARTED|Overall Study||16||
48389268|NCT04682353|101283376|FG001|STARTED|Overall Study||15||
48389269|NCT04682353|101283377|FG002|STARTED|Overall Study||14||
48389270|NCT04682353|101283378|FG003|STARTED|Overall Study||15||
48389271|NCT04682353|101283375|FG000|Received at Least 1 Dose of Study Drug|Overall Study||16||
48389272|NCT04682353|101283376|FG001|Received at Least 1 Dose of Study Drug|Overall Study||15||
48389273|NCT04682353|101283377|FG002|Received at Least 1 Dose of Study Drug|Overall Study||14||
48389274|NCT04682353|101283378|FG003|Received at Least 1 Dose of Study Drug|Overall Study||15||
48389275|NCT04682353|101283375|FG000|COMPLETED|Overall Study||16||
48389276|NCT04682353|101283376|FG001|COMPLETED|Overall Study||13||
48389277|NCT04682353|101283377|FG002|COMPLETED|Overall Study||14||
48389278|NCT04682353|101283378|FG003|COMPLETED|Overall Study||14||
48389279|NCT04682353|101283375|FG000|NOT COMPLETED|Overall Study||0||
48389280|NCT04682353|101283376|FG001|NOT COMPLETED|Overall Study||2||
48389281|NCT04682353|101283377|FG002|NOT COMPLETED|Overall Study||0||
48389282|NCT04682353|101283378|FG003|NOT COMPLETED|Overall Study||1||
48389283|NCT01117012|101283379|FG000|STARTED|Overall Study||89||
48389284|NCT01117012|101283380|FG001|STARTED|Overall Study||103||
48389285|NCT01117012|101283379|FG000|COMPLETED|Overall Study||81||
48389286|NCT01117012|101283380|FG001|COMPLETED|Overall Study||98||
48389287|NCT01117012|101283379|FG000|NOT COMPLETED|Overall Study||8||
48389288|NCT01117012|101283380|FG001|NOT COMPLETED|Overall Study||5||
48389289|NCT00418379|101283381|FG000|STARTED|Year 1||207||
48389290|NCT00418379|101283382|FG001|STARTED|Year 1||207||
48389291|NCT00418379|101283383|FG002|STARTED|Year 1||219||
48389292|NCT00418379|101283381|FG000|COMPLETED|Year 1||189||
48389293|NCT00418379|101283382|FG001|COMPLETED|Year 1||179||
48389294|NCT00418379|101283383|FG002|COMPLETED|Year 1||204||
48389295|NCT00418379|101283381|FG000|NOT COMPLETED|Year 1||18||
48389296|NCT00418379|101283382|FG001|NOT COMPLETED|Year 1||28||
48389297|NCT00418379|101283383|FG002|NOT COMPLETED|Year 1||15||
48389298|NCT00418379|101283381|FG000|STARTED|Year 2||167||
48389299|NCT00418379|101283382|FG001|STARTED|Year 2||159||
48389300|NCT00418379|101283383|FG002|STARTED|Year 2||182||
48389301|NCT00418379|101283381|FG000|COMPLETED|Year 2||159||
48389302|NCT00418379|101283382|FG001|COMPLETED|Year 2||155||
48389303|NCT00418379|101283383|FG002|COMPLETED|Year 2||172||
48389304|NCT00418379|101283381|FG000|NOT COMPLETED|Year 2||8||
48389305|NCT00418379|101283382|FG001|NOT COMPLETED|Year 2||4||
48389306|NCT00418379|101283383|FG002|NOT COMPLETED|Year 2||10||
48689713|NCT03326063|102022762|FG001|STARTED|Overall Study||18||
48389307|NCT00418379|101283381|FG000|STARTED|Year 3||151||
48389308|NCT00418379|101283382|FG001|STARTED|Year 3||148||
48389309|NCT00418379|101283383|FG002|STARTED|Year 3||166||
48389310|NCT00418379|101283381|FG000|COMPLETED|Year 3||148||
48389311|NCT00418379|101283382|FG001|COMPLETED|Year 3||146||
48389312|NCT00418379|101283383|FG002|COMPLETED|Year 3||163||
48389313|NCT00418379|101283381|FG000|NOT COMPLETED|Year 3||3||
48389314|NCT00418379|101283382|FG001|NOT COMPLETED|Year 3||2||
48389315|NCT00418379|101283383|FG002|NOT COMPLETED|Year 3||3||
48389316|NCT00418379|101283381|FG000|STARTED|Year 4||145||
48389317|NCT00418379|101283382|FG001|STARTED|Year 4||141||
48389318|NCT00418379|101283383|FG002|STARTED|Year 4||156||
48389319|NCT00418379|101283381|FG000|COMPLETED|Year 4||142||
48389320|NCT00418379|101283382|FG001|COMPLETED|Year 4||136||
48389321|NCT00418379|101283383|FG002|COMPLETED|Year 4||154||
48541983|NCT01531439|101662821|FG000|NOT COMPLETED|Overall Study||4||
48541984|NCT01531439|101662822|FG001|NOT COMPLETED|Overall Study||1||
48541985|NCT00025259|101662823|FG000|STARTED|Overall Study||52||
48541986|NCT00025259|101662824|FG001|STARTED|Overall Study||381||
48541987|NCT00025259|101662825|FG002|STARTED|Overall Study||382||
48541988|NCT00025259|101662826|FG003|STARTED|Overall Study||571||
48541989|NCT00025259|101662827|FG004|STARTED|Overall Study||42||
48389322|NCT00418379|101283381|FG000|NOT COMPLETED|Year 4||3||
48389323|NCT00418379|101283382|FG001|NOT COMPLETED|Year 4||5||
48389324|NCT00418379|101283383|FG002|NOT COMPLETED|Year 4||2||
48389325|NCT00418379|101283381|FG000|STARTED|Year 5||128||
48689714|NCT03326063|102022761|FG000|COMPLETED|Overall Study||17||
48389326|NCT00418379|101283382|FG001|STARTED|Year 5||120||
48389327|NCT00418379|101283383|FG002|STARTED|Year 5||134||
48389328|NCT00418379|101283381|FG000|COMPLETED|Year 5||126||
48389329|NCT00418379|101283382|FG001|COMPLETED|Year 5||115||
48389330|NCT00418379|101283383|FG002|COMPLETED|Year 5||131||
48389331|NCT00418379|101283381|FG000|NOT COMPLETED|Year 5||2||
48389332|NCT00418379|101283382|FG001|NOT COMPLETED|Year 5||5||
48389333|NCT00418379|101283383|FG002|NOT COMPLETED|Year 5||3||
48389334|NCT00377429|101283384|FG000|STARTED|Overall Study||47||
48389335|NCT00377429|101283384|FG000|COMPLETED|Overall Study||32||
48389336|NCT00377429|101283384|FG000|NOT COMPLETED|Overall Study||15||
48389337|NCT01673191|101283385|FG000|STARTED|Overall Study||26||
48689715|NCT03326063|102022762|FG001|COMPLETED|Overall Study||18||
48389338|NCT01673191|101283386|FG001|STARTED|Overall Study||11||
48389339|NCT01673191|101283385|FG000|COMPLETED|Overall Study||26||
48389340|NCT01673191|101283386|FG001|COMPLETED|Overall Study||11||
48389341|NCT01673191|101283385|FG000|NOT COMPLETED|Overall Study||0||
48389342|NCT01673191|101283386|FG001|NOT COMPLETED|Overall Study||0||
48389343|NCT00475540|101283387|FG000|STARTED|3 Months||32||
48389344|NCT00475540|101283388|FG001|STARTED|3 Months||33||
48389345|NCT00475540|101283387|FG000|COMPLETED|3 Months||32||
48389346|NCT00475540|101283388|FG001|COMPLETED|3 Months||33||
48389347|NCT00475540|101283387|FG000|NOT COMPLETED|3 Months||0||
48389348|NCT00475540|101283388|FG001|NOT COMPLETED|3 Months||0||
48389349|NCT00475540|101283387|FG000|STARTED|12 Months||32||
48389350|NCT00475540|101283388|FG001|STARTED|12 Months||33||
48389351|NCT00475540|101283387|FG000|COMPLETED|12 Months||32||
48389352|NCT00475540|101283388|FG001|COMPLETED|12 Months||33||
48389353|NCT00475540|101283387|FG000|NOT COMPLETED|12 Months||0||
48389354|NCT00475540|101283388|FG001|NOT COMPLETED|12 Months||0||
48389355|NCT00475540|101283387|FG000|STARTED|36 Months||33||
48389356|NCT00475540|101283388|FG001|STARTED|36 Months||32||
48389357|NCT00475540|101283387|FG000|COMPLETED|36 Months||25||
48389358|NCT00475540|101283388|FG001|COMPLETED|36 Months||26||
48389359|NCT00475540|101283387|FG000|NOT COMPLETED|36 Months||8||
48389360|NCT00475540|101283388|FG001|NOT COMPLETED|36 Months||6||
48389361|NCT02835677|101283389|FG000|STARTED|Overall Study||25||
48389362|NCT02835677|101283389|FG000|COMPLETED|Overall Study||25||
48389363|NCT02835677|101283389|FG000|NOT COMPLETED|Overall Study||0||
48389364|NCT00631540|101283390|FG000|STARTED|Overall Study||100||
48389365|NCT00631540|101283390|FG000|COMPLETED|Overall Study||86||
48389366|NCT00631540|101283390|FG000|NOT COMPLETED|Overall Study||14||
48389367|NCT05128682|101283391|FG000|STARTED|Overall Study||4||
48389368|NCT05128682|101283391|FG000|COMPLETED|Overall Study||4||
48389369|NCT05128682|101283391|FG000|NOT COMPLETED|Overall Study||0||
48389370|NCT02451202|101283392|FG000|STARTED|Overall Study||51||
48389371|NCT02451202|101283393|FG001|STARTED|Overall Study||51||
48389372|NCT02451202|101283392|FG000|COMPLETED|Overall Study||49||
48389373|NCT02451202|101283393|FG001|COMPLETED|Overall Study||48||
48389374|NCT02451202|101283392|FG000|NOT COMPLETED|Overall Study||2||
48389375|NCT02451202|101283393|FG001|NOT COMPLETED|Overall Study||3||
48389376|NCT05064332|101283394|FG000|STARTED|Period 1||10||
48389377|NCT05064332|101283394|FG000|COMPLETED|Period 1||10||
48389378|NCT05064332|101283394|FG000|NOT COMPLETED|Period 1||0||
48389379|NCT05064332|101283394|FG000|STARTED|Period 2||10||
48389380|NCT05064332|101283394|FG000|COMPLETED|Period 2||10||
48389381|NCT05064332|101283394|FG000|NOT COMPLETED|Period 2||0||
48389382|NCT03726333|101283395|FG000|STARTED|Overall Study||0||
48389383|NCT03726333|101283396|FG001|STARTED|Overall Study||0||
48389384|NCT03726333|101283397|FG002|STARTED|Overall Study||1||
48389385|NCT03726333|101283398|FG003|STARTED|Overall Study||0||
48389386|NCT03726333|101283399|FG004|STARTED|Overall Study||0||
48389387|NCT03726333|101283395|FG000|COMPLETED|Overall Study||0||
48389388|NCT03726333|101283396|FG001|COMPLETED|Overall Study||0||
48389389|NCT03726333|101283397|FG002|COMPLETED|Overall Study||0||
48389390|NCT03726333|101283398|FG003|COMPLETED|Overall Study||0||
48389391|NCT03726333|101283399|FG004|COMPLETED|Overall Study||0||
48389392|NCT03726333|101283395|FG000|NOT COMPLETED|Overall Study||0||
48389393|NCT03726333|101283396|FG001|NOT COMPLETED|Overall Study||0||
48389394|NCT03726333|101283397|FG002|NOT COMPLETED|Overall Study||1||
48389395|NCT03726333|101283398|FG003|NOT COMPLETED|Overall Study||0||
48389396|NCT03726333|101283399|FG004|NOT COMPLETED|Overall Study||0||
48389397|NCT01654523|101283400|FG000|STARTED|Overall Study||20||
48389398|NCT01654523|101283400|FG000|COMPLETED|Overall Study||19||
48389399|NCT01654523|101283400|FG000|NOT COMPLETED|Overall Study||1||
48389400|NCT02007954|101283401|FG000|STARTED|Overall Study||24||
48389401|NCT02007954|101283401|FG000|Completed First TACE|Overall Study||24|Number of patients who completed the first treatment on protocol and included in analysis|
48389402|NCT02007954|101283401|FG000|Completed First Clinical and Imaging|Overall Study||23|Participants completing this milestone will be analyzed for image response outcomes|
48389403|NCT02007954|101283401|FG000|COMPLETED|Overall Study||17|Participants who have completed all 6 months of treatment on trial|
48389404|NCT02007954|101283401|FG000|NOT COMPLETED|Overall Study||7||
48389405|NCT00304915|101283402|FG000|STARTED|Overall Study||123||
48389406|NCT00304915|101283403|FG001|STARTED|Overall Study||126||
48389407|NCT00304915|101283402|FG000|COMPLETED|Overall Study||105||
48389408|NCT00304915|101283403|FG001|COMPLETED|Overall Study||110||
48389409|NCT00304915|101283402|FG000|NOT COMPLETED|Overall Study||18||
48389410|NCT00304915|101283403|FG001|NOT COMPLETED|Overall Study||16||
48389411|NCT03248947|101283404|FG000|STARTED|Overall Study||71||
48389412|NCT03248947|101283404|FG000|COMPLETED|Overall Study||63||
48389413|NCT03248947|101283404|FG000|NOT COMPLETED|Overall Study||8||
48389414|NCT00862121|101283405|FG000|STARTED|Overall Study||8||
48389415|NCT00862121|101283406|FG001|STARTED|Overall Study||12||
48389416|NCT00862121|101283405|FG000|Full Analysis Set (FAS)|Overall Study||7||
48389417|NCT00862121|101283406|FG001|Full Analysis Set (FAS)|Overall Study||11||
48389418|NCT00862121|101283405|FG000|Safety Analysis Set|Overall Study||8||
48389419|NCT00862121|101283406|FG001|Safety Analysis Set|Overall Study||11||
48389420|NCT00862121|101283405|FG000|COMPLETED|Overall Study||7||
48389421|NCT00862121|101283406|FG001|COMPLETED|Overall Study||4||
48389422|NCT00862121|101283405|FG000|NOT COMPLETED|Overall Study||1||
48389423|NCT00862121|101283406|FG001|NOT COMPLETED|Overall Study||8||
48389424|NCT00120289|101283407|FG000|STARTED|Overall Study||1718||
48389425|NCT00120289|101283408|FG001|STARTED|Overall Study||1696||
48389426|NCT00120289|101283407|FG000|COMPLETED|Overall Study||1597||
48389427|NCT00120289|101283408|FG001|COMPLETED|Overall Study||1587||
48389428|NCT00120289|101283407|FG000|NOT COMPLETED|Overall Study||121||
48389429|NCT00120289|101283408|FG001|NOT COMPLETED|Overall Study||109||
48389430|NCT00839423|101283409|FG000|STARTED|Overall Study||105||
48389431|NCT00839423|101283410|FG001|STARTED|Overall Study||108||
48389432|NCT00839423|101283411|FG002|STARTED|Overall Study||100||
48389433|NCT00839423|101283412|FG003|STARTED|Overall Study||113||
48389434|NCT00839423|101283409|FG000|COMPLETED|Overall Study||87||
48389435|NCT00839423|101283410|FG001|COMPLETED|Overall Study||98||
48389436|NCT00839423|101283411|FG002|COMPLETED|Overall Study||82||
48389437|NCT00839423|101283412|FG003|COMPLETED|Overall Study||93||
48389438|NCT00839423|101283409|FG000|NOT COMPLETED|Overall Study||18||
48389439|NCT00839423|101283410|FG001|NOT COMPLETED|Overall Study||10||
48689716|NCT03326063|102022761|FG000|NOT COMPLETED|Overall Study||1||
48689717|NCT03326063|102022762|FG001|NOT COMPLETED|Overall Study||0||
48689718|NCT03046446|102022763|FG000|STARTED|Overall Study||208||
48689719|NCT03046446|102022763|FG000|Second Injection|Overall Study||179|1 patient received 2nd injection after week 24 and is not included in the efficacy data analysis.|
48689720|NCT03046446|102022763|FG000|Completed at Week 12|Overall Study||10||
48689721|NCT03046446|102022763|FG000|Completed at Week 24|Overall Study||6||
48689722|NCT03046446|102022763|FG000|Completed at Week 52|Overall Study||133||
48689723|NCT03046446|102022763|FG000|COMPLETED|Overall Study||149||
48689724|NCT03046446|102022763|FG000|NOT COMPLETED|Overall Study||59||
48689725|NCT04512001|102022764|FG000|STARTED|Week 0 to Week 24||302||
48689726|NCT04512001|102022765|FG001|STARTED|Week 0 to Week 24||302||
48689727|NCT04512001|102022766|FG002|STARTED|Week 0 to Week 24||0||
48689728|NCT04512001|102022767|FG003|STARTED|Week 0 to Week 24||0||
48260045|NCT00550446|100958836|FG000|NOT COMPLETED|Post Week 12||3||
48260046|NCT00550446|100958837|FG001|NOT COMPLETED|Post Week 12||2||
48260047|NCT00550446|100958838|FG002|NOT COMPLETED|Post Week 12||3||
48260048|NCT00550446|100958839|FG003|NOT COMPLETED|Post Week 12||3||
48260049|NCT00550446|100958840|FG004|NOT COMPLETED|Post Week 12||2||
48260050|NCT00550446|100958841|FG005|NOT COMPLETED|Post Week 12||1||
48260051|NCT00550446|100958842|FG006|NOT COMPLETED|Post Week 12||2||
48260052|NCT00550446|100958843|FG007|NOT COMPLETED|Post Week 12||1||
48260053|NCT00550446|100958844|FG008|NOT COMPLETED|Post Week 12||2||
48260054|NCT00550446|100958845|FG009|NOT COMPLETED|Post Week 12||7||
48260055|NCT00550446|100958846|FG010|NOT COMPLETED|Post Week 12||1||
48260056|NCT02031536|100958847|FG000|STARTED|Overall Study||2||
48260057|NCT02031536|100958848|FG001|STARTED|Overall Study||0||
48260058|NCT02031536|100958847|FG000|COMPLETED|Overall Study||1||
48260059|NCT02031536|100958848|FG001|COMPLETED|Overall Study||0||
48260060|NCT02031536|100958847|FG000|NOT COMPLETED|Overall Study||1||
48260061|NCT02031536|100958848|FG001|NOT COMPLETED|Overall Study||0||
48260062|NCT00908349|100958849|FG000|STARTED|Overall Study||214||
48260063|NCT00908349|100958849|FG000|COMPLETED|Overall Study||179||
48260064|NCT00908349|100958849|FG000|NOT COMPLETED|Overall Study||35||
48260065|NCT01657799|100958850|FG000|STARTED|Overall Study||102||
48260066|NCT01657799|100958851|FG001|STARTED|Overall Study||103||
48260067|NCT01657799|100958852|FG002|STARTED|Overall Study||102||
48260068|NCT01657799|100958850|FG000|Received Treatment|Overall Study||101||
48260069|NCT01657799|100958851|FG001|Received Treatment|Overall Study||103||
48260070|NCT01657799|100958852|FG002|Received Treatment|Overall Study||102||
48260071|NCT01657799|100958850|FG000|COMPLETED|Overall Study||0||
48260072|NCT01657799|100958851|FG001|COMPLETED|Overall Study||0||
48260073|NCT01657799|100958852|FG002|COMPLETED|Overall Study||0||
48260074|NCT01657799|100958850|FG000|NOT COMPLETED|Overall Study||102||
48260075|NCT01657799|100958851|FG001|NOT COMPLETED|Overall Study||103||
48260076|NCT01657799|100958852|FG002|NOT COMPLETED|Overall Study||102||
48260077|NCT00598871|100958853|FG000|STARTED|Overall Study||3||
48260078|NCT00598871|100958854|FG001|STARTED|Overall Study||9||
48260079|NCT00598871|100958853|FG000|COMPLETED|Overall Study||3||
48260080|NCT00598871|100958854|FG001|COMPLETED|Overall Study||8||
48260081|NCT00598871|100958853|FG000|NOT COMPLETED|Overall Study||0||
48260082|NCT00598871|100958854|FG001|NOT COMPLETED|Overall Study||1||
48260083|NCT00569010|100958855|FG000|STARTED|Overall Study||6||
48260084|NCT00569010|100958856|FG001|STARTED|Overall Study||6||
48260085|NCT00569010|100958857|FG002|STARTED|Overall Study||11||
48260086|NCT00569010|100958858|FG003|STARTED|Overall Study||11||
48260087|NCT00569010|100958855|FG000|COMPLETED|Overall Study||6||
48260088|NCT00569010|100958856|FG001|COMPLETED|Overall Study||6||
48260089|NCT00569010|100958857|FG002|COMPLETED|Overall Study||11||
48260090|NCT00569010|100958858|FG003|COMPLETED|Overall Study||11||
48389440|NCT00839423|101283411|FG002|NOT COMPLETED|Overall Study||18||
48389441|NCT00839423|101283412|FG003|NOT COMPLETED|Overall Study||20||
48389442|NCT03558191|101283413|FG000|STARTED|Overall Study||156||
48389443|NCT03558191|101283413|FG000|Treated|Overall Study||156||
48689729|NCT04512001|102022768|FG004|STARTED|Week 0 to Week 24||0||
48689730|NCT04512001|102022764|FG000|Received Treatment|Week 0 to Week 24||302||
48710796|NCT01012921|102078022|FG001|STARTED|Overall Study||60||
48260091|NCT00569010|100958855|FG000|NOT COMPLETED|Overall Study||0||
48260092|NCT00569010|100958856|FG001|NOT COMPLETED|Overall Study||0||
48260093|NCT00569010|100958857|FG002|NOT COMPLETED|Overall Study||0||
48260094|NCT00569010|100958858|FG003|NOT COMPLETED|Overall Study||0||
48260095|NCT02542410|100958859|FG000|STARTED|Overall Study||5||
48260096|NCT02542410|100958860|FG001|STARTED|Overall Study||5||
48260097|NCT02542410|100958859|FG000|COMPLETED|Overall Study||3||
48260098|NCT02542410|100958860|FG001|COMPLETED|Overall Study||4||
48389444|NCT03558191|101283413|FG000|COMPLETED|Overall Study||131||
48389445|NCT03558191|101283413|FG000|NOT COMPLETED|Overall Study||25||
48389446|NCT00270998|101283414|FG000|STARTED|3 Month Follow-up||149||
48389447|NCT00270998|101283415|FG001|STARTED|3 Month Follow-up||146||
48389448|NCT00270998|101283416|FG002|STARTED|3 Month Follow-up||150||
48389449|NCT00270998|101283414|FG000|COMPLETED|3 Month Follow-up||110||
48389450|NCT00270998|101283415|FG001|COMPLETED|3 Month Follow-up||124||
48389451|NCT00270998|101283416|FG002|COMPLETED|3 Month Follow-up||132||
48389452|NCT00270998|101283414|FG000|NOT COMPLETED|3 Month Follow-up||39||
48389453|NCT00270998|101283415|FG001|NOT COMPLETED|3 Month Follow-up||22||
48389454|NCT00270998|101283416|FG002|NOT COMPLETED|3 Month Follow-up||18||
48389455|NCT00270998|101283414|FG000|STARTED|12 Month Follow-up||110||
48389456|NCT00270998|101283415|FG001|STARTED|12 Month Follow-up||124||
48389457|NCT00270998|101283416|FG002|STARTED|12 Month Follow-up||132||
48389458|NCT00270998|101283414|FG000|COMPLETED|12 Month Follow-up||96||
48389459|NCT00270998|101283415|FG001|COMPLETED|12 Month Follow-up||99||
48389460|NCT00270998|101283416|FG002|COMPLETED|12 Month Follow-up||111||
48389461|NCT00270998|101283414|FG000|NOT COMPLETED|12 Month Follow-up||14||
48389462|NCT00270998|101283415|FG001|NOT COMPLETED|12 Month Follow-up||25||
48389463|NCT00270998|101283416|FG002|NOT COMPLETED|12 Month Follow-up||21||
48389464|NCT01188096|101283417|FG000|STARTED|Overall Study||23||
48389465|NCT01188096|101283417|FG000|COMPLETED|Overall Study||17||
48389466|NCT01188096|101283417|FG000|NOT COMPLETED|Overall Study||6||
48389467|NCT01033487|101283418|FG000|STARTED|First Intervention Period||2||
48260099|NCT02542410|100958859|FG000|NOT COMPLETED|Overall Study||2||
48260100|NCT02542410|100958860|FG001|NOT COMPLETED|Overall Study||1||
48260101|NCT00943722|100958861|FG000|STARTED|Base Study||648||
48260102|NCT00943722|100958862|FG001|STARTED|Base Study||643||
48260103|NCT00943722|100958863|FG002|STARTED|Base Study||644||
48260104|NCT00943722|100958864|FG003|STARTED|Base Study||669||
48260105|NCT00943722|100958865|FG004|STARTED|Base Study||470||
48260106|NCT00943722|100958866|FG005|STARTED|Base Study||0||
48260107|NCT00943722|100958867|FG006|STARTED|Base Study||0||
48260108|NCT00943722|100958861|FG000|Vaccination 1|Base Study||646||
48260109|NCT00943722|100958862|FG001|Vaccination 1|Base Study||642||
48260110|NCT00943722|100958863|FG002|Vaccination 1|Base Study||644||
48260111|NCT00943722|100958864|FG003|Vaccination 1|Base Study||666||
48260112|NCT00943722|100958865|FG004|Vaccination 1|Base Study||468||
48260113|NCT00943722|100958866|FG005|Vaccination 1|Base Study||0||
48260114|NCT00943722|100958867|FG006|Vaccination 1|Base Study||0||
48260115|NCT00943722|100958861|FG000|Vaccination 2|Base Study||637||
48260116|NCT00943722|100958862|FG001|Vaccination 2|Base Study||633||
48260117|NCT00943722|100958863|FG002|Vaccination 2|Base Study||638||
48389468|NCT01033487|101283419|FG001|STARTED|First Intervention Period||3||
48389469|NCT01033487|101283420|FG002|STARTED|First Intervention Period||2||
48389470|NCT01033487|101283421|FG003|STARTED|First Intervention Period||2||
48389471|NCT01033487|101283422|FG004|STARTED|First Intervention Period||2||
48389472|NCT01033487|101283423|FG005|STARTED|First Intervention Period||2||
48389473|NCT01033487|101283424|FG006|STARTED|First Intervention Period||2||
48389474|NCT01033487|101283425|FG007|STARTED|First Intervention Period||3||
48389475|NCT01033487|101283426|FG008|STARTED|First Intervention Period||2||
48389476|NCT01033487|101283427|FG009|STARTED|First Intervention Period||2||
48389477|NCT01033487|101283418|FG000|COMPLETED|First Intervention Period||2||
48389478|NCT01033487|101283419|FG001|COMPLETED|First Intervention Period||3||
48389479|NCT01033487|101283420|FG002|COMPLETED|First Intervention Period||2||
48389480|NCT01033487|101283421|FG003|COMPLETED|First Intervention Period||2||
48389481|NCT01033487|101283422|FG004|COMPLETED|First Intervention Period||2||
48389482|NCT01033487|101283423|FG005|COMPLETED|First Intervention Period||2||
48389483|NCT01033487|101283424|FG006|COMPLETED|First Intervention Period||2||
48389484|NCT01033487|101283425|FG007|COMPLETED|First Intervention Period||3||
48389485|NCT01033487|101283426|FG008|COMPLETED|First Intervention Period||2||
48260118|NCT00943722|100958864|FG003|Vaccination 2|Base Study||658||
48260119|NCT00943722|100958865|FG004|Vaccination 2|Base Study||462||
48260120|NCT00943722|100958866|FG005|Vaccination 2|Base Study||0||
48260121|NCT00943722|100958867|FG006|Vaccination 2|Base Study||0||
48260122|NCT00943722|100958861|FG000|Vaccination 3|Base Study||635||
48260123|NCT00943722|100958862|FG001|Vaccination 3|Base Study||627||
48389486|NCT01033487|101283427|FG009|COMPLETED|First Intervention Period||2||
48389487|NCT01033487|101283418|FG000|NOT COMPLETED|First Intervention Period||0||
48389488|NCT01033487|101283419|FG001|NOT COMPLETED|First Intervention Period||0||
48389489|NCT01033487|101283420|FG002|NOT COMPLETED|First Intervention Period||0||
48389490|NCT01033487|101283421|FG003|NOT COMPLETED|First Intervention Period||0||
48389491|NCT01033487|101283422|FG004|NOT COMPLETED|First Intervention Period||0||
48389492|NCT01033487|101283423|FG005|NOT COMPLETED|First Intervention Period||0||
48541990|NCT00025259|101662828|FG005|STARTED|Overall Study||153||
48389493|NCT01033487|101283424|FG006|NOT COMPLETED|First Intervention Period||0||
48389494|NCT01033487|101283425|FG007|NOT COMPLETED|First Intervention Period||0||
48260124|NCT00943722|100958863|FG002|Vaccination 3|Base Study||637||
48260125|NCT00943722|100958864|FG003|Vaccination 3|Base Study||653||
48260126|NCT00943722|100958865|FG004|Vaccination 3|Base Study||455||
48260127|NCT00943722|100958866|FG005|Vaccination 3|Base Study||0||
48260128|NCT00943722|100958867|FG006|Vaccination 3|Base Study||0||
48260129|NCT00943722|100958861|FG000|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||643||
48260130|NCT00943722|100958862|FG001|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||639||
48260131|NCT00943722|100958863|FG002|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||641||
48260132|NCT00943722|100958864|FG003|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||662||
48260133|NCT00943722|100958865|FG004|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||466||
48260134|NCT00943722|100958866|FG005|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||0||
48260135|NCT00943722|100958867|FG006|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||0||
48260136|NCT00943722|100958861|FG000|COMPLETED|Base Study||623||
48260137|NCT00943722|100958862|FG001|COMPLETED|Base Study||621||
48260138|NCT00943722|100958863|FG002|COMPLETED|Base Study||631||
48260139|NCT00943722|100958864|FG003|COMPLETED|Base Study||647||
48260140|NCT00943722|100958865|FG004|COMPLETED|Base Study||444||
48260141|NCT00943722|100958866|FG005|COMPLETED|Base Study||0||
48260142|NCT00943722|100958867|FG006|COMPLETED|Base Study||0||
48260143|NCT00943722|100958861|FG000|NOT COMPLETED|Base Study||25||
48260144|NCT00943722|100958862|FG001|NOT COMPLETED|Base Study||22||
48260145|NCT00943722|100958863|FG002|NOT COMPLETED|Base Study||13||
48260146|NCT00943722|100958864|FG003|NOT COMPLETED|Base Study||22||
48260147|NCT00943722|100958865|FG004|NOT COMPLETED|Base Study||26||
48260148|NCT00943722|100958866|FG005|NOT COMPLETED|Base Study||0||
48260149|NCT00943722|100958867|FG006|NOT COMPLETED|Base Study||0||
48260150|NCT00943722|100958861|FG000|STARTED|First Extension Study: EXT 1||0|The optional EXT1 included eligible participants from the base study, with the exception of 16-26 year old females.|
48260151|NCT00943722|100958862|FG001|STARTED|First Extension Study: EXT 1||0|The optional EXT1 included eligible participants from the base study, with the exception of 16-26 year old females.|
48260152|NCT00943722|100958863|FG002|STARTED|First Extension Study: EXT 1||0|The optional EXT1 included eligible participants from the base study, with the exception of 16-26 year old females.|
48260153|NCT00943722|100958864|FG003|STARTED|First Extension Study: EXT 1||0|The optional EXT1 included eligible participants from the base study, with the exception of 16-26 year old females.|
48260154|NCT00943722|100958865|FG004|STARTED|First Extension Study: EXT 1||0|The optional EXT1 included eligible participants from the base study, with the exception of 16-26 year old females.|
48260155|NCT00943722|100958866|FG005|STARTED|First Extension Study: EXT 1||1604|The optional EXT1 included eligible participants from the base study, with the exception of 16-26 year old females.|
48260156|NCT00943722|100958867|FG006|STARTED|First Extension Study: EXT 1||568|The optional EXT1 included eligible participants from the base study, with the exception of 16-26 year old females.|
48260157|NCT00943722|100958861|FG000|COMPLETED|First Extension Study: EXT 1||0||
48260158|NCT00943722|100958862|FG001|COMPLETED|First Extension Study: EXT 1||0||
48260159|NCT00943722|100958863|FG002|COMPLETED|First Extension Study: EXT 1||0||
48260160|NCT00943722|100958864|FG003|COMPLETED|First Extension Study: EXT 1||0||
48260161|NCT00943722|100958865|FG004|COMPLETED|First Extension Study: EXT 1||0||
48260162|NCT00943722|100958866|FG005|COMPLETED|First Extension Study: EXT 1||1489||
48260163|NCT00943722|100958867|FG006|COMPLETED|First Extension Study: EXT 1||527||
48260164|NCT00943722|100958861|FG000|NOT COMPLETED|First Extension Study: EXT 1||0||
48260165|NCT00943722|100958862|FG001|NOT COMPLETED|First Extension Study: EXT 1||0||
48260166|NCT00943722|100958863|FG002|NOT COMPLETED|First Extension Study: EXT 1||0||
48260167|NCT00943722|100958864|FG003|NOT COMPLETED|First Extension Study: EXT 1||0||
48260168|NCT00943722|100958865|FG004|NOT COMPLETED|First Extension Study: EXT 1||0||
48260169|NCT00943722|100958866|FG005|NOT COMPLETED|First Extension Study: EXT 1||115||
48260170|NCT00943722|100958867|FG006|NOT COMPLETED|First Extension Study: EXT 1||41||
48260171|NCT00943722|100958861|FG000|STARTED|Second Extension Study: EXT 2||0|The optional EXT2 included eligible participants from the base study, with the exception of 16-26 year old females.|
48260172|NCT00943722|100958862|FG001|STARTED|Second Extension Study: EXT 2||0|The optional EXT2 included eligible participants from the base study, with the exception of 16-26 year old females.|
48260173|NCT00943722|100958863|FG002|STARTED|Second Extension Study: EXT 2||0|The optional EXT2 included eligible participants from the base study, with the exception of 16-26 year old females.|
48260174|NCT00943722|100958864|FG003|STARTED|Second Extension Study: EXT 2||0|The optional EXT2 included eligible participants from the base study, with the exception of 16-26 year old females.|
48260175|NCT00943722|100958865|FG004|STARTED|Second Extension Study: EXT 2||0|The optional EXT2 included eligible participants from the base study, with the exception of 16-26 year old females.|
48260176|NCT00943722|100958866|FG005|STARTED|Second Extension Study: EXT 2||971|The optional EXT2 included eligible participants from the base study, with the exception of 16-26 year old females.|
48294146|NCT02527343|101047538|FG002|COMPLETED|OLE Period-Year 1: Week 53 to 104||0||
48389495|NCT01033487|101283426|FG008|NOT COMPLETED|First Intervention Period||0||
48389496|NCT01033487|101283427|FG009|NOT COMPLETED|First Intervention Period||0||
48389497|NCT01033487|101283418|FG000|STARTED|Between Period 1 and 2 (At Least 7 Days)||2||
48389498|NCT01033487|101283419|FG001|STARTED|Between Period 1 and 2 (At Least 7 Days)||3||
48389499|NCT01033487|101283420|FG002|STARTED|Between Period 1 and 2 (At Least 7 Days)||2||
48389500|NCT01033487|101283421|FG003|STARTED|Between Period 1 and 2 (At Least 7 Days)||2||
48260177|NCT00943722|100958867|FG006|STARTED|Second Extension Study: EXT 2||301|The optional EXT2 included eligible participants from the base study, with the exception of 16-26 year old females.|
48260178|NCT00943722|100958861|FG000|COMPLETED|Second Extension Study: EXT 2||0||
48260179|NCT00943722|100958862|FG001|COMPLETED|Second Extension Study: EXT 2||0||
48260180|NCT00943722|100958863|FG002|COMPLETED|Second Extension Study: EXT 2||0||
48260181|NCT00943722|100958864|FG003|COMPLETED|Second Extension Study: EXT 2||0||
48260182|NCT00943722|100958865|FG004|COMPLETED|Second Extension Study: EXT 2||0||
48260183|NCT00943722|100958866|FG005|COMPLETED|Second Extension Study: EXT 2||720||
48260184|NCT00943722|100958867|FG006|COMPLETED|Second Extension Study: EXT 2||202||
48260185|NCT00943722|100958861|FG000|NOT COMPLETED|Second Extension Study: EXT 2||0||
48260186|NCT00943722|100958862|FG001|NOT COMPLETED|Second Extension Study: EXT 2||0||
48260187|NCT00943722|100958863|FG002|NOT COMPLETED|Second Extension Study: EXT 2||0||
48260188|NCT00943722|100958864|FG003|NOT COMPLETED|Second Extension Study: EXT 2||0||
48260189|NCT00943722|100958865|FG004|NOT COMPLETED|Second Extension Study: EXT 2||0||
48389501|NCT01033487|101283422|FG004|STARTED|Between Period 1 and 2 (At Least 7 Days)||2||
48389502|NCT01033487|101283423|FG005|STARTED|Between Period 1 and 2 (At Least 7 Days)||2||
48389503|NCT01033487|101283424|FG006|STARTED|Between Period 1 and 2 (At Least 7 Days)||2||
48389504|NCT01033487|101283425|FG007|STARTED|Between Period 1 and 2 (At Least 7 Days)||3||
48389505|NCT01033487|101283426|FG008|STARTED|Between Period 1 and 2 (At Least 7 Days)||2||
48260190|NCT00943722|100958866|FG005|NOT COMPLETED|Second Extension Study: EXT 2||251||
48260191|NCT00943722|100958867|FG006|NOT COMPLETED|Second Extension Study: EXT 2||99||
48260192|NCT02058836|100958868|FG000|STARTED|Overall Study||4||
48260193|NCT02058836|100958869|FG001|STARTED|Overall Study||4||
48260194|NCT02058836|100958868|FG000|COMPLETED|Overall Study||3||
48260195|NCT02058836|100958869|FG001|COMPLETED|Overall Study||3||
48260196|NCT02058836|100958868|FG000|NOT COMPLETED|Overall Study||1||
48260197|NCT02058836|100958869|FG001|NOT COMPLETED|Overall Study||1||
48260198|NCT01447576|100958870|FG000|STARTED|Overall Study||1036||
48389506|NCT01033487|101283427|FG009|STARTED|Between Period 1 and 2 (At Least 7 Days)||2||
48389507|NCT01033487|101283418|FG000|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2||
48389508|NCT01033487|101283419|FG001|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3||
48389509|NCT01033487|101283420|FG002|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2||
48260199|NCT01447576|100958870|FG000|COMPLETED|Overall Study||560||
48260200|NCT01447576|100958870|FG000|NOT COMPLETED|Overall Study||476||
48260201|NCT03082898|100958871|FG000|STARTED|Overall Study||27||
48260202|NCT03082898|100958872|FG001|STARTED|Overall Study||12||
48260203|NCT03082898|100958871|FG000|COMPLETED|Overall Study||24||
48260204|NCT03082898|100958872|FG001|COMPLETED|Overall Study||11||
48260205|NCT03082898|100958871|FG000|NOT COMPLETED|Overall Study||3||
48260206|NCT03082898|100958872|FG001|NOT COMPLETED|Overall Study||1||
48260207|NCT01473992|100958873|FG000|STARTED|Overall Study||10||
48260208|NCT01473992|100958874|FG001|STARTED|Overall Study||10||
48260209|NCT01473992|100958875|FG002|STARTED|Overall Study||5||
48260210|NCT01473992|100958873|FG000|COMPLETED|Overall Study||10||
48260211|NCT01473992|100958874|FG001|COMPLETED|Overall Study||10||
48260212|NCT01473992|100958875|FG002|COMPLETED|Overall Study||5||
48260213|NCT01473992|100958873|FG000|NOT COMPLETED|Overall Study||0||
48260214|NCT01473992|100958874|FG001|NOT COMPLETED|Overall Study||0||
48260215|NCT01473992|100958875|FG002|NOT COMPLETED|Overall Study||0||
48260216|NCT01772823|100958876|FG000|STARTED|Behavioral Intervention (BL -3MV or PCC)||128||
48260217|NCT01772823|100958877|FG001|STARTED|Behavioral Intervention (BL -3MV or PCC)||72||
48260218|NCT01772823|100958876|FG000|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||116||
48389510|NCT01033487|101283421|FG003|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2||
48389511|NCT01033487|101283422|FG004|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2||
48260219|NCT01772823|100958877|FG001|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||70||
48389512|NCT01033487|101283423|FG005|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2||
48260220|NCT01772823|100958876|FG000|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||12||
48260221|NCT01772823|100958877|FG001|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||2||
48260222|NCT01772823|100958876|FG000|STARTED|Treatment Phase (Week 0- Week 48)||116||
48389513|NCT01033487|101283424|FG006|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2||
48389514|NCT01033487|101283425|FG007|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3||
48389515|NCT01033487|101283426|FG008|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2||
48389516|NCT01033487|101283427|FG009|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2||
48389517|NCT01033487|101283418|FG000|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0||
48389518|NCT01033487|101283419|FG001|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0||
48389519|NCT01033487|101283420|FG002|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0||
48389520|NCT01033487|101283421|FG003|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0||
48389521|NCT01033487|101283422|FG004|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0||
48389522|NCT01033487|101283423|FG005|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0||
48389523|NCT01033487|101283424|FG006|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0||
48389524|NCT01033487|101283425|FG007|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0||
48389525|NCT01033487|101283426|FG008|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0||
48541991|NCT00025259|101662829|FG006|STARTED|Overall Study||153||
48260223|NCT01772823|100958877|FG001|STARTED|Treatment Phase (Week 0- Week 48)||70||
48389526|NCT01033487|101283427|FG009|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0||
48389527|NCT01033487|101283418|FG000|STARTED|Second Intervention Period||2||
48389528|NCT01033487|101283419|FG001|STARTED|Second Intervention Period||3||
48389529|NCT01033487|101283420|FG002|STARTED|Second Intervention Period||2||
48389530|NCT01033487|101283421|FG003|STARTED|Second Intervention Period||2||
48541992|NCT00025259|101662823|FG000|COMPLETED|Overall Study||7||
48541993|NCT00025259|101662824|FG001|COMPLETED|Overall Study||292||
48541994|NCT00025259|101662825|FG002|COMPLETED|Overall Study||301||
48541995|NCT00025259|101662826|FG003|COMPLETED|Overall Study||457||
48541996|NCT00025259|101662827|FG004|COMPLETED|Overall Study||6||
48541997|NCT00025259|101662828|FG005|COMPLETED|Overall Study||101||
48541998|NCT00025259|101662829|FG006|COMPLETED|Overall Study||102||
48541999|NCT00025259|101662823|FG000|NOT COMPLETED|Overall Study||45||
48542000|NCT00025259|101662824|FG001|NOT COMPLETED|Overall Study||89||
48542001|NCT00025259|101662825|FG002|NOT COMPLETED|Overall Study||81||
48542002|NCT00025259|101662826|FG003|NOT COMPLETED|Overall Study||114||
48542003|NCT00025259|101662827|FG004|NOT COMPLETED|Overall Study||36||
48542004|NCT00025259|101662828|FG005|NOT COMPLETED|Overall Study||52||
48542005|NCT00025259|101662829|FG006|NOT COMPLETED|Overall Study||51||
48096375|NCT03566823|100560387|FG000|NOT COMPLETED|Overall Study||2||
48389531|NCT01033487|101283422|FG004|STARTED|Second Intervention Period||2||
48542006|NCT03548337|101662830|FG000|STARTED|Infant Series||151||
48542007|NCT03548337|101662831|FG001|STARTED|Infant Series||150||
48542008|NCT03548337|101662830|FG000|Vaccination 1|Infant Series||150||
48542009|NCT03548337|101662831|FG001|Vaccination 1|Infant Series||150||
48542010|NCT03548337|101662830|FG000|Vaccination 2|Infant Series||144||
48542011|NCT03548337|101662831|FG001|Vaccination 2|Infant Series||144||
48542012|NCT03548337|101662830|FG000|Vaccination 3|Infant Series||144||
48542013|NCT03548337|101662831|FG001|Vaccination 3|Infant Series||141||
48542014|NCT03548337|101662830|FG000|COMPLETED|Infant Series||139||
48542015|NCT03548337|101662831|FG001|COMPLETED|Infant Series||139||
48542016|NCT03548337|101662830|FG000|NOT COMPLETED|Infant Series||12||
48542017|NCT03548337|101662831|FG001|NOT COMPLETED|Infant Series||11||
48542018|NCT03548337|101662830|FG000|STARTED|Toddler Dose||139||
48542019|NCT03548337|101662831|FG001|STARTED|Toddler Dose||139||
48542020|NCT03548337|101662830|FG000|Vaccination 4|Toddler Dose||139||
48542021|NCT03548337|101662831|FG001|Vaccination 4|Toddler Dose||139||
48542022|NCT03548337|101662830|FG000|COMPLETED|Toddler Dose||138||
48542023|NCT03548337|101662831|FG001|COMPLETED|Toddler Dose||138||
48542024|NCT03548337|101662830|FG000|NOT COMPLETED|Toddler Dose||1||
48542025|NCT03548337|101662831|FG001|NOT COMPLETED|Toddler Dose||1||
48542026|NCT01061476|101662832|FG000|STARTED|Overall Study||12||
48542027|NCT01061476|101662832|FG000|COMPLETED|Overall Study||12||
48542028|NCT01061476|101662832|FG000|NOT COMPLETED|Overall Study||0||
48542029|NCT05329259|101662833|FG000|STARTED|Vaccination Period||200||
48542030|NCT05329259|101662833|FG000|COMPLETED|Vaccination Period||200||
48542031|NCT05329259|101662833|FG000|NOT COMPLETED|Vaccination Period||0||
48542032|NCT05329259|101662833|FG000|STARTED|1-Month Follow-Up Period||200||
48542033|NCT05329259|101662833|FG000|COMPLETED|1-Month Follow-Up Period||200||
48542034|NCT05329259|101662833|FG000|NOT COMPLETED|1-Month Follow-Up Period||0||
48542035|NCT01326923|101662834|FG000|STARTED|Overall Study||7||
48542036|NCT01326923|101662834|FG000|COMPLETED|Overall Study||7||
48542037|NCT01326923|101662834|FG000|NOT COMPLETED|Overall Study||0||
48542038|NCT02901548|101662835|FG000|STARTED|Overall Study||17||
48542039|NCT02901548|101662835|FG000|COMPLETED|Overall Study||13||
48542040|NCT02901548|101662835|FG000|NOT COMPLETED|Overall Study||4||
48542041|NCT02764151|101662836|FG000|STARTED|Overall Study||2||
48389532|NCT01033487|101283423|FG005|STARTED|Second Intervention Period||2||
48542042|NCT02764151|101662837|FG001|STARTED|Overall Study||4||
48542043|NCT02764151|101662838|FG002|STARTED|Overall Study||3||
48542044|NCT02764151|101662839|FG003|STARTED|Overall Study||8||
48542045|NCT02764151|101662836|FG000|COMPLETED|Overall Study||2||
48542046|NCT02764151|101662837|FG001|COMPLETED|Overall Study||4||
48542047|NCT02764151|101662838|FG002|COMPLETED|Overall Study||3||
48542048|NCT02764151|101662839|FG003|COMPLETED|Overall Study||5||
48542049|NCT02764151|101662836|FG000|NOT COMPLETED|Overall Study||0||
48542050|NCT02764151|101662837|FG001|NOT COMPLETED|Overall Study||0||
48542051|NCT02764151|101662838|FG002|NOT COMPLETED|Overall Study||0||
48542052|NCT02764151|101662839|FG003|NOT COMPLETED|Overall Study||3||
48542053|NCT02865460|101662840|FG000|STARTED|Overall Study||51||
48389533|NCT01033487|101283424|FG006|STARTED|Second Intervention Period||2||
48542054|NCT02865460|101662841|FG001|STARTED|Overall Study||49||
48542055|NCT02865460|101662840|FG000|COMPLETED|Overall Study||41||
48389534|NCT01033487|101283425|FG007|STARTED|Second Intervention Period||3||
48542056|NCT02865460|101662841|FG001|COMPLETED|Overall Study||43||
48542057|NCT02865460|101662840|FG000|NOT COMPLETED|Overall Study||10||
48542058|NCT02865460|101662841|FG001|NOT COMPLETED|Overall Study||6||
48542059|NCT02564887|101662842|FG000|STARTED|Overall Study||16||
48542060|NCT02564887|101662843|FG001|STARTED|Overall Study||10||
48542061|NCT02564887|101662842|FG000|COMPLETED|Overall Study||10||
48542062|NCT02564887|101662843|FG001|COMPLETED|Overall Study||10||
48542063|NCT02564887|101662842|FG000|NOT COMPLETED|Overall Study||6||
48389535|NCT01033487|101283426|FG008|STARTED|Second Intervention Period||2||
48542064|NCT02564887|101662843|FG001|NOT COMPLETED|Overall Study||0||
48542065|NCT01027195|101662844|FG000|STARTED|Overall Study||71||
48542066|NCT01027195|101662845|FG001|STARTED|Overall Study||69||
48542067|NCT01027195|101662844|FG000|COMPLETED|Overall Study||71||
48542068|NCT01027195|101662845|FG001|COMPLETED|Overall Study||69||
48542069|NCT01027195|101662844|FG000|NOT COMPLETED|Overall Study||0||
48542070|NCT01027195|101662845|FG001|NOT COMPLETED|Overall Study||0||
48542071|NCT02520297|101662846|FG000|STARTED|Overall Study||1||
48542072|NCT02520297|101662846|FG000|COMPLETED|Overall Study||1||
48542073|NCT02520297|101662846|FG000|NOT COMPLETED|Overall Study||0||
48542074|NCT00548470|101662847|FG000|STARTED|Overall Study||14||
48542075|NCT00548470|101662847|FG000|COMPLETED|Overall Study||12||
48542076|NCT00548470|101662847|FG000|NOT COMPLETED|Overall Study||2||
48542077|NCT02455518|101662848|FG000|STARTED|Overall Study||104||
48542078|NCT02455518|101662849|FG001|STARTED|Overall Study||104||
48542079|NCT02455518|101662850|FG002|STARTED|Overall Study||104||
48542080|NCT02455518|101662851|FG003|STARTED|Overall Study||104||
48542081|NCT02455518|101662848|FG000|COMPLETED|Overall Study||104||
48542082|NCT02455518|101662849|FG001|COMPLETED|Overall Study||103||
48542083|NCT02455518|101662850|FG002|COMPLETED|Overall Study||103||
48542084|NCT02455518|101662851|FG003|COMPLETED|Overall Study||101||
48542085|NCT02455518|101662848|FG000|NOT COMPLETED|Overall Study||0||
48542086|NCT02455518|101662849|FG001|NOT COMPLETED|Overall Study||1||
48542087|NCT02455518|101662850|FG002|NOT COMPLETED|Overall Study||1||
48542088|NCT02455518|101662851|FG003|NOT COMPLETED|Overall Study||3||
48542089|NCT02421224|101662852|FG000|STARTED|Overall Study||444||12
48542090|NCT02421224|101662853|FG001|STARTED|Overall Study||397||11
48542091|NCT02421224|101662854|FG002|STARTED|Overall Study||508||11
48542092|NCT02421224|101662855|FG003|STARTED|Overall Study||482||11
48542093|NCT02421224|101662856|FG004|STARTED|Overall Study||495||11
48542094|NCT02421224|101662857|FG005|STARTED|Overall Study||515||11
48542095|NCT02421224|101662858|FG006|STARTED|Overall Study||489||11
48542096|NCT02421224|101662859|FG007|STARTED|Overall Study||364||11
48542097|NCT02421224|101662860|FG008|STARTED|Overall Study||496||12
48542098|NCT02421224|101662852|FG000|COMPLETED|Overall Study||442||12
48542099|NCT02421224|101662853|FG001|COMPLETED|Overall Study||394||11
48542100|NCT02421224|101662854|FG002|COMPLETED|Overall Study||507||11
48542101|NCT02421224|101662855|FG003|COMPLETED|Overall Study||479||11
48542102|NCT02421224|101662856|FG004|COMPLETED|Overall Study||491||11
48542103|NCT02421224|101662857|FG005|COMPLETED|Overall Study||513||11
48542104|NCT02421224|101662858|FG006|COMPLETED|Overall Study||489||11
48542105|NCT02421224|101662859|FG007|COMPLETED|Overall Study||362||11
48542106|NCT02421224|101662860|FG008|COMPLETED|Overall Study||495||12
48542107|NCT02421224|101662852|FG000|NOT COMPLETED|Overall Study||2||0
48542108|NCT02421224|101662853|FG001|NOT COMPLETED|Overall Study||3||0
48260224|NCT01772823|100958876|FG000|COMPLETED|Treatment Phase (Week 0- Week 48)||88||
48260225|NCT01772823|100958877|FG001|COMPLETED|Treatment Phase (Week 0- Week 48)||52||
48260226|NCT01772823|100958876|FG000|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||28||
48260227|NCT01772823|100958877|FG001|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||18||
48260228|NCT01772823|100958876|FG000|STARTED|Extension Phase (Visits 24,48wks Post tx||63||
48260229|NCT01772823|100958877|FG001|STARTED|Extension Phase (Visits 24,48wks Post tx||42||
48542109|NCT02421224|101662854|FG002|NOT COMPLETED|Overall Study||1||0
48542110|NCT02421224|101662855|FG003|NOT COMPLETED|Overall Study||3||0
48542111|NCT02421224|101662856|FG004|NOT COMPLETED|Overall Study||4||0
48542112|NCT02421224|101662857|FG005|NOT COMPLETED|Overall Study||2||0
48542113|NCT02421224|101662858|FG006|NOT COMPLETED|Overall Study||0||0
48542114|NCT02421224|101662859|FG007|NOT COMPLETED|Overall Study||2||0
48542115|NCT02421224|101662860|FG008|NOT COMPLETED|Overall Study||1||0
48542116|NCT02448368|101662861|FG000|STARTED|Overall Study||2||
48542117|NCT02448368|101662862|FG001|STARTED|Overall Study||2||
48542118|NCT02448368|101662863|FG002|STARTED|Overall Study||2||
48542119|NCT02448368|101662864|FG003|STARTED|Overall Study||2||
48542120|NCT02448368|101662865|FG004|STARTED|Overall Study||2||
48542121|NCT02448368|101662866|FG005|STARTED|Overall Study||2||
48542122|NCT02448368|101662867|FG006|STARTED|Overall Study||2||
48542123|NCT02448368|101662868|FG007|STARTED|Overall Study||2||
48542124|NCT02448368|101662869|FG008|STARTED|Overall Study||2||
48542125|NCT02448368|101662870|FG009|STARTED|Overall Study||2||
48542126|NCT02448368|101662871|FG010|STARTED|Overall Study||5||
48542127|NCT02448368|101662872|FG011|STARTED|Overall Study||5||
48542128|NCT02448368|101662873|FG012|STARTED|Overall Study||5||
48542129|NCT02448368|101662861|FG000|COMPLETED|Overall Study||2||
48542130|NCT02448368|101662862|FG001|COMPLETED|Overall Study||2||
48542131|NCT02448368|101662863|FG002|COMPLETED|Overall Study||2||
48542132|NCT02448368|101662864|FG003|COMPLETED|Overall Study||2||
48542133|NCT02448368|101662865|FG004|COMPLETED|Overall Study||2||
48542134|NCT02448368|101662866|FG005|COMPLETED|Overall Study||2||
48542135|NCT02448368|101662867|FG006|COMPLETED|Overall Study||2||
48542136|NCT02448368|101662868|FG007|COMPLETED|Overall Study||2||
48542137|NCT02448368|101662869|FG008|COMPLETED|Overall Study||2||
48542138|NCT02448368|101662870|FG009|COMPLETED|Overall Study||2||
48542139|NCT02448368|101662871|FG010|COMPLETED|Overall Study||5||
48542140|NCT02448368|101662872|FG011|COMPLETED|Overall Study||5||
48542141|NCT02448368|101662873|FG012|COMPLETED|Overall Study||5||
48542142|NCT02448368|101662861|FG000|NOT COMPLETED|Overall Study||0||
48542143|NCT02448368|101662862|FG001|NOT COMPLETED|Overall Study||0||
48542144|NCT02448368|101662863|FG002|NOT COMPLETED|Overall Study||0||
48542145|NCT02448368|101662864|FG003|NOT COMPLETED|Overall Study||0||
48542146|NCT02448368|101662865|FG004|NOT COMPLETED|Overall Study||0||
48542147|NCT02448368|101662866|FG005|NOT COMPLETED|Overall Study||0||
48542148|NCT02448368|101662867|FG006|NOT COMPLETED|Overall Study||0||
48542149|NCT02448368|101662868|FG007|NOT COMPLETED|Overall Study||0||
48542150|NCT02448368|101662869|FG008|NOT COMPLETED|Overall Study||0||
48542151|NCT02448368|101662870|FG009|NOT COMPLETED|Overall Study||0||
48542152|NCT02448368|101662871|FG010|NOT COMPLETED|Overall Study||0||
48542153|NCT02448368|101662872|FG011|NOT COMPLETED|Overall Study||0||
48542154|NCT02448368|101662873|FG012|NOT COMPLETED|Overall Study||0||
48542155|NCT02667067|101662874|FG000|STARTED|Overall Study||117||
48542156|NCT02667067|101662875|FG001|STARTED|Overall Study||150||
48542157|NCT02667067|101662874|FG000|COMPLETED|Overall Study||96||
48542158|NCT02667067|101662875|FG001|COMPLETED|Overall Study||139||
48542159|NCT02667067|101662874|FG000|NOT COMPLETED|Overall Study||21||
48542160|NCT02667067|101662875|FG001|NOT COMPLETED|Overall Study||11||
48542161|NCT00873457|101662876|FG000|STARTED|Overall Study||16||
48542162|NCT00873457|101662876|FG000|COMPLETED|Overall Study||16||
48542163|NCT00873457|101662876|FG000|NOT COMPLETED|Overall Study||0||
48542164|NCT03369197|101662877|FG000|STARTED|Overall Study||53||
48542165|NCT03369197|101662878|FG001|STARTED|Overall Study||58||
48542166|NCT03369197|101662877|FG000|COMPLETED|Overall Study||53||
48542167|NCT03369197|101662878|FG001|COMPLETED|Overall Study||58||
48542168|NCT03369197|101662877|FG000|NOT COMPLETED|Overall Study||0||
48542169|NCT03369197|101662878|FG001|NOT COMPLETED|Overall Study||0||
48542170|NCT00337181|101662879|FG000|STARTED|Overall Study||49||
48542171|NCT00337181|101662880|FG001|STARTED|Overall Study||65||
48542172|NCT00337181|101662879|FG000|COMPLETED|Overall Study||49||
48542173|NCT00337181|101662880|FG001|COMPLETED|Overall Study||65||
48542174|NCT00337181|101662879|FG000|NOT COMPLETED|Overall Study||0||
48542175|NCT00337181|101662880|FG001|NOT COMPLETED|Overall Study||0||
48542176|NCT04435184|101662881|FG000|STARTED|Overall Study||25||
48542177|NCT04435184|101662882|FG001|STARTED|Overall Study||25||
48542178|NCT04435184|101662881|FG000|COMPLETED|Overall Study||22||
48542179|NCT04435184|101662882|FG001|COMPLETED|Overall Study||20||
48542180|NCT04435184|101662881|FG000|NOT COMPLETED|Overall Study||3||
48542181|NCT04435184|101662882|FG001|NOT COMPLETED|Overall Study||5||
48542182|NCT04710979|101662883|FG000|STARTED|Overall Study||34||
48542183|NCT04710979|101662884|FG001|STARTED|Overall Study||34||
48542184|NCT04710979|101662883|FG000|Post-Intervention|Overall Study||31||
48542185|NCT04710979|101662884|FG001|Post-Intervention|Overall Study||26||
48542186|NCT04710979|101662883|FG000|3-Month Follow-Up|Overall Study||23||
48542187|NCT04710979|101662884|FG001|3-Month Follow-Up|Overall Study||28||
48542188|NCT04710979|101662883|FG000|COMPLETED|Overall Study||31||
48542189|NCT04710979|101662884|FG001|COMPLETED|Overall Study||30||
48542190|NCT04710979|101662883|FG000|NOT COMPLETED|Overall Study||3||
48542191|NCT04710979|101662884|FG001|NOT COMPLETED|Overall Study||4||
48542192|NCT00253448|101662885|FG000|STARTED|Overall Study||35||
48542193|NCT00253448|101662885|FG000|COMPLETED|Overall Study||34||
48542194|NCT00253448|101662885|FG000|NOT COMPLETED|Overall Study||1||
48542195|NCT02047734|101662886|FG000|STARTED|Overall Study||443||
48542196|NCT02047734|101662887|FG001|STARTED|Overall Study||443||
48542197|NCT02047734|101662888|FG002|STARTED|Overall Study||434||
48542198|NCT02047734|101662886|FG000|Received Treatment|Overall Study||441||
48542199|NCT02047734|101662887|FG001|Received Treatment|Overall Study||439||
48542200|NCT02047734|101662888|FG002|Received Treatment|Overall Study||433||
48542201|NCT02047734|101662886|FG000|COMPLETED|Overall Study||376|Completed study drug|
48542202|NCT02047734|101662887|FG001|COMPLETED|Overall Study||374|Completed study drug|
48542203|NCT02047734|101662888|FG002|COMPLETED|Overall Study||388|Completed study drug|
48542204|NCT02047734|101662886|FG000|NOT COMPLETED|Overall Study||67||
48542205|NCT02047734|101662887|FG001|NOT COMPLETED|Overall Study||69||
48542206|NCT02047734|101662888|FG002|NOT COMPLETED|Overall Study||46||
48542207|NCT04380961|101662889|FG000|STARTED|Overall Study||140||
48542208|NCT04380961|101662890|FG001|STARTED|Overall Study||72||
48542209|NCT04380961|101662889|FG000|Treated|Overall Study||139||
48542210|NCT04380961|101662890|FG001|Treated|Overall Study||70||
48542211|NCT04380961|101662889|FG000|Participants Who Entered the Follow-up Phase|Overall Study||118||
48542212|NCT04380961|101662890|FG001|Participants Who Entered the Follow-up Phase|Overall Study||57||
48542213|NCT04380961|101662889|FG000|COMPLETED|Overall Study||96||
48542214|NCT04380961|101662890|FG001|COMPLETED|Overall Study||43||
48542215|NCT04380961|101662889|FG000|NOT COMPLETED|Overall Study||44||
48542216|NCT04380961|101662890|FG001|NOT COMPLETED|Overall Study||29||
48542217|NCT00985491|101662891|FG000|STARTED|Overall Study||46||
48542218|NCT00985491|101662891|FG000|Received Device|Overall Study||43||
48542219|NCT00985491|101662891|FG000|COMPLETED|Overall Study||27||
48542220|NCT00985491|101662891|FG000|NOT COMPLETED|Overall Study||19||
48542221|NCT01855828|101662892|FG000|STARTED|Overall Study||50||
48542222|NCT01855828|101662892|FG000|COMPLETED|Overall Study||48||
48542223|NCT01855828|101662892|FG000|NOT COMPLETED|Overall Study||2||
48542224|NCT03007238|101662893|FG000|STARTED|Overall Study||10||
48260230|NCT01772823|100958876|FG000|COMPLETED|Extension Phase (Visits 24,48wks Post tx||53||
48260231|NCT01772823|100958877|FG001|COMPLETED|Extension Phase (Visits 24,48wks Post tx||33||
48260232|NCT01772823|100958876|FG000|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||10||
48260233|NCT01772823|100958877|FG001|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||9||
48260234|NCT01434680|100958878|FG000|STARTED|Overall Study||299||
48260235|NCT01434680|100958879|FG001|STARTED|Overall Study||268||
48260236|NCT01434680|100958880|FG002|STARTED|Overall Study||306||
48260237|NCT01434680|100958881|FG003|STARTED|Overall Study||119||
48260238|NCT01434680|100958878|FG000|COMPLETED|Overall Study||296||
48260239|NCT01434680|100958879|FG001|COMPLETED|Overall Study||266||
48260240|NCT01434680|100958880|FG002|COMPLETED|Overall Study||304||
48260241|NCT01434680|100958881|FG003|COMPLETED|Overall Study||119||
48260242|NCT01434680|100958878|FG000|NOT COMPLETED|Overall Study||3||
48260243|NCT01434680|100958879|FG001|NOT COMPLETED|Overall Study||2||
48260244|NCT01434680|100958880|FG002|NOT COMPLETED|Overall Study||2||
48260245|NCT01434680|100958881|FG003|NOT COMPLETED|Overall Study||0||
48260246|NCT03780010|100958882|FG000|STARTED|Overall Study||3||
48260247|NCT03780010|100958883|FG001|STARTED|Overall Study||12||
48260248|NCT03780010|100958882|FG000|COMPLETED|Overall Study||3||
48260249|NCT03780010|100958883|FG001|COMPLETED|Overall Study||12||
48260250|NCT03780010|100958882|FG000|NOT COMPLETED|Overall Study||0||
48260251|NCT03780010|100958883|FG001|NOT COMPLETED|Overall Study||0||
48260252|NCT03448536|100958884|FG000|STARTED|Overall Study||100||
48260253|NCT03448536|100958885|FG001|STARTED|Overall Study||101||
48260254|NCT03448536|100958884|FG000|Completed First Intervention|Overall Study||83|Per Protocol (PP) population|
48260255|NCT03448536|100958885|FG001|Completed First Intervention|Overall Study||78|Per Protocol (PP) population|
48260256|NCT03448536|100958884|FG000|Completed First Intervention|Overall Study||95|Safety population|
48260257|NCT03448536|100958885|FG001|Completed First Intervention|Overall Study||97|Safety population|
48260258|NCT03448536|100958884|FG000|Completed Second Intervention|Overall Study||82|Per Protocol (PP) population|
48260259|NCT03448536|100958885|FG001|Completed Second Intervention|Overall Study||87|Per Protocol (PP) population|
48260260|NCT03448536|100958884|FG000|COMPLETED|Overall Study||88|Completed second intervention in Safety population|
48260261|NCT03448536|100958885|FG001|COMPLETED|Overall Study||97|Completed second intervention in Safety population|
48260262|NCT03448536|100958884|FG000|NOT COMPLETED|Overall Study||12||
48260263|NCT03448536|100958885|FG001|NOT COMPLETED|Overall Study||4||
48260264|NCT00803777|100958886|FG000|STARTED|Overall Study||147||
48260265|NCT00803777|100958886|FG000|COMPLETED|Overall Study||147||
48260266|NCT00803777|100958886|FG000|NOT COMPLETED|Overall Study||0||
48260267|NCT01993849|100958887|FG000|STARTED|Overall Study||12||
48260268|NCT01993849|100958888|FG001|STARTED|Overall Study||11||
48260269|NCT01993849|100958887|FG000|COMPLETED|Overall Study||9||
48260270|NCT01993849|100958888|FG001|COMPLETED|Overall Study||9||
48260271|NCT01993849|100958887|FG000|NOT COMPLETED|Overall Study||3||
48260272|NCT01993849|100958888|FG001|NOT COMPLETED|Overall Study||2||
48260273|NCT00565266|100958889|FG000|STARTED|Overall Study||210||
48260274|NCT00565266|100958889|FG000|COMPLETED|Overall Study||174||
48260275|NCT00565266|100958889|FG000|NOT COMPLETED|Overall Study||36||
48260276|NCT00336817|100958890|FG000|STARTED|Overall Study||15||
48260277|NCT00336817|100958891|FG001|STARTED|Overall Study||15||
48260278|NCT00336817|100958890|FG000|COMPLETED|Overall Study||14||
48260279|NCT00336817|100958891|FG001|COMPLETED|Overall Study||13||
48260280|NCT00336817|100958890|FG000|NOT COMPLETED|Overall Study||1||
48260281|NCT00336817|100958891|FG001|NOT COMPLETED|Overall Study||2||
48260282|NCT00666198|100958892|FG000|STARTED|Overall Study||3337||
48260283|NCT00666198|100958892|FG000|COMPLETED|Overall Study||3304||
48260284|NCT00666198|100958892|FG000|NOT COMPLETED|Overall Study||33||
48260285|NCT02276638|100958893|FG000|STARTED|Overall Study||28||
48260286|NCT02276638|100958894|FG001|STARTED|Overall Study||28||
48260287|NCT02276638|100958895|FG002|STARTED|Overall Study||23||
48260288|NCT02276638|100958893|FG000|COMPLETED|Overall Study||28||
48260289|NCT02276638|100958894|FG001|COMPLETED|Overall Study||28||
48260290|NCT02276638|100958895|FG002|COMPLETED|Overall Study||23||
48260291|NCT02276638|100958893|FG000|NOT COMPLETED|Overall Study||0||
48260292|NCT02276638|100958894|FG001|NOT COMPLETED|Overall Study||0||
48260293|NCT02276638|100958895|FG002|NOT COMPLETED|Overall Study||0||
48260294|NCT01099579|100958896|FG000|STARTED|Stage 1 (ATV Powder Formulation)||21||
48260295|NCT01099579|100958897|FG001|STARTED|Stage 1 (ATV Powder Formulation)||19||
48260296|NCT01099579|100958898|FG002|STARTED|Stage 1 (ATV Powder Formulation)||16||
48260297|NCT01099579|100958896|FG000|COMPLETED|Stage 1 (ATV Powder Formulation)||17||
48260298|NCT01099579|100958897|FG001|COMPLETED|Stage 1 (ATV Powder Formulation)||14||
48260299|NCT01099579|100958898|FG002|COMPLETED|Stage 1 (ATV Powder Formulation)||15||
48260300|NCT01099579|100958896|FG000|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||4||
48260301|NCT01099579|100958897|FG001|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||5||
48260302|NCT01099579|100958898|FG002|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||1||
48260303|NCT01099579|100958896|FG000|STARTED|Stage 2 (ATV Capsule)||16||
48260304|NCT01099579|100958897|FG001|STARTED|Stage 2 (ATV Capsule)||14||
48260305|NCT01099579|100958898|FG002|STARTED|Stage 2 (ATV Capsule)||15||
48260306|NCT01099579|100958896|FG000|COMPLETED|Stage 2 (ATV Capsule)||10||
48260307|NCT01099579|100958897|FG001|COMPLETED|Stage 2 (ATV Capsule)||9||
48689731|NCT04512001|102022765|FG001|Received Treatment|Week 0 to Week 24||302||
48689732|NCT04512001|102022766|FG002|Received Treatment|Week 0 to Week 24||0||
48260308|NCT01099579|100958898|FG002|COMPLETED|Stage 2 (ATV Capsule)||9||
48260309|NCT01099579|100958896|FG000|NOT COMPLETED|Stage 2 (ATV Capsule)||6||
48260310|NCT01099579|100958897|FG001|NOT COMPLETED|Stage 2 (ATV Capsule)||5||
48260311|NCT01099579|100958898|FG002|NOT COMPLETED|Stage 2 (ATV Capsule)||6||
48260312|NCT01983462|100958899|FG000|STARTED|Overall Study||11||
48260313|NCT01983462|100958900|FG001|STARTED|Overall Study||11||
48689733|NCT04512001|102022767|FG003|Received Treatment|Week 0 to Week 24||0||
48689734|NCT04512001|102022768|FG004|Received Treatment|Week 0 to Week 24||0||
48689735|NCT04512001|102022764|FG000|COMPLETED|Week 0 to Week 24||267|Re-randomized at Week 24|
48689736|NCT04512001|102022765|FG001|COMPLETED|Week 0 to Week 24||276|Re-randomized at Week 24|
48689737|NCT04512001|102022766|FG002|COMPLETED|Week 0 to Week 24||0|Re-randomized at Week 24|
48689738|NCT04512001|102022767|FG003|COMPLETED|Week 0 to Week 24||0|Re-randomized at Week 24|
48689739|NCT04512001|102022768|FG004|COMPLETED|Week 0 to Week 24||0|Re-randomized at Week 24|
48689740|NCT04512001|102022764|FG000|NOT COMPLETED|Week 0 to Week 24||35||
48689741|NCT04512001|102022765|FG001|NOT COMPLETED|Week 0 to Week 24||26||
48689742|NCT04512001|102022766|FG002|NOT COMPLETED|Week 0 to Week 24||0||
48689743|NCT04512001|102022767|FG003|NOT COMPLETED|Week 0 to Week 24||0||
48689744|NCT04512001|102022768|FG004|NOT COMPLETED|Week 0 to Week 24||0||
48689745|NCT04512001|102022764|FG000|STARTED|Week 24 to Week 63||0||
48689746|NCT04512001|102022765|FG001|STARTED|Week 24 to Week 63||0||
48689747|NCT04512001|102022766|FG002|STARTED|Week 24 to Week 63||267||
48689748|NCT04512001|102022767|FG003|STARTED|Week 24 to Week 63||139||
48689749|NCT04512001|102022768|FG004|STARTED|Week 24 to Week 63||137||
48689750|NCT04512001|102022764|FG000|Received Treatment|Week 24 to Week 63||0||
48689751|NCT04512001|102022765|FG001|Received Treatment|Week 24 to Week 63||0||
48689752|NCT04512001|102022766|FG002|Received Treatment|Week 24 to Week 63||266||
48689753|NCT04512001|102022767|FG003|Received Treatment|Week 24 to Week 63||139||
48689754|NCT04512001|102022768|FG004|Received Treatment|Week 24 to Week 63||136||
48689755|NCT04512001|102022764|FG000|COMPLETED|Week 24 to Week 63||0||
48689756|NCT04512001|102022765|FG001|COMPLETED|Week 24 to Week 63||0||
48689757|NCT04512001|102022766|FG002|COMPLETED|Week 24 to Week 63||244||
48689758|NCT04512001|102022767|FG003|COMPLETED|Week 24 to Week 63||123||
48689759|NCT04512001|102022768|FG004|COMPLETED|Week 24 to Week 63||122||
48689760|NCT04512001|102022764|FG000|NOT COMPLETED|Week 24 to Week 63||0||
48689761|NCT04512001|102022765|FG001|NOT COMPLETED|Week 24 to Week 63||0||
48689762|NCT04512001|102022766|FG002|NOT COMPLETED|Week 24 to Week 63||23||
48689763|NCT04512001|102022767|FG003|NOT COMPLETED|Week 24 to Week 63||16||
48689764|NCT04512001|102022768|FG004|NOT COMPLETED|Week 24 to Week 63||15||
48689765|NCT02554799|102022769|FG000|STARTED|Overall Study||9||
48689766|NCT02554799|102022770|FG001|STARTED|Overall Study||9||
48689767|NCT02554799|102022769|FG000|COMPLETED|Overall Study||9||
48689768|NCT02554799|102022770|FG001|COMPLETED|Overall Study||9||
48689769|NCT02554799|102022769|FG000|NOT COMPLETED|Overall Study||0||
48689770|NCT02554799|102022770|FG001|NOT COMPLETED|Overall Study||0||
48689771|NCT01356498|102022771|FG000|STARTED|Overall Study||35||
48689772|NCT01356498|102022772|FG001|STARTED|Overall Study||25||
48689773|NCT01356498|102022773|FG002|STARTED|Overall Study||23||
48689774|NCT01356498|102022774|FG003|STARTED|Overall Study||22||
48689775|NCT01356498|102022775|FG004|STARTED|Overall Study||28||
48689776|NCT01356498|102022776|FG005|STARTED|Overall Study||16||
48689777|NCT01356498|102022771|FG000|COMPLETED|Overall Study||24||
48689778|NCT01356498|102022772|FG001|COMPLETED|Overall Study||17||
48689779|NCT01356498|102022773|FG002|COMPLETED|Overall Study||11||
48689780|NCT01356498|102022774|FG003|COMPLETED|Overall Study||8||
48689781|NCT01356498|102022775|FG004|COMPLETED|Overall Study||8||
48689782|NCT01356498|102022776|FG005|COMPLETED|Overall Study||2||
48689783|NCT01356498|102022771|FG000|NOT COMPLETED|Overall Study||11||
48689784|NCT01356498|102022772|FG001|NOT COMPLETED|Overall Study||8||
48260314|NCT01983462|100958901|FG002|STARTED|Overall Study||11||
48260315|NCT01983462|100958899|FG000|COMPLETED|Overall Study||10||
48260316|NCT01983462|100958900|FG001|COMPLETED|Overall Study||11||
48260317|NCT01983462|100958901|FG002|COMPLETED|Overall Study||11||
48260318|NCT01983462|100958899|FG000|NOT COMPLETED|Overall Study||1||
48260319|NCT01983462|100958900|FG001|NOT COMPLETED|Overall Study||0||
48260320|NCT01983462|100958901|FG002|NOT COMPLETED|Overall Study||0||
48260321|NCT01101061|100958902|FG000|STARTED|Overall Study||6||
48260322|NCT01101061|100958903|FG001|STARTED|Overall Study||6||
48260323|NCT01101061|100958904|FG002|STARTED|Overall Study||7||
48260324|NCT01101061|100958905|FG003|STARTED|Overall Study||6||
48689785|NCT01356498|102022773|FG002|NOT COMPLETED|Overall Study||12||
48689786|NCT01356498|102022774|FG003|NOT COMPLETED|Overall Study||14||
48689787|NCT01356498|102022775|FG004|NOT COMPLETED|Overall Study||20||
48689788|NCT01356498|102022776|FG005|NOT COMPLETED|Overall Study||14||
48689789|NCT01104545|102022777|FG000|STARTED|Overall Study||8||
48689790|NCT01104545|102022778|FG001|STARTED|Overall Study||8||
48689791|NCT01104545|102022779|FG002|STARTED|Overall Study||8||
48689792|NCT01104545|102022777|FG000|COMPLETED|Overall Study||8||
48689793|NCT01104545|102022778|FG001|COMPLETED|Overall Study||7||
48689794|NCT01104545|102022779|FG002|COMPLETED|Overall Study||6||
48689795|NCT01104545|102022777|FG000|NOT COMPLETED|Overall Study||0||
48689796|NCT01104545|102022778|FG001|NOT COMPLETED|Overall Study||1||
48689797|NCT01104545|102022779|FG002|NOT COMPLETED|Overall Study||2||
48689798|NCT01772550|102022780|FG000|STARTED|Overall Study||102||
48689799|NCT01772550|102022781|FG001|STARTED|Overall Study||103||
48689800|NCT01772550|102022782|FG002|STARTED|Overall Study||33||
48689801|NCT01772550|102022780|FG000|CT Pancreas|Overall Study||40||
48689802|NCT01772550|102022781|FG001|CT Pancreas|Overall Study||36||
48689803|NCT01772550|102022782|FG002|CT Pancreas|Overall Study||8||
48689804|NCT01772550|102022780|FG000|CT Angiogram|Overall Study||24||
48689805|NCT01772550|102022781|FG001|CT Angiogram|Overall Study||25||
48689806|NCT01772550|102022782|FG002|CT Angiogram|Overall Study||4||
48689807|NCT01772550|102022780|FG000|CT Liver|Overall Study||18||
48689808|NCT01772550|102022781|FG001|CT Liver|Overall Study||14||
48689809|NCT01772550|102022782|FG002|CT Liver|Overall Study||8||
48689810|NCT01772550|102022780|FG000|CT Kidney|Overall Study||12||
48689811|NCT01772550|102022781|FG001|CT Kidney|Overall Study||19||
48689812|NCT01772550|102022782|FG002|CT Kidney|Overall Study||6||
48689813|NCT01772550|102022780|FG000|CT Cardiac|Overall Study||7||
48689814|NCT01772550|102022781|FG001|CT Cardiac|Overall Study||7||
48689815|NCT01772550|102022782|FG002|CT Cardiac|Overall Study||1||
48689816|NCT01772550|102022780|FG000|COMPLETED|Overall Study||101||
48689817|NCT01772550|102022781|FG001|COMPLETED|Overall Study||102||
48689818|NCT01772550|102022782|FG002|COMPLETED|Overall Study||27||
48689819|NCT01772550|102022780|FG000|NOT COMPLETED|Overall Study||1||
48689820|NCT01772550|102022781|FG001|NOT COMPLETED|Overall Study||1||
48096376|NCT03566823|100560388|FG001|NOT COMPLETED|Overall Study||3||
48096377|NCT03566823|100560389|FG002|NOT COMPLETED|Overall Study||2||
48096378|NCT02677922|100560390|FG000|STARTED|Pre-Treatment Period||3||
48096379|NCT02677922|100560391|FG001|STARTED|Pre-Treatment Period||3||
48096380|NCT02677922|100560392|FG002|STARTED|Pre-Treatment Period||7||
48096381|NCT02677922|100560393|FG003|STARTED|Pre-Treatment Period||16||
48096382|NCT02677922|100560394|FG004|STARTED|Pre-Treatment Period||68||
48096383|NCT02677922|100560395|FG005|STARTED|Pre-Treatment Period||33||
48096384|NCT02677922|100560390|FG000|COMPLETED|Pre-Treatment Period||3||
48096385|NCT02677922|100560391|FG001|COMPLETED|Pre-Treatment Period||3||
48096386|NCT02677922|100560392|FG002|COMPLETED|Pre-Treatment Period||7||
48389536|NCT01033487|101283427|FG009|STARTED|Second Intervention Period||2||
48389537|NCT01033487|101283418|FG000|COMPLETED|Second Intervention Period||2||
48689821|NCT01772550|102022782|FG002|NOT COMPLETED|Overall Study||6||
48689822|NCT01350258|102022783|FG000|STARTED|Overall Study||8||
48689823|NCT01350258|102022783|FG000|COMPLETED|Overall Study||8||
48096387|NCT02677922|100560393|FG003|COMPLETED|Pre-Treatment Period||16||
48096388|NCT02677922|100560394|FG004|COMPLETED|Pre-Treatment Period||68||
48096389|NCT02677922|100560395|FG005|COMPLETED|Pre-Treatment Period||32||
48096390|NCT02677922|100560390|FG000|NOT COMPLETED|Pre-Treatment Period||0||
48096391|NCT02677922|100560391|FG001|NOT COMPLETED|Pre-Treatment Period||0||
48096392|NCT02677922|100560392|FG002|NOT COMPLETED|Pre-Treatment Period||0||
48096393|NCT02677922|100560393|FG003|NOT COMPLETED|Pre-Treatment Period||0||
48096394|NCT02677922|100560394|FG004|NOT COMPLETED|Pre-Treatment Period||0||
48096395|NCT02677922|100560395|FG005|NOT COMPLETED|Pre-Treatment Period||1||
48096396|NCT02677922|100560390|FG000|STARTED|Treatment Period||3||
48096397|NCT02677922|100560391|FG001|STARTED|Treatment Period||3||
48096398|NCT02677922|100560392|FG002|STARTED|Treatment Period||7||
48689824|NCT01350258|102022783|FG000|NOT COMPLETED|Overall Study||0||
48689825|NCT03232827|102022784|FG000|STARTED|Flavored-sweetened (FS)||80||
48689826|NCT03232827|102022784|FG000|COMPLETED|Flavored-sweetened (FS)||80||
48096399|NCT02677922|100560393|FG003|STARTED|Treatment Period||16||
48096400|NCT02677922|100560394|FG004|STARTED|Treatment Period||68||
48096401|NCT02677922|100560395|FG005|STARTED|Treatment Period||32||
48096402|NCT02677922|100560390|FG000|COMPLETED|Treatment Period||1|Ongoing|
48096403|NCT02677922|100560391|FG001|COMPLETED|Treatment Period||1|Ongoing|
48389538|NCT01033487|101283419|FG001|COMPLETED|Second Intervention Period||3||
48389539|NCT01033487|101283420|FG002|COMPLETED|Second Intervention Period||2||
48689827|NCT03232827|102022784|FG000|NOT COMPLETED|Flavored-sweetened (FS)||0||
48389540|NCT01033487|101283421|FG003|COMPLETED|Second Intervention Period||2||
48389541|NCT01033487|101283422|FG004|COMPLETED|Second Intervention Period||2||
48689828|NCT03232827|102022784|FG000|STARTED|Unflavored-sweetened (US)||86||
48689829|NCT03232827|102022784|FG000|COMPLETED|Unflavored-sweetened (US)||86||
48689830|NCT03232827|102022784|FG000|NOT COMPLETED|Unflavored-sweetened (US)||0||
48689831|NCT03232827|102022784|FG000|STARTED|Unflavored-very Low Sweetened (UU)||66||
48689832|NCT03232827|102022784|FG000|COMPLETED|Unflavored-very Low Sweetened (UU)||66||
48689833|NCT03232827|102022784|FG000|NOT COMPLETED|Unflavored-very Low Sweetened (UU)||0||
48689834|NCT03232827|102022784|FG000|STARTED|Flavored-very Low Sweetened||66||
48096404|NCT02677922|100560392|FG002|COMPLETED|Treatment Period||4|Ongoing|
48096405|NCT02677922|100560393|FG003|COMPLETED|Treatment Period||3|Ongoing|
48096406|NCT02677922|100560394|FG004|COMPLETED|Treatment Period||21|Ongoing|
48096407|NCT02677922|100560395|FG005|COMPLETED|Treatment Period||1|Ongoing|
48389542|NCT01033487|101283423|FG005|COMPLETED|Second Intervention Period||2||
48689835|NCT03232827|102022784|FG000|COMPLETED|Flavored-very Low Sweetened||66||
48689836|NCT03232827|102022784|FG000|NOT COMPLETED|Flavored-very Low Sweetened||0||
48689837|NCT03146663|102022785|FG000|STARTED|Overall Study||25||
48096408|NCT02677922|100560390|FG000|NOT COMPLETED|Treatment Period||2||
48096409|NCT02677922|100560391|FG001|NOT COMPLETED|Treatment Period||2||
48096410|NCT02677922|100560392|FG002|NOT COMPLETED|Treatment Period||3||
48096411|NCT02677922|100560393|FG003|NOT COMPLETED|Treatment Period||13||
48096412|NCT02677922|100560394|FG004|NOT COMPLETED|Treatment Period||47||
48096413|NCT02677922|100560395|FG005|NOT COMPLETED|Treatment Period||31||
48096414|NCT00811473|100560396|FG000|STARTED|Overall Study||93||
48096415|NCT00811473|100560397|FG001|STARTED|Overall Study||100||
48096416|NCT00811473|100560396|FG000|COMPLETED|Overall Study||70||
48096417|NCT00811473|100560397|FG001|COMPLETED|Overall Study||74||
48096418|NCT00811473|100560396|FG000|NOT COMPLETED|Overall Study||23||
48096419|NCT00811473|100560397|FG001|NOT COMPLETED|Overall Study||26||
48096420|NCT00571987|100560398|FG000|STARTED|Overall Study||107||
48096421|NCT00571987|100560398|FG000|COMPLETED|Overall Study||100||
48096422|NCT00571987|100560398|FG000|NOT COMPLETED|Overall Study||7||
48096423|NCT03303079|100560399|FG000|STARTED|Overall Study||189||
48096424|NCT03303079|100560400|FG001|STARTED|Overall Study||191||
48096425|NCT03303079|100560401|FG002|STARTED|Overall Study||191||
48096426|NCT03303079|100560399|FG000|COMPLETED|Overall Study||182||
48096427|NCT03303079|100560400|FG001|COMPLETED|Overall Study||180||
48096428|NCT03303079|100560401|FG002|COMPLETED|Overall Study||179||
48096429|NCT03303079|100560399|FG000|NOT COMPLETED|Overall Study||7||
48096430|NCT03303079|100560400|FG001|NOT COMPLETED|Overall Study||11||
48096431|NCT03303079|100560401|FG002|NOT COMPLETED|Overall Study||12||
48096432|NCT04039412|100560402|FG000|STARTED|Overall Study||110||
48096433|NCT04039412|100560403|FG001|STARTED|Overall Study||110||
48096434|NCT04039412|100560404|FG002|STARTED|Overall Study||110||
48096435|NCT04039412|100560402|FG000|COMPLETED|Overall Study||109||
48096436|NCT04039412|100560403|FG001|COMPLETED|Overall Study||107||
48096437|NCT04039412|100560404|FG002|COMPLETED|Overall Study||108||
48096438|NCT04039412|100560402|FG000|NOT COMPLETED|Overall Study||1||
48096439|NCT04039412|100560403|FG001|NOT COMPLETED|Overall Study||3||
48096440|NCT04039412|100560404|FG002|NOT COMPLETED|Overall Study||2||
48096441|NCT00680745|100560405|FG000|STARTED|Overall Study||154||
48096442|NCT00680745|100560406|FG001|STARTED|Overall Study||145||
48096443|NCT00680745|100560407|FG002|STARTED|Overall Study||151||
48096444|NCT00680745|100560408|FG003|STARTED|Overall Study||146||
48096445|NCT00680745|100560405|FG000|COMPLETED|Overall Study||140||
48096446|NCT00680745|100560406|FG001|COMPLETED|Overall Study||132||
48096447|NCT00680745|100560407|FG002|COMPLETED|Overall Study||141||
48096448|NCT00680745|100560408|FG003|COMPLETED|Overall Study||133||
48096449|NCT00680745|100560405|FG000|NOT COMPLETED|Overall Study||14||
48096450|NCT00680745|100560406|FG001|NOT COMPLETED|Overall Study||13||
48096451|NCT00680745|100560407|FG002|NOT COMPLETED|Overall Study||10||
48096452|NCT00680745|100560408|FG003|NOT COMPLETED|Overall Study||13||
48096453|NCT04615923|100560409|FG000|STARTED|Overall Study||120||
48096454|NCT04615923|100560410|FG001|STARTED|Overall Study||42||
48096455|NCT04615923|100560409|FG000|COMPLETED|Overall Study||96||
48096456|NCT04615923|100560410|FG001|COMPLETED|Overall Study||38||
48096457|NCT04615923|100560409|FG000|NOT COMPLETED|Overall Study||24||
48096458|NCT04615923|100560410|FG001|NOT COMPLETED|Overall Study||4||
48096459|NCT02794103|100560411|FG000|STARTED|Overall Study||18||
48096460|NCT02794103|100560411|FG000|COMPLETED|Overall Study||15||
48096461|NCT02794103|100560411|FG000|NOT COMPLETED|Overall Study||3||
48096462|NCT01537029|100560412|FG000|STARTED|Overall Study||15||
48096463|NCT01537029|100560412|FG000|COMPLETED|Overall Study||15||
48096464|NCT01537029|100560412|FG000|NOT COMPLETED|Overall Study||0||
48096465|NCT01996826|100560413|FG000|STARTED|Overall Study||39||
48096466|NCT01996826|100560414|FG001|STARTED|Overall Study||36||
48096467|NCT01996826|100560413|FG000|COMPLETED|Overall Study||32||
48096468|NCT01996826|100560414|FG001|COMPLETED|Overall Study||33||
48096469|NCT01996826|100560413|FG000|NOT COMPLETED|Overall Study||7||
48096470|NCT01996826|100560414|FG001|NOT COMPLETED|Overall Study||3||
48096471|NCT00196716|100560415|FG000|STARTED|1.0 mg/kg Period||21||
48096472|NCT00196716|100560415|FG000|COMPLETED|1.0 mg/kg Period||21||
48096473|NCT00196716|100560415|FG000|NOT COMPLETED|1.0 mg/kg Period||0||
48542225|NCT03007238|101662893|FG000|COMPLETED|Overall Study||10||
48096474|NCT00196716|100560415|FG000|STARTED|0.3 mg/kg Period||21||
48096475|NCT00196716|100560415|FG000|COMPLETED|0.3 mg/kg Period||21||
48096476|NCT00196716|100560415|FG000|NOT COMPLETED|0.3 mg/kg Period||0||
48096477|NCT03195088|100560416|FG000|STARTED|Overall Study||4|Started are treated|
48096478|NCT03195088|100560417|FG001|STARTED|Overall Study||6|Started are treated|
48096479|NCT03195088|100560418|FG002|STARTED|Overall Study||6|Started are treated|
48096480|NCT03195088|100560416|FG000|COMPLETED|Overall Study||4||
48096481|NCT03195088|100560417|FG001|COMPLETED|Overall Study||6||
48096482|NCT03195088|100560418|FG002|COMPLETED|Overall Study||6||
48096483|NCT03195088|100560416|FG000|NOT COMPLETED|Overall Study||0||
48096484|NCT03195088|100560417|FG001|NOT COMPLETED|Overall Study||0||
48096485|NCT03195088|100560418|FG002|NOT COMPLETED|Overall Study||0||
48096486|NCT02169739|100560419|FG000|STARTED|Overall Study||2||
48096487|NCT02169739|100560420|FG001|STARTED|Overall Study||4||
48096488|NCT02169739|100560419|FG000|COMPLETED|Overall Study||2||
48096489|NCT02169739|100560420|FG001|COMPLETED|Overall Study||0||
48096490|NCT02169739|100560419|FG000|NOT COMPLETED|Overall Study||0||
48096491|NCT02169739|100560420|FG001|NOT COMPLETED|Overall Study||4||
48096492|NCT02135146|100560421|FG000|STARTED|Overall Study||20||
48096493|NCT02135146|100560422|FG001|STARTED|Overall Study||20||
48096494|NCT02135146|100560421|FG000|COMPLETED|Overall Study||20||
48096495|NCT02135146|100560422|FG001|COMPLETED|Overall Study||20||
48096496|NCT02135146|100560421|FG000|NOT COMPLETED|Overall Study||0||
48096497|NCT02135146|100560422|FG001|NOT COMPLETED|Overall Study||0||
48096498|NCT01519960|100560423|FG000|STARTED|Overall Study||101||
48096499|NCT01519960|100560424|FG001|STARTED|Overall Study||50||
48096500|NCT01519960|100560425|FG002|STARTED|Overall Study||10||
48096501|NCT01519960|100560423|FG000|Completed Week 48|Overall Study||99||
48260325|NCT01101061|100958906|FG004|STARTED|Overall Study||2||
48260326|NCT01101061|100958907|FG005|STARTED|Overall Study||4||
48260327|NCT01101061|100958902|FG000|Received Study Drug|Overall Study||6||
48260328|NCT01101061|100958903|FG001|Received Study Drug|Overall Study||6||
48260329|NCT01101061|100958904|FG002|Received Study Drug|Overall Study||6||
48260330|NCT01101061|100958905|FG003|Received Study Drug|Overall Study||6||
48096502|NCT01519960|100560424|FG001|Completed Week 48|Overall Study||47||
48096503|NCT01519960|100560425|FG002|Completed Week 48|Overall Study||10||
48096504|NCT01519960|100560423|FG000|Completed Follow-Up (FU) Week 12|Overall Study||99||
48096505|NCT01519960|100560424|FG001|Completed Follow-Up (FU) Week 12|Overall Study||26||
48096506|NCT01519960|100560425|FG002|Completed Follow-Up (FU) Week 12|Overall Study||10||
48096507|NCT01519960|100560423|FG000|Completed FU Week 24|Overall Study||99||
48096508|NCT01519960|100560424|FG001|Completed FU Week 24|Overall Study||15||
48096509|NCT01519960|100560425|FG002|Completed FU Week 24|Overall Study||10||
48096510|NCT01519960|100560423|FG000|Completed FU 5 Year|Overall Study||75||
48096511|NCT01519960|100560424|FG001|Completed FU 5 Year|Overall Study||28||
48096512|NCT01519960|100560425|FG002|Completed FU 5 Year|Overall Study||5||
48096513|NCT01519960|100560423|FG000|Switch Group|Overall Study||0||
48096514|NCT01519960|100560424|FG001|Switch Group|Overall Study||33||
48096515|NCT01519960|100560425|FG002|Switch Group|Overall Study||0||
48096516|NCT01519960|100560423|FG000|COMPLETED|Overall Study||75||
48096517|NCT01519960|100560424|FG001|COMPLETED|Overall Study||28||
48096518|NCT01519960|100560425|FG002|COMPLETED|Overall Study||5||
48096519|NCT01519960|100560423|FG000|NOT COMPLETED|Overall Study||26||
48096520|NCT01519960|100560424|FG001|NOT COMPLETED|Overall Study||22||
48096521|NCT01519960|100560425|FG002|NOT COMPLETED|Overall Study||5||
48096522|NCT01608659|100560426|FG000|STARTED|Overall Study||110||
48096523|NCT01608659|100560426|FG000|COMPLETED|Overall Study||94||
48096524|NCT01608659|100560426|FG000|NOT COMPLETED|Overall Study||16||
48096525|NCT03179995|100560427|FG000|STARTED|Overall Study||11||
48096526|NCT03179995|100560428|FG001|STARTED|Overall Study||12||
48096527|NCT03179995|100560427|FG000|COMPLETED|Overall Study||11||
48096528|NCT03179995|100560428|FG001|COMPLETED|Overall Study||12||
48096529|NCT03179995|100560427|FG000|NOT COMPLETED|Overall Study||0||
48096530|NCT03179995|100560428|FG001|NOT COMPLETED|Overall Study||0||
48096531|NCT01165554|100560429|FG000|STARTED|Overall Study||203||
48096532|NCT01165554|100560429|FG000|COMPLETED|Overall Study||180||
48096533|NCT01165554|100560429|FG000|NOT COMPLETED|Overall Study||23||
48096534|NCT03611790|100560430|FG000|STARTED|Overall Study||30||
48096535|NCT03611790|100560430|FG000|COMPLETED|Overall Study||30||
48260331|NCT01101061|100958906|FG004|Received Study Drug|Overall Study||2||
48260332|NCT01101061|100958907|FG005|Received Study Drug|Overall Study||4||
48260333|NCT01101061|100958902|FG000|COMPLETED|Overall Study||6||
48260334|NCT01101061|100958903|FG001|COMPLETED|Overall Study||6||
48260335|NCT01101061|100958904|FG002|COMPLETED|Overall Study||6||
48260336|NCT01101061|100958905|FG003|COMPLETED|Overall Study||6||
48260337|NCT01101061|100958906|FG004|COMPLETED|Overall Study||2||
48260338|NCT01101061|100958907|FG005|COMPLETED|Overall Study||4||
48260339|NCT01101061|100958902|FG000|NOT COMPLETED|Overall Study||0||
48260340|NCT01101061|100958903|FG001|NOT COMPLETED|Overall Study||0||
48096536|NCT03611790|100560430|FG000|NOT COMPLETED|Overall Study||0||
48096537|NCT01963403|100560431|FG000|STARTED|Overall Study||13||
48096538|NCT01963403|100560432|FG001|STARTED|Overall Study||13||
48096539|NCT01963403|100560431|FG000|COMPLETED|Overall Study||11||
48096540|NCT01963403|100560432|FG001|COMPLETED|Overall Study||9||
48096541|NCT01963403|100560431|FG000|NOT COMPLETED|Overall Study||2||
48096542|NCT01963403|100560432|FG001|NOT COMPLETED|Overall Study||4||
48096543|NCT01106898|100560433|FG000|STARTED|Overall Study||100||
48096544|NCT01106898|100560433|FG000|COMPLETED|Overall Study||94||
48096545|NCT01106898|100560433|FG000|NOT COMPLETED|Overall Study||6||
48260341|NCT01101061|100958904|FG002|NOT COMPLETED|Overall Study||1||
48260342|NCT01101061|100958905|FG003|NOT COMPLETED|Overall Study||0||
48260343|NCT01101061|100958906|FG004|NOT COMPLETED|Overall Study||0||
48260344|NCT01101061|100958907|FG005|NOT COMPLETED|Overall Study||0||
48096546|NCT05022784|100560434|FG000|STARTED|Overall Study||1798||
48096547|NCT05022784|100560434|FG000|Eligible Patients|Overall Study||1798||
48096548|NCT05022784|100560434|FG000|COMPLETED|Overall Study||1798||
48096549|NCT05022784|100560434|FG000|NOT COMPLETED|Overall Study||0||
48096550|NCT02875860|100560435|FG000|STARTED|Overall Study||2||
48096551|NCT02875860|100560436|FG001|STARTED|Overall Study||3||
48096552|NCT02875860|100560435|FG000|COMPLETED|Overall Study||2||
48096553|NCT02875860|100560436|FG001|COMPLETED|Overall Study||2||
48096554|NCT02875860|100560435|FG000|NOT COMPLETED|Overall Study||0||
48260345|NCT01263054|100958908|FG000|STARTED|Overall Study||29||
48096555|NCT02875860|100560436|FG001|NOT COMPLETED|Overall Study||1||
48096556|NCT01053819|100560437|FG000|STARTED|Overall Study||6||
48096557|NCT01053819|100560437|FG000|COMPLETED|Overall Study||6||
48096558|NCT01053819|100560437|FG000|NOT COMPLETED|Overall Study||0||
48096559|NCT02350881|100560438|FG000|STARTED|Overall Study||64||
48096560|NCT02350881|100560438|FG000|COMPLETED|Overall Study||64||
48096561|NCT02350881|100560438|FG000|NOT COMPLETED|Overall Study||0||
48096562|NCT02278250|100560439|FG000|STARTED|Overall Study||2||
48096563|NCT02278250|100560440|FG001|STARTED|Overall Study||1||
48096564|NCT02278250|100560441|FG002|STARTED|Overall Study||2||
48096565|NCT02278250|100560442|FG003|STARTED|Overall Study||1||
48389543|NCT01033487|101283424|FG006|COMPLETED|Second Intervention Period||2||
48389544|NCT01033487|101283425|FG007|COMPLETED|Second Intervention Period||3||
48389545|NCT01033487|101283426|FG008|COMPLETED|Second Intervention Period||2||
48689838|NCT03146663|102022786|FG001|STARTED|Overall Study||28||
48689839|NCT03146663|102022785|FG000|COMPLETED|Overall Study||24||
48096566|NCT02278250|100560443|FG004|STARTED|Overall Study||1||
48096567|NCT02278250|100560444|FG005|STARTED|Overall Study||2||
48096568|NCT02278250|100560445|FG006|STARTED|Overall Study||4||
48096569|NCT02278250|100560446|FG007|STARTED|Overall Study||12||
48096570|NCT02278250|100560447|FG008|STARTED|Overall Study||10||
48096571|NCT02278250|100560448|FG009|STARTED|Overall Study||7||
48096572|NCT02278250|100560449|FG010|STARTED|Overall Study||7||
48096573|NCT02278250|100560450|FG011|STARTED|Overall Study||5||
48096574|NCT02278250|100560451|FG012|STARTED|Overall Study||7||
48096575|NCT02278250|100560452|FG013|STARTED|Overall Study||7||
48096576|NCT02278250|100560453|FG014|STARTED|Overall Study||3||
48096577|NCT02278250|100560454|FG015|STARTED|Overall Study||7||
48096578|NCT02278250|100560455|FG016|STARTED|Overall Study||6||
48096579|NCT02278250|100560456|FG017|STARTED|Overall Study||13||
48096580|NCT02278250|100560439|FG000|COMPLETED|Overall Study||2||
48096581|NCT02278250|100560440|FG001|COMPLETED|Overall Study||1||
48096582|NCT02278250|100560441|FG002|COMPLETED|Overall Study||2||
48096583|NCT02278250|100560442|FG003|COMPLETED|Overall Study||1||
48689840|NCT03146663|102022786|FG001|COMPLETED|Overall Study||27||
48689841|NCT03146663|102022785|FG000|NOT COMPLETED|Overall Study||1||
48689842|NCT03146663|102022786|FG001|NOT COMPLETED|Overall Study||1||
48689843|NCT03835481|102022787|FG000|STARTED|Double-blind Period||2|Enrolled|
48689844|NCT03835481|102022788|FG001|STARTED|Double-blind Period||20|Enrolled|
48689845|NCT03835481|102022789|FG002|STARTED|Double-blind Period||16|Enrolled|
48689846|NCT03835481|102022790|FG003|STARTED|Double-blind Period||49|Enrolled|
48689847|NCT03835481|102022791|FG004|STARTED|Double-blind Period||78|Enrolled|
48689848|NCT03835481|102022787|FG000|COMPLETED|Double-blind Period||2|Completed week 12|
48689849|NCT03835481|102022788|FG001|COMPLETED|Double-blind Period||18|Completed week 12|
48689850|NCT03835481|102022789|FG002|COMPLETED|Double-blind Period||15|Completed week 12|
48689851|NCT03835481|102022790|FG003|COMPLETED|Double-blind Period||46|Completed week 12|
48689852|NCT03835481|102022791|FG004|COMPLETED|Double-blind Period||37|Completed week 12|
48689853|NCT03835481|102022787|FG000|NOT COMPLETED|Double-blind Period||0||
48689854|NCT03835481|102022788|FG001|NOT COMPLETED|Double-blind Period||2||
48689855|NCT03835481|102022789|FG002|NOT COMPLETED|Double-blind Period||1||
48689856|NCT03835481|102022790|FG003|NOT COMPLETED|Double-blind Period||3||
48689857|NCT03835481|102022791|FG004|NOT COMPLETED|Double-blind Period||41||
48689858|NCT03835481|102022787|FG000|STARTED|Open Label Period (After Week 12)||0|Patients assigned to 25 or 50 mg in part 1 were reassigned to 100 mg in the open label period.|
48689859|NCT03835481|102022788|FG001|STARTED|Open Label Period (After Week 12)||0|Patients assigned to 25 or 50 mg in part 1 were reassigned to 100 mg in the open label period.|
48689860|NCT03835481|102022789|FG002|STARTED|Open Label Period (After Week 12)||35|Patients assigned to 25 or 50 mg in part 1 were reassigned to 100 mg in the open label period.|
48689861|NCT03835481|102022790|FG003|STARTED|Open Label Period (After Week 12)||46|Patients assigned to 25 or 50 mg in part 1 were reassigned to 100 mg in the open label period.|
48689862|NCT03835481|102022791|FG004|STARTED|Open Label Period (After Week 12)||37|Patients assigned to 25 or 50 mg in part 1 were reassigned to 100 mg in the open label period.|
48689863|NCT03835481|102022787|FG000|COMPLETED|Open Label Period (After Week 12)||0||
48689864|NCT03835481|102022788|FG001|COMPLETED|Open Label Period (After Week 12)||0||
48096584|NCT02278250|100560443|FG004|COMPLETED|Overall Study||1||
48096585|NCT02278250|100560444|FG005|COMPLETED|Overall Study||2||
48389546|NCT01033487|101283427|FG009|COMPLETED|Second Intervention Period||2||
48389547|NCT01033487|101283418|FG000|NOT COMPLETED|Second Intervention Period||0||
48389548|NCT01033487|101283419|FG001|NOT COMPLETED|Second Intervention Period||0||
48389549|NCT01033487|101283420|FG002|NOT COMPLETED|Second Intervention Period||0||
48389550|NCT01033487|101283421|FG003|NOT COMPLETED|Second Intervention Period||0||
48389551|NCT01033487|101283422|FG004|NOT COMPLETED|Second Intervention Period||0||
48096586|NCT02278250|100560445|FG006|COMPLETED|Overall Study||4||
48096587|NCT02278250|100560446|FG007|COMPLETED|Overall Study||12||
48096588|NCT02278250|100560447|FG008|COMPLETED|Overall Study||10||
48096589|NCT02278250|100560448|FG009|COMPLETED|Overall Study||7||
48096590|NCT02278250|100560449|FG010|COMPLETED|Overall Study||7||
48096591|NCT02278250|100560450|FG011|COMPLETED|Overall Study||5||
48096592|NCT02278250|100560451|FG012|COMPLETED|Overall Study||7||
48096593|NCT02278250|100560452|FG013|COMPLETED|Overall Study||7||
48096594|NCT02278250|100560453|FG014|COMPLETED|Overall Study||3||
48389552|NCT01033487|101283423|FG005|NOT COMPLETED|Second Intervention Period||0||
48096595|NCT02278250|100560454|FG015|COMPLETED|Overall Study||7||
48096596|NCT02278250|100560455|FG016|COMPLETED|Overall Study||6||
48096597|NCT02278250|100560456|FG017|COMPLETED|Overall Study||13||
48096598|NCT02278250|100560439|FG000|NOT COMPLETED|Overall Study||0||
48096599|NCT02278250|100560440|FG001|NOT COMPLETED|Overall Study||0||
48096600|NCT02278250|100560441|FG002|NOT COMPLETED|Overall Study||0||
48096601|NCT02278250|100560442|FG003|NOT COMPLETED|Overall Study||0||
48096602|NCT02278250|100560443|FG004|NOT COMPLETED|Overall Study||0||
48096603|NCT02278250|100560444|FG005|NOT COMPLETED|Overall Study||0||
48096604|NCT02278250|100560445|FG006|NOT COMPLETED|Overall Study||0||
48096605|NCT02278250|100560446|FG007|NOT COMPLETED|Overall Study||0||
48096606|NCT02278250|100560447|FG008|NOT COMPLETED|Overall Study||0||
48096607|NCT02278250|100560448|FG009|NOT COMPLETED|Overall Study||0||
48096608|NCT02278250|100560449|FG010|NOT COMPLETED|Overall Study||0||
48096609|NCT02278250|100560450|FG011|NOT COMPLETED|Overall Study||0||
48096610|NCT02278250|100560451|FG012|NOT COMPLETED|Overall Study||0||
48096611|NCT02278250|100560452|FG013|NOT COMPLETED|Overall Study||0||
48096612|NCT02278250|100560453|FG014|NOT COMPLETED|Overall Study||0||
48260346|NCT01263054|100958909|FG001|STARTED|Overall Study||34||
48260347|NCT01263054|100958908|FG000|COMPLETED|Overall Study||24||
48260348|NCT01263054|100958909|FG001|COMPLETED|Overall Study||28||
48260349|NCT01263054|100958908|FG000|NOT COMPLETED|Overall Study||5||
48260350|NCT01263054|100958909|FG001|NOT COMPLETED|Overall Study||6||
48260351|NCT03635086|100958910|FG000|STARTED|Overall Study||12||
48260352|NCT03635086|100958911|FG001|STARTED|Overall Study||12||
48689865|NCT03835481|102022789|FG002|COMPLETED|Open Label Period (After Week 12)||0||
48689866|NCT03835481|102022790|FG003|COMPLETED|Open Label Period (After Week 12)||0||
48689867|NCT03835481|102022791|FG004|COMPLETED|Open Label Period (After Week 12)||0||
48689868|NCT03835481|102022787|FG000|NOT COMPLETED|Open Label Period (After Week 12)||0||
48689869|NCT03835481|102022788|FG001|NOT COMPLETED|Open Label Period (After Week 12)||0||
48689870|NCT03835481|102022789|FG002|NOT COMPLETED|Open Label Period (After Week 12)||35||
48260353|NCT03635086|100958912|FG002|STARTED|Overall Study||12||
48260354|NCT03635086|100958913|FG003|STARTED|Overall Study||12||
48260355|NCT03635086|100958914|FG004|STARTED|Overall Study||12||
48260356|NCT03635086|100958910|FG000|COMPLETED|Overall Study||11||
48689871|NCT03835481|102022790|FG003|NOT COMPLETED|Open Label Period (After Week 12)||46||
48689872|NCT03835481|102022791|FG004|NOT COMPLETED|Open Label Period (After Week 12)||37||
48689873|NCT00792740|102022792|FG000|STARTED|Overall Study||26||
48689874|NCT00792740|102022793|FG001|STARTED|Overall Study||25||
48689875|NCT00792740|102022792|FG000|COMPLETED|Overall Study||19||
48689876|NCT00792740|102022793|FG001|COMPLETED|Overall Study||18||
48689877|NCT00792740|102022792|FG000|NOT COMPLETED|Overall Study||7||
48689878|NCT00792740|102022793|FG001|NOT COMPLETED|Overall Study||7||
48689879|NCT05253755|102022794|FG000|STARTED|Overall Study||10||20
48689880|NCT05253755|102022794|FG000|COMPLETED|Overall Study||9||18
48689881|NCT05253755|102022794|FG000|NOT COMPLETED|Overall Study||1||2
48689882|NCT02443337|102022795|FG000|STARTED|Overall Study||15||
48096613|NCT02278250|100560454|FG015|NOT COMPLETED|Overall Study||0||
48096614|NCT02278250|100560455|FG016|NOT COMPLETED|Overall Study||0||
48096615|NCT02278250|100560456|FG017|NOT COMPLETED|Overall Study||0||
48096616|NCT01372501|100560457|FG000|STARTED|Overall Study||19||
48096617|NCT01372501|100560457|FG000|COMPLETED|Overall Study||14||
48096618|NCT01372501|100560457|FG000|NOT COMPLETED|Overall Study||5||
48096619|NCT00483379|100560458|FG000|STARTED|Treatment Period||6||
48096620|NCT00483379|100560459|FG001|STARTED|Treatment Period||7||
48096621|NCT00483379|100560458|FG000|COMPLETED|Treatment Period||4||
48096622|NCT00483379|100560459|FG001|COMPLETED|Treatment Period||7||
48096623|NCT00483379|100560458|FG000|NOT COMPLETED|Treatment Period||2||
48096624|NCT00483379|100560459|FG001|NOT COMPLETED|Treatment Period||0||
48096625|NCT00483379|100560458|FG000|STARTED|Extension Period||1||
48096626|NCT00483379|100560459|FG001|STARTED|Extension Period||2||
48096627|NCT00483379|100560458|FG000|COMPLETED|Extension Period||1||
48096628|NCT00483379|100560459|FG001|COMPLETED|Extension Period||2||
48096629|NCT00483379|100560458|FG000|NOT COMPLETED|Extension Period||0||
48096630|NCT00483379|100560459|FG001|NOT COMPLETED|Extension Period||0||
48096631|NCT00674661|100560460|FG000|STARTED|Overall Study||67||
48260357|NCT03635086|100958911|FG001|COMPLETED|Overall Study||11||
48260358|NCT03635086|100958912|FG002|COMPLETED|Overall Study||11||
48260359|NCT03635086|100958913|FG003|COMPLETED|Overall Study||12||
48260360|NCT03635086|100958914|FG004|COMPLETED|Overall Study||12||
48260361|NCT03635086|100958910|FG000|NOT COMPLETED|Overall Study||1||
48260362|NCT03635086|100958911|FG001|NOT COMPLETED|Overall Study||1||
48260363|NCT03635086|100958912|FG002|NOT COMPLETED|Overall Study||1||
48689883|NCT02443337|102022796|FG001|STARTED|Overall Study||16||
48096632|NCT00674661|100560461|FG001|STARTED|Overall Study||63||
48096633|NCT00674661|100560460|FG000|COMPLETED|Overall Study||56||
48096634|NCT00674661|100560461|FG001|COMPLETED|Overall Study||48||
48096635|NCT00674661|100560460|FG000|NOT COMPLETED|Overall Study||11||
48096636|NCT00674661|100560461|FG001|NOT COMPLETED|Overall Study||15||
48096637|NCT01852942|100560462|FG000|STARTED|Overall Study||25||
48096638|NCT01852942|100560463|FG001|STARTED|Overall Study||27||
48096639|NCT01852942|100560462|FG000|COMPLETED|Overall Study||20||
48096640|NCT01852942|100560463|FG001|COMPLETED|Overall Study||21||
48389553|NCT01033487|101283424|FG006|NOT COMPLETED|Second Intervention Period||0||
48389554|NCT01033487|101283425|FG007|NOT COMPLETED|Second Intervention Period||0||
48389555|NCT01033487|101283426|FG008|NOT COMPLETED|Second Intervention Period||0||
48389556|NCT01033487|101283427|FG009|NOT COMPLETED|Second Intervention Period||0||
48389557|NCT01033487|101283418|FG000|STARTED|Between Period 2 and 3 (At Least 7 Days)||2||
48389558|NCT01033487|101283419|FG001|STARTED|Between Period 2 and 3 (At Least 7 Days)||3||
48389559|NCT01033487|101283420|FG002|STARTED|Between Period 2 and 3 (At Least 7 Days)||2||
48389560|NCT01033487|101283421|FG003|STARTED|Between Period 2 and 3 (At Least 7 Days)||2||
48389561|NCT01033487|101283422|FG004|STARTED|Between Period 2 and 3 (At Least 7 Days)||2||
48389562|NCT01033487|101283423|FG005|STARTED|Between Period 2 and 3 (At Least 7 Days)||2||
48389563|NCT01033487|101283424|FG006|STARTED|Between Period 2 and 3 (At Least 7 Days)||2||
48389564|NCT01033487|101283425|FG007|STARTED|Between Period 2 and 3 (At Least 7 Days)||3||
48389565|NCT01033487|101283426|FG008|STARTED|Between Period 2 and 3 (At Least 7 Days)||2||
48389566|NCT01033487|101283427|FG009|STARTED|Between Period 2 and 3 (At Least 7 Days)||2||
48389567|NCT01033487|101283418|FG000|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2||
48389568|NCT01033487|101283419|FG001|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3||
48389569|NCT01033487|101283420|FG002|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2||
48389570|NCT01033487|101283421|FG003|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2||
48389571|NCT01033487|101283422|FG004|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2||
48389572|NCT01033487|101283423|FG005|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2||
48389573|NCT01033487|101283424|FG006|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2||
48389574|NCT01033487|101283425|FG007|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3||
48389575|NCT01033487|101283426|FG008|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2||
48389576|NCT01033487|101283427|FG009|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2||
48389577|NCT01033487|101283418|FG000|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0||
48389578|NCT01033487|101283419|FG001|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0||
48389579|NCT01033487|101283420|FG002|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0||
48389580|NCT01033487|101283421|FG003|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0||
48389581|NCT01033487|101283422|FG004|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0||
48389582|NCT01033487|101283423|FG005|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0||
48389583|NCT01033487|101283424|FG006|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0||
48389584|NCT01033487|101283425|FG007|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0||
48389585|NCT01033487|101283426|FG008|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0||
48389586|NCT01033487|101283427|FG009|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0||
48389587|NCT01033487|101283418|FG000|STARTED|Third Intervention Period||2||
48389588|NCT01033487|101283419|FG001|STARTED|Third Intervention Period||3||
48389589|NCT01033487|101283420|FG002|STARTED|Third Intervention Period||2||
48389590|NCT01033487|101283421|FG003|STARTED|Third Intervention Period||2||
48389591|NCT01033487|101283422|FG004|STARTED|Third Intervention Period||2||
48389592|NCT01033487|101283423|FG005|STARTED|Third Intervention Period||2||
48389593|NCT01033487|101283424|FG006|STARTED|Third Intervention Period||2||
48389594|NCT01033487|101283425|FG007|STARTED|Third Intervention Period||3||
48389595|NCT01033487|101283426|FG008|STARTED|Third Intervention Period||2||
48389596|NCT01033487|101283427|FG009|STARTED|Third Intervention Period||2||
48389597|NCT01033487|101283418|FG000|COMPLETED|Third Intervention Period||2||
48389598|NCT01033487|101283419|FG001|COMPLETED|Third Intervention Period||3||
48389599|NCT01033487|101283420|FG002|COMPLETED|Third Intervention Period||2||
48389600|NCT01033487|101283421|FG003|COMPLETED|Third Intervention Period||2||
48389601|NCT01033487|101283422|FG004|COMPLETED|Third Intervention Period||2||
48389602|NCT01033487|101283423|FG005|COMPLETED|Third Intervention Period||2||
48389603|NCT01033487|101283424|FG006|COMPLETED|Third Intervention Period||2||
48389604|NCT01033487|101283425|FG007|COMPLETED|Third Intervention Period||3||
48389605|NCT01033487|101283426|FG008|COMPLETED|Third Intervention Period||2||
48389606|NCT01033487|101283427|FG009|COMPLETED|Third Intervention Period||2||
48389607|NCT01033487|101283418|FG000|NOT COMPLETED|Third Intervention Period||0||
48389608|NCT01033487|101283419|FG001|NOT COMPLETED|Third Intervention Period||0||
48389609|NCT01033487|101283420|FG002|NOT COMPLETED|Third Intervention Period||0||
48389610|NCT01033487|101283421|FG003|NOT COMPLETED|Third Intervention Period||0||
48389611|NCT01033487|101283422|FG004|NOT COMPLETED|Third Intervention Period||0||
48389612|NCT01033487|101283423|FG005|NOT COMPLETED|Third Intervention Period||0||
48389613|NCT01033487|101283424|FG006|NOT COMPLETED|Third Intervention Period||0||
48389614|NCT01033487|101283425|FG007|NOT COMPLETED|Third Intervention Period||0||
48389615|NCT01033487|101283426|FG008|NOT COMPLETED|Third Intervention Period||0||
48389616|NCT01033487|101283427|FG009|NOT COMPLETED|Third Intervention Period||0||
48389617|NCT01033487|101283418|FG000|STARTED|Between Period 3 and 4 (At Least 7 Days)||2||
48389618|NCT01033487|101283419|FG001|STARTED|Between Period 3 and 4 (At Least 7 Days)||3||
48389619|NCT01033487|101283420|FG002|STARTED|Between Period 3 and 4 (At Least 7 Days)||2||
48389620|NCT01033487|101283421|FG003|STARTED|Between Period 3 and 4 (At Least 7 Days)||2||
48389621|NCT01033487|101283422|FG004|STARTED|Between Period 3 and 4 (At Least 7 Days)||2||
48389622|NCT01033487|101283423|FG005|STARTED|Between Period 3 and 4 (At Least 7 Days)||2||
48389623|NCT01033487|101283424|FG006|STARTED|Between Period 3 and 4 (At Least 7 Days)||2||
48389624|NCT01033487|101283425|FG007|STARTED|Between Period 3 and 4 (At Least 7 Days)||3||
48389625|NCT01033487|101283426|FG008|STARTED|Between Period 3 and 4 (At Least 7 Days)||2||
48389626|NCT01033487|101283427|FG009|STARTED|Between Period 3 and 4 (At Least 7 Days)||2||
48389627|NCT01033487|101283418|FG000|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2||
48389628|NCT01033487|101283419|FG001|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3||
48389629|NCT01033487|101283420|FG002|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2||
48389630|NCT01033487|101283421|FG003|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2||
48389631|NCT01033487|101283422|FG004|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2||
48389632|NCT01033487|101283423|FG005|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2||
48389633|NCT01033487|101283424|FG006|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2||
48389634|NCT01033487|101283425|FG007|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3||
48389635|NCT01033487|101283426|FG008|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2||
48389636|NCT01033487|101283427|FG009|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2||
48389637|NCT01033487|101283418|FG000|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0||
48389638|NCT01033487|101283419|FG001|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0||
48389639|NCT01033487|101283420|FG002|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0||
48389640|NCT01033487|101283421|FG003|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0||
48389641|NCT01033487|101283422|FG004|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0||
48389642|NCT01033487|101283423|FG005|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0||
48389643|NCT01033487|101283424|FG006|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0||
48389644|NCT01033487|101283425|FG007|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0||
48389645|NCT01033487|101283426|FG008|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0||
48389646|NCT01033487|101283427|FG009|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0||
48389647|NCT01033487|101283418|FG000|STARTED|Fourth Intervention Period||2||
48389648|NCT01033487|101283419|FG001|STARTED|Fourth Intervention Period||3||
48389649|NCT01033487|101283420|FG002|STARTED|Fourth Intervention Period||2||
48389650|NCT01033487|101283421|FG003|STARTED|Fourth Intervention Period||2||
48389651|NCT01033487|101283422|FG004|STARTED|Fourth Intervention Period||2||
48389652|NCT01033487|101283423|FG005|STARTED|Fourth Intervention Period||2||
48389653|NCT01033487|101283424|FG006|STARTED|Fourth Intervention Period||2||
48389654|NCT01033487|101283425|FG007|STARTED|Fourth Intervention Period||3||
48389655|NCT01033487|101283426|FG008|STARTED|Fourth Intervention Period||2||
48389656|NCT01033487|101283427|FG009|STARTED|Fourth Intervention Period||2||
48389657|NCT01033487|101283418|FG000|COMPLETED|Fourth Intervention Period||2||
48389658|NCT01033487|101283419|FG001|COMPLETED|Fourth Intervention Period||3||
48389659|NCT01033487|101283420|FG002|COMPLETED|Fourth Intervention Period||2||
48389660|NCT01033487|101283421|FG003|COMPLETED|Fourth Intervention Period||2||
48389661|NCT01033487|101283422|FG004|COMPLETED|Fourth Intervention Period||2||
48389662|NCT01033487|101283423|FG005|COMPLETED|Fourth Intervention Period||2||
48389663|NCT01033487|101283424|FG006|COMPLETED|Fourth Intervention Period||2||
48389664|NCT01033487|101283425|FG007|COMPLETED|Fourth Intervention Period||3||
48389665|NCT01033487|101283426|FG008|COMPLETED|Fourth Intervention Period||1||
48389666|NCT01033487|101283427|FG009|COMPLETED|Fourth Intervention Period||2||
48389667|NCT01033487|101283418|FG000|NOT COMPLETED|Fourth Intervention Period||0||
48389668|NCT01033487|101283419|FG001|NOT COMPLETED|Fourth Intervention Period||0||
48389669|NCT01033487|101283420|FG002|NOT COMPLETED|Fourth Intervention Period||0||
48389670|NCT01033487|101283421|FG003|NOT COMPLETED|Fourth Intervention Period||0||
48389671|NCT01033487|101283422|FG004|NOT COMPLETED|Fourth Intervention Period||0||
48389672|NCT01033487|101283423|FG005|NOT COMPLETED|Fourth Intervention Period||0||
48389673|NCT01033487|101283424|FG006|NOT COMPLETED|Fourth Intervention Period||0||
48389674|NCT01033487|101283425|FG007|NOT COMPLETED|Fourth Intervention Period||0||
48389675|NCT01033487|101283426|FG008|NOT COMPLETED|Fourth Intervention Period||1||
48389676|NCT01033487|101283427|FG009|NOT COMPLETED|Fourth Intervention Period||0||
48389677|NCT01033487|101283418|FG000|STARTED|Between Period 4 and 5 (At Least 7 Days)||2||
48389678|NCT01033487|101283419|FG001|STARTED|Between Period 4 and 5 (At Least 7 Days)||3||
48389679|NCT01033487|101283420|FG002|STARTED|Between Period 4 and 5 (At Least 7 Days)||2||
48542226|NCT03007238|101662893|FG000|NOT COMPLETED|Overall Study||0||
48542227|NCT00289120|101662894|FG000|STARTED|Overall Study||13||
48542228|NCT00289120|101662894|FG000|COMPLETED|Overall Study||13||
48542229|NCT00289120|101662894|FG000|NOT COMPLETED|Overall Study||0||
48689884|NCT02443337|102022795|FG000|Received at Least One Dose of Study Drug|Overall Study||15||
48389680|NCT01033487|101283421|FG003|STARTED|Between Period 4 and 5 (At Least 7 Days)||2||
48389681|NCT01033487|101283422|FG004|STARTED|Between Period 4 and 5 (At Least 7 Days)||2||
48389682|NCT01033487|101283423|FG005|STARTED|Between Period 4 and 5 (At Least 7 Days)||2||
48389683|NCT01033487|101283424|FG006|STARTED|Between Period 4 and 5 (At Least 7 Days)||2||
48542230|NCT00863772|101662895|FG000|STARTED|Overall Study||74||
48542231|NCT00863772|101662896|FG001|STARTED|Overall Study||74||
48542232|NCT00863772|101662897|FG002|STARTED|Overall Study||72||
48542233|NCT00863772|101662895|FG000|Treated|Overall Study||73||
48689885|NCT02443337|102022796|FG001|Received at Least One Dose of Study Drug|Overall Study||16||
48689886|NCT02443337|102022795|FG000|COMPLETED|Overall Study||10||
48689887|NCT02443337|102022796|FG001|COMPLETED|Overall Study||14||
48542234|NCT00863772|101662896|FG001|Treated|Overall Study||74||
48542235|NCT00863772|101662897|FG002|Treated|Overall Study||72||
48260364|NCT03635086|100958913|FG003|NOT COMPLETED|Overall Study||0||
48389684|NCT01033487|101283425|FG007|STARTED|Between Period 4 and 5 (At Least 7 Days)||3||
48260365|NCT03635086|100958914|FG004|NOT COMPLETED|Overall Study||0||
48260366|NCT00835185|100958915|FG000|STARTED|Overall Study||44||
48260367|NCT00835185|100958915|FG000|Received at Least 1 Dose of Study Drug|Overall Study||44||
48260368|NCT00835185|100958915|FG000|COMPLETED|Overall Study||44||
48389685|NCT01033487|101283426|FG008|STARTED|Between Period 4 and 5 (At Least 7 Days)||1||
48389686|NCT01033487|101283427|FG009|STARTED|Between Period 4 and 5 (At Least 7 Days)||2||
48389687|NCT01033487|101283418|FG000|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2||
48389688|NCT01033487|101283419|FG001|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3||
48389689|NCT01033487|101283420|FG002|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2||
48389690|NCT01033487|101283421|FG003|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2||
48389691|NCT01033487|101283422|FG004|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2||
48389692|NCT01033487|101283423|FG005|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2||
48389693|NCT01033487|101283424|FG006|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2||
48389694|NCT01033487|101283425|FG007|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3||
48389695|NCT01033487|101283426|FG008|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||1||
48389696|NCT01033487|101283427|FG009|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2||
48389697|NCT01033487|101283418|FG000|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0||
48389698|NCT01033487|101283419|FG001|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0||
48389699|NCT01033487|101283420|FG002|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0||
48389700|NCT01033487|101283421|FG003|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0||
48389701|NCT01033487|101283422|FG004|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0||
48389702|NCT01033487|101283423|FG005|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0||
48389703|NCT01033487|101283424|FG006|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0||
48389704|NCT01033487|101283425|FG007|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0||
48389705|NCT01033487|101283426|FG008|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0||
48389706|NCT01033487|101283427|FG009|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0||
48389707|NCT01033487|101283418|FG000|STARTED|Fifth Intervention Period||2||
48389708|NCT01033487|101283419|FG001|STARTED|Fifth Intervention Period||3||
48389709|NCT01033487|101283420|FG002|STARTED|Fifth Intervention Period||2||
48389710|NCT01033487|101283421|FG003|STARTED|Fifth Intervention Period||2||
48389711|NCT01033487|101283422|FG004|STARTED|Fifth Intervention Period||2||
48389712|NCT01033487|101283423|FG005|STARTED|Fifth Intervention Period||2||
48389713|NCT01033487|101283424|FG006|STARTED|Fifth Intervention Period||2||
48389714|NCT01033487|101283425|FG007|STARTED|Fifth Intervention Period||3||
48389715|NCT01033487|101283426|FG008|STARTED|Fifth Intervention Period||1||
48389716|NCT01033487|101283427|FG009|STARTED|Fifth Intervention Period||2||
48389717|NCT01033487|101283418|FG000|COMPLETED|Fifth Intervention Period||2||
48389718|NCT01033487|101283419|FG001|COMPLETED|Fifth Intervention Period||3||
48389719|NCT01033487|101283420|FG002|COMPLETED|Fifth Intervention Period||2||
48389720|NCT01033487|101283421|FG003|COMPLETED|Fifth Intervention Period||2||
48389721|NCT01033487|101283422|FG004|COMPLETED|Fifth Intervention Period||2||
48389722|NCT01033487|101283423|FG005|COMPLETED|Fifth Intervention Period||2||
48389723|NCT01033487|101283424|FG006|COMPLETED|Fifth Intervention Period||2||
48389724|NCT01033487|101283425|FG007|COMPLETED|Fifth Intervention Period||3||
48389725|NCT01033487|101283426|FG008|COMPLETED|Fifth Intervention Period||1||
48389726|NCT01033487|101283427|FG009|COMPLETED|Fifth Intervention Period||2||
48389727|NCT01033487|101283418|FG000|NOT COMPLETED|Fifth Intervention Period||0||
48389728|NCT01033487|101283419|FG001|NOT COMPLETED|Fifth Intervention Period||0||
48389729|NCT01033487|101283420|FG002|NOT COMPLETED|Fifth Intervention Period||0||
48389730|NCT01033487|101283421|FG003|NOT COMPLETED|Fifth Intervention Period||0||
48389731|NCT01033487|101283422|FG004|NOT COMPLETED|Fifth Intervention Period||0||
48389732|NCT01033487|101283423|FG005|NOT COMPLETED|Fifth Intervention Period||0||
48389733|NCT01033487|101283424|FG006|NOT COMPLETED|Fifth Intervention Period||0||
48389734|NCT01033487|101283425|FG007|NOT COMPLETED|Fifth Intervention Period||0||
48389735|NCT01033487|101283426|FG008|NOT COMPLETED|Fifth Intervention Period||0||
48389736|NCT01033487|101283427|FG009|NOT COMPLETED|Fifth Intervention Period||0||
48389737|NCT03450915|101283428|FG000|STARTED|Overall Study||6230||
48389738|NCT03450915|101283429|FG001|STARTED|Overall Study||6230||
48389739|NCT03450915|101283428|FG000|COMPLETED|Overall Study||5827||
48389740|NCT03450915|101283429|FG001|COMPLETED|Overall Study||5855||
48389741|NCT03450915|101283428|FG000|NOT COMPLETED|Overall Study||403||
48260369|NCT00835185|100958915|FG000|NOT COMPLETED|Overall Study||0||
48260370|NCT02531867|100958916|FG000|STARTED|Overall Study||13||
48260371|NCT02531867|100958916|FG000|COMPLETED|Overall Study||13||
48260372|NCT02531867|100958916|FG000|NOT COMPLETED|Overall Study||0||
48260373|NCT02250534|100958917|FG000|STARTED|Overall Study||254||
48260374|NCT02250534|100958918|FG001|STARTED|Overall Study||235||
48389742|NCT03450915|101283429|FG001|NOT COMPLETED|Overall Study||375||
48389743|NCT04015440|101283430|FG000|STARTED|Overall Study||117||
48260375|NCT02250534|100958919|FG002|STARTED|Overall Study||286||
48389744|NCT04015440|101283431|FG001|STARTED|Overall Study||112||
48389745|NCT04015440|101283430|FG000|COMPLETED|Overall Study||109||
48389746|NCT04015440|101283431|FG001|COMPLETED|Overall Study||108||
48389747|NCT04015440|101283430|FG000|NOT COMPLETED|Overall Study||8||
48389748|NCT04015440|101283431|FG001|NOT COMPLETED|Overall Study||4||
48389749|NCT02443571|101283432|FG000|STARTED|Overall Study||596||
48389750|NCT02443571|101283433|FG001|STARTED|Overall Study||95||
48389751|NCT02443571|101283434|FG002|STARTED|Overall Study||23||
48389752|NCT02443571|101283432|FG000|COMPLETED|Overall Study||596||
48389753|NCT02443571|101283433|FG001|COMPLETED|Overall Study||95||
48389754|NCT02443571|101283434|FG002|COMPLETED|Overall Study||23||
48389755|NCT02443571|101283432|FG000|NOT COMPLETED|Overall Study||0||
48389756|NCT02443571|101283433|FG001|NOT COMPLETED|Overall Study||0||
48389757|NCT02443571|101283434|FG002|NOT COMPLETED|Overall Study||0||
48389758|NCT01175213|101283435|FG000|STARTED|IGSC, 10%/rHuPH20||63||
48389759|NCT01175213|101283436|FG001|STARTED|IGSC, 10%/rHuPH20||3||
48389760|NCT01175213|101283435|FG000|COMPLETED|IGSC, 10%/rHuPH20||48||
48389761|NCT01175213|101283436|FG001|COMPLETED|IGSC, 10%/rHuPH20||3||
48389762|NCT01175213|101283435|FG000|NOT COMPLETED|IGSC, 10%/rHuPH20||15||
48389763|NCT01175213|101283436|FG001|NOT COMPLETED|IGSC, 10%/rHuPH20||0||
48389764|NCT01175213|101283435|FG000|STARTED|Safety Follow-up||48||
48389765|NCT01175213|101283436|FG001|STARTED|Safety Follow-up||3||
48389766|NCT01175213|101283435|FG000|COMPLETED|Safety Follow-up||47||
48389767|NCT01175213|101283436|FG001|COMPLETED|Safety Follow-up||3||
48389768|NCT01175213|101283435|FG000|NOT COMPLETED|Safety Follow-up||1||
48389769|NCT01175213|101283436|FG001|NOT COMPLETED|Safety Follow-up||0||
48389770|NCT01164865|101283437|FG000|STARTED|Overall Study||39||
48389771|NCT01164865|101283438|FG001|STARTED|Overall Study||39||
48389772|NCT01164865|101283437|FG000|COMPLETED|Overall Study||37||
48389773|NCT01164865|101283438|FG001|COMPLETED|Overall Study||38||
48389774|NCT01164865|101283437|FG000|NOT COMPLETED|Overall Study||2||
48389775|NCT01164865|101283438|FG001|NOT COMPLETED|Overall Study||1||
48389776|NCT01626989|101283439|FG000|STARTED|Screening Period||44||
48260376|NCT02250534|100958917|FG000|COMPLETED|Overall Study||218||
48260377|NCT02250534|100958918|FG001|COMPLETED|Overall Study||190||
48260378|NCT02250534|100958919|FG002|COMPLETED|Overall Study||224||
48260379|NCT02250534|100958917|FG000|NOT COMPLETED|Overall Study||36||
48260380|NCT02250534|100958918|FG001|NOT COMPLETED|Overall Study||45||
48260381|NCT02250534|100958919|FG002|NOT COMPLETED|Overall Study||62||
48260382|NCT01606319|100958920|FG000|STARTED|Overall Study||150||
48389777|NCT01626989|101283440|FG001|STARTED|Screening Period||0||
48389778|NCT01626989|101283441|FG002|STARTED|Screening Period||0||
48389779|NCT01626989|101283439|FG000|COMPLETED|Screening Period||27||
48389780|NCT01626989|101283440|FG001|COMPLETED|Screening Period||0||
48260383|NCT01606319|100958921|FG001|STARTED|Overall Study||150||
48260384|NCT01606319|100958920|FG000|COMPLETED|Overall Study||116||
48260385|NCT01606319|100958921|FG001|COMPLETED|Overall Study||110||
48389781|NCT01626989|101283441|FG002|COMPLETED|Screening Period||0||
48389782|NCT01626989|101283439|FG000|NOT COMPLETED|Screening Period||17||
48389783|NCT01626989|101283440|FG001|NOT COMPLETED|Screening Period||0||
48389784|NCT01626989|101283441|FG002|NOT COMPLETED|Screening Period||0||
48389785|NCT01626989|101283439|FG000|STARTED|Fist Intervention (Night 1)||0||
48389786|NCT01626989|101283440|FG001|STARTED|Fist Intervention (Night 1)||15||
48389787|NCT01626989|101283441|FG002|STARTED|Fist Intervention (Night 1)||12||
48389788|NCT01626989|101283439|FG000|COMPLETED|Fist Intervention (Night 1)||0||
48389789|NCT01626989|101283440|FG001|COMPLETED|Fist Intervention (Night 1)||15||
48389790|NCT01626989|101283441|FG002|COMPLETED|Fist Intervention (Night 1)||12||
48389791|NCT01626989|101283439|FG000|NOT COMPLETED|Fist Intervention (Night 1)||0||
48389792|NCT01626989|101283440|FG001|NOT COMPLETED|Fist Intervention (Night 1)||0||
48389793|NCT01626989|101283441|FG002|NOT COMPLETED|Fist Intervention (Night 1)||0||
48389794|NCT01626989|101283439|FG000|STARTED|Second Intervention (Night 2)||0||
48389795|NCT01626989|101283440|FG001|STARTED|Second Intervention (Night 2)||15||
48389796|NCT01626989|101283441|FG002|STARTED|Second Intervention (Night 2)||12||
48389797|NCT01626989|101283439|FG000|COMPLETED|Second Intervention (Night 2)||0||
48389798|NCT01626989|101283440|FG001|COMPLETED|Second Intervention (Night 2)||15||
48389799|NCT01626989|101283441|FG002|COMPLETED|Second Intervention (Night 2)||12||
48389800|NCT01626989|101283439|FG000|NOT COMPLETED|Second Intervention (Night 2)||0||
48389801|NCT01626989|101283440|FG001|NOT COMPLETED|Second Intervention (Night 2)||0||
48389802|NCT01626989|101283441|FG002|NOT COMPLETED|Second Intervention (Night 2)||0||
48389803|NCT03017846|101283442|FG000|STARTED|Overall Study||30||
48260386|NCT01606319|100958920|FG000|NOT COMPLETED|Overall Study||34||
48260387|NCT01606319|100958921|FG001|NOT COMPLETED|Overall Study||40||
48260388|NCT04245345|100958922|FG000|STARTED|Overall Study||157||
48389804|NCT03017846|101283442|FG000|COMPLETED|Overall Study||25||
48389805|NCT03017846|101283442|FG000|NOT COMPLETED|Overall Study||5||
48389806|NCT03288324|101283443|FG000|STARTED|Overall Study||12||
48389807|NCT03288324|101283443|FG000|COMPLETED|Overall Study||11||
48389808|NCT03288324|101283443|FG000|NOT COMPLETED|Overall Study||1||
48389809|NCT02119026|101283444|FG000|STARTED|1st-line Treatment||58||
48389810|NCT02119026|101283445|FG001|STARTED|1st-line Treatment||62||
48389811|NCT02119026|101283444|FG000|COMPLETED|1st-line Treatment||32||
48389812|NCT02119026|101283445|FG001|COMPLETED|1st-line Treatment||24||
48389813|NCT02119026|101283444|FG000|NOT COMPLETED|1st-line Treatment||26||
48389814|NCT02119026|101283445|FG001|NOT COMPLETED|1st-line Treatment||38||
48389815|NCT02119026|101283444|FG000|STARTED|2nd-line Treatment||32||
48260389|NCT04245345|100958922|FG000|Implanted|Overall Study||152||
48260390|NCT04245345|100958922|FG000|1-month Visit|Overall Study||139||
48260391|NCT04245345|100958922|FG000|Complete Heart Block at 1-month|Overall Study||56||
48260392|NCT04245345|100958922|FG000|At Least 500 Evaluable Beats|Overall Study||54||
48260393|NCT04245345|100958922|FG000|COMPLETED|Overall Study||54||
48260394|NCT04245345|100958922|FG000|NOT COMPLETED|Overall Study||103||
48260395|NCT01522703|100958923|FG000|STARTED|Overall Study||25||
48260396|NCT01522703|100958924|FG001|STARTED|Overall Study||26||
48260397|NCT01522703|100958923|FG000|COMPLETED|Overall Study||20||
48260398|NCT01522703|100958924|FG001|COMPLETED|Overall Study||20||
48260399|NCT01522703|100958923|FG000|NOT COMPLETED|Overall Study||5||
48260400|NCT01522703|100958924|FG001|NOT COMPLETED|Overall Study||6||
48389816|NCT02119026|101283445|FG001|STARTED|2nd-line Treatment||24||
48389817|NCT02119026|101283444|FG000|COMPLETED|2nd-line Treatment||23||
48389818|NCT02119026|101283445|FG001|COMPLETED|2nd-line Treatment||22||
48389819|NCT02119026|101283444|FG000|NOT COMPLETED|2nd-line Treatment||9||
48389820|NCT02119026|101283445|FG001|NOT COMPLETED|2nd-line Treatment||2||
48389821|NCT00804843|101283446|FG000|STARTED|Overall Study||50||
48389822|NCT00804843|101283447|FG001|STARTED|Overall Study||50||
48389823|NCT00804843|101283446|FG000|COMPLETED|Overall Study||40||
48389824|NCT00804843|101283447|FG001|COMPLETED|Overall Study||43||
48389825|NCT00804843|101283446|FG000|NOT COMPLETED|Overall Study||10||
48389826|NCT00804843|101283447|FG001|NOT COMPLETED|Overall Study||7||
48389827|NCT02293993|101283448|FG000|STARTED|Course 1 (DLT Evaluation Period)||4||
48389828|NCT02293993|101283449|FG001|STARTED|Course 1 (DLT Evaluation Period)||6||
48389829|NCT02293993|101283450|FG002|STARTED|Course 1 (DLT Evaluation Period)||7||
48389830|NCT02293993|101283451|FG003|STARTED|Course 1 (DLT Evaluation Period)||4||
48389831|NCT02293993|101283448|FG000|COMPLETED|Course 1 (DLT Evaluation Period)||3||
48389832|NCT02293993|101283449|FG001|COMPLETED|Course 1 (DLT Evaluation Period)||6||
48389833|NCT02293993|101283450|FG002|COMPLETED|Course 1 (DLT Evaluation Period)||7||
48389834|NCT02293993|101283451|FG003|COMPLETED|Course 1 (DLT Evaluation Period)||3||
48389835|NCT02293993|101283448|FG000|NOT COMPLETED|Course 1 (DLT Evaluation Period)||1||
48389836|NCT02293993|101283449|FG001|NOT COMPLETED|Course 1 (DLT Evaluation Period)||0||
48389837|NCT02293993|101283450|FG002|NOT COMPLETED|Course 1 (DLT Evaluation Period)||0||
48389838|NCT02293993|101283451|FG003|NOT COMPLETED|Course 1 (DLT Evaluation Period)||1||
48389839|NCT02293993|101283448|FG000|STARTED|Course ≥2 (Extended Treatment Period)||2||
48389840|NCT02293993|101283449|FG001|STARTED|Course ≥2 (Extended Treatment Period)||5||
48389841|NCT02293993|101283450|FG002|STARTED|Course ≥2 (Extended Treatment Period)||6||
48096641|NCT01852942|100560462|FG000|NOT COMPLETED|Overall Study||5||
48096642|NCT01852942|100560463|FG001|NOT COMPLETED|Overall Study||6||
48096643|NCT01462084|100560464|FG000|STARTED|Overall Study||11||
48096644|NCT01462084|100560465|FG001|STARTED|Overall Study||10||
48096645|NCT01462084|100560464|FG000|Included for Analysis|Overall Study||9||
48096646|NCT01462084|100560465|FG001|Included for Analysis|Overall Study||9||
48096647|NCT01462084|100560464|FG000|COMPLETED|Overall Study||9||
48096648|NCT01462084|100560465|FG001|COMPLETED|Overall Study||9||
48096649|NCT01462084|100560464|FG000|NOT COMPLETED|Overall Study||2||
48096650|NCT01462084|100560465|FG001|NOT COMPLETED|Overall Study||1||
48096651|NCT01403246|100560466|FG000|STARTED|Overall Study||9||
48096652|NCT01403246|100560466|FG000|COMPLETED|Overall Study||9||
48096653|NCT01403246|100560466|FG000|NOT COMPLETED|Overall Study||0||
48096654|NCT01912287|100560467|FG000|STARTED|Overall Study||93||
48096655|NCT01912287|100560468|FG001|STARTED|Overall Study||90||
48096656|NCT01912287|100560469|FG002|STARTED|Overall Study||43||
48096657|NCT01912287|100560467|FG000|COMPLETED|Overall Study||60||
48096658|NCT01912287|100560468|FG001|COMPLETED|Overall Study||67||
48096659|NCT01912287|100560469|FG002|COMPLETED|Overall Study||28||
48096660|NCT01912287|100560467|FG000|NOT COMPLETED|Overall Study||33||
48096661|NCT01912287|100560468|FG001|NOT COMPLETED|Overall Study||23||
48096662|NCT01912287|100560469|FG002|NOT COMPLETED|Overall Study||15||
48260401|NCT02447718|100958925|FG000|STARTED|Overall Study||78||
48260402|NCT02447718|100958926|FG001|STARTED|Overall Study||78||
48260403|NCT02447718|100958925|FG000|Received Prevnar®13|Overall Study||74||
48260404|NCT02447718|100958926|FG001|Received Prevnar®13|Overall Study||0||
48260405|NCT02447718|100958925|FG000|Received Pediacel®|Overall Study||73||
48260406|NCT02447718|100958926|FG001|Received Pediacel®|Overall Study||0||
48260407|NCT02447718|100958925|FG000|Received Pneumovax® 23|Overall Study||73||
48260408|NCT02447718|100958926|FG001|Received Pneumovax® 23|Overall Study||0||
48260409|NCT02447718|100958925|FG000|COMPLETED|Overall Study||66||
48260410|NCT02447718|100958926|FG001|COMPLETED|Overall Study||78||
48260411|NCT02447718|100958925|FG000|NOT COMPLETED|Overall Study||12||
48260412|NCT02447718|100958926|FG001|NOT COMPLETED|Overall Study||0||
48389842|NCT02293993|101283451|FG003|STARTED|Course ≥2 (Extended Treatment Period)||3||
48389843|NCT02293993|101283448|FG000|COMPLETED|Course ≥2 (Extended Treatment Period)||0||
48096663|NCT01475331|100560470|FG000|STARTED|Overall Study||23||
48096664|NCT01475331|100560471|FG001|STARTED|Overall Study||23||
48096665|NCT01475331|100560470|FG000|COMPLETED|Overall Study||18||
48096666|NCT01475331|100560471|FG001|COMPLETED|Overall Study||21||
48389844|NCT02293993|101283449|FG001|COMPLETED|Course ≥2 (Extended Treatment Period)||0||
48389845|NCT02293993|101283450|FG002|COMPLETED|Course ≥2 (Extended Treatment Period)||1||
48389846|NCT02293993|101283451|FG003|COMPLETED|Course ≥2 (Extended Treatment Period)||2||
48389847|NCT02293993|101283448|FG000|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||2||
48389848|NCT02293993|101283449|FG001|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||5||
48389849|NCT02293993|101283450|FG002|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||5||
48389850|NCT02293993|101283451|FG003|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||1||
48389851|NCT01074658|101283452|FG000|STARTED|Overall Study||1015||
48389852|NCT01074658|101283452|FG000|Attempted Implant|Overall Study||996||
48389853|NCT01074658|101283452|FG000|COMPLETED|Overall Study||996||
48389854|NCT01074658|101283452|FG000|NOT COMPLETED|Overall Study||19||
48389855|NCT01184846|101283453|FG000|STARTED|Overall Study||28||
48389856|NCT01184846|101283453|FG000|COMPLETED|Overall Study||25||
48389857|NCT01184846|101283453|FG000|NOT COMPLETED|Overall Study||3||
48389858|NCT03728504|101283454|FG000|STARTED|Overall Study||33||
48389859|NCT03728504|101283455|FG001|STARTED|Overall Study||32||
48389860|NCT03728504|101283456|FG002|STARTED|Overall Study||32||
48389861|NCT03728504|101283454|FG000|COMPLETED|Overall Study||27||
48389862|NCT03728504|101283455|FG001|COMPLETED|Overall Study||19||
48389863|NCT03728504|101283456|FG002|COMPLETED|Overall Study||22||
48689888|NCT02443337|102022795|FG000|NOT COMPLETED|Overall Study||5||
48689889|NCT02443337|102022796|FG001|NOT COMPLETED|Overall Study||2||
48689890|NCT01309204|102022797|FG000|STARTED|Overall Study||452||
48689891|NCT01309204|102022798|FG001|STARTED|Overall Study||436||
48689892|NCT01309204|102022797|FG000|COMPLETED|Overall Study||385||
48689893|NCT01309204|102022798|FG001|COMPLETED|Overall Study||361||
48689894|NCT01309204|102022797|FG000|NOT COMPLETED|Overall Study||67||
48689895|NCT01309204|102022798|FG001|NOT COMPLETED|Overall Study||75||
48689896|NCT02997865|102022799|FG000|STARTED|Overall Study||69||
48689897|NCT02997865|102022800|FG001|STARTED|Overall Study||70||
48689898|NCT02997865|102022799|FG000|COMPLETED|Overall Study||56||
48689899|NCT02997865|102022800|FG001|COMPLETED|Overall Study||66||
48689900|NCT02997865|102022799|FG000|NOT COMPLETED|Overall Study||13||
48689901|NCT02997865|102022800|FG001|NOT COMPLETED|Overall Study||4||
48689902|NCT01127633|102022801|FG000|STARTED|Overall Study||723||
48689903|NCT01127633|102022802|FG001|STARTED|Overall Study||734||
48689904|NCT01127633|102022801|FG000|Received at Least 1 Dose of Study Drug|Overall Study||723||
48689905|NCT01127633|102022802|FG001|Received at Least 1 Dose of Study Drug|Overall Study||734||
48689906|NCT01127633|102022801|FG000|COMPLETED|Overall Study||70||
48689907|NCT01127633|102022802|FG001|COMPLETED|Overall Study||61||
48689908|NCT01127633|102022801|FG000|NOT COMPLETED|Overall Study||653||
48689909|NCT01127633|102022802|FG001|NOT COMPLETED|Overall Study||673||
48689910|NCT00508105|102022803|FG000|STARTED|Overall Study||44||
48689911|NCT00508105|102022804|FG001|STARTED|Overall Study||43||
48389864|NCT03728504|101283454|FG000|NOT COMPLETED|Overall Study||6||
48389865|NCT03728504|101283455|FG001|NOT COMPLETED|Overall Study||13||
48389866|NCT03728504|101283456|FG002|NOT COMPLETED|Overall Study||10||
48389867|NCT03115112|101283457|FG000|STARTED|Overall Study||192||
48389868|NCT03115112|101283458|FG001|STARTED|Overall Study||194||
48389869|NCT03115112|101283457|FG000|Intention-to-treat|Overall Study||191|One randomized subject in each group was excluded in the ITT and the safety populations due to site closure for GCP violation.|
48389870|NCT03115112|101283458|FG001|Intention-to-treat|Overall Study||193|One randomized subject in each group was excluded in the ITT and the safety populations due to site closure for GCP violation.|
48389871|NCT03115112|101283457|FG000|COMPLETED|Overall Study||180||
48389872|NCT03115112|101283458|FG001|COMPLETED|Overall Study||189||
48389873|NCT03115112|101283457|FG000|NOT COMPLETED|Overall Study||12||
48389874|NCT03115112|101283458|FG001|NOT COMPLETED|Overall Study||5||
48389875|NCT00098020|101283459|FG000|STARTED|Overall Study||12||
48389876|NCT00098020|101283459|FG000|Started Isotretinoin|Overall Study||8||
48389877|NCT00098020|101283459|FG000|COMPLETED|Overall Study||6||
48689912|NCT00508105|102022803|FG000|COMPLETED|Overall Study||40||
48689913|NCT00508105|102022804|FG001|COMPLETED|Overall Study||37||
48689914|NCT00508105|102022803|FG000|NOT COMPLETED|Overall Study||4||
48689915|NCT00508105|102022804|FG001|NOT COMPLETED|Overall Study||6||
48689916|NCT01433042|102022805|FG000|STARTED|Overall Study||225||
48689917|NCT01433042|102022805|FG000|COMPLETED|Overall Study||224||
48689918|NCT01433042|102022805|FG000|NOT COMPLETED|Overall Study||1||
48689919|NCT02236572|102022806|FG000|STARTED|Overall Study||17||
48689920|NCT02236572|102022806|FG000|COMPLETED|Overall Study||14||
48689921|NCT02236572|102022806|FG000|NOT COMPLETED|Overall Study||3||
48689922|NCT01673854|102022807|FG000|STARTED|Vem 1 Phase (Vemurafenib, 960 mg)||46||
48689923|NCT01673854|102022807|FG000|COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||46||
48689924|NCT01673854|102022807|FG000|NOT COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||0||
48689925|NCT01673854|102022807|FG000|STARTED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||46||
48689926|NCT01673854|102022807|FG000|COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||19||
48689927|NCT01673854|102022807|FG000|NOT COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||27||
48689928|NCT01673854|102022807|FG000|STARTED|Vem 2 Phase (Vemurafenib Retreatment)||19||
48689929|NCT01673854|102022807|FG000|COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||0||
48689930|NCT01673854|102022807|FG000|NOT COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||19||
48689931|NCT01886235|102022808|FG000|STARTED|Overall Study||10||
48689932|NCT01886235|102022808|FG000|COMPLETED|Overall Study||10||
48689933|NCT01886235|102022808|FG000|NOT COMPLETED|Overall Study||0||
48689934|NCT01135459|102022809|FG000|STARTED|Overall Study||92||
48389878|NCT00098020|101283459|FG000|NOT COMPLETED|Overall Study||6||
48389879|NCT01151540|101283460|FG000|STARTED|Overall Study||54||
48389880|NCT01151540|101283460|FG000|COMPLETED|Overall Study||41||
48389881|NCT01151540|101283460|FG000|NOT COMPLETED|Overall Study||13||
48389882|NCT03846219|101283461|FG000|STARTED|Overall Study||72|Patients randomized|
48389883|NCT03846219|101283462|FG001|STARTED|Overall Study||69|Patients randomized|
48389884|NCT03846219|101283463|FG002|STARTED|Overall Study||69|Patients randomized|
48260413|NCT02460562|100958927|FG000|STARTED|Overall Study||74||
48260414|NCT02460562|100958928|FG001|STARTED|Overall Study||76||
48260415|NCT02460562|100958927|FG000|COMPLETED|Overall Study||59||
48260416|NCT02460562|100958928|FG001|COMPLETED|Overall Study||60||
48260417|NCT02460562|100958927|FG000|NOT COMPLETED|Overall Study||15||
48260418|NCT02460562|100958928|FG001|NOT COMPLETED|Overall Study||16||
48260419|NCT00810342|100958929|FG000|STARTED|Month 1 Follow-up||154||
48260420|NCT00810342|100958930|FG001|STARTED|Month 1 Follow-up||157||
48260421|NCT00810342|100958929|FG000|COMPLETED|Month 1 Follow-up||149||
48260422|NCT00810342|100958930|FG001|COMPLETED|Month 1 Follow-up||155||
48260423|NCT00810342|100958929|FG000|NOT COMPLETED|Month 1 Follow-up||5||
48389885|NCT03846219|101283461|FG000|Patients Treated|Overall Study||71||
48389886|NCT03846219|101283462|FG001|Patients Treated|Overall Study||69||
48389887|NCT03846219|101283463|FG002|Patients Treated|Overall Study||69||
48389888|NCT03846219|101283461|FG000|COMPLETED|Overall Study||69||
48389889|NCT03846219|101283462|FG001|COMPLETED|Overall Study||65||
48389890|NCT03846219|101283463|FG002|COMPLETED|Overall Study||64||
48389891|NCT03846219|101283461|FG000|NOT COMPLETED|Overall Study||3||
48389892|NCT03846219|101283462|FG001|NOT COMPLETED|Overall Study||4||
48389893|NCT03846219|101283463|FG002|NOT COMPLETED|Overall Study||5||
48389894|NCT02677220|101283464|FG000|STARTED|Overall Study||1||
48389895|NCT02677220|101283464|FG000|COMPLETED|Overall Study||0||
48389896|NCT02677220|101283464|FG000|NOT COMPLETED|Overall Study||1||
48389897|NCT00718666|101283465|FG000|STARTED|Persistence Phase Year 1||118||
48389898|NCT00718666|101283466|FG001|STARTED|Persistence Phase Year 1||130||
48389899|NCT00718666|101283467|FG002|STARTED|Persistence Phase Year 1||0||
48389900|NCT00718666|101283465|FG000|COMPLETED|Persistence Phase Year 1||118||
48389901|NCT00718666|101283466|FG001|COMPLETED|Persistence Phase Year 1||130||
48389902|NCT00718666|101283467|FG002|COMPLETED|Persistence Phase Year 1||0||
48389903|NCT00718666|101283465|FG000|NOT COMPLETED|Persistence Phase Year 1||0||
48260424|NCT00810342|100958930|FG001|NOT COMPLETED|Month 1 Follow-up||2||
48260425|NCT00810342|100958929|FG000|STARTED|6-month Follow-up||149||
48260426|NCT00810342|100958930|FG001|STARTED|6-month Follow-up||155||
48260427|NCT00810342|100958929|FG000|COMPLETED|6-month Follow-up||125||
48260428|NCT00810342|100958930|FG001|COMPLETED|6-month Follow-up||147||
48260429|NCT00810342|100958929|FG000|NOT COMPLETED|6-month Follow-up||24||
48389904|NCT00718666|101283466|FG001|NOT COMPLETED|Persistence Phase Year 1||0||
48389905|NCT00718666|101283467|FG002|NOT COMPLETED|Persistence Phase Year 1||0||
48389906|NCT00718666|101283465|FG000|STARTED|Persistence Phase Year 3||98||
48389907|NCT00718666|101283466|FG001|STARTED|Persistence Phase Year 3||104||
48389908|NCT00718666|101283467|FG002|STARTED|Persistence Phase Year 3||0||
48389909|NCT00718666|101283465|FG000|COMPLETED|Persistence Phase Year 3||98||
48389910|NCT00718666|101283466|FG001|COMPLETED|Persistence Phase Year 3||104||
48389911|NCT00718666|101283467|FG002|COMPLETED|Persistence Phase Year 3||0||
48389912|NCT00718666|101283465|FG000|NOT COMPLETED|Persistence Phase Year 3||0||
48389913|NCT00718666|101283466|FG001|NOT COMPLETED|Persistence Phase Year 3||0||
48389914|NCT00718666|101283467|FG002|NOT COMPLETED|Persistence Phase Year 3||0||
48389915|NCT00718666|101283465|FG000|STARTED|Persistence Phase Year 5||70||
48389916|NCT00718666|101283466|FG001|STARTED|Persistence Phase Year 5||82||
48389917|NCT00718666|101283467|FG002|STARTED|Persistence Phase Year 5||0||
48389918|NCT00718666|101283465|FG000|COMPLETED|Persistence Phase Year 5||70||
48389919|NCT00718666|101283466|FG001|COMPLETED|Persistence Phase Year 5||82||
48389920|NCT00718666|101283467|FG002|COMPLETED|Persistence Phase Year 5||0||
48389921|NCT00718666|101283465|FG000|NOT COMPLETED|Persistence Phase Year 5||0||
48389922|NCT00718666|101283466|FG001|NOT COMPLETED|Persistence Phase Year 5||0||
48389923|NCT00718666|101283467|FG002|NOT COMPLETED|Persistence Phase Year 5||0||
48389924|NCT00718666|101283465|FG000|STARTED|Booster Phase Year 5||38||
48389925|NCT00718666|101283466|FG001|STARTED|Booster Phase Year 5||46||
48389926|NCT00718666|101283467|FG002|STARTED|Booster Phase Year 5||100||
48389927|NCT00718666|101283465|FG000|COMPLETED|Booster Phase Year 5||36||
48260430|NCT00810342|100958930|FG001|NOT COMPLETED|6-month Follow-up||8||
48260431|NCT00810342|100958929|FG000|STARTED|12-month Followup||125||
48260432|NCT00810342|100958930|FG001|STARTED|12-month Followup||147||
48260433|NCT00810342|100958929|FG000|COMPLETED|12-month Followup||113||
48260434|NCT00810342|100958930|FG001|COMPLETED|12-month Followup||136||
48260435|NCT00810342|100958929|FG000|NOT COMPLETED|12-month Followup||12||
48389928|NCT00718666|101283466|FG001|COMPLETED|Booster Phase Year 5||46||
48389929|NCT00718666|101283467|FG002|COMPLETED|Booster Phase Year 5||94||
48389930|NCT00718666|101283465|FG000|NOT COMPLETED|Booster Phase Year 5||2||
48389931|NCT00718666|101283466|FG001|NOT COMPLETED|Booster Phase Year 5||0||
48389932|NCT00718666|101283467|FG002|NOT COMPLETED|Booster Phase Year 5||6||
48260436|NCT00810342|100958930|FG001|NOT COMPLETED|12-month Followup||11||
48260437|NCT02138097|100958931|FG000|STARTED|Overall Study||155345||
48260438|NCT02138097|100958932|FG001|STARTED|Overall Study||459722||
48542236|NCT00863772|101662895|FG000|COMPLETED|Overall Study||6||
48542237|NCT00863772|101662896|FG001|COMPLETED|Overall Study||9||
48542238|NCT00863772|101662897|FG002|COMPLETED|Overall Study||11||
48542239|NCT00863772|101662895|FG000|NOT COMPLETED|Overall Study||68||
48542240|NCT00863772|101662896|FG001|NOT COMPLETED|Overall Study||65||
48542241|NCT00863772|101662897|FG002|NOT COMPLETED|Overall Study||61||
48542242|NCT03578549|101662898|FG000|STARTED|Overall Study||30||
48542243|NCT03578549|101662898|FG000|COMPLETED|Overall Study||29||
48096667|NCT01475331|100560470|FG000|NOT COMPLETED|Overall Study||5||
48260439|NCT02138097|100958931|FG000|COMPLETED|Overall Study||155345||
48542244|NCT03578549|101662898|FG000|NOT COMPLETED|Overall Study||1||
48542245|NCT01727726|101662899|FG000|STARTED|Overall Study||197||
48542246|NCT01727726|101662900|FG001|STARTED|Overall Study||100||
48542247|NCT01727726|101662901|FG002|STARTED|Overall Study||206||
48542248|NCT01727726|101662899|FG000|COMPLETED|Overall Study||171||
48542249|NCT01727726|101662900|FG001|COMPLETED|Overall Study||86||
48542250|NCT01727726|101662901|FG002|COMPLETED|Overall Study||186||
48542251|NCT01727726|101662899|FG000|NOT COMPLETED|Overall Study||26||
48542252|NCT01727726|101662900|FG001|NOT COMPLETED|Overall Study||14||
48542253|NCT01727726|101662901|FG002|NOT COMPLETED|Overall Study||20||
48542254|NCT01434810|101662902|FG000|STARTED|Overall Study||224||
48542255|NCT01434810|101662903|FG001|STARTED|Overall Study||223||
48542256|NCT01434810|101662902|FG000|COMPLETED|Overall Study||201||
48542257|NCT01434810|101662903|FG001|COMPLETED|Overall Study||213||
48542258|NCT01434810|101662902|FG000|NOT COMPLETED|Overall Study||23||
48542259|NCT01434810|101662903|FG001|NOT COMPLETED|Overall Study||10||
48542260|NCT02691143|101662904|FG000|STARTED|Overall Study||27||
48542261|NCT02691143|101662905|FG001|STARTED|Overall Study||23||
48542262|NCT02691143|101662904|FG000|COMPLETED|Overall Study||27||
48542263|NCT02691143|101662905|FG001|COMPLETED|Overall Study||23||
48542264|NCT02691143|101662904|FG000|NOT COMPLETED|Overall Study||0||
48542265|NCT02691143|101662905|FG001|NOT COMPLETED|Overall Study||0||
48542266|NCT00875797|101662906|FG000|STARTED|Overall Study||45||
48542267|NCT00875797|101662907|FG001|STARTED|Overall Study||45||
48542268|NCT00875797|101662906|FG000|COMPLETED|Overall Study||39||
48542269|NCT00875797|101662907|FG001|COMPLETED|Overall Study||42||
48542270|NCT00875797|101662906|FG000|NOT COMPLETED|Overall Study||6||
48542271|NCT00875797|101662907|FG001|NOT COMPLETED|Overall Study||3||
48542272|NCT03086551|101662908|FG000|STARTED|First Intervention||5||
48542273|NCT03086551|101662909|FG001|STARTED|First Intervention||5||
48542274|NCT03086551|101662908|FG000|COMPLETED|First Intervention||4||
48542275|NCT03086551|101662909|FG001|COMPLETED|First Intervention||4||
48542276|NCT03086551|101662908|FG000|NOT COMPLETED|First Intervention||1||
48542277|NCT03086551|101662909|FG001|NOT COMPLETED|First Intervention||1||
48542278|NCT03086551|101662908|FG000|STARTED|Washout||4||
48542279|NCT03086551|101662909|FG001|STARTED|Washout||4||
48542280|NCT03086551|101662908|FG000|COMPLETED|Washout||1||
48542281|NCT03086551|101662909|FG001|COMPLETED|Washout||1||
48542282|NCT03086551|101662908|FG000|NOT COMPLETED|Washout||3||
48542283|NCT03086551|101662909|FG001|NOT COMPLETED|Washout||3||
48542284|NCT03086551|101662908|FG000|STARTED|Second Intervention||1||
48689935|NCT01135459|102022810|FG001|STARTED|Overall Study||91||
48689936|NCT01135459|102022809|FG000|Received at Least 1 Dose of Study Drug|Overall Study||92||
48689937|NCT01135459|102022810|FG001|Received at Least 1 Dose of Study Drug|Overall Study||91||
48689938|NCT01135459|102022809|FG000|COMPLETED|Overall Study||71||
48689939|NCT01135459|102022810|FG001|COMPLETED|Overall Study||71||
48689940|NCT01135459|102022809|FG000|NOT COMPLETED|Overall Study||21||
48689941|NCT01135459|102022810|FG001|NOT COMPLETED|Overall Study||20||
48689942|NCT00803738|102022811|FG000|STARTED|Overall Study||286||
48689943|NCT00803738|102022812|FG001|STARTED|Overall Study||286||
48689944|NCT00803738|102022811|FG000|COMPLETED|Overall Study||192||
48689945|NCT00803738|102022812|FG001|COMPLETED|Overall Study||176||
48689946|NCT00803738|102022811|FG000|NOT COMPLETED|Overall Study||94||
48689947|NCT00803738|102022812|FG001|NOT COMPLETED|Overall Study||110||
48260440|NCT02138097|100958932|FG001|COMPLETED|Overall Study||459722||
48260441|NCT02138097|100958931|FG000|NOT COMPLETED|Overall Study||0||
48260442|NCT02138097|100958932|FG001|NOT COMPLETED|Overall Study||0||
48542285|NCT03086551|101662909|FG001|STARTED|Second Intervention||1||
48542286|NCT03086551|101662908|FG000|COMPLETED|Second Intervention||1||
48542287|NCT03086551|101662909|FG001|COMPLETED|Second Intervention||1||
48542288|NCT03086551|101662908|FG000|NOT COMPLETED|Second Intervention||0||
48542289|NCT03086551|101662909|FG001|NOT COMPLETED|Second Intervention||0||
48542290|NCT00704847|101662910|FG000|STARTED|Overall Study||521||
48689948|NCT02936869|102022813|FG000|STARTED|Overall Study||104||
48689949|NCT02936869|102022814|FG001|STARTED|Overall Study||103||
48689950|NCT02936869|102022813|FG000|COMPLETED|Overall Study||102||
48260443|NCT02562898|100958933|FG000|STARTED|Overall Study||10||
48542291|NCT00704847|101662911|FG001|STARTED|Overall Study||509||
48542292|NCT00704847|101662910|FG000|COMPLETED|Overall Study||300||
48542293|NCT00704847|101662911|FG001|COMPLETED|Overall Study||339||
48542294|NCT00704847|101662910|FG000|NOT COMPLETED|Overall Study||221||
48542295|NCT00704847|101662911|FG001|NOT COMPLETED|Overall Study||170||
48689951|NCT02936869|102022814|FG001|COMPLETED|Overall Study||98||
48689952|NCT02936869|102022813|FG000|NOT COMPLETED|Overall Study||2||
48689953|NCT02936869|102022814|FG001|NOT COMPLETED|Overall Study||5||
48542296|NCT02203331|101662912|FG000|STARTED|Overall Study||52||
48542297|NCT02203331|101662913|FG001|STARTED|Overall Study||53||
48542298|NCT02203331|101662914|FG002|STARTED|Overall Study||55||
48542299|NCT02203331|101662915|FG003|STARTED|Overall Study||53||
48542300|NCT02203331|101662916|FG004|STARTED|Overall Study||53||
48542301|NCT02203331|101662917|FG005|STARTED|Overall Study||53||
48542302|NCT02203331|101662912|FG000|Treated|Overall Study||49||
48542303|NCT02203331|101662913|FG001|Treated|Overall Study||50||
48542304|NCT02203331|101662914|FG002|Treated|Overall Study||54||
48542305|NCT02203331|101662915|FG003|Treated|Overall Study||49||
48542306|NCT02203331|101662916|FG004|Treated|Overall Study||50||
48542307|NCT02203331|101662917|FG005|Treated|Overall Study||53||
48542308|NCT02203331|101662912|FG000|COMPLETED|Overall Study||45||
48542309|NCT02203331|101662913|FG001|COMPLETED|Overall Study||39||
48542310|NCT02203331|101662914|FG002|COMPLETED|Overall Study||50||
48096668|NCT01475331|100560471|FG001|NOT COMPLETED|Overall Study||2||
48096669|NCT00255047|100560472|FG000|STARTED|Overall Study||538||
48096670|NCT00255047|100560473|FG001|STARTED|Overall Study||535||
48096671|NCT00255047|100560474|FG002|STARTED|Overall Study||546||
48096672|NCT00255047|100560475|FG003|STARTED|Overall Study||548||
48096673|NCT00255047|100560472|FG000|COMPLETED|Overall Study||490||
48096674|NCT00255047|100560473|FG001|COMPLETED|Overall Study||487||
48096675|NCT00255047|100560474|FG002|COMPLETED|Overall Study||496||
48096676|NCT00255047|100560475|FG003|COMPLETED|Overall Study||502||
48096677|NCT00255047|100560472|FG000|NOT COMPLETED|Overall Study||48||
48096678|NCT00255047|100560473|FG001|NOT COMPLETED|Overall Study||48||
48096679|NCT00255047|100560474|FG002|NOT COMPLETED|Overall Study||50||
48096680|NCT00255047|100560475|FG003|NOT COMPLETED|Overall Study||46||
48096681|NCT00772772|100560476|FG000|STARTED|Overall Study||12||
48096682|NCT00772772|100560476|FG000|COMPLETED|Overall Study||12||
48096683|NCT00772772|100560476|FG000|NOT COMPLETED|Overall Study||0||
48096684|NCT01077804|100560477|FG000|STARTED|Overall Study||7585||
48096685|NCT01077804|100560477|FG000|COMPLETED|Overall Study||7386||
48096686|NCT01077804|100560477|FG000|NOT COMPLETED|Overall Study||199||
48096687|NCT02451839|100560478|FG000|STARTED|Overall Study||72||
48096688|NCT02451839|100560479|FG001|STARTED|Overall Study||59||
48096689|NCT02451839|100560480|FG002|STARTED|Overall Study||37||
48096690|NCT02451839|100560478|FG000|Baseline WHODAS Data Recorded|Overall Study||70||
48096691|NCT02451839|100560479|FG001|Baseline WHODAS Data Recorded|Overall Study||57||
48096692|NCT02451839|100560480|FG002|Baseline WHODAS Data Recorded|Overall Study||37||
48096693|NCT02451839|100560478|FG000|COMPLETED|Overall Study||44||
48096694|NCT02451839|100560479|FG001|COMPLETED|Overall Study||40||
48096695|NCT02451839|100560480|FG002|COMPLETED|Overall Study||30||
48096696|NCT02451839|100560478|FG000|NOT COMPLETED|Overall Study||28||
48096697|NCT02451839|100560479|FG001|NOT COMPLETED|Overall Study||19||
48542311|NCT02203331|101662915|FG003|COMPLETED|Overall Study||46||
48542312|NCT02203331|101662916|FG004|COMPLETED|Overall Study||46||
48542313|NCT02203331|101662917|FG005|COMPLETED|Overall Study||46||
48542314|NCT02203331|101662912|FG000|NOT COMPLETED|Overall Study||7||
48542315|NCT02203331|101662913|FG001|NOT COMPLETED|Overall Study||14||
48542316|NCT02203331|101662914|FG002|NOT COMPLETED|Overall Study||5||
48542317|NCT02203331|101662915|FG003|NOT COMPLETED|Overall Study||7||
48542318|NCT02203331|101662916|FG004|NOT COMPLETED|Overall Study||7||
48542319|NCT02203331|101662917|FG005|NOT COMPLETED|Overall Study||7||
48542320|NCT01243775|101662918|FG000|STARTED|Overall Study||33||
48542321|NCT01243775|101662918|FG000|COMPLETED|Overall Study||31||
48542322|NCT01243775|101662918|FG000|NOT COMPLETED|Overall Study||2||
48542323|NCT01559389|101662919|FG000|STARTED|Overall Study||69||
48542324|NCT01559389|101662920|FG001|STARTED|Overall Study||69||
48542325|NCT01559389|101662919|FG000|COMPLETED|Overall Study||49||
48542326|NCT01559389|101662920|FG001|COMPLETED|Overall Study||49||
48542327|NCT01559389|101662919|FG000|NOT COMPLETED|Overall Study||20||
48542328|NCT01559389|101662920|FG001|NOT COMPLETED|Overall Study||20||
48542329|NCT03203850|101662921|FG000|STARTED|Overall Study||30||
48542330|NCT03203850|101662922|FG001|STARTED|Overall Study||15||
48542331|NCT03203850|101662921|FG000|COMPLETED|Overall Study||22||
48542332|NCT03203850|101662922|FG001|COMPLETED|Overall Study||12||
48542333|NCT03203850|101662921|FG000|NOT COMPLETED|Overall Study||8||
48542334|NCT03203850|101662922|FG001|NOT COMPLETED|Overall Study||3||
48542335|NCT00794508|101662923|FG000|STARTED|Overall Study||10||
48542336|NCT00794508|101662923|FG000|COMPLETED|Overall Study||10||
48542337|NCT00794508|101662923|FG000|NOT COMPLETED|Overall Study||0||
48542338|NCT00950365|101662924|FG000|STARTED|Overall Study||27||
48096698|NCT02451839|100560480|FG002|NOT COMPLETED|Overall Study||7||
48096699|NCT01013701|100560481|FG000|STARTED|Overall Study||7||
48542339|NCT00950365|101662925|FG001|STARTED|Overall Study||52||
48542340|NCT00950365|101662924|FG000|COMPLETED|Overall Study||25||
48542341|NCT00950365|101662925|FG001|COMPLETED|Overall Study||50||
48096700|NCT01013701|100560481|FG000|COMPLETED|Overall Study||0||
48096701|NCT01013701|100560481|FG000|NOT COMPLETED|Overall Study||7||
48096702|NCT01404325|100560482|FG000|STARTED|Overall Study||67||
48542342|NCT00950365|101662924|FG000|NOT COMPLETED|Overall Study||2||
48096703|NCT01404325|100560483|FG001|STARTED|Overall Study||63||
48096704|NCT01404325|100560482|FG000|COMPLETED|Overall Study||63||
48096705|NCT01404325|100560483|FG001|COMPLETED|Overall Study||61||
48096706|NCT01404325|100560482|FG000|NOT COMPLETED|Overall Study||4||
48096707|NCT01404325|100560483|FG001|NOT COMPLETED|Overall Study||2||
48096708|NCT02140567|100560484|FG000|STARTED|Overall Study||140||
48096709|NCT02140567|100560484|FG000|COMPLETED|Overall Study||134||
48096710|NCT02140567|100560484|FG000|NOT COMPLETED|Overall Study||6||
48096711|NCT01805024|100560485|FG000|STARTED|Overall Study||4||
48096712|NCT01805024|100560486|FG001|STARTED|Overall Study||4||
48096713|NCT01805024|100560487|FG002|STARTED|Overall Study||4||
48096714|NCT01805024|100560488|FG003|STARTED|Overall Study||8||
48096715|NCT01805024|100560485|FG000|COMPLETED|Overall Study||4||
48096716|NCT01805024|100560486|FG001|COMPLETED|Overall Study||4||
48096717|NCT01805024|100560487|FG002|COMPLETED|Overall Study||4||
48096718|NCT01805024|100560488|FG003|COMPLETED|Overall Study||8||
48096719|NCT01805024|100560485|FG000|NOT COMPLETED|Overall Study||0||
48096720|NCT01805024|100560486|FG001|NOT COMPLETED|Overall Study||0||
48096721|NCT01805024|100560487|FG002|NOT COMPLETED|Overall Study||0||
48096722|NCT01805024|100560488|FG003|NOT COMPLETED|Overall Study||0||
48096723|NCT02409459|100560489|FG000|STARTED|Overall Study||41||
48096724|NCT02409459|100560490|FG001|STARTED|Overall Study||40||
48096725|NCT02409459|100560489|FG000|COMPLETED|Overall Study||40||
48096726|NCT02409459|100560490|FG001|COMPLETED|Overall Study||39||
48096727|NCT02409459|100560489|FG000|NOT COMPLETED|Overall Study||1||
48096728|NCT02409459|100560490|FG001|NOT COMPLETED|Overall Study||1||
48096729|NCT01505868|100560491|FG000|STARTED|Overall Study||4||
48096730|NCT01505868|100560492|FG001|STARTED|Overall Study||3||
48096731|NCT01505868|100560493|FG002|STARTED|Overall Study||3||
48096732|NCT01505868|100560494|FG003|STARTED|Overall Study||79||
48096733|NCT01505868|100560495|FG004|STARTED|Overall Study||81||
48096734|NCT01505868|100560491|FG000|COMPLETED|Overall Study||3||
48096735|NCT01505868|100560492|FG001|COMPLETED|Overall Study||3||
48096736|NCT01505868|100560493|FG002|COMPLETED|Overall Study||3||
48096737|NCT01505868|100560494|FG003|COMPLETED|Overall Study||79||
48096738|NCT01505868|100560495|FG004|COMPLETED|Overall Study||81||
48096739|NCT01505868|100560491|FG000|NOT COMPLETED|Overall Study||1||
48096740|NCT01505868|100560492|FG001|NOT COMPLETED|Overall Study||0||
48096741|NCT01505868|100560493|FG002|NOT COMPLETED|Overall Study||0||
48096742|NCT01505868|100560494|FG003|NOT COMPLETED|Overall Study||0||
48096743|NCT01505868|100560495|FG004|NOT COMPLETED|Overall Study||0||
48096744|NCT03441633|100560496|FG000|STARTED|Overall Study||4712||
48096745|NCT03441633|100560497|FG001|STARTED|Overall Study||1423||
48096746|NCT03441633|100560498|FG002|STARTED|Overall Study||32212||
48096747|NCT03441633|100560499|FG003|STARTED|Overall Study||192||
48096748|NCT03441633|100560500|FG004|STARTED|Overall Study||2286||
48096749|NCT03441633|100560501|FG005|STARTED|Overall Study||363||
48096750|NCT03441633|100560502|FG006|STARTED|Overall Study||2855||
48096751|NCT03441633|100560503|FG007|STARTED|Overall Study||953||
48096752|NCT03441633|100560504|FG008|STARTED|Overall Study||5132||
48096753|NCT03441633|100560505|FG009|STARTED|Overall Study||1562||
48096754|NCT03441633|100560496|FG000|COMPLETED|Overall Study||4712||
48096755|NCT03441633|100560497|FG001|COMPLETED|Overall Study||1423||
48096756|NCT03441633|100560498|FG002|COMPLETED|Overall Study||32212||
48096757|NCT03441633|100560499|FG003|COMPLETED|Overall Study||192||
48096758|NCT03441633|100560500|FG004|COMPLETED|Overall Study||2286||
48096759|NCT03441633|100560501|FG005|COMPLETED|Overall Study||363||
48096760|NCT03441633|100560502|FG006|COMPLETED|Overall Study||2855||
48096761|NCT03441633|100560503|FG007|COMPLETED|Overall Study||953||
48096762|NCT03441633|100560504|FG008|COMPLETED|Overall Study||5132||
48096763|NCT03441633|100560505|FG009|COMPLETED|Overall Study||1562||
48096764|NCT03441633|100560496|FG000|NOT COMPLETED|Overall Study||0||
48096765|NCT03441633|100560497|FG001|NOT COMPLETED|Overall Study||0||
48096766|NCT03441633|100560498|FG002|NOT COMPLETED|Overall Study||0||
48096767|NCT03441633|100560499|FG003|NOT COMPLETED|Overall Study||0||
48096768|NCT03441633|100560500|FG004|NOT COMPLETED|Overall Study||0||
48096769|NCT03441633|100560501|FG005|NOT COMPLETED|Overall Study||0||
48096770|NCT03441633|100560502|FG006|NOT COMPLETED|Overall Study||0||
48096771|NCT03441633|100560503|FG007|NOT COMPLETED|Overall Study||0||
48096772|NCT03441633|100560504|FG008|NOT COMPLETED|Overall Study||0||
48096773|NCT03441633|100560505|FG009|NOT COMPLETED|Overall Study||0||
48096774|NCT03045081|100560506|FG000|STARTED|Overall Study||51||
48096775|NCT03045081|100560507|FG001|STARTED|Overall Study||48||
48096776|NCT03045081|100560506|FG000|COMPLETED|Overall Study||45||
48096777|NCT03045081|100560507|FG001|COMPLETED|Overall Study||37||
48096778|NCT03045081|100560506|FG000|NOT COMPLETED|Overall Study||6||
48096779|NCT03045081|100560507|FG001|NOT COMPLETED|Overall Study||11||
48096780|NCT01466348|100560508|FG000|STARTED|Period I - First Intervention||36||
48096781|NCT01466348|100560509|FG001|STARTED|Period I - First Intervention||36||
48096782|NCT01466348|100560508|FG000|Intent To Treat (ITT) Population|Period I - First Intervention||36||
48096783|NCT01466348|100560509|FG001|Intent To Treat (ITT) Population|Period I - First Intervention||35||
48096784|NCT01466348|100560508|FG000|COMPLETED|Period I - First Intervention||36||
48096785|NCT01466348|100560509|FG001|COMPLETED|Period I - First Intervention||35||
48096786|NCT01466348|100560508|FG000|NOT COMPLETED|Period I - First Intervention||0||
48096787|NCT01466348|100560509|FG001|NOT COMPLETED|Period I - First Intervention||1||
48096788|NCT01466348|100560508|FG000|STARTED|Period II - Second Intervention||35||
48096789|NCT01466348|100560509|FG001|STARTED|Period II - Second Intervention||36||
48096790|NCT01466348|100560508|FG000|COMPLETED|Period II - Second Intervention||35||
48096791|NCT01466348|100560509|FG001|COMPLETED|Period II - Second Intervention||36||
48096792|NCT01466348|100560508|FG000|NOT COMPLETED|Period II - Second Intervention||0||
48096793|NCT01466348|100560509|FG001|NOT COMPLETED|Period II - Second Intervention||0||
48096794|NCT01969240|100560510|FG000|STARTED|Overall Study||451||
48096795|NCT01969240|100560511|FG001|STARTED|Overall Study||447||
48096796|NCT01969240|100560510|FG000|COMPLETED|Overall Study||451||
48096797|NCT01969240|100560511|FG001|COMPLETED|Overall Study||447||
48096798|NCT01969240|100560510|FG000|NOT COMPLETED|Overall Study||0||
48096799|NCT01969240|100560511|FG001|NOT COMPLETED|Overall Study||0||
48096800|NCT03219294|100560512|FG000|STARTED|Overall Study||58||
48096801|NCT03219294|100560513|FG001|STARTED|Overall Study||58||
48096802|NCT03219294|100560512|FG000|COMPLETED|Overall Study||58||
48096803|NCT03219294|100560513|FG001|COMPLETED|Overall Study||58||
48096804|NCT03219294|100560512|FG000|NOT COMPLETED|Overall Study||0||
48096805|NCT03219294|100560513|FG001|NOT COMPLETED|Overall Study||0||
48096806|NCT00525174|100560514|FG000|STARTED|Overall Study||97||
48096807|NCT00525174|100560515|FG001|STARTED|Overall Study||89||
48096808|NCT00525174|100560514|FG000|COMPLETED|Overall Study||88||
48096809|NCT00525174|100560515|FG001|COMPLETED|Overall Study||81||
48096810|NCT00525174|100560514|FG000|NOT COMPLETED|Overall Study||9||
48096811|NCT00525174|100560515|FG001|NOT COMPLETED|Overall Study||8||
48096812|NCT03089606|100560516|FG000|STARTED|Overall Study||27||
48096813|NCT03089606|100560516|FG000|COMPLETED|Overall Study||26||
48096814|NCT03089606|100560516|FG000|NOT COMPLETED|Overall Study||1||
48096815|NCT02750592|100560517|FG000|STARTED|Overall Study||30||
48096816|NCT02750592|100560517|FG000|COMPLETED|Overall Study||25||
48260444|NCT02562898|100958934|FG001|STARTED|Overall Study||8||
48260445|NCT02562898|100958933|FG000|COMPLETED|Overall Study||10||
48260446|NCT02562898|100958934|FG001|COMPLETED|Overall Study||8||
48260447|NCT02562898|100958933|FG000|NOT COMPLETED|Overall Study||0||
48260448|NCT02562898|100958934|FG001|NOT COMPLETED|Overall Study||0||
48260449|NCT01859611|100958935|FG000|STARTED|Overall Study||51||
48260450|NCT01859611|100958935|FG000|COMPLETED|Overall Study||43||
48260451|NCT01859611|100958935|FG000|NOT COMPLETED|Overall Study||8||
48260452|NCT00813098|100958936|FG000|STARTED|Overall Study||49||
48260453|NCT00813098|100958937|FG001|STARTED|Overall Study||54||
48260454|NCT00813098|100958938|FG002|STARTED|Overall Study||52||
48260455|NCT00813098|100958936|FG000|COMPLETED|Overall Study||46||
48260456|NCT00813098|100958937|FG001|COMPLETED|Overall Study||46||
48260457|NCT00813098|100958938|FG002|COMPLETED|Overall Study||50||
48260458|NCT00813098|100958936|FG000|NOT COMPLETED|Overall Study||3||
48260459|NCT00813098|100958937|FG001|NOT COMPLETED|Overall Study||8||
48260460|NCT00813098|100958938|FG002|NOT COMPLETED|Overall Study||2||
48260461|NCT01519778|100958939|FG000|STARTED|Overall Study||200||
48260462|NCT01519778|100958939|FG000|COMPLETED|Overall Study||186||
48260463|NCT01519778|100958939|FG000|NOT COMPLETED|Overall Study||14||
48260464|NCT04974723|100958940|FG000|STARTED|Overall Study||11027||
48260465|NCT04974723|100958941|FG001|STARTED|Overall Study||11027||
48260466|NCT04974723|100958940|FG000|COMPLETED|Overall Study||11027|This study is a retrospective claims-based cohort study, patients included in the analyses did not actively participate in the study and no study visits were required.|
48260467|NCT04974723|100958941|FG001|COMPLETED|Overall Study||11027|This study is a retrospective claims-based cohort study, patients included in the analyses did not actively participate in the study and no study visits were required.|
48260468|NCT04974723|100958940|FG000|NOT COMPLETED|Overall Study||0||
48260469|NCT04974723|100958941|FG001|NOT COMPLETED|Overall Study||0||
48260470|NCT02166476|100958942|FG000|STARTED|Overall Study||272|5 participants were randomized but not dosed: 4 withdrew consent, 1 did not meet inclusion criteria.|
48260471|NCT02166476|100958943|FG001|STARTED|Overall Study||273|5 participants were randomized but not dosed: 4 withdrew consent, 1 did not meet inclusion criteria.|
48260472|NCT02166476|100958942|FG000|Received at Least 1 Dose of Study Drug|Overall Study||272|Randomized participants included in the Safety and modified intent-to-treat \[MITT\] populations.|
48260473|NCT02166476|100958943|FG001|Received at Least 1 Dose of Study Drug|Overall Study||273|Randomized participants included in the Safety and modified intent-to-treat \[MITT\] populations.|
48260474|NCT02166476|100958942|FG000|COMPLETED|Overall Study||258||
48260475|NCT02166476|100958943|FG001|COMPLETED|Overall Study||250||
48260476|NCT02166476|100958942|FG000|NOT COMPLETED|Overall Study||14||
48260477|NCT02166476|100958943|FG001|NOT COMPLETED|Overall Study||23||
48260478|NCT03834623|100958944|FG000|STARTED|Overall Study||11||
48260479|NCT03834623|100958945|FG001|STARTED|Overall Study||12||
48389933|NCT00836277|101283468|FG000|STARTED|Overall Study||24||
48096817|NCT02750592|100560517|FG000|NOT COMPLETED|Overall Study||5||
48096818|NCT03633487|100560518|FG000|STARTED|Overall Study||24||
48096819|NCT03633487|100560518|FG000|COMPLETED|Overall Study||24||
48096820|NCT03633487|100560518|FG000|NOT COMPLETED|Overall Study||0||
48096821|NCT01895855|100560519|FG000|STARTED|Overall Study||95||
48096822|NCT01895855|100560520|FG001|STARTED|Overall Study||102||
48096823|NCT01895855|100560519|FG000|COMPLETED|Overall Study||95||
48096824|NCT01895855|100560520|FG001|COMPLETED|Overall Study||102||
48096825|NCT01895855|100560519|FG000|NOT COMPLETED|Overall Study||0||
48096826|NCT01895855|100560520|FG001|NOT COMPLETED|Overall Study||0||
48096827|NCT00495170|100560521|FG000|STARTED|Overall Study||84||
48096828|NCT00495170|100560521|FG000|COMPLETED|Overall Study||64||
48096829|NCT00495170|100560521|FG000|NOT COMPLETED|Overall Study||20||
48096830|NCT04251221|100560522|FG000|STARTED|Overall Study||11||
48096831|NCT04251221|100560523|FG001|STARTED|Overall Study||3||
48096832|NCT04251221|100560522|FG000|COMPLETED|Overall Study||9||
48096833|NCT04251221|100560523|FG001|COMPLETED|Overall Study||3||
48096834|NCT04251221|100560522|FG000|NOT COMPLETED|Overall Study||2||
48096835|NCT04251221|100560523|FG001|NOT COMPLETED|Overall Study||0||
48096836|NCT01998737|100560524|FG000|STARTED|Overall Study||911||
48096837|NCT01998737|100560525|FG001|STARTED|Overall Study||100||
48096838|NCT01998737|100560524|FG000|COMPLETED|Overall Study||888||
48096839|NCT01998737|100560525|FG001|COMPLETED|Overall Study||100||
48096840|NCT01998737|100560524|FG000|NOT COMPLETED|Overall Study||23||
48096841|NCT01998737|100560525|FG001|NOT COMPLETED|Overall Study||0||
48096842|NCT01042236|100560526|FG000|STARTED|Treatment Period 1||3||
48096843|NCT01042236|100560527|FG001|STARTED|Treatment Period 1||4||
48096844|NCT01042236|100560528|FG002|STARTED|Treatment Period 1||3||
48096845|NCT01042236|100560529|FG003|STARTED|Treatment Period 1||5||
48096846|NCT01042236|100560530|FG004|STARTED|Treatment Period 1||4||
48096847|NCT01042236|100560531|FG005|STARTED|Treatment Period 1||3||
48096848|NCT01042236|100560526|FG000|COMPLETED|Treatment Period 1||3||
48096849|NCT01042236|100560527|FG001|COMPLETED|Treatment Period 1||3||
48096850|NCT01042236|100560528|FG002|COMPLETED|Treatment Period 1||3||
48096851|NCT01042236|100560529|FG003|COMPLETED|Treatment Period 1||5||
48096852|NCT01042236|100560530|FG004|COMPLETED|Treatment Period 1||3||
48096853|NCT01042236|100560531|FG005|COMPLETED|Treatment Period 1||3||
48096854|NCT01042236|100560526|FG000|NOT COMPLETED|Treatment Period 1||0||
48096855|NCT01042236|100560527|FG001|NOT COMPLETED|Treatment Period 1||1||
48096856|NCT01042236|100560528|FG002|NOT COMPLETED|Treatment Period 1||0||
48096857|NCT01042236|100560529|FG003|NOT COMPLETED|Treatment Period 1||0||
48096858|NCT01042236|100560530|FG004|NOT COMPLETED|Treatment Period 1||1||
48096859|NCT01042236|100560531|FG005|NOT COMPLETED|Treatment Period 1||0||
48096860|NCT01042236|100560526|FG000|STARTED|Treatment Period 2||3||
48096861|NCT01042236|100560527|FG001|STARTED|Treatment Period 2||3||
48096862|NCT01042236|100560528|FG002|STARTED|Treatment Period 2||3||
48096863|NCT01042236|100560529|FG003|STARTED|Treatment Period 2||5||
48096864|NCT01042236|100560530|FG004|STARTED|Treatment Period 2||3||
48096865|NCT01042236|100560531|FG005|STARTED|Treatment Period 2||3||
48096866|NCT01042236|100560526|FG000|COMPLETED|Treatment Period 2||3||
48096867|NCT01042236|100560527|FG001|COMPLETED|Treatment Period 2||3||
48096868|NCT01042236|100560528|FG002|COMPLETED|Treatment Period 2||3||
48389934|NCT00836277|101283468|FG000|COMPLETED|Overall Study||18||
48389935|NCT00836277|101283468|FG000|NOT COMPLETED|Overall Study||6||
48389936|NCT00870818|101283469|FG000|STARTED|Overall Study||32||
48389937|NCT00870818|101283470|FG001|STARTED|Overall Study||73||
48389938|NCT00870818|101283471|FG002|STARTED|Overall Study||38||
48389939|NCT00870818|101283472|FG003|STARTED|Overall Study||38||
48389940|NCT00870818|101283473|FG004|STARTED|Overall Study||38||
48389941|NCT00870818|101283469|FG000|Completed 6 Months|Overall Study||31||
48389942|NCT00870818|101283470|FG001|Completed 6 Months|Overall Study||22||
48389943|NCT00870818|101283471|FG002|Completed 6 Months|Overall Study||13||
48096869|NCT01042236|100560529|FG003|COMPLETED|Treatment Period 2||5||
48096870|NCT01042236|100560530|FG004|COMPLETED|Treatment Period 2||3||
48096871|NCT01042236|100560531|FG005|COMPLETED|Treatment Period 2||3||
48096872|NCT01042236|100560526|FG000|NOT COMPLETED|Treatment Period 2||0||
48096873|NCT01042236|100560527|FG001|NOT COMPLETED|Treatment Period 2||0||
48096874|NCT01042236|100560528|FG002|NOT COMPLETED|Treatment Period 2||0||
48096875|NCT01042236|100560529|FG003|NOT COMPLETED|Treatment Period 2||0||
48096876|NCT01042236|100560530|FG004|NOT COMPLETED|Treatment Period 2||0||
48096877|NCT01042236|100560531|FG005|NOT COMPLETED|Treatment Period 2||0||
48096878|NCT01042236|100560526|FG000|STARTED|Treatment Period 3||3||
48096879|NCT01042236|100560527|FG001|STARTED|Treatment Period 3||3||
48096880|NCT01042236|100560528|FG002|STARTED|Treatment Period 3||3||
48096881|NCT01042236|100560529|FG003|STARTED|Treatment Period 3||5||
48096882|NCT01042236|100560530|FG004|STARTED|Treatment Period 3||3||
48096883|NCT01042236|100560531|FG005|STARTED|Treatment Period 3||3||
48096884|NCT01042236|100560526|FG000|COMPLETED|Treatment Period 3||3||
48096885|NCT01042236|100560527|FG001|COMPLETED|Treatment Period 3||3||
48096886|NCT01042236|100560528|FG002|COMPLETED|Treatment Period 3||3||
48096887|NCT01042236|100560529|FG003|COMPLETED|Treatment Period 3||3||
48096888|NCT01042236|100560530|FG004|COMPLETED|Treatment Period 3||3||
48096889|NCT01042236|100560531|FG005|COMPLETED|Treatment Period 3||3||
48096890|NCT01042236|100560526|FG000|NOT COMPLETED|Treatment Period 3||0||
48096891|NCT01042236|100560527|FG001|NOT COMPLETED|Treatment Period 3||0||
48096892|NCT01042236|100560528|FG002|NOT COMPLETED|Treatment Period 3||0||
48096893|NCT01042236|100560529|FG003|NOT COMPLETED|Treatment Period 3||2||
48096894|NCT01042236|100560530|FG004|NOT COMPLETED|Treatment Period 3||0||
48096895|NCT01042236|100560531|FG005|NOT COMPLETED|Treatment Period 3||0||
48096896|NCT04962009|100560532|FG000|STARTED|Overall Study||12||
48096897|NCT04962009|100560532|FG000|COMPLETED|Overall Study||10||
48096898|NCT04962009|100560532|FG000|NOT COMPLETED|Overall Study||2||
48096899|NCT01831154|100560533|FG000|STARTED|Overall Study||15||
48389944|NCT00870818|101283472|FG003|Completed 6 Months|Overall Study||13||
48096900|NCT01831154|100560534|FG001|STARTED|Overall Study||11||
48096901|NCT01831154|100560535|FG002|STARTED|Overall Study||11||
48096902|NCT01831154|100560533|FG000|COMPLETED|Overall Study||15||
48096903|NCT01831154|100560534|FG001|COMPLETED|Overall Study||11||
48096904|NCT01831154|100560535|FG002|COMPLETED|Overall Study||11||
48096905|NCT01831154|100560533|FG000|NOT COMPLETED|Overall Study||0||
48096906|NCT01831154|100560534|FG001|NOT COMPLETED|Overall Study||0||
48096907|NCT01831154|100560535|FG002|NOT COMPLETED|Overall Study||0||
48096908|NCT01428453|100560536|FG000|STARTED|Overall Study||62||
48096909|NCT01428453|100560537|FG001|STARTED|Overall Study||61||
48096910|NCT01428453|100560536|FG000|COMPLETED|Overall Study||56||
48096911|NCT01428453|100560537|FG001|COMPLETED|Overall Study||52||
48096912|NCT01428453|100560536|FG000|NOT COMPLETED|Overall Study||6||
48096913|NCT01428453|100560537|FG001|NOT COMPLETED|Overall Study||9||
48096914|NCT01359449|100560538|FG000|STARTED|Overall Study||61||
48096915|NCT01359449|100560539|FG001|STARTED|Overall Study||62||
48096916|NCT01359449|100560538|FG000|COMPLETED|Overall Study||57||
48096917|NCT01359449|100560539|FG001|COMPLETED|Overall Study||58||
48096918|NCT01359449|100560538|FG000|NOT COMPLETED|Overall Study||4||
48096919|NCT01359449|100560539|FG001|NOT COMPLETED|Overall Study||4||
48096920|NCT02047747|100560540|FG000|STARTED|Overall Study||4||
48096921|NCT02047747|100560540|FG000|COMPLETED|Overall Study||1||
48096922|NCT02047747|100560540|FG000|NOT COMPLETED|Overall Study||3||
48096923|NCT01304966|100560541|FG000|STARTED|Overall Study||15||
48096924|NCT01304966|100560541|FG000|COMPLETED|Overall Study||15||
48096925|NCT01304966|100560541|FG000|NOT COMPLETED|Overall Study||0||
48096926|NCT02699554|100560542|FG000|STARTED|Overall Study||55||
48096927|NCT02699554|100560542|FG000|COMPLETED|Overall Study||46||
48096928|NCT02699554|100560542|FG000|NOT COMPLETED|Overall Study||9||
48096929|NCT01601782|100560543|FG000|STARTED|Overall Study||16||
48096930|NCT01601782|100560543|FG000|COMPLETED|Overall Study||16||
48096931|NCT01601782|100560543|FG000|NOT COMPLETED|Overall Study||0||
48096932|NCT00624052|100560544|FG000|STARTED|Overall Study||219||
48096933|NCT00624052|100560545|FG001|STARTED|Overall Study||436||
48096934|NCT00624052|100560546|FG002|STARTED|Overall Study||91||
48096935|NCT00624052|100560547|FG003|STARTED|Overall Study||92||
48096936|NCT00624052|100560544|FG000|COMPLETED|Overall Study||204||
48260480|NCT03834623|100958944|FG000|COMPLETED|Overall Study||11||
48260481|NCT03834623|100958945|FG001|COMPLETED|Overall Study||11||
48260482|NCT03834623|100958944|FG000|NOT COMPLETED|Overall Study||0||
48260483|NCT03834623|100958945|FG001|NOT COMPLETED|Overall Study||1||
48260484|NCT01383447|100958946|FG000|STARTED|Overall Study||2||
48260485|NCT01383447|100958946|FG000|COMPLETED|Overall Study||0||
48260486|NCT01383447|100958946|FG000|NOT COMPLETED|Overall Study||2||
48260487|NCT00420784|100958947|FG000|STARTED|Overall Study||115||
48260488|NCT00420784|100958948|FG001|STARTED|Overall Study||113||
48096937|NCT00624052|100560545|FG001|COMPLETED|Overall Study||422||
48096938|NCT00624052|100560546|FG002|COMPLETED|Overall Study||88||
48096939|NCT00624052|100560547|FG003|COMPLETED|Overall Study||88||
48096940|NCT00624052|100560544|FG000|NOT COMPLETED|Overall Study||15||
48096941|NCT00624052|100560545|FG001|NOT COMPLETED|Overall Study||14||
48260489|NCT00420784|100958949|FG002|STARTED|Overall Study||111||
48260490|NCT00420784|100958950|FG003|STARTED|Overall Study||114||
48689954|NCT00923351|102022815|FG000|STARTED|Overall Study||6||
48689955|NCT00923351|102022816|FG001|STARTED|Overall Study||26||
48689956|NCT00923351|102022817|FG002|STARTED|Overall Study||12||
48096942|NCT00624052|100560546|FG002|NOT COMPLETED|Overall Study||3||
48096943|NCT00624052|100560547|FG003|NOT COMPLETED|Overall Study||4||
48689957|NCT00923351|102022815|FG000|COMPLETED|Overall Study||6||
48689958|NCT00923351|102022816|FG001|COMPLETED|Overall Study||26||
48096944|NCT02631954|100560548|FG000|STARTED|Overall Study||12||
48096945|NCT02631954|100560549|FG001|STARTED|Overall Study||12||
48096946|NCT02631954|100560548|FG000|COMPLETED|Overall Study||12||
48096947|NCT02631954|100560549|FG001|COMPLETED|Overall Study||12||
48096948|NCT02631954|100560548|FG000|NOT COMPLETED|Overall Study||0||
48096949|NCT02631954|100560549|FG001|NOT COMPLETED|Overall Study||0||
48096950|NCT02493608|100560550|FG000|STARTED|Overall Study||48||
48096951|NCT02493608|100560551|FG001|STARTED|Overall Study||48||
48096952|NCT02493608|100560550|FG000|COMPLETED|Overall Study||48||
48096953|NCT02493608|100560551|FG001|COMPLETED|Overall Study||48||
48689959|NCT00923351|102022817|FG002|COMPLETED|Overall Study||0||
48689960|NCT00923351|102022815|FG000|NOT COMPLETED|Overall Study||0||
48689961|NCT00923351|102022816|FG001|NOT COMPLETED|Overall Study||0||
48096954|NCT02493608|100560550|FG000|NOT COMPLETED|Overall Study||0||
48096955|NCT02493608|100560551|FG001|NOT COMPLETED|Overall Study||0||
48096956|NCT01826487|100560552|FG000|STARTED|Overall Study||115||
48096957|NCT01826487|100560553|FG001|STARTED|Overall Study||115||
48096958|NCT01826487|100560552|FG000|As-treated Population|Overall Study||115|All Randomized participants who received any study treatment.|
48096959|NCT01826487|100560553|FG001|As-treated Population|Overall Study||115|All Randomized participants who received any study treatment.|
48096960|NCT01826487|100560552|FG000|ITT Population|Overall Study||114|Received any study treatment; had a valid baseline, and at least 1 valid post-baseline 6MWD value.|
48096961|NCT01826487|100560553|FG001|ITT Population|Overall Study||114|Received any study treatment; had a valid baseline, and at least 1 valid post-baseline 6MWD value.|
48096962|NCT01826487|100560552|FG000|COMPLETED|Overall Study||111||
48096963|NCT01826487|100560553|FG001|COMPLETED|Overall Study||110||
48096964|NCT01826487|100560552|FG000|NOT COMPLETED|Overall Study||4||
48096965|NCT01826487|100560553|FG001|NOT COMPLETED|Overall Study||5||
48096966|NCT01894581|100560554|FG000|STARTED|Overall Study||20||
48096967|NCT01894581|100560555|FG001|STARTED|Overall Study||19||
48096968|NCT01894581|100560554|FG000|COMPLETED|Overall Study||15||
48096969|NCT01894581|100560555|FG001|COMPLETED|Overall Study||12||
48096970|NCT01894581|100560554|FG000|NOT COMPLETED|Overall Study||5||
48096971|NCT01894581|100560555|FG001|NOT COMPLETED|Overall Study||7||
48096972|NCT01394523|100560556|FG000|STARTED|Overall Study||13||
48096973|NCT01394523|100560557|FG001|STARTED|Overall Study||13||
48542343|NCT00950365|101662925|FG001|NOT COMPLETED|Overall Study||2||
48542344|NCT01004744|101662926|FG000|STARTED|Overall Study||10||
48542345|NCT01004744|101662926|FG000|COMPLETED|Overall Study||10||
48542346|NCT01004744|101662926|FG000|NOT COMPLETED|Overall Study||0||
48542347|NCT00841828|101662927|FG000|STARTED|Overall Study||52||
48096974|NCT01394523|100560558|FG002|STARTED|Overall Study||13||
48096975|NCT01394523|100560556|FG000|COMPLETED|Overall Study||12||
48096976|NCT01394523|100560557|FG001|COMPLETED|Overall Study||13||
48096977|NCT01394523|100560558|FG002|COMPLETED|Overall Study||13||
48096978|NCT01394523|100560556|FG000|NOT COMPLETED|Overall Study||1||
48096979|NCT01394523|100560557|FG001|NOT COMPLETED|Overall Study||0||
48096980|NCT01394523|100560558|FG002|NOT COMPLETED|Overall Study||0||
48096981|NCT02742987|100560559|FG000|STARTED|Overall Study||21||
48096982|NCT02742987|100560560|FG001|STARTED|Overall Study||21||
48096983|NCT02742987|100560559|FG000|COMPLETED|Overall Study||21||
48096984|NCT02742987|100560560|FG001|COMPLETED|Overall Study||21||
48096985|NCT02742987|100560559|FG000|NOT COMPLETED|Overall Study||0||
48096986|NCT02742987|100560560|FG001|NOT COMPLETED|Overall Study||0||
48096987|NCT00378209|100560561|FG000|STARTED|Overall Study||64||
48096988|NCT00378209|100560561|FG000|COMPLETED|Overall Study||42||
48096989|NCT00378209|100560561|FG000|NOT COMPLETED|Overall Study||22||
48096990|NCT00463346|100560562|FG000|STARTED|Overall Study||12||
48096991|NCT00463346|100560563|FG001|STARTED|Overall Study||11||
48096992|NCT00463346|100560562|FG000|COMPLETED|Overall Study||9||
48096993|NCT00463346|100560563|FG001|COMPLETED|Overall Study||8||
48096994|NCT00463346|100560562|FG000|NOT COMPLETED|Overall Study||3||
48096995|NCT00463346|100560563|FG001|NOT COMPLETED|Overall Study||3||
48096996|NCT02951156|100560564|FG000|STARTED|Overall Study||9||
48096997|NCT02951156|100560565|FG001|STARTED|Overall Study||9||
48096998|NCT02951156|100560566|FG002|STARTED|Overall Study||11||
48096999|NCT02951156|100560564|FG000|COMPLETED|Overall Study||0||
48097000|NCT02951156|100560565|FG001|COMPLETED|Overall Study||0||
48097001|NCT02951156|100560566|FG002|COMPLETED|Overall Study||1||
48097002|NCT02951156|100560564|FG000|NOT COMPLETED|Overall Study||9||
48097003|NCT02951156|100560565|FG001|NOT COMPLETED|Overall Study||9||
48097004|NCT02951156|100560566|FG002|NOT COMPLETED|Overall Study||10||
48097005|NCT00660530|100560567|FG000|STARTED|Overall Study||11||
48097006|NCT00660530|100560567|FG000|COMPLETED|Overall Study||11||
48097007|NCT00660530|100560567|FG000|NOT COMPLETED|Overall Study||0||
48097008|NCT00368654|100560568|FG000|STARTED|Overall Study||3||
48097009|NCT00368654|100560569|FG001|STARTED|Overall Study||3||
48097010|NCT00368654|100560570|FG002|STARTED|Overall Study||3||
48097011|NCT00368654|100560571|FG003|STARTED|Overall Study||3||
48097012|NCT00368654|100560568|FG000|COMPLETED|Overall Study||0||
48097013|NCT00368654|100560569|FG001|COMPLETED|Overall Study||0||
48097014|NCT00368654|100560570|FG002|COMPLETED|Overall Study||0||
48542348|NCT00841828|101662928|FG001|STARTED|Overall Study||50||
48542349|NCT00841828|101662927|FG000|COMPLETED|Overall Study||42||
48542350|NCT00841828|101662928|FG001|COMPLETED|Overall Study||48||
48542351|NCT00841828|101662927|FG000|NOT COMPLETED|Overall Study||10||
48542352|NCT00841828|101662928|FG001|NOT COMPLETED|Overall Study||2||
48542353|NCT03769207|101662929|FG000|STARTED|Overall Study||17||
48689962|NCT00923351|102022817|FG002|NOT COMPLETED|Overall Study||12||
48689963|NCT00434993|102022818|FG000|STARTED|Overall Study||152||
48097015|NCT00368654|100560571|FG003|COMPLETED|Overall Study||0||
48097016|NCT00368654|100560568|FG000|NOT COMPLETED|Overall Study||3||
48097017|NCT00368654|100560569|FG001|NOT COMPLETED|Overall Study||3||
48097018|NCT00368654|100560570|FG002|NOT COMPLETED|Overall Study||3||
48097019|NCT00368654|100560571|FG003|NOT COMPLETED|Overall Study||3||
48097020|NCT01541969|100560572|FG000|STARTED|Double-blind (0-12 Weeks)||50||
48097021|NCT01541969|100560573|FG001|STARTED|Double-blind (0-12 Weeks)||50||
48097022|NCT01541969|100560572|FG000|COMPLETED|Double-blind (0-12 Weeks)||44||
48097023|NCT01541969|100560573|FG001|COMPLETED|Double-blind (0-12 Weeks)||48||
48389945|NCT00870818|101283473|FG004|Completed 6 Months|Overall Study||11||
48097024|NCT01541969|100560572|FG000|NOT COMPLETED|Double-blind (0-12 Weeks)||6||
48097025|NCT01541969|100560573|FG001|NOT COMPLETED|Double-blind (0-12 Weeks)||2||
48097026|NCT01541969|100560572|FG000|STARTED|Open Label Extension (12-36 Weeks)||44||
48097027|NCT01541969|100560573|FG001|STARTED|Open Label Extension (12-36 Weeks)||48||
48097028|NCT01541969|100560572|FG000|COMPLETED|Open Label Extension (12-36 Weeks)||33||
48097029|NCT01541969|100560573|FG001|COMPLETED|Open Label Extension (12-36 Weeks)||35||
48097030|NCT01541969|100560572|FG000|NOT COMPLETED|Open Label Extension (12-36 Weeks)||11||
48097031|NCT01541969|100560573|FG001|NOT COMPLETED|Open Label Extension (12-36 Weeks)||13||
48097032|NCT01290640|100560574|FG000|STARTED|Overall Study||12||
48260491|NCT00420784|100958947|FG000|COMPLETED|Overall Study||86||
48260492|NCT00420784|100958948|FG001|COMPLETED|Overall Study||55||
48260493|NCT00420784|100958949|FG002|COMPLETED|Overall Study||58||
48260494|NCT00420784|100958950|FG003|COMPLETED|Overall Study||36||
48260495|NCT00420784|100958947|FG000|NOT COMPLETED|Overall Study||29||
48260496|NCT00420784|100958948|FG001|NOT COMPLETED|Overall Study||58||
48260497|NCT00420784|100958949|FG002|NOT COMPLETED|Overall Study||53||
48260498|NCT00420784|100958950|FG003|NOT COMPLETED|Overall Study||78||
48260499|NCT01755546|100958951|FG000|STARTED|Screened and Taper (Rollover and DeNovo)||304||
48260500|NCT01755546|100958951|FG000|COMPLETED|Screened and Taper (Rollover and DeNovo)||294||
48260501|NCT01755546|100958951|FG000|NOT COMPLETED|Screened and Taper (Rollover and DeNovo)||10||
48260502|NCT01755546|100958951|FG000|STARTED|Titration Phase||294||
48260503|NCT01755546|100958951|FG000|COMPLETED|Titration Phase||224||
48260504|NCT01755546|100958951|FG000|NOT COMPLETED|Titration Phase||70||
48260505|NCT01755546|100958951|FG000|STARTED|Long Term Treatment||224||
48260506|NCT01755546|100958951|FG000|COMPLETED|Long Term Treatment||103||
48260507|NCT01755546|100958951|FG000|NOT COMPLETED|Long Term Treatment||121||
48260508|NCT02431455|100958952|FG000|STARTED|Overall Study||112||
48260509|NCT02431455|100958953|FG001|STARTED|Overall Study||112||
48260510|NCT02431455|100958952|FG000|COMPLETED|Overall Study||112||
48389946|NCT00870818|101283469|FG000|Completed 12 Months|Overall Study||27||
48389947|NCT00870818|101283470|FG001|Completed 12 Months|Overall Study||2||
48389948|NCT00870818|101283471|FG002|Completed 12 Months|Overall Study||3||
48389949|NCT00870818|101283472|FG003|Completed 12 Months|Overall Study||2||
48389950|NCT00870818|101283473|FG004|Completed 12 Months|Overall Study||2||
48389951|NCT00870818|101283469|FG000|Completed 18 Months|Overall Study||5||
48389952|NCT00870818|101283470|FG001|Completed 18 Months|Overall Study||0||
48389953|NCT00870818|101283471|FG002|Completed 18 Months|Overall Study||0||
48389954|NCT00870818|101283472|FG003|Completed 18 Months|Overall Study||0||
48389955|NCT00870818|101283473|FG004|Completed 18 Months|Overall Study||0||
48389956|NCT00870818|101283469|FG000|Completed 21 Months|Overall Study||1||
48097033|NCT01290640|100560575|FG001|STARTED|Overall Study||10||
48260511|NCT02431455|100958953|FG001|COMPLETED|Overall Study||112||
48260512|NCT02431455|100958952|FG000|NOT COMPLETED|Overall Study||0||
48389957|NCT00870818|101283470|FG001|Completed 21 Months|Overall Study||0||
48389958|NCT00870818|101283471|FG002|Completed 21 Months|Overall Study||0||
48389959|NCT00870818|101283472|FG003|Completed 21 Months|Overall Study||0||
48389960|NCT00870818|101283473|FG004|Completed 21 Months|Overall Study||0||
48389961|NCT00870818|101283469|FG000|COMPLETED|Overall Study||0||
48389962|NCT00870818|101283470|FG001|COMPLETED|Overall Study||0||
48389963|NCT00870818|101283471|FG002|COMPLETED|Overall Study||0||
48389964|NCT00870818|101283472|FG003|COMPLETED|Overall Study||0||
48389965|NCT00870818|101283473|FG004|COMPLETED|Overall Study||0||
48389966|NCT00870818|101283469|FG000|NOT COMPLETED|Overall Study||32||
48389967|NCT00870818|101283470|FG001|NOT COMPLETED|Overall Study||73||
48389968|NCT00870818|101283471|FG002|NOT COMPLETED|Overall Study||38||
48097034|NCT01290640|100560574|FG000|COMPLETED|Overall Study||12||
48097035|NCT01290640|100560575|FG001|COMPLETED|Overall Study||10||
48097036|NCT01290640|100560574|FG000|NOT COMPLETED|Overall Study||0||
48097037|NCT01290640|100560575|FG001|NOT COMPLETED|Overall Study||0||
48097038|NCT03538158|100563617|FG000|STARTED|Overall Study||92||
48097039|NCT03538158|100563618|FG001|STARTED|Overall Study||89||
48097040|NCT03538158|100563617|FG000|12 Week Intervention Phase|Overall Study||82||
48260513|NCT02431455|100958953|FG001|NOT COMPLETED|Overall Study||0||
48260514|NCT01310699|100958954|FG000|STARTED|Overall Study||132||
48260515|NCT01310699|100958955|FG001|STARTED|Overall Study||149||
48260516|NCT01310699|100958954|FG000|COMPLETED|Overall Study||128||
48260517|NCT01310699|100958955|FG001|COMPLETED|Overall Study||143||
48260518|NCT01310699|100958954|FG000|NOT COMPLETED|Overall Study||4||
48260519|NCT01310699|100958955|FG001|NOT COMPLETED|Overall Study||6||
48260520|NCT01266161|100958956|FG000|STARTED|Overall Study||52||
48260521|NCT01266161|100958957|FG001|STARTED|Overall Study||54||
48260522|NCT01266161|100958956|FG000|COMPLETED|Overall Study||48||
48260523|NCT01266161|100958957|FG001|COMPLETED|Overall Study||53||
48260524|NCT01266161|100958956|FG000|NOT COMPLETED|Overall Study||4||
48260525|NCT01266161|100958957|FG001|NOT COMPLETED|Overall Study||1||
48260526|NCT00952848|100958958|FG000|STARTED|Overall Study||18||
48260527|NCT00952848|100958958|FG000|COMPLETED|Overall Study||14||
48260528|NCT00952848|100958958|FG000|NOT COMPLETED|Overall Study||4||
48260529|NCT04398368|100958959|FG000|STARTED|Overall Study||25||
48260530|NCT04398368|100958959|FG000|COMPLETED|Overall Study||23||
48260531|NCT04398368|100958959|FG000|NOT COMPLETED|Overall Study||2||
48260532|NCT02881047|100958960|FG000|STARTED|Overall Study||8||
48260533|NCT02881047|100958960|FG000|COMPLETED|Overall Study||6||
48260534|NCT02881047|100958960|FG000|NOT COMPLETED|Overall Study||2||
48260535|NCT00590226|100958961|FG000|STARTED|Overall Study||67||
48260536|NCT00590226|100958962|FG001|STARTED|Overall Study||63||
48260537|NCT00590226|100958961|FG000|COMPLETED|Overall Study||67||
48260538|NCT00590226|100958962|FG001|COMPLETED|Overall Study||63||
48260539|NCT00590226|100958961|FG000|NOT COMPLETED|Overall Study||0||
48542354|NCT03769207|101662929|FG000|Attended First Study Visit|Overall Study||11||
48542355|NCT03769207|101662929|FG000|ECG Patch Shipped|Overall Study||11||
48542356|NCT03769207|101662929|FG000|ECG Patch Returned and Readable|Overall Study||9||
48542357|NCT03769207|101662929|FG000|Attended Second Study Visit|Overall Study||6||
48542358|NCT03769207|101662929|FG000|COMPLETED|Overall Study||6||
48542359|NCT03769207|101662929|FG000|NOT COMPLETED|Overall Study||11||
48542360|NCT00670202|101662930|FG000|STARTED|Overall Study||2||
48542361|NCT00670202|101662931|FG001|STARTED|Overall Study||0||
48542362|NCT00670202|101662930|FG000|COMPLETED|Overall Study||2||
48542363|NCT00670202|101662931|FG001|COMPLETED|Overall Study||0||
48542364|NCT00670202|101662930|FG000|NOT COMPLETED|Overall Study||0||
48542365|NCT00670202|101662931|FG001|NOT COMPLETED|Overall Study||0||
48542366|NCT02652611|101662932|FG000|STARTED|Overall Study||15||
48542367|NCT02652611|101662933|FG001|STARTED|Overall Study||45||
48542368|NCT02652611|101662932|FG000|COMPLETED|Overall Study||14||
48542369|NCT02652611|101662933|FG001|COMPLETED|Overall Study||14||
48542370|NCT02652611|101662932|FG000|NOT COMPLETED|Overall Study||1||
48097041|NCT03538158|100563618|FG001|12 Week Intervention Phase|Overall Study||82||
48097042|NCT03538158|100563617|FG000|12 Week Maintenance Phase|Overall Study||77||
48097043|NCT03538158|100563618|FG001|12 Week Maintenance Phase|Overall Study||81||
48097044|NCT03538158|100563617|FG000|COMPLETED|Overall Study||77||
48097045|NCT03538158|100563618|FG001|COMPLETED|Overall Study||81||
48097046|NCT03538158|100563617|FG000|NOT COMPLETED|Overall Study||15||
48097047|NCT03538158|100563618|FG001|NOT COMPLETED|Overall Study||8||
48097048|NCT01547000|100563619|FG000|STARTED|Overall Study||18||
48097049|NCT01547000|100563620|FG001|STARTED|Overall Study||16||
48097050|NCT01547000|100563619|FG000|COMPLETED|Overall Study||18||
48097051|NCT01547000|100563620|FG001|COMPLETED|Overall Study||16||
48097052|NCT01547000|100563619|FG000|NOT COMPLETED|Overall Study||0||
48097053|NCT01547000|100563620|FG001|NOT COMPLETED|Overall Study||0||
48097054|NCT03232281|100563621|FG000|STARTED|Overall Study||150||
48097055|NCT03232281|100563622|FG001|STARTED|Overall Study||150||
48260540|NCT00590226|100958962|FG001|NOT COMPLETED|Overall Study||0||
48260541|NCT00025506|100958963|FG000|STARTED|Overall Study||55||
48542371|NCT02652611|101662933|FG001|NOT COMPLETED|Overall Study||31||
48542372|NCT01316315|101662934|FG000|STARTED|Sequence 1||7||
48542373|NCT01316315|101662935|FG001|STARTED|Sequence 1||7||
48542374|NCT01316315|101662934|FG000|COMPLETED|Sequence 1||7||
48542375|NCT01316315|101662935|FG001|COMPLETED|Sequence 1||7||
48542376|NCT01316315|101662934|FG000|NOT COMPLETED|Sequence 1||0||
48260542|NCT00025506|100958963|FG000|COMPLETED|Overall Study||45||
48542377|NCT01316315|101662935|FG001|NOT COMPLETED|Sequence 1||0||
48542378|NCT01316315|101662934|FG000|STARTED|Sequence 2||7||
48097056|NCT03232281|100563621|FG000|Received Treatment|Overall Study||149||
48097057|NCT03232281|100563622|FG001|Received Treatment|Overall Study||150||
48097058|NCT03232281|100563621|FG000|Completed Week 12|Overall Study||143||
48260543|NCT00025506|100958963|FG000|NOT COMPLETED|Overall Study||10||
48260544|NCT00884650|100958964|FG000|STARTED|Overall Study||25||
48260545|NCT00884650|100958965|FG001|STARTED|Overall Study||29||
48260546|NCT00884650|100958964|FG000|COMPLETED|Overall Study||16||
48260547|NCT00884650|100958965|FG001|COMPLETED|Overall Study||21||
48097059|NCT03232281|100563622|FG001|Completed Week 12|Overall Study||148||
48097060|NCT03232281|100563621|FG000|Completed Week 24|Overall Study||143||
48097061|NCT03232281|100563622|FG001|Completed Week 24|Overall Study||144||
48097062|NCT03232281|100563621|FG000|COMPLETED|Overall Study||143||
48097063|NCT03232281|100563622|FG001|COMPLETED|Overall Study||144||
48097064|NCT03232281|100563621|FG000|NOT COMPLETED|Overall Study||7||
48542379|NCT01316315|101662935|FG001|STARTED|Sequence 2||7||
48542380|NCT01316315|101662934|FG000|COMPLETED|Sequence 2||7||
48542381|NCT01316315|101662935|FG001|COMPLETED|Sequence 2||7||
48542382|NCT01316315|101662934|FG000|NOT COMPLETED|Sequence 2||0||
48542383|NCT01316315|101662935|FG001|NOT COMPLETED|Sequence 2||0||
48542384|NCT03464630|101662936|FG000|STARTED|Overall Study||184|Consented, pre-assessed, \& randomized|
48542385|NCT03464630|101662937|FG001|STARTED|Overall Study||184|Consented, pre-assessed, \& randomized|
48542386|NCT03464630|101662936|FG000|Initiated & Completed Orientation Session|Overall Study||172||
48542387|NCT03464630|101662937|FG001|Initiated & Completed Orientation Session|Overall Study||182||
48542388|NCT03464630|101662936|FG000|Initiated & Completed S1 Intervention Content|Overall Study||170||
48542389|NCT03464630|101662937|FG001|Initiated & Completed S1 Intervention Content|Overall Study||172||
48542390|NCT03464630|101662936|FG000|Initiated Post-Assessment|Overall Study||142||
48542391|NCT03464630|101662937|FG001|Initiated Post-Assessment|Overall Study||158||
48542392|NCT03464630|101662936|FG000|COMPLETED|Overall Study||98|Initiated \& completed 6-month Follow Up|
48542393|NCT03464630|101662937|FG001|COMPLETED|Overall Study||118|Initiated \& completed 6-month Follow Up|
48542394|NCT03464630|101662936|FG000|NOT COMPLETED|Overall Study||86||
48542395|NCT03464630|101662937|FG001|NOT COMPLETED|Overall Study||66||
48542396|NCT03485352|101662938|FG000|STARTED|Overall Study||122||
48542397|NCT03485352|101662938|FG000|3 Months|Overall Study||117||
48542398|NCT03485352|101662938|FG000|COMPLETED|Overall Study||113||
48542399|NCT03485352|101662938|FG000|NOT COMPLETED|Overall Study||9||
48542400|NCT02374346|101662939|FG000|STARTED|Overall Study||494||
48542401|NCT02374346|101662939|FG000|COMPLETED|Overall Study||446||
48542402|NCT02374346|101662939|FG000|NOT COMPLETED|Overall Study||48||
48542403|NCT04693416|101662940|FG000|STARTED|Overall Study||50||
48542404|NCT04693416|101662941|FG001|STARTED|Overall Study||21||
48542405|NCT04693416|101662940|FG000|COMPLETED|Overall Study||37||
48542406|NCT04693416|101662941|FG001|COMPLETED|Overall Study||21||
48542407|NCT04693416|101662940|FG000|NOT COMPLETED|Overall Study||13||
48542408|NCT04693416|101662941|FG001|NOT COMPLETED|Overall Study||0||
48542409|NCT03700385|101662942|FG000|STARTED|Overall Study||40||
48542410|NCT03700385|101662942|FG000|COMPLETED|Overall Study||39||
48542411|NCT03700385|101662942|FG000|NOT COMPLETED|Overall Study||1||
48542412|NCT00282919|101662943|FG000|STARTED|Overall Study||110||
48542413|NCT00282919|101662943|FG000|COMPLETED|Overall Study||103||
48542414|NCT00282919|101662943|FG000|NOT COMPLETED|Overall Study||7||
48542415|NCT02309138|101662944|FG000|STARTED|Overall Study||460||
48542416|NCT02309138|101662945|FG001|STARTED|Overall Study||461||
48542417|NCT02309138|101662944|FG000|COMPLETED|Overall Study||412||
48542418|NCT02309138|101662945|FG001|COMPLETED|Overall Study||443||
48542419|NCT02309138|101662944|FG000|NOT COMPLETED|Overall Study||48||
48542420|NCT02309138|101662945|FG001|NOT COMPLETED|Overall Study||18||
48542421|NCT01994291|101662946|FG000|STARTED|Overall Study||99||
48542422|NCT01994291|101662947|FG001|STARTED|Overall Study||43||
48542423|NCT01994291|101662948|FG002|STARTED|Overall Study||56||
48542424|NCT01994291|101662946|FG000|Received Treatment|Overall Study||99||
48542425|NCT01994291|101662947|FG001|Received Treatment|Overall Study||43||
48542426|NCT01994291|101662948|FG002|Received Treatment|Overall Study||56||
48542427|NCT01994291|101662946|FG000|COMPLETED|Overall Study||84||
48542428|NCT01994291|101662947|FG001|COMPLETED|Overall Study||36||
48542429|NCT01994291|101662948|FG002|COMPLETED|Overall Study||47||
48542430|NCT01994291|101662946|FG000|NOT COMPLETED|Overall Study||15||
48542431|NCT01994291|101662947|FG001|NOT COMPLETED|Overall Study||7||
48542432|NCT01994291|101662948|FG002|NOT COMPLETED|Overall Study||9||
48097065|NCT03232281|100563622|FG001|NOT COMPLETED|Overall Study||6||
48097066|NCT01154218|100563623|FG000|STARTED|First Intervention Period||9||
48097067|NCT01154218|100563624|FG001|STARTED|First Intervention Period||9||
48542433|NCT01862484|101662949|FG000|STARTED|Overall Study||15||
48542434|NCT01862484|101662950|FG001|STARTED|Overall Study||14||
48542435|NCT01862484|101662949|FG000|COMPLETED|Overall Study||13||
48542436|NCT01862484|101662950|FG001|COMPLETED|Overall Study||6||
48542437|NCT01862484|101662949|FG000|NOT COMPLETED|Overall Study||2||
48542438|NCT01862484|101662950|FG001|NOT COMPLETED|Overall Study||8||
48542439|NCT02794597|101662951|FG000|STARTED|Overall Study||63||
48542440|NCT02794597|101662952|FG001|STARTED|Overall Study||56||
48542441|NCT02794597|101662951|FG000|COMPLETED|Overall Study||63||
48542442|NCT02794597|101662952|FG001|COMPLETED|Overall Study||56||
48542443|NCT02794597|101662951|FG000|NOT COMPLETED|Overall Study||0||
48542444|NCT02794597|101662952|FG001|NOT COMPLETED|Overall Study||0||
48097068|NCT01154218|100563625|FG002|STARTED|First Intervention Period||9||
48097069|NCT01154218|100563626|FG003|STARTED|First Intervention Period||9||
48097070|NCT01154218|100563623|FG000|COMPLETED|First Intervention Period||9||
48542445|NCT02714426|101662953|FG000|STARTED|Overall Study||21||
48097071|NCT01154218|100563624|FG001|COMPLETED|First Intervention Period||9||
48097072|NCT01154218|100563625|FG002|COMPLETED|First Intervention Period||9||
48542446|NCT02714426|101662954|FG001|STARTED|Overall Study||21||
48542447|NCT02714426|101662953|FG000|COMPLETED|Overall Study||19||
48542448|NCT02714426|101662954|FG001|COMPLETED|Overall Study||19||
48542449|NCT02714426|101662953|FG000|NOT COMPLETED|Overall Study||2||
48689964|NCT00434993|102022819|FG001|STARTED|Overall Study||130||
48542450|NCT02714426|101662954|FG001|NOT COMPLETED|Overall Study||2||
48542451|NCT03714828|101662955|FG000|STARTED|Overall Study||11||24
48542452|NCT03714828|101662955|FG000|COMPLETED|Overall Study||11||24
48542453|NCT03714828|101662955|FG000|NOT COMPLETED|Overall Study||0||0
48542454|NCT04762277|101662956|FG000|STARTED|Overall Study||17||
48542455|NCT04762277|101662957|FG001|STARTED|Overall Study||35||
48542456|NCT04762277|101662956|FG000|COMPLETED|Overall Study||16|Completed treatment|
48542457|NCT04762277|101662957|FG001|COMPLETED|Overall Study||32|Completed treatment|
48542458|NCT04762277|101662956|FG000|NOT COMPLETED|Overall Study||1||
48542459|NCT04762277|101662957|FG001|NOT COMPLETED|Overall Study||3||
48542460|NCT01054404|101662958|FG000|STARTED|Overall Study||10||
48542461|NCT01054404|101662959|FG001|STARTED|Overall Study||13||
48542462|NCT01054404|101662958|FG000|COMPLETED|Overall Study||10||
48542463|NCT01054404|101662959|FG001|COMPLETED|Overall Study||13||
48542464|NCT01054404|101662958|FG000|NOT COMPLETED|Overall Study||0||
48542465|NCT01054404|101662959|FG001|NOT COMPLETED|Overall Study||0||
48542466|NCT00805961|101662960|FG000|STARTED|Modality Therapy||68||
48542467|NCT00805961|101662960|FG000|COMPLETED|Modality Therapy||64||
48542468|NCT00805961|101662960|FG000|NOT COMPLETED|Modality Therapy||4||
48542469|NCT00805961|101662960|FG000|STARTED|Treatment-Free Interval||64||
48542470|NCT00805961|101662960|FG000|COMPLETED|Treatment-Free Interval||57||
48542471|NCT00805961|101662960|FG000|NOT COMPLETED|Treatment-Free Interval||7||
48542472|NCT00805961|101662960|FG000|STARTED|Maintenance Treatment||57||
48542473|NCT00805961|101662960|FG000|COMPLETED|Maintenance Treatment||23||
48542474|NCT00805961|101662960|FG000|NOT COMPLETED|Maintenance Treatment||34||
48542475|NCT02201277|101662961|FG000|STARTED|Overall Study||24||25
48542476|NCT02201277|101662962|FG001|STARTED|Overall Study||21||20
48542477|NCT02201277|101662961|FG000|Filter Retrieval|Overall Study||17||17
48542478|NCT02201277|101662962|FG001|Filter Retrieval|Overall Study||16||16
48542479|NCT02201277|101662961|FG000|Signed ICF But Did Not Enroll|Overall Study||0||0
48542480|NCT02201277|101662962|FG001|Signed ICF But Did Not Enroll|Overall Study||1||1
48542481|NCT02201277|101662961|FG000|Filter Ruled to be Permanent|Overall Study||2||2
48542482|NCT02201277|101662962|FG001|Filter Ruled to be Permanent|Overall Study||2||2
48542483|NCT02201277|101662961|FG000|Lost to Follow up|Overall Study||2||2
48542484|NCT02201277|101662962|FG001|Lost to Follow up|Overall Study||1||1
48542485|NCT02201277|101662961|FG000|Death (Before Removal)|Overall Study||3|All cause mortality not related to the study devices.|3
48542486|NCT02201277|101662962|FG001|Death (Before Removal)|Overall Study||4|All cause mortality not related to the study devices.|4
48542487|NCT02201277|101662961|FG000|Complicated Retrieval|Overall Study||2|2 filters failed 1st attempts at retrieval then success.|2
48542488|NCT02201277|101662962|FG001|Complicated Retrieval|Overall Study||0|2 filters failed 1st attempts at retrieval then success.|0
48542489|NCT02201277|101662961|FG000|Failed Retrieval (Referred Elsewhere)|Overall Study||1||1
48542490|NCT02201277|101662962|FG001|Failed Retrieval (Referred Elsewhere)|Overall Study||0||0
48542491|NCT02201277|101662961|FG000|COMPLETED|Overall Study||17||18
48542492|NCT02201277|101662962|FG001|COMPLETED|Overall Study||16||16
48389969|NCT00870818|101283472|FG003|NOT COMPLETED|Overall Study||38||
48389970|NCT00870818|101283473|FG004|NOT COMPLETED|Overall Study||38||
48542493|NCT02201277|101662961|FG000|NOT COMPLETED|Overall Study||7||7
48542494|NCT02201277|101662962|FG001|NOT COMPLETED|Overall Study||5||4
48542495|NCT02813265|101662963|FG000|STARTED|Overall Study||459||
48542496|NCT02813265|101662964|FG001|STARTED|Overall Study||456||
48542497|NCT02813265|101662963|FG000|COMPLETED|Overall Study||455||
48542498|NCT02813265|101662964|FG001|COMPLETED|Overall Study||453||
48542499|NCT02813265|101662963|FG000|NOT COMPLETED|Overall Study||4||
48542500|NCT02813265|101662964|FG001|NOT COMPLETED|Overall Study||3||
48542501|NCT01025453|101662965|FG000|STARTED|Overall Study||37||
48542502|NCT01025453|101662965|FG000|COMPLETED|Overall Study||37||
48542503|NCT01025453|101662965|FG000|NOT COMPLETED|Overall Study||0||
48542504|NCT00264550|101662966|FG000|STARTED|Overall Study||133||
48542505|NCT00264550|101662967|FG001|STARTED|Overall Study||133||
48542506|NCT00264550|101662968|FG002|STARTED|Overall Study||89||
48542507|NCT00264550|101662969|FG003|STARTED|Overall Study||89||
48542508|NCT00264550|101662966|FG000|COMPLETED|Overall Study||90||
48542509|NCT00264550|101662967|FG001|COMPLETED|Overall Study||92||
48542510|NCT00264550|101662968|FG002|COMPLETED|Overall Study||72||
48542511|NCT00264550|101662969|FG003|COMPLETED|Overall Study||59||
48542512|NCT00264550|101662966|FG000|NOT COMPLETED|Overall Study||43||
48542513|NCT00264550|101662967|FG001|NOT COMPLETED|Overall Study||41||
48542514|NCT00264550|101662968|FG002|NOT COMPLETED|Overall Study||17||
48542515|NCT00264550|101662969|FG003|NOT COMPLETED|Overall Study||30||
48542516|NCT04895982|101662970|FG000|STARTED|Overall Study||9||
48542517|NCT04895982|101662971|FG001|STARTED|Overall Study||15||
48389971|NCT02802878|101283474|FG000|STARTED|Overall Study||21||
48389972|NCT02802878|101283475|FG001|STARTED|Overall Study||21||
48542518|NCT04895982|101662972|FG002|STARTED|Overall Study||13||
48542519|NCT04895982|101662973|FG003|STARTED|Overall Study||19||
48689965|NCT00434993|102022818|FG000|COMPLETED|Overall Study||152||
48542520|NCT04895982|101662974|FG004|STARTED|Overall Study||24||
48542521|NCT04895982|101662975|FG005|STARTED|Overall Study||22||
48542522|NCT04895982|101662976|FG006|STARTED|Overall Study||7||
48542523|NCT04895982|101662977|FG007|STARTED|Overall Study||1||
48542524|NCT04895982|101662978|FG008|STARTED|Overall Study||7||
48542525|NCT04895982|101662979|FG009|STARTED|Overall Study||5||
48542526|NCT04895982|101662980|FG010|STARTED|Overall Study||1||
48542527|NCT04895982|101662981|FG011|STARTED|Overall Study||1||
48542528|NCT04895982|101662970|FG000|Dose 1|Overall Study||9||
48542529|NCT04895982|101662971|FG001|Dose 1|Overall Study||15||
48542530|NCT04895982|101662972|FG002|Dose 1|Overall Study||13||
48542531|NCT04895982|101662973|FG003|Dose 1|Overall Study||19||
48542532|NCT04895982|101662974|FG004|Dose 1|Overall Study||24||
48542533|NCT04895982|101662975|FG005|Dose 1|Overall Study||22||
48542534|NCT04895982|101662976|FG006|Dose 1|Overall Study||7||
48542535|NCT04895982|101662977|FG007|Dose 1|Overall Study||1||
48542536|NCT04895982|101662978|FG008|Dose 1|Overall Study||7||
48542537|NCT04895982|101662979|FG009|Dose 1|Overall Study||5||
48542538|NCT04895982|101662980|FG010|Dose 1|Overall Study||1||
48542539|NCT04895982|101662981|FG011|Dose 1|Overall Study||1||
48542540|NCT04895982|101662970|FG000|Dose 2|Overall Study||9||
48542541|NCT04895982|101662971|FG001|Dose 2|Overall Study||15||
48542542|NCT04895982|101662972|FG002|Dose 2|Overall Study||12||
48542543|NCT04895982|101662973|FG003|Dose 2|Overall Study||19||
48542544|NCT04895982|101662974|FG004|Dose 2|Overall Study||24||
48542545|NCT04895982|101662975|FG005|Dose 2|Overall Study||22||
48542546|NCT04895982|101662976|FG006|Dose 2|Overall Study||7||
48097073|NCT01154218|100563626|FG003|COMPLETED|First Intervention Period||9||
48097074|NCT01154218|100563623|FG000|NOT COMPLETED|First Intervention Period||0||
48097075|NCT01154218|100563624|FG001|NOT COMPLETED|First Intervention Period||0||
48097076|NCT01154218|100563625|FG002|NOT COMPLETED|First Intervention Period||0||
48097077|NCT01154218|100563626|FG003|NOT COMPLETED|First Intervention Period||0||
48097078|NCT01154218|100563623|FG000|STARTED|Washout Period (at Least 14 Days)||9||
48689966|NCT00434993|102022819|FG001|COMPLETED|Overall Study||130||
48689967|NCT00434993|102022818|FG000|NOT COMPLETED|Overall Study||0||
48689968|NCT00434993|102022819|FG001|NOT COMPLETED|Overall Study||0||
48689969|NCT01109108|102022820|FG000|STARTED|Overall Study||4035||
48689970|NCT01109108|102022821|FG001|STARTED|Overall Study||4755||
48689971|NCT01109108|102022820|FG000|COMPLETED|Overall Study||4035||
48689972|NCT01109108|102022821|FG001|COMPLETED|Overall Study||4755||
48097079|NCT01154218|100563624|FG001|STARTED|Washout Period (at Least 14 Days)||9||
48097080|NCT01154218|100563625|FG002|STARTED|Washout Period (at Least 14 Days)||9||
48097081|NCT01154218|100563626|FG003|STARTED|Washout Period (at Least 14 Days)||9||
48097082|NCT01154218|100563623|FG000|COMPLETED|Washout Period (at Least 14 Days)||9||
48097083|NCT01154218|100563624|FG001|COMPLETED|Washout Period (at Least 14 Days)||9||
48097084|NCT01154218|100563625|FG002|COMPLETED|Washout Period (at Least 14 Days)||9||
48097085|NCT01154218|100563626|FG003|COMPLETED|Washout Period (at Least 14 Days)||9||
48097086|NCT01154218|100563623|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48097087|NCT01154218|100563624|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48097088|NCT01154218|100563625|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48097089|NCT01154218|100563626|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48542547|NCT04895982|101662977|FG007|Dose 2|Overall Study||1||
48542548|NCT04895982|101662978|FG008|Dose 2|Overall Study||7||
48542549|NCT04895982|101662979|FG009|Dose 2|Overall Study||5||
48542550|NCT04895982|101662980|FG010|Dose 2|Overall Study||1||
48542551|NCT04895982|101662981|FG011|Dose 2|Overall Study||1||
48542552|NCT04895982|101662970|FG000|Dose 3|Overall Study||9||
48542553|NCT04895982|101662971|FG001|Dose 3|Overall Study||15||
48542554|NCT04895982|101662972|FG002|Dose 3|Overall Study||11||
48542555|NCT04895982|101662973|FG003|Dose 3|Overall Study||17||
48542556|NCT04895982|101662974|FG004|Dose 3|Overall Study||24||
48542557|NCT04895982|101662975|FG005|Dose 3|Overall Study||22||
48542558|NCT04895982|101662976|FG006|Dose 3|Overall Study||7||
48689973|NCT01109108|102022820|FG000|NOT COMPLETED|Overall Study||0||
48689974|NCT01109108|102022821|FG001|NOT COMPLETED|Overall Study||0||
48689975|NCT01582009|102022822|FG000|STARTED|Overall Study||26||
48689976|NCT01582009|102022822|FG000|COMPLETED|Overall Study||24||
48689977|NCT01582009|102022822|FG000|NOT COMPLETED|Overall Study||2||
48689978|NCT00325130|102022823|FG000|STARTED|Overall Study||518||
48689979|NCT00325130|102022824|FG001|STARTED|Overall Study||524||
48542559|NCT04895982|101662977|FG007|Dose 3|Overall Study||1||
48542560|NCT04895982|101662978|FG008|Dose 3|Overall Study||6||
48542561|NCT04895982|101662979|FG009|Dose 3|Overall Study||5||
48542562|NCT04895982|101662980|FG010|Dose 3|Overall Study||1||
48542563|NCT04895982|101662981|FG011|Dose 3|Overall Study||1||
48542564|NCT04895982|101662970|FG000|Dose 4|Overall Study||7||
48689980|NCT00325130|102022823|FG000|COMPLETED|Overall Study||499||
48689981|NCT00325130|102022824|FG001|COMPLETED|Overall Study||494||
48260548|NCT00884650|100958964|FG000|NOT COMPLETED|Overall Study||9||
48260549|NCT00884650|100958965|FG001|NOT COMPLETED|Overall Study||8||
48260550|NCT00585078|100958966|FG000|STARTED|Overall Study||40||
48260551|NCT00585078|100958966|FG000|Treated|Overall Study||37||
48260552|NCT00585078|100958966|FG000|Toxicity Evaluable|Overall Study||36|Participants who received treatment and with toxicity data reported were evaluable for toxicity.|
48260553|NCT00585078|100958966|FG000|Response Evaluable|Overall Study||24|Per protocol, participants must have completed 2 cycles of treatment to be evaluable for response.|
48260554|NCT00585078|100958966|FG000|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|
48260555|NCT00585078|100958966|FG000|NOT COMPLETED|Overall Study||40||
48260556|NCT00656201|100958967|FG000|STARTED|Overall Study||235||
48260557|NCT00656201|100958968|FG001|STARTED|Overall Study||233||
48260558|NCT00656201|100958967|FG000|COMPLETED|Overall Study||206||
48260559|NCT00656201|100958968|FG001|COMPLETED|Overall Study||201||
48260560|NCT00656201|100958967|FG000|NOT COMPLETED|Overall Study||29||
48260561|NCT00656201|100958968|FG001|NOT COMPLETED|Overall Study||32||
48260562|NCT01806389|100958969|FG000|STARTED|Overall Study||14||
48260563|NCT01806389|100958969|FG000|COMPLETED|Overall Study||10||
48260564|NCT01806389|100958969|FG000|NOT COMPLETED|Overall Study||4||
48260565|NCT00394589|100958970|FG000|STARTED|Overall Study||14||
48260566|NCT00394589|100958971|FG001|STARTED|Overall Study||11||
48260567|NCT00394589|100958972|FG002|STARTED|Overall Study||18||
48260568|NCT00394589|100958970|FG000|COMPLETED|Overall Study||6||
48260569|NCT00394589|100958971|FG001|COMPLETED|Overall Study||8||
48260570|NCT00394589|100958972|FG002|COMPLETED|Overall Study||11||
48260571|NCT00394589|100958970|FG000|NOT COMPLETED|Overall Study||8||
48260572|NCT00394589|100958971|FG001|NOT COMPLETED|Overall Study||3||
48260573|NCT00394589|100958972|FG002|NOT COMPLETED|Overall Study||7||
48260574|NCT02632812|100958973|FG000|STARTED|Overall Study||12||
48260575|NCT02632812|100958974|FG001|STARTED|Overall Study||12||
48260576|NCT02632812|100958973|FG000|COMPLETED|Overall Study||12||
48260577|NCT02632812|100958974|FG001|COMPLETED|Overall Study||12||
48260578|NCT02632812|100958973|FG000|NOT COMPLETED|Overall Study||0||
48260579|NCT02632812|100958974|FG001|NOT COMPLETED|Overall Study||0||
48260580|NCT00745498|100958975|FG000|STARTED|Overall Study||41||
48260581|NCT00745498|100958976|FG001|STARTED|Overall Study||43||
48260582|NCT00745498|100958977|FG002|STARTED|Overall Study||42||
48542565|NCT04895982|101662971|FG001|Dose 4|Overall Study||13||
48542566|NCT04895982|101662972|FG002|Dose 4|Overall Study||6||
48542567|NCT04895982|101662973|FG003|Dose 4|Overall Study||14||
48542568|NCT04895982|101662974|FG004|Dose 4|Overall Study||20||
48542569|NCT04895982|101662975|FG005|Dose 4|Overall Study||17||
48542570|NCT04895982|101662976|FG006|Dose 4|Overall Study||5||
48689982|NCT00325130|102022823|FG000|NOT COMPLETED|Overall Study||19||
48689983|NCT00325130|102022824|FG001|NOT COMPLETED|Overall Study||30||
48689984|NCT02819297|102022825|FG000|STARTED|Overall Study||299||
48689985|NCT02819297|102022826|FG001|STARTED|Overall Study||304||
48689986|NCT02819297|102022825|FG000|COMPLETED|Overall Study||239||
48689987|NCT02819297|102022826|FG001|COMPLETED|Overall Study||252||
48689988|NCT02819297|102022825|FG000|NOT COMPLETED|Overall Study||60||
48689989|NCT02819297|102022826|FG001|NOT COMPLETED|Overall Study||52||
48689990|NCT00910910|102022827|FG000|STARTED|Overall Study||225||
48689991|NCT00910910|102022828|FG001|STARTED|Overall Study||225||
48260583|NCT00745498|100958975|FG000|COMPLETED|Overall Study||36||
48260584|NCT00745498|100958976|FG001|COMPLETED|Overall Study||37||
48260585|NCT00745498|100958977|FG002|COMPLETED|Overall Study||34||
48260586|NCT00745498|100958975|FG000|NOT COMPLETED|Overall Study||5||
48260587|NCT00745498|100958976|FG001|NOT COMPLETED|Overall Study||6||
48542571|NCT04895982|101662977|FG007|Dose 4|Overall Study||1||
48542572|NCT04895982|101662978|FG008|Dose 4|Overall Study||3||
48542573|NCT04895982|101662979|FG009|Dose 4|Overall Study||3||
48542574|NCT04895982|101662980|FG010|Dose 4|Overall Study||1||
48542575|NCT04895982|101662981|FG011|Dose 4|Overall Study||0||
48542576|NCT04895982|101662970|FG000|COMPLETED|Overall Study||7||
48689992|NCT00910910|102022827|FG000|Safety Population|Overall Study||224||
48689993|NCT00910910|102022828|FG001|Safety Population|Overall Study||223||
48689994|NCT00910910|102022827|FG000|COMPLETED|Overall Study||0||
48689995|NCT00910910|102022828|FG001|COMPLETED|Overall Study||1||
48689996|NCT00910910|102022827|FG000|NOT COMPLETED|Overall Study||225||
48689997|NCT00910910|102022828|FG001|NOT COMPLETED|Overall Study||224||
48689998|NCT01623167|102022829|FG000|STARTED|Overall Study||30||
48689999|NCT01623167|102022830|FG001|STARTED|Overall Study||31||
48690000|NCT01623167|102022831|FG002|STARTED|Overall Study||31||
48260588|NCT00745498|100958977|FG002|NOT COMPLETED|Overall Study||8||
48260589|NCT03065933|100958978|FG000|STARTED|Overall Study||5||
48260590|NCT03065933|100958978|FG000|COMPLETED|Overall Study||0||
48260591|NCT03065933|100958978|FG000|NOT COMPLETED|Overall Study||5||
48260592|NCT02762903|100958979|FG000|STARTED|Overall Study||30||
48260593|NCT02762903|100958980|FG001|STARTED|Overall Study||30||
48260594|NCT02762903|100958979|FG000|COMPLETED|Overall Study||30||
48260595|NCT02762903|100958980|FG001|COMPLETED|Overall Study||29||
48260596|NCT02762903|100958979|FG000|NOT COMPLETED|Overall Study||0||
48542577|NCT04895982|101662971|FG001|COMPLETED|Overall Study||12||
48542578|NCT04895982|101662972|FG002|COMPLETED|Overall Study||6||
48542579|NCT04895982|101662973|FG003|COMPLETED|Overall Study||16||
48542580|NCT04895982|101662974|FG004|COMPLETED|Overall Study||20||
48542581|NCT04895982|101662975|FG005|COMPLETED|Overall Study||18||
48542582|NCT04895982|101662976|FG006|COMPLETED|Overall Study||5||
48542583|NCT04895982|101662977|FG007|COMPLETED|Overall Study||0||
48542584|NCT04895982|101662978|FG008|COMPLETED|Overall Study||3||
48542585|NCT04895982|101662979|FG009|COMPLETED|Overall Study||3||
48542586|NCT04895982|101662980|FG010|COMPLETED|Overall Study||1||
48690001|NCT01623167|102022829|FG000|COMPLETED|Overall Study||13||
48690002|NCT01623167|102022830|FG001|COMPLETED|Overall Study||17||
48690003|NCT01623167|102022831|FG002|COMPLETED|Overall Study||18||
48690004|NCT01623167|102022829|FG000|NOT COMPLETED|Overall Study||17||
48690005|NCT01623167|102022830|FG001|NOT COMPLETED|Overall Study||14||
48690006|NCT01623167|102022831|FG002|NOT COMPLETED|Overall Study||13||
48690007|NCT01088295|102022832|FG000|STARTED|Overall Study||36||
48690008|NCT01088295|102022832|FG000|COMPLETED|Overall Study||35||
48690009|NCT01088295|102022832|FG000|NOT COMPLETED|Overall Study||1||
48690010|NCT00255723|102022833|FG000|STARTED|Overall Study||56||
48690011|NCT00255723|102022834|FG001|STARTED|Overall Study||41||
48690012|NCT00255723|102022833|FG000|COMPLETED|Overall Study||54||
48690013|NCT00255723|102022834|FG001|COMPLETED|Overall Study||39||
48690014|NCT00255723|102022833|FG000|NOT COMPLETED|Overall Study||2||
48690015|NCT00255723|102022834|FG001|NOT COMPLETED|Overall Study||2||
48690016|NCT01803880|102022835|FG000|STARTED|Overall Study||19||
48690017|NCT01803880|102022836|FG001|STARTED|Overall Study||28||
48690018|NCT01803880|102022837|FG002|STARTED|Overall Study||29||
48690019|NCT01803880|102022835|FG000|COMPLETED|Overall Study||13||
48690020|NCT01803880|102022836|FG001|COMPLETED|Overall Study||18||
48690021|NCT01803880|102022837|FG002|COMPLETED|Overall Study||14||
48690022|NCT01803880|102022835|FG000|NOT COMPLETED|Overall Study||6||
48690023|NCT01803880|102022836|FG001|NOT COMPLETED|Overall Study||10||
48690024|NCT01803880|102022837|FG002|NOT COMPLETED|Overall Study||15||
48690025|NCT04005391|102022838|FG000|STARTED|Overall Study||108||
48690026|NCT04005391|102022839|FG001|STARTED|Overall Study||100||
48542587|NCT04895982|101662981|FG011|COMPLETED|Overall Study||0||
48542588|NCT04895982|101662970|FG000|NOT COMPLETED|Overall Study||2||
48542589|NCT04895982|101662971|FG001|NOT COMPLETED|Overall Study||3||
48542590|NCT04895982|101662972|FG002|NOT COMPLETED|Overall Study||7||
48542591|NCT04895982|101662973|FG003|NOT COMPLETED|Overall Study||3||
48690027|NCT04005391|102022838|FG000|COMPLETED|Overall Study||101|Primary Outcome Three Months|
48690028|NCT04005391|102022839|FG001|COMPLETED|Overall Study||100|Primary Outcome Three Months|
48690029|NCT04005391|102022838|FG000|NOT COMPLETED|Overall Study||7||
48690030|NCT04005391|102022839|FG001|NOT COMPLETED|Overall Study||0||
48690031|NCT03367403|102022840|FG000|STARTED|Overall Study||131||
48690032|NCT03367403|102022841|FG001|STARTED|Overall Study||126||
48690033|NCT03367403|102022842|FG002|STARTED|Overall Study||15||
48690034|NCT03367403|102022840|FG000|Received at Least One Dose of Study Drug|Overall Study||131||
48690035|NCT03367403|102022841|FG001|Received at Least One Dose of Study Drug|Overall Study||125||
48690036|NCT03367403|102022842|FG002|Received at Least One Dose of Study Drug|Overall Study||15||
48690037|NCT03367403|102022840|FG000|COMPLETED|Overall Study||94||
48690038|NCT03367403|102022841|FG001|COMPLETED|Overall Study||93||
48690039|NCT03367403|102022842|FG002|COMPLETED|Overall Study||12||
48690040|NCT03367403|102022840|FG000|NOT COMPLETED|Overall Study||37||
48690041|NCT03367403|102022841|FG001|NOT COMPLETED|Overall Study||33||
48690042|NCT03367403|102022842|FG002|NOT COMPLETED|Overall Study||3||
48690043|NCT02509936|102022843|FG000|STARTED|Overall Study||163||
48542592|NCT04895982|101662974|FG004|NOT COMPLETED|Overall Study||4||
48690044|NCT02509936|102022844|FG001|STARTED|Overall Study||161||
48690045|NCT02509936|102022843|FG000|COMPLETED|Overall Study||151||
48690046|NCT02509936|102022844|FG001|COMPLETED|Overall Study||145||
48690047|NCT02509936|102022843|FG000|NOT COMPLETED|Overall Study||12||
48690048|NCT02509936|102022844|FG001|NOT COMPLETED|Overall Study||16||
48542593|NCT04895982|101662975|FG005|NOT COMPLETED|Overall Study||4||
48542594|NCT04895982|101662976|FG006|NOT COMPLETED|Overall Study||2||
48542595|NCT04895982|101662977|FG007|NOT COMPLETED|Overall Study||1||
48690049|NCT04396795|102022845|FG000|STARTED|Baseline||28||
48690050|NCT04396795|102022846|FG001|STARTED|Baseline||33||
48690051|NCT04396795|102022845|FG000|COMPLETED|Baseline||28||
48690052|NCT04396795|102022846|FG001|COMPLETED|Baseline||33||
48690053|NCT04396795|102022845|FG000|NOT COMPLETED|Baseline||0||
48690054|NCT04396795|102022846|FG001|NOT COMPLETED|Baseline||0||
48690055|NCT04396795|102022845|FG000|STARTED|Month 1||28||
48690056|NCT04396795|102022846|FG001|STARTED|Month 1||33||
48690057|NCT04396795|102022845|FG000|COMPLETED|Month 1||26||
48690058|NCT04396795|102022846|FG001|COMPLETED|Month 1||30||
48690059|NCT04396795|102022845|FG000|NOT COMPLETED|Month 1||2||
48690060|NCT04396795|102022846|FG001|NOT COMPLETED|Month 1||3||
48690061|NCT04396795|102022845|FG000|STARTED|Month 3||26||
48690062|NCT04396795|102022846|FG001|STARTED|Month 3||30||
48690063|NCT04396795|102022845|FG000|COMPLETED|Month 3||25||
48690064|NCT04396795|102022846|FG001|COMPLETED|Month 3||27||
48690065|NCT04396795|102022845|FG000|NOT COMPLETED|Month 3||1||
48690066|NCT04396795|102022846|FG001|NOT COMPLETED|Month 3||3||
48690067|NCT04396795|102022845|FG000|STARTED|Month 6||25||
48690068|NCT04396795|102022846|FG001|STARTED|Month 6||27||
48690069|NCT04396795|102022845|FG000|COMPLETED|Month 6||22||
48690070|NCT04396795|102022846|FG001|COMPLETED|Month 6||24||
48542596|NCT04895982|101662978|FG008|NOT COMPLETED|Overall Study||4||
48542597|NCT04895982|101662979|FG009|NOT COMPLETED|Overall Study||2||
48542598|NCT04895982|101662980|FG010|NOT COMPLETED|Overall Study||0||
48542599|NCT04895982|101662981|FG011|NOT COMPLETED|Overall Study||1||
48542600|NCT02495623|101662982|FG000|STARTED|Overall Study||25||
48097090|NCT01154218|100563623|FG000|STARTED|Second Intervention Period||9||
48097091|NCT01154218|100563624|FG001|STARTED|Second Intervention Period||9||
48097092|NCT01154218|100563625|FG002|STARTED|Second Intervention Period||9||
48097093|NCT01154218|100563626|FG003|STARTED|Second Intervention Period||9||
48690071|NCT04396795|102022845|FG000|NOT COMPLETED|Month 6||3||
48690072|NCT04396795|102022846|FG001|NOT COMPLETED|Month 6||3||
48690073|NCT01833494|102022847|FG000|STARTED|Overall Study||161||
48690074|NCT01833494|102022847|FG000|COMPLETED|Overall Study||116||
48690075|NCT01833494|102022847|FG000|NOT COMPLETED|Overall Study||45||
48690076|NCT01650831|102022848|FG000|STARTED|Overall Study||113||
48690077|NCT01650831|102022848|FG000|COMPLETED|Overall Study||112||
48690078|NCT01650831|102022848|FG000|NOT COMPLETED|Overall Study||1||
48690079|NCT01467466|102022849|FG000|STARTED|Overall Study||1300||
48690080|NCT01467466|102022850|FG001|STARTED|Overall Study||1292||
48690081|NCT01467466|102022851|FG002|STARTED|Overall Study||1294||
48690082|NCT01467466|102022852|FG003|STARTED|Overall Study||1291||
48690083|NCT01467466|102022849|FG000|COMPLETED|Overall Study||1191||
48690084|NCT01467466|102022850|FG001|COMPLETED|Overall Study||1188||
48690085|NCT01467466|102022851|FG002|COMPLETED|Overall Study||1190||
48690086|NCT01467466|102022852|FG003|COMPLETED|Overall Study||1203||
48690087|NCT01467466|102022849|FG000|NOT COMPLETED|Overall Study||109||
48690088|NCT01467466|102022850|FG001|NOT COMPLETED|Overall Study||104||
48690089|NCT01467466|102022851|FG002|NOT COMPLETED|Overall Study||104||
48097094|NCT01154218|100563623|FG000|COMPLETED|Second Intervention Period||9||
48690090|NCT01467466|102022852|FG003|NOT COMPLETED|Overall Study||88||
48097095|NCT01154218|100563624|FG001|COMPLETED|Second Intervention Period||9||
48097096|NCT01154218|100563625|FG002|COMPLETED|Second Intervention Period||9||
48097097|NCT01154218|100563626|FG003|COMPLETED|Second Intervention Period||9||
48097098|NCT01154218|100563623|FG000|NOT COMPLETED|Second Intervention Period||0||
48097099|NCT01154218|100563624|FG001|NOT COMPLETED|Second Intervention Period||0||
48097100|NCT01154218|100563625|FG002|NOT COMPLETED|Second Intervention Period||0||
48097101|NCT01154218|100563626|FG003|NOT COMPLETED|Second Intervention Period||0||
48097102|NCT01154218|100563623|FG000|STARTED|Washout Period (at Least 14 Days)||9||
48097103|NCT01154218|100563624|FG001|STARTED|Washout Period (at Least 14 Days)||9||
48097104|NCT01154218|100563625|FG002|STARTED|Washout Period (at Least 14 Days)||9||
48097105|NCT01154218|100563626|FG003|STARTED|Washout Period (at Least 14 Days)||9||
48097106|NCT01154218|100563623|FG000|COMPLETED|Washout Period (at Least 14 Days)||9||
48097107|NCT01154218|100563624|FG001|COMPLETED|Washout Period (at Least 14 Days)||9||
48097108|NCT01154218|100563625|FG002|COMPLETED|Washout Period (at Least 14 Days)||9||
48097109|NCT01154218|100563626|FG003|COMPLETED|Washout Period (at Least 14 Days)||9||
48097110|NCT01154218|100563623|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48097111|NCT01154218|100563624|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48097112|NCT01154218|100563625|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48542601|NCT02495623|101662983|FG001|STARTED|Overall Study||26||
48542602|NCT02495623|101662984|FG002|STARTED|Overall Study||28||
48542603|NCT02495623|101662982|FG000|Dosed|Overall Study||22||
48097113|NCT01154218|100563626|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48097114|NCT01154218|100563623|FG000|STARTED|Third Intervention Period||9||
48097115|NCT01154218|100563624|FG001|STARTED|Third Intervention Period||9||
48097116|NCT01154218|100563625|FG002|STARTED|Third Intervention Period||9||
48542604|NCT02495623|101662983|FG001|Dosed|Overall Study||19||
48542605|NCT02495623|101662984|FG002|Dosed|Overall Study||22||
48542606|NCT02495623|101662982|FG000|COMPLETED|Overall Study||20||
48690091|NCT03592771|102025750|FG000|STARTED|Overall Study||104||
48690092|NCT03592771|102025751|FG001|STARTED|Overall Study||98||
48690093|NCT03592771|102025752|FG002|STARTED|Overall Study||102||
48690094|NCT03592771|102025750|FG000|COMPLETED|Overall Study||97||
48690095|NCT03592771|102025751|FG001|COMPLETED|Overall Study||84||
48690096|NCT03592771|102025752|FG002|COMPLETED|Overall Study||85||
48260597|NCT02762903|100958980|FG001|NOT COMPLETED|Overall Study||1||
48260598|NCT02239744|100958981|FG000|STARTED|Period 1||17||
48260599|NCT02239744|100958982|FG001|STARTED|Period 1||18||
48260600|NCT02239744|100958981|FG000|COMPLETED|Period 1||17||
48260601|NCT02239744|100958982|FG001|COMPLETED|Period 1||18||
48260602|NCT02239744|100958981|FG000|NOT COMPLETED|Period 1||0||
48260603|NCT02239744|100958982|FG001|NOT COMPLETED|Period 1||0||
48260604|NCT02239744|100958981|FG000|STARTED|Period 2||17||
48260605|NCT02239744|100958982|FG001|STARTED|Period 2||18||
48260606|NCT02239744|100958981|FG000|COMPLETED|Period 2||17||
48260607|NCT02239744|100958982|FG001|COMPLETED|Period 2||18||
48260608|NCT02239744|100958981|FG000|NOT COMPLETED|Period 2||0||
48260609|NCT02239744|100958982|FG001|NOT COMPLETED|Period 2||0||
48260610|NCT02526186|100958983|FG000|STARTED|Overall Study||33||
48260611|NCT02526186|100958984|FG001|STARTED|Overall Study||37||
48260612|NCT02526186|100958983|FG000|COMPLETED|Overall Study||33||
48260613|NCT02526186|100958984|FG001|COMPLETED|Overall Study||37||
48260614|NCT02526186|100958983|FG000|NOT COMPLETED|Overall Study||0||
48260615|NCT02526186|100958984|FG001|NOT COMPLETED|Overall Study||0||
48260616|NCT00975676|100958985|FG000|STARTED|Overall Study||32||
48260617|NCT00975676|100958986|FG001|STARTED|Overall Study||91||
48260618|NCT00975676|100958985|FG000|COMPLETED|Overall Study||26||
48260619|NCT00975676|100958986|FG001|COMPLETED|Overall Study||83||
48260620|NCT00975676|100958985|FG000|NOT COMPLETED|Overall Study||6||
48260621|NCT00975676|100958986|FG001|NOT COMPLETED|Overall Study||8||
48260622|NCT03016598|100958987|FG000|STARTED|Overall Study||18||
48260623|NCT03016598|100958988|FG001|STARTED|Overall Study||22||
48260624|NCT03016598|100958987|FG000|COMPLETED|Overall Study||18||
48260625|NCT03016598|100958988|FG001|COMPLETED|Overall Study||20||
48260626|NCT03016598|100958987|FG000|NOT COMPLETED|Overall Study||0||
48260627|NCT03016598|100958988|FG001|NOT COMPLETED|Overall Study||2||
48260628|NCT01233999|100958989|FG000|STARTED|Overall Study||10||
48260629|NCT01233999|100958989|FG000|COMPLETED|Overall Study||8||
48260630|NCT01233999|100958989|FG000|NOT COMPLETED|Overall Study||2||
48260631|NCT01789840|100958990|FG000|STARTED|Overall Study||52||
48260632|NCT01789840|100958991|FG001|STARTED|Overall Study||7||
48260633|NCT01789840|100958990|FG000|COMPLETED|Overall Study||52||
48260634|NCT01789840|100958991|FG001|COMPLETED|Overall Study||6||
48260635|NCT01789840|100958990|FG000|NOT COMPLETED|Overall Study||0||
48260636|NCT01789840|100958991|FG001|NOT COMPLETED|Overall Study||1||
48260637|NCT02296892|100958992|FG000|STARTED|Overall Study||310||
48260638|NCT02296892|100958993|FG001|STARTED|Overall Study||63||
48097117|NCT01154218|100563626|FG003|STARTED|Third Intervention Period||9||
48097118|NCT01154218|100563623|FG000|COMPLETED|Third Intervention Period||9||
48097119|NCT01154218|100563624|FG001|COMPLETED|Third Intervention Period||8||
48097120|NCT01154218|100563625|FG002|COMPLETED|Third Intervention Period||9||
48097121|NCT01154218|100563626|FG003|COMPLETED|Third Intervention Period||9||
48097122|NCT01154218|100563623|FG000|NOT COMPLETED|Third Intervention Period||0||
48097123|NCT01154218|100563624|FG001|NOT COMPLETED|Third Intervention Period||1||
48260639|NCT02296892|100958994|FG002|STARTED|Overall Study||73||
48260640|NCT02296892|100958992|FG000|Safety Population|Overall Study||303|All randomized patients who received any amount of the trial drug and were analyzed as treated|
48260641|NCT02296892|100958993|FG001|Safety Population|Overall Study||59|All randomized patients who received any amount of the trial drug and were analyzed as treated|
48260642|NCT02296892|100958994|FG002|Safety Population|Overall Study||69|All randomized patients who received any amount of the trial drug and were analyzed as treated|
48260643|NCT02296892|100958992|FG000|Complete Trial Treatment Period|Overall Study||303||
48260644|NCT02296892|100958993|FG001|Complete Trial Treatment Period|Overall Study||59||
48260645|NCT02296892|100958994|FG002|Complete Trial Treatment Period|Overall Study||69||
48260646|NCT02296892|100958992|FG000|COMPLETED|Overall Study||298||
48260647|NCT02296892|100958993|FG001|COMPLETED|Overall Study||59||
48260648|NCT02296892|100958994|FG002|COMPLETED|Overall Study||68||
48260649|NCT02296892|100958992|FG000|NOT COMPLETED|Overall Study||12||
48260650|NCT02296892|100958993|FG001|NOT COMPLETED|Overall Study||4||
48260651|NCT02296892|100958994|FG002|NOT COMPLETED|Overall Study||5||
48260652|NCT01083199|100958995|FG000|STARTED|Overall Study||10||
48260653|NCT01083199|100958995|FG000|COMPLETED|Overall Study||10||
48260654|NCT01083199|100958995|FG000|NOT COMPLETED|Overall Study||0||
48260655|NCT01907113|100958996|FG000|STARTED|Overall Study||8||
48260656|NCT01907113|100958997|FG001|STARTED|Overall Study||9||
48260657|NCT01907113|100958998|FG002|STARTED|Overall Study||7||
48260658|NCT01907113|100958999|FG003|STARTED|Overall Study||8||
48260659|NCT01907113|100959000|FG004|STARTED|Overall Study||8||
48260660|NCT01907113|100958996|FG000|COMPLETED|Overall Study||8||
48097124|NCT01154218|100563625|FG002|NOT COMPLETED|Third Intervention Period||0||
48260661|NCT01907113|100958997|FG001|COMPLETED|Overall Study||9||
48097125|NCT01154218|100563626|FG003|NOT COMPLETED|Third Intervention Period||0||
48260662|NCT01907113|100958998|FG002|COMPLETED|Overall Study||7||
48260663|NCT01907113|100958999|FG003|COMPLETED|Overall Study||8||
48260664|NCT01907113|100959000|FG004|COMPLETED|Overall Study||8||
48260665|NCT01907113|100958996|FG000|NOT COMPLETED|Overall Study||0||
48260666|NCT01907113|100958997|FG001|NOT COMPLETED|Overall Study||0||
48260667|NCT01907113|100958998|FG002|NOT COMPLETED|Overall Study||0||
48260668|NCT01907113|100958999|FG003|NOT COMPLETED|Overall Study||0||
48542607|NCT02495623|101662983|FG001|COMPLETED|Overall Study||17||
48542608|NCT02495623|101662984|FG002|COMPLETED|Overall Study||20||
48542609|NCT02495623|101662982|FG000|NOT COMPLETED|Overall Study||5||
48260669|NCT01907113|100959000|FG004|NOT COMPLETED|Overall Study||0||
48260670|NCT02037776|100959001|FG000|STARTED|Overall Study||61||
48260671|NCT02037776|100959002|FG001|STARTED|Overall Study||64||
48260672|NCT02037776|100959001|FG000|COMPLETED|Overall Study||56||
48260673|NCT02037776|100959002|FG001|COMPLETED|Overall Study||60||
48542610|NCT02495623|101662983|FG001|NOT COMPLETED|Overall Study||9||
48542611|NCT02495623|101662984|FG002|NOT COMPLETED|Overall Study||8||
48542612|NCT05984186|101662985|FG000|STARTED|FiO2=100% With Flow=5LPM||15||
48542613|NCT05984186|101662985|FG000|COMPLETED|FiO2=100% With Flow=5LPM||15||
48542614|NCT05984186|101662985|FG000|NOT COMPLETED|FiO2=100% With Flow=5LPM||0||
48542615|NCT05984186|101662985|FG000|STARTED|FiO2=21% With Flow=25-35LPM||15||
48542616|NCT05984186|101662985|FG000|COMPLETED|FiO2=21% With Flow=25-35LPM||15||
48542617|NCT05984186|101662985|FG000|NOT COMPLETED|FiO2=21% With Flow=25-35LPM||0||
48542618|NCT05984186|101662985|FG000|STARTED|FiO2=100% With Flow=25-35LPM||15||
48542619|NCT05984186|101662985|FG000|COMPLETED|FiO2=100% With Flow=25-35LPM||15||
48542620|NCT05984186|101662985|FG000|NOT COMPLETED|FiO2=100% With Flow=25-35LPM||0||
48542621|NCT05984186|101662985|FG000|STARTED|FiO2=21% With Flow=5LPM||15||
48542622|NCT05984186|101662985|FG000|COMPLETED|FiO2=21% With Flow=5LPM||15||
48542623|NCT05984186|101662985|FG000|NOT COMPLETED|FiO2=21% With Flow=5LPM||0||
48542624|NCT03244644|101662986|FG000|STARTED|Overall Study||87||
48542625|NCT03244644|101662987|FG001|STARTED|Overall Study||180||
48542626|NCT03244644|101662986|FG000|COMPLETED|Overall Study||75||
48542627|NCT03244644|101662987|FG001|COMPLETED|Overall Study||159||
48542628|NCT03244644|101662986|FG000|NOT COMPLETED|Overall Study||12||
48542629|NCT03244644|101662987|FG001|NOT COMPLETED|Overall Study||21||
48542630|NCT04623086|101662988|FG000|STARTED|Overall Study||19|"I have now edited the numbers to reflect that only those who were assigned a treatment arm are included among started. I have removed the ones who were either screen failures or withdrew consent prior to being assigned a treatment arm now."|
48542631|NCT04623086|101662989|FG001|STARTED|Overall Study||18|"I have now edited the numbers to reflect that only those who were assigned a treatment arm are included among started. I have removed the ones who were either screen failures or withdrew consent prior to being assigned a treatment arm now."|
48542632|NCT04623086|101662990|FG002|STARTED|Overall Study||10|"I have now edited the numbers to reflect that only those who were assigned a treatment arm are included among started. I have removed the ones who were either screen failures or withdrew consent prior to being assigned a treatment arm now."|
48542633|NCT04623086|101662988|FG000|COMPLETED|Overall Study||19||
48542634|NCT04623086|101662989|FG001|COMPLETED|Overall Study||18||
48542635|NCT04623086|101662990|FG002|COMPLETED|Overall Study||0||
48542636|NCT04623086|101662988|FG000|NOT COMPLETED|Overall Study||0||
48542637|NCT04623086|101662989|FG001|NOT COMPLETED|Overall Study||0||
48542638|NCT04623086|101662990|FG002|NOT COMPLETED|Overall Study||10||
48542639|NCT03376061|101662991|FG000|STARTED|Overall Study||49||
48542640|NCT03376061|101662992|FG001|STARTED|Overall Study||48||
48542641|NCT03376061|101662991|FG000|COMPLETED|Overall Study||49||
48542642|NCT03376061|101662992|FG001|COMPLETED|Overall Study||48||
48542643|NCT03376061|101662991|FG000|NOT COMPLETED|Overall Study||0||
48542644|NCT03376061|101662992|FG001|NOT COMPLETED|Overall Study||0||
48542645|NCT01006018|101662993|FG000|STARTED|Overall Study||0||
48542646|NCT01006018|101662994|FG001|STARTED|Overall Study||0||
48542647|NCT01006018|101662995|FG002|STARTED|Overall Study||0||
48542648|NCT01006018|101662993|FG000|COMPLETED|Overall Study||0||
48542649|NCT01006018|101662994|FG001|COMPLETED|Overall Study||0||
48542650|NCT01006018|101662995|FG002|COMPLETED|Overall Study||0||
48542651|NCT01006018|101662993|FG000|NOT COMPLETED|Overall Study||0||
48542652|NCT01006018|101662994|FG001|NOT COMPLETED|Overall Study||0||
48542653|NCT01006018|101662995|FG002|NOT COMPLETED|Overall Study||0||
48542654|NCT01374269|101662996|FG000|STARTED|Overall Study||46||
48542655|NCT01374269|101662997|FG001|STARTED|Overall Study||44||
48542656|NCT01374269|101662996|FG000|COMPLETED|Overall Study||40||
48542657|NCT01374269|101662997|FG001|COMPLETED|Overall Study||39||
48260674|NCT02037776|100959001|FG000|NOT COMPLETED|Overall Study||5||
48260675|NCT02037776|100959002|FG001|NOT COMPLETED|Overall Study||4||
48260676|NCT01813305|100959003|FG000|STARTED|Overall Study||98||
48260677|NCT01813305|100959004|FG001|STARTED|Overall Study||26||
48260678|NCT01813305|100959003|FG000|COMPLETED|Overall Study||63||
48542658|NCT01374269|101662996|FG000|NOT COMPLETED|Overall Study||6||
48542659|NCT01374269|101662997|FG001|NOT COMPLETED|Overall Study||5||
48542660|NCT00710866|101662998|FG000|STARTED|Overall Study||133||
48542661|NCT00710866|101662999|FG001|STARTED|Overall Study||134||
48542662|NCT00710866|101662998|FG000|COMPLETED|Overall Study||124||
48542663|NCT00710866|101662999|FG001|COMPLETED|Overall Study||128||
48542664|NCT00710866|101662998|FG000|NOT COMPLETED|Overall Study||9||
48542665|NCT00710866|101662999|FG001|NOT COMPLETED|Overall Study||6||
48542666|NCT03207386|101663000|FG000|STARTED|Overall Study||2647||
48542667|NCT03207386|101663000|FG000|COMPLETED|Overall Study||1487||
48542668|NCT03207386|101663000|FG000|NOT COMPLETED|Overall Study||1160||
48542669|NCT01955083|101663001|FG000|STARTED|Overall Study||15||
48542670|NCT01955083|101663002|FG001|STARTED|Overall Study||15||
48542671|NCT01955083|101663001|FG000|COMPLETED|Overall Study||14||
48260679|NCT01813305|100959004|FG001|COMPLETED|Overall Study||18||
48260680|NCT01813305|100959003|FG000|NOT COMPLETED|Overall Study||35||
48260681|NCT01813305|100959004|FG001|NOT COMPLETED|Overall Study||8||
48260682|NCT00927901|100959005|FG000|STARTED|Treatment Period 1||7||
48260683|NCT00927901|100959006|FG001|STARTED|Treatment Period 1||7||
48260684|NCT00927901|100959007|FG002|STARTED|Treatment Period 1||7||
48260685|NCT00927901|100959008|FG003|STARTED|Treatment Period 1||9||
48260686|NCT00927901|100959005|FG000|COMPLETED|Treatment Period 1||7||
48260687|NCT00927901|100959006|FG001|COMPLETED|Treatment Period 1||7||
48260688|NCT00927901|100959007|FG002|COMPLETED|Treatment Period 1||6||
48260689|NCT00927901|100959008|FG003|COMPLETED|Treatment Period 1||9||
48260690|NCT00927901|100959005|FG000|NOT COMPLETED|Treatment Period 1||0||
48260691|NCT00927901|100959006|FG001|NOT COMPLETED|Treatment Period 1||0||
48260692|NCT00927901|100959007|FG002|NOT COMPLETED|Treatment Period 1||1||
48260693|NCT00927901|100959008|FG003|NOT COMPLETED|Treatment Period 1||0||
48260694|NCT00927901|100959005|FG000|STARTED|Treatment Period 2||7||
48260695|NCT00927901|100959006|FG001|STARTED|Treatment Period 2||7||
48260696|NCT00927901|100959007|FG002|STARTED|Treatment Period 2||6||
48260697|NCT00927901|100959008|FG003|STARTED|Treatment Period 2||9||
48260698|NCT00927901|100959005|FG000|COMPLETED|Treatment Period 2||7||
48260699|NCT00927901|100959006|FG001|COMPLETED|Treatment Period 2||7||
48260700|NCT00927901|100959007|FG002|COMPLETED|Treatment Period 2||6||
48260701|NCT00927901|100959008|FG003|COMPLETED|Treatment Period 2||9||
48260702|NCT00927901|100959005|FG000|NOT COMPLETED|Treatment Period 2||0||
48260703|NCT00927901|100959006|FG001|NOT COMPLETED|Treatment Period 2||0||
48097126|NCT01154218|100563623|FG000|STARTED|Washout Period (at Least 14 Days)||9||
48097127|NCT01154218|100563624|FG001|STARTED|Washout Period (at Least 14 Days)||8||
48097128|NCT01154218|100563625|FG002|STARTED|Washout Period (at Least 14 Days)||9||
48097129|NCT01154218|100563626|FG003|STARTED|Washout Period (at Least 14 Days)||9||
48097130|NCT01154218|100563623|FG000|COMPLETED|Washout Period (at Least 14 Days)||9||
48097131|NCT01154218|100563624|FG001|COMPLETED|Washout Period (at Least 14 Days)||8||
48097132|NCT01154218|100563625|FG002|COMPLETED|Washout Period (at Least 14 Days)||9||
48097133|NCT01154218|100563626|FG003|COMPLETED|Washout Period (at Least 14 Days)||8||
48097134|NCT01154218|100563623|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48260704|NCT00927901|100959007|FG002|NOT COMPLETED|Treatment Period 2||0||
48260705|NCT00927901|100959008|FG003|NOT COMPLETED|Treatment Period 2||0||
48260706|NCT00927901|100959005|FG000|STARTED|Treatment Period 3||7||
48260707|NCT00927901|100959006|FG001|STARTED|Treatment Period 3||7||
48260708|NCT00927901|100959007|FG002|STARTED|Treatment Period 3||6||
48260709|NCT00927901|100959008|FG003|STARTED|Treatment Period 3||9||
48260710|NCT00927901|100959005|FG000|COMPLETED|Treatment Period 3||7||
48260711|NCT00927901|100959006|FG001|COMPLETED|Treatment Period 3||7||
48542672|NCT01955083|101663002|FG001|COMPLETED|Overall Study||14||
48542673|NCT01955083|101663001|FG000|NOT COMPLETED|Overall Study||1||
48542674|NCT01955083|101663002|FG001|NOT COMPLETED|Overall Study||1||
48542675|NCT01377012|101663003|FG000|STARTED|Core Study||210||
48542676|NCT01377012|101663004|FG001|STARTED|Core Study||213||
48542677|NCT01377012|101663005|FG002|STARTED|Core Study||214||
48542678|NCT01377012|101663003|FG000|wk16 Re-randomized to AIN 75mg NR|Core Study||0||
48542679|NCT01377012|101663004|FG001|wk16 Re-randomized to AIN 75mg NR|Core Study||0||
48542680|NCT01377012|101663005|FG002|wk16 Re-randomized to AIN 75mg NR|Core Study||56||
48542681|NCT01377012|101663003|FG000|wk16 Re-randomized to AIN 150mg NR|Core Study||0||
48542682|NCT01377012|101663004|FG001|wk16 Re-randomized to AIN 150mg NR|Core Study||0||
48542683|NCT01377012|101663005|FG002|wk16 Re-randomized to AIN 150mg NR|Core Study||53||
48542684|NCT01377012|101663003|FG000|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0||
48542685|NCT01377012|101663004|FG001|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0||
48542686|NCT01377012|101663005|FG002|wk 24 Re-randomized to AIN 75 mg Res|Core Study||38||
48542687|NCT01377012|101663003|FG000|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0||
48542688|NCT01377012|101663004|FG001|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0||
48542689|NCT01377012|101663005|FG002|wk 24 Re-randomized to AIN 150 mg Res|Core Study||34||
48542690|NCT01377012|101663003|FG000|COMPLETED|Core Study||76||
48542691|NCT01377012|101663004|FG001|COMPLETED|Core Study||81||
48542692|NCT01377012|101663005|FG002|COMPLETED|Core Study||80||
48542693|NCT01377012|101663003|FG000|NOT COMPLETED|Core Study||134||
48542694|NCT01377012|101663004|FG001|NOT COMPLETED|Core Study||132||
48542695|NCT01377012|101663005|FG002|NOT COMPLETED|Core Study||134||
48542696|NCT01377012|101663003|FG000|STARTED|Extension Study, Weeks 104-260||57||
48542697|NCT01377012|101663004|FG001|STARTED|Extension Study, Weeks 104-260||71||
48542698|NCT01377012|101663005|FG002|STARTED|Extension Study, Weeks 104-260||68||
48542699|NCT01377012|101663003|FG000|COMPLETED|Extension Study, Weeks 104-260||0||
48542700|NCT01377012|101663004|FG001|COMPLETED|Extension Study, Weeks 104-260||0||
48141387|NCT01297062|100670416|FG006|NOT COMPLETED|Overall Study||8||
48260712|NCT00927901|100959007|FG002|COMPLETED|Treatment Period 3||6||
48260713|NCT00927901|100959008|FG003|COMPLETED|Treatment Period 3||9||
48260714|NCT00927901|100959005|FG000|NOT COMPLETED|Treatment Period 3||0||
48260715|NCT00927901|100959006|FG001|NOT COMPLETED|Treatment Period 3||0||
48260716|NCT00927901|100959007|FG002|NOT COMPLETED|Treatment Period 3||0||
48260717|NCT00927901|100959008|FG003|NOT COMPLETED|Treatment Period 3||0||
48260718|NCT00927901|100959005|FG000|STARTED|Treatment Period 4||7||
48260719|NCT00927901|100959006|FG001|STARTED|Treatment Period 4||7||
48690097|NCT03592771|102025750|FG000|NOT COMPLETED|Overall Study||7||
48690098|NCT03592771|102025751|FG001|NOT COMPLETED|Overall Study||14||
48690099|NCT03592771|102025752|FG002|NOT COMPLETED|Overall Study||17||
48690100|NCT00075764|102025753|FG000|STARTED|Overall Study||345||
48690101|NCT00075764|102025754|FG001|STARTED|Overall Study||349||
48690102|NCT00075764|102025753|FG000|COMPLETED|Overall Study||0||
48690103|NCT00075764|102025754|FG001|COMPLETED|Overall Study||0||
48690104|NCT00075764|102025753|FG000|NOT COMPLETED|Overall Study||345||
48690105|NCT00075764|102025754|FG001|NOT COMPLETED|Overall Study||349||
48690106|NCT01585779|102025755|FG000|STARTED|Overall Study||36||
48690107|NCT01585779|102025756|FG001|STARTED|Overall Study||28||
48690108|NCT01585779|102025755|FG000|COMPLETED|Overall Study||26||
48690109|NCT01585779|102025756|FG001|COMPLETED|Overall Study||21||
48690110|NCT01585779|102025755|FG000|NOT COMPLETED|Overall Study||10||
48690111|NCT01585779|102025756|FG001|NOT COMPLETED|Overall Study||7||
48690112|NCT03900728|102025757|FG000|STARTED|Overall Study||40||
48690113|NCT03900728|102025758|FG001|STARTED|Overall Study||57||
48260720|NCT00927901|100959007|FG002|STARTED|Treatment Period 4||6||
48260721|NCT00927901|100959008|FG003|STARTED|Treatment Period 4||9||
48260722|NCT00927901|100959005|FG000|COMPLETED|Treatment Period 4||7||
48260723|NCT00927901|100959006|FG001|COMPLETED|Treatment Period 4||7||
48260724|NCT00927901|100959007|FG002|COMPLETED|Treatment Period 4||5||
48260725|NCT00927901|100959008|FG003|COMPLETED|Treatment Period 4||8||
48260726|NCT00927901|100959005|FG000|NOT COMPLETED|Treatment Period 4||0||
48260727|NCT00927901|100959006|FG001|NOT COMPLETED|Treatment Period 4||0||
48260728|NCT00927901|100959007|FG002|NOT COMPLETED|Treatment Period 4||1||
48260729|NCT00927901|100959008|FG003|NOT COMPLETED|Treatment Period 4||1||
48260730|NCT00020722|100959009|FG000|STARTED|Overall Study||7||
48260731|NCT00020722|100959009|FG000|COMPLETED|Overall Study||7||
48260732|NCT00020722|100959009|FG000|NOT COMPLETED|Overall Study||0||
48260733|NCT02113410|100959010|FG000|STARTED|Overall Study||65||
48260734|NCT02113410|100959011|FG001|STARTED|Overall Study||66||
48260735|NCT02113410|100959010|FG000|COMPLETED|Overall Study||49||
48260736|NCT02113410|100959011|FG001|COMPLETED|Overall Study||63||
48260737|NCT02113410|100959010|FG000|NOT COMPLETED|Overall Study||16||
48260738|NCT02113410|100959011|FG001|NOT COMPLETED|Overall Study||3||
48260739|NCT00777634|100959012|FG000|STARTED|Overall Study||134||
48260740|NCT00777634|100959013|FG001|STARTED|Overall Study||134||
48260741|NCT00777634|100959012|FG000|COMPLETED|Overall Study||129||
48260742|NCT00777634|100959013|FG001|COMPLETED|Overall Study||133||
48260743|NCT00777634|100959012|FG000|NOT COMPLETED|Overall Study||5||
48260744|NCT00777634|100959013|FG001|NOT COMPLETED|Overall Study||1||
48260745|NCT01585298|100959014|FG000|STARTED|Overall Study||6998||
48260746|NCT01585298|100959014|FG000|COMPLETED|Overall Study||6961||
48260747|NCT01585298|100959014|FG000|NOT COMPLETED|Overall Study||37||
48260748|NCT02466243|100959015|FG000|STARTED|Part A Treatment Period (Double Blind)||11||
48389973|NCT02802878|101283474|FG000|COMPLETED|Overall Study||17||
48389974|NCT02802878|101283475|FG001|COMPLETED|Overall Study||18||
48389975|NCT02802878|101283474|FG000|NOT COMPLETED|Overall Study||4||
48389976|NCT02802878|101283475|FG001|NOT COMPLETED|Overall Study||3||
48389977|NCT01707368|101283476|FG000|STARTED|Overall Study||561||
48389978|NCT01707368|101283476|FG000|COMPLETED|Overall Study||393||
48389979|NCT01707368|101283476|FG000|NOT COMPLETED|Overall Study||168||
48389980|NCT00405652|101283477|FG000|STARTED|Overall Study||34||
48389981|NCT00405652|101283477|FG000|COMPLETED|Overall Study||30||
48690114|NCT03900728|102025759|FG002|STARTED|Overall Study||39||
48690115|NCT03900728|102025757|FG000|COMPLETED|Overall Study||40||
48690116|NCT03900728|102025758|FG001|COMPLETED|Overall Study||57||
48690117|NCT03900728|102025759|FG002|COMPLETED|Overall Study||35||
48690118|NCT03900728|102025757|FG000|NOT COMPLETED|Overall Study||0||
48690119|NCT03900728|102025758|FG001|NOT COMPLETED|Overall Study||0||
48260749|NCT02466243|100959016|FG001|STARTED|Part A Treatment Period (Double Blind)||11||
48260750|NCT02466243|100959015|FG000|COMPLETED|Part A Treatment Period (Double Blind)||11||
48260751|NCT02466243|100959016|FG001|COMPLETED|Part A Treatment Period (Double Blind)||11||
48260752|NCT02466243|100959015|FG000|NOT COMPLETED|Part A Treatment Period (Double Blind)||0||
48260753|NCT02466243|100959016|FG001|NOT COMPLETED|Part A Treatment Period (Double Blind)||0||
48260754|NCT02466243|100959015|FG000|STARTED|Part B Open-label Treatment Period||11||
48260755|NCT02466243|100959016|FG001|STARTED|Part B Open-label Treatment Period||10||
48260756|NCT02466243|100959015|FG000|COMPLETED|Part B Open-label Treatment Period||0||
48260757|NCT02466243|100959016|FG001|COMPLETED|Part B Open-label Treatment Period||0||
48389982|NCT00405652|101283477|FG000|NOT COMPLETED|Overall Study||4||
48389983|NCT01476748|101283478|FG000|STARTED|Overall Study||5||
48389984|NCT01476748|101283479|FG001|STARTED|Overall Study||5||
48389985|NCT01476748|101283480|FG002|STARTED|Overall Study||5||
48389986|NCT01476748|101283478|FG000|COMPLETED|Overall Study||5||
48389987|NCT01476748|101283479|FG001|COMPLETED|Overall Study||5||
48389988|NCT01476748|101283480|FG002|COMPLETED|Overall Study||5||
48389989|NCT01476748|101283478|FG000|NOT COMPLETED|Overall Study||0||
48389990|NCT01476748|101283479|FG001|NOT COMPLETED|Overall Study||0||
48690120|NCT03900728|102025759|FG002|NOT COMPLETED|Overall Study||4||
48690121|NCT02689206|102025760|FG000|STARTED|Overall Study||20||
48690122|NCT02689206|102025761|FG001|STARTED|Overall Study||20||
48690123|NCT02689206|102025762|FG002|STARTED|Overall Study||20||
48260758|NCT02466243|100959015|FG000|NOT COMPLETED|Part B Open-label Treatment Period||11||
48260759|NCT02466243|100959016|FG001|NOT COMPLETED|Part B Open-label Treatment Period||10||
48260760|NCT01151423|100959017|FG000|STARTED|Overall Study||36||
48260761|NCT01151423|100959018|FG001|STARTED|Overall Study||39||
48260762|NCT01151423|100959017|FG000|Received Study Drug|Overall Study||35||
48260763|NCT01151423|100959018|FG001|Received Study Drug|Overall Study||37||
48260764|NCT01151423|100959017|FG000|COMPLETED|Overall Study||20||
48260765|NCT01151423|100959018|FG001|COMPLETED|Overall Study||21||
48260766|NCT01151423|100959017|FG000|NOT COMPLETED|Overall Study||16||
48260767|NCT01151423|100959018|FG001|NOT COMPLETED|Overall Study||18||
48260768|NCT01466790|100959019|FG000|STARTED|Overall Study||24||
48260769|NCT01466790|100959020|FG001|STARTED|Overall Study||15||
48260770|NCT01466790|100959021|FG002|STARTED|Overall Study||27||
48260771|NCT01466790|100959022|FG003|STARTED|Overall Study||14||
48260772|NCT01466790|100959023|FG004|STARTED|Overall Study||30||
48260773|NCT01466790|100959024|FG005|STARTED|Overall Study||16||
48260774|NCT01466790|100959025|FG006|STARTED|Overall Study||27||
48260775|NCT01466790|100959026|FG007|STARTED|Overall Study||14||
48260776|NCT01466790|100959019|FG000|COMPLETED|Overall Study||20||
48260777|NCT01466790|100959020|FG001|COMPLETED|Overall Study||14||
48260778|NCT01466790|100959021|FG002|COMPLETED|Overall Study||27||
48260779|NCT01466790|100959022|FG003|COMPLETED|Overall Study||14||
48260780|NCT01466790|100959023|FG004|COMPLETED|Overall Study||27||
48260781|NCT01466790|100959024|FG005|COMPLETED|Overall Study||16||
48260782|NCT01466790|100959025|FG006|COMPLETED|Overall Study||26||
48260783|NCT01466790|100959026|FG007|COMPLETED|Overall Study||13||
48260784|NCT01466790|100959019|FG000|NOT COMPLETED|Overall Study||4||
48260785|NCT01466790|100959020|FG001|NOT COMPLETED|Overall Study||1||
48260786|NCT01466790|100959021|FG002|NOT COMPLETED|Overall Study||0||
48260787|NCT01466790|100959022|FG003|NOT COMPLETED|Overall Study||0||
48260788|NCT01466790|100959023|FG004|NOT COMPLETED|Overall Study||3||
48260789|NCT01466790|100959024|FG005|NOT COMPLETED|Overall Study||0||
48260790|NCT01466790|100959025|FG006|NOT COMPLETED|Overall Study||1||
48260791|NCT01466790|100959026|FG007|NOT COMPLETED|Overall Study||1||
48260792|NCT01999777|100959027|FG000|STARTED|Overall Study||31||
48260793|NCT01999777|100959028|FG001|STARTED|Overall Study||31||
48260794|NCT01999777|100959027|FG000|COMPLETED|Overall Study||31||
48260795|NCT01999777|100959028|FG001|COMPLETED|Overall Study||31||
48260796|NCT01999777|100959027|FG000|NOT COMPLETED|Overall Study||0||
48260797|NCT01999777|100959028|FG001|NOT COMPLETED|Overall Study||0||
48260798|NCT02520310|100959029|FG000|STARTED|At 30 Days Clinical Follow-up||30||
48260799|NCT02520310|100959029|FG000|COMPLETED|At 30 Days Clinical Follow-up||30||
48260800|NCT02520310|100959029|FG000|NOT COMPLETED|At 30 Days Clinical Follow-up||0||
48260801|NCT02520310|100959029|FG000|STARTED|At 6 Months Clinical Follow-up||30||
48260802|NCT02520310|100959029|FG000|COMPLETED|At 6 Months Clinical Follow-up||29||
48260803|NCT02520310|100959029|FG000|NOT COMPLETED|At 6 Months Clinical Follow-up||1||
48260804|NCT02520310|100959029|FG000|STARTED|At 1 Year Clinical Follow-up||29||
48260805|NCT02520310|100959029|FG000|COMPLETED|At 1 Year Clinical Follow-up||28||
48260806|NCT02520310|100959029|FG000|NOT COMPLETED|At 1 Year Clinical Follow-up||1||
48260807|NCT02520310|100959029|FG000|STARTED|At 2 Year Clinical Follow-up||28||
48260808|NCT02520310|100959029|FG000|COMPLETED|At 2 Year Clinical Follow-up||28||
48260809|NCT02520310|100959029|FG000|NOT COMPLETED|At 2 Year Clinical Follow-up||0||
48542701|NCT01377012|101663005|FG002|COMPLETED|Extension Study, Weeks 104-260||0||
48542702|NCT01377012|101663003|FG000|NOT COMPLETED|Extension Study, Weeks 104-260||57||
48542703|NCT01377012|101663004|FG001|NOT COMPLETED|Extension Study, Weeks 104-260||71||
48260810|NCT02520310|100959029|FG000|STARTED|AT 3 Year Clinical Follow-up||28||
48260811|NCT02520310|100959029|FG000|COMPLETED|AT 3 Year Clinical Follow-up||24||
48542704|NCT01377012|101663005|FG002|NOT COMPLETED|Extension Study, Weeks 104-260||68||
48542705|NCT02759692|101663006|FG000|STARTED|Period 1||141||
48542706|NCT02759692|101663007|FG001|STARTED|Period 1||142||
48542707|NCT02759692|101663006|FG000|COMPLETED|Period 1||138||
48542708|NCT02759692|101663007|FG001|COMPLETED|Period 1||140||
48542709|NCT02759692|101663006|FG000|NOT COMPLETED|Period 1||3||
48260812|NCT02520310|100959029|FG000|NOT COMPLETED|AT 3 Year Clinical Follow-up||4||
48260813|NCT02520310|100959029|FG000|STARTED|AT 4 Year Clinical Follow-up||24||
48260814|NCT02520310|100959029|FG000|COMPLETED|AT 4 Year Clinical Follow-up||22||
48260815|NCT02520310|100959029|FG000|NOT COMPLETED|AT 4 Year Clinical Follow-up||2||
48260816|NCT02132117|100959030|FG000|STARTED|Overall Study||224||
48260817|NCT02132117|100959031|FG001|STARTED|Overall Study||221||
48260818|NCT02132117|100959030|FG000|COMPLETED|Overall Study||213||
48260819|NCT02132117|100959031|FG001|COMPLETED|Overall Study||216||
48260820|NCT02132117|100959030|FG000|NOT COMPLETED|Overall Study||11||
48260821|NCT02132117|100959031|FG001|NOT COMPLETED|Overall Study||5||
48260822|NCT03596242|100959032|FG000|STARTED|Overall Study||12||
48260823|NCT03596242|100959033|FG001|STARTED|Overall Study||12||
48260824|NCT03596242|100959032|FG000|COMPLETED|Overall Study||10||
48260825|NCT03596242|100959033|FG001|COMPLETED|Overall Study||10||
48260826|NCT03596242|100959032|FG000|NOT COMPLETED|Overall Study||2||
48260827|NCT03596242|100959033|FG001|NOT COMPLETED|Overall Study||2||
48260828|NCT00307164|100959034|FG000|STARTED|Overall Study||83||
48260829|NCT00307164|100959035|FG001|STARTED|Overall Study||82||
48542710|NCT02759692|101663007|FG001|NOT COMPLETED|Period 1||2||
48260830|NCT00307164|100959034|FG000|COMPLETED|Overall Study||68||
48260831|NCT00307164|100959035|FG001|COMPLETED|Overall Study||68||
48260832|NCT00307164|100959034|FG000|NOT COMPLETED|Overall Study||15||
48260833|NCT00307164|100959035|FG001|NOT COMPLETED|Overall Study||14||
48260834|NCT03443414|100959036|FG000|STARTED|Overall Study||82||
48260835|NCT03443414|100959037|FG001|STARTED|Overall Study||81||
48260836|NCT03443414|100959038|FG002|STARTED|Overall Study||82||
48260837|NCT03443414|100959039|FG003|STARTED|Overall Study||80||
48260838|NCT03443414|100959040|FG004|STARTED|Overall Study||80||
48260839|NCT03443414|100959036|FG000|Received Treatment|Overall Study||81||
48260840|NCT03443414|100959037|FG001|Received Treatment|Overall Study||81||
48260841|NCT03443414|100959038|FG002|Received Treatment|Overall Study||82||
48260842|NCT03443414|100959039|FG003|Received Treatment|Overall Study||80||
48260843|NCT03443414|100959040|FG004|Received Treatment|Overall Study||79||
48260844|NCT03443414|100959036|FG000|COMPLETED|Overall Study||71||
48260845|NCT03443414|100959037|FG001|COMPLETED|Overall Study||78||
48260846|NCT03443414|100959038|FG002|COMPLETED|Overall Study||76||
48260847|NCT03443414|100959039|FG003|COMPLETED|Overall Study||75||
48260848|NCT03443414|100959040|FG004|COMPLETED|Overall Study||75||
48260849|NCT03443414|100959036|FG000|NOT COMPLETED|Overall Study||11||
48260850|NCT03443414|100959037|FG001|NOT COMPLETED|Overall Study||3||
48260851|NCT03443414|100959038|FG002|NOT COMPLETED|Overall Study||6||
48260852|NCT03443414|100959039|FG003|NOT COMPLETED|Overall Study||5||
48260853|NCT03443414|100959040|FG004|NOT COMPLETED|Overall Study||5||
48260854|NCT01777490|100959041|FG000|STARTED|Overall Study||123||
48260855|NCT01777490|100959042|FG001|STARTED|Overall Study||123||
48260856|NCT01777490|100959043|FG002|STARTED|Overall Study||119||
48260857|NCT01777490|100959044|FG003|STARTED|Overall Study||119||
48260858|NCT01777490|100959041|FG000|COMPLETED|Overall Study||123|Primary outcome is gathered from medical records. Survey outcomes have lower completion rates.|
48260859|NCT01777490|100959042|FG001|COMPLETED|Overall Study||123|Primary outcome is gathered from medical records. Survey outcomes have lower completion rates.|
48260860|NCT01777490|100959043|FG002|COMPLETED|Overall Study||118|Primary outcome is gathered from medical records. Survey outcomes have lower completion rates.|
48260861|NCT01777490|100959044|FG003|COMPLETED|Overall Study||118|Primary outcome is gathered from medical records. Survey outcomes have lower completion rates.|
48260862|NCT01777490|100959041|FG000|NOT COMPLETED|Overall Study||0||
48260863|NCT01777490|100959042|FG001|NOT COMPLETED|Overall Study||0||
48260864|NCT01777490|100959043|FG002|NOT COMPLETED|Overall Study||1||
48260865|NCT01777490|100959044|FG003|NOT COMPLETED|Overall Study||1||
48260866|NCT00412880|100959045|FG000|STARTED|Overall Study||23||
48260867|NCT00412880|100959045|FG000|COMPLETED|Overall Study||0||
48260868|NCT00412880|100959045|FG000|NOT COMPLETED|Overall Study||23||
48260869|NCT01242371|100959046|FG000|STARTED|Overall Study||33||
48260870|NCT01242371|100959047|FG001|STARTED|Overall Study||32||
48260871|NCT01242371|100959046|FG000|COMPLETED|Overall Study||31||
48260872|NCT01242371|100959047|FG001|COMPLETED|Overall Study||27||
48260873|NCT01242371|100959046|FG000|NOT COMPLETED|Overall Study||2||
48260874|NCT01242371|100959047|FG001|NOT COMPLETED|Overall Study||5||
48260875|NCT01283022|100959048|FG000|STARTED|Overall Study||24||
48260876|NCT01283022|100959048|FG000|COMPLETED|Overall Study||24||
48260877|NCT01283022|100959048|FG000|NOT COMPLETED|Overall Study||0||
48260878|NCT01937195|100959049|FG000|STARTED|Overall Study||95||
48260879|NCT01937195|100959049|FG000|COMPLETED|Overall Study||95||
48260880|NCT01937195|100959049|FG000|NOT COMPLETED|Overall Study||0||
48260881|NCT03634839|100959050|FG000|STARTED|First Intervention (2 Hours)||20||
48260882|NCT03634839|100959051|FG001|STARTED|First Intervention (2 Hours)||22||
48260883|NCT03634839|100959050|FG000|COMPLETED|First Intervention (2 Hours)||20||
48260884|NCT03634839|100959051|FG001|COMPLETED|First Intervention (2 Hours)||20||
48260885|NCT03634839|100959050|FG000|NOT COMPLETED|First Intervention (2 Hours)||0||
48260886|NCT03634839|100959051|FG001|NOT COMPLETED|First Intervention (2 Hours)||2||
48260887|NCT03634839|100959050|FG000|STARTED|30 Minutes Break||20||
48542711|NCT02759692|101663006|FG000|STARTED|Period 2||138||
48542712|NCT02759692|101663007|FG001|STARTED|Period 2||140||
48542713|NCT02759692|101663006|FG000|COMPLETED|Period 2||137||
48542714|NCT02759692|101663007|FG001|COMPLETED|Period 2||139||
48542715|NCT02759692|101663006|FG000|NOT COMPLETED|Period 2||1||
48542716|NCT02759692|101663007|FG001|NOT COMPLETED|Period 2||1||
48542717|NCT02759692|101663006|FG000|STARTED|Period 3||137||
48542718|NCT02759692|101663007|FG001|STARTED|Period 3||139||
48542719|NCT02759692|101663006|FG000|COMPLETED|Period 3||137||
48542720|NCT02759692|101663007|FG001|COMPLETED|Period 3||139||
48542721|NCT02759692|101663006|FG000|NOT COMPLETED|Period 3||0||
48542722|NCT02759692|101663007|FG001|NOT COMPLETED|Period 3||0||
48260888|NCT03634839|100959051|FG001|STARTED|30 Minutes Break||20||
48260889|NCT03634839|100959050|FG000|COMPLETED|30 Minutes Break||20||
48260890|NCT03634839|100959051|FG001|COMPLETED|30 Minutes Break||20||
48260891|NCT03634839|100959050|FG000|NOT COMPLETED|30 Minutes Break||0||
48260892|NCT03634839|100959051|FG001|NOT COMPLETED|30 Minutes Break||0||
48260893|NCT03634839|100959050|FG000|STARTED|Second Intervention (2 Hours)||20||
48260894|NCT03634839|100959051|FG001|STARTED|Second Intervention (2 Hours)||20||
48260895|NCT03634839|100959050|FG000|COMPLETED|Second Intervention (2 Hours)||20||
48542723|NCT01191944|101663008|FG000|STARTED|Overall Study||234||
48542724|NCT01191944|101663009|FG001|STARTED|Overall Study||239||
48542725|NCT01191944|101663008|FG000|COMPLETED|Overall Study||217||
48260896|NCT03634839|100959051|FG001|COMPLETED|Second Intervention (2 Hours)||20||
48260897|NCT03634839|100959050|FG000|NOT COMPLETED|Second Intervention (2 Hours)||0||
48260898|NCT03634839|100959051|FG001|NOT COMPLETED|Second Intervention (2 Hours)||0||
48260899|NCT00621192|100959052|FG000|STARTED|Overall Study||39||
48260900|NCT00621192|100959053|FG001|STARTED|Overall Study||103||
48260901|NCT00621192|100959054|FG002|STARTED|Overall Study||31||
48260902|NCT00621192|100959055|FG003|STARTED|Overall Study||27||
48260903|NCT00621192|100959052|FG000|Safety Population|Overall Study||39||
48260904|NCT00621192|100959053|FG001|Safety Population|Overall Study||103||
48260905|NCT00621192|100959054|FG002|Safety Population|Overall Study||31||
48260906|NCT00621192|100959055|FG003|Safety Population|Overall Study||27||
48260907|NCT00621192|100959052|FG000|Efficacy Population|Overall Study||39||
48260908|NCT00621192|100959053|FG001|Efficacy Population|Overall Study||101||
48260909|NCT00621192|100959054|FG002|Efficacy Population|Overall Study||28||
48260910|NCT00621192|100959055|FG003|Efficacy Population|Overall Study||27||
48260911|NCT00621192|100959052|FG000|COMPLETED|Overall Study||35||
48260912|NCT00621192|100959053|FG001|COMPLETED|Overall Study||94||
48260913|NCT00621192|100959054|FG002|COMPLETED|Overall Study||26||
48260914|NCT00621192|100959055|FG003|COMPLETED|Overall Study||24||
48260915|NCT00621192|100959052|FG000|NOT COMPLETED|Overall Study||4||
48260916|NCT00621192|100959053|FG001|NOT COMPLETED|Overall Study||9||
48260917|NCT00621192|100959054|FG002|NOT COMPLETED|Overall Study||5||
48260918|NCT00621192|100959055|FG003|NOT COMPLETED|Overall Study||3||
48260919|NCT00664105|100959056|FG000|STARTED|Overall Study||63||
48542726|NCT01191944|101663009|FG001|COMPLETED|Overall Study||220||
48542727|NCT01191944|101663008|FG000|NOT COMPLETED|Overall Study||17||
48542728|NCT01191944|101663009|FG001|NOT COMPLETED|Overall Study||19||
48542729|NCT01613313|101663010|FG000|STARTED|Overall Study||2||
48542730|NCT01613313|101663011|FG001|STARTED|Overall Study||4||
48542731|NCT01613313|101663012|FG002|STARTED|Overall Study||4||
48542732|NCT01613313|101663013|FG003|STARTED|Overall Study||4||
48542733|NCT01613313|101663010|FG000|COMPLETED|Overall Study||2||
48542734|NCT01613313|101663011|FG001|COMPLETED|Overall Study||4||
48542735|NCT01613313|101663012|FG002|COMPLETED|Overall Study||4||
48542736|NCT01613313|101663013|FG003|COMPLETED|Overall Study||4||
48542737|NCT01613313|101663010|FG000|NOT COMPLETED|Overall Study||0||
48542738|NCT01613313|101663011|FG001|NOT COMPLETED|Overall Study||0||
48542739|NCT01613313|101663012|FG002|NOT COMPLETED|Overall Study||0||
48542740|NCT01613313|101663013|FG003|NOT COMPLETED|Overall Study||0||
48260920|NCT00664105|100959056|FG000|COMPLETED|Overall Study||39||
48260921|NCT00664105|100959056|FG000|NOT COMPLETED|Overall Study||24||
48260922|NCT00920647|100959057|FG000|STARTED|Overall Study||4||
48542741|NCT02540850|101663014|FG000|STARTED|Overall Study||360||
48542742|NCT02540850|101663015|FG001|STARTED|Overall Study||396||
48542743|NCT02540850|101663016|FG002|STARTED|Overall Study||444||
48542744|NCT02540850|101663014|FG000|COMPLETED|Overall Study||291||
48542745|NCT02540850|101663015|FG001|COMPLETED|Overall Study||330||
48542746|NCT02540850|101663016|FG002|COMPLETED|Overall Study||410||
48542747|NCT02540850|101663014|FG000|NOT COMPLETED|Overall Study||69||
48542748|NCT02540850|101663015|FG001|NOT COMPLETED|Overall Study||66||
48542749|NCT02540850|101663016|FG002|NOT COMPLETED|Overall Study||34||
48542750|NCT04589663|101666863|FG000|STARTED|Overall Study||24||
48542751|NCT04589663|101666863|FG000|COMPLETED|Overall Study||24||
48690124|NCT02689206|102025763|FG003|STARTED|Overall Study||21||
48690125|NCT02689206|102025764|FG004|STARTED|Overall Study||22||
48690126|NCT02689206|102025760|FG000|COMPLETED|Overall Study||17||
48542752|NCT04589663|101666863|FG000|NOT COMPLETED|Overall Study||0||
48542753|NCT03201445|101666864|FG000|STARTED|Part A DB Phase (Through Week 13)||69||
48542754|NCT03201445|101666865|FG001|STARTED|Part A DB Phase (Through Week 13)||70||
48542755|NCT03201445|101666864|FG000|COMPLETED|Part A DB Phase (Through Week 13)||68||
48542756|NCT03201445|101666865|FG001|COMPLETED|Part A DB Phase (Through Week 13)||67||
48542757|NCT03201445|101666864|FG000|NOT COMPLETED|Part A DB Phase (Through Week 13)||1||
48542758|NCT03201445|101666865|FG001|NOT COMPLETED|Part A DB Phase (Through Week 13)||3||
48542759|NCT03201445|101666864|FG000|STARTED|Part B DB Phase (Week 13 to 26)||45||
48690127|NCT02689206|102025761|FG001|COMPLETED|Overall Study||19||
48260923|NCT00920647|100959058|FG001|STARTED|Overall Study||4||
48690128|NCT02689206|102025762|FG002|COMPLETED|Overall Study||16||
48690129|NCT02689206|102025763|FG003|COMPLETED|Overall Study||17||
48260924|NCT00920647|100959059|FG002|STARTED|Overall Study||4||
48260925|NCT00920647|100959060|FG003|STARTED|Overall Study||4||
48260926|NCT00920647|100959057|FG000|COMPLETED|Overall Study||4||
48260927|NCT00920647|100959058|FG001|COMPLETED|Overall Study||4||
48260928|NCT00920647|100959059|FG002|COMPLETED|Overall Study||4||
48260929|NCT00920647|100959060|FG003|COMPLETED|Overall Study||4||
48260930|NCT00920647|100959057|FG000|NOT COMPLETED|Overall Study||0||
48542760|NCT03201445|101666865|FG001|STARTED|Part B DB Phase (Week 13 to 26)||38||
48542761|NCT03201445|101666864|FG000|COMPLETED|Part B DB Phase (Week 13 to 26)||42||
48542762|NCT03201445|101666865|FG001|COMPLETED|Part B DB Phase (Week 13 to 26)||38||
48542763|NCT03201445|101666864|FG000|NOT COMPLETED|Part B DB Phase (Week 13 to 26)||3||
48542764|NCT03201445|101666865|FG001|NOT COMPLETED|Part B DB Phase (Week 13 to 26)||0||
48542765|NCT03201445|101666864|FG000|STARTED|OL Phase (13 Weeks)||24||
48690130|NCT02689206|102025764|FG004|COMPLETED|Overall Study||14||
48690131|NCT02689206|102025760|FG000|NOT COMPLETED|Overall Study||3||
48542766|NCT03201445|101666865|FG001|STARTED|OL Phase (13 Weeks)||23||
48542767|NCT03201445|101666864|FG000|COMPLETED|OL Phase (13 Weeks)||22||
48542768|NCT03201445|101666865|FG001|COMPLETED|OL Phase (13 Weeks)||20||
48542769|NCT03201445|101666864|FG000|NOT COMPLETED|OL Phase (13 Weeks)||2||
48542770|NCT03201445|101666865|FG001|NOT COMPLETED|OL Phase (13 Weeks)||3||
48542771|NCT03201445|101666864|FG000|STARTED|LTE: DB Study Drug (up to Week 195)||38|Participants who continued DB study drug after Week 26 (IBD responder and did not meet sperm decrease threshold) in the LTE.|
48542772|NCT03201445|101666865|FG001|STARTED|LTE: DB Study Drug (up to Week 195)||34|Participants who continued DB study drug after Week 26 (IBD responder and did not meet sperm decrease threshold) in the LTE.|
48542773|NCT03201445|101666864|FG000|COMPLETED|LTE: DB Study Drug (up to Week 195)||8||
48542774|NCT03201445|101666865|FG001|COMPLETED|LTE: DB Study Drug (up to Week 195)||5||
48542775|NCT03201445|101666864|FG000|NOT COMPLETED|LTE: DB Study Drug (up to Week 195)||30||
48542776|NCT03201445|101666865|FG001|NOT COMPLETED|LTE: DB Study Drug (up to Week 195)||29||
48542777|NCT03201445|101666864|FG000|STARTED|LTE: OL Study Drug (Up to Week 195)||18|Participants who continued OL filgotinib (IBD responder and did not meet sperm decrease threshold) in the LTE.|
48542778|NCT03201445|101666865|FG001|STARTED|LTE: OL Study Drug (Up to Week 195)||16|Participants who continued OL filgotinib (IBD responder and did not meet sperm decrease threshold) in the LTE.|
48542779|NCT03201445|101666864|FG000|COMPLETED|LTE: OL Study Drug (Up to Week 195)||0||
48542780|NCT03201445|101666865|FG001|COMPLETED|LTE: OL Study Drug (Up to Week 195)||2||
48542781|NCT03201445|101666864|FG000|NOT COMPLETED|LTE: OL Study Drug (Up to Week 195)||18||
48542782|NCT03201445|101666865|FG001|NOT COMPLETED|LTE: OL Study Drug (Up to Week 195)||14||
48542783|NCT03201445|101666864|FG000|STARTED|Monitoring Phase (Up to Week 52)||15|The participants who experienced a ≥50% decrease in sperm concentration, and/or motility, and/or morphology at any time at/after 13 weeks on study drug, discontinued study drug and switched to standard of care, and started the MP.|
48542784|NCT03201445|101666865|FG001|STARTED|Monitoring Phase (Up to Week 52)||21|The participants who experienced a ≥50% decrease in sperm concentration, and/or motility, and/or morphology at any time at/after 13 weeks on study drug, discontinued study drug and switched to standard of care, and started the MP.|
48542785|NCT03201445|101666864|FG000|COMPLETED|Monitoring Phase (Up to Week 52)||14||
48542786|NCT03201445|101666865|FG001|COMPLETED|Monitoring Phase (Up to Week 52)||19||
48542787|NCT03201445|101666864|FG000|NOT COMPLETED|Monitoring Phase (Up to Week 52)||1||
48542788|NCT03201445|101666865|FG001|NOT COMPLETED|Monitoring Phase (Up to Week 52)||2||
48542789|NCT02766283|101666866|FG000|STARTED|Overall Study||843||
48542790|NCT02766283|101666866|FG000|COMPLETED|Overall Study||816||
48542791|NCT02766283|101666866|FG000|NOT COMPLETED|Overall Study||27||
48542792|NCT03047629|101666867|FG000|STARTED|Overall Study||10||
48542793|NCT03047629|101666868|FG001|STARTED|Overall Study||26||
48542794|NCT03047629|101666869|FG002|STARTED|Overall Study||8||
48542795|NCT03047629|101666867|FG000|COMPLETED|Overall Study||9||
48542796|NCT03047629|101666868|FG001|COMPLETED|Overall Study||20||
48542797|NCT03047629|101666869|FG002|COMPLETED|Overall Study||8||
48542798|NCT03047629|101666867|FG000|NOT COMPLETED|Overall Study||1||
48542799|NCT03047629|101666868|FG001|NOT COMPLETED|Overall Study||6||
48542800|NCT03047629|101666869|FG002|NOT COMPLETED|Overall Study||0||
48542801|NCT04036110|101666870|FG000|STARTED|Overall Study||12||
48542802|NCT04036110|101666871|FG001|STARTED|Overall Study||12||
48542803|NCT04036110|101666872|FG002|STARTED|Overall Study||12||
48542804|NCT04036110|101666870|FG000|COMPLETED|Overall Study||5||
48542805|NCT04036110|101666871|FG001|COMPLETED|Overall Study||5||
48542806|NCT04036110|101666872|FG002|COMPLETED|Overall Study||10||
48542807|NCT04036110|101666870|FG000|NOT COMPLETED|Overall Study||7||
48542808|NCT04036110|101666871|FG001|NOT COMPLETED|Overall Study||7||
48542809|NCT04036110|101666872|FG002|NOT COMPLETED|Overall Study||2||
48542810|NCT02198963|101666873|FG000|STARTED|Overall Study||43||
48542811|NCT02198963|101666873|FG000|COMPLETED|Overall Study||36||
48542812|NCT02198963|101666873|FG000|NOT COMPLETED|Overall Study||7||
48542813|NCT01959295|101666874|FG000|STARTED|Overall Study||311||
48542814|NCT01959295|101666875|FG001|STARTED|Overall Study||157||
48542815|NCT01959295|101666874|FG000|COMPLETED|Overall Study||278||
48542816|NCT01959295|101666875|FG001|COMPLETED|Overall Study||140||
48542817|NCT01959295|101666874|FG000|NOT COMPLETED|Overall Study||33||
48542818|NCT01959295|101666875|FG001|NOT COMPLETED|Overall Study||17||
48542819|NCT02646761|101666876|FG000|STARTED|Overall Study||18||
48542820|NCT02646761|101666877|FG001|STARTED|Overall Study||20||
48542821|NCT02646761|101666876|FG000|Subject Withdrew Before Baseline|Overall Study||5||
48542822|NCT02646761|101666877|FG001|Subject Withdrew Before Baseline|Overall Study||8||
48542823|NCT02646761|101666876|FG000|Baseline Assessment|Overall Study||13||
48542824|NCT02646761|101666877|FG001|Baseline Assessment|Overall Study||12||
48542825|NCT02646761|101666876|FG000|5-week Assessment|Overall Study||12||
48542826|NCT02646761|101666877|FG001|5-week Assessment|Overall Study||10||
48542827|NCT02646761|101666876|FG000|COMPLETED|Overall Study||10||
48542828|NCT02646761|101666877|FG001|COMPLETED|Overall Study||10||
48542829|NCT02646761|101666876|FG000|NOT COMPLETED|Overall Study||8||
48542830|NCT02646761|101666877|FG001|NOT COMPLETED|Overall Study||10||
48542831|NCT03138655|101666878|FG000|STARTED|Overall Study||10||
48542832|NCT03138655|101666879|FG001|STARTED|Overall Study||9||
48542833|NCT03138655|101666880|FG002|STARTED|Overall Study||11||
48542834|NCT03138655|101666881|FG003|STARTED|Overall Study||10||
48542835|NCT03138655|101666882|FG004|STARTED|Overall Study||13||
48542836|NCT03138655|101666883|FG005|STARTED|Overall Study||12||
48542837|NCT03138655|101666884|FG006|STARTED|Overall Study||12||
48542838|NCT03138655|101666885|FG007|STARTED|Overall Study||12||
48542839|NCT03138655|101666878|FG000|COMPLETED|Overall Study||7||
48542840|NCT03138655|101666879|FG001|COMPLETED|Overall Study||7||
48542841|NCT03138655|101666880|FG002|COMPLETED|Overall Study||9||
48542842|NCT03138655|101666881|FG003|COMPLETED|Overall Study||7||
48542843|NCT03138655|101666882|FG004|COMPLETED|Overall Study||11||
48542844|NCT03138655|101666883|FG005|COMPLETED|Overall Study||7||
48542845|NCT03138655|101666884|FG006|COMPLETED|Overall Study||9||
48542846|NCT03138655|101666885|FG007|COMPLETED|Overall Study||10||
48542847|NCT03138655|101666878|FG000|NOT COMPLETED|Overall Study||3||
48542848|NCT03138655|101666879|FG001|NOT COMPLETED|Overall Study||2||
48542849|NCT03138655|101666880|FG002|NOT COMPLETED|Overall Study||2||
48260931|NCT00920647|100959058|FG001|NOT COMPLETED|Overall Study||0||
48260932|NCT00920647|100959059|FG002|NOT COMPLETED|Overall Study||0||
48260933|NCT00920647|100959060|FG003|NOT COMPLETED|Overall Study||0||
48260934|NCT01350232|100959061|FG000|STARTED|Overall Study||2||
48260935|NCT01350232|100959061|FG000|COMPLETED|Overall Study||2||
48260936|NCT01350232|100959061|FG000|NOT COMPLETED|Overall Study||0||
48260937|NCT00521976|100959062|FG000|STARTED|Overall Study||871||
48260938|NCT00521976|100959062|FG000|COMPLETED|Overall Study||871||
48260939|NCT00521976|100959062|FG000|NOT COMPLETED|Overall Study||0||
48260940|NCT00030823|100959063|FG000|STARTED|Overall Study||14||
48260941|NCT00030823|100959063|FG000|COMPLETED|Overall Study||13||
48260942|NCT00030823|100959063|FG000|NOT COMPLETED|Overall Study||1||
48260943|NCT01688310|100959064|FG000|STARTED|Overall Study||100||
48260944|NCT01688310|100959065|FG001|STARTED|Overall Study||100||
48260945|NCT01688310|100959064|FG000|COMPLETED|Overall Study||100||
48260946|NCT01688310|100959065|FG001|COMPLETED|Overall Study||100||
48260947|NCT01688310|100959064|FG000|NOT COMPLETED|Overall Study||0||
48260948|NCT01688310|100959065|FG001|NOT COMPLETED|Overall Study||0||
48260949|NCT00761956|100959066|FG000|STARTED|Overall Study||87||
48260950|NCT00761956|100959067|FG001|STARTED|Overall Study||102||
48260951|NCT00761956|100959066|FG000|COMPLETED|Overall Study||52||
48260952|NCT00761956|100959067|FG001|COMPLETED|Overall Study||48||
48260953|NCT00761956|100959066|FG000|NOT COMPLETED|Overall Study||35||
48260954|NCT00761956|100959067|FG001|NOT COMPLETED|Overall Study||54||
48542850|NCT03138655|101666881|FG003|NOT COMPLETED|Overall Study||3||
48542851|NCT03138655|101666882|FG004|NOT COMPLETED|Overall Study||2||
48542852|NCT03138655|101666883|FG005|NOT COMPLETED|Overall Study||5||
48542853|NCT03138655|101666884|FG006|NOT COMPLETED|Overall Study||3||
48542854|NCT03138655|101666885|FG007|NOT COMPLETED|Overall Study||2||
48542855|NCT01338870|101666886|FG000|STARTED|Overall Study||50||
48542856|NCT01338870|101666887|FG001|STARTED|Overall Study||49||
48542857|NCT01338870|101666888|FG002|STARTED|Overall Study||50||
48542858|NCT01338870|101666889|FG003|STARTED|Overall Study||50||
48542859|NCT01338870|101666890|FG004|STARTED|Overall Study||52||
48542860|NCT01338870|101666891|FG005|STARTED|Overall Study||50||
48542861|NCT01338870|101666886|FG000|COMPLETED|Overall Study||41||
48542862|NCT01338870|101666887|FG001|COMPLETED|Overall Study||37||
48542863|NCT01338870|101666888|FG002|COMPLETED|Overall Study||39||
48542864|NCT01338870|101666889|FG003|COMPLETED|Overall Study||41||
48260955|NCT02706951|100959068|FG000|STARTED|Period 1||216||
48260956|NCT02706951|100959069|FG001|STARTED|Period 1||217||
48260957|NCT02706951|100959070|FG002|STARTED|Period 1||215||
48260958|NCT02706951|100959071|FG003|STARTED|Period 1||0||
48260959|NCT02706951|100959072|FG004|STARTED|Period 1||0||
48260960|NCT02706951|100959068|FG000|COMPLETED|Period 1||203|Completed Period 1 (Week 14) study participation|
48260961|NCT02706951|100959069|FG001|COMPLETED|Period 1||201|Completed Period 1 (Week 14) study participation|
48260962|NCT02706951|100959070|FG002|COMPLETED|Period 1||205|Completed Period 1 (Week 14) study participation|
48260963|NCT02706951|100959071|FG003|COMPLETED|Period 1||0|Completed Period 1 (Week 14) study participation|
48260964|NCT02706951|100959072|FG004|COMPLETED|Period 1||0|Completed Period 1 (Week 14) study participation|
48260965|NCT02706951|100959068|FG000|NOT COMPLETED|Period 1||13||
48260966|NCT02706951|100959069|FG001|NOT COMPLETED|Period 1||16||
48260967|NCT02706951|100959070|FG002|NOT COMPLETED|Period 1||10||
48260968|NCT02706951|100959071|FG003|NOT COMPLETED|Period 1||0||
48260969|NCT02706951|100959072|FG004|NOT COMPLETED|Period 1||0||
48260970|NCT02706951|100959068|FG000|STARTED|Period 2||0||
48260971|NCT02706951|100959069|FG001|STARTED|Period 2||0||
48260972|NCT02706951|100959070|FG002|STARTED|Period 2||0||
48260973|NCT02706951|100959071|FG003|STARTED|Period 2||302||
48260974|NCT02706951|100959072|FG004|STARTED|Period 2||300||
48260975|NCT02706951|100959068|FG000|COMPLETED|Period 2||0||
48260976|NCT02706951|100959069|FG001|COMPLETED|Period 2||0||
48260977|NCT02706951|100959070|FG002|COMPLETED|Period 2||0||
48260978|NCT02706951|100959071|FG003|COMPLETED|Period 2||184||
48260979|NCT02706951|100959072|FG004|COMPLETED|Period 2||180||
48260980|NCT02706951|100959068|FG000|NOT COMPLETED|Period 2||0||
48260981|NCT02706951|100959069|FG001|NOT COMPLETED|Period 2||0||
48542865|NCT01338870|101666890|FG004|COMPLETED|Overall Study||46||
48542866|NCT01338870|101666891|FG005|COMPLETED|Overall Study||44||
48542867|NCT01338870|101666886|FG000|NOT COMPLETED|Overall Study||9||
48542868|NCT01338870|101666887|FG001|NOT COMPLETED|Overall Study||12||
48542869|NCT01338870|101666888|FG002|NOT COMPLETED|Overall Study||11||
48542870|NCT01338870|101666889|FG003|NOT COMPLETED|Overall Study||9||
48542871|NCT01338870|101666890|FG004|NOT COMPLETED|Overall Study||6||
48542872|NCT01338870|101666891|FG005|NOT COMPLETED|Overall Study||6||
48542873|NCT01442688|101666892|FG000|STARTED|First Intervention||31||
48542874|NCT01442688|101666893|FG001|STARTED|First Intervention||31||
48542875|NCT01442688|101666892|FG000|COMPLETED|First Intervention||29||
48542876|NCT01442688|101666893|FG001|COMPLETED|First Intervention||31||
48542877|NCT01442688|101666892|FG000|NOT COMPLETED|First Intervention||2||
48542878|NCT01442688|101666893|FG001|NOT COMPLETED|First Intervention||0||
48542879|NCT01442688|101666892|FG000|STARTED|Second Intervention||29||
48542880|NCT01442688|101666893|FG001|STARTED|Second Intervention||31||
48542881|NCT01442688|101666892|FG000|COMPLETED|Second Intervention||28||
48542882|NCT01442688|101666893|FG001|COMPLETED|Second Intervention||31||
48542883|NCT01442688|101666892|FG000|NOT COMPLETED|Second Intervention||1||
48542884|NCT01442688|101666893|FG001|NOT COMPLETED|Second Intervention||0||
48542885|NCT04604795|101666894|FG000|STARTED|Part A: Period 1 (Day 1)||3||
48542886|NCT04604795|101666895|FG001|STARTED|Part A: Period 1 (Day 1)||3||
48542887|NCT04604795|101666896|FG002|STARTED|Part A: Period 1 (Day 1)||3||
48542888|NCT04604795|101666897|FG003|STARTED|Part A: Period 1 (Day 1)||3||
48542889|NCT04604795|101666898|FG004|STARTED|Part A: Period 1 (Day 1)||0||
48542890|NCT04604795|101666899|FG005|STARTED|Part A: Period 1 (Day 1)||0||
48542891|NCT04604795|101666900|FG006|STARTED|Part A: Period 1 (Day 1)||0||
48542892|NCT04604795|101666901|FG007|STARTED|Part A: Period 1 (Day 1)||0||
48542893|NCT04604795|101666902|FG008|STARTED|Part A: Period 1 (Day 1)||0||
48542894|NCT04604795|101666903|FG009|STARTED|Part A: Period 1 (Day 1)||0||
48542895|NCT04604795|101666894|FG000|COMPLETED|Part A: Period 1 (Day 1)||3||
48542896|NCT04604795|101666895|FG001|COMPLETED|Part A: Period 1 (Day 1)||3||
48542897|NCT04604795|101666896|FG002|COMPLETED|Part A: Period 1 (Day 1)||3||
48542898|NCT04604795|101666897|FG003|COMPLETED|Part A: Period 1 (Day 1)||3||
48542899|NCT04604795|101666898|FG004|COMPLETED|Part A: Period 1 (Day 1)||0||
48542900|NCT04604795|101666899|FG005|COMPLETED|Part A: Period 1 (Day 1)||0||
48542901|NCT04604795|101666900|FG006|COMPLETED|Part A: Period 1 (Day 1)||0||
48542902|NCT04604795|101666901|FG007|COMPLETED|Part A: Period 1 (Day 1)||0||
48542903|NCT04604795|101666902|FG008|COMPLETED|Part A: Period 1 (Day 1)||0||
48542904|NCT04604795|101666903|FG009|COMPLETED|Part A: Period 1 (Day 1)||0||
48542905|NCT04604795|101666894|FG000|NOT COMPLETED|Part A: Period 1 (Day 1)||0||
48542906|NCT04604795|101666895|FG001|NOT COMPLETED|Part A: Period 1 (Day 1)||0||
48542907|NCT04604795|101666896|FG002|NOT COMPLETED|Part A: Period 1 (Day 1)||0||
48542908|NCT04604795|101666897|FG003|NOT COMPLETED|Part A: Period 1 (Day 1)||0||
48542909|NCT04604795|101666898|FG004|NOT COMPLETED|Part A: Period 1 (Day 1)||0||
48542910|NCT04604795|101666899|FG005|NOT COMPLETED|Part A: Period 1 (Day 1)||0||
48542911|NCT04604795|101666900|FG006|NOT COMPLETED|Part A: Period 1 (Day 1)||0||
48542912|NCT04604795|101666901|FG007|NOT COMPLETED|Part A: Period 1 (Day 1)||0||
48542913|NCT04604795|101666902|FG008|NOT COMPLETED|Part A: Period 1 (Day 1)||0||
48542914|NCT04604795|101666903|FG009|NOT COMPLETED|Part A: Period 1 (Day 1)||0||
48542915|NCT04604795|101666894|FG000|STARTED|Part A: Washout Period 1(Up to Day 20)||3||
48542916|NCT04604795|101666895|FG001|STARTED|Part A: Washout Period 1(Up to Day 20)||3||
48542917|NCT04604795|101666896|FG002|STARTED|Part A: Washout Period 1(Up to Day 20)||3||
48542918|NCT04604795|101666897|FG003|STARTED|Part A: Washout Period 1(Up to Day 20)||3||
48542919|NCT04604795|101666898|FG004|STARTED|Part A: Washout Period 1(Up to Day 20)||0||
48542920|NCT04604795|101666899|FG005|STARTED|Part A: Washout Period 1(Up to Day 20)||0||
48542921|NCT04604795|101666900|FG006|STARTED|Part A: Washout Period 1(Up to Day 20)||0||
48542922|NCT04604795|101666901|FG007|STARTED|Part A: Washout Period 1(Up to Day 20)||0||
48542923|NCT04604795|101666902|FG008|STARTED|Part A: Washout Period 1(Up to Day 20)||0||
48542924|NCT04604795|101666903|FG009|STARTED|Part A: Washout Period 1(Up to Day 20)||0||
48542925|NCT04604795|101666894|FG000|COMPLETED|Part A: Washout Period 1(Up to Day 20)||2||
48542926|NCT04604795|101666895|FG001|COMPLETED|Part A: Washout Period 1(Up to Day 20)||2||
48542927|NCT04604795|101666896|FG002|COMPLETED|Part A: Washout Period 1(Up to Day 20)||3||
48542928|NCT04604795|101666897|FG003|COMPLETED|Part A: Washout Period 1(Up to Day 20)||3||
48542929|NCT04604795|101666898|FG004|COMPLETED|Part A: Washout Period 1(Up to Day 20)||0||
48542930|NCT04604795|101666899|FG005|COMPLETED|Part A: Washout Period 1(Up to Day 20)||0||
48542931|NCT04604795|101666900|FG006|COMPLETED|Part A: Washout Period 1(Up to Day 20)||0||
48542932|NCT04604795|101666901|FG007|COMPLETED|Part A: Washout Period 1(Up to Day 20)||0||
48542933|NCT04604795|101666902|FG008|COMPLETED|Part A: Washout Period 1(Up to Day 20)||0||
48542934|NCT04604795|101666903|FG009|COMPLETED|Part A: Washout Period 1(Up to Day 20)||0||
48542935|NCT04604795|101666894|FG000|NOT COMPLETED|Part A: Washout Period 1(Up to Day 20)||1||
48542936|NCT04604795|101666895|FG001|NOT COMPLETED|Part A: Washout Period 1(Up to Day 20)||1||
48542937|NCT04604795|101666896|FG002|NOT COMPLETED|Part A: Washout Period 1(Up to Day 20)||0||
48542938|NCT04604795|101666897|FG003|NOT COMPLETED|Part A: Washout Period 1(Up to Day 20)||0||
48542939|NCT04604795|101666898|FG004|NOT COMPLETED|Part A: Washout Period 1(Up to Day 20)||0||
48542940|NCT04604795|101666899|FG005|NOT COMPLETED|Part A: Washout Period 1(Up to Day 20)||0||
48542941|NCT04604795|101666900|FG006|NOT COMPLETED|Part A: Washout Period 1(Up to Day 20)||0||
48542942|NCT04604795|101666901|FG007|NOT COMPLETED|Part A: Washout Period 1(Up to Day 20)||0||
48542943|NCT04604795|101666902|FG008|NOT COMPLETED|Part A: Washout Period 1(Up to Day 20)||0||
48097135|NCT01154218|100563624|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48097136|NCT01154218|100563625|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48097137|NCT01154218|100563626|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||1||
48097138|NCT01154218|100563623|FG000|STARTED|Fourth Intervention Period||9||
48542944|NCT04604795|101666903|FG009|NOT COMPLETED|Part A: Washout Period 1(Up to Day 20)||0||
48542945|NCT04604795|101666894|FG000|STARTED|Part A: Period 2 (Day 1)||3||
48542946|NCT04604795|101666895|FG001|STARTED|Part A: Period 2 (Day 1)||3||
48542947|NCT04604795|101666896|FG002|STARTED|Part A: Period 2 (Day 1)||3||
48542948|NCT04604795|101666897|FG003|STARTED|Part A: Period 2 (Day 1)||3||
48542949|NCT04604795|101666898|FG004|STARTED|Part A: Period 2 (Day 1)||0||
48690132|NCT02689206|102025761|FG001|NOT COMPLETED|Overall Study||1||
48690133|NCT02689206|102025762|FG002|NOT COMPLETED|Overall Study||4||
48690134|NCT02689206|102025763|FG003|NOT COMPLETED|Overall Study||4||
48690135|NCT02689206|102025764|FG004|NOT COMPLETED|Overall Study||8||
48690136|NCT00661726|102025765|FG000|STARTED|Overall Study||6||
48690137|NCT00661726|102025765|FG000|COMPLETED|Overall Study||5||
48690138|NCT00661726|102025765|FG000|NOT COMPLETED|Overall Study||1||
48690139|NCT01107392|102025766|FG000|STARTED|Overall Study||158||
48690140|NCT01107392|102025767|FG001|STARTED|Overall Study||157||
48690141|NCT01107392|102025766|FG000|COMPLETED|Overall Study||153||
48690142|NCT01107392|102025767|FG001|COMPLETED|Overall Study||154||
48690143|NCT01107392|102025766|FG000|NOT COMPLETED|Overall Study||5||
48690144|NCT01107392|102025767|FG001|NOT COMPLETED|Overall Study||3||
48690145|NCT01628523|102025768|FG000|STARTED|Overall Study||219||
48690146|NCT01628523|102025768|FG000|COMPLETED|Overall Study||219||
48690147|NCT01628523|102025768|FG000|NOT COMPLETED|Overall Study||0||
48690148|NCT00938912|102025769|FG000|STARTED|Overall Study||365||
48690149|NCT00938912|102025769|FG000|COMPLETED|Overall Study||254||
48690150|NCT00938912|102025769|FG000|NOT COMPLETED|Overall Study||111||
48690151|NCT00620373|102025770|FG000|STARTED|Overall Study||969||
48690152|NCT00620373|102025770|FG000|COMPLETED|Overall Study||936||
48690153|NCT00620373|102025770|FG000|NOT COMPLETED|Overall Study||33||
48690154|NCT01978145|102025771|FG000|STARTED|Treatment Period 1||214||
48690155|NCT01978145|102025772|FG001|STARTED|Treatment Period 1||212||
48690156|NCT01978145|102025771|FG000|COMPLETED|Treatment Period 1||205||
48690157|NCT01978145|102025772|FG001|COMPLETED|Treatment Period 1||196||
48690158|NCT01978145|102025771|FG000|NOT COMPLETED|Treatment Period 1||9||
48690159|NCT01978145|102025772|FG001|NOT COMPLETED|Treatment Period 1||16||
48690160|NCT01978145|102025771|FG000|STARTED|Washout Period 1||205||
48690161|NCT01978145|102025772|FG001|STARTED|Washout Period 1||196||
48690162|NCT01978145|102025771|FG000|COMPLETED|Washout Period 1||204||
48690163|NCT01978145|102025772|FG001|COMPLETED|Washout Period 1||193||
48690164|NCT01978145|102025771|FG000|NOT COMPLETED|Washout Period 1||1||
48690165|NCT01978145|102025772|FG001|NOT COMPLETED|Washout Period 1||3||
48097139|NCT01154218|100563624|FG001|STARTED|Fourth Intervention Period||8||
48542950|NCT04604795|101666899|FG005|STARTED|Part A: Period 2 (Day 1)||0||
48542951|NCT04604795|101666900|FG006|STARTED|Part A: Period 2 (Day 1)||0||
48542952|NCT04604795|101666901|FG007|STARTED|Part A: Period 2 (Day 1)||0||
48542953|NCT04604795|101666902|FG008|STARTED|Part A: Period 2 (Day 1)||0||
48542954|NCT04604795|101666903|FG009|STARTED|Part A: Period 2 (Day 1)||0||
48542955|NCT04604795|101666894|FG000|New Participant Enrolled and Dosed|Part A: Period 2 (Day 1)||1||
48542956|NCT04604795|101666895|FG001|New Participant Enrolled and Dosed|Part A: Period 2 (Day 1)||1||
48542957|NCT04604795|101666896|FG002|New Participant Enrolled and Dosed|Part A: Period 2 (Day 1)||0||
48542958|NCT04604795|101666897|FG003|New Participant Enrolled and Dosed|Part A: Period 2 (Day 1)||0||
48542959|NCT04604795|101666898|FG004|New Participant Enrolled and Dosed|Part A: Period 2 (Day 1)||0||
48542960|NCT04604795|101666899|FG005|New Participant Enrolled and Dosed|Part A: Period 2 (Day 1)||0||
48542961|NCT04604795|101666900|FG006|New Participant Enrolled and Dosed|Part A: Period 2 (Day 1)||0||
48542962|NCT04604795|101666901|FG007|New Participant Enrolled and Dosed|Part A: Period 2 (Day 1)||0||
48542963|NCT04604795|101666902|FG008|New Participant Enrolled and Dosed|Part A: Period 2 (Day 1)||0||
48542964|NCT04604795|101666903|FG009|New Participant Enrolled and Dosed|Part A: Period 2 (Day 1)||0||
48542965|NCT04604795|101666894|FG000|COMPLETED|Part A: Period 2 (Day 1)||3||
48542966|NCT04604795|101666895|FG001|COMPLETED|Part A: Period 2 (Day 1)||3||
48097140|NCT01154218|100563625|FG002|STARTED|Fourth Intervention Period||9||
48542967|NCT04604795|101666896|FG002|COMPLETED|Part A: Period 2 (Day 1)||3||
48690166|NCT01978145|102025771|FG000|STARTED|Treatment Period 2||204||
48690167|NCT01978145|102025772|FG001|STARTED|Treatment Period 2||193||
48690168|NCT01978145|102025771|FG000|COMPLETED|Treatment Period 2||185||
48690169|NCT01978145|102025772|FG001|COMPLETED|Treatment Period 2||179||
48690170|NCT01978145|102025771|FG000|NOT COMPLETED|Treatment Period 2||19||
48690171|NCT01978145|102025772|FG001|NOT COMPLETED|Treatment Period 2||14||
48690172|NCT00402324|102025773|FG000|STARTED|Overall Study||101||
48690173|NCT00402324|102025774|FG001|STARTED|Overall Study||101||
48690174|NCT00402324|102025773|FG000|COMPLETED|Overall Study||58||
48690175|NCT00402324|102025774|FG001|COMPLETED|Overall Study||60||
48690176|NCT00402324|102025773|FG000|NOT COMPLETED|Overall Study||43||
48097141|NCT01154218|100563626|FG003|STARTED|Fourth Intervention Period||8||
48097142|NCT01154218|100563623|FG000|COMPLETED|Fourth Intervention Period||8||
48097143|NCT01154218|100563624|FG001|COMPLETED|Fourth Intervention Period||8||
48097144|NCT01154218|100563625|FG002|COMPLETED|Fourth Intervention Period||9||
48097145|NCT01154218|100563626|FG003|COMPLETED|Fourth Intervention Period||8||
48097146|NCT01154218|100563623|FG000|NOT COMPLETED|Fourth Intervention Period||1||
48097147|NCT01154218|100563624|FG001|NOT COMPLETED|Fourth Intervention Period||0||
48097148|NCT01154218|100563625|FG002|NOT COMPLETED|Fourth Intervention Period||0||
48097149|NCT01154218|100563626|FG003|NOT COMPLETED|Fourth Intervention Period||0||
48097150|NCT00380978|100563627|FG000|STARTED|Overall Study||408||
48097151|NCT00380978|100563628|FG001|STARTED|Overall Study||410||
48097152|NCT00380978|100563627|FG000|COMPLETED|Overall Study||406||
48097153|NCT00380978|100563628|FG001|COMPLETED|Overall Study||400||
48097154|NCT00380978|100563627|FG000|NOT COMPLETED|Overall Study||2||
48097155|NCT00380978|100563628|FG001|NOT COMPLETED|Overall Study||10||
48097156|NCT01986855|100563629|FG000|STARTED|Overall Study||158||
48097157|NCT01986855|100563630|FG001|STARTED|Overall Study||156||
48097158|NCT01986855|100563631|FG002|STARTED|Overall Study||154||
48097159|NCT01986855|100563629|FG000|Treated|Overall Study||158||
48097160|NCT01986855|100563630|FG001|Treated|Overall Study||155||
48097161|NCT01986855|100563631|FG002|Treated|Overall Study||154||
48097162|NCT01986855|100563629|FG000|COMPLETED|Overall Study||145||
48097163|NCT01986855|100563630|FG001|COMPLETED|Overall Study||142||
48097164|NCT01986855|100563631|FG002|COMPLETED|Overall Study||143||
48097165|NCT01986855|100563629|FG000|NOT COMPLETED|Overall Study||13||
48097166|NCT01986855|100563630|FG001|NOT COMPLETED|Overall Study||14||
48097167|NCT01986855|100563631|FG002|NOT COMPLETED|Overall Study||11||
48097168|NCT01278485|100563632|FG000|STARTED|Overall Study||719||
48097169|NCT01278485|100563632|FG000|COMPLETED|Overall Study||719||
48097170|NCT01278485|100563632|FG000|NOT COMPLETED|Overall Study||0||
48097171|NCT00455429|100563633|FG000|STARTED|Overall Study||18||
48097172|NCT00455429|100563634|FG001|STARTED|Overall Study||15||
48097173|NCT00455429|100563635|FG002|STARTED|Overall Study||17||
48097174|NCT00455429|100563636|FG003|STARTED|Overall Study||34||
48097175|NCT00455429|100563633|FG000|Treated|Overall Study||18||
48097176|NCT00455429|100563634|FG001|Treated|Overall Study||15||
48097177|NCT00455429|100563635|FG002|Treated|Overall Study||17||
48097178|NCT00455429|100563636|FG003|Treated|Overall Study||32||
48097179|NCT00455429|100563633|FG000|COMPLETED|Overall Study||16||
48097180|NCT00455429|100563634|FG001|COMPLETED|Overall Study||10||
48097181|NCT00455429|100563635|FG002|COMPLETED|Overall Study||16||
48097182|NCT00455429|100563636|FG003|COMPLETED|Overall Study||20||
48097183|NCT00455429|100563633|FG000|NOT COMPLETED|Overall Study||2||
48097184|NCT00455429|100563634|FG001|NOT COMPLETED|Overall Study||5||
48097185|NCT00455429|100563635|FG002|NOT COMPLETED|Overall Study||1||
48097186|NCT00455429|100563636|FG003|NOT COMPLETED|Overall Study||14||
48097187|NCT00914862|100563637|FG000|STARTED|Overall Study||6||
48097188|NCT00914862|100563638|FG001|STARTED|Overall Study||6||
48097189|NCT00914862|100563639|FG002|STARTED|Overall Study||8||
48097190|NCT00914862|100563640|FG003|STARTED|Overall Study||8||
48097191|NCT00914862|100563641|FG004|STARTED|Overall Study||28||
48097192|NCT00914862|100563637|FG000|COMPLETED|Overall Study||6||
48097193|NCT00914862|100563638|FG001|COMPLETED|Overall Study||6||
48097194|NCT00914862|100563639|FG002|COMPLETED|Overall Study||8||
48097195|NCT00914862|100563640|FG003|COMPLETED|Overall Study||8||
48097196|NCT00914862|100563641|FG004|COMPLETED|Overall Study||28||
48097197|NCT00914862|100563637|FG000|NOT COMPLETED|Overall Study||0||
48097198|NCT00914862|100563638|FG001|NOT COMPLETED|Overall Study||0||
48097199|NCT00914862|100563639|FG002|NOT COMPLETED|Overall Study||0||
48097200|NCT00914862|100563640|FG003|NOT COMPLETED|Overall Study||0||
48097201|NCT00914862|100563641|FG004|NOT COMPLETED|Overall Study||0||
48097202|NCT04396990|100563642|FG000|STARTED|Overall Study||20||20
48097203|NCT04396990|100563643|FG001|STARTED|Overall Study||20||20
48097204|NCT04396990|100563642|FG000|COMPLETED|Overall Study||20||20
48097205|NCT04396990|100563643|FG001|COMPLETED|Overall Study||20||20
48097206|NCT04396990|100563642|FG000|NOT COMPLETED|Overall Study||0||0
48097207|NCT04396990|100563643|FG001|NOT COMPLETED|Overall Study||0||0
48097208|NCT02268812|100563644|FG000|STARTED|Overall Study||77||
48097209|NCT02268812|100563645|FG001|STARTED|Overall Study||72||
48097210|NCT02268812|100563646|FG002|STARTED|Overall Study||30||
48097211|NCT02268812|100563647|FG003|STARTED|Overall Study||40||
48097212|NCT02268812|100563644|FG000|COMPLETED|Overall Study||61||
48097213|NCT02268812|100563645|FG001|COMPLETED|Overall Study||40||
48097214|NCT02268812|100563646|FG002|COMPLETED|Overall Study||21||
48097215|NCT02268812|100563647|FG003|COMPLETED|Overall Study||26||
48097216|NCT02268812|100563644|FG000|NOT COMPLETED|Overall Study||16||
48097217|NCT02268812|100563645|FG001|NOT COMPLETED|Overall Study||32||
48097218|NCT02268812|100563646|FG002|NOT COMPLETED|Overall Study||9||
48097219|NCT02268812|100563647|FG003|NOT COMPLETED|Overall Study||14||
48097220|NCT02338960|100563648|FG000|STARTED|Core Study||306||
48097221|NCT02338960|100563649|FG001|STARTED|Core Study||308||
48097222|NCT02338960|100563648|FG000|Received Intervention|Core Study||303||
48097223|NCT02338960|100563649|FG001|Received Intervention|Core Study||301||
48097224|NCT02338960|100563648|FG000|COMPLETED|Core Study||219||
48097225|NCT02338960|100563649|FG001|COMPLETED|Core Study||173||
48097226|NCT02338960|100563648|FG000|NOT COMPLETED|Core Study||87||
48097227|NCT02338960|100563649|FG001|NOT COMPLETED|Core Study||135||
48097228|NCT02338960|100563648|FG000|STARTED|Open Label Extension||191|321/392 Subjects who completed the Core Study continued into the optional OLE study.|
48097229|NCT02338960|100563649|FG001|STARTED|Open Label Extension||130|321/392 Subjects who completed the Core Study continued into the optional OLE study.|
48097230|NCT02338960|100563648|FG000|COMPLETED|Open Label Extension||77||
48097231|NCT02338960|100563649|FG001|COMPLETED|Open Label Extension||51||
48097232|NCT02338960|100563648|FG000|NOT COMPLETED|Open Label Extension||114||
48097233|NCT02338960|100563649|FG001|NOT COMPLETED|Open Label Extension||79||
48097234|NCT02632552|100563650|FG000|STARTED|Overall Study||80||
48097235|NCT02632552|100563651|FG001|STARTED|Overall Study||60||
48097236|NCT02632552|100563650|FG000|COMPLETED|Overall Study||57||
48097237|NCT02632552|100563651|FG001|COMPLETED|Overall Study||50||
48097238|NCT02632552|100563650|FG000|NOT COMPLETED|Overall Study||23||
48097239|NCT02632552|100563651|FG001|NOT COMPLETED|Overall Study||10||
48097240|NCT02268786|100563652|FG000|STARTED|Overall Study||330||
48097241|NCT02268786|100563653|FG001|STARTED|Overall Study||331||
48542968|NCT04604795|101666897|FG003|COMPLETED|Part A: Period 2 (Day 1)||3||
48542969|NCT04604795|101666898|FG004|COMPLETED|Part A: Period 2 (Day 1)||0||
48542970|NCT04604795|101666899|FG005|COMPLETED|Part A: Period 2 (Day 1)||0||
48542971|NCT04604795|101666900|FG006|COMPLETED|Part A: Period 2 (Day 1)||0||
48542972|NCT04604795|101666901|FG007|COMPLETED|Part A: Period 2 (Day 1)||0||
48542973|NCT04604795|101666902|FG008|COMPLETED|Part A: Period 2 (Day 1)||0||
48690177|NCT00402324|102025774|FG001|NOT COMPLETED|Overall Study||41||
48690178|NCT02453750|102025775|FG000|STARTED|Overall Study||21||
48097242|NCT02268786|100563652|FG000|COMPLETED|Overall Study||274||
48097243|NCT02268786|100563653|FG001|COMPLETED|Overall Study||313||
48097244|NCT02268786|100563652|FG000|NOT COMPLETED|Overall Study||56||
48097245|NCT02268786|100563653|FG001|NOT COMPLETED|Overall Study||18||
48097246|NCT00560950|100563654|FG000|STARTED|Overall Study||72||
48097247|NCT00560950|100563655|FG001|STARTED|Overall Study||71||
48097248|NCT00560950|100563654|FG000|COMPLETED|Overall Study||71||
48097249|NCT00560950|100563655|FG001|COMPLETED|Overall Study||71||
48097250|NCT00560950|100563654|FG000|NOT COMPLETED|Overall Study||1||
48097251|NCT00560950|100563655|FG001|NOT COMPLETED|Overall Study||0||
48097252|NCT00254540|100563656|FG000|STARTED|Overall Study||25||
48097253|NCT00254540|100563657|FG001|STARTED|Overall Study||26||
48097254|NCT00254540|100563656|FG000|COMPLETED|Overall Study||6||
48097255|NCT00254540|100563657|FG001|COMPLETED|Overall Study||4||
48097256|NCT00254540|100563656|FG000|NOT COMPLETED|Overall Study||19||
48097257|NCT00254540|100563657|FG001|NOT COMPLETED|Overall Study||22||
48097258|NCT01846611|100563658|FG000|STARTED|Overall Study||289||
48097259|NCT01846611|100563659|FG001|STARTED|Overall Study||287||
48097260|NCT01846611|100563658|FG000|Treated|Overall Study||286||
48097261|NCT01846611|100563659|FG001|Treated|Overall Study||282||
48097262|NCT01846611|100563658|FG000|COMPLETED|Overall Study||251||
48097263|NCT01846611|100563659|FG001|COMPLETED|Overall Study||244||
48097264|NCT01846611|100563658|FG000|NOT COMPLETED|Overall Study||38||
48097265|NCT01846611|100563659|FG001|NOT COMPLETED|Overall Study||43||
48097266|NCT00944450|100563660|FG000|STARTED|Period 1||6||
48097267|NCT00944450|100563661|FG001|STARTED|Period 1||6||
48097268|NCT00944450|100563660|FG000|COMPLETED|Period 1||6||
48097269|NCT00944450|100563661|FG001|COMPLETED|Period 1||6||
48097270|NCT00944450|100563660|FG000|NOT COMPLETED|Period 1||0||
48097271|NCT00944450|100563661|FG001|NOT COMPLETED|Period 1||0||
48097272|NCT00944450|100563660|FG000|STARTED|Period 2||6||
48097273|NCT00944450|100563661|FG001|STARTED|Period 2||6||
48097274|NCT00944450|100563660|FG000|COMPLETED|Period 2||6||
48097275|NCT00944450|100563661|FG001|COMPLETED|Period 2||6||
48097276|NCT00944450|100563660|FG000|NOT COMPLETED|Period 2||0||
48097277|NCT00944450|100563661|FG001|NOT COMPLETED|Period 2||0||
48097278|NCT01589445|100563662|FG000|STARTED|001 (Pioglitazone) -3 Months||77||
48097279|NCT01589445|100563662|FG000|COMPLETED|001 (Pioglitazone) -3 Months||70||
48097280|NCT01589445|100563662|FG000|NOT COMPLETED|001 (Pioglitazone) -3 Months||7||
48542974|NCT04604795|101666903|FG009|COMPLETED|Part A: Period 2 (Day 1)||0||
48097281|NCT01589445|100563662|FG000|STARTED|002 (Metformin)-3 Months||70||
48097282|NCT01589445|100563662|FG000|COMPLETED|002 (Metformin)-3 Months||61||
48097283|NCT01589445|100563662|FG000|NOT COMPLETED|002 (Metformin)-3 Months||9||
48097284|NCT02436356|100563663|FG000|STARTED|Overall Study||33||
48097285|NCT02436356|100563664|FG001|STARTED|Overall Study||11||
48097286|NCT02436356|100563665|FG002|STARTED|Overall Study||4||
48542975|NCT04604795|101666894|FG000|NOT COMPLETED|Part A: Period 2 (Day 1)||0||
48097287|NCT02436356|100563663|FG000|High Energy Fracture|Overall Study||14||
48097288|NCT02436356|100563664|FG001|High Energy Fracture|Overall Study||0||
48097289|NCT02436356|100563665|FG002|High Energy Fracture|Overall Study||4||
48097290|NCT02436356|100563663|FG000|Low Energy Fracture|Overall Study||19||
48097291|NCT02436356|100563664|FG001|Low Energy Fracture|Overall Study||0||
48097292|NCT02436356|100563665|FG002|Low Energy Fracture|Overall Study||0||
48097293|NCT02436356|100563663|FG000|COMPLETED|Overall Study||28||
48097294|NCT02436356|100563664|FG001|COMPLETED|Overall Study||10||
48097295|NCT02436356|100563665|FG002|COMPLETED|Overall Study||2||
48097296|NCT02436356|100563663|FG000|NOT COMPLETED|Overall Study||5||
48097297|NCT02436356|100563664|FG001|NOT COMPLETED|Overall Study||1||
48097298|NCT02436356|100563665|FG002|NOT COMPLETED|Overall Study||2||
48097299|NCT00469092|100563666|FG000|STARTED|Overall Study||239||
48097300|NCT00469092|100563667|FG001|STARTED|Overall Study||241||
48097301|NCT00469092|100563666|FG000|Exposed to Study Drug|Overall Study||231||
48097302|NCT00469092|100563667|FG001|Exposed to Study Drug|Overall Study||238||
48097303|NCT00469092|100563666|FG000|COMPLETED|Overall Study||213||
48097304|NCT00469092|100563667|FG001|COMPLETED|Overall Study||220||
48097305|NCT00469092|100563666|FG000|NOT COMPLETED|Overall Study||26||
48097306|NCT00469092|100563667|FG001|NOT COMPLETED|Overall Study||21||
48097307|NCT02337907|100563668|FG000|STARTED|Overall Study||55||
48097308|NCT02337907|100563669|FG001|STARTED|Overall Study||53||
48097309|NCT02337907|100563670|FG002|STARTED|Overall Study||55||
48097310|NCT02337907|100563671|FG003|STARTED|Overall Study||55||
48097311|NCT02337907|100563672|FG004|STARTED|Overall Study||106||
48097312|NCT02337907|100563673|FG005|STARTED|Overall Study||5||
48097313|NCT02337907|100563668|FG000|COMPLETED|Overall Study||51||
48097314|NCT02337907|100563669|FG001|COMPLETED|Overall Study||49||
48097315|NCT02337907|100563670|FG002|COMPLETED|Overall Study||54||
48097316|NCT02337907|100563671|FG003|COMPLETED|Overall Study||51||
48097317|NCT02337907|100563672|FG004|COMPLETED|Overall Study||96||
48097318|NCT02337907|100563673|FG005|COMPLETED|Overall Study||4||
48097319|NCT02337907|100563668|FG000|NOT COMPLETED|Overall Study||4||
48097320|NCT02337907|100563669|FG001|NOT COMPLETED|Overall Study||4||
48097321|NCT02337907|100563670|FG002|NOT COMPLETED|Overall Study||1||
48097322|NCT02337907|100563671|FG003|NOT COMPLETED|Overall Study||4||
48097323|NCT02337907|100563672|FG004|NOT COMPLETED|Overall Study||10||
48097324|NCT02337907|100563673|FG005|NOT COMPLETED|Overall Study||1||
48097325|NCT00567892|100563674|FG000|STARTED|First Treatment (2 or 4 Weeks)||7||
48097326|NCT00567892|100563675|FG001|STARTED|First Treatment (2 or 4 Weeks)||7||
48097327|NCT00567892|100563676|FG002|STARTED|First Treatment (2 or 4 Weeks)||10||
48097328|NCT00567892|100563677|FG003|STARTED|First Treatment (2 or 4 Weeks)||10||
48097329|NCT00567892|100563674|FG000|COMPLETED|First Treatment (2 or 4 Weeks)||7||
48097330|NCT00567892|100563675|FG001|COMPLETED|First Treatment (2 or 4 Weeks)||7||
48097331|NCT00567892|100563676|FG002|COMPLETED|First Treatment (2 or 4 Weeks)||9||
48097332|NCT00567892|100563677|FG003|COMPLETED|First Treatment (2 or 4 Weeks)||6||
48097333|NCT00567892|100563674|FG000|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0||
48097334|NCT00567892|100563675|FG001|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0||
48097335|NCT00567892|100563676|FG002|NOT COMPLETED|First Treatment (2 or 4 Weeks)||1||
48097336|NCT00567892|100563677|FG003|NOT COMPLETED|First Treatment (2 or 4 Weeks)||4||
48097337|NCT00567892|100563674|FG000|STARTED|Washout (2 Weeks)||7||
48097338|NCT00567892|100563675|FG001|STARTED|Washout (2 Weeks)||7||
48097339|NCT00567892|100563676|FG002|STARTED|Washout (2 Weeks)||9||
48097340|NCT00567892|100563677|FG003|STARTED|Washout (2 Weeks)||6||
48097341|NCT00567892|100563674|FG000|COMPLETED|Washout (2 Weeks)||7||
48097342|NCT00567892|100563675|FG001|COMPLETED|Washout (2 Weeks)||7||
48097343|NCT00567892|100563676|FG002|COMPLETED|Washout (2 Weeks)||9||
48097344|NCT00567892|100563677|FG003|COMPLETED|Washout (2 Weeks)||6||
48097345|NCT00567892|100563674|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
48097346|NCT00567892|100563675|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
48097347|NCT00567892|100563676|FG002|NOT COMPLETED|Washout (2 Weeks)||0||
48097348|NCT00567892|100563677|FG003|NOT COMPLETED|Washout (2 Weeks)||0||
48097349|NCT00567892|100563674|FG000|STARTED|Second Treatment (2 or 4 Weeks)||7||
48097350|NCT00567892|100563675|FG001|STARTED|Second Treatment (2 or 4 Weeks)||7||
48097351|NCT00567892|100563676|FG002|STARTED|Second Treatment (2 or 4 Weeks)||9||
48097352|NCT00567892|100563677|FG003|STARTED|Second Treatment (2 or 4 Weeks)||6||
48097353|NCT00567892|100563674|FG000|COMPLETED|Second Treatment (2 or 4 Weeks)||7||
48097354|NCT00567892|100563675|FG001|COMPLETED|Second Treatment (2 or 4 Weeks)||7||
48097355|NCT00567892|100563676|FG002|COMPLETED|Second Treatment (2 or 4 Weeks)||9||
48690179|NCT02453750|102025775|FG000|COMPLETED|Overall Study||21||
48690180|NCT02453750|102025775|FG000|NOT COMPLETED|Overall Study||0||
48690181|NCT00626886|102025776|FG000|STARTED|Overall Study||24||
48690182|NCT00626886|102025777|FG001|STARTED|Overall Study||29||
48690183|NCT00626886|102025776|FG000|COMPLETED|Overall Study||24||
48097356|NCT00567892|100563677|FG003|COMPLETED|Second Treatment (2 or 4 Weeks)||5||
48097357|NCT00567892|100563674|FG000|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0||
48097358|NCT00567892|100563675|FG001|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0||
48690184|NCT00626886|102025777|FG001|COMPLETED|Overall Study||29||
48690185|NCT00626886|102025776|FG000|NOT COMPLETED|Overall Study||0||
48690186|NCT00626886|102025777|FG001|NOT COMPLETED|Overall Study||0||
48690187|NCT03559517|102025778|FG000|STARTED|Overall Study||8||
48690188|NCT03559517|102025779|FG001|STARTED|Overall Study||9||
48690189|NCT03559517|102025780|FG002|STARTED|Overall Study||12||
48097359|NCT00567892|100563676|FG002|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0||
48097360|NCT00567892|100563677|FG003|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||1||
48097361|NCT01519453|100563678|FG000|STARTED|Overall Study||199||
48097362|NCT01519453|100563679|FG001|STARTED|Overall Study||199||
48097363|NCT01519453|100563678|FG000|3 Month|Overall Study||160||
48097364|NCT01519453|100563679|FG001|3 Month|Overall Study||181||
48097365|NCT01519453|100563678|FG000|6 Month|Overall Study||153||
48097366|NCT01519453|100563679|FG001|6 Month|Overall Study||175||
48097367|NCT01519453|100563678|FG000|9 Month|Overall Study||159||
48097368|NCT01519453|100563679|FG001|9 Month|Overall Study||166||
48097369|NCT01519453|100563678|FG000|COMPLETED|Overall Study||147|Number completing 12 month follow up assessment|
48097370|NCT01519453|100563679|FG001|COMPLETED|Overall Study||163|Number completing 12 month follow up assessment|
48097371|NCT01519453|100563678|FG000|NOT COMPLETED|Overall Study||52||
48097372|NCT01519453|100563679|FG001|NOT COMPLETED|Overall Study||36||
48097373|NCT00695396|100563680|FG000|STARTED|Overall Study||8||
48097374|NCT00695396|100563681|FG001|STARTED|Overall Study||8||
48097375|NCT00695396|100563682|FG002|STARTED|Overall Study||9||
48097376|NCT00695396|100563680|FG000|COMPLETED|Overall Study||1||
48097377|NCT00695396|100563681|FG001|COMPLETED|Overall Study||0||
48097378|NCT00695396|100563682|FG002|COMPLETED|Overall Study||1||
48097379|NCT00695396|100563680|FG000|NOT COMPLETED|Overall Study||7||
48097380|NCT00695396|100563681|FG001|NOT COMPLETED|Overall Study||8||
48097381|NCT00695396|100563682|FG002|NOT COMPLETED|Overall Study||8||
48097382|NCT00503308|100563683|FG000|STARTED|Overall Study||146||
48097383|NCT00503308|100563684|FG001|STARTED|Overall Study||135||
48097384|NCT00503308|100563683|FG000|COMPLETED|Overall Study||144||
48097385|NCT00503308|100563684|FG001|COMPLETED|Overall Study||134||
48097386|NCT00503308|100563683|FG000|NOT COMPLETED|Overall Study||2||
48097387|NCT00503308|100563684|FG001|NOT COMPLETED|Overall Study||1||
48260982|NCT02706951|100959070|FG002|NOT COMPLETED|Period 2||0||
48260983|NCT02706951|100959071|FG003|NOT COMPLETED|Period 2||118||
48260984|NCT02706951|100959072|FG004|NOT COMPLETED|Period 2||120||
48260985|NCT03468179|100959073|FG000|STARTED|Overall Study||10||
48260986|NCT03468179|100959073|FG000|COMPLETED|Overall Study||10||
48260987|NCT03468179|100959073|FG000|NOT COMPLETED|Overall Study||0||
48260988|NCT00936598|100959074|FG000|STARTED|Overall Study||4||
48389991|NCT01476748|101283480|FG002|NOT COMPLETED|Overall Study||0||
48389992|NCT00680953|101283481|FG000|STARTED|Overall Study||500||
48389993|NCT00680953|101283482|FG001|STARTED|Overall Study||511||
48389994|NCT00680953|101283483|FG002|STARTED|Overall Study||251||
48389995|NCT00680953|101283481|FG000|COMPLETED|Overall Study||414||
48389996|NCT00680953|101283482|FG001|COMPLETED|Overall Study||416||
48389997|NCT00680953|101283483|FG002|COMPLETED|Overall Study||204||
48389998|NCT00680953|101283481|FG000|NOT COMPLETED|Overall Study||86||
48389999|NCT00680953|101283482|FG001|NOT COMPLETED|Overall Study||95||
48390000|NCT00680953|101283483|FG002|NOT COMPLETED|Overall Study||47||
48390001|NCT00453180|101283484|FG000|STARTED|Overall Study||16||
48390002|NCT00453180|101283485|FG001|STARTED|Overall Study||15||
48390003|NCT00453180|101283484|FG000|COMPLETED|Overall Study||13||
48390004|NCT00453180|101283485|FG001|COMPLETED|Overall Study||12||
48390005|NCT00453180|101283484|FG000|NOT COMPLETED|Overall Study||3||
48390006|NCT00453180|101283485|FG001|NOT COMPLETED|Overall Study||3||
48390007|NCT02714504|101283486|FG000|STARTED|Overall Study||61||
48390008|NCT02714504|101283487|FG001|STARTED|Overall Study||178||
48390009|NCT02714504|101283486|FG000|COMPLETED|Overall Study||61||
48390010|NCT02714504|101283487|FG001|COMPLETED|Overall Study||178||
48390011|NCT02714504|101283486|FG000|NOT COMPLETED|Overall Study||0||
48390012|NCT02714504|101283487|FG001|NOT COMPLETED|Overall Study||0||
48390013|NCT01993615|101283488|FG000|STARTED|Overall Study||40||
48390014|NCT01993615|101283489|FG001|STARTED|Overall Study||40||
48390015|NCT01993615|101283488|FG000|COMPLETED|Overall Study||39||
48390016|NCT01993615|101283489|FG001|COMPLETED|Overall Study||40||
48390017|NCT01993615|101283488|FG000|NOT COMPLETED|Overall Study||1||
48542976|NCT04604795|101666895|FG001|NOT COMPLETED|Part A: Period 2 (Day 1)||0||
48542977|NCT04604795|101666896|FG002|NOT COMPLETED|Part A: Period 2 (Day 1)||0||
48097388|NCT01287897|100563685|FG000|STARTED|Overall Study||70||
48097389|NCT01287897|100563686|FG001|STARTED|Overall Study||69||
48097390|NCT01287897|100563687|FG002|STARTED|Overall Study||71||
48097391|NCT01287897|100563688|FG003|STARTED|Overall Study||40||
48097392|NCT01287897|100563685|FG000|Treated|Overall Study||69||
48097393|NCT01287897|100563686|FG001|Treated|Overall Study||67||
48097394|NCT01287897|100563687|FG002|Treated|Overall Study||71||
48097395|NCT01287897|100563688|FG003|Treated|Overall Study||40||
48097396|NCT01287897|100563685|FG000|Completed Treatment Period|Overall Study||58||
48260989|NCT00936598|100959075|FG001|STARTED|Overall Study||1||
48260990|NCT00936598|100959074|FG000|COMPLETED|Overall Study||2||
48260991|NCT00936598|100959075|FG001|COMPLETED|Overall Study||1||
48260992|NCT00936598|100959074|FG000|NOT COMPLETED|Overall Study||2||
48097397|NCT01287897|100563686|FG001|Completed Treatment Period|Overall Study||52||
48260993|NCT00936598|100959075|FG001|NOT COMPLETED|Overall Study||0||
48260994|NCT00594022|100959076|FG000|STARTED|Overall Study||176||
48260995|NCT00594022|100959077|FG001|STARTED|Overall Study||173||
48260996|NCT00594022|100959076|FG000|COMPLETED|Overall Study||176||
48260997|NCT00594022|100959077|FG001|COMPLETED|Overall Study||173||
48260998|NCT00594022|100959076|FG000|NOT COMPLETED|Overall Study||0||
48260999|NCT00594022|100959077|FG001|NOT COMPLETED|Overall Study||0||
48261000|NCT01103232|100959078|FG000|STARTED|Overall Study||13||
48261001|NCT01103232|100959079|FG001|STARTED|Overall Study||13||
48261002|NCT01103232|100959078|FG000|COMPLETED|Overall Study||12||
48261003|NCT01103232|100959079|FG001|COMPLETED|Overall Study||11||
48261004|NCT01103232|100959078|FG000|NOT COMPLETED|Overall Study||1||
48261005|NCT01103232|100959079|FG001|NOT COMPLETED|Overall Study||2||
48261006|NCT02977286|100959080|FG000|STARTED|Overall Study||6||
48390018|NCT01993615|101283489|FG001|NOT COMPLETED|Overall Study||0||
48390019|NCT02494778|101283490|FG000|STARTED|Overall Study||248||
48390020|NCT02494778|101283490|FG000|COMPLETED|Overall Study||27||
48390021|NCT02494778|101283490|FG000|NOT COMPLETED|Overall Study||221||
48390022|NCT02750267|101283491|FG000|STARTED|Overall Study||6||
48390023|NCT02750267|101283492|FG001|STARTED|Overall Study||6||
48390024|NCT02750267|101283491|FG000|COMPLETED|Overall Study||6||
48390025|NCT02750267|101283492|FG001|COMPLETED|Overall Study||6||
48542978|NCT04604795|101666897|FG003|NOT COMPLETED|Part A: Period 2 (Day 1)||0||
48542979|NCT04604795|101666898|FG004|NOT COMPLETED|Part A: Period 2 (Day 1)||0||
48542980|NCT04604795|101666899|FG005|NOT COMPLETED|Part A: Period 2 (Day 1)||0||
48542981|NCT04604795|101666900|FG006|NOT COMPLETED|Part A: Period 2 (Day 1)||0||
48542982|NCT04604795|101666901|FG007|NOT COMPLETED|Part A: Period 2 (Day 1)||0||
48542983|NCT04604795|101666902|FG008|NOT COMPLETED|Part A: Period 2 (Day 1)||0||
48542984|NCT04604795|101666903|FG009|NOT COMPLETED|Part A: Period 2 (Day 1)||0||
48542985|NCT04604795|101666894|FG000|STARTED|Part A: Washout Period 2 (Up to Day 12)||3||
48542986|NCT04604795|101666895|FG001|STARTED|Part A: Washout Period 2 (Up to Day 12)||3||
48542987|NCT04604795|101666896|FG002|STARTED|Part A: Washout Period 2 (Up to Day 12)||3||
48542988|NCT04604795|101666897|FG003|STARTED|Part A: Washout Period 2 (Up to Day 12)||3||
48542989|NCT04604795|101666898|FG004|STARTED|Part A: Washout Period 2 (Up to Day 12)||0||
48542990|NCT04604795|101666899|FG005|STARTED|Part A: Washout Period 2 (Up to Day 12)||0||
48542991|NCT04604795|101666900|FG006|STARTED|Part A: Washout Period 2 (Up to Day 12)||0||
48542992|NCT04604795|101666901|FG007|STARTED|Part A: Washout Period 2 (Up to Day 12)||0||
48542993|NCT04604795|101666902|FG008|STARTED|Part A: Washout Period 2 (Up to Day 12)||0||
48542994|NCT04604795|101666903|FG009|STARTED|Part A: Washout Period 2 (Up to Day 12)||0||
48542995|NCT04604795|101666894|FG000|COMPLETED|Part A: Washout Period 2 (Up to Day 12)||3||
48542996|NCT04604795|101666895|FG001|COMPLETED|Part A: Washout Period 2 (Up to Day 12)||3||
48542997|NCT04604795|101666896|FG002|COMPLETED|Part A: Washout Period 2 (Up to Day 12)||3||
48542998|NCT04604795|101666897|FG003|COMPLETED|Part A: Washout Period 2 (Up to Day 12)||3||
48542999|NCT04604795|101666898|FG004|COMPLETED|Part A: Washout Period 2 (Up to Day 12)||0||
48543000|NCT04604795|101666899|FG005|COMPLETED|Part A: Washout Period 2 (Up to Day 12)||0||
48543001|NCT04604795|101666900|FG006|COMPLETED|Part A: Washout Period 2 (Up to Day 12)||0||
48543002|NCT04604795|101666901|FG007|COMPLETED|Part A: Washout Period 2 (Up to Day 12)||0||
48543003|NCT04604795|101666902|FG008|COMPLETED|Part A: Washout Period 2 (Up to Day 12)||0||
48543004|NCT04604795|101666903|FG009|COMPLETED|Part A: Washout Period 2 (Up to Day 12)||0||
48543005|NCT04604795|101666894|FG000|NOT COMPLETED|Part A: Washout Period 2 (Up to Day 12)||0||
48543006|NCT04604795|101666895|FG001|NOT COMPLETED|Part A: Washout Period 2 (Up to Day 12)||0||
48543007|NCT04604795|101666896|FG002|NOT COMPLETED|Part A: Washout Period 2 (Up to Day 12)||0||
48543008|NCT04604795|101666897|FG003|NOT COMPLETED|Part A: Washout Period 2 (Up to Day 12)||0||
48543009|NCT04604795|101666898|FG004|NOT COMPLETED|Part A: Washout Period 2 (Up to Day 12)||0||
48543010|NCT04604795|101666899|FG005|NOT COMPLETED|Part A: Washout Period 2 (Up to Day 12)||0||
48543011|NCT04604795|101666900|FG006|NOT COMPLETED|Part A: Washout Period 2 (Up to Day 12)||0||
48543012|NCT04604795|101666901|FG007|NOT COMPLETED|Part A: Washout Period 2 (Up to Day 12)||0||
48543013|NCT04604795|101666902|FG008|NOT COMPLETED|Part A: Washout Period 2 (Up to Day 12)||0||
48543014|NCT04604795|101666903|FG009|NOT COMPLETED|Part A: Washout Period 2 (Up to Day 12)||0||
48543015|NCT04604795|101666894|FG000|STARTED|Part A: Period 3 (Day 1)||3||
48543016|NCT04604795|101666895|FG001|STARTED|Part A: Period 3 (Day 1)||3||
48543017|NCT04604795|101666896|FG002|STARTED|Part A: Period 3 (Day 1)||3||
48543018|NCT04604795|101666897|FG003|STARTED|Part A: Period 3 (Day 1)||3||
48543019|NCT04604795|101666898|FG004|STARTED|Part A: Period 3 (Day 1)||0||
48543020|NCT04604795|101666899|FG005|STARTED|Part A: Period 3 (Day 1)||0||
48543021|NCT04604795|101666900|FG006|STARTED|Part A: Period 3 (Day 1)||0||
48543022|NCT04604795|101666901|FG007|STARTED|Part A: Period 3 (Day 1)||0||
48390026|NCT02750267|101283491|FG000|NOT COMPLETED|Overall Study||0||
48390027|NCT02750267|101283492|FG001|NOT COMPLETED|Overall Study||0||
48390028|NCT00442767|101283493|FG000|STARTED|Overall Study||8||
48390029|NCT00442767|101283493|FG000|COMPLETED|Overall Study||8||
48390030|NCT00442767|101283493|FG000|NOT COMPLETED|Overall Study||0||
48390031|NCT00818207|101283494|FG000|STARTED|Overall Study||696||
48390032|NCT00818207|101283495|FG001|STARTED|Overall Study||684||
48390033|NCT00818207|101283494|FG000|COMPLETED|Overall Study||474||
48390034|NCT00818207|101283495|FG001|COMPLETED|Overall Study||417||
48390035|NCT00818207|101283494|FG000|NOT COMPLETED|Overall Study||222||
48543023|NCT04604795|101666902|FG008|STARTED|Part A: Period 3 (Day 1)||0||
48543024|NCT04604795|101666903|FG009|STARTED|Part A: Period 3 (Day 1)||0||
48543025|NCT04604795|101666894|FG000|COMPLETED|Part A: Period 3 (Day 1)||3||
48543026|NCT04604795|101666895|FG001|COMPLETED|Part A: Period 3 (Day 1)||3||
48543027|NCT04604795|101666896|FG002|COMPLETED|Part A: Period 3 (Day 1)||3||
48543028|NCT04604795|101666897|FG003|COMPLETED|Part A: Period 3 (Day 1)||3||
48543029|NCT04604795|101666898|FG004|COMPLETED|Part A: Period 3 (Day 1)||0||
48543030|NCT04604795|101666899|FG005|COMPLETED|Part A: Period 3 (Day 1)||0||
48543031|NCT04604795|101666900|FG006|COMPLETED|Part A: Period 3 (Day 1)||0||
48390036|NCT00818207|101283495|FG001|NOT COMPLETED|Overall Study||267||
48390037|NCT01829217|101283496|FG000|STARTED|Overall Study||13||
48390038|NCT01829217|101283496|FG000|COMPLETED|Overall Study||13||
48390039|NCT01829217|101283496|FG000|NOT COMPLETED|Overall Study||0||
48390040|NCT01181102|101283497|FG000|STARTED|Overall Study||360||
48390041|NCT01181102|101283498|FG001|STARTED|Overall Study||356||
48390042|NCT01181102|101283497|FG000|Safety Analysis Set|Overall Study||354||
48390043|NCT01181102|101283498|FG001|Safety Analysis Set|Overall Study||349||
48390044|NCT01181102|101283497|FG000|Efficacy Analysis Population|Overall Study||299||
48390045|NCT01181102|101283498|FG001|Efficacy Analysis Population|Overall Study||295||
48390046|NCT01181102|101283497|FG000|COMPLETED|Overall Study||309||
48390047|NCT01181102|101283498|FG001|COMPLETED|Overall Study||310||
48390048|NCT01181102|101283497|FG000|NOT COMPLETED|Overall Study||51||
48390049|NCT01181102|101283498|FG001|NOT COMPLETED|Overall Study||46||
48390050|NCT03074149|101283499|FG000|STARTED|Overall Study||96||
48390051|NCT03074149|101283500|FG001|STARTED|Overall Study||205||
48390052|NCT03074149|101283499|FG000|COMPLETED|Overall Study||64||
48543032|NCT04604795|101666901|FG007|COMPLETED|Part A: Period 3 (Day 1)||0||
48390053|NCT03074149|101283500|FG001|COMPLETED|Overall Study||125||
48390054|NCT03074149|101283499|FG000|NOT COMPLETED|Overall Study||32||
48390055|NCT03074149|101283500|FG001|NOT COMPLETED|Overall Study||80||
48390056|NCT03495453|101283501|FG000|STARTED|Overall Study||30||
48390057|NCT03495453|101283502|FG001|STARTED|Overall Study||30||
48390058|NCT03495453|101283501|FG000|COMPLETED|Overall Study||30||
48097398|NCT01287897|100563687|FG002|Completed Treatment Period|Overall Study||58||
48097399|NCT01287897|100563688|FG003|Completed Treatment Period|Overall Study||29||
48390059|NCT03495453|101283502|FG001|COMPLETED|Overall Study||29||
48097400|NCT01287897|100563685|FG000|Completed Follow-up Period|Overall Study||3||
48097401|NCT01287897|100563686|FG001|Completed Follow-up Period|Overall Study||8||
48097402|NCT01287897|100563687|FG002|Completed Follow-up Period|Overall Study||3||
48097403|NCT01287897|100563688|FG003|Completed Follow-up Period|Overall Study||4||
48097404|NCT01287897|100563685|FG000|Enrolled in NCT01345318|Overall Study||56||
48097405|NCT01287897|100563686|FG001|Enrolled in NCT01345318|Overall Study||50||
48097406|NCT01287897|100563687|FG002|Enrolled in NCT01345318|Overall Study||56||
48097407|NCT01287897|100563688|FG003|Enrolled in NCT01345318|Overall Study||29||
48097408|NCT01287897|100563685|FG000|COMPLETED|Overall Study||59||
48097409|NCT01287897|100563686|FG001|COMPLETED|Overall Study||58||
48097410|NCT01287897|100563687|FG002|COMPLETED|Overall Study||59||
48097411|NCT01287897|100563688|FG003|COMPLETED|Overall Study||33||
48097412|NCT01287897|100563685|FG000|NOT COMPLETED|Overall Study||11||
48097413|NCT01287897|100563686|FG001|NOT COMPLETED|Overall Study||11||
48097414|NCT01287897|100563687|FG002|NOT COMPLETED|Overall Study||12||
48097415|NCT01287897|100563688|FG003|NOT COMPLETED|Overall Study||7||
48097416|NCT02081079|100563689|FG000|STARTED|Overall Study||44||
48097417|NCT02081079|100563690|FG001|STARTED|Overall Study||41||
48097418|NCT02081079|100563689|FG000|COMPLETED|Overall Study||40||
48097419|NCT02081079|100563690|FG001|COMPLETED|Overall Study||39||
48097420|NCT02081079|100563689|FG000|NOT COMPLETED|Overall Study||4||
48097421|NCT02081079|100563690|FG001|NOT COMPLETED|Overall Study||2||
48097422|NCT00225251|100563691|FG000|STARTED|Overall Study||11||
48097423|NCT00225251|100563692|FG001|STARTED|Overall Study||7||
48097424|NCT00225251|100563691|FG000|COMPLETED|Overall Study||10||
48097425|NCT00225251|100563692|FG001|COMPLETED|Overall Study||6||
48390060|NCT03495453|101283501|FG000|NOT COMPLETED|Overall Study||0||
48390061|NCT03495453|101283502|FG001|NOT COMPLETED|Overall Study||1||
48390062|NCT00834886|101283503|FG000|STARTED|Overall Study||10||
48390063|NCT00834886|101283504|FG001|STARTED|Overall Study||10||
48390064|NCT00834886|101283505|FG002|STARTED|Overall Study||10||
48390065|NCT00834886|101283506|FG003|STARTED|Overall Study||10||
48390066|NCT00834886|101283503|FG000|COMPLETED|Overall Study||10||
48543033|NCT04604795|101666902|FG008|COMPLETED|Part A: Period 3 (Day 1)||0||
48543034|NCT04604795|101666903|FG009|COMPLETED|Part A: Period 3 (Day 1)||0||
48543035|NCT04604795|101666894|FG000|NOT COMPLETED|Part A: Period 3 (Day 1)||0||
48543036|NCT04604795|101666895|FG001|NOT COMPLETED|Part A: Period 3 (Day 1)||0||
48543037|NCT04604795|101666896|FG002|NOT COMPLETED|Part A: Period 3 (Day 1)||0||
48543038|NCT04604795|101666897|FG003|NOT COMPLETED|Part A: Period 3 (Day 1)||0||
48390067|NCT00834886|101283504|FG001|COMPLETED|Overall Study||9||
48390068|NCT00834886|101283505|FG002|COMPLETED|Overall Study||9||
48543039|NCT04604795|101666898|FG004|NOT COMPLETED|Part A: Period 3 (Day 1)||0||
48543040|NCT04604795|101666899|FG005|NOT COMPLETED|Part A: Period 3 (Day 1)||0||
48543041|NCT04604795|101666900|FG006|NOT COMPLETED|Part A: Period 3 (Day 1)||0||
48543042|NCT04604795|101666901|FG007|NOT COMPLETED|Part A: Period 3 (Day 1)||0||
48543043|NCT04604795|101666902|FG008|NOT COMPLETED|Part A: Period 3 (Day 1)||0||
48543044|NCT04604795|101666903|FG009|NOT COMPLETED|Part A: Period 3 (Day 1)||0||
48390069|NCT00834886|101283506|FG003|COMPLETED|Overall Study||10||
48390070|NCT00834886|101283503|FG000|NOT COMPLETED|Overall Study||0||
48390071|NCT00834886|101283504|FG001|NOT COMPLETED|Overall Study||1||
48390072|NCT00834886|101283505|FG002|NOT COMPLETED|Overall Study||1||
48097426|NCT00225251|100563691|FG000|NOT COMPLETED|Overall Study||1||
48097427|NCT00225251|100563692|FG001|NOT COMPLETED|Overall Study||1||
48097428|NCT00602576|100563693|FG000|STARTED|Overall Study||38||
48097429|NCT00602576|100563694|FG001|STARTED|Overall Study||40||
48097430|NCT00602576|100563695|FG002|STARTED|Overall Study||38||
48390073|NCT00834886|101283506|FG003|NOT COMPLETED|Overall Study||0||
48390074|NCT04142216|101283507|FG000|STARTED|Overall Study||28||
48097431|NCT00602576|100563696|FG003|STARTED|Overall Study||53||
48097432|NCT00602576|100563693|FG000|COMPLETED|Overall Study||38||
48097433|NCT00602576|100563694|FG001|COMPLETED|Overall Study||40||
48097434|NCT00602576|100563695|FG002|COMPLETED|Overall Study||38||
48097435|NCT00602576|100563696|FG003|COMPLETED|Overall Study||53||
48097436|NCT00602576|100563693|FG000|NOT COMPLETED|Overall Study||0||
48097437|NCT00602576|100563694|FG001|NOT COMPLETED|Overall Study||0||
48097438|NCT00602576|100563695|FG002|NOT COMPLETED|Overall Study||0||
48543045|NCT04604795|101666894|FG000|STARTED|Part A: Washout Period 3 (Up to Day 20)||3||
48543046|NCT04604795|101666895|FG001|STARTED|Part A: Washout Period 3 (Up to Day 20)||3||
48543047|NCT04604795|101666896|FG002|STARTED|Part A: Washout Period 3 (Up to Day 20)||3||
48543048|NCT04604795|101666897|FG003|STARTED|Part A: Washout Period 3 (Up to Day 20)||3||
48543049|NCT04604795|101666898|FG004|STARTED|Part A: Washout Period 3 (Up to Day 20)||0||
48097439|NCT00602576|100563696|FG003|NOT COMPLETED|Overall Study||0||
48097440|NCT03065244|100563697|FG000|STARTED|Overall Study||50||
48097441|NCT03065244|100563698|FG001|STARTED|Overall Study||55||
48097442|NCT03065244|100563697|FG000|Participants Who Failed 1st Treatment and Crossed Over to Receive Other Treatment|Overall Study||22||
48097443|NCT03065244|100563698|FG001|Participants Who Failed 1st Treatment and Crossed Over to Receive Other Treatment|Overall Study||9||
48097444|NCT03065244|100563697|FG000|COMPLETED|Overall Study||47||
48097445|NCT03065244|100563698|FG001|COMPLETED|Overall Study||51||
48097446|NCT03065244|100563697|FG000|NOT COMPLETED|Overall Study||3||
48097447|NCT03065244|100563698|FG001|NOT COMPLETED|Overall Study||4||
48097448|NCT00333866|100563699|FG000|STARTED|Overall Study||189||
48097449|NCT00333866|100563700|FG001|STARTED|Overall Study||187||
48097450|NCT00333866|100563701|FG002|STARTED|Overall Study||184||
48097451|NCT00333866|100563702|FG003|STARTED|Overall Study||187||
48097452|NCT00333866|100563699|FG000|TREATED|Overall Study||184||
48097453|NCT00333866|100563700|FG001|TREATED|Overall Study||184||
48097454|NCT00333866|100563701|FG002|TREATED|Overall Study||182||
48097455|NCT00333866|100563702|FG003|TREATED|Overall Study||186||
48097456|NCT00333866|100563699|FG000|COMPLETED|Overall Study||141||
48390075|NCT04142216|101283508|FG001|STARTED|Overall Study||28||
48543050|NCT04604795|101666899|FG005|STARTED|Part A: Washout Period 3 (Up to Day 20)||0||
48543051|NCT04604795|101666900|FG006|STARTED|Part A: Washout Period 3 (Up to Day 20)||0||
48543052|NCT04604795|101666901|FG007|STARTED|Part A: Washout Period 3 (Up to Day 20)||0||
48543053|NCT04604795|101666902|FG008|STARTED|Part A: Washout Period 3 (Up to Day 20)||0||
48543054|NCT04604795|101666903|FG009|STARTED|Part A: Washout Period 3 (Up to Day 20)||0||
48097457|NCT00333866|100563700|FG001|COMPLETED|Overall Study||123||
48097458|NCT00333866|100563701|FG002|COMPLETED|Overall Study||133||
48097459|NCT00333866|100563702|FG003|COMPLETED|Overall Study||121||
48097460|NCT00333866|100563699|FG000|NOT COMPLETED|Overall Study||48||
48097461|NCT00333866|100563700|FG001|NOT COMPLETED|Overall Study||64||
48097462|NCT00333866|100563701|FG002|NOT COMPLETED|Overall Study||51||
48390076|NCT04142216|101283507|FG000|COMPLETED|Overall Study||22||
48390077|NCT04142216|101283508|FG001|COMPLETED|Overall Study||22||
48390078|NCT04142216|101283507|FG000|NOT COMPLETED|Overall Study||6||
48390079|NCT04142216|101283508|FG001|NOT COMPLETED|Overall Study||6||
48390080|NCT04721977|101283509|FG000|STARTED|Overall Study||66||
48390081|NCT04721977|101283509|FG000|Japanese Participants|Overall Study||53||
48390082|NCT04721977|101283509|FG000|COMPLETED|Overall Study||0||
48390083|NCT04721977|101283509|FG000|NOT COMPLETED|Overall Study||66||
48390084|NCT02862548|101283510|FG000|STARTED|Randomized Phase (Up to Week 48)||26||
48390085|NCT02862548|101283511|FG001|STARTED|Randomized Phase (Up to Week 48)||25||
48390086|NCT02862548|101283510|FG000|COMPLETED|Randomized Phase (Up to Week 48)||26||
48390087|NCT02862548|101283511|FG001|COMPLETED|Randomized Phase (Up to Week 48)||24||
48390088|NCT02862548|101283510|FG000|NOT COMPLETED|Randomized Phase (Up to Week 48)||0||
48390089|NCT02862548|101283511|FG001|NOT COMPLETED|Randomized Phase (Up to Week 48)||1||
48390090|NCT02862548|101283510|FG000|STARTED|OLE Phase (Week 49 to Week 192)||26||
48390091|NCT02862548|101283511|FG001|STARTED|OLE Phase (Week 49 to Week 192)||24||
48390092|NCT02862548|101283510|FG000|COMPLETED|OLE Phase (Week 49 to Week 192)||23||
48390093|NCT02862548|101283511|FG001|COMPLETED|OLE Phase (Week 49 to Week 192)||23||
48390094|NCT02862548|101283510|FG000|NOT COMPLETED|OLE Phase (Week 49 to Week 192)||3||
48390095|NCT02862548|101283511|FG001|NOT COMPLETED|OLE Phase (Week 49 to Week 192)||1||
48390096|NCT00980785|101283512|FG000|STARTED|Overall Study||6||
48390097|NCT00980785|101283513|FG001|STARTED|Overall Study||8||
48390098|NCT00980785|101283512|FG000|COMPLETED|Overall Study||6||
48390099|NCT00980785|101283513|FG001|COMPLETED|Overall Study||8||
48390100|NCT00980785|101283512|FG000|NOT COMPLETED|Overall Study||0||
48390101|NCT00980785|101283513|FG001|NOT COMPLETED|Overall Study||0||
48390102|NCT02475850|101283514|FG000|STARTED|Overall Study||2802||
48390103|NCT02475850|101283515|FG001|STARTED|Overall Study||2649||
48390104|NCT02475850|101283514|FG000|COMPLETED|Overall Study||2209||
48390105|NCT02475850|101283515|FG001|COMPLETED|Overall Study||2165||
48390106|NCT02475850|101283514|FG000|NOT COMPLETED|Overall Study||593||
48543055|NCT04604795|101666894|FG000|COMPLETED|Part A: Washout Period 3 (Up to Day 20)||3||
48543056|NCT04604795|101666895|FG001|COMPLETED|Part A: Washout Period 3 (Up to Day 20)||3||
48543057|NCT04604795|101666896|FG002|COMPLETED|Part A: Washout Period 3 (Up to Day 20)||3||
48543058|NCT04604795|101666897|FG003|COMPLETED|Part A: Washout Period 3 (Up to Day 20)||3||
48543059|NCT04604795|101666898|FG004|COMPLETED|Part A: Washout Period 3 (Up to Day 20)||0||
48543060|NCT04604795|101666899|FG005|COMPLETED|Part A: Washout Period 3 (Up to Day 20)||0||
48543061|NCT04604795|101666900|FG006|COMPLETED|Part A: Washout Period 3 (Up to Day 20)||0||
48543062|NCT04604795|101666901|FG007|COMPLETED|Part A: Washout Period 3 (Up to Day 20)||0||
48543063|NCT04604795|101666902|FG008|COMPLETED|Part A: Washout Period 3 (Up to Day 20)||0||
48543064|NCT04604795|101666903|FG009|COMPLETED|Part A: Washout Period 3 (Up to Day 20)||0||
48543065|NCT04604795|101666894|FG000|NOT COMPLETED|Part A: Washout Period 3 (Up to Day 20)||0||
48543066|NCT04604795|101666895|FG001|NOT COMPLETED|Part A: Washout Period 3 (Up to Day 20)||0||
48543067|NCT04604795|101666896|FG002|NOT COMPLETED|Part A: Washout Period 3 (Up to Day 20)||0||
48543068|NCT04604795|101666897|FG003|NOT COMPLETED|Part A: Washout Period 3 (Up to Day 20)||0||
48097463|NCT00333866|100563702|FG003|NOT COMPLETED|Overall Study||66||
48097464|NCT03020407|100563703|FG000|STARTED|Overall Study||105||
48097465|NCT03020407|100563704|FG001|STARTED|Overall Study||106||
48097466|NCT03020407|100563703|FG000|COMPLETED|Overall Study||101||
48261007|NCT02977286|100959081|FG001|STARTED|Overall Study||6||
48261008|NCT02977286|100959080|FG000|COMPLETED|Overall Study||6||
48261009|NCT02977286|100959081|FG001|COMPLETED|Overall Study||6||
48261010|NCT02977286|100959080|FG000|NOT COMPLETED|Overall Study||0||
48261011|NCT02977286|100959081|FG001|NOT COMPLETED|Overall Study||0||
48543069|NCT04604795|101666898|FG004|NOT COMPLETED|Part A: Washout Period 3 (Up to Day 20)||0||
48543070|NCT04604795|101666899|FG005|NOT COMPLETED|Part A: Washout Period 3 (Up to Day 20)||0||
48543071|NCT04604795|101666900|FG006|NOT COMPLETED|Part A: Washout Period 3 (Up to Day 20)||0||
48543072|NCT04604795|101666901|FG007|NOT COMPLETED|Part A: Washout Period 3 (Up to Day 20)||0||
48543073|NCT04604795|101666902|FG008|NOT COMPLETED|Part A: Washout Period 3 (Up to Day 20)||0||
48543074|NCT04604795|101666903|FG009|NOT COMPLETED|Part A: Washout Period 3 (Up to Day 20)||0||
48543075|NCT04604795|101666894|FG000|STARTED|Part A: Period 4 (Day 1)||3||
48543076|NCT04604795|101666895|FG001|STARTED|Part A: Period 4 (Day 1)||3||
48543077|NCT04604795|101666896|FG002|STARTED|Part A: Period 4 (Day 1)||3||
48543078|NCT04604795|101666897|FG003|STARTED|Part A: Period 4 (Day 1)||3||
48543079|NCT04604795|101666898|FG004|STARTED|Part A: Period 4 (Day 1)||0||
48543080|NCT04604795|101666899|FG005|STARTED|Part A: Period 4 (Day 1)||0||
48543081|NCT04604795|101666900|FG006|STARTED|Part A: Period 4 (Day 1)||0||
48543082|NCT04604795|101666901|FG007|STARTED|Part A: Period 4 (Day 1)||0||
48543083|NCT04604795|101666902|FG008|STARTED|Part A: Period 4 (Day 1)||0||
48543084|NCT04604795|101666903|FG009|STARTED|Part A: Period 4 (Day 1)||0||
48543085|NCT04604795|101666894|FG000|COMPLETED|Part A: Period 4 (Day 1)||3||
48543086|NCT04604795|101666895|FG001|COMPLETED|Part A: Period 4 (Day 1)||3||
48543087|NCT04604795|101666896|FG002|COMPLETED|Part A: Period 4 (Day 1)||3||
48543088|NCT04604795|101666897|FG003|COMPLETED|Part A: Period 4 (Day 1)||3||
48543089|NCT04604795|101666898|FG004|COMPLETED|Part A: Period 4 (Day 1)||0||
48543090|NCT04604795|101666899|FG005|COMPLETED|Part A: Period 4 (Day 1)||0||
48543091|NCT04604795|101666900|FG006|COMPLETED|Part A: Period 4 (Day 1)||0||
48543092|NCT04604795|101666901|FG007|COMPLETED|Part A: Period 4 (Day 1)||0||
48543093|NCT04604795|101666902|FG008|COMPLETED|Part A: Period 4 (Day 1)||0||
48543094|NCT04604795|101666903|FG009|COMPLETED|Part A: Period 4 (Day 1)||0||
48543095|NCT04604795|101666894|FG000|NOT COMPLETED|Part A: Period 4 (Day 1)||0||
48543096|NCT04604795|101666895|FG001|NOT COMPLETED|Part A: Period 4 (Day 1)||0||
48543097|NCT04604795|101666896|FG002|NOT COMPLETED|Part A: Period 4 (Day 1)||0||
48543098|NCT04604795|101666897|FG003|NOT COMPLETED|Part A: Period 4 (Day 1)||0||
48543099|NCT04604795|101666898|FG004|NOT COMPLETED|Part A: Period 4 (Day 1)||0||
48543100|NCT04604795|101666899|FG005|NOT COMPLETED|Part A: Period 4 (Day 1)||0||
48543101|NCT04604795|101666900|FG006|NOT COMPLETED|Part A: Period 4 (Day 1)||0||
48543102|NCT04604795|101666901|FG007|NOT COMPLETED|Part A: Period 4 (Day 1)||0||
48543103|NCT04604795|101666902|FG008|NOT COMPLETED|Part A: Period 4 (Day 1)||0||
48543104|NCT04604795|101666903|FG009|NOT COMPLETED|Part A: Period 4 (Day 1)||0||
48543105|NCT04604795|101666894|FG000|STARTED|Part B: Up to Day 14||0||
48543106|NCT04604795|101666895|FG001|STARTED|Part B: Up to Day 14||0||
48543107|NCT04604795|101666896|FG002|STARTED|Part B: Up to Day 14||0||
48543108|NCT04604795|101666897|FG003|STARTED|Part B: Up to Day 14||0||
48543109|NCT04604795|101666898|FG004|STARTED|Part B: Up to Day 14||10||
48261012|NCT02161406|100959082|FG000|STARTED|Overall Study||44||
48261013|NCT02161406|100959083|FG001|STARTED|Overall Study||44||
48261014|NCT02161406|100959082|FG000|COMPLETED|Overall Study||34||
48261015|NCT02161406|100959083|FG001|COMPLETED|Overall Study||35||
48261016|NCT02161406|100959082|FG000|NOT COMPLETED|Overall Study||10||
48261017|NCT02161406|100959083|FG001|NOT COMPLETED|Overall Study||9||
48261018|NCT00684203|100959084|FG000|STARTED|Overall Study||40||
48261019|NCT00684203|100959085|FG001|STARTED|Overall Study||31||
48261020|NCT00684203|100959086|FG002|STARTED|Overall Study||21||
48261021|NCT00684203|100959087|FG003|STARTED|Overall Study||6||
48261022|NCT00684203|100959088|FG004|STARTED|Overall Study||17||
48261023|NCT00684203|100959089|FG005|STARTED|Overall Study||2||
48261024|NCT00684203|100959084|FG000|COMPLETED|Overall Study||31||
48261025|NCT00684203|100959085|FG001|COMPLETED|Overall Study||23||
48261026|NCT00684203|100959086|FG002|COMPLETED|Overall Study||12||
48261027|NCT00684203|100959087|FG003|COMPLETED|Overall Study||6||
48390107|NCT02475850|101283515|FG001|NOT COMPLETED|Overall Study||484||
48390108|NCT02322411|101283516|FG000|STARTED|Overall Study||14||
48390109|NCT02322411|101283517|FG001|STARTED|Overall Study||16||
48390110|NCT02322411|101283516|FG000|Randomized|Overall Study||14||
48543110|NCT04604795|101666899|FG005|STARTED|Part B: Up to Day 14||10||
48543111|NCT04604795|101666900|FG006|STARTED|Part B: Up to Day 14||9||
48543112|NCT04604795|101666901|FG007|STARTED|Part B: Up to Day 14||9||
48261028|NCT00684203|100959088|FG004|COMPLETED|Overall Study||17||
48261029|NCT00684203|100959089|FG005|COMPLETED|Overall Study||2||
48261030|NCT00684203|100959084|FG000|NOT COMPLETED|Overall Study||9||
48261031|NCT00684203|100959085|FG001|NOT COMPLETED|Overall Study||8||
48261032|NCT00684203|100959086|FG002|NOT COMPLETED|Overall Study||9||
48261033|NCT00684203|100959087|FG003|NOT COMPLETED|Overall Study||0||
48261034|NCT00684203|100959088|FG004|NOT COMPLETED|Overall Study||0||
48261035|NCT00684203|100959089|FG005|NOT COMPLETED|Overall Study||0||
48294147|NCT02527343|101047539|FG003|COMPLETED|OLE Period-Year 1: Week 53 to 104||0||
48294148|NCT02527343|101047540|FG004|COMPLETED|OLE Period-Year 1: Week 53 to 104||1||
48261036|NCT04561778|100959090|FG000|STARTED|Overall Study||50|"originally 50 patients were randomized to each group, however according to the protocol, participants in the BiV Pacing arm may have crossed over to the HOT-CRT arm because BiV Pacing could not be achieved.~* 50 patients randomized to BiV - 43 received BiV treatment~* 50 patients randomized to HOTCRT - 57 received HOTCRT treatment~* There were 11 cross overs in total, 9 from BiV to HOTCRT and 2 from HOTCRT to BiV"|
48261037|NCT04561778|100959091|FG001|STARTED|Overall Study||50|"originally 50 patients were randomized to each group, however according to the protocol, participants in the BiV Pacing arm may have crossed over to the HOT-CRT arm because BiV Pacing could not be achieved.~* 50 patients randomized to BiV - 43 received BiV treatment~* 50 patients randomized to HOTCRT - 57 received HOTCRT treatment~* There were 11 cross overs in total, 9 from BiV to HOTCRT and 2 from HOTCRT to BiV"|
48261038|NCT04561778|100959090|FG000|Cross Over to HOTCRT|Overall Study||9||
48261039|NCT04561778|100959091|FG001|Cross Over to HOTCRT|Overall Study||0||
48261040|NCT04561778|100959090|FG000|Cross Over to BiV|Overall Study||0||
48261041|NCT04561778|100959091|FG001|Cross Over to BiV|Overall Study||2||
48261042|NCT04561778|100959090|FG000|COMPLETED|Overall Study||50||
48261043|NCT04561778|100959091|FG001|COMPLETED|Overall Study||50||
48261044|NCT04561778|100959090|FG000|NOT COMPLETED|Overall Study||0||
48261045|NCT04561778|100959091|FG001|NOT COMPLETED|Overall Study||0||
48261046|NCT04147195|100959092|FG000|STARTED|Overall Study||20||
48261047|NCT04147195|100959093|FG001|STARTED|Overall Study||21||
48261048|NCT04147195|100959092|FG000|PD Analysis Set|Overall Study||20|Participants with available PD data and no major protocol deviations with impact on PD data.|
48261049|NCT04147195|100959093|FG001|PD Analysis Set|Overall Study||17|Participants with available PD data and no major protocol deviations with impact on PD data.|
48261050|NCT04147195|100959092|FG000|COMPLETED|Overall Study||16||
48261051|NCT04147195|100959093|FG001|COMPLETED|Overall Study||15||
48261052|NCT04147195|100959092|FG000|NOT COMPLETED|Overall Study||4||
48261053|NCT04147195|100959093|FG001|NOT COMPLETED|Overall Study||6||
48261054|NCT04016805|100959094|FG000|STARTED|Overall Study||30||
48261055|NCT04016805|100959095|FG001|STARTED|Overall Study||6||
48261056|NCT04016805|100959096|FG002|STARTED|Overall Study||5||
48261057|NCT04016805|100959094|FG000|COMPLETED|Overall Study||0||
48261058|NCT04016805|100959095|FG001|COMPLETED|Overall Study||0||
48261059|NCT04016805|100959096|FG002|COMPLETED|Overall Study||0||
48261060|NCT04016805|100959094|FG000|NOT COMPLETED|Overall Study||30||
48261061|NCT04016805|100959095|FG001|NOT COMPLETED|Overall Study||6||
48261062|NCT04016805|100959096|FG002|NOT COMPLETED|Overall Study||5||
48261063|NCT02271230|100959097|FG000|STARTED|Overall Study||6463||
48261064|NCT02271230|100959098|FG001|STARTED|Overall Study||6464||
48261065|NCT02271230|100959099|FG002|STARTED|Overall Study||6470||
48261066|NCT02271230|100959100|FG003|STARTED|Overall Study||6474||
48261067|NCT02271230|100959097|FG000|COMPLETED|Overall Study||6463||
48543113|NCT04604795|101666902|FG008|STARTED|Part B: Up to Day 14||0||
48543114|NCT04604795|101666903|FG009|STARTED|Part B: Up to Day 14||0||
48261068|NCT02271230|100959098|FG001|COMPLETED|Overall Study||6464||
48261069|NCT02271230|100959099|FG002|COMPLETED|Overall Study||6470||
48261070|NCT02271230|100959100|FG003|COMPLETED|Overall Study||6474||
48261071|NCT02271230|100959097|FG000|NOT COMPLETED|Overall Study||0||
48261072|NCT02271230|100959098|FG001|NOT COMPLETED|Overall Study||0||
48261073|NCT02271230|100959099|FG002|NOT COMPLETED|Overall Study||0||
48261074|NCT02271230|100959100|FG003|NOT COMPLETED|Overall Study||0||
48261075|NCT03128671|100959101|FG000|STARTED|Enrollment||89||
48261076|NCT03128671|100959102|FG001|STARTED|Enrollment||89||
48261077|NCT03128671|100959101|FG000|COMPLETED|Enrollment||89||
48261078|NCT03128671|100959102|FG001|COMPLETED|Enrollment||89||
48261079|NCT03128671|100959101|FG000|NOT COMPLETED|Enrollment||0||
48261080|NCT03128671|100959102|FG001|NOT COMPLETED|Enrollment||0||
48261081|NCT03128671|100959101|FG000|STARTED|Allocation||89||
48261082|NCT03128671|100959102|FG001|STARTED|Allocation||89||
48261083|NCT03128671|100959101|FG000|COMPLETED|Allocation||80||
48261084|NCT03128671|100959102|FG001|COMPLETED|Allocation||89||
48261085|NCT03128671|100959101|FG000|NOT COMPLETED|Allocation||9||
48261086|NCT03128671|100959102|FG001|NOT COMPLETED|Allocation||0||
48261087|NCT03128671|100959101|FG000|STARTED|Intervention||80||
48261088|NCT03128671|100959102|FG001|STARTED|Intervention||89||
48261089|NCT03128671|100959101|FG000|COMPLETED|Intervention||44||
48261090|NCT03128671|100959102|FG001|COMPLETED|Intervention||55||
48261091|NCT03128671|100959101|FG000|NOT COMPLETED|Intervention||36||
48261092|NCT03128671|100959102|FG001|NOT COMPLETED|Intervention||34||
48261093|NCT03616964|100959103|FG000|STARTED|Overall Study||257||
48261094|NCT03616964|100959104|FG001|STARTED|Overall Study||262||
48261095|NCT03616964|100959105|FG002|STARTED|Overall Study||259||
48261096|NCT03616964|100959103|FG000|Received at Least One Dose of Study Drug|Overall Study||256||
48261097|NCT03616964|100959104|FG001|Received at Least One Dose of Study Drug|Overall Study||261||
48261098|NCT03616964|100959105|FG002|Received at Least One Dose of Study Drug|Overall Study||258||
48261099|NCT03616964|100959103|FG000|Safety Population|Overall Study||256|All randomized participants who received at least one dose of study drug and who did not discontinue from the study for the reason 'Lost to Follow-up' at the first postbaseline visit.|
48261100|NCT03616964|100959104|FG001|Safety Population|Overall Study||261|All randomized participants who received at least one dose of study drug and who did not discontinue from the study for the reason 'Lost to Follow-up' at the first postbaseline visit.|
48294149|NCT02527343|101047541|FG005|COMPLETED|OLE Period-Year 1: Week 53 to 104||3||
48543115|NCT04604795|101666894|FG000|COMPLETED|Part B: Up to Day 14||0||
48690190|NCT03559517|102025778|FG000|COMPLETED|Overall Study||7||
48261101|NCT03616964|100959105|FG002|Safety Population|Overall Study||258|All randomized participants who received at least one dose of study drug and who did not discontinue from the study for the reason 'Lost to Follow-up' at the first postbaseline visit.|
48261102|NCT03616964|100959103|FG000|Pharmacokinetic (PK) Population|Overall Study||0|Participants with estimated glomerular filtration rate less than (\<) 60 milliliter/minute (mL/min)/1.73 square meter (m2) at screening randomized to the 4 mg dose received a dose of 2 mg QD.|
48261103|NCT03616964|100959104|FG001|Pharmacokinetic (PK) Population|Overall Study||277|Participants with estimated glomerular filtration rate less than (\<) 60 milliliter/minute (mL/min)/1.73 square meter (m2) at screening randomized to the 4 mg dose received a dose of 2 mg QD.|
48261104|NCT03616964|100959105|FG002|Pharmacokinetic (PK) Population|Overall Study||241|Participants with estimated glomerular filtration rate less than (\<) 60 milliliter/minute (mL/min)/1.73 square meter (m2) at screening randomized to the 4 mg dose received a dose of 2 mg QD.|
48261105|NCT03616964|100959103|FG000|COMPLETED|Overall Study||212||
48261106|NCT03616964|100959104|FG001|COMPLETED|Overall Study||222||
48261107|NCT03616964|100959105|FG002|COMPLETED|Overall Study||205||
48261108|NCT03616964|100959103|FG000|NOT COMPLETED|Overall Study||45||
48261109|NCT03616964|100959104|FG001|NOT COMPLETED|Overall Study||40||
48261110|NCT03616964|100959105|FG002|NOT COMPLETED|Overall Study||54||
48261111|NCT03831854|100959106|FG000|STARTED|Overall Study||23||
48261112|NCT03831854|100959107|FG001|STARTED|Overall Study||23||
48261113|NCT03831854|100959106|FG000|COMPLETED|Overall Study||23||
48261114|NCT03831854|100959107|FG001|COMPLETED|Overall Study||23||
48261115|NCT03831854|100959106|FG000|NOT COMPLETED|Overall Study||0||
48261116|NCT03831854|100959107|FG001|NOT COMPLETED|Overall Study||0||
48261117|NCT00988533|100959108|FG000|STARTED|Overall Study||30||
48261118|NCT00988533|100959108|FG000|COMPLETED|Overall Study||27||
48261119|NCT00988533|100959108|FG000|NOT COMPLETED|Overall Study||3||
48261120|NCT03713320|100959109|FG000|STARTED|Randomized Period||19||
48261121|NCT03713320|100959110|FG001|STARTED|Randomized Period||18||
48261122|NCT03713320|100959111|FG002|STARTED|Randomized Period||0||
48261123|NCT03713320|100959109|FG000|COMPLETED|Randomized Period||4||
48261124|NCT03713320|100959110|FG001|COMPLETED|Randomized Period||8||
48261125|NCT03713320|100959111|FG002|COMPLETED|Randomized Period||0||
48690191|NCT03559517|102025779|FG001|COMPLETED|Overall Study||9||
48690192|NCT03559517|102025780|FG002|COMPLETED|Overall Study||12||
48690193|NCT03559517|102025778|FG000|NOT COMPLETED|Overall Study||1||
48690194|NCT03559517|102025779|FG001|NOT COMPLETED|Overall Study||0||
48690195|NCT03559517|102025780|FG002|NOT COMPLETED|Overall Study||0||
48690196|NCT02956746|102025781|FG000|STARTED|Overall Study||40||
48690197|NCT02956746|102025782|FG001|STARTED|Overall Study||40||
48690198|NCT02956746|102025783|FG002|STARTED|Overall Study||42||
48261126|NCT03713320|100959109|FG000|NOT COMPLETED|Randomized Period||15||
48261127|NCT03713320|100959110|FG001|NOT COMPLETED|Randomized Period||10||
48261128|NCT03713320|100959111|FG002|NOT COMPLETED|Randomized Period||0||
48543116|NCT04604795|101666895|FG001|COMPLETED|Part B: Up to Day 14||0||
48543117|NCT04604795|101666896|FG002|COMPLETED|Part B: Up to Day 14||0||
48261129|NCT03713320|100959109|FG000|STARTED|Cobomarsen Crossover Period||0||
48261130|NCT03713320|100959110|FG001|STARTED|Cobomarsen Crossover Period||0||
48261131|NCT03713320|100959111|FG002|STARTED|Cobomarsen Crossover Period||7||
48261132|NCT03713320|100959109|FG000|COMPLETED|Cobomarsen Crossover Period||0||
48261133|NCT03713320|100959110|FG001|COMPLETED|Cobomarsen Crossover Period||0||
48261134|NCT03713320|100959111|FG002|COMPLETED|Cobomarsen Crossover Period||0||
48261135|NCT03713320|100959109|FG000|NOT COMPLETED|Cobomarsen Crossover Period||0||
48261136|NCT03713320|100959110|FG001|NOT COMPLETED|Cobomarsen Crossover Period||0||
48261137|NCT03713320|100959111|FG002|NOT COMPLETED|Cobomarsen Crossover Period||7||
48261138|NCT02314104|100959112|FG000|STARTED|Overall Study||71||
48261139|NCT02314104|100959113|FG001|STARTED|Overall Study||78||
48261140|NCT02314104|100959114|FG002|STARTED|Overall Study||71||
48261141|NCT02314104|100959112|FG000|COMPLETED|Overall Study||57||
48261142|NCT02314104|100959113|FG001|COMPLETED|Overall Study||58||
48261143|NCT02314104|100959114|FG002|COMPLETED|Overall Study||53||
48261144|NCT02314104|100959112|FG000|NOT COMPLETED|Overall Study||14||
48261145|NCT02314104|100959113|FG001|NOT COMPLETED|Overall Study||20||
48261146|NCT02314104|100959114|FG002|NOT COMPLETED|Overall Study||18||
48261147|NCT01774305|100959115|FG000|STARTED|Overall Study||71||
48261148|NCT01774305|100959116|FG001|STARTED|Overall Study||71||
48261149|NCT01774305|100959115|FG000|COMPLETED|Overall Study||70||
48261150|NCT01774305|100959116|FG001|COMPLETED|Overall Study||71||
48261151|NCT01774305|100959115|FG000|NOT COMPLETED|Overall Study||1||
48543118|NCT04604795|101666897|FG003|COMPLETED|Part B: Up to Day 14||0||
48543119|NCT04604795|101666898|FG004|COMPLETED|Part B: Up to Day 14||8||
48543120|NCT04604795|101666899|FG005|COMPLETED|Part B: Up to Day 14||9||
48543121|NCT04604795|101666900|FG006|COMPLETED|Part B: Up to Day 14||9||
48543122|NCT04604795|101666901|FG007|COMPLETED|Part B: Up to Day 14||9||
48543123|NCT04604795|101666902|FG008|COMPLETED|Part B: Up to Day 14||0||
48690199|NCT02956746|102025784|FG003|STARTED|Overall Study||42||
48543124|NCT04604795|101666903|FG009|COMPLETED|Part B: Up to Day 14||0||
48543125|NCT04604795|101666894|FG000|NOT COMPLETED|Part B: Up to Day 14||0||
48543126|NCT04604795|101666895|FG001|NOT COMPLETED|Part B: Up to Day 14||0||
48690200|NCT02956746|102025781|FG000|COMPLETED|Overall Study||38||
48690201|NCT02956746|102025782|FG001|COMPLETED|Overall Study||37||
48690202|NCT02956746|102025783|FG002|COMPLETED|Overall Study||36||
48543127|NCT04604795|101666896|FG002|NOT COMPLETED|Part B: Up to Day 14||0||
48543128|NCT04604795|101666897|FG003|NOT COMPLETED|Part B: Up to Day 14||0||
48543129|NCT04604795|101666898|FG004|NOT COMPLETED|Part B: Up to Day 14||2||
48543130|NCT04604795|101666899|FG005|NOT COMPLETED|Part B: Up to Day 14||1||
48543131|NCT04604795|101666900|FG006|NOT COMPLETED|Part B: Up to Day 14||0||
48543132|NCT04604795|101666901|FG007|NOT COMPLETED|Part B: Up to Day 14||0||
48690203|NCT02956746|102025784|FG003|COMPLETED|Overall Study||38||
48261152|NCT01774305|100959116|FG001|NOT COMPLETED|Overall Study||0||
48261153|NCT02895360|100959117|FG000|STARTED|Phase 1 - 30 mg/m² Cohort||4||
48261154|NCT02895360|100959118|FG001|STARTED|Phase 1 - 30 mg/m² Cohort||0||
48261155|NCT02895360|100959119|FG002|STARTED|Phase 1 - 30 mg/m² Cohort||0||
48261156|NCT02895360|100959120|FG003|STARTED|Phase 1 - 30 mg/m² Cohort||0||
48261157|NCT02895360|100959121|FG004|STARTED|Phase 1 - 30 mg/m² Cohort||0||
48261158|NCT02895360|100959122|FG005|STARTED|Phase 1 - 30 mg/m² Cohort||0||
48261159|NCT02895360|100959117|FG000|COMPLETED|Phase 1 - 30 mg/m² Cohort||0||
48261160|NCT02895360|100959118|FG001|COMPLETED|Phase 1 - 30 mg/m² Cohort||0||
48261161|NCT02895360|100959119|FG002|COMPLETED|Phase 1 - 30 mg/m² Cohort||0||
48261162|NCT02895360|100959120|FG003|COMPLETED|Phase 1 - 30 mg/m² Cohort||0||
48261163|NCT02895360|100959121|FG004|COMPLETED|Phase 1 - 30 mg/m² Cohort||0||
48261164|NCT02895360|100959122|FG005|COMPLETED|Phase 1 - 30 mg/m² Cohort||0||
48261165|NCT02895360|100959117|FG000|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||4||
48261166|NCT02895360|100959118|FG001|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0||
48261167|NCT02895360|100959119|FG002|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0||
48261168|NCT02895360|100959120|FG003|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0||
48261169|NCT02895360|100959121|FG004|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0||
48261170|NCT02895360|100959122|FG005|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0||
48261171|NCT02895360|100959117|FG000|STARTED|Phase 1 - 45 mg/m² Cohort||0||
48261172|NCT02895360|100959118|FG001|STARTED|Phase 1 - 45 mg/m² Cohort||3||
48261173|NCT02895360|100959119|FG002|STARTED|Phase 1 - 45 mg/m² Cohort||0||
48261174|NCT02895360|100959120|FG003|STARTED|Phase 1 - 45 mg/m² Cohort||0||
48261175|NCT02895360|100959121|FG004|STARTED|Phase 1 - 45 mg/m² Cohort||0||
48261176|NCT02895360|100959122|FG005|STARTED|Phase 1 - 45 mg/m² Cohort||0||
48261177|NCT02895360|100959117|FG000|COMPLETED|Phase 1 - 45 mg/m² Cohort||0||
48261178|NCT02895360|100959118|FG001|COMPLETED|Phase 1 - 45 mg/m² Cohort||0||
48261179|NCT02895360|100959119|FG002|COMPLETED|Phase 1 - 45 mg/m² Cohort||0||
48261180|NCT02895360|100959120|FG003|COMPLETED|Phase 1 - 45 mg/m² Cohort||0||
48261181|NCT02895360|100959121|FG004|COMPLETED|Phase 1 - 45 mg/m² Cohort||0||
48261182|NCT02895360|100959122|FG005|COMPLETED|Phase 1 - 45 mg/m² Cohort||0||
48261183|NCT02895360|100959117|FG000|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0||
48261184|NCT02895360|100959118|FG001|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||3||
48261185|NCT02895360|100959119|FG002|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0||
48261186|NCT02895360|100959120|FG003|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0||
48261187|NCT02895360|100959121|FG004|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0||
48261188|NCT02895360|100959122|FG005|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0||
48261189|NCT02895360|100959117|FG000|STARTED|Phase 1 - 70 mg/m² Cohort||0||
48261190|NCT02895360|100959118|FG001|STARTED|Phase 1 - 70 mg/m² Cohort||0||
48261191|NCT02895360|100959119|FG002|STARTED|Phase 1 - 70 mg/m² Cohort||9||
48261192|NCT02895360|100959120|FG003|STARTED|Phase 1 - 70 mg/m² Cohort||0||
48261193|NCT02895360|100959121|FG004|STARTED|Phase 1 - 70 mg/m² Cohort||0||
48261194|NCT02895360|100959122|FG005|STARTED|Phase 1 - 70 mg/m² Cohort||0||
48261195|NCT02895360|100959117|FG000|COMPLETED|Phase 1 - 70 mg/m² Cohort||0||
48261196|NCT02895360|100959118|FG001|COMPLETED|Phase 1 - 70 mg/m² Cohort||0||
48261197|NCT02895360|100959119|FG002|COMPLETED|Phase 1 - 70 mg/m² Cohort||0||
48261198|NCT02895360|100959120|FG003|COMPLETED|Phase 1 - 70 mg/m² Cohort||0||
48261199|NCT02895360|100959121|FG004|COMPLETED|Phase 1 - 70 mg/m² Cohort||0||
48261200|NCT02895360|100959122|FG005|COMPLETED|Phase 1 - 70 mg/m² Cohort||0||
48261201|NCT02895360|100959117|FG000|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0||
48261202|NCT02895360|100959118|FG001|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0||
48543133|NCT04604795|101666902|FG008|NOT COMPLETED|Part B: Up to Day 14||0||
48543134|NCT04604795|101666903|FG009|NOT COMPLETED|Part B: Up to Day 14||0||
48543135|NCT04604795|101666894|FG000|STARTED|Part C: Period 1 (Day 1)||0||
48543136|NCT04604795|101666895|FG001|STARTED|Part C: Period 1 (Day 1)||0||
48543137|NCT04604795|101666896|FG002|STARTED|Part C: Period 1 (Day 1)||0||
48543138|NCT04604795|101666897|FG003|STARTED|Part C: Period 1 (Day 1)||0||
48543139|NCT04604795|101666898|FG004|STARTED|Part C: Period 1 (Day 1)||0||
48543140|NCT04604795|101666899|FG005|STARTED|Part C: Period 1 (Day 1)||0||
48543141|NCT04604795|101666900|FG006|STARTED|Part C: Period 1 (Day 1)||0||
48543142|NCT04604795|101666901|FG007|STARTED|Part C: Period 1 (Day 1)||0||
48543143|NCT04604795|101666902|FG008|STARTED|Part C: Period 1 (Day 1)||6||
48261203|NCT02895360|100959119|FG002|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||9||
48390111|NCT02322411|101283517|FG001|Randomized|Overall Study||16||
48543144|NCT04604795|101666903|FG009|STARTED|Part C: Period 1 (Day 1)||6||
48543145|NCT04604795|101666894|FG000|COMPLETED|Part C: Period 1 (Day 1)||0||
48690204|NCT02956746|102025781|FG000|NOT COMPLETED|Overall Study||2||
48261204|NCT02895360|100959120|FG003|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0||
48261205|NCT02895360|100959121|FG004|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0||
48543146|NCT04604795|101666895|FG001|COMPLETED|Part C: Period 1 (Day 1)||0||
48543147|NCT04604795|101666896|FG002|COMPLETED|Part C: Period 1 (Day 1)||0||
48543148|NCT04604795|101666897|FG003|COMPLETED|Part C: Period 1 (Day 1)||0||
48543149|NCT04604795|101666898|FG004|COMPLETED|Part C: Period 1 (Day 1)||0||
48543150|NCT04604795|101666899|FG005|COMPLETED|Part C: Period 1 (Day 1)||0||
48543151|NCT04604795|101666900|FG006|COMPLETED|Part C: Period 1 (Day 1)||0||
48261206|NCT02895360|100959122|FG005|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0||
48261207|NCT02895360|100959117|FG000|STARTED|Phase 1 - 90 mg/m² Cohort||0||
48261208|NCT02895360|100959118|FG001|STARTED|Phase 1 - 90 mg/m² Cohort||0||
48261209|NCT02895360|100959119|FG002|STARTED|Phase 1 - 90 mg/m² Cohort||0||
48261210|NCT02895360|100959120|FG003|STARTED|Phase 1 - 90 mg/m² Cohort||4||
48261211|NCT02895360|100959121|FG004|STARTED|Phase 1 - 90 mg/m² Cohort||0||
48261212|NCT02895360|100959122|FG005|STARTED|Phase 1 - 90 mg/m² Cohort||0||
48261213|NCT02895360|100959117|FG000|COMPLETED|Phase 1 - 90 mg/m² Cohort||0||
48261214|NCT02895360|100959118|FG001|COMPLETED|Phase 1 - 90 mg/m² Cohort||0||
48261215|NCT02895360|100959119|FG002|COMPLETED|Phase 1 - 90 mg/m² Cohort||0||
48261216|NCT02895360|100959120|FG003|COMPLETED|Phase 1 - 90 mg/m² Cohort||0||
48261217|NCT02895360|100959121|FG004|COMPLETED|Phase 1 - 90 mg/m² Cohort||0||
48543152|NCT04604795|101666901|FG007|COMPLETED|Part C: Period 1 (Day 1)||0||
48543153|NCT04604795|101666902|FG008|COMPLETED|Part C: Period 1 (Day 1)||6||
48543154|NCT04604795|101666903|FG009|COMPLETED|Part C: Period 1 (Day 1)||6||
48261218|NCT02895360|100959122|FG005|COMPLETED|Phase 1 - 90 mg/m² Cohort||0||
48261219|NCT02895360|100959117|FG000|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0||
48261220|NCT02895360|100959118|FG001|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0||
48261221|NCT02895360|100959119|FG002|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0||
48261222|NCT02895360|100959120|FG003|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||4||
48261223|NCT02895360|100959121|FG004|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0||
48261224|NCT02895360|100959122|FG005|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0||
48261225|NCT02895360|100959117|FG000|STARTED|Phase 2a||0||
48261226|NCT02895360|100959118|FG001|STARTED|Phase 2a||0||
48543155|NCT04604795|101666894|FG000|NOT COMPLETED|Part C: Period 1 (Day 1)||0||
48543156|NCT04604795|101666895|FG001|NOT COMPLETED|Part C: Period 1 (Day 1)||0||
48543157|NCT04604795|101666896|FG002|NOT COMPLETED|Part C: Period 1 (Day 1)||0||
48543158|NCT04604795|101666897|FG003|NOT COMPLETED|Part C: Period 1 (Day 1)||0||
48543159|NCT04604795|101666898|FG004|NOT COMPLETED|Part C: Period 1 (Day 1)||0||
48261227|NCT02895360|100959119|FG002|STARTED|Phase 2a||0||
48261228|NCT02895360|100959120|FG003|STARTED|Phase 2a||0||
48261229|NCT02895360|100959121|FG004|STARTED|Phase 2a||11||
48261230|NCT02895360|100959122|FG005|STARTED|Phase 2a||12||
48261231|NCT02895360|100959117|FG000|COMPLETED|Phase 2a||0||
48261232|NCT02895360|100959118|FG001|COMPLETED|Phase 2a||0||
48261233|NCT02895360|100959119|FG002|COMPLETED|Phase 2a||0||
48261234|NCT02895360|100959120|FG003|COMPLETED|Phase 2a||0||
48261235|NCT02895360|100959121|FG004|COMPLETED|Phase 2a||0||
48261236|NCT02895360|100959122|FG005|COMPLETED|Phase 2a||0||
48261237|NCT02895360|100959117|FG000|NOT COMPLETED|Phase 2a||0||
48261238|NCT02895360|100959118|FG001|NOT COMPLETED|Phase 2a||0||
48261239|NCT02895360|100959119|FG002|NOT COMPLETED|Phase 2a||0||
48261240|NCT02895360|100959120|FG003|NOT COMPLETED|Phase 2a||0||
48261241|NCT02895360|100959121|FG004|NOT COMPLETED|Phase 2a||11||
48261242|NCT02895360|100959122|FG005|NOT COMPLETED|Phase 2a||12||
48261243|NCT02599688|100959123|FG000|STARTED|Overall Study||18||
48543160|NCT04604795|101666899|FG005|NOT COMPLETED|Part C: Period 1 (Day 1)||0||
48543161|NCT04604795|101666900|FG006|NOT COMPLETED|Part C: Period 1 (Day 1)||0||
48543162|NCT04604795|101666901|FG007|NOT COMPLETED|Part C: Period 1 (Day 1)||0||
48543163|NCT04604795|101666902|FG008|NOT COMPLETED|Part C: Period 1 (Day 1)||0||
48543164|NCT04604795|101666903|FG009|NOT COMPLETED|Part C: Period 1 (Day 1)||0||
48543165|NCT04604795|101666894|FG000|STARTED|Part C: Washout Period 1 (Up to Day 6)||0||
48543166|NCT04604795|101666895|FG001|STARTED|Part C: Washout Period 1 (Up to Day 6)||0||
48543167|NCT04604795|101666896|FG002|STARTED|Part C: Washout Period 1 (Up to Day 6)||0||
48543168|NCT04604795|101666897|FG003|STARTED|Part C: Washout Period 1 (Up to Day 6)||0||
48543169|NCT04604795|101666898|FG004|STARTED|Part C: Washout Period 1 (Up to Day 6)||0||
48543170|NCT04604795|101666899|FG005|STARTED|Part C: Washout Period 1 (Up to Day 6)||0||
48543171|NCT04604795|101666900|FG006|STARTED|Part C: Washout Period 1 (Up to Day 6)||0||
48543172|NCT04604795|101666901|FG007|STARTED|Part C: Washout Period 1 (Up to Day 6)||0||
48543173|NCT04604795|101666902|FG008|STARTED|Part C: Washout Period 1 (Up to Day 6)||6||
48543174|NCT04604795|101666903|FG009|STARTED|Part C: Washout Period 1 (Up to Day 6)||6||
48543175|NCT04604795|101666894|FG000|COMPLETED|Part C: Washout Period 1 (Up to Day 6)||0||
48543176|NCT04604795|101666895|FG001|COMPLETED|Part C: Washout Period 1 (Up to Day 6)||0||
48261244|NCT02599688|100959123|FG000|COMPLETED|Overall Study||14||
48261245|NCT02599688|100959123|FG000|NOT COMPLETED|Overall Study||4||
48261246|NCT02720211|100959124|FG000|STARTED|Overall Study||5||
48261247|NCT02720211|100959125|FG001|STARTED|Overall Study||5||
48261248|NCT02720211|100959124|FG000|COMPLETED|Overall Study||5||
48261249|NCT02720211|100959125|FG001|COMPLETED|Overall Study||5||
48261250|NCT02720211|100959124|FG000|NOT COMPLETED|Overall Study||0||
48261251|NCT02720211|100959125|FG001|NOT COMPLETED|Overall Study||0||
48261252|NCT02781311|100959126|FG000|STARTED|Overall Study||74||
48261253|NCT02781311|100959127|FG001|STARTED|Overall Study||83||
48543177|NCT04604795|101666896|FG002|COMPLETED|Part C: Washout Period 1 (Up to Day 6)||0||
48543178|NCT04604795|101666897|FG003|COMPLETED|Part C: Washout Period 1 (Up to Day 6)||0||
48543179|NCT04604795|101666898|FG004|COMPLETED|Part C: Washout Period 1 (Up to Day 6)||0||
48543180|NCT04604795|101666899|FG005|COMPLETED|Part C: Washout Period 1 (Up to Day 6)||0||
48543181|NCT04604795|101666900|FG006|COMPLETED|Part C: Washout Period 1 (Up to Day 6)||0||
48543182|NCT04604795|101666901|FG007|COMPLETED|Part C: Washout Period 1 (Up to Day 6)||0||
48543183|NCT04604795|101666902|FG008|COMPLETED|Part C: Washout Period 1 (Up to Day 6)||6||
48543184|NCT04604795|101666903|FG009|COMPLETED|Part C: Washout Period 1 (Up to Day 6)||5||
48543185|NCT04604795|101666894|FG000|NOT COMPLETED|Part C: Washout Period 1 (Up to Day 6)||0||
48543186|NCT04604795|101666895|FG001|NOT COMPLETED|Part C: Washout Period 1 (Up to Day 6)||0||
48543187|NCT04604795|101666896|FG002|NOT COMPLETED|Part C: Washout Period 1 (Up to Day 6)||0||
48543188|NCT04604795|101666897|FG003|NOT COMPLETED|Part C: Washout Period 1 (Up to Day 6)||0||
48543189|NCT04604795|101666898|FG004|NOT COMPLETED|Part C: Washout Period 1 (Up to Day 6)||0||
48543190|NCT04604795|101666899|FG005|NOT COMPLETED|Part C: Washout Period 1 (Up to Day 6)||0||
48543191|NCT04604795|101666900|FG006|NOT COMPLETED|Part C: Washout Period 1 (Up to Day 6)||0||
48543192|NCT04604795|101666901|FG007|NOT COMPLETED|Part C: Washout Period 1 (Up to Day 6)||0||
48543193|NCT04604795|101666902|FG008|NOT COMPLETED|Part C: Washout Period 1 (Up to Day 6)||0||
48543194|NCT04604795|101666903|FG009|NOT COMPLETED|Part C: Washout Period 1 (Up to Day 6)||1||
48543195|NCT04604795|101666894|FG000|STARTED|Part C: Period 2 (Day 1)||0||
48543196|NCT04604795|101666895|FG001|STARTED|Part C: Period 2 (Day 1)||0||
48543197|NCT04604795|101666896|FG002|STARTED|Part C: Period 2 (Day 1)||0||
48543198|NCT04604795|101666897|FG003|STARTED|Part C: Period 2 (Day 1)||0||
48543199|NCT04604795|101666898|FG004|STARTED|Part C: Period 2 (Day 1)||0||
48543200|NCT04604795|101666899|FG005|STARTED|Part C: Period 2 (Day 1)||0||
48543201|NCT04604795|101666900|FG006|STARTED|Part C: Period 2 (Day 1)||0||
48543202|NCT04604795|101666901|FG007|STARTED|Part C: Period 2 (Day 1)||0||
48543203|NCT04604795|101666902|FG008|STARTED|Part C: Period 2 (Day 1)||6||
48543204|NCT04604795|101666903|FG009|STARTED|Part C: Period 2 (Day 1)||5||
48543205|NCT04604795|101666894|FG000|COMPLETED|Part C: Period 2 (Day 1)||0||
48543206|NCT04604795|101666895|FG001|COMPLETED|Part C: Period 2 (Day 1)||0||
48543207|NCT04604795|101666896|FG002|COMPLETED|Part C: Period 2 (Day 1)||0||
48543208|NCT04604795|101666897|FG003|COMPLETED|Part C: Period 2 (Day 1)||0||
48543209|NCT04604795|101666898|FG004|COMPLETED|Part C: Period 2 (Day 1)||0||
48543210|NCT04604795|101666899|FG005|COMPLETED|Part C: Period 2 (Day 1)||0||
48543211|NCT04604795|101666900|FG006|COMPLETED|Part C: Period 2 (Day 1)||0||
48543212|NCT04604795|101666901|FG007|COMPLETED|Part C: Period 2 (Day 1)||0||
48543213|NCT04604795|101666902|FG008|COMPLETED|Part C: Period 2 (Day 1)||6||
48543214|NCT04604795|101666903|FG009|COMPLETED|Part C: Period 2 (Day 1)||5||
48543215|NCT04604795|101666894|FG000|NOT COMPLETED|Part C: Period 2 (Day 1)||0||
48543216|NCT04604795|101666895|FG001|NOT COMPLETED|Part C: Period 2 (Day 1)||0||
48543217|NCT04604795|101666896|FG002|NOT COMPLETED|Part C: Period 2 (Day 1)||0||
48543218|NCT04604795|101666897|FG003|NOT COMPLETED|Part C: Period 2 (Day 1)||0||
48543219|NCT04604795|101666898|FG004|NOT COMPLETED|Part C: Period 2 (Day 1)||0||
48543220|NCT04604795|101666899|FG005|NOT COMPLETED|Part C: Period 2 (Day 1)||0||
48543221|NCT04604795|101666900|FG006|NOT COMPLETED|Part C: Period 2 (Day 1)||0||
48543222|NCT04604795|101666901|FG007|NOT COMPLETED|Part C: Period 2 (Day 1)||0||
48543223|NCT04604795|101666902|FG008|NOT COMPLETED|Part C: Period 2 (Day 1)||0||
48543224|NCT04604795|101666903|FG009|NOT COMPLETED|Part C: Period 2 (Day 1)||0||
48543225|NCT04604795|101666894|FG000|STARTED|Part C: Washout Period 2 (Up to Day 24)||0||
48543226|NCT04604795|101666895|FG001|STARTED|Part C: Washout Period 2 (Up to Day 24)||0||
48543227|NCT04604795|101666896|FG002|STARTED|Part C: Washout Period 2 (Up to Day 24)||0||
48543228|NCT04604795|101666897|FG003|STARTED|Part C: Washout Period 2 (Up to Day 24)||0||
48543229|NCT04604795|101666898|FG004|STARTED|Part C: Washout Period 2 (Up to Day 24)||0||
48543230|NCT04604795|101666899|FG005|STARTED|Part C: Washout Period 2 (Up to Day 24)||0||
48543231|NCT04604795|101666900|FG006|STARTED|Part C: Washout Period 2 (Up to Day 24)||0||
48543232|NCT04604795|101666901|FG007|STARTED|Part C: Washout Period 2 (Up to Day 24)||0||
48543233|NCT04604795|101666902|FG008|STARTED|Part C: Washout Period 2 (Up to Day 24)||6||
48543234|NCT04604795|101666903|FG009|STARTED|Part C: Washout Period 2 (Up to Day 24)||5||
48543235|NCT04604795|101666894|FG000|COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
48543236|NCT04604795|101666895|FG001|COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
48543237|NCT04604795|101666896|FG002|COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
48543238|NCT04604795|101666897|FG003|COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
48543239|NCT04604795|101666898|FG004|COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
48543240|NCT04604795|101666899|FG005|COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
48543241|NCT04604795|101666900|FG006|COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
48543242|NCT04604795|101666901|FG007|COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
48543243|NCT04604795|101666902|FG008|COMPLETED|Part C: Washout Period 2 (Up to Day 24)||6||
48543244|NCT04604795|101666903|FG009|COMPLETED|Part C: Washout Period 2 (Up to Day 24)||5||
48543245|NCT04604795|101666894|FG000|NOT COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
48543246|NCT04604795|101666895|FG001|NOT COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
48543247|NCT04604795|101666896|FG002|NOT COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
48543248|NCT04604795|101666897|FG003|NOT COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
48543249|NCT04604795|101666898|FG004|NOT COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
48543250|NCT04604795|101666899|FG005|NOT COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
48543251|NCT04604795|101666900|FG006|NOT COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
48543252|NCT04604795|101666901|FG007|NOT COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
48543253|NCT04604795|101666902|FG008|NOT COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
48543254|NCT04604795|101666903|FG009|NOT COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
48543255|NCT04604795|101666894|FG000|STARTED|Part C: Period 3 (Day 1)||0||
48543256|NCT04604795|101666895|FG001|STARTED|Part C: Period 3 (Day 1)||0||
48543257|NCT04604795|101666896|FG002|STARTED|Part C: Period 3 (Day 1)||0||
48543258|NCT04604795|101666897|FG003|STARTED|Part C: Period 3 (Day 1)||0||
48543259|NCT04604795|101666898|FG004|STARTED|Part C: Period 3 (Day 1)||0||
48543260|NCT04604795|101666899|FG005|STARTED|Part C: Period 3 (Day 1)||0||
48543261|NCT04604795|101666900|FG006|STARTED|Part C: Period 3 (Day 1)||0||
48543262|NCT04604795|101666901|FG007|STARTED|Part C: Period 3 (Day 1)||0||
48543263|NCT04604795|101666902|FG008|STARTED|Part C: Period 3 (Day 1)||6||
48543264|NCT04604795|101666903|FG009|STARTED|Part C: Period 3 (Day 1)||6||
48543265|NCT04604795|101666894|FG000|New Participant Enrolled and Dosed|Part C: Period 3 (Day 1)||0||
48543266|NCT04604795|101666895|FG001|New Participant Enrolled and Dosed|Part C: Period 3 (Day 1)||0||
48543267|NCT04604795|101666896|FG002|New Participant Enrolled and Dosed|Part C: Period 3 (Day 1)||0||
48543268|NCT04604795|101666897|FG003|New Participant Enrolled and Dosed|Part C: Period 3 (Day 1)||0||
48543269|NCT04604795|101666898|FG004|New Participant Enrolled and Dosed|Part C: Period 3 (Day 1)||0||
48543270|NCT04604795|101666899|FG005|New Participant Enrolled and Dosed|Part C: Period 3 (Day 1)||0||
48097467|NCT03020407|100563704|FG001|COMPLETED|Overall Study||101||
48097468|NCT03020407|100563703|FG000|NOT COMPLETED|Overall Study||4||
48097469|NCT03020407|100563704|FG001|NOT COMPLETED|Overall Study||5||
48543271|NCT04604795|101666900|FG006|New Participant Enrolled and Dosed|Part C: Period 3 (Day 1)||0||
48543272|NCT04604795|101666901|FG007|New Participant Enrolled and Dosed|Part C: Period 3 (Day 1)||0||
48543273|NCT04604795|101666902|FG008|New Participant Enrolled and Dosed|Part C: Period 3 (Day 1)||0||
48543274|NCT04604795|101666903|FG009|New Participant Enrolled and Dosed|Part C: Period 3 (Day 1)||1||
48543275|NCT04604795|101666894|FG000|COMPLETED|Part C: Period 3 (Day 1)||0||
48543276|NCT04604795|101666895|FG001|COMPLETED|Part C: Period 3 (Day 1)||0||
48543277|NCT04604795|101666896|FG002|COMPLETED|Part C: Period 3 (Day 1)||0||
48543278|NCT04604795|101666897|FG003|COMPLETED|Part C: Period 3 (Day 1)||0||
48543279|NCT04604795|101666898|FG004|COMPLETED|Part C: Period 3 (Day 1)||0||
48543280|NCT04604795|101666899|FG005|COMPLETED|Part C: Period 3 (Day 1)||0||
48543281|NCT04604795|101666900|FG006|COMPLETED|Part C: Period 3 (Day 1)||0||
48543282|NCT04604795|101666901|FG007|COMPLETED|Part C: Period 3 (Day 1)||0||
48543283|NCT04604795|101666902|FG008|COMPLETED|Part C: Period 3 (Day 1)||6||
48543284|NCT04604795|101666903|FG009|COMPLETED|Part C: Period 3 (Day 1)||6||
48543285|NCT04604795|101666894|FG000|NOT COMPLETED|Part C: Period 3 (Day 1)||0||
48543286|NCT04604795|101666895|FG001|NOT COMPLETED|Part C: Period 3 (Day 1)||0||
48543287|NCT04604795|101666896|FG002|NOT COMPLETED|Part C: Period 3 (Day 1)||0||
48543288|NCT04604795|101666897|FG003|NOT COMPLETED|Part C: Period 3 (Day 1)||0||
48543289|NCT04604795|101666898|FG004|NOT COMPLETED|Part C: Period 3 (Day 1)||0||
48543290|NCT04604795|101666899|FG005|NOT COMPLETED|Part C: Period 3 (Day 1)||0||
48543291|NCT04604795|101666900|FG006|NOT COMPLETED|Part C: Period 3 (Day 1)||0||
48543292|NCT04604795|101666901|FG007|NOT COMPLETED|Part C: Period 3 (Day 1)||0||
48543293|NCT04604795|101666902|FG008|NOT COMPLETED|Part C: Period 3 (Day 1)||0||
48543294|NCT04604795|101666903|FG009|NOT COMPLETED|Part C: Period 3 (Day 1)||0||
48543295|NCT04604795|101666894|FG000|STARTED|Part C: Washout Period 3 (Up to Day10)||0||
48543296|NCT04604795|101666895|FG001|STARTED|Part C: Washout Period 3 (Up to Day10)||0||
48543297|NCT04604795|101666896|FG002|STARTED|Part C: Washout Period 3 (Up to Day10)||0||
48543298|NCT04604795|101666897|FG003|STARTED|Part C: Washout Period 3 (Up to Day10)||0||
48543299|NCT04604795|101666898|FG004|STARTED|Part C: Washout Period 3 (Up to Day10)||0||
48543300|NCT04604795|101666899|FG005|STARTED|Part C: Washout Period 3 (Up to Day10)||0||
48543301|NCT04604795|101666900|FG006|STARTED|Part C: Washout Period 3 (Up to Day10)||0||
48543302|NCT04604795|101666901|FG007|STARTED|Part C: Washout Period 3 (Up to Day10)||0||
48097470|NCT03019939|100563705|FG000|STARTED|Overall Study||65||
48097471|NCT03019939|100563705|FG000|COMPLETED|Overall Study||65||
48097472|NCT03019939|100563705|FG000|NOT COMPLETED|Overall Study||0||
48097473|NCT00772707|100563706|FG000|STARTED|Overall Study||114||
48097474|NCT00772707|100563706|FG000|COMPLETED|Overall Study||111||
48543303|NCT04604795|101666902|FG008|STARTED|Part C: Washout Period 3 (Up to Day10)||6||
48543304|NCT04604795|101666903|FG009|STARTED|Part C: Washout Period 3 (Up to Day10)||6||
48543305|NCT04604795|101666894|FG000|COMPLETED|Part C: Washout Period 3 (Up to Day10)||0||
48543306|NCT04604795|101666895|FG001|COMPLETED|Part C: Washout Period 3 (Up to Day10)||0||
48543307|NCT04604795|101666896|FG002|COMPLETED|Part C: Washout Period 3 (Up to Day10)||0||
48543308|NCT04604795|101666897|FG003|COMPLETED|Part C: Washout Period 3 (Up to Day10)||0||
48543309|NCT04604795|101666898|FG004|COMPLETED|Part C: Washout Period 3 (Up to Day10)||0||
48543310|NCT04604795|101666899|FG005|COMPLETED|Part C: Washout Period 3 (Up to Day10)||0||
48543311|NCT04604795|101666900|FG006|COMPLETED|Part C: Washout Period 3 (Up to Day10)||0||
48097475|NCT00772707|100563706|FG000|NOT COMPLETED|Overall Study||3||
48097476|NCT01144442|100563707|FG000|STARTED|Overall Study||10||
48097477|NCT01144442|100563707|FG000|COMPLETED|Overall Study||10||
48097478|NCT01144442|100563707|FG000|NOT COMPLETED|Overall Study||0||
48097479|NCT02068443|100563708|FG000|STARTED|Overall Study||71||
48097480|NCT02068443|100563709|FG001|STARTED|Overall Study||152||
48261254|NCT02781311|100959128|FG002|STARTED|Overall Study||12||
48543312|NCT04604795|101666901|FG007|COMPLETED|Part C: Washout Period 3 (Up to Day10)||0||
48543313|NCT04604795|101666902|FG008|COMPLETED|Part C: Washout Period 3 (Up to Day10)||5||
48543314|NCT04604795|101666903|FG009|COMPLETED|Part C: Washout Period 3 (Up to Day10)||6||
48543315|NCT04604795|101666894|FG000|NOT COMPLETED|Part C: Washout Period 3 (Up to Day10)||0||
48543316|NCT04604795|101666895|FG001|NOT COMPLETED|Part C: Washout Period 3 (Up to Day10)||0||
48543317|NCT04604795|101666896|FG002|NOT COMPLETED|Part C: Washout Period 3 (Up to Day10)||0||
48543318|NCT04604795|101666897|FG003|NOT COMPLETED|Part C: Washout Period 3 (Up to Day10)||0||
48543319|NCT04604795|101666898|FG004|NOT COMPLETED|Part C: Washout Period 3 (Up to Day10)||0||
48543320|NCT04604795|101666899|FG005|NOT COMPLETED|Part C: Washout Period 3 (Up to Day10)||0||
48543321|NCT04604795|101666900|FG006|NOT COMPLETED|Part C: Washout Period 3 (Up to Day10)||0||
48543322|NCT04604795|101666901|FG007|NOT COMPLETED|Part C: Washout Period 3 (Up to Day10)||0||
48543323|NCT04604795|101666902|FG008|NOT COMPLETED|Part C: Washout Period 3 (Up to Day10)||1||
48543324|NCT04604795|101666903|FG009|NOT COMPLETED|Part C: Washout Period 3 (Up to Day10)||0||
48543325|NCT04604795|101666894|FG000|STARTED|Part C: Period 4 (Day 1)||0||
48097481|NCT02068443|100563710|FG002|STARTED|Overall Study||151||
48097482|NCT02068443|100563708|FG000|COMPLETED|Overall Study||64||
48097483|NCT02068443|100563709|FG001|COMPLETED|Overall Study||146||
48097484|NCT02068443|100563710|FG002|COMPLETED|Overall Study||148||
48097485|NCT02068443|100563708|FG000|NOT COMPLETED|Overall Study||7||
48097486|NCT02068443|100563709|FG001|NOT COMPLETED|Overall Study||6||
48097487|NCT02068443|100563710|FG002|NOT COMPLETED|Overall Study||3||
48097488|NCT01382446|100563711|FG000|STARTED|Overall Study||33||
48097489|NCT01382446|100563712|FG001|STARTED|Overall Study||33||
48097490|NCT01382446|100563711|FG000|COMPLETED|Overall Study||30||
48097491|NCT01382446|100563712|FG001|COMPLETED|Overall Study||29||
48097492|NCT01382446|100563711|FG000|NOT COMPLETED|Overall Study||3||
48097493|NCT01382446|100563712|FG001|NOT COMPLETED|Overall Study||4||
48097494|NCT02084147|100563713|FG000|STARTED|Overall Study||72||
48097495|NCT02084147|100563713|FG000|COMPLETED|Overall Study||72||
48097496|NCT02084147|100563713|FG000|NOT COMPLETED|Overall Study||0||
48097497|NCT00641862|100563714|FG000|STARTED|Overall Study||183||
48097498|NCT00641862|100563715|FG001|STARTED|Overall Study||183||
48097499|NCT00641862|100563714|FG000|COMPLETED|Overall Study||139||
48097500|NCT00641862|100563715|FG001|COMPLETED|Overall Study||145||
48097501|NCT00641862|100563714|FG000|NOT COMPLETED|Overall Study||44||
48097502|NCT00641862|100563715|FG001|NOT COMPLETED|Overall Study||38||
48097503|NCT02127567|100563716|FG000|STARTED|Overall Study||41||
48097504|NCT02127567|100563716|FG000|COMPLETED|Overall Study||41||
48097505|NCT02127567|100563716|FG000|NOT COMPLETED|Overall Study||0||
48097506|NCT01465022|100563717|FG000|STARTED|Overall Study||64||
48097507|NCT01465022|100563718|FG001|STARTED|Overall Study||63||
48097508|NCT01465022|100563719|FG002|STARTED|Overall Study||70||
48097509|NCT01465022|100563717|FG000|COMPLETED|Overall Study||41||
48097510|NCT01465022|100563718|FG001|COMPLETED|Overall Study||40||
48097511|NCT01465022|100563719|FG002|COMPLETED|Overall Study||0||
48097512|NCT01465022|100563717|FG000|NOT COMPLETED|Overall Study||23||
48097513|NCT01465022|100563718|FG001|NOT COMPLETED|Overall Study||23||
48097514|NCT01465022|100563719|FG002|NOT COMPLETED|Overall Study||70||
48097515|NCT00091273|100563720|FG000|STARTED|Overall Study||9||
48097516|NCT00091273|100563720|FG000|COMPLETED|Overall Study||9||
48097517|NCT00091273|100563720|FG000|NOT COMPLETED|Overall Study||0||
48097518|NCT00171223|100563721|FG000|STARTED|Overall Study||152||
48097519|NCT00171223|100563722|FG001|STARTED|Overall Study||188||
48097520|NCT00171223|100563723|FG002|STARTED|Overall Study||192||
48097521|NCT00171223|100563721|FG000|COMPLETED|Overall Study||12|Disposition data is reported till end of study.|
48097522|NCT00171223|100563722|FG001|COMPLETED|Overall Study||47|Disposition data is reported till end of study.|
48543326|NCT04604795|101666895|FG001|STARTED|Part C: Period 4 (Day 1)||0||
48543327|NCT04604795|101666896|FG002|STARTED|Part C: Period 4 (Day 1)||0||
48543328|NCT04604795|101666897|FG003|STARTED|Part C: Period 4 (Day 1)||0||
48543329|NCT04604795|101666898|FG004|STARTED|Part C: Period 4 (Day 1)||0||
48543330|NCT04604795|101666899|FG005|STARTED|Part C: Period 4 (Day 1)||0||
48543331|NCT04604795|101666900|FG006|STARTED|Part C: Period 4 (Day 1)||0||
48543332|NCT04604795|101666901|FG007|STARTED|Part C: Period 4 (Day 1)||0||
48543333|NCT04604795|101666902|FG008|STARTED|Part C: Period 4 (Day 1)||5||
48543334|NCT04604795|101666903|FG009|STARTED|Part C: Period 4 (Day 1)||6||
48543335|NCT04604795|101666894|FG000|COMPLETED|Part C: Period 4 (Day 1)||0||
48543336|NCT04604795|101666895|FG001|COMPLETED|Part C: Period 4 (Day 1)||0||
48543337|NCT04604795|101666896|FG002|COMPLETED|Part C: Period 4 (Day 1)||0||
48543338|NCT04604795|101666897|FG003|COMPLETED|Part C: Period 4 (Day 1)||0||
48097523|NCT00171223|100563723|FG002|COMPLETED|Overall Study||22|Disposition data is reported till end of study.|
48097524|NCT00171223|100563721|FG000|NOT COMPLETED|Overall Study||140||
48097525|NCT00171223|100563722|FG001|NOT COMPLETED|Overall Study||141||
48097526|NCT00171223|100563723|FG002|NOT COMPLETED|Overall Study||170||
48543339|NCT04604795|101666898|FG004|COMPLETED|Part C: Period 4 (Day 1)||0||
48543340|NCT04604795|101666899|FG005|COMPLETED|Part C: Period 4 (Day 1)||0||
48543341|NCT04604795|101666900|FG006|COMPLETED|Part C: Period 4 (Day 1)||0||
48543342|NCT04604795|101666901|FG007|COMPLETED|Part C: Period 4 (Day 1)||0||
48543343|NCT04604795|101666902|FG008|COMPLETED|Part C: Period 4 (Day 1)||5||
48543344|NCT04604795|101666903|FG009|COMPLETED|Part C: Period 4 (Day 1)||6||
48543345|NCT04604795|101666894|FG000|NOT COMPLETED|Part C: Period 4 (Day 1)||0||
48543346|NCT04604795|101666895|FG001|NOT COMPLETED|Part C: Period 4 (Day 1)||0||
48543347|NCT04604795|101666896|FG002|NOT COMPLETED|Part C: Period 4 (Day 1)||0||
48543348|NCT04604795|101666897|FG003|NOT COMPLETED|Part C: Period 4 (Day 1)||0||
48543349|NCT04604795|101666898|FG004|NOT COMPLETED|Part C: Period 4 (Day 1)||0||
48543350|NCT04604795|101666899|FG005|NOT COMPLETED|Part C: Period 4 (Day 1)||0||
48543351|NCT04604795|101666900|FG006|NOT COMPLETED|Part C: Period 4 (Day 1)||0||
48543352|NCT04604795|101666901|FG007|NOT COMPLETED|Part C: Period 4 (Day 1)||0||
48690205|NCT02956746|102025782|FG001|NOT COMPLETED|Overall Study||3||
48690206|NCT02956746|102025783|FG002|NOT COMPLETED|Overall Study||6||
48690207|NCT02956746|102025784|FG003|NOT COMPLETED|Overall Study||4||
48690208|NCT01784367|102025785|FG000|STARTED|Overall Study||25||
48690209|NCT01784367|102025786|FG001|STARTED|Overall Study||25||
48690210|NCT01784367|102025785|FG000|COMPLETED|Overall Study||25||
48690211|NCT01784367|102025786|FG001|COMPLETED|Overall Study||25||
48690212|NCT01784367|102025785|FG000|NOT COMPLETED|Overall Study||0||
48690213|NCT01784367|102025786|FG001|NOT COMPLETED|Overall Study||0||
48690214|NCT01574287|102025787|FG000|STARTED|Overall Study||4||
48690215|NCT01574287|102025787|FG000|COMPLETED|Overall Study||4||
48261255|NCT02781311|100959126|FG000|Safety Population (Treated)|Overall Study||73||
48261256|NCT02781311|100959127|FG001|Safety Population (Treated)|Overall Study||81||
48261257|NCT02781311|100959128|FG002|Safety Population (Treated)|Overall Study||12||
48261258|NCT02781311|100959126|FG000|mITT Population|Overall Study||70||
48261259|NCT02781311|100959127|FG001|mITT Population|Overall Study||78||
48261260|NCT02781311|100959128|FG002|mITT Population|Overall Study||11||
48261261|NCT02781311|100959126|FG000|COMPLETED|Overall Study||48||
48261262|NCT02781311|100959127|FG001|COMPLETED|Overall Study||57||
48261263|NCT02781311|100959128|FG002|COMPLETED|Overall Study||8||
48261264|NCT02781311|100959126|FG000|NOT COMPLETED|Overall Study||26||
48261265|NCT02781311|100959127|FG001|NOT COMPLETED|Overall Study||26||
48261266|NCT02781311|100959128|FG002|NOT COMPLETED|Overall Study||4||
48261267|NCT00632021|100959129|FG000|STARTED|Overall Study||432||
48261268|NCT00632021|100959130|FG001|STARTED|Overall Study||430||
48261269|NCT00632021|100959129|FG000|COMPLETED|Overall Study||428||
48261270|NCT00632021|100959130|FG001|COMPLETED|Overall Study||423||
48261271|NCT00632021|100959129|FG000|NOT COMPLETED|Overall Study||4||
48261272|NCT00632021|100959130|FG001|NOT COMPLETED|Overall Study||7||
48261273|NCT01649557|100959131|FG000|STARTED|Overall Study||179||
48261274|NCT01649557|100959132|FG001|STARTED|Overall Study||41||
48261275|NCT01649557|100959133|FG002|STARTED|Overall Study||24||
48261276|NCT01649557|100959131|FG000|6-week Enrollers|Overall Study||159||
48261277|NCT01649557|100959132|FG001|6-week Enrollers|Overall Study||35||
48261278|NCT01649557|100959133|FG002|6-week Enrollers|Overall Study||22||
48261279|NCT01649557|100959131|FG000|52-week Enrollers|Overall Study||20||
48261280|NCT01649557|100959132|FG001|52-week Enrollers|Overall Study||6||
48261281|NCT01649557|100959133|FG002|52-week Enrollers|Overall Study||2||
48261282|NCT01649557|100959131|FG000|COMPLETED|Overall Study||135||
48261283|NCT01649557|100959132|FG001|COMPLETED|Overall Study||27||
48261284|NCT01649557|100959133|FG002|COMPLETED|Overall Study||15||
48261285|NCT01649557|100959131|FG000|NOT COMPLETED|Overall Study||44||
48543353|NCT04604795|101666902|FG008|NOT COMPLETED|Part C: Period 4 (Day 1)||0||
48543354|NCT04604795|101666903|FG009|NOT COMPLETED|Part C: Period 4 (Day 1)||0||
48543355|NCT04604795|101666894|FG000|STARTED|Part C: Washout Period 4 (Up to Day 13)||0||
48543356|NCT04604795|101666895|FG001|STARTED|Part C: Washout Period 4 (Up to Day 13)||0||
48543357|NCT04604795|101666896|FG002|STARTED|Part C: Washout Period 4 (Up to Day 13)||0||
48543358|NCT04604795|101666897|FG003|STARTED|Part C: Washout Period 4 (Up to Day 13)||0||
48543359|NCT04604795|101666898|FG004|STARTED|Part C: Washout Period 4 (Up to Day 13)||0||
48543360|NCT04604795|101666899|FG005|STARTED|Part C: Washout Period 4 (Up to Day 13)||0||
48543361|NCT04604795|101666900|FG006|STARTED|Part C: Washout Period 4 (Up to Day 13)||0||
48690216|NCT01574287|102025787|FG000|NOT COMPLETED|Overall Study||0||
48690217|NCT01525862|102025788|FG000|STARTED|Overall Study||21||
48690218|NCT01525862|102025788|FG000|COMPLETED|Overall Study||21||
48690219|NCT01525862|102025788|FG000|NOT COMPLETED|Overall Study||0||
48690220|NCT01901614|102025789|FG000|STARTED|Overall Study||3||
48261286|NCT01649557|100959132|FG001|NOT COMPLETED|Overall Study||14||
48261287|NCT01649557|100959133|FG002|NOT COMPLETED|Overall Study||9||
48261288|NCT01190644|100959134|FG000|STARTED|Overall Study||5||
48690221|NCT01901614|102025790|FG001|STARTED|Overall Study||2||
48261289|NCT01190644|100959134|FG000|Treated|Overall Study||4||
48261290|NCT01190644|100959134|FG000|COMPLETED|Overall Study||2||
48261291|NCT01190644|100959134|FG000|NOT COMPLETED|Overall Study||3||
48261292|NCT00848510|100959135|FG000|STARTED|Overall Study||10||
48261293|NCT00848510|100959136|FG001|STARTED|Overall Study||13||
48261294|NCT00848510|100959137|FG002|STARTED|Overall Study||8||
48261295|NCT00848510|100959138|FG003|STARTED|Overall Study||10||
48261296|NCT00848510|100959135|FG000|COMPLETED|Overall Study||10||
48261297|NCT00848510|100959136|FG001|COMPLETED|Overall Study||13||
48261298|NCT00848510|100959137|FG002|COMPLETED|Overall Study||8||
48261299|NCT00848510|100959138|FG003|COMPLETED|Overall Study||10||
48261300|NCT00848510|100959135|FG000|NOT COMPLETED|Overall Study||0||
48261301|NCT00848510|100959136|FG001|NOT COMPLETED|Overall Study||0||
48261302|NCT00848510|100959137|FG002|NOT COMPLETED|Overall Study||0||
48261303|NCT00848510|100959138|FG003|NOT COMPLETED|Overall Study||0||
48261304|NCT01536171|100959139|FG000|STARTED|Overall Study||22||
48261305|NCT01536171|100959139|FG000|COMPLETED|Overall Study||21||
48261306|NCT01536171|100959139|FG000|NOT COMPLETED|Overall Study||1||
48261307|NCT01296763|100962650|FG000|STARTED|Overall Study||7||
48690222|NCT01901614|102025789|FG000|COMPLETED|Overall Study||1||
48690223|NCT01901614|102025790|FG001|COMPLETED|Overall Study||1||
48690224|NCT01901614|102025789|FG000|NOT COMPLETED|Overall Study||2||
48690225|NCT01901614|102025790|FG001|NOT COMPLETED|Overall Study||1||
48690226|NCT02522429|102025791|FG000|STARTED|Overall Study||23||
48690227|NCT02522429|102025791|FG000|COMPLETED|Overall Study||11||
48690228|NCT02522429|102025791|FG000|NOT COMPLETED|Overall Study||12||
48690229|NCT00787839|102025792|FG000|STARTED|Overall Study||1939||
48690230|NCT00787839|102025792|FG000|Consented|Overall Study||1939||
48690231|NCT00787839|102025792|FG000|Completed GCT Screening|Overall Study||1876||
48690232|NCT00787839|102025792|FG000|Complete GCT, OGTT, A1c, Demographics|Overall Study||1535||
48690233|NCT00787839|102025792|FG000|COMPLETED|Overall Study||1535||
48690234|NCT00787839|102025792|FG000|NOT COMPLETED|Overall Study||404||
48690235|NCT00940290|102025793|FG000|STARTED|Overall Study||54||
48690236|NCT00940290|102025794|FG001|STARTED|Overall Study||53||
48690237|NCT00940290|102025795|FG002|STARTED|Overall Study||55||
48690238|NCT00940290|102025796|FG003|STARTED|Overall Study||54||
48690239|NCT00940290|102025793|FG000|COMPLETED|Overall Study||54||
48690240|NCT00940290|102025794|FG001|COMPLETED|Overall Study||53||
48690241|NCT00940290|102025795|FG002|COMPLETED|Overall Study||55||
48690242|NCT00940290|102025796|FG003|COMPLETED|Overall Study||54||
48690243|NCT00940290|102025793|FG000|NOT COMPLETED|Overall Study||0||
48690244|NCT00940290|102025794|FG001|NOT COMPLETED|Overall Study||0||
48690245|NCT00940290|102025795|FG002|NOT COMPLETED|Overall Study||0||
48690246|NCT00940290|102025796|FG003|NOT COMPLETED|Overall Study||0||
48690247|NCT02544035|102025797|FG000|STARTED|Overall Study||60||
48097527|NCT03287804|100563724|FG000|STARTED|Overall Study||12||
48097528|NCT03287804|100563724|FG000|Leukaperesed|Overall Study||12||
48097529|NCT03287804|100563724|FG000|Started Pre-conditioning Therapy|Overall Study||11||
48097530|NCT03287804|100563724|FG000|Received Study Treatment|Overall Study||11||
48097531|NCT03287804|100563724|FG000|COMPLETED|Overall Study||1||
48097532|NCT03287804|100563724|FG000|NOT COMPLETED|Overall Study||11||
48097533|NCT02074995|100563725|FG000|STARTED|Overall Study||1||
48097534|NCT02074995|100563726|FG001|STARTED|Overall Study||0||
48097535|NCT02074995|100563727|FG002|STARTED|Overall Study||0||
48097536|NCT02074995|100563725|FG000|COMPLETED|Overall Study||1||
48097537|NCT02074995|100563726|FG001|COMPLETED|Overall Study||0||
48097538|NCT02074995|100563727|FG002|COMPLETED|Overall Study||0||
48097539|NCT02074995|100563725|FG000|NOT COMPLETED|Overall Study||0||
48097540|NCT02074995|100563726|FG001|NOT COMPLETED|Overall Study||0||
48097541|NCT02074995|100563727|FG002|NOT COMPLETED|Overall Study||0||
48097542|NCT01340144|100563728|FG000|STARTED|Overall Study||625||
48097543|NCT01340144|100563729|FG001|STARTED|Overall Study||625||
48097544|NCT01340144|100563728|FG000|COMPLETED|Overall Study||553||
48097545|NCT01340144|100563729|FG001|COMPLETED|Overall Study||567||
48097546|NCT01340144|100563728|FG000|NOT COMPLETED|Overall Study||72||
48097547|NCT01340144|100563729|FG001|NOT COMPLETED|Overall Study||58||
48097548|NCT00311623|100563730|FG000|STARTED|Overall Study||10||
48097549|NCT00311623|100563731|FG001|STARTED|Overall Study||20||
48097550|NCT00311623|100563732|FG002|STARTED|Overall Study||2||
48097551|NCT00311623|100563730|FG000|COMPLETED|Overall Study||10||
48097552|NCT00311623|100563731|FG001|COMPLETED|Overall Study||20||
48097553|NCT00311623|100563732|FG002|COMPLETED|Overall Study||0||
48097554|NCT00311623|100563730|FG000|NOT COMPLETED|Overall Study||0||
48097555|NCT00311623|100563731|FG001|NOT COMPLETED|Overall Study||0||
48097556|NCT00311623|100563732|FG002|NOT COMPLETED|Overall Study||2||
48097557|NCT00894322|100563733|FG000|STARTED|Overall Study||30||
48261308|NCT01296763|100962651|FG001|STARTED|Overall Study||5||
48261309|NCT01296763|100962652|FG002|STARTED|Overall Study||6||
48261310|NCT01296763|100962650|FG000|COMPLETED|Overall Study||7||
48261311|NCT01296763|100962651|FG001|COMPLETED|Overall Study||5||
48261312|NCT01296763|100962652|FG002|COMPLETED|Overall Study||6||
48261313|NCT01296763|100962650|FG000|NOT COMPLETED|Overall Study||0||
48690248|NCT02544035|102025798|FG001|STARTED|Overall Study||61||
48690249|NCT02544035|102025799|FG002|STARTED|Overall Study||62||
48690250|NCT02544035|102025800|FG003|STARTED|Overall Study||60||
48097558|NCT00894322|100563734|FG001|STARTED|Overall Study||23||
48690251|NCT02544035|102025801|FG004|STARTED|Overall Study||60||
48690252|NCT02544035|102025802|FG005|STARTED|Overall Study||61||
48690253|NCT02544035|102025803|FG006|STARTED|Overall Study||62||
48097559|NCT00894322|100563735|FG002|STARTED|Overall Study||12||
48097560|NCT00894322|100563733|FG000|COMPLETED|Overall Study||29||
48097561|NCT00894322|100563734|FG001|COMPLETED|Overall Study||23||
48097562|NCT00894322|100563735|FG002|COMPLETED|Overall Study||12||
48097563|NCT00894322|100563733|FG000|NOT COMPLETED|Overall Study||1||
48097564|NCT00894322|100563734|FG001|NOT COMPLETED|Overall Study||0||
48097565|NCT00894322|100563735|FG002|NOT COMPLETED|Overall Study||0||
48543362|NCT04604795|101666901|FG007|STARTED|Part C: Washout Period 4 (Up to Day 13)||0||
48543363|NCT04604795|101666902|FG008|STARTED|Part C: Washout Period 4 (Up to Day 13)||5||
48543364|NCT04604795|101666903|FG009|STARTED|Part C: Washout Period 4 (Up to Day 13)||6||
48543365|NCT04604795|101666894|FG000|COMPLETED|Part C: Washout Period 4 (Up to Day 13)||0||
48543366|NCT04604795|101666895|FG001|COMPLETED|Part C: Washout Period 4 (Up to Day 13)||0||
48543367|NCT04604795|101666896|FG002|COMPLETED|Part C: Washout Period 4 (Up to Day 13)||0||
48543368|NCT04604795|101666897|FG003|COMPLETED|Part C: Washout Period 4 (Up to Day 13)||0||
48543369|NCT04604795|101666898|FG004|COMPLETED|Part C: Washout Period 4 (Up to Day 13)||0||
48543370|NCT04604795|101666899|FG005|COMPLETED|Part C: Washout Period 4 (Up to Day 13)||0||
48543371|NCT04604795|101666900|FG006|COMPLETED|Part C: Washout Period 4 (Up to Day 13)||0||
48543372|NCT04604795|101666901|FG007|COMPLETED|Part C: Washout Period 4 (Up to Day 13)||0||
48543373|NCT04604795|101666902|FG008|COMPLETED|Part C: Washout Period 4 (Up to Day 13)||4||
48543374|NCT04604795|101666903|FG009|COMPLETED|Part C: Washout Period 4 (Up to Day 13)||6||
48543375|NCT04604795|101666894|FG000|NOT COMPLETED|Part C: Washout Period 4 (Up to Day 13)||0||
48543376|NCT04604795|101666895|FG001|NOT COMPLETED|Part C: Washout Period 4 (Up to Day 13)||0||
48543377|NCT04604795|101666896|FG002|NOT COMPLETED|Part C: Washout Period 4 (Up to Day 13)||0||
48543378|NCT04604795|101666897|FG003|NOT COMPLETED|Part C: Washout Period 4 (Up to Day 13)||0||
48543379|NCT04604795|101666898|FG004|NOT COMPLETED|Part C: Washout Period 4 (Up to Day 13)||0||
48543380|NCT04604795|101666899|FG005|NOT COMPLETED|Part C: Washout Period 4 (Up to Day 13)||0||
48543381|NCT04604795|101666900|FG006|NOT COMPLETED|Part C: Washout Period 4 (Up to Day 13)||0||
48543382|NCT04604795|101666901|FG007|NOT COMPLETED|Part C: Washout Period 4 (Up to Day 13)||0||
48543383|NCT04604795|101666902|FG008|NOT COMPLETED|Part C: Washout Period 4 (Up to Day 13)||1||
48543384|NCT04604795|101666903|FG009|NOT COMPLETED|Part C: Washout Period 4 (Up to Day 13)||0||
48543385|NCT04604795|101666894|FG000|STARTED|Part C: Period 5 (Day 1)||0||
48543386|NCT04604795|101666895|FG001|STARTED|Part C: Period 5 (Day 1)||0||
48543387|NCT04604795|101666896|FG002|STARTED|Part C: Period 5 (Day 1)||0||
48543388|NCT04604795|101666897|FG003|STARTED|Part C: Period 5 (Day 1)||0||
48543389|NCT04604795|101666898|FG004|STARTED|Part C: Period 5 (Day 1)||0||
48543390|NCT04604795|101666899|FG005|STARTED|Part C: Period 5 (Day 1)||0||
48543391|NCT04604795|101666900|FG006|STARTED|Part C: Period 5 (Day 1)||0||
48543392|NCT04604795|101666901|FG007|STARTED|Part C: Period 5 (Day 1)||0||
48543393|NCT04604795|101666902|FG008|STARTED|Part C: Period 5 (Day 1)||4||
48543394|NCT04604795|101666903|FG009|STARTED|Part C: Period 5 (Day 1)||6||
48543395|NCT04604795|101666894|FG000|COMPLETED|Part C: Period 5 (Day 1)||0||
48543396|NCT04604795|101666895|FG001|COMPLETED|Part C: Period 5 (Day 1)||0||
48543397|NCT04604795|101666896|FG002|COMPLETED|Part C: Period 5 (Day 1)||0||
48543398|NCT04604795|101666897|FG003|COMPLETED|Part C: Period 5 (Day 1)||0||
48543399|NCT04604795|101666898|FG004|COMPLETED|Part C: Period 5 (Day 1)||0||
48543400|NCT04604795|101666899|FG005|COMPLETED|Part C: Period 5 (Day 1)||0||
48543401|NCT04604795|101666900|FG006|COMPLETED|Part C: Period 5 (Day 1)||0||
48543402|NCT04604795|101666901|FG007|COMPLETED|Part C: Period 5 (Day 1)||0||
48543403|NCT04604795|101666902|FG008|COMPLETED|Part C: Period 5 (Day 1)||3||
48543404|NCT04604795|101666903|FG009|COMPLETED|Part C: Period 5 (Day 1)||6||
48543405|NCT04604795|101666894|FG000|NOT COMPLETED|Part C: Period 5 (Day 1)||0||
48543406|NCT04604795|101666895|FG001|NOT COMPLETED|Part C: Period 5 (Day 1)||0||
48543407|NCT04604795|101666896|FG002|NOT COMPLETED|Part C: Period 5 (Day 1)||0||
48543408|NCT04604795|101666897|FG003|NOT COMPLETED|Part C: Period 5 (Day 1)||0||
48543409|NCT04604795|101666898|FG004|NOT COMPLETED|Part C: Period 5 (Day 1)||0||
48543410|NCT04604795|101666899|FG005|NOT COMPLETED|Part C: Period 5 (Day 1)||0||
48543411|NCT04604795|101666900|FG006|NOT COMPLETED|Part C: Period 5 (Day 1)||0||
48543412|NCT04604795|101666901|FG007|NOT COMPLETED|Part C: Period 5 (Day 1)||0||
48543413|NCT04604795|101666902|FG008|NOT COMPLETED|Part C: Period 5 (Day 1)||1||
48543414|NCT04604795|101666903|FG009|NOT COMPLETED|Part C: Period 5 (Day 1)||0||
48543415|NCT01111825|101666904|FG000|STARTED|Overall Study||8||
48543416|NCT01111825|101666905|FG001|STARTED|Overall Study||6||
48543417|NCT01111825|101666906|FG002|STARTED|Overall Study||37||
48543418|NCT01111825|101666907|FG003|STARTED|Overall Study||48||
48543419|NCT01111825|101666904|FG000|COMPLETED|Overall Study||5|Completed means completed study or died.|
48261314|NCT01296763|100962651|FG001|NOT COMPLETED|Overall Study||0||
48543420|NCT01111825|101666905|FG001|COMPLETED|Overall Study||5|Completed means completed study or died.|
48543421|NCT01111825|101666906|FG002|COMPLETED|Overall Study||29|Completed means completed study or died.|
48543422|NCT01111825|101666907|FG003|COMPLETED|Overall Study||27|Completed means completed study or died.|
48543423|NCT01111825|101666904|FG000|NOT COMPLETED|Overall Study||3||
48543424|NCT01111825|101666905|FG001|NOT COMPLETED|Overall Study||1||
48097566|NCT01275833|100563736|FG000|STARTED|Overall Study||1||
48097567|NCT01275833|100563737|FG001|STARTED|Overall Study||1||
48543425|NCT01111825|101666906|FG002|NOT COMPLETED|Overall Study||8||
48543426|NCT01111825|101666907|FG003|NOT COMPLETED|Overall Study||21||
48543427|NCT03904108|101666908|FG000|STARTED|Overall Study||3||
48097568|NCT01275833|100563736|FG000|COMPLETED|Overall Study||0||
48543428|NCT03904108|101666908|FG000|COMPLETED|Overall Study||3||
48543429|NCT03904108|101666908|FG000|NOT COMPLETED|Overall Study||0||
48543430|NCT01045135|101666909|FG000|STARTED|Overall Study||300||
48261315|NCT01296763|100962652|FG002|NOT COMPLETED|Overall Study||0||
48261316|NCT04182113|100962653|FG000|STARTED|First Intervention (Week 1)||4||
48543431|NCT01045135|101666909|FG000|COMPLETED|Overall Study||274||
48543432|NCT01045135|101666909|FG000|NOT COMPLETED|Overall Study||26||
48543433|NCT01958073|101666910|FG000|STARTED|Randomized Period||9||
48543434|NCT01958073|101666911|FG001|STARTED|Randomized Period||9||
48543435|NCT01958073|101666912|FG002|STARTED|Randomized Period||17||
48543436|NCT01958073|101666913|FG003|STARTED|Randomized Period||0||
48543437|NCT01958073|101666914|FG004|STARTED|Randomized Period||0||
48543438|NCT01958073|101666910|FG000|COMPLETED|Randomized Period||7||
48543439|NCT01958073|101666911|FG001|COMPLETED|Randomized Period||8||
48543440|NCT01958073|101666912|FG002|COMPLETED|Randomized Period||11||
48543441|NCT01958073|101666913|FG003|COMPLETED|Randomized Period||0||
48543442|NCT01958073|101666914|FG004|COMPLETED|Randomized Period||0||
48543443|NCT01958073|101666910|FG000|NOT COMPLETED|Randomized Period||2||
48543444|NCT01958073|101666911|FG001|NOT COMPLETED|Randomized Period||1||
48543445|NCT01958073|101666912|FG002|NOT COMPLETED|Randomized Period||6||
48543446|NCT01958073|101666913|FG003|NOT COMPLETED|Randomized Period||0||
48543447|NCT01958073|101666914|FG004|NOT COMPLETED|Randomized Period||0||
48543448|NCT01958073|101666910|FG000|STARTED|Open Label Period||0||
48543449|NCT01958073|101666911|FG001|STARTED|Open Label Period||0||
48543450|NCT01958073|101666912|FG002|STARTED|Open Label Period||0||
48543451|NCT01958073|101666913|FG003|STARTED|Open Label Period||5||
48543452|NCT01958073|101666914|FG004|STARTED|Open Label Period||17||
48543453|NCT01958073|101666910|FG000|COMPLETED|Open Label Period||0||
48543454|NCT01958073|101666911|FG001|COMPLETED|Open Label Period||0||
48543455|NCT01958073|101666912|FG002|COMPLETED|Open Label Period||0||
48543456|NCT01958073|101666913|FG003|COMPLETED|Open Label Period||5||
48543457|NCT01958073|101666914|FG004|COMPLETED|Open Label Period||17||
48543458|NCT01958073|101666910|FG000|NOT COMPLETED|Open Label Period||0||
48543459|NCT01958073|101666911|FG001|NOT COMPLETED|Open Label Period||0||
48543460|NCT01958073|101666912|FG002|NOT COMPLETED|Open Label Period||0||
48543461|NCT01958073|101666913|FG003|NOT COMPLETED|Open Label Period||0||
48543462|NCT01958073|101666914|FG004|NOT COMPLETED|Open Label Period||0||
48543463|NCT00961402|101666915|FG000|STARTED|Overall Study||64||
48543464|NCT00961402|101666916|FG001|STARTED|Overall Study||66||
48543465|NCT00961402|101666915|FG000|Randomized|Overall Study||64||
48543466|NCT00961402|101666916|FG001|Randomized|Overall Study||66||
48543467|NCT00961402|101666915|FG000|COMPLETED|Overall Study||63||
48543468|NCT00961402|101666916|FG001|COMPLETED|Overall Study||61||
48543469|NCT00961402|101666915|FG000|NOT COMPLETED|Overall Study||1||
48543470|NCT00961402|101666916|FG001|NOT COMPLETED|Overall Study||5||
48543471|NCT02753920|101666917|FG000|STARTED|Overall Study||87||
48543472|NCT02753920|101666918|FG001|STARTED|Overall Study||86||
48543473|NCT02753920|101666917|FG000|COMPLETED|Overall Study||87||
48543474|NCT02753920|101666918|FG001|COMPLETED|Overall Study||86||
48543475|NCT02753920|101666917|FG000|NOT COMPLETED|Overall Study||0||
48543476|NCT02753920|101666918|FG001|NOT COMPLETED|Overall Study||0||
48543477|NCT02137486|101666919|FG000|STARTED|Overall Study||112||
48543478|NCT02137486|101666920|FG001|STARTED|Overall Study||102||
48543479|NCT02137486|101666919|FG000|COMPLETED|Overall Study||112||
48543480|NCT02137486|101666920|FG001|COMPLETED|Overall Study||102||
48543481|NCT02137486|101666919|FG000|NOT COMPLETED|Overall Study||0||
48543482|NCT02137486|101666920|FG001|NOT COMPLETED|Overall Study||0||
48543483|NCT01851330|101666921|FG000|STARTED|Overall Study||215||
48543484|NCT01851330|101666922|FG001|STARTED|Overall Study||216||
48543485|NCT01851330|101666923|FG002|STARTED|Overall Study||216||
48543486|NCT01851330|101666921|FG000|COMPLETED|Overall Study||202||
48543487|NCT01851330|101666922|FG001|COMPLETED|Overall Study||200||
48543488|NCT01851330|101666923|FG002|COMPLETED|Overall Study||204||
48543489|NCT01851330|101666921|FG000|NOT COMPLETED|Overall Study||13||
48543490|NCT01851330|101666922|FG001|NOT COMPLETED|Overall Study||16||
48543491|NCT01851330|101666923|FG002|NOT COMPLETED|Overall Study||12||
48543492|NCT04803305|101666924|FG000|STARTED|Part A: 6-week Double-blind Treatment||6||
48543493|NCT04803305|101666925|FG001|STARTED|Part A: 6-week Double-blind Treatment||12||
48543494|NCT04803305|101666924|FG000|COMPLETED|Part A: 6-week Double-blind Treatment||5||
48543495|NCT04803305|101666925|FG001|COMPLETED|Part A: 6-week Double-blind Treatment||9||
48543496|NCT04803305|101666924|FG000|NOT COMPLETED|Part A: 6-week Double-blind Treatment||1||
48543497|NCT04803305|101666925|FG001|NOT COMPLETED|Part A: 6-week Double-blind Treatment||3||
48543498|NCT04803305|101666924|FG000|STARTED|Part B: OLT Period up to 18 Weeks||5||
48543499|NCT04803305|101666925|FG001|STARTED|Part B: OLT Period up to 18 Weeks||9||
48543500|NCT04803305|101666924|FG000|COMPLETED|Part B: OLT Period up to 18 Weeks||2||
48543501|NCT04803305|101666925|FG001|COMPLETED|Part B: OLT Period up to 18 Weeks||5||
48543502|NCT04803305|101666924|FG000|NOT COMPLETED|Part B: OLT Period up to 18 Weeks||3||
48543503|NCT04803305|101666925|FG001|NOT COMPLETED|Part B: OLT Period up to 18 Weeks||4||
48543504|NCT01141205|101666926|FG000|STARTED|Overall Study||18||
48543505|NCT01141205|101666927|FG001|STARTED|Overall Study||5||
48543506|NCT01141205|101666926|FG000|COMPLETED|Overall Study||15||
48543507|NCT01141205|101666927|FG001|COMPLETED|Overall Study||3||
48543508|NCT01141205|101666926|FG000|NOT COMPLETED|Overall Study||3||
48543509|NCT01141205|101666927|FG001|NOT COMPLETED|Overall Study||2||
48543510|NCT02842073|101666928|FG000|STARTED|Overall Study||12||
48543511|NCT02842073|101666928|FG000|COMPLETED|Overall Study||11||
48543512|NCT02842073|101666928|FG000|NOT COMPLETED|Overall Study||1||
48543513|NCT02252406|101666929|FG000|STARTED|Starting Dose Ranolazine 500 mg BID||16||
48543514|NCT02252406|101666930|FG001|STARTED|Starting Dose Ranolazine 500 mg BID||17||
48543515|NCT02252406|101666929|FG000|COMPLETED|Starting Dose Ranolazine 500 mg BID||12||
48543516|NCT02252406|101666930|FG001|COMPLETED|Starting Dose Ranolazine 500 mg BID||14||
48261317|NCT04182113|100962654|FG001|STARTED|First Intervention (Week 1)||5||
48261318|NCT04182113|100962655|FG002|STARTED|First Intervention (Week 1)||4||
48261319|NCT04182113|100962656|FG003|STARTED|First Intervention (Week 1)||4||
48261320|NCT04182113|100962657|FG004|STARTED|First Intervention (Week 1)||3||
48261321|NCT04182113|100962658|FG005|STARTED|First Intervention (Week 1)||4||
48261322|NCT04182113|100962653|FG000|COMPLETED|First Intervention (Week 1)||4||
48261323|NCT04182113|100962654|FG001|COMPLETED|First Intervention (Week 1)||5||
48261324|NCT04182113|100962655|FG002|COMPLETED|First Intervention (Week 1)||4||
48261325|NCT04182113|100962656|FG003|COMPLETED|First Intervention (Week 1)||4||
48261326|NCT04182113|100962657|FG004|COMPLETED|First Intervention (Week 1)||3||
48261327|NCT04182113|100962658|FG005|COMPLETED|First Intervention (Week 1)||4||
48261328|NCT04182113|100962653|FG000|NOT COMPLETED|First Intervention (Week 1)||0||
48261329|NCT04182113|100962654|FG001|NOT COMPLETED|First Intervention (Week 1)||0||
48261330|NCT04182113|100962655|FG002|NOT COMPLETED|First Intervention (Week 1)||0||
48261331|NCT04182113|100962656|FG003|NOT COMPLETED|First Intervention (Week 1)||0||
48097569|NCT01275833|100563737|FG001|COMPLETED|Overall Study||0||
48097570|NCT01275833|100563736|FG000|NOT COMPLETED|Overall Study||1||
48261332|NCT04182113|100962657|FG004|NOT COMPLETED|First Intervention (Week 1)||0||
48261333|NCT04182113|100962658|FG005|NOT COMPLETED|First Intervention (Week 1)||0||
48543517|NCT02252406|101666929|FG000|NOT COMPLETED|Starting Dose Ranolazine 500 mg BID||4||
48543518|NCT02252406|101666930|FG001|NOT COMPLETED|Starting Dose Ranolazine 500 mg BID||3||
48097571|NCT01275833|100563737|FG001|NOT COMPLETED|Overall Study||1||
48097572|NCT01266460|100563738|FG000|STARTED|Overall Study||50||
48097573|NCT01266460|100563738|FG000|COMPLETED|Overall Study||16||
48097574|NCT01266460|100563738|FG000|NOT COMPLETED|Overall Study||34||
48097575|NCT00644280|100563739|FG000|STARTED|Overall Study||6||
48543519|NCT02252406|101666929|FG000|STARTED|Titrated to Ranolazine 1000mg BID||12||
48543520|NCT02252406|101666930|FG001|STARTED|Titrated to Ranolazine 1000mg BID||14||
48543521|NCT02252406|101666929|FG000|COMPLETED|Titrated to Ranolazine 1000mg BID||9||
48097576|NCT00644280|100563740|FG001|STARTED|Overall Study||5||
48097577|NCT00644280|100563739|FG000|COMPLETED|Overall Study||6||
48543522|NCT02252406|101666930|FG001|COMPLETED|Titrated to Ranolazine 1000mg BID||13||
48543523|NCT02252406|101666929|FG000|NOT COMPLETED|Titrated to Ranolazine 1000mg BID||3||
48543524|NCT02252406|101666930|FG001|NOT COMPLETED|Titrated to Ranolazine 1000mg BID||1||
48543525|NCT00233402|101666931|FG000|STARTED|Overall Study||384||
48543526|NCT00233402|101666932|FG001|STARTED|Overall Study||395||
48543527|NCT00233402|101666931|FG000|COMPLETED|Overall Study||280||
48543528|NCT00233402|101666932|FG001|COMPLETED|Overall Study||271||
48543529|NCT00233402|101666931|FG000|NOT COMPLETED|Overall Study||104||
48543530|NCT00233402|101666932|FG001|NOT COMPLETED|Overall Study||124||
48543531|NCT01608061|101666933|FG000|STARTED|Blinded Period||21||
48097578|NCT00644280|100563740|FG001|COMPLETED|Overall Study||5||
48261334|NCT04182113|100962653|FG000|STARTED|Second Intervention (Week 2)||4||
48543532|NCT01608061|101666934|FG001|STARTED|Blinded Period||21||
48543533|NCT01608061|101666933|FG000|COMPLETED|Blinded Period||21||
48543534|NCT01608061|101666934|FG001|COMPLETED|Blinded Period||21||
48543535|NCT01608061|101666933|FG000|NOT COMPLETED|Blinded Period||0||
48543536|NCT01608061|101666934|FG001|NOT COMPLETED|Blinded Period||0||
48543537|NCT01608061|101666933|FG000|STARTED|Long Term Follow-Up||21||
48543538|NCT01608061|101666934|FG001|STARTED|Long Term Follow-Up||21||
48543539|NCT01608061|101666933|FG000|COMPLETED|Long Term Follow-Up||14||
48543540|NCT01608061|101666934|FG001|COMPLETED|Long Term Follow-Up||16||
48543541|NCT01608061|101666933|FG000|NOT COMPLETED|Long Term Follow-Up||7||
48543542|NCT01608061|101666934|FG001|NOT COMPLETED|Long Term Follow-Up||5||
48543543|NCT01608061|101666933|FG000|STARTED|Extension Period||14||
48543544|NCT01608061|101666934|FG001|STARTED|Extension Period||16||
48543545|NCT01608061|101666933|FG000|COMPLETED|Extension Period||14||
48543546|NCT01608061|101666934|FG001|COMPLETED|Extension Period||14||
48543547|NCT01608061|101666933|FG000|NOT COMPLETED|Extension Period||0||
48097579|NCT00644280|100563739|FG000|NOT COMPLETED|Overall Study||0||
48543548|NCT01608061|101666934|FG001|NOT COMPLETED|Extension Period||2||
48543549|NCT02613182|101666935|FG000|STARTED|Overall Study||34||
48543550|NCT02613182|101666935|FG000|Number of Patients Dosed|Overall Study||34||
48543551|NCT02613182|101666935|FG000|COMPLETED|Overall Study||0||
48097580|NCT00644280|100563740|FG001|NOT COMPLETED|Overall Study||0||
48097581|NCT02246673|100563741|FG000|STARTED|Overall Study||14||
48097582|NCT02246673|100563742|FG001|STARTED|Overall Study||12||
48097583|NCT02246673|100563743|FG002|STARTED|Overall Study||12||
48097584|NCT02246673|100563744|FG003|STARTED|Overall Study||14||
48543552|NCT02613182|101666935|FG000|NOT COMPLETED|Overall Study||34||
48543553|NCT01917916|101666936|FG000|STARTED|Overall Study||12||
48543554|NCT01917916|101666937|FG001|STARTED|Overall Study||12||
48543555|NCT01917916|101666938|FG002|STARTED|Overall Study||12||
48543556|NCT01917916|101666939|FG003|STARTED|Overall Study||12||
48543557|NCT01917916|101666940|FG004|STARTED|Overall Study||16||
48543558|NCT01917916|101666936|FG000|COMPLETED|Overall Study||12||
48543559|NCT01917916|101666937|FG001|COMPLETED|Overall Study||12||
48543560|NCT01917916|101666938|FG002|COMPLETED|Overall Study||12||
48543561|NCT01917916|101666939|FG003|COMPLETED|Overall Study||12||
48543562|NCT01917916|101666940|FG004|COMPLETED|Overall Study||16||
48543563|NCT01917916|101666936|FG000|NOT COMPLETED|Overall Study||0||
48543564|NCT01917916|101666937|FG001|NOT COMPLETED|Overall Study||0||
48543565|NCT01917916|101666938|FG002|NOT COMPLETED|Overall Study||0||
48543566|NCT01917916|101666939|FG003|NOT COMPLETED|Overall Study||0||
48543567|NCT01917916|101666940|FG004|NOT COMPLETED|Overall Study||0||
48543568|NCT01954745|101666941|FG000|STARTED|Overall Study||19||
48543569|NCT01954745|101666941|FG000|COMPLETED|Overall Study||0||
48543570|NCT01954745|101666941|FG000|NOT COMPLETED|Overall Study||19||
48261335|NCT04182113|100962654|FG001|STARTED|Second Intervention (Week 2)||5||
48261336|NCT04182113|100962655|FG002|STARTED|Second Intervention (Week 2)||4||
48261337|NCT04182113|100962656|FG003|STARTED|Second Intervention (Week 2)||4||
48261338|NCT04182113|100962657|FG004|STARTED|Second Intervention (Week 2)||3||
48261339|NCT04182113|100962658|FG005|STARTED|Second Intervention (Week 2)||4||
48543571|NCT05264129|101666942|FG000|STARTED|Period 1 Atogepant (Day1 to Wk12)||262||
48543572|NCT05264129|101666943|FG001|STARTED|Period 1 Atogepant (Day1 to Wk12)||0||
48543573|NCT05264129|101666942|FG000|COMPLETED|Period 1 Atogepant (Day1 to Wk12)||221||
48543574|NCT05264129|101666943|FG001|COMPLETED|Period 1 Atogepant (Day1 to Wk12)||0||
48543575|NCT05264129|101666942|FG000|NOT COMPLETED|Period 1 Atogepant (Day1 to Wk12)||41||
48543576|NCT05264129|101666943|FG001|NOT COMPLETED|Period 1 Atogepant (Day1 to Wk12)||0||
48543577|NCT05264129|101666942|FG000|STARTED|Period 2 Atogepant+Ubrogepant (Wk12-24)||0||
48097585|NCT02246673|100563745|FG004|STARTED|Overall Study||12||
48097586|NCT02246673|100563741|FG000|COMPLETED|Overall Study||13||
48097587|NCT02246673|100563742|FG001|COMPLETED|Overall Study||12||
48097588|NCT02246673|100563743|FG002|COMPLETED|Overall Study||12||
48543578|NCT05264129|101666943|FG001|STARTED|Period 2 Atogepant+Ubrogepant (Wk12-24)||218||
48543579|NCT05264129|101666942|FG000|COMPLETED|Period 2 Atogepant+Ubrogepant (Wk12-24)||0||
48543580|NCT05264129|101666943|FG001|COMPLETED|Period 2 Atogepant+Ubrogepant (Wk12-24)||203||
48543581|NCT05264129|101666942|FG000|NOT COMPLETED|Period 2 Atogepant+Ubrogepant (Wk12-24)||0||
48543582|NCT05264129|101666943|FG001|NOT COMPLETED|Period 2 Atogepant+Ubrogepant (Wk12-24)||15||
48543583|NCT03495921|101666944|FG000|STARTED|Main Study||3||
48543584|NCT03495921|101666945|FG001|STARTED|Main Study||2||
48543585|NCT03495921|101666944|FG000|COMPLETED|Main Study||3||
48543586|NCT03495921|101666945|FG001|COMPLETED|Main Study||2||
48543587|NCT03495921|101666944|FG000|NOT COMPLETED|Main Study||0||
48543588|NCT03495921|101666945|FG001|NOT COMPLETED|Main Study||0||
48543589|NCT03495921|101666944|FG000|STARTED|Group B Crossover to Vigil Alone||0||
48543590|NCT03495921|101666945|FG001|STARTED|Group B Crossover to Vigil Alone||1||
48543591|NCT03495921|101666944|FG000|COMPLETED|Group B Crossover to Vigil Alone||0||
48543592|NCT03495921|101666945|FG001|COMPLETED|Group B Crossover to Vigil Alone||1||
48543593|NCT03495921|101666944|FG000|NOT COMPLETED|Group B Crossover to Vigil Alone||0||
48543594|NCT03495921|101666945|FG001|NOT COMPLETED|Group B Crossover to Vigil Alone||0||
48543595|NCT00477633|101666946|FG000|STARTED|Overall Study||1700||
48543596|NCT00477633|101666946|FG000|COMPLETED|Overall Study||991||
48543597|NCT00477633|101666946|FG000|NOT COMPLETED|Overall Study||709||
48543598|NCT00396812|101666947|FG000|STARTED|Overall Study||4||
48543599|NCT00396812|101666947|FG000|COMPLETED|Overall Study||3||
48543600|NCT00396812|101666947|FG000|NOT COMPLETED|Overall Study||1||
48543601|NCT01973595|101666948|FG000|STARTED|Intervention Phase 1||15||
48543602|NCT01973595|101666949|FG001|STARTED|Intervention Phase 1||14||
48543603|NCT01973595|101666950|FG002|STARTED|Intervention Phase 1||15||
48543604|NCT01973595|101666951|FG003|STARTED|Intervention Phase 1||14||
48543605|NCT01973595|101666948|FG000|COMPLETED|Intervention Phase 1||15||
48543606|NCT01973595|101666949|FG001|COMPLETED|Intervention Phase 1||14||
48543607|NCT01973595|101666950|FG002|COMPLETED|Intervention Phase 1||15||
48543608|NCT01973595|101666951|FG003|COMPLETED|Intervention Phase 1||14||
48543609|NCT01973595|101666948|FG000|NOT COMPLETED|Intervention Phase 1||0||
48543610|NCT01973595|101666949|FG001|NOT COMPLETED|Intervention Phase 1||0||
48543611|NCT01973595|101666950|FG002|NOT COMPLETED|Intervention Phase 1||0||
48543612|NCT01973595|101666951|FG003|NOT COMPLETED|Intervention Phase 1||0||
48543613|NCT01973595|101666948|FG000|STARTED|Washout||15||
48543614|NCT01973595|101666949|FG001|STARTED|Washout||14||
48543615|NCT01973595|101666950|FG002|STARTED|Washout||15||
48543616|NCT01973595|101666951|FG003|STARTED|Washout||14||
48097589|NCT02246673|100563744|FG003|COMPLETED|Overall Study||12||
48097590|NCT02246673|100563745|FG004|COMPLETED|Overall Study||11||
48097591|NCT02246673|100563741|FG000|NOT COMPLETED|Overall Study||1||
48097592|NCT02246673|100563742|FG001|NOT COMPLETED|Overall Study||0||
48097593|NCT02246673|100563743|FG002|NOT COMPLETED|Overall Study||0||
48097594|NCT02246673|100563744|FG003|NOT COMPLETED|Overall Study||2||
48543617|NCT01973595|101666948|FG000|COMPLETED|Washout||14||
48543618|NCT01973595|101666949|FG001|COMPLETED|Washout||14||
48543619|NCT01973595|101666950|FG002|COMPLETED|Washout||14||
48690254|NCT02544035|102025804|FG007|STARTED|Overall Study||60||
48097595|NCT02246673|100563745|FG004|NOT COMPLETED|Overall Study||1||
48097596|NCT02024867|100563746|FG000|STARTED|Overall Study||134||
48097597|NCT02024867|100563747|FG001|STARTED|Overall Study||131||
48097598|NCT02024867|100563746|FG000|COMPLETED|Overall Study||125||
48097599|NCT02024867|100563747|FG001|COMPLETED|Overall Study||124||
48097600|NCT02024867|100563746|FG000|NOT COMPLETED|Overall Study||9||
48690255|NCT02544035|102025797|FG000|COMPLETED|Overall Study||60||
48097601|NCT02024867|100563747|FG001|NOT COMPLETED|Overall Study||7||
48097602|NCT01675128|100563748|FG000|STARTED|Overall Study||4||
48097603|NCT01675128|100563749|FG001|STARTED|Overall Study||10||
48097604|NCT01675128|100563750|FG002|STARTED|Overall Study||10||
48097605|NCT01675128|100563748|FG000|COMPLETED|Overall Study||2||
48261340|NCT04182113|100962653|FG000|COMPLETED|Second Intervention (Week 2)||4||
48261341|NCT04182113|100962654|FG001|COMPLETED|Second Intervention (Week 2)||5||
48261342|NCT04182113|100962655|FG002|COMPLETED|Second Intervention (Week 2)||4||
48261343|NCT04182113|100962656|FG003|COMPLETED|Second Intervention (Week 2)||4||
48690256|NCT02544035|102025798|FG001|COMPLETED|Overall Study||61||
48097606|NCT01675128|100563749|FG001|COMPLETED|Overall Study||8||
48097607|NCT01675128|100563750|FG002|COMPLETED|Overall Study||9||
48097608|NCT01675128|100563748|FG000|NOT COMPLETED|Overall Study||2||
48097609|NCT01675128|100563749|FG001|NOT COMPLETED|Overall Study||2||
48097610|NCT01675128|100563750|FG002|NOT COMPLETED|Overall Study||1||
48097611|NCT02877082|100563751|FG000|STARTED|Overall Study||5||
48097612|NCT02877082|100563751|FG000|COMPLETED|Overall Study||0||
48097613|NCT02877082|100563751|FG000|NOT COMPLETED|Overall Study||5||
48097614|NCT01782859|100563752|FG000|STARTED|Overall Study||20||
48097615|NCT01782859|100563753|FG001|STARTED|Overall Study||20||
48261344|NCT04182113|100962657|FG004|COMPLETED|Second Intervention (Week 2)||3||
48543620|NCT01973595|101666951|FG003|COMPLETED|Washout||14||
48543621|NCT01973595|101666948|FG000|NOT COMPLETED|Washout||1||
48543622|NCT01973595|101666949|FG001|NOT COMPLETED|Washout||0||
48543623|NCT01973595|101666950|FG002|NOT COMPLETED|Washout||1||
48543624|NCT01973595|101666951|FG003|NOT COMPLETED|Washout||0||
48543625|NCT01973595|101666948|FG000|STARTED|Intervention Phase 2||14||
48543626|NCT01973595|101666949|FG001|STARTED|Intervention Phase 2||14||
48543627|NCT01973595|101666950|FG002|STARTED|Intervention Phase 2||14||
48543628|NCT01973595|101666951|FG003|STARTED|Intervention Phase 2||14||
48543629|NCT01973595|101666948|FG000|COMPLETED|Intervention Phase 2||14||
48543630|NCT01973595|101666949|FG001|COMPLETED|Intervention Phase 2||14||
48543631|NCT01973595|101666950|FG002|COMPLETED|Intervention Phase 2||14||
48543632|NCT01973595|101666951|FG003|COMPLETED|Intervention Phase 2||14||
48543633|NCT01973595|101666948|FG000|NOT COMPLETED|Intervention Phase 2||0||
48543634|NCT01973595|101666949|FG001|NOT COMPLETED|Intervention Phase 2||0||
48543635|NCT01973595|101666950|FG002|NOT COMPLETED|Intervention Phase 2||0||
48543636|NCT01973595|101666951|FG003|NOT COMPLETED|Intervention Phase 2||0||
48543637|NCT00993421|101666952|FG000|STARTED|Overall Study||49||
48543638|NCT00993421|101666953|FG001|STARTED|Overall Study||49||
48543639|NCT00993421|101666954|FG002|STARTED|Overall Study||48||
48690257|NCT02544035|102025799|FG002|COMPLETED|Overall Study||62||
48690258|NCT02544035|102025800|FG003|COMPLETED|Overall Study||60||
48690259|NCT02544035|102025801|FG004|COMPLETED|Overall Study||60||
48690260|NCT02544035|102025802|FG005|COMPLETED|Overall Study||61||
48690261|NCT02544035|102025803|FG006|COMPLETED|Overall Study||62||
48690262|NCT02544035|102025804|FG007|COMPLETED|Overall Study||60||
48690263|NCT02544035|102025797|FG000|NOT COMPLETED|Overall Study||0||
48097616|NCT01782859|100563752|FG000|COMPLETED|Overall Study||14||
48097617|NCT01782859|100563753|FG001|COMPLETED|Overall Study||13||
48097618|NCT01782859|100563752|FG000|NOT COMPLETED|Overall Study||6||
48097619|NCT01782859|100563753|FG001|NOT COMPLETED|Overall Study||7||
48097620|NCT01794806|100563754|FG000|STARTED|Overall Study||31||
48097621|NCT01794806|100563755|FG001|STARTED|Overall Study||28||
48097622|NCT01794806|100563754|FG000|1 Week|Overall Study||28||
48097623|NCT01794806|100563755|FG001|1 Week|Overall Study||28||
48097624|NCT01794806|100563754|FG000|4 Weeks|Overall Study||26||
48097625|NCT01794806|100563755|FG001|4 Weeks|Overall Study||27||
48097626|NCT01794806|100563754|FG000|COMPLETED|Overall Study||26||
48097627|NCT01794806|100563755|FG001|COMPLETED|Overall Study||27||
48097628|NCT01794806|100563754|FG000|NOT COMPLETED|Overall Study||5||
48097629|NCT01794806|100563755|FG001|NOT COMPLETED|Overall Study||1||
48097630|NCT00887354|100563756|FG000|STARTED|Treatment Phase (Week 0 to Week 26)||111||
48097631|NCT00887354|100563757|FG001|STARTED|Treatment Phase (Week 0 to Week 26)||113||
48097632|NCT00887354|100563756|FG000|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||106||
48097633|NCT00887354|100563757|FG001|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||110||
48097634|NCT00887354|100563756|FG000|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||86||
48097635|NCT00887354|100563757|FG001|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||85||
48097636|NCT00887354|100563756|FG000|COMPLETED|Treatment Phase (Week 0 to Week 26)||60||
48097637|NCT00887354|100563757|FG001|COMPLETED|Treatment Phase (Week 0 to Week 26)||65||
48097638|NCT00887354|100563756|FG000|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||51||
48097639|NCT00887354|100563757|FG001|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||48||
48543640|NCT00993421|101666955|FG003|STARTED|Overall Study||49||
48543641|NCT00993421|101666956|FG004|STARTED|Overall Study||52||
48543642|NCT00993421|101666957|FG005|STARTED|Overall Study||50||
48097640|NCT00887354|100563756|FG000|STARTED|Open Label Phase (Week 26 to Week 78)||60||
48097641|NCT00887354|100563757|FG001|STARTED|Open Label Phase (Week 26 to Week 78)||65||
48097642|NCT00887354|100563756|FG000|COMPLETED|Open Label Phase (Week 26 to Week 78)||57||
48097643|NCT00887354|100563757|FG001|COMPLETED|Open Label Phase (Week 26 to Week 78)||59||
48097644|NCT00887354|100563756|FG000|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||3||
48097645|NCT00887354|100563757|FG001|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||6||
48097646|NCT01374087|100563758|FG000|STARTED|Overall Study||16|Subjects treated|
48097647|NCT01374087|100563759|FG001|STARTED|Overall Study||15|Subjects treated|
48097648|NCT01374087|100563758|FG000|COMPLETED|Overall Study||0||
48543643|NCT00993421|101666958|FG006|STARTED|Overall Study||46||
48097649|NCT01374087|100563759|FG001|COMPLETED|Overall Study||0||
48097650|NCT01374087|100563758|FG000|NOT COMPLETED|Overall Study||16||
48097651|NCT01374087|100563759|FG001|NOT COMPLETED|Overall Study||15||
48097652|NCT00841087|100563760|FG000|STARTED|Overall Study||33||
48097653|NCT00841087|100563761|FG001|STARTED|Overall Study||32||
48097654|NCT00841087|100563760|FG000|COMPLETED|Overall Study||33||
48097655|NCT00841087|100563761|FG001|COMPLETED|Overall Study||32||
48097656|NCT00841087|100563760|FG000|NOT COMPLETED|Overall Study||0||
48097657|NCT00841087|100563761|FG001|NOT COMPLETED|Overall Study||0||
48097658|NCT05359666|100563762|FG000|STARTED|Overall Study||294||
48097659|NCT05359666|100563763|FG001|STARTED|Overall Study||298||
48097660|NCT05359666|100563762|FG000|COMPLETED|Overall Study||294||
48097661|NCT05359666|100563763|FG001|COMPLETED|Overall Study||298||
48097662|NCT05359666|100563762|FG000|NOT COMPLETED|Overall Study||0||
48097663|NCT05359666|100563763|FG001|NOT COMPLETED|Overall Study||0||
48097664|NCT03556579|100563764|FG000|STARTED|Visit 1||16||
48097665|NCT03556579|100563765|FG001|STARTED|Visit 1||14||
48097666|NCT03556579|100563766|FG002|STARTED|Visit 1||14||
48097667|NCT03556579|100563767|FG003|STARTED|Visit 1||16||
48097668|NCT03556579|100563764|FG000|COMPLETED|Visit 1||16||
48097669|NCT03556579|100563765|FG001|COMPLETED|Visit 1||14||
48097670|NCT03556579|100563766|FG002|COMPLETED|Visit 1||14||
48097671|NCT03556579|100563767|FG003|COMPLETED|Visit 1||16||
48097672|NCT03556579|100563764|FG000|NOT COMPLETED|Visit 1||0||
48097673|NCT03556579|100563765|FG001|NOT COMPLETED|Visit 1||0||
48097674|NCT03556579|100563766|FG002|NOT COMPLETED|Visit 1||0||
48097675|NCT03556579|100563767|FG003|NOT COMPLETED|Visit 1||0||
48097676|NCT03556579|100563764|FG000|STARTED|Visit 2||16||
48097677|NCT03556579|100563765|FG001|STARTED|Visit 2||14||
48097678|NCT03556579|100563766|FG002|STARTED|Visit 2||14||
48097679|NCT03556579|100563767|FG003|STARTED|Visit 2||16||
48097680|NCT03556579|100563764|FG000|COMPLETED|Visit 2||16||
48097681|NCT03556579|100563765|FG001|COMPLETED|Visit 2||14||
48097682|NCT03556579|100563766|FG002|COMPLETED|Visit 2||14||
48097683|NCT03556579|100563767|FG003|COMPLETED|Visit 2||16||
48097684|NCT03556579|100563764|FG000|NOT COMPLETED|Visit 2||0||
48097685|NCT03556579|100563765|FG001|NOT COMPLETED|Visit 2||0||
48097686|NCT03556579|100563766|FG002|NOT COMPLETED|Visit 2||0||
48097687|NCT03556579|100563767|FG003|NOT COMPLETED|Visit 2||0||
48097688|NCT02532647|100563768|FG000|STARTED|Overall Study||32||
48097689|NCT02532647|100563769|FG001|STARTED|Overall Study||16||
48097690|NCT02532647|100563770|FG002|STARTED|Overall Study||31||
48097691|NCT02532647|100563768|FG000|Safety Population|Overall Study||31|Safety Population: all randomised patients who received any amount of trial drug|
48097692|NCT02532647|100563769|FG001|Safety Population|Overall Study||16|Safety Population: all randomised patients who received any amount of trial drug|
48097693|NCT02532647|100563770|FG002|Safety Population|Overall Study||30|Safety Population: all randomised patients who received any amount of trial drug|
48097694|NCT02532647|100563768|FG000|COMPLETED|Overall Study||31||
48097695|NCT02532647|100563769|FG001|COMPLETED|Overall Study||16||
48097696|NCT02532647|100563770|FG002|COMPLETED|Overall Study||30||
48097697|NCT02532647|100563768|FG000|NOT COMPLETED|Overall Study||1||
48097698|NCT02532647|100563769|FG001|NOT COMPLETED|Overall Study||0||
48097699|NCT02532647|100563770|FG002|NOT COMPLETED|Overall Study||1||
48097700|NCT01528254|100563771|FG000|STARTED|Overall Study||998|All randomized patients (RAN)|
48097701|NCT01528254|100563772|FG001|STARTED|Overall Study||1003|All randomized patients (RAN)|
48097702|NCT01528254|100563771|FG000|Safety Set|Overall Study||998|At least one dose of study medication|
48097703|NCT01528254|100563772|FG001|Safety Set|Overall Study||1001|At least one dose of study medication|
48097704|NCT01528254|100563771|FG000|Full Analysis Set (FAS)|Overall Study||983|At least one randomized study medication and a post-randomization efficacy parameter assessment.|
48097705|NCT01528254|100563772|FG001|Full Analysis Set (FAS)|Overall Study||989|At least one randomized study medication and a post-randomization efficacy parameter assessment.|
48097706|NCT01528254|100563771|FG000|Completed Treatment Period 1|Overall Study||458||
48097707|NCT01528254|100563772|FG001|Completed Treatment Period 1|Overall Study||273||
48097708|NCT01528254|100563771|FG000|Completed Treatment Period 2|Overall Study||244||
48097709|NCT01528254|100563772|FG001|Completed Treatment Period 2|Overall Study||399||
48097710|NCT01528254|100563771|FG000|Completed Treatment Period 3|Overall Study||109||
48097711|NCT01528254|100563772|FG001|Completed Treatment Period 3|Overall Study||115||
48097712|NCT01528254|100563771|FG000|COMPLETED|Overall Study||811||
48543644|NCT00993421|101666952|FG000|COMPLETED|Overall Study||5||
48097713|NCT01528254|100563772|FG001|COMPLETED|Overall Study||787||
48097714|NCT01528254|100563771|FG000|NOT COMPLETED|Overall Study||187||
48097715|NCT01528254|100563772|FG001|NOT COMPLETED|Overall Study||216||
48097716|NCT01622699|100563773|FG000|STARTED|Overall Study||213||
48097717|NCT01622699|100563774|FG001|STARTED|Overall Study||217||
48097718|NCT01622699|100563773|FG000|COMPLETED|Overall Study||213||
48097719|NCT01622699|100563774|FG001|COMPLETED|Overall Study||217||
48097720|NCT01622699|100563773|FG000|NOT COMPLETED|Overall Study||0||
48097721|NCT01622699|100563774|FG001|NOT COMPLETED|Overall Study||0||
48097722|NCT02545101|100563775|FG000|STARTED|Overall Study||100||
48097723|NCT02545101|100563775|FG000|COMPLETED|Overall Study||100||
48097724|NCT02545101|100563775|FG000|NOT COMPLETED|Overall Study||0||
48097725|NCT01365507|100563776|FG000|STARTED|Overall Study||136||
48097726|NCT01365507|100563777|FG001|STARTED|Overall Study||140||
48097727|NCT01365507|100563776|FG000|Exposed|Overall Study||134||
48097728|NCT01365507|100563777|FG001|Exposed|Overall Study||140||
48097729|NCT01365507|100563776|FG000|COMPLETED|Overall Study||127||
48097730|NCT01365507|100563777|FG001|COMPLETED|Overall Study||131||
48097731|NCT01365507|100563776|FG000|NOT COMPLETED|Overall Study||9||
48097732|NCT01365507|100563777|FG001|NOT COMPLETED|Overall Study||9||
48097733|NCT01531374|100563778|FG000|STARTED|Overall Study||1285||
48097734|NCT01531374|100563779|FG001|STARTED|Overall Study||373||
48097735|NCT01531374|100563780|FG002|STARTED|Overall Study||1119||
48097736|NCT01531374|100563778|FG000|COMPLETED|Overall Study||921||
48097737|NCT01531374|100563779|FG001|COMPLETED|Overall Study||231||
48097738|NCT01531374|100563780|FG002|COMPLETED|Overall Study||836||
48097739|NCT01531374|100563778|FG000|NOT COMPLETED|Overall Study||364||
48097740|NCT01531374|100563779|FG001|NOT COMPLETED|Overall Study||142||
48097741|NCT01531374|100563780|FG002|NOT COMPLETED|Overall Study||283||
48097742|NCT03453684|100563781|FG000|STARTED|Overall Study||60||
48261345|NCT04182113|100962658|FG005|COMPLETED|Second Intervention (Week 2)||4||
48261346|NCT04182113|100962653|FG000|NOT COMPLETED|Second Intervention (Week 2)||0||
48261347|NCT04182113|100962654|FG001|NOT COMPLETED|Second Intervention (Week 2)||0||
48261348|NCT04182113|100962655|FG002|NOT COMPLETED|Second Intervention (Week 2)||0||
48261349|NCT04182113|100962656|FG003|NOT COMPLETED|Second Intervention (Week 2)||0||
48261350|NCT04182113|100962657|FG004|NOT COMPLETED|Second Intervention (Week 2)||0||
48261351|NCT04182113|100962658|FG005|NOT COMPLETED|Second Intervention (Week 2)||0||
48261352|NCT04182113|100962653|FG000|STARTED|Third Intervention (Week 3)||4||
48261353|NCT04182113|100962654|FG001|STARTED|Third Intervention (Week 3)||5||
48261354|NCT04182113|100962655|FG002|STARTED|Third Intervention (Week 3)||4||
48261355|NCT04182113|100962656|FG003|STARTED|Third Intervention (Week 3)||4||
48261356|NCT04182113|100962657|FG004|STARTED|Third Intervention (Week 3)||3||
48261357|NCT04182113|100962658|FG005|STARTED|Third Intervention (Week 3)||3||
48690264|NCT02544035|102025798|FG001|NOT COMPLETED|Overall Study||0||
48690265|NCT02544035|102025799|FG002|NOT COMPLETED|Overall Study||0||
48690266|NCT02544035|102025800|FG003|NOT COMPLETED|Overall Study||0||
48690267|NCT02544035|102025801|FG004|NOT COMPLETED|Overall Study||0||
48690268|NCT02544035|102025802|FG005|NOT COMPLETED|Overall Study||0||
48690269|NCT02544035|102025803|FG006|NOT COMPLETED|Overall Study||0||
48690270|NCT02544035|102025804|FG007|NOT COMPLETED|Overall Study||0||
48690271|NCT01104402|102025805|FG000|STARTED|Overall Study||132||
48690272|NCT01104402|102025806|FG001|STARTED|Overall Study||135||
48690273|NCT01104402|102025805|FG000|COMPLETED|Overall Study||111||
48690274|NCT01104402|102025806|FG001|COMPLETED|Overall Study||102||
48690275|NCT01104402|102025805|FG000|NOT COMPLETED|Overall Study||21||
48261358|NCT04182113|100962653|FG000|COMPLETED|Third Intervention (Week 3)||4||
48261359|NCT04182113|100962654|FG001|COMPLETED|Third Intervention (Week 3)||5||
48261360|NCT04182113|100962655|FG002|COMPLETED|Third Intervention (Week 3)||4||
48261361|NCT04182113|100962656|FG003|COMPLETED|Third Intervention (Week 3)||4||
48261362|NCT04182113|100962657|FG004|COMPLETED|Third Intervention (Week 3)||3||
48261363|NCT04182113|100962658|FG005|COMPLETED|Third Intervention (Week 3)||3||
48261364|NCT04182113|100962653|FG000|NOT COMPLETED|Third Intervention (Week 3)||0||
48261365|NCT04182113|100962654|FG001|NOT COMPLETED|Third Intervention (Week 3)||0||
48261366|NCT04182113|100962655|FG002|NOT COMPLETED|Third Intervention (Week 3)||0||
48261367|NCT04182113|100962656|FG003|NOT COMPLETED|Third Intervention (Week 3)||0||
48261368|NCT04182113|100962657|FG004|NOT COMPLETED|Third Intervention (Week 3)||0||
48261369|NCT04182113|100962658|FG005|NOT COMPLETED|Third Intervention (Week 3)||0||
48261370|NCT02581059|100962659|FG000|STARTED|Study Treatment||4||
48690276|NCT01104402|102025806|FG001|NOT COMPLETED|Overall Study||33||
48097743|NCT03453684|100563781|FG000|COMPLETED|Overall Study||60||
48097744|NCT03453684|100563781|FG000|NOT COMPLETED|Overall Study||0||
48097745|NCT01522755|100563782|FG000|STARTED|Overall Study||409||
48097746|NCT01522755|100563782|FG000|COMPLETED|Overall Study||409||
48097747|NCT01522755|100563782|FG000|NOT COMPLETED|Overall Study||0||
48097748|NCT01786954|100563783|FG000|STARTED|Overall Study||34||
48097749|NCT01786954|100563784|FG001|STARTED|Overall Study||34||
48097750|NCT01786954|100563783|FG000|COMPLETED|Overall Study||34||
48097751|NCT01786954|100563784|FG001|COMPLETED|Overall Study||34||
48097752|NCT01786954|100563783|FG000|NOT COMPLETED|Overall Study||0||
48097753|NCT01786954|100563784|FG001|NOT COMPLETED|Overall Study||0||
48141388|NCT04764396|100670417|FG000|STARTED|Overall Study||1||
48097754|NCT02489344|100563785|FG000|STARTED|ACT13739 (Initial Study): 26 Weeks||11|Enrolled and treated.|
48097755|NCT02489344|100563785|FG000|COMPLETED|ACT13739 (Initial Study): 26 Weeks||9||
48097756|NCT02489344|100563785|FG000|NOT COMPLETED|ACT13739 (Initial Study): 26 Weeks||2||
48097757|NCT02489344|100563785|FG000|STARTED|LTS14116 (Extension Study): 31 Months||8|Enrolled and treated.|
48097758|NCT02489344|100563785|FG000|COMPLETED|LTS14116 (Extension Study): 31 Months||5|2 participant completed,not discontinued early,but counted not completed due to no completion record|
48097759|NCT02489344|100563785|FG000|NOT COMPLETED|LTS14116 (Extension Study): 31 Months||3||
48097760|NCT03878745|100563786|FG000|STARTED|Overall Study||55||
48097761|NCT03878745|100563786|FG000|COMPLETED|Overall Study||55||
48097762|NCT03878745|100563786|FG000|NOT COMPLETED|Overall Study||0||
48097763|NCT02085785|100563787|FG000|STARTED|Overall Study||7||
48097764|NCT02085785|100563788|FG001|STARTED|Overall Study||8||
48097765|NCT02085785|100563787|FG000|COMPLETED|Overall Study||5||
48097766|NCT02085785|100563788|FG001|COMPLETED|Overall Study||6||
48097767|NCT02085785|100563787|FG000|NOT COMPLETED|Overall Study||2||
48097768|NCT02085785|100563788|FG001|NOT COMPLETED|Overall Study||2||
48097769|NCT01558752|100563789|FG000|STARTED|Overall Study||42||
48097770|NCT01558752|100563790|FG001|STARTED|Overall Study||46||
48097771|NCT01558752|100563789|FG000|COMPLETED|Overall Study||40||
48097772|NCT01558752|100563790|FG001|COMPLETED|Overall Study||46||
48097773|NCT01558752|100563789|FG000|NOT COMPLETED|Overall Study||2||
48097774|NCT01558752|100563790|FG001|NOT COMPLETED|Overall Study||0||
48097775|NCT00535990|100563791|FG000|STARTED|Overall Study||250||
48097776|NCT00535990|100563791|FG000|COMPLETED|Overall Study||250||
48097777|NCT00535990|100563791|FG000|NOT COMPLETED|Overall Study||0||
48097778|NCT02410954|100563792|FG000|STARTED|Overall Study||14||
48097779|NCT02410954|100563793|FG001|STARTED|Overall Study||0||
48097780|NCT02410954|100563792|FG000|COMPLETED|Overall Study||0||
48097781|NCT02410954|100563793|FG001|COMPLETED|Overall Study||0||
48097782|NCT02410954|100563792|FG000|NOT COMPLETED|Overall Study||14||
48097783|NCT02410954|100563793|FG001|NOT COMPLETED|Overall Study||0||
48097784|NCT00227903|100563794|FG000|STARTED|Overall Study||91||
48097785|NCT00227903|100563795|FG001|STARTED|Overall Study||92||
48097786|NCT00227903|100563794|FG000|Received ≥ 1 Follow-up Assessment|Overall Study||86||
48097787|NCT00227903|100563795|FG001|Received ≥ 1 Follow-up Assessment|Overall Study||82||
48097788|NCT00227903|100563794|FG000|COMPLETED|Overall Study||86||
48097789|NCT00227903|100563795|FG001|COMPLETED|Overall Study||82||
48097790|NCT00227903|100563794|FG000|NOT COMPLETED|Overall Study||5||
48097791|NCT00227903|100563795|FG001|NOT COMPLETED|Overall Study||10||
48097792|NCT00862446|100563796|FG000|STARTED|Overall Study||48||
48097793|NCT00862446|100563796|FG000|COMPLETED|Overall Study||48||
48097794|NCT00862446|100563796|FG000|NOT COMPLETED|Overall Study||0||
48097795|NCT03019107|100563797|FG000|STARTED|Overall Study||1||
48097796|NCT03019107|100563798|FG001|STARTED|Overall Study||0||
48097797|NCT03019107|100563797|FG000|COMPLETED|Overall Study||1||
48097798|NCT03019107|100563798|FG001|COMPLETED|Overall Study||0||
48097799|NCT03019107|100563797|FG000|NOT COMPLETED|Overall Study||0||
48097800|NCT03019107|100563798|FG001|NOT COMPLETED|Overall Study||0||
48097801|NCT02406651|100563799|FG000|STARTED|Overall Study||30||
48097802|NCT02406651|100563799|FG000|COMPLETED|Overall Study||27||
48097803|NCT02406651|100563799|FG000|NOT COMPLETED|Overall Study||3||
48097804|NCT02074631|100563800|FG000|STARTED|Overall Study||32||
48390112|NCT02322411|101283516|FG000|All Baseline Measures Analyzed|Overall Study||13||
48390113|NCT02322411|101283517|FG001|All Baseline Measures Analyzed|Overall Study||16||
48390114|NCT02322411|101283516|FG000|COMPLETED|Overall Study||9||
48390115|NCT02322411|101283517|FG001|COMPLETED|Overall Study||9||
48390116|NCT02322411|101283516|FG000|NOT COMPLETED|Overall Study||5||
48390117|NCT02322411|101283517|FG001|NOT COMPLETED|Overall Study||7||
48390118|NCT01406652|101283518|FG000|STARTED|Overall Study||109||
48390119|NCT01406652|101283519|FG001|STARTED|Overall Study||115||
48390120|NCT01406652|101283518|FG000|COMPLETED|Overall Study||89||
48390121|NCT01406652|101283519|FG001|COMPLETED|Overall Study||95||
48390122|NCT01406652|101283518|FG000|NOT COMPLETED|Overall Study||20||
48261371|NCT02581059|100962660|FG001|STARTED|Study Treatment||6||
48261372|NCT02581059|100962659|FG000|COMPLETED|Study Treatment||0||
48261373|NCT02581059|100962660|FG001|COMPLETED|Study Treatment||1||
48261374|NCT02581059|100962659|FG000|NOT COMPLETED|Study Treatment||4||
48261375|NCT02581059|100962660|FG001|NOT COMPLETED|Study Treatment||5||
48261376|NCT02581059|100962659|FG000|STARTED|Follow up||3|Treatment and Follow up both are at different time period. Therefore, the number of subjects to start follow up is not equal to the number of subjects who have completed treatment.|
48261377|NCT02581059|100962660|FG001|STARTED|Follow up||5|Treatment and Follow up both are at different time period. Therefore, the number of subjects to start follow up is not equal to the number of subjects who have completed treatment.|
48261378|NCT02581059|100962659|FG000|COMPLETED|Follow up||0||
48261379|NCT02581059|100962660|FG001|COMPLETED|Follow up||0||
48261380|NCT02581059|100962659|FG000|NOT COMPLETED|Follow up||3||
48261381|NCT02581059|100962660|FG001|NOT COMPLETED|Follow up||5||
48261382|NCT04120376|100962661|FG000|STARTED|Overall Study||108||
48261383|NCT04120376|100962662|FG001|STARTED|Overall Study||27||
48261384|NCT04120376|100962661|FG000|COMPLETED|Overall Study||99||
48261385|NCT04120376|100962662|FG001|COMPLETED|Overall Study||27||
48261386|NCT04120376|100962661|FG000|NOT COMPLETED|Overall Study||9||
48261387|NCT04120376|100962662|FG001|NOT COMPLETED|Overall Study||0||
48261388|NCT03229486|100962663|FG000|STARTED|Overall Study||20||
48261389|NCT03229486|100962664|FG001|STARTED|Overall Study||20||
48261390|NCT03229486|100962663|FG000|COMPLETED|Overall Study||20||
48261391|NCT03229486|100962664|FG001|COMPLETED|Overall Study||19||
48390123|NCT01406652|101283519|FG001|NOT COMPLETED|Overall Study||20||
48390124|NCT03736629|101283520|FG000|STARTED|Overall Study||3||
48261392|NCT03229486|100962663|FG000|NOT COMPLETED|Overall Study||0||
48261393|NCT03229486|100962664|FG001|NOT COMPLETED|Overall Study||1||
48261394|NCT01834586|100962665|FG000|STARTED|Overall Study||30||
48261395|NCT01834586|100962665|FG000|COMPLETED|Overall Study||29||
48261396|NCT01834586|100962665|FG000|NOT COMPLETED|Overall Study||1||
48261397|NCT02684123|100962666|FG000|STARTED|Phase 1||20||
48261398|NCT02684123|100962667|FG001|STARTED|Phase 1||10||
48261399|NCT02684123|100962666|FG000|COMPLETED|Phase 1||12||
48261400|NCT02684123|100962667|FG001|COMPLETED|Phase 1||9||
48261401|NCT02684123|100962666|FG000|NOT COMPLETED|Phase 1||8||
48261402|NCT02684123|100962667|FG001|NOT COMPLETED|Phase 1||1||
48261403|NCT02684123|100962666|FG000|STARTED|Eligibility Determination for Phase 2||12||
48261404|NCT02684123|100962667|FG001|STARTED|Eligibility Determination for Phase 2||9||
48261405|NCT02684123|100962666|FG000|COMPLETED|Eligibility Determination for Phase 2||1||
48261406|NCT02684123|100962667|FG001|COMPLETED|Eligibility Determination for Phase 2||9||
48261407|NCT02684123|100962666|FG000|NOT COMPLETED|Eligibility Determination for Phase 2||11||
48261408|NCT02684123|100962667|FG001|NOT COMPLETED|Eligibility Determination for Phase 2||0||
48261409|NCT02684123|100962666|FG000|STARTED|Phase 2||1||
48261410|NCT02684123|100962667|FG001|STARTED|Phase 2||9||
48261411|NCT02684123|100962666|FG000|COMPLETED|Phase 2||0||
48261412|NCT02684123|100962667|FG001|COMPLETED|Phase 2||1||
48261413|NCT02684123|100962666|FG000|NOT COMPLETED|Phase 2||1||
48261414|NCT02684123|100962667|FG001|NOT COMPLETED|Phase 2||8||
48261415|NCT03563313|100962668|FG000|STARTED|Overall Study||112||
48261416|NCT03563313|100962669|FG001|STARTED|Overall Study||56||
48261417|NCT03563313|100962668|FG000|COMPLETED|Overall Study||112||
48261418|NCT03563313|100962669|FG001|COMPLETED|Overall Study||56||
48261419|NCT03563313|100962668|FG000|NOT COMPLETED|Overall Study||0||
48261420|NCT03563313|100962669|FG001|NOT COMPLETED|Overall Study||0||
48261421|NCT01628692|100962670|FG000|STARTED|Overall Study||53||
48261422|NCT01628692|100962671|FG001|STARTED|Overall Study||23||
48261423|NCT01628692|100962672|FG002|STARTED|Overall Study||51||
48261424|NCT01628692|100962673|FG003|STARTED|Overall Study||20||
48261425|NCT01628692|100962674|FG004|STARTED|Overall Study||12||
48261426|NCT01628692|100962675|FG005|STARTED|Overall Study||9||
48261427|NCT01628692|100962670|FG000|COMPLETED|Overall Study||46||
48261428|NCT01628692|100962671|FG001|COMPLETED|Overall Study||17||
48261429|NCT01628692|100962672|FG002|COMPLETED|Overall Study||43||
48261430|NCT01628692|100962673|FG003|COMPLETED|Overall Study||19||
48261431|NCT01628692|100962674|FG004|COMPLETED|Overall Study||8||
48261432|NCT01628692|100962675|FG005|COMPLETED|Overall Study||0||
48261433|NCT01628692|100962670|FG000|NOT COMPLETED|Overall Study||7||
48261434|NCT01628692|100962671|FG001|NOT COMPLETED|Overall Study||6||
48390125|NCT03736629|101283521|FG001|STARTED|Overall Study||2||
48390126|NCT03736629|101283522|FG002|STARTED|Overall Study||12||
48390127|NCT03736629|101283520|FG000|COMPLETED|Overall Study||3||
48390128|NCT03736629|101283521|FG001|COMPLETED|Overall Study||2||
48390129|NCT03736629|101283522|FG002|COMPLETED|Overall Study||12||
48390130|NCT03736629|101283520|FG000|NOT COMPLETED|Overall Study||0||
48390131|NCT03736629|101283521|FG001|NOT COMPLETED|Overall Study||0||
48390132|NCT03736629|101283522|FG002|NOT COMPLETED|Overall Study||0||
48390133|NCT02680587|101283523|FG000|STARTED|Overall Study||18||
48390134|NCT02680587|101283524|FG001|STARTED|Overall Study||36||
48390135|NCT02680587|101283523|FG000|COMPLETED|Overall Study||17||
48390136|NCT02680587|101283524|FG001|COMPLETED|Overall Study||36||
48390137|NCT02680587|101283523|FG000|NOT COMPLETED|Overall Study||1||
48390138|NCT02680587|101283524|FG001|NOT COMPLETED|Overall Study||0||
48390139|NCT01815580|101283525|FG000|STARTED|Overall Study||110||
48543645|NCT00993421|101666953|FG001|COMPLETED|Overall Study||4||
48543646|NCT00993421|101666954|FG002|COMPLETED|Overall Study||5||
48543647|NCT00993421|101666955|FG003|COMPLETED|Overall Study||4||
48390140|NCT01815580|101283526|FG001|STARTED|Overall Study||115||
48390141|NCT01815580|101283525|FG000|COMPLETED|Overall Study||98||
48390142|NCT01815580|101283526|FG001|COMPLETED|Overall Study||100||
48390143|NCT01815580|101283525|FG000|NOT COMPLETED|Overall Study||12||
48390144|NCT01815580|101283526|FG001|NOT COMPLETED|Overall Study||15||
48390145|NCT05200455|101283527|FG000|STARTED|Overall Study||34||
48390146|NCT05200455|101283527|FG000|COMPLETED|Overall Study||30||
48390147|NCT05200455|101283527|FG000|NOT COMPLETED|Overall Study||4||
48390148|NCT03372603|101283528|FG000|STARTED|Treatment Period 1 (Up to 7 Days)||9||
48390149|NCT03372603|101283529|FG001|STARTED|Treatment Period 1 (Up to 7 Days)||8||
48543648|NCT00993421|101666956|FG004|COMPLETED|Overall Study||6||
48543649|NCT00993421|101666957|FG005|COMPLETED|Overall Study||4||
48390150|NCT03372603|101283528|FG000|COMPLETED|Treatment Period 1 (Up to 7 Days)||9||
48390151|NCT03372603|101283529|FG001|COMPLETED|Treatment Period 1 (Up to 7 Days)||8||
48390152|NCT03372603|101283528|FG000|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0||
48690277|NCT00135330|102025807|FG000|STARTED|Overall Study||45||
48690278|NCT00135330|102025808|FG001|STARTED|Overall Study||47||
48261435|NCT01628692|100962672|FG002|NOT COMPLETED|Overall Study||8||
48543650|NCT00993421|101666958|FG006|COMPLETED|Overall Study||4||
48543651|NCT00993421|101666952|FG000|NOT COMPLETED|Overall Study||44||
48543652|NCT00993421|101666953|FG001|NOT COMPLETED|Overall Study||45||
48543653|NCT00993421|101666954|FG002|NOT COMPLETED|Overall Study||43||
48543654|NCT00993421|101666955|FG003|NOT COMPLETED|Overall Study||45||
48543655|NCT00993421|101666956|FG004|NOT COMPLETED|Overall Study||46||
48543656|NCT00993421|101666957|FG005|NOT COMPLETED|Overall Study||46||
48543657|NCT00993421|101666958|FG006|NOT COMPLETED|Overall Study||42||
48543658|NCT01546454|101666959|FG000|STARTED|Natural Menstrual Cycle||4||
48543659|NCT01546454|101666959|FG000|COMPLETED|Natural Menstrual Cycle||4||
48543660|NCT01546454|101666959|FG000|NOT COMPLETED|Natural Menstrual Cycle||0||
48543661|NCT01546454|101666959|FG000|STARTED|Oral Contraceptive Cycle||4||
48543662|NCT01546454|101666959|FG000|COMPLETED|Oral Contraceptive Cycle||4||
48543663|NCT01546454|101666959|FG000|NOT COMPLETED|Oral Contraceptive Cycle||0||
48543664|NCT01546454|101666959|FG000|STARTED|Eligard Treatment||4||
48543665|NCT01546454|101666959|FG000|COMPLETED|Eligard Treatment||4||
48543666|NCT01546454|101666959|FG000|NOT COMPLETED|Eligard Treatment||0||
48543667|NCT01546454|101666959|FG000|STARTED|Estrogen/Progesterone Replacement Cycle||4||
48543668|NCT01546454|101666959|FG000|COMPLETED|Estrogen/Progesterone Replacement Cycle||4||
48543669|NCT01546454|101666959|FG000|NOT COMPLETED|Estrogen/Progesterone Replacement Cycle||0||
48543670|NCT00425373|101666960|FG000|STARTED|Overall Study||159||
48543671|NCT00425373|101666961|FG001|STARTED|Overall Study||167||
48543672|NCT00425373|101666962|FG002|STARTED|Overall Study||160||
48543673|NCT00425373|101666963|FG003|STARTED|Overall Study||162||
48543674|NCT00425373|101666964|FG004|STARTED|Overall Study||169||
48543675|NCT00425373|101666965|FG005|STARTED|Overall Study||163||
48543676|NCT00425373|101666966|FG006|STARTED|Overall Study||161||
48543677|NCT00425373|101666967|FG007|STARTED|Overall Study||161||
48543678|NCT00425373|101666968|FG008|STARTED|Overall Study||166||
48543679|NCT00425373|101666960|FG000|COMPLETED|Overall Study||154||
48543680|NCT00425373|101666961|FG001|COMPLETED|Overall Study||164||
48543681|NCT00425373|101666962|FG002|COMPLETED|Overall Study||157||
48690279|NCT00135330|102025809|FG002|STARTED|Overall Study||45||
48690280|NCT00135330|102025807|FG000|COMPLETED|Overall Study||33||
48690281|NCT00135330|102025808|FG001|COMPLETED|Overall Study||34||
48261436|NCT01628692|100962673|FG003|NOT COMPLETED|Overall Study||1||
48261437|NCT01628692|100962674|FG004|NOT COMPLETED|Overall Study||4||
48261438|NCT01628692|100962675|FG005|NOT COMPLETED|Overall Study||9||
48261439|NCT00944229|100962676|FG000|STARTED|Overall Study||58||
48261440|NCT00944229|100962676|FG000|COMPLETED|Overall Study||33||
48261441|NCT00944229|100962676|FG000|NOT COMPLETED|Overall Study||25||
48261442|NCT00513747|100962677|FG000|STARTED|Overall Study||17||
48261443|NCT00513747|100962678|FG001|STARTED|Overall Study||11||
48261444|NCT00513747|100962679|FG002|STARTED|Overall Study||55||
48390153|NCT03372603|101283529|FG001|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0||
48390154|NCT03372603|101283528|FG000|STARTED|Wash-out Period (14-21 Days)||9||
48390155|NCT03372603|101283529|FG001|STARTED|Wash-out Period (14-21 Days)||8||
48390156|NCT03372603|101283528|FG000|COMPLETED|Wash-out Period (14-21 Days)||8||
48390157|NCT03372603|101283529|FG001|COMPLETED|Wash-out Period (14-21 Days)||8||
48390158|NCT03372603|101283528|FG000|NOT COMPLETED|Wash-out Period (14-21 Days)||1||
48390159|NCT03372603|101283529|FG001|NOT COMPLETED|Wash-out Period (14-21 Days)||0||
48390160|NCT03372603|101283528|FG000|STARTED|Treatment Period 2 (Up to 7 Days)||8||
48390161|NCT03372603|101283529|FG001|STARTED|Treatment Period 2 (Up to 7 Days)||8||
48390162|NCT03372603|101283528|FG000|COMPLETED|Treatment Period 2 (Up to 7 Days)||7||
48390163|NCT03372603|101283529|FG001|COMPLETED|Treatment Period 2 (Up to 7 Days)||8||
48390164|NCT03372603|101283528|FG000|NOT COMPLETED|Treatment Period 2 (Up to 7 Days)||1||
48390165|NCT03372603|101283529|FG001|NOT COMPLETED|Treatment Period 2 (Up to 7 Days)||0||
48390166|NCT00707343|101283530|FG000|STARTED|Overall Study||15||
48390167|NCT00707343|101283530|FG000|COMPLETED|Overall Study||15||
48543682|NCT00425373|101666963|FG003|COMPLETED|Overall Study||160||
48543683|NCT00425373|101666964|FG004|COMPLETED|Overall Study||159||
48543684|NCT00425373|101666965|FG005|COMPLETED|Overall Study||154||
48543685|NCT00425373|101666966|FG006|COMPLETED|Overall Study||154||
48543686|NCT00425373|101666967|FG007|COMPLETED|Overall Study||151||
48543687|NCT00425373|101666968|FG008|COMPLETED|Overall Study||148||
48543688|NCT00425373|101666960|FG000|NOT COMPLETED|Overall Study||5||
48543689|NCT00425373|101666961|FG001|NOT COMPLETED|Overall Study||3||
48543690|NCT00425373|101666962|FG002|NOT COMPLETED|Overall Study||3||
48543691|NCT00425373|101666963|FG003|NOT COMPLETED|Overall Study||2||
48261445|NCT00513747|100962677|FG000|Received at Least One Dose of Treatment|Overall Study||9|Participants received at least one dose of treatment and were evaluated for adverse events.|
48294150|NCT02527343|101047536|FG000|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0||
48390168|NCT00707343|101283530|FG000|NOT COMPLETED|Overall Study||0||
48390169|NCT02671461|101283531|FG000|STARTED|Treatment||3||
48690282|NCT00135330|102025809|FG002|COMPLETED|Overall Study||34||
48390170|NCT02671461|101283532|FG001|STARTED|Treatment||5||
48390171|NCT02671461|101283533|FG002|STARTED|Treatment||7||
48390172|NCT02671461|101283531|FG000|COMPLETED|Treatment||1||
48390173|NCT02671461|101283532|FG001|COMPLETED|Treatment||2||
48543692|NCT00425373|101666964|FG004|NOT COMPLETED|Overall Study||10||
48543693|NCT00425373|101666965|FG005|NOT COMPLETED|Overall Study||9||
48543694|NCT00425373|101666966|FG006|NOT COMPLETED|Overall Study||7||
48543695|NCT00425373|101666967|FG007|NOT COMPLETED|Overall Study||10||
48543696|NCT00425373|101666968|FG008|NOT COMPLETED|Overall Study||18||
48543697|NCT03999749|101666969|FG000|STARTED|Overall Study||71||
48543698|NCT03999749|101666969|FG000|COMPLETED|Overall Study||16||
48261446|NCT00513747|100962678|FG001|Received at Least One Dose of Treatment|Overall Study||11|Participants received at least one dose of treatment and were evaluated for adverse events.|
48261447|NCT00513747|100962679|FG002|Received at Least One Dose of Treatment|Overall Study||40|Participants received at least one dose of treatment and were evaluated for adverse events.|
48261448|NCT00513747|100962677|FG000|COMPLETED|Overall Study||17||
48261449|NCT00513747|100962678|FG001|COMPLETED|Overall Study||11||
48390174|NCT02671461|101283533|FG002|COMPLETED|Treatment||2||
48543699|NCT03999749|101666969|FG000|NOT COMPLETED|Overall Study||55||
48543700|NCT00535405|101666970|FG000|STARTED|Overall Study||257||
48543701|NCT00535405|101666971|FG001|STARTED|Overall Study||259||
48543702|NCT00535405|101666972|FG002|STARTED|Overall Study||259||
48543703|NCT00535405|101666973|FG003|STARTED|Overall Study||257||
48543704|NCT00535405|101666974|FG004|STARTED|Overall Study||257||
48543705|NCT00535405|101666970|FG000|COMPLETED|Overall Study||240||
48543706|NCT00535405|101666971|FG001|COMPLETED|Overall Study||233||
48543707|NCT00535405|101666972|FG002|COMPLETED|Overall Study||241||
48543708|NCT00535405|101666973|FG003|COMPLETED|Overall Study||235||
48543709|NCT00535405|101666974|FG004|COMPLETED|Overall Study||241||
48543710|NCT00535405|101666970|FG000|NOT COMPLETED|Overall Study||17||
48543711|NCT00535405|101666971|FG001|NOT COMPLETED|Overall Study||26||
48543712|NCT00535405|101666972|FG002|NOT COMPLETED|Overall Study||18||
48543713|NCT00535405|101666973|FG003|NOT COMPLETED|Overall Study||22||
48543714|NCT00535405|101666974|FG004|NOT COMPLETED|Overall Study||16||
48543715|NCT00451048|101666975|FG000|STARTED|Overall Study||10||
48543716|NCT00451048|101666975|FG000|COMPLETED|Overall Study||10||
48543717|NCT00451048|101666975|FG000|NOT COMPLETED|Overall Study||0||
48543718|NCT04759768|101666976|FG000|STARTED|First Intervention (1 Day)||34||
48261450|NCT00513747|100962679|FG002|COMPLETED|Overall Study||55||
48261451|NCT00513747|100962677|FG000|NOT COMPLETED|Overall Study||0||
48261452|NCT00513747|100962678|FG001|NOT COMPLETED|Overall Study||0||
48261453|NCT00513747|100962679|FG002|NOT COMPLETED|Overall Study||0||
48261454|NCT01333111|100962680|FG000|STARTED|Overall Study||30||
48261455|NCT01333111|100962681|FG001|STARTED|Overall Study||29||
48390175|NCT02671461|101283531|FG000|NOT COMPLETED|Treatment||2||
48390176|NCT02671461|101283532|FG001|NOT COMPLETED|Treatment||3||
48390177|NCT02671461|101283533|FG002|NOT COMPLETED|Treatment||5||
48390178|NCT02671461|101283531|FG000|STARTED|Follow-up||2||
48390179|NCT02671461|101283532|FG001|STARTED|Follow-up||5||
48390180|NCT02671461|101283533|FG002|STARTED|Follow-up||7||
48390181|NCT02671461|101283531|FG000|COMPLETED|Follow-up||1||
48390182|NCT02671461|101283532|FG001|COMPLETED|Follow-up||4||
48390183|NCT02671461|101283533|FG002|COMPLETED|Follow-up||6||
48390184|NCT02671461|101283531|FG000|NOT COMPLETED|Follow-up||1||
48390185|NCT02671461|101283532|FG001|NOT COMPLETED|Follow-up||1||
48390186|NCT02671461|101283533|FG002|NOT COMPLETED|Follow-up||1||
48390187|NCT02887859|101283534|FG000|STARTED|Overall Study||15||
48390188|NCT02887859|101283534|FG000|COMPLETED|Overall Study||0||
48390189|NCT02887859|101283534|FG000|NOT COMPLETED|Overall Study||15||
48390190|NCT04671342|101283535|FG000|STARTED|Consented and Screened (Visit 1)||306||
48390191|NCT04671342|101283535|FG000|COMPLETED|Consented and Screened (Visit 1)||259||
48390192|NCT04671342|101283535|FG000|NOT COMPLETED|Consented and Screened (Visit 1)||47||
48390193|NCT04671342|101283535|FG000|STARTED|Completed Visit 2 With Evaluable Data||259||
48390194|NCT04671342|101283535|FG000|COMPLETED|Completed Visit 2 With Evaluable Data||200||
48390195|NCT04671342|101283535|FG000|NOT COMPLETED|Completed Visit 2 With Evaluable Data||59||
48390196|NCT02261883|101283536|FG000|STARTED|Overall Study||21||
48390197|NCT02261883|101283537|FG001|STARTED|Overall Study||21||
48390198|NCT02261883|101283536|FG000|COMPLETED|Overall Study||15||
48390199|NCT02261883|101283537|FG001|COMPLETED|Overall Study||18||
48390200|NCT02261883|101283536|FG000|NOT COMPLETED|Overall Study||6||
48390201|NCT02261883|101283537|FG001|NOT COMPLETED|Overall Study||3||
48390202|NCT00089479|101283538|FG000|STARTED|Overall Study||1304||
48390203|NCT00089479|101283539|FG001|STARTED|Overall Study||1307||
48390204|NCT00089479|101283538|FG000|Received Treatment|Overall Study||1305||
48390205|NCT00089479|101283539|FG001|Received Treatment|Overall Study||1283||
48390206|NCT00089479|101283538|FG000|COMPLETED|Overall Study||973||
48390207|NCT00089479|101283539|FG001|COMPLETED|Overall Study||1018||
48390208|NCT00089479|101283538|FG000|NOT COMPLETED|Overall Study||331||
48543719|NCT04759768|101666977|FG001|STARTED|First Intervention (1 Day)||34||
48543720|NCT04759768|101666976|FG000|COMPLETED|First Intervention (1 Day)||34||
48543721|NCT04759768|101666977|FG001|COMPLETED|First Intervention (1 Day)||34||
48543722|NCT04759768|101666976|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48543723|NCT04759768|101666977|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48543724|NCT04759768|101666976|FG000|STARTED|Washout (7 Days)||34||
48543725|NCT04759768|101666977|FG001|STARTED|Washout (7 Days)||34||
48543726|NCT04759768|101666976|FG000|COMPLETED|Washout (7 Days)||34||
48543727|NCT04759768|101666977|FG001|COMPLETED|Washout (7 Days)||32||
48543728|NCT04759768|101666976|FG000|NOT COMPLETED|Washout (7 Days)||0||
48543729|NCT04759768|101666977|FG001|NOT COMPLETED|Washout (7 Days)||2||
48543730|NCT04759768|101666976|FG000|STARTED|Second Intervention (1 Day)||34||
48543731|NCT04759768|101666977|FG001|STARTED|Second Intervention (1 Day)||32||
48543732|NCT04759768|101666976|FG000|COMPLETED|Second Intervention (1 Day)||34||
48543733|NCT04759768|101666977|FG001|COMPLETED|Second Intervention (1 Day)||32||
48543734|NCT04759768|101666976|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48543735|NCT04759768|101666977|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48543736|NCT02022748|101666978|FG000|STARTED|Overall Study||8||
48543737|NCT02022748|101666979|FG001|STARTED|Overall Study||6||
48543738|NCT02022748|101666980|FG002|STARTED|Overall Study||13||
48543739|NCT02022748|101666978|FG000|Subject Who Started Treatment|Overall Study||8||
48543740|NCT02022748|101666979|FG001|Subject Who Started Treatment|Overall Study||6||
48543741|NCT02022748|101666980|FG002|Subject Who Started Treatment|Overall Study||13||
48543742|NCT02022748|101666978|FG000|Subjects Who Completed Treatment|Overall Study||7||
48543743|NCT02022748|101666979|FG001|Subjects Who Completed Treatment|Overall Study||4||
48543744|NCT02022748|101666980|FG002|Subjects Who Completed Treatment|Overall Study||13||
48543745|NCT02022748|101666978|FG000|COMPLETED|Overall Study||7||
48543746|NCT02022748|101666979|FG001|COMPLETED|Overall Study||4||
48543747|NCT02022748|101666980|FG002|COMPLETED|Overall Study||13||
48543748|NCT02022748|101666978|FG000|NOT COMPLETED|Overall Study||1||
48543749|NCT02022748|101666979|FG001|NOT COMPLETED|Overall Study||2||
48543750|NCT02022748|101666980|FG002|NOT COMPLETED|Overall Study||0||
48543751|NCT02015065|101666981|FG000|STARTED|Overall Study||2||
48543752|NCT02015065|101666982|FG001|STARTED|Overall Study||5||
48543753|NCT02015065|101666983|FG002|STARTED|Overall Study||2||
48543754|NCT02015065|101666981|FG000|COMPLETED|Overall Study||1||
48543755|NCT02015065|101666982|FG001|COMPLETED|Overall Study||3||
48543756|NCT02015065|101666983|FG002|COMPLETED|Overall Study||1||
48543757|NCT02015065|101666981|FG000|NOT COMPLETED|Overall Study||1||
48543758|NCT02015065|101666982|FG001|NOT COMPLETED|Overall Study||2||
48543759|NCT02015065|101666983|FG002|NOT COMPLETED|Overall Study||1||
48543760|NCT00242632|101666984|FG000|STARTED|Overall Study||11||
48543761|NCT00242632|101666985|FG001|STARTED|Overall Study||11||
48543762|NCT00242632|101666984|FG000|COMPLETED|Overall Study||11||
48543763|NCT00242632|101666985|FG001|COMPLETED|Overall Study||11||
48543764|NCT00242632|101666984|FG000|NOT COMPLETED|Overall Study||0||
48543765|NCT00242632|101666985|FG001|NOT COMPLETED|Overall Study||0||
48543766|NCT03138590|101666986|FG000|STARTED|Overall Study||10||
48543767|NCT03138590|101666987|FG001|STARTED|Overall Study||10||
48543768|NCT03138590|101666986|FG000|COMPLETED|Overall Study||10||
48543769|NCT03138590|101666987|FG001|COMPLETED|Overall Study||10||
48543770|NCT03138590|101666986|FG000|NOT COMPLETED|Overall Study||0||
48543771|NCT03138590|101666987|FG001|NOT COMPLETED|Overall Study||0||
48543772|NCT01319500|101666988|FG000|STARTED|Overall Study||1187||
48543773|NCT01319500|101666989|FG001|STARTED|Overall Study||2589||
48543774|NCT01319500|101666988|FG000|COMPLETED|Overall Study||1187||
48543775|NCT01319500|101666989|FG001|COMPLETED|Overall Study||2589||
48543776|NCT01319500|101666988|FG000|NOT COMPLETED|Overall Study||0||
48543777|NCT01319500|101666989|FG001|NOT COMPLETED|Overall Study||0||
48543778|NCT04877457|101666990|FG000|STARTED|Overall Study||2||
48543779|NCT04877457|101666991|FG001|STARTED|Overall Study||1||
48543780|NCT04877457|101666990|FG000|COMPLETED|Overall Study||0||
48543781|NCT04877457|101666991|FG001|COMPLETED|Overall Study||0||
48543782|NCT04877457|101666990|FG000|NOT COMPLETED|Overall Study||2||
48543783|NCT04877457|101666991|FG001|NOT COMPLETED|Overall Study||1||
48543784|NCT00900822|101666992|FG000|STARTED|9 Months Histological Evaluation||11||
48543785|NCT00900822|101666992|FG000|COMPLETED|9 Months Histological Evaluation||11||
48543786|NCT00900822|101666992|FG000|NOT COMPLETED|9 Months Histological Evaluation||0||
48543787|NCT00900822|101666992|FG000|STARTED|12 Months Clinical Evaluation||11||
48543788|NCT00900822|101666992|FG000|COMPLETED|12 Months Clinical Evaluation||11||
48543789|NCT00900822|101666992|FG000|NOT COMPLETED|12 Months Clinical Evaluation||0||
48543790|NCT01775189|101666993|FG000|STARTED|Naloxone Challenge Phase||45||
48543791|NCT01775189|101666994|FG001|STARTED|Naloxone Challenge Phase||0||
48543792|NCT01775189|101666995|FG002|STARTED|Naloxone Challenge Phase||0||
48543793|NCT01775189|101666996|FG003|STARTED|Naloxone Challenge Phase||0||
48543794|NCT01775189|101666997|FG004|STARTED|Naloxone Challenge Phase||0||
48543795|NCT01775189|101666998|FG005|STARTED|Naloxone Challenge Phase||0||
48543796|NCT01775189|101666999|FG006|STARTED|Naloxone Challenge Phase||0||
48543797|NCT01775189|101666993|FG000|COMPLETED|Naloxone Challenge Phase||45||
48543798|NCT01775189|101666994|FG001|COMPLETED|Naloxone Challenge Phase||0||
48543799|NCT01775189|101666995|FG002|COMPLETED|Naloxone Challenge Phase||0||
48543800|NCT01775189|101666996|FG003|COMPLETED|Naloxone Challenge Phase||0||
48543801|NCT01775189|101666997|FG004|COMPLETED|Naloxone Challenge Phase||0||
48543802|NCT01775189|101666998|FG005|COMPLETED|Naloxone Challenge Phase||0||
48543803|NCT01775189|101666999|FG006|COMPLETED|Naloxone Challenge Phase||0||
48543804|NCT01775189|101666993|FG000|NOT COMPLETED|Naloxone Challenge Phase||0||
48543805|NCT01775189|101666994|FG001|NOT COMPLETED|Naloxone Challenge Phase||0||
48543806|NCT01775189|101666995|FG002|NOT COMPLETED|Naloxone Challenge Phase||0||
48261456|NCT01333111|100962682|FG002|STARTED|Overall Study||15||
48261457|NCT01333111|100962680|FG000|COMPLETED|Overall Study||28||
48543807|NCT01775189|101666996|FG003|NOT COMPLETED|Naloxone Challenge Phase||0||
48543808|NCT01775189|101666997|FG004|NOT COMPLETED|Naloxone Challenge Phase||0||
48543809|NCT01775189|101666998|FG005|NOT COMPLETED|Naloxone Challenge Phase||0||
48543810|NCT01775189|101666999|FG006|NOT COMPLETED|Naloxone Challenge Phase||0||
48543811|NCT01775189|101666993|FG000|STARTED|Drug Discrimination Phase: Day 1||0||
48543812|NCT01775189|101666994|FG001|STARTED|Drug Discrimination Phase: Day 1||22||
48543813|NCT01775189|101666995|FG002|STARTED|Drug Discrimination Phase: Day 1||23||
48543814|NCT01775189|101666996|FG003|STARTED|Drug Discrimination Phase: Day 1||0||
48543815|NCT01775189|101666997|FG004|STARTED|Drug Discrimination Phase: Day 1||0||
48543816|NCT01775189|101666998|FG005|STARTED|Drug Discrimination Phase: Day 1||0||
48543817|NCT01775189|101666999|FG006|STARTED|Drug Discrimination Phase: Day 1||0||
48543818|NCT01775189|101666993|FG000|COMPLETED|Drug Discrimination Phase: Day 1||0||
48543819|NCT01775189|101666994|FG001|COMPLETED|Drug Discrimination Phase: Day 1||19||
48543820|NCT01775189|101666995|FG002|COMPLETED|Drug Discrimination Phase: Day 1||23||
48543821|NCT01775189|101666996|FG003|COMPLETED|Drug Discrimination Phase: Day 1||0||
48543822|NCT01775189|101666997|FG004|COMPLETED|Drug Discrimination Phase: Day 1||0||
48543823|NCT01775189|101666998|FG005|COMPLETED|Drug Discrimination Phase: Day 1||0||
48543824|NCT01775189|101666999|FG006|COMPLETED|Drug Discrimination Phase: Day 1||0||
48543825|NCT01775189|101666993|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
48543826|NCT01775189|101666994|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 1||3||
48543827|NCT01775189|101666995|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
48543828|NCT01775189|101666996|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
48543829|NCT01775189|101666997|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
48543830|NCT01775189|101666998|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
48543831|NCT01775189|101666999|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
48543832|NCT01775189|101666993|FG000|STARTED|Drug Discrimination Phase: Day 2||0||
48543833|NCT01775189|101666994|FG001|STARTED|Drug Discrimination Phase: Day 2||19||
48543834|NCT01775189|101666995|FG002|STARTED|Drug Discrimination Phase: Day 2||23||
48543835|NCT01775189|101666996|FG003|STARTED|Drug Discrimination Phase: Day 2||0||
48543836|NCT01775189|101666997|FG004|STARTED|Drug Discrimination Phase: Day 2||0||
48543837|NCT01775189|101666998|FG005|STARTED|Drug Discrimination Phase: Day 2||0||
48543838|NCT01775189|101666999|FG006|STARTED|Drug Discrimination Phase: Day 2||0||
48543839|NCT01775189|101666993|FG000|COMPLETED|Drug Discrimination Phase: Day 2||0||
48543840|NCT01775189|101666994|FG001|COMPLETED|Drug Discrimination Phase: Day 2||16||
48543841|NCT01775189|101666995|FG002|COMPLETED|Drug Discrimination Phase: Day 2||16||
48543842|NCT01775189|101666996|FG003|COMPLETED|Drug Discrimination Phase: Day 2||0||
48543843|NCT01775189|101666997|FG004|COMPLETED|Drug Discrimination Phase: Day 2||0||
48543844|NCT01775189|101666998|FG005|COMPLETED|Drug Discrimination Phase: Day 2||0||
48543845|NCT01775189|101666999|FG006|COMPLETED|Drug Discrimination Phase: Day 2||0||
48543846|NCT01775189|101666993|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
48261458|NCT01333111|100962681|FG001|COMPLETED|Overall Study||26||
48261459|NCT01333111|100962682|FG002|COMPLETED|Overall Study||13||
48261460|NCT01333111|100962680|FG000|NOT COMPLETED|Overall Study||2||
48261461|NCT01333111|100962681|FG001|NOT COMPLETED|Overall Study||3||
48261462|NCT01333111|100962682|FG002|NOT COMPLETED|Overall Study||2||
48261463|NCT03545412|100962683|FG000|STARTED|Overall Study||25||
48261464|NCT03545412|100962683|FG000|COMPLETED|Overall Study||25||
48261465|NCT03545412|100962683|FG000|NOT COMPLETED|Overall Study||0||
48261466|NCT02548078|100962684|FG000|STARTED|Overall Study||300||
48261467|NCT02548078|100962685|FG001|STARTED|Overall Study||300||
48261468|NCT02548078|100962684|FG000|COMPLETED|Overall Study||295||
48261469|NCT02548078|100962685|FG001|COMPLETED|Overall Study||294||
48261470|NCT02548078|100962684|FG000|NOT COMPLETED|Overall Study||5||
48261471|NCT02548078|100962685|FG001|NOT COMPLETED|Overall Study||6||
48261472|NCT00243022|100962686|FG000|STARTED|Overall Study||7||
48261473|NCT00243022|100962687|FG001|STARTED|Overall Study||5||
48261474|NCT00243022|100962686|FG000|COMPLETED|Overall Study||5||
48543847|NCT01775189|101666994|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 2||3||
48543848|NCT01775189|101666995|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 2||7||
48543849|NCT01775189|101666996|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
48543850|NCT01775189|101666997|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
48543851|NCT01775189|101666998|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
48543852|NCT01775189|101666999|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
48543853|NCT01775189|101666993|FG000|STARTED|Treatment Phase: First Intervention||0||
48543854|NCT01775189|101666994|FG001|STARTED|Treatment Phase: First Intervention||0||
48543855|NCT01775189|101666995|FG002|STARTED|Treatment Phase: First Intervention||0||
48543856|NCT01775189|101666996|FG003|STARTED|Treatment Phase: First Intervention||8||
48543857|NCT01775189|101666997|FG004|STARTED|Treatment Phase: First Intervention||8||
48261475|NCT00243022|100962687|FG001|COMPLETED|Overall Study||4||
48261476|NCT00243022|100962686|FG000|NOT COMPLETED|Overall Study||2||
48592713|NCT00176436|101783166|FG001|NOT COMPLETED|Overall Study||5||
48261477|NCT00243022|100962687|FG001|NOT COMPLETED|Overall Study||1||
48261478|NCT04009629|100962688|FG000|STARTED|Overall Study||23||
48261479|NCT04009629|100962689|FG001|STARTED|Overall Study||38||
48261480|NCT04009629|100962688|FG000|COMPLETED|Overall Study||21||
48261481|NCT04009629|100962689|FG001|COMPLETED|Overall Study||38||
48261482|NCT04009629|100962688|FG000|NOT COMPLETED|Overall Study||2||
48261483|NCT04009629|100962689|FG001|NOT COMPLETED|Overall Study||0||
48261484|NCT04042077|100962690|FG000|STARTED|Overall Study||134||
48261485|NCT04042077|100962691|FG001|STARTED|Overall Study||132||
48261486|NCT04042077|100962690|FG000|Vancomycin IV|Overall Study||0||
48261487|NCT04042077|100962691|FG001|Vancomycin IV|Overall Study||2||
48261488|NCT04042077|100962690|FG000|Linezolid IV, With the Option to Switch to Linezolid Oral|Overall Study||0||
48261489|NCT04042077|100962691|FG001|Linezolid IV, With the Option to Switch to Linezolid Oral|Overall Study||8||
48261490|NCT04042077|100962690|FG000|Piperacillin/Tazobactam IV|Overall Study||0||
48261491|NCT04042077|100962691|FG001|Piperacillin/Tazobactam IV|Overall Study||68||
48261492|NCT04042077|100962690|FG000|Tigecycline IV|Overall Study||0||
48690283|NCT00135330|102025807|FG000|NOT COMPLETED|Overall Study||12||
48690284|NCT00135330|102025808|FG001|NOT COMPLETED|Overall Study||13||
48690285|NCT00135330|102025809|FG002|NOT COMPLETED|Overall Study||11||
48690286|NCT05559905|102025810|FG000|STARTED|Overall Study||40||
48690287|NCT05559905|102025811|FG001|STARTED|Overall Study||36||
48690288|NCT05559905|102025812|FG002|STARTED|Overall Study||40||
48690289|NCT05559905|102025810|FG000|Started Study Medication|Overall Study||39||
48690290|NCT05559905|102025811|FG001|Started Study Medication|Overall Study||36||
48690291|NCT05559905|102025812|FG002|Started Study Medication|Overall Study||40||
48690292|NCT05559905|102025810|FG000|COMPLETED|Overall Study||38||
48690293|NCT05559905|102025811|FG001|COMPLETED|Overall Study||36||
48690294|NCT05559905|102025812|FG002|COMPLETED|Overall Study||40||
48690295|NCT05559905|102025810|FG000|NOT COMPLETED|Overall Study||2||
48690296|NCT05559905|102025811|FG001|NOT COMPLETED|Overall Study||0||
48690297|NCT05559905|102025812|FG002|NOT COMPLETED|Overall Study||0||
48690298|NCT03226249|102025813|FG000|STARTED|PEM Induction Cycles 1-3, and PET#2||30||
48690299|NCT03226249|102025813|FG000|PEM Cycle 1|PEM Induction Cycles 1-3, and PET#2||30||
48690300|NCT03226249|102025813|FG000|PEM Cycle 2|PEM Induction Cycles 1-3, and PET#2||30||
48690301|NCT03226249|102025813|FG000|PEM Cycle 3|PEM Induction Cycles 1-3, and PET#2||30||
48690302|NCT03226249|102025813|FG000|PET#2|PEM Induction Cycles 1-3, and PET#2||30||
48690303|NCT03226249|102025813|FG000|COMPLETED|PEM Induction Cycles 1-3, and PET#2||30||
48690304|NCT03226249|102025813|FG000|NOT COMPLETED|PEM Induction Cycles 1-3, and PET#2||0||
48690305|NCT03226249|102025813|FG000|STARTED|2 Cycles of AVD + PET#3||30||
48690306|NCT03226249|102025813|FG000|AVD Cycle 1|2 Cycles of AVD + PET#3||30||
48690307|NCT03226249|102025813|FG000|AVD Cycle 2|2 Cycles of AVD + PET#3||30||
48690308|NCT03226249|102025813|FG000|PET#3|2 Cycles of AVD + PET#3||30||
48690309|NCT03226249|102025813|FG000|COMPLETED|2 Cycles of AVD + PET#3||30||
48690310|NCT03226249|102025813|FG000|NOT COMPLETED|2 Cycles of AVD + PET#3||0||
48690311|NCT03226249|102025813|FG000|STARTED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||30||
48690312|NCT03226249|102025813|FG000|2-4 Cycles of AVD +/- Chemo & RT|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29||
48690313|NCT03226249|102025813|FG000|PET#4|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29||
48690314|NCT03226249|102025813|FG000|COMPLETED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29||
48690315|NCT03226249|102025813|FG000|NOT COMPLETED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||1||
48690316|NCT03226249|102025813|FG000|STARTED|PEM Consolidation (1-2 Years)||29||
48690317|NCT03226249|102025813|FG000|COMPLETED|PEM Consolidation (1-2 Years)||0||
48690318|NCT03226249|102025813|FG000|NOT COMPLETED|PEM Consolidation (1-2 Years)||29||
48690319|NCT03226249|102025813|FG000|STARTED|Survival Follow-up||30||
48690320|NCT03226249|102025813|FG000|COMPLETED|Survival Follow-up||0||
48690321|NCT03226249|102025813|FG000|NOT COMPLETED|Survival Follow-up||30||
48690322|NCT03098433|102025814|FG000|STARTED|Overall Study||22||
48690323|NCT03098433|102025814|FG000|COMPLETED|Overall Study||12||
48690324|NCT03098433|102025814|FG000|NOT COMPLETED|Overall Study||10||
48690325|NCT02649920|102025815|FG000|STARTED|Overall Study||2||
48690326|NCT02649920|102025816|FG001|STARTED|Overall Study||0||
48690327|NCT02649920|102025815|FG000|COMPLETED|Overall Study||2||
48690328|NCT02649920|102025816|FG001|COMPLETED|Overall Study||0||
48690329|NCT02649920|102025815|FG000|NOT COMPLETED|Overall Study||0||
48690330|NCT02649920|102025816|FG001|NOT COMPLETED|Overall Study||0||
48690331|NCT01390298|102025817|FG000|STARTED|Overall Study||55||
48690332|NCT01390298|102025817|FG000|COMPLETED|Overall Study||31||
48690333|NCT01390298|102025817|FG000|NOT COMPLETED|Overall Study||24||
48261493|NCT04042077|100962691|FG001|Tigecycline IV|Overall Study||54||
48261494|NCT04042077|100962690|FG000|COMPLETED|Overall Study||127||
48261495|NCT04042077|100962691|FG001|COMPLETED|Overall Study||127||
48261496|NCT04042077|100962690|FG000|NOT COMPLETED|Overall Study||7||
48690334|NCT03748706|102025818|FG000|STARTED|Overall Study||13||
48690335|NCT03748706|102025818|FG000|COMPLETED|Overall Study||12||
48690336|NCT03748706|102025818|FG000|NOT COMPLETED|Overall Study||1||
48690337|NCT03587428|102025819|FG000|STARTED|Period 1||3||
48690338|NCT03587428|102025820|FG001|STARTED|Period 1||2||
48690339|NCT03587428|102025821|FG002|STARTED|Period 1||3||
48690340|NCT03587428|102025822|FG003|STARTED|Period 1||3||
48690341|NCT03587428|102025823|FG004|STARTED|Period 1||2||
48690342|NCT03587428|102025824|FG005|STARTED|Period 1||2||
48690343|NCT03587428|102025819|FG000|COMPLETED|Period 1||3||
48690344|NCT03587428|102025820|FG001|COMPLETED|Period 1||2||
48690345|NCT03587428|102025821|FG002|COMPLETED|Period 1||3||
48543858|NCT01775189|101666998|FG005|STARTED|Treatment Phase: First Intervention||8||
48543859|NCT01775189|101666999|FG006|STARTED|Treatment Phase: First Intervention||8||
48543860|NCT01775189|101666993|FG000|COMPLETED|Treatment Phase: First Intervention||0||
48543861|NCT01775189|101666994|FG001|COMPLETED|Treatment Phase: First Intervention||0||
48543862|NCT01775189|101666995|FG002|COMPLETED|Treatment Phase: First Intervention||0||
48543863|NCT01775189|101666996|FG003|COMPLETED|Treatment Phase: First Intervention||8||
48543864|NCT01775189|101666997|FG004|COMPLETED|Treatment Phase: First Intervention||8||
48543865|NCT01775189|101666998|FG005|COMPLETED|Treatment Phase: First Intervention||8||
48543866|NCT01775189|101666999|FG006|COMPLETED|Treatment Phase: First Intervention||8||
48543867|NCT01775189|101666993|FG000|NOT COMPLETED|Treatment Phase: First Intervention||0||
48543868|NCT01775189|101666994|FG001|NOT COMPLETED|Treatment Phase: First Intervention||0||
48543869|NCT01775189|101666995|FG002|NOT COMPLETED|Treatment Phase: First Intervention||0||
48543870|NCT01775189|101666996|FG003|NOT COMPLETED|Treatment Phase: First Intervention||0||
48543871|NCT01775189|101666997|FG004|NOT COMPLETED|Treatment Phase: First Intervention||0||
48543872|NCT01775189|101666998|FG005|NOT COMPLETED|Treatment Phase: First Intervention||0||
48543873|NCT01775189|101666999|FG006|NOT COMPLETED|Treatment Phase: First Intervention||0||
48543874|NCT01775189|101666993|FG000|STARTED|Treatment Phase: Washout Period 1||0||
48543875|NCT01775189|101666994|FG001|STARTED|Treatment Phase: Washout Period 1||0||
48543876|NCT01775189|101666995|FG002|STARTED|Treatment Phase: Washout Period 1||0||
48543877|NCT01775189|101666996|FG003|STARTED|Treatment Phase: Washout Period 1||8||
48543878|NCT01775189|101666997|FG004|STARTED|Treatment Phase: Washout Period 1||8||
48543879|NCT01775189|101666998|FG005|STARTED|Treatment Phase: Washout Period 1||8||
48543880|NCT01775189|101666999|FG006|STARTED|Treatment Phase: Washout Period 1||8||
48543881|NCT01775189|101666993|FG000|COMPLETED|Treatment Phase: Washout Period 1||0||
48543882|NCT01775189|101666994|FG001|COMPLETED|Treatment Phase: Washout Period 1||0||
48543883|NCT01775189|101666995|FG002|COMPLETED|Treatment Phase: Washout Period 1||0||
48543884|NCT01775189|101666996|FG003|COMPLETED|Treatment Phase: Washout Period 1||8||
48543885|NCT01775189|101666997|FG004|COMPLETED|Treatment Phase: Washout Period 1||8||
48543886|NCT01775189|101666998|FG005|COMPLETED|Treatment Phase: Washout Period 1||7||
48543887|NCT01775189|101666999|FG006|COMPLETED|Treatment Phase: Washout Period 1||8||
48543888|NCT01775189|101666993|FG000|NOT COMPLETED|Treatment Phase: Washout Period 1||0||
48543889|NCT01775189|101666994|FG001|NOT COMPLETED|Treatment Phase: Washout Period 1||0||
48543890|NCT01775189|101666995|FG002|NOT COMPLETED|Treatment Phase: Washout Period 1||0||
48543891|NCT01775189|101666996|FG003|NOT COMPLETED|Treatment Phase: Washout Period 1||0||
48543892|NCT01775189|101666997|FG004|NOT COMPLETED|Treatment Phase: Washout Period 1||0||
48543893|NCT01775189|101666998|FG005|NOT COMPLETED|Treatment Phase: Washout Period 1||1||
48543894|NCT01775189|101666999|FG006|NOT COMPLETED|Treatment Phase: Washout Period 1||0||
48543895|NCT01775189|101666993|FG000|STARTED|Treatment Phase: Second Intervention||0||
48543896|NCT01775189|101666994|FG001|STARTED|Treatment Phase: Second Intervention||0||
48543897|NCT01775189|101666995|FG002|STARTED|Treatment Phase: Second Intervention||0||
48543898|NCT01775189|101666996|FG003|STARTED|Treatment Phase: Second Intervention||8||
48543899|NCT01775189|101666997|FG004|STARTED|Treatment Phase: Second Intervention||8||
48543900|NCT01775189|101666998|FG005|STARTED|Treatment Phase: Second Intervention||7||
48543901|NCT01775189|101666999|FG006|STARTED|Treatment Phase: Second Intervention||8||
48543902|NCT01775189|101666993|FG000|COMPLETED|Treatment Phase: Second Intervention||0||
48543903|NCT01775189|101666994|FG001|COMPLETED|Treatment Phase: Second Intervention||0||
48543904|NCT01775189|101666995|FG002|COMPLETED|Treatment Phase: Second Intervention||0||
48543905|NCT01775189|101666996|FG003|COMPLETED|Treatment Phase: Second Intervention||8||
48543906|NCT01775189|101666997|FG004|COMPLETED|Treatment Phase: Second Intervention||8||
48543907|NCT01775189|101666998|FG005|COMPLETED|Treatment Phase: Second Intervention||7||
48690346|NCT03587428|102025822|FG003|COMPLETED|Period 1||3||
48690347|NCT03587428|102025823|FG004|COMPLETED|Period 1||2||
48690348|NCT03587428|102025824|FG005|COMPLETED|Period 1||2||
48690349|NCT03587428|102025819|FG000|NOT COMPLETED|Period 1||0||
48690350|NCT03587428|102025820|FG001|NOT COMPLETED|Period 1||0||
48690351|NCT03587428|102025821|FG002|NOT COMPLETED|Period 1||0||
48690352|NCT03587428|102025822|FG003|NOT COMPLETED|Period 1||0||
48261497|NCT04042077|100962691|FG001|NOT COMPLETED|Overall Study||5||
48543908|NCT01775189|101666999|FG006|COMPLETED|Treatment Phase: Second Intervention||8||
48543909|NCT01775189|101666993|FG000|NOT COMPLETED|Treatment Phase: Second Intervention||0||
48690353|NCT03587428|102025823|FG004|NOT COMPLETED|Period 1||0||
48690354|NCT03587428|102025824|FG005|NOT COMPLETED|Period 1||0||
48690355|NCT03587428|102025819|FG000|STARTED|Period 2||3||
48690356|NCT03587428|102025820|FG001|STARTED|Period 2||2||
48690357|NCT03587428|102025821|FG002|STARTED|Period 2||3||
48690358|NCT03587428|102025822|FG003|STARTED|Period 2||3||
48690359|NCT03587428|102025823|FG004|STARTED|Period 2||2||
48690360|NCT03587428|102025824|FG005|STARTED|Period 2||2||
48690361|NCT03587428|102025819|FG000|COMPLETED|Period 2||3||
48690362|NCT03587428|102025820|FG001|COMPLETED|Period 2||2||
48690363|NCT03587428|102025821|FG002|COMPLETED|Period 2||3||
48690364|NCT03587428|102025822|FG003|COMPLETED|Period 2||3||
48690365|NCT03587428|102025823|FG004|COMPLETED|Period 2||2||
48690366|NCT03587428|102025824|FG005|COMPLETED|Period 2||2||
48690367|NCT03587428|102025819|FG000|NOT COMPLETED|Period 2||0||
48261498|NCT01667549|100962692|FG000|STARTED|Overall Study||20||
48261499|NCT01667549|100962693|FG001|STARTED|Overall Study||20||
48261500|NCT01667549|100962694|FG002|STARTED|Overall Study||21||
48261501|NCT01667549|100962695|FG003|STARTED|Overall Study||20||
48261502|NCT01667549|100962696|FG004|STARTED|Overall Study||16||
48261503|NCT01667549|100962692|FG000|COMPLETED|Overall Study||17||
48261504|NCT01667549|100962693|FG001|COMPLETED|Overall Study||15||
48543910|NCT01775189|101666994|FG001|NOT COMPLETED|Treatment Phase: Second Intervention||0||
48543911|NCT01775189|101666995|FG002|NOT COMPLETED|Treatment Phase: Second Intervention||0||
48543912|NCT01775189|101666996|FG003|NOT COMPLETED|Treatment Phase: Second Intervention||0||
48543913|NCT01775189|101666997|FG004|NOT COMPLETED|Treatment Phase: Second Intervention||0||
48543914|NCT01775189|101666998|FG005|NOT COMPLETED|Treatment Phase: Second Intervention||0||
48543915|NCT01775189|101666999|FG006|NOT COMPLETED|Treatment Phase: Second Intervention||0||
48543916|NCT01775189|101666993|FG000|STARTED|Treatment Phase: Washout Period 2||0||
48543917|NCT01775189|101666994|FG001|STARTED|Treatment Phase: Washout Period 2||0||
48543918|NCT01775189|101666995|FG002|STARTED|Treatment Phase: Washout Period 2||0||
48543919|NCT01775189|101666996|FG003|STARTED|Treatment Phase: Washout Period 2||8||
48543920|NCT01775189|101666997|FG004|STARTED|Treatment Phase: Washout Period 2||8||
48543921|NCT01775189|101666998|FG005|STARTED|Treatment Phase: Washout Period 2||7||
48543922|NCT01775189|101666999|FG006|STARTED|Treatment Phase: Washout Period 2||8||
48543923|NCT01775189|101666993|FG000|COMPLETED|Treatment Phase: Washout Period 2||0||
48543924|NCT01775189|101666994|FG001|COMPLETED|Treatment Phase: Washout Period 2||0||
48543925|NCT01775189|101666995|FG002|COMPLETED|Treatment Phase: Washout Period 2||0||
48543926|NCT01775189|101666996|FG003|COMPLETED|Treatment Phase: Washout Period 2||7||
48543927|NCT01775189|101666997|FG004|COMPLETED|Treatment Phase: Washout Period 2||8||
48543928|NCT01775189|101666998|FG005|COMPLETED|Treatment Phase: Washout Period 2||7||
48543929|NCT01775189|101666999|FG006|COMPLETED|Treatment Phase: Washout Period 2||8||
48543930|NCT01775189|101666993|FG000|NOT COMPLETED|Treatment Phase: Washout Period 2||0||
48690368|NCT03587428|102025820|FG001|NOT COMPLETED|Period 2||0||
48261505|NCT01667549|100962694|FG002|COMPLETED|Overall Study||14||
48261506|NCT01667549|100962695|FG003|COMPLETED|Overall Study||14||
48261507|NCT01667549|100962696|FG004|COMPLETED|Overall Study||15||
48261508|NCT01667549|100962692|FG000|NOT COMPLETED|Overall Study||3||
48261509|NCT01667549|100962693|FG001|NOT COMPLETED|Overall Study||5||
48261510|NCT01667549|100962694|FG002|NOT COMPLETED|Overall Study||7||
48261511|NCT01667549|100962695|FG003|NOT COMPLETED|Overall Study||6||
48261512|NCT01667549|100962696|FG004|NOT COMPLETED|Overall Study||1||
48261513|NCT03017937|100962697|FG000|STARTED|Overall Study||155||
48261514|NCT03017937|100962697|FG000|COMPLETED|Overall Study||155||
48261515|NCT03017937|100962697|FG000|NOT COMPLETED|Overall Study||0||
48261516|NCT01928693|100962698|FG000|STARTED|Overall Study||0||
48261517|NCT01928693|100962699|FG001|STARTED|Overall Study||1||
48261518|NCT01928693|100962700|FG002|STARTED|Overall Study||1||
48261519|NCT01928693|100962698|FG000|COMPLETED|Overall Study||0||
48261520|NCT01928693|100962699|FG001|COMPLETED|Overall Study||1||
48261521|NCT01928693|100962700|FG002|COMPLETED|Overall Study||1||
48261522|NCT01928693|100962698|FG000|NOT COMPLETED|Overall Study||0||
48261523|NCT01928693|100962699|FG001|NOT COMPLETED|Overall Study||0||
48261524|NCT01928693|100962700|FG002|NOT COMPLETED|Overall Study||0||
48261525|NCT01939301|100962701|FG000|STARTED|Overall Study||39||
48261526|NCT01939301|100962702|FG001|STARTED|Overall Study||39||
48261527|NCT01939301|100962701|FG000|COMPLETED|Overall Study||38||
48261528|NCT01939301|100962702|FG001|COMPLETED|Overall Study||38||
48261529|NCT01939301|100962701|FG000|NOT COMPLETED|Overall Study||1||
48261530|NCT01939301|100962702|FG001|NOT COMPLETED|Overall Study||1||
48261531|NCT01150045|100962703|FG000|STARTED|Overall Study||615||
48261532|NCT01150045|100962704|FG001|STARTED|Overall Study||647||
48261533|NCT01150045|100962705|FG002|STARTED|Overall Study||646||
48261534|NCT01150045|100962706|FG003|STARTED|Overall Study||618||
48261535|NCT01150045|100962703|FG000|COMPLETED|Overall Study||615||
48261536|NCT01150045|100962704|FG001|COMPLETED|Overall Study||646||
48543931|NCT01775189|101666994|FG001|NOT COMPLETED|Treatment Phase: Washout Period 2||0||
48543932|NCT01775189|101666995|FG002|NOT COMPLETED|Treatment Phase: Washout Period 2||0||
48690369|NCT03587428|102025821|FG002|NOT COMPLETED|Period 2||0||
48690370|NCT03587428|102025822|FG003|NOT COMPLETED|Period 2||0||
48690371|NCT03587428|102025823|FG004|NOT COMPLETED|Period 2||0||
48690372|NCT03587428|102025824|FG005|NOT COMPLETED|Period 2||0||
48261537|NCT01150045|100962705|FG002|COMPLETED|Overall Study||646||
48261538|NCT01150045|100962706|FG003|COMPLETED|Overall Study||617||
48261539|NCT01150045|100962703|FG000|NOT COMPLETED|Overall Study||0||
48261540|NCT01150045|100962704|FG001|NOT COMPLETED|Overall Study||1||
48261541|NCT01150045|100962705|FG002|NOT COMPLETED|Overall Study||0||
48261542|NCT01150045|100962706|FG003|NOT COMPLETED|Overall Study||1||
48261543|NCT00013611|100962707|FG000|STARTED|Overall Study||849||
48261544|NCT00013611|100962708|FG001|STARTED|Overall Study||846||
48261545|NCT00013611|100962707|FG000|COMPLETED|Overall Study||758||
48261546|NCT00013611|100962708|FG001|COMPLETED|Overall Study||746||
48261547|NCT00013611|100962707|FG000|NOT COMPLETED|Overall Study||91||
48261548|NCT00013611|100962708|FG001|NOT COMPLETED|Overall Study||100||
48543933|NCT01775189|101666996|FG003|NOT COMPLETED|Treatment Phase: Washout Period 2||1||
48543934|NCT01775189|101666997|FG004|NOT COMPLETED|Treatment Phase: Washout Period 2||0||
48543935|NCT01775189|101666998|FG005|NOT COMPLETED|Treatment Phase: Washout Period 2||0||
48543936|NCT01775189|101666999|FG006|NOT COMPLETED|Treatment Phase: Washout Period 2||0||
48261549|NCT03783689|100962709|FG000|STARTED|Overall Study||19||
48261550|NCT03783689|100962710|FG001|STARTED|Overall Study||19||
48261551|NCT03783689|100962709|FG000|Safety Set|Overall Study||19|All subjects who were consented, randomized, and underwent Lead placement.|
48261552|NCT03783689|100962710|FG001|Safety Set|Overall Study||19|All subjects who were consented, randomized, and underwent Lead placement.|
48261553|NCT03783689|100962709|FG000|Full Analysis Set|Overall Study||18|Subjects who were consented, randomized, and continued to meet eligibility criteria prior to undergoing Lead placement.|
48261554|NCT03783689|100962710|FG001|Full Analysis Set|Overall Study||18|Subjects who were consented, randomized, and continued to meet eligibility criteria prior to undergoing Lead placement.|
48261555|NCT03783689|100962709|FG000|Per Protocol Set|Overall Study||13|Subjects who were consented, randomized, continued to meet eligibility criteria prior to undergoing Lead placement, were implanted with at least one Lead, reported coverage of comfortable sensations in the target areas during weeks 5 to 8 post-start of treatment (SOT), have adequate diary completion for each qualifying region of pain, and continued eligibility during weeks 1 to 8 post-SOT.|
48261556|NCT03783689|100962710|FG001|Per Protocol Set|Overall Study||16|Subjects who were consented, randomized, continued to meet eligibility criteria prior to undergoing Lead placement, were implanted with at least one Lead, reported coverage of comfortable sensations in the target areas during weeks 5 to 8 post-start of treatment (SOT), have adequate diary completion for each qualifying region of pain, and continued eligibility during weeks 1 to 8 post-SOT.|
48294151|NCT02527343|101047537|FG001|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0||
48543937|NCT01775189|101666993|FG000|STARTED|Treatment Phase: Third Intervention||0||
48543938|NCT01775189|101666994|FG001|STARTED|Treatment Phase: Third Intervention||0||
48543939|NCT01775189|101666995|FG002|STARTED|Treatment Phase: Third Intervention||0||
48543940|NCT01775189|101666996|FG003|STARTED|Treatment Phase: Third Intervention||7||
48543941|NCT01775189|101666997|FG004|STARTED|Treatment Phase: Third Intervention||8||
48543942|NCT01775189|101666998|FG005|STARTED|Treatment Phase: Third Intervention||7||
48543943|NCT01775189|101666999|FG006|STARTED|Treatment Phase: Third Intervention||8||
48543944|NCT01775189|101666993|FG000|COMPLETED|Treatment Phase: Third Intervention||0||
48543945|NCT01775189|101666994|FG001|COMPLETED|Treatment Phase: Third Intervention||0||
48543946|NCT01775189|101666995|FG002|COMPLETED|Treatment Phase: Third Intervention||0||
48543947|NCT01775189|101666996|FG003|COMPLETED|Treatment Phase: Third Intervention||7||
48543948|NCT01775189|101666997|FG004|COMPLETED|Treatment Phase: Third Intervention||8||
48543949|NCT01775189|101666998|FG005|COMPLETED|Treatment Phase: Third Intervention||7||
48543950|NCT01775189|101666999|FG006|COMPLETED|Treatment Phase: Third Intervention||8||
48543951|NCT01775189|101666993|FG000|NOT COMPLETED|Treatment Phase: Third Intervention||0||
48543952|NCT01775189|101666994|FG001|NOT COMPLETED|Treatment Phase: Third Intervention||0||
48543953|NCT01775189|101666995|FG002|NOT COMPLETED|Treatment Phase: Third Intervention||0||
48543954|NCT01775189|101666996|FG003|NOT COMPLETED|Treatment Phase: Third Intervention||0||
48543955|NCT01775189|101666997|FG004|NOT COMPLETED|Treatment Phase: Third Intervention||0||
48543956|NCT01775189|101666998|FG005|NOT COMPLETED|Treatment Phase: Third Intervention||0||
48543957|NCT01775189|101666999|FG006|NOT COMPLETED|Treatment Phase: Third Intervention||0||
48543958|NCT01775189|101666993|FG000|STARTED|Treatment Phase: Washout Period 3||0||
48543959|NCT01775189|101666994|FG001|STARTED|Treatment Phase: Washout Period 3||0||
48543960|NCT01775189|101666995|FG002|STARTED|Treatment Phase: Washout Period 3||0||
48543961|NCT01775189|101666996|FG003|STARTED|Treatment Phase: Washout Period 3||7||
48543962|NCT01775189|101666997|FG004|STARTED|Treatment Phase: Washout Period 3||8||
48543963|NCT01775189|101666998|FG005|STARTED|Treatment Phase: Washout Period 3||7||
48543964|NCT01775189|101666999|FG006|STARTED|Treatment Phase: Washout Period 3||8||
48543965|NCT01775189|101666993|FG000|COMPLETED|Treatment Phase: Washout Period 3||0||
48543966|NCT01775189|101666994|FG001|COMPLETED|Treatment Phase: Washout Period 3||0||
48543967|NCT01775189|101666995|FG002|COMPLETED|Treatment Phase: Washout Period 3||0||
48543968|NCT01775189|101666996|FG003|COMPLETED|Treatment Phase: Washout Period 3||6||
48543969|NCT01775189|101666997|FG004|COMPLETED|Treatment Phase: Washout Period 3||8||
48543970|NCT01775189|101666998|FG005|COMPLETED|Treatment Phase: Washout Period 3||7||
48543971|NCT01775189|101666999|FG006|COMPLETED|Treatment Phase: Washout Period 3||7||
48543972|NCT01775189|101666993|FG000|NOT COMPLETED|Treatment Phase: Washout Period 3||0||
48543973|NCT01775189|101666994|FG001|NOT COMPLETED|Treatment Phase: Washout Period 3||0||
48543974|NCT01775189|101666995|FG002|NOT COMPLETED|Treatment Phase: Washout Period 3||0||
48543975|NCT01775189|101666996|FG003|NOT COMPLETED|Treatment Phase: Washout Period 3||1||
48543976|NCT01775189|101666997|FG004|NOT COMPLETED|Treatment Phase: Washout Period 3||0||
48543977|NCT01775189|101666998|FG005|NOT COMPLETED|Treatment Phase: Washout Period 3||0||
48543978|NCT01775189|101666999|FG006|NOT COMPLETED|Treatment Phase: Washout Period 3||1||
48543979|NCT01775189|101666993|FG000|STARTED|Treatment Phase: Fourth Intervention||0||
48543980|NCT01775189|101666994|FG001|STARTED|Treatment Phase: Fourth Intervention||0||
48261557|NCT03783689|100962709|FG000|Group 2 (Control Group Treatment Crossover)|Overall Study||0|Subjects who were consented, randomized to Group 2 (Control), received sham stimulation treatment, and crossed over to receive active stimulation treatment.|
48261558|NCT03783689|100962710|FG001|Group 2 (Control Group Treatment Crossover)|Overall Study||9|Subjects who were consented, randomized to Group 2 (Control), received sham stimulation treatment, and crossed over to receive active stimulation treatment.|
48261559|NCT03783689|100962709|FG000|COMPLETED|Overall Study||10||
48261560|NCT03783689|100962710|FG001|COMPLETED|Overall Study||14||
48261561|NCT03783689|100962709|FG000|NOT COMPLETED|Overall Study||9||
48261562|NCT03783689|100962710|FG001|NOT COMPLETED|Overall Study||5||
48261563|NCT01267240|100962711|FG000|STARTED|Overall Study||25||
48261564|NCT01267240|100962711|FG000|COMPLETED|Overall Study||25||
48261565|NCT01267240|100962711|FG000|NOT COMPLETED|Overall Study||0||
48261566|NCT01010204|100962712|FG000|STARTED|Overall Study||31||
48261567|NCT01010204|100962713|FG001|STARTED|Overall Study||29||
48261568|NCT01010204|100962712|FG000|COMPLETED|Overall Study||24||
48261569|NCT01010204|100962713|FG001|COMPLETED|Overall Study||20||
48261570|NCT01010204|100962712|FG000|NOT COMPLETED|Overall Study||7||
48261571|NCT01010204|100962713|FG001|NOT COMPLETED|Overall Study||9||
48261572|NCT02781649|100962714|FG000|STARTED|Overall Study||7||
48261573|NCT02781649|100962715|FG001|STARTED|Overall Study||0||
48261574|NCT02781649|100962716|FG002|STARTED|Overall Study||3||
48261575|NCT02781649|100962714|FG000|COMPLETED|Overall Study||7||
48261576|NCT02781649|100962715|FG001|COMPLETED|Overall Study||0||
48261577|NCT02781649|100962716|FG002|COMPLETED|Overall Study||3||
48261578|NCT02781649|100962714|FG000|NOT COMPLETED|Overall Study||0||
48261579|NCT02781649|100962715|FG001|NOT COMPLETED|Overall Study||0||
48261580|NCT02781649|100962716|FG002|NOT COMPLETED|Overall Study||0||
48261581|NCT03062449|100962717|FG000|STARTED|Overall Study||16||
48261582|NCT03062449|100962718|FG001|STARTED|Overall Study||13||
48261583|NCT03062449|100962717|FG000|Completed Treatment|Overall Study||10||
48261584|NCT03062449|100962718|FG001|Completed Treatment|Overall Study||12||
48261585|NCT03062449|100962717|FG000|COMPLETED|Overall Study||9|Completed all follow-up|
48261586|NCT03062449|100962718|FG001|COMPLETED|Overall Study||12|Completed all follow-up|
48261587|NCT03062449|100962717|FG000|NOT COMPLETED|Overall Study||7||
48261588|NCT03062449|100962718|FG001|NOT COMPLETED|Overall Study||1||
48261589|NCT01375751|100962719|FG000|STARTED|Overall Study||56||
48261590|NCT01375751|100962720|FG001|STARTED|Overall Study||56||
48261591|NCT01375751|100962721|FG002|STARTED|Overall Study||56||
48261592|NCT01375751|100962719|FG000|Received Treatment|Overall Study||56||
48261593|NCT01375751|100962720|FG001|Received Treatment|Overall Study||55||
48261594|NCT01375751|100962721|FG002|Received Treatment|Overall Study||56||
48261595|NCT01375751|100962719|FG000|COMPLETED|Overall Study||56||
48261596|NCT01375751|100962720|FG001|COMPLETED|Overall Study||55||
48261597|NCT01375751|100962721|FG002|COMPLETED|Overall Study||56||
48261598|NCT01375751|100962719|FG000|NOT COMPLETED|Overall Study||0||
48261599|NCT01375751|100962720|FG001|NOT COMPLETED|Overall Study||1||
48261600|NCT01375751|100962721|FG002|NOT COMPLETED|Overall Study||0||
48261601|NCT00079339|100962722|FG000|STARTED|Overall Study||5||
48261602|NCT00079339|100962723|FG001|STARTED|Overall Study||40||
48261603|NCT00079339|100962724|FG002|STARTED|Overall Study||6||
48261604|NCT00079339|100962722|FG000|Enrolled in Phase I|Overall Study||5||
48261605|NCT00079339|100962723|FG001|Enrolled in Phase I|Overall Study||6||
48261606|NCT00079339|100962724|FG002|Enrolled in Phase I|Overall Study||6||
48261607|NCT00079339|100962722|FG000|Maximum Tolerated Dose (MTD) Estimation|Overall Study||3||
48261608|NCT00079339|100962723|FG001|Maximum Tolerated Dose (MTD) Estimation|Overall Study||6||
48261609|NCT00079339|100962724|FG002|Maximum Tolerated Dose (MTD) Estimation|Overall Study||5||
48261610|NCT00079339|100962722|FG000|Enrolled in Phase II|Overall Study||0||
48261611|NCT00079339|100962723|FG001|Enrolled in Phase II|Overall Study||40||
48261612|NCT00079339|100962724|FG002|Enrolled in Phase II|Overall Study||0||
48261613|NCT00079339|100962722|FG000|COMPLETED|Overall Study||0||
48261614|NCT00079339|100962723|FG001|COMPLETED|Overall Study||1||
48261615|NCT00079339|100962724|FG002|COMPLETED|Overall Study||0||
48261616|NCT00079339|100962722|FG000|NOT COMPLETED|Overall Study||5||
48261617|NCT00079339|100962723|FG001|NOT COMPLETED|Overall Study||39||
48261618|NCT00079339|100962724|FG002|NOT COMPLETED|Overall Study||6||
48261619|NCT00755417|100962725|FG000|STARTED|Overall Study||174||
48261620|NCT00755417|100962726|FG001|STARTED|Overall Study||181||
48261621|NCT00755417|100962727|FG002|STARTED|Overall Study||177||
48261622|NCT00755417|100962725|FG000|COMPLETED|Overall Study||112||
48261623|NCT00755417|100962726|FG001|COMPLETED|Overall Study||126||
48261624|NCT00755417|100962727|FG002|COMPLETED|Overall Study||135||
48261625|NCT00755417|100962725|FG000|NOT COMPLETED|Overall Study||62||
48261626|NCT00755417|100962726|FG001|NOT COMPLETED|Overall Study||55||
48261627|NCT00755417|100962727|FG002|NOT COMPLETED|Overall Study||42||
48261628|NCT03546816|100962728|FG000|STARTED|Overall Study||142||
48261629|NCT03546816|100962729|FG001|STARTED|Overall Study||143||
48261630|NCT03546816|100962728|FG000|COMPLETED|Overall Study||121||
48261631|NCT03546816|100962729|FG001|COMPLETED|Overall Study||124||
48261632|NCT03546816|100962728|FG000|NOT COMPLETED|Overall Study||21||
48261633|NCT03546816|100962729|FG001|NOT COMPLETED|Overall Study||19||
48261634|NCT00368641|100962730|FG000|STARTED|Overall Study||6||
48261635|NCT00368641|100962731|FG001|STARTED|Overall Study||6||
48261636|NCT00368641|100962730|FG000|COMPLETED|Overall Study||0||
48543981|NCT01775189|101666995|FG002|STARTED|Treatment Phase: Fourth Intervention||0||
48543982|NCT01775189|101666996|FG003|STARTED|Treatment Phase: Fourth Intervention||6||
48097805|NCT02074631|100563801|FG001|STARTED|Overall Study||31||
48261637|NCT00368641|100962731|FG001|COMPLETED|Overall Study||0||
48261638|NCT00368641|100962730|FG000|NOT COMPLETED|Overall Study||6||
48261639|NCT00368641|100962731|FG001|NOT COMPLETED|Overall Study||6||
48261640|NCT04074343|100962732|FG000|STARTED|Overall Study||20||
48261641|NCT04074343|100962732|FG000|COMPLETED|Overall Study||20||
48261642|NCT04074343|100962732|FG000|NOT COMPLETED|Overall Study||0||
48261643|NCT00004146|100962733|FG000|STARTED|Overall Study||55||
48261644|NCT00004146|100962733|FG000|COMPLETED|Overall Study||55||
48261645|NCT00004146|100962733|FG000|NOT COMPLETED|Overall Study||0||
48261646|NCT03506347|100962734|FG000|STARTED|Overall Study||12||
48261647|NCT03506347|100962735|FG001|STARTED|Overall Study||12||
48261648|NCT03506347|100962734|FG000|COMPLETED|Overall Study||12||
48261649|NCT03506347|100962735|FG001|COMPLETED|Overall Study||12||
48261650|NCT03506347|100962734|FG000|NOT COMPLETED|Overall Study||0||
48261651|NCT03506347|100962735|FG001|NOT COMPLETED|Overall Study||0||
48261652|NCT01012245|100962736|FG000|STARTED|Overall Study||28812||
48261653|NCT01012245|100962736|FG000|COMPLETED|Overall Study||26385||
48261654|NCT01012245|100962736|FG000|NOT COMPLETED|Overall Study||2427||
48261655|NCT03672175|100962737|FG000|STARTED|Treatment Period (Days 1 to 14)||193||
48261656|NCT03672175|100962738|FG001|STARTED|Treatment Period (Days 1 to 14)||194||
48261657|NCT03672175|100962739|FG002|STARTED|Treatment Period (Days 1 to 14)||194||
48261658|NCT03672175|100962737|FG000|Safety Set|Treatment Period (Days 1 to 14)||190|Safety Set included all participants who were administered investigational product (IP) \[SAGE-217 20 mg, SAGE-217 30 mg, or SAGE-217 matched placebo\].|
48261659|NCT03672175|100962738|FG001|Safety Set|Treatment Period (Days 1 to 14)||188|Safety Set included all participants who were administered investigational product (IP) \[SAGE-217 20 mg, SAGE-217 30 mg, or SAGE-217 matched placebo\].|
48261660|NCT03672175|100962739|FG002|Safety Set|Treatment Period (Days 1 to 14)||192|Safety Set included all participants who were administered investigational product (IP) \[SAGE-217 20 mg, SAGE-217 30 mg, or SAGE-217 matched placebo\].|
48294152|NCT02527343|101047538|FG002|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0||
48294153|NCT02527343|101047539|FG003|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0||
48294154|NCT02527343|101047540|FG004|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||11||
48390209|NCT00089479|101283539|FG001|NOT COMPLETED|Overall Study||289||
48390210|NCT00927264|101283540|FG000|STARTED|Overall Study||165||
48390211|NCT00927264|101283541|FG001|STARTED|Overall Study||165||
48390212|NCT00927264|101283540|FG000|COMPLETED|Overall Study||109||
48390213|NCT00927264|101283541|FG001|COMPLETED|Overall Study||140||
48390214|NCT00927264|101283540|FG000|NOT COMPLETED|Overall Study||56||
48097806|NCT02074631|100563800|FG000|COMPLETED|Overall Study||30||
48097807|NCT02074631|100563801|FG001|COMPLETED|Overall Study||24||
48097808|NCT02074631|100563800|FG000|NOT COMPLETED|Overall Study||2||
48097809|NCT02074631|100563801|FG001|NOT COMPLETED|Overall Study||7||
48097810|NCT04152603|100563802|FG000|STARTED|Overall Study||52||
48097811|NCT04152603|100563803|FG001|STARTED|Overall Study||77||
48097812|NCT04152603|100563804|FG002|STARTED|Overall Study||9||
48097813|NCT04152603|100563802|FG000|Neonates|Overall Study||33||
48097814|NCT04152603|100563803|FG001|Neonates|Overall Study||56||
48097815|NCT04152603|100563804|FG002|Neonates|Overall Study||0||
48097816|NCT04152603|100563802|FG000|Parents/LARs|Overall Study||19||
48097817|NCT04152603|100563803|FG001|Parents/LARs|Overall Study||21||
48097818|NCT04152603|100563804|FG002|Parents/LARs|Overall Study||0||
48097819|NCT04152603|100563802|FG000|COMPLETED|Overall Study||52||
48097820|NCT04152603|100563803|FG001|COMPLETED|Overall Study||77||
48097821|NCT04152603|100563804|FG002|COMPLETED|Overall Study||9||
48390215|NCT00927264|101283541|FG001|NOT COMPLETED|Overall Study||25||
48097822|NCT04152603|100563802|FG000|NOT COMPLETED|Overall Study||0||
48097823|NCT04152603|100563803|FG001|NOT COMPLETED|Overall Study||0||
48097824|NCT04152603|100563804|FG002|NOT COMPLETED|Overall Study||0||
48097825|NCT03605303|100563805|FG000|STARTED|Period 1||2||
48097826|NCT03605303|100563806|FG001|STARTED|Period 1||1||
48097827|NCT03605303|100563805|FG000|COMPLETED|Period 1||0||
48390216|NCT01061736|101283542|FG000|STARTED|Overall Study||50||
48390217|NCT01061736|101283543|FG001|STARTED|Overall Study||50||
48390218|NCT01061736|101283544|FG002|STARTED|Overall Study||51||
48390219|NCT01061736|101283545|FG003|STARTED|Overall Study||51||
48390220|NCT01061736|101283546|FG004|STARTED|Overall Study||52||
48390221|NCT01061736|101283547|FG005|STARTED|Overall Study||52||
48390222|NCT01061736|101283548|FG006|STARTED|Overall Study||84||
48390223|NCT01061736|101283549|FG007|STARTED|Overall Study||430||
48390224|NCT01061736|101283550|FG008|STARTED|Overall Study||427||
48390225|NCT01061736|101283551|FG009|STARTED|Overall Study||428||
48390226|NCT01061736|101283542|FG000|Treated|Overall Study||50||
48390227|NCT01061736|101283543|FG001|Treated|Overall Study||50||
48390228|NCT01061736|101283544|FG002|Treated|Overall Study||51||
48390229|NCT01061736|101283545|FG003|Treated|Overall Study||51||
48261661|NCT03672175|100962737|FG000|Modified Full Analysis Set (mFAS)|Treatment Period (Days 1 to 14)||157|mFAS included all randomized participants with valid baseline Hamilton Rating Scale for Depression (HAM-D) and at least 1 post-baseline HAM-D evaluation, with a total HAM-D score of at least 22 at baseline.|
48261662|NCT03672175|100962738|FG001|Modified Full Analysis Set (mFAS)|Treatment Period (Days 1 to 14)||159|mFAS included all randomized participants with valid baseline Hamilton Rating Scale for Depression (HAM-D) and at least 1 post-baseline HAM-D evaluation, with a total HAM-D score of at least 22 at baseline.|
48261663|NCT03672175|100962739|FG002|Modified Full Analysis Set (mFAS)|Treatment Period (Days 1 to 14)||166|mFAS included all randomized participants with valid baseline Hamilton Rating Scale for Depression (HAM-D) and at least 1 post-baseline HAM-D evaluation, with a total HAM-D score of at least 22 at baseline.|
48261664|NCT03672175|100962737|FG000|COMPLETED|Treatment Period (Days 1 to 14)||182||
48261665|NCT03672175|100962738|FG001|COMPLETED|Treatment Period (Days 1 to 14)||180||
48261666|NCT03672175|100962739|FG002|COMPLETED|Treatment Period (Days 1 to 14)||185||
48261667|NCT03672175|100962737|FG000|NOT COMPLETED|Treatment Period (Days 1 to 14)||11||
48261668|NCT03672175|100962738|FG001|NOT COMPLETED|Treatment Period (Days 1 to 14)||14||
48261669|NCT03672175|100962739|FG002|NOT COMPLETED|Treatment Period (Days 1 to 14)||9||
48261670|NCT03672175|100962737|FG000|STARTED|FU Period (Days 15 to 42)||182||
48690373|NCT03587428|102025819|FG000|STARTED|Period 3||3||
48690374|NCT03587428|102025820|FG001|STARTED|Period 3||2||
48690375|NCT03587428|102025821|FG002|STARTED|Period 3||3||
48690376|NCT03587428|102025822|FG003|STARTED|Period 3||3||
48261671|NCT03672175|100962738|FG001|STARTED|FU Period (Days 15 to 42)||180||
48261672|NCT03672175|100962739|FG002|STARTED|FU Period (Days 15 to 42)||185||
48261673|NCT03672175|100962737|FG000|COMPLETED|FU Period (Days 15 to 42)||178||
48261674|NCT03672175|100962738|FG001|COMPLETED|FU Period (Days 15 to 42)||170||
48261675|NCT03672175|100962739|FG002|COMPLETED|FU Period (Days 15 to 42)||178||
48261676|NCT03672175|100962737|FG000|NOT COMPLETED|FU Period (Days 15 to 42)||4||
48261677|NCT03672175|100962738|FG001|NOT COMPLETED|FU Period (Days 15 to 42)||10||
48261678|NCT03672175|100962739|FG002|NOT COMPLETED|FU Period (Days 15 to 42)||7||
48261679|NCT03672175|100962737|FG000|STARTED|Extended FU Period (Days 43 to 182)||178||
48390230|NCT01061736|101283546|FG004|Treated|Overall Study||51||
48390231|NCT01061736|101283547|FG005|Treated|Overall Study||52||
48390232|NCT01061736|101283548|FG006|Treated|Overall Study||84||
48390233|NCT01061736|101283549|FG007|Treated|Overall Study||428||
48390234|NCT01061736|101283550|FG008|Treated|Overall Study||426||
48390235|NCT01061736|101283551|FG009|Treated|Overall Study||428||
48390236|NCT01061736|101283542|FG000|Rescued|Overall Study||0||
48390237|NCT01061736|101283543|FG001|Rescued|Overall Study||0||
48390238|NCT01061736|101283544|FG002|Rescued|Overall Study||0||
48390239|NCT01061736|101283545|FG003|Rescued|Overall Study||0||
48390240|NCT01061736|101283546|FG004|Rescued|Overall Study||0||
48390241|NCT01061736|101283547|FG005|Rescued|Overall Study||0||
48390242|NCT01061736|101283548|FG006|Rescued|Overall Study||0||
48390243|NCT01061736|101283549|FG007|Rescued|Overall Study||61||
48390244|NCT01061736|101283550|FG008|Rescued|Overall Study||55||
48390245|NCT01061736|101283551|FG009|Rescued|Overall Study||168||
48390246|NCT01061736|101283542|FG000|COMPLETED|Overall Study||37||
48390247|NCT01061736|101283543|FG001|COMPLETED|Overall Study||46||
48390248|NCT01061736|101283544|FG002|COMPLETED|Overall Study||45||
48390249|NCT01061736|101283545|FG003|COMPLETED|Overall Study||48||
48390250|NCT01061736|101283546|FG004|COMPLETED|Overall Study||45||
48390251|NCT01061736|101283547|FG005|COMPLETED|Overall Study||49||
48390252|NCT01061736|101283548|FG006|COMPLETED|Overall Study||0||
48390253|NCT01061736|101283549|FG007|COMPLETED|Overall Study||336||
48690377|NCT03587428|102025823|FG004|STARTED|Period 3||2||
48690378|NCT03587428|102025824|FG005|STARTED|Period 3||2||
48390254|NCT01061736|101283550|FG008|COMPLETED|Overall Study||330||
48390255|NCT01061736|101283551|FG009|COMPLETED|Overall Study||354||
48390256|NCT01061736|101283542|FG000|NOT COMPLETED|Overall Study||13||
48390257|NCT01061736|101283543|FG001|NOT COMPLETED|Overall Study||4||
48390258|NCT01061736|101283544|FG002|NOT COMPLETED|Overall Study||6||
48390259|NCT01061736|101283545|FG003|NOT COMPLETED|Overall Study||3||
48390260|NCT01061736|101283546|FG004|NOT COMPLETED|Overall Study||7||
48390261|NCT01061736|101283547|FG005|NOT COMPLETED|Overall Study||3||
48390262|NCT01061736|101283548|FG006|NOT COMPLETED|Overall Study||84||
48390263|NCT01061736|101283549|FG007|NOT COMPLETED|Overall Study||94||
48390264|NCT01061736|101283550|FG008|NOT COMPLETED|Overall Study||97||
48390265|NCT01061736|101283551|FG009|NOT COMPLETED|Overall Study||74||
48390266|NCT00485589|101283552|FG000|STARTED|Overall Study||210||
48390267|NCT00485589|101283553|FG001|STARTED|Overall Study||200||
48390268|NCT00485589|101283554|FG002|STARTED|Overall Study||203||
48390269|NCT00485589|101283552|FG000|COMPLETED|Overall Study||183||
48390270|NCT00485589|101283553|FG001|COMPLETED|Overall Study||180||
48390271|NCT00485589|101283554|FG002|COMPLETED|Overall Study||185||
48390272|NCT00485589|101283552|FG000|NOT COMPLETED|Overall Study||27||
48390273|NCT00485589|101283553|FG001|NOT COMPLETED|Overall Study||20||
48390274|NCT00485589|101283554|FG002|NOT COMPLETED|Overall Study||18||
48390275|NCT01283997|101283555|FG000|STARTED|Overall Study||39||
48390276|NCT01283997|101283556|FG001|STARTED|Overall Study||40||
48690379|NCT03587428|102025819|FG000|COMPLETED|Period 3||3||
48690380|NCT03587428|102025820|FG001|COMPLETED|Period 3||2||
48690381|NCT03587428|102025821|FG002|COMPLETED|Period 3||3||
48261680|NCT03672175|100962738|FG001|STARTED|Extended FU Period (Days 43 to 182)||170||
48261681|NCT03672175|100962739|FG002|STARTED|Extended FU Period (Days 43 to 182)||178||
48543983|NCT01775189|101666997|FG004|STARTED|Treatment Phase: Fourth Intervention||8||
48543984|NCT01775189|101666998|FG005|STARTED|Treatment Phase: Fourth Intervention||7||
48543985|NCT01775189|101666999|FG006|STARTED|Treatment Phase: Fourth Intervention||7||
48543986|NCT01775189|101666993|FG000|COMPLETED|Treatment Phase: Fourth Intervention||0||
48543987|NCT01775189|101666994|FG001|COMPLETED|Treatment Phase: Fourth Intervention||0||
48261682|NCT03672175|100962737|FG000|Extended FU Safety Set|Extended FU Period (Days 43 to 182)||129|Extended FU Safety Set included all participants in the Safety Set of treatment period who consented or reconsented to participate in the study in the 6-month FU period.|
48261683|NCT03672175|100962738|FG001|Extended FU Safety Set|Extended FU Period (Days 43 to 182)||127|Extended FU Safety Set included all participants in the Safety Set of treatment period who consented or reconsented to participate in the study in the 6-month FU period.|
48261684|NCT03672175|100962739|FG002|Extended FU Safety Set|Extended FU Period (Days 43 to 182)||131|Extended FU Safety Set included all participants in the Safety Set of treatment period who consented or reconsented to participate in the study in the 6-month FU period.|
48261685|NCT03672175|100962737|FG000|COMPLETED|Extended FU Period (Days 43 to 182)||141||
48261686|NCT03672175|100962738|FG001|COMPLETED|Extended FU Period (Days 43 to 182)||131||
48261687|NCT03672175|100962739|FG002|COMPLETED|Extended FU Period (Days 43 to 182)||141||
48261688|NCT03672175|100962737|FG000|NOT COMPLETED|Extended FU Period (Days 43 to 182)||37||
48261689|NCT03672175|100962738|FG001|NOT COMPLETED|Extended FU Period (Days 43 to 182)||39||
48261690|NCT03672175|100962739|FG002|NOT COMPLETED|Extended FU Period (Days 43 to 182)||37||
48261691|NCT01214421|100962740|FG000|STARTED|Overall Study||557||
48261692|NCT01214421|100962741|FG001|STARTED|Overall Study||314||
48261693|NCT01214421|100962742|FG002|STARTED|Overall Study||181||
48261694|NCT01214421|100962743|FG003|STARTED|Overall Study||31||
48261695|NCT01214421|100962740|FG000|COMPLETED|Overall Study||507||
48261696|NCT01214421|100962741|FG001|COMPLETED|Overall Study||256||
48261697|NCT01214421|100962742|FG002|COMPLETED|Overall Study||143||
48261698|NCT01214421|100962743|FG003|COMPLETED|Overall Study||22||
48261699|NCT01214421|100962740|FG000|NOT COMPLETED|Overall Study||50||
48261700|NCT01214421|100962741|FG001|NOT COMPLETED|Overall Study||58||
48261701|NCT01214421|100962742|FG002|NOT COMPLETED|Overall Study||38||
48261702|NCT01214421|100962743|FG003|NOT COMPLETED|Overall Study||9||
48261703|NCT02689453|100962744|FG000|STARTED|Overall Study||3||
48261704|NCT02689453|100962745|FG001|STARTED|Overall Study||4||
48261705|NCT02689453|100962746|FG002|STARTED|Overall Study||4||
48261706|NCT02689453|100962744|FG000|COMPLETED|Overall Study||3||
48261707|NCT02689453|100962745|FG001|COMPLETED|Overall Study||3||
48261708|NCT02689453|100962746|FG002|COMPLETED|Overall Study||3||
48261709|NCT02689453|100962744|FG000|NOT COMPLETED|Overall Study||0||
48261710|NCT02689453|100962745|FG001|NOT COMPLETED|Overall Study||1||
48261711|NCT02689453|100962746|FG002|NOT COMPLETED|Overall Study||1||
48261712|NCT03792347|100962747|FG000|STARTED|Overall Study||20||
48261713|NCT03792347|100962747|FG000|COMPLETED|Overall Study||20||
48261714|NCT03792347|100962747|FG000|NOT COMPLETED|Overall Study||0||
48261715|NCT02284009|100962748|FG000|STARTED|Overall Study||17||
48261716|NCT02284009|100962749|FG001|STARTED|Overall Study||50||
48261717|NCT02284009|100962748|FG000|COMPLETED|Overall Study||11||
48261718|NCT02284009|100962749|FG001|COMPLETED|Overall Study||40||
48261719|NCT02284009|100962748|FG000|NOT COMPLETED|Overall Study||6||
48261720|NCT02284009|100962749|FG001|NOT COMPLETED|Overall Study||10||
48261721|NCT01667406|100962750|FG000|STARTED|Overall Study||2||
48261722|NCT01667406|100962751|FG001|STARTED|Overall Study||3||
48261723|NCT01667406|100962752|FG002|STARTED|Overall Study||24||
48261724|NCT01667406|100962753|FG003|STARTED|Overall Study||24||
48261725|NCT01667406|100962754|FG004|STARTED|Overall Study||5||
48261726|NCT01667406|100962755|FG005|STARTED|Overall Study||20||
48261727|NCT01667406|100962756|FG006|STARTED|Overall Study||15||
48261728|NCT01667406|100962757|FG007|STARTED|Overall Study||20||
48261729|NCT01667406|100962758|FG008|STARTED|Overall Study||31||
48261730|NCT01667406|100962759|FG009|STARTED|Overall Study||31||
48261731|NCT01667406|100962750|FG000|COMPLETED|Overall Study||2||
48261732|NCT01667406|100962751|FG001|COMPLETED|Overall Study||3||
48261733|NCT01667406|100962752|FG002|COMPLETED|Overall Study||24||
48261734|NCT01667406|100962753|FG003|COMPLETED|Overall Study||24||
48261735|NCT01667406|100962754|FG004|COMPLETED|Overall Study||5||
48261736|NCT01667406|100962755|FG005|COMPLETED|Overall Study||20||
48261737|NCT01667406|100962756|FG006|COMPLETED|Overall Study||15||
48261738|NCT01667406|100962757|FG007|COMPLETED|Overall Study||20||
48261739|NCT01667406|100962758|FG008|COMPLETED|Overall Study||31||
48261740|NCT01667406|100962759|FG009|COMPLETED|Overall Study||31||
48261741|NCT01667406|100962750|FG000|NOT COMPLETED|Overall Study||0||
48261742|NCT01667406|100962751|FG001|NOT COMPLETED|Overall Study||0||
48543988|NCT01775189|101666995|FG002|COMPLETED|Treatment Phase: Fourth Intervention||0||
48543989|NCT01775189|101666996|FG003|COMPLETED|Treatment Phase: Fourth Intervention||6||
48543990|NCT01775189|101666997|FG004|COMPLETED|Treatment Phase: Fourth Intervention||8||
48543991|NCT01775189|101666998|FG005|COMPLETED|Treatment Phase: Fourth Intervention||7||
48543992|NCT01775189|101666999|FG006|COMPLETED|Treatment Phase: Fourth Intervention||7||
48543993|NCT01775189|101666993|FG000|NOT COMPLETED|Treatment Phase: Fourth Intervention||0||
48690382|NCT03587428|102025822|FG003|COMPLETED|Period 3||3||
48690383|NCT03587428|102025823|FG004|COMPLETED|Period 3||2||
48690384|NCT03587428|102025824|FG005|COMPLETED|Period 3||2||
48690385|NCT03587428|102025819|FG000|NOT COMPLETED|Period 3||0||
48690386|NCT03587428|102025820|FG001|NOT COMPLETED|Period 3||0||
48690387|NCT03587428|102025821|FG002|NOT COMPLETED|Period 3||0||
48690388|NCT03587428|102025822|FG003|NOT COMPLETED|Period 3||0||
48690389|NCT03587428|102025823|FG004|NOT COMPLETED|Period 3||0||
48690390|NCT03587428|102025824|FG005|NOT COMPLETED|Period 3||0||
48690391|NCT01220401|102025825|FG000|STARTED|Overall Study||21||
48690392|NCT01220401|102025825|FG000|COMPLETED|Overall Study||18||
48690393|NCT01220401|102025825|FG000|NOT COMPLETED|Overall Study||3||
48690394|NCT02370368|102025826|FG000|STARTED|Overall Study||14||
48690395|NCT02370368|102025827|FG001|STARTED|Overall Study||13||
48690396|NCT02370368|102025826|FG000|COMPLETED|Overall Study||8||
48690397|NCT02370368|102025827|FG001|COMPLETED|Overall Study||7||
48690398|NCT02370368|102025826|FG000|NOT COMPLETED|Overall Study||6||
48690399|NCT02370368|102025827|FG001|NOT COMPLETED|Overall Study||6||
48690400|NCT03012191|102025828|FG000|STARTED|Overall Study||2||
48690401|NCT03012191|102025829|FG001|STARTED|Overall Study||2||
48690402|NCT03012191|102025830|FG002|STARTED|Overall Study||2||
48690403|NCT03012191|102025828|FG000|COMPLETED|Overall Study||2||
48097828|NCT03605303|100563806|FG001|COMPLETED|Period 1||0||
48261743|NCT01667406|100962752|FG002|NOT COMPLETED|Overall Study||0||
48261744|NCT01667406|100962753|FG003|NOT COMPLETED|Overall Study||0||
48261745|NCT01667406|100962754|FG004|NOT COMPLETED|Overall Study||0||
48261746|NCT01667406|100962755|FG005|NOT COMPLETED|Overall Study||0||
48261747|NCT01667406|100962756|FG006|NOT COMPLETED|Overall Study||0||
48261748|NCT01667406|100962757|FG007|NOT COMPLETED|Overall Study||0||
48261749|NCT01667406|100962758|FG008|NOT COMPLETED|Overall Study||0||
48261750|NCT01667406|100962759|FG009|NOT COMPLETED|Overall Study||0||
48261751|NCT01124097|100962760|FG000|STARTED|Overall Study||60||
48261752|NCT01124097|100962761|FG001|STARTED|Overall Study||60||
48261753|NCT01124097|100962762|FG002|STARTED|Overall Study||60||
48261754|NCT01124097|100962763|FG003|STARTED|Overall Study||60||
48261755|NCT01124097|100962760|FG000|Safety Population|Overall Study||60||
48261756|NCT01124097|100962761|FG001|Safety Population|Overall Study||60||
48261757|NCT01124097|100962762|FG002|Safety Population|Overall Study||60||
48261758|NCT01124097|100962763|FG003|Safety Population|Overall Study||60||
48261759|NCT01124097|100962760|FG000|Efficacy Population|Overall Study||52||
48261760|NCT01124097|100962761|FG001|Efficacy Population|Overall Study||53||
48261761|NCT01124097|100962762|FG002|Efficacy Population|Overall Study||53||
48261762|NCT01124097|100962763|FG003|Efficacy Population|Overall Study||51||
48261763|NCT01124097|100962760|FG000|COMPLETED|Overall Study||26||
48261764|NCT01124097|100962761|FG001|COMPLETED|Overall Study||38||
48261765|NCT01124097|100962762|FG002|COMPLETED|Overall Study||40||
48261766|NCT01124097|100962763|FG003|COMPLETED|Overall Study||46||
48261767|NCT01124097|100962760|FG000|NOT COMPLETED|Overall Study||34||
48261768|NCT01124097|100962761|FG001|NOT COMPLETED|Overall Study||22||
48261769|NCT01124097|100962762|FG002|NOT COMPLETED|Overall Study||20||
48261770|NCT01124097|100962763|FG003|NOT COMPLETED|Overall Study||14||
48261771|NCT00612352|100962764|FG000|STARTED|Overall Study||65||
48261772|NCT00612352|100962765|FG001|STARTED|Overall Study||115||
48261773|NCT00612352|100962764|FG000|40%mg & 100%mg|Overall Study||1|Subjects that completed 2 test days (40%mg ethanol \& 100%mg ethanol)|
48261774|NCT00612352|100962765|FG001|40%mg & 100%mg|Overall Study||1|Subjects that completed 2 test days (40%mg ethanol \& 100%mg ethanol)|
48261775|NCT00612352|100962764|FG000|Placebo & 100%mg|Overall Study||1|Subjects that completed 2 test days (placebo \& 100%mg ethanol)|
48261776|NCT00612352|100962765|FG001|Placebo & 100%mg|Overall Study||0|Subjects that completed 2 test days (placebo \& 100%mg ethanol)|
48261777|NCT00612352|100962764|FG000|100%mg|Overall Study||2|Subjects that completed 1 test day (100%mg ethanol)|
48261778|NCT00612352|100962765|FG001|100%mg|Overall Study||1|Subjects that completed 1 test day (100%mg ethanol)|
48261779|NCT00612352|100962764|FG000|40%mg|Overall Study||1|Subjects that completed 1 test day (40%mg ethanol)|
48261780|NCT00612352|100962765|FG001|40%mg|Overall Study||0|Subjects that completed 1 test day (40%mg ethanol)|
48261781|NCT00612352|100962764|FG000|Placebo|Overall Study||4|Subjects that completed 1 test day (placebo)|
48261782|NCT00612352|100962765|FG001|Placebo|Overall Study||4|Subjects that completed 1 test day (placebo)|
48261783|NCT00612352|100962764|FG000|COMPLETED|Overall Study||56|Completed all three test dates.|
48261784|NCT00612352|100962765|FG001|COMPLETED|Overall Study||109|Completed all three test dates.|
48261785|NCT00612352|100962764|FG000|NOT COMPLETED|Overall Study||9||
48261786|NCT00612352|100962765|FG001|NOT COMPLETED|Overall Study||6||
48690404|NCT03012191|102025829|FG001|COMPLETED|Overall Study||2||
48690405|NCT03012191|102025830|FG002|COMPLETED|Overall Study||2||
48690406|NCT03012191|102025828|FG000|NOT COMPLETED|Overall Study||0||
48690407|NCT03012191|102025829|FG001|NOT COMPLETED|Overall Study||0||
48690408|NCT03012191|102025830|FG002|NOT COMPLETED|Overall Study||0||
48690409|NCT01925768|102025831|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||109||
48690410|NCT01925768|102025832|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||110||
48543994|NCT01775189|101666994|FG001|NOT COMPLETED|Treatment Phase: Fourth Intervention||0||
48543995|NCT01775189|101666995|FG002|NOT COMPLETED|Treatment Phase: Fourth Intervention||0||
48543996|NCT01775189|101666996|FG003|NOT COMPLETED|Treatment Phase: Fourth Intervention||0||
48543997|NCT01775189|101666997|FG004|NOT COMPLETED|Treatment Phase: Fourth Intervention||0||
48543998|NCT01775189|101666998|FG005|NOT COMPLETED|Treatment Phase: Fourth Intervention||0||
48543999|NCT01775189|101666999|FG006|NOT COMPLETED|Treatment Phase: Fourth Intervention||0||
48544000|NCT02814890|101667000|FG000|STARTED|Overall Study||33||
48544001|NCT02814890|101667001|FG001|STARTED|Overall Study||32||
48544002|NCT02814890|101667000|FG000|COMPLETED|Overall Study||30||
48544003|NCT02814890|101667001|FG001|COMPLETED|Overall Study||30||
48544004|NCT02814890|101667000|FG000|NOT COMPLETED|Overall Study||3||
48544005|NCT02814890|101667001|FG001|NOT COMPLETED|Overall Study||2||
48544006|NCT01449370|101667002|FG000|STARTED|Overall Study||6||
48544007|NCT01449370|101667003|FG001|STARTED|Overall Study||6||
48544008|NCT01449370|101667004|FG002|STARTED|Overall Study||8||
48544009|NCT01449370|101667005|FG003|STARTED|Overall Study||4||
48544010|NCT01449370|101667006|FG004|STARTED|Overall Study||3||
48544011|NCT01449370|101667007|FG005|STARTED|Overall Study||3||
48544012|NCT01449370|101667008|FG006|STARTED|Overall Study||3||
48544013|NCT01449370|101667009|FG007|STARTED|Overall Study||3||
48544014|NCT01449370|101667010|FG008|STARTED|Overall Study||12||
48544015|NCT01449370|101667011|FG009|STARTED|Overall Study||3||
48544016|NCT01449370|101667012|FG010|STARTED|Overall Study||3||
48544017|NCT01449370|101667013|FG011|STARTED|Overall Study||3||
48261787|NCT01936467|100962766|FG000|STARTED|Overall Study||60||
48544018|NCT01449370|101667014|FG012|STARTED|Overall Study||3||
48544019|NCT01449370|101667015|FG013|STARTED|Overall Study||11||
48544020|NCT01449370|101667016|FG014|STARTED|Overall Study||3||
48544021|NCT01449370|101667017|FG015|STARTED|Overall Study||3||
48544022|NCT01449370|101667018|FG016|STARTED|Overall Study||7||
48544023|NCT01449370|101667019|FG017|STARTED|Overall Study||3||
48544024|NCT01449370|101667020|FG018|STARTED|Overall Study||3||
48544025|NCT01449370|101667021|FG019|STARTED|Overall Study||3||
48544026|NCT01449370|101667022|FG020|STARTED|Overall Study||6||
48544027|NCT01449370|101667023|FG021|STARTED|Overall Study||4||
48544028|NCT01449370|101667024|FG022|STARTED|Overall Study||4||
48544029|NCT01449370|101667025|FG023|STARTED|Overall Study||10||
48544030|NCT01449370|101667026|FG024|STARTED|Overall Study||8||
48544031|NCT01449370|101667002|FG000|COMPLETED|Overall Study||0||
48544032|NCT01449370|101667003|FG001|COMPLETED|Overall Study||0||
48544033|NCT01449370|101667004|FG002|COMPLETED|Overall Study||0||
48261788|NCT01936467|100962767|FG001|STARTED|Overall Study||61||
48261789|NCT01936467|100962766|FG000|COMPLETED|Overall Study||60||
48261790|NCT01936467|100962767|FG001|COMPLETED|Overall Study||61||
48261791|NCT01936467|100962766|FG000|NOT COMPLETED|Overall Study||0||
48261792|NCT01936467|100962767|FG001|NOT COMPLETED|Overall Study||0||
48261793|NCT01434745|100962768|FG000|STARTED|Overall Study||0||
48261794|NCT01434745|100962769|FG001|STARTED|Overall Study||0||
48261795|NCT01434745|100962768|FG000|COMPLETED|Overall Study||0||
48261796|NCT01434745|100962769|FG001|COMPLETED|Overall Study||0||
48261797|NCT01434745|100962768|FG000|NOT COMPLETED|Overall Study||0||
48261798|NCT01434745|100962769|FG001|NOT COMPLETED|Overall Study||0||
48261799|NCT04732871|100962770|FG000|STARTED|Overall Study||993||
48261800|NCT04732871|100962771|FG001|STARTED|Overall Study||329||
48261801|NCT04732871|100962772|FG002|STARTED|Overall Study||331||
48261802|NCT04732871|100962770|FG000|COMPLETED|Overall Study||938||
48544034|NCT01449370|101667005|FG003|COMPLETED|Overall Study||0||
48544035|NCT01449370|101667006|FG004|COMPLETED|Overall Study||0||
48544036|NCT01449370|101667007|FG005|COMPLETED|Overall Study||0||
48544037|NCT01449370|101667008|FG006|COMPLETED|Overall Study||0||
48544038|NCT01449370|101667009|FG007|COMPLETED|Overall Study||0||
48544039|NCT01449370|101667010|FG008|COMPLETED|Overall Study||0||
48544040|NCT01449370|101667011|FG009|COMPLETED|Overall Study||0||
48544041|NCT01449370|101667012|FG010|COMPLETED|Overall Study||0||
48544042|NCT01449370|101667013|FG011|COMPLETED|Overall Study||0||
48544043|NCT01449370|101667014|FG012|COMPLETED|Overall Study||0||
48261803|NCT04732871|100962771|FG001|COMPLETED|Overall Study||317||
48261804|NCT04732871|100962772|FG002|COMPLETED|Overall Study||317||
48261805|NCT04732871|100962770|FG000|NOT COMPLETED|Overall Study||55||
48544044|NCT01449370|101667015|FG013|COMPLETED|Overall Study||0||
48544045|NCT01449370|101667016|FG014|COMPLETED|Overall Study||0||
48544046|NCT01449370|101667017|FG015|COMPLETED|Overall Study||0||
48544047|NCT01449370|101667018|FG016|COMPLETED|Overall Study||0||
48544048|NCT01449370|101667019|FG017|COMPLETED|Overall Study||0||
48544049|NCT01449370|101667020|FG018|COMPLETED|Overall Study||0||
48544050|NCT01449370|101667021|FG019|COMPLETED|Overall Study||0||
48544051|NCT01449370|101667022|FG020|COMPLETED|Overall Study||0||
48544052|NCT01449370|101667023|FG021|COMPLETED|Overall Study||0||
48544053|NCT01449370|101667024|FG022|COMPLETED|Overall Study||0||
48544054|NCT01449370|101667025|FG023|COMPLETED|Overall Study||0||
48261806|NCT04732871|100962771|FG001|NOT COMPLETED|Overall Study||12||
48261807|NCT04732871|100962772|FG002|NOT COMPLETED|Overall Study||14||
48261808|NCT00916305|100962773|FG000|STARTED|Overall Study||28||
48261809|NCT00916305|100962774|FG001|STARTED|Overall Study||37||
48261810|NCT00916305|100962773|FG000|COMPLETED|Overall Study||7||
48544055|NCT01449370|101667026|FG024|COMPLETED|Overall Study||0||
48544056|NCT01449370|101667002|FG000|NOT COMPLETED|Overall Study||6||
48544057|NCT01449370|101667003|FG001|NOT COMPLETED|Overall Study||6||
48544058|NCT01449370|101667004|FG002|NOT COMPLETED|Overall Study||8||
48544059|NCT01449370|101667005|FG003|NOT COMPLETED|Overall Study||4||
48544060|NCT01449370|101667006|FG004|NOT COMPLETED|Overall Study||3||
48544061|NCT01449370|101667007|FG005|NOT COMPLETED|Overall Study||3||
48544062|NCT01449370|101667008|FG006|NOT COMPLETED|Overall Study||3||
48544063|NCT01449370|101667009|FG007|NOT COMPLETED|Overall Study||3||
48544064|NCT01449370|101667010|FG008|NOT COMPLETED|Overall Study||12||
48544065|NCT01449370|101667011|FG009|NOT COMPLETED|Overall Study||3||
48544066|NCT01449370|101667012|FG010|NOT COMPLETED|Overall Study||3||
48544067|NCT01449370|101667013|FG011|NOT COMPLETED|Overall Study||3||
48544068|NCT01449370|101667014|FG012|NOT COMPLETED|Overall Study||3||
48544069|NCT01449370|101667015|FG013|NOT COMPLETED|Overall Study||11||
48544070|NCT01449370|101667016|FG014|NOT COMPLETED|Overall Study||3||
48544071|NCT01449370|101667017|FG015|NOT COMPLETED|Overall Study||3||
48544072|NCT01449370|101667018|FG016|NOT COMPLETED|Overall Study||7||
48544073|NCT01449370|101667019|FG017|NOT COMPLETED|Overall Study||3||
48544074|NCT01449370|101667020|FG018|NOT COMPLETED|Overall Study||3||
48544075|NCT01449370|101667021|FG019|NOT COMPLETED|Overall Study||3||
48544076|NCT01449370|101667022|FG020|NOT COMPLETED|Overall Study||6||
48544077|NCT01449370|101667023|FG021|NOT COMPLETED|Overall Study||4||
48544078|NCT01449370|101667024|FG022|NOT COMPLETED|Overall Study||4||
48544079|NCT01449370|101667025|FG023|NOT COMPLETED|Overall Study||10||
48544080|NCT01449370|101667026|FG024|NOT COMPLETED|Overall Study||8||
48544081|NCT01178528|101667027|FG000|STARTED|Overall Study||41||
48544082|NCT01178528|101667028|FG001|STARTED|Overall Study||38||
48544083|NCT01178528|101667029|FG002|STARTED|Overall Study||42||
48544084|NCT01178528|101667027|FG000|COMPLETED|Overall Study||41||
48544085|NCT01178528|101667028|FG001|COMPLETED|Overall Study||38||
48544086|NCT01178528|101667029|FG002|COMPLETED|Overall Study||42||
48544087|NCT01178528|101667027|FG000|NOT COMPLETED|Overall Study||0||
48544088|NCT01178528|101667028|FG001|NOT COMPLETED|Overall Study||0||
48544089|NCT01178528|101667029|FG002|NOT COMPLETED|Overall Study||0||
48544090|NCT02698033|101667030|FG000|STARTED|Overall Study||7||
48544091|NCT02698033|101667030|FG000|COMPLETED|Overall Study||6||
48544092|NCT02698033|101667030|FG000|NOT COMPLETED|Overall Study||1||
48544093|NCT00998868|101667031|FG000|STARTED|Overall Study||51||
48544094|NCT00998868|101667031|FG000|COMPLETED|Overall Study||51||
48544095|NCT00998868|101667031|FG000|NOT COMPLETED|Overall Study||0||
48544096|NCT00555152|101667032|FG000|STARTED|Period Open at BCM: 1/17/08-3/8/10||2||
48544097|NCT00555152|101667033|FG001|STARTED|Period Open at BCM: 1/17/08-3/8/10||0||
48544098|NCT00555152|101667034|FG002|STARTED|Period Open at BCM: 1/17/08-3/8/10||0||
48544099|NCT00555152|101667035|FG003|STARTED|Period Open at BCM: 1/17/08-3/8/10||1||
48544100|NCT00555152|101667032|FG000|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||2||
48544101|NCT00555152|101667033|FG001|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0||
48544102|NCT00555152|101667034|FG002|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0||
48544103|NCT00555152|101667035|FG003|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||1||
48544104|NCT00555152|101667032|FG000|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0||
48544105|NCT00555152|101667033|FG001|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0||
48544106|NCT00555152|101667034|FG002|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0||
48544107|NCT00555152|101667035|FG003|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0||
48544108|NCT00555152|101667032|FG000|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||0||
48544109|NCT00555152|101667033|FG001|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||10||
48544110|NCT00555152|101667034|FG002|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||0||
48544111|NCT00555152|101667035|FG003|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||9||
48544112|NCT00555152|101667032|FG000|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0||
48544113|NCT00555152|101667033|FG001|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||10||
48544114|NCT00555152|101667034|FG002|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0||
48544115|NCT00555152|101667035|FG003|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||9||
48544116|NCT00555152|101667032|FG000|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0||
48544117|NCT00555152|101667033|FG001|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0||
48544118|NCT00555152|101667034|FG002|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0||
48544119|NCT00555152|101667035|FG003|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0||
48544120|NCT00754546|101667036|FG000|STARTED|Overall Study||20||
48544121|NCT00754546|101667036|FG000|COMPLETED|Overall Study||20||
48544122|NCT00754546|101667036|FG000|NOT COMPLETED|Overall Study||0||
48544123|NCT01708967|101667037|FG000|STARTED|Overall Study||50||
48544124|NCT01708967|101667038|FG001|STARTED|Overall Study||50||
48544125|NCT01708967|101667037|FG000|COMPLETED|Overall Study||50||
48544126|NCT01708967|101667038|FG001|COMPLETED|Overall Study||43||
48544127|NCT01708967|101667037|FG000|NOT COMPLETED|Overall Study||0||
48544128|NCT01708967|101667038|FG001|NOT COMPLETED|Overall Study||7||
48544129|NCT02296931|101667039|FG000|STARTED|Overall Study||10||
48544130|NCT02296931|101667040|FG001|STARTED|Overall Study||24||
48544131|NCT02296931|101667039|FG000|COMPLETED|Overall Study||10||
48544132|NCT02296931|101667040|FG001|COMPLETED|Overall Study||22||
48544133|NCT02296931|101667039|FG000|NOT COMPLETED|Overall Study||0||
48544134|NCT02296931|101667040|FG001|NOT COMPLETED|Overall Study||2||
48544135|NCT01589497|101667041|FG000|STARTED|Overall Study||18||
48544136|NCT01589497|101667042|FG001|STARTED|Overall Study||17||
48544137|NCT01589497|101667043|FG002|STARTED|Overall Study||16||
48544138|NCT01589497|101667044|FG003|STARTED|Overall Study||18||
48544139|NCT01589497|101667041|FG000|COMPLETED|Overall Study||17||
48544140|NCT01589497|101667042|FG001|COMPLETED|Overall Study||16||
48544141|NCT01589497|101667043|FG002|COMPLETED|Overall Study||15||
48544142|NCT01589497|101667044|FG003|COMPLETED|Overall Study||17||
48544143|NCT01589497|101667041|FG000|NOT COMPLETED|Overall Study||1||
48544144|NCT01589497|101667042|FG001|NOT COMPLETED|Overall Study||1||
48544145|NCT01589497|101667043|FG002|NOT COMPLETED|Overall Study||1||
48544146|NCT01589497|101667044|FG003|NOT COMPLETED|Overall Study||1||
48544147|NCT00385008|101667045|FG000|STARTED|Overall Study||10||
48544148|NCT00385008|101667046|FG001|STARTED|Overall Study||10||
48544149|NCT00385008|101667045|FG000|In Absence of Migraine|Overall Study||10||
48544150|NCT00385008|101667046|FG001|In Absence of Migraine|Overall Study||10||
48544151|NCT00385008|101667045|FG000|In Presence of Migraine|Overall Study||5|5 participants out of 10 in each arm were re-dosed in presence of migraine.|
48544152|NCT00385008|101667046|FG001|In Presence of Migraine|Overall Study||5|5 participants out of 10 in each arm were re-dosed in presence of migraine.|
48544153|NCT00385008|101667045|FG000|COMPLETED|Overall Study||10||
48544154|NCT00385008|101667046|FG001|COMPLETED|Overall Study||10||
48544155|NCT00385008|101667045|FG000|NOT COMPLETED|Overall Study||0||
48544156|NCT00385008|101667046|FG001|NOT COMPLETED|Overall Study||0||
48544157|NCT02374138|101667047|FG000|STARTED|Six Month Follow Up||110||
48544158|NCT02374138|101667048|FG001|STARTED|Six Month Follow Up||107||
48544159|NCT02374138|101667047|FG000|COMPLETED|Six Month Follow Up||102||
48544160|NCT02374138|101667048|FG001|COMPLETED|Six Month Follow Up||93||
48544161|NCT02374138|101667047|FG000|NOT COMPLETED|Six Month Follow Up||8||
48544162|NCT02374138|101667048|FG001|NOT COMPLETED|Six Month Follow Up||14||
48544163|NCT02374138|101667047|FG000|STARTED|Twelve Month FollowUp||110|All participants were contacted at 12m, regardless of whether they completed the 6m interview.|
48544164|NCT02374138|101667048|FG001|STARTED|Twelve Month FollowUp||107|All participants were contacted at 12m, regardless of whether they completed the 6m interview.|
48544165|NCT02374138|101667047|FG000|COMPLETED|Twelve Month FollowUp||101||
48544166|NCT02374138|101667048|FG001|COMPLETED|Twelve Month FollowUp||95||
48544167|NCT02374138|101667047|FG000|NOT COMPLETED|Twelve Month FollowUp||9||
48544168|NCT02374138|101667048|FG001|NOT COMPLETED|Twelve Month FollowUp||12||
48544169|NCT02052011|101667049|FG000|STARTED|Overall Study||21||
48544170|NCT02052011|101667050|FG001|STARTED|Overall Study||10||
48544171|NCT02052011|101667049|FG000|COMPLETED|Overall Study||17||
48544172|NCT02052011|101667050|FG001|COMPLETED|Overall Study||8||
48544173|NCT02052011|101667049|FG000|NOT COMPLETED|Overall Study||4||
48544174|NCT02052011|101667050|FG001|NOT COMPLETED|Overall Study||2||
48544175|NCT00789997|101667051|FG000|STARTED|Overall Study||41||
48544176|NCT00789997|101667052|FG001|STARTED|Overall Study||40||
48544177|NCT00789997|101667051|FG000|COMPLETED|Overall Study||40||
48544178|NCT00789997|101667052|FG001|COMPLETED|Overall Study||38||
48544179|NCT00789997|101667051|FG000|NOT COMPLETED|Overall Study||1||
48544180|NCT00789997|101667052|FG001|NOT COMPLETED|Overall Study||2||
48544181|NCT02466685|101667053|FG000|STARTED|Overall Study||30||
48544182|NCT02466685|101667054|FG001|STARTED|Overall Study||30||
48544183|NCT02466685|101667053|FG000|COMPLETED|Overall Study||22||
48544184|NCT02466685|101667054|FG001|COMPLETED|Overall Study||26||
48261811|NCT00916305|100962774|FG001|COMPLETED|Overall Study||9||
48261812|NCT00916305|100962773|FG000|NOT COMPLETED|Overall Study||21||
48261813|NCT00916305|100962774|FG001|NOT COMPLETED|Overall Study||28||
48261814|NCT03409731|100962775|FG000|STARTED|Overall Study||135||
48261815|NCT03409731|100962775|FG000|COMPLETED|Overall Study||114||
48544185|NCT02466685|101667053|FG000|NOT COMPLETED|Overall Study||8||
48261816|NCT03409731|100962775|FG000|NOT COMPLETED|Overall Study||21||
48544186|NCT02466685|101667054|FG001|NOT COMPLETED|Overall Study||4||
48544187|NCT02614274|101667055|FG000|STARTED|Overall Study||9||
48544188|NCT02614274|101667055|FG000|COMPLETED|Overall Study||5||
48544189|NCT02614274|101667055|FG000|NOT COMPLETED|Overall Study||4||
48544190|NCT00224289|101667056|FG000|STARTED|Overall Study||17||
48544191|NCT00224289|101667056|FG000|COMPLETED|Overall Study||17||
48544192|NCT00224289|101667056|FG000|NOT COMPLETED|Overall Study||0||
48544193|NCT02473926|101667057|FG000|STARTED|Overall Study||28||
48544194|NCT02473926|101667058|FG001|STARTED|Overall Study||22||
48544195|NCT02473926|101667057|FG000|COMPLETED|Overall Study||25||
48544196|NCT02473926|101667058|FG001|COMPLETED|Overall Study||22||
48544197|NCT02473926|101667057|FG000|NOT COMPLETED|Overall Study||3||
48544198|NCT02473926|101667058|FG001|NOT COMPLETED|Overall Study||0||
48544199|NCT00362466|101667059|FG000|STARTED|Overall Study||2||
48544200|NCT00362466|101667060|FG001|STARTED|Overall Study||1||
48544201|NCT00362466|101667059|FG000|COMPLETED|Overall Study||2||
48544202|NCT00362466|101667060|FG001|COMPLETED|Overall Study||1||
48261817|NCT01339299|100962776|FG000|STARTED|Overall Study||50||
48544203|NCT00362466|101667059|FG000|NOT COMPLETED|Overall Study||0||
48544204|NCT00362466|101667060|FG001|NOT COMPLETED|Overall Study||0||
48544205|NCT04971187|101667061|FG000|STARTED|Overall Study||3||
48261818|NCT01339299|100962777|FG001|STARTED|Overall Study||50||
48544206|NCT04971187|101667061|FG000|COMPLETED|Overall Study||1||
48544207|NCT04971187|101667061|FG000|NOT COMPLETED|Overall Study||2||
48544208|NCT04611529|101667062|FG000|STARTED|2-day Follow up||65||
48544209|NCT04611529|101667063|FG001|STARTED|2-day Follow up||66||
48690411|NCT01925768|102025831|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||109||
48690412|NCT01925768|102025832|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||109||
48261819|NCT01339299|100962776|FG000|COMPLETED|Overall Study||50||
48261820|NCT01339299|100962777|FG001|COMPLETED|Overall Study||50||
48261821|NCT01339299|100962776|FG000|NOT COMPLETED|Overall Study||0||
48261822|NCT01339299|100962777|FG001|NOT COMPLETED|Overall Study||0||
48261823|NCT04140266|100962778|FG000|STARTED|Overall Study||296|Mothers and infants are added as two milestones.|
48261824|NCT04140266|100962779|FG001|STARTED|Overall Study||98|Mothers and infants are added as two milestones.|
48261825|NCT04140266|100962778|FG000|Mothers|Overall Study||148||
48261826|NCT04140266|100962779|FG001|Mothers|Overall Study||49||
48261827|NCT04140266|100962778|FG000|Infants|Overall Study||148||
48261828|NCT04140266|100962779|FG001|Infants|Overall Study||49||
48261829|NCT04140266|100962778|FG000|COMPLETED|Overall Study||290||
48261830|NCT04140266|100962779|FG001|COMPLETED|Overall Study||96||
48261831|NCT04140266|100962778|FG000|NOT COMPLETED|Overall Study||6||
48261832|NCT04140266|100962779|FG001|NOT COMPLETED|Overall Study||2||
48261833|NCT01261247|100962780|FG000|STARTED|Overall Study||41||
48261834|NCT01261247|100962780|FG000|COMPLETED|Overall Study||39||
48261835|NCT01261247|100962780|FG000|NOT COMPLETED|Overall Study||2||
48261836|NCT01841697|100962781|FG000|STARTED|Overall Study||322||
48261837|NCT01841697|100962782|FG001|STARTED|Overall Study||320||
48261838|NCT01841697|100962781|FG000|COMPLETED|Overall Study||302||
48261839|NCT01841697|100962782|FG001|COMPLETED|Overall Study||302||
48261840|NCT01841697|100962781|FG000|NOT COMPLETED|Overall Study||20||
48261841|NCT01841697|100962782|FG001|NOT COMPLETED|Overall Study||18||
48261842|NCT01270828|100962783|FG000|STARTED|Pregabalin CR SB||0||
48261843|NCT01270828|100962784|FG001|STARTED|Pregabalin CR SB||0||
48261844|NCT01270828|100962785|FG002|STARTED|Pregabalin CR SB||806||
48261845|NCT01270828|100962783|FG000|COMPLETED|Pregabalin CR SB||0||
48261846|NCT01270828|100962784|FG001|COMPLETED|Pregabalin CR SB||0||
48261847|NCT01270828|100962785|FG002|COMPLETED|Pregabalin CR SB||660||
48261848|NCT01270828|100962783|FG000|NOT COMPLETED|Pregabalin CR SB||0||
48261849|NCT01270828|100962784|FG001|NOT COMPLETED|Pregabalin CR SB||0||
48261850|NCT01270828|100962785|FG002|NOT COMPLETED|Pregabalin CR SB||146||
48261851|NCT01270828|100962783|FG000|STARTED|Double Blind Phase||208||
48261852|NCT01270828|100962784|FG001|STARTED|Double Blind Phase||205||
48261853|NCT01270828|100962785|FG002|STARTED|Double Blind Phase||0||
48261854|NCT01270828|100962783|FG000|COMPLETED|Double Blind Phase||182||
48261855|NCT01270828|100962784|FG001|COMPLETED|Double Blind Phase||160||
48261856|NCT01270828|100962785|FG002|COMPLETED|Double Blind Phase||0||
48261857|NCT01270828|100962783|FG000|NOT COMPLETED|Double Blind Phase||26||
48261858|NCT01270828|100962784|FG001|NOT COMPLETED|Double Blind Phase||45||
48261859|NCT01270828|100962785|FG002|NOT COMPLETED|Double Blind Phase||0||
48261860|NCT04947514|100962786|FG000|STARTED|Overall Study||98||196
48261861|NCT04947514|100962786|FG000|COMPLETED|Overall Study||98||196
48261862|NCT04947514|100962786|FG000|NOT COMPLETED|Overall Study||0||0
48261863|NCT03174782|100962787|FG000|STARTED|Overall Study||19||
48261864|NCT03174782|100962788|FG001|STARTED|Overall Study||23||
48261865|NCT03174782|100962787|FG000|COMPLETED|Overall Study||18||
48261866|NCT03174782|100962788|FG001|COMPLETED|Overall Study||22||
48261867|NCT03174782|100962787|FG000|NOT COMPLETED|Overall Study||1||
48261868|NCT03174782|100962788|FG001|NOT COMPLETED|Overall Study||1||
48261869|NCT00464945|100962789|FG000|STARTED|Infant Series||135||
48390277|NCT01283997|101283555|FG000|COMPLETED|Overall Study||23||
48261870|NCT00464945|100962790|FG001|STARTED|Infant Series||134||
48261871|NCT00464945|100962789|FG000|Vaccinated Dose 1|Infant Series||134||
48261872|NCT00464945|100962790|FG001|Vaccinated Dose 1|Infant Series||134||
48261873|NCT00464945|100962789|FG000|Vaccinated Dose 2|Infant Series||132||
48261874|NCT00464945|100962790|FG001|Vaccinated Dose 2|Infant Series||133||
48390278|NCT01283997|101283556|FG001|COMPLETED|Overall Study||23||
48390279|NCT01283997|101283555|FG000|NOT COMPLETED|Overall Study||16||
48390280|NCT01283997|101283556|FG001|NOT COMPLETED|Overall Study||17||
48390281|NCT00892957|101283557|FG000|STARTED|Intraoperative Day 0||70||
48390282|NCT00892957|101283558|FG001|STARTED|Intraoperative Day 0||70||
48390283|NCT00892957|101283557|FG000|COMPLETED|Intraoperative Day 0||70||
48390284|NCT00892957|101283558|FG001|COMPLETED|Intraoperative Day 0||70||
48390285|NCT00892957|101283557|FG000|NOT COMPLETED|Intraoperative Day 0||0||
48390286|NCT00892957|101283558|FG001|NOT COMPLETED|Intraoperative Day 0||0||
48390287|NCT00892957|101283557|FG000|STARTED|Postoperative Day 1 Assessment||70||
48390288|NCT00892957|101283558|FG001|STARTED|Postoperative Day 1 Assessment||70||
48390289|NCT00892957|101283557|FG000|COMPLETED|Postoperative Day 1 Assessment||70||
48544210|NCT04611529|101667064|FG002|STARTED|2-day Follow up||66||
48592714|NCT02143791|101783167|FG000|STARTED|Enrolled||125||
48261875|NCT00464945|100962789|FG000|Vaccinated Dose 3|Infant Series||132||
48261876|NCT00464945|100962790|FG001|Vaccinated Dose 3|Infant Series||133||
48261877|NCT00464945|100962789|FG000|COMPLETED|Infant Series||131||
48261878|NCT00464945|100962790|FG001|COMPLETED|Infant Series||133||
48592715|NCT02143791|101783167|FG000|COMPLETED|Enrolled||121||
48544211|NCT04611529|101667062|FG000|COMPLETED|2-day Follow up||60|"Having Completed the 2-day follow up entailed having data collected for purposes of the Primary Outcome Measure (primary analysis) which was Change in Pain Disability - Roland Morris Disability Questionnaire (RMDQ) Score. If data was not collected for this Primary Outcome Measure these participants were considered Lost to follow-up at the 2-day timepoint."|
48544212|NCT04611529|101667063|FG001|COMPLETED|2-day Follow up||60|"Having Completed the 2-day follow up entailed having data collected for purposes of the Primary Outcome Measure (primary analysis) which was Change in Pain Disability - Roland Morris Disability Questionnaire (RMDQ) Score. If data was not collected for this Primary Outcome Measure these participants were considered Lost to follow-up at the 2-day timepoint."|
48544213|NCT04611529|101667064|FG002|COMPLETED|2-day Follow up||63|"Having Completed the 2-day follow up entailed having data collected for purposes of the Primary Outcome Measure (primary analysis) which was Change in Pain Disability - Roland Morris Disability Questionnaire (RMDQ) Score. If data was not collected for this Primary Outcome Measure these participants were considered Lost to follow-up at the 2-day timepoint."|
48544214|NCT04611529|101667062|FG000|NOT COMPLETED|2-day Follow up||5||
48544215|NCT04611529|101667063|FG001|NOT COMPLETED|2-day Follow up||6||
48544216|NCT04611529|101667064|FG002|NOT COMPLETED|2-day Follow up||3||
48544217|NCT04611529|101667062|FG000|STARTED|7-day Follow up||60||
48544218|NCT04611529|101667063|FG001|STARTED|7-day Follow up||60||
48544219|NCT04611529|101667064|FG002|STARTED|7-day Follow up||63||
48544220|NCT04611529|101667062|FG000|COMPLETED|7-day Follow up||60||
48544221|NCT04611529|101667063|FG001|COMPLETED|7-day Follow up||60||
48544222|NCT04611529|101667064|FG002|COMPLETED|7-day Follow up||63||
48544223|NCT04611529|101667062|FG000|NOT COMPLETED|7-day Follow up||0||
48544224|NCT04611529|101667063|FG001|NOT COMPLETED|7-day Follow up||0||
48544225|NCT04611529|101667064|FG002|NOT COMPLETED|7-day Follow up||0||
48544226|NCT00489827|101667065|FG000|STARTED|Overall Study||430||
48544227|NCT00489827|101667066|FG001|STARTED|Overall Study||435||
48544228|NCT00489827|101667065|FG000|COMPLETED|Overall Study||428||
48544229|NCT00489827|101667066|FG001|COMPLETED|Overall Study||433||
48544230|NCT00489827|101667065|FG000|NOT COMPLETED|Overall Study||2||
48544231|NCT00489827|101667066|FG001|NOT COMPLETED|Overall Study||2||
48544232|NCT02012348|101667067|FG000|STARTED|Overall Study||10||
48544233|NCT02012348|101667068|FG001|STARTED|Overall Study||10||
48690413|NCT01925768|102025831|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||101||
48097829|NCT03605303|100563805|FG000|NOT COMPLETED|Period 1||2||
48097830|NCT03605303|100563806|FG001|NOT COMPLETED|Period 1||1||
48097831|NCT03605303|100563805|FG000|STARTED|Period 2||0||
48544234|NCT02012348|101667069|FG002|STARTED|Overall Study||10||
48544235|NCT02012348|101667067|FG000|COMPLETED|Overall Study||10||
48544236|NCT02012348|101667068|FG001|COMPLETED|Overall Study||10||
48544237|NCT02012348|101667069|FG002|COMPLETED|Overall Study||10||
48544238|NCT02012348|101667067|FG000|NOT COMPLETED|Overall Study||0||
48690414|NCT01925768|102025832|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||91||
48690415|NCT01925768|102025831|FG000|Escaped Early (EE)|Placebo-controlled Phase (Week 0 - 24)||35||
48097832|NCT03605303|100563806|FG001|STARTED|Period 2||0||
48097833|NCT03605303|100563805|FG000|COMPLETED|Period 2||0||
48097834|NCT03605303|100563806|FG001|COMPLETED|Period 2||0||
48097835|NCT03605303|100563805|FG000|NOT COMPLETED|Period 2||0||
48097836|NCT03605303|100563806|FG001|NOT COMPLETED|Period 2||0||
48097837|NCT00735787|100563807|FG000|STARTED|Period 1||23||
48097838|NCT00735787|100563808|FG001|STARTED|Period 1||49||
48097839|NCT00735787|100563807|FG000|COMPLETED|Period 1||17||
48544239|NCT02012348|101667068|FG001|NOT COMPLETED|Overall Study||0||
48544240|NCT02012348|101667069|FG002|NOT COMPLETED|Overall Study||0||
48544241|NCT03390426|101667070|FG000|STARTED|Overall Study||15||
48544242|NCT03390426|101667071|FG001|STARTED|Overall Study||16||
48544243|NCT03390426|101667070|FG000|COMPLETED|Overall Study||15||
48544244|NCT03390426|101667071|FG001|COMPLETED|Overall Study||15||
48097840|NCT00735787|100563808|FG001|COMPLETED|Period 1||41||
48097841|NCT00735787|100563807|FG000|NOT COMPLETED|Period 1||6||
48097842|NCT00735787|100563808|FG001|NOT COMPLETED|Period 1||8||
48097843|NCT00735787|100563807|FG000|STARTED|Period 2||18||
48097844|NCT00735787|100563808|FG001|STARTED|Period 2||41||
48097845|NCT00735787|100563807|FG000|COMPLETED|Period 2||13||
48097846|NCT00735787|100563808|FG001|COMPLETED|Period 2||40||
48097847|NCT00735787|100563807|FG000|NOT COMPLETED|Period 2||5||
48097848|NCT00735787|100563808|FG001|NOT COMPLETED|Period 2||1||
48097849|NCT05855005|100563809|FG000|STARTED|Overall Study||30||
48097850|NCT05855005|100563809|FG000|COMPLETED|Overall Study||30||
48097851|NCT05855005|100563809|FG000|NOT COMPLETED|Overall Study||0||
48097852|NCT01870583|100563810|FG000|STARTED|Overall Study||467||
48097853|NCT01870583|100563811|FG001|STARTED|Overall Study||474||
48097854|NCT01870583|100563812|FG002|STARTED|Overall Study||463||
48097855|NCT01870583|100563810|FG000|COMPLETED|Overall Study||456||
48097856|NCT01870583|100563811|FG001|COMPLETED|Overall Study||456||
48710797|NCT01012921|102078021|FG000|COMPLETED|Overall Study||47||
48097857|NCT01870583|100563812|FG002|COMPLETED|Overall Study||455||
48097858|NCT01870583|100563810|FG000|NOT COMPLETED|Overall Study||11||
48097859|NCT01870583|100563811|FG001|NOT COMPLETED|Overall Study||18||
48097860|NCT01870583|100563812|FG002|NOT COMPLETED|Overall Study||8||
48097861|NCT00227305|100563813|FG000|STARTED|Overall Study||381||
48097862|NCT00227305|100563813|FG000|Drug Received|Overall Study||380||
48544245|NCT03390426|101667070|FG000|NOT COMPLETED|Overall Study||0||
48544246|NCT03390426|101667071|FG001|NOT COMPLETED|Overall Study||1||
48544247|NCT01756079|101667072|FG000|STARTED|Lead-in: Day 0 to Week 4||58||
48544248|NCT01756079|101667072|FG000|COMPLETED|Lead-in: Day 0 to Week 4||58||
48544249|NCT01756079|101667072|FG000|NOT COMPLETED|Lead-in: Day 0 to Week 4||0||
48544250|NCT01756079|101667072|FG000|STARTED|Treatment / Follow-up: Week 4 to Week 72||58||
48544251|NCT01756079|101667072|FG000|Treated in Treatment Period|Treatment / Follow-up: Week 4 to Week 72||54||
48544252|NCT01756079|101667072|FG000|COMPLETED|Treatment / Follow-up: Week 4 to Week 72||23||
48544253|NCT01756079|101667072|FG000|NOT COMPLETED|Treatment / Follow-up: Week 4 to Week 72||35||
48544254|NCT03172494|101667073|FG000|STARTED|Overall Study||361||
48544255|NCT03172494|101667074|FG001|STARTED|Overall Study||179||
48544256|NCT03172494|101667075|FG002|STARTED|Overall Study||180||
48544257|NCT03172494|101667073|FG000|Full Analysis Set (FAS)|Overall Study||361||
48544258|NCT03172494|101667074|FG001|Full Analysis Set (FAS)|Overall Study||179||
48544259|NCT03172494|101667075|FG002|Full Analysis Set (FAS)|Overall Study||180||
48544260|NCT03172494|101667073|FG000|Safety Analysis Set (SAS)|Overall Study||358||
48544261|NCT03172494|101667074|FG001|Safety Analysis Set (SAS)|Overall Study||175||
48544262|NCT03172494|101667075|FG002|Safety Analysis Set (SAS)|Overall Study||180||
48544263|NCT03172494|101667073|FG000|Exposed|Overall Study||358||
48544264|NCT03172494|101667074|FG001|Exposed|Overall Study||175||
48544265|NCT03172494|101667075|FG002|Exposed|Overall Study||180||
48544266|NCT03172494|101667073|FG000|COMPLETED|Overall Study||341||
48544267|NCT03172494|101667074|FG001|COMPLETED|Overall Study||167||
48544268|NCT03172494|101667075|FG002|COMPLETED|Overall Study||151||
48544269|NCT03172494|101667073|FG000|NOT COMPLETED|Overall Study||20||
48544270|NCT03172494|101667074|FG001|NOT COMPLETED|Overall Study||12||
48544271|NCT03172494|101667075|FG002|NOT COMPLETED|Overall Study||29||
48544272|NCT02125877|101667076|FG000|STARTED|Overall Study||86||
48544273|NCT02125877|101667077|FG001|STARTED|Overall Study||87||
48544274|NCT02125877|101667076|FG000|Pharmacokinetic Analysis Set|Overall Study||83||
48544275|NCT02125877|101667077|FG001|Pharmacokinetic Analysis Set|Overall Study||83||
48544276|NCT02125877|101667076|FG000|Pharmacokinetic Subset A|Overall Study||16||
48544277|NCT02125877|101667077|FG001|Pharmacokinetic Subset A|Overall Study||15||
48544278|NCT02125877|101667076|FG000|Safety Set|Overall Study||86||
48544279|NCT02125877|101667077|FG001|Safety Set|Overall Study||87||
48544280|NCT02125877|101667076|FG000|COMPLETED|Overall Study||73||
48544281|NCT02125877|101667077|FG001|COMPLETED|Overall Study||77||
48544282|NCT02125877|101667076|FG000|NOT COMPLETED|Overall Study||13||
48544283|NCT02125877|101667077|FG001|NOT COMPLETED|Overall Study||10||
48544284|NCT04204057|101667078|FG000|STARTED|Overall Study||21||
48544285|NCT04204057|101667078|FG000|COMPLETED|Overall Study||21||
48544286|NCT04204057|101667078|FG000|NOT COMPLETED|Overall Study||0||
48544287|NCT03196219|101667079|FG000|STARTED|Overall Study||8||
48544288|NCT03196219|101667080|FG001|STARTED|Overall Study||6||
48544289|NCT03196219|101667081|FG002|STARTED|Overall Study||6||
48544290|NCT03196219|101667082|FG003|STARTED|Overall Study||0||
48544291|NCT03196219|101667079|FG000|COMPLETED|Overall Study||8||
48544292|NCT03196219|101667080|FG001|COMPLETED|Overall Study||6||
48544293|NCT03196219|101667081|FG002|COMPLETED|Overall Study||6||
48544294|NCT03196219|101667082|FG003|COMPLETED|Overall Study||0||
48544295|NCT03196219|101667079|FG000|NOT COMPLETED|Overall Study||0||
48544296|NCT03196219|101667080|FG001|NOT COMPLETED|Overall Study||0||
48544297|NCT03196219|101667081|FG002|NOT COMPLETED|Overall Study||0||
48544298|NCT03196219|101667082|FG003|NOT COMPLETED|Overall Study||0||
48544299|NCT00242684|101667083|FG000|STARTED|Overall Study||446||
48544300|NCT00242684|101667083|FG000|COMPLETED|Overall Study||446||
48544301|NCT00242684|101667083|FG000|NOT COMPLETED|Overall Study||0||
48544302|NCT01305044|101667084|FG000|STARTED|Overall Study||32||
48544303|NCT01305044|101667085|FG001|STARTED|Overall Study||31||
48544304|NCT01305044|101667084|FG000|COMPLETED|Overall Study||29||
48544305|NCT01305044|101667085|FG001|COMPLETED|Overall Study||25||
48544306|NCT01305044|101667084|FG000|NOT COMPLETED|Overall Study||3||
48544307|NCT01305044|101667085|FG001|NOT COMPLETED|Overall Study||6||
48544308|NCT01831258|101667086|FG000|STARTED|Overall Study||35||
48544309|NCT01831258|101667087|FG001|STARTED|Overall Study||35||
48544310|NCT01831258|101667086|FG000|COMPLETED|Overall Study||30||
48544311|NCT01831258|101667087|FG001|COMPLETED|Overall Study||32||
48544312|NCT01831258|101667086|FG000|NOT COMPLETED|Overall Study||5||
48261879|NCT00464945|100962789|FG000|NOT COMPLETED|Infant Series||4||
48544313|NCT01831258|101667087|FG001|NOT COMPLETED|Overall Study||3||
48544314|NCT03583086|101667088|FG000|STARTED|Overall Study||3||
48544315|NCT03583086|101667089|FG001|STARTED|Overall Study||7||
48544316|NCT03583086|101667090|FG002|STARTED|Overall Study||19||
48544317|NCT03583086|101667091|FG003|STARTED|Overall Study||15||
48544318|NCT03583086|101667092|FG004|STARTED|Overall Study||17||
48261880|NCT00464945|100962790|FG001|NOT COMPLETED|Infant Series||1||
48261881|NCT00464945|100962789|FG000|STARTED|After Infant Series||131||
48544319|NCT03583086|101667093|FG005|STARTED|Overall Study||18||
48261882|NCT00464945|100962790|FG001|STARTED|After Infant Series||133||
48544320|NCT03583086|101667094|FG006|STARTED|Overall Study||9||
48544321|NCT03583086|101667088|FG000|COMPLETED|Overall Study||1||
48544322|NCT03583086|101667089|FG001|COMPLETED|Overall Study||1||
48544323|NCT03583086|101667090|FG002|COMPLETED|Overall Study||4||
48544324|NCT03583086|101667091|FG003|COMPLETED|Overall Study||4||
48544325|NCT03583086|101667092|FG004|COMPLETED|Overall Study||2||
48544326|NCT03583086|101667093|FG005|COMPLETED|Overall Study||2||
48544327|NCT03583086|101667094|FG006|COMPLETED|Overall Study||1||
48544328|NCT03583086|101667088|FG000|NOT COMPLETED|Overall Study||2||
48544329|NCT03583086|101667089|FG001|NOT COMPLETED|Overall Study||6||
48544330|NCT03583086|101667090|FG002|NOT COMPLETED|Overall Study||15||
48544331|NCT03583086|101667091|FG003|NOT COMPLETED|Overall Study||11||
48544332|NCT03583086|101667092|FG004|NOT COMPLETED|Overall Study||15||
48544333|NCT03583086|101667093|FG005|NOT COMPLETED|Overall Study||16||
48544334|NCT03583086|101667094|FG006|NOT COMPLETED|Overall Study||8||
48544335|NCT02794246|101667095|FG000|STARTED|Overall Study||6||
48544336|NCT02794246|101667095|FG000|Treated|Overall Study||3||
48544337|NCT02794246|101667095|FG000|COMPLETED|Overall Study||0||
48544338|NCT02794246|101667095|FG000|NOT COMPLETED|Overall Study||6||
48544339|NCT01392625|101667096|FG000|STARTED|Overall Study||18||
48544340|NCT01392625|101667097|FG001|STARTED|Overall Study||19||
48544341|NCT01392625|101667096|FG000|COMPLETED|Overall Study||16||
48544342|NCT01392625|101667097|FG001|COMPLETED|Overall Study||18||
48544343|NCT01392625|101667096|FG000|NOT COMPLETED|Overall Study||2||
48544344|NCT01392625|101667097|FG001|NOT COMPLETED|Overall Study||1||
48544345|NCT02181790|101667098|FG000|STARTED|Overall Study||2||
48544346|NCT02181790|101667099|FG001|STARTED|Overall Study||0||
48544347|NCT02181790|101667098|FG000|COMPLETED|Overall Study||0||
48544348|NCT02181790|101667099|FG001|COMPLETED|Overall Study||0||
48544349|NCT02181790|101667098|FG000|NOT COMPLETED|Overall Study||2||
48544350|NCT02181790|101667099|FG001|NOT COMPLETED|Overall Study||0||
48544351|NCT02922738|101667100|FG000|STARTED|Overall Study||175||
48544352|NCT02922738|101667101|FG001|STARTED|Overall Study||290||
48544353|NCT02922738|101667100|FG000|COMPLETED|Overall Study||175||
48544354|NCT02922738|101667101|FG001|COMPLETED|Overall Study||290||
48544355|NCT02922738|101667100|FG000|NOT COMPLETED|Overall Study||0||
48544356|NCT02922738|101667101|FG001|NOT COMPLETED|Overall Study||0||
48544357|NCT03020589|101667102|FG000|STARTED|Overall Study||40||
48544358|NCT03020589|101667103|FG001|STARTED|Overall Study||57||
48544359|NCT03020589|101667102|FG000|COMPLETED|Overall Study||40||
48544360|NCT03020589|101667103|FG001|COMPLETED|Overall Study||57||
48544361|NCT03020589|101667102|FG000|NOT COMPLETED|Overall Study||0||
48544362|NCT03020589|101667103|FG001|NOT COMPLETED|Overall Study||0||
48544363|NCT04102189|101667104|FG000|STARTED|Overall Study||134||
48544364|NCT04102189|101667105|FG001|STARTED|Overall Study||67||
48544365|NCT04102189|101667104|FG000|Treated|Overall Study||133||
48544366|NCT04102189|101667105|FG001|Treated|Overall Study||67||
48544367|NCT04102189|101667104|FG000|Full Analysis Set (FAS)|Overall Study||134||
48544368|NCT04102189|101667105|FG001|Full Analysis Set (FAS)|Overall Study||67||
48544369|NCT04102189|101667104|FG000|Safety Analysis Set|Overall Study||133||
48544370|NCT04102189|101667105|FG001|Safety Analysis Set|Overall Study||67||
48544371|NCT04102189|101667104|FG000|COMPLETED|Overall Study||132||
48544372|NCT04102189|101667105|FG001|COMPLETED|Overall Study||64||
48544373|NCT04102189|101667104|FG000|NOT COMPLETED|Overall Study||2||
48544374|NCT04102189|101667105|FG001|NOT COMPLETED|Overall Study||3||
48544375|NCT04590040|101667106|FG000|STARTED|Washout Period||64||
48261883|NCT00464945|100962789|FG000|COMPLETED|After Infant Series||131||
48261884|NCT00464945|100962790|FG001|COMPLETED|After Infant Series||131||
48261885|NCT00464945|100962789|FG000|NOT COMPLETED|After Infant Series||0||
48261886|NCT00464945|100962790|FG001|NOT COMPLETED|After Infant Series||2||
48261887|NCT00464945|100962789|FG000|STARTED|Toddler Dose||131||
48261888|NCT00464945|100962790|FG001|STARTED|Toddler Dose||131||
48261889|NCT00464945|100962789|FG000|COMPLETED|Toddler Dose||131||
48261890|NCT00464945|100962790|FG001|COMPLETED|Toddler Dose||130||
48261891|NCT00464945|100962789|FG000|NOT COMPLETED|Toddler Dose||0||
48261892|NCT00464945|100962790|FG001|NOT COMPLETED|Toddler Dose||1||
48261893|NCT00926575|100962791|FG000|STARTED|Overall Study||70||
48544376|NCT04590040|101667107|FG001|STARTED|Washout Period||64||
48544377|NCT04590040|101667108|FG002|STARTED|Washout Period||64||
48544378|NCT04590040|101667106|FG000|COMPLETED|Washout Period||64||
48544379|NCT04590040|101667107|FG001|COMPLETED|Washout Period||64||
48544380|NCT04590040|101667108|FG002|COMPLETED|Washout Period||64||
48261894|NCT00926575|100962792|FG001|STARTED|Overall Study||70||
48261895|NCT00926575|100962791|FG000|COMPLETED|Overall Study||54||
48261896|NCT00926575|100962792|FG001|COMPLETED|Overall Study||53||
48261897|NCT00926575|100962791|FG000|NOT COMPLETED|Overall Study||16||
48261898|NCT00926575|100962792|FG001|NOT COMPLETED|Overall Study||17||
48261899|NCT00884897|100962793|FG000|STARTED|Overall Study||13||
48544381|NCT04590040|101667106|FG000|NOT COMPLETED|Washout Period||0||
48544382|NCT04590040|101667107|FG001|NOT COMPLETED|Washout Period||0||
48544383|NCT04590040|101667108|FG002|NOT COMPLETED|Washout Period||0||
48544384|NCT04590040|101667106|FG000|STARTED|Treatment Period||64||
48544385|NCT04590040|101667107|FG001|STARTED|Treatment Period||64||
48261900|NCT00884897|100962794|FG001|STARTED|Overall Study||15||
48261901|NCT00884897|100962793|FG000|COMPLETED|Overall Study||13||
48261902|NCT00884897|100962794|FG001|COMPLETED|Overall Study||15||
48544386|NCT04590040|101667108|FG002|STARTED|Treatment Period||64||
48544387|NCT04590040|101667106|FG000|COMPLETED|Treatment Period||62||
48544388|NCT04590040|101667107|FG001|COMPLETED|Treatment Period||59||
48261903|NCT00884897|100962793|FG000|NOT COMPLETED|Overall Study||0||
48261904|NCT00884897|100962794|FG001|NOT COMPLETED|Overall Study||0||
48261905|NCT03231969|100962795|FG000|STARTED|Overall Study||30||
48261906|NCT03231969|100962796|FG001|STARTED|Overall Study||30||
48261907|NCT03231969|100962797|FG002|STARTED|Overall Study||31||
48261908|NCT03231969|100962798|FG003|STARTED|Overall Study||30||
48261909|NCT03231969|100962795|FG000|COMPLETED|Overall Study||28||
48261910|NCT03231969|100962796|FG001|COMPLETED|Overall Study||28||
48261911|NCT03231969|100962797|FG002|COMPLETED|Overall Study||30||
48261912|NCT03231969|100962798|FG003|COMPLETED|Overall Study||30||
48261913|NCT03231969|100962795|FG000|NOT COMPLETED|Overall Study||2||
48261914|NCT03231969|100962796|FG001|NOT COMPLETED|Overall Study||2||
48261915|NCT03231969|100962797|FG002|NOT COMPLETED|Overall Study||1||
48261916|NCT03231969|100962798|FG003|NOT COMPLETED|Overall Study||0||
48261917|NCT04883060|100962799|FG000|STARTED|Overall Study||40||
48261918|NCT04883060|100962799|FG000|COMPLETED|Overall Study||40||
48261919|NCT04883060|100962799|FG000|NOT COMPLETED|Overall Study||0||
48261920|NCT02706847|100962800|FG000|STARTED|Period 1: Day 1 to Week 12||85||
48261921|NCT02706847|100962801|FG001|STARTED|Period 1: Day 1 to Week 12||84||
48261922|NCT02706847|100962802|FG002|STARTED|Period 1: Day 1 to Week 12||165||
48261923|NCT02706847|100962803|FG003|STARTED|Period 1: Day 1 to Week 12||165||
48261924|NCT02706847|100962800|FG000|Received Study Treatment|Period 1: Day 1 to Week 12||85||
48261925|NCT02706847|100962801|FG001|Received Study Treatment|Period 1: Day 1 to Week 12||84||
48261926|NCT02706847|100962802|FG002|Received Study Treatment|Period 1: Day 1 to Week 12||164||
48261927|NCT02706847|100962803|FG003|Received Study Treatment|Period 1: Day 1 to Week 12||165||
48261928|NCT02706847|100962800|FG000|COMPLETED|Period 1: Day 1 to Week 12||75||
48261929|NCT02706847|100962801|FG001|COMPLETED|Period 1: Day 1 to Week 12||76||
48261930|NCT02706847|100962802|FG002|COMPLETED|Period 1: Day 1 to Week 12||157||
48261931|NCT02706847|100962803|FG003|COMPLETED|Period 1: Day 1 to Week 12||149||
48261932|NCT02706847|100962800|FG000|NOT COMPLETED|Period 1: Day 1 to Week 12||10||
48261933|NCT02706847|100962801|FG001|NOT COMPLETED|Period 1: Day 1 to Week 12||8||
48261934|NCT02706847|100962802|FG002|NOT COMPLETED|Period 1: Day 1 to Week 12||8||
48261935|NCT02706847|100962803|FG003|NOT COMPLETED|Period 1: Day 1 to Week 12||16||
48261936|NCT02706847|100962800|FG000|STARTED|Period 1: Week 12 to Week 24||75||
48261937|NCT02706847|100962801|FG001|STARTED|Period 1: Week 12 to Week 24||76||
48261938|NCT02706847|100962802|FG002|STARTED|Period 1: Week 12 to Week 24||157||
48261939|NCT02706847|100962803|FG003|STARTED|Period 1: Week 12 to Week 24||149||
48261940|NCT02706847|100962800|FG000|Received Study Treatment|Period 1: Week 12 to Week 24||72||
48261941|NCT02706847|100962801|FG001|Received Study Treatment|Period 1: Week 12 to Week 24||75||
48261942|NCT02706847|100962802|FG002|Received Study Treatment|Period 1: Week 12 to Week 24||156||
48261943|NCT02706847|100962803|FG003|Received Study Treatment|Period 1: Week 12 to Week 24||148||
48390290|NCT00892957|101283558|FG001|COMPLETED|Postoperative Day 1 Assessment||70||
48690416|NCT01925768|102025832|FG001|Escaped Early (EE)|Placebo-controlled Phase (Week 0 - 24)||13||
48690417|NCT01925768|102025831|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||98||
48690418|NCT01925768|102025832|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||87||
48261944|NCT02706847|100962800|FG000|COMPLETED|Period 1: Week 12 to Week 24||72||
48261945|NCT02706847|100962801|FG001|COMPLETED|Period 1: Week 12 to Week 24||74||
48261946|NCT02706847|100962802|FG002|COMPLETED|Period 1: Week 12 to Week 24||153||
48261947|NCT02706847|100962803|FG003|COMPLETED|Period 1: Week 12 to Week 24||135||
48261948|NCT02706847|100962800|FG000|NOT COMPLETED|Period 1: Week 12 to Week 24||3||
48261949|NCT02706847|100962801|FG001|NOT COMPLETED|Period 1: Week 12 to Week 24||2||
48261950|NCT02706847|100962802|FG002|NOT COMPLETED|Period 1: Week 12 to Week 24||4||
48261951|NCT02706847|100962803|FG003|NOT COMPLETED|Period 1: Week 12 to Week 24||14||
48261952|NCT02706847|100962800|FG000|STARTED|Period 2: Week 24 to Week 260||71|Six participants completed the Week 24 visit but did not continue into Period 2.|
48261953|NCT02706847|100962801|FG001|STARTED|Period 2: Week 24 to Week 260||73|Six participants completed the Week 24 visit but did not continue into Period 2.|
48261954|NCT02706847|100962802|FG002|STARTED|Period 2: Week 24 to Week 260||152|Six participants completed the Week 24 visit but did not continue into Period 2.|
48261955|NCT02706847|100962803|FG003|STARTED|Period 2: Week 24 to Week 260||132|Six participants completed the Week 24 visit but did not continue into Period 2.|
48261956|NCT02706847|100962800|FG000|Switched to Upadacitinib 15 mg After Protocol Amendment 4|Period 2: Week 24 to Week 260||0||
48261957|NCT02706847|100962801|FG001|Switched to Upadacitinib 15 mg After Protocol Amendment 4|Period 2: Week 24 to Week 260||44||
48261958|NCT02706847|100962802|FG002|Switched to Upadacitinib 15 mg After Protocol Amendment 4|Period 2: Week 24 to Week 260||0||
48261959|NCT02706847|100962803|FG003|Switched to Upadacitinib 15 mg After Protocol Amendment 4|Period 2: Week 24 to Week 260||94||
48261960|NCT02706847|100962800|FG000|COMPLETED|Period 2: Week 24 to Week 260||35||
48261961|NCT02706847|100962801|FG001|COMPLETED|Period 2: Week 24 to Week 260||41||
48261962|NCT02706847|100962802|FG002|COMPLETED|Period 2: Week 24 to Week 260||81||
48261963|NCT02706847|100962803|FG003|COMPLETED|Period 2: Week 24 to Week 260||82||
48390291|NCT00892957|101283557|FG000|NOT COMPLETED|Postoperative Day 1 Assessment||0||
48390292|NCT00892957|101283558|FG001|NOT COMPLETED|Postoperative Day 1 Assessment||0||
48390293|NCT00892957|101283557|FG000|STARTED|Between Postoperative Day 1 and Day 14||70||
48390294|NCT00892957|101283558|FG001|STARTED|Between Postoperative Day 1 and Day 14||70||
48690419|NCT01925768|102025831|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||11||
48261964|NCT02706847|100962800|FG000|NOT COMPLETED|Period 2: Week 24 to Week 260||36||
48261965|NCT02706847|100962801|FG001|NOT COMPLETED|Period 2: Week 24 to Week 260||32||
48261966|NCT02706847|100962802|FG002|NOT COMPLETED|Period 2: Week 24 to Week 260||71||
48261967|NCT02706847|100962803|FG003|NOT COMPLETED|Period 2: Week 24 to Week 260||50||
48261968|NCT02149524|100962804|FG000|STARTED|Overall Study||438||
48261969|NCT02149524|100962805|FG001|STARTED|Overall Study||437||
48261970|NCT02149524|100962804|FG000|COMPLETED|Overall Study||384||
48261971|NCT02149524|100962805|FG001|COMPLETED|Overall Study||380||
48261972|NCT02149524|100962804|FG000|NOT COMPLETED|Overall Study||54||
48261973|NCT02149524|100962805|FG001|NOT COMPLETED|Overall Study||57||
48261974|NCT05702541|100962806|FG000|STARTED|First Wear Period (Approx 2 Days)||8||
48261975|NCT05702541|100962807|FG001|STARTED|First Wear Period (Approx 2 Days)||8||
48261976|NCT05702541|100962806|FG000|COMPLETED|First Wear Period (Approx 2 Days)||8||
48261977|NCT05702541|100962807|FG001|COMPLETED|First Wear Period (Approx 2 Days)||8||
48261978|NCT05702541|100962806|FG000|NOT COMPLETED|First Wear Period (Approx 2 Days)||0||
48261979|NCT05702541|100962807|FG001|NOT COMPLETED|First Wear Period (Approx 2 Days)||0||
48261980|NCT05702541|100962806|FG000|STARTED|Second Wear Period (Approx 2 Days)||8||
48261981|NCT05702541|100962807|FG001|STARTED|Second Wear Period (Approx 2 Days)||8||
48261982|NCT05702541|100962806|FG000|COMPLETED|Second Wear Period (Approx 2 Days)||8||
48261983|NCT05702541|100962807|FG001|COMPLETED|Second Wear Period (Approx 2 Days)||8||
48261984|NCT05702541|100962806|FG000|NOT COMPLETED|Second Wear Period (Approx 2 Days)||0||
48261985|NCT05702541|100962807|FG001|NOT COMPLETED|Second Wear Period (Approx 2 Days)||0||
48261986|NCT00516139|100962808|FG000|STARTED|Overall Study||122||
48261987|NCT00516139|100962808|FG000|COMPLETED|Overall Study||84||
48261988|NCT00516139|100962808|FG000|NOT COMPLETED|Overall Study||38||
48261989|NCT01845805|100962809|FG000|STARTED|Overall Study||24||
48261990|NCT01845805|100962810|FG001|STARTED|Overall Study||25||
48261991|NCT01845805|100962809|FG000|COMPLETED|Overall Study||6||
48261992|NCT01845805|100962810|FG001|COMPLETED|Overall Study||9||
48261993|NCT01845805|100962809|FG000|NOT COMPLETED|Overall Study||18||
48261994|NCT01845805|100962810|FG001|NOT COMPLETED|Overall Study||16||
48261995|NCT04544865|100962811|FG000|STARTED|Overall Study||109||
48261996|NCT04544865|100962812|FG001|STARTED|Overall Study||131||
48261997|NCT04544865|100962811|FG000|COMPLETED|Overall Study||98||
48261998|NCT04544865|100962812|FG001|COMPLETED|Overall Study||120||
48261999|NCT04544865|100962811|FG000|NOT COMPLETED|Overall Study||11||
48262000|NCT04544865|100962812|FG001|NOT COMPLETED|Overall Study||11||
48262001|NCT02485899|100962813|FG000|STARTED|Overall Study||24||
48262002|NCT02485899|100962814|FG001|STARTED|Overall Study||42||
48262003|NCT02485899|100962813|FG000|COMPLETED|Overall Study||17||
48262004|NCT02485899|100962814|FG001|COMPLETED|Overall Study||42||
48262005|NCT02485899|100962813|FG000|NOT COMPLETED|Overall Study||7||
48262006|NCT02485899|100962814|FG001|NOT COMPLETED|Overall Study||0||
48262007|NCT00798304|100962815|FG000|STARTED|Overall Study||14||
48262008|NCT00798304|100962816|FG001|STARTED|Overall Study||22||
48262009|NCT00798304|100962817|FG002|STARTED|Overall Study||10||
48262010|NCT00798304|100962815|FG000|COMPLETED|Overall Study||0||
48262011|NCT00798304|100962816|FG001|COMPLETED|Overall Study||0||
48262012|NCT00798304|100962817|FG002|COMPLETED|Overall Study||0||
48262013|NCT00798304|100962815|FG000|NOT COMPLETED|Overall Study||14||
48262014|NCT00798304|100962816|FG001|NOT COMPLETED|Overall Study||22||
48262015|NCT00798304|100962817|FG002|NOT COMPLETED|Overall Study||10||
48262016|NCT01355978|100962818|FG000|STARTED|Overall Study||22||
48262017|NCT01355978|100962818|FG000|COMPLETED|Overall Study||18||
48262018|NCT01355978|100962818|FG000|NOT COMPLETED|Overall Study||4||
48262019|NCT00174447|100962819|FG000|STARTED|Overall Study||43||
48262020|NCT00174447|100962819|FG000|COMPLETED|Overall Study||5||
48262021|NCT00174447|100962819|FG000|NOT COMPLETED|Overall Study||38||
48262022|NCT04594733|100962820|FG000|STARTED|First Intervention (8 Weeks)||7||
48262023|NCT04594733|100962821|FG001|STARTED|First Intervention (8 Weeks)||7||
48262024|NCT04594733|100962820|FG000|Received Intervention|First Intervention (8 Weeks)||7||
48262025|NCT04594733|100962821|FG001|Received Intervention|First Intervention (8 Weeks)||7||
48262026|NCT04594733|100962820|FG000|COMPLETED|First Intervention (8 Weeks)||7||
48262027|NCT04594733|100962821|FG001|COMPLETED|First Intervention (8 Weeks)||3||
48262028|NCT04594733|100962820|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0||
48262029|NCT04594733|100962821|FG001|NOT COMPLETED|First Intervention (8 Weeks)||4||
48262030|NCT04594733|100962820|FG000|STARTED|First Washout (2 Weeks)||7||
48262031|NCT04594733|100962821|FG001|STARTED|First Washout (2 Weeks)||3||
48262032|NCT04594733|100962820|FG000|COMPLETED|First Washout (2 Weeks)||7||
48262033|NCT04594733|100962821|FG001|COMPLETED|First Washout (2 Weeks)||3||
48262034|NCT04594733|100962820|FG000|NOT COMPLETED|First Washout (2 Weeks)||0||
48262035|NCT04594733|100962821|FG001|NOT COMPLETED|First Washout (2 Weeks)||0||
48262036|NCT04594733|100962820|FG000|STARTED|Second Intervention (8 Weeks)||7||
48262037|NCT04594733|100962821|FG001|STARTED|Second Intervention (8 Weeks)||3||
48262038|NCT04594733|100962820|FG000|COMPLETED|Second Intervention (8 Weeks)||5||
48262039|NCT04594733|100962821|FG001|COMPLETED|Second Intervention (8 Weeks)||3||
48262040|NCT04594733|100962820|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||2||
48262041|NCT04594733|100962821|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0||
48262042|NCT04594733|100962820|FG000|STARTED|Second Washout (2 Weeks)||5||
48544389|NCT04590040|101667108|FG002|COMPLETED|Treatment Period||62||
48544390|NCT04590040|101667106|FG000|NOT COMPLETED|Treatment Period||2||
48544391|NCT04590040|101667107|FG001|NOT COMPLETED|Treatment Period||5||
48544392|NCT04590040|101667108|FG002|NOT COMPLETED|Treatment Period||2||
48544393|NCT04558918|101667109|FG000|STARTED|Randomized Treatment Period||62||
48544394|NCT04558918|101667110|FG001|STARTED|Randomized Treatment Period||35||
48544395|NCT04558918|101667109|FG000|COMPLETED|Randomized Treatment Period||62|completed the randomized treatment period|
48544396|NCT04558918|101667110|FG001|COMPLETED|Randomized Treatment Period||35|completed the randomized treatment period|
48544397|NCT04558918|101667109|FG000|NOT COMPLETED|Randomized Treatment Period||0||
48544398|NCT04558918|101667110|FG001|NOT COMPLETED|Randomized Treatment Period||0||
48544399|NCT04558918|101667109|FG000|STARTED|Extension Treatment Period||61||
48544400|NCT04558918|101667110|FG001|STARTED|Extension Treatment Period||34||
48262043|NCT04594733|100962821|FG001|STARTED|Second Washout (2 Weeks)||3||
48262044|NCT04594733|100962820|FG000|COMPLETED|Second Washout (2 Weeks)||5||
48262045|NCT04594733|100962821|FG001|COMPLETED|Second Washout (2 Weeks)||3||
48544401|NCT04558918|101667109|FG000|Full Analysis Set|Extension Treatment Period||62|Includes all patients to whom study treatment has been assigned by randomization|
48544402|NCT04558918|101667110|FG001|Full Analysis Set|Extension Treatment Period||35|Includes all patients to whom study treatment has been assigned by randomization|
48544403|NCT04558918|101667109|FG000|Combined Full Analysis Set|Extension Treatment Period||62|Includes all patients randomized to LNP023 200 mg b.i.d and all patientsrandomized to anti-C5 treatment and who switched to LNP023 in the treatment extension period.|
48544404|NCT04558918|101667110|FG001|Combined Full Analysis Set|Extension Treatment Period||34|Includes all patients randomized to LNP023 200 mg b.i.d and all patientsrandomized to anti-C5 treatment and who switched to LNP023 in the treatment extension period.|
48544405|NCT04558918|101667109|FG000|COMPLETED|Extension Treatment Period||61|Completed the extension treatment period|
48544406|NCT04558918|101667110|FG001|COMPLETED|Extension Treatment Period||34|Completed the extension treatment period|
48544407|NCT04558918|101667109|FG000|NOT COMPLETED|Extension Treatment Period||0||
48544408|NCT04558918|101667110|FG001|NOT COMPLETED|Extension Treatment Period||0||
48544409|NCT02513212|101667111|FG000|STARTED|Overall Study||12||
48262046|NCT04594733|100962820|FG000|NOT COMPLETED|Second Washout (2 Weeks)||0||
48262047|NCT04594733|100962821|FG001|NOT COMPLETED|Second Washout (2 Weeks)||0||
48262048|NCT00873327|100962822|FG000|STARTED|Overall Study||32||
48262049|NCT00873327|100962822|FG000|COMPLETED|Overall Study||32||
48262050|NCT00873327|100962822|FG000|NOT COMPLETED|Overall Study||0||
48262051|NCT01289210|100962823|FG000|STARTED|Overall Study||2||
48544410|NCT02513212|101667112|FG001|STARTED|Overall Study||12||
48544411|NCT02513212|101667111|FG000|COMPLETED|Overall Study||11||
48544412|NCT02513212|101667112|FG001|COMPLETED|Overall Study||12||
48544413|NCT02513212|101667111|FG000|NOT COMPLETED|Overall Study||1||
48544414|NCT02513212|101667112|FG001|NOT COMPLETED|Overall Study||0||
48544415|NCT01998841|101667113|FG000|STARTED|Study Period A||85||
48544416|NCT01998841|101667114|FG001|STARTED|Study Period A||84||
48544417|NCT01998841|101667115|FG002|STARTED|Study Period A||83||
48544418|NCT01998841|101667116|FG003|STARTED|Study Period A||0||
48544419|NCT01998841|101667117|FG004|STARTED|Study Period A||0||
48544420|NCT01998841|101667113|FG000|COMPLETED|Study Period A||79||
48544421|NCT01998841|101667114|FG001|COMPLETED|Study Period A||78||
48544422|NCT01998841|101667115|FG002|COMPLETED|Study Period A||80||
48544423|NCT01998841|101667116|FG003|COMPLETED|Study Period A||0||
48544424|NCT01998841|101667117|FG004|COMPLETED|Study Period A||0||
48544425|NCT01998841|101667113|FG000|NOT COMPLETED|Study Period A||6||
48544426|NCT01998841|101667114|FG001|NOT COMPLETED|Study Period A||6||
48544427|NCT01998841|101667115|FG002|NOT COMPLETED|Study Period A||3||
48544428|NCT01998841|101667116|FG003|NOT COMPLETED|Study Period A||0||
48544429|NCT01998841|101667117|FG004|NOT COMPLETED|Study Period A||0||
48544430|NCT01998841|101667113|FG000|STARTED|Study Period B||0||
48544431|NCT01998841|101667114|FG001|STARTED|Study Period B||0||
48544432|NCT01998841|101667115|FG002|STARTED|Study Period B||0||
48544433|NCT01998841|101667116|FG003|STARTED|Study Period B||147||
48544434|NCT01998841|101667117|FG004|STARTED|Study Period B||72||
48544435|NCT01998841|101667113|FG000|COMPLETED|Study Period B||0||
48544436|NCT01998841|101667114|FG001|COMPLETED|Study Period B||0||
48544437|NCT01998841|101667115|FG002|COMPLETED|Study Period B||0||
48544438|NCT01998841|101667116|FG003|COMPLETED|Study Period B||140||
48544439|NCT01998841|101667117|FG004|COMPLETED|Study Period B||70||
48544440|NCT01998841|101667113|FG000|NOT COMPLETED|Study Period B||0||
48544441|NCT01998841|101667114|FG001|NOT COMPLETED|Study Period B||0||
48544442|NCT01998841|101667115|FG002|NOT COMPLETED|Study Period B||0||
48544443|NCT01998841|101667116|FG003|NOT COMPLETED|Study Period B||7||
48544444|NCT01998841|101667117|FG004|NOT COMPLETED|Study Period B||2||
48544445|NCT03997851|101667118|FG000|STARTED|Overall Study||17||136
48544446|NCT03997851|101667118|FG000|COMPLETED|Overall Study||17||136
48544447|NCT03997851|101667118|FG000|NOT COMPLETED|Overall Study||0||0
48544448|NCT01328379|101667119|FG000|STARTED|Overall Study||143||
48262052|NCT01289210|100962823|FG000|COMPLETED|Overall Study||1||
48262053|NCT01289210|100962823|FG000|NOT COMPLETED|Overall Study||1||
48262054|NCT02339545|100962824|FG000|STARTED|Overall Study||15||
48544449|NCT01328379|101667120|FG001|STARTED|Overall Study||144||
48544450|NCT01328379|101667121|FG002|STARTED|Overall Study||143||
48544451|NCT01328379|101667119|FG000|COMPLETED|Overall Study||142||
48544452|NCT01328379|101667120|FG001|COMPLETED|Overall Study||144||
48544453|NCT01328379|101667121|FG002|COMPLETED|Overall Study||143||
48544454|NCT01328379|101667119|FG000|NOT COMPLETED|Overall Study||1||
48544455|NCT01328379|101667120|FG001|NOT COMPLETED|Overall Study||0||
48544456|NCT01328379|101667121|FG002|NOT COMPLETED|Overall Study||0||
48544457|NCT04977479|101667122|FG000|STARTED|First Period of Crossover||8||
48544458|NCT04977479|101667123|FG001|STARTED|First Period of Crossover||8||
48544459|NCT04977479|101667124|FG002|STARTED|First Period of Crossover||0||
48544460|NCT04977479|101667122|FG000|COMPLETED|First Period of Crossover||8||
48544461|NCT04977479|101667123|FG001|COMPLETED|First Period of Crossover||8||
48544462|NCT04977479|101667124|FG002|COMPLETED|First Period of Crossover||0||
48544463|NCT04977479|101667122|FG000|NOT COMPLETED|First Period of Crossover||0||
48544464|NCT04977479|101667123|FG001|NOT COMPLETED|First Period of Crossover||0||
48544465|NCT04977479|101667124|FG002|NOT COMPLETED|First Period of Crossover||0||
48544466|NCT04977479|101667122|FG000|STARTED|Washout Period||8||
48544467|NCT04977479|101667123|FG001|STARTED|Washout Period||8||
48544468|NCT04977479|101667124|FG002|STARTED|Washout Period||0||
48544469|NCT04977479|101667122|FG000|COMPLETED|Washout Period||8||
48544470|NCT04977479|101667123|FG001|COMPLETED|Washout Period||8||
48544471|NCT04977479|101667124|FG002|COMPLETED|Washout Period||0||
48544472|NCT04977479|101667122|FG000|NOT COMPLETED|Washout Period||0||
48544473|NCT04977479|101667123|FG001|NOT COMPLETED|Washout Period||0||
48544474|NCT04977479|101667124|FG002|NOT COMPLETED|Washout Period||0||
48544475|NCT04977479|101667122|FG000|STARTED|Second Period of Crossover||8||
48544476|NCT04977479|101667123|FG001|STARTED|Second Period of Crossover||8||
48544477|NCT04977479|101667124|FG002|STARTED|Second Period of Crossover||0||
48544478|NCT04977479|101667122|FG000|COMPLETED|Second Period of Crossover||8||
48544479|NCT04977479|101667123|FG001|COMPLETED|Second Period of Crossover||8||
48544480|NCT04977479|101667124|FG002|COMPLETED|Second Period of Crossover||0||
48544481|NCT04977479|101667122|FG000|NOT COMPLETED|Second Period of Crossover||0||
48544482|NCT04977479|101667123|FG001|NOT COMPLETED|Second Period of Crossover||0||
48544483|NCT04977479|101667124|FG002|NOT COMPLETED|Second Period of Crossover||0||
48544484|NCT04977479|101667122|FG000|STARTED|Open Label||0||
48544485|NCT04977479|101667123|FG001|STARTED|Open Label||0||
48544486|NCT04977479|101667124|FG002|STARTED|Open Label||16||
48544487|NCT04977479|101667122|FG000|COMPLETED|Open Label||0||
48262055|NCT02339545|100962824|FG000|COMPLETED|Overall Study||15||
48262056|NCT02339545|100962824|FG000|NOT COMPLETED|Overall Study||0||
48262057|NCT01266018|100962825|FG000|STARTED|Overall Study||9||
48262058|NCT01266018|100962826|FG001|STARTED|Overall Study||13||
48262059|NCT01266018|100962825|FG000|COMPLETED|Overall Study||8||
48262060|NCT01266018|100962826|FG001|COMPLETED|Overall Study||12||
48262061|NCT01266018|100962825|FG000|NOT COMPLETED|Overall Study||1||
48262062|NCT01266018|100962826|FG001|NOT COMPLETED|Overall Study||1||
48262063|NCT00443209|100962827|FG000|STARTED|Months 1 to 12 Treatment Period||712||
48262064|NCT00443209|100962828|FG001|STARTED|Months 1 to 12 Treatment Period||356||
48262065|NCT00443209|100962827|FG000|Treated|Months 1 to 12 Treatment Period||641||
48262066|NCT00443209|100962828|FG001|Treated|Months 1 to 12 Treatment Period||313||
48262067|NCT00443209|100962827|FG000|COMPLETED|Months 1 to 12 Treatment Period||367||
48262068|NCT00443209|100962828|FG001|COMPLETED|Months 1 to 12 Treatment Period||202||
48262069|NCT00443209|100962827|FG000|NOT COMPLETED|Months 1 to 12 Treatment Period||345||
48262070|NCT00443209|100962828|FG001|NOT COMPLETED|Months 1 to 12 Treatment Period||154||
48262071|NCT00443209|100962827|FG000|STARTED|Months 13 to 18 Treatment Period||186||
48262072|NCT00443209|100962828|FG001|STARTED|Months 13 to 18 Treatment Period||86||
48262073|NCT00443209|100962827|FG000|COMPLETED|Months 13 to 18 Treatment Period||87||
48262074|NCT00443209|100962828|FG001|COMPLETED|Months 13 to 18 Treatment Period||39||
48262075|NCT00443209|100962827|FG000|NOT COMPLETED|Months 13 to 18 Treatment Period||99||
48262076|NCT00443209|100962828|FG001|NOT COMPLETED|Months 13 to 18 Treatment Period||47||
48262077|NCT03045809|100962829|FG000|STARTED|Overall Study||705||
48262078|NCT03045809|100962829|FG000|Attended an Additional Visit (if Needed)|Overall Study||51||
48262079|NCT03045809|100962829|FG000|COMPLETED|Overall Study||705||
48262080|NCT03045809|100962829|FG000|NOT COMPLETED|Overall Study||0||
48262081|NCT02121912|100962830|FG000|STARTED|Overall Study||25||
48262082|NCT02121912|100962831|FG001|STARTED|Overall Study||25||
48262083|NCT02121912|100962830|FG000|COMPLETED|Overall Study||21||
48544488|NCT04977479|101667123|FG001|COMPLETED|Open Label||0||
48544489|NCT04977479|101667124|FG002|COMPLETED|Open Label||16||
48544490|NCT04977479|101667122|FG000|NOT COMPLETED|Open Label||0||
48544491|NCT04977479|101667123|FG001|NOT COMPLETED|Open Label||0||
48544492|NCT04977479|101667124|FG002|NOT COMPLETED|Open Label||0||
48544493|NCT00970593|101667125|FG000|STARTED|Overall Study||11||
48544494|NCT00970593|101667126|FG001|STARTED|Overall Study||15||
48544495|NCT00970593|101667127|FG002|STARTED|Overall Study||13||
48544496|NCT00970593|101667128|FG003|STARTED|Overall Study||12||
48544497|NCT00970593|101667129|FG004|STARTED|Overall Study||20||
48544498|NCT00970593|101667130|FG005|STARTED|Overall Study||5||
48544499|NCT00970593|101667131|FG006|STARTED|Overall Study||16||
48262084|NCT02121912|100962831|FG001|COMPLETED|Overall Study||25||
48544500|NCT00970593|101667125|FG000|COMPLETED|Overall Study||10||
48544501|NCT00970593|101667126|FG001|COMPLETED|Overall Study||14||
48544502|NCT00970593|101667127|FG002|COMPLETED|Overall Study||7||
48262085|NCT02121912|100962830|FG000|NOT COMPLETED|Overall Study||4||
48262086|NCT02121912|100962831|FG001|NOT COMPLETED|Overall Study||0||
48262087|NCT02559310|100962832|FG000|STARTED|Overall Study||276||
48262088|NCT02559310|100962833|FG001|STARTED|Overall Study||275||
48262089|NCT02559310|100962832|FG000|COMPLETED|Overall Study||249||
48690420|NCT01925768|102025832|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23||
48690421|NCT01925768|102025831|FG000|STARTED|ActiveTreatment/Extension (Weeks 24-104)||95||
48690422|NCT01925768|102025832|FG001|STARTED|ActiveTreatment/Extension (Weeks 24-104)||85||
48690423|NCT01925768|102025831|FG000|COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||75||
48690424|NCT01925768|102025832|FG001|COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||67||
48690425|NCT01925768|102025831|FG000|NOT COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||20||
48690426|NCT01925768|102025832|FG001|NOT COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||18||
48690427|NCT02277249|102025833|FG000|STARTED|Overall Study||30||
48690428|NCT02277249|102025834|FG001|STARTED|Overall Study||30||
48690429|NCT02277249|102025833|FG000|COMPLETED|Overall Study||30||
48097863|NCT00227305|100563813|FG000|COMPLETED|Overall Study||237||
48097864|NCT00227305|100563813|FG000|NOT COMPLETED|Overall Study||144||
48097865|NCT00679263|100563814|FG000|STARTED|Visit 3/Dose 2||10||
48097866|NCT00679263|100563815|FG001|STARTED|Visit 3/Dose 2||11||
48097867|NCT00679263|100563816|FG002|STARTED|Visit 3/Dose 2||11||
48097868|NCT00679263|100563814|FG000|COMPLETED|Visit 3/Dose 2||9||
48097869|NCT00679263|100563815|FG001|COMPLETED|Visit 3/Dose 2||6||
48097870|NCT00679263|100563816|FG002|COMPLETED|Visit 3/Dose 2||11||
48097871|NCT00679263|100563814|FG000|NOT COMPLETED|Visit 3/Dose 2||1||
48097872|NCT00679263|100563815|FG001|NOT COMPLETED|Visit 3/Dose 2||5||
48097873|NCT00679263|100563816|FG002|NOT COMPLETED|Visit 3/Dose 2||0||
48097874|NCT00679263|100563814|FG000|STARTED|Visit 2/Dose 1||11||
48097875|NCT00679263|100563815|FG001|STARTED|Visit 2/Dose 1||6||
48097876|NCT00679263|100563816|FG002|STARTED|Visit 2/Dose 1||11||
48097877|NCT00679263|100563814|FG000|COMPLETED|Visit 2/Dose 1||9||
48097878|NCT00679263|100563815|FG001|COMPLETED|Visit 2/Dose 1||5||
48097879|NCT00679263|100563816|FG002|COMPLETED|Visit 2/Dose 1||11||
48097880|NCT00679263|100563814|FG000|NOT COMPLETED|Visit 2/Dose 1||2||
48097881|NCT00679263|100563815|FG001|NOT COMPLETED|Visit 2/Dose 1||1||
48097882|NCT00679263|100563816|FG002|NOT COMPLETED|Visit 2/Dose 1||0||
48097883|NCT04127331|100563817|FG000|STARTED|Overall Study||41||
48097884|NCT04127331|100563818|FG001|STARTED|Overall Study||32||
48097885|NCT04127331|100563819|FG002|STARTED|Overall Study||27||
48097886|NCT04127331|100563817|FG000|COMPLETED|Overall Study||41||
48097887|NCT04127331|100563818|FG001|COMPLETED|Overall Study||32||
48097888|NCT04127331|100563819|FG002|COMPLETED|Overall Study||27||
48097889|NCT04127331|100563817|FG000|NOT COMPLETED|Overall Study||0||
48097890|NCT04127331|100563818|FG001|NOT COMPLETED|Overall Study||0||
48097891|NCT04127331|100563819|FG002|NOT COMPLETED|Overall Study||0||
48097892|NCT00993291|100563820|FG000|STARTED|Overall Study||20||
48097893|NCT00993291|100563820|FG000|COMPLETED|Overall Study||19||
48097894|NCT00993291|100563820|FG000|NOT COMPLETED|Overall Study||1||
48097895|NCT01199289|100563821|FG000|STARTED|Overall Study||77||
48097896|NCT01199289|100563822|FG001|STARTED|Overall Study||75||
48097897|NCT01199289|100563823|FG002|STARTED|Overall Study||76||
48097898|NCT01199289|100563824|FG003|STARTED|Overall Study||77||
48097899|NCT01199289|100563821|FG000|Participants Who Received Study Treatment|Overall Study||76||
48097900|NCT01199289|100563822|FG001|Participants Who Received Study Treatment|Overall Study||74||
48097901|NCT01199289|100563823|FG002|Participants Who Received Study Treatment|Overall Study||76||
48097902|NCT01199289|100563824|FG003|Participants Who Received Study Treatment|Overall Study||76||
48097903|NCT01199289|100563821|FG000|COMPLETED|Overall Study||68||
48097904|NCT01199289|100563822|FG001|COMPLETED|Overall Study||68||
48097905|NCT01199289|100563823|FG002|COMPLETED|Overall Study||71||
48097906|NCT01199289|100563824|FG003|COMPLETED|Overall Study||65||
48097907|NCT01199289|100563821|FG000|NOT COMPLETED|Overall Study||9||
48097908|NCT01199289|100563822|FG001|NOT COMPLETED|Overall Study||7||
48097909|NCT01199289|100563823|FG002|NOT COMPLETED|Overall Study||5||
48097910|NCT01199289|100563824|FG003|NOT COMPLETED|Overall Study||12||
48097911|NCT01319812|100563825|FG000|STARTED|Overall Study||161||
48097912|NCT01319812|100563826|FG001|STARTED|Overall Study||302||
48097913|NCT01319812|100563825|FG000|COMPLETED|Overall Study||145||
48097914|NCT01319812|100563826|FG001|COMPLETED|Overall Study||280||
48097915|NCT01319812|100563825|FG000|NOT COMPLETED|Overall Study||16||
48097916|NCT01319812|100563826|FG001|NOT COMPLETED|Overall Study||22||
48097917|NCT00862810|100563827|FG000|STARTED|Overall Study||33||
48097918|NCT00862810|100563828|FG001|STARTED|Overall Study||39||
48097919|NCT00862810|100563827|FG000|COMPLETED|Overall Study||29||
48097920|NCT00862810|100563828|FG001|COMPLETED|Overall Study||35||
48097921|NCT00862810|100563827|FG000|NOT COMPLETED|Overall Study||4||
48097922|NCT00862810|100563828|FG001|NOT COMPLETED|Overall Study||4||
48097923|NCT02802592|100563829|FG000|STARTED|Overall Study||4||
48097924|NCT02802592|100563829|FG000|COMPLETED|Overall Study||0||
48097925|NCT02802592|100563829|FG000|NOT COMPLETED|Overall Study||4||
48097926|NCT00728130|100563830|FG000|STARTED|Overall Study||22||
48097927|NCT00728130|100563830|FG000|COMPLETED|Overall Study||19||
48097928|NCT00728130|100563830|FG000|NOT COMPLETED|Overall Study||3||
48097929|NCT02956486|100563831|FG000|STARTED|Core Phase||1108||
48097930|NCT02956486|100563832|FG001|STARTED|Core Phase||1104||
48097931|NCT02956486|100563833|FG002|STARTED|Core Phase||0||
48097932|NCT02956486|100563831|FG000|Treated|Core Phase||1108||
48097933|NCT02956486|100563832|FG001|Treated|Core Phase||1101||
48097934|NCT02956486|100563833|FG002|Treated|Core Phase||0||
48097935|NCT02956486|100563831|FG000|Safety Analysis Set (SAS)|Core Phase||1105||
48097936|NCT02956486|100563832|FG001|Safety Analysis Set (SAS)|Core Phase||1099||
48097937|NCT02956486|100563833|FG002|Safety Analysis Set (SAS)|Core Phase||0||
48097938|NCT02956486|100563831|FG000|Full Analysis Set (FAS)|Core Phase||1084||
48097939|NCT02956486|100563832|FG001|Full Analysis Set (FAS)|Core Phase||1062||
48097940|NCT02956486|100563833|FG002|Full Analysis Set (FAS)|Core Phase||0||
48097941|NCT02956486|100563831|FG000|COMPLETED|Core Phase||29||
48097942|NCT02956486|100563832|FG001|COMPLETED|Core Phase||32||
48097943|NCT02956486|100563833|FG002|COMPLETED|Core Phase||0||
48097944|NCT02956486|100563831|FG000|NOT COMPLETED|Core Phase||1079||
48097945|NCT02956486|100563832|FG001|NOT COMPLETED|Core Phase||1072||
48097946|NCT02956486|100563833|FG002|NOT COMPLETED|Core Phase||0||
48097947|NCT02956486|100563831|FG000|STARTED|Extension Phase||0||
48097948|NCT02956486|100563832|FG001|STARTED|Extension Phase||0||
48097949|NCT02956486|100563833|FG002|STARTED|Extension Phase||19||
48097950|NCT02956486|100563831|FG000|Treated|Extension Phase||0||
48097951|NCT02956486|100563832|FG001|Treated|Extension Phase||0||
48097952|NCT02956486|100563833|FG002|Treated|Extension Phase||18||
48097953|NCT02956486|100563831|FG000|Safety Analysis Set (SAS)|Extension Phase||0||
48097954|NCT02956486|100563832|FG001|Safety Analysis Set (SAS)|Extension Phase||0||
48097955|NCT02956486|100563833|FG002|Safety Analysis Set (SAS)|Extension Phase||18||
48097956|NCT02956486|100563831|FG000|COMPLETED|Extension Phase||0||
48097957|NCT02956486|100563832|FG001|COMPLETED|Extension Phase||0||
48097958|NCT02956486|100563833|FG002|COMPLETED|Extension Phase||0||
48097959|NCT02956486|100563831|FG000|NOT COMPLETED|Extension Phase||0||
48097960|NCT02956486|100563832|FG001|NOT COMPLETED|Extension Phase||0||
48097961|NCT02956486|100563833|FG002|NOT COMPLETED|Extension Phase||19||
48097962|NCT00664742|100563834|FG000|STARTED|Overall Study||607||
48097963|NCT00664742|100563834|FG000|COMPLETED|Overall Study||481||
48097964|NCT00664742|100563834|FG000|NOT COMPLETED|Overall Study||126||
48097965|NCT00705107|100563835|FG000|STARTED|Overall Study||267||
48097966|NCT00705107|100563835|FG000|COMPLETED|Overall Study||218||
48097967|NCT00705107|100563835|FG000|NOT COMPLETED|Overall Study||49||
48097968|NCT04007523|100563836|FG000|STARTED|Overall Study||15|Of note: the Withdrawals by Subjects in this section occurred after trial arm allocation and were separate from the n=3 withdrawals listed above in the Pre-assignment Details.|
48097969|NCT04007523|100563837|FG001|STARTED|Overall Study||12|Of note: the Withdrawals by Subjects in this section occurred after trial arm allocation and were separate from the n=3 withdrawals listed above in the Pre-assignment Details.|
48097970|NCT04007523|100563838|FG002|STARTED|Overall Study||14|Of note: the Withdrawals by Subjects in this section occurred after trial arm allocation and were separate from the n=3 withdrawals listed above in the Pre-assignment Details.|
48097971|NCT04007523|100563839|FG003|STARTED|Overall Study||16|Of note: the Withdrawals by Subjects in this section occurred after trial arm allocation and were separate from the n=3 withdrawals listed above in the Pre-assignment Details.|
48097972|NCT04007523|100563836|FG000|COMPLETED|Overall Study||15||
48097973|NCT04007523|100563837|FG001|COMPLETED|Overall Study||10||
48097974|NCT04007523|100563838|FG002|COMPLETED|Overall Study||11||
48097975|NCT04007523|100563839|FG003|COMPLETED|Overall Study||13||
48097976|NCT04007523|100563836|FG000|NOT COMPLETED|Overall Study||0||
48097977|NCT04007523|100563837|FG001|NOT COMPLETED|Overall Study||2||
48097978|NCT04007523|100563838|FG002|NOT COMPLETED|Overall Study||3||
48097979|NCT04007523|100563839|FG003|NOT COMPLETED|Overall Study||3||
48097980|NCT02710045|100563840|FG000|STARTED|Overall Study||106||
48097981|NCT02710045|100563841|FG001|STARTED|Overall Study||115||
48097982|NCT02710045|100563842|FG002|STARTED|Overall Study||81||
48097983|NCT02710045|100563840|FG000|COMPLETED|Overall Study||95||
48097984|NCT02710045|100563841|FG001|COMPLETED|Overall Study||98||
48097985|NCT02710045|100563842|FG002|COMPLETED|Overall Study||68||
48097986|NCT02710045|100563840|FG000|NOT COMPLETED|Overall Study||11||
48097987|NCT02710045|100563841|FG001|NOT COMPLETED|Overall Study||17||
48097988|NCT02710045|100563842|FG002|NOT COMPLETED|Overall Study||13||
48262090|NCT02559310|100962833|FG001|COMPLETED|Overall Study||256||
48544503|NCT00970593|101667128|FG003|COMPLETED|Overall Study||12||
48544504|NCT00970593|101667129|FG004|COMPLETED|Overall Study||20||
48262091|NCT02559310|100962832|FG000|NOT COMPLETED|Overall Study||27||
48262092|NCT02559310|100962833|FG001|NOT COMPLETED|Overall Study||19||
48262093|NCT00610727|100962834|FG000|STARTED|Overall Study||14||
48262094|NCT00610727|100962835|FG001|STARTED|Overall Study||8||
48262095|NCT00610727|100962836|FG002|STARTED|Overall Study||8||
48262096|NCT00610727|100962837|FG003|STARTED|Overall Study||8||
48544505|NCT00970593|101667130|FG005|COMPLETED|Overall Study||5||
48097989|NCT00309842|100563843|FG000|STARTED|Overall Study||213||
48097990|NCT00309842|100563843|FG000|COMPLETED|Overall Study||212||
48097991|NCT00309842|100563843|FG000|NOT COMPLETED|Overall Study||1||
48097992|NCT03970733|100563844|FG000|STARTED|Main Study Phase (18 Months)||97||
48097993|NCT03970733|100563845|FG001|STARTED|Main Study Phase (18 Months)||98||
48097994|NCT03970733|100563846|FG002|STARTED|Main Study Phase (18 Months)||51||
48097995|NCT03970733|100563847|FG003|STARTED|Main Study Phase (18 Months)||0||
48097996|NCT03970733|100563848|FG004|STARTED|Main Study Phase (18 Months)||0||
48544506|NCT00970593|101667131|FG006|COMPLETED|Overall Study||14||
48262097|NCT00610727|100962838|FG004|STARTED|Overall Study||8||
48262098|NCT00610727|100962839|FG005|STARTED|Overall Study||8||
48262099|NCT00610727|100962834|FG000|COMPLETED|Overall Study||14||
48097997|NCT03970733|100563844|FG000|COMPLETED|Main Study Phase (18 Months)||89|Participants who completed Day 545 (Month 18)|
48097998|NCT03970733|100563845|FG001|COMPLETED|Main Study Phase (18 Months)||84|Participants who completed Day 545 (Month 18)|
48097999|NCT03970733|100563846|FG002|COMPLETED|Main Study Phase (18 Months)||46|Participants who completed Day 545 (Month 18)|
48098000|NCT03970733|100563847|FG003|COMPLETED|Main Study Phase (18 Months)||0|Participants who completed Day 545 (Month 18)|
48098001|NCT03970733|100563848|FG004|COMPLETED|Main Study Phase (18 Months)||0|Participants who completed Day 545 (Month 18)|
48098002|NCT03970733|100563844|FG000|NOT COMPLETED|Main Study Phase (18 Months)||8||
48098003|NCT03970733|100563845|FG001|NOT COMPLETED|Main Study Phase (18 Months)||14||
48098004|NCT03970733|100563846|FG002|NOT COMPLETED|Main Study Phase (18 Months)||5||
48098005|NCT03970733|100563847|FG003|NOT COMPLETED|Main Study Phase (18 Months)||0||
48098006|NCT03970733|100563848|FG004|NOT COMPLETED|Main Study Phase (18 Months)||0||
48098007|NCT03970733|100563844|FG000|STARTED|Booster Phase (Approx. 12 Months)||0||
48098008|NCT03970733|100563845|FG001|STARTED|Booster Phase (Approx. 12 Months)||0||
48098009|NCT03970733|100563846|FG002|STARTED|Booster Phase (Approx. 12 Months)||0||
48098010|NCT03970733|100563847|FG003|STARTED|Booster Phase (Approx. 12 Months)||39||
48098011|NCT03970733|100563848|FG004|STARTED|Booster Phase (Approx. 12 Months)||19||
48098012|NCT03970733|100563844|FG000|COMPLETED|Booster Phase (Approx. 12 Months)||0||
48098013|NCT03970733|100563845|FG001|COMPLETED|Booster Phase (Approx. 12 Months)||0||
48098014|NCT03970733|100563846|FG002|COMPLETED|Booster Phase (Approx. 12 Months)||0||
48098015|NCT03970733|100563847|FG003|COMPLETED|Booster Phase (Approx. 12 Months)||39||
48098016|NCT03970733|100563848|FG004|COMPLETED|Booster Phase (Approx. 12 Months)||18||
48098017|NCT03970733|100563844|FG000|NOT COMPLETED|Booster Phase (Approx. 12 Months)||0||
48098018|NCT03970733|100563845|FG001|NOT COMPLETED|Booster Phase (Approx. 12 Months)||0||
48098019|NCT03970733|100563846|FG002|NOT COMPLETED|Booster Phase (Approx. 12 Months)||0||
48098020|NCT03970733|100563847|FG003|NOT COMPLETED|Booster Phase (Approx. 12 Months)||0||
48098021|NCT03970733|100563848|FG004|NOT COMPLETED|Booster Phase (Approx. 12 Months)||1||
48098022|NCT02039674|100563849|FG000|STARTED|Overall Study||13||
48098023|NCT02039674|100563850|FG001|STARTED|Overall Study||12||
48098024|NCT02039674|100563851|FG002|STARTED|Overall Study||12||
48098025|NCT02039674|100563852|FG003|STARTED|Overall Study||13||
48098026|NCT02039674|100563853|FG004|STARTED|Overall Study||12||
48098027|NCT02039674|100563854|FG005|STARTED|Overall Study||12||
48098028|NCT02039674|100563855|FG006|STARTED|Overall Study||3||
48098029|NCT02039674|100563856|FG007|STARTED|Overall Study||3||
48098030|NCT02039674|100563857|FG008|STARTED|Overall Study||12||
48098031|NCT02039674|100563858|FG009|STARTED|Overall Study||12||
48098032|NCT02039674|100563859|FG010|STARTED|Overall Study||7||
48098033|NCT02039674|100563860|FG011|STARTED|Overall Study||60||
48098034|NCT02039674|100563861|FG012|STARTED|Overall Study||63||
48098035|NCT02039674|100563862|FG013|STARTED|Overall Study||33||
48262100|NCT00610727|100962835|FG001|COMPLETED|Overall Study||8||
48262101|NCT00610727|100962836|FG002|COMPLETED|Overall Study||8||
48262102|NCT00610727|100962837|FG003|COMPLETED|Overall Study||8||
48262103|NCT00610727|100962838|FG004|COMPLETED|Overall Study||8||
48262104|NCT00610727|100962839|FG005|COMPLETED|Overall Study||8||
48262105|NCT00610727|100962834|FG000|NOT COMPLETED|Overall Study||0||
48262106|NCT00610727|100962835|FG001|NOT COMPLETED|Overall Study||0||
48544507|NCT00970593|101667125|FG000|NOT COMPLETED|Overall Study||1||
48544508|NCT00970593|101667126|FG001|NOT COMPLETED|Overall Study||1||
48544509|NCT00970593|101667127|FG002|NOT COMPLETED|Overall Study||6||
48544510|NCT00970593|101667128|FG003|NOT COMPLETED|Overall Study||0||
48544511|NCT00970593|101667129|FG004|NOT COMPLETED|Overall Study||0||
48544512|NCT00970593|101667130|FG005|NOT COMPLETED|Overall Study||0||
48544513|NCT00970593|101667131|FG006|NOT COMPLETED|Overall Study||2||
48544514|NCT01342757|101667132|FG000|STARTED|Overall Study||12||
48098036|NCT02039674|100563849|FG000|Treated|Overall Study||13||
48098037|NCT02039674|100563850|FG001|Treated|Overall Study||12||
48262107|NCT00610727|100962836|FG002|NOT COMPLETED|Overall Study||0||
48262108|NCT00610727|100962837|FG003|NOT COMPLETED|Overall Study||0||
48098038|NCT02039674|100563851|FG002|Treated|Overall Study||11||
48098039|NCT02039674|100563852|FG003|Treated|Overall Study||13||
48098040|NCT02039674|100563853|FG004|Treated|Overall Study||12||
48098041|NCT02039674|100563854|FG005|Treated|Overall Study||12||
48098042|NCT02039674|100563855|FG006|Treated|Overall Study||3||
48098043|NCT02039674|100563856|FG007|Treated|Overall Study||3||
48098044|NCT02039674|100563857|FG008|Treated|Overall Study||12||
48098045|NCT02039674|100563858|FG009|Treated|Overall Study||12||
48098046|NCT02039674|100563859|FG010|Treated|Overall Study||7||
48098047|NCT02039674|100563860|FG011|Treated|Overall Study||59||
48098048|NCT02039674|100563861|FG012|Treated|Overall Study||62||
48098049|NCT02039674|100563862|FG013|Treated|Overall Study||33||
48098050|NCT02039674|100563849|FG000|Received Second Course of Pembrolizumab|Overall Study||2||
48262109|NCT00610727|100962838|FG004|NOT COMPLETED|Overall Study||0||
48262110|NCT00610727|100962839|FG005|NOT COMPLETED|Overall Study||0||
48262111|NCT04211389|100962840|FG000|STARTED|Overall Study||290||
48262112|NCT04211389|100962841|FG001|STARTED|Overall Study||152||
48544515|NCT01342757|101667132|FG000|COMPLETED|Overall Study||12||
48098051|NCT02039674|100563850|FG001|Received Second Course of Pembrolizumab|Overall Study||0||
48098052|NCT02039674|100563851|FG002|Received Second Course of Pembrolizumab|Overall Study||0||
48098053|NCT02039674|100563852|FG003|Received Second Course of Pembrolizumab|Overall Study||1||
48098054|NCT02039674|100563853|FG004|Received Second Course of Pembrolizumab|Overall Study||0||
48690430|NCT02277249|102025834|FG001|COMPLETED|Overall Study||30||
48690431|NCT02277249|102025833|FG000|NOT COMPLETED|Overall Study||0||
48690432|NCT02277249|102025834|FG001|NOT COMPLETED|Overall Study||0||
48098055|NCT02039674|100563854|FG005|Received Second Course of Pembrolizumab|Overall Study||0||
48098056|NCT02039674|100563855|FG006|Received Second Course of Pembrolizumab|Overall Study||0||
48098057|NCT02039674|100563856|FG007|Received Second Course of Pembrolizumab|Overall Study||0||
48098058|NCT02039674|100563857|FG008|Received Second Course of Pembrolizumab|Overall Study||0||
48098059|NCT02039674|100563858|FG009|Received Second Course of Pembrolizumab|Overall Study||1||
48098060|NCT02039674|100563859|FG010|Received Second Course of Pembrolizumab|Overall Study||0||
48098061|NCT02039674|100563860|FG011|Received Second Course of Pembrolizumab|Overall Study||2||
48098062|NCT02039674|100563861|FG012|Received Second Course of Pembrolizumab|Overall Study||0||
48098063|NCT02039674|100563862|FG013|Received Second Course of Pembrolizumab|Overall Study||0||
48098064|NCT02039674|100563849|FG000|Switched Over to Pembrolizumab|Overall Study||0||
48098065|NCT02039674|100563850|FG001|Switched Over to Pembrolizumab|Overall Study||0||
48098066|NCT02039674|100563851|FG002|Switched Over to Pembrolizumab|Overall Study||0||
48098067|NCT02039674|100563852|FG003|Switched Over to Pembrolizumab|Overall Study||0||
48098068|NCT02039674|100563853|FG004|Switched Over to Pembrolizumab|Overall Study||0||
48098069|NCT02039674|100563854|FG005|Switched Over to Pembrolizumab|Overall Study||0||
48098070|NCT02039674|100563855|FG006|Switched Over to Pembrolizumab|Overall Study||0||
48098071|NCT02039674|100563856|FG007|Switched Over to Pembrolizumab|Overall Study||0||
48098072|NCT02039674|100563857|FG008|Switched Over to Pembrolizumab|Overall Study||0||
48098073|NCT02039674|100563858|FG009|Switched Over to Pembrolizumab|Overall Study||0||
48098074|NCT02039674|100563859|FG010|Switched Over to Pembrolizumab|Overall Study||0||
48098075|NCT02039674|100563860|FG011|Switched Over to Pembrolizumab|Overall Study||0||
48098076|NCT02039674|100563861|FG012|Switched Over to Pembrolizumab|Overall Study||28||
48098077|NCT02039674|100563862|FG013|Switched Over to Pembrolizumab|Overall Study||0||
48098078|NCT02039674|100563849|FG000|COMPLETED|Overall Study||0||
48098079|NCT02039674|100563850|FG001|COMPLETED|Overall Study||0||
48098080|NCT02039674|100563851|FG002|COMPLETED|Overall Study||0||
48098081|NCT02039674|100563852|FG003|COMPLETED|Overall Study||0||
48098082|NCT02039674|100563853|FG004|COMPLETED|Overall Study||0||
48098083|NCT02039674|100563854|FG005|COMPLETED|Overall Study||0||
48098084|NCT02039674|100563855|FG006|COMPLETED|Overall Study||0||
48098085|NCT02039674|100563856|FG007|COMPLETED|Overall Study||0||
48098086|NCT02039674|100563857|FG008|COMPLETED|Overall Study||0||
48098087|NCT02039674|100563858|FG009|COMPLETED|Overall Study||0||
48098088|NCT02039674|100563859|FG010|COMPLETED|Overall Study||0||
48098089|NCT02039674|100563860|FG011|COMPLETED|Overall Study||0||
48098090|NCT02039674|100563861|FG012|COMPLETED|Overall Study||0||
48098091|NCT02039674|100563862|FG013|COMPLETED|Overall Study||0||
48098092|NCT02039674|100563849|FG000|NOT COMPLETED|Overall Study||13||
48098093|NCT02039674|100563850|FG001|NOT COMPLETED|Overall Study||12||
48098094|NCT02039674|100563851|FG002|NOT COMPLETED|Overall Study||12||
48098095|NCT02039674|100563852|FG003|NOT COMPLETED|Overall Study||13||
48098096|NCT02039674|100563853|FG004|NOT COMPLETED|Overall Study||12||
48098097|NCT02039674|100563854|FG005|NOT COMPLETED|Overall Study||12||
48098098|NCT02039674|100563855|FG006|NOT COMPLETED|Overall Study||3||
48098099|NCT02039674|100563856|FG007|NOT COMPLETED|Overall Study||3||
48098100|NCT02039674|100563857|FG008|NOT COMPLETED|Overall Study||12||
48098101|NCT02039674|100563858|FG009|NOT COMPLETED|Overall Study||12||
48098102|NCT02039674|100563859|FG010|NOT COMPLETED|Overall Study||7||
48098103|NCT02039674|100563860|FG011|NOT COMPLETED|Overall Study||60||
48098104|NCT02039674|100563861|FG012|NOT COMPLETED|Overall Study||63||
48098105|NCT02039674|100563862|FG013|NOT COMPLETED|Overall Study||33||
48690433|NCT00282087|102025835|FG000|STARTED|Overall Study||47||
48690434|NCT00282087|102025835|FG000|COMPLETED|Overall Study||46||
48690435|NCT00282087|102025835|FG000|NOT COMPLETED|Overall Study||1||
48690436|NCT02674464|102025836|FG000|STARTED|Overall Study||927||15
48690437|NCT02674464|102025837|FG001|STARTED|Overall Study||893||15
48098106|NCT02189473|100563863|FG000|STARTED|Overall Study||101||
48098107|NCT02189473|100563864|FG001|STARTED|Overall Study||102||
48098108|NCT02189473|100563863|FG000|COMPLETED|Overall Study||78||
48690438|NCT02674464|102025836|FG000|6 Month Follow-up|Overall Study||771|6 month survey data collection of adverse events|15
48098109|NCT02189473|100563864|FG001|COMPLETED|Overall Study||77||
48690439|NCT02674464|102025837|FG001|6 Month Follow-up|Overall Study||806|6 month survey data collection of adverse events|15
48098110|NCT02189473|100563863|FG000|NOT COMPLETED|Overall Study||23||
48098111|NCT02189473|100563864|FG001|NOT COMPLETED|Overall Study||25||
48098112|NCT01358357|100563865|FG000|STARTED|Open Label Phase||0||
48098113|NCT01358357|100563866|FG001|STARTED|Open Label Phase||0||
48098114|NCT01358357|100563867|FG002|STARTED|Open Label Phase||965||
48710798|NCT01012921|102078022|FG001|COMPLETED|Overall Study||47||
48098115|NCT01358357|100563865|FG000|COMPLETED|Open Label Phase||0||
48098116|NCT01358357|100563866|FG001|COMPLETED|Open Label Phase||0||
48098117|NCT01358357|100563867|FG002|COMPLETED|Open Label Phase||503||
48098118|NCT01358357|100563865|FG000|NOT COMPLETED|Open Label Phase||0||
48098119|NCT01358357|100563866|FG001|NOT COMPLETED|Open Label Phase||0||
48098120|NCT01358357|100563867|FG002|NOT COMPLETED|Open Label Phase||462||
48098121|NCT01358357|100563865|FG000|STARTED|Double-Blind Phase||246||
48098122|NCT01358357|100563866|FG001|STARTED|Double-Blind Phase||250||
48098123|NCT01358357|100563867|FG002|STARTED|Double-Blind Phase||0||
48262113|NCT04211389|100962840|FG000|COMPLETED|Overall Study||264||
48262114|NCT04211389|100962841|FG001|COMPLETED|Overall Study||131||
48262115|NCT04211389|100962840|FG000|NOT COMPLETED|Overall Study||26||
48262116|NCT04211389|100962841|FG001|NOT COMPLETED|Overall Study||21||
48544516|NCT01342757|101667132|FG000|NOT COMPLETED|Overall Study||0||
48544517|NCT04974749|101667133|FG000|STARTED|Overall Study||20||
48098124|NCT01358357|100563865|FG000|COMPLETED|Double-Blind Phase||166||
48098125|NCT01358357|100563866|FG001|COMPLETED|Double-Blind Phase||150||
48098126|NCT01358357|100563867|FG002|COMPLETED|Double-Blind Phase||0||
48098127|NCT01358357|100563865|FG000|NOT COMPLETED|Double-Blind Phase||80||
48098128|NCT01358357|100563866|FG001|NOT COMPLETED|Double-Blind Phase||100||
48098129|NCT01358357|100563867|FG002|NOT COMPLETED|Double-Blind Phase||0||
48098130|NCT02882854|100563868|FG000|STARTED|Overall Study||40||
48098131|NCT02882854|100563869|FG001|STARTED|Overall Study||44||
48098132|NCT02882854|100563868|FG000|COMPLETED|Overall Study||39||
48098133|NCT02882854|100563869|FG001|COMPLETED|Overall Study||41||
48098134|NCT02882854|100563868|FG000|NOT COMPLETED|Overall Study||1||
48098135|NCT02882854|100563869|FG001|NOT COMPLETED|Overall Study||3||
48098136|NCT00620828|100563870|FG000|STARTED|Overall Study||32||
48098137|NCT00620828|100563871|FG001|STARTED|Overall Study||35||
48098138|NCT00620828|100563870|FG000|Number of Subjects Enrolled = 67|Overall Study||32||
48098139|NCT00620828|100563871|FG001|Number of Subjects Enrolled = 67|Overall Study||35||
48098140|NCT00620828|100563870|FG000|COMPLETED|Overall Study||32||
48098141|NCT00620828|100563871|FG001|COMPLETED|Overall Study||35||
48098142|NCT00620828|100563870|FG000|NOT COMPLETED|Overall Study||0||
48098143|NCT00620828|100563871|FG001|NOT COMPLETED|Overall Study||0||
48098144|NCT00501293|100563872|FG000|STARTED|Optimization Period||110||
48098145|NCT00501293|100563873|FG001|STARTED|Optimization Period||53||
48098146|NCT00501293|100563872|FG000|COMPLETED|Optimization Period||109||
48098147|NCT00501293|100563873|FG001|COMPLETED|Optimization Period||53||
48098148|NCT00501293|100563872|FG000|NOT COMPLETED|Optimization Period||1||
48098149|NCT00501293|100563873|FG001|NOT COMPLETED|Optimization Period||0||
48098150|NCT00501293|100563872|FG000|STARTED|Maintenance Period||109||
48098151|NCT00501293|100563873|FG001|STARTED|Maintenance Period||53||
48098152|NCT00501293|100563872|FG000|COMPLETED|Maintenance Period||63||
48098153|NCT00501293|100563873|FG001|COMPLETED|Maintenance Period||25||
48544518|NCT04974749|101667133|FG000|COMPLETED|Overall Study||17||
48544519|NCT04974749|101667133|FG000|NOT COMPLETED|Overall Study||3||
48544520|NCT03713632|101667134|FG000|STARTED|Treatment Period 1 (Until Week 16)||181||
48544521|NCT03713632|101667135|FG001|STARTED|Treatment Period 1 (Until Week 16)||180||
48544522|NCT03713632|101667136|FG002|STARTED|Treatment Period 1 (Until Week 16)||183||
48544523|NCT03713632|101667137|FG003|STARTED|Treatment Period 1 (Until Week 16)||0||
48544524|NCT03713632|101667138|FG004|STARTED|Treatment Period 1 (Until Week 16)||0||
48544525|NCT03713632|101667134|FG000|Full Analysis Set|Treatment Period 1 (Until Week 16)||180||
48544526|NCT03713632|101667135|FG001|Full Analysis Set|Treatment Period 1 (Until Week 16)||180||
48544527|NCT03713632|101667136|FG002|Full Analysis Set|Treatment Period 1 (Until Week 16)||183||
48544528|NCT03713632|101667137|FG003|Full Analysis Set|Treatment Period 1 (Until Week 16)||0||
48544529|NCT03713632|101667138|FG004|Full Analysis Set|Treatment Period 1 (Until Week 16)||0||
48544530|NCT03713632|101667134|FG000|COMPLETED|Treatment Period 1 (Until Week 16)||170||
48544531|NCT03713632|101667135|FG001|COMPLETED|Treatment Period 1 (Until Week 16)||169||
48544532|NCT03713632|101667136|FG002|COMPLETED|Treatment Period 1 (Until Week 16)||167||
48544533|NCT03713632|101667137|FG003|COMPLETED|Treatment Period 1 (Until Week 16)||0||
48544534|NCT03713632|101667138|FG004|COMPLETED|Treatment Period 1 (Until Week 16)||0||
48690440|NCT02674464|102025836|FG000|COMPLETED|Overall Study||790|12 month follow-up (primary endpoint)|15
48690441|NCT02674464|102025837|FG001|COMPLETED|Overall Study||733|12 month follow-up (primary endpoint)|15
48690442|NCT02674464|102025836|FG000|NOT COMPLETED|Overall Study||137||0
48098154|NCT00501293|100563872|FG000|NOT COMPLETED|Maintenance Period||46||
48098155|NCT00501293|100563873|FG001|NOT COMPLETED|Maintenance Period||28||
48098156|NCT02197806|100563874|FG000|STARTED|Overall Study||15||
48262117|NCT01639742|100962842|FG000|STARTED|Overall Study||18||
48262118|NCT01639742|100962842|FG000|COMPLETED|Overall Study||0||
48262119|NCT01639742|100962842|FG000|NOT COMPLETED|Overall Study||18||
48544535|NCT03713632|101667134|FG000|NOT COMPLETED|Treatment Period 1 (Until Week 16)||11||
48098157|NCT02197806|100563875|FG001|STARTED|Overall Study||17||
48098158|NCT02197806|100563876|FG002|STARTED|Overall Study||16||
48098159|NCT02197806|100563877|FG003|STARTED|Overall Study||17||
48098160|NCT02197806|100563874|FG000|COMPLETED|Overall Study||15||
48098161|NCT02197806|100563875|FG001|COMPLETED|Overall Study||16||
48098162|NCT02197806|100563876|FG002|COMPLETED|Overall Study||16||
48098163|NCT02197806|100563877|FG003|COMPLETED|Overall Study||16||
48098164|NCT02197806|100563874|FG000|NOT COMPLETED|Overall Study||0||
48098165|NCT02197806|100563875|FG001|NOT COMPLETED|Overall Study||1||
48544536|NCT03713632|101667135|FG001|NOT COMPLETED|Treatment Period 1 (Until Week 16)||11||
48544537|NCT03713632|101667136|FG002|NOT COMPLETED|Treatment Period 1 (Until Week 16)||16||
48544538|NCT03713632|101667137|FG003|NOT COMPLETED|Treatment Period 1 (Until Week 16)||0||
48544539|NCT03713632|101667138|FG004|NOT COMPLETED|Treatment Period 1 (Until Week 16)||0||
48544540|NCT03713632|101667134|FG000|STARTED|Treatment Period 2 (After Week 16)||170||
48544541|NCT03713632|101667135|FG001|STARTED|Treatment Period 2 (After Week 16)||169||
48544542|NCT03713632|101667136|FG002|STARTED|Treatment Period 2 (After Week 16)||0||
48544543|NCT03713632|101667137|FG003|STARTED|Treatment Period 2 (After Week 16)||81||
48544544|NCT03713632|101667138|FG004|STARTED|Treatment Period 2 (After Week 16)||86||
48544545|NCT03713632|101667134|FG000|COMPLETED|Treatment Period 2 (After Week 16)||149||
48544546|NCT03713632|101667135|FG001|COMPLETED|Treatment Period 2 (After Week 16)||133||
48544547|NCT03713632|101667136|FG002|COMPLETED|Treatment Period 2 (After Week 16)||0||
48098166|NCT02197806|100563876|FG002|NOT COMPLETED|Overall Study||0||
48098167|NCT02197806|100563877|FG003|NOT COMPLETED|Overall Study||1||
48098168|NCT04256785|100563878|FG000|STARTED|Overall Study||54||
48098169|NCT04256785|100563879|FG001|STARTED|Overall Study||56||
48262120|NCT03598699|100962843|FG000|STARTED|Overall Study||54||
48544548|NCT03713632|101667137|FG003|COMPLETED|Treatment Period 2 (After Week 16)||68||
48544549|NCT03713632|101667138|FG004|COMPLETED|Treatment Period 2 (After Week 16)||69||
48544550|NCT03713632|101667134|FG000|NOT COMPLETED|Treatment Period 2 (After Week 16)||21||
48544551|NCT03713632|101667135|FG001|NOT COMPLETED|Treatment Period 2 (After Week 16)||36||
48544552|NCT03713632|101667136|FG002|NOT COMPLETED|Treatment Period 2 (After Week 16)||0||
48544553|NCT03713632|101667137|FG003|NOT COMPLETED|Treatment Period 2 (After Week 16)||13||
48544554|NCT03713632|101667138|FG004|NOT COMPLETED|Treatment Period 2 (After Week 16)||17||
48544555|NCT00997204|101667139|FG000|STARTED|Naive Treatment Phase||25||
48544556|NCT00997204|101667140|FG001|STARTED|Naive Treatment Phase||79||
48544557|NCT00997204|101667139|FG000|COMPLETED|Naive Treatment Phase||19||
48544558|NCT00997204|101667140|FG001|COMPLETED|Naive Treatment Phase||0||
48544559|NCT00997204|101667139|FG000|NOT COMPLETED|Naive Treatment Phase||6||
48544560|NCT00997204|101667140|FG001|NOT COMPLETED|Naive Treatment Phase||79||
48544561|NCT00997204|101667139|FG000|STARTED|Self-administration Phase||19||
48544562|NCT00997204|101667140|FG001|STARTED|Self-administration Phase||78||
48544563|NCT00997204|101667139|FG000|COMPLETED|Self-administration Phase||19||
48544564|NCT00997204|101667140|FG001|COMPLETED|Self-administration Phase||77||
48544565|NCT00997204|101667139|FG000|NOT COMPLETED|Self-administration Phase||0||
48544566|NCT00997204|101667140|FG001|NOT COMPLETED|Self-administration Phase||1||
48544567|NCT03509857|101667141|FG000|STARTED|Overall Study||50||
48544568|NCT03509857|101667142|FG001|STARTED|Overall Study||50||
48544569|NCT03509857|101667141|FG000|COMPLETED|Overall Study||50||
48544570|NCT03509857|101667142|FG001|COMPLETED|Overall Study||50||
48544571|NCT03509857|101667141|FG000|NOT COMPLETED|Overall Study||0||
48544572|NCT03509857|101667142|FG001|NOT COMPLETED|Overall Study||0||
48544573|NCT03150407|101667143|FG000|STARTED|Period 1||36||
48544574|NCT03150407|101667144|FG001|STARTED|Period 1||36||
48544575|NCT03150407|101667143|FG000|COMPLETED|Period 1||32||
48544576|NCT03150407|101667144|FG001|COMPLETED|Period 1||34||
48544577|NCT03150407|101667143|FG000|NOT COMPLETED|Period 1||4||
48544578|NCT03150407|101667144|FG001|NOT COMPLETED|Period 1||2||
48544579|NCT03150407|101667143|FG000|STARTED|Washout||32||
48544580|NCT03150407|101667144|FG001|STARTED|Washout||34||
48544581|NCT03150407|101667143|FG000|COMPLETED|Washout||31||
48544582|NCT03150407|101667144|FG001|COMPLETED|Washout||33||
48544583|NCT03150407|101667143|FG000|NOT COMPLETED|Washout||1||
48544584|NCT03150407|101667144|FG001|NOT COMPLETED|Washout||1||
48544585|NCT03150407|101667143|FG000|STARTED|Period 2||31||
48544586|NCT03150407|101667144|FG001|STARTED|Period 2||33||
48544587|NCT03150407|101667143|FG000|COMPLETED|Period 2||30||
48544588|NCT03150407|101667144|FG001|COMPLETED|Period 2||33||
48544589|NCT03150407|101667143|FG000|NOT COMPLETED|Period 2||1||
48544590|NCT03150407|101667144|FG001|NOT COMPLETED|Period 2||0||
48544591|NCT03150407|101667143|FG000|STARTED|Long-Term Safety Extension||27||
48544592|NCT03150407|101667144|FG001|STARTED|Long-Term Safety Extension||30||
48544593|NCT03150407|101667143|FG000|COMPLETED|Long-Term Safety Extension||26||
48544594|NCT03150407|101667144|FG001|COMPLETED|Long-Term Safety Extension||27||
48544595|NCT03150407|101667143|FG000|NOT COMPLETED|Long-Term Safety Extension||1||
48098170|NCT04256785|100563878|FG000|COMPLETED|Overall Study||26||
48098171|NCT04256785|100563879|FG001|COMPLETED|Overall Study||31||
48098172|NCT04256785|100563878|FG000|NOT COMPLETED|Overall Study||28||
48262121|NCT03598699|100962844|FG001|STARTED|Overall Study||48||
48544596|NCT03150407|101667144|FG001|NOT COMPLETED|Long-Term Safety Extension||3||
48544597|NCT04975191|101667145|FG000|STARTED|Overall Study||66||
48544598|NCT04975191|101667146|FG001|STARTED|Overall Study||61||
48544599|NCT04975191|101667147|FG002|STARTED|Overall Study||63||
48544600|NCT04975191|101667148|FG003|STARTED|Overall Study||62||
48544601|NCT04975191|101667145|FG000|COMPLETED|Overall Study||52||
48544602|NCT04975191|101667146|FG001|COMPLETED|Overall Study||56||
48098173|NCT04256785|100563879|FG001|NOT COMPLETED|Overall Study||25||
48098174|NCT00100815|100563880|FG000|STARTED|Overall Study||50||
48098175|NCT00100815|100563880|FG000|COMPLETED|Overall Study||1||
48098176|NCT00100815|100563880|FG000|NOT COMPLETED|Overall Study||49||
48544603|NCT04975191|101667147|FG002|COMPLETED|Overall Study||53||
48544604|NCT04975191|101667148|FG003|COMPLETED|Overall Study||52||
48544605|NCT04975191|101667145|FG000|NOT COMPLETED|Overall Study||14||
48544606|NCT04975191|101667146|FG001|NOT COMPLETED|Overall Study||5||
48544607|NCT04975191|101667147|FG002|NOT COMPLETED|Overall Study||10||
48544608|NCT04975191|101667148|FG003|NOT COMPLETED|Overall Study||10||
48544609|NCT02318303|101667149|FG000|STARTED|Overall Study||159||
48544610|NCT02318303|101667150|FG001|STARTED|Overall Study||158||
48544611|NCT02318303|101667151|FG002|STARTED|Overall Study||160||
48544612|NCT02318303|101667152|FG003|STARTED|Overall Study||158||
48544613|NCT02318303|101667153|FG004|STARTED|Overall Study||157||
48544614|NCT02318303|101667154|FG005|STARTED|Overall Study||159||
48544615|NCT02318303|101667155|FG006|STARTED|Overall Study||160||
48544616|NCT02318303|101667149|FG000|COMPLETED|Overall Study||155||
48544617|NCT02318303|101667150|FG001|COMPLETED|Overall Study||155||
48544618|NCT02318303|101667151|FG002|COMPLETED|Overall Study||157||
48544619|NCT02318303|101667152|FG003|COMPLETED|Overall Study||155||
48544620|NCT02318303|101667153|FG004|COMPLETED|Overall Study||152||
48690443|NCT02674464|102025837|FG001|NOT COMPLETED|Overall Study||160||0
48690444|NCT04248712|102025838|FG000|STARTED|Overall Study||1||
48690445|NCT04248712|102025839|FG001|STARTED|Overall Study||0||
48690446|NCT04248712|102025838|FG000|COMPLETED|Overall Study||1||
48690447|NCT04248712|102025839|FG001|COMPLETED|Overall Study||0||
48690448|NCT04248712|102025838|FG000|NOT COMPLETED|Overall Study||0||
48690449|NCT04248712|102025839|FG001|NOT COMPLETED|Overall Study||0||
48690450|NCT02079909|102025840|FG000|STARTED|Overall Study||158||
48690451|NCT02079909|102025841|FG001|STARTED|Overall Study||166||
48690452|NCT02079909|102025842|FG002|STARTED|Overall Study||158||
48690453|NCT02079909|102025840|FG000|COMPLETED|Overall Study||120||
48690454|NCT02079909|102025841|FG001|COMPLETED|Overall Study||117||
48690455|NCT02079909|102025842|FG002|COMPLETED|Overall Study||140||
48690456|NCT02079909|102025840|FG000|NOT COMPLETED|Overall Study||38||
48690457|NCT02079909|102025841|FG001|NOT COMPLETED|Overall Study||49||
48690458|NCT02079909|102025842|FG002|NOT COMPLETED|Overall Study||18||
48690459|NCT02446769|102025843|FG000|STARTED|Screening Period||18||
48690460|NCT02446769|102025844|FG001|STARTED|Screening Period||0||
48690461|NCT02446769|102025845|FG002|STARTED|Screening Period||0||
48690462|NCT02446769|102025843|FG000|COMPLETED|Screening Period||7||
48690463|NCT02446769|102025844|FG001|COMPLETED|Screening Period||0||
48690464|NCT02446769|102025845|FG002|COMPLETED|Screening Period||0||
48690465|NCT02446769|102025843|FG000|NOT COMPLETED|Screening Period||11||
48690466|NCT02446769|102025844|FG001|NOT COMPLETED|Screening Period||0||
48690467|NCT02446769|102025845|FG002|NOT COMPLETED|Screening Period||0||
48690468|NCT02446769|102025843|FG000|STARTED|Study Period||0||
48690469|NCT02446769|102025844|FG001|STARTED|Study Period||4||
48690470|NCT02446769|102025845|FG002|STARTED|Study Period||3||
48690471|NCT02446769|102025843|FG000|COMPLETED|Study Period||0||
48690472|NCT02446769|102025844|FG001|COMPLETED|Study Period||2||
48544621|NCT02318303|101667154|FG005|COMPLETED|Overall Study||153||
48544622|NCT02318303|101667155|FG006|COMPLETED|Overall Study||158||
48544623|NCT02318303|101667149|FG000|NOT COMPLETED|Overall Study||4||
48544624|NCT02318303|101667150|FG001|NOT COMPLETED|Overall Study||3||
48544625|NCT02318303|101667151|FG002|NOT COMPLETED|Overall Study||3||
48544626|NCT02318303|101667152|FG003|NOT COMPLETED|Overall Study||3||
48544627|NCT02318303|101667153|FG004|NOT COMPLETED|Overall Study||5||
48544628|NCT02318303|101667154|FG005|NOT COMPLETED|Overall Study||6||
48544629|NCT02318303|101667155|FG006|NOT COMPLETED|Overall Study||2||
48544630|NCT00735397|101667156|FG000|STARTED|Overall Study||1218||
48544631|NCT00735397|101667156|FG000|COMPLETED|Overall Study||35||
48544632|NCT00735397|101667156|FG000|NOT COMPLETED|Overall Study||1183||
48544633|NCT02845700|101667157|FG000|STARTED|Baseline Appointment||6||
48544634|NCT02845700|101667158|FG001|STARTED|Baseline Appointment||7||
48544635|NCT02845700|101667157|FG000|COMPLETED|Baseline Appointment||6||
48544636|NCT02845700|101667158|FG001|COMPLETED|Baseline Appointment||7||
48544637|NCT02845700|101667157|FG000|NOT COMPLETED|Baseline Appointment||0||
48544638|NCT02845700|101667158|FG001|NOT COMPLETED|Baseline Appointment||0||
48544639|NCT02845700|101667157|FG000|STARTED|Intervention Session 1||5||
48544640|NCT02845700|101667158|FG001|STARTED|Intervention Session 1||6||
48544641|NCT02845700|101667157|FG000|COMPLETED|Intervention Session 1||5||
48690473|NCT02446769|102025845|FG002|COMPLETED|Study Period||3||
48690474|NCT02446769|102025843|FG000|NOT COMPLETED|Study Period||0||
48690475|NCT02446769|102025844|FG001|NOT COMPLETED|Study Period||2||
48690476|NCT02446769|102025845|FG002|NOT COMPLETED|Study Period||0||
48690477|NCT00394329|102025846|FG000|STARTED|Overall Study||71||
48544642|NCT02845700|101667158|FG001|COMPLETED|Intervention Session 1||6||
48544643|NCT02845700|101667157|FG000|NOT COMPLETED|Intervention Session 1||0||
48544644|NCT02845700|101667158|FG001|NOT COMPLETED|Intervention Session 1||0||
48544645|NCT02845700|101667157|FG000|STARTED|Intervention Session 2||5||
48544646|NCT02845700|101667158|FG001|STARTED|Intervention Session 2||6||
48544647|NCT02845700|101667157|FG000|COMPLETED|Intervention Session 2||5||
48544648|NCT02845700|101667158|FG001|COMPLETED|Intervention Session 2||6||
48690478|NCT00394329|102025847|FG001|STARTED|Overall Study||72||
48690479|NCT00394329|102025848|FG002|STARTED|Overall Study||71||
48690480|NCT00394329|102025849|FG003|STARTED|Overall Study||74||
48690481|NCT00394329|102025846|FG000|COMPLETED|Overall Study||63||
48544649|NCT02845700|101667157|FG000|NOT COMPLETED|Intervention Session 2||0||
48544650|NCT02845700|101667158|FG001|NOT COMPLETED|Intervention Session 2||0||
48544651|NCT02845700|101667157|FG000|STARTED|Month 1 Follow-Up||2||
48544652|NCT02845700|101667158|FG001|STARTED|Month 1 Follow-Up||4||
48544653|NCT02845700|101667157|FG000|COMPLETED|Month 1 Follow-Up||2||
48544654|NCT02845700|101667158|FG001|COMPLETED|Month 1 Follow-Up||4||
48544655|NCT02845700|101667157|FG000|NOT COMPLETED|Month 1 Follow-Up||0||
48544656|NCT02845700|101667158|FG001|NOT COMPLETED|Month 1 Follow-Up||0||
48544657|NCT02213510|101667159|FG000|STARTED|Overall Study||21||
48544658|NCT02213510|101667160|FG001|STARTED|Overall Study||19||
48544659|NCT02213510|101667159|FG000|COMPLETED|Overall Study||20||
48544660|NCT02213510|101667160|FG001|COMPLETED|Overall Study||18||
48544661|NCT02213510|101667159|FG000|NOT COMPLETED|Overall Study||1||
48544662|NCT02213510|101667160|FG001|NOT COMPLETED|Overall Study||1||
48544663|NCT01307748|101667161|FG000|STARTED|Overall Study||31||
48544664|NCT01307748|101667162|FG001|STARTED|Overall Study||31||
48544665|NCT01307748|101667163|FG002|STARTED|Overall Study||30||
48544666|NCT01307748|101667161|FG000|COMPLETED|Overall Study||31||
48544667|NCT01307748|101667162|FG001|COMPLETED|Overall Study||31||
48544668|NCT01307748|101667163|FG002|COMPLETED|Overall Study||30||
48544669|NCT01307748|101667161|FG000|NOT COMPLETED|Overall Study||0||
48544670|NCT01307748|101667162|FG001|NOT COMPLETED|Overall Study||0||
48544671|NCT01307748|101667163|FG002|NOT COMPLETED|Overall Study||0||
48544672|NCT00735618|101667164|FG000|STARTED|Overall Study||19||
48544673|NCT00735618|101667164|FG000|COMPLETED|Overall Study||19||
48544674|NCT00735618|101667164|FG000|NOT COMPLETED|Overall Study||0||
48544675|NCT00631657|101667165|FG000|STARTED|6-Month Treatment Period||344||
48544676|NCT00631657|101667166|FG001|STARTED|6-Month Treatment Period||0||
48544677|NCT00631657|101667167|FG002|STARTED|6-Month Treatment Period||116||
48544678|NCT00631657|101667165|FG000|Treated|6-Month Treatment Period||342||
48544679|NCT00631657|101667166|FG001|Treated|6-Month Treatment Period||0||
48544680|NCT00631657|101667167|FG002|Treated|6-Month Treatment Period||115||
48544681|NCT00631657|101667165|FG000|COMPLETED|6-Month Treatment Period||203||
48544682|NCT00631657|101667166|FG001|COMPLETED|6-Month Treatment Period||0||
48544683|NCT00631657|101667167|FG002|COMPLETED|6-Month Treatment Period||66||
48544684|NCT00631657|101667165|FG000|NOT COMPLETED|6-Month Treatment Period||141||
48544685|NCT00631657|101667166|FG001|NOT COMPLETED|6-Month Treatment Period||0||
48544686|NCT00631657|101667167|FG002|NOT COMPLETED|6-Month Treatment Period||50||
48544687|NCT00631657|101667165|FG000|STARTED|7-Day Discontinuation Period||67||
48544688|NCT00631657|101667166|FG001|STARTED|7-Day Discontinuation Period||137||
48544689|NCT00631657|101667167|FG002|STARTED|7-Day Discontinuation Period||66||
48544690|NCT00631657|101667165|FG000|Treated|7-Day Discontinuation Period||66||
48544691|NCT00631657|101667166|FG001|Treated|7-Day Discontinuation Period||136||
48544692|NCT00631657|101667167|FG002|Treated|7-Day Discontinuation Period||65||
48544693|NCT00631657|101667165|FG000|COMPLETED|7-Day Discontinuation Period||65||
48544694|NCT00631657|101667166|FG001|COMPLETED|7-Day Discontinuation Period||136||
48544695|NCT00631657|101667167|FG002|COMPLETED|7-Day Discontinuation Period||65||
48544696|NCT00631657|101667165|FG000|NOT COMPLETED|7-Day Discontinuation Period||2||
48544697|NCT00631657|101667166|FG001|NOT COMPLETED|7-Day Discontinuation Period||1||
48544698|NCT00631657|101667167|FG002|NOT COMPLETED|7-Day Discontinuation Period||1||
48544699|NCT03510598|101667168|FG000|STARTED|Overall Study||16||
48544700|NCT03510598|101667168|FG000|COMPLETED|Overall Study||15||
48544701|NCT03510598|101667168|FG000|NOT COMPLETED|Overall Study||1||
48544702|NCT00141778|101667169|FG000|STARTED|Randomization Prior to Study Med||152||
48544703|NCT00141778|101667170|FG001|STARTED|Randomization Prior to Study Med||153||
48544704|NCT00141778|101667171|FG002|STARTED|Randomization Prior to Study Med||153||
48544705|NCT00141778|101667169|FG000|COMPLETED|Randomization Prior to Study Med||147||
48544706|NCT00141778|101667170|FG001|COMPLETED|Randomization Prior to Study Med||151||
48544707|NCT00141778|101667171|FG002|COMPLETED|Randomization Prior to Study Med||147||
48690482|NCT00394329|102025847|FG001|COMPLETED|Overall Study||63||
48544708|NCT00141778|101667169|FG000|NOT COMPLETED|Randomization Prior to Study Med||5||
48544709|NCT00141778|101667170|FG001|NOT COMPLETED|Randomization Prior to Study Med||2||
48544710|NCT00141778|101667171|FG002|NOT COMPLETED|Randomization Prior to Study Med||6||
48544711|NCT00141778|101667169|FG000|STARTED|Started Study Medication||147||
48544712|NCT00141778|101667170|FG001|STARTED|Started Study Medication||151||
48544713|NCT00141778|101667171|FG002|STARTED|Started Study Medication||147||
48544714|NCT00141778|101667169|FG000|COMPLETED|Started Study Medication||145||
48544715|NCT00141778|101667170|FG001|COMPLETED|Started Study Medication||144||
48544716|NCT00141778|101667171|FG002|COMPLETED|Started Study Medication||143||
48544717|NCT00141778|101667169|FG000|NOT COMPLETED|Started Study Medication||2||
48544718|NCT00141778|101667170|FG001|NOT COMPLETED|Started Study Medication||7||
48544719|NCT00141778|101667171|FG002|NOT COMPLETED|Started Study Medication||4||
48544720|NCT03035929|101667172|FG000|STARTED|Overall Study||10||
48544721|NCT03035929|101667172|FG000|COMPLETED|Overall Study||10||
48544722|NCT03035929|101667172|FG000|NOT COMPLETED|Overall Study||0||
48544723|NCT01906515|101667173|FG000|STARTED|Overall Study||45||
48544724|NCT01906515|101667174|FG001|STARTED|Overall Study||61||
48544725|NCT01906515|101667173|FG000|COMPLETED|Overall Study||45||
48544726|NCT01906515|101667174|FG001|COMPLETED|Overall Study||61||
48690483|NCT00394329|102025848|FG002|COMPLETED|Overall Study||58||
48544727|NCT01906515|101667173|FG000|NOT COMPLETED|Overall Study||0||
48544728|NCT01906515|101667174|FG001|NOT COMPLETED|Overall Study||0||
48544729|NCT01474200|101667175|FG000|STARTED|Overall Study||110||
48544730|NCT01474200|101667176|FG001|STARTED|Overall Study||114||
48544731|NCT01474200|101667175|FG000|COMPLETED|Overall Study||81||
48544732|NCT01474200|101667176|FG001|COMPLETED|Overall Study||84||
48544733|NCT01474200|101667175|FG000|NOT COMPLETED|Overall Study||29||
48544734|NCT01474200|101667176|FG001|NOT COMPLETED|Overall Study||30||
48544735|NCT04874155|101667177|FG000|STARTED|Overall Study||68||
48544736|NCT04874155|101667178|FG001|STARTED|Overall Study||65||
48544737|NCT04874155|101667177|FG000|COMPLETED|Overall Study||65||
48544738|NCT04874155|101667178|FG001|COMPLETED|Overall Study||62||
48544739|NCT04874155|101667177|FG000|NOT COMPLETED|Overall Study||3||
48544740|NCT04874155|101667178|FG001|NOT COMPLETED|Overall Study||3||
48544741|NCT03516513|101667179|FG000|STARTED|Overall Study||4||
48544742|NCT03516513|101667180|FG001|STARTED|Overall Study||7||
48544743|NCT03516513|101667181|FG002|STARTED|Overall Study||4||
48544744|NCT03516513|101667182|FG003|STARTED|Overall Study||9||
48544745|NCT03516513|101667179|FG000|COMPLETED|Overall Study||2||
48544746|NCT03516513|101667180|FG001|COMPLETED|Overall Study||5||
48544747|NCT03516513|101667181|FG002|COMPLETED|Overall Study||4||
48544748|NCT03516513|101667182|FG003|COMPLETED|Overall Study||9||
48544749|NCT03516513|101667179|FG000|NOT COMPLETED|Overall Study||2||
48544750|NCT03516513|101667180|FG001|NOT COMPLETED|Overall Study||2||
48544751|NCT03516513|101667181|FG002|NOT COMPLETED|Overall Study||0||
48544752|NCT03516513|101667182|FG003|NOT COMPLETED|Overall Study||0||
48544753|NCT00660907|101667183|FG000|STARTED|Overall Study||406||
48544754|NCT00660907|101667184|FG001|STARTED|Overall Study||408||
48544755|NCT00660907|101667183|FG000|COMPLETED|Overall Study||322||
48544756|NCT00660907|101667184|FG001|COMPLETED|Overall Study||314||
48544757|NCT00660907|101667183|FG000|NOT COMPLETED|Overall Study||84||
48544758|NCT00660907|101667184|FG001|NOT COMPLETED|Overall Study||94||
48544759|NCT00773474|101667185|FG000|STARTED|Overall Study||29||
48544760|NCT00773474|101667185|FG000|COMPLETED|Overall Study||29||
48544761|NCT00773474|101667185|FG000|NOT COMPLETED|Overall Study||0||
48544762|NCT03532373|101667186|FG000|STARTED|Overall Study||19||
48544763|NCT03532373|101667187|FG001|STARTED|Overall Study||30||
48544764|NCT03532373|101667186|FG000|COMPLETED|Overall Study||19||
48544765|NCT03532373|101667187|FG001|COMPLETED|Overall Study||30||
48544766|NCT03532373|101667186|FG000|NOT COMPLETED|Overall Study||0||
48544767|NCT03532373|101667187|FG001|NOT COMPLETED|Overall Study||0||
48544768|NCT01890434|101667188|FG000|STARTED|Overall Study||478|Treated with gadobutrol|
48544769|NCT01890434|101667188|FG000|Evaluated for Efficacy|Overall Study||389||
48544770|NCT01890434|101667188|FG000|COMPLETED|Overall Study||458|Follow-up (FU) completed|
48544771|NCT01890434|101667188|FG000|NOT COMPLETED|Overall Study||20||
48544772|NCT04388553|101667189|FG000|STARTED|Overall Study||36||
48262122|NCT03598699|100962843|FG000|COMPLETED|Overall Study||45||
48262123|NCT03598699|100962844|FG001|COMPLETED|Overall Study||46||
48262124|NCT03598699|100962843|FG000|NOT COMPLETED|Overall Study||9||
48262125|NCT03598699|100962844|FG001|NOT COMPLETED|Overall Study||2||
48262126|NCT01238536|100962845|FG000|STARTED|Overall Study||200||
48262127|NCT01238536|100962846|FG001|STARTED|Overall Study||200||
48262128|NCT01238536|100962845|FG000|COMPLETED|Overall Study||153||
48262129|NCT01238536|100962846|FG001|COMPLETED|Overall Study||150||
48262130|NCT01238536|100962845|FG000|NOT COMPLETED|Overall Study||47||
48262131|NCT01238536|100962846|FG001|NOT COMPLETED|Overall Study||50||
48262132|NCT05382039|100962847|FG000|STARTED|Overall Study||21||
48262133|NCT05382039|100962848|FG001|STARTED|Overall Study||12||
48262134|NCT05382039|100962849|FG002|STARTED|Overall Study||12||
48262135|NCT05382039|100962847|FG000|COMPLETED|Overall Study||16||
48262136|NCT05382039|100962848|FG001|COMPLETED|Overall Study||12||
48262137|NCT05382039|100962849|FG002|COMPLETED|Overall Study||10||
48262138|NCT05382039|100962847|FG000|NOT COMPLETED|Overall Study||5||
48544773|NCT04388553|101667190|FG001|STARTED|Overall Study||35||
48544774|NCT04388553|101667189|FG000|COMPLETED|Overall Study||35||
48544775|NCT04388553|101667190|FG001|COMPLETED|Overall Study||35||
48544776|NCT04388553|101667189|FG000|NOT COMPLETED|Overall Study||1||
48262139|NCT05382039|100962848|FG001|NOT COMPLETED|Overall Study||0||
48262140|NCT05382039|100962849|FG002|NOT COMPLETED|Overall Study||2||
48262141|NCT01196819|100962850|FG000|STARTED|Overall Study||231||
48262142|NCT01196819|100962851|FG001|STARTED|Overall Study||227||
48262143|NCT01196819|100962850|FG000|COMPLETED|Overall Study||225||
48262144|NCT01196819|100962851|FG001|COMPLETED|Overall Study||227||
48262145|NCT01196819|100962850|FG000|NOT COMPLETED|Overall Study||6||
48262146|NCT01196819|100962851|FG001|NOT COMPLETED|Overall Study||0||
48262147|NCT02080546|100962852|FG000|STARTED|Overall Study||57||
48544777|NCT04388553|101667190|FG001|NOT COMPLETED|Overall Study||0||
48544778|NCT04208750|101667191|FG000|STARTED|Overall Study||58||
48544779|NCT04208750|101667192|FG001|STARTED|Overall Study||61||
48544780|NCT04208750|101667191|FG000|Visit 2|Overall Study||58||
48544781|NCT04208750|101667192|FG001|Visit 2|Overall Study||61||
48544782|NCT04208750|101667191|FG000|Visit 3|Overall Study||58||
48544783|NCT04208750|101667192|FG001|Visit 3|Overall Study||53||
48262148|NCT02080546|100962853|FG001|STARTED|Overall Study||63||
48262149|NCT02080546|100962852|FG000|COMPLETED|Overall Study||49||
48544784|NCT04208750|101667191|FG000|Visit 4|Overall Study||43||
48544785|NCT04208750|101667192|FG001|Visit 4|Overall Study||47||
48544786|NCT04208750|101667191|FG000|COMPLETED|Overall Study||42||
48544787|NCT04208750|101667192|FG001|COMPLETED|Overall Study||46||
48544788|NCT04208750|101667191|FG000|NOT COMPLETED|Overall Study||16||
48544789|NCT04208750|101667192|FG001|NOT COMPLETED|Overall Study||15||
48544790|NCT02682927|101667193|FG000|STARTED|Overall Study||40||
48544791|NCT02682927|101667194|FG001|STARTED|Overall Study||39||
48544792|NCT02682927|101667195|FG002|STARTED|Overall Study||40||
48544793|NCT02682927|101667196|FG003|STARTED|Overall Study||48||
48544794|NCT02682927|101667197|FG004|STARTED|Overall Study||46||
48544795|NCT02682927|101667198|FG005|STARTED|Overall Study||49||
48544796|NCT02682927|101667193|FG000|COMPLETED|Overall Study||37||
48544797|NCT02682927|101667194|FG001|COMPLETED|Overall Study||39||
48544798|NCT02682927|101667195|FG002|COMPLETED|Overall Study||34||
48544799|NCT02682927|101667196|FG003|COMPLETED|Overall Study||43||
48544800|NCT02682927|101667197|FG004|COMPLETED|Overall Study||45||
48544801|NCT02682927|101667198|FG005|COMPLETED|Overall Study||46||
48544802|NCT02682927|101667193|FG000|NOT COMPLETED|Overall Study||3||
48544803|NCT02682927|101667194|FG001|NOT COMPLETED|Overall Study||0||
48544804|NCT02682927|101667195|FG002|NOT COMPLETED|Overall Study||6||
48544805|NCT02682927|101667196|FG003|NOT COMPLETED|Overall Study||5||
48544806|NCT02682927|101667197|FG004|NOT COMPLETED|Overall Study||1||
48544807|NCT02682927|101667198|FG005|NOT COMPLETED|Overall Study||3||
48544808|NCT00976911|101667199|FG000|STARTED|Overall Study||182||
48544809|NCT00976911|101667200|FG001|STARTED|Overall Study||179||
48544810|NCT00976911|101667199|FG000|COMPLETED|Overall Study||0||
48544811|NCT00976911|101667200|FG001|COMPLETED|Overall Study||0||
48544812|NCT00976911|101667199|FG000|NOT COMPLETED|Overall Study||182||
48262150|NCT02080546|100962853|FG001|COMPLETED|Overall Study||52||
48544813|NCT00976911|101667200|FG001|NOT COMPLETED|Overall Study||179||
48544814|NCT00243412|101667201|FG000|STARTED|Overall Study||21||
48544815|NCT00243412|101667202|FG001|STARTED|Overall Study||21||
48544816|NCT00243412|101667201|FG000|Safety Evaluable|Overall Study||21||
48544817|NCT00243412|101667202|FG001|Safety Evaluable|Overall Study||20||
48544818|NCT00243412|101667201|FG000|COMPLETED|Overall Study||11||
48544819|NCT00243412|101667202|FG001|COMPLETED|Overall Study||10||
48544820|NCT00243412|101667201|FG000|NOT COMPLETED|Overall Study||10||
48544821|NCT00243412|101667202|FG001|NOT COMPLETED|Overall Study||11||
48544822|NCT04842292|101667203|FG000|STARTED|Overall Study||2||
48544823|NCT04842292|101667203|FG000|COMPLETED|Overall Study||2||
48262151|NCT02080546|100962852|FG000|NOT COMPLETED|Overall Study||8||
48262152|NCT02080546|100962853|FG001|NOT COMPLETED|Overall Study||11||
48262153|NCT00283283|100962854|FG000|STARTED|Overall Study||274||
48262154|NCT00283283|100962855|FG001|STARTED|Overall Study||284||
48262155|NCT00283283|100962856|FG002|STARTED|Overall Study||280||
48262156|NCT00283283|100962857|FG003|STARTED|Overall Study||276||
48262157|NCT00283283|100962854|FG000|COMPLETED|Overall Study||274||
48262158|NCT00283283|100962855|FG001|COMPLETED|Overall Study||284||
48262159|NCT00283283|100962856|FG002|COMPLETED|Overall Study||280||
48262160|NCT00283283|100962857|FG003|COMPLETED|Overall Study||276||
48262161|NCT00283283|100962854|FG000|NOT COMPLETED|Overall Study||0||
48262162|NCT00283283|100962855|FG001|NOT COMPLETED|Overall Study||0||
48262163|NCT00283283|100962856|FG002|NOT COMPLETED|Overall Study||0||
48262164|NCT00283283|100962857|FG003|NOT COMPLETED|Overall Study||0||
48262165|NCT01227616|100962858|FG000|STARTED|Overall Study||196||
48262166|NCT01227616|100962859|FG001|STARTED|Overall Study||97||
48262167|NCT01227616|100962858|FG000|COMPLETED|Overall Study||142||
48262168|NCT01227616|100962859|FG001|COMPLETED|Overall Study||74||
48262169|NCT01227616|100962858|FG000|NOT COMPLETED|Overall Study||54||
48262170|NCT01227616|100962859|FG001|NOT COMPLETED|Overall Study||23||
48262171|NCT01809899|100962860|FG000|STARTED|Overall Study||8||
48262172|NCT01809899|100962861|FG001|STARTED|Overall Study||4||
48262173|NCT01809899|100962860|FG000|COMPLETED|Overall Study||8||
48262174|NCT01809899|100962861|FG001|COMPLETED|Overall Study||4||
48262175|NCT01809899|100962860|FG000|NOT COMPLETED|Overall Study||0||
48262176|NCT01809899|100962861|FG001|NOT COMPLETED|Overall Study||0||
48262177|NCT02022111|100962862|FG000|STARTED|Overall Study||196||
48544824|NCT04842292|101667203|FG000|NOT COMPLETED|Overall Study||0||
48544825|NCT02156167|101667204|FG000|STARTED|Overall Study||15||
48544826|NCT02156167|101667204|FG000|COMPLETED|Overall Study||15||
48544827|NCT02156167|101667204|FG000|NOT COMPLETED|Overall Study||0||
48544828|NCT00879411|101667205|FG000|STARTED|Overall Study||701||
48544829|NCT00879411|101667205|FG000|COMPLETED|Overall Study||539||
48544830|NCT00879411|101667205|FG000|NOT COMPLETED|Overall Study||162||
48544831|NCT01853332|101671200|FG000|STARTED|Overall Study||210||
48262178|NCT02022111|100962863|FG001|STARTED|Overall Study||208||
48544832|NCT01853332|101671200|FG000|COMPLETED|Overall Study||151||
48544833|NCT01853332|101671200|FG000|NOT COMPLETED|Overall Study||59||
48544834|NCT03151304|101671201|FG000|STARTED|Overall Study||64||
48262179|NCT02022111|100962862|FG000|COMPLETED|Overall Study||186||
48262180|NCT02022111|100962863|FG001|COMPLETED|Overall Study||193||
48544835|NCT03151304|101671201|FG000|COMPLETED|Overall Study||0||
48544836|NCT03151304|101671201|FG000|NOT COMPLETED|Overall Study||64||
48262181|NCT02022111|100962862|FG000|NOT COMPLETED|Overall Study||10||
48544837|NCT02740114|101671202|FG000|STARTED|Overall Study||54||
48690484|NCT00394329|102025849|FG003|COMPLETED|Overall Study||50||
48690485|NCT00394329|102025846|FG000|NOT COMPLETED|Overall Study||8||
48690486|NCT00394329|102025847|FG001|NOT COMPLETED|Overall Study||9||
48690487|NCT00394329|102025848|FG002|NOT COMPLETED|Overall Study||13||
48262182|NCT02022111|100962863|FG001|NOT COMPLETED|Overall Study||15||
48262183|NCT03432390|100962864|FG000|STARTED|Apnea Period||36||
48262184|NCT03432390|100962865|FG001|STARTED|Apnea Period||36||
48262185|NCT03432390|100962864|FG000|COMPLETED|Apnea Period||34||
48262186|NCT03432390|100962865|FG001|COMPLETED|Apnea Period||34||
48262187|NCT03432390|100962864|FG000|NOT COMPLETED|Apnea Period||2||
48262188|NCT03432390|100962865|FG001|NOT COMPLETED|Apnea Period||2||
48262189|NCT03432390|100962864|FG000|STARTED|Recovery Period||34||
48262190|NCT03432390|100962865|FG001|STARTED|Recovery Period||34||
48262191|NCT03432390|100962864|FG000|COMPLETED|Recovery Period||34||
48262192|NCT03432390|100962865|FG001|COMPLETED|Recovery Period||34||
48262193|NCT03432390|100962864|FG000|NOT COMPLETED|Recovery Period||0||
48262194|NCT03432390|100962865|FG001|NOT COMPLETED|Recovery Period||0||
48262195|NCT00943787|100962866|FG000|STARTED|Overall Study||41||
48262196|NCT00943787|100962866|FG000|COMPLETED|Overall Study||34||
48262197|NCT00943787|100962866|FG000|NOT COMPLETED|Overall Study||7||
48262198|NCT04092452|100962867|FG000|STARTED|Overall Study||48||
48262199|NCT04092452|100962868|FG001|STARTED|Overall Study||47||
48262200|NCT04092452|100962869|FG002|STARTED|Overall Study||52||
48262201|NCT04092452|100962870|FG003|STARTED|Overall Study||47||
48262202|NCT04092452|100962867|FG000|COMPLETED|Overall Study||35|(treatment completed)|
48262203|NCT04092452|100962868|FG001|COMPLETED|Overall Study||30|(treatment completed)|
48262204|NCT04092452|100962869|FG002|COMPLETED|Overall Study||37|(treatment completed)|
48262205|NCT04092452|100962870|FG003|COMPLETED|Overall Study||31|(treatment completed)|
48262206|NCT04092452|100962867|FG000|NOT COMPLETED|Overall Study||13||
48544838|NCT02740114|101671203|FG001|STARTED|Overall Study||48||
48544839|NCT02740114|101671202|FG000|COMPLETED|Overall Study||54||
48544840|NCT02740114|101671203|FG001|COMPLETED|Overall Study||48||
48544841|NCT02740114|101671202|FG000|NOT COMPLETED|Overall Study||0||
48544842|NCT02740114|101671203|FG001|NOT COMPLETED|Overall Study||0||
48544843|NCT00796107|101671204|FG000|STARTED|Overall Study||6||
48544844|NCT00796107|101671204|FG000|COMPLETED|Overall Study||0||
48544845|NCT00796107|101671204|FG000|NOT COMPLETED|Overall Study||6||
48544846|NCT03649347|101671205|FG000|STARTED|Overall Study||13||
48544847|NCT03649347|101671206|FG001|STARTED|Overall Study||12||
48544848|NCT03649347|101671207|FG002|STARTED|Overall Study||0||
48544849|NCT03649347|101671208|FG003|STARTED|Overall Study||0||
48544850|NCT03649347|101671205|FG000|COMPLETED|Overall Study||13||
48544851|NCT03649347|101671206|FG001|COMPLETED|Overall Study||12||
48544852|NCT03649347|101671207|FG002|COMPLETED|Overall Study||0||
48544853|NCT03649347|101671208|FG003|COMPLETED|Overall Study||0||
48544854|NCT03649347|101671205|FG000|NOT COMPLETED|Overall Study||0||
48544855|NCT03649347|101671206|FG001|NOT COMPLETED|Overall Study||0||
48544856|NCT03649347|101671207|FG002|NOT COMPLETED|Overall Study||0||
48544857|NCT03649347|101671208|FG003|NOT COMPLETED|Overall Study||0||
48544858|NCT01669603|101671209|FG000|STARTED|Overall Study||95||
48544859|NCT01669603|101671210|FG001|STARTED|Overall Study||95||
48544860|NCT01669603|101671209|FG000|COMPLETED|Overall Study||58||
48544861|NCT01669603|101671210|FG001|COMPLETED|Overall Study||57||
48544862|NCT01669603|101671209|FG000|NOT COMPLETED|Overall Study||37||
48544863|NCT01669603|101671210|FG001|NOT COMPLETED|Overall Study||38||
48544864|NCT04277962|101671211|FG000|STARTED|Overall Study||0||
48544865|NCT04277962|101671211|FG000|COMPLETED|Overall Study||0||
48544866|NCT04277962|101671211|FG000|NOT COMPLETED|Overall Study||0||
48544867|NCT01121562|101671212|FG000|STARTED|Overall Study||12||
48544868|NCT01121562|101671212|FG000|COMPLETED|Overall Study||0||
48544869|NCT01121562|101671212|FG000|NOT COMPLETED|Overall Study||12||
48544870|NCT00582660|101671213|FG000|STARTED|Overall Study||20||
48544871|NCT00582660|101671214|FG001|STARTED|Overall Study||20||
48262207|NCT04092452|100962868|FG001|NOT COMPLETED|Overall Study||17||
48262208|NCT04092452|100962869|FG002|NOT COMPLETED|Overall Study||15||
48262209|NCT04092452|100962870|FG003|NOT COMPLETED|Overall Study||16||
48262210|NCT00723749|100962871|FG000|STARTED|Overall Study||345||
48544872|NCT00582660|101671213|FG000|COMPLETED|Overall Study||20||
48544873|NCT00582660|101671214|FG001|COMPLETED|Overall Study||20||
48544874|NCT00582660|101671213|FG000|NOT COMPLETED|Overall Study||0||
48544875|NCT00582660|101671214|FG001|NOT COMPLETED|Overall Study||0||
48544876|NCT03785327|101671215|FG000|STARTED|Overall Study||0||
48544877|NCT03785327|101671216|FG001|STARTED|Overall Study||0||
48544878|NCT03785327|101671217|FG002|STARTED|Overall Study||38||
48544879|NCT03785327|101671218|FG003|STARTED|Overall Study||40||
48544880|NCT03785327|101671215|FG000|COMPLETED|Overall Study||0||
48690488|NCT00394329|102025849|FG003|NOT COMPLETED|Overall Study||24||
48690489|NCT01861704|102025850|FG000|STARTED|Overall Study||70||
48690490|NCT01861704|102025851|FG001|STARTED|Overall Study||107||
48690491|NCT01861704|102025850|FG000|COMPLETED|Overall Study||67||
48690492|NCT01861704|102025851|FG001|COMPLETED|Overall Study||104||
48690493|NCT01861704|102025850|FG000|NOT COMPLETED|Overall Study||3||
48690494|NCT01861704|102025851|FG001|NOT COMPLETED|Overall Study||3||
48690495|NCT01279044|102025852|FG000|STARTED|PHASE 1 - Formative||59||
48690496|NCT01279044|102025853|FG001|STARTED|PHASE 1 - Formative||0||
48544881|NCT03785327|101671216|FG001|COMPLETED|Overall Study||0||
48544882|NCT03785327|101671217|FG002|COMPLETED|Overall Study||38||
48544883|NCT03785327|101671218|FG003|COMPLETED|Overall Study||40||
48544884|NCT03785327|101671215|FG000|NOT COMPLETED|Overall Study||0||
48544885|NCT03785327|101671216|FG001|NOT COMPLETED|Overall Study||0||
48544886|NCT03785327|101671217|FG002|NOT COMPLETED|Overall Study||0||
48544887|NCT03785327|101671218|FG003|NOT COMPLETED|Overall Study||0||
48544888|NCT01911897|101671219|FG000|STARTED|Overall Study||30||
48262211|NCT00723749|100962871|FG000|COMPLETED|Overall Study||182||
48262212|NCT00723749|100962871|FG000|NOT COMPLETED|Overall Study||163||
48262213|NCT00302159|100962872|FG000|STARTED|Overall Study||43||
48262214|NCT00302159|100962872|FG000|COMPLETED|Overall Study||41||
48262215|NCT00302159|100962872|FG000|NOT COMPLETED|Overall Study||2||
48262216|NCT03790306|100962873|FG000|STARTED|Overall Study||207||
48262217|NCT03790306|100962873|FG000|COMPLETED|Overall Study||207||
48262218|NCT03790306|100962873|FG000|NOT COMPLETED|Overall Study||0||
48262219|NCT01150461|100962874|FG000|STARTED|Overall Study||11||
48262220|NCT01150461|100962875|FG001|STARTED|Overall Study||9||
48262221|NCT01150461|100962874|FG000|COMPLETED|Overall Study||11||
48262222|NCT01150461|100962875|FG001|COMPLETED|Overall Study||9||
48262223|NCT01150461|100962874|FG000|NOT COMPLETED|Overall Study||0||
48262224|NCT01150461|100962875|FG001|NOT COMPLETED|Overall Study||0||
48262225|NCT02643628|100962876|FG000|STARTED|Overall Study||21||
48262226|NCT02643628|100962877|FG001|STARTED|Overall Study||23||
48262227|NCT02643628|100962876|FG000|COMPLETED|Overall Study||20||
48262228|NCT02643628|100962877|FG001|COMPLETED|Overall Study||17||
48262229|NCT02643628|100962876|FG000|NOT COMPLETED|Overall Study||1||
48262230|NCT02643628|100962877|FG001|NOT COMPLETED|Overall Study||6||
48262231|NCT01952847|100962878|FG000|STARTED|Overall Study||27||
48262232|NCT01952847|100962879|FG001|STARTED|Overall Study||26||
48262233|NCT01952847|100962880|FG002|STARTED|Overall Study||7||
48262234|NCT01952847|100962881|FG003|STARTED|Overall Study||7||
48262235|NCT01952847|100962878|FG000|COMPLETED|Overall Study||25||
48262236|NCT01952847|100962879|FG001|COMPLETED|Overall Study||24||
48262237|NCT01952847|100962880|FG002|COMPLETED|Overall Study||7||
48262238|NCT01952847|100962881|FG003|COMPLETED|Overall Study||6||
48262239|NCT01952847|100962878|FG000|NOT COMPLETED|Overall Study||2||
48262240|NCT01952847|100962879|FG001|NOT COMPLETED|Overall Study||2||
48262241|NCT01952847|100962880|FG002|NOT COMPLETED|Overall Study||0||
48262242|NCT01952847|100962881|FG003|NOT COMPLETED|Overall Study||1||
48262243|NCT00992992|100962882|FG000|STARTED|Overall Study||25||
48262244|NCT00992992|100962882|FG000|COMPLETED|Overall Study||0||
48262245|NCT00992992|100962882|FG000|NOT COMPLETED|Overall Study||25||
48262246|NCT02719743|100962883|FG000|STARTED|Overall Study||38||
48262247|NCT02719743|100962884|FG001|STARTED|Overall Study||37||
48262248|NCT02719743|100962885|FG002|STARTED|Overall Study||38||
48262249|NCT02719743|100962886|FG003|STARTED|Overall Study||37||
48262250|NCT02719743|100962887|FG004|STARTED|Overall Study||35||
48262251|NCT02719743|100962883|FG000|COMPLETED|Overall Study||37||
48262252|NCT02719743|100962884|FG001|COMPLETED|Overall Study||34||
48262253|NCT02719743|100962885|FG002|COMPLETED|Overall Study||38||
48262254|NCT02719743|100962886|FG003|COMPLETED|Overall Study||36||
48262255|NCT02719743|100962887|FG004|COMPLETED|Overall Study||33||
48262256|NCT02719743|100962883|FG000|NOT COMPLETED|Overall Study||1||
48262257|NCT02719743|100962884|FG001|NOT COMPLETED|Overall Study||3||
48262258|NCT02719743|100962885|FG002|NOT COMPLETED|Overall Study||0||
48262259|NCT02719743|100962886|FG003|NOT COMPLETED|Overall Study||1||
48262260|NCT02719743|100962887|FG004|NOT COMPLETED|Overall Study||2||
48262261|NCT01392703|100962888|FG000|STARTED|Day 1||26||
48544889|NCT01911897|101671219|FG000|COMPLETED|Overall Study||27||
48544890|NCT01911897|101671219|FG000|NOT COMPLETED|Overall Study||3||
48544891|NCT01174043|101671220|FG000|STARTED|Overall Study||11||
48544892|NCT01174043|101671220|FG000|COMPLETED|Overall Study||0||
48544893|NCT01174043|101671220|FG000|NOT COMPLETED|Overall Study||11||
48544894|NCT02229474|101671221|FG000|STARTED|Overall Study||16||
48544895|NCT02229474|101671222|FG001|STARTED|Overall Study||18||
48544896|NCT02229474|101671221|FG000|COMPLETED|Overall Study||16||
48544897|NCT02229474|101671222|FG001|COMPLETED|Overall Study||15||
48262262|NCT01392703|100962889|FG001|STARTED|Day 1||26||
48262263|NCT01392703|100962890|FG002|STARTED|Day 1||26||
48544898|NCT02229474|101671221|FG000|NOT COMPLETED|Overall Study||0||
48262264|NCT01392703|100962888|FG000|COMPLETED|Day 1||26||
48262265|NCT01392703|100962889|FG001|COMPLETED|Day 1||26||
48544899|NCT02229474|101671222|FG001|NOT COMPLETED|Overall Study||3||
48262266|NCT01392703|100962890|FG002|COMPLETED|Day 1||26||
48262267|NCT01392703|100962888|FG000|NOT COMPLETED|Day 1||0||
48262268|NCT01392703|100962889|FG001|NOT COMPLETED|Day 1||0||
48262269|NCT01392703|100962890|FG002|NOT COMPLETED|Day 1||0||
48262270|NCT01392703|100962888|FG000|STARTED|Day 5||26||
48262271|NCT01392703|100962889|FG001|STARTED|Day 5||25||
48544900|NCT01098487|101671223|FG000|STARTED|Overall Study||162||
48544901|NCT01098487|101671223|FG000|COMPLETED|Overall Study||118||
48544902|NCT01098487|101671223|FG000|NOT COMPLETED|Overall Study||44||
48262272|NCT01392703|100962890|FG002|STARTED|Day 5||26||
48262273|NCT01392703|100962888|FG000|COMPLETED|Day 5||26||
48262274|NCT01392703|100962889|FG001|COMPLETED|Day 5||25||
48544903|NCT00799825|101671224|FG000|STARTED|Overall Study||344||
48544904|NCT00799825|101671224|FG000|COMPLETED|Overall Study||296||
48544905|NCT00799825|101671224|FG000|NOT COMPLETED|Overall Study||48||
48544906|NCT02089659|101671225|FG000|STARTED|Overall Study||8||
48544907|NCT02089659|101671226|FG001|STARTED|Overall Study||8||
48544908|NCT02089659|101671227|FG002|STARTED|Overall Study||0||
48544909|NCT02089659|101671225|FG000|COMPLETED|Overall Study||8||
48544910|NCT02089659|101671226|FG001|COMPLETED|Overall Study||8||
48544911|NCT02089659|101671227|FG002|COMPLETED|Overall Study||0||
48544912|NCT02089659|101671225|FG000|NOT COMPLETED|Overall Study||0||
48690497|NCT01279044|102025854|FG002|STARTED|PHASE 1 - Formative||0||
48690498|NCT01279044|102025852|FG000|COMPLETED|PHASE 1 - Formative||59||
48690499|NCT01279044|102025853|FG001|COMPLETED|PHASE 1 - Formative||0||
48690500|NCT01279044|102025854|FG002|COMPLETED|PHASE 1 - Formative||0||
48262275|NCT01392703|100962890|FG002|COMPLETED|Day 5||26||
48262276|NCT01392703|100962888|FG000|NOT COMPLETED|Day 5||0||
48262277|NCT01392703|100962889|FG001|NOT COMPLETED|Day 5||0||
48262278|NCT01392703|100962890|FG002|NOT COMPLETED|Day 5||0||
48262279|NCT01392703|100962888|FG000|STARTED|Day 9||26||
48262280|NCT01392703|100962889|FG001|STARTED|Day 9||26||
48544913|NCT02089659|101671226|FG001|NOT COMPLETED|Overall Study||0||
48544914|NCT02089659|101671227|FG002|NOT COMPLETED|Overall Study||0||
48544915|NCT01109147|101671228|FG000|STARTED|Overall Study||17||
48544916|NCT01109147|101671229|FG001|STARTED|Overall Study||14||
48544917|NCT01109147|101671230|FG002|STARTED|Overall Study||36||
48544918|NCT01109147|101671228|FG000|COMPLETED|Overall Study||15||
48544919|NCT01109147|101671229|FG001|COMPLETED|Overall Study||11||
48544920|NCT01109147|101671230|FG002|COMPLETED|Overall Study||26||
48544921|NCT01109147|101671228|FG000|NOT COMPLETED|Overall Study||2||
48544922|NCT01109147|101671229|FG001|NOT COMPLETED|Overall Study||3||
48544923|NCT01109147|101671230|FG002|NOT COMPLETED|Overall Study||10||
48544924|NCT02029196|101671231|FG000|STARTED|Overall Study||306||
48544925|NCT02029196|101671232|FG001|STARTED|Overall Study||102||
48544926|NCT02029196|101671231|FG000|COMPLETED|Overall Study||286||
48544927|NCT02029196|101671232|FG001|COMPLETED|Overall Study||101||
48544928|NCT02029196|101671231|FG000|NOT COMPLETED|Overall Study||20||
48544929|NCT02029196|101671232|FG001|NOT COMPLETED|Overall Study||1||
48544930|NCT03331835|101671233|FG000|STARTED|Overall Study||105||
48544931|NCT03331835|101671234|FG001|STARTED|Overall Study||105||
48544932|NCT03331835|101671233|FG000|COMPLETED|Overall Study||91||
48544933|NCT03331835|101671234|FG001|COMPLETED|Overall Study||58||
48544934|NCT03331835|101671233|FG000|NOT COMPLETED|Overall Study||14||
48544935|NCT03331835|101671234|FG001|NOT COMPLETED|Overall Study||47||
48544936|NCT00125515|101671235|FG000|STARTED|Overall Study||27||
48544937|NCT00125515|101671236|FG001|STARTED|Overall Study||27||
48544938|NCT00125515|101671237|FG002|STARTED|Overall Study||27||
48544939|NCT00125515|101671235|FG000|COMPLETED|Overall Study||7||
48544940|NCT00125515|101671236|FG001|COMPLETED|Overall Study||7||
48544941|NCT00125515|101671237|FG002|COMPLETED|Overall Study||6||
48262281|NCT01392703|100962890|FG002|STARTED|Day 9||25||
48262282|NCT01392703|100962888|FG000|COMPLETED|Day 9||26||
48544942|NCT00125515|101671235|FG000|NOT COMPLETED|Overall Study||20||
48544943|NCT00125515|101671236|FG001|NOT COMPLETED|Overall Study||20||
48544944|NCT00125515|101671237|FG002|NOT COMPLETED|Overall Study||21||
48544945|NCT01783912|101671238|FG000|STARTED|Overall Study||118||
48544946|NCT01783912|101671239|FG001|STARTED|Overall Study||104||
48544947|NCT01783912|101671240|FG002|STARTED|Overall Study||48||
48544948|NCT01783912|101671238|FG000|COMPLETED|Overall Study||88||
48544949|NCT01783912|101671239|FG001|COMPLETED|Overall Study||58||
48544950|NCT01783912|101671240|FG002|COMPLETED|Overall Study||25||
48262283|NCT01392703|100962889|FG001|COMPLETED|Day 9||26||
48262284|NCT01392703|100962890|FG002|COMPLETED|Day 9||25||
48262285|NCT01392703|100962888|FG000|NOT COMPLETED|Day 9||0||
48262286|NCT01392703|100962889|FG001|NOT COMPLETED|Day 9||0||
48262287|NCT01392703|100962890|FG002|NOT COMPLETED|Day 9||0||
48262288|NCT04919070|100962891|FG000|STARTED|Overall Study||5||
48262289|NCT04919070|100962891|FG000|COMPLETED|Overall Study||5||
48262290|NCT04919070|100962891|FG000|NOT COMPLETED|Overall Study||0||
48262291|NCT00113269|100962892|FG000|STARTED|Overall Study||76||
48544951|NCT01783912|101671238|FG000|NOT COMPLETED|Overall Study||30||
48544952|NCT01783912|101671239|FG001|NOT COMPLETED|Overall Study||46||
48544953|NCT01783912|101671240|FG002|NOT COMPLETED|Overall Study||23||
48544954|NCT00810511|101671241|FG000|STARTED|Overall Study||107||
48544955|NCT00810511|101671242|FG001|STARTED|Overall Study||106||
48544956|NCT00810511|101671241|FG000|COMPLETED|Overall Study||97||
48544957|NCT00810511|101671242|FG001|COMPLETED|Overall Study||102||
48544958|NCT00810511|101671241|FG000|NOT COMPLETED|Overall Study||10||
48544959|NCT00810511|101671242|FG001|NOT COMPLETED|Overall Study||4||
48690501|NCT01279044|102025852|FG000|NOT COMPLETED|PHASE 1 - Formative||0||
48690502|NCT01279044|102025853|FG001|NOT COMPLETED|PHASE 1 - Formative||0||
48690503|NCT01279044|102025854|FG002|NOT COMPLETED|PHASE 1 - Formative||0||
48690504|NCT01279044|102025852|FG000|STARTED|PHASE 2 - Randmonized Controlled Trial||0||
48690505|NCT01279044|102025853|FG001|STARTED|PHASE 2 - Randmonized Controlled Trial||162||
48690506|NCT01279044|102025854|FG002|STARTED|PHASE 2 - Randmonized Controlled Trial||164||
48544960|NCT03907657|101671243|FG000|STARTED|Overall Study Subjects||15||
48544961|NCT03907657|101671243|FG000|COMPLETED|Overall Study Subjects||15||
48544962|NCT03907657|101671243|FG000|NOT COMPLETED|Overall Study Subjects||0||
48544963|NCT03907657|101671243|FG000|STARTED|CEUS||15||
48544964|NCT03907657|101671243|FG000|COMPLETED|CEUS||15||
48544965|NCT03907657|101671243|FG000|NOT COMPLETED|CEUS||0||
48544966|NCT03907657|101671243|FG000|STARTED|B Mode||15||
48544967|NCT03907657|101671243|FG000|COMPLETED|B Mode||15||
48544968|NCT03907657|101671243|FG000|NOT COMPLETED|B Mode||0||
48544969|NCT00940316|101671244|FG000|STARTED|Reached First Response at 8 Weeks||13||
48544970|NCT00940316|101671245|FG001|STARTED|Reached First Response at 8 Weeks||13||
48544971|NCT00940316|101671246|FG002|STARTED|Reached First Response at 8 Weeks||2||
48544972|NCT00940316|101671244|FG000|COMPLETED|Reached First Response at 8 Weeks||10||
48544973|NCT00940316|101671245|FG001|COMPLETED|Reached First Response at 8 Weeks||9||
48544974|NCT00940316|101671246|FG002|COMPLETED|Reached First Response at 8 Weeks||2||
48544975|NCT00940316|101671244|FG000|NOT COMPLETED|Reached First Response at 8 Weeks||3||
48544976|NCT00940316|101671245|FG001|NOT COMPLETED|Reached First Response at 8 Weeks||4||
48544977|NCT00940316|101671246|FG002|NOT COMPLETED|Reached First Response at 8 Weeks||0||
48544978|NCT00940316|101671244|FG000|STARTED|Moved on to be Treated Cycle 5||10||
48544979|NCT00940316|101671245|FG001|STARTED|Moved on to be Treated Cycle 5||9||
48544980|NCT00940316|101671246|FG002|STARTED|Moved on to be Treated Cycle 5||2||
48544981|NCT00940316|101671244|FG000|COMPLETED|Moved on to be Treated Cycle 5||8||
48544982|NCT00940316|101671245|FG001|COMPLETED|Moved on to be Treated Cycle 5||9||
48544983|NCT00940316|101671246|FG002|COMPLETED|Moved on to be Treated Cycle 5||2||
48544984|NCT00940316|101671244|FG000|NOT COMPLETED|Moved on to be Treated Cycle 5||2||
48544985|NCT00940316|101671245|FG001|NOT COMPLETED|Moved on to be Treated Cycle 5||0||
48544986|NCT00940316|101671246|FG002|NOT COMPLETED|Moved on to be Treated Cycle 5||0||
48544987|NCT00940316|101671244|FG000|STARTED|Treated After Cycle 5||8||
48544988|NCT00940316|101671245|FG001|STARTED|Treated After Cycle 5||9||
48544989|NCT00940316|101671246|FG002|STARTED|Treated After Cycle 5||2||
48544990|NCT00940316|101671244|FG000|COMPLETED|Treated After Cycle 5||8||
48544991|NCT00940316|101671245|FG001|COMPLETED|Treated After Cycle 5||8||
48544992|NCT00940316|101671246|FG002|COMPLETED|Treated After Cycle 5||1||
48544993|NCT00940316|101671244|FG000|NOT COMPLETED|Treated After Cycle 5||0||
48544994|NCT00940316|101671245|FG001|NOT COMPLETED|Treated After Cycle 5||1||
48544995|NCT00940316|101671246|FG002|NOT COMPLETED|Treated After Cycle 5||1||
48544996|NCT00940316|101671244|FG000|STARTED|Crossed Over to Arm A After Progression||0|Patients on Arm B that progressed were able to cross over and be treated on arm A if still eligible.|
48544997|NCT00940316|101671245|FG001|STARTED|Crossed Over to Arm A After Progression||3|Patients on Arm B that progressed were able to cross over and be treated on arm A if still eligible.|
48544998|NCT00940316|101671246|FG002|STARTED|Crossed Over to Arm A After Progression||0|Patients on Arm B that progressed were able to cross over and be treated on arm A if still eligible.|
48544999|NCT00940316|101671244|FG000|Treated for Cycle One|Crossed Over to Arm A After Progression||0||
48545000|NCT00940316|101671245|FG001|Treated for Cycle One|Crossed Over to Arm A After Progression||3||
48545001|NCT00940316|101671246|FG002|Treated for Cycle One|Crossed Over to Arm A After Progression||0||
48545002|NCT00940316|101671244|FG000|COMPLETED|Crossed Over to Arm A After Progression||0||
48545003|NCT00940316|101671245|FG001|COMPLETED|Crossed Over to Arm A After Progression||3||
48545004|NCT00940316|101671246|FG002|COMPLETED|Crossed Over to Arm A After Progression||0||
48545005|NCT00940316|101671244|FG000|NOT COMPLETED|Crossed Over to Arm A After Progression||0||
48545006|NCT00940316|101671245|FG001|NOT COMPLETED|Crossed Over to Arm A After Progression||0||
48545007|NCT00940316|101671246|FG002|NOT COMPLETED|Crossed Over to Arm A After Progression||0||
48545008|NCT00940316|101671244|FG000|STARTED|Follow up Every 3 Months||13|All patients that receive treatment on the study go into follow up at treatment completion.|
48545009|NCT00940316|101671245|FG001|STARTED|Follow up Every 3 Months||13|All patients that receive treatment on the study go into follow up at treatment completion.|
48545010|NCT00940316|101671246|FG002|STARTED|Follow up Every 3 Months||2|All patients that receive treatment on the study go into follow up at treatment completion.|
48545011|NCT00940316|101671244|FG000|COMPLETED|Follow up Every 3 Months||13||
48545012|NCT00940316|101671245|FG001|COMPLETED|Follow up Every 3 Months||13||
48545013|NCT00940316|101671246|FG002|COMPLETED|Follow up Every 3 Months||2||
48545014|NCT00940316|101671244|FG000|NOT COMPLETED|Follow up Every 3 Months||0||
48545015|NCT00940316|101671245|FG001|NOT COMPLETED|Follow up Every 3 Months||0||
48545016|NCT00940316|101671246|FG002|NOT COMPLETED|Follow up Every 3 Months||0||
48545017|NCT04936035|101671247|FG000|STARTED|Overall Study||76||
48545018|NCT04936035|101671248|FG001|STARTED|Overall Study||78||
48690507|NCT01279044|102025852|FG000|COMPLETED|PHASE 2 - Randmonized Controlled Trial||0||
48690508|NCT01279044|102025853|FG001|COMPLETED|PHASE 2 - Randmonized Controlled Trial||151||
48545019|NCT04936035|101671249|FG002|STARTED|Overall Study||73||
48545020|NCT04936035|101671250|FG003|STARTED|Overall Study||75||
48545021|NCT04936035|101671251|FG004|STARTED|Overall Study||76||
48545022|NCT04936035|101671247|FG000|COMPLETED|Overall Study||70||
48545023|NCT04936035|101671248|FG001|COMPLETED|Overall Study||70||
48545024|NCT04936035|101671249|FG002|COMPLETED|Overall Study||70||
48690509|NCT01279044|102025854|FG002|COMPLETED|PHASE 2 - Randmonized Controlled Trial||161||
48690510|NCT01279044|102025852|FG000|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||0||
48690511|NCT01279044|102025853|FG001|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||11||
48545025|NCT04936035|101671250|FG003|COMPLETED|Overall Study||68||
48545026|NCT04936035|101671251|FG004|COMPLETED|Overall Study||69||
48545027|NCT04936035|101671247|FG000|NOT COMPLETED|Overall Study||6||
48545028|NCT04936035|101671248|FG001|NOT COMPLETED|Overall Study||8||
48545029|NCT04936035|101671249|FG002|NOT COMPLETED|Overall Study||3||
48545030|NCT04936035|101671250|FG003|NOT COMPLETED|Overall Study||7||
48545031|NCT04936035|101671251|FG004|NOT COMPLETED|Overall Study||7||
48545032|NCT02445963|101671252|FG000|STARTED|Overall Study||9||
48545033|NCT02445963|101671253|FG001|STARTED|Overall Study||9||
48545034|NCT02445963|101671254|FG002|STARTED|Overall Study||10||
48545035|NCT02445963|101671255|FG003|STARTED|Overall Study||10||
48545036|NCT02445963|101671252|FG000|COMPLETED|Overall Study||7||
48545037|NCT02445963|101671253|FG001|COMPLETED|Overall Study||9||
48545038|NCT02445963|101671254|FG002|COMPLETED|Overall Study||9||
48545039|NCT02445963|101671255|FG003|COMPLETED|Overall Study||10||
48545040|NCT02445963|101671252|FG000|NOT COMPLETED|Overall Study||2||
48545041|NCT02445963|101671253|FG001|NOT COMPLETED|Overall Study||0||
48545042|NCT02445963|101671254|FG002|NOT COMPLETED|Overall Study||1||
48545043|NCT02445963|101671255|FG003|NOT COMPLETED|Overall Study||0||
48545044|NCT00582010|101671256|FG000|STARTED|Overall Study||40||
48545045|NCT00582010|101671257|FG001|STARTED|Overall Study||40||
48545046|NCT00582010|101671256|FG000|COMPLETED|Overall Study||40||
48545047|NCT00582010|101671257|FG001|COMPLETED|Overall Study||39||
48545048|NCT00582010|101671256|FG000|NOT COMPLETED|Overall Study||0||
48545049|NCT00582010|101671257|FG001|NOT COMPLETED|Overall Study||1||
48545050|NCT01769456|101671258|FG000|STARTED|Overall Study||78||
48545051|NCT01769456|101671258|FG000|COMPLETED|Overall Study||41||
48545052|NCT01769456|101671258|FG000|NOT COMPLETED|Overall Study||37||
48545053|NCT02467478|101671259|FG000|STARTED|Overall Study||17||
48545054|NCT02467478|101671260|FG001|STARTED|Overall Study||14||
48545055|NCT02467478|101671259|FG000|COMPLETED|Overall Study||17||
48545056|NCT02467478|101671260|FG001|COMPLETED|Overall Study||14||
48545057|NCT02467478|101671259|FG000|NOT COMPLETED|Overall Study||0||
48545058|NCT02467478|101671260|FG001|NOT COMPLETED|Overall Study||0||
48545059|NCT01371539|101671261|FG000|STARTED|Period One: One Week||53||
48545060|NCT01371539|101671262|FG001|STARTED|Period One: One Week||51||
48545061|NCT01371539|101671261|FG000|COMPLETED|Period One: One Week||53||
48545062|NCT01371539|101671262|FG001|COMPLETED|Period One: One Week||50||
48545063|NCT01371539|101671261|FG000|NOT COMPLETED|Period One: One Week||0||
48545064|NCT01371539|101671262|FG001|NOT COMPLETED|Period One: One Week||1||
48545065|NCT01371539|101671261|FG000|STARTED|Period Two: One Week||53||
48545066|NCT01371539|101671262|FG001|STARTED|Period Two: One Week||50||
48545067|NCT01371539|101671261|FG000|COMPLETED|Period Two: One Week||53||
48545068|NCT01371539|101671262|FG001|COMPLETED|Period Two: One Week||47||
48545069|NCT01371539|101671261|FG000|NOT COMPLETED|Period Two: One Week||0||
48545070|NCT01371539|101671262|FG001|NOT COMPLETED|Period Two: One Week||3||
48545071|NCT02279108|101671263|FG000|STARTED|Overall Study||50||
48545072|NCT02279108|101671264|FG001|STARTED|Overall Study||50||
48545073|NCT02279108|101671263|FG000|COMPLETED|Overall Study||50||
48545074|NCT02279108|101671264|FG001|COMPLETED|Overall Study||49||
48545075|NCT02279108|101671263|FG000|NOT COMPLETED|Overall Study||0||
48545076|NCT02279108|101671264|FG001|NOT COMPLETED|Overall Study||1||
48545077|NCT02806024|101671265|FG000|STARTED|Overall Study||7||
48545078|NCT02806024|101671266|FG001|STARTED|Overall Study||7||
48545079|NCT02806024|101671265|FG000|COMPLETED|Overall Study||6||
48545080|NCT02806024|101671266|FG001|COMPLETED|Overall Study||5||
48545081|NCT02806024|101671265|FG000|NOT COMPLETED|Overall Study||1||
48545082|NCT02806024|101671266|FG001|NOT COMPLETED|Overall Study||2||
48545083|NCT05513391|101671267|FG000|STARTED|Overall Study||183||
48545084|NCT05513391|101671268|FG001|STARTED|Overall Study||183||
48545085|NCT05513391|101671267|FG000|Safety Analysis Set|Overall Study||181|Safety analysis set included participants who received at least 1 dose of the study vaccine.|
48545086|NCT05513391|101671268|FG001|Safety Analysis Set|Overall Study||181|Safety analysis set included participants who received at least 1 dose of the study vaccine.|
48545087|NCT05513391|101671267|FG000|COMPLETED|Overall Study||177||
48545088|NCT05513391|101671268|FG001|COMPLETED|Overall Study||177||
48545089|NCT05513391|101671267|FG000|NOT COMPLETED|Overall Study||6||
48545090|NCT05513391|101671268|FG001|NOT COMPLETED|Overall Study||6||
48545091|NCT01118975|101671269|FG000|STARTED|Overall Study||9||
48545092|NCT01118975|101671270|FG001|STARTED|Overall Study||3||
48545093|NCT01118975|101671269|FG000|COMPLETED|Overall Study||9||
48545094|NCT01118975|101671270|FG001|COMPLETED|Overall Study||2||
48545095|NCT01118975|101671269|FG000|NOT COMPLETED|Overall Study||0||
48545096|NCT01118975|101671270|FG001|NOT COMPLETED|Overall Study||1||
48545097|NCT00380744|101671271|FG000|STARTED|Overall Study||20||
48545098|NCT00380744|101671272|FG001|STARTED|Overall Study||4||
48545099|NCT00380744|101671273|FG002|STARTED|Overall Study||20||
48545100|NCT00380744|101671274|FG003|STARTED|Overall Study||4||
48545101|NCT00380744|101671275|FG004|STARTED|Overall Study||23||
48545102|NCT00380744|101671276|FG005|STARTED|Overall Study||25||
48545103|NCT00380744|101671277|FG006|STARTED|Overall Study||25||
48545104|NCT00380744|101671271|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20||
48545105|NCT00380744|101671272|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4||
48545106|NCT00380744|101671273|FG002|Received at Least 1 Dose of Study Drug|Overall Study||20||
48545107|NCT00380744|101671274|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4||
48545108|NCT00380744|101671275|FG004|Received at Least 1 Dose of Study Drug|Overall Study||23||
48545109|NCT00380744|101671276|FG005|Received at Least 1 Dose of Study Drug|Overall Study||25||
48262292|NCT00113269|100962893|FG001|STARTED|Overall Study||70||
48262293|NCT00113269|100962894|FG002|STARTED|Overall Study||175||
48262294|NCT00113269|100962895|FG003|STARTED|Overall Study||180||
48262295|NCT00113269|100962892|FG000|Received Treatment|Overall Study||70||
48262296|NCT00113269|100962893|FG001|Received Treatment|Overall Study||69||
48262297|NCT00113269|100962894|FG002|Received Treatment|Overall Study||164||
48262298|NCT00113269|100962895|FG003|Received Treatment|Overall Study||171||
48262299|NCT00113269|100962892|FG000|COMPLETED|Overall Study||51||
48262300|NCT00113269|100962893|FG001|COMPLETED|Overall Study||48||
48262301|NCT00113269|100962894|FG002|COMPLETED|Overall Study||134||
48262302|NCT00113269|100962895|FG003|COMPLETED|Overall Study||140||
48262303|NCT00113269|100962892|FG000|NOT COMPLETED|Overall Study||25||
48262304|NCT00113269|100962893|FG001|NOT COMPLETED|Overall Study||22||
48262305|NCT00113269|100962894|FG002|NOT COMPLETED|Overall Study||41||
48262306|NCT00113269|100962895|FG003|NOT COMPLETED|Overall Study||40||
48262307|NCT00784147|100962896|FG000|STARTED|Overall Study||59||
48262308|NCT00784147|100962897|FG001|STARTED|Overall Study||54||
48262309|NCT00784147|100962896|FG000|COMPLETED|Overall Study||51||
48262310|NCT00784147|100962897|FG001|COMPLETED|Overall Study||45||
48262311|NCT00784147|100962896|FG000|NOT COMPLETED|Overall Study||8||
48262312|NCT00784147|100962897|FG001|NOT COMPLETED|Overall Study||9||
48262313|NCT02636608|100962898|FG000|STARTED|Overall Study||244||
48262314|NCT02636608|100962898|FG000|Received Treatment|Overall Study||243||
48262315|NCT02636608|100962898|FG000|COMPLETED|Overall Study||233|Completed defined as having an HCV RNA assessment performed at least 10 weeks post-treatment|
48262316|NCT02636608|100962898|FG000|NOT COMPLETED|Overall Study||11||
48262317|NCT00250432|100962899|FG000|STARTED|Overall Study||104||
48262318|NCT00250432|100962900|FG001|STARTED|Overall Study||100||
48262319|NCT00250432|100962899|FG000|COMPLETED|Overall Study||59||
48262320|NCT00250432|100962900|FG001|COMPLETED|Overall Study||53||
48262321|NCT00250432|100962899|FG000|NOT COMPLETED|Overall Study||45||
48262322|NCT00250432|100962900|FG001|NOT COMPLETED|Overall Study||47||
48262323|NCT00511836|100962901|FG000|STARTED|Double-blind Period||16||
48262324|NCT00511836|100962902|FG001|STARTED|Double-blind Period||15||
48262325|NCT00511836|100962901|FG000|COMPLETED|Double-blind Period||15||
48262326|NCT00511836|100962902|FG001|COMPLETED|Double-blind Period||15||
48262327|NCT00511836|100962901|FG000|NOT COMPLETED|Double-blind Period||1||
48262328|NCT00511836|100962902|FG001|NOT COMPLETED|Double-blind Period||0||
48545110|NCT00380744|101671277|FG006|Received at Least 1 Dose of Study Drug|Overall Study||25||
48545111|NCT00380744|101671271|FG000|COMPLETED|Overall Study||19||
48545112|NCT00380744|101671272|FG001|COMPLETED|Overall Study||4||
48545113|NCT00380744|101671273|FG002|COMPLETED|Overall Study||20||
48545114|NCT00380744|101671274|FG003|COMPLETED|Overall Study||4||
48545115|NCT00380744|101671275|FG004|COMPLETED|Overall Study||23||
48545116|NCT00380744|101671276|FG005|COMPLETED|Overall Study||25||
48262329|NCT00511836|100962901|FG000|STARTED|Optional Open-label VIVITROL (2 Months)||22||
48262330|NCT00511836|100962902|FG001|STARTED|Optional Open-label VIVITROL (2 Months)||0||
48262331|NCT00511836|100962901|FG000|COMPLETED|Optional Open-label VIVITROL (2 Months)||6||
48262332|NCT00511836|100962902|FG001|COMPLETED|Optional Open-label VIVITROL (2 Months)||0||
48262333|NCT00511836|100962901|FG000|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||16||
48262334|NCT00511836|100962902|FG001|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||0||
48262335|NCT01130168|100962903|FG000|STARTED|Period 1||6||
48262336|NCT01130168|100962904|FG001|STARTED|Period 1||7||
48262337|NCT01130168|100962905|FG002|STARTED|Period 1||6||
48262338|NCT01130168|100962906|FG003|STARTED|Period 1||8||
48262339|NCT01130168|100962907|FG004|STARTED|Period 1||5||
48262340|NCT01130168|100962908|FG005|STARTED|Period 1||6||
48262341|NCT01130168|100962903|FG000|COMPLETED|Period 1||6||
48262342|NCT01130168|100962904|FG001|COMPLETED|Period 1||6||
48262343|NCT01130168|100962905|FG002|COMPLETED|Period 1||5||
48262344|NCT01130168|100962906|FG003|COMPLETED|Period 1||5||
48262345|NCT01130168|100962907|FG004|COMPLETED|Period 1||5||
48262346|NCT01130168|100962908|FG005|COMPLETED|Period 1||6||
48262347|NCT01130168|100962903|FG000|NOT COMPLETED|Period 1||0||
48262348|NCT01130168|100962904|FG001|NOT COMPLETED|Period 1||1||
48262349|NCT01130168|100962905|FG002|NOT COMPLETED|Period 1||1||
48262350|NCT01130168|100962906|FG003|NOT COMPLETED|Period 1||3||
48262351|NCT01130168|100962907|FG004|NOT COMPLETED|Period 1||0||
48262352|NCT01130168|100962908|FG005|NOT COMPLETED|Period 1||0||
48262353|NCT01130168|100962903|FG000|STARTED|Period 2||6||
48262354|NCT01130168|100962904|FG001|STARTED|Period 2||6||
48262355|NCT01130168|100962905|FG002|STARTED|Period 2||5||
48545117|NCT00380744|101671277|FG006|COMPLETED|Overall Study||24||
48545118|NCT00380744|101671271|FG000|NOT COMPLETED|Overall Study||1||
48545119|NCT00380744|101671272|FG001|NOT COMPLETED|Overall Study||0||
48545120|NCT00380744|101671273|FG002|NOT COMPLETED|Overall Study||0||
48545121|NCT00380744|101671274|FG003|NOT COMPLETED|Overall Study||0||
48545122|NCT00380744|101671275|FG004|NOT COMPLETED|Overall Study||0||
48262356|NCT01130168|100962906|FG003|STARTED|Period 2||5||
48262357|NCT01130168|100962907|FG004|STARTED|Period 2||5||
48262358|NCT01130168|100962908|FG005|STARTED|Period 2||6||
48545123|NCT00380744|101671276|FG005|NOT COMPLETED|Overall Study||0||
48545124|NCT00380744|101671277|FG006|NOT COMPLETED|Overall Study||1||
48545125|NCT02216097|101671278|FG000|STARTED|Overall Study||8||
48262359|NCT01130168|100962903|FG000|COMPLETED|Period 2||6||
48262360|NCT01130168|100962904|FG001|COMPLETED|Period 2||6||
48262361|NCT01130168|100962905|FG002|COMPLETED|Period 2||5||
48262362|NCT01130168|100962906|FG003|COMPLETED|Period 2||5||
48262363|NCT01130168|100962907|FG004|COMPLETED|Period 2||5||
48262364|NCT01130168|100962908|FG005|COMPLETED|Period 2||6||
48262365|NCT01130168|100962903|FG000|NOT COMPLETED|Period 2||0||
48262366|NCT01130168|100962904|FG001|NOT COMPLETED|Period 2||0||
48262367|NCT01130168|100962905|FG002|NOT COMPLETED|Period 2||0||
48262368|NCT01130168|100962906|FG003|NOT COMPLETED|Period 2||0||
48262369|NCT01130168|100962907|FG004|NOT COMPLETED|Period 2||0||
48262370|NCT01130168|100962908|FG005|NOT COMPLETED|Period 2||0||
48262371|NCT01130168|100962903|FG000|STARTED|Period 3||6||
48262372|NCT01130168|100962904|FG001|STARTED|Period 3||6||
48262373|NCT01130168|100962905|FG002|STARTED|Period 3||5||
48262374|NCT01130168|100962906|FG003|STARTED|Period 3||5||
48262375|NCT01130168|100962907|FG004|STARTED|Period 3||5||
48262376|NCT01130168|100962908|FG005|STARTED|Period 3||6||
48262377|NCT01130168|100962903|FG000|COMPLETED|Period 3||6||
48262378|NCT01130168|100962904|FG001|COMPLETED|Period 3||6||
48262379|NCT01130168|100962905|FG002|COMPLETED|Period 3||5||
48262380|NCT01130168|100962906|FG003|COMPLETED|Period 3||5||
48262381|NCT01130168|100962907|FG004|COMPLETED|Period 3||5||
48262382|NCT01130168|100962908|FG005|COMPLETED|Period 3||6||
48262383|NCT01130168|100962903|FG000|NOT COMPLETED|Period 3||0||
48262384|NCT01130168|100962904|FG001|NOT COMPLETED|Period 3||0||
48262385|NCT01130168|100962905|FG002|NOT COMPLETED|Period 3||0||
48545126|NCT02216097|101671279|FG001|STARTED|Overall Study||6||
48545127|NCT02216097|101671278|FG000|COMPLETED|Overall Study||8||
48545128|NCT02216097|101671279|FG001|COMPLETED|Overall Study||6||
48545129|NCT02216097|101671278|FG000|NOT COMPLETED|Overall Study||0||
48545130|NCT02216097|101671279|FG001|NOT COMPLETED|Overall Study||0||
48545131|NCT00786409|101671280|FG000|STARTED|Overall Study||27||
48545132|NCT00786409|101671280|FG000|COMPLETED|Overall Study||20||
48262386|NCT01130168|100962906|FG003|NOT COMPLETED|Period 3||0||
48262387|NCT01130168|100962907|FG004|NOT COMPLETED|Period 3||0||
48262388|NCT01130168|100962908|FG005|NOT COMPLETED|Period 3||0||
48262389|NCT01937026|100962909|FG000|STARTED|Period 1 (Day 1 Through Predose Day 3)||18||
48262390|NCT01937026|100962909|FG000|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||18||
48262391|NCT01937026|100962909|FG000|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||18||
48262392|NCT01937026|100962909|FG000|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0||
48262393|NCT01937026|100962909|FG000|STARTED|Period 2 (At Dosing Day 3 Through Day 8)||18||
48262394|NCT01937026|100962909|FG000|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day 8)||18||
48262395|NCT01937026|100962909|FG000|Received Probenecid on Days 3 Through 7|Period 2 (At Dosing Day 3 Through Day 8)||18||
48262396|NCT01937026|100962909|FG000|COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||18||
48262397|NCT01937026|100962909|FG000|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||0||
48262398|NCT00691600|100962910|FG000|STARTED|Overall Study||12||
48262399|NCT00691600|100962911|FG001|STARTED|Overall Study||11||
48262400|NCT00691600|100962910|FG000|COMPLETED|Overall Study||12||
48262401|NCT00691600|100962911|FG001|COMPLETED|Overall Study||11||
48262402|NCT00691600|100962910|FG000|NOT COMPLETED|Overall Study||0||
48262403|NCT00691600|100962911|FG001|NOT COMPLETED|Overall Study||0||
48262404|NCT01390441|100962912|FG000|STARTED|Treatment Period||23||
48262405|NCT01390441|100962913|FG001|STARTED|Treatment Period||22||
48262406|NCT01390441|100962914|FG002|STARTED|Treatment Period||18||
48262407|NCT01390441|100962915|FG003|STARTED|Treatment Period||19||
48545133|NCT00786409|101671280|FG000|NOT COMPLETED|Overall Study||7||
48545134|NCT00281957|101671281|FG000|STARTED|Overall Study||67||
48545135|NCT00281957|101671282|FG001|STARTED|Overall Study||42||
48545136|NCT00281957|101671281|FG000|Eligible|Overall Study||66||
48545137|NCT00281957|101671282|FG001|Eligible|Overall Study||40||
48545138|NCT00281957|101671281|FG000|Eligible and Received Treatment|Overall Study||63||
48545139|NCT00281957|101671282|FG001|Eligible and Received Treatment|Overall Study||39||
48545140|NCT00281957|101671281|FG000|COMPLETED|Overall Study||0||
48545141|NCT00281957|101671282|FG001|COMPLETED|Overall Study||0||
48262408|NCT01390441|100962916|FG004|STARTED|Treatment Period||18||
48262409|NCT01390441|100962912|FG000|COMPLETED|Treatment Period||22||
48262410|NCT01390441|100962913|FG001|COMPLETED|Treatment Period||21||
48545142|NCT00281957|101671281|FG000|NOT COMPLETED|Overall Study||67||
48545143|NCT00281957|101671282|FG001|NOT COMPLETED|Overall Study||42||
48545144|NCT01650584|101671283|FG000|STARTED|Overall Study||35||70
48545145|NCT01650584|101671283|FG000|ISTA Tears|Overall Study||35||35
48545146|NCT01650584|101671283|FG000|Systane|Overall Study||35||35
48545147|NCT01650584|101671283|FG000|COMPLETED|Overall Study||35||70
48262411|NCT01390441|100962914|FG002|COMPLETED|Treatment Period||8||
48262412|NCT01390441|100962915|FG003|COMPLETED|Treatment Period||6||
48262413|NCT01390441|100962916|FG004|COMPLETED|Treatment Period||7||
48262414|NCT01390441|100962912|FG000|NOT COMPLETED|Treatment Period||1||
48262415|NCT01390441|100962913|FG001|NOT COMPLETED|Treatment Period||1||
48262416|NCT01390441|100962914|FG002|NOT COMPLETED|Treatment Period||10||
48262417|NCT01390441|100962915|FG003|NOT COMPLETED|Treatment Period||13||
48262418|NCT01390441|100962916|FG004|NOT COMPLETED|Treatment Period||11||
48262419|NCT01390441|100962912|FG000|STARTED|Extension Period||15||
48262420|NCT01390441|100962913|FG001|STARTED|Extension Period||13||
48262421|NCT01390441|100962914|FG002|STARTED|Extension Period||1||
48262422|NCT01390441|100962915|FG003|STARTED|Extension Period||1||
48262423|NCT01390441|100962916|FG004|STARTED|Extension Period||3||
48262424|NCT01390441|100962912|FG000|COMPLETED|Extension Period||12||
48262425|NCT01390441|100962913|FG001|COMPLETED|Extension Period||12||
48262426|NCT01390441|100962914|FG002|COMPLETED|Extension Period||1||
48262427|NCT01390441|100962915|FG003|COMPLETED|Extension Period||0||
48262428|NCT01390441|100962916|FG004|COMPLETED|Extension Period||3||
48262429|NCT01390441|100962912|FG000|NOT COMPLETED|Extension Period||3||
48262430|NCT01390441|100962913|FG001|NOT COMPLETED|Extension Period||1||
48262431|NCT01390441|100962914|FG002|NOT COMPLETED|Extension Period||0||
48262432|NCT01390441|100962915|FG003|NOT COMPLETED|Extension Period||1||
48262433|NCT01390441|100962916|FG004|NOT COMPLETED|Extension Period||0||
48262434|NCT00543062|100962917|FG000|STARTED|Overall Study||12||
48262435|NCT00543062|100962918|FG001|STARTED|Overall Study||12||
48262436|NCT00543062|100962919|FG002|STARTED|Overall Study||12||
48262437|NCT00543062|100962920|FG003|STARTED|Overall Study||12||
48262438|NCT00543062|100962917|FG000|COMPLETED|Overall Study||10||
48262439|NCT00543062|100962918|FG001|COMPLETED|Overall Study||11||
48262440|NCT00543062|100962919|FG002|COMPLETED|Overall Study||9||
48262441|NCT00543062|100962920|FG003|COMPLETED|Overall Study||11||
48262442|NCT00543062|100962917|FG000|NOT COMPLETED|Overall Study||2||
48262443|NCT00543062|100962918|FG001|NOT COMPLETED|Overall Study||1||
48262444|NCT00543062|100962919|FG002|NOT COMPLETED|Overall Study||3||
48262445|NCT00543062|100962920|FG003|NOT COMPLETED|Overall Study||1||
48262446|NCT02676843|100962921|FG000|STARTED|Overall Study||7||
48262447|NCT02676843|100962921|FG000|COMPLETED|Overall Study||7||
48262448|NCT02676843|100962921|FG000|NOT COMPLETED|Overall Study||0||
48262449|NCT02706249|100962922|FG000|STARTED|Overall Study||25|Patients consented|
48262450|NCT02706249|100962923|FG001|STARTED|Overall Study||25|Patients consented|
48262451|NCT02706249|100962922|FG000|COMPLETED|Overall Study||23|Evaluated for VTE and safety|
48262452|NCT02706249|100962923|FG001|COMPLETED|Overall Study||24|Evaluated for VTE and safety|
48262453|NCT02706249|100962922|FG000|NOT COMPLETED|Overall Study||2||
48262454|NCT02706249|100962923|FG001|NOT COMPLETED|Overall Study||1||
48262455|NCT03218566|100962924|FG000|STARTED|Overall Study||119||
48262456|NCT03218566|100962924|FG000|COMPLETED|Overall Study||110||
48262457|NCT03218566|100962924|FG000|NOT COMPLETED|Overall Study||9||
48262458|NCT01236352|100962925|FG000|STARTED|Overall Study||4||
48262459|NCT01236352|100962926|FG001|STARTED|Overall Study||4||
48262460|NCT01236352|100962927|FG002|STARTED|Overall Study||4||
48262461|NCT01236352|100962928|FG003|STARTED|Overall Study||4||
48262462|NCT01236352|100962929|FG004|STARTED|Overall Study||4||
48262463|NCT01236352|100962930|FG005|STARTED|Overall Study||4||
48262464|NCT01236352|100962931|FG006|STARTED|Overall Study||8||
48262465|NCT01236352|100962932|FG007|STARTED|Overall Study||7||
48262466|NCT01236352|100962933|FG008|STARTED|Overall Study||3||
48262467|NCT01236352|100962934|FG009|STARTED|Overall Study||22||
48262468|NCT01236352|100962935|FG010|STARTED|Overall Study||20||
48262469|NCT01236352|100962925|FG000|COMPLETED|Overall Study||0||
48262470|NCT01236352|100962926|FG001|COMPLETED|Overall Study||0||
48262471|NCT01236352|100962927|FG002|COMPLETED|Overall Study||0||
48262472|NCT01236352|100962928|FG003|COMPLETED|Overall Study||1||
48262473|NCT01236352|100962929|FG004|COMPLETED|Overall Study||0||
48262474|NCT01236352|100962930|FG005|COMPLETED|Overall Study||0||
48262475|NCT01236352|100962931|FG006|COMPLETED|Overall Study||0||
48262476|NCT01236352|100962932|FG007|COMPLETED|Overall Study||0||
48262477|NCT01236352|100962933|FG008|COMPLETED|Overall Study||0||
48262478|NCT01236352|100962934|FG009|COMPLETED|Overall Study||0||
48262479|NCT01236352|100962935|FG010|COMPLETED|Overall Study||0||
48262480|NCT01236352|100962925|FG000|NOT COMPLETED|Overall Study||4||
48262481|NCT01236352|100962926|FG001|NOT COMPLETED|Overall Study||4||
48262482|NCT01236352|100962927|FG002|NOT COMPLETED|Overall Study||4||
48262483|NCT01236352|100962928|FG003|NOT COMPLETED|Overall Study||3||
48262484|NCT01236352|100962929|FG004|NOT COMPLETED|Overall Study||4||
48262485|NCT01236352|100962930|FG005|NOT COMPLETED|Overall Study||4||
48262486|NCT01236352|100962931|FG006|NOT COMPLETED|Overall Study||8||
48262487|NCT01236352|100962932|FG007|NOT COMPLETED|Overall Study||7||
48262488|NCT01236352|100962933|FG008|NOT COMPLETED|Overall Study||3||
48262489|NCT01236352|100962934|FG009|NOT COMPLETED|Overall Study||22||
48262490|NCT01236352|100962935|FG010|NOT COMPLETED|Overall Study||20||
48262491|NCT01322009|100962936|FG000|STARTED|Overall Study||7||
48262492|NCT01322009|100962937|FG001|STARTED|Overall Study||7||
48262493|NCT01322009|100962936|FG000|COMPLETED|Overall Study||7||
48262494|NCT01322009|100962937|FG001|COMPLETED|Overall Study||4||
48262495|NCT01322009|100962936|FG000|NOT COMPLETED|Overall Study||0||
48262496|NCT01322009|100962937|FG001|NOT COMPLETED|Overall Study||3||
48262497|NCT03178045|100962938|FG000|STARTED|Overall Study||1396||
48262498|NCT03178045|100962939|FG001|STARTED|Overall Study||1397||
48262499|NCT03178045|100962938|FG000|COMPLETED|Overall Study||1310||
48545148|NCT01650584|101671283|FG000|NOT COMPLETED|Overall Study||0||0
48545149|NCT04113785|101671284|FG000|STARTED|Overall Study||21||
48545150|NCT04113785|101671284|FG000|COMPLETED|Overall Study||21||
48545151|NCT04113785|101671284|FG000|NOT COMPLETED|Overall Study||0||
48545152|NCT02391987|101671285|FG000|STARTED|Overall Study||54||
48262500|NCT03178045|100962939|FG001|COMPLETED|Overall Study||1314||
48262501|NCT03178045|100962938|FG000|NOT COMPLETED|Overall Study||86||
48262502|NCT03178045|100962939|FG001|NOT COMPLETED|Overall Study||83||
48262503|NCT03113383|100962940|FG000|STARTED|Overall Study||4||
48262504|NCT03113383|100962941|FG001|STARTED|Overall Study||0||
48262505|NCT03113383|100962940|FG000|COMPLETED|Overall Study||0||
48262506|NCT03113383|100962941|FG001|COMPLETED|Overall Study||0||
48262507|NCT03113383|100962940|FG000|NOT COMPLETED|Overall Study||4||
48262508|NCT03113383|100962941|FG001|NOT COMPLETED|Overall Study||0||
48262509|NCT00909532|100962942|FG000|STARTED|Overall Study||78||
48262510|NCT00909532|100962943|FG001|STARTED|Overall Study||83||
48545153|NCT02391987|101671286|FG001|STARTED|Overall Study||58||
48545154|NCT02391987|101671285|FG000|COMPLETED|Overall Study||54||
48262511|NCT00909532|100962942|FG000|Completed Treatment Period, Week 24|Overall Study||71||
48262512|NCT00909532|100962943|FG001|Completed Treatment Period, Week 24|Overall Study||80||
48262513|NCT00909532|100962942|FG000|COMPLETED|Overall Study||68||
48262514|NCT00909532|100962943|FG001|COMPLETED|Overall Study||77||
48262515|NCT00909532|100962942|FG000|NOT COMPLETED|Overall Study||10||
48262516|NCT00909532|100962943|FG001|NOT COMPLETED|Overall Study||6||
48262517|NCT02630706|100962944|FG000|STARTED|Overall Study||170||
48262518|NCT02630706|100962945|FG001|STARTED|Overall Study||169||
48262519|NCT02630706|100962946|FG002|STARTED|Overall Study||167||
48262520|NCT02630706|100962944|FG000|Treated|Overall Study||170||
48262521|NCT02630706|100962945|FG001|Treated|Overall Study||169||
48262522|NCT02630706|100962946|FG002|Treated|Overall Study||167||
48390295|NCT00892957|101283557|FG000|COMPLETED|Between Postoperative Day 1 and Day 14||70||
48390296|NCT00892957|101283558|FG001|COMPLETED|Between Postoperative Day 1 and Day 14||66||
48390297|NCT00892957|101283557|FG000|NOT COMPLETED|Between Postoperative Day 1 and Day 14||0||
48390298|NCT00892957|101283558|FG001|NOT COMPLETED|Between Postoperative Day 1 and Day 14||4||
48390299|NCT00892957|101283557|FG000|STARTED|Postoperative Day 14 Assessment||68||
48390300|NCT00892957|101283558|FG001|STARTED|Postoperative Day 14 Assessment||66||
48390301|NCT00892957|101283557|FG000|COMPLETED|Postoperative Day 14 Assessment||68||
48390302|NCT00892957|101283558|FG001|COMPLETED|Postoperative Day 14 Assessment||66||
48390303|NCT00892957|101283557|FG000|NOT COMPLETED|Postoperative Day 14 Assessment||0||
48390304|NCT00892957|101283558|FG001|NOT COMPLETED|Postoperative Day 14 Assessment||0||
48390305|NCT00892957|101283557|FG000|STARTED|Postoperative Day 30 Assessment||70||
48390306|NCT00892957|101283558|FG001|STARTED|Postoperative Day 30 Assessment||66||
48390307|NCT00892957|101283557|FG000|COMPLETED|Postoperative Day 30 Assessment||70||
48390308|NCT00892957|101283558|FG001|COMPLETED|Postoperative Day 30 Assessment||66||
48390309|NCT00892957|101283557|FG000|NOT COMPLETED|Postoperative Day 30 Assessment||0||
48545155|NCT02391987|101671286|FG001|COMPLETED|Overall Study||58||
48545156|NCT02391987|101671285|FG000|NOT COMPLETED|Overall Study||0||
48545157|NCT02391987|101671286|FG001|NOT COMPLETED|Overall Study||0||
48545158|NCT02198183|101671287|FG000|STARTED|Overall Study||34||
48545159|NCT02198183|101671287|FG000|COMPLETED|Overall Study||25||
48545160|NCT02198183|101671287|FG000|NOT COMPLETED|Overall Study||9||
48545161|NCT01085357|101671288|FG000|STARTED|Overall Study||374||
48262523|NCT02630706|100962944|FG000|COMPLETED|Overall Study||163||
48262524|NCT02630706|100962945|FG001|COMPLETED|Overall Study||160||
48262525|NCT02630706|100962946|FG002|COMPLETED|Overall Study||157||
48262526|NCT02630706|100962944|FG000|NOT COMPLETED|Overall Study||7||
48262527|NCT02630706|100962945|FG001|NOT COMPLETED|Overall Study||9||
48262528|NCT02630706|100962946|FG002|NOT COMPLETED|Overall Study||10||
48262529|NCT01262092|100962947|FG000|STARTED|Buprenorphine+Gabapentin/Plac Induction||16||
48262530|NCT01262092|100962948|FG001|STARTED|Buprenorphine+Gabapentin/Plac Induction||14||
48262531|NCT01262092|100962947|FG000|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13||
48262532|NCT01262092|100962948|FG001|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13||
48262533|NCT01262092|100962947|FG000|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||3||
48262534|NCT01262092|100962948|FG001|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||1||
48262535|NCT01262092|100962947|FG000|STARTED|Buprenorphine Taper||12||
48262536|NCT01262092|100962948|FG001|STARTED|Buprenorphine Taper||13||
48262537|NCT01262092|100962947|FG000|COMPLETED|Buprenorphine Taper||11||
48262538|NCT01262092|100962948|FG001|COMPLETED|Buprenorphine Taper||12||
48390310|NCT00892957|101283558|FG001|NOT COMPLETED|Postoperative Day 30 Assessment||0||
48390311|NCT03095053|101283559|FG000|STARTED|Overall Study||109||
48390312|NCT03095053|101283560|FG001|STARTED|Overall Study||111||
48390313|NCT03095053|101283559|FG000|COMPLETED|Overall Study||80||
48545162|NCT01085357|101671289|FG001|STARTED|Overall Study||131||
48545163|NCT01085357|101671288|FG000|COMPLETED|Overall Study||355||
48545164|NCT01085357|101671289|FG001|COMPLETED|Overall Study||125||
48390314|NCT03095053|101283560|FG001|COMPLETED|Overall Study||111||
48545165|NCT01085357|101671288|FG000|NOT COMPLETED|Overall Study||19||
48545166|NCT01085357|101671289|FG001|NOT COMPLETED|Overall Study||6||
48262539|NCT01262092|100962947|FG000|NOT COMPLETED|Buprenorphine Taper||1||
48262540|NCT01262092|100962948|FG001|NOT COMPLETED|Buprenorphine Taper||1||
48262541|NCT01262092|100962947|FG000|STARTED|Gabapentin Taper||10||
48262542|NCT01262092|100962948|FG001|STARTED|Gabapentin Taper||11||
48262543|NCT01262092|100962947|FG000|COMPLETED|Gabapentin Taper||9||
48262544|NCT01262092|100962948|FG001|COMPLETED|Gabapentin Taper||11||
48262545|NCT01262092|100962947|FG000|NOT COMPLETED|Gabapentin Taper||1||
48262546|NCT01262092|100962948|FG001|NOT COMPLETED|Gabapentin Taper||0||
48262547|NCT00727506|100962949|FG000|STARTED|Overall Study||6||
48262548|NCT00727506|100962950|FG001|STARTED|Overall Study||8||
48262549|NCT00727506|100962951|FG002|STARTED|Overall Study||18||
48262550|NCT00727506|100962952|FG003|STARTED|Overall Study||39||
48262551|NCT00727506|100962953|FG004|STARTED|Overall Study||41||
48262552|NCT00727506|100962954|FG005|STARTED|Overall Study||39||
48262553|NCT00727506|100962949|FG000|COMPLETED|Overall Study||0||
48262554|NCT00727506|100962950|FG001|COMPLETED|Overall Study||0||
48262555|NCT00727506|100962951|FG002|COMPLETED|Overall Study||0||
48262556|NCT00727506|100962952|FG003|COMPLETED|Overall Study||0||
48262557|NCT00727506|100962953|FG004|COMPLETED|Overall Study||0||
48262558|NCT00727506|100962954|FG005|COMPLETED|Overall Study||0||
48262559|NCT00727506|100962949|FG000|NOT COMPLETED|Overall Study||6||
48262560|NCT00727506|100962950|FG001|NOT COMPLETED|Overall Study||8||
48262561|NCT00727506|100962951|FG002|NOT COMPLETED|Overall Study||18||
48262562|NCT00727506|100962952|FG003|NOT COMPLETED|Overall Study||39||
48262563|NCT00727506|100962953|FG004|NOT COMPLETED|Overall Study||41||
48262564|NCT00727506|100962954|FG005|NOT COMPLETED|Overall Study||39||
48262565|NCT03024996|100962955|FG000|STARTED|Overall Study||390||
48262566|NCT03024996|100962956|FG001|STARTED|Overall Study||388||
48262567|NCT03024996|100962955|FG000|COMPLETED|Overall Study||0||
48262568|NCT03024996|100962956|FG001|COMPLETED|Overall Study||0||
48262569|NCT03024996|100962955|FG000|NOT COMPLETED|Overall Study||390||
48262570|NCT03024996|100962956|FG001|NOT COMPLETED|Overall Study||388||
48262571|NCT01174264|100962957|FG000|STARTED|Single Dose Pharmacokinetics||23||
48262572|NCT01174264|100962958|FG001|STARTED|Single Dose Pharmacokinetics||20||
48262573|NCT01174264|100962959|FG002|STARTED|Single Dose Pharmacokinetics||20||
48262574|NCT01174264|100962957|FG000|COMPLETED|Single Dose Pharmacokinetics||22||
48262575|NCT01174264|100962958|FG001|COMPLETED|Single Dose Pharmacokinetics||20||
48262576|NCT01174264|100962959|FG002|COMPLETED|Single Dose Pharmacokinetics||18||
48262577|NCT01174264|100962957|FG000|NOT COMPLETED|Single Dose Pharmacokinetics||1||
48545167|NCT04338269|101671290|FG000|STARTED|Overall Study||259||
48545168|NCT04338269|101671291|FG001|STARTED|Overall Study||263||
48545169|NCT04338269|101671290|FG000|Received at Least One Dose of Study Treatment|Overall Study||256||
48545170|NCT04338269|101671291|FG001|Received at Least One Dose of Study Treatment|Overall Study||262||
48545171|NCT04338269|101671290|FG000|COMPLETED|Overall Study||157|Early Discontinuation|
48262578|NCT01174264|100962958|FG001|NOT COMPLETED|Single Dose Pharmacokinetics||0||
48262579|NCT01174264|100962959|FG002|NOT COMPLETED|Single Dose Pharmacokinetics||2||
48262580|NCT01174264|100962957|FG000|STARTED|Steady-state Pharmacokinetics||31||
48262581|NCT01174264|100962958|FG001|STARTED|Steady-state Pharmacokinetics||0||
48262582|NCT01174264|100962959|FG002|STARTED|Steady-state Pharmacokinetics||29||
48262583|NCT01174264|100962957|FG000|COMPLETED|Steady-state Pharmacokinetics||25||
48262584|NCT01174264|100962958|FG001|COMPLETED|Steady-state Pharmacokinetics||0||
48262585|NCT01174264|100962959|FG002|COMPLETED|Steady-state Pharmacokinetics||27||
48262586|NCT01174264|100962957|FG000|NOT COMPLETED|Steady-state Pharmacokinetics||6||
48262587|NCT01174264|100962958|FG001|NOT COMPLETED|Steady-state Pharmacokinetics||0||
48262588|NCT01174264|100962959|FG002|NOT COMPLETED|Steady-state Pharmacokinetics||2||
48262589|NCT04333732|100962960|FG000|STARTED|Overall Study||1722|Number randomised|
48262590|NCT04333732|100962961|FG001|STARTED|Overall Study||1689|Number randomised|
48262591|NCT04333732|100962960|FG000|COMPLETED|Overall Study||1607|60 day follow-up for primary outcome|
48262592|NCT04333732|100962961|FG001|COMPLETED|Overall Study||1545|60 day follow-up for primary outcome|
48262593|NCT04333732|100962960|FG000|NOT COMPLETED|Overall Study||115||
48262594|NCT04333732|100962961|FG001|NOT COMPLETED|Overall Study||144||
48262595|NCT00358644|100962962|FG000|STARTED|Overall Study||55||
48262596|NCT00358644|100962962|FG000|COMPLETED|Overall Study||5||
48262597|NCT00358644|100962962|FG000|NOT COMPLETED|Overall Study||50||
48545172|NCT04338269|101671291|FG001|COMPLETED|Overall Study||161|Early Discontinuation|
48545173|NCT04338269|101671290|FG000|NOT COMPLETED|Overall Study||102||
48545174|NCT04338269|101671291|FG001|NOT COMPLETED|Overall Study||102||
48545175|NCT01653912|101671292|FG000|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||4||
48545176|NCT01653912|101671293|FG001|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0||
48545177|NCT01653912|101671294|FG002|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0||
48545178|NCT01653912|101671295|FG003|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0||
48545179|NCT01653912|101671296|FG004|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0||
48262598|NCT03617289|100962963|FG000|STARTED|Overall Study||18||
48262599|NCT03617289|100962964|FG001|STARTED|Overall Study||19||
48262600|NCT03617289|100962963|FG000|COMPLETED|Overall Study||18||
48262601|NCT03617289|100962964|FG001|COMPLETED|Overall Study||19||
48262602|NCT03617289|100962963|FG000|NOT COMPLETED|Overall Study||0||
48262603|NCT03617289|100962964|FG001|NOT COMPLETED|Overall Study||0||
48262604|NCT00447590|100962965|FG000|STARTED|Overall Study||153||
48262605|NCT00447590|100962965|FG000|COMPLETED|Overall Study||93||
48262606|NCT00447590|100962965|FG000|NOT COMPLETED|Overall Study||60||
48262607|NCT01929876|100966585|FG000|STARTED|Period 1||16||
48262608|NCT01929876|100966585|FG000|COMPLETED|Period 1||16||
48262609|NCT01929876|100966585|FG000|NOT COMPLETED|Period 1||0||
48262610|NCT01929876|100966585|FG000|STARTED|Period 2||16||
48262611|NCT01929876|100966585|FG000|COMPLETED|Period 2||15||
48262612|NCT01929876|100966585|FG000|NOT COMPLETED|Period 2||1||
48262613|NCT02561247|100966586|FG000|STARTED|Overall Study||23||
48262614|NCT02561247|100966586|FG000|COMPLETED|Overall Study||17||
48545180|NCT01653912|101671297|FG005|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0||
48545181|NCT01653912|101671292|FG000|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||4||
48545182|NCT01653912|101671293|FG001|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0||
48545183|NCT01653912|101671294|FG002|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0||
48545184|NCT01653912|101671295|FG003|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0||
48690512|NCT01279044|102025854|FG002|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||3||
48690513|NCT03663569|102025855|FG000|STARTED|Overall Study||4819||
48262615|NCT02561247|100966586|FG000|NOT COMPLETED|Overall Study||6||
48262616|NCT01209598|100966587|FG000|STARTED|Overall Study||30||
48262617|NCT01209598|100966588|FG001|STARTED|Overall Study||60||
48262618|NCT01209598|100966587|FG000|COMPLETED|Overall Study||29||
48262619|NCT01209598|100966588|FG001|COMPLETED|Overall Study||60||
48262620|NCT01209598|100966587|FG000|NOT COMPLETED|Overall Study||1||
48262621|NCT01209598|100966588|FG001|NOT COMPLETED|Overall Study||0||
48262622|NCT01821937|100966589|FG000|STARTED|Overall Study||10||
48262623|NCT01821937|100966590|FG001|STARTED|Overall Study||15||
48262624|NCT01821937|100966589|FG000|COMPLETED|Overall Study||10||
48262625|NCT01821937|100966590|FG001|COMPLETED|Overall Study||12||
48262626|NCT01821937|100966589|FG000|NOT COMPLETED|Overall Study||0||
48262627|NCT01821937|100966590|FG001|NOT COMPLETED|Overall Study||3||
48262628|NCT00583947|100966591|FG000|STARTED|Cross-over Period||27||
48262629|NCT00583947|100966592|FG001|STARTED|Cross-over Period||26||
48262630|NCT00583947|100966591|FG000|COMPLETED|Cross-over Period||22||
48262631|NCT00583947|100966592|FG001|COMPLETED|Cross-over Period||24||
48262632|NCT00583947|100966591|FG000|NOT COMPLETED|Cross-over Period||5||
48262633|NCT00583947|100966592|FG001|NOT COMPLETED|Cross-over Period||2||
48262634|NCT00583947|100966591|FG000|STARTED|Washout||22||
48262635|NCT00583947|100966592|FG001|STARTED|Washout||24||
48262636|NCT00583947|100966591|FG000|COMPLETED|Washout||22||
48262637|NCT00583947|100966592|FG001|COMPLETED|Washout||24||
48262638|NCT00583947|100966591|FG000|NOT COMPLETED|Washout||0||
48262639|NCT00583947|100966592|FG001|NOT COMPLETED|Washout||0||
48262640|NCT00583947|100966591|FG000|STARTED|Open Label Period||22||
48262641|NCT00583947|100966592|FG001|STARTED|Open Label Period||24||
48262642|NCT00583947|100966591|FG000|COMPLETED|Open Label Period||22||
48262643|NCT00583947|100966592|FG001|COMPLETED|Open Label Period||24||
48262644|NCT00583947|100966591|FG000|NOT COMPLETED|Open Label Period||0||
48262645|NCT00583947|100966592|FG001|NOT COMPLETED|Open Label Period||0||
48262646|NCT02209181|100966593|FG000|STARTED|Overall Study||67||
48262647|NCT02209181|100966594|FG001|STARTED|Overall Study||67||
48262648|NCT02209181|100966595|FG002|STARTED|Overall Study||69||
48262649|NCT02209181|100966596|FG003|STARTED|Overall Study||66||
48262650|NCT02209181|100966593|FG000|COMPLETED|Overall Study||66||
48262651|NCT02209181|100966594|FG001|COMPLETED|Overall Study||66||
48262652|NCT02209181|100966595|FG002|COMPLETED|Overall Study||68||
48262653|NCT02209181|100966596|FG003|COMPLETED|Overall Study||66||
48262654|NCT02209181|100966593|FG000|NOT COMPLETED|Overall Study||1||
48262655|NCT02209181|100966594|FG001|NOT COMPLETED|Overall Study||1||
48262656|NCT02209181|100966595|FG002|NOT COMPLETED|Overall Study||1||
48262657|NCT02209181|100966596|FG003|NOT COMPLETED|Overall Study||0||
48545185|NCT01653912|101671296|FG004|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0||
48262658|NCT04468230|100966597|FG000|STARTED|Overall Study||4||
48262659|NCT04468230|100966597|FG000|COMPLETED|Overall Study||2||
48262660|NCT04468230|100966597|FG000|NOT COMPLETED|Overall Study||2||
48262661|NCT00462605|100966598|FG000|STARTED|Overall Study||24||
48262662|NCT00462605|100966598|FG000|COMPLETED|Overall Study||10||
48262663|NCT00462605|100966598|FG000|NOT COMPLETED|Overall Study||14||
48262664|NCT01715207|100966599|FG000|STARTED|Overall Study||15||
48262665|NCT01715207|100966600|FG001|STARTED|Overall Study||15||
48262666|NCT01715207|100966599|FG000|COMPLETED|Overall Study||14||
48262667|NCT01715207|100966600|FG001|COMPLETED|Overall Study||14||
48262668|NCT01715207|100966599|FG000|NOT COMPLETED|Overall Study||1||
48545186|NCT01653912|101671297|FG005|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0||
48545187|NCT01653912|101671292|FG000|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0||
48545188|NCT01653912|101671293|FG001|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0||
48545189|NCT01653912|101671294|FG002|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0||
48545190|NCT01653912|101671295|FG003|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0||
48545191|NCT01653912|101671296|FG004|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0||
48262669|NCT01715207|100966600|FG001|NOT COMPLETED|Overall Study||1||
48262670|NCT01646385|100966601|FG000|STARTED|Overall Study||3529||
48545192|NCT01653912|101671297|FG005|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0||
48262671|NCT01646385|100966602|FG001|STARTED|Overall Study||2864||
48262672|NCT01646385|100966601|FG000|COMPLETED|Overall Study||2691||
48262673|NCT01646385|100966602|FG001|COMPLETED|Overall Study||1993||
48262674|NCT01646385|100966601|FG000|NOT COMPLETED|Overall Study||838||
48262675|NCT01646385|100966602|FG001|NOT COMPLETED|Overall Study||871||
48262676|NCT00583466|100966603|FG000|STARTED|Overall Study||18||
48262677|NCT00583466|100966603|FG000|COMPLETED|Overall Study||18||
48262678|NCT00583466|100966603|FG000|NOT COMPLETED|Overall Study||0||
48262679|NCT00490698|100966604|FG000|STARTED|Overall Study||11||
48262680|NCT00490698|100966604|FG000|COMPLETED|Overall Study||1||
48262681|NCT00490698|100966604|FG000|NOT COMPLETED|Overall Study||10||
48262682|NCT02145169|100966605|FG000|STARTED|Overall Study||0||
48262683|NCT02145169|100966605|FG000|COMPLETED|Overall Study||0||
48262684|NCT02145169|100966605|FG000|NOT COMPLETED|Overall Study||0||
48262685|NCT02287233|100966606|FG000|STARTED|Overall Study||8||
48262686|NCT02287233|100966607|FG001|STARTED|Overall Study||10||
48262687|NCT02287233|100966608|FG002|STARTED|Overall Study||76||
48262688|NCT02287233|100966606|FG000|Treated|Overall Study||8||
48262689|NCT02287233|100966607|FG001|Treated|Overall Study||10||
48262690|NCT02287233|100966608|FG002|Treated|Overall Study||74||
48262691|NCT02287233|100966606|FG000|COMPLETED|Overall Study||0|Indicates participants remaining on study|
48262692|NCT02287233|100966607|FG001|COMPLETED|Overall Study||0|Indicates participants remaining on study|
48262693|NCT02287233|100966608|FG002|COMPLETED|Overall Study||0|Indicates participants remaining on study|
48262694|NCT02287233|100966606|FG000|NOT COMPLETED|Overall Study||8||
48262695|NCT02287233|100966607|FG001|NOT COMPLETED|Overall Study||10||
48262696|NCT02287233|100966608|FG002|NOT COMPLETED|Overall Study||76||
48262697|NCT03602586|100966609|FG000|STARTED|Overall Study||14||
48262698|NCT03602586|100966609|FG000|COMPLETED|Overall Study||11||
48262699|NCT03602586|100966609|FG000|NOT COMPLETED|Overall Study||3||
48262700|NCT04692467|100966610|FG000|STARTED|Overall Study||124||
48262701|NCT04692467|100966611|FG001|STARTED|Overall Study||126||
48262702|NCT04692467|100966610|FG000|COMPLETED|Overall Study||124||
48262703|NCT04692467|100966611|FG001|COMPLETED|Overall Study||126||
48262704|NCT04692467|100966610|FG000|NOT COMPLETED|Overall Study||0||
48262705|NCT04692467|100966611|FG001|NOT COMPLETED|Overall Study||0||
48262706|NCT00853372|100966612|FG000|STARTED|Overall Study||43||
48262707|NCT00853372|100966613|FG001|STARTED|Overall Study||42||
48545193|NCT01653912|101671292|FG000|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0||
48545194|NCT01653912|101671293|FG001|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||4||
48545195|NCT01653912|101671294|FG002|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0||
48545196|NCT01653912|101671295|FG003|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0||
48545197|NCT01653912|101671296|FG004|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0||
48545198|NCT01653912|101671297|FG005|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0||
48262708|NCT00853372|100966612|FG000|COMPLETED|Overall Study||11||
48262709|NCT00853372|100966613|FG001|COMPLETED|Overall Study||13||
48262710|NCT00853372|100966612|FG000|NOT COMPLETED|Overall Study||32||
48545199|NCT01653912|101671292|FG000|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0||
48545200|NCT01653912|101671293|FG001|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||3||
48545201|NCT01653912|101671294|FG002|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0||
48262711|NCT00853372|100966613|FG001|NOT COMPLETED|Overall Study||29||
48262712|NCT02980523|100966614|FG000|STARTED|Overall Study||30||60
48262713|NCT02980523|100966615|FG001|STARTED|Overall Study||30||60
48262714|NCT02980523|100966616|FG002|STARTED|Overall Study||30||60
48262715|NCT02980523|100966617|FG003|STARTED|Overall Study||30||60
48262716|NCT02980523|100966618|FG004|STARTED|Overall Study||30||60
48262717|NCT02980523|100966614|FG000|COMPLETED|Overall Study||27||54
48545202|NCT01653912|101671295|FG003|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0||
48545203|NCT01653912|101671296|FG004|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0||
48545204|NCT01653912|101671297|FG005|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0||
48545205|NCT01653912|101671292|FG000|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0||
48545206|NCT01653912|101671293|FG001|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||1||
48545207|NCT01653912|101671294|FG002|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0||
48545208|NCT01653912|101671295|FG003|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0||
48545209|NCT01653912|101671296|FG004|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0||
48545210|NCT01653912|101671297|FG005|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0||
48545211|NCT01653912|101671292|FG000|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0||
48545212|NCT01653912|101671293|FG001|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0||
48262718|NCT02980523|100966615|FG001|COMPLETED|Overall Study||19||38
48262719|NCT02980523|100966616|FG002|COMPLETED|Overall Study||24||48
48262720|NCT02980523|100966617|FG003|COMPLETED|Overall Study||21||42
48262721|NCT02980523|100966618|FG004|COMPLETED|Overall Study||20||40
48262722|NCT02980523|100966614|FG000|NOT COMPLETED|Overall Study||3||6
48262723|NCT02980523|100966615|FG001|NOT COMPLETED|Overall Study||11||22
48262724|NCT02980523|100966616|FG002|NOT COMPLETED|Overall Study||6||12
48262725|NCT02980523|100966617|FG003|NOT COMPLETED|Overall Study||9||18
48262726|NCT02980523|100966618|FG004|NOT COMPLETED|Overall Study||10||20
48262727|NCT02111863|100966619|FG000|STARTED|Overall Study||6||
48262728|NCT02111863|100966619|FG000|COMPLETED|Overall Study||6||
48262729|NCT02111863|100966619|FG000|NOT COMPLETED|Overall Study||0||
48262730|NCT03316807|100966620|FG000|STARTED|Overall Study||91||
48262731|NCT03316807|100966621|FG001|STARTED|Overall Study||91||
48262732|NCT03316807|100966620|FG000|COMPLETED|Overall Study||60||
48262733|NCT03316807|100966621|FG001|COMPLETED|Overall Study||65||
48545213|NCT01653912|101671294|FG002|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||6||
48545214|NCT01653912|101671295|FG003|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0||
48262734|NCT03316807|100966620|FG000|NOT COMPLETED|Overall Study||31||
48262735|NCT03316807|100966621|FG001|NOT COMPLETED|Overall Study||26||
48262736|NCT00856245|100966622|FG000|STARTED|Overall Study||19||
48262737|NCT00856245|100966622|FG000|COMPLETED|Overall Study||14||
48262738|NCT00856245|100966622|FG000|NOT COMPLETED|Overall Study||5||
48262739|NCT01772563|100966623|FG000|STARTED|Cycle 1||28||
48262740|NCT01772563|100966623|FG000|Treated With 300 mg Volasertib|Cycle 1||3||
48262741|NCT01772563|100966623|FG000|Treated With 250 mg of Volasertib|Cycle 1||25||
48262742|NCT01772563|100966623|FG000|COMPLETED|Cycle 1||24|Patients continuing to \>=Cycle 2|
48262743|NCT01772563|100966623|FG000|NOT COMPLETED|Cycle 1||4||
48262744|NCT01772563|100966623|FG000|STARTED|Cycle 2 and Beyond||24|Patients started mono-therapy (Cycle 2 and beyond)|
48262745|NCT01772563|100966623|FG000|Treated With 300 mg Volasertib in Cycle 2|Cycle 2 and Beyond||1||
48262746|NCT01772563|100966623|FG000|Treated With 250 mg Volasertib in Cycle 2|Cycle 2 and Beyond||21||
48262747|NCT01772563|100966623|FG000|Treated With 200 mg Volasertib in Cycle 2|Cycle 2 and Beyond||1||
48262748|NCT01772563|100966623|FG000|COMPLETED|Cycle 2 and Beyond||1||
48262749|NCT01772563|100966623|FG000|NOT COMPLETED|Cycle 2 and Beyond||23||
48262750|NCT03197025|100966624|FG000|STARTED|Overall Study||1||
48262751|NCT03197025|100966624|FG000|COMPLETED|Overall Study||1||
48545215|NCT01653912|101671296|FG004|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0||
48545216|NCT01653912|101671297|FG005|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0||
48545217|NCT01653912|101671292|FG000|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0||
48545218|NCT01653912|101671293|FG001|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0||
48545219|NCT01653912|101671294|FG002|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||4||
48545220|NCT01653912|101671295|FG003|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0||
48545221|NCT01653912|101671296|FG004|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0||
48545222|NCT01653912|101671297|FG005|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0||
48545223|NCT01653912|101671292|FG000|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0||
48545224|NCT01653912|101671293|FG001|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0||
48545225|NCT01653912|101671294|FG002|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||2||
48545226|NCT01653912|101671295|FG003|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0||
48545227|NCT01653912|101671296|FG004|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0||
48545228|NCT01653912|101671297|FG005|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0||
48545229|NCT01653912|101671292|FG000|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0||
48545230|NCT01653912|101671293|FG001|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0||
48545231|NCT01653912|101671294|FG002|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0||
48545232|NCT01653912|101671295|FG003|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||12||
48545233|NCT01653912|101671296|FG004|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0||
48545234|NCT01653912|101671297|FG005|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0||
48545235|NCT01653912|101671292|FG000|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0||
48545236|NCT01653912|101671293|FG001|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0||
48098177|NCT02357901|100563881|FG000|STARTED|Run-In Period (Days -14 to Day -1)||665||
48098178|NCT02357901|100563882|FG001|STARTED|Run-In Period (Days -14 to Day -1)||0||
48098179|NCT02357901|100563883|FG002|STARTED|Run-In Period (Days -14 to Day -1)||0||
48262752|NCT03197025|100966624|FG000|NOT COMPLETED|Overall Study||0||
48545237|NCT01653912|101671294|FG002|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0||
48545238|NCT01653912|101671295|FG003|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||10||
48545239|NCT01653912|101671296|FG004|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0||
48545240|NCT01653912|101671297|FG005|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0||
48545241|NCT01653912|101671292|FG000|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0||
48545242|NCT01653912|101671293|FG001|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0||
48545243|NCT01653912|101671294|FG002|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0||
48545244|NCT01653912|101671295|FG003|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||2||
48545245|NCT01653912|101671296|FG004|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0||
48545246|NCT01653912|101671297|FG005|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0||
48545247|NCT01653912|101671292|FG000|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0||
48545248|NCT01653912|101671293|FG001|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0||
48545249|NCT01653912|101671294|FG002|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0||
48098180|NCT02357901|100563884|FG003|STARTED|Run-In Period (Days -14 to Day -1)||0||
48098181|NCT02357901|100563881|FG000|COMPLETED|Run-In Period (Days -14 to Day -1)||504||
48098182|NCT02357901|100563882|FG001|COMPLETED|Run-In Period (Days -14 to Day -1)||0||
48098183|NCT02357901|100563883|FG002|COMPLETED|Run-In Period (Days -14 to Day -1)||0||
48545250|NCT01653912|101671295|FG003|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0||
48545251|NCT01653912|101671296|FG004|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||3||
48545252|NCT01653912|101671297|FG005|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0||
48545253|NCT01653912|101671292|FG000|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0||
48262753|NCT01062269|100966625|FG000|STARTED|Overall Study||42||
48262754|NCT01062269|100966625|FG000|COMPLETED|Overall Study||42||
48262755|NCT01062269|100966625|FG000|NOT COMPLETED|Overall Study||0||
48262756|NCT01788475|100966626|FG000|STARTED|Overall Study||3||
48262757|NCT01788475|100966627|FG001|STARTED|Overall Study||0||
48545254|NCT01653912|101671293|FG001|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0||
48545255|NCT01653912|101671294|FG002|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0||
48545256|NCT01653912|101671295|FG003|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0||
48545257|NCT01653912|101671296|FG004|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||3||
48545258|NCT01653912|101671297|FG005|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0||
48545259|NCT01653912|101671292|FG000|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0||
48545260|NCT01653912|101671293|FG001|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0||
48545261|NCT01653912|101671294|FG002|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0||
48690514|NCT03663569|102025855|FG000|COMPLETED|Overall Study||4756||
48098184|NCT02357901|100563884|FG003|COMPLETED|Run-In Period (Days -14 to Day -1)||0||
48098185|NCT02357901|100563881|FG000|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||161||
48098186|NCT02357901|100563882|FG001|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0||
48098187|NCT02357901|100563883|FG002|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0||
48098188|NCT02357901|100563884|FG003|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0||
48098189|NCT02357901|100563881|FG000|STARTED|Treatment Period (Day 1 to Week 24)||0||
48098190|NCT02357901|100563882|FG001|STARTED|Treatment Period (Day 1 to Week 24)||203||
48098191|NCT02357901|100563883|FG002|STARTED|Treatment Period (Day 1 to Week 24)||201||
48098192|NCT02357901|100563884|FG003|STARTED|Treatment Period (Day 1 to Week 24)||100||
48098193|NCT02357901|100563881|FG000|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||0|Analyzed as treated.|
48098194|NCT02357901|100563882|FG001|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||203|Analyzed as treated.|
48098195|NCT02357901|100563883|FG002|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||201|Analyzed as treated.|
48098196|NCT02357901|100563884|FG003|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||100|Analyzed as treated.|
48098197|NCT02357901|100563881|FG000|Full Analysis Set|Treatment Period (Day 1 to Week 24)||0|Analyzed as randomized. One site excluded from efficacy analyses due to compliance issues.|
48098198|NCT02357901|100563882|FG001|Full Analysis Set|Treatment Period (Day 1 to Week 24)||194|Analyzed as randomized. One site excluded from efficacy analyses due to compliance issues.|
48098199|NCT02357901|100563883|FG002|Full Analysis Set|Treatment Period (Day 1 to Week 24)||196|Analyzed as randomized. One site excluded from efficacy analyses due to compliance issues.|
48098200|NCT02357901|100563884|FG003|Full Analysis Set|Treatment Period (Day 1 to Week 24)||99|Analyzed as randomized. One site excluded from efficacy analyses due to compliance issues.|
48098201|NCT02357901|100563881|FG000|COMPLETED|Treatment Period (Day 1 to Week 24)||0||
48098202|NCT02357901|100563882|FG001|COMPLETED|Treatment Period (Day 1 to Week 24)||125||
48098203|NCT02357901|100563883|FG002|COMPLETED|Treatment Period (Day 1 to Week 24)||129||
48098204|NCT02357901|100563884|FG003|COMPLETED|Treatment Period (Day 1 to Week 24)||34||
48098205|NCT02357901|100563881|FG000|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||0||
48098206|NCT02357901|100563882|FG001|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||78||
48098207|NCT02357901|100563883|FG002|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||72||
48098208|NCT02357901|100563884|FG003|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||66||
48098209|NCT01387347|100563885|FG000|STARTED|Overall Study||36||
48098210|NCT01387347|100563886|FG001|STARTED|Overall Study||36||
48098211|NCT01387347|100563885|FG000|COMPLETED|Overall Study||34||
48098212|NCT01387347|100563886|FG001|COMPLETED|Overall Study||35||
48098213|NCT01387347|100563885|FG000|NOT COMPLETED|Overall Study||2||
48098214|NCT01387347|100563886|FG001|NOT COMPLETED|Overall Study||1||
48098215|NCT00616655|100563887|FG000|STARTED|Overall Study||152||
48098216|NCT00616655|100563888|FG001|STARTED|Overall Study||153||
48262758|NCT01788475|100966628|FG002|STARTED|Overall Study||0||
48262759|NCT01788475|100966626|FG000|COMPLETED|Overall Study||0||
48262760|NCT01788475|100966627|FG001|COMPLETED|Overall Study||0||
48690515|NCT03663569|102025855|FG000|NOT COMPLETED|Overall Study||63||
48262761|NCT01788475|100966628|FG002|COMPLETED|Overall Study||0||
48262762|NCT01788475|100966626|FG000|NOT COMPLETED|Overall Study||3||
48262763|NCT01788475|100966627|FG001|NOT COMPLETED|Overall Study||0||
48262764|NCT01788475|100966628|FG002|NOT COMPLETED|Overall Study||0||
48262765|NCT00575042|100966629|FG000|STARTED|Overall Study||20||
48690516|NCT01901289|102025856|FG000|STARTED|Overall Study||200||
48690517|NCT01901289|102025856|FG000|12-Month Follow-up|Overall Study||194||
48690518|NCT01901289|102025856|FG000|COMPLETED|Overall Study||115||
48690519|NCT01901289|102025856|FG000|NOT COMPLETED|Overall Study||85||
48098217|NCT00616655|100563889|FG002|STARTED|Overall Study||151||
48262766|NCT00575042|100966629|FG000|COMPLETED|Overall Study||17||
48262767|NCT00575042|100966629|FG000|NOT COMPLETED|Overall Study||3||
48262768|NCT00632502|100966630|FG000|STARTED|Overall Study||25||
48262769|NCT00632502|100966631|FG001|STARTED|Overall Study||12||
48262770|NCT00632502|100966630|FG000|Treated|Overall Study||22||
48262771|NCT00632502|100966631|FG001|Treated|Overall Study||12||
48262772|NCT00632502|100966630|FG000|Completed Treatment|Overall Study||19||
48545262|NCT01653912|101671295|FG003|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0||
48690520|NCT00288015|102025857|FG000|STARTED|Registered to Study||32||
48690521|NCT00288015|102025857|FG000|COMPLETED|Registered to Study||32||
48098218|NCT00616655|100563887|FG000|COMPLETED|Overall Study||117||
48098219|NCT00616655|100563888|FG001|COMPLETED|Overall Study||112||
48098220|NCT00616655|100563889|FG002|COMPLETED|Overall Study||103||
48262773|NCT00632502|100966631|FG001|Completed Treatment|Overall Study||9||
48262774|NCT00632502|100966630|FG000|COMPLETED|Overall Study||22||
48262775|NCT00632502|100966631|FG001|COMPLETED|Overall Study||11||
48262776|NCT00632502|100966630|FG000|NOT COMPLETED|Overall Study||3||
48098221|NCT00616655|100563887|FG000|NOT COMPLETED|Overall Study||35||
48098222|NCT00616655|100563888|FG001|NOT COMPLETED|Overall Study||41||
48098223|NCT00616655|100563889|FG002|NOT COMPLETED|Overall Study||48||
48098224|NCT00591942|100563890|FG000|STARTED|Overall Study||36|Participants enrolled in both arms. 2 teeth were used in each subject, each with differing cement.|36
48098225|NCT00591942|100563891|FG001|STARTED|Overall Study||36|Participants enrolled in both arms. 2 teeth were used in each subject, each with differing cement.|36
48098226|NCT00591942|100563890|FG000|COMPLETED|Overall Study||36||36
48098227|NCT00591942|100563891|FG001|COMPLETED|Overall Study||36||36
48098228|NCT00591942|100563890|FG000|NOT COMPLETED|Overall Study||0||0
48098229|NCT00591942|100563891|FG001|NOT COMPLETED|Overall Study||0||0
48098230|NCT01724060|100563892|FG000|STARTED|Overall Study||10||
48098231|NCT01724060|100563893|FG001|STARTED|Overall Study||10||
48098232|NCT01724060|100563894|FG002|STARTED|Overall Study||10||
48098233|NCT01724060|100563895|FG003|STARTED|Overall Study||10||
48098234|NCT01724060|100563896|FG004|STARTED|Overall Study||10||
48098235|NCT01724060|100563897|FG005|STARTED|Overall Study||10||
48098236|NCT01724060|100563898|FG006|STARTED|Overall Study||10||
48098237|NCT01724060|100563899|FG007|STARTED|Overall Study||10||
48098238|NCT01724060|100563892|FG000|COMPLETED|Overall Study||10||
48098239|NCT01724060|100563893|FG001|COMPLETED|Overall Study||10||
48098240|NCT01724060|100563894|FG002|COMPLETED|Overall Study||10||
48098241|NCT01724060|100563895|FG003|COMPLETED|Overall Study||10||
48098242|NCT01724060|100563896|FG004|COMPLETED|Overall Study||10||
48098243|NCT01724060|100563897|FG005|COMPLETED|Overall Study||10||
48098244|NCT01724060|100563898|FG006|COMPLETED|Overall Study||10||
48098245|NCT01724060|100563899|FG007|COMPLETED|Overall Study||10||
48098246|NCT01724060|100563892|FG000|NOT COMPLETED|Overall Study||0||
48098247|NCT01724060|100563893|FG001|NOT COMPLETED|Overall Study||0||
48098248|NCT01724060|100563894|FG002|NOT COMPLETED|Overall Study||0||
48098249|NCT01724060|100563895|FG003|NOT COMPLETED|Overall Study||0||
48098250|NCT01724060|100563896|FG004|NOT COMPLETED|Overall Study||0||
48262777|NCT00632502|100966631|FG001|NOT COMPLETED|Overall Study||1||
48262778|NCT02786004|100966632|FG000|STARTED|Overall Study||14||
48098251|NCT01724060|100563897|FG005|NOT COMPLETED|Overall Study||0||
48098252|NCT01724060|100563898|FG006|NOT COMPLETED|Overall Study||0||
48545263|NCT01653912|101671296|FG004|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0||
48545264|NCT01653912|101671297|FG005|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0||
48545265|NCT01653912|101671292|FG000|STARTED|Phase 2: GSK2110183 125 mg||0||
48098253|NCT01724060|100563899|FG007|NOT COMPLETED|Overall Study||0||
48098254|NCT05102383|100563900|FG000|STARTED|Overall Study||30||
48098255|NCT05102383|100563900|FG000|COMPLETED|Overall Study||30||
48098256|NCT05102383|100563900|FG000|NOT COMPLETED|Overall Study||0||
48098257|NCT00946712|100563901|FG000|STARTED|Overall Study||671||
48098258|NCT00946712|100563902|FG001|STARTED|Overall Study||662||
48098259|NCT00946712|100563901|FG000|COMPLETED|Overall Study||124||
48262779|NCT02786004|100966633|FG001|STARTED|Overall Study||10||
48262780|NCT02786004|100966632|FG000|COMPLETED|Overall Study||14||
48262781|NCT02786004|100966633|FG001|COMPLETED|Overall Study||9||
48262782|NCT02786004|100966632|FG000|NOT COMPLETED|Overall Study||0||
48545266|NCT01653912|101671293|FG001|STARTED|Phase 2: GSK2110183 125 mg||0||
48545267|NCT01653912|101671294|FG002|STARTED|Phase 2: GSK2110183 125 mg||0||
48545268|NCT01653912|101671295|FG003|STARTED|Phase 2: GSK2110183 125 mg||0||
48545269|NCT01653912|101671296|FG004|STARTED|Phase 2: GSK2110183 125 mg||0||
48545270|NCT01653912|101671297|FG005|STARTED|Phase 2: GSK2110183 125 mg||30||
48545271|NCT01653912|101671292|FG000|COMPLETED|Phase 2: GSK2110183 125 mg||0||
48545272|NCT01653912|101671293|FG001|COMPLETED|Phase 2: GSK2110183 125 mg||0||
48545273|NCT01653912|101671294|FG002|COMPLETED|Phase 2: GSK2110183 125 mg||0||
48545274|NCT01653912|101671295|FG003|COMPLETED|Phase 2: GSK2110183 125 mg||0||
48545275|NCT01653912|101671296|FG004|COMPLETED|Phase 2: GSK2110183 125 mg||0||
48545276|NCT01653912|101671297|FG005|COMPLETED|Phase 2: GSK2110183 125 mg||22||
48545277|NCT01653912|101671292|FG000|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0||
48545278|NCT01653912|101671293|FG001|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0||
48098260|NCT00946712|100563902|FG001|COMPLETED|Overall Study||0||
48098261|NCT00946712|100563901|FG000|NOT COMPLETED|Overall Study||547||
48098262|NCT00946712|100563902|FG001|NOT COMPLETED|Overall Study||662||
48098263|NCT00303498|100563903|FG000|STARTED|Run-In-Phase (10 Weeks)||128||
48098264|NCT00303498|100563904|FG001|STARTED|Run-In-Phase (10 Weeks)||64||
48098265|NCT00303498|100563903|FG000|Treated|Run-In-Phase (10 Weeks)||127||
48098266|NCT00303498|100563904|FG001|Treated|Run-In-Phase (10 Weeks)||64||
48098267|NCT00303498|100563903|FG000|COMPLETED|Run-In-Phase (10 Weeks)||104||
48098268|NCT00303498|100563904|FG001|COMPLETED|Run-In-Phase (10 Weeks)||56||
48098269|NCT00303498|100563903|FG000|NOT COMPLETED|Run-In-Phase (10 Weeks)||24||
48098270|NCT00303498|100563904|FG001|NOT COMPLETED|Run-In-Phase (10 Weeks)||8||
48098271|NCT00303498|100563903|FG000|STARTED|Maintenance Phase (24 Weeks)||104||
48098272|NCT00303498|100563904|FG001|STARTED|Maintenance Phase (24 Weeks)||56||
48098273|NCT00303498|100563903|FG000|COMPLETED|Maintenance Phase (24 Weeks)||90||
48098274|NCT00303498|100563904|FG001|COMPLETED|Maintenance Phase (24 Weeks)||48||
48098275|NCT00303498|100563903|FG000|NOT COMPLETED|Maintenance Phase (24 Weeks)||14||
48098276|NCT00303498|100563904|FG001|NOT COMPLETED|Maintenance Phase (24 Weeks)||8||
48098277|NCT01821534|100563905|FG000|STARTED|Overall Study||201||
48098278|NCT01821534|100563905|FG000|COMPLETED|Overall Study||201||
48098279|NCT01821534|100563905|FG000|NOT COMPLETED|Overall Study||0||
48098280|NCT02005250|100563906|FG000|STARTED|Overall Study||61||
48098281|NCT02005250|100563907|FG001|STARTED|Overall Study||32||
48098282|NCT02005250|100563906|FG000|COMPLETED|Overall Study||46||
48098283|NCT02005250|100563907|FG001|COMPLETED|Overall Study||27||
48098284|NCT02005250|100563906|FG000|NOT COMPLETED|Overall Study||15||
48098285|NCT02005250|100563907|FG001|NOT COMPLETED|Overall Study||5||
48098286|NCT04903249|100563908|FG000|STARTED|Overall Study||37||
48098287|NCT04903249|100563908|FG000|Received Intervention|Overall Study||30||
48098288|NCT04903249|100563908|FG000|Week 2 Follow-up|Overall Study||30||
48098289|NCT04903249|100563908|FG000|Week 6 Follow-up|Overall Study||30||
48098290|NCT04903249|100563908|FG000|Week 12 Follow-up|Overall Study||30||
48098291|NCT04903249|100563908|FG000|COMPLETED|Overall Study||30||
48098292|NCT04903249|100563908|FG000|NOT COMPLETED|Overall Study||7||
48098293|NCT01985581|100563909|FG000|STARTED|First Intervention||25||
48098294|NCT01985581|100563910|FG001|STARTED|First Intervention||25||
48098295|NCT01985581|100563909|FG000|COMPLETED|First Intervention||22||
48098296|NCT01985581|100563910|FG001|COMPLETED|First Intervention||23||
48098297|NCT01985581|100563909|FG000|NOT COMPLETED|First Intervention||3||
48098298|NCT01985581|100563910|FG001|NOT COMPLETED|First Intervention||2||
48098299|NCT01985581|100563909|FG000|STARTED|Second Intervention||22||
48098300|NCT01985581|100563910|FG001|STARTED|Second Intervention||23||
48098301|NCT01985581|100563909|FG000|COMPLETED|Second Intervention||20||
48098302|NCT01985581|100563910|FG001|COMPLETED|Second Intervention||19||
48098303|NCT01985581|100563909|FG000|NOT COMPLETED|Second Intervention||2||
48098304|NCT01985581|100563910|FG001|NOT COMPLETED|Second Intervention||4||
48098305|NCT04949165|100563911|FG000|STARTED|Overall Study||105||
48098306|NCT04949165|100563912|FG001|STARTED|Overall Study||118||
48098307|NCT04949165|100563911|FG000|COMPLETED|Overall Study||74||
48098308|NCT04949165|100563912|FG001|COMPLETED|Overall Study||56||
48098309|NCT04949165|100563911|FG000|NOT COMPLETED|Overall Study||31||
48098310|NCT04949165|100563912|FG001|NOT COMPLETED|Overall Study||62||
48098311|NCT02604212|100563913|FG000|STARTED|Overall Study||6||
48098312|NCT02604212|100563914|FG001|STARTED|Overall Study||5||
48098313|NCT02604212|100563915|FG002|STARTED|Overall Study||10||
48098314|NCT02604212|100563916|FG003|STARTED|Overall Study||11||
48098315|NCT02604212|100563913|FG000|COMPLETED|Overall Study||4||
48098316|NCT02604212|100563914|FG001|COMPLETED|Overall Study||4||
48098317|NCT02604212|100563915|FG002|COMPLETED|Overall Study||6||
48098318|NCT02604212|100563916|FG003|COMPLETED|Overall Study||8||
48098319|NCT02604212|100563913|FG000|NOT COMPLETED|Overall Study||2||
48098320|NCT02604212|100563914|FG001|NOT COMPLETED|Overall Study||1||
48098321|NCT02604212|100563915|FG002|NOT COMPLETED|Overall Study||4||
48098322|NCT02604212|100563916|FG003|NOT COMPLETED|Overall Study||3||
48098323|NCT03684512|100563917|FG000|STARTED|Overall Study||57||
48098324|NCT03684512|100563918|FG001|STARTED|Overall Study||59||
48098325|NCT03684512|100563917|FG000|Completed 6 Months|Overall Study||47||
48098326|NCT03684512|100563918|FG001|Completed 6 Months|Overall Study||54||
48098327|NCT03684512|100563917|FG000|Completed 12 Month Active Intervention|Overall Study||40||
48098328|NCT03684512|100563918|FG001|Completed 12 Month Active Intervention|Overall Study||48||
48098329|NCT03684512|100563917|FG000|COMPLETED|Overall Study||37||
48098330|NCT03684512|100563918|FG001|COMPLETED|Overall Study||45||
48098331|NCT03684512|100563917|FG000|NOT COMPLETED|Overall Study||20||
48098332|NCT03684512|100563918|FG001|NOT COMPLETED|Overall Study||14||
48098333|NCT00832585|100563919|FG000|STARTED|Overall Study||5||
48098334|NCT00832585|100563919|FG000|COMPLETED|Overall Study||3||
48098335|NCT00832585|100563919|FG000|NOT COMPLETED|Overall Study||2||
48098336|NCT04166435|100563920|FG000|STARTED|Overall Study||11||
48098337|NCT04166435|100563920|FG000|COMPLETED|Overall Study||9||
48098338|NCT04166435|100563920|FG000|NOT COMPLETED|Overall Study||2||
48098339|NCT01092182|100563921|FG000|STARTED|Overall Study||15||
48098340|NCT01092182|100563922|FG001|STARTED|Overall Study||98||
48098341|NCT01092182|100563923|FG002|STARTED|Overall Study||81||
48098342|NCT01092182|100563921|FG000|COMPLETED|Overall Study||14||
48098343|NCT01092182|100563922|FG001|COMPLETED|Overall Study||80||
48098344|NCT01092182|100563923|FG002|COMPLETED|Overall Study||53||
48098345|NCT01092182|100563921|FG000|NOT COMPLETED|Overall Study||1||
48098346|NCT01092182|100563922|FG001|NOT COMPLETED|Overall Study||18||
48098347|NCT01092182|100563923|FG002|NOT COMPLETED|Overall Study||28||
48098348|NCT00450333|100563924|FG000|STARTED|Overall Study||98||
48098349|NCT00450333|100563925|FG001|STARTED|Overall Study||107||
48098350|NCT00450333|100563926|FG002|STARTED|Overall Study||100||
48098351|NCT00450333|100563927|FG003|STARTED|Overall Study||102||
48098352|NCT00450333|100563924|FG000|COMPLETED|Overall Study||44||
48098353|NCT00450333|100563925|FG001|COMPLETED|Overall Study||44||
48098354|NCT00450333|100563926|FG002|COMPLETED|Overall Study||75||
48098355|NCT00450333|100563927|FG003|COMPLETED|Overall Study||74||
48098356|NCT00450333|100563924|FG000|NOT COMPLETED|Overall Study||54||
48098357|NCT00450333|100563925|FG001|NOT COMPLETED|Overall Study||63||
48098358|NCT00450333|100563926|FG002|NOT COMPLETED|Overall Study||25||
48098359|NCT00450333|100563927|FG003|NOT COMPLETED|Overall Study||28||
48098360|NCT00228917|100563928|FG000|STARTED|Overall Study||193||
48098361|NCT00228917|100563929|FG001|STARTED|Overall Study||96||
48098362|NCT00228917|100563930|FG002|STARTED|Overall Study||65||
48098363|NCT00228917|100563931|FG003|STARTED|Overall Study||33||
48098364|NCT00228917|100563932|FG004|STARTED|Overall Study||205||
48098365|NCT00228917|100563933|FG005|STARTED|Overall Study||104||
48098366|NCT00228917|100563934|FG006|STARTED|Overall Study||69||
48098367|NCT00228917|100563935|FG007|STARTED|Overall Study||33||
48098368|NCT00228917|100563928|FG000|COMPLETED|Overall Study||193||
48098369|NCT00228917|100563929|FG001|COMPLETED|Overall Study||96||
48098370|NCT00228917|100563930|FG002|COMPLETED|Overall Study||65||
48098371|NCT00228917|100563931|FG003|COMPLETED|Overall Study||33||
48098372|NCT00228917|100563932|FG004|COMPLETED|Overall Study||205||
48098373|NCT00228917|100563933|FG005|COMPLETED|Overall Study||102||
48098374|NCT00228917|100563934|FG006|COMPLETED|Overall Study||69||
48098375|NCT00228917|100563935|FG007|COMPLETED|Overall Study||33||
48098376|NCT00228917|100563928|FG000|NOT COMPLETED|Overall Study||0||
48098377|NCT00228917|100563929|FG001|NOT COMPLETED|Overall Study||0||
48098378|NCT00228917|100563930|FG002|NOT COMPLETED|Overall Study||0||
48098379|NCT00228917|100563931|FG003|NOT COMPLETED|Overall Study||0||
48098380|NCT00228917|100563932|FG004|NOT COMPLETED|Overall Study||0||
48098381|NCT00228917|100563933|FG005|NOT COMPLETED|Overall Study||2||
48098382|NCT00228917|100563934|FG006|NOT COMPLETED|Overall Study||0||
48098383|NCT00228917|100563935|FG007|NOT COMPLETED|Overall Study||0||
48098384|NCT03540147|100568034|FG000|STARTED|Overall Study||20||
48098385|NCT03540147|100568034|FG000|COMPLETED|Overall Study||20||
48098386|NCT03540147|100568034|FG000|NOT COMPLETED|Overall Study||0||
48098387|NCT00629499|100568035|FG000|STARTED|Overall Study||63||
48098388|NCT00629499|100568035|FG000|COMPLETED|Overall Study||63||
48098389|NCT00629499|100568035|FG000|NOT COMPLETED|Overall Study||0||
48098390|NCT02556333|100568036|FG000|STARTED|Overall Study||1||
48098391|NCT02556333|100568036|FG000|COMPLETED|Overall Study||1||
48098392|NCT02556333|100568036|FG000|NOT COMPLETED|Overall Study||0||
48098393|NCT02389998|100568037|FG000|STARTED|Overall Study||16||
48098394|NCT02389998|100568038|FG001|STARTED|Overall Study||15||
48098395|NCT02389998|100568037|FG000|COMPLETED|Overall Study||15||
48098396|NCT02389998|100568038|FG001|COMPLETED|Overall Study||15||
48098397|NCT02389998|100568037|FG000|NOT COMPLETED|Overall Study||1||
48098398|NCT02389998|100568038|FG001|NOT COMPLETED|Overall Study||0||
48098399|NCT02155647|100568039|FG000|STARTED|Overall Study||88||
48098400|NCT02155647|100568040|FG001|STARTED|Overall Study||116||
48098401|NCT02155647|100568039|FG000|COMPLETED|Overall Study||88||
48098402|NCT02155647|100568040|FG001|COMPLETED|Overall Study||116||
48098403|NCT02155647|100568039|FG000|NOT COMPLETED|Overall Study||0||
48098404|NCT02155647|100568040|FG001|NOT COMPLETED|Overall Study||0||
48098405|NCT03011307|100568041|FG000|STARTED|Overall Study||50||
48098406|NCT03011307|100568042|FG001|STARTED|Overall Study||48||
48098407|NCT03011307|100568041|FG000|COMPLETED|Overall Study||44||
48098408|NCT03011307|100568042|FG001|COMPLETED|Overall Study||46||
48098409|NCT03011307|100568041|FG000|NOT COMPLETED|Overall Study||6||
48098410|NCT03011307|100568042|FG001|NOT COMPLETED|Overall Study||2||
48098411|NCT03038815|100568043|FG000|STARTED|Controll Condition, 1 Hour||10||
48098412|NCT03038815|100568044|FG001|STARTED|Controll Condition, 1 Hour||10||
48098413|NCT03038815|100568043|FG000|COMPLETED|Controll Condition, 1 Hour||10||
48098414|NCT03038815|100568044|FG001|COMPLETED|Controll Condition, 1 Hour||10||
48098415|NCT03038815|100568043|FG000|NOT COMPLETED|Controll Condition, 1 Hour||0||
48098416|NCT03038815|100568044|FG001|NOT COMPLETED|Controll Condition, 1 Hour||0||
48098417|NCT03038815|100568043|FG000|STARTED|Intervention 1, 1 Hour||10||
48098418|NCT03038815|100568044|FG001|STARTED|Intervention 1, 1 Hour||10||
48098419|NCT03038815|100568043|FG000|COMPLETED|Intervention 1, 1 Hour||10||
48098420|NCT03038815|100568044|FG001|COMPLETED|Intervention 1, 1 Hour||10||
48098421|NCT03038815|100568043|FG000|NOT COMPLETED|Intervention 1, 1 Hour||0||
48098422|NCT03038815|100568044|FG001|NOT COMPLETED|Intervention 1, 1 Hour||0||
48098423|NCT03038815|100568043|FG000|STARTED|Intervention 2, 1 Hour||10||
48098424|NCT03038815|100568044|FG001|STARTED|Intervention 2, 1 Hour||10||
48098425|NCT03038815|100568043|FG000|COMPLETED|Intervention 2, 1 Hour||10||
48098426|NCT03038815|100568044|FG001|COMPLETED|Intervention 2, 1 Hour||10||
48098427|NCT03038815|100568043|FG000|NOT COMPLETED|Intervention 2, 1 Hour||0||
48098428|NCT03038815|100568044|FG001|NOT COMPLETED|Intervention 2, 1 Hour||0||
48098429|NCT00824044|100568045|FG000|STARTED|Overall Study||23||
48098430|NCT00824044|100568046|FG001|STARTED|Overall Study||16||
48098431|NCT00824044|100568045|FG000|COMPLETED|Overall Study||14||
48098432|NCT00824044|100568046|FG001|COMPLETED|Overall Study||10||
48098433|NCT00824044|100568045|FG000|NOT COMPLETED|Overall Study||9||
48098434|NCT00824044|100568046|FG001|NOT COMPLETED|Overall Study||6||
48098435|NCT02587065|100568047|FG000|STARTED|Overall Study||193||
48098436|NCT02587065|100568047|FG000|COMPLETED|Overall Study||166||
48098437|NCT02587065|100568047|FG000|NOT COMPLETED|Overall Study||27||
48098438|NCT02929823|100568048|FG000|STARTED|Overall Study||42||
48098439|NCT02929823|100568049|FG001|STARTED|Overall Study||46||
48098440|NCT02929823|100568050|FG002|STARTED|Overall Study||42||
48098441|NCT02929823|100568048|FG000|COMPLETED|Overall Study||39||
48098442|NCT02929823|100568049|FG001|COMPLETED|Overall Study||40||
48098443|NCT02929823|100568050|FG002|COMPLETED|Overall Study||38||
48098444|NCT02929823|100568048|FG000|NOT COMPLETED|Overall Study||3||
48098445|NCT02929823|100568049|FG001|NOT COMPLETED|Overall Study||6||
48098446|NCT02929823|100568050|FG002|NOT COMPLETED|Overall Study||4||
48098447|NCT02617511|100568051|FG000|STARTED|Overall Study||12||
48098448|NCT02617511|100568052|FG001|STARTED|Overall Study||12||
48098449|NCT02617511|100568051|FG000|COMPLETED|Overall Study||11||
48098450|NCT02617511|100568052|FG001|COMPLETED|Overall Study||12||
48098451|NCT02617511|100568051|FG000|NOT COMPLETED|Overall Study||1||
48098452|NCT02617511|100568052|FG001|NOT COMPLETED|Overall Study||0||
48098453|NCT00867451|100568053|FG000|STARTED|Overall Study||4||
48098454|NCT00867451|100568054|FG001|STARTED|Overall Study||4||
48098455|NCT00867451|100568053|FG000|COMPLETED|Overall Study||4||
48098456|NCT00867451|100568054|FG001|COMPLETED|Overall Study||4||
48098457|NCT00867451|100568053|FG000|NOT COMPLETED|Overall Study||0||
48098458|NCT00867451|100568054|FG001|NOT COMPLETED|Overall Study||0||
48098459|NCT04339296|100568055|FG000|STARTED|Overall Study||24||
48098460|NCT04339296|100568056|FG001|STARTED|Overall Study||26||
48098461|NCT04339296|100568055|FG000|Completed Baseline|Overall Study||23||
48098462|NCT04339296|100568056|FG001|Completed Baseline|Overall Study||25||
48098463|NCT04339296|100568055|FG000|Received Allocated Intervention|Overall Study||21||
48098464|NCT04339296|100568056|FG001|Received Allocated Intervention|Overall Study||24||
48098465|NCT04339296|100568055|FG000|COMPLETED|Overall Study||16||
48098466|NCT04339296|100568056|FG001|COMPLETED|Overall Study||17||
48098467|NCT04339296|100568055|FG000|NOT COMPLETED|Overall Study||8||
48098468|NCT04339296|100568056|FG001|NOT COMPLETED|Overall Study||9||
48098469|NCT00159250|100568057|FG000|STARTED|Overall Study||2||
48098470|NCT00159250|100568058|FG001|STARTED|Overall Study||5||
48098471|NCT00159250|100568057|FG000|COMPLETED|Overall Study||2||
48098472|NCT00159250|100568058|FG001|COMPLETED|Overall Study||5||
48098473|NCT00159250|100568057|FG000|NOT COMPLETED|Overall Study||0||
48098474|NCT00159250|100568058|FG001|NOT COMPLETED|Overall Study||0||
48098475|NCT00525733|100568059|FG000|STARTED|Overall Study||14||
48262783|NCT02786004|100966633|FG001|NOT COMPLETED|Overall Study||1||
48262784|NCT02367430|100966634|FG000|STARTED|Overall Study||14||
48262785|NCT02367430|100966634|FG000|COMPLETED|Overall Study||11||
48262786|NCT02367430|100966634|FG000|NOT COMPLETED|Overall Study||3||
48262787|NCT01336205|100966635|FG000|STARTED|Overall Study||563||
48262788|NCT01336205|100966636|FG001|STARTED|Overall Study||281||
48262789|NCT01336205|100966635|FG000|COMPLETED|Overall Study||330||
48262790|NCT01336205|100966636|FG001|COMPLETED|Overall Study||192||
48262791|NCT01336205|100966635|FG000|NOT COMPLETED|Overall Study||233||
48262792|NCT01336205|100966636|FG001|NOT COMPLETED|Overall Study||89||
48262793|NCT00624013|100966637|FG000|STARTED|Overall Study||44||
48262794|NCT00624013|100966638|FG001|STARTED|Overall Study||45||
48262795|NCT00624013|100966637|FG000|COMPLETED|Overall Study||36||
48262796|NCT00624013|100966638|FG001|COMPLETED|Overall Study||39||
48262797|NCT00624013|100966637|FG000|NOT COMPLETED|Overall Study||8||
48262798|NCT00624013|100966638|FG001|NOT COMPLETED|Overall Study||6||
48262799|NCT04147858|100966639|FG000|STARTED|Overall Study||101||
48262800|NCT04147858|100966640|FG001|STARTED|Overall Study||104||
48262801|NCT04147858|100966641|FG002|STARTED|Overall Study||105||
48262802|NCT04147858|100966639|FG000|COMPLETED|Overall Study||84||
48262803|NCT04147858|100966640|FG001|COMPLETED|Overall Study||82||
48262804|NCT04147858|100966641|FG002|COMPLETED|Overall Study||85||
48262805|NCT04147858|100966639|FG000|NOT COMPLETED|Overall Study||17||
48098476|NCT00525733|100568060|FG001|STARTED|Overall Study||26||
48098477|NCT00525733|100568059|FG000|COMPLETED|Overall Study||11||
48098478|NCT00525733|100568060|FG001|COMPLETED|Overall Study||23||
48098479|NCT00525733|100568059|FG000|NOT COMPLETED|Overall Study||3||
48098480|NCT00525733|100568060|FG001|NOT COMPLETED|Overall Study||3||
48098481|NCT03642210|100568061|FG000|STARTED|Overall Study||105||
48098482|NCT03642210|100568061|FG000|Modified Intent to Treat (MITT)|Overall Study||89|MITT: All participants with qualifying Baseline data at study entry for whom the IUS is successfully inserted and for whom there is at least one assessment of MBL during the Treatment Phase Cycle 3 or Cycle 6. All MBL values reported for both validated and unvalidated used feminine hygiene products were included. This is the main population for the efficacy analyses.|
48262806|NCT04147858|100966640|FG001|NOT COMPLETED|Overall Study||22||
48262807|NCT04147858|100966641|FG002|NOT COMPLETED|Overall Study||20||
48262808|NCT00891046|100966642|FG000|STARTED|Overall Study||33||
48262809|NCT00891046|100966643|FG001|STARTED|Overall Study||63||
48262810|NCT00891046|100966644|FG002|STARTED|Overall Study||40||
48262811|NCT00891046|100966645|FG003|STARTED|Overall Study||11||
48262812|NCT00891046|100966646|FG004|STARTED|Overall Study||123||
48262813|NCT00891046|100966642|FG000|COMPLETED|Overall Study||21||
48262814|NCT00891046|100966643|FG001|COMPLETED|Overall Study||54||
48262815|NCT00891046|100966644|FG002|COMPLETED|Overall Study||17||
48262816|NCT00891046|100966645|FG003|COMPLETED|Overall Study||8||
48262817|NCT00891046|100966646|FG004|COMPLETED|Overall Study||84||
48262818|NCT00891046|100966642|FG000|NOT COMPLETED|Overall Study||12||
48262819|NCT00891046|100966643|FG001|NOT COMPLETED|Overall Study||9||
48098483|NCT03642210|100568061|FG000|COMPLETED|Overall Study||81||
48098484|NCT03642210|100568061|FG000|NOT COMPLETED|Overall Study||24||
48098485|NCT01628601|100568062|FG000|STARTED|Overall Study||392||
48098486|NCT01628601|100568062|FG000|COMPLETED|Overall Study||351||
48262820|NCT00891046|100966644|FG002|NOT COMPLETED|Overall Study||23||
48545279|NCT01653912|101671294|FG002|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0||
48545280|NCT01653912|101671295|FG003|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0||
48545281|NCT01653912|101671296|FG004|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0||
48545282|NCT01653912|101671297|FG005|NOT COMPLETED|Phase 2: GSK2110183 125 mg||8||
48545283|NCT00230178|101671298|FG000|STARTED|Overall Study||94||
48545284|NCT00230178|101671299|FG001|STARTED|Overall Study||93||
48545285|NCT00230178|101671300|FG002|STARTED|Overall Study||93||
48545286|NCT00230178|101671298|FG000|Treated|Overall Study||92||
48545287|NCT00230178|101671299|FG001|Treated|Overall Study||92||
48545288|NCT00230178|101671300|FG002|Treated|Overall Study||91||
48545289|NCT00230178|101671298|FG000|COMPLETED|Overall Study||90||
48545290|NCT00230178|101671299|FG001|COMPLETED|Overall Study||86||
48545291|NCT00230178|101671300|FG002|COMPLETED|Overall Study||86||
48545292|NCT00230178|101671298|FG000|NOT COMPLETED|Overall Study||4||
48545293|NCT00230178|101671299|FG001|NOT COMPLETED|Overall Study||7||
48545294|NCT00230178|101671300|FG002|NOT COMPLETED|Overall Study||7||
48098487|NCT01628601|100568062|FG000|NOT COMPLETED|Overall Study||41||
48098488|NCT01229423|100568063|FG000|STARTED|Overall Study||62||
48545295|NCT00920790|101671301|FG000|STARTED|Overall Study||27||
48545296|NCT00920790|101671301|FG000|COMPLETED|Overall Study||13||
48545297|NCT00920790|101671301|FG000|NOT COMPLETED|Overall Study||14||
48545298|NCT02439970|101671302|FG000|STARTED|Overall Study||2||
48545299|NCT02439970|101671303|FG001|STARTED|Overall Study||3||
48545300|NCT02439970|101671302|FG000|COMPLETED|Overall Study||0||
48545301|NCT02439970|101671303|FG001|COMPLETED|Overall Study||0||
48545302|NCT02439970|101671302|FG000|NOT COMPLETED|Overall Study||2||
48545303|NCT02439970|101671303|FG001|NOT COMPLETED|Overall Study||3||
48545304|NCT03852537|101671304|FG000|STARTED|Overall Study||23||
48545305|NCT03852537|101671305|FG001|STARTED|Overall Study||21||
48545306|NCT03852537|101671304|FG000|COMPLETED|Overall Study||23||
48545307|NCT03852537|101671305|FG001|COMPLETED|Overall Study||21||
48545308|NCT03852537|101671304|FG000|NOT COMPLETED|Overall Study||0||
48545309|NCT03852537|101671305|FG001|NOT COMPLETED|Overall Study||0||
48545310|NCT03907878|101671306|FG000|STARTED|Treatment Period||66||
48545311|NCT03907878|101671306|FG000|COMPLETED|Treatment Period||55||
48545312|NCT03907878|101671306|FG000|NOT COMPLETED|Treatment Period||11||
48545313|NCT03907878|101671306|FG000|STARTED|Follow-up Period||66||
48545314|NCT03907878|101671306|FG000|COMPLETED|Follow-up Period||60||
48545315|NCT03907878|101671306|FG000|NOT COMPLETED|Follow-up Period||6||
48545316|NCT02886624|101671307|FG000|STARTED|8-week Treatment||30||
48545317|NCT02886624|101671307|FG000|COMPLETED|8-week Treatment||30||
48545318|NCT02886624|101671307|FG000|NOT COMPLETED|8-week Treatment||0||
48545319|NCT02886624|101671307|FG000|STARTED|12-week Post Treatment Follow-up||30||
48545320|NCT02886624|101671307|FG000|COMPLETED|12-week Post Treatment Follow-up||29||
48545321|NCT02886624|101671307|FG000|NOT COMPLETED|12-week Post Treatment Follow-up||1||
48545322|NCT02886624|101671307|FG000|STARTED|48-week Post Treatment Follow-up||29||
48545323|NCT02886624|101671307|FG000|COMPLETED|48-week Post Treatment Follow-up||28||
48545324|NCT02886624|101671307|FG000|NOT COMPLETED|48-week Post Treatment Follow-up||1||
48098489|NCT01229423|100568063|FG000|COMPLETED|Overall Study||47||
48098490|NCT01229423|100568063|FG000|NOT COMPLETED|Overall Study||15||
48098491|NCT00322842|100568064|FG000|STARTED|Overall Study||4||
48098492|NCT00322842|100568065|FG001|STARTED|Overall Study||31||
48098493|NCT00322842|100568064|FG000|COMPLETED|Overall Study||2||
48098494|NCT00322842|100568065|FG001|COMPLETED|Overall Study||29||
48098495|NCT00322842|100568064|FG000|NOT COMPLETED|Overall Study||2||
48098496|NCT00322842|100568065|FG001|NOT COMPLETED|Overall Study||2||
48098497|NCT00326950|100568066|FG000|STARTED|Overall Study||15||
48098498|NCT00326950|100568066|FG000|COMPLETED|Overall Study||14||
48098499|NCT00326950|100568066|FG000|NOT COMPLETED|Overall Study||1||
48098500|NCT00183092|100568067|FG000|STARTED|Double-blind (Baseline - Month 2)||23||
48098501|NCT00183092|100568068|FG001|STARTED|Double-blind (Baseline - Month 2)||28||
48545325|NCT04080544|101671308|FG000|STARTED|Overall Study||125||
48545326|NCT04080544|101671308|FG000|COMPLETED|Overall Study||125||
48545327|NCT04080544|101671308|FG000|NOT COMPLETED|Overall Study||0||
48545328|NCT01263938|101671309|FG000|STARTED|Overall Study||5||
48098502|NCT00183092|100568069|FG002|STARTED|Double-blind (Baseline - Month 2)||0||
48098503|NCT00183092|100568070|FG003|STARTED|Double-blind (Baseline - Month 2)||0||
48098504|NCT00183092|100568067|FG000|Alive at Month 2|Double-blind (Baseline - Month 2)||13||
48098505|NCT00183092|100568068|FG001|Alive at Month 2|Double-blind (Baseline - Month 2)||19||
48098506|NCT00183092|100568069|FG002|Alive at Month 2|Double-blind (Baseline - Month 2)||0||
48098507|NCT00183092|100568070|FG003|Alive at Month 2|Double-blind (Baseline - Month 2)||0||
48098508|NCT00183092|100568067|FG000|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||10||
48098509|NCT00183092|100568068|FG001|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||16||
48098510|NCT00183092|100568069|FG002|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0||
48098511|NCT00183092|100568070|FG003|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0||
48545329|NCT01263938|101671309|FG000|COMPLETED|Overall Study||5||
48545330|NCT01263938|101671309|FG000|NOT COMPLETED|Overall Study||0||
48545331|NCT00306995|101671310|FG000|STARTED|Study Part I||55||
48545332|NCT00306995|101671311|FG001|STARTED|Study Part I||55||
48545333|NCT00306995|101671312|FG002|STARTED|Study Part I||55||
48545334|NCT00306995|101671313|FG003|STARTED|Study Part I||55||
48690522|NCT00288015|102025857|FG000|NOT COMPLETED|Registered to Study||0||
48690523|NCT00288015|102025857|FG000|STARTED|Bevacizumab Treatment Cycles 1-2||32||
48690524|NCT00288015|102025857|FG000|COMPLETED|Bevacizumab Treatment Cycles 1-2||30||
48690525|NCT00288015|102025857|FG000|NOT COMPLETED|Bevacizumab Treatment Cycles 1-2||2||
48690526|NCT00288015|102025857|FG000|STARTED|First Response Assessment||30||
48690527|NCT00288015|102025857|FG000|COMPLETED|First Response Assessment||26||
48690528|NCT00288015|102025857|FG000|NOT COMPLETED|First Response Assessment||4||
48690529|NCT00288015|102025857|FG000|STARTED|Continued Bevacizumab Cycle 3+||26||
48690530|NCT00288015|102025857|FG000|COMPLETED|Continued Bevacizumab Cycle 3+||19||
48545335|NCT00306995|101671314|FG004|STARTED|Study Part I||55||
48545336|NCT00306995|101671315|FG005|STARTED|Study Part I||55||
48545337|NCT00306995|101671316|FG006|STARTED|Study Part I||55||
48545338|NCT00306995|101671310|FG000|COMPLETED|Study Part I||55||
48545339|NCT00306995|101671311|FG001|COMPLETED|Study Part I||55||
48545340|NCT00306995|101671312|FG002|COMPLETED|Study Part I||55||
48545341|NCT00306995|101671313|FG003|COMPLETED|Study Part I||55||
48545342|NCT00306995|101671314|FG004|COMPLETED|Study Part I||55||
48545343|NCT00306995|101671315|FG005|COMPLETED|Study Part I||55||
48545344|NCT00306995|101671316|FG006|COMPLETED|Study Part I||54||
48545345|NCT00306995|101671310|FG000|NOT COMPLETED|Study Part I||0||
48545346|NCT00306995|101671311|FG001|NOT COMPLETED|Study Part I||0||
48545347|NCT00306995|101671312|FG002|NOT COMPLETED|Study Part I||0||
48545348|NCT00306995|101671313|FG003|NOT COMPLETED|Study Part I||0||
48545349|NCT00306995|101671314|FG004|NOT COMPLETED|Study Part I||0||
48545350|NCT00306995|101671315|FG005|NOT COMPLETED|Study Part I||0||
48545351|NCT00306995|101671316|FG006|NOT COMPLETED|Study Part I||1||
48545352|NCT00306995|101671310|FG000|STARTED|Study Part II for Subset 1||27||
48545353|NCT00306995|101671311|FG001|STARTED|Study Part II for Subset 1||26||
48545354|NCT00306995|101671312|FG002|STARTED|Study Part II for Subset 1||27||
48545355|NCT00306995|101671313|FG003|STARTED|Study Part II for Subset 1||27||
48545356|NCT00306995|101671314|FG004|STARTED|Study Part II for Subset 1||27||
48545357|NCT00306995|101671315|FG005|STARTED|Study Part II for Subset 1||26||
48545358|NCT00306995|101671316|FG006|STARTED|Study Part II for Subset 1||23||
48545359|NCT00306995|101671310|FG000|COMPLETED|Study Part II for Subset 1||27||
48545360|NCT00306995|101671311|FG001|COMPLETED|Study Part II for Subset 1||26||
48545361|NCT00306995|101671312|FG002|COMPLETED|Study Part II for Subset 1||27||
48545362|NCT00306995|101671313|FG003|COMPLETED|Study Part II for Subset 1||27||
48545363|NCT00306995|101671314|FG004|COMPLETED|Study Part II for Subset 1||27||
48545364|NCT00306995|101671315|FG005|COMPLETED|Study Part II for Subset 1||26||
48545365|NCT00306995|101671316|FG006|COMPLETED|Study Part II for Subset 1||23||
48545366|NCT00306995|101671310|FG000|NOT COMPLETED|Study Part II for Subset 1||0||
48545367|NCT00306995|101671311|FG001|NOT COMPLETED|Study Part II for Subset 1||0||
48545368|NCT00306995|101671312|FG002|NOT COMPLETED|Study Part II for Subset 1||0||
48545369|NCT00306995|101671313|FG003|NOT COMPLETED|Study Part II for Subset 1||0||
48545370|NCT00306995|101671314|FG004|NOT COMPLETED|Study Part II for Subset 1||0||
48545371|NCT00306995|101671315|FG005|NOT COMPLETED|Study Part II for Subset 1||0||
48545372|NCT00306995|101671316|FG006|NOT COMPLETED|Study Part II for Subset 1||0||
48545373|NCT00306995|101671310|FG000|STARTED|Study Part II for Subset 2||23||
48545374|NCT00306995|101671311|FG001|STARTED|Study Part II for Subset 2||24||
48545375|NCT00306995|101671312|FG002|STARTED|Study Part II for Subset 2||23||
48545376|NCT00306995|101671313|FG003|STARTED|Study Part II for Subset 2||22||
48690531|NCT00288015|102025857|FG000|NOT COMPLETED|Continued Bevacizumab Cycle 3+||7||
48690532|NCT00288015|102025857|FG000|STARTED|Follow up for Survival x 2 Years||29|Includes all patients who received bevacizumab cycle 1 and were still living.|
48690533|NCT00288015|102025857|FG000|COMPLETED|Follow up for Survival x 2 Years||3||
48690534|NCT00288015|102025857|FG000|NOT COMPLETED|Follow up for Survival x 2 Years||26||
48690535|NCT02526212|102025858|FG000|STARTED|Overall Study||10||
48690536|NCT02526212|102025859|FG001|STARTED|Overall Study||8||
48545377|NCT00306995|101671314|FG004|STARTED|Study Part II for Subset 2||23||
48545378|NCT00306995|101671315|FG005|STARTED|Study Part II for Subset 2||26||
48545379|NCT00306995|101671316|FG006|STARTED|Study Part II for Subset 2||24||
48545380|NCT00306995|101671310|FG000|COMPLETED|Study Part II for Subset 2||23||
48545381|NCT00306995|101671311|FG001|COMPLETED|Study Part II for Subset 2||23||
48545382|NCT00306995|101671312|FG002|COMPLETED|Study Part II for Subset 2||23||
48545383|NCT00306995|101671313|FG003|COMPLETED|Study Part II for Subset 2||22||
48690537|NCT02526212|102025858|FG000|COMPLETED|Overall Study||8||
48545384|NCT00306995|101671314|FG004|COMPLETED|Study Part II for Subset 2||23||
48545385|NCT00306995|101671315|FG005|COMPLETED|Study Part II for Subset 2||26||
48545386|NCT00306995|101671316|FG006|COMPLETED|Study Part II for Subset 2||24||
48545387|NCT00306995|101671310|FG000|NOT COMPLETED|Study Part II for Subset 2||0||
48545388|NCT00306995|101671311|FG001|NOT COMPLETED|Study Part II for Subset 2||1||
48545389|NCT00306995|101671312|FG002|NOT COMPLETED|Study Part II for Subset 2||0||
48545390|NCT00306995|101671313|FG003|NOT COMPLETED|Study Part II for Subset 2||0||
48545391|NCT00306995|101671314|FG004|NOT COMPLETED|Study Part II for Subset 2||0||
48545392|NCT00306995|101671315|FG005|NOT COMPLETED|Study Part II for Subset 2||0||
48545393|NCT00306995|101671316|FG006|NOT COMPLETED|Study Part II for Subset 2||0||
48545394|NCT01887171|101671317|FG000|STARTED|Overall Study||43||
48545395|NCT01887171|101671318|FG001|STARTED|Overall Study||43||
48545396|NCT01887171|101671317|FG000|COMPLETED|Overall Study||43||
48545397|NCT01887171|101671318|FG001|COMPLETED|Overall Study||43||
48545398|NCT01887171|101671317|FG000|NOT COMPLETED|Overall Study||0||
48545399|NCT01887171|101671318|FG001|NOT COMPLETED|Overall Study||0||
48545400|NCT02441660|101671319|FG000|STARTED|Sequence 1 (12 Weeks)||5||
48545401|NCT02441660|101671320|FG001|STARTED|Sequence 1 (12 Weeks)||6||
48545402|NCT02441660|101671319|FG000|COMPLETED|Sequence 1 (12 Weeks)||5||
48545403|NCT02441660|101671320|FG001|COMPLETED|Sequence 1 (12 Weeks)||6||
48545404|NCT02441660|101671319|FG000|NOT COMPLETED|Sequence 1 (12 Weeks)||0||
48545405|NCT02441660|101671320|FG001|NOT COMPLETED|Sequence 1 (12 Weeks)||0||
48545406|NCT02441660|101671319|FG000|STARTED|Sequence 2 (12 Weeks)||5||
48545407|NCT02441660|101671320|FG001|STARTED|Sequence 2 (12 Weeks)||6||
48545408|NCT02441660|101671319|FG000|COMPLETED|Sequence 2 (12 Weeks)||5||
48545409|NCT02441660|101671320|FG001|COMPLETED|Sequence 2 (12 Weeks)||6||
48545410|NCT02441660|101671319|FG000|NOT COMPLETED|Sequence 2 (12 Weeks)||0||
48545411|NCT02441660|101671320|FG001|NOT COMPLETED|Sequence 2 (12 Weeks)||0||
48545412|NCT03714919|101671321|FG000|STARTED|Overall Study||10||
48545413|NCT03714919|101671321|FG000|COMPLETED|Overall Study||10||
48545414|NCT03714919|101671321|FG000|NOT COMPLETED|Overall Study||0||
48545415|NCT00998309|101671322|FG000|STARTED|Overall Study||502||
48545416|NCT00998309|101671322|FG000|COMPLETED|Overall Study||498||
48545417|NCT00998309|101671322|FG000|NOT COMPLETED|Overall Study||4||
48545418|NCT00474266|101671323|FG000|STARTED|Overall Study||375||
48545419|NCT00474266|101671324|FG001|STARTED|Overall Study||374||
48545420|NCT00474266|101671325|FG002|STARTED|Overall Study||126||
48545421|NCT00474266|101671326|FG003|STARTED|Overall Study||125||
48545422|NCT00474266|101671323|FG000|COMPLETED|Overall Study||368||
48545423|NCT00474266|101671324|FG001|COMPLETED|Overall Study||354||
48545424|NCT00474266|101671325|FG002|COMPLETED|Overall Study||122||
48545425|NCT00474266|101671326|FG003|COMPLETED|Overall Study||118||
48545426|NCT00474266|101671323|FG000|NOT COMPLETED|Overall Study||7||
48545427|NCT00474266|101671324|FG001|NOT COMPLETED|Overall Study||20||
48545428|NCT00474266|101671325|FG002|NOT COMPLETED|Overall Study||4||
48545429|NCT00474266|101671326|FG003|NOT COMPLETED|Overall Study||7||
48545430|NCT00901576|101671327|FG000|STARTED|First Intervention||6||
48545431|NCT00901576|101671328|FG001|STARTED|First Intervention||7||
48545432|NCT00901576|101671329|FG002|STARTED|First Intervention||7||
48545433|NCT00901576|101671330|FG003|STARTED|First Intervention||6||
48545434|NCT00901576|101671331|FG004|STARTED|First Intervention||6||
48545435|NCT00901576|101671332|FG005|STARTED|First Intervention||6||
48545436|NCT00901576|101671327|FG000|COMPLETED|First Intervention||6||
48545437|NCT00901576|101671328|FG001|COMPLETED|First Intervention||7||
48545438|NCT00901576|101671329|FG002|COMPLETED|First Intervention||7||
48545439|NCT00901576|101671330|FG003|COMPLETED|First Intervention||6||
48545440|NCT00901576|101671331|FG004|COMPLETED|First Intervention||6||
48545441|NCT00901576|101671332|FG005|COMPLETED|First Intervention||6||
48545442|NCT00901576|101671327|FG000|NOT COMPLETED|First Intervention||0||
48545443|NCT00901576|101671328|FG001|NOT COMPLETED|First Intervention||0||
48545444|NCT00901576|101671329|FG002|NOT COMPLETED|First Intervention||0||
48545445|NCT00901576|101671330|FG003|NOT COMPLETED|First Intervention||0||
48545446|NCT00901576|101671331|FG004|NOT COMPLETED|First Intervention||0||
48545447|NCT00901576|101671332|FG005|NOT COMPLETED|First Intervention||0||
48545448|NCT00901576|101671327|FG000|STARTED|Washout||6||
48545449|NCT00901576|101671328|FG001|STARTED|Washout||7||
48545450|NCT00901576|101671329|FG002|STARTED|Washout||7||
48545451|NCT00901576|101671330|FG003|STARTED|Washout||6||
48545452|NCT00901576|101671331|FG004|STARTED|Washout||6||
48545453|NCT00901576|101671332|FG005|STARTED|Washout||6||
48545454|NCT00901576|101671327|FG000|COMPLETED|Washout||6||
48545455|NCT00901576|101671328|FG001|COMPLETED|Washout||7||
48545456|NCT00901576|101671329|FG002|COMPLETED|Washout||7||
48545457|NCT00901576|101671330|FG003|COMPLETED|Washout||6||
48545458|NCT00901576|101671331|FG004|COMPLETED|Washout||6||
48545459|NCT00901576|101671332|FG005|COMPLETED|Washout||6||
48545460|NCT00901576|101671327|FG000|NOT COMPLETED|Washout||0||
48545461|NCT00901576|101671328|FG001|NOT COMPLETED|Washout||0||
48545462|NCT00901576|101671329|FG002|NOT COMPLETED|Washout||0||
48545463|NCT00901576|101671330|FG003|NOT COMPLETED|Washout||0||
48545464|NCT00901576|101671331|FG004|NOT COMPLETED|Washout||0||
48545465|NCT00901576|101671332|FG005|NOT COMPLETED|Washout||0||
48545466|NCT00901576|101671327|FG000|STARTED|Second Intervention||6||
48545467|NCT00901576|101671328|FG001|STARTED|Second Intervention||7||
48545468|NCT00901576|101671329|FG002|STARTED|Second Intervention||7||
48545469|NCT00901576|101671330|FG003|STARTED|Second Intervention||6||
48545470|NCT00901576|101671331|FG004|STARTED|Second Intervention||6||
48545471|NCT00901576|101671332|FG005|STARTED|Second Intervention||6||
48545472|NCT00901576|101671327|FG000|COMPLETED|Second Intervention||5||
48545473|NCT00901576|101671328|FG001|COMPLETED|Second Intervention||7||
48545474|NCT00901576|101671329|FG002|COMPLETED|Second Intervention||7||
48545475|NCT00901576|101671330|FG003|COMPLETED|Second Intervention||5||
48545476|NCT00901576|101671331|FG004|COMPLETED|Second Intervention||6||
48545477|NCT00901576|101671332|FG005|COMPLETED|Second Intervention||5||
48545478|NCT00901576|101671327|FG000|NOT COMPLETED|Second Intervention||1||
48545479|NCT00901576|101671328|FG001|NOT COMPLETED|Second Intervention||0||
48545480|NCT00901576|101671329|FG002|NOT COMPLETED|Second Intervention||0||
48545481|NCT00901576|101671330|FG003|NOT COMPLETED|Second Intervention||1||
48545482|NCT00901576|101671331|FG004|NOT COMPLETED|Second Intervention||0||
48545483|NCT00901576|101671332|FG005|NOT COMPLETED|Second Intervention||1||
48545484|NCT00901576|101671327|FG000|STARTED|Washout||5||
48545485|NCT00901576|101671328|FG001|STARTED|Washout||7||
48545486|NCT00901576|101671329|FG002|STARTED|Washout||7||
48545487|NCT00901576|101671330|FG003|STARTED|Washout||5||
48545488|NCT00901576|101671331|FG004|STARTED|Washout||6||
48545489|NCT00901576|101671332|FG005|STARTED|Washout||5||
48545490|NCT00901576|101671327|FG000|COMPLETED|Washout||5||
48545491|NCT00901576|101671328|FG001|COMPLETED|Washout||7||
48545492|NCT00901576|101671329|FG002|COMPLETED|Washout||7||
48545493|NCT00901576|101671330|FG003|COMPLETED|Washout||5||
48545494|NCT00901576|101671331|FG004|COMPLETED|Washout||6||
48545495|NCT00901576|101671332|FG005|COMPLETED|Washout||5||
48545496|NCT00901576|101671327|FG000|NOT COMPLETED|Washout||0||
48545497|NCT00901576|101671328|FG001|NOT COMPLETED|Washout||0||
48545498|NCT00901576|101671329|FG002|NOT COMPLETED|Washout||0||
48545499|NCT00901576|101671330|FG003|NOT COMPLETED|Washout||0||
48545500|NCT00901576|101671331|FG004|NOT COMPLETED|Washout||0||
48545501|NCT00901576|101671332|FG005|NOT COMPLETED|Washout||0||
48545502|NCT00901576|101671327|FG000|STARTED|Third Intervention||5||
48545503|NCT00901576|101671328|FG001|STARTED|Third Intervention||7||
48545504|NCT00901576|101671329|FG002|STARTED|Third Intervention||7||
48545505|NCT00901576|101671330|FG003|STARTED|Third Intervention||5||
48545506|NCT00901576|101671331|FG004|STARTED|Third Intervention||6||
48545507|NCT00901576|101671332|FG005|STARTED|Third Intervention||5||
48545508|NCT00901576|101671327|FG000|COMPLETED|Third Intervention||5||
48545509|NCT00901576|101671328|FG001|COMPLETED|Third Intervention||7||
48545510|NCT00901576|101671329|FG002|COMPLETED|Third Intervention||7||
48545511|NCT00901576|101671330|FG003|COMPLETED|Third Intervention||5||
48545512|NCT00901576|101671331|FG004|COMPLETED|Third Intervention||6||
48545513|NCT00901576|101671332|FG005|COMPLETED|Third Intervention||5||
48545514|NCT00901576|101671327|FG000|NOT COMPLETED|Third Intervention||0||
48545515|NCT00901576|101671328|FG001|NOT COMPLETED|Third Intervention||0||
48545516|NCT00901576|101671329|FG002|NOT COMPLETED|Third Intervention||0||
48545517|NCT00901576|101671330|FG003|NOT COMPLETED|Third Intervention||0||
48545518|NCT00901576|101671331|FG004|NOT COMPLETED|Third Intervention||0||
48545519|NCT00901576|101671332|FG005|NOT COMPLETED|Third Intervention||0||
48545520|NCT05478252|101671333|FG000|STARTED|Overall Study||291||
48545521|NCT05478252|101671334|FG001|STARTED|Overall Study||97||
48545522|NCT05478252|101671333|FG000|Full Analysis Set|Overall Study||291||
48545523|NCT05478252|101671334|FG001|Full Analysis Set|Overall Study||97||
48545524|NCT05478252|101671333|FG000|Safety Analysis Set|Overall Study||291||
48545525|NCT05478252|101671334|FG001|Safety Analysis Set|Overall Study||97||
48545526|NCT05478252|101671333|FG000|COMPLETED|Overall Study||283||
48545527|NCT05478252|101671334|FG001|COMPLETED|Overall Study||91||
48545528|NCT05478252|101671333|FG000|NOT COMPLETED|Overall Study||8||
48545529|NCT05478252|101671334|FG001|NOT COMPLETED|Overall Study||6||
48545530|NCT02290223|101671335|FG000|STARTED|Baseline||189||
48545531|NCT02290223|101671336|FG001|STARTED|Baseline||187||
48545532|NCT02290223|101671335|FG000|COMPLETED|Baseline||189||
48545533|NCT02290223|101671336|FG001|COMPLETED|Baseline||187||
48545534|NCT02290223|101671335|FG000|NOT COMPLETED|Baseline||0||
48545535|NCT02290223|101671336|FG001|NOT COMPLETED|Baseline||0||
48545536|NCT02290223|101671335|FG000|STARTED|6 Months||189||
48545537|NCT02290223|101671336|FG001|STARTED|6 Months||187||
48545538|NCT02290223|101671335|FG000|COMPLETED|6 Months||173||
48545539|NCT02290223|101671336|FG001|COMPLETED|6 Months||181||
48545540|NCT02290223|101671335|FG000|NOT COMPLETED|6 Months||16||
48545541|NCT02290223|101671336|FG001|NOT COMPLETED|6 Months||6||
48545542|NCT02290223|101671335|FG000|STARTED|12 Months||182||
48545543|NCT02290223|101671336|FG001|STARTED|12 Months||187||
48545544|NCT02290223|101671335|FG000|COMPLETED|12 Months||166||
48545545|NCT02290223|101671336|FG001|COMPLETED|12 Months||176||
48545546|NCT02290223|101671335|FG000|NOT COMPLETED|12 Months||16||
48545547|NCT02290223|101671336|FG001|NOT COMPLETED|12 Months||11||
48545548|NCT00258128|101671337|FG000|STARTED|Overall Study||8||
48545549|NCT00258128|101671338|FG001|STARTED|Overall Study||9||
48545550|NCT00258128|101671337|FG000|COMPLETED|Overall Study||8||
48545551|NCT00258128|101671338|FG001|COMPLETED|Overall Study||9||
48545552|NCT00258128|101671337|FG000|NOT COMPLETED|Overall Study||0||
48545553|NCT00258128|101671338|FG001|NOT COMPLETED|Overall Study||0||
48545554|NCT00727597|101671339|FG000|STARTED|Overall Study||51||
48545555|NCT00727597|101671340|FG001|STARTED|Overall Study||50||
48545556|NCT00727597|101671339|FG000|COMPLETED|Overall Study||51||
48545557|NCT00727597|101671340|FG001|COMPLETED|Overall Study||50||
48545558|NCT00727597|101671339|FG000|NOT COMPLETED|Overall Study||0||
48545559|NCT00727597|101671340|FG001|NOT COMPLETED|Overall Study||0||
48545560|NCT02876757|101671341|FG000|STARTED|Overall Study||93197||
48545561|NCT02876757|101671342|FG001|STARTED|Overall Study||93197||
48545562|NCT02876757|101671341|FG000|COMPLETED|Overall Study||93197||
48545563|NCT02876757|101671342|FG001|COMPLETED|Overall Study||93197||
48545564|NCT02876757|101671341|FG000|NOT COMPLETED|Overall Study||0||
48545565|NCT02876757|101671342|FG001|NOT COMPLETED|Overall Study||0||
48545566|NCT00681031|101671343|FG000|STARTED|Overall Study||96||
48545567|NCT00681031|101671343|FG000|COMPLETED|Overall Study||96||
48545568|NCT00681031|101671343|FG000|NOT COMPLETED|Overall Study||0||
48545569|NCT00478244|101671344|FG000|STARTED|Overall Study||7||
48545570|NCT00478244|101671344|FG000|COMPLETED|Overall Study||6||
48545571|NCT00478244|101671344|FG000|NOT COMPLETED|Overall Study||1||
48545572|NCT01590797|101671345|FG000|STARTED|Overall Study||234||
48545573|NCT01590797|101671346|FG001|STARTED|Overall Study||233||
48545574|NCT01590797|101671345|FG000|COMPLETED|Overall Study||217||
48545575|NCT01590797|101671346|FG001|COMPLETED|Overall Study||217||
48545576|NCT01590797|101671345|FG000|NOT COMPLETED|Overall Study||17||
48545577|NCT01590797|101671346|FG001|NOT COMPLETED|Overall Study||16||
48545578|NCT00101283|101671347|FG000|STARTED|Overall Study||16||
48545579|NCT00101283|101671348|FG001|STARTED|Overall Study||16||
48545580|NCT00101283|101671347|FG000|Began Treatment|Overall Study||16||
48545581|NCT00101283|101671348|FG001|Began Treatment|Overall Study||13||
48545582|NCT00101283|101671347|FG000|COMPLETED|Overall Study||16||
48262821|NCT00891046|100966645|FG003|NOT COMPLETED|Overall Study||3||
48262822|NCT00891046|100966646|FG004|NOT COMPLETED|Overall Study||39||
48262823|NCT01453023|100966647|FG000|STARTED|Treatment Period (TP) 1||13||
48262824|NCT01453023|100966648|FG001|STARTED|Treatment Period (TP) 1||13||
48262825|NCT01453023|100966647|FG000|COMPLETED|Treatment Period (TP) 1||12||
48262826|NCT01453023|100966648|FG001|COMPLETED|Treatment Period (TP) 1||12||
48262827|NCT01453023|100966647|FG000|NOT COMPLETED|Treatment Period (TP) 1||1||
48262828|NCT01453023|100966648|FG001|NOT COMPLETED|Treatment Period (TP) 1||1||
48262829|NCT01453023|100966647|FG000|STARTED|Washout Period||12||
48262830|NCT01453023|100966648|FG001|STARTED|Washout Period||12||
48262831|NCT01453023|100966647|FG000|COMPLETED|Washout Period||12||
48262832|NCT01453023|100966648|FG001|COMPLETED|Washout Period||12||
48262833|NCT01453023|100966647|FG000|NOT COMPLETED|Washout Period||0||
48262834|NCT01453023|100966648|FG001|NOT COMPLETED|Washout Period||0||
48262835|NCT01453023|100966647|FG000|STARTED|Treatment Period 2||12||
48262836|NCT01453023|100966648|FG001|STARTED|Treatment Period 2||12||
48262837|NCT01453023|100966647|FG000|COMPLETED|Treatment Period 2||12||
48262838|NCT01453023|100966648|FG001|COMPLETED|Treatment Period 2||11||
48262839|NCT01453023|100966647|FG000|NOT COMPLETED|Treatment Period 2||0||
48262840|NCT01453023|100966648|FG001|NOT COMPLETED|Treatment Period 2||1||
48262841|NCT00675584|100966649|FG000|STARTED|Overall Study||139||
48262842|NCT00675584|100966650|FG001|STARTED|Overall Study||139||
48262843|NCT00675584|100966649|FG000|COMPLETED|Overall Study||100||
48262844|NCT00675584|100966650|FG001|COMPLETED|Overall Study||113||
48262845|NCT00675584|100966649|FG000|NOT COMPLETED|Overall Study||39||
48262846|NCT00675584|100966650|FG001|NOT COMPLETED|Overall Study||26||
48262847|NCT00823836|100966651|FG000|STARTED|NV and PR/XR Switching Phases||156||
48545583|NCT00101283|101671348|FG001|COMPLETED|Overall Study||13||
48545584|NCT00101283|101671347|FG000|NOT COMPLETED|Overall Study||0||
48545585|NCT00101283|101671348|FG001|NOT COMPLETED|Overall Study||3||
48545586|NCT03336528|101671349|FG000|STARTED|Overall Study||92||
48545587|NCT03336528|101671350|FG001|STARTED|Overall Study||88||
48545588|NCT03336528|101671349|FG000|Participated in Optional Outpatient Study|Overall Study||72||
48545589|NCT03336528|101671350|FG001|Participated in Optional Outpatient Study|Overall Study||59||
48545590|NCT03336528|101671349|FG000|COMPLETED|Overall Study||82|Completed inpatient portion of the study|
48545591|NCT03336528|101671350|FG001|COMPLETED|Overall Study||79|Completed inpatient portion of the study|
48545592|NCT03336528|101671349|FG000|NOT COMPLETED|Overall Study||10||
48545593|NCT03336528|101671350|FG001|NOT COMPLETED|Overall Study||9||
48545594|NCT03447743|101671351|FG000|STARTED|Overall Study||9||
48545595|NCT03447743|101671351|FG000|COMPLETED|Overall Study||2||
48545596|NCT03447743|101671351|FG000|NOT COMPLETED|Overall Study||7||
48545597|NCT00314951|101671352|FG000|STARTED|Enrollment||323||
48545598|NCT00314951|101671353|FG001|STARTED|Enrollment||306||
48545599|NCT00314951|101671352|FG000|COMPLETED|Enrollment||323||
48545600|NCT00314951|101671353|FG001|COMPLETED|Enrollment||300||
48545601|NCT00314951|101671352|FG000|NOT COMPLETED|Enrollment||0||
48545602|NCT00314951|101671353|FG001|NOT COMPLETED|Enrollment||6||
48545603|NCT00314951|101671352|FG000|STARTED|Treatment||323||
48545604|NCT00314951|101671353|FG001|STARTED|Treatment||300||
48545605|NCT00314951|101671352|FG000|COMPLETED|Treatment||307||
48545606|NCT00314951|101671353|FG001|COMPLETED|Treatment||289||
48545607|NCT00314951|101671352|FG000|NOT COMPLETED|Treatment||16||
48545608|NCT00314951|101671353|FG001|NOT COMPLETED|Treatment||11||
48545609|NCT00314951|101671352|FG000|STARTED|Follow-up||307||
48545610|NCT00314951|101671353|FG001|STARTED|Follow-up||289||
48262848|NCT00823836|100966652|FG001|STARTED|NV and PR/XR Switching Phases||146||
48262849|NCT00823836|100966651|FG000|COMPLETED|NV and PR/XR Switching Phases||124||
48262850|NCT00823836|100966652|FG001|COMPLETED|NV and PR/XR Switching Phases||117||
48262851|NCT00823836|100966651|FG000|NOT COMPLETED|NV and PR/XR Switching Phases||32||
48262852|NCT00823836|100966652|FG001|NOT COMPLETED|NV and PR/XR Switching Phases||29||
48262853|NCT00823836|100966651|FG000|STARTED|Long-term Phase||73||
48262854|NCT00823836|100966652|FG001|STARTED|Long-term Phase||84||
48262855|NCT00823836|100966651|FG000|COMPLETED|Long-term Phase||68||
48262856|NCT00823836|100966652|FG001|COMPLETED|Long-term Phase||79||
48262857|NCT00823836|100966651|FG000|NOT COMPLETED|Long-term Phase||5||
48262858|NCT00823836|100966652|FG001|NOT COMPLETED|Long-term Phase||5||
48262859|NCT00356811|100966653|FG000|STARTED|Overall Study||57||
48262860|NCT00356811|100966653|FG000|COMPLETED|Overall Study||8||
48262861|NCT00356811|100966653|FG000|NOT COMPLETED|Overall Study||49||
48262862|NCT02577003|100966654|FG000|STARTED|Overall Study||73||
48262863|NCT02577003|100966655|FG001|STARTED|Overall Study||70||
48262864|NCT02577003|100966654|FG000|COMPLETED|Overall Study||71||
48262865|NCT02577003|100966655|FG001|COMPLETED|Overall Study||65||
48262866|NCT02577003|100966654|FG000|NOT COMPLETED|Overall Study||2||
48262867|NCT02577003|100966655|FG001|NOT COMPLETED|Overall Study||5||
48262868|NCT02818998|100966656|FG000|STARTED|Overall Study||155||
48262869|NCT02818998|100966657|FG001|STARTED|Overall Study||154||
48262870|NCT02818998|100966658|FG002|STARTED|Overall Study||154||
48262871|NCT02818998|100966656|FG000|Completed Week 52 Visit|Overall Study||144||
48262872|NCT02818998|100966657|FG001|Completed Week 52 Visit|Overall Study||146||
48262873|NCT02818998|100966658|FG002|Completed Week 52 Visit|Overall Study||140||
48262874|NCT02818998|100966656|FG000|COMPLETED|Overall Study||137|Completed Week 100 visit|
48262875|NCT02818998|100966657|FG001|COMPLETED|Overall Study||138|Completed Week 100 visit|
48262876|NCT02818998|100966658|FG002|COMPLETED|Overall Study||136|Completed Week 100 visit|
48262877|NCT02818998|100966656|FG000|NOT COMPLETED|Overall Study||18||
48262878|NCT02818998|100966657|FG001|NOT COMPLETED|Overall Study||16||
48262879|NCT02818998|100966658|FG002|NOT COMPLETED|Overall Study||18||
48262880|NCT01210651|100966659|FG000|STARTED|Overall Study||20||
48262881|NCT01210651|100966660|FG001|STARTED|Overall Study||18||
48262882|NCT01210651|100966659|FG000|Number Attending 1st Assigned Session|Overall Study||18||
48262883|NCT01210651|100966660|FG001|Number Attending 1st Assigned Session|Overall Study||12||
48262884|NCT01210651|100966659|FG000|COMPLETED|Overall Study||15||
48262885|NCT01210651|100966660|FG001|COMPLETED|Overall Study||10||
48262886|NCT01210651|100966659|FG000|NOT COMPLETED|Overall Study||5||
48262887|NCT01210651|100966660|FG001|NOT COMPLETED|Overall Study||8||
48262888|NCT01059305|100966661|FG000|STARTED|Overall Study||10||
48262889|NCT01059305|100966661|FG000|COMPLETED|Overall Study||10||
48262890|NCT01059305|100966661|FG000|NOT COMPLETED|Overall Study||0||
48262891|NCT01677299|100966662|FG000|STARTED|Overall Study||6||
48262892|NCT01677299|100966663|FG001|STARTED|Overall Study||6||
48262893|NCT01677299|100966664|FG002|STARTED|Overall Study||6||
48262894|NCT01677299|100966665|FG003|STARTED|Overall Study||6||
48262895|NCT01677299|100966662|FG000|COMPLETED|Overall Study||6||
48262896|NCT01677299|100966663|FG001|COMPLETED|Overall Study||3||
48262897|NCT01677299|100966664|FG002|COMPLETED|Overall Study||5||
48262898|NCT01677299|100966665|FG003|COMPLETED|Overall Study||5||
48262899|NCT01677299|100966662|FG000|NOT COMPLETED|Overall Study||0||
48262900|NCT01677299|100966663|FG001|NOT COMPLETED|Overall Study||3||
48262901|NCT01677299|100966664|FG002|NOT COMPLETED|Overall Study||1||
48262902|NCT01677299|100966665|FG003|NOT COMPLETED|Overall Study||1||
48262903|NCT01090011|100966666|FG000|STARTED|Overall Study||171||
48262904|NCT01090011|100966666|FG000|COMPLETED|Overall Study||0||
48262905|NCT01090011|100966666|FG000|NOT COMPLETED|Overall Study||171||
48262906|NCT00624910|100966667|FG000|STARTED|Overall Study||28||
48262907|NCT00624910|100966668|FG001|STARTED|Overall Study||15||
48262908|NCT00624910|100966669|FG002|STARTED|Overall Study||11||
48262909|NCT00624910|100966667|FG000|COMPLETED|Overall Study||28||
48262910|NCT00624910|100966668|FG001|COMPLETED|Overall Study||15||
48262911|NCT00624910|100966669|FG002|COMPLETED|Overall Study||11||
48262912|NCT00624910|100966667|FG000|NOT COMPLETED|Overall Study||0||
48262913|NCT00624910|100966668|FG001|NOT COMPLETED|Overall Study||0||
48262914|NCT00624910|100966669|FG002|NOT COMPLETED|Overall Study||0||
48262915|NCT02498236|100966670|FG000|STARTED|Overall Study||6||
48262916|NCT02498236|100966671|FG001|STARTED|Overall Study||6||
48262917|NCT02498236|100966672|FG002|STARTED|Overall Study||6||
48262918|NCT02498236|100966673|FG003|STARTED|Overall Study||6||
48262919|NCT02498236|100966674|FG004|STARTED|Overall Study||7||
48262920|NCT02498236|100966675|FG005|STARTED|Overall Study||6||
48262921|NCT02498236|100966676|FG006|STARTED|Overall Study||7||
48262922|NCT02498236|100966677|FG007|STARTED|Overall Study||7||
48262923|NCT02498236|100966670|FG000|Randomized|Overall Study||6||
48262924|NCT02498236|100966671|FG001|Randomized|Overall Study||6||
48262925|NCT02498236|100966672|FG002|Randomized|Overall Study||6||
48262926|NCT02498236|100966673|FG003|Randomized|Overall Study||6||
48262927|NCT02498236|100966674|FG004|Randomized|Overall Study||7||
48690538|NCT02526212|102025859|FG001|COMPLETED|Overall Study||7||
48690539|NCT02526212|102025858|FG000|NOT COMPLETED|Overall Study||2||
48690540|NCT02526212|102025859|FG001|NOT COMPLETED|Overall Study||1||
48690541|NCT00175916|102025860|FG000|STARTED|Overall Study||853||
48690542|NCT00175916|102025860|FG000|COMPLETED|Overall Study||234||
48690543|NCT00175916|102025860|FG000|NOT COMPLETED|Overall Study||619||
48690544|NCT00711594|102025861|FG000|STARTED|Overall Study||3||
48690545|NCT00711594|102025862|FG001|STARTED|Overall Study||3||
48098512|NCT00183092|100568067|FG000|COMPLETED|Double-blind (Baseline - Month 2)||11||
48098513|NCT00183092|100568068|FG001|COMPLETED|Double-blind (Baseline - Month 2)||16||
48098514|NCT00183092|100568069|FG002|COMPLETED|Double-blind (Baseline - Month 2)||0||
48098515|NCT00183092|100568070|FG003|COMPLETED|Double-blind (Baseline - Month 2)||0||
48098516|NCT00183092|100568067|FG000|NOT COMPLETED|Double-blind (Baseline - Month 2)||12||
48098517|NCT00183092|100568068|FG001|NOT COMPLETED|Double-blind (Baseline - Month 2)||12||
48098518|NCT00183092|100568069|FG002|NOT COMPLETED|Double-blind (Baseline - Month 2)||0||
48098519|NCT00183092|100568070|FG003|NOT COMPLETED|Double-blind (Baseline - Month 2)||0||
48098520|NCT00183092|100568067|FG000|STARTED|Open-label Period (Month 2 Until Death)||10||
48098521|NCT00183092|100568068|FG001|STARTED|Open-label Period (Month 2 Until Death)||14||
48098522|NCT00183092|100568069|FG002|STARTED|Open-label Period (Month 2 Until Death)||1||
48098523|NCT00183092|100568070|FG003|STARTED|Open-label Period (Month 2 Until Death)||1||
48098524|NCT00183092|100568067|FG000|COMPLETED|Open-label Period (Month 2 Until Death)||0||
48262928|NCT02498236|100966675|FG005|Randomized|Overall Study||6||
48262929|NCT02498236|100966676|FG006|Randomized|Overall Study||7||
48262930|NCT02498236|100966677|FG007|Randomized|Overall Study||7||
48262931|NCT02498236|100966670|FG000|COMPLETED|Overall Study||5||
48262932|NCT02498236|100966671|FG001|COMPLETED|Overall Study||6||
48262933|NCT02498236|100966672|FG002|COMPLETED|Overall Study||6||
48262934|NCT02498236|100966673|FG003|COMPLETED|Overall Study||6||
48262935|NCT02498236|100966674|FG004|COMPLETED|Overall Study||6||
48262936|NCT02498236|100966675|FG005|COMPLETED|Overall Study||6||
48262937|NCT02498236|100966676|FG006|COMPLETED|Overall Study||6||
48262938|NCT02498236|100966677|FG007|COMPLETED|Overall Study||6||
48262939|NCT02498236|100966670|FG000|NOT COMPLETED|Overall Study||1||
48262940|NCT02498236|100966671|FG001|NOT COMPLETED|Overall Study||0||
48262941|NCT02498236|100966672|FG002|NOT COMPLETED|Overall Study||0||
48262942|NCT02498236|100966673|FG003|NOT COMPLETED|Overall Study||0||
48262943|NCT02498236|100966674|FG004|NOT COMPLETED|Overall Study||1||
48262944|NCT02498236|100966675|FG005|NOT COMPLETED|Overall Study||0||
48262945|NCT02498236|100966676|FG006|NOT COMPLETED|Overall Study||1||
48262946|NCT02498236|100966677|FG007|NOT COMPLETED|Overall Study||1||
48262947|NCT00580489|100966678|FG000|STARTED|Overall Study||104||
48262948|NCT00580489|100966679|FG001|STARTED|Overall Study||100||
48262949|NCT00580489|100966678|FG000|COMPLETED|Overall Study||104||
48262950|NCT00580489|100966679|FG001|COMPLETED|Overall Study||100||
48262951|NCT00580489|100966678|FG000|NOT COMPLETED|Overall Study||0||
48262952|NCT00580489|100966679|FG001|NOT COMPLETED|Overall Study||0||
48262953|NCT02825251|100966680|FG000|STARTED|Overall Study||236||
48262954|NCT02825251|100966681|FG001|STARTED|Overall Study||236||
48262955|NCT02825251|100966680|FG000|COMPLETED|Overall Study||233||
48262956|NCT02825251|100966681|FG001|COMPLETED|Overall Study||230||
48262957|NCT02825251|100966680|FG000|NOT COMPLETED|Overall Study||3||
48262958|NCT02825251|100966681|FG001|NOT COMPLETED|Overall Study||6||
48262959|NCT02994784|100966682|FG000|STARTED|Enrolled||27||
48262960|NCT02994784|100966682|FG000|COMPLETED|Enrolled||27||
48262961|NCT02994784|100966682|FG000|NOT COMPLETED|Enrolled||0||
48262962|NCT02994784|100966682|FG000|STARTED|6 Months Follow-up||27||
48262963|NCT02994784|100966682|FG000|COMPLETED|6 Months Follow-up||24||
48262964|NCT02994784|100966682|FG000|NOT COMPLETED|6 Months Follow-up||3||
48262965|NCT02994784|100966682|FG000|STARTED|12 Month Follow-up||24||
48262966|NCT02994784|100966682|FG000|COMPLETED|12 Month Follow-up||24||
48262967|NCT02994784|100966682|FG000|NOT COMPLETED|12 Month Follow-up||0||
48262968|NCT01592396|100966683|FG000|STARTED|Overall Study||10||
48262969|NCT01592396|100966684|FG001|STARTED|Overall Study||10||
48262970|NCT01592396|100966683|FG000|COMPLETED|Overall Study||10||
48262971|NCT01592396|100966684|FG001|COMPLETED|Overall Study||10||
48262972|NCT01592396|100966683|FG000|NOT COMPLETED|Overall Study||0||
48262973|NCT01592396|100966684|FG001|NOT COMPLETED|Overall Study||0||
48262974|NCT00520845|100966685|FG000|STARTED|Overall Study||23||
48262975|NCT00520845|100966685|FG000|COMPLETED|Overall Study||1||
48262976|NCT00520845|100966685|FG000|NOT COMPLETED|Overall Study||22||
48690546|NCT00711594|102025863|FG002|STARTED|Overall Study||6||
48690547|NCT00711594|102025864|FG003|STARTED|Overall Study||62||
48690548|NCT00711594|102025861|FG000|COMPLETED|Overall Study||0||
48690549|NCT00711594|102025862|FG001|COMPLETED|Overall Study||0||
48690550|NCT00711594|102025863|FG002|COMPLETED|Overall Study||0||
48690551|NCT00711594|102025864|FG003|COMPLETED|Overall Study||0||
48690552|NCT00711594|102025861|FG000|NOT COMPLETED|Overall Study||3||
48690553|NCT00711594|102025862|FG001|NOT COMPLETED|Overall Study||3||
48690554|NCT00711594|102025863|FG002|NOT COMPLETED|Overall Study||6||
48690555|NCT00711594|102025864|FG003|NOT COMPLETED|Overall Study||62||
48690556|NCT00298389|102025865|FG000|STARTED|Overall Study||20||
48690557|NCT00298389|102025866|FG001|STARTED|Overall Study||17||
48690558|NCT00298389|102025867|FG002|STARTED|Overall Study||19||
48098525|NCT00183092|100568068|FG001|COMPLETED|Open-label Period (Month 2 Until Death)||0||
48098526|NCT00183092|100568069|FG002|COMPLETED|Open-label Period (Month 2 Until Death)||0||
48098527|NCT00183092|100568070|FG003|COMPLETED|Open-label Period (Month 2 Until Death)||0||
48098528|NCT00183092|100568067|FG000|NOT COMPLETED|Open-label Period (Month 2 Until Death)||10||
48098529|NCT00183092|100568068|FG001|NOT COMPLETED|Open-label Period (Month 2 Until Death)||14||
48545611|NCT00314951|101671352|FG000|COMPLETED|Follow-up||263||
48545612|NCT00314951|101671353|FG001|COMPLETED|Follow-up||255||
48545613|NCT00314951|101671352|FG000|NOT COMPLETED|Follow-up||44||
48545614|NCT00314951|101671353|FG001|NOT COMPLETED|Follow-up||34||
48545615|NCT04797221|101671354|FG000|STARTED|Overall Study||28||
48690559|NCT00298389|102025865|FG000|COMPLETED|Overall Study||20||
48690560|NCT00298389|102025866|FG001|COMPLETED|Overall Study||17||
48690561|NCT00298389|102025867|FG002|COMPLETED|Overall Study||19||
48690562|NCT00298389|102025865|FG000|NOT COMPLETED|Overall Study||0||
48690563|NCT00298389|102025866|FG001|NOT COMPLETED|Overall Study||0||
48690564|NCT00298389|102025867|FG002|NOT COMPLETED|Overall Study||0||
48098530|NCT00183092|100568069|FG002|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1||
48098531|NCT00183092|100568070|FG003|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1||
48098532|NCT02016482|100568071|FG000|STARTED|Period A||108||
48098533|NCT02016482|100568072|FG001|STARTED|Period A||109||
48098534|NCT02016482|100568071|FG000|COMPLETED|Period A||94||
48098535|NCT02016482|100568072|FG001|COMPLETED|Period A||94||
48098536|NCT02016482|100568071|FG000|NOT COMPLETED|Period A||14||
48098537|NCT02016482|100568072|FG001|NOT COMPLETED|Period A||15||
48098538|NCT02016482|100568071|FG000|STARTED|Period B||94||
48098539|NCT02016482|100568072|FG001|STARTED|Period B||94||
48098540|NCT02016482|100568071|FG000|COMPLETED|Period B||81||
48098541|NCT02016482|100568072|FG001|COMPLETED|Period B||87||
48098542|NCT02016482|100568071|FG000|NOT COMPLETED|Period B||13||
48098543|NCT02016482|100568072|FG001|NOT COMPLETED|Period B||7||
48098544|NCT03739112|100568073|FG000|STARTED|Overall Study||6396||
48098545|NCT03739112|100568074|FG001|STARTED|Overall Study||6398||
48098546|NCT03739112|100568073|FG000|Vaccinated|Overall Study||6365||
48098547|NCT03739112|100568074|FG001|Vaccinated|Overall Study||6373||
48098548|NCT03739112|100568073|FG000|COMPLETED|Overall Study||6196||
48098549|NCT03739112|100568074|FG001|COMPLETED|Overall Study||6222||
48098550|NCT03739112|100568073|FG000|NOT COMPLETED|Overall Study||200||
48098551|NCT03739112|100568074|FG001|NOT COMPLETED|Overall Study||176||
48098552|NCT05265260|100568075|FG000|STARTED|Overall Study||32||
48098553|NCT05265260|100568075|FG000|COMPLETED|Overall Study||32||
48098554|NCT05265260|100568075|FG000|NOT COMPLETED|Overall Study||0||
48098555|NCT00949325|100568076|FG000|STARTED|Overall Study||3||
48098556|NCT00949325|100568077|FG001|STARTED|Overall Study||18||
48098557|NCT00949325|100568078|FG002|STARTED|Overall Study||3||
48098558|NCT00949325|100568076|FG000|COMPLETED|Overall Study||3||
48098559|NCT00949325|100568077|FG001|COMPLETED|Overall Study||16||
48098560|NCT00949325|100568078|FG002|COMPLETED|Overall Study||3||
48098561|NCT00949325|100568076|FG000|NOT COMPLETED|Overall Study||0||
48098562|NCT00949325|100568077|FG001|NOT COMPLETED|Overall Study||2||
48098563|NCT00949325|100568078|FG002|NOT COMPLETED|Overall Study||0||
48098564|NCT02972554|100568079|FG000|STARTED|Overall Study||44||
48545616|NCT04797221|101671354|FG000|COMPLETED|Overall Study||28||
48545617|NCT04797221|101671354|FG000|NOT COMPLETED|Overall Study||0||
48545618|NCT02487303|101671355|FG000|STARTED|Overall Study||49||
48545619|NCT02487303|101671356|FG001|STARTED|Overall Study||51||
48545620|NCT02487303|101671357|FG002|STARTED|Overall Study||48||
48545621|NCT02487303|101671355|FG000|COMPLETED|Overall Study||47||
48545622|NCT02487303|101671356|FG001|COMPLETED|Overall Study||47||
48545623|NCT02487303|101671357|FG002|COMPLETED|Overall Study||47||
48690565|NCT01098253|102025868|FG000|STARTED|Overall Study||94||
48098565|NCT02972554|100568080|FG001|STARTED|Overall Study||48||
48098566|NCT02972554|100568079|FG000|COMPLETED|Overall Study||44||
48098567|NCT02972554|100568080|FG001|COMPLETED|Overall Study||48||
48098568|NCT02972554|100568079|FG000|NOT COMPLETED|Overall Study||0||
48545624|NCT02487303|101671355|FG000|NOT COMPLETED|Overall Study||2||
48545625|NCT02487303|101671356|FG001|NOT COMPLETED|Overall Study||4||
48545626|NCT02487303|101671357|FG002|NOT COMPLETED|Overall Study||1||
48545627|NCT04868500|101671358|FG000|STARTED|Overall Study||42||
48545628|NCT04868500|101671359|FG001|STARTED|Overall Study||7||
48545629|NCT04868500|101671358|FG000|Not Started|Overall Study||4|Participants and Clinical Site Staff who terminated early due to clinician's decision and who never opened the Application (App)|
48592716|NCT02143791|101783167|FG000|NOT COMPLETED|Enrolled||4||
48592717|NCT02143791|101783167|FG000|STARTED|Trial Stimulation||121||
48690566|NCT01098253|102025869|FG001|STARTED|Overall Study||88||
48098569|NCT02972554|100568080|FG001|NOT COMPLETED|Overall Study||0||
48098570|NCT01050257|100568081|FG000|STARTED|Overall Study||50||
48098571|NCT01050257|100568082|FG001|STARTED|Overall Study||53||
48098572|NCT01050257|100568083|FG002|STARTED|Overall Study||15||
48098573|NCT01050257|100568081|FG000|Received Treatment|Overall Study||49||
48098574|NCT01050257|100568082|FG001|Received Treatment|Overall Study||50||
48098575|NCT01050257|100568083|FG002|Received Treatment|Overall Study||14||
48690567|NCT01098253|102025868|FG000|COMPLETED|Overall Study||92||
48690568|NCT01098253|102025869|FG001|COMPLETED|Overall Study||88||
48690569|NCT01098253|102025868|FG000|NOT COMPLETED|Overall Study||2||
48545630|NCT04868500|101671359|FG001|Not Started|Overall Study||1|Participants and Clinical Site Staff who terminated early due to clinician's decision and who never opened the Application (App)|
48545631|NCT04868500|101671358|FG000|COMPLETED|Overall Study||38||
48545632|NCT04868500|101671359|FG001|COMPLETED|Overall Study||6||
48545633|NCT04868500|101671358|FG000|NOT COMPLETED|Overall Study||4||
48545634|NCT04868500|101671359|FG001|NOT COMPLETED|Overall Study||1||
48545635|NCT03203681|101671360|FG000|STARTED|Overall Study||60||
48545636|NCT03203681|101671360|FG000|3 Month|Overall Study||44||
48545637|NCT03203681|101671360|FG000|6 Months|Overall Study||33||
48545638|NCT03203681|101671360|FG000|COMPLETED|Overall Study||33||
48545639|NCT03203681|101671360|FG000|NOT COMPLETED|Overall Study||27||
48545640|NCT03545893|101671361|FG000|STARTED|Overall Study||35||
48545641|NCT03545893|101671362|FG001|STARTED|Overall Study||35||
48545642|NCT03545893|101671361|FG000|COMPLETED|Overall Study||35||
48545643|NCT03545893|101671362|FG001|COMPLETED|Overall Study||35||
48545644|NCT03545893|101671361|FG000|NOT COMPLETED|Overall Study||0||
48545645|NCT03545893|101671362|FG001|NOT COMPLETED|Overall Study||0||
48545646|NCT04807400|101671363|FG000|STARTED|Overall Study||298||
48545647|NCT04807400|101671364|FG001|STARTED|Overall Study||297||
48545648|NCT04807400|101671365|FG002|STARTED|Overall Study||297||
48545649|NCT04807400|101671363|FG000|Full Analysis Set|Overall Study||297|Full Analysis Set (FAS) comprised of all randomized participants except for those mis-randomized participants who did not receive study drug.|
48545650|NCT04807400|101671364|FG001|Full Analysis Set|Overall Study||297|Full Analysis Set (FAS) comprised of all randomized participants except for those mis-randomized participants who did not receive study drug.|
48545651|NCT04807400|101671365|FG002|Full Analysis Set|Overall Study||297|Full Analysis Set (FAS) comprised of all randomized participants except for those mis-randomized participants who did not receive study drug.|
48545652|NCT04807400|101671363|FG000|Safety Set|Overall Study||273|Safety Set comprised all participants who received at least one dose of study treatment.|
48545653|NCT04807400|101671364|FG001|Safety Set|Overall Study||281|Safety Set comprised all participants who received at least one dose of study treatment.|
48545654|NCT04807400|101671365|FG002|Safety Set|Overall Study||290|Safety Set comprised all participants who received at least one dose of study treatment.|
48545655|NCT04807400|101671363|FG000|COMPLETED|Overall Study||248||
48545656|NCT04807400|101671364|FG001|COMPLETED|Overall Study||252||
48545657|NCT04807400|101671365|FG002|COMPLETED|Overall Study||234||
48545658|NCT04807400|101671363|FG000|NOT COMPLETED|Overall Study||50||
48545659|NCT04807400|101671364|FG001|NOT COMPLETED|Overall Study||45||
48545660|NCT04807400|101671365|FG002|NOT COMPLETED|Overall Study||63||
48545661|NCT03741400|101671366|FG000|STARTED|Overall Study||30||
48545662|NCT03741400|101671367|FG001|STARTED|Overall Study||30||
48545663|NCT03741400|101671366|FG000|COMPLETED|Overall Study||24||
48545664|NCT03741400|101671367|FG001|COMPLETED|Overall Study||18||
48545665|NCT03741400|101671366|FG000|NOT COMPLETED|Overall Study||6||
48545666|NCT03741400|101671367|FG001|NOT COMPLETED|Overall Study||12||
48545667|NCT00633243|101671368|FG000|STARTED|Overall Study||12||
48545668|NCT00633243|101671369|FG001|STARTED|Overall Study||9||
48545669|NCT00633243|101671368|FG000|COMPLETED|Overall Study||11||
48545670|NCT00633243|101671369|FG001|COMPLETED|Overall Study||2||
48545671|NCT00633243|101671368|FG000|NOT COMPLETED|Overall Study||1||
48545672|NCT00633243|101671369|FG001|NOT COMPLETED|Overall Study||7||
48545673|NCT00486031|101671370|FG000|STARTED|Overall Study||443||
48545674|NCT00486031|101671370|FG000|COMPLETED|Overall Study||440||
48545675|NCT00486031|101671370|FG000|NOT COMPLETED|Overall Study||3||
48545676|NCT01632280|101671371|FG000|STARTED|Overall Study||6||
48545677|NCT01632280|101671372|FG001|STARTED|Overall Study||6||
48545678|NCT01632280|101671371|FG000|COMPLETED|Overall Study||5||
48545679|NCT01632280|101671372|FG001|COMPLETED|Overall Study||6||
48545680|NCT01632280|101671371|FG000|NOT COMPLETED|Overall Study||1||
48545681|NCT01632280|101671372|FG001|NOT COMPLETED|Overall Study||0||
48545682|NCT02862730|101671373|FG000|STARTED|Tslim Training Visit (2 Weeks)||4||
48545683|NCT02862730|101671374|FG001|STARTED|Tslim Training Visit (2 Weeks)||1||
48545684|NCT02862730|101671375|FG002|STARTED|Tslim Training Visit (2 Weeks)||8||
48545685|NCT02862730|101671376|FG003|STARTED|Tslim Training Visit (2 Weeks)||5||
48545686|NCT02862730|101671377|FG004|STARTED|Tslim Training Visit (2 Weeks)||5||
48545687|NCT02862730|101671378|FG005|STARTED|Tslim Training Visit (2 Weeks)||1||
48545688|NCT02862730|101671379|FG006|STARTED|Tslim Training Visit (2 Weeks)||1||
48545689|NCT02862730|101671373|FG000|COMPLETED|Tslim Training Visit (2 Weeks)||4||
48545690|NCT02862730|101671374|FG001|COMPLETED|Tslim Training Visit (2 Weeks)||1||
48545691|NCT02862730|101671375|FG002|COMPLETED|Tslim Training Visit (2 Weeks)||7||
48545692|NCT02862730|101671376|FG003|COMPLETED|Tslim Training Visit (2 Weeks)||5||
48545693|NCT02862730|101671377|FG004|COMPLETED|Tslim Training Visit (2 Weeks)||5||
48545694|NCT02862730|101671378|FG005|COMPLETED|Tslim Training Visit (2 Weeks)||1||
48545695|NCT02862730|101671379|FG006|COMPLETED|Tslim Training Visit (2 Weeks)||1||
48545696|NCT02862730|101671373|FG000|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0||
48545697|NCT02862730|101671374|FG001|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0||
48545698|NCT02862730|101671375|FG002|NOT COMPLETED|Tslim Training Visit (2 Weeks)||1||
48545699|NCT02862730|101671376|FG003|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0||
48545700|NCT02862730|101671377|FG004|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0||
48545701|NCT02862730|101671378|FG005|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0||
48545702|NCT02862730|101671379|FG006|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0||
48262977|NCT04292470|100966686|FG000|STARTED|Overall Study||2||
48262978|NCT04292470|100966687|FG001|STARTED|Overall Study||5||
48262979|NCT04292470|100966686|FG000|COMPLETED|Overall Study||2||
48262980|NCT04292470|100966687|FG001|COMPLETED|Overall Study||4||
48262981|NCT04292470|100966686|FG000|NOT COMPLETED|Overall Study||0||
48262982|NCT04292470|100966687|FG001|NOT COMPLETED|Overall Study||1||
48262983|NCT01426347|100966688|FG000|STARTED|Overall Study||41||
48262984|NCT01426347|100966689|FG001|STARTED|Overall Study||42||
48390315|NCT03095053|101283559|FG000|NOT COMPLETED|Overall Study||29||
48390316|NCT03095053|101283560|FG001|NOT COMPLETED|Overall Study||0||
48390317|NCT02983058|101283561|FG000|STARTED|Overall Study||7||
48390318|NCT02983058|101283562|FG001|STARTED|Overall Study||5||
48390319|NCT02983058|101283561|FG000|COMPLETED|Overall Study||2||
48390320|NCT02983058|101283562|FG001|COMPLETED|Overall Study||2||
48390321|NCT02983058|101283561|FG000|NOT COMPLETED|Overall Study||5||
48390322|NCT02983058|101283562|FG001|NOT COMPLETED|Overall Study||3||
48390323|NCT01379924|101283563|FG000|STARTED|Baseline||72||
48390324|NCT01379924|101283564|FG001|STARTED|Baseline||68||
48390325|NCT01379924|101283563|FG000|COMPLETED|Baseline||72||
48390326|NCT01379924|101283564|FG001|COMPLETED|Baseline||68||
48390327|NCT01379924|101283563|FG000|NOT COMPLETED|Baseline||0||
48390328|NCT01379924|101283564|FG001|NOT COMPLETED|Baseline||0||
48390329|NCT01379924|101283563|FG000|STARTED|12-month Assessment||72||
48390330|NCT01379924|101283564|FG001|STARTED|12-month Assessment||68||
48390331|NCT01379924|101283563|FG000|COMPLETED|12-month Assessment||62||
48390332|NCT01379924|101283564|FG001|COMPLETED|12-month Assessment||55||
48390333|NCT01379924|101283563|FG000|NOT COMPLETED|12-month Assessment||10||
48390334|NCT01379924|101283564|FG001|NOT COMPLETED|12-month Assessment||13||
48390335|NCT01379924|101283563|FG000|STARTED|24-month Assessment||62||
48390336|NCT01379924|101283564|FG001|STARTED|24-month Assessment||55||
48390337|NCT01379924|101283563|FG000|COMPLETED|24-month Assessment||55||
48390338|NCT01379924|101283564|FG001|COMPLETED|24-month Assessment||52||
48390339|NCT01379924|101283563|FG000|NOT COMPLETED|24-month Assessment||7||
48390340|NCT01379924|101283564|FG001|NOT COMPLETED|24-month Assessment||3||
48390341|NCT01379924|101283563|FG000|STARTED|36-month Assessment||55||
48390342|NCT01379924|101283564|FG001|STARTED|36-month Assessment||52||
48390343|NCT01379924|101283563|FG000|COMPLETED|36-month Assessment||52||
48390344|NCT01379924|101283564|FG001|COMPLETED|36-month Assessment||48||
48390345|NCT01379924|101283563|FG000|NOT COMPLETED|36-month Assessment||3||
48390346|NCT01379924|101283564|FG001|NOT COMPLETED|36-month Assessment||4||
48390347|NCT04019795|101283565|FG000|STARTED|Overall Study||42||
48390348|NCT04019795|101283566|FG001|STARTED|Overall Study||39||
48390349|NCT04019795|101283567|FG002|STARTED|Overall Study||41||
48390350|NCT04019795|101283568|FG003|STARTED|Overall Study||38||
48390351|NCT04019795|101283565|FG000|COMPLETED|Overall Study||37||
48390352|NCT04019795|101283566|FG001|COMPLETED|Overall Study||35||
48390353|NCT04019795|101283567|FG002|COMPLETED|Overall Study||35||
48390354|NCT04019795|101283568|FG003|COMPLETED|Overall Study||35||
48390355|NCT04019795|101283565|FG000|NOT COMPLETED|Overall Study||5||
48390356|NCT04019795|101283566|FG001|NOT COMPLETED|Overall Study||4||
48390357|NCT04019795|101283567|FG002|NOT COMPLETED|Overall Study||6||
48390358|NCT04019795|101283568|FG003|NOT COMPLETED|Overall Study||3||
48390359|NCT03050216|101283569|FG000|STARTED|Overall Study||8||
48390360|NCT03050216|101283569|FG000|COMPLETED|Overall Study||8||
48390361|NCT03050216|101283569|FG000|NOT COMPLETED|Overall Study||0||
48390362|NCT00983359|101283570|FG000|STARTED|Overall Study||40||
48390363|NCT00983359|101283570|FG000|Not Eligible for Analysis|Overall Study||1||
48262985|NCT01426347|100966688|FG000|COMPLETED|Overall Study||34||
48262986|NCT01426347|100966689|FG001|COMPLETED|Overall Study||39||
48262987|NCT01426347|100966688|FG000|NOT COMPLETED|Overall Study||7||
48262988|NCT01426347|100966689|FG001|NOT COMPLETED|Overall Study||3||
48262989|NCT02906020|100966690|FG000|STARTED|Part 1: Dose Escalation Period||4||
48390364|NCT00983359|101283570|FG000|COMPLETED|Overall Study||39||
48390365|NCT00983359|101283570|FG000|NOT COMPLETED|Overall Study||1||
48390366|NCT04197986|101283571|FG000|STARTED|Overall Study||20||
48390367|NCT04197986|101283572|FG001|STARTED|Overall Study||19||
48390368|NCT04197986|101283571|FG000|Treatment Ended|Overall Study||20|Per protocol, patients continued treatment for a maximum of 52 weeks (13 cycles), or until confirmed local/regional or contralateral invasive or metastatic recurrence.|
48390369|NCT04197986|101283572|FG001|Treatment Ended|Overall Study||19|Per protocol, patients continued treatment for a maximum of 52 weeks (13 cycles), or until confirmed local/regional or contralateral invasive or metastatic recurrence.|
48390370|NCT04197986|101283571|FG000|COMPLETED|Overall Study||20||
48390371|NCT04197986|101283572|FG001|COMPLETED|Overall Study||19||
48262990|NCT02906020|100966691|FG001|STARTED|Part 1: Dose Escalation Period||4||
48262991|NCT02906020|100966692|FG002|STARTED|Part 1: Dose Escalation Period||5||
48262992|NCT02906020|100966693|FG003|STARTED|Part 1: Dose Escalation Period||4||
48262993|NCT02906020|100966694|FG004|STARTED|Part 1: Dose Escalation Period||3||
48262994|NCT02906020|100966695|FG005|STARTED|Part 1: Dose Escalation Period||3||
48262995|NCT02906020|100966696|FG006|STARTED|Part 1: Dose Escalation Period||3||
48390372|NCT04197986|101283571|FG000|NOT COMPLETED|Overall Study||0||
48390373|NCT04197986|101283572|FG001|NOT COMPLETED|Overall Study||0||
48390374|NCT00979017|101283573|FG000|STARTED|Overall Study||41||
48390375|NCT00979017|101283573|FG000|COMPLETED|Overall Study||41||
48098576|NCT01050257|100568081|FG000|Safety Population: Actual Dose Received|Overall Study||48||
48098577|NCT01050257|100568082|FG001|Safety Population: Actual Dose Received|Overall Study||51||
48098578|NCT01050257|100568083|FG002|Safety Population: Actual Dose Received|Overall Study||14||
48098579|NCT01050257|100568081|FG000|Intent-to-treat Infected Confirmed|Overall Study||30||
48098580|NCT01050257|100568082|FG001|Intent-to-treat Infected Confirmed|Overall Study||32||
48098581|NCT01050257|100568083|FG002|Intent-to-treat Infected Confirmed|Overall Study||10||
48098582|NCT01050257|100568081|FG000|Switched to Oral Treatment|Overall Study||28||
48098583|NCT01050257|100568082|FG001|Switched to Oral Treatment|Overall Study||31||
48545703|NCT02862730|101671373|FG000|STARTED|First Rest Period (1-12 Weeks)||4||
48545704|NCT02862730|101671374|FG001|STARTED|First Rest Period (1-12 Weeks)||1||
48545705|NCT02862730|101671375|FG002|STARTED|First Rest Period (1-12 Weeks)||7||
48545706|NCT02862730|101671376|FG003|STARTED|First Rest Period (1-12 Weeks)||5||
48545707|NCT02862730|101671377|FG004|STARTED|First Rest Period (1-12 Weeks)||5||
48545708|NCT02862730|101671378|FG005|STARTED|First Rest Period (1-12 Weeks)||1||
48545709|NCT02862730|101671379|FG006|STARTED|First Rest Period (1-12 Weeks)||1||
48545710|NCT02862730|101671373|FG000|COMPLETED|First Rest Period (1-12 Weeks)||4||
48545711|NCT02862730|101671374|FG001|COMPLETED|First Rest Period (1-12 Weeks)||1||
48545712|NCT02862730|101671375|FG002|COMPLETED|First Rest Period (1-12 Weeks)||7||
48545713|NCT02862730|101671376|FG003|COMPLETED|First Rest Period (1-12 Weeks)||5||
48545714|NCT02862730|101671377|FG004|COMPLETED|First Rest Period (1-12 Weeks)||5||
48545715|NCT02862730|101671378|FG005|COMPLETED|First Rest Period (1-12 Weeks)||1||
48545716|NCT02862730|101671379|FG006|COMPLETED|First Rest Period (1-12 Weeks)||1||
48545717|NCT02862730|101671373|FG000|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
48545718|NCT02862730|101671374|FG001|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
48545719|NCT02862730|101671375|FG002|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
48545720|NCT02862730|101671376|FG003|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
48545721|NCT02862730|101671377|FG004|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
48545722|NCT02862730|101671378|FG005|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
48545723|NCT02862730|101671379|FG006|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
48545724|NCT02862730|101671373|FG000|STARTED|First Intervention (84 Hours)||4||
48098584|NCT01050257|100568083|FG002|Switched to Oral Treatment|Overall Study||3||
48098585|NCT01050257|100568081|FG000|COMPLETED|Overall Study||39||
48098586|NCT01050257|100568082|FG001|COMPLETED|Overall Study||40||
48098587|NCT01050257|100568083|FG002|COMPLETED|Overall Study||8||
48098588|NCT01050257|100568081|FG000|NOT COMPLETED|Overall Study||11||
48098589|NCT01050257|100568082|FG001|NOT COMPLETED|Overall Study||13||
48098590|NCT01050257|100568083|FG002|NOT COMPLETED|Overall Study||7||
48545725|NCT02862730|101671374|FG001|STARTED|First Intervention (84 Hours)||1||
48545726|NCT02862730|101671375|FG002|STARTED|First Intervention (84 Hours)||7||
48545727|NCT02862730|101671376|FG003|STARTED|First Intervention (84 Hours)||5||
48545728|NCT02862730|101671377|FG004|STARTED|First Intervention (84 Hours)||5||
48545729|NCT02862730|101671378|FG005|STARTED|First Intervention (84 Hours)||1||
48545730|NCT02862730|101671379|FG006|STARTED|First Intervention (84 Hours)||1||
48545731|NCT02862730|101671373|FG000|COMPLETED|First Intervention (84 Hours)||4||
48545732|NCT02862730|101671374|FG001|COMPLETED|First Intervention (84 Hours)||1||
48545733|NCT02862730|101671375|FG002|COMPLETED|First Intervention (84 Hours)||7||
48545734|NCT02862730|101671376|FG003|COMPLETED|First Intervention (84 Hours)||5||
48545735|NCT02862730|101671377|FG004|COMPLETED|First Intervention (84 Hours)||5||
48545736|NCT02862730|101671378|FG005|COMPLETED|First Intervention (84 Hours)||1||
48545737|NCT02862730|101671379|FG006|COMPLETED|First Intervention (84 Hours)||1||
48545738|NCT02862730|101671373|FG000|NOT COMPLETED|First Intervention (84 Hours)||0||
48545739|NCT02862730|101671374|FG001|NOT COMPLETED|First Intervention (84 Hours)||0||
48545740|NCT02862730|101671375|FG002|NOT COMPLETED|First Intervention (84 Hours)||0||
48545741|NCT02862730|101671376|FG003|NOT COMPLETED|First Intervention (84 Hours)||0||
48545742|NCT02862730|101671377|FG004|NOT COMPLETED|First Intervention (84 Hours)||0||
48545743|NCT02862730|101671378|FG005|NOT COMPLETED|First Intervention (84 Hours)||0||
48545744|NCT02862730|101671379|FG006|NOT COMPLETED|First Intervention (84 Hours)||0||
48545745|NCT02862730|101671373|FG000|STARTED|Second Rest Period (7-45 Days)||4||
48545746|NCT02862730|101671374|FG001|STARTED|Second Rest Period (7-45 Days)||1||
48545747|NCT02862730|101671375|FG002|STARTED|Second Rest Period (7-45 Days)||7||
48545748|NCT02862730|101671376|FG003|STARTED|Second Rest Period (7-45 Days)||5||
48545749|NCT02862730|101671377|FG004|STARTED|Second Rest Period (7-45 Days)||5||
48545750|NCT02862730|101671378|FG005|STARTED|Second Rest Period (7-45 Days)||1||
48545751|NCT02862730|101671379|FG006|STARTED|Second Rest Period (7-45 Days)||1||
48545752|NCT02862730|101671373|FG000|COMPLETED|Second Rest Period (7-45 Days)||4||
48545753|NCT02862730|101671374|FG001|COMPLETED|Second Rest Period (7-45 Days)||1||
48545754|NCT02862730|101671375|FG002|COMPLETED|Second Rest Period (7-45 Days)||7||
48545755|NCT02862730|101671376|FG003|COMPLETED|Second Rest Period (7-45 Days)||5||
48545756|NCT02862730|101671377|FG004|COMPLETED|Second Rest Period (7-45 Days)||5||
48592718|NCT02143791|101783167|FG000|COMPLETED|Trial Stimulation||100||
48098591|NCT02542631|100568084|FG000|STARTED|Overall Study||139|278|
48098592|NCT02542631|100568085|FG001|STARTED|Overall Study||139|278|
48098593|NCT02542631|100568084|FG000|COMPLETED|Overall Study||108|216|
48545757|NCT02862730|101671378|FG005|COMPLETED|Second Rest Period (7-45 Days)||1||
48545758|NCT02862730|101671379|FG006|COMPLETED|Second Rest Period (7-45 Days)||1||
48545759|NCT02862730|101671373|FG000|NOT COMPLETED|Second Rest Period (7-45 Days)||0||
48545760|NCT02862730|101671374|FG001|NOT COMPLETED|Second Rest Period (7-45 Days)||0||
48545761|NCT02862730|101671375|FG002|NOT COMPLETED|Second Rest Period (7-45 Days)||0||
48545762|NCT02862730|101671376|FG003|NOT COMPLETED|Second Rest Period (7-45 Days)||0||
48545763|NCT02862730|101671377|FG004|NOT COMPLETED|Second Rest Period (7-45 Days)||0||
48545764|NCT02862730|101671378|FG005|NOT COMPLETED|Second Rest Period (7-45 Days)||0||
48545765|NCT02862730|101671379|FG006|NOT COMPLETED|Second Rest Period (7-45 Days)||0||
48545766|NCT02862730|101671373|FG000|STARTED|Second Intervention (84 Hours)||4||
48545767|NCT02862730|101671374|FG001|STARTED|Second Intervention (84 Hours)||1||
48545768|NCT02862730|101671375|FG002|STARTED|Second Intervention (84 Hours)||7||
48545769|NCT02862730|101671376|FG003|STARTED|Second Intervention (84 Hours)||5||
48545770|NCT02862730|101671377|FG004|STARTED|Second Intervention (84 Hours)||5||
48545771|NCT02862730|101671378|FG005|STARTED|Second Intervention (84 Hours)||1||
48545772|NCT02862730|101671379|FG006|STARTED|Second Intervention (84 Hours)||1||
48545773|NCT02862730|101671373|FG000|COMPLETED|Second Intervention (84 Hours)||3||
48545774|NCT02862730|101671374|FG001|COMPLETED|Second Intervention (84 Hours)||1||
48545775|NCT02862730|101671375|FG002|COMPLETED|Second Intervention (84 Hours)||7||
48545776|NCT02862730|101671376|FG003|COMPLETED|Second Intervention (84 Hours)||5||
48545777|NCT02862730|101671377|FG004|COMPLETED|Second Intervention (84 Hours)||5||
48545778|NCT02862730|101671378|FG005|COMPLETED|Second Intervention (84 Hours)||1||
48545779|NCT02862730|101671379|FG006|COMPLETED|Second Intervention (84 Hours)||1||
48545780|NCT02862730|101671373|FG000|NOT COMPLETED|Second Intervention (84 Hours)||1||
48262996|NCT02906020|100966697|FG007|STARTED|Part 1: Dose Escalation Period||3||
48262997|NCT02906020|100966698|FG008|STARTED|Part 1: Dose Escalation Period||0||
48545781|NCT02862730|101671374|FG001|NOT COMPLETED|Second Intervention (84 Hours)||0||
48545782|NCT02862730|101671375|FG002|NOT COMPLETED|Second Intervention (84 Hours)||0||
48545783|NCT02862730|101671376|FG003|NOT COMPLETED|Second Intervention (84 Hours)||0||
48545784|NCT02862730|101671377|FG004|NOT COMPLETED|Second Intervention (84 Hours)||0||
48545785|NCT02862730|101671378|FG005|NOT COMPLETED|Second Intervention (84 Hours)||0||
48545786|NCT02862730|101671379|FG006|NOT COMPLETED|Second Intervention (84 Hours)||0||
48545787|NCT02862730|101671373|FG000|STARTED|Third Rest Period (7-45 Days)||3||
48545788|NCT02862730|101671374|FG001|STARTED|Third Rest Period (7-45 Days)||1||
48545789|NCT02862730|101671375|FG002|STARTED|Third Rest Period (7-45 Days)||7||
48545790|NCT02862730|101671376|FG003|STARTED|Third Rest Period (7-45 Days)||5||
48545791|NCT02862730|101671377|FG004|STARTED|Third Rest Period (7-45 Days)||5||
48545792|NCT02862730|101671378|FG005|STARTED|Third Rest Period (7-45 Days)||1||
48545793|NCT02862730|101671379|FG006|STARTED|Third Rest Period (7-45 Days)||1||
48545794|NCT02862730|101671373|FG000|COMPLETED|Third Rest Period (7-45 Days)||3||
48545795|NCT02862730|101671374|FG001|COMPLETED|Third Rest Period (7-45 Days)||1||
48545796|NCT02862730|101671375|FG002|COMPLETED|Third Rest Period (7-45 Days)||6||
48545797|NCT02862730|101671376|FG003|COMPLETED|Third Rest Period (7-45 Days)||5||
48545798|NCT02862730|101671377|FG004|COMPLETED|Third Rest Period (7-45 Days)||4||
48545799|NCT02862730|101671378|FG005|COMPLETED|Third Rest Period (7-45 Days)||1||
48545800|NCT02862730|101671379|FG006|COMPLETED|Third Rest Period (7-45 Days)||1||
48262998|NCT02906020|100966699|FG009|STARTED|Part 1: Dose Escalation Period||0||
48262999|NCT02906020|100966700|FG010|STARTED|Part 1: Dose Escalation Period||0||
48263000|NCT02906020|100966701|FG011|STARTED|Part 1: Dose Escalation Period||0||
48263001|NCT02906020|100966702|FG012|STARTED|Part 1: Dose Escalation Period||0||
48263002|NCT02906020|100966703|FG013|STARTED|Part 1: Dose Escalation Period||0||
48263003|NCT02906020|100966704|FG014|STARTED|Part 1: Dose Escalation Period||0||
48263004|NCT02906020|100966705|FG015|STARTED|Part 1: Dose Escalation Period||0||
48390376|NCT00979017|101283573|FG000|NOT COMPLETED|Overall Study||0||
48390377|NCT02395653|101283574|FG000|STARTED|Overall Study||71||
48545801|NCT02862730|101671373|FG000|NOT COMPLETED|Third Rest Period (7-45 Days)||0||
48545802|NCT02862730|101671374|FG001|NOT COMPLETED|Third Rest Period (7-45 Days)||0||
48545803|NCT02862730|101671375|FG002|NOT COMPLETED|Third Rest Period (7-45 Days)||1||
48545804|NCT02862730|101671376|FG003|NOT COMPLETED|Third Rest Period (7-45 Days)||0||
48545805|NCT02862730|101671377|FG004|NOT COMPLETED|Third Rest Period (7-45 Days)||1||
48545806|NCT02862730|101671378|FG005|NOT COMPLETED|Third Rest Period (7-45 Days)||0||
48545807|NCT02862730|101671379|FG006|NOT COMPLETED|Third Rest Period (7-45 Days)||0||
48545808|NCT02862730|101671373|FG000|STARTED|Third Intervention (84 Hours)||3||
48545809|NCT02862730|101671374|FG001|STARTED|Third Intervention (84 Hours)||1||
48545810|NCT02862730|101671375|FG002|STARTED|Third Intervention (84 Hours)||6||
48545811|NCT02862730|101671376|FG003|STARTED|Third Intervention (84 Hours)||5||
48545812|NCT02862730|101671377|FG004|STARTED|Third Intervention (84 Hours)||4||
48545813|NCT02862730|101671378|FG005|STARTED|Third Intervention (84 Hours)||1||
48545814|NCT02862730|101671379|FG006|STARTED|Third Intervention (84 Hours)||1||
48545815|NCT02862730|101671373|FG000|COMPLETED|Third Intervention (84 Hours)||3||
48545816|NCT02862730|101671374|FG001|COMPLETED|Third Intervention (84 Hours)||1||
48545817|NCT02862730|101671375|FG002|COMPLETED|Third Intervention (84 Hours)||6||
48545818|NCT02862730|101671376|FG003|COMPLETED|Third Intervention (84 Hours)||4||
48545819|NCT02862730|101671377|FG004|COMPLETED|Third Intervention (84 Hours)||4||
48545820|NCT02862730|101671378|FG005|COMPLETED|Third Intervention (84 Hours)||1||
48545821|NCT02862730|101671379|FG006|COMPLETED|Third Intervention (84 Hours)||1||
48545822|NCT02862730|101671373|FG000|NOT COMPLETED|Third Intervention (84 Hours)||0||
48545823|NCT02862730|101671374|FG001|NOT COMPLETED|Third Intervention (84 Hours)||0||
48545824|NCT02862730|101671375|FG002|NOT COMPLETED|Third Intervention (84 Hours)||0||
48545825|NCT02862730|101671376|FG003|NOT COMPLETED|Third Intervention (84 Hours)||1||
48545826|NCT02862730|101671377|FG004|NOT COMPLETED|Third Intervention (84 Hours)||0||
48545827|NCT02862730|101671378|FG005|NOT COMPLETED|Third Intervention (84 Hours)||0||
48545828|NCT02862730|101671379|FG006|NOT COMPLETED|Third Intervention (84 Hours)||0||
48545829|NCT02862730|101671373|FG000|STARTED|Fourth Rest Period (7-45 Days)||3||
48545830|NCT02862730|101671374|FG001|STARTED|Fourth Rest Period (7-45 Days)||1||
48545831|NCT02862730|101671375|FG002|STARTED|Fourth Rest Period (7-45 Days)||6||
48545832|NCT02862730|101671376|FG003|STARTED|Fourth Rest Period (7-45 Days)||4||
48545833|NCT02862730|101671377|FG004|STARTED|Fourth Rest Period (7-45 Days)||4||
48545834|NCT02862730|101671378|FG005|STARTED|Fourth Rest Period (7-45 Days)||1||
48545835|NCT02862730|101671379|FG006|STARTED|Fourth Rest Period (7-45 Days)||1||
48545836|NCT02862730|101671373|FG000|COMPLETED|Fourth Rest Period (7-45 Days)||3||
48545837|NCT02862730|101671374|FG001|COMPLETED|Fourth Rest Period (7-45 Days)||1||
48545838|NCT02862730|101671375|FG002|COMPLETED|Fourth Rest Period (7-45 Days)||6||
48545839|NCT02862730|101671376|FG003|COMPLETED|Fourth Rest Period (7-45 Days)||4||
48545840|NCT02862730|101671377|FG004|COMPLETED|Fourth Rest Period (7-45 Days)||4||
48545841|NCT02862730|101671378|FG005|COMPLETED|Fourth Rest Period (7-45 Days)||1||
48545842|NCT02862730|101671379|FG006|COMPLETED|Fourth Rest Period (7-45 Days)||1||
48545843|NCT02862730|101671373|FG000|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0||
48545844|NCT02862730|101671374|FG001|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0||
48545845|NCT02862730|101671375|FG002|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0||
48545846|NCT02862730|101671376|FG003|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0||
48545847|NCT02862730|101671377|FG004|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0||
48545848|NCT02862730|101671378|FG005|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0||
48545849|NCT02862730|101671379|FG006|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0||
48545850|NCT02862730|101671373|FG000|STARTED|Fourth Intervention (84 Hours)||3||
48545851|NCT02862730|101671374|FG001|STARTED|Fourth Intervention (84 Hours)||1||
48545852|NCT02862730|101671375|FG002|STARTED|Fourth Intervention (84 Hours)||6||
48545853|NCT02862730|101671376|FG003|STARTED|Fourth Intervention (84 Hours)||4||
48545854|NCT02862730|101671377|FG004|STARTED|Fourth Intervention (84 Hours)||4||
48545855|NCT02862730|101671378|FG005|STARTED|Fourth Intervention (84 Hours)||1||
48545856|NCT02862730|101671379|FG006|STARTED|Fourth Intervention (84 Hours)||1||
48545857|NCT02862730|101671373|FG000|COMPLETED|Fourth Intervention (84 Hours)||3||
48545858|NCT02862730|101671374|FG001|COMPLETED|Fourth Intervention (84 Hours)||1||
48545859|NCT02862730|101671375|FG002|COMPLETED|Fourth Intervention (84 Hours)||6||
48545860|NCT02862730|101671376|FG003|COMPLETED|Fourth Intervention (84 Hours)||4||
48545861|NCT02862730|101671377|FG004|COMPLETED|Fourth Intervention (84 Hours)||4||
48545862|NCT02862730|101671378|FG005|COMPLETED|Fourth Intervention (84 Hours)||1||
48690570|NCT01098253|102025869|FG001|NOT COMPLETED|Overall Study||0||
48690571|NCT02466425|102025870|FG000|STARTED|Overall Study||132||
48690572|NCT02466425|102025871|FG001|STARTED|Overall Study||132||
48690573|NCT02466425|102025870|FG000|Treated|Overall Study||131||
48690574|NCT02466425|102025871|FG001|Treated|Overall Study||132||
48690575|NCT02466425|102025870|FG000|COMPLETED|Overall Study||118||
48690576|NCT02466425|102025871|FG001|COMPLETED|Overall Study||116||
48690577|NCT02466425|102025870|FG000|NOT COMPLETED|Overall Study||14||
48690578|NCT02466425|102025871|FG001|NOT COMPLETED|Overall Study||16||
48690579|NCT02626156|102025872|FG000|STARTED|Baseline (Visit 1 to Visit 2)||29||
48690580|NCT02626156|102025873|FG001|STARTED|Baseline (Visit 1 to Visit 2)||29||
48690581|NCT02626156|102025874|FG002|STARTED|Baseline (Visit 1 to Visit 2)||42||
48690582|NCT02626156|102025875|FG003|STARTED|Baseline (Visit 1 to Visit 2)||40||
48690583|NCT02626156|102025872|FG000|COMPLETED|Baseline (Visit 1 to Visit 2)||23||
48690584|NCT02626156|102025873|FG001|COMPLETED|Baseline (Visit 1 to Visit 2)||22||
48545863|NCT02862730|101671379|FG006|COMPLETED|Fourth Intervention (84 Hours)||1||
48545864|NCT02862730|101671373|FG000|NOT COMPLETED|Fourth Intervention (84 Hours)||0||
48545865|NCT02862730|101671374|FG001|NOT COMPLETED|Fourth Intervention (84 Hours)||0||
48545866|NCT02862730|101671375|FG002|NOT COMPLETED|Fourth Intervention (84 Hours)||0||
48545867|NCT02862730|101671376|FG003|NOT COMPLETED|Fourth Intervention (84 Hours)||0||
48545868|NCT02862730|101671377|FG004|NOT COMPLETED|Fourth Intervention (84 Hours)||0||
48690585|NCT02626156|102025874|FG002|COMPLETED|Baseline (Visit 1 to Visit 2)||37||
48690586|NCT02626156|102025875|FG003|COMPLETED|Baseline (Visit 1 to Visit 2)||35||
48690587|NCT02626156|102025872|FG000|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||6||
48545869|NCT02862730|101671378|FG005|NOT COMPLETED|Fourth Intervention (84 Hours)||0||
48545870|NCT02862730|101671379|FG006|NOT COMPLETED|Fourth Intervention (84 Hours)||0||
48545871|NCT04005352|101671380|FG000|STARTED|Overall Study||366||
48545872|NCT04005352|101671381|FG001|STARTED|Overall Study||368||
48690588|NCT02626156|102025873|FG001|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||7||
48690589|NCT02626156|102025874|FG002|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||5||
48690590|NCT02626156|102025875|FG003|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||5||
48690591|NCT02626156|102025872|FG000|STARTED|Study Visit 3||23||
48545873|NCT04005352|101671380|FG000|COMPLETED|Overall Study||317||
48545874|NCT04005352|101671381|FG001|COMPLETED|Overall Study||307||
48545875|NCT04005352|101671380|FG000|NOT COMPLETED|Overall Study||49||
48545876|NCT04005352|101671381|FG001|NOT COMPLETED|Overall Study||61||
48545877|NCT03016975|101671382|FG000|STARTED|At 30 Days Follow-up||12||
48545878|NCT03016975|101671383|FG001|STARTED|At 30 Days Follow-up||0||
48690592|NCT02626156|102025873|FG001|STARTED|Study Visit 3||22||
48690593|NCT02626156|102025874|FG002|STARTED|Study Visit 3||37||
48690594|NCT02626156|102025875|FG003|STARTED|Study Visit 3||35||
48690595|NCT02626156|102025872|FG000|COMPLETED|Study Visit 3||15||
48690596|NCT02626156|102025873|FG001|COMPLETED|Study Visit 3||17||
48098594|NCT02542631|100568085|FG001|COMPLETED|Overall Study||108|216|
48098595|NCT02542631|100568084|FG000|NOT COMPLETED|Overall Study||31||
48098596|NCT02542631|100568085|FG001|NOT COMPLETED|Overall Study||31||
48098597|NCT01581307|100568086|FG000|STARTED|Overall Study||9||
48098598|NCT01581307|100568086|FG000|COMPLETED|Overall Study||8||
48098599|NCT01581307|100568086|FG000|NOT COMPLETED|Overall Study||1||
48098600|NCT00786487|100568087|FG000|STARTED|Overall Study||10||
48098601|NCT00786487|100568088|FG001|STARTED|Overall Study||7||
48098602|NCT00786487|100568089|FG002|STARTED|Overall Study||9||
48098603|NCT00786487|100568090|FG003|STARTED|Overall Study||7||
48098604|NCT00786487|100568087|FG000|COMPLETED|Overall Study||10||
48098605|NCT00786487|100568088|FG001|COMPLETED|Overall Study||7||
48098606|NCT00786487|100568089|FG002|COMPLETED|Overall Study||9||
48098607|NCT00786487|100568090|FG003|COMPLETED|Overall Study||7||
48098608|NCT00786487|100568087|FG000|NOT COMPLETED|Overall Study||0||
48098609|NCT00786487|100568088|FG001|NOT COMPLETED|Overall Study||0||
48098610|NCT00786487|100568089|FG002|NOT COMPLETED|Overall Study||0||
48098611|NCT00786487|100568090|FG003|NOT COMPLETED|Overall Study||0||
48098612|NCT04318990|100568091|FG000|STARTED|Overall Study||150||
48098613|NCT04318990|100568092|FG001|STARTED|Overall Study||150||
48098614|NCT04318990|100568091|FG000|COMPLETED|Overall Study||112||
48098615|NCT04318990|100568092|FG001|COMPLETED|Overall Study||104||
48098616|NCT04318990|100568091|FG000|NOT COMPLETED|Overall Study||38||
48098617|NCT04318990|100568092|FG001|NOT COMPLETED|Overall Study||46||
48098618|NCT01010906|100568093|FG000|STARTED|Overall Study||10||
48098619|NCT01010906|100568094|FG001|STARTED|Overall Study||10||
48098620|NCT01010906|100568095|FG002|STARTED|Overall Study||10||
48098621|NCT01010906|100568096|FG003|STARTED|Overall Study||10||
48545879|NCT03016975|101671384|FG002|STARTED|At 30 Days Follow-up||0||
48545880|NCT03016975|101671382|FG000|COMPLETED|At 30 Days Follow-up||11||
48545881|NCT03016975|101671383|FG001|COMPLETED|At 30 Days Follow-up||0||
48545882|NCT03016975|101671384|FG002|COMPLETED|At 30 Days Follow-up||0||
48545883|NCT03016975|101671382|FG000|NOT COMPLETED|At 30 Days Follow-up||1||
48545884|NCT03016975|101671383|FG001|NOT COMPLETED|At 30 Days Follow-up||0||
48545885|NCT03016975|101671384|FG002|NOT COMPLETED|At 30 Days Follow-up||0||
48545886|NCT03016975|101671382|FG000|STARTED|At 6 Months Follow-up||11||
48545887|NCT03016975|101671383|FG001|STARTED|At 6 Months Follow-up||0||
48545888|NCT03016975|101671384|FG002|STARTED|At 6 Months Follow-up||0||
48098622|NCT01010906|100568097|FG004|STARTED|Overall Study||10||
48098623|NCT01010906|100568098|FG005|STARTED|Overall Study||10||
48098624|NCT01010906|100568093|FG000|COMPLETED|Overall Study||10||
48098625|NCT01010906|100568094|FG001|COMPLETED|Overall Study||10||
48098626|NCT01010906|100568095|FG002|COMPLETED|Overall Study||10||
48098627|NCT01010906|100568096|FG003|COMPLETED|Overall Study||10||
48098628|NCT01010906|100568097|FG004|COMPLETED|Overall Study||10||
48098629|NCT01010906|100568098|FG005|COMPLETED|Overall Study||10||
48098630|NCT01010906|100568093|FG000|NOT COMPLETED|Overall Study||0||
48690597|NCT02626156|102025874|FG002|COMPLETED|Study Visit 3||33||
48690598|NCT02626156|102025875|FG003|COMPLETED|Study Visit 3||33||
48690599|NCT02626156|102025872|FG000|NOT COMPLETED|Study Visit 3||8||
48690600|NCT02626156|102025873|FG001|NOT COMPLETED|Study Visit 3||5||
48690601|NCT02626156|102025874|FG002|NOT COMPLETED|Study Visit 3||4||
48690602|NCT02626156|102025875|FG003|NOT COMPLETED|Study Visit 3||2||
48098631|NCT01010906|100568094|FG001|NOT COMPLETED|Overall Study||0||
48098632|NCT01010906|100568095|FG002|NOT COMPLETED|Overall Study||0||
48098633|NCT01010906|100568096|FG003|NOT COMPLETED|Overall Study||0||
48098634|NCT01010906|100568097|FG004|NOT COMPLETED|Overall Study||0||
48098635|NCT01010906|100568098|FG005|NOT COMPLETED|Overall Study||0||
48098636|NCT01467947|100568099|FG000|STARTED|Overall Study||46||
48098637|NCT01467947|100568099|FG000|COMPLETED|Overall Study||46||
48098638|NCT01467947|100568099|FG000|NOT COMPLETED|Overall Study||0||
48098639|NCT01722240|100568100|FG000|STARTED|Overall Study||35||
48098640|NCT01722240|100568101|FG001|STARTED|Overall Study||34||
48098641|NCT01722240|100568100|FG000|COMPLETED|Overall Study||26||
48098642|NCT01722240|100568101|FG001|COMPLETED|Overall Study||20||
48098643|NCT01722240|100568100|FG000|NOT COMPLETED|Overall Study||9||
48098644|NCT01722240|100568101|FG001|NOT COMPLETED|Overall Study||14||
48098645|NCT04120974|100568102|FG000|STARTED|Overall Study||90||
48098646|NCT04120974|100568102|FG000|COMPLETED|Overall Study||82||
48098647|NCT04120974|100568102|FG000|NOT COMPLETED|Overall Study||8||
48098648|NCT01172847|100568103|FG000|STARTED|Overall Study||24||
48098649|NCT01172847|100568103|FG000|Oseltamivir|Overall Study||24||
48098650|NCT01172847|100568103|FG000|Rimantadine|Overall Study||22||
48098651|NCT01172847|100568103|FG000|Oseltamivir + Rimantadine|Overall Study||21||
48098652|NCT01172847|100568103|FG000|COMPLETED|Overall Study||21||
48098653|NCT01172847|100568103|FG000|NOT COMPLETED|Overall Study||3||
48545889|NCT03016975|101671382|FG000|COMPLETED|At 6 Months Follow-up||6||
48545890|NCT03016975|101671383|FG001|COMPLETED|At 6 Months Follow-up||0||
48545891|NCT03016975|101671384|FG002|COMPLETED|At 6 Months Follow-up||0||
48545892|NCT03016975|101671382|FG000|NOT COMPLETED|At 6 Months Follow-up||5||
48545893|NCT03016975|101671383|FG001|NOT COMPLETED|At 6 Months Follow-up||0||
48545894|NCT03016975|101671384|FG002|NOT COMPLETED|At 6 Months Follow-up||0||
48545895|NCT03016975|101671382|FG000|STARTED|At 1 Year Follow-up||6||
48545896|NCT03016975|101671383|FG001|STARTED|At 1 Year Follow-up||0||
48545897|NCT03016975|101671384|FG002|STARTED|At 1 Year Follow-up||0||
48545898|NCT03016975|101671382|FG000|COMPLETED|At 1 Year Follow-up||6||
48545899|NCT03016975|101671383|FG001|COMPLETED|At 1 Year Follow-up||0||
48545900|NCT03016975|101671384|FG002|COMPLETED|At 1 Year Follow-up||0||
48545901|NCT03016975|101671382|FG000|NOT COMPLETED|At 1 Year Follow-up||0||
48545902|NCT03016975|101671383|FG001|NOT COMPLETED|At 1 Year Follow-up||0||
48545903|NCT03016975|101671384|FG002|NOT COMPLETED|At 1 Year Follow-up||0||
48545904|NCT03016975|101671382|FG000|STARTED|At 2 Year Follow-up||6||
48545905|NCT03016975|101671383|FG001|STARTED|At 2 Year Follow-up||0||
48545906|NCT03016975|101671384|FG002|STARTED|At 2 Year Follow-up||0||
48545907|NCT03016975|101671382|FG000|COMPLETED|At 2 Year Follow-up||5||
48545908|NCT03016975|101671383|FG001|COMPLETED|At 2 Year Follow-up||0||
48545909|NCT03016975|101671384|FG002|COMPLETED|At 2 Year Follow-up||0||
48098654|NCT00071760|100568104|FG000|STARTED|Overall Study||28||
48098655|NCT00071760|100568105|FG001|STARTED|Overall Study||26||
48098656|NCT00071760|100568104|FG000|COMPLETED|Overall Study||21||
48098657|NCT00071760|100568105|FG001|COMPLETED|Overall Study||18||
48545910|NCT03016975|101671382|FG000|NOT COMPLETED|At 2 Year Follow-up||1||
48545911|NCT03016975|101671383|FG001|NOT COMPLETED|At 2 Year Follow-up||0||
48545912|NCT03016975|101671384|FG002|NOT COMPLETED|At 2 Year Follow-up||0||
48545913|NCT03016975|101671382|FG000|STARTED|At 3 Year Follow-up||5||
48545914|NCT03016975|101671383|FG001|STARTED|At 3 Year Follow-up||0||
48545915|NCT03016975|101671384|FG002|STARTED|At 3 Year Follow-up||0||
48098658|NCT00071760|100568104|FG000|NOT COMPLETED|Overall Study||7||
48098659|NCT00071760|100568105|FG001|NOT COMPLETED|Overall Study||8||
48098660|NCT00951665|100568106|FG000|STARTED|Phase 1b||29||
48098661|NCT00951665|100568107|FG001|STARTED|Phase 1b||10||
48098662|NCT00951665|100568108|FG002|STARTED|Phase 1b||21||
48098663|NCT00951665|100568109|FG003|STARTED|Phase 1b||3||
48545916|NCT03016975|101671382|FG000|COMPLETED|At 3 Year Follow-up||3||
48098664|NCT00951665|100568110|FG004|STARTED|Phase 1b||0||
48098665|NCT00951665|100568111|FG005|STARTED|Phase 1b||0||
48098666|NCT00951665|100568106|FG000|Started Treatment|Phase 1b||26||
48098667|NCT00951665|100568107|FG001|Started Treatment|Phase 1b||10||
48098668|NCT00951665|100568108|FG002|Started Treatment|Phase 1b||21||
48098669|NCT00951665|100568109|FG003|Started Treatment|Phase 1b||3||
48545917|NCT03016975|101671383|FG001|COMPLETED|At 3 Year Follow-up||0||
48545918|NCT03016975|101671384|FG002|COMPLETED|At 3 Year Follow-up||0||
48098670|NCT00951665|100568110|FG004|Started Treatment|Phase 1b||0||
48098671|NCT00951665|100568111|FG005|Started Treatment|Phase 1b||0||
48098672|NCT00951665|100568106|FG000|COMPLETED|Phase 1b||7||
48098673|NCT00951665|100568107|FG001|COMPLETED|Phase 1b||6||
48098674|NCT00951665|100568108|FG002|COMPLETED|Phase 1b||4||
48098675|NCT00951665|100568109|FG003|COMPLETED|Phase 1b||2||
48098676|NCT00951665|100568110|FG004|COMPLETED|Phase 1b||0||
48098677|NCT00951665|100568111|FG005|COMPLETED|Phase 1b||0||
48098678|NCT00951665|100568106|FG000|NOT COMPLETED|Phase 1b||22||
48098679|NCT00951665|100568107|FG001|NOT COMPLETED|Phase 1b||4||
48098680|NCT00951665|100568108|FG002|NOT COMPLETED|Phase 1b||17||
48545919|NCT03016975|101671382|FG000|NOT COMPLETED|At 3 Year Follow-up||2||
48545920|NCT03016975|101671383|FG001|NOT COMPLETED|At 3 Year Follow-up||0||
48545921|NCT03016975|101671384|FG002|NOT COMPLETED|At 3 Year Follow-up||0||
48545922|NCT03016975|101671382|FG000|STARTED|At 4-year Follow-up||3||
48098681|NCT00951665|100568109|FG003|NOT COMPLETED|Phase 1b||1||
48098682|NCT00951665|100568110|FG004|NOT COMPLETED|Phase 1b||0||
48098683|NCT00951665|100568111|FG005|NOT COMPLETED|Phase 1b||0||
48098684|NCT00951665|100568106|FG000|STARTED|Phase 2a||0||
48098685|NCT00951665|100568107|FG001|STARTED|Phase 2a||0||
48098686|NCT00951665|100568108|FG002|STARTED|Phase 2a||0||
48098687|NCT00951665|100568109|FG003|STARTED|Phase 2a||0||
48098688|NCT00951665|100568110|FG004|STARTED|Phase 2a||22||
48098689|NCT00951665|100568111|FG005|STARTED|Phase 2a||22||
48098690|NCT00951665|100568106|FG000|COMPLETED|Phase 2a||0||
48098691|NCT00951665|100568107|FG001|COMPLETED|Phase 2a||0||
48098692|NCT00951665|100568108|FG002|COMPLETED|Phase 2a||0||
48098693|NCT00951665|100568109|FG003|COMPLETED|Phase 2a||0||
48098694|NCT00951665|100568110|FG004|COMPLETED|Phase 2a||10||
48098695|NCT00951665|100568111|FG005|COMPLETED|Phase 2a||15||
48098696|NCT00951665|100568106|FG000|NOT COMPLETED|Phase 2a||0||
48098697|NCT00951665|100568107|FG001|NOT COMPLETED|Phase 2a||0||
48098698|NCT00951665|100568108|FG002|NOT COMPLETED|Phase 2a||0||
48098699|NCT00951665|100568109|FG003|NOT COMPLETED|Phase 2a||0||
48098700|NCT00951665|100568110|FG004|NOT COMPLETED|Phase 2a||12||
48098701|NCT00951665|100568111|FG005|NOT COMPLETED|Phase 2a||7||
48098702|NCT01951339|100568112|FG000|STARTED|Overall Study||15||
48098703|NCT01951339|100568113|FG001|STARTED|Overall Study||15||
48098704|NCT01951339|100568112|FG000|COMPLETED|Overall Study||13||
48098705|NCT01951339|100568113|FG001|COMPLETED|Overall Study||14||
48098706|NCT01951339|100568112|FG000|NOT COMPLETED|Overall Study||2||
48098707|NCT01951339|100568113|FG001|NOT COMPLETED|Overall Study||1||
48098708|NCT04595513|100568114|FG000|STARTED|Overall Study||5||
48098709|NCT04595513|100568114|FG000|COMPLETED|Overall Study||5||
48098710|NCT04595513|100568114|FG000|NOT COMPLETED|Overall Study||0||
48098711|NCT04532099|100568115|FG000|STARTED|First Wear Period (30 Days)||33||
48098712|NCT04532099|100568116|FG001|STARTED|First Wear Period (30 Days)||33||
48098713|NCT04532099|100568117|FG002|STARTED|First Wear Period (30 Days)||66||
48098714|NCT04532099|100568115|FG000|COMPLETED|First Wear Period (30 Days)||32||
48098715|NCT04532099|100568116|FG001|COMPLETED|First Wear Period (30 Days)||33||
48098716|NCT04532099|100568117|FG002|COMPLETED|First Wear Period (30 Days)||66||
48098717|NCT04532099|100568115|FG000|NOT COMPLETED|First Wear Period (30 Days)||1||
48098718|NCT04532099|100568116|FG001|NOT COMPLETED|First Wear Period (30 Days)||0||
48098719|NCT04532099|100568117|FG002|NOT COMPLETED|First Wear Period (30 Days)||0||
48098720|NCT04532099|100568115|FG000|STARTED|Second Wear Period (30 Days)||32||
48098721|NCT04532099|100568116|FG001|STARTED|Second Wear Period (30 Days)||33||
48098722|NCT04532099|100568117|FG002|STARTED|Second Wear Period (30 Days)||0||
48098723|NCT04532099|100568115|FG000|COMPLETED|Second Wear Period (30 Days)||32||
48098724|NCT04532099|100568116|FG001|COMPLETED|Second Wear Period (30 Days)||33||
48098725|NCT04532099|100568117|FG002|COMPLETED|Second Wear Period (30 Days)||0||
48263005|NCT02906020|100966690|FG000|Treated|Part 1: Dose Escalation Period||4||
48263006|NCT02906020|100966691|FG001|Treated|Part 1: Dose Escalation Period||4||
48263007|NCT02906020|100966692|FG002|Treated|Part 1: Dose Escalation Period||5||
48098726|NCT04532099|100568115|FG000|NOT COMPLETED|Second Wear Period (30 Days)||0||
48098727|NCT04532099|100568116|FG001|NOT COMPLETED|Second Wear Period (30 Days)||0||
48098728|NCT04532099|100568117|FG002|NOT COMPLETED|Second Wear Period (30 Days)||0||
48098729|NCT03879655|100568118|FG000|STARTED|Overall Study||2||
48098730|NCT03879655|100568118|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2||
48098731|NCT03879655|100568118|FG000|COMPLETED|Overall Study||2||
48098732|NCT03879655|100568118|FG000|NOT COMPLETED|Overall Study||0||
48098733|NCT03388294|100568119|FG000|STARTED|Overall Study||42||21
48098734|NCT03388294|100568120|FG001|STARTED|Overall Study||30||15
48098735|NCT03388294|100568119|FG000|Posttest 1|Overall Study||38||19
48098736|NCT03388294|100568120|FG001|Posttest 1|Overall Study||30||15
48098737|NCT03388294|100568119|FG000|Posttest 2|Overall Study||38||19
48098738|NCT03388294|100568120|FG001|Posttest 2|Overall Study||30||15
48098739|NCT03388294|100568119|FG000|COMPLETED|Overall Study||38||19
48098740|NCT03388294|100568120|FG001|COMPLETED|Overall Study||30||15
48098741|NCT03388294|100568119|FG000|NOT COMPLETED|Overall Study||4||2
48098742|NCT03388294|100568120|FG001|NOT COMPLETED|Overall Study||0||0
48098743|NCT02424383|100568121|FG000|STARTED|Overall Study||1005||
48098744|NCT02424383|100568121|FG000|Per-Protocol Population|Overall Study||966||
48098745|NCT02424383|100568121|FG000|COMPLETED|Overall Study||629||
48263008|NCT02906020|100966693|FG003|Treated|Part 1: Dose Escalation Period||4||
48263009|NCT02906020|100966694|FG004|Treated|Part 1: Dose Escalation Period||3||
48263010|NCT02906020|100966695|FG005|Treated|Part 1: Dose Escalation Period||3||
48263011|NCT02906020|100966696|FG006|Treated|Part 1: Dose Escalation Period||3||
48263012|NCT02906020|100966697|FG007|Treated|Part 1: Dose Escalation Period||3||
48263013|NCT02906020|100966698|FG008|Treated|Part 1: Dose Escalation Period||0||
48098746|NCT02424383|100568121|FG000|NOT COMPLETED|Overall Study||376||
48098747|NCT03054870|100568122|FG000|STARTED|Day of Ventilation Imaging||210||
48098748|NCT03054870|100568122|FG000|COMPLETED|Day of Ventilation Imaging||205||
48098749|NCT03054870|100568122|FG000|NOT COMPLETED|Day of Ventilation Imaging||5||
48098750|NCT03054870|100568122|FG000|STARTED|24-hour Follow-up||118||
48098751|NCT03054870|100568122|FG000|COMPLETED|24-hour Follow-up||118||
48098752|NCT03054870|100568122|FG000|NOT COMPLETED|24-hour Follow-up||0||
48263014|NCT02906020|100966699|FG009|Treated|Part 1: Dose Escalation Period||0||
48263015|NCT02906020|100966700|FG010|Treated|Part 1: Dose Escalation Period||0||
48263016|NCT02906020|100966701|FG011|Treated|Part 1: Dose Escalation Period||0||
48263017|NCT02906020|100966702|FG012|Treated|Part 1: Dose Escalation Period||0||
48263018|NCT02906020|100966703|FG013|Treated|Part 1: Dose Escalation Period||0||
48545923|NCT03016975|101671383|FG001|STARTED|At 4-year Follow-up||0||
48545924|NCT03016975|101671384|FG002|STARTED|At 4-year Follow-up||0||
48545925|NCT03016975|101671382|FG000|COMPLETED|At 4-year Follow-up||2||
48690603|NCT02626156|102025872|FG000|STARTED|Study Visit 4||15||
48690604|NCT02626156|102025873|FG001|STARTED|Study Visit 4||17||
48263019|NCT02906020|100966704|FG014|Treated|Part 1: Dose Escalation Period||0||
48263020|NCT02906020|100966705|FG015|Treated|Part 1: Dose Escalation Period||0||
48263021|NCT02906020|100966690|FG000|COMPLETED|Part 1: Dose Escalation Period||4||
48263022|NCT02906020|100966691|FG001|COMPLETED|Part 1: Dose Escalation Period||3||
48263023|NCT02906020|100966692|FG002|COMPLETED|Part 1: Dose Escalation Period||5||
48263024|NCT02906020|100966693|FG003|COMPLETED|Part 1: Dose Escalation Period||3||
48263025|NCT02906020|100966694|FG004|COMPLETED|Part 1: Dose Escalation Period||3||
48263026|NCT02906020|100966695|FG005|COMPLETED|Part 1: Dose Escalation Period||3||
48263027|NCT02906020|100966696|FG006|COMPLETED|Part 1: Dose Escalation Period||3||
48263028|NCT02906020|100966697|FG007|COMPLETED|Part 1: Dose Escalation Period||3||
48263029|NCT02906020|100966698|FG008|COMPLETED|Part 1: Dose Escalation Period||0||
48263030|NCT02906020|100966699|FG009|COMPLETED|Part 1: Dose Escalation Period||0||
48263031|NCT02906020|100966700|FG010|COMPLETED|Part 1: Dose Escalation Period||0||
48545926|NCT03016975|101671383|FG001|COMPLETED|At 4-year Follow-up||0||
48098753|NCT03054870|100568122|FG000|STARTED|Blinded Read of Images||200||
48098754|NCT03054870|100568122|FG000|COMPLETED|Blinded Read of Images||200||
48098755|NCT03054870|100568122|FG000|NOT COMPLETED|Blinded Read of Images||0||
48098756|NCT00101907|100568123|FG000|STARTED|Overall Study||8||
48098757|NCT00101907|100568124|FG001|STARTED|Overall Study||8||
48098758|NCT00101907|100568125|FG002|STARTED|Overall Study||6||
48098759|NCT00101907|100568126|FG003|STARTED|Overall Study||6||
48098760|NCT00101907|100568127|FG004|STARTED|Overall Study||11||
48098761|NCT00101907|100568128|FG005|STARTED|Overall Study||2||
48098762|NCT00101907|100568123|FG000|COMPLETED|Overall Study||6||
48098763|NCT00101907|100568124|FG001|COMPLETED|Overall Study||7||
48263032|NCT02906020|100966701|FG011|COMPLETED|Part 1: Dose Escalation Period||0||
48263033|NCT02906020|100966702|FG012|COMPLETED|Part 1: Dose Escalation Period||0||
48263034|NCT02906020|100966703|FG013|COMPLETED|Part 1: Dose Escalation Period||0||
48263035|NCT02906020|100966704|FG014|COMPLETED|Part 1: Dose Escalation Period||0||
48263036|NCT02906020|100966705|FG015|COMPLETED|Part 1: Dose Escalation Period||0||
48263037|NCT02906020|100966690|FG000|NOT COMPLETED|Part 1: Dose Escalation Period||0||
48263038|NCT02906020|100966691|FG001|NOT COMPLETED|Part 1: Dose Escalation Period||1||
48263039|NCT02906020|100966692|FG002|NOT COMPLETED|Part 1: Dose Escalation Period||0||
48263040|NCT02906020|100966693|FG003|NOT COMPLETED|Part 1: Dose Escalation Period||1||
48263041|NCT02906020|100966694|FG004|NOT COMPLETED|Part 1: Dose Escalation Period||0||
48263042|NCT02906020|100966695|FG005|NOT COMPLETED|Part 1: Dose Escalation Period||0||
48263043|NCT02906020|100966696|FG006|NOT COMPLETED|Part 1: Dose Escalation Period||0||
48263044|NCT02906020|100966697|FG007|NOT COMPLETED|Part 1: Dose Escalation Period||0||
48263045|NCT02906020|100966698|FG008|NOT COMPLETED|Part 1: Dose Escalation Period||0||
48545927|NCT03016975|101671384|FG002|COMPLETED|At 4-year Follow-up||0||
48545928|NCT03016975|101671382|FG000|NOT COMPLETED|At 4-year Follow-up||1||
48545929|NCT03016975|101671383|FG001|NOT COMPLETED|At 4-year Follow-up||0||
48545930|NCT03016975|101671384|FG002|NOT COMPLETED|At 4-year Follow-up||0||
48690605|NCT02626156|102025874|FG002|STARTED|Study Visit 4||33||
48690606|NCT02626156|102025875|FG003|STARTED|Study Visit 4||33||
48098764|NCT00101907|100568125|FG002|COMPLETED|Overall Study||5||
48263046|NCT02906020|100966699|FG009|NOT COMPLETED|Part 1: Dose Escalation Period||0||
48545931|NCT03016975|101671382|FG000|STARTED|At 5-year Follow-up||2||
48098765|NCT00101907|100568126|FG003|COMPLETED|Overall Study||5||
48098766|NCT00101907|100568127|FG004|COMPLETED|Overall Study||6||
48545932|NCT03016975|101671383|FG001|STARTED|At 5-year Follow-up||0||
48545933|NCT03016975|101671384|FG002|STARTED|At 5-year Follow-up||0||
48545934|NCT03016975|101671382|FG000|COMPLETED|At 5-year Follow-up||2||
48545935|NCT03016975|101671383|FG001|COMPLETED|At 5-year Follow-up||0||
48545936|NCT03016975|101671384|FG002|COMPLETED|At 5-year Follow-up||0||
48545937|NCT03016975|101671382|FG000|NOT COMPLETED|At 5-year Follow-up||0||
48545938|NCT03016975|101671383|FG001|NOT COMPLETED|At 5-year Follow-up||0||
48690607|NCT02626156|102025872|FG000|COMPLETED|Study Visit 4||12||
48690608|NCT02626156|102025873|FG001|COMPLETED|Study Visit 4||15||
48690609|NCT02626156|102025874|FG002|COMPLETED|Study Visit 4||24||
48690610|NCT02626156|102025875|FG003|COMPLETED|Study Visit 4||28||
48690611|NCT02626156|102025872|FG000|NOT COMPLETED|Study Visit 4||3||
48690612|NCT02626156|102025873|FG001|NOT COMPLETED|Study Visit 4||2||
48098767|NCT00101907|100568128|FG005|COMPLETED|Overall Study||2||
48098768|NCT00101907|100568123|FG000|NOT COMPLETED|Overall Study||2||
48098769|NCT00101907|100568124|FG001|NOT COMPLETED|Overall Study||1||
48098770|NCT00101907|100568125|FG002|NOT COMPLETED|Overall Study||1||
48098771|NCT00101907|100568126|FG003|NOT COMPLETED|Overall Study||1||
48098772|NCT00101907|100568127|FG004|NOT COMPLETED|Overall Study||5||
48098773|NCT00101907|100568128|FG005|NOT COMPLETED|Overall Study||0||
48098774|NCT02981342|100568129|FG000|STARTED|Overall Study||7||
48098775|NCT02981342|100568130|FG001|STARTED|Overall Study||33||
48098776|NCT02981342|100568131|FG002|STARTED|Overall Study||33||
48098777|NCT02981342|100568132|FG003|STARTED|Overall Study||33||
48098778|NCT02981342|100568129|FG000|Received at Least One Dose of Study Drug|Overall Study||7||
48098779|NCT02981342|100568130|FG001|Received at Least One Dose of Study Drug|Overall Study||32||
48098780|NCT02981342|100568131|FG002|Received at Least One Dose of Study Drug|Overall Study||33||
48098781|NCT02981342|100568132|FG003|Received at Least One Dose of Study Drug|Overall Study||26||
48098782|NCT02981342|100568129|FG000|COMPLETED|Overall Study||7||
48098783|NCT02981342|100568130|FG001|COMPLETED|Overall Study||22||
48098784|NCT02981342|100568131|FG002|COMPLETED|Overall Study||20||
48098785|NCT02981342|100568132|FG003|COMPLETED|Overall Study||19||
48098786|NCT02981342|100568129|FG000|NOT COMPLETED|Overall Study||0||
48098787|NCT02981342|100568130|FG001|NOT COMPLETED|Overall Study||11||
48098788|NCT02981342|100568131|FG002|NOT COMPLETED|Overall Study||13||
48098789|NCT02981342|100568132|FG003|NOT COMPLETED|Overall Study||14||
48098790|NCT05584644|100568133|FG000|STARTED|Overall Study||105||
48098791|NCT05584644|100568134|FG001|STARTED|Overall Study||45||
48098792|NCT05584644|100568133|FG000|COMPLETED|Overall Study||105||
48098793|NCT05584644|100568134|FG001|COMPLETED|Overall Study||45||
48098794|NCT05584644|100568133|FG000|NOT COMPLETED|Overall Study||0||
48098795|NCT05584644|100568134|FG001|NOT COMPLETED|Overall Study||0||
48098796|NCT03255382|100568135|FG000|STARTED|Overall Study||60||
48098797|NCT03255382|100568136|FG001|STARTED|Overall Study||60||
48098798|NCT03255382|100568135|FG000|COMPLETED|Overall Study||47||
48098799|NCT03255382|100568136|FG001|COMPLETED|Overall Study||60||
48098800|NCT03255382|100568135|FG000|NOT COMPLETED|Overall Study||13||
48098801|NCT03255382|100568136|FG001|NOT COMPLETED|Overall Study||0||
48098802|NCT02245841|100568137|FG000|STARTED|Overall Study||19||
48098803|NCT02245841|100568137|FG000|COMPLETED|Overall Study||15||
48098804|NCT02245841|100568137|FG000|NOT COMPLETED|Overall Study||4||
48098805|NCT00484939|100568138|FG000|STARTED|Overall Study||140||
48098806|NCT00484939|100568139|FG001|STARTED|Overall Study||140||
48098807|NCT00484939|100568138|FG000|COMPLETED|Overall Study||0||
48098808|NCT00484939|100568139|FG001|COMPLETED|Overall Study||0||
48098809|NCT00484939|100568138|FG000|NOT COMPLETED|Overall Study||140||
48098810|NCT00484939|100568139|FG001|NOT COMPLETED|Overall Study||140||
48098811|NCT01265849|100568140|FG000|STARTED|Overall Study||396||
48098812|NCT01265849|100568141|FG001|STARTED|Overall Study||398||
48098813|NCT01265849|100568142|FG002|STARTED|Overall Study||134||
48098814|NCT01265849|100568140|FG000|COMPLETED|Overall Study||350||
48098815|NCT01265849|100568141|FG001|COMPLETED|Overall Study||337||
48098816|NCT01265849|100568142|FG002|COMPLETED|Overall Study||115||
48098817|NCT01265849|100568140|FG000|NOT COMPLETED|Overall Study||46||
48098818|NCT01265849|100568141|FG001|NOT COMPLETED|Overall Study||61||
48098819|NCT01265849|100568142|FG002|NOT COMPLETED|Overall Study||19||
48098820|NCT02921776|100568143|FG000|STARTED|Overall Study||13||
48098821|NCT02921776|100568144|FG001|STARTED|Overall Study||23||
48098822|NCT02921776|100568145|FG002|STARTED|Overall Study||7||
48098823|NCT02921776|100568146|FG003|STARTED|Overall Study||31||
48098824|NCT02921776|100568147|FG004|STARTED|Overall Study||32||
48098825|NCT02921776|100568148|FG005|STARTED|Overall Study||7||
48098826|NCT02921776|100568149|FG006|STARTED|Overall Study||18||
48098827|NCT02921776|100568150|FG007|STARTED|Overall Study||16||
48098828|NCT02921776|100568143|FG000|COMPLETED|Overall Study||11||
48098829|NCT02921776|100568144|FG001|COMPLETED|Overall Study||15||
48098830|NCT02921776|100568145|FG002|COMPLETED|Overall Study||7||
48098831|NCT02921776|100568146|FG003|COMPLETED|Overall Study||23||
48098832|NCT02921776|100568147|FG004|COMPLETED|Overall Study||26||
48098833|NCT02921776|100568148|FG005|COMPLETED|Overall Study||5||
48098834|NCT02921776|100568149|FG006|COMPLETED|Overall Study||7||
48098835|NCT02921776|100568150|FG007|COMPLETED|Overall Study||9||
48098836|NCT02921776|100568143|FG000|NOT COMPLETED|Overall Study||2||
48098837|NCT02921776|100568144|FG001|NOT COMPLETED|Overall Study||8||
48098838|NCT02921776|100568145|FG002|NOT COMPLETED|Overall Study||0||
48098839|NCT02921776|100568146|FG003|NOT COMPLETED|Overall Study||8||
48098840|NCT02921776|100568147|FG004|NOT COMPLETED|Overall Study||6||
48098841|NCT02921776|100568148|FG005|NOT COMPLETED|Overall Study||2||
48098842|NCT02921776|100568149|FG006|NOT COMPLETED|Overall Study||11||
48098843|NCT02921776|100568150|FG007|NOT COMPLETED|Overall Study||7||
48098844|NCT00555750|100568151|FG000|STARTED|Overall Study||10||
48098845|NCT00555750|100568152|FG001|STARTED|Overall Study||10||
48098846|NCT00555750|100568151|FG000|COMPLETED|Overall Study||10||
48098847|NCT00555750|100568152|FG001|COMPLETED|Overall Study||10||
48098848|NCT00555750|100568151|FG000|NOT COMPLETED|Overall Study||0||
48098849|NCT00555750|100568152|FG001|NOT COMPLETED|Overall Study||0||
48098850|NCT02385084|100568153|FG000|STARTED|Period 1||3||
48098851|NCT02385084|100568154|FG001|STARTED|Period 1||3||
48098852|NCT02385084|100568155|FG002|STARTED|Period 1||3||
48098853|NCT02385084|100568156|FG003|STARTED|Period 1||3||
48098854|NCT02385084|100568157|FG004|STARTED|Period 1||3||
48098855|NCT02385084|100568158|FG005|STARTED|Period 1||3||
48098856|NCT02385084|100568153|FG000|Received LY2409021|Period 1||3||
48098857|NCT02385084|100568154|FG001|Received LY2409021|Period 1||3||
48098858|NCT02385084|100568155|FG002|Received LY2409021|Period 1||3||
48098859|NCT02385084|100568156|FG003|Received LY2409021|Period 1||3||
48098860|NCT02385084|100568157|FG004|Received LY2409021|Period 1||3||
48098861|NCT02385084|100568158|FG005|Received LY2409021|Period 1||3||
48098862|NCT02385084|100568153|FG000|Washout|Period 1||3||
48098863|NCT02385084|100568154|FG001|Washout|Period 1||3||
48098864|NCT02385084|100568155|FG002|Washout|Period 1||3||
48098865|NCT02385084|100568156|FG003|Washout|Period 1||3||
48098866|NCT02385084|100568157|FG004|Washout|Period 1||3||
48098867|NCT02385084|100568158|FG005|Washout|Period 1||3||
48098868|NCT02385084|100568153|FG000|COMPLETED|Period 1||3||
48098869|NCT02385084|100568154|FG001|COMPLETED|Period 1||3||
48098870|NCT02385084|100568155|FG002|COMPLETED|Period 1||3||
48098871|NCT02385084|100568156|FG003|COMPLETED|Period 1||3||
48098872|NCT02385084|100568157|FG004|COMPLETED|Period 1||3||
48098873|NCT02385084|100568158|FG005|COMPLETED|Period 1||3||
48098874|NCT02385084|100568153|FG000|NOT COMPLETED|Period 1||0||
48098875|NCT02385084|100568154|FG001|NOT COMPLETED|Period 1||0||
48098876|NCT02385084|100568155|FG002|NOT COMPLETED|Period 1||0||
48098877|NCT02385084|100568156|FG003|NOT COMPLETED|Period 1||0||
48098878|NCT02385084|100568157|FG004|NOT COMPLETED|Period 1||0||
48098879|NCT02385084|100568158|FG005|NOT COMPLETED|Period 1||0||
48098880|NCT02385084|100568153|FG000|STARTED|Period 2||2||
48098881|NCT02385084|100568154|FG001|STARTED|Period 2||3||
48098882|NCT02385084|100568155|FG002|STARTED|Period 2||3||
48098883|NCT02385084|100568156|FG003|STARTED|Period 2||3||
48098884|NCT02385084|100568157|FG004|STARTED|Period 2||3||
48098885|NCT02385084|100568158|FG005|STARTED|Period 2||3||
48098886|NCT02385084|100568153|FG000|Received LY2409021|Period 2||2||
48098887|NCT02385084|100568154|FG001|Received LY2409021|Period 2||3||
48098888|NCT02385084|100568155|FG002|Received LY2409021|Period 2||3||
48098889|NCT02385084|100568156|FG003|Received LY2409021|Period 2||3||
48098890|NCT02385084|100568157|FG004|Received LY2409021|Period 2||3||
48098891|NCT02385084|100568158|FG005|Received LY2409021|Period 2||3||
48098892|NCT02385084|100568153|FG000|Washout|Period 2||2||
48098893|NCT02385084|100568154|FG001|Washout|Period 2||3||
48098894|NCT02385084|100568155|FG002|Washout|Period 2||3||
48098895|NCT02385084|100568156|FG003|Washout|Period 2||3||
48098896|NCT02385084|100568157|FG004|Washout|Period 2||3||
48098897|NCT02385084|100568158|FG005|Washout|Period 2||3||
48098898|NCT02385084|100568153|FG000|COMPLETED|Period 2||2||
48098899|NCT02385084|100568154|FG001|COMPLETED|Period 2||3||
48098900|NCT02385084|100568155|FG002|COMPLETED|Period 2||2||
48098901|NCT02385084|100568156|FG003|COMPLETED|Period 2||3||
48098902|NCT02385084|100568157|FG004|COMPLETED|Period 2||3||
48098903|NCT02385084|100568158|FG005|COMPLETED|Period 2||3||
48098904|NCT02385084|100568153|FG000|NOT COMPLETED|Period 2||0||
48098905|NCT02385084|100568154|FG001|NOT COMPLETED|Period 2||0||
48098906|NCT02385084|100568155|FG002|NOT COMPLETED|Period 2||1||
48098907|NCT02385084|100568156|FG003|NOT COMPLETED|Period 2||0||
48098908|NCT02385084|100568157|FG004|NOT COMPLETED|Period 2||0||
48098909|NCT02385084|100568158|FG005|NOT COMPLETED|Period 2||0||
48098910|NCT02385084|100568153|FG000|STARTED|Period 3||2||
48098911|NCT02385084|100568154|FG001|STARTED|Period 3||3||
48098912|NCT02385084|100568155|FG002|STARTED|Period 3||1||
48098913|NCT02385084|100568156|FG003|STARTED|Period 3||3||
48098914|NCT02385084|100568157|FG004|STARTED|Period 3||2||
48098915|NCT02385084|100568158|FG005|STARTED|Period 3||3||
48098916|NCT02385084|100568153|FG000|Received LY2409021|Period 3||2||
48098917|NCT02385084|100568154|FG001|Received LY2409021|Period 3||3||
48098918|NCT02385084|100568155|FG002|Received LY2409021|Period 3||1||
48390378|NCT02395653|101283574|FG000|Received at Least 1 Dose of Study Drug|Overall Study||61|Participants included in the Safety Population.|
48390379|NCT02395653|101283574|FG000|COMPLETED|Overall Study||59||
48390380|NCT02395653|101283574|FG000|NOT COMPLETED|Overall Study||12||
48390381|NCT01207388|101283575|FG000|STARTED|Overall Study||116||
48390382|NCT01207388|101283575|FG000|COMPLETED|Overall Study||48||
48390383|NCT01207388|101283575|FG000|NOT COMPLETED|Overall Study||68||
48098919|NCT02385084|100568156|FG003|Received LY2409021|Period 3||3||
48098920|NCT02385084|100568157|FG004|Received LY2409021|Period 3||2||
48098921|NCT02385084|100568158|FG005|Received LY2409021|Period 3||3||
48098922|NCT02385084|100568153|FG000|Washout|Period 3||2||
48098923|NCT02385084|100568154|FG001|Washout|Period 3||3||
48098924|NCT02385084|100568155|FG002|Washout|Period 3||1||
48098925|NCT02385084|100568156|FG003|Washout|Period 3||3||
48098926|NCT02385084|100568157|FG004|Washout|Period 3||2||
48098927|NCT02385084|100568158|FG005|Washout|Period 3||3||
48098928|NCT02385084|100568153|FG000|COMPLETED|Period 3||2||
48098929|NCT02385084|100568154|FG001|COMPLETED|Period 3||3||
48098930|NCT02385084|100568155|FG002|COMPLETED|Period 3||1||
48098931|NCT02385084|100568156|FG003|COMPLETED|Period 3||3||
48098932|NCT02385084|100568157|FG004|COMPLETED|Period 3||2||
48098933|NCT02385084|100568158|FG005|COMPLETED|Period 3||3||
48545939|NCT03016975|101671384|FG002|NOT COMPLETED|At 5-year Follow-up||0||
48545940|NCT01783886|101671385|FG000|STARTED|Overall Study||127||
48545941|NCT01783886|101671386|FG001|STARTED|Overall Study||127||
48545942|NCT01783886|101671387|FG002|STARTED|Overall Study||127||
48545943|NCT01783886|101671385|FG000|Participants Received Treatment|Overall Study||127||
48545944|NCT01783886|101671386|FG001|Participants Received Treatment|Overall Study||127||
48545945|NCT01783886|101671387|FG002|Participants Received Treatment|Overall Study||124||
48545946|NCT01783886|101671385|FG000|COMPLETED|Overall Study||122||
48545947|NCT01783886|101671386|FG001|COMPLETED|Overall Study||116||
48545948|NCT01783886|101671387|FG002|COMPLETED|Overall Study||117||
48545949|NCT01783886|101671385|FG000|NOT COMPLETED|Overall Study||5||
48545950|NCT01783886|101671386|FG001|NOT COMPLETED|Overall Study||11||
48545951|NCT01783886|101671387|FG002|NOT COMPLETED|Overall Study||10||
48545952|NCT00459043|101671388|FG000|STARTED|Overall Study||15||
48545953|NCT00459043|101671389|FG001|STARTED|Overall Study||15||
48545954|NCT00459043|101671388|FG000|COMPLETED|Overall Study||14||
48545955|NCT00459043|101671389|FG001|COMPLETED|Overall Study||15||
48545956|NCT00459043|101671388|FG000|NOT COMPLETED|Overall Study||1||
48545957|NCT00459043|101671389|FG001|NOT COMPLETED|Overall Study||0||
48545958|NCT03008174|101671390|FG000|STARTED|Overall Study||10||
48545959|NCT03008174|101671391|FG001|STARTED|Overall Study||10||
48545960|NCT03008174|101671390|FG000|COMPLETED|Overall Study||7||
48545961|NCT03008174|101671391|FG001|COMPLETED|Overall Study||6||
48545962|NCT03008174|101671390|FG000|NOT COMPLETED|Overall Study||3||
48545963|NCT03008174|101671391|FG001|NOT COMPLETED|Overall Study||4||
48545964|NCT01611857|101671392|FG000|STARTED|Overall Study||15||
48545965|NCT01611857|101671393|FG001|STARTED|Overall Study||34||
48545966|NCT01611857|101671392|FG000|Tivantinib 120 mg|Overall Study||5||
48545967|NCT01611857|101671393|FG001|Tivantinib 120 mg|Overall Study||0||
48545968|NCT01611857|101671392|FG000|Tivantinib 240 mg|Overall Study||3||
48545969|NCT01611857|101671393|FG001|Tivantinib 240 mg|Overall Study||0||
48545970|NCT01611857|101671392|FG000|Tivantinib 360 mg|Overall Study||7||
48545971|NCT01611857|101671393|FG001|Tivantinib 360 mg|Overall Study||32||
48545972|NCT01611857|101671392|FG000|COMPLETED|Overall Study||15||
48545973|NCT01611857|101671393|FG001|COMPLETED|Overall Study||32||
48545974|NCT01611857|101671392|FG000|NOT COMPLETED|Overall Study||0||
48545975|NCT01611857|101671393|FG001|NOT COMPLETED|Overall Study||2||
48545976|NCT02676765|101671394|FG000|STARTED|Overall Study||10||
48545977|NCT02676765|101671395|FG001|STARTED|Overall Study||10||
48545978|NCT02676765|101671394|FG000|COMPLETED|Overall Study||10||
48545979|NCT02676765|101671395|FG001|COMPLETED|Overall Study||9||
48545980|NCT02676765|101671394|FG000|NOT COMPLETED|Overall Study||0||
48545981|NCT02676765|101671395|FG001|NOT COMPLETED|Overall Study||1||
48545982|NCT01661062|101671396|FG000|STARTED|Overall Study||23||
48545983|NCT01661062|101671396|FG000|COMPLETED|Overall Study||18||
48545984|NCT01661062|101671396|FG000|NOT COMPLETED|Overall Study||5||
48545985|NCT03765788|101671397|FG000|STARTED|Overall Study||27||
48545986|NCT03765788|101671398|FG001|STARTED|Overall Study||25||
48690613|NCT02626156|102025874|FG002|NOT COMPLETED|Study Visit 4||9||
48545987|NCT03765788|101671397|FG000|COMPLETED|Overall Study||22||
48545988|NCT03765788|101671398|FG001|COMPLETED|Overall Study||17||
48545989|NCT03765788|101671397|FG000|NOT COMPLETED|Overall Study||5||
48545990|NCT03765788|101671398|FG001|NOT COMPLETED|Overall Study||8||
48545991|NCT02694328|101671399|FG000|STARTED|Overall Study||276||
48545992|NCT02694328|101671400|FG001|STARTED|Overall Study||274||
48545993|NCT02694328|101671399|FG000|COMPLETED|Overall Study||176||
48545994|NCT02694328|101671400|FG001|COMPLETED|Overall Study||176||
48545995|NCT02694328|101671399|FG000|NOT COMPLETED|Overall Study||100||
48545996|NCT02694328|101671400|FG001|NOT COMPLETED|Overall Study||98||
48690614|NCT02626156|102025875|FG003|NOT COMPLETED|Study Visit 4||5||
48690615|NCT01771991|102025876|FG000|STARTED|Overall Study||38||
48690616|NCT01771991|102025877|FG001|STARTED|Overall Study||36||
48545997|NCT04252092|101671401|FG000|STARTED|Overall Study||15||
48545998|NCT04252092|101671402|FG001|STARTED|Overall Study||15||
48545999|NCT04252092|101671401|FG000|COMPLETED|Overall Study||15||
48546000|NCT04252092|101671402|FG001|COMPLETED|Overall Study||15||
48546001|NCT04252092|101671401|FG000|NOT COMPLETED|Overall Study||0||
48546002|NCT04252092|101671402|FG001|NOT COMPLETED|Overall Study||0||
48546003|NCT00696787|101671403|FG000|STARTED|Overall Study||40||
48546004|NCT00696787|101671404|FG001|STARTED|Overall Study||42||
48546005|NCT00696787|101671405|FG002|STARTED|Overall Study||43||
48546006|NCT00696787|101671403|FG000|COMPLETED|Overall Study||25||
48546007|NCT00696787|101671404|FG001|COMPLETED|Overall Study||22||
48546008|NCT00696787|101671405|FG002|COMPLETED|Overall Study||17||
48546009|NCT00696787|101671403|FG000|NOT COMPLETED|Overall Study||15||
48546010|NCT00696787|101671404|FG001|NOT COMPLETED|Overall Study||20||
48546011|NCT00696787|101671405|FG002|NOT COMPLETED|Overall Study||26||
48546012|NCT01687972|101671406|FG000|STARTED|Overall Study||44||
48546013|NCT01687972|101671407|FG001|STARTED|Overall Study||44||
48546014|NCT01687972|101671406|FG000|COMPLETED|Overall Study||44||
48546015|NCT01687972|101671407|FG001|COMPLETED|Overall Study||44||
48546016|NCT01687972|101671406|FG000|NOT COMPLETED|Overall Study||0||
48546017|NCT01687972|101671407|FG001|NOT COMPLETED|Overall Study||0||
48690617|NCT01771991|102025876|FG000|Started Treatment|Overall Study||37||
48690618|NCT01771991|102025877|FG001|Started Treatment|Overall Study||34||
48690619|NCT01771991|102025876|FG000|COMPLETED|Overall Study||30||
48690620|NCT01771991|102025877|FG001|COMPLETED|Overall Study||30||
48690621|NCT01771991|102025876|FG000|NOT COMPLETED|Overall Study||8||
48690622|NCT01771991|102025877|FG001|NOT COMPLETED|Overall Study||6||
48690623|NCT02846792|102025878|FG000|STARTED|Overall Study||5||
48690624|NCT02846792|102025878|FG000|COMPLETED|Overall Study||5||
48690625|NCT02846792|102025878|FG000|NOT COMPLETED|Overall Study||0||
48690626|NCT01683630|102025879|FG000|STARTED|Overall Study||1404||
48690627|NCT01683630|102025880|FG001|STARTED|Overall Study||445||
48690628|NCT01683630|102025879|FG000|COMPLETED|Overall Study||1404||
48690629|NCT01683630|102025880|FG001|COMPLETED|Overall Study||445||
48690630|NCT01683630|102025879|FG000|NOT COMPLETED|Overall Study||0||
48690631|NCT01683630|102025880|FG001|NOT COMPLETED|Overall Study||0||
48263047|NCT02906020|100966700|FG010|NOT COMPLETED|Part 1: Dose Escalation Period||0||
48263048|NCT02906020|100966701|FG011|NOT COMPLETED|Part 1: Dose Escalation Period||0||
48263049|NCT02906020|100966702|FG012|NOT COMPLETED|Part 1: Dose Escalation Period||0||
48390384|NCT00321269|101283576|FG000|STARTED|Overall Study||74||
48263050|NCT02906020|100966703|FG013|NOT COMPLETED|Part 1: Dose Escalation Period||0||
48263051|NCT02906020|100966704|FG014|NOT COMPLETED|Part 1: Dose Escalation Period||0||
48263052|NCT02906020|100966705|FG015|NOT COMPLETED|Part 1: Dose Escalation Period||0||
48263053|NCT02906020|100966690|FG000|STARTED|Part 2: Double-blind Treatment Period||0||
48263054|NCT02906020|100966691|FG001|STARTED|Part 2: Double-blind Treatment Period||0||
48263055|NCT02906020|100966692|FG002|STARTED|Part 2: Double-blind Treatment Period||0||
48263056|NCT02906020|100966693|FG003|STARTED|Part 2: Double-blind Treatment Period||0||
48263057|NCT02906020|100966694|FG004|STARTED|Part 2: Double-blind Treatment Period||0||
48263058|NCT02906020|100966695|FG005|STARTED|Part 2: Double-blind Treatment Period||0||
48263059|NCT02906020|100966696|FG006|STARTED|Part 2: Double-blind Treatment Period||0||
48263060|NCT02906020|100966697|FG007|STARTED|Part 2: Double-blind Treatment Period||0||
48263061|NCT02906020|100966698|FG008|STARTED|Part 2: Double-blind Treatment Period||111||
48263062|NCT02906020|100966699|FG009|STARTED|Part 2: Double-blind Treatment Period||110||
48263063|NCT02906020|100966700|FG010|STARTED|Part 2: Double-blind Treatment Period||10||
48263064|NCT02906020|100966701|FG011|STARTED|Part 2: Double-blind Treatment Period||13||
48263065|NCT02906020|100966702|FG012|STARTED|Part 2: Double-blind Treatment Period||0||
48263066|NCT02906020|100966703|FG013|STARTED|Part 2: Double-blind Treatment Period||0||
48390385|NCT00321269|101283577|FG001|STARTED|Overall Study||74||
48390386|NCT00321269|101283576|FG000|COMPLETED|Overall Study||66||
48390387|NCT00321269|101283577|FG001|COMPLETED|Overall Study||68||
48390388|NCT00321269|101283576|FG000|NOT COMPLETED|Overall Study||8||
48390389|NCT00321269|101283577|FG001|NOT COMPLETED|Overall Study||6||
48390390|NCT04047121|101283578|FG000|STARTED|Overall Study||310||
48390391|NCT04047121|101283579|FG001|STARTED|Overall Study||299||
48390392|NCT04047121|101283580|FG002|STARTED|Overall Study||79||
48390393|NCT04047121|101283581|FG003|STARTED|Overall Study||287||
48390394|NCT04047121|101283582|FG004|STARTED|Overall Study||112||
48390395|NCT04047121|101283583|FG005|STARTED|Overall Study||262||
48390396|NCT04047121|101283578|FG000|COMPLETED|Overall Study||310||
48390397|NCT04047121|101283579|FG001|COMPLETED|Overall Study||299||
48390398|NCT04047121|101283580|FG002|COMPLETED|Overall Study||79||
48390399|NCT04047121|101283581|FG003|COMPLETED|Overall Study||287||
48390400|NCT04047121|101283582|FG004|COMPLETED|Overall Study||112||
48390401|NCT04047121|101283583|FG005|COMPLETED|Overall Study||262||
48390402|NCT04047121|101283578|FG000|NOT COMPLETED|Overall Study||0||
48390403|NCT04047121|101283579|FG001|NOT COMPLETED|Overall Study||0||
48390404|NCT04047121|101283580|FG002|NOT COMPLETED|Overall Study||0||
48390405|NCT04047121|101283581|FG003|NOT COMPLETED|Overall Study||0||
48390406|NCT04047121|101283582|FG004|NOT COMPLETED|Overall Study||0||
48390407|NCT04047121|101283583|FG005|NOT COMPLETED|Overall Study||0||
48390408|NCT02527148|101283584|FG000|STARTED|Overall Study||50||
48390409|NCT02527148|101283585|FG001|STARTED|Overall Study||50||
48390410|NCT02527148|101283584|FG000|COMPLETED|Overall Study||49||
48390411|NCT02527148|101283585|FG001|COMPLETED|Overall Study||50||
48390412|NCT02527148|101283584|FG000|NOT COMPLETED|Overall Study||1||
48390413|NCT02527148|101283585|FG001|NOT COMPLETED|Overall Study||0||
48390414|NCT01668030|101283586|FG000|STARTED|Overall Study||10||10
48390415|NCT01668030|101283587|FG001|STARTED|Overall Study||10||10
48390416|NCT01668030|101283586|FG000|COMPLETED|Overall Study||10||10
48390417|NCT01668030|101283587|FG001|COMPLETED|Overall Study||10||10
48390418|NCT01668030|101283586|FG000|NOT COMPLETED|Overall Study||0||0
48390419|NCT01668030|101283587|FG001|NOT COMPLETED|Overall Study||0||0
48390420|NCT02586077|101283588|FG000|STARTED|Overall Study||36||
48390421|NCT02586077|101283588|FG000|COMPLETED|Overall Study||28||
48390422|NCT02586077|101283588|FG000|NOT COMPLETED|Overall Study||8||
48390423|NCT00792701|101283589|FG000|STARTED|Overall Study||19||
48390424|NCT00792701|101283590|FG001|STARTED|Overall Study||66||
48390425|NCT00792701|101283589|FG000|Eligible|Overall Study||18||
48390426|NCT00792701|101283590|FG001|Eligible|Overall Study||63||
48390427|NCT00792701|101283589|FG000|Eligible and Analyzable|Overall Study||17||
48390428|NCT00792701|101283590|FG001|Eligible and Analyzable|Overall Study||44||
48690632|NCT00335738|102025881|FG000|STARTED|Overall Study||108||
48690633|NCT00335738|102025882|FG001|STARTED|Overall Study||223||
48098934|NCT02385084|100568153|FG000|NOT COMPLETED|Period 3||0||
48098935|NCT02385084|100568154|FG001|NOT COMPLETED|Period 3||0||
48098936|NCT02385084|100568155|FG002|NOT COMPLETED|Period 3||0||
48098937|NCT02385084|100568156|FG003|NOT COMPLETED|Period 3||0||
48098938|NCT02385084|100568157|FG004|NOT COMPLETED|Period 3||0||
48098939|NCT02385084|100568158|FG005|NOT COMPLETED|Period 3||0||
48098940|NCT02411292|100568159|FG000|STARTED|Overall Study||110||
48098941|NCT02411292|100568159|FG000|COMPLETED|Overall Study||89||
48098942|NCT02411292|100568159|FG000|NOT COMPLETED|Overall Study||21||
48098943|NCT00507442|100568160|FG000|STARTED|Overall Study||42||
48098944|NCT00507442|100568161|FG001|STARTED|Overall Study||66||
48098945|NCT00507442|100568162|FG002|STARTED|Overall Study||33||
48098946|NCT00507442|100568163|FG003|STARTED|Overall Study||17||
48098947|NCT00507442|100568160|FG000|COMPLETED|Overall Study||26||
48098948|NCT00507442|100568161|FG001|COMPLETED|Overall Study||39||
48098949|NCT00507442|100568162|FG002|COMPLETED|Overall Study||18||
48098950|NCT00507442|100568163|FG003|COMPLETED|Overall Study||12||
48098951|NCT00507442|100568160|FG000|NOT COMPLETED|Overall Study||16||
48098952|NCT00507442|100568161|FG001|NOT COMPLETED|Overall Study||27||
48098953|NCT00507442|100568162|FG002|NOT COMPLETED|Overall Study||15||
48098954|NCT00507442|100568163|FG003|NOT COMPLETED|Overall Study||5||
48098955|NCT01291056|100568164|FG000|STARTED|Intervention One (Menstraution Day 3-7)||10||
48098956|NCT01291056|100568165|FG001|STARTED|Intervention One (Menstraution Day 3-7)||10||
48098957|NCT01291056|100568164|FG000|COMPLETED|Intervention One (Menstraution Day 3-7)||10||
48098958|NCT01291056|100568165|FG001|COMPLETED|Intervention One (Menstraution Day 3-7)||10||
48098959|NCT01291056|100568164|FG000|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0||
48098960|NCT01291056|100568165|FG001|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0||
48098961|NCT01291056|100568164|FG000|STARTED|Washout||10||
48098962|NCT01291056|100568165|FG001|STARTED|Washout||10||
48098963|NCT01291056|100568164|FG000|COMPLETED|Washout||10||
48098964|NCT01291056|100568165|FG001|COMPLETED|Washout||10||
48098965|NCT01291056|100568164|FG000|NOT COMPLETED|Washout||0||
48098966|NCT01291056|100568165|FG001|NOT COMPLETED|Washout||0||
48098967|NCT01291056|100568164|FG000|STARTED|Intervention Two (Menstration Days 3-7)||10||
48098968|NCT01291056|100568165|FG001|STARTED|Intervention Two (Menstration Days 3-7)||10||
48098969|NCT01291056|100568164|FG000|COMPLETED|Intervention Two (Menstration Days 3-7)||10||
48098970|NCT01291056|100568165|FG001|COMPLETED|Intervention Two (Menstration Days 3-7)||10||
48098971|NCT01291056|100568164|FG000|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0||
48098972|NCT01291056|100568165|FG001|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0||
48098973|NCT02432846|100568166|FG000|STARTED|Overall Study (4 Arms/Strata)||17||
48098974|NCT02432846|100568167|FG001|STARTED|Overall Study (4 Arms/Strata)||8||
48098975|NCT02432846|100568168|FG002|STARTED|Overall Study (4 Arms/Strata)||41||
48098976|NCT02432846|100568169|FG003|STARTED|Overall Study (4 Arms/Strata)||22||
48098977|NCT02432846|100568170|FG004|STARTED|Overall Study (4 Arms/Strata)||0||
48098978|NCT02432846|100568171|FG005|STARTED|Overall Study (4 Arms/Strata)||0||
48098979|NCT02432846|100568166|FG000|COMPLETED|Overall Study (4 Arms/Strata)||2||
48098980|NCT02432846|100568167|FG001|COMPLETED|Overall Study (4 Arms/Strata)||0||
48098981|NCT02432846|100568168|FG002|COMPLETED|Overall Study (4 Arms/Strata)||17||
48098982|NCT02432846|100568169|FG003|COMPLETED|Overall Study (4 Arms/Strata)||8||
48098983|NCT02432846|100568170|FG004|COMPLETED|Overall Study (4 Arms/Strata)||0||
48098984|NCT02432846|100568171|FG005|COMPLETED|Overall Study (4 Arms/Strata)||0||
48098985|NCT02432846|100568166|FG000|NOT COMPLETED|Overall Study (4 Arms/Strata)||15||
48098986|NCT02432846|100568167|FG001|NOT COMPLETED|Overall Study (4 Arms/Strata)||8||
48098987|NCT02432846|100568168|FG002|NOT COMPLETED|Overall Study (4 Arms/Strata)||24||
48098988|NCT02432846|100568169|FG003|NOT COMPLETED|Overall Study (4 Arms/Strata)||14||
48098989|NCT02432846|100568170|FG004|NOT COMPLETED|Overall Study (4 Arms/Strata)||0||
48263067|NCT02906020|100966704|FG014|STARTED|Part 2: Double-blind Treatment Period||0||
48263068|NCT02906020|100966705|FG015|STARTED|Part 2: Double-blind Treatment Period||0||
48263069|NCT02906020|100966690|FG000|Treated|Part 2: Double-blind Treatment Period||0||
48263070|NCT02906020|100966691|FG001|Treated|Part 2: Double-blind Treatment Period||0||
48263071|NCT02906020|100966692|FG002|Treated|Part 2: Double-blind Treatment Period||0||
48263072|NCT02906020|100966693|FG003|Treated|Part 2: Double-blind Treatment Period||0||
48263073|NCT02906020|100966694|FG004|Treated|Part 2: Double-blind Treatment Period||0||
48263074|NCT02906020|100966695|FG005|Treated|Part 2: Double-blind Treatment Period||0||
48098990|NCT02432846|100568171|FG005|NOT COMPLETED|Overall Study (4 Arms/Strata)||0||
48098991|NCT02432846|100568166|FG000|STARTED|Overall Study (2 Total/Combined Groups)||0||
48098992|NCT02432846|100568167|FG001|STARTED|Overall Study (2 Total/Combined Groups)||0||
48098993|NCT02432846|100568168|FG002|STARTED|Overall Study (2 Total/Combined Groups)||0||
48098994|NCT02432846|100568169|FG003|STARTED|Overall Study (2 Total/Combined Groups)||0||
48098995|NCT02432846|100568170|FG004|STARTED|Overall Study (2 Total/Combined Groups)||58||
48263075|NCT02906020|100966696|FG006|Treated|Part 2: Double-blind Treatment Period||0||
48098996|NCT02432846|100568171|FG005|STARTED|Overall Study (2 Total/Combined Groups)||30||
48098997|NCT02432846|100568166|FG000|COMPLETED|Overall Study (2 Total/Combined Groups)||0||
48098998|NCT02432846|100568167|FG001|COMPLETED|Overall Study (2 Total/Combined Groups)||0||
48098999|NCT02432846|100568168|FG002|COMPLETED|Overall Study (2 Total/Combined Groups)||0||
48099000|NCT02432846|100568169|FG003|COMPLETED|Overall Study (2 Total/Combined Groups)||0||
48390429|NCT00792701|101283589|FG000|COMPLETED|Overall Study||0||
48390430|NCT00792701|101283590|FG001|COMPLETED|Overall Study||22||
48390431|NCT00792701|101283589|FG000|NOT COMPLETED|Overall Study||19||
48390432|NCT00792701|101283590|FG001|NOT COMPLETED|Overall Study||44||
48390433|NCT05197140|101283591|FG000|STARTED|Overall Study||11||
48390434|NCT05197140|101283592|FG001|STARTED|Overall Study||11||
48390435|NCT05197140|101283593|FG002|STARTED|Overall Study||11||
48390436|NCT05197140|101283591|FG000|COMPLETED|Overall Study||8||
48099001|NCT02432846|100568170|FG004|COMPLETED|Overall Study (2 Total/Combined Groups)||19||
48099002|NCT02432846|100568171|FG005|COMPLETED|Overall Study (2 Total/Combined Groups)||8||
48099003|NCT02432846|100568166|FG000|NOT COMPLETED|Overall Study (2 Total/Combined Groups)||0||
48099004|NCT02432846|100568167|FG001|NOT COMPLETED|Overall Study (2 Total/Combined Groups)||0||
48099005|NCT02432846|100568168|FG002|NOT COMPLETED|Overall Study (2 Total/Combined Groups)||0||
48099006|NCT02432846|100568169|FG003|NOT COMPLETED|Overall Study (2 Total/Combined Groups)||0||
48099007|NCT02432846|100568170|FG004|NOT COMPLETED|Overall Study (2 Total/Combined Groups)||39||
48099008|NCT02432846|100568171|FG005|NOT COMPLETED|Overall Study (2 Total/Combined Groups)||22||
48099009|NCT03164928|100568172|FG000|STARTED|Overall Study||16||
48099010|NCT03164928|100568173|FG001|STARTED|Overall Study||8||
48099011|NCT03164928|100568172|FG000|COMPLETED|Overall Study||15||
48099012|NCT03164928|100568173|FG001|COMPLETED|Overall Study||8||
48099013|NCT03164928|100568172|FG000|NOT COMPLETED|Overall Study||1||
48099014|NCT03164928|100568173|FG001|NOT COMPLETED|Overall Study||0||
48099015|NCT01400516|100568174|FG000|STARTED|Primary Trial||12||
48099016|NCT01400516|100568175|FG001|STARTED|Primary Trial||14||
48099017|NCT01400516|100568174|FG000|COMPLETED|Primary Trial||12||
48099018|NCT01400516|100568175|FG001|COMPLETED|Primary Trial||12||
48099019|NCT01400516|100568174|FG000|NOT COMPLETED|Primary Trial||0||
48099020|NCT01400516|100568175|FG001|NOT COMPLETED|Primary Trial||2||
48099021|NCT01400516|100568174|FG000|STARTED|Extension Trial||6||
48099022|NCT01400516|100568175|FG001|STARTED|Extension Trial||7||
48099023|NCT01400516|100568174|FG000|COMPLETED|Extension Trial||6||
48099024|NCT01400516|100568175|FG001|COMPLETED|Extension Trial||7||
48099025|NCT01400516|100568174|FG000|NOT COMPLETED|Extension Trial||0||
48099026|NCT01400516|100568175|FG001|NOT COMPLETED|Extension Trial||0||
48099027|NCT01295515|100568176|FG000|STARTED|Overall Study||7||
48099028|NCT01295515|100568176|FG000|COMPLETED|Overall Study||7||
48099029|NCT01295515|100568176|FG000|NOT COMPLETED|Overall Study||0||
48099030|NCT01696994|100568177|FG000|STARTED|Overall Study||39111||
48099031|NCT01696994|100568178|FG001|STARTED|Overall Study||39105||
48099032|NCT01696994|100568177|FG000|COMPLETED|Overall Study||33919||
48099033|NCT01696994|100568178|FG001|COMPLETED|Overall Study||30668||
48099034|NCT01696994|100568177|FG000|NOT COMPLETED|Overall Study||5192||
48099035|NCT01696994|100568178|FG001|NOT COMPLETED|Overall Study||8437||
48099036|NCT02447081|100568179|FG000|STARTED|Overall Study||1088||
48099037|NCT02447081|100568179|FG000|COMPLETED|Overall Study||864||
48099038|NCT02447081|100568179|FG000|NOT COMPLETED|Overall Study||224||
48099039|NCT03082599|100568180|FG000|STARTED|Overall Study||40||
48099040|NCT03082599|100568181|FG001|STARTED|Overall Study||39||
48099041|NCT03082599|100568180|FG000|COMPLETED|Overall Study||39||
48390437|NCT05197140|101283592|FG001|COMPLETED|Overall Study||8||
48390438|NCT05197140|101283593|FG002|COMPLETED|Overall Study||8||
48390439|NCT05197140|101283591|FG000|NOT COMPLETED|Overall Study||3||
48390440|NCT05197140|101283592|FG001|NOT COMPLETED|Overall Study||3||
48390441|NCT05197140|101283593|FG002|NOT COMPLETED|Overall Study||3||
48390442|NCT01369849|101283594|FG000|STARTED|Overall Study||6||
48390443|NCT01369849|101283595|FG001|STARTED|Overall Study||4||
48099042|NCT03082599|100568181|FG001|COMPLETED|Overall Study||39||
48099043|NCT03082599|100568180|FG000|NOT COMPLETED|Overall Study||1||
48099044|NCT03082599|100568181|FG001|NOT COMPLETED|Overall Study||0||
48099045|NCT01179477|100568182|FG000|STARTED|Overall Study||1930||
48099046|NCT01179477|100568182|FG000|COMPLETED|Overall Study||843||
48099047|NCT01179477|100568182|FG000|NOT COMPLETED|Overall Study||1087||
48099048|NCT01173718|100568183|FG000|STARTED|Overall Study||138||
48099049|NCT01173718|100568183|FG000|COMPLETED|Overall Study||94||
48099050|NCT01173718|100568183|FG000|NOT COMPLETED|Overall Study||44||
48099051|NCT02738333|100568184|FG000|STARTED|Overall Study||106||
48099052|NCT02738333|100568185|FG001|STARTED|Overall Study||108||
48099053|NCT02738333|100568186|FG002|STARTED|Overall Study||25||
48099054|NCT02738333|100568184|FG000|COMPLETED|Overall Study||104||
48099055|NCT02738333|100568185|FG001|COMPLETED|Overall Study||108||
48099056|NCT02738333|100568186|FG002|COMPLETED|Overall Study||25||
48099057|NCT02738333|100568184|FG000|NOT COMPLETED|Overall Study||2||
48390444|NCT01369849|101283596|FG002|STARTED|Overall Study||5||
48390445|NCT01369849|101283594|FG000|COMPLETED|Overall Study||6||
48099058|NCT02738333|100568185|FG001|NOT COMPLETED|Overall Study||0||
48099059|NCT02738333|100568186|FG002|NOT COMPLETED|Overall Study||0||
48099060|NCT01288287|100568187|FG000|STARTED|Overall Study||149||
48099061|NCT01288287|100568187|FG000|Safety Set|Overall Study||147||
48099062|NCT01288287|100568187|FG000|Full Analysis Set|Overall Study||111||
48099063|NCT01288287|100568187|FG000|COMPLETED|Overall Study||103||
48099064|NCT01288287|100568187|FG000|NOT COMPLETED|Overall Study||46||
48390446|NCT01369849|101283595|FG001|COMPLETED|Overall Study||3||
48390447|NCT01369849|101283596|FG002|COMPLETED|Overall Study||4||
48390448|NCT01369849|101283594|FG000|NOT COMPLETED|Overall Study||0||
48099065|NCT00454987|100568188|FG000|STARTED|Booster Period (NCT00258700)||359||
48099066|NCT00454987|100568189|FG001|STARTED|Booster Period (NCT00258700)||117||
48099067|NCT00454987|100568190|FG002|STARTED|Booster Period (NCT00258700)||0||
48099068|NCT00454987|100568188|FG000|COMPLETED|Booster Period (NCT00258700)||357||
48099069|NCT00454987|100568189|FG001|COMPLETED|Booster Period (NCT00258700)||116||
48099070|NCT00454987|100568190|FG002|COMPLETED|Booster Period (NCT00258700)||0||
48099071|NCT00454987|100568188|FG000|NOT COMPLETED|Booster Period (NCT00258700)||2||
48099072|NCT00454987|100568189|FG001|NOT COMPLETED|Booster Period (NCT00258700)||1||
48099073|NCT00454987|100568190|FG002|NOT COMPLETED|Booster Period (NCT00258700)||0||
48099074|NCT00454987|100568188|FG000|STARTED|Year 1 (NCT00454987)||221||
48099075|NCT00454987|100568189|FG001|STARTED|Year 1 (NCT00454987)||67||
48099076|NCT00454987|100568190|FG002|STARTED|Year 1 (NCT00454987)||0||
48099077|NCT00454987|100568188|FG000|COMPLETED|Year 1 (NCT00454987)||221||
48099078|NCT00454987|100568189|FG001|COMPLETED|Year 1 (NCT00454987)||67||
48099079|NCT00454987|100568190|FG002|COMPLETED|Year 1 (NCT00454987)||0||
48099080|NCT00454987|100568188|FG000|NOT COMPLETED|Year 1 (NCT00454987)||0||
48390449|NCT01369849|101283595|FG001|NOT COMPLETED|Overall Study||1||
48546018|NCT01808573|101671408|FG000|STARTED|Overall Study||307||
48546019|NCT01808573|101671409|FG001|STARTED|Overall Study||314||
48546020|NCT01808573|101671408|FG000|Received Treatment|Overall Study||303||
48690634|NCT00335738|102025881|FG000|COMPLETED|Overall Study||97||
48690635|NCT00335738|102025882|FG001|COMPLETED|Overall Study||219||
48690636|NCT00335738|102025881|FG000|NOT COMPLETED|Overall Study||11||
48690637|NCT00335738|102025882|FG001|NOT COMPLETED|Overall Study||4||
48690638|NCT02036580|102025883|FG000|STARTED|Overall Study||8||
48690639|NCT02036580|102025884|FG001|STARTED|Overall Study||8||
48546021|NCT01808573|101671409|FG001|Received Treatment|Overall Study||311||
48546022|NCT01808573|101671408|FG000|COMPLETED|Overall Study||0||
48546023|NCT01808573|101671409|FG001|COMPLETED|Overall Study||0||
48546024|NCT01808573|101671408|FG000|NOT COMPLETED|Overall Study||307||
48690640|NCT02036580|102025885|FG002|STARTED|Overall Study||4||
48390450|NCT01369849|101283596|FG002|NOT COMPLETED|Overall Study||1||
48390451|NCT00305604|101283597|FG000|STARTED|Overall Study||102||
48390452|NCT00305604|101283598|FG001|STARTED|Overall Study||104||
48390453|NCT00305604|101283597|FG000|COMPLETED|Overall Study||70||
48390454|NCT00305604|101283598|FG001|COMPLETED|Overall Study||57||
48390455|NCT00305604|101283597|FG000|NOT COMPLETED|Overall Study||32||
48390456|NCT00305604|101283598|FG001|NOT COMPLETED|Overall Study||47||
48390457|NCT01122030|101283599|FG000|STARTED|Overall Study||18||
48390458|NCT01122030|101283600|FG001|STARTED|Overall Study||9||
48390459|NCT01122030|101283601|FG002|STARTED|Overall Study||9||
48390460|NCT01122030|101283602|FG003|STARTED|Overall Study||9||
48390461|NCT01122030|101283603|FG004|STARTED|Overall Study||9||
48099081|NCT00454987|100568189|FG001|NOT COMPLETED|Year 1 (NCT00454987)||0||
48099082|NCT00454987|100568190|FG002|NOT COMPLETED|Year 1 (NCT00454987)||0||
48099083|NCT00454987|100568188|FG000|STARTED|Year 2 (NCT00454987)||235||
48099084|NCT00454987|100568189|FG001|STARTED|Year 2 (NCT00454987)||77||
48099085|NCT00454987|100568190|FG002|STARTED|Year 2 (NCT00454987)||74||
48099086|NCT00454987|100568188|FG000|COMPLETED|Year 2 (NCT00454987)||235||
48390462|NCT01122030|101283604|FG005|STARTED|Overall Study||9||
48390463|NCT01122030|101283605|FG006|STARTED|Overall Study||9||
48390464|NCT01122030|101283599|FG000|Received Treatment|Overall Study||18||
48390465|NCT01122030|101283600|FG001|Received Treatment|Overall Study||9||
48390466|NCT01122030|101283601|FG002|Received Treatment|Overall Study||9||
48390467|NCT01122030|101283602|FG003|Received Treatment|Overall Study||9||
48390468|NCT01122030|101283603|FG004|Received Treatment|Overall Study||9||
48390469|NCT01122030|101283604|FG005|Received Treatment|Overall Study||9||
48546025|NCT01808573|101671409|FG001|NOT COMPLETED|Overall Study||314||
48546026|NCT00295061|101671410|FG000|STARTED|Overall Study||12||
48546027|NCT00295061|101671411|FG001|STARTED|Overall Study||12||
48690641|NCT02036580|102025883|FG000|COMPLETED|Overall Study||7||
48690642|NCT02036580|102025884|FG001|COMPLETED|Overall Study||7||
48099087|NCT00454987|100568189|FG001|COMPLETED|Year 2 (NCT00454987)||77||
48099088|NCT00454987|100568190|FG002|COMPLETED|Year 2 (NCT00454987)||74||
48099089|NCT00454987|100568188|FG000|NOT COMPLETED|Year 2 (NCT00454987)||0||
48099090|NCT00454987|100568189|FG001|NOT COMPLETED|Year 2 (NCT00454987)||0||
48099091|NCT00454987|100568190|FG002|NOT COMPLETED|Year 2 (NCT00454987)||0||
48099092|NCT00454987|100568188|FG000|STARTED|Year 4 (NCT00454987)||206||
48099093|NCT00454987|100568189|FG001|STARTED|Year 4 (NCT00454987)||62||
48546028|NCT00295061|101671410|FG000|COMPLETED|Overall Study||12||
48546029|NCT00295061|101671411|FG001|COMPLETED|Overall Study||12||
48546030|NCT00295061|101671410|FG000|NOT COMPLETED|Overall Study||0||
48690643|NCT02036580|102025885|FG002|COMPLETED|Overall Study||4||
48690644|NCT02036580|102025883|FG000|NOT COMPLETED|Overall Study||1||
48690645|NCT02036580|102025884|FG001|NOT COMPLETED|Overall Study||1||
48099094|NCT00454987|100568190|FG002|STARTED|Year 4 (NCT00454987)||0||
48099095|NCT00454987|100568188|FG000|COMPLETED|Year 4 (NCT00454987)||206||
48390470|NCT01122030|101283605|FG006|Received Treatment|Overall Study||9||
48390471|NCT01122030|101283599|FG000|COMPLETED|Overall Study||18||
48390472|NCT01122030|101283600|FG001|COMPLETED|Overall Study||9||
48390473|NCT01122030|101283601|FG002|COMPLETED|Overall Study||9||
48390474|NCT01122030|101283602|FG003|COMPLETED|Overall Study||9||
48099096|NCT00454987|100568189|FG001|COMPLETED|Year 4 (NCT00454987)||62||
48099097|NCT00454987|100568190|FG002|COMPLETED|Year 4 (NCT00454987)||0||
48099098|NCT00454987|100568188|FG000|NOT COMPLETED|Year 4 (NCT00454987)||0||
48099099|NCT00454987|100568189|FG001|NOT COMPLETED|Year 4 (NCT00454987)||0||
48099100|NCT00454987|100568190|FG002|NOT COMPLETED|Year 4 (NCT00454987)||0||
48099101|NCT00720057|100568191|FG000|STARTED|Overall Study||153||
48099102|NCT00720057|100568192|FG001|STARTED|Overall Study||159||
48263076|NCT02906020|100966697|FG007|Treated|Part 2: Double-blind Treatment Period||0||
48263077|NCT02906020|100966698|FG008|Treated|Part 2: Double-blind Treatment Period||111||
48263078|NCT02906020|100966699|FG009|Treated|Part 2: Double-blind Treatment Period||110||
48263079|NCT02906020|100966700|FG010|Treated|Part 2: Double-blind Treatment Period||10||
48263080|NCT02906020|100966701|FG011|Treated|Part 2: Double-blind Treatment Period||13||
48263081|NCT02906020|100966702|FG012|Treated|Part 2: Double-blind Treatment Period||0||
48263082|NCT02906020|100966703|FG013|Treated|Part 2: Double-blind Treatment Period||0||
48263083|NCT02906020|100966704|FG014|Treated|Part 2: Double-blind Treatment Period||0||
48263084|NCT02906020|100966705|FG015|Treated|Part 2: Double-blind Treatment Period||0||
48263085|NCT02906020|100966690|FG000|COMPLETED|Part 2: Double-blind Treatment Period||0||
48263086|NCT02906020|100966691|FG001|COMPLETED|Part 2: Double-blind Treatment Period||0||
48263087|NCT02906020|100966692|FG002|COMPLETED|Part 2: Double-blind Treatment Period||0||
48263088|NCT02906020|100966693|FG003|COMPLETED|Part 2: Double-blind Treatment Period||0||
48263089|NCT02906020|100966694|FG004|COMPLETED|Part 2: Double-blind Treatment Period||0||
48390475|NCT01122030|101283603|FG004|COMPLETED|Overall Study||9||
48390476|NCT01122030|101283604|FG005|COMPLETED|Overall Study||9||
48390477|NCT01122030|101283605|FG006|COMPLETED|Overall Study||9||
48390478|NCT01122030|101283599|FG000|NOT COMPLETED|Overall Study||0||
48390479|NCT01122030|101283600|FG001|NOT COMPLETED|Overall Study||0||
48390480|NCT01122030|101283601|FG002|NOT COMPLETED|Overall Study||0||
48390481|NCT01122030|101283602|FG003|NOT COMPLETED|Overall Study||0||
48390482|NCT01122030|101283603|FG004|NOT COMPLETED|Overall Study||0||
48390483|NCT01122030|101283604|FG005|NOT COMPLETED|Overall Study||0||
48390484|NCT01122030|101283605|FG006|NOT COMPLETED|Overall Study||0||
48390485|NCT02487277|101283606|FG000|STARTED|Overall Study||3||
48390486|NCT02487277|101283607|FG001|STARTED|Overall Study||0||
48390487|NCT02487277|101283606|FG000|COMPLETED|Overall Study||3||
48390488|NCT02487277|101283607|FG001|COMPLETED|Overall Study||0||
48390489|NCT02487277|101283606|FG000|NOT COMPLETED|Overall Study||0||
48390490|NCT02487277|101283607|FG001|NOT COMPLETED|Overall Study||0||
48390491|NCT05340322|101283608|FG000|STARTED|Overall Study||503||
48390492|NCT05340322|101283608|FG000|COMPLETED|Overall Study||503||
48390493|NCT05340322|101283608|FG000|NOT COMPLETED|Overall Study||0||
48390494|NCT00838006|101283609|FG000|STARTED|Overall Study||102||
48390495|NCT00838006|101283610|FG001|STARTED|Overall Study||98||
48390496|NCT00838006|101283611|FG002|STARTED|Overall Study||142||
48390497|NCT00838006|101283609|FG000|3-month Post-deployment Follow-up|Overall Study||92||
48390498|NCT00838006|101283610|FG001|3-month Post-deployment Follow-up|Overall Study||80||
48390499|NCT00838006|101283611|FG002|3-month Post-deployment Follow-up|Overall Study||135||
48390500|NCT00838006|101283609|FG000|COMPLETED|Overall Study||68||
48390501|NCT00838006|101283610|FG001|COMPLETED|Overall Study||72||
48390502|NCT00838006|101283611|FG002|COMPLETED|Overall Study||94||
48390503|NCT00838006|101283609|FG000|NOT COMPLETED|Overall Study||34||
48390504|NCT00838006|101283610|FG001|NOT COMPLETED|Overall Study||26||
48390505|NCT00838006|101283611|FG002|NOT COMPLETED|Overall Study||48||
48390506|NCT02727660|101283612|FG000|STARTED|Overall Study||619|mITT Population|
48390507|NCT02727660|101283613|FG001|STARTED|Overall Study||617|mITT Population|
48099103|NCT00720057|100568191|FG000|COMPLETED|Overall Study||152||
48263090|NCT02906020|100966695|FG005|COMPLETED|Part 2: Double-blind Treatment Period||0||
48263091|NCT02906020|100966696|FG006|COMPLETED|Part 2: Double-blind Treatment Period||0||
48263092|NCT02906020|100966697|FG007|COMPLETED|Part 2: Double-blind Treatment Period||0||
48263093|NCT02906020|100966698|FG008|COMPLETED|Part 2: Double-blind Treatment Period||99||
48263094|NCT02906020|100966699|FG009|COMPLETED|Part 2: Double-blind Treatment Period||85||
48263095|NCT02906020|100966700|FG010|COMPLETED|Part 2: Double-blind Treatment Period||10||
48263096|NCT02906020|100966701|FG011|COMPLETED|Part 2: Double-blind Treatment Period||13||
48263097|NCT02906020|100966702|FG012|COMPLETED|Part 2: Double-blind Treatment Period||0||
48263098|NCT02906020|100966703|FG013|COMPLETED|Part 2: Double-blind Treatment Period||0||
48263099|NCT02906020|100966704|FG014|COMPLETED|Part 2: Double-blind Treatment Period||0||
48263100|NCT02906020|100966705|FG015|COMPLETED|Part 2: Double-blind Treatment Period||0||
48263101|NCT02906020|100966690|FG000|NOT COMPLETED|Part 2: Double-blind Treatment Period||0||
48263102|NCT02906020|100966691|FG001|NOT COMPLETED|Part 2: Double-blind Treatment Period||0||
48263103|NCT02906020|100966692|FG002|NOT COMPLETED|Part 2: Double-blind Treatment Period||0||
48263104|NCT02906020|100966693|FG003|NOT COMPLETED|Part 2: Double-blind Treatment Period||0||
48390508|NCT02727660|101283614|FG002|STARTED|Overall Study||607|mITT Population|
48390509|NCT02727660|101283612|FG000|COMPLETED|Overall Study||503|Completed Study Treatment|
48390510|NCT02727660|101283613|FG001|COMPLETED|Overall Study||501|Completed Study Treatment|
48390511|NCT02727660|101283614|FG002|COMPLETED|Overall Study||442|Completed Study Treatment|
48099104|NCT00720057|100568192|FG001|COMPLETED|Overall Study||156||
48099105|NCT00720057|100568191|FG000|NOT COMPLETED|Overall Study||1||
48263105|NCT02906020|100966694|FG004|NOT COMPLETED|Part 2: Double-blind Treatment Period||0||
48263106|NCT02906020|100966695|FG005|NOT COMPLETED|Part 2: Double-blind Treatment Period||0||
48546031|NCT00295061|101671411|FG001|NOT COMPLETED|Overall Study||0||
48546032|NCT01696279|101671412|FG000|STARTED|Part 1: Single Dose Lanthanum Carbonate||20||
48546033|NCT01696279|101671413|FG001|STARTED|Part 1: Single Dose Lanthanum Carbonate||0||
48546034|NCT01696279|101671414|FG002|STARTED|Part 1: Single Dose Lanthanum Carbonate||0||
48546035|NCT01696279|101671415|FG003|STARTED|Part 1: Single Dose Lanthanum Carbonate||0||
48546036|NCT01696279|101671412|FG000|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||20||
48546037|NCT01696279|101671413|FG001|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0||
48546038|NCT01696279|101671414|FG002|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0||
48546039|NCT01696279|101671415|FG003|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0||
48546040|NCT01696279|101671412|FG000|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||19||
48546041|NCT01696279|101671413|FG001|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0||
48546042|NCT01696279|101671414|FG002|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0||
48546043|NCT01696279|101671415|FG003|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0||
48546044|NCT01696279|101671412|FG000|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||19||
48546045|NCT01696279|101671413|FG001|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0||
48546046|NCT01696279|101671414|FG002|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0||
48546047|NCT01696279|101671415|FG003|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0||
48546048|NCT01696279|101671412|FG000|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||1||
48546049|NCT01696279|101671413|FG001|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0||
48546050|NCT01696279|101671414|FG002|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0||
48546051|NCT01696279|101671415|FG003|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0||
48099106|NCT00720057|100568192|FG001|NOT COMPLETED|Overall Study||3||
48099107|NCT02522286|100568193|FG000|STARTED|Overall Study||78||
48099108|NCT02522286|100568194|FG001|STARTED|Overall Study||75||
48099109|NCT02522286|100568195|FG002|STARTED|Overall Study||75||
48099110|NCT02522286|100568196|FG003|STARTED|Overall Study||78||
48099111|NCT02522286|100568193|FG000|COMPLETED|Overall Study||75||
48099112|NCT02522286|100568194|FG001|COMPLETED|Overall Study||75||
48099113|NCT02522286|100568195|FG002|COMPLETED|Overall Study||75||
48099114|NCT02522286|100568196|FG003|COMPLETED|Overall Study||75||
48099115|NCT02522286|100568193|FG000|NOT COMPLETED|Overall Study||3||
48546052|NCT01696279|101671412|FG000|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0||
48546053|NCT01696279|101671413|FG001|STARTED|Part 2a: Calcium Carbonate + Lanthanum||53||
48546054|NCT01696279|101671414|FG002|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0||
48546055|NCT01696279|101671415|FG003|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0||
48546056|NCT01696279|101671412|FG000|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0||
48546057|NCT01696279|101671413|FG001|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||37||
48546058|NCT01696279|101671414|FG002|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0||
48546059|NCT01696279|101671415|FG003|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0||
48546060|NCT01696279|101671412|FG000|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0||
48546061|NCT01696279|101671413|FG001|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||53||
48546062|NCT01696279|101671414|FG002|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0||
48546063|NCT01696279|101671415|FG003|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0||
48546064|NCT01696279|101671412|FG000|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0||
48546065|NCT01696279|101671413|FG001|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||17||
48546066|NCT01696279|101671414|FG002|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0||
48546067|NCT01696279|101671415|FG003|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0||
48546068|NCT01696279|101671412|FG000|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0||
48546069|NCT01696279|101671413|FG001|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||25||
48546070|NCT01696279|101671414|FG002|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0||
48546071|NCT01696279|101671415|FG003|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0||
48546072|NCT01696279|101671412|FG000|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0||
48546073|NCT01696279|101671413|FG001|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||34||
48546074|NCT01696279|101671414|FG002|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0||
48546075|NCT01696279|101671415|FG003|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0||
48546076|NCT01696279|101671412|FG000|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0||
48546077|NCT01696279|101671413|FG001|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||34||
48546078|NCT01696279|101671414|FG002|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0||
48546079|NCT01696279|101671415|FG003|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0||
48263107|NCT02906020|100966696|FG006|NOT COMPLETED|Part 2: Double-blind Treatment Period||0||
48263108|NCT02906020|100966697|FG007|NOT COMPLETED|Part 2: Double-blind Treatment Period||0||
48546080|NCT01696279|101671412|FG000|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0||
48099116|NCT02522286|100568194|FG001|NOT COMPLETED|Overall Study||0||
48099117|NCT02522286|100568195|FG002|NOT COMPLETED|Overall Study||0||
48099118|NCT02522286|100568196|FG003|NOT COMPLETED|Overall Study||3||
48099119|NCT00870896|100568197|FG000|STARTED|Overall Study||5||
48263109|NCT02906020|100966698|FG008|NOT COMPLETED|Part 2: Double-blind Treatment Period||12||
48546081|NCT01696279|101671413|FG001|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||19||
48546082|NCT01696279|101671414|FG002|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0||
48546083|NCT01696279|101671415|FG003|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0||
48546084|NCT01696279|101671412|FG000|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
48546085|NCT01696279|101671413|FG001|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
48546086|NCT01696279|101671414|FG002|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||9||
48546087|NCT01696279|101671415|FG003|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
48546088|NCT01696279|101671412|FG000|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
48546089|NCT01696279|101671413|FG001|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
48546090|NCT01696279|101671414|FG002|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||9||
48546091|NCT01696279|101671415|FG003|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
48546092|NCT01696279|101671412|FG000|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
48546093|NCT01696279|101671413|FG001|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
48546094|NCT01696279|101671414|FG002|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||9||
48546095|NCT01696279|101671415|FG003|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
48546096|NCT01696279|101671412|FG000|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
48546097|NCT01696279|101671413|FG001|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
48546098|NCT01696279|101671414|FG002|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
48546099|NCT01696279|101671415|FG003|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
48546100|NCT01696279|101671412|FG000|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
48546101|NCT01696279|101671413|FG001|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
48546102|NCT01696279|101671414|FG002|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||9||
48546103|NCT01696279|101671415|FG003|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
48546104|NCT01696279|101671412|FG000|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
48546105|NCT01696279|101671413|FG001|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
48546106|NCT01696279|101671414|FG002|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||8||
48546107|NCT01696279|101671415|FG003|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
48546108|NCT01696279|101671412|FG000|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
48546109|NCT01696279|101671413|FG001|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
48263110|NCT02906020|100966699|FG009|NOT COMPLETED|Part 2: Double-blind Treatment Period||25||
48263111|NCT02906020|100966700|FG010|NOT COMPLETED|Part 2: Double-blind Treatment Period||0||
48263112|NCT02906020|100966701|FG011|NOT COMPLETED|Part 2: Double-blind Treatment Period||0||
48263113|NCT02906020|100966702|FG012|NOT COMPLETED|Part 2: Double-blind Treatment Period||0||
48263114|NCT02906020|100966703|FG013|NOT COMPLETED|Part 2: Double-blind Treatment Period||0||
48390512|NCT02727660|101283612|FG000|NOT COMPLETED|Overall Study||116||
48546110|NCT01696279|101671414|FG002|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||1||
48546111|NCT01696279|101671415|FG003|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
48546112|NCT01696279|101671412|FG000|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0||
48546113|NCT01696279|101671413|FG001|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0||
48546114|NCT01696279|101671414|FG002|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0||
48546115|NCT01696279|101671415|FG003|STARTED|Part 3: Lanthanum Carbonate (6 Months)||42||
48546116|NCT01696279|101671412|FG000|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0||
48546117|NCT01696279|101671413|FG001|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0||
48546118|NCT01696279|101671414|FG002|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0||
48546119|NCT01696279|101671415|FG003|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||34||
48546120|NCT01696279|101671412|FG000|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0||
48546121|NCT01696279|101671413|FG001|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0||
48546122|NCT01696279|101671414|FG002|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0||
48546123|NCT01696279|101671415|FG003|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||8||
48546124|NCT00717041|101671416|FG000|STARTED|Overall Study||1206||
48546125|NCT00717041|101671416|FG000|COMPLETED|Overall Study||1206||
48546126|NCT00717041|101671416|FG000|NOT COMPLETED|Overall Study||0||
48546127|NCT05794503|101671417|FG000|STARTED|Overall Study||117||
48546128|NCT05794503|101671418|FG001|STARTED|Overall Study||118||
48263115|NCT02906020|100966704|FG014|NOT COMPLETED|Part 2: Double-blind Treatment Period||0||
48263116|NCT02906020|100966705|FG015|NOT COMPLETED|Part 2: Double-blind Treatment Period||0||
48263117|NCT02906020|100966690|FG000|STARTED|Part 2: Long-term Follow-up Period||0||
48390513|NCT02727660|101283613|FG001|NOT COMPLETED|Overall Study||116||
48390514|NCT02727660|101283614|FG002|NOT COMPLETED|Overall Study||165||
48390515|NCT00735670|101283615|FG000|STARTED|Overall Study||10||
48390516|NCT00735670|101283616|FG001|STARTED|Overall Study||11||
48390517|NCT00735670|101283615|FG000|COMPLETED|Overall Study||6||
48263118|NCT02906020|100966691|FG001|STARTED|Part 2: Long-term Follow-up Period||0||
48263119|NCT02906020|100966692|FG002|STARTED|Part 2: Long-term Follow-up Period||0||
48263120|NCT02906020|100966693|FG003|STARTED|Part 2: Long-term Follow-up Period||0||
48390518|NCT00735670|101283616|FG001|COMPLETED|Overall Study||6||
48390519|NCT00735670|101283615|FG000|NOT COMPLETED|Overall Study||4||
48390520|NCT00735670|101283616|FG001|NOT COMPLETED|Overall Study||5||
48546129|NCT05794503|101671417|FG000|COMPLETED|Overall Study||112||
48546130|NCT05794503|101671418|FG001|COMPLETED|Overall Study||118||
48546131|NCT05794503|101671417|FG000|NOT COMPLETED|Overall Study||5||
48546132|NCT05794503|101671418|FG001|NOT COMPLETED|Overall Study||0||
48546133|NCT03094637|101671419|FG000|STARTED|Overall Study||17||
48546134|NCT03094637|101671420|FG001|STARTED|Overall Study||20||
48546135|NCT03094637|101671419|FG000|COMPLETED|Overall Study||17||
48546136|NCT03094637|101671420|FG001|COMPLETED|Overall Study||20||
48546137|NCT03094637|101671419|FG000|NOT COMPLETED|Overall Study||0||
48546138|NCT03094637|101671420|FG001|NOT COMPLETED|Overall Study||0||
48099120|NCT00870896|100568197|FG000|COMPLETED|Overall Study||5||
48099121|NCT00870896|100568197|FG000|NOT COMPLETED|Overall Study||0||
48099122|NCT04249310|100568198|FG000|STARTED|Overall Study||1436|Unmatched cohort|
48099123|NCT04249310|100568199|FG001|STARTED|Overall Study||5352|Unmatched cohort|
48099124|NCT04249310|100568198|FG000|PS-matched Cohort|Overall Study||1412||
48099125|NCT04249310|100568199|FG001|PS-matched Cohort|Overall Study||1412||
48099126|NCT04249310|100568198|FG000|hdPS-matched Cohort|Overall Study||1302||
48099127|NCT04249310|100568199|FG001|hdPS-matched Cohort|Overall Study||1302||
48099128|NCT04249310|100568198|FG000|COMPLETED|Overall Study||1436||
48099129|NCT04249310|100568199|FG001|COMPLETED|Overall Study||5352||
48099130|NCT04249310|100568198|FG000|NOT COMPLETED|Overall Study||0||
48099131|NCT04249310|100568199|FG001|NOT COMPLETED|Overall Study||0||
48099132|NCT01574612|100568200|FG000|STARTED|Overall Study||54||
48099133|NCT01574612|100568200|FG000|COMPLETED|Overall Study||46||
48099134|NCT01574612|100568200|FG000|NOT COMPLETED|Overall Study||8||
48099135|NCT03519347|100568201|FG000|STARTED|Baseline Observation Period||5||
48099136|NCT03519347|100568202|FG001|STARTED|Baseline Observation Period||4||
48546139|NCT05410964|101671421|FG000|STARTED|Overall Study||122||
48546140|NCT05410964|101671421|FG000|COMPLETED|Overall Study||122||
48546141|NCT05410964|101671421|FG000|NOT COMPLETED|Overall Study||0||
48546142|NCT03685344|101671422|FG000|STARTED|Overall Study||3||
48546143|NCT03685344|101671423|FG001|STARTED|Overall Study||3||
48546144|NCT03685344|101671424|FG002|STARTED|Overall Study||7||
48546145|NCT03685344|101671425|FG003|STARTED|Overall Study||0||
48546146|NCT03685344|101671422|FG000|Received Treatment|Overall Study||3||
48546147|NCT03685344|101671423|FG001|Received Treatment|Overall Study||3||
48546148|NCT03685344|101671424|FG002|Received Treatment|Overall Study||7||
48546149|NCT03685344|101671425|FG003|Received Treatment|Overall Study||0||
48099137|NCT03519347|100568203|FG002|STARTED|Baseline Observation Period||4||
48099138|NCT03519347|100568204|FG003|STARTED|Baseline Observation Period||6||
48099139|NCT03519347|100568201|FG000|COMPLETED|Baseline Observation Period||5||
48099140|NCT03519347|100568202|FG001|COMPLETED|Baseline Observation Period||4||
48099141|NCT03519347|100568203|FG002|COMPLETED|Baseline Observation Period||4||
48099142|NCT03519347|100568204|FG003|COMPLETED|Baseline Observation Period||6||
48099143|NCT03519347|100568201|FG000|NOT COMPLETED|Baseline Observation Period||0||
48099144|NCT03519347|100568202|FG001|NOT COMPLETED|Baseline Observation Period||0||
48099145|NCT03519347|100568203|FG002|NOT COMPLETED|Baseline Observation Period||0||
48099146|NCT03519347|100568204|FG003|NOT COMPLETED|Baseline Observation Period||0||
48099147|NCT03519347|100568201|FG000|STARTED|Interventional Crossover Period 1||5||
48099148|NCT03519347|100568202|FG001|STARTED|Interventional Crossover Period 1||4||
48099149|NCT03519347|100568203|FG002|STARTED|Interventional Crossover Period 1||4||
48099150|NCT03519347|100568204|FG003|STARTED|Interventional Crossover Period 1||6||
48099151|NCT03519347|100568201|FG000|COMPLETED|Interventional Crossover Period 1||5||
48099152|NCT03519347|100568202|FG001|COMPLETED|Interventional Crossover Period 1||4||
48099153|NCT03519347|100568203|FG002|COMPLETED|Interventional Crossover Period 1||4||
48099154|NCT03519347|100568204|FG003|COMPLETED|Interventional Crossover Period 1||5||
48099155|NCT03519347|100568201|FG000|NOT COMPLETED|Interventional Crossover Period 1||0||
48099156|NCT03519347|100568202|FG001|NOT COMPLETED|Interventional Crossover Period 1||0||
48099157|NCT03519347|100568203|FG002|NOT COMPLETED|Interventional Crossover Period 1||0||
48099158|NCT03519347|100568204|FG003|NOT COMPLETED|Interventional Crossover Period 1||1||
48099159|NCT03519347|100568201|FG000|STARTED|Interventional Crossover Period 2||4||
48099160|NCT03519347|100568202|FG001|STARTED|Interventional Crossover Period 2||4||
48099161|NCT03519347|100568203|FG002|STARTED|Interventional Crossover Period 2||4||
48099162|NCT03519347|100568204|FG003|STARTED|Interventional Crossover Period 2||5||
48099163|NCT03519347|100568201|FG000|COMPLETED|Interventional Crossover Period 2||4||
48099164|NCT03519347|100568202|FG001|COMPLETED|Interventional Crossover Period 2||4||
48263121|NCT02906020|100966694|FG004|STARTED|Part 2: Long-term Follow-up Period||0||
48263122|NCT02906020|100966695|FG005|STARTED|Part 2: Long-term Follow-up Period||0||
48099165|NCT03519347|100568203|FG002|COMPLETED|Interventional Crossover Period 2||4||
48099166|NCT03519347|100568204|FG003|COMPLETED|Interventional Crossover Period 2||5||
48099167|NCT03519347|100568201|FG000|NOT COMPLETED|Interventional Crossover Period 2||0||
48099168|NCT03519347|100568202|FG001|NOT COMPLETED|Interventional Crossover Period 2||0||
48099169|NCT03519347|100568203|FG002|NOT COMPLETED|Interventional Crossover Period 2||0||
48099170|NCT03519347|100568204|FG003|NOT COMPLETED|Interventional Crossover Period 2||0||
48099171|NCT03519347|100568201|FG000|STARTED|Interventional Crossover Period 3||3||
48263123|NCT02906020|100966696|FG006|STARTED|Part 2: Long-term Follow-up Period||0||
48263124|NCT02906020|100966697|FG007|STARTED|Part 2: Long-term Follow-up Period||0||
48546150|NCT03685344|101671422|FG000|COMPLETED|Overall Study||0||
48546151|NCT03685344|101671423|FG001|COMPLETED|Overall Study||0||
48546152|NCT03685344|101671424|FG002|COMPLETED|Overall Study||0||
48263125|NCT02906020|100966698|FG008|STARTED|Part 2: Long-term Follow-up Period||0||
48263126|NCT02906020|100966699|FG009|STARTED|Part 2: Long-term Follow-up Period||0||
48263127|NCT02906020|100966700|FG010|STARTED|Part 2: Long-term Follow-up Period||0||
48263128|NCT02906020|100966701|FG011|STARTED|Part 2: Long-term Follow-up Period||0||
48263129|NCT02906020|100966702|FG012|STARTED|Part 2: Long-term Follow-up Period||99||
48263130|NCT02906020|100966703|FG013|STARTED|Part 2: Long-term Follow-up Period||85||
48546153|NCT03685344|101671425|FG003|COMPLETED|Overall Study||0||
48546154|NCT03685344|101671422|FG000|NOT COMPLETED|Overall Study||3||
48546155|NCT03685344|101671423|FG001|NOT COMPLETED|Overall Study||3||
48546156|NCT03685344|101671424|FG002|NOT COMPLETED|Overall Study||7||
48546157|NCT03685344|101671425|FG003|NOT COMPLETED|Overall Study||0||
48546158|NCT04036838|101671426|FG000|STARTED|Overall Study||415||
48546159|NCT04036838|101671426|FG000|COMPLETED|Overall Study||324||
48546160|NCT04036838|101671426|FG000|NOT COMPLETED|Overall Study||91||
48099172|NCT03519347|100568202|FG001|STARTED|Interventional Crossover Period 3||4||
48099173|NCT03519347|100568203|FG002|STARTED|Interventional Crossover Period 3||4||
48099174|NCT03519347|100568204|FG003|STARTED|Interventional Crossover Period 3||5||
48099175|NCT03519347|100568201|FG000|COMPLETED|Interventional Crossover Period 3||3||
48546161|NCT01924559|101671427|FG000|STARTED|Overall Study||37||
48546162|NCT01924559|101671427|FG000|COMPLETED|Overall Study||37||
48546163|NCT01924559|101671427|FG000|NOT COMPLETED|Overall Study||0||
48546164|NCT04642404|101671428|FG000|STARTED|Overall Study||21||
48546165|NCT04642404|101671429|FG001|STARTED|Overall Study||20||
48546166|NCT04642404|101671430|FG002|STARTED|Overall Study||23||
48546167|NCT04642404|101671428|FG000|COMPLETED|Overall Study||20||
48546168|NCT04642404|101671429|FG001|COMPLETED|Overall Study||20||
48546169|NCT04642404|101671430|FG002|COMPLETED|Overall Study||21||
48546170|NCT04642404|101671428|FG000|NOT COMPLETED|Overall Study||1||
48546171|NCT04642404|101671429|FG001|NOT COMPLETED|Overall Study||0||
48546172|NCT04642404|101671430|FG002|NOT COMPLETED|Overall Study||2||
48546173|NCT04194645|101671431|FG000|STARTED|Treatment Period 1 (SRD and BA Part)||4||
48546174|NCT04194645|101671432|FG001|STARTED|Treatment Period 1 (SRD and BA Part)||9||
48546175|NCT04194645|101671433|FG002|STARTED|Treatment Period 1 (SRD and BA Part)||6||
48546176|NCT04194645|101671434|FG003|STARTED|Treatment Period 1 (SRD and BA Part)||6||
48546177|NCT04194645|101671435|FG004|STARTED|Treatment Period 1 (SRD and BA Part)||6||
48546178|NCT04194645|101671436|FG005|STARTED|Treatment Period 1 (SRD and BA Part)||6||
48546179|NCT04194645|101671437|FG006|STARTED|Treatment Period 1 (SRD and BA Part)||6||
48099176|NCT03519347|100568202|FG001|COMPLETED|Interventional Crossover Period 3||4||
48546180|NCT04194645|101671438|FG007|STARTED|Treatment Period 1 (SRD and BA Part)||5||
48546181|NCT04194645|101671439|FG008|STARTED|Treatment Period 1 (SRD and BA Part)||6||
48546182|NCT04194645|101671440|FG009|STARTED|Treatment Period 1 (SRD and BA Part)||2||
48546183|NCT04194645|101671441|FG010|STARTED|Treatment Period 1 (SRD and BA Part)||2||
48546184|NCT04194645|101671442|FG011|STARTED|Treatment Period 1 (SRD and BA Part)||2||
48546185|NCT04194645|101671443|FG012|STARTED|Treatment Period 1 (SRD and BA Part)||2||
48546186|NCT04194645|101671444|FG013|STARTED|Treatment Period 1 (SRD and BA Part)||2||
48546187|NCT04194645|101671445|FG014|STARTED|Treatment Period 1 (SRD and BA Part)||2||
48546188|NCT04194645|101671431|FG000|COMPLETED|Treatment Period 1 (SRD and BA Part)||4||
48546189|NCT04194645|101671432|FG001|COMPLETED|Treatment Period 1 (SRD and BA Part)||9||
48546190|NCT04194645|101671433|FG002|COMPLETED|Treatment Period 1 (SRD and BA Part)||6||
48546191|NCT04194645|101671434|FG003|COMPLETED|Treatment Period 1 (SRD and BA Part)||6||
48546192|NCT04194645|101671435|FG004|COMPLETED|Treatment Period 1 (SRD and BA Part)||6||
48546193|NCT04194645|101671436|FG005|COMPLETED|Treatment Period 1 (SRD and BA Part)||6||
48546194|NCT04194645|101671437|FG006|COMPLETED|Treatment Period 1 (SRD and BA Part)||6||
48546195|NCT04194645|101671438|FG007|COMPLETED|Treatment Period 1 (SRD and BA Part)||5||
48546196|NCT04194645|101671439|FG008|COMPLETED|Treatment Period 1 (SRD and BA Part)||6||
48099177|NCT03519347|100568203|FG002|COMPLETED|Interventional Crossover Period 3||4||
48099178|NCT03519347|100568204|FG003|COMPLETED|Interventional Crossover Period 3||5||
48099179|NCT03519347|100568201|FG000|NOT COMPLETED|Interventional Crossover Period 3||0||
48099180|NCT03519347|100568202|FG001|NOT COMPLETED|Interventional Crossover Period 3||0||
48099181|NCT03519347|100568203|FG002|NOT COMPLETED|Interventional Crossover Period 3||0||
48099182|NCT03519347|100568204|FG003|NOT COMPLETED|Interventional Crossover Period 3||0||
48099183|NCT03519347|100568201|FG000|STARTED|Interventional Crossover Period 4||3||
48099184|NCT03519347|100568202|FG001|STARTED|Interventional Crossover Period 4||4||
48099185|NCT03519347|100568203|FG002|STARTED|Interventional Crossover Period 4||3||
48099186|NCT03519347|100568204|FG003|STARTED|Interventional Crossover Period 4||5||
48263131|NCT02906020|100966704|FG014|STARTED|Part 2: Long-term Follow-up Period||10||
48263132|NCT02906020|100966705|FG015|STARTED|Part 2: Long-term Follow-up Period||11||
48263133|NCT02906020|100966690|FG000|Treated|Part 2: Long-term Follow-up Period||0||
48263134|NCT02906020|100966691|FG001|Treated|Part 2: Long-term Follow-up Period||0||
48263135|NCT02906020|100966692|FG002|Treated|Part 2: Long-term Follow-up Period||0||
48263136|NCT02906020|100966693|FG003|Treated|Part 2: Long-term Follow-up Period||0||
48263137|NCT02906020|100966694|FG004|Treated|Part 2: Long-term Follow-up Period||0||
48546197|NCT04194645|101671440|FG009|COMPLETED|Treatment Period 1 (SRD and BA Part)||2||
48546198|NCT04194645|101671441|FG010|COMPLETED|Treatment Period 1 (SRD and BA Part)||2||
48546199|NCT04194645|101671442|FG011|COMPLETED|Treatment Period 1 (SRD and BA Part)||2||
48546200|NCT04194645|101671443|FG012|COMPLETED|Treatment Period 1 (SRD and BA Part)||2||
48546201|NCT04194645|101671444|FG013|COMPLETED|Treatment Period 1 (SRD and BA Part)||2||
48546202|NCT04194645|101671445|FG014|COMPLETED|Treatment Period 1 (SRD and BA Part)||2||
48546203|NCT04194645|101671431|FG000|NOT COMPLETED|Treatment Period 1 (SRD and BA Part)||0||
48546204|NCT04194645|101671432|FG001|NOT COMPLETED|Treatment Period 1 (SRD and BA Part)||0||
48546205|NCT04194645|101671433|FG002|NOT COMPLETED|Treatment Period 1 (SRD and BA Part)||0||
48546206|NCT04194645|101671434|FG003|NOT COMPLETED|Treatment Period 1 (SRD and BA Part)||0||
48546207|NCT04194645|101671435|FG004|NOT COMPLETED|Treatment Period 1 (SRD and BA Part)||0||
48546208|NCT04194645|101671436|FG005|NOT COMPLETED|Treatment Period 1 (SRD and BA Part)||0||
48546209|NCT04194645|101671437|FG006|NOT COMPLETED|Treatment Period 1 (SRD and BA Part)||0||
48546210|NCT04194645|101671438|FG007|NOT COMPLETED|Treatment Period 1 (SRD and BA Part)||0||
48546211|NCT04194645|101671439|FG008|NOT COMPLETED|Treatment Period 1 (SRD and BA Part)||0||
48546212|NCT04194645|101671440|FG009|NOT COMPLETED|Treatment Period 1 (SRD and BA Part)||0||
48546213|NCT04194645|101671441|FG010|NOT COMPLETED|Treatment Period 1 (SRD and BA Part)||0||
48546214|NCT04194645|101671442|FG011|NOT COMPLETED|Treatment Period 1 (SRD and BA Part)||0||
48546215|NCT04194645|101671443|FG012|NOT COMPLETED|Treatment Period 1 (SRD and BA Part)||0||
48546216|NCT04194645|101671444|FG013|NOT COMPLETED|Treatment Period 1 (SRD and BA Part)||0||
48546217|NCT04194645|101671445|FG014|NOT COMPLETED|Treatment Period 1 (SRD and BA Part)||0||
48546218|NCT04194645|101671431|FG000|STARTED|Wash-out Period 1 (BA Part Only)||4||
48546219|NCT04194645|101671432|FG001|STARTED|Wash-out Period 1 (BA Part Only)||9||
48546220|NCT04194645|101671433|FG002|STARTED|Wash-out Period 1 (BA Part Only)||6||
48546221|NCT04194645|101671434|FG003|STARTED|Wash-out Period 1 (BA Part Only)||6||
48546222|NCT04194645|101671435|FG004|STARTED|Wash-out Period 1 (BA Part Only)||6||
48546223|NCT04194645|101671436|FG005|STARTED|Wash-out Period 1 (BA Part Only)||6||
48546224|NCT04194645|101671437|FG006|STARTED|Wash-out Period 1 (BA Part Only)||6||
48546225|NCT04194645|101671438|FG007|STARTED|Wash-out Period 1 (BA Part Only)||5||
48546226|NCT04194645|101671439|FG008|STARTED|Wash-out Period 1 (BA Part Only)||6||
48546227|NCT04194645|101671440|FG009|STARTED|Wash-out Period 1 (BA Part Only)||2||
48546228|NCT04194645|101671441|FG010|STARTED|Wash-out Period 1 (BA Part Only)||2||
48546229|NCT04194645|101671442|FG011|STARTED|Wash-out Period 1 (BA Part Only)||2||
48546230|NCT04194645|101671443|FG012|STARTED|Wash-out Period 1 (BA Part Only)||2||
48546231|NCT04194645|101671444|FG013|STARTED|Wash-out Period 1 (BA Part Only)||2||
48546232|NCT04194645|101671445|FG014|STARTED|Wash-out Period 1 (BA Part Only)||2||
48546233|NCT04194645|101671431|FG000|COMPLETED|Wash-out Period 1 (BA Part Only)||0||
48546234|NCT04194645|101671432|FG001|COMPLETED|Wash-out Period 1 (BA Part Only)||0||
48546235|NCT04194645|101671433|FG002|COMPLETED|Wash-out Period 1 (BA Part Only)||0||
48546236|NCT04194645|101671434|FG003|COMPLETED|Wash-out Period 1 (BA Part Only)||0||
48546237|NCT04194645|101671435|FG004|COMPLETED|Wash-out Period 1 (BA Part Only)||0||
48546238|NCT04194645|101671436|FG005|COMPLETED|Wash-out Period 1 (BA Part Only)||0||
48546239|NCT04194645|101671437|FG006|COMPLETED|Wash-out Period 1 (BA Part Only)||0||
48546240|NCT04194645|101671438|FG007|COMPLETED|Wash-out Period 1 (BA Part Only)||0||
48546241|NCT04194645|101671439|FG008|COMPLETED|Wash-out Period 1 (BA Part Only)||0||
48546242|NCT04194645|101671440|FG009|COMPLETED|Wash-out Period 1 (BA Part Only)||2||
48546243|NCT04194645|101671441|FG010|COMPLETED|Wash-out Period 1 (BA Part Only)||2||
48546244|NCT04194645|101671442|FG011|COMPLETED|Wash-out Period 1 (BA Part Only)||2||
48546245|NCT04194645|101671443|FG012|COMPLETED|Wash-out Period 1 (BA Part Only)||2||
48546246|NCT04194645|101671444|FG013|COMPLETED|Wash-out Period 1 (BA Part Only)||2||
48546247|NCT04194645|101671445|FG014|COMPLETED|Wash-out Period 1 (BA Part Only)||2||
48546248|NCT04194645|101671431|FG000|NOT COMPLETED|Wash-out Period 1 (BA Part Only)||4||
48546249|NCT04194645|101671432|FG001|NOT COMPLETED|Wash-out Period 1 (BA Part Only)||9||
48546250|NCT04194645|101671433|FG002|NOT COMPLETED|Wash-out Period 1 (BA Part Only)||6||
48546251|NCT04194645|101671434|FG003|NOT COMPLETED|Wash-out Period 1 (BA Part Only)||6||
48546252|NCT04194645|101671435|FG004|NOT COMPLETED|Wash-out Period 1 (BA Part Only)||6||
48546253|NCT04194645|101671436|FG005|NOT COMPLETED|Wash-out Period 1 (BA Part Only)||6||
48546254|NCT04194645|101671437|FG006|NOT COMPLETED|Wash-out Period 1 (BA Part Only)||6||
48546255|NCT04194645|101671438|FG007|NOT COMPLETED|Wash-out Period 1 (BA Part Only)||5||
48546256|NCT04194645|101671439|FG008|NOT COMPLETED|Wash-out Period 1 (BA Part Only)||6||
48546257|NCT04194645|101671440|FG009|NOT COMPLETED|Wash-out Period 1 (BA Part Only)||0||
48546258|NCT04194645|101671441|FG010|NOT COMPLETED|Wash-out Period 1 (BA Part Only)||0||
48546259|NCT04194645|101671442|FG011|NOT COMPLETED|Wash-out Period 1 (BA Part Only)||0||
48546260|NCT04194645|101671443|FG012|NOT COMPLETED|Wash-out Period 1 (BA Part Only)||0||
48546261|NCT04194645|101671444|FG013|NOT COMPLETED|Wash-out Period 1 (BA Part Only)||0||
48546262|NCT04194645|101671445|FG014|NOT COMPLETED|Wash-out Period 1 (BA Part Only)||0||
48546263|NCT04194645|101671431|FG000|STARTED|Treatment Period 2 (BA Part Only)||0||
48546264|NCT04194645|101671432|FG001|STARTED|Treatment Period 2 (BA Part Only)||0||
48546265|NCT04194645|101671433|FG002|STARTED|Treatment Period 2 (BA Part Only)||0||
48546266|NCT04194645|101671434|FG003|STARTED|Treatment Period 2 (BA Part Only)||0||
48546267|NCT04194645|101671435|FG004|STARTED|Treatment Period 2 (BA Part Only)||0||
48546268|NCT04194645|101671436|FG005|STARTED|Treatment Period 2 (BA Part Only)||0||
48546269|NCT04194645|101671437|FG006|STARTED|Treatment Period 2 (BA Part Only)||0||
48546270|NCT04194645|101671438|FG007|STARTED|Treatment Period 2 (BA Part Only)||0||
48546271|NCT04194645|101671439|FG008|STARTED|Treatment Period 2 (BA Part Only)||0||
48546272|NCT04194645|101671440|FG009|STARTED|Treatment Period 2 (BA Part Only)||2||
48263138|NCT02906020|100966695|FG005|Treated|Part 2: Long-term Follow-up Period||0||
48263139|NCT02906020|100966696|FG006|Treated|Part 2: Long-term Follow-up Period||0||
48263140|NCT02906020|100966697|FG007|Treated|Part 2: Long-term Follow-up Period||0||
48263141|NCT02906020|100966698|FG008|Treated|Part 2: Long-term Follow-up Period||0||
48263142|NCT02906020|100966699|FG009|Treated|Part 2: Long-term Follow-up Period||0||
48546273|NCT04194645|101671441|FG010|STARTED|Treatment Period 2 (BA Part Only)||2||
48546274|NCT04194645|101671442|FG011|STARTED|Treatment Period 2 (BA Part Only)||2||
48546275|NCT04194645|101671443|FG012|STARTED|Treatment Period 2 (BA Part Only)||2||
48546276|NCT04194645|101671444|FG013|STARTED|Treatment Period 2 (BA Part Only)||2||
48546277|NCT04194645|101671445|FG014|STARTED|Treatment Period 2 (BA Part Only)||2||
48546278|NCT04194645|101671431|FG000|COMPLETED|Treatment Period 2 (BA Part Only)||0||
48546279|NCT04194645|101671432|FG001|COMPLETED|Treatment Period 2 (BA Part Only)||0||
48546280|NCT04194645|101671433|FG002|COMPLETED|Treatment Period 2 (BA Part Only)||0||
48546281|NCT04194645|101671434|FG003|COMPLETED|Treatment Period 2 (BA Part Only)||0||
48546282|NCT04194645|101671435|FG004|COMPLETED|Treatment Period 2 (BA Part Only)||0||
48546283|NCT04194645|101671436|FG005|COMPLETED|Treatment Period 2 (BA Part Only)||0||
48546284|NCT04194645|101671437|FG006|COMPLETED|Treatment Period 2 (BA Part Only)||0||
48546285|NCT04194645|101671438|FG007|COMPLETED|Treatment Period 2 (BA Part Only)||0||
48546286|NCT04194645|101671439|FG008|COMPLETED|Treatment Period 2 (BA Part Only)||0||
48546287|NCT04194645|101671440|FG009|COMPLETED|Treatment Period 2 (BA Part Only)||2||
48546288|NCT04194645|101671441|FG010|COMPLETED|Treatment Period 2 (BA Part Only)||2||
48546289|NCT04194645|101671442|FG011|COMPLETED|Treatment Period 2 (BA Part Only)||2||
48546290|NCT04194645|101671443|FG012|COMPLETED|Treatment Period 2 (BA Part Only)||2||
48546291|NCT04194645|101671444|FG013|COMPLETED|Treatment Period 2 (BA Part Only)||2||
48546292|NCT04194645|101671445|FG014|COMPLETED|Treatment Period 2 (BA Part Only)||2||
48546293|NCT04194645|101671431|FG000|NOT COMPLETED|Treatment Period 2 (BA Part Only)||0||
48546294|NCT04194645|101671432|FG001|NOT COMPLETED|Treatment Period 2 (BA Part Only)||0||
48546295|NCT04194645|101671433|FG002|NOT COMPLETED|Treatment Period 2 (BA Part Only)||0||
48546296|NCT04194645|101671434|FG003|NOT COMPLETED|Treatment Period 2 (BA Part Only)||0||
48546297|NCT04194645|101671435|FG004|NOT COMPLETED|Treatment Period 2 (BA Part Only)||0||
48546298|NCT04194645|101671436|FG005|NOT COMPLETED|Treatment Period 2 (BA Part Only)||0||
48546299|NCT04194645|101671437|FG006|NOT COMPLETED|Treatment Period 2 (BA Part Only)||0||
48546300|NCT04194645|101671438|FG007|NOT COMPLETED|Treatment Period 2 (BA Part Only)||0||
48546301|NCT04194645|101671439|FG008|NOT COMPLETED|Treatment Period 2 (BA Part Only)||0||
48546302|NCT04194645|101671440|FG009|NOT COMPLETED|Treatment Period 2 (BA Part Only)||0||
48546303|NCT04194645|101671441|FG010|NOT COMPLETED|Treatment Period 2 (BA Part Only)||0||
48546304|NCT04194645|101671442|FG011|NOT COMPLETED|Treatment Period 2 (BA Part Only)||0||
48546305|NCT04194645|101671443|FG012|NOT COMPLETED|Treatment Period 2 (BA Part Only)||0||
48546306|NCT04194645|101671444|FG013|NOT COMPLETED|Treatment Period 2 (BA Part Only)||0||
48546307|NCT04194645|101671445|FG014|NOT COMPLETED|Treatment Period 2 (BA Part Only)||0||
48546308|NCT04194645|101671431|FG000|STARTED|Wash-out Period 2 (BA Part Only)||0||
48546309|NCT04194645|101671432|FG001|STARTED|Wash-out Period 2 (BA Part Only)||0||
48546310|NCT04194645|101671433|FG002|STARTED|Wash-out Period 2 (BA Part Only)||0||
48546311|NCT04194645|101671434|FG003|STARTED|Wash-out Period 2 (BA Part Only)||0||
48546312|NCT04194645|101671435|FG004|STARTED|Wash-out Period 2 (BA Part Only)||0||
48546313|NCT04194645|101671436|FG005|STARTED|Wash-out Period 2 (BA Part Only)||0||
48546314|NCT04194645|101671437|FG006|STARTED|Wash-out Period 2 (BA Part Only)||0||
48546315|NCT04194645|101671438|FG007|STARTED|Wash-out Period 2 (BA Part Only)||0||
48263143|NCT02906020|100966700|FG010|Treated|Part 2: Long-term Follow-up Period||0||
48263144|NCT02906020|100966701|FG011|Treated|Part 2: Long-term Follow-up Period||0||
48263145|NCT02906020|100966702|FG012|Treated|Part 2: Long-term Follow-up Period||87||
48263146|NCT02906020|100966703|FG013|Treated|Part 2: Long-term Follow-up Period||75||
48263147|NCT02906020|100966704|FG014|Treated|Part 2: Long-term Follow-up Period||10||
48263148|NCT02906020|100966705|FG015|Treated|Part 2: Long-term Follow-up Period||11||
48263149|NCT02906020|100966690|FG000|COMPLETED|Part 2: Long-term Follow-up Period||0||
48263150|NCT02906020|100966691|FG001|COMPLETED|Part 2: Long-term Follow-up Period||0||
48263151|NCT02906020|100966692|FG002|COMPLETED|Part 2: Long-term Follow-up Period||0||
48263152|NCT02906020|100966693|FG003|COMPLETED|Part 2: Long-term Follow-up Period||0||
48263153|NCT02906020|100966694|FG004|COMPLETED|Part 2: Long-term Follow-up Period||0||
48263154|NCT02906020|100966695|FG005|COMPLETED|Part 2: Long-term Follow-up Period||0||
48263155|NCT02906020|100966696|FG006|COMPLETED|Part 2: Long-term Follow-up Period||0||
48263156|NCT02906020|100966697|FG007|COMPLETED|Part 2: Long-term Follow-up Period||0||
48546316|NCT04194645|101671439|FG008|STARTED|Wash-out Period 2 (BA Part Only)||0||
48546317|NCT04194645|101671440|FG009|STARTED|Wash-out Period 2 (BA Part Only)||2||
48546318|NCT04194645|101671441|FG010|STARTED|Wash-out Period 2 (BA Part Only)||2||
48546319|NCT04194645|101671442|FG011|STARTED|Wash-out Period 2 (BA Part Only)||2||
48546320|NCT04194645|101671443|FG012|STARTED|Wash-out Period 2 (BA Part Only)||2||
48546321|NCT04194645|101671444|FG013|STARTED|Wash-out Period 2 (BA Part Only)||2||
48546322|NCT04194645|101671445|FG014|STARTED|Wash-out Period 2 (BA Part Only)||2||
48546323|NCT04194645|101671431|FG000|COMPLETED|Wash-out Period 2 (BA Part Only)||0||
48546324|NCT04194645|101671432|FG001|COMPLETED|Wash-out Period 2 (BA Part Only)||0||
48546325|NCT04194645|101671433|FG002|COMPLETED|Wash-out Period 2 (BA Part Only)||0||
48546326|NCT04194645|101671434|FG003|COMPLETED|Wash-out Period 2 (BA Part Only)||0||
48546327|NCT04194645|101671435|FG004|COMPLETED|Wash-out Period 2 (BA Part Only)||0||
48546328|NCT04194645|101671436|FG005|COMPLETED|Wash-out Period 2 (BA Part Only)||0||
48546329|NCT04194645|101671437|FG006|COMPLETED|Wash-out Period 2 (BA Part Only)||0||
48546330|NCT04194645|101671438|FG007|COMPLETED|Wash-out Period 2 (BA Part Only)||0||
48546331|NCT04194645|101671439|FG008|COMPLETED|Wash-out Period 2 (BA Part Only)||0||
48546332|NCT04194645|101671440|FG009|COMPLETED|Wash-out Period 2 (BA Part Only)||1||
48546333|NCT04194645|101671441|FG010|COMPLETED|Wash-out Period 2 (BA Part Only)||2||
48546334|NCT04194645|101671442|FG011|COMPLETED|Wash-out Period 2 (BA Part Only)||2||
48546335|NCT04194645|101671443|FG012|COMPLETED|Wash-out Period 2 (BA Part Only)||2||
48263157|NCT02906020|100966698|FG008|COMPLETED|Part 2: Long-term Follow-up Period||0||
48263158|NCT02906020|100966699|FG009|COMPLETED|Part 2: Long-term Follow-up Period||0||
48263159|NCT02906020|100966700|FG010|COMPLETED|Part 2: Long-term Follow-up Period||0||
48263160|NCT02906020|100966701|FG011|COMPLETED|Part 2: Long-term Follow-up Period||0||
48546336|NCT04194645|101671444|FG013|COMPLETED|Wash-out Period 2 (BA Part Only)||2||
48546337|NCT04194645|101671445|FG014|COMPLETED|Wash-out Period 2 (BA Part Only)||2||
48546338|NCT04194645|101671431|FG000|NOT COMPLETED|Wash-out Period 2 (BA Part Only)||0||
48546339|NCT04194645|101671432|FG001|NOT COMPLETED|Wash-out Period 2 (BA Part Only)||0||
48546340|NCT04194645|101671433|FG002|NOT COMPLETED|Wash-out Period 2 (BA Part Only)||0||
48546341|NCT04194645|101671434|FG003|NOT COMPLETED|Wash-out Period 2 (BA Part Only)||0||
48546342|NCT04194645|101671435|FG004|NOT COMPLETED|Wash-out Period 2 (BA Part Only)||0||
48546343|NCT04194645|101671436|FG005|NOT COMPLETED|Wash-out Period 2 (BA Part Only)||0||
48546344|NCT04194645|101671437|FG006|NOT COMPLETED|Wash-out Period 2 (BA Part Only)||0||
48546345|NCT04194645|101671438|FG007|NOT COMPLETED|Wash-out Period 2 (BA Part Only)||0||
48546346|NCT04194645|101671439|FG008|NOT COMPLETED|Wash-out Period 2 (BA Part Only)||0||
48546347|NCT04194645|101671440|FG009|NOT COMPLETED|Wash-out Period 2 (BA Part Only)||1||
48546348|NCT04194645|101671441|FG010|NOT COMPLETED|Wash-out Period 2 (BA Part Only)||0||
48546349|NCT04194645|101671442|FG011|NOT COMPLETED|Wash-out Period 2 (BA Part Only)||0||
48546350|NCT04194645|101671443|FG012|NOT COMPLETED|Wash-out Period 2 (BA Part Only)||0||
48546351|NCT04194645|101671444|FG013|NOT COMPLETED|Wash-out Period 2 (BA Part Only)||0||
48546352|NCT04194645|101671445|FG014|NOT COMPLETED|Wash-out Period 2 (BA Part Only)||0||
48546353|NCT04194645|101671431|FG000|STARTED|Treatment Period 3 (BA Part Only)||0||
48546354|NCT04194645|101671432|FG001|STARTED|Treatment Period 3 (BA Part Only)||0||
48546355|NCT04194645|101671433|FG002|STARTED|Treatment Period 3 (BA Part Only)||0||
48546356|NCT04194645|101671434|FG003|STARTED|Treatment Period 3 (BA Part Only)||0||
48546357|NCT04194645|101671435|FG004|STARTED|Treatment Period 3 (BA Part Only)||0||
48546358|NCT04194645|101671436|FG005|STARTED|Treatment Period 3 (BA Part Only)||0||
48546359|NCT04194645|101671437|FG006|STARTED|Treatment Period 3 (BA Part Only)||0||
48546360|NCT04194645|101671438|FG007|STARTED|Treatment Period 3 (BA Part Only)||0||
48546361|NCT04194645|101671439|FG008|STARTED|Treatment Period 3 (BA Part Only)||0||
48546362|NCT04194645|101671440|FG009|STARTED|Treatment Period 3 (BA Part Only)||1||
48546363|NCT04194645|101671441|FG010|STARTED|Treatment Period 3 (BA Part Only)||2||
48546364|NCT04194645|101671442|FG011|STARTED|Treatment Period 3 (BA Part Only)||2||
48546365|NCT04194645|101671443|FG012|STARTED|Treatment Period 3 (BA Part Only)||2||
48546366|NCT04194645|101671444|FG013|STARTED|Treatment Period 3 (BA Part Only)||2||
48546367|NCT04194645|101671445|FG014|STARTED|Treatment Period 3 (BA Part Only)||2||
48546368|NCT04194645|101671431|FG000|COMPLETED|Treatment Period 3 (BA Part Only)||0||
48546369|NCT04194645|101671432|FG001|COMPLETED|Treatment Period 3 (BA Part Only)||0||
48546370|NCT04194645|101671433|FG002|COMPLETED|Treatment Period 3 (BA Part Only)||0||
48546371|NCT04194645|101671434|FG003|COMPLETED|Treatment Period 3 (BA Part Only)||0||
48263161|NCT02906020|100966702|FG012|COMPLETED|Part 2: Long-term Follow-up Period||0||
48263162|NCT02906020|100966703|FG013|COMPLETED|Part 2: Long-term Follow-up Period||0||
48263163|NCT02906020|100966704|FG014|COMPLETED|Part 2: Long-term Follow-up Period||0||
48263164|NCT02906020|100966705|FG015|COMPLETED|Part 2: Long-term Follow-up Period||0||
48263165|NCT02906020|100966690|FG000|NOT COMPLETED|Part 2: Long-term Follow-up Period||0||
48263166|NCT02906020|100966691|FG001|NOT COMPLETED|Part 2: Long-term Follow-up Period||0||
48263167|NCT02906020|100966692|FG002|NOT COMPLETED|Part 2: Long-term Follow-up Period||0||
48263168|NCT02906020|100966693|FG003|NOT COMPLETED|Part 2: Long-term Follow-up Period||0||
48263169|NCT02906020|100966694|FG004|NOT COMPLETED|Part 2: Long-term Follow-up Period||0||
48263170|NCT02906020|100966695|FG005|NOT COMPLETED|Part 2: Long-term Follow-up Period||0||
48263171|NCT02906020|100966696|FG006|NOT COMPLETED|Part 2: Long-term Follow-up Period||0||
48546372|NCT04194645|101671435|FG004|COMPLETED|Treatment Period 3 (BA Part Only)||0||
48546373|NCT04194645|101671436|FG005|COMPLETED|Treatment Period 3 (BA Part Only)||0||
48546374|NCT04194645|101671437|FG006|COMPLETED|Treatment Period 3 (BA Part Only)||0||
48546375|NCT04194645|101671438|FG007|COMPLETED|Treatment Period 3 (BA Part Only)||0||
48546376|NCT04194645|101671439|FG008|COMPLETED|Treatment Period 3 (BA Part Only)||0||
48546377|NCT04194645|101671440|FG009|COMPLETED|Treatment Period 3 (BA Part Only)||1||
48546378|NCT04194645|101671441|FG010|COMPLETED|Treatment Period 3 (BA Part Only)||2||
48546379|NCT04194645|101671442|FG011|COMPLETED|Treatment Period 3 (BA Part Only)||2||
48546380|NCT04194645|101671443|FG012|COMPLETED|Treatment Period 3 (BA Part Only)||2||
48546381|NCT04194645|101671444|FG013|COMPLETED|Treatment Period 3 (BA Part Only)||2||
48546382|NCT04194645|101671445|FG014|COMPLETED|Treatment Period 3 (BA Part Only)||2||
48546383|NCT04194645|101671431|FG000|NOT COMPLETED|Treatment Period 3 (BA Part Only)||0||
48546384|NCT04194645|101671432|FG001|NOT COMPLETED|Treatment Period 3 (BA Part Only)||0||
48546385|NCT04194645|101671433|FG002|NOT COMPLETED|Treatment Period 3 (BA Part Only)||0||
48546386|NCT04194645|101671434|FG003|NOT COMPLETED|Treatment Period 3 (BA Part Only)||0||
48546387|NCT04194645|101671435|FG004|NOT COMPLETED|Treatment Period 3 (BA Part Only)||0||
48546388|NCT04194645|101671436|FG005|NOT COMPLETED|Treatment Period 3 (BA Part Only)||0||
48546389|NCT04194645|101671437|FG006|NOT COMPLETED|Treatment Period 3 (BA Part Only)||0||
48546390|NCT04194645|101671438|FG007|NOT COMPLETED|Treatment Period 3 (BA Part Only)||0||
48546391|NCT04194645|101671439|FG008|NOT COMPLETED|Treatment Period 3 (BA Part Only)||0||
48546392|NCT04194645|101671440|FG009|NOT COMPLETED|Treatment Period 3 (BA Part Only)||0||
48546393|NCT04194645|101671441|FG010|NOT COMPLETED|Treatment Period 3 (BA Part Only)||0||
48546394|NCT04194645|101671442|FG011|NOT COMPLETED|Treatment Period 3 (BA Part Only)||0||
48546395|NCT04194645|101671443|FG012|NOT COMPLETED|Treatment Period 3 (BA Part Only)||0||
48546396|NCT04194645|101671444|FG013|NOT COMPLETED|Treatment Period 3 (BA Part Only)||0||
48546397|NCT04194645|101671445|FG014|NOT COMPLETED|Treatment Period 3 (BA Part Only)||0||
48546398|NCT00534404|101671446|FG000|STARTED|Overall Study||827||
48546399|NCT00534404|101671447|FG001|STARTED|Overall Study||830||
48546400|NCT00534404|101671448|FG002|STARTED|Overall Study||828||
48546401|NCT00534404|101671446|FG000|Completed at Least 1 Online Session|Overall Study||781||
48546402|NCT00534404|101671447|FG001|Completed at Least 1 Online Session|Overall Study||813||
48546403|NCT00534404|101671448|FG002|Completed at Least 1 Online Session|Overall Study||658||
48546404|NCT00534404|101671446|FG000|Completed First NRT Order|Overall Study||765||
48546405|NCT00534404|101671447|FG001|Completed First NRT Order|Overall Study||821||
48546406|NCT00534404|101671448|FG002|Completed First NRT Order|Overall Study||0||
48546407|NCT00534404|101671446|FG000|Completed Second NRT Order|Overall Study||640||
48546408|NCT00534404|101671447|FG001|Completed Second NRT Order|Overall Study||789||
48546409|NCT00534404|101671448|FG002|Completed Second NRT Order|Overall Study||0||
48546410|NCT00534404|101671446|FG000|Completed at Least 1 Counseling Call|Overall Study||813||
48546411|NCT00534404|101671447|FG001|Completed at Least 1 Counseling Call|Overall Study||0||
48546412|NCT00534404|101671448|FG002|Completed at Least 1 Counseling Call|Overall Study||0||
48546413|NCT00534404|101671446|FG000|1-month Follow up Completed|Overall Study||742||
48546414|NCT00534404|101671447|FG001|1-month Follow up Completed|Overall Study||781||
48546415|NCT00534404|101671448|FG002|1-month Follow up Completed|Overall Study||626||
48546416|NCT00534404|101671446|FG000|3-month Follow up Completed|Overall Study||682||
48546417|NCT00534404|101671447|FG001|3-month Follow up Completed|Overall Study||731||
48546418|NCT00534404|101671448|FG002|3-month Follow up Completed|Overall Study||593||
48546419|NCT00534404|101671446|FG000|COMPLETED|Overall Study||647||
48546420|NCT00534404|101671447|FG001|COMPLETED|Overall Study||687||
48546421|NCT00534404|101671448|FG002|COMPLETED|Overall Study||586||
48546422|NCT00534404|101671446|FG000|NOT COMPLETED|Overall Study||180||
48546423|NCT00534404|101671447|FG001|NOT COMPLETED|Overall Study||143||
48546424|NCT00534404|101671448|FG002|NOT COMPLETED|Overall Study||242||
48546425|NCT00996892|101671449|FG000|STARTED|Dose-Escalation Stage 1||4||
48546426|NCT00996892|101671450|FG001|STARTED|Dose-Escalation Stage 1||3||
48546427|NCT00996892|101671451|FG002|STARTED|Dose-Escalation Stage 1||3||
48546428|NCT00996892|101671452|FG003|STARTED|Dose-Escalation Stage 1||9||
48546429|NCT00996892|101671453|FG004|STARTED|Dose-Escalation Stage 1||11||
48546430|NCT00996892|101671454|FG005|STARTED|Dose-Escalation Stage 1||10||
48546431|NCT00996892|101671455|FG006|STARTED|Dose-Escalation Stage 1||4||
48546432|NCT00996892|101671456|FG007|STARTED|Dose-Escalation Stage 1||0||
48546433|NCT00996892|101671457|FG008|STARTED|Dose-Escalation Stage 1||0||
48546434|NCT00996892|101671458|FG009|STARTED|Dose-Escalation Stage 1||0||
48546435|NCT00996892|101671459|FG010|STARTED|Dose-Escalation Stage 1||0||
48546436|NCT00996892|101671460|FG011|STARTED|Dose-Escalation Stage 1||0||
48546437|NCT00996892|101671461|FG012|STARTED|Dose-Escalation Stage 1||0||
48546438|NCT00996892|101671462|FG013|STARTED|Dose-Escalation Stage 1||0||
48546439|NCT00996892|101671463|FG014|STARTED|Dose-Escalation Stage 1||0||
48546440|NCT00996892|101671464|FG015|STARTED|Dose-Escalation Stage 1||0||
48546441|NCT00996892|101671465|FG016|STARTED|Dose-Escalation Stage 1||0||
48546442|NCT00996892|101671466|FG017|STARTED|Dose-Escalation Stage 1||0||
48546443|NCT00996892|101671467|FG018|STARTED|Dose-Escalation Stage 1||0||
48546444|NCT00996892|101671468|FG019|STARTED|Dose-Escalation Stage 1||0||
48546445|NCT00996892|101671449|FG000|COMPLETED|Dose-Escalation Stage 1||0||
48546446|NCT00996892|101671450|FG001|COMPLETED|Dose-Escalation Stage 1||0||
48546447|NCT00996892|101671451|FG002|COMPLETED|Dose-Escalation Stage 1||0||
48546448|NCT00996892|101671452|FG003|COMPLETED|Dose-Escalation Stage 1||0||
48546449|NCT00996892|101671453|FG004|COMPLETED|Dose-Escalation Stage 1||0||
48390521|NCT01915108|101283617|FG000|STARTED|Overall Study||32||
48390522|NCT01915108|101283618|FG001|STARTED|Overall Study||32||
48390523|NCT01915108|101283619|FG002|STARTED|Overall Study||32||
48390524|NCT01915108|101283620|FG003|STARTED|Overall Study||32||
48390525|NCT01915108|101283617|FG000|COMPLETED|Overall Study||30||
48390526|NCT01915108|101283618|FG001|COMPLETED|Overall Study||29||
48390527|NCT01915108|101283619|FG002|COMPLETED|Overall Study||31||
48390528|NCT01915108|101283620|FG003|COMPLETED|Overall Study||30||
48546450|NCT00996892|101671454|FG005|COMPLETED|Dose-Escalation Stage 1||0||
48546451|NCT00996892|101671455|FG006|COMPLETED|Dose-Escalation Stage 1||0||
48546452|NCT00996892|101671456|FG007|COMPLETED|Dose-Escalation Stage 1||0||
48546453|NCT00996892|101671457|FG008|COMPLETED|Dose-Escalation Stage 1||0||
48099187|NCT03519347|100568201|FG000|COMPLETED|Interventional Crossover Period 4||3||
48099188|NCT03519347|100568202|FG001|COMPLETED|Interventional Crossover Period 4||4||
48099189|NCT03519347|100568203|FG002|COMPLETED|Interventional Crossover Period 4||3||
48099190|NCT03519347|100568204|FG003|COMPLETED|Interventional Crossover Period 4||5||
48099191|NCT03519347|100568201|FG000|NOT COMPLETED|Interventional Crossover Period 4||0||
48099192|NCT03519347|100568202|FG001|NOT COMPLETED|Interventional Crossover Period 4||0||
48099193|NCT03519347|100568203|FG002|NOT COMPLETED|Interventional Crossover Period 4||0||
48099194|NCT03519347|100568204|FG003|NOT COMPLETED|Interventional Crossover Period 4||0||
48099195|NCT05778786|100568205|FG000|STARTED|Period 1||95||
48099196|NCT05778786|100568206|FG001|STARTED|Period 1||93||
48099197|NCT05778786|100568205|FG000|COMPLETED|Period 1||91||
48099198|NCT05778786|100568206|FG001|COMPLETED|Period 1||90||
48099199|NCT05778786|100568205|FG000|NOT COMPLETED|Period 1||4||
48099200|NCT05778786|100568206|FG001|NOT COMPLETED|Period 1||3||
48099201|NCT05778786|100568205|FG000|STARTED|Period 2||91||
48099202|NCT05778786|100568206|FG001|STARTED|Period 2||90||
48099203|NCT05778786|100568205|FG000|COMPLETED|Period 2||91||
48099204|NCT05778786|100568206|FG001|COMPLETED|Period 2||88||
48099205|NCT05778786|100568205|FG000|NOT COMPLETED|Period 2||0||
48099206|NCT05778786|100568206|FG001|NOT COMPLETED|Period 2||2||
48099207|NCT03439670|100568207|FG000|STARTED|Overall Study||30||
48099208|NCT03439670|100568208|FG001|STARTED|Overall Study||30||
48099209|NCT03439670|100568209|FG002|STARTED|Overall Study||15||
48099210|NCT03439670|100568210|FG003|STARTED|Overall Study||16||
48099211|NCT03439670|100568211|FG004|STARTED|Overall Study||15||
48099212|NCT03439670|100568212|FG005|STARTED|Overall Study||15||
48099213|NCT03439670|100568207|FG000|COMPLETED|Overall Study||28||
48099214|NCT03439670|100568208|FG001|COMPLETED|Overall Study||26||
48263172|NCT02906020|100966697|FG007|NOT COMPLETED|Part 2: Long-term Follow-up Period||0||
48263173|NCT02906020|100966698|FG008|NOT COMPLETED|Part 2: Long-term Follow-up Period||0||
48263174|NCT02906020|100966699|FG009|NOT COMPLETED|Part 2: Long-term Follow-up Period||0||
48263175|NCT02906020|100966700|FG010|NOT COMPLETED|Part 2: Long-term Follow-up Period||0||
48263176|NCT02906020|100966701|FG011|NOT COMPLETED|Part 2: Long-term Follow-up Period||0||
48263177|NCT02906020|100966702|FG012|NOT COMPLETED|Part 2: Long-term Follow-up Period||99||
48263178|NCT02906020|100966703|FG013|NOT COMPLETED|Part 2: Long-term Follow-up Period||85||
48263179|NCT02906020|100966704|FG014|NOT COMPLETED|Part 2: Long-term Follow-up Period||10||
48263180|NCT02906020|100966705|FG015|NOT COMPLETED|Part 2: Long-term Follow-up Period||11||
48263181|NCT01814072|100966706|FG000|STARTED|Overall Study||18||
48263182|NCT01814072|100966707|FG001|STARTED|Overall Study||18||
48263183|NCT01814072|100966708|FG002|STARTED|Overall Study||18||
48390529|NCT01915108|101283617|FG000|NOT COMPLETED|Overall Study||2||
48390530|NCT01915108|101283618|FG001|NOT COMPLETED|Overall Study||3||
48390531|NCT01915108|101283619|FG002|NOT COMPLETED|Overall Study||1||
48390532|NCT01915108|101283620|FG003|NOT COMPLETED|Overall Study||2||
48390533|NCT01975246|101283621|FG000|STARTED|Overall Study||149||
48390534|NCT01975246|101283622|FG001|STARTED|Overall Study||160||
48390535|NCT01975246|101283621|FG000|COMPLETED|Overall Study||145||
48390536|NCT01975246|101283622|FG001|COMPLETED|Overall Study||158||
48390537|NCT01975246|101283621|FG000|NOT COMPLETED|Overall Study||4||
48390538|NCT01975246|101283622|FG001|NOT COMPLETED|Overall Study||2||
48390539|NCT00719953|101283623|FG000|STARTED|Overall Study||30||
48546454|NCT00996892|101671458|FG009|COMPLETED|Dose-Escalation Stage 1||0||
48546455|NCT00996892|101671459|FG010|COMPLETED|Dose-Escalation Stage 1||0||
48546456|NCT00996892|101671460|FG011|COMPLETED|Dose-Escalation Stage 1||0||
48546457|NCT00996892|101671461|FG012|COMPLETED|Dose-Escalation Stage 1||0||
48546458|NCT00996892|101671462|FG013|COMPLETED|Dose-Escalation Stage 1||0||
48546459|NCT00996892|101671463|FG014|COMPLETED|Dose-Escalation Stage 1||0||
48546460|NCT00996892|101671464|FG015|COMPLETED|Dose-Escalation Stage 1||0||
48546461|NCT00996892|101671465|FG016|COMPLETED|Dose-Escalation Stage 1||0||
48546462|NCT00996892|101671466|FG017|COMPLETED|Dose-Escalation Stage 1||0||
48546463|NCT00996892|101671467|FG018|COMPLETED|Dose-Escalation Stage 1||0||
48099215|NCT03439670|100568209|FG002|COMPLETED|Overall Study||15||
48099216|NCT03439670|100568210|FG003|COMPLETED|Overall Study||15||
48546464|NCT00996892|101671468|FG019|COMPLETED|Dose-Escalation Stage 1||0||
48546465|NCT00996892|101671449|FG000|NOT COMPLETED|Dose-Escalation Stage 1||4||
48546466|NCT00996892|101671450|FG001|NOT COMPLETED|Dose-Escalation Stage 1||3||
48546467|NCT00996892|101671451|FG002|NOT COMPLETED|Dose-Escalation Stage 1||3||
48099217|NCT03439670|100568211|FG004|COMPLETED|Overall Study||14||
48099218|NCT03439670|100568212|FG005|COMPLETED|Overall Study||14||
48099219|NCT03439670|100568207|FG000|NOT COMPLETED|Overall Study||2||
48099220|NCT03439670|100568208|FG001|NOT COMPLETED|Overall Study||4||
48099221|NCT03439670|100568209|FG002|NOT COMPLETED|Overall Study||0||
48099222|NCT03439670|100568210|FG003|NOT COMPLETED|Overall Study||1||
48099223|NCT03439670|100568211|FG004|NOT COMPLETED|Overall Study||1||
48099224|NCT03439670|100568212|FG005|NOT COMPLETED|Overall Study||1||
48099225|NCT00302042|100568213|FG000|STARTED|Overall Study||46||
48099226|NCT00302042|100568214|FG001|STARTED|Overall Study||46||
48690646|NCT02036580|102025885|FG002|NOT COMPLETED|Overall Study||0||
48690647|NCT00735553|102025886|FG000|STARTED|Overall Study||77||
48690648|NCT00735553|102025886|FG000|COMPLETED|Overall Study||0||
48690649|NCT00735553|102025886|FG000|NOT COMPLETED|Overall Study||77||
48690650|NCT00625391|102025887|FG000|STARTED|Overall Study||44||
48690651|NCT00625391|102025888|FG001|STARTED|Overall Study||47||
48690652|NCT00625391|102025889|FG002|STARTED|Overall Study||42||
48690653|NCT00625391|102025890|FG003|STARTED|Overall Study||38||
48690654|NCT00625391|102025887|FG000|COMPLETED|Overall Study||37||
48690655|NCT00625391|102025888|FG001|COMPLETED|Overall Study||39||
48690656|NCT00625391|102025889|FG002|COMPLETED|Overall Study||37||
48690657|NCT00625391|102025890|FG003|COMPLETED|Overall Study||37||
48690658|NCT00625391|102025887|FG000|NOT COMPLETED|Overall Study||7||
48099227|NCT00302042|100568213|FG000|COMPLETED|Overall Study||39||
48099228|NCT00302042|100568214|FG001|COMPLETED|Overall Study||38||
48099229|NCT00302042|100568213|FG000|NOT COMPLETED|Overall Study||7||
48099230|NCT00302042|100568214|FG001|NOT COMPLETED|Overall Study||8||
48099231|NCT02355691|100568215|FG000|STARTED|Overall Study||7||
48099232|NCT02355691|100568216|FG001|STARTED|Overall Study||9||
48099233|NCT02355691|100568215|FG000|1st Postop Visit|Overall Study||7||
48099234|NCT02355691|100568216|FG001|1st Postop Visit|Overall Study||9||
48099235|NCT02355691|100568215|FG000|2nd Postop Visit|Overall Study||7||
48099236|NCT02355691|100568216|FG001|2nd Postop Visit|Overall Study||9||
48099237|NCT02355691|100568215|FG000|COMPLETED|Overall Study||0||
48099238|NCT02355691|100568216|FG001|COMPLETED|Overall Study||0||
48099239|NCT02355691|100568215|FG000|NOT COMPLETED|Overall Study||7||
48099240|NCT02355691|100568216|FG001|NOT COMPLETED|Overall Study||9||
48099241|NCT00945139|100568217|FG000|STARTED|Overall Study||46||
48099242|NCT00945139|100568217|FG000|COMPLETED|Overall Study||46||
48099243|NCT00945139|100568217|FG000|NOT COMPLETED|Overall Study||0||
48099244|NCT00598663|100568218|FG000|STARTED|First Intervention (6 Months)||76||
48099245|NCT00598663|100568219|FG001|STARTED|First Intervention (6 Months)||77||
48099246|NCT00598663|100568218|FG000|COMPLETED|First Intervention (6 Months)||73||
48099247|NCT00598663|100568219|FG001|COMPLETED|First Intervention (6 Months)||71||
48099248|NCT00598663|100568218|FG000|NOT COMPLETED|First Intervention (6 Months)||3||
48099249|NCT00598663|100568219|FG001|NOT COMPLETED|First Intervention (6 Months)||6||
48099250|NCT00598663|100568218|FG000|STARTED|Washout (4 Months)||73||
48099251|NCT00598663|100568219|FG001|STARTED|Washout (4 Months)||71||
48099252|NCT00598663|100568218|FG000|COMPLETED|Washout (4 Months)||73||
48099253|NCT00598663|100568219|FG001|COMPLETED|Washout (4 Months)||70||
48099254|NCT00598663|100568218|FG000|NOT COMPLETED|Washout (4 Months)||0||
48099255|NCT00598663|100568219|FG001|NOT COMPLETED|Washout (4 Months)||1||
48099256|NCT00598663|100568218|FG000|STARTED|Second Intervention (6 Months)||73||
48099257|NCT00598663|100568219|FG001|STARTED|Second Intervention (6 Months)||70||
48099258|NCT00598663|100568218|FG000|COMPLETED|Second Intervention (6 Months)||69||
48099259|NCT00598663|100568219|FG001|COMPLETED|Second Intervention (6 Months)||69||
48099260|NCT00598663|100568218|FG000|NOT COMPLETED|Second Intervention (6 Months)||4||
48099261|NCT00598663|100568219|FG001|NOT COMPLETED|Second Intervention (6 Months)||1||
48099262|NCT00665353|100568220|FG000|STARTED|Study Step 1||19||
48099263|NCT00665353|100568220|FG000|COMPLETED|Study Step 1||16||
48099264|NCT00665353|100568220|FG000|NOT COMPLETED|Study Step 1||3||
48099265|NCT00665353|100568220|FG000|STARTED|Study Step 2||16||
48099266|NCT00665353|100568220|FG000|COMPLETED|Study Step 2||2||
48099267|NCT00665353|100568220|FG000|NOT COMPLETED|Study Step 2||14||
48099268|NCT03889158|100568221|FG000|STARTED|Overall Study||20||
48690659|NCT00625391|102025888|FG001|NOT COMPLETED|Overall Study||8||
48690660|NCT00625391|102025889|FG002|NOT COMPLETED|Overall Study||5||
48099269|NCT03889158|100568222|FG001|STARTED|Overall Study||15||
48690661|NCT00625391|102025890|FG003|NOT COMPLETED|Overall Study||1||
48690662|NCT00237666|102025891|FG000|STARTED|Overall Study||30||
48690663|NCT00237666|102025891|FG000|COMPLETED|Overall Study||24||
48690664|NCT00237666|102025891|FG000|NOT COMPLETED|Overall Study||6||
48690665|NCT02318368|102025892|FG000|STARTED|Overall Study||7||
48690666|NCT02318368|102025893|FG001|STARTED|Overall Study||3||
48099270|NCT03889158|100568221|FG000|COMPLETED|Overall Study||16||
48099271|NCT03889158|100568222|FG001|COMPLETED|Overall Study||9||
48099272|NCT03889158|100568221|FG000|NOT COMPLETED|Overall Study||4||
48099273|NCT03889158|100568222|FG001|NOT COMPLETED|Overall Study||6||
48099274|NCT01975909|100568223|FG000|STARTED|Overall Study||10||
48099275|NCT01975909|100568224|FG001|STARTED|Overall Study||10||
48099276|NCT01975909|100568223|FG000|COMPLETED|Overall Study||10||
48099277|NCT01975909|100568224|FG001|COMPLETED|Overall Study||10||
48099278|NCT01975909|100568223|FG000|NOT COMPLETED|Overall Study||0||
48099279|NCT01975909|100568224|FG001|NOT COMPLETED|Overall Study||0||
48099280|NCT02672423|100568225|FG000|STARTED|Period 1||7||
48099281|NCT02672423|100568226|FG001|STARTED|Period 1||7||
48099282|NCT02672423|100568227|FG002|STARTED|Period 1||14||
48099283|NCT02672423|100568228|FG003|STARTED|Period 1||15||
48099284|NCT02672423|100568229|FG004|STARTED|Period 1||15||
48099285|NCT02672423|100568230|FG005|STARTED|Period 1||15||
48099286|NCT02672423|100568231|FG006|STARTED|Period 1||15||
48099287|NCT02672423|100568232|FG007|STARTED|Period 1||15||
48099288|NCT02672423|100568233|FG008|STARTED|Period 1||12||
48099289|NCT02672423|100568234|FG009|STARTED|Period 1||12||
48099290|NCT02672423|100568225|FG000|Received at Least One Dose of Study Drug|Period 1||7||
48099291|NCT02672423|100568226|FG001|Received at Least One Dose of Study Drug|Period 1||7||
48099292|NCT02672423|100568227|FG002|Received at Least One Dose of Study Drug|Period 1||14||
48099293|NCT02672423|100568228|FG003|Received at Least One Dose of Study Drug|Period 1||15||
48099294|NCT02672423|100568229|FG004|Received at Least One Dose of Study Drug|Period 1||15||
48099295|NCT02672423|100568230|FG005|Received at Least One Dose of Study Drug|Period 1||15||
48099296|NCT02672423|100568231|FG006|Received at Least One Dose of Study Drug|Period 1||15||
48099297|NCT02672423|100568232|FG007|Received at Least One Dose of Study Drug|Period 1||15||
48099298|NCT02672423|100568233|FG008|Received at Least One Dose of Study Drug|Period 1||12||
48099299|NCT02672423|100568234|FG009|Received at Least One Dose of Study Drug|Period 1||12||
48099300|NCT02672423|100568225|FG000|COMPLETED|Period 1||7||
48099301|NCT02672423|100568226|FG001|COMPLETED|Period 1||7||
48099302|NCT02672423|100568227|FG002|COMPLETED|Period 1||14||
48099303|NCT02672423|100568228|FG003|COMPLETED|Period 1||15||
48099304|NCT02672423|100568229|FG004|COMPLETED|Period 1||14||
48099305|NCT02672423|100568230|FG005|COMPLETED|Period 1||15||
48099306|NCT02672423|100568231|FG006|COMPLETED|Period 1||15||
48099307|NCT02672423|100568232|FG007|COMPLETED|Period 1||15||
48099308|NCT02672423|100568233|FG008|COMPLETED|Period 1||12||
48099309|NCT02672423|100568234|FG009|COMPLETED|Period 1||12||
48099310|NCT02672423|100568225|FG000|NOT COMPLETED|Period 1||0||
48099311|NCT02672423|100568226|FG001|NOT COMPLETED|Period 1||0||
48099312|NCT02672423|100568227|FG002|NOT COMPLETED|Period 1||0||
48099313|NCT02672423|100568228|FG003|NOT COMPLETED|Period 1||0||
48099314|NCT02672423|100568229|FG004|NOT COMPLETED|Period 1||1||
48099315|NCT02672423|100568230|FG005|NOT COMPLETED|Period 1||0||
48099316|NCT02672423|100568231|FG006|NOT COMPLETED|Period 1||0||
48099317|NCT02672423|100568232|FG007|NOT COMPLETED|Period 1||0||
48099318|NCT02672423|100568233|FG008|NOT COMPLETED|Period 1||0||
48099319|NCT02672423|100568234|FG009|NOT COMPLETED|Period 1||0||
48099320|NCT02672423|100568225|FG000|STARTED|Washout 1||7||
48546468|NCT00996892|101671452|FG003|NOT COMPLETED|Dose-Escalation Stage 1||9||
48099321|NCT02672423|100568226|FG001|STARTED|Washout 1||7||
48099322|NCT02672423|100568227|FG002|STARTED|Washout 1||14||
48099323|NCT02672423|100568228|FG003|STARTED|Washout 1||15||
48099324|NCT02672423|100568229|FG004|STARTED|Washout 1||14||
48099325|NCT02672423|100568230|FG005|STARTED|Washout 1||15||
48099326|NCT02672423|100568231|FG006|STARTED|Washout 1||15||
48099327|NCT02672423|100568232|FG007|STARTED|Washout 1||15||
48099328|NCT02672423|100568233|FG008|STARTED|Washout 1||12||
48099329|NCT02672423|100568234|FG009|STARTED|Washout 1||12||
48099330|NCT02672423|100568225|FG000|COMPLETED|Washout 1||7||
48099331|NCT02672423|100568226|FG001|COMPLETED|Washout 1||7||
48099332|NCT02672423|100568227|FG002|COMPLETED|Washout 1||14||
48099333|NCT02672423|100568228|FG003|COMPLETED|Washout 1||15||
48099334|NCT02672423|100568229|FG004|COMPLETED|Washout 1||14||
48390540|NCT00719953|101283623|FG000|COMPLETED|Overall Study||26||
48390541|NCT00719953|101283623|FG000|NOT COMPLETED|Overall Study||4||
48390542|NCT00976248|101283624|FG000|STARTED|Overall Study||33||
48390543|NCT00976248|101283624|FG000|COMPLETED|Overall Study||33||
48390544|NCT00976248|101283624|FG000|NOT COMPLETED|Overall Study||0||
48390545|NCT02823600|101283625|FG000|STARTED|Overall Study||68||
48390546|NCT02823600|101283625|FG000|COMPLETED|Overall Study||68||
48390547|NCT02823600|101283625|FG000|NOT COMPLETED|Overall Study||0||
48390548|NCT01606735|101283626|FG000|STARTED|Overall Study||58||
48546469|NCT00996892|101671453|FG004|NOT COMPLETED|Dose-Escalation Stage 1||11||
48099335|NCT02672423|100568230|FG005|COMPLETED|Washout 1||15||
48390549|NCT01606735|101283627|FG001|STARTED|Overall Study||56||
48390550|NCT01606735|101283628|FG002|STARTED|Overall Study||58||
48099336|NCT02672423|100568231|FG006|COMPLETED|Washout 1||15||
48099337|NCT02672423|100568232|FG007|COMPLETED|Washout 1||15||
48099338|NCT02672423|100568233|FG008|COMPLETED|Washout 1||12||
48099339|NCT02672423|100568234|FG009|COMPLETED|Washout 1||12||
48099340|NCT02672423|100568225|FG000|NOT COMPLETED|Washout 1||0||
48099341|NCT02672423|100568226|FG001|NOT COMPLETED|Washout 1||0||
48099342|NCT02672423|100568227|FG002|NOT COMPLETED|Washout 1||0||
48099343|NCT02672423|100568228|FG003|NOT COMPLETED|Washout 1||0||
48099344|NCT02672423|100568229|FG004|NOT COMPLETED|Washout 1||0||
48099345|NCT02672423|100568230|FG005|NOT COMPLETED|Washout 1||0||
48099346|NCT02672423|100568231|FG006|NOT COMPLETED|Washout 1||0||
48099347|NCT02672423|100568232|FG007|NOT COMPLETED|Washout 1||0||
48099348|NCT02672423|100568233|FG008|NOT COMPLETED|Washout 1||0||
48390551|NCT01606735|101283626|FG000|COMPLETED|Overall Study||58||
48390552|NCT01606735|101283627|FG001|COMPLETED|Overall Study||56||
48390553|NCT01606735|101283628|FG002|COMPLETED|Overall Study||58||
48390554|NCT01606735|101283626|FG000|NOT COMPLETED|Overall Study||0||
48099349|NCT02672423|100568234|FG009|NOT COMPLETED|Washout 1||0||
48099350|NCT02672423|100568225|FG000|STARTED|Period 2||7||
48099351|NCT02672423|100568226|FG001|STARTED|Period 2||7||
48099352|NCT02672423|100568227|FG002|STARTED|Period 2||14||
48099353|NCT02672423|100568228|FG003|STARTED|Period 2||15||
48099354|NCT02672423|100568229|FG004|STARTED|Period 2||14||
48099355|NCT02672423|100568230|FG005|STARTED|Period 2||15||
48099356|NCT02672423|100568231|FG006|STARTED|Period 2||15||
48099357|NCT02672423|100568232|FG007|STARTED|Period 2||15||
48099358|NCT02672423|100568233|FG008|STARTED|Period 2||12||
48099359|NCT02672423|100568234|FG009|STARTED|Period 2||12||
48099360|NCT02672423|100568225|FG000|COMPLETED|Period 2||7||
48099361|NCT02672423|100568226|FG001|COMPLETED|Period 2||7||
48099362|NCT02672423|100568227|FG002|COMPLETED|Period 2||13||
48099363|NCT02672423|100568228|FG003|COMPLETED|Period 2||15||
48099364|NCT02672423|100568229|FG004|COMPLETED|Period 2||14||
48099365|NCT02672423|100568230|FG005|COMPLETED|Period 2||15||
48099366|NCT02672423|100568231|FG006|COMPLETED|Period 2||15||
48099367|NCT02672423|100568232|FG007|COMPLETED|Period 2||15||
48099368|NCT02672423|100568233|FG008|COMPLETED|Period 2||12||
48099369|NCT02672423|100568234|FG009|COMPLETED|Period 2||12||
48099370|NCT02672423|100568225|FG000|NOT COMPLETED|Period 2||0||
48099371|NCT02672423|100568226|FG001|NOT COMPLETED|Period 2||0||
48099372|NCT02672423|100568227|FG002|NOT COMPLETED|Period 2||1||
48099373|NCT02672423|100568228|FG003|NOT COMPLETED|Period 2||0||
48099374|NCT02672423|100568229|FG004|NOT COMPLETED|Period 2||0||
48099375|NCT02672423|100568230|FG005|NOT COMPLETED|Period 2||0||
48099376|NCT02672423|100568231|FG006|NOT COMPLETED|Period 2||0||
48099377|NCT02672423|100568232|FG007|NOT COMPLETED|Period 2||0||
48099378|NCT02672423|100568233|FG008|NOT COMPLETED|Period 2||0||
48099379|NCT02672423|100568234|FG009|NOT COMPLETED|Period 2||0||
48099380|NCT02672423|100568225|FG000|STARTED|Washout 2||7||
48099381|NCT02672423|100568226|FG001|STARTED|Washout 2||7||
48099382|NCT02672423|100568227|FG002|STARTED|Washout 2||13||
48099383|NCT02672423|100568228|FG003|STARTED|Washout 2||15||
48099384|NCT02672423|100568229|FG004|STARTED|Washout 2||14||
48099385|NCT02672423|100568230|FG005|STARTED|Washout 2||15||
48546470|NCT00996892|101671454|FG005|NOT COMPLETED|Dose-Escalation Stage 1||10||
48546471|NCT00996892|101671455|FG006|NOT COMPLETED|Dose-Escalation Stage 1||4||
48546472|NCT00996892|101671456|FG007|NOT COMPLETED|Dose-Escalation Stage 1||0||
48099386|NCT02672423|100568231|FG006|STARTED|Washout 2||15||
48099387|NCT02672423|100568232|FG007|STARTED|Washout 2||15||
48099388|NCT02672423|100568233|FG008|STARTED|Washout 2||12||
48099389|NCT02672423|100568234|FG009|STARTED|Washout 2||12||
48099390|NCT02672423|100568225|FG000|COMPLETED|Washout 2||7||
48263184|NCT01814072|100966709|FG003|STARTED|Overall Study||18||
48263185|NCT01814072|100966710|FG004|STARTED|Overall Study||18||
48263186|NCT01814072|100966711|FG005|STARTED|Overall Study||18||
48263187|NCT01814072|100966712|FG006|STARTED|Overall Study||18||
48263188|NCT01814072|100966713|FG007|STARTED|Overall Study||18||
48263189|NCT01814072|100966714|FG008|STARTED|Overall Study||19||
48263190|NCT01814072|100966715|FG009|STARTED|Overall Study||18||
48099391|NCT02672423|100568226|FG001|COMPLETED|Washout 2||7||
48099392|NCT02672423|100568227|FG002|COMPLETED|Washout 2||13||
48099393|NCT02672423|100568228|FG003|COMPLETED|Washout 2||15||
48099394|NCT02672423|100568229|FG004|COMPLETED|Washout 2||14||
48099395|NCT02672423|100568230|FG005|COMPLETED|Washout 2||15||
48099396|NCT02672423|100568231|FG006|COMPLETED|Washout 2||15||
48099397|NCT02672423|100568232|FG007|COMPLETED|Washout 2||15||
48099398|NCT02672423|100568233|FG008|COMPLETED|Washout 2||12||
48099399|NCT02672423|100568234|FG009|COMPLETED|Washout 2||12||
48099400|NCT02672423|100568225|FG000|NOT COMPLETED|Washout 2||0||
48263191|NCT01814072|100966716|FG010|STARTED|Overall Study||18||
48546473|NCT00996892|101671457|FG008|NOT COMPLETED|Dose-Escalation Stage 1||0||
48546474|NCT00996892|101671458|FG009|NOT COMPLETED|Dose-Escalation Stage 1||0||
48546475|NCT00996892|101671459|FG010|NOT COMPLETED|Dose-Escalation Stage 1||0||
48099401|NCT02672423|100568226|FG001|NOT COMPLETED|Washout 2||0||
48099402|NCT02672423|100568227|FG002|NOT COMPLETED|Washout 2||0||
48263192|NCT01814072|100966717|FG011|STARTED|Overall Study||18||
48546476|NCT00996892|101671460|FG011|NOT COMPLETED|Dose-Escalation Stage 1||0||
48263193|NCT01814072|100966718|FG012|STARTED|Overall Study||18||
48263194|NCT01814072|100966719|FG013|STARTED|Overall Study||18||
48099403|NCT02672423|100568228|FG003|NOT COMPLETED|Washout 2||0||
48099404|NCT02672423|100568229|FG004|NOT COMPLETED|Washout 2||0||
48099405|NCT02672423|100568230|FG005|NOT COMPLETED|Washout 2||0||
48099406|NCT02672423|100568231|FG006|NOT COMPLETED|Washout 2||0||
48099407|NCT02672423|100568232|FG007|NOT COMPLETED|Washout 2||0||
48099408|NCT02672423|100568233|FG008|NOT COMPLETED|Washout 2||0||
48099409|NCT02672423|100568234|FG009|NOT COMPLETED|Washout 2||0||
48099410|NCT02672423|100568225|FG000|STARTED|Period 3||0||
48099411|NCT02672423|100568226|FG001|STARTED|Period 3||0||
48099412|NCT02672423|100568227|FG002|STARTED|Period 3||13||
48099413|NCT02672423|100568228|FG003|STARTED|Period 3||15||
48099414|NCT02672423|100568229|FG004|STARTED|Period 3||14||
48099415|NCT02672423|100568230|FG005|STARTED|Period 3||15||
48099416|NCT02672423|100568231|FG006|STARTED|Period 3||15||
48099417|NCT02672423|100568232|FG007|STARTED|Period 3||15||
48099418|NCT02672423|100568233|FG008|STARTED|Period 3||0||
48263195|NCT01814072|100966720|FG014|STARTED|Overall Study||18||
48546477|NCT00996892|101671461|FG012|NOT COMPLETED|Dose-Escalation Stage 1||0||
48546478|NCT00996892|101671462|FG013|NOT COMPLETED|Dose-Escalation Stage 1||0||
48546479|NCT00996892|101671463|FG014|NOT COMPLETED|Dose-Escalation Stage 1||0||
48690667|NCT02318368|102025892|FG000|COMPLETED|Overall Study||0||
48690668|NCT02318368|102025893|FG001|COMPLETED|Overall Study||0||
48690669|NCT02318368|102025892|FG000|NOT COMPLETED|Overall Study||7||
48099419|NCT02672423|100568234|FG009|STARTED|Period 3||0||
48546480|NCT00996892|101671464|FG015|NOT COMPLETED|Dose-Escalation Stage 1||0||
48546481|NCT00996892|101671465|FG016|NOT COMPLETED|Dose-Escalation Stage 1||0||
48099420|NCT02672423|100568225|FG000|COMPLETED|Period 3||0||
48099421|NCT02672423|100568226|FG001|COMPLETED|Period 3||0||
48099422|NCT02672423|100568227|FG002|COMPLETED|Period 3||13||
48099423|NCT02672423|100568228|FG003|COMPLETED|Period 3||15||
48099424|NCT02672423|100568229|FG004|COMPLETED|Period 3||14||
48099425|NCT02672423|100568230|FG005|COMPLETED|Period 3||14||
48099426|NCT02672423|100568231|FG006|COMPLETED|Period 3||15||
48099427|NCT02672423|100568232|FG007|COMPLETED|Period 3||14||
48099428|NCT02672423|100568233|FG008|COMPLETED|Period 3||0||
48099429|NCT02672423|100568234|FG009|COMPLETED|Period 3||0||
48099430|NCT02672423|100568225|FG000|NOT COMPLETED|Period 3||0||
48099431|NCT02672423|100568226|FG001|NOT COMPLETED|Period 3||0||
48099432|NCT02672423|100568227|FG002|NOT COMPLETED|Period 3||0||
48099433|NCT02672423|100568228|FG003|NOT COMPLETED|Period 3||0||
48099434|NCT02672423|100568229|FG004|NOT COMPLETED|Period 3||0||
48099435|NCT02672423|100568230|FG005|NOT COMPLETED|Period 3||1||
48099436|NCT02672423|100568231|FG006|NOT COMPLETED|Period 3||0||
48099437|NCT02672423|100568232|FG007|NOT COMPLETED|Period 3||1||
48099438|NCT02672423|100568233|FG008|NOT COMPLETED|Period 3||0||
48099439|NCT02672423|100568234|FG009|NOT COMPLETED|Period 3||0||
48099440|NCT03388619|100568235|FG000|STARTED|Overall Study||3||
48099441|NCT03388619|100568236|FG001|STARTED|Overall Study||3||
48099442|NCT03388619|100568237|FG002|STARTED|Overall Study||9||
48099443|NCT03388619|100568238|FG003|STARTED|Overall Study||3||
48099444|NCT03388619|100568239|FG004|STARTED|Overall Study||3||
48099445|NCT03388619|100568240|FG005|STARTED|Overall Study||9||
48099446|NCT03388619|100568235|FG000|Follow-up Period Completed.|Overall Study||3||
48099447|NCT03388619|100568236|FG001|Follow-up Period Completed.|Overall Study||3||
48099448|NCT03388619|100568237|FG002|Follow-up Period Completed.|Overall Study||5||
48099449|NCT03388619|100568238|FG003|Follow-up Period Completed.|Overall Study||3||
48546482|NCT00996892|101671466|FG017|NOT COMPLETED|Dose-Escalation Stage 1||0||
48546483|NCT00996892|101671467|FG018|NOT COMPLETED|Dose-Escalation Stage 1||0||
48546484|NCT00996892|101671468|FG019|NOT COMPLETED|Dose-Escalation Stage 1||0||
48546485|NCT00996892|101671449|FG000|STARTED|Dose-Escalation Stage 1A||0||
48546486|NCT00996892|101671450|FG001|STARTED|Dose-Escalation Stage 1A||0||
48546487|NCT00996892|101671451|FG002|STARTED|Dose-Escalation Stage 1A||0||
48546488|NCT00996892|101671452|FG003|STARTED|Dose-Escalation Stage 1A||0||
48546489|NCT00996892|101671453|FG004|STARTED|Dose-Escalation Stage 1A||0||
48690670|NCT02318368|102025893|FG001|NOT COMPLETED|Overall Study||3||
48690671|NCT03162796|102025894|FG000|STARTED|Placebo Controlled Period: Week 0 - 24||126||
48690672|NCT03162796|102025895|FG001|STARTED|Placebo Controlled Period: Week 0 - 24||127||
48690673|NCT03162796|102025896|FG002|STARTED|Placebo Controlled Period: Week 0 - 24||128||
48690674|NCT03162796|102025894|FG000|COMPLETED|Placebo Controlled Period: Week 0 - 24||114||
48690675|NCT03162796|102025895|FG001|COMPLETED|Placebo Controlled Period: Week 0 - 24||123||
48690676|NCT03162796|102025896|FG002|COMPLETED|Placebo Controlled Period: Week 0 - 24||125||
48690677|NCT03162796|102025894|FG000|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||12||
48690678|NCT03162796|102025895|FG001|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||4||
48690679|NCT03162796|102025896|FG002|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||3||
48690680|NCT03162796|102025894|FG000|STARTED|Active Treatment Period: Week 24 - 52||114||
48690681|NCT03162796|102025895|FG001|STARTED|Active Treatment Period: Week 24 - 52||123||
48690682|NCT03162796|102025896|FG002|STARTED|Active Treatment Period: Week 24 - 52||125||
48690683|NCT03162796|102025894|FG000|COMPLETED|Active Treatment Period: Week 24 - 52||107||
48690684|NCT03162796|102025895|FG001|COMPLETED|Active Treatment Period: Week 24 - 52||116||
48690685|NCT03162796|102025896|FG002|COMPLETED|Active Treatment Period: Week 24 - 52||124||
48690686|NCT03162796|102025894|FG000|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7||
48690687|NCT03162796|102025895|FG001|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7||
48690688|NCT03162796|102025896|FG002|NOT COMPLETED|Active Treatment Period: Week 24 - 52||1||
48690689|NCT03162796|102025894|FG000|STARTED|Safety Follow-up: Week 52 - 60||107||
48690690|NCT03162796|102025895|FG001|STARTED|Safety Follow-up: Week 52 - 60||116||
48099450|NCT03388619|100568239|FG004|Follow-up Period Completed.|Overall Study||3||
48099451|NCT03388619|100568240|FG005|Follow-up Period Completed.|Overall Study||8||
48099452|NCT03388619|100568235|FG000|COMPLETED|Overall Study||3||
48099453|NCT03388619|100568236|FG001|COMPLETED|Overall Study||3||
48546490|NCT00996892|101671454|FG005|STARTED|Dose-Escalation Stage 1A||0||
48099454|NCT03388619|100568237|FG002|COMPLETED|Overall Study||9||
48099455|NCT03388619|100568238|FG003|COMPLETED|Overall Study||3||
48099456|NCT03388619|100568239|FG004|COMPLETED|Overall Study||3||
48099457|NCT03388619|100568240|FG005|COMPLETED|Overall Study||9||
48099458|NCT03388619|100568235|FG000|NOT COMPLETED|Overall Study||0||
48099459|NCT03388619|100568236|FG001|NOT COMPLETED|Overall Study||0||
48099460|NCT03388619|100568237|FG002|NOT COMPLETED|Overall Study||0||
48099461|NCT03388619|100568238|FG003|NOT COMPLETED|Overall Study||0||
48099462|NCT03388619|100568239|FG004|NOT COMPLETED|Overall Study||0||
48099463|NCT03388619|100568240|FG005|NOT COMPLETED|Overall Study||0||
48099464|NCT00383149|100568241|FG000|STARTED|Overall Study||54||
48099465|NCT00383149|100568241|FG000|COMPLETED|Overall Study||0||
48099466|NCT00383149|100568241|FG000|NOT COMPLETED|Overall Study||54||
48099467|NCT02045797|100568242|FG000|STARTED|Overall Study||58||
48099468|NCT02045797|100568243|FG001|STARTED|Overall Study||39||
48099469|NCT02045797|100568244|FG002|STARTED|Overall Study||25||
48099470|NCT02045797|100568242|FG000|COMPLETED|Overall Study||51||
48099471|NCT02045797|100568243|FG001|COMPLETED|Overall Study||32||
48099472|NCT02045797|100568244|FG002|COMPLETED|Overall Study||24||
48099473|NCT02045797|100568242|FG000|NOT COMPLETED|Overall Study||7||
48690691|NCT03162796|102025896|FG002|STARTED|Safety Follow-up: Week 52 - 60||124||
48690692|NCT03162796|102025894|FG000|COMPLETED|Safety Follow-up: Week 52 - 60||106||
48690693|NCT03162796|102025895|FG001|COMPLETED|Safety Follow-up: Week 52 - 60||114||
48690694|NCT03162796|102025896|FG002|COMPLETED|Safety Follow-up: Week 52 - 60||123||
48690695|NCT03162796|102025894|FG000|NOT COMPLETED|Safety Follow-up: Week 52 - 60||1||
48690696|NCT03162796|102025895|FG001|NOT COMPLETED|Safety Follow-up: Week 52 - 60||2||
48099474|NCT02045797|100568243|FG001|NOT COMPLETED|Overall Study||7||
48546491|NCT00996892|101671455|FG006|STARTED|Dose-Escalation Stage 1A||0||
48546492|NCT00996892|101671456|FG007|STARTED|Dose-Escalation Stage 1A||3||
48546493|NCT00996892|101671457|FG008|STARTED|Dose-Escalation Stage 1A||3||
48546494|NCT00996892|101671458|FG009|STARTED|Dose-Escalation Stage 1A||4||
48546495|NCT00996892|101671459|FG010|STARTED|Dose-Escalation Stage 1A||7||
48546496|NCT00996892|101671460|FG011|STARTED|Dose-Escalation Stage 1A||9||
48546497|NCT00996892|101671461|FG012|STARTED|Dose-Escalation Stage 1A||8||
48546498|NCT00996892|101671462|FG013|STARTED|Dose-Escalation Stage 1A||5||
48546499|NCT00996892|101671463|FG014|STARTED|Dose-Escalation Stage 1A||0||
48099475|NCT02045797|100568244|FG002|NOT COMPLETED|Overall Study||1||
48099476|NCT03525210|100568245|FG000|STARTED|Overall Study||100||
48099477|NCT03525210|100568246|FG001|STARTED|Overall Study||171||
48546500|NCT00996892|101671464|FG015|STARTED|Dose-Escalation Stage 1A||0||
48546501|NCT00996892|101671465|FG016|STARTED|Dose-Escalation Stage 1A||0||
48546502|NCT00996892|101671466|FG017|STARTED|Dose-Escalation Stage 1A||0||
48546503|NCT00996892|101671467|FG018|STARTED|Dose-Escalation Stage 1A||0||
48690697|NCT03162796|102025896|FG002|NOT COMPLETED|Safety Follow-up: Week 52 - 60||1||
48690698|NCT00819156|102025897|FG000|STARTED|Overall Study||30||
48690699|NCT00819156|102025898|FG001|STARTED|Overall Study||33||
48690700|NCT00819156|102025899|FG002|STARTED|Overall Study||32||
48690701|NCT00819156|102025900|FG003|STARTED|Overall Study||30||
48546504|NCT00996892|101671468|FG019|STARTED|Dose-Escalation Stage 1A||0||
48546505|NCT00996892|101671449|FG000|COMPLETED|Dose-Escalation Stage 1A||0||
48546506|NCT00996892|101671450|FG001|COMPLETED|Dose-Escalation Stage 1A||0||
48546507|NCT00996892|101671451|FG002|COMPLETED|Dose-Escalation Stage 1A||0||
48546508|NCT00996892|101671452|FG003|COMPLETED|Dose-Escalation Stage 1A||0||
48546509|NCT00996892|101671453|FG004|COMPLETED|Dose-Escalation Stage 1A||0||
48546510|NCT00996892|101671454|FG005|COMPLETED|Dose-Escalation Stage 1A||0||
48546511|NCT00996892|101671455|FG006|COMPLETED|Dose-Escalation Stage 1A||0||
48546512|NCT00996892|101671456|FG007|COMPLETED|Dose-Escalation Stage 1A||0||
48546513|NCT00996892|101671457|FG008|COMPLETED|Dose-Escalation Stage 1A||0||
48546514|NCT00996892|101671458|FG009|COMPLETED|Dose-Escalation Stage 1A||0||
48546515|NCT00996892|101671459|FG010|COMPLETED|Dose-Escalation Stage 1A||0||
48099478|NCT03525210|100568245|FG000|COMPLETED|Overall Study||96||
48099479|NCT03525210|100568246|FG001|COMPLETED|Overall Study||169||
48099480|NCT03525210|100568245|FG000|NOT COMPLETED|Overall Study||4||
48099481|NCT03525210|100568246|FG001|NOT COMPLETED|Overall Study||2||
48099482|NCT02205333|100568247|FG000|STARTED|Overall Study||8||
48099483|NCT02205333|100568248|FG001|STARTED|Overall Study||6||
48099484|NCT02205333|100568249|FG002|STARTED|Overall Study||3||
48099485|NCT02205333|100568250|FG003|STARTED|Overall Study||7||
48099486|NCT02205333|100568251|FG004|STARTED|Overall Study||6||
48099487|NCT02205333|100568252|FG005|STARTED|Overall Study||7||
48099488|NCT02205333|100568253|FG006|STARTED|Overall Study||7||
48099489|NCT02205333|100568254|FG007|STARTED|Overall Study||3||
48099490|NCT02205333|100568255|FG008|STARTED|Overall Study||1||
48099491|NCT02205333|100568247|FG000|COMPLETED|Overall Study||2||
48099492|NCT02205333|100568248|FG001|COMPLETED|Overall Study||0||
48099493|NCT02205333|100568249|FG002|COMPLETED|Overall Study||1||
48099494|NCT02205333|100568250|FG003|COMPLETED|Overall Study||0||
48099495|NCT02205333|100568251|FG004|COMPLETED|Overall Study||1||
48099496|NCT02205333|100568252|FG005|COMPLETED|Overall Study||4||
48099497|NCT02205333|100568253|FG006|COMPLETED|Overall Study||2||
48099498|NCT02205333|100568254|FG007|COMPLETED|Overall Study||1||
48099499|NCT02205333|100568255|FG008|COMPLETED|Overall Study||1||
48546516|NCT00996892|101671460|FG011|COMPLETED|Dose-Escalation Stage 1A||0||
48546517|NCT00996892|101671461|FG012|COMPLETED|Dose-Escalation Stage 1A||0||
48546518|NCT00996892|101671462|FG013|COMPLETED|Dose-Escalation Stage 1A||0||
48546519|NCT00996892|101671463|FG014|COMPLETED|Dose-Escalation Stage 1A||0||
48546520|NCT00996892|101671464|FG015|COMPLETED|Dose-Escalation Stage 1A||0||
48546521|NCT00996892|101671465|FG016|COMPLETED|Dose-Escalation Stage 1A||0||
48546522|NCT00996892|101671466|FG017|COMPLETED|Dose-Escalation Stage 1A||0||
48546523|NCT00996892|101671467|FG018|COMPLETED|Dose-Escalation Stage 1A||0||
48546524|NCT00996892|101671468|FG019|COMPLETED|Dose-Escalation Stage 1A||0||
48546525|NCT00996892|101671449|FG000|NOT COMPLETED|Dose-Escalation Stage 1A||0||
48546526|NCT00996892|101671450|FG001|NOT COMPLETED|Dose-Escalation Stage 1A||0||
48546527|NCT00996892|101671451|FG002|NOT COMPLETED|Dose-Escalation Stage 1A||0||
48546528|NCT00996892|101671452|FG003|NOT COMPLETED|Dose-Escalation Stage 1A||0||
48546529|NCT00996892|101671453|FG004|NOT COMPLETED|Dose-Escalation Stage 1A||0||
48546530|NCT00996892|101671454|FG005|NOT COMPLETED|Dose-Escalation Stage 1A||0||
48546531|NCT00996892|101671455|FG006|NOT COMPLETED|Dose-Escalation Stage 1A||0||
48546532|NCT00996892|101671456|FG007|NOT COMPLETED|Dose-Escalation Stage 1A||3||
48546533|NCT00996892|101671457|FG008|NOT COMPLETED|Dose-Escalation Stage 1A||3||
48099500|NCT02205333|100568247|FG000|NOT COMPLETED|Overall Study||6||
48099501|NCT02205333|100568248|FG001|NOT COMPLETED|Overall Study||6||
48099502|NCT02205333|100568249|FG002|NOT COMPLETED|Overall Study||2||
48099503|NCT02205333|100568250|FG003|NOT COMPLETED|Overall Study||7||
48099504|NCT02205333|100568251|FG004|NOT COMPLETED|Overall Study||5||
48099505|NCT02205333|100568252|FG005|NOT COMPLETED|Overall Study||3||
48099506|NCT02205333|100568253|FG006|NOT COMPLETED|Overall Study||5||
48099507|NCT02205333|100568254|FG007|NOT COMPLETED|Overall Study||2||
48099508|NCT02205333|100568255|FG008|NOT COMPLETED|Overall Study||0||
48099509|NCT00281684|100568256|FG000|STARTED|Overall Study||37||
48099510|NCT00281684|100568257|FG001|STARTED|Overall Study||36||
48099511|NCT00281684|100568258|FG002|STARTED|Overall Study||34||
48099512|NCT00281684|100568259|FG003|STARTED|Overall Study||38||
48099513|NCT00281684|100568256|FG000|COMPLETED|Overall Study||36||
48099514|NCT00281684|100568257|FG001|COMPLETED|Overall Study||36||
48099515|NCT00281684|100568258|FG002|COMPLETED|Overall Study||33||
48099516|NCT00281684|100568259|FG003|COMPLETED|Overall Study||38||
48099517|NCT00281684|100568256|FG000|NOT COMPLETED|Overall Study||1||
48099518|NCT00281684|100568257|FG001|NOT COMPLETED|Overall Study||0||
48099519|NCT00281684|100568258|FG002|NOT COMPLETED|Overall Study||1||
48099520|NCT00281684|100568259|FG003|NOT COMPLETED|Overall Study||0||
48099521|NCT03165110|100568260|FG000|STARTED|Overall Study||47||
48099522|NCT03165110|100568260|FG000|COMPLETED|Overall Study||46||
48099523|NCT03165110|100568260|FG000|NOT COMPLETED|Overall Study||1||
48099524|NCT01254227|100568261|FG000|STARTED|Overall Study||60||
48099525|NCT01254227|100568261|FG000|Completion of 12 Months|Overall Study||39||
48099526|NCT01254227|100568261|FG000|Completion of 24 Months|Overall Study||34||
48099527|NCT01254227|100568261|FG000|COMPLETED|Overall Study||34||
48099528|NCT01254227|100568261|FG000|NOT COMPLETED|Overall Study||26||
48099529|NCT01980355|100568262|FG000|STARTED|Overall Study||39||
48099530|NCT01980355|100568263|FG001|STARTED|Overall Study||37||
48099531|NCT01980355|100568262|FG000|COMPLETED|Overall Study||39||
48099532|NCT01980355|100568263|FG001|COMPLETED|Overall Study||37||
48099533|NCT01980355|100568262|FG000|NOT COMPLETED|Overall Study||0||
48099534|NCT01980355|100568263|FG001|NOT COMPLETED|Overall Study||0||
48099535|NCT02144233|100568264|FG000|STARTED|Overall Study||39||
48099536|NCT02144233|100568265|FG001|STARTED|Overall Study||38||
48099537|NCT02144233|100568264|FG000|COMPLETED|Overall Study||39||
48099538|NCT02144233|100568265|FG001|COMPLETED|Overall Study||38||
48099539|NCT02144233|100568264|FG000|NOT COMPLETED|Overall Study||0||
48546534|NCT00996892|101671458|FG009|NOT COMPLETED|Dose-Escalation Stage 1A||4||
48546535|NCT00996892|101671459|FG010|NOT COMPLETED|Dose-Escalation Stage 1A||7||
48546536|NCT00996892|101671460|FG011|NOT COMPLETED|Dose-Escalation Stage 1A||9||
48546537|NCT00996892|101671461|FG012|NOT COMPLETED|Dose-Escalation Stage 1A||8||
48546538|NCT00996892|101671462|FG013|NOT COMPLETED|Dose-Escalation Stage 1A||5||
48546539|NCT00996892|101671463|FG014|NOT COMPLETED|Dose-Escalation Stage 1A||0||
48546540|NCT00996892|101671464|FG015|NOT COMPLETED|Dose-Escalation Stage 1A||0||
48592719|NCT02143791|101783167|FG000|NOT COMPLETED|Trial Stimulation||21||
48099540|NCT02144233|100568265|FG001|NOT COMPLETED|Overall Study||0||
48099541|NCT00994240|100568266|FG000|STARTED|Overall Study||41||
48099542|NCT00994240|100568267|FG001|STARTED|Overall Study||44||
48099543|NCT00994240|100568266|FG000|COMPLETED|Overall Study||35||
48099544|NCT00994240|100568267|FG001|COMPLETED|Overall Study||39||
48099545|NCT00994240|100568266|FG000|NOT COMPLETED|Overall Study||6||
48099546|NCT00994240|100568267|FG001|NOT COMPLETED|Overall Study||5||
48099547|NCT03928847|100568268|FG000|STARTED|Overall Study||5||
48099548|NCT03928847|100568269|FG001|STARTED|Overall Study||5||
48099549|NCT03928847|100568270|FG002|STARTED|Overall Study||5||
48099550|NCT03928847|100568271|FG003|STARTED|Overall Study||10||
48099551|NCT03928847|100568272|FG004|STARTED|Overall Study||10||
48099552|NCT03928847|100568268|FG000|COMPLETED|Overall Study||5||
48099553|NCT03928847|100568269|FG001|COMPLETED|Overall Study||5||
48099554|NCT03928847|100568270|FG002|COMPLETED|Overall Study||5||
48099555|NCT03928847|100568271|FG003|COMPLETED|Overall Study||10||
48099556|NCT03928847|100568272|FG004|COMPLETED|Overall Study||10||
48099557|NCT03928847|100568268|FG000|NOT COMPLETED|Overall Study||0||
48099558|NCT03928847|100568269|FG001|NOT COMPLETED|Overall Study||0||
48099559|NCT03928847|100568270|FG002|NOT COMPLETED|Overall Study||0||
48099560|NCT03928847|100568271|FG003|NOT COMPLETED|Overall Study||0||
48099561|NCT03928847|100568272|FG004|NOT COMPLETED|Overall Study||0||
48099562|NCT05024058|100568273|FG000|STARTED|Treatment||5||
48099563|NCT05024058|100568274|FG001|STARTED|Treatment||6||
48099564|NCT05024058|100568275|FG002|STARTED|Treatment||4||
48099565|NCT05024058|100568276|FG003|STARTED|Treatment||2||
48099566|NCT05024058|100568277|FG004|STARTED|Treatment||3||
48099567|NCT05024058|100568278|FG005|STARTED|Treatment||3||
48099568|NCT05024058|100568279|FG006|STARTED|Treatment||1||
48099569|NCT05024058|100568280|FG007|STARTED|Treatment||3||
48099570|NCT05024058|100568281|FG008|STARTED|Treatment||6||
48099571|NCT05024058|100568282|FG009|STARTED|Treatment||6||
48099572|NCT05024058|100568273|FG000|COMPLETED|Treatment||0||
48099573|NCT05024058|100568274|FG001|COMPLETED|Treatment||0||
48099574|NCT05024058|100568275|FG002|COMPLETED|Treatment||0||
48099575|NCT05024058|100568276|FG003|COMPLETED|Treatment||0||
48099576|NCT05024058|100568277|FG004|COMPLETED|Treatment||0||
48099577|NCT05024058|100568278|FG005|COMPLETED|Treatment||0||
48099578|NCT05024058|100568279|FG006|COMPLETED|Treatment||0||
48099579|NCT05024058|100568280|FG007|COMPLETED|Treatment||0||
48099580|NCT05024058|100568281|FG008|COMPLETED|Treatment||0||
48390555|NCT01606735|101283627|FG001|NOT COMPLETED|Overall Study||0||
48390556|NCT01606735|101283628|FG002|NOT COMPLETED|Overall Study||0||
48099581|NCT05024058|100568282|FG009|COMPLETED|Treatment||0||
48099582|NCT05024058|100568273|FG000|NOT COMPLETED|Treatment||5||
48099583|NCT05024058|100568274|FG001|NOT COMPLETED|Treatment||6||
48099584|NCT05024058|100568275|FG002|NOT COMPLETED|Treatment||4||
48263196|NCT01814072|100966721|FG015|STARTED|Overall Study||18||
48263197|NCT01814072|100966722|FG016|STARTED|Overall Study||17||
48390557|NCT03627494|101283629|FG000|STARTED|Part A Period 1 (4 Days)||3||
48390558|NCT03627494|101283630|FG001|STARTED|Part A Period 1 (4 Days)||3||
48390559|NCT03627494|101283631|FG002|STARTED|Part A Period 1 (4 Days)||3||
48390560|NCT03627494|101283632|FG003|STARTED|Part A Period 1 (4 Days)||3||
48390561|NCT03627494|101283633|FG004|STARTED|Part A Period 1 (4 Days)||3||
48390562|NCT03627494|101283634|FG005|STARTED|Part A Period 1 (4 Days)||3||
48390563|NCT03627494|101283635|FG006|STARTED|Part A Period 1 (4 Days)||0||
48390564|NCT03627494|101283636|FG007|STARTED|Part A Period 1 (4 Days)||0||
48390565|NCT03627494|101283637|FG008|STARTED|Part A Period 1 (4 Days)||0||
48390566|NCT03627494|101283638|FG009|STARTED|Part A Period 1 (4 Days)||0||
48390567|NCT03627494|101283639|FG010|STARTED|Part A Period 1 (4 Days)||0||
48390568|NCT03627494|101283640|FG011|STARTED|Part A Period 1 (4 Days)||0||
48546541|NCT00996892|101671465|FG016|NOT COMPLETED|Dose-Escalation Stage 1A||0||
48546542|NCT00996892|101671466|FG017|NOT COMPLETED|Dose-Escalation Stage 1A||0||
48546543|NCT00996892|101671467|FG018|NOT COMPLETED|Dose-Escalation Stage 1A||0||
48546544|NCT00996892|101671468|FG019|NOT COMPLETED|Dose-Escalation Stage 1A||0||
48546545|NCT00996892|101671449|FG000|STARTED|Dose-Escalation Stage 1B||0||
48546546|NCT00996892|101671450|FG001|STARTED|Dose-Escalation Stage 1B||0||
48546547|NCT00996892|101671451|FG002|STARTED|Dose-Escalation Stage 1B||0||
48546548|NCT00996892|101671452|FG003|STARTED|Dose-Escalation Stage 1B||0||
48546549|NCT00996892|101671453|FG004|STARTED|Dose-Escalation Stage 1B||0||
48546550|NCT00996892|101671454|FG005|STARTED|Dose-Escalation Stage 1B||0||
48546551|NCT00996892|101671455|FG006|STARTED|Dose-Escalation Stage 1B||0||
48099585|NCT05024058|100568276|FG003|NOT COMPLETED|Treatment||2||
48263198|NCT01814072|100966723|FG017|STARTED|Overall Study||18||
48263199|NCT01814072|100966724|FG018|STARTED|Overall Study||17||
48263200|NCT01814072|100966725|FG019|STARTED|Overall Study||16||
48263201|NCT01814072|100966726|FG020|STARTED|Overall Study||16||
48263202|NCT01814072|100966727|FG021|STARTED|Overall Study||17||
48263203|NCT01814072|100966728|FG022|STARTED|Overall Study||17||
48263204|NCT01814072|100966729|FG023|STARTED|Overall Study||18||
48263205|NCT01814072|100966730|FG024|STARTED|Overall Study||17||
48263206|NCT01814072|100966731|FG025|STARTED|Overall Study||16||
48263207|NCT01814072|100966732|FG026|STARTED|Overall Study||18||
48263208|NCT01814072|100966733|FG027|STARTED|Overall Study||17||
48263209|NCT01814072|100966734|FG028|STARTED|Overall Study||18||
48390569|NCT03627494|101283629|FG000|COMPLETED|Part A Period 1 (4 Days)||3|0|
48390570|NCT03627494|101283630|FG001|COMPLETED|Part A Period 1 (4 Days)||3|0|
48390571|NCT03627494|101283631|FG002|COMPLETED|Part A Period 1 (4 Days)||3|0|
48390572|NCT03627494|101283632|FG003|COMPLETED|Part A Period 1 (4 Days)||3|0|
48390573|NCT03627494|101283633|FG004|COMPLETED|Part A Period 1 (4 Days)||3|0|
48546552|NCT00996892|101671456|FG007|STARTED|Dose-Escalation Stage 1B||0||
48099586|NCT05024058|100568277|FG004|NOT COMPLETED|Treatment||3||
48263210|NCT01814072|100966735|FG029|STARTED|Overall Study||17||
48263211|NCT01814072|100966736|FG030|STARTED|Overall Study||17||
48099587|NCT05024058|100568278|FG005|NOT COMPLETED|Treatment||3||
48099588|NCT05024058|100568279|FG006|NOT COMPLETED|Treatment||1||
48099589|NCT05024058|100568280|FG007|NOT COMPLETED|Treatment||3||
48263212|NCT01814072|100966737|FG031|STARTED|Overall Study||17||
48263213|NCT01814072|100966706|FG000|3-mo Visit|Overall Study||15||
48263214|NCT01814072|100966707|FG001|3-mo Visit|Overall Study||18||
48263215|NCT01814072|100966708|FG002|3-mo Visit|Overall Study||16||
48690702|NCT00819156|102025901|FG004|STARTED|Overall Study||33||
48099590|NCT05024058|100568281|FG008|NOT COMPLETED|Treatment||6||
48099591|NCT05024058|100568282|FG009|NOT COMPLETED|Treatment||6||
48099592|NCT05024058|100568273|FG000|STARTED|Follow-up||2||
48099593|NCT05024058|100568274|FG001|STARTED|Follow-up||5||
48690703|NCT00819156|102025902|FG005|STARTED|Overall Study||31||
48690704|NCT00819156|102025897|FG000|Randomised and Treated (ITT Population)|Overall Study||30||
48690705|NCT00819156|102025898|FG001|Randomised and Treated (ITT Population)|Overall Study||32||
48690706|NCT00819156|102025899|FG002|Randomised and Treated (ITT Population)|Overall Study||32||
48690707|NCT00819156|102025900|FG003|Randomised and Treated (ITT Population)|Overall Study||30||
48099594|NCT05024058|100568275|FG002|STARTED|Follow-up||4||
48099595|NCT05024058|100568276|FG003|STARTED|Follow-up||0||
48099596|NCT05024058|100568277|FG004|STARTED|Follow-up||3||
48099597|NCT05024058|100568278|FG005|STARTED|Follow-up||2||
48099598|NCT05024058|100568279|FG006|STARTED|Follow-up||0||
48099599|NCT05024058|100568280|FG007|STARTED|Follow-up||2||
48263216|NCT01814072|100966709|FG003|3-mo Visit|Overall Study||18||
48099600|NCT05024058|100568281|FG008|STARTED|Follow-up||5||
48099601|NCT05024058|100568282|FG009|STARTED|Follow-up||6||
48099602|NCT05024058|100568273|FG000|COMPLETED|Follow-up||1||
48099603|NCT05024058|100568274|FG001|COMPLETED|Follow-up||5||
48099604|NCT05024058|100568275|FG002|COMPLETED|Follow-up||3||
48099605|NCT05024058|100568276|FG003|COMPLETED|Follow-up||0||
48099606|NCT05024058|100568277|FG004|COMPLETED|Follow-up||3||
48099607|NCT05024058|100568278|FG005|COMPLETED|Follow-up||2||
48099608|NCT05024058|100568279|FG006|COMPLETED|Follow-up||0||
48263217|NCT01814072|100966710|FG004|3-mo Visit|Overall Study||15||
48263218|NCT01814072|100966711|FG005|3-mo Visit|Overall Study||15||
48263219|NCT01814072|100966712|FG006|3-mo Visit|Overall Study||16||
48263220|NCT01814072|100966713|FG007|3-mo Visit|Overall Study||18||
48263221|NCT01814072|100966714|FG008|3-mo Visit|Overall Study||18||
48263222|NCT01814072|100966715|FG009|3-mo Visit|Overall Study||15||
48263223|NCT01814072|100966716|FG010|3-mo Visit|Overall Study||18||
48690708|NCT00819156|102025901|FG004|Randomised and Treated (ITT Population)|Overall Study||33||
48099609|NCT05024058|100568280|FG007|COMPLETED|Follow-up||1||
48099610|NCT05024058|100568281|FG008|COMPLETED|Follow-up||5||
48099611|NCT05024058|100568282|FG009|COMPLETED|Follow-up||5||
48099612|NCT05024058|100568273|FG000|NOT COMPLETED|Follow-up||1||
48099613|NCT05024058|100568274|FG001|NOT COMPLETED|Follow-up||0||
48099614|NCT05024058|100568275|FG002|NOT COMPLETED|Follow-up||1||
48099615|NCT05024058|100568276|FG003|NOT COMPLETED|Follow-up||0||
48099616|NCT05024058|100568277|FG004|NOT COMPLETED|Follow-up||0||
48099617|NCT05024058|100568278|FG005|NOT COMPLETED|Follow-up||0||
48099618|NCT05024058|100568279|FG006|NOT COMPLETED|Follow-up||0||
48099619|NCT05024058|100568280|FG007|NOT COMPLETED|Follow-up||1||
48099620|NCT05024058|100568281|FG008|NOT COMPLETED|Follow-up||0||
48099621|NCT05024058|100568282|FG009|NOT COMPLETED|Follow-up||1||
48099622|NCT03683758|100568283|FG000|STARTED|Overall Study||11||
48099623|NCT03683758|100568284|FG001|STARTED|Overall Study||10||
48263224|NCT01814072|100966717|FG011|3-mo Visit|Overall Study||17||
48263225|NCT01814072|100966718|FG012|3-mo Visit|Overall Study||16||
48263226|NCT01814072|100966719|FG013|3-mo Visit|Overall Study||16||
48690709|NCT00819156|102025902|FG005|Randomised and Treated (ITT Population)|Overall Study||30||
48263227|NCT01814072|100966720|FG014|3-mo Visit|Overall Study||16||
48263228|NCT01814072|100966721|FG015|3-mo Visit|Overall Study||16||
48263229|NCT01814072|100966722|FG016|3-mo Visit|Overall Study||16||
48263230|NCT01814072|100966723|FG017|3-mo Visit|Overall Study||16||
48263231|NCT01814072|100966724|FG018|3-mo Visit|Overall Study||14||
48263232|NCT01814072|100966725|FG019|3-mo Visit|Overall Study||13||
48263233|NCT01814072|100966726|FG020|3-mo Visit|Overall Study||15||
48263234|NCT01814072|100966727|FG021|3-mo Visit|Overall Study||17||
48263235|NCT01814072|100966728|FG022|3-mo Visit|Overall Study||15||
48263236|NCT01814072|100966729|FG023|3-mo Visit|Overall Study||18||
48263237|NCT01814072|100966730|FG024|3-mo Visit|Overall Study||13||
48263238|NCT01814072|100966731|FG025|3-mo Visit|Overall Study||14||
48263239|NCT01814072|100966732|FG026|3-mo Visit|Overall Study||17||
48263240|NCT01814072|100966733|FG027|3-mo Visit|Overall Study||14||
48263241|NCT01814072|100966734|FG028|3-mo Visit|Overall Study||15||
48690710|NCT00819156|102025897|FG000|COMPLETED|Overall Study||20||
48263242|NCT01814072|100966735|FG029|3-mo Visit|Overall Study||16||
48690711|NCT00819156|102025898|FG001|COMPLETED|Overall Study||23||
48690712|NCT00819156|102025899|FG002|COMPLETED|Overall Study||26||
48099624|NCT03683758|100568283|FG000|COMPLETED|Overall Study||8||
48099625|NCT03683758|100568284|FG001|COMPLETED|Overall Study||7||
48263243|NCT01814072|100966736|FG030|3-mo Visit|Overall Study||16||
48099626|NCT03683758|100568283|FG000|NOT COMPLETED|Overall Study||3||
48099627|NCT03683758|100568284|FG001|NOT COMPLETED|Overall Study||3||
48263244|NCT01814072|100966737|FG031|3-mo Visit|Overall Study||17||
48263245|NCT01814072|100966706|FG000|Intent to Treat|Overall Study||4||
48099628|NCT03756688|100568285|FG000|STARTED|Overall Study||28||
48099629|NCT03756688|100568286|FG001|STARTED|Overall Study||28||
48263246|NCT01814072|100966707|FG001|Intent to Treat|Overall Study||2||
48263247|NCT01814072|100966708|FG002|Intent to Treat|Overall Study||3||
48099630|NCT03756688|100568287|FG002|STARTED|Overall Study||27||
48263248|NCT01814072|100966709|FG003|Intent to Treat|Overall Study||0||
48263249|NCT01814072|100966710|FG004|Intent to Treat|Overall Study||4||
48263250|NCT01814072|100966711|FG005|Intent to Treat|Overall Study||6||
48263251|NCT01814072|100966712|FG006|Intent to Treat|Overall Study||4||
48263252|NCT01814072|100966713|FG007|Intent to Treat|Overall Study||1||
48263253|NCT01814072|100966714|FG008|Intent to Treat|Overall Study||3||
48263254|NCT01814072|100966715|FG009|Intent to Treat|Overall Study||5||
48263255|NCT01814072|100966716|FG010|Intent to Treat|Overall Study||1||
48263256|NCT01814072|100966717|FG011|Intent to Treat|Overall Study||2||
48263257|NCT01814072|100966718|FG012|Intent to Treat|Overall Study||3||
48263258|NCT01814072|100966719|FG013|Intent to Treat|Overall Study||2||
48263259|NCT01814072|100966720|FG014|Intent to Treat|Overall Study||3||
48263260|NCT01814072|100966721|FG015|Intent to Treat|Overall Study||2||
48263261|NCT01814072|100966722|FG016|Intent to Treat|Overall Study||3||
48546553|NCT00996892|101671457|FG008|STARTED|Dose-Escalation Stage 1B||0||
48546554|NCT00996892|101671458|FG009|STARTED|Dose-Escalation Stage 1B||0||
48546555|NCT00996892|101671459|FG010|STARTED|Dose-Escalation Stage 1B||0||
48546556|NCT00996892|101671460|FG011|STARTED|Dose-Escalation Stage 1B||0||
48546557|NCT00996892|101671461|FG012|STARTED|Dose-Escalation Stage 1B||0||
48546558|NCT00996892|101671462|FG013|STARTED|Dose-Escalation Stage 1B||0||
48546559|NCT00996892|101671463|FG014|STARTED|Dose-Escalation Stage 1B||4||
48546560|NCT00996892|101671464|FG015|STARTED|Dose-Escalation Stage 1B||3||
48263262|NCT01814072|100966723|FG017|Intent to Treat|Overall Study||1||
48263263|NCT01814072|100966724|FG018|Intent to Treat|Overall Study||3||
48263264|NCT01814072|100966725|FG019|Intent to Treat|Overall Study||5||
48263265|NCT01814072|100966726|FG020|Intent to Treat|Overall Study||2||
48263266|NCT01814072|100966727|FG021|Intent to Treat|Overall Study||1||
48263267|NCT01814072|100966728|FG022|Intent to Treat|Overall Study||4||
48263268|NCT01814072|100966729|FG023|Intent to Treat|Overall Study||1||
48263269|NCT01814072|100966730|FG024|Intent to Treat|Overall Study||6||
48263270|NCT01814072|100966731|FG025|Intent to Treat|Overall Study||2||
48263271|NCT01814072|100966732|FG026|Intent to Treat|Overall Study||2||
48263272|NCT01814072|100966733|FG027|Intent to Treat|Overall Study||4||
48263273|NCT01814072|100966734|FG028|Intent to Treat|Overall Study||4||
48546561|NCT00996892|101671465|FG016|STARTED|Dose-Escalation Stage 1B||3||
48546562|NCT00996892|101671466|FG017|STARTED|Dose-Escalation Stage 1B||5||
48546563|NCT00996892|101671467|FG018|STARTED|Dose-Escalation Stage 1B||0||
48546564|NCT00996892|101671468|FG019|STARTED|Dose-Escalation Stage 1B||0||
48546565|NCT00996892|101671449|FG000|COMPLETED|Dose-Escalation Stage 1B||0||
48690713|NCT00819156|102025900|FG003|COMPLETED|Overall Study||28||
48690714|NCT00819156|102025901|FG004|COMPLETED|Overall Study||27||
48690715|NCT00819156|102025902|FG005|COMPLETED|Overall Study||23||
48690716|NCT00819156|102025897|FG000|NOT COMPLETED|Overall Study||10||
48690717|NCT00819156|102025898|FG001|NOT COMPLETED|Overall Study||10||
48690718|NCT00819156|102025899|FG002|NOT COMPLETED|Overall Study||6||
48690719|NCT00819156|102025900|FG003|NOT COMPLETED|Overall Study||2||
48690720|NCT00819156|102025901|FG004|NOT COMPLETED|Overall Study||6||
48690721|NCT00819156|102025902|FG005|NOT COMPLETED|Overall Study||8||
48690722|NCT03885154|102025903|FG000|STARTED|Overall Study||12||
48263274|NCT01814072|100966735|FG029|Intent to Treat|Overall Study||3||
48263275|NCT01814072|100966736|FG030|Intent to Treat|Overall Study||2||
48263276|NCT01814072|100966737|FG031|Intent to Treat|Overall Study||0||
48546566|NCT00996892|101671450|FG001|COMPLETED|Dose-Escalation Stage 1B||0||
48546567|NCT00996892|101671451|FG002|COMPLETED|Dose-Escalation Stage 1B||0||
48546568|NCT00996892|101671452|FG003|COMPLETED|Dose-Escalation Stage 1B||0||
48690723|NCT03885154|102025904|FG001|STARTED|Overall Study||10||
48690724|NCT03885154|102025905|FG002|STARTED|Overall Study||0||
48690725|NCT03885154|102025906|FG003|STARTED|Overall Study||2||
48690726|NCT03885154|102025903|FG000|COMPLETED|Overall Study||12||
48690727|NCT03885154|102025904|FG001|COMPLETED|Overall Study||10||
48263277|NCT01814072|100966706|FG000|COMPLETED|Overall Study||14||
48263278|NCT01814072|100966707|FG001|COMPLETED|Overall Study||16||
48263279|NCT01814072|100966708|FG002|COMPLETED|Overall Study||15||
48263280|NCT01814072|100966709|FG003|COMPLETED|Overall Study||18||
48263281|NCT01814072|100966710|FG004|COMPLETED|Overall Study||14||
48263282|NCT01814072|100966711|FG005|COMPLETED|Overall Study||12||
48263283|NCT01814072|100966712|FG006|COMPLETED|Overall Study||14||
48546569|NCT00996892|101671453|FG004|COMPLETED|Dose-Escalation Stage 1B||0||
48546570|NCT00996892|101671454|FG005|COMPLETED|Dose-Escalation Stage 1B||0||
48546571|NCT00996892|101671455|FG006|COMPLETED|Dose-Escalation Stage 1B||0||
48690728|NCT03885154|102025905|FG002|COMPLETED|Overall Study||0||
48263284|NCT01814072|100966713|FG007|COMPLETED|Overall Study||17||
48263285|NCT01814072|100966714|FG008|COMPLETED|Overall Study||16||
48263286|NCT01814072|100966715|FG009|COMPLETED|Overall Study||13||
48263287|NCT01814072|100966716|FG010|COMPLETED|Overall Study||17||
48263288|NCT01814072|100966717|FG011|COMPLETED|Overall Study||16||
48263289|NCT01814072|100966718|FG012|COMPLETED|Overall Study||15||
48263290|NCT01814072|100966719|FG013|COMPLETED|Overall Study||16||
48263291|NCT01814072|100966720|FG014|COMPLETED|Overall Study||15||
48546572|NCT00996892|101671456|FG007|COMPLETED|Dose-Escalation Stage 1B||0||
48546573|NCT00996892|101671457|FG008|COMPLETED|Dose-Escalation Stage 1B||0||
48546574|NCT00996892|101671458|FG009|COMPLETED|Dose-Escalation Stage 1B||0||
48263292|NCT01814072|100966721|FG015|COMPLETED|Overall Study||16||
48263293|NCT01814072|100966722|FG016|COMPLETED|Overall Study||14||
48263294|NCT01814072|100966723|FG017|COMPLETED|Overall Study||17||
48263295|NCT01814072|100966724|FG018|COMPLETED|Overall Study||14||
48263296|NCT01814072|100966725|FG019|COMPLETED|Overall Study||11||
48263297|NCT01814072|100966726|FG020|COMPLETED|Overall Study||14||
48263298|NCT01814072|100966727|FG021|COMPLETED|Overall Study||16||
48263299|NCT01814072|100966728|FG022|COMPLETED|Overall Study||13||
48263300|NCT01814072|100966729|FG023|COMPLETED|Overall Study||17||
48263301|NCT01814072|100966730|FG024|COMPLETED|Overall Study||11||
48263302|NCT01814072|100966731|FG025|COMPLETED|Overall Study||14||
48263303|NCT01814072|100966732|FG026|COMPLETED|Overall Study||16||
48263304|NCT01814072|100966733|FG027|COMPLETED|Overall Study||13||
48263305|NCT01814072|100966734|FG028|COMPLETED|Overall Study||14||
48263306|NCT01814072|100966735|FG029|COMPLETED|Overall Study||14||
48263307|NCT01814072|100966736|FG030|COMPLETED|Overall Study||15||
48263308|NCT01814072|100966737|FG031|COMPLETED|Overall Study||17||
48263309|NCT01814072|100966706|FG000|NOT COMPLETED|Overall Study||4||
48263310|NCT01814072|100966707|FG001|NOT COMPLETED|Overall Study||2||
48263311|NCT01814072|100966708|FG002|NOT COMPLETED|Overall Study||3||
48263312|NCT01814072|100966709|FG003|NOT COMPLETED|Overall Study||0||
48263313|NCT01814072|100966710|FG004|NOT COMPLETED|Overall Study||4||
48263314|NCT01814072|100966711|FG005|NOT COMPLETED|Overall Study||6||
48263315|NCT01814072|100966712|FG006|NOT COMPLETED|Overall Study||4||
48263316|NCT01814072|100966713|FG007|NOT COMPLETED|Overall Study||1||
48263317|NCT01814072|100966714|FG008|NOT COMPLETED|Overall Study||3||
48263318|NCT01814072|100966715|FG009|NOT COMPLETED|Overall Study||5||
48263319|NCT01814072|100966716|FG010|NOT COMPLETED|Overall Study||1||
48263320|NCT01814072|100966717|FG011|NOT COMPLETED|Overall Study||2||
48263321|NCT01814072|100966718|FG012|NOT COMPLETED|Overall Study||3||
48263322|NCT01814072|100966719|FG013|NOT COMPLETED|Overall Study||2||
48263323|NCT01814072|100966720|FG014|NOT COMPLETED|Overall Study||3||
48263324|NCT01814072|100966721|FG015|NOT COMPLETED|Overall Study||2||
48263325|NCT01814072|100966722|FG016|NOT COMPLETED|Overall Study||3||
48263326|NCT01814072|100966723|FG017|NOT COMPLETED|Overall Study||1||
48263327|NCT01814072|100966724|FG018|NOT COMPLETED|Overall Study||3||
48546575|NCT00996892|101671459|FG010|COMPLETED|Dose-Escalation Stage 1B||0||
48546576|NCT00996892|101671460|FG011|COMPLETED|Dose-Escalation Stage 1B||0||
48546577|NCT00996892|101671461|FG012|COMPLETED|Dose-Escalation Stage 1B||0||
48546578|NCT00996892|101671462|FG013|COMPLETED|Dose-Escalation Stage 1B||0||
48546579|NCT00996892|101671463|FG014|COMPLETED|Dose-Escalation Stage 1B||0||
48546580|NCT00996892|101671464|FG015|COMPLETED|Dose-Escalation Stage 1B||0||
48546581|NCT00996892|101671465|FG016|COMPLETED|Dose-Escalation Stage 1B||0||
48546582|NCT00996892|101671466|FG017|COMPLETED|Dose-Escalation Stage 1B||0||
48546583|NCT00996892|101671467|FG018|COMPLETED|Dose-Escalation Stage 1B||0||
48546584|NCT00996892|101671468|FG019|COMPLETED|Dose-Escalation Stage 1B||0||
48546585|NCT00996892|101671449|FG000|NOT COMPLETED|Dose-Escalation Stage 1B||0||
48546586|NCT00996892|101671450|FG001|NOT COMPLETED|Dose-Escalation Stage 1B||0||
48546587|NCT00996892|101671451|FG002|NOT COMPLETED|Dose-Escalation Stage 1B||0||
48546588|NCT00996892|101671452|FG003|NOT COMPLETED|Dose-Escalation Stage 1B||0||
48546589|NCT00996892|101671453|FG004|NOT COMPLETED|Dose-Escalation Stage 1B||0||
48546590|NCT00996892|101671454|FG005|NOT COMPLETED|Dose-Escalation Stage 1B||0||
48546591|NCT00996892|101671455|FG006|NOT COMPLETED|Dose-Escalation Stage 1B||0||
48546592|NCT00996892|101671456|FG007|NOT COMPLETED|Dose-Escalation Stage 1B||0||
48546593|NCT00996892|101671457|FG008|NOT COMPLETED|Dose-Escalation Stage 1B||0||
48546594|NCT00996892|101671458|FG009|NOT COMPLETED|Dose-Escalation Stage 1B||0||
48546595|NCT00996892|101671459|FG010|NOT COMPLETED|Dose-Escalation Stage 1B||0||
48546596|NCT00996892|101671460|FG011|NOT COMPLETED|Dose-Escalation Stage 1B||0||
48546597|NCT00996892|101671461|FG012|NOT COMPLETED|Dose-Escalation Stage 1B||0||
48546598|NCT00996892|101671462|FG013|NOT COMPLETED|Dose-Escalation Stage 1B||0||
48546599|NCT00996892|101671463|FG014|NOT COMPLETED|Dose-Escalation Stage 1B||4||
48546600|NCT00996892|101671464|FG015|NOT COMPLETED|Dose-Escalation Stage 1B||3||
48546601|NCT00996892|101671465|FG016|NOT COMPLETED|Dose-Escalation Stage 1B||3||
48546602|NCT00996892|101671466|FG017|NOT COMPLETED|Dose-Escalation Stage 1B||5||
48546603|NCT00996892|101671467|FG018|NOT COMPLETED|Dose-Escalation Stage 1B||0||
48546604|NCT00996892|101671468|FG019|NOT COMPLETED|Dose-Escalation Stage 1B||0||
48546605|NCT00996892|101671449|FG000|STARTED|Expansion Stage 2||0||
48263328|NCT01814072|100966725|FG019|NOT COMPLETED|Overall Study||5||
48263329|NCT01814072|100966726|FG020|NOT COMPLETED|Overall Study||2||
48263330|NCT01814072|100966727|FG021|NOT COMPLETED|Overall Study||1||
48263331|NCT01814072|100966728|FG022|NOT COMPLETED|Overall Study||4||
48263332|NCT01814072|100966729|FG023|NOT COMPLETED|Overall Study||1||
48546606|NCT00996892|101671450|FG001|STARTED|Expansion Stage 2||0||
48546607|NCT00996892|101671451|FG002|STARTED|Expansion Stage 2||0||
48546608|NCT00996892|101671452|FG003|STARTED|Expansion Stage 2||0||
48546609|NCT00996892|101671453|FG004|STARTED|Expansion Stage 2||0||
48546610|NCT00996892|101671454|FG005|STARTED|Expansion Stage 2||0||
48263333|NCT01814072|100966730|FG024|NOT COMPLETED|Overall Study||6||
48263334|NCT01814072|100966731|FG025|NOT COMPLETED|Overall Study||2||
48546611|NCT00996892|101671455|FG006|STARTED|Expansion Stage 2||0||
48546612|NCT00996892|101671456|FG007|STARTED|Expansion Stage 2||0||
48546613|NCT00996892|101671457|FG008|STARTED|Expansion Stage 2||0||
48546614|NCT00996892|101671458|FG009|STARTED|Expansion Stage 2||0||
48546615|NCT00996892|101671459|FG010|STARTED|Expansion Stage 2||0||
48546616|NCT00996892|101671460|FG011|STARTED|Expansion Stage 2||0||
48546617|NCT00996892|101671461|FG012|STARTED|Expansion Stage 2||0||
48546618|NCT00996892|101671462|FG013|STARTED|Expansion Stage 2||0||
48546619|NCT00996892|101671463|FG014|STARTED|Expansion Stage 2||0||
48546620|NCT00996892|101671464|FG015|STARTED|Expansion Stage 2||0||
48546621|NCT00996892|101671465|FG016|STARTED|Expansion Stage 2||0||
48546622|NCT00996892|101671466|FG017|STARTED|Expansion Stage 2||0||
48546623|NCT00996892|101671467|FG018|STARTED|Expansion Stage 2||35||
48546624|NCT00996892|101671468|FG019|STARTED|Expansion Stage 2||0||
48546625|NCT00996892|101671449|FG000|COMPLETED|Expansion Stage 2||0||
48546626|NCT00996892|101671450|FG001|COMPLETED|Expansion Stage 2||0||
48546627|NCT00996892|101671451|FG002|COMPLETED|Expansion Stage 2||0||
48546628|NCT00996892|101671452|FG003|COMPLETED|Expansion Stage 2||0||
48546629|NCT00996892|101671453|FG004|COMPLETED|Expansion Stage 2||0||
48546630|NCT00996892|101671454|FG005|COMPLETED|Expansion Stage 2||0||
48546631|NCT00996892|101671455|FG006|COMPLETED|Expansion Stage 2||0||
48546632|NCT00996892|101671456|FG007|COMPLETED|Expansion Stage 2||0||
48546633|NCT00996892|101671457|FG008|COMPLETED|Expansion Stage 2||0||
48546634|NCT00996892|101671458|FG009|COMPLETED|Expansion Stage 2||0||
48546635|NCT00996892|101671459|FG010|COMPLETED|Expansion Stage 2||0||
48546636|NCT00996892|101671460|FG011|COMPLETED|Expansion Stage 2||0||
48546637|NCT00996892|101671461|FG012|COMPLETED|Expansion Stage 2||0||
48546638|NCT00996892|101671462|FG013|COMPLETED|Expansion Stage 2||0||
48546639|NCT00996892|101671463|FG014|COMPLETED|Expansion Stage 2||0||
48390574|NCT03627494|101283634|FG005|COMPLETED|Part A Period 1 (4 Days)||3|0|
48390575|NCT03627494|101283635|FG006|COMPLETED|Part A Period 1 (4 Days)||0|0|
48390576|NCT03627494|101283636|FG007|COMPLETED|Part A Period 1 (4 Days)||0|0|
48390577|NCT03627494|101283637|FG008|COMPLETED|Part A Period 1 (4 Days)||0|0|
48546640|NCT00996892|101671464|FG015|COMPLETED|Expansion Stage 2||0||
48546641|NCT00996892|101671465|FG016|COMPLETED|Expansion Stage 2||0||
48546642|NCT00996892|101671466|FG017|COMPLETED|Expansion Stage 2||0||
48546643|NCT00996892|101671467|FG018|COMPLETED|Expansion Stage 2||0||
48546644|NCT00996892|101671468|FG019|COMPLETED|Expansion Stage 2||0||
48546645|NCT00996892|101671449|FG000|NOT COMPLETED|Expansion Stage 2||0||
48546646|NCT00996892|101671450|FG001|NOT COMPLETED|Expansion Stage 2||0||
48546647|NCT00996892|101671451|FG002|NOT COMPLETED|Expansion Stage 2||0||
48546648|NCT00996892|101671452|FG003|NOT COMPLETED|Expansion Stage 2||0||
48546649|NCT00996892|101671453|FG004|NOT COMPLETED|Expansion Stage 2||0||
48546650|NCT00996892|101671454|FG005|NOT COMPLETED|Expansion Stage 2||0||
48546651|NCT00996892|101671455|FG006|NOT COMPLETED|Expansion Stage 2||0||
48546652|NCT00996892|101671456|FG007|NOT COMPLETED|Expansion Stage 2||0||
48546653|NCT00996892|101671457|FG008|NOT COMPLETED|Expansion Stage 2||0||
48546654|NCT00996892|101671458|FG009|NOT COMPLETED|Expansion Stage 2||0||
48546655|NCT00996892|101671459|FG010|NOT COMPLETED|Expansion Stage 2||0||
48546656|NCT00996892|101671460|FG011|NOT COMPLETED|Expansion Stage 2||0||
48546657|NCT00996892|101671461|FG012|NOT COMPLETED|Expansion Stage 2||0||
48546658|NCT00996892|101671462|FG013|NOT COMPLETED|Expansion Stage 2||0||
48546659|NCT00996892|101671463|FG014|NOT COMPLETED|Expansion Stage 2||0||
48546660|NCT00996892|101671464|FG015|NOT COMPLETED|Expansion Stage 2||0||
48546661|NCT00996892|101671465|FG016|NOT COMPLETED|Expansion Stage 2||0||
48690729|NCT03885154|102025906|FG003|COMPLETED|Overall Study||2||
48690730|NCT03885154|102025903|FG000|NOT COMPLETED|Overall Study||0||
48690731|NCT03885154|102025904|FG001|NOT COMPLETED|Overall Study||0||
48690732|NCT03885154|102025905|FG002|NOT COMPLETED|Overall Study||0||
48099631|NCT03756688|100568288|FG003|STARTED|Overall Study||27||
48546662|NCT00996892|101671466|FG017|NOT COMPLETED|Expansion Stage 2||0||
48546663|NCT00996892|101671467|FG018|NOT COMPLETED|Expansion Stage 2||35||
48546664|NCT00996892|101671468|FG019|NOT COMPLETED|Expansion Stage 2||0||
48099632|NCT03756688|100568285|FG000|COMPLETED|Overall Study||26||
48099633|NCT03756688|100568286|FG001|COMPLETED|Overall Study||17||
48099634|NCT03756688|100568287|FG002|COMPLETED|Overall Study||19||
48099635|NCT03756688|100568288|FG003|COMPLETED|Overall Study||24||
48390578|NCT03627494|101283638|FG009|COMPLETED|Part A Period 1 (4 Days)||0|0|
48546665|NCT00996892|101671449|FG000|STARTED|Expansion Stage 2A||0||
48546666|NCT00996892|101671450|FG001|STARTED|Expansion Stage 2A||0||
48546667|NCT00996892|101671451|FG002|STARTED|Expansion Stage 2A||0||
48690733|NCT03885154|102025906|FG003|NOT COMPLETED|Overall Study||0||
48099636|NCT03756688|100568285|FG000|NOT COMPLETED|Overall Study||2||
48546668|NCT00996892|101671452|FG003|STARTED|Expansion Stage 2A||0||
48546669|NCT00996892|101671453|FG004|STARTED|Expansion Stage 2A||0||
48546670|NCT00996892|101671454|FG005|STARTED|Expansion Stage 2A||0||
48546671|NCT00996892|101671455|FG006|STARTED|Expansion Stage 2A||0||
48546672|NCT00996892|101671456|FG007|STARTED|Expansion Stage 2A||0||
48546673|NCT00996892|101671457|FG008|STARTED|Expansion Stage 2A||0||
48546674|NCT00996892|101671458|FG009|STARTED|Expansion Stage 2A||0||
48546675|NCT00996892|101671459|FG010|STARTED|Expansion Stage 2A||0||
48546676|NCT00996892|101671460|FG011|STARTED|Expansion Stage 2A||0||
48099637|NCT03756688|100568286|FG001|NOT COMPLETED|Overall Study||11||
48099638|NCT03756688|100568287|FG002|NOT COMPLETED|Overall Study||8||
48099639|NCT03756688|100568288|FG003|NOT COMPLETED|Overall Study||3||
48099640|NCT01457885|100568289|FG000|STARTED|Overall Study||74||
48546677|NCT00996892|101671461|FG012|STARTED|Expansion Stage 2A||0||
48546678|NCT00996892|101671462|FG013|STARTED|Expansion Stage 2A||0||
48546679|NCT00996892|101671463|FG014|STARTED|Expansion Stage 2A||0||
48546680|NCT00996892|101671464|FG015|STARTED|Expansion Stage 2A||0||
48546681|NCT00996892|101671465|FG016|STARTED|Expansion Stage 2A||0||
48546682|NCT00996892|101671466|FG017|STARTED|Expansion Stage 2A||0||
48546683|NCT00996892|101671467|FG018|STARTED|Expansion Stage 2A||0||
48546684|NCT00996892|101671468|FG019|STARTED|Expansion Stage 2A||45||
48546685|NCT00996892|101671449|FG000|COMPLETED|Expansion Stage 2A||0||
48546686|NCT00996892|101671450|FG001|COMPLETED|Expansion Stage 2A||0||
48546687|NCT00996892|101671451|FG002|COMPLETED|Expansion Stage 2A||0||
48546688|NCT00996892|101671452|FG003|COMPLETED|Expansion Stage 2A||0||
48546689|NCT00996892|101671453|FG004|COMPLETED|Expansion Stage 2A||0||
48546690|NCT00996892|101671454|FG005|COMPLETED|Expansion Stage 2A||0||
48546691|NCT00996892|101671455|FG006|COMPLETED|Expansion Stage 2A||0||
48546692|NCT00996892|101671456|FG007|COMPLETED|Expansion Stage 2A||0||
48390579|NCT03627494|101283639|FG010|COMPLETED|Part A Period 1 (4 Days)||0|0|
48390580|NCT03627494|101283640|FG011|COMPLETED|Part A Period 1 (4 Days)||0|0|
48390581|NCT03627494|101283629|FG000|NOT COMPLETED|Part A Period 1 (4 Days)||0||
48390582|NCT03627494|101283630|FG001|NOT COMPLETED|Part A Period 1 (4 Days)||0||
48390583|NCT03627494|101283631|FG002|NOT COMPLETED|Part A Period 1 (4 Days)||0||
48390584|NCT03627494|101283632|FG003|NOT COMPLETED|Part A Period 1 (4 Days)||0||
48390585|NCT03627494|101283633|FG004|NOT COMPLETED|Part A Period 1 (4 Days)||0||
48390586|NCT03627494|101283634|FG005|NOT COMPLETED|Part A Period 1 (4 Days)||0||
48546693|NCT00996892|101671457|FG008|COMPLETED|Expansion Stage 2A||0||
48546694|NCT00996892|101671458|FG009|COMPLETED|Expansion Stage 2A||0||
48546695|NCT00996892|101671459|FG010|COMPLETED|Expansion Stage 2A||0||
48546696|NCT00996892|101671460|FG011|COMPLETED|Expansion Stage 2A||0||
48546697|NCT00996892|101671461|FG012|COMPLETED|Expansion Stage 2A||0||
48546698|NCT00996892|101671462|FG013|COMPLETED|Expansion Stage 2A||0||
48546699|NCT00996892|101671463|FG014|COMPLETED|Expansion Stage 2A||0||
48546700|NCT00996892|101671464|FG015|COMPLETED|Expansion Stage 2A||0||
48546701|NCT00996892|101671465|FG016|COMPLETED|Expansion Stage 2A||0||
48546702|NCT00996892|101671466|FG017|COMPLETED|Expansion Stage 2A||0||
48546703|NCT00996892|101671467|FG018|COMPLETED|Expansion Stage 2A||0||
48546704|NCT00996892|101671468|FG019|COMPLETED|Expansion Stage 2A||0||
48546705|NCT00996892|101671449|FG000|NOT COMPLETED|Expansion Stage 2A||0||
48546706|NCT00996892|101671450|FG001|NOT COMPLETED|Expansion Stage 2A||0||
48546707|NCT00996892|101671451|FG002|NOT COMPLETED|Expansion Stage 2A||0||
48546708|NCT00996892|101671452|FG003|NOT COMPLETED|Expansion Stage 2A||0||
48546709|NCT00996892|101671453|FG004|NOT COMPLETED|Expansion Stage 2A||0||
48546710|NCT00996892|101671454|FG005|NOT COMPLETED|Expansion Stage 2A||0||
48546711|NCT00996892|101671455|FG006|NOT COMPLETED|Expansion Stage 2A||0||
48546712|NCT00996892|101671456|FG007|NOT COMPLETED|Expansion Stage 2A||0||
48546713|NCT00996892|101671457|FG008|NOT COMPLETED|Expansion Stage 2A||0||
48546714|NCT00996892|101671458|FG009|NOT COMPLETED|Expansion Stage 2A||0||
48546715|NCT00996892|101671459|FG010|NOT COMPLETED|Expansion Stage 2A||0||
48546716|NCT00996892|101671460|FG011|NOT COMPLETED|Expansion Stage 2A||0||
48099641|NCT01457885|100568289|FG000|COMPLETED|Overall Study||74||
48390587|NCT03627494|101283635|FG006|NOT COMPLETED|Part A Period 1 (4 Days)||0||
48546717|NCT00996892|101671461|FG012|NOT COMPLETED|Expansion Stage 2A||0||
48546718|NCT00996892|101671462|FG013|NOT COMPLETED|Expansion Stage 2A||0||
48546719|NCT00996892|101671463|FG014|NOT COMPLETED|Expansion Stage 2A||0||
48546720|NCT00996892|101671464|FG015|NOT COMPLETED|Expansion Stage 2A||0||
48546721|NCT00996892|101671465|FG016|NOT COMPLETED|Expansion Stage 2A||0||
48546722|NCT00996892|101671466|FG017|NOT COMPLETED|Expansion Stage 2A||0||
48546723|NCT00996892|101671467|FG018|NOT COMPLETED|Expansion Stage 2A||0||
48546724|NCT00996892|101671468|FG019|NOT COMPLETED|Expansion Stage 2A||45||
48546725|NCT01611779|101671469|FG000|STARTED|Overall Study||5||
48546726|NCT01611779|101671469|FG000|COMPLETED|Overall Study||5||
48546727|NCT01611779|101671469|FG000|NOT COMPLETED|Overall Study||0||
48546728|NCT04414345|101671470|FG000|STARTED|Overall Study||120||
48546729|NCT04414345|101671471|FG001|STARTED|Overall Study||41||
48546730|NCT04414345|101671470|FG000|COMPLETED|Overall Study||110||
48546731|NCT04414345|101671471|FG001|COMPLETED|Overall Study||35||
48546732|NCT04414345|101671470|FG000|NOT COMPLETED|Overall Study||10||
48546733|NCT04414345|101671471|FG001|NOT COMPLETED|Overall Study||6||
48546734|NCT04003896|101671472|FG000|STARTED|Overall Study||4||
48099642|NCT01457885|100568289|FG000|NOT COMPLETED|Overall Study||0||
48099643|NCT02290509|100568290|FG000|STARTED|Overall Study||1011||
48390588|NCT03627494|101283636|FG007|NOT COMPLETED|Part A Period 1 (4 Days)||0||
48390589|NCT03627494|101283637|FG008|NOT COMPLETED|Part A Period 1 (4 Days)||0||
48546735|NCT04003896|101671472|FG000|COMPLETED|Overall Study||0||
48546736|NCT04003896|101671472|FG000|NOT COMPLETED|Overall Study||4||
48546737|NCT03010683|101671473|FG000|STARTED|Overall Study||30||
48546738|NCT03010683|101671474|FG001|STARTED|Overall Study||30||
48546739|NCT03010683|101671473|FG000|COMPLETED|Overall Study||30||
48546740|NCT03010683|101671474|FG001|COMPLETED|Overall Study||30||
48546741|NCT03010683|101671473|FG000|NOT COMPLETED|Overall Study||0||
48546742|NCT03010683|101671474|FG001|NOT COMPLETED|Overall Study||0||
48546743|NCT04909229|101671475|FG000|STARTED|Overall Study||50||
48546744|NCT04909229|101671476|FG001|STARTED|Overall Study||50||
48546745|NCT04909229|101671475|FG000|COMPLETED|Overall Study||47||
48546746|NCT04909229|101671476|FG001|COMPLETED|Overall Study||49||
48546747|NCT04909229|101671475|FG000|NOT COMPLETED|Overall Study||3||
48546748|NCT04909229|101671476|FG001|NOT COMPLETED|Overall Study||1||
48546749|NCT04196140|101671477|FG000|STARTED|Phase 2||240||
48546750|NCT04196140|101671477|FG000|COMPLETED|Phase 2||235||
48546751|NCT04196140|101671477|FG000|NOT COMPLETED|Phase 2||5||
48546752|NCT04196140|101671477|FG000|STARTED|Phase 3||224||
48546753|NCT04196140|101671477|FG000|COMPLETED|Phase 3||208||
48546754|NCT04196140|101671477|FG000|NOT COMPLETED|Phase 3||16||
48546755|NCT01715571|101671478|FG000|STARTED|Overall Study||11||
48546756|NCT01715571|101671478|FG000|COMPLETED|Overall Study||3||
48546757|NCT01715571|101671478|FG000|NOT COMPLETED|Overall Study||8||
48546758|NCT01184079|101671479|FG000|STARTED|Overall Study||111||
48546759|NCT01184079|101671480|FG001|STARTED|Overall Study||109||
48546760|NCT01184079|101671479|FG000|Dose 2|Overall Study||110||
48546761|NCT01184079|101671480|FG001|Dose 2|Overall Study||108||
48546762|NCT01184079|101671479|FG000|Dose 3|Overall Study||101||
48546763|NCT01184079|101671480|FG001|Dose 3|Overall Study||107||
48690734|NCT02229825|102025907|FG000|STARTED|Overall Study||167||
48690735|NCT02229825|102025908|FG001|STARTED|Overall Study||172||
48690736|NCT02229825|102025907|FG000|Treated|Overall Study||167||
48546764|NCT01184079|101671479|FG000|Final Blood Draw|Overall Study||97||
48546765|NCT01184079|101671480|FG001|Final Blood Draw|Overall Study||107||
48546766|NCT01184079|101671479|FG000|COMPLETED|Overall Study||97||
48546767|NCT01184079|101671480|FG001|COMPLETED|Overall Study||107||
48690737|NCT02229825|102025908|FG001|Treated|Overall Study||171||
48690738|NCT02229825|102025907|FG000|COMPLETED|Overall Study||143||
48690739|NCT02229825|102025908|FG001|COMPLETED|Overall Study||142||
48690740|NCT02229825|102025907|FG000|NOT COMPLETED|Overall Study||24||
48690741|NCT02229825|102025908|FG001|NOT COMPLETED|Overall Study||30||
48690742|NCT02595866|102025909|FG000|STARTED|Overall Study||34||
48690743|NCT02595866|102025910|FG001|STARTED|Overall Study||24||
48690744|NCT02595866|102025909|FG000|COMPLETED|Overall Study||2|Participants who completed 2 years or 35 cycles of study treatment.|
48690745|NCT02595866|102025910|FG001|COMPLETED|Overall Study||2|Participants who completed 2 years or 35 cycles of study treatment.|
48099644|NCT02290509|100568291|FG001|STARTED|Overall Study||339||
48099645|NCT02290509|100568290|FG000|COMPLETED|Overall Study||962||
48099646|NCT02290509|100568291|FG001|COMPLETED|Overall Study||325||
48099647|NCT02290509|100568290|FG000|NOT COMPLETED|Overall Study||49||
48099648|NCT02290509|100568291|FG001|NOT COMPLETED|Overall Study||14||
48099649|NCT01199744|100568292|FG000|STARTED|Overall Study||1575||
48099650|NCT01199744|100568292|FG000|COMPLETED|Overall Study||1575||
48099651|NCT01199744|100568292|FG000|NOT COMPLETED|Overall Study||0||
48099652|NCT00877877|100568293|FG000|STARTED|Year 5||397||
48099653|NCT00877877|100568293|FG000|COMPLETED|Year 5||397||
48099654|NCT00877877|100568293|FG000|NOT COMPLETED|Year 5||0||
48546768|NCT01184079|101671479|FG000|NOT COMPLETED|Overall Study||14||
48546769|NCT01184079|101671480|FG001|NOT COMPLETED|Overall Study||2||
48546770|NCT03106987|101671481|FG000|STARTED|Overall Study||74||
48546771|NCT03106987|101671482|FG001|STARTED|Overall Study||38||
48546772|NCT03106987|101671483|FG002|STARTED|Overall Study||72||
48546773|NCT03106987|101671484|FG003|STARTED|Overall Study||36||
48546774|NCT03106987|101671481|FG000|COMPLETED|Overall Study||30||
48546775|NCT03106987|101671482|FG001|COMPLETED|Overall Study||15||
48546776|NCT03106987|101671483|FG002|COMPLETED|Overall Study||54||
48546777|NCT03106987|101671484|FG003|COMPLETED|Overall Study||25||
48546778|NCT03106987|101671481|FG000|NOT COMPLETED|Overall Study||44||
48546779|NCT03106987|101671482|FG001|NOT COMPLETED|Overall Study||23||
48546780|NCT03106987|101671483|FG002|NOT COMPLETED|Overall Study||18||
48546781|NCT03106987|101671484|FG003|NOT COMPLETED|Overall Study||11||
48546782|NCT04482387|101671485|FG000|STARTED|Overall Study||120||120
48546783|NCT04482387|101671485|FG000|COMPLETED|Overall Study||120||120
48546784|NCT04482387|101671485|FG000|NOT COMPLETED|Overall Study||0||0
48546785|NCT01333397|101671486|FG000|STARTED|Overall Study||35||
48546786|NCT01333397|101671487|FG001|STARTED|Overall Study||36||
48546787|NCT01333397|101671488|FG002|STARTED|Overall Study||35||
48546788|NCT01333397|101671489|FG003|STARTED|Overall Study||35||
48546789|NCT01333397|101671490|FG004|STARTED|Overall Study||35||
48546790|NCT01333397|101671486|FG000|COMPLETED|Overall Study||34||
48099655|NCT00877877|100568293|FG000|STARTED|Year 6||529||
48099656|NCT00877877|100568293|FG000|COMPLETED|Year 6||529||
48546791|NCT01333397|101671487|FG001|COMPLETED|Overall Study||36||
48546792|NCT01333397|101671488|FG002|COMPLETED|Overall Study||35||
48546793|NCT01333397|101671489|FG003|COMPLETED|Overall Study||34||
48690746|NCT02595866|102025909|FG000|NOT COMPLETED|Overall Study||32||
48546794|NCT01333397|101671490|FG004|COMPLETED|Overall Study||35||
48546795|NCT01333397|101671486|FG000|NOT COMPLETED|Overall Study||1||
48690747|NCT02595866|102025910|FG001|NOT COMPLETED|Overall Study||22||
48263335|NCT01814072|100966732|FG026|NOT COMPLETED|Overall Study||2||
48263336|NCT01814072|100966733|FG027|NOT COMPLETED|Overall Study||4||
48263337|NCT01814072|100966734|FG028|NOT COMPLETED|Overall Study||4||
48263338|NCT01814072|100966735|FG029|NOT COMPLETED|Overall Study||3||
48263339|NCT01814072|100966736|FG030|NOT COMPLETED|Overall Study||2||
48263340|NCT01814072|100966737|FG031|NOT COMPLETED|Overall Study||0||
48263341|NCT04530604|100966738|FG000|STARTED|Overall Study||12||
48263342|NCT04530604|100966738|FG000|Completed Dosing|Overall Study||10|"One participant discontinued defibrotide early when a pre-therapy blood culture became positive for potential pathogen while the participant was on study therapy. The patient discontinued study at that time but was still evaluable for toxicity and response.~Another stopped defibrotide when endotracheal aspirate grew oral flora and H. influenza."|
48690748|NCT02201329|102025911|FG000|STARTED|Overall Study||5||
48690749|NCT02201329|102025911|FG000|COMPLETED|Overall Study||0||
48690750|NCT02201329|102025911|FG000|NOT COMPLETED|Overall Study||5||
48263343|NCT04530604|100966738|FG000|COMPLETED|Overall Study||12||
48263344|NCT04530604|100966738|FG000|NOT COMPLETED|Overall Study||0||
48263345|NCT00825305|100966739|FG000|STARTED|Overall Study||550||
48263346|NCT00825305|100966740|FG001|STARTED|Overall Study||275||
48263347|NCT00825305|100966739|FG000|COMPLETED|Overall Study||533||
48263348|NCT00825305|100966740|FG001|COMPLETED|Overall Study||252||
48263349|NCT00825305|100966739|FG000|NOT COMPLETED|Overall Study||17||
48263350|NCT00825305|100966740|FG001|NOT COMPLETED|Overall Study||23||
48263351|NCT02242643|100966741|FG000|STARTED|Overall Study||1207||
48390590|NCT03627494|101283638|FG009|NOT COMPLETED|Part A Period 1 (4 Days)||0||
48390591|NCT03627494|101283639|FG010|NOT COMPLETED|Part A Period 1 (4 Days)||0||
48390592|NCT03627494|101283640|FG011|NOT COMPLETED|Part A Period 1 (4 Days)||0||
48390593|NCT03627494|101283629|FG000|STARTED|Part A Washout 1 (7 Days)||3||
48390594|NCT03627494|101283630|FG001|STARTED|Part A Washout 1 (7 Days)||3||
48390595|NCT03627494|101283631|FG002|STARTED|Part A Washout 1 (7 Days)||3||
48390596|NCT03627494|101283632|FG003|STARTED|Part A Washout 1 (7 Days)||3||
48546796|NCT01333397|101671487|FG001|NOT COMPLETED|Overall Study||0||
48546797|NCT01333397|101671488|FG002|NOT COMPLETED|Overall Study||0||
48546798|NCT01333397|101671489|FG003|NOT COMPLETED|Overall Study||1||
48546799|NCT01333397|101671490|FG004|NOT COMPLETED|Overall Study||0||
48546800|NCT02800642|101671491|FG000|STARTED|Overall Study||162||
48690751|NCT03930771|102025912|FG000|STARTED|Overall Study||1||
48263352|NCT02242643|100966742|FG001|STARTED|Overall Study||1217||
48263353|NCT02242643|100966741|FG000|COMPLETED|Overall Study||1132||
48390597|NCT03627494|101283633|FG004|STARTED|Part A Washout 1 (7 Days)||3||
48546801|NCT02800642|101671491|FG000|COMPLETED|Overall Study||137||
48546802|NCT02800642|101671491|FG000|NOT COMPLETED|Overall Study||25||
48546803|NCT02774642|101671492|FG000|STARTED|Overall Study||52||
48546804|NCT02774642|101671493|FG001|STARTED|Overall Study||42||
48690752|NCT03930771|102025912|FG000|COMPLETED|Overall Study||1||
48263354|NCT02242643|100966742|FG001|COMPLETED|Overall Study||1139||
48263355|NCT02242643|100966741|FG000|NOT COMPLETED|Overall Study||75||
48263356|NCT02242643|100966742|FG001|NOT COMPLETED|Overall Study||78||
48263357|NCT02335905|100966743|FG000|STARTED|Overall Study||11||
48263358|NCT02335905|100966743|FG000|COMPLETED|Overall Study||7||
48263359|NCT02335905|100966743|FG000|NOT COMPLETED|Overall Study||4||
48390598|NCT03627494|101283634|FG005|STARTED|Part A Washout 1 (7 Days)||3||
48390599|NCT03627494|101283635|FG006|STARTED|Part A Washout 1 (7 Days)||0||
48390600|NCT03627494|101283636|FG007|STARTED|Part A Washout 1 (7 Days)||0||
48390601|NCT03627494|101283637|FG008|STARTED|Part A Washout 1 (7 Days)||0||
48390602|NCT03627494|101283638|FG009|STARTED|Part A Washout 1 (7 Days)||0||
48390603|NCT03627494|101283639|FG010|STARTED|Part A Washout 1 (7 Days)||0||
48390604|NCT03627494|101283640|FG011|STARTED|Part A Washout 1 (7 Days)||0||
48390605|NCT03627494|101283629|FG000|COMPLETED|Part A Washout 1 (7 Days)||3||
48390606|NCT03627494|101283630|FG001|COMPLETED|Part A Washout 1 (7 Days)||3||
48390607|NCT03627494|101283631|FG002|COMPLETED|Part A Washout 1 (7 Days)||3||
48390608|NCT03627494|101283632|FG003|COMPLETED|Part A Washout 1 (7 Days)||3||
48390609|NCT03627494|101283633|FG004|COMPLETED|Part A Washout 1 (7 Days)||3||
48390610|NCT03627494|101283634|FG005|COMPLETED|Part A Washout 1 (7 Days)||3||
48390611|NCT03627494|101283635|FG006|COMPLETED|Part A Washout 1 (7 Days)||0||
48390612|NCT03627494|101283636|FG007|COMPLETED|Part A Washout 1 (7 Days)||0||
48390613|NCT03627494|101283637|FG008|COMPLETED|Part A Washout 1 (7 Days)||0||
48390614|NCT03627494|101283638|FG009|COMPLETED|Part A Washout 1 (7 Days)||0||
48390615|NCT03627494|101283639|FG010|COMPLETED|Part A Washout 1 (7 Days)||0||
48390616|NCT03627494|101283640|FG011|COMPLETED|Part A Washout 1 (7 Days)||0||
48390617|NCT03627494|101283629|FG000|NOT COMPLETED|Part A Washout 1 (7 Days)||0||
48390618|NCT03627494|101283630|FG001|NOT COMPLETED|Part A Washout 1 (7 Days)||0||
48390619|NCT03627494|101283631|FG002|NOT COMPLETED|Part A Washout 1 (7 Days)||0||
48390620|NCT03627494|101283632|FG003|NOT COMPLETED|Part A Washout 1 (7 Days)||0||
48690753|NCT03930771|102025912|FG000|NOT COMPLETED|Overall Study||0||
48690754|NCT05331053|102025913|FG000|STARTED|Overall Study||6||
48390621|NCT03627494|101283633|FG004|NOT COMPLETED|Part A Washout 1 (7 Days)||0||
48390622|NCT03627494|101283634|FG005|NOT COMPLETED|Part A Washout 1 (7 Days)||0||
48546805|NCT02774642|101671492|FG000|COMPLETED|Overall Study||43||
48546806|NCT02774642|101671493|FG001|COMPLETED|Overall Study||35||
48546807|NCT02774642|101671492|FG000|NOT COMPLETED|Overall Study||9||
48546808|NCT02774642|101671493|FG001|NOT COMPLETED|Overall Study||7||
48546809|NCT02461160|101671494|FG000|STARTED|Overall Study||8||
48546810|NCT02461160|101671495|FG001|STARTED|Overall Study||6||
48546811|NCT02461160|101671496|FG002|STARTED|Overall Study||6||
48263360|NCT00356759|100966744|FG000|STARTED|Overall Study||126||
48263361|NCT00356759|100966745|FG001|STARTED|Overall Study||124||
48263362|NCT00356759|100966744|FG000|COMPLETED|Overall Study||112||
48263363|NCT00356759|100966745|FG001|COMPLETED|Overall Study||114||
48263364|NCT00356759|100966744|FG000|NOT COMPLETED|Overall Study||14||
48263365|NCT00356759|100966745|FG001|NOT COMPLETED|Overall Study||10||
48263366|NCT02106195|100966746|FG000|STARTED|Overall Study||8||
48263367|NCT02106195|100966746|FG000|COMPLETED|Overall Study||5||
48546812|NCT02461160|101671497|FG003|STARTED|Overall Study||12||
48546813|NCT02461160|101671498|FG004|STARTED|Overall Study||6||
48546814|NCT02461160|101671499|FG005|STARTED|Overall Study||6||
48546815|NCT02461160|101671500|FG006|STARTED|Overall Study||6||
48546816|NCT02461160|101671501|FG007|STARTED|Overall Study||6||
48546817|NCT02461160|101671502|FG008|STARTED|Overall Study||12||
48546818|NCT02461160|101671503|FG009|STARTED|Overall Study||4||
48546819|NCT02461160|101671504|FG010|STARTED|Overall Study||4||
48546820|NCT02461160|101671505|FG011|STARTED|Overall Study||4||
48546821|NCT02461160|101671506|FG012|STARTED|Overall Study||8||
48546822|NCT02461160|101671494|FG000|COMPLETED|Overall Study||8||
48546823|NCT02461160|101671495|FG001|COMPLETED|Overall Study||6||
48546824|NCT02461160|101671496|FG002|COMPLETED|Overall Study||6||
48546825|NCT02461160|101671497|FG003|COMPLETED|Overall Study||12||
48546826|NCT02461160|101671498|FG004|COMPLETED|Overall Study||6||
48546827|NCT02461160|101671499|FG005|COMPLETED|Overall Study||6||
48546828|NCT02461160|101671500|FG006|COMPLETED|Overall Study||6||
48263368|NCT02106195|100966746|FG000|NOT COMPLETED|Overall Study||3||
48546829|NCT02461160|101671501|FG007|COMPLETED|Overall Study||5||
48546830|NCT02461160|101671502|FG008|COMPLETED|Overall Study||12||
48546831|NCT02461160|101671503|FG009|COMPLETED|Overall Study||4||
48546832|NCT02461160|101671504|FG010|COMPLETED|Overall Study||4||
48546833|NCT02461160|101671505|FG011|COMPLETED|Overall Study||4||
48546834|NCT02461160|101671506|FG012|COMPLETED|Overall Study||8||
48546835|NCT02461160|101671494|FG000|NOT COMPLETED|Overall Study||0||
48546836|NCT02461160|101671495|FG001|NOT COMPLETED|Overall Study||0||
48546837|NCT02461160|101671496|FG002|NOT COMPLETED|Overall Study||0||
48546838|NCT02461160|101671497|FG003|NOT COMPLETED|Overall Study||0||
48546839|NCT02461160|101671498|FG004|NOT COMPLETED|Overall Study||0||
48546840|NCT02461160|101671499|FG005|NOT COMPLETED|Overall Study||0||
48546841|NCT02461160|101671500|FG006|NOT COMPLETED|Overall Study||0||
48546842|NCT02461160|101671501|FG007|NOT COMPLETED|Overall Study||1||
48546843|NCT02461160|101671502|FG008|NOT COMPLETED|Overall Study||0||
48546844|NCT02461160|101671503|FG009|NOT COMPLETED|Overall Study||0||
48546845|NCT02461160|101671504|FG010|NOT COMPLETED|Overall Study||0||
48546846|NCT02461160|101671505|FG011|NOT COMPLETED|Overall Study||0||
48546847|NCT02461160|101671506|FG012|NOT COMPLETED|Overall Study||0||
48546848|NCT01038297|101671507|FG000|STARTED|Part A: Skin Testing Phase (50 Days)||10||
48546849|NCT01038297|101671508|FG001|STARTED|Part A: Skin Testing Phase (50 Days)||10||
48546850|NCT01038297|101671509|FG002|STARTED|Part A: Skin Testing Phase (50 Days)||10||
48546851|NCT01038297|101671507|FG000|COMPLETED|Part A: Skin Testing Phase (50 Days)||9||
48546852|NCT01038297|101671508|FG001|COMPLETED|Part A: Skin Testing Phase (50 Days)||10||
48546853|NCT01038297|101671509|FG002|COMPLETED|Part A: Skin Testing Phase (50 Days)||10||
48546854|NCT01038297|101671507|FG000|NOT COMPLETED|Part A: Skin Testing Phase (50 Days)||1||
48546855|NCT01038297|101671508|FG001|NOT COMPLETED|Part A: Skin Testing Phase (50 Days)||0||
48546856|NCT01038297|101671509|FG002|NOT COMPLETED|Part A: Skin Testing Phase (50 Days)||0||
48546857|NCT01038297|101671507|FG000|STARTED|Part B: Active Dosing Phase (13 Weeks)||9||
48546858|NCT01038297|101671508|FG001|STARTED|Part B: Active Dosing Phase (13 Weeks)||10||
48546859|NCT01038297|101671509|FG002|STARTED|Part B: Active Dosing Phase (13 Weeks)||10||
48546860|NCT01038297|101671507|FG000|COMPLETED|Part B: Active Dosing Phase (13 Weeks)||9||
48546861|NCT01038297|101671508|FG001|COMPLETED|Part B: Active Dosing Phase (13 Weeks)||10||
48546862|NCT01038297|101671509|FG002|COMPLETED|Part B: Active Dosing Phase (13 Weeks)||10||
48263369|NCT03054337|100966747|FG000|STARTED|Primary Efficacy Period (6 Weeks)||12||
48263370|NCT03054337|100966748|FG001|STARTED|Primary Efficacy Period (6 Weeks)||12||
48263371|NCT03054337|100966749|FG002|STARTED|Primary Efficacy Period (6 Weeks)||13||
48263372|NCT03054337|100966750|FG003|STARTED|Primary Efficacy Period (6 Weeks)||5||
48263373|NCT03054337|100966751|FG004|STARTED|Primary Efficacy Period (6 Weeks)||4||
48263374|NCT03054337|100966752|FG005|STARTED|Primary Efficacy Period (6 Weeks)||5||
48263375|NCT03054337|100966747|FG000|COMPLETED|Primary Efficacy Period (6 Weeks)||12||
48263376|NCT03054337|100966748|FG001|COMPLETED|Primary Efficacy Period (6 Weeks)||12||
48546863|NCT01038297|101671507|FG000|NOT COMPLETED|Part B: Active Dosing Phase (13 Weeks)||0||
48546864|NCT01038297|101671508|FG001|NOT COMPLETED|Part B: Active Dosing Phase (13 Weeks)||0||
48546865|NCT01038297|101671509|FG002|NOT COMPLETED|Part B: Active Dosing Phase (13 Weeks)||0||
48546866|NCT02859142|101671510|FG000|STARTED|Overall Study||61||
48546867|NCT02859142|101671511|FG001|STARTED|Overall Study||61||
48546868|NCT02859142|101671510|FG000|COMPLETED|Overall Study||57|Completed indicates the number of participants completing the study, including those who discontinued medication but opted to remain in the study.|
48690755|NCT05331053|102025913|FG000|COMPLETED|Overall Study||6||
48099657|NCT00877877|100568293|FG000|NOT COMPLETED|Year 6||0||
48099658|NCT00877877|100568293|FG000|STARTED|Year 7||523||
48099659|NCT00877877|100568293|FG000|COMPLETED|Year 7||523||
48263377|NCT03054337|100966749|FG002|COMPLETED|Primary Efficacy Period (6 Weeks)||13||
48263378|NCT03054337|100966750|FG003|COMPLETED|Primary Efficacy Period (6 Weeks)||5||
48263379|NCT03054337|100966751|FG004|COMPLETED|Primary Efficacy Period (6 Weeks)||4||
48099660|NCT00877877|100568293|FG000|NOT COMPLETED|Year 7||0||
48099661|NCT00877877|100568293|FG000|STARTED|Year 8||522||
48099662|NCT00877877|100568293|FG000|COMPLETED|Year 8||522||
48099663|NCT00877877|100568293|FG000|NOT COMPLETED|Year 8||0||
48099664|NCT00877877|100568293|FG000|STARTED|Year 9||507||
48099665|NCT00877877|100568293|FG000|COMPLETED|Year 9||507||
48099666|NCT00877877|100568293|FG000|NOT COMPLETED|Year 9||0||
48099667|NCT00877877|100568293|FG000|STARTED|Year 10||495||
48099668|NCT00877877|100568293|FG000|COMPLETED|Year 10||495||
48099669|NCT00877877|100568293|FG000|NOT COMPLETED|Year 10||0||
48099670|NCT02461225|100568294|FG000|STARTED|Overall Study||19||
48099671|NCT02461225|100568295|FG001|STARTED|Overall Study||11||
48099672|NCT02461225|100568294|FG000|COMPLETED|Overall Study||19||
48099673|NCT02461225|100568295|FG001|COMPLETED|Overall Study||11||
48099674|NCT02461225|100568294|FG000|NOT COMPLETED|Overall Study||0||
48099675|NCT02461225|100568295|FG001|NOT COMPLETED|Overall Study||0||
48099676|NCT00536107|100568296|FG000|STARTED|Overall Study||8||
48099677|NCT00536107|100568297|FG001|STARTED|Overall Study||6||
48099678|NCT00536107|100568296|FG000|COMPLETED|Overall Study||0||
48099679|NCT00536107|100568297|FG001|COMPLETED|Overall Study||0||
48099680|NCT00536107|100568296|FG000|NOT COMPLETED|Overall Study||8||
48099681|NCT00536107|100568297|FG001|NOT COMPLETED|Overall Study||6||
48099682|NCT00464568|100568298|FG000|STARTED|Overall Study||32||
48099683|NCT00464568|100568298|FG000|COMPLETED|Overall Study||30||
48099684|NCT00464568|100568298|FG000|NOT COMPLETED|Overall Study||2||
48099685|NCT02255500|100568299|FG000|STARTED|Overall Study||16||
48099686|NCT02255500|100568300|FG001|STARTED|Overall Study||7||
48099687|NCT02255500|100568299|FG000|COMPLETED|Overall Study||15||
48099688|NCT02255500|100568300|FG001|COMPLETED|Overall Study||7||
48099689|NCT02255500|100568299|FG000|NOT COMPLETED|Overall Study||1||
48099690|NCT02255500|100568300|FG001|NOT COMPLETED|Overall Study||0||
48099691|NCT03204305|100568301|FG000|STARTED|Overall Study||21||
48099692|NCT03204305|100568302|FG001|STARTED|Overall Study||7||
48099693|NCT03204305|100568303|FG002|STARTED|Overall Study||8||
48099694|NCT03204305|100568304|FG003|STARTED|Overall Study||7||
48099695|NCT03204305|100568301|FG000|COMPLETED|Overall Study||10||
48099696|NCT03204305|100568302|FG001|COMPLETED|Overall Study||2||
48099697|NCT03204305|100568303|FG002|COMPLETED|Overall Study||8||
48099698|NCT03204305|100568304|FG003|COMPLETED|Overall Study||7||
48099699|NCT03204305|100568301|FG000|NOT COMPLETED|Overall Study||11||
48099700|NCT03204305|100568302|FG001|NOT COMPLETED|Overall Study||5||
48099701|NCT03204305|100568303|FG002|NOT COMPLETED|Overall Study||0||
48099702|NCT03204305|100568304|FG003|NOT COMPLETED|Overall Study||0||
48099703|NCT05544786|100568305|FG000|STARTED|Overall Study||2||
48099704|NCT05544786|100568306|FG001|STARTED|Overall Study||2||
48099705|NCT05544786|100568307|FG002|STARTED|Overall Study||2||
48099706|NCT05544786|100568308|FG003|STARTED|Overall Study||2||
48099707|NCT05544786|100568309|FG004|STARTED|Overall Study||2||
48263380|NCT03054337|100966752|FG005|COMPLETED|Primary Efficacy Period (6 Weeks)||5||
48263381|NCT03054337|100966747|FG000|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0||
48263382|NCT03054337|100966748|FG001|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0||
48263383|NCT03054337|100966749|FG002|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0||
48263384|NCT03054337|100966750|FG003|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0||
48263385|NCT03054337|100966751|FG004|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0||
48690756|NCT05331053|102025913|FG000|NOT COMPLETED|Overall Study||0||
48099708|NCT05544786|100568310|FG005|STARTED|Overall Study||2||
48099709|NCT05544786|100568305|FG000|COMPLETED|Overall Study||2||
48099710|NCT05544786|100568306|FG001|COMPLETED|Overall Study||2||
48099711|NCT05544786|100568307|FG002|COMPLETED|Overall Study||2||
48099712|NCT05544786|100568308|FG003|COMPLETED|Overall Study||2||
48099713|NCT05544786|100568309|FG004|COMPLETED|Overall Study||2||
48099714|NCT05544786|100568310|FG005|COMPLETED|Overall Study||2||
48099715|NCT05544786|100568305|FG000|NOT COMPLETED|Overall Study||0||
48099716|NCT05544786|100568306|FG001|NOT COMPLETED|Overall Study||0||
48099717|NCT05544786|100568307|FG002|NOT COMPLETED|Overall Study||0||
48099718|NCT05544786|100568308|FG003|NOT COMPLETED|Overall Study||0||
48099719|NCT05544786|100568309|FG004|NOT COMPLETED|Overall Study||0||
48099720|NCT05544786|100568310|FG005|NOT COMPLETED|Overall Study||0||
48099721|NCT01765153|100568311|FG000|STARTED|Training Phase 1||10||
48099722|NCT01765153|100568312|FG001|STARTED|Training Phase 1||11||
48099723|NCT01765153|100568311|FG000|COMPLETED|Training Phase 1||9||
48099724|NCT01765153|100568312|FG001|COMPLETED|Training Phase 1||10||
48099725|NCT01765153|100568311|FG000|NOT COMPLETED|Training Phase 1||1||
48099726|NCT01765153|100568312|FG001|NOT COMPLETED|Training Phase 1||1||
48099727|NCT01765153|100568311|FG000|STARTED|Rest Phase 1||9||
48099728|NCT01765153|100568312|FG001|STARTED|Rest Phase 1||10||
48099729|NCT01765153|100568311|FG000|COMPLETED|Rest Phase 1||9||
48099730|NCT01765153|100568312|FG001|COMPLETED|Rest Phase 1||9||
48099731|NCT01765153|100568311|FG000|NOT COMPLETED|Rest Phase 1||0||
48099732|NCT01765153|100568312|FG001|NOT COMPLETED|Rest Phase 1||1||
48099733|NCT01765153|100568311|FG000|STARTED|Training Phase 2||10||
48099734|NCT01765153|100568312|FG001|STARTED|Training Phase 2||9||
48099735|NCT01765153|100568311|FG000|COMPLETED|Training Phase 2||10||
48099736|NCT01765153|100568312|FG001|COMPLETED|Training Phase 2||8||
48099737|NCT01765153|100568311|FG000|NOT COMPLETED|Training Phase 2||0||
48099738|NCT01765153|100568312|FG001|NOT COMPLETED|Training Phase 2||1||
48099739|NCT01765153|100568311|FG000|STARTED|Rest Phase 2||10||
48099740|NCT01765153|100568312|FG001|STARTED|Rest Phase 2||8||
48099741|NCT01765153|100568311|FG000|COMPLETED|Rest Phase 2||8||
48099742|NCT01765153|100568312|FG001|COMPLETED|Rest Phase 2||7||
48099743|NCT01765153|100568311|FG000|NOT COMPLETED|Rest Phase 2||2||
48099744|NCT01765153|100568312|FG001|NOT COMPLETED|Rest Phase 2||1||
48099745|NCT03777007|100568313|FG000|STARTED|Overall Study||40||
48099746|NCT03777007|100568313|FG000|COMPLETED|Overall Study||40||
48099747|NCT03777007|100568313|FG000|NOT COMPLETED|Overall Study||0||
48099748|NCT00605475|100568314|FG000|STARTED|Overall Study||10||
48099749|NCT00605475|100568315|FG001|STARTED|Overall Study||5||
48099750|NCT00605475|100568316|FG002|STARTED|Overall Study||45||
48099751|NCT00605475|100568317|FG003|STARTED|Overall Study||45||
48099752|NCT00605475|100568318|FG004|STARTED|Overall Study||25||
48099753|NCT00605475|100568319|FG005|STARTED|Overall Study||24||
48099754|NCT00605475|100568320|FG006|STARTED|Overall Study||23||
48099755|NCT00605475|100568321|FG007|STARTED|Overall Study||24||
48099756|NCT00605475|100568322|FG008|STARTED|Overall Study||20||
48099757|NCT00605475|100568323|FG009|STARTED|Overall Study||10||
48099758|NCT00605475|100568314|FG000|COMPLETED|Overall Study||10||
48099759|NCT00605475|100568315|FG001|COMPLETED|Overall Study||5||
48099760|NCT00605475|100568316|FG002|COMPLETED|Overall Study||45||
48099761|NCT00605475|100568317|FG003|COMPLETED|Overall Study||45||
48099762|NCT00605475|100568318|FG004|COMPLETED|Overall Study||24||
48099763|NCT00605475|100568319|FG005|COMPLETED|Overall Study||22||
48099764|NCT00605475|100568320|FG006|COMPLETED|Overall Study||22||
48099765|NCT00605475|100568321|FG007|COMPLETED|Overall Study||24||
48099766|NCT00605475|100568322|FG008|COMPLETED|Overall Study||18||
48099767|NCT00605475|100568323|FG009|COMPLETED|Overall Study||8||
48099768|NCT00605475|100568314|FG000|NOT COMPLETED|Overall Study||0||
48099769|NCT00605475|100568315|FG001|NOT COMPLETED|Overall Study||0||
48099770|NCT00605475|100568316|FG002|NOT COMPLETED|Overall Study||0||
48099771|NCT00605475|100568317|FG003|NOT COMPLETED|Overall Study||0||
48099772|NCT00605475|100568318|FG004|NOT COMPLETED|Overall Study||1||
48099773|NCT00605475|100568319|FG005|NOT COMPLETED|Overall Study||2||
48099774|NCT00605475|100568320|FG006|NOT COMPLETED|Overall Study||1||
48099775|NCT00605475|100568321|FG007|NOT COMPLETED|Overall Study||0||
48099776|NCT00605475|100568322|FG008|NOT COMPLETED|Overall Study||2||
48099777|NCT00605475|100568323|FG009|NOT COMPLETED|Overall Study||2||
48099778|NCT03492099|100568324|FG000|STARTED|Overall Study||47||
48099779|NCT03492099|100568324|FG000|COMPLETED|Overall Study||43||
48099780|NCT03492099|100568324|FG000|NOT COMPLETED|Overall Study||4||
48099781|NCT01523886|100568325|FG000|STARTED|Overall Study||25||
48099782|NCT01523886|100568326|FG001|STARTED|Overall Study||24||
48099783|NCT01523886|100568325|FG000|COMPLETED|Overall Study||25||
48099784|NCT01523886|100568326|FG001|COMPLETED|Overall Study||23||
48099785|NCT01523886|100568325|FG000|NOT COMPLETED|Overall Study||0||
48099786|NCT01523886|100568326|FG001|NOT COMPLETED|Overall Study||1||
48099787|NCT01148745|100568327|FG000|STARTED|Overall Study||15||
48099788|NCT01148745|100568327|FG000|COMPLETED|Overall Study||15||
48099789|NCT01148745|100568327|FG000|NOT COMPLETED|Overall Study||0||
48099790|NCT04147455|100568328|FG000|STARTED|Overall Study||397||
48099791|NCT04147455|100568329|FG001|STARTED|Overall Study||396||
48099792|NCT04147455|100568328|FG000|COMPLETED|Overall Study||375||
48099793|NCT04147455|100568329|FG001|COMPLETED|Overall Study||364||
48099794|NCT04147455|100568328|FG000|NOT COMPLETED|Overall Study||22||
48099795|NCT04147455|100568329|FG001|NOT COMPLETED|Overall Study||32||
48099796|NCT01994629|100568330|FG000|STARTED|Overall Study||100||
48099797|NCT01994629|100568331|FG001|STARTED|Overall Study||102||
48099798|NCT01994629|100568330|FG000|COMPLETED|Overall Study||99||
48099799|NCT01994629|100568331|FG001|COMPLETED|Overall Study||99||
48099800|NCT01994629|100568330|FG000|NOT COMPLETED|Overall Study||1||
48099801|NCT01994629|100568331|FG001|NOT COMPLETED|Overall Study||3||
48099802|NCT04665050|100568332|FG000|STARTED|Overall Study||51||
48099803|NCT04665050|100568333|FG001|STARTED|Overall Study||51||
48099804|NCT04665050|100568332|FG000|COMPLETED|Overall Study||51||
48099805|NCT04665050|100568333|FG001|COMPLETED|Overall Study||51||
48099806|NCT04665050|100568332|FG000|NOT COMPLETED|Overall Study||0||
48099807|NCT04665050|100568333|FG001|NOT COMPLETED|Overall Study||0||
48099808|NCT00613015|100568334|FG000|STARTED|Overall Study||13||
48099809|NCT00613015|100568335|FG001|STARTED|Overall Study||12||
48099810|NCT00613015|100568336|FG002|STARTED|Overall Study||26||
48099811|NCT00613015|100568337|FG003|STARTED|Overall Study||24||
48099812|NCT00613015|100568338|FG004|STARTED|Overall Study||15||
48099813|NCT00613015|100568339|FG005|STARTED|Overall Study||19||
48099814|NCT00613015|100568334|FG000|COMPLETED|Overall Study||13||
48099815|NCT00613015|100568335|FG001|COMPLETED|Overall Study||11||
48099816|NCT00613015|100568336|FG002|COMPLETED|Overall Study||23||
48263386|NCT03054337|100966752|FG005|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0||
48263387|NCT03054337|100966747|FG000|STARTED|Dose Adjustment and Maintenance Period||12||
48263388|NCT03054337|100966748|FG001|STARTED|Dose Adjustment and Maintenance Period||12||
48263389|NCT03054337|100966749|FG002|STARTED|Dose Adjustment and Maintenance Period||13||
48263390|NCT03054337|100966750|FG003|STARTED|Dose Adjustment and Maintenance Period||5||
48263391|NCT03054337|100966751|FG004|STARTED|Dose Adjustment and Maintenance Period||4||
48390623|NCT03627494|101283635|FG006|NOT COMPLETED|Part A Washout 1 (7 Days)||0||
48390624|NCT03627494|101283636|FG007|NOT COMPLETED|Part A Washout 1 (7 Days)||0||
48690757|NCT02291133|102025914|FG000|STARTED|Overall Study||25||
48690758|NCT02291133|102025914|FG000|COMPLETED|Overall Study||24||
48690759|NCT02291133|102025914|FG000|NOT COMPLETED|Overall Study||1||
48690760|NCT00861692|102025915|FG000|STARTED|Overall Study||20||
48263392|NCT03054337|100966752|FG005|STARTED|Dose Adjustment and Maintenance Period||5||
48390625|NCT03627494|101283637|FG008|NOT COMPLETED|Part A Washout 1 (7 Days)||0||
48690761|NCT00861692|102025915|FG000|COMPLETED|Overall Study||14||
48690762|NCT00861692|102025915|FG000|NOT COMPLETED|Overall Study||6||
48690763|NCT01539070|102025916|FG000|STARTED|Overall Study||168||
48690764|NCT01539070|102025917|FG001|STARTED|Overall Study||138||
48690765|NCT01539070|102025916|FG000|COMPLETED|Overall Study||109||
48690766|NCT01539070|102025917|FG001|COMPLETED|Overall Study||99||
48690767|NCT01539070|102025916|FG000|NOT COMPLETED|Overall Study||59||
48690768|NCT01539070|102025917|FG001|NOT COMPLETED|Overall Study||39||
48690769|NCT00269087|102025918|FG000|STARTED|Overall Study||122||
48690770|NCT00269087|102025918|FG000|COMPLETED|Overall Study||88||
48690771|NCT00269087|102025918|FG000|NOT COMPLETED|Overall Study||34||
48690772|NCT01047007|102025919|FG000|STARTED|Overall Study||3||
48690773|NCT01047007|102025920|FG001|STARTED|Overall Study||6||
48690774|NCT01047007|102025921|FG002|STARTED|Overall Study||2||
48690775|NCT01047007|102025922|FG003|STARTED|Overall Study||0||
48690776|NCT01047007|102025919|FG000|Treated|Overall Study||3||
48690777|NCT01047007|102025920|FG001|Treated|Overall Study||6||
48690778|NCT01047007|102025921|FG002|Treated|Overall Study||2||
48690779|NCT01047007|102025922|FG003|Treated|Overall Study||0||
48690780|NCT01047007|102025919|FG000|COMPLETED|Overall Study||1||
48690781|NCT01047007|102025920|FG001|COMPLETED|Overall Study||0||
48690782|NCT01047007|102025921|FG002|COMPLETED|Overall Study||0||
48690783|NCT01047007|102025922|FG003|COMPLETED|Overall Study||0||
48690784|NCT01047007|102025919|FG000|NOT COMPLETED|Overall Study||2||
48690785|NCT01047007|102025920|FG001|NOT COMPLETED|Overall Study||6||
48690786|NCT01047007|102025921|FG002|NOT COMPLETED|Overall Study||2||
48690787|NCT01047007|102025922|FG003|NOT COMPLETED|Overall Study||0||
48690788|NCT03423238|102025923|FG000|STARTED|Overall Study||19||
48690789|NCT03423238|102025924|FG001|STARTED|Overall Study||19||
48690790|NCT03423238|102025923|FG000|COMPLETED|Overall Study||17||
48690791|NCT03423238|102025924|FG001|COMPLETED|Overall Study||19||
48690792|NCT03423238|102025923|FG000|NOT COMPLETED|Overall Study||2||
48690793|NCT03423238|102025924|FG001|NOT COMPLETED|Overall Study||0||
48690794|NCT00887159|102025925|FG000|STARTED|Overall Study||56||
48099817|NCT00613015|100568337|FG003|COMPLETED|Overall Study||21||
48099818|NCT00613015|100568338|FG004|COMPLETED|Overall Study||13||
48099819|NCT00613015|100568339|FG005|COMPLETED|Overall Study||16||
48099820|NCT00613015|100568334|FG000|NOT COMPLETED|Overall Study||0||
48099821|NCT00613015|100568335|FG001|NOT COMPLETED|Overall Study||1||
48099822|NCT00613015|100568336|FG002|NOT COMPLETED|Overall Study||3||
48099823|NCT00613015|100568337|FG003|NOT COMPLETED|Overall Study||3||
48099824|NCT00613015|100568338|FG004|NOT COMPLETED|Overall Study||2||
48099825|NCT00613015|100568339|FG005|NOT COMPLETED|Overall Study||3||
48099826|NCT00853723|100568340|FG000|STARTED|Overall Study||35||
48099827|NCT00853723|100568341|FG001|STARTED|Overall Study||35||
48099828|NCT00853723|100568342|FG002|STARTED|Overall Study||35||
48099829|NCT00853723|100568340|FG000|COMPLETED|Overall Study||29||
48099830|NCT00853723|100568341|FG001|COMPLETED|Overall Study||28||
48099831|NCT00853723|100568342|FG002|COMPLETED|Overall Study||33||
48099832|NCT00853723|100568340|FG000|NOT COMPLETED|Overall Study||6||
48099833|NCT00853723|100568341|FG001|NOT COMPLETED|Overall Study||7||
48099834|NCT00853723|100568342|FG002|NOT COMPLETED|Overall Study||2||
48099835|NCT02141282|100568343|FG000|STARTED|Overall Study||43||
48099836|NCT02141282|100568344|FG001|STARTED|Overall Study||21||
48099837|NCT02141282|100568345|FG002|STARTED|Overall Study||48||
48099838|NCT02141282|100568346|FG003|STARTED|Overall Study||15||
48099839|NCT02141282|100568343|FG000|COMPLETED|Overall Study||0||
48099840|NCT02141282|100568344|FG001|COMPLETED|Overall Study||0||
48099841|NCT02141282|100568345|FG002|COMPLETED|Overall Study||0||
48099842|NCT02141282|100568346|FG003|COMPLETED|Overall Study||0||
48099843|NCT02141282|100568343|FG000|NOT COMPLETED|Overall Study||43||
48099844|NCT02141282|100568344|FG001|NOT COMPLETED|Overall Study||21||
48099845|NCT02141282|100568345|FG002|NOT COMPLETED|Overall Study||48||
48099846|NCT02141282|100568346|FG003|NOT COMPLETED|Overall Study||15||
48099847|NCT02653456|100568347|FG000|STARTED|Overall Study||64||
48099848|NCT02653456|100568347|FG000|COMPLETED|Overall Study||59||
48099849|NCT02653456|100568347|FG000|NOT COMPLETED|Overall Study||5||
48099850|NCT00982488|100568348|FG000|STARTED|Overall Study||185||
48263393|NCT03054337|100966747|FG000|COMPLETED|Dose Adjustment and Maintenance Period||11||
48099851|NCT00982488|100568349|FG001|STARTED|Overall Study||14||
48099852|NCT00982488|100568350|FG002|STARTED|Overall Study||34||
48099853|NCT00982488|100568351|FG003|STARTED|Overall Study||3||
48099854|NCT00982488|100568352|FG004|STARTED|Overall Study||1||
48099855|NCT00982488|100568348|FG000|COMPLETED|Overall Study||0||
48099856|NCT00982488|100568349|FG001|COMPLETED|Overall Study||0||
48099857|NCT00982488|100568350|FG002|COMPLETED|Overall Study||0||
48099858|NCT00982488|100568351|FG003|COMPLETED|Overall Study||0||
48099859|NCT00982488|100568352|FG004|COMPLETED|Overall Study||0||
48099860|NCT00982488|100568348|FG000|NOT COMPLETED|Overall Study||185||
48099861|NCT00982488|100568349|FG001|NOT COMPLETED|Overall Study||14||
48099862|NCT00982488|100568350|FG002|NOT COMPLETED|Overall Study||34||
48099863|NCT00982488|100568351|FG003|NOT COMPLETED|Overall Study||3||
48099864|NCT00982488|100568352|FG004|NOT COMPLETED|Overall Study||1||
48099865|NCT00768144|100568353|FG000|STARTED|Overall Study||36||
48099866|NCT00768144|100568353|FG000|COMPLETED|Overall Study||0||
48099867|NCT00768144|100568353|FG000|NOT COMPLETED|Overall Study||36||
48099868|NCT01955161|100568354|FG000|STARTED|Overall Study||310||
48099869|NCT01955161|100568355|FG001|STARTED|Overall Study||313||
48099870|NCT01955161|100568356|FG002|STARTED|Overall Study||310||
48099871|NCT01955161|100568354|FG000|Treated|Overall Study||308||
48099872|NCT01955161|100568355|FG001|Treated|Overall Study||313||
48099873|NCT01955161|100568356|FG002|Treated|Overall Study||309||
48099874|NCT01955161|100568354|FG000|COMPLETED|Overall Study||283||
48099875|NCT01955161|100568355|FG001|COMPLETED|Overall Study||288||
48099876|NCT01955161|100568356|FG002|COMPLETED|Overall Study||275||
48099877|NCT01955161|100568354|FG000|NOT COMPLETED|Overall Study||27||
48099878|NCT01955161|100568355|FG001|NOT COMPLETED|Overall Study||25||
48099879|NCT01955161|100568356|FG002|NOT COMPLETED|Overall Study||35||
48099880|NCT04652479|100568357|FG000|STARTED|Run-in Period (14 Days)||25||
48099881|NCT04652479|100568358|FG001|STARTED|Run-in Period (14 Days)||0||
48099882|NCT04652479|100568359|FG002|STARTED|Run-in Period (14 Days)||0||
48099883|NCT04652479|100568357|FG000|COMPLETED|Run-in Period (14 Days)||25||
48099884|NCT04652479|100568358|FG001|COMPLETED|Run-in Period (14 Days)||0||
48099885|NCT04652479|100568359|FG002|COMPLETED|Run-in Period (14 Days)||0||
48099886|NCT04652479|100568357|FG000|NOT COMPLETED|Run-in Period (14 Days)||0||
48099887|NCT04652479|100568358|FG001|NOT COMPLETED|Run-in Period (14 Days)||0||
48099888|NCT04652479|100568359|FG002|NOT COMPLETED|Run-in Period (14 Days)||0||
48099889|NCT04652479|100568357|FG000|STARTED|Treatment Period 1 (14 Days)||0||
48099890|NCT04652479|100568358|FG001|STARTED|Treatment Period 1 (14 Days)||8||
48099891|NCT04652479|100568359|FG002|STARTED|Treatment Period 1 (14 Days)||9||
48099892|NCT04652479|100568357|FG000|COMPLETED|Treatment Period 1 (14 Days)||0||
48099893|NCT04652479|100568358|FG001|COMPLETED|Treatment Period 1 (14 Days)||8||
48099894|NCT04652479|100568359|FG002|COMPLETED|Treatment Period 1 (14 Days)||9||
48099895|NCT04652479|100568357|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||0||
48099896|NCT04652479|100568358|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||0||
48263394|NCT03054337|100966748|FG001|COMPLETED|Dose Adjustment and Maintenance Period||10||
48099897|NCT04652479|100568359|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||0||
48099898|NCT04652479|100568357|FG000|STARTED|Washout Period (2 Days)||0||
48099899|NCT04652479|100568358|FG001|STARTED|Washout Period (2 Days)||8||
48099900|NCT04652479|100568359|FG002|STARTED|Washout Period (2 Days)||9||
48099901|NCT04652479|100568357|FG000|COMPLETED|Washout Period (2 Days)||0||
48099902|NCT04652479|100568358|FG001|COMPLETED|Washout Period (2 Days)||8||
48099903|NCT04652479|100568359|FG002|COMPLETED|Washout Period (2 Days)||9||
48099904|NCT04652479|100568357|FG000|NOT COMPLETED|Washout Period (2 Days)||0||
48099905|NCT04652479|100568358|FG001|NOT COMPLETED|Washout Period (2 Days)||0||
48099906|NCT04652479|100568359|FG002|NOT COMPLETED|Washout Period (2 Days)||0||
48099907|NCT04652479|100568357|FG000|STARTED|Treatment Period 2 (14 Days||0||
48099908|NCT04652479|100568358|FG001|STARTED|Treatment Period 2 (14 Days||8||
48099909|NCT04652479|100568359|FG002|STARTED|Treatment Period 2 (14 Days||9||
48099910|NCT04652479|100568357|FG000|Completed Both Interventions With no Major Protocol Deviations|Treatment Period 2 (14 Days||0||
48099911|NCT04652479|100568358|FG001|Completed Both Interventions With no Major Protocol Deviations|Treatment Period 2 (14 Days||8||
48099912|NCT04652479|100568359|FG002|Completed Both Interventions With no Major Protocol Deviations|Treatment Period 2 (14 Days||8||
48099913|NCT04652479|100568357|FG000|COMPLETED|Treatment Period 2 (14 Days||0||
48099914|NCT04652479|100568358|FG001|COMPLETED|Treatment Period 2 (14 Days||8||
48099915|NCT04652479|100568359|FG002|COMPLETED|Treatment Period 2 (14 Days||9||
48099916|NCT04652479|100568357|FG000|NOT COMPLETED|Treatment Period 2 (14 Days||0||
48099917|NCT04652479|100568358|FG001|NOT COMPLETED|Treatment Period 2 (14 Days||0||
48099918|NCT04652479|100568359|FG002|NOT COMPLETED|Treatment Period 2 (14 Days||0||
48099919|NCT00775931|100568360|FG000|STARTED|Overall Study||6||
48099920|NCT00775931|100568361|FG001|STARTED|Overall Study||1||
48099921|NCT00775931|100568360|FG000|COMPLETED|Overall Study||6||
48099922|NCT00775931|100568361|FG001|COMPLETED|Overall Study||1||
48099923|NCT00775931|100568360|FG000|NOT COMPLETED|Overall Study||0||
48099924|NCT00775931|100568361|FG001|NOT COMPLETED|Overall Study||0||
48099925|NCT00456547|100568362|FG000|STARTED|Overall Study||12||
48099926|NCT00456547|100568363|FG001|STARTED|Overall Study||12||
48099927|NCT00456547|100568362|FG000|COMPLETED|Overall Study||12||
48099928|NCT00456547|100568363|FG001|COMPLETED|Overall Study||12||
48099929|NCT00456547|100568362|FG000|NOT COMPLETED|Overall Study||0||
48099930|NCT00456547|100568363|FG001|NOT COMPLETED|Overall Study||0||
48099931|NCT04984993|100568364|FG000|STARTED|Overall Study||96||
48099932|NCT04984993|100568365|FG001|STARTED|Overall Study||96||
48099933|NCT04984993|100568364|FG000|Received Treatment|Overall Study||94||
48099934|NCT04984993|100568365|FG001|Received Treatment|Overall Study||94||
48099935|NCT04984993|100568364|FG000|COMPLETED|Overall Study||82||
48099936|NCT04984993|100568365|FG001|COMPLETED|Overall Study||92||
48099937|NCT04984993|100568364|FG000|NOT COMPLETED|Overall Study||14||
48099938|NCT04984993|100568365|FG001|NOT COMPLETED|Overall Study||4||
48099939|NCT03724812|100568366|FG000|STARTED|Overall Study||46||
48099940|NCT03724812|100568366|FG000|Discharge|Overall Study||46||
48099941|NCT03724812|100568366|FG000|30 Day Follow-Up|Overall Study||45||
48099942|NCT03724812|100568366|FG000|6 Month Follow-Up|Overall Study||42||
48099943|NCT03724812|100568366|FG000|12-Month Follow-Up|Overall Study||42||
48099944|NCT03724812|100568366|FG000|COMPLETED|Overall Study||42||
48099945|NCT03724812|100568366|FG000|NOT COMPLETED|Overall Study||4||
48099946|NCT00385996|100568367|FG000|STARTED|Overall Study||22||
48099947|NCT00385996|100568367|FG000|COMPLETED|Overall Study||22||
48099948|NCT00385996|100568367|FG000|NOT COMPLETED|Overall Study||0||
48099949|NCT02659709|100568368|FG000|STARTED|Overall Study||50||
48099950|NCT02659709|100568368|FG000|COMPLETED|Overall Study||50||
48099951|NCT02659709|100568368|FG000|NOT COMPLETED|Overall Study||0||
48099952|NCT02009046|100568369|FG000|STARTED|Overall Study||1025||
48099953|NCT02009046|100568370|FG001|STARTED|Overall Study||884||
48099954|NCT02009046|100568369|FG000|SEI Curriculum Only|Overall Study||461||
48099955|NCT02009046|100568370|FG001|SEI Curriculum Only|Overall Study||0||
48099956|NCT02009046|100568369|FG000|SEI Curriculum + 3 SchoolWide Components|Overall Study||544||
48099957|NCT02009046|100568370|FG001|SEI Curriculum + 3 SchoolWide Components|Overall Study||0||
48099958|NCT02009046|100568369|FG000|Ctrl Curriculum Only|Overall Study||0||
48099959|NCT02009046|100568370|FG001|Ctrl Curriculum Only|Overall Study||456||
48099960|NCT02009046|100568369|FG000|Ctrl Curriculm +1 SchoolWide Component|Overall Study||0||
48099961|NCT02009046|100568370|FG001|Ctrl Curriculm +1 SchoolWide Component|Overall Study||428||
48099962|NCT02009046|100568369|FG000|COMPLETED|Overall Study||769||
48099963|NCT02009046|100568370|FG001|COMPLETED|Overall Study||678||
48099964|NCT02009046|100568369|FG000|NOT COMPLETED|Overall Study||256||
48099965|NCT02009046|100568370|FG001|NOT COMPLETED|Overall Study||206||
48099966|NCT01466387|100568371|FG000|STARTED|Overall Study||101||
48099967|NCT01466387|100568372|FG001|STARTED|Overall Study||100||
48099968|NCT01466387|100568373|FG002|STARTED|Overall Study||99||
48099969|NCT01466387|100568374|FG003|STARTED|Overall Study||101||
48099970|NCT01466387|100568375|FG004|STARTED|Overall Study||51||
48099971|NCT01466387|100568376|FG005|STARTED|Overall Study||100||
48099972|NCT01466387|100568371|FG000|COMPLETED|Overall Study||100||
48099973|NCT01466387|100568372|FG001|COMPLETED|Overall Study||100||
48099974|NCT01466387|100568373|FG002|COMPLETED|Overall Study||98||
48099975|NCT01466387|100568374|FG003|COMPLETED|Overall Study||99||
48099976|NCT01466387|100568375|FG004|COMPLETED|Overall Study||51||
48099977|NCT01466387|100568376|FG005|COMPLETED|Overall Study||99||
48263395|NCT03054337|100966749|FG002|COMPLETED|Dose Adjustment and Maintenance Period||12||
48546869|NCT02859142|101671511|FG001|COMPLETED|Overall Study||52|Completed indicates the number of participants completing the study, including those who discontinued medication but opted to remain in the study.|
48546870|NCT02859142|101671510|FG000|NOT COMPLETED|Overall Study||4||
48546871|NCT02859142|101671511|FG001|NOT COMPLETED|Overall Study||9||
48546872|NCT02960490|101671512|FG000|STARTED|Treatment Phase(Double-blind): 12 Weeks||34||
48546873|NCT02960490|101671513|FG001|STARTED|Treatment Phase(Double-blind): 12 Weeks||32||
48546874|NCT02960490|101671514|FG002|STARTED|Treatment Phase(Double-blind): 12 Weeks||0||
48546875|NCT02960490|101671515|FG003|STARTED|Treatment Phase(Double-blind): 12 Weeks||0||
48546876|NCT02960490|101671516|FG004|STARTED|Treatment Phase(Double-blind): 12 Weeks||0||
48546877|NCT02960490|101671517|FG005|STARTED|Treatment Phase(Double-blind): 12 Weeks||0||
48546878|NCT02960490|101671518|FG006|STARTED|Treatment Phase(Double-blind): 12 Weeks||0||
48546879|NCT02960490|101671519|FG007|STARTED|Treatment Phase(Double-blind): 12 Weeks||0||
48546880|NCT02960490|101671520|FG008|STARTED|Treatment Phase(Double-blind): 12 Weeks||0||
48546881|NCT02960490|101671521|FG009|STARTED|Treatment Phase(Double-blind): 12 Weeks||0||
48546882|NCT02960490|101671512|FG000|Treated|Treatment Phase(Double-blind): 12 Weeks||33||
48546883|NCT02960490|101671513|FG001|Treated|Treatment Phase(Double-blind): 12 Weeks||31||
48546884|NCT02960490|101671514|FG002|Treated|Treatment Phase(Double-blind): 12 Weeks||0||
48546885|NCT02960490|101671515|FG003|Treated|Treatment Phase(Double-blind): 12 Weeks||0||
48546886|NCT02960490|101671516|FG004|Treated|Treatment Phase(Double-blind): 12 Weeks||0||
48546887|NCT02960490|101671517|FG005|Treated|Treatment Phase(Double-blind): 12 Weeks||0||
48546888|NCT02960490|101671518|FG006|Treated|Treatment Phase(Double-blind): 12 Weeks||0||
48546889|NCT02960490|101671519|FG007|Treated|Treatment Phase(Double-blind): 12 Weeks||0||
48546890|NCT02960490|101671520|FG008|Treated|Treatment Phase(Double-blind): 12 Weeks||0||
48546891|NCT02960490|101671521|FG009|Treated|Treatment Phase(Double-blind): 12 Weeks||0||
48546892|NCT02960490|101671512|FG000|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||33||
48546893|NCT02960490|101671513|FG001|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||31||
48546894|NCT02960490|101671514|FG002|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0||
48546895|NCT02960490|101671515|FG003|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0||
48546896|NCT02960490|101671516|FG004|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0||
48546897|NCT02960490|101671517|FG005|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0||
48546898|NCT02960490|101671518|FG006|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0||
48546899|NCT02960490|101671519|FG007|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0||
48546900|NCT02960490|101671520|FG008|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0||
48546901|NCT02960490|101671521|FG009|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0||
48546902|NCT02960490|101671512|FG000|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||33||
48546903|NCT02960490|101671513|FG001|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||31||
48546904|NCT02960490|101671514|FG002|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0||
48546905|NCT02960490|101671515|FG003|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0||
48546906|NCT02960490|101671516|FG004|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0||
48546907|NCT02960490|101671517|FG005|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0||
48099978|NCT01466387|100568371|FG000|NOT COMPLETED|Overall Study||1||
48099979|NCT01466387|100568372|FG001|NOT COMPLETED|Overall Study||0||
48099980|NCT01466387|100568373|FG002|NOT COMPLETED|Overall Study||1||
48099981|NCT01466387|100568374|FG003|NOT COMPLETED|Overall Study||2||
48099982|NCT01466387|100568375|FG004|NOT COMPLETED|Overall Study||0||
48099983|NCT01466387|100568376|FG005|NOT COMPLETED|Overall Study||1||
48099984|NCT01405963|100568377|FG000|STARTED|Overall Study||15||
48099985|NCT01405963|100568378|FG001|STARTED|Overall Study||16||
48099986|NCT01405963|100568377|FG000|COMPLETED|Overall Study||13||
48099987|NCT01405963|100568378|FG001|COMPLETED|Overall Study||14||
48099988|NCT01405963|100568377|FG000|NOT COMPLETED|Overall Study||2||
48099989|NCT01405963|100568378|FG001|NOT COMPLETED|Overall Study||2||
48099990|NCT02232425|100568379|FG000|STARTED|Overall Study||58||
48099991|NCT02232425|100568380|FG001|STARTED|Overall Study||30||
48099992|NCT02232425|100568379|FG000|COMPLETED|Overall Study||44||
48099993|NCT02232425|100568380|FG001|COMPLETED|Overall Study||22||
48099994|NCT02232425|100568379|FG000|NOT COMPLETED|Overall Study||14||
48099995|NCT02232425|100568380|FG001|NOT COMPLETED|Overall Study||8||
48099996|NCT03144674|100568381|FG000|STARTED|Overall Study||4||
48099997|NCT03144674|100568382|FG001|STARTED|Overall Study||6||
48099998|NCT03144674|100568383|FG002|STARTED|Overall Study||28||
48099999|NCT03144674|100568384|FG003|STARTED|Overall Study||72||
48100000|NCT03144674|100568381|FG000|COMPLETED|Overall Study||0||
48100001|NCT03144674|100568382|FG001|COMPLETED|Overall Study||0||
48100002|NCT03144674|100568383|FG002|COMPLETED|Overall Study||0||
48100003|NCT03144674|100568384|FG003|COMPLETED|Overall Study||0||
48100004|NCT03144674|100568381|FG000|NOT COMPLETED|Overall Study||4||
48390626|NCT03627494|101283638|FG009|NOT COMPLETED|Part A Washout 1 (7 Days)||0||
48100005|NCT03144674|100568382|FG001|NOT COMPLETED|Overall Study||6||
48100006|NCT03144674|100568383|FG002|NOT COMPLETED|Overall Study||28||
48100007|NCT03144674|100568384|FG003|NOT COMPLETED|Overall Study||72||
48100008|NCT04267133|100568385|FG000|STARTED|Overall Study||256||
48100009|NCT04267133|100568385|FG000|COMPLETED|Overall Study||251||
48100010|NCT04267133|100568385|FG000|NOT COMPLETED|Overall Study||5||
48100011|NCT00605813|100568386|FG000|STARTED|Overall Study||542||
48100012|NCT00605813|100568386|FG000|COMPLETED|Overall Study||517||
48100013|NCT00605813|100568386|FG000|NOT COMPLETED|Overall Study||25||
48100014|NCT01057017|100568387|FG000|STARTED|Overall Study||5||
48100015|NCT01057017|100568387|FG000|COMPLETED|Overall Study||5||
48100016|NCT01057017|100568387|FG000|NOT COMPLETED|Overall Study||0||
48100017|NCT02064166|100568388|FG000|STARTED|Overall Study||9||
48100018|NCT02064166|100568389|FG001|STARTED|Overall Study||6||
48100019|NCT02064166|100568388|FG000|COMPLETED|Overall Study||8||
48100020|NCT02064166|100568389|FG001|COMPLETED|Overall Study||6||
48100021|NCT02064166|100568388|FG000|NOT COMPLETED|Overall Study||1||
48100022|NCT02064166|100568389|FG001|NOT COMPLETED|Overall Study||0||
48100023|NCT00741039|100568390|FG000|STARTED|Overall Study||102||
48100024|NCT00741039|100568391|FG001|STARTED|Overall Study||25||
48100025|NCT00741039|100568390|FG000|COMPLETED|Overall Study||100||
48100026|NCT00741039|100568391|FG001|COMPLETED|Overall Study||25||
48100027|NCT00741039|100568390|FG000|NOT COMPLETED|Overall Study||2||
48100028|NCT00741039|100568391|FG001|NOT COMPLETED|Overall Study||0||
48100029|NCT01096810|100568392|FG000|STARTED|Overall Study||20||
48100030|NCT01096810|100568392|FG000|COMPLETED|Overall Study||20||
48100031|NCT01096810|100568392|FG000|NOT COMPLETED|Overall Study||0||
48100032|NCT00945009|100568393|FG000|STARTED|Overall Study||201||
48100033|NCT00945009|100568394|FG001|STARTED|Overall Study||39||
48100034|NCT00945009|100568395|FG002|STARTED|Overall Study||9||
48100035|NCT00945009|100568393|FG000|COMPLETED|Overall Study||156||
48100036|NCT00945009|100568394|FG001|COMPLETED|Overall Study||32||
48390627|NCT03627494|101283639|FG010|NOT COMPLETED|Part A Washout 1 (7 Days)||0||
48390628|NCT03627494|101283640|FG011|NOT COMPLETED|Part A Washout 1 (7 Days)||0||
48390629|NCT03627494|101283629|FG000|STARTED|Part A Period 2 (4 Days)||3||
48390630|NCT03627494|101283630|FG001|STARTED|Part A Period 2 (4 Days)||3||
48390631|NCT03627494|101283631|FG002|STARTED|Part A Period 2 (4 Days)||3||
48390632|NCT03627494|101283632|FG003|STARTED|Part A Period 2 (4 Days)||3||
48100037|NCT00945009|100568395|FG002|COMPLETED|Overall Study||6||
48100038|NCT00945009|100568393|FG000|NOT COMPLETED|Overall Study||45||
48100039|NCT00945009|100568394|FG001|NOT COMPLETED|Overall Study||7||
48100040|NCT00945009|100568395|FG002|NOT COMPLETED|Overall Study||3||
48100041|NCT00518323|100568396|FG000|STARTED|Overall Study||54||
48100042|NCT00518323|100568397|FG001|STARTED|Overall Study||48||
48100043|NCT00518323|100568398|FG002|STARTED|Overall Study||48||
48100044|NCT00518323|100568399|FG003|STARTED|Overall Study||51||
48100045|NCT00518323|100568396|FG000|COMPLETED|Overall Study||35||
48100046|NCT00518323|100568397|FG001|COMPLETED|Overall Study||40||
48100047|NCT00518323|100568398|FG002|COMPLETED|Overall Study||37||
48100048|NCT00518323|100568399|FG003|COMPLETED|Overall Study||26||
48100049|NCT00518323|100568396|FG000|NOT COMPLETED|Overall Study||19||
48100050|NCT00518323|100568397|FG001|NOT COMPLETED|Overall Study||8||
48100051|NCT00518323|100568398|FG002|NOT COMPLETED|Overall Study||11||
48100052|NCT00518323|100568399|FG003|NOT COMPLETED|Overall Study||25||
48390633|NCT03627494|101283633|FG004|STARTED|Part A Period 2 (4 Days)||3||
48390634|NCT03627494|101283634|FG005|STARTED|Part A Period 2 (4 Days)||3||
48100053|NCT02974296|100568400|FG000|STARTED|Overall Study||10||
48100054|NCT02974296|100568401|FG001|STARTED|Overall Study||23||
48100055|NCT02974296|100568400|FG000|COMPLETED|Overall Study||10||
48100056|NCT02974296|100568401|FG001|COMPLETED|Overall Study||22||
48100057|NCT02974296|100568400|FG000|NOT COMPLETED|Overall Study||0||
48100058|NCT02974296|100568401|FG001|NOT COMPLETED|Overall Study||1||
48100059|NCT01046682|100568402|FG000|STARTED|Overall Study||20||
48100060|NCT01046682|100568403|FG001|STARTED|Overall Study||20||
48100061|NCT01046682|100568402|FG000|COMPLETED|Overall Study||18||
48100062|NCT01046682|100568403|FG001|COMPLETED|Overall Study||20||
48100063|NCT01046682|100568402|FG000|NOT COMPLETED|Overall Study||2||
48100064|NCT01046682|100568403|FG001|NOT COMPLETED|Overall Study||0||
48100065|NCT02530450|100568404|FG000|STARTED|Overall Study||16||
48100066|NCT02530450|100568405|FG001|STARTED|Overall Study||14||
48100067|NCT02530450|100568404|FG000|COMPLETED|Overall Study||10||
48100068|NCT02530450|100568405|FG001|COMPLETED|Overall Study||9||
48100069|NCT02530450|100568404|FG000|NOT COMPLETED|Overall Study||6||
48100070|NCT02530450|100568405|FG001|NOT COMPLETED|Overall Study||5||
48100071|NCT02867709|100568406|FG000|STARTED|Treatment Period||563||
48100072|NCT02867709|100568407|FG001|STARTED|Treatment Period||561||
48100073|NCT02867709|100568408|FG002|STARTED|Treatment Period||562||
48100074|NCT02867709|100568406|FG000|Safety Population: Received Study Drug|Treatment Period||499||
48100075|NCT02867709|100568407|FG001|Safety Population: Received Study Drug|Treatment Period||478||
48100076|NCT02867709|100568408|FG002|Safety Population: Received Study Drug|Treatment Period||488||
48100077|NCT02867709|100568406|FG000|COMPLETED|Treatment Period||493||
48100078|NCT02867709|100568407|FG001|COMPLETED|Treatment Period||474||
48100079|NCT02867709|100568408|FG002|COMPLETED|Treatment Period||487||
48100080|NCT02867709|100568406|FG000|NOT COMPLETED|Treatment Period||70||
48100081|NCT02867709|100568407|FG001|NOT COMPLETED|Treatment Period||87||
48100082|NCT02867709|100568408|FG002|NOT COMPLETED|Treatment Period||75||
48100083|NCT02867709|100568406|FG000|STARTED|Safety Follow-up Period||493||
48100084|NCT02867709|100568407|FG001|STARTED|Safety Follow-up Period||474||
48100085|NCT02867709|100568408|FG002|STARTED|Safety Follow-up Period||487||
48690795|NCT00887159|102025926|FG001|STARTED|Overall Study||56||
48690796|NCT00887159|102025927|FG002|STARTED|Overall Study||56||
48690797|NCT00887159|102025925|FG000|Patients Who Started Assigned Treatment|Overall Study||53||
48690798|NCT00887159|102025926|FG001|Patients Who Started Assigned Treatment|Overall Study||53||
48690799|NCT00887159|102025927|FG002|Patients Who Started Assigned Treatment|Overall Study||52||
48100086|NCT02867709|100568406|FG000|COMPLETED|Safety Follow-up Period||482||
48100087|NCT02867709|100568407|FG001|COMPLETED|Safety Follow-up Period||459||
48100088|NCT02867709|100568408|FG002|COMPLETED|Safety Follow-up Period||473||
48100089|NCT02867709|100568406|FG000|NOT COMPLETED|Safety Follow-up Period||11||
48100090|NCT02867709|100568407|FG001|NOT COMPLETED|Safety Follow-up Period||15||
48100091|NCT02867709|100568408|FG002|NOT COMPLETED|Safety Follow-up Period||14||
48100092|NCT02004028|100572150|FG000|STARTED|Overall Study||10||
48100093|NCT02004028|100572151|FG001|STARTED|Overall Study||10||
48100094|NCT02004028|100572152|FG002|STARTED|Overall Study||10||
48100095|NCT02004028|100572153|FG003|STARTED|Overall Study||5||
48100096|NCT02004028|100572150|FG000|COMPLETED|Overall Study||10||
48100097|NCT02004028|100572151|FG001|COMPLETED|Overall Study||10||
48100098|NCT02004028|100572152|FG002|COMPLETED|Overall Study||10||
48100099|NCT02004028|100572153|FG003|COMPLETED|Overall Study||5||
48100100|NCT02004028|100572150|FG000|NOT COMPLETED|Overall Study||0||
48100101|NCT02004028|100572151|FG001|NOT COMPLETED|Overall Study||0||
48100102|NCT02004028|100572152|FG002|NOT COMPLETED|Overall Study||0||
48100103|NCT02004028|100572153|FG003|NOT COMPLETED|Overall Study||0||
48100104|NCT02341807|100572154|FG000|STARTED|Overall Study||5||
48100105|NCT02341807|100572155|FG001|STARTED|Overall Study||5||
48100106|NCT02341807|100572156|FG002|STARTED|Overall Study||5||
48100107|NCT02341807|100572154|FG000|Received at Least 1 Dose of Study Drug|Overall Study||5||
48100108|NCT02341807|100572155|FG001|Received at Least 1 Dose of Study Drug|Overall Study||5||
48690800|NCT00887159|102025925|FG000|Eligible and Treated Patients|Overall Study||48||
48690801|NCT00887159|102025926|FG001|Eligible and Treated Patients|Overall Study||52||
48690802|NCT00887159|102025927|FG002|Eligible and Treated Patients|Overall Study||52||
48690803|NCT00887159|102025925|FG000|Eligible/Treated Pts With CTCs Results|Overall Study||40||
48100109|NCT02341807|100572156|FG002|Received at Least 1 Dose of Study Drug|Overall Study||5||
48100110|NCT02341807|100572154|FG000|COMPLETED|Overall Study||5||
48100111|NCT02341807|100572155|FG001|COMPLETED|Overall Study||4||
48100112|NCT02341807|100572156|FG002|COMPLETED|Overall Study||5||
48100113|NCT02341807|100572154|FG000|NOT COMPLETED|Overall Study||0||
48100114|NCT02341807|100572155|FG001|NOT COMPLETED|Overall Study||1||
48100115|NCT02341807|100572156|FG002|NOT COMPLETED|Overall Study||0||
48100116|NCT00520975|100572157|FG000|STARTED|Overall Study||48||
48100117|NCT00520975|100572158|FG001|STARTED|Overall Study||48||
48100118|NCT00520975|100572157|FG000|Treated and Reported Adverse Events Data|Overall Study||47||
48100119|NCT00520975|100572158|FG001|Treated and Reported Adverse Events Data|Overall Study||45||
48100120|NCT00520975|100572157|FG000|COMPLETED|Overall Study||0||
48100121|NCT00520975|100572158|FG001|COMPLETED|Overall Study||0||
48100122|NCT00520975|100572157|FG000|NOT COMPLETED|Overall Study||48||
48100123|NCT00520975|100572158|FG001|NOT COMPLETED|Overall Study||48||
48100124|NCT01334723|100572159|FG000|STARTED|Overall Study||17293||
48100125|NCT01334723|100572160|FG001|STARTED|Overall Study||17739||
48100126|NCT01334723|100572159|FG000|COMPLETED|Overall Study||17293||
48100127|NCT01334723|100572160|FG001|COMPLETED|Overall Study||17739||
48546908|NCT02960490|101671518|FG006|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0||
48100128|NCT01334723|100572159|FG000|NOT COMPLETED|Overall Study||0||
48100129|NCT01334723|100572160|FG001|NOT COMPLETED|Overall Study||0||
48100130|NCT02723084|100572161|FG000|STARTED|Overall Study||90||
48100131|NCT02723084|100572162|FG001|STARTED|Overall Study||46||
48100132|NCT02723084|100572161|FG000|COMPLETED|Overall Study||86||
48100133|NCT02723084|100572162|FG001|COMPLETED|Overall Study||45||
48100134|NCT02723084|100572161|FG000|NOT COMPLETED|Overall Study||4||
48100135|NCT02723084|100572162|FG001|NOT COMPLETED|Overall Study||1||
48100136|NCT01030523|100572163|FG000|STARTED|Initial Study (5 Years)||50||67
48100137|NCT01030523|100572164|FG001|STARTED|Initial Study (5 Years)||51||70
48100138|NCT01030523|100572163|FG000|COMPLETED|Initial Study (5 Years)||44||60
48100139|NCT01030523|100572164|FG001|COMPLETED|Initial Study (5 Years)||46||64
48100140|NCT01030523|100572163|FG000|NOT COMPLETED|Initial Study (5 Years)||6||7
48100141|NCT01030523|100572164|FG001|NOT COMPLETED|Initial Study (5 Years)||5||6
48100142|NCT01030523|100572163|FG000|STARTED|Follow-up Extension (10 Years)||36||48
48100143|NCT01030523|100572164|FG001|STARTED|Follow-up Extension (10 Years)||41||57
48100144|NCT01030523|100572163|FG000|COMPLETED|Follow-up Extension (10 Years)||29||39
48100145|NCT01030523|100572164|FG001|COMPLETED|Follow-up Extension (10 Years)||32||47
48100146|NCT01030523|100572163|FG000|NOT COMPLETED|Follow-up Extension (10 Years)||7||9
48100147|NCT01030523|100572164|FG001|NOT COMPLETED|Follow-up Extension (10 Years)||9||10
48100148|NCT03839212|100572165|FG000|STARTED|Overall Study||18||
48100149|NCT03839212|100572165|FG000|COMPLETED|Overall Study||14||
48100150|NCT03839212|100572165|FG000|NOT COMPLETED|Overall Study||4||
48100151|NCT02635828|100572166|FG000|STARTED|Overall Study||54||
48100152|NCT02635828|100572166|FG000|COMPLETED|Overall Study||40||
48100153|NCT02635828|100572166|FG000|NOT COMPLETED|Overall Study||14||
48100154|NCT00967993|100572167|FG000|STARTED|Overall Study||22||
48100155|NCT00967993|100572167|FG000|COMPLETED|Overall Study||18||
48100156|NCT00967993|100572167|FG000|NOT COMPLETED|Overall Study||4||
48100157|NCT00056563|100572168|FG000|STARTED|Overall Study||121||
48100158|NCT00056563|100572169|FG001|STARTED|Overall Study||134||
48100159|NCT00056563|100572168|FG000|COMPLETED|Overall Study||121||
48100160|NCT00056563|100572169|FG001|COMPLETED|Overall Study||134||
48100161|NCT00056563|100572168|FG000|NOT COMPLETED|Overall Study||0||
48100162|NCT00056563|100572169|FG001|NOT COMPLETED|Overall Study||0||
48100163|NCT03927612|100572170|FG000|STARTED|Overall Study||24||
48100164|NCT03927612|100572171|FG001|STARTED|Overall Study||24||
48546909|NCT02960490|101671519|FG007|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0||
48546910|NCT02960490|101671520|FG008|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0||
48100165|NCT03927612|100572170|FG000|COMPLETED|Overall Study||24||
48100166|NCT03927612|100572171|FG001|COMPLETED|Overall Study||24||
48100167|NCT03927612|100572170|FG000|NOT COMPLETED|Overall Study||0||
48100168|NCT03927612|100572171|FG001|NOT COMPLETED|Overall Study||0||
48100169|NCT00861146|100572172|FG000|STARTED|Overall Study||105||
48100170|NCT00861146|100572173|FG001|STARTED|Overall Study||46||
48100171|NCT00861146|100572172|FG000|Week 2 Assessment|Overall Study||97||
48100172|NCT00861146|100572173|FG001|Week 2 Assessment|Overall Study||45||
48100173|NCT00861146|100572172|FG000|Week 13 Assessment|Overall Study||85||
48100174|NCT00861146|100572173|FG001|Week 13 Assessment|Overall Study||38||
48100175|NCT00861146|100572172|FG000|COMPLETED|Overall Study||85||
48100176|NCT00861146|100572173|FG001|COMPLETED|Overall Study||38||
48100177|NCT00861146|100572172|FG000|NOT COMPLETED|Overall Study||20||
48100178|NCT00861146|100572173|FG001|NOT COMPLETED|Overall Study||8||
48100179|NCT00413192|100572174|FG000|STARTED|Overall Study||37||
48100180|NCT00413192|100572175|FG001|STARTED|Overall Study||40||
48100181|NCT00413192|100572176|FG002|STARTED|Overall Study||19||
48100182|NCT00413192|100572177|FG003|STARTED|Overall Study||32||
48100183|NCT00413192|100572174|FG000|COMPLETED|Overall Study||0||
48100184|NCT00413192|100572175|FG001|COMPLETED|Overall Study||0||
48100185|NCT00413192|100572176|FG002|COMPLETED|Overall Study||0||
48100186|NCT00413192|100572177|FG003|COMPLETED|Overall Study||0||
48263396|NCT03054337|100966750|FG003|COMPLETED|Dose Adjustment and Maintenance Period||5||
48263397|NCT03054337|100966751|FG004|COMPLETED|Dose Adjustment and Maintenance Period||4||
48263398|NCT03054337|100966752|FG005|COMPLETED|Dose Adjustment and Maintenance Period||4||
48263399|NCT03054337|100966747|FG000|NOT COMPLETED|Dose Adjustment and Maintenance Period||1||
48263400|NCT03054337|100966748|FG001|NOT COMPLETED|Dose Adjustment and Maintenance Period||2||
48263401|NCT03054337|100966749|FG002|NOT COMPLETED|Dose Adjustment and Maintenance Period||1||
48263402|NCT03054337|100966750|FG003|NOT COMPLETED|Dose Adjustment and Maintenance Period||0||
48263403|NCT03054337|100966751|FG004|NOT COMPLETED|Dose Adjustment and Maintenance Period||0||
48263404|NCT03054337|100966752|FG005|NOT COMPLETED|Dose Adjustment and Maintenance Period||1||
48263405|NCT02080403|100966753|FG000|STARTED|Overall Study||146||
48263406|NCT02080403|100966754|FG001|STARTED|Overall Study||144||
48263407|NCT02080403|100966753|FG000|COMPLETED|Overall Study||131||
48263408|NCT02080403|100966754|FG001|COMPLETED|Overall Study||132||
48390635|NCT03627494|101283635|FG006|STARTED|Part A Period 2 (4 Days)||0||
48390636|NCT03627494|101283636|FG007|STARTED|Part A Period 2 (4 Days)||0||
48390637|NCT03627494|101283637|FG008|STARTED|Part A Period 2 (4 Days)||0||
48390638|NCT03627494|101283638|FG009|STARTED|Part A Period 2 (4 Days)||0||
48390639|NCT03627494|101283639|FG010|STARTED|Part A Period 2 (4 Days)||0||
48390640|NCT03627494|101283640|FG011|STARTED|Part A Period 2 (4 Days)||0||
48390641|NCT03627494|101283629|FG000|COMPLETED|Part A Period 2 (4 Days)||3||
48390642|NCT03627494|101283630|FG001|COMPLETED|Part A Period 2 (4 Days)||3||
48390643|NCT03627494|101283631|FG002|COMPLETED|Part A Period 2 (4 Days)||3||
48390644|NCT03627494|101283632|FG003|COMPLETED|Part A Period 2 (4 Days)||3||
48390645|NCT03627494|101283633|FG004|COMPLETED|Part A Period 2 (4 Days)||3||
48390646|NCT03627494|101283634|FG005|COMPLETED|Part A Period 2 (4 Days)||3||
48390647|NCT03627494|101283635|FG006|COMPLETED|Part A Period 2 (4 Days)||0||
48390648|NCT03627494|101283636|FG007|COMPLETED|Part A Period 2 (4 Days)||0||
48390649|NCT03627494|101283637|FG008|COMPLETED|Part A Period 2 (4 Days)||0||
48390650|NCT03627494|101283638|FG009|COMPLETED|Part A Period 2 (4 Days)||0||
48390651|NCT03627494|101283639|FG010|COMPLETED|Part A Period 2 (4 Days)||0||
48390652|NCT03627494|101283640|FG011|COMPLETED|Part A Period 2 (4 Days)||0||
48390653|NCT03627494|101283629|FG000|NOT COMPLETED|Part A Period 2 (4 Days)||0||
48390654|NCT03627494|101283630|FG001|NOT COMPLETED|Part A Period 2 (4 Days)||0||
48390655|NCT03627494|101283631|FG002|NOT COMPLETED|Part A Period 2 (4 Days)||0||
48390656|NCT03627494|101283632|FG003|NOT COMPLETED|Part A Period 2 (4 Days)||0||
48390657|NCT03627494|101283633|FG004|NOT COMPLETED|Part A Period 2 (4 Days)||0||
48390658|NCT03627494|101283634|FG005|NOT COMPLETED|Part A Period 2 (4 Days)||0||
48390659|NCT03627494|101283635|FG006|NOT COMPLETED|Part A Period 2 (4 Days)||0||
48390660|NCT03627494|101283636|FG007|NOT COMPLETED|Part A Period 2 (4 Days)||0||
48390661|NCT03627494|101283637|FG008|NOT COMPLETED|Part A Period 2 (4 Days)||0||
48390662|NCT03627494|101283638|FG009|NOT COMPLETED|Part A Period 2 (4 Days)||0||
48390663|NCT03627494|101283639|FG010|NOT COMPLETED|Part A Period 2 (4 Days)||0||
48390664|NCT03627494|101283640|FG011|NOT COMPLETED|Part A Period 2 (4 Days)||0||
48390665|NCT03627494|101283629|FG000|STARTED|Part A Washout 2 (7 Days)||3||
48390666|NCT03627494|101283630|FG001|STARTED|Part A Washout 2 (7 Days)||3||
48390667|NCT03627494|101283631|FG002|STARTED|Part A Washout 2 (7 Days)||3||
48390668|NCT03627494|101283632|FG003|STARTED|Part A Washout 2 (7 Days)||3||
48390669|NCT03627494|101283633|FG004|STARTED|Part A Washout 2 (7 Days)||3||
48390670|NCT03627494|101283634|FG005|STARTED|Part A Washout 2 (7 Days)||3||
48390671|NCT03627494|101283635|FG006|STARTED|Part A Washout 2 (7 Days)||0||
48390672|NCT03627494|101283636|FG007|STARTED|Part A Washout 2 (7 Days)||0||
48710799|NCT01012921|102078021|FG000|NOT COMPLETED|Overall Study||10||
48263409|NCT02080403|100966753|FG000|NOT COMPLETED|Overall Study||15||
48263410|NCT02080403|100966754|FG001|NOT COMPLETED|Overall Study||12||
48263411|NCT02547441|100966755|FG000|STARTED|Double-Blind Study Period||235||
48263412|NCT02547441|100966756|FG001|STARTED|Double-Blind Study Period||228||
48263413|NCT02547441|100966755|FG000|COMPLETED|Double-Blind Study Period||211||
48263414|NCT02547441|100966756|FG001|COMPLETED|Double-Blind Study Period||196||
48263415|NCT02547441|100966755|FG000|NOT COMPLETED|Double-Blind Study Period||24||
48263416|NCT02547441|100966756|FG001|NOT COMPLETED|Double-Blind Study Period||32||
48263417|NCT02547441|100966755|FG000|STARTED|Open-Label Study Period||188||
48263418|NCT02547441|100966756|FG001|STARTED|Open-Label Study Period||175||
48263419|NCT02547441|100966755|FG000|COMPLETED|Open-Label Study Period||66||
48263420|NCT02547441|100966756|FG001|COMPLETED|Open-Label Study Period||48||
48263421|NCT02547441|100966755|FG000|NOT COMPLETED|Open-Label Study Period||122||
48263422|NCT02547441|100966756|FG001|NOT COMPLETED|Open-Label Study Period||127||
48263423|NCT02872012|100966757|FG000|STARTED|Overall Study||4||
48263424|NCT02872012|100966758|FG001|STARTED|Overall Study||7||
48263425|NCT02872012|100966759|FG002|STARTED|Overall Study||4||
48263426|NCT02872012|100966760|FG003|STARTED|Overall Study||3||
48263427|NCT02872012|100966761|FG004|STARTED|Overall Study||5||
48263428|NCT02872012|100966757|FG000|COMPLETED|Overall Study||3||
48263429|NCT02872012|100966758|FG001|COMPLETED|Overall Study||7||
48390673|NCT03627494|101283637|FG008|STARTED|Part A Washout 2 (7 Days)||0||
48390674|NCT03627494|101283638|FG009|STARTED|Part A Washout 2 (7 Days)||0||
48390675|NCT03627494|101283639|FG010|STARTED|Part A Washout 2 (7 Days)||0||
48390676|NCT03627494|101283640|FG011|STARTED|Part A Washout 2 (7 Days)||0||
48390677|NCT03627494|101283629|FG000|COMPLETED|Part A Washout 2 (7 Days)||2||
48546911|NCT02960490|101671521|FG009|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0||
48546912|NCT02960490|101671512|FG000|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||29||
48546913|NCT02960490|101671513|FG001|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||26||
48546914|NCT02960490|101671514|FG002|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0||
48546915|NCT02960490|101671515|FG003|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0||
48546916|NCT02960490|101671516|FG004|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0||
48546917|NCT02960490|101671517|FG005|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0||
48546918|NCT02960490|101671518|FG006|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0||
48546919|NCT02960490|101671519|FG007|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0||
48546920|NCT02960490|101671520|FG008|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0||
48546921|NCT02960490|101671521|FG009|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0||
48546922|NCT02960490|101671512|FG000|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||5||
48546923|NCT02960490|101671513|FG001|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||6||
48546924|NCT02960490|101671514|FG002|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0||
48546925|NCT02960490|101671515|FG003|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0||
48546926|NCT02960490|101671516|FG004|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0||
48546927|NCT02960490|101671517|FG005|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0||
48546928|NCT02960490|101671518|FG006|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0||
48546929|NCT02960490|101671519|FG007|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0||
48546930|NCT02960490|101671520|FG008|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0||
48546931|NCT02960490|101671521|FG009|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0||
48546932|NCT02960490|101671512|FG000|STARTED|Re-randomized Participants: 12 Weeks||0||
48546933|NCT02960490|101671513|FG001|STARTED|Re-randomized Participants: 12 Weeks||0||
48546934|NCT02960490|101671514|FG002|STARTED|Re-randomized Participants: 12 Weeks||15||
48546935|NCT02960490|101671515|FG003|STARTED|Re-randomized Participants: 12 Weeks||14||
48546936|NCT02960490|101671516|FG004|STARTED|Re-randomized Participants: 12 Weeks||14||
48546937|NCT02960490|101671517|FG005|STARTED|Re-randomized Participants: 12 Weeks||12||
48546938|NCT02960490|101671518|FG006|STARTED|Re-randomized Participants: 12 Weeks||0||
48546939|NCT02960490|101671519|FG007|STARTED|Re-randomized Participants: 12 Weeks||0||
48546940|NCT02960490|101671520|FG008|STARTED|Re-randomized Participants: 12 Weeks||0||
48546941|NCT02960490|101671521|FG009|STARTED|Re-randomized Participants: 12 Weeks||0||
48546942|NCT02960490|101671512|FG000|Treated|Re-randomized Participants: 12 Weeks||0||
48546943|NCT02960490|101671513|FG001|Treated|Re-randomized Participants: 12 Weeks||0||
48546944|NCT02960490|101671514|FG002|Treated|Re-randomized Participants: 12 Weeks||15||
48546945|NCT02960490|101671515|FG003|Treated|Re-randomized Participants: 12 Weeks||14||
48546946|NCT02960490|101671516|FG004|Treated|Re-randomized Participants: 12 Weeks||14||
48546947|NCT02960490|101671517|FG005|Treated|Re-randomized Participants: 12 Weeks||12||
48546948|NCT02960490|101671518|FG006|Treated|Re-randomized Participants: 12 Weeks||0||
48546949|NCT02960490|101671519|FG007|Treated|Re-randomized Participants: 12 Weeks||0||
48546950|NCT02960490|101671520|FG008|Treated|Re-randomized Participants: 12 Weeks||0||
48546951|NCT02960490|101671521|FG009|Treated|Re-randomized Participants: 12 Weeks||0||
48546952|NCT02960490|101671512|FG000|FAS|Re-randomized Participants: 12 Weeks||0||
48546953|NCT02960490|101671513|FG001|FAS|Re-randomized Participants: 12 Weeks||0||
48546954|NCT02960490|101671514|FG002|FAS|Re-randomized Participants: 12 Weeks||15||
48546955|NCT02960490|101671515|FG003|FAS|Re-randomized Participants: 12 Weeks||14||
48546956|NCT02960490|101671516|FG004|FAS|Re-randomized Participants: 12 Weeks||14||
48546957|NCT02960490|101671517|FG005|FAS|Re-randomized Participants: 12 Weeks||12||
48546958|NCT02960490|101671518|FG006|FAS|Re-randomized Participants: 12 Weeks||0||
48546959|NCT02960490|101671519|FG007|FAS|Re-randomized Participants: 12 Weeks||0||
48546960|NCT02960490|101671520|FG008|FAS|Re-randomized Participants: 12 Weeks||0||
48546961|NCT02960490|101671521|FG009|FAS|Re-randomized Participants: 12 Weeks||0||
48546962|NCT02960490|101671512|FG000|SAS|Re-randomized Participants: 12 Weeks||0||
48546963|NCT02960490|101671513|FG001|SAS|Re-randomized Participants: 12 Weeks||0||
48546964|NCT02960490|101671514|FG002|SAS|Re-randomized Participants: 12 Weeks||15||
48546965|NCT02960490|101671515|FG003|SAS|Re-randomized Participants: 12 Weeks||14||
48546966|NCT02960490|101671516|FG004|SAS|Re-randomized Participants: 12 Weeks||14||
48546967|NCT02960490|101671517|FG005|SAS|Re-randomized Participants: 12 Weeks||12||
48546968|NCT02960490|101671518|FG006|SAS|Re-randomized Participants: 12 Weeks||0||
48546969|NCT02960490|101671519|FG007|SAS|Re-randomized Participants: 12 Weeks||0||
48546970|NCT02960490|101671520|FG008|SAS|Re-randomized Participants: 12 Weeks||0||
48546971|NCT02960490|101671521|FG009|SAS|Re-randomized Participants: 12 Weeks||0||
48546972|NCT02960490|101671512|FG000|COMPLETED|Re-randomized Participants: 12 Weeks||0||
48546973|NCT02960490|101671513|FG001|COMPLETED|Re-randomized Participants: 12 Weeks||0||
48546974|NCT02960490|101671514|FG002|COMPLETED|Re-randomized Participants: 12 Weeks||13||
48546975|NCT02960490|101671515|FG003|COMPLETED|Re-randomized Participants: 12 Weeks||12||
48546976|NCT02960490|101671516|FG004|COMPLETED|Re-randomized Participants: 12 Weeks||13||
48546977|NCT02960490|101671517|FG005|COMPLETED|Re-randomized Participants: 12 Weeks||10||
48546978|NCT02960490|101671518|FG006|COMPLETED|Re-randomized Participants: 12 Weeks||0||
48546979|NCT02960490|101671519|FG007|COMPLETED|Re-randomized Participants: 12 Weeks||0||
48546980|NCT02960490|101671520|FG008|COMPLETED|Re-randomized Participants: 12 Weeks||0||
48710800|NCT01012921|102078022|FG001|NOT COMPLETED|Overall Study||13||
48690804|NCT00887159|102025926|FG001|Eligible/Treated Pts With CTCs Results|Overall Study||42||
48690805|NCT00887159|102025927|FG002|Eligible/Treated Pts With CTCs Results|Overall Study||38||
48690806|NCT00887159|102025925|FG000|COMPLETED|Overall Study||27||
48690807|NCT00887159|102025926|FG001|COMPLETED|Overall Study||0||
48690808|NCT00887159|102025927|FG002|COMPLETED|Overall Study||0||
48690809|NCT00887159|102025925|FG000|NOT COMPLETED|Overall Study||29||
48690810|NCT00887159|102025926|FG001|NOT COMPLETED|Overall Study||56||
48100187|NCT00413192|100572174|FG000|NOT COMPLETED|Overall Study||37||
48100188|NCT00413192|100572175|FG001|NOT COMPLETED|Overall Study||40||
48100189|NCT00413192|100572176|FG002|NOT COMPLETED|Overall Study||19||
48100190|NCT00413192|100572177|FG003|NOT COMPLETED|Overall Study||32||
48100191|NCT02608268|100572178|FG000|STARTED|Overall Study||14||
48100192|NCT02608268|100572179|FG001|STARTED|Overall Study||9||
48100193|NCT02608268|100572180|FG002|STARTED|Overall Study||16||
48100194|NCT02608268|100572181|FG003|STARTED|Overall Study||5||
48263430|NCT02872012|100966759|FG002|COMPLETED|Overall Study||4||
48263431|NCT02872012|100966760|FG003|COMPLETED|Overall Study||3||
48263432|NCT02872012|100966761|FG004|COMPLETED|Overall Study||5||
48263433|NCT02872012|100966757|FG000|NOT COMPLETED|Overall Study||1||
48263434|NCT02872012|100966758|FG001|NOT COMPLETED|Overall Study||0||
48263435|NCT02872012|100966759|FG002|NOT COMPLETED|Overall Study||0||
48263436|NCT02872012|100966760|FG003|NOT COMPLETED|Overall Study||0||
48263437|NCT02872012|100966761|FG004|NOT COMPLETED|Overall Study||0||
48263438|NCT03004404|100966762|FG000|STARTED|Period 1||18||
48263439|NCT03004404|100966763|FG001|STARTED|Period 1||6||
48263440|NCT03004404|100966764|FG002|STARTED|Period 1||6||
48263441|NCT03004404|100966765|FG003|STARTED|Period 1||6||
48390678|NCT03627494|101283630|FG001|COMPLETED|Part A Washout 2 (7 Days)||3||
48390679|NCT03627494|101283631|FG002|COMPLETED|Part A Washout 2 (7 Days)||2||
48390680|NCT03627494|101283632|FG003|COMPLETED|Part A Washout 2 (7 Days)||3||
48390681|NCT03627494|101283633|FG004|COMPLETED|Part A Washout 2 (7 Days)||3||
48390682|NCT03627494|101283634|FG005|COMPLETED|Part A Washout 2 (7 Days)||3||
48390683|NCT03627494|101283635|FG006|COMPLETED|Part A Washout 2 (7 Days)||0||
48390684|NCT03627494|101283636|FG007|COMPLETED|Part A Washout 2 (7 Days)||0||
48390685|NCT03627494|101283637|FG008|COMPLETED|Part A Washout 2 (7 Days)||0||
48390686|NCT03627494|101283638|FG009|COMPLETED|Part A Washout 2 (7 Days)||0||
48390687|NCT03627494|101283639|FG010|COMPLETED|Part A Washout 2 (7 Days)||0||
48390688|NCT03627494|101283640|FG011|COMPLETED|Part A Washout 2 (7 Days)||0||
48390689|NCT03627494|101283629|FG000|NOT COMPLETED|Part A Washout 2 (7 Days)||1||
48390690|NCT03627494|101283630|FG001|NOT COMPLETED|Part A Washout 2 (7 Days)||0||
48390691|NCT03627494|101283631|FG002|NOT COMPLETED|Part A Washout 2 (7 Days)||1||
48390692|NCT03627494|101283632|FG003|NOT COMPLETED|Part A Washout 2 (7 Days)||0||
48390693|NCT03627494|101283633|FG004|NOT COMPLETED|Part A Washout 2 (7 Days)||0||
48390694|NCT03627494|101283634|FG005|NOT COMPLETED|Part A Washout 2 (7 Days)||0||
48390695|NCT03627494|101283635|FG006|NOT COMPLETED|Part A Washout 2 (7 Days)||0||
48390696|NCT03627494|101283636|FG007|NOT COMPLETED|Part A Washout 2 (7 Days)||0||
48390697|NCT03627494|101283637|FG008|NOT COMPLETED|Part A Washout 2 (7 Days)||0||
48390698|NCT03627494|101283638|FG009|NOT COMPLETED|Part A Washout 2 (7 Days)||0||
48390699|NCT03627494|101283639|FG010|NOT COMPLETED|Part A Washout 2 (7 Days)||0||
48390700|NCT03627494|101283640|FG011|NOT COMPLETED|Part A Washout 2 (7 Days)||0||
48390701|NCT03627494|101283629|FG000|STARTED|Part A Period3(4days)+Follow-up(14days)||2||
48390702|NCT03627494|101283630|FG001|STARTED|Part A Period3(4days)+Follow-up(14days)||3||
48390703|NCT03627494|101283631|FG002|STARTED|Part A Period3(4days)+Follow-up(14days)||2||
48690811|NCT00887159|102025927|FG002|NOT COMPLETED|Overall Study||56||
48690812|NCT00851890|102025928|FG000|STARTED|Overall Study||8||
48690813|NCT00851890|102025929|FG001|STARTED|Overall Study||8||
48690814|NCT00851890|102025930|FG002|STARTED|Overall Study||8||
48690815|NCT00851890|102025931|FG003|STARTED|Overall Study||6||
48690816|NCT00851890|102025928|FG000|COMPLETED|Overall Study||8||
48690817|NCT00851890|102025929|FG001|COMPLETED|Overall Study||7||
48690818|NCT00851890|102025930|FG002|COMPLETED|Overall Study||8||
48690819|NCT00851890|102025931|FG003|COMPLETED|Overall Study||5||
48690820|NCT00851890|102025928|FG000|NOT COMPLETED|Overall Study||0||
48690821|NCT00851890|102025929|FG001|NOT COMPLETED|Overall Study||1||
48690822|NCT00851890|102025930|FG002|NOT COMPLETED|Overall Study||0||
48690823|NCT00851890|102025931|FG003|NOT COMPLETED|Overall Study||1||
48690824|NCT01541735|102025932|FG000|STARTED|Overall Study||7||
48690825|NCT01541735|102025933|FG001|STARTED|Overall Study||7||
48690826|NCT01541735|102025932|FG000|COMPLETED|Overall Study||7||
48690827|NCT01541735|102025933|FG001|COMPLETED|Overall Study||7||
48100195|NCT02608268|100572182|FG004|STARTED|Overall Study||2||
48390704|NCT03627494|101283632|FG003|STARTED|Part A Period3(4days)+Follow-up(14days)||3||
48390705|NCT03627494|101283633|FG004|STARTED|Part A Period3(4days)+Follow-up(14days)||3||
48690828|NCT01541735|102025932|FG000|NOT COMPLETED|Overall Study||0||
48690829|NCT01541735|102025933|FG001|NOT COMPLETED|Overall Study||0||
48690830|NCT03697161|102025934|FG000|STARTED|Overall Study||7||
48690831|NCT03697161|102025935|FG001|STARTED|Overall Study||8||
48690832|NCT03697161|102025936|FG002|STARTED|Overall Study||8||
48263442|NCT03004404|100966766|FG004|STARTED|Period 1||6||
48690833|NCT03697161|102025934|FG000|COMPLETED|Overall Study||6||
48263443|NCT03004404|100966767|FG005|STARTED|Period 1||6||
48263444|NCT03004404|100966768|FG006|STARTED|Period 1||6||
48263445|NCT03004404|100966769|FG007|STARTED|Period 1||6||
48263446|NCT03004404|100966770|FG008|STARTED|Period 1||6||
48263447|NCT03004404|100966771|FG009|STARTED|Period 1||6||
48263448|NCT03004404|100966772|FG010|STARTED|Period 1||2||
48263449|NCT03004404|100966773|FG011|STARTED|Period 1||2||
48263450|NCT03004404|100966774|FG012|STARTED|Period 1||2||
48263451|NCT03004404|100966775|FG013|STARTED|Period 1||2||
48263452|NCT03004404|100966776|FG014|STARTED|Period 1||2||
48263453|NCT03004404|100966777|FG015|STARTED|Period 1||2||
48263454|NCT03004404|100966762|FG000|COMPLETED|Period 1||18||
48263455|NCT03004404|100966763|FG001|COMPLETED|Period 1||6||
48390706|NCT03627494|101283634|FG005|STARTED|Part A Period3(4days)+Follow-up(14days)||3||
48390707|NCT03627494|101283635|FG006|STARTED|Part A Period3(4days)+Follow-up(14days)||0||
48390708|NCT03627494|101283636|FG007|STARTED|Part A Period3(4days)+Follow-up(14days)||0||
48390709|NCT03627494|101283637|FG008|STARTED|Part A Period3(4days)+Follow-up(14days)||0||
48390710|NCT03627494|101283638|FG009|STARTED|Part A Period3(4days)+Follow-up(14days)||0||
48390711|NCT03627494|101283639|FG010|STARTED|Part A Period3(4days)+Follow-up(14days)||0||
48390712|NCT03627494|101283640|FG011|STARTED|Part A Period3(4days)+Follow-up(14days)||0||
48390713|NCT03627494|101283629|FG000|COMPLETED|Part A Period3(4days)+Follow-up(14days)||2||
48390714|NCT03627494|101283630|FG001|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3||
48390715|NCT03627494|101283631|FG002|COMPLETED|Part A Period3(4days)+Follow-up(14days)||2||
48390716|NCT03627494|101283632|FG003|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3||
48390717|NCT03627494|101283633|FG004|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3||
48390718|NCT03627494|101283634|FG005|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3||
48390719|NCT03627494|101283635|FG006|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
48390720|NCT03627494|101283636|FG007|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
48390721|NCT03627494|101283637|FG008|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
48390722|NCT03627494|101283638|FG009|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
48390723|NCT03627494|101283639|FG010|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
48390724|NCT03627494|101283640|FG011|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
48390725|NCT03627494|101283629|FG000|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
48390726|NCT03627494|101283630|FG001|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
48390727|NCT03627494|101283631|FG002|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
48390728|NCT03627494|101283632|FG003|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
48390729|NCT03627494|101283633|FG004|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
48390730|NCT03627494|101283634|FG005|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
48390731|NCT03627494|101283635|FG006|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
48390732|NCT03627494|101283636|FG007|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
48390733|NCT03627494|101283637|FG008|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
48390734|NCT03627494|101283638|FG009|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
48390735|NCT03627494|101283639|FG010|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
48390736|NCT03627494|101283640|FG011|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
48390737|NCT03627494|101283629|FG000|STARTED|Part B (Maximum of 34 Days)||0||
48390738|NCT03627494|101283630|FG001|STARTED|Part B (Maximum of 34 Days)||0||
48390739|NCT03627494|101283631|FG002|STARTED|Part B (Maximum of 34 Days)||0||
48390740|NCT03627494|101283632|FG003|STARTED|Part B (Maximum of 34 Days)||0||
48390741|NCT03627494|101283633|FG004|STARTED|Part B (Maximum of 34 Days)||0||
48690834|NCT03697161|102025935|FG001|COMPLETED|Overall Study||7||
48263456|NCT03004404|100966764|FG002|COMPLETED|Period 1||6||
48263457|NCT03004404|100966765|FG003|COMPLETED|Period 1||6||
48263458|NCT03004404|100966766|FG004|COMPLETED|Period 1||6||
48263459|NCT03004404|100966767|FG005|COMPLETED|Period 1||6||
48263460|NCT03004404|100966768|FG006|COMPLETED|Period 1||6||
48263461|NCT03004404|100966769|FG007|COMPLETED|Period 1||6||
48263462|NCT03004404|100966770|FG008|COMPLETED|Period 1||6||
48263463|NCT03004404|100966771|FG009|COMPLETED|Period 1||6||
48263464|NCT03004404|100966772|FG010|COMPLETED|Period 1||2||
48263465|NCT03004404|100966773|FG011|COMPLETED|Period 1||2||
48263466|NCT03004404|100966774|FG012|COMPLETED|Period 1||2||
48263467|NCT03004404|100966775|FG013|COMPLETED|Period 1||2||
48263468|NCT03004404|100966776|FG014|COMPLETED|Period 1||2||
48263469|NCT03004404|100966777|FG015|COMPLETED|Period 1||2||
48263470|NCT03004404|100966762|FG000|NOT COMPLETED|Period 1||0||
48263471|NCT03004404|100966763|FG001|NOT COMPLETED|Period 1||0||
48263472|NCT03004404|100966764|FG002|NOT COMPLETED|Period 1||0||
48263473|NCT03004404|100966765|FG003|NOT COMPLETED|Period 1||0||
48263474|NCT03004404|100966766|FG004|NOT COMPLETED|Period 1||0||
48263475|NCT03004404|100966767|FG005|NOT COMPLETED|Period 1||0||
48263476|NCT03004404|100966768|FG006|NOT COMPLETED|Period 1||0||
48263477|NCT03004404|100966769|FG007|NOT COMPLETED|Period 1||0||
48263478|NCT03004404|100966770|FG008|NOT COMPLETED|Period 1||0||
48263479|NCT03004404|100966771|FG009|NOT COMPLETED|Period 1||0||
48390742|NCT03627494|101283634|FG005|STARTED|Part B (Maximum of 34 Days)||0||
48263480|NCT03004404|100966772|FG010|NOT COMPLETED|Period 1||0||
48263481|NCT03004404|100966773|FG011|NOT COMPLETED|Period 1||0||
48263482|NCT03004404|100966774|FG012|NOT COMPLETED|Period 1||0||
48263483|NCT03004404|100966775|FG013|NOT COMPLETED|Period 1||0||
48263484|NCT03004404|100966776|FG014|NOT COMPLETED|Period 1||0||
48263485|NCT03004404|100966777|FG015|NOT COMPLETED|Period 1||0||
48263486|NCT03004404|100966762|FG000|STARTED|Period 2||0||
48263487|NCT03004404|100966763|FG001|STARTED|Period 2||0||
48263488|NCT03004404|100966764|FG002|STARTED|Period 2||0||
48263489|NCT03004404|100966765|FG003|STARTED|Period 2||0||
48263490|NCT03004404|100966766|FG004|STARTED|Period 2||0||
48690835|NCT03697161|102025936|FG002|COMPLETED|Overall Study||7||
48690836|NCT03697161|102025934|FG000|NOT COMPLETED|Overall Study||1||
48690837|NCT03697161|102025935|FG001|NOT COMPLETED|Overall Study||1||
48690838|NCT03697161|102025936|FG002|NOT COMPLETED|Overall Study||1||
48690839|NCT00703846|102025937|FG000|STARTED|Overall Study||500||
48690840|NCT00703846|102025937|FG000|COMPLETED|Overall Study||363||
48690841|NCT00703846|102025937|FG000|NOT COMPLETED|Overall Study||137||
48690842|NCT00353301|102025938|FG000|STARTED|Overall Study||25||
48690843|NCT00353301|102025938|FG000|COMPLETED|Overall Study||25||
48263491|NCT03004404|100966767|FG005|STARTED|Period 2||0||
48263492|NCT03004404|100966768|FG006|STARTED|Period 2||0||
48390743|NCT03627494|101283635|FG006|STARTED|Part B (Maximum of 34 Days)||9||
48690844|NCT00353301|102025938|FG000|NOT COMPLETED|Overall Study||0||
48690845|NCT01496287|102025939|FG000|STARTED|Overall Study||70||
48263493|NCT03004404|100966769|FG007|STARTED|Period 2||0||
48263494|NCT03004404|100966770|FG008|STARTED|Period 2||6||
48263495|NCT03004404|100966771|FG009|STARTED|Period 2||0||
48263496|NCT03004404|100966772|FG010|STARTED|Period 2||2||
48263497|NCT03004404|100966773|FG011|STARTED|Period 2||2||
48263498|NCT03004404|100966774|FG012|STARTED|Period 2||2||
48263499|NCT03004404|100966775|FG013|STARTED|Period 2||2||
48263500|NCT03004404|100966776|FG014|STARTED|Period 2||2||
48263501|NCT03004404|100966777|FG015|STARTED|Period 2||2||
48263502|NCT03004404|100966762|FG000|COMPLETED|Period 2||0||
48263503|NCT03004404|100966763|FG001|COMPLETED|Period 2||0||
48263504|NCT03004404|100966764|FG002|COMPLETED|Period 2||0||
48263505|NCT03004404|100966765|FG003|COMPLETED|Period 2||0||
48263506|NCT03004404|100966766|FG004|COMPLETED|Period 2||0||
48263507|NCT03004404|100966767|FG005|COMPLETED|Period 2||0||
48263508|NCT03004404|100966768|FG006|COMPLETED|Period 2||0||
48390744|NCT03627494|101283636|FG007|STARTED|Part B (Maximum of 34 Days)||9||
48390745|NCT03627494|101283637|FG008|STARTED|Part B (Maximum of 34 Days)||9||
48263509|NCT03004404|100966769|FG007|COMPLETED|Period 2||0||
48263510|NCT03004404|100966770|FG008|COMPLETED|Period 2||5||
48263511|NCT03004404|100966771|FG009|COMPLETED|Period 2||0||
48263512|NCT03004404|100966772|FG010|COMPLETED|Period 2||2||
48263513|NCT03004404|100966773|FG011|COMPLETED|Period 2||2||
48263514|NCT03004404|100966774|FG012|COMPLETED|Period 2||2||
48263515|NCT03004404|100966775|FG013|COMPLETED|Period 2||2||
48263516|NCT03004404|100966776|FG014|COMPLETED|Period 2||2||
48263517|NCT03004404|100966777|FG015|COMPLETED|Period 2||1||
48263518|NCT03004404|100966762|FG000|NOT COMPLETED|Period 2||0||
48263519|NCT03004404|100966763|FG001|NOT COMPLETED|Period 2||0||
48263520|NCT03004404|100966764|FG002|NOT COMPLETED|Period 2||0||
48263521|NCT03004404|100966765|FG003|NOT COMPLETED|Period 2||0||
48390746|NCT03627494|101283638|FG009|STARTED|Part B (Maximum of 34 Days)||9||
48390747|NCT03627494|101283639|FG010|STARTED|Part B (Maximum of 34 Days)||0||
48390748|NCT03627494|101283640|FG011|STARTED|Part B (Maximum of 34 Days)||0||
48690846|NCT01496287|102025939|FG000|COMPLETED|Overall Study||64||
48690847|NCT01496287|102025939|FG000|NOT COMPLETED|Overall Study||6||
48690848|NCT03115411|102025940|FG000|STARTED|Overall Study||23||
48690849|NCT03115411|102025940|FG000|COMPLETED|Overall Study||23||
48690850|NCT03115411|102025940|FG000|NOT COMPLETED|Overall Study||0||
48690851|NCT00375505|102025941|FG000|STARTED|Overall Study||36||
48690852|NCT00375505|102025942|FG001|STARTED|Overall Study||34||
48690853|NCT00375505|102025941|FG000|COMPLETED|Overall Study||35||
48690854|NCT00375505|102025942|FG001|COMPLETED|Overall Study||32||
48690855|NCT00375505|102025941|FG000|NOT COMPLETED|Overall Study||1||
48690856|NCT00375505|102025942|FG001|NOT COMPLETED|Overall Study||2||
48690857|NCT02702609|102025943|FG000|STARTED|Overall Study||24||
48690858|NCT02702609|102025944|FG001|STARTED|Overall Study||21||
48690859|NCT02702609|102025943|FG000|Implant Placement|Overall Study||23||
48690860|NCT02702609|102025944|FG001|Implant Placement|Overall Study||21||
48690861|NCT02702609|102025943|FG000|Crown Delivery|Overall Study||16||
48690862|NCT02702609|102025944|FG001|Crown Delivery|Overall Study||18||
48263522|NCT03004404|100966766|FG004|NOT COMPLETED|Period 2||0||
48263523|NCT03004404|100966767|FG005|NOT COMPLETED|Period 2||0||
48263524|NCT03004404|100966768|FG006|NOT COMPLETED|Period 2||0||
48263525|NCT03004404|100966769|FG007|NOT COMPLETED|Period 2||0||
48263526|NCT03004404|100966770|FG008|NOT COMPLETED|Period 2||1||
48263527|NCT03004404|100966771|FG009|NOT COMPLETED|Period 2||0||
48263528|NCT03004404|100966772|FG010|NOT COMPLETED|Period 2||0||
48263529|NCT03004404|100966773|FG011|NOT COMPLETED|Period 2||0||
48690863|NCT02702609|102025943|FG000|COMPLETED|Overall Study||15||
48690864|NCT02702609|102025944|FG001|COMPLETED|Overall Study||17||
48690865|NCT02702609|102025943|FG000|NOT COMPLETED|Overall Study||9||
48690866|NCT02702609|102025944|FG001|NOT COMPLETED|Overall Study||4||
48690867|NCT01014767|102025945|FG000|STARTED|Overall Study||12||
48263530|NCT03004404|100966774|FG012|NOT COMPLETED|Period 2||0||
48263531|NCT03004404|100966775|FG013|NOT COMPLETED|Period 2||0||
48263532|NCT03004404|100966776|FG014|NOT COMPLETED|Period 2||0||
48263533|NCT03004404|100966777|FG015|NOT COMPLETED|Period 2||1||
48690868|NCT01014767|102025946|FG001|STARTED|Overall Study||1||
48690869|NCT01014767|102025947|FG002|STARTED|Overall Study||4||
48690870|NCT01014767|102025948|FG003|STARTED|Overall Study||1||
48690871|NCT01014767|102025945|FG000|COMPLETED|Overall Study||0||
48690872|NCT01014767|102025946|FG001|COMPLETED|Overall Study||0||
48690873|NCT01014767|102025947|FG002|COMPLETED|Overall Study||0||
48690874|NCT01014767|102025948|FG003|COMPLETED|Overall Study||0||
48690875|NCT01014767|102025945|FG000|NOT COMPLETED|Overall Study||12||
48690876|NCT01014767|102025946|FG001|NOT COMPLETED|Overall Study||1||
48263534|NCT03004404|100966762|FG000|STARTED|Period 3||0||
48263535|NCT03004404|100966763|FG001|STARTED|Period 3||0||
48263536|NCT03004404|100966764|FG002|STARTED|Period 3||0||
48263537|NCT03004404|100966765|FG003|STARTED|Period 3||0||
48263538|NCT03004404|100966766|FG004|STARTED|Period 3||0||
48263539|NCT03004404|100966767|FG005|STARTED|Period 3||0||
48263540|NCT03004404|100966768|FG006|STARTED|Period 3||0||
48263541|NCT03004404|100966769|FG007|STARTED|Period 3||0||
48263542|NCT03004404|100966770|FG008|STARTED|Period 3||0||
48263543|NCT03004404|100966771|FG009|STARTED|Period 3||0||
48263544|NCT03004404|100966772|FG010|STARTED|Period 3||2||
48263545|NCT03004404|100966773|FG011|STARTED|Period 3||2||
48263546|NCT03004404|100966774|FG012|STARTED|Period 3||2||
48263547|NCT03004404|100966775|FG013|STARTED|Period 3||2||
48263548|NCT03004404|100966776|FG014|STARTED|Period 3||2||
48263549|NCT03004404|100966777|FG015|STARTED|Period 3||1||
48263550|NCT03004404|100966762|FG000|COMPLETED|Period 3||0||
48263551|NCT03004404|100966763|FG001|COMPLETED|Period 3||0||
48263552|NCT03004404|100966764|FG002|COMPLETED|Period 3||0||
48263553|NCT03004404|100966765|FG003|COMPLETED|Period 3||0||
48263554|NCT03004404|100966766|FG004|COMPLETED|Period 3||0||
48263555|NCT03004404|100966767|FG005|COMPLETED|Period 3||0||
48263556|NCT03004404|100966768|FG006|COMPLETED|Period 3||0||
48263557|NCT03004404|100966769|FG007|COMPLETED|Period 3||0||
48263558|NCT03004404|100966770|FG008|COMPLETED|Period 3||0||
48263559|NCT03004404|100966771|FG009|COMPLETED|Period 3||0||
48263560|NCT03004404|100966772|FG010|COMPLETED|Period 3||2||
48263561|NCT03004404|100966773|FG011|COMPLETED|Period 3||2||
48263562|NCT03004404|100966774|FG012|COMPLETED|Period 3||2||
48390749|NCT03627494|101283629|FG000|COMPLETED|Part B (Maximum of 34 Days)||0||
48390750|NCT03627494|101283630|FG001|COMPLETED|Part B (Maximum of 34 Days)||0||
48263563|NCT03004404|100966775|FG013|COMPLETED|Period 3||2||
48263564|NCT03004404|100966776|FG014|COMPLETED|Period 3||2||
48263565|NCT03004404|100966777|FG015|COMPLETED|Period 3||1||
48263566|NCT03004404|100966762|FG000|NOT COMPLETED|Period 3||0||
48263567|NCT03004404|100966763|FG001|NOT COMPLETED|Period 3||0||
48263568|NCT03004404|100966764|FG002|NOT COMPLETED|Period 3||0||
48263569|NCT03004404|100966765|FG003|NOT COMPLETED|Period 3||0||
48263570|NCT03004404|100966766|FG004|NOT COMPLETED|Period 3||0||
48263571|NCT03004404|100966767|FG005|NOT COMPLETED|Period 3||0||
48263572|NCT03004404|100966768|FG006|NOT COMPLETED|Period 3||0||
48263573|NCT03004404|100966769|FG007|NOT COMPLETED|Period 3||0||
48263574|NCT03004404|100966770|FG008|NOT COMPLETED|Period 3||0||
48263575|NCT03004404|100966771|FG009|NOT COMPLETED|Period 3||0||
48263576|NCT03004404|100966772|FG010|NOT COMPLETED|Period 3||0||
48263577|NCT03004404|100966773|FG011|NOT COMPLETED|Period 3||0||
48263578|NCT03004404|100966774|FG012|NOT COMPLETED|Period 3||0||
48263579|NCT03004404|100966775|FG013|NOT COMPLETED|Period 3||0||
48263580|NCT03004404|100966776|FG014|NOT COMPLETED|Period 3||0||
48263581|NCT03004404|100966777|FG015|NOT COMPLETED|Period 3||0||
48263582|NCT01343251|100966778|FG000|STARTED|Overall Study||16||
48263583|NCT01343251|100966779|FG001|STARTED|Overall Study||17||
48263584|NCT01343251|100966778|FG000|COMPLETED|Overall Study||16||
48690877|NCT01014767|102025947|FG002|NOT COMPLETED|Overall Study||4||
48690878|NCT01014767|102025948|FG003|NOT COMPLETED|Overall Study||1||
48690879|NCT01453036|102025949|FG000|STARTED|Overall Study||308||
48263585|NCT01343251|100966779|FG001|COMPLETED|Overall Study||17||
48263586|NCT01343251|100966778|FG000|NOT COMPLETED|Overall Study||0||
48263587|NCT01343251|100966779|FG001|NOT COMPLETED|Overall Study||0||
48263588|NCT03865953|100966780|FG000|STARTED|First Intervention (4 Weeks)||25||
48263589|NCT03865953|100966781|FG001|STARTED|First Intervention (4 Weeks)||28||
48263590|NCT03865953|100966780|FG000|COMPLETED|First Intervention (4 Weeks)||23||
48263591|NCT03865953|100966781|FG001|COMPLETED|First Intervention (4 Weeks)||27||
48263592|NCT03865953|100966780|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2||
48263593|NCT03865953|100966781|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1||
48263594|NCT03865953|100966780|FG000|STARTED|Washout/Baseline Period (3 Weeks)||23||
48263595|NCT03865953|100966781|FG001|STARTED|Washout/Baseline Period (3 Weeks)||27||
48690880|NCT01453036|102025950|FG001|STARTED|Overall Study||308||
48690881|NCT01453036|102025951|FG002|STARTED|Overall Study||308||
48690882|NCT01453036|102025949|FG000|COMPLETED|Overall Study||282||
48690883|NCT01453036|102025950|FG001|COMPLETED|Overall Study||193||
48263596|NCT03865953|100966780|FG000|COMPLETED|Washout/Baseline Period (3 Weeks)||23||
48263597|NCT03865953|100966781|FG001|COMPLETED|Washout/Baseline Period (3 Weeks)||27||
48263598|NCT03865953|100966780|FG000|NOT COMPLETED|Washout/Baseline Period (3 Weeks)||0||
48263599|NCT03865953|100966781|FG001|NOT COMPLETED|Washout/Baseline Period (3 Weeks)||0||
48690884|NCT01453036|102025951|FG002|COMPLETED|Overall Study||277||
48690885|NCT01453036|102025949|FG000|NOT COMPLETED|Overall Study||26||
48690886|NCT01453036|102025950|FG001|NOT COMPLETED|Overall Study||115||
48690887|NCT01453036|102025951|FG002|NOT COMPLETED|Overall Study||31||
48690888|NCT03506412|102025952|FG000|STARTED|Overall Study||18||
48690889|NCT03506412|102025953|FG001|STARTED|Overall Study||19||
48690890|NCT03506412|102025952|FG000|COMPLETED|Overall Study||18||
48690891|NCT03506412|102025953|FG001|COMPLETED|Overall Study||19||
48690892|NCT03506412|102025952|FG000|NOT COMPLETED|Overall Study||0||
48690893|NCT03506412|102025953|FG001|NOT COMPLETED|Overall Study||0||
48690894|NCT01169701|102025954|FG000|STARTED|Overall Study||36||
48690895|NCT01169701|102025955|FG001|STARTED|Overall Study||35||
48263600|NCT03865953|100966780|FG000|STARTED|Second Intervention (4 Weeks)||23||
48263601|NCT03865953|100966781|FG001|STARTED|Second Intervention (4 Weeks)||27||
48263602|NCT03865953|100966780|FG000|COMPLETED|Second Intervention (4 Weeks)||23||
48263603|NCT03865953|100966781|FG001|COMPLETED|Second Intervention (4 Weeks)||25||
48263604|NCT03865953|100966780|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0||
48263605|NCT03865953|100966781|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||2||
48263606|NCT02386839|100966782|FG000|STARTED|Overall Study||36||
48263607|NCT02386839|100966783|FG001|STARTED|Overall Study||40||
48263608|NCT02386839|100966782|FG000|COMPLETED|Overall Study||20||
48263609|NCT02386839|100966783|FG001|COMPLETED|Overall Study||25||
48263610|NCT02386839|100966782|FG000|NOT COMPLETED|Overall Study||16||
48263611|NCT02386839|100966783|FG001|NOT COMPLETED|Overall Study||15||
48263612|NCT00738283|100966784|FG000|STARTED|Overall Study||17||
48263613|NCT00738283|100966784|FG000|COMPLETED|Overall Study||13||
48546981|NCT02960490|101671521|FG009|COMPLETED|Re-randomized Participants: 12 Weeks||0||
48546982|NCT02960490|101671512|FG000|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0||
48546983|NCT02960490|101671513|FG001|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0||
48546984|NCT02960490|101671514|FG002|NOT COMPLETED|Re-randomized Participants: 12 Weeks||2||
48546985|NCT02960490|101671515|FG003|NOT COMPLETED|Re-randomized Participants: 12 Weeks||2||
48546986|NCT02960490|101671516|FG004|NOT COMPLETED|Re-randomized Participants: 12 Weeks||1||
48546987|NCT02960490|101671517|FG005|NOT COMPLETED|Re-randomized Participants: 12 Weeks||2||
48546988|NCT02960490|101671518|FG006|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0||
48546989|NCT02960490|101671519|FG007|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0||
48546990|NCT02960490|101671520|FG008|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0||
48546991|NCT02960490|101671521|FG009|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0||
48690896|NCT01169701|102025954|FG000|Safety Set|Overall Study||36||
48263614|NCT00738283|100966784|FG000|NOT COMPLETED|Overall Study||4||
48263615|NCT04396847|100966785|FG000|STARTED|Overall Study||1||
48390751|NCT03627494|101283631|FG002|COMPLETED|Part B (Maximum of 34 Days)||0||
48390752|NCT03627494|101283632|FG003|COMPLETED|Part B (Maximum of 34 Days)||0||
48390753|NCT03627494|101283633|FG004|COMPLETED|Part B (Maximum of 34 Days)||0||
48390754|NCT03627494|101283634|FG005|COMPLETED|Part B (Maximum of 34 Days)||0||
48390755|NCT03627494|101283635|FG006|COMPLETED|Part B (Maximum of 34 Days)||9||
48390756|NCT03627494|101283636|FG007|COMPLETED|Part B (Maximum of 34 Days)||9||
48390757|NCT03627494|101283637|FG008|COMPLETED|Part B (Maximum of 34 Days)||7||
48390758|NCT03627494|101283638|FG009|COMPLETED|Part B (Maximum of 34 Days)||9||
48390759|NCT03627494|101283639|FG010|COMPLETED|Part B (Maximum of 34 Days)||0||
48390760|NCT03627494|101283640|FG011|COMPLETED|Part B (Maximum of 34 Days)||0||
48390761|NCT03627494|101283629|FG000|NOT COMPLETED|Part B (Maximum of 34 Days)||0||
48390762|NCT03627494|101283630|FG001|NOT COMPLETED|Part B (Maximum of 34 Days)||0||
48390763|NCT03627494|101283631|FG002|NOT COMPLETED|Part B (Maximum of 34 Days)||0||
48390764|NCT03627494|101283632|FG003|NOT COMPLETED|Part B (Maximum of 34 Days)||0||
48390765|NCT03627494|101283633|FG004|NOT COMPLETED|Part B (Maximum of 34 Days)||0||
48390766|NCT03627494|101283634|FG005|NOT COMPLETED|Part B (Maximum of 34 Days)||0||
48390767|NCT03627494|101283635|FG006|NOT COMPLETED|Part B (Maximum of 34 Days)||0||
48390768|NCT03627494|101283636|FG007|NOT COMPLETED|Part B (Maximum of 34 Days)||0||
48390769|NCT03627494|101283637|FG008|NOT COMPLETED|Part B (Maximum of 34 Days)||2||
48390770|NCT03627494|101283638|FG009|NOT COMPLETED|Part B (Maximum of 34 Days)||0||
48546992|NCT02960490|101671512|FG000|STARTED|Extension Phase(Open-label): 80 Weeks||0||
48690897|NCT01169701|102025955|FG001|Safety Set|Overall Study||35||
48690898|NCT01169701|102025954|FG000|Intent to Treat (ITT) Set|Overall Study||32||
48690899|NCT01169701|102025955|FG001|Intent to Treat (ITT) Set|Overall Study||28||
48690900|NCT01169701|102025954|FG000|COMPLETED|Overall Study||31||
48690901|NCT01169701|102025955|FG001|COMPLETED|Overall Study||25||
48690902|NCT01169701|102025954|FG000|NOT COMPLETED|Overall Study||5||
48263616|NCT04396847|100966786|FG001|STARTED|Overall Study||0||
48263617|NCT04396847|100966785|FG000|COMPLETED|Overall Study||1||
48390771|NCT03627494|101283639|FG010|NOT COMPLETED|Part B (Maximum of 34 Days)||0||
48390772|NCT03627494|101283640|FG011|NOT COMPLETED|Part B (Maximum of 34 Days)||0||
48390773|NCT03627494|101283629|FG000|STARTED|Part C Period 1 (4 Days)||0||
48690903|NCT01169701|102025955|FG001|NOT COMPLETED|Overall Study||10||
48263618|NCT04396847|100966786|FG001|COMPLETED|Overall Study||0||
48263619|NCT04396847|100966785|FG000|NOT COMPLETED|Overall Study||0||
48690904|NCT00460655|102025956|FG000|STARTED|Double-Blind Phase (12 Weeks)||58||
48100196|NCT02608268|100572183|FG005|STARTED|Overall Study||4||
48100197|NCT02608268|100572184|FG006|STARTED|Overall Study||6||
48100198|NCT02608268|100572185|FG007|STARTED|Overall Study||2||
48100199|NCT02608268|100572186|FG008|STARTED|Overall Study||8||
48100200|NCT02608268|100572187|FG009|STARTED|Overall Study||9||
48100201|NCT02608268|100572188|FG010|STARTED|Overall Study||6||
48100202|NCT02608268|100572189|FG011|STARTED|Overall Study||6||
48100203|NCT02608268|100572190|FG012|STARTED|Overall Study||6||
48100204|NCT02608268|100572191|FG013|STARTED|Overall Study||13||
48100205|NCT02608268|100572192|FG014|STARTED|Overall Study||6||
48100206|NCT02608268|100572193|FG015|STARTED|Overall Study||5||
48100207|NCT02608268|100572194|FG016|STARTED|Overall Study||5||
48100208|NCT02608268|100572195|FG017|STARTED|Overall Study||6||
48100209|NCT02608268|100572196|FG018|STARTED|Overall Study||6||
48100210|NCT02608268|100572197|FG019|STARTED|Overall Study||3||
48100211|NCT02608268|100572198|FG020|STARTED|Overall Study||12||
48100212|NCT02608268|100572199|FG021|STARTED|Overall Study||5||
48100213|NCT02608268|100572200|FG022|STARTED|Overall Study||7||
48100214|NCT02608268|100572201|FG023|STARTED|Overall Study||6||
48100215|NCT02608268|100572202|FG024|STARTED|Overall Study||6||
48263620|NCT04396847|100966786|FG001|NOT COMPLETED|Overall Study||0||
48263621|NCT00696488|100966787|FG000|STARTED|Overall Study||20||
48263622|NCT00696488|100966787|FG000|COMPLETED|Overall Study||20||
48263623|NCT00696488|100966787|FG000|NOT COMPLETED|Overall Study||0||
48390774|NCT03627494|101283630|FG001|STARTED|Part C Period 1 (4 Days)||0||
48390775|NCT03627494|101283631|FG002|STARTED|Part C Period 1 (4 Days)||0||
48390776|NCT03627494|101283632|FG003|STARTED|Part C Period 1 (4 Days)||0||
48390777|NCT03627494|101283633|FG004|STARTED|Part C Period 1 (4 Days)||0||
48390778|NCT03627494|101283634|FG005|STARTED|Part C Period 1 (4 Days)||0||
48390779|NCT03627494|101283635|FG006|STARTED|Part C Period 1 (4 Days)||0||
48390780|NCT03627494|101283636|FG007|STARTED|Part C Period 1 (4 Days)||0||
48390781|NCT03627494|101283637|FG008|STARTED|Part C Period 1 (4 Days)||0||
48390782|NCT03627494|101283638|FG009|STARTED|Part C Period 1 (4 Days)||0||
48390783|NCT03627494|101283639|FG010|STARTED|Part C Period 1 (4 Days)||6||
48390784|NCT03627494|101283640|FG011|STARTED|Part C Period 1 (4 Days)||6||
48546993|NCT02960490|101671513|FG001|STARTED|Extension Phase(Open-label): 80 Weeks||0||
48546994|NCT02960490|101671514|FG002|STARTED|Extension Phase(Open-label): 80 Weeks||0||
48546995|NCT02960490|101671515|FG003|STARTED|Extension Phase(Open-label): 80 Weeks||0||
48546996|NCT02960490|101671516|FG004|STARTED|Extension Phase(Open-label): 80 Weeks||0||
48546997|NCT02960490|101671517|FG005|STARTED|Extension Phase(Open-label): 80 Weeks||0||
48546998|NCT02960490|101671518|FG006|STARTED|Extension Phase(Open-label): 80 Weeks||13||
48690905|NCT00460655|102025957|FG001|STARTED|Double-Blind Phase (12 Weeks)||62||
48690906|NCT00460655|102025958|FG002|STARTED|Double-Blind Phase (12 Weeks)||0||
48690907|NCT00460655|102025959|FG003|STARTED|Double-Blind Phase (12 Weeks)||0||
48690908|NCT00460655|102025956|FG000|COMPLETED|Double-Blind Phase (12 Weeks)||52||
48690909|NCT00460655|102025957|FG001|COMPLETED|Double-Blind Phase (12 Weeks)||61||
48100216|NCT02608268|100572203|FG025|STARTED|Overall Study||14||
48100217|NCT02608268|100572204|FG026|STARTED|Overall Study||17||
48100218|NCT02608268|100572205|FG027|STARTED|Overall Study||15||
48100219|NCT02608268|100572206|FG028|STARTED|Overall Study||17||
48100220|NCT02608268|100572207|FG029|STARTED|Overall Study||16||
48100221|NCT02608268|100572178|FG000|COMPLETED|Overall Study||0||
48100222|NCT02608268|100572179|FG001|COMPLETED|Overall Study||0||
48100223|NCT02608268|100572180|FG002|COMPLETED|Overall Study||0||
48100224|NCT02608268|100572181|FG003|COMPLETED|Overall Study||0||
48390785|NCT03627494|101283629|FG000|COMPLETED|Part C Period 1 (4 Days)||0||
48390786|NCT03627494|101283630|FG001|COMPLETED|Part C Period 1 (4 Days)||0||
48390787|NCT03627494|101283631|FG002|COMPLETED|Part C Period 1 (4 Days)||0||
48390788|NCT03627494|101283632|FG003|COMPLETED|Part C Period 1 (4 Days)||0||
48390789|NCT03627494|101283633|FG004|COMPLETED|Part C Period 1 (4 Days)||0||
48390790|NCT03627494|101283634|FG005|COMPLETED|Part C Period 1 (4 Days)||0||
48390791|NCT03627494|101283635|FG006|COMPLETED|Part C Period 1 (4 Days)||0||
48546999|NCT02960490|101671519|FG007|STARTED|Extension Phase(Open-label): 80 Weeks||11||
48547000|NCT02960490|101671520|FG008|STARTED|Extension Phase(Open-label): 80 Weeks||13||
48547001|NCT02960490|101671521|FG009|STARTED|Extension Phase(Open-label): 80 Weeks||10||
48547002|NCT02960490|101671512|FG000|Treated|Extension Phase(Open-label): 80 Weeks||0||
48547003|NCT02960490|101671513|FG001|Treated|Extension Phase(Open-label): 80 Weeks||0||
48547004|NCT02960490|101671514|FG002|Treated|Extension Phase(Open-label): 80 Weeks||0||
48100225|NCT02608268|100572182|FG004|COMPLETED|Overall Study||0||
48263624|NCT01844726|100966788|FG000|STARTED|Overall Study||22||
48390792|NCT03627494|101283636|FG007|COMPLETED|Part C Period 1 (4 Days)||0||
48690910|NCT00460655|102025958|FG002|COMPLETED|Double-Blind Phase (12 Weeks)||0||
48690911|NCT00460655|102025959|FG003|COMPLETED|Double-Blind Phase (12 Weeks)||0||
48263625|NCT01844726|100966789|FG001|STARTED|Overall Study||22||
48263626|NCT01844726|100966788|FG000|COMPLETED|Overall Study||21||
48263627|NCT01844726|100966789|FG001|COMPLETED|Overall Study||21||
48100226|NCT02608268|100572183|FG005|COMPLETED|Overall Study||0||
48100227|NCT02608268|100572184|FG006|COMPLETED|Overall Study||0||
48547005|NCT02960490|101671515|FG003|Treated|Extension Phase(Open-label): 80 Weeks||0||
48547006|NCT02960490|101671516|FG004|Treated|Extension Phase(Open-label): 80 Weeks||0||
48547007|NCT02960490|101671517|FG005|Treated|Extension Phase(Open-label): 80 Weeks||0||
48100228|NCT02608268|100572185|FG007|COMPLETED|Overall Study||0||
48100229|NCT02608268|100572186|FG008|COMPLETED|Overall Study||0||
48100230|NCT02608268|100572187|FG009|COMPLETED|Overall Study||0||
48100231|NCT02608268|100572188|FG010|COMPLETED|Overall Study||0||
48100232|NCT02608268|100572189|FG011|COMPLETED|Overall Study||0||
48100233|NCT02608268|100572190|FG012|COMPLETED|Overall Study||0||
48100234|NCT02608268|100572191|FG013|COMPLETED|Overall Study||0||
48100235|NCT02608268|100572192|FG014|COMPLETED|Overall Study||0||
48100236|NCT02608268|100572193|FG015|COMPLETED|Overall Study||0||
48100237|NCT02608268|100572194|FG016|COMPLETED|Overall Study||0||
48100238|NCT02608268|100572195|FG017|COMPLETED|Overall Study||0||
48100239|NCT02608268|100572196|FG018|COMPLETED|Overall Study||0||
48100240|NCT02608268|100572197|FG019|COMPLETED|Overall Study||0||
48100241|NCT02608268|100572198|FG020|COMPLETED|Overall Study||0||
48100242|NCT02608268|100572199|FG021|COMPLETED|Overall Study||0||
48100243|NCT02608268|100572200|FG022|COMPLETED|Overall Study||0||
48100244|NCT02608268|100572201|FG023|COMPLETED|Overall Study||0||
48100245|NCT02608268|100572202|FG024|COMPLETED|Overall Study||0||
48100246|NCT02608268|100572203|FG025|COMPLETED|Overall Study||0||
48100247|NCT02608268|100572204|FG026|COMPLETED|Overall Study||0||
48100248|NCT02608268|100572205|FG027|COMPLETED|Overall Study||0||
48100249|NCT02608268|100572206|FG028|COMPLETED|Overall Study||0||
48100250|NCT02608268|100572207|FG029|COMPLETED|Overall Study||0||
48100251|NCT02608268|100572178|FG000|NOT COMPLETED|Overall Study||14||
48100252|NCT02608268|100572179|FG001|NOT COMPLETED|Overall Study||9||
48100253|NCT02608268|100572180|FG002|NOT COMPLETED|Overall Study||16||
48100254|NCT02608268|100572181|FG003|NOT COMPLETED|Overall Study||5||
48100255|NCT02608268|100572182|FG004|NOT COMPLETED|Overall Study||2||
48100256|NCT02608268|100572183|FG005|NOT COMPLETED|Overall Study||4||
48100257|NCT02608268|100572184|FG006|NOT COMPLETED|Overall Study||6||
48100258|NCT02608268|100572185|FG007|NOT COMPLETED|Overall Study||2||
48100259|NCT02608268|100572186|FG008|NOT COMPLETED|Overall Study||8||
48100260|NCT02608268|100572187|FG009|NOT COMPLETED|Overall Study||9||
48100261|NCT02608268|100572188|FG010|NOT COMPLETED|Overall Study||6||
48100262|NCT02608268|100572189|FG011|NOT COMPLETED|Overall Study||6||
48100263|NCT02608268|100572190|FG012|NOT COMPLETED|Overall Study||6||
48100264|NCT02608268|100572191|FG013|NOT COMPLETED|Overall Study||13||
48100265|NCT02608268|100572192|FG014|NOT COMPLETED|Overall Study||6||
48100266|NCT02608268|100572193|FG015|NOT COMPLETED|Overall Study||5||
48100267|NCT02608268|100572194|FG016|NOT COMPLETED|Overall Study||5||
48100268|NCT02608268|100572195|FG017|NOT COMPLETED|Overall Study||6||
48100269|NCT02608268|100572196|FG018|NOT COMPLETED|Overall Study||6||
48100270|NCT02608268|100572197|FG019|NOT COMPLETED|Overall Study||3||
48100271|NCT02608268|100572198|FG020|NOT COMPLETED|Overall Study||12||
48100272|NCT02608268|100572199|FG021|NOT COMPLETED|Overall Study||5||
48100273|NCT02608268|100572200|FG022|NOT COMPLETED|Overall Study||7||
48100274|NCT02608268|100572201|FG023|NOT COMPLETED|Overall Study||6||
48100275|NCT02608268|100572202|FG024|NOT COMPLETED|Overall Study||6||
48547008|NCT02960490|101671518|FG006|Treated|Extension Phase(Open-label): 80 Weeks||13||
48100276|NCT02608268|100572203|FG025|NOT COMPLETED|Overall Study||14||
48100277|NCT02608268|100572204|FG026|NOT COMPLETED|Overall Study||17||
48100278|NCT02608268|100572205|FG027|NOT COMPLETED|Overall Study||15||
48100279|NCT02608268|100572206|FG028|NOT COMPLETED|Overall Study||17||
48100280|NCT02608268|100572207|FG029|NOT COMPLETED|Overall Study||16||
48547009|NCT02960490|101671519|FG007|Treated|Extension Phase(Open-label): 80 Weeks||11||
48547010|NCT02960490|101671520|FG008|Treated|Extension Phase(Open-label): 80 Weeks||13||
48547011|NCT02960490|101671521|FG009|Treated|Extension Phase(Open-label): 80 Weeks||10||
48547012|NCT02960490|101671512|FG000|FAS|Extension Phase(Open-label): 80 Weeks||0||
48547013|NCT02960490|101671513|FG001|FAS|Extension Phase(Open-label): 80 Weeks||0||
48547014|NCT02960490|101671514|FG002|FAS|Extension Phase(Open-label): 80 Weeks||0||
48547015|NCT02960490|101671515|FG003|FAS|Extension Phase(Open-label): 80 Weeks||0||
48547016|NCT02960490|101671516|FG004|FAS|Extension Phase(Open-label): 80 Weeks||0||
48100281|NCT01536379|100572208|FG000|STARTED|Overall Study||13||
48100282|NCT01536379|100572209|FG001|STARTED|Overall Study||12||
48100283|NCT01536379|100572208|FG000|COMPLETED|Overall Study||11||
48100284|NCT01536379|100572209|FG001|COMPLETED|Overall Study||9||
48100285|NCT01536379|100572208|FG000|NOT COMPLETED|Overall Study||2||
48100286|NCT01536379|100572209|FG001|NOT COMPLETED|Overall Study||3||
48710801|NCT00380029|102078023|FG000|STARTED|Overall Study||20||
48100287|NCT01075204|100572210|FG000|STARTED|Overall Study||335||
48100288|NCT01075204|100572210|FG000|COMPLETED|Overall Study||335||
48100289|NCT01075204|100572210|FG000|NOT COMPLETED|Overall Study||0||
48100290|NCT01951157|100572211|FG000|STARTED|Overall Study||22||
48100291|NCT01951157|100572212|FG001|STARTED|Overall Study||22||
48100292|NCT01951157|100572213|FG002|STARTED|Overall Study||25||
48100293|NCT01951157|100572211|FG000|COMPLETED|Overall Study||0||
48100294|NCT01951157|100572212|FG001|COMPLETED|Overall Study||0||
48100295|NCT01951157|100572213|FG002|COMPLETED|Overall Study||0||
48100296|NCT01951157|100572211|FG000|NOT COMPLETED|Overall Study||22||
48100297|NCT01951157|100572212|FG001|NOT COMPLETED|Overall Study||22||
48100298|NCT01951157|100572213|FG002|NOT COMPLETED|Overall Study||25||
48100299|NCT05319795|100572214|FG000|STARTED|Overall Study||5||
48100300|NCT05319795|100572214|FG000|COMPLETED|Overall Study||5||
48100301|NCT05319795|100572214|FG000|NOT COMPLETED|Overall Study||0||
48100302|NCT03240679|100572215|FG000|STARTED|Overall Study||1||
48100303|NCT03240679|100572216|FG001|STARTED|Overall Study||2||
48100304|NCT03240679|100572215|FG000|COMPLETED|Overall Study||1||
48100305|NCT03240679|100572216|FG001|COMPLETED|Overall Study||2||
48100306|NCT03240679|100572215|FG000|NOT COMPLETED|Overall Study||0||
48100307|NCT03240679|100572216|FG001|NOT COMPLETED|Overall Study||0||
48100308|NCT03616899|100572217|FG000|STARTED|Overall Study||447||
48100309|NCT03616899|100572218|FG001|STARTED|Overall Study||454||
48100310|NCT03616899|100572217|FG000|COMPLETED|Overall Study||437||
48100311|NCT03616899|100572218|FG001|COMPLETED|Overall Study||453||
48100312|NCT03616899|100572217|FG000|NOT COMPLETED|Overall Study||10||
48100313|NCT03616899|100572218|FG001|NOT COMPLETED|Overall Study||1||
48100314|NCT02420691|100572219|FG000|STARTED|Overall Study||20||
48100315|NCT02420691|100572219|FG000|COMPLETED|Overall Study||14||
48100316|NCT02420691|100572219|FG000|NOT COMPLETED|Overall Study||6||
48100317|NCT01245270|100572220|FG000|STARTED|Overall Study||4||
48100318|NCT01245270|100572221|FG001|STARTED|Overall Study||4||
48100319|NCT01245270|100572220|FG000|COMPLETED|Overall Study||4||
48100320|NCT01245270|100572221|FG001|COMPLETED|Overall Study||4||
48100321|NCT01245270|100572220|FG000|NOT COMPLETED|Overall Study||0||
48100322|NCT01245270|100572221|FG001|NOT COMPLETED|Overall Study||0||
48100323|NCT02225743|100572222|FG000|STARTED|Overall Study||120||
48100324|NCT02225743|100572222|FG000|COMPLETED|Overall Study||102||
48100325|NCT02225743|100572222|FG000|NOT COMPLETED|Overall Study||18||
48100326|NCT00600938|100572223|FG000|STARTED|Core Study||98||
48100327|NCT00600938|100572224|FG001|STARTED|Core Study||99||
48100328|NCT00600938|100572225|FG002|STARTED|Core Study||0||
48100329|NCT00600938|100572226|FG003|STARTED|Core Study||0||
48390793|NCT03627494|101283637|FG008|COMPLETED|Part C Period 1 (4 Days)||0||
48390794|NCT03627494|101283638|FG009|COMPLETED|Part C Period 1 (4 Days)||0||
48690912|NCT00460655|102025956|FG000|NOT COMPLETED|Double-Blind Phase (12 Weeks)||6||
48690913|NCT00460655|102025957|FG001|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1||
48690914|NCT00460655|102025958|FG002|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0||
48690915|NCT00460655|102025959|FG003|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0||
48690916|NCT00460655|102025956|FG000|STARTED|Open-Label Phase (36 Weeks)||0||
48690917|NCT00460655|102025957|FG001|STARTED|Open-Label Phase (36 Weeks)||0||
48690918|NCT00460655|102025958|FG002|STARTED|Open-Label Phase (36 Weeks)||52||
48690919|NCT00460655|102025959|FG003|STARTED|Open-Label Phase (36 Weeks)||61||
48690920|NCT00460655|102025956|FG000|COMPLETED|Open-Label Phase (36 Weeks)||0||
48100330|NCT00600938|100572223|FG000|Core Safety Set|Core Study||96||
48100331|NCT00600938|100572224|FG001|Core Safety Set|Core Study||91||
48100332|NCT00600938|100572225|FG002|Core Safety Set|Core Study||0||
48100333|NCT00600938|100572226|FG003|Core Safety Set|Core Study||0||
48100334|NCT00600938|100572223|FG000|Per Protocol Set (PPS)|Core Study||91||
48690921|NCT00460655|102025957|FG001|COMPLETED|Open-Label Phase (36 Weeks)||0||
48100335|NCT00600938|100572224|FG001|Per Protocol Set (PPS)|Core Study||81||
48100336|NCT00600938|100572225|FG002|Per Protocol Set (PPS)|Core Study||0||
48100337|NCT00600938|100572226|FG003|Per Protocol Set (PPS)|Core Study||0||
48100338|NCT00600938|100572223|FG000|COMPLETED|Core Study||82||
48100339|NCT00600938|100572224|FG001|COMPLETED|Core Study||78||
48100340|NCT00600938|100572225|FG002|COMPLETED|Core Study||0||
48100341|NCT00600938|100572226|FG003|COMPLETED|Core Study||0||
48100342|NCT00600938|100572223|FG000|NOT COMPLETED|Core Study||16||
48100343|NCT00600938|100572224|FG001|NOT COMPLETED|Core Study||21||
48100344|NCT00600938|100572225|FG002|NOT COMPLETED|Core Study||0||
48100345|NCT00600938|100572226|FG003|NOT COMPLETED|Core Study||0||
48100346|NCT00600938|100572223|FG000|STARTED|Extension Study||74||
48100347|NCT00600938|100572224|FG001|STARTED|Extension Study||29||
48100348|NCT00600938|100572225|FG002|STARTED|Extension Study||42||
48100349|NCT00600938|100572226|FG003|STARTED|Extension Study||1||
48100350|NCT00600938|100572223|FG000|Extension Safety Set|Extension Study||73||
48100351|NCT00600938|100572224|FG001|Extension Safety Set|Extension Study||29||
48100352|NCT00600938|100572225|FG002|Extension Safety Set|Extension Study||42||
48100353|NCT00600938|100572226|FG003|Extension Safety Set|Extension Study||1||
48100354|NCT00600938|100572223|FG000|COMPLETED|Extension Study||65||
48100355|NCT00600938|100572224|FG001|COMPLETED|Extension Study||24||
48100356|NCT00600938|100572225|FG002|COMPLETED|Extension Study||33||
48100357|NCT00600938|100572226|FG003|COMPLETED|Extension Study||0||
48100358|NCT00600938|100572223|FG000|NOT COMPLETED|Extension Study||9||
48100359|NCT00600938|100572224|FG001|NOT COMPLETED|Extension Study||5||
48100360|NCT00600938|100572225|FG002|NOT COMPLETED|Extension Study||9||
48100361|NCT00600938|100572226|FG003|NOT COMPLETED|Extension Study||1||
48100362|NCT00391989|100572227|FG000|STARTED|Overall Study||55||
48100363|NCT00391989|100572227|FG000|COMPLETED|Overall Study||53||
48100364|NCT00391989|100572227|FG000|NOT COMPLETED|Overall Study||2||
48100365|NCT02081690|100572228|FG000|STARTED|Overall Study||88||
48100366|NCT02081690|100572228|FG000|COMPLETED|Overall Study||81||
48100367|NCT02081690|100572228|FG000|NOT COMPLETED|Overall Study||7||
48100368|NCT02315755|100572229|FG000|STARTED|Overall Study||102||
48100369|NCT02315755|100572229|FG000|COMPLETED|Overall Study||102||
48100370|NCT02315755|100572229|FG000|NOT COMPLETED|Overall Study||0||
48100371|NCT05089682|100572230|FG000|STARTED|Overall Study||4||
48100372|NCT05089682|100572230|FG000|COMPLETED|Overall Study||2||
48100373|NCT05089682|100572230|FG000|NOT COMPLETED|Overall Study||2||
48100374|NCT00704535|100572231|FG000|STARTED|Overall Study||4105||
48100375|NCT00704535|100572231|FG000|COMPLETED|Overall Study||3959||
48100376|NCT00704535|100572231|FG000|NOT COMPLETED|Overall Study||146||
48100377|NCT02636868|100572232|FG000|STARTED|Overall Study||73||
48100378|NCT02636868|100572233|FG001|STARTED|Overall Study||76||
48100379|NCT02636868|100572234|FG002|STARTED|Overall Study||72||
48100380|NCT02636868|100572232|FG000|COMPLETED|Overall Study||73||
48100381|NCT02636868|100572233|FG001|COMPLETED|Overall Study||75||
48100382|NCT02636868|100572234|FG002|COMPLETED|Overall Study||70||
48100383|NCT02636868|100572232|FG000|NOT COMPLETED|Overall Study||0||
48100384|NCT02636868|100572233|FG001|NOT COMPLETED|Overall Study||1||
48100385|NCT02636868|100572234|FG002|NOT COMPLETED|Overall Study||2||
48100386|NCT01485640|100572235|FG000|STARTED|Overall Study||162||
48100387|NCT01485640|100572235|FG000|COMPLETED|Overall Study||40||
48100388|NCT01485640|100572235|FG000|NOT COMPLETED|Overall Study||122||
48100389|NCT00566150|100572236|FG000|STARTED|Overall Study||19||
48100390|NCT00566150|100572237|FG001|STARTED|Overall Study||16||
48100391|NCT00566150|100572236|FG000|COMPLETED|Overall Study||10||
48100392|NCT00566150|100572237|FG001|COMPLETED|Overall Study||11||
48100393|NCT00566150|100572236|FG000|NOT COMPLETED|Overall Study||9||
48100394|NCT00566150|100572237|FG001|NOT COMPLETED|Overall Study||5||
48100395|NCT03311659|100572238|FG000|STARTED|Overall Study||447||
48100396|NCT03311659|100572238|FG000|COMPLETED|Overall Study||446||
48100397|NCT03311659|100572238|FG000|NOT COMPLETED|Overall Study||1||
48100398|NCT00238121|100572239|FG000|STARTED|Overall Study||40||
48100399|NCT00238121|100572240|FG001|STARTED|Overall Study||16||
48100400|NCT00238121|100572239|FG000|COMPLETED|Overall Study||37||
48100401|NCT00238121|100572240|FG001|COMPLETED|Overall Study||14||
48100402|NCT00238121|100572239|FG000|NOT COMPLETED|Overall Study||3||
48100403|NCT00238121|100572240|FG001|NOT COMPLETED|Overall Study||2||
48100404|NCT03745144|100572241|FG000|STARTED|Run-in-Period (Day 0 to Day 28)||28||
48100405|NCT03745144|100572242|FG001|STARTED|Run-in-Period (Day 0 to Day 28)||0||
48100406|NCT03745144|100572243|FG002|STARTED|Run-in-Period (Day 0 to Day 28)||0||
48100407|NCT03745144|100572241|FG000|Safety Analysis Set|Run-in-Period (Day 0 to Day 28)||28|Safety Analysis Set included all participant who were administered any dose of the trial medication.|
48100408|NCT03745144|100572242|FG001|Safety Analysis Set|Run-in-Period (Day 0 to Day 28)||0|Safety Analysis Set included all participant who were administered any dose of the trial medication.|
48100409|NCT03745144|100572243|FG002|Safety Analysis Set|Run-in-Period (Day 0 to Day 28)||0|Safety Analysis Set included all participant who were administered any dose of the trial medication.|
48100410|NCT03745144|100572241|FG000|Pharmacokinetic Analysis Set|Run-in-Period (Day 0 to Day 28)||21|Pharmacokinetic Analysis Set included all participants in the Safety Set without clinically important protocol deviations/violations and absence of factors/events likely to affect Pharmacokinetics (PK).|
48141389|NCT04764396|100670418|FG001|STARTED|Overall Study||1||
48141390|NCT04764396|100670417|FG000|COMPLETED|Overall Study||0||
48100411|NCT03745144|100572242|FG001|Pharmacokinetic Analysis Set|Run-in-Period (Day 0 to Day 28)||0|Pharmacokinetic Analysis Set included all participants in the Safety Set without clinically important protocol deviations/violations and absence of factors/events likely to affect Pharmacokinetics (PK).|
48547017|NCT02960490|101671517|FG005|FAS|Extension Phase(Open-label): 80 Weeks||0||
48547018|NCT02960490|101671518|FG006|FAS|Extension Phase(Open-label): 80 Weeks||13||
48547019|NCT02960490|101671519|FG007|FAS|Extension Phase(Open-label): 80 Weeks||11||
48547020|NCT02960490|101671520|FG008|FAS|Extension Phase(Open-label): 80 Weeks||13||
48141391|NCT04764396|100670418|FG001|COMPLETED|Overall Study||1||
48547021|NCT02960490|101671521|FG009|FAS|Extension Phase(Open-label): 80 Weeks||10||
48547022|NCT02960490|101671512|FG000|SAS|Extension Phase(Open-label): 80 Weeks||0||
48547023|NCT02960490|101671513|FG001|SAS|Extension Phase(Open-label): 80 Weeks||0||
48547024|NCT02960490|101671514|FG002|SAS|Extension Phase(Open-label): 80 Weeks||0||
48547025|NCT02960490|101671515|FG003|SAS|Extension Phase(Open-label): 80 Weeks||0||
48100412|NCT03745144|100572243|FG002|Pharmacokinetic Analysis Set|Run-in-Period (Day 0 to Day 28)||0|Pharmacokinetic Analysis Set included all participants in the Safety Set without clinically important protocol deviations/violations and absence of factors/events likely to affect Pharmacokinetics (PK).|
48100413|NCT03745144|100572241|FG000|COMPLETED|Run-in-Period (Day 0 to Day 28)||24||
48100414|NCT03745144|100572242|FG001|COMPLETED|Run-in-Period (Day 0 to Day 28)||0||
48100415|NCT03745144|100572243|FG002|COMPLETED|Run-in-Period (Day 0 to Day 28)||0||
48100416|NCT03745144|100572241|FG000|NOT COMPLETED|Run-in-Period (Day 0 to Day 28)||4||
48100417|NCT03745144|100572242|FG001|NOT COMPLETED|Run-in-Period (Day 0 to Day 28)||0||
48100418|NCT03745144|100572243|FG002|NOT COMPLETED|Run-in-Period (Day 0 to Day 28)||0||
48100419|NCT03745144|100572241|FG000|STARTED|Period 1||0||
48100420|NCT03745144|100572242|FG001|STARTED|Period 1||13||
48100421|NCT03745144|100572243|FG002|STARTED|Period 1||11||
48100422|NCT03745144|100572241|FG000|COMPLETED|Period 1||0||
48100423|NCT03745144|100572242|FG001|COMPLETED|Period 1||13||
48100424|NCT03745144|100572243|FG002|COMPLETED|Period 1||10||
48100425|NCT03745144|100572241|FG000|NOT COMPLETED|Period 1||0||
48100426|NCT03745144|100572242|FG001|NOT COMPLETED|Period 1||0||
48100427|NCT03745144|100572243|FG002|NOT COMPLETED|Period 1||1||
48100428|NCT03745144|100572241|FG000|STARTED|Period 2||0||
48100429|NCT03745144|100572242|FG001|STARTED|Period 2||13||
48100430|NCT03745144|100572243|FG002|STARTED|Period 2||10||
48547026|NCT02960490|101671516|FG004|SAS|Extension Phase(Open-label): 80 Weeks||0||
48547027|NCT02960490|101671517|FG005|SAS|Extension Phase(Open-label): 80 Weeks||0||
48547028|NCT02960490|101671518|FG006|SAS|Extension Phase(Open-label): 80 Weeks||13||
48547029|NCT02960490|101671519|FG007|SAS|Extension Phase(Open-label): 80 Weeks||11||
48100431|NCT03745144|100572241|FG000|COMPLETED|Period 2||0||
48263628|NCT01844726|100966788|FG000|NOT COMPLETED|Overall Study||1||
48263629|NCT01844726|100966789|FG001|NOT COMPLETED|Overall Study||1||
48263630|NCT01256671|100966790|FG000|STARTED|Overall Study||530||
48263631|NCT01256671|100966790|FG000|Safety Population|Overall Study||521||
48263632|NCT01256671|100966790|FG000|COMPLETED|Overall Study||435||
48263633|NCT01256671|100966790|FG000|NOT COMPLETED|Overall Study||95||
48263634|NCT01843777|100966791|FG000|STARTED|Overall Study||11||
48263635|NCT01843777|100966792|FG001|STARTED|Overall Study||10||
48263636|NCT01843777|100966791|FG000|Per Protocol Population|Overall Study||11||
48263637|NCT01843777|100966792|FG001|Per Protocol Population|Overall Study||9||
48263638|NCT01843777|100966791|FG000|COMPLETED|Overall Study||10||
48263639|NCT01843777|100966792|FG001|COMPLETED|Overall Study||10||
48263640|NCT01843777|100966791|FG000|NOT COMPLETED|Overall Study||1||
48263641|NCT01843777|100966792|FG001|NOT COMPLETED|Overall Study||0||
48263642|NCT01468077|100966793|FG000|STARTED|Overall Study||22||
48263643|NCT01468077|100966794|FG001|STARTED|Overall Study||25||
48263644|NCT01468077|100966793|FG000|COMPLETED|Overall Study||18||
48263645|NCT01468077|100966794|FG001|COMPLETED|Overall Study||22||
48263646|NCT01468077|100966793|FG000|NOT COMPLETED|Overall Study||4||
48263647|NCT01468077|100966794|FG001|NOT COMPLETED|Overall Study||3||
48263648|NCT01292304|100966795|FG000|STARTED|Overall Study||10||
48263649|NCT01292304|100966795|FG000|COMPLETED|Overall Study||10||
48263650|NCT01292304|100966795|FG000|NOT COMPLETED|Overall Study||0||
48263651|NCT00844597|100966796|FG000|STARTED|Overall Study||4||
48263652|NCT00844597|100966797|FG001|STARTED|Overall Study||2||
48263653|NCT00844597|100966798|FG002|STARTED|Overall Study||2||
48263654|NCT00844597|100966799|FG003|STARTED|Overall Study||3||
48263655|NCT00844597|100966800|FG004|STARTED|Overall Study||4||
48263656|NCT00844597|100966801|FG005|STARTED|Overall Study||4||
48263657|NCT00844597|100966796|FG000|COMPLETED|Overall Study||4||
48263658|NCT00844597|100966797|FG001|COMPLETED|Overall Study||2||
48100432|NCT03745144|100572242|FG001|COMPLETED|Period 2||13||
48100433|NCT03745144|100572243|FG002|COMPLETED|Period 2||10||
48263659|NCT00844597|100966798|FG002|COMPLETED|Overall Study||2||
48263660|NCT00844597|100966799|FG003|COMPLETED|Overall Study||2||
48263661|NCT00844597|100966800|FG004|COMPLETED|Overall Study||4||
48263662|NCT00844597|100966801|FG005|COMPLETED|Overall Study||4||
48263663|NCT00844597|100966796|FG000|NOT COMPLETED|Overall Study||0||
48263664|NCT00844597|100966797|FG001|NOT COMPLETED|Overall Study||0||
48100434|NCT03745144|100572241|FG000|NOT COMPLETED|Period 2||0||
48100435|NCT03745144|100572242|FG001|NOT COMPLETED|Period 2||0||
48100436|NCT03745144|100572243|FG002|NOT COMPLETED|Period 2||0||
48100437|NCT01480076|100572244|FG000|STARTED|Overall Study||901||
48100438|NCT01480076|100572244|FG000|Intent to Treat Population|Overall Study||835||
48100439|NCT01480076|100572244|FG000|COMPLETED|Overall Study||611||
48100440|NCT01480076|100572244|FG000|NOT COMPLETED|Overall Study||290||
48100441|NCT01633892|100572245|FG000|STARTED|Overall Study||5||
48100442|NCT01633892|100572245|FG000|COMPLETED|Overall Study||5||
48263665|NCT00844597|100966798|FG002|NOT COMPLETED|Overall Study||0||
48263666|NCT00844597|100966799|FG003|NOT COMPLETED|Overall Study||1||
48263667|NCT00844597|100966800|FG004|NOT COMPLETED|Overall Study||0||
48263668|NCT00844597|100966801|FG005|NOT COMPLETED|Overall Study||0||
48263669|NCT03850275|100966802|FG000|STARTED|Overall Study||5||
48263670|NCT03850275|100966803|FG001|STARTED|Overall Study||5||
48263671|NCT03850275|100966804|FG002|STARTED|Overall Study||5||
48263672|NCT03850275|100966805|FG003|STARTED|Overall Study||5||
48263673|NCT03850275|100966806|FG004|STARTED|Overall Study||5||
48547030|NCT02960490|101671520|FG008|SAS|Extension Phase(Open-label): 80 Weeks||13||
48263674|NCT03850275|100966807|FG005|STARTED|Overall Study||5||
48690922|NCT00460655|102025958|FG002|COMPLETED|Open-Label Phase (36 Weeks)||45||
48690923|NCT00460655|102025959|FG003|COMPLETED|Open-Label Phase (36 Weeks)||52||
48690924|NCT00460655|102025956|FG000|NOT COMPLETED|Open-Label Phase (36 Weeks)||0||
48690925|NCT00460655|102025957|FG001|NOT COMPLETED|Open-Label Phase (36 Weeks)||0||
48690926|NCT00460655|102025958|FG002|NOT COMPLETED|Open-Label Phase (36 Weeks)||7||
48690927|NCT00460655|102025959|FG003|NOT COMPLETED|Open-Label Phase (36 Weeks)||9||
48690928|NCT02998671|102025960|FG000|STARTED|Period 1||21||
48690929|NCT02998671|102025961|FG001|STARTED|Period 1||13||
48690930|NCT02998671|102025962|FG002|STARTED|Period 1||6||
48100443|NCT01633892|100572245|FG000|NOT COMPLETED|Overall Study||0||
48690931|NCT02998671|102025963|FG003|STARTED|Period 1||8||
48100444|NCT03479307|100572246|FG000|STARTED|Overall Study||91||
48263675|NCT03850275|100966802|FG000|COMPLETED|Overall Study||5||
48263676|NCT03850275|100966803|FG001|COMPLETED|Overall Study||5||
48690932|NCT02998671|102025964|FG004|STARTED|Period 1||4||
48100445|NCT03479307|100572247|FG001|STARTED|Overall Study||90||
48100446|NCT03479307|100572248|FG002|STARTED|Overall Study||47||
48100447|NCT03479307|100572246|FG000|COMPLETED|Overall Study||90||
48100448|NCT03479307|100572247|FG001|COMPLETED|Overall Study||89||
48100449|NCT03479307|100572248|FG002|COMPLETED|Overall Study||47||
48100450|NCT03479307|100572246|FG000|NOT COMPLETED|Overall Study||1||
48100451|NCT03479307|100572247|FG001|NOT COMPLETED|Overall Study||1||
48100452|NCT03479307|100572248|FG002|NOT COMPLETED|Overall Study||0||
48100453|NCT01474876|100572249|FG000|STARTED|Overall Study||403||
48100454|NCT01474876|100572250|FG001|STARTED|Overall Study||151||
48100455|NCT01474876|100572251|FG002|STARTED|Overall Study||1||
48100456|NCT01474876|100572249|FG000|COMPLETED|Overall Study||337||
48100457|NCT01474876|100572250|FG001|COMPLETED|Overall Study||128||
48100458|NCT01474876|100572251|FG002|COMPLETED|Overall Study||1||
48100459|NCT01474876|100572249|FG000|NOT COMPLETED|Overall Study||66||
48100460|NCT01474876|100572250|FG001|NOT COMPLETED|Overall Study||23||
48100461|NCT01474876|100572251|FG002|NOT COMPLETED|Overall Study||0||
48100462|NCT02171260|100572252|FG000|STARTED|Overall Study||6||
48100463|NCT02171260|100572253|FG001|STARTED|Overall Study||6||
48100464|NCT02171260|100572254|FG002|STARTED|Overall Study||5||
48100465|NCT02171260|100572255|FG003|STARTED|Overall Study||5||
48100466|NCT02171260|100572252|FG000|COMPLETED|Overall Study||0||
48100467|NCT02171260|100572253|FG001|COMPLETED|Overall Study||0||
48100468|NCT02171260|100572254|FG002|COMPLETED|Overall Study||0||
48100469|NCT02171260|100572255|FG003|COMPLETED|Overall Study||0||
48100470|NCT02171260|100572252|FG000|NOT COMPLETED|Overall Study||6||
48100471|NCT02171260|100572253|FG001|NOT COMPLETED|Overall Study||6||
48100472|NCT02171260|100572254|FG002|NOT COMPLETED|Overall Study||5||
48100473|NCT02171260|100572255|FG003|NOT COMPLETED|Overall Study||5||
48100474|NCT00909779|100572256|FG000|STARTED|Overall Study||421||
48100475|NCT00909779|100572257|FG001|STARTED|Overall Study||420||
48100476|NCT00909779|100572256|FG000|COMPLETED|Overall Study||211||
48100477|NCT00909779|100572257|FG001|COMPLETED|Overall Study||255||
48100478|NCT00909779|100572256|FG000|NOT COMPLETED|Overall Study||210||
48100479|NCT00909779|100572257|FG001|NOT COMPLETED|Overall Study||165||
48100480|NCT00278954|100572258|FG000|STARTED|Overall Study||50||
48100481|NCT00278954|100572258|FG000|COMPLETED|Overall Study||45||
48100482|NCT00278954|100572258|FG000|NOT COMPLETED|Overall Study||5||
48100483|NCT01086540|100572259|FG000|STARTED|Overall Study||29||
48100484|NCT01086540|100572260|FG001|STARTED|Overall Study||28||
48100485|NCT01086540|100572259|FG000|COMPLETED|Overall Study||23||
48100486|NCT01086540|100572260|FG001|COMPLETED|Overall Study||26||
48100487|NCT01086540|100572259|FG000|NOT COMPLETED|Overall Study||6||
48100488|NCT01086540|100572260|FG001|NOT COMPLETED|Overall Study||2||
48100489|NCT04404855|100572261|FG000|STARTED|Overall Study||119||
48100490|NCT04404855|100572262|FG001|STARTED|Overall Study||121||
48100491|NCT04404855|100572261|FG000|COMPLETED|Overall Study||50||
48100492|NCT04404855|100572262|FG001|COMPLETED|Overall Study||86||
48100493|NCT04404855|100572261|FG000|NOT COMPLETED|Overall Study||69||
48100494|NCT04404855|100572262|FG001|NOT COMPLETED|Overall Study||35||
48100495|NCT00415909|100572263|FG000|STARTED|Overall Study||3||
48100496|NCT00415909|100572263|FG000|COMPLETED|Overall Study||0||
48100497|NCT00415909|100572263|FG000|NOT COMPLETED|Overall Study||3||
48100498|NCT02419742|100572264|FG000|STARTED|Overall Study||58||
48100499|NCT02419742|100572265|FG001|STARTED|Overall Study||52||
48100500|NCT02419742|100572264|FG000|COMPLETED|Overall Study||53||
48100501|NCT02419742|100572265|FG001|COMPLETED|Overall Study||50||
48100502|NCT02419742|100572264|FG000|NOT COMPLETED|Overall Study||5||
48100503|NCT02419742|100572265|FG001|NOT COMPLETED|Overall Study||2||
48100504|NCT02136576|100572266|FG000|STARTED|Overall Study||13||13
48100505|NCT02136576|100572267|FG001|STARTED|Overall Study||13||13
48100506|NCT02136576|100572268|FG002|STARTED|Overall Study||13||13
48100507|NCT02136576|100572266|FG000|COMPLETED|Overall Study||11||11
48100508|NCT02136576|100572267|FG001|COMPLETED|Overall Study||13||13
48100509|NCT02136576|100572268|FG002|COMPLETED|Overall Study||13||13
48100510|NCT02136576|100572266|FG000|NOT COMPLETED|Overall Study||2||2
48100511|NCT02136576|100572267|FG001|NOT COMPLETED|Overall Study||0||0
48100512|NCT02136576|100572268|FG002|NOT COMPLETED|Overall Study||0||0
48100513|NCT00369512|100572269|FG000|STARTED|Overall Study||15||
48100514|NCT00369512|100572269|FG000|COMPLETED|Overall Study||15||
48100515|NCT00369512|100572269|FG000|NOT COMPLETED|Overall Study||0||
48100516|NCT01429272|100572270|FG000|STARTED|Overall Study||30||
48100517|NCT01429272|100572271|FG001|STARTED|Overall Study||31||
48100518|NCT01429272|100572272|FG002|STARTED|Overall Study||19||
48100519|NCT01429272|100572273|FG003|STARTED|Overall Study||19||
48100520|NCT01429272|100572270|FG000|COMPLETED|Overall Study||24||
48100521|NCT01429272|100572271|FG001|COMPLETED|Overall Study||22||
48100522|NCT01429272|100572272|FG002|COMPLETED|Overall Study||15||
48100523|NCT01429272|100572273|FG003|COMPLETED|Overall Study||14||
48100524|NCT01429272|100572270|FG000|NOT COMPLETED|Overall Study||6||
48100525|NCT01429272|100572271|FG001|NOT COMPLETED|Overall Study||9||
48100526|NCT01429272|100572272|FG002|NOT COMPLETED|Overall Study||4||
48100527|NCT01429272|100572273|FG003|NOT COMPLETED|Overall Study||5||
48100528|NCT00335972|100572274|FG000|STARTED|Overall Study||71||
48100529|NCT00335972|100572275|FG001|STARTED|Overall Study||71||
48100530|NCT00335972|100572274|FG000|COMPLETED|Overall Study||71||
48100531|NCT00335972|100572275|FG001|COMPLETED|Overall Study||68||
48100532|NCT00335972|100572274|FG000|NOT COMPLETED|Overall Study||0||
48100533|NCT00335972|100572275|FG001|NOT COMPLETED|Overall Study||3||
48100534|NCT03025542|100572276|FG000|STARTED|Overall Study||32||
48100535|NCT03025542|100572277|FG001|STARTED|Overall Study||17||
48100536|NCT03025542|100572276|FG000|COMPLETED|Overall Study||30||
48100537|NCT03025542|100572277|FG001|COMPLETED|Overall Study||15||
48100538|NCT03025542|100572276|FG000|NOT COMPLETED|Overall Study||2||
48100539|NCT03025542|100572277|FG001|NOT COMPLETED|Overall Study||2||
48100540|NCT01113632|100572278|FG000|STARTED|Overall Study||33||
48100541|NCT01113632|100572279|FG001|STARTED|Overall Study||44||
48100542|NCT01113632|100572278|FG000|COMPLETED|Overall Study||2||
48100543|NCT01113632|100572279|FG001|COMPLETED|Overall Study||19||
48100544|NCT01113632|100572278|FG000|NOT COMPLETED|Overall Study||31||
48100545|NCT01113632|100572279|FG001|NOT COMPLETED|Overall Study||25||
48100546|NCT02701647|100572280|FG000|STARTED|Overall Study||17||
48100547|NCT02701647|100572281|FG001|STARTED|Overall Study||17||
48100548|NCT02701647|100572282|FG002|STARTED|Overall Study||17||
48100549|NCT02701647|100572280|FG000|COMPLETED|Overall Study||17||
48100550|NCT02701647|100572281|FG001|COMPLETED|Overall Study||17||
48100551|NCT02701647|100572282|FG002|COMPLETED|Overall Study||16||
48100552|NCT02701647|100572280|FG000|NOT COMPLETED|Overall Study||0||
48100553|NCT02701647|100572281|FG001|NOT COMPLETED|Overall Study||0||
48100554|NCT02701647|100572282|FG002|NOT COMPLETED|Overall Study||1||
48100555|NCT03571581|100572283|FG000|STARTED|Overall Study||33||
48100556|NCT03571581|100572283|FG000|COMPLETED|Overall Study||29||
48100557|NCT03571581|100572283|FG000|NOT COMPLETED|Overall Study||4||
48100558|NCT02293655|100572284|FG000|STARTED|Overall Study||92||
48100559|NCT02293655|100572285|FG001|STARTED|Overall Study||17||
48100560|NCT02293655|100572284|FG000|COMPLETED|Overall Study||85||
48100561|NCT02293655|100572285|FG001|COMPLETED|Overall Study||15||
48100562|NCT02293655|100572284|FG000|NOT COMPLETED|Overall Study||7||
48100563|NCT02293655|100572285|FG001|NOT COMPLETED|Overall Study||2||
48100564|NCT03040466|100572286|FG000|STARTED|Overall Study||65||
48100565|NCT03040466|100572287|FG001|STARTED|Overall Study||115||
48100566|NCT03040466|100572286|FG000|COMPLETED|Overall Study||65||
48100567|NCT03040466|100572287|FG001|COMPLETED|Overall Study||115||
48100568|NCT03040466|100572286|FG000|NOT COMPLETED|Overall Study||0||
48100569|NCT03040466|100572287|FG001|NOT COMPLETED|Overall Study||0||
48100570|NCT01510379|100572288|FG000|STARTED|Overall Study||49||
48100571|NCT01510379|100572289|FG001|STARTED|Overall Study||51||
48100572|NCT01510379|100572288|FG000|COMPLETED|Overall Study||49||
48100573|NCT01510379|100572289|FG001|COMPLETED|Overall Study||51||
48100574|NCT01510379|100572288|FG000|NOT COMPLETED|Overall Study||0||
48100575|NCT01510379|100572289|FG001|NOT COMPLETED|Overall Study||0||
48100576|NCT01367158|100572290|FG000|STARTED|Overall Study||25||
48100577|NCT01367158|100572291|FG001|STARTED|Overall Study||49||
48100578|NCT01367158|100572292|FG002|STARTED|Overall Study||24||
48100579|NCT01367158|100572293|FG003|STARTED|Overall Study||49||
48100580|NCT01367158|100572294|FG004|STARTED|Overall Study||25||
48100581|NCT01367158|100572295|FG005|STARTED|Overall Study||48||
48100582|NCT01367158|100572296|FG006|STARTED|Overall Study||25||
48100583|NCT01367158|100572297|FG007|STARTED|Overall Study||49||
48100584|NCT01367158|100572298|FG008|STARTED|Overall Study||23||
48100585|NCT01367158|100572299|FG009|STARTED|Overall Study||50||
48100586|NCT01367158|100572300|FG010|STARTED|Overall Study||73||
48100587|NCT01367158|100572290|FG000|COMPLETED|Overall Study||25||
48100588|NCT01367158|100572291|FG001|COMPLETED|Overall Study||46||
48100589|NCT01367158|100572292|FG002|COMPLETED|Overall Study||23||
48100590|NCT01367158|100572293|FG003|COMPLETED|Overall Study||48||
48100591|NCT01367158|100572294|FG004|COMPLETED|Overall Study||23||
48100592|NCT01367158|100572295|FG005|COMPLETED|Overall Study||46||
48100593|NCT01367158|100572296|FG006|COMPLETED|Overall Study||25||
48100594|NCT01367158|100572297|FG007|COMPLETED|Overall Study||47||
48100595|NCT01367158|100572298|FG008|COMPLETED|Overall Study||23||
48100596|NCT01367158|100572299|FG009|COMPLETED|Overall Study||50||
48100597|NCT01367158|100572300|FG010|COMPLETED|Overall Study||72||
48100598|NCT01367158|100572290|FG000|NOT COMPLETED|Overall Study||0||
48100599|NCT01367158|100572291|FG001|NOT COMPLETED|Overall Study||3||
48100600|NCT01367158|100572292|FG002|NOT COMPLETED|Overall Study||1||
48100601|NCT01367158|100572293|FG003|NOT COMPLETED|Overall Study||1||
48100602|NCT01367158|100572294|FG004|NOT COMPLETED|Overall Study||2||
48100603|NCT01367158|100572295|FG005|NOT COMPLETED|Overall Study||2||
48100604|NCT01367158|100572296|FG006|NOT COMPLETED|Overall Study||0||
48100605|NCT01367158|100572297|FG007|NOT COMPLETED|Overall Study||2||
48100606|NCT01367158|100572298|FG008|NOT COMPLETED|Overall Study||0||
48100607|NCT01367158|100572299|FG009|NOT COMPLETED|Overall Study||0||
48100608|NCT01367158|100572300|FG010|NOT COMPLETED|Overall Study||1||
48100609|NCT02117999|100572301|FG000|STARTED|Overall Study||20||22
48100610|NCT02117999|100572302|FG001|STARTED|Overall Study||10||12
48100611|NCT02117999|100572301|FG000|Mean Kmax Change in Corneal Topography|Overall Study||20||22
48100612|NCT02117999|100572302|FG001|Mean Kmax Change in Corneal Topography|Overall Study||10||12
48100613|NCT02117999|100572301|FG000|COMPLETED|Overall Study||20||22
48100614|NCT02117999|100572302|FG001|COMPLETED|Overall Study||10||12
48100615|NCT02117999|100572301|FG000|NOT COMPLETED|Overall Study||0||0
48100616|NCT02117999|100572302|FG001|NOT COMPLETED|Overall Study||0||0
48100617|NCT02250443|100572303|FG000|STARTED|Overall Study||10||
48100618|NCT02250443|100572303|FG000|COMPLETED|Overall Study||0||
48100619|NCT02250443|100572303|FG000|NOT COMPLETED|Overall Study||10||
48100620|NCT01327300|100572304|FG000|STARTED|First Intervention (12 Weeks)||5||
48100621|NCT01327300|100572305|FG001|STARTED|First Intervention (12 Weeks)||2||
48100622|NCT01327300|100572304|FG000|COMPLETED|First Intervention (12 Weeks)||5||
48100623|NCT01327300|100572305|FG001|COMPLETED|First Intervention (12 Weeks)||2||
48100624|NCT01327300|100572304|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0||
48100625|NCT01327300|100572305|FG001|NOT COMPLETED|First Intervention (12 Weeks)||0||
48100626|NCT01327300|100572304|FG000|STARTED|Washout (3 Weeks)||5||
48100627|NCT01327300|100572305|FG001|STARTED|Washout (3 Weeks)||2||
48100628|NCT01327300|100572304|FG000|COMPLETED|Washout (3 Weeks)||4||
48100629|NCT01327300|100572305|FG001|COMPLETED|Washout (3 Weeks)||2||
48100630|NCT01327300|100572304|FG000|NOT COMPLETED|Washout (3 Weeks)||1||
48100631|NCT01327300|100572305|FG001|NOT COMPLETED|Washout (3 Weeks)||0||
48100632|NCT01327300|100572304|FG000|STARTED|Second Intervention (12 Weeks)||4||
48100633|NCT01327300|100572305|FG001|STARTED|Second Intervention (12 Weeks)||2||
48100634|NCT01327300|100572304|FG000|COMPLETED|Second Intervention (12 Weeks)||4||
48100635|NCT01327300|100572305|FG001|COMPLETED|Second Intervention (12 Weeks)||2||
48100636|NCT01327300|100572304|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0||
48547031|NCT02960490|101671521|FG009|SAS|Extension Phase(Open-label): 80 Weeks||10||
48547032|NCT02960490|101671512|FG000|COMPLETED|Extension Phase(Open-label): 80 Weeks||0||
48547033|NCT02960490|101671513|FG001|COMPLETED|Extension Phase(Open-label): 80 Weeks||0||
48547034|NCT02960490|101671514|FG002|COMPLETED|Extension Phase(Open-label): 80 Weeks||0||
48547035|NCT02960490|101671515|FG003|COMPLETED|Extension Phase(Open-label): 80 Weeks||0||
48547036|NCT02960490|101671516|FG004|COMPLETED|Extension Phase(Open-label): 80 Weeks||0||
48547037|NCT02960490|101671517|FG005|COMPLETED|Extension Phase(Open-label): 80 Weeks||0||
48547038|NCT02960490|101671518|FG006|COMPLETED|Extension Phase(Open-label): 80 Weeks||4||
48547039|NCT02960490|101671519|FG007|COMPLETED|Extension Phase(Open-label): 80 Weeks||5||
48547040|NCT02960490|101671520|FG008|COMPLETED|Extension Phase(Open-label): 80 Weeks||9||
48100637|NCT01327300|100572305|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0||
48100638|NCT00930579|100572306|FG000|STARTED|Overall Study||35||
48100639|NCT00930579|100572306|FG000|COMPLETED|Overall Study||33||
48100640|NCT00930579|100572306|FG000|NOT COMPLETED|Overall Study||2||
48100641|NCT00363779|100572307|FG000|STARTED|Overall Study||5||
48100642|NCT00363779|100572307|FG000|COMPLETED|Overall Study||5||
48100643|NCT00363779|100572307|FG000|NOT COMPLETED|Overall Study||0||
48100644|NCT01012622|100572308|FG000|STARTED|Overall Study||142||
48100645|NCT01012622|100572308|FG000|COMPLETED|Overall Study||111||
48100646|NCT01012622|100572308|FG000|NOT COMPLETED|Overall Study||31||
48100647|NCT00755131|100572309|FG000|STARTED|Overall Study||37||
48100648|NCT00755131|100572310|FG001|STARTED|Overall Study||38||
48100649|NCT00755131|100572309|FG000|COMPLETED|Overall Study||37||
48100650|NCT00755131|100572310|FG001|COMPLETED|Overall Study||38||
48100651|NCT00755131|100572309|FG000|NOT COMPLETED|Overall Study||0||
48100652|NCT00755131|100572310|FG001|NOT COMPLETED|Overall Study||0||
48100653|NCT00878709|100572311|FG000|STARTED|Overall Study||1420||
48100654|NCT00878709|100572312|FG001|STARTED|Overall Study||1420||
48100655|NCT00878709|100572311|FG000|COMPLETED|Overall Study||1095||
48100656|NCT00878709|100572312|FG001|COMPLETED|Overall Study||1183||
48100657|NCT00878709|100572311|FG000|NOT COMPLETED|Overall Study||325||
48100658|NCT00878709|100572312|FG001|NOT COMPLETED|Overall Study||237||
48100659|NCT01733407|100572313|FG000|STARTED|Overall Study||9||
48100660|NCT01733407|100572314|FG001|STARTED|Overall Study||9||
48100661|NCT01733407|100572313|FG000|COMPLETED|Overall Study||7||
48100662|NCT01733407|100572314|FG001|COMPLETED|Overall Study||9||
48100663|NCT01733407|100572313|FG000|NOT COMPLETED|Overall Study||2||
48547041|NCT02960490|101671521|FG009|COMPLETED|Extension Phase(Open-label): 80 Weeks||3||
48547042|NCT02960490|101671512|FG000|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0||
48547043|NCT02960490|101671513|FG001|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0||
48547044|NCT02960490|101671514|FG002|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0||
48547045|NCT02960490|101671515|FG003|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0||
48547046|NCT02960490|101671516|FG004|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0||
48547047|NCT02960490|101671517|FG005|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0||
48547048|NCT02960490|101671518|FG006|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||9||
48547049|NCT02960490|101671519|FG007|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||6||
48547050|NCT02960490|101671520|FG008|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||4||
48547051|NCT02960490|101671521|FG009|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||7||
48547052|NCT05022212|101671522|FG000|STARTED|Overall Study||32||
48100664|NCT01733407|100572314|FG001|NOT COMPLETED|Overall Study||0||
48100665|NCT02092662|100572315|FG000|STARTED|Overall Study||38||
48100666|NCT02092662|100572316|FG001|STARTED|Overall Study||19||
48100667|NCT02092662|100572315|FG000|Recruited|Overall Study||38||
48100668|NCT02092662|100572316|FG001|Recruited|Overall Study||19||
48100669|NCT02092662|100572315|FG000|COMPLETED|Overall Study||25||
48100670|NCT02092662|100572316|FG001|COMPLETED|Overall Study||19||
48100671|NCT02092662|100572315|FG000|NOT COMPLETED|Overall Study||13||
48100672|NCT02092662|100572316|FG001|NOT COMPLETED|Overall Study||0||
48100673|NCT02968979|100572317|FG000|STARTED|Overall Study||539||
48100674|NCT02968979|100572317|FG000|COMPLETED|Overall Study||531||
48100675|NCT02968979|100572317|FG000|NOT COMPLETED|Overall Study||8||
48100676|NCT00545155|100572318|FG000|STARTED|Overall Study||187||
48100677|NCT00545155|100572318|FG000|COMPLETED|Overall Study||187||
48100678|NCT00545155|100572318|FG000|NOT COMPLETED|Overall Study||0||
48100679|NCT03045887|100572319|FG000|STARTED|Part A, Period (1 Day)||7||
48100680|NCT03045887|100572320|FG001|STARTED|Part A, Period (1 Day)||4||
48100681|NCT03045887|100572321|FG002|STARTED|Part A, Period (1 Day)||5||
48100682|NCT03045887|100572322|FG003|STARTED|Part A, Period (1 Day)||5||
48100683|NCT03045887|100572323|FG004|STARTED|Part A, Period (1 Day)||4||
48100684|NCT03045887|100572324|FG005|STARTED|Part A, Period (1 Day)||4||
48100685|NCT03045887|100572325|FG006|STARTED|Part A, Period (1 Day)||4||
48100686|NCT03045887|100572326|FG007|STARTED|Part A, Period (1 Day)||4||
48100687|NCT03045887|100572327|FG008|STARTED|Part A, Period (1 Day)||0||
48100688|NCT03045887|100572328|FG009|STARTED|Part A, Period (1 Day)||0||
48100689|NCT03045887|100572319|FG000|COMPLETED|Part A, Period (1 Day)||7||
48100690|NCT03045887|100572320|FG001|COMPLETED|Part A, Period (1 Day)||4||
48100691|NCT03045887|100572321|FG002|COMPLETED|Part A, Period (1 Day)||5||
48100692|NCT03045887|100572322|FG003|COMPLETED|Part A, Period (1 Day)||5||
48100693|NCT03045887|100572323|FG004|COMPLETED|Part A, Period (1 Day)||4||
48100694|NCT03045887|100572324|FG005|COMPLETED|Part A, Period (1 Day)||4||
48100695|NCT03045887|100572325|FG006|COMPLETED|Part A, Period (1 Day)||4||
48100696|NCT03045887|100572326|FG007|COMPLETED|Part A, Period (1 Day)||4||
48100697|NCT03045887|100572327|FG008|COMPLETED|Part A, Period (1 Day)||0||
48100698|NCT03045887|100572328|FG009|COMPLETED|Part A, Period (1 Day)||0||
48100699|NCT03045887|100572319|FG000|NOT COMPLETED|Part A, Period (1 Day)||0||
48100700|NCT03045887|100572320|FG001|NOT COMPLETED|Part A, Period (1 Day)||0||
48100701|NCT03045887|100572321|FG002|NOT COMPLETED|Part A, Period (1 Day)||0||
48100702|NCT03045887|100572322|FG003|NOT COMPLETED|Part A, Period (1 Day)||0||
48100703|NCT03045887|100572323|FG004|NOT COMPLETED|Part A, Period (1 Day)||0||
48100704|NCT03045887|100572324|FG005|NOT COMPLETED|Part A, Period (1 Day)||0||
48100705|NCT03045887|100572325|FG006|NOT COMPLETED|Part A, Period (1 Day)||0||
48100706|NCT03045887|100572326|FG007|NOT COMPLETED|Part A, Period (1 Day)||0||
48100707|NCT03045887|100572327|FG008|NOT COMPLETED|Part A, Period (1 Day)||0||
48100708|NCT03045887|100572328|FG009|NOT COMPLETED|Part A, Period (1 Day)||0||
48100709|NCT03045887|100572319|FG000|STARTED|Part A,Washout Period 1(4 Weeks)||7||
48100710|NCT03045887|100572320|FG001|STARTED|Part A,Washout Period 1(4 Weeks)||4||
48100711|NCT03045887|100572321|FG002|STARTED|Part A,Washout Period 1(4 Weeks)||5||
48100712|NCT03045887|100572322|FG003|STARTED|Part A,Washout Period 1(4 Weeks)||5||
48100713|NCT03045887|100572323|FG004|STARTED|Part A,Washout Period 1(4 Weeks)||4||
48100714|NCT03045887|100572324|FG005|STARTED|Part A,Washout Period 1(4 Weeks)||4||
48100715|NCT03045887|100572325|FG006|STARTED|Part A,Washout Period 1(4 Weeks)||4||
48100716|NCT03045887|100572326|FG007|STARTED|Part A,Washout Period 1(4 Weeks)||4||
48100717|NCT03045887|100572327|FG008|STARTED|Part A,Washout Period 1(4 Weeks)||0||
48100718|NCT03045887|100572328|FG009|STARTED|Part A,Washout Period 1(4 Weeks)||0||
48100719|NCT03045887|100572319|FG000|COMPLETED|Part A,Washout Period 1(4 Weeks)||4||
48100720|NCT03045887|100572320|FG001|COMPLETED|Part A,Washout Period 1(4 Weeks)||4||
48100721|NCT03045887|100572321|FG002|COMPLETED|Part A,Washout Period 1(4 Weeks)||5||
48100722|NCT03045887|100572322|FG003|COMPLETED|Part A,Washout Period 1(4 Weeks)||4||
48100723|NCT03045887|100572323|FG004|COMPLETED|Part A,Washout Period 1(4 Weeks)||4||
48100724|NCT03045887|100572324|FG005|COMPLETED|Part A,Washout Period 1(4 Weeks)||4||
48547053|NCT05022212|101671523|FG001|STARTED|Overall Study||13||
48547054|NCT05022212|101671522|FG000|COMPLETED|Overall Study||32||
48547055|NCT05022212|101671523|FG001|COMPLETED|Overall Study||11||
48100725|NCT03045887|100572325|FG006|COMPLETED|Part A,Washout Period 1(4 Weeks)||4||
48547056|NCT05022212|101671522|FG000|NOT COMPLETED|Overall Study||0||
48547057|NCT05022212|101671523|FG001|NOT COMPLETED|Overall Study||2||
48100726|NCT03045887|100572326|FG007|COMPLETED|Part A,Washout Period 1(4 Weeks)||4||
48100727|NCT03045887|100572327|FG008|COMPLETED|Part A,Washout Period 1(4 Weeks)||0||
48100728|NCT03045887|100572328|FG009|COMPLETED|Part A,Washout Period 1(4 Weeks)||0||
48100729|NCT03045887|100572319|FG000|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||3||
48100730|NCT03045887|100572320|FG001|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0||
48100731|NCT03045887|100572321|FG002|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0||
48100732|NCT03045887|100572322|FG003|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||1||
48100733|NCT03045887|100572323|FG004|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0||
48100734|NCT03045887|100572324|FG005|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0||
48547058|NCT02224157|101671524|FG000|STARTED|Overall Study||2095|Patients randomised and received treatment|
48547059|NCT02224157|101671525|FG001|STARTED|Overall Study||2094|Patients randomised and received treatment|
48547060|NCT02224157|101671524|FG000|Patients Who Completed Treatment|Overall Study||1924||
48547061|NCT02224157|101671525|FG001|Patients Who Completed Treatment|Overall Study||1903||
48547062|NCT02224157|101671524|FG000|COMPLETED|Overall Study||1985||
48100735|NCT03045887|100572325|FG006|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0||
48547063|NCT02224157|101671525|FG001|COMPLETED|Overall Study||1983||
48547064|NCT02224157|101671524|FG000|NOT COMPLETED|Overall Study||110||
48547065|NCT02224157|101671525|FG001|NOT COMPLETED|Overall Study||111||
48100736|NCT03045887|100572326|FG007|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0||
48100737|NCT03045887|100572327|FG008|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0||
48100738|NCT03045887|100572328|FG009|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0||
48100739|NCT03045887|100572319|FG000|STARTED|Part A, Period 2 (1 Day)||4||
48100740|NCT03045887|100572320|FG001|STARTED|Part A, Period 2 (1 Day)||4||
48100741|NCT03045887|100572321|FG002|STARTED|Part A, Period 2 (1 Day)||5||
48100742|NCT03045887|100572322|FG003|STARTED|Part A, Period 2 (1 Day)||4||
48100743|NCT03045887|100572323|FG004|STARTED|Part A, Period 2 (1 Day)||4||
48100744|NCT03045887|100572324|FG005|STARTED|Part A, Period 2 (1 Day)||4||
48100745|NCT03045887|100572325|FG006|STARTED|Part A, Period 2 (1 Day)||4||
48100746|NCT03045887|100572326|FG007|STARTED|Part A, Period 2 (1 Day)||4||
48100747|NCT03045887|100572327|FG008|STARTED|Part A, Period 2 (1 Day)||0||
48100748|NCT03045887|100572328|FG009|STARTED|Part A, Period 2 (1 Day)||0||
48100749|NCT03045887|100572319|FG000|COMPLETED|Part A, Period 2 (1 Day)||3||
48100750|NCT03045887|100572320|FG001|COMPLETED|Part A, Period 2 (1 Day)||4||
48100751|NCT03045887|100572321|FG002|COMPLETED|Part A, Period 2 (1 Day)||5||
48100752|NCT03045887|100572322|FG003|COMPLETED|Part A, Period 2 (1 Day)||4||
48100753|NCT03045887|100572323|FG004|COMPLETED|Part A, Period 2 (1 Day)||4||
48100754|NCT03045887|100572324|FG005|COMPLETED|Part A, Period 2 (1 Day)||4||
48100755|NCT03045887|100572325|FG006|COMPLETED|Part A, Period 2 (1 Day)||4||
48100756|NCT03045887|100572326|FG007|COMPLETED|Part A, Period 2 (1 Day)||4||
48100757|NCT03045887|100572327|FG008|COMPLETED|Part A, Period 2 (1 Day)||0||
48100758|NCT03045887|100572328|FG009|COMPLETED|Part A, Period 2 (1 Day)||0||
48100759|NCT03045887|100572319|FG000|NOT COMPLETED|Part A, Period 2 (1 Day)||1||
48100760|NCT03045887|100572320|FG001|NOT COMPLETED|Part A, Period 2 (1 Day)||0||
48100761|NCT03045887|100572321|FG002|NOT COMPLETED|Part A, Period 2 (1 Day)||0||
48100762|NCT03045887|100572322|FG003|NOT COMPLETED|Part A, Period 2 (1 Day)||0||
48100763|NCT03045887|100572323|FG004|NOT COMPLETED|Part A, Period 2 (1 Day)||0||
48100764|NCT03045887|100572324|FG005|NOT COMPLETED|Part A, Period 2 (1 Day)||0||
48100765|NCT03045887|100572325|FG006|NOT COMPLETED|Part A, Period 2 (1 Day)||0||
48100766|NCT03045887|100572326|FG007|NOT COMPLETED|Part A, Period 2 (1 Day)||0||
48100767|NCT03045887|100572327|FG008|NOT COMPLETED|Part A, Period 2 (1 Day)||0||
48100768|NCT03045887|100572328|FG009|NOT COMPLETED|Part A, Period 2 (1 Day)||0||
48100769|NCT03045887|100572319|FG000|STARTED|Part A,Washout Period 2 (4 Weeks)||3||
48100770|NCT03045887|100572320|FG001|STARTED|Part A,Washout Period 2 (4 Weeks)||4||
48100771|NCT03045887|100572321|FG002|STARTED|Part A,Washout Period 2 (4 Weeks)||5||
48100772|NCT03045887|100572322|FG003|STARTED|Part A,Washout Period 2 (4 Weeks)||4||
48100773|NCT03045887|100572323|FG004|STARTED|Part A,Washout Period 2 (4 Weeks)||4||
48100774|NCT03045887|100572324|FG005|STARTED|Part A,Washout Period 2 (4 Weeks)||4||
48100775|NCT03045887|100572325|FG006|STARTED|Part A,Washout Period 2 (4 Weeks)||4||
48100776|NCT03045887|100572326|FG007|STARTED|Part A,Washout Period 2 (4 Weeks)||4||
48100777|NCT03045887|100572327|FG008|STARTED|Part A,Washout Period 2 (4 Weeks)||0||
48100778|NCT03045887|100572328|FG009|STARTED|Part A,Washout Period 2 (4 Weeks)||0||
48100779|NCT03045887|100572319|FG000|COMPLETED|Part A,Washout Period 2 (4 Weeks)||3||
48100780|NCT03045887|100572320|FG001|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4||
48100781|NCT03045887|100572321|FG002|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4||
48100782|NCT03045887|100572322|FG003|COMPLETED|Part A,Washout Period 2 (4 Weeks)||2||
48100783|NCT03045887|100572323|FG004|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4||
48100784|NCT03045887|100572324|FG005|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4||
48100785|NCT03045887|100572325|FG006|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4||
48100786|NCT03045887|100572326|FG007|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4||
48100787|NCT03045887|100572327|FG008|COMPLETED|Part A,Washout Period 2 (4 Weeks)||0||
48100788|NCT03045887|100572328|FG009|COMPLETED|Part A,Washout Period 2 (4 Weeks)||0||
48100789|NCT03045887|100572319|FG000|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0||
48100790|NCT03045887|100572320|FG001|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0||
48100791|NCT03045887|100572321|FG002|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||1||
48100792|NCT03045887|100572322|FG003|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||2||
48100793|NCT03045887|100572323|FG004|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0||
48100794|NCT03045887|100572324|FG005|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0||
48100795|NCT03045887|100572325|FG006|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0||
48100796|NCT03045887|100572326|FG007|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0||
48100797|NCT03045887|100572327|FG008|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0||
48100798|NCT03045887|100572328|FG009|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0||
48100799|NCT03045887|100572319|FG000|STARTED|Part A, Period 3 (1 Day)||3||
48100800|NCT03045887|100572320|FG001|STARTED|Part A, Period 3 (1 Day)||4||
48100801|NCT03045887|100572321|FG002|STARTED|Part A, Period 3 (1 Day)||4||
48100802|NCT03045887|100572322|FG003|STARTED|Part A, Period 3 (1 Day)||2||
48100803|NCT03045887|100572323|FG004|STARTED|Part A, Period 3 (1 Day)||4||
48100804|NCT03045887|100572324|FG005|STARTED|Part A, Period 3 (1 Day)||4||
48100805|NCT03045887|100572325|FG006|STARTED|Part A, Period 3 (1 Day)||4||
48100806|NCT03045887|100572326|FG007|STARTED|Part A, Period 3 (1 Day)||4||
48100807|NCT03045887|100572327|FG008|STARTED|Part A, Period 3 (1 Day)||0||
48100808|NCT03045887|100572328|FG009|STARTED|Part A, Period 3 (1 Day)||0||
48100809|NCT03045887|100572319|FG000|COMPLETED|Part A, Period 3 (1 Day)||3||
48100810|NCT03045887|100572320|FG001|COMPLETED|Part A, Period 3 (1 Day)||4||
48100811|NCT03045887|100572321|FG002|COMPLETED|Part A, Period 3 (1 Day)||4||
48100812|NCT03045887|100572322|FG003|COMPLETED|Part A, Period 3 (1 Day)||2||
48100813|NCT03045887|100572323|FG004|COMPLETED|Part A, Period 3 (1 Day)||4||
48100814|NCT03045887|100572324|FG005|COMPLETED|Part A, Period 3 (1 Day)||4||
48100815|NCT03045887|100572325|FG006|COMPLETED|Part A, Period 3 (1 Day)||4||
48100816|NCT03045887|100572326|FG007|COMPLETED|Part A, Period 3 (1 Day)||4||
48100817|NCT03045887|100572327|FG008|COMPLETED|Part A, Period 3 (1 Day)||0||
48100818|NCT03045887|100572328|FG009|COMPLETED|Part A, Period 3 (1 Day)||0||
48100819|NCT03045887|100572319|FG000|NOT COMPLETED|Part A, Period 3 (1 Day)||0||
48100820|NCT03045887|100572320|FG001|NOT COMPLETED|Part A, Period 3 (1 Day)||0||
48100821|NCT03045887|100572321|FG002|NOT COMPLETED|Part A, Period 3 (1 Day)||0||
48100822|NCT03045887|100572322|FG003|NOT COMPLETED|Part A, Period 3 (1 Day)||0||
48100823|NCT03045887|100572323|FG004|NOT COMPLETED|Part A, Period 3 (1 Day)||0||
48100824|NCT03045887|100572324|FG005|NOT COMPLETED|Part A, Period 3 (1 Day)||0||
48100825|NCT03045887|100572325|FG006|NOT COMPLETED|Part A, Period 3 (1 Day)||0||
48100826|NCT03045887|100572326|FG007|NOT COMPLETED|Part A, Period 3 (1 Day)||0||
48100827|NCT03045887|100572327|FG008|NOT COMPLETED|Part A, Period 3 (1 Day)||0||
48100828|NCT03045887|100572328|FG009|NOT COMPLETED|Part A, Period 3 (1 Day)||0||
48100829|NCT03045887|100572319|FG000|STARTED|Part B (14 Days)||0||
48100830|NCT03045887|100572320|FG001|STARTED|Part B (14 Days)||0||
48100831|NCT03045887|100572321|FG002|STARTED|Part B (14 Days)||0||
48100832|NCT03045887|100572322|FG003|STARTED|Part B (14 Days)||0||
48100833|NCT03045887|100572323|FG004|STARTED|Part B (14 Days)||0||
48100834|NCT03045887|100572324|FG005|STARTED|Part B (14 Days)||0||
48100835|NCT03045887|100572325|FG006|STARTED|Part B (14 Days)||0||
48100836|NCT03045887|100572326|FG007|STARTED|Part B (14 Days)||0||
48100837|NCT03045887|100572327|FG008|STARTED|Part B (14 Days)||3||
48100838|NCT03045887|100572328|FG009|STARTED|Part B (14 Days)||9||
48100839|NCT03045887|100572319|FG000|COMPLETED|Part B (14 Days)||0||
48100840|NCT03045887|100572320|FG001|COMPLETED|Part B (14 Days)||0||
48100841|NCT03045887|100572321|FG002|COMPLETED|Part B (14 Days)||0||
48100842|NCT03045887|100572322|FG003|COMPLETED|Part B (14 Days)||0||
48100843|NCT03045887|100572323|FG004|COMPLETED|Part B (14 Days)||0||
48100844|NCT03045887|100572324|FG005|COMPLETED|Part B (14 Days)||0||
48100845|NCT03045887|100572325|FG006|COMPLETED|Part B (14 Days)||0||
48100846|NCT03045887|100572326|FG007|COMPLETED|Part B (14 Days)||0||
48100847|NCT03045887|100572327|FG008|COMPLETED|Part B (14 Days)||3||
48100848|NCT03045887|100572328|FG009|COMPLETED|Part B (14 Days)||9||
48100849|NCT03045887|100572319|FG000|NOT COMPLETED|Part B (14 Days)||0||
48100850|NCT03045887|100572320|FG001|NOT COMPLETED|Part B (14 Days)||0||
48100851|NCT03045887|100572321|FG002|NOT COMPLETED|Part B (14 Days)||0||
48100852|NCT03045887|100572322|FG003|NOT COMPLETED|Part B (14 Days)||0||
48100853|NCT03045887|100572323|FG004|NOT COMPLETED|Part B (14 Days)||0||
48100854|NCT03045887|100572324|FG005|NOT COMPLETED|Part B (14 Days)||0||
48100855|NCT03045887|100572325|FG006|NOT COMPLETED|Part B (14 Days)||0||
48263677|NCT03850275|100966804|FG002|COMPLETED|Overall Study||5||
48263678|NCT03850275|100966805|FG003|COMPLETED|Overall Study||5||
48263679|NCT03850275|100966806|FG004|COMPLETED|Overall Study||5||
48263680|NCT03850275|100966807|FG005|COMPLETED|Overall Study||5||
48263681|NCT03850275|100966802|FG000|NOT COMPLETED|Overall Study||0||
48547066|NCT01555697|101671526|FG000|STARTED|Overall Study||10||
48547067|NCT01555697|101671527|FG001|STARTED|Overall Study||10||
48100856|NCT03045887|100572326|FG007|NOT COMPLETED|Part B (14 Days)||0||
48100857|NCT03045887|100572327|FG008|NOT COMPLETED|Part B (14 Days)||0||
48100858|NCT03045887|100572328|FG009|NOT COMPLETED|Part B (14 Days)||0||
48100859|NCT03892460|100572329|FG000|STARTED|Overall Study||30||
48100860|NCT03892460|100572330|FG001|STARTED|Overall Study||24||
48100861|NCT03892460|100572329|FG000|Randomization|Overall Study||25||
48100862|NCT03892460|100572330|FG001|Randomization|Overall Study||20||
48100863|NCT03892460|100572329|FG000|COMPLETED|Overall Study||18||
48100864|NCT03892460|100572330|FG001|COMPLETED|Overall Study||19||
48100865|NCT03892460|100572329|FG000|NOT COMPLETED|Overall Study||12||
48100866|NCT03892460|100572330|FG001|NOT COMPLETED|Overall Study||5||
48100867|NCT01848756|100572331|FG000|STARTED|Overall Study||15||
48100868|NCT01848756|100572331|FG000|COMPLETED|Overall Study||12||
48100869|NCT01848756|100572331|FG000|NOT COMPLETED|Overall Study||3||
48100870|NCT00651755|100572332|FG000|STARTED|Cycle 1 (First 21 Days)||11||
48100871|NCT00651755|100572333|FG001|STARTED|Cycle 1 (First 21 Days)||9||
48100872|NCT00651755|100572332|FG000|COMPLETED|Cycle 1 (First 21 Days)||10||
48100873|NCT00651755|100572333|FG001|COMPLETED|Cycle 1 (First 21 Days)||9||
48100874|NCT00651755|100572332|FG000|NOT COMPLETED|Cycle 1 (First 21 Days)||1||
48100875|NCT00651755|100572333|FG001|NOT COMPLETED|Cycle 1 (First 21 Days)||0||
48100876|NCT00651755|100572332|FG000|STARTED|Cycle 2 (Second 21 Days)||10||
48100877|NCT00651755|100572333|FG001|STARTED|Cycle 2 (Second 21 Days)||9||
48100878|NCT00651755|100572332|FG000|COMPLETED|Cycle 2 (Second 21 Days)||10||
48100879|NCT00651755|100572333|FG001|COMPLETED|Cycle 2 (Second 21 Days)||8||
48263682|NCT03850275|100966803|FG001|NOT COMPLETED|Overall Study||0||
48263683|NCT03850275|100966804|FG002|NOT COMPLETED|Overall Study||0||
48100880|NCT00651755|100572332|FG000|NOT COMPLETED|Cycle 2 (Second 21 Days)||0||
48263684|NCT03850275|100966805|FG003|NOT COMPLETED|Overall Study||0||
48263685|NCT03850275|100966806|FG004|NOT COMPLETED|Overall Study||0||
48547068|NCT01555697|101671528|FG002|STARTED|Overall Study||10||
48263686|NCT03850275|100966807|FG005|NOT COMPLETED|Overall Study||0||
48263687|NCT02312206|100966808|FG000|STARTED|Overall Study||130||
48263688|NCT02312206|100966809|FG001|STARTED|Overall Study||130||
48263689|NCT02312206|100966808|FG000|Informed Consent Obtained|Overall Study||130||
48263690|NCT02312206|100966809|FG001|Informed Consent Obtained|Overall Study||130||
48263691|NCT02312206|100966808|FG000|COMPLETED|Overall Study||0||
48263692|NCT02312206|100966809|FG001|COMPLETED|Overall Study||0||
48263693|NCT02312206|100966808|FG000|NOT COMPLETED|Overall Study||130||
48263694|NCT02312206|100966809|FG001|NOT COMPLETED|Overall Study||130||
48263695|NCT01240915|100966810|FG000|STARTED|Overall Study||2||
48263696|NCT01240915|100966811|FG001|STARTED|Overall Study||3||
48263697|NCT01240915|100966812|FG002|STARTED|Overall Study||2||
48263698|NCT01240915|100966813|FG003|STARTED|Overall Study||4||
48263699|NCT01240915|100966814|FG004|STARTED|Overall Study||6||
48263700|NCT01240915|100966815|FG005|STARTED|Overall Study||23||
48263701|NCT01240915|100966816|FG006|STARTED|Overall Study||25||
48263702|NCT01240915|100966817|FG007|STARTED|Overall Study||19||
48263703|NCT01240915|100966818|FG008|STARTED|Overall Study||21||
48263704|NCT01240915|100966810|FG000|COMPLETED|Overall Study||0||
48263705|NCT01240915|100966811|FG001|COMPLETED|Overall Study||2||
48263706|NCT01240915|100966812|FG002|COMPLETED|Overall Study||2||
48263707|NCT01240915|100966813|FG003|COMPLETED|Overall Study||1||
48263708|NCT01240915|100966814|FG004|COMPLETED|Overall Study||2||
48263709|NCT01240915|100966815|FG005|COMPLETED|Overall Study||13||
48263710|NCT01240915|100966816|FG006|COMPLETED|Overall Study||17||
48263711|NCT01240915|100966817|FG007|COMPLETED|Overall Study||15||
48263712|NCT01240915|100966818|FG008|COMPLETED|Overall Study||13||
48263713|NCT01240915|100966810|FG000|NOT COMPLETED|Overall Study||2||
48263714|NCT01240915|100966811|FG001|NOT COMPLETED|Overall Study||1||
48263715|NCT01240915|100966812|FG002|NOT COMPLETED|Overall Study||0||
48263716|NCT01240915|100966813|FG003|NOT COMPLETED|Overall Study||3||
48263717|NCT01240915|100966814|FG004|NOT COMPLETED|Overall Study||4||
48547069|NCT01555697|101671529|FG003|STARTED|Overall Study||10||
48547070|NCT01555697|101671530|FG004|STARTED|Overall Study||10||
48547071|NCT01555697|101671531|FG005|STARTED|Overall Study||10||
48547072|NCT01555697|101671532|FG006|STARTED|Overall Study||10||
48547073|NCT01555697|101671533|FG007|STARTED|Overall Study||10||
48547074|NCT01555697|101671526|FG000|6 Hours Lab Testing Day 1|Overall Study||10||
48547075|NCT01555697|101671527|FG001|6 Hours Lab Testing Day 1|Overall Study||10||
48547076|NCT01555697|101671528|FG002|6 Hours Lab Testing Day 1|Overall Study||10||
48690933|NCT02998671|102025960|FG000|COMPLETED|Period 1||17||
48690934|NCT02998671|102025961|FG001|COMPLETED|Period 1||10||
48690935|NCT02998671|102025962|FG002|COMPLETED|Period 1||6||
48690936|NCT02998671|102025963|FG003|COMPLETED|Period 1||8||
48263718|NCT01240915|100966815|FG005|NOT COMPLETED|Overall Study||10||
48263719|NCT01240915|100966816|FG006|NOT COMPLETED|Overall Study||8||
48263720|NCT01240915|100966817|FG007|NOT COMPLETED|Overall Study||4||
48263721|NCT01240915|100966818|FG008|NOT COMPLETED|Overall Study||8||
48263722|NCT01729845|100966819|FG000|STARTED|Safety/Tolerability of Dec/MEC||6||
48263723|NCT01729845|100966820|FG001|STARTED|Safety/Tolerability of Dec/MEC||34||
48263724|NCT01729845|100966821|FG002|STARTED|Safety/Tolerability of Dec/MEC||12||
48263725|NCT01729845|100966819|FG000|COMPLETED|Safety/Tolerability of Dec/MEC||6||
48263726|NCT01729845|100966820|FG001|COMPLETED|Safety/Tolerability of Dec/MEC||34||
48263727|NCT01729845|100966821|FG002|COMPLETED|Safety/Tolerability of Dec/MEC||12||
48263728|NCT01729845|100966819|FG000|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0||
48263729|NCT01729845|100966820|FG001|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0||
48547077|NCT01555697|101671529|FG003|6 Hours Lab Testing Day 1|Overall Study||10||
48547078|NCT01555697|101671530|FG004|6 Hours Lab Testing Day 1|Overall Study||10||
48547079|NCT01555697|101671531|FG005|6 Hours Lab Testing Day 1|Overall Study||10||
48547080|NCT01555697|101671532|FG006|6 Hours Lab Testing Day 1|Overall Study||10||
48547081|NCT01555697|101671533|FG007|6 Hours Lab Testing Day 1|Overall Study||10||
48547082|NCT01555697|101671526|FG000|Approx 7 Day Washout|Overall Study||10||
48690937|NCT02998671|102025964|FG004|COMPLETED|Period 1||0||
48690938|NCT02998671|102025960|FG000|NOT COMPLETED|Period 1||4||
48263730|NCT01729845|100966821|FG002|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0||
48263731|NCT01729845|100966819|FG000|STARTED|Efficacy of Dec/MEC||0||
48263732|NCT01729845|100966820|FG001|STARTED|Efficacy of Dec/MEC||22||
48263733|NCT01729845|100966821|FG002|STARTED|Efficacy of Dec/MEC||0||
48263734|NCT01729845|100966819|FG000|COMPLETED|Efficacy of Dec/MEC||0||
48263735|NCT01729845|100966820|FG001|COMPLETED|Efficacy of Dec/MEC||22||
48263736|NCT01729845|100966821|FG002|COMPLETED|Efficacy of Dec/MEC||0||
48263737|NCT01729845|100966819|FG000|NOT COMPLETED|Efficacy of Dec/MEC||0||
48263738|NCT01729845|100966820|FG001|NOT COMPLETED|Efficacy of Dec/MEC||0||
48263739|NCT01729845|100966821|FG002|NOT COMPLETED|Efficacy of Dec/MEC||0||
48263740|NCT01160237|100966822|FG000|STARTED|Overall Study||4||
48263741|NCT01160237|100966823|FG001|STARTED|Overall Study||3||
48263742|NCT01160237|100966824|FG002|STARTED|Overall Study||0||
48263743|NCT01160237|100966822|FG000|COMPLETED|Overall Study||4||
48263744|NCT01160237|100966823|FG001|COMPLETED|Overall Study||3||
48263745|NCT01160237|100966824|FG002|COMPLETED|Overall Study||0||
48547083|NCT01555697|101671527|FG001|Approx 7 Day Washout|Overall Study||10||
48690939|NCT02998671|102025961|FG001|NOT COMPLETED|Period 1||3||
48547084|NCT01555697|101671528|FG002|Approx 7 Day Washout|Overall Study||10||
48547085|NCT01555697|101671529|FG003|Approx 7 Day Washout|Overall Study||10||
48547086|NCT01555697|101671530|FG004|Approx 7 Day Washout|Overall Study||10||
48547087|NCT01555697|101671531|FG005|Approx 7 Day Washout|Overall Study||10||
48547088|NCT01555697|101671532|FG006|Approx 7 Day Washout|Overall Study||10||
48547089|NCT01555697|101671533|FG007|Approx 7 Day Washout|Overall Study||10||
48547090|NCT01555697|101671526|FG000|6 Hours Lab Testing Day 2|Overall Study||10||
48547091|NCT01555697|101671527|FG001|6 Hours Lab Testing Day 2|Overall Study||10||
48547092|NCT01555697|101671528|FG002|6 Hours Lab Testing Day 2|Overall Study||10||
48547093|NCT01555697|101671529|FG003|6 Hours Lab Testing Day 2|Overall Study||10||
48547094|NCT01555697|101671530|FG004|6 Hours Lab Testing Day 2|Overall Study||10||
48547095|NCT01555697|101671531|FG005|6 Hours Lab Testing Day 2|Overall Study||10||
48547096|NCT01555697|101671532|FG006|6 Hours Lab Testing Day 2|Overall Study||10||
48547097|NCT01555697|101671533|FG007|6 Hours Lab Testing Day 2|Overall Study||10||
48547098|NCT01555697|101671526|FG000|COMPLETED|Overall Study||10||
48547099|NCT01555697|101671527|FG001|COMPLETED|Overall Study||10||
48547100|NCT01555697|101671528|FG002|COMPLETED|Overall Study||10||
48547101|NCT01555697|101671529|FG003|COMPLETED|Overall Study||10||
48547102|NCT01555697|101671530|FG004|COMPLETED|Overall Study||10||
48547103|NCT01555697|101671531|FG005|COMPLETED|Overall Study||10||
48690940|NCT02998671|102025962|FG002|NOT COMPLETED|Period 1||0||
48690941|NCT02998671|102025963|FG003|NOT COMPLETED|Period 1||0||
48690942|NCT02998671|102025964|FG004|NOT COMPLETED|Period 1||4||
48690943|NCT02998671|102025960|FG000|STARTED|Period 2||17||
48690944|NCT02998671|102025961|FG001|STARTED|Period 2||10||
48690945|NCT02998671|102025962|FG002|STARTED|Period 2||6||
48690946|NCT02998671|102025963|FG003|STARTED|Period 2||8||
48690947|NCT02998671|102025964|FG004|STARTED|Period 2||0||
48690948|NCT02998671|102025960|FG000|COMPLETED|Period 2||14||
48690949|NCT02998671|102025961|FG001|COMPLETED|Period 2||3||
48690950|NCT02998671|102025962|FG002|COMPLETED|Period 2||5||
48690951|NCT02998671|102025963|FG003|COMPLETED|Period 2||4||
48690952|NCT02998671|102025964|FG004|COMPLETED|Period 2||0||
48690953|NCT02998671|102025960|FG000|NOT COMPLETED|Period 2||3||
48690954|NCT02998671|102025961|FG001|NOT COMPLETED|Period 2||7||
48690955|NCT02998671|102025962|FG002|NOT COMPLETED|Period 2||1||
48690956|NCT02998671|102025963|FG003|NOT COMPLETED|Period 2||4||
48690957|NCT02998671|102025964|FG004|NOT COMPLETED|Period 2||0||
48690958|NCT03012828|102025965|FG000|STARTED|Overall Study||10||
48690959|NCT03012828|102025966|FG001|STARTED|Overall Study||10||
48690960|NCT03012828|102025967|FG002|STARTED|Overall Study||10||
48690961|NCT03012828|102025968|FG003|STARTED|Overall Study||10||
48690962|NCT03012828|102025969|FG004|STARTED|Overall Study||10||
48690963|NCT03012828|102025970|FG005|STARTED|Overall Study||10||
48690964|NCT03012828|102025965|FG000|COMPLETED|Overall Study||9||
48690965|NCT03012828|102025966|FG001|COMPLETED|Overall Study||10||
48690966|NCT03012828|102025967|FG002|COMPLETED|Overall Study||8||
48690967|NCT03012828|102025968|FG003|COMPLETED|Overall Study||10||
48690968|NCT03012828|102025969|FG004|COMPLETED|Overall Study||8||
48547104|NCT01555697|101671532|FG006|COMPLETED|Overall Study||10||
48547105|NCT01555697|101671533|FG007|COMPLETED|Overall Study||10||
48547106|NCT01555697|101671526|FG000|NOT COMPLETED|Overall Study||0||
48547107|NCT01555697|101671527|FG001|NOT COMPLETED|Overall Study||0||
48547108|NCT01555697|101671528|FG002|NOT COMPLETED|Overall Study||0||
48547109|NCT01555697|101671529|FG003|NOT COMPLETED|Overall Study||0||
48547110|NCT01555697|101671530|FG004|NOT COMPLETED|Overall Study||0||
48547111|NCT01555697|101671531|FG005|NOT COMPLETED|Overall Study||0||
48547112|NCT01555697|101671532|FG006|NOT COMPLETED|Overall Study||0||
48547113|NCT01555697|101671533|FG007|NOT COMPLETED|Overall Study||0||
48547114|NCT02125721|101671534|FG000|STARTED|Overall Study||10||
48547115|NCT02125721|101671534|FG000|COMPLETED|Overall Study||10||
48690969|NCT03012828|102025970|FG005|COMPLETED|Overall Study||8||
48690970|NCT03012828|102025965|FG000|NOT COMPLETED|Overall Study||1||
48690971|NCT03012828|102025966|FG001|NOT COMPLETED|Overall Study||0||
48690972|NCT03012828|102025967|FG002|NOT COMPLETED|Overall Study||2||
48690973|NCT03012828|102025968|FG003|NOT COMPLETED|Overall Study||0||
48690974|NCT03012828|102025969|FG004|NOT COMPLETED|Overall Study||2||
48690975|NCT03012828|102025970|FG005|NOT COMPLETED|Overall Study||2||
48690976|NCT03394781|102025971|FG000|STARTED|Overall Study||3||
48690977|NCT03394781|102025972|FG001|STARTED|Overall Study||2||
48690978|NCT03394781|102025971|FG000|COMPLETED|Overall Study||3||
48690979|NCT03394781|102025972|FG001|COMPLETED|Overall Study||2||
48690980|NCT03394781|102025971|FG000|NOT COMPLETED|Overall Study||0||
48690981|NCT03394781|102025972|FG001|NOT COMPLETED|Overall Study||0||
48690982|NCT02998684|102025973|FG000|STARTED|Overall Study||7||
48690983|NCT02998684|102025974|FG001|STARTED|Overall Study||7||
48690984|NCT02998684|102025973|FG000|COMPLETED|Overall Study||4||
48690985|NCT02998684|102025974|FG001|COMPLETED|Overall Study||6||
48690986|NCT02998684|102025973|FG000|NOT COMPLETED|Overall Study||3||
48690987|NCT02998684|102025974|FG001|NOT COMPLETED|Overall Study||1||
48690988|NCT00615719|102025975|FG000|STARTED|Overall Study||35||
48690989|NCT00615719|102025975|FG000|COMPLETED|Overall Study||30||
48690990|NCT00615719|102025975|FG000|NOT COMPLETED|Overall Study||5||
48690991|NCT03525600|102025976|FG000|STARTED|Overall Study||206||
48690992|NCT03525600|102025977|FG001|STARTED|Overall Study||208||
48690993|NCT03525600|102025978|FG002|STARTED|Overall Study||102||
48690994|NCT03525600|102025979|FG003|STARTED|Overall Study||105||
48690995|NCT03525600|102025976|FG000|COMPLETED|Overall Study||147||
48690996|NCT03525600|102025977|FG001|COMPLETED|Overall Study||161||
48690997|NCT03525600|102025978|FG002|COMPLETED|Overall Study||78||
48690998|NCT03525600|102025979|FG003|COMPLETED|Overall Study||83||
48690999|NCT03525600|102025976|FG000|NOT COMPLETED|Overall Study||59||
48691000|NCT03525600|102025977|FG001|NOT COMPLETED|Overall Study||47||
48691001|NCT03525600|102025978|FG002|NOT COMPLETED|Overall Study||24||
48691002|NCT03525600|102025979|FG003|NOT COMPLETED|Overall Study||22||
48691003|NCT00582712|102025980|FG000|STARTED|Overall Study||5||
48691004|NCT00582712|102025980|FG000|COMPLETED|Overall Study||1||
48691005|NCT00582712|102025980|FG000|NOT COMPLETED|Overall Study||4||
48691006|NCT02705105|102025981|FG000|STARTED|Treatment||4||
48691007|NCT02705105|102025982|FG001|STARTED|Treatment||110||
48691008|NCT02705105|102025981|FG000|Subjects Who Were Replaced|Treatment||1||
48691009|NCT02705105|102025982|FG001|Subjects Who Were Replaced|Treatment||0||
48691010|NCT02705105|102025981|FG000|D/C From Treatment Phase|Treatment||4||
48691011|NCT02705105|102025982|FG001|D/C From Treatment Phase|Treatment||107||
48691012|NCT02705105|102025981|FG000|D/C From Follow-Up|Treatment||4||
48547116|NCT02125721|101671534|FG000|NOT COMPLETED|Overall Study||0||
48547117|NCT03656744|101671535|FG000|STARTED|Overall Study||34||
48547118|NCT03656744|101671536|FG001|STARTED|Overall Study||34||
48547119|NCT03656744|101671537|FG002|STARTED|Overall Study||33||
48547120|NCT03656744|101671535|FG000|COMPLETED|Overall Study||29||
48547121|NCT03656744|101671536|FG001|COMPLETED|Overall Study||27||
48547122|NCT03656744|101671537|FG002|COMPLETED|Overall Study||32||
48547123|NCT03656744|101671535|FG000|NOT COMPLETED|Overall Study||5||
48547124|NCT03656744|101671536|FG001|NOT COMPLETED|Overall Study||7||
48547125|NCT03656744|101671537|FG002|NOT COMPLETED|Overall Study||1||
48547126|NCT04233073|101671538|FG000|STARTED|Overall Study||10||
48547127|NCT04233073|101671538|FG000|Treated With Any Amount of Andexanet|Overall Study||10||
48547128|NCT04233073|101671538|FG000|Efficacy Set|Overall Study||6||
48547129|NCT04233073|101671538|FG000|COMPLETED|Overall Study||5||
48547130|NCT04233073|101671538|FG000|NOT COMPLETED|Overall Study||5||
48547131|NCT02032680|101671539|FG000|STARTED|Overall Study||22||
48547132|NCT02032680|101671540|FG001|STARTED|Overall Study||8||
48547133|NCT02032680|101671539|FG000|COMPLETED|Overall Study||16||
48547134|NCT02032680|101671540|FG001|COMPLETED|Overall Study||7||
48547135|NCT02032680|101671539|FG000|NOT COMPLETED|Overall Study||6||
48547136|NCT02032680|101671540|FG001|NOT COMPLETED|Overall Study||1||
48547137|NCT02256436|101671541|FG000|STARTED|Overall Study||272||
48547138|NCT02256436|101671542|FG001|STARTED|Overall Study||270||
48547139|NCT02256436|101671541|FG000|Treated|Overall Study||255||
48547140|NCT02256436|101671542|FG001|Treated|Overall Study||266||
48547141|NCT02256436|101671541|FG000|Switched Over to Pembrolizumab|Overall Study||13||
48547142|NCT02256436|101671542|FG001|Switched Over to Pembrolizumab|Overall Study||0||
48547143|NCT02256436|101671541|FG000|COMPLETED|Overall Study||0||
48547144|NCT02256436|101671542|FG001|COMPLETED|Overall Study||0||
48547145|NCT02256436|101671541|FG000|NOT COMPLETED|Overall Study||272||
48547146|NCT02256436|101671542|FG001|NOT COMPLETED|Overall Study||270||
48547147|NCT00041132|101671543|FG000|STARTED|Overall Study||56||
48547148|NCT00041132|101671543|FG000|Eligible|Overall Study||49||
48547149|NCT00041132|101671543|FG000|Eligible and Began Protocol Therapy|Overall Study||49||
48691013|NCT02705105|102025982|FG001|D/C From Follow-Up|Treatment||110||
48691014|NCT02705105|102025981|FG000|COMPLETED|Treatment||0||
48691015|NCT02705105|102025982|FG001|COMPLETED|Treatment||1||
48691016|NCT02705105|102025981|FG000|NOT COMPLETED|Treatment||4||
48691017|NCT02705105|102025982|FG001|NOT COMPLETED|Treatment||109||
48691018|NCT02705105|102025981|FG000|STARTED|Follow-Up||4||
48691019|NCT02705105|102025982|FG001|STARTED|Follow-Up||110||
48691020|NCT02705105|102025981|FG000|COMPLETED|Follow-Up||0||
48547150|NCT00041132|101671543|FG000|COMPLETED|Overall Study||26||
48691021|NCT02705105|102025982|FG001|COMPLETED|Follow-Up||0||
48547151|NCT00041132|101671543|FG000|NOT COMPLETED|Overall Study||30||
48547152|NCT01128179|101671544|FG000|STARTED|Overall Study||23||
48547153|NCT01128179|101671545|FG001|STARTED|Overall Study||12||
48547154|NCT01128179|101671544|FG000|COMPLETED|Overall Study||21||
48547155|NCT01128179|101671545|FG001|COMPLETED|Overall Study||12||
48547156|NCT01128179|101671544|FG000|NOT COMPLETED|Overall Study||2||
48547157|NCT01128179|101671545|FG001|NOT COMPLETED|Overall Study||0||
48547158|NCT01266031|101671546|FG000|STARTED|Overall Study||6||
48547159|NCT01266031|101671547|FG001|STARTED|Overall Study||41||
48691022|NCT02705105|102025981|FG000|NOT COMPLETED|Follow-Up||4||
48691023|NCT02705105|102025982|FG001|NOT COMPLETED|Follow-Up||110||
48691024|NCT01773967|102025983|FG000|STARTED|Overall Study||483||
48691025|NCT01773967|102025984|FG001|STARTED|Overall Study||488||
48691026|NCT01773967|102025983|FG000|COMPLETED|Overall Study||468||
48691027|NCT01773967|102025984|FG001|COMPLETED|Overall Study||475||
48691028|NCT01773967|102025983|FG000|NOT COMPLETED|Overall Study||15||
48691029|NCT01773967|102025984|FG001|NOT COMPLETED|Overall Study||13||
48691030|NCT00880269|102025985|FG000|STARTED|Overall Study||32||
48691031|NCT00880269|102025986|FG001|STARTED|Overall Study||27||
48547160|NCT01266031|101671548|FG002|STARTED|Overall Study||49||
48547161|NCT01266031|101671546|FG000|COMPLETED|Overall Study||6||
48547162|NCT01266031|101671547|FG001|COMPLETED|Overall Study||38||
48547163|NCT01266031|101671548|FG002|COMPLETED|Overall Study||47||
48547164|NCT01266031|101671546|FG000|NOT COMPLETED|Overall Study||0||
48547165|NCT01266031|101671547|FG001|NOT COMPLETED|Overall Study||3||
48547166|NCT01266031|101671548|FG002|NOT COMPLETED|Overall Study||2||
48547167|NCT02129608|101675133|FG000|STARTED|Overall Study||15||
48547168|NCT02129608|101675134|FG001|STARTED|Overall Study||14||
48547169|NCT02129608|101675135|FG002|STARTED|Overall Study||15||
48547170|NCT02129608|101675133|FG000|End of Treatment|Overall Study||15||
48547171|NCT02129608|101675134|FG001|End of Treatment|Overall Study||13||
48263746|NCT01160237|100966822|FG000|NOT COMPLETED|Overall Study||0||
48263747|NCT01160237|100966823|FG001|NOT COMPLETED|Overall Study||0||
48263748|NCT01160237|100966824|FG002|NOT COMPLETED|Overall Study||0||
48263749|NCT01807182|100966825|FG000|STARTED|Overall Study||10||
48263750|NCT01807182|100966825|FG000|COMPLETED|Overall Study||7||
48263751|NCT01807182|100966825|FG000|NOT COMPLETED|Overall Study||3||
48263752|NCT00966264|100966826|FG000|STARTED|Overall Study||119||
48691032|NCT00880269|102025985|FG000|Discontinued Treatment|Overall Study||32||
48691033|NCT00880269|102025986|FG001|Discontinued Treatment|Overall Study||27||
48263753|NCT00966264|100966827|FG001|STARTED|Overall Study||117||
48263754|NCT00966264|100966826|FG000|COMPLETED|Overall Study||115||
48263755|NCT00966264|100966827|FG001|COMPLETED|Overall Study||114||
48263756|NCT00966264|100966826|FG000|NOT COMPLETED|Overall Study||4||
48263757|NCT00966264|100966827|FG001|NOT COMPLETED|Overall Study||3||
48263758|NCT00786643|100966828|FG000|STARTED|Overall Study||20||
48263759|NCT00786643|100966829|FG001|STARTED|Overall Study||28||
48263760|NCT00786643|100966828|FG000|COMPLETED|Overall Study||20||
48263761|NCT00786643|100966829|FG001|COMPLETED|Overall Study||28||
48263762|NCT00786643|100966828|FG000|NOT COMPLETED|Overall Study||0||
48263763|NCT00786643|100966829|FG001|NOT COMPLETED|Overall Study||0||
48547172|NCT02129608|101675135|FG002|End of Treatment|Overall Study||12||
48263764|NCT03379545|100966830|FG000|STARTED|Overall Study||29||
48263765|NCT03379545|100966830|FG000|COMPLETED|Overall Study||29||
48263766|NCT03379545|100966830|FG000|NOT COMPLETED|Overall Study||0||
48263767|NCT04996940|100966831|FG000|STARTED|Overall Study||28||
48547173|NCT02129608|101675133|FG000|COMPLETED|Overall Study||15||
48547174|NCT02129608|101675134|FG001|COMPLETED|Overall Study||13||
48547175|NCT02129608|101675135|FG002|COMPLETED|Overall Study||12||
48547176|NCT02129608|101675133|FG000|NOT COMPLETED|Overall Study||0||
48547177|NCT02129608|101675134|FG001|NOT COMPLETED|Overall Study||1||
48547178|NCT02129608|101675135|FG002|NOT COMPLETED|Overall Study||3||
48547179|NCT04411914|101675136|FG000|STARTED|CLAV 500mg/Day for Days 1-3||10||
48547180|NCT04411914|101675137|FG001|STARTED|CLAV 500mg/Day for Days 1-3||3||
48547181|NCT04411914|101675136|FG000|COMPLETED|CLAV 500mg/Day for Days 1-3||9||
48547182|NCT04411914|101675137|FG001|COMPLETED|CLAV 500mg/Day for Days 1-3||3||
48547183|NCT04411914|101675136|FG000|NOT COMPLETED|CLAV 500mg/Day for Days 1-3||1||
48547184|NCT04411914|101675137|FG001|NOT COMPLETED|CLAV 500mg/Day for Days 1-3||0||
48547185|NCT04411914|101675136|FG000|STARTED|CLAV 750mg/Day for Days 4-6||9||
48547186|NCT04411914|101675137|FG001|STARTED|CLAV 750mg/Day for Days 4-6||3||
48547187|NCT04411914|101675136|FG000|COMPLETED|CLAV 750mg/Day for Days 4-6||9||
48547188|NCT04411914|101675137|FG001|COMPLETED|CLAV 750mg/Day for Days 4-6||3||
48547189|NCT04411914|101675136|FG000|NOT COMPLETED|CLAV 750mg/Day for Days 4-6||0||
48547190|NCT04411914|101675137|FG001|NOT COMPLETED|CLAV 750mg/Day for Days 4-6||0||
48547191|NCT04411914|101675136|FG000|STARTED|CLAV 1000m/d for Days 7-10||9||
48547192|NCT04411914|101675137|FG001|STARTED|CLAV 1000m/d for Days 7-10||3||
48547193|NCT04411914|101675136|FG000|COMPLETED|CLAV 1000m/d for Days 7-10||9||
48547194|NCT04411914|101675137|FG001|COMPLETED|CLAV 1000m/d for Days 7-10||3||
48547195|NCT04411914|101675136|FG000|NOT COMPLETED|CLAV 1000m/d for Days 7-10||0||
48547196|NCT04411914|101675137|FG001|NOT COMPLETED|CLAV 1000m/d for Days 7-10||0||
48547197|NCT01931878|101675138|FG000|STARTED|First Intervention||10||
48547198|NCT01931878|101675139|FG001|STARTED|First Intervention||14||
48547199|NCT01931878|101675138|FG000|COMPLETED|First Intervention||9||
48547200|NCT01931878|101675139|FG001|COMPLETED|First Intervention||14||
48547201|NCT01931878|101675138|FG000|NOT COMPLETED|First Intervention||1||
48547202|NCT01931878|101675139|FG001|NOT COMPLETED|First Intervention||0||
48547203|NCT01931878|101675138|FG000|STARTED|Second Intervention (After 3 Months)||9||
48547204|NCT01931878|101675139|FG001|STARTED|Second Intervention (After 3 Months)||14||
48263768|NCT04996940|100966832|FG001|STARTED|Overall Study||24||
48263769|NCT04996940|100966831|FG000|COMPLETED|Overall Study||28||
48263770|NCT04996940|100966832|FG001|COMPLETED|Overall Study||24||
48263771|NCT04996940|100966831|FG000|NOT COMPLETED|Overall Study||0||
48263772|NCT04996940|100966832|FG001|NOT COMPLETED|Overall Study||0||
48263773|NCT01318876|100966833|FG000|STARTED|Day 8 Survey||7645||
48263774|NCT01318876|100966833|FG000|COMPLETED|Day 8 Survey||5825||
48263775|NCT01318876|100966833|FG000|NOT COMPLETED|Day 8 Survey||1820||
48263776|NCT01318876|100966833|FG000|STARTED|Day 29 Survey||7549||
48263777|NCT01318876|100966833|FG000|COMPLETED|Day 29 Survey||5724||
48547205|NCT01931878|101675138|FG000|COMPLETED|Second Intervention (After 3 Months)||9||
48547206|NCT01931878|101675139|FG001|COMPLETED|Second Intervention (After 3 Months)||12||
48547207|NCT01931878|101675138|FG000|NOT COMPLETED|Second Intervention (After 3 Months)||0||
48547208|NCT01931878|101675139|FG001|NOT COMPLETED|Second Intervention (After 3 Months)||2||
48547209|NCT04152863|101675140|FG000|STARTED|Overall Study||28||
48547210|NCT04152863|101675141|FG001|STARTED|Overall Study||28||
48547211|NCT04152863|101675142|FG002|STARTED|Overall Study||29||
48547212|NCT04152863|101675140|FG000|Treated|Overall Study||28||
48547213|NCT04152863|101675141|FG001|Treated|Overall Study||28||
48547214|NCT04152863|101675142|FG002|Treated|Overall Study||26||
48547215|NCT04152863|101675140|FG000|COMPLETED|Overall Study||0||
48547216|NCT04152863|101675141|FG001|COMPLETED|Overall Study||0||
48547217|NCT04152863|101675142|FG002|COMPLETED|Overall Study||0||
48547218|NCT04152863|101675140|FG000|NOT COMPLETED|Overall Study||28||
48547219|NCT04152863|101675141|FG001|NOT COMPLETED|Overall Study||28||
48547220|NCT04152863|101675142|FG002|NOT COMPLETED|Overall Study||29||
48547221|NCT04303780|101675143|FG000|STARTED|Overall Study||171||
48547222|NCT04303780|101675144|FG001|STARTED|Overall Study||174||
48547223|NCT04303780|101675143|FG000|Switched From Docetaxel to AMG 510|Overall Study||0||
48547224|NCT04303780|101675144|FG001|Switched From Docetaxel to AMG 510|Overall Study||46||
48547225|NCT04303780|101675143|FG000|COMPLETED|Overall Study||0|Number of participants who have completed the study as of the primary analysis completion date (02 August 2022).|
48547226|NCT04303780|101675144|FG001|COMPLETED|Overall Study||3|Number of participants who have completed the study as of the primary analysis completion date (02 August 2022).|
48547227|NCT04303780|101675143|FG000|NOT COMPLETED|Overall Study||171||
48547228|NCT04303780|101675144|FG001|NOT COMPLETED|Overall Study||171||
48547229|NCT00761657|101675145|FG000|STARTED|Part 1 (up to Day 57)||0||
48547230|NCT00761657|101675146|FG001|STARTED|Part 1 (up to Day 57)||0||
48547231|NCT00761657|101675147|FG002|STARTED|Part 1 (up to Day 57)||12||
48547232|NCT00761657|101675148|FG003|STARTED|Part 1 (up to Day 57)||10||
48547233|NCT00761657|101675149|FG004|STARTED|Part 1 (up to Day 57)||0||
48547234|NCT00761657|101675150|FG005|STARTED|Part 1 (up to Day 57)||0||
48547235|NCT00761657|101675151|FG006|STARTED|Part 1 (up to Day 57)||1||
48547236|NCT00761657|101675152|FG007|STARTED|Part 1 (up to Day 57)||2||
48547237|NCT00761657|101675153|FG008|STARTED|Part 1 (up to Day 57)||10||
48547238|NCT00761657|101675145|FG000|Safety Population|Part 1 (up to Day 57)||0|Participants who received at least 1 dose of study drug.|
48547239|NCT00761657|101675146|FG001|Safety Population|Part 1 (up to Day 57)||0|Participants who received at least 1 dose of study drug.|
48547240|NCT00761657|101675147|FG002|Safety Population|Part 1 (up to Day 57)||12|Participants who received at least 1 dose of study drug.|
48547241|NCT00761657|101675148|FG003|Safety Population|Part 1 (up to Day 57)||9|Participants who received at least 1 dose of study drug.|
48547242|NCT00761657|101675149|FG004|Safety Population|Part 1 (up to Day 57)||0|Participants who received at least 1 dose of study drug.|
48547243|NCT00761657|101675150|FG005|Safety Population|Part 1 (up to Day 57)||0|Participants who received at least 1 dose of study drug.|
48547244|NCT00761657|101675151|FG006|Safety Population|Part 1 (up to Day 57)||1|Participants who received at least 1 dose of study drug.|
48547245|NCT00761657|101675152|FG007|Safety Population|Part 1 (up to Day 57)||2|Participants who received at least 1 dose of study drug.|
48547246|NCT00761657|101675153|FG008|Safety Population|Part 1 (up to Day 57)||10|Participants who received at least 1 dose of study drug.|
48547247|NCT00761657|101675145|FG000|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0|Participants who were anemic at baseline (hemoglobin \[Hb\] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
48547248|NCT00761657|101675146|FG001|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0|Participants who were anemic at baseline (hemoglobin \[Hb\] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
48547249|NCT00761657|101675147|FG002|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||5|Participants who were anemic at baseline (hemoglobin \[Hb\] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
48547250|NCT00761657|101675148|FG003|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||5|Participants who were anemic at baseline (hemoglobin \[Hb\] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
48547251|NCT00761657|101675149|FG004|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0|Participants who were anemic at baseline (hemoglobin \[Hb\] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
48547252|NCT00761657|101675150|FG005|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0|Participants who were anemic at baseline (hemoglobin \[Hb\] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
48547253|NCT00761657|101675151|FG006|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0|Participants who were anemic at baseline (hemoglobin \[Hb\] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
48547254|NCT00761657|101675152|FG007|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||1|Participants who were anemic at baseline (hemoglobin \[Hb\] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
48547255|NCT00761657|101675153|FG008|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||6|Participants who were anemic at baseline (hemoglobin \[Hb\] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
48547256|NCT00761657|101675145|FG000|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0|Participants treated with roxadustat at the 2 PK sites.|
48547257|NCT00761657|101675146|FG001|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0|Participants treated with roxadustat at the 2 PK sites.|
48547258|NCT00761657|101675147|FG002|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||5|Participants treated with roxadustat at the 2 PK sites.|
48547259|NCT00761657|101675148|FG003|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||3|Participants treated with roxadustat at the 2 PK sites.|
48100881|NCT00651755|100572333|FG001|NOT COMPLETED|Cycle 2 (Second 21 Days)||1||
48100882|NCT04693507|100572334|FG000|STARTED|Overall Study||9||
48263778|NCT01318876|100966833|FG000|NOT COMPLETED|Day 29 Survey||1825||
48263779|NCT00455741|100966834|FG000|STARTED|Overall Study||13||
48263780|NCT00455741|100966835|FG001|STARTED|Overall Study||12||
48263781|NCT00455741|100966834|FG000|COMPLETED|Overall Study||13||
48263782|NCT00455741|100966835|FG001|COMPLETED|Overall Study||11||
48263783|NCT00455741|100966834|FG000|NOT COMPLETED|Overall Study||0||
48263784|NCT00455741|100966835|FG001|NOT COMPLETED|Overall Study||1||
48263785|NCT01015677|100966836|FG000|STARTED|Overall Study||34||
48263786|NCT01015677|100966837|FG001|STARTED|Overall Study||32||
48263787|NCT01015677|100966838|FG002|STARTED|Overall Study||33||
48263788|NCT01015677|100966836|FG000|COMPLETED|Overall Study||33||
48263789|NCT01015677|100966837|FG001|COMPLETED|Overall Study||28||
48390795|NCT03627494|101283639|FG010|COMPLETED|Part C Period 1 (4 Days)||6||
48390796|NCT03627494|101283640|FG011|COMPLETED|Part C Period 1 (4 Days)||6||
48390797|NCT03627494|101283629|FG000|NOT COMPLETED|Part C Period 1 (4 Days)||0||
48390798|NCT03627494|101283630|FG001|NOT COMPLETED|Part C Period 1 (4 Days)||0||
48390799|NCT03627494|101283631|FG002|NOT COMPLETED|Part C Period 1 (4 Days)||0||
48390800|NCT03627494|101283632|FG003|NOT COMPLETED|Part C Period 1 (4 Days)||0||
48390801|NCT03627494|101283633|FG004|NOT COMPLETED|Part C Period 1 (4 Days)||0||
48390802|NCT03627494|101283634|FG005|NOT COMPLETED|Part C Period 1 (4 Days)||0||
48390803|NCT03627494|101283635|FG006|NOT COMPLETED|Part C Period 1 (4 Days)||0||
48390804|NCT03627494|101283636|FG007|NOT COMPLETED|Part C Period 1 (4 Days)||0||
48390805|NCT03627494|101283637|FG008|NOT COMPLETED|Part C Period 1 (4 Days)||0||
48390806|NCT03627494|101283638|FG009|NOT COMPLETED|Part C Period 1 (4 Days)||0||
48390807|NCT03627494|101283639|FG010|NOT COMPLETED|Part C Period 1 (4 Days)||0||
48390808|NCT03627494|101283640|FG011|NOT COMPLETED|Part C Period 1 (4 Days)||0||
48390809|NCT03627494|101283629|FG000|STARTED|Part C Washout 1 (7 Days)||0||
48390810|NCT03627494|101283630|FG001|STARTED|Part C Washout 1 (7 Days)||0||
48390811|NCT03627494|101283631|FG002|STARTED|Part C Washout 1 (7 Days)||0||
48390812|NCT03627494|101283632|FG003|STARTED|Part C Washout 1 (7 Days)||0||
48390813|NCT03627494|101283633|FG004|STARTED|Part C Washout 1 (7 Days)||0||
48390814|NCT03627494|101283634|FG005|STARTED|Part C Washout 1 (7 Days)||0||
48390815|NCT03627494|101283635|FG006|STARTED|Part C Washout 1 (7 Days)||0||
48390816|NCT03627494|101283636|FG007|STARTED|Part C Washout 1 (7 Days)||0||
48390817|NCT03627494|101283637|FG008|STARTED|Part C Washout 1 (7 Days)||0||
48390818|NCT03627494|101283638|FG009|STARTED|Part C Washout 1 (7 Days)||0||
48390819|NCT03627494|101283639|FG010|STARTED|Part C Washout 1 (7 Days)||6||
48390820|NCT03627494|101283640|FG011|STARTED|Part C Washout 1 (7 Days)||6||
48390821|NCT03627494|101283629|FG000|COMPLETED|Part C Washout 1 (7 Days)||0||
48390822|NCT03627494|101283630|FG001|COMPLETED|Part C Washout 1 (7 Days)||0||
48390823|NCT03627494|101283631|FG002|COMPLETED|Part C Washout 1 (7 Days)||0||
48390824|NCT03627494|101283632|FG003|COMPLETED|Part C Washout 1 (7 Days)||0||
48390825|NCT03627494|101283633|FG004|COMPLETED|Part C Washout 1 (7 Days)||0||
48390826|NCT03627494|101283634|FG005|COMPLETED|Part C Washout 1 (7 Days)||0||
48390827|NCT03627494|101283635|FG006|COMPLETED|Part C Washout 1 (7 Days)||0||
48390828|NCT03627494|101283636|FG007|COMPLETED|Part C Washout 1 (7 Days)||0||
48390829|NCT03627494|101283637|FG008|COMPLETED|Part C Washout 1 (7 Days)||0||
48390830|NCT03627494|101283638|FG009|COMPLETED|Part C Washout 1 (7 Days)||0||
48390831|NCT03627494|101283639|FG010|COMPLETED|Part C Washout 1 (7 Days)||5||
48390832|NCT03627494|101283640|FG011|COMPLETED|Part C Washout 1 (7 Days)||5||
48390833|NCT03627494|101283629|FG000|NOT COMPLETED|Part C Washout 1 (7 Days)||0||
48547260|NCT00761657|101675149|FG004|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0|Participants treated with roxadustat at the 2 PK sites.|
48547261|NCT00761657|101675150|FG005|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0|Participants treated with roxadustat at the 2 PK sites.|
48592720|NCT02143791|101783167|FG000|STARTED|Burst Stimulation Only (3 Months)||100||
48263790|NCT01015677|100966838|FG002|COMPLETED|Overall Study||33||
48390834|NCT03627494|101283630|FG001|NOT COMPLETED|Part C Washout 1 (7 Days)||0||
48390835|NCT03627494|101283631|FG002|NOT COMPLETED|Part C Washout 1 (7 Days)||0||
48390836|NCT03627494|101283632|FG003|NOT COMPLETED|Part C Washout 1 (7 Days)||0||
48390837|NCT03627494|101283633|FG004|NOT COMPLETED|Part C Washout 1 (7 Days)||0||
48390838|NCT03627494|101283634|FG005|NOT COMPLETED|Part C Washout 1 (7 Days)||0||
48390839|NCT03627494|101283635|FG006|NOT COMPLETED|Part C Washout 1 (7 Days)||0||
48390840|NCT03627494|101283636|FG007|NOT COMPLETED|Part C Washout 1 (7 Days)||0||
48390841|NCT03627494|101283637|FG008|NOT COMPLETED|Part C Washout 1 (7 Days)||0||
48390842|NCT03627494|101283638|FG009|NOT COMPLETED|Part C Washout 1 (7 Days)||0||
48390843|NCT03627494|101283639|FG010|NOT COMPLETED|Part C Washout 1 (7 Days)||1||
48390844|NCT03627494|101283640|FG011|NOT COMPLETED|Part C Washout 1 (7 Days)||1||
48390845|NCT03627494|101283629|FG000|STARTED|Part C Period2(4days)+Follow-up(14days)||0||
48390846|NCT03627494|101283630|FG001|STARTED|Part C Period2(4days)+Follow-up(14days)||0||
48263791|NCT01015677|100966836|FG000|NOT COMPLETED|Overall Study||1||
48263792|NCT01015677|100966837|FG001|NOT COMPLETED|Overall Study||4||
48263793|NCT01015677|100966838|FG002|NOT COMPLETED|Overall Study||0||
48263794|NCT04646369|100966839|FG000|STARTED|Overall Study||23||
48263795|NCT04646369|100966840|FG001|STARTED|Overall Study||38||
48547262|NCT00761657|101675151|FG006|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||1|Participants treated with roxadustat at the 2 PK sites.|
48547263|NCT00761657|101675152|FG007|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||2|Participants treated with roxadustat at the 2 PK sites.|
48547264|NCT00761657|101675153|FG008|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0|Participants treated with roxadustat at the 2 PK sites.|
48547265|NCT00761657|101675145|FG000|COMPLETED|Part 1 (up to Day 57)||0||
48547266|NCT00761657|101675146|FG001|COMPLETED|Part 1 (up to Day 57)||0||
48547267|NCT00761657|101675147|FG002|COMPLETED|Part 1 (up to Day 57)||8||
48547268|NCT00761657|101675148|FG003|COMPLETED|Part 1 (up to Day 57)||4||
48547269|NCT00761657|101675149|FG004|COMPLETED|Part 1 (up to Day 57)||0||
48547270|NCT00761657|101675150|FG005|COMPLETED|Part 1 (up to Day 57)||0||
48547271|NCT00761657|101675151|FG006|COMPLETED|Part 1 (up to Day 57)||0||
48547272|NCT00761657|101675152|FG007|COMPLETED|Part 1 (up to Day 57)||1||
48547273|NCT00761657|101675153|FG008|COMPLETED|Part 1 (up to Day 57)||9||
48547274|NCT00761657|101675145|FG000|NOT COMPLETED|Part 1 (up to Day 57)||0||
48547275|NCT00761657|101675146|FG001|NOT COMPLETED|Part 1 (up to Day 57)||0||
48547276|NCT00761657|101675147|FG002|NOT COMPLETED|Part 1 (up to Day 57)||4||
48547277|NCT00761657|101675148|FG003|NOT COMPLETED|Part 1 (up to Day 57)||6||
48547278|NCT00761657|101675149|FG004|NOT COMPLETED|Part 1 (up to Day 57)||0||
48547279|NCT00761657|101675150|FG005|NOT COMPLETED|Part 1 (up to Day 57)||0||
48547280|NCT00761657|101675151|FG006|NOT COMPLETED|Part 1 (up to Day 57)||1||
48547281|NCT00761657|101675152|FG007|NOT COMPLETED|Part 1 (up to Day 57)||1||
48547282|NCT00761657|101675153|FG008|NOT COMPLETED|Part 1 (up to Day 57)||1||
48547283|NCT00761657|101675145|FG000|STARTED|Part 2 (up to Day 114)||10||
48547284|NCT00761657|101675146|FG001|STARTED|Part 2 (up to Day 114)||13||
48547285|NCT00761657|101675147|FG002|STARTED|Part 2 (up to Day 114)||0||
48547286|NCT00761657|101675148|FG003|STARTED|Part 2 (up to Day 114)||0||
48547287|NCT00761657|101675149|FG004|STARTED|Part 2 (up to Day 114)||10||
48547288|NCT00761657|101675150|FG005|STARTED|Part 2 (up to Day 114)||11||
48547289|NCT00761657|101675151|FG006|STARTED|Part 2 (up to Day 114)||10||
48547290|NCT00761657|101675152|FG007|STARTED|Part 2 (up to Day 114)||10||
48547291|NCT00761657|101675153|FG008|STARTED|Part 2 (up to Day 114)||18||
48547292|NCT00761657|101675145|FG000|Safety Population|Part 2 (up to Day 114)||10|Participants who received at least 1 dose of study drug.|
48547293|NCT00761657|101675146|FG001|Safety Population|Part 2 (up to Day 114)||13|Participants who received at least 1 dose of study drug.|
48547294|NCT00761657|101675147|FG002|Safety Population|Part 2 (up to Day 114)||0|Participants who received at least 1 dose of study drug.|
48547295|NCT00761657|101675148|FG003|Safety Population|Part 2 (up to Day 114)||0|Participants who received at least 1 dose of study drug.|
48547296|NCT00761657|101675149|FG004|Safety Population|Part 2 (up to Day 114)||10|Participants who received at least 1 dose of study drug.|
48547297|NCT00761657|101675150|FG005|Safety Population|Part 2 (up to Day 114)||11|Participants who received at least 1 dose of study drug.|
48547298|NCT00761657|101675151|FG006|Safety Population|Part 2 (up to Day 114)||10|Participants who received at least 1 dose of study drug.|
48547299|NCT00761657|101675152|FG007|Safety Population|Part 2 (up to Day 114)||10|Participants who received at least 1 dose of study drug.|
48547300|NCT00761657|101675153|FG008|Safety Population|Part 2 (up to Day 114)||18|Participants who received at least 1 dose of study drug.|
48547301|NCT00761657|101675145|FG000|EE Population|Part 2 (up to Day 114)||10|Participants who were anemic at baseline (hemoglobin \[Hb\] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
48547302|NCT00761657|101675146|FG001|EE Population|Part 2 (up to Day 114)||12|Participants who were anemic at baseline (hemoglobin \[Hb\] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
48547303|NCT00761657|101675147|FG002|EE Population|Part 2 (up to Day 114)||0|Participants who were anemic at baseline (hemoglobin \[Hb\] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
48547304|NCT00761657|101675148|FG003|EE Population|Part 2 (up to Day 114)||0|Participants who were anemic at baseline (hemoglobin \[Hb\] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
48547305|NCT00761657|101675149|FG004|EE Population|Part 2 (up to Day 114)||10|Participants who were anemic at baseline (hemoglobin \[Hb\] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
48547306|NCT00761657|101675150|FG005|EE Population|Part 2 (up to Day 114)||11|Participants who were anemic at baseline (hemoglobin \[Hb\] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
48547307|NCT00761657|101675151|FG006|EE Population|Part 2 (up to Day 114)||10|Participants who were anemic at baseline (hemoglobin \[Hb\] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
48547308|NCT00761657|101675152|FG007|EE Population|Part 2 (up to Day 114)||10|Participants who were anemic at baseline (hemoglobin \[Hb\] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
48547309|NCT00761657|101675153|FG008|EE Population|Part 2 (up to Day 114)||11|Participants who were anemic at baseline (hemoglobin \[Hb\] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
48547310|NCT00761657|101675145|FG000|PK Population|Part 2 (up to Day 114)||10|Participants who received roxadustat and had sufficient plasma data to allow calculation of PK parameters.|
48547311|NCT00761657|101675146|FG001|PK Population|Part 2 (up to Day 114)||13|Participants who received roxadustat and had sufficient plasma data to allow calculation of PK parameters.|
48547312|NCT00761657|101675147|FG002|PK Population|Part 2 (up to Day 114)||0|Participants who received roxadustat and had sufficient plasma data to allow calculation of PK parameters.|
48691034|NCT00880269|102025985|FG000|COMPLETED|Overall Study||0||
48263796|NCT04646369|100966841|FG002|STARTED|Overall Study||39||
48263797|NCT04646369|100966839|FG000|COMPLETED|Overall Study||23||
48263798|NCT04646369|100966840|FG001|COMPLETED|Overall Study||38||
48263799|NCT04646369|100966841|FG002|COMPLETED|Overall Study||39||
48263800|NCT04646369|100966839|FG000|NOT COMPLETED|Overall Study||0||
48263801|NCT04646369|100966840|FG001|NOT COMPLETED|Overall Study||0||
48263802|NCT04646369|100966841|FG002|NOT COMPLETED|Overall Study||0||
48263803|NCT02153905|100966842|FG000|STARTED|Overall Study||1||
48263804|NCT02153905|100966843|FG001|STARTED|Overall Study||2||
48263805|NCT02153905|100966842|FG000|COMPLETED|Overall Study||0||
48263806|NCT02153905|100966843|FG001|COMPLETED|Overall Study||2||
48263807|NCT02153905|100966842|FG000|NOT COMPLETED|Overall Study||1||
48263808|NCT02153905|100966843|FG001|NOT COMPLETED|Overall Study||0||
48263809|NCT00813982|100966844|FG000|STARTED|Overall Study||59||
48263810|NCT00813982|100966844|FG000|COMPLETED|Overall Study||59||
48263811|NCT00813982|100966844|FG000|NOT COMPLETED|Overall Study||0||
48263812|NCT02755129|100966845|FG000|STARTED|Overall Study||15||
48263813|NCT02755129|100966845|FG000|COMPLETED|Overall Study||15||
48263814|NCT02755129|100966845|FG000|NOT COMPLETED|Overall Study||0||
48263815|NCT02367352|100966846|FG000|STARTED|Overall Study||9||
48263816|NCT02367352|100966847|FG001|STARTED|Overall Study||0||
48263817|NCT02367352|100966848|FG002|STARTED|Overall Study||0||
48263818|NCT02367352|100966846|FG000|COMPLETED|Overall Study||0||
48263819|NCT02367352|100966847|FG001|COMPLETED|Overall Study||0||
48263820|NCT02367352|100966848|FG002|COMPLETED|Overall Study||0||
48263821|NCT02367352|100966846|FG000|NOT COMPLETED|Overall Study||9||
48263822|NCT02367352|100966847|FG001|NOT COMPLETED|Overall Study||0||
48263823|NCT02367352|100966848|FG002|NOT COMPLETED|Overall Study||0||
48263824|NCT01013961|100966849|FG000|STARTED|Overall Study||16||
48263825|NCT01013961|100966850|FG001|STARTED|Overall Study||15||
48263826|NCT01013961|100966849|FG000|COMPLETED|Overall Study||13||
48263827|NCT01013961|100966850|FG001|COMPLETED|Overall Study||12||
48263828|NCT01013961|100966849|FG000|NOT COMPLETED|Overall Study||3||
48263829|NCT01013961|100966850|FG001|NOT COMPLETED|Overall Study||3||
48263830|NCT02586415|100966851|FG000|STARTED|Overall Study||92||
48263831|NCT02586415|100966852|FG001|STARTED|Overall Study||90||
48263832|NCT02586415|100966851|FG000|24 Hour Assessment|Overall Study||91||
48263833|NCT02586415|100966852|FG001|24 Hour Assessment|Overall Study||90||
48263834|NCT02586415|100966851|FG000|Day 30 Assessment|Overall Study||81||
48263835|NCT02586415|100966852|FG001|Day 30 Assessment|Overall Study||70||
48263836|NCT02586415|100966851|FG000|Day 90 Assessment|Overall Study||78||
48263837|NCT02586415|100966852|FG001|Day 90 Assessment|Overall Study||65||
48263838|NCT02586415|100966851|FG000|COMPLETED|Overall Study||78||
48263839|NCT02586415|100966852|FG001|COMPLETED|Overall Study||65||
48263840|NCT02586415|100966851|FG000|NOT COMPLETED|Overall Study||14||
48390847|NCT03627494|101283631|FG002|STARTED|Part C Period2(4days)+Follow-up(14days)||0||
48390848|NCT03627494|101283632|FG003|STARTED|Part C Period2(4days)+Follow-up(14days)||0||
48390849|NCT03627494|101283633|FG004|STARTED|Part C Period2(4days)+Follow-up(14days)||0||
48390850|NCT03627494|101283634|FG005|STARTED|Part C Period2(4days)+Follow-up(14days)||0||
48390851|NCT03627494|101283635|FG006|STARTED|Part C Period2(4days)+Follow-up(14days)||0||
48390852|NCT03627494|101283636|FG007|STARTED|Part C Period2(4days)+Follow-up(14days)||0||
48390853|NCT03627494|101283637|FG008|STARTED|Part C Period2(4days)+Follow-up(14days)||0||
48390854|NCT03627494|101283638|FG009|STARTED|Part C Period2(4days)+Follow-up(14days)||0||
48390855|NCT03627494|101283639|FG010|STARTED|Part C Period2(4days)+Follow-up(14days)||5||
48390856|NCT03627494|101283640|FG011|STARTED|Part C Period2(4days)+Follow-up(14days)||5||
48390857|NCT03627494|101283629|FG000|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
48390858|NCT03627494|101283630|FG001|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
48390859|NCT03627494|101283631|FG002|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
48390860|NCT03627494|101283632|FG003|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
48547313|NCT00761657|101675148|FG003|PK Population|Part 2 (up to Day 114)||0|Participants who received roxadustat and had sufficient plasma data to allow calculation of PK parameters.|
48547314|NCT00761657|101675149|FG004|PK Population|Part 2 (up to Day 114)||10|Participants who received roxadustat and had sufficient plasma data to allow calculation of PK parameters.|
48263841|NCT02586415|100966852|FG001|NOT COMPLETED|Overall Study||25||
48263842|NCT00475644|100966853|FG000|STARTED|Overall Study||66||
48263843|NCT00475644|100966853|FG000|Received at Least One Dose of Study Drug|Overall Study||66||
48263844|NCT00475644|100966853|FG000|COMPLETED|Overall Study||53||
48263845|NCT00475644|100966853|FG000|NOT COMPLETED|Overall Study||13||
48263846|NCT01536587|100966854|FG000|STARTED|Overall Study||32||
48263847|NCT01536587|100966854|FG000|COMPLETED|Overall Study||30||
48263848|NCT01536587|100966854|FG000|NOT COMPLETED|Overall Study||2||
48263849|NCT01288209|100966855|FG000|STARTED|Overall Study||53||
48390861|NCT03627494|101283633|FG004|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
48263850|NCT01288209|100966856|FG001|STARTED|Overall Study||53||
48263851|NCT01288209|100966855|FG000|COMPLETED|Overall Study||51||
48263852|NCT01288209|100966856|FG001|COMPLETED|Overall Study||50||
48263853|NCT01288209|100966855|FG000|NOT COMPLETED|Overall Study||2||
48263854|NCT01288209|100966856|FG001|NOT COMPLETED|Overall Study||3||
48263855|NCT02419417|100966857|FG000|STARTED|Overall Study||5||
48263856|NCT02419417|100966858|FG001|STARTED|Overall Study||4||
48263857|NCT02419417|100966859|FG002|STARTED|Overall Study||13||
48547315|NCT00761657|101675150|FG005|PK Population|Part 2 (up to Day 114)||11|Participants who received roxadustat and had sufficient plasma data to allow calculation of PK parameters.|
48547316|NCT00761657|101675151|FG006|PK Population|Part 2 (up to Day 114)||10|Participants who received roxadustat and had sufficient plasma data to allow calculation of PK parameters.|
48547317|NCT00761657|101675152|FG007|PK Population|Part 2 (up to Day 114)||10|Participants who received roxadustat and had sufficient plasma data to allow calculation of PK parameters.|
48547318|NCT00761657|101675153|FG008|PK Population|Part 2 (up to Day 114)||0|Participants who received roxadustat and had sufficient plasma data to allow calculation of PK parameters.|
48547319|NCT00761657|101675145|FG000|COMPLETED|Part 2 (up to Day 114)||10||
48547320|NCT00761657|101675146|FG001|COMPLETED|Part 2 (up to Day 114)||13||
48547321|NCT00761657|101675147|FG002|COMPLETED|Part 2 (up to Day 114)||0||
48547322|NCT00761657|101675148|FG003|COMPLETED|Part 2 (up to Day 114)||0||
48547323|NCT00761657|101675149|FG004|COMPLETED|Part 2 (up to Day 114)||10||
48547324|NCT00761657|101675150|FG005|COMPLETED|Part 2 (up to Day 114)||11||
48547325|NCT00761657|101675151|FG006|COMPLETED|Part 2 (up to Day 114)||10||
48547326|NCT00761657|101675152|FG007|COMPLETED|Part 2 (up to Day 114)||10||
48547327|NCT00761657|101675153|FG008|COMPLETED|Part 2 (up to Day 114)||17||
48547328|NCT00761657|101675145|FG000|NOT COMPLETED|Part 2 (up to Day 114)||0||
48547329|NCT00761657|101675146|FG001|NOT COMPLETED|Part 2 (up to Day 114)||0||
48547330|NCT00761657|101675147|FG002|NOT COMPLETED|Part 2 (up to Day 114)||0||
48547331|NCT00761657|101675148|FG003|NOT COMPLETED|Part 2 (up to Day 114)||0||
48547332|NCT00761657|101675149|FG004|NOT COMPLETED|Part 2 (up to Day 114)||0||
48547333|NCT00761657|101675150|FG005|NOT COMPLETED|Part 2 (up to Day 114)||0||
48547334|NCT00761657|101675151|FG006|NOT COMPLETED|Part 2 (up to Day 114)||0||
48547335|NCT00761657|101675152|FG007|NOT COMPLETED|Part 2 (up to Day 114)||0||
48547336|NCT00761657|101675153|FG008|NOT COMPLETED|Part 2 (up to Day 114)||1||
48547337|NCT00811928|101675154|FG000|STARTED|Overall Study||129||
48547338|NCT00811928|101675155|FG001|STARTED|Overall Study||123||
48547339|NCT00811928|101675154|FG000|COMPLETED|Overall Study||90||
48547340|NCT00811928|101675155|FG001|COMPLETED|Overall Study||90||
48547341|NCT00811928|101675154|FG000|NOT COMPLETED|Overall Study||39||
48547342|NCT00811928|101675155|FG001|NOT COMPLETED|Overall Study||33||
48547343|NCT02597127|101675156|FG000|STARTED|Overall Study||60||
48547344|NCT02597127|101675157|FG001|STARTED|Overall Study||62||
48547345|NCT02597127|101675158|FG002|STARTED|Overall Study||66||
48547346|NCT02597127|101675159|FG003|STARTED|Overall Study||65||
48547347|NCT02597127|101675160|FG004|STARTED|Overall Study||62||
48547348|NCT02597127|101675161|FG005|STARTED|Overall Study||63||
48547349|NCT02597127|101675162|FG006|STARTED|Overall Study||61||
48547350|NCT02597127|101675163|FG007|STARTED|Overall Study||62||
48547351|NCT02597127|101675156|FG000|Treated|Overall Study||60||
48100883|NCT04693507|100572335|FG001|STARTED|Overall Study||41||
48100884|NCT04693507|100572334|FG000|COMPLETED|Overall Study||5||
48100885|NCT04693507|100572335|FG001|COMPLETED|Overall Study||32||
48100886|NCT04693507|100572334|FG000|NOT COMPLETED|Overall Study||4||
48100887|NCT04693507|100572335|FG001|NOT COMPLETED|Overall Study||9||
48100888|NCT00973739|100572336|FG000|STARTED|Overall Study||21||
48100889|NCT00973739|100572336|FG000|COMPLETED|Overall Study||17||
48100890|NCT00973739|100572336|FG000|NOT COMPLETED|Overall Study||4||
48100891|NCT03774433|100572337|FG000|STARTED|Overall Study||114||
48100892|NCT03774433|100572337|FG000|COMPLETED|Overall Study||100||
48100893|NCT03774433|100572337|FG000|NOT COMPLETED|Overall Study||14||
48100894|NCT05045144|100572338|FG000|STARTED|Overall Study||220||
48547352|NCT02597127|101675157|FG001|Treated|Overall Study||61||
48547353|NCT02597127|101675158|FG002|Treated|Overall Study||65||
48100895|NCT05045144|100572339|FG001|STARTED|Overall Study||223||
48100896|NCT05045144|100572340|FG002|STARTED|Overall Study||218||
48100897|NCT05045144|100572341|FG003|STARTED|Overall Study||438||
48100898|NCT05045144|100572342|FG004|STARTED|Overall Study||440||
48100899|NCT05045144|100572338|FG000|COMPLETED|Overall Study||217||
48100900|NCT05045144|100572339|FG001|COMPLETED|Overall Study||220||
48100901|NCT05045144|100572340|FG002|COMPLETED|Overall Study||214||
48547354|NCT02597127|101675159|FG003|Treated|Overall Study||65||
48100902|NCT05045144|100572341|FG003|COMPLETED|Overall Study||433||
48100903|NCT05045144|100572342|FG004|COMPLETED|Overall Study||427||
48100904|NCT05045144|100572338|FG000|NOT COMPLETED|Overall Study||3||
48100905|NCT05045144|100572339|FG001|NOT COMPLETED|Overall Study||3||
48100906|NCT05045144|100572340|FG002|NOT COMPLETED|Overall Study||4||
48100907|NCT05045144|100572341|FG003|NOT COMPLETED|Overall Study||5||
48100908|NCT05045144|100572342|FG004|NOT COMPLETED|Overall Study||13||
48100909|NCT01412021|100572343|FG000|STARTED|Overall Study||375|registered participants|
48100910|NCT01412021|100572343|FG000|Case Report Forms Locked|Overall Study||368||
48100911|NCT01412021|100572343|FG000|COMPLETED|Overall Study||356|Safety Analysis|
48100912|NCT01412021|100572343|FG000|NOT COMPLETED|Overall Study||19||
48100913|NCT00453921|100572344|FG000|STARTED|Overall Study||19||
48100914|NCT00453921|100572345|FG001|STARTED|Overall Study||18||
48547355|NCT02597127|101675160|FG004|Treated|Overall Study||61||
48547356|NCT02597127|101675161|FG005|Treated|Overall Study||62||
48547357|NCT02597127|101675162|FG006|Treated|Overall Study||61||
48100915|NCT00453921|100572346|FG002|STARTED|Overall Study||20||
48100916|NCT00453921|100572347|FG003|STARTED|Overall Study||19||
48100917|NCT00453921|100572344|FG000|COMPLETED|Overall Study||18||
48100918|NCT00453921|100572345|FG001|COMPLETED|Overall Study||17||
48100919|NCT00453921|100572346|FG002|COMPLETED|Overall Study||18||
48100920|NCT00453921|100572347|FG003|COMPLETED|Overall Study||18||
48100921|NCT00453921|100572344|FG000|NOT COMPLETED|Overall Study||1||
48100922|NCT00453921|100572345|FG001|NOT COMPLETED|Overall Study||1||
48100923|NCT00453921|100572346|FG002|NOT COMPLETED|Overall Study||2||
48100924|NCT00453921|100572347|FG003|NOT COMPLETED|Overall Study||1||
48100925|NCT01997515|100572348|FG000|STARTED|Overall Study||40||
48100926|NCT01997515|100572349|FG001|STARTED|Overall Study||40||
48100927|NCT01997515|100572348|FG000|COMPLETED|Overall Study||36||
48100928|NCT01997515|100572349|FG001|COMPLETED|Overall Study||35||
48100929|NCT01997515|100572348|FG000|NOT COMPLETED|Overall Study||4||
48100930|NCT01997515|100572349|FG001|NOT COMPLETED|Overall Study||5||
48100931|NCT00329407|100572350|FG000|STARTED|Overall Study||10||
48100932|NCT00329407|100572350|FG000|COMPLETED|Overall Study||9||
48100933|NCT00329407|100572350|FG000|NOT COMPLETED|Overall Study||1||
48100934|NCT01454570|100572351|FG000|STARTED|Overall Study||19||
48100935|NCT01454570|100572351|FG000|COMPLETED|Overall Study||10||
48100936|NCT01454570|100572351|FG000|NOT COMPLETED|Overall Study||9||
48100937|NCT03002012|100572352|FG000|STARTED|Overall Study||11||
48100938|NCT03002012|100572353|FG001|STARTED|Overall Study||11||
48100939|NCT03002012|100572352|FG000|COMPLETED|Overall Study||11||
48100940|NCT03002012|100572353|FG001|COMPLETED|Overall Study||11||
48100941|NCT03002012|100572352|FG000|NOT COMPLETED|Overall Study||0||
48100942|NCT03002012|100572353|FG001|NOT COMPLETED|Overall Study||0||
48100943|NCT02855437|100572354|FG000|STARTED|Phase 1||23||
48691035|NCT00880269|102025986|FG001|COMPLETED|Overall Study||0||
48691036|NCT00880269|102025985|FG000|NOT COMPLETED|Overall Study||32||
48691037|NCT00880269|102025986|FG001|NOT COMPLETED|Overall Study||27||
48691038|NCT03578926|102025987|FG000|STARTED|First Intervention||21||
48691039|NCT03578926|102025988|FG001|STARTED|First Intervention||23||
48691040|NCT03578926|102025987|FG000|COMPLETED|First Intervention||21||
48691041|NCT03578926|102025988|FG001|COMPLETED|First Intervention||23||
48691042|NCT03578926|102025987|FG000|NOT COMPLETED|First Intervention||0||
48100944|NCT02855437|100572355|FG001|STARTED|Phase 1||21||
48100945|NCT02855437|100572354|FG000|COMPLETED|Phase 1||21||
48100946|NCT02855437|100572355|FG001|COMPLETED|Phase 1||19||
48100947|NCT02855437|100572354|FG000|NOT COMPLETED|Phase 1||2||
48100948|NCT02855437|100572355|FG001|NOT COMPLETED|Phase 1||2||
48100949|NCT02855437|100572354|FG000|STARTED|Crossover Period (Same Day)||21||
48100950|NCT02855437|100572355|FG001|STARTED|Crossover Period (Same Day)||19||
48100951|NCT02855437|100572354|FG000|COMPLETED|Crossover Period (Same Day)||21||
48100952|NCT02855437|100572355|FG001|COMPLETED|Crossover Period (Same Day)||19||
48100953|NCT02855437|100572354|FG000|NOT COMPLETED|Crossover Period (Same Day)||0||
48100954|NCT02855437|100572355|FG001|NOT COMPLETED|Crossover Period (Same Day)||0||
48100955|NCT02855437|100572354|FG000|STARTED|Phase 2||21||
48100956|NCT02855437|100572355|FG001|STARTED|Phase 2||19||
48100957|NCT02855437|100572354|FG000|COMPLETED|Phase 2||20||
48100958|NCT02855437|100572355|FG001|COMPLETED|Phase 2||18||
48100959|NCT02855437|100572354|FG000|NOT COMPLETED|Phase 2||1||
48100960|NCT02855437|100572355|FG001|NOT COMPLETED|Phase 2||1||
48100961|NCT02467465|100572356|FG000|STARTED|Overall Study||15||
48100962|NCT02467465|100572357|FG001|STARTED|Overall Study||15||
48100963|NCT02467465|100572356|FG000|COMPLETED|Overall Study||15||
48100964|NCT02467465|100572357|FG001|COMPLETED|Overall Study||15||
48100965|NCT02467465|100572356|FG000|NOT COMPLETED|Overall Study||0||
48100966|NCT02467465|100572357|FG001|NOT COMPLETED|Overall Study||0||
48100967|NCT01990495|100572358|FG000|STARTED|Overall Study||18||
48100968|NCT01990495|100572359|FG001|STARTED|Overall Study||19||
48100969|NCT01990495|100572358|FG000|COMPLETED|Overall Study||13||
48263858|NCT02419417|100966860|FG003|STARTED|Overall Study||10||
48100970|NCT01990495|100572359|FG001|COMPLETED|Overall Study||15||
48100971|NCT01990495|100572358|FG000|NOT COMPLETED|Overall Study||5||
48100972|NCT01990495|100572359|FG001|NOT COMPLETED|Overall Study||4||
48100973|NCT02447133|100572360|FG000|STARTED|Overall Study||12||
48100974|NCT02447133|100572360|FG000|COMPLETED|Overall Study||12||
48100975|NCT02447133|100572360|FG000|NOT COMPLETED|Overall Study||0||
48100976|NCT01662908|100572361|FG000|STARTED|Overall Study||56||
48100977|NCT01662908|100572362|FG001|STARTED|Overall Study||28||
48100978|NCT01662908|100572361|FG000|COMPLETED|Overall Study||50||
48100979|NCT01662908|100572362|FG001|COMPLETED|Overall Study||23||
48100980|NCT01662908|100572361|FG000|NOT COMPLETED|Overall Study||6||
48100981|NCT01662908|100572362|FG001|NOT COMPLETED|Overall Study||5||
48100982|NCT00496756|100572363|FG000|STARTED|Overall Study||14||
48100983|NCT00496756|100572363|FG000|COMPLETED|Overall Study||11||
48100984|NCT00496756|100572363|FG000|NOT COMPLETED|Overall Study||3||
48100985|NCT00256698|100572364|FG000|STARTED|Overall Study||258||
48100986|NCT00256698|100572365|FG001|STARTED|Overall Study||256||
48100987|NCT00256698|100572364|FG000|COMPLETED|Overall Study||91||
48100988|NCT00256698|100572365|FG001|COMPLETED|Overall Study||84||
48100989|NCT00256698|100572364|FG000|NOT COMPLETED|Overall Study||167||
48100990|NCT00256698|100572365|FG001|NOT COMPLETED|Overall Study||172||
48100991|NCT00471848|100572366|FG000|STARTED|Overall Study||35||
48100992|NCT00471848|100572366|FG000|COMPLETED|Overall Study||35||
48100993|NCT00471848|100572366|FG000|NOT COMPLETED|Overall Study||0||
48100994|NCT03717480|100572367|FG000|STARTED|Overall Study||2|Assignment to study arm|
48100995|NCT03717480|100572367|FG000|Receipt of Investigational Product/Study Treatment|Overall Study||1||
48100996|NCT03717480|100572367|FG000|COMPLETED|Overall Study||1|Survival to day 100 for evaluation of primary endpoint (severe acute GVHD-free survival rate)|
48100997|NCT03717480|100572367|FG000|NOT COMPLETED|Overall Study||1||
48100998|NCT00325754|100572368|FG000|STARTED|Overall Study||11||
48100999|NCT00325754|100572369|FG001|STARTED|Overall Study||11||
48101000|NCT00325754|100572368|FG000|COMPLETED|Overall Study||7||
48101001|NCT00325754|100572369|FG001|COMPLETED|Overall Study||10||
48101002|NCT00325754|100572368|FG000|NOT COMPLETED|Overall Study||4||
48101003|NCT00325754|100572369|FG001|NOT COMPLETED|Overall Study||1||
48101004|NCT02068222|100572370|FG000|STARTED|Overall Study||10||
48101005|NCT02068222|100572370|FG000|COMPLETED|Overall Study||9||
48101006|NCT02068222|100572370|FG000|NOT COMPLETED|Overall Study||1||
48101007|NCT04356690|100572371|FG000|STARTED|Overall Study||6||
48101008|NCT04356690|100572372|FG001|STARTED|Overall Study||2||
48101009|NCT04356690|100572371|FG000|COMPLETED|Overall Study||6||
48101010|NCT04356690|100572372|FG001|COMPLETED|Overall Study||2||
48101011|NCT04356690|100572371|FG000|NOT COMPLETED|Overall Study||0||
48101012|NCT04356690|100572372|FG001|NOT COMPLETED|Overall Study||0||
48101013|NCT00885755|100572373|FG000|STARTED|Part I: Trastuzumab+Taxane||31||
48101014|NCT00885755|100572374|FG001|STARTED|Part I: Trastuzumab+Taxane||1||
48101015|NCT00885755|100572375|FG002|STARTED|Part I: Trastuzumab+Taxane||1||
48101016|NCT00885755|100572373|FG000|COMPLETED|Part I: Trastuzumab+Taxane||13||
48101017|NCT00885755|100572374|FG001|COMPLETED|Part I: Trastuzumab+Taxane||1||
48101018|NCT00885755|100572375|FG002|COMPLETED|Part I: Trastuzumab+Taxane||0||
48101019|NCT00885755|100572373|FG000|NOT COMPLETED|Part I: Trastuzumab+Taxane||18||
48101020|NCT00885755|100572374|FG001|NOT COMPLETED|Part I: Trastuzumab+Taxane||0||
48101021|NCT00885755|100572375|FG002|NOT COMPLETED|Part I: Trastuzumab+Taxane||1||
48101022|NCT00885755|100572373|FG000|STARTED|Part II: Trastuzumab + Capecitabine.||13||
48101023|NCT00885755|100572374|FG001|STARTED|Part II: Trastuzumab + Capecitabine.||1||
48101024|NCT00885755|100572375|FG002|STARTED|Part II: Trastuzumab + Capecitabine.||0||
48101025|NCT00885755|100572373|FG000|COMPLETED|Part II: Trastuzumab + Capecitabine.||8||
48101026|NCT00885755|100572374|FG001|COMPLETED|Part II: Trastuzumab + Capecitabine.||1||
48101027|NCT00885755|100572375|FG002|COMPLETED|Part II: Trastuzumab + Capecitabine.||0||
48101028|NCT00885755|100572373|FG000|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||5||
48101029|NCT00885755|100572374|FG001|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0||
48101030|NCT00885755|100572375|FG002|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0||
48101031|NCT00429507|100572376|FG000|STARTED|Overall Study||12||
48101032|NCT00429507|100572376|FG000|COMPLETED|Overall Study||12||
48101033|NCT00429507|100572376|FG000|NOT COMPLETED|Overall Study||0||
48101034|NCT04035161|100572377|FG000|STARTED|Overall Study||1121||
48101035|NCT04035161|100572377|FG000|Treated With Investigational Product|Overall Study||609||
48101036|NCT04035161|100572377|FG000|Treated With Reference Standard|Overall Study||419||
48101037|NCT04035161|100572377|FG000|Treated With Active Control|Overall Study||609||
48101038|NCT04035161|100572377|FG000|Treated With Negative Control|Overall Study||605||
48101039|NCT04035161|100572377|FG000|COMPLETED|Overall Study||1121||
48101040|NCT04035161|100572377|FG000|NOT COMPLETED|Overall Study||0||
48101041|NCT03897179|100572378|FG000|STARTED|Overall Study||27||
48101042|NCT03897179|100572378|FG000|COMPLETED|Overall Study||26||
48101043|NCT03897179|100572378|FG000|NOT COMPLETED|Overall Study||1||
48101044|NCT00708942|100572379|FG000|STARTED|Overall Study||47||
48101045|NCT00708942|100572380|FG001|STARTED|Overall Study||12||
48101046|NCT00708942|100572381|FG002|STARTED|Overall Study||11||
48101047|NCT00708942|100572382|FG003|STARTED|Overall Study||10||
48101048|NCT00708942|100572383|FG004|STARTED|Overall Study||3||
48101049|NCT00708942|100572379|FG000|COMPLETED|Overall Study||40||
48101050|NCT00708942|100572380|FG001|COMPLETED|Overall Study||11||
48101051|NCT00708942|100572381|FG002|COMPLETED|Overall Study||9||
48101052|NCT00708942|100572382|FG003|COMPLETED|Overall Study||10||
48101053|NCT00708942|100572383|FG004|COMPLETED|Overall Study||2||
48101054|NCT00708942|100572379|FG000|NOT COMPLETED|Overall Study||7||
48101055|NCT00708942|100572380|FG001|NOT COMPLETED|Overall Study||1||
48101056|NCT00708942|100572381|FG002|NOT COMPLETED|Overall Study||2||
48101057|NCT00708942|100572382|FG003|NOT COMPLETED|Overall Study||0||
48101058|NCT00708942|100572383|FG004|NOT COMPLETED|Overall Study||1||
48101059|NCT03098173|100572384|FG000|STARTED|Overall Study||81||
48101060|NCT03098173|100572385|FG001|STARTED|Overall Study||81||
48101061|NCT03098173|100572384|FG000|COMPLETED|Overall Study||80||
48101062|NCT03098173|100572385|FG001|COMPLETED|Overall Study||79||
48101063|NCT03098173|100572384|FG000|NOT COMPLETED|Overall Study||1||
48101064|NCT03098173|100572385|FG001|NOT COMPLETED|Overall Study||2||
48101065|NCT04415281|100572386|FG000|STARTED|Overall Study||7||
48101066|NCT04415281|100572387|FG001|STARTED|Overall Study||6||
48101067|NCT04415281|100572386|FG000|COMPLETED|Overall Study||7||
48101068|NCT04415281|100572387|FG001|COMPLETED|Overall Study||6||
48101069|NCT04415281|100572386|FG000|NOT COMPLETED|Overall Study||0||
48101070|NCT04415281|100572387|FG001|NOT COMPLETED|Overall Study||0||
48101071|NCT00788892|100572388|FG000|STARTED|Overall Study||85||
48101072|NCT00788892|100572389|FG001|STARTED|Overall Study||41||
48101073|NCT00788892|100572388|FG000|COMPLETED|Overall Study||36||
48101074|NCT00788892|100572389|FG001|COMPLETED|Overall Study||18||
48547358|NCT02597127|101675163|FG007|Treated|Overall Study||62||
48547359|NCT02597127|101675156|FG000|COMPLETED|Overall Study||59|LDL-C returned to \>80% of baseline from Day 210-360 or completed Day 360 with LDL-C\<=80% of baseline|
48547360|NCT02597127|101675157|FG001|COMPLETED|Overall Study||59|LDL-C returned to \>80% of baseline from Day 210-360 or completed Day 360 with LDL-C\<=80% of baseline|
48547361|NCT02597127|101675158|FG002|COMPLETED|Overall Study||58|LDL-C returned to \>80% of baseline from Day 210-360 or completed Day 360 with LDL-C\<=80% of baseline|
48547362|NCT02597127|101675159|FG003|COMPLETED|Overall Study||60|LDL-C returned to \>80% of baseline from Day 210-360 or completed Day 360 with LDL-C\<=80% of baseline|
48547363|NCT02597127|101675160|FG004|COMPLETED|Overall Study||57|LDL-C returned to \>80% of baseline from Day 210-360 or completed Day 360 with LDL-C\<=80% of baseline|
48547364|NCT02597127|101675161|FG005|COMPLETED|Overall Study||59|LDL-C returned to \>80% of baseline from Day 210-360 or completed Day 360 with LDL-C\<=80% of baseline|
48547365|NCT02597127|101675162|FG006|COMPLETED|Overall Study||57|LDL-C returned to \>80% of baseline from Day 210-360 or completed Day 360 with LDL-C\<=80% of baseline|
48547366|NCT02597127|101675163|FG007|COMPLETED|Overall Study||60|LDL-C returned to \>80% of baseline from Day 210-360 or completed Day 360 with LDL-C\<=80% of baseline|
48547367|NCT02597127|101675156|FG000|NOT COMPLETED|Overall Study||1||
48547368|NCT02597127|101675157|FG001|NOT COMPLETED|Overall Study||3||
48547369|NCT02597127|101675158|FG002|NOT COMPLETED|Overall Study||8||
48547370|NCT02597127|101675159|FG003|NOT COMPLETED|Overall Study||5||
48547371|NCT02597127|101675160|FG004|NOT COMPLETED|Overall Study||5||
48547372|NCT02597127|101675161|FG005|NOT COMPLETED|Overall Study||4||
48547373|NCT02597127|101675162|FG006|NOT COMPLETED|Overall Study||4||
48547374|NCT02597127|101675163|FG007|NOT COMPLETED|Overall Study||2||
48547375|NCT02929056|101675164|FG000|STARTED|Overall Study||1||
48547376|NCT02929056|101675165|FG001|STARTED|Overall Study||1||
48547377|NCT02929056|101675164|FG000|COMPLETED|Overall Study||1||
48547378|NCT02929056|101675165|FG001|COMPLETED|Overall Study||0||
48547379|NCT02929056|101675164|FG000|NOT COMPLETED|Overall Study||0||
48547380|NCT02929056|101675165|FG001|NOT COMPLETED|Overall Study||1||
48547381|NCT00618332|101675166|FG000|STARTED|Overall Study||20||
48547382|NCT00618332|101675167|FG001|STARTED|Overall Study||20||
48547383|NCT00618332|101675166|FG000|COMPLETED|Overall Study||20||
48547384|NCT00618332|101675167|FG001|COMPLETED|Overall Study||20||
48547385|NCT00618332|101675166|FG000|NOT COMPLETED|Overall Study||0||
48547386|NCT00618332|101675167|FG001|NOT COMPLETED|Overall Study||0||
48547387|NCT05299528|101675168|FG000|STARTED|Surgeon Recruitment||35|In this initial recruitment phase, only surgeons were recruited.|
48547388|NCT05299528|101675169|FG001|STARTED|Surgeon Recruitment||0|In this initial recruitment phase, only surgeons were recruited.|
48547389|NCT05299528|101675170|FG002|STARTED|Surgeon Recruitment||6|In this initial recruitment phase, only surgeons were recruited.|
48547390|NCT05299528|101675171|FG003|STARTED|Surgeon Recruitment||6|In this initial recruitment phase, only surgeons were recruited.|
48547391|NCT05299528|101675172|FG004|STARTED|Surgeon Recruitment||0|In this initial recruitment phase, only surgeons were recruited.|
48547392|NCT05299528|101675173|FG005|STARTED|Surgeon Recruitment||0|In this initial recruitment phase, only surgeons were recruited.|
48547393|NCT05299528|101675174|FG006|STARTED|Surgeon Recruitment||0|In this initial recruitment phase, only surgeons were recruited.|
48547394|NCT05299528|101675168|FG000|Surgeon Recruitment|Surgeon Recruitment||35||
48547395|NCT05299528|101675169|FG001|Surgeon Recruitment|Surgeon Recruitment||0||
48547396|NCT05299528|101675170|FG002|Surgeon Recruitment|Surgeon Recruitment||6||
48547397|NCT05299528|101675171|FG003|Surgeon Recruitment|Surgeon Recruitment||6||
48547398|NCT05299528|101675172|FG004|Surgeon Recruitment|Surgeon Recruitment||0||
48547399|NCT05299528|101675173|FG005|Surgeon Recruitment|Surgeon Recruitment||0||
48547400|NCT05299528|101675174|FG006|Surgeon Recruitment|Surgeon Recruitment||0||
48547401|NCT05299528|101675168|FG000|COMPLETED|Surgeon Recruitment||35||
48547402|NCT05299528|101675169|FG001|COMPLETED|Surgeon Recruitment||0||
48547403|NCT05299528|101675170|FG002|COMPLETED|Surgeon Recruitment||6||
48547404|NCT05299528|101675171|FG003|COMPLETED|Surgeon Recruitment||6||
48547405|NCT05299528|101675172|FG004|COMPLETED|Surgeon Recruitment||0||
48547406|NCT05299528|101675173|FG005|COMPLETED|Surgeon Recruitment||0||
48101075|NCT00788892|100572388|FG000|NOT COMPLETED|Overall Study||49||
48101076|NCT00788892|100572389|FG001|NOT COMPLETED|Overall Study||23||
48101077|NCT00451321|100572390|FG000|STARTED|Overall Study||8||
48101078|NCT00451321|100572391|FG001|STARTED|Overall Study||15||
48101079|NCT00451321|100572392|FG002|STARTED|Overall Study||18||
48101080|NCT00451321|100572393|FG003|STARTED|Overall Study||19||
48101081|NCT00451321|100572394|FG004|STARTED|Overall Study||7||
48101082|NCT00451321|100572395|FG005|STARTED|Overall Study||9||
48101083|NCT00451321|100572396|FG006|STARTED|Overall Study||6||
48101084|NCT00451321|100572397|FG007|STARTED|Overall Study||6||
48101085|NCT00451321|100572390|FG000|COMPLETED|Overall Study||1||
48101086|NCT00451321|100572391|FG001|COMPLETED|Overall Study||10||
48101087|NCT00451321|100572392|FG002|COMPLETED|Overall Study||0||
48101088|NCT00451321|100572393|FG003|COMPLETED|Overall Study||7||
48101089|NCT00451321|100572394|FG004|COMPLETED|Overall Study||0||
48101090|NCT00451321|100572395|FG005|COMPLETED|Overall Study||0||
48101091|NCT00451321|100572396|FG006|COMPLETED|Overall Study||0||
48101092|NCT00451321|100572397|FG007|COMPLETED|Overall Study||0||
48101093|NCT00451321|100572390|FG000|NOT COMPLETED|Overall Study||7||
48101094|NCT00451321|100572391|FG001|NOT COMPLETED|Overall Study||5||
48101095|NCT00451321|100572392|FG002|NOT COMPLETED|Overall Study||18||
48101096|NCT00451321|100572393|FG003|NOT COMPLETED|Overall Study||12||
48101097|NCT00451321|100572394|FG004|NOT COMPLETED|Overall Study||7||
48101098|NCT00451321|100572395|FG005|NOT COMPLETED|Overall Study||9||
48101099|NCT00451321|100572396|FG006|NOT COMPLETED|Overall Study||6||
48101100|NCT00451321|100572397|FG007|NOT COMPLETED|Overall Study||6||
48101101|NCT03559179|100572398|FG000|STARTED|Overall Study||8||
48101102|NCT03559179|100572399|FG001|STARTED|Overall Study||24||
48101103|NCT03559179|100572400|FG002|STARTED|Overall Study||23||
48101104|NCT03559179|100572398|FG000|COMPLETED|Overall Study||8||
48101105|NCT03559179|100572399|FG001|COMPLETED|Overall Study||23||
48101106|NCT03559179|100572400|FG002|COMPLETED|Overall Study||23||
48101107|NCT03559179|100572398|FG000|NOT COMPLETED|Overall Study||0||
48101108|NCT03559179|100572399|FG001|NOT COMPLETED|Overall Study||1||
48101109|NCT03559179|100572400|FG002|NOT COMPLETED|Overall Study||0||
48101110|NCT02446236|100572401|FG000|STARTED|Overall Study||5||
48101111|NCT02446236|100572402|FG001|STARTED|Overall Study||3||
48101112|NCT02446236|100572403|FG002|STARTED|Overall Study||19||
48101113|NCT02446236|100572401|FG000|COMPLETED|Overall Study||4||
48101114|NCT02446236|100572402|FG001|COMPLETED|Overall Study||3||
48101115|NCT02446236|100572403|FG002|COMPLETED|Overall Study||17||
48101116|NCT02446236|100572401|FG000|NOT COMPLETED|Overall Study||1||
48101117|NCT02446236|100572402|FG001|NOT COMPLETED|Overall Study||0||
48101118|NCT02446236|100572403|FG002|NOT COMPLETED|Overall Study||2||
48101119|NCT01312818|100572404|FG000|STARTED|Overall Study||2||
48101120|NCT01312818|100572404|FG000|COMPLETED|Overall Study||2||
48101121|NCT01312818|100572404|FG000|NOT COMPLETED|Overall Study||0||
48101122|NCT01751386|100572405|FG000|STARTED|Overall Study||20||
48101123|NCT01751386|100572406|FG001|STARTED|Overall Study||19||
48101124|NCT01751386|100572405|FG000|COMPLETED|Overall Study||18||
48101125|NCT01751386|100572406|FG001|COMPLETED|Overall Study||16||
48101126|NCT01751386|100572405|FG000|NOT COMPLETED|Overall Study||2||
48101127|NCT01751386|100572406|FG001|NOT COMPLETED|Overall Study||3||
48101128|NCT02917031|100572407|FG000|STARTED|Overall Study||112|Participants who received treatment|
48101129|NCT02917031|100572408|FG001|STARTED|Overall Study||115|Participants who received treatment|
48101130|NCT02917031|100572409|FG002|STARTED|Overall Study||120|Participants who received treatment|
48101131|NCT02917031|100572407|FG000|COMPLETED|Overall Study||94||
48101132|NCT02917031|100572408|FG001|COMPLETED|Overall Study||102||
48101133|NCT02917031|100572409|FG002|COMPLETED|Overall Study||105||
48101134|NCT02917031|100572407|FG000|NOT COMPLETED|Overall Study||18||
48101135|NCT02917031|100572408|FG001|NOT COMPLETED|Overall Study||13||
48101136|NCT02917031|100572409|FG002|NOT COMPLETED|Overall Study||15||
48101137|NCT01774786|100572410|FG000|STARTED|Overall Study||388|Intent-to-Treat (ITT) population|
48101138|NCT01774786|100572411|FG001|STARTED|Overall Study||392|Intent-to-Treat (ITT) population|
48101139|NCT01774786|100572410|FG000|Did Not Receive Any Study Treatment|Overall Study||4||
48101140|NCT01774786|100572411|FG001|Did Not Receive Any Study Treatment|Overall Study||3||
48101141|NCT01774786|100572410|FG000|Received at Least One Dose of Pertuzumab|Overall Study||384|Pertuzumab Safety Population|
48101142|NCT01774786|100572411|FG001|Received at Least One Dose of Pertuzumab|Overall Study||1|Pertuzumab Safety Population|
48263859|NCT02419417|100966861|FG004|STARTED|Overall Study||13||
48691043|NCT03578926|102025988|FG001|NOT COMPLETED|First Intervention||0||
48691044|NCT03578926|102025987|FG000|STARTED|Second Intervention||23||
48691045|NCT03578926|102025988|FG001|STARTED|Second Intervention||21||
48691046|NCT03578926|102025987|FG000|COMPLETED|Second Intervention||23||
48691047|NCT03578926|102025988|FG001|COMPLETED|Second Intervention||21||
48691048|NCT03578926|102025987|FG000|NOT COMPLETED|Second Intervention||0||
48691049|NCT03578926|102025988|FG001|NOT COMPLETED|Second Intervention||0||
48691050|NCT00500357|102025989|FG000|STARTED|Overall Study||105||
48691051|NCT00500357|102025989|FG000|Received 13vPnC (Vax 3)|Overall Study||105||
48691052|NCT00500357|102025989|FG000|Evaluable Immunogenicity Population|Overall Study||98||
48101143|NCT01774786|100572410|FG000|Received Placebo (No Pertuzumab)|Overall Study||0|Placebo Safety Population|
48101144|NCT01774786|100572411|FG001|Received Placebo (No Pertuzumab)|Overall Study||388|Placebo Safety Population|
48101145|NCT01774786|100572410|FG000|COMPLETED|Overall Study||60||
48101146|NCT01774786|100572411|FG001|COMPLETED|Overall Study||46||
48101147|NCT01774786|100572410|FG000|NOT COMPLETED|Overall Study||328||
48101148|NCT01774786|100572411|FG001|NOT COMPLETED|Overall Study||346||
48101149|NCT00302458|100572412|FG000|STARTED|Overall Study||29||
48101150|NCT00302458|100572412|FG000|COMPLETED|Overall Study||26||
48101151|NCT00302458|100572412|FG000|NOT COMPLETED|Overall Study||3||
48101152|NCT03720470|100572413|FG000|STARTED|Treatment Period: First Part 16 Weeks||131||
48101153|NCT03720470|100572414|FG001|STARTED|Treatment Period: First Part 16 Weeks||0||
48101154|NCT03720470|100572415|FG002|STARTED|Treatment Period: First Part 16 Weeks||0||
48101155|NCT03720470|100572416|FG003|STARTED|Treatment Period: First Part 16 Weeks||238||
48263860|NCT02419417|100966862|FG005|STARTED|Overall Study||4||
48691053|NCT00500357|102025989|FG000|COMPLETED|Overall Study||104||
48691054|NCT00500357|102025989|FG000|NOT COMPLETED|Overall Study||1||
48691055|NCT02346903|102025990|FG000|STARTED|Overall Study||99||
48691056|NCT02346903|102025990|FG000|COMPLETED|Overall Study||99||
48691057|NCT02346903|102025990|FG000|NOT COMPLETED|Overall Study||0||
48101156|NCT03720470|100572417|FG004|STARTED|Treatment Period: First Part 16 Weeks||226||
48101157|NCT03720470|100572418|FG005|STARTED|Treatment Period: First Part 16 Weeks||243||
48101158|NCT03720470|100572413|FG000|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||131||
48101159|NCT03720470|100572414|FG001|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||0||
48101160|NCT03720470|100572415|FG002|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||0||
48101161|NCT03720470|100572416|FG003|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||238||
48101162|NCT03720470|100572417|FG004|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||226||
48101163|NCT03720470|100572418|FG005|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||242||
48101164|NCT03720470|100572413|FG000|Full Analysis Set|Treatment Period: First Part 16 Weeks||131||
48101165|NCT03720470|100572414|FG001|Full Analysis Set|Treatment Period: First Part 16 Weeks||0||
48101166|NCT03720470|100572415|FG002|Full Analysis Set|Treatment Period: First Part 16 Weeks||0||
48101167|NCT03720470|100572416|FG003|Full Analysis Set|Treatment Period: First Part 16 Weeks||238||
48101168|NCT03720470|100572417|FG004|Full Analysis Set|Treatment Period: First Part 16 Weeks||226||
48101169|NCT03720470|100572418|FG005|Full Analysis Set|Treatment Period: First Part 16 Weeks||242||
48101170|NCT03720470|100572413|FG000|COMPLETED|Treatment Period: First Part 16 Weeks||117||
48101171|NCT03720470|100572414|FG001|COMPLETED|Treatment Period: First Part 16 Weeks||0||
48101172|NCT03720470|100572415|FG002|COMPLETED|Treatment Period: First Part 16 Weeks||0||
48101173|NCT03720470|100572416|FG003|COMPLETED|Treatment Period: First Part 16 Weeks||217||
48101174|NCT03720470|100572417|FG004|COMPLETED|Treatment Period: First Part 16 Weeks||208||
48101175|NCT03720470|100572418|FG005|COMPLETED|Treatment Period: First Part 16 Weeks||223||
48101176|NCT03720470|100572413|FG000|NOT COMPLETED|Treatment Period: First Part 16 Weeks||14||
48101177|NCT03720470|100572414|FG001|NOT COMPLETED|Treatment Period: First Part 16 Weeks||0||
48101178|NCT03720470|100572415|FG002|NOT COMPLETED|Treatment Period: First Part 16 Weeks||0||
48101179|NCT03720470|100572416|FG003|NOT COMPLETED|Treatment Period: First Part 16 Weeks||21||
48101180|NCT03720470|100572417|FG004|NOT COMPLETED|Treatment Period: First Part 16 Weeks||18||
48101181|NCT03720470|100572418|FG005|NOT COMPLETED|Treatment Period: First Part 16 Weeks||20||
48101182|NCT03720470|100572413|FG000|STARTED|Treatment Period: Final 4 Weeks||0||
48101183|NCT03720470|100572414|FG001|STARTED|Treatment Period: Final 4 Weeks||60||
48101184|NCT03720470|100572415|FG002|STARTED|Treatment Period: Final 4 Weeks||57||
48101185|NCT03720470|100572416|FG003|STARTED|Treatment Period: Final 4 Weeks||217||
48101186|NCT03720470|100572417|FG004|STARTED|Treatment Period: Final 4 Weeks||208||
48101187|NCT03720470|100572418|FG005|STARTED|Treatment Period: Final 4 Weeks||223||
48101188|NCT03720470|100572413|FG000|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||0||
48101189|NCT03720470|100572414|FG001|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||60||
48101190|NCT03720470|100572415|FG002|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||57||
48101191|NCT03720470|100572416|FG003|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||217||
48101192|NCT03720470|100572417|FG004|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||208||
48101193|NCT03720470|100572418|FG005|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||223||
48101194|NCT03720470|100572413|FG000|Full Analysis Set|Treatment Period: Final 4 Weeks||0||
48101195|NCT03720470|100572414|FG001|Full Analysis Set|Treatment Period: Final 4 Weeks||60||
48101196|NCT03720470|100572415|FG002|Full Analysis Set|Treatment Period: Final 4 Weeks||57||
48101197|NCT03720470|100572416|FG003|Full Analysis Set|Treatment Period: Final 4 Weeks||217||
48101198|NCT03720470|100572417|FG004|Full Analysis Set|Treatment Period: Final 4 Weeks||208||
48101199|NCT03720470|100572418|FG005|Full Analysis Set|Treatment Period: Final 4 Weeks||223||
48101200|NCT03720470|100572413|FG000|COMPLETED|Treatment Period: Final 4 Weeks||0||
48101201|NCT03720470|100572414|FG001|COMPLETED|Treatment Period: Final 4 Weeks||58||
48101202|NCT03720470|100572415|FG002|COMPLETED|Treatment Period: Final 4 Weeks||55||
48101203|NCT03720470|100572416|FG003|COMPLETED|Treatment Period: Final 4 Weeks||210||
48101204|NCT03720470|100572417|FG004|COMPLETED|Treatment Period: Final 4 Weeks||204||
48101205|NCT03720470|100572418|FG005|COMPLETED|Treatment Period: Final 4 Weeks||218||
48101206|NCT03720470|100572413|FG000|NOT COMPLETED|Treatment Period: Final 4 Weeks||0||
48101207|NCT03720470|100572414|FG001|NOT COMPLETED|Treatment Period: Final 4 Weeks||2||
48101208|NCT03720470|100572415|FG002|NOT COMPLETED|Treatment Period: Final 4 Weeks||2||
48101209|NCT03720470|100572416|FG003|NOT COMPLETED|Treatment Period: Final 4 Weeks||7||
48101210|NCT03720470|100572417|FG004|NOT COMPLETED|Treatment Period: Final 4 Weeks||4||
48101211|NCT03720470|100572418|FG005|NOT COMPLETED|Treatment Period: Final 4 Weeks||5||
48691058|NCT00770562|102025991|FG000|STARTED|Overall Study||53||
48691059|NCT00770562|102025992|FG001|STARTED|Overall Study||50||
48691060|NCT00770562|102025991|FG000|COMPLETED|Overall Study||52||
48691061|NCT00770562|102025992|FG001|COMPLETED|Overall Study||49||
48101212|NCT05218018|100572419|FG000|STARTED|Overall Study||30||
48691062|NCT00770562|102025991|FG000|NOT COMPLETED|Overall Study||1||
48691063|NCT00770562|102025992|FG001|NOT COMPLETED|Overall Study||1||
48691064|NCT04482439|102025993|FG000|STARTED|Overall Study||35||
48691065|NCT04482439|102025993|FG000|COMPLETED|Overall Study||33||
48691066|NCT04482439|102025993|FG000|NOT COMPLETED|Overall Study||2||
48101213|NCT05218018|100572419|FG000|COMPLETED|Overall Study||30||
48101214|NCT05218018|100572419|FG000|NOT COMPLETED|Overall Study||0||
48101215|NCT02747420|100572420|FG000|STARTED|Overall Study||18||
48101216|NCT02747420|100572421|FG001|STARTED|Overall Study||22||
48101217|NCT02747420|100572420|FG000|COMPLETED|Overall Study||11||
48263861|NCT02419417|100966863|FG006|STARTED|Overall Study||4||
48263862|NCT02419417|100966864|FG007|STARTED|Overall Study||6||
48263863|NCT02419417|100966865|FG008|STARTED|Overall Study||13||
48263864|NCT02419417|100966866|FG009|STARTED|Overall Study||10||
48263865|NCT02419417|100966867|FG010|STARTED|Overall Study||1||
48263866|NCT02419417|100966857|FG000|COMPLETED|Overall Study||0||
48263867|NCT02419417|100966858|FG001|COMPLETED|Overall Study||0||
48263868|NCT02419417|100966859|FG002|COMPLETED|Overall Study||0||
48390862|NCT03627494|101283634|FG005|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
48390863|NCT03627494|101283635|FG006|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
48390864|NCT03627494|101283636|FG007|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
48390865|NCT03627494|101283637|FG008|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
48390866|NCT03627494|101283638|FG009|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
48390867|NCT03627494|101283639|FG010|COMPLETED|Part C Period2(4days)+Follow-up(14days)||5||
48390868|NCT03627494|101283640|FG011|COMPLETED|Part C Period2(4days)+Follow-up(14days)||5||
48390869|NCT03627494|101283629|FG000|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
48390870|NCT03627494|101283630|FG001|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
48390871|NCT03627494|101283631|FG002|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
48390872|NCT03627494|101283632|FG003|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
48390873|NCT03627494|101283633|FG004|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
48691067|NCT03458325|102025994|FG000|STARTED|Overall Study||25||
48691068|NCT03458325|102025994|FG000|COMPLETED|Overall Study||24||
48691069|NCT03458325|102025994|FG000|NOT COMPLETED|Overall Study||1||
48547407|NCT05299528|101675174|FG006|COMPLETED|Surgeon Recruitment||0||
48547408|NCT05299528|101675168|FG000|NOT COMPLETED|Surgeon Recruitment||0||
48547409|NCT05299528|101675169|FG001|NOT COMPLETED|Surgeon Recruitment||0||
48547410|NCT05299528|101675170|FG002|NOT COMPLETED|Surgeon Recruitment||0||
48547411|NCT05299528|101675171|FG003|NOT COMPLETED|Surgeon Recruitment||0||
48547412|NCT05299528|101675172|FG004|NOT COMPLETED|Surgeon Recruitment||0||
48547413|NCT05299528|101675173|FG005|NOT COMPLETED|Surgeon Recruitment||0||
48547414|NCT05299528|101675174|FG006|NOT COMPLETED|Surgeon Recruitment||0||
48547415|NCT05299528|101675168|FG000|STARTED|Phase 1 Patient Recruitment||0|During Phase 1, patient participants from the surgeons enrolled in the surgeon recruitment phase were enrolled in the study|
48547416|NCT05299528|101675169|FG001|STARTED|Phase 1 Patient Recruitment||135|During Phase 1, patient participants from the surgeons enrolled in the surgeon recruitment phase were enrolled in the study|
48592721|NCT02143791|101783167|FG000|COMPLETED|Burst Stimulation Only (3 Months)||92||
48691070|NCT00758069|102025995|FG000|STARTED|Overall Study||27||
48691071|NCT00758069|102025996|FG001|STARTED|Overall Study||25||
48691072|NCT00758069|102025997|FG002|STARTED|Overall Study||28||
48691073|NCT00758069|102025995|FG000|COMPLETED|Overall Study||26||
48691074|NCT00758069|102025996|FG001|COMPLETED|Overall Study||25||
48691075|NCT00758069|102025997|FG002|COMPLETED|Overall Study||27||
48101218|NCT02747420|100572421|FG001|COMPLETED|Overall Study||18||
48263869|NCT02419417|100966860|FG003|COMPLETED|Overall Study||0||
48263870|NCT02419417|100966861|FG004|COMPLETED|Overall Study||0||
48263871|NCT02419417|100966862|FG005|COMPLETED|Overall Study||0||
48263872|NCT02419417|100966863|FG006|COMPLETED|Overall Study||0||
48263873|NCT02419417|100966864|FG007|COMPLETED|Overall Study||0||
48263874|NCT02419417|100966865|FG008|COMPLETED|Overall Study||0||
48263875|NCT02419417|100966866|FG009|COMPLETED|Overall Study||0||
48263876|NCT02419417|100966867|FG010|COMPLETED|Overall Study||0||
48263877|NCT02419417|100966857|FG000|NOT COMPLETED|Overall Study||5||
48263878|NCT02419417|100966858|FG001|NOT COMPLETED|Overall Study||4||
48691076|NCT00758069|102025995|FG000|NOT COMPLETED|Overall Study||1||
48263879|NCT02419417|100966859|FG002|NOT COMPLETED|Overall Study||13||
48263880|NCT02419417|100966860|FG003|NOT COMPLETED|Overall Study||10||
48263881|NCT02419417|100966861|FG004|NOT COMPLETED|Overall Study||13||
48691077|NCT00758069|102025996|FG001|NOT COMPLETED|Overall Study||0||
48691078|NCT00758069|102025997|FG002|NOT COMPLETED|Overall Study||1||
48691079|NCT00581399|102025998|FG000|STARTED|Overall Study||46||
48691080|NCT00581399|102025999|FG001|STARTED|Overall Study||48||
48691081|NCT00581399|102025998|FG000|COMPLETED|Overall Study||46||
48691082|NCT00581399|102025999|FG001|COMPLETED|Overall Study||48||
48263882|NCT02419417|100966862|FG005|NOT COMPLETED|Overall Study||4||
48263883|NCT02419417|100966863|FG006|NOT COMPLETED|Overall Study||4||
48263884|NCT02419417|100966864|FG007|NOT COMPLETED|Overall Study||6||
48263885|NCT02419417|100966865|FG008|NOT COMPLETED|Overall Study||13||
48263886|NCT02419417|100966866|FG009|NOT COMPLETED|Overall Study||10||
48263887|NCT02419417|100966867|FG010|NOT COMPLETED|Overall Study||1||
48547417|NCT05299528|101675170|FG002|STARTED|Phase 1 Patient Recruitment||0|During Phase 1, patient participants from the surgeons enrolled in the surgeon recruitment phase were enrolled in the study|
48547418|NCT05299528|101675171|FG003|STARTED|Phase 1 Patient Recruitment||0|During Phase 1, patient participants from the surgeons enrolled in the surgeon recruitment phase were enrolled in the study|
48547419|NCT05299528|101675172|FG004|STARTED|Phase 1 Patient Recruitment||0|During Phase 1, patient participants from the surgeons enrolled in the surgeon recruitment phase were enrolled in the study|
48547420|NCT05299528|101675173|FG005|STARTED|Phase 1 Patient Recruitment||0|During Phase 1, patient participants from the surgeons enrolled in the surgeon recruitment phase were enrolled in the study|
48547421|NCT05299528|101675174|FG006|STARTED|Phase 1 Patient Recruitment||0|During Phase 1, patient participants from the surgeons enrolled in the surgeon recruitment phase were enrolled in the study|
48263888|NCT01660256|100966868|FG000|STARTED|Overall Study||84||
48263889|NCT01660256|100966869|FG001|STARTED|Overall Study||83||
48263890|NCT01660256|100966870|FG002|STARTED|Overall Study||42||
48263891|NCT01660256|100966868|FG000|COMPLETED|Overall Study||79||
48263892|NCT01660256|100966869|FG001|COMPLETED|Overall Study||83||
48263893|NCT01660256|100966870|FG002|COMPLETED|Overall Study||38||
48263894|NCT01660256|100966868|FG000|NOT COMPLETED|Overall Study||5||
48263895|NCT01660256|100966869|FG001|NOT COMPLETED|Overall Study||0||
48263896|NCT01660256|100966870|FG002|NOT COMPLETED|Overall Study||4||
48263897|NCT01784523|100966871|FG000|STARTED|Overall Study||7||
48263898|NCT01784523|100966872|FG001|STARTED|Overall Study||4||
48263899|NCT01784523|100966871|FG000|COMPLETED|Overall Study||0||
48263900|NCT01784523|100966872|FG001|COMPLETED|Overall Study||0||
48263901|NCT01784523|100966871|FG000|NOT COMPLETED|Overall Study||7||
48263902|NCT01784523|100966872|FG001|NOT COMPLETED|Overall Study||4||
48263903|NCT00760747|100966873|FG000|STARTED|Study Period II||57||
48263904|NCT00760747|100966874|FG001|STARTED|Study Period II||55||
48263905|NCT00760747|100966873|FG000|Received at Least One Dose of Study Drug|Study Period II||57||
48263906|NCT00760747|100966874|FG001|Received at Least One Dose of Study Drug|Study Period II||54||
48263907|NCT00760747|100966873|FG000|COMPLETED|Study Period II||44||
48263908|NCT00760747|100966874|FG001|COMPLETED|Study Period II||41||
48263909|NCT00760747|100966873|FG000|NOT COMPLETED|Study Period II||13||
48263910|NCT00760747|100966874|FG001|NOT COMPLETED|Study Period II||14||
48263911|NCT00760747|100966873|FG000|STARTED|Study Period III||44||
48547422|NCT05299528|101675168|FG000|COMPLETED|Phase 1 Patient Recruitment||0||
48547423|NCT05299528|101675169|FG001|COMPLETED|Phase 1 Patient Recruitment||131||
48547424|NCT05299528|101675170|FG002|COMPLETED|Phase 1 Patient Recruitment||0||
48547425|NCT05299528|101675171|FG003|COMPLETED|Phase 1 Patient Recruitment||0||
48547426|NCT05299528|101675172|FG004|COMPLETED|Phase 1 Patient Recruitment||0||
48547427|NCT05299528|101675173|FG005|COMPLETED|Phase 1 Patient Recruitment||0||
48263912|NCT00760747|100966874|FG001|STARTED|Study Period III||41||
48263913|NCT00760747|100966873|FG000|COMPLETED|Study Period III||41||
48263914|NCT00760747|100966874|FG001|COMPLETED|Study Period III||38||
48263915|NCT00760747|100966873|FG000|NOT COMPLETED|Study Period III||3||
48263916|NCT00760747|100966874|FG001|NOT COMPLETED|Study Period III||3||
48263917|NCT00617929|100966875|FG000|STARTED|Overall Study||12||
48263918|NCT00617929|100966875|FG000|COMPLETED|Overall Study||11||
48263919|NCT00617929|100966875|FG000|NOT COMPLETED|Overall Study||1||
48263920|NCT04067843|100966876|FG000|STARTED|Overall Study||10||
48263921|NCT04067843|100966877|FG001|STARTED|Overall Study||10||
48263922|NCT04067843|100966876|FG000|COMPLETED|Overall Study||10||
48263923|NCT04067843|100966877|FG001|COMPLETED|Overall Study||10||
48263924|NCT04067843|100966876|FG000|NOT COMPLETED|Overall Study||0||
48263925|NCT04067843|100966877|FG001|NOT COMPLETED|Overall Study||0||
48263926|NCT01689363|100966878|FG000|STARTED|Overall Study||32||
48263927|NCT01689363|100966879|FG001|STARTED|Overall Study||32||
48263928|NCT01689363|100966880|FG002|STARTED|Overall Study||32||
48263929|NCT01689363|100966881|FG003|STARTED|Overall Study||31||
48263930|NCT01689363|100966882|FG004|STARTED|Overall Study||31||
48263931|NCT01689363|100966883|FG005|STARTED|Overall Study||31||
48547428|NCT05299528|101675174|FG006|COMPLETED|Phase 1 Patient Recruitment||0||
48263932|NCT01689363|100966884|FG006|STARTED|Overall Study||32||
48263933|NCT01689363|100966885|FG007|STARTED|Overall Study||32||
48263934|NCT01689363|100966878|FG000|COMPLETED|Overall Study||32||
48263935|NCT01689363|100966879|FG001|COMPLETED|Overall Study||31||
48263936|NCT01689363|100966880|FG002|COMPLETED|Overall Study||32||
48263937|NCT01689363|100966881|FG003|COMPLETED|Overall Study||31||
48263938|NCT01689363|100966882|FG004|COMPLETED|Overall Study||31||
48263939|NCT01689363|100966883|FG005|COMPLETED|Overall Study||31||
48263940|NCT01689363|100966884|FG006|COMPLETED|Overall Study||32||
48263941|NCT01689363|100966885|FG007|COMPLETED|Overall Study||32||
48263942|NCT01689363|100966878|FG000|NOT COMPLETED|Overall Study||0||
48263943|NCT01689363|100966879|FG001|NOT COMPLETED|Overall Study||1||
48263944|NCT01689363|100966880|FG002|NOT COMPLETED|Overall Study||0||
48263945|NCT01689363|100966881|FG003|NOT COMPLETED|Overall Study||0||
48263946|NCT01689363|100966882|FG004|NOT COMPLETED|Overall Study||0||
48263947|NCT01689363|100966883|FG005|NOT COMPLETED|Overall Study||0||
48263948|NCT01689363|100966884|FG006|NOT COMPLETED|Overall Study||0||
48263949|NCT01689363|100966885|FG007|NOT COMPLETED|Overall Study||0||
48263950|NCT00590564|100966886|FG000|STARTED|Overall Study||42||
48263951|NCT00590564|100966886|FG000|COMPLETED|Overall Study||24||
48263952|NCT00590564|100966886|FG000|NOT COMPLETED|Overall Study||18||
48263953|NCT01111240|100966887|FG000|STARTED|Overall Study||4635||
48263954|NCT01111240|100966887|FG000|COMPLETED|Overall Study||3569||
48263955|NCT01111240|100966887|FG000|NOT COMPLETED|Overall Study||1066||
48263956|NCT03343093|100966888|FG000|STARTED|Overall Study||199||
48263957|NCT03343093|100966889|FG001|STARTED|Overall Study||204||
48263958|NCT03343093|100966888|FG000|COMPLETED|Overall Study||180||
48263959|NCT03343093|100966889|FG001|COMPLETED|Overall Study||175||
48263960|NCT03343093|100966888|FG000|NOT COMPLETED|Overall Study||19||
48263961|NCT03343093|100966889|FG001|NOT COMPLETED|Overall Study||29||
48263962|NCT03329300|100966890|FG000|STARTED|Overall Study||17||
48263963|NCT03329300|100966891|FG001|STARTED|Overall Study||17||
48263964|NCT03329300|100966890|FG000|COMPLETED|Overall Study||17||
48263965|NCT03329300|100966891|FG001|COMPLETED|Overall Study||17||
48263966|NCT03329300|100966890|FG000|NOT COMPLETED|Overall Study||0||
48263967|NCT03329300|100966891|FG001|NOT COMPLETED|Overall Study||0||
48263968|NCT02266342|100966892|FG000|STARTED|Overall Study||154||
48263969|NCT02266342|100966892|FG000|COMPLETED|Overall Study||60||
48263970|NCT02266342|100966892|FG000|NOT COMPLETED|Overall Study||94||
48263971|NCT05224843|100966893|FG000|STARTED|Overall Study||80||
48263972|NCT05224843|100966893|FG000|COMPLETED|Overall Study||80||
48263973|NCT05224843|100966893|FG000|NOT COMPLETED|Overall Study||0||
48263974|NCT00859976|100966894|FG000|STARTED|Overall Study||82||
48263975|NCT00859976|100966895|FG001|STARTED|Overall Study||85||
48547429|NCT05299528|101675168|FG000|NOT COMPLETED|Phase 1 Patient Recruitment||0||
48547430|NCT05299528|101675169|FG001|NOT COMPLETED|Phase 1 Patient Recruitment||4||
48547431|NCT05299528|101675170|FG002|NOT COMPLETED|Phase 1 Patient Recruitment||0||
48547432|NCT05299528|101675171|FG003|NOT COMPLETED|Phase 1 Patient Recruitment||0||
48547433|NCT05299528|101675172|FG004|NOT COMPLETED|Phase 1 Patient Recruitment||0||
48547434|NCT05299528|101675173|FG005|NOT COMPLETED|Phase 1 Patient Recruitment||0||
48547435|NCT05299528|101675174|FG006|NOT COMPLETED|Phase 1 Patient Recruitment||0||
48263976|NCT00859976|100966894|FG000|COMPLETED|Overall Study||66||
48263977|NCT00859976|100966895|FG001|COMPLETED|Overall Study||67||
48263978|NCT00859976|100966894|FG000|NOT COMPLETED|Overall Study||16||
48263979|NCT00859976|100966895|FG001|NOT COMPLETED|Overall Study||18||
48263980|NCT01496365|100966896|FG000|STARTED|Overall Study||112||
48263981|NCT01496365|100966897|FG001|STARTED|Overall Study||56||
48263982|NCT01496365|100966898|FG002|STARTED|Overall Study||57||
48263983|NCT01496365|100966899|FG003|STARTED|Overall Study||57||
48263984|NCT01496365|100966900|FG004|STARTED|Overall Study||57||
48263985|NCT01496365|100966901|FG005|STARTED|Overall Study||56||
48263986|NCT01496365|100966902|FG006|STARTED|Overall Study||57||
48263987|NCT01496365|100966896|FG000|COMPLETED|Overall Study||97||
48263988|NCT01496365|100966897|FG001|COMPLETED|Overall Study||41||
48263989|NCT01496365|100966898|FG002|COMPLETED|Overall Study||51||
48263990|NCT01496365|100966899|FG003|COMPLETED|Overall Study||53||
48263991|NCT01496365|100966900|FG004|COMPLETED|Overall Study||44||
48263992|NCT01496365|100966901|FG005|COMPLETED|Overall Study||46||
48263993|NCT01496365|100966902|FG006|COMPLETED|Overall Study||51||
48263994|NCT01496365|100966896|FG000|NOT COMPLETED|Overall Study||15||
48263995|NCT01496365|100966897|FG001|NOT COMPLETED|Overall Study||15||
48263996|NCT01496365|100966898|FG002|NOT COMPLETED|Overall Study||6||
48263997|NCT01496365|100966899|FG003|NOT COMPLETED|Overall Study||4||
48263998|NCT01496365|100966900|FG004|NOT COMPLETED|Overall Study||13||
48263999|NCT01496365|100966901|FG005|NOT COMPLETED|Overall Study||10||
48547436|NCT05299528|101675168|FG000|STARTED|Surgeon Randomization||0|35 surgeons who did not have at least 3 patients who had specified surgeries during phase 1 were not randomized|
48547437|NCT05299528|101675169|FG001|STARTED|Surgeon Randomization||0|35 surgeons who did not have at least 3 patients who had specified surgeries during phase 1 were not randomized|
48547438|NCT05299528|101675170|FG002|STARTED|Surgeon Randomization||6|35 surgeons who did not have at least 3 patients who had specified surgeries during phase 1 were not randomized|
48264000|NCT01496365|100966902|FG006|NOT COMPLETED|Overall Study||6||
48264001|NCT01951768|100966903|FG000|STARTED|Overall Study||43||
48264002|NCT01951768|100966904|FG001|STARTED|Overall Study||45||
48264003|NCT01951768|100966903|FG000|COMPLETED|Overall Study||43||
48264004|NCT01951768|100966904|FG001|COMPLETED|Overall Study||45||
48264005|NCT01951768|100966903|FG000|NOT COMPLETED|Overall Study||0||
48264006|NCT01951768|100966904|FG001|NOT COMPLETED|Overall Study||0||
48264007|NCT01458522|100966905|FG000|STARTED|Overall Study||37||
48264008|NCT01458522|100966906|FG001|STARTED|Overall Study||37||
48264009|NCT01458522|100966905|FG000|Received First Drug|Overall Study||35||
48264010|NCT01458522|100966906|FG001|Received First Drug|Overall Study||35||
48264011|NCT01458522|100966905|FG000|Crossover to Second Drug|Overall Study||15||
48264012|NCT01458522|100966906|FG001|Crossover to Second Drug|Overall Study||10||
48294155|NCT02527343|101047541|FG005|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||9||
48547439|NCT05299528|101675171|FG003|STARTED|Surgeon Randomization||6|35 surgeons who did not have at least 3 patients who had specified surgeries during phase 1 were not randomized|
48547440|NCT05299528|101675172|FG004|STARTED|Surgeon Randomization||0|35 surgeons who did not have at least 3 patients who had specified surgeries during phase 1 were not randomized|
48547441|NCT05299528|101675173|FG005|STARTED|Surgeon Randomization||0|35 surgeons who did not have at least 3 patients who had specified surgeries during phase 1 were not randomized|
48547442|NCT05299528|101675174|FG006|STARTED|Surgeon Randomization||0|35 surgeons who did not have at least 3 patients who had specified surgeries during phase 1 were not randomized|
48547443|NCT05299528|101675168|FG000|COMPLETED|Surgeon Randomization||0||
48547444|NCT05299528|101675169|FG001|COMPLETED|Surgeon Randomization||0||
48547445|NCT05299528|101675170|FG002|COMPLETED|Surgeon Randomization||6||
48547446|NCT05299528|101675171|FG003|COMPLETED|Surgeon Randomization||6||
48547447|NCT05299528|101675172|FG004|COMPLETED|Surgeon Randomization||0||
48547448|NCT05299528|101675173|FG005|COMPLETED|Surgeon Randomization||0||
48547449|NCT05299528|101675174|FG006|COMPLETED|Surgeon Randomization||0||
48547450|NCT05299528|101675168|FG000|NOT COMPLETED|Surgeon Randomization||0||
48547451|NCT05299528|101675169|FG001|NOT COMPLETED|Surgeon Randomization||0||
48547452|NCT05299528|101675170|FG002|NOT COMPLETED|Surgeon Randomization||0||
48547453|NCT05299528|101675171|FG003|NOT COMPLETED|Surgeon Randomization||0||
48547454|NCT05299528|101675172|FG004|NOT COMPLETED|Surgeon Randomization||0||
48547455|NCT05299528|101675173|FG005|NOT COMPLETED|Surgeon Randomization||0||
48547456|NCT05299528|101675174|FG006|NOT COMPLETED|Surgeon Randomization||0||
48547457|NCT05299528|101675168|FG000|STARTED|Phase 2 Patient Recruitment||0|During Phase 2, patient participants from the surgeons who were randomized to receive the Direct or No Direct Feedback Intervention were enrolled in the study. The 58 patient participants in this period are not included in the 135 patient participants enrolled in Phase 1 Patient Recruitment.|
48547458|NCT05299528|101675169|FG001|STARTED|Phase 2 Patient Recruitment||0|During Phase 2, patient participants from the surgeons who were randomized to receive the Direct or No Direct Feedback Intervention were enrolled in the study. The 58 patient participants in this period are not included in the 135 patient participants enrolled in Phase 1 Patient Recruitment.|
48547459|NCT05299528|101675170|FG002|STARTED|Phase 2 Patient Recruitment||0|During Phase 2, patient participants from the surgeons who were randomized to receive the Direct or No Direct Feedback Intervention were enrolled in the study. The 58 patient participants in this period are not included in the 135 patient participants enrolled in Phase 1 Patient Recruitment.|
48547460|NCT05299528|101675171|FG003|STARTED|Phase 2 Patient Recruitment||0|During Phase 2, patient participants from the surgeons who were randomized to receive the Direct or No Direct Feedback Intervention were enrolled in the study. The 58 patient participants in this period are not included in the 135 patient participants enrolled in Phase 1 Patient Recruitment.|
48547461|NCT05299528|101675172|FG004|STARTED|Phase 2 Patient Recruitment||27|During Phase 2, patient participants from the surgeons who were randomized to receive the Direct or No Direct Feedback Intervention were enrolled in the study. The 58 patient participants in this period are not included in the 135 patient participants enrolled in Phase 1 Patient Recruitment.|
48547462|NCT05299528|101675173|FG005|STARTED|Phase 2 Patient Recruitment||31|During Phase 2, patient participants from the surgeons who were randomized to receive the Direct or No Direct Feedback Intervention were enrolled in the study. The 58 patient participants in this period are not included in the 135 patient participants enrolled in Phase 1 Patient Recruitment.|
48547463|NCT05299528|101675174|FG006|STARTED|Phase 2 Patient Recruitment||225|During Phase 2, patient participants from the surgeons who were randomized to receive the Direct or No Direct Feedback Intervention were enrolled in the study. The 58 patient participants in this period are not included in the 135 patient participants enrolled in Phase 1 Patient Recruitment.|
48547464|NCT05299528|101675168|FG000|COMPLETED|Phase 2 Patient Recruitment||0||
48547465|NCT05299528|101675169|FG001|COMPLETED|Phase 2 Patient Recruitment||0||
48547466|NCT05299528|101675170|FG002|COMPLETED|Phase 2 Patient Recruitment||0||
48547467|NCT05299528|101675171|FG003|COMPLETED|Phase 2 Patient Recruitment||0||
48547468|NCT05299528|101675172|FG004|COMPLETED|Phase 2 Patient Recruitment||27||
48547469|NCT05299528|101675173|FG005|COMPLETED|Phase 2 Patient Recruitment||30||
48547470|NCT05299528|101675174|FG006|COMPLETED|Phase 2 Patient Recruitment||225||
48547471|NCT05299528|101675168|FG000|NOT COMPLETED|Phase 2 Patient Recruitment||0||
48547472|NCT05299528|101675169|FG001|NOT COMPLETED|Phase 2 Patient Recruitment||0||
48547473|NCT05299528|101675170|FG002|NOT COMPLETED|Phase 2 Patient Recruitment||0||
48547474|NCT05299528|101675171|FG003|NOT COMPLETED|Phase 2 Patient Recruitment||0||
48547475|NCT05299528|101675172|FG004|NOT COMPLETED|Phase 2 Patient Recruitment||0||
48547476|NCT05299528|101675173|FG005|NOT COMPLETED|Phase 2 Patient Recruitment||1||
48691083|NCT00581399|102025998|FG000|NOT COMPLETED|Overall Study||0||
48691084|NCT00581399|102025999|FG001|NOT COMPLETED|Overall Study||0||
48691085|NCT02676895|102026000|FG000|STARTED|Overall Study||22||
48101219|NCT02747420|100572420|FG000|NOT COMPLETED|Overall Study||7||
48101220|NCT02747420|100572421|FG001|NOT COMPLETED|Overall Study||4||
48101221|NCT03137693|100572422|FG000|STARTED|Overall Study||20||
48101222|NCT03137693|100572422|FG000|COMPLETED|Overall Study||20||
48101223|NCT03137693|100572422|FG000|NOT COMPLETED|Overall Study||0||
48101224|NCT03316885|100572423|FG000|STARTED|Overall Study||215||430
48101225|NCT03316885|100572423|FG000|Implanted in First Eye Only|Overall Study||215||215
48101226|NCT03316885|100572423|FG000|Implanted in Second Eye Only|Overall Study||209||209
48101227|NCT03316885|100572423|FG000|Implanted in 1 Eye Only|Overall Study||6||6
48101228|NCT03316885|100572423|FG000|COMPLETED|Overall Study||183||365
48101229|NCT03316885|100572423|FG000|NOT COMPLETED|Overall Study||32||65
48101230|NCT01378221|100575275|FG000|STARTED|Overall Study||36||
48547477|NCT05299528|101675174|FG006|NOT COMPLETED|Phase 2 Patient Recruitment||0||
48547478|NCT05299528|101675168|FG000|STARTED|Surgeon Follow-up||0||
48547479|NCT05299528|101675169|FG001|STARTED|Surgeon Follow-up||0||
48547480|NCT05299528|101675170|FG002|STARTED|Surgeon Follow-up||6||
48547481|NCT05299528|101675171|FG003|STARTED|Surgeon Follow-up||6||
48547482|NCT05299528|101675172|FG004|STARTED|Surgeon Follow-up||0||
48547483|NCT05299528|101675173|FG005|STARTED|Surgeon Follow-up||0||
48547484|NCT05299528|101675174|FG006|STARTED|Surgeon Follow-up||0||
48547485|NCT05299528|101675168|FG000|COMPLETED|Surgeon Follow-up||0||
48547486|NCT05299528|101675169|FG001|COMPLETED|Surgeon Follow-up||0||
48547487|NCT05299528|101675170|FG002|COMPLETED|Surgeon Follow-up||5||
48547488|NCT05299528|101675171|FG003|COMPLETED|Surgeon Follow-up||6||
48547489|NCT05299528|101675172|FG004|COMPLETED|Surgeon Follow-up||0||
48547490|NCT05299528|101675173|FG005|COMPLETED|Surgeon Follow-up||0||
48547491|NCT05299528|101675174|FG006|COMPLETED|Surgeon Follow-up||0||
48547492|NCT05299528|101675168|FG000|NOT COMPLETED|Surgeon Follow-up||0||
48547493|NCT05299528|101675169|FG001|NOT COMPLETED|Surgeon Follow-up||0||
48547494|NCT05299528|101675170|FG002|NOT COMPLETED|Surgeon Follow-up||1||
48547495|NCT05299528|101675171|FG003|NOT COMPLETED|Surgeon Follow-up||0||
48547496|NCT05299528|101675172|FG004|NOT COMPLETED|Surgeon Follow-up||0||
48547497|NCT05299528|101675173|FG005|NOT COMPLETED|Surgeon Follow-up||0||
48547498|NCT05299528|101675174|FG006|NOT COMPLETED|Surgeon Follow-up||0||
48547499|NCT03112642|101675175|FG000|STARTED|Overall Study||6||
48547500|NCT03112642|101675176|FG001|STARTED|Overall Study||2||
48547501|NCT03112642|101675175|FG000|COMPLETED|Overall Study||6||
48547502|NCT03112642|101675176|FG001|COMPLETED|Overall Study||2||
48691086|NCT02676895|102026001|FG001|STARTED|Overall Study||26||
48691087|NCT02676895|102026002|FG002|STARTED|Overall Study||24||
48691088|NCT02676895|102026000|FG000|COMPLETED|Overall Study||20||
48691089|NCT02676895|102026001|FG001|COMPLETED|Overall Study||23||
48691090|NCT02676895|102026002|FG002|COMPLETED|Overall Study||21||
48101231|NCT01378221|100575276|FG001|STARTED|Overall Study||39||
48547503|NCT03112642|101675175|FG000|NOT COMPLETED|Overall Study||0||
48547504|NCT03112642|101675176|FG001|NOT COMPLETED|Overall Study||0||
48547505|NCT01107197|101675177|FG000|STARTED|Overall Study||99||
48547506|NCT01107197|101675178|FG001|STARTED|Overall Study||101||
48547507|NCT01107197|101675177|FG000|COMPLETED|Overall Study||79||
48547508|NCT01107197|101675178|FG001|COMPLETED|Overall Study||78||
48101232|NCT01378221|100575275|FG000|COMPLETED|Overall Study||29||
48101233|NCT01378221|100575276|FG001|COMPLETED|Overall Study||30||
48101234|NCT01378221|100575275|FG000|NOT COMPLETED|Overall Study||7||
48101235|NCT01378221|100575276|FG001|NOT COMPLETED|Overall Study||9||
48101236|NCT00149747|100575277|FG000|STARTED|Overall Study||36||
48101237|NCT00149747|100575278|FG001|STARTED|Overall Study||30||
48101238|NCT00149747|100575277|FG000|COMPLETED|Overall Study||32||
48101239|NCT00149747|100575278|FG001|COMPLETED|Overall Study||27||
48101240|NCT00149747|100575277|FG000|NOT COMPLETED|Overall Study||4||
48101241|NCT00149747|100575278|FG001|NOT COMPLETED|Overall Study||3||
48101242|NCT01746979|100575279|FG000|STARTED|Overall Study||346||
48101243|NCT01746979|100575280|FG001|STARTED|Overall Study||347||
48101244|NCT01746979|100575279|FG000|COMPLETED|Overall Study||0||
48101245|NCT01746979|100575280|FG001|COMPLETED|Overall Study||0||
48101246|NCT01746979|100575279|FG000|NOT COMPLETED|Overall Study||346||
48101247|NCT01746979|100575280|FG001|NOT COMPLETED|Overall Study||347||
48101248|NCT04964128|100575281|FG000|STARTED|Phase 1 (Software Release Tag 1.0)||18||
48101249|NCT04964128|100575281|FG000|COMPLETED|Phase 1 (Software Release Tag 1.0)||17||
48101250|NCT04964128|100575281|FG000|NOT COMPLETED|Phase 1 (Software Release Tag 1.0)||1||
48101251|NCT04964128|100575281|FG000|STARTED|Phase 2 (Software Release Tag 2.0)||18||
48101252|NCT04964128|100575281|FG000|COMPLETED|Phase 2 (Software Release Tag 2.0)||17||
48101253|NCT04964128|100575281|FG000|NOT COMPLETED|Phase 2 (Software Release Tag 2.0)||1||
48101254|NCT01853046|100575282|FG000|STARTED|Overall Study||18||
48101255|NCT01853046|100575283|FG001|STARTED|Overall Study||6||
48101256|NCT01853046|100575282|FG000|Received Treatment|Overall Study||18||
48101257|NCT01853046|100575283|FG001|Received Treatment|Overall Study||6||
48101258|NCT01853046|100575282|FG000|COMPLETED|Overall Study||0||
48101259|NCT01853046|100575283|FG001|COMPLETED|Overall Study||0||
48101260|NCT01853046|100575282|FG000|NOT COMPLETED|Overall Study||18||
48101261|NCT01853046|100575283|FG001|NOT COMPLETED|Overall Study||6||
48101262|NCT01969812|100575284|FG000|STARTED|Overall Study||12||
48101263|NCT01969812|100575285|FG001|STARTED|Overall Study||10||
48547509|NCT01107197|101675177|FG000|NOT COMPLETED|Overall Study||20||
48547510|NCT01107197|101675178|FG001|NOT COMPLETED|Overall Study||23||
48547511|NCT00048737|101675179|FG000|STARTED|Overall Study||70||
48547512|NCT00048737|101675179|FG000|COMPLETED|Overall Study||70||
48547513|NCT00048737|101675179|FG000|NOT COMPLETED|Overall Study||0||
48547514|NCT00625872|101675180|FG000|STARTED|Overall Study||12||
48101264|NCT01969812|100575284|FG000|COMPLETED|Overall Study||12||
48547515|NCT00625872|101675181|FG001|STARTED|Overall Study||11||
48691091|NCT02676895|102026000|FG000|NOT COMPLETED|Overall Study||2||
48691092|NCT02676895|102026001|FG001|NOT COMPLETED|Overall Study||3||
48691093|NCT02676895|102026002|FG002|NOT COMPLETED|Overall Study||3||
48101265|NCT01969812|100575285|FG001|COMPLETED|Overall Study||10||
48101266|NCT01969812|100575284|FG000|NOT COMPLETED|Overall Study||0||
48547516|NCT00625872|101675180|FG000|Treated|Overall Study||12||
48691094|NCT00289289|102026003|FG000|STARTED|Overall Study||132||
48691095|NCT00289289|102026004|FG001|STARTED|Overall Study||124||
48691096|NCT00289289|102026005|FG002|STARTED|Overall Study||144||
48691097|NCT00289289|102026003|FG000|COMPLETED|Overall Study||113||
48691098|NCT00289289|102026004|FG001|COMPLETED|Overall Study||114||
48691099|NCT00289289|102026005|FG002|COMPLETED|Overall Study||95||
48691100|NCT00289289|102026003|FG000|NOT COMPLETED|Overall Study||19||
48691101|NCT00289289|102026004|FG001|NOT COMPLETED|Overall Study||10||
48691102|NCT00289289|102026005|FG002|NOT COMPLETED|Overall Study||49||
48691103|NCT00244725|102026006|FG000|STARTED|Overall Study||237||
48691104|NCT00244725|102026007|FG001|STARTED|Overall Study||245||
48691105|NCT00244725|102026008|FG002|STARTED|Overall Study||239||
48691106|NCT00244725|102026009|FG003|STARTED|Overall Study||237||
48691107|NCT00244725|102026006|FG000|COMPLETED|Overall Study||214||
48264013|NCT01458522|100966905|FG000|COMPLETED|Overall Study||34|Completed all assigned intervention \& observation. Not all subjects were assigned to crossover.|
48264014|NCT01458522|100966906|FG001|COMPLETED|Overall Study||26|Completed all assigned intervention \& observation. Not all subjects were assigned to crossover.|
48264015|NCT01458522|100966905|FG000|NOT COMPLETED|Overall Study||3||
48264016|NCT01458522|100966906|FG001|NOT COMPLETED|Overall Study||11||
48264017|NCT03194867|100966907|FG000|STARTED|Overall Study||3|Enrolled for Phase 1; randomized for Phase 2|
48264018|NCT03194867|100966908|FG001|STARTED|Overall Study||34|Enrolled for Phase 1; randomized for Phase 2|
48264019|NCT03194867|100966909|FG002|STARTED|Overall Study||36|Enrolled for Phase 1; randomized for Phase 2|
48264020|NCT03194867|100966910|FG003|STARTED|Overall Study||36|Enrolled for Phase 1; randomized for Phase 2|
48264021|NCT03194867|100966907|FG000|Randomized and Treated|Overall Study||3|Enrolled for Phase1; randomized for Phase 2. Phase 2 Isatuximab + CemiplimabQ2W, one participant was randomized but not treated.|
48264022|NCT03194867|100966908|FG001|Randomized and Treated|Overall Study||34|Enrolled for Phase1; randomized for Phase 2. Phase 2 Isatuximab + CemiplimabQ2W, one participant was randomized but not treated.|
48264023|NCT03194867|100966909|FG002|Randomized and Treated|Overall Study||35|Enrolled for Phase1; randomized for Phase 2. Phase 2 Isatuximab + CemiplimabQ2W, one participant was randomized but not treated.|
48264024|NCT03194867|100966910|FG003|Randomized and Treated|Overall Study||36|Enrolled for Phase1; randomized for Phase 2. Phase 2 Isatuximab + CemiplimabQ2W, one participant was randomized but not treated.|
48264025|NCT03194867|100966907|FG000|COMPLETED|Overall Study||3|Participants with end of study or death from any cause forms completed.|
48264026|NCT03194867|100966908|FG001|COMPLETED|Overall Study||34|Participants with end of study or death from any cause forms completed.|
48264027|NCT03194867|100966909|FG002|COMPLETED|Overall Study||35|Participants with end of study or death from any cause forms completed.|
48264028|NCT03194867|100966910|FG003|COMPLETED|Overall Study||36|Participants with end of study or death from any cause forms completed.|
48264029|NCT03194867|100966907|FG000|NOT COMPLETED|Overall Study||0||
48264030|NCT03194867|100966908|FG001|NOT COMPLETED|Overall Study||0||
48264031|NCT03194867|100966909|FG002|NOT COMPLETED|Overall Study||1||
48264032|NCT03194867|100966910|FG003|NOT COMPLETED|Overall Study||0||
48264033|NCT03080142|100966911|FG000|STARTED|Overall Study||42||
48264034|NCT03080142|100966912|FG001|STARTED|Overall Study||44||
48264035|NCT03080142|100966911|FG000|COMPLETED|Overall Study||42||
48390874|NCT03627494|101283634|FG005|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
48390875|NCT03627494|101283635|FG006|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
48390876|NCT03627494|101283636|FG007|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
48390877|NCT03627494|101283637|FG008|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
48390878|NCT03627494|101283638|FG009|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
48390879|NCT03627494|101283639|FG010|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
48390880|NCT03627494|101283640|FG011|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
48390881|NCT05053126|101283641|FG000|STARTED|Overall Study||10||
48390882|NCT05053126|101283642|FG001|STARTED|Overall Study||10||
48390883|NCT05053126|101283643|FG002|STARTED|Overall Study||10||
48390884|NCT05053126|101283644|FG003|STARTED|Overall Study||10||
48691108|NCT00244725|102026007|FG001|COMPLETED|Overall Study||226||
48691109|NCT00244725|102026008|FG002|COMPLETED|Overall Study||215||
48691110|NCT00244725|102026009|FG003|COMPLETED|Overall Study||216||
48691111|NCT00244725|102026006|FG000|NOT COMPLETED|Overall Study||23||
48691112|NCT00244725|102026007|FG001|NOT COMPLETED|Overall Study||19||
48691113|NCT00244725|102026008|FG002|NOT COMPLETED|Overall Study||24||
48691114|NCT00244725|102026009|FG003|NOT COMPLETED|Overall Study||21||
48691115|NCT01268046|102026010|FG000|STARTED|Overall Study||13||
48691116|NCT01268046|102026011|FG001|STARTED|Overall Study||9||
48691117|NCT01268046|102026012|FG002|STARTED|Overall Study||8||
48691118|NCT01268046|102026013|FG003|STARTED|Overall Study||8||
48691119|NCT01268046|102026010|FG000|COMPLETED|Overall Study||12||
48691120|NCT01268046|102026011|FG001|COMPLETED|Overall Study||9||
48691121|NCT01268046|102026012|FG002|COMPLETED|Overall Study||7||
48101267|NCT01969812|100575285|FG001|NOT COMPLETED|Overall Study||0||
48264036|NCT03080142|100966912|FG001|COMPLETED|Overall Study||44||
48264037|NCT03080142|100966911|FG000|NOT COMPLETED|Overall Study||0||
48264038|NCT03080142|100966912|FG001|NOT COMPLETED|Overall Study||0||
48264039|NCT00980590|100966913|FG000|STARTED|Overall Study||50||
48264040|NCT00980590|100966914|FG001|STARTED|Overall Study||50||
48264041|NCT00980590|100966913|FG000|COMPLETED|Overall Study||50||
48264042|NCT00980590|100966914|FG001|COMPLETED|Overall Study||50||
48264043|NCT00980590|100966913|FG000|NOT COMPLETED|Overall Study||0||
48264044|NCT00980590|100966914|FG001|NOT COMPLETED|Overall Study||0||
48264045|NCT01443923|100966915|FG000|STARTED|Overall Study||3||
48264046|NCT01443923|100966916|FG001|STARTED|Overall Study||1||
48264047|NCT01443923|100966915|FG000|COMPLETED|Overall Study||2||
48264048|NCT01443923|100966916|FG001|COMPLETED|Overall Study||1||
48264049|NCT01443923|100966915|FG000|NOT COMPLETED|Overall Study||1||
48264050|NCT01443923|100966916|FG001|NOT COMPLETED|Overall Study||0||
48264051|NCT02990468|100966917|FG000|STARTED|Phase 1: Dose Escalation||3||
48264052|NCT02990468|100966918|FG001|STARTED|Phase 1: Dose Escalation||3||
48264053|NCT02990468|100966919|FG002|STARTED|Phase 1: Dose Escalation||0||
48264054|NCT02990468|100966917|FG000|COMPLETED|Phase 1: Dose Escalation||3||
48264055|NCT02990468|100966918|FG001|COMPLETED|Phase 1: Dose Escalation||3||
48264056|NCT02990468|100966919|FG002|COMPLETED|Phase 1: Dose Escalation||0||
48264057|NCT02990468|100966917|FG000|NOT COMPLETED|Phase 1: Dose Escalation||0||
48264058|NCT02990468|100966918|FG001|NOT COMPLETED|Phase 1: Dose Escalation||0||
48264059|NCT02990468|100966919|FG002|NOT COMPLETED|Phase 1: Dose Escalation||0||
48264060|NCT02990468|100966917|FG000|STARTED|Phase 2: MTD||0||
48264061|NCT02990468|100966918|FG001|STARTED|Phase 2: MTD||0||
48264062|NCT02990468|100966919|FG002|STARTED|Phase 2: MTD||23||
48264063|NCT02990468|100966917|FG000|COMPLETED|Phase 2: MTD||0||
48264064|NCT02990468|100966918|FG001|COMPLETED|Phase 2: MTD||0||
48547517|NCT00625872|101675181|FG001|Treated|Overall Study||10||
48547518|NCT00625872|101675180|FG000|COMPLETED|Overall Study||8||
48547519|NCT00625872|101675181|FG001|COMPLETED|Overall Study||5||
48547520|NCT00625872|101675180|FG000|NOT COMPLETED|Overall Study||4||
48547521|NCT00625872|101675181|FG001|NOT COMPLETED|Overall Study||6||
48547522|NCT03168334|101675182|FG000|STARTED|Overall Study||397||
48547523|NCT03168334|101675183|FG001|STARTED|Overall Study||404||
48547524|NCT03168334|101675182|FG000|COMPLETED|Overall Study||345||
48547525|NCT03168334|101675183|FG001|COMPLETED|Overall Study||366||
48547526|NCT03168334|101675182|FG000|NOT COMPLETED|Overall Study||52||
48547527|NCT03168334|101675183|FG001|NOT COMPLETED|Overall Study||38||
48547528|NCT00359801|101675184|FG000|STARTED|Overall Study||987||
48547529|NCT00359801|101675185|FG001|STARTED|Overall Study||989||
48547530|NCT00359801|101675184|FG000|COMPLETED|Overall Study||682||
48547531|NCT00359801|101675185|FG001|COMPLETED|Overall Study||769||
48547532|NCT00359801|101675184|FG000|NOT COMPLETED|Overall Study||305||
48547533|NCT00359801|101675185|FG001|NOT COMPLETED|Overall Study||220||
48547534|NCT02565511|101675186|FG000|STARTED|Overall Study||42||
48547535|NCT02565511|101675187|FG001|STARTED|Overall Study||23||
48264065|NCT02990468|100966919|FG002|COMPLETED|Phase 2: MTD||22||
48264066|NCT02990468|100966917|FG000|NOT COMPLETED|Phase 2: MTD||0||
48264067|NCT02990468|100966918|FG001|NOT COMPLETED|Phase 2: MTD||0||
48264068|NCT02990468|100966919|FG002|NOT COMPLETED|Phase 2: MTD||1||
48264069|NCT02595372|100966920|FG000|STARTED|Overall Study||42||
48264070|NCT02595372|100966920|FG000|COMPLETED|Overall Study||33||
48264071|NCT02595372|100966920|FG000|NOT COMPLETED|Overall Study||9||
48390885|NCT05053126|101283645|FG004|STARTED|Overall Study||10||
48390886|NCT05053126|101283646|FG005|STARTED|Overall Study||10||
48390887|NCT05053126|101283641|FG000|COMPLETED|Overall Study||10||
48390888|NCT05053126|101283642|FG001|COMPLETED|Overall Study||10||
48390889|NCT05053126|101283643|FG002|COMPLETED|Overall Study||10||
48390890|NCT05053126|101283644|FG003|COMPLETED|Overall Study||9||
48390891|NCT05053126|101283645|FG004|COMPLETED|Overall Study||10||
48390892|NCT05053126|101283646|FG005|COMPLETED|Overall Study||9||
48390893|NCT05053126|101283641|FG000|NOT COMPLETED|Overall Study||0||
48390894|NCT05053126|101283642|FG001|NOT COMPLETED|Overall Study||0||
48390895|NCT05053126|101283643|FG002|NOT COMPLETED|Overall Study||0||
48390896|NCT05053126|101283644|FG003|NOT COMPLETED|Overall Study||1||
48390897|NCT05053126|101283645|FG004|NOT COMPLETED|Overall Study||0||
48390898|NCT05053126|101283646|FG005|NOT COMPLETED|Overall Study||1||
48547536|NCT02565511|101675188|FG002|STARTED|Overall Study||251||
48547537|NCT02565511|101675189|FG003|STARTED|Overall Study||164||
48264072|NCT01791413|100970690|FG000|STARTED|Overall Study||20||
48390899|NCT00393068|101283647|FG000|STARTED|Overall Study||62||
48547538|NCT02565511|101675186|FG000|3 Patients Were Mis-randomized|Overall Study||0||
48547539|NCT02565511|101675187|FG001|3 Patients Were Mis-randomized|Overall Study||0||
48547540|NCT02565511|101675188|FG002|3 Patients Were Mis-randomized|Overall Study||2||
48264073|NCT01791413|100970691|FG001|STARTED|Overall Study||20||
48264074|NCT01791413|100970690|FG000|COMPLETED|Overall Study||15||
48264075|NCT01791413|100970691|FG001|COMPLETED|Overall Study||19||
48264076|NCT01791413|100970690|FG000|NOT COMPLETED|Overall Study||5||
48264077|NCT01791413|100970691|FG001|NOT COMPLETED|Overall Study||1||
48264078|NCT03566979|100970692|FG000|STARTED|Overall Study||58||
48390900|NCT00393068|101283647|FG000|COMPLETED|Overall Study||44||
48390901|NCT00393068|101283647|FG000|NOT COMPLETED|Overall Study||18||
48547541|NCT02565511|101675189|FG003|3 Patients Were Mis-randomized|Overall Study||1||
48547542|NCT02565511|101675186|FG000|COMPLETED|Overall Study||0||
48547543|NCT02565511|101675187|FG001|COMPLETED|Overall Study||0||
48547544|NCT02565511|101675188|FG002|COMPLETED|Overall Study||0||
48547545|NCT02565511|101675189|FG003|COMPLETED|Overall Study||0||
48547546|NCT02565511|101675186|FG000|NOT COMPLETED|Overall Study||42||
48264079|NCT03566979|100970693|FG001|STARTED|Overall Study||152||
48264080|NCT03566979|100970694|FG002|STARTED|Overall Study||142||
48264081|NCT03566979|100970695|FG003|STARTED|Overall Study||149||
48264082|NCT03566979|100970692|FG000|COMPLETED|Overall Study||53||
48264083|NCT03566979|100970693|FG001|COMPLETED|Overall Study||145||
48264084|NCT03566979|100970694|FG002|COMPLETED|Overall Study||132||
48264085|NCT03566979|100970695|FG003|COMPLETED|Overall Study||143||
48264086|NCT03566979|100970692|FG000|NOT COMPLETED|Overall Study||5||
48264087|NCT03566979|100970693|FG001|NOT COMPLETED|Overall Study||7||
48264088|NCT03566979|100970694|FG002|NOT COMPLETED|Overall Study||10||
48264089|NCT03566979|100970695|FG003|NOT COMPLETED|Overall Study||6||
48264090|NCT01602510|100970696|FG000|STARTED|Open Label Phase||420||
48264091|NCT01602510|100970697|FG001|STARTED|Open Label Phase||0||
48264092|NCT01602510|100970698|FG002|STARTED|Open Label Phase||0||
48264093|NCT01602510|100970696|FG000|COMPLETED|Open Label Phase||117||
48264094|NCT01602510|100970697|FG001|COMPLETED|Open Label Phase||0||
48264095|NCT01602510|100970698|FG002|COMPLETED|Open Label Phase||0||
48264096|NCT01602510|100970696|FG000|NOT COMPLETED|Open Label Phase||303||
48264097|NCT01602510|100970697|FG001|NOT COMPLETED|Open Label Phase||0||
48264098|NCT01602510|100970698|FG002|NOT COMPLETED|Open Label Phase||0||
48264099|NCT01602510|100970696|FG000|STARTED|Randomized Phase||0||
48264100|NCT01602510|100970697|FG001|STARTED|Randomized Phase||133||
48264101|NCT01602510|100970698|FG002|STARTED|Randomized Phase||131||
48264102|NCT01602510|100970696|FG000|COMPLETED|Randomized Phase||0||
48264103|NCT01602510|100970697|FG001|COMPLETED|Randomized Phase||59||
48264104|NCT01602510|100970698|FG002|COMPLETED|Randomized Phase||58||
48264105|NCT01602510|100970696|FG000|NOT COMPLETED|Randomized Phase||0||
48264106|NCT01602510|100970697|FG001|NOT COMPLETED|Randomized Phase||74||
48264107|NCT01602510|100970698|FG002|NOT COMPLETED|Randomized Phase||73||
48264108|NCT02446613|100970699|FG000|STARTED|Overall Study||6||
48264109|NCT02446613|100970700|FG001|STARTED|Overall Study||10||
48264110|NCT02446613|100970699|FG000|COMPLETED|Overall Study||6||
48264111|NCT02446613|100970700|FG001|COMPLETED|Overall Study||10||
48264112|NCT02446613|100970699|FG000|NOT COMPLETED|Overall Study||0||
48264113|NCT02446613|100970700|FG001|NOT COMPLETED|Overall Study||0||
48264114|NCT04547023|100970701|FG000|STARTED|Overall Study||100||
48264115|NCT04547023|100970702|FG001|STARTED|Overall Study||100||
48264116|NCT04547023|100970701|FG000|COMPLETED|Overall Study||96||
48264117|NCT04547023|100970702|FG001|COMPLETED|Overall Study||97||
48264118|NCT04547023|100970701|FG000|NOT COMPLETED|Overall Study||4||
48264119|NCT04547023|100970702|FG001|NOT COMPLETED|Overall Study||3||
48264120|NCT00127842|100970703|FG000|STARTED|Overall Study||110||
48264121|NCT00127842|100970703|FG000|COMPLETED|Overall Study||71||
48264122|NCT00127842|100970703|FG000|NOT COMPLETED|Overall Study||39||
48390902|NCT03210220|101283648|FG000|STARTED|Overall Study||20||
48390903|NCT03210220|101283649|FG001|STARTED|Overall Study||20||
48390904|NCT03210220|101283648|FG000|COMPLETED|Overall Study||19||
48390905|NCT03210220|101283649|FG001|COMPLETED|Overall Study||20||
48390906|NCT03210220|101283648|FG000|NOT COMPLETED|Overall Study||1||
48390907|NCT03210220|101283649|FG001|NOT COMPLETED|Overall Study||0||
48390908|NCT00168064|101283650|FG000|STARTED|Overall Study||130||
48390909|NCT00168064|101283651|FG001|STARTED|Overall Study||130||
48390910|NCT00168064|101283650|FG000|COMPLETED|Overall Study||81||
48390911|NCT00168064|101283651|FG001|COMPLETED|Overall Study||86||
48390912|NCT00168064|101283650|FG000|NOT COMPLETED|Overall Study||49||
48264123|NCT00362375|100970704|FG000|STARTED|Overall Study||161||
48264124|NCT00362375|100970705|FG001|STARTED|Overall Study||152||
48264125|NCT00362375|100970704|FG000|COMPLETED|Overall Study||121||
48264126|NCT00362375|100970705|FG001|COMPLETED|Overall Study||117||
48264127|NCT00362375|100970704|FG000|NOT COMPLETED|Overall Study||40||
48264128|NCT00362375|100970705|FG001|NOT COMPLETED|Overall Study||35||
48264129|NCT02375347|100970706|FG000|STARTED|Overall Study||13||
48264130|NCT02375347|100970706|FG000|COMPLETED|Overall Study||12||
48264131|NCT02375347|100970706|FG000|NOT COMPLETED|Overall Study||1||
48390913|NCT00168064|101283651|FG001|NOT COMPLETED|Overall Study||44||
48264132|NCT01790295|100970707|FG000|STARTED|Overall Study||21||
48264133|NCT01790295|100970707|FG000|COMPLETED|Overall Study||10||
48264134|NCT01790295|100970707|FG000|NOT COMPLETED|Overall Study||11||
48264135|NCT01177956|100970708|FG000|STARTED|Overall Study||68||
48264136|NCT01177956|100970708|FG000|COMPLETED|Overall Study||68||
48390914|NCT00949910|101287544|FG000|STARTED|Overall Study||6586||
48264137|NCT01177956|100970708|FG000|NOT COMPLETED|Overall Study||0||
48264138|NCT03339271|100970709|FG000|STARTED|Overall Study||195||
48264139|NCT03339271|100970710|FG001|STARTED|Overall Study||189||
48390915|NCT00949910|101287544|FG000|COMPLETED|Overall Study||10||
48547547|NCT02565511|101675187|FG001|NOT COMPLETED|Overall Study||23||
48547548|NCT02565511|101675188|FG002|NOT COMPLETED|Overall Study||251||
48547549|NCT02565511|101675189|FG003|NOT COMPLETED|Overall Study||164||
48547550|NCT01199380|101675190|FG000|STARTED|Overall Study||88||
48264140|NCT03339271|100970709|FG000|COMPLETED|Overall Study||195||
48264141|NCT03339271|100970710|FG001|COMPLETED|Overall Study||189||
48264142|NCT03339271|100970709|FG000|NOT COMPLETED|Overall Study||0||
48264143|NCT03339271|100970710|FG001|NOT COMPLETED|Overall Study||0||
48264144|NCT00905034|100970711|FG000|STARTED|Overall Study||37||
48264145|NCT00905034|100970711|FG000|COMPLETED|Overall Study||36||
48264146|NCT00905034|100970711|FG000|NOT COMPLETED|Overall Study||1||
48264147|NCT03267810|100970712|FG000|STARTED|Overall Study||13||
48264148|NCT03267810|100970713|FG001|STARTED|Overall Study||13||
48264149|NCT03267810|100970712|FG000|COMPLETED|Overall Study||10||
48264150|NCT03267810|100970713|FG001|COMPLETED|Overall Study||12||
48264151|NCT03267810|100970712|FG000|NOT COMPLETED|Overall Study||3||
48264152|NCT03267810|100970713|FG001|NOT COMPLETED|Overall Study||1||
48264153|NCT00913523|100970714|FG000|STARTED|Overall Study||162||
48264154|NCT00913523|100970715|FG001|STARTED|Overall Study||159||
48264155|NCT00913523|100970716|FG002|STARTED|Overall Study||161||
48264156|NCT00913523|100970714|FG000|COMPLETED|Overall Study||144||
48264157|NCT00913523|100970715|FG001|COMPLETED|Overall Study||143||
48264158|NCT00913523|100970716|FG002|COMPLETED|Overall Study||147||
48264159|NCT00913523|100970714|FG000|NOT COMPLETED|Overall Study||18||
48264160|NCT00913523|100970715|FG001|NOT COMPLETED|Overall Study||16||
48264161|NCT00913523|100970716|FG002|NOT COMPLETED|Overall Study||14||
48264162|NCT02232399|100970717|FG000|STARTED|Overall Study||39||
48264163|NCT02232399|100970718|FG001|STARTED|Overall Study||33||
48264164|NCT02232399|100970717|FG000|COMPLETED|Overall Study||38||
48264165|NCT02232399|100970718|FG001|COMPLETED|Overall Study||32||
48264166|NCT02232399|100970717|FG000|NOT COMPLETED|Overall Study||1||
48264167|NCT02232399|100970718|FG001|NOT COMPLETED|Overall Study||1||
48264168|NCT01781832|100970719|FG000|STARTED|Overall Study||26||
48264169|NCT01781832|100970719|FG000|COMPLETED|Overall Study||25||
48264170|NCT01781832|100970719|FG000|NOT COMPLETED|Overall Study||1||
48264171|NCT01939353|100970720|FG000|STARTED|Placebo Run-in (1 Week)||45||
48264172|NCT01939353|100970720|FG000|COMPLETED|Placebo Run-in (1 Week)||41||
48390916|NCT00949910|101287544|FG000|NOT COMPLETED|Overall Study||6576||
48547551|NCT01199380|101675191|FG001|STARTED|Overall Study||96||
48547552|NCT01199380|101675190|FG000|COMPLETED|Overall Study||78||
48547553|NCT01199380|101675191|FG001|COMPLETED|Overall Study||81||
48547554|NCT01199380|101675190|FG000|NOT COMPLETED|Overall Study||10||
48547555|NCT01199380|101675191|FG001|NOT COMPLETED|Overall Study||15||
48264173|NCT01939353|100970720|FG000|NOT COMPLETED|Placebo Run-in (1 Week)||4||
48264174|NCT01939353|100970720|FG000|STARTED|CTN SR Treatment Phase (4 Weeks)||41||
48264175|NCT01939353|100970720|FG000|COMPLETED|CTN SR Treatment Phase (4 Weeks)||37||
48264176|NCT01939353|100970720|FG000|NOT COMPLETED|CTN SR Treatment Phase (4 Weeks)||4||
48264177|NCT04312256|100970721|FG000|STARTED|Overall Study||81||
48264178|NCT04312256|100970721|FG000|COMPLETED|Overall Study||81||
48264179|NCT04312256|100970721|FG000|NOT COMPLETED|Overall Study||0||
48264180|NCT01163474|100970722|FG000|STARTED|Overall Study||40||
48264181|NCT01163474|100970722|FG000|COMPLETED|Overall Study||24||
48264182|NCT01163474|100970722|FG000|NOT COMPLETED|Overall Study||16||
48264183|NCT03124693|100970723|FG000|STARTED|Overall Study||90||
48264184|NCT03124693|100970723|FG000|COMPLETED|Overall Study||90||
48264185|NCT03124693|100970723|FG000|NOT COMPLETED|Overall Study||0||
48264186|NCT00147277|100970724|FG000|STARTED|Overall Study||475||
48390917|NCT03746808|101287545|FG000|STARTED|Overall Study||78||
48390918|NCT03746808|101287546|FG001|STARTED|Overall Study||41||
48390919|NCT03746808|101287545|FG000|COMPLETED|Overall Study||71||
48390920|NCT03746808|101287546|FG001|COMPLETED|Overall Study||34||
48264187|NCT00147277|100970725|FG001|STARTED|Overall Study||450||
48264188|NCT00147277|100970724|FG000|COMPLETED|Overall Study||475||
48264189|NCT00147277|100970725|FG001|COMPLETED|Overall Study||450||
48264190|NCT00147277|100970724|FG000|NOT COMPLETED|Overall Study||0||
48264191|NCT00147277|100970725|FG001|NOT COMPLETED|Overall Study||0||
48264192|NCT00781937|100970726|FG000|STARTED|Main Trial Period Through Week 56||212||
48264193|NCT00781937|100970727|FG001|STARTED|Main Trial Period Through Week 56||210||
48264194|NCT00781937|100970726|FG000|COMPLETED|Main Trial Period Through Week 56||159||
48264195|NCT00781937|100970727|FG001|COMPLETED|Main Trial Period Through Week 56||146||
48264196|NCT00781937|100970726|FG000|NOT COMPLETED|Main Trial Period Through Week 56||53||
48264197|NCT00781937|100970727|FG001|NOT COMPLETED|Main Trial Period Through Week 56||64||
48264198|NCT00781937|100970726|FG000|STARTED|Follow up Period (Week 56-68)||159||
48264199|NCT00781937|100970727|FG001|STARTED|Follow up Period (Week 56-68)||146||
48264200|NCT00781937|100970726|FG000|COMPLETED|Follow up Period (Week 56-68)||153||
48264201|NCT00781937|100970727|FG001|COMPLETED|Follow up Period (Week 56-68)||141||
48264202|NCT00781937|100970726|FG000|NOT COMPLETED|Follow up Period (Week 56-68)||6||
48264203|NCT00781937|100970727|FG001|NOT COMPLETED|Follow up Period (Week 56-68)||5||
48264204|NCT03513068|100970728|FG000|STARTED|Overall Study||54||
48390921|NCT03746808|101287545|FG000|NOT COMPLETED|Overall Study||7||
48390922|NCT03746808|101287546|FG001|NOT COMPLETED|Overall Study||7||
48547556|NCT00486525|101675192|FG000|STARTED|Overall Study||100||
48547557|NCT00486525|101675193|FG001|STARTED|Overall Study||100||
48547558|NCT00486525|101675192|FG000|COMPLETED|Overall Study||94||
48547559|NCT00486525|101675193|FG001|COMPLETED|Overall Study||87||
48547560|NCT00486525|101675192|FG000|NOT COMPLETED|Overall Study||6||
48547561|NCT00486525|101675193|FG001|NOT COMPLETED|Overall Study||13||
48547562|NCT00822692|101675194|FG000|STARTED|Overall Study||63||
48547563|NCT00822692|101675195|FG001|STARTED|Overall Study||76||
48547564|NCT00822692|101675194|FG000|COMPLETED|Overall Study||46||
48547565|NCT00822692|101675195|FG001|COMPLETED|Overall Study||51||
48547566|NCT00822692|101675194|FG000|NOT COMPLETED|Overall Study||17||
48547567|NCT00822692|101675195|FG001|NOT COMPLETED|Overall Study||25||
48547568|NCT00717288|101675196|FG000|STARTED|Overall Study||28||
48390923|NCT01788150|101287547|FG000|STARTED|Overall Study||108||
48390924|NCT01788150|101287548|FG001|STARTED|Overall Study||51||
48390925|NCT01788150|101287547|FG000|COMPLETED|Overall Study||95||
48390926|NCT01788150|101287548|FG001|COMPLETED|Overall Study||48||
48390927|NCT01788150|101287547|FG000|NOT COMPLETED|Overall Study||13||
48390928|NCT01788150|101287548|FG001|NOT COMPLETED|Overall Study||3||
48390929|NCT00749268|101287549|FG000|STARTED|Overall Study||106||
48390930|NCT00749268|101287550|FG001|STARTED|Overall Study||110||
48390931|NCT00749268|101287549|FG000|COMPLETED|Overall Study||72||
48390932|NCT00749268|101287550|FG001|COMPLETED|Overall Study||74||
48390933|NCT00749268|101287549|FG000|NOT COMPLETED|Overall Study||34||
48390934|NCT00749268|101287550|FG001|NOT COMPLETED|Overall Study||36||
48390935|NCT01641991|101287551|FG000|STARTED|Overall Study||82||
48390936|NCT01641991|101287552|FG001|STARTED|Overall Study||82||
48390937|NCT01641991|101287553|FG002|STARTED|Overall Study||82||
48390938|NCT01641991|101287554|FG003|STARTED|Overall Study||82||
48390939|NCT01641991|101287551|FG000|COMPLETED|Overall Study||73||
48390940|NCT01641991|101287552|FG001|COMPLETED|Overall Study||74||
48101268|NCT01163279|100575286|FG000|STARTED|Overall Study||10||
48101269|NCT01163279|100575287|FG001|STARTED|Overall Study||9||
48101270|NCT01163279|100575286|FG000|COMPLETED|Overall Study||8||
48101271|NCT01163279|100575287|FG001|COMPLETED|Overall Study||9||
48101272|NCT01163279|100575286|FG000|NOT COMPLETED|Overall Study||2||
48101273|NCT01163279|100575287|FG001|NOT COMPLETED|Overall Study||0||
48101274|NCT01556581|100575288|FG000|STARTED|Overall Study||61||
48101275|NCT01556581|100575289|FG001|STARTED|Overall Study||58||
48101276|NCT01556581|100575288|FG000|COMPLETED|Overall Study||61||
48101277|NCT01556581|100575289|FG001|COMPLETED|Overall Study||58||
48101278|NCT01556581|100575288|FG000|NOT COMPLETED|Overall Study||0||
48101279|NCT01556581|100575289|FG001|NOT COMPLETED|Overall Study||0||
48101280|NCT02517996|100575290|FG000|STARTED|Overall Study||8||
48101281|NCT02517996|100575291|FG001|STARTED|Overall Study||9||
48101282|NCT02517996|100575290|FG000|COMPLETED|Overall Study||8||
48101283|NCT02517996|100575291|FG001|COMPLETED|Overall Study||9||
48101284|NCT02517996|100575290|FG000|NOT COMPLETED|Overall Study||0||
48101285|NCT02517996|100575291|FG001|NOT COMPLETED|Overall Study||0||
48101286|NCT04809220|100575292|FG000|STARTED|Overall Study||395||
48101287|NCT04809220|100575293|FG001|STARTED|Overall Study||196||
48101288|NCT04809220|100575292|FG000|Exposed to at Least 1 Dose of Study Intervention (Excluding the GCP Compliance Investigative Site)|Overall Study||391||
48101289|NCT04809220|100575293|FG001|Exposed to at Least 1 Dose of Study Intervention (Excluding the GCP Compliance Investigative Site)|Overall Study||195||
48101290|NCT04809220|100575292|FG000|COMPLETED|Overall Study||377||
48101291|NCT04809220|100575293|FG001|COMPLETED|Overall Study||190||
48101292|NCT04809220|100575292|FG000|NOT COMPLETED|Overall Study||18||
48101293|NCT04809220|100575293|FG001|NOT COMPLETED|Overall Study||6||
48101294|NCT04127786|100575294|FG000|STARTED|Primary Series||607||
48101295|NCT04127786|100575295|FG001|STARTED|Primary Series||203||
48101296|NCT04127786|100575296|FG002|STARTED|Primary Series||200||
48101297|NCT04127786|100575297|FG003|STARTED|Primary Series||420||
48101298|NCT04127786|100575298|FG004|STARTED|Primary Series||139||
48101299|NCT04127786|100575299|FG005|STARTED|Primary Series||139||
48101300|NCT04127786|100575294|FG000|Safety Analysis Set (SafAS)|Primary Series||607|SafAS included participant who had received at least one dose of the study vaccine and were analyzed according to the actual treatment received.|
48101301|NCT04127786|100575295|FG001|Safety Analysis Set (SafAS)|Primary Series||202|SafAS included participant who had received at least one dose of the study vaccine and were analyzed according to the actual treatment received.|
48101302|NCT04127786|100575296|FG002|Safety Analysis Set (SafAS)|Primary Series||200|SafAS included participant who had received at least one dose of the study vaccine and were analyzed according to the actual treatment received.|
48101303|NCT04127786|100575297|FG003|Safety Analysis Set (SafAS)|Primary Series||419|SafAS included participant who had received at least one dose of the study vaccine and were analyzed according to the actual treatment received.|
48101304|NCT04127786|100575298|FG004|Safety Analysis Set (SafAS)|Primary Series||139|SafAS included participant who had received at least one dose of the study vaccine and were analyzed according to the actual treatment received.|
48101305|NCT04127786|100575299|FG005|Safety Analysis Set (SafAS)|Primary Series||139|SafAS included participant who had received at least one dose of the study vaccine and were analyzed according to the actual treatment received.|
48141392|NCT04764396|100670417|FG000|NOT COMPLETED|Overall Study||1||
48390941|NCT01641991|101287553|FG002|COMPLETED|Overall Study||65||
48390942|NCT01641991|101287554|FG003|COMPLETED|Overall Study||66||
48390943|NCT01641991|101287551|FG000|NOT COMPLETED|Overall Study||9||
48390944|NCT01641991|101287552|FG001|NOT COMPLETED|Overall Study||8||
48390945|NCT01641991|101287553|FG002|NOT COMPLETED|Overall Study||17||
48390946|NCT01641991|101287554|FG003|NOT COMPLETED|Overall Study||16||
48547569|NCT00717288|101675197|FG001|STARTED|Overall Study||29||
48547570|NCT00717288|101675198|FG002|STARTED|Overall Study||25||
48547571|NCT00717288|101675196|FG000|COMPLETED|Overall Study||28||
48547572|NCT00717288|101675197|FG001|COMPLETED|Overall Study||29||
48101306|NCT04127786|100575294|FG000|Per-protocol Analysis Set (PPAS) for Day 28|Primary Series||519|PPAS for Day 28 included all participants who received at least 1 dose of the study vaccine in the primary series, with no relevant protocol deviation before Day 28.|
48691122|NCT01268046|102026013|FG003|COMPLETED|Overall Study||7||
48691123|NCT01268046|102026010|FG000|NOT COMPLETED|Overall Study||1||
48691124|NCT01268046|102026011|FG001|NOT COMPLETED|Overall Study||0||
48691125|NCT01268046|102026012|FG002|NOT COMPLETED|Overall Study||1||
48691126|NCT01268046|102026013|FG003|NOT COMPLETED|Overall Study||1||
48691127|NCT03024112|102026014|FG000|STARTED|Overall Study||25||
48691128|NCT03024112|102026015|FG001|STARTED|Overall Study||26||
48691129|NCT03024112|102026014|FG000|COMPLETED|Overall Study||18||
48691130|NCT03024112|102026015|FG001|COMPLETED|Overall Study||26||
48691131|NCT03024112|102026014|FG000|NOT COMPLETED|Overall Study||7||
48101307|NCT04127786|100575295|FG001|Per-protocol Analysis Set (PPAS) for Day 28|Primary Series||169|PPAS for Day 28 included all participants who received at least 1 dose of the study vaccine in the primary series, with no relevant protocol deviation before Day 28.|
48101308|NCT04127786|100575296|FG002|Per-protocol Analysis Set (PPAS) for Day 28|Primary Series||160|PPAS for Day 28 included all participants who received at least 1 dose of the study vaccine in the primary series, with no relevant protocol deviation before Day 28.|
48101309|NCT04127786|100575297|FG003|Per-protocol Analysis Set (PPAS) for Day 28|Primary Series||342|PPAS for Day 28 included all participants who received at least 1 dose of the study vaccine in the primary series, with no relevant protocol deviation before Day 28.|
48101310|NCT04127786|100575298|FG004|Per-protocol Analysis Set (PPAS) for Day 28|Primary Series||120|PPAS for Day 28 included all participants who received at least 1 dose of the study vaccine in the primary series, with no relevant protocol deviation before Day 28.|
48101311|NCT04127786|100575299|FG005|Per-protocol Analysis Set (PPAS) for Day 28|Primary Series||124|PPAS for Day 28 included all participants who received at least 1 dose of the study vaccine in the primary series, with no relevant protocol deviation before Day 28.|
48101312|NCT04127786|100575294|FG000|COMPLETED|Primary Series||599|Completed the active phase of Primary series.|
48101313|NCT04127786|100575295|FG001|COMPLETED|Primary Series||199|Completed the active phase of Primary series.|
48101314|NCT04127786|100575296|FG002|COMPLETED|Primary Series||196|Completed the active phase of Primary series.|
48101315|NCT04127786|100575297|FG003|COMPLETED|Primary Series||415|Completed the active phase of Primary series.|
48101316|NCT04127786|100575298|FG004|COMPLETED|Primary Series||137|Completed the active phase of Primary series.|
48101317|NCT04127786|100575299|FG005|COMPLETED|Primary Series||138|Completed the active phase of Primary series.|
48101318|NCT04127786|100575294|FG000|NOT COMPLETED|Primary Series||8||
48101319|NCT04127786|100575295|FG001|NOT COMPLETED|Primary Series||4||
48101320|NCT04127786|100575296|FG002|NOT COMPLETED|Primary Series||4||
48101321|NCT04127786|100575297|FG003|NOT COMPLETED|Primary Series||5||
48101322|NCT04127786|100575298|FG004|NOT COMPLETED|Primary Series||2||
48101323|NCT04127786|100575299|FG005|NOT COMPLETED|Primary Series||1||
48101324|NCT04127786|100575294|FG000|STARTED|Booster Phase||94||
48101325|NCT04127786|100575295|FG001|STARTED|Booster Phase||31||
48101326|NCT04127786|100575296|FG002|STARTED|Booster Phase||32||
48101327|NCT04127786|100575297|FG003|STARTED|Booster Phase||0||
48101328|NCT04127786|100575298|FG004|STARTED|Booster Phase||0||
48101329|NCT04127786|100575299|FG005|STARTED|Booster Phase||0||
48101330|NCT04127786|100575294|FG000|SafAS|Booster Phase||94||
48101331|NCT04127786|100575295|FG001|SafAS|Booster Phase||31||
48101332|NCT04127786|100575296|FG002|SafAS|Booster Phase||32||
48101333|NCT04127786|100575297|FG003|SafAS|Booster Phase||0||
48101334|NCT04127786|100575298|FG004|SafAS|Booster Phase||0||
48101335|NCT04127786|100575299|FG005|SafAS|Booster Phase||0||
48101336|NCT04127786|100575294|FG000|COMPLETED|Booster Phase||92|Completed the active phase of Booster Phase of Cohort 1.|
48101337|NCT04127786|100575295|FG001|COMPLETED|Booster Phase||31|Completed the active phase of Booster Phase of Cohort 1.|
48101338|NCT04127786|100575296|FG002|COMPLETED|Booster Phase||32|Completed the active phase of Booster Phase of Cohort 1.|
48101339|NCT04127786|100575297|FG003|COMPLETED|Booster Phase||0|Completed the active phase of Booster Phase of Cohort 1.|
48101340|NCT04127786|100575298|FG004|COMPLETED|Booster Phase||0|Completed the active phase of Booster Phase of Cohort 1.|
48101341|NCT04127786|100575299|FG005|COMPLETED|Booster Phase||0|Completed the active phase of Booster Phase of Cohort 1.|
48101342|NCT04127786|100575294|FG000|NOT COMPLETED|Booster Phase||2||
48101343|NCT04127786|100575295|FG001|NOT COMPLETED|Booster Phase||0||
48101344|NCT04127786|100575296|FG002|NOT COMPLETED|Booster Phase||0||
48101345|NCT04127786|100575297|FG003|NOT COMPLETED|Booster Phase||0||
48101346|NCT04127786|100575298|FG004|NOT COMPLETED|Booster Phase||0||
48101347|NCT04127786|100575299|FG005|NOT COMPLETED|Booster Phase||0||
48101348|NCT01770483|100575300|FG000|STARTED|Overall Study||33||
48101349|NCT01770483|100575301|FG001|STARTED|Overall Study||33||
48101350|NCT01770483|100575300|FG000|COMPLETED|Overall Study||33||
48101351|NCT01770483|100575301|FG001|COMPLETED|Overall Study||33||
48101352|NCT01770483|100575300|FG000|NOT COMPLETED|Overall Study||0||
48101353|NCT01770483|100575301|FG001|NOT COMPLETED|Overall Study||0||
48101354|NCT00657241|100575302|FG000|STARTED|Overall Study||15||
48101355|NCT00657241|100575303|FG001|STARTED|Overall Study||15||
48101356|NCT00657241|100575302|FG000|COMPLETED|Overall Study||15||
48101357|NCT00657241|100575303|FG001|COMPLETED|Overall Study||15||
48101358|NCT00657241|100575302|FG000|NOT COMPLETED|Overall Study||0||
48264205|NCT03513068|100970729|FG001|STARTED|Overall Study||54||
48264206|NCT03513068|100970728|FG000|COMPLETED|Overall Study||49||
48691132|NCT03024112|102026015|FG001|NOT COMPLETED|Overall Study||0||
48264207|NCT03513068|100970729|FG001|COMPLETED|Overall Study||48||
48264208|NCT03513068|100970728|FG000|NOT COMPLETED|Overall Study||5||
48264209|NCT03513068|100970729|FG001|NOT COMPLETED|Overall Study||6||
48264210|NCT00633945|100970730|FG000|STARTED|Overall Study||5||
48264211|NCT00633945|100970730|FG000|COMPLETED|Overall Study||3||
48264212|NCT00633945|100970730|FG000|NOT COMPLETED|Overall Study||2||
48264213|NCT01296555|100970731|FG000|STARTED|Overall Study||6||
48264214|NCT01296555|100970732|FG001|STARTED|Overall Study||3||
48264215|NCT01296555|100970733|FG002|STARTED|Overall Study||4||
48264216|NCT01296555|100970734|FG003|STARTED|Overall Study||10||
48264217|NCT01296555|100970735|FG004|STARTED|Overall Study||11||
48264218|NCT01296555|100970736|FG005|STARTED|Overall Study||20||
48691133|NCT03265145|102026016|FG000|STARTED|Overall Study||356||
48691134|NCT03265145|102026017|FG001|STARTED|Overall Study||358||
48264219|NCT01296555|100970737|FG006|STARTED|Overall Study||20||
48264220|NCT01296555|100970738|FG007|STARTED|Overall Study||13||
48264221|NCT01296555|100970739|FG008|STARTED|Overall Study||10||
48264222|NCT01296555|100970740|FG009|STARTED|Overall Study||20||
48264223|NCT01296555|100970741|FG010|STARTED|Overall Study||8||
48264224|NCT01296555|100970742|FG011|STARTED|Overall Study||21||
48264225|NCT01296555|100970743|FG012|STARTED|Overall Study||6||
48264226|NCT01296555|100970744|FG013|STARTED|Overall Study||21||
48264227|NCT01296555|100970745|FG014|STARTED|Overall Study||35||
48264228|NCT01296555|100970746|FG015|STARTED|Overall Study||20||
48547573|NCT00717288|101675198|FG002|COMPLETED|Overall Study||25||
48547574|NCT00717288|101675196|FG000|NOT COMPLETED|Overall Study||0||
48547575|NCT00717288|101675197|FG001|NOT COMPLETED|Overall Study||0||
48264229|NCT01296555|100970747|FG016|STARTED|Overall Study||20||
48264230|NCT01296555|100970748|FG017|STARTED|Overall Study||19||
48264231|NCT01296555|100970749|FG018|STARTED|Overall Study||20||
48264232|NCT01296555|100970750|FG019|STARTED|Overall Study||27||
48264233|NCT01296555|100970751|FG020|STARTED|Overall Study||28||
48264234|NCT01296555|100970752|FG021|STARTED|Overall Study||20||
48264235|NCT01296555|100970753|FG022|STARTED|Overall Study||20||
48264236|NCT01296555|100970754|FG023|STARTED|Overall Study||20||
48264237|NCT01296555|100970755|FG024|STARTED|Overall Study||10||
48264238|NCT01296555|100970756|FG025|STARTED|Overall Study||10||
48264239|NCT01296555|100970757|FG026|STARTED|Overall Study||70||
48264240|NCT01296555|100970758|FG027|STARTED|Overall Study||122||
48264241|NCT01296555|100970759|FG028|STARTED|Overall Study||60||
48264242|NCT01296555|100970731|FG000|COMPLETED|Overall Study||0||
48264243|NCT01296555|100970732|FG001|COMPLETED|Overall Study||0||
48547576|NCT00717288|101675198|FG002|NOT COMPLETED|Overall Study||0||
48547577|NCT03277066|101675199|FG000|STARTED|Overall Study||71||
48691135|NCT03265145|102026016|FG000|COMPLETED|Overall Study||285|12 Month Study Observation Period|
48691136|NCT03265145|102026017|FG001|COMPLETED|Overall Study||302|12 Month Study Observation Period|
48264244|NCT01296555|100970733|FG002|COMPLETED|Overall Study||0||
48264245|NCT01296555|100970734|FG003|COMPLETED|Overall Study||0||
48264246|NCT01296555|100970735|FG004|COMPLETED|Overall Study||0||
48264247|NCT01296555|100970736|FG005|COMPLETED|Overall Study||0||
48264248|NCT01296555|100970737|FG006|COMPLETED|Overall Study||0||
48264249|NCT01296555|100970738|FG007|COMPLETED|Overall Study||0||
48264250|NCT01296555|100970739|FG008|COMPLETED|Overall Study||0||
48264251|NCT01296555|100970740|FG009|COMPLETED|Overall Study||0||
48264252|NCT01296555|100970741|FG010|COMPLETED|Overall Study||0||
48264253|NCT01296555|100970742|FG011|COMPLETED|Overall Study||1||
48264254|NCT01296555|100970743|FG012|COMPLETED|Overall Study||0||
48264255|NCT01296555|100970744|FG013|COMPLETED|Overall Study||0||
48264256|NCT01296555|100970745|FG014|COMPLETED|Overall Study||0||
48264257|NCT01296555|100970746|FG015|COMPLETED|Overall Study||0||
48264258|NCT01296555|100970747|FG016|COMPLETED|Overall Study||0||
48264259|NCT01296555|100970748|FG017|COMPLETED|Overall Study||1||
48264260|NCT01296555|100970749|FG018|COMPLETED|Overall Study||0||
48264261|NCT01296555|100970750|FG019|COMPLETED|Overall Study||0||
48264262|NCT01296555|100970751|FG020|COMPLETED|Overall Study||0||
48264263|NCT01296555|100970752|FG021|COMPLETED|Overall Study||0||
48264264|NCT01296555|100970753|FG022|COMPLETED|Overall Study||0||
48264265|NCT01296555|100970754|FG023|COMPLETED|Overall Study||0||
48264266|NCT01296555|100970755|FG024|COMPLETED|Overall Study||0||
48264267|NCT01296555|100970756|FG025|COMPLETED|Overall Study||0||
48264268|NCT01296555|100970757|FG026|COMPLETED|Overall Study||0||
48264269|NCT01296555|100970758|FG027|COMPLETED|Overall Study||1||
48264270|NCT01296555|100970759|FG028|COMPLETED|Overall Study||0||
48264271|NCT01296555|100970731|FG000|NOT COMPLETED|Overall Study||6||
48264272|NCT01296555|100970732|FG001|NOT COMPLETED|Overall Study||3||
48547578|NCT03277066|101675200|FG001|STARTED|Overall Study||72||
48547579|NCT03277066|101675201|FG002|STARTED|Overall Study||146||
48264273|NCT01296555|100970733|FG002|NOT COMPLETED|Overall Study||4||
48264274|NCT01296555|100970734|FG003|NOT COMPLETED|Overall Study||10||
48592722|NCT02143791|101783167|FG000|NOT COMPLETED|Burst Stimulation Only (3 Months)||8||
48592723|NCT02143791|101783167|FG000|STARTED|Any Programming (3-6 Months)||92||
48264275|NCT01296555|100970735|FG004|NOT COMPLETED|Overall Study||11||
48264276|NCT01296555|100970736|FG005|NOT COMPLETED|Overall Study||20||
48264277|NCT01296555|100970737|FG006|NOT COMPLETED|Overall Study||20||
48264278|NCT01296555|100970738|FG007|NOT COMPLETED|Overall Study||13||
48264279|NCT01296555|100970739|FG008|NOT COMPLETED|Overall Study||10||
48264280|NCT01296555|100970740|FG009|NOT COMPLETED|Overall Study||20||
48264281|NCT01296555|100970741|FG010|NOT COMPLETED|Overall Study||8||
48264282|NCT01296555|100970742|FG011|NOT COMPLETED|Overall Study||20||
48264283|NCT01296555|100970743|FG012|NOT COMPLETED|Overall Study||6||
48264284|NCT01296555|100970744|FG013|NOT COMPLETED|Overall Study||21||
48264285|NCT01296555|100970745|FG014|NOT COMPLETED|Overall Study||35||
48264286|NCT01296555|100970746|FG015|NOT COMPLETED|Overall Study||20||
48264287|NCT01296555|100970747|FG016|NOT COMPLETED|Overall Study||20||
48264288|NCT01296555|100970748|FG017|NOT COMPLETED|Overall Study||18||
48264289|NCT01296555|100970749|FG018|NOT COMPLETED|Overall Study||20||
48264290|NCT01296555|100970750|FG019|NOT COMPLETED|Overall Study||27||
48264291|NCT01296555|100970751|FG020|NOT COMPLETED|Overall Study||28||
48264292|NCT01296555|100970752|FG021|NOT COMPLETED|Overall Study||20||
48264293|NCT01296555|100970753|FG022|NOT COMPLETED|Overall Study||20||
48264294|NCT01296555|100970754|FG023|NOT COMPLETED|Overall Study||20||
48264295|NCT01296555|100970755|FG024|NOT COMPLETED|Overall Study||10||
48264296|NCT01296555|100970756|FG025|NOT COMPLETED|Overall Study||10||
48264297|NCT01296555|100970757|FG026|NOT COMPLETED|Overall Study||70||
48264298|NCT01296555|100970758|FG027|NOT COMPLETED|Overall Study||121||
48264299|NCT01296555|100970759|FG028|NOT COMPLETED|Overall Study||60||
48264300|NCT00566813|100970760|FG000|STARTED|Overall Study||4||
48264301|NCT00566813|100970761|FG001|STARTED|Overall Study||6||
48264302|NCT00566813|100970760|FG000|COMPLETED|Overall Study||4||
48264303|NCT00566813|100970761|FG001|COMPLETED|Overall Study||6||
48264304|NCT00566813|100970760|FG000|NOT COMPLETED|Overall Study||0||
48264305|NCT00566813|100970761|FG001|NOT COMPLETED|Overall Study||0||
48264306|NCT02229227|100970762|FG000|STARTED|Overall Study||402||
48264307|NCT02229227|100970763|FG001|STARTED|Overall Study||412||
48264308|NCT02229227|100970762|FG000|COMPLETED|Overall Study||351||
48264309|NCT02229227|100970763|FG001|COMPLETED|Overall Study||350||
48264310|NCT02229227|100970762|FG000|NOT COMPLETED|Overall Study||51||
48264311|NCT02229227|100970763|FG001|NOT COMPLETED|Overall Study||62||
48264312|NCT01889069|100970764|FG000|STARTED|Overall Study||158|All Enrolled Participants|
48264313|NCT01889069|100970764|FG000|COMPLETED|Overall Study||113||
48264314|NCT01889069|100970764|FG000|NOT COMPLETED|Overall Study||45||
48264315|NCT01077128|100970765|FG000|STARTED|Overall Study||500||
48264316|NCT01077128|100970765|FG000|COMPLETED|Overall Study||433||
48264317|NCT01077128|100970765|FG000|NOT COMPLETED|Overall Study||67||
48264318|NCT04831047|100970766|FG000|STARTED|Overall Study||57||
48264319|NCT04831047|100970767|FG001|STARTED|Overall Study||57||
48264320|NCT04831047|100970766|FG000|COMPLETED|Overall Study||57||
48264321|NCT04831047|100970767|FG001|COMPLETED|Overall Study||57||
48264322|NCT04831047|100970766|FG000|NOT COMPLETED|Overall Study||0||
48264323|NCT04831047|100970767|FG001|NOT COMPLETED|Overall Study||0||
48264324|NCT00727740|100970768|FG000|STARTED|Overall Study||56||
48264325|NCT00727740|100970769|FG001|STARTED|Overall Study||61||
48264326|NCT00727740|100970768|FG000|COMPLETED|Overall Study||56||
48264327|NCT00727740|100970769|FG001|COMPLETED|Overall Study||61||
48264328|NCT00727740|100970768|FG000|NOT COMPLETED|Overall Study||0||
48264329|NCT00727740|100970769|FG001|NOT COMPLETED|Overall Study||0||
48264330|NCT05000047|100970770|FG000|STARTED|Overall Study||30||
48264331|NCT05000047|100970770|FG000|COMPLETED|Overall Study||30||
48264332|NCT05000047|100970770|FG000|NOT COMPLETED|Overall Study||0||
48264333|NCT02046512|100970771|FG000|STARTED|Overall Study||45||
48264334|NCT02046512|100970772|FG001|STARTED|Overall Study||44||
48264335|NCT02046512|100970771|FG000|COMPLETED|Overall Study||44||
48264336|NCT02046512|100970772|FG001|COMPLETED|Overall Study||44||
48264337|NCT02046512|100970771|FG000|NOT COMPLETED|Overall Study||1||
48264338|NCT02046512|100970772|FG001|NOT COMPLETED|Overall Study||0||
48264339|NCT02659098|100970773|FG000|STARTED|Overall Study||21||
48264340|NCT02659098|100970773|FG000|COMPLETED|Overall Study||14||
48264341|NCT02659098|100970773|FG000|NOT COMPLETED|Overall Study||7||
48264342|NCT04403542|100970774|FG000|STARTED|Overall Study||18||36
48264343|NCT04403542|100970775|FG001|STARTED|Overall Study||18||36
48264344|NCT04403542|100970774|FG000|COMPLETED|Overall Study||18||36
48390947|NCT02223429|101287555|FG000|STARTED|Overall Study||8||
48264345|NCT04403542|100970775|FG001|COMPLETED|Overall Study||18||36
48264346|NCT04403542|100970774|FG000|NOT COMPLETED|Overall Study||0||0
48264347|NCT04403542|100970775|FG001|NOT COMPLETED|Overall Study||0||0
48264348|NCT04069585|100970776|FG000|STARTED|Overall Study||30||
48264349|NCT04069585|100970776|FG000|COMPLETED|Overall Study||30||
48264350|NCT04069585|100970776|FG000|NOT COMPLETED|Overall Study||0||
48390948|NCT02223429|101287556|FG001|STARTED|Overall Study||8||
48264351|NCT01850030|100970777|FG000|STARTED|Overall Study||520||
48264352|NCT01850030|100970778|FG001|STARTED|Overall Study||511||
48264353|NCT01850030|100970777|FG000|COMPLETED|Overall Study||173||
48264354|NCT01850030|100970778|FG001|COMPLETED|Overall Study||142||
48264355|NCT01850030|100970777|FG000|NOT COMPLETED|Overall Study||347||
48264356|NCT01850030|100970778|FG001|NOT COMPLETED|Overall Study||369||
48264357|NCT01896726|100970779|FG000|STARTED|Treatment Period 1 (Days 1-22)||20||
48264358|NCT01896726|100970779|FG000|Received Microgynon|Treatment Period 1 (Days 1-22)||20||
48264359|NCT01896726|100970779|FG000|COMPLETED|Treatment Period 1 (Days 1-22)||20||
48547580|NCT03277066|101675199|FG000|COMPLETED|Overall Study||69|These numbers are the Full Analysis Set population include all randomized subjects who have had at least 1 patch of double-blind study drug applied and who have at least 1 post-baseline assessment of the primary efficacy measure.|
48547581|NCT03277066|101675200|FG001|COMPLETED|Overall Study||71|These numbers are the Full Analysis Set population include all randomized subjects who have had at least 1 patch of double-blind study drug applied and who have at least 1 post-baseline assessment of the primary efficacy measure.|
48547582|NCT03277066|101675201|FG002|COMPLETED|Overall Study||143|These numbers are the Full Analysis Set population include all randomized subjects who have had at least 1 patch of double-blind study drug applied and who have at least 1 post-baseline assessment of the primary efficacy measure.|
48547583|NCT03277066|101675199|FG000|NOT COMPLETED|Overall Study||2||
48547584|NCT03277066|101675200|FG001|NOT COMPLETED|Overall Study||1||
48547585|NCT03277066|101675201|FG002|NOT COMPLETED|Overall Study||3||
48547586|NCT03180645|101675202|FG000|STARTED|Overall Study||24||
48547587|NCT03180645|101675203|FG001|STARTED|Overall Study||24||
48547588|NCT03180645|101675204|FG002|STARTED|Overall Study||24||
48547589|NCT03180645|101675202|FG000|COMPLETED|Overall Study||24||
48547590|NCT03180645|101675203|FG001|COMPLETED|Overall Study||23||
48547591|NCT03180645|101675204|FG002|COMPLETED|Overall Study||22||
48547592|NCT03180645|101675202|FG000|NOT COMPLETED|Overall Study||0||
48547593|NCT03180645|101675203|FG001|NOT COMPLETED|Overall Study||1||
48547594|NCT03180645|101675204|FG002|NOT COMPLETED|Overall Study||2||
48547595|NCT00369486|101675205|FG000|STARTED|4-Week Visit||38||
48547596|NCT00369486|101675206|FG001|STARTED|4-Week Visit||21||
48547597|NCT00369486|101675207|FG002|STARTED|4-Week Visit||23||
48547598|NCT00369486|101675208|FG003|STARTED|4-Week Visit||22||
48547599|NCT00369486|101675209|FG004|STARTED|4-Week Visit||25||
48547600|NCT00369486|101675205|FG000|COMPLETED|4-Week Visit||36||
48547601|NCT00369486|101675206|FG001|COMPLETED|4-Week Visit||19||
48547602|NCT00369486|101675207|FG002|COMPLETED|4-Week Visit||22||
48547603|NCT00369486|101675208|FG003|COMPLETED|4-Week Visit||20||
48547604|NCT00369486|101675209|FG004|COMPLETED|4-Week Visit||24||
48547605|NCT00369486|101675205|FG000|NOT COMPLETED|4-Week Visit||2||
48547606|NCT00369486|101675206|FG001|NOT COMPLETED|4-Week Visit||2||
48547607|NCT00369486|101675207|FG002|NOT COMPLETED|4-Week Visit||1||
48547608|NCT00369486|101675208|FG003|NOT COMPLETED|4-Week Visit||2||
48547609|NCT00369486|101675209|FG004|NOT COMPLETED|4-Week Visit||1||
48547610|NCT00369486|101675205|FG000|STARTED|8-Week Visit||38||
48547611|NCT00369486|101675206|FG001|STARTED|8-Week Visit||21||
48547612|NCT00369486|101675207|FG002|STARTED|8-Week Visit||22||
48547613|NCT00369486|101675208|FG003|STARTED|8-Week Visit||22||
48547614|NCT00369486|101675209|FG004|STARTED|8-Week Visit||25||
48547615|NCT00369486|101675205|FG000|COMPLETED|8-Week Visit||38||
48547616|NCT00369486|101675206|FG001|COMPLETED|8-Week Visit||20||
48547617|NCT00369486|101675207|FG002|COMPLETED|8-Week Visit||22||
48547618|NCT00369486|101675208|FG003|COMPLETED|8-Week Visit||21||
48547619|NCT00369486|101675209|FG004|COMPLETED|8-Week Visit||24||
48547620|NCT00369486|101675205|FG000|NOT COMPLETED|8-Week Visit||0||
48547621|NCT00369486|101675206|FG001|NOT COMPLETED|8-Week Visit||1||
48547622|NCT00369486|101675207|FG002|NOT COMPLETED|8-Week Visit||0||
48547623|NCT00369486|101675208|FG003|NOT COMPLETED|8-Week Visit||1||
48264360|NCT01896726|100970779|FG000|NOT COMPLETED|Treatment Period 1 (Days 1-22)||0||
48264361|NCT01896726|100970779|FG000|STARTED|Treatment Period 2 (Days 23-31)||20||
48264362|NCT01896726|100970779|FG000|Received at Least 1 Dose of Baricitinib|Treatment Period 2 (Days 23-31)||20||
48547624|NCT00369486|101675209|FG004|NOT COMPLETED|8-Week Visit||1||
48547625|NCT00369486|101675205|FG000|STARTED|17-Week Visit||38||
48547626|NCT00369486|101675206|FG001|STARTED|17-Week Visit||21||
48547627|NCT00369486|101675207|FG002|STARTED|17-Week Visit||23||
48547628|NCT00369486|101675208|FG003|STARTED|17-Week Visit||22||
48547629|NCT00369486|101675209|FG004|STARTED|17-Week Visit||25||
48264363|NCT01896726|100970779|FG000|Received Microgynon|Treatment Period 2 (Days 23-31)||18||
48547630|NCT00369486|101675205|FG000|COMPLETED|17-Week Visit||38||
48547631|NCT00369486|101675206|FG001|COMPLETED|17-Week Visit||21||
48547632|NCT00369486|101675207|FG002|COMPLETED|17-Week Visit||22||
48547633|NCT00369486|101675208|FG003|COMPLETED|17-Week Visit||21||
48547634|NCT00369486|101675209|FG004|COMPLETED|17-Week Visit||24||
48547635|NCT00369486|101675205|FG000|NOT COMPLETED|17-Week Visit||0||
48547636|NCT00369486|101675206|FG001|NOT COMPLETED|17-Week Visit||0||
48547637|NCT00369486|101675207|FG002|NOT COMPLETED|17-Week Visit||1||
48547638|NCT00369486|101675208|FG003|NOT COMPLETED|17-Week Visit||1||
48547639|NCT00369486|101675209|FG004|NOT COMPLETED|17-Week Visit||1||
48264364|NCT01896726|100970779|FG000|COMPLETED|Treatment Period 2 (Days 23-31)||18||
48264365|NCT01896726|100970779|FG000|NOT COMPLETED|Treatment Period 2 (Days 23-31)||2||
48547640|NCT00369486|101675205|FG000|STARTED|34-Week Visit||38||
48547641|NCT00369486|101675206|FG001|STARTED|34-Week Visit||21||
48547642|NCT00369486|101675207|FG002|STARTED|34-Week Visit||23||
48547643|NCT00369486|101675208|FG003|STARTED|34-Week Visit||22||
48547644|NCT00369486|101675209|FG004|STARTED|34-Week Visit||25||
48547645|NCT00369486|101675205|FG000|COMPLETED|34-Week Visit||38||
48547646|NCT00369486|101675206|FG001|COMPLETED|34-Week Visit||20||
48547647|NCT00369486|101675207|FG002|COMPLETED|34-Week Visit||22||
48547648|NCT00369486|101675208|FG003|COMPLETED|34-Week Visit||19||
48547649|NCT00369486|101675209|FG004|COMPLETED|34-Week Visit||22||
48547650|NCT00369486|101675205|FG000|NOT COMPLETED|34-Week Visit||0||
48264366|NCT00794170|100970780|FG000|STARTED|Overall Study||157||
48264367|NCT00794170|100970781|FG001|STARTED|Overall Study||155||
48264368|NCT00794170|100970780|FG000|COMPLETED|Overall Study||150||
48264369|NCT00794170|100970781|FG001|COMPLETED|Overall Study||152||
48264370|NCT00794170|100970780|FG000|NOT COMPLETED|Overall Study||7||
48264371|NCT00794170|100970781|FG001|NOT COMPLETED|Overall Study||3||
48264372|NCT00798434|100970782|FG000|STARTED|Double-Blind||396||
48264373|NCT00798434|100970783|FG001|STARTED|Double-Blind||398||
48264374|NCT00798434|100970782|FG000|Received Treatment|Double-Blind||393||
48264375|NCT00798434|100970783|FG001|Received Treatment|Double-Blind||392||
48264376|NCT00798434|100970782|FG000|COMPLETED|Double-Blind||341||
48264377|NCT00798434|100970783|FG001|COMPLETED|Double-Blind||314||
48264378|NCT00798434|100970782|FG000|NOT COMPLETED|Double-Blind||55||
48264379|NCT00798434|100970783|FG001|NOT COMPLETED|Double-Blind||84||
48264380|NCT00798434|100970782|FG000|STARTED|Open-Label||341||
48264381|NCT00798434|100970783|FG001|STARTED|Open-Label||314||
48264382|NCT00798434|100970782|FG000|Received Treatment|Open-Label||341||
48264383|NCT00798434|100970783|FG001|Received Treatment|Open-Label||313||
48264384|NCT00798434|100970782|FG000|COMPLETED|Open-Label||299||
48264385|NCT00798434|100970783|FG001|COMPLETED|Open-Label||282||
48264386|NCT00798434|100970782|FG000|NOT COMPLETED|Open-Label||42||
48264387|NCT00798434|100970783|FG001|NOT COMPLETED|Open-Label||32||
48264388|NCT04367480|100970784|FG000|STARTED|Overall Study||72||
48264389|NCT04367480|100970785|FG001|STARTED|Overall Study||72||
48264390|NCT04367480|100970784|FG000|Received Intervention and Completed Baseline Assessments|Overall Study||72||
48264391|NCT04367480|100970785|FG001|Received Intervention and Completed Baseline Assessments|Overall Study||70||
48264392|NCT04367480|100970784|FG000|COMPLETED|Overall Study||68||
48264393|NCT04367480|100970785|FG001|COMPLETED|Overall Study||62||
48264394|NCT04367480|100970784|FG000|NOT COMPLETED|Overall Study||4||
48264395|NCT04367480|100970785|FG001|NOT COMPLETED|Overall Study||10||
48264396|NCT02094898|100970786|FG000|STARTED|Overall Study||12||
48264397|NCT02094898|100970786|FG000|COMPLETED|Overall Study||7||
48264398|NCT02094898|100970786|FG000|NOT COMPLETED|Overall Study||5||
48264399|NCT02844777|100970787|FG000|STARTED|Overall Study||29||
48264400|NCT02844777|100970788|FG001|STARTED|Overall Study||32||
48264401|NCT02844777|100970789|FG002|STARTED|Overall Study||32||
48264402|NCT02844777|100970787|FG000|COMPLETED|Overall Study||27||
48264403|NCT02844777|100970788|FG001|COMPLETED|Overall Study||32||
48264404|NCT02844777|100970789|FG002|COMPLETED|Overall Study||32||
48264405|NCT02844777|100970787|FG000|NOT COMPLETED|Overall Study||2||
48264406|NCT02844777|100970788|FG001|NOT COMPLETED|Overall Study||0||
48264407|NCT02844777|100970789|FG002|NOT COMPLETED|Overall Study||0||
48264408|NCT00351377|100970790|FG000|STARTED|Overall Study||111||
48264409|NCT00351377|100970790|FG000|COMPLETED|Overall Study||104||
48264410|NCT00351377|100970790|FG000|NOT COMPLETED|Overall Study||7||
48264411|NCT01080300|100970791|FG000|STARTED|Overall Study||300||
48264412|NCT01080300|100970792|FG001|STARTED|Overall Study||295||
48264413|NCT01080300|100970791|FG000|COMPLETED|Overall Study||206||
48264414|NCT01080300|100970792|FG001|COMPLETED|Overall Study||191||
48264415|NCT01080300|100970791|FG000|NOT COMPLETED|Overall Study||94||
48264416|NCT01080300|100970792|FG001|NOT COMPLETED|Overall Study||104||
48264417|NCT00869947|100970793|FG000|STARTED|Overall Study||8||
48264418|NCT00869947|100970794|FG001|STARTED|Overall Study||8||
48264419|NCT00869947|100970793|FG000|COMPLETED|Overall Study||8||
48264420|NCT00869947|100970794|FG001|COMPLETED|Overall Study||8||
48264421|NCT00869947|100970793|FG000|NOT COMPLETED|Overall Study||0||
48264422|NCT00869947|100970794|FG001|NOT COMPLETED|Overall Study||0||
48264423|NCT00672451|100970795|FG000|STARTED|Overall Study||1||
48264424|NCT00672451|100970796|FG001|STARTED|Overall Study||2||
48264425|NCT00672451|100970795|FG000|COMPLETED|Overall Study||1||
48264426|NCT00672451|100970796|FG001|COMPLETED|Overall Study||2||
48264427|NCT00672451|100970795|FG000|NOT COMPLETED|Overall Study||0||
48264428|NCT00672451|100970796|FG001|NOT COMPLETED|Overall Study||0||
48264429|NCT02397447|100970797|FG000|STARTED|Overall Study||12||
48264430|NCT02397447|100970798|FG001|STARTED|Overall Study||12||
48264431|NCT02397447|100970797|FG000|COMPLETED|Overall Study||10||
48264432|NCT02397447|100970798|FG001|COMPLETED|Overall Study||10||
48264433|NCT02397447|100970797|FG000|NOT COMPLETED|Overall Study||2||
48264434|NCT02397447|100970798|FG001|NOT COMPLETED|Overall Study||2||
48264435|NCT02127125|100970799|FG000|STARTED|Overall Study||6|Passed screening for inclusion in study, assigned to intervention after baseline measurements.|
48264436|NCT02127125|100970800|FG001|STARTED|Overall Study||8|Passed screening for inclusion in study, assigned to intervention after baseline measurements.|
48264437|NCT02127125|100970801|FG002|STARTED|Overall Study||9|Passed screening for inclusion in study, assigned to intervention after baseline measurements.|
48264438|NCT02127125|100970802|FG003|STARTED|Overall Study||11|Passed screening for inclusion in study, assigned to intervention after baseline measurements.|
48264439|NCT02127125|100970803|FG004|STARTED|Overall Study||12|Passed screening for inclusion in study, assigned to intervention after baseline measurements.|
48264440|NCT02127125|100970804|FG005|STARTED|Overall Study||12|Passed screening for inclusion in study, assigned to intervention after baseline measurements.|
48264441|NCT02127125|100970805|FG006|STARTED|Overall Study||2|Passed screening for inclusion in study, assigned to intervention after baseline measurements.|
48390949|NCT02223429|101287557|FG002|STARTED|Overall Study||8||
48390950|NCT02223429|101287558|FG003|STARTED|Overall Study||8||
48264442|NCT02127125|100970806|FG007|STARTED|Overall Study||0|Passed screening for inclusion in study, assigned to intervention after baseline measurements.|
48264443|NCT02127125|100970807|FG008|STARTED|Overall Study||1|Passed screening for inclusion in study, assigned to intervention after baseline measurements.|
48264444|NCT02127125|100970799|FG000|COMPLETED|Overall Study||6||
48264445|NCT02127125|100970800|FG001|COMPLETED|Overall Study||8||
48547651|NCT00369486|101675206|FG001|NOT COMPLETED|34-Week Visit||1||
48547652|NCT00369486|101675207|FG002|NOT COMPLETED|34-Week Visit||1||
48547653|NCT00369486|101675208|FG003|NOT COMPLETED|34-Week Visit||3||
48547654|NCT00369486|101675209|FG004|NOT COMPLETED|34-Week Visit||3||
48547655|NCT00396565|101675210|FG000|STARTED|Overall Study||136||
48547656|NCT00396565|101675211|FG001|STARTED|Overall Study||138||
48547657|NCT00396565|101675212|FG002|STARTED|Overall Study||47||
48547658|NCT00396565|101675210|FG000|COMPLETED|Overall Study||88||
48547659|NCT00396565|101675211|FG001|COMPLETED|Overall Study||47||
48547660|NCT00396565|101675212|FG002|COMPLETED|Overall Study||30||
48547661|NCT00396565|101675210|FG000|NOT COMPLETED|Overall Study||48||
48547662|NCT00396565|101675211|FG001|NOT COMPLETED|Overall Study||91||
48547663|NCT00396565|101675212|FG002|NOT COMPLETED|Overall Study||17||
48547664|NCT00719615|101675213|FG000|STARTED|Overall Study||42||
48547665|NCT00719615|101675214|FG001|STARTED|Overall Study||45||
48547666|NCT00719615|101675215|FG002|STARTED|Overall Study||24||
48547667|NCT00719615|101675213|FG000|COMPLETED|Overall Study||42||
48547668|NCT00719615|101675214|FG001|COMPLETED|Overall Study||45||
48547669|NCT00719615|101675215|FG002|COMPLETED|Overall Study||24||
48547670|NCT00719615|101675213|FG000|NOT COMPLETED|Overall Study||0||
48547671|NCT00719615|101675214|FG001|NOT COMPLETED|Overall Study||0||
48547672|NCT00719615|101675215|FG002|NOT COMPLETED|Overall Study||0||
48547673|NCT01504997|101675216|FG000|STARTED|Overall Study||18||
48547674|NCT01504997|101675216|FG000|COMPLETED|Overall Study||18||
48547675|NCT01504997|101675216|FG000|NOT COMPLETED|Overall Study||0||
48547676|NCT00663026|101675217|FG000|STARTED|Overall Study||19||
48101359|NCT00657241|100575303|FG001|NOT COMPLETED|Overall Study||0||
48101360|NCT01854905|100575304|FG000|STARTED|Overall Study||400||
48101361|NCT01854905|100575304|FG000|COMPLETED|Overall Study||400||
48101362|NCT01854905|100575304|FG000|NOT COMPLETED|Overall Study||0||
48101363|NCT03839511|100575305|FG000|STARTED|Overall Study||4||
48101364|NCT03839511|100575305|FG000|COMPLETED|Overall Study||4||
48101365|NCT03839511|100575305|FG000|NOT COMPLETED|Overall Study||0||
48101366|NCT02275481|100575306|FG000|STARTED|Overall Study||32||
48101367|NCT02275481|100575307|FG001|STARTED|Overall Study||34||
48101368|NCT02275481|100575306|FG000|COMPLETED|Overall Study||23||
48101369|NCT02275481|100575307|FG001|COMPLETED|Overall Study||31||
48101370|NCT02275481|100575306|FG000|NOT COMPLETED|Overall Study||9||
48101371|NCT02275481|100575307|FG001|NOT COMPLETED|Overall Study||3||
48101372|NCT02590939|100575308|FG000|STARTED|Overall Study||52||
48101373|NCT02590939|100575309|FG001|STARTED|Overall Study||54||
48101374|NCT02590939|100575308|FG000|COMPLETED|Overall Study||47||
48101375|NCT02590939|100575309|FG001|COMPLETED|Overall Study||52||
48101376|NCT02590939|100575308|FG000|NOT COMPLETED|Overall Study||5||
48101377|NCT02590939|100575309|FG001|NOT COMPLETED|Overall Study||2||
48101378|NCT00923559|100575310|FG000|STARTED|Overall Study||40||
48101379|NCT00923559|100575311|FG001|STARTED|Overall Study||40||
48101380|NCT00923559|100575310|FG000|COMPLETED|Overall Study||38||
48264446|NCT02127125|100970801|FG002|COMPLETED|Overall Study||8||
48547677|NCT00663026|101675218|FG001|STARTED|Overall Study||29||
48547678|NCT00663026|101675219|FG002|STARTED|Overall Study||31||
48547679|NCT00663026|101675217|FG000|COMPLETED|Overall Study||17||
48547680|NCT00663026|101675218|FG001|COMPLETED|Overall Study||23||
48547681|NCT00663026|101675219|FG002|COMPLETED|Overall Study||27||
48101381|NCT00923559|100575311|FG001|COMPLETED|Overall Study||37||
48101382|NCT00923559|100575310|FG000|NOT COMPLETED|Overall Study||2||
48101383|NCT00923559|100575311|FG001|NOT COMPLETED|Overall Study||3||
48101384|NCT00192504|100575312|FG000|STARTED|Overall Study||5||
48264447|NCT02127125|100970802|FG003|COMPLETED|Overall Study||10||
48264448|NCT02127125|100970803|FG004|COMPLETED|Overall Study||9||
48547682|NCT00663026|101675217|FG000|NOT COMPLETED|Overall Study||2||
48547683|NCT00663026|101675218|FG001|NOT COMPLETED|Overall Study||6||
48547684|NCT00663026|101675219|FG002|NOT COMPLETED|Overall Study||4||
48547685|NCT04370834|101675220|FG000|STARTED|Overall Study||1||
48547686|NCT04370834|101675220|FG000|COMPLETED|Overall Study||1||
48547687|NCT04370834|101675220|FG000|NOT COMPLETED|Overall Study||0||
48547688|NCT00595309|101675221|FG000|STARTED|Overall Study||198||
48547689|NCT00595309|101675221|FG000|COMPLETED|Overall Study||194||
48547690|NCT00595309|101675221|FG000|NOT COMPLETED|Overall Study||4||
48547691|NCT02268877|101675222|FG000|STARTED|Overall Study||122|122 patients were randomized to this arm.|
48547692|NCT02268877|101675223|FG001|STARTED|Overall Study||111|122 patients were randomized to this arm.|
48547693|NCT02268877|101675222|FG000|COMPLETED|Overall Study||118|118 patients received the intervention|
48547694|NCT02268877|101675223|FG001|COMPLETED|Overall Study||106|118 patients received the intervention|
48547695|NCT02268877|101675222|FG000|NOT COMPLETED|Overall Study||4||
48547696|NCT02268877|101675223|FG001|NOT COMPLETED|Overall Study||5||
48547697|NCT04172597|101675224|FG000|STARTED|Overall Study||0||
48547698|NCT04172597|101675225|FG001|STARTED|Overall Study||0||
48547699|NCT04172597|101675226|FG002|STARTED|Overall Study||0||
48101385|NCT00192504|100575313|FG001|STARTED|Overall Study||5||
48101386|NCT00192504|100575314|FG002|STARTED|Overall Study||6||
48101387|NCT00192504|100575315|FG003|STARTED|Overall Study||15||
48101388|NCT00192504|100575312|FG000|COMPLETED|Overall Study||4||
48101389|NCT00192504|100575313|FG001|COMPLETED|Overall Study||5||
48101390|NCT00192504|100575314|FG002|COMPLETED|Overall Study||5||
48101391|NCT00192504|100575315|FG003|COMPLETED|Overall Study||15||
48101392|NCT00192504|100575312|FG000|NOT COMPLETED|Overall Study||1||
48101393|NCT00192504|100575313|FG001|NOT COMPLETED|Overall Study||0||
48101394|NCT00192504|100575314|FG002|NOT COMPLETED|Overall Study||1||
48101395|NCT00192504|100575315|FG003|NOT COMPLETED|Overall Study||0||
48101396|NCT01142310|100575316|FG000|STARTED|Overall Study||26||
48101397|NCT01142310|100575317|FG001|STARTED|Overall Study||28||
48101398|NCT01142310|100575316|FG000|COMPLETED|Overall Study||17||
48101399|NCT01142310|100575317|FG001|COMPLETED|Overall Study||16||
48101400|NCT01142310|100575316|FG000|NOT COMPLETED|Overall Study||9||
48101401|NCT01142310|100575317|FG001|NOT COMPLETED|Overall Study||12||
48101402|NCT01614990|100575318|FG000|STARTED|Overall Study||10||
48101403|NCT01614990|100575319|FG001|STARTED|Overall Study||5||
48101404|NCT01614990|100575318|FG000|COMPLETED|Overall Study||9||
48101405|NCT01614990|100575319|FG001|COMPLETED|Overall Study||4||
48101406|NCT01614990|100575318|FG000|NOT COMPLETED|Overall Study||1||
48101407|NCT01614990|100575319|FG001|NOT COMPLETED|Overall Study||1||
48101408|NCT02784821|100575320|FG000|STARTED|Overall Study||11||
48101409|NCT02784821|100575321|FG001|STARTED|Overall Study||32||
48101410|NCT02784821|100575322|FG002|STARTED|Overall Study||28||
48101411|NCT02784821|100575323|FG003|STARTED|Overall Study||27||
48101412|NCT02784821|100575320|FG000|COMPLETED|Overall Study||11||
48101413|NCT02784821|100575321|FG001|COMPLETED|Overall Study||27||
48101414|NCT02784821|100575322|FG002|COMPLETED|Overall Study||24||
48101415|NCT02784821|100575323|FG003|COMPLETED|Overall Study||22||
48101416|NCT02784821|100575320|FG000|NOT COMPLETED|Overall Study||0||
48101417|NCT02784821|100575321|FG001|NOT COMPLETED|Overall Study||5||
48101418|NCT02784821|100575322|FG002|NOT COMPLETED|Overall Study||4||
48101419|NCT02784821|100575323|FG003|NOT COMPLETED|Overall Study||5||
48101420|NCT04151290|100575324|FG000|STARTED|Overall Study||711||
48101421|NCT04151290|100575324|FG000|COMPLETED|Overall Study||425||
48101422|NCT04151290|100575324|FG000|NOT COMPLETED|Overall Study||286||
48101423|NCT02503332|100575325|FG000|STARTED|Overall Study||86||
48101424|NCT02503332|100575326|FG001|STARTED|Overall Study||79||
48101425|NCT02503332|100575327|FG002|STARTED|Overall Study||41||
48101426|NCT02503332|100575328|FG003|STARTED|Overall Study||40||
48101427|NCT02503332|100575325|FG000|COMPLETED|Overall Study||52|Completed treatment.|
48101428|NCT02503332|100575326|FG001|COMPLETED|Overall Study||60|Completed treatment.|
48101429|NCT02503332|100575327|FG002|COMPLETED|Overall Study||33|Completed treatment.|
48101430|NCT02503332|100575328|FG003|COMPLETED|Overall Study||36|Completed treatment.|
48101431|NCT02503332|100575325|FG000|NOT COMPLETED|Overall Study||34||
48264449|NCT02127125|100970804|FG005|COMPLETED|Overall Study||9||
48264450|NCT02127125|100970805|FG006|COMPLETED|Overall Study||2||
48101432|NCT02503332|100575326|FG001|NOT COMPLETED|Overall Study||19||
48101433|NCT02503332|100575327|FG002|NOT COMPLETED|Overall Study||8||
48101434|NCT02503332|100575328|FG003|NOT COMPLETED|Overall Study||4||
48101435|NCT00706979|100575329|FG000|STARTED|Overall Study||426||
48101436|NCT00706979|100575330|FG001|STARTED|Overall Study||423||
48101437|NCT00706979|100575329|FG000|COMPLETED|Overall Study||426||
48264451|NCT02127125|100970806|FG007|COMPLETED|Overall Study||0||
48264452|NCT02127125|100970807|FG008|COMPLETED|Overall Study||1||
48264453|NCT02127125|100970799|FG000|NOT COMPLETED|Overall Study||0||
48390951|NCT02223429|101287555|FG000|COMPLETED|Overall Study||7||
48390952|NCT02223429|101287556|FG001|COMPLETED|Overall Study||8||
48101438|NCT00706979|100575330|FG001|COMPLETED|Overall Study||423||
48101439|NCT00706979|100575329|FG000|NOT COMPLETED|Overall Study||0||
48101440|NCT00706979|100575330|FG001|NOT COMPLETED|Overall Study||0||
48101441|NCT02229318|100575331|FG000|STARTED|Overall Study||11||
48101442|NCT02229318|100575331|FG000|COMPLETED|Overall Study||11||
48101443|NCT02229318|100575331|FG000|NOT COMPLETED|Overall Study||0||
48101444|NCT03340025|100575332|FG000|STARTED|Overall Study||11||
48101445|NCT03340025|100575333|FG001|STARTED|Overall Study||9||
48101446|NCT03340025|100575332|FG000|COMPLETED|Overall Study||9||
48101447|NCT03340025|100575333|FG001|COMPLETED|Overall Study||7||
48390953|NCT02223429|101287557|FG002|COMPLETED|Overall Study||8||
48390954|NCT02223429|101287558|FG003|COMPLETED|Overall Study||8||
48101448|NCT03340025|100575332|FG000|NOT COMPLETED|Overall Study||2||
48101449|NCT03340025|100575333|FG001|NOT COMPLETED|Overall Study||2||
48101450|NCT00462761|100575334|FG000|STARTED|Overall Study||76||
48101451|NCT00462761|100575334|FG000|COMPLETED|Overall Study||0||
48101452|NCT00462761|100575334|FG000|NOT COMPLETED|Overall Study||76||
48101453|NCT00445965|100575335|FG000|STARTED|Overall Study||78||
48101454|NCT00445965|100575335|FG000|COMPLETED|Overall Study||45||
48101455|NCT00445965|100575335|FG000|NOT COMPLETED|Overall Study||33||
48264454|NCT02127125|100970800|FG001|NOT COMPLETED|Overall Study||0||
48264455|NCT02127125|100970801|FG002|NOT COMPLETED|Overall Study||1||
48264456|NCT02127125|100970802|FG003|NOT COMPLETED|Overall Study||1||
48264457|NCT02127125|100970803|FG004|NOT COMPLETED|Overall Study||3||
48264458|NCT02127125|100970804|FG005|NOT COMPLETED|Overall Study||3||
48101456|NCT02625090|100575336|FG000|STARTED|Overall Study||42||
48101457|NCT02625090|100575336|FG000|COMPLETED|Overall Study||0||
48101458|NCT02625090|100575336|FG000|NOT COMPLETED|Overall Study||42||
48101459|NCT00826800|100575337|FG000|STARTED|Overall Study||2||
48101460|NCT00826800|100575337|FG000|COMPLETED|Overall Study||2||
48101461|NCT00826800|100575337|FG000|NOT COMPLETED|Overall Study||0||
48101462|NCT04662801|100575338|FG000|STARTED|Overall Study||12||
48101463|NCT04662801|100575339|FG001|STARTED|Overall Study||10||
48101464|NCT04662801|100575338|FG000|COMPLETED|Overall Study||9||
48101465|NCT04662801|100575339|FG001|COMPLETED|Overall Study||7||
48101466|NCT04662801|100575338|FG000|NOT COMPLETED|Overall Study||3||
48101467|NCT04662801|100575339|FG001|NOT COMPLETED|Overall Study||3||
48101468|NCT02369341|100575340|FG000|STARTED|Overall Study||63||
48101469|NCT02369341|100575341|FG001|STARTED|Overall Study||57||
48101470|NCT02369341|100575340|FG000|COMPLETED|Overall Study||62||
48101471|NCT02369341|100575341|FG001|COMPLETED|Overall Study||57||
48101472|NCT02369341|100575340|FG000|NOT COMPLETED|Overall Study||1||
48101473|NCT02369341|100575341|FG001|NOT COMPLETED|Overall Study||0||
48101474|NCT01048723|100575342|FG000|STARTED|Overall Study||2||
48101475|NCT01048723|100575342|FG000|COMPLETED|Overall Study||2||
48101476|NCT01048723|100575342|FG000|NOT COMPLETED|Overall Study||0||
48101477|NCT05333900|100575343|FG000|STARTED|Overall Study||7||
48101478|NCT05333900|100575344|FG001|STARTED|Overall Study||8||
48101479|NCT05333900|100575343|FG000|COMPLETED|Overall Study||6||
48101480|NCT05333900|100575344|FG001|COMPLETED|Overall Study||5||
48101481|NCT05333900|100575343|FG000|NOT COMPLETED|Overall Study||1||
48101482|NCT05333900|100575344|FG001|NOT COMPLETED|Overall Study||3||
48101483|NCT00218296|100575345|FG000|STARTED|Overall Study||163|Randomized at phone screen.|
48101484|NCT00218296|100575346|FG001|STARTED|Overall Study||169|Randomized at phone screen.|
48101485|NCT00218296|100575345|FG000|Attended Visti|Overall Study||97||
48101486|NCT00218296|100575346|FG001|Attended Visti|Overall Study||102||
48101487|NCT00218296|100575345|FG000|COMPLETED|Overall Study||52||
48101488|NCT00218296|100575346|FG001|COMPLETED|Overall Study||48||
48101489|NCT00218296|100575345|FG000|NOT COMPLETED|Overall Study||111||
48101490|NCT00218296|100575346|FG001|NOT COMPLETED|Overall Study||121||
48101491|NCT02261714|100575347|FG000|STARTED|Overall Study||32||
48101492|NCT02261714|100575347|FG000|COMPLETED|Overall Study||4||
48101493|NCT02261714|100575347|FG000|NOT COMPLETED|Overall Study||28||
48101494|NCT02310464|100575348|FG000|STARTED|Overall Study||4||
48101495|NCT02310464|100575349|FG001|STARTED|Overall Study||3||
48101496|NCT02310464|100575350|FG002|STARTED|Overall Study||4||
48101497|NCT02310464|100575351|FG003|STARTED|Overall Study||14||
48101498|NCT02310464|100575348|FG000|COMPLETED|Overall Study||0||
48101499|NCT02310464|100575349|FG001|COMPLETED|Overall Study||0||
48101500|NCT02310464|100575350|FG002|COMPLETED|Overall Study||0||
48101501|NCT02310464|100575351|FG003|COMPLETED|Overall Study||1||
48101502|NCT02310464|100575348|FG000|NOT COMPLETED|Overall Study||4||
48101503|NCT02310464|100575349|FG001|NOT COMPLETED|Overall Study||3||
48101504|NCT02310464|100575350|FG002|NOT COMPLETED|Overall Study||4||
48101505|NCT02310464|100575351|FG003|NOT COMPLETED|Overall Study||13||
48101506|NCT00470574|100575352|FG000|STARTED|Overall Study||7||
48101507|NCT00470574|100575352|FG000|COMPLETED|Overall Study||7||
48101508|NCT00470574|100575352|FG000|NOT COMPLETED|Overall Study||0||
48101509|NCT01522365|100575353|FG000|STARTED|Overall Study||20|Split-mouth design, i.e. each subject is randomized to both treatments. 20 subjects in total were enrolled (same subject in both treatment arms).|41
48101510|NCT01522365|100575354|FG001|STARTED|Overall Study||20|Split-mouth design, i.e. each subject is randomized to both treatments. 20 subjects in total were enrolled (same subject in both treatment arms).|41
48101511|NCT01522365|100575353|FG000|Intention-to-Treat|Overall Study||19||38
48101512|NCT01522365|100575354|FG001|Intention-to-Treat|Overall Study||19||38
48101513|NCT01522365|100575353|FG000|COMPLETED|Overall Study||18|Split-mouth design, i.e. each subject is randomized to both treatments. 18 subjects in total completed the study (same subject in both treatment arms).|36
48101514|NCT01522365|100575354|FG001|COMPLETED|Overall Study||18|Split-mouth design, i.e. each subject is randomized to both treatments. 18 subjects in total completed the study (same subject in both treatment arms).|36
48101515|NCT01522365|100575353|FG000|NOT COMPLETED|Overall Study||2||5
48101516|NCT01522365|100575354|FG001|NOT COMPLETED|Overall Study||2||5
48101517|NCT00409617|100575355|FG000|STARTED|Overall Study||945||
48101518|NCT00409617|100575355|FG000|COMPLETED|Overall Study||785||
48101519|NCT00409617|100575355|FG000|NOT COMPLETED|Overall Study||160||
48101520|NCT01807897|100575356|FG000|STARTED|Overall Study||31||
48101521|NCT01807897|100575357|FG001|STARTED|Overall Study||29||
48101522|NCT01807897|100575358|FG002|STARTED|Overall Study||14||
48101523|NCT01807897|100575356|FG000|COMPLETED|Overall Study||24||
48101524|NCT01807897|100575357|FG001|COMPLETED|Overall Study||27||
48101525|NCT01807897|100575358|FG002|COMPLETED|Overall Study||13||
48101526|NCT01807897|100575356|FG000|NOT COMPLETED|Overall Study||7||
48101527|NCT01807897|100575357|FG001|NOT COMPLETED|Overall Study||2||
48101528|NCT01807897|100575358|FG002|NOT COMPLETED|Overall Study||1||
48101529|NCT01820754|100575359|FG000|STARTED|Overall Study||24||
48101530|NCT01820754|100575359|FG000|COMPLETED|Overall Study||24||
48101531|NCT01820754|100575359|FG000|NOT COMPLETED|Overall Study||0||
48101532|NCT05071183|100575360|FG000|STARTED|Overall Study||2||
48101533|NCT05071183|100575361|FG001|STARTED|Overall Study||5||
48547700|NCT04172597|101675227|FG003|STARTED|Overall Study||0||
48547701|NCT04172597|101675228|FG004|STARTED|Overall Study||1||
48547702|NCT04172597|101675224|FG000|COMPLETED|Overall Study||0||
48547703|NCT04172597|101675225|FG001|COMPLETED|Overall Study||0||
48547704|NCT04172597|101675226|FG002|COMPLETED|Overall Study||0||
48547705|NCT04172597|101675227|FG003|COMPLETED|Overall Study||0||
48547706|NCT04172597|101675228|FG004|COMPLETED|Overall Study||0||
48547707|NCT04172597|101675224|FG000|NOT COMPLETED|Overall Study||0||
48547708|NCT04172597|101675225|FG001|NOT COMPLETED|Overall Study||0||
48547709|NCT04172597|101675226|FG002|NOT COMPLETED|Overall Study||0||
48547710|NCT04172597|101675227|FG003|NOT COMPLETED|Overall Study||0||
48547711|NCT04172597|101675228|FG004|NOT COMPLETED|Overall Study||1||
48547712|NCT01244503|101675229|FG000|STARTED|Overall Study||61||
48547713|NCT01244503|101675229|FG000|COMPLETED|Overall Study||61||
48547714|NCT01244503|101675229|FG000|NOT COMPLETED|Overall Study||0||
48547715|NCT02914210|101675230|FG000|STARTED|Overall Study||153||
48547716|NCT02914210|101675231|FG001|STARTED|Overall Study||153||
48547717|NCT02914210|101675230|FG000|COMPLETED|Overall Study||143||
48547718|NCT02914210|101675231|FG001|COMPLETED|Overall Study||144||
48547719|NCT02914210|101675230|FG000|NOT COMPLETED|Overall Study||10||
48547720|NCT02914210|101675231|FG001|NOT COMPLETED|Overall Study||9||
48547721|NCT01437488|101675232|FG000|STARTED|Overall Study||14||
48547722|NCT01437488|101675232|FG000|COMPLETED|Overall Study||14||
48547723|NCT01437488|101675232|FG000|NOT COMPLETED|Overall Study||0||
48547724|NCT01098474|101675233|FG000|STARTED|Active Phase||50||
48547725|NCT01098474|101675234|FG001|STARTED|Active Phase||50||
48547726|NCT01098474|101675235|FG002|STARTED|Active Phase||50||
48547727|NCT01098474|101675236|FG003|STARTED|Active Phase||49||
48547728|NCT01098474|101675237|FG004|STARTED|Active Phase||52||
48547729|NCT01098474|101675238|FG005|STARTED|Active Phase||49||
48547730|NCT01098474|101675233|FG000|COMPLETED|Active Phase||48||
48547731|NCT01098474|101675234|FG001|COMPLETED|Active Phase||49||
48547732|NCT01098474|101675235|FG002|COMPLETED|Active Phase||45||
48547733|NCT01098474|101675236|FG003|COMPLETED|Active Phase||49||
48547734|NCT01098474|101675237|FG004|COMPLETED|Active Phase||52||
48547735|NCT01098474|101675238|FG005|COMPLETED|Active Phase||49||
48547736|NCT01098474|101675233|FG000|NOT COMPLETED|Active Phase||2||
48547737|NCT01098474|101675234|FG001|NOT COMPLETED|Active Phase||1||
48547738|NCT01098474|101675235|FG002|NOT COMPLETED|Active Phase||5||
48547739|NCT01098474|101675236|FG003|NOT COMPLETED|Active Phase||0||
48547740|NCT01098474|101675237|FG004|NOT COMPLETED|Active Phase||0||
48547741|NCT01098474|101675238|FG005|NOT COMPLETED|Active Phase||0||
48547742|NCT01098474|101675233|FG000|STARTED|Follow Up Phase||48||
48547743|NCT01098474|101675234|FG001|STARTED|Follow Up Phase||49||
48547744|NCT01098474|101675235|FG002|STARTED|Follow Up Phase||45||
48547745|NCT01098474|101675236|FG003|STARTED|Follow Up Phase||49||
48691137|NCT03265145|102026016|FG000|NOT COMPLETED|Overall Study||71||
48547746|NCT01098474|101675237|FG004|STARTED|Follow Up Phase||52||
48547747|NCT01098474|101675238|FG005|STARTED|Follow Up Phase||49||
48547748|NCT01098474|101675233|FG000|COMPLETED|Follow Up Phase||48||
48547749|NCT01098474|101675234|FG001|COMPLETED|Follow Up Phase||49||
48547750|NCT01098474|101675235|FG002|COMPLETED|Follow Up Phase||45||
48547751|NCT01098474|101675236|FG003|COMPLETED|Follow Up Phase||47||
48547752|NCT01098474|101675237|FG004|COMPLETED|Follow Up Phase||50||
48547753|NCT01098474|101675238|FG005|COMPLETED|Follow Up Phase||44||
48547754|NCT01098474|101675233|FG000|NOT COMPLETED|Follow Up Phase||0||
48547755|NCT01098474|101675234|FG001|NOT COMPLETED|Follow Up Phase||0||
48547756|NCT01098474|101675235|FG002|NOT COMPLETED|Follow Up Phase||0||
48547757|NCT01098474|101675236|FG003|NOT COMPLETED|Follow Up Phase||2||
48547758|NCT01098474|101675237|FG004|NOT COMPLETED|Follow Up Phase||2||
48547759|NCT01098474|101675238|FG005|NOT COMPLETED|Follow Up Phase||5||
48547760|NCT01784055|101675239|FG000|STARTED|Overall Study||126||
48547761|NCT01784055|101675239|FG000|COMPLETED|Overall Study||100||
48547762|NCT01784055|101675239|FG000|NOT COMPLETED|Overall Study||26||
48547763|NCT01144715|101675240|FG000|STARTED|Overall Study||51||
48547764|NCT01144715|101675241|FG001|STARTED|Overall Study||48||
48547765|NCT01144715|101675240|FG000|COMPLETED|Overall Study||47||
48547766|NCT01144715|101675241|FG001|COMPLETED|Overall Study||45||
48547767|NCT01144715|101675240|FG000|NOT COMPLETED|Overall Study||4||
48547768|NCT01144715|101675241|FG001|NOT COMPLETED|Overall Study||3||
48547769|NCT02292940|101675242|FG000|STARTED|Overall Study||165477||
48547770|NCT02292940|101675243|FG001|STARTED|Overall Study||3000||
48547771|NCT02292940|101675242|FG000|COMPLETED|Overall Study||165477||
48547772|NCT02292940|101675243|FG001|COMPLETED|Overall Study||1824||
48547773|NCT02292940|101675242|FG000|NOT COMPLETED|Overall Study||0||
48547774|NCT02292940|101675243|FG001|NOT COMPLETED|Overall Study||1176||
48547775|NCT05093829|101675244|FG000|STARTED|Step 1 Randomization||401||
48547776|NCT05093829|101675245|FG001|STARTED|Step 1 Randomization||201||
48547777|NCT05093829|101675246|FG002|STARTED|Step 1 Randomization||123||
48547778|NCT05093829|101675247|FG003|STARTED|Step 1 Randomization||400||
48547779|NCT05093829|101675248|FG004|STARTED|Step 1 Randomization||200||
48547780|NCT05093829|101675244|FG000|COMPLETED|Step 1 Randomization||401||
48547781|NCT05093829|101675245|FG001|COMPLETED|Step 1 Randomization||201||
48547782|NCT05093829|101675246|FG002|COMPLETED|Step 1 Randomization||123||
48547783|NCT05093829|101675247|FG003|COMPLETED|Step 1 Randomization||400||
48101534|NCT05071183|100575362|FG002|STARTED|Overall Study||2||
48101535|NCT05071183|100575360|FG000|COMPLETED|Overall Study||0||
48101536|NCT05071183|100575361|FG001|COMPLETED|Overall Study||0||
48101537|NCT05071183|100575362|FG002|COMPLETED|Overall Study||0||
48101538|NCT05071183|100575360|FG000|NOT COMPLETED|Overall Study||2||
48101539|NCT05071183|100575361|FG001|NOT COMPLETED|Overall Study||5||
48101540|NCT05071183|100575362|FG002|NOT COMPLETED|Overall Study||2||
48547784|NCT05093829|101675248|FG004|COMPLETED|Step 1 Randomization||200||
48547785|NCT05093829|101675244|FG000|NOT COMPLETED|Step 1 Randomization||0||
48547786|NCT05093829|101675245|FG001|NOT COMPLETED|Step 1 Randomization||0||
48547787|NCT05093829|101675246|FG002|NOT COMPLETED|Step 1 Randomization||0||
48547788|NCT05093829|101675247|FG003|NOT COMPLETED|Step 1 Randomization||0||
48101541|NCT00003901|100575363|FG000|STARTED|Overall Study||1047||
48101542|NCT00003901|100575363|FG000|COMPLETED|Overall Study||1030||
48691138|NCT03265145|102026017|FG001|NOT COMPLETED|Overall Study||56||
48691139|NCT01963793|102026018|FG000|STARTED|Overall Study||20||
48101543|NCT00003901|100575363|FG000|NOT COMPLETED|Overall Study||17||
48101544|NCT02664909|100575364|FG000|STARTED|Overall Study||17||
48101545|NCT02664909|100575365|FG001|STARTED|Overall Study||19||
48101546|NCT02664909|100575364|FG000|COMPLETED|Overall Study||15||
48101547|NCT02664909|100575365|FG001|COMPLETED|Overall Study||16||
48101548|NCT02664909|100575364|FG000|NOT COMPLETED|Overall Study||2||
48101549|NCT02664909|100575365|FG001|NOT COMPLETED|Overall Study||3||
48101550|NCT00896337|100575366|FG000|STARTED|Overall Study||125||
48101551|NCT00896337|100575366|FG000|COMPLETED|Overall Study||100||
48101552|NCT00896337|100575366|FG000|NOT COMPLETED|Overall Study||25||
48101553|NCT00939809|100575367|FG000|STARTED|Overall Study||31||
48101554|NCT00939809|100575367|FG000|COMPLETED|Overall Study||28||
48101555|NCT00939809|100575367|FG000|NOT COMPLETED|Overall Study||3||
48101556|NCT02385266|100575368|FG000|STARTED|Overall Study||12||
48101557|NCT02385266|100575369|FG001|STARTED|Overall Study||12||
48101558|NCT02385266|100575368|FG000|COMPLETED|Overall Study||11||
48101559|NCT02385266|100575369|FG001|COMPLETED|Overall Study||9||
48101560|NCT02385266|100575368|FG000|NOT COMPLETED|Overall Study||1||
48101561|NCT02385266|100575369|FG001|NOT COMPLETED|Overall Study||3||
48101562|NCT01498458|100575370|FG000|STARTED|Overall Study||8||
48101563|NCT01498458|100575370|FG000|COMPLETED|Overall Study||1||
48101564|NCT01498458|100575370|FG000|NOT COMPLETED|Overall Study||7||
48101565|NCT02762266|100575371|FG000|STARTED|Overall Study||6||
48101566|NCT02762266|100575372|FG001|STARTED|Overall Study||6||
48547789|NCT05093829|101675248|FG004|NOT COMPLETED|Step 1 Randomization||0||
48547790|NCT05093829|101675244|FG000|STARTED|Step 2 Randomization||401||
48547791|NCT05093829|101675245|FG001|STARTED|Step 2 Randomization||201||
48547792|NCT05093829|101675246|FG002|STARTED|Step 2 Randomization||123||
48547793|NCT05093829|101675247|FG003|STARTED|Step 2 Randomization||400||
48547794|NCT05093829|101675248|FG004|STARTED|Step 2 Randomization||200||
48547795|NCT05093829|101675244|FG000|COMPLETED|Step 2 Randomization||401||
48547796|NCT05093829|101675245|FG001|COMPLETED|Step 2 Randomization||201||
48547797|NCT05093829|101675246|FG002|COMPLETED|Step 2 Randomization||0||
48547798|NCT05093829|101675247|FG003|COMPLETED|Step 2 Randomization||400||
48101567|NCT02762266|100575371|FG000|Received Treatment|Overall Study||4||
48101568|NCT02762266|100575372|FG001|Received Treatment|Overall Study||6||
48101569|NCT02762266|100575371|FG000|COMPLETED|Overall Study||4||
48101570|NCT02762266|100575372|FG001|COMPLETED|Overall Study||6||
48101571|NCT02762266|100575371|FG000|NOT COMPLETED|Overall Study||2||
48101572|NCT02762266|100575372|FG001|NOT COMPLETED|Overall Study||0||
48101573|NCT02436759|100575373|FG000|STARTED|Overall Study||94||
48101574|NCT02436759|100575374|FG001|STARTED|Overall Study||46||
48101575|NCT02436759|100575373|FG000|Subjects Randomized|Overall Study||94||
48101576|NCT02436759|100575374|FG001|Subjects Randomized|Overall Study||46||
48101577|NCT02436759|100575373|FG000|Subjects Treated|Overall Study||94||
48101578|NCT02436759|100575374|FG001|Subjects Treated|Overall Study||46||
48101579|NCT02436759|100575373|FG000|COMPLETED|Overall Study||90||
48101580|NCT02436759|100575374|FG001|COMPLETED|Overall Study||45||
48101581|NCT02436759|100575373|FG000|NOT COMPLETED|Overall Study||4||
48101582|NCT02436759|100575374|FG001|NOT COMPLETED|Overall Study||1||
48101583|NCT01359254|100575375|FG000|STARTED|Overall Study||1||
48101584|NCT01359254|100575376|FG001|STARTED|Overall Study||0||
48101585|NCT01359254|100575375|FG000|COMPLETED|Overall Study||0||
48101586|NCT01359254|100575376|FG001|COMPLETED|Overall Study||0||
48101587|NCT01359254|100575375|FG000|NOT COMPLETED|Overall Study||1||
48101588|NCT01359254|100575376|FG001|NOT COMPLETED|Overall Study||0||
48101589|NCT00703885|100575377|FG000|STARTED|Overall Study||16||
48101590|NCT00703885|100575377|FG000|COMPLETED|Overall Study||16||
48547799|NCT05093829|101675248|FG004|COMPLETED|Step 2 Randomization||200||
48547800|NCT05093829|101675244|FG000|NOT COMPLETED|Step 2 Randomization||0||
48547801|NCT05093829|101675245|FG001|NOT COMPLETED|Step 2 Randomization||0||
48547802|NCT05093829|101675246|FG002|NOT COMPLETED|Step 2 Randomization||123||
48101591|NCT00703885|100575377|FG000|NOT COMPLETED|Overall Study||0||
48547803|NCT05093829|101675247|FG003|NOT COMPLETED|Step 2 Randomization||0||
48101592|NCT01132482|100575378|FG000|STARTED|Overall Study||13||
48101593|NCT01132482|100575379|FG001|STARTED|Overall Study||6||
48691140|NCT01963793|102026018|FG000|COMPLETED|Overall Study||20||
48691141|NCT01963793|102026018|FG000|NOT COMPLETED|Overall Study||0||
48101594|NCT01132482|100575378|FG000|COMPLETED|Overall Study||12||
48101595|NCT01132482|100575379|FG001|COMPLETED|Overall Study||6||
48101596|NCT01132482|100575378|FG000|NOT COMPLETED|Overall Study||1||
48101597|NCT01132482|100575379|FG001|NOT COMPLETED|Overall Study||0||
48101598|NCT01017237|100575380|FG000|STARTED|Overall Study||10||
48101599|NCT01017237|100575381|FG001|STARTED|Overall Study||8||
48101600|NCT01017237|100575380|FG000|COMPLETED|Overall Study||5||
48101601|NCT01017237|100575381|FG001|COMPLETED|Overall Study||6||
48101602|NCT01017237|100575380|FG000|NOT COMPLETED|Overall Study||5||
48101603|NCT01017237|100575381|FG001|NOT COMPLETED|Overall Study||2||
48101604|NCT00360828|100575382|FG000|STARTED|Overall Study||10||
48101605|NCT00360828|100575382|FG000|COMPLETED|Overall Study||9||
48101606|NCT00360828|100575382|FG000|NOT COMPLETED|Overall Study||1||
48101607|NCT03760796|100575383|FG000|STARTED|Overall Study||200||
48101608|NCT03760796|100575384|FG001|STARTED|Overall Study||864||
48101609|NCT03760796|100575383|FG000|COMPLETED|Overall Study||200||
48101610|NCT03760796|100575384|FG001|COMPLETED|Overall Study||864||
48101611|NCT03760796|100575383|FG000|NOT COMPLETED|Overall Study||0||
48101612|NCT03760796|100575384|FG001|NOT COMPLETED|Overall Study||0||
48101613|NCT01139450|100575385|FG000|STARTED|Overall Study||302||
48101614|NCT01139450|100575386|FG001|STARTED|Overall Study||297||
48101615|NCT01139450|100575387|FG002|STARTED|Overall Study||300||
48101616|NCT01139450|100575385|FG000|COMPLETED|Overall Study||275||
48101617|NCT01139450|100575386|FG001|COMPLETED|Overall Study||272||
48101618|NCT01139450|100575387|FG002|COMPLETED|Overall Study||262||
48101619|NCT01139450|100575385|FG000|NOT COMPLETED|Overall Study||27||
48101620|NCT01139450|100575386|FG001|NOT COMPLETED|Overall Study||25||
48101621|NCT01139450|100575387|FG002|NOT COMPLETED|Overall Study||38||
48101622|NCT02574247|100575388|FG000|STARTED|Overall Study||10||
48101623|NCT02574247|100575389|FG001|STARTED|Overall Study||8||
48101624|NCT02574247|100575390|FG002|STARTED|Overall Study||10||
48101625|NCT02574247|100575388|FG000|COMPLETED|Overall Study||5||
48101626|NCT02574247|100575389|FG001|COMPLETED|Overall Study||5||
48101627|NCT02574247|100575390|FG002|COMPLETED|Overall Study||5||
48101628|NCT02574247|100575388|FG000|NOT COMPLETED|Overall Study||5||
48101629|NCT02574247|100575389|FG001|NOT COMPLETED|Overall Study||3||
48101630|NCT02574247|100575390|FG002|NOT COMPLETED|Overall Study||5||
48101631|NCT01420289|100575391|FG000|STARTED|Overall Study||18||
48101632|NCT01420289|100575392|FG001|STARTED|Overall Study||16||
48101633|NCT01420289|100575391|FG000|COMPLETED|Overall Study||18||
48101634|NCT01420289|100575392|FG001|COMPLETED|Overall Study||16||
48101635|NCT01420289|100575391|FG000|NOT COMPLETED|Overall Study||0||
48101636|NCT01420289|100575392|FG001|NOT COMPLETED|Overall Study||0||
48101637|NCT02121483|100575393|FG000|STARTED|Overall Study||9||
48101638|NCT02121483|100575394|FG001|STARTED|Overall Study||8||
48101639|NCT02121483|100575395|FG002|STARTED|Overall Study||10||
48101640|NCT02121483|100575393|FG000|COMPLETED|Overall Study||9||
48101641|NCT02121483|100575394|FG001|COMPLETED|Overall Study||8||
48101642|NCT02121483|100575395|FG002|COMPLETED|Overall Study||10||
48101643|NCT02121483|100575393|FG000|NOT COMPLETED|Overall Study||0||
48101644|NCT02121483|100575394|FG001|NOT COMPLETED|Overall Study||0||
48101645|NCT02121483|100575395|FG002|NOT COMPLETED|Overall Study||0||
48101646|NCT00119392|100575396|FG000|STARTED|Overall Study||45||
48101647|NCT00119392|100575396|FG000|COMPLETED|Overall Study||40||
48101648|NCT00119392|100575396|FG000|NOT COMPLETED|Overall Study||5||
48101649|NCT03989440|100575397|FG000|STARTED|Overall Study||6||
48101650|NCT03989440|100575398|FG001|STARTED|Overall Study||6||
48101651|NCT03989440|100575399|FG002|STARTED|Overall Study||6||
48101652|NCT03989440|100575400|FG003|STARTED|Overall Study||7||
48101653|NCT03989440|100575401|FG004|STARTED|Overall Study||14||
48101654|NCT03989440|100575402|FG005|STARTED|Overall Study||13||
48101655|NCT03989440|100575397|FG000|COMPLETED|Overall Study||6||
48101656|NCT03989440|100575398|FG001|COMPLETED|Overall Study||6||
48101657|NCT03989440|100575399|FG002|COMPLETED|Overall Study||5||
48101658|NCT03989440|100575400|FG003|COMPLETED|Overall Study||6||
48101659|NCT03989440|100575401|FG004|COMPLETED|Overall Study||14||
48101660|NCT03989440|100575402|FG005|COMPLETED|Overall Study||13||
48101661|NCT03989440|100575397|FG000|NOT COMPLETED|Overall Study||0||
48101662|NCT03989440|100575398|FG001|NOT COMPLETED|Overall Study||0||
48101663|NCT03989440|100575399|FG002|NOT COMPLETED|Overall Study||1||
48101664|NCT03989440|100575400|FG003|NOT COMPLETED|Overall Study||1||
48101665|NCT03989440|100575401|FG004|NOT COMPLETED|Overall Study||0||
48101666|NCT03989440|100575402|FG005|NOT COMPLETED|Overall Study||0||
48101667|NCT04307446|100575403|FG000|STARTED|Overall Study||12||
48101668|NCT04307446|100575404|FG001|STARTED|Overall Study||11||
48101669|NCT04307446|100575403|FG000|COMPLETED|Overall Study||10||
48101670|NCT04307446|100575404|FG001|COMPLETED|Overall Study||11||
48101671|NCT04307446|100575403|FG000|NOT COMPLETED|Overall Study||2||
48101672|NCT04307446|100575404|FG001|NOT COMPLETED|Overall Study||0||
48101673|NCT02206828|100575405|FG000|STARTED|Overall Study||100||
48101674|NCT02206828|100575405|FG000|COMPLETED|Overall Study||93||
48101675|NCT02206828|100575405|FG000|NOT COMPLETED|Overall Study||7||
48101676|NCT03560531|100575406|FG000|STARTED|Overall Study||16||
48101677|NCT03560531|100575407|FG001|STARTED|Overall Study||3||
48101678|NCT03560531|100575408|FG002|STARTED|Overall Study||3||
48101679|NCT03560531|100575409|FG003|STARTED|Overall Study||6||
48101680|NCT03560531|100575410|FG004|STARTED|Overall Study||15||
48101681|NCT03560531|100575411|FG005|STARTED|Overall Study||3||
48101682|NCT03560531|100575412|FG006|STARTED|Overall Study||10||
48101683|NCT03560531|100575413|FG007|STARTED|Overall Study||75||
48101684|NCT03560531|100575414|FG008|STARTED|Overall Study||10||
48101685|NCT03560531|100575415|FG009|STARTED|Overall Study||5||
48101686|NCT03560531|100575416|FG010|STARTED|Overall Study||18||
48101687|NCT03560531|100575417|FG011|STARTED|Overall Study||2||
48101688|NCT03560531|100575418|FG012|STARTED|Overall Study||12||
48101689|NCT03560531|100575419|FG013|STARTED|Overall Study||3||
48101690|NCT03560531|100575406|FG000|COMPLETED|Overall Study||0||
48101691|NCT03560531|100575407|FG001|COMPLETED|Overall Study||0||
48101692|NCT03560531|100575408|FG002|COMPLETED|Overall Study||0||
48101693|NCT03560531|100575409|FG003|COMPLETED|Overall Study||0||
48101694|NCT03560531|100575410|FG004|COMPLETED|Overall Study||0||
48101695|NCT03560531|100575411|FG005|COMPLETED|Overall Study||0||
48101696|NCT03560531|100575412|FG006|COMPLETED|Overall Study||0||
48101697|NCT03560531|100575413|FG007|COMPLETED|Overall Study||0||
48101698|NCT03560531|100575414|FG008|COMPLETED|Overall Study||0||
48101699|NCT03560531|100575415|FG009|COMPLETED|Overall Study||0||
48101700|NCT03560531|100575416|FG010|COMPLETED|Overall Study||0||
48101701|NCT03560531|100575417|FG011|COMPLETED|Overall Study||0||
48101702|NCT03560531|100575418|FG012|COMPLETED|Overall Study||0||
48101703|NCT03560531|100575419|FG013|COMPLETED|Overall Study||0||
48101704|NCT03560531|100575406|FG000|NOT COMPLETED|Overall Study||16||
48101705|NCT03560531|100575407|FG001|NOT COMPLETED|Overall Study||3||
48101706|NCT03560531|100575408|FG002|NOT COMPLETED|Overall Study||3||
48101707|NCT03560531|100575409|FG003|NOT COMPLETED|Overall Study||6||
48101708|NCT03560531|100575410|FG004|NOT COMPLETED|Overall Study||15||
48101709|NCT03560531|100575411|FG005|NOT COMPLETED|Overall Study||3||
48101710|NCT03560531|100575412|FG006|NOT COMPLETED|Overall Study||10||
48101711|NCT03560531|100575413|FG007|NOT COMPLETED|Overall Study||75||
48101712|NCT03560531|100575414|FG008|NOT COMPLETED|Overall Study||10||
48101713|NCT03560531|100575415|FG009|NOT COMPLETED|Overall Study||5||
48101714|NCT03560531|100575416|FG010|NOT COMPLETED|Overall Study||18||
48101715|NCT03560531|100575417|FG011|NOT COMPLETED|Overall Study||2||
48101716|NCT03560531|100575418|FG012|NOT COMPLETED|Overall Study||12||
48101717|NCT03560531|100575419|FG013|NOT COMPLETED|Overall Study||3||
48101718|NCT00584558|100575420|FG000|STARTED|Overall Study||2420||
48101719|NCT00584558|100575420|FG000|COMPLETED|Overall Study||2420||
48101720|NCT00584558|100575420|FG000|NOT COMPLETED|Overall Study||0||
48101721|NCT02226003|100575421|FG000|STARTED|Overall Study||98||
48101722|NCT02226003|100575422|FG001|STARTED|Overall Study||96||
48101723|NCT02226003|100575423|FG002|STARTED|Overall Study||97||
48101724|NCT02226003|100575421|FG000|COMPLETED|Overall Study||96||
48101725|NCT02226003|100575422|FG001|COMPLETED|Overall Study||95||
48101726|NCT02226003|100575423|FG002|COMPLETED|Overall Study||91||
48101727|NCT02226003|100575421|FG000|NOT COMPLETED|Overall Study||2||
48101728|NCT02226003|100575422|FG001|NOT COMPLETED|Overall Study||1||
48101729|NCT02226003|100575423|FG002|NOT COMPLETED|Overall Study||6||
48101730|NCT00791518|100575424|FG000|STARTED|Overall Study||1084||
48101731|NCT00791518|100575424|FG000|COMPLETED|Overall Study||991||
48101732|NCT00791518|100575424|FG000|NOT COMPLETED|Overall Study||93||
48101733|NCT00491387|100575425|FG000|STARTED|Overall Study||24||
48101734|NCT00491387|100575425|FG000|Study Enrollment|Overall Study||24||
48101735|NCT00491387|100575425|FG000|COMPLETED|Overall Study||4||
48101736|NCT00491387|100575425|FG000|NOT COMPLETED|Overall Study||20||
48101737|NCT00460031|100575426|FG000|STARTED|Overall Study||34||
48101738|NCT00460031|100575426|FG000|COMPLETED|Overall Study||23||
48101739|NCT00460031|100575426|FG000|NOT COMPLETED|Overall Study||11||
48101740|NCT00278109|100575427|FG000|STARTED|Overall Study||25||
48101741|NCT00278109|100575427|FG000|Completed 3 Cycles of Chemotherapy|Overall Study||25||
48101742|NCT00278109|100575427|FG000|COMPLETED|Overall Study||21||
48101743|NCT00278109|100575427|FG000|NOT COMPLETED|Overall Study||4||
48101744|NCT04105998|100575428|FG000|STARTED|First Study Day||12||
48101745|NCT04105998|100575429|FG001|STARTED|First Study Day||10||
48101746|NCT04105998|100575428|FG000|COMPLETED|First Study Day||12||
48101747|NCT04105998|100575429|FG001|COMPLETED|First Study Day||10||
48101748|NCT04105998|100575428|FG000|NOT COMPLETED|First Study Day||0||
48101749|NCT04105998|100575429|FG001|NOT COMPLETED|First Study Day||0||
48101750|NCT04105998|100575428|FG000|STARTED|Second Study Day||12||
48101751|NCT04105998|100575429|FG001|STARTED|Second Study Day||10||
48101752|NCT04105998|100575428|FG000|COMPLETED|Second Study Day||10||
48101753|NCT04105998|100575429|FG001|COMPLETED|Second Study Day||10||
48101754|NCT04105998|100575428|FG000|NOT COMPLETED|Second Study Day||2||
48101755|NCT04105998|100575429|FG001|NOT COMPLETED|Second Study Day||0||
48101756|NCT02726074|100575430|FG000|STARTED|Overall Study||106||
48101757|NCT02726074|100575430|FG000|Treated|Overall Study||102||
48101758|NCT02726074|100575430|FG000|COMPLETED|Overall Study||80||
48101759|NCT02726074|100575430|FG000|NOT COMPLETED|Overall Study||26||
48101760|NCT00851799|100575431|FG000|STARTED|Overall Study||109||
48101761|NCT00851799|100575432|FG001|STARTED|Overall Study||106||
48101762|NCT00851799|100575433|FG002|STARTED|Overall Study||113||
48101763|NCT00851799|100575431|FG000|COMPLETED|Overall Study||93||
48101764|NCT00851799|100575432|FG001|COMPLETED|Overall Study||93||
48547804|NCT05093829|101675248|FG004|NOT COMPLETED|Step 2 Randomization||0||
48547805|NCT01495702|101675249|FG000|STARTED|Randomized Phase||292||
48547806|NCT01495702|101675250|FG001|STARTED|Randomized Phase||147||
48547807|NCT01495702|101675249|FG000|COMPLETED|Randomized Phase||266||
48547808|NCT01495702|101675250|FG001|COMPLETED|Randomized Phase||119||
48547809|NCT01495702|101675249|FG000|NOT COMPLETED|Randomized Phase||26||
48547810|NCT01495702|101675250|FG001|NOT COMPLETED|Randomized Phase||28||
48547811|NCT01495702|101675249|FG000|STARTED|Extension Phase||26||
48547812|NCT01495702|101675250|FG001|STARTED|Extension Phase||2||
48547813|NCT01495702|101675249|FG000|COMPLETED|Extension Phase||26||
48547814|NCT01495702|101675250|FG001|COMPLETED|Extension Phase||2||
48547815|NCT01495702|101675249|FG000|NOT COMPLETED|Extension Phase||0||
48547816|NCT01495702|101675250|FG001|NOT COMPLETED|Extension Phase||0||
48547817|NCT01609023|101675251|FG000|STARTED|Overall Study||67||
48547818|NCT01609023|101675251|FG000|COMPLETED|Overall Study||34||
48547819|NCT01609023|101675251|FG000|NOT COMPLETED|Overall Study||33||
48547820|NCT04096040|101675252|FG000|STARTED|Overall Study||265||
48547821|NCT04096040|101675252|FG000|COMPLETED|Overall Study||249||
48547822|NCT04096040|101675252|FG000|NOT COMPLETED|Overall Study||16||
48547823|NCT00537511|101675253|FG000|STARTED|Treatment Period (Combination)||22||
48547824|NCT00537511|101675253|FG000|Intent-to-Treat (ITT) Populaton|Treatment Period (Combination)||22||
48547825|NCT00537511|101675253|FG000|Safety Population|Treatment Period (Combination)||22||
48547826|NCT00537511|101675253|FG000|COMPLETED|Treatment Period (Combination)||17||
48547827|NCT00537511|101675253|FG000|NOT COMPLETED|Treatment Period (Combination)||5||
48547828|NCT00537511|101675253|FG000|STARTED|Extension Period (Combination)||17||
48547829|NCT00537511|101675253|FG000|COMPLETED|Extension Period (Combination)||11||
48547830|NCT00537511|101675253|FG000|NOT COMPLETED|Extension Period (Combination)||6||
48547831|NCT00537511|101675253|FG000|STARTED|Recovery Period (Monotherapy)||11||
48547832|NCT00537511|101675253|FG000|COMPLETED|Recovery Period (Monotherapy)||3||
48547833|NCT00537511|101675253|FG000|NOT COMPLETED|Recovery Period (Monotherapy)||8||
48547834|NCT00537511|101675253|FG000|STARTED|Maintenance Phase (Monotherapy)||8||
48547835|NCT00537511|101675253|FG000|COMPLETED|Maintenance Phase (Monotherapy)||0||
48547836|NCT00537511|101675253|FG000|NOT COMPLETED|Maintenance Phase (Monotherapy)||8||
48547837|NCT03414684|101675254|FG000|STARTED|First-course Treatment||39||
48547838|NCT03414684|101675255|FG001|STARTED|First-course Treatment||39||
48547839|NCT03414684|101675254|FG000|Started Treatment|First-course Treatment||37||
48547840|NCT03414684|101675255|FG001|Started Treatment|First-course Treatment||38||
48547841|NCT03414684|101675254|FG000|COMPLETED|First-course Treatment||0||
48547842|NCT03414684|101675255|FG001|COMPLETED|First-course Treatment||0||
48547843|NCT03414684|101675254|FG000|NOT COMPLETED|First-course Treatment||39||
48547844|NCT03414684|101675255|FG001|NOT COMPLETED|First-course Treatment||39||
48547845|NCT03414684|101675254|FG000|STARTED|Crossover Treatment||0||
48547846|NCT03414684|101675255|FG001|STARTED|Crossover Treatment||18||
48547847|NCT03414684|101675254|FG000|COMPLETED|Crossover Treatment||0||
48547848|NCT03414684|101675255|FG001|COMPLETED|Crossover Treatment||0||
48547849|NCT03414684|101675254|FG000|NOT COMPLETED|Crossover Treatment||0||
48547850|NCT03414684|101675255|FG001|NOT COMPLETED|Crossover Treatment||18||
48547851|NCT04068792|101675256|FG000|STARTED|Overall Study||11||
48547852|NCT04068792|101675257|FG001|STARTED|Overall Study||11||
48547853|NCT04068792|101675256|FG000|COMPLETED|Overall Study||11||
48547854|NCT04068792|101675257|FG001|COMPLETED|Overall Study||11||
48547855|NCT04068792|101675256|FG000|NOT COMPLETED|Overall Study||0||
48547856|NCT04068792|101675257|FG001|NOT COMPLETED|Overall Study||0||
48547857|NCT02460679|101675258|FG000|STARTED|Overall Study||19||
48547858|NCT02460679|101675258|FG000|Received at Least 1 Dose of Study Drug|Overall Study||19||
48547859|NCT02460679|101675258|FG000|COMPLETED|Overall Study||14||
48547860|NCT02460679|101675258|FG000|NOT COMPLETED|Overall Study||5||
48547861|NCT03327948|101675259|FG000|STARTED|Overall Study||129||
48547862|NCT03327948|101675259|FG000|COMPLETED|Overall Study||126||
48547863|NCT03327948|101675259|FG000|NOT COMPLETED|Overall Study||3||
48547864|NCT04420273|101675260|FG000|STARTED|Overall Study||501||
48547865|NCT04420273|101675261|FG001|STARTED|Overall Study||499||
48547866|NCT04420273|101675260|FG000|COMPLETED|Overall Study||390||
48547867|NCT04420273|101675261|FG001|COMPLETED|Overall Study||414||
48101765|NCT00851799|100575433|FG002|COMPLETED|Overall Study||89||
48101766|NCT00851799|100575431|FG000|NOT COMPLETED|Overall Study||16||
48101767|NCT00851799|100575432|FG001|NOT COMPLETED|Overall Study||13||
48101768|NCT00851799|100575433|FG002|NOT COMPLETED|Overall Study||24||
48101769|NCT02285907|100575434|FG000|STARTED|Overall Study||21||
48101770|NCT02285907|100575434|FG000|Began 1st Intervention|Overall Study||21||
48101771|NCT02285907|100575434|FG000|Began 2nd Intervention|Overall Study||21||
48547868|NCT04420273|101675260|FG000|NOT COMPLETED|Overall Study||111||
48547869|NCT04420273|101675261|FG001|NOT COMPLETED|Overall Study||85||
48547870|NCT02290405|101675262|FG000|STARTED|Overall Study||36||
48547871|NCT02290405|101675263|FG001|STARTED|Overall Study||53||
48547872|NCT02290405|101675262|FG000|COMPLETED|Overall Study||35||
48547873|NCT02290405|101675263|FG001|COMPLETED|Overall Study||53||
48547874|NCT02290405|101675262|FG000|NOT COMPLETED|Overall Study||1||
48547875|NCT02290405|101675263|FG001|NOT COMPLETED|Overall Study||0||
48547876|NCT01473407|101675264|FG000|STARTED|Overall Study||306||
48101772|NCT02285907|100575434|FG000|Began 3rd Intervention|Overall Study||21||
48101773|NCT02285907|100575434|FG000|Began 4th Intervention|Overall Study||21||
48101774|NCT02285907|100575434|FG000|COMPLETED|Overall Study||21||
48101775|NCT02285907|100575434|FG000|NOT COMPLETED|Overall Study||0||
48101776|NCT00751348|100575435|FG000|STARTED|Overall Study||313||
48101777|NCT00751348|100575436|FG001|STARTED|Overall Study||161||
48101778|NCT00751348|100575435|FG000|COMPLETED|Overall Study||307||
48101779|NCT00751348|100575436|FG001|COMPLETED|Overall Study||159||
48101780|NCT00751348|100575435|FG000|NOT COMPLETED|Overall Study||6||
48101781|NCT00751348|100575436|FG001|NOT COMPLETED|Overall Study||2||
48101782|NCT02036502|100575437|FG000|STARTED|Part 1:Dose Determination/Escalation||6||
48101783|NCT02036502|100575438|FG001|STARTED|Part 1:Dose Determination/Escalation||4||
48101784|NCT02036502|100575439|FG002|STARTED|Part 1:Dose Determination/Escalation||0||
48101785|NCT02036502|100575440|FG003|STARTED|Part 1:Dose Determination/Escalation||0||
48101786|NCT02036502|100575441|FG004|STARTED|Part 1:Dose Determination/Escalation||0||
48101787|NCT02036502|100575442|FG005|STARTED|Part 1:Dose Determination/Escalation||0||
48101788|NCT02036502|100575443|FG006|STARTED|Part 1:Dose Determination/Escalation||0||
48101789|NCT02036502|100575444|FG007|STARTED|Part 1:Dose Determination/Escalation||0||
48101790|NCT02036502|100575437|FG000|Treated|Part 1:Dose Determination/Escalation||6||
48101791|NCT02036502|100575438|FG001|Treated|Part 1:Dose Determination/Escalation||3||
48101792|NCT02036502|100575439|FG002|Treated|Part 1:Dose Determination/Escalation||0||
48101793|NCT02036502|100575440|FG003|Treated|Part 1:Dose Determination/Escalation||0||
48101794|NCT02036502|100575441|FG004|Treated|Part 1:Dose Determination/Escalation||0||
48101795|NCT02036502|100575442|FG005|Treated|Part 1:Dose Determination/Escalation||0||
48101796|NCT02036502|100575443|FG006|Treated|Part 1:Dose Determination/Escalation||0||
48101797|NCT02036502|100575444|FG007|Treated|Part 1:Dose Determination/Escalation||0||
48101798|NCT02036502|100575437|FG000|COMPLETED|Part 1:Dose Determination/Escalation||0||
48101799|NCT02036502|100575438|FG001|COMPLETED|Part 1:Dose Determination/Escalation||0||
48101800|NCT02036502|100575439|FG002|COMPLETED|Part 1:Dose Determination/Escalation||0||
48101801|NCT02036502|100575440|FG003|COMPLETED|Part 1:Dose Determination/Escalation||0||
48101802|NCT02036502|100575441|FG004|COMPLETED|Part 1:Dose Determination/Escalation||0||
48101803|NCT02036502|100575442|FG005|COMPLETED|Part 1:Dose Determination/Escalation||0||
48101804|NCT02036502|100575443|FG006|COMPLETED|Part 1:Dose Determination/Escalation||0||
48101805|NCT02036502|100575444|FG007|COMPLETED|Part 1:Dose Determination/Escalation||0||
48101806|NCT02036502|100575437|FG000|NOT COMPLETED|Part 1:Dose Determination/Escalation||6||
48101807|NCT02036502|100575438|FG001|NOT COMPLETED|Part 1:Dose Determination/Escalation||4||
48101808|NCT02036502|100575439|FG002|NOT COMPLETED|Part 1:Dose Determination/Escalation||0||
48101809|NCT02036502|100575440|FG003|NOT COMPLETED|Part 1:Dose Determination/Escalation||0||
48101810|NCT02036502|100575441|FG004|NOT COMPLETED|Part 1:Dose Determination/Escalation||0||
48101811|NCT02036502|100575442|FG005|NOT COMPLETED|Part 1:Dose Determination/Escalation||0||
48101812|NCT02036502|100575443|FG006|NOT COMPLETED|Part 1:Dose Determination/Escalation||0||
48101813|NCT02036502|100575444|FG007|NOT COMPLETED|Part 1:Dose Determination/Escalation||0||
48101814|NCT02036502|100575437|FG000|STARTED|Part 2:Dose Confirmation||0||
48101815|NCT02036502|100575438|FG001|STARTED|Part 2:Dose Confirmation||0||
48101816|NCT02036502|100575439|FG002|STARTED|Part 2:Dose Confirmation||6||
48101817|NCT02036502|100575440|FG003|STARTED|Part 2:Dose Confirmation||2||
48101818|NCT02036502|100575441|FG004|STARTED|Part 2:Dose Confirmation||1||
48101819|NCT02036502|100575442|FG005|STARTED|Part 2:Dose Confirmation||0||
48101820|NCT02036502|100575443|FG006|STARTED|Part 2:Dose Confirmation||0||
48101821|NCT02036502|100575444|FG007|STARTED|Part 2:Dose Confirmation||0||
48101822|NCT02036502|100575437|FG000|Treated|Part 2:Dose Confirmation||0||
48101823|NCT02036502|100575438|FG001|Treated|Part 2:Dose Confirmation||0||
48101824|NCT02036502|100575439|FG002|Treated|Part 2:Dose Confirmation||6||
48101825|NCT02036502|100575440|FG003|Treated|Part 2:Dose Confirmation||1||
48101826|NCT02036502|100575441|FG004|Treated|Part 2:Dose Confirmation||1||
48101827|NCT02036502|100575442|FG005|Treated|Part 2:Dose Confirmation||0||
48101828|NCT02036502|100575443|FG006|Treated|Part 2:Dose Confirmation||0||
48101829|NCT02036502|100575444|FG007|Treated|Part 2:Dose Confirmation||0||
48101830|NCT02036502|100575437|FG000|COMPLETED|Part 2:Dose Confirmation||0||
48101831|NCT02036502|100575438|FG001|COMPLETED|Part 2:Dose Confirmation||0||
48101832|NCT02036502|100575439|FG002|COMPLETED|Part 2:Dose Confirmation||0||
48101833|NCT02036502|100575440|FG003|COMPLETED|Part 2:Dose Confirmation||0||
48101834|NCT02036502|100575441|FG004|COMPLETED|Part 2:Dose Confirmation||0||
48101835|NCT02036502|100575442|FG005|COMPLETED|Part 2:Dose Confirmation||0||
48101836|NCT02036502|100575443|FG006|COMPLETED|Part 2:Dose Confirmation||0||
48101837|NCT02036502|100575444|FG007|COMPLETED|Part 2:Dose Confirmation||0||
48101838|NCT02036502|100575437|FG000|NOT COMPLETED|Part 2:Dose Confirmation||0||
48101839|NCT02036502|100575438|FG001|NOT COMPLETED|Part 2:Dose Confirmation||0||
48101840|NCT02036502|100575439|FG002|NOT COMPLETED|Part 2:Dose Confirmation||6||
48101841|NCT02036502|100575440|FG003|NOT COMPLETED|Part 2:Dose Confirmation||2||
48101842|NCT02036502|100575441|FG004|NOT COMPLETED|Part 2:Dose Confirmation||1||
48101843|NCT02036502|100575442|FG005|NOT COMPLETED|Part 2:Dose Confirmation||0||
48101844|NCT02036502|100575443|FG006|NOT COMPLETED|Part 2:Dose Confirmation||0||
48101845|NCT02036502|100575444|FG007|NOT COMPLETED|Part 2:Dose Confirmation||0||
48101846|NCT02036502|100575437|FG000|STARTED|Part 3:Dose Expansion||0||
48101847|NCT02036502|100575438|FG001|STARTED|Part 3:Dose Expansion||0||
48101848|NCT02036502|100575439|FG002|STARTED|Part 3:Dose Expansion||0||
48101849|NCT02036502|100575440|FG003|STARTED|Part 3:Dose Expansion||0||
48101850|NCT02036502|100575441|FG004|STARTED|Part 3:Dose Expansion||0||
48101851|NCT02036502|100575442|FG005|STARTED|Part 3:Dose Expansion||47||
48101852|NCT02036502|100575443|FG006|STARTED|Part 3:Dose Expansion||1||
48101853|NCT02036502|100575444|FG007|STARTED|Part 3:Dose Expansion||10||
48101854|NCT02036502|100575437|FG000|Treated|Part 3:Dose Expansion||0||
48101855|NCT02036502|100575438|FG001|Treated|Part 3:Dose Expansion||0||
48101856|NCT02036502|100575439|FG002|Treated|Part 3:Dose Expansion||0||
48101857|NCT02036502|100575440|FG003|Treated|Part 3:Dose Expansion||0||
48101858|NCT02036502|100575441|FG004|Treated|Part 3:Dose Expansion||0||
48101859|NCT02036502|100575442|FG005|Treated|Part 3:Dose Expansion||45||
48264459|NCT02127125|100970805|FG006|NOT COMPLETED|Overall Study||0||
48264460|NCT02127125|100970806|FG007|NOT COMPLETED|Overall Study||0||
48264461|NCT02127125|100970807|FG008|NOT COMPLETED|Overall Study||0||
48390955|NCT02223429|101287555|FG000|NOT COMPLETED|Overall Study||1||
48390956|NCT02223429|101287556|FG001|NOT COMPLETED|Overall Study||0||
48390957|NCT02223429|101287557|FG002|NOT COMPLETED|Overall Study||0||
48390958|NCT02223429|101287558|FG003|NOT COMPLETED|Overall Study||0||
48390959|NCT00587769|101287559|FG000|STARTED|Overall Study||38||
48390960|NCT00587769|101287559|FG000|COMPLETED|Overall Study||38||
48390961|NCT00587769|101287559|FG000|NOT COMPLETED|Overall Study||0||
48390962|NCT03219567|101287560|FG000|STARTED|Overall Study||18||
48390963|NCT03219567|101287561|FG001|STARTED|Overall Study||64||
48390964|NCT03219567|101287560|FG000|COMPLETED|Overall Study||18||
48390965|NCT03219567|101287561|FG001|COMPLETED|Overall Study||63||
48390966|NCT03219567|101287560|FG000|NOT COMPLETED|Overall Study||0||
48390967|NCT03219567|101287561|FG001|NOT COMPLETED|Overall Study||1||
48390968|NCT03297216|101287562|FG000|STARTED|Overall Study||399||
48390969|NCT03297216|101287563|FG001|STARTED|Overall Study||401||
48390970|NCT03297216|101287562|FG000|Discontinued Intervention|Overall Study||5||
48390971|NCT03297216|101287563|FG001|Discontinued Intervention|Overall Study||4||
48390972|NCT03297216|101287562|FG000|Infants Born During Study|Overall Study||399||
48101860|NCT02036502|100575443|FG006|Treated|Part 3:Dose Expansion||1||
48101861|NCT02036502|100575444|FG007|Treated|Part 3:Dose Expansion||10||
48101862|NCT02036502|100575437|FG000|COMPLETED|Part 3:Dose Expansion||0||
48101863|NCT02036502|100575438|FG001|COMPLETED|Part 3:Dose Expansion||0||
48101864|NCT02036502|100575439|FG002|COMPLETED|Part 3:Dose Expansion||0||
48101865|NCT02036502|100575440|FG003|COMPLETED|Part 3:Dose Expansion||0||
48101866|NCT02036502|100575441|FG004|COMPLETED|Part 3:Dose Expansion||0||
48101867|NCT02036502|100575442|FG005|COMPLETED|Part 3:Dose Expansion||0||
48101868|NCT02036502|100575443|FG006|COMPLETED|Part 3:Dose Expansion||0||
48101869|NCT02036502|100575444|FG007|COMPLETED|Part 3:Dose Expansion||0||
48101870|NCT02036502|100575437|FG000|NOT COMPLETED|Part 3:Dose Expansion||0||
48101871|NCT02036502|100575438|FG001|NOT COMPLETED|Part 3:Dose Expansion||0||
48101872|NCT02036502|100575439|FG002|NOT COMPLETED|Part 3:Dose Expansion||0||
48101873|NCT02036502|100575440|FG003|NOT COMPLETED|Part 3:Dose Expansion||0||
48101874|NCT02036502|100575441|FG004|NOT COMPLETED|Part 3:Dose Expansion||0||
48101875|NCT02036502|100575442|FG005|NOT COMPLETED|Part 3:Dose Expansion||47||
48264462|NCT01937975|100970808|FG000|STARTED|Overall Study||8||
48101876|NCT02036502|100575443|FG006|NOT COMPLETED|Part 3:Dose Expansion||1||
48101877|NCT02036502|100575444|FG007|NOT COMPLETED|Part 3:Dose Expansion||10||
48101878|NCT01218555|100575445|FG000|STARTED|Overall Study||3||
48101879|NCT01218555|100575446|FG001|STARTED|Overall Study||3||
48101880|NCT01218555|100575447|FG002|STARTED|Overall Study||5||
48101881|NCT01218555|100575448|FG003|STARTED|Overall Study||3||
48101882|NCT01218555|100575449|FG004|STARTED|Overall Study||8||
48101883|NCT01218555|100575450|FG005|STARTED|Overall Study||22||
48101884|NCT01218555|100575445|FG000|COMPLETED|Overall Study||3||
48101885|NCT01218555|100575446|FG001|COMPLETED|Overall Study||3||
48101886|NCT01218555|100575447|FG002|COMPLETED|Overall Study||5||
48101887|NCT01218555|100575448|FG003|COMPLETED|Overall Study||3||
48390973|NCT03297216|101287563|FG001|Infants Born During Study|Overall Study||401||
48390974|NCT03297216|101287562|FG000|COMPLETED|Overall Study||396||
48390975|NCT03297216|101287563|FG001|COMPLETED|Overall Study||396||
48390976|NCT03297216|101287562|FG000|NOT COMPLETED|Overall Study||3||
48390977|NCT03297216|101287563|FG001|NOT COMPLETED|Overall Study||5||
48390978|NCT02486367|101287564|FG000|STARTED|Overall Study||30||
48390979|NCT02486367|101287565|FG001|STARTED|Overall Study||30||
48390980|NCT02486367|101287564|FG000|COMPLETED|Overall Study||30||
48390981|NCT02486367|101287565|FG001|COMPLETED|Overall Study||30||
48101888|NCT01218555|100575449|FG004|COMPLETED|Overall Study||8||
48101889|NCT01218555|100575450|FG005|COMPLETED|Overall Study||22||
48101890|NCT01218555|100575445|FG000|NOT COMPLETED|Overall Study||0||
48264463|NCT01937975|100970809|FG001|STARTED|Overall Study||8||
48264464|NCT01937975|100970810|FG002|STARTED|Overall Study||8||
48264465|NCT01937975|100970808|FG000|COMPLETED|Overall Study||8||
48264466|NCT01937975|100970809|FG001|COMPLETED|Overall Study||8||
48264467|NCT01937975|100970810|FG002|COMPLETED|Overall Study||8||
48264468|NCT01937975|100970808|FG000|NOT COMPLETED|Overall Study||0||
48390982|NCT02486367|101287564|FG000|NOT COMPLETED|Overall Study||0||
48390983|NCT02486367|101287565|FG001|NOT COMPLETED|Overall Study||0||
48390984|NCT02034552|101287566|FG000|STARTED|Overall Study||22||
48390985|NCT02034552|101287567|FG001|STARTED|Overall Study||24||
48390986|NCT02034552|101287568|FG002|STARTED|Overall Study||22||
48390987|NCT02034552|101287566|FG000|Received Treatment|Overall Study||19||
48390988|NCT02034552|101287567|FG001|Received Treatment|Overall Study||22||
48390989|NCT02034552|101287568|FG002|Received Treatment|Overall Study||22||
48390990|NCT02034552|101287566|FG000|COMPLETED|Overall Study||8||
48390991|NCT02034552|101287567|FG001|COMPLETED|Overall Study||4||
48390992|NCT02034552|101287568|FG002|COMPLETED|Overall Study||5||
48390993|NCT02034552|101287566|FG000|NOT COMPLETED|Overall Study||14||
48101891|NCT01218555|100575446|FG001|NOT COMPLETED|Overall Study||0||
48101892|NCT01218555|100575447|FG002|NOT COMPLETED|Overall Study||0||
48101893|NCT01218555|100575448|FG003|NOT COMPLETED|Overall Study||0||
48101894|NCT01218555|100575449|FG004|NOT COMPLETED|Overall Study||0||
48101895|NCT01218555|100575450|FG005|NOT COMPLETED|Overall Study||0||
48101896|NCT00697515|100575451|FG000|STARTED|Dose Optimization Period||142||
48101897|NCT00697515|100575452|FG001|STARTED|Dose Optimization Period||0||
48101898|NCT00697515|100575451|FG000|COMPLETED|Dose Optimization Period||127||
48101899|NCT00697515|100575452|FG001|COMPLETED|Dose Optimization Period||0||
48101900|NCT00697515|100575451|FG000|NOT COMPLETED|Dose Optimization Period||15||
48101901|NCT00697515|100575452|FG001|NOT COMPLETED|Dose Optimization Period||0||
48101902|NCT00697515|100575451|FG000|STARTED|First Intervention (Crossover Period)||63||
48101903|NCT00697515|100575452|FG001|STARTED|First Intervention (Crossover Period)||64||
48101904|NCT00697515|100575451|FG000|COMPLETED|First Intervention (Crossover Period)||53||
48101905|NCT00697515|100575452|FG001|COMPLETED|First Intervention (Crossover Period)||52||
48101906|NCT00697515|100575451|FG000|NOT COMPLETED|First Intervention (Crossover Period)||10||
48101907|NCT00697515|100575452|FG001|NOT COMPLETED|First Intervention (Crossover Period)||12||
48101908|NCT00697515|100575451|FG000|STARTED|Second Intervention (Crossover Period)||53||
48101909|NCT00697515|100575452|FG001|STARTED|Second Intervention (Crossover Period)||52||
48101910|NCT00697515|100575451|FG000|COMPLETED|Second Intervention (Crossover Period)||52||
48101911|NCT00697515|100575452|FG001|COMPLETED|Second Intervention (Crossover Period)||51||
48101912|NCT00697515|100575451|FG000|NOT COMPLETED|Second Intervention (Crossover Period)||1||
48101913|NCT00697515|100575452|FG001|NOT COMPLETED|Second Intervention (Crossover Period)||1||
48101914|NCT00587483|100575453|FG000|STARTED|Overall Study||115||
48101915|NCT00587483|100575454|FG001|STARTED|Overall Study||115||
48101916|NCT00587483|100575455|FG002|STARTED|Overall Study||112||
48101917|NCT00587483|100575453|FG000|COMPLETED|Overall Study||115||
48101918|NCT00587483|100575454|FG001|COMPLETED|Overall Study||115||
48101919|NCT00587483|100575455|FG002|COMPLETED|Overall Study||112||
48101920|NCT00587483|100575453|FG000|NOT COMPLETED|Overall Study||0||
48101921|NCT00587483|100575454|FG001|NOT COMPLETED|Overall Study||0||
48101922|NCT00587483|100575455|FG002|NOT COMPLETED|Overall Study||0||
48101923|NCT00108160|100575456|FG000|STARTED|Overall Study||83||
48101924|NCT00108160|100575457|FG001|STARTED|Overall Study||63||
48101925|NCT00108160|100575456|FG000|Completed Visit 0 (Baseline)|Overall Study||79||
48101926|NCT00108160|100575457|FG001|Completed Visit 0 (Baseline)|Overall Study||60||
48101927|NCT00108160|100575456|FG000|Completed Visit 1 (2 Wks)|Overall Study||72||
48390994|NCT02034552|101287567|FG001|NOT COMPLETED|Overall Study||20||
48390995|NCT02034552|101287568|FG002|NOT COMPLETED|Overall Study||17||
48390996|NCT02516150|101287569|FG000|STARTED|Overall Study||15||
48390997|NCT02516150|101287569|FG000|COMPLETED|Overall Study||15||
48390998|NCT02516150|101287569|FG000|NOT COMPLETED|Overall Study||0||
48390999|NCT00965146|101287570|FG000|STARTED|Overall Study||210||
48391000|NCT00965146|101287570|FG000|COMPLETED|Overall Study||0||
48391001|NCT00965146|101287570|FG000|NOT COMPLETED|Overall Study||210||
48391002|NCT04126031|101287571|FG000|STARTED|Part A||10||
48391003|NCT04126031|101287572|FG001|STARTED|Part A||8||
48391004|NCT04126031|101287573|FG002|STARTED|Part A||9||
48391005|NCT04126031|101287574|FG003|STARTED|Part A||0||
48391006|NCT04126031|101287575|FG004|STARTED|Part A||0||
48391007|NCT04126031|101287576|FG005|STARTED|Part A||0||
48101928|NCT00108160|100575457|FG001|Completed Visit 1 (2 Wks)|Overall Study||54||
48101929|NCT00108160|100575456|FG000|Completed Visit 2 (3 mo)|Overall Study||54||
48101930|NCT00108160|100575457|FG001|Completed Visit 2 (3 mo)|Overall Study||46||
48101931|NCT00108160|100575456|FG000|Completed Visit 3 (6 mo)|Overall Study||44||
48391008|NCT04126031|101287571|FG000|Treated|Part A||9||
48391009|NCT04126031|101287572|FG001|Treated|Part A||8||
48391010|NCT04126031|101287573|FG002|Treated|Part A||8||
48391011|NCT04126031|101287574|FG003|Treated|Part A||0||
48391012|NCT04126031|101287575|FG004|Treated|Part A||0||
48391013|NCT04126031|101287576|FG005|Treated|Part A||0||
48391014|NCT04126031|101287571|FG000|COMPLETED|Part A||9||
48391015|NCT04126031|101287572|FG001|COMPLETED|Part A||8||
48101932|NCT00108160|100575457|FG001|Completed Visit 3 (6 mo)|Overall Study||38||
48101933|NCT00108160|100575456|FG000|Completed Visit 4 (9 mo)|Overall Study||38||
48101934|NCT00108160|100575457|FG001|Completed Visit 4 (9 mo)|Overall Study||37||
48391016|NCT04126031|101287573|FG002|COMPLETED|Part A||8||
48391017|NCT04126031|101287574|FG003|COMPLETED|Part A||0||
48391018|NCT04126031|101287575|FG004|COMPLETED|Part A||0||
48391019|NCT04126031|101287576|FG005|COMPLETED|Part A||0||
48391020|NCT04126031|101287571|FG000|NOT COMPLETED|Part A||1||
48391021|NCT04126031|101287572|FG001|NOT COMPLETED|Part A||0||
48101935|NCT00108160|100575456|FG000|Completed Visit 5 (12 mo)|Overall Study||37||
48101936|NCT00108160|100575457|FG001|Completed Visit 5 (12 mo)|Overall Study||37||
48101937|NCT00108160|100575456|FG000|Completed Visit 6 (15 mo)|Overall Study||36||
48101938|NCT00108160|100575457|FG001|Completed Visit 6 (15 mo)|Overall Study||33||
48101939|NCT00108160|100575456|FG000|Completed Visit 7 (18 mo)|Overall Study||34||
48101940|NCT00108160|100575457|FG001|Completed Visit 7 (18 mo)|Overall Study||31||
48101941|NCT00108160|100575456|FG000|COMPLETED|Overall Study||44||
48547877|NCT01473407|101675265|FG001|STARTED|Overall Study||306||
48547878|NCT01473407|101675264|FG000|COMPLETED|Overall Study||252||
48691142|NCT00241176|102026019|FG000|STARTED|Overall Study||11||
48101942|NCT00108160|100575457|FG001|COMPLETED|Overall Study||42||
48101943|NCT00108160|100575456|FG000|NOT COMPLETED|Overall Study||39||
48101944|NCT00108160|100575457|FG001|NOT COMPLETED|Overall Study||21||
48101945|NCT01471379|100575458|FG000|STARTED|Overall Study||1||
48101946|NCT01471379|100575459|FG001|STARTED|Overall Study||1||
48101947|NCT01471379|100575460|FG002|STARTED|Overall Study||0||
48101948|NCT01471379|100575458|FG000|COMPLETED|Overall Study||0||
48101949|NCT01471379|100575459|FG001|COMPLETED|Overall Study||0||
48264469|NCT01937975|100970809|FG001|NOT COMPLETED|Overall Study||0||
48264470|NCT01937975|100970810|FG002|NOT COMPLETED|Overall Study||0||
48264471|NCT00980746|100970811|FG000|STARTED|Overall Study||85||
48264472|NCT00980746|100970812|FG001|STARTED|Overall Study||89||
48264473|NCT00980746|100970813|FG002|STARTED|Overall Study||95||
48264474|NCT00980746|100970814|FG003|STARTED|Overall Study||100||
48264475|NCT00980746|100970815|FG004|STARTED|Overall Study||92||
48264476|NCT00980746|100970816|FG005|STARTED|Overall Study||96||
48264477|NCT00980746|100970811|FG000|Randomized|Overall Study||85||
48264478|NCT00980746|100970812|FG001|Randomized|Overall Study||89||
48264479|NCT00980746|100970813|FG002|Randomized|Overall Study||95||
48264480|NCT00980746|100970814|FG003|Randomized|Overall Study||100||
48264481|NCT00980746|100970815|FG004|Randomized|Overall Study||92||
48264482|NCT00980746|100970816|FG005|Randomized|Overall Study||96||
48264483|NCT00980746|100970811|FG000|Safety Population|Overall Study||85||
48264484|NCT00980746|100970812|FG001|Safety Population|Overall Study||89||
48264485|NCT00980746|100970813|FG002|Safety Population|Overall Study||95||
48264486|NCT00980746|100970814|FG003|Safety Population|Overall Study||100||
48264487|NCT00980746|100970815|FG004|Safety Population|Overall Study||92||
48264488|NCT00980746|100970816|FG005|Safety Population|Overall Study||96||
48264489|NCT00980746|100970811|FG000|Per-protocol|Overall Study||55||
48264490|NCT00980746|100970812|FG001|Per-protocol|Overall Study||66||
48264491|NCT00980746|100970813|FG002|Per-protocol|Overall Study||73||
48264492|NCT00980746|100970814|FG003|Per-protocol|Overall Study||62||
48264493|NCT00980746|100970815|FG004|Per-protocol|Overall Study||73||
48264494|NCT00980746|100970816|FG005|Per-protocol|Overall Study||74||
48264495|NCT00980746|100970811|FG000|COMPLETED|Overall Study||58||
48264496|NCT00980746|100970812|FG001|COMPLETED|Overall Study||67||
48264497|NCT00980746|100970813|FG002|COMPLETED|Overall Study||75||
48691143|NCT00241176|102026019|FG000|COMPLETED|Overall Study||11||
48691144|NCT00241176|102026019|FG000|NOT COMPLETED|Overall Study||0||
48691145|NCT00515528|102026020|FG000|STARTED|Overall Study||10||
48691146|NCT00515528|102026021|FG001|STARTED|Overall Study||7||
48101950|NCT01471379|100575460|FG002|COMPLETED|Overall Study||0||
48101951|NCT01471379|100575458|FG000|NOT COMPLETED|Overall Study||1||
48101952|NCT01471379|100575459|FG001|NOT COMPLETED|Overall Study||1||
48264498|NCT00980746|100970814|FG003|COMPLETED|Overall Study||64||
48264499|NCT00980746|100970815|FG004|COMPLETED|Overall Study||75||
48264500|NCT00980746|100970816|FG005|COMPLETED|Overall Study||78||
48264501|NCT00980746|100970811|FG000|NOT COMPLETED|Overall Study||27||
48264502|NCT00980746|100970812|FG001|NOT COMPLETED|Overall Study||22||
48264503|NCT00980746|100970813|FG002|NOT COMPLETED|Overall Study||20||
48264504|NCT00980746|100970814|FG003|NOT COMPLETED|Overall Study||36||
48264505|NCT00980746|100970815|FG004|NOT COMPLETED|Overall Study||17||
48264506|NCT00980746|100970816|FG005|NOT COMPLETED|Overall Study||18||
48264507|NCT01821105|100970817|FG000|STARTED|Overall Study||21||
48691147|NCT00515528|102026020|FG000|COMPLETED|Overall Study||10||
48691148|NCT00515528|102026021|FG001|COMPLETED|Overall Study||7||
48691149|NCT00515528|102026020|FG000|NOT COMPLETED|Overall Study||0||
48101953|NCT01471379|100575460|FG002|NOT COMPLETED|Overall Study||0||
48101954|NCT01476696|100575461|FG000|STARTED|Overall Study||15||
48101955|NCT01476696|100575462|FG001|STARTED|Overall Study||9||
48264508|NCT01821105|100970817|FG000|COMPLETED|Overall Study||21||
48264509|NCT01821105|100970817|FG000|NOT COMPLETED|Overall Study||0||
48264510|NCT01189110|100970818|FG000|STARTED|Overall Study||64||
48264511|NCT01189110|100970819|FG001|STARTED|Overall Study||61||
48691150|NCT00515528|102026021|FG001|NOT COMPLETED|Overall Study||0||
48691151|NCT01637584|102026022|FG000|STARTED|Overall Study||20||
48691152|NCT01637584|102026023|FG001|STARTED|Overall Study||20||
48264512|NCT01189110|100970818|FG000|COMPLETED|Overall Study||64||
48264513|NCT01189110|100970819|FG001|COMPLETED|Overall Study||61||
48101956|NCT01476696|100575463|FG002|STARTED|Overall Study||9||
48101957|NCT01476696|100575461|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15||
48264514|NCT01189110|100970818|FG000|NOT COMPLETED|Overall Study||0||
48264515|NCT01189110|100970819|FG001|NOT COMPLETED|Overall Study||0||
48264516|NCT03151746|100970820|FG000|STARTED|Overall Study||9||
48264517|NCT03151746|100970821|FG001|STARTED|Overall Study||11||
48264518|NCT03151746|100970820|FG000|COMPLETED|Overall Study||9||
48264519|NCT03151746|100970821|FG001|COMPLETED|Overall Study||11||
48264520|NCT03151746|100970820|FG000|NOT COMPLETED|Overall Study||0||
48264521|NCT03151746|100970821|FG001|NOT COMPLETED|Overall Study||0||
48264522|NCT02701062|100970822|FG000|STARTED|Baseline||376||
48264523|NCT02701062|100970823|FG001|STARTED|Baseline||186||
48264524|NCT02701062|100970822|FG000|COMPLETED|Baseline||376||
48264525|NCT02701062|100970823|FG001|COMPLETED|Baseline||186||
48264526|NCT02701062|100970822|FG000|NOT COMPLETED|Baseline||0||
48264527|NCT02701062|100970823|FG001|NOT COMPLETED|Baseline||0||
48264528|NCT02701062|100970822|FG000|STARTED|Index Procedure||376||
48264529|NCT02701062|100970823|FG001|STARTED|Index Procedure||186||
48264530|NCT02701062|100970822|FG000|COMPLETED|Index Procedure||376||
48264531|NCT02701062|100970823|FG001|COMPLETED|Index Procedure||186||
48264532|NCT02701062|100970822|FG000|NOT COMPLETED|Index Procedure||0||
48264533|NCT02701062|100970823|FG001|NOT COMPLETED|Index Procedure||0||
48264534|NCT02701062|100970822|FG000|STARTED|Discharge||376||
48264535|NCT02701062|100970823|FG001|STARTED|Discharge||186||
48264536|NCT02701062|100970822|FG000|COMPLETED|Discharge||376||
48264537|NCT02701062|100970823|FG001|COMPLETED|Discharge||186||
48264538|NCT02701062|100970822|FG000|NOT COMPLETED|Discharge||0||
48264539|NCT02701062|100970823|FG001|NOT COMPLETED|Discharge||0||
48264540|NCT02701062|100970822|FG000|STARTED|30 Day Follow-up||376||
48264541|NCT02701062|100970823|FG001|STARTED|30 Day Follow-up||186||
48264542|NCT02701062|100970822|FG000|COMPLETED|30 Day Follow-up||366||
48264543|NCT02701062|100970823|FG001|COMPLETED|30 Day Follow-up||183||
48391022|NCT04126031|101287573|FG002|NOT COMPLETED|Part A||1||
48391023|NCT04126031|101287574|FG003|NOT COMPLETED|Part A||0||
48391024|NCT04126031|101287575|FG004|NOT COMPLETED|Part A||0||
48391025|NCT04126031|101287576|FG005|NOT COMPLETED|Part A||0||
48391026|NCT04126031|101287571|FG000|STARTED|Part B||0||
48391027|NCT04126031|101287572|FG001|STARTED|Part B||0||
48264544|NCT02701062|100970822|FG000|NOT COMPLETED|30 Day Follow-up||10||
48391028|NCT04126031|101287573|FG002|STARTED|Part B||0||
48391029|NCT04126031|101287574|FG003|STARTED|Part B||8||
48391030|NCT04126031|101287575|FG004|STARTED|Part B||5||
48391031|NCT04126031|101287576|FG005|STARTED|Part B||8||
48391032|NCT04126031|101287571|FG000|COMPLETED|Part B||0||
48391033|NCT04126031|101287572|FG001|COMPLETED|Part B||0||
48391034|NCT04126031|101287573|FG002|COMPLETED|Part B||0||
48391035|NCT04126031|101287574|FG003|COMPLETED|Part B||8||
48391036|NCT04126031|101287575|FG004|COMPLETED|Part B||4||
48391037|NCT04126031|101287576|FG005|COMPLETED|Part B||6||
48391038|NCT04126031|101287571|FG000|NOT COMPLETED|Part B||0||
48391039|NCT04126031|101287572|FG001|NOT COMPLETED|Part B||0||
48391040|NCT04126031|101287573|FG002|NOT COMPLETED|Part B||0||
48391041|NCT04126031|101287574|FG003|NOT COMPLETED|Part B||0||
48391042|NCT04126031|101287575|FG004|NOT COMPLETED|Part B||1||
48391043|NCT04126031|101287576|FG005|NOT COMPLETED|Part B||2||
48391044|NCT00141037|101287577|FG000|STARTED|Overall Study||60||
48391045|NCT00141037|101287578|FG001|STARTED|Overall Study||70||
48391046|NCT00141037|101287577|FG000|COMPLETED|Overall Study||50||
48391047|NCT00141037|101287578|FG001|COMPLETED|Overall Study||52||
48391048|NCT00141037|101287577|FG000|NOT COMPLETED|Overall Study||10||
48391049|NCT00141037|101287578|FG001|NOT COMPLETED|Overall Study||18||
48391050|NCT05109702|101287579|FG000|STARTED|Placebo Run-in Period (14 Days)||260||
48391051|NCT05109702|101287580|FG001|STARTED|Placebo Run-in Period (14 Days)||0||
48391052|NCT05109702|101287581|FG002|STARTED|Placebo Run-in Period (14 Days)||0||
48264545|NCT02701062|100970823|FG001|NOT COMPLETED|30 Day Follow-up||3||
48264546|NCT02701062|100970822|FG000|STARTED|90 Day Follow-up||366||
48391053|NCT05109702|101287579|FG000|COMPLETED|Placebo Run-in Period (14 Days)||260||
48391054|NCT05109702|101287580|FG001|COMPLETED|Placebo Run-in Period (14 Days)||0||
48391055|NCT05109702|101287581|FG002|COMPLETED|Placebo Run-in Period (14 Days)||0||
48391056|NCT05109702|101287579|FG000|NOT COMPLETED|Placebo Run-in Period (14 Days)||0||
48391057|NCT05109702|101287580|FG001|NOT COMPLETED|Placebo Run-in Period (14 Days)||0||
48101958|NCT01476696|100575462|FG001|Received at Least 1 Dose of Study Drug|Overall Study||9||
48264547|NCT02701062|100970823|FG001|STARTED|90 Day Follow-up||183||
48264548|NCT02701062|100970822|FG000|COMPLETED|90 Day Follow-up||308||
48264549|NCT02701062|100970823|FG001|COMPLETED|90 Day Follow-up||72||
48264550|NCT02701062|100970822|FG000|NOT COMPLETED|90 Day Follow-up||58||
48264551|NCT02701062|100970823|FG001|NOT COMPLETED|90 Day Follow-up||111||
48391058|NCT05109702|101287581|FG002|NOT COMPLETED|Placebo Run-in Period (14 Days)||0||
48391059|NCT05109702|101287579|FG000|STARTED|Treatment Period (8 Weeks)||0||
48391060|NCT05109702|101287580|FG001|STARTED|Treatment Period (8 Weeks)||130||
48391061|NCT05109702|101287581|FG002|STARTED|Treatment Period (8 Weeks)||130||
48391062|NCT05109702|101287579|FG000|COMPLETED|Treatment Period (8 Weeks)||0||
48391063|NCT05109702|101287580|FG001|COMPLETED|Treatment Period (8 Weeks)||116||
48547879|NCT01473407|101675265|FG001|COMPLETED|Overall Study||259||
48547880|NCT01473407|101675264|FG000|NOT COMPLETED|Overall Study||54||
48547881|NCT01473407|101675265|FG001|NOT COMPLETED|Overall Study||47||
48547882|NCT00397514|101675266|FG000|STARTED|Overall Study||34||
48547883|NCT00397514|101675266|FG000|COMPLETED|Overall Study||25||
48547884|NCT00397514|101675266|FG000|NOT COMPLETED|Overall Study||9||
48547885|NCT01450683|101675267|FG000|STARTED|Overall Study||4||
48547886|NCT01450683|101675267|FG000|COMPLETED|Overall Study||2||
48547887|NCT01450683|101675267|FG000|NOT COMPLETED|Overall Study||2||
48547888|NCT03593538|101675268|FG000|STARTED|Overall Study||26||
48547889|NCT03593538|101675269|FG001|STARTED|Overall Study||21||
48547890|NCT03593538|101675270|FG002|STARTED|Overall Study||22||
48547891|NCT03593538|101675268|FG000|COMPLETED|Overall Study||15||
48547892|NCT03593538|101675269|FG001|COMPLETED|Overall Study||15||
48547893|NCT03593538|101675270|FG002|COMPLETED|Overall Study||11||
48547894|NCT03593538|101675268|FG000|NOT COMPLETED|Overall Study||11||
48547895|NCT03593538|101675269|FG001|NOT COMPLETED|Overall Study||6||
48547896|NCT03593538|101675270|FG002|NOT COMPLETED|Overall Study||11||
48547897|NCT00450801|101675271|FG000|STARTED|Overall Study||22||
48547898|NCT00450801|101675271|FG000|COMPLETED|Overall Study||21||
48547899|NCT00450801|101675271|FG000|NOT COMPLETED|Overall Study||1||
48547900|NCT02910011|101675272|FG000|STARTED|Overall Study||15||
48547901|NCT02910011|101675272|FG000|COMPLETED|Overall Study||13||
48547902|NCT02910011|101675272|FG000|NOT COMPLETED|Overall Study||2||
48547903|NCT02757326|101675273|FG000|STARTED|Overall Study||3||
48547904|NCT02757326|101675274|FG001|STARTED|Overall Study||4||
48547905|NCT02757326|101675275|FG002|STARTED|Overall Study||6||
48547906|NCT02757326|101675273|FG000|COMPLETED|Overall Study||3||
48547907|NCT02757326|101675274|FG001|COMPLETED|Overall Study||4||
48547908|NCT02757326|101675275|FG002|COMPLETED|Overall Study||6||
48547909|NCT02757326|101675273|FG000|NOT COMPLETED|Overall Study||0||
48547910|NCT02757326|101675274|FG001|NOT COMPLETED|Overall Study||0||
48547911|NCT02757326|101675275|FG002|NOT COMPLETED|Overall Study||0||
48547912|NCT01198132|101675276|FG000|STARTED|Overall Study||63||
48547913|NCT01198132|101675277|FG001|STARTED|Overall Study||66||
48547914|NCT01198132|101675276|FG000|COMPLETED|Overall Study||45||
48547915|NCT01198132|101675277|FG001|COMPLETED|Overall Study||45||
48547916|NCT01198132|101675276|FG000|NOT COMPLETED|Overall Study||18||
48547917|NCT01198132|101675277|FG001|NOT COMPLETED|Overall Study||21||
48547918|NCT05676814|101675278|FG000|STARTED|Overall Study||16||
48547919|NCT05676814|101675279|FG001|STARTED|Overall Study||15||
48547920|NCT05676814|101675278|FG000|COMPLETED|Overall Study||12||
48547921|NCT05676814|101675279|FG001|COMPLETED|Overall Study||8||
48547922|NCT05676814|101675278|FG000|NOT COMPLETED|Overall Study||4||
48547923|NCT05676814|101675279|FG001|NOT COMPLETED|Overall Study||7||
48547924|NCT03449446|101675280|FG000|STARTED|Overall Study||39||
48547925|NCT03449446|101675281|FG001|STARTED|Overall Study||40||
48547926|NCT03449446|101675282|FG002|STARTED|Overall Study||41||
48547927|NCT03449446|101675283|FG003|STARTED|Overall Study||80||
48547928|NCT03449446|101675284|FG004|STARTED|Overall Study||78||
48547929|NCT03449446|101675285|FG005|STARTED|Overall Study||78||
48547930|NCT03449446|101675286|FG006|STARTED|Overall Study||39||
48547931|NCT03449446|101675280|FG000|COMPLETED|Overall Study||3||
48547932|NCT03449446|101675281|FG001|COMPLETED|Overall Study||33||
48547933|NCT03449446|101675282|FG002|COMPLETED|Overall Study||34||
48547934|NCT03449446|101675283|FG003|COMPLETED|Overall Study||71||
48547935|NCT03449446|101675284|FG004|COMPLETED|Overall Study||66||
48547936|NCT03449446|101675285|FG005|COMPLETED|Overall Study||69||
48547937|NCT03449446|101675286|FG006|COMPLETED|Overall Study||38||
48547938|NCT03449446|101675280|FG000|NOT COMPLETED|Overall Study||36||
48547939|NCT03449446|101675281|FG001|NOT COMPLETED|Overall Study||7||
48547940|NCT03449446|101675282|FG002|NOT COMPLETED|Overall Study||7||
48547941|NCT03449446|101675283|FG003|NOT COMPLETED|Overall Study||9||
48547942|NCT03449446|101675284|FG004|NOT COMPLETED|Overall Study||12||
48547943|NCT03449446|101675285|FG005|NOT COMPLETED|Overall Study||9||
48547944|NCT03449446|101675286|FG006|NOT COMPLETED|Overall Study||1||
48547945|NCT03200717|101675287|FG000|STARTED|Overall Study||47||
48547946|NCT03200717|101675288|FG001|STARTED|Overall Study||15||
48547947|NCT03200717|101675287|FG000|COMPLETED|Overall Study||6||
48547948|NCT03200717|101675288|FG001|COMPLETED|Overall Study||0||
48547949|NCT03200717|101675287|FG000|NOT COMPLETED|Overall Study||41||
48547950|NCT03200717|101675288|FG001|NOT COMPLETED|Overall Study||15||
48547951|NCT00118534|101675289|FG000|STARTED|Overall Study||472||
48547952|NCT00118534|101675290|FG001|STARTED|Overall Study||471||
48547953|NCT00118534|101675289|FG000|COMPLETED|Overall Study||472||
48547954|NCT00118534|101675290|FG001|COMPLETED|Overall Study||471||
48547955|NCT00118534|101675289|FG000|NOT COMPLETED|Overall Study||0||
48547956|NCT00118534|101675290|FG001|NOT COMPLETED|Overall Study||0||
48547957|NCT02026687|101675291|FG000|STARTED|Overall Study||40||
48547958|NCT02026687|101675292|FG001|STARTED|Overall Study||40||
48547959|NCT02026687|101675291|FG000|COMPLETED|Overall Study||39||
48547960|NCT02026687|101675292|FG001|COMPLETED|Overall Study||38||
48547961|NCT02026687|101675291|FG000|NOT COMPLETED|Overall Study||1||
48547962|NCT02026687|101675292|FG001|NOT COMPLETED|Overall Study||2||
48547963|NCT01639157|101675293|FG000|STARTED|Overall Study||4||
48547964|NCT01639157|101675294|FG001|STARTED|Overall Study||5||
48691153|NCT01637584|102026022|FG000|COMPLETED|Overall Study||19||
48691154|NCT01637584|102026023|FG001|COMPLETED|Overall Study||17||
48691155|NCT01637584|102026022|FG000|NOT COMPLETED|Overall Study||1||
48691156|NCT01637584|102026023|FG001|NOT COMPLETED|Overall Study||3||
48691157|NCT04262882|102026024|FG000|STARTED|Overall Study||84||42
48691158|NCT04262882|102026025|FG001|STARTED|Overall Study||76||38
48547965|NCT01639157|101675293|FG000|COMPLETED|Overall Study||4||
48547966|NCT01639157|101675294|FG001|COMPLETED|Overall Study||5||
48547967|NCT01639157|101675293|FG000|NOT COMPLETED|Overall Study||0||
48547968|NCT01639157|101675294|FG001|NOT COMPLETED|Overall Study||0||
48547969|NCT05320887|101675295|FG000|STARTED|Overall Study||0||
48547970|NCT05320887|101675296|FG001|STARTED|Overall Study||32||
48547971|NCT05320887|101675297|FG002|STARTED|Overall Study||0||
48547972|NCT05320887|101675298|FG003|STARTED|Overall Study||32||
48691159|NCT04262882|102026024|FG000|COMPLETED|Overall Study||69||35
48691160|NCT04262882|102026025|FG001|COMPLETED|Overall Study||70||35
48691161|NCT04262882|102026024|FG000|NOT COMPLETED|Overall Study||15||7
48691162|NCT04262882|102026025|FG001|NOT COMPLETED|Overall Study||6||3
48691163|NCT02467192|102028831|FG000|STARTED|Overall Study||203||
48264552|NCT02701062|100970822|FG000|STARTED|365 Day Follow-up||308||
48264553|NCT02701062|100970823|FG001|STARTED|365 Day Follow-up||72||
48264554|NCT02701062|100970822|FG000|COMPLETED|365 Day Follow-up||294||
48264555|NCT02701062|100970823|FG001|COMPLETED|365 Day Follow-up||69||
48264556|NCT02701062|100970822|FG000|NOT COMPLETED|365 Day Follow-up||14||
48264557|NCT02701062|100970823|FG001|NOT COMPLETED|365 Day Follow-up||3||
48264558|NCT04978090|100970824|FG000|STARTED|Overall Study||2||
48264559|NCT04978090|100970824|FG000|COMPLETED|Overall Study||0||
48264560|NCT04978090|100970824|FG000|NOT COMPLETED|Overall Study||2||
48264561|NCT01580904|100970825|FG000|STARTED|Overall Study||51||
48264562|NCT01580904|100970826|FG001|STARTED|Overall Study||49||
48264563|NCT01580904|100970825|FG000|COMPLETED|Overall Study||47||
48547973|NCT05320887|101675295|FG000|COMPLETED|Overall Study||0||
48691164|NCT02467192|102028831|FG000|COMPLETED|Overall Study||200||
48691165|NCT02467192|102028831|FG000|NOT COMPLETED|Overall Study||3||
48691166|NCT02195700|102028832|FG000|STARTED|Overall Study||58||
48691167|NCT02195700|102028833|FG001|STARTED|Overall Study||59||
48691168|NCT02195700|102028832|FG000|Safety and ITT Populations|Overall Study||58||
48691169|NCT02195700|102028833|FG001|Safety and ITT Populations|Overall Study||59||
48691170|NCT02195700|102028832|FG000|Modified ITT Population|Overall Study||56||
48691171|NCT02195700|102028833|FG001|Modified ITT Population|Overall Study||57||
48547974|NCT05320887|101675296|FG001|COMPLETED|Overall Study||29||
48547975|NCT05320887|101675297|FG002|COMPLETED|Overall Study||0||
48547976|NCT05320887|101675298|FG003|COMPLETED|Overall Study||32||
48547977|NCT05320887|101675295|FG000|NOT COMPLETED|Overall Study||0||
48547978|NCT05320887|101675296|FG001|NOT COMPLETED|Overall Study||3||
48547979|NCT05320887|101675297|FG002|NOT COMPLETED|Overall Study||0||
48547980|NCT05320887|101675298|FG003|NOT COMPLETED|Overall Study||0||
48547981|NCT02289729|101675299|FG000|STARTED|Overall Study||59||
48547982|NCT02289729|101675299|FG000|COMPLETED|Overall Study||53||
48547983|NCT02289729|101675299|FG000|NOT COMPLETED|Overall Study||6||
48547984|NCT01106014|101675300|FG000|STARTED|Overall Study||574||
48547985|NCT01106014|101675301|FG001|STARTED|Overall Study||582||
48264564|NCT01580904|100970826|FG001|COMPLETED|Overall Study||42||
48264565|NCT01580904|100970825|FG000|NOT COMPLETED|Overall Study||4||
48264566|NCT01580904|100970826|FG001|NOT COMPLETED|Overall Study||7||
48264567|NCT00405938|100970827|FG000|STARTED|Overall Study||38||
48547986|NCT01106014|101675300|FG000|COMPLETED|Overall Study||289||
48547987|NCT01106014|101675301|FG001|COMPLETED|Overall Study||252||
48547988|NCT01106014|101675300|FG000|NOT COMPLETED|Overall Study||285||
48547989|NCT01106014|101675301|FG001|NOT COMPLETED|Overall Study||330||
48547990|NCT01881984|101675302|FG000|STARTED|Overall Study||4||
48547991|NCT01881984|101675302|FG000|COMPLETED|Overall Study||4||
48547992|NCT01881984|101675302|FG000|NOT COMPLETED|Overall Study||0||
48691172|NCT02195700|102028832|FG000|Maintenance Period|Overall Study||53||
48691173|NCT02195700|102028833|FG001|Maintenance Period|Overall Study||54||
48691174|NCT02195700|102028832|FG000|COMPLETED|Overall Study||52||
48691175|NCT02195700|102028833|FG001|COMPLETED|Overall Study||52||
48691176|NCT02195700|102028832|FG000|NOT COMPLETED|Overall Study||6||
48264568|NCT00405938|100970828|FG001|STARTED|Overall Study||41||
48264569|NCT00405938|100970827|FG000|COMPLETED|Overall Study||38||
48264570|NCT00405938|100970828|FG001|COMPLETED|Overall Study||41||
48264571|NCT00405938|100970827|FG000|NOT COMPLETED|Overall Study||0||
48264572|NCT00405938|100970828|FG001|NOT COMPLETED|Overall Study||0||
48547993|NCT00715624|101675303|FG000|STARTED|Overall Study||167||
48547994|NCT00715624|101675304|FG001|STARTED|Overall Study||329||
48547995|NCT00715624|101675303|FG000|Treated/Safety Population|Overall Study||167||
48547996|NCT00715624|101675304|FG001|Treated/Safety Population|Overall Study||328||
48547997|NCT00715624|101675303|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study||166||
48264573|NCT01263509|100970829|FG000|STARTED|Enrolled - Long-Term Extension Study||61||
48691177|NCT02195700|102028833|FG001|NOT COMPLETED|Overall Study||7||
48691178|NCT01101958|102028834|FG000|STARTED|Overall Study||62||
48691179|NCT01101958|102028835|FG001|STARTED|Overall Study||34||
48691180|NCT01101958|102028834|FG000|COMPLETED|Overall Study||51||
48691181|NCT01101958|102028835|FG001|COMPLETED|Overall Study||29||
48264574|NCT01263509|100970830|FG001|STARTED|Enrolled - Long-Term Extension Study||60||
48264575|NCT01263509|100970831|FG002|STARTED|Enrolled - Long-Term Extension Study||32||
48264576|NCT01263509|100970832|FG003|STARTED|Enrolled - Long-Term Extension Study||26||
48264577|NCT01263509|100970829|FG000|COMPLETED|Enrolled - Long-Term Extension Study||61||
48264578|NCT01263509|100970830|FG001|COMPLETED|Enrolled - Long-Term Extension Study||60||
48264579|NCT01263509|100970831|FG002|COMPLETED|Enrolled - Long-Term Extension Study||32||
48264580|NCT01263509|100970832|FG003|COMPLETED|Enrolled - Long-Term Extension Study||26||
48391064|NCT05109702|101287581|FG002|COMPLETED|Treatment Period (8 Weeks)||122||
48547998|NCT00715624|101675304|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||327||
48547999|NCT00715624|101675303|FG000|COMPLETED|Overall Study||115||
48548000|NCT00715624|101675304|FG001|COMPLETED|Overall Study||213||
48548001|NCT00715624|101675303|FG000|NOT COMPLETED|Overall Study||52||
48548002|NCT00715624|101675304|FG001|NOT COMPLETED|Overall Study||116||
48548003|NCT01137071|101675305|FG000|STARTED|Overall Study||29||
48548004|NCT01137071|101675305|FG000|COMPLETED|Overall Study||15||
48548005|NCT01137071|101675305|FG000|NOT COMPLETED|Overall Study||14||
48548006|NCT04113018|101675306|FG000|STARTED|Overall Study||39||
48548007|NCT04113018|101675306|FG000|COMPLETED|Overall Study||0||
48548008|NCT04113018|101675306|FG000|NOT COMPLETED|Overall Study||39||
48548009|NCT03132155|101675307|FG000|STARTED|Overall Study||8||
48548010|NCT03132155|101675307|FG000|COMPLETED|Overall Study||0||
48548011|NCT03132155|101675307|FG000|NOT COMPLETED|Overall Study||8||
48548012|NCT01964976|101675308|FG000|STARTED|Overall Study||1096||
48264581|NCT01263509|100970829|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
48264582|NCT01263509|100970830|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
48264583|NCT01263509|100970831|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
48264584|NCT01263509|100970832|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
48264585|NCT01263509|100970829|FG000|STARTED|Entered - Long-Term Extension Study||61||
48264586|NCT01263509|100970830|FG001|STARTED|Entered - Long-Term Extension Study||60||
48264587|NCT01263509|100970831|FG002|STARTED|Entered - Long-Term Extension Study||32||
48264588|NCT01263509|100970832|FG003|STARTED|Entered - Long-Term Extension Study||26||
48264589|NCT01263509|100970829|FG000|COMPLETED|Entered - Long-Term Extension Study||53||
48264590|NCT01263509|100970830|FG001|COMPLETED|Entered - Long-Term Extension Study||48||
48264591|NCT01263509|100970831|FG002|COMPLETED|Entered - Long-Term Extension Study||27||
48264592|NCT01263509|100970832|FG003|COMPLETED|Entered - Long-Term Extension Study||24||
48264593|NCT01263509|100970829|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||8||
48264594|NCT01263509|100970830|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||12||
48264595|NCT01263509|100970831|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||5||
48264596|NCT01263509|100970832|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||2||
48264597|NCT02838134|100970833|FG000|STARTED|Overall Study||50||
48264598|NCT02838134|100970834|FG001|STARTED|Overall Study||51||
48264599|NCT02838134|100970833|FG000|COMPLETED|Overall Study||48||
48264600|NCT02838134|100970834|FG001|COMPLETED|Overall Study||48||
48264601|NCT02838134|100970833|FG000|NOT COMPLETED|Overall Study||2||
48391065|NCT05109702|101287579|FG000|NOT COMPLETED|Treatment Period (8 Weeks)||0||
48391066|NCT05109702|101287580|FG001|NOT COMPLETED|Treatment Period (8 Weeks)||14||
48391067|NCT05109702|101287581|FG002|NOT COMPLETED|Treatment Period (8 Weeks)||8||
48391068|NCT01203787|101287582|FG000|STARTED|Overall Study||63||
48391069|NCT01203787|101287583|FG001|STARTED|Overall Study||57||
48391070|NCT01203787|101287582|FG000|COMPLETED|Overall Study||32||
48391071|NCT01203787|101287583|FG001|COMPLETED|Overall Study||30||
48391072|NCT01203787|101287582|FG000|NOT COMPLETED|Overall Study||31||
48391073|NCT01203787|101287583|FG001|NOT COMPLETED|Overall Study||27||
48391074|NCT01769469|101287584|FG000|STARTED|Overall Study||101||
48391075|NCT01769469|101287584|FG000|COMPLETED|Overall Study||66||
48391076|NCT01769469|101287584|FG000|NOT COMPLETED|Overall Study||35||
48391077|NCT03625141|101287585|FG000|STARTED|Overall Study||15||
48391078|NCT03625141|101287586|FG001|STARTED|Overall Study||65||
48391079|NCT03625141|101287585|FG000|COMPLETED|Overall Study||0||
48391080|NCT03625141|101287586|FG001|COMPLETED|Overall Study||0||
48391081|NCT03625141|101287585|FG000|NOT COMPLETED|Overall Study||15||
48391082|NCT03625141|101287586|FG001|NOT COMPLETED|Overall Study||65||
48391083|NCT00629525|101287587|FG000|STARTED|Overall Study||35||
48391084|NCT00629525|101287587|FG000|COMPLETED|Overall Study||32||
48391085|NCT00629525|101287587|FG000|NOT COMPLETED|Overall Study||3||
48391086|NCT00444080|101287588|FG000|STARTED|Overall Study||61||
48391087|NCT00444080|101287589|FG001|STARTED|Overall Study||59||
48391088|NCT00444080|101287588|FG000|COMPLETED|Overall Study||61||
48391089|NCT00444080|101287589|FG001|COMPLETED|Overall Study||59||
48391090|NCT00444080|101287588|FG000|NOT COMPLETED|Overall Study||0||
48391091|NCT00444080|101287589|FG001|NOT COMPLETED|Overall Study||0||
48391092|NCT00166517|101287590|FG000|STARTED|Overall Study||115||
48548013|NCT01964976|101675308|FG000|COMPLETED|Overall Study||1065||
48548014|NCT01964976|101675308|FG000|NOT COMPLETED|Overall Study||31||
48391093|NCT00166517|101287591|FG001|STARTED|Overall Study||63||
48391094|NCT00166517|101287590|FG000|Vaccinated at Visit 1|Overall Study||115||
48391095|NCT00166517|101287591|FG001|Vaccinated at Visit 1|Overall Study||63||
48391096|NCT00166517|101287590|FG000|Vaccinated at Visit 2|Overall Study||112||
48548015|NCT01412086|101675309|FG000|STARTED|Overall Study||112||
48548016|NCT01412086|101675309|FG000|COMPLETED|Overall Study||112||
48548017|NCT01412086|101675309|FG000|NOT COMPLETED|Overall Study||0||
48548018|NCT01806571|101675310|FG000|STARTED|Overall Study||34||
48548019|NCT01806571|101675310|FG000|COMPLETED|Overall Study||34||
48548020|NCT01806571|101675310|FG000|NOT COMPLETED|Overall Study||0||
48548021|NCT02289456|101675311|FG000|STARTED|Induction Period||40||
48548022|NCT02289456|101675311|FG000|Treated Population|Induction Period||40||
48548023|NCT02289456|101675311|FG000|COMPLETED|Induction Period||16||
48548024|NCT02289456|101675311|FG000|NOT COMPLETED|Induction Period||24||
48548025|NCT02289456|101675311|FG000|STARTED|Monotherapy Period||16||
48548026|NCT02289456|101675311|FG000|COMPLETED|Monotherapy Period||0||
48548027|NCT02289456|101675311|FG000|NOT COMPLETED|Monotherapy Period||16||
48548028|NCT00708227|101675312|FG000|STARTED|Overall Study||19||
48548029|NCT00708227|101675313|FG001|STARTED|Overall Study||26||
48548030|NCT00708227|101675314|FG002|STARTED|Overall Study||18||
48548031|NCT00708227|101675315|FG003|STARTED|Overall Study||25||
48548032|NCT00708227|101675312|FG000|COMPLETED|Overall Study||18||
48548033|NCT00708227|101675313|FG001|COMPLETED|Overall Study||21||
48548034|NCT00708227|101675314|FG002|COMPLETED|Overall Study||17||
48548035|NCT00708227|101675315|FG003|COMPLETED|Overall Study||22||
48548036|NCT00708227|101675312|FG000|NOT COMPLETED|Overall Study||1||
48548037|NCT00708227|101675313|FG001|NOT COMPLETED|Overall Study||5||
48548038|NCT00708227|101675314|FG002|NOT COMPLETED|Overall Study||1||
48548039|NCT00708227|101675315|FG003|NOT COMPLETED|Overall Study||3||
48548040|NCT02552121|101675316|FG000|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||3||
48548041|NCT02552121|101675317|FG001|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0||
48548042|NCT02552121|101675318|FG002|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0||
48548043|NCT02552121|101675319|FG003|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0||
48548044|NCT02552121|101675320|FG004|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0||
48548045|NCT02552121|101675321|FG005|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0||
48548046|NCT02552121|101675322|FG006|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0||
48548047|NCT02552121|101675323|FG007|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0||
48548048|NCT02552121|101675316|FG000|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0||
48548049|NCT02552121|101675317|FG001|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0||
48548050|NCT02552121|101675318|FG002|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0||
48548051|NCT02552121|101675319|FG003|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0||
48548052|NCT02552121|101675320|FG004|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0||
48548053|NCT02552121|101675321|FG005|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0||
48548054|NCT02552121|101675322|FG006|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0||
48548055|NCT02552121|101675323|FG007|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0||
48548056|NCT02552121|101675316|FG000|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||3||
48548057|NCT02552121|101675317|FG001|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0||
48548058|NCT02552121|101675318|FG002|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0||
48548059|NCT02552121|101675319|FG003|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0||
48548060|NCT02552121|101675320|FG004|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0||
48548061|NCT02552121|101675321|FG005|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0||
48548062|NCT02552121|101675322|FG006|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0||
48548063|NCT02552121|101675323|FG007|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0||
48548064|NCT02552121|101675316|FG000|STARTED|Part 1: Dose Level 2 (Week 17-48)||0||
48548065|NCT02552121|101675317|FG001|STARTED|Part 1: Dose Level 2 (Week 17-48)||6||
48548066|NCT02552121|101675318|FG002|STARTED|Part 1: Dose Level 2 (Week 17-48)||0||
48548067|NCT02552121|101675319|FG003|STARTED|Part 1: Dose Level 2 (Week 17-48)||0||
48548068|NCT02552121|101675320|FG004|STARTED|Part 1: Dose Level 2 (Week 17-48)||0||
48548069|NCT02552121|101675321|FG005|STARTED|Part 1: Dose Level 2 (Week 17-48)||0||
48548070|NCT02552121|101675322|FG006|STARTED|Part 1: Dose Level 2 (Week 17-48)||0||
48548071|NCT02552121|101675323|FG007|STARTED|Part 1: Dose Level 2 (Week 17-48)||0||
48548072|NCT02552121|101675316|FG000|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0||
48548073|NCT02552121|101675317|FG001|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0||
48548074|NCT02552121|101675318|FG002|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0||
48548075|NCT02552121|101675319|FG003|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0||
48548076|NCT02552121|101675320|FG004|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0||
48548077|NCT02552121|101675321|FG005|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0||
48548078|NCT02552121|101675322|FG006|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0||
48548079|NCT02552121|101675323|FG007|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0||
48548080|NCT02552121|101675316|FG000|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0||
48548081|NCT02552121|101675317|FG001|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||6||
48548082|NCT02552121|101675318|FG002|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0||
48548083|NCT02552121|101675319|FG003|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0||
48548084|NCT02552121|101675320|FG004|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0||
48548085|NCT02552121|101675321|FG005|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0||
48548086|NCT02552121|101675322|FG006|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0||
48548087|NCT02552121|101675323|FG007|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0||
48548088|NCT02552121|101675316|FG000|STARTED|Part 2: Cohort Expansion||0||
48548089|NCT02552121|101675317|FG001|STARTED|Part 2: Cohort Expansion||0||
48548090|NCT02552121|101675318|FG002|STARTED|Part 2: Cohort Expansion||11||
48548091|NCT02552121|101675319|FG003|STARTED|Part 2: Cohort Expansion||3||
48691182|NCT01101958|102028834|FG000|NOT COMPLETED|Overall Study||11||
48691183|NCT01101958|102028835|FG001|NOT COMPLETED|Overall Study||5||
48691184|NCT00995436|102028836|FG000|STARTED|Overall Study||25||
48691185|NCT00995436|102028837|FG001|STARTED|Overall Study||27||
48691186|NCT00995436|102028838|FG002|STARTED|Overall Study||26||
48691187|NCT00995436|102028836|FG000|COMPLETED|Overall Study||23||
48691188|NCT00995436|102028837|FG001|COMPLETED|Overall Study||22||
48691189|NCT00995436|102028838|FG002|COMPLETED|Overall Study||26||
48691190|NCT00995436|102028836|FG000|NOT COMPLETED|Overall Study||2||
48691191|NCT00995436|102028837|FG001|NOT COMPLETED|Overall Study||5||
48691192|NCT00995436|102028838|FG002|NOT COMPLETED|Overall Study||0||
48691193|NCT05141175|102028839|FG000|STARTED|Overall Study||20||
48691194|NCT05141175|102028839|FG000|COMPLETED|Overall Study||19||
48691195|NCT05141175|102028839|FG000|NOT COMPLETED|Overall Study||1||
48691196|NCT00070109|102028840|FG000|STARTED|Overall Study||8||
48691197|NCT00070109|102028841|FG001|STARTED|Overall Study||6||
48691198|NCT00070109|102028842|FG002|STARTED|Overall Study||8||
48691199|NCT00070109|102028843|FG003|STARTED|Overall Study||20||
48691200|NCT00070109|102028844|FG004|STARTED|Overall Study||8||
48691201|NCT00070109|102028840|FG000|COMPLETED|Overall Study||0||
48691202|NCT00070109|102028841|FG001|COMPLETED|Overall Study||0||
48691203|NCT00070109|102028842|FG002|COMPLETED|Overall Study||0||
48691204|NCT00070109|102028843|FG003|COMPLETED|Overall Study||0||
48691205|NCT00070109|102028844|FG004|COMPLETED|Overall Study||0||
48691206|NCT00070109|102028840|FG000|NOT COMPLETED|Overall Study||8||
48691207|NCT00070109|102028841|FG001|NOT COMPLETED|Overall Study||6||
48691208|NCT00070109|102028842|FG002|NOT COMPLETED|Overall Study||8||
48691209|NCT00070109|102028843|FG003|NOT COMPLETED|Overall Study||20||
48691210|NCT00070109|102028844|FG004|NOT COMPLETED|Overall Study||8||
48691211|NCT03941964|102028845|FG000|STARTED|Overall Study||30||
48691212|NCT03941964|102028846|FG001|STARTED|Overall Study||30||
48691213|NCT03941964|102028845|FG000|COMPLETED|Overall Study||7||
48691214|NCT03941964|102028846|FG001|COMPLETED|Overall Study||11||
48691215|NCT03941964|102028845|FG000|NOT COMPLETED|Overall Study||23||
48691216|NCT03941964|102028846|FG001|NOT COMPLETED|Overall Study||19||
48691217|NCT01454505|102028847|FG000|STARTED|Overall Study||35||
48691218|NCT01454505|102028848|FG001|STARTED|Overall Study||15||
48691219|NCT01454505|102028849|FG002|STARTED|Overall Study||40||
48691220|NCT01454505|102028850|FG003|STARTED|Overall Study||20||
48691221|NCT01454505|102028847|FG000|COMPLETED|Overall Study||35||
48691222|NCT01454505|102028848|FG001|COMPLETED|Overall Study||15||
48691223|NCT01454505|102028849|FG002|COMPLETED|Overall Study||40||
48691224|NCT01454505|102028850|FG003|COMPLETED|Overall Study||20||
48691225|NCT01454505|102028847|FG000|NOT COMPLETED|Overall Study||0||
48691226|NCT01454505|102028848|FG001|NOT COMPLETED|Overall Study||0||
48691227|NCT01454505|102028849|FG002|NOT COMPLETED|Overall Study||0||
48691228|NCT01454505|102028850|FG003|NOT COMPLETED|Overall Study||0||
48691229|NCT02016716|102028851|FG000|STARTED|Overall Study||53||
48691230|NCT02016716|102028852|FG001|STARTED|Overall Study||118||
48691231|NCT02016716|102028853|FG002|STARTED|Overall Study||123||
48691232|NCT02016716|102028851|FG000|Received Study Treatment|Overall Study||53||
48691233|NCT02016716|102028852|FG001|Received Study Treatment|Overall Study||118||
48691234|NCT02016716|102028853|FG002|Received Study Treatment|Overall Study||123||
48691235|NCT02016716|102028851|FG000|COMPLETED|Overall Study||47||
48691236|NCT02016716|102028852|FG001|COMPLETED|Overall Study||110||
48691237|NCT02016716|102028853|FG002|COMPLETED|Overall Study||117||
48691238|NCT02016716|102028851|FG000|NOT COMPLETED|Overall Study||6||
48691239|NCT02016716|102028852|FG001|NOT COMPLETED|Overall Study||8||
48691240|NCT02016716|102028853|FG002|NOT COMPLETED|Overall Study||6||
48691241|NCT01475643|102028854|FG000|STARTED|Overall Study||54||
48691242|NCT01475643|102028855|FG001|STARTED|Overall Study||53||
48691243|NCT01475643|102028854|FG000|COMPLETED|Overall Study||40||
48691244|NCT01475643|102028855|FG001|COMPLETED|Overall Study||43||
48691245|NCT01475643|102028854|FG000|NOT COMPLETED|Overall Study||14||
48691246|NCT01475643|102028855|FG001|NOT COMPLETED|Overall Study||10||
48691247|NCT00335283|102028856|FG000|STARTED|Overall Study||36||
48691248|NCT00335283|102028857|FG001|STARTED|Overall Study||39||
48691249|NCT00335283|102028856|FG000|COMPLETED|Overall Study||30||
48691250|NCT00335283|102028857|FG001|COMPLETED|Overall Study||34||
48691251|NCT00335283|102028856|FG000|NOT COMPLETED|Overall Study||6||
48691252|NCT00335283|102028857|FG001|NOT COMPLETED|Overall Study||5||
48691253|NCT01063062|102028858|FG000|STARTED|Overall Study||30||
48691254|NCT01063062|102028859|FG001|STARTED|Overall Study||77||
48691255|NCT01063062|102028858|FG000|Received Study Drug|Overall Study||29||
48691256|NCT01063062|102028859|FG001|Received Study Drug|Overall Study||76||
48691257|NCT01063062|102028858|FG000|COMPLETED|Overall Study||22||
48691258|NCT01063062|102028859|FG001|COMPLETED|Overall Study||65||
48691259|NCT01063062|102028858|FG000|NOT COMPLETED|Overall Study||8||
48691260|NCT01063062|102028859|FG001|NOT COMPLETED|Overall Study||12||
48691261|NCT01407952|102028860|FG000|STARTED|Overall Study||297||
48691262|NCT01407952|102028861|FG001|STARTED|Overall Study||303||
48691263|NCT01407952|102028860|FG000|COMPLETED|Overall Study||251||
48691264|NCT01407952|102028861|FG001|COMPLETED|Overall Study||266||
48691265|NCT01407952|102028860|FG000|NOT COMPLETED|Overall Study||46||
48691266|NCT01407952|102028861|FG001|NOT COMPLETED|Overall Study||37||
48101959|NCT01476696|100575463|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9||
48101960|NCT01476696|100575461|FG000|COMPLETED|Overall Study||12||
48101961|NCT01476696|100575462|FG001|COMPLETED|Overall Study||8||
48101962|NCT01476696|100575463|FG002|COMPLETED|Overall Study||9||
48101963|NCT01476696|100575461|FG000|NOT COMPLETED|Overall Study||3||
48101964|NCT01476696|100575462|FG001|NOT COMPLETED|Overall Study||1||
48101965|NCT01476696|100575463|FG002|NOT COMPLETED|Overall Study||0||
48101966|NCT00589316|100575464|FG000|STARTED|Overall Study||1||
48101967|NCT00589316|100575465|FG001|STARTED|Overall Study||1||
48101968|NCT00589316|100575466|FG002|STARTED|Overall Study||5||
48101969|NCT00589316|100575467|FG003|STARTED|Overall Study||1||
48101970|NCT00589316|100575468|FG004|STARTED|Overall Study||1||
48101971|NCT00589316|100575469|FG005|STARTED|Overall Study||2||
48101972|NCT00589316|100575470|FG006|STARTED|Overall Study||7||
48101973|NCT00589316|100575471|FG007|STARTED|Overall Study||7||
48101974|NCT00589316|100575464|FG000|COMPLETED|Overall Study||1||
48101975|NCT00589316|100575465|FG001|COMPLETED|Overall Study||1||
48101976|NCT00589316|100575466|FG002|COMPLETED|Overall Study||5||
48101977|NCT00589316|100575467|FG003|COMPLETED|Overall Study||1||
48101978|NCT00589316|100575468|FG004|COMPLETED|Overall Study||1||
48548092|NCT02552121|101675320|FG004|STARTED|Part 2: Cohort Expansion||1||
48548093|NCT02552121|101675321|FG005|STARTED|Part 2: Cohort Expansion||5||
48548094|NCT02552121|101675322|FG006|STARTED|Part 2: Cohort Expansion||1||
48548095|NCT02552121|101675323|FG007|STARTED|Part 2: Cohort Expansion||3||
48548096|NCT02552121|101675316|FG000|COMPLETED|Part 2: Cohort Expansion||0||
48548097|NCT02552121|101675317|FG001|COMPLETED|Part 2: Cohort Expansion||0||
48548098|NCT02552121|101675318|FG002|COMPLETED|Part 2: Cohort Expansion||0||
48548099|NCT02552121|101675319|FG003|COMPLETED|Part 2: Cohort Expansion||0||
48548100|NCT02552121|101675320|FG004|COMPLETED|Part 2: Cohort Expansion||0||
48548101|NCT02552121|101675321|FG005|COMPLETED|Part 2: Cohort Expansion||1||
48548102|NCT02552121|101675322|FG006|COMPLETED|Part 2: Cohort Expansion||0||
48548103|NCT02552121|101675323|FG007|COMPLETED|Part 2: Cohort Expansion||0||
48548104|NCT02552121|101675316|FG000|NOT COMPLETED|Part 2: Cohort Expansion||0||
48548105|NCT02552121|101675317|FG001|NOT COMPLETED|Part 2: Cohort Expansion||0||
48548106|NCT02552121|101675318|FG002|NOT COMPLETED|Part 2: Cohort Expansion||11||
48548107|NCT02552121|101675319|FG003|NOT COMPLETED|Part 2: Cohort Expansion||3||
48264602|NCT02838134|100970834|FG001|NOT COMPLETED|Overall Study||3||
48264603|NCT04351269|100970835|FG000|STARTED|Overall Study||237||
48264604|NCT04351269|100970836|FG001|STARTED|Overall Study||260||
48548108|NCT02552121|101675320|FG004|NOT COMPLETED|Part 2: Cohort Expansion||1||
48548109|NCT02552121|101675321|FG005|NOT COMPLETED|Part 2: Cohort Expansion||4||
48548110|NCT02552121|101675322|FG006|NOT COMPLETED|Part 2: Cohort Expansion||1||
48548111|NCT02552121|101675323|FG007|NOT COMPLETED|Part 2: Cohort Expansion||3||
48548112|NCT01350245|101675324|FG000|STARTED|Overall Study||28||
48548113|NCT01350245|101675324|FG000|COMPLETED|Overall Study||28||
48548114|NCT01350245|101675324|FG000|NOT COMPLETED|Overall Study||0||
48548115|NCT01399658|101675325|FG000|STARTED|Overall Study||93||
48548116|NCT01399658|101675325|FG000|COMPLETED|Overall Study||87||
48548117|NCT01399658|101675325|FG000|NOT COMPLETED|Overall Study||6||
48548118|NCT03245827|101675326|FG000|STARTED|Overall Study||1||
48548119|NCT03245827|101675327|FG001|STARTED|Overall Study||0||
48548120|NCT03245827|101675328|FG002|STARTED|Overall Study||3||
48548121|NCT03245827|101675329|FG003|STARTED|Overall Study||5||
48548122|NCT03245827|101675326|FG000|COMPLETED|Overall Study||1||
48548123|NCT03245827|101675327|FG001|COMPLETED|Overall Study||0||
48101979|NCT00589316|100575469|FG005|COMPLETED|Overall Study||2||
48101980|NCT00589316|100575470|FG006|COMPLETED|Overall Study||7||
48101981|NCT00589316|100575471|FG007|COMPLETED|Overall Study||7||
48101982|NCT00589316|100575464|FG000|NOT COMPLETED|Overall Study||0||
48101983|NCT00589316|100575465|FG001|NOT COMPLETED|Overall Study||0||
48101984|NCT00589316|100575466|FG002|NOT COMPLETED|Overall Study||0||
48101985|NCT00589316|100575467|FG003|NOT COMPLETED|Overall Study||0||
48101986|NCT00589316|100575468|FG004|NOT COMPLETED|Overall Study||0||
48101987|NCT00589316|100575469|FG005|NOT COMPLETED|Overall Study||0||
48548124|NCT03245827|101675328|FG002|COMPLETED|Overall Study||3||
48548125|NCT03245827|101675329|FG003|COMPLETED|Overall Study||5||
48548126|NCT03245827|101675326|FG000|NOT COMPLETED|Overall Study||0||
48548127|NCT03245827|101675327|FG001|NOT COMPLETED|Overall Study||0||
48548128|NCT03245827|101675328|FG002|NOT COMPLETED|Overall Study||0||
48101988|NCT00589316|100575470|FG006|NOT COMPLETED|Overall Study||0||
48101989|NCT00589316|100575471|FG007|NOT COMPLETED|Overall Study||0||
48101990|NCT00323492|100575472|FG000|STARTED|Study Phase 1||47||
48101991|NCT00323492|100575473|FG001|STARTED|Study Phase 1||45||
48101992|NCT00323492|100575474|FG002|STARTED|Study Phase 1||0||
48101993|NCT00323492|100575472|FG000|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||46||
48264605|NCT04351269|100970837|FG002|STARTED|Overall Study||100||
48548129|NCT03245827|101675329|FG003|NOT COMPLETED|Overall Study||0||
48548130|NCT01523002|101675330|FG000|STARTED|Period 1||26|Arm A: metaprolol (Day 1) Arm B: pyronaridine-artesunate (Days 1, 2 \& 3)|
48548131|NCT01523002|101675331|FG001|STARTED|Period 1||30|Arm A: metaprolol (Day 1) Arm B: pyronaridine-artesunate (Days 1, 2 \& 3)|
48548132|NCT01523002|101675330|FG000|COMPLETED|Period 1||24||
48548133|NCT01523002|101675331|FG001|COMPLETED|Period 1||19||
48264606|NCT04351269|100970835|FG000|COMPLETED|Overall Study||165||
48264607|NCT04351269|100970836|FG001|COMPLETED|Overall Study||219||
48264608|NCT04351269|100970837|FG002|COMPLETED|Overall Study||71||
48264609|NCT04351269|100970835|FG000|NOT COMPLETED|Overall Study||72||
48264610|NCT04351269|100970836|FG001|NOT COMPLETED|Overall Study||41||
48264611|NCT04351269|100970837|FG002|NOT COMPLETED|Overall Study||29||
48264612|NCT03682185|100970838|FG000|STARTED|Overall Study||105||
48264613|NCT03682185|100970839|FG001|STARTED|Overall Study||105||
48264614|NCT03682185|100970840|FG002|STARTED|Overall Study||105||
48264615|NCT03682185|100970841|FG003|STARTED|Overall Study||105||
48264616|NCT03682185|100970842|FG004|STARTED|Overall Study||1||
48264617|NCT03682185|100970838|FG000|COMPLETED|Overall Study||94||
48264618|NCT03682185|100970839|FG001|COMPLETED|Overall Study||95||
48264619|NCT03682185|100970840|FG002|COMPLETED|Overall Study||94||
48264620|NCT03682185|100970841|FG003|COMPLETED|Overall Study||95||
48264621|NCT03682185|100970842|FG004|COMPLETED|Overall Study||0||
48264622|NCT03682185|100970838|FG000|NOT COMPLETED|Overall Study||11||
48264623|NCT03682185|100970839|FG001|NOT COMPLETED|Overall Study||10||
48101994|NCT00323492|100575473|FG001|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||45||
48264624|NCT03682185|100970840|FG002|NOT COMPLETED|Overall Study||11||
48391097|NCT00166517|101287591|FG001|Vaccinated at Visit 2|Overall Study||61||
48391098|NCT00166517|101287590|FG000|Vaccinated at Visit 3|Overall Study||110||
48391099|NCT00166517|101287591|FG001|Vaccinated at Visit 3|Overall Study||61||
48391100|NCT00166517|101287590|FG000|COMPLETED|Overall Study||110||
48391101|NCT00166517|101287591|FG001|COMPLETED|Overall Study||61||
48391102|NCT00166517|101287590|FG000|NOT COMPLETED|Overall Study||5||
48391103|NCT00166517|101287591|FG001|NOT COMPLETED|Overall Study||2||
48391104|NCT00788697|101287592|FG000|STARTED|Overall Study||349||
48548134|NCT01523002|101675330|FG000|NOT COMPLETED|Period 1||2||
48548135|NCT01523002|101675331|FG001|NOT COMPLETED|Period 1||11||
48548136|NCT01523002|101675330|FG000|STARTED|Period 2||24|Arm A: pyronaridine-artesunate (Days 8 \& 9); pyronaridine-artesunate and metoprolol (Day 10) Arm B: pyronaridine-artesunate (Days 61, 62 \& 63)|
48548137|NCT01523002|101675331|FG001|STARTED|Period 2||19|Arm A: pyronaridine-artesunate (Days 8 \& 9); pyronaridine-artesunate and metoprolol (Day 10) Arm B: pyronaridine-artesunate (Days 61, 62 \& 63)|
48548138|NCT01523002|101675330|FG000|COMPLETED|Period 2||18||
48548139|NCT01523002|101675331|FG001|COMPLETED|Period 2||13||
48548140|NCT01523002|101675330|FG000|NOT COMPLETED|Period 2||6||
48548141|NCT01523002|101675331|FG001|NOT COMPLETED|Period 2||6||
48548142|NCT01523002|101675330|FG000|STARTED|Period 3||18|Arm A: Pyronaridine-artesunate (Days 98, 99 \& 100) Arm B: NA for study design|
48548143|NCT01523002|101675331|FG001|STARTED|Period 3||0|Arm A: Pyronaridine-artesunate (Days 98, 99 \& 100) Arm B: NA for study design|
48548144|NCT01523002|101675330|FG000|COMPLETED|Period 3||14||
48548145|NCT01523002|101675331|FG001|COMPLETED|Period 3||0||
48548146|NCT01523002|101675330|FG000|NOT COMPLETED|Period 3||4||
48548147|NCT01523002|101675331|FG001|NOT COMPLETED|Period 3||0||
48548148|NCT01478373|101675332|FG000|STARTED|Treatment Phase||39||
48548149|NCT01478373|101675332|FG000|COMPLETED|Treatment Phase||38||
48548150|NCT01478373|101675332|FG000|NOT COMPLETED|Treatment Phase||1||
48548151|NCT01478373|101675332|FG000|STARTED|Survival Phase||38||
48548152|NCT01478373|101675332|FG000|COMPLETED|Survival Phase||0||
48548153|NCT01478373|101675332|FG000|NOT COMPLETED|Survival Phase||38||
48548154|NCT02586155|101675333|FG000|STARTED|Overall Study||1215||
48548155|NCT02586155|101675334|FG001|STARTED|Overall Study||1210||
48548156|NCT02586155|101675333|FG000|Final Number Randomized|Overall Study||1212||
48264625|NCT03682185|100970841|FG003|NOT COMPLETED|Overall Study||10||
48264626|NCT03682185|100970842|FG004|NOT COMPLETED|Overall Study||1||
48264627|NCT00935532|100970843|FG000|STARTED|Overall Study||215||
48264628|NCT00935532|100970844|FG001|STARTED|Overall Study||212||
48264629|NCT00935532|100970843|FG000|COMPLETED|Overall Study||193||
48391105|NCT00788697|101287592|FG000|COMPLETED|Overall Study||240||
48391106|NCT00788697|101287592|FG000|NOT COMPLETED|Overall Study||109||
48391107|NCT00810095|101287593|FG000|STARTED|Overall Study||40||
48391108|NCT00810095|101287593|FG000|COMPLETED|Overall Study||40||
48391109|NCT00810095|101287593|FG000|NOT COMPLETED|Overall Study||0||
48391110|NCT00289744|101287594|FG000|STARTED|Year 6 Long-term Follow-up||178||
48391111|NCT00289744|101287595|FG001|STARTED|Year 6 Long-term Follow-up||0||
48391112|NCT00289744|101287596|FG002|STARTED|Year 6 Long-term Follow-up||0||
48391113|NCT00289744|101287594|FG000|COMPLETED|Year 6 Long-term Follow-up||178||
48391114|NCT00289744|101287595|FG001|COMPLETED|Year 6 Long-term Follow-up||0||
48548157|NCT02586155|101675334|FG001|Final Number Randomized|Overall Study||1206||
48548158|NCT02586155|101675333|FG000|COMPLETED|Overall Study||1088||
48548159|NCT02586155|101675334|FG001|COMPLETED|Overall Study||1083||
48548160|NCT02586155|101675333|FG000|NOT COMPLETED|Overall Study||127||
48548161|NCT02586155|101675334|FG001|NOT COMPLETED|Overall Study||127||
48264630|NCT00935532|100970844|FG001|COMPLETED|Overall Study||201||
48264631|NCT00935532|100970843|FG000|NOT COMPLETED|Overall Study||22||
48264632|NCT00935532|100970844|FG001|NOT COMPLETED|Overall Study||11||
48264633|NCT01963169|100970845|FG000|STARTED|Overall Study||301||
48264634|NCT01963169|100970846|FG001|STARTED|Overall Study||302||
48264635|NCT01963169|100970847|FG002|STARTED|Overall Study||263||
48391115|NCT00289744|101287596|FG002|COMPLETED|Year 6 Long-term Follow-up||0||
48548162|NCT03120325|101675335|FG000|STARTED|Overall Study||17||
48548163|NCT03120325|101675336|FG001|STARTED|Overall Study||1||
48548164|NCT03120325|101675337|FG002|STARTED|Overall Study||6||
48548165|NCT03120325|101675335|FG000|Used Device (Received Treatment)|Overall Study||15||
48548166|NCT03120325|101675336|FG001|Used Device (Received Treatment)|Overall Study||1||
48548167|NCT03120325|101675337|FG002|Used Device (Received Treatment)|Overall Study||5||
48548168|NCT03120325|101675335|FG000|COMPLETED|Overall Study||15||
48548169|NCT03120325|101675336|FG001|COMPLETED|Overall Study||1||
48548170|NCT03120325|101675337|FG002|COMPLETED|Overall Study||5||
48264636|NCT01963169|100970845|FG000|COMPLETED|Overall Study||242||
48264637|NCT01963169|100970846|FG001|COMPLETED|Overall Study||220||
48264638|NCT01963169|100970847|FG002|COMPLETED|Overall Study||237||
48264639|NCT01963169|100970845|FG000|NOT COMPLETED|Overall Study||59||
48264640|NCT01963169|100970846|FG001|NOT COMPLETED|Overall Study||82||
48264641|NCT01963169|100970847|FG002|NOT COMPLETED|Overall Study||26||
48548171|NCT03120325|101675335|FG000|NOT COMPLETED|Overall Study||2||
48548172|NCT03120325|101675336|FG001|NOT COMPLETED|Overall Study||0||
48548173|NCT03120325|101675337|FG002|NOT COMPLETED|Overall Study||1||
48548174|NCT01876446|101675338|FG000|STARTED|Overall Study||20||
48548175|NCT01876446|101675339|FG001|STARTED|Overall Study||18||
48548176|NCT01876446|101675338|FG000|COMPLETED|Overall Study||18||
48548177|NCT01876446|101675339|FG001|COMPLETED|Overall Study||12||
48548178|NCT01876446|101675338|FG000|NOT COMPLETED|Overall Study||2||
48548179|NCT01876446|101675339|FG001|NOT COMPLETED|Overall Study||6||
48548180|NCT04359797|101675340|FG000|STARTED|Overall Study||243||
48548181|NCT04359797|101675341|FG001|STARTED|Overall Study||258||
48548182|NCT04359797|101675340|FG000|COMPLETED|Overall Study||243||
48548183|NCT04359797|101675341|FG001|COMPLETED|Overall Study||258||
48548184|NCT04359797|101675340|FG000|NOT COMPLETED|Overall Study||0||
48548185|NCT04359797|101675341|FG001|NOT COMPLETED|Overall Study||0||
48548186|NCT01308424|101675342|FG000|STARTED|Baseline Eligibility||242||
48548187|NCT01308424|101675343|FG001|STARTED|Baseline Eligibility||0||
48548188|NCT01308424|101675344|FG002|STARTED|Baseline Eligibility||0||
48548189|NCT01308424|101675342|FG000|COMPLETED|Baseline Eligibility||171||
48548190|NCT01308424|101675343|FG001|COMPLETED|Baseline Eligibility||0||
48548191|NCT01308424|101675344|FG002|COMPLETED|Baseline Eligibility||0||
48264642|NCT05144945|100970848|FG000|STARTED|Overall Study||150||
48264643|NCT05144945|100970849|FG001|STARTED|Overall Study||151||
48264644|NCT05144945|100970848|FG000|Safety Analysis Set|Overall Study||149|Participants who received a dose of the study vaccine and were analyzed according to the vaccine they actually received.|
48264645|NCT05144945|100970849|FG001|Safety Analysis Set|Overall Study||151|Participants who received a dose of the study vaccine and were analyzed according to the vaccine they actually received.|
48264646|NCT05144945|100970848|FG000|COMPLETED|Overall Study||149||
48264647|NCT05144945|100970849|FG001|COMPLETED|Overall Study||151||
48264648|NCT05144945|100970848|FG000|NOT COMPLETED|Overall Study||1||
48264649|NCT05144945|100970849|FG001|NOT COMPLETED|Overall Study||0||
48264650|NCT04650698|100970850|FG000|STARTED|Overall Study||12||
48264651|NCT04650698|100970851|FG001|STARTED|Overall Study||7||
48264652|NCT04650698|100970850|FG000|COMPLETED|Overall Study||10||
48264653|NCT04650698|100970851|FG001|COMPLETED|Overall Study||5||
48264654|NCT04650698|100970850|FG000|NOT COMPLETED|Overall Study||2||
48264655|NCT04650698|100970851|FG001|NOT COMPLETED|Overall Study||2||
48264656|NCT01485120|100970852|FG000|STARTED|Overall Study||34||
48264657|NCT01485120|100970852|FG000|COMPLETED|Overall Study||32||
48264658|NCT01485120|100970852|FG000|NOT COMPLETED|Overall Study||2||
48264659|NCT02641587|100970853|FG000|STARTED|Confinement Period||80||
48264660|NCT02641587|100970854|FG001|STARTED|Confinement Period||40||
48264661|NCT02641587|100970853|FG000|COMPLETED|Confinement Period||77||
48264662|NCT02641587|100970854|FG001|COMPLETED|Confinement Period||39||
48264663|NCT02641587|100970853|FG000|NOT COMPLETED|Confinement Period||3||
48264664|NCT02641587|100970854|FG001|NOT COMPLETED|Confinement Period||1||
48264665|NCT02641587|100970853|FG000|STARTED|Ambulatory Period||77||
48264666|NCT02641587|100970854|FG001|STARTED|Ambulatory Period||39||
48548192|NCT01308424|101675342|FG000|NOT COMPLETED|Baseline Eligibility||71||
48548193|NCT01308424|101675343|FG001|NOT COMPLETED|Baseline Eligibility||0||
48548194|NCT01308424|101675344|FG002|NOT COMPLETED|Baseline Eligibility||0||
48548195|NCT01308424|101675342|FG000|STARTED|Randomization||0||
48548196|NCT01308424|101675343|FG001|STARTED|Randomization||87||
48548197|NCT01308424|101675344|FG002|STARTED|Randomization||84||
48548198|NCT01308424|101675342|FG000|COMPLETED|Randomization||0||
48548199|NCT01308424|101675343|FG001|COMPLETED|Randomization||84||
48548200|NCT01308424|101675344|FG002|COMPLETED|Randomization||82||
48548201|NCT01308424|101675342|FG000|NOT COMPLETED|Randomization||0||
48548202|NCT01308424|101675343|FG001|NOT COMPLETED|Randomization||3||
48264667|NCT02641587|100970853|FG000|COMPLETED|Ambulatory Period||76||
48264668|NCT02641587|100970854|FG001|COMPLETED|Ambulatory Period||39||
48264669|NCT02641587|100970853|FG000|NOT COMPLETED|Ambulatory Period||1||
48264670|NCT02641587|100970854|FG001|NOT COMPLETED|Ambulatory Period||0||
48264671|NCT00759642|100970855|FG000|STARTED|Overall Study||33||
48264672|NCT00759642|100970855|FG000|COMPLETED|Overall Study||33||
48264673|NCT00759642|100970855|FG000|NOT COMPLETED|Overall Study||0||
48548203|NCT01308424|101675344|FG002|NOT COMPLETED|Randomization||2||
48548204|NCT00699998|101675345|FG000|STARTED|Overall Study||3620||
48548205|NCT00699998|101675346|FG001|STARTED|Overall Study||1043||
48548206|NCT00699998|101675347|FG002|STARTED|Overall Study||3623||
48391116|NCT00289744|101287594|FG000|NOT COMPLETED|Year 6 Long-term Follow-up||0||
48101995|NCT00323492|100575474|FG002|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||0||
48101996|NCT00323492|100575472|FG000|COMPLETED|Study Phase 1||45||
48101997|NCT00323492|100575473|FG001|COMPLETED|Study Phase 1||45||
48101998|NCT00323492|100575474|FG002|COMPLETED|Study Phase 1||0||
48101999|NCT00323492|100575472|FG000|NOT COMPLETED|Study Phase 1||2||
48102000|NCT00323492|100575473|FG001|NOT COMPLETED|Study Phase 1||0||
48102001|NCT00323492|100575474|FG002|NOT COMPLETED|Study Phase 1||0||
48102002|NCT00323492|100575472|FG000|STARTED|Study Phase 2||44||
48102003|NCT00323492|100575473|FG001|STARTED|Study Phase 2||18||
48102004|NCT00323492|100575474|FG002|STARTED|Study Phase 2||25||
48102005|NCT00323492|100575472|FG000|COMPLETED|Study Phase 2||40||
48102006|NCT00323492|100575473|FG001|COMPLETED|Study Phase 2||17||
48102007|NCT00323492|100575474|FG002|COMPLETED|Study Phase 2||24||
48102008|NCT00323492|100575472|FG000|NOT COMPLETED|Study Phase 2||4||
48102009|NCT00323492|100575473|FG001|NOT COMPLETED|Study Phase 2||1||
48102010|NCT00323492|100575474|FG002|NOT COMPLETED|Study Phase 2||1||
48102011|NCT03886220|100575475|FG000|STARTED|Treatment Period||28||
48102012|NCT03886220|100575476|FG001|STARTED|Treatment Period||54||
48102013|NCT03886220|100575475|FG000|COMPLETED|Treatment Period||23|Completed study drug treatment.|
48102014|NCT03886220|100575476|FG001|COMPLETED|Treatment Period||42|Completed study drug treatment.|
48102015|NCT03886220|100575475|FG000|NOT COMPLETED|Treatment Period||5||
48102016|NCT03886220|100575476|FG001|NOT COMPLETED|Treatment Period||12||
48102017|NCT03886220|100575475|FG000|STARTED|Post-Treatment Follow-Up Period||25|Entered the post-treatment follow-up period (includes some participants who discontinued study drug during the treatment period).|
48102018|NCT03886220|100575476|FG001|STARTED|Post-Treatment Follow-Up Period||41|Entered the post-treatment follow-up period (includes some participants who discontinued study drug during the treatment period).|
48102019|NCT03886220|100575475|FG000|COMPLETED|Post-Treatment Follow-Up Period||23||
48102020|NCT03886220|100575476|FG001|COMPLETED|Post-Treatment Follow-Up Period||39||
48102021|NCT03886220|100575475|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||2||
48102022|NCT03886220|100575476|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||2||
48264674|NCT04411186|100970856|FG000|STARTED|Overall Study||50||
48391117|NCT00289744|101287595|FG001|NOT COMPLETED|Year 6 Long-term Follow-up||0||
48391118|NCT00289744|101287596|FG002|NOT COMPLETED|Year 6 Long-term Follow-up||0||
48391119|NCT00289744|101287594|FG000|STARTED|Year 7 Long-term Follow-up||175||
48391120|NCT00289744|101287595|FG001|STARTED|Year 7 Long-term Follow-up||0||
48391121|NCT00289744|101287596|FG002|STARTED|Year 7 Long-term Follow-up||0||
48264675|NCT04411186|100970857|FG001|STARTED|Overall Study||50||
48264676|NCT04411186|100970856|FG000|COMPLETED|Overall Study||50||
48264677|NCT04411186|100970857|FG001|COMPLETED|Overall Study||49||
48264678|NCT04411186|100970856|FG000|NOT COMPLETED|Overall Study||0||
48264679|NCT04411186|100970857|FG001|NOT COMPLETED|Overall Study||1||
48264680|NCT01197612|100970858|FG000|STARTED|Overall Study||18||
48264681|NCT01197612|100970858|FG000|Week 3|Overall Study||16||
48264682|NCT01197612|100970858|FG000|Returned for Week 24|Overall Study||6||
48264683|NCT01197612|100970858|FG000|COMPLETED|Overall Study||6||
48264684|NCT01197612|100970858|FG000|NOT COMPLETED|Overall Study||12||
48264685|NCT00121667|100970859|FG000|STARTED|Short Term (ST) Period||192||
48264686|NCT00121667|100970860|FG001|STARTED|Short Term (ST) Period||191||
48264687|NCT00121667|100970861|FG002|STARTED|Short Term (ST) Period||181||
48264688|NCT00121667|100970862|FG003|STARTED|Short Term (ST) Period||179||
48264689|NCT00121667|100970859|FG000|COMPLETED|Short Term (ST) Period||148||
48264690|NCT00121667|100970860|FG001|COMPLETED|Short Term (ST) Period||143||
48264691|NCT00121667|100970861|FG002|COMPLETED|Short Term (ST) Period||140||
48264692|NCT00121667|100970862|FG003|COMPLETED|Short Term (ST) Period||112||
48264693|NCT00121667|100970859|FG000|NOT COMPLETED|Short Term (ST) Period||44||
48264694|NCT00121667|100970860|FG001|NOT COMPLETED|Short Term (ST) Period||48||
48264695|NCT00121667|100970861|FG002|NOT COMPLETED|Short Term (ST) Period||41||
48264696|NCT00121667|100970862|FG003|NOT COMPLETED|Short Term (ST) Period||67||
48264697|NCT00121667|100970859|FG000|STARTED|Short Term (ST) + Long Term (LT) Period||192||
48264698|NCT00121667|100970860|FG001|STARTED|Short Term (ST) + Long Term (LT) Period||191||
48264699|NCT00121667|100970861|FG002|STARTED|Short Term (ST) + Long Term (LT) Period||181||
48264700|NCT00121667|100970862|FG003|STARTED|Short Term (ST) + Long Term (LT) Period||179||
48264701|NCT00121667|100970859|FG000|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||14||
48264702|NCT00121667|100970860|FG001|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||18||
48264703|NCT00121667|100970861|FG002|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||23||
48264704|NCT00121667|100970862|FG003|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||7||
48264705|NCT00121667|100970859|FG000|COMPLETED|Short Term (ST) + Long Term (LT) Period||64||
48264706|NCT00121667|100970860|FG001|COMPLETED|Short Term (ST) + Long Term (LT) Period||58||
48264707|NCT00121667|100970861|FG002|COMPLETED|Short Term (ST) + Long Term (LT) Period||68||
48264708|NCT00121667|100970862|FG003|COMPLETED|Short Term (ST) + Long Term (LT) Period||39||
48391122|NCT00289744|101287594|FG000|COMPLETED|Year 7 Long-term Follow-up||175||
48391123|NCT00289744|101287595|FG001|COMPLETED|Year 7 Long-term Follow-up||0||
48391124|NCT00289744|101287596|FG002|COMPLETED|Year 7 Long-term Follow-up||0||
48391125|NCT00289744|101287594|FG000|NOT COMPLETED|Year 7 Long-term Follow-up||0||
48391126|NCT00289744|101287595|FG001|NOT COMPLETED|Year 7 Long-term Follow-up||0||
48548207|NCT00699998|101675348|FG003|STARTED|Overall Study||1040||
48548208|NCT00699998|101675345|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3590||
48548209|NCT00699998|101675346|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1033||
48548210|NCT00699998|101675347|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3590||
48548211|NCT00699998|101675348|FG003|Received at Least 1 Dose of Study Drug|Overall Study||1027||
48548212|NCT00699998|101675345|FG000|COMPLETED|Overall Study||3421||
48102023|NCT04335279|100575477|FG000|STARTED|Overall Study||86||
48102024|NCT04335279|100575478|FG001|STARTED|Overall Study||86||
48102025|NCT04335279|100575477|FG000|Completed Measures Post-intervention|Overall Study||78|Completion of outcome measures post-intervention|
48102026|NCT04335279|100575478|FG001|Completed Measures Post-intervention|Overall Study||83|Completion of outcome measures post-intervention|
48102027|NCT04335279|100575477|FG000|COMPLETED|Overall Study||75|Completion of outcome measures 6-weeks post-intervention|
48102028|NCT04335279|100575478|FG001|COMPLETED|Overall Study||76|Completion of outcome measures 6-weeks post-intervention|
48102029|NCT04335279|100575477|FG000|NOT COMPLETED|Overall Study||11||
48102030|NCT04335279|100575478|FG001|NOT COMPLETED|Overall Study||10||
48102031|NCT02968563|100575479|FG000|STARTED|Overall Study||5||
48102032|NCT02968563|100575480|FG001|STARTED|Overall Study||30||
48102033|NCT02968563|100575479|FG000|COMPLETED|Overall Study||4||
48102034|NCT02968563|100575480|FG001|COMPLETED|Overall Study||22||
48102035|NCT02968563|100575479|FG000|NOT COMPLETED|Overall Study||1||
48102036|NCT02968563|100575480|FG001|NOT COMPLETED|Overall Study||8||
48102037|NCT03204981|100575481|FG000|STARTED|Overall Study||52||
48102038|NCT03204981|100575481|FG000|COMPLETED|Overall Study||46||
48102039|NCT03204981|100575481|FG000|NOT COMPLETED|Overall Study||6||
48102040|NCT00673179|100575482|FG000|STARTED|Overall Study||7||
48102041|NCT00673179|100575483|FG001|STARTED|Overall Study||0||
48102042|NCT00673179|100575482|FG000|COMPLETED|Overall Study||4||
48102043|NCT00673179|100575483|FG001|COMPLETED|Overall Study||0||
48102044|NCT00673179|100575482|FG000|NOT COMPLETED|Overall Study||3||
48102045|NCT00673179|100575483|FG001|NOT COMPLETED|Overall Study||0||
48102046|NCT03424265|100575484|FG000|STARTED|Overall Study||29||
48102047|NCT03424265|100575485|FG001|STARTED|Overall Study||34||
48102048|NCT03424265|100575484|FG000|COMPLETED|Overall Study||28||
48102049|NCT03424265|100575485|FG001|COMPLETED|Overall Study||32||
48102050|NCT03424265|100575484|FG000|NOT COMPLETED|Overall Study||1||
48102051|NCT03424265|100575485|FG001|NOT COMPLETED|Overall Study||2||
48102052|NCT00177970|100575486|FG000|STARTED|Overall Study||0||
48102053|NCT00177970|100575487|FG001|STARTED|Overall Study||0||
48102054|NCT00177970|100575486|FG000|COMPLETED|Overall Study||0||
48102055|NCT00177970|100575487|FG001|COMPLETED|Overall Study||0||
48548213|NCT00699998|101675346|FG001|COMPLETED|Overall Study||957||
48548214|NCT00699998|101675347|FG002|COMPLETED|Overall Study||3417||
48548215|NCT00699998|101675348|FG003|COMPLETED|Overall Study||958||
48548216|NCT00699998|101675345|FG000|NOT COMPLETED|Overall Study||199||
48548217|NCT00699998|101675346|FG001|NOT COMPLETED|Overall Study||86||
48548218|NCT00699998|101675347|FG002|NOT COMPLETED|Overall Study||206||
48548219|NCT00699998|101675348|FG003|NOT COMPLETED|Overall Study||82||
48548220|NCT05493501|101675349|FG000|STARTED|Overall Study||1||
48548221|NCT05493501|101675350|FG001|STARTED|Overall Study||2||
48548222|NCT05493501|101675351|FG002|STARTED|Overall Study||5||
48548223|NCT05493501|101675349|FG000|COMPLETED|Overall Study||0||
48548224|NCT05493501|101675350|FG001|COMPLETED|Overall Study||0||
48548225|NCT05493501|101675351|FG002|COMPLETED|Overall Study||0||
48548226|NCT05493501|101675349|FG000|NOT COMPLETED|Overall Study||1||
48548227|NCT05493501|101675350|FG001|NOT COMPLETED|Overall Study||2||
48548228|NCT05493501|101675351|FG002|NOT COMPLETED|Overall Study||5||
48548229|NCT04052620|101675352|FG000|STARTED|Overall Study||150||
48548230|NCT04052620|101675353|FG001|STARTED|Overall Study||152||
48548231|NCT04052620|101675352|FG000|COMPLETED|Overall Study||143||
48548232|NCT04052620|101675353|FG001|COMPLETED|Overall Study||145||
48548233|NCT04052620|101675352|FG000|NOT COMPLETED|Overall Study||7||
48548234|NCT04052620|101675353|FG001|NOT COMPLETED|Overall Study||7||
48691267|NCT01248728|102028862|FG000|STARTED|Overall Study||19||
48548235|NCT03993379|101675354|FG000|STARTED|Overall Study||0||
48548236|NCT03993379|101675355|FG001|STARTED|Overall Study||3||
48548237|NCT03993379|101675356|FG002|STARTED|Overall Study||0||
48548238|NCT03993379|101675357|FG003|STARTED|Overall Study||0||
48548239|NCT03993379|101675354|FG000|COMPLETED|Overall Study||0||
48548240|NCT03993379|101675355|FG001|COMPLETED|Overall Study||0||
48102056|NCT00177970|100575486|FG000|NOT COMPLETED|Overall Study||0||
48102057|NCT00177970|100575487|FG001|NOT COMPLETED|Overall Study||0||
48102058|NCT01505608|100575488|FG000|STARTED|Phase I||0||
48102059|NCT01505608|100575489|FG001|STARTED|Phase I||8||
48102060|NCT01505608|100575488|FG000|COMPLETED|Phase I||0||
48102061|NCT01505608|100575489|FG001|COMPLETED|Phase I||2||
48102062|NCT01505608|100575488|FG000|NOT COMPLETED|Phase I||0||
48102063|NCT01505608|100575489|FG001|NOT COMPLETED|Phase I||6||
48102064|NCT01505608|100575488|FG000|STARTED|Phase II||2||
48102065|NCT01505608|100575489|FG001|STARTED|Phase II||4||
48102066|NCT01505608|100575488|FG000|COMPLETED|Phase II||0||
48102067|NCT01505608|100575489|FG001|COMPLETED|Phase II||2||
48548241|NCT03993379|101675356|FG002|COMPLETED|Overall Study||0||
48548242|NCT03993379|101675357|FG003|COMPLETED|Overall Study||0||
48691268|NCT01248728|102028863|FG001|STARTED|Overall Study||19||
48102068|NCT01505608|100575488|FG000|NOT COMPLETED|Phase II||2||
48102069|NCT01505608|100575489|FG001|NOT COMPLETED|Phase II||2||
48102070|NCT01623323|100575490|FG000|STARTED|Overall Study||705||
48102071|NCT01623323|100575490|FG000|COMPLETED|Overall Study||601||
48102072|NCT01623323|100575490|FG000|NOT COMPLETED|Overall Study||104||
48102073|NCT02356692|100575491|FG000|STARTED|Overall Study||60||60
48102074|NCT02356692|100575492|FG001|STARTED|Overall Study||60||60
48102075|NCT02356692|100575491|FG000|COMPLETED|Overall Study||60||60
48102076|NCT02356692|100575492|FG001|COMPLETED|Overall Study||60||60
48102077|NCT02356692|100575491|FG000|NOT COMPLETED|Overall Study||0||0
48102078|NCT02356692|100575492|FG001|NOT COMPLETED|Overall Study||0||0
48102079|NCT01464346|100575493|FG000|STARTED|Overall Study||29||
48102080|NCT01464346|100575494|FG001|STARTED|Overall Study||32||
48102081|NCT01464346|100575495|FG002|STARTED|Overall Study||29||
48102082|NCT01464346|100575493|FG000|COMPLETED|Overall Study||29||
48264709|NCT00121667|100970859|FG000|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||128||
48264710|NCT00121667|100970860|FG001|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||133||
48264711|NCT00121667|100970861|FG002|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||113||
48264712|NCT00121667|100970862|FG003|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||140||
48264713|NCT02623998|100970863|FG000|STARTED|Overall Study||50||
48264714|NCT02623998|100970864|FG001|STARTED|Overall Study||52||
48264715|NCT02623998|100970863|FG000|COMPLETED|Overall Study||48||
48264716|NCT02623998|100970864|FG001|COMPLETED|Overall Study||51||
48264717|NCT02623998|100970863|FG000|NOT COMPLETED|Overall Study||2||
48264718|NCT02623998|100970864|FG001|NOT COMPLETED|Overall Study||1||
48264719|NCT01437423|100970865|FG000|STARTED|Overall Study||662||
48548243|NCT03993379|101675354|FG000|NOT COMPLETED|Overall Study||0||
48548244|NCT03993379|101675355|FG001|NOT COMPLETED|Overall Study||3||
48548245|NCT03993379|101675356|FG002|NOT COMPLETED|Overall Study||0||
48548246|NCT03993379|101675357|FG003|NOT COMPLETED|Overall Study||0||
48548247|NCT03001453|101675358|FG000|STARTED|Overall Study||50||
48548248|NCT03001453|101675359|FG001|STARTED|Overall Study||57||
48548249|NCT03001453|101675358|FG000|COMPLETED|Overall Study||50||
48548250|NCT03001453|101675359|FG001|COMPLETED|Overall Study||57||
48548251|NCT03001453|101675358|FG000|NOT COMPLETED|Overall Study||0||
48548252|NCT03001453|101675359|FG001|NOT COMPLETED|Overall Study||0||
48548253|NCT03104855|101675360|FG000|STARTED|Overall Study||5||
48548254|NCT03104855|101675361|FG001|STARTED|Overall Study||5||
48548255|NCT03104855|101675360|FG000|COMPLETED|Overall Study||5||
48548256|NCT03104855|101675361|FG001|COMPLETED|Overall Study||5||
48102083|NCT01464346|100575494|FG001|COMPLETED|Overall Study||32||
48102084|NCT01464346|100575495|FG002|COMPLETED|Overall Study||28||
48102085|NCT01464346|100575493|FG000|NOT COMPLETED|Overall Study||0||
48102086|NCT01464346|100575494|FG001|NOT COMPLETED|Overall Study||0||
48102087|NCT01464346|100575495|FG002|NOT COMPLETED|Overall Study||1||
48102088|NCT01632202|100575496|FG000|STARTED|Overall Study||1||
48102089|NCT01632202|100575497|FG001|STARTED|Overall Study||7||
48264720|NCT01437423|100970865|FG000|COMPLETED|Overall Study||647||
48264721|NCT01437423|100970865|FG000|NOT COMPLETED|Overall Study||15||
48264722|NCT00150618|100970866|FG000|STARTED|Overall Study||62||
48264723|NCT00150618|100970867|FG001|STARTED|Overall Study||65||
48264724|NCT00150618|100970868|FG002|STARTED|Overall Study||65||
48264725|NCT00150618|100970869|FG003|STARTED|Overall Study||66||
48264726|NCT00150618|100970870|FG004|STARTED|Overall Study||66||
48548257|NCT03104855|101675360|FG000|NOT COMPLETED|Overall Study||0||
48548258|NCT03104855|101675361|FG001|NOT COMPLETED|Overall Study||0||
48548259|NCT01941498|101675362|FG000|STARTED|Overall Study||97||
48548260|NCT01941498|101675362|FG000|COMPLETED|Overall Study||96||
48548261|NCT01941498|101675362|FG000|NOT COMPLETED|Overall Study||1||
48548262|NCT00005957|101675363|FG000|STARTED|Overall Study||916||
48548263|NCT00005957|101675364|FG001|STARTED|Overall Study||916||
48102090|NCT01632202|100575496|FG000|COMPLETED|Overall Study||1||
48548264|NCT00005957|101675363|FG000|COMPLETED|Overall Study||908||
48548265|NCT00005957|101675364|FG001|COMPLETED|Overall Study||888||
48548266|NCT00005957|101675363|FG000|NOT COMPLETED|Overall Study||8||
48548267|NCT00005957|101675364|FG001|NOT COMPLETED|Overall Study||28||
48102091|NCT01632202|100575497|FG001|COMPLETED|Overall Study||7||
48102092|NCT01632202|100575496|FG000|NOT COMPLETED|Overall Study||0||
48102093|NCT01632202|100575497|FG001|NOT COMPLETED|Overall Study||0||
48548268|NCT02508935|101675365|FG000|STARTED|Overall Study||23||
48548269|NCT02508935|101675365|FG000|COMPLETED|Overall Study||0||
48548270|NCT02508935|101675365|FG000|NOT COMPLETED|Overall Study||23||
48548271|NCT01618344|101675366|FG000|STARTED|Overall Study||32||
48548272|NCT01618344|101675366|FG000|COMPLETED|Overall Study||23||
48548273|NCT01618344|101675366|FG000|NOT COMPLETED|Overall Study||9||
48548274|NCT03452137|101675367|FG000|STARTED|Overall Study||203||
48548275|NCT03452137|101675368|FG001|STARTED|Overall Study||203||
48102094|NCT02515045|100575498|FG000|STARTED|Overall Study||29||29
48102095|NCT02515045|100575499|FG001|STARTED|Overall Study||30||30
48102096|NCT02515045|100575500|FG002|STARTED|Overall Study||59||59
48264727|NCT00150618|100970866|FG000|COMPLETED|Overall Study||45||
48264728|NCT00150618|100970867|FG001|COMPLETED|Overall Study||47||
48264729|NCT00150618|100970868|FG002|COMPLETED|Overall Study||38||
48264730|NCT00150618|100970869|FG003|COMPLETED|Overall Study||40||
48691269|NCT01248728|102028862|FG000|COMPLETED|Overall Study||15||
48102097|NCT02515045|100575498|FG000|COMPLETED|Overall Study||29||29
48102098|NCT02515045|100575499|FG001|COMPLETED|Overall Study||26||26
48102099|NCT02515045|100575500|FG002|COMPLETED|Overall Study||55||55
48102100|NCT02515045|100575498|FG000|NOT COMPLETED|Overall Study||0||0
48102101|NCT02515045|100575499|FG001|NOT COMPLETED|Overall Study||4||4
48102102|NCT02515045|100575500|FG002|NOT COMPLETED|Overall Study||4||4
48391127|NCT00289744|101287596|FG002|NOT COMPLETED|Year 7 Long-term Follow-up||0||
48391128|NCT00289744|101287594|FG000|STARTED|Year 8 Long-term Follow-up||174||
48102103|NCT00634088|100575501|FG000|STARTED|Time Period 1: Dose Level 1||6||
48102104|NCT00634088|100575502|FG001|STARTED|Time Period 1: Dose Level 1||0||
48102105|NCT00634088|100575503|FG002|STARTED|Time Period 1: Dose Level 1||0||
48102106|NCT00634088|100575504|FG003|STARTED|Time Period 1: Dose Level 1||0||
48102107|NCT00634088|100575501|FG000|COMPLETED|Time Period 1: Dose Level 1||0||
48102108|NCT00634088|100575502|FG001|COMPLETED|Time Period 1: Dose Level 1||0||
48102109|NCT00634088|100575503|FG002|COMPLETED|Time Period 1: Dose Level 1||0||
48102110|NCT00634088|100575504|FG003|COMPLETED|Time Period 1: Dose Level 1||0||
48102111|NCT00634088|100575501|FG000|NOT COMPLETED|Time Period 1: Dose Level 1||6||
48102112|NCT00634088|100575502|FG001|NOT COMPLETED|Time Period 1: Dose Level 1||0||
48102113|NCT00634088|100575503|FG002|NOT COMPLETED|Time Period 1: Dose Level 1||0||
48102114|NCT00634088|100575504|FG003|NOT COMPLETED|Time Period 1: Dose Level 1||0||
48102115|NCT00634088|100575501|FG000|STARTED|Time Period 2: Dose Level 2||0||
48102116|NCT00634088|100575502|FG001|STARTED|Time Period 2: Dose Level 2||3||
48102117|NCT00634088|100575503|FG002|STARTED|Time Period 2: Dose Level 2||0||
48102118|NCT00634088|100575504|FG003|STARTED|Time Period 2: Dose Level 2||0||
48102119|NCT00634088|100575501|FG000|COMPLETED|Time Period 2: Dose Level 2||0||
48102120|NCT00634088|100575502|FG001|COMPLETED|Time Period 2: Dose Level 2||0||
48102121|NCT00634088|100575503|FG002|COMPLETED|Time Period 2: Dose Level 2||0||
48102122|NCT00634088|100575504|FG003|COMPLETED|Time Period 2: Dose Level 2||0||
48102123|NCT00634088|100575501|FG000|NOT COMPLETED|Time Period 2: Dose Level 2||0||
48102124|NCT00634088|100575502|FG001|NOT COMPLETED|Time Period 2: Dose Level 2||3||
48102125|NCT00634088|100575503|FG002|NOT COMPLETED|Time Period 2: Dose Level 2||0||
48102126|NCT00634088|100575504|FG003|NOT COMPLETED|Time Period 2: Dose Level 2||0||
48102127|NCT00634088|100575501|FG000|STARTED|Time Period 3: Dose Level 3||0||
48102128|NCT00634088|100575502|FG001|STARTED|Time Period 3: Dose Level 3||0||
48102129|NCT00634088|100575503|FG002|STARTED|Time Period 3: Dose Level 3||1||
48102130|NCT00634088|100575504|FG003|STARTED|Time Period 3: Dose Level 3||0||
48102131|NCT00634088|100575501|FG000|COMPLETED|Time Period 3: Dose Level 3||0||
48102132|NCT00634088|100575502|FG001|COMPLETED|Time Period 3: Dose Level 3||0||
48102133|NCT00634088|100575503|FG002|COMPLETED|Time Period 3: Dose Level 3||0||
48102134|NCT00634088|100575504|FG003|COMPLETED|Time Period 3: Dose Level 3||0||
48102135|NCT00634088|100575501|FG000|NOT COMPLETED|Time Period 3: Dose Level 3||0||
48102136|NCT00634088|100575502|FG001|NOT COMPLETED|Time Period 3: Dose Level 3||0||
48102137|NCT00634088|100575503|FG002|NOT COMPLETED|Time Period 3: Dose Level 3||1||
48102138|NCT00634088|100575504|FG003|NOT COMPLETED|Time Period 3: Dose Level 3||0||
48102139|NCT00634088|100575501|FG000|STARTED|Time Period 4: Triplet Combination||0||
48102140|NCT00634088|100575502|FG001|STARTED|Time Period 4: Triplet Combination||0||
48102141|NCT00634088|100575503|FG002|STARTED|Time Period 4: Triplet Combination||0||
48102142|NCT00634088|100575504|FG003|STARTED|Time Period 4: Triplet Combination||0||
48102143|NCT00634088|100575501|FG000|COMPLETED|Time Period 4: Triplet Combination||0||
48102144|NCT00634088|100575502|FG001|COMPLETED|Time Period 4: Triplet Combination||0||
48102145|NCT00634088|100575503|FG002|COMPLETED|Time Period 4: Triplet Combination||0||
48102146|NCT00634088|100575504|FG003|COMPLETED|Time Period 4: Triplet Combination||0||
48102147|NCT00634088|100575501|FG000|NOT COMPLETED|Time Period 4: Triplet Combination||0||
48548276|NCT03452137|101675367|FG000|Received at Least One Dose of Study Drug|Overall Study||203|Safety-Evaluable Population|
48548277|NCT03452137|101675368|FG001|Received at Least One Dose of Study Drug|Overall Study||202|Safety-Evaluable Population|
48548278|NCT03452137|101675367|FG000|COMPLETED|Overall Study||0||
48548279|NCT03452137|101675368|FG001|COMPLETED|Overall Study||0||
48102148|NCT00634088|100575502|FG001|NOT COMPLETED|Time Period 4: Triplet Combination||0||
48102149|NCT00634088|100575503|FG002|NOT COMPLETED|Time Period 4: Triplet Combination||0||
48102150|NCT00634088|100575504|FG003|NOT COMPLETED|Time Period 4: Triplet Combination||0||
48102151|NCT01062555|100575505|FG000|STARTED|Phase 1||266||
48102152|NCT01062555|100575506|FG001|STARTED|Phase 1||261||
48102153|NCT01062555|100575507|FG002|STARTED|Phase 1||0||
48102154|NCT01062555|100575508|FG003|STARTED|Phase 1||0||
48102155|NCT01062555|100575505|FG000|COMPLETED|Phase 1||243||
48102156|NCT01062555|100575506|FG001|COMPLETED|Phase 1||235||
48102157|NCT01062555|100575507|FG002|COMPLETED|Phase 1||0||
48102158|NCT01062555|100575508|FG003|COMPLETED|Phase 1||0||
48102159|NCT01062555|100575505|FG000|NOT COMPLETED|Phase 1||23||
48102160|NCT01062555|100575506|FG001|NOT COMPLETED|Phase 1||26||
48102161|NCT01062555|100575507|FG002|NOT COMPLETED|Phase 1||0||
48102162|NCT01062555|100575508|FG003|NOT COMPLETED|Phase 1||0||
48102163|NCT01062555|100575505|FG000|STARTED|Phase 2||0||
48102164|NCT01062555|100575506|FG001|STARTED|Phase 2||0||
48102165|NCT01062555|100575507|FG002|STARTED|Phase 2||86||
48102166|NCT01062555|100575508|FG003|STARTED|Phase 2||87||
48102167|NCT01062555|100575505|FG000|COMPLETED|Phase 2||0||
48391129|NCT00289744|101287595|FG001|STARTED|Year 8 Long-term Follow-up||0||
48102168|NCT01062555|100575506|FG001|COMPLETED|Phase 2||0||
48102169|NCT01062555|100575507|FG002|COMPLETED|Phase 2||71||
48102170|NCT01062555|100575508|FG003|COMPLETED|Phase 2||53||
48102171|NCT01062555|100575505|FG000|NOT COMPLETED|Phase 2||0||
48102172|NCT01062555|100575506|FG001|NOT COMPLETED|Phase 2||0||
48102173|NCT01062555|100575507|FG002|NOT COMPLETED|Phase 2||15||
48102174|NCT01062555|100575508|FG003|NOT COMPLETED|Phase 2||34||
48102175|NCT03805932|100575509|FG000|STARTED|Overall Study||3||
48102176|NCT03805932|100575510|FG001|STARTED|Overall Study||15||
48102177|NCT03805932|100575509|FG000|COMPLETED|Overall Study||3||
48102178|NCT03805932|100575510|FG001|COMPLETED|Overall Study||15||
48102179|NCT03805932|100575509|FG000|NOT COMPLETED|Overall Study||0||
48102180|NCT03805932|100575510|FG001|NOT COMPLETED|Overall Study||0||
48102181|NCT03836963|100575511|FG000|STARTED|Overall Study||2||
48102182|NCT03836963|100575512|FG001|STARTED|Overall Study||1||
48102183|NCT03836963|100575513|FG002|STARTED|Overall Study||3||
48102184|NCT03836963|100575511|FG000|COMPLETED|Overall Study||1||
48102185|NCT03836963|100575512|FG001|COMPLETED|Overall Study||1||
48102186|NCT03836963|100575513|FG002|COMPLETED|Overall Study||2||
48102187|NCT03836963|100575511|FG000|NOT COMPLETED|Overall Study||1||
48102188|NCT03836963|100575512|FG001|NOT COMPLETED|Overall Study||0||
48102189|NCT03836963|100575513|FG002|NOT COMPLETED|Overall Study||1||
48102190|NCT00857220|100575514|FG000|STARTED|Overall Study||304||
48102191|NCT00857220|100575514|FG000|COMPLETED|Overall Study||121||
48102192|NCT00857220|100575514|FG000|NOT COMPLETED|Overall Study||183||
48102193|NCT00799578|100575515|FG000|STARTED|Overall Study||13||
48391130|NCT00289744|101287596|FG002|STARTED|Year 8 Long-term Follow-up||0||
48391131|NCT00289744|101287594|FG000|COMPLETED|Year 8 Long-term Follow-up||174||
48391132|NCT00289744|101287595|FG001|COMPLETED|Year 8 Long-term Follow-up||0||
48391133|NCT00289744|101287596|FG002|COMPLETED|Year 8 Long-term Follow-up||0||
48391134|NCT00289744|101287594|FG000|NOT COMPLETED|Year 8 Long-term Follow-up||0||
48548280|NCT03452137|101675367|FG000|NOT COMPLETED|Overall Study||203||
48548281|NCT03452137|101675368|FG001|NOT COMPLETED|Overall Study||203||
48548282|NCT05445492|101675369|FG000|STARTED|Overall Study||41||
48548283|NCT05445492|101675369|FG000|COMPLETED|Overall Study||40||
48548284|NCT05445492|101675369|FG000|NOT COMPLETED|Overall Study||1||
48548285|NCT00238355|101675370|FG000|STARTED|Overall Study||13||
48548286|NCT00238355|101675370|FG000|COMPLETED|Overall Study||10||
48102194|NCT00799578|100575515|FG000|COMPLETED|Overall Study||11||
48102195|NCT00799578|100575515|FG000|NOT COMPLETED|Overall Study||2||
48102196|NCT01094548|100575516|FG000|STARTED|Overall Study||17||
48548287|NCT00238355|101675370|FG000|NOT COMPLETED|Overall Study||3||
48548288|NCT00352417|101675371|FG000|STARTED|Overall Study||24||
48548289|NCT00352417|101675372|FG001|STARTED|Overall Study||26||
48102197|NCT01094548|100575517|FG001|STARTED|Overall Study||17||
48102198|NCT01094548|100575516|FG000|COMPLETED|Overall Study||17||
48102199|NCT01094548|100575517|FG001|COMPLETED|Overall Study||17||
48102200|NCT01094548|100575516|FG000|NOT COMPLETED|Overall Study||0||
48391135|NCT00289744|101287595|FG001|NOT COMPLETED|Year 8 Long-term Follow-up||0||
48548290|NCT00352417|101675371|FG000|COMPLETED|Overall Study||19||
48548291|NCT00352417|101675372|FG001|COMPLETED|Overall Study||21||
48548292|NCT00352417|101675371|FG000|NOT COMPLETED|Overall Study||5||
48548293|NCT00352417|101675372|FG001|NOT COMPLETED|Overall Study||5||
48548294|NCT02165735|101675373|FG000|STARTED|Overall Study||180||
48548295|NCT02165735|101675374|FG001|STARTED|Overall Study||180||
48548296|NCT02165735|101675373|FG000|COMPLETED|Overall Study||164||
48548297|NCT02165735|101675374|FG001|COMPLETED|Overall Study||166||
48548298|NCT02165735|101675373|FG000|NOT COMPLETED|Overall Study||16||
48548299|NCT02165735|101675374|FG001|NOT COMPLETED|Overall Study||14||
48548300|NCT02040077|101675375|FG000|STARTED|Overall Study||27||
48548301|NCT02040077|101675376|FG001|STARTED|Overall Study||24||
48548302|NCT02040077|101675377|FG002|STARTED|Overall Study||25||
48548303|NCT02040077|101675375|FG000|COMPLETED|Overall Study||27|Completed primary intervention|
48391136|NCT00289744|101287596|FG002|NOT COMPLETED|Year 8 Long-term Follow-up||0||
48391137|NCT00289744|101287594|FG000|STARTED|Year 9 Long-term Follow-up||173||
48391138|NCT00289744|101287595|FG001|STARTED|Year 9 Long-term Follow-up||0||
48548304|NCT02040077|101675376|FG001|COMPLETED|Overall Study||24|Completed primary intervention|
48548305|NCT02040077|101675377|FG002|COMPLETED|Overall Study||25|Completed primary intervention|
48548306|NCT02040077|101675375|FG000|NOT COMPLETED|Overall Study||0||
48548307|NCT02040077|101675376|FG001|NOT COMPLETED|Overall Study||0||
48548308|NCT02040077|101675377|FG002|NOT COMPLETED|Overall Study||0||
48548309|NCT03473015|101675378|FG000|STARTED|Overall Study||25||
48548310|NCT03473015|101675379|FG001|STARTED|Overall Study||30||
48548311|NCT03473015|101675380|FG002|STARTED|Overall Study||50||
48548312|NCT03473015|101675378|FG000|Post-stenting IMR|Overall Study||25||
48102201|NCT01094548|100575517|FG001|NOT COMPLETED|Overall Study||0||
48102202|NCT01592344|100575518|FG000|STARTED|Overall Study||45||
48102203|NCT01592344|100575519|FG001|STARTED|Overall Study||49||
48102204|NCT01592344|100575518|FG000|COMPLETED|Overall Study||41||
48102205|NCT01592344|100575519|FG001|COMPLETED|Overall Study||44||
48102206|NCT01592344|100575518|FG000|NOT COMPLETED|Overall Study||4||
48102207|NCT01592344|100575519|FG001|NOT COMPLETED|Overall Study||5||
48102208|NCT03406858|100575520|FG000|STARTED|Overall Study||15||
48102209|NCT03406858|100575520|FG000|COMPLETED|Overall Study||13||
48691270|NCT01248728|102028863|FG001|COMPLETED|Overall Study||17||
48102210|NCT03406858|100575520|FG000|NOT COMPLETED|Overall Study||2||
48102211|NCT02642432|100575521|FG000|STARTED|Overall Study||146||
48102212|NCT02642432|100575521|FG000|COMPLETED|Overall Study||138||
48391139|NCT00289744|101287596|FG002|STARTED|Year 9 Long-term Follow-up||0||
48391140|NCT00289744|101287594|FG000|COMPLETED|Year 9 Long-term Follow-up||173||
48391141|NCT00289744|101287595|FG001|COMPLETED|Year 9 Long-term Follow-up||0||
48391142|NCT00289744|101287596|FG002|COMPLETED|Year 9 Long-term Follow-up||0||
48691271|NCT01248728|102028862|FG000|NOT COMPLETED|Overall Study||4||
48102213|NCT02642432|100575521|FG000|NOT COMPLETED|Overall Study||8||
48102214|NCT02874742|100575522|FG000|STARTED|Overall Study||103||
48102215|NCT02874742|100575523|FG001|STARTED|Overall Study||104||
48102216|NCT02874742|100575524|FG002|STARTED|Overall Study||16||
48102217|NCT02874742|100575522|FG000|Treated (Safety Analysis Set)|Overall Study||101||
48102218|NCT02874742|100575523|FG001|Treated (Safety Analysis Set)|Overall Study||100||
48102219|NCT02874742|100575524|FG002|Treated (Safety Analysis Set)|Overall Study||16||
48102220|NCT02874742|100575522|FG000|COMPLETED|Overall Study||76||
48102221|NCT02874742|100575523|FG001|COMPLETED|Overall Study||88||
48102222|NCT02874742|100575524|FG002|COMPLETED|Overall Study||15||
48102223|NCT02874742|100575522|FG000|NOT COMPLETED|Overall Study||27||
48102224|NCT02874742|100575523|FG001|NOT COMPLETED|Overall Study||16||
48102225|NCT02874742|100575524|FG002|NOT COMPLETED|Overall Study||1||
48102226|NCT00527943|100575525|FG000|STARTED|Overall Study||6471||
48102227|NCT00527943|100575526|FG001|STARTED|Overall Study||6473||
48102228|NCT00527943|100575525|FG000|Received Treatment|Overall Study||6441||
48102229|NCT00527943|100575526|FG001|Received Treatment|Overall Study||6446||
48102230|NCT00527943|100575525|FG000|COMPLETED|Overall Study||6311||
48102231|NCT00527943|100575526|FG001|COMPLETED|Overall Study||6327||
48102232|NCT00527943|100575525|FG000|NOT COMPLETED|Overall Study||160||
48102233|NCT00527943|100575526|FG001|NOT COMPLETED|Overall Study||146||
48102234|NCT02211131|100575527|FG000|STARTED|Overall Study||74||
48102235|NCT02211131|100575528|FG001|STARTED|Overall Study||76||
48102236|NCT02211131|100575527|FG000|COMPLETED|Overall Study||40||
48102237|NCT02211131|100575528|FG001|COMPLETED|Overall Study||48||
48102238|NCT02211131|100575527|FG000|NOT COMPLETED|Overall Study||34||
48102239|NCT02211131|100575528|FG001|NOT COMPLETED|Overall Study||28||
48264731|NCT00150618|100970870|FG004|COMPLETED|Overall Study||41||
48264732|NCT00150618|100970866|FG000|NOT COMPLETED|Overall Study||17||
48264733|NCT00150618|100970867|FG001|NOT COMPLETED|Overall Study||18||
48264734|NCT00150618|100970868|FG002|NOT COMPLETED|Overall Study||27||
48264735|NCT00150618|100970869|FG003|NOT COMPLETED|Overall Study||26||
48264736|NCT00150618|100970870|FG004|NOT COMPLETED|Overall Study||25||
48264737|NCT00958711|100970871|FG000|STARTED|Overall Study||42||
48264738|NCT00958711|100970872|FG001|STARTED|Overall Study||48||
48264739|NCT00958711|100970871|FG000|COMPLETED|Overall Study||29||
48264740|NCT00958711|100970872|FG001|COMPLETED|Overall Study||27||
48264741|NCT00958711|100970871|FG000|NOT COMPLETED|Overall Study||13||
48264742|NCT00958711|100970872|FG001|NOT COMPLETED|Overall Study||21||
48264743|NCT02263040|100970873|FG000|STARTED|Overall Study||87||
48264744|NCT02263040|100970874|FG001|STARTED|Overall Study||83||
48264745|NCT02263040|100970873|FG000|COMPLETED|Overall Study||87||
48264746|NCT02263040|100970874|FG001|COMPLETED|Overall Study||83||
48264747|NCT02263040|100970873|FG000|NOT COMPLETED|Overall Study||0||
48264748|NCT02263040|100970874|FG001|NOT COMPLETED|Overall Study||0||
48264749|NCT04949802|100970875|FG000|STARTED|Overall Study||15||22
48264750|NCT04949802|100970875|FG000|COMPLETED|Overall Study||12||18
48391143|NCT00289744|101287594|FG000|NOT COMPLETED|Year 9 Long-term Follow-up||0||
48391144|NCT00289744|101287595|FG001|NOT COMPLETED|Year 9 Long-term Follow-up||0||
48548313|NCT03473015|101675379|FG001|Post-stenting IMR|Overall Study||30||
48691272|NCT01248728|102028863|FG001|NOT COMPLETED|Overall Study||2||
48691273|NCT01030952|102028864|FG000|STARTED|Overall Study||51||
48691274|NCT01030952|102028865|FG001|STARTED|Overall Study||52||
48691275|NCT01030952|102028864|FG000|COMPLETED|Overall Study||49||
48102240|NCT03632655|100575529|FG000|STARTED|Overall Study||22||
48102241|NCT03632655|100575530|FG001|STARTED|Overall Study||16||
48102242|NCT03632655|100575529|FG000|COMPLETED|Overall Study||0||
48102243|NCT03632655|100575530|FG001|COMPLETED|Overall Study||0||
48102244|NCT03632655|100575529|FG000|NOT COMPLETED|Overall Study||22||
48102245|NCT03632655|100575530|FG001|NOT COMPLETED|Overall Study||16||
48102246|NCT04668950|100575531|FG000|STARTED|Overall Study||334||
48102247|NCT04668950|100575532|FG001|STARTED|Overall Study||336||
48102248|NCT04668950|100575531|FG000|COMPLETED|Overall Study||272||
48102249|NCT04668950|100575532|FG001|COMPLETED|Overall Study||275||
48102250|NCT04668950|100575531|FG000|NOT COMPLETED|Overall Study||62||
48102251|NCT04668950|100575532|FG001|NOT COMPLETED|Overall Study||61||
48102252|NCT02430337|100575533|FG000|STARTED|Overall Study||11||
48102253|NCT02430337|100575534|FG001|STARTED|Overall Study||20||
48102254|NCT02430337|100575533|FG000|COMPLETED|Overall Study||11||
48102255|NCT02430337|100575534|FG001|COMPLETED|Overall Study||20||
48102256|NCT02430337|100575533|FG000|NOT COMPLETED|Overall Study||0||
48102257|NCT02430337|100575534|FG001|NOT COMPLETED|Overall Study||0||
48102258|NCT00026793|100575535|FG000|STARTED|Overall Study||29||
48102259|NCT00026793|100575535|FG000|COMPLETED|Overall Study||21||
48264751|NCT04949802|100970875|FG000|NOT COMPLETED|Overall Study||3||4
48691276|NCT01030952|102028865|FG001|COMPLETED|Overall Study||49||
48691277|NCT01030952|102028864|FG000|NOT COMPLETED|Overall Study||2||
48691278|NCT01030952|102028865|FG001|NOT COMPLETED|Overall Study||3||
48691279|NCT00683930|102028866|FG000|STARTED|Overall Study||36||
48691280|NCT00683930|102028867|FG001|STARTED|Overall Study||21||
48691281|NCT00683930|102028868|FG002|STARTED|Overall Study||37||
48691282|NCT00683930|102028866|FG000|COMPLETED|Overall Study||29||
48691283|NCT00683930|102028867|FG001|COMPLETED|Overall Study||18||
48691284|NCT00683930|102028868|FG002|COMPLETED|Overall Study||28||
48691285|NCT00683930|102028866|FG000|NOT COMPLETED|Overall Study||7||
48691286|NCT00683930|102028867|FG001|NOT COMPLETED|Overall Study||3||
48691287|NCT00683930|102028868|FG002|NOT COMPLETED|Overall Study||9||
48691288|NCT01132846|102028869|FG000|STARTED|Overall Study||122||
48691289|NCT01132846|102028870|FG001|STARTED|Overall Study||119||
48691290|NCT01132846|102028871|FG002|STARTED|Overall Study||119||
48691291|NCT01132846|102028869|FG000|COMPLETED|Overall Study||106||
48691292|NCT01132846|102028870|FG001|COMPLETED|Overall Study||101||
48691293|NCT01132846|102028871|FG002|COMPLETED|Overall Study||108||
48691294|NCT01132846|102028869|FG000|NOT COMPLETED|Overall Study||16||
48691295|NCT01132846|102028870|FG001|NOT COMPLETED|Overall Study||18||
48691296|NCT01132846|102028871|FG002|NOT COMPLETED|Overall Study||11||
48691297|NCT00194077|102028872|FG000|STARTED|Overall Study||30||
48691298|NCT00194077|102028873|FG001|STARTED|Overall Study||30||
48691299|NCT00194077|102028872|FG000|COMPLETED|Overall Study||6||
48691300|NCT00194077|102028873|FG001|COMPLETED|Overall Study||0||
48691301|NCT00194077|102028872|FG000|NOT COMPLETED|Overall Study||24||
48691302|NCT00194077|102028873|FG001|NOT COMPLETED|Overall Study||30||
48691303|NCT01262560|102028874|FG000|STARTED|Overall Study||53||
48691304|NCT01262560|102028875|FG001|STARTED|Overall Study||54||
48691305|NCT01262560|102028876|FG002|STARTED|Overall Study||56||
48691306|NCT01262560|102028874|FG000|COMPLETED|Overall Study||53||
48691307|NCT01262560|102028875|FG001|COMPLETED|Overall Study||53||
48691308|NCT01262560|102028876|FG002|COMPLETED|Overall Study||54||
48691309|NCT01262560|102028874|FG000|NOT COMPLETED|Overall Study||0||
48264752|NCT00307047|100970876|FG000|STARTED|Overall Study||2458||
48264753|NCT00307047|100970877|FG001|STARTED|Overall Study||1229||
48264754|NCT00307047|100970876|FG000|COMPLETED|Overall Study||2389||
48264755|NCT00307047|100970877|FG001|COMPLETED|Overall Study||1180||
48264756|NCT00307047|100970876|FG000|NOT COMPLETED|Overall Study||69||
48691310|NCT01262560|102028875|FG001|NOT COMPLETED|Overall Study||1||
48691311|NCT01262560|102028876|FG002|NOT COMPLETED|Overall Study||2||
48691312|NCT01461499|102028877|FG000|STARTED|Overall Study||119||
48691313|NCT01461499|102028878|FG001|STARTED|Overall Study||118||
48691314|NCT01461499|102028877|FG000|COMPLETED|Overall Study||111||
48691315|NCT01461499|102028878|FG001|COMPLETED|Overall Study||114||
48691316|NCT01461499|102028877|FG000|NOT COMPLETED|Overall Study||8||
48691317|NCT01461499|102028878|FG001|NOT COMPLETED|Overall Study||4||
48691318|NCT05175131|102028879|FG000|STARTED|Overall Study||155||
48691319|NCT05175131|102028880|FG001|STARTED|Overall Study||155||
48691320|NCT05175131|102028881|FG002|STARTED|Overall Study||155||
48691321|NCT05175131|102028879|FG000|COMPLETED|Overall Study||153||
48691322|NCT05175131|102028880|FG001|COMPLETED|Overall Study||154||
48691323|NCT05175131|102028881|FG002|COMPLETED|Overall Study||152||
48691324|NCT05175131|102028879|FG000|NOT COMPLETED|Overall Study||2||
48691325|NCT05175131|102028880|FG001|NOT COMPLETED|Overall Study||1||
48691326|NCT05175131|102028881|FG002|NOT COMPLETED|Overall Study||3||
48691327|NCT00652314|102028882|FG000|STARTED|Overall Study||62||
48691328|NCT00652314|102028883|FG001|STARTED|Overall Study||35||
48691329|NCT00652314|102028882|FG000|COMPLETED|Overall Study||53||
48691330|NCT00652314|102028883|FG001|COMPLETED|Overall Study||26||
48691331|NCT00652314|102028882|FG000|NOT COMPLETED|Overall Study||9||
48691332|NCT00652314|102028883|FG001|NOT COMPLETED|Overall Study||9||
48691333|NCT05059301|102028884|FG000|STARTED|Overall Study||251||
48691334|NCT05059301|102028885|FG001|STARTED|Overall Study||253||
48691335|NCT05059301|102028886|FG002|STARTED|Overall Study||253||
48691336|NCT05059301|102028884|FG000|COMPLETED|Overall Study||249||
48691337|NCT05059301|102028885|FG001|COMPLETED|Overall Study||248||
48691338|NCT05059301|102028886|FG002|COMPLETED|Overall Study||248||
48264757|NCT00307047|100970877|FG001|NOT COMPLETED|Overall Study||49||
48691339|NCT05059301|102028884|FG000|NOT COMPLETED|Overall Study||2||
48691340|NCT05059301|102028885|FG001|NOT COMPLETED|Overall Study||5||
48691341|NCT05059301|102028886|FG002|NOT COMPLETED|Overall Study||5||
48691342|NCT02707965|102028887|FG000|STARTED|Overall Study||3||
48691343|NCT02707965|102028888|FG001|STARTED|Overall Study||2||
48691344|NCT02707965|102028889|FG002|STARTED|Overall Study||4||
48264758|NCT01193010|100970878|FG000|STARTED|Overall Study||20||
48264759|NCT01193010|100970879|FG001|STARTED|Overall Study||20||
48264760|NCT01193010|100970878|FG000|COMPLETED|Overall Study||17||
48691345|NCT02707965|102028890|FG003|STARTED|Overall Study||0||
48691346|NCT02707965|102028891|FG004|STARTED|Overall Study||2||
48691347|NCT02707965|102028892|FG005|STARTED|Overall Study||1||
48691348|NCT02707965|102028893|FG006|STARTED|Overall Study||0||
48691349|NCT02707965|102028894|FG007|STARTED|Overall Study||3||
48691350|NCT02707965|102028895|FG008|STARTED|Overall Study||1||
48691351|NCT02707965|102028896|FG009|STARTED|Overall Study||0||
48691352|NCT02707965|102028897|FG010|STARTED|Overall Study||1||
48691353|NCT02707965|102028898|FG011|STARTED|Overall Study||0||
48691354|NCT02707965|102028899|FG012|STARTED|Overall Study||0||
48691355|NCT02707965|102028900|FG013|STARTED|Overall Study||2||
48691356|NCT02707965|102028901|FG014|STARTED|Overall Study||2||
48691357|NCT02707965|102028902|FG015|STARTED|Overall Study||0||
48691358|NCT02707965|102028887|FG000|COMPLETED|Overall Study||2||
48691359|NCT02707965|102028888|FG001|COMPLETED|Overall Study||1||
48691360|NCT02707965|102028889|FG002|COMPLETED|Overall Study||3||
48691361|NCT02707965|102028890|FG003|COMPLETED|Overall Study||0||
48691362|NCT02707965|102028891|FG004|COMPLETED|Overall Study||2||
48691363|NCT02707965|102028892|FG005|COMPLETED|Overall Study||1||
48691364|NCT02707965|102028893|FG006|COMPLETED|Overall Study||0||
48691365|NCT02707965|102028894|FG007|COMPLETED|Overall Study||0||
48691366|NCT02707965|102028895|FG008|COMPLETED|Overall Study||1||
48691367|NCT02707965|102028896|FG009|COMPLETED|Overall Study||0||
48691368|NCT02707965|102028897|FG010|COMPLETED|Overall Study||1||
48691369|NCT02707965|102028898|FG011|COMPLETED|Overall Study||0||
48691370|NCT02707965|102028899|FG012|COMPLETED|Overall Study||0||
48691371|NCT02707965|102028900|FG013|COMPLETED|Overall Study||2||
48691372|NCT02707965|102028901|FG014|COMPLETED|Overall Study||0||
48691373|NCT02707965|102028902|FG015|COMPLETED|Overall Study||0||
48691374|NCT02707965|102028887|FG000|NOT COMPLETED|Overall Study||1||
48691375|NCT02707965|102028888|FG001|NOT COMPLETED|Overall Study||1||
48691376|NCT02707965|102028889|FG002|NOT COMPLETED|Overall Study||1||
48691377|NCT02707965|102028890|FG003|NOT COMPLETED|Overall Study||0||
48691378|NCT02707965|102028891|FG004|NOT COMPLETED|Overall Study||0||
48691379|NCT02707965|102028892|FG005|NOT COMPLETED|Overall Study||0||
48691380|NCT02707965|102028893|FG006|NOT COMPLETED|Overall Study||0||
48691381|NCT02707965|102028894|FG007|NOT COMPLETED|Overall Study||3||
48691382|NCT02707965|102028895|FG008|NOT COMPLETED|Overall Study||0||
48691383|NCT02707965|102028896|FG009|NOT COMPLETED|Overall Study||0||
48691384|NCT02707965|102028897|FG010|NOT COMPLETED|Overall Study||0||
48691385|NCT02707965|102028898|FG011|NOT COMPLETED|Overall Study||0||
48391145|NCT00289744|101287596|FG002|NOT COMPLETED|Year 9 Long-term Follow-up||0||
48391146|NCT00289744|101287594|FG000|STARTED|Year 10 Long-term Follow-up||171||
48691386|NCT02707965|102028899|FG012|NOT COMPLETED|Overall Study||0||
48391147|NCT00289744|101287595|FG001|STARTED|Year 10 Long-term Follow-up||0||
48391148|NCT00289744|101287596|FG002|STARTED|Year 10 Long-term Follow-up||0||
48391149|NCT00289744|101287594|FG000|COMPLETED|Year 10 Long-term Follow-up||171||
48391150|NCT00289744|101287595|FG001|COMPLETED|Year 10 Long-term Follow-up||0||
48391151|NCT00289744|101287596|FG002|COMPLETED|Year 10 Long-term Follow-up||0||
48391152|NCT00289744|101287594|FG000|NOT COMPLETED|Year 10 Long-term Follow-up||0||
48391153|NCT00289744|101287595|FG001|NOT COMPLETED|Year 10 Long-term Follow-up||0||
48391154|NCT00289744|101287596|FG002|NOT COMPLETED|Year 10 Long-term Follow-up||0||
48548314|NCT03473015|101675380|FG002|Post-stenting IMR|Overall Study||50||
48691387|NCT02707965|102028900|FG013|NOT COMPLETED|Overall Study||0||
48691388|NCT02707965|102028901|FG014|NOT COMPLETED|Overall Study||2||
48691389|NCT02707965|102028902|FG015|NOT COMPLETED|Overall Study||0||
48691390|NCT03415581|102028903|FG000|STARTED|Overall Study||7|"Enrollment numbers are shown as a function of participants who were randomized to placebo (N=7) and active doxazosin (N=6) first. Prior to testing under active and placebo conditions participants completed stabilization on each medication Stabilization (Weeks 1-2 and 5-6), prior to testing under each medication Testing (Weeks 3-4 and 7-8). Thus, for the entire duration of the trial was 8 weeks for each participant (who completed)."|
48691391|NCT03415581|102028904|FG001|STARTED|Overall Study||6|"Enrollment numbers are shown as a function of participants who were randomized to placebo (N=7) and active doxazosin (N=6) first. Prior to testing under active and placebo conditions participants completed stabilization on each medication Stabilization (Weeks 1-2 and 5-6), prior to testing under each medication Testing (Weeks 3-4 and 7-8). Thus, for the entire duration of the trial was 8 weeks for each participant (who completed)."|
48691392|NCT03415581|102028903|FG000|COMPLETED|Overall Study||1||
48691393|NCT03415581|102028904|FG001|COMPLETED|Overall Study||1||
48691394|NCT03415581|102028903|FG000|NOT COMPLETED|Overall Study||6||
48691395|NCT03415581|102028904|FG001|NOT COMPLETED|Overall Study||5||
48691396|NCT03028129|102028905|FG000|STARTED|Overall Study||258||
48691397|NCT03028129|102028906|FG001|STARTED|Overall Study||209||
48691398|NCT03028129|102028905|FG000|COMPLETED|Overall Study||132||
48691399|NCT03028129|102028906|FG001|COMPLETED|Overall Study||122||
48691400|NCT03028129|102028905|FG000|NOT COMPLETED|Overall Study||126||
48691401|NCT03028129|102028906|FG001|NOT COMPLETED|Overall Study||87||
48691402|NCT04830215|102028907|FG000|STARTED|Overall Study||122||
48391155|NCT00289744|101287594|FG000|STARTED|Additional Dose Phase||0||
48391156|NCT00289744|101287595|FG001|STARTED|Additional Dose Phase||19||
48391157|NCT00289744|101287596|FG002|STARTED|Additional Dose Phase||6||
48391158|NCT00289744|101287594|FG000|COMPLETED|Additional Dose Phase||0||
48391159|NCT00289744|101287595|FG001|COMPLETED|Additional Dose Phase||19||
48391160|NCT00289744|101287596|FG002|COMPLETED|Additional Dose Phase||6||
48691403|NCT04830215|102028907|FG000|Efficacy Analysis Set|Overall Study||120|The Efficacy Analysis Set included all participants who had a baseline value and at least one post-baseline efficacy evaluation for Inventory of Depressive Symptomatology Self-Report (IDS-SR) total score and IDS-SR-10-engagement during the open label treatment phase.|
48391161|NCT00289744|101287594|FG000|NOT COMPLETED|Additional Dose Phase||0||
48391162|NCT00289744|101287595|FG001|NOT COMPLETED|Additional Dose Phase||0||
48548315|NCT03473015|101675378|FG000|IMR Reassessment 24-48 Hours Post-PCI|Overall Study||20||
48548316|NCT03473015|101675379|FG001|IMR Reassessment 24-48 Hours Post-PCI|Overall Study||0||
48548317|NCT03473015|101675380|FG002|IMR Reassessment 24-48 Hours Post-PCI|Overall Study||31||
48548318|NCT03473015|101675378|FG000|Acute Cardiac MRI Within 24 Hours|Overall Study||17||
48548319|NCT03473015|101675379|FG001|Acute Cardiac MRI Within 24 Hours|Overall Study||17||
48548320|NCT03473015|101675380|FG002|Acute Cardiac MRI Within 24 Hours|Overall Study||29||
48548321|NCT03473015|101675378|FG000|Cardiac MRI at 6 Months|Overall Study||14||
48548322|NCT03473015|101675379|FG001|Cardiac MRI at 6 Months|Overall Study||16||
48548323|NCT03473015|101675380|FG002|Cardiac MRI at 6 Months|Overall Study||24||
48548324|NCT03473015|101675378|FG000|COMPLETED|Overall Study||25||
48548325|NCT03473015|101675379|FG001|COMPLETED|Overall Study||30||
48548326|NCT03473015|101675380|FG002|COMPLETED|Overall Study||50||
48548327|NCT03473015|101675378|FG000|NOT COMPLETED|Overall Study||0||
48548328|NCT03473015|101675379|FG001|NOT COMPLETED|Overall Study||0||
48548329|NCT03473015|101675380|FG002|NOT COMPLETED|Overall Study||0||
48548330|NCT04019626|101675381|FG000|STARTED|Overall Study||42||
48548331|NCT04019626|101675382|FG001|STARTED|Overall Study||42||
48691404|NCT04830215|102028907|FG000|Safety Analysis Set|Overall Study||120|The Safety Analysis Set included all participants who received at least one dose of open-label brexpiprazole.|
48691405|NCT04830215|102028907|FG000|COMPLETED|Overall Study||111||
48691406|NCT04830215|102028907|FG000|NOT COMPLETED|Overall Study||11||
48691407|NCT02316353|102028908|FG000|STARTED|Overall Study||63||
48691408|NCT02316353|102028909|FG001|STARTED|Overall Study||63||
48548332|NCT04019626|101675383|FG002|STARTED|Overall Study||45||
48548333|NCT04019626|101675384|FG003|STARTED|Overall Study||46||
48548334|NCT04019626|101675385|FG004|STARTED|Overall Study||44||
48548335|NCT04019626|101675386|FG005|STARTED|Overall Study||21||
48548336|NCT04019626|101675381|FG000|COMPLETED|Overall Study||36||
48548337|NCT04019626|101675382|FG001|COMPLETED|Overall Study||32||
48548338|NCT04019626|101675383|FG002|COMPLETED|Overall Study||37||
48548339|NCT04019626|101675384|FG003|COMPLETED|Overall Study||39||
48548340|NCT04019626|101675385|FG004|COMPLETED|Overall Study||38||
48548341|NCT04019626|101675386|FG005|COMPLETED|Overall Study||20||
48548342|NCT04019626|101675381|FG000|NOT COMPLETED|Overall Study||6||
48548343|NCT04019626|101675382|FG001|NOT COMPLETED|Overall Study||10||
48548344|NCT04019626|101675383|FG002|NOT COMPLETED|Overall Study||8||
48548345|NCT04019626|101675384|FG003|NOT COMPLETED|Overall Study||7||
48548346|NCT04019626|101675385|FG004|NOT COMPLETED|Overall Study||6||
48548347|NCT04019626|101675386|FG005|NOT COMPLETED|Overall Study||1||
48548348|NCT02624180|101675387|FG000|STARTED|Overall Study||43||
48548349|NCT02624180|101675388|FG001|STARTED|Overall Study||38||
48548350|NCT02624180|101675387|FG000|COMPLETED|Overall Study||37|Participants completing primary endpoint at 8 weeks|
48548351|NCT02624180|101675388|FG001|COMPLETED|Overall Study||34|Participants completing primary endpoint at 8 weeks|
48548352|NCT02624180|101675387|FG000|NOT COMPLETED|Overall Study||6||
48548353|NCT02624180|101675388|FG001|NOT COMPLETED|Overall Study||4||
48548354|NCT00202930|101675389|FG000|STARTED|Overall Study||4||
48548355|NCT00202930|101675389|FG000|COMPLETED|Overall Study||4||
48548356|NCT00202930|101675389|FG000|NOT COMPLETED|Overall Study||0||
48548357|NCT00129545|101675390|FG000|STARTED|Overall Study||93||
48548358|NCT00129545|101675391|FG001|STARTED|Overall Study||463||
48548359|NCT00129545|101675392|FG002|STARTED|Overall Study||244||
48548360|NCT00129545|101675390|FG000|COMPLETED|Overall Study||67||
48548361|NCT00129545|101675391|FG001|COMPLETED|Overall Study||299||
48548362|NCT00129545|101675392|FG002|COMPLETED|Overall Study||133||
48548363|NCT00129545|101675390|FG000|NOT COMPLETED|Overall Study||26||
48548364|NCT00129545|101675391|FG001|NOT COMPLETED|Overall Study||164||
48548365|NCT00129545|101675392|FG002|NOT COMPLETED|Overall Study||111||
48548366|NCT00720382|101675393|FG000|STARTED|Overall Study||466||
48548367|NCT00720382|101675394|FG001|STARTED|Overall Study||237||
48548368|NCT00720382|101675393|FG000|COMPLETED|Overall Study||290||
48548369|NCT00720382|101675394|FG001|COMPLETED|Overall Study||178||
48548370|NCT00720382|101675393|FG000|NOT COMPLETED|Overall Study||176||
48691409|NCT02316353|102028908|FG000|COMPLETED|Overall Study||55||
48548371|NCT00720382|101675394|FG001|NOT COMPLETED|Overall Study||59||
48548372|NCT04805515|101675395|FG000|STARTED|Overall Study||393||
48548373|NCT04805515|101675396|FG001|STARTED|Overall Study||401||
48548374|NCT04805515|101675395|FG000|Wave 2 Survey|Overall Study||313||
48548375|NCT04805515|101675396|FG001|Wave 2 Survey|Overall Study||318||
48691410|NCT02316353|102028909|FG001|COMPLETED|Overall Study||55||
48691411|NCT02316353|102028908|FG000|NOT COMPLETED|Overall Study||8||
48548376|NCT04805515|101675395|FG000|COMPLETED|Overall Study||290||
48548377|NCT04805515|101675396|FG001|COMPLETED|Overall Study||319||
48548378|NCT04805515|101675395|FG000|NOT COMPLETED|Overall Study||103||
48691412|NCT02316353|102028909|FG001|NOT COMPLETED|Overall Study||8||
48691413|NCT03233828|102028910|FG000|STARTED|Overall Study||1||
48548379|NCT04805515|101675396|FG001|NOT COMPLETED|Overall Study||82||
48548380|NCT03098082|101675397|FG000|STARTED|Overall Study||394||
48548381|NCT03098082|101675397|FG000|COMPLETED|Overall Study||254||
48548382|NCT03098082|101675397|FG000|NOT COMPLETED|Overall Study||140||
48548383|NCT01346293|101675398|FG000|STARTED|Overall Study||2743||
48548384|NCT01346293|101675399|FG001|STARTED|Overall Study||629||
48691414|NCT03233828|102028911|FG001|STARTED|Overall Study||0||
48548385|NCT01346293|101675398|FG000|COMPLETED|Overall Study||2676||
48548386|NCT01346293|101675399|FG001|COMPLETED|Overall Study||608||
48548387|NCT01346293|101675398|FG000|NOT COMPLETED|Overall Study||67||
48548388|NCT01346293|101675399|FG001|NOT COMPLETED|Overall Study||21||
48548389|NCT02871492|101675400|FG000|STARTED|Overall Study||73||
48548390|NCT02871492|101675401|FG001|STARTED|Overall Study||73||
48548391|NCT02871492|101675402|FG002|STARTED|Overall Study||77||
48548392|NCT02871492|101675400|FG000|COMPLETED|Overall Study||67||
48548393|NCT02871492|101675401|FG001|COMPLETED|Overall Study||70||
48548394|NCT02871492|101675402|FG002|COMPLETED|Overall Study||71||
48548395|NCT02871492|101675400|FG000|NOT COMPLETED|Overall Study||6||
48548396|NCT02871492|101675401|FG001|NOT COMPLETED|Overall Study||3||
48548397|NCT02871492|101675402|FG002|NOT COMPLETED|Overall Study||6||
48548398|NCT02487225|101675403|FG000|STARTED|Overall Study||45||
48548399|NCT02487225|101675404|FG001|STARTED|Overall Study||38||
48548400|NCT02487225|101675403|FG000|COMPLETED|Overall Study||18||
48548401|NCT02487225|101675404|FG001|COMPLETED|Overall Study||8||
48548402|NCT02487225|101675403|FG000|NOT COMPLETED|Overall Study||27||
48548403|NCT02487225|101675404|FG001|NOT COMPLETED|Overall Study||30||
48548404|NCT00569855|101675405|FG000|STARTED|Overall Study||785||
48548405|NCT00569855|101675405|FG000|COMPLETED|Overall Study||785||
48548406|NCT00569855|101675405|FG000|NOT COMPLETED|Overall Study||0||
48548407|NCT02657928|101675406|FG000|STARTED|Overall Study||20||
48548408|NCT02657928|101675407|FG001|STARTED|Overall Study||20||
48691415|NCT03233828|102028910|FG000|COMPLETED|Overall Study||0||
48691416|NCT03233828|102028911|FG001|COMPLETED|Overall Study||0||
48691417|NCT03233828|102028910|FG000|NOT COMPLETED|Overall Study||1||
48691418|NCT03233828|102028911|FG001|NOT COMPLETED|Overall Study||0||
48548409|NCT02657928|101675406|FG000|COMPLETED|Overall Study||20||
48548410|NCT02657928|101675407|FG001|COMPLETED|Overall Study||20||
48548411|NCT02657928|101675406|FG000|NOT COMPLETED|Overall Study||0||
48548412|NCT02657928|101675407|FG001|NOT COMPLETED|Overall Study||0||
48548413|NCT02075515|101675408|FG000|STARTED|Overall Study||218||
48548414|NCT02075515|101675409|FG001|STARTED|Overall Study||217||
48548415|NCT02075515|101675410|FG002|STARTED|Overall Study||216||
48548416|NCT02075515|101675408|FG000|COMPLETED|Overall Study||214||
48548417|NCT02075515|101675409|FG001|COMPLETED|Overall Study||212||
48548418|NCT02075515|101675410|FG002|COMPLETED|Overall Study||208||
48548419|NCT02075515|101675408|FG000|NOT COMPLETED|Overall Study||4||
48548420|NCT02075515|101675409|FG001|NOT COMPLETED|Overall Study||5||
48548421|NCT02075515|101675410|FG002|NOT COMPLETED|Overall Study||8||
48548422|NCT03758716|101675411|FG000|STARTED|Overall Study||12||
48548423|NCT03758716|101675411|FG000|COMPLETED|Overall Study||12||
48548424|NCT03758716|101675411|FG000|NOT COMPLETED|Overall Study||0||
48691419|NCT00626782|102028912|FG000|STARTED|Overall Study||12||
48691420|NCT00626782|102028913|FG001|STARTED|Overall Study||12||
48548425|NCT00853099|101675412|FG000|STARTED|Double-blind Period||96||
48548426|NCT00853099|101675413|FG001|STARTED|Double-blind Period||87||
48548427|NCT00853099|101675414|FG002|STARTED|Double-blind Period||91||
48548428|NCT00853099|101675415|FG003|STARTED|Double-blind Period||0||
48548429|NCT00853099|101675412|FG000|Treated|Double-blind Period||96||
48548430|NCT00853099|101675413|FG001|Treated|Double-blind Period||87||
48548431|NCT00853099|101675414|FG002|Treated|Double-blind Period||90||
48548432|NCT00853099|101675415|FG003|Treated|Double-blind Period||0||
48548433|NCT00853099|101675412|FG000|Completed Week 8|Double-blind Period||92||
48548434|NCT00853099|101675413|FG001|Completed Week 8|Double-blind Period||85||
48548435|NCT00853099|101675414|FG002|Completed Week 8|Double-blind Period||86||
48548436|NCT00853099|101675415|FG003|Completed Week 8|Double-blind Period||0||
48548437|NCT00853099|101675412|FG000|COMPLETED|Double-blind Period||73||
48548438|NCT00853099|101675413|FG001|COMPLETED|Double-blind Period||58||
48548439|NCT00853099|101675414|FG002|COMPLETED|Double-blind Period||60||
48548440|NCT00853099|101675415|FG003|COMPLETED|Double-blind Period||0||
48548441|NCT00853099|101675412|FG000|NOT COMPLETED|Double-blind Period||23||
48548442|NCT00853099|101675413|FG001|NOT COMPLETED|Double-blind Period||29||
48548443|NCT00853099|101675414|FG002|NOT COMPLETED|Double-blind Period||31||
48548444|NCT00853099|101675415|FG003|NOT COMPLETED|Double-blind Period||0||
48548445|NCT00853099|101675412|FG000|STARTED|Double-blind + Open-label Periods||0||
48548446|NCT00853099|101675413|FG001|STARTED|Double-blind + Open-label Periods||0||
48548447|NCT00853099|101675414|FG002|STARTED|Double-blind + Open-label Periods||0||
48548448|NCT00853099|101675415|FG003|STARTED|Double-blind + Open-label Periods||266||
48548449|NCT00853099|101675412|FG000|COMPLETED|Double-blind + Open-label Periods||0||
48548450|NCT00853099|101675413|FG001|COMPLETED|Double-blind + Open-label Periods||0||
48548451|NCT00853099|101675414|FG002|COMPLETED|Double-blind + Open-label Periods||0||
48548452|NCT00853099|101675415|FG003|COMPLETED|Double-blind + Open-label Periods||119||
48548453|NCT00853099|101675412|FG000|NOT COMPLETED|Double-blind + Open-label Periods||0||
48548454|NCT00853099|101675413|FG001|NOT COMPLETED|Double-blind + Open-label Periods||0||
48548455|NCT00853099|101675414|FG002|NOT COMPLETED|Double-blind + Open-label Periods||0||
48548456|NCT00853099|101675415|FG003|NOT COMPLETED|Double-blind + Open-label Periods||147||
48548457|NCT04309617|101675416|FG000|STARTED|Overall Study||618||
48691421|NCT00626782|102028912|FG000|COMPLETED|Overall Study||12||
48548458|NCT04309617|101675416|FG000|Modified High Risk of Recurrence|Overall Study||136||
48548459|NCT04309617|101675416|FG000|COMPLETED|Overall Study||618||
48548460|NCT04309617|101675416|FG000|NOT COMPLETED|Overall Study||0||
48548461|NCT05534061|101675417|FG000|STARTED|Overall Study||177||
48548462|NCT05534061|101675418|FG001|STARTED|Overall Study||172||
48548463|NCT05534061|101675417|FG000|COMPLETED|Overall Study||177||
48548464|NCT05534061|101675418|FG001|COMPLETED|Overall Study||172||
48548465|NCT05534061|101675417|FG000|NOT COMPLETED|Overall Study||0||
48548466|NCT05534061|101675418|FG001|NOT COMPLETED|Overall Study||0||
48548467|NCT04546724|101675419|FG000|STARTED|Overall Study||3082|In total, 4,128 subjects were randomized, of whom 3,093 subjects were randomized in the VLA1553 arm and 1,035 subjects in the placebo arm. Ten subjects in VLA1553 arm and 1 in placebo arm did not receive their vaccination. All vaccinated subjects were included in the Safety population, except for 1 subject that was vaccinated twice.|
48548468|NCT04546724|101675420|FG001|STARTED|Overall Study||1033|In total, 4,128 subjects were randomized, of whom 3,093 subjects were randomized in the VLA1553 arm and 1,035 subjects in the placebo arm. Ten subjects in VLA1553 arm and 1 in placebo arm did not receive their vaccination. All vaccinated subjects were included in the Safety population, except for 1 subject that was vaccinated twice.|
48548469|NCT04546724|101675419|FG000|COMPLETED|Overall Study||2724||
48548470|NCT04546724|101675420|FG001|COMPLETED|Overall Study||920||
48548471|NCT04546724|101675419|FG000|NOT COMPLETED|Overall Study||358||
48548472|NCT04546724|101675420|FG001|NOT COMPLETED|Overall Study||113||
48548473|NCT04439201|101675421|FG000|STARTED|Overall Study||40||
48548474|NCT04439201|101675421|FG000|Eligible|Overall Study||37||
48548475|NCT04439201|101675421|FG000|Started Protocol Therapy|Overall Study||38||
48548476|NCT04439201|101675421|FG000|Eligible and Treated|Overall Study||36||
48548477|NCT04439201|101675421|FG000|Mutation Status Confirmed|Overall Study||36||
48548478|NCT04439201|101675421|FG000|Eligible, Treated and Mutation Status Confirmed|Overall Study||32|This is the primary analysis population.|
48548479|NCT04439201|101675421|FG000|COMPLETED|Overall Study||0|Treatment continued until disease progression or intolerability.|
48548480|NCT04439201|101675421|FG000|NOT COMPLETED|Overall Study||40||
48548481|NCT00796757|101675422|FG000|STARTED|Overall Study||146||
48548482|NCT00796757|101675422|FG000|COMPLETED|Overall Study||60||
48548483|NCT00796757|101675422|FG000|NOT COMPLETED|Overall Study||86||
48548484|NCT03097991|101675423|FG000|STARTED|Overall Study||140||70
48264761|NCT01193010|100970879|FG001|COMPLETED|Overall Study||20||
48264762|NCT01193010|100970878|FG000|NOT COMPLETED|Overall Study||3||
48264763|NCT01193010|100970879|FG001|NOT COMPLETED|Overall Study||0||
48264764|NCT03197766|100970880|FG000|STARTED|Overall Study||60||
48264765|NCT03197766|100970881|FG001|STARTED|Overall Study||61||
48264766|NCT03197766|100970880|FG000|COMPLETED|Overall Study||58||
48264767|NCT03197766|100970881|FG001|COMPLETED|Overall Study||61||
48548485|NCT03097991|101675424|FG001|STARTED|Overall Study||136||68
48548486|NCT03097991|101675423|FG000|3 Months Post|Overall Study||88||44
48548487|NCT03097991|101675424|FG001|3 Months Post|Overall Study||102||54
48548488|NCT03097991|101675423|FG000|COMPLETED|Overall Study||90|12 months post|45
48548489|NCT03097991|101675424|FG001|COMPLETED|Overall Study||86|12 months post|43
48548490|NCT03097991|101675423|FG000|NOT COMPLETED|Overall Study||50||25
48548491|NCT03097991|101675424|FG001|NOT COMPLETED|Overall Study||50||25
48548492|NCT02503787|101675425|FG000|STARTED|Enrollment||64||
48548493|NCT02503787|101675425|FG000|COMPLETED|Enrollment||44||
48102260|NCT00026793|100575535|FG000|NOT COMPLETED|Overall Study||8||
48102261|NCT02994732|100575536|FG000|STARTED|Overall Study||6||
48102262|NCT02994732|100575536|FG000|COMPLETED|Overall Study||6||
48102263|NCT02994732|100575536|FG000|NOT COMPLETED|Overall Study||0||
48102264|NCT02347189|100575537|FG000|STARTED|Overall Study||39|Number of subjects consented|
48102265|NCT02347189|100575537|FG000|Catheterized|Overall Study||39|Number of subject catheterized with the intent of implant Melody TPV PB1016|
48102266|NCT02347189|100575537|FG000|Implanted|Overall Study||30|Number of subjects implanted with a Melody TPV PB1016|
48102267|NCT02347189|100575537|FG000|Implanted > 24 Hours|Overall Study||30|Number of subjects implanted successfully for at least 24 hours|
48102268|NCT02347189|100575537|FG000|COMPLETED|Overall Study||28|Number of subjects with evaluable data at 6 months|
48102269|NCT02347189|100575537|FG000|NOT COMPLETED|Overall Study||11||
48102270|NCT01176266|100575538|FG000|STARTED|Overall Study||69||
48102271|NCT01176266|100575538|FG000|COMPLETED|Overall Study||60||
48102272|NCT01176266|100575538|FG000|NOT COMPLETED|Overall Study||9||
48102273|NCT01290666|100575539|FG000|STARTED|Overall Study||93||
48102274|NCT01290666|100575539|FG000|COMPLETED|Overall Study||55||
48102275|NCT01290666|100575539|FG000|NOT COMPLETED|Overall Study||38||
48102276|NCT01085097|100575540|FG000|STARTED|Overall Study||15||
48102277|NCT01085097|100575541|FG001|STARTED|Overall Study||16||
48102278|NCT01085097|100575542|FG002|STARTED|Overall Study||15||
48102279|NCT01085097|100575540|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15||
48548494|NCT02503787|101675425|FG000|NOT COMPLETED|Enrollment||20||
48548495|NCT02503787|101675425|FG000|STARTED|Device Trial (HD Programming Trial)||44||
48548496|NCT02503787|101675425|FG000|COMPLETED|Device Trial (HD Programming Trial)||37||
48548497|NCT02503787|101675425|FG000|NOT COMPLETED|Device Trial (HD Programming Trial)||7||
48548498|NCT02503787|101675425|FG000|STARTED|Successful Trial (≥50% Pain Relief)||37||
48141393|NCT04764396|100670418|FG001|NOT COMPLETED|Overall Study||0||
48264768|NCT03197766|100970880|FG000|NOT COMPLETED|Overall Study||2||
48264769|NCT03197766|100970881|FG001|NOT COMPLETED|Overall Study||0||
48548499|NCT02503787|101675425|FG000|COMPLETED|Successful Trial (≥50% Pain Relief)||32||
48548500|NCT02503787|101675425|FG000|NOT COMPLETED|Successful Trial (≥50% Pain Relief)||5||
48548501|NCT02503787|101675425|FG000|STARTED|Implant to 3 Month Endpoint||32||
48548502|NCT02503787|101675425|FG000|COMPLETED|Implant to 3 Month Endpoint||29||
48548503|NCT02503787|101675425|FG000|NOT COMPLETED|Implant to 3 Month Endpoint||3||
48548504|NCT03423940|101675426|FG000|STARTED|Overall Study||5||
48548505|NCT03423940|101675427|FG001|STARTED|Overall Study||12||
48548506|NCT03423940|101675426|FG000|COMPLETED|Overall Study||4||
48548507|NCT03423940|101675427|FG001|COMPLETED|Overall Study||9||
48548508|NCT03423940|101675426|FG000|NOT COMPLETED|Overall Study||1||
48548509|NCT03423940|101675427|FG001|NOT COMPLETED|Overall Study||3||
48548510|NCT02084160|101675428|FG000|STARTED|Overall Study||579||
48548511|NCT02084160|101675428|FG000|COMPLETED|Overall Study||579|579 patient records were reviewed for follow up events, only a small portion had events to report|
48548512|NCT02084160|101675428|FG000|NOT COMPLETED|Overall Study||0||
48548513|NCT02420912|101675429|FG000|STARTED|Overall Study||7||
48548514|NCT02420912|101675430|FG001|STARTED|Overall Study||3||
48548515|NCT02420912|101675431|FG002|STARTED|Overall Study||26||
48548516|NCT02420912|101675429|FG000|COMPLETED|Overall Study||7||
48548517|NCT02420912|101675430|FG001|COMPLETED|Overall Study||3||
48548518|NCT02420912|101675431|FG002|COMPLETED|Overall Study||26||
48548519|NCT02420912|101675429|FG000|NOT COMPLETED|Overall Study||0||
48548520|NCT02420912|101675430|FG001|NOT COMPLETED|Overall Study||0||
48548521|NCT02420912|101675431|FG002|NOT COMPLETED|Overall Study||0||
48548522|NCT05101343|101675432|FG000|STARTED|Overall Study||19||
48548523|NCT05101343|101675433|FG001|STARTED|Overall Study||18||
48548524|NCT05101343|101675432|FG000|COMPLETED|Overall Study||17||
48548525|NCT05101343|101675433|FG001|COMPLETED|Overall Study||17||
48264770|NCT00770588|100970882|FG000|STARTED|Overall Study||148||
48264771|NCT00770588|100970883|FG001|STARTED|Overall Study||148||
48264772|NCT00770588|100970882|FG000|COMPLETED|Overall Study||67||
48264773|NCT00770588|100970883|FG001|COMPLETED|Overall Study||53||
48264774|NCT00770588|100970882|FG000|NOT COMPLETED|Overall Study||81||
48264775|NCT00770588|100970883|FG001|NOT COMPLETED|Overall Study||95||
48264776|NCT01191008|100970884|FG000|STARTED|Overall Study||633||
48264777|NCT01191008|100970884|FG000|COMPLETED|Overall Study||618||
48548526|NCT05101343|101675432|FG000|NOT COMPLETED|Overall Study||2||
48548527|NCT05101343|101675433|FG001|NOT COMPLETED|Overall Study||1||
48548528|NCT02368314|101675434|FG000|STARTED|Overall Study||64||
48548529|NCT02368314|101675435|FG001|STARTED|Overall Study||60||
48548530|NCT02368314|101675434|FG000|COMPLETED|Overall Study||61||
48548531|NCT02368314|101675435|FG001|COMPLETED|Overall Study||57||
48548532|NCT02368314|101675434|FG000|NOT COMPLETED|Overall Study||3||
48548533|NCT02368314|101675435|FG001|NOT COMPLETED|Overall Study||3||
48548534|NCT02833337|101675436|FG000|STARTED|Overall Study||180||
48264778|NCT01191008|100970884|FG000|NOT COMPLETED|Overall Study||15||
48548535|NCT02833337|101675436|FG000|COMPLETED|Overall Study||180|180 completed|
48548536|NCT02833337|101675436|FG000|NOT COMPLETED|Overall Study||0||
48548537|NCT00616421|101675437|FG000|STARTED|Overall Study||359||
48548538|NCT00616421|101675438|FG001|STARTED|Overall Study||1278||
48548539|NCT00616421|101675439|FG002|STARTED|Overall Study||1270||
48548540|NCT00616421|101675437|FG000|COMPLETED|Overall Study||333||
48548541|NCT00616421|101675438|FG001|COMPLETED|Overall Study||1240||
48548542|NCT00616421|101675439|FG002|COMPLETED|Overall Study||1229||
48548543|NCT00616421|101675437|FG000|NOT COMPLETED|Overall Study||26||
48548544|NCT00616421|101675438|FG001|NOT COMPLETED|Overall Study||38||
48548545|NCT00616421|101675439|FG002|NOT COMPLETED|Overall Study||41||
48548546|NCT00805675|101675440|FG000|STARTED|Overall Study||16||
48548547|NCT00805675|101675441|FG001|STARTED|Overall Study||14||
48548548|NCT00805675|101675442|FG002|STARTED|Overall Study||16||
48548549|NCT00805675|101675440|FG000|COMPLETED|Overall Study||16||
48548550|NCT00805675|101675441|FG001|COMPLETED|Overall Study||14||
48548551|NCT00805675|101675442|FG002|COMPLETED|Overall Study||15||
48548552|NCT00805675|101675440|FG000|NOT COMPLETED|Overall Study||0||
48548553|NCT00805675|101675441|FG001|NOT COMPLETED|Overall Study||0||
48548554|NCT00805675|101675442|FG002|NOT COMPLETED|Overall Study||1||
48548555|NCT04660331|101675443|FG000|STARTED|PROMOTE Key Informant Interviews (Aim 1)||13||
48548556|NCT04660331|101675444|FG001|STARTED|PROMOTE Key Informant Interviews (Aim 1)||11||
48548557|NCT04660331|101675445|FG002|STARTED|PROMOTE Key Informant Interviews (Aim 1)||0||
48548558|NCT04660331|101675443|FG000|COMPLETED|PROMOTE Key Informant Interviews (Aim 1)||13||
48548559|NCT04660331|101675444|FG001|COMPLETED|PROMOTE Key Informant Interviews (Aim 1)||11||
48548560|NCT04660331|101675445|FG002|COMPLETED|PROMOTE Key Informant Interviews (Aim 1)||0||
48548561|NCT04660331|101675443|FG000|NOT COMPLETED|PROMOTE Key Informant Interviews (Aim 1)||0||
48548562|NCT04660331|101675444|FG001|NOT COMPLETED|PROMOTE Key Informant Interviews (Aim 1)||0||
48548563|NCT04660331|101675445|FG002|NOT COMPLETED|PROMOTE Key Informant Interviews (Aim 1)||0||
48102280|NCT01085097|100575541|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16||
48102281|NCT01085097|100575542|FG002|Received at Least 1 Dose of Study Drug|Overall Study||15||
48102282|NCT01085097|100575540|FG000|COMPLETED|Overall Study||13||
48102283|NCT01085097|100575541|FG001|COMPLETED|Overall Study||16||
48102284|NCT01085097|100575542|FG002|COMPLETED|Overall Study||13||
48102285|NCT01085097|100575540|FG000|NOT COMPLETED|Overall Study||2||
48391163|NCT00289744|101287596|FG002|NOT COMPLETED|Additional Dose Phase||0||
48391164|NCT05563714|101287597|FG000|STARTED|Overall Study||110||
48391165|NCT05563714|101287598|FG001|STARTED|Overall Study||110||
48391166|NCT05563714|101287599|FG002|STARTED|Overall Study||61||
48391167|NCT05563714|101287600|FG003|STARTED|Overall Study||60||
48391168|NCT05563714|101287597|FG000|COMPLETED|Overall Study||81||
48391169|NCT05563714|101287598|FG001|COMPLETED|Overall Study||83||
48391170|NCT05563714|101287599|FG002|COMPLETED|Overall Study||61||
48391171|NCT05563714|101287600|FG003|COMPLETED|Overall Study||60||
48391172|NCT05563714|101287597|FG000|NOT COMPLETED|Overall Study||29||
48391173|NCT05563714|101287598|FG001|NOT COMPLETED|Overall Study||27||
48391174|NCT05563714|101287599|FG002|NOT COMPLETED|Overall Study||0||
48391175|NCT05563714|101287600|FG003|NOT COMPLETED|Overall Study||0||
48391176|NCT04732819|101287601|FG000|STARTED|Overall Study||12582||70
48391177|NCT04732819|101287602|FG001|STARTED|Overall Study||11186||63
48391178|NCT04732819|101287601|FG000|COMPLETED|Overall Study||12582||70
48391179|NCT04732819|101287602|FG001|COMPLETED|Overall Study||11186||63
48391180|NCT04732819|101287601|FG000|NOT COMPLETED|Overall Study||0||0
48391181|NCT04732819|101287602|FG001|NOT COMPLETED|Overall Study||0||0
48391182|NCT02437487|101287603|FG000|STARTED|Overall Study||59||
48391183|NCT02437487|101287604|FG001|STARTED|Overall Study||30||
48391184|NCT02437487|101287603|FG000|Actual Treatment Received|Overall Study||60||
48391185|NCT02437487|101287604|FG001|Actual Treatment Received|Overall Study||29||
48391186|NCT02437487|101287603|FG000|Intention-to-Treat Population|Overall Study||59||
48391187|NCT02437487|101287604|FG001|Intention-to-Treat Population|Overall Study||30||
48391188|NCT02437487|101287603|FG000|COMPLETED|Overall Study||32||
48391189|NCT02437487|101287604|FG001|COMPLETED|Overall Study||16||
48391190|NCT02437487|101287603|FG000|NOT COMPLETED|Overall Study||27||
48391191|NCT02437487|101287604|FG001|NOT COMPLETED|Overall Study||14||
48391192|NCT02472795|101287605|FG000|STARTED|Overall Study||12||
48391193|NCT02472795|101287606|FG001|STARTED|Overall Study||12||
48391194|NCT02472795|101287607|FG002|STARTED|Overall Study||13||
48391195|NCT02472795|101287608|FG003|STARTED|Overall Study||13||
48391196|NCT02472795|101287609|FG004|STARTED|Overall Study||17||
48391197|NCT02472795|101287605|FG000|Pharmacodynamic Set|Overall Study||12||
48391198|NCT02472795|101287606|FG001|Pharmacodynamic Set|Overall Study||10||
48391199|NCT02472795|101287607|FG002|Pharmacodynamic Set|Overall Study||13||
48391200|NCT02472795|101287608|FG003|Pharmacodynamic Set|Overall Study||13||
48391201|NCT02472795|101287609|FG004|Pharmacodynamic Set|Overall Study||16||
48391202|NCT02472795|101287605|FG000|Modified Pharmacodynamic Analysis Set|Overall Study||12||
48391203|NCT02472795|101287606|FG001|Modified Pharmacodynamic Analysis Set|Overall Study||10||
48391204|NCT02472795|101287607|FG002|Modified Pharmacodynamic Analysis Set|Overall Study||13||
48391205|NCT02472795|101287608|FG003|Modified Pharmacodynamic Analysis Set|Overall Study||9||
48391206|NCT02472795|101287609|FG004|Modified Pharmacodynamic Analysis Set|Overall Study||16||
48391207|NCT02472795|101287605|FG000|COMPLETED|Overall Study||12||
48391208|NCT02472795|101287606|FG001|COMPLETED|Overall Study||11||
48391209|NCT02472795|101287607|FG002|COMPLETED|Overall Study||13||
48391210|NCT02472795|101287608|FG003|COMPLETED|Overall Study||13||
48391211|NCT02472795|101287609|FG004|COMPLETED|Overall Study||14||
48391212|NCT02472795|101287605|FG000|NOT COMPLETED|Overall Study||0||
48391213|NCT02472795|101287606|FG001|NOT COMPLETED|Overall Study||1||
48391214|NCT02472795|101287607|FG002|NOT COMPLETED|Overall Study||0||
48391215|NCT02472795|101287608|FG003|NOT COMPLETED|Overall Study||0||
48391216|NCT02472795|101287609|FG004|NOT COMPLETED|Overall Study||3||
48391217|NCT01419015|101287610|FG000|STARTED|Overall Study||17||
48391218|NCT01419015|101287610|FG000|COMPLETED|Overall Study||15||
48391219|NCT01419015|101287610|FG000|NOT COMPLETED|Overall Study||2||
48391220|NCT04430283|101287611|FG000|STARTED|Overall Study||2||
48102286|NCT01085097|100575541|FG001|NOT COMPLETED|Overall Study||0||
48102287|NCT01085097|100575542|FG002|NOT COMPLETED|Overall Study||2||
48102288|NCT02735551|100575543|FG000|STARTED|Overall Study||3||
48102289|NCT02735551|100575544|FG001|STARTED|Overall Study||0||
48102290|NCT02735551|100575545|FG002|STARTED|Overall Study||0||
48391221|NCT04430283|101287612|FG001|STARTED|Overall Study||2||
48391222|NCT04430283|101287613|FG002|STARTED|Overall Study||4||
48391223|NCT04430283|101287611|FG000|COMPLETED|Overall Study||0||
48391224|NCT04430283|101287612|FG001|COMPLETED|Overall Study||0||
48391225|NCT04430283|101287613|FG002|COMPLETED|Overall Study||0||
48102291|NCT02735551|100575543|FG000|COMPLETED|Overall Study||3||
48102292|NCT02735551|100575544|FG001|COMPLETED|Overall Study||0||
48391226|NCT04430283|101287611|FG000|NOT COMPLETED|Overall Study||2||
48391227|NCT04430283|101287612|FG001|NOT COMPLETED|Overall Study||2||
48391228|NCT04430283|101287613|FG002|NOT COMPLETED|Overall Study||4||
48391229|NCT01928082|101287614|FG000|STARTED|Overall Study||1||
48391230|NCT01928082|101287614|FG000|COMPLETED|Overall Study||0||
48391231|NCT01928082|101287614|FG000|NOT COMPLETED|Overall Study||1||
48548564|NCT04660331|101675443|FG000|STARTED|PROMOTE Intervention (Aim 2)||0||
48548565|NCT04660331|101675444|FG001|STARTED|PROMOTE Intervention (Aim 2)||0||
48548566|NCT04660331|101675445|FG002|STARTED|PROMOTE Intervention (Aim 2)||18||
48548567|NCT04660331|101675443|FG000|COMPLETED|PROMOTE Intervention (Aim 2)||0||
48548568|NCT04660331|101675444|FG001|COMPLETED|PROMOTE Intervention (Aim 2)||0||
48548569|NCT04660331|101675445|FG002|COMPLETED|PROMOTE Intervention (Aim 2)||13||
48548570|NCT04660331|101675443|FG000|NOT COMPLETED|PROMOTE Intervention (Aim 2)||0||
48548571|NCT04660331|101675444|FG001|NOT COMPLETED|PROMOTE Intervention (Aim 2)||0||
48548572|NCT04660331|101675445|FG002|NOT COMPLETED|PROMOTE Intervention (Aim 2)||5||
48548573|NCT01721317|101675446|FG000|STARTED|Overall Study||2||
48548574|NCT01721317|101675447|FG001|STARTED|Overall Study||4||
48548575|NCT01721317|101675446|FG000|COMPLETED|Overall Study||0||
48548576|NCT01721317|101675447|FG001|COMPLETED|Overall Study||0||
48548577|NCT01721317|101675446|FG000|NOT COMPLETED|Overall Study||2||
48548578|NCT01721317|101675447|FG001|NOT COMPLETED|Overall Study||4||
48548579|NCT02096744|101675448|FG000|STARTED|Treatment Period 1(7 Days)||29||
48548580|NCT02096744|101675449|FG001|STARTED|Treatment Period 1(7 Days)||29||
48548581|NCT02096744|101675448|FG000|COMPLETED|Treatment Period 1(7 Days)||28||
48548582|NCT02096744|101675449|FG001|COMPLETED|Treatment Period 1(7 Days)||28||
48548583|NCT02096744|101675448|FG000|NOT COMPLETED|Treatment Period 1(7 Days)||1||
48548584|NCT02096744|101675449|FG001|NOT COMPLETED|Treatment Period 1(7 Days)||1||
48548585|NCT02096744|101675448|FG000|STARTED|Washout Period 1(7 Days)||28||
48548586|NCT02096744|101675449|FG001|STARTED|Washout Period 1(7 Days)||28||
48548587|NCT02096744|101675448|FG000|COMPLETED|Washout Period 1(7 Days)||28||
48548588|NCT02096744|101675449|FG001|COMPLETED|Washout Period 1(7 Days)||28||
48548589|NCT02096744|101675448|FG000|NOT COMPLETED|Washout Period 1(7 Days)||0||
48548590|NCT02096744|101675449|FG001|NOT COMPLETED|Washout Period 1(7 Days)||0||
48548591|NCT02096744|101675448|FG000|STARTED|Treatment Period 2 (7 Days)||28||
48548592|NCT02096744|101675449|FG001|STARTED|Treatment Period 2 (7 Days)||28||
48548593|NCT02096744|101675448|FG000|COMPLETED|Treatment Period 2 (7 Days)||28||
48548594|NCT02096744|101675449|FG001|COMPLETED|Treatment Period 2 (7 Days)||28||
48548595|NCT02096744|101675448|FG000|NOT COMPLETED|Treatment Period 2 (7 Days)||0||
48548596|NCT02096744|101675449|FG001|NOT COMPLETED|Treatment Period 2 (7 Days)||0||
48548597|NCT02096744|101675448|FG000|STARTED|Washout Period 2 (3 Days)||28||
48548598|NCT02096744|101675449|FG001|STARTED|Washout Period 2 (3 Days)||28||
48548599|NCT02096744|101675448|FG000|COMPLETED|Washout Period 2 (3 Days)||28||
48548600|NCT02096744|101675449|FG001|COMPLETED|Washout Period 2 (3 Days)||28||
48264779|NCT02514551|100970885|FG000|STARTED|Overall Study||123||
48264780|NCT02514551|100970886|FG001|STARTED|Overall Study||122||
48548601|NCT02096744|101675448|FG000|NOT COMPLETED|Washout Period 2 (3 Days)||0||
48548602|NCT02096744|101675449|FG001|NOT COMPLETED|Washout Period 2 (3 Days)||0||
48548603|NCT02096744|101675448|FG000|STARTED|Treatment Period 3 (7 Days)||28||
48548604|NCT02096744|101675449|FG001|STARTED|Treatment Period 3 (7 Days)||28||
48548605|NCT02096744|101675448|FG000|COMPLETED|Treatment Period 3 (7 Days)||28||
48548606|NCT02096744|101675449|FG001|COMPLETED|Treatment Period 3 (7 Days)||27||
48548607|NCT02096744|101675448|FG000|NOT COMPLETED|Treatment Period 3 (7 Days)||0||
48548608|NCT02096744|101675449|FG001|NOT COMPLETED|Treatment Period 3 (7 Days)||1||
48548609|NCT00611624|101679435|FG000|STARTED|Overall Study||28||
48548610|NCT00611624|101679435|FG000|COMPLETED|Overall Study||28||
48548611|NCT00611624|101679435|FG000|NOT COMPLETED|Overall Study||0||
48548612|NCT01512160|101679436|FG000|STARTED|Overall Study||22||
48548613|NCT01512160|101679437|FG001|STARTED|Overall Study||23||
48548614|NCT01512160|101679438|FG002|STARTED|Overall Study||22||
48548615|NCT01512160|101679439|FG003|STARTED|Overall Study||23||
48548616|NCT01512160|101679436|FG000|COMPLETED|Overall Study||20||
48548617|NCT01512160|101679437|FG001|COMPLETED|Overall Study||23||
48548618|NCT01512160|101679438|FG002|COMPLETED|Overall Study||22||
48548619|NCT01512160|101679439|FG003|COMPLETED|Overall Study||22||
48548620|NCT01512160|101679436|FG000|NOT COMPLETED|Overall Study||2||
48548621|NCT01512160|101679437|FG001|NOT COMPLETED|Overall Study||0||
48264781|NCT02514551|100970885|FG000|Received at Least One Dose of Study Drug|Overall Study||123||
48264782|NCT02514551|100970886|FG001|Received at Least One Dose of Study Drug|Overall Study||120||
48264783|NCT02514551|100970885|FG000|COMPLETED|Overall Study||123||
48548622|NCT01512160|101679438|FG002|NOT COMPLETED|Overall Study||0||
48548623|NCT01512160|101679439|FG003|NOT COMPLETED|Overall Study||1||
48548624|NCT03834142|101679440|FG000|STARTED|Overall Study||10||
48548625|NCT03834142|101679441|FG001|STARTED|Overall Study||10||
48548626|NCT03834142|101679440|FG000|COMPLETED|Overall Study||10||
48548627|NCT03834142|101679441|FG001|COMPLETED|Overall Study||10||
48548628|NCT03834142|101679440|FG000|NOT COMPLETED|Overall Study||0||
48548629|NCT03834142|101679441|FG001|NOT COMPLETED|Overall Study||0||
48548630|NCT00706485|101679442|FG000|STARTED|Overall Study||5||
48548631|NCT00706485|101679442|FG000|COMPLETED|Overall Study||5||
48548632|NCT00706485|101679442|FG000|NOT COMPLETED|Overall Study||0||
48548633|NCT02411916|101679443|FG000|STARTED|Overall Study||73||
48548634|NCT02411916|101679444|FG001|STARTED|Overall Study||70||
48548635|NCT02411916|101679443|FG000|COMPLETED|Overall Study||73||
48548636|NCT02411916|101679444|FG001|COMPLETED|Overall Study||70||
48548637|NCT02411916|101679443|FG000|NOT COMPLETED|Overall Study||0||
48548638|NCT02411916|101679444|FG001|NOT COMPLETED|Overall Study||0||
48548639|NCT01645787|101679445|FG000|STARTED|First Intervention Short Term (2 Weeks)||6||
48548640|NCT01645787|101679446|FG001|STARTED|First Intervention Short Term (2 Weeks)||5||
48548641|NCT01645787|101679445|FG000|COMPLETED|First Intervention Short Term (2 Weeks)||6||
48548642|NCT01645787|101679446|FG001|COMPLETED|First Intervention Short Term (2 Weeks)||5||
48548643|NCT01645787|101679445|FG000|NOT COMPLETED|First Intervention Short Term (2 Weeks)||0||
48548644|NCT01645787|101679446|FG001|NOT COMPLETED|First Intervention Short Term (2 Weeks)||0||
48548645|NCT01645787|101679445|FG000|STARTED|Washout (1 Week)||6||
48548646|NCT01645787|101679446|FG001|STARTED|Washout (1 Week)||5||
48548647|NCT01645787|101679445|FG000|COMPLETED|Washout (1 Week)||6||
48548648|NCT01645787|101679446|FG001|COMPLETED|Washout (1 Week)||5||
48548649|NCT01645787|101679445|FG000|NOT COMPLETED|Washout (1 Week)||0||
48548650|NCT01645787|101679446|FG001|NOT COMPLETED|Washout (1 Week)||0||
48548651|NCT01645787|101679445|FG000|STARTED|Second Intervention (2 Weeks)||6||
48548652|NCT01645787|101679446|FG001|STARTED|Second Intervention (2 Weeks)||5||
48548653|NCT01645787|101679445|FG000|COMPLETED|Second Intervention (2 Weeks)||6||
48548654|NCT01645787|101679446|FG001|COMPLETED|Second Intervention (2 Weeks)||5||
48548655|NCT01645787|101679445|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48548656|NCT01645787|101679446|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48548657|NCT01645787|101679445|FG000|STARTED|Washout (2 Weeks)||6||
48548658|NCT01645787|101679446|FG001|STARTED|Washout (2 Weeks)||5||
48548659|NCT01645787|101679445|FG000|COMPLETED|Washout (2 Weeks)||5||
48548660|NCT01645787|101679446|FG001|COMPLETED|Washout (2 Weeks)||5||
48548661|NCT01645787|101679445|FG000|NOT COMPLETED|Washout (2 Weeks)||1||
48548662|NCT01645787|101679446|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
48548663|NCT01645787|101679445|FG000|STARTED|Third Intervention Long Term (6 Weeks)||5||
48548664|NCT01645787|101679446|FG001|STARTED|Third Intervention Long Term (6 Weeks)||5||
48548665|NCT01645787|101679445|FG000|COMPLETED|Third Intervention Long Term (6 Weeks)||5||
48548666|NCT01645787|101679446|FG001|COMPLETED|Third Intervention Long Term (6 Weeks)||5||
48548667|NCT01645787|101679445|FG000|NOT COMPLETED|Third Intervention Long Term (6 Weeks)||0||
48264784|NCT02514551|100970886|FG001|COMPLETED|Overall Study||119||
48264785|NCT02514551|100970885|FG000|NOT COMPLETED|Overall Study||0||
48264786|NCT02514551|100970886|FG001|NOT COMPLETED|Overall Study||3||
48264787|NCT01895036|100970887|FG000|STARTED|Overall Study||6||
48548668|NCT01645787|101679446|FG001|NOT COMPLETED|Third Intervention Long Term (6 Weeks)||0||
48548669|NCT01645787|101679445|FG000|STARTED|Washout (2 Weeks)||5||
48548670|NCT01645787|101679446|FG001|STARTED|Washout (2 Weeks)||5||
48548671|NCT01645787|101679445|FG000|COMPLETED|Washout (2 Weeks)||5||
48548672|NCT01645787|101679446|FG001|COMPLETED|Washout (2 Weeks)||5||
48548673|NCT01645787|101679445|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
48548674|NCT01645787|101679446|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
48548675|NCT01645787|101679445|FG000|STARTED|Fourth Intervention (6 Weeks)||5||
48548676|NCT01645787|101679446|FG001|STARTED|Fourth Intervention (6 Weeks)||5||
48548677|NCT01645787|101679445|FG000|COMPLETED|Fourth Intervention (6 Weeks)||5||
48548678|NCT01645787|101679446|FG001|COMPLETED|Fourth Intervention (6 Weeks)||5||
48548679|NCT01645787|101679445|FG000|NOT COMPLETED|Fourth Intervention (6 Weeks)||0||
48548680|NCT01645787|101679446|FG001|NOT COMPLETED|Fourth Intervention (6 Weeks)||0||
48548681|NCT03910673|101679447|FG000|STARTED|Overall Study||7||
48548682|NCT03910673|101679448|FG001|STARTED|Overall Study||6||
48548683|NCT03910673|101679449|FG002|STARTED|Overall Study||7||
48548684|NCT03910673|101679450|FG003|STARTED|Overall Study||13||
48548685|NCT03910673|101679451|FG004|STARTED|Overall Study||6||
48548686|NCT03910673|101679447|FG000|Enrolled and Randomized|Overall Study||6||
48548687|NCT03910673|101679448|FG001|Enrolled and Randomized|Overall Study||6||
48548688|NCT03910673|101679449|FG002|Enrolled and Randomized|Overall Study||6||
48548689|NCT03910673|101679450|FG003|Enrolled and Randomized|Overall Study||6||
48548690|NCT03910673|101679451|FG004|Enrolled and Randomized|Overall Study||6||
48548691|NCT03910673|101679447|FG000|Enrolled as Replacement|Overall Study||1||
48548692|NCT03910673|101679448|FG001|Enrolled as Replacement|Overall Study||0||
48548693|NCT03910673|101679449|FG002|Enrolled as Replacement|Overall Study||1||
48548694|NCT03910673|101679450|FG003|Enrolled as Replacement|Overall Study||7||
48548695|NCT03910673|101679451|FG004|Enrolled as Replacement|Overall Study||0||
48548696|NCT03910673|101679447|FG000|Began Infusion of Dose 1|Overall Study||7||
48548697|NCT03910673|101679448|FG001|Began Infusion of Dose 1|Overall Study||6||
48548698|NCT03910673|101679449|FG002|Began Infusion of Dose 1|Overall Study||7||
48548699|NCT03910673|101679450|FG003|Began Infusion of Dose 1|Overall Study||13||
48548700|NCT03910673|101679451|FG004|Began Infusion of Dose 1|Overall Study||6||
48548701|NCT03910673|101679447|FG000|Completed Dose 1|Overall Study||7||
48548702|NCT03910673|101679448|FG001|Completed Dose 1|Overall Study||6||
48548703|NCT03910673|101679449|FG002|Completed Dose 1|Overall Study||7||
48548704|NCT03910673|101679450|FG003|Completed Dose 1|Overall Study||13||
48548705|NCT03910673|101679451|FG004|Completed Dose 1|Overall Study||6||
48548706|NCT03910673|101679447|FG000|Completed Dose 2|Overall Study||7||
48548707|NCT03910673|101679448|FG001|Completed Dose 2|Overall Study||6||
48548708|NCT03910673|101679449|FG002|Completed Dose 2|Overall Study||7||
48548709|NCT03910673|101679450|FG003|Completed Dose 2|Overall Study||13||
48548710|NCT03910673|101679451|FG004|Completed Dose 2|Overall Study||6||
48548711|NCT03910673|101679447|FG000|Completed Dose 3|Overall Study||6||
48264788|NCT01895036|100970887|FG000|COMPLETED|Overall Study||6||
48548712|NCT03910673|101679448|FG001|Completed Dose 3|Overall Study||6||
48548713|NCT03910673|101679449|FG002|Completed Dose 3|Overall Study||7||
48548714|NCT03910673|101679450|FG003|Completed Dose 3|Overall Study||12||
48548715|NCT03910673|101679451|FG004|Completed Dose 3|Overall Study||6||
48548716|NCT03910673|101679447|FG000|Completed All Scheduled Treatment|Overall Study||6||
48548717|NCT03910673|101679448|FG001|Completed All Scheduled Treatment|Overall Study||6||
48102293|NCT02735551|100575545|FG002|COMPLETED|Overall Study||0||
48102294|NCT02735551|100575543|FG000|NOT COMPLETED|Overall Study||0||
48102295|NCT02735551|100575544|FG001|NOT COMPLETED|Overall Study||0||
48102296|NCT02735551|100575545|FG002|NOT COMPLETED|Overall Study||0||
48102297|NCT02013167|100575546|FG000|STARTED|Overall Study||134||
48102298|NCT02013167|100575547|FG001|STARTED|Overall Study||271||
48102299|NCT02013167|100575546|FG000|Received Treatment|Overall Study||109||
48102300|NCT02013167|100575547|FG001|Received Treatment|Overall Study||267||
48102301|NCT02013167|100575546|FG000|COMPLETED|Overall Study||33||
48102302|NCT02013167|100575547|FG001|COMPLETED|Overall Study||93||
48102303|NCT02013167|100575546|FG000|NOT COMPLETED|Overall Study||101||
48102304|NCT02013167|100575547|FG001|NOT COMPLETED|Overall Study||178||
48548718|NCT03910673|101679449|FG002|Completed All Scheduled Treatment|Overall Study||7||
48548719|NCT03910673|101679450|FG003|Completed All Scheduled Treatment|Overall Study||12||
48548720|NCT03910673|101679451|FG004|Completed All Scheduled Treatment|Overall Study||6||
48548721|NCT03910673|101679447|FG000|Completed All PK Blood Draws|Overall Study||6||
48548722|NCT03910673|101679448|FG001|Completed All PK Blood Draws|Overall Study||6||
48548723|NCT03910673|101679449|FG002|Completed All PK Blood Draws|Overall Study||6||
48691422|NCT00626782|102028913|FG001|COMPLETED|Overall Study||12||
48691423|NCT00626782|102028912|FG000|NOT COMPLETED|Overall Study||0||
48691424|NCT00626782|102028913|FG001|NOT COMPLETED|Overall Study||0||
48691425|NCT00978419|102028914|FG000|STARTED|Overall Study||0||
48691426|NCT00978419|102028915|FG001|STARTED|Overall Study||0||
48691427|NCT00978419|102028914|FG000|COMPLETED|Overall Study||0||
48691428|NCT00978419|102028915|FG001|COMPLETED|Overall Study||0||
48691429|NCT00978419|102028914|FG000|NOT COMPLETED|Overall Study||0||
48691430|NCT00978419|102028915|FG001|NOT COMPLETED|Overall Study||0||
48691431|NCT01048242|102028916|FG000|STARTED|Overall Study||12||
48691432|NCT01048242|102028917|FG001|STARTED|Overall Study||15||
48691433|NCT01048242|102028916|FG000|COMPLETED|Overall Study||8||
48548724|NCT03910673|101679450|FG003|Completed All PK Blood Draws|Overall Study||6||
48548725|NCT03910673|101679451|FG004|Completed All PK Blood Draws|Overall Study||6||
48264789|NCT01895036|100970887|FG000|NOT COMPLETED|Overall Study||0||
48264790|NCT00880022|100970888|FG000|STARTED|Overall Study||23||
48691434|NCT01048242|102028917|FG001|COMPLETED|Overall Study||13||
48691435|NCT01048242|102028916|FG000|NOT COMPLETED|Overall Study||4||
48691436|NCT01048242|102028917|FG001|NOT COMPLETED|Overall Study||2||
48691437|NCT01916824|102028918|FG000|STARTED|Overall Study||24||
48691438|NCT01916824|102028919|FG001|STARTED|Overall Study||29||
48691439|NCT01916824|102028918|FG000|COMPLETED|Overall Study||17||
48691440|NCT01916824|102028919|FG001|COMPLETED|Overall Study||20||
48691441|NCT01916824|102028918|FG000|NOT COMPLETED|Overall Study||7||
48691442|NCT01916824|102028919|FG001|NOT COMPLETED|Overall Study||9||
48691443|NCT03782259|102028920|FG000|STARTED|Overall Study||31||
48691444|NCT03782259|102028921|FG001|STARTED|Overall Study||31||
48691445|NCT03782259|102028920|FG000|COMPLETED|Overall Study||29||
48691446|NCT03782259|102028921|FG001|COMPLETED|Overall Study||27||
48691447|NCT03782259|102028920|FG000|NOT COMPLETED|Overall Study||2||
48691448|NCT03782259|102028921|FG001|NOT COMPLETED|Overall Study||4||
48691449|NCT02366923|102028922|FG000|STARTED|Overall Study||28||
48691450|NCT02366923|102028922|FG000|COMPLETED|Overall Study||22||
48691451|NCT02366923|102028922|FG000|NOT COMPLETED|Overall Study||6||
48691452|NCT02038946|102028923|FG000|STARTED|Overall Study||92||
48691453|NCT02038946|102028923|FG000|COMPLETED|Overall Study||80|Completed = Participants continuing in the Follow-up period|
48691454|NCT02038946|102028923|FG000|NOT COMPLETED|Overall Study||12||
48102305|NCT01263301|100575548|FG000|STARTED|Overall Study||5||
48102306|NCT01263301|100575549|FG001|STARTED|Overall Study||11||
48102307|NCT01263301|100575548|FG000|COMPLETED|Overall Study||5||
48102308|NCT01263301|100575549|FG001|COMPLETED|Overall Study||11||
48102309|NCT01263301|100575548|FG000|NOT COMPLETED|Overall Study||0||
48264791|NCT00880022|100970889|FG001|STARTED|Overall Study||24||
48548726|NCT03910673|101679447|FG000|Completed Bronchoscopy With BAL|Overall Study||6||
48691455|NCT03050450|102028924|FG000|STARTED|Overall Study||6||
48102310|NCT01263301|100575549|FG001|NOT COMPLETED|Overall Study||0||
48102311|NCT02120950|100575550|FG000|STARTED|Overall Study||157||
48102312|NCT02120950|100575551|FG001|STARTED|Overall Study||161||
48264792|NCT00880022|100970888|FG000|COMPLETED|Overall Study||21||
48264793|NCT00880022|100970889|FG001|COMPLETED|Overall Study||21||
48691456|NCT03050450|102028925|FG001|STARTED|Overall Study||0||
48691457|NCT03050450|102028926|FG002|STARTED|Overall Study||0||
48691458|NCT03050450|102028927|FG003|STARTED|Overall Study||0||
48691459|NCT03050450|102028928|FG004|STARTED|Overall Study||0||
48691460|NCT03050450|102028924|FG000|COMPLETED|Overall Study||5||
48691461|NCT03050450|102028925|FG001|COMPLETED|Overall Study||0||
48691462|NCT03050450|102028926|FG002|COMPLETED|Overall Study||0||
48691463|NCT03050450|102028927|FG003|COMPLETED|Overall Study||0||
48548727|NCT03910673|101679448|FG001|Completed Bronchoscopy With BAL|Overall Study||6||
48548728|NCT03910673|101679449|FG002|Completed Bronchoscopy With BAL|Overall Study||6||
48548729|NCT03910673|101679450|FG003|Completed Bronchoscopy With BAL|Overall Study||6||
48548730|NCT03910673|101679451|FG004|Completed Bronchoscopy With BAL|Overall Study||6||
48548731|NCT03910673|101679447|FG000|Completed All Plasma Urea Samples|Overall Study||6||
48548732|NCT03910673|101679448|FG001|Completed All Plasma Urea Samples|Overall Study||6||
48548733|NCT03910673|101679449|FG002|Completed All Plasma Urea Samples|Overall Study||6||
48548734|NCT03910673|101679450|FG003|Completed All Plasma Urea Samples|Overall Study||6||
48548735|NCT03910673|101679451|FG004|Completed All Plasma Urea Samples|Overall Study||6||
48548736|NCT03910673|101679447|FG000|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6||
48548737|NCT03910673|101679448|FG001|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6||
48548738|NCT03910673|101679449|FG002|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6||
48548739|NCT03910673|101679450|FG003|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6||
48548740|NCT03910673|101679451|FG004|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6||
48548741|NCT03910673|101679447|FG000|COMPLETED|Overall Study||7||
48548742|NCT03910673|101679448|FG001|COMPLETED|Overall Study||6||
48548743|NCT03910673|101679449|FG002|COMPLETED|Overall Study||7||
48548744|NCT03910673|101679450|FG003|COMPLETED|Overall Study||11||
48548745|NCT03910673|101679451|FG004|COMPLETED|Overall Study||6||
48548746|NCT03910673|101679447|FG000|NOT COMPLETED|Overall Study||0||
48548747|NCT03910673|101679448|FG001|NOT COMPLETED|Overall Study||0||
48548748|NCT03910673|101679449|FG002|NOT COMPLETED|Overall Study||0||
48548749|NCT03910673|101679450|FG003|NOT COMPLETED|Overall Study||2||
48548750|NCT03910673|101679451|FG004|NOT COMPLETED|Overall Study||0||
48548751|NCT00061932|101679452|FG000|STARTED|Overall Study||29||
48548752|NCT00061932|101679453|FG001|STARTED|Overall Study||12||
48548753|NCT00061932|101679452|FG000|COMPLETED|Overall Study||16||
48548754|NCT00061932|101679453|FG001|COMPLETED|Overall Study||8||
48548755|NCT00061932|101679452|FG000|NOT COMPLETED|Overall Study||13||
48548756|NCT00061932|101679453|FG001|NOT COMPLETED|Overall Study||4||
48548757|NCT02171195|101679454|FG000|STARTED|Overall Study||16||
48548758|NCT02171195|101679455|FG001|STARTED|Overall Study||6||
48548759|NCT02171195|101679456|FG002|STARTED|Overall Study||6||
48548760|NCT02171195|101679457|FG003|STARTED|Overall Study||6||
48548761|NCT02171195|101679458|FG004|STARTED|Overall Study||6||
48548762|NCT02171195|101679459|FG005|STARTED|Overall Study||6||
48548763|NCT02171195|101679460|FG006|STARTED|Overall Study||6||
48548764|NCT02171195|101679461|FG007|STARTED|Overall Study||6||
48548765|NCT02171195|101679462|FG008|STARTED|Overall Study||6||
48548766|NCT02171195|101679454|FG000|COMPLETED|Overall Study||16||
48548767|NCT02171195|101679455|FG001|COMPLETED|Overall Study||6||
48548768|NCT02171195|101679456|FG002|COMPLETED|Overall Study||6||
48548769|NCT02171195|101679457|FG003|COMPLETED|Overall Study||6||
48548770|NCT02171195|101679458|FG004|COMPLETED|Overall Study||6||
48548771|NCT02171195|101679459|FG005|COMPLETED|Overall Study||6||
48548772|NCT02171195|101679460|FG006|COMPLETED|Overall Study||6||
48548773|NCT02171195|101679461|FG007|COMPLETED|Overall Study||6||
48548774|NCT02171195|101679462|FG008|COMPLETED|Overall Study||6||
48548775|NCT02171195|101679454|FG000|NOT COMPLETED|Overall Study||0||
48548776|NCT02171195|101679455|FG001|NOT COMPLETED|Overall Study||0||
48548777|NCT02171195|101679456|FG002|NOT COMPLETED|Overall Study||0||
48548778|NCT02171195|101679457|FG003|NOT COMPLETED|Overall Study||0||
48548779|NCT02171195|101679458|FG004|NOT COMPLETED|Overall Study||0||
48548780|NCT02171195|101679459|FG005|NOT COMPLETED|Overall Study||0||
48548781|NCT02171195|101679460|FG006|NOT COMPLETED|Overall Study||0||
48548782|NCT02171195|101679461|FG007|NOT COMPLETED|Overall Study||0||
48548783|NCT02171195|101679462|FG008|NOT COMPLETED|Overall Study||0||
48548784|NCT00098774|101679463|FG000|STARTED|Overall Study||44||
48548785|NCT00098774|101679463|FG000|COMPLETED|Overall Study||26||
48548786|NCT00098774|101679463|FG000|NOT COMPLETED|Overall Study||18||
48548787|NCT04581330|101679464|FG000|STARTED|Overall Study||10||10
48548788|NCT04581330|101679465|FG001|STARTED|Overall Study||10||10
48548789|NCT04581330|101679464|FG000|COMPLETED|Overall Study||10||10
48548790|NCT04581330|101679465|FG001|COMPLETED|Overall Study||10||10
48548791|NCT04581330|101679464|FG000|NOT COMPLETED|Overall Study||0||0
48548792|NCT04581330|101679465|FG001|NOT COMPLETED|Overall Study||0||0
48548793|NCT01524978|101679466|FG000|STARTED|Overall Study||62||
48548794|NCT01524978|101679467|FG001|STARTED|Overall Study||4||
48548795|NCT01524978|101679468|FG002|STARTED|Overall Study||10||
48548796|NCT01524978|101679469|FG003|STARTED|Overall Study||27||
48548797|NCT01524978|101679470|FG004|STARTED|Overall Study||9||
48548798|NCT01524978|101679471|FG005|STARTED|Overall Study||9||
48548799|NCT01524978|101679472|FG006|STARTED|Overall Study||26||
48548800|NCT01524978|101679473|FG007|STARTED|Overall Study||12||
48548801|NCT01524978|101679474|FG008|STARTED|Overall Study||12||
48548802|NCT01524978|101679475|FG009|STARTED|Overall Study||9||
48548803|NCT01524978|101679476|FG010|STARTED|Overall Study||28||
48548804|NCT01524978|101679466|FG000|COMPLETED|Overall Study||0||
48548805|NCT01524978|101679467|FG001|COMPLETED|Overall Study||0||
48548806|NCT01524978|101679468|FG002|COMPLETED|Overall Study||0||
48548807|NCT01524978|101679469|FG003|COMPLETED|Overall Study||0||
48548808|NCT01524978|101679470|FG004|COMPLETED|Overall Study||0||
48548809|NCT01524978|101679471|FG005|COMPLETED|Overall Study||0||
48548810|NCT01524978|101679472|FG006|COMPLETED|Overall Study||0||
48548811|NCT01524978|101679473|FG007|COMPLETED|Overall Study||0||
48548812|NCT01524978|101679474|FG008|COMPLETED|Overall Study||0||
48548813|NCT01524978|101679475|FG009|COMPLETED|Overall Study||0||
48548814|NCT01524978|101679476|FG010|COMPLETED|Overall Study||0||
48548815|NCT01524978|101679466|FG000|NOT COMPLETED|Overall Study||62||
48548816|NCT01524978|101679467|FG001|NOT COMPLETED|Overall Study||4||
48548817|NCT01524978|101679468|FG002|NOT COMPLETED|Overall Study||10||
48548818|NCT01524978|101679469|FG003|NOT COMPLETED|Overall Study||27||
48548819|NCT01524978|101679470|FG004|NOT COMPLETED|Overall Study||9||
48548820|NCT01524978|101679471|FG005|NOT COMPLETED|Overall Study||9||
48548821|NCT01524978|101679472|FG006|NOT COMPLETED|Overall Study||26||
48548822|NCT01524978|101679473|FG007|NOT COMPLETED|Overall Study||12||
48548823|NCT01524978|101679474|FG008|NOT COMPLETED|Overall Study||12||
48548824|NCT01524978|101679475|FG009|NOT COMPLETED|Overall Study||9||
48548825|NCT01524978|101679476|FG010|NOT COMPLETED|Overall Study||28||
48548826|NCT00492778|101679477|FG000|STARTED|Overall Study||82||
48548827|NCT00492778|101679478|FG001|STARTED|Overall Study||83||
48548828|NCT00492778|101679477|FG000|COMPLETED|Overall Study||74||
48548829|NCT00492778|101679478|FG001|COMPLETED|Overall Study||82||
48548830|NCT00492778|101679477|FG000|NOT COMPLETED|Overall Study||8||
48548831|NCT00492778|101679478|FG001|NOT COMPLETED|Overall Study||1||
48548832|NCT03168022|101679479|FG000|STARTED|Overall Study||21||
48548833|NCT03168022|101679480|FG001|STARTED|Overall Study||22||
48548834|NCT03168022|101679479|FG000|COMPLETED|Overall Study||21||
48548835|NCT03168022|101679480|FG001|COMPLETED|Overall Study||21||
48548836|NCT03168022|101679479|FG000|NOT COMPLETED|Overall Study||0||
48548837|NCT03168022|101679480|FG001|NOT COMPLETED|Overall Study||1||
48548838|NCT00411411|101679481|FG000|STARTED|Overall Study||24||
48548839|NCT00411411|101679482|FG001|STARTED|Overall Study||25||
48548840|NCT00411411|101679481|FG000|COMPLETED|Overall Study||24||
48548841|NCT00411411|101679482|FG001|COMPLETED|Overall Study||25||
48548842|NCT00411411|101679481|FG000|NOT COMPLETED|Overall Study||0||
48548843|NCT00411411|101679482|FG001|NOT COMPLETED|Overall Study||0||
48548844|NCT01500473|101679483|FG000|STARTED|Overall Study||1||
48548845|NCT01500473|101679483|FG000|COMPLETED|Overall Study||1||
48548846|NCT01500473|101679483|FG000|NOT COMPLETED|Overall Study||0||
48548847|NCT02620579|101679484|FG000|STARTED|Overall Study||62||
48548848|NCT02620579|101679485|FG001|STARTED|Overall Study||57||
48548849|NCT02620579|101679486|FG002|STARTED|Overall Study||57||
48548850|NCT02620579|101679487|FG003|STARTED|Overall Study||57||
48548851|NCT02620579|101679484|FG000|COMPLETED|Overall Study||62||
48548852|NCT02620579|101679485|FG001|COMPLETED|Overall Study||56||
48548853|NCT02620579|101679486|FG002|COMPLETED|Overall Study||56||
48548854|NCT02620579|101679487|FG003|COMPLETED|Overall Study||56||
48548855|NCT02620579|101679484|FG000|NOT COMPLETED|Overall Study||0||
48548856|NCT02620579|101679485|FG001|NOT COMPLETED|Overall Study||1||
48548857|NCT02620579|101679486|FG002|NOT COMPLETED|Overall Study||1||
48548858|NCT02620579|101679487|FG003|NOT COMPLETED|Overall Study||1||
48548859|NCT02028676|101679488|FG000|STARTED|Initial Enrolment: CDM vs LCM||606||
48548860|NCT02028676|101679489|FG001|STARTED|Initial Enrolment: CDM vs LCM||600||
48548861|NCT02028676|101679490|FG002|STARTED|Initial Enrolment: CDM vs LCM||0||
48548862|NCT02028676|101679491|FG003|STARTED|Initial Enrolment: CDM vs LCM||0||
48548863|NCT02028676|101679492|FG004|STARTED|Initial Enrolment: CDM vs LCM||0||
48548864|NCT02028676|101679493|FG005|STARTED|Initial Enrolment: CDM vs LCM||0||
48548865|NCT02028676|101679494|FG006|STARTED|Initial Enrolment: CDM vs LCM||0||
48548866|NCT02028676|101679495|FG007|STARTED|Initial Enrolment: CDM vs LCM||0||
48548867|NCT02028676|101679496|FG008|STARTED|Initial Enrolment: CDM vs LCM||0||
48264794|NCT00880022|100970888|FG000|NOT COMPLETED|Overall Study||2||
48264795|NCT00880022|100970889|FG001|NOT COMPLETED|Overall Study||3||
48264796|NCT03784820|100970890|FG000|STARTED|Overall Study||11||
48264797|NCT03784820|100970891|FG001|STARTED|Overall Study||11||
48264798|NCT03784820|100970892|FG002|STARTED|Overall Study||11||
48264799|NCT03784820|100970893|FG003|STARTED|Overall Study||11||
48264800|NCT03784820|100970890|FG000|Pre (T0) Intent-to-Treat (ITT)|Overall Study||11||
48264801|NCT03784820|100970891|FG001|Pre (T0) Intent-to-Treat (ITT)|Overall Study||11||
48264802|NCT03784820|100970892|FG002|Pre (T0) Intent-to-Treat (ITT)|Overall Study||11||
48264803|NCT03784820|100970893|FG003|Pre (T0) Intent-to-Treat (ITT)|Overall Study||11||
48264804|NCT03784820|100970890|FG000|Mid-Treatment (T1) Intent-to-Treat (ITT)|Overall Study||10||
48264805|NCT03784820|100970891|FG001|Mid-Treatment (T1) Intent-to-Treat (ITT)|Overall Study||7||
48264806|NCT03784820|100970892|FG002|Mid-Treatment (T1) Intent-to-Treat (ITT)|Overall Study||9||
48264807|NCT03784820|100970893|FG003|Mid-Treatment (T1) Intent-to-Treat (ITT)|Overall Study||9||
48264808|NCT03784820|100970890|FG000|Post (T2) Intent-to-Treat (ITT)|Overall Study||7||
48548868|NCT02028676|101679488|FG000|COMPLETED|Initial Enrolment: CDM vs LCM||606||
48548869|NCT02028676|101679489|FG001|COMPLETED|Initial Enrolment: CDM vs LCM||600||
48548870|NCT02028676|101679490|FG002|COMPLETED|Initial Enrolment: CDM vs LCM||0||
48548871|NCT02028676|101679491|FG003|COMPLETED|Initial Enrolment: CDM vs LCM||0||
48548872|NCT02028676|101679492|FG004|COMPLETED|Initial Enrolment: CDM vs LCM||0||
48548873|NCT02028676|101679493|FG005|COMPLETED|Initial Enrolment: CDM vs LCM||0||
48548874|NCT02028676|101679494|FG006|COMPLETED|Initial Enrolment: CDM vs LCM||0||
48264809|NCT03784820|100970891|FG001|Post (T2) Intent-to-Treat (ITT)|Overall Study||6||
48264810|NCT03784820|100970892|FG002|Post (T2) Intent-to-Treat (ITT)|Overall Study||9||
48264811|NCT03784820|100970893|FG003|Post (T2) Intent-to-Treat (ITT)|Overall Study||9||
48264812|NCT03784820|100970890|FG000|3 Month Fup (T3) Intent-to-Treat (ITT)|Overall Study||6||
48264813|NCT03784820|100970891|FG001|3 Month Fup (T3) Intent-to-Treat (ITT)|Overall Study||6||
48264814|NCT03784820|100970892|FG002|3 Month Fup (T3) Intent-to-Treat (ITT)|Overall Study||9||
48264815|NCT03784820|100970893|FG003|3 Month Fup (T3) Intent-to-Treat (ITT)|Overall Study||9||
48264816|NCT03784820|100970890|FG000|6 Month Fup (T4) Intent-to-Treat (ITT)|Overall Study||6||
48264817|NCT03784820|100970891|FG001|6 Month Fup (T4) Intent-to-Treat (ITT)|Overall Study||6||
48264818|NCT03784820|100970892|FG002|6 Month Fup (T4) Intent-to-Treat (ITT)|Overall Study||8||
48264819|NCT03784820|100970893|FG003|6 Month Fup (T4) Intent-to-Treat (ITT)|Overall Study||8||
48264820|NCT03784820|100970890|FG000|Pre (T0) Modified Intent-to-Treat (mITT)|Overall Study||11||
48264821|NCT03784820|100970891|FG001|Pre (T0) Modified Intent-to-Treat (mITT)|Overall Study||11||
48264822|NCT03784820|100970892|FG002|Pre (T0) Modified Intent-to-Treat (mITT)|Overall Study||10||
48264823|NCT03784820|100970893|FG003|Pre (T0) Modified Intent-to-Treat (mITT)|Overall Study||10||
48264824|NCT03784820|100970890|FG000|Mid-Treatment (T1) Modified Intent-to-Treat (mITT)|Overall Study||10||
48264825|NCT03784820|100970891|FG001|Mid-Treatment (T1) Modified Intent-to-Treat (mITT)|Overall Study||7||
48548875|NCT02028676|101679495|FG007|COMPLETED|Initial Enrolment: CDM vs LCM||0||
48548876|NCT02028676|101679496|FG008|COMPLETED|Initial Enrolment: CDM vs LCM||0||
48548877|NCT02028676|101679488|FG000|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0||
48548878|NCT02028676|101679489|FG001|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0||
48548879|NCT02028676|101679490|FG002|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0||
48548880|NCT02028676|101679491|FG003|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0||
48548881|NCT02028676|101679492|FG004|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0||
48548882|NCT02028676|101679493|FG005|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0||
48548883|NCT02028676|101679494|FG006|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0||
48548884|NCT02028676|101679495|FG007|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0||
48548885|NCT02028676|101679496|FG008|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0||
48548886|NCT02028676|101679488|FG000|STARTED|Initial Enrolment: Induction ART||0||
48548887|NCT02028676|101679489|FG001|STARTED|Initial Enrolment: Induction ART||0||
48548888|NCT02028676|101679490|FG002|STARTED|Initial Enrolment: Induction ART||397||
48548889|NCT02028676|101679491|FG003|STARTED|Initial Enrolment: Induction ART||404||
48548890|NCT02028676|101679492|FG004|STARTED|Initial Enrolment: Induction ART||405||
48548891|NCT02028676|101679493|FG005|STARTED|Initial Enrolment: Induction ART||0||
48264826|NCT03784820|100970892|FG002|Mid-Treatment (T1) Modified Intent-to-Treat (mITT)|Overall Study||8||
48264827|NCT03784820|100970893|FG003|Mid-Treatment (T1) Modified Intent-to-Treat (mITT)|Overall Study||8||
48264828|NCT03784820|100970890|FG000|Post (T2) Modified Intent-to-Treat (mITT)|Overall Study||7||
48264829|NCT03784820|100970891|FG001|Post (T2) Modified Intent-to-Treat (mITT)|Overall Study||6||
48548892|NCT02028676|101679494|FG006|STARTED|Initial Enrolment: Induction ART||0||
48548893|NCT02028676|101679495|FG007|STARTED|Initial Enrolment: Induction ART||0||
48548894|NCT02028676|101679496|FG008|STARTED|Initial Enrolment: Induction ART||0||
48548895|NCT02028676|101679488|FG000|COMPLETED|Initial Enrolment: Induction ART||0||
48548896|NCT02028676|101679489|FG001|COMPLETED|Initial Enrolment: Induction ART||0||
48548897|NCT02028676|101679490|FG002|COMPLETED|Initial Enrolment: Induction ART||397||
48548898|NCT02028676|101679491|FG003|COMPLETED|Initial Enrolment: Induction ART||404||
48548899|NCT02028676|101679492|FG004|COMPLETED|Initial Enrolment: Induction ART||405||
48548900|NCT02028676|101679493|FG005|COMPLETED|Initial Enrolment: Induction ART||0||
48548901|NCT02028676|101679494|FG006|COMPLETED|Initial Enrolment: Induction ART||0||
48548902|NCT02028676|101679495|FG007|COMPLETED|Initial Enrolment: Induction ART||0||
48548903|NCT02028676|101679496|FG008|COMPLETED|Initial Enrolment: Induction ART||0||
48548904|NCT02028676|101679488|FG000|NOT COMPLETED|Initial Enrolment: Induction ART||0||
48548905|NCT02028676|101679489|FG001|NOT COMPLETED|Initial Enrolment: Induction ART||0||
48548906|NCT02028676|101679490|FG002|NOT COMPLETED|Initial Enrolment: Induction ART||0||
48548907|NCT02028676|101679491|FG003|NOT COMPLETED|Initial Enrolment: Induction ART||0||
48548908|NCT02028676|101679492|FG004|NOT COMPLETED|Initial Enrolment: Induction ART||0||
48691464|NCT03050450|102028928|FG004|COMPLETED|Overall Study||0||
48691465|NCT03050450|102028924|FG000|NOT COMPLETED|Overall Study||1||
48691466|NCT03050450|102028925|FG001|NOT COMPLETED|Overall Study||0||
48691467|NCT03050450|102028926|FG002|NOT COMPLETED|Overall Study||0||
48691468|NCT03050450|102028927|FG003|NOT COMPLETED|Overall Study||0||
48691469|NCT03050450|102028928|FG004|NOT COMPLETED|Overall Study||0||
48548909|NCT02028676|101679493|FG005|NOT COMPLETED|Initial Enrolment: Induction ART||0||
48548910|NCT02028676|101679494|FG006|NOT COMPLETED|Initial Enrolment: Induction ART||0||
48548911|NCT02028676|101679495|FG007|NOT COMPLETED|Initial Enrolment: Induction ART||0||
48548912|NCT02028676|101679496|FG008|NOT COMPLETED|Initial Enrolment: Induction ART||0||
48691470|NCT00322049|102028929|FG000|STARTED|Overall Study||4||
48691471|NCT00322049|102028930|FG001|STARTED|Overall Study||10||
48691472|NCT00322049|102028931|FG002|STARTED|Overall Study||20||
48691473|NCT00322049|102028932|FG003|STARTED|Overall Study||17||
48691474|NCT00322049|102028929|FG000|COMPLETED|Overall Study||4||
48691475|NCT00322049|102028930|FG001|COMPLETED|Overall Study||9||
48691476|NCT00322049|102028931|FG002|COMPLETED|Overall Study||20||
48102313|NCT02120950|100575552|FG002|STARTED|Overall Study||15||
48102314|NCT02120950|100575550|FG000|COMPLETED|Overall Study||137||
48102315|NCT02120950|100575551|FG001|COMPLETED|Overall Study||147||
48102316|NCT02120950|100575552|FG002|COMPLETED|Overall Study||0||
48102317|NCT02120950|100575550|FG000|NOT COMPLETED|Overall Study||20||
48102318|NCT02120950|100575551|FG001|NOT COMPLETED|Overall Study||14||
48102319|NCT02120950|100575552|FG002|NOT COMPLETED|Overall Study||15||
48102320|NCT00006101|100575553|FG000|STARTED|Overall Study||38||
48102321|NCT00006101|100575554|FG001|STARTED|Overall Study||38||
48102322|NCT00006101|100575553|FG000|COMPLETED|Overall Study||33||
48102323|NCT00006101|100575554|FG001|COMPLETED|Overall Study||33||
48264830|NCT03784820|100970892|FG002|Post (T2) Modified Intent-to-Treat (mITT)|Overall Study||8||
48264831|NCT03784820|100970893|FG003|Post (T2) Modified Intent-to-Treat (mITT)|Overall Study||8||
48264832|NCT03784820|100970890|FG000|3 Month Fup (T3) Modified Intent-to-Treat (mITT)|Overall Study||6||
48264833|NCT03784820|100970891|FG001|3 Month Fup (T3) Modified Intent-to-Treat (mITT)|Overall Study||6||
48264834|NCT03784820|100970892|FG002|3 Month Fup (T3) Modified Intent-to-Treat (mITT)|Overall Study||8||
48264835|NCT03784820|100970893|FG003|3 Month Fup (T3) Modified Intent-to-Treat (mITT)|Overall Study||8||
48264836|NCT03784820|100970890|FG000|6 Month Fup (T4) Modified Intent-to-Treat (mITT)|Overall Study||6||
48264837|NCT03784820|100970891|FG001|6 Month Fup (T4) Modified Intent-to-Treat (mITT)|Overall Study||6||
48264838|NCT03784820|100970892|FG002|6 Month Fup (T4) Modified Intent-to-Treat (mITT)|Overall Study||7||
48391232|NCT00373490|101287615|FG000|STARTED|Overall Study||10||
48391233|NCT00373490|101287616|FG001|STARTED|Overall Study||6||
48391234|NCT00373490|101287615|FG000|COMPLETED|Overall Study||1||
48391235|NCT00373490|101287616|FG001|COMPLETED|Overall Study||0||
48391236|NCT00373490|101287615|FG000|NOT COMPLETED|Overall Study||9||
48264839|NCT03784820|100970893|FG003|6 Month Fup (T4) Modified Intent-to-Treat (mITT)|Overall Study||7||
48391237|NCT00373490|101287616|FG001|NOT COMPLETED|Overall Study||6||
48391238|NCT03801356|101287617|FG000|STARTED|Overall Study||11||
48264840|NCT03784820|100970890|FG000|COMPLETED|Overall Study||6||
48391239|NCT03801356|101287617|FG000|COMPLETED|Overall Study||11||
48391240|NCT03801356|101287617|FG000|NOT COMPLETED|Overall Study||0||
48391241|NCT01989754|101287618|FG000|STARTED|Overall Study||2905||
48391242|NCT01989754|101287619|FG001|STARTED|Overall Study||2907||
48391243|NCT01989754|101287618|FG000|Treated|Overall Study||2903||
48391244|NCT01989754|101287619|FG001|Treated|Overall Study||2904||
48391245|NCT01989754|101287618|FG000|COMPLETED|Overall Study||2866||
48391246|NCT01989754|101287619|FG001|COMPLETED|Overall Study||2872||
48391247|NCT01989754|101287618|FG000|NOT COMPLETED|Overall Study||39||
48391248|NCT01989754|101287619|FG001|NOT COMPLETED|Overall Study||35||
48391249|NCT00476996|101287620|FG000|STARTED|Blinded Treatment Phase (up to Week 48)||277||
48391250|NCT00476996|101287621|FG001|STARTED|Blinded Treatment Phase (up to Week 48)||277||
48391251|NCT00476996|101287622|FG002|STARTED|Blinded Treatment Phase (up to Week 48)||282||
48391252|NCT00476996|101287623|FG003|STARTED|Blinded Treatment Phase (up to Week 48)||0||
48391253|NCT00476996|101287620|FG000|COMPLETED|Blinded Treatment Phase (up to Week 48)||205||
48391254|NCT00476996|101287621|FG001|COMPLETED|Blinded Treatment Phase (up to Week 48)||222||
48391255|NCT00476996|101287622|FG002|COMPLETED|Blinded Treatment Phase (up to Week 48)||237||
48391256|NCT00476996|101287623|FG003|COMPLETED|Blinded Treatment Phase (up to Week 48)||0||
48391257|NCT00476996|101287620|FG000|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||72||
48391258|NCT00476996|101287621|FG001|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||55||
48391259|NCT00476996|101287622|FG002|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||45||
48391260|NCT00476996|101287623|FG003|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||0||
48391261|NCT00476996|101287620|FG000|STARTED|OLE Phase (From Week 48)||0||
48391262|NCT00476996|101287621|FG001|STARTED|OLE Phase (From Week 48)||0||
48391263|NCT00476996|101287622|FG002|STARTED|OLE Phase (From Week 48)||0||
48391264|NCT00476996|101287623|FG003|STARTED|OLE Phase (From Week 48)||664||
48391265|NCT00476996|101287620|FG000|COMPLETED|OLE Phase (From Week 48)||0||
48391266|NCT00476996|101287621|FG001|COMPLETED|OLE Phase (From Week 48)||0||
48391267|NCT00476996|101287622|FG002|COMPLETED|OLE Phase (From Week 48)||0||
48391268|NCT00476996|101287623|FG003|COMPLETED|OLE Phase (From Week 48)||0||
48391269|NCT00476996|101287620|FG000|NOT COMPLETED|OLE Phase (From Week 48)||0||
48391270|NCT00476996|101287621|FG001|NOT COMPLETED|OLE Phase (From Week 48)||0||
48391271|NCT00476996|101287622|FG002|NOT COMPLETED|OLE Phase (From Week 48)||0||
48391272|NCT00476996|101287623|FG003|NOT COMPLETED|OLE Phase (From Week 48)||664||
48391273|NCT00992186|101287624|FG000|STARTED|Overall Study||46||
48391274|NCT00992186|101287624|FG000|COMPLETED|Overall Study||0||
48391275|NCT00992186|101287624|FG000|NOT COMPLETED|Overall Study||46||
48391276|NCT00970268|101287625|FG000|STARTED|Overall Study||139||
48391277|NCT00970268|101287626|FG001|STARTED|Overall Study||152||
48102324|NCT00006101|100575553|FG000|NOT COMPLETED|Overall Study||5||
48264841|NCT03784820|100970891|FG001|COMPLETED|Overall Study||6||
48391278|NCT00970268|101287625|FG000|COMPLETED|Overall Study||96||
48391279|NCT00970268|101287626|FG001|COMPLETED|Overall Study||103||
48391280|NCT00970268|101287625|FG000|NOT COMPLETED|Overall Study||43||
48102325|NCT00006101|100575554|FG001|NOT COMPLETED|Overall Study||5||
48102326|NCT01393405|100575555|FG000|STARTED|Induction Period (week1-16)||179||
48102327|NCT01393405|100575556|FG001|STARTED|Induction Period (week1-16)||0||
48102328|NCT01393405|100575557|FG002|STARTED|Induction Period (week1-16)||0||
48102329|NCT01393405|100575555|FG000|COMPLETED|Induction Period (week1-16)||84||
48102330|NCT01393405|100575556|FG001|COMPLETED|Induction Period (week1-16)||0||
48102331|NCT01393405|100575557|FG002|COMPLETED|Induction Period (week1-16)||0||
48102332|NCT01393405|100575555|FG000|NOT COMPLETED|Induction Period (week1-16)||95||
48102333|NCT01393405|100575556|FG001|NOT COMPLETED|Induction Period (week1-16)||0||
48102334|NCT01393405|100575557|FG002|NOT COMPLETED|Induction Period (week1-16)||0||
48102335|NCT01393405|100575555|FG000|STARTED|Maintenance Period Week||0|84 patients completed the induction period and were randomized to maintenance period|
48102336|NCT01393405|100575556|FG001|STARTED|Maintenance Period Week||44|84 patients completed the induction period and were randomized to maintenance period|
48102337|NCT01393405|100575557|FG002|STARTED|Maintenance Period Week||40|84 patients completed the induction period and were randomized to maintenance period|
48102338|NCT01393405|100575555|FG000|COMPLETED|Maintenance Period Week||0||
48102339|NCT01393405|100575556|FG001|COMPLETED|Maintenance Period Week||15||
48102340|NCT01393405|100575557|FG002|COMPLETED|Maintenance Period Week||16||
48102341|NCT01393405|100575555|FG000|NOT COMPLETED|Maintenance Period Week||0||
48102342|NCT01393405|100575556|FG001|NOT COMPLETED|Maintenance Period Week||29||
48102343|NCT01393405|100575557|FG002|NOT COMPLETED|Maintenance Period Week||24||
48102344|NCT02520011|100575558|FG000|STARTED|Overall Study||11||
48102345|NCT02520011|100575559|FG001|STARTED|Overall Study||79||
48102346|NCT02520011|100575560|FG002|STARTED|Overall Study||14||
48102347|NCT02520011|100575558|FG000|Stage 1|Overall Study||0||
48102348|NCT02520011|100575559|FG001|Stage 1|Overall Study||32||
48102349|NCT02520011|100575560|FG002|Stage 1|Overall Study||10||
48102350|NCT02520011|100575558|FG000|Stage 2|Overall Study||11||
48102351|NCT02520011|100575559|FG001|Stage 2|Overall Study||47||
48102352|NCT02520011|100575560|FG002|Stage 2|Overall Study||4||
48102353|NCT02520011|100575558|FG000|COMPLETED|Overall Study||6||
48102354|NCT02520011|100575559|FG001|COMPLETED|Overall Study||33||
48102355|NCT02520011|100575560|FG002|COMPLETED|Overall Study||5||
48102356|NCT02520011|100575558|FG000|NOT COMPLETED|Overall Study||5||
48102357|NCT02520011|100575559|FG001|NOT COMPLETED|Overall Study||46||
48102358|NCT02520011|100575560|FG002|NOT COMPLETED|Overall Study||9||
48102359|NCT02603835|100575561|FG000|STARTED|Overall Study||100||
48102360|NCT02603835|100575561|FG000|COMPLETED|Overall Study||93||
48102361|NCT02603835|100575561|FG000|NOT COMPLETED|Overall Study||7||
48102362|NCT02621242|100575562|FG000|STARTED|Overall Study||9||
48102363|NCT02621242|100575562|FG000|COMPLETED|Overall Study||8||
48102364|NCT02621242|100575562|FG000|NOT COMPLETED|Overall Study||1||
48102365|NCT00151320|100575563|FG000|STARTED|Overall Study||76||
48102366|NCT00151320|100575563|FG000|COMPLETED|Overall Study||76||
48102367|NCT00151320|100575563|FG000|NOT COMPLETED|Overall Study||0||
48102368|NCT00912990|100575564|FG000|STARTED|Overall Study||16||
48102369|NCT00912990|100575565|FG001|STARTED|Overall Study||18||
48391281|NCT00970268|101287626|FG001|NOT COMPLETED|Overall Study||49||
48391282|NCT02943265|101287627|FG000|STARTED|Overall Study||648||
48391283|NCT02943265|101287628|FG001|STARTED|Overall Study||2674||
48102370|NCT00912990|100575564|FG000|COMPLETED|Overall Study||16||
48102371|NCT00912990|100575565|FG001|COMPLETED|Overall Study||18||
48102372|NCT00912990|100575564|FG000|NOT COMPLETED|Overall Study||0||
48391284|NCT02943265|101287629|FG002|STARTED|Overall Study||1000||
48391285|NCT02943265|101287627|FG000|Eligible After Review|Overall Study||634|Initial eligibility based on EHR data extraction. A detailed review by study team was conducted to confirm all eligibility criteria met.|
48391286|NCT02943265|101287628|FG001|Eligible After Review|Overall Study||2092|Initial eligibility based on EHR data extraction. A detailed review by study team was conducted to confirm all eligibility criteria met.|
48404090|NCT03689972|101321767|FG001|NOT COMPLETED|Part 2:Run-in Period (Week73uptoWeek107)||0||
48102373|NCT00912990|100575565|FG001|NOT COMPLETED|Overall Study||0||
48102374|NCT00481195|100575566|FG000|STARTED|Overall Study||128||
48102375|NCT00481195|100575567|FG001|STARTED|Overall Study||129||
48102376|NCT00481195|100575566|FG000|COMPLETED|Overall Study||89||
48102377|NCT00481195|100575567|FG001|COMPLETED|Overall Study||90||
48102378|NCT00481195|100575566|FG000|NOT COMPLETED|Overall Study||39||
48102379|NCT00481195|100575567|FG001|NOT COMPLETED|Overall Study||39||
48102380|NCT00704028|100575568|FG000|STARTED|Overall Study||82||
48102381|NCT00704028|100575569|FG001|STARTED|Overall Study||78||
48102382|NCT00704028|100575568|FG000|COMPLETED|Overall Study||70||
48102383|NCT00704028|100575569|FG001|COMPLETED|Overall Study||57||
48264842|NCT03784820|100970892|FG002|COMPLETED|Overall Study||8||
48264843|NCT03784820|100970893|FG003|COMPLETED|Overall Study||8||
48264844|NCT03784820|100970890|FG000|NOT COMPLETED|Overall Study||5||
48264845|NCT03784820|100970891|FG001|NOT COMPLETED|Overall Study||5||
48264846|NCT03784820|100970892|FG002|NOT COMPLETED|Overall Study||3||
48264847|NCT03784820|100970893|FG003|NOT COMPLETED|Overall Study||3||
48264848|NCT03126110|100970894|FG000|STARTED|Phase 1||4||
48264849|NCT03126110|100970895|FG001|STARTED|Phase 1||4||
48102384|NCT00704028|100575568|FG000|NOT COMPLETED|Overall Study||12||
48102385|NCT00704028|100575569|FG001|NOT COMPLETED|Overall Study||21||
48102386|NCT03063476|100575570|FG000|STARTED|Overall Study||2||
48102387|NCT03063476|100575570|FG000|COMPLETED|Overall Study||2||
48102388|NCT03063476|100575570|FG000|NOT COMPLETED|Overall Study||0||
48264850|NCT03126110|100970896|FG002|STARTED|Phase 1||5||
48102389|NCT02014363|100575571|FG000|STARTED|Overall Study||55||
48102390|NCT02014363|100575572|FG001|STARTED|Overall Study||54||
48102391|NCT02014363|100575573|FG002|STARTED|Overall Study||55||
48102392|NCT02014363|100575571|FG000|COMPLETED|Overall Study||38||
48102393|NCT02014363|100575572|FG001|COMPLETED|Overall Study||35||
48102394|NCT02014363|100575573|FG002|COMPLETED|Overall Study||31||
48102395|NCT02014363|100575571|FG000|NOT COMPLETED|Overall Study||17||
48102396|NCT02014363|100575572|FG001|NOT COMPLETED|Overall Study||19||
48102397|NCT02014363|100575573|FG002|NOT COMPLETED|Overall Study||24||
48102398|NCT00549562|100575574|FG000|STARTED|Overall Study||25||
48102399|NCT00549562|100575574|FG000|COMPLETED|Overall Study||23||
48102400|NCT00549562|100575574|FG000|NOT COMPLETED|Overall Study||2||
48102401|NCT02319031|100575575|FG000|STARTED|Treatment Period||24||
48264851|NCT03126110|100970897|FG003|STARTED|Phase 1||4||
48264852|NCT03126110|100970898|FG004|STARTED|Phase 1||5||
48264853|NCT03126110|100970899|FG005|STARTED|Phase 1||4||
48264854|NCT03126110|100970900|FG006|STARTED|Phase 1||4||
48391287|NCT02943265|101287629|FG002|Eligible After Review|Overall Study||1000|Initial eligibility based on EHR data extraction. A detailed review by study team was conducted to confirm all eligibility criteria met.|
48391288|NCT02943265|101287627|FG000|COMPLETED|Overall Study||634||
48391289|NCT02943265|101287628|FG001|COMPLETED|Overall Study||2092||
48391290|NCT02943265|101287629|FG002|COMPLETED|Overall Study||1000||
48391291|NCT02943265|101287627|FG000|NOT COMPLETED|Overall Study||14||
48391292|NCT02943265|101287628|FG001|NOT COMPLETED|Overall Study||582||
48391293|NCT02943265|101287629|FG002|NOT COMPLETED|Overall Study||0||
48391294|NCT02227849|101287630|FG000|STARTED|Overall Study||71||
48391295|NCT02227849|101287630|FG000|COMPLETED|Overall Study||63||
48391296|NCT02227849|101287630|FG000|NOT COMPLETED|Overall Study||8||
48391297|NCT01357980|101287631|FG000|STARTED|Overall Study||16||
48391298|NCT01357980|101287632|FG001|STARTED|Overall Study||7||
48391299|NCT01357980|101287633|FG002|STARTED|Overall Study||17||
48391300|NCT01357980|101287634|FG003|STARTED|Overall Study||7||
48391301|NCT01357980|101287631|FG000|COMPLETED|Overall Study||16||
48391302|NCT01357980|101287632|FG001|COMPLETED|Overall Study||6||
48391303|NCT01357980|101287633|FG002|COMPLETED|Overall Study||16||
48391304|NCT01357980|101287634|FG003|COMPLETED|Overall Study||7||
48391305|NCT01357980|101287631|FG000|NOT COMPLETED|Overall Study||0||
48391306|NCT01357980|101287632|FG001|NOT COMPLETED|Overall Study||1||
48391307|NCT01357980|101287633|FG002|NOT COMPLETED|Overall Study||1||
48391308|NCT01357980|101287634|FG003|NOT COMPLETED|Overall Study||0||
48391309|NCT01419080|101287635|FG000|STARTED|Overall Study||797||
48102402|NCT02319031|100575576|FG001|STARTED|Treatment Period||26||
48102403|NCT02319031|100575575|FG000|COMPLETED|Treatment Period||23||
48102404|NCT02319031|100575576|FG001|COMPLETED|Treatment Period||26||
48264855|NCT03126110|100970901|FG007|STARTED|Phase 1||4||
48264856|NCT03126110|100970902|FG008|STARTED|Phase 1||8||
48264857|NCT03126110|100970903|FG009|STARTED|Phase 1||3||
48264858|NCT03126110|100970904|FG010|STARTED|Phase 1||6||
48264859|NCT03126110|100970905|FG011|STARTED|Phase 1||0||
48264860|NCT03126110|100970906|FG012|STARTED|Phase 1||0||
48264861|NCT03126110|100970907|FG013|STARTED|Phase 1||0||
48391310|NCT01419080|101287635|FG000|COMPLETED|Overall Study||666||
48102405|NCT02319031|100575575|FG000|NOT COMPLETED|Treatment Period||1||
48102406|NCT02319031|100575576|FG001|NOT COMPLETED|Treatment Period||0||
48102407|NCT02319031|100575575|FG000|STARTED|Follow-Up Period||23||
48102408|NCT02319031|100575576|FG001|STARTED|Follow-Up Period||26||
48102409|NCT02319031|100575575|FG000|COMPLETED|Follow-Up Period||23||
48102410|NCT02319031|100575576|FG001|COMPLETED|Follow-Up Period||26||
48102411|NCT02319031|100575575|FG000|NOT COMPLETED|Follow-Up Period||0||
48102412|NCT02319031|100575576|FG001|NOT COMPLETED|Follow-Up Period||0||
48102413|NCT01324349|100575577|FG000|STARTED|Overall Study||32||
48102414|NCT01324349|100575578|FG001|STARTED|Overall Study||18||
48102415|NCT01324349|100575577|FG000|COMPLETED|Overall Study||31||
48102416|NCT01324349|100575578|FG001|COMPLETED|Overall Study||16||
48102417|NCT01324349|100575577|FG000|NOT COMPLETED|Overall Study||1||
48102418|NCT01324349|100575578|FG001|NOT COMPLETED|Overall Study||2||
48102419|NCT02449174|100575579|FG000|STARTED|Overall Study||36||
48102420|NCT02449174|100575580|FG001|STARTED|Overall Study||32||
48102421|NCT02449174|100575579|FG000|COMPLETED|Overall Study||36||
48102422|NCT02449174|100575580|FG001|COMPLETED|Overall Study||32||
48102423|NCT02449174|100575579|FG000|NOT COMPLETED|Overall Study||0||
48102424|NCT02449174|100575580|FG001|NOT COMPLETED|Overall Study||0||
48264862|NCT03126110|100970908|FG014|STARTED|Phase 1||0||
48264863|NCT03126110|100970909|FG015|STARTED|Phase 1||0||
48264864|NCT03126110|100970910|FG016|STARTED|Phase 1||0||
48102425|NCT03448185|100575581|FG000|STARTED|Overall Study||16||
48102426|NCT03448185|100575582|FG001|STARTED|Overall Study||24||
48102427|NCT03448185|100575583|FG002|STARTED|Overall Study||18||
48102428|NCT03448185|100575584|FG003|STARTED|Overall Study||22||
48102429|NCT03448185|100575581|FG000|COMPLETED|Overall Study||13||
48102430|NCT03448185|100575582|FG001|COMPLETED|Overall Study||13||
48102431|NCT03448185|100575583|FG002|COMPLETED|Overall Study||14||
48264865|NCT03126110|100970894|FG000|COMPLETED|Phase 1||0||
48264866|NCT03126110|100970895|FG001|COMPLETED|Phase 1||1||
48102432|NCT03448185|100575584|FG003|COMPLETED|Overall Study||16||
48391311|NCT01419080|101287635|FG000|NOT COMPLETED|Overall Study||131||
48391312|NCT00424294|101287636|FG000|STARTED|Overall Study||36||
48102433|NCT03448185|100575581|FG000|NOT COMPLETED|Overall Study||3||
48102434|NCT03448185|100575582|FG001|NOT COMPLETED|Overall Study||11||
48102435|NCT03448185|100575583|FG002|NOT COMPLETED|Overall Study||4||
48391313|NCT00424294|101287637|FG001|STARTED|Overall Study||34||
48391314|NCT00424294|101287636|FG000|Treated|Overall Study||35||
48391315|NCT00424294|101287637|FG001|Treated|Overall Study||34||
48391316|NCT00424294|101287636|FG000|COMPLETED|Overall Study||28||
48391317|NCT00424294|101287637|FG001|COMPLETED|Overall Study||19||
48391318|NCT00424294|101287636|FG000|NOT COMPLETED|Overall Study||8||
48391319|NCT00424294|101287637|FG001|NOT COMPLETED|Overall Study||15||
48391320|NCT02807844|101287638|FG000|STARTED|Overall Study||6||
48391321|NCT02807844|101287639|FG001|STARTED|Overall Study||12||
48391322|NCT02807844|101287640|FG002|STARTED|Overall Study||12||
48391323|NCT02807844|101287641|FG003|STARTED|Overall Study||13||
48391324|NCT02807844|101287642|FG004|STARTED|Overall Study||6||
48102436|NCT03448185|100575584|FG003|NOT COMPLETED|Overall Study||6||
48102437|NCT02066467|100575585|FG000|STARTED|Overall Study||863||
48102438|NCT02066467|100575585|FG000|COMPLETED|Overall Study||648||
48102439|NCT02066467|100575585|FG000|NOT COMPLETED|Overall Study||215||
48102440|NCT03626714|100578466|FG000|STARTED|Overall Study||8||
48391325|NCT02807844|101287643|FG005|STARTED|Overall Study||11||
48391326|NCT02807844|101287644|FG006|STARTED|Overall Study||20||
48391327|NCT02807844|101287645|FG007|STARTED|Overall Study||20||
48391328|NCT02807844|101287646|FG008|STARTED|Overall Study||21||
48391329|NCT02807844|101287647|FG009|STARTED|Overall Study||20||
48391330|NCT02807844|101287638|FG000|COMPLETED|Overall Study||0||
48391331|NCT02807844|101287639|FG001|COMPLETED|Overall Study||0||
48391332|NCT02807844|101287640|FG002|COMPLETED|Overall Study||0||
48391333|NCT02807844|101287641|FG003|COMPLETED|Overall Study||0||
48391334|NCT02807844|101287642|FG004|COMPLETED|Overall Study||0||
48391335|NCT02807844|101287643|FG005|COMPLETED|Overall Study||0||
48391336|NCT02807844|101287644|FG006|COMPLETED|Overall Study||0||
48391337|NCT02807844|101287645|FG007|COMPLETED|Overall Study||0||
48548913|NCT02028676|101679488|FG000|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0||
48548914|NCT02028676|101679489|FG001|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0||
48548915|NCT02028676|101679490|FG002|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0||
48548916|NCT02028676|101679491|FG003|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0||
48548917|NCT02028676|101679492|FG004|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0||
48548918|NCT02028676|101679493|FG005|STARTED|Subsequent Once vs Twice Daily ABC+3TC||336||
48548919|NCT02028676|101679494|FG006|STARTED|Subsequent Once vs Twice Daily ABC+3TC||333||
48548920|NCT02028676|101679495|FG007|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0||
48548921|NCT02028676|101679496|FG008|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0||
48391338|NCT02807844|101287646|FG008|COMPLETED|Overall Study||0||
48391339|NCT02807844|101287647|FG009|COMPLETED|Overall Study||0||
48391340|NCT02807844|101287638|FG000|NOT COMPLETED|Overall Study||6||
48391341|NCT02807844|101287639|FG001|NOT COMPLETED|Overall Study||12||
48391342|NCT02807844|101287640|FG002|NOT COMPLETED|Overall Study||12||
48391343|NCT02807844|101287641|FG003|NOT COMPLETED|Overall Study||13||
48391344|NCT02807844|101287642|FG004|NOT COMPLETED|Overall Study||6||
48548922|NCT02028676|101679488|FG000|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0||
48691477|NCT00322049|102028932|FG003|COMPLETED|Overall Study||16||
48691478|NCT00322049|102028929|FG000|NOT COMPLETED|Overall Study||0||
48391345|NCT02807844|101287643|FG005|NOT COMPLETED|Overall Study||11||
48391346|NCT02807844|101287644|FG006|NOT COMPLETED|Overall Study||20||
48548923|NCT02028676|101679489|FG001|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0||
48548924|NCT02028676|101679490|FG002|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0||
48548925|NCT02028676|101679491|FG003|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0||
48691479|NCT00322049|102028930|FG001|NOT COMPLETED|Overall Study||1||
48691480|NCT00322049|102028931|FG002|NOT COMPLETED|Overall Study||0||
48102441|NCT03626714|100578466|FG000|COMPLETED|Overall Study||8||
48102442|NCT03626714|100578466|FG000|NOT COMPLETED|Overall Study||0||
48691481|NCT00322049|102028932|FG003|NOT COMPLETED|Overall Study||1||
48102443|NCT00537381|100578467|FG000|STARTED|Overall Study||65||
48102444|NCT00537381|100578468|FG001|STARTED|Overall Study||66||
48102445|NCT00537381|100578467|FG000|COMPLETED|Overall Study||9||
48691482|NCT01183429|102028933|FG000|STARTED|Overall Study||39||
48102446|NCT00537381|100578468|FG001|COMPLETED|Overall Study||4||
48102447|NCT00537381|100578467|FG000|NOT COMPLETED|Overall Study||56||
48102448|NCT00537381|100578468|FG001|NOT COMPLETED|Overall Study||62||
48102449|NCT01316276|100578469|FG000|STARTED|Overall Study||206||
48102450|NCT01316276|100578469|FG000|COMPLETED|Overall Study||139||
48102451|NCT01316276|100578469|FG000|NOT COMPLETED|Overall Study||67||
48102452|NCT02149173|100578470|FG000|STARTED|Overall Study||29||
48102453|NCT02149173|100578470|FG000|COMPLETED|Overall Study||29||
48102454|NCT02149173|100578470|FG000|NOT COMPLETED|Overall Study||0||
48102455|NCT00588822|100578471|FG000|STARTED|Overall Study||21||
48391347|NCT02807844|101287645|FG007|NOT COMPLETED|Overall Study||20||
48391348|NCT02807844|101287646|FG008|NOT COMPLETED|Overall Study||21||
48391349|NCT02807844|101287647|FG009|NOT COMPLETED|Overall Study||20||
48691483|NCT01183429|102028933|FG000|COMPLETED|Overall Study||39||
48102456|NCT00588822|100578471|FG000|COMPLETED|Overall Study||13||
48102457|NCT00588822|100578471|FG000|NOT COMPLETED|Overall Study||8||
48102458|NCT00477672|100578472|FG000|STARTED|Overall Study||98||
48102459|NCT00477672|100578473|FG001|STARTED|Overall Study||101||
48102460|NCT00477672|100578474|FG002|STARTED|Overall Study||99||
48102461|NCT00477672|100578472|FG000|COMPLETED|Overall Study||91||
48102462|NCT00477672|100578473|FG001|COMPLETED|Overall Study||85||
48102463|NCT00477672|100578474|FG002|COMPLETED|Overall Study||83||
48102464|NCT00477672|100578472|FG000|NOT COMPLETED|Overall Study||7||
48102465|NCT00477672|100578473|FG001|NOT COMPLETED|Overall Study||16||
48102466|NCT00477672|100578474|FG002|NOT COMPLETED|Overall Study||16||
48102467|NCT03869450|100578475|FG000|STARTED|Overall Study||31||
48102468|NCT03869450|100578476|FG001|STARTED|Overall Study||25||
48102469|NCT03869450|100578477|FG002|STARTED|Overall Study||34||
48102470|NCT03869450|100578475|FG000|COMPLETED|Overall Study||30||
48102471|NCT03869450|100578476|FG001|COMPLETED|Overall Study||23||
48102472|NCT03869450|100578477|FG002|COMPLETED|Overall Study||34||
48102473|NCT03869450|100578475|FG000|NOT COMPLETED|Overall Study||1||
48102474|NCT03869450|100578476|FG001|NOT COMPLETED|Overall Study||2||
48102475|NCT03869450|100578477|FG002|NOT COMPLETED|Overall Study||0||
48102476|NCT03318315|100578478|FG000|STARTED|Overall Study||62||
48102477|NCT03318315|100578479|FG001|STARTED|Overall Study||53||
48102478|NCT03318315|100578480|FG002|STARTED|Overall Study||34||
48102479|NCT03318315|100578478|FG000|Received First Vaccination|Overall Study||62||
48102480|NCT03318315|100578479|FG001|Received First Vaccination|Overall Study||53||
48102481|NCT03318315|100578480|FG002|Received First Vaccination|Overall Study||34||
48102482|NCT03318315|100578478|FG000|Received Second Vaccination|Overall Study||59||
48102483|NCT03318315|100578479|FG001|Received Second Vaccination|Overall Study||48||
48102484|NCT03318315|100578480|FG002|Received Second Vaccination|Overall Study||0||
48102485|NCT03318315|100578478|FG000|Received Third Vaccination|Overall Study||0||
48102486|NCT03318315|100578479|FG001|Received Third Vaccination|Overall Study||46||
48102487|NCT03318315|100578480|FG002|Received Third Vaccination|Overall Study||0||
48102488|NCT03318315|100578478|FG000|COMPLETED|Overall Study||58||
48102489|NCT03318315|100578479|FG001|COMPLETED|Overall Study||50||
48264867|NCT03126110|100970896|FG002|COMPLETED|Phase 1||0||
48264868|NCT03126110|100970897|FG003|COMPLETED|Phase 1||0||
48264869|NCT03126110|100970898|FG004|COMPLETED|Phase 1||0||
48264870|NCT03126110|100970899|FG005|COMPLETED|Phase 1||0||
48264871|NCT03126110|100970900|FG006|COMPLETED|Phase 1||1||
48264872|NCT03126110|100970901|FG007|COMPLETED|Phase 1||0||
48264873|NCT03126110|100970902|FG008|COMPLETED|Phase 1||0||
48264874|NCT03126110|100970903|FG009|COMPLETED|Phase 1||0||
48264875|NCT03126110|100970904|FG010|COMPLETED|Phase 1||0||
48264876|NCT03126110|100970905|FG011|COMPLETED|Phase 1||0||
48102490|NCT03318315|100578480|FG002|COMPLETED|Overall Study||30||
48102491|NCT03318315|100578478|FG000|NOT COMPLETED|Overall Study||4||
48102492|NCT03318315|100578479|FG001|NOT COMPLETED|Overall Study||3||
48102493|NCT03318315|100578480|FG002|NOT COMPLETED|Overall Study||4||
48102494|NCT02618434|100578481|FG000|STARTED|Overall Study||94|The number of subjects is based on the Safety Population which included all randomized subjects who received at least 1 dose of study drug and have at least one post-randomization safety measurements.|
48102495|NCT02618434|100578482|FG001|STARTED|Overall Study||56|The number of subjects is based on the Safety Population which included all randomized subjects who received at least 1 dose of study drug and have at least one post-randomization safety measurements.|
48102496|NCT02618434|100578483|FG002|STARTED|Overall Study||142|The number of subjects is based on the Safety Population which included all randomized subjects who received at least 1 dose of study drug and have at least one post-randomization safety measurements.|
48102497|NCT02618434|100578481|FG000|Intent-to-Treat|Overall Study||92|The number of subjects is based on the Intent-to-Treat Population (ITT) which included all subjects who received at least 1 dose of study drug and have a baseline and at least 1 valid post-randomization assessment of frequency of IA behaviors based on IA diary entry.|
48102498|NCT02618434|100578482|FG001|Intent-to-Treat|Overall Study||55|The number of subjects is based on the Intent-to-Treat Population (ITT) which included all subjects who received at least 1 dose of study drug and have a baseline and at least 1 valid post-randomization assessment of frequency of IA behaviors based on IA diary entry.|
48102499|NCT02618434|100578483|FG002|Intent-to-Treat|Overall Study||140|The number of subjects is based on the Intent-to-Treat Population (ITT) which included all subjects who received at least 1 dose of study drug and have a baseline and at least 1 valid post-randomization assessment of frequency of IA behaviors based on IA diary entry.|
48102500|NCT02618434|100578481|FG000|Modified Intent-to Treat|Overall Study||90|The number of subjects is based on the Modified Intent-to-Treat Population (mITT) which included all subjects who received at least 1 dose of study drug and had a Baseline IA frequency ≥6 per week and at least 1 valid post-randomization assessment of frequency of IA behaviors based on IA diary entry.|
48141394|NCT01454583|100670419|FG000|STARTED|1st Year||10177||
48141395|NCT01454583|100670420|FG001|STARTED|1st Year||2696||
48264877|NCT03126110|100970906|FG012|COMPLETED|Phase 1||0||
48264878|NCT03126110|100970907|FG013|COMPLETED|Phase 1||0||
48264879|NCT03126110|100970908|FG014|COMPLETED|Phase 1||0||
48264880|NCT03126110|100970909|FG015|COMPLETED|Phase 1||0||
48264881|NCT03126110|100970910|FG016|COMPLETED|Phase 1||0||
48264882|NCT03126110|100970894|FG000|NOT COMPLETED|Phase 1||4||
48141396|NCT01454583|100670421|FG002|STARTED|1st Year||2113||
48264883|NCT03126110|100970895|FG001|NOT COMPLETED|Phase 1||3||
48264884|NCT03126110|100970896|FG002|NOT COMPLETED|Phase 1||5||
48264885|NCT03126110|100970897|FG003|NOT COMPLETED|Phase 1||4||
48264886|NCT03126110|100970898|FG004|NOT COMPLETED|Phase 1||5||
48102501|NCT02618434|100578482|FG001|Modified Intent-to Treat|Overall Study||53|The number of subjects is based on the Modified Intent-to-Treat Population (mITT) which included all subjects who received at least 1 dose of study drug and had a Baseline IA frequency ≥6 per week and at least 1 valid post-randomization assessment of frequency of IA behaviors based on IA diary entry.|
48102502|NCT02618434|100578483|FG002|Modified Intent-to Treat|Overall Study||135|The number of subjects is based on the Modified Intent-to-Treat Population (mITT) which included all subjects who received at least 1 dose of study drug and had a Baseline IA frequency ≥6 per week and at least 1 valid post-randomization assessment of frequency of IA behaviors based on IA diary entry.|
48102503|NCT02618434|100578481|FG000|COMPLETED|Overall Study||84|Safety Population only|
48102504|NCT02618434|100578482|FG001|COMPLETED|Overall Study||45|Safety Population only|
48102505|NCT02618434|100578483|FG002|COMPLETED|Overall Study||113|Safety Population only|
48102506|NCT02618434|100578481|FG000|NOT COMPLETED|Overall Study||10||
48102507|NCT02618434|100578482|FG001|NOT COMPLETED|Overall Study||11||
48102508|NCT02618434|100578483|FG002|NOT COMPLETED|Overall Study||29||
48102509|NCT00623727|100578484|FG000|STARTED|Double Blind (DB)||70||
48102510|NCT00623727|100578485|FG001|STARTED|Double Blind (DB)||73||
48102511|NCT00623727|100578484|FG000|Participants Received Treatment|Double Blind (DB)||67||
48102512|NCT00623727|100578485|FG001|Participants Received Treatment|Double Blind (DB)||72||
48102513|NCT00623727|100578484|FG000|COMPLETED|Double Blind (DB)||34||
48102514|NCT00623727|100578485|FG001|COMPLETED|Double Blind (DB)||41||
48102515|NCT00623727|100578484|FG000|NOT COMPLETED|Double Blind (DB)||36||
48102516|NCT00623727|100578485|FG001|NOT COMPLETED|Double Blind (DB)||32||
48102517|NCT00623727|100578484|FG000|STARTED|Open Label Follow-up||0||
48102518|NCT00623727|100578485|FG001|STARTED|Open Label Follow-up||26||
48102519|NCT00623727|100578484|FG000|COMPLETED|Open Label Follow-up||0||
48102520|NCT00623727|100578485|FG001|COMPLETED|Open Label Follow-up||18||
48102521|NCT00623727|100578484|FG000|NOT COMPLETED|Open Label Follow-up||0||
48102522|NCT00623727|100578485|FG001|NOT COMPLETED|Open Label Follow-up||8||
48102523|NCT00623727|100578484|FG000|STARTED|Open Label Extension Period||20||
48102524|NCT00623727|100578485|FG001|STARTED|Open Label Extension Period||0||
48102525|NCT00623727|100578484|FG000|COMPLETED|Open Label Extension Period||20||
48102526|NCT00623727|100578485|FG001|COMPLETED|Open Label Extension Period||0||
48102527|NCT00623727|100578484|FG000|NOT COMPLETED|Open Label Extension Period||0||
48548926|NCT02028676|101679492|FG004|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0||
48548927|NCT02028676|101679493|FG005|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||336||
48548928|NCT02028676|101679494|FG006|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||333||
48548929|NCT02028676|101679495|FG007|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0||
48548930|NCT02028676|101679496|FG008|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0||
48548931|NCT02028676|101679488|FG000|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0||
48548932|NCT02028676|101679489|FG001|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0||
48548933|NCT02028676|101679490|FG002|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0||
48548934|NCT02028676|101679491|FG003|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0||
48548935|NCT02028676|101679492|FG004|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0||
48548936|NCT02028676|101679493|FG005|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0||
48548937|NCT02028676|101679494|FG006|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0||
48548938|NCT02028676|101679495|FG007|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0||
48548939|NCT02028676|101679496|FG008|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0||
48548940|NCT02028676|101679488|FG000|STARTED|Subsequent Cotrimoxazole Randomization||0||
48548941|NCT02028676|101679489|FG001|STARTED|Subsequent Cotrimoxazole Randomization||0||
48102528|NCT00623727|100578485|FG001|NOT COMPLETED|Open Label Extension Period||0||
48102529|NCT01527682|100578486|FG000|STARTED|Overall Study||37||69
48102530|NCT01527682|100578486|FG000|COMPLETED|Overall Study||29||45
48102531|NCT01527682|100578486|FG000|NOT COMPLETED|Overall Study||8||24
48102532|NCT01132547|100578487|FG000|STARTED|Overall Study||9||
48548942|NCT02028676|101679490|FG002|STARTED|Subsequent Cotrimoxazole Randomization||0||
48102533|NCT01132547|100578488|FG001|STARTED|Overall Study||13||
48102534|NCT01132547|100578487|FG000|COMPLETED|Overall Study||5||
48102535|NCT01132547|100578488|FG001|COMPLETED|Overall Study||12||
48102536|NCT01132547|100578487|FG000|NOT COMPLETED|Overall Study||4||
48102537|NCT01132547|100578488|FG001|NOT COMPLETED|Overall Study||1||
48102538|NCT02098109|100578489|FG000|STARTED|Overall Study||49||
48102539|NCT02098109|100578490|FG001|STARTED|Overall Study||51||
48102540|NCT02098109|100578489|FG000|COMPLETED|Overall Study||46||
48102541|NCT02098109|100578490|FG001|COMPLETED|Overall Study||51||
48102542|NCT02098109|100578489|FG000|NOT COMPLETED|Overall Study||3||
48102543|NCT02098109|100578490|FG001|NOT COMPLETED|Overall Study||0||
48102544|NCT02807350|100578491|FG000|STARTED|Overall Study||196||
48102545|NCT02807350|100578492|FG001|STARTED|Overall Study||190||
48102546|NCT02807350|100578491|FG000|6 mo Follow Up Visit|Overall Study||188||
48102547|NCT02807350|100578492|FG001|6 mo Follow Up Visit|Overall Study||171||
48102548|NCT02807350|100578491|FG000|12 mo Follow Up Visit|Overall Study||189||
48102549|NCT02807350|100578492|FG001|12 mo Follow Up Visit|Overall Study||169||
48102550|NCT02807350|100578491|FG000|15 mo Follow Up Visit|Overall Study||180||
48102551|NCT02807350|100578492|FG001|15 mo Follow Up Visit|Overall Study||153||
48102552|NCT02807350|100578491|FG000|COMPLETED|Overall Study||176||
48102553|NCT02807350|100578492|FG001|COMPLETED|Overall Study||155||
48102554|NCT02807350|100578491|FG000|NOT COMPLETED|Overall Study||20||
48102555|NCT02807350|100578492|FG001|NOT COMPLETED|Overall Study||35||
48102556|NCT03020823|100578493|FG000|STARTED|Overall Study||10||
48102557|NCT03020823|100578493|FG000|12 mg/m² Only|Overall Study||3||
48102558|NCT03020823|100578493|FG000|12 & 18 mg/m²|Overall Study||4||
48691484|NCT01183429|102028933|FG000|NOT COMPLETED|Overall Study||0||
48691485|NCT03703232|102028934|FG000|STARTED|Overall Study||31||
48691486|NCT03703232|102028934|FG000|COMPLETED|Overall Study||31||
48691487|NCT03703232|102028934|FG000|NOT COMPLETED|Overall Study||0||
48691488|NCT04245449|102028935|FG000|STARTED|Overall Study||7||
48691489|NCT04245449|102028935|FG000|COMPLETED|Overall Study||0||
48691490|NCT04245449|102028935|FG000|NOT COMPLETED|Overall Study||7||
48691491|NCT03086408|102028936|FG000|STARTED|Overall Study||10||
48691492|NCT03086408|102028937|FG001|STARTED|Overall Study||10||
48691493|NCT03086408|102028936|FG000|COMPLETED|Overall Study||10||
48691494|NCT03086408|102028937|FG001|COMPLETED|Overall Study||10||
48691495|NCT03086408|102028936|FG000|NOT COMPLETED|Overall Study||0||
48102559|NCT03020823|100578493|FG000|12, 18 & 24 mg/m²|Overall Study||3||
48102560|NCT03020823|100578493|FG000|COMPLETED|Overall Study||0||
48102561|NCT03020823|100578493|FG000|NOT COMPLETED|Overall Study||10||
48102562|NCT02612428|100578494|FG000|STARTED|VTL-308||78||
48102563|NCT02612428|100578495|FG001|STARTED|VTL-308||73||
48102564|NCT02612428|100578494|FG000|COMPLETED|VTL-308||64||
48102565|NCT02612428|100578495|FG001|COMPLETED|VTL-308||56||
48102566|NCT02612428|100578494|FG000|NOT COMPLETED|VTL-308||14||
48102567|NCT02612428|100578495|FG001|NOT COMPLETED|VTL-308||17||
48102568|NCT02612428|100578494|FG000|STARTED|VTL-308E||64||
48102569|NCT02612428|100578495|FG001|STARTED|VTL-308E||56||
48102570|NCT02612428|100578494|FG000|COMPLETED|VTL-308E||53||
48102571|NCT02612428|100578495|FG001|COMPLETED|VTL-308E||49||
48691496|NCT03086408|102028937|FG001|NOT COMPLETED|Overall Study||0||
48102572|NCT02612428|100578494|FG000|NOT COMPLETED|VTL-308E||11||
48102573|NCT02612428|100578495|FG001|NOT COMPLETED|VTL-308E||7||
48102574|NCT01165138|100578496|FG000|STARTED|Overall Study||0||
48691497|NCT03299244|102028938|FG000|STARTED|Overall Study||317||
48102575|NCT01165138|100578497|FG001|STARTED|Overall Study||203||
48102576|NCT01165138|100578498|FG002|STARTED|Overall Study||205||
48102577|NCT01165138|100578499|FG003|STARTED|Overall Study||201||
48102578|NCT01165138|100578496|FG000|COMPLETED|Overall Study||0||
48102579|NCT01165138|100578497|FG001|COMPLETED|Overall Study||151||
48102580|NCT01165138|100578498|FG002|COMPLETED|Overall Study||185||
48102581|NCT01165138|100578499|FG003|COMPLETED|Overall Study||179||
48102582|NCT01165138|100578496|FG000|NOT COMPLETED|Overall Study||0||
48102583|NCT01165138|100578497|FG001|NOT COMPLETED|Overall Study||52||
48102584|NCT01165138|100578498|FG002|NOT COMPLETED|Overall Study||20||
48102585|NCT01165138|100578499|FG003|NOT COMPLETED|Overall Study||22||
48102586|NCT00304356|100578500|FG000|STARTED|Nitazoxanide||27||
48102587|NCT00304356|100578500|FG000|COMPLETED|Nitazoxanide||22||
48102588|NCT00304356|100578500|FG000|NOT COMPLETED|Nitazoxanide||5||
48102589|NCT00304356|100578500|FG000|STARTED|Nitazoxanide||27||
48102590|NCT00304356|100578500|FG000|COMPLETED|Nitazoxanide||22||
48102591|NCT00304356|100578500|FG000|NOT COMPLETED|Nitazoxanide||5||
48102592|NCT00862186|100578501|FG000|STARTED|Overall Study||15||
48102593|NCT00862186|100578501|FG000|COMPLETED|Overall Study||15||
48102594|NCT00862186|100578501|FG000|NOT COMPLETED|Overall Study||0||
48102595|NCT01232920|100578502|FG000|STARTED|Overall Study||41||
48102596|NCT01232920|100578503|FG001|STARTED|Overall Study||39||
48102597|NCT01232920|100578502|FG000|COMPLETED|Overall Study||35||
48102598|NCT01232920|100578503|FG001|COMPLETED|Overall Study||32||
48102599|NCT01232920|100578502|FG000|NOT COMPLETED|Overall Study||6||
48102600|NCT01232920|100578503|FG001|NOT COMPLETED|Overall Study||7||
48102601|NCT03274986|100578504|FG000|STARTED|Overall Study||107|All subjects with attempted implantation, as treated.|
48102602|NCT03274986|100578505|FG001|STARTED|Overall Study||113|All subjects with attempted implantation, as treated.|
48102603|NCT03274986|100578504|FG000|Successful Implantation, as Treated|Overall Study||107||
48102604|NCT03274986|100578505|FG001|Successful Implantation, as Treated|Overall Study||113||
48102605|NCT03274986|100578504|FG000|COMPLETED|Overall Study||107||
48102606|NCT03274986|100578505|FG001|COMPLETED|Overall Study||111||
48102607|NCT03274986|100578504|FG000|NOT COMPLETED|Overall Study||0||
48102608|NCT03274986|100578505|FG001|NOT COMPLETED|Overall Study||2||
48102609|NCT01976442|100578506|FG000|STARTED|Overall Study||69||
48102610|NCT01976442|100578507|FG001|STARTED|Overall Study||31||
48102611|NCT01976442|100578506|FG000|COMPLETED|Overall Study||69||
48102612|NCT01976442|100578507|FG001|COMPLETED|Overall Study||31||
48102613|NCT01976442|100578506|FG000|NOT COMPLETED|Overall Study||0||
48102614|NCT01976442|100578507|FG001|NOT COMPLETED|Overall Study||0||
48102615|NCT00076011|100578508|FG000|STARTED|Overall Study||52||
48102616|NCT00076011|100578508|FG000|COMPLETED|Overall Study||0||
48102617|NCT00076011|100578508|FG000|NOT COMPLETED|Overall Study||52||
48102618|NCT00271947|100578509|FG000|STARTED|Overall Study||1||
48102619|NCT00271947|100578509|FG000|COMPLETED|Overall Study||0||
48102620|NCT00271947|100578509|FG000|NOT COMPLETED|Overall Study||1||
48102621|NCT03200899|100578510|FG000|STARTED|Overall Study||93||
48102622|NCT03200899|100578511|FG001|STARTED|Overall Study||90||
48102623|NCT03200899|100578510|FG000|T2 - Immediately Post-intervention|Overall Study||85||
48102624|NCT03200899|100578511|FG001|T2 - Immediately Post-intervention|Overall Study||78||
48102625|NCT03200899|100578510|FG000|T3 - 3-months Post-intervention|Overall Study||82||
48102626|NCT03200899|100578511|FG001|T3 - 3-months Post-intervention|Overall Study||74||
48102627|NCT03200899|100578510|FG000|COMPLETED|Overall Study||83||
48102628|NCT03200899|100578511|FG001|COMPLETED|Overall Study||67||
48102629|NCT03200899|100578510|FG000|NOT COMPLETED|Overall Study||10||
48102630|NCT03200899|100578511|FG001|NOT COMPLETED|Overall Study||23||
48102631|NCT03320564|100578512|FG000|STARTED|Overall Study||2||
48102632|NCT03320564|100578512|FG000|COMPLETED|Overall Study||1||
48102633|NCT03320564|100578512|FG000|NOT COMPLETED|Overall Study||1||
48102634|NCT01148511|100578513|FG000|STARTED|Exposed to Study Drug||99||
48102635|NCT01148511|100578514|FG001|STARTED|Exposed to Study Drug||0||
48102636|NCT01148511|100578515|FG002|STARTED|Exposed to Study Drug||0||
48102637|NCT01148511|100578513|FG000|COMPLETED|Exposed to Study Drug||93||
48102638|NCT01148511|100578514|FG001|COMPLETED|Exposed to Study Drug||0||
48102639|NCT01148511|100578515|FG002|COMPLETED|Exposed to Study Drug||0||
48102640|NCT01148511|100578513|FG000|NOT COMPLETED|Exposed to Study Drug||6||
48102641|NCT01148511|100578514|FG001|NOT COMPLETED|Exposed to Study Drug||0||
48102642|NCT01148511|100578515|FG002|NOT COMPLETED|Exposed to Study Drug||0||
48102643|NCT01148511|100578513|FG000|STARTED|Randomized||0||
48102644|NCT01148511|100578514|FG001|STARTED|Randomized||48||
48102645|NCT01148511|100578515|FG002|STARTED|Randomized||45||
48102646|NCT01148511|100578513|FG000|COMPLETED|Randomized||0||
48102647|NCT01148511|100578514|FG001|COMPLETED|Randomized||38||
48102648|NCT01148511|100578515|FG002|COMPLETED|Randomized||39||
48102649|NCT01148511|100578513|FG000|NOT COMPLETED|Randomized||0||
48102650|NCT01148511|100578514|FG001|NOT COMPLETED|Randomized||10||
48102651|NCT01148511|100578515|FG002|NOT COMPLETED|Randomized||6||
48102652|NCT02741700|100578516|FG000|STARTED|Overall Study||152||
48102653|NCT02741700|100578517|FG001|STARTED|Overall Study||154||
48391350|NCT02849626|101287648|FG000|STARTED|Core Phase (up to 23 Weeks)||149||
48391351|NCT02849626|101287649|FG001|STARTED|Core Phase (up to 23 Weeks)||31||
48391352|NCT02849626|101287650|FG002|STARTED|Core Phase (up to 23 Weeks)||0||
48391353|NCT02849626|101287651|FG003|STARTED|Core Phase (up to 23 Weeks)||0||
48391354|NCT02849626|101287648|FG000|COMPLETED|Core Phase (up to 23 Weeks)||122||
48102654|NCT02741700|100578516|FG000|COMPLETED|Overall Study||126||
48102655|NCT02741700|100578517|FG001|COMPLETED|Overall Study||135||
48102656|NCT02741700|100578516|FG000|NOT COMPLETED|Overall Study||26||
48102657|NCT02741700|100578517|FG001|NOT COMPLETED|Overall Study||19||
48102658|NCT00407563|100578518|FG000|STARTED|Overall Study||48||
48102659|NCT00407563|100578518|FG000|COMPLETED|Overall Study||47||
48102660|NCT00407563|100578518|FG000|NOT COMPLETED|Overall Study||1||
48264887|NCT03126110|100970899|FG005|NOT COMPLETED|Phase 1||4||
48264888|NCT03126110|100970900|FG006|NOT COMPLETED|Phase 1||3||
48264889|NCT03126110|100970901|FG007|NOT COMPLETED|Phase 1||4||
48264890|NCT03126110|100970902|FG008|NOT COMPLETED|Phase 1||8||
48264891|NCT03126110|100970903|FG009|NOT COMPLETED|Phase 1||3||
48264892|NCT03126110|100970904|FG010|NOT COMPLETED|Phase 1||6||
48264893|NCT03126110|100970905|FG011|NOT COMPLETED|Phase 1||0||
48264894|NCT03126110|100970906|FG012|NOT COMPLETED|Phase 1||0||
48264895|NCT03126110|100970907|FG013|NOT COMPLETED|Phase 1||0||
48264896|NCT03126110|100970908|FG014|NOT COMPLETED|Phase 1||0||
48264897|NCT03126110|100970909|FG015|NOT COMPLETED|Phase 1||0||
48264898|NCT03126110|100970910|FG016|NOT COMPLETED|Phase 1||0||
48264899|NCT03126110|100970894|FG000|STARTED|Phase 2||0||
48391355|NCT02849626|101287649|FG001|COMPLETED|Core Phase (up to 23 Weeks)||24||
48391356|NCT02849626|101287650|FG002|COMPLETED|Core Phase (up to 23 Weeks)||0||
48391357|NCT02849626|101287651|FG003|COMPLETED|Core Phase (up to 23 Weeks)||0||
48391358|NCT02849626|101287648|FG000|NOT COMPLETED|Core Phase (up to 23 Weeks)||27||
48391359|NCT02849626|101287649|FG001|NOT COMPLETED|Core Phase (up to 23 Weeks)||7||
48391360|NCT02849626|101287650|FG002|NOT COMPLETED|Core Phase (up to 23 Weeks)||0||
48391361|NCT02849626|101287651|FG003|NOT COMPLETED|Core Phase (up to 23 Weeks)||0||
48391362|NCT02849626|101287648|FG000|STARTED|Extension Phase A (up to 29 Weeks)||116||
48391363|NCT02849626|101287649|FG001|STARTED|Extension Phase A (up to 29 Weeks)||20||
48391364|NCT02849626|101287650|FG002|STARTED|Extension Phase A (up to 29 Weeks)||0||
48391365|NCT02849626|101287651|FG003|STARTED|Extension Phase A (up to 29 Weeks)||0||
48391366|NCT02849626|101287648|FG000|COMPLETED|Extension Phase A (up to 29 Weeks)||105||
48391367|NCT02849626|101287649|FG001|COMPLETED|Extension Phase A (up to 29 Weeks)||17||
48391368|NCT02849626|101287650|FG002|COMPLETED|Extension Phase A (up to 29 Weeks)||0||
48391369|NCT02849626|101287651|FG003|COMPLETED|Extension Phase A (up to 29 Weeks)||0||
48391370|NCT02849626|101287648|FG000|NOT COMPLETED|Extension Phase A (up to 29 Weeks)||11||
48391371|NCT02849626|101287649|FG001|NOT COMPLETED|Extension Phase A (up to 29 Weeks)||3||
48391372|NCT02849626|101287650|FG002|NOT COMPLETED|Extension Phase A (up to 29 Weeks)||0||
48391373|NCT02849626|101287651|FG003|NOT COMPLETED|Extension Phase A (up to 29 Weeks)||0||
48391374|NCT02849626|101287648|FG000|STARTED|Extension Phase B (up to 89 Weeks)||0||
48391375|NCT02849626|101287649|FG001|STARTED|Extension Phase B (up to 89 Weeks)||0||
48391376|NCT02849626|101287650|FG002|STARTED|Extension Phase B (up to 89 Weeks)||41||
48391377|NCT02849626|101287651|FG003|STARTED|Extension Phase B (up to 89 Weeks)||1||
48264900|NCT03126110|100970895|FG001|STARTED|Phase 2||0||
48391378|NCT02849626|101287648|FG000|COMPLETED|Extension Phase B (up to 89 Weeks)||0||
48391379|NCT02849626|101287649|FG001|COMPLETED|Extension Phase B (up to 89 Weeks)||0||
48391380|NCT02849626|101287650|FG002|COMPLETED|Extension Phase B (up to 89 Weeks)||36||
48391381|NCT02849626|101287651|FG003|COMPLETED|Extension Phase B (up to 89 Weeks)||1||
48391382|NCT02849626|101287648|FG000|NOT COMPLETED|Extension Phase B (up to 89 Weeks)||0||
48391383|NCT02849626|101287649|FG001|NOT COMPLETED|Extension Phase B (up to 89 Weeks)||0||
48391384|NCT02849626|101287650|FG002|NOT COMPLETED|Extension Phase B (up to 89 Weeks)||5||
48391385|NCT02849626|101287651|FG003|NOT COMPLETED|Extension Phase B (up to 89 Weeks)||0||
48391386|NCT04024072|101287652|FG000|STARTED|Overall Study||249||
48391387|NCT04024072|101287653|FG001|STARTED|Overall Study||246||
48391388|NCT04024072|101287652|FG000|COMPLETED|Overall Study||247||
48391389|NCT04024072|101287653|FG001|COMPLETED|Overall Study||237||
48391390|NCT04024072|101287652|FG000|NOT COMPLETED|Overall Study||2||
48391391|NCT04024072|101287653|FG001|NOT COMPLETED|Overall Study||9||
48391392|NCT01601470|101287654|FG000|STARTED|Period 1 - Sildenafil||28||
48102661|NCT01319877|100578519|FG000|STARTED|Overall Study||453||
48102662|NCT01319877|100578520|FG001|STARTED|Overall Study||153||
48102663|NCT01319877|100578519|FG000|COMPLETED|Overall Study||345||
48102664|NCT01319877|100578520|FG001|COMPLETED|Overall Study||108||
48102665|NCT01319877|100578519|FG000|NOT COMPLETED|Overall Study||108||
48102666|NCT01319877|100578520|FG001|NOT COMPLETED|Overall Study||45||
48102667|NCT03338062|100578521|FG000|STARTED|Overall Study||10||
48264901|NCT03126110|100970896|FG002|STARTED|Phase 2||0||
48264902|NCT03126110|100970897|FG003|STARTED|Phase 2||0||
48264903|NCT03126110|100970898|FG004|STARTED|Phase 2||0||
48264904|NCT03126110|100970899|FG005|STARTED|Phase 2||0||
48391393|NCT01601470|101287654|FG000|PK Analysis Set|Period 1 - Sildenafil||28||
48391394|NCT01601470|101287654|FG000|Safety Set|Period 1 - Sildenafil||28||
48391395|NCT01601470|101287654|FG000|COMPLETED|Period 1 - Sildenafil||28||
48264905|NCT03126110|100970900|FG006|STARTED|Phase 2||0||
48102668|NCT03338062|100578522|FG001|STARTED|Overall Study||5||
48102669|NCT03338062|100578521|FG000|COMPLETED|Overall Study||9||
48102670|NCT03338062|100578522|FG001|COMPLETED|Overall Study||5||
48102671|NCT03338062|100578521|FG000|NOT COMPLETED|Overall Study||1||
48102672|NCT03338062|100578522|FG001|NOT COMPLETED|Overall Study||0||
48102673|NCT01706003|100578523|FG000|STARTED|Overall Study||23||
48102674|NCT01706003|100578524|FG001|STARTED|Overall Study||22||
48102675|NCT01706003|100578523|FG000|COMPLETED|Overall Study||12||
48102676|NCT01706003|100578524|FG001|COMPLETED|Overall Study||18||
48102677|NCT01706003|100578523|FG000|NOT COMPLETED|Overall Study||11||
48102678|NCT01706003|100578524|FG001|NOT COMPLETED|Overall Study||4||
48391396|NCT01601470|101287654|FG000|NOT COMPLETED|Period 1 - Sildenafil||0||
48391397|NCT01601470|101287654|FG000|STARTED|Period 2 - LCZ696||28||
48391398|NCT01601470|101287654|FG000|PK Analysis Set|Period 2 - LCZ696||27||
48391399|NCT01601470|101287654|FG000|Safety Set|Period 2 - LCZ696||27||
48391400|NCT01601470|101287654|FG000|COMPLETED|Period 2 - LCZ696||27||
48391401|NCT01601470|101287654|FG000|NOT COMPLETED|Period 2 - LCZ696||1||
48391402|NCT01601470|101287654|FG000|STARTED|Period 3 - LCZ696+Sildenafil||27||
48391403|NCT01601470|101287654|FG000|PK Analysis Set|Period 3 - LCZ696+Sildenafil||27||
48391404|NCT01601470|101287654|FG000|Safety Set|Period 3 - LCZ696+Sildenafil||27||
48264906|NCT03126110|100970901|FG007|STARTED|Phase 2||0||
48264907|NCT03126110|100970902|FG008|STARTED|Phase 2||0||
48264908|NCT03126110|100970903|FG009|STARTED|Phase 2||0||
48264909|NCT03126110|100970904|FG010|STARTED|Phase 2||0||
48264910|NCT03126110|100970905|FG011|STARTED|Phase 2||8||
48264911|NCT03126110|100970906|FG012|STARTED|Phase 2||16||
48264912|NCT03126110|100970907|FG013|STARTED|Phase 2||46||
48264913|NCT03126110|100970908|FG014|STARTED|Phase 2||18||
48391405|NCT01601470|101287654|FG000|COMPLETED|Period 3 - LCZ696+Sildenafil||27||
48548943|NCT02028676|101679491|FG003|STARTED|Subsequent Cotrimoxazole Randomization||0||
48548944|NCT02028676|101679492|FG004|STARTED|Subsequent Cotrimoxazole Randomization||0||
48548945|NCT02028676|101679493|FG005|STARTED|Subsequent Cotrimoxazole Randomization||0||
48548946|NCT02028676|101679494|FG006|STARTED|Subsequent Cotrimoxazole Randomization||0||
48548947|NCT02028676|101679495|FG007|STARTED|Subsequent Cotrimoxazole Randomization||376||
48102679|NCT03483675|100578525|FG000|STARTED|Overall Study||9||
48548948|NCT02028676|101679496|FG008|STARTED|Subsequent Cotrimoxazole Randomization||382||
48548949|NCT02028676|101679488|FG000|COMPLETED|Subsequent Cotrimoxazole Randomization||0||
48548950|NCT02028676|101679489|FG001|COMPLETED|Subsequent Cotrimoxazole Randomization||0||
48548951|NCT02028676|101679490|FG002|COMPLETED|Subsequent Cotrimoxazole Randomization||0||
48548952|NCT02028676|101679491|FG003|COMPLETED|Subsequent Cotrimoxazole Randomization||0||
48548953|NCT02028676|101679492|FG004|COMPLETED|Subsequent Cotrimoxazole Randomization||0||
48548954|NCT02028676|101679493|FG005|COMPLETED|Subsequent Cotrimoxazole Randomization||0||
48102680|NCT03483675|100578526|FG001|STARTED|Overall Study||8||
48102681|NCT03483675|100578525|FG000|COMPLETED|Overall Study||9||
48102682|NCT03483675|100578526|FG001|COMPLETED|Overall Study||8||
48102683|NCT03483675|100578525|FG000|NOT COMPLETED|Overall Study||0||
48102684|NCT03483675|100578526|FG001|NOT COMPLETED|Overall Study||0||
48102685|NCT04782856|100578527|FG000|STARTED|Overall Study||7||
48102686|NCT04782856|100578528|FG001|STARTED|Overall Study||6||
48264914|NCT03126110|100970909|FG015|STARTED|Phase 2||4||
48391406|NCT01601470|101287654|FG000|NOT COMPLETED|Period 3 - LCZ696+Sildenafil||0||
48391407|NCT01966263|101287655|FG000|STARTED|Overall Study||40||
48391408|NCT01966263|101287656|FG001|STARTED|Overall Study||40||
48391409|NCT01966263|101287655|FG000|COMPLETED|Overall Study||40||
48391410|NCT01966263|101287656|FG001|COMPLETED|Overall Study||40||
48548955|NCT02028676|101679494|FG006|COMPLETED|Subsequent Cotrimoxazole Randomization||0||
48548956|NCT02028676|101679495|FG007|COMPLETED|Subsequent Cotrimoxazole Randomization||376||
48548957|NCT02028676|101679496|FG008|COMPLETED|Subsequent Cotrimoxazole Randomization||382||
48548958|NCT02028676|101679488|FG000|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0||
48548959|NCT02028676|101679489|FG001|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0||
48548960|NCT02028676|101679490|FG002|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0||
48548961|NCT02028676|101679491|FG003|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0||
48548962|NCT02028676|101679492|FG004|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0||
48548963|NCT02028676|101679493|FG005|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0||
48548964|NCT02028676|101679494|FG006|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0||
48548965|NCT02028676|101679495|FG007|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0||
48102687|NCT04782856|100578527|FG000|COMPLETED|Overall Study||7||
48102688|NCT04782856|100578528|FG001|COMPLETED|Overall Study||5||
48102689|NCT04782856|100578527|FG000|NOT COMPLETED|Overall Study||0||
48102690|NCT04782856|100578528|FG001|NOT COMPLETED|Overall Study||1||
48102691|NCT01277523|100578529|FG000|STARTED|Overall Study||135||
48102692|NCT01277523|100578530|FG001|STARTED|Overall Study||127||
48264915|NCT03126110|100970910|FG016|STARTED|Phase 2||2||
48264916|NCT03126110|100970894|FG000|COMPLETED|Phase 2||0||
48264917|NCT03126110|100970895|FG001|COMPLETED|Phase 2||0||
48264918|NCT03126110|100970896|FG002|COMPLETED|Phase 2||0||
48264919|NCT03126110|100970897|FG003|COMPLETED|Phase 2||0||
48391411|NCT01966263|101287655|FG000|NOT COMPLETED|Overall Study||0||
48264920|NCT03126110|100970898|FG004|COMPLETED|Phase 2||0||
48264921|NCT03126110|100970899|FG005|COMPLETED|Phase 2||0||
48264922|NCT03126110|100970900|FG006|COMPLETED|Phase 2||0||
48264923|NCT03126110|100970901|FG007|COMPLETED|Phase 2||0||
48264924|NCT03126110|100970902|FG008|COMPLETED|Phase 2||0||
48264925|NCT03126110|100970903|FG009|COMPLETED|Phase 2||0||
48264926|NCT03126110|100970904|FG010|COMPLETED|Phase 2||0||
48264927|NCT03126110|100970905|FG011|COMPLETED|Phase 2||0||
48264928|NCT03126110|100970906|FG012|COMPLETED|Phase 2||0||
48264929|NCT03126110|100970907|FG013|COMPLETED|Phase 2||12||
48264930|NCT03126110|100970908|FG014|COMPLETED|Phase 2||2||
48264931|NCT03126110|100970909|FG015|COMPLETED|Phase 2||0||
48391412|NCT01966263|101287656|FG001|NOT COMPLETED|Overall Study||0||
48391413|NCT03300258|101287657|FG000|STARTED|Overall Study||44||
48391414|NCT03300258|101287658|FG001|STARTED|Overall Study||0||
48691498|NCT03299244|102028939|FG001|STARTED|Overall Study||320||
48691499|NCT03299244|102028938|FG000|Received Treatment|Overall Study||315||
48691500|NCT03299244|102028939|FG001|Received Treatment|Overall Study||318||
48691501|NCT03299244|102028938|FG000|COMPLETED|Overall Study||270||
48691502|NCT03299244|102028939|FG001|COMPLETED|Overall Study||282||
48691503|NCT03299244|102028938|FG000|NOT COMPLETED|Overall Study||47||
48691504|NCT03299244|102028939|FG001|NOT COMPLETED|Overall Study||38||
48102693|NCT01277523|100578531|FG002|STARTED|Overall Study||130||
48102694|NCT01277523|100578529|FG000|COMPLETED|Overall Study||132||
48102695|NCT01277523|100578530|FG001|COMPLETED|Overall Study||126||
48102696|NCT01277523|100578531|FG002|COMPLETED|Overall Study||130||
48102697|NCT01277523|100578529|FG000|NOT COMPLETED|Overall Study||3||
48102698|NCT01277523|100578530|FG001|NOT COMPLETED|Overall Study||1||
48102699|NCT01277523|100578531|FG002|NOT COMPLETED|Overall Study||0||
48102700|NCT02580357|100578532|FG000|STARTED|Overall Study||18||
48102701|NCT02580357|100578533|FG001|STARTED|Overall Study||18||
48102702|NCT02580357|100578534|FG002|STARTED|Overall Study||18||
48102703|NCT02580357|100578532|FG000|COMPLETED|Overall Study||15||
48102704|NCT02580357|100578533|FG001|COMPLETED|Overall Study||18||
48264932|NCT03126110|100970910|FG016|COMPLETED|Phase 2||0||
48391415|NCT03300258|101287659|FG002|STARTED|Overall Study||0||
48391416|NCT03300258|101287660|FG003|STARTED|Overall Study||0||
48391417|NCT03300258|101287657|FG000|Group 1: Reaching Against a Spring-Like Torque|Overall Study||12||
48391418|NCT03300258|101287658|FG001|Group 1: Reaching Against a Spring-Like Torque|Overall Study||0||
48391419|NCT03300258|101287659|FG002|Group 1: Reaching Against a Spring-Like Torque|Overall Study||0||
48391420|NCT03300258|101287660|FG003|Group 1: Reaching Against a Spring-Like Torque|Overall Study||0||
48391421|NCT03300258|101287657|FG000|Group 2: Reaching Against a Damper-like Force|Overall Study||11||
48391422|NCT03300258|101287658|FG001|Group 2: Reaching Against a Damper-like Force|Overall Study||0||
48391423|NCT03300258|101287659|FG002|Group 2: Reaching Against a Damper-like Force|Overall Study||0||
48391424|NCT03300258|101287660|FG003|Group 2: Reaching Against a Damper-like Force|Overall Study||0||
48391425|NCT03300258|101287657|FG000|Group 3: Half-Reversed Cycling Task|Overall Study||21||
48391426|NCT03300258|101287658|FG001|Group 3: Half-Reversed Cycling Task|Overall Study||0||
48391427|NCT03300258|101287659|FG002|Group 3: Half-Reversed Cycling Task|Overall Study||0||
48391428|NCT03300258|101287660|FG003|Group 3: Half-Reversed Cycling Task|Overall Study||0||
48391429|NCT03300258|101287657|FG000|COMPLETED|Overall Study||44||
48391430|NCT03300258|101287658|FG001|COMPLETED|Overall Study||0||
48391431|NCT03300258|101287659|FG002|COMPLETED|Overall Study||0||
48391432|NCT03300258|101287660|FG003|COMPLETED|Overall Study||0||
48391433|NCT03300258|101287657|FG000|NOT COMPLETED|Overall Study||0||
48691505|NCT01823198|102028940|FG000|STARTED|Overall Study||6||
48691506|NCT01823198|102028941|FG001|STARTED|Overall Study||6||
48691507|NCT01823198|102028942|FG002|STARTED|Overall Study||4||
48691508|NCT01823198|102028943|FG003|STARTED|Overall Study||4||
48391434|NCT03300258|101287658|FG001|NOT COMPLETED|Overall Study||0||
48391435|NCT03300258|101287659|FG002|NOT COMPLETED|Overall Study||0||
48391436|NCT03300258|101287660|FG003|NOT COMPLETED|Overall Study||0||
48691509|NCT01823198|102028944|FG004|STARTED|Overall Study||1||
48391437|NCT04199793|101287661|FG000|STARTED|Overall Study||4||
48391438|NCT04199793|101287662|FG001|STARTED|Overall Study||4||
48391439|NCT04199793|101287661|FG000|COMPLETED|Overall Study||1||
48391440|NCT04199793|101287662|FG001|COMPLETED|Overall Study||1||
48102705|NCT02580357|100578534|FG002|COMPLETED|Overall Study||18||
48102706|NCT02580357|100578532|FG000|NOT COMPLETED|Overall Study||3||
48102707|NCT02580357|100578533|FG001|NOT COMPLETED|Overall Study||0||
48264933|NCT03126110|100970894|FG000|NOT COMPLETED|Phase 2||0||
48264934|NCT03126110|100970895|FG001|NOT COMPLETED|Phase 2||0||
48264935|NCT03126110|100970896|FG002|NOT COMPLETED|Phase 2||0||
48391441|NCT04199793|101287661|FG000|NOT COMPLETED|Overall Study||3||
48391442|NCT04199793|101287662|FG001|NOT COMPLETED|Overall Study||3||
48391443|NCT00764946|101287663|FG000|STARTED|Overall Study||98||
48391444|NCT00764946|101287664|FG001|STARTED|Overall Study||89||
48691510|NCT01823198|102028945|FG005|STARTED|Overall Study||21||
48691511|NCT01823198|102028946|FG006|STARTED|Overall Study||21||
48102708|NCT02580357|100578534|FG002|NOT COMPLETED|Overall Study||0||
48264936|NCT03126110|100970897|FG003|NOT COMPLETED|Phase 2||0||
48548966|NCT02028676|101679496|FG008|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0||
48548967|NCT01228019|101679497|FG000|STARTED|Overall Study||1166||
48548968|NCT01228019|101679497|FG000|COMPLETED|Overall Study||862||
48548969|NCT01228019|101679497|FG000|NOT COMPLETED|Overall Study||304||
48548970|NCT04542057|101679498|FG000|STARTED|Overall Study||499||
48548971|NCT04542057|101679499|FG001|STARTED|Overall Study||291||
48548972|NCT04542057|101679498|FG000|Received Treatment|Overall Study||498||
48548973|NCT04542057|101679499|FG001|Received Treatment|Overall Study||291||
48548974|NCT04542057|101679498|FG000|COMPLETED|Overall Study||393||
48548975|NCT04542057|101679499|FG001|COMPLETED|Overall Study||218||
48548976|NCT04542057|101679498|FG000|NOT COMPLETED|Overall Study||106||
48548977|NCT04542057|101679499|FG001|NOT COMPLETED|Overall Study||73||
48548978|NCT02422797|101679500|FG000|STARTED|Early Switch Phase (Up to Week 52)||261||
48548979|NCT02422797|101679501|FG001|STARTED|Early Switch Phase (Up to Week 52)||255||
48548980|NCT02422797|101679500|FG000|COMPLETED|Early Switch Phase (Up to Week 52)||245||
48548981|NCT02422797|101679501|FG001|COMPLETED|Early Switch Phase (Up to Week 52)||239||
48548982|NCT02422797|101679500|FG000|NOT COMPLETED|Early Switch Phase (Up to Week 52)||16||
48548983|NCT02422797|101679501|FG001|NOT COMPLETED|Early Switch Phase (Up to Week 52)||16||
48548984|NCT02422797|101679500|FG000|STARTED|Late Switch Phase (Week 52 to Week 148)||245||
48548985|NCT02422797|101679501|FG001|STARTED|Late Switch Phase (Week 52 to Week 148)||239||
48548986|NCT02422797|101679500|FG000|COMPLETED|Late Switch Phase (Week 52 to Week 148)||222||
48548987|NCT02422797|101679501|FG001|COMPLETED|Late Switch Phase (Week 52 to Week 148)||221||
48548988|NCT02422797|101679500|FG000|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||23||
48548989|NCT02422797|101679501|FG001|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||18||
48548990|NCT02422797|101679500|FG000|STARTED|Continuation Phase(Week 148 to Week 410)||208||
48548991|NCT02422797|101679501|FG001|STARTED|Continuation Phase(Week 148 to Week 410)||204||
48548992|NCT02422797|101679500|FG000|COMPLETED|Continuation Phase(Week 148 to Week 410)||201||
48548993|NCT02422797|101679501|FG001|COMPLETED|Continuation Phase(Week 148 to Week 410)||194||
48548994|NCT02422797|101679500|FG000|NOT COMPLETED|Continuation Phase(Week 148 to Week 410)||7||
48548995|NCT02422797|101679501|FG001|NOT COMPLETED|Continuation Phase(Week 148 to Week 410)||10||
48264937|NCT03126110|100970898|FG004|NOT COMPLETED|Phase 2||0||
48264938|NCT03126110|100970899|FG005|NOT COMPLETED|Phase 2||0||
48264939|NCT03126110|100970900|FG006|NOT COMPLETED|Phase 2||0||
48264940|NCT03126110|100970901|FG007|NOT COMPLETED|Phase 2||0||
48264941|NCT03126110|100970902|FG008|NOT COMPLETED|Phase 2||0||
48264942|NCT03126110|100970903|FG009|NOT COMPLETED|Phase 2||0||
48264943|NCT03126110|100970904|FG010|NOT COMPLETED|Phase 2||0||
48264944|NCT03126110|100970905|FG011|NOT COMPLETED|Phase 2||8||
48548996|NCT01755091|101679502|FG000|STARTED|Overall Study||26||
48548997|NCT01755091|101679503|FG001|STARTED|Overall Study||22||
48548998|NCT01755091|101679504|FG002|STARTED|Overall Study||27||
48548999|NCT01755091|101679502|FG000|COMPLETED|Overall Study||17||
48549000|NCT01755091|101679503|FG001|COMPLETED|Overall Study||19||
48549001|NCT01755091|101679504|FG002|COMPLETED|Overall Study||20||
48549002|NCT01755091|101679502|FG000|NOT COMPLETED|Overall Study||9||
48549003|NCT01755091|101679503|FG001|NOT COMPLETED|Overall Study||3||
48549004|NCT01755091|101679504|FG002|NOT COMPLETED|Overall Study||7||
48549005|NCT01957761|101679505|FG000|STARTED|Overall Study||189||
48549006|NCT01957761|101679505|FG000|COMPLETED|Overall Study||189||
48549007|NCT01957761|101679505|FG000|NOT COMPLETED|Overall Study||0||
48549008|NCT02934191|101679506|FG000|STARTED|Overall Study||87||
48549009|NCT02934191|101679507|FG001|STARTED|Overall Study||85||
48264945|NCT03126110|100970906|FG012|NOT COMPLETED|Phase 2||16||
48264946|NCT03126110|100970907|FG013|NOT COMPLETED|Phase 2||34||
48264947|NCT03126110|100970908|FG014|NOT COMPLETED|Phase 2||16||
48264948|NCT03126110|100970909|FG015|NOT COMPLETED|Phase 2||4||
48264949|NCT03126110|100970910|FG016|NOT COMPLETED|Phase 2||2||
48264950|NCT00731133|100970911|FG000|STARTED|Overall Study||15||
48264951|NCT00731133|100970911|FG000|COMPLETED|Overall Study||5||
48264952|NCT00731133|100970911|FG000|NOT COMPLETED|Overall Study||10||
48264953|NCT02669615|100970912|FG000|STARTED|Overall Study||24||
48264954|NCT02669615|100970912|FG000|COMPLETED|Overall Study||24||
48264955|NCT02669615|100970912|FG000|NOT COMPLETED|Overall Study||0||
48264956|NCT01479270|100970913|FG000|STARTED|Overall Study||28||
48264957|NCT01479270|100970914|FG001|STARTED|Overall Study||28||
48549010|NCT02934191|101679506|FG000|COMPLETED|Overall Study||87||
48549011|NCT02934191|101679507|FG001|COMPLETED|Overall Study||85||
48549012|NCT02934191|101679506|FG000|NOT COMPLETED|Overall Study||0||
48549013|NCT02934191|101679507|FG001|NOT COMPLETED|Overall Study||0||
48549014|NCT01994850|101679508|FG000|STARTED|Overall Study||32||
48549015|NCT01994850|101679508|FG000|COMPLETED|Overall Study||30||
48549016|NCT01994850|101679508|FG000|NOT COMPLETED|Overall Study||2||
48549017|NCT00362336|101679509|FG000|STARTED|Overall Study||243||
48549018|NCT00362336|101679510|FG001|STARTED|Overall Study||242||
48549019|NCT00362336|101679511|FG002|STARTED|Overall Study||137||
48549020|NCT00362336|101679509|FG000|COMPLETED|Overall Study||233||
48549021|NCT00362336|101679510|FG001|COMPLETED|Overall Study||235||
48264958|NCT01479270|100970913|FG000|COMPLETED|Overall Study||28||
48264959|NCT01479270|100970914|FG001|COMPLETED|Overall Study||28||
48264960|NCT01479270|100970913|FG000|NOT COMPLETED|Overall Study||0||
48264961|NCT01479270|100970914|FG001|NOT COMPLETED|Overall Study||0||
48549022|NCT00362336|101679511|FG002|COMPLETED|Overall Study||134||
48549023|NCT00362336|101679509|FG000|NOT COMPLETED|Overall Study||10||
48549024|NCT00362336|101679510|FG001|NOT COMPLETED|Overall Study||7||
48549025|NCT00362336|101679511|FG002|NOT COMPLETED|Overall Study||3||
48549026|NCT04201197|101679512|FG000|STARTED|Overall Study||22||
48549027|NCT04201197|101679512|FG000|Placebo, THC, THC+CBD|Overall Study||3||
48549028|NCT04201197|101679512|FG000|Placebo, THC+CBD, THC|Overall Study||3||
48549029|NCT04201197|101679512|FG000|THC, Placebo, THC+CBD|Overall Study||3||
48549030|NCT04201197|101679512|FG000|THC, THC+CBD, Placebo|Overall Study||3||
48549031|NCT04201197|101679512|FG000|THC+CBD, THC, Placebo|Overall Study||3||
48549032|NCT04201197|101679512|FG000|THC+CBD, THC, Placebo|Overall Study||3||
48549033|NCT04201197|101679512|FG000|COMPLETED|Overall Study||18||
48549034|NCT04201197|101679512|FG000|NOT COMPLETED|Overall Study||4||
48549035|NCT01072617|101679513|FG000|STARTED|Overall Study||8||
48264962|NCT00388804|100970915|FG000|STARTED|Overall Study||17||
48264963|NCT00388804|100970916|FG001|STARTED|Overall Study||21||
48264964|NCT00388804|100970915|FG000|COMPLETED|Overall Study||17||
48264965|NCT00388804|100970916|FG001|COMPLETED|Overall Study||21||
48264966|NCT00388804|100970915|FG000|NOT COMPLETED|Overall Study||0||
48264967|NCT00388804|100970916|FG001|NOT COMPLETED|Overall Study||0||
48264968|NCT00967005|100970917|FG000|STARTED|Overall Study||13||
48264969|NCT00967005|100970918|FG001|STARTED|Overall Study||15||
48264970|NCT00967005|100970917|FG000|Treatment Completion|Overall Study||10||
48264971|NCT00967005|100970918|FG001|Treatment Completion|Overall Study||10||
48264972|NCT00967005|100970917|FG000|COMPLETED|Overall Study||6||
48264973|NCT00967005|100970918|FG001|COMPLETED|Overall Study||5||
48264974|NCT00967005|100970917|FG000|NOT COMPLETED|Overall Study||7||
48264975|NCT00967005|100970918|FG001|NOT COMPLETED|Overall Study||10||
48264976|NCT00208325|100970919|FG000|STARTED|Overall Study||193||
48264977|NCT00208325|100970920|FG001|STARTED|Overall Study||196||
48264978|NCT00208325|100970921|FG002|STARTED|Overall Study||170||
48264979|NCT00208325|100970922|FG003|STARTED|Overall Study||161||
48264980|NCT00208325|100970919|FG000|COMPLETED|Overall Study||142||
48264981|NCT00208325|100970920|FG001|COMPLETED|Overall Study||142||
48264982|NCT00208325|100970921|FG002|COMPLETED|Overall Study||156||
48264983|NCT00208325|100970922|FG003|COMPLETED|Overall Study||147||
48264984|NCT00208325|100970919|FG000|NOT COMPLETED|Overall Study||51||
48264985|NCT00208325|100970920|FG001|NOT COMPLETED|Overall Study||54||
48264986|NCT00208325|100970921|FG002|NOT COMPLETED|Overall Study||14||
48264987|NCT00208325|100970922|FG003|NOT COMPLETED|Overall Study||14||
48264988|NCT02593123|100970923|FG000|STARTED|Overall Study||18||
48264989|NCT02593123|100970924|FG001|STARTED|Overall Study||13||
48549036|NCT01072617|101679513|FG000|COMPLETED|Overall Study||8||
48549037|NCT01072617|101679513|FG000|NOT COMPLETED|Overall Study||0||
48549038|NCT01260701|101679514|FG000|STARTED|Overall Study||75||
48549039|NCT01260701|101679514|FG000|Eligible|Overall Study||71||
48549040|NCT01260701|101679514|FG000|Eligible and Began Protocol Therapy|Overall Study||70||
48549041|NCT01260701|101679514|FG000|COMPLETED|Overall Study||0||
48549042|NCT01260701|101679514|FG000|NOT COMPLETED|Overall Study||75||
48549043|NCT03482973|101679515|FG000|STARTED|Overall Study||40||
48549044|NCT03482973|101679516|FG001|STARTED|Overall Study||40||
48549045|NCT03482973|101679515|FG000|COMPLETED|Overall Study||40||
48549046|NCT03482973|101679516|FG001|COMPLETED|Overall Study||40||
48549047|NCT03482973|101679515|FG000|NOT COMPLETED|Overall Study||0||
48264990|NCT02593123|100970923|FG000|COMPLETED|Overall Study||15||
48549048|NCT03482973|101679516|FG001|NOT COMPLETED|Overall Study||0||
48549049|NCT00996489|101679517|FG000|STARTED|Overall Study||459||
48549050|NCT00996489|101679517|FG000|COMPLETED|Overall Study||298||
48549051|NCT00996489|101679517|FG000|NOT COMPLETED|Overall Study||161||
48549052|NCT01659125|101679518|FG000|STARTED|Overall Study||26||
48549053|NCT01659125|101679518|FG000|Initiated Treatment|Overall Study||24||
48549054|NCT01659125|101679518|FG000|Completed the Posttreatment Assessment|Overall Study||17||
48549055|NCT01659125|101679518|FG000|Completed 3-month Follow-up|Overall Study||16||
48549056|NCT01659125|101679518|FG000|Completed 6-month Follow-up|Overall Study||12||
48549057|NCT01659125|101679518|FG000|COMPLETED|Overall Study||12||
48549058|NCT01659125|101679518|FG000|NOT COMPLETED|Overall Study||14||
48549059|NCT00456300|101679519|FG000|STARTED|Overall Study||5|"Started means recruited, not enrolled."|
48549060|NCT00456300|101679520|FG001|STARTED|Overall Study||4|"Started means recruited, not enrolled."|
48264991|NCT02593123|100970924|FG001|COMPLETED|Overall Study||11||
48264992|NCT02593123|100970923|FG000|NOT COMPLETED|Overall Study||3||
48264993|NCT02593123|100970924|FG001|NOT COMPLETED|Overall Study||2||
48264994|NCT00422734|100970925|FG000|STARTED|Overall Study||78||
48264995|NCT00422734|100970926|FG001|STARTED|Overall Study||264||
48264996|NCT00422734|100970925|FG000|COMPLETED|Overall Study||64||
48264997|NCT00422734|100970926|FG001|COMPLETED|Overall Study||243||
48264998|NCT00422734|100970925|FG000|NOT COMPLETED|Overall Study||14||
48264999|NCT00422734|100970926|FG001|NOT COMPLETED|Overall Study||21||
48549061|NCT00456300|101679519|FG000|COMPLETED|Overall Study||4||
48549062|NCT00456300|101679520|FG001|COMPLETED|Overall Study||4||
48549063|NCT00456300|101679519|FG000|NOT COMPLETED|Overall Study||1||
48549064|NCT00456300|101679520|FG001|NOT COMPLETED|Overall Study||0||
48549065|NCT00706589|101679521|FG000|STARTED|Overall Study||32||
48549066|NCT00706589|101679522|FG001|STARTED|Overall Study||29||
48549067|NCT00706589|101679521|FG000|COMPLETED|Overall Study||29||
48549068|NCT00706589|101679522|FG001|COMPLETED|Overall Study||25||
48549069|NCT00706589|101679521|FG000|NOT COMPLETED|Overall Study||3||
48549070|NCT00706589|101679522|FG001|NOT COMPLETED|Overall Study||4||
48549071|NCT00897910|101679523|FG000|STARTED|Overall Study||6||
48549072|NCT00897910|101679523|FG000|COMPLETED|Overall Study||6||
48549073|NCT00897910|101679523|FG000|NOT COMPLETED|Overall Study||0||
48549074|NCT02290444|101679524|FG000|STARTED|Overall Study||30||
48549075|NCT02290444|101679525|FG001|STARTED|Overall Study||34||
48549076|NCT02290444|101679524|FG000|COMPLETED|Overall Study||29||
48691512|NCT01823198|102028940|FG000|COMPLETED|Overall Study||6||
48691513|NCT01823198|102028941|FG001|COMPLETED|Overall Study||5||
48691514|NCT01823198|102028942|FG002|COMPLETED|Overall Study||4||
48691515|NCT01823198|102028943|FG003|COMPLETED|Overall Study||4||
48691516|NCT01823198|102028944|FG004|COMPLETED|Overall Study||1||
48691517|NCT01823198|102028945|FG005|COMPLETED|Overall Study||18||
48691518|NCT01823198|102028946|FG006|COMPLETED|Overall Study||18||
48691519|NCT01823198|102028940|FG000|NOT COMPLETED|Overall Study||0||
48691520|NCT01823198|102028941|FG001|NOT COMPLETED|Overall Study||1||
48691521|NCT01823198|102028942|FG002|NOT COMPLETED|Overall Study||0||
48691522|NCT01823198|102028943|FG003|NOT COMPLETED|Overall Study||0||
48691523|NCT01823198|102028944|FG004|NOT COMPLETED|Overall Study||0||
48691524|NCT01823198|102028945|FG005|NOT COMPLETED|Overall Study||3||
48691525|NCT01823198|102028946|FG006|NOT COMPLETED|Overall Study||3||
48691526|NCT03611881|102028947|FG000|STARTED|Overall Study||82||
48691527|NCT03611881|102028948|FG001|STARTED|Overall Study||82||
48691528|NCT03611881|102028949|FG002|STARTED|Overall Study||80||
48691529|NCT03611881|102028950|FG003|STARTED|Overall Study||79||
48691530|NCT03611881|102028951|FG004|STARTED|Overall Study||79||
48691531|NCT03611881|102028952|FG005|STARTED|Overall Study||81||
48691532|NCT03611881|102028953|FG006|STARTED|Overall Study||81||
48691533|NCT03611881|102028954|FG007|STARTED|Overall Study||78||
48691534|NCT03611881|102028947|FG000|COMPLETED|Overall Study||82||
48691535|NCT03611881|102028948|FG001|COMPLETED|Overall Study||82||
48691536|NCT03611881|102028949|FG002|COMPLETED|Overall Study||80||
48691537|NCT03611881|102028950|FG003|COMPLETED|Overall Study||79||
48691538|NCT03611881|102028951|FG004|COMPLETED|Overall Study||79||
48691539|NCT03611881|102028952|FG005|COMPLETED|Overall Study||81||
48691540|NCT03611881|102028953|FG006|COMPLETED|Overall Study||81||
48691541|NCT03611881|102028954|FG007|COMPLETED|Overall Study||78||
48691542|NCT03611881|102028947|FG000|NOT COMPLETED|Overall Study||0||
48691543|NCT03611881|102028948|FG001|NOT COMPLETED|Overall Study||0||
48691544|NCT03611881|102028949|FG002|NOT COMPLETED|Overall Study||0||
48691545|NCT03611881|102028950|FG003|NOT COMPLETED|Overall Study||0||
48691546|NCT03611881|102028951|FG004|NOT COMPLETED|Overall Study||0||
48691547|NCT03611881|102028952|FG005|NOT COMPLETED|Overall Study||0||
48691548|NCT03611881|102028953|FG006|NOT COMPLETED|Overall Study||0||
48549077|NCT02290444|101679525|FG001|COMPLETED|Overall Study||32||
48549078|NCT02290444|101679524|FG000|NOT COMPLETED|Overall Study||1||
48549079|NCT02290444|101679525|FG001|NOT COMPLETED|Overall Study||2||
48549080|NCT00299130|101679526|FG000|STARTED|Treatment Period (up to 5 Years)||172||
48549081|NCT00299130|101679527|FG001|STARTED|Treatment Period (up to 5 Years)||168||
48549082|NCT00299130|101679528|FG002|STARTED|Treatment Period (up to 5 Years)||171||
48549083|NCT00299130|101679526|FG000|Treated|Treatment Period (up to 5 Years)||172||
48549084|NCT00299130|101679527|FG001|Treated|Treatment Period (up to 5 Years)||167||
48549085|NCT00299130|101679528|FG002|Treated|Treatment Period (up to 5 Years)||170||
48549086|NCT00299130|101679526|FG000|Completed 24 Weeks|Treatment Period (up to 5 Years)||159||
48549087|NCT00299130|101679527|FG001|Completed 24 Weeks|Treatment Period (up to 5 Years)||162||
48549088|NCT00299130|101679528|FG002|Completed 24 Weeks|Treatment Period (up to 5 Years)||166||
48691549|NCT03611881|102028954|FG007|NOT COMPLETED|Overall Study||0||
48691550|NCT00436046|102028955|FG000|STARTED|Overall Study||32||
48691551|NCT00436046|102028956|FG001|STARTED|Overall Study||32||
48691552|NCT00436046|102028957|FG002|STARTED|Overall Study||31||
48691553|NCT00436046|102028955|FG000|COMPLETED|Overall Study||32||
48691554|NCT00436046|102028956|FG001|COMPLETED|Overall Study||32||
48691555|NCT00436046|102028957|FG002|COMPLETED|Overall Study||31||
48691556|NCT00436046|102028955|FG000|NOT COMPLETED|Overall Study||0||
48691557|NCT00436046|102028956|FG001|NOT COMPLETED|Overall Study||0||
48691558|NCT00436046|102028957|FG002|NOT COMPLETED|Overall Study||0||
48549089|NCT00299130|101679526|FG000|Completed 48 Weeks|Treatment Period (up to 5 Years)||155||
48549090|NCT00299130|101679527|FG001|Completed 48 Weeks|Treatment Period (up to 5 Years)||157||
48549091|NCT00299130|101679528|FG002|Completed 48 Weeks|Treatment Period (up to 5 Years)||158||
48691559|NCT01061723|102028958|FG000|STARTED|Overall Study||50||
48691560|NCT01061723|102028959|FG001|STARTED|Overall Study||49||
48691561|NCT01061723|102028960|FG002|STARTED|Overall Study||50||
48691562|NCT01061723|102028961|FG003|STARTED|Overall Study||52||
48691563|NCT01061723|102028962|FG004|STARTED|Overall Study||50||
48691564|NCT01061723|102028963|FG005|STARTED|Overall Study||50||
48691565|NCT01061723|102028958|FG000|Treated|Overall Study||50||
48691566|NCT01061723|102028959|FG001|Treated|Overall Study||49||
48549092|NCT00299130|101679526|FG000|Completed 144 Weeks|Treatment Period (up to 5 Years)||133||
48549093|NCT00299130|101679527|FG001|Completed 144 Weeks|Treatment Period (up to 5 Years)||138||
48265000|NCT02820597|100970927|FG000|STARTED|Overall Study||27||
48549094|NCT00299130|101679528|FG002|Completed 144 Weeks|Treatment Period (up to 5 Years)||132||
48549095|NCT00299130|101679526|FG000|COMPLETED|Treatment Period (up to 5 Years)||119||
48549096|NCT00299130|101679527|FG001|COMPLETED|Treatment Period (up to 5 Years)||125||
48549097|NCT00299130|101679528|FG002|COMPLETED|Treatment Period (up to 5 Years)||121||
48549098|NCT00299130|101679526|FG000|NOT COMPLETED|Treatment Period (up to 5 Years)||53||
48549099|NCT00299130|101679527|FG001|NOT COMPLETED|Treatment Period (up to 5 Years)||43||
48549100|NCT00299130|101679528|FG002|NOT COMPLETED|Treatment Period (up to 5 Years)||50||
48549101|NCT00299130|101679526|FG000|STARTED|Safety Follow-up (SFU) (48 Weeks)||167||
48549102|NCT00299130|101679527|FG001|STARTED|Safety Follow-up (SFU) (48 Weeks)||165||
48265001|NCT02820597|100970927|FG000|1-day Post Treatment|Overall Study||27||
48265002|NCT02820597|100970927|FG000|7-day Post Treatment|Overall Study||27||
48265003|NCT02820597|100970927|FG000|30-day Post Treatment|Overall Study||27||
48265004|NCT02820597|100970927|FG000|90-day Post Treatment|Overall Study||24||
48265005|NCT02820597|100970927|FG000|180-day Post Treatment|Overall Study||21|Initially, study was complete upon 90 days follow-up, the 180-day visit was added later.|
48265006|NCT02820597|100970927|FG000|COMPLETED|Overall Study||15|Initially, study was complete upon 90 days follow-up, the 365-day visit was added later.|
48265007|NCT02820597|100970927|FG000|NOT COMPLETED|Overall Study||12||
48265008|NCT01766713|100970928|FG000|STARTED|Overall Study||25||
48265009|NCT01766713|100970929|FG001|STARTED|Overall Study||25||
48265010|NCT01766713|100970928|FG000|COMPLETED|Overall Study||23||
48265011|NCT01766713|100970929|FG001|COMPLETED|Overall Study||22||
48265012|NCT01766713|100970928|FG000|NOT COMPLETED|Overall Study||2||
48265013|NCT01766713|100970929|FG001|NOT COMPLETED|Overall Study||3||
48265014|NCT01216072|100970930|FG000|STARTED|Open-Label Core Period ( 6 Months)||790||
48265015|NCT01216072|100970931|FG001|STARTED|Open-Label Core Period ( 6 Months)||263||
48265016|NCT01216072|100970930|FG000|Full Analysis Set|Open-Label Core Period ( 6 Months)||789||
48549103|NCT00299130|101679528|FG002|STARTED|Safety Follow-up (SFU) (48 Weeks)||168||
48549104|NCT00299130|101679526|FG000|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||122||
48549105|NCT00299130|101679527|FG001|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||120||
48549106|NCT00299130|101679528|FG002|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||123||
48265017|NCT01216072|100970931|FG001|Full Analysis Set|Open-Label Core Period ( 6 Months)||263||
48265018|NCT01216072|100970930|FG000|Safety Set|Open-Label Core Period ( 6 Months)||783||
48265019|NCT01216072|100970931|FG001|Safety Set|Open-Label Core Period ( 6 Months)||245||
48265020|NCT01216072|100970930|FG000|COMPLETED|Open-Label Core Period ( 6 Months)||714||
48265021|NCT01216072|100970931|FG001|COMPLETED|Open-Label Core Period ( 6 Months)||229||
48265022|NCT01216072|100970930|FG000|NOT COMPLETED|Open-Label Core Period ( 6 Months)||76||
48265023|NCT01216072|100970931|FG001|NOT COMPLETED|Open-Label Core Period ( 6 Months)||34||
48265024|NCT01216072|100970930|FG000|STARTED|Open-Label Extension Period (3 Months)||0||
48265025|NCT01216072|100970931|FG001|STARTED|Open-Label Extension Period (3 Months)||195||
48265026|NCT01216072|100970930|FG000|Safety Set|Open-Label Extension Period (3 Months)||0||
48265027|NCT01216072|100970931|FG001|Safety Set|Open-Label Extension Period (3 Months)||193||
48265028|NCT01216072|100970930|FG000|COMPLETED|Open-Label Extension Period (3 Months)||0||
48265029|NCT01216072|100970931|FG001|COMPLETED|Open-Label Extension Period (3 Months)||181||
48265030|NCT01216072|100970930|FG000|NOT COMPLETED|Open-Label Extension Period (3 Months)||0||
48265031|NCT01216072|100970931|FG001|NOT COMPLETED|Open-Label Extension Period (3 Months)||14||
48265032|NCT03023722|100970932|FG000|STARTED|Overall Study||18||
48549107|NCT00299130|101679526|FG000|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45||
48549108|NCT00299130|101679527|FG001|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45||
48549109|NCT00299130|101679528|FG002|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45||
48549110|NCT00299130|101679526|FG000|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||0||
48549111|NCT00299130|101679527|FG001|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||82||
48549112|NCT00299130|101679528|FG002|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||44||
48549113|NCT00299130|101679526|FG000|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0||
48549114|NCT00299130|101679527|FG001|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||74||
48549115|NCT00299130|101679528|FG002|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||38||
48549116|NCT00299130|101679526|FG000|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0||
48549117|NCT00299130|101679527|FG001|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||8||
48549118|NCT00299130|101679528|FG002|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||6||
48549119|NCT03450473|101679529|FG000|STARTED|Overall Study||24||
48549120|NCT03450473|101679529|FG000|COMPLETED|Overall Study||20||
48549121|NCT03450473|101679529|FG000|NOT COMPLETED|Overall Study||4||
48549122|NCT02964312|101679530|FG000|STARTED|Overall Study||166||
48549123|NCT02964312|101679530|FG000|1-Month Follow-up|Overall Study||164||
48549124|NCT02964312|101679530|FG000|3-Month Follow-up|Overall Study||159||
48549125|NCT02964312|101679530|FG000|6-Month Follow-up|Overall Study||152||
48549126|NCT02964312|101679530|FG000|12-Month Follow-up|Overall Study||139||
48265033|NCT03023722|100970932|FG000|COMPLETED|Overall Study||14||
48265034|NCT03023722|100970932|FG000|NOT COMPLETED|Overall Study||4||
48265035|NCT03482752|100970933|FG000|STARTED|Overall Study||60||
48265036|NCT03482752|100970933|FG000|Safety Analysis Set|Overall Study||59|The safety analysis set included all enrolled participants who were exposed to molgramostim nebulizer solution in SAV006-03.|
48294156|NCT02527343|101047536|FG000|STARTED|OLE Period-Year 2: Week 105 to 156||0||
48265037|NCT03482752|100970933|FG000|COMPLETED|Overall Study||56|The participants who remained in the study when the study was terminated were classified as early terminators.|
48265038|NCT03482752|100970933|FG000|NOT COMPLETED|Overall Study||4||
48265039|NCT02392104|100970934|FG000|STARTED|Overall Study||50||
48265040|NCT02392104|100970934|FG000|COMPLETED|Overall Study||39||
48265041|NCT02392104|100970934|FG000|NOT COMPLETED|Overall Study||11||
48265042|NCT00979953|100970935|FG000|STARTED|Overall Study||101||
48265043|NCT00979953|100970936|FG001|STARTED|Overall Study||99||
48265044|NCT00979953|100970937|FG002|STARTED|Overall Study||104||
48265045|NCT00979953|100970938|FG003|STARTED|Overall Study||104||
48265046|NCT00979953|100970935|FG000|Received at Least 1 Dose of Study Drug|Overall Study||101||
48265047|NCT00979953|100970936|FG001|Received at Least 1 Dose of Study Drug|Overall Study||99||
48265048|NCT00979953|100970937|FG002|Received at Least 1 Dose of Study Drug|Overall Study||104||
48265049|NCT00979953|100970938|FG003|Received at Least 1 Dose of Study Drug|Overall Study||104||
48265050|NCT00979953|100970935|FG000|COMPLETED|Overall Study||93||
48265051|NCT00979953|100970936|FG001|COMPLETED|Overall Study||94||
48265052|NCT00979953|100970937|FG002|COMPLETED|Overall Study||82||
48265053|NCT00979953|100970938|FG003|COMPLETED|Overall Study||97||
48265054|NCT00979953|100970935|FG000|NOT COMPLETED|Overall Study||8||
48265055|NCT00979953|100970936|FG001|NOT COMPLETED|Overall Study||5||
48265056|NCT00979953|100970937|FG002|NOT COMPLETED|Overall Study||22||
48265057|NCT00979953|100970938|FG003|NOT COMPLETED|Overall Study||7||
48549127|NCT02964312|101679530|FG000|18-Month Follow-up|Overall Study||112|The 18-mo and 24-mo follow-up visits required participants to sign an new consent to participate.|
48549128|NCT02964312|101679530|FG000|24-Month Follow-up|Overall Study||102||
48549129|NCT02964312|101679530|FG000|COMPLETED|Overall Study||102||
48549130|NCT02964312|101679530|FG000|NOT COMPLETED|Overall Study||64||
48549131|NCT01111318|101679531|FG000|STARTED|Overall Study||12||
48549132|NCT01111318|101679532|FG001|STARTED|Overall Study||8||
48549133|NCT01111318|101679533|FG002|STARTED|Overall Study||8||
48549134|NCT01111318|101679534|FG003|STARTED|Overall Study||8||
48549135|NCT01111318|101679531|FG000|COMPLETED|Overall Study||12||
48549136|NCT01111318|101679532|FG001|COMPLETED|Overall Study||8||
48549137|NCT01111318|101679533|FG002|COMPLETED|Overall Study||8||
48549138|NCT01111318|101679534|FG003|COMPLETED|Overall Study||8||
48549139|NCT01111318|101679531|FG000|NOT COMPLETED|Overall Study||0||
48549140|NCT01111318|101679532|FG001|NOT COMPLETED|Overall Study||0||
48549141|NCT01111318|101679533|FG002|NOT COMPLETED|Overall Study||0||
48549142|NCT01111318|101679534|FG003|NOT COMPLETED|Overall Study||0||
48549143|NCT00683657|101679535|FG000|STARTED|Overall Study||46||
48549144|NCT00683657|101679536|FG001|STARTED|Overall Study||47||
48549145|NCT00683657|101679535|FG000|Randomized Subjects Data Set|Overall Study||46||
48549146|NCT00683657|101679536|FG001|Randomized Subjects Data Set|Overall Study||47||
48549147|NCT00683657|101679535|FG000|COMPLETED|Overall Study||45||
48549148|NCT00683657|101679536|FG001|COMPLETED|Overall Study||46||
48549149|NCT00683657|101679535|FG000|NOT COMPLETED|Overall Study||1||
48549150|NCT00683657|101679536|FG001|NOT COMPLETED|Overall Study||1||
48549151|NCT03736031|101679537|FG000|STARTED|Overall Study||56||
48549152|NCT03736031|101679538|FG001|STARTED|Overall Study||46||
48549153|NCT03736031|101679537|FG000|COMPLETED|Overall Study||24||
48549154|NCT03736031|101679538|FG001|COMPLETED|Overall Study||40||
48549155|NCT03736031|101679537|FG000|NOT COMPLETED|Overall Study||32||
48549156|NCT03736031|101679538|FG001|NOT COMPLETED|Overall Study||6||
48549157|NCT03281876|101679539|FG000|STARTED|Overall Study||304||
48549158|NCT03281876|101679540|FG001|STARTED|Overall Study||302||
48549159|NCT03281876|101679539|FG000|COMPLETED|Overall Study||281||
48549160|NCT03281876|101679540|FG001|COMPLETED|Overall Study||263||
48549161|NCT03281876|101679539|FG000|NOT COMPLETED|Overall Study||23||
48549162|NCT03281876|101679540|FG001|NOT COMPLETED|Overall Study||39||
48549163|NCT06372210|101679541|FG000|STARTED|Overall Study||24||
48549164|NCT06372210|101679542|FG001|STARTED|Overall Study||30||
48549165|NCT06372210|101679541|FG000|COMPLETED|Overall Study||24||
48549166|NCT06372210|101679542|FG001|COMPLETED|Overall Study||30||
48549167|NCT06372210|101679541|FG000|NOT COMPLETED|Overall Study||0||
48549168|NCT06372210|101679542|FG001|NOT COMPLETED|Overall Study||0||
48549169|NCT02819284|101679543|FG000|STARTED|Overall Study||452||
48102709|NCT02418195|100578535|FG000|STARTED|Overall Study||62||
48102710|NCT02418195|100578536|FG001|STARTED|Overall Study||63||
48265058|NCT00855413|100970939|FG000|STARTED|Overall Study||15||
48265059|NCT00855413|100970939|FG000|COMPLETED|Overall Study||15||
48265060|NCT00855413|100970939|FG000|NOT COMPLETED|Overall Study||0||
48265061|NCT02034162|100970940|FG000|STARTED|Double-blind||146||
48265062|NCT02034162|100970941|FG001|STARTED|Double-blind||149||
48265063|NCT02034162|100970942|FG002|STARTED|Double-blind||0||
48265064|NCT02034162|100970940|FG000|COMPLETED|Double-blind||137||
48265065|NCT02034162|100970941|FG001|COMPLETED|Double-blind||141||
48265066|NCT02034162|100970942|FG002|COMPLETED|Double-blind||0||
48265067|NCT02034162|100970940|FG000|NOT COMPLETED|Double-blind||9||
48265068|NCT02034162|100970941|FG001|NOT COMPLETED|Double-blind||8||
48265069|NCT02034162|100970942|FG002|NOT COMPLETED|Double-blind||0||
48265070|NCT02034162|100970940|FG000|STARTED|Open-label||0||
48265071|NCT02034162|100970941|FG001|STARTED|Open-label||0||
48265072|NCT02034162|100970942|FG002|STARTED|Open-label||278||
48102711|NCT02418195|100578537|FG002|STARTED|Overall Study||61||
48549170|NCT02819284|101679544|FG001|STARTED|Overall Study||453||
48549171|NCT02819284|101679543|FG000|COMPLETED|Overall Study||447||
48549172|NCT02819284|101679544|FG001|COMPLETED|Overall Study||448||
48549173|NCT02819284|101679543|FG000|NOT COMPLETED|Overall Study||5||
48549174|NCT02819284|101679544|FG001|NOT COMPLETED|Overall Study||5||
48549175|NCT03323398|101679545|FG000|STARTED|Overall Study||11||
48549176|NCT03323398|101679546|FG001|STARTED|Overall Study||12||
48549177|NCT03323398|101679547|FG002|STARTED|Overall Study||12||
48549178|NCT03323398|101679548|FG003|STARTED|Overall Study||3||
48549179|NCT03323398|101679549|FG004|STARTED|Overall Study||1||
48549180|NCT03323398|101679550|FG005|STARTED|Overall Study||3||
48549181|NCT03323398|101679551|FG006|STARTED|Overall Study||3||
48549182|NCT03323398|101679552|FG007|STARTED|Overall Study||1||
48549183|NCT03323398|101679553|FG008|STARTED|Overall Study||15||
48549184|NCT03323398|101679545|FG000|Received At Least 1 Dose of Study Drug|Overall Study||11||
48549185|NCT03323398|101679546|FG001|Received At Least 1 Dose of Study Drug|Overall Study||12||
48549186|NCT03323398|101679547|FG002|Received At Least 1 Dose of Study Drug|Overall Study||12||
48549187|NCT03323398|101679548|FG003|Received At Least 1 Dose of Study Drug|Overall Study||3||
48549188|NCT03323398|101679549|FG004|Received At Least 1 Dose of Study Drug|Overall Study||1||
48549189|NCT03323398|101679550|FG005|Received At Least 1 Dose of Study Drug|Overall Study||3||
48549190|NCT03323398|101679551|FG006|Received At Least 1 Dose of Study Drug|Overall Study||3||
48549191|NCT03323398|101679552|FG007|Received At Least 1 Dose of Study Drug|Overall Study||1||
48549192|NCT03323398|101679553|FG008|Received At Least 1 Dose of Study Drug|Overall Study||15||
48549193|NCT03323398|101679545|FG000|COMPLETED|Overall Study||2||
48549194|NCT03323398|101679546|FG001|COMPLETED|Overall Study||1||
48549195|NCT03323398|101679547|FG002|COMPLETED|Overall Study||2||
48549196|NCT03323398|101679548|FG003|COMPLETED|Overall Study||1||
48549197|NCT03323398|101679549|FG004|COMPLETED|Overall Study||0||
48549198|NCT03323398|101679550|FG005|COMPLETED|Overall Study||0||
48549199|NCT03323398|101679551|FG006|COMPLETED|Overall Study||1||
48549200|NCT03323398|101679552|FG007|COMPLETED|Overall Study||0||
48549201|NCT03323398|101679553|FG008|COMPLETED|Overall Study||7||
48549202|NCT03323398|101679545|FG000|NOT COMPLETED|Overall Study||9||
48549203|NCT03323398|101679546|FG001|NOT COMPLETED|Overall Study||11||
48549204|NCT03323398|101679547|FG002|NOT COMPLETED|Overall Study||10||
48549205|NCT03323398|101679548|FG003|NOT COMPLETED|Overall Study||2||
48549206|NCT03323398|101679549|FG004|NOT COMPLETED|Overall Study||1||
48549207|NCT03323398|101679550|FG005|NOT COMPLETED|Overall Study||3||
48549208|NCT03323398|101679551|FG006|NOT COMPLETED|Overall Study||2||
48549209|NCT03323398|101679552|FG007|NOT COMPLETED|Overall Study||1||
48549210|NCT03323398|101679553|FG008|NOT COMPLETED|Overall Study||8||
48549211|NCT00345631|101679554|FG000|STARTED|Overall Study||87||
48549212|NCT00345631|101679555|FG001|STARTED|Overall Study||267||
48549213|NCT00345631|101679556|FG002|STARTED|Overall Study||134||
48549214|NCT00345631|101679554|FG000|COMPLETED|Overall Study||83||
48549215|NCT00345631|101679555|FG001|COMPLETED|Overall Study||259||
48549216|NCT00345631|101679556|FG002|COMPLETED|Overall Study||128||
48549217|NCT00345631|101679554|FG000|NOT COMPLETED|Overall Study||4||
48549218|NCT00345631|101679555|FG001|NOT COMPLETED|Overall Study||8||
48549219|NCT00345631|101679556|FG002|NOT COMPLETED|Overall Study||6||
48549220|NCT02972892|101679557|FG000|STARTED|Overall Study||110||
48549221|NCT02972892|101679558|FG001|STARTED|Overall Study||118||
48549222|NCT02972892|101679557|FG000|COMPLETED|Overall Study||101||
48549223|NCT02972892|101679558|FG001|COMPLETED|Overall Study||116||
48549224|NCT02972892|101679557|FG000|NOT COMPLETED|Overall Study||9||
48549225|NCT02972892|101679558|FG001|NOT COMPLETED|Overall Study||2||
48549226|NCT01988129|101679559|FG000|STARTED|Overall Study||601||
48549227|NCT01988129|101679560|FG001|STARTED|Overall Study||588||
48549228|NCT01988129|101679559|FG000|Attended Education Session|Overall Study||542||
48549229|NCT01988129|101679560|FG001|Attended Education Session|Overall Study||18||
48549230|NCT01988129|101679559|FG000|Screened for Sleep Disorders|Overall Study||416||
48549231|NCT01988129|101679560|FG001|Screened for Sleep Disorders|Overall Study||15||
48549232|NCT01988129|101679559|FG000|Completed 1-year Follow-up Survey|Overall Study||100||
48549233|NCT01988129|101679560|FG001|Completed 1-year Follow-up Survey|Overall Study||4||
48549234|NCT01988129|101679559|FG000|COMPLETED|Overall Study||601||
48549235|NCT01988129|101679560|FG001|COMPLETED|Overall Study||588||
48549236|NCT01988129|101679559|FG000|NOT COMPLETED|Overall Study||0||
48549237|NCT01988129|101679560|FG001|NOT COMPLETED|Overall Study||0||
48549238|NCT01992185|101679561|FG000|STARTED|Overall Study||7||
48549239|NCT01992185|101679562|FG001|STARTED|Overall Study||8||
48549240|NCT01992185|101679561|FG000|COMPLETED|Overall Study||7||
48549241|NCT01992185|101679562|FG001|COMPLETED|Overall Study||8||
48549242|NCT01992185|101679561|FG000|NOT COMPLETED|Overall Study||0||
48549243|NCT01992185|101679562|FG001|NOT COMPLETED|Overall Study||0||
48549244|NCT01297985|101679563|FG000|STARTED|Overall Study||212||
48549245|NCT01297985|101679564|FG001|STARTED|Overall Study||216||
48549246|NCT01297985|101679563|FG000|COMPLETED|Overall Study||157||
48549247|NCT01297985|101679564|FG001|COMPLETED|Overall Study||163||
48549248|NCT01297985|101679563|FG000|NOT COMPLETED|Overall Study||55||
48549249|NCT01297985|101679564|FG001|NOT COMPLETED|Overall Study||53||
48549250|NCT02652949|101679565|FG000|STARTED|30-Day Follow-up for Primary Endpoint||87||
48691567|NCT01061723|102028960|FG002|Treated|Overall Study||50||
48549251|NCT02652949|101679565|FG000|COMPLETED|30-Day Follow-up for Primary Endpoint||86||
48549252|NCT02652949|101679565|FG000|NOT COMPLETED|30-Day Follow-up for Primary Endpoint||1||
48549253|NCT02652949|101679565|FG000|STARTED|30-Day Follow-up for Secondary Endpoint||100||
48549254|NCT02652949|101679565|FG000|COMPLETED|30-Day Follow-up for Secondary Endpoint||99||
48549255|NCT02652949|101679565|FG000|NOT COMPLETED|30-Day Follow-up for Secondary Endpoint||1||
48549256|NCT02652949|101679565|FG000|STARTED|6-Month Follow-up Secondary Endpoint||99||
48549257|NCT02652949|101679565|FG000|COMPLETED|6-Month Follow-up Secondary Endpoint||91||
48549258|NCT02652949|101679565|FG000|NOT COMPLETED|6-Month Follow-up Secondary Endpoint||8||
48549259|NCT02652949|101679565|FG000|STARTED|12-Month Follow-up Secondary Endpoint||91||
48549260|NCT02652949|101679565|FG000|COMPLETED|12-Month Follow-up Secondary Endpoint||87||
48549261|NCT02652949|101679565|FG000|NOT COMPLETED|12-Month Follow-up Secondary Endpoint||4||
48549262|NCT02652949|101679565|FG000|STARTED|24-Month Follow-up Secondary Endpoint||87||
48549263|NCT02652949|101679565|FG000|COMPLETED|24-Month Follow-up Secondary Endpoint||52||
48549264|NCT02652949|101679565|FG000|NOT COMPLETED|24-Month Follow-up Secondary Endpoint||35||
48549265|NCT02652949|101679565|FG000|STARTED|36-Month Follow-up Secondary Endpoint||52||
48549266|NCT02652949|101679565|FG000|COMPLETED|36-Month Follow-up Secondary Endpoint||48||
48549267|NCT02652949|101679565|FG000|NOT COMPLETED|36-Month Follow-up Secondary Endpoint||4||
48549268|NCT02652949|101679565|FG000|STARTED|48-Month Follow-up Secondary Endpoint||48||
48549269|NCT02652949|101679565|FG000|COMPLETED|48-Month Follow-up Secondary Endpoint||42||
48549270|NCT02652949|101679565|FG000|NOT COMPLETED|48-Month Follow-up Secondary Endpoint||6||
48549271|NCT02652949|101679565|FG000|STARTED|60-Month Follow-up Secondary Endpoint||42||
48549272|NCT02652949|101679565|FG000|COMPLETED|60-Month Follow-up Secondary Endpoint||36||
48549273|NCT02652949|101679565|FG000|NOT COMPLETED|60-Month Follow-up Secondary Endpoint||6||
48549274|NCT00736632|101679566|FG000|STARTED|Overall Study||44||
48549275|NCT00736632|101679567|FG001|STARTED|Overall Study||50||
48549276|NCT00736632|101679568|FG002|STARTED|Overall Study||31||
48549277|NCT00736632|101679566|FG000|COMPLETED|Overall Study||44||
48549278|NCT00736632|101679567|FG001|COMPLETED|Overall Study||50||
48549279|NCT00736632|101679568|FG002|COMPLETED|Overall Study||31||
48549280|NCT00736632|101679566|FG000|NOT COMPLETED|Overall Study||0||
48549281|NCT00736632|101679567|FG001|NOT COMPLETED|Overall Study||0||
48549282|NCT00736632|101679568|FG002|NOT COMPLETED|Overall Study||0||
48549283|NCT02899195|101679569|FG000|STARTED|Concurrent Durvalumab||55||
48549284|NCT02899195|101679569|FG000|COMPLETED|Concurrent Durvalumab||44||
48549285|NCT02899195|101679569|FG000|NOT COMPLETED|Concurrent Durvalumab||11||
48549286|NCT02899195|101679569|FG000|STARTED|Maintenance Durvalumab||44||
48549287|NCT02899195|101679569|FG000|COMPLETED|Maintenance Durvalumab||10||
48549288|NCT02899195|101679569|FG000|NOT COMPLETED|Maintenance Durvalumab||34||
48549289|NCT00948155|101679570|FG000|STARTED|First Intervention 21 Days||14||
48549290|NCT00948155|101679571|FG001|STARTED|First Intervention 21 Days||15||
48549291|NCT00948155|101679570|FG000|COMPLETED|First Intervention 21 Days||12||
48549292|NCT00948155|101679571|FG001|COMPLETED|First Intervention 21 Days||13||
48549293|NCT00948155|101679570|FG000|NOT COMPLETED|First Intervention 21 Days||2||
48549294|NCT00948155|101679571|FG001|NOT COMPLETED|First Intervention 21 Days||2||
48549295|NCT00948155|101679570|FG000|STARTED|Washout 14 Days||12||
48549296|NCT00948155|101679571|FG001|STARTED|Washout 14 Days||13||
48549297|NCT00948155|101679570|FG000|COMPLETED|Washout 14 Days||11||
48549298|NCT00948155|101679571|FG001|COMPLETED|Washout 14 Days||11||
48549299|NCT00948155|101679570|FG000|NOT COMPLETED|Washout 14 Days||1||
48549300|NCT00948155|101679571|FG001|NOT COMPLETED|Washout 14 Days||2||
48549301|NCT00948155|101679570|FG000|STARTED|Second Intervention 21 Days||11||
48549302|NCT00948155|101679571|FG001|STARTED|Second Intervention 21 Days||11||
48549303|NCT00948155|101679570|FG000|COMPLETED|Second Intervention 21 Days||9||
48549304|NCT00948155|101679571|FG001|COMPLETED|Second Intervention 21 Days||8||
48549305|NCT00948155|101679570|FG000|NOT COMPLETED|Second Intervention 21 Days||2||
48102712|NCT02418195|100578538|FG003|STARTED|Overall Study||61||
48102713|NCT02418195|100578535|FG000|COMPLETED|Overall Study||62||
48102714|NCT02418195|100578536|FG001|COMPLETED|Overall Study||63||
48549306|NCT00948155|101679571|FG001|NOT COMPLETED|Second Intervention 21 Days||3||
48549307|NCT00258960|101679572|FG000|STARTED|Overall Study||49||
48549308|NCT00258960|101679572|FG000|COMPLETED|Overall Study||32||
48549309|NCT00258960|101679572|FG000|NOT COMPLETED|Overall Study||17||
48549310|NCT02215967|101679573|FG000|STARTED|Overall Study||3||
48549311|NCT02215967|101679574|FG001|STARTED|Overall Study||3||
48549312|NCT02215967|101679575|FG002|STARTED|Overall Study||5||
48549313|NCT02215967|101679576|FG003|STARTED|Overall Study||19||
48549314|NCT02215967|101679573|FG000|COMPLETED|Overall Study||3||
48102715|NCT02418195|100578537|FG002|COMPLETED|Overall Study||61||
48549315|NCT02215967|101679574|FG001|COMPLETED|Overall Study||3||
48549316|NCT02215967|101679575|FG002|COMPLETED|Overall Study||4||
48549317|NCT02215967|101679576|FG003|COMPLETED|Overall Study||16||
48549318|NCT02215967|101679573|FG000|NOT COMPLETED|Overall Study||0||
48549319|NCT02215967|101679574|FG001|NOT COMPLETED|Overall Study||0||
48549320|NCT02215967|101679575|FG002|NOT COMPLETED|Overall Study||1||
48549321|NCT02215967|101679576|FG003|NOT COMPLETED|Overall Study||3||
48549322|NCT02711878|101679577|FG000|STARTED|Overall Study||76||
48102716|NCT02418195|100578538|FG003|COMPLETED|Overall Study||61||
48102717|NCT02418195|100578535|FG000|NOT COMPLETED|Overall Study||0||
48102718|NCT02418195|100578536|FG001|NOT COMPLETED|Overall Study||0||
48102719|NCT02418195|100578537|FG002|NOT COMPLETED|Overall Study||0||
48102720|NCT02418195|100578538|FG003|NOT COMPLETED|Overall Study||0||
48102721|NCT01289847|100578539|FG000|STARTED|Overall Study||25||
48102722|NCT01289847|100578539|FG000|COMPLETED|Overall Study||24||
48102723|NCT01289847|100578539|FG000|NOT COMPLETED|Overall Study||1||
48102724|NCT02486042|100578540|FG000|STARTED|Overall Study||20||
48102725|NCT02486042|100578541|FG001|STARTED|Overall Study||21||
48102726|NCT02486042|100578540|FG000|COMPLETED|Overall Study||17||
48102727|NCT02486042|100578541|FG001|COMPLETED|Overall Study||10||
48102728|NCT02486042|100578540|FG000|NOT COMPLETED|Overall Study||3||
48102729|NCT02486042|100578541|FG001|NOT COMPLETED|Overall Study||11||
48102730|NCT01623596|100578542|FG000|STARTED|Overall Study||436||
48102731|NCT01623596|100578543|FG001|STARTED|Overall Study||439||
48102732|NCT01623596|100578542|FG000|On Randomized Treatment|Overall Study||352||
48102733|NCT01623596|100578543|FG001|On Randomized Treatment|Overall Study||125||
48102734|NCT01623596|100578542|FG000|On Switched Treatment|Overall Study||22||
48102735|NCT01623596|100578543|FG001|On Switched Treatment|Overall Study||214||
48102736|NCT01623596|100578542|FG000|COMPLETED|Overall Study||374||
48102737|NCT01623596|100578543|FG001|COMPLETED|Overall Study||339||
48549323|NCT02711878|101679578|FG001|STARTED|Overall Study||39||
48549324|NCT02711878|101679577|FG000|Completed Visit T1 (13-15 Weeks Post Baseline)|Overall Study||69||
48549325|NCT02711878|101679578|FG001|Completed Visit T1 (13-15 Weeks Post Baseline)|Overall Study||33||
48549326|NCT02711878|101679577|FG000|Completed Visit T2 (28-30 Weeks Post Baseline)|Overall Study||68||
48549327|NCT02711878|101679578|FG001|Completed Visit T2 (28-30 Weeks Post Baseline)|Overall Study||33||
48549328|NCT02711878|101679577|FG000|Completed Visit T3 (56-58 Weeks Post Baseline)|Overall Study||72||
48549329|NCT02711878|101679578|FG001|Completed Visit T3 (56-58 Weeks Post Baseline)|Overall Study||31||
48549330|NCT02711878|101679577|FG000|COMPLETED|Overall Study||68||
48549331|NCT02711878|101679578|FG001|COMPLETED|Overall Study||33||
48549332|NCT02711878|101679577|FG000|NOT COMPLETED|Overall Study||8||
48102738|NCT01623596|100578542|FG000|NOT COMPLETED|Overall Study||62||
48102739|NCT01623596|100578543|FG001|NOT COMPLETED|Overall Study||100||
48102740|NCT02658136|100578544|FG000|STARTED|Overall Study||15|Approved: 02-03-2016 (1-day study)|
48102741|NCT02658136|100578544|FG000|COMPLETED|Overall Study||15||
48102742|NCT02658136|100578544|FG000|NOT COMPLETED|Overall Study||0||
48102743|NCT02916563|100578545|FG000|STARTED|Overall Study||50||
48102744|NCT02916563|100578545|FG000|COMPLETED|Overall Study||50||
48102745|NCT02916563|100578545|FG000|NOT COMPLETED|Overall Study||0||
48102746|NCT01524627|100578546|FG000|STARTED|Overall Study||22||
48102747|NCT01524627|100578547|FG001|STARTED|Overall Study||21||
48102748|NCT01524627|100578546|FG000|COMPLETED|Overall Study||21||
48102749|NCT01524627|100578547|FG001|COMPLETED|Overall Study||19||
48102750|NCT01524627|100578546|FG000|NOT COMPLETED|Overall Study||1||
48102751|NCT01524627|100578547|FG001|NOT COMPLETED|Overall Study||2||
48102752|NCT03202264|100578548|FG000|STARTED|Overall Study||30||
48102753|NCT03202264|100578548|FG000|COMPLETED|Overall Study||14||
48102754|NCT03202264|100578548|FG000|NOT COMPLETED|Overall Study||16||
48102755|NCT02132767|100578549|FG000|STARTED|Overall Study||262||
48102756|NCT02132767|100578550|FG001|STARTED|Overall Study||261||
48102757|NCT02132767|100578549|FG000|COMPLETED|Overall Study||245||
48102758|NCT02132767|100578550|FG001|COMPLETED|Overall Study||246||
48102759|NCT02132767|100578549|FG000|NOT COMPLETED|Overall Study||17||
48102760|NCT02132767|100578550|FG001|NOT COMPLETED|Overall Study||15||
48102761|NCT03930446|100578551|FG000|STARTED|Overall Study||40||
48102762|NCT03930446|100578552|FG001|STARTED|Overall Study||40||
48102763|NCT03930446|100578551|FG000|COMPLETED|Overall Study||40||
48102764|NCT03930446|100578552|FG001|COMPLETED|Overall Study||40||
48102765|NCT03930446|100578551|FG000|NOT COMPLETED|Overall Study||0||
48102766|NCT03930446|100578552|FG001|NOT COMPLETED|Overall Study||0||
48102767|NCT01514760|100578553|FG000|STARTED|Overall Study||22||
48549333|NCT02711878|101679578|FG001|NOT COMPLETED|Overall Study||6||
48549334|NCT00742963|101679579|FG000|STARTED|Overall Study||101||
48691568|NCT01061723|102028961|FG003|Treated|Overall Study||52||
48102768|NCT01514760|100578553|FG000|COMPLETED|Overall Study||20||
48102769|NCT01514760|100578553|FG000|NOT COMPLETED|Overall Study||2||
48102770|NCT01380184|100578554|FG000|STARTED|Part 1 (19 Days)||15||
48102771|NCT01380184|100578554|FG000|COMPLETED|Part 1 (19 Days)||14||
48102772|NCT01380184|100578554|FG000|NOT COMPLETED|Part 1 (19 Days)||1||
48102773|NCT01380184|100578554|FG000|STARTED|Washout Period (≥2 Days)||14||
48102774|NCT01380184|100578554|FG000|COMPLETED|Washout Period (≥2 Days)||14||
48102775|NCT01380184|100578554|FG000|NOT COMPLETED|Washout Period (≥2 Days)||0||
48102776|NCT01380184|100578554|FG000|STARTED|Part 2||14||
48102777|NCT01380184|100578554|FG000|COMPLETED|Part 2||0||
48102778|NCT01380184|100578554|FG000|NOT COMPLETED|Part 2||14||
48102779|NCT01347541|100578555|FG000|STARTED|Overall Study||3||
48102780|NCT01347541|100578556|FG001|STARTED|Overall Study||1||
48102781|NCT01347541|100578555|FG000|COMPLETED|Overall Study||3||
48102782|NCT01347541|100578556|FG001|COMPLETED|Overall Study||1||
48102783|NCT01347541|100578555|FG000|NOT COMPLETED|Overall Study||0||
48549335|NCT00742963|101679579|FG000|Completed All Treatment Cycles|Overall Study||68||
48549336|NCT00742963|101679579|FG000|COMPLETED|Overall Study||68||
48549337|NCT00742963|101679579|FG000|NOT COMPLETED|Overall Study||33||
48549338|NCT01461538|101679580|FG000|STARTED|Overall Study||46||
48549339|NCT01461538|101679581|FG001|STARTED|Overall Study||28||
48549340|NCT01461538|101679582|FG002|STARTED|Overall Study||9||
48549341|NCT01461538|101679580|FG000|COMPLETED|Overall Study||28||
48549342|NCT01461538|101679581|FG001|COMPLETED|Overall Study||20||
48549343|NCT01461538|101679582|FG002|COMPLETED|Overall Study||7||
48549344|NCT01461538|101679580|FG000|NOT COMPLETED|Overall Study||18||
48549345|NCT01461538|101679581|FG001|NOT COMPLETED|Overall Study||8||
48549346|NCT01461538|101679582|FG002|NOT COMPLETED|Overall Study||2||
48549347|NCT00979199|101679583|FG000|STARTED|Overall Study||697||
48691569|NCT01061723|102028962|FG004|Treated|Overall Study||50||
48691570|NCT01061723|102028963|FG005|Treated|Overall Study||49||
48691571|NCT01061723|102028958|FG000|COMPLETED|Overall Study||46||
48102784|NCT01347541|100578556|FG001|NOT COMPLETED|Overall Study||0||
48102785|NCT00973479|100578557|FG000|STARTED|Overall Study||197||
48102786|NCT00973479|100578558|FG001|STARTED|Overall Study||395||
48102787|NCT00973479|100578557|FG000|COMPLETED|Overall Study||160||
48102788|NCT00973479|100578558|FG001|COMPLETED|Overall Study||326||
48102789|NCT00973479|100578557|FG000|NOT COMPLETED|Overall Study||37||
48102790|NCT00973479|100578558|FG001|NOT COMPLETED|Overall Study||69||
48102791|NCT03343483|100578559|FG000|STARTED|Overall Study||146||
48102792|NCT03343483|100578560|FG001|STARTED|Overall Study||145||
48102793|NCT03343483|100578559|FG000|COMPLETED|Overall Study||129||
48102794|NCT03343483|100578560|FG001|COMPLETED|Overall Study||112||
48102795|NCT03343483|100578559|FG000|NOT COMPLETED|Overall Study||17||
48102796|NCT03343483|100578560|FG001|NOT COMPLETED|Overall Study||33||
48102797|NCT04697693|100578561|FG000|STARTED|Overall Study||1||
48102798|NCT04697693|100578561|FG000|COMPLETED|Overall Study||1||
48102799|NCT04697693|100578561|FG000|NOT COMPLETED|Overall Study||0||
48102800|NCT00644969|100578562|FG000|STARTED|Treatment Phase||85||
48102801|NCT00644969|100578563|FG001|STARTED|Treatment Phase||43||
48102802|NCT00644969|100578562|FG000|COMPLETED|Treatment Phase||71||
48102803|NCT00644969|100578563|FG001|COMPLETED|Treatment Phase||40||
48102804|NCT00644969|100578562|FG000|NOT COMPLETED|Treatment Phase||14||
48102805|NCT00644969|100578563|FG001|NOT COMPLETED|Treatment Phase||3||
48102806|NCT00644969|100578562|FG000|STARTED|Post Treatment Phase||71||
48102807|NCT00644969|100578563|FG001|STARTED|Post Treatment Phase||40||
48549348|NCT00979199|101679583|FG000|COMPLETED|Overall Study||475||
48549349|NCT00979199|101679583|FG000|NOT COMPLETED|Overall Study||222||
48549350|NCT02729909|101679584|FG000|STARTED|Overall Study||105||
48549351|NCT02729909|101679585|FG001|STARTED|Overall Study||106||
48549352|NCT02729909|101679584|FG000|COMPLETED|Overall Study||104||
48102808|NCT00644969|100578562|FG000|COMPLETED|Post Treatment Phase||61||
48102809|NCT00644969|100578563|FG001|COMPLETED|Post Treatment Phase||37||
48102810|NCT00644969|100578562|FG000|NOT COMPLETED|Post Treatment Phase||10||
48102811|NCT00644969|100578563|FG001|NOT COMPLETED|Post Treatment Phase||3||
48102812|NCT00316199|100578564|FG000|STARTED|Overall Study||60||
48102813|NCT00316199|100578564|FG000|COMPLETED|Overall Study||48||
48102814|NCT00316199|100578564|FG000|NOT COMPLETED|Overall Study||12||
48102815|NCT01661712|100578565|FG000|STARTED|Overall Study||18|1st night, patients completed intervention/sham arm in randomised assigned order, cross-over design.|
48102816|NCT01661712|100578566|FG001|STARTED|Overall Study||18|1st night, patients completed intervention/sham arm in randomised assigned order, cross-over design.|
48102817|NCT01661712|100578565|FG000|Washout Period|Overall Study||18|Washout period of \>3 nights.|
48102818|NCT01661712|100578566|FG001|Washout Period|Overall Study||18|Washout period of \>3 nights.|
48102819|NCT01661712|100578565|FG000|COMPLETED|Overall Study||18|2nd night, patients completed intervention/sham arm in randomised assigned order, cross-over design.|
48102820|NCT01661712|100578566|FG001|COMPLETED|Overall Study||18|2nd night, patients completed intervention/sham arm in randomised assigned order, cross-over design.|
48102821|NCT01661712|100578565|FG000|NOT COMPLETED|Overall Study||0||
48102822|NCT01661712|100578566|FG001|NOT COMPLETED|Overall Study||0||
48102823|NCT01052207|100578567|FG000|STARTED|Overall Study||60||
48102824|NCT01052207|100578568|FG001|STARTED|Overall Study||42||
48102825|NCT01052207|100578567|FG000|COMPLETED|Overall Study||60||
48102826|NCT01052207|100578568|FG001|COMPLETED|Overall Study||42||
48102827|NCT01052207|100578567|FG000|NOT COMPLETED|Overall Study||0||
48102828|NCT01052207|100578568|FG001|NOT COMPLETED|Overall Study||0||
48102829|NCT01859494|100578569|FG000|STARTED|Overall Study||219||
48102830|NCT01859494|100578569|FG000|COMPLETED|Overall Study||218||
48102831|NCT01859494|100578569|FG000|NOT COMPLETED|Overall Study||1||
48102832|NCT04014075|100578570|FG000|STARTED|Overall Study||79||
48102833|NCT04014075|100578570|FG000|COMPLETED|Overall Study||10|Completed = Participants ongoing treatment as of 08 Nov 2021, Not Completed = Participants who discontinued treatment|
48102834|NCT04014075|100578570|FG000|NOT COMPLETED|Overall Study||69||
48102835|NCT00847288|100578571|FG000|STARTED|Overall Study||841||
48102836|NCT00847288|100578572|FG001|STARTED|Overall Study||827||
48102837|NCT00847288|100578571|FG000|COMPLETED|Overall Study||811||
48102838|NCT00847288|100578572|FG001|COMPLETED|Overall Study||780||
48102839|NCT00847288|100578571|FG000|NOT COMPLETED|Overall Study||30||
48102840|NCT00847288|100578572|FG001|NOT COMPLETED|Overall Study||47||
48102841|NCT00624806|100578573|FG000|STARTED|Overall Study||10||
48391445|NCT00764946|101287665|FG002|STARTED|Overall Study||22||
48391446|NCT00764946|101287663|FG000|TREATED|Overall Study||97||
48391447|NCT00764946|101287664|FG001|TREATED|Overall Study||88||
48391448|NCT00764946|101287665|FG002|TREATED|Overall Study||21||
48391449|NCT00764946|101287663|FG000|COMPLETED|Overall Study||85||
48102842|NCT00624806|100578574|FG001|STARTED|Overall Study||8||
48102843|NCT00624806|100578573|FG000|COMPLETED|Overall Study||10||
48102844|NCT00624806|100578574|FG001|COMPLETED|Overall Study||8||
48102845|NCT00624806|100578573|FG000|NOT COMPLETED|Overall Study||0||
48102846|NCT00624806|100578574|FG001|NOT COMPLETED|Overall Study||0||
48102847|NCT01335230|100578575|FG000|STARTED|Overall Study||10||
48102848|NCT01335230|100578576|FG001|STARTED|Overall Study||10||
48102849|NCT01335230|100578577|FG002|STARTED|Overall Study||10||
48102850|NCT01335230|100578578|FG003|STARTED|Overall Study||10||
48102851|NCT01335230|100578575|FG000|COMPLETED|Overall Study||10||
48102852|NCT01335230|100578576|FG001|COMPLETED|Overall Study||10||
48102853|NCT01335230|100578577|FG002|COMPLETED|Overall Study||10||
48102854|NCT01335230|100578578|FG003|COMPLETED|Overall Study||10||
48102855|NCT01335230|100578575|FG000|NOT COMPLETED|Overall Study||0||
48102856|NCT01335230|100578576|FG001|NOT COMPLETED|Overall Study||0||
48102857|NCT01335230|100578577|FG002|NOT COMPLETED|Overall Study||0||
48102858|NCT01335230|100578578|FG003|NOT COMPLETED|Overall Study||0||
48102859|NCT01625455|100578579|FG000|STARTED|Overall Study||2||
48102860|NCT01625455|100578580|FG001|STARTED|Overall Study||3||
48102861|NCT01625455|100578579|FG000|COMPLETED|Overall Study||2||
48102862|NCT01625455|100578580|FG001|COMPLETED|Overall Study||3||
48102863|NCT01625455|100578579|FG000|NOT COMPLETED|Overall Study||0||
48102864|NCT01625455|100578580|FG001|NOT COMPLETED|Overall Study||0||
48391450|NCT00764946|101287664|FG001|COMPLETED|Overall Study||72||
48391451|NCT00764946|101287665|FG002|COMPLETED|Overall Study||18||
48391452|NCT00764946|101287663|FG000|NOT COMPLETED|Overall Study||13||
48391453|NCT00764946|101287664|FG001|NOT COMPLETED|Overall Study||17||
48391454|NCT00764946|101287665|FG002|NOT COMPLETED|Overall Study||4||
48102865|NCT02808130|100578581|FG000|STARTED|Overall Study||15||
48102866|NCT02808130|100578582|FG001|STARTED|Overall Study||15||
48102867|NCT02808130|100578583|FG002|STARTED|Overall Study||15||
48102868|NCT02808130|100578584|FG003|STARTED|Overall Study||15||
48102869|NCT02808130|100578585|FG004|STARTED|Overall Study||15||
48102870|NCT02808130|100578586|FG005|STARTED|Overall Study||15||
48102871|NCT02808130|100578581|FG000|COMPLETED|Overall Study||15||
48102872|NCT02808130|100578582|FG001|COMPLETED|Overall Study||15||
48102873|NCT02808130|100578583|FG002|COMPLETED|Overall Study||15||
48102874|NCT02808130|100578584|FG003|COMPLETED|Overall Study||15||
48102875|NCT02808130|100578585|FG004|COMPLETED|Overall Study||15||
48102876|NCT02808130|100578586|FG005|COMPLETED|Overall Study||15||
48391455|NCT04209530|101287666|FG000|STARTED|Overall Study||4||
48102877|NCT02808130|100578581|FG000|NOT COMPLETED|Overall Study||0||
48102878|NCT02808130|100578582|FG001|NOT COMPLETED|Overall Study||0||
48102879|NCT02808130|100578583|FG002|NOT COMPLETED|Overall Study||0||
48102880|NCT02808130|100578584|FG003|NOT COMPLETED|Overall Study||0||
48102881|NCT02808130|100578585|FG004|NOT COMPLETED|Overall Study||0||
48102882|NCT02808130|100578586|FG005|NOT COMPLETED|Overall Study||0||
48102883|NCT01455012|100578587|FG000|STARTED|Overall Study||41||
48102884|NCT01455012|100578588|FG001|STARTED|Overall Study||40||
48102885|NCT01455012|100578587|FG000|COMPLETED|Overall Study||30||
48691572|NCT01061723|102028959|FG001|COMPLETED|Overall Study||43||
48691573|NCT01061723|102028960|FG002|COMPLETED|Overall Study||40||
48691574|NCT01061723|102028961|FG003|COMPLETED|Overall Study||44||
48691575|NCT01061723|102028962|FG004|COMPLETED|Overall Study||47||
48691576|NCT01061723|102028963|FG005|COMPLETED|Overall Study||41||
48691577|NCT01061723|102028958|FG000|NOT COMPLETED|Overall Study||4||
48102886|NCT01455012|100578588|FG001|COMPLETED|Overall Study||36||
48102887|NCT01455012|100578587|FG000|NOT COMPLETED|Overall Study||11||
48102888|NCT01455012|100578588|FG001|NOT COMPLETED|Overall Study||4||
48102889|NCT01817725|100578589|FG000|STARTED|Overall Study||20||
48102890|NCT01817725|100578589|FG000|COMPLETED|Overall Study||19||
48102891|NCT01817725|100578589|FG000|NOT COMPLETED|Overall Study||1||
48102892|NCT02290106|100578590|FG000|STARTED|Overall Study||25||
48102893|NCT02290106|100578591|FG001|STARTED|Overall Study||25||
48102894|NCT02290106|100578590|FG000|COMPLETED|Overall Study||24||
48102895|NCT02290106|100578591|FG001|COMPLETED|Overall Study||23||
48102896|NCT02290106|100578590|FG000|NOT COMPLETED|Overall Study||1||
48102897|NCT02290106|100578591|FG001|NOT COMPLETED|Overall Study||2||
48102898|NCT04309656|100578592|FG000|STARTED|Overall Study||24||
48102899|NCT04309656|100578593|FG001|STARTED|Overall Study||24||
48102900|NCT04309656|100578592|FG000|COMPLETED|Overall Study||24||
48102901|NCT04309656|100578593|FG001|COMPLETED|Overall Study||24||
48102902|NCT04309656|100578592|FG000|NOT COMPLETED|Overall Study||0||
48102903|NCT04309656|100578593|FG001|NOT COMPLETED|Overall Study||0||
48102904|NCT05129488|100578594|FG000|STARTED|Overall Study||33||66
48102905|NCT05129488|100578594|FG000|Contact Lenses With Solution|Overall Study||30||60
48102906|NCT05129488|100578594|FG000|Contact Lenses Without Solution|Overall Study||30||60
48102907|NCT05129488|100578594|FG000|COMPLETED|Overall Study||30||60
48102908|NCT05129488|100578594|FG000|NOT COMPLETED|Overall Study||3||6
48102909|NCT03131440|100578595|FG000|STARTED|Overall Study||8||
48102910|NCT03131440|100578596|FG001|STARTED|Overall Study||9||
48102911|NCT03131440|100578597|FG002|STARTED|Overall Study||8||
48102912|NCT03131440|100578598|FG003|STARTED|Overall Study||8||
48102913|NCT03131440|100578599|FG004|STARTED|Overall Study||9||
48102914|NCT03131440|100578600|FG005|STARTED|Overall Study||9||
48102915|NCT03131440|100578601|FG006|STARTED|Overall Study||9||
48102916|NCT03131440|100578602|FG007|STARTED|Overall Study||9||
48102917|NCT03131440|100578603|FG008|STARTED|Overall Study||9||
48102918|NCT03131440|100578604|FG009|STARTED|Overall Study||8||
48102919|NCT03131440|100578605|FG010|STARTED|Overall Study||8||
48102920|NCT03131440|100578606|FG011|STARTED|Overall Study||8||
48102921|NCT03131440|100578607|FG012|STARTED|Overall Study||8||
48102922|NCT03131440|100578608|FG013|STARTED|Overall Study||8||
48102923|NCT03131440|100578609|FG014|STARTED|Overall Study||8||
48102924|NCT03131440|100578610|FG015|STARTED|Overall Study||8||
48102925|NCT03131440|100578611|FG016|STARTED|Overall Study||8||
48102926|NCT03131440|100578612|FG017|STARTED|Overall Study||8||
48102927|NCT03131440|100578613|FG018|STARTED|Overall Study||8||
48102928|NCT03131440|100578614|FG019|STARTED|Overall Study||9||
48102929|NCT03131440|100578615|FG020|STARTED|Overall Study||8||
48102930|NCT03131440|100578616|FG021|STARTED|Overall Study||8||
48102931|NCT03131440|100578617|FG022|STARTED|Overall Study||9||
48102932|NCT03131440|100578618|FG023|STARTED|Overall Study||8||
48102933|NCT03131440|100578619|FG024|STARTED|Overall Study||9||
48102934|NCT03131440|100578620|FG025|STARTED|Overall Study||8||
48102935|NCT03131440|100578621|FG026|STARTED|Overall Study||9||
48102936|NCT03131440|100578622|FG027|STARTED|Overall Study||9||
48102937|NCT03131440|100578623|FG028|STARTED|Overall Study||8||
48102938|NCT03131440|100578624|FG029|STARTED|Overall Study||9||
48102939|NCT03131440|100578625|FG030|STARTED|Overall Study||9||
48102940|NCT03131440|100578626|FG031|STARTED|Overall Study||8||
48102941|NCT03131440|100578595|FG000|COMPLETED|Overall Study||7|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
48102942|NCT03131440|100578596|FG001|COMPLETED|Overall Study||6|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
48102943|NCT03131440|100578597|FG002|COMPLETED|Overall Study||8|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
48102944|NCT03131440|100578598|FG003|COMPLETED|Overall Study||8|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
48102945|NCT03131440|100578599|FG004|COMPLETED|Overall Study||8|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
48691578|NCT01061723|102028959|FG001|NOT COMPLETED|Overall Study||6||
48102946|NCT03131440|100578600|FG005|COMPLETED|Overall Study||8|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
48102947|NCT03131440|100578601|FG006|COMPLETED|Overall Study||9|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
48102948|NCT03131440|100578602|FG007|COMPLETED|Overall Study||8|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
48265073|NCT02034162|100970940|FG000|COMPLETED|Open-label||0||
48265074|NCT02034162|100970941|FG001|COMPLETED|Open-label||0||
48265075|NCT02034162|100970942|FG002|COMPLETED|Open-label||278||
48265076|NCT02034162|100970940|FG000|NOT COMPLETED|Open-label||0||
48265077|NCT02034162|100970941|FG001|NOT COMPLETED|Open-label||0||
48265078|NCT02034162|100970942|FG002|NOT COMPLETED|Open-label||0||
48265079|NCT00894504|100970943|FG000|STARTED|Overall Study||71||
48265080|NCT00894504|100970943|FG000|COMPLETED|Overall Study||0||
48265081|NCT00894504|100970943|FG000|NOT COMPLETED|Overall Study||71||
48265082|NCT00349466|100970944|FG000|STARTED|Overall Study||42||
48391456|NCT04209530|101287667|FG001|STARTED|Overall Study||3||
48391457|NCT04209530|101287666|FG000|COMPLETED|Overall Study||0||
48691579|NCT01061723|102028960|FG002|NOT COMPLETED|Overall Study||10||
48691580|NCT01061723|102028961|FG003|NOT COMPLETED|Overall Study||8||
48691581|NCT01061723|102028962|FG004|NOT COMPLETED|Overall Study||3||
48691582|NCT01061723|102028963|FG005|NOT COMPLETED|Overall Study||9||
48691583|NCT00932438|102028964|FG000|STARTED|Overall Study||40||
48102949|NCT03131440|100578603|FG008|COMPLETED|Overall Study||8|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
48102950|NCT03131440|100578604|FG009|COMPLETED|Overall Study||7|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
48102951|NCT03131440|100578605|FG010|COMPLETED|Overall Study||8|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
48102952|NCT03131440|100578606|FG011|COMPLETED|Overall Study||7|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
48102953|NCT03131440|100578607|FG012|COMPLETED|Overall Study||7|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
48102954|NCT03131440|100578608|FG013|COMPLETED|Overall Study||8|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
48102955|NCT03131440|100578609|FG014|COMPLETED|Overall Study||7|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
48102956|NCT03131440|100578610|FG015|COMPLETED|Overall Study||8|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
48102957|NCT03131440|100578611|FG016|COMPLETED|Overall Study||8|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
48102958|NCT03131440|100578612|FG017|COMPLETED|Overall Study||8|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
48102959|NCT03131440|100578613|FG018|COMPLETED|Overall Study||7|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
48102960|NCT03131440|100578614|FG019|COMPLETED|Overall Study||7|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
48102961|NCT03131440|100578615|FG020|COMPLETED|Overall Study||6|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
48102962|NCT03131440|100578616|FG021|COMPLETED|Overall Study||7|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
48102963|NCT03131440|100578617|FG022|COMPLETED|Overall Study||7|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
48102964|NCT03131440|100578618|FG023|COMPLETED|Overall Study||8|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
48102965|NCT03131440|100578619|FG024|COMPLETED|Overall Study||8|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
48102966|NCT03131440|100578620|FG025|COMPLETED|Overall Study||7|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
48102967|NCT03131440|100578621|FG026|COMPLETED|Overall Study||9|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
48102968|NCT03131440|100578622|FG027|COMPLETED|Overall Study||7|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
48102969|NCT03131440|100578623|FG028|COMPLETED|Overall Study||8|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
48102970|NCT03131440|100578624|FG029|COMPLETED|Overall Study||7|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
48102971|NCT03131440|100578625|FG030|COMPLETED|Overall Study||8|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
48102972|NCT03131440|100578626|FG031|COMPLETED|Overall Study||8|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
48102973|NCT03131440|100578595|FG000|NOT COMPLETED|Overall Study||1||
48102974|NCT03131440|100578596|FG001|NOT COMPLETED|Overall Study||3||
48102975|NCT03131440|100578597|FG002|NOT COMPLETED|Overall Study||0||
48102976|NCT03131440|100578598|FG003|NOT COMPLETED|Overall Study||0||
48265083|NCT00349466|100970945|FG001|STARTED|Overall Study||38||
48265084|NCT00349466|100970944|FG000|COMPLETED|Overall Study||33||
48265085|NCT00349466|100970945|FG001|COMPLETED|Overall Study||35||
48265086|NCT00349466|100970944|FG000|NOT COMPLETED|Overall Study||9||
48265087|NCT00349466|100970945|FG001|NOT COMPLETED|Overall Study||3||
48265088|NCT04463680|100970946|FG000|STARTED|Overall Study||24||
48265089|NCT04463680|100970946|FG000|COMPLETED|Overall Study||15||
48265090|NCT04463680|100970946|FG000|NOT COMPLETED|Overall Study||9||
48265091|NCT00133575|100970947|FG000|STARTED|Overall Study||10||
48265092|NCT00133575|100970948|FG001|STARTED|Overall Study||10||
48265093|NCT00133575|100970949|FG002|STARTED|Overall Study||10||
48265094|NCT00133575|100970950|FG003|STARTED|Overall Study||10||
48265095|NCT00133575|100970951|FG004|STARTED|Overall Study||10||
48265096|NCT00133575|100970952|FG005|STARTED|Overall Study||10||
48265097|NCT00133575|100970953|FG006|STARTED|Overall Study||12||
48265098|NCT00133575|100970947|FG000|COMPLETED|Overall Study||10||
48391458|NCT04209530|101287667|FG001|COMPLETED|Overall Study||0||
48391459|NCT04209530|101287666|FG000|NOT COMPLETED|Overall Study||4||
48691584|NCT00932438|102028965|FG001|STARTED|Overall Study||30||
48102977|NCT03131440|100578599|FG004|NOT COMPLETED|Overall Study||1||
48102978|NCT03131440|100578600|FG005|NOT COMPLETED|Overall Study||1||
48102979|NCT03131440|100578601|FG006|NOT COMPLETED|Overall Study||0||
48391460|NCT04209530|101287667|FG001|NOT COMPLETED|Overall Study||3||
48391461|NCT01337167|101287668|FG000|STARTED|Infant Series||986||
48391462|NCT01337167|101287669|FG001|STARTED|Infant Series||487||
48391463|NCT01337167|101287668|FG000|COMPLETED|Infant Series||924||
48391464|NCT01337167|101287669|FG001|COMPLETED|Infant Series||460||
48391465|NCT01337167|101287668|FG000|NOT COMPLETED|Infant Series||62||
48391466|NCT01337167|101287669|FG001|NOT COMPLETED|Infant Series||27||
48391467|NCT01337167|101287668|FG000|STARTED|Interim Period||924||
48102980|NCT03131440|100578602|FG007|NOT COMPLETED|Overall Study||1||
48391468|NCT01337167|101287669|FG001|STARTED|Interim Period||460||
48391469|NCT01337167|101287668|FG000|COMPLETED|Interim Period||843||
48391470|NCT01337167|101287669|FG001|COMPLETED|Interim Period||420||
48391471|NCT01337167|101287668|FG000|NOT COMPLETED|Interim Period||81||
48391472|NCT01337167|101287669|FG001|NOT COMPLETED|Interim Period||40||
48102981|NCT03131440|100578603|FG008|NOT COMPLETED|Overall Study||1||
48102982|NCT03131440|100578604|FG009|NOT COMPLETED|Overall Study||1||
48102983|NCT03131440|100578605|FG010|NOT COMPLETED|Overall Study||0||
48102984|NCT03131440|100578606|FG011|NOT COMPLETED|Overall Study||1||
48102985|NCT03131440|100578607|FG012|NOT COMPLETED|Overall Study||1||
48391473|NCT01337167|101287668|FG000|STARTED|Toddler Vaccinations||843||
48102986|NCT03131440|100578608|FG013|NOT COMPLETED|Overall Study||0||
48102987|NCT03131440|100578609|FG014|NOT COMPLETED|Overall Study||1||
48391474|NCT01337167|101287669|FG001|STARTED|Toddler Vaccinations||420||
48391475|NCT01337167|101287668|FG000|COMPLETED|Toddler Vaccinations||829||
48391476|NCT01337167|101287669|FG001|COMPLETED|Toddler Vaccinations||407||
48102988|NCT03131440|100578610|FG015|NOT COMPLETED|Overall Study||0||
48102989|NCT03131440|100578611|FG016|NOT COMPLETED|Overall Study||0||
48102990|NCT03131440|100578612|FG017|NOT COMPLETED|Overall Study||0||
48102991|NCT03131440|100578613|FG018|NOT COMPLETED|Overall Study||1||
48102992|NCT03131440|100578614|FG019|NOT COMPLETED|Overall Study||2||
48102993|NCT03131440|100578615|FG020|NOT COMPLETED|Overall Study||2||
48102994|NCT03131440|100578616|FG021|NOT COMPLETED|Overall Study||1||
48102995|NCT03131440|100578617|FG022|NOT COMPLETED|Overall Study||2||
48102996|NCT03131440|100578618|FG023|NOT COMPLETED|Overall Study||0||
48102997|NCT03131440|100578619|FG024|NOT COMPLETED|Overall Study||1||
48102998|NCT03131440|100578620|FG025|NOT COMPLETED|Overall Study||1||
48102999|NCT03131440|100578621|FG026|NOT COMPLETED|Overall Study||0||
48103000|NCT03131440|100578622|FG027|NOT COMPLETED|Overall Study||2||
48103001|NCT03131440|100578623|FG028|NOT COMPLETED|Overall Study||0||
48103002|NCT03131440|100578624|FG029|NOT COMPLETED|Overall Study||2||
48103003|NCT03131440|100578625|FG030|NOT COMPLETED|Overall Study||1||
48103004|NCT03131440|100578626|FG031|NOT COMPLETED|Overall Study||0||
48103005|NCT03342742|100578627|FG000|STARTED|Overall Study||15||
48103006|NCT03342742|100578628|FG001|STARTED|Overall Study||13||
48103007|NCT03342742|100578627|FG000|COMPLETED|Overall Study||13||
48103008|NCT03342742|100578628|FG001|COMPLETED|Overall Study||11||
48103009|NCT03342742|100578627|FG000|NOT COMPLETED|Overall Study||2||
48103010|NCT03342742|100578628|FG001|NOT COMPLETED|Overall Study||2||
48103011|NCT01957462|100578629|FG000|STARTED|Test Period 1||16||
48103012|NCT01957462|100578630|FG001|STARTED|Test Period 1||15||
48103013|NCT01957462|100578629|FG000|COMPLETED|Test Period 1||14||
48103014|NCT01957462|100578630|FG001|COMPLETED|Test Period 1||15||
48103015|NCT01957462|100578629|FG000|NOT COMPLETED|Test Period 1||2||
48103016|NCT01957462|100578630|FG001|NOT COMPLETED|Test Period 1||0||
48103017|NCT01957462|100578629|FG000|STARTED|Test Period 2||14||
48103018|NCT01957462|100578630|FG001|STARTED|Test Period 2||15||
48103019|NCT01957462|100578629|FG000|COMPLETED|Test Period 2||14||
48103020|NCT01957462|100578630|FG001|COMPLETED|Test Period 2||15||
48103021|NCT01957462|100578629|FG000|NOT COMPLETED|Test Period 2||0||
48103022|NCT01957462|100578630|FG001|NOT COMPLETED|Test Period 2||0||
48103023|NCT00265343|100578631|FG000|STARTED|Overall Study||134||
48103024|NCT00265343|100578632|FG001|STARTED|Overall Study||172||
48103025|NCT00265343|100578631|FG000|COMPLETED|Overall Study||113||
48103026|NCT00265343|100578632|FG001|COMPLETED|Overall Study||153||
48103027|NCT00265343|100578631|FG000|NOT COMPLETED|Overall Study||21||
48103028|NCT00265343|100578632|FG001|NOT COMPLETED|Overall Study||19||
48103029|NCT04552587|100578633|FG000|STARTED|Overall Study||50||
48103030|NCT04552587|100578633|FG000|Patients|Overall Study||23||
48103031|NCT04552587|100578633|FG000|Caregivers|Overall Study||23||
48103032|NCT04552587|100578633|FG000|COMPLETED|Overall Study||46||
48103033|NCT04552587|100578633|FG000|NOT COMPLETED|Overall Study||4||
48103034|NCT00698581|100578634|FG000|STARTED|Overall Study||68||
48103035|NCT00698581|100578635|FG001|STARTED|Overall Study||20||
48103036|NCT00698581|100578634|FG000|COMPLETED|Overall Study||23||
48103037|NCT00698581|100578635|FG001|COMPLETED|Overall Study||8||
48103038|NCT00698581|100578634|FG000|NOT COMPLETED|Overall Study||45||
48103039|NCT00698581|100578635|FG001|NOT COMPLETED|Overall Study||12||
48103040|NCT01425879|100578636|FG000|STARTED|Overall Study||8||
48103041|NCT01425879|100578636|FG000|COMPLETED|Overall Study||8||
48103042|NCT01425879|100578636|FG000|NOT COMPLETED|Overall Study||0||
48103043|NCT02295995|100578637|FG000|STARTED|Overall Study||36||
48103044|NCT02295995|100578638|FG001|STARTED|Overall Study||18||
48103045|NCT02295995|100578637|FG000|COMPLETED|Overall Study||31||
48103046|NCT02295995|100578638|FG001|COMPLETED|Overall Study||17||
48103047|NCT02295995|100578637|FG000|NOT COMPLETED|Overall Study||5||
48103048|NCT02295995|100578638|FG001|NOT COMPLETED|Overall Study||1||
48103049|NCT04646499|100578639|FG000|STARTED|Overall Study||14||
48103050|NCT04646499|100578639|FG000|COMPLETED|Overall Study||13||
48103051|NCT04646499|100578639|FG000|NOT COMPLETED|Overall Study||1||
48103052|NCT03265249|100578640|FG000|STARTED|Overall Study||12||
48103053|NCT03265249|100578641|FG001|STARTED|Overall Study||15||
48103054|NCT03265249|100578640|FG000|COMPLETED|Overall Study||12||
48103055|NCT03265249|100578641|FG001|COMPLETED|Overall Study||14||
48103056|NCT03265249|100578640|FG000|NOT COMPLETED|Overall Study||0||
48103057|NCT03265249|100578641|FG001|NOT COMPLETED|Overall Study||1||
48103058|NCT04098107|100578642|FG000|STARTED|Overall Study||10||
48103059|NCT04098107|100578642|FG000|COMPLETED|Overall Study||10||
48103060|NCT04098107|100578642|FG000|NOT COMPLETED|Overall Study||0||
48103061|NCT02053753|100578643|FG000|STARTED|Overall Study||72||
48103062|NCT02053753|100578644|FG001|STARTED|Overall Study||74||
48103063|NCT02053753|100578643|FG000|Received Treatment|Overall Study||71||
48103064|NCT02053753|100578644|FG001|Received Treatment|Overall Study||71||
48103065|NCT02053753|100578643|FG000|COMPLETED|Overall Study||65||
48103066|NCT02053753|100578644|FG001|COMPLETED|Overall Study||66||
48103067|NCT02053753|100578643|FG000|NOT COMPLETED|Overall Study||7||
48103068|NCT02053753|100578644|FG001|NOT COMPLETED|Overall Study||8||
48103069|NCT03054857|100578645|FG000|STARTED|Overall Study||50||
48103070|NCT03054857|100578646|FG001|STARTED|Overall Study||50||
48103071|NCT03054857|100578645|FG000|COMPLETED|Overall Study||49||
48103072|NCT03054857|100578646|FG001|COMPLETED|Overall Study||50||
48103073|NCT03054857|100578645|FG000|NOT COMPLETED|Overall Study||1||
48103074|NCT03054857|100578646|FG001|NOT COMPLETED|Overall Study||0||
48103075|NCT01526889|100578647|FG000|STARTED|Treatment Period||18||
48103076|NCT01526889|100578648|FG001|STARTED|Treatment Period||7||
48103077|NCT01526889|100578647|FG000|COMPLETED|Treatment Period||16||
48103078|NCT01526889|100578648|FG001|COMPLETED|Treatment Period||7||
48103079|NCT01526889|100578647|FG000|NOT COMPLETED|Treatment Period||2||
48103080|NCT01526889|100578648|FG001|NOT COMPLETED|Treatment Period||0||
48103081|NCT01526889|100578647|FG000|STARTED|Treatment Extension Period||5||
48103082|NCT01526889|100578648|FG001|STARTED|Treatment Extension Period||0||
48103083|NCT01526889|100578647|FG000|COMPLETED|Treatment Extension Period||4||
48691585|NCT00932438|102028964|FG000|COMPLETED|Overall Study||39||
48103084|NCT01526889|100578648|FG001|COMPLETED|Treatment Extension Period||0||
48103085|NCT01526889|100578647|FG000|NOT COMPLETED|Treatment Extension Period||1||
48265099|NCT00133575|100970948|FG001|COMPLETED|Overall Study||10||
48265100|NCT00133575|100970949|FG002|COMPLETED|Overall Study||8||
48265101|NCT00133575|100970950|FG003|COMPLETED|Overall Study||9||
48265102|NCT00133575|100970951|FG004|COMPLETED|Overall Study||6||
48265103|NCT00133575|100970952|FG005|COMPLETED|Overall Study||9||
48265104|NCT00133575|100970953|FG006|COMPLETED|Overall Study||9||
48265105|NCT00133575|100970947|FG000|NOT COMPLETED|Overall Study||0||
48265106|NCT00133575|100970948|FG001|NOT COMPLETED|Overall Study||0||
48265107|NCT00133575|100970949|FG002|NOT COMPLETED|Overall Study||2||
48265108|NCT00133575|100970950|FG003|NOT COMPLETED|Overall Study||1||
48265109|NCT00133575|100970951|FG004|NOT COMPLETED|Overall Study||4||
48265110|NCT00133575|100970952|FG005|NOT COMPLETED|Overall Study||1||
48265111|NCT00133575|100970953|FG006|NOT COMPLETED|Overall Study||3||
48265112|NCT00383123|100970954|FG000|STARTED|Overall Study||2115||
48265113|NCT00383123|100970955|FG001|STARTED|Overall Study||1210||
48265114|NCT00383123|100970954|FG000|COMPLETED|Overall Study||2004||
48265115|NCT00383123|100970955|FG001|COMPLETED|Overall Study||1124||
48265116|NCT00383123|100970954|FG000|NOT COMPLETED|Overall Study||111||
48691586|NCT00932438|102028965|FG001|COMPLETED|Overall Study||30||
48691587|NCT00932438|102028964|FG000|NOT COMPLETED|Overall Study||1||
48691588|NCT00932438|102028965|FG001|NOT COMPLETED|Overall Study||0||
48691589|NCT02010593|102028966|FG000|STARTED|Overall Study||72||
48691590|NCT02010593|102028967|FG001|STARTED|Overall Study||24||
48691591|NCT02010593|102028966|FG000|COMPLETED|Overall Study||70||
48691592|NCT02010593|102028967|FG001|COMPLETED|Overall Study||22||
48103086|NCT01526889|100578648|FG001|NOT COMPLETED|Treatment Extension Period||0||
48103087|NCT00371254|100578649|FG000|STARTED|Overall Study||23||
48103088|NCT00371254|100578650|FG001|STARTED|Overall Study||21||
48103089|NCT00371254|100578649|FG000|COMPLETED|Overall Study||0||
48103090|NCT00371254|100578650|FG001|COMPLETED|Overall Study||0||
48103091|NCT00371254|100578649|FG000|NOT COMPLETED|Overall Study||23||
48103092|NCT00371254|100578650|FG001|NOT COMPLETED|Overall Study||21||
48103093|NCT04254978|100578651|FG000|STARTED|Initial Treatment Period (ITP)||73||
48103094|NCT04254978|100578651|FG000|COMPLETED|Initial Treatment Period (ITP)||64||
48265117|NCT00383123|100970955|FG001|NOT COMPLETED|Overall Study||86||
48265118|NCT01131104|100970956|FG000|STARTED|Overall Study||345||
48265119|NCT01131104|100970956|FG000|Study Set|Overall Study||344||
48265120|NCT01131104|100970956|FG000|Adjudication-Confirmed NAION Set|Overall Study||279||
48265121|NCT01131104|100970956|FG000|30-Day Analysis Set|Overall Study||24|Participants had adjudication-confirmed NAION and complete PDE5 inhibitor information.|
48265122|NCT01131104|100970956|FG000|42-Day Analysis Set|Overall Study||28|Participants had adjudication-confirmed NAION and complete PDE5 inhibitor information.|
48265123|NCT01131104|100970956|FG000|12-Month Analysis Set|Overall Study||26|Participants had adjudication-confirmed NAION and complete PDE5 inhibitor information.|
48265124|NCT01131104|100970956|FG000|COMPLETED|Overall Study||332||
48265125|NCT01131104|100970956|FG000|NOT COMPLETED|Overall Study||13||
48265126|NCT01151215|100970957|FG000|STARTED|Overall Study||120||
48265127|NCT01151215|100970958|FG001|STARTED|Overall Study||118||
48265128|NCT01151215|100970959|FG002|STARTED|Overall Study||121||
48265129|NCT01151215|100970957|FG000|COMPLETED|Overall Study||100||
48265130|NCT01151215|100970958|FG001|COMPLETED|Overall Study||95||
48265131|NCT01151215|100970959|FG002|COMPLETED|Overall Study||102||
48265132|NCT01151215|100970957|FG000|NOT COMPLETED|Overall Study||20||
48265133|NCT01151215|100970958|FG001|NOT COMPLETED|Overall Study||23||
48265134|NCT01151215|100970959|FG002|NOT COMPLETED|Overall Study||19||
48265135|NCT01436305|100970960|FG000|STARTED|Overall Study||6||
48265136|NCT01436305|100970961|FG001|STARTED|Overall Study||6||
48265137|NCT01436305|100970962|FG002|STARTED|Overall Study||7||
48265138|NCT01436305|100970960|FG000|COMPLETED|Overall Study||4||
48265139|NCT01436305|100970961|FG001|COMPLETED|Overall Study||2||
48265140|NCT01436305|100970962|FG002|COMPLETED|Overall Study||7||
48265141|NCT01436305|100970960|FG000|NOT COMPLETED|Overall Study||2||
48265142|NCT01436305|100970961|FG001|NOT COMPLETED|Overall Study||4||
48265143|NCT01436305|100970962|FG002|NOT COMPLETED|Overall Study||0||
48691593|NCT02010593|102028966|FG000|NOT COMPLETED|Overall Study||2||
48691594|NCT02010593|102028967|FG001|NOT COMPLETED|Overall Study||2||
48103095|NCT04254978|100578651|FG000|NOT COMPLETED|Initial Treatment Period (ITP)||9||
48103096|NCT04254978|100578651|FG000|STARTED|Additional Treatment Period (ATP)||63||
48103097|NCT04254978|100578651|FG000|COMPLETED|Additional Treatment Period (ATP)||52||
48265144|NCT00305344|100970963|FG000|STARTED|Overall Study||23||
48265145|NCT00305344|100970963|FG000|COMPLETED|Overall Study||23||
48265146|NCT00305344|100970963|FG000|NOT COMPLETED|Overall Study||0||
48265147|NCT02332902|100970964|FG000|STARTED|Overall Study||24||
48265148|NCT02332902|100970964|FG000|Received Study Drug|Overall Study||22||
48265149|NCT02332902|100970964|FG000|COMPLETED|Overall Study||17||
48265150|NCT02332902|100970964|FG000|NOT COMPLETED|Overall Study||7||
48265151|NCT01882764|100970965|FG000|STARTED|Overall Study||47||
48265152|NCT01882764|100970966|FG001|STARTED|Overall Study||19||
48265153|NCT01882764|100970965|FG000|COMPLETED|Overall Study||0||
48265154|NCT01882764|100970966|FG001|COMPLETED|Overall Study||1||
48265155|NCT01882764|100970965|FG000|NOT COMPLETED|Overall Study||47||
48265156|NCT01882764|100970966|FG001|NOT COMPLETED|Overall Study||18||
48265157|NCT00547534|100970967|FG000|STARTED|Overall Study||30||
48265158|NCT00547534|100970967|FG000|COMPLETED|Overall Study||19||
48265159|NCT00547534|100970967|FG000|NOT COMPLETED|Overall Study||11||
48391477|NCT01337167|101287668|FG000|NOT COMPLETED|Toddler Vaccinations||14||
48391478|NCT01337167|101287669|FG001|NOT COMPLETED|Toddler Vaccinations||13||
48391479|NCT00290589|101287670|FG000|STARTED|Overall Study||39||
48391480|NCT00290589|101287671|FG001|STARTED|Overall Study||43||
48391481|NCT00290589|101287670|FG000|COMPLETED|Overall Study||37||
48391482|NCT00290589|101287671|FG001|COMPLETED|Overall Study||41||
48391483|NCT00290589|101287670|FG000|NOT COMPLETED|Overall Study||2||
48265160|NCT02688530|100970968|FG000|STARTED|Overall Study||35||
48391484|NCT00290589|101287671|FG001|NOT COMPLETED|Overall Study||2||
48391485|NCT03457103|101287672|FG000|STARTED|Overall Study||22||
48391486|NCT03457103|101287673|FG001|STARTED|Overall Study||9||
48391487|NCT03457103|101287672|FG000|COMPLETED|Overall Study||14||
48391488|NCT03457103|101287673|FG001|COMPLETED|Overall Study||3||
48391489|NCT03457103|101287672|FG000|NOT COMPLETED|Overall Study||8||
48391490|NCT03457103|101287673|FG001|NOT COMPLETED|Overall Study||6||
48391491|NCT00400712|101287674|FG000|STARTED|Overall Study||52||
48391492|NCT00400712|101287675|FG001|STARTED|Overall Study||51||
48391493|NCT00400712|101287674|FG000|COMPLETED|Overall Study||35||
48391494|NCT00400712|101287675|FG001|COMPLETED|Overall Study||35||
48391495|NCT00400712|101287674|FG000|NOT COMPLETED|Overall Study||17||
48391496|NCT00400712|101287675|FG001|NOT COMPLETED|Overall Study||16||
48391497|NCT05202223|101287676|FG000|STARTED|Overall Study||80||
48391498|NCT05202223|101287676|FG000|COMPLETED|Overall Study||52||
48391499|NCT05202223|101287676|FG000|NOT COMPLETED|Overall Study||28||
48391500|NCT00045487|101287677|FG000|STARTED|Overall Study||41||
48391501|NCT00045487|101287677|FG000|COMPLETED|Overall Study||30||
48391502|NCT00045487|101287677|FG000|NOT COMPLETED|Overall Study||11||
48391503|NCT02604810|101287678|FG000|STARTED|IGIV-C 10%, 4-5 Weeks||52||
48391504|NCT02604810|101287678|FG000|COMPLETED|IGIV-C 10%, 4-5 Weeks||49||
48391505|NCT02604810|101287678|FG000|NOT COMPLETED|IGIV-C 10%, 4-5 Weeks||3||
48391506|NCT02604810|101287678|FG000|STARTED|IGSC 20%, 24 Weeks||49||
48391507|NCT02604810|101287678|FG000|COMPLETED|IGSC 20%, 24 Weeks||42||
48391508|NCT02604810|101287678|FG000|NOT COMPLETED|IGSC 20%, 24 Weeks||7||
48391509|NCT03172481|101287679|FG000|STARTED|Open-label||156||
48391510|NCT03172481|101287680|FG001|STARTED|Open-label||0||
48391511|NCT03172481|101287679|FG000|COMPLETED|Open-label||148||
48391512|NCT03172481|101287680|FG001|COMPLETED|Open-label||0||
48391513|NCT03172481|101287679|FG000|NOT COMPLETED|Open-label||8||
48391514|NCT03172481|101287680|FG001|NOT COMPLETED|Open-label||0||
48391515|NCT03172481|101287679|FG000|STARTED|Double-blind||75|From 148 subjects who completed the Open-label period, 75 randomly received PRC-063|
48391516|NCT03172481|101287680|FG001|STARTED|Double-blind||73|From 148 subjects who completed the Open-label period, 75 randomly received PRC-063|
48391517|NCT03172481|101287679|FG000|COMPLETED|Double-blind||74||
48391518|NCT03172481|101287680|FG001|COMPLETED|Double-blind||73||
48391519|NCT03172481|101287679|FG000|NOT COMPLETED|Double-blind||1||
48391520|NCT03172481|101287680|FG001|NOT COMPLETED|Double-blind||0||
48391521|NCT01754207|101287681|FG000|STARTED|Overall Study||20||
48391522|NCT01754207|101287681|FG000|COMPLETED|Overall Study||17||
48391523|NCT01754207|101287681|FG000|NOT COMPLETED|Overall Study||3||
48391524|NCT02690207|101287682|FG000|STARTED|Overall Study||8687||
48391525|NCT02690207|101287682|FG000|COMPLETED|Overall Study||8434||
48265161|NCT02688530|100970969|FG001|STARTED|Overall Study||35||
48265162|NCT02688530|100970970|FG002|STARTED|Overall Study||35||
48265163|NCT02688530|100970971|FG003|STARTED|Overall Study||35||
48265164|NCT02688530|100970968|FG000|COMPLETED|Overall Study||35||
48391526|NCT02690207|101287682|FG000|NOT COMPLETED|Overall Study||253||
48391527|NCT00781963|101287683|FG000|STARTED|Overall Study||106||
48391528|NCT00781963|101287684|FG001|STARTED|Overall Study||53||
48265165|NCT02688530|100970969|FG001|COMPLETED|Overall Study||34||
48265166|NCT02688530|100970970|FG002|COMPLETED|Overall Study||33||
48265167|NCT02688530|100970971|FG003|COMPLETED|Overall Study||35||
48265168|NCT02688530|100970968|FG000|NOT COMPLETED|Overall Study||0||
48265169|NCT02688530|100970969|FG001|NOT COMPLETED|Overall Study||1||
48391529|NCT00781963|101287683|FG000|COMPLETED|Overall Study||89||
48391530|NCT00781963|101287684|FG001|COMPLETED|Overall Study||51||
48391531|NCT00781963|101287683|FG000|NOT COMPLETED|Overall Study||17||
48391532|NCT00781963|101287684|FG001|NOT COMPLETED|Overall Study||2||
48391533|NCT00085917|101287685|FG000|STARTED|Overall Study||15||
48391534|NCT00085917|101287686|FG001|STARTED|Overall Study||14||
48265170|NCT02688530|100970970|FG002|NOT COMPLETED|Overall Study||2||
48265171|NCT02688530|100970971|FG003|NOT COMPLETED|Overall Study||0||
48265172|NCT04936685|100970972|FG000|STARTED|Overall Study||93||
48265173|NCT04936685|100970973|FG001|STARTED|Overall Study||116||
48265174|NCT04936685|100970972|FG000|COMPLETED|Overall Study||92||
48265175|NCT04936685|100970973|FG001|COMPLETED|Overall Study||116||
48265176|NCT04936685|100970972|FG000|NOT COMPLETED|Overall Study||1||
48265177|NCT04936685|100970973|FG001|NOT COMPLETED|Overall Study||0||
48549353|NCT02729909|101679585|FG001|COMPLETED|Overall Study||101||
48549354|NCT02729909|101679584|FG000|NOT COMPLETED|Overall Study||1||
48549355|NCT02729909|101679585|FG001|NOT COMPLETED|Overall Study||5||
48549356|NCT01427608|101679586|FG000|STARTED|Overall Study||64||
48549357|NCT01427608|101679587|FG001|STARTED|Overall Study||62||
48549358|NCT01427608|101679586|FG000|COMPLETED|Overall Study||43||
48549359|NCT01427608|101679587|FG001|COMPLETED|Overall Study||24||
48549360|NCT01427608|101679586|FG000|NOT COMPLETED|Overall Study||21||
48549361|NCT01427608|101679587|FG001|NOT COMPLETED|Overall Study||38||
48549362|NCT00852202|101679588|FG000|STARTED|Overall Study||77||
48549363|NCT00852202|101679589|FG001|STARTED|Overall Study||75||
48549364|NCT00852202|101679590|FG002|STARTED|Overall Study||75||
48549365|NCT00852202|101679588|FG000|COMPLETED|Overall Study||60||
48549366|NCT00852202|101679589|FG001|COMPLETED|Overall Study||63||
48549367|NCT00852202|101679590|FG002|COMPLETED|Overall Study||49||
48549368|NCT00852202|101679588|FG000|NOT COMPLETED|Overall Study||17||
48549369|NCT00852202|101679589|FG001|NOT COMPLETED|Overall Study||12||
48549370|NCT00852202|101679590|FG002|NOT COMPLETED|Overall Study||26||
48549371|NCT02201784|101679591|FG000|STARTED|Overall Study||30||
48549372|NCT02201784|101679592|FG001|STARTED|Overall Study||30||
48549373|NCT02201784|101679591|FG000|COMPLETED|Overall Study||28||
48549374|NCT02201784|101679592|FG001|COMPLETED|Overall Study||30||
48549375|NCT02201784|101679591|FG000|NOT COMPLETED|Overall Study||2||
48691595|NCT04560816|102028968|FG000|STARTED|Overall Study||11||
48691596|NCT04560816|102028969|FG001|STARTED|Overall Study||10||
48691597|NCT04560816|102028970|FG002|STARTED|Overall Study||8||
48691598|NCT04560816|102028971|FG003|STARTED|Overall Study||9||
48691599|NCT04560816|102028972|FG004|STARTED|Overall Study||11||
48691600|NCT04560816|102028973|FG005|STARTED|Overall Study||8||
48691601|NCT04560816|102028968|FG000|COMPLETED|Overall Study||8||
48691602|NCT04560816|102028969|FG001|COMPLETED|Overall Study||9||
48691603|NCT04560816|102028970|FG002|COMPLETED|Overall Study||7||
48691604|NCT04560816|102028971|FG003|COMPLETED|Overall Study||9||
48691605|NCT04560816|102028972|FG004|COMPLETED|Overall Study||8||
48691606|NCT04560816|102028973|FG005|COMPLETED|Overall Study||8||
48691607|NCT04560816|102028968|FG000|NOT COMPLETED|Overall Study||3||
48691608|NCT04560816|102028969|FG001|NOT COMPLETED|Overall Study||1||
48691609|NCT04560816|102028970|FG002|NOT COMPLETED|Overall Study||1||
48691610|NCT04560816|102028971|FG003|NOT COMPLETED|Overall Study||0||
48691611|NCT04560816|102028972|FG004|NOT COMPLETED|Overall Study||3||
48691612|NCT04560816|102028973|FG005|NOT COMPLETED|Overall Study||0||
48691613|NCT02565147|102028974|FG000|STARTED|Overall Study||38||
48691614|NCT02565147|102028975|FG001|STARTED|Overall Study||40||
48691615|NCT02565147|102028974|FG000|Received Study Drug|Overall Study||38|Safety Population included all enrolled participants who received either bivalirudin or UFH.|
48691616|NCT02565147|102028975|FG001|Received Study Drug|Overall Study||40|Safety Population included all enrolled participants who received either bivalirudin or UFH.|
48691617|NCT02565147|102028974|FG000|Per-Protocol Population|Overall Study||28|Enrolled participants who underwent successful PPCI and Day-5 CMR without major protocol deviations.|
48691618|NCT02565147|102028975|FG001|Per-Protocol Population|Overall Study||36|Enrolled participants who underwent successful PPCI and Day-5 CMR without major protocol deviations.|
48691619|NCT02565147|102028974|FG000|COMPLETED|Overall Study||32||
48691620|NCT02565147|102028975|FG001|COMPLETED|Overall Study||37||
48265178|NCT01744704|100970974|FG000|STARTED|Overall Study||3||
48265179|NCT01744704|100970975|FG001|STARTED|Overall Study||3||
48549376|NCT02201784|101679592|FG001|NOT COMPLETED|Overall Study||0||
48549377|NCT02237092|101679593|FG000|STARTED|Overall Study||196||
48549378|NCT02237092|101679593|FG000|COMPLETED|Overall Study||196||
48549379|NCT02237092|101679593|FG000|NOT COMPLETED|Overall Study||0||
48549380|NCT01557517|101679594|FG000|STARTED|Overall Study||19||
48549381|NCT01557517|101679595|FG001|STARTED|Overall Study||21||
48549382|NCT01557517|101679594|FG000|COMPLETED|Overall Study||17||
48691621|NCT02565147|102028974|FG000|NOT COMPLETED|Overall Study||6||
48265180|NCT01744704|100970976|FG002|STARTED|Overall Study||3||
48265181|NCT01744704|100970977|FG003|STARTED|Overall Study||6||
48549383|NCT01557517|101679595|FG001|COMPLETED|Overall Study||17||
48549384|NCT01557517|101679594|FG000|NOT COMPLETED|Overall Study||2||
48265182|NCT01744704|100970978|FG004|STARTED|Overall Study||6||
48549385|NCT01557517|101679595|FG001|NOT COMPLETED|Overall Study||4||
48691622|NCT02565147|102028975|FG001|NOT COMPLETED|Overall Study||3||
48691623|NCT00935493|102028976|FG000|STARTED|Overall Study||41||
48691624|NCT00935493|102028977|FG001|STARTED|Overall Study||41||
48691625|NCT00935493|102028978|FG002|STARTED|Overall Study||41||
48691626|NCT00935493|102028976|FG000|COMPLETED|Overall Study||40||
48691627|NCT00935493|102028977|FG001|COMPLETED|Overall Study||39||
48691628|NCT00935493|102028978|FG002|COMPLETED|Overall Study||40||
48691629|NCT00935493|102028976|FG000|NOT COMPLETED|Overall Study||1||
48691630|NCT00935493|102028977|FG001|NOT COMPLETED|Overall Study||2||
48691631|NCT00935493|102028978|FG002|NOT COMPLETED|Overall Study||1||
48691632|NCT00269113|102028979|FG000|STARTED|Overall Study||177||
48691633|NCT00269113|102028980|FG001|STARTED|Overall Study||183||
48691634|NCT00269113|102028979|FG000|COMPLETED|Overall Study||103||
48691635|NCT00269113|102028980|FG001|COMPLETED|Overall Study||146||
48691636|NCT00269113|102028979|FG000|NOT COMPLETED|Overall Study||74||
48691637|NCT00269113|102028980|FG001|NOT COMPLETED|Overall Study||37||
48103098|NCT04254978|100578651|FG000|NOT COMPLETED|Additional Treatment Period (ATP)||11||
48103099|NCT03035955|100578652|FG000|STARTED|Overall Study||10||
48691638|NCT00694577|102028981|FG000|STARTED|Overall Study||99||
48691639|NCT00694577|102028982|FG001|STARTED|Overall Study||101||
48691640|NCT00694577|102028983|FG002|STARTED|Overall Study||124||
48691641|NCT00694577|102028981|FG000|COMPLETED|Overall Study||98||
48103100|NCT03035955|100578653|FG001|STARTED|Overall Study||10||
48103101|NCT03035955|100578652|FG000|COMPLETED|Overall Study||9||
48103102|NCT03035955|100578653|FG001|COMPLETED|Overall Study||9||
48103103|NCT03035955|100578652|FG000|NOT COMPLETED|Overall Study||1||
48103104|NCT03035955|100578653|FG001|NOT COMPLETED|Overall Study||1||
48265183|NCT01744704|100970979|FG005|STARTED|Overall Study||7||
48265184|NCT01744704|100970980|FG006|STARTED|Overall Study||6||
48265185|NCT01744704|100970981|FG007|STARTED|Overall Study||9||
48265186|NCT01744704|100970982|FG008|STARTED|Overall Study||3||
48391535|NCT00085917|101287685|FG000|COMPLETED|Overall Study||11||
48391536|NCT00085917|101287686|FG001|COMPLETED|Overall Study||11||
48391537|NCT00085917|101287685|FG000|NOT COMPLETED|Overall Study||4||
48391538|NCT00085917|101287686|FG001|NOT COMPLETED|Overall Study||3||
48691642|NCT00694577|102028982|FG001|COMPLETED|Overall Study||101||
48691643|NCT00694577|102028983|FG002|COMPLETED|Overall Study||124||
48691644|NCT00694577|102028981|FG000|NOT COMPLETED|Overall Study||1||
48691645|NCT00694577|102028982|FG001|NOT COMPLETED|Overall Study||0||
48691646|NCT00694577|102028983|FG002|NOT COMPLETED|Overall Study||0||
48691647|NCT03035864|102028984|FG000|STARTED|Treatment Period||120||
48691648|NCT03035864|102028985|FG001|STARTED|Treatment Period||60||
48103105|NCT05876273|100578654|FG000|STARTED|Overall Study||8||
48265187|NCT01744704|100970983|FG009|STARTED|Overall Study||9||
48265188|NCT01744704|100970984|FG010|STARTED|Overall Study||9||
48265189|NCT01744704|100970985|FG011|STARTED|Overall Study||10||
48265190|NCT01744704|100970974|FG000|COMPLETED|Overall Study||3||
48265191|NCT01744704|100970975|FG001|COMPLETED|Overall Study||3||
48391539|NCT00798577|101287687|FG000|STARTED|Overall Study||17||
48391540|NCT00798577|101287688|FG001|STARTED|Overall Study||7||
48391541|NCT00798577|101287687|FG000|COMPLETED|Overall Study||17||
48391542|NCT00798577|101287688|FG001|COMPLETED|Overall Study||7||
48391543|NCT00798577|101287687|FG000|NOT COMPLETED|Overall Study||0||
48391544|NCT00798577|101287688|FG001|NOT COMPLETED|Overall Study||0||
48391545|NCT02427750|101287689|FG000|STARTED|Overall Study||63||
48391546|NCT02427750|101287690|FG001|STARTED|Overall Study||63||
48391547|NCT02427750|101287689|FG000|COMPLETED|Overall Study||63||
48391548|NCT02427750|101287690|FG001|COMPLETED|Overall Study||63||
48391549|NCT02427750|101287689|FG000|NOT COMPLETED|Overall Study||0||
48103106|NCT05876273|100578655|FG001|STARTED|Overall Study||7||
48103107|NCT05876273|100578654|FG000|COMPLETED|Overall Study||8||
48103108|NCT05876273|100578655|FG001|COMPLETED|Overall Study||7||
48265192|NCT01744704|100970976|FG002|COMPLETED|Overall Study||3||
48265193|NCT01744704|100970977|FG003|COMPLETED|Overall Study||6||
48265194|NCT01744704|100970978|FG004|COMPLETED|Overall Study||6||
48265195|NCT01744704|100970979|FG005|COMPLETED|Overall Study||7||
48265196|NCT01744704|100970980|FG006|COMPLETED|Overall Study||6||
48265197|NCT01744704|100970981|FG007|COMPLETED|Overall Study||9||
48691649|NCT03035864|102028984|FG000|COMPLETED|Treatment Period||116||
48691650|NCT03035864|102028985|FG001|COMPLETED|Treatment Period||59||
48691651|NCT03035864|102028984|FG000|NOT COMPLETED|Treatment Period||4||
48691652|NCT03035864|102028985|FG001|NOT COMPLETED|Treatment Period||1||
48691653|NCT03035864|102028984|FG000|STARTED|Follow-up Period||116||
48691654|NCT03035864|102028985|FG001|STARTED|Follow-up Period||59||
48691655|NCT03035864|102028984|FG000|COMPLETED|Follow-up Period||105||
48691656|NCT03035864|102028985|FG001|COMPLETED|Follow-up Period||55||
48691657|NCT03035864|102028984|FG000|NOT COMPLETED|Follow-up Period||11||
48691658|NCT03035864|102028985|FG001|NOT COMPLETED|Follow-up Period||4||
48691659|NCT03046927|102028986|FG000|STARTED|Overall Study||18||
48691660|NCT03046927|102028987|FG001|STARTED|Overall Study||18||
48691661|NCT03046927|102028986|FG000|COMPLETED|Overall Study||13||
48691662|NCT03046927|102028987|FG001|COMPLETED|Overall Study||16||
48691663|NCT03046927|102028986|FG000|NOT COMPLETED|Overall Study||5||
48691664|NCT03046927|102028987|FG001|NOT COMPLETED|Overall Study||2||
48691665|NCT03275246|102028988|FG000|STARTED|Overall Study||8||
48691666|NCT03275246|102028988|FG000|COMPLETED|Overall Study||2||
48691667|NCT03275246|102028988|FG000|NOT COMPLETED|Overall Study||6||
48691668|NCT02125838|102028989|FG000|STARTED|Overall Study||54||
48691669|NCT02125838|102028990|FG001|STARTED|Overall Study||54||
48103109|NCT05876273|100578654|FG000|NOT COMPLETED|Overall Study||0||
48103110|NCT05876273|100578655|FG001|NOT COMPLETED|Overall Study||0||
48103111|NCT00174915|100578656|FG000|STARTED|Overall Study||267||
48265198|NCT01744704|100970982|FG008|COMPLETED|Overall Study||3||
48265199|NCT01744704|100970983|FG009|COMPLETED|Overall Study||9||
48265200|NCT01744704|100970984|FG010|COMPLETED|Overall Study||9||
48265201|NCT01744704|100970985|FG011|COMPLETED|Overall Study||10||
48265202|NCT01744704|100970974|FG000|NOT COMPLETED|Overall Study||0||
48265203|NCT01744704|100970975|FG001|NOT COMPLETED|Overall Study||0||
48265204|NCT01744704|100970976|FG002|NOT COMPLETED|Overall Study||0||
48265205|NCT01744704|100970977|FG003|NOT COMPLETED|Overall Study||0||
48265206|NCT01744704|100970978|FG004|NOT COMPLETED|Overall Study||0||
48265207|NCT01744704|100970979|FG005|NOT COMPLETED|Overall Study||0||
48265208|NCT01744704|100970980|FG006|NOT COMPLETED|Overall Study||0||
48265209|NCT01744704|100970981|FG007|NOT COMPLETED|Overall Study||0||
48265210|NCT01744704|100970982|FG008|NOT COMPLETED|Overall Study||0||
48265211|NCT01744704|100970983|FG009|NOT COMPLETED|Overall Study||0||
48265212|NCT01744704|100970984|FG010|NOT COMPLETED|Overall Study||0||
48265213|NCT01744704|100970985|FG011|NOT COMPLETED|Overall Study||0||
48265214|NCT00325598|100970986|FG000|STARTED|Overall Study||50||
48265215|NCT00325598|100970987|FG001|STARTED|Overall Study||50||
48265216|NCT00325598|100970986|FG000|COMPLETED|Overall Study||50||
48265217|NCT00325598|100970987|FG001|COMPLETED|Overall Study||50||
48265218|NCT00325598|100970986|FG000|NOT COMPLETED|Overall Study||0||
48265219|NCT00325598|100970987|FG001|NOT COMPLETED|Overall Study||0||
48265220|NCT05020145|100970988|FG000|STARTED|Overall Study||225796||
48265221|NCT05020145|100970989|FG001|STARTED|Overall Study||1051951||
48265222|NCT05020145|100970988|FG000|Fully Vaccinated|Overall Study||212945||
48265223|NCT05020145|100970989|FG001|Fully Vaccinated|Overall Study||963962||
48265224|NCT05020145|100970988|FG000|COMPLETED|Overall Study||225796||
48265225|NCT05020145|100970989|FG001|COMPLETED|Overall Study||1051951||
48265226|NCT05020145|100970988|FG000|NOT COMPLETED|Overall Study||0||
48265227|NCT05020145|100970989|FG001|NOT COMPLETED|Overall Study||0||
48265228|NCT02615509|100970990|FG000|STARTED|Overall Study||347||
48265229|NCT02615509|100970990|FG000|COMPLETED|Overall Study||201||
48265230|NCT02615509|100970990|FG000|NOT COMPLETED|Overall Study||146||
48265231|NCT01573949|100970991|FG000|STARTED|Overall Study||7||
48265232|NCT01573949|100970991|FG000|COMPLETED|Overall Study||7||
48265233|NCT01573949|100970991|FG000|NOT COMPLETED|Overall Study||0||
48265234|NCT01948076|100970992|FG000|STARTED|Overall Study||20||
48265235|NCT01948076|100970993|FG001|STARTED|Overall Study||20||
48265236|NCT01948076|100970992|FG000|COMPLETED|Overall Study||20||
48265237|NCT01948076|100970993|FG001|COMPLETED|Overall Study||19||
48265238|NCT01948076|100970992|FG000|NOT COMPLETED|Overall Study||0||
48265239|NCT01948076|100970993|FG001|NOT COMPLETED|Overall Study||1||
48265240|NCT02078492|100970994|FG000|STARTED|Overall Study||80||
48265241|NCT02078492|100970995|FG001|STARTED|Overall Study||80||
48691670|NCT02125838|102028989|FG000|COMPLETED|Overall Study||50||
48691671|NCT02125838|102028990|FG001|COMPLETED|Overall Study||50||
48691672|NCT02125838|102028989|FG000|NOT COMPLETED|Overall Study||4||
48691673|NCT02125838|102028990|FG001|NOT COMPLETED|Overall Study||4||
48265242|NCT02078492|100970996|FG002|STARTED|Overall Study||80||
48265243|NCT02078492|100970994|FG000|COMPLETED|Overall Study||80||
48265244|NCT02078492|100970995|FG001|COMPLETED|Overall Study||80||
48265245|NCT02078492|100970996|FG002|COMPLETED|Overall Study||80||
48691674|NCT02384044|102028991|FG000|STARTED|Overall Study||15||
48103112|NCT00174915|100578657|FG001|STARTED|Overall Study||269||
48265246|NCT02078492|100970994|FG000|NOT COMPLETED|Overall Study||0||
48265247|NCT02078492|100970995|FG001|NOT COMPLETED|Overall Study||0||
48265248|NCT02078492|100970996|FG002|NOT COMPLETED|Overall Study||0||
48265249|NCT00667459|100970997|FG000|STARTED|Overall Study||280||
48265250|NCT00667459|100970998|FG001|STARTED|Overall Study||265||
48265251|NCT00667459|100970997|FG000|COMPLETED|Overall Study||272||
48265252|NCT00667459|100970998|FG001|COMPLETED|Overall Study||220||
48265253|NCT00667459|100970997|FG000|NOT COMPLETED|Overall Study||8||
48265254|NCT00667459|100970998|FG001|NOT COMPLETED|Overall Study||45||
48265255|NCT02536742|100970999|FG000|STARTED|Overall Study||124||
48265256|NCT02536742|100970999|FG000|COMPLETED|Overall Study||122||
48265257|NCT02536742|100970999|FG000|NOT COMPLETED|Overall Study||2||
48265258|NCT00839956|100971000|FG000|STARTED|Overall Study||31||
48265259|NCT00839956|100971000|FG000|COMPLETED|Overall Study||19||
48265260|NCT00839956|100971000|FG000|NOT COMPLETED|Overall Study||12||
48265261|NCT00334542|100971001|FG000|STARTED|Overall Study||50||
48265262|NCT00334542|100971001|FG000|COMPLETED|Overall Study||45||
48103113|NCT00174915|100578658|FG002|STARTED|Overall Study||134||
48103114|NCT00174915|100578659|FG003|STARTED|Overall Study||268||
48549386|NCT02861014|101679596|FG000|STARTED|Primary Analysis||680||
48549387|NCT02861014|101679596|FG000|COMPLETED|Primary Analysis||641||
48549388|NCT02861014|101679596|FG000|NOT COMPLETED|Primary Analysis||39||
48549389|NCT02861014|101679596|FG000|STARTED|Safety Follow-up||64||
48549390|NCT02861014|101679596|FG000|COMPLETED|Safety Follow-up||14||
48549391|NCT02861014|101679596|FG000|NOT COMPLETED|Safety Follow-up||50||
48103115|NCT00174915|100578660|FG004|STARTED|Overall Study||134||
48103116|NCT00174915|100578656|FG000|COMPLETED|Overall Study||174||
48103117|NCT00174915|100578657|FG001|COMPLETED|Overall Study||200||
48103118|NCT00174915|100578658|FG002|COMPLETED|Overall Study||86||
48103119|NCT00174915|100578659|FG003|COMPLETED|Overall Study||211||
48103120|NCT00174915|100578660|FG004|COMPLETED|Overall Study||101||
48103121|NCT00174915|100578656|FG000|NOT COMPLETED|Overall Study||93||
48103122|NCT00174915|100578657|FG001|NOT COMPLETED|Overall Study||69||
48103123|NCT00174915|100578658|FG002|NOT COMPLETED|Overall Study||48||
48103124|NCT00174915|100578659|FG003|NOT COMPLETED|Overall Study||57||
48549392|NCT01284361|101679597|FG000|STARTED|Overall Study||91||
48549393|NCT01284361|101679597|FG000|COMPLETED|Overall Study||82||
48549394|NCT01284361|101679597|FG000|NOT COMPLETED|Overall Study||9||
48691675|NCT02384044|102028992|FG001|STARTED|Overall Study||15||
48691676|NCT02384044|102028991|FG000|COMPLETED|Overall Study||15||
48691677|NCT02384044|102028992|FG001|COMPLETED|Overall Study||15||
48691678|NCT02384044|102028991|FG000|NOT COMPLETED|Overall Study||0||
48691679|NCT02384044|102028992|FG001|NOT COMPLETED|Overall Study||0||
48691680|NCT01364480|102028993|FG000|STARTED|Overall Study||1||
48549395|NCT03645863|101679598|FG000|STARTED|Overall Study||21||
48549396|NCT03645863|101679599|FG001|STARTED|Overall Study||20||
48549397|NCT03645863|101679600|FG002|STARTED|Overall Study||20||
48549398|NCT03645863|101679598|FG000|COMPLETED|Overall Study||20||
48549399|NCT03645863|101679599|FG001|COMPLETED|Overall Study||20||
48549400|NCT03645863|101679600|FG002|COMPLETED|Overall Study||20||
48691681|NCT01364480|102028993|FG000|COMPLETED|Overall Study||1||
48691682|NCT01364480|102028993|FG000|NOT COMPLETED|Overall Study||0||
48691683|NCT02298868|102028994|FG000|STARTED|Overall Study||10||
48691684|NCT02298868|102028994|FG000|COMPLETED|Overall Study||7||
48691685|NCT02298868|102028994|FG000|NOT COMPLETED|Overall Study||3||
48103125|NCT00174915|100578660|FG004|NOT COMPLETED|Overall Study||33||
48103126|NCT02939560|100578661|FG000|STARTED|Overall Study||13||
48103127|NCT02939560|100578661|FG000|COMPLETED|Overall Study||10||
48549401|NCT03645863|101679598|FG000|NOT COMPLETED|Overall Study||1||
48549402|NCT03645863|101679599|FG001|NOT COMPLETED|Overall Study||0||
48549403|NCT03645863|101679600|FG002|NOT COMPLETED|Overall Study||0||
48549404|NCT00128401|101679601|FG000|STARTED|Overall Study||20||
48549405|NCT00128401|101679602|FG001|STARTED|Overall Study||19||
48549406|NCT00128401|101679601|FG000|COMPLETED|Overall Study||14||
48549407|NCT00128401|101679602|FG001|COMPLETED|Overall Study||15||
48549408|NCT00128401|101679601|FG000|NOT COMPLETED|Overall Study||6||
48549409|NCT00128401|101679602|FG001|NOT COMPLETED|Overall Study||4||
48691686|NCT01897727|102028995|FG000|STARTED|Overall Study||8||
48265263|NCT00334542|100971001|FG000|NOT COMPLETED|Overall Study||5||
48265264|NCT01107899|100971002|FG000|STARTED|Overall Study||10||
48265265|NCT01107899|100971003|FG001|STARTED|Overall Study||10||
48265266|NCT01107899|100971004|FG002|STARTED|Overall Study||9||
48265267|NCT01107899|100971002|FG000|Received at Least One Dose of Study Drug|Overall Study||10||
48549410|NCT01911273|101679603|FG000|STARTED|Overall Study||1||
48549411|NCT01911273|101679604|FG001|STARTED|Overall Study||2||
48691687|NCT01897727|102028996|FG001|STARTED|Overall Study||9||
48691688|NCT01897727|102028995|FG000|COMPLETED|Overall Study||8||
48691689|NCT01897727|102028996|FG001|COMPLETED|Overall Study||8||
48691690|NCT01897727|102028995|FG000|NOT COMPLETED|Overall Study||0||
48691691|NCT01897727|102028996|FG001|NOT COMPLETED|Overall Study||1||
48103128|NCT02939560|100578661|FG000|NOT COMPLETED|Overall Study||3||
48103129|NCT00828191|100578662|FG000|STARTED|Overall Study||400||
48103130|NCT00828191|100578663|FG001|STARTED|Overall Study||400||
48103131|NCT00828191|100578662|FG000|COMPLETED|Overall Study||392||
48103132|NCT00828191|100578663|FG001|COMPLETED|Overall Study||390||
48691692|NCT01959178|102028997|FG000|STARTED|Overall Study||73||
48265268|NCT01107899|100971003|FG001|Received at Least One Dose of Study Drug|Overall Study||10||
48265269|NCT01107899|100971004|FG002|Received at Least One Dose of Study Drug|Overall Study||8||
48265270|NCT01107899|100971002|FG000|Loading Dose (LD) Intent to Treat (ITT)|Overall Study||5||
48265271|NCT01107899|100971003|FG001|Loading Dose (LD) Intent to Treat (ITT)|Overall Study||10||
48265272|NCT01107899|100971004|FG002|Loading Dose (LD) Intent to Treat (ITT)|Overall Study||6||
48265273|NCT01107899|100971002|FG000|ITT Washout Population|Overall Study||5||
48265274|NCT01107899|100971003|FG001|ITT Washout Population|Overall Study||10||
48265275|NCT01107899|100971004|FG002|ITT Washout Population|Overall Study||6||
48265276|NCT01107899|100971002|FG000|Primary Washout Population|Overall Study||5||
48265277|NCT01107899|100971003|FG001|Primary Washout Population|Overall Study||10||
48265278|NCT01107899|100971004|FG002|Primary Washout Population|Overall Study||4||
48265279|NCT01107899|100971002|FG000|COMPLETED|Overall Study||5||
48265280|NCT01107899|100971003|FG001|COMPLETED|Overall Study||10||
48265281|NCT01107899|100971004|FG002|COMPLETED|Overall Study||5||
48265282|NCT01107899|100971002|FG000|NOT COMPLETED|Overall Study||5||
48265283|NCT01107899|100971003|FG001|NOT COMPLETED|Overall Study||0||
48265284|NCT01107899|100971004|FG002|NOT COMPLETED|Overall Study||4||
48265285|NCT02638597|100971005|FG000|STARTED|Overall Study||8||
48265286|NCT02638597|100971006|FG001|STARTED|Overall Study||8||
48265287|NCT02638597|100971005|FG000|COMPLETED|Overall Study||4||
48265288|NCT02638597|100971006|FG001|COMPLETED|Overall Study||3||
48265289|NCT02638597|100971005|FG000|NOT COMPLETED|Overall Study||4||
48265290|NCT02638597|100971006|FG001|NOT COMPLETED|Overall Study||5||
48265291|NCT00929253|100971007|FG000|STARTED|Overall Study||91||
48265292|NCT00929253|100971008|FG001|STARTED|Overall Study||79||
48265293|NCT00929253|100971007|FG000|COMPLETED|Overall Study||91||
48549412|NCT01911273|101679603|FG000|COMPLETED|Overall Study||0||
48549413|NCT01911273|101679604|FG001|COMPLETED|Overall Study||0||
48549414|NCT01911273|101679603|FG000|NOT COMPLETED|Overall Study||1||
48549415|NCT01911273|101679604|FG001|NOT COMPLETED|Overall Study||2||
48549416|NCT03142191|101679605|FG000|STARTED|Placebo Controlled Period||39||
48549417|NCT03142191|101679606|FG001|STARTED|Placebo Controlled Period||37||
48549418|NCT03142191|101679607|FG002|STARTED|Placebo Controlled Period||36||
48549419|NCT03142191|101679608|FG003|STARTED|Placebo Controlled Period||15||
48549420|NCT03142191|101679609|FG004|STARTED|Placebo Controlled Period||8||
48549421|NCT03142191|101679605|FG000|COMPLETED|Placebo Controlled Period||32||
48549422|NCT03142191|101679606|FG001|COMPLETED|Placebo Controlled Period||28||
48549423|NCT03142191|101679607|FG002|COMPLETED|Placebo Controlled Period||31||
48549424|NCT03142191|101679608|FG003|COMPLETED|Placebo Controlled Period||15||
48549425|NCT03142191|101679609|FG004|COMPLETED|Placebo Controlled Period||7||
48549426|NCT03142191|101679605|FG000|NOT COMPLETED|Placebo Controlled Period||7||
48549427|NCT03142191|101679606|FG001|NOT COMPLETED|Placebo Controlled Period||9||
48549428|NCT03142191|101679607|FG002|NOT COMPLETED|Placebo Controlled Period||5||
48549429|NCT03142191|101679608|FG003|NOT COMPLETED|Placebo Controlled Period||0||
48549430|NCT03142191|101679609|FG004|NOT COMPLETED|Placebo Controlled Period||1||
48549431|NCT03142191|101679605|FG000|STARTED|Active Treatment Extension Period||31||
48549432|NCT03142191|101679606|FG001|STARTED|Active Treatment Extension Period||27||
48549433|NCT03142191|101679607|FG002|STARTED|Active Treatment Extension Period||30||
48549434|NCT03142191|101679608|FG003|STARTED|Active Treatment Extension Period||15||
48549435|NCT03142191|101679609|FG004|STARTED|Active Treatment Extension Period||6||
48549436|NCT03142191|101679605|FG000|CC-90001 200mg|Active Treatment Extension Period||0|Participants who were in the placebo arm during treatment period and are now taking CC-90001 200mg|
48265294|NCT00929253|100971008|FG001|COMPLETED|Overall Study||79||
48265295|NCT00929253|100971007|FG000|NOT COMPLETED|Overall Study||0||
48265296|NCT00929253|100971008|FG001|NOT COMPLETED|Overall Study||0||
48265297|NCT02768597|100971009|FG000|STARTED|Overall Study||34||
48265298|NCT02768597|100971010|FG001|STARTED|Overall Study||28||
48265299|NCT02768597|100971011|FG002|STARTED|Overall Study||29||
48265300|NCT02768597|100971012|FG003|STARTED|Overall Study||22||
48549437|NCT03142191|101679606|FG001|CC-90001 200mg|Active Treatment Extension Period||0|Participants who were in the placebo arm during treatment period and are now taking CC-90001 200mg|
48549438|NCT03142191|101679607|FG002|CC-90001 200mg|Active Treatment Extension Period||15|Participants who were in the placebo arm during treatment period and are now taking CC-90001 200mg|
48549439|NCT03142191|101679608|FG003|CC-90001 200mg|Active Treatment Extension Period||0|Participants who were in the placebo arm during treatment period and are now taking CC-90001 200mg|
48549440|NCT03142191|101679609|FG004|CC-90001 200mg|Active Treatment Extension Period||3|Participants who were in the placebo arm during treatment period and are now taking CC-90001 200mg|
48549441|NCT03142191|101679605|FG000|CC-90001 400mg|Active Treatment Extension Period||0|Participants who were in the placebo arm during treatment period and are now taking CC-90001 400mg|
48549442|NCT03142191|101679606|FG001|CC-90001 400mg|Active Treatment Extension Period||0|Participants who were in the placebo arm during treatment period and are now taking CC-90001 400mg|
48549443|NCT03142191|101679607|FG002|CC-90001 400mg|Active Treatment Extension Period||15|Participants who were in the placebo arm during treatment period and are now taking CC-90001 400mg|
48549444|NCT03142191|101679608|FG003|CC-90001 400mg|Active Treatment Extension Period||0|Participants who were in the placebo arm during treatment period and are now taking CC-90001 400mg|
48549445|NCT03142191|101679609|FG004|CC-90001 400mg|Active Treatment Extension Period||3|Participants who were in the placebo arm during treatment period and are now taking CC-90001 400mg|
48549446|NCT03142191|101679605|FG000|COMPLETED|Active Treatment Extension Period||5||
48549447|NCT03142191|101679606|FG001|COMPLETED|Active Treatment Extension Period||13||
48549448|NCT03142191|101679607|FG002|COMPLETED|Active Treatment Extension Period||15||
48549449|NCT03142191|101679608|FG003|COMPLETED|Active Treatment Extension Period||3||
48549450|NCT03142191|101679609|FG004|COMPLETED|Active Treatment Extension Period||0||
48549451|NCT03142191|101679605|FG000|NOT COMPLETED|Active Treatment Extension Period||26||
48549452|NCT03142191|101679606|FG001|NOT COMPLETED|Active Treatment Extension Period||14||
48549453|NCT03142191|101679607|FG002|NOT COMPLETED|Active Treatment Extension Period||15||
48549454|NCT03142191|101679608|FG003|NOT COMPLETED|Active Treatment Extension Period||12||
48549455|NCT03142191|101679609|FG004|NOT COMPLETED|Active Treatment Extension Period||6||
48549456|NCT00916643|101679610|FG000|STARTED|Overall Study||113||
48549457|NCT00916643|101679610|FG000|COMPLETED|Overall Study||113||
48549458|NCT00916643|101679610|FG000|NOT COMPLETED|Overall Study||0||
48549459|NCT00445146|101679611|FG000|STARTED|Overall Study||192||
48549460|NCT00445146|101679611|FG000|COMPLETED|Overall Study||73||
48549461|NCT00445146|101679611|FG000|NOT COMPLETED|Overall Study||119||
48549462|NCT02755285|101679612|FG000|STARTED|Overall Study||20||
48549463|NCT02755285|101679612|FG000|COMPLETED|Overall Study||20||
48549464|NCT02755285|101679612|FG000|NOT COMPLETED|Overall Study||0||
48549465|NCT03717012|101679613|FG000|STARTED|Overall Study||9||
48549466|NCT03717012|101679614|FG001|STARTED|Overall Study||10||
48549467|NCT03717012|101679613|FG000|COMPLETED|Overall Study||8||
48549468|NCT03717012|101679614|FG001|COMPLETED|Overall Study||4||
48549469|NCT03717012|101679613|FG000|NOT COMPLETED|Overall Study||1||
48549470|NCT03717012|101679614|FG001|NOT COMPLETED|Overall Study||6||
48549471|NCT02123446|101679615|FG000|STARTED|Period 1 (7 Days)||14||
48549472|NCT02123446|101679616|FG001|STARTED|Period 1 (7 Days)||14||
48549473|NCT02123446|101679615|FG000|COMPLETED|Period 1 (7 Days)||14||
48549474|NCT02123446|101679616|FG001|COMPLETED|Period 1 (7 Days)||14||
48549475|NCT02123446|101679615|FG000|NOT COMPLETED|Period 1 (7 Days)||0||
48549476|NCT02123446|101679616|FG001|NOT COMPLETED|Period 1 (7 Days)||0||
48549477|NCT02123446|101679615|FG000|STARTED|Washout Period (1 Day)||14||
48549478|NCT02123446|101679616|FG001|STARTED|Washout Period (1 Day)||14||
48549479|NCT02123446|101679615|FG000|COMPLETED|Washout Period (1 Day)||13||
48549480|NCT02123446|101679616|FG001|COMPLETED|Washout Period (1 Day)||14||
48549481|NCT02123446|101679615|FG000|NOT COMPLETED|Washout Period (1 Day)||1||
48549482|NCT02123446|101679616|FG001|NOT COMPLETED|Washout Period (1 Day)||0||
48549483|NCT02123446|101679615|FG000|STARTED|Period 2 (7 Days)||13||
48549484|NCT02123446|101679616|FG001|STARTED|Period 2 (7 Days)||14||
48549485|NCT02123446|101679615|FG000|COMPLETED|Period 2 (7 Days)||13||
48549486|NCT02123446|101679616|FG001|COMPLETED|Period 2 (7 Days)||14||
48549487|NCT02123446|101679615|FG000|NOT COMPLETED|Period 2 (7 Days)||0||
48549488|NCT02123446|101679616|FG001|NOT COMPLETED|Period 2 (7 Days)||0||
48549489|NCT01625988|101679617|FG000|STARTED|Overall Study||108||
48549490|NCT01625988|101679618|FG001|STARTED|Overall Study||110||
48549491|NCT01625988|101679617|FG000|Received at Least One Dose of Study Drug|Overall Study||107||
48549492|NCT01625988|101679618|FG001|Received at Least One Dose of Study Drug|Overall Study||110||
48549493|NCT01625988|101679617|FG000|COMPLETED|Overall Study||94||
48549494|NCT01625988|101679618|FG001|COMPLETED|Overall Study||97||
48549495|NCT01625988|101679617|FG000|NOT COMPLETED|Overall Study||14||
48549496|NCT01625988|101679618|FG001|NOT COMPLETED|Overall Study||13||
48549497|NCT00553735|101679619|FG000|STARTED|Overall Study||8||
48549498|NCT00553735|101679619|FG000|COMPLETED|Overall Study||1||
48549499|NCT00553735|101679619|FG000|NOT COMPLETED|Overall Study||7||
48549500|NCT00402116|101679620|FG000|STARTED|Overall Study||6||
48265301|NCT02768597|100971009|FG000|COMPLETED|Overall Study||34||
48265302|NCT02768597|100971010|FG001|COMPLETED|Overall Study||28||
48265303|NCT02768597|100971011|FG002|COMPLETED|Overall Study||29||
48265304|NCT02768597|100971012|FG003|COMPLETED|Overall Study||22||
48265305|NCT02768597|100971009|FG000|NOT COMPLETED|Overall Study||0||
48265306|NCT02768597|100971010|FG001|NOT COMPLETED|Overall Study||0||
48265307|NCT02768597|100971011|FG002|NOT COMPLETED|Overall Study||0||
48265308|NCT02768597|100971012|FG003|NOT COMPLETED|Overall Study||0||
48265309|NCT03334253|100971013|FG000|STARTED|Overall Study||125||
48265310|NCT03334253|100971014|FG001|STARTED|Overall Study||62||
48265311|NCT03334253|100971013|FG000|COMPLETED|Overall Study||118||
48549501|NCT00402116|101679621|FG001|STARTED|Overall Study||6||
48549502|NCT00402116|101679622|FG002|STARTED|Overall Study||60||
48549503|NCT00402116|101679620|FG000|COMPLETED|Overall Study||3||
48549504|NCT00402116|101679621|FG001|COMPLETED|Overall Study||0||
48549505|NCT00402116|101679622|FG002|COMPLETED|Overall Study||5||
48549506|NCT00402116|101679620|FG000|NOT COMPLETED|Overall Study||3||
48549507|NCT00402116|101679621|FG001|NOT COMPLETED|Overall Study||6||
48549508|NCT00402116|101679622|FG002|NOT COMPLETED|Overall Study||55||
48549509|NCT02229461|101679623|FG000|STARTED|Overall Study||17||
48549510|NCT02229461|101679624|FG001|STARTED|Overall Study||17||
48549511|NCT02229461|101679625|FG002|STARTED|Overall Study||17||
48549512|NCT02229461|101679626|FG003|STARTED|Overall Study||17||
48549513|NCT02229461|101679627|FG004|STARTED|Overall Study||17||
48549514|NCT02229461|101679628|FG005|STARTED|Overall Study||17||
48549515|NCT02229461|101679623|FG000|COMPLETED|Overall Study||17||
48549516|NCT02229461|101679624|FG001|COMPLETED|Overall Study||17||
48691693|NCT01959178|102028998|FG001|STARTED|Overall Study||73||
48691694|NCT01959178|102028997|FG000|COMPLETED|Overall Study||71||
48691695|NCT01959178|102028998|FG001|COMPLETED|Overall Study||71||
48265312|NCT03334253|100971014|FG001|COMPLETED|Overall Study||57||
48265313|NCT03334253|100971013|FG000|NOT COMPLETED|Overall Study||7||
48265314|NCT03334253|100971014|FG001|NOT COMPLETED|Overall Study||5||
48265315|NCT02645123|100971015|FG000|STARTED|Overall Study||25||
48265316|NCT02645123|100971016|FG001|STARTED|Overall Study||25||
48265317|NCT02645123|100971017|FG002|STARTED|Overall Study||25||
48265318|NCT02645123|100971015|FG000|COMPLETED|Overall Study||25||
48265319|NCT02645123|100971016|FG001|COMPLETED|Overall Study||25||
48265320|NCT02645123|100971017|FG002|COMPLETED|Overall Study||25||
48265321|NCT02645123|100971015|FG000|NOT COMPLETED|Overall Study||0||
48265322|NCT02645123|100971016|FG001|NOT COMPLETED|Overall Study||0||
48265323|NCT02645123|100971017|FG002|NOT COMPLETED|Overall Study||0||
48265324|NCT04115189|100971018|FG000|STARTED|Overall Study||42||
48265325|NCT04115189|100971019|FG001|STARTED|Overall Study||15||
48265326|NCT04115189|100971018|FG000|COMPLETED|Overall Study||42||
48265327|NCT04115189|100971019|FG001|COMPLETED|Overall Study||15||
48549517|NCT02229461|101679625|FG002|COMPLETED|Overall Study||17||
48549518|NCT02229461|101679626|FG003|COMPLETED|Overall Study||17||
48549519|NCT02229461|101679627|FG004|COMPLETED|Overall Study||17||
48549520|NCT02229461|101679628|FG005|COMPLETED|Overall Study||17||
48549521|NCT02229461|101679623|FG000|NOT COMPLETED|Overall Study||0||
48549522|NCT02229461|101679624|FG001|NOT COMPLETED|Overall Study||0||
48549523|NCT02229461|101679625|FG002|NOT COMPLETED|Overall Study||0||
48549524|NCT02229461|101679626|FG003|NOT COMPLETED|Overall Study||0||
48549525|NCT02229461|101679627|FG004|NOT COMPLETED|Overall Study||0||
48549526|NCT02229461|101679628|FG005|NOT COMPLETED|Overall Study||0||
48549527|NCT01277159|101679629|FG000|STARTED|Overall Study||21||
48549528|NCT01277159|101679630|FG001|STARTED|Overall Study||22||
48549529|NCT01277159|101679631|FG002|STARTED|Overall Study||22||
48549530|NCT01277159|101679632|FG003|STARTED|Overall Study||22||
48549531|NCT01277159|101679633|FG004|STARTED|Overall Study||21||
48549532|NCT01277159|101679629|FG000|COMPLETED|Overall Study||17||
48549533|NCT01277159|101679630|FG001|COMPLETED|Overall Study||21||
48549534|NCT01277159|101679631|FG002|COMPLETED|Overall Study||19||
48549535|NCT01277159|101679632|FG003|COMPLETED|Overall Study||19||
48549536|NCT01277159|101679633|FG004|COMPLETED|Overall Study||16||
48549537|NCT01277159|101679629|FG000|NOT COMPLETED|Overall Study||4||
48549538|NCT01277159|101679630|FG001|NOT COMPLETED|Overall Study||1||
48549539|NCT01277159|101679631|FG002|NOT COMPLETED|Overall Study||3||
48549540|NCT01277159|101679632|FG003|NOT COMPLETED|Overall Study||3||
48549541|NCT01277159|101679633|FG004|NOT COMPLETED|Overall Study||5||
48549542|NCT02085447|101679634|FG000|STARTED|Overall Study||30||
48549543|NCT02085447|101679634|FG000|COMPLETED|Overall Study||26||
48549544|NCT02085447|101679634|FG000|NOT COMPLETED|Overall Study||4||
48549545|NCT01128543|101679635|FG000|STARTED|Overall Study||29||
48549546|NCT01128543|101679635|FG000|COMPLETED|Overall Study||25||
48691696|NCT01959178|102028997|FG000|NOT COMPLETED|Overall Study||2||
48265328|NCT04115189|100971018|FG000|NOT COMPLETED|Overall Study||0||
48265329|NCT04115189|100971019|FG001|NOT COMPLETED|Overall Study||0||
48265330|NCT00416598|100971020|FG000|STARTED|Induction & Intensification||546||
48265331|NCT00416598|100971020|FG000|COMPLETED|Induction & Intensification||134||
48265332|NCT00416598|100971020|FG000|NOT COMPLETED|Induction & Intensification||412||
48265333|NCT00416598|100971020|FG000|STARTED|Decitabine Maintenance||134||
48265334|NCT00416598|100971020|FG000|COMPLETED|Decitabine Maintenance||62||
48265335|NCT00416598|100971020|FG000|NOT COMPLETED|Decitabine Maintenance||72||
48265336|NCT00263211|100971021|FG000|STARTED|Overall Study||24||
48265337|NCT00263211|100971022|FG001|STARTED|Overall Study||24||
48265338|NCT00263211|100971021|FG000|COMPLETED|Overall Study||19||
48549547|NCT01128543|101679635|FG000|NOT COMPLETED|Overall Study||4||
48549548|NCT03076775|101679636|FG000|STARTED|Overall Study||44||
48549549|NCT03076775|101679637|FG001|STARTED|Overall Study||42||
48549550|NCT03076775|101679636|FG000|Neonates Born During Study|Overall Study||43||
48549551|NCT03076775|101679637|FG001|Neonates Born During Study|Overall Study||42||
48549552|NCT03076775|101679636|FG000|Umbilical Cord Blood Collected|Overall Study||33||
48549553|NCT03076775|101679637|FG001|Umbilical Cord Blood Collected|Overall Study||38||
48549554|NCT03076775|101679636|FG000|COMPLETED|Overall Study||43||
48549555|NCT03076775|101679637|FG001|COMPLETED|Overall Study||42||
48691697|NCT01959178|102028998|FG001|NOT COMPLETED|Overall Study||2||
48691698|NCT01181804|102028999|FG000|STARTED|Period 1, Fed (Part 1)||30||
48691699|NCT01181804|102029000|FG001|STARTED|Period 1, Fed (Part 1)||30||
48691700|NCT01181804|102029001|FG002|STARTED|Period 1, Fed (Part 1)||0||
48691701|NCT01181804|102029002|FG003|STARTED|Period 1, Fed (Part 1)||0||
48691702|NCT01181804|102028999|FG000|COMPLETED|Period 1, Fed (Part 1)||30||
48691703|NCT01181804|102029000|FG001|COMPLETED|Period 1, Fed (Part 1)||30||
48691704|NCT01181804|102029001|FG002|COMPLETED|Period 1, Fed (Part 1)||0||
48691705|NCT01181804|102029002|FG003|COMPLETED|Period 1, Fed (Part 1)||0||
48691706|NCT01181804|102028999|FG000|NOT COMPLETED|Period 1, Fed (Part 1)||0||
48265339|NCT00263211|100971022|FG001|COMPLETED|Overall Study||23||
48549556|NCT03076775|101679636|FG000|NOT COMPLETED|Overall Study||1||
48549557|NCT03076775|101679637|FG001|NOT COMPLETED|Overall Study||0||
48549558|NCT00972595|101679638|FG000|STARTED|Period 1||23||
48103133|NCT00828191|100578662|FG000|NOT COMPLETED|Overall Study||8||
48103134|NCT00828191|100578663|FG001|NOT COMPLETED|Overall Study||10||
48103135|NCT04898673|100578664|FG000|STARTED|Overall Study||11||
48103136|NCT04898673|100578665|FG001|STARTED|Overall Study||10||
48103137|NCT04898673|100578664|FG000|CP1110 Sound Processor|Overall Study||10||
48103138|NCT04898673|100578665|FG001|CP1110 Sound Processor|Overall Study||10||
48103139|NCT04898673|100578664|FG000|CP1000 Sound Processor|Overall Study||10||
48103140|NCT04898673|100578665|FG001|CP1000 Sound Processor|Overall Study||10||
48103141|NCT04898673|100578664|FG000|COMPLETED|Overall Study||10||
48103142|NCT04898673|100578665|FG001|COMPLETED|Overall Study||10||
48103143|NCT04898673|100578664|FG000|NOT COMPLETED|Overall Study||1||
48103144|NCT04898673|100578665|FG001|NOT COMPLETED|Overall Study||0||
48103145|NCT01187043|100578666|FG000|STARTED|Overall Study||12||
48103146|NCT01187043|100578667|FG001|STARTED|Overall Study||10||
48103147|NCT01187043|100578668|FG002|STARTED|Overall Study||12||
48103148|NCT01187043|100578669|FG003|STARTED|Overall Study||12||
48103149|NCT01187043|100578670|FG004|STARTED|Overall Study||12||
48103150|NCT01187043|100578666|FG000|COMPLETED|Overall Study||11||
48103151|NCT01187043|100578667|FG001|COMPLETED|Overall Study||10||
48103152|NCT01187043|100578668|FG002|COMPLETED|Overall Study||8||
48103153|NCT01187043|100578669|FG003|COMPLETED|Overall Study||12||
48103154|NCT01187043|100578670|FG004|COMPLETED|Overall Study||10||
48103155|NCT01187043|100578666|FG000|NOT COMPLETED|Overall Study||1||
48103156|NCT01187043|100578667|FG001|NOT COMPLETED|Overall Study||0||
48103157|NCT01187043|100578668|FG002|NOT COMPLETED|Overall Study||4||
48265340|NCT00263211|100971021|FG000|NOT COMPLETED|Overall Study||5||
48265341|NCT00263211|100971022|FG001|NOT COMPLETED|Overall Study||1||
48265342|NCT01986114|100971023|FG000|STARTED|Overall Study||495||
48265343|NCT01986114|100971023|FG000|COMPLETED|Overall Study||339||
48265344|NCT01986114|100971023|FG000|NOT COMPLETED|Overall Study||156||
48103158|NCT01187043|100578669|FG003|NOT COMPLETED|Overall Study||0||
48103159|NCT01187043|100578670|FG004|NOT COMPLETED|Overall Study||2||
48103160|NCT04865354|100578671|FG000|STARTED|First Wear Period (8 Days)||83||
48103161|NCT04865354|100578672|FG001|STARTED|First Wear Period (8 Days)||84||
48103162|NCT04865354|100578671|FG000|COMPLETED|First Wear Period (8 Days)||82||
48103163|NCT04865354|100578672|FG001|COMPLETED|First Wear Period (8 Days)||83||
48103164|NCT04865354|100578671|FG000|NOT COMPLETED|First Wear Period (8 Days)||1||
48103165|NCT04865354|100578672|FG001|NOT COMPLETED|First Wear Period (8 Days)||1||
48103166|NCT04865354|100578671|FG000|STARTED|Second Wear Period (8 Days)||82||
48103167|NCT04865354|100578672|FG001|STARTED|Second Wear Period (8 Days)||83||
48103168|NCT04865354|100578671|FG000|COMPLETED|Second Wear Period (8 Days)||81||
48103169|NCT04865354|100578672|FG001|COMPLETED|Second Wear Period (8 Days)||83||
48103170|NCT04865354|100578671|FG000|NOT COMPLETED|Second Wear Period (8 Days)||1||
48103171|NCT04865354|100578672|FG001|NOT COMPLETED|Second Wear Period (8 Days)||0||
48103172|NCT01708174|100578673|FG000|STARTED|Treatment Period||2||
48103173|NCT01708174|100578674|FG001|STARTED|Treatment Period||16||
48103174|NCT01708174|100578675|FG002|STARTED|Treatment Period||4||
48103175|NCT01708174|100578673|FG000|Pharmacokinetic Analysis Set|Treatment Period||2||
48103176|NCT01708174|100578674|FG001|Pharmacokinetic Analysis Set|Treatment Period||13||
48103177|NCT01708174|100578675|FG002|Pharmacokinetic Analysis Set|Treatment Period||0||
48103178|NCT01708174|100578673|FG000|COMPLETED|Treatment Period||1||
48103179|NCT01708174|100578674|FG001|COMPLETED|Treatment Period||14||
48103180|NCT01708174|100578675|FG002|COMPLETED|Treatment Period||3||
48103181|NCT01708174|100578673|FG000|NOT COMPLETED|Treatment Period||1||
48103182|NCT01708174|100578674|FG001|NOT COMPLETED|Treatment Period||2||
48103183|NCT01708174|100578675|FG002|NOT COMPLETED|Treatment Period||1||
48391550|NCT02427750|101287690|FG001|NOT COMPLETED|Overall Study||0||
48391551|NCT02591238|101287691|FG000|STARTED|Overall Study||16||
48391552|NCT02591238|101287692|FG001|STARTED|Overall Study||17||
48391553|NCT02591238|101287693|FG002|STARTED|Overall Study||17||
48103184|NCT01708174|100578673|FG000|STARTED|Survival Follow-up||1||
48103185|NCT01708174|100578674|FG001|STARTED|Survival Follow-up||10||
48103186|NCT01708174|100578675|FG002|STARTED|Survival Follow-up||0||
48103187|NCT01708174|100578673|FG000|COMPLETED|Survival Follow-up||1||
48103188|NCT01708174|100578674|FG001|COMPLETED|Survival Follow-up||10||
48103189|NCT01708174|100578675|FG002|COMPLETED|Survival Follow-up||0||
48103190|NCT01708174|100578673|FG000|NOT COMPLETED|Survival Follow-up||0||
48103191|NCT01708174|100578674|FG001|NOT COMPLETED|Survival Follow-up||0||
48103192|NCT01708174|100578675|FG002|NOT COMPLETED|Survival Follow-up||0||
48265345|NCT04596995|100971024|FG000|STARTED|Overall Study||43||
48265346|NCT04596995|100971024|FG000|COMPLETED|Overall Study||14||
48265347|NCT04596995|100971024|FG000|NOT COMPLETED|Overall Study||29||
48265348|NCT00577135|100971025|FG000|STARTED|Overall Study||74||
48265349|NCT00577135|100971026|FG001|STARTED|Overall Study||82||
48265350|NCT00577135|100971027|FG002|STARTED|Overall Study||77||
48103193|NCT03095456|100578676|FG000|STARTED|Overall Study||103||
48265351|NCT00577135|100971028|FG003|STARTED|Overall Study||75||
48265352|NCT00577135|100971025|FG000|COMPLETED|Overall Study||74||
48265353|NCT00577135|100971026|FG001|COMPLETED|Overall Study||82||
48391554|NCT02591238|101287694|FG003|STARTED|Overall Study||18||
48391555|NCT02591238|101287691|FG000|COMPLETED|Overall Study||15||
48391556|NCT02591238|101287692|FG001|COMPLETED|Overall Study||16||
48103194|NCT03095456|100578677|FG001|STARTED|Overall Study||104||
48103195|NCT03095456|100578676|FG000|COMPLETED|Overall Study||99||
48103196|NCT03095456|100578677|FG001|COMPLETED|Overall Study||96||
48103197|NCT03095456|100578676|FG000|NOT COMPLETED|Overall Study||4||
48265354|NCT00577135|100971027|FG002|COMPLETED|Overall Study||77||
48265355|NCT00577135|100971028|FG003|COMPLETED|Overall Study||75||
48265356|NCT00577135|100971025|FG000|NOT COMPLETED|Overall Study||0||
48103198|NCT03095456|100578677|FG001|NOT COMPLETED|Overall Study||8||
48103199|NCT00352846|100578678|FG000|STARTED|Overall Study||37||
48103200|NCT00352846|100578679|FG001|STARTED|Overall Study||37||
48103201|NCT00352846|100578678|FG000|COMPLETED|Overall Study||29||
48103202|NCT00352846|100578679|FG001|COMPLETED|Overall Study||24||
48103203|NCT00352846|100578678|FG000|NOT COMPLETED|Overall Study||8||
48103204|NCT00352846|100578679|FG001|NOT COMPLETED|Overall Study||13||
48103205|NCT03760146|100578680|FG000|STARTED|Overall Study||1514||
48103206|NCT03760146|100578681|FG001|STARTED|Overall Study||1495||
48103207|NCT03760146|100578682|FG002|STARTED|Overall Study||334||
48103208|NCT03760146|100578683|FG003|STARTED|Overall Study||111||
48103209|NCT03760146|100578684|FG004|STARTED|Overall Study||336||
48103210|NCT03760146|100578685|FG005|STARTED|Overall Study||112||
48103211|NCT03760146|100578680|FG000|Evaluable 13-Matched Immunogenicity Population|Overall Study||1435||
48103212|NCT03760146|100578681|FG001|Evaluable 13-Matched Immunogenicity Population|Overall Study||1420||
48103213|NCT03760146|100578682|FG002|Evaluable 13-Matched Immunogenicity Population|Overall Study||0||
48103214|NCT03760146|100578683|FG003|Evaluable 13-Matched Immunogenicity Population|Overall Study||0||
48103215|NCT03760146|100578684|FG004|Evaluable 13-Matched Immunogenicity Population|Overall Study||0||
48103216|NCT03760146|100578685|FG005|Evaluable 13-Matched Immunogenicity Population|Overall Study||0||
48103217|NCT03760146|100578680|FG000|Evaluable 7-Additional Immunogenicity Population|Overall Study||1433||
48103218|NCT03760146|100578681|FG001|Evaluable 7-Additional Immunogenicity Population|Overall Study||1383||
48103219|NCT03760146|100578682|FG002|Evaluable 7-Additional Immunogenicity Population|Overall Study||0||
48103220|NCT03760146|100578683|FG003|Evaluable 7-Additional Immunogenicity Population|Overall Study||0||
48103221|NCT03760146|100578684|FG004|Evaluable 7-Additional Immunogenicity Population|Overall Study||0||
48103222|NCT03760146|100578685|FG005|Evaluable 7-Additional Immunogenicity Population|Overall Study||0||
48103223|NCT03760146|100578680|FG000|Vaccination 1|Overall Study||1507||
48103224|NCT03760146|100578681|FG001|Vaccination 1|Overall Study||1490||
48103225|NCT03760146|100578682|FG002|Vaccination 1|Overall Study||334||
48103226|NCT03760146|100578683|FG003|Vaccination 1|Overall Study||111||
48103227|NCT03760146|100578684|FG004|Vaccination 1|Overall Study||335||
48103228|NCT03760146|100578685|FG005|Vaccination 1|Overall Study||112||
48103229|NCT03760146|100578680|FG000|Vaccination 2|Overall Study||1461||
48103230|NCT03760146|100578681|FG001|Vaccination 2|Overall Study||1446||
48103231|NCT03760146|100578682|FG002|Vaccination 2|Overall Study||0||
48103232|NCT03760146|100578683|FG003|Vaccination 2|Overall Study||0||
48103233|NCT03760146|100578684|FG004|Vaccination 2|Overall Study||0||
48103234|NCT03760146|100578685|FG005|Vaccination 2|Overall Study||0||
48103235|NCT03760146|100578680|FG000|Safety Population|Overall Study||1507||
48103236|NCT03760146|100578681|FG001|Safety Population|Overall Study||1490||
48103237|NCT03760146|100578682|FG002|Safety Population|Overall Study||334||
48391557|NCT02591238|101287693|FG002|COMPLETED|Overall Study||17||
48391558|NCT02591238|101287694|FG003|COMPLETED|Overall Study||15||
48549559|NCT00972595|101679639|FG001|STARTED|Period 1||22||
48549560|NCT00972595|101679638|FG000|COMPLETED|Period 1||22||
48549561|NCT00972595|101679639|FG001|COMPLETED|Period 1||22||
48549562|NCT00972595|101679638|FG000|NOT COMPLETED|Period 1||1||
48103238|NCT03760146|100578683|FG003|Safety Population|Overall Study||111||
48103239|NCT03760146|100578684|FG004|Safety Population|Overall Study||335||
48103240|NCT03760146|100578685|FG005|Safety Population|Overall Study||112||
48103241|NCT03760146|100578680|FG000|Evaluable-20 Immunogenicity Population|Overall Study||946||
48103242|NCT03760146|100578681|FG001|Evaluable-20 Immunogenicity Population|Overall Study||0||
48265357|NCT00577135|100971026|FG001|NOT COMPLETED|Overall Study||0||
48265358|NCT00577135|100971027|FG002|NOT COMPLETED|Overall Study||0||
48103243|NCT03760146|100578682|FG002|Evaluable-20 Immunogenicity Population|Overall Study||321||
48103244|NCT03760146|100578683|FG003|Evaluable-20 Immunogenicity Population|Overall Study||0||
48103245|NCT03760146|100578684|FG004|Evaluable-20 Immunogenicity Population|Overall Study||317||
48265359|NCT00577135|100971028|FG003|NOT COMPLETED|Overall Study||0||
48265360|NCT03080493|100971029|FG000|STARTED|Overall Study||61||
48265361|NCT03080493|100971030|FG001|STARTED|Overall Study||60||
48141397|NCT01454583|100670419|FG000|COMPLETED|1st Year||9120||
48265362|NCT03080493|100971029|FG000|COMPLETED|Overall Study||60||
48265363|NCT03080493|100971030|FG001|COMPLETED|Overall Study||58||
48265364|NCT03080493|100971029|FG000|NOT COMPLETED|Overall Study||1||
48265365|NCT03080493|100971030|FG001|NOT COMPLETED|Overall Study||2||
48265366|NCT00478205|100971031|FG000|STARTED|Overall Study||981||
48265367|NCT00478205|100971032|FG001|STARTED|Overall Study||486||
48391559|NCT02591238|101287691|FG000|NOT COMPLETED|Overall Study||1||
48391560|NCT02591238|101287692|FG001|NOT COMPLETED|Overall Study||1||
48391561|NCT02591238|101287693|FG002|NOT COMPLETED|Overall Study||0||
48549563|NCT00972595|101679639|FG001|NOT COMPLETED|Period 1||0||
48265368|NCT00478205|100971031|FG000|COMPLETED|Overall Study||685||
48549564|NCT00972595|101679638|FG000|STARTED|Period 2||22||
48265369|NCT00478205|100971032|FG001|COMPLETED|Overall Study||399||
48265370|NCT00478205|100971031|FG000|NOT COMPLETED|Overall Study||296||
48265371|NCT00478205|100971032|FG001|NOT COMPLETED|Overall Study||87||
48265372|NCT01732549|100971033|FG000|STARTED|Overall Study||71||
48265373|NCT01732549|100971034|FG001|STARTED|Overall Study||73||
48265374|NCT01732549|100971033|FG000|Ongoing in Treatment Period:Data Cut-off|Overall Study||12||
48265375|NCT01732549|100971034|FG001|Ongoing in Treatment Period:Data Cut-off|Overall Study||12||
48265376|NCT01732549|100971033|FG000|Withdrawn During Treatment:Data Cut-off|Overall Study||59||
48265377|NCT01732549|100971034|FG001|Withdrawn During Treatment:Data Cut-off|Overall Study||61||
48265378|NCT01732549|100971033|FG000|Ongoing Treatment Period:Final Analysis|Overall Study||0||
48265379|NCT01732549|100971034|FG001|Ongoing Treatment Period:Final Analysis|Overall Study||0||
48265380|NCT01732549|100971033|FG000|Withdrawn During Treatment:Final Analysi|Overall Study||71||
48265381|NCT01732549|100971034|FG001|Withdrawn During Treatment:Final Analysi|Overall Study||73||
48265382|NCT01732549|100971033|FG000|COMPLETED|Overall Study||0||
48265383|NCT01732549|100971034|FG001|COMPLETED|Overall Study||0||
48265384|NCT01732549|100971033|FG000|NOT COMPLETED|Overall Study||71||
48265385|NCT01732549|100971034|FG001|NOT COMPLETED|Overall Study||73||
48265386|NCT00475228|100971035|FG000|STARTED|Overall Study||44||
48265387|NCT00475228|100971036|FG001|STARTED|Overall Study||44||
48549565|NCT00972595|101679639|FG001|STARTED|Period 2||22||
48549566|NCT00972595|101679638|FG000|COMPLETED|Period 2||22||
48549567|NCT00972595|101679639|FG001|COMPLETED|Period 2||22||
48549568|NCT00972595|101679638|FG000|NOT COMPLETED|Period 2||0||
48549569|NCT00972595|101679639|FG001|NOT COMPLETED|Period 2||0||
48549570|NCT03420521|101679640|FG000|STARTED|Overall Study||9||
48549571|NCT03420521|101679640|FG000|COMPLETED|Overall Study||9||
48549572|NCT03420521|101679640|FG000|NOT COMPLETED|Overall Study||0||
48549573|NCT04902014|101679641|FG000|STARTED|Overall Study||10||
48549574|NCT04902014|101679642|FG001|STARTED|Overall Study||10||
48549575|NCT04902014|101679643|FG002|STARTED|Overall Study||10||
48549576|NCT04902014|101679644|FG003|STARTED|Overall Study||10||
48549577|NCT04902014|101679641|FG000|COMPLETED|Overall Study||10||
48549578|NCT04902014|101679642|FG001|COMPLETED|Overall Study||10||
48549579|NCT04902014|101679643|FG002|COMPLETED|Overall Study||10||
48549580|NCT04902014|101679644|FG003|COMPLETED|Overall Study||10||
48549581|NCT04902014|101679641|FG000|NOT COMPLETED|Overall Study||0||
48549582|NCT04902014|101679642|FG001|NOT COMPLETED|Overall Study||0||
48549583|NCT04902014|101679643|FG002|NOT COMPLETED|Overall Study||0||
48549584|NCT04902014|101679644|FG003|NOT COMPLETED|Overall Study||0||
48549585|NCT03280381|101679645|FG000|STARTED|Overall Study||101||
48549586|NCT03280381|101679646|FG001|STARTED|Overall Study||99||
48549587|NCT03280381|101679645|FG000|COMPLETED|Overall Study||101||
48549588|NCT03280381|101679646|FG001|COMPLETED|Overall Study||97||
48549589|NCT03280381|101679645|FG000|NOT COMPLETED|Overall Study||0||
48549590|NCT03280381|101679646|FG001|NOT COMPLETED|Overall Study||2||
48549591|NCT03573830|101679647|FG000|STARTED|Overall Study||364||
48549592|NCT03573830|101679648|FG001|STARTED|Overall Study||367||
48549593|NCT03573830|101679647|FG000|Reviewed Assigned Material|Overall Study||364|Whether participants completed their assigned intervention.|
48549594|NCT03573830|101679648|FG001|Reviewed Assigned Material|Overall Study||360|Whether participants completed their assigned intervention.|
48265388|NCT00475228|100971035|FG000|COMPLETED|Overall Study||27||
48265389|NCT00475228|100971036|FG001|COMPLETED|Overall Study||27||
48265390|NCT00475228|100971035|FG000|NOT COMPLETED|Overall Study||17||
48265391|NCT00475228|100971036|FG001|NOT COMPLETED|Overall Study||17||
48549595|NCT03573830|101679647|FG000|COMPLETED|Overall Study||360||
48103246|NCT03760146|100578685|FG005|Evaluable-20 Immunogenicity Population|Overall Study||0||
48103247|NCT03760146|100578680|FG000|COMPLETED|Overall Study||1418||
48103248|NCT03760146|100578681|FG001|COMPLETED|Overall Study||1417||
48103249|NCT03760146|100578682|FG002|COMPLETED|Overall Study||323||
48103250|NCT03760146|100578683|FG003|COMPLETED|Overall Study||109||
48103251|NCT03760146|100578684|FG004|COMPLETED|Overall Study||319||
48103252|NCT03760146|100578685|FG005|COMPLETED|Overall Study||104||
48103253|NCT03760146|100578680|FG000|NOT COMPLETED|Overall Study||96||
48103254|NCT03760146|100578681|FG001|NOT COMPLETED|Overall Study||78||
48103255|NCT03760146|100578682|FG002|NOT COMPLETED|Overall Study||11||
48103256|NCT03760146|100578683|FG003|NOT COMPLETED|Overall Study||2||
48103257|NCT03760146|100578684|FG004|NOT COMPLETED|Overall Study||17||
48103258|NCT03760146|100578685|FG005|NOT COMPLETED|Overall Study||8||
48103259|NCT00262509|100578686|FG000|STARTED|Overall Study||8||
48103260|NCT00262509|100578687|FG001|STARTED|Overall Study||9||
48103261|NCT00262509|100578686|FG000|COMPLETED|Overall Study||8||
48103262|NCT00262509|100578687|FG001|COMPLETED|Overall Study||9||
48103263|NCT00262509|100578686|FG000|NOT COMPLETED|Overall Study||0||
48103264|NCT00262509|100578687|FG001|NOT COMPLETED|Overall Study||0||
48103265|NCT01280552|100578688|FG000|STARTED|Overall Study||81||
48103266|NCT01280552|100578689|FG001|STARTED|Overall Study||43||
48103267|NCT01280552|100578688|FG000|COMPLETED|Overall Study||75||
48103268|NCT01280552|100578689|FG001|COMPLETED|Overall Study||42||
48103269|NCT01280552|100578688|FG000|NOT COMPLETED|Overall Study||6||
48103270|NCT01280552|100578689|FG001|NOT COMPLETED|Overall Study||1||
48103271|NCT00733746|100578690|FG000|STARTED|Overall Study||119||
48103272|NCT00733746|100578690|FG000|COMPLETED|Overall Study||114||
48103273|NCT00733746|100578690|FG000|NOT COMPLETED|Overall Study||5||
48103274|NCT03745937|100578691|FG000|STARTED|Overall Study||2||
48103275|NCT03745937|100578692|FG001|STARTED|Overall Study||6||
48103276|NCT03745937|100578693|FG002|STARTED|Overall Study||3||
48103277|NCT03745937|100578694|FG003|STARTED|Overall Study||9||
48103278|NCT03745937|100578691|FG000|COMPLETED|Overall Study||2||
48103279|NCT03745937|100578692|FG001|COMPLETED|Overall Study||5||
48103280|NCT03745937|100578693|FG002|COMPLETED|Overall Study||3||
48103281|NCT03745937|100578694|FG003|COMPLETED|Overall Study||7||
48103282|NCT03745937|100578691|FG000|NOT COMPLETED|Overall Study||0||
48103283|NCT03745937|100578692|FG001|NOT COMPLETED|Overall Study||1||
48103284|NCT03745937|100578693|FG002|NOT COMPLETED|Overall Study||0||
48103285|NCT03745937|100578694|FG003|NOT COMPLETED|Overall Study||2||
48103286|NCT01852812|100578695|FG000|STARTED|Overall Study||51||
48103287|NCT01852812|100578696|FG001|STARTED|Overall Study||18||
48103288|NCT01852812|100578697|FG002|STARTED|Overall Study||18||
48103289|NCT01852812|100578695|FG000|COMPLETED|Overall Study||51||
48103290|NCT01852812|100578696|FG001|COMPLETED|Overall Study||17||
48103291|NCT01852812|100578697|FG002|COMPLETED|Overall Study||17||
48103292|NCT01852812|100578695|FG000|NOT COMPLETED|Overall Study||0||
48103293|NCT01852812|100578696|FG001|NOT COMPLETED|Overall Study||1||
48103294|NCT01852812|100578697|FG002|NOT COMPLETED|Overall Study||1||
48103295|NCT00729183|100578698|FG000|STARTED|Overall Study||109||
48103296|NCT00729183|100578699|FG001|STARTED|Overall Study||105||
48103297|NCT00729183|100578698|FG000|COMPLETED|Overall Study||84||
48103298|NCT00729183|100578699|FG001|COMPLETED|Overall Study||90||
48103299|NCT00729183|100578698|FG000|NOT COMPLETED|Overall Study||25||
48103300|NCT00729183|100578699|FG001|NOT COMPLETED|Overall Study||15||
48103301|NCT03642717|100578700|FG000|STARTED|Overall Study||658||
48103302|NCT03642717|100578700|FG000|COMPLETED|Overall Study||620||
48103303|NCT03642717|100578700|FG000|NOT COMPLETED|Overall Study||38||
48103304|NCT01342510|100578701|FG000|STARTED|Overall Study||50||
48103305|NCT01342510|100578702|FG001|STARTED|Overall Study||50||
48103306|NCT01342510|100578703|FG002|STARTED|Overall Study||50||
48103307|NCT01342510|100578704|FG003|STARTED|Overall Study||50||
48103308|NCT01342510|100578701|FG000|COMPLETED|Overall Study||38||
48103309|NCT01342510|100578702|FG001|COMPLETED|Overall Study||44||
48103310|NCT01342510|100578703|FG002|COMPLETED|Overall Study||37||
48103311|NCT01342510|100578704|FG003|COMPLETED|Overall Study||39||
48103312|NCT01342510|100578701|FG000|NOT COMPLETED|Overall Study||12||
48103313|NCT01342510|100578702|FG001|NOT COMPLETED|Overall Study||6||
48103314|NCT01342510|100578703|FG002|NOT COMPLETED|Overall Study||13||
48103315|NCT01342510|100578704|FG003|NOT COMPLETED|Overall Study||11||
48103316|NCT02291055|100578705|FG000|STARTED|Overall Study||5||
48103317|NCT02291055|100578706|FG001|STARTED|Overall Study||5||
48103318|NCT02291055|100578707|FG002|STARTED|Overall Study||11||
48103319|NCT02291055|100578708|FG003|STARTED|Overall Study||27||
48103320|NCT02291055|100578709|FG004|STARTED|Overall Study||27||
48103321|NCT02291055|100578705|FG000|COMPLETED|Overall Study||0||
48103322|NCT02291055|100578706|FG001|COMPLETED|Overall Study||0||
48103323|NCT02291055|100578707|FG002|COMPLETED|Overall Study||3||
48103324|NCT02291055|100578708|FG003|COMPLETED|Overall Study||0||
48103325|NCT02291055|100578709|FG004|COMPLETED|Overall Study||0||
48103326|NCT02291055|100578705|FG000|NOT COMPLETED|Overall Study||5||
48103327|NCT02291055|100578706|FG001|NOT COMPLETED|Overall Study||5||
48103328|NCT02291055|100578707|FG002|NOT COMPLETED|Overall Study||8||
48103329|NCT02291055|100578708|FG003|NOT COMPLETED|Overall Study||27||
48103330|NCT02291055|100578709|FG004|NOT COMPLETED|Overall Study||27||
48265392|NCT00882115|100975217|FG000|STARTED|Overall Study||38||
48265393|NCT00882115|100975217|FG000|COMPLETED|Overall Study||29||
48265394|NCT00882115|100975217|FG000|NOT COMPLETED|Overall Study||9||
48265395|NCT00193479|100975218|FG000|STARTED|Induction Chemotherapy||51||
48265396|NCT00193479|100975218|FG000|COMPLETED|Induction Chemotherapy||48||
48265397|NCT00193479|100975218|FG000|NOT COMPLETED|Induction Chemotherapy||3||
48265398|NCT00193479|100975218|FG000|STARTED|Maintenance Rituximab||48||
48265399|NCT00193479|100975218|FG000|COMPLETED|Maintenance Rituximab||44||
48265400|NCT00193479|100975218|FG000|NOT COMPLETED|Maintenance Rituximab||4||
48265401|NCT04210843|100975219|FG000|STARTED|First Half Treatment Period (52 Weeks)||290||
48265402|NCT04210843|100975220|FG001|STARTED|First Half Treatment Period (52 Weeks)||743||
48265403|NCT04210843|100975219|FG000|COMPLETED|First Half Treatment Period (52 Weeks)||140||
48265404|NCT04210843|100975220|FG001|COMPLETED|First Half Treatment Period (52 Weeks)||369||
48265405|NCT04210843|100975219|FG000|NOT COMPLETED|First Half Treatment Period (52 Weeks)||150||
48265406|NCT04210843|100975220|FG001|NOT COMPLETED|First Half Treatment Period (52 Weeks)||374||
48265407|NCT04210843|100975219|FG000|STARTED|Second Half Treatment Period (52 Weeks)||77|Participants with Urticaria Activity Score (UAS7)\>6 at Week 52 or who relapsed (UAS7 ≥ 16) during the observation period|
48265408|NCT04210843|100975220|FG001|STARTED|Second Half Treatment Period (52 Weeks)||206|Participants with Urticaria Activity Score (UAS7)\>6 at Week 52 or who relapsed (UAS7 ≥ 16) during the observation period|
48265409|NCT04210843|100975219|FG000|COMPLETED|Second Half Treatment Period (52 Weeks)||1||
48265410|NCT04210843|100975220|FG001|COMPLETED|Second Half Treatment Period (52 Weeks)||2||
48265411|NCT04210843|100975219|FG000|NOT COMPLETED|Second Half Treatment Period (52 Weeks)||76||
48265412|NCT04210843|100975220|FG001|NOT COMPLETED|Second Half Treatment Period (52 Weeks)||204||
48265413|NCT04210843|100975219|FG000|STARTED|Observation Period 2 (up to 52 Weeks)||69|Participants with UAS7 ≤ 6 at Week 52|
48265414|NCT04210843|100975220|FG001|STARTED|Observation Period 2 (up to 52 Weeks)||201|Participants with UAS7 ≤ 6 at Week 52|
48265415|NCT04210843|100975219|FG000|COMPLETED|Observation Period 2 (up to 52 Weeks)||24||
48265416|NCT04210843|100975220|FG001|COMPLETED|Observation Period 2 (up to 52 Weeks)||91||
48265417|NCT04210843|100975219|FG000|NOT COMPLETED|Observation Period 2 (up to 52 Weeks)||45||
48265418|NCT04210843|100975220|FG001|NOT COMPLETED|Observation Period 2 (up to 52 Weeks)||110||
48265419|NCT04210843|100975219|FG000|STARTED|Follow-up Period (up to 12 or 52 Weeks)||180||
48265420|NCT04210843|100975220|FG001|STARTED|Follow-up Period (up to 12 or 52 Weeks)||471||
48265421|NCT04210843|100975219|FG000|COMPLETED|Follow-up Period (up to 12 or 52 Weeks)||157||
48265422|NCT04210843|100975220|FG001|COMPLETED|Follow-up Period (up to 12 or 52 Weeks)||407||
48265423|NCT04210843|100975219|FG000|NOT COMPLETED|Follow-up Period (up to 12 or 52 Weeks)||23||
48265424|NCT04210843|100975220|FG001|NOT COMPLETED|Follow-up Period (up to 12 or 52 Weeks)||64||
48265425|NCT05155566|100975221|FG000|STARTED|Overall Study||574||
48265426|NCT05155566|100975222|FG001|STARTED|Overall Study||273||
48265427|NCT05155566|100975221|FG000|COMPLETED|Overall Study||574||
48265428|NCT05155566|100975222|FG001|COMPLETED|Overall Study||273||
48265429|NCT05155566|100975221|FG000|NOT COMPLETED|Overall Study||0||
48265430|NCT05155566|100975222|FG001|NOT COMPLETED|Overall Study||0||
48691707|NCT01181804|102029000|FG001|NOT COMPLETED|Period 1, Fed (Part 1)||0||
48691708|NCT01181804|102029001|FG002|NOT COMPLETED|Period 1, Fed (Part 1)||0||
48691709|NCT01181804|102029002|FG003|NOT COMPLETED|Period 1, Fed (Part 1)||0||
48691710|NCT01181804|102028999|FG000|STARTED|Period 2, Fed (Part 1)||30||
48691711|NCT01181804|102029000|FG001|STARTED|Period 2, Fed (Part 1)||30||
48691712|NCT01181804|102029001|FG002|STARTED|Period 2, Fed (Part 1)||0||
48691713|NCT01181804|102029002|FG003|STARTED|Period 2, Fed (Part 1)||0||
48691714|NCT01181804|102028999|FG000|COMPLETED|Period 2, Fed (Part 1)||30||
48691715|NCT01181804|102029000|FG001|COMPLETED|Period 2, Fed (Part 1)||30||
48691716|NCT01181804|102029001|FG002|COMPLETED|Period 2, Fed (Part 1)||0||
48265431|NCT02007200|100975223|FG000|STARTED|Overall Study||55||
48265432|NCT02007200|100975223|FG000|COMPLETED|Overall Study||55||
48691717|NCT01181804|102029002|FG003|COMPLETED|Period 2, Fed (Part 1)||0||
48691718|NCT01181804|102028999|FG000|NOT COMPLETED|Period 2, Fed (Part 1)||0||
48691719|NCT01181804|102029000|FG001|NOT COMPLETED|Period 2, Fed (Part 1)||0||
48691720|NCT01181804|102029001|FG002|NOT COMPLETED|Period 2, Fed (Part 1)||0||
48691721|NCT01181804|102029002|FG003|NOT COMPLETED|Period 2, Fed (Part 1)||0||
48691722|NCT01181804|102028999|FG000|STARTED|Period 3, Fasted (Part 2)||0||
48691723|NCT01181804|102029000|FG001|STARTED|Period 3, Fasted (Part 2)||0||
48691724|NCT01181804|102029001|FG002|STARTED|Period 3, Fasted (Part 2)||59||
48691725|NCT01181804|102029002|FG003|STARTED|Period 3, Fasted (Part 2)||58||
48691726|NCT01181804|102028999|FG000|COMPLETED|Period 3, Fasted (Part 2)||0||
48691727|NCT01181804|102029000|FG001|COMPLETED|Period 3, Fasted (Part 2)||0||
48691728|NCT01181804|102029001|FG002|COMPLETED|Period 3, Fasted (Part 2)||59||
48691729|NCT01181804|102029002|FG003|COMPLETED|Period 3, Fasted (Part 2)||58||
48691730|NCT01181804|102028999|FG000|NOT COMPLETED|Period 3, Fasted (Part 2)||0||
48691731|NCT01181804|102029000|FG001|NOT COMPLETED|Period 3, Fasted (Part 2)||0||
48691732|NCT01181804|102029001|FG002|NOT COMPLETED|Period 3, Fasted (Part 2)||0||
48691733|NCT01181804|102029002|FG003|NOT COMPLETED|Period 3, Fasted (Part 2)||0||
48691734|NCT01181804|102028999|FG000|STARTED|Period 4, Fasted (Part 2)||0||
48691735|NCT01181804|102029000|FG001|STARTED|Period 4, Fasted (Part 2)||0||
48691736|NCT01181804|102029001|FG002|STARTED|Period 4, Fasted (Part 2)||59||
48691737|NCT01181804|102029002|FG003|STARTED|Period 4, Fasted (Part 2)||58||
48691738|NCT01181804|102028999|FG000|COMPLETED|Period 4, Fasted (Part 2)||0||
48691739|NCT01181804|102029000|FG001|COMPLETED|Period 4, Fasted (Part 2)||0||
48691740|NCT01181804|102029001|FG002|COMPLETED|Period 4, Fasted (Part 2)||58||
48691741|NCT01181804|102029002|FG003|COMPLETED|Period 4, Fasted (Part 2)||58||
48691742|NCT01181804|102028999|FG000|NOT COMPLETED|Period 4, Fasted (Part 2)||0||
48691743|NCT01181804|102029000|FG001|NOT COMPLETED|Period 4, Fasted (Part 2)||0||
48103331|NCT01150123|100578710|FG000|STARTED|Overall Study||40||
48265433|NCT02007200|100975223|FG000|NOT COMPLETED|Overall Study||0||
48265434|NCT02366143|100975224|FG000|STARTED|Overall Study||400||
48265435|NCT02366143|100975225|FG001|STARTED|Overall Study||400||
48265436|NCT02366143|100975226|FG002|STARTED|Overall Study||402||
48265437|NCT02366143|100975224|FG000|COMPLETED|Overall Study||0||
48265438|NCT02366143|100975225|FG001|COMPLETED|Overall Study||0||
48265439|NCT02366143|100975226|FG002|COMPLETED|Overall Study||0||
48265440|NCT02366143|100975224|FG000|NOT COMPLETED|Overall Study||400||
48265441|NCT02366143|100975225|FG001|NOT COMPLETED|Overall Study||400||
48265442|NCT02366143|100975226|FG002|NOT COMPLETED|Overall Study||402||
48265443|NCT00780455|100975227|FG000|STARTED|Overall Study||2||
48265444|NCT00780455|100975228|FG001|STARTED|Overall Study||2||
48265445|NCT00780455|100975227|FG000|COMPLETED|Overall Study||2||
48265446|NCT00780455|100975228|FG001|COMPLETED|Overall Study||2||
48265447|NCT00780455|100975227|FG000|NOT COMPLETED|Overall Study||0||
48265448|NCT00780455|100975228|FG001|NOT COMPLETED|Overall Study||0||
48265449|NCT01908751|100975229|FG000|STARTED|Overall Study||22||
48265450|NCT01908751|100975230|FG001|STARTED|Overall Study||23||
48265451|NCT01908751|100975231|FG002|STARTED|Overall Study||21||
48265452|NCT01908751|100975232|FG003|STARTED|Overall Study||20||
48265453|NCT01908751|100975229|FG000|COMPLETED|Overall Study||17||
48265454|NCT01908751|100975230|FG001|COMPLETED|Overall Study||18||
48265455|NCT01908751|100975231|FG002|COMPLETED|Overall Study||16||
48265456|NCT01908751|100975232|FG003|COMPLETED|Overall Study||16||
48265457|NCT01908751|100975229|FG000|NOT COMPLETED|Overall Study||5||
48265458|NCT01908751|100975230|FG001|NOT COMPLETED|Overall Study||5||
48265459|NCT01908751|100975231|FG002|NOT COMPLETED|Overall Study||5||
48549596|NCT03573830|101679648|FG001|COMPLETED|Overall Study||360||
48549597|NCT03573830|101679647|FG000|NOT COMPLETED|Overall Study||4||
48549598|NCT03573830|101679648|FG001|NOT COMPLETED|Overall Study||7||
48549599|NCT00489255|101679649|FG000|STARTED|Screening and Initial Randomization||145||
48549600|NCT00489255|101679650|FG001|STARTED|Screening and Initial Randomization||49||
48549601|NCT00489255|101679649|FG000|COMPLETED|Screening and Initial Randomization||136||
48549602|NCT00489255|101679650|FG001|COMPLETED|Screening and Initial Randomization||46||
48549603|NCT00489255|101679649|FG000|NOT COMPLETED|Screening and Initial Randomization||9||
48549604|NCT00489255|101679650|FG001|NOT COMPLETED|Screening and Initial Randomization||3||
48549605|NCT00489255|101679649|FG000|STARTED|Period 1: Days 1 to 28||136||
48549606|NCT00489255|101679650|FG001|STARTED|Period 1: Days 1 to 28||46||
48549607|NCT00489255|101679649|FG000|Completed and Follow Period 2|Period 1: Days 1 to 28||94||
48549608|NCT00489255|101679650|FG001|Completed and Follow Period 2|Period 1: Days 1 to 28||29||
48549609|NCT00489255|101679649|FG000|Completed But Discontinued Study|Period 1: Days 1 to 28||13||
48549610|NCT00489255|101679650|FG001|Completed But Discontinued Study|Period 1: Days 1 to 28||5||
48549611|NCT00489255|101679649|FG000|COMPLETED|Period 1: Days 1 to 28||107||
48549612|NCT00489255|101679650|FG001|COMPLETED|Period 1: Days 1 to 28||34||
48549613|NCT00489255|101679649|FG000|NOT COMPLETED|Period 1: Days 1 to 28||29||
48549614|NCT00489255|101679650|FG001|NOT COMPLETED|Period 1: Days 1 to 28||12||
48549615|NCT00489255|101679649|FG000|STARTED|Period 2: Days 29 to 56||64||
48549616|NCT00489255|101679650|FG001|STARTED|Period 2: Days 29 to 56||59||
48549617|NCT00489255|101679649|FG000|Completed and Follow Period 3|Period 2: Days 29 to 56||58||
48549618|NCT00489255|101679650|FG001|Completed and Follow Period 3|Period 2: Days 29 to 56||52||
48549619|NCT00489255|101679649|FG000|Completed But Discontinued Study|Period 2: Days 29 to 56||3||
48549620|NCT00489255|101679650|FG001|Completed But Discontinued Study|Period 2: Days 29 to 56||3||
48549621|NCT00489255|101679649|FG000|COMPLETED|Period 2: Days 29 to 56||61||
48549622|NCT00489255|101679650|FG001|COMPLETED|Period 2: Days 29 to 56||55||
48265460|NCT01908751|100975232|FG003|NOT COMPLETED|Overall Study||4||
48265461|NCT00706654|100975233|FG000|STARTED|Conversion Phase||709||
48265462|NCT00706654|100975234|FG001|STARTED|Conversion Phase||0||
48265463|NCT00706654|100975235|FG002|STARTED|Conversion Phase||0||
48265464|NCT00706654|100975236|FG003|STARTED|Conversion Phase||0||
48265465|NCT00706654|100975233|FG000|COMPLETED|Conversion Phase||614||
48265466|NCT00706654|100975234|FG001|COMPLETED|Conversion Phase||0||
48265467|NCT00706654|100975235|FG002|COMPLETED|Conversion Phase||0||
48549623|NCT00489255|101679649|FG000|NOT COMPLETED|Period 2: Days 29 to 56||3||
48549624|NCT00489255|101679650|FG001|NOT COMPLETED|Period 2: Days 29 to 56||4||
48691744|NCT01181804|102029001|FG002|NOT COMPLETED|Period 4, Fasted (Part 2)||1||
48691745|NCT01181804|102029002|FG003|NOT COMPLETED|Period 4, Fasted (Part 2)||0||
48691746|NCT02266147|102029003|FG000|STARTED|PART 1: Dose Escalation||3||
48691747|NCT02266147|102029004|FG001|STARTED|PART 1: Dose Escalation||3||
48691748|NCT02266147|102029005|FG002|STARTED|PART 1: Dose Escalation||3||
48691749|NCT02266147|102029006|FG003|STARTED|PART 1: Dose Escalation||4||
48103332|NCT01150123|100578711|FG001|STARTED|Overall Study||40||
48265468|NCT00706654|100975236|FG003|COMPLETED|Conversion Phase||0||
48265469|NCT00706654|100975233|FG000|NOT COMPLETED|Conversion Phase||95||
48549625|NCT00489255|101679649|FG000|STARTED|Period 3: Days 57 to 84||28||
48549626|NCT00489255|101679650|FG001|STARTED|Period 3: Days 57 to 84||82||
48549627|NCT00489255|101679649|FG000|COMPLETED|Period 3: Days 57 to 84||24||
48549628|NCT00489255|101679650|FG001|COMPLETED|Period 3: Days 57 to 84||78||
48549629|NCT00489255|101679649|FG000|NOT COMPLETED|Period 3: Days 57 to 84||4||
48549630|NCT00489255|101679650|FG001|NOT COMPLETED|Period 3: Days 57 to 84||4||
48549631|NCT01598194|101679651|FG000|STARTED|Overall Study||30||
48549632|NCT01598194|101679652|FG001|STARTED|Overall Study||30||
48549633|NCT01598194|101679651|FG000|2 Passes With 25G for Cytology|Overall Study||30||
48549634|NCT01598194|101679652|FG001|2 Passes With 25G for Cytology|Overall Study||30||
48549635|NCT01598194|101679651|FG000|1 Pass With 22Gpc for Cytology|Overall Study||29||
48549636|NCT01598194|101679652|FG001|1 Pass With 22Gpc for Cytology|Overall Study||30||
48549637|NCT01598194|101679651|FG000|1 Pass With 22Gpc for Histology|Overall Study||27||
48549638|NCT01598194|101679652|FG001|1 Pass With 22Gpc for Histology|Overall Study||29||
48549639|NCT01598194|101679651|FG000|COMPLETED|Overall Study||30||
48549640|NCT01598194|101679652|FG001|COMPLETED|Overall Study||30||
48549641|NCT01598194|101679651|FG000|NOT COMPLETED|Overall Study||0||
48549642|NCT01598194|101679652|FG001|NOT COMPLETED|Overall Study||0||
48549643|NCT02533180|101679653|FG000|STARTED|Overall Study||39||
48549644|NCT02533180|101679654|FG001|STARTED|Overall Study||61||
48549645|NCT02533180|101679653|FG000|COMPLETED|Overall Study||0||
48549646|NCT02533180|101679654|FG001|COMPLETED|Overall Study||50||
48549647|NCT02533180|101679653|FG000|NOT COMPLETED|Overall Study||39||
48549648|NCT02533180|101679654|FG001|NOT COMPLETED|Overall Study||11||
48549649|NCT00377832|101679655|FG000|STARTED|Overall Study||7||
48549650|NCT00377832|101679656|FG001|STARTED|Overall Study||6||
48549651|NCT00377832|101679655|FG000|COMPLETED|Overall Study||7||
48549652|NCT00377832|101679656|FG001|COMPLETED|Overall Study||6||
48549653|NCT00377832|101679655|FG000|NOT COMPLETED|Overall Study||0||
48549654|NCT00377832|101679656|FG001|NOT COMPLETED|Overall Study||0||
48549655|NCT02730663|101679657|FG000|STARTED|Overall Study||36|1 subject in screening failure(impossible to undergo the stent procedure)|
48549656|NCT02730663|101679657|FG000|COMPLETED|Overall Study||35||
48549657|NCT02730663|101679657|FG000|NOT COMPLETED|Overall Study||1||
48549658|NCT04520009|101679658|FG000|STARTED|Overall Study||19||
48549659|NCT04520009|101679659|FG001|STARTED|Overall Study||18||
48549660|NCT04520009|101679658|FG000|COMPLETED|Overall Study||19||
48549661|NCT04520009|101679659|FG001|COMPLETED|Overall Study||18||
48549662|NCT04520009|101679658|FG000|NOT COMPLETED|Overall Study||0||
48549663|NCT04520009|101679659|FG001|NOT COMPLETED|Overall Study||0||
48549664|NCT01256502|101679660|FG000|STARTED|Overall Study||139||
48549665|NCT01256502|101679660|FG000|COMPLETED|Overall Study||129||
48549666|NCT01256502|101679660|FG000|NOT COMPLETED|Overall Study||10||
48549667|NCT03071276|101679661|FG000|STARTED|Overall Study||37||
48549668|NCT03071276|101679661|FG000|COMPLETED|Overall Study||22||
48549669|NCT03071276|101679661|FG000|NOT COMPLETED|Overall Study||15||
48549670|NCT03672227|101679662|FG000|STARTED|Overall Study||112||
48549671|NCT03672227|101679663|FG001|STARTED|Overall Study||52||
48549672|NCT03672227|101679662|FG000|Teachers Started|Overall Study||8||
48549673|NCT03672227|101679663|FG001|Teachers Started|Overall Study||6||
48549674|NCT03672227|101679662|FG000|Children Started|Overall Study||52||
48549675|NCT03672227|101679663|FG001|Children Started|Overall Study||23||
48549676|NCT03672227|101679662|FG000|Parents Started|Overall Study||52||
48549677|NCT03672227|101679663|FG001|Parents Started|Overall Study||23||
48549678|NCT03672227|101679662|FG000|COMPLETED|Overall Study||105||
48549679|NCT03672227|101679663|FG001|COMPLETED|Overall Study||52||
48549680|NCT03672227|101679662|FG000|NOT COMPLETED|Overall Study||7||
48549681|NCT03672227|101679663|FG001|NOT COMPLETED|Overall Study||0||
48549682|NCT01682811|101679664|FG000|STARTED|Part 1 Levulan Injection||1||9
48549683|NCT01682811|101679665|FG001|STARTED|Part 1 Levulan Injection||0||0
48549684|NCT01682811|101679666|FG002|STARTED|Part 1 Levulan Injection||0||0
48549685|NCT01682811|101679667|FG003|STARTED|Part 1 Levulan Injection||0||0
48549686|NCT01682811|101679668|FG004|STARTED|Part 1 Levulan Injection||0||0
48549687|NCT01682811|101679669|FG005|STARTED|Part 1 Levulan Injection||0||0
48549688|NCT01682811|101679670|FG006|STARTED|Part 1 Levulan Injection||0||0
48549689|NCT01682811|101679664|FG000|Control|Part 1 Levulan Injection||1||3
48549690|NCT01682811|101679665|FG001|Control|Part 1 Levulan Injection||0||0
48549691|NCT01682811|101679666|FG002|Control|Part 1 Levulan Injection||0||0
48549692|NCT01682811|101679667|FG003|Control|Part 1 Levulan Injection||0||0
48549693|NCT01682811|101679668|FG004|Control|Part 1 Levulan Injection||0||0
48549694|NCT01682811|101679669|FG005|Control|Part 1 Levulan Injection||0||0
48549695|NCT01682811|101679670|FG006|Control|Part 1 Levulan Injection||0||0
48549696|NCT01682811|101679664|FG000|Treated 3 Hours|Part 1 Levulan Injection||1||3
48549697|NCT01682811|101679665|FG001|Treated 3 Hours|Part 1 Levulan Injection||0||0
48549698|NCT01682811|101679666|FG002|Treated 3 Hours|Part 1 Levulan Injection||0||0
48549699|NCT01682811|101679667|FG003|Treated 3 Hours|Part 1 Levulan Injection||0||0
48549700|NCT01682811|101679668|FG004|Treated 3 Hours|Part 1 Levulan Injection||0||0
48549701|NCT01682811|101679669|FG005|Treated 3 Hours|Part 1 Levulan Injection||0||0
48549702|NCT01682811|101679670|FG006|Treated 3 Hours|Part 1 Levulan Injection||0||0
48549703|NCT01682811|101679664|FG000|Treated 24 Hours|Part 1 Levulan Injection||1||3
48103333|NCT01150123|100578712|FG002|STARTED|Overall Study||39||
48103334|NCT01150123|100578713|FG003|STARTED|Overall Study||40||
48103335|NCT01150123|100578714|FG004|STARTED|Overall Study||40||
48103336|NCT01150123|100578715|FG005|STARTED|Overall Study||40||
48103337|NCT01150123|100578716|FG006|STARTED|Overall Study||39||
48549704|NCT01682811|101679665|FG001|Treated 24 Hours|Part 1 Levulan Injection||0||0
48549705|NCT01682811|101679666|FG002|Treated 24 Hours|Part 1 Levulan Injection||0||0
48549706|NCT01682811|101679667|FG003|Treated 24 Hours|Part 1 Levulan Injection||0||0
48549707|NCT01682811|101679668|FG004|Treated 24 Hours|Part 1 Levulan Injection||0||0
48549708|NCT01682811|101679669|FG005|Treated 24 Hours|Part 1 Levulan Injection||0||0
48549709|NCT01682811|101679670|FG006|Treated 24 Hours|Part 1 Levulan Injection||0||0
48549710|NCT01682811|101679664|FG000|COMPLETED|Part 1 Levulan Injection||1||9
48549711|NCT01682811|101679665|FG001|COMPLETED|Part 1 Levulan Injection||0||0
48549712|NCT01682811|101679666|FG002|COMPLETED|Part 1 Levulan Injection||0||0
48549713|NCT01682811|101679667|FG003|COMPLETED|Part 1 Levulan Injection||0||0
48549714|NCT01682811|101679668|FG004|COMPLETED|Part 1 Levulan Injection||0||0
48549715|NCT01682811|101679669|FG005|COMPLETED|Part 1 Levulan Injection||0||0
48549716|NCT01682811|101679670|FG006|COMPLETED|Part 1 Levulan Injection||0||0
48549717|NCT01682811|101679664|FG000|NOT COMPLETED|Part 1 Levulan Injection||0||0
48549718|NCT01682811|101679665|FG001|NOT COMPLETED|Part 1 Levulan Injection||0||0
48549719|NCT01682811|101679666|FG002|NOT COMPLETED|Part 1 Levulan Injection||0||0
48549720|NCT01682811|101679667|FG003|NOT COMPLETED|Part 1 Levulan Injection||0||0
48549721|NCT01682811|101679668|FG004|NOT COMPLETED|Part 1 Levulan Injection||0||0
48549722|NCT01682811|101679669|FG005|NOT COMPLETED|Part 1 Levulan Injection||0||0
48549723|NCT01682811|101679670|FG006|NOT COMPLETED|Part 1 Levulan Injection||0||0
48549724|NCT01682811|101679664|FG000|STARTED|Part 1 Levulan Painting||0||0
48103338|NCT01150123|100578717|FG007|STARTED|Overall Study||40||
48103339|NCT01150123|100578718|FG008|STARTED|Overall Study||20||
48103340|NCT01150123|100578719|FG009|STARTED|Overall Study||40||
48103341|NCT01150123|100578720|FG010|STARTED|Overall Study||40||
48103342|NCT01150123|100578721|FG011|STARTED|Overall Study||40||
48103343|NCT01150123|100578722|FG012|STARTED|Overall Study||40||
48103344|NCT01150123|100578723|FG013|STARTED|Overall Study||40||
48103345|NCT01150123|100578724|FG014|STARTED|Overall Study||40||
48103346|NCT01150123|100578725|FG015|STARTED|Overall Study||40||
48103347|NCT01150123|100578726|FG016|STARTED|Overall Study||40||
48103348|NCT01150123|100578727|FG017|STARTED|Overall Study||20||
48103349|NCT01150123|100578710|FG000|COMPLETED|Overall Study||37||
48103350|NCT01150123|100578711|FG001|COMPLETED|Overall Study||38||
48103351|NCT01150123|100578712|FG002|COMPLETED|Overall Study||35||
48103352|NCT01150123|100578713|FG003|COMPLETED|Overall Study||37||
48103353|NCT01150123|100578714|FG004|COMPLETED|Overall Study||37||
48103354|NCT01150123|100578715|FG005|COMPLETED|Overall Study||34||
48103355|NCT01150123|100578716|FG006|COMPLETED|Overall Study||39||
48103356|NCT01150123|100578717|FG007|COMPLETED|Overall Study||37||
48103357|NCT01150123|100578718|FG008|COMPLETED|Overall Study||15||
48103358|NCT01150123|100578719|FG009|COMPLETED|Overall Study||39||
48103359|NCT01150123|100578720|FG010|COMPLETED|Overall Study||38||
48103360|NCT01150123|100578721|FG011|COMPLETED|Overall Study||39||
48103361|NCT01150123|100578722|FG012|COMPLETED|Overall Study||37||
48103362|NCT01150123|100578723|FG013|COMPLETED|Overall Study||40||
48549725|NCT01682811|101679665|FG001|STARTED|Part 1 Levulan Painting||1||9
48549726|NCT01682811|101679666|FG002|STARTED|Part 1 Levulan Painting||0||0
48549727|NCT01682811|101679667|FG003|STARTED|Part 1 Levulan Painting||0||0
48549728|NCT01682811|101679668|FG004|STARTED|Part 1 Levulan Painting||0||0
48549729|NCT01682811|101679669|FG005|STARTED|Part 1 Levulan Painting||0||0
48549730|NCT01682811|101679670|FG006|STARTED|Part 1 Levulan Painting||0||0
48549731|NCT01682811|101679664|FG000|Control|Part 1 Levulan Painting||0||0
48549732|NCT01682811|101679665|FG001|Control|Part 1 Levulan Painting||1||3
48549733|NCT01682811|101679666|FG002|Control|Part 1 Levulan Painting||0||0
48549734|NCT01682811|101679667|FG003|Control|Part 1 Levulan Painting||0||0
48549735|NCT01682811|101679668|FG004|Control|Part 1 Levulan Painting||0||0
48549736|NCT01682811|101679669|FG005|Control|Part 1 Levulan Painting||0||0
48549737|NCT01682811|101679670|FG006|Control|Part 1 Levulan Painting||0||0
48549738|NCT01682811|101679664|FG000|Treated 3 Hours|Part 1 Levulan Painting||0||0
48549739|NCT01682811|101679665|FG001|Treated 3 Hours|Part 1 Levulan Painting||1||3
48549740|NCT01682811|101679666|FG002|Treated 3 Hours|Part 1 Levulan Painting||0||0
48549741|NCT01682811|101679667|FG003|Treated 3 Hours|Part 1 Levulan Painting||0||0
48549742|NCT01682811|101679668|FG004|Treated 3 Hours|Part 1 Levulan Painting||0||0
48549743|NCT01682811|101679669|FG005|Treated 3 Hours|Part 1 Levulan Painting||0||0
48549744|NCT01682811|101679670|FG006|Treated 3 Hours|Part 1 Levulan Painting||0||0
48549745|NCT01682811|101679664|FG000|Treated 24 Hours|Part 1 Levulan Painting||0||0
48103363|NCT01150123|100578724|FG014|COMPLETED|Overall Study||40||
48103364|NCT01150123|100578725|FG015|COMPLETED|Overall Study||39||
48103365|NCT01150123|100578726|FG016|COMPLETED|Overall Study||40||
48103366|NCT01150123|100578727|FG017|COMPLETED|Overall Study||19||
48103367|NCT01150123|100578710|FG000|NOT COMPLETED|Overall Study||3||
48103368|NCT01150123|100578711|FG001|NOT COMPLETED|Overall Study||2||
48103369|NCT01150123|100578712|FG002|NOT COMPLETED|Overall Study||4||
48265470|NCT00706654|100975234|FG001|NOT COMPLETED|Conversion Phase||0||
48265471|NCT00706654|100975235|FG002|NOT COMPLETED|Conversion Phase||0||
48265472|NCT00706654|100975236|FG003|NOT COMPLETED|Conversion Phase||0||
48265473|NCT00706654|100975233|FG000|STARTED|Oral Stabilization Phase||842||
48265474|NCT00706654|100975234|FG001|STARTED|Oral Stabilization Phase||0||
48265475|NCT00706654|100975235|FG002|STARTED|Oral Stabilization Phase||0||
48265476|NCT00706654|100975236|FG003|STARTED|Oral Stabilization Phase||0||
48265477|NCT00706654|100975233|FG000|COMPLETED|Oral Stabilization Phase||662||
48265478|NCT00706654|100975234|FG001|COMPLETED|Oral Stabilization Phase||0||
48265479|NCT00706654|100975235|FG002|COMPLETED|Oral Stabilization Phase||0||
48265480|NCT00706654|100975236|FG003|COMPLETED|Oral Stabilization Phase||0||
48265481|NCT00706654|100975233|FG000|NOT COMPLETED|Oral Stabilization Phase||180||
48265482|NCT00706654|100975234|FG001|NOT COMPLETED|Oral Stabilization Phase||0||
48265483|NCT00706654|100975235|FG002|NOT COMPLETED|Oral Stabilization Phase||0||
48265484|NCT00706654|100975236|FG003|NOT COMPLETED|Oral Stabilization Phase||0||
48265485|NCT00706654|100975233|FG000|STARTED|Depot Maintenance Phase||0||
48265486|NCT00706654|100975234|FG001|STARTED|Depot Maintenance Phase||265||
48265487|NCT00706654|100975235|FG002|STARTED|Depot Maintenance Phase||266||
48265488|NCT00706654|100975236|FG003|STARTED|Depot Maintenance Phase||131||
48265489|NCT00706654|100975233|FG000|COMPLETED|Depot Maintenance Phase||0||
48265490|NCT00706654|100975234|FG001|COMPLETED|Depot Maintenance Phase||196||
48265491|NCT00706654|100975235|FG002|COMPLETED|Depot Maintenance Phase||178||
48265492|NCT00706654|100975236|FG003|COMPLETED|Depot Maintenance Phase||61||
48265493|NCT00706654|100975233|FG000|NOT COMPLETED|Depot Maintenance Phase||0||
48265494|NCT00706654|100975234|FG001|NOT COMPLETED|Depot Maintenance Phase||69||
48265495|NCT00706654|100975235|FG002|NOT COMPLETED|Depot Maintenance Phase||88||
48265496|NCT00706654|100975236|FG003|NOT COMPLETED|Depot Maintenance Phase||70||
48265497|NCT01594827|100975237|FG000|STARTED|Overall Study||14||
48265498|NCT01594827|100975238|FG001|STARTED|Overall Study||15||
48265499|NCT01594827|100975237|FG000|COMPLETED|Overall Study||10||
48549746|NCT01682811|101679665|FG001|Treated 24 Hours|Part 1 Levulan Painting||1||3
48549747|NCT01682811|101679666|FG002|Treated 24 Hours|Part 1 Levulan Painting||0||0
48549748|NCT01682811|101679667|FG003|Treated 24 Hours|Part 1 Levulan Painting||0||0
48549749|NCT01682811|101679668|FG004|Treated 24 Hours|Part 1 Levulan Painting||0||0
48549750|NCT01682811|101679669|FG005|Treated 24 Hours|Part 1 Levulan Painting||0||0
48549751|NCT01682811|101679670|FG006|Treated 24 Hours|Part 1 Levulan Painting||0||0
48549752|NCT01682811|101679664|FG000|COMPLETED|Part 1 Levulan Painting||0||0
48549753|NCT01682811|101679665|FG001|COMPLETED|Part 1 Levulan Painting||1||9
48549754|NCT01682811|101679666|FG002|COMPLETED|Part 1 Levulan Painting||0||0
48549755|NCT01682811|101679667|FG003|COMPLETED|Part 1 Levulan Painting||0||0
48549756|NCT01682811|101679668|FG004|COMPLETED|Part 1 Levulan Painting||0||0
48549757|NCT01682811|101679669|FG005|COMPLETED|Part 1 Levulan Painting||0||0
48549758|NCT01682811|101679670|FG006|COMPLETED|Part 1 Levulan Painting||0||0
48549759|NCT01682811|101679664|FG000|NOT COMPLETED|Part 1 Levulan Painting||0||0
48549760|NCT01682811|101679665|FG001|NOT COMPLETED|Part 1 Levulan Painting||0||0
48549761|NCT01682811|101679666|FG002|NOT COMPLETED|Part 1 Levulan Painting||0||0
48549762|NCT01682811|101679667|FG003|NOT COMPLETED|Part 1 Levulan Painting||0||0
48549763|NCT01682811|101679668|FG004|NOT COMPLETED|Part 1 Levulan Painting||0||0
48265500|NCT01594827|100975238|FG001|COMPLETED|Overall Study||15||
48549764|NCT01682811|101679669|FG005|NOT COMPLETED|Part 1 Levulan Painting||0||0
48549765|NCT01682811|101679670|FG006|NOT COMPLETED|Part 1 Levulan Painting||0||0
48549766|NCT01682811|101679664|FG000|STARTED|Part 1 Levulan Painted Twice||0||0
48549767|NCT01682811|101679665|FG001|STARTED|Part 1 Levulan Painted Twice||0||0
48549768|NCT01682811|101679666|FG002|STARTED|Part 1 Levulan Painted Twice||2||12
48549769|NCT01682811|101679667|FG003|STARTED|Part 1 Levulan Painted Twice||0||0
48549770|NCT01682811|101679668|FG004|STARTED|Part 1 Levulan Painted Twice||0||0
48549771|NCT01682811|101679669|FG005|STARTED|Part 1 Levulan Painted Twice||0||0
48549772|NCT01682811|101679670|FG006|STARTED|Part 1 Levulan Painted Twice||0||0
48549773|NCT01682811|101679664|FG000|Control|Part 1 Levulan Painted Twice||0||0
48549774|NCT01682811|101679665|FG001|Control|Part 1 Levulan Painted Twice||0||0
48549775|NCT01682811|101679666|FG002|Control|Part 1 Levulan Painted Twice||2||6
48549776|NCT01682811|101679667|FG003|Control|Part 1 Levulan Painted Twice||0||0
48549777|NCT01682811|101679668|FG004|Control|Part 1 Levulan Painted Twice||0||0
48549778|NCT01682811|101679669|FG005|Control|Part 1 Levulan Painted Twice||0||0
48549779|NCT01682811|101679670|FG006|Control|Part 1 Levulan Painted Twice||0||0
48549780|NCT01682811|101679664|FG000|Treated 24 Hours|Part 1 Levulan Painted Twice||0||0
48549781|NCT01682811|101679665|FG001|Treated 24 Hours|Part 1 Levulan Painted Twice||0||0
48265501|NCT01594827|100975237|FG000|NOT COMPLETED|Overall Study||4||
48265502|NCT01594827|100975238|FG001|NOT COMPLETED|Overall Study||0||
48265503|NCT01774045|100975239|FG000|STARTED|Overall Study||23||
48265504|NCT01774045|100975240|FG001|STARTED|Overall Study||7||
48265505|NCT01774045|100975239|FG000|COMPLETED|Overall Study||23||
48265506|NCT01774045|100975240|FG001|COMPLETED|Overall Study||7||
48265507|NCT01774045|100975239|FG000|NOT COMPLETED|Overall Study||0||
48265508|NCT01774045|100975240|FG001|NOT COMPLETED|Overall Study||0||
48265509|NCT01512797|100975241|FG000|STARTED|Overall Study||16||
48265510|NCT01512797|100975242|FG001|STARTED|Overall Study||16||
48549782|NCT01682811|101679666|FG002|Treated 24 Hours|Part 1 Levulan Painted Twice||2||6
48549783|NCT01682811|101679667|FG003|Treated 24 Hours|Part 1 Levulan Painted Twice||0||0
48549784|NCT01682811|101679668|FG004|Treated 24 Hours|Part 1 Levulan Painted Twice||0||0
48549785|NCT01682811|101679669|FG005|Treated 24 Hours|Part 1 Levulan Painted Twice||0||0
48549786|NCT01682811|101679670|FG006|Treated 24 Hours|Part 1 Levulan Painted Twice||0||0
48549787|NCT01682811|101679664|FG000|COMPLETED|Part 1 Levulan Painted Twice||0||0
48549788|NCT01682811|101679665|FG001|COMPLETED|Part 1 Levulan Painted Twice||0||0
48549789|NCT01682811|101679666|FG002|COMPLETED|Part 1 Levulan Painted Twice||2||12
48549790|NCT01682811|101679667|FG003|COMPLETED|Part 1 Levulan Painted Twice||0||0
48549791|NCT01682811|101679668|FG004|COMPLETED|Part 1 Levulan Painted Twice||0||0
48549792|NCT01682811|101679669|FG005|COMPLETED|Part 1 Levulan Painted Twice||0||0
48549793|NCT01682811|101679670|FG006|COMPLETED|Part 1 Levulan Painted Twice||0||0
48549794|NCT01682811|101679664|FG000|NOT COMPLETED|Part 1 Levulan Painted Twice||0||0
48549795|NCT01682811|101679665|FG001|NOT COMPLETED|Part 1 Levulan Painted Twice||0||0
48549796|NCT01682811|101679666|FG002|NOT COMPLETED|Part 1 Levulan Painted Twice||0||0
48549797|NCT01682811|101679667|FG003|NOT COMPLETED|Part 1 Levulan Painted Twice||0||0
48549798|NCT01682811|101679668|FG004|NOT COMPLETED|Part 1 Levulan Painted Twice||0||0
48549799|NCT01682811|101679669|FG005|NOT COMPLETED|Part 1 Levulan Painted Twice||0||0
48549800|NCT01682811|101679670|FG006|NOT COMPLETED|Part 1 Levulan Painted Twice||0||0
48549801|NCT01682811|101679664|FG000|STARTED|Part 1 Levulan Paint Twice Microneedling||0||0
48549802|NCT01682811|101679665|FG001|STARTED|Part 1 Levulan Paint Twice Microneedling||0||0
48549803|NCT01682811|101679666|FG002|STARTED|Part 1 Levulan Paint Twice Microneedling||0||0
48549804|NCT01682811|101679667|FG003|STARTED|Part 1 Levulan Paint Twice Microneedling||2||12
48549805|NCT01682811|101679668|FG004|STARTED|Part 1 Levulan Paint Twice Microneedling||0||0
48265511|NCT01512797|100975241|FG000|COMPLETED|Overall Study||16||
48549806|NCT01682811|101679669|FG005|STARTED|Part 1 Levulan Paint Twice Microneedling||0||0
48549807|NCT01682811|101679670|FG006|STARTED|Part 1 Levulan Paint Twice Microneedling||0||0
48549808|NCT01682811|101679664|FG000|Control|Part 1 Levulan Paint Twice Microneedling||0||0
48549809|NCT01682811|101679665|FG001|Control|Part 1 Levulan Paint Twice Microneedling||0||0
48549810|NCT01682811|101679666|FG002|Control|Part 1 Levulan Paint Twice Microneedling||0||0
48549811|NCT01682811|101679667|FG003|Control|Part 1 Levulan Paint Twice Microneedling||2||6
48549812|NCT01682811|101679668|FG004|Control|Part 1 Levulan Paint Twice Microneedling||0||0
48549813|NCT01682811|101679669|FG005|Control|Part 1 Levulan Paint Twice Microneedling||0||0
48549814|NCT01682811|101679670|FG006|Control|Part 1 Levulan Paint Twice Microneedling||0||0
48549815|NCT01682811|101679664|FG000|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0||0
48549816|NCT01682811|101679665|FG001|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0||0
48549817|NCT01682811|101679666|FG002|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0||0
48549818|NCT01682811|101679667|FG003|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||2||6
48549819|NCT01682811|101679668|FG004|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0||0
48549820|NCT01682811|101679669|FG005|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0||0
48549821|NCT01682811|101679670|FG006|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0||0
48549822|NCT01682811|101679664|FG000|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0||0
48549823|NCT01682811|101679665|FG001|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0||0
48549824|NCT01682811|101679666|FG002|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0||0
48549825|NCT01682811|101679667|FG003|COMPLETED|Part 1 Levulan Paint Twice Microneedling||2||12
48549826|NCT01682811|101679668|FG004|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0||0
48549827|NCT01682811|101679669|FG005|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0||0
48549828|NCT01682811|101679670|FG006|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0||0
48549829|NCT01682811|101679664|FG000|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0||0
48549830|NCT01682811|101679665|FG001|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0||0
48549831|NCT01682811|101679666|FG002|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0||0
48549832|NCT01682811|101679667|FG003|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0||0
48549833|NCT01682811|101679668|FG004|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0||0
48549834|NCT01682811|101679669|FG005|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0||0
48549835|NCT01682811|101679670|FG006|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0||0
48549836|NCT01682811|101679664|FG000|STARTED|Part 2 Dose Level 1||0||0
48549837|NCT01682811|101679665|FG001|STARTED|Part 2 Dose Level 1||0||0
48549838|NCT01682811|101679666|FG002|STARTED|Part 2 Dose Level 1||0||0
48549839|NCT01682811|101679667|FG003|STARTED|Part 2 Dose Level 1||0||0
48549840|NCT01682811|101679668|FG004|STARTED|Part 2 Dose Level 1||11||60
48549841|NCT01682811|101679669|FG005|STARTED|Part 2 Dose Level 1||0||0
48265512|NCT01512797|100975242|FG001|COMPLETED|Overall Study||16||
48549842|NCT01682811|101679670|FG006|STARTED|Part 2 Dose Level 1||0||0
48549843|NCT01682811|101679664|FG000|Control|Part 2 Dose Level 1||0||0
48549844|NCT01682811|101679665|FG001|Control|Part 2 Dose Level 1||0||0
48549845|NCT01682811|101679666|FG002|Control|Part 2 Dose Level 1||0||0
48549846|NCT01682811|101679667|FG003|Control|Part 2 Dose Level 1||0||0
48549847|NCT01682811|101679668|FG004|Control|Part 2 Dose Level 1||10||30
48549848|NCT01682811|101679669|FG005|Control|Part 2 Dose Level 1||0||0
48103370|NCT01150123|100578713|FG003|NOT COMPLETED|Overall Study||3||
48103371|NCT01150123|100578714|FG004|NOT COMPLETED|Overall Study||3||
48103372|NCT01150123|100578715|FG005|NOT COMPLETED|Overall Study||6||
48103373|NCT01150123|100578716|FG006|NOT COMPLETED|Overall Study||0||
48103374|NCT01150123|100578717|FG007|NOT COMPLETED|Overall Study||3||
48103375|NCT01150123|100578718|FG008|NOT COMPLETED|Overall Study||5||
48103376|NCT01150123|100578719|FG009|NOT COMPLETED|Overall Study||1||
48103377|NCT01150123|100578720|FG010|NOT COMPLETED|Overall Study||2||
48265513|NCT01512797|100975241|FG000|NOT COMPLETED|Overall Study||0||
48265514|NCT01512797|100975242|FG001|NOT COMPLETED|Overall Study||0||
48265515|NCT00504075|100975243|FG000|STARTED|Overall Study||35||
48265516|NCT00504075|100975243|FG000|COMPLETED|Overall Study||27||
48265517|NCT00504075|100975243|FG000|NOT COMPLETED|Overall Study||8||
48265518|NCT04160988|100975244|FG000|STARTED|Overall Study||703||
48265519|NCT04160988|100975244|FG000|COMPLETED|Overall Study||675||
48265520|NCT04160988|100975244|FG000|NOT COMPLETED|Overall Study||28||
48265521|NCT00132678|100975245|FG000|STARTED|Period II (Open-Label Oral Risperidone)||0||
48391562|NCT02591238|101287694|FG003|NOT COMPLETED|Overall Study||3||
48391563|NCT00605722|101287695|FG000|STARTED|Overall Study||51||
48391564|NCT00605722|101287695|FG000|COMPLETED|Overall Study||0||
48391565|NCT00605722|101287695|FG000|NOT COMPLETED|Overall Study||51||
48391566|NCT03084718|101287696|FG000|STARTED|Overall Study||120||
48391567|NCT03084718|101287697|FG001|STARTED|Overall Study||120||
48391568|NCT03084718|101287698|FG002|STARTED|Overall Study||122||
48391569|NCT03084718|101287699|FG003|STARTED|Overall Study||124||
48391570|NCT03084718|101287700|FG004|STARTED|Overall Study||124||
48391571|NCT03084718|101287696|FG000|COMPLETED|Overall Study||109||
48391572|NCT03084718|101287697|FG001|COMPLETED|Overall Study||110||
48391573|NCT03084718|101287698|FG002|COMPLETED|Overall Study||110||
48391574|NCT03084718|101287699|FG003|COMPLETED|Overall Study||110||
48391575|NCT03084718|101287700|FG004|COMPLETED|Overall Study||120||
48391576|NCT03084718|101287696|FG000|NOT COMPLETED|Overall Study||11||
48391577|NCT03084718|101287697|FG001|NOT COMPLETED|Overall Study||10||
48391578|NCT03084718|101287698|FG002|NOT COMPLETED|Overall Study||12||
48391579|NCT03084718|101287699|FG003|NOT COMPLETED|Overall Study||14||
48391580|NCT03084718|101287700|FG004|NOT COMPLETED|Overall Study||4||
48391581|NCT01784588|101287701|FG000|STARTED|Overall Study||141||
48391582|NCT01784588|101287702|FG001|STARTED|Overall Study||140||
48391583|NCT01784588|101287701|FG000|COMPLETED|Overall Study||104||
48391584|NCT01784588|101287702|FG001|COMPLETED|Overall Study||108||
48391585|NCT01784588|101287701|FG000|NOT COMPLETED|Overall Study||37||
48391586|NCT01784588|101287702|FG001|NOT COMPLETED|Overall Study||32||
48103378|NCT01150123|100578721|FG011|NOT COMPLETED|Overall Study||1||
48103379|NCT01150123|100578722|FG012|NOT COMPLETED|Overall Study||3||
48103380|NCT01150123|100578723|FG013|NOT COMPLETED|Overall Study||0||
48103381|NCT01150123|100578724|FG014|NOT COMPLETED|Overall Study||0||
48103382|NCT01150123|100578725|FG015|NOT COMPLETED|Overall Study||1||
48103383|NCT01150123|100578726|FG016|NOT COMPLETED|Overall Study||0||
48265522|NCT00132678|100975246|FG001|STARTED|Period II (Open-Label Oral Risperidone)||0||
48265523|NCT00132678|100975247|FG002|STARTED|Period II (Open-Label Oral Risperidone)||440||
48265524|NCT00132678|100975245|FG000|COMPLETED|Period II (Open-Label Oral Risperidone)||0||
48265525|NCT00132678|100975246|FG001|COMPLETED|Period II (Open-Label Oral Risperidone)||0||
48265526|NCT00132678|100975247|FG002|COMPLETED|Period II (Open-Label Oral Risperidone)||382||
48265527|NCT00132678|100975245|FG000|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0||
48265528|NCT00132678|100975246|FG001|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0||
48265529|NCT00132678|100975247|FG002|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||58||
48265530|NCT00132678|100975245|FG000|STARTED|Period III (Open-Label Stabilization)||501||
48265531|NCT00132678|100975246|FG001|STARTED|Period III (Open-Label Stabilization)||0||
48265532|NCT00132678|100975247|FG002|STARTED|Period III (Open-Label Stabilization)||0||
48391587|NCT00118911|101287703|FG000|STARTED|Overall Study||43||
48391588|NCT00118911|101287704|FG001|STARTED|Overall Study||43||
48391589|NCT00118911|101287703|FG000|Received Intervention as Assigned|Overall Study||41||
48391590|NCT00118911|101287704|FG001|Received Intervention as Assigned|Overall Study||38||
48391591|NCT00118911|101287703|FG000|Completed Post-Treatment Assessment|Overall Study||41||
48391592|NCT00118911|101287704|FG001|Completed Post-Treatment Assessment|Overall Study||37||
48391593|NCT00118911|101287703|FG000|6 Month Follow-up|Overall Study||37||
48391594|NCT00118911|101287704|FG001|6 Month Follow-up|Overall Study||30||
48391595|NCT00118911|101287703|FG000|12 Month Follow-up|Overall Study||38||
48391596|NCT00118911|101287704|FG001|12 Month Follow-up|Overall Study||32||
48391597|NCT00118911|101287703|FG000|COMPLETED|Overall Study||41||
48391598|NCT00118911|101287704|FG001|COMPLETED|Overall Study||38||
48391599|NCT00118911|101287703|FG000|NOT COMPLETED|Overall Study||2||
48391600|NCT00118911|101287704|FG001|NOT COMPLETED|Overall Study||5||
48391601|NCT03438578|101287705|FG000|STARTED|Overall Study||100||
48391602|NCT03438578|101287706|FG001|STARTED|Overall Study||100||
48391603|NCT03438578|101287705|FG000|COMPLETED|Overall Study||99||
48391604|NCT03438578|101287706|FG001|COMPLETED|Overall Study||96||
48391605|NCT03438578|101287705|FG000|NOT COMPLETED|Overall Study||1||
48391606|NCT03438578|101287706|FG001|NOT COMPLETED|Overall Study||4||
48391607|NCT02928380|101287707|FG000|STARTED|Period 1||13||
48391608|NCT02928380|101287708|FG001|STARTED|Period 1||14||
48549849|NCT01682811|101679670|FG006|Control|Part 2 Dose Level 1||0||0
48549850|NCT01682811|101679664|FG000|Treated|Part 2 Dose Level 1||0||0
48549851|NCT01682811|101679665|FG001|Treated|Part 2 Dose Level 1||0||0
48265533|NCT00132678|100975245|FG000|COMPLETED|Period III (Open-Label Stabilization)||303||
48265534|NCT00132678|100975246|FG001|COMPLETED|Period III (Open-Label Stabilization)||0||
48265535|NCT00132678|100975247|FG002|COMPLETED|Period III (Open-Label Stabilization)||0||
48265536|NCT00132678|100975245|FG000|NOT COMPLETED|Period III (Open-Label Stabilization)||198||
48265537|NCT00132678|100975246|FG001|NOT COMPLETED|Period III (Open-Label Stabilization)||0||
48265538|NCT00132678|100975247|FG002|NOT COMPLETED|Period III (Open-Label Stabilization)||0||
48265539|NCT00132678|100975245|FG000|STARTED|Period IV (Double-Blind Treatment)||154||
48265540|NCT00132678|100975246|FG001|STARTED|Period IV (Double-Blind Treatment)||149||
48265541|NCT00132678|100975247|FG002|STARTED|Period IV (Double-Blind Treatment)||0||
48265542|NCT00132678|100975245|FG000|COMPLETED|Period IV (Double-Blind Treatment)||117||
48265543|NCT00132678|100975246|FG001|COMPLETED|Period IV (Double-Blind Treatment)||109||
48265544|NCT00132678|100975247|FG002|COMPLETED|Period IV (Double-Blind Treatment)||0||
48265545|NCT00132678|100975245|FG000|NOT COMPLETED|Period IV (Double-Blind Treatment)||37||
48265546|NCT00132678|100975246|FG001|NOT COMPLETED|Period IV (Double-Blind Treatment)||40||
48265547|NCT00132678|100975247|FG002|NOT COMPLETED|Period IV (Double-Blind Treatment)||0||
48265548|NCT01262547|100975248|FG000|STARTED|Overall Study||3||
48265549|NCT01262547|100975248|FG000|COMPLETED|Overall Study||3||
48265550|NCT01262547|100975248|FG000|NOT COMPLETED|Overall Study||0||
48265551|NCT01067846|100975249|FG000|STARTED|Overall Study||29||
48265552|NCT01067846|100975250|FG001|STARTED|Overall Study||30||
48265553|NCT01067846|100975249|FG000|Completed 3 Tx Sessions|Overall Study||15||
48265554|NCT01067846|100975250|FG001|Completed 3 Tx Sessions|Overall Study||15||
48265555|NCT01067846|100975249|FG000|COMPLETED|Overall Study||10||
48265556|NCT01067846|100975250|FG001|COMPLETED|Overall Study||11||
48265557|NCT01067846|100975249|FG000|NOT COMPLETED|Overall Study||19||
48265558|NCT01067846|100975250|FG001|NOT COMPLETED|Overall Study||19||
48265559|NCT02431052|100975251|FG000|STARTED|Overall Study||53||
48265560|NCT02431052|100975252|FG001|STARTED|Overall Study||50||
48265561|NCT02431052|100975253|FG002|STARTED|Overall Study||106||
48265562|NCT02431052|100975254|FG003|STARTED|Overall Study||110||
48265563|NCT02431052|100975255|FG004|STARTED|Overall Study||101||
48265564|NCT02431052|100975251|FG000|COMPLETED|Overall Study||42||
48265565|NCT02431052|100975252|FG001|COMPLETED|Overall Study||46||
48265566|NCT02431052|100975253|FG002|COMPLETED|Overall Study||94||
48265567|NCT02431052|100975254|FG003|COMPLETED|Overall Study||94||
48265568|NCT02431052|100975255|FG004|COMPLETED|Overall Study||86||
48265569|NCT02431052|100975251|FG000|NOT COMPLETED|Overall Study||11||
48265570|NCT02431052|100975252|FG001|NOT COMPLETED|Overall Study||4||
48265571|NCT02431052|100975253|FG002|NOT COMPLETED|Overall Study||12||
48265572|NCT02431052|100975254|FG003|NOT COMPLETED|Overall Study||16||
48265573|NCT02431052|100975255|FG004|NOT COMPLETED|Overall Study||15||
48549852|NCT01682811|101679666|FG002|Treated|Part 2 Dose Level 1||0||0
48549853|NCT01682811|101679667|FG003|Treated|Part 2 Dose Level 1||0||0
48265574|NCT00847626|100975256|FG000|STARTED|Overall Study||156||
48265575|NCT00847626|100975257|FG001|STARTED|Overall Study||154||
48265576|NCT00847626|100975258|FG002|STARTED|Overall Study||147||
48265577|NCT00847626|100975259|FG003|STARTED|Overall Study||156||
48265578|NCT00847626|100975260|FG004|STARTED|Overall Study||153||
48265579|NCT00847626|100975261|FG005|STARTED|Overall Study||162||
48265580|NCT00847626|100975262|FG006|STARTED|Overall Study||157||
48265581|NCT00847626|100975263|FG007|STARTED|Overall Study||160||
48265582|NCT00847626|100975264|FG008|STARTED|Overall Study||155||
48265583|NCT00847626|100975265|FG009|STARTED|Overall Study||153||
48265584|NCT00847626|100975266|FG010|STARTED|Overall Study||162||
48265585|NCT00847626|100975256|FG000|COMPLETED|Overall Study||135||
48549854|NCT01682811|101679668|FG004|Treated|Part 2 Dose Level 1||10||30
48549855|NCT01682811|101679669|FG005|Treated|Part 2 Dose Level 1||0||0
48549856|NCT01682811|101679670|FG006|Treated|Part 2 Dose Level 1||0||0
48549857|NCT01682811|101679664|FG000|COMPLETED|Part 2 Dose Level 1||0||0
48691750|NCT02266147|102029003|FG000|COMPLETED|PART 1: Dose Escalation||2||
48265586|NCT00847626|100975257|FG001|COMPLETED|Overall Study||131||
48265587|NCT00847626|100975258|FG002|COMPLETED|Overall Study||131||
48265588|NCT00847626|100975259|FG003|COMPLETED|Overall Study||125||
48265589|NCT00847626|100975260|FG004|COMPLETED|Overall Study||125||
48265590|NCT00847626|100975261|FG005|COMPLETED|Overall Study||125||
48265591|NCT00847626|100975262|FG006|COMPLETED|Overall Study||135||
48265592|NCT00847626|100975263|FG007|COMPLETED|Overall Study||141||
48549858|NCT01682811|101679665|FG001|COMPLETED|Part 2 Dose Level 1||0||0
48549859|NCT01682811|101679666|FG002|COMPLETED|Part 2 Dose Level 1||0||0
48549860|NCT01682811|101679667|FG003|COMPLETED|Part 2 Dose Level 1||0||0
48549861|NCT01682811|101679668|FG004|COMPLETED|Part 2 Dose Level 1||0||0
48549862|NCT01682811|101679669|FG005|COMPLETED|Part 2 Dose Level 1||0||0
48265593|NCT00847626|100975264|FG008|COMPLETED|Overall Study||141||
48265594|NCT00847626|100975265|FG009|COMPLETED|Overall Study||139||
48265595|NCT00847626|100975266|FG010|COMPLETED|Overall Study||142||
48265596|NCT00847626|100975256|FG000|NOT COMPLETED|Overall Study||21||
48549863|NCT01682811|101679670|FG006|COMPLETED|Part 2 Dose Level 1||0||0
48549864|NCT01682811|101679664|FG000|NOT COMPLETED|Part 2 Dose Level 1||0||0
48549865|NCT01682811|101679665|FG001|NOT COMPLETED|Part 2 Dose Level 1||0||0
48549866|NCT01682811|101679666|FG002|NOT COMPLETED|Part 2 Dose Level 1||0||0
48549867|NCT01682811|101679667|FG003|NOT COMPLETED|Part 2 Dose Level 1||0||0
48549868|NCT01682811|101679668|FG004|NOT COMPLETED|Part 2 Dose Level 1||11||60
48549869|NCT01682811|101679669|FG005|NOT COMPLETED|Part 2 Dose Level 1||0||0
48549870|NCT01682811|101679670|FG006|NOT COMPLETED|Part 2 Dose Level 1||0||0
48549871|NCT01682811|101679664|FG000|STARTED|Part 2 Dose Level 2||0||0
48549872|NCT01682811|101679665|FG001|STARTED|Part 2 Dose Level 2||0||0
48549873|NCT01682811|101679666|FG002|STARTED|Part 2 Dose Level 2||0||0
48549874|NCT01682811|101679667|FG003|STARTED|Part 2 Dose Level 2||0||0
48549875|NCT01682811|101679668|FG004|STARTED|Part 2 Dose Level 2||0||0
48549876|NCT01682811|101679669|FG005|STARTED|Part 2 Dose Level 2||3||18
48549877|NCT01682811|101679670|FG006|STARTED|Part 2 Dose Level 2||0||0
48549878|NCT01682811|101679664|FG000|Control|Part 2 Dose Level 2||0||0
48549879|NCT01682811|101679665|FG001|Control|Part 2 Dose Level 2||0||0
48549880|NCT01682811|101679666|FG002|Control|Part 2 Dose Level 2||0||0
48549881|NCT01682811|101679667|FG003|Control|Part 2 Dose Level 2||0||0
48549882|NCT01682811|101679668|FG004|Control|Part 2 Dose Level 2||0||0
48691751|NCT02266147|102029004|FG001|COMPLETED|PART 1: Dose Escalation||0||
48691752|NCT02266147|102029005|FG002|COMPLETED|PART 1: Dose Escalation||0||
48691753|NCT02266147|102029006|FG003|COMPLETED|PART 1: Dose Escalation||0||
48691754|NCT02266147|102029003|FG000|NOT COMPLETED|PART 1: Dose Escalation||1||
48691755|NCT02266147|102029004|FG001|NOT COMPLETED|PART 1: Dose Escalation||3||
48691756|NCT02266147|102029005|FG002|NOT COMPLETED|PART 1: Dose Escalation||3||
48691757|NCT02266147|102029006|FG003|NOT COMPLETED|PART 1: Dose Escalation||4||
48691758|NCT02266147|102029003|FG000|STARTED|PART 2: Dose Expansion||7|Sponsor terminated the trial early during Part 2 and participants should be counted once per row.|
48549883|NCT01682811|101679669|FG005|Control|Part 2 Dose Level 2||3||9
48549884|NCT01682811|101679670|FG006|Control|Part 2 Dose Level 2||0||0
48549885|NCT01682811|101679664|FG000|Treated|Part 2 Dose Level 2||0||0
48549886|NCT01682811|101679665|FG001|Treated|Part 2 Dose Level 2||0||0
48549887|NCT01682811|101679666|FG002|Treated|Part 2 Dose Level 2||0||0
48549888|NCT01682811|101679667|FG003|Treated|Part 2 Dose Level 2||0||0
48549889|NCT01682811|101679668|FG004|Treated|Part 2 Dose Level 2||0||0
48549890|NCT01682811|101679669|FG005|Treated|Part 2 Dose Level 2||3||9
48549891|NCT01682811|101679670|FG006|Treated|Part 2 Dose Level 2||0||0
48549892|NCT01682811|101679664|FG000|COMPLETED|Part 2 Dose Level 2||0||0
48549893|NCT01682811|101679665|FG001|COMPLETED|Part 2 Dose Level 2||0||0
48549894|NCT01682811|101679666|FG002|COMPLETED|Part 2 Dose Level 2||0||0
48549895|NCT01682811|101679667|FG003|COMPLETED|Part 2 Dose Level 2||0||0
48549896|NCT01682811|101679668|FG004|COMPLETED|Part 2 Dose Level 2||0||0
48549897|NCT01682811|101679669|FG005|COMPLETED|Part 2 Dose Level 2||0||0
48549898|NCT01682811|101679670|FG006|COMPLETED|Part 2 Dose Level 2||0||0
48549899|NCT01682811|101679664|FG000|NOT COMPLETED|Part 2 Dose Level 2||0||0
48549900|NCT01682811|101679665|FG001|NOT COMPLETED|Part 2 Dose Level 2||0||0
48549901|NCT01682811|101679666|FG002|NOT COMPLETED|Part 2 Dose Level 2||0||0
48549902|NCT01682811|101679667|FG003|NOT COMPLETED|Part 2 Dose Level 2||0||0
48549903|NCT01682811|101679668|FG004|NOT COMPLETED|Part 2 Dose Level 2||0||0
48549904|NCT01682811|101679669|FG005|NOT COMPLETED|Part 2 Dose Level 2||3||18
48549905|NCT01682811|101679670|FG006|NOT COMPLETED|Part 2 Dose Level 2||0||0
48549906|NCT01682811|101679664|FG000|STARTED|Part 2 Dose Level 3||0||0
48549907|NCT01682811|101679665|FG001|STARTED|Part 2 Dose Level 3||0||0
48549908|NCT01682811|101679666|FG002|STARTED|Part 2 Dose Level 3||0||0
48549909|NCT01682811|101679667|FG003|STARTED|Part 2 Dose Level 3||0||0
48549910|NCT01682811|101679668|FG004|STARTED|Part 2 Dose Level 3||0||0
48549911|NCT01682811|101679669|FG005|STARTED|Part 2 Dose Level 3||0||0
48549912|NCT01682811|101679670|FG006|STARTED|Part 2 Dose Level 3||0||0
48549913|NCT01682811|101679664|FG000|Control|Part 2 Dose Level 3||0||0
48549914|NCT01682811|101679665|FG001|Control|Part 2 Dose Level 3||0||0
48549915|NCT01682811|101679666|FG002|Control|Part 2 Dose Level 3||0||0
48549916|NCT01682811|101679667|FG003|Control|Part 2 Dose Level 3||0||0
48549917|NCT01682811|101679668|FG004|Control|Part 2 Dose Level 3||0||0
48549918|NCT01682811|101679669|FG005|Control|Part 2 Dose Level 3||0||0
48549919|NCT01682811|101679670|FG006|Control|Part 2 Dose Level 3||0||0
48549920|NCT01682811|101679664|FG000|Treated|Part 2 Dose Level 3||0||0
48549921|NCT01682811|101679665|FG001|Treated|Part 2 Dose Level 3||0||0
48549922|NCT01682811|101679666|FG002|Treated|Part 2 Dose Level 3||0||0
48549923|NCT01682811|101679667|FG003|Treated|Part 2 Dose Level 3||0||0
48691759|NCT02266147|102029004|FG001|STARTED|PART 2: Dose Expansion||0|Sponsor terminated the trial early during Part 2 and participants should be counted once per row.|
48691760|NCT02266147|102029005|FG002|STARTED|PART 2: Dose Expansion||0|Sponsor terminated the trial early during Part 2 and participants should be counted once per row.|
48691761|NCT02266147|102029006|FG003|STARTED|PART 2: Dose Expansion||9|Sponsor terminated the trial early during Part 2 and participants should be counted once per row.|
48691762|NCT02266147|102029003|FG000|COMPLETED|PART 2: Dose Expansion||0||
48691763|NCT02266147|102029004|FG001|COMPLETED|PART 2: Dose Expansion||0||
48691764|NCT02266147|102029005|FG002|COMPLETED|PART 2: Dose Expansion||0||
48691765|NCT02266147|102029006|FG003|COMPLETED|PART 2: Dose Expansion||0||
48691766|NCT02266147|102029003|FG000|NOT COMPLETED|PART 2: Dose Expansion||7||
48549924|NCT01682811|101679668|FG004|Treated|Part 2 Dose Level 3||0||0
48549925|NCT01682811|101679669|FG005|Treated|Part 2 Dose Level 3||0||0
48549926|NCT01682811|101679670|FG006|Treated|Part 2 Dose Level 3||0||0
48549927|NCT01682811|101679664|FG000|COMPLETED|Part 2 Dose Level 3||0||0
48549928|NCT01682811|101679665|FG001|COMPLETED|Part 2 Dose Level 3||0||0
48549929|NCT01682811|101679666|FG002|COMPLETED|Part 2 Dose Level 3||0||0
48549930|NCT01682811|101679667|FG003|COMPLETED|Part 2 Dose Level 3||0||0
48549931|NCT01682811|101679668|FG004|COMPLETED|Part 2 Dose Level 3||0||0
48549932|NCT01682811|101679669|FG005|COMPLETED|Part 2 Dose Level 3||0||0
48549933|NCT01682811|101679670|FG006|COMPLETED|Part 2 Dose Level 3||0||0
48549934|NCT01682811|101679664|FG000|NOT COMPLETED|Part 2 Dose Level 3||0||0
48549935|NCT01682811|101679665|FG001|NOT COMPLETED|Part 2 Dose Level 3||0||0
48549936|NCT01682811|101679666|FG002|NOT COMPLETED|Part 2 Dose Level 3||0||0
48549937|NCT01682811|101679667|FG003|NOT COMPLETED|Part 2 Dose Level 3||0||0
48103384|NCT01150123|100578727|FG017|NOT COMPLETED|Overall Study||1||
48103385|NCT01816893|100578728|FG000|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11||
48103386|NCT01816893|100578729|FG001|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11||
48103387|NCT01816893|100578728|FG000|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11||
48103388|NCT01816893|100578729|FG001|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11||
48103389|NCT01816893|100578728|FG000|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0||
48103390|NCT01816893|100578729|FG001|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0||
48103391|NCT01816893|100578728|FG000|STARTED|Washout Period||11||
48103392|NCT01816893|100578729|FG001|STARTED|Washout Period||11||
48103393|NCT01816893|100578728|FG000|COMPLETED|Washout Period||9||
48103394|NCT01816893|100578729|FG001|COMPLETED|Washout Period||11||
48103395|NCT01816893|100578728|FG000|NOT COMPLETED|Washout Period||2||
48103396|NCT01816893|100578729|FG001|NOT COMPLETED|Washout Period||0||
48103397|NCT01816893|100578728|FG000|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||9||
48103398|NCT01816893|100578729|FG001|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||11||
48103399|NCT01816893|100578728|FG000|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||9||
48103400|NCT01816893|100578729|FG001|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||11||
48103401|NCT01816893|100578728|FG000|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0||
48103402|NCT01816893|100578729|FG001|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0||
48103403|NCT00076687|100578730|FG000|STARTED|Overall Study||48||
48103404|NCT00076687|100578731|FG001|STARTED|Overall Study||52||
48103405|NCT00076687|100578732|FG002|STARTED|Overall Study||55||
48103406|NCT00076687|100578730|FG000|COMPLETED|Overall Study||42||
48103407|NCT00076687|100578731|FG001|COMPLETED|Overall Study||47||
48103408|NCT00076687|100578732|FG002|COMPLETED|Overall Study||51||
48103409|NCT00076687|100578730|FG000|NOT COMPLETED|Overall Study||6||
48103410|NCT00076687|100578731|FG001|NOT COMPLETED|Overall Study||5||
48103411|NCT00076687|100578732|FG002|NOT COMPLETED|Overall Study||4||
48103412|NCT01035944|100578733|FG000|STARTED|Overall Study||14||
48103413|NCT01035944|100578734|FG001|STARTED|Overall Study||14||
48103414|NCT01035944|100578735|FG002|STARTED|Overall Study||5||
48103415|NCT01035944|100578736|FG003|STARTED|Overall Study||4||
48103416|NCT01035944|100578733|FG000|COMPLETED|Overall Study||11||
48103417|NCT01035944|100578734|FG001|COMPLETED|Overall Study||13||
48103418|NCT01035944|100578735|FG002|COMPLETED|Overall Study||4||
48103419|NCT01035944|100578736|FG003|COMPLETED|Overall Study||4||
48103420|NCT01035944|100578733|FG000|NOT COMPLETED|Overall Study||3||
48103421|NCT01035944|100578734|FG001|NOT COMPLETED|Overall Study||1||
48549938|NCT01682811|101679668|FG004|NOT COMPLETED|Part 2 Dose Level 3||0||0
48549939|NCT01682811|101679669|FG005|NOT COMPLETED|Part 2 Dose Level 3||0||0
48549940|NCT01682811|101679670|FG006|NOT COMPLETED|Part 2 Dose Level 3||0||0
48549941|NCT04138043|101679671|FG000|STARTED|Overall Study||2||
48549942|NCT04138043|101679672|FG001|STARTED|Overall Study||7||
48549943|NCT04138043|101679671|FG000|COMPLETED|Overall Study||2||
48549944|NCT04138043|101679672|FG001|COMPLETED|Overall Study||6||
48549945|NCT04138043|101679671|FG000|NOT COMPLETED|Overall Study||0||
48549946|NCT04138043|101679672|FG001|NOT COMPLETED|Overall Study||1||
48549947|NCT00619060|101679673|FG000|STARTED|Overall Study||10||
48549948|NCT00619060|101679674|FG001|STARTED|Overall Study||12||
48549949|NCT00619060|101679673|FG000|COMPLETED|Overall Study||10||
48103422|NCT01035944|100578735|FG002|NOT COMPLETED|Overall Study||1||
48549950|NCT00619060|101679674|FG001|COMPLETED|Overall Study||12||
48549951|NCT00619060|101679673|FG000|NOT COMPLETED|Overall Study||0||
48549952|NCT00619060|101679674|FG001|NOT COMPLETED|Overall Study||0||
48549953|NCT01823497|101679675|FG000|STARTED|Overall Study||19||
48549954|NCT01823497|101679676|FG001|STARTED|Overall Study||17||
48549955|NCT01823497|101679675|FG000|COMPLETED|Overall Study||16||
48549956|NCT01823497|101679676|FG001|COMPLETED|Overall Study||9||
48549957|NCT01823497|101679675|FG000|NOT COMPLETED|Overall Study||3||
48549958|NCT01823497|101679676|FG001|NOT COMPLETED|Overall Study||8||
48549959|NCT04306211|101679677|FG000|STARTED|Overall Study||6||
48549960|NCT04306211|101679678|FG001|STARTED|Overall Study||5||
48103423|NCT01035944|100578736|FG003|NOT COMPLETED|Overall Study||0||
48103424|NCT03752307|100578737|FG000|STARTED|Overall Study||1||
48103425|NCT03752307|100578738|FG001|STARTED|Overall Study||1||
48103426|NCT03752307|100578737|FG000|COMPLETED|Overall Study||1||
48549961|NCT04306211|101679677|FG000|COMPLETED|Overall Study||6||
48265597|NCT00847626|100975257|FG001|NOT COMPLETED|Overall Study||23||
48265598|NCT00847626|100975258|FG002|NOT COMPLETED|Overall Study||16||
48265599|NCT00847626|100975259|FG003|NOT COMPLETED|Overall Study||31||
48265600|NCT00847626|100975260|FG004|NOT COMPLETED|Overall Study||28||
48265601|NCT00847626|100975261|FG005|NOT COMPLETED|Overall Study||37||
48265602|NCT00847626|100975262|FG006|NOT COMPLETED|Overall Study||22||
48265603|NCT00847626|100975263|FG007|NOT COMPLETED|Overall Study||19||
48265604|NCT00847626|100975264|FG008|NOT COMPLETED|Overall Study||14||
48103427|NCT03752307|100578738|FG001|COMPLETED|Overall Study||1||
48265605|NCT00847626|100975265|FG009|NOT COMPLETED|Overall Study||14||
48265606|NCT00847626|100975266|FG010|NOT COMPLETED|Overall Study||20||
48265607|NCT02563548|100975267|FG000|STARTED|Dose Escalation (Up to 46 Weeks)||3||
48265608|NCT02563548|100975268|FG001|STARTED|Dose Escalation (Up to 46 Weeks)||2||
48265609|NCT02563548|100975269|FG002|STARTED|Dose Escalation (Up to 46 Weeks)||7||
48265610|NCT02563548|100975270|FG003|STARTED|Dose Escalation (Up to 46 Weeks)||2||
48265611|NCT02563548|100975271|FG004|STARTED|Dose Escalation (Up to 46 Weeks)||0||
48265612|NCT02563548|100975272|FG005|STARTED|Dose Escalation (Up to 46 Weeks)||0||
48265613|NCT02563548|100975267|FG000|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||3||
48265614|NCT02563548|100975268|FG001|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||2||
48265615|NCT02563548|100975269|FG002|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||7||
48265616|NCT02563548|100975270|FG003|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||2||
48265617|NCT02563548|100975271|FG004|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||0||
48549962|NCT04306211|101679678|FG001|COMPLETED|Overall Study||5||
48549963|NCT04306211|101679677|FG000|NOT COMPLETED|Overall Study||0||
48549964|NCT04306211|101679678|FG001|NOT COMPLETED|Overall Study||0||
48549965|NCT04082338|101679679|FG000|STARTED|Overall Study Baseline||191||
48549966|NCT04082338|101679680|FG001|STARTED|Overall Study Baseline||191||
48549967|NCT04082338|101679679|FG000|COMPLETED|Overall Study Baseline||191||
48549968|NCT04082338|101679680|FG001|COMPLETED|Overall Study Baseline||191||
48549969|NCT04082338|101679679|FG000|NOT COMPLETED|Overall Study Baseline||0||
48549970|NCT04082338|101679680|FG001|NOT COMPLETED|Overall Study Baseline||0||
48549971|NCT04082338|101679679|FG000|STARTED|12-month Follow-up||191||
48549972|NCT04082338|101679680|FG001|STARTED|12-month Follow-up||191||
48549973|NCT04082338|101679679|FG000|COMPLETED|12-month Follow-up||186||
48549974|NCT04082338|101679680|FG001|COMPLETED|12-month Follow-up||186||
48549975|NCT04082338|101679679|FG000|NOT COMPLETED|12-month Follow-up||5||
48549976|NCT04082338|101679680|FG001|NOT COMPLETED|12-month Follow-up||5||
48549977|NCT04082338|101679679|FG000|STARTED|18-month Follow-up||186||
48549978|NCT04082338|101679680|FG001|STARTED|18-month Follow-up||186||
48549979|NCT04082338|101679679|FG000|COMPLETED|18-month Follow-up||181||
48549980|NCT04082338|101679680|FG001|COMPLETED|18-month Follow-up||184||
48549981|NCT04082338|101679679|FG000|NOT COMPLETED|18-month Follow-up||5||
48549982|NCT04082338|101679680|FG001|NOT COMPLETED|18-month Follow-up||2||
48549983|NCT00658879|101679681|FG000|STARTED|Overall Study||251||
48549984|NCT00658879|101679681|FG000|COMPLETED|Overall Study||250||
48549985|NCT00658879|101679681|FG000|NOT COMPLETED|Overall Study||1||
48549986|NCT01420965|101679682|FG000|STARTED|Overall Study||2||
48549987|NCT01420965|101679683|FG001|STARTED|Overall Study||2||
48549988|NCT01420965|101679684|FG002|STARTED|Overall Study||3||
48549989|NCT01420965|101679682|FG000|COMPLETED|Overall Study||1||
48549990|NCT01420965|101679683|FG001|COMPLETED|Overall Study||1||
48549991|NCT01420965|101679684|FG002|COMPLETED|Overall Study||3||
48549992|NCT01420965|101679682|FG000|NOT COMPLETED|Overall Study||1||
48549993|NCT01420965|101679683|FG001|NOT COMPLETED|Overall Study||1||
48549994|NCT01420965|101679684|FG002|NOT COMPLETED|Overall Study||0||
48549995|NCT02463357|101679685|FG000|STARTED|Overall Study||20||
48549996|NCT02463357|101679686|FG001|STARTED|Overall Study||20||
48549997|NCT02463357|101679687|FG002|STARTED|Overall Study||20||
48549998|NCT02463357|101679688|FG003|STARTED|Overall Study||19||
48549999|NCT02463357|101679689|FG004|STARTED|Overall Study||20||
48103428|NCT03752307|100578737|FG000|NOT COMPLETED|Overall Study||0||
48391609|NCT02928380|101287709|FG002|STARTED|Period 1||14||
48550000|NCT02463357|101679685|FG000|COMPLETED|Overall Study||19||
48550001|NCT02463357|101679686|FG001|COMPLETED|Overall Study||20||
48550002|NCT02463357|101679687|FG002|COMPLETED|Overall Study||20||
48550003|NCT02463357|101679688|FG003|COMPLETED|Overall Study||19||
48550004|NCT02463357|101679689|FG004|COMPLETED|Overall Study||19||
48550005|NCT02463357|101679685|FG000|NOT COMPLETED|Overall Study||1||
48550006|NCT02463357|101679686|FG001|NOT COMPLETED|Overall Study||0||
48550007|NCT02463357|101679687|FG002|NOT COMPLETED|Overall Study||0||
48550008|NCT02463357|101679688|FG003|NOT COMPLETED|Overall Study||0||
48550009|NCT02463357|101679689|FG004|NOT COMPLETED|Overall Study||1||
48550010|NCT02794727|101679690|FG000|STARTED|Overall Study||44||
48550011|NCT02794727|101679691|FG001|STARTED|Overall Study||46||
48550012|NCT02794727|101679692|FG002|STARTED|Overall Study||45||
48550013|NCT02794727|101679690|FG000|COMPLETED|Overall Study||44||
48103429|NCT03752307|100578738|FG001|NOT COMPLETED|Overall Study||0||
48550014|NCT02794727|101679691|FG001|COMPLETED|Overall Study||46||
48550015|NCT02794727|101679692|FG002|COMPLETED|Overall Study||44||
48550016|NCT02794727|101679690|FG000|NOT COMPLETED|Overall Study||0||
48550017|NCT02794727|101679691|FG001|NOT COMPLETED|Overall Study||0||
48265618|NCT02563548|100975272|FG005|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||0||
48265619|NCT02563548|100975267|FG000|COMPLETED|Dose Escalation (Up to 46 Weeks)||0||
48265620|NCT02563548|100975268|FG001|COMPLETED|Dose Escalation (Up to 46 Weeks)||0||
48265621|NCT02563548|100975269|FG002|COMPLETED|Dose Escalation (Up to 46 Weeks)||0||
48265622|NCT02563548|100975270|FG003|COMPLETED|Dose Escalation (Up to 46 Weeks)||0||
48265623|NCT02563548|100975271|FG004|COMPLETED|Dose Escalation (Up to 46 Weeks)||0||
48265624|NCT02563548|100975272|FG005|COMPLETED|Dose Escalation (Up to 46 Weeks)||0||
48265625|NCT02563548|100975267|FG000|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||3||
48265626|NCT02563548|100975268|FG001|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||2||
48265627|NCT02563548|100975269|FG002|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||7||
48265628|NCT02563548|100975270|FG003|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||2||
48265629|NCT02563548|100975271|FG004|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||0||
48265630|NCT02563548|100975272|FG005|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||0||
48265631|NCT02563548|100975267|FG000|STARTED|Dose Expansion (Up to 60 Weeks)||0||
48265632|NCT02563548|100975268|FG001|STARTED|Dose Expansion (Up to 60 Weeks)||0||
48265633|NCT02563548|100975269|FG002|STARTED|Dose Expansion (Up to 60 Weeks)||0||
48265634|NCT02563548|100975270|FG003|STARTED|Dose Expansion (Up to 60 Weeks)||0||
48265635|NCT02563548|100975271|FG004|STARTED|Dose Expansion (Up to 60 Weeks)||25||
48265636|NCT02563548|100975272|FG005|STARTED|Dose Expansion (Up to 60 Weeks)||17||
48265637|NCT02563548|100975267|FG000|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0||
48265638|NCT02563548|100975268|FG001|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0||
48265639|NCT02563548|100975269|FG002|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0||
48265640|NCT02563548|100975270|FG003|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0||
48265641|NCT02563548|100975271|FG004|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||24||
48265642|NCT02563548|100975272|FG005|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||17||
48265643|NCT02563548|100975267|FG000|COMPLETED|Dose Expansion (Up to 60 Weeks)||0||
48265644|NCT02563548|100975268|FG001|COMPLETED|Dose Expansion (Up to 60 Weeks)||0||
48265645|NCT02563548|100975269|FG002|COMPLETED|Dose Expansion (Up to 60 Weeks)||0||
48265646|NCT02563548|100975270|FG003|COMPLETED|Dose Expansion (Up to 60 Weeks)||0||
48265647|NCT02563548|100975271|FG004|COMPLETED|Dose Expansion (Up to 60 Weeks)||0||
48265648|NCT02563548|100975272|FG005|COMPLETED|Dose Expansion (Up to 60 Weeks)||0||
48265649|NCT02563548|100975267|FG000|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0||
48550018|NCT02794727|101679692|FG002|NOT COMPLETED|Overall Study||1||
48550019|NCT05560386|101679693|FG000|STARTED|Overall Study||13||
48550020|NCT05560386|101679694|FG001|STARTED|Overall Study||41||
48550021|NCT05560386|101679693|FG000|COMPLETED|Overall Study||13||
48550022|NCT05560386|101679694|FG001|COMPLETED|Overall Study||24||
48550023|NCT05560386|101679693|FG000|NOT COMPLETED|Overall Study||0||
48550024|NCT05560386|101679694|FG001|NOT COMPLETED|Overall Study||17||
48550025|NCT00194779|101679695|FG000|STARTED|Overall Study||50||
48550026|NCT00194779|101679695|FG000|COMPLETED|Overall Study||50||
48550027|NCT00194779|101679695|FG000|NOT COMPLETED|Overall Study||0||
48550028|NCT03751007|101679696|FG000|STARTED|Overall Study||2||
48550029|NCT03751007|101679697|FG001|STARTED|Overall Study||5||
48550030|NCT03751007|101679698|FG002|STARTED|Overall Study||2||
48550031|NCT03751007|101679699|FG003|STARTED|Overall Study||5||
48550032|NCT03751007|101679700|FG004|STARTED|Overall Study||2||
48550033|NCT03751007|101679701|FG005|STARTED|Overall Study||4||
48550034|NCT03751007|101679702|FG006|STARTED|Overall Study||2||
48265650|NCT02563548|100975268|FG001|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0||
48265651|NCT02563548|100975269|FG002|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0||
48265652|NCT02563548|100975270|FG003|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0||
48550035|NCT03751007|101679703|FG007|STARTED|Overall Study||5||
48550036|NCT03751007|101679704|FG008|STARTED|Overall Study||10||
48550037|NCT03751007|101679705|FG009|STARTED|Overall Study||2||
48550038|NCT03751007|101679706|FG010|STARTED|Overall Study||5||
48550039|NCT03751007|101679707|FG011|STARTED|Overall Study||1||
48550040|NCT03751007|101679696|FG000|COMPLETED|Overall Study||2||
48550041|NCT03751007|101679697|FG001|COMPLETED|Overall Study||5||
48550042|NCT03751007|101679698|FG002|COMPLETED|Overall Study||2||
48550043|NCT03751007|101679699|FG003|COMPLETED|Overall Study||4||
48550044|NCT03751007|101679700|FG004|COMPLETED|Overall Study||2||
48550045|NCT03751007|101679701|FG005|COMPLETED|Overall Study||4||
48550046|NCT03751007|101679702|FG006|COMPLETED|Overall Study||2||
48550047|NCT03751007|101679703|FG007|COMPLETED|Overall Study||4||
48550048|NCT03751007|101679704|FG008|COMPLETED|Overall Study||10||
48550049|NCT03751007|101679705|FG009|COMPLETED|Overall Study||2||
48550050|NCT03751007|101679706|FG010|COMPLETED|Overall Study||4||
48550051|NCT03751007|101679707|FG011|COMPLETED|Overall Study||0||
48550052|NCT03751007|101679696|FG000|NOT COMPLETED|Overall Study||0||
48550053|NCT03751007|101679697|FG001|NOT COMPLETED|Overall Study||0||
48550054|NCT03751007|101679698|FG002|NOT COMPLETED|Overall Study||0||
48550055|NCT03751007|101679699|FG003|NOT COMPLETED|Overall Study||1||
48550056|NCT03751007|101679700|FG004|NOT COMPLETED|Overall Study||0||
48550057|NCT03751007|101679701|FG005|NOT COMPLETED|Overall Study||0||
48550058|NCT03751007|101679702|FG006|NOT COMPLETED|Overall Study||0||
48265653|NCT02563548|100975271|FG004|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||25||
48550059|NCT03751007|101679703|FG007|NOT COMPLETED|Overall Study||1||
48550060|NCT03751007|101679704|FG008|NOT COMPLETED|Overall Study||0||
48550061|NCT03751007|101679705|FG009|NOT COMPLETED|Overall Study||0||
48550062|NCT03751007|101679706|FG010|NOT COMPLETED|Overall Study||1||
48550063|NCT03751007|101679707|FG011|NOT COMPLETED|Overall Study||1||
48550064|NCT02481869|101679708|FG000|STARTED|Overall Study||5||
48550065|NCT02481869|101679709|FG001|STARTED|Overall Study||6||
48265654|NCT02563548|100975272|FG005|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||17||
48265655|NCT01867047|100975273|FG000|STARTED|Overall Study||31||
48265656|NCT01867047|100975274|FG001|STARTED|Overall Study||28||
48265657|NCT01867047|100975273|FG000|COMPLETED|Overall Study||23||
48265658|NCT01867047|100975274|FG001|COMPLETED|Overall Study||23||
48265659|NCT01867047|100975273|FG000|NOT COMPLETED|Overall Study||8||
48550066|NCT02481869|101679708|FG000|COMPLETED|Overall Study||0||
48550067|NCT02481869|101679709|FG001|COMPLETED|Overall Study||2||
48550068|NCT02481869|101679708|FG000|NOT COMPLETED|Overall Study||5||
48550069|NCT02481869|101679709|FG001|NOT COMPLETED|Overall Study||4||
48550070|NCT01252277|101679710|FG000|STARTED|Overall Study||36||
48550071|NCT01252277|101679710|FG000|COMPLETED|Overall Study||34||
48550072|NCT01252277|101679710|FG000|NOT COMPLETED|Overall Study||2||
48550073|NCT00378573|101679711|FG000|STARTED|Treatment Period||17||
48550074|NCT00378573|101679711|FG000|COMPLETED|Treatment Period||0||
48550075|NCT00378573|101679711|FG000|NOT COMPLETED|Treatment Period||17||
48550076|NCT00378573|101679711|FG000|STARTED|Follow-up||17||
48550077|NCT00378573|101679711|FG000|COMPLETED|Follow-up||3||
48550078|NCT00378573|101679711|FG000|NOT COMPLETED|Follow-up||14||
48550079|NCT00447876|101679712|FG000|STARTED|Overall Study||20||
48550080|NCT00447876|101679713|FG001|STARTED|Overall Study||20||
48550081|NCT00447876|101679712|FG000|COMPLETED|Overall Study||17||
48550082|NCT00447876|101679713|FG001|COMPLETED|Overall Study||16||
48550083|NCT00447876|101679712|FG000|NOT COMPLETED|Overall Study||3||
48550084|NCT00447876|101679713|FG001|NOT COMPLETED|Overall Study||4||
48550085|NCT01047527|101679714|FG000|STARTED|Overall Study||180||
48550086|NCT01047527|101679715|FG001|STARTED|Overall Study||173||
48691767|NCT02266147|102029004|FG001|NOT COMPLETED|PART 2: Dose Expansion||0||
48265660|NCT01867047|100975274|FG001|NOT COMPLETED|Overall Study||5||
48265661|NCT03325777|100975275|FG000|STARTED|Overall Study||46||
48265662|NCT03325777|100975276|FG001|STARTED|Overall Study||50||
48265663|NCT03325777|100975275|FG000|COMPLETED|Overall Study||37||
48265664|NCT03325777|100975276|FG001|COMPLETED|Overall Study||38||
48265665|NCT03325777|100975275|FG000|NOT COMPLETED|Overall Study||9||
48265666|NCT03325777|100975276|FG001|NOT COMPLETED|Overall Study||12||
48265667|NCT02344342|100975277|FG000|STARTED|Overall Study||13||
48265668|NCT02344342|100975278|FG001|STARTED|Overall Study||11||
48265669|NCT02344342|100975279|FG002|STARTED|Overall Study||14||
48265670|NCT02344342|100975280|FG003|STARTED|Overall Study||13||
48265671|NCT02344342|100975277|FG000|COMPLETED|Overall Study||2||
48265672|NCT02344342|100975278|FG001|COMPLETED|Overall Study||2||
48265673|NCT02344342|100975279|FG002|COMPLETED|Overall Study||0||
48265674|NCT02344342|100975280|FG003|COMPLETED|Overall Study||3||
48265675|NCT02344342|100975277|FG000|NOT COMPLETED|Overall Study||11||
48265676|NCT02344342|100975278|FG001|NOT COMPLETED|Overall Study||9||
48265677|NCT02344342|100975279|FG002|NOT COMPLETED|Overall Study||14||
48265678|NCT02344342|100975280|FG003|NOT COMPLETED|Overall Study||10||
48265679|NCT03178344|100975281|FG000|STARTED|First Session||10||
48265680|NCT03178344|100975282|FG001|STARTED|First Session||10||
48265681|NCT03178344|100975281|FG000|COMPLETED|First Session||10||
48265682|NCT03178344|100975282|FG001|COMPLETED|First Session||10||
48265683|NCT03178344|100975281|FG000|NOT COMPLETED|First Session||0||
48265684|NCT03178344|100975282|FG001|NOT COMPLETED|First Session||0||
48550087|NCT01047527|101679716|FG002|STARTED|Overall Study||172||
48550088|NCT01047527|101679714|FG000|8 Weeks|Overall Study||148||
48550089|NCT01047527|101679715|FG001|8 Weeks|Overall Study||142||
48550090|NCT01047527|101679716|FG002|8 Weeks|Overall Study||138||
48550091|NCT01047527|101679714|FG000|24 Weeks|Overall Study||111||
48550092|NCT01047527|101679715|FG001|24 Weeks|Overall Study||123||
48550093|NCT01047527|101679716|FG002|24 Weeks|Overall Study||119||
48550094|NCT01047527|101679714|FG000|COMPLETED|Overall Study||95||
48550095|NCT01047527|101679715|FG001|COMPLETED|Overall Study||112||
48550096|NCT01047527|101679716|FG002|COMPLETED|Overall Study||107||
48550097|NCT01047527|101679714|FG000|NOT COMPLETED|Overall Study||85||
48550098|NCT01047527|101679715|FG001|NOT COMPLETED|Overall Study||61||
48550099|NCT01047527|101679716|FG002|NOT COMPLETED|Overall Study||65||
48550100|NCT04778904|101679717|FG000|STARTED|Overall Study||10||
48550101|NCT04778904|101679718|FG001|STARTED|Overall Study||18||
48550102|NCT04778904|101679719|FG002|STARTED|Overall Study||18||
48550103|NCT04778904|101679720|FG003|STARTED|Overall Study||9||
48550104|NCT04778904|101679717|FG000|COMPLETED|Overall Study||9||
48550105|NCT04778904|101679718|FG001|COMPLETED|Overall Study||18||
48550106|NCT04778904|101679719|FG002|COMPLETED|Overall Study||17||
48550107|NCT04778904|101679720|FG003|COMPLETED|Overall Study||9||
48550108|NCT04778904|101679717|FG000|NOT COMPLETED|Overall Study||1||
48550109|NCT04778904|101679718|FG001|NOT COMPLETED|Overall Study||0||
48265685|NCT03178344|100975281|FG000|STARTED|Washout Period (5-9 Days)||10||
48550110|NCT04778904|101679719|FG002|NOT COMPLETED|Overall Study||1||
48265686|NCT03178344|100975282|FG001|STARTED|Washout Period (5-9 Days)||10||
48265687|NCT03178344|100975281|FG000|COMPLETED|Washout Period (5-9 Days)||10||
48265688|NCT03178344|100975282|FG001|COMPLETED|Washout Period (5-9 Days)||10||
48265689|NCT03178344|100975281|FG000|NOT COMPLETED|Washout Period (5-9 Days)||0||
48265690|NCT03178344|100975282|FG001|NOT COMPLETED|Washout Period (5-9 Days)||0||
48265691|NCT03178344|100975281|FG000|STARTED|Second Session||10||
48265692|NCT03178344|100975282|FG001|STARTED|Second Session||10||
48265693|NCT03178344|100975281|FG000|COMPLETED|Second Session||10||
48265694|NCT03178344|100975282|FG001|COMPLETED|Second Session||10||
48265695|NCT03178344|100975281|FG000|NOT COMPLETED|Second Session||0||
48265696|NCT03178344|100975282|FG001|NOT COMPLETED|Second Session||0||
48265697|NCT01907269|100975283|FG000|STARTED|6 Month Outcome Measures Post-interventi||1342||
48265698|NCT01907269|100975284|FG001|STARTED|6 Month Outcome Measures Post-interventi||1342||
48265699|NCT01907269|100975283|FG000|COMPLETED|6 Month Outcome Measures Post-interventi||953||
48265700|NCT01907269|100975284|FG001|COMPLETED|6 Month Outcome Measures Post-interventi||1053||
48265701|NCT01907269|100975283|FG000|NOT COMPLETED|6 Month Outcome Measures Post-interventi||389||
48265702|NCT01907269|100975284|FG001|NOT COMPLETED|6 Month Outcome Measures Post-interventi||289||
48265703|NCT01907269|100975283|FG000|STARTED|18 Month Outcome Measures Post-intervent||1178||
48265704|NCT01907269|100975284|FG001|STARTED|18 Month Outcome Measures Post-intervent||1250||
48265705|NCT01907269|100975283|FG000|COMPLETED|18 Month Outcome Measures Post-intervent||859||
48265706|NCT01907269|100975284|FG001|COMPLETED|18 Month Outcome Measures Post-intervent||970||
48265707|NCT01907269|100975283|FG000|NOT COMPLETED|18 Month Outcome Measures Post-intervent||319||
48265708|NCT01907269|100975284|FG001|NOT COMPLETED|18 Month Outcome Measures Post-intervent||280||
48265709|NCT02493946|100975285|FG000|STARTED|DB Period||126||
48265710|NCT02493946|100975286|FG001|STARTED|DB Period||64||
48265711|NCT02493946|100975287|FG002|STARTED|DB Period||0||
48265712|NCT02493946|100975285|FG000|COMPLETED|DB Period||118||
48265713|NCT02493946|100975286|FG001|COMPLETED|DB Period||59||
48265714|NCT02493946|100975287|FG002|COMPLETED|DB Period||0||
48265715|NCT02493946|100975285|FG000|NOT COMPLETED|DB Period||8||
48265716|NCT02493946|100975286|FG001|NOT COMPLETED|DB Period||5||
48265717|NCT02493946|100975287|FG002|NOT COMPLETED|DB Period||0||
48265718|NCT02493946|100975285|FG000|STARTED|Open Label Period||0||
48265719|NCT02493946|100975286|FG001|STARTED|Open Label Period||0||
48265720|NCT02493946|100975287|FG002|STARTED|Open Label Period||595||
48265721|NCT02493946|100975285|FG000|COMPLETED|Open Label Period||0||
48265722|NCT02493946|100975286|FG001|COMPLETED|Open Label Period||0||
48265723|NCT02493946|100975287|FG002|COMPLETED|Open Label Period||509||
48265724|NCT02493946|100975285|FG000|NOT COMPLETED|Open Label Period||0||
48265725|NCT02493946|100975286|FG001|NOT COMPLETED|Open Label Period||0||
48265726|NCT02493946|100975287|FG002|NOT COMPLETED|Open Label Period||86||
48265727|NCT05302440|100975288|FG000|STARTED|Overall Study||20||
48265728|NCT05302440|100975288|FG000|COMPLETED|Overall Study||20||
48265729|NCT05302440|100975288|FG000|NOT COMPLETED|Overall Study||0||
48265730|NCT00566540|100975289|FG000|STARTED|Overall Study||11||
48265731|NCT00566540|100975289|FG000|COMPLETED|Overall Study||11||
48265732|NCT00566540|100975289|FG000|NOT COMPLETED|Overall Study||0||
48265733|NCT00572533|100975290|FG000|STARTED|Overall Study||31||
48265734|NCT00572533|100975291|FG001|STARTED|Overall Study||31||
48265735|NCT00572533|100975290|FG000|COMPLETED|Overall Study||24||
48265736|NCT00572533|100975291|FG001|COMPLETED|Overall Study||28||
48265737|NCT00572533|100975290|FG000|NOT COMPLETED|Overall Study||7||
48265738|NCT00572533|100975291|FG001|NOT COMPLETED|Overall Study||3||
48265739|NCT01327612|100975292|FG000|STARTED|Overall Study||2||
48265740|NCT01327612|100975293|FG001|STARTED|Overall Study||1||
48265741|NCT01327612|100975294|FG002|STARTED|Overall Study||1||
48265742|NCT01327612|100975295|FG003|STARTED|Overall Study||1||
48265743|NCT01327612|100975296|FG004|STARTED|Overall Study||2||
48265744|NCT01327612|100975297|FG005|STARTED|Overall Study||3||
48265745|NCT01327612|100975298|FG006|STARTED|Overall Study||2||
48265746|NCT01327612|100975292|FG000|COMPLETED|Overall Study||1||
48265747|NCT01327612|100975293|FG001|COMPLETED|Overall Study||0||
48265748|NCT01327612|100975294|FG002|COMPLETED|Overall Study||0||
48265749|NCT01327612|100975295|FG003|COMPLETED|Overall Study||0||
48265750|NCT01327612|100975296|FG004|COMPLETED|Overall Study||0||
48265751|NCT01327612|100975297|FG005|COMPLETED|Overall Study||0||
48265752|NCT01327612|100975298|FG006|COMPLETED|Overall Study||0||
48265753|NCT01327612|100975292|FG000|NOT COMPLETED|Overall Study||1||
48265754|NCT01327612|100975293|FG001|NOT COMPLETED|Overall Study||1||
48265755|NCT01327612|100975294|FG002|NOT COMPLETED|Overall Study||1||
48265756|NCT01327612|100975295|FG003|NOT COMPLETED|Overall Study||1||
48265757|NCT01327612|100975296|FG004|NOT COMPLETED|Overall Study||2||
48265758|NCT01327612|100975297|FG005|NOT COMPLETED|Overall Study||3||
48265759|NCT01327612|100975298|FG006|NOT COMPLETED|Overall Study||2||
48265760|NCT01199068|100975299|FG000|STARTED|Overall Study||3||
48265761|NCT01199068|100975300|FG001|STARTED|Overall Study||3||
48265762|NCT01199068|100975301|FG002|STARTED|Overall Study||9||
48265763|NCT01199068|100975299|FG000|Received Treatment|Overall Study||3||
48265764|NCT01199068|100975300|FG001|Received Treatment|Overall Study||3||
48265765|NCT01199068|100975301|FG002|Received Treatment|Overall Study||8||
48265766|NCT01199068|100975299|FG000|COMPLETED|Overall Study||0||
48265767|NCT01199068|100975300|FG001|COMPLETED|Overall Study||0||
48103430|NCT02801942|100578739|FG000|STARTED|Overall Study||12||
48103431|NCT02801942|100578740|FG001|STARTED|Overall Study||10||
48103432|NCT02801942|100578739|FG000|COMPLETED|Overall Study||12||
48103433|NCT02801942|100578740|FG001|COMPLETED|Overall Study||10||
48103434|NCT02801942|100578739|FG000|NOT COMPLETED|Overall Study||0||
48103435|NCT02801942|100578740|FG001|NOT COMPLETED|Overall Study||0||
48103436|NCT01341600|100578741|FG000|STARTED|Clopidogrel 75 mg||6||
48103437|NCT01341600|100578742|FG001|STARTED|Clopidogrel 75 mg||6||
48103438|NCT01341600|100578743|FG002|STARTED|Clopidogrel 75 mg||6||
48103439|NCT01341600|100578741|FG000|COMPLETED|Clopidogrel 75 mg||6||
48103440|NCT01341600|100578742|FG001|COMPLETED|Clopidogrel 75 mg||6||
48550111|NCT04778904|101679720|FG003|NOT COMPLETED|Overall Study||0||
48550112|NCT02905032|101679721|FG000|STARTED|Overall Study||467||
48550113|NCT02905032|101679722|FG001|STARTED|Overall Study||475||
48550114|NCT02905032|101679723|FG002|STARTED|Overall Study||244||
48550115|NCT02905032|101679721|FG000|COMPLETED|Overall Study||459||
48550116|NCT02905032|101679722|FG001|COMPLETED|Overall Study||463||
48550117|NCT02905032|101679723|FG002|COMPLETED|Overall Study||244||
48550118|NCT02905032|101679721|FG000|NOT COMPLETED|Overall Study||8||
48550119|NCT02905032|101679722|FG001|NOT COMPLETED|Overall Study||12||
48550120|NCT02905032|101679723|FG002|NOT COMPLETED|Overall Study||0||
48550121|NCT03577301|101679724|FG000|STARTED|Overall Study||24||
48550122|NCT03577301|101679725|FG001|STARTED|Overall Study||21||
48550123|NCT03577301|101679726|FG002|STARTED|Overall Study||16||
48550124|NCT03577301|101679727|FG003|STARTED|Overall Study||22||
48550125|NCT03577301|101679724|FG000|COMPLETED|Overall Study||24||
48550126|NCT03577301|101679725|FG001|COMPLETED|Overall Study||21||
48550127|NCT03577301|101679726|FG002|COMPLETED|Overall Study||16||
48550128|NCT03577301|101679727|FG003|COMPLETED|Overall Study||22||
48550129|NCT03577301|101679724|FG000|NOT COMPLETED|Overall Study||0||
48550130|NCT03577301|101679725|FG001|NOT COMPLETED|Overall Study||0||
48550131|NCT03577301|101679726|FG002|NOT COMPLETED|Overall Study||0||
48550132|NCT03577301|101679727|FG003|NOT COMPLETED|Overall Study||0||
48103441|NCT01341600|100578743|FG002|COMPLETED|Clopidogrel 75 mg||6||
48103442|NCT01341600|100578741|FG000|NOT COMPLETED|Clopidogrel 75 mg||0||
48103443|NCT01341600|100578742|FG001|NOT COMPLETED|Clopidogrel 75 mg||0||
48103444|NCT01341600|100578743|FG002|NOT COMPLETED|Clopidogrel 75 mg||0||
48103445|NCT01341600|100578741|FG000|STARTED|Clopidogrel 150 mg||6||
48103446|NCT01341600|100578742|FG001|STARTED|Clopidogrel 150 mg||6||
48103447|NCT01341600|100578743|FG002|STARTED|Clopidogrel 150 mg||6||
48103448|NCT01341600|100578741|FG000|COMPLETED|Clopidogrel 150 mg||6||
48103449|NCT01341600|100578742|FG001|COMPLETED|Clopidogrel 150 mg||6||
48103450|NCT01341600|100578743|FG002|COMPLETED|Clopidogrel 150 mg||6||
48103451|NCT01341600|100578741|FG000|NOT COMPLETED|Clopidogrel 150 mg||0||
48103452|NCT01341600|100578742|FG001|NOT COMPLETED|Clopidogrel 150 mg||0||
48103453|NCT01341600|100578743|FG002|NOT COMPLETED|Clopidogrel 150 mg||0||
48103454|NCT01341600|100578741|FG000|STARTED|Clopidogrel 225 mg||6||
48103455|NCT01341600|100578742|FG001|STARTED|Clopidogrel 225 mg||6||
48103456|NCT01341600|100578743|FG002|STARTED|Clopidogrel 225 mg||6||
48103457|NCT01341600|100578741|FG000|COMPLETED|Clopidogrel 225 mg||6||
48103458|NCT01341600|100578742|FG001|COMPLETED|Clopidogrel 225 mg||6||
48103459|NCT01341600|100578743|FG002|COMPLETED|Clopidogrel 225 mg||6||
48103460|NCT01341600|100578741|FG000|NOT COMPLETED|Clopidogrel 225 mg||0||
48103461|NCT01341600|100578742|FG001|NOT COMPLETED|Clopidogrel 225 mg||0||
48103462|NCT01341600|100578743|FG002|NOT COMPLETED|Clopidogrel 225 mg||0||
48550133|NCT00794339|101679728|FG000|STARTED|Overall Study||73||
48550134|NCT00794339|101679728|FG000|Eligible|Overall Study||69||
48550135|NCT00794339|101679728|FG000|Evaluable|Overall Study||59||
48550136|NCT00794339|101679728|FG000|COMPLETED|Overall Study||59||
48550137|NCT00794339|101679728|FG000|NOT COMPLETED|Overall Study||14||
48550138|NCT03340974|101679729|FG000|STARTED|Active Protocol Treatment||18||
48550139|NCT03340974|101679730|FG001|STARTED|Active Protocol Treatment||6||
48550140|NCT03340974|101679731|FG002|STARTED|Active Protocol Treatment||6||
48550141|NCT03340974|101679732|FG003|STARTED|Active Protocol Treatment||12||
48550142|NCT03340974|101679729|FG000|COMPLETED|Active Protocol Treatment||18|Completed 12 month Follow up Period|
48550143|NCT03340974|101679730|FG001|COMPLETED|Active Protocol Treatment||6|Completed 12 month Follow up Period|
48550144|NCT03340974|101679731|FG002|COMPLETED|Active Protocol Treatment||6|Completed 12 month Follow up Period|
48550145|NCT03340974|101679732|FG003|COMPLETED|Active Protocol Treatment||12|Completed 12 month Follow up Period|
48550146|NCT03340974|101679729|FG000|NOT COMPLETED|Active Protocol Treatment||0||
48103463|NCT01341600|100578741|FG000|STARTED|Clopidogrel Plus Omeprazole||5||
48103464|NCT01341600|100578742|FG001|STARTED|Clopidogrel Plus Omeprazole||5||
48550147|NCT03340974|101679730|FG001|NOT COMPLETED|Active Protocol Treatment||0||
48550148|NCT03340974|101679731|FG002|NOT COMPLETED|Active Protocol Treatment||0||
48550149|NCT03340974|101679732|FG003|NOT COMPLETED|Active Protocol Treatment||0||
48550150|NCT03340974|101679729|FG000|STARTED|Completion of Study -Long Term Follow up||18||
48550151|NCT03340974|101679730|FG001|STARTED|Completion of Study -Long Term Follow up||6||
48550152|NCT03340974|101679731|FG002|STARTED|Completion of Study -Long Term Follow up||6||
48103465|NCT01341600|100578743|FG002|STARTED|Clopidogrel Plus Omeprazole||4||
48103466|NCT01341600|100578741|FG000|COMPLETED|Clopidogrel Plus Omeprazole||5||
48103467|NCT01341600|100578742|FG001|COMPLETED|Clopidogrel Plus Omeprazole||5||
48265768|NCT01199068|100975301|FG002|COMPLETED|Overall Study||0||
48265769|NCT01199068|100975299|FG000|NOT COMPLETED|Overall Study||3||
48265770|NCT01199068|100975300|FG001|NOT COMPLETED|Overall Study||3||
48265771|NCT01199068|100975301|FG002|NOT COMPLETED|Overall Study||9||
48265772|NCT01641653|100975302|FG000|STARTED|Overall Study||30||
48265773|NCT01641653|100975303|FG001|STARTED|Overall Study||30||
48265774|NCT01641653|100975302|FG000|COMPLETED|Overall Study||30||
48265775|NCT01641653|100975303|FG001|COMPLETED|Overall Study||30||
48265776|NCT01641653|100975302|FG000|NOT COMPLETED|Overall Study||0||
48265777|NCT01641653|100975303|FG001|NOT COMPLETED|Overall Study||0||
48265778|NCT00978562|100975304|FG000|STARTED|Overall Study||14||
48265779|NCT00978562|100975304|FG000|COMPLETED|Overall Study||12||
48265780|NCT00978562|100975304|FG000|NOT COMPLETED|Overall Study||2||
48265781|NCT02522728|100975305|FG000|STARTED|Overall Study||28||
48265782|NCT02522728|100975306|FG001|STARTED|Overall Study||30||
48265783|NCT02522728|100975305|FG000|COMPLETED|Overall Study||16||
48265784|NCT02522728|100975306|FG001|COMPLETED|Overall Study||19||
48265785|NCT02522728|100975305|FG000|NOT COMPLETED|Overall Study||12||
48265786|NCT02522728|100975306|FG001|NOT COMPLETED|Overall Study||11||
48265787|NCT00725712|100975307|FG000|STARTED|Overall Study||48||
48265788|NCT00725712|100975308|FG001|STARTED|Overall Study||26||
48265789|NCT00725712|100975307|FG000|COMPLETED|Overall Study||0||
48265790|NCT00725712|100975308|FG001|COMPLETED|Overall Study||0||
48265791|NCT00725712|100975307|FG000|NOT COMPLETED|Overall Study||48||
48265792|NCT00725712|100975308|FG001|NOT COMPLETED|Overall Study||26||
48265793|NCT03721705|100975309|FG000|STARTED|Overall Study||95||
48265794|NCT03721705|100975310|FG001|STARTED|Overall Study||95||
48265795|NCT03721705|100975309|FG000|COMPLETED|Overall Study||85||
48265796|NCT03721705|100975310|FG001|COMPLETED|Overall Study||77||
48265797|NCT03721705|100975309|FG000|NOT COMPLETED|Overall Study||10||
48265798|NCT03721705|100975310|FG001|NOT COMPLETED|Overall Study||18||
48265799|NCT01572740|100975311|FG000|STARTED|Overall Study||127||
48391610|NCT02928380|101287710|FG003|STARTED|Period 1||14||
48391611|NCT02928380|101287711|FG004|STARTED|Period 1||14||
48391612|NCT02928380|101287712|FG005|STARTED|Period 1||14||
48391613|NCT02928380|101287707|FG000|COMPLETED|Period 1||13||
48391614|NCT02928380|101287708|FG001|COMPLETED|Period 1||14||
48391615|NCT02928380|101287709|FG002|COMPLETED|Period 1||14||
48391616|NCT02928380|101287710|FG003|COMPLETED|Period 1||14||
48391617|NCT02928380|101287711|FG004|COMPLETED|Period 1||14||
48391618|NCT02928380|101287712|FG005|COMPLETED|Period 1||14||
48391619|NCT02928380|101287707|FG000|NOT COMPLETED|Period 1||0||
48391620|NCT02928380|101287708|FG001|NOT COMPLETED|Period 1||0||
48391621|NCT02928380|101287709|FG002|NOT COMPLETED|Period 1||0||
48391622|NCT02928380|101287710|FG003|NOT COMPLETED|Period 1||0||
48391623|NCT02928380|101287711|FG004|NOT COMPLETED|Period 1||0||
48391624|NCT02928380|101287712|FG005|NOT COMPLETED|Period 1||0||
48391625|NCT02928380|101287707|FG000|STARTED|Wash Out Period 1||13||
48391626|NCT02928380|101287708|FG001|STARTED|Wash Out Period 1||14||
48391627|NCT02928380|101287709|FG002|STARTED|Wash Out Period 1||14||
48391628|NCT02928380|101287710|FG003|STARTED|Wash Out Period 1||14||
48391629|NCT02928380|101287711|FG004|STARTED|Wash Out Period 1||14||
48391630|NCT02928380|101287712|FG005|STARTED|Wash Out Period 1||14||
48391631|NCT02928380|101287707|FG000|COMPLETED|Wash Out Period 1||13||
48391632|NCT02928380|101287708|FG001|COMPLETED|Wash Out Period 1||14||
48391633|NCT02928380|101287709|FG002|COMPLETED|Wash Out Period 1||14||
48391634|NCT02928380|101287710|FG003|COMPLETED|Wash Out Period 1||14||
48391635|NCT02928380|101287711|FG004|COMPLETED|Wash Out Period 1||14||
48391636|NCT02928380|101287712|FG005|COMPLETED|Wash Out Period 1||14||
48391637|NCT02928380|101287707|FG000|NOT COMPLETED|Wash Out Period 1||0||
48391638|NCT02928380|101287708|FG001|NOT COMPLETED|Wash Out Period 1||0||
48391639|NCT02928380|101287709|FG002|NOT COMPLETED|Wash Out Period 1||0||
48391640|NCT02928380|101287710|FG003|NOT COMPLETED|Wash Out Period 1||0||
48391641|NCT02928380|101287711|FG004|NOT COMPLETED|Wash Out Period 1||0||
48391642|NCT02928380|101287712|FG005|NOT COMPLETED|Wash Out Period 1||0||
48391643|NCT02928380|101287707|FG000|STARTED|Period 2||13||
48391644|NCT02928380|101287708|FG001|STARTED|Period 2||14||
48391645|NCT02928380|101287709|FG002|STARTED|Period 2||14||
48391646|NCT02928380|101287710|FG003|STARTED|Period 2||14||
48391647|NCT02928380|101287711|FG004|STARTED|Period 2||14||
48265800|NCT01572740|100975312|FG001|STARTED|Overall Study||130||
48265801|NCT01572740|100975311|FG000|COMPLETED|Overall Study||121||
48265802|NCT01572740|100975312|FG001|COMPLETED|Overall Study||125||
48391648|NCT02928380|101287712|FG005|STARTED|Period 2||14||
48391649|NCT02928380|101287707|FG000|COMPLETED|Period 2||13||
48391650|NCT02928380|101287708|FG001|COMPLETED|Period 2||14||
48265803|NCT01572740|100975311|FG000|NOT COMPLETED|Overall Study||6||
48265804|NCT01572740|100975312|FG001|NOT COMPLETED|Overall Study||5||
48265805|NCT00267098|100975313|FG000|STARTED|Overall Study||109||
48265806|NCT00267098|100975314|FG001|STARTED|Overall Study||51||
48265807|NCT00267098|100975315|FG002|STARTED|Overall Study||243||
48265808|NCT00267098|100975316|FG003|STARTED|Overall Study||241||
48391651|NCT02928380|101287709|FG002|COMPLETED|Period 2||14||
48391652|NCT02928380|101287710|FG003|COMPLETED|Period 2||14||
48391653|NCT02928380|101287711|FG004|COMPLETED|Period 2||14||
48391654|NCT02928380|101287712|FG005|COMPLETED|Period 2||14||
48391655|NCT02928380|101287707|FG000|NOT COMPLETED|Period 2||0||
48550153|NCT03340974|101679732|FG003|STARTED|Completion of Study -Long Term Follow up||12||
48550154|NCT03340974|101679729|FG000|COMPLETED|Completion of Study -Long Term Follow up||0||
48550155|NCT03340974|101679730|FG001|COMPLETED|Completion of Study -Long Term Follow up||0||
48550156|NCT03340974|101679731|FG002|COMPLETED|Completion of Study -Long Term Follow up||0||
48550157|NCT03340974|101679732|FG003|COMPLETED|Completion of Study -Long Term Follow up||0||
48550158|NCT03340974|101679729|FG000|NOT COMPLETED|Completion of Study -Long Term Follow up||18||
48550159|NCT03340974|101679730|FG001|NOT COMPLETED|Completion of Study -Long Term Follow up||6||
48265809|NCT00267098|100975317|FG004|STARTED|Overall Study||47||
48691768|NCT02266147|102029005|FG002|NOT COMPLETED|PART 2: Dose Expansion||0||
48691769|NCT02266147|102029006|FG003|NOT COMPLETED|PART 2: Dose Expansion||9||
48265810|NCT00267098|100975318|FG005|STARTED|Overall Study||106||
48265811|NCT00267098|100975319|FG006|STARTED|Overall Study||101||
48265812|NCT00267098|100975320|FG007|STARTED|Overall Study||20||
48265813|NCT00267098|100975313|FG000|COMPLETED|Overall Study||0||
48265814|NCT00267098|100975314|FG001|COMPLETED|Overall Study||0||
48265815|NCT00267098|100975315|FG002|COMPLETED|Overall Study||149||
48265816|NCT00267098|100975316|FG003|COMPLETED|Overall Study||135||
48265817|NCT00267098|100975317|FG004|COMPLETED|Overall Study||10||
48265818|NCT00267098|100975318|FG005|COMPLETED|Overall Study||66||
48265819|NCT00267098|100975319|FG006|COMPLETED|Overall Study||55||
48265820|NCT00267098|100975320|FG007|COMPLETED|Overall Study||5||
48265821|NCT00267098|100975313|FG000|NOT COMPLETED|Overall Study||109||
48265822|NCT00267098|100975314|FG001|NOT COMPLETED|Overall Study||51||
48265823|NCT00267098|100975315|FG002|NOT COMPLETED|Overall Study||94||
48265824|NCT00267098|100975316|FG003|NOT COMPLETED|Overall Study||106||
48265825|NCT00267098|100975317|FG004|NOT COMPLETED|Overall Study||37||
48265826|NCT00267098|100975318|FG005|NOT COMPLETED|Overall Study||40||
48265827|NCT00267098|100975319|FG006|NOT COMPLETED|Overall Study||46||
48265828|NCT00267098|100975320|FG007|NOT COMPLETED|Overall Study||15||
48265829|NCT02160730|100975321|FG000|STARTED|Overall Study||4||
48265830|NCT02160730|100975321|FG000|COMPLETED|Overall Study||4||
48265831|NCT02160730|100975321|FG000|NOT COMPLETED|Overall Study||0||
48265832|NCT00203268|100975322|FG000|STARTED|Early Treatment||13||
48265833|NCT00203268|100975322|FG000|COMPLETED|Early Treatment||9||
48265834|NCT00203268|100975322|FG000|NOT COMPLETED|Early Treatment||4||
48265835|NCT00203268|100975322|FG000|STARTED|Late Treatment||9||
48265836|NCT00203268|100975322|FG000|COMPLETED|Late Treatment||9||
48265837|NCT00203268|100975322|FG000|NOT COMPLETED|Late Treatment||0||
48265838|NCT04529005|100975323|FG000|STARTED|Overall Study||20||
48265839|NCT04529005|100975323|FG000|COMPLETED|Overall Study||20||
48391656|NCT02928380|101287708|FG001|NOT COMPLETED|Period 2||0||
48391657|NCT02928380|101287709|FG002|NOT COMPLETED|Period 2||0||
48391658|NCT02928380|101287710|FG003|NOT COMPLETED|Period 2||0||
48391659|NCT02928380|101287711|FG004|NOT COMPLETED|Period 2||0||
48391660|NCT02928380|101287712|FG005|NOT COMPLETED|Period 2||0||
48391661|NCT02928380|101287707|FG000|STARTED|Wash Out Period 2||13||
48691770|NCT02455804|102029007|FG000|STARTED|Overall Study||65||
48265840|NCT04529005|100975323|FG000|NOT COMPLETED|Overall Study||0||
48265841|NCT01513330|100975324|FG000|STARTED|SenSura Mio First,||64||
48265842|NCT01513330|100975325|FG001|STARTED|SenSura Mio First,||58||
48265843|NCT01513330|100975324|FG000|COMPLETED|SenSura Mio First,||60||
48265844|NCT01513330|100975325|FG001|COMPLETED|SenSura Mio First,||56||
48265845|NCT01513330|100975324|FG000|NOT COMPLETED|SenSura Mio First,||4||
48265846|NCT01513330|100975325|FG001|NOT COMPLETED|SenSura Mio First,||2||
48265847|NCT01513330|100975324|FG000|STARTED|Standard Care First,||60||
48265848|NCT01513330|100975325|FG001|STARTED|Standard Care First,||56||
48265849|NCT01513330|100975324|FG000|COMPLETED|Standard Care First,||56||
48391662|NCT02928380|101287708|FG001|STARTED|Wash Out Period 2||14||
48391663|NCT02928380|101287709|FG002|STARTED|Wash Out Period 2||14||
48391664|NCT02928380|101287710|FG003|STARTED|Wash Out Period 2||14||
48391665|NCT02928380|101287711|FG004|STARTED|Wash Out Period 2||14||
48391666|NCT02928380|101287712|FG005|STARTED|Wash Out Period 2||14||
48391667|NCT02928380|101287707|FG000|COMPLETED|Wash Out Period 2||13||
48391668|NCT02928380|101287708|FG001|COMPLETED|Wash Out Period 2||14||
48391669|NCT02928380|101287709|FG002|COMPLETED|Wash Out Period 2||14||
48391670|NCT02928380|101287710|FG003|COMPLETED|Wash Out Period 2||14||
48391671|NCT02928380|101287711|FG004|COMPLETED|Wash Out Period 2||14||
48391672|NCT02928380|101287712|FG005|COMPLETED|Wash Out Period 2||14||
48691771|NCT02455804|102029007|FG000|COMPLETED|Overall Study||46||
48265850|NCT01513330|100975325|FG001|COMPLETED|Standard Care First,||52||
48265851|NCT01513330|100975324|FG000|NOT COMPLETED|Standard Care First,||4||
48391673|NCT02928380|101287707|FG000|NOT COMPLETED|Wash Out Period 2||0||
48391674|NCT02928380|101287708|FG001|NOT COMPLETED|Wash Out Period 2||0||
48391675|NCT02928380|101287709|FG002|NOT COMPLETED|Wash Out Period 2||0||
48391676|NCT02928380|101287710|FG003|NOT COMPLETED|Wash Out Period 2||0||
48265852|NCT01513330|100975325|FG001|NOT COMPLETED|Standard Care First,||4||
48265853|NCT01304498|100975326|FG000|STARTED|Overall Study||300||
48391677|NCT02928380|101287711|FG004|NOT COMPLETED|Wash Out Period 2||0||
48391678|NCT02928380|101287712|FG005|NOT COMPLETED|Wash Out Period 2||0||
48265854|NCT01304498|100975327|FG001|STARTED|Overall Study||300||
48391679|NCT02928380|101287707|FG000|STARTED|Period 3||13||
48391680|NCT02928380|101287708|FG001|STARTED|Period 3||14||
48550160|NCT03340974|101679731|FG002|NOT COMPLETED|Completion of Study -Long Term Follow up||6||
48550161|NCT03340974|101679732|FG003|NOT COMPLETED|Completion of Study -Long Term Follow up||12||
48550162|NCT02130622|101679733|FG000|STARTED|Overall Study||2||
48550163|NCT02130622|101679734|FG001|STARTED|Overall Study||1||
48550164|NCT02130622|101679733|FG000|COMPLETED|Overall Study||2||
48550165|NCT02130622|101679734|FG001|COMPLETED|Overall Study||1||
48550166|NCT02130622|101679733|FG000|NOT COMPLETED|Overall Study||0||
48550167|NCT02130622|101679734|FG001|NOT COMPLETED|Overall Study||0||
48265855|NCT01304498|100975326|FG000|Received ≥1 Dose|Overall Study||300||
48265856|NCT01304498|100975327|FG001|Received ≥1 Dose|Overall Study||300||
48265857|NCT01304498|100975326|FG000|COMPLETED|Overall Study||294||
48265858|NCT01304498|100975327|FG001|COMPLETED|Overall Study||295||
48265859|NCT01304498|100975326|FG000|NOT COMPLETED|Overall Study||6||
48265860|NCT01304498|100975327|FG001|NOT COMPLETED|Overall Study||5||
48550168|NCT03278626|101679735|FG000|STARTED|Overall Study||12||
48550169|NCT03278626|101679735|FG000|COMPLETED|Overall Study||7||
48550170|NCT03278626|101679735|FG000|NOT COMPLETED|Overall Study||5||
48550171|NCT04927845|101679736|FG000|STARTED|Overall Study||255||
48550172|NCT04927845|101679737|FG001|STARTED|Overall Study||283||
48550173|NCT04927845|101679736|FG000|Posttest|Overall Study||149||
48550174|NCT04927845|101679737|FG001|Posttest|Overall Study||241||
48550175|NCT04927845|101679736|FG000|2-month Follow-up|Overall Study||114||
48550176|NCT04927845|101679737|FG001|2-month Follow-up|Overall Study||218||
48550177|NCT04927845|101679736|FG000|5-month Follow-up|Overall Study||113||
48550178|NCT04927845|101679737|FG001|5-month Follow-up|Overall Study||139||
48550179|NCT04927845|101679736|FG000|COMPLETED|Overall Study||244|Participants who were not excluded post hoc due to invalid data reported in their survey responses|
48550180|NCT04927845|101679737|FG001|COMPLETED|Overall Study||275|Participants who were not excluded post hoc due to invalid data reported in their survey responses|
48550181|NCT04927845|101679736|FG000|NOT COMPLETED|Overall Study||11||
48550182|NCT04927845|101679737|FG001|NOT COMPLETED|Overall Study||8||
48550183|NCT01255137|101679738|FG000|STARTED|Overall Study||13||
48550184|NCT01255137|101679738|FG000|COMPLETED|Overall Study||13||
48550185|NCT01255137|101679738|FG000|NOT COMPLETED|Overall Study||0||
48550186|NCT03408171|101679739|FG000|STARTED|Overall Study||20||
48550187|NCT03408171|101679740|FG001|STARTED|Overall Study||20||
48550188|NCT03408171|101679739|FG000|COMPLETED|Overall Study||20||
48550189|NCT03408171|101679740|FG001|COMPLETED|Overall Study||20||
48550190|NCT03408171|101679739|FG000|NOT COMPLETED|Overall Study||0||
48550191|NCT03408171|101679740|FG001|NOT COMPLETED|Overall Study||0||
48550192|NCT04779879|101679741|FG000|STARTED|Part A: Up to Week 24||8||
48550193|NCT04779879|101679742|FG001|STARTED|Part A: Up to Week 24||22||
48550194|NCT04779879|101679743|FG002|STARTED|Part A: Up to Week 24||0||
48550195|NCT04779879|101679744|FG003|STARTED|Part A: Up to Week 24||0||
48550196|NCT04779879|101679745|FG004|STARTED|Part A: Up to Week 24||0||
48550197|NCT04779879|101679746|FG005|STARTED|Part A: Up to Week 24||0||
48550198|NCT04779879|101679741|FG000|Treatment Received|Part A: Up to Week 24||8||
48550199|NCT04779879|101679742|FG001|Treatment Received|Part A: Up to Week 24||22||
48550200|NCT04779879|101679743|FG002|Treatment Received|Part A: Up to Week 24||0||
48550201|NCT04779879|101679744|FG003|Treatment Received|Part A: Up to Week 24||0||
48550202|NCT04779879|101679745|FG004|Treatment Received|Part A: Up to Week 24||0||
48550203|NCT04779879|101679746|FG005|Treatment Received|Part A: Up to Week 24||0||
48550204|NCT04779879|101679741|FG000|COMPLETED|Part A: Up to Week 24||8||
48103468|NCT01341600|100578743|FG002|COMPLETED|Clopidogrel Plus Omeprazole||4||
48103469|NCT01341600|100578741|FG000|NOT COMPLETED|Clopidogrel Plus Omeprazole||0||
48550205|NCT04779879|101679742|FG001|COMPLETED|Part A: Up to Week 24||22||
48550206|NCT04779879|101679743|FG002|COMPLETED|Part A: Up to Week 24||0||
48550207|NCT04779879|101679744|FG003|COMPLETED|Part A: Up to Week 24||0||
48550208|NCT04779879|101679745|FG004|COMPLETED|Part A: Up to Week 24||0||
48550209|NCT04779879|101679746|FG005|COMPLETED|Part A: Up to Week 24||0||
48550210|NCT04779879|101679741|FG000|NOT COMPLETED|Part A: Up to Week 24||0||
48550211|NCT04779879|101679742|FG001|NOT COMPLETED|Part A: Up to Week 24||0||
48550212|NCT04779879|101679743|FG002|NOT COMPLETED|Part A: Up to Week 24||0||
48550213|NCT04779879|101679744|FG003|NOT COMPLETED|Part A: Up to Week 24||0||
48550214|NCT04779879|101679745|FG004|NOT COMPLETED|Part A: Up to Week 24||0||
48550215|NCT04779879|101679746|FG005|NOT COMPLETED|Part A: Up to Week 24||0||
48550216|NCT04779879|101679741|FG000|STARTED|Part B: Up to Week 36||0||
48550217|NCT04779879|101679742|FG001|STARTED|Part B: Up to Week 36||0||
48550218|NCT04779879|101679743|FG002|STARTED|Part B: Up to Week 36||84||
48550219|NCT04779879|101679744|FG003|STARTED|Part B: Up to Week 36||83||
48550220|NCT04779879|101679745|FG004|STARTED|Part B: Up to Week 36||0||
48550221|NCT04779879|101679746|FG005|STARTED|Part B: Up to Week 36||0||
48550222|NCT04779879|101679741|FG000|Treatment Received|Part B: Up to Week 36||0||
48550223|NCT04779879|101679742|FG001|Treatment Received|Part B: Up to Week 36||0||
48550224|NCT04779879|101679743|FG002|Treatment Received|Part B: Up to Week 36||84||
48550225|NCT04779879|101679744|FG003|Treatment Received|Part B: Up to Week 36||82||
48550226|NCT04779879|101679745|FG004|Treatment Received|Part B: Up to Week 36||0||
48550227|NCT04779879|101679746|FG005|Treatment Received|Part B: Up to Week 36||0||
48550228|NCT04779879|101679741|FG000|COMPLETED|Part B: Up to Week 36||0||
48550229|NCT04779879|101679742|FG001|COMPLETED|Part B: Up to Week 36||0||
48550230|NCT04779879|101679743|FG002|COMPLETED|Part B: Up to Week 36||84||
48550231|NCT04779879|101679744|FG003|COMPLETED|Part B: Up to Week 36||81||
48550232|NCT04779879|101679745|FG004|COMPLETED|Part B: Up to Week 36||0||
48550233|NCT04779879|101679746|FG005|COMPLETED|Part B: Up to Week 36||0||
48550234|NCT04779879|101679741|FG000|NOT COMPLETED|Part B: Up to Week 36||0||
48550235|NCT04779879|101679742|FG001|NOT COMPLETED|Part B: Up to Week 36||0||
48550236|NCT04779879|101679743|FG002|NOT COMPLETED|Part B: Up to Week 36||0||
48550237|NCT04779879|101679744|FG003|NOT COMPLETED|Part B: Up to Week 36||2||
48550238|NCT04779879|101679745|FG004|NOT COMPLETED|Part B: Up to Week 36||0||
48550239|NCT04779879|101679746|FG005|NOT COMPLETED|Part B: Up to Week 36||0||
48550240|NCT04779879|101679741|FG000|STARTED|Part C: Up to Week 36||0||
48550241|NCT04779879|101679742|FG001|STARTED|Part C: Up to Week 36||0||
48550242|NCT04779879|101679743|FG002|STARTED|Part C: Up to Week 36||0||
48550243|NCT04779879|101679744|FG003|STARTED|Part C: Up to Week 36||0||
48550244|NCT04779879|101679745|FG004|STARTED|Part C: Up to Week 36||79||
48550245|NCT04779879|101679746|FG005|STARTED|Part C: Up to Week 36||78||
48550246|NCT04779879|101679741|FG000|Treatment Received|Part C: Up to Week 36||0||
48550247|NCT04779879|101679742|FG001|Treatment Received|Part C: Up to Week 36||0||
48550248|NCT04779879|101679743|FG002|Treatment Received|Part C: Up to Week 36||0||
48550249|NCT04779879|101679744|FG003|Treatment Received|Part C: Up to Week 36||0||
48550250|NCT04779879|101679745|FG004|Treatment Received|Part C: Up to Week 36||79||
48550251|NCT04779879|101679746|FG005|Treatment Received|Part C: Up to Week 36||78||
48550252|NCT04779879|101679741|FG000|COMPLETED|Part C: Up to Week 36||0||
48550253|NCT04779879|101679742|FG001|COMPLETED|Part C: Up to Week 36||0||
48550254|NCT04779879|101679743|FG002|COMPLETED|Part C: Up to Week 36||0||
48550255|NCT04779879|101679744|FG003|COMPLETED|Part C: Up to Week 36||0||
48550256|NCT04779879|101679745|FG004|COMPLETED|Part C: Up to Week 36||75||
48550257|NCT04779879|101679746|FG005|COMPLETED|Part C: Up to Week 36||75||
48550258|NCT04779879|101679741|FG000|NOT COMPLETED|Part C: Up to Week 36||0||
48550259|NCT04779879|101679742|FG001|NOT COMPLETED|Part C: Up to Week 36||0||
48550260|NCT04779879|101679743|FG002|NOT COMPLETED|Part C: Up to Week 36||0||
48550261|NCT04779879|101679744|FG003|NOT COMPLETED|Part C: Up to Week 36||0||
48550262|NCT04779879|101679745|FG004|NOT COMPLETED|Part C: Up to Week 36||4||
48550263|NCT04779879|101679746|FG005|NOT COMPLETED|Part C: Up to Week 36||3||
48550264|NCT02246114|101679747|FG000|STARTED|Overall Study||1||
48550265|NCT02246114|101679748|FG001|STARTED|Overall Study||0||
48550266|NCT02246114|101679747|FG000|COMPLETED|Overall Study||0||
48550267|NCT02246114|101679748|FG001|COMPLETED|Overall Study||0||
48550268|NCT02246114|101679747|FG000|NOT COMPLETED|Overall Study||1||
48550269|NCT02246114|101679748|FG001|NOT COMPLETED|Overall Study||0||
48550270|NCT01927575|101679749|FG000|STARTED|Overall Study||1||
48550271|NCT01927575|101679749|FG000|COMPLETED|Overall Study||1||
48550272|NCT01927575|101679749|FG000|NOT COMPLETED|Overall Study||0||
48550273|NCT02943590|101679750|FG000|STARTED|Overall Study||150||
48550274|NCT02943590|101679751|FG001|STARTED|Overall Study||150||
48550275|NCT02943590|101679750|FG000|COMPLETED|Overall Study||144||
48550276|NCT02943590|101679751|FG001|COMPLETED|Overall Study||142||
48550277|NCT02943590|101679750|FG000|NOT COMPLETED|Overall Study||6||
48550278|NCT02943590|101679751|FG001|NOT COMPLETED|Overall Study||8||
48550279|NCT00270855|101679752|FG000|STARTED|Overall Study||15||
48550280|NCT00270855|101679753|FG001|STARTED|Overall Study||14||
48550281|NCT00270855|101679752|FG000|COMPLETED|Overall Study||7||
48550282|NCT00270855|101679753|FG001|COMPLETED|Overall Study||6||
48550283|NCT00270855|101679752|FG000|NOT COMPLETED|Overall Study||8||
48550284|NCT00270855|101679753|FG001|NOT COMPLETED|Overall Study||8||
48550285|NCT00324987|101679754|FG000|STARTED|Overall Study||6||
48550286|NCT00324987|101679755|FG001|STARTED|Overall Study||6||
48550287|NCT00324987|101679754|FG000|COMPLETED|Overall Study||0||
48550288|NCT00324987|101679755|FG001|COMPLETED|Overall Study||0||
48550289|NCT00324987|101679754|FG000|NOT COMPLETED|Overall Study||6||
48550290|NCT00324987|101679755|FG001|NOT COMPLETED|Overall Study||6||
48550291|NCT02559180|101679756|FG000|STARTED|Overall Study||20||
48550292|NCT02559180|101679756|FG000|COMPLETED|Overall Study||16||
48550293|NCT02559180|101679756|FG000|NOT COMPLETED|Overall Study||4||
48550294|NCT00704132|101679757|FG000|STARTED|Overall Study||26||
48550295|NCT00704132|101679758|FG001|STARTED|Overall Study||24||
48550296|NCT00704132|101679757|FG000|COMPLETED|Overall Study||25||
48550297|NCT00704132|101679758|FG001|COMPLETED|Overall Study||22||
48550298|NCT00704132|101679757|FG000|NOT COMPLETED|Overall Study||1||
48550299|NCT00704132|101679758|FG001|NOT COMPLETED|Overall Study||2||
48550300|NCT00134901|101679759|FG000|STARTED|Overall Study||39||
48550301|NCT00134901|101679760|FG001|STARTED|Overall Study||42||
48550302|NCT00134901|101679759|FG000|COMPLETED|Overall Study||22||
48550303|NCT00134901|101679760|FG001|COMPLETED|Overall Study||27||
48550304|NCT00134901|101679759|FG000|NOT COMPLETED|Overall Study||17||
48550305|NCT00134901|101679760|FG001|NOT COMPLETED|Overall Study||15||
48550306|NCT01332292|101679761|FG000|STARTED|Treatment Period 1 (14 Days)||14||
48550307|NCT01332292|101679762|FG001|STARTED|Treatment Period 1 (14 Days)||13||
48550308|NCT01332292|101679761|FG000|COMPLETED|Treatment Period 1 (14 Days)||12||
48550309|NCT01332292|101679762|FG001|COMPLETED|Treatment Period 1 (14 Days)||12||
48550310|NCT01332292|101679761|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||2||
48550311|NCT01332292|101679762|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1||
48550312|NCT01332292|101679761|FG000|STARTED|Washout Period (>=7 Days)||12||
48550313|NCT01332292|101679762|FG001|STARTED|Washout Period (>=7 Days)||12||
48550314|NCT01332292|101679761|FG000|COMPLETED|Washout Period (>=7 Days)||12||
48550315|NCT01332292|101679762|FG001|COMPLETED|Washout Period (>=7 Days)||12||
48550316|NCT01332292|101679761|FG000|NOT COMPLETED|Washout Period (>=7 Days)||0||
48550317|NCT01332292|101679762|FG001|NOT COMPLETED|Washout Period (>=7 Days)||0||
48550318|NCT01332292|101679761|FG000|STARTED|Treatment Period 2 (14 Days)||12||
48550319|NCT01332292|101679762|FG001|STARTED|Treatment Period 2 (14 Days)||12||
48550320|NCT01332292|101679761|FG000|COMPLETED|Treatment Period 2 (14 Days)||11||
48550321|NCT01332292|101679762|FG001|COMPLETED|Treatment Period 2 (14 Days)||11||
48550322|NCT01332292|101679761|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||1||
48550323|NCT01332292|101679762|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||1||
48550324|NCT00171951|101679763|FG000|STARTED|Overall Study||19||
48103470|NCT01341600|100578742|FG001|NOT COMPLETED|Clopidogrel Plus Omeprazole||0||
48103471|NCT01341600|100578743|FG002|NOT COMPLETED|Clopidogrel Plus Omeprazole||0||
48103472|NCT02410382|100578744|FG000|STARTED|Overall Study||0||
48550325|NCT00171951|101679763|FG000|COMPLETED|Overall Study||3||
48550326|NCT00171951|101679763|FG000|NOT COMPLETED|Overall Study||16||
48550327|NCT00741338|101679764|FG000|STARTED|Overall Study||3||
48550328|NCT00741338|101679765|FG001|STARTED|Overall Study||3||
48550329|NCT00741338|101679764|FG000|COMPLETED|Overall Study||3||
48550330|NCT00741338|101679765|FG001|COMPLETED|Overall Study||2||
48550331|NCT00741338|101679764|FG000|NOT COMPLETED|Overall Study||0||
48550332|NCT00741338|101679765|FG001|NOT COMPLETED|Overall Study||1||
48550333|NCT00104572|101679766|FG000|STARTED|Overall Study||13||
48550334|NCT00104572|101679767|FG001|STARTED|Overall Study||13||
48550335|NCT00104572|101679768|FG002|STARTED|Overall Study||9||
48550336|NCT00104572|101679766|FG000|COMPLETED|Overall Study||10||
48550337|NCT00104572|101679767|FG001|COMPLETED|Overall Study||10||
48550338|NCT00104572|101679768|FG002|COMPLETED|Overall Study||9||
48550339|NCT00104572|101679766|FG000|NOT COMPLETED|Overall Study||3||
48550340|NCT00104572|101679767|FG001|NOT COMPLETED|Overall Study||3||
48550341|NCT00104572|101679768|FG002|NOT COMPLETED|Overall Study||0||
48550342|NCT00911300|101679769|FG000|STARTED|Overall Study||175||
48550343|NCT00911300|101679770|FG001|STARTED|Overall Study||174||
48550344|NCT00911300|101679769|FG000|COMPLETED|Overall Study||140||
48550345|NCT00911300|101679770|FG001|COMPLETED|Overall Study||131||
48550346|NCT00911300|101679769|FG000|NOT COMPLETED|Overall Study||35||
48550347|NCT00911300|101679770|FG001|NOT COMPLETED|Overall Study||43||
48550348|NCT01545518|101679771|FG000|STARTED|Overall Study||20||
48550349|NCT01545518|101679771|FG000|COMPLETED|Overall Study||20||
48550350|NCT01545518|101679771|FG000|NOT COMPLETED|Overall Study||0||
48550351|NCT02661217|101679772|FG000|STARTED|Overall Study||500|Randomized|
48550352|NCT02661217|101679773|FG001|STARTED|Overall Study||502|Randomized|
48550353|NCT02661217|101679772|FG000|Started 10 Weeks Treatment Epoch|Overall Study||497||
48550354|NCT02661217|101679773|FG001|Started 10 Weeks Treatment Epoch|Overall Study||501||
48550355|NCT02661217|101679772|FG000|Completed 10 Weeks Treatment Epoch|Overall Study||460||
48550356|NCT02661217|101679773|FG001|Completed 10 Weeks Treatment Epoch|Overall Study||455||
48550357|NCT02661217|101679772|FG000|COMPLETED|Overall Study||425|Completed 16 weeks follow-up epoch|
48550358|NCT02661217|101679773|FG001|COMPLETED|Overall Study||419|Completed 16 weeks follow-up epoch|
48550359|NCT02661217|101679772|FG000|NOT COMPLETED|Overall Study||75||
48550360|NCT02661217|101679773|FG001|NOT COMPLETED|Overall Study||83||
48550361|NCT02763826|101679774|FG000|STARTED|Part 1 Dose Escalation, 1 mA||3||
48550362|NCT02763826|101679775|FG001|STARTED|Part 1 Dose Escalation, 1 mA||0||
48103473|NCT02410382|100578745|FG001|STARTED|Overall Study||0||
48550363|NCT02763826|101679776|FG002|STARTED|Part 1 Dose Escalation, 1 mA||0||
48550364|NCT02763826|101679777|FG003|STARTED|Part 1 Dose Escalation, 1 mA||0||
48550365|NCT02763826|101679778|FG004|STARTED|Part 1 Dose Escalation, 1 mA||0||
48550366|NCT02763826|101679779|FG005|STARTED|Part 1 Dose Escalation, 1 mA||0||
48550367|NCT02763826|101679780|FG006|STARTED|Part 1 Dose Escalation, 1 mA||0||
48550368|NCT02763826|101679781|FG007|STARTED|Part 1 Dose Escalation, 1 mA||0||
48550369|NCT02763826|101679774|FG000|COMPLETED|Part 1 Dose Escalation, 1 mA||3||
48550370|NCT02763826|101679775|FG001|COMPLETED|Part 1 Dose Escalation, 1 mA||0||
48550371|NCT02763826|101679776|FG002|COMPLETED|Part 1 Dose Escalation, 1 mA||0||
48103474|NCT02410382|100578744|FG000|COMPLETED|Overall Study||0||
48103475|NCT02410382|100578745|FG001|COMPLETED|Overall Study||0||
48103476|NCT02410382|100578744|FG000|NOT COMPLETED|Overall Study||0||
48550372|NCT02763826|101679777|FG003|COMPLETED|Part 1 Dose Escalation, 1 mA||0||
48550373|NCT02763826|101679778|FG004|COMPLETED|Part 1 Dose Escalation, 1 mA||0||
48550374|NCT02763826|101679779|FG005|COMPLETED|Part 1 Dose Escalation, 1 mA||0||
48550375|NCT02763826|101679780|FG006|COMPLETED|Part 1 Dose Escalation, 1 mA||0||
48550376|NCT02763826|101679781|FG007|COMPLETED|Part 1 Dose Escalation, 1 mA||0||
48550377|NCT02763826|101679774|FG000|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0||
48550378|NCT02763826|101679775|FG001|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0||
48550379|NCT02763826|101679776|FG002|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0||
48550380|NCT02763826|101679777|FG003|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0||
48550381|NCT02763826|101679778|FG004|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0||
48103477|NCT02410382|100578745|FG001|NOT COMPLETED|Overall Study||0||
48691772|NCT02455804|102029007|FG000|NOT COMPLETED|Overall Study||19||
48691773|NCT02406573|102029008|FG000|STARTED|Overall Study||30||
48691774|NCT02406573|102029008|FG000|COMPLETED|Overall Study||30||
48691775|NCT02406573|102029008|FG000|NOT COMPLETED|Overall Study||0||
48691776|NCT03198767|102029009|FG000|STARTED|Overall Study||8||
48691777|NCT03198767|102029010|FG001|STARTED|Overall Study||8||
48691778|NCT03198767|102029011|FG002|STARTED|Overall Study||8||
48103478|NCT01586819|100578746|FG000|STARTED|Overall Study||12||
48103479|NCT01586819|100578747|FG001|STARTED|Overall Study||14||
48103480|NCT01586819|100578746|FG000|COMPLETED|Overall Study||11||
48103481|NCT01586819|100578747|FG001|COMPLETED|Overall Study||14||
48103482|NCT01586819|100578746|FG000|NOT COMPLETED|Overall Study||1||
48103483|NCT01586819|100578747|FG001|NOT COMPLETED|Overall Study||0||
48103484|NCT00735878|100578748|FG000|STARTED|Phase I- Dose Determination||1||
48103485|NCT00735878|100578749|FG001|STARTED|Phase I- Dose Determination||7||
48103486|NCT00735878|100578750|FG002|STARTED|Phase I- Dose Determination||5||
48103487|NCT00735878|100578748|FG000|COMPLETED|Phase I- Dose Determination||1||
48103488|NCT00735878|100578749|FG001|COMPLETED|Phase I- Dose Determination||7||
48103489|NCT00735878|100578750|FG002|COMPLETED|Phase I- Dose Determination||4||
48103490|NCT00735878|100578748|FG000|NOT COMPLETED|Phase I- Dose Determination||0||
48103491|NCT00735878|100578749|FG001|NOT COMPLETED|Phase I- Dose Determination||0||
48103492|NCT00735878|100578750|FG002|NOT COMPLETED|Phase I- Dose Determination||1||
48103493|NCT00735878|100578748|FG000|STARTED|Phase II- Determined Dose||0||
48103494|NCT00735878|100578749|FG001|STARTED|Phase II- Determined Dose||7||
48103495|NCT00735878|100578750|FG002|STARTED|Phase II- Determined Dose||0||
48103496|NCT00735878|100578748|FG000|COMPLETED|Phase II- Determined Dose||0||
48103497|NCT00735878|100578749|FG001|COMPLETED|Phase II- Determined Dose||7||
48103498|NCT00735878|100578750|FG002|COMPLETED|Phase II- Determined Dose||0||
48103499|NCT00735878|100578748|FG000|NOT COMPLETED|Phase II- Determined Dose||0||
48103500|NCT00735878|100578749|FG001|NOT COMPLETED|Phase II- Determined Dose||0||
48103501|NCT00735878|100578750|FG002|NOT COMPLETED|Phase II- Determined Dose||0||
48103502|NCT03329690|100578751|FG000|STARTED|Overall Study||126||
48103503|NCT03329690|100578752|FG001|STARTED|Overall Study||55||
48103504|NCT03329690|100578753|FG002|STARTED|Overall Study||7||
48103505|NCT03329690|100578754|FG003|STARTED|Overall Study||21||
48103506|NCT03329690|100578755|FG004|STARTED|Overall Study||24||
48103507|NCT03329690|100578751|FG000|Received Treatment|Overall Study||125||
48103508|NCT03329690|100578752|FG001|Received Treatment|Overall Study||55||
48103509|NCT03329690|100578753|FG002|Received Treatment|Overall Study||7||
48103510|NCT03329690|100578754|FG003|Received Treatment|Overall Study||20||
48103511|NCT03329690|100578755|FG004|Received Treatment|Overall Study||24||
48103512|NCT03329690|100578751|FG000|COMPLETED|Overall Study||0||
48103513|NCT03329690|100578752|FG001|COMPLETED|Overall Study||0||
48103514|NCT03329690|100578753|FG002|COMPLETED|Overall Study||0||
48103515|NCT03329690|100578754|FG003|COMPLETED|Overall Study||0||
48103516|NCT03329690|100578755|FG004|COMPLETED|Overall Study||0||
48103517|NCT03329690|100578751|FG000|NOT COMPLETED|Overall Study||126||
48103518|NCT03329690|100578752|FG001|NOT COMPLETED|Overall Study||55||
48103519|NCT03329690|100578753|FG002|NOT COMPLETED|Overall Study||7||
48103520|NCT03329690|100578754|FG003|NOT COMPLETED|Overall Study||21||
48103521|NCT03329690|100578755|FG004|NOT COMPLETED|Overall Study||24||
48103522|NCT00827255|100578756|FG000|STARTED|Overall Study||35||
48103523|NCT00827255|100578756|FG000|COMPLETED|Overall Study||35||
48103524|NCT00827255|100578756|FG000|NOT COMPLETED|Overall Study||0||
48103525|NCT00127712|100578757|FG000|STARTED|Overall Study||65||
48103526|NCT00127712|100578758|FG001|STARTED|Overall Study||65||
48103527|NCT00127712|100578757|FG000|COMPLETED|Overall Study||60||
48103528|NCT00127712|100578758|FG001|COMPLETED|Overall Study||65||
48103529|NCT00127712|100578757|FG000|NOT COMPLETED|Overall Study||5||
48103530|NCT00127712|100578758|FG001|NOT COMPLETED|Overall Study||0||
48103531|NCT01787175|100578759|FG000|STARTED|Overall Study||30||
48103532|NCT01787175|100578760|FG001|STARTED|Overall Study||28||
48103533|NCT01787175|100578759|FG000|COMPLETED|Overall Study||30||
48103534|NCT01787175|100578760|FG001|COMPLETED|Overall Study||28||
48391681|NCT02928380|101287709|FG002|STARTED|Period 3||14||
48691779|NCT03198767|102029012|FG003|STARTED|Overall Study||6||
48103535|NCT01787175|100578759|FG000|NOT COMPLETED|Overall Study||0||
48103536|NCT01787175|100578760|FG001|NOT COMPLETED|Overall Study||0||
48103537|NCT01478321|100578761|FG000|STARTED|Concurrent Therapy (5 Weeks)||54||
48103538|NCT01478321|100578761|FG000|COMPLETED|Concurrent Therapy (5 Weeks)||38||
48103539|NCT01478321|100578761|FG000|NOT COMPLETED|Concurrent Therapy (5 Weeks)||16||
48103540|NCT01478321|100578761|FG000|STARTED|Started Adjuvant Therapy||38||
48103541|NCT01478321|100578761|FG000|Completed First Cycle|Started Adjuvant Therapy||37||
48103542|NCT01478321|100578761|FG000|COMPLETED|Started Adjuvant Therapy||37||
48103543|NCT01478321|100578761|FG000|NOT COMPLETED|Started Adjuvant Therapy||1||
48103544|NCT01478321|100578761|FG000|STARTED|Adjuvant Therapy Until PD or Toxicity||37||
48691780|NCT03198767|102029013|FG004|STARTED|Overall Study||8||
48691781|NCT03198767|102029014|FG005|STARTED|Overall Study||8||
48691782|NCT03198767|102029015|FG006|STARTED|Overall Study||8||
48691783|NCT03198767|102029009|FG000|COMPLETED|Overall Study||8||
48691784|NCT03198767|102029010|FG001|COMPLETED|Overall Study||8||
48691785|NCT03198767|102029011|FG002|COMPLETED|Overall Study||8||
48103545|NCT01478321|100578761|FG000|Went on to Cycle 2 +|Adjuvant Therapy Until PD or Toxicity||27||
48103546|NCT01478321|100578761|FG000|COMPLETED|Adjuvant Therapy Until PD or Toxicity||27||
48103547|NCT01478321|100578761|FG000|NOT COMPLETED|Adjuvant Therapy Until PD or Toxicity||10||
48103548|NCT01478321|100578761|FG000|STARTED|Follow-up Until Death or 12.31.18 Occurs||54|All patients that receive one dose of study treatment go into the follow up portion of the study.|
48103549|NCT01478321|100578761|FG000|COMPLETED|Follow-up Until Death or 12.31.18 Occurs||54||
48103550|NCT01478321|100578761|FG000|NOT COMPLETED|Follow-up Until Death or 12.31.18 Occurs||0||
48103551|NCT03608774|100578762|FG000|STARTED|Overall Study||89||
48103552|NCT03608774|100578763|FG001|STARTED|Overall Study||88||
48103553|NCT03608774|100578762|FG000|COMPLETED|Overall Study||82||
48103554|NCT03608774|100578763|FG001|COMPLETED|Overall Study||81||
48103555|NCT03608774|100578762|FG000|NOT COMPLETED|Overall Study||7||
48103556|NCT03608774|100578763|FG001|NOT COMPLETED|Overall Study||7||
48103557|NCT02131402|100578764|FG000|STARTED|Overall Study||60||
48103558|NCT02131402|100578764|FG000|COMPLETED|Overall Study||60||
48103559|NCT02131402|100578764|FG000|NOT COMPLETED|Overall Study||0||
48103560|NCT03745092|100578765|FG000|STARTED|Overall Study||26||
48103561|NCT03745092|100578766|FG001|STARTED|Overall Study||23||
48103562|NCT03745092|100578765|FG000|COMPLETED|Overall Study||26||
48103563|NCT03745092|100578766|FG001|COMPLETED|Overall Study||23||
48103564|NCT03745092|100578765|FG000|NOT COMPLETED|Overall Study||0||
48103565|NCT03745092|100578766|FG001|NOT COMPLETED|Overall Study||0||
48103566|NCT02945410|100578767|FG000|STARTED|Intervention 1 (5 Days)||3||
48103567|NCT02945410|100578768|FG001|STARTED|Intervention 1 (5 Days)||4||
48103568|NCT02945410|100578769|FG002|STARTED|Intervention 1 (5 Days)||2||
48103569|NCT02945410|100578770|FG003|STARTED|Intervention 1 (5 Days)||3||
48103570|NCT02945410|100578771|FG004|STARTED|Intervention 1 (5 Days)||2||
48103571|NCT02945410|100578772|FG005|STARTED|Intervention 1 (5 Days)||1||
48103572|NCT02945410|100578767|FG000|COMPLETED|Intervention 1 (5 Days)||2||
48103573|NCT02945410|100578768|FG001|COMPLETED|Intervention 1 (5 Days)||1||
48103574|NCT02945410|100578769|FG002|COMPLETED|Intervention 1 (5 Days)||2||
48103575|NCT02945410|100578770|FG003|COMPLETED|Intervention 1 (5 Days)||3||
48103576|NCT02945410|100578771|FG004|COMPLETED|Intervention 1 (5 Days)||2||
48103577|NCT02945410|100578772|FG005|COMPLETED|Intervention 1 (5 Days)||0||
48103578|NCT02945410|100578767|FG000|NOT COMPLETED|Intervention 1 (5 Days)||1||
48103579|NCT02945410|100578768|FG001|NOT COMPLETED|Intervention 1 (5 Days)||3||
48103580|NCT02945410|100578769|FG002|NOT COMPLETED|Intervention 1 (5 Days)||0||
48103581|NCT02945410|100578770|FG003|NOT COMPLETED|Intervention 1 (5 Days)||0||
48103582|NCT02945410|100578771|FG004|NOT COMPLETED|Intervention 1 (5 Days)||0||
48103583|NCT02945410|100578772|FG005|NOT COMPLETED|Intervention 1 (5 Days)||1||
48103584|NCT02945410|100578767|FG000|STARTED|Washout 1 (14 Days)||2||
48103585|NCT02945410|100578768|FG001|STARTED|Washout 1 (14 Days)||1||
48103586|NCT02945410|100578769|FG002|STARTED|Washout 1 (14 Days)||2||
48103587|NCT02945410|100578770|FG003|STARTED|Washout 1 (14 Days)||3||
48103588|NCT02945410|100578771|FG004|STARTED|Washout 1 (14 Days)||2||
48103589|NCT02945410|100578772|FG005|STARTED|Washout 1 (14 Days)||0||
48103590|NCT02945410|100578767|FG000|COMPLETED|Washout 1 (14 Days)||2||
48103591|NCT02945410|100578768|FG001|COMPLETED|Washout 1 (14 Days)||1||
48103592|NCT02945410|100578769|FG002|COMPLETED|Washout 1 (14 Days)||0||
48103593|NCT02945410|100578770|FG003|COMPLETED|Washout 1 (14 Days)||3||
48103594|NCT02945410|100578771|FG004|COMPLETED|Washout 1 (14 Days)||1||
48103595|NCT02945410|100578772|FG005|COMPLETED|Washout 1 (14 Days)||0||
48103596|NCT02945410|100578767|FG000|NOT COMPLETED|Washout 1 (14 Days)||0||
48103597|NCT02945410|100578768|FG001|NOT COMPLETED|Washout 1 (14 Days)||0||
48103598|NCT02945410|100578769|FG002|NOT COMPLETED|Washout 1 (14 Days)||2||
48103599|NCT02945410|100578770|FG003|NOT COMPLETED|Washout 1 (14 Days)||0||
48103600|NCT02945410|100578771|FG004|NOT COMPLETED|Washout 1 (14 Days)||1||
48103601|NCT02945410|100578772|FG005|NOT COMPLETED|Washout 1 (14 Days)||0||
48103602|NCT02945410|100578767|FG000|STARTED|Intervention 2 (5 Days)||2||
48103603|NCT02945410|100578768|FG001|STARTED|Intervention 2 (5 Days)||1||
48103604|NCT02945410|100578769|FG002|STARTED|Intervention 2 (5 Days)||0||
48103605|NCT02945410|100578770|FG003|STARTED|Intervention 2 (5 Days)||3||
48103606|NCT02945410|100578771|FG004|STARTED|Intervention 2 (5 Days)||1||
48103607|NCT02945410|100578772|FG005|STARTED|Intervention 2 (5 Days)||0||
48103608|NCT02945410|100578767|FG000|COMPLETED|Intervention 2 (5 Days)||2||
48103609|NCT02945410|100578768|FG001|COMPLETED|Intervention 2 (5 Days)||1||
48103610|NCT02945410|100578769|FG002|COMPLETED|Intervention 2 (5 Days)||0||
48103611|NCT02945410|100578770|FG003|COMPLETED|Intervention 2 (5 Days)||3||
48103612|NCT02945410|100578771|FG004|COMPLETED|Intervention 2 (5 Days)||1||
48103613|NCT02945410|100578772|FG005|COMPLETED|Intervention 2 (5 Days)||0||
48103614|NCT02945410|100578767|FG000|NOT COMPLETED|Intervention 2 (5 Days)||0||
48103615|NCT02945410|100578768|FG001|NOT COMPLETED|Intervention 2 (5 Days)||0||
48103616|NCT02945410|100578769|FG002|NOT COMPLETED|Intervention 2 (5 Days)||0||
48103617|NCT02945410|100578770|FG003|NOT COMPLETED|Intervention 2 (5 Days)||0||
48103618|NCT02945410|100578771|FG004|NOT COMPLETED|Intervention 2 (5 Days)||0||
48103619|NCT02945410|100578772|FG005|NOT COMPLETED|Intervention 2 (5 Days)||0||
48103620|NCT02945410|100578767|FG000|STARTED|Washout 2 (14 Days)||2||
48103621|NCT02945410|100578768|FG001|STARTED|Washout 2 (14 Days)||1||
48103622|NCT02945410|100578769|FG002|STARTED|Washout 2 (14 Days)||0||
48103623|NCT02945410|100578770|FG003|STARTED|Washout 2 (14 Days)||3||
48103624|NCT02945410|100578771|FG004|STARTED|Washout 2 (14 Days)||1||
48103625|NCT02945410|100578772|FG005|STARTED|Washout 2 (14 Days)||0||
48103626|NCT02945410|100578767|FG000|COMPLETED|Washout 2 (14 Days)||2||
48103627|NCT02945410|100578768|FG001|COMPLETED|Washout 2 (14 Days)||1||
48103628|NCT02945410|100578769|FG002|COMPLETED|Washout 2 (14 Days)||0||
48103629|NCT02945410|100578770|FG003|COMPLETED|Washout 2 (14 Days)||3||
48103630|NCT02945410|100578771|FG004|COMPLETED|Washout 2 (14 Days)||1||
48103631|NCT02945410|100578772|FG005|COMPLETED|Washout 2 (14 Days)||0||
48103632|NCT02945410|100578767|FG000|NOT COMPLETED|Washout 2 (14 Days)||0||
48103633|NCT02945410|100578768|FG001|NOT COMPLETED|Washout 2 (14 Days)||0||
48103634|NCT02945410|100578769|FG002|NOT COMPLETED|Washout 2 (14 Days)||0||
48103635|NCT02945410|100578770|FG003|NOT COMPLETED|Washout 2 (14 Days)||0||
48103636|NCT02945410|100578771|FG004|NOT COMPLETED|Washout 2 (14 Days)||0||
48103637|NCT02945410|100578772|FG005|NOT COMPLETED|Washout 2 (14 Days)||0||
48103638|NCT02945410|100578767|FG000|STARTED|Intervention 3 (5 Days)||2||
48103639|NCT02945410|100578768|FG001|STARTED|Intervention 3 (5 Days)||1||
48103640|NCT02945410|100578769|FG002|STARTED|Intervention 3 (5 Days)||0||
48103641|NCT02945410|100578770|FG003|STARTED|Intervention 3 (5 Days)||3||
48103642|NCT02945410|100578771|FG004|STARTED|Intervention 3 (5 Days)||1||
48103643|NCT02945410|100578772|FG005|STARTED|Intervention 3 (5 Days)||0||
48103644|NCT02945410|100578767|FG000|COMPLETED|Intervention 3 (5 Days)||2||
48103645|NCT02945410|100578768|FG001|COMPLETED|Intervention 3 (5 Days)||1||
48103646|NCT02945410|100578769|FG002|COMPLETED|Intervention 3 (5 Days)||0||
48103647|NCT02945410|100578770|FG003|COMPLETED|Intervention 3 (5 Days)||3||
48103648|NCT02945410|100578771|FG004|COMPLETED|Intervention 3 (5 Days)||1||
48103649|NCT02945410|100578772|FG005|COMPLETED|Intervention 3 (5 Days)||0||
48103650|NCT02945410|100578767|FG000|NOT COMPLETED|Intervention 3 (5 Days)||0||
48103651|NCT02945410|100578768|FG001|NOT COMPLETED|Intervention 3 (5 Days)||0||
48103652|NCT02945410|100578769|FG002|NOT COMPLETED|Intervention 3 (5 Days)||0||
48103653|NCT02945410|100578770|FG003|NOT COMPLETED|Intervention 3 (5 Days)||0||
48103654|NCT02945410|100578771|FG004|NOT COMPLETED|Intervention 3 (5 Days)||0||
48103655|NCT02945410|100578772|FG005|NOT COMPLETED|Intervention 3 (5 Days)||0||
48103656|NCT01806896|100578773|FG000|STARTED|Overall Study||20||
48103657|NCT01806896|100578774|FG001|STARTED|Overall Study||17||
48103658|NCT01806896|100578773|FG000|Received Treatment|Overall Study||19||
48265861|NCT03768336|100975328|FG000|STARTED|Overall Study||35|This is total number enrolled (signed consent and completed baseline)|
48265862|NCT03768336|100975329|FG001|STARTED|Overall Study||37|This is total number enrolled (signed consent and completed baseline)|
48265863|NCT03768336|100975328|FG000|Baseline Completion|Overall Study||35||
48265864|NCT03768336|100975329|FG001|Baseline Completion|Overall Study||37||
48265865|NCT03768336|100975328|FG000|Remained Eligible|Overall Study||33||
48265866|NCT03768336|100975329|FG001|Remained Eligible|Overall Study||37||
48265867|NCT03768336|100975328|FG000|Program Initiation|Overall Study||29||
48265868|NCT03768336|100975329|FG001|Program Initiation|Overall Study||35||
48265869|NCT03768336|100975328|FG000|Follow up Survey #1|Overall Study||29||
48265870|NCT03768336|100975329|FG001|Follow up Survey #1|Overall Study||35||
48265871|NCT03768336|100975328|FG000|Follow up Survey #2|Overall Study||29||
48265872|NCT03768336|100975329|FG001|Follow up Survey #2|Overall Study||34||
48265873|NCT03768336|100975328|FG000|COMPLETED|Overall Study||29||
48265874|NCT03768336|100975329|FG001|COMPLETED|Overall Study||34||
48265875|NCT03768336|100975328|FG000|NOT COMPLETED|Overall Study||6||
48265876|NCT03768336|100975329|FG001|NOT COMPLETED|Overall Study||3||
48265877|NCT00277095|100975330|FG000|STARTED|Overall Study||124||
48265878|NCT00277095|100975330|FG000|COMPLETED|Overall Study||103||
48265879|NCT00277095|100975330|FG000|NOT COMPLETED|Overall Study||21||
48265880|NCT02638103|100975331|FG000|STARTED|Overall Study||419||
48265881|NCT02638103|100975332|FG001|STARTED|Overall Study||526||
48265882|NCT02638103|100975333|FG002|STARTED|Overall Study||420||
48265883|NCT02638103|100975334|FG003|STARTED|Overall Study||525||
48265884|NCT02638103|100975331|FG000|Safety Analysis Set|Overall Study||418|Received at least 1 dose of study drug|
48265885|NCT02638103|100975332|FG001|Safety Analysis Set|Overall Study||526|Received at least 1 dose of study drug|
48265886|NCT02638103|100975333|FG002|Safety Analysis Set|Overall Study||419|Received at least 1 dose of study drug|
48265887|NCT02638103|100975334|FG003|Safety Analysis Set|Overall Study||525|Received at least 1 dose of study drug|
48265888|NCT02638103|100975331|FG000|Full Analysis Set (FAS)|Overall Study||416|Participants in safety analysis set who had at least 10 days of post-baseline efficacy assessment.|
48265889|NCT02638103|100975332|FG001|Full Analysis Set (FAS)|Overall Study||520|Participants in safety analysis set who had at least 10 days of post-baseline efficacy assessment.|
48265890|NCT02638103|100975333|FG002|Full Analysis Set (FAS)|Overall Study||419|Participants in safety analysis set who had at least 10 days of post-baseline efficacy assessment.|
48550382|NCT02763826|101679779|FG005|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0||
48550383|NCT02763826|101679780|FG006|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0||
48550384|NCT02763826|101679781|FG007|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0||
48550385|NCT02763826|101679774|FG000|STARTED|Part 1 Dose Escalation, 2 mA||0||
48550386|NCT02763826|101679775|FG001|STARTED|Part 1 Dose Escalation, 2 mA||3||
48550387|NCT02763826|101679776|FG002|STARTED|Part 1 Dose Escalation, 2 mA||0||
48550388|NCT02763826|101679777|FG003|STARTED|Part 1 Dose Escalation, 2 mA||0||
48550389|NCT02763826|101679778|FG004|STARTED|Part 1 Dose Escalation, 2 mA||0||
48265891|NCT02638103|100975334|FG003|Full Analysis Set (FAS)|Overall Study||523|Participants in safety analysis set who had at least 10 days of post-baseline efficacy assessment.|
48265892|NCT02638103|100975331|FG000|COMPLETED|Overall Study||313||
48265893|NCT02638103|100975332|FG001|COMPLETED|Overall Study||408||
48265894|NCT02638103|100975333|FG002|COMPLETED|Overall Study||335||
48265895|NCT02638103|100975334|FG003|COMPLETED|Overall Study||383||
48265896|NCT02638103|100975331|FG000|NOT COMPLETED|Overall Study||106||
48265897|NCT02638103|100975332|FG001|NOT COMPLETED|Overall Study||118||
48265898|NCT02638103|100975333|FG002|NOT COMPLETED|Overall Study||85||
48265899|NCT02638103|100975334|FG003|NOT COMPLETED|Overall Study||142||
48265900|NCT02763215|100975335|FG000|STARTED|Overall Study||64||
48265901|NCT02763215|100975335|FG000|COMPLETED|Overall Study||57||
48265902|NCT02763215|100975335|FG000|NOT COMPLETED|Overall Study||7||
48265903|NCT03819634|100975336|FG000|STARTED|Overall Study||24||
48265904|NCT03819634|100975336|FG000|COMPLETED|Overall Study||22||
48550390|NCT02763826|101679779|FG005|STARTED|Part 1 Dose Escalation, 2 mA||0||
48550391|NCT02763826|101679780|FG006|STARTED|Part 1 Dose Escalation, 2 mA||0||
48550392|NCT02763826|101679781|FG007|STARTED|Part 1 Dose Escalation, 2 mA||0||
48550393|NCT02763826|101679774|FG000|COMPLETED|Part 1 Dose Escalation, 2 mA||0||
48550394|NCT02763826|101679775|FG001|COMPLETED|Part 1 Dose Escalation, 2 mA||3||
48550395|NCT02763826|101679776|FG002|COMPLETED|Part 1 Dose Escalation, 2 mA||0||
48550396|NCT02763826|101679777|FG003|COMPLETED|Part 1 Dose Escalation, 2 mA||0||
48550397|NCT02763826|101679778|FG004|COMPLETED|Part 1 Dose Escalation, 2 mA||0||
48103659|NCT01806896|100578774|FG001|Received Treatment|Overall Study||17||
48103660|NCT01806896|100578773|FG000|COMPLETED|Overall Study||17||
48103661|NCT01806896|100578774|FG001|COMPLETED|Overall Study||17||
48103662|NCT01806896|100578773|FG000|NOT COMPLETED|Overall Study||3||
48103663|NCT01806896|100578774|FG001|NOT COMPLETED|Overall Study||0||
48103664|NCT01528072|100578775|FG000|STARTED|Overall Study||140||
48103665|NCT01528072|100578775|FG000|COMPLETED|Overall Study||66||
48103666|NCT01528072|100578775|FG000|NOT COMPLETED|Overall Study||74||
48103667|NCT04944901|100578776|FG000|STARTED|Treatment Period 1||7||
48103668|NCT04944901|100578777|FG001|STARTED|Treatment Period 1||8||
48103669|NCT04944901|100578776|FG000|COMPLETED|Treatment Period 1||7||
48103670|NCT04944901|100578777|FG001|COMPLETED|Treatment Period 1||8||
48103671|NCT04944901|100578776|FG000|NOT COMPLETED|Treatment Period 1||0||
48103672|NCT04944901|100578777|FG001|NOT COMPLETED|Treatment Period 1||0||
48103673|NCT04944901|100578776|FG000|STARTED|Treatment Period 2||7||
48103674|NCT04944901|100578777|FG001|STARTED|Treatment Period 2||8||
48103675|NCT04944901|100578776|FG000|COMPLETED|Treatment Period 2||7||
48103676|NCT04944901|100578777|FG001|COMPLETED|Treatment Period 2||8||
48103677|NCT04944901|100578776|FG000|NOT COMPLETED|Treatment Period 2||0||
48103678|NCT04944901|100578777|FG001|NOT COMPLETED|Treatment Period 2||0||
48103679|NCT04327999|100582772|FG000|STARTED|Overall Study||9||
48103680|NCT04327999|100582772|FG000|COMPLETED|Overall Study||8|1 patient was excluded for deviation from protocol|
48103681|NCT04327999|100582772|FG000|NOT COMPLETED|Overall Study||1||
48103682|NCT00006478|100582773|FG000|STARTED|Overall Study||19||
48103683|NCT00006478|100582773|FG000|COMPLETED|Overall Study||12||
48103684|NCT00006478|100582773|FG000|NOT COMPLETED|Overall Study||7||
48103685|NCT00312494|100582774|FG000|STARTED|Overall Study||232||
48103686|NCT00312494|100582775|FG001|STARTED|Overall Study||226||
48103687|NCT00312494|100582776|FG002|STARTED|Overall Study||222||
48103688|NCT00312494|100582774|FG000|Received Study Treatment|Overall Study||223||
48103689|NCT00312494|100582775|FG001|Received Study Treatment|Overall Study||216||
48103690|NCT00312494|100582776|FG002|Received Study Treatment|Overall Study||217||
48103691|NCT00312494|100582774|FG000|COMPLETED|Overall Study||161||
48103692|NCT00312494|100582775|FG001|COMPLETED|Overall Study||168||
48103693|NCT00312494|100582776|FG002|COMPLETED|Overall Study||179||
48103694|NCT00312494|100582774|FG000|NOT COMPLETED|Overall Study||71||
48103695|NCT00312494|100582775|FG001|NOT COMPLETED|Overall Study||58||
48103696|NCT00312494|100582776|FG002|NOT COMPLETED|Overall Study||43||
48103697|NCT00731770|100582777|FG000|STARTED|Overall Study||5||
48103698|NCT00731770|100582778|FG001|STARTED|Overall Study||5||
48103699|NCT00731770|100582777|FG000|COMPLETED|Overall Study||5||
48103700|NCT00731770|100582778|FG001|COMPLETED|Overall Study||5||
48103701|NCT00731770|100582777|FG000|NOT COMPLETED|Overall Study||0||
48103702|NCT00731770|100582778|FG001|NOT COMPLETED|Overall Study||0||
48103703|NCT01712256|100582779|FG000|STARTED|Overall Study||33||
48103704|NCT01712256|100582779|FG000|COMPLETED|Overall Study||32||
48103705|NCT01712256|100582779|FG000|NOT COMPLETED|Overall Study||1||
48103706|NCT00178841|100582780|FG000|STARTED|Overall Study||4||
48103707|NCT00178841|100582780|FG000|COMPLETED|Overall Study||4||
48103708|NCT00178841|100582780|FG000|NOT COMPLETED|Overall Study||0||
48103709|NCT02120794|100582781|FG000|STARTED|Overall Study||194||
48103710|NCT02120794|100582781|FG000|COMPLETED|Overall Study||136||
48103711|NCT02120794|100582781|FG000|NOT COMPLETED|Overall Study||58||
48103712|NCT01002755|100582782|FG000|STARTED|Overall Study||36||
48103713|NCT01002755|100582782|FG000|COMPLETED|Overall Study||36||
48103714|NCT01002755|100582782|FG000|NOT COMPLETED|Overall Study||0||
48103715|NCT00181961|100582783|FG000|STARTED|Overall Study||7|Protocol defined enrolled as screened participants. Baseline visit determined randomization.|
48103716|NCT00181961|100582784|FG001|STARTED|Overall Study||9|Protocol defined enrolled as screened participants. Baseline visit determined randomization.|
48103717|NCT00181961|100582783|FG000|COMPLETED|Overall Study||6||
48103718|NCT00181961|100582784|FG001|COMPLETED|Overall Study||4||
48103719|NCT00181961|100582783|FG000|NOT COMPLETED|Overall Study||1||
48103720|NCT00181961|100582784|FG001|NOT COMPLETED|Overall Study||5||
48103721|NCT01736696|100582785|FG000|STARTED|Overall Study||5||
48103722|NCT01736696|100582786|FG001|STARTED|Overall Study||5||
48103723|NCT01736696|100582787|FG002|STARTED|Overall Study||10||
48103724|NCT01736696|100582788|FG003|STARTED|Overall Study||9||
48103725|NCT01736696|100582789|FG004|STARTED|Overall Study||9||
48103726|NCT01736696|100582790|FG005|STARTED|Overall Study||8||
48103727|NCT01736696|100582791|FG006|STARTED|Overall Study||13||
48103728|NCT01736696|100582785|FG000|COMPLETED|Overall Study||5||
48103729|NCT01736696|100582786|FG001|COMPLETED|Overall Study||5||
48103730|NCT01736696|100582787|FG002|COMPLETED|Overall Study||9||
48103731|NCT01736696|100582788|FG003|COMPLETED|Overall Study||9||
48103732|NCT01736696|100582789|FG004|COMPLETED|Overall Study||9||
48103733|NCT01736696|100582790|FG005|COMPLETED|Overall Study||8||
48103734|NCT01736696|100582791|FG006|COMPLETED|Overall Study||13||
48103735|NCT01736696|100582785|FG000|NOT COMPLETED|Overall Study||0||
48103736|NCT01736696|100582786|FG001|NOT COMPLETED|Overall Study||0||
48103737|NCT01736696|100582787|FG002|NOT COMPLETED|Overall Study||1||
48103738|NCT01736696|100582788|FG003|NOT COMPLETED|Overall Study||0||
48103739|NCT01736696|100582789|FG004|NOT COMPLETED|Overall Study||0||
48103740|NCT01736696|100582790|FG005|NOT COMPLETED|Overall Study||0||
48103741|NCT01736696|100582791|FG006|NOT COMPLETED|Overall Study||0||
48103742|NCT01559012|100582792|FG000|STARTED|Overall Study||6||
48103743|NCT01559012|100582793|FG001|STARTED|Overall Study||7||
48103744|NCT01559012|100582792|FG000|COMPLETED|Overall Study||6||
48103745|NCT01559012|100582793|FG001|COMPLETED|Overall Study||6||
48103746|NCT01559012|100582792|FG000|NOT COMPLETED|Overall Study||0||
48103747|NCT01559012|100582793|FG001|NOT COMPLETED|Overall Study||1||
48103748|NCT01452412|100582794|FG000|STARTED|Overall Study||74||
48103749|NCT01452412|100582795|FG001|STARTED|Overall Study||75||
48103750|NCT01452412|100582794|FG000|COMPLETED|Overall Study||46||
48103751|NCT01452412|100582795|FG001|COMPLETED|Overall Study||58||
48103752|NCT01452412|100582794|FG000|NOT COMPLETED|Overall Study||28||
48103753|NCT01452412|100582795|FG001|NOT COMPLETED|Overall Study||17||
48103754|NCT00112502|100582796|FG000|STARTED|Overall Study||22||
48103755|NCT00112502|100582797|FG001|STARTED|Overall Study||22||
48103756|NCT00112502|100582798|FG002|STARTED|Overall Study||22||
48103757|NCT00112502|100582799|FG003|STARTED|Overall Study||22||
48103758|NCT00112502|100582800|FG004|STARTED|Overall Study||23||
48103759|NCT00112502|100582801|FG005|STARTED|Overall Study||22||
48103760|NCT00112502|100582802|FG006|STARTED|Overall Study||23||
48103761|NCT00112502|100582803|FG007|STARTED|Overall Study||22||
48103762|NCT00112502|100582796|FG000|COMPLETED|Overall Study||22||
48103763|NCT00112502|100582797|FG001|COMPLETED|Overall Study||21||
48103764|NCT00112502|100582798|FG002|COMPLETED|Overall Study||21||
48103765|NCT00112502|100582799|FG003|COMPLETED|Overall Study||18||
48103766|NCT00112502|100582800|FG004|COMPLETED|Overall Study||21||
48103767|NCT00112502|100582801|FG005|COMPLETED|Overall Study||17||
48103768|NCT00112502|100582802|FG006|COMPLETED|Overall Study||20||
48103769|NCT00112502|100582803|FG007|COMPLETED|Overall Study||15||
48103770|NCT00112502|100582796|FG000|NOT COMPLETED|Overall Study||0||
48103771|NCT00112502|100582797|FG001|NOT COMPLETED|Overall Study||1||
48265905|NCT03819634|100975336|FG000|NOT COMPLETED|Overall Study||2||
48265906|NCT00425607|100975337|FG000|STARTED|Overall Study||29||
48265907|NCT00425607|100975337|FG000|Received Treatment|Overall Study||28||
48265908|NCT00425607|100975337|FG000|COMPLETED|Overall Study||27||
48550398|NCT02763826|101679779|FG005|COMPLETED|Part 1 Dose Escalation, 2 mA||0||
48550399|NCT02763826|101679780|FG006|COMPLETED|Part 1 Dose Escalation, 2 mA||0||
48550400|NCT02763826|101679781|FG007|COMPLETED|Part 1 Dose Escalation, 2 mA||0||
48550401|NCT02763826|101679774|FG000|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0||
48550402|NCT02763826|101679775|FG001|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0||
48550403|NCT02763826|101679776|FG002|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0||
48550404|NCT02763826|101679777|FG003|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0||
48550405|NCT02763826|101679778|FG004|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0||
48550406|NCT02763826|101679779|FG005|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0||
48550407|NCT02763826|101679780|FG006|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0||
48550408|NCT02763826|101679781|FG007|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0||
48550409|NCT02763826|101679774|FG000|STARTED|Part 1 Dose Escalation, 2.5 mA||0||
48550410|NCT02763826|101679775|FG001|STARTED|Part 1 Dose Escalation, 2.5 mA||0||
48550411|NCT02763826|101679776|FG002|STARTED|Part 1 Dose Escalation, 2.5 mA||3||
48550412|NCT02763826|101679777|FG003|STARTED|Part 1 Dose Escalation, 2.5 mA||0||
48550413|NCT02763826|101679778|FG004|STARTED|Part 1 Dose Escalation, 2.5 mA||0||
48550414|NCT02763826|101679779|FG005|STARTED|Part 1 Dose Escalation, 2.5 mA||0||
48550415|NCT02763826|101679780|FG006|STARTED|Part 1 Dose Escalation, 2.5 mA||0||
48550416|NCT02763826|101679781|FG007|STARTED|Part 1 Dose Escalation, 2.5 mA||0||
48550417|NCT02763826|101679774|FG000|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0||
48550418|NCT02763826|101679775|FG001|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0||
48550419|NCT02763826|101679776|FG002|COMPLETED|Part 1 Dose Escalation, 2.5 mA||3||
48550420|NCT02763826|101679777|FG003|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0||
48550421|NCT02763826|101679778|FG004|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0||
48550422|NCT02763826|101679779|FG005|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0||
48691786|NCT03198767|102029012|FG003|COMPLETED|Overall Study||0||
48691787|NCT03198767|102029013|FG004|COMPLETED|Overall Study||8||
48103772|NCT00112502|100582798|FG002|NOT COMPLETED|Overall Study||1||
48103773|NCT00112502|100582799|FG003|NOT COMPLETED|Overall Study||4||
48103774|NCT00112502|100582800|FG004|NOT COMPLETED|Overall Study||2||
48103775|NCT00112502|100582801|FG005|NOT COMPLETED|Overall Study||5||
48103776|NCT00112502|100582802|FG006|NOT COMPLETED|Overall Study||3||
48103777|NCT00112502|100582803|FG007|NOT COMPLETED|Overall Study||7||
48103778|NCT02073279|100582804|FG000|STARTED|Double-blind Period||32||
48103779|NCT02073279|100582805|FG001|STARTED|Double-blind Period||63||
48103780|NCT02073279|100582804|FG000|COMPLETED|Double-blind Period||28|Double-blind Period|
48103781|NCT02073279|100582805|FG001|COMPLETED|Double-blind Period||56|Double-blind Period|
48103782|NCT02073279|100582804|FG000|NOT COMPLETED|Double-blind Period||4||
48103783|NCT02073279|100582805|FG001|NOT COMPLETED|Double-blind Period||7||
48103784|NCT02073279|100582804|FG000|STARTED|Open-label Extension Period||28||
48265909|NCT00425607|100975337|FG000|NOT COMPLETED|Overall Study||2||
48265910|NCT01377389|100975338|FG000|STARTED|Overall Study||30||
48691788|NCT03198767|102029014|FG005|COMPLETED|Overall Study||8||
48691789|NCT03198767|102029015|FG006|COMPLETED|Overall Study||8||
48103785|NCT02073279|100582805|FG001|STARTED|Open-label Extension Period||56||
48103786|NCT02073279|100582804|FG000|COMPLETED|Open-label Extension Period||21||
48103787|NCT02073279|100582805|FG001|COMPLETED|Open-label Extension Period||41||
48103788|NCT02073279|100582804|FG000|NOT COMPLETED|Open-label Extension Period||7||
48265911|NCT01377389|100975338|FG000|COMPLETED|Overall Study||27||
48103789|NCT02073279|100582805|FG001|NOT COMPLETED|Open-label Extension Period||15||
48103790|NCT02775344|100582806|FG000|STARTED|Overall Study||40||
48103791|NCT02775344|100582807|FG001|STARTED|Overall Study||40||
48103792|NCT02775344|100582806|FG000|COMPLETED|Overall Study||37||
48103793|NCT02775344|100582807|FG001|COMPLETED|Overall Study||38||
48265912|NCT01377389|100975338|FG000|NOT COMPLETED|Overall Study||3||
48265913|NCT01077518|100975339|FG000|STARTED|Treatment Phase - no Optional Ofa||173||
48550423|NCT02763826|101679780|FG006|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0||
48550424|NCT02763826|101679781|FG007|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0||
48265914|NCT01077518|100975340|FG001|STARTED|Treatment Phase - no Optional Ofa||173||
48265915|NCT01077518|100975341|FG002|STARTED|Treatment Phase - no Optional Ofa||0||
48265916|NCT01077518|100975339|FG000|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||64||
48103794|NCT02775344|100582806|FG000|NOT COMPLETED|Overall Study||3||
48103795|NCT02775344|100582807|FG001|NOT COMPLETED|Overall Study||2||
48103796|NCT00778700|100582808|FG000|STARTED|Overall Study||50||
48103797|NCT00778700|100582809|FG001|STARTED|Overall Study||51||
48103798|NCT00778700|100582810|FG002|STARTED|Overall Study||49||
48265917|NCT01077518|100975340|FG001|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||64||
48265918|NCT01077518|100975341|FG002|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||0||
48265919|NCT01077518|100975339|FG000|Safety Population|Treatment Phase - no Optional Ofa||172||
48265920|NCT01077518|100975340|FG001|Safety Population|Treatment Phase - no Optional Ofa||170||
48265921|NCT01077518|100975341|FG002|Safety Population|Treatment Phase - no Optional Ofa||0||
48265922|NCT01077518|100975339|FG000|COMPLETED|Treatment Phase - no Optional Ofa||95||
48550425|NCT02763826|101679774|FG000|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0||
48550426|NCT02763826|101679775|FG001|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0||
48550427|NCT02763826|101679776|FG002|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0||
48550428|NCT02763826|101679777|FG003|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0||
48550429|NCT02763826|101679778|FG004|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0||
48550430|NCT02763826|101679779|FG005|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0||
48550431|NCT02763826|101679780|FG006|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0||
48550432|NCT02763826|101679781|FG007|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0||
48550433|NCT02763826|101679774|FG000|STARTED|Part 1 Dose Escalation, 3 mA||0||
48550434|NCT02763826|101679775|FG001|STARTED|Part 1 Dose Escalation, 3 mA||0||
48550435|NCT02763826|101679776|FG002|STARTED|Part 1 Dose Escalation, 3 mA||0||
48550436|NCT02763826|101679777|FG003|STARTED|Part 1 Dose Escalation, 3 mA||3||
48550437|NCT02763826|101679778|FG004|STARTED|Part 1 Dose Escalation, 3 mA||0||
48550438|NCT02763826|101679779|FG005|STARTED|Part 1 Dose Escalation, 3 mA||0||
48550439|NCT02763826|101679780|FG006|STARTED|Part 1 Dose Escalation, 3 mA||0||
48550440|NCT02763826|101679781|FG007|STARTED|Part 1 Dose Escalation, 3 mA||0||
48550441|NCT02763826|101679774|FG000|COMPLETED|Part 1 Dose Escalation, 3 mA||0||
48550442|NCT02763826|101679775|FG001|COMPLETED|Part 1 Dose Escalation, 3 mA||0||
48550443|NCT02763826|101679776|FG002|COMPLETED|Part 1 Dose Escalation, 3 mA||0||
48550444|NCT02763826|101679777|FG003|COMPLETED|Part 1 Dose Escalation, 3 mA||3||
48550445|NCT02763826|101679778|FG004|COMPLETED|Part 1 Dose Escalation, 3 mA||0||
48550446|NCT02763826|101679779|FG005|COMPLETED|Part 1 Dose Escalation, 3 mA||0||
48550447|NCT02763826|101679780|FG006|COMPLETED|Part 1 Dose Escalation, 3 mA||0||
48550448|NCT02763826|101679781|FG007|COMPLETED|Part 1 Dose Escalation, 3 mA||0||
48550449|NCT02763826|101679774|FG000|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0||
48550450|NCT02763826|101679775|FG001|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0||
48550451|NCT02763826|101679776|FG002|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0||
48550452|NCT02763826|101679777|FG003|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0||
48550453|NCT02763826|101679778|FG004|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0||
48550454|NCT02763826|101679779|FG005|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0||
48550455|NCT02763826|101679780|FG006|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0||
48550456|NCT02763826|101679781|FG007|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0||
48550457|NCT02763826|101679774|FG000|STARTED|Part 1 Dose Escalation, 3.5 mA||0||
48550458|NCT02763826|101679775|FG001|STARTED|Part 1 Dose Escalation, 3.5 mA||0||
48103799|NCT00778700|100582811|FG003|STARTED|Overall Study||49||
48103800|NCT00778700|100582808|FG000|COMPLETED|Overall Study||32||
48103801|NCT00778700|100582809|FG001|COMPLETED|Overall Study||44||
48103802|NCT00778700|100582810|FG002|COMPLETED|Overall Study||43||
48103803|NCT00778700|100582811|FG003|COMPLETED|Overall Study||36||
48103804|NCT00778700|100582808|FG000|NOT COMPLETED|Overall Study||18||
48103805|NCT00778700|100582809|FG001|NOT COMPLETED|Overall Study||7||
48103806|NCT00778700|100582810|FG002|NOT COMPLETED|Overall Study||6||
48103807|NCT00778700|100582811|FG003|NOT COMPLETED|Overall Study||13||
48103808|NCT00746941|100582812|FG000|STARTED|Overall Study||7||
48103809|NCT00746941|100582813|FG001|STARTED|Overall Study||5||
48103810|NCT00746941|100582814|FG002|STARTED|Overall Study||5||
48103811|NCT00746941|100582815|FG003|STARTED|Overall Study||20||
48103812|NCT00746941|100582812|FG000|COMPLETED|Overall Study||0||
48103813|NCT00746941|100582813|FG001|COMPLETED|Overall Study||1||
48103814|NCT00746941|100582814|FG002|COMPLETED|Overall Study||3||
48103815|NCT00746941|100582815|FG003|COMPLETED|Overall Study||7||
48103816|NCT00746941|100582812|FG000|NOT COMPLETED|Overall Study||7||
48103817|NCT00746941|100582813|FG001|NOT COMPLETED|Overall Study||4||
48103818|NCT00746941|100582814|FG002|NOT COMPLETED|Overall Study||2||
48103819|NCT00746941|100582815|FG003|NOT COMPLETED|Overall Study||13||
48103820|NCT01838642|100582816|FG000|STARTED|Overall Study||3||
48103821|NCT01838642|100582816|FG000|COMPLETED|Overall Study||2||
48103822|NCT01838642|100582816|FG000|NOT COMPLETED|Overall Study||1||
48103823|NCT04220411|100582817|FG000|STARTED|Overall Study||6||
48103824|NCT04220411|100582818|FG001|STARTED|Overall Study||3||
48103825|NCT04220411|100582819|FG002|STARTED|Overall Study||6||
48103826|NCT04220411|100582820|FG003|STARTED|Overall Study||2||
48103827|NCT04220411|100582817|FG000|COMPLETED|Overall Study||6||
48691790|NCT03198767|102029009|FG000|NOT COMPLETED|Overall Study||0||
48691791|NCT03198767|102029010|FG001|NOT COMPLETED|Overall Study||0||
48691792|NCT03198767|102029011|FG002|NOT COMPLETED|Overall Study||0||
48691793|NCT03198767|102029012|FG003|NOT COMPLETED|Overall Study||6||
48691794|NCT03198767|102029013|FG004|NOT COMPLETED|Overall Study||0||
48103828|NCT04220411|100582818|FG001|COMPLETED|Overall Study||3||
48103829|NCT04220411|100582819|FG002|COMPLETED|Overall Study||6||
48103830|NCT04220411|100582820|FG003|COMPLETED|Overall Study||1||
48103831|NCT04220411|100582817|FG000|NOT COMPLETED|Overall Study||0||
48103832|NCT04220411|100582818|FG001|NOT COMPLETED|Overall Study||0||
48103833|NCT04220411|100582819|FG002|NOT COMPLETED|Overall Study||0||
48103834|NCT04220411|100582820|FG003|NOT COMPLETED|Overall Study||1||
48103835|NCT03917420|100582821|FG000|STARTED|Overall Study||10||
48103836|NCT03917420|100582821|FG000|COMPLETED|Overall Study||10||
48103837|NCT03917420|100582821|FG000|NOT COMPLETED|Overall Study||0||
48103838|NCT01886807|100582822|FG000|STARTED|Overall Study||164||
48103839|NCT01886807|100582823|FG001|STARTED|Overall Study||155||
48103840|NCT01886807|100582824|FG002|STARTED|Overall Study||163||
48103841|NCT01886807|100582822|FG000|COMPLETED|Overall Study||159||
48103842|NCT01886807|100582823|FG001|COMPLETED|Overall Study||145||
48103843|NCT01886807|100582824|FG002|COMPLETED|Overall Study||153||
48103844|NCT01886807|100582822|FG000|NOT COMPLETED|Overall Study||5||
48103845|NCT01886807|100582823|FG001|NOT COMPLETED|Overall Study||10||
48103846|NCT01886807|100582824|FG002|NOT COMPLETED|Overall Study||10||
48103847|NCT03220217|100582825|FG000|STARTED|Overall Study||8|Received 68Ga-satoreotide trizoxetan|
48103848|NCT03220217|100582826|FG001|STARTED|Overall Study||10|Received 68Ga-satoreotide trizoxetan|
48103849|NCT03220217|100582827|FG002|STARTED|Overall Study||11|Received 68Ga-satoreotide trizoxetan|
48103850|NCT03220217|100582825|FG000|COMPLETED|Overall Study||8|Completed Study|
48103851|NCT03220217|100582826|FG001|COMPLETED|Overall Study||9|Completed Study|
48103852|NCT03220217|100582827|FG002|COMPLETED|Overall Study||10|Completed Study|
48691795|NCT03198767|102029014|FG005|NOT COMPLETED|Overall Study||0||
48691796|NCT03198767|102029015|FG006|NOT COMPLETED|Overall Study||0||
48691797|NCT01966354|102029016|FG000|STARTED|Overall Study||75||
48691798|NCT01966354|102029017|FG001|STARTED|Overall Study||73||
48691799|NCT01966354|102029018|FG002|STARTED|Overall Study||72||
48691800|NCT01966354|102029016|FG000|COMPLETED|Overall Study||75||
48103853|NCT03220217|100582825|FG000|NOT COMPLETED|Overall Study||0||
48103854|NCT03220217|100582826|FG001|NOT COMPLETED|Overall Study||1||
48103855|NCT03220217|100582827|FG002|NOT COMPLETED|Overall Study||1||
48103856|NCT01068509|100582828|FG000|STARTED|Overall Study||7||
48103857|NCT01068509|100582829|FG001|STARTED|Overall Study||29||
48103858|NCT01068509|100582830|FG002|STARTED|Overall Study||27||
48103859|NCT01068509|100582828|FG000|COMPLETED|Overall Study||1||
48103860|NCT01068509|100582829|FG001|COMPLETED|Overall Study||7||
48103861|NCT01068509|100582830|FG002|COMPLETED|Overall Study||6||
48103862|NCT01068509|100582828|FG000|NOT COMPLETED|Overall Study||6||
48103863|NCT01068509|100582829|FG001|NOT COMPLETED|Overall Study||22||
48103864|NCT01068509|100582830|FG002|NOT COMPLETED|Overall Study||21||
48103865|NCT01413360|100582831|FG000|STARTED|Overall Study||10||
48103866|NCT01413360|100582831|FG000|COMPLETED|Overall Study||7||
48103867|NCT01413360|100582831|FG000|NOT COMPLETED|Overall Study||3||
48103868|NCT00978068|100582832|FG000|STARTED|Overall Study||87||
48103869|NCT00978068|100582833|FG001|STARTED|Overall Study||89||
48691801|NCT01966354|102029017|FG001|COMPLETED|Overall Study||73||
48691802|NCT01966354|102029018|FG002|COMPLETED|Overall Study||72||
48103870|NCT00978068|100582832|FG000|Initiated Study Drugs|Overall Study||84||
48103871|NCT00978068|100582833|FG001|Initiated Study Drugs|Overall Study||86||
48103872|NCT00978068|100582832|FG000|COMPLETED|Overall Study||83||
48103873|NCT00978068|100582833|FG001|COMPLETED|Overall Study||80||
48103874|NCT00978068|100582832|FG000|NOT COMPLETED|Overall Study||4||
48103875|NCT00978068|100582833|FG001|NOT COMPLETED|Overall Study||9||
48103876|NCT02940327|100582834|FG000|STARTED|Overall Study||24||
48103877|NCT02940327|100582834|FG000|COMPLETED|Overall Study||24||
48103878|NCT02940327|100582834|FG000|NOT COMPLETED|Overall Study||0||
48103879|NCT01971853|100582835|FG000|STARTED|Overall Study||0||
48103880|NCT01971853|100582836|FG001|STARTED|Overall Study||0||
48103881|NCT01971853|100582835|FG000|COMPLETED|Overall Study||0||
48103882|NCT01971853|100582836|FG001|COMPLETED|Overall Study||0||
48103883|NCT01971853|100582835|FG000|NOT COMPLETED|Overall Study||0||
48103884|NCT01971853|100582836|FG001|NOT COMPLETED|Overall Study||0||
48103885|NCT01498952|100582837|FG000|STARTED|Overall Study||3||
48103886|NCT01498952|100582838|FG001|STARTED|Overall Study||3||
48103887|NCT01498952|100582839|FG002|STARTED|Overall Study||0||
48103888|NCT01498952|100582840|FG003|STARTED|Overall Study||0||
48103889|NCT01498952|100582841|FG004|STARTED|Overall Study||0||
48103890|NCT01498952|100582837|FG000|COMPLETED|Overall Study||1||
48103891|NCT01498952|100582838|FG001|COMPLETED|Overall Study||1||
48103892|NCT01498952|100582839|FG002|COMPLETED|Overall Study||0||
48103893|NCT01498952|100582840|FG003|COMPLETED|Overall Study||0||
48103894|NCT01498952|100582841|FG004|COMPLETED|Overall Study||0||
48103895|NCT01498952|100582837|FG000|NOT COMPLETED|Overall Study||2||
48103896|NCT01498952|100582838|FG001|NOT COMPLETED|Overall Study||2||
48691803|NCT01966354|102029016|FG000|NOT COMPLETED|Overall Study||0||
48691804|NCT01966354|102029017|FG001|NOT COMPLETED|Overall Study||0||
48103897|NCT01498952|100582839|FG002|NOT COMPLETED|Overall Study||0||
48103898|NCT01498952|100582840|FG003|NOT COMPLETED|Overall Study||0||
48103899|NCT01498952|100582841|FG004|NOT COMPLETED|Overall Study||0||
48103900|NCT00702403|100582842|FG000|STARTED|From Consent to Engraftment||57||
48103901|NCT00702403|100582842|FG000|Ineligible for Study Drug|From Consent to Engraftment||17||
48103902|NCT00702403|100582842|FG000|COMPLETED|From Consent to Engraftment||40||
48103903|NCT00702403|100582842|FG000|NOT COMPLETED|From Consent to Engraftment||17||
48691805|NCT01966354|102029018|FG002|NOT COMPLETED|Overall Study||0||
48691806|NCT02096952|102029019|FG000|STARTED|Overall Study||15||
48691807|NCT02096952|102029019|FG000|COMPLETED|Overall Study||14||
48691808|NCT02096952|102029019|FG000|NOT COMPLETED|Overall Study||1||
48691809|NCT01831466|102029020|FG000|STARTED|Overall Study||71||
48691810|NCT01831466|102029021|FG001|STARTED|Overall Study||70||
48691811|NCT01831466|102029022|FG002|STARTED|Overall Study||71||
48691812|NCT01831466|102029023|FG003|STARTED|Overall Study||70||
48550459|NCT02763826|101679776|FG002|STARTED|Part 1 Dose Escalation, 3.5 mA||0||
48550460|NCT02763826|101679777|FG003|STARTED|Part 1 Dose Escalation, 3.5 mA||0||
48550461|NCT02763826|101679778|FG004|STARTED|Part 1 Dose Escalation, 3.5 mA||3||
48550462|NCT02763826|101679779|FG005|STARTED|Part 1 Dose Escalation, 3.5 mA||0||
48550463|NCT02763826|101679780|FG006|STARTED|Part 1 Dose Escalation, 3.5 mA||0||
48550464|NCT02763826|101679781|FG007|STARTED|Part 1 Dose Escalation, 3.5 mA||0||
48550465|NCT02763826|101679774|FG000|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0||
48550466|NCT02763826|101679775|FG001|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0||
48550467|NCT02763826|101679776|FG002|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0||
48550468|NCT02763826|101679777|FG003|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0||
48550469|NCT02763826|101679778|FG004|COMPLETED|Part 1 Dose Escalation, 3.5 mA||3||
48550470|NCT02763826|101679779|FG005|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0||
48550471|NCT02763826|101679780|FG006|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0||
48691813|NCT01831466|102029024|FG004|STARTED|Overall Study||74||
48691814|NCT01831466|102029025|FG005|STARTED|Overall Study||74||
48691815|NCT01831466|102029026|FG006|STARTED|Overall Study||7||
48691816|NCT01831466|102029027|FG007|STARTED|Overall Study||7||
48691817|NCT01831466|102029028|FG008|STARTED|Overall Study||7||
48550472|NCT02763826|101679781|FG007|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0||
48550473|NCT02763826|101679774|FG000|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0||
48550474|NCT02763826|101679775|FG001|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0||
48550475|NCT02763826|101679776|FG002|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0||
48103904|NCT00702403|100582842|FG000|STARTED|From Engraftment to Study Completion||40||
48103905|NCT00702403|100582842|FG000|Patient Drop-outs|From Engraftment to Study Completion||27||
48103906|NCT00702403|100582842|FG000|COMPLETED|From Engraftment to Study Completion||13||
48103907|NCT00702403|100582842|FG000|NOT COMPLETED|From Engraftment to Study Completion||27||
48103908|NCT03244865|100582843|FG000|STARTED|Overall Study||35||
48103909|NCT03244865|100582843|FG000|COMPLETED|Overall Study||35||
48103910|NCT03244865|100582843|FG000|NOT COMPLETED|Overall Study||0||
48103911|NCT03141281|100582844|FG000|STARTED|Overall Study||57||
48103912|NCT03141281|100582845|FG001|STARTED|Overall Study||59||
48103913|NCT03141281|100582846|FG002|STARTED|Overall Study||56||
48103914|NCT03141281|100582847|FG003|STARTED|Overall Study||58||
48103915|NCT03141281|100582844|FG000|Post-Test|Overall Study||50||
48550476|NCT02763826|101679777|FG003|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0||
48550477|NCT02763826|101679778|FG004|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0||
48550478|NCT02763826|101679779|FG005|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0||
48550479|NCT02763826|101679780|FG006|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0||
48550480|NCT02763826|101679781|FG007|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0||
48550481|NCT02763826|101679774|FG000|STARTED|Part 1 Dose Escalation, 4 mA||0||
48550482|NCT02763826|101679775|FG001|STARTED|Part 1 Dose Escalation, 4 mA||0||
48550483|NCT02763826|101679776|FG002|STARTED|Part 1 Dose Escalation, 4 mA||0||
48550484|NCT02763826|101679777|FG003|STARTED|Part 1 Dose Escalation, 4 mA||0||
48550485|NCT02763826|101679778|FG004|STARTED|Part 1 Dose Escalation, 4 mA||0||
48550486|NCT02763826|101679779|FG005|STARTED|Part 1 Dose Escalation, 4 mA||3||
48550487|NCT02763826|101679780|FG006|STARTED|Part 1 Dose Escalation, 4 mA||0||
48103916|NCT03141281|100582845|FG001|Post-Test|Overall Study||47||
48103917|NCT03141281|100582846|FG002|Post-Test|Overall Study||50||
48103918|NCT03141281|100582847|FG003|Post-Test|Overall Study||56||
48550488|NCT02763826|101679781|FG007|STARTED|Part 1 Dose Escalation, 4 mA||0||
48550489|NCT02763826|101679774|FG000|COMPLETED|Part 1 Dose Escalation, 4 mA||0||
48550490|NCT02763826|101679775|FG001|COMPLETED|Part 1 Dose Escalation, 4 mA||0||
48550491|NCT02763826|101679776|FG002|COMPLETED|Part 1 Dose Escalation, 4 mA||0||
48550492|NCT02763826|101679777|FG003|COMPLETED|Part 1 Dose Escalation, 4 mA||0||
48550493|NCT02763826|101679778|FG004|COMPLETED|Part 1 Dose Escalation, 4 mA||0||
48550494|NCT02763826|101679779|FG005|COMPLETED|Part 1 Dose Escalation, 4 mA||3||
48550495|NCT02763826|101679780|FG006|COMPLETED|Part 1 Dose Escalation, 4 mA||0||
48550496|NCT02763826|101679781|FG007|COMPLETED|Part 1 Dose Escalation, 4 mA||0||
48550497|NCT02763826|101679774|FG000|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0||
48550498|NCT02763826|101679775|FG001|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0||
48550499|NCT02763826|101679776|FG002|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0||
48550500|NCT02763826|101679777|FG003|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0||
48550501|NCT02763826|101679778|FG004|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0||
48550502|NCT02763826|101679779|FG005|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0||
48691818|NCT01831466|102029029|FG009|STARTED|Overall Study||7||
48691819|NCT01831466|102029030|FG010|STARTED|Overall Study||6||
48691820|NCT01831466|102029031|FG011|STARTED|Overall Study||7||
48691821|NCT01831466|102029020|FG000|COMPLETED|Overall Study||55||
48691822|NCT01831466|102029021|FG001|COMPLETED|Overall Study||52||
48691823|NCT01831466|102029022|FG002|COMPLETED|Overall Study||48||
48691824|NCT01831466|102029023|FG003|COMPLETED|Overall Study||51||
48691825|NCT01831466|102029024|FG004|COMPLETED|Overall Study||57||
48691826|NCT01831466|102029025|FG005|COMPLETED|Overall Study||48||
48691827|NCT01831466|102029026|FG006|COMPLETED|Overall Study||6||
48691828|NCT01831466|102029027|FG007|COMPLETED|Overall Study||5||
48691829|NCT01831466|102029028|FG008|COMPLETED|Overall Study||4||
48691830|NCT01831466|102029029|FG009|COMPLETED|Overall Study||2||
48103919|NCT03141281|100582844|FG000|COMPLETED|Overall Study||45||
48103920|NCT03141281|100582845|FG001|COMPLETED|Overall Study||38||
48103921|NCT03141281|100582846|FG002|COMPLETED|Overall Study||42||
48103922|NCT03141281|100582847|FG003|COMPLETED|Overall Study||47||
48550503|NCT02763826|101679780|FG006|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0||
48550504|NCT02763826|101679781|FG007|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0||
48550505|NCT02763826|101679774|FG000|STARTED|Part 2 Montage Effect, 1st Intervention||0||
48550506|NCT02763826|101679775|FG001|STARTED|Part 2 Montage Effect, 1st Intervention||0||
48550507|NCT02763826|101679776|FG002|STARTED|Part 2 Montage Effect, 1st Intervention||0||
48550508|NCT02763826|101679777|FG003|STARTED|Part 2 Montage Effect, 1st Intervention||0||
48550509|NCT02763826|101679778|FG004|STARTED|Part 2 Montage Effect, 1st Intervention||0||
48550510|NCT02763826|101679779|FG005|STARTED|Part 2 Montage Effect, 1st Intervention||6||
48550511|NCT02763826|101679780|FG006|STARTED|Part 2 Montage Effect, 1st Intervention||6||
48550512|NCT02763826|101679781|FG007|STARTED|Part 2 Montage Effect, 1st Intervention||7||
48550513|NCT02763826|101679774|FG000|COMPLETED|Part 2 Montage Effect, 1st Intervention||0||
48550514|NCT02763826|101679775|FG001|COMPLETED|Part 2 Montage Effect, 1st Intervention||0||
48550515|NCT02763826|101679776|FG002|COMPLETED|Part 2 Montage Effect, 1st Intervention||0||
48550516|NCT02763826|101679777|FG003|COMPLETED|Part 2 Montage Effect, 1st Intervention||0||
48550517|NCT02763826|101679778|FG004|COMPLETED|Part 2 Montage Effect, 1st Intervention||0||
48550518|NCT02763826|101679779|FG005|COMPLETED|Part 2 Montage Effect, 1st Intervention||6||
48550519|NCT02763826|101679780|FG006|COMPLETED|Part 2 Montage Effect, 1st Intervention||6||
48550520|NCT02763826|101679781|FG007|COMPLETED|Part 2 Montage Effect, 1st Intervention||7||
48550521|NCT02763826|101679774|FG000|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0||
48550522|NCT02763826|101679775|FG001|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0||
48550523|NCT02763826|101679776|FG002|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0||
48550524|NCT02763826|101679777|FG003|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0||
48550525|NCT02763826|101679778|FG004|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0||
48550526|NCT02763826|101679779|FG005|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0||
48550527|NCT02763826|101679780|FG006|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0||
48550528|NCT02763826|101679781|FG007|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0||
48550529|NCT02763826|101679774|FG000|STARTED|Part 2 Montage Effect, 2nd Intervention||0||
48550530|NCT02763826|101679775|FG001|STARTED|Part 2 Montage Effect, 2nd Intervention||0||
48550531|NCT02763826|101679776|FG002|STARTED|Part 2 Montage Effect, 2nd Intervention||0||
48550532|NCT02763826|101679777|FG003|STARTED|Part 2 Montage Effect, 2nd Intervention||0||
48550533|NCT02763826|101679778|FG004|STARTED|Part 2 Montage Effect, 2nd Intervention||0||
48550534|NCT02763826|101679779|FG005|STARTED|Part 2 Montage Effect, 2nd Intervention||6||
48550535|NCT02763826|101679780|FG006|STARTED|Part 2 Montage Effect, 2nd Intervention||6||
48550536|NCT02763826|101679781|FG007|STARTED|Part 2 Montage Effect, 2nd Intervention||6||
48550537|NCT02763826|101679774|FG000|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0||
48550538|NCT02763826|101679775|FG001|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0||
48550539|NCT02763826|101679776|FG002|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0||
48550540|NCT02763826|101679777|FG003|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0||
48550541|NCT02763826|101679778|FG004|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0||
48550542|NCT02763826|101679779|FG005|COMPLETED|Part 2 Montage Effect, 2nd Intervention||6||
48103923|NCT03141281|100582844|FG000|NOT COMPLETED|Overall Study||12||
48103924|NCT03141281|100582845|FG001|NOT COMPLETED|Overall Study||21||
48103925|NCT03141281|100582846|FG002|NOT COMPLETED|Overall Study||14||
48103926|NCT03141281|100582847|FG003|NOT COMPLETED|Overall Study||11||
48103927|NCT03526458|100582848|FG000|STARTED|Overall Study||20||
48550543|NCT02763826|101679780|FG006|COMPLETED|Part 2 Montage Effect, 2nd Intervention||6||
48550544|NCT02763826|101679781|FG007|COMPLETED|Part 2 Montage Effect, 2nd Intervention||6||
48550545|NCT02763826|101679774|FG000|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0||
48550546|NCT02763826|101679775|FG001|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0||
48550547|NCT02763826|101679776|FG002|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0||
48550548|NCT02763826|101679777|FG003|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0||
48550549|NCT02763826|101679778|FG004|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0||
48550550|NCT02763826|101679779|FG005|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0||
48550551|NCT02763826|101679780|FG006|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0||
48550552|NCT02763826|101679781|FG007|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0||
48550553|NCT02763826|101679774|FG000|STARTED|Part 2 Montage Effect, 3rd Intervention||0||
48550554|NCT02763826|101679775|FG001|STARTED|Part 2 Montage Effect, 3rd Intervention||0||
48550555|NCT02763826|101679776|FG002|STARTED|Part 2 Montage Effect, 3rd Intervention||0||
48550556|NCT02763826|101679777|FG003|STARTED|Part 2 Montage Effect, 3rd Intervention||0||
48550557|NCT02763826|101679778|FG004|STARTED|Part 2 Montage Effect, 3rd Intervention||0||
48550558|NCT02763826|101679779|FG005|STARTED|Part 2 Montage Effect, 3rd Intervention||6||
48550559|NCT02763826|101679780|FG006|STARTED|Part 2 Montage Effect, 3rd Intervention||6||
48550560|NCT02763826|101679781|FG007|STARTED|Part 2 Montage Effect, 3rd Intervention||6||
48550561|NCT02763826|101679774|FG000|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0||
48550562|NCT02763826|101679775|FG001|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0||
48103928|NCT03526458|100582849|FG001|STARTED|Overall Study||20||
48691831|NCT01831466|102029030|FG010|COMPLETED|Overall Study||4||
48691832|NCT01831466|102029031|FG011|COMPLETED|Overall Study||3||
48691833|NCT01831466|102029020|FG000|NOT COMPLETED|Overall Study||16||
48691834|NCT01831466|102029021|FG001|NOT COMPLETED|Overall Study||18||
48691835|NCT01831466|102029022|FG002|NOT COMPLETED|Overall Study||23||
48691836|NCT01831466|102029023|FG003|NOT COMPLETED|Overall Study||19||
48691837|NCT01831466|102029024|FG004|NOT COMPLETED|Overall Study||17||
48691838|NCT01831466|102029025|FG005|NOT COMPLETED|Overall Study||26||
48691839|NCT01831466|102029026|FG006|NOT COMPLETED|Overall Study||1||
48691840|NCT01831466|102029027|FG007|NOT COMPLETED|Overall Study||2||
48691841|NCT01831466|102029028|FG008|NOT COMPLETED|Overall Study||3||
48691842|NCT01831466|102029029|FG009|NOT COMPLETED|Overall Study||5||
48691843|NCT01831466|102029030|FG010|NOT COMPLETED|Overall Study||2||
48265923|NCT01077518|100975340|FG001|COMPLETED|Treatment Phase - no Optional Ofa||108||
48265924|NCT01077518|100975341|FG002|COMPLETED|Treatment Phase - no Optional Ofa||0||
48265925|NCT01077518|100975339|FG000|NOT COMPLETED|Treatment Phase - no Optional Ofa||78||
48265926|NCT01077518|100975340|FG001|NOT COMPLETED|Treatment Phase - no Optional Ofa||65||
48265927|NCT01077518|100975341|FG002|NOT COMPLETED|Treatment Phase - no Optional Ofa||0||
48265928|NCT01077518|100975339|FG000|STARTED|Optional Ofa Phase||0||
48265929|NCT01077518|100975340|FG001|STARTED|Optional Ofa Phase||0||
48265930|NCT01077518|100975341|FG002|STARTED|Optional Ofa Phase||32||
48265931|NCT01077518|100975339|FG000|Completed 5-year Follow-up|Optional Ofa Phase||0||
48265932|NCT01077518|100975340|FG001|Completed 5-year Follow-up|Optional Ofa Phase||0||
48265933|NCT01077518|100975341|FG002|Completed 5-year Follow-up|Optional Ofa Phase||12||
48265934|NCT01077518|100975339|FG000|COMPLETED|Optional Ofa Phase||0||
48265935|NCT01077518|100975340|FG001|COMPLETED|Optional Ofa Phase||0||
48265936|NCT01077518|100975341|FG002|COMPLETED|Optional Ofa Phase||16||
48265937|NCT01077518|100975339|FG000|NOT COMPLETED|Optional Ofa Phase||0||
48265938|NCT01077518|100975340|FG001|NOT COMPLETED|Optional Ofa Phase||0||
48265939|NCT01077518|100975341|FG002|NOT COMPLETED|Optional Ofa Phase||16||
48265940|NCT01721954|100975342|FG000|STARTED|Overall Study||105||
48265941|NCT01721954|100975343|FG001|STARTED|Overall Study||104||
48265942|NCT01721954|100975342|FG000|COMPLETED|Overall Study||35||
48265943|NCT01721954|100975343|FG001|COMPLETED|Overall Study||35||
48265944|NCT01721954|100975342|FG000|NOT COMPLETED|Overall Study||70||
48550563|NCT02763826|101679776|FG002|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0||
48550564|NCT02763826|101679777|FG003|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0||
48550565|NCT02763826|101679778|FG004|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0||
48550566|NCT02763826|101679779|FG005|COMPLETED|Part 2 Montage Effect, 3rd Intervention||6||
48550567|NCT02763826|101679780|FG006|COMPLETED|Part 2 Montage Effect, 3rd Intervention||6||
48550568|NCT02763826|101679781|FG007|COMPLETED|Part 2 Montage Effect, 3rd Intervention||6||
48550569|NCT02763826|101679774|FG000|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0||
48550570|NCT02763826|101679775|FG001|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0||
48550571|NCT02763826|101679776|FG002|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0||
48550572|NCT02763826|101679777|FG003|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0||
48550573|NCT02763826|101679778|FG004|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0||
48550574|NCT02763826|101679779|FG005|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0||
48550575|NCT02763826|101679780|FG006|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0||
48550576|NCT02763826|101679781|FG007|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0||
48550577|NCT00661895|101679782|FG000|STARTED|Overall Study||49||
48550578|NCT00661895|101679783|FG001|STARTED|Overall Study||50||
48550579|NCT00661895|101679782|FG000|COMPLETED|Overall Study||49||
48550580|NCT00661895|101679783|FG001|COMPLETED|Overall Study||50||
48550581|NCT00661895|101679782|FG000|NOT COMPLETED|Overall Study||0||
48550582|NCT00661895|101679783|FG001|NOT COMPLETED|Overall Study||0||
48550583|NCT02088697|101679784|FG000|STARTED|Period I||25||
48550584|NCT02088697|101679785|FG001|STARTED|Period I||25||
48550585|NCT02088697|101679784|FG000|COMPLETED|Period I||24||
48550586|NCT02088697|101679785|FG001|COMPLETED|Period I||21||
48691844|NCT01831466|102029031|FG011|NOT COMPLETED|Overall Study||4||
48691845|NCT00149799|102029032|FG000|STARTED|Open Label Escitalopram (Phase I)||100||
48691846|NCT00149799|102029033|FG001|STARTED|Open Label Escitalopram (Phase I)||0||
48691847|NCT00149799|102029034|FG002|STARTED|Open Label Escitalopram (Phase I)||0||
48691848|NCT00149799|102029032|FG000|COMPLETED|Open Label Escitalopram (Phase I)||74||
48265945|NCT01721954|100975343|FG001|NOT COMPLETED|Overall Study||69||
48265946|NCT02356705|100975344|FG000|STARTED|Overall Study||14||
48265947|NCT02356705|100975345|FG001|STARTED|Overall Study||14||
48265948|NCT02356705|100975346|FG002|STARTED|Overall Study||14||
48265949|NCT02356705|100975344|FG000|COMPLETED|Overall Study||14||
48265950|NCT02356705|100975345|FG001|COMPLETED|Overall Study||14||
48265951|NCT02356705|100975346|FG002|COMPLETED|Overall Study||14||
48265952|NCT02356705|100975344|FG000|NOT COMPLETED|Overall Study||0||
48265953|NCT02356705|100975345|FG001|NOT COMPLETED|Overall Study||0||
48550587|NCT02088697|101679784|FG000|NOT COMPLETED|Period I||1||
48550588|NCT02088697|101679785|FG001|NOT COMPLETED|Period I||4||
48550589|NCT02088697|101679784|FG000|STARTED|Wash-out Period (at Least 10 Days)||24||
48550590|NCT02088697|101679785|FG001|STARTED|Wash-out Period (at Least 10 Days)||21||
48550591|NCT02088697|101679784|FG000|COMPLETED|Wash-out Period (at Least 10 Days)||23||
48550592|NCT02088697|101679785|FG001|COMPLETED|Wash-out Period (at Least 10 Days)||21||
48550593|NCT02088697|101679784|FG000|NOT COMPLETED|Wash-out Period (at Least 10 Days)||1||
48550594|NCT02088697|101679785|FG001|NOT COMPLETED|Wash-out Period (at Least 10 Days)||0||
48550595|NCT02088697|101679784|FG000|STARTED|Period II||23||
48550596|NCT02088697|101679785|FG001|STARTED|Period II||21||
48550597|NCT02088697|101679784|FG000|COMPLETED|Period II||23||
48550598|NCT02088697|101679785|FG001|COMPLETED|Period II||21||
48550599|NCT02088697|101679784|FG000|NOT COMPLETED|Period II||0||
48550600|NCT02088697|101679785|FG001|NOT COMPLETED|Period II||0||
48550601|NCT03624920|101679786|FG000|STARTED|Overall Study||14||
48550602|NCT03624920|101679787|FG001|STARTED|Overall Study||14||
48103929|NCT03526458|100582848|FG000|COMPLETED|Overall Study||12||
48103930|NCT03526458|100582849|FG001|COMPLETED|Overall Study||15||
48103931|NCT03526458|100582848|FG000|NOT COMPLETED|Overall Study||8||
48103932|NCT03526458|100582849|FG001|NOT COMPLETED|Overall Study||5||
48103933|NCT00798369|100582850|FG000|STARTED|Overall Study||28||
48103934|NCT00798369|100582851|FG001|STARTED|Overall Study||29||
48103935|NCT00798369|100582852|FG002|STARTED|Overall Study||29||
48103936|NCT00798369|100582853|FG003|STARTED|Overall Study||29||
48103937|NCT00798369|100582854|FG004|STARTED|Overall Study||28||
48103938|NCT00798369|100582855|FG005|STARTED|Overall Study||57||
48103939|NCT00798369|100582850|FG000|COMPLETED|Overall Study||27||
48103940|NCT00798369|100582851|FG001|COMPLETED|Overall Study||28||
48103941|NCT00798369|100582852|FG002|COMPLETED|Overall Study||27||
48103942|NCT00798369|100582853|FG003|COMPLETED|Overall Study||28||
48103943|NCT00798369|100582854|FG004|COMPLETED|Overall Study||27||
48103944|NCT00798369|100582855|FG005|COMPLETED|Overall Study||54||
48103945|NCT00798369|100582850|FG000|NOT COMPLETED|Overall Study||1||
48103946|NCT00798369|100582851|FG001|NOT COMPLETED|Overall Study||1||
48103947|NCT00798369|100582852|FG002|NOT COMPLETED|Overall Study||2||
48103948|NCT00798369|100582853|FG003|NOT COMPLETED|Overall Study||1||
48103949|NCT00798369|100582854|FG004|NOT COMPLETED|Overall Study||1||
48103950|NCT00798369|100582855|FG005|NOT COMPLETED|Overall Study||3||
48550603|NCT03624920|101679788|FG002|STARTED|Overall Study||13||
48550604|NCT03624920|101679789|FG003|STARTED|Overall Study||13||
48550605|NCT03624920|101679790|FG004|STARTED|Overall Study||11||
48550606|NCT03624920|101679791|FG005|STARTED|Overall Study||12||
48550607|NCT03624920|101679786|FG000|COMPLETED|Overall Study||13||
48550608|NCT03624920|101679787|FG001|COMPLETED|Overall Study||12||
48550609|NCT03624920|101679788|FG002|COMPLETED|Overall Study||12||
48550610|NCT03624920|101679789|FG003|COMPLETED|Overall Study||12||
48550611|NCT03624920|101679790|FG004|COMPLETED|Overall Study||7||
48550612|NCT03624920|101679791|FG005|COMPLETED|Overall Study||11||
48550613|NCT03624920|101679786|FG000|NOT COMPLETED|Overall Study||1||
48550614|NCT03624920|101679787|FG001|NOT COMPLETED|Overall Study||2||
48550615|NCT03624920|101679788|FG002|NOT COMPLETED|Overall Study||1||
48550616|NCT03624920|101679789|FG003|NOT COMPLETED|Overall Study||1||
48550617|NCT03624920|101679790|FG004|NOT COMPLETED|Overall Study||4||
48550618|NCT03624920|101679791|FG005|NOT COMPLETED|Overall Study||1||
48550619|NCT01734161|101679792|FG000|STARTED|Overall Study||61||
48550620|NCT01734161|101679793|FG001|STARTED|Overall Study||61||
48550621|NCT01734161|101679792|FG000|COMPLETED|Overall Study||55||
48550622|NCT01734161|101679793|FG001|COMPLETED|Overall Study||53||
48550623|NCT01734161|101679792|FG000|NOT COMPLETED|Overall Study||6||
48550624|NCT01734161|101679793|FG001|NOT COMPLETED|Overall Study||8||
48550625|NCT04414618|101679794|FG000|STARTED|Overall Study||23||
48550626|NCT04414618|101679795|FG001|STARTED|Overall Study||19||
48550627|NCT04414618|101679794|FG000|COMPLETED|Overall Study||15||
48550628|NCT04414618|101679795|FG001|COMPLETED|Overall Study||12||
48550629|NCT04414618|101679794|FG000|NOT COMPLETED|Overall Study||8||
48550630|NCT04414618|101679795|FG001|NOT COMPLETED|Overall Study||7||
48550631|NCT02108912|101679796|FG000|STARTED|Overall Study||9||
48550632|NCT02108912|101679797|FG001|STARTED|Overall Study||7||
48550633|NCT02108912|101679796|FG000|COMPLETED|Overall Study||6||
48550634|NCT02108912|101679797|FG001|COMPLETED|Overall Study||6||
48103951|NCT04568590|100582856|FG000|STARTED|Overall Study||510||
48103952|NCT04568590|100582856|FG000|COMPLETED|Overall Study||73||
48103953|NCT04568590|100582856|FG000|NOT COMPLETED|Overall Study||437||
48103954|NCT03792672|100582857|FG000|STARTED|Treatment Period 1 (1 Day)||4||
48103955|NCT03792672|100582858|FG001|STARTED|Treatment Period 1 (1 Day)||4||
48103956|NCT03792672|100582859|FG002|STARTED|Treatment Period 1 (1 Day)||4||
48103957|NCT03792672|100582860|FG003|STARTED|Treatment Period 1 (1 Day)||4||
48103958|NCT03792672|100582861|FG004|STARTED|Treatment Period 1 (1 Day)||4||
48103959|NCT03792672|100582862|FG005|STARTED|Treatment Period 1 (1 Day)||4||
48550635|NCT02108912|101679796|FG000|NOT COMPLETED|Overall Study||3||
48550636|NCT02108912|101679797|FG001|NOT COMPLETED|Overall Study||1||
48103960|NCT03792672|100582857|FG000|COMPLETED|Treatment Period 1 (1 Day)||4||
48103961|NCT03792672|100582858|FG001|COMPLETED|Treatment Period 1 (1 Day)||4||
48103962|NCT03792672|100582859|FG002|COMPLETED|Treatment Period 1 (1 Day)||4||
48550637|NCT00739063|101679798|FG000|STARTED|Overall Study||11||
48550638|NCT00739063|101679798|FG000|COMPLETED|Overall Study||3||
48550639|NCT00739063|101679798|FG000|NOT COMPLETED|Overall Study||8||
48550640|NCT01689779|101679799|FG000|STARTED|Overall Study||28||
48550641|NCT01689779|101679800|FG001|STARTED|Overall Study||32||
48550642|NCT01689779|101679799|FG000|COMPLETED|Overall Study||28||
48550643|NCT01689779|101679800|FG001|COMPLETED|Overall Study||32||
48550644|NCT01689779|101679799|FG000|NOT COMPLETED|Overall Study||0||
48550645|NCT01689779|101679800|FG001|NOT COMPLETED|Overall Study||0||
48550646|NCT02536846|101679801|FG000|STARTED|Overall Study||10|35 participants were enrolled and 10 were allocated to receive olanzapine.|
48550647|NCT02536846|101679801|FG000|COMPLETED|Overall Study||9||
48550648|NCT02536846|101679801|FG000|NOT COMPLETED|Overall Study||1||
48550649|NCT01372748|101679802|FG000|STARTED|Overall Study||11045||
48550650|NCT01372748|101679803|FG001|STARTED|Overall Study||12642||
48550651|NCT01372748|101679802|FG000|COMPLETED|Overall Study||11022||
48550652|NCT01372748|101679803|FG001|COMPLETED|Overall Study||12603||
48550653|NCT01372748|101679802|FG000|NOT COMPLETED|Overall Study||23||
48550654|NCT01372748|101679803|FG001|NOT COMPLETED|Overall Study||39||
48550655|NCT03691727|101679804|FG000|STARTED|Overall Study||18||
48550656|NCT03691727|101679805|FG001|STARTED|Overall Study||12||
48550657|NCT03691727|101679804|FG000|COMPLETED|Overall Study||16||
48550658|NCT03691727|101679805|FG001|COMPLETED|Overall Study||11||
48550659|NCT03691727|101679804|FG000|NOT COMPLETED|Overall Study||2||
48550660|NCT03691727|101679805|FG001|NOT COMPLETED|Overall Study||1||
48550661|NCT01794455|101679806|FG000|STARTED|Overall Study||0||
48550662|NCT01794455|101679807|FG001|STARTED|Overall Study||1||
48550663|NCT01794455|101679806|FG000|COMPLETED|Overall Study||0||
48550664|NCT01794455|101679807|FG001|COMPLETED|Overall Study||1||
48550665|NCT01794455|101679806|FG000|NOT COMPLETED|Overall Study||0||
48550666|NCT01794455|101679807|FG001|NOT COMPLETED|Overall Study||0||
48550667|NCT03659929|101679808|FG000|STARTED|Overall Study||106||
48550668|NCT03659929|101679809|FG001|STARTED|Overall Study||107||
48550669|NCT03659929|101679810|FG002|STARTED|Overall Study||107||
48550670|NCT03659929|101679808|FG000|COMPLETED|Overall Study||92||
48550671|NCT03659929|101679809|FG001|COMPLETED|Overall Study||87||
48550672|NCT03659929|101679810|FG002|COMPLETED|Overall Study||87||
48550673|NCT03659929|101679808|FG000|NOT COMPLETED|Overall Study||14||
48550674|NCT03659929|101679809|FG001|NOT COMPLETED|Overall Study||20||
48550675|NCT03659929|101679810|FG002|NOT COMPLETED|Overall Study||20||
48550676|NCT01408043|101679811|FG000|STARTED|Overall Study||25||
48550677|NCT01408043|101679811|FG000|COMPLETED|Overall Study||24||
48550678|NCT01408043|101679811|FG000|NOT COMPLETED|Overall Study||1||
48550679|NCT01406574|101679812|FG000|STARTED|Overall Study||7||
48550680|NCT01406574|101679813|FG001|STARTED|Overall Study||4||
48550681|NCT01406574|101679814|FG002|STARTED|Overall Study||7||
48550682|NCT01406574|101679815|FG003|STARTED|Overall Study||5||
48550683|NCT01406574|101679812|FG000|COMPLETED|Overall Study||6||
48550684|NCT01406574|101679813|FG001|COMPLETED|Overall Study||3||
48550685|NCT01406574|101679814|FG002|COMPLETED|Overall Study||6||
48265954|NCT02356705|100975346|FG002|NOT COMPLETED|Overall Study||0||
48265955|NCT05186311|100975347|FG000|STARTED|Part A: Serum||136||
48265956|NCT05186311|100975347|FG000|COMPLETED|Part A: Serum||135||
48265957|NCT05186311|100975347|FG000|NOT COMPLETED|Part A: Serum||1||
48265958|NCT05186311|100975347|FG000|STARTED|Part B: EDTA||126||
48265959|NCT05186311|100975347|FG000|COMPLETED|Part B: EDTA||125||
48265960|NCT05186311|100975347|FG000|NOT COMPLETED|Part B: EDTA||1||
48265961|NCT01658020|100975348|FG000|STARTED|Overall Study||175||
48265962|NCT01658020|100975349|FG001|STARTED|Overall Study||167||
48265963|NCT01658020|100975348|FG000|COMPLETED|Overall Study||167||
48265964|NCT01658020|100975349|FG001|COMPLETED|Overall Study||158||
48550686|NCT01406574|101679815|FG003|COMPLETED|Overall Study||1||
48550687|NCT01406574|101679812|FG000|NOT COMPLETED|Overall Study||1||
48550688|NCT01406574|101679813|FG001|NOT COMPLETED|Overall Study||1||
48550689|NCT01406574|101679814|FG002|NOT COMPLETED|Overall Study||1||
48550690|NCT01406574|101679815|FG003|NOT COMPLETED|Overall Study||4||
48550691|NCT00640315|101679816|FG000|STARTED|Overall Study||10||
48265965|NCT01658020|100975348|FG000|NOT COMPLETED|Overall Study||8||
48265966|NCT01658020|100975349|FG001|NOT COMPLETED|Overall Study||9||
48265967|NCT01634269|100975350|FG000|STARTED|Overall Study||20||
48265968|NCT01634269|100975350|FG000|30 Days|Overall Study||20||
48550692|NCT00640315|101679817|FG001|STARTED|Overall Study||13||
48550693|NCT00640315|101679816|FG000|Participants Received Treatment|Overall Study||10||
48550694|NCT00640315|101679817|FG001|Participants Received Treatment|Overall Study||13||
48550695|NCT00640315|101679816|FG000|COMPLETED|Overall Study||10||
48550696|NCT00640315|101679817|FG001|COMPLETED|Overall Study||12||
48550697|NCT00640315|101679816|FG000|NOT COMPLETED|Overall Study||0||
48550698|NCT00640315|101679817|FG001|NOT COMPLETED|Overall Study||1||
48550699|NCT04578535|101679818|FG000|STARTED|Overall Study||8||
48550700|NCT04578535|101679819|FG001|STARTED|Overall Study||8||
48550701|NCT04578535|101679820|FG002|STARTED|Overall Study||8||
48550702|NCT04578535|101679821|FG003|STARTED|Overall Study||9||
48550703|NCT04578535|101679822|FG004|STARTED|Overall Study||8||
48550704|NCT04578535|101679823|FG005|STARTED|Overall Study||10||
48265969|NCT01634269|100975350|FG000|6 Month|Overall Study||20||
48265970|NCT01634269|100975350|FG000|12 Month|Overall Study||20||
48265971|NCT01634269|100975350|FG000|24 Month|Overall Study||18||
48265972|NCT01634269|100975350|FG000|COMPLETED|Overall Study||18||
48265973|NCT01634269|100975350|FG000|NOT COMPLETED|Overall Study||2||
48265974|NCT01417104|100975351|FG000|STARTED|Overall Study||34||
48265975|NCT01417104|100975352|FG001|STARTED|Overall Study||37||
48691849|NCT00149799|102029033|FG001|COMPLETED|Open Label Escitalopram (Phase I)||0||
48691850|NCT00149799|102029034|FG002|COMPLETED|Open Label Escitalopram (Phase I)||0||
48691851|NCT00149799|102029032|FG000|NOT COMPLETED|Open Label Escitalopram (Phase I)||26||
48691852|NCT00149799|102029033|FG001|NOT COMPLETED|Open Label Escitalopram (Phase I)||0||
48691853|NCT00149799|102029034|FG002|NOT COMPLETED|Open Label Escitalopram (Phase I)||0||
48691854|NCT00149799|102029032|FG000|STARTED|Discontinuation (Phase II)||0||
48550705|NCT04578535|101679818|FG000|COMPLETED|Overall Study||6||
48550706|NCT04578535|101679819|FG001|COMPLETED|Overall Study||8||
48550707|NCT04578535|101679820|FG002|COMPLETED|Overall Study||8||
48550708|NCT04578535|101679821|FG003|COMPLETED|Overall Study||7||
48550709|NCT04578535|101679822|FG004|COMPLETED|Overall Study||6||
48550710|NCT04578535|101679823|FG005|COMPLETED|Overall Study||3||
48550711|NCT04578535|101679818|FG000|NOT COMPLETED|Overall Study||2||
48550712|NCT04578535|101679819|FG001|NOT COMPLETED|Overall Study||0||
48550713|NCT04578535|101679820|FG002|NOT COMPLETED|Overall Study||0||
48550714|NCT04578535|101679821|FG003|NOT COMPLETED|Overall Study||2||
48550715|NCT04578535|101679822|FG004|NOT COMPLETED|Overall Study||2||
48550716|NCT04578535|101679823|FG005|NOT COMPLETED|Overall Study||7||
48550717|NCT01273896|101679824|FG000|STARTED|Overall Study||22||
48550718|NCT01273896|101679824|FG000|COMPLETED|Overall Study||22||
48550719|NCT01273896|101679824|FG000|NOT COMPLETED|Overall Study||0||
48550720|NCT03475992|101683024|FG000|STARTED|Overall Study||11||
48550721|NCT03475992|101683025|FG001|STARTED|Overall Study||9||
48550722|NCT03475992|101683026|FG002|STARTED|Overall Study||5||
48550723|NCT03475992|101683024|FG000|COMPLETED|Overall Study||11||
48550724|NCT03475992|101683025|FG001|COMPLETED|Overall Study||9||
48391682|NCT02928380|101287710|FG003|STARTED|Period 3||14||
48391683|NCT02928380|101287711|FG004|STARTED|Period 3||14||
48391684|NCT02928380|101287712|FG005|STARTED|Period 3||14||
48391685|NCT02928380|101287707|FG000|COMPLETED|Period 3||13||
48391686|NCT02928380|101287708|FG001|COMPLETED|Period 3||14||
48391687|NCT02928380|101287709|FG002|COMPLETED|Period 3||14||
48391688|NCT02928380|101287710|FG003|COMPLETED|Period 3||14||
48391689|NCT02928380|101287711|FG004|COMPLETED|Period 3||14||
48391690|NCT02928380|101287712|FG005|COMPLETED|Period 3||14||
48391691|NCT02928380|101287707|FG000|NOT COMPLETED|Period 3||0||
48391692|NCT02928380|101287708|FG001|NOT COMPLETED|Period 3||0||
48391693|NCT02928380|101287709|FG002|NOT COMPLETED|Period 3||0||
48391694|NCT02928380|101287710|FG003|NOT COMPLETED|Period 3||0||
48391695|NCT02928380|101287711|FG004|NOT COMPLETED|Period 3||0||
48391696|NCT02928380|101287712|FG005|NOT COMPLETED|Period 3||0||
48391697|NCT03479216|101287713|FG000|STARTED|Overall Study||31||
48391698|NCT03479216|101287714|FG001|STARTED|Overall Study||31||
48391699|NCT03479216|101287713|FG000|COMPLETED|Overall Study||26||
48391700|NCT03479216|101287714|FG001|COMPLETED|Overall Study||26||
48391701|NCT03479216|101287713|FG000|NOT COMPLETED|Overall Study||5||
48391702|NCT03479216|101287714|FG001|NOT COMPLETED|Overall Study||5||
48391703|NCT01103778|101287715|FG000|STARTED|Overall Study||11||
48391704|NCT01103778|101287715|FG000|COMPLETED|Overall Study||8||
48391705|NCT01103778|101287715|FG000|NOT COMPLETED|Overall Study||3||
48391706|NCT00225147|101287716|FG000|STARTED|Double-blind Phase||13||
48391707|NCT00225147|101287717|FG001|STARTED|Double-blind Phase||12||
48550725|NCT03475992|101683026|FG002|COMPLETED|Overall Study||5||
48550726|NCT03475992|101683024|FG000|NOT COMPLETED|Overall Study||0||
48550727|NCT03475992|101683025|FG001|NOT COMPLETED|Overall Study||0||
48550728|NCT03475992|101683026|FG002|NOT COMPLETED|Overall Study||0||
48691855|NCT00149799|102029033|FG001|STARTED|Discontinuation (Phase II)||28||
48391708|NCT00225147|101287718|FG002|STARTED|Double-blind Phase||13||
48391709|NCT00225147|101287719|FG003|STARTED|Double-blind Phase||0||
48391710|NCT00225147|101287716|FG000|COMPLETED|Double-blind Phase||13||
48391711|NCT00225147|101287717|FG001|COMPLETED|Double-blind Phase||12||
48391712|NCT00225147|101287718|FG002|COMPLETED|Double-blind Phase||13||
48391713|NCT00225147|101287719|FG003|COMPLETED|Double-blind Phase||0||
48391714|NCT00225147|101287716|FG000|NOT COMPLETED|Double-blind Phase||0||
48391715|NCT00225147|101287717|FG001|NOT COMPLETED|Double-blind Phase||0||
48391716|NCT00225147|101287718|FG002|NOT COMPLETED|Double-blind Phase||0||
48391717|NCT00225147|101287719|FG003|NOT COMPLETED|Double-blind Phase||0||
48391718|NCT00225147|101287716|FG000|STARTED|Open-label Phase||0||
48391719|NCT00225147|101287717|FG001|STARTED|Open-label Phase||0||
48391720|NCT00225147|101287718|FG002|STARTED|Open-label Phase||0||
48391721|NCT00225147|101287719|FG003|STARTED|Open-label Phase||62||
48550729|NCT03280264|101683027|FG000|STARTED|Overall Study||18||
48550730|NCT03280264|101683027|FG000|COMPLETED|Overall Study||15||
48391722|NCT00225147|101287716|FG000|COMPLETED|Open-label Phase||0||
48391723|NCT00225147|101287717|FG001|COMPLETED|Open-label Phase||0||
48391724|NCT00225147|101287718|FG002|COMPLETED|Open-label Phase||0||
48391725|NCT00225147|101287719|FG003|COMPLETED|Open-label Phase||52||
48391726|NCT00225147|101287716|FG000|NOT COMPLETED|Open-label Phase||0||
48550731|NCT03280264|101683027|FG000|NOT COMPLETED|Overall Study||3||
48550732|NCT03127514|101683028|FG000|STARTED|Overall Study||48||
48550733|NCT03127514|101683029|FG001|STARTED|Overall Study||89||
48550734|NCT03127514|101683028|FG000|COMPLETED|Overall Study||38||
48550735|NCT03127514|101683029|FG001|COMPLETED|Overall Study||67||
48550736|NCT03127514|101683028|FG000|NOT COMPLETED|Overall Study||10||
48103963|NCT03792672|100582860|FG003|COMPLETED|Treatment Period 1 (1 Day)||4||
48103964|NCT03792672|100582861|FG004|COMPLETED|Treatment Period 1 (1 Day)||4||
48103965|NCT03792672|100582862|FG005|COMPLETED|Treatment Period 1 (1 Day)||4||
48103966|NCT03792672|100582857|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
48103967|NCT03792672|100582858|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
48103968|NCT03792672|100582859|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
48103969|NCT03792672|100582860|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
48103970|NCT03792672|100582861|FG004|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
48103971|NCT03792672|100582862|FG005|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
48103972|NCT03792672|100582857|FG000|STARTED|Washout Period 1 (10 Days)||4||
48103973|NCT03792672|100582858|FG001|STARTED|Washout Period 1 (10 Days)||4||
48103974|NCT03792672|100582859|FG002|STARTED|Washout Period 1 (10 Days)||4||
48265976|NCT01417104|100975351|FG000|COMPLETED|Overall Study||28||
48265977|NCT01417104|100975352|FG001|COMPLETED|Overall Study||35||
48265978|NCT01417104|100975351|FG000|NOT COMPLETED|Overall Study||6||
48265979|NCT01417104|100975352|FG001|NOT COMPLETED|Overall Study||2||
48265980|NCT00379769|100975353|FG000|STARTED|Main Study||1117||
48265981|NCT00379769|100975354|FG001|STARTED|Main Study||1105||
48265982|NCT00379769|100975355|FG002|STARTED|Main Study||1103||
48265983|NCT00379769|100975356|FG003|STARTED|Main Study||1122||
48265984|NCT00379769|100975357|FG004|STARTED|Main Study||0||
48265985|NCT00379769|100975358|FG005|STARTED|Main Study||0||
48265986|NCT00379769|100975353|FG000|COMPLETED|Main Study||939||
48265987|NCT00379769|100975354|FG001|COMPLETED|Main Study||906||
48265988|NCT00379769|100975355|FG002|COMPLETED|Main Study||896||
48391727|NCT00225147|101287717|FG001|NOT COMPLETED|Open-label Phase||0||
48391728|NCT00225147|101287718|FG002|NOT COMPLETED|Open-label Phase||0||
48391729|NCT00225147|101287719|FG003|NOT COMPLETED|Open-label Phase||10||
48391730|NCT03934710|101287720|FG000|STARTED|Overall Study||18||
48391731|NCT03934710|101287721|FG001|STARTED|Overall Study||19||
48391732|NCT03934710|101287722|FG002|STARTED|Overall Study||19||
48391733|NCT03934710|101287720|FG000|COMPLETED|Overall Study||18||
48391734|NCT03934710|101287721|FG001|COMPLETED|Overall Study||19||
48391735|NCT03934710|101287722|FG002|COMPLETED|Overall Study||19||
48391736|NCT03934710|101287720|FG000|NOT COMPLETED|Overall Study||0||
48391737|NCT03934710|101287721|FG001|NOT COMPLETED|Overall Study||0||
48391738|NCT03934710|101287722|FG002|NOT COMPLETED|Overall Study||0||
48391739|NCT02483078|101287723|FG000|STARTED|Part 1 One-week Randomized||25||
48391740|NCT02483078|101287724|FG001|STARTED|Part 1 One-week Randomized||27||
48391741|NCT02483078|101287723|FG000|COMPLETED|Part 1 One-week Randomized||25||
48391742|NCT02483078|101287724|FG001|COMPLETED|Part 1 One-week Randomized||26||
48391743|NCT02483078|101287723|FG000|NOT COMPLETED|Part 1 One-week Randomized||0||
48391744|NCT02483078|101287724|FG001|NOT COMPLETED|Part 1 One-week Randomized||1||
48391745|NCT02483078|101287723|FG000|STARTED|Part 2 Open Label Treatment Period||25||
48391746|NCT02483078|101287724|FG001|STARTED|Part 2 Open Label Treatment Period||26||
48391747|NCT02483078|101287723|FG000|COMPLETED|Part 2 Open Label Treatment Period||25||
48391748|NCT02483078|101287724|FG001|COMPLETED|Part 2 Open Label Treatment Period||21||
48391749|NCT02483078|101287723|FG000|NOT COMPLETED|Part 2 Open Label Treatment Period||0||
48391750|NCT02483078|101287724|FG001|NOT COMPLETED|Part 2 Open Label Treatment Period||5||
48391751|NCT02394795|101287725|FG000|STARTED|Overall Study||404||
48391752|NCT02394795|101287726|FG001|STARTED|Overall Study||407||
48391753|NCT02394795|101287725|FG000|COMPLETED|Overall Study||1||
48391754|NCT02394795|101287726|FG001|COMPLETED|Overall Study||1||
48391755|NCT02394795|101287725|FG000|NOT COMPLETED|Overall Study||403||
48391756|NCT02394795|101287726|FG001|NOT COMPLETED|Overall Study||406||
48391757|NCT01742078|101287727|FG000|STARTED|Overall Study||6||
48391758|NCT01742078|101287728|FG001|STARTED|Overall Study||6||
48391759|NCT01742078|101287729|FG002|STARTED|Overall Study||6||
48550737|NCT03127514|101683029|FG001|NOT COMPLETED|Overall Study||22||
48550738|NCT00995774|101683030|FG000|STARTED|Training Period 1||7||
48550739|NCT00995774|101683031|FG001|STARTED|Training Period 1||5||
48550740|NCT00995774|101683030|FG000|COMPLETED|Training Period 1||7||
48103975|NCT03792672|100582860|FG003|STARTED|Washout Period 1 (10 Days)||4||
48103976|NCT03792672|100582861|FG004|STARTED|Washout Period 1 (10 Days)||4||
48103977|NCT03792672|100582862|FG005|STARTED|Washout Period 1 (10 Days)||4||
48103978|NCT03792672|100582857|FG000|COMPLETED|Washout Period 1 (10 Days)||4||
48391760|NCT01742078|101287730|FG003|STARTED|Overall Study||6||
48391761|NCT01742078|101287731|FG004|STARTED|Overall Study||6||
48391762|NCT01742078|101287732|FG005|STARTED|Overall Study||6||
48391763|NCT01742078|101287733|FG006|STARTED|Overall Study||6||
48391764|NCT01742078|101287734|FG007|STARTED|Overall Study||6||
48391765|NCT01742078|101287735|FG008|STARTED|Overall Study||12||
48391766|NCT01742078|101287727|FG000|RECEIVED STUDY DRUG|Overall Study||6||
48391767|NCT01742078|101287728|FG001|RECEIVED STUDY DRUG|Overall Study||6||
48391768|NCT01742078|101287729|FG002|RECEIVED STUDY DRUG|Overall Study||6||
48391769|NCT01742078|101287730|FG003|RECEIVED STUDY DRUG|Overall Study||6||
48550741|NCT00995774|101683031|FG001|COMPLETED|Training Period 1||5||
48550742|NCT00995774|101683030|FG000|NOT COMPLETED|Training Period 1||0||
48265989|NCT00379769|100975356|FG003|COMPLETED|Main Study||892||
48265990|NCT00379769|100975357|FG004|COMPLETED|Main Study||0||
48265991|NCT00379769|100975358|FG005|COMPLETED|Main Study||0||
48103979|NCT03792672|100582858|FG001|COMPLETED|Washout Period 1 (10 Days)||4||
48103980|NCT03792672|100582859|FG002|COMPLETED|Washout Period 1 (10 Days)||4||
48103981|NCT03792672|100582860|FG003|COMPLETED|Washout Period 1 (10 Days)||4||
48103982|NCT03792672|100582861|FG004|COMPLETED|Washout Period 1 (10 Days)||4||
48103983|NCT03792672|100582862|FG005|COMPLETED|Washout Period 1 (10 Days)||4||
48103984|NCT03792672|100582857|FG000|NOT COMPLETED|Washout Period 1 (10 Days)||0||
48103985|NCT03792672|100582858|FG001|NOT COMPLETED|Washout Period 1 (10 Days)||0||
48103986|NCT03792672|100582859|FG002|NOT COMPLETED|Washout Period 1 (10 Days)||0||
48103987|NCT03792672|100582860|FG003|NOT COMPLETED|Washout Period 1 (10 Days)||0||
48103988|NCT03792672|100582861|FG004|NOT COMPLETED|Washout Period 1 (10 Days)||0||
48103989|NCT03792672|100582862|FG005|NOT COMPLETED|Washout Period 1 (10 Days)||0||
48103990|NCT03792672|100582857|FG000|STARTED|Treatment Period 2 (1 Day)||4||
48103991|NCT03792672|100582858|FG001|STARTED|Treatment Period 2 (1 Day)||4||
48103992|NCT03792672|100582859|FG002|STARTED|Treatment Period 2 (1 Day)||4||
48103993|NCT03792672|100582860|FG003|STARTED|Treatment Period 2 (1 Day)||4||
48103994|NCT03792672|100582861|FG004|STARTED|Treatment Period 2 (1 Day)||4||
48103995|NCT03792672|100582862|FG005|STARTED|Treatment Period 2 (1 Day)||4||
48103996|NCT03792672|100582857|FG000|COMPLETED|Treatment Period 2 (1 Day)||4||
48103997|NCT03792672|100582858|FG001|COMPLETED|Treatment Period 2 (1 Day)||4||
48103998|NCT03792672|100582859|FG002|COMPLETED|Treatment Period 2 (1 Day)||4||
48103999|NCT03792672|100582860|FG003|COMPLETED|Treatment Period 2 (1 Day)||4||
48104000|NCT03792672|100582861|FG004|COMPLETED|Treatment Period 2 (1 Day)||4||
48104001|NCT03792672|100582862|FG005|COMPLETED|Treatment Period 2 (1 Day)||4||
48104002|NCT03792672|100582857|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
48104003|NCT03792672|100582858|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
48104004|NCT03792672|100582859|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
48104005|NCT03792672|100582860|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
48104006|NCT03792672|100582861|FG004|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
48104007|NCT03792672|100582862|FG005|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
48104008|NCT03792672|100582857|FG000|STARTED|Washout Period 2 (10 Days)||4||
48104009|NCT03792672|100582858|FG001|STARTED|Washout Period 2 (10 Days)||4||
48104010|NCT03792672|100582859|FG002|STARTED|Washout Period 2 (10 Days)||4||
48104011|NCT03792672|100582860|FG003|STARTED|Washout Period 2 (10 Days)||4||
48104012|NCT03792672|100582861|FG004|STARTED|Washout Period 2 (10 Days)||4||
48104013|NCT03792672|100582862|FG005|STARTED|Washout Period 2 (10 Days)||4||
48104014|NCT03792672|100582857|FG000|COMPLETED|Washout Period 2 (10 Days)||4||
48104015|NCT03792672|100582858|FG001|COMPLETED|Washout Period 2 (10 Days)||4||
48104016|NCT03792672|100582859|FG002|COMPLETED|Washout Period 2 (10 Days)||4||
48104017|NCT03792672|100582860|FG003|COMPLETED|Washout Period 2 (10 Days)||4||
48104018|NCT03792672|100582861|FG004|COMPLETED|Washout Period 2 (10 Days)||4||
48104019|NCT03792672|100582862|FG005|COMPLETED|Washout Period 2 (10 Days)||4||
48104020|NCT03792672|100582857|FG000|NOT COMPLETED|Washout Period 2 (10 Days)||0||
48104021|NCT03792672|100582858|FG001|NOT COMPLETED|Washout Period 2 (10 Days)||0||
48104022|NCT03792672|100582859|FG002|NOT COMPLETED|Washout Period 2 (10 Days)||0||
48104023|NCT03792672|100582860|FG003|NOT COMPLETED|Washout Period 2 (10 Days)||0||
48104024|NCT03792672|100582861|FG004|NOT COMPLETED|Washout Period 2 (10 Days)||0||
48104025|NCT03792672|100582862|FG005|NOT COMPLETED|Washout Period 2 (10 Days)||0||
48104026|NCT03792672|100582857|FG000|STARTED|Treatment Period 3 (1 Day)||4||
48104027|NCT03792672|100582858|FG001|STARTED|Treatment Period 3 (1 Day)||4||
48104028|NCT03792672|100582859|FG002|STARTED|Treatment Period 3 (1 Day)||4||
48104029|NCT03792672|100582860|FG003|STARTED|Treatment Period 3 (1 Day)||4||
48104030|NCT03792672|100582861|FG004|STARTED|Treatment Period 3 (1 Day)||4||
48104031|NCT03792672|100582862|FG005|STARTED|Treatment Period 3 (1 Day)||4||
48104032|NCT03792672|100582857|FG000|COMPLETED|Treatment Period 3 (1 Day)||4||
48104033|NCT03792672|100582858|FG001|COMPLETED|Treatment Period 3 (1 Day)||4||
48104034|NCT03792672|100582859|FG002|COMPLETED|Treatment Period 3 (1 Day)||4||
48104035|NCT03792672|100582860|FG003|COMPLETED|Treatment Period 3 (1 Day)||4||
48104036|NCT03792672|100582861|FG004|COMPLETED|Treatment Period 3 (1 Day)||4||
48104037|NCT03792672|100582862|FG005|COMPLETED|Treatment Period 3 (1 Day)||4||
48104038|NCT03792672|100582857|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
48104039|NCT03792672|100582858|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
48104040|NCT03792672|100582859|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
48104041|NCT03792672|100582860|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
48104042|NCT03792672|100582861|FG004|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
48104043|NCT03792672|100582862|FG005|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
48104044|NCT03792672|100582857|FG000|STARTED|Washout Period 3 (10 Days)||4||
48104045|NCT03792672|100582858|FG001|STARTED|Washout Period 3 (10 Days)||4||
48104046|NCT03792672|100582859|FG002|STARTED|Washout Period 3 (10 Days)||4||
48104047|NCT03792672|100582860|FG003|STARTED|Washout Period 3 (10 Days)||4||
48104048|NCT03792672|100582861|FG004|STARTED|Washout Period 3 (10 Days)||4||
48104049|NCT03792672|100582862|FG005|STARTED|Washout Period 3 (10 Days)||4||
48104050|NCT03792672|100582857|FG000|COMPLETED|Washout Period 3 (10 Days)||3||
48104051|NCT03792672|100582858|FG001|COMPLETED|Washout Period 3 (10 Days)||4||
48104052|NCT03792672|100582859|FG002|COMPLETED|Washout Period 3 (10 Days)||3||
48104053|NCT03792672|100582860|FG003|COMPLETED|Washout Period 3 (10 Days)||2||
48104054|NCT03792672|100582861|FG004|COMPLETED|Washout Period 3 (10 Days)||4||
48104055|NCT03792672|100582862|FG005|COMPLETED|Washout Period 3 (10 Days)||4||
48104056|NCT03792672|100582857|FG000|NOT COMPLETED|Washout Period 3 (10 Days)||1||
48104057|NCT03792672|100582858|FG001|NOT COMPLETED|Washout Period 3 (10 Days)||0||
48104058|NCT03792672|100582859|FG002|NOT COMPLETED|Washout Period 3 (10 Days)||1||
48104059|NCT03792672|100582860|FG003|NOT COMPLETED|Washout Period 3 (10 Days)||2||
48104060|NCT03792672|100582861|FG004|NOT COMPLETED|Washout Period 3 (10 Days)||0||
48104061|NCT03792672|100582862|FG005|NOT COMPLETED|Washout Period 3 (10 Days)||0||
48104062|NCT03792672|100582857|FG000|STARTED|Treatment Period 4 (2 Days)||3||
48104063|NCT03792672|100582858|FG001|STARTED|Treatment Period 4 (2 Days)||4||
48104064|NCT03792672|100582859|FG002|STARTED|Treatment Period 4 (2 Days)||3||
48104065|NCT03792672|100582860|FG003|STARTED|Treatment Period 4 (2 Days)||2||
48104066|NCT03792672|100582861|FG004|STARTED|Treatment Period 4 (2 Days)||4||
48104067|NCT03792672|100582862|FG005|STARTED|Treatment Period 4 (2 Days)||4||
48104068|NCT03792672|100582857|FG000|COMPLETED|Treatment Period 4 (2 Days)||2||
48104069|NCT03792672|100582858|FG001|COMPLETED|Treatment Period 4 (2 Days)||4||
48104070|NCT03792672|100582859|FG002|COMPLETED|Treatment Period 4 (2 Days)||3||
48104071|NCT03792672|100582860|FG003|COMPLETED|Treatment Period 4 (2 Days)||2||
48104072|NCT03792672|100582861|FG004|COMPLETED|Treatment Period 4 (2 Days)||4||
48104073|NCT03792672|100582862|FG005|COMPLETED|Treatment Period 4 (2 Days)||4||
48104074|NCT03792672|100582857|FG000|NOT COMPLETED|Treatment Period 4 (2 Days)||1||
48104075|NCT03792672|100582858|FG001|NOT COMPLETED|Treatment Period 4 (2 Days)||0||
48104076|NCT03792672|100582859|FG002|NOT COMPLETED|Treatment Period 4 (2 Days)||0||
48104077|NCT03792672|100582860|FG003|NOT COMPLETED|Treatment Period 4 (2 Days)||0||
48104078|NCT03792672|100582861|FG004|NOT COMPLETED|Treatment Period 4 (2 Days)||0||
48104079|NCT03792672|100582862|FG005|NOT COMPLETED|Treatment Period 4 (2 Days)||0||
48104080|NCT03465878|100582863|FG000|STARTED|Period 1-Part A First Intervention Day 1||21||
48104081|NCT03465878|100582864|FG001|STARTED|Period 1-Part A First Intervention Day 1||21||
48104082|NCT03465878|100582865|FG002|STARTED|Period 1-Part A First Intervention Day 1||0||
48104083|NCT03465878|100582866|FG003|STARTED|Period 1-Part A First Intervention Day 1||0||
48104084|NCT03465878|100582863|FG000|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||21||
48104085|NCT03465878|100582864|FG001|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||21||
48104086|NCT03465878|100582865|FG002|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||0||
48104087|NCT03465878|100582866|FG003|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||0||
48104088|NCT03465878|100582863|FG000|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||7||
48104089|NCT03465878|100582864|FG001|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||6||
48104090|NCT03465878|100582865|FG002|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||0||
48104091|NCT03465878|100582866|FG003|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||0||
48104092|NCT03465878|100582863|FG000|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||7||
48104093|NCT03465878|100582864|FG001|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||7||
48104094|NCT03465878|100582865|FG002|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||0||
48691856|NCT00149799|102029034|FG002|STARTED|Discontinuation (Phase II)||30||
48691857|NCT00149799|102029032|FG000|COMPLETED|Discontinuation (Phase II)||0||
48691858|NCT00149799|102029033|FG001|COMPLETED|Discontinuation (Phase II)||25||
48691859|NCT00149799|102029034|FG002|COMPLETED|Discontinuation (Phase II)||21||
48691860|NCT00149799|102029032|FG000|NOT COMPLETED|Discontinuation (Phase II)||0||
48691861|NCT00149799|102029033|FG001|NOT COMPLETED|Discontinuation (Phase II)||3||
48691862|NCT00149799|102029034|FG002|NOT COMPLETED|Discontinuation (Phase II)||9||
48691863|NCT02425956|102029035|FG000|STARTED|Overall Study||21||
48691864|NCT02425956|102029035|FG000|COMPLETED|Overall Study||21||
48104095|NCT03465878|100582866|FG003|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||0||
48104096|NCT03465878|100582863|FG000|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||7||
48104097|NCT03465878|100582864|FG001|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||8||
48104098|NCT03465878|100582865|FG002|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||0||
48104099|NCT03465878|100582866|FG003|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||0||
48104100|NCT03465878|100582863|FG000|COMPLETED|Period 1-Part A First Intervention Day 1||21||
48104101|NCT03465878|100582864|FG001|COMPLETED|Period 1-Part A First Intervention Day 1||20||
48104102|NCT03465878|100582865|FG002|COMPLETED|Period 1-Part A First Intervention Day 1||0||
48104103|NCT03465878|100582866|FG003|COMPLETED|Period 1-Part A First Intervention Day 1||0||
48691865|NCT02425956|102029035|FG000|NOT COMPLETED|Overall Study||0||
48691866|NCT02147197|102029036|FG000|STARTED|Overall Study||56||
48691867|NCT02147197|102029037|FG001|STARTED|Overall Study||53||
48691868|NCT02147197|102029038|FG002|STARTED|Overall Study||48||
48691869|NCT02147197|102029036|FG000|COMPLETED|Overall Study||47||
48691870|NCT02147197|102029037|FG001|COMPLETED|Overall Study||47||
48691871|NCT02147197|102029038|FG002|COMPLETED|Overall Study||39||
48691872|NCT02147197|102029036|FG000|NOT COMPLETED|Overall Study||9||
48691873|NCT02147197|102029037|FG001|NOT COMPLETED|Overall Study||6||
48104104|NCT03465878|100582863|FG000|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0||
48104105|NCT03465878|100582864|FG001|NOT COMPLETED|Period 1-Part A First Intervention Day 1||1||
48104106|NCT03465878|100582865|FG002|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0||
48104107|NCT03465878|100582866|FG003|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0||
48104108|NCT03465878|100582863|FG000|STARTED|Period2-Part A Second Intervention Day 1||21||
48104109|NCT03465878|100582864|FG001|STARTED|Period2-Part A Second Intervention Day 1||20||
48104110|NCT03465878|100582865|FG002|STARTED|Period2-Part A Second Intervention Day 1||0||
48104111|NCT03465878|100582866|FG003|STARTED|Period2-Part A Second Intervention Day 1||0||
48104112|NCT03465878|100582863|FG000|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||7||
48104113|NCT03465878|100582864|FG001|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||6||
48104114|NCT03465878|100582865|FG002|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||0||
48104115|NCT03465878|100582866|FG003|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||0||
48104116|NCT03465878|100582863|FG000|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||7||
48104117|NCT03465878|100582864|FG001|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||7||
48104118|NCT03465878|100582865|FG002|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||0||
48104119|NCT03465878|100582866|FG003|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||0||
48104120|NCT03465878|100582863|FG000|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||7||
48104121|NCT03465878|100582864|FG001|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||7||
48104122|NCT03465878|100582865|FG002|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||0||
48104123|NCT03465878|100582866|FG003|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||0||
48104124|NCT03465878|100582863|FG000|COMPLETED|Period2-Part A Second Intervention Day 1||21||
48104125|NCT03465878|100582864|FG001|COMPLETED|Period2-Part A Second Intervention Day 1||20||
48104126|NCT03465878|100582865|FG002|COMPLETED|Period2-Part A Second Intervention Day 1||0||
48104127|NCT03465878|100582866|FG003|COMPLETED|Period2-Part A Second Intervention Day 1||0||
48104128|NCT03465878|100582863|FG000|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0||
48104129|NCT03465878|100582864|FG001|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0||
48104130|NCT03465878|100582865|FG002|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0||
48104131|NCT03465878|100582866|FG003|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0||
48104132|NCT03465878|100582863|FG000|STARTED|Period 1-Part B First Intervention Day 1||0||
48104133|NCT03465878|100582864|FG001|STARTED|Period 1-Part B First Intervention Day 1||0||
48104134|NCT03465878|100582865|FG002|STARTED|Period 1-Part B First Intervention Day 1||20||
48104135|NCT03465878|100582866|FG003|STARTED|Period 1-Part B First Intervention Day 1||19||
48104136|NCT03465878|100582863|FG000|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||0||
48104137|NCT03465878|100582864|FG001|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||0||
48104138|NCT03465878|100582865|FG002|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||20||
48104139|NCT03465878|100582866|FG003|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||17||
48104140|NCT03465878|100582863|FG000|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||0||
48104141|NCT03465878|100582864|FG001|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||0||
48104142|NCT03465878|100582865|FG002|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||6||
48265992|NCT00379769|100975353|FG000|NOT COMPLETED|Main Study||178||
48265993|NCT00379769|100975354|FG001|NOT COMPLETED|Main Study||199||
48104143|NCT03465878|100582866|FG003|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||6||
48104144|NCT03465878|100582863|FG000|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||0||
48104145|NCT03465878|100582864|FG001|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||0||
48104146|NCT03465878|100582865|FG002|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||7||
48104147|NCT03465878|100582866|FG003|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||6||
48104148|NCT03465878|100582863|FG000|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||0||
48104149|NCT03465878|100582864|FG001|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||0||
48104150|NCT03465878|100582865|FG002|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||7||
48104151|NCT03465878|100582866|FG003|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||5||
48104152|NCT03465878|100582863|FG000|COMPLETED|Period 1-Part B First Intervention Day 1||0||
48104153|NCT03465878|100582864|FG001|COMPLETED|Period 1-Part B First Intervention Day 1||0||
48104154|NCT03465878|100582865|FG002|COMPLETED|Period 1-Part B First Intervention Day 1||20||
48265994|NCT00379769|100975355|FG002|NOT COMPLETED|Main Study||207||
48265995|NCT00379769|100975356|FG003|NOT COMPLETED|Main Study||230||
48265996|NCT00379769|100975357|FG004|NOT COMPLETED|Main Study||0||
48265997|NCT00379769|100975358|FG005|NOT COMPLETED|Main Study||0||
48391770|NCT01742078|101287731|FG004|RECEIVED STUDY DRUG|Overall Study||6||
48391771|NCT01742078|101287732|FG005|RECEIVED STUDY DRUG|Overall Study||6||
48391772|NCT01742078|101287733|FG006|RECEIVED STUDY DRUG|Overall Study||6||
48265998|NCT00379769|100975353|FG000|STARTED|Observational Follow-up||0||
48265999|NCT00379769|100975354|FG001|STARTED|Observational Follow-up||0||
48266000|NCT00379769|100975355|FG002|STARTED|Observational Follow-up||0||
48266001|NCT00379769|100975356|FG003|STARTED|Observational Follow-up||0||
48266002|NCT00379769|100975357|FG004|STARTED|Observational Follow-up||1280||
48266003|NCT00379769|100975358|FG005|STARTED|Observational Follow-up||1250||
48391773|NCT01742078|101287734|FG007|RECEIVED STUDY DRUG|Overall Study||6||
48104155|NCT03465878|100582866|FG003|COMPLETED|Period 1-Part B First Intervention Day 1||17||
48104156|NCT03465878|100582863|FG000|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0||
48104157|NCT03465878|100582864|FG001|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0||
48104158|NCT03465878|100582865|FG002|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0||
48104159|NCT03465878|100582866|FG003|NOT COMPLETED|Period 1-Part B First Intervention Day 1||2||
48104160|NCT03465878|100582863|FG000|STARTED|Period2-Part B Second Intervention Day 1||0||
48104161|NCT03465878|100582864|FG001|STARTED|Period2-Part B Second Intervention Day 1||0||
48104162|NCT03465878|100582865|FG002|STARTED|Period2-Part B Second Intervention Day 1||20||
48104163|NCT03465878|100582866|FG003|STARTED|Period2-Part B Second Intervention Day 1||17||
48104164|NCT03465878|100582863|FG000|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||0||
48104165|NCT03465878|100582864|FG001|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||0||
48104166|NCT03465878|100582865|FG002|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||6||
48104167|NCT03465878|100582866|FG003|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||6||
48104168|NCT03465878|100582863|FG000|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||0||
48104169|NCT03465878|100582864|FG001|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||0||
48104170|NCT03465878|100582865|FG002|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||7||
48104171|NCT03465878|100582866|FG003|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||6||
48104172|NCT03465878|100582863|FG000|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||0||
48104173|NCT03465878|100582864|FG001|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||0||
48104174|NCT03465878|100582865|FG002|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||7||
48104175|NCT03465878|100582866|FG003|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||5||
48104176|NCT03465878|100582863|FG000|COMPLETED|Period2-Part B Second Intervention Day 1||0||
48104177|NCT03465878|100582864|FG001|COMPLETED|Period2-Part B Second Intervention Day 1||0||
48104178|NCT03465878|100582865|FG002|COMPLETED|Period2-Part B Second Intervention Day 1||20||
48104179|NCT03465878|100582866|FG003|COMPLETED|Period2-Part B Second Intervention Day 1||17||
48104180|NCT03465878|100582863|FG000|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0||
48104181|NCT03465878|100582864|FG001|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0||
48104182|NCT03465878|100582865|FG002|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0||
48104183|NCT03465878|100582866|FG003|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0||
48104184|NCT01177540|100582867|FG000|STARTED|Overall Study||11||
48104185|NCT01177540|100582868|FG001|STARTED|Overall Study||14||
48104186|NCT01177540|100582867|FG000|COMPLETED|Overall Study||10||
48104187|NCT01177540|100582868|FG001|COMPLETED|Overall Study||14||
48104188|NCT01177540|100582867|FG000|NOT COMPLETED|Overall Study||1||
48104189|NCT01177540|100582868|FG001|NOT COMPLETED|Overall Study||0||
48104190|NCT04425746|100582869|FG000|STARTED|Overall Study||9||
48104191|NCT04425746|100582870|FG001|STARTED|Overall Study||7||
48104192|NCT04425746|100582869|FG000|COMPLETED|Overall Study||9||
48104193|NCT04425746|100582870|FG001|COMPLETED|Overall Study||6||
48550743|NCT00995774|101683031|FG001|NOT COMPLETED|Training Period 1||0||
48550744|NCT00995774|101683030|FG000|STARTED|Washout Period||7||
48550745|NCT00995774|101683031|FG001|STARTED|Washout Period||5||
48550746|NCT00995774|101683030|FG000|COMPLETED|Washout Period||7||
48550747|NCT00995774|101683031|FG001|COMPLETED|Washout Period||5||
48550748|NCT00995774|101683030|FG000|NOT COMPLETED|Washout Period||0||
48550749|NCT00995774|101683031|FG001|NOT COMPLETED|Washout Period||0||
48104194|NCT04425746|100582869|FG000|NOT COMPLETED|Overall Study||0||
48104195|NCT04425746|100582870|FG001|NOT COMPLETED|Overall Study||1||
48104196|NCT02519712|100582871|FG000|STARTED|Overall Study||4||
48104197|NCT02519712|100582871|FG000|COMPLETED|Overall Study||0||
48104198|NCT02519712|100582871|FG000|NOT COMPLETED|Overall Study||4||
48104199|NCT03303404|100582872|FG000|STARTED|Overall Study||22||
48104200|NCT03303404|100582872|FG000|COMPLETED|Overall Study||22||
48104201|NCT03303404|100582872|FG000|NOT COMPLETED|Overall Study||0||
48104202|NCT00718328|100582873|FG000|STARTED|Overall Study||1||
48104203|NCT00718328|100582874|FG001|STARTED|Overall Study||0||
48104204|NCT00718328|100582873|FG000|COMPLETED|Overall Study||0||
48104205|NCT00718328|100582874|FG001|COMPLETED|Overall Study||0||
48104206|NCT00718328|100582873|FG000|NOT COMPLETED|Overall Study||1||
48104207|NCT00718328|100582874|FG001|NOT COMPLETED|Overall Study||0||
48104208|NCT00116831|100582875|FG000|STARTED|Overall Study||337||
48104209|NCT00116831|100582876|FG001|STARTED|Overall Study||331||
48266004|NCT00379769|100975353|FG000|COMPLETED|Observational Follow-up||0||
48550750|NCT00995774|101683030|FG000|STARTED|Training Period 2||7||
48550751|NCT00995774|101683031|FG001|STARTED|Training Period 2||5||
48104210|NCT00116831|100582875|FG000|COMPLETED|Overall Study||264||
48550752|NCT00995774|101683030|FG000|COMPLETED|Training Period 2||5||
48550753|NCT00995774|101683031|FG001|COMPLETED|Training Period 2||5||
48550754|NCT00995774|101683030|FG000|NOT COMPLETED|Training Period 2||2||
48550755|NCT00995774|101683031|FG001|NOT COMPLETED|Training Period 2||0||
48550756|NCT02017015|101683032|FG000|STARTED|Overall Study||83||
48266005|NCT00379769|100975354|FG001|COMPLETED|Observational Follow-up||0||
48266006|NCT00379769|100975355|FG002|COMPLETED|Observational Follow-up||0||
48550757|NCT02017015|101683032|FG000|Safety Population|Overall Study||83||
48550758|NCT02017015|101683032|FG000|COMPLETED|Overall Study||14||
48104211|NCT00116831|100582876|FG001|COMPLETED|Overall Study||259||
48104212|NCT00116831|100582875|FG000|NOT COMPLETED|Overall Study||73||
48104213|NCT00116831|100582876|FG001|NOT COMPLETED|Overall Study||72||
48104214|NCT02466555|100582877|FG000|STARTED|Overall Study||30||
48104215|NCT02466555|100582877|FG000|COMPLETED|Overall Study||28||
48104216|NCT02466555|100582877|FG000|NOT COMPLETED|Overall Study||2||
48104217|NCT04248933|100582878|FG000|STARTED|Overall Study||37||
48104218|NCT04248933|100582878|FG000|Initiated Peer Activate|Overall Study||32||
48104219|NCT04248933|100582878|FG000|Completed Peer Activate Completers (>= 4 Sessions)|Overall Study||26||
48104220|NCT04248933|100582878|FG000|COMPLETED|Overall Study||26||
48266007|NCT00379769|100975356|FG003|COMPLETED|Observational Follow-up||0||
48266008|NCT00379769|100975357|FG004|COMPLETED|Observational Follow-up||1131||
48104221|NCT04248933|100582878|FG000|NOT COMPLETED|Overall Study||11||
48104222|NCT00748215|100582879|FG000|STARTED|Overall Study||50||
48104223|NCT00748215|100582880|FG001|STARTED|Overall Study||50||
48104224|NCT00748215|100582879|FG000|Open Label CASAD After Initial 6 Weeks Intervention|Overall Study||22||
48104225|NCT00748215|100582880|FG001|Open Label CASAD After Initial 6 Weeks Intervention|Overall Study||17||
48104226|NCT00748215|100582879|FG000|COMPLETED|Overall Study||41||
48266009|NCT00379769|100975358|FG005|COMPLETED|Observational Follow-up||1102||
48266010|NCT00379769|100975353|FG000|NOT COMPLETED|Observational Follow-up||0||
48266011|NCT00379769|100975354|FG001|NOT COMPLETED|Observational Follow-up||0||
48266012|NCT00379769|100975355|FG002|NOT COMPLETED|Observational Follow-up||0||
48266013|NCT00379769|100975356|FG003|NOT COMPLETED|Observational Follow-up||0||
48266014|NCT00379769|100975357|FG004|NOT COMPLETED|Observational Follow-up||149||
48104227|NCT00748215|100582880|FG001|COMPLETED|Overall Study||32||
48104228|NCT00748215|100582879|FG000|NOT COMPLETED|Overall Study||9||
48104229|NCT00748215|100582880|FG001|NOT COMPLETED|Overall Study||18||
48104230|NCT00696137|100582881|FG000|STARTED|Overall Study||5||
48104231|NCT00696137|100582881|FG000|COMPLETED|Overall Study||3||
48104232|NCT00696137|100582881|FG000|NOT COMPLETED|Overall Study||2||
48104233|NCT01417481|100582882|FG000|STARTED|First Intervention (8 Weeks)||8||
48104234|NCT01417481|100582883|FG001|STARTED|First Intervention (8 Weeks)||7||
48104235|NCT01417481|100582882|FG000|COMPLETED|First Intervention (8 Weeks)||8||
48104236|NCT01417481|100582883|FG001|COMPLETED|First Intervention (8 Weeks)||5||
48104237|NCT01417481|100582882|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0||
48104238|NCT01417481|100582883|FG001|NOT COMPLETED|First Intervention (8 Weeks)||2||
48104239|NCT01417481|100582882|FG000|STARTED|Washout (2 Weeks)||8||
48104240|NCT01417481|100582883|FG001|STARTED|Washout (2 Weeks)||5||
48104241|NCT01417481|100582882|FG000|COMPLETED|Washout (2 Weeks)||8||
48104242|NCT01417481|100582883|FG001|COMPLETED|Washout (2 Weeks)||5||
48104243|NCT01417481|100582882|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
48104244|NCT01417481|100582883|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
48266015|NCT00379769|100975358|FG005|NOT COMPLETED|Observational Follow-up||148||
48266016|NCT02301377|100975359|FG000|STARTED|Overall Study||3||
48266017|NCT02301377|100975360|FG001|STARTED|Overall Study||2||
48266018|NCT02301377|100975359|FG000|COMPLETED|Overall Study||3||
48266019|NCT02301377|100975360|FG001|COMPLETED|Overall Study||2||
48266020|NCT02301377|100975359|FG000|NOT COMPLETED|Overall Study||0||
48266021|NCT02301377|100975360|FG001|NOT COMPLETED|Overall Study||0||
48266022|NCT05262751|100975361|FG000|STARTED|Treatment Period 1||3||
48391774|NCT01742078|101287735|FG008|RECEIVED STUDY DRUG|Overall Study||12||
48391775|NCT01742078|101287727|FG000|COMPLETED|Overall Study||6||
48391776|NCT01742078|101287728|FG001|COMPLETED|Overall Study||6||
48391777|NCT01742078|101287729|FG002|COMPLETED|Overall Study||6||
48104245|NCT01417481|100582882|FG000|STARTED|Second Period (8 Weeks)||8||
48104246|NCT01417481|100582883|FG001|STARTED|Second Period (8 Weeks)||5||
48104247|NCT01417481|100582882|FG000|COMPLETED|Second Period (8 Weeks)||8||
48104248|NCT01417481|100582883|FG001|COMPLETED|Second Period (8 Weeks)||5||
48104249|NCT01417481|100582882|FG000|NOT COMPLETED|Second Period (8 Weeks)||0||
48104250|NCT01417481|100582883|FG001|NOT COMPLETED|Second Period (8 Weeks)||0||
48104251|NCT03639766|100582884|FG000|STARTED|Overall Study||3||
48104252|NCT03639766|100582884|FG000|COMPLETED|Overall Study||3||
48104253|NCT03639766|100582884|FG000|NOT COMPLETED|Overall Study||0||
48104254|NCT03615807|100582885|FG000|STARTED|Overall Study||91||
48104255|NCT03615807|100582886|FG001|STARTED|Overall Study||91||
48104256|NCT03615807|100582885|FG000|COMPLETED|Overall Study||79||
48104257|NCT03615807|100582886|FG001|COMPLETED|Overall Study||80||
48104258|NCT03615807|100582885|FG000|NOT COMPLETED|Overall Study||12||
48104259|NCT03615807|100582886|FG001|NOT COMPLETED|Overall Study||11||
48104260|NCT03552575|100582887|FG000|STARTED|Overall Study||47||
48104261|NCT03552575|100582888|FG001|STARTED|Overall Study||46||
48104262|NCT03552575|100582887|FG000|COMPLETED|Overall Study||46||
48104263|NCT03552575|100582888|FG001|COMPLETED|Overall Study||46||
48266023|NCT05262751|100975362|FG001|STARTED|Treatment Period 1||2||
48266024|NCT05262751|100975363|FG002|STARTED|Treatment Period 1||2||
48266025|NCT05262751|100975364|FG003|STARTED|Treatment Period 1||5||
48266026|NCT05262751|100975365|FG004|STARTED|Treatment Period 1||5||
48104264|NCT03552575|100582887|FG000|NOT COMPLETED|Overall Study||1||
48104265|NCT03552575|100582888|FG001|NOT COMPLETED|Overall Study||0||
48104266|NCT04059146|100582889|FG000|STARTED|Overall Study||33||
48104267|NCT04059146|100582890|FG001|STARTED|Overall Study||33||
48104268|NCT04059146|100582889|FG000|COMPLETED|Overall Study||33||
48104269|NCT04059146|100582890|FG001|COMPLETED|Overall Study||32||
48104270|NCT04059146|100582889|FG000|NOT COMPLETED|Overall Study||0||
48104271|NCT04059146|100582890|FG001|NOT COMPLETED|Overall Study||1||
48104272|NCT03257631|100582891|FG000|STARTED|Overall Study||11|The intent-to-treat population includes all enrolled participants, regardless of whether they received any treatment or not|
48104273|NCT03257631|100582892|FG001|STARTED|Overall Study||9|The intent-to-treat population includes all enrolled participants, regardless of whether they received any treatment or not|
48104274|NCT03257631|100582893|FG002|STARTED|Overall Study||23|The intent-to-treat population includes all enrolled participants, regardless of whether they received any treatment or not|
48104275|NCT03257631|100582894|FG003|STARTED|Overall Study||10|The intent-to-treat population includes all enrolled participants, regardless of whether they received any treatment or not|
48104276|NCT03257631|100582891|FG000|Received Study Drug|Overall Study||11|The safety population included all participants who received at least 1 dose of study drug|
48104277|NCT03257631|100582892|FG001|Received Study Drug|Overall Study||9|The safety population included all participants who received at least 1 dose of study drug|
48104278|NCT03257631|100582893|FG002|Received Study Drug|Overall Study||22|The safety population included all participants who received at least 1 dose of study drug|
48104279|NCT03257631|100582894|FG003|Received Study Drug|Overall Study||10|The safety population included all participants who received at least 1 dose of study drug|
48104280|NCT03257631|100582891|FG000|COMPLETED|Overall Study||0||
48104281|NCT03257631|100582892|FG001|COMPLETED|Overall Study||0||
48104282|NCT03257631|100582893|FG002|COMPLETED|Overall Study||1||
48104283|NCT03257631|100582894|FG003|COMPLETED|Overall Study||0||
48104284|NCT03257631|100582891|FG000|NOT COMPLETED|Overall Study||11||
48104285|NCT03257631|100582892|FG001|NOT COMPLETED|Overall Study||9||
48104286|NCT03257631|100582893|FG002|NOT COMPLETED|Overall Study||22||
48104287|NCT03257631|100582894|FG003|NOT COMPLETED|Overall Study||10||
48104288|NCT00176592|100582895|FG000|STARTED|Overall Study||36||
48104289|NCT00176592|100582896|FG001|STARTED|Overall Study||39||
48104290|NCT00176592|100582895|FG000|Followed for 1 Year|Overall Study||35||
48104291|NCT00176592|100582896|FG001|Followed for 1 Year|Overall Study||35||
48104292|NCT00176592|100582895|FG000|Followed for 2 Years|Overall Study||29||
48104293|NCT00176592|100582896|FG001|Followed for 2 Years|Overall Study||35||
48104294|NCT00176592|100582895|FG000|COMPLETED|Overall Study||36||
48104295|NCT00176592|100582896|FG001|COMPLETED|Overall Study||39||
48104296|NCT00176592|100582895|FG000|NOT COMPLETED|Overall Study||0||
48104297|NCT00176592|100582896|FG001|NOT COMPLETED|Overall Study||0||
48104298|NCT00656630|100582897|FG000|STARTED|Overall Study||22||
48104299|NCT00656630|100582898|FG001|STARTED|Overall Study||27||
48104300|NCT00656630|100582899|FG002|STARTED|Overall Study||19||
48104301|NCT00656630|100582897|FG000|COMPLETED|Overall Study||20||
48104302|NCT00656630|100582898|FG001|COMPLETED|Overall Study||25||
48104303|NCT00656630|100582899|FG002|COMPLETED|Overall Study||17||
48104304|NCT00656630|100582897|FG000|NOT COMPLETED|Overall Study||2||
48104305|NCT00656630|100582898|FG001|NOT COMPLETED|Overall Study||2||
48104306|NCT00656630|100582899|FG002|NOT COMPLETED|Overall Study||2||
48104307|NCT01925404|100582900|FG000|STARTED|Overall Study||0|The numbers reported are the number of parks assigned to the study arm|12
48104308|NCT01925404|100582901|FG001|STARTED|Overall Study||0|The numbers reported are the number of parks assigned to the study arm|12
48104309|NCT01925404|100582902|FG002|STARTED|Overall Study||0|The numbers reported are the number of parks assigned to the study arm|12
48104310|NCT01925404|100582903|FG003|STARTED|Overall Study||0|The numbers reported are the number of parks assigned to the study arm|12
48104311|NCT01925404|100582900|FG000|COMPLETED|Overall Study||0||12
48104312|NCT01925404|100582901|FG001|COMPLETED|Overall Study||0||12
48104313|NCT01925404|100582902|FG002|COMPLETED|Overall Study||0||12
48104314|NCT01925404|100582903|FG003|COMPLETED|Overall Study||0||12
48104315|NCT01925404|100582900|FG000|NOT COMPLETED|Overall Study||0||0
48104316|NCT01925404|100582901|FG001|NOT COMPLETED|Overall Study||0||0
48550759|NCT02017015|101683032|FG000|NOT COMPLETED|Overall Study||69||
48550760|NCT02452476|101683033|FG000|STARTED|Overall Study||64||
48550761|NCT02452476|101683034|FG001|STARTED|Overall Study||59||
48550762|NCT02452476|101683033|FG000|COMPLETED|Overall Study||53||
48550763|NCT02452476|101683034|FG001|COMPLETED|Overall Study||49||
48550764|NCT02452476|101683033|FG000|NOT COMPLETED|Overall Study||11||
48550765|NCT02452476|101683034|FG001|NOT COMPLETED|Overall Study||10||
48550766|NCT03514966|101683035|FG000|STARTED|Overall Study||40||
48550767|NCT03514966|101683036|FG001|STARTED|Overall Study||43||
48550768|NCT03514966|101683035|FG000|COMPLETED|Overall Study||40||
48104317|NCT01925404|100582902|FG002|NOT COMPLETED|Overall Study||0||0
48104318|NCT01925404|100582903|FG003|NOT COMPLETED|Overall Study||0||0
48104319|NCT01380743|100582904|FG000|STARTED|Overall Study||6||
48104320|NCT01380743|100582905|FG001|STARTED|Overall Study||6||
48550769|NCT03514966|101683036|FG001|COMPLETED|Overall Study||43||
48550770|NCT03514966|101683035|FG000|NOT COMPLETED|Overall Study||0||
48550771|NCT03514966|101683036|FG001|NOT COMPLETED|Overall Study||0||
48104321|NCT01380743|100582906|FG002|STARTED|Overall Study||6||
48104322|NCT01380743|100582907|FG003|STARTED|Overall Study||7||
48104323|NCT01380743|100582904|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
48104324|NCT01380743|100582905|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
48104325|NCT01380743|100582906|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
48550772|NCT03066258|101683037|FG000|STARTED|Overall Study||6||
48104326|NCT01380743|100582907|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7||
48104327|NCT01380743|100582904|FG000|COMPLETED|Overall Study||6||
48104328|NCT01380743|100582905|FG001|COMPLETED|Overall Study||6||
48104329|NCT01380743|100582906|FG002|COMPLETED|Overall Study||6||
48104330|NCT01380743|100582907|FG003|COMPLETED|Overall Study||7||
48104331|NCT01380743|100582904|FG000|NOT COMPLETED|Overall Study||0||
48104332|NCT01380743|100582905|FG001|NOT COMPLETED|Overall Study||0||
48104333|NCT01380743|100582906|FG002|NOT COMPLETED|Overall Study||0||
48104334|NCT01380743|100582907|FG003|NOT COMPLETED|Overall Study||0||
48104335|NCT04608500|100582908|FG000|STARTED|Overall Study||514||
48104336|NCT04608500|100582909|FG001|STARTED|Overall Study||257||
48104337|NCT04608500|100582908|FG000|COMPLETED|Overall Study||479||
48104338|NCT04608500|100582909|FG001|COMPLETED|Overall Study||239||
48104339|NCT04608500|100582908|FG000|NOT COMPLETED|Overall Study||35||
48550773|NCT03066258|101683038|FG001|STARTED|Overall Study||6||
48550774|NCT03066258|101683039|FG002|STARTED|Overall Study||6||
48550775|NCT03066258|101683040|FG003|STARTED|Overall Study||12||
48550776|NCT03066258|101683041|FG004|STARTED|Overall Study||12||
48550777|NCT03066258|101683037|FG000|COMPLETED|Overall Study||5||
48550778|NCT03066258|101683038|FG001|COMPLETED|Overall Study||6||
48550779|NCT03066258|101683039|FG002|COMPLETED|Overall Study||6||
48550780|NCT03066258|101683040|FG003|COMPLETED|Overall Study||12||
48550781|NCT03066258|101683041|FG004|COMPLETED|Overall Study||11||
48104340|NCT04608500|100582909|FG001|NOT COMPLETED|Overall Study||18||
48104341|NCT03336216|100582910|FG000|STARTED|Randomization||54||
48104342|NCT03336216|100582911|FG001|STARTED|Randomization||54||
48104343|NCT03336216|100582912|FG002|STARTED|Randomization||54||
48104344|NCT03336216|100582913|FG003|STARTED|Randomization||43||
48104345|NCT03336216|100582910|FG000|COMPLETED|Randomization||40||
48104346|NCT03336216|100582911|FG001|COMPLETED|Randomization||49||
48104347|NCT03336216|100582912|FG002|COMPLETED|Randomization||48||
48104348|NCT03336216|100582913|FG003|COMPLETED|Randomization||42||
48104349|NCT03336216|100582910|FG000|NOT COMPLETED|Randomization||14||
48104350|NCT03336216|100582911|FG001|NOT COMPLETED|Randomization||5||
48104351|NCT03336216|100582912|FG002|NOT COMPLETED|Randomization||6||
48104352|NCT03336216|100582913|FG003|NOT COMPLETED|Randomization||1||
48104353|NCT03336216|100582910|FG000|STARTED|Treatment||40||
48104354|NCT03336216|100582911|FG001|STARTED|Treatment||49||
48550782|NCT03066258|101683037|FG000|NOT COMPLETED|Overall Study||1||
48550783|NCT03066258|101683038|FG001|NOT COMPLETED|Overall Study||0||
48550784|NCT03066258|101683039|FG002|NOT COMPLETED|Overall Study||0||
48550785|NCT03066258|101683040|FG003|NOT COMPLETED|Overall Study||0||
48550786|NCT03066258|101683041|FG004|NOT COMPLETED|Overall Study||1||
48550787|NCT01696760|101683042|FG000|STARTED|Overall Study||9||
48550788|NCT01696760|101683043|FG001|STARTED|Overall Study||3||
48550789|NCT01696760|101683042|FG000|COMPLETED|Overall Study||9||
48550790|NCT01696760|101683043|FG001|COMPLETED|Overall Study||3||
48550791|NCT01696760|101683042|FG000|NOT COMPLETED|Overall Study||0||
48550792|NCT01696760|101683043|FG001|NOT COMPLETED|Overall Study||0||
48550793|NCT03093701|101683044|FG000|STARTED|Overall Study||10||
48550794|NCT03093701|101683045|FG001|STARTED|Overall Study||10||
48550795|NCT03093701|101683046|FG002|STARTED|Overall Study||11||
48550796|NCT03093701|101683047|FG003|STARTED|Overall Study||0||
48550797|NCT03093701|101683044|FG000|COMPLETED|Overall Study||10||
48550798|NCT03093701|101683045|FG001|COMPLETED|Overall Study||7||
48550799|NCT03093701|101683046|FG002|COMPLETED|Overall Study||11||
48550800|NCT03093701|101683047|FG003|COMPLETED|Overall Study||0||
48550801|NCT03093701|101683044|FG000|NOT COMPLETED|Overall Study||0||
48550802|NCT03093701|101683045|FG001|NOT COMPLETED|Overall Study||3||
48550803|NCT03093701|101683046|FG002|NOT COMPLETED|Overall Study||0||
48550804|NCT03093701|101683047|FG003|NOT COMPLETED|Overall Study||0||
48550805|NCT02301390|101683048|FG000|STARTED|Overall Study||27||
48550806|NCT02301390|101683049|FG001|STARTED|Overall Study||26||
48550807|NCT02301390|101683048|FG000|COMPLETED|Overall Study||17||
48550808|NCT02301390|101683049|FG001|COMPLETED|Overall Study||13||
48550809|NCT02301390|101683048|FG000|NOT COMPLETED|Overall Study||10||
48104355|NCT03336216|100582912|FG002|STARTED|Treatment||48||
48104356|NCT03336216|100582913|FG003|STARTED|Treatment||42||
48104357|NCT03336216|100582910|FG000|COMPLETED|Treatment||0||
48104358|NCT03336216|100582911|FG001|COMPLETED|Treatment||1||
48104359|NCT03336216|100582912|FG002|COMPLETED|Treatment||0||
48104360|NCT03336216|100582913|FG003|COMPLETED|Treatment||1||
48104361|NCT03336216|100582910|FG000|NOT COMPLETED|Treatment||40||
48104362|NCT03336216|100582911|FG001|NOT COMPLETED|Treatment||48||
48104363|NCT03336216|100582912|FG002|NOT COMPLETED|Treatment||48||
48104364|NCT03336216|100582913|FG003|NOT COMPLETED|Treatment||41||
48104365|NCT04475588|100582914|FG000|STARTED|Overall Study||22||
48104366|NCT04475588|100582915|FG001|STARTED|Overall Study||10||
48104367|NCT04475588|100582914|FG000|COMPLETED|Overall Study||20||
48104368|NCT04475588|100582915|FG001|COMPLETED|Overall Study||10||
48104369|NCT04475588|100582914|FG000|NOT COMPLETED|Overall Study||2||
48550810|NCT02301390|101683049|FG001|NOT COMPLETED|Overall Study||13||
48550811|NCT04315506|101683050|FG000|STARTED|Overall Study||264||
48550812|NCT04315506|101683051|FG001|STARTED|Overall Study||268||
48550813|NCT04315506|101683050|FG000|COMPLETED|Overall Study||182||
48550814|NCT04315506|101683051|FG001|COMPLETED|Overall Study||177||
48550815|NCT04315506|101683050|FG000|NOT COMPLETED|Overall Study||82||
48550816|NCT04315506|101683051|FG001|NOT COMPLETED|Overall Study||91||
48550817|NCT01130493|101683052|FG000|STARTED|Open-label Dose Conversion to IPX066||110||
48550818|NCT01130493|101683053|FG001|STARTED|Open-label Dose Conversion to IPX066||0||
48550819|NCT01130493|101683054|FG002|STARTED|Open-label Dose Conversion to IPX066||0||
48550820|NCT01130493|101683052|FG000|COMPLETED|Open-label Dose Conversion to IPX066||91||
48550821|NCT01130493|101683053|FG001|COMPLETED|Open-label Dose Conversion to IPX066||0||
48550822|NCT01130493|101683054|FG002|COMPLETED|Open-label Dose Conversion to IPX066||0||
48550823|NCT01130493|101683052|FG000|NOT COMPLETED|Open-label Dose Conversion to IPX066||19||
48550824|NCT01130493|101683053|FG001|NOT COMPLETED|Open-label Dose Conversion to IPX066||0||
48550825|NCT01130493|101683054|FG002|NOT COMPLETED|Open-label Dose Conversion to IPX066||0||
48550826|NCT01130493|101683052|FG000|STARTED|Part 1: Double-blind Treatment Period 1||0||
48550827|NCT01130493|101683053|FG001|STARTED|Part 1: Double-blind Treatment Period 1||48||
48550828|NCT01130493|101683054|FG002|STARTED|Part 1: Double-blind Treatment Period 1||43||
48550829|NCT01130493|101683052|FG000|COMPLETED|Part 1: Double-blind Treatment Period 1||0||
48550830|NCT01130493|101683053|FG001|COMPLETED|Part 1: Double-blind Treatment Period 1||46||
48550831|NCT01130493|101683054|FG002|COMPLETED|Part 1: Double-blind Treatment Period 1||43||
48550832|NCT01130493|101683052|FG000|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0||
48550833|NCT01130493|101683053|FG001|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||2||
48550834|NCT01130493|101683054|FG002|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0||
48550835|NCT01130493|101683052|FG000|STARTED|Part 1: Open-Label IPX066 Washout||0||
48550836|NCT01130493|101683053|FG001|STARTED|Part 1: Open-Label IPX066 Washout||46||
48550837|NCT01130493|101683054|FG002|STARTED|Part 1: Open-Label IPX066 Washout||43||
48550838|NCT01130493|101683052|FG000|COMPLETED|Part 1: Open-Label IPX066 Washout||0||
48550839|NCT01130493|101683053|FG001|COMPLETED|Part 1: Open-Label IPX066 Washout||45||
48550840|NCT01130493|101683054|FG002|COMPLETED|Part 1: Open-Label IPX066 Washout||41||
48550841|NCT01130493|101683052|FG000|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||0||
48104370|NCT04475588|100582915|FG001|NOT COMPLETED|Overall Study||0||
48104371|NCT02046148|100582916|FG000|STARTED|Overall Study||49||
48104372|NCT02046148|100582917|FG001|STARTED|Overall Study||26||
48550842|NCT01130493|101683053|FG001|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||1||
48104373|NCT02046148|100582916|FG000|COMPLETED|Overall Study||48||
48550843|NCT01130493|101683054|FG002|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||2||
48550844|NCT01130493|101683052|FG000|STARTED|Part 1: Double-blind Treatment Period 2||0||
48550845|NCT01130493|101683053|FG001|STARTED|Part 1: Double-blind Treatment Period 2||45||
48550846|NCT01130493|101683054|FG002|STARTED|Part 1: Double-blind Treatment Period 2||41||
48550847|NCT01130493|101683052|FG000|COMPLETED|Part 1: Double-blind Treatment Period 2||0||
48550848|NCT01130493|101683053|FG001|COMPLETED|Part 1: Double-blind Treatment Period 2||45||
48550849|NCT01130493|101683054|FG002|COMPLETED|Part 1: Double-blind Treatment Period 2||39||
48550850|NCT01130493|101683052|FG000|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0||
48550851|NCT01130493|101683053|FG001|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0||
48691874|NCT02147197|102029038|FG002|NOT COMPLETED|Overall Study||9||
48691875|NCT02933879|102029039|FG000|STARTED|Overall Study||64||
48691876|NCT02933879|102029040|FG001|STARTED|Overall Study||62||
48691877|NCT02933879|102029041|FG002|STARTED|Overall Study||58||
48104374|NCT02046148|100582917|FG001|COMPLETED|Overall Study||23||
48550852|NCT01130493|101683054|FG002|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||2||
48550853|NCT01130493|101683052|FG000|STARTED|Part 2: OLE||0|10 subjects did not roll over to Part 2 (OLE) as it was optional. Reasons were not collected.|
48550854|NCT01130493|101683053|FG001|STARTED|Part 2: OLE||39|10 subjects did not roll over to Part 2 (OLE) as it was optional. Reasons were not collected.|
48550855|NCT01130493|101683054|FG002|STARTED|Part 2: OLE||35|10 subjects did not roll over to Part 2 (OLE) as it was optional. Reasons were not collected.|
48550856|NCT01130493|101683052|FG000|COMPLETED|Part 2: OLE||0||
48550857|NCT01130493|101683053|FG001|COMPLETED|Part 2: OLE||36||
48550858|NCT01130493|101683054|FG002|COMPLETED|Part 2: OLE||30||
48550859|NCT01130493|101683052|FG000|NOT COMPLETED|Part 2: OLE||0||
48550860|NCT01130493|101683053|FG001|NOT COMPLETED|Part 2: OLE||3||
48550861|NCT01130493|101683054|FG002|NOT COMPLETED|Part 2: OLE||5||
48550862|NCT02463773|101683055|FG000|STARTED|Overall Study||14||
48550863|NCT02463773|101683055|FG000|COMPLETED|Overall Study||14||
48550864|NCT02463773|101683055|FG000|NOT COMPLETED|Overall Study||0||
48550865|NCT01821807|101683056|FG000|STARTED|Overall Study||150||
48550866|NCT01821807|101683057|FG001|STARTED|Overall Study||110||
48550867|NCT01821807|101683056|FG000|COMPLETED|Overall Study||147||
48550868|NCT01821807|101683057|FG001|COMPLETED|Overall Study||109||
48691878|NCT02933879|102029039|FG000|COMPLETED|Overall Study||48||
48104375|NCT02046148|100582916|FG000|NOT COMPLETED|Overall Study||1||
48104376|NCT02046148|100582917|FG001|NOT COMPLETED|Overall Study||3||
48104377|NCT02113956|100582918|FG000|STARTED|Intervention End (5 Weeks Post Baseline)||150||
48104378|NCT02113956|100582919|FG001|STARTED|Intervention End (5 Weeks Post Baseline)||152||
48104379|NCT02113956|100582918|FG000|COMPLETED|Intervention End (5 Weeks Post Baseline)||141||
48266027|NCT05262751|100975366|FG005|STARTED|Treatment Period 1||4||
48266028|NCT05262751|100975361|FG000|COMPLETED|Treatment Period 1||3||
48266029|NCT05262751|100975362|FG001|COMPLETED|Treatment Period 1||2||
48266030|NCT05262751|100975363|FG002|COMPLETED|Treatment Period 1||2||
48266031|NCT05262751|100975364|FG003|COMPLETED|Treatment Period 1||5||
48266032|NCT05262751|100975365|FG004|COMPLETED|Treatment Period 1||5||
48266033|NCT05262751|100975366|FG005|COMPLETED|Treatment Period 1||4||
48266034|NCT05262751|100975361|FG000|NOT COMPLETED|Treatment Period 1||0||
48266035|NCT05262751|100975362|FG001|NOT COMPLETED|Treatment Period 1||0||
48266036|NCT05262751|100975363|FG002|NOT COMPLETED|Treatment Period 1||0||
48266037|NCT05262751|100975364|FG003|NOT COMPLETED|Treatment Period 1||0||
48266038|NCT05262751|100975365|FG004|NOT COMPLETED|Treatment Period 1||0||
48266039|NCT05262751|100975366|FG005|NOT COMPLETED|Treatment Period 1||0||
48266040|NCT05262751|100975361|FG000|STARTED|Washout Period 1||3||
48266041|NCT05262751|100975362|FG001|STARTED|Washout Period 1||2||
48266042|NCT05262751|100975363|FG002|STARTED|Washout Period 1||2||
48266043|NCT05262751|100975364|FG003|STARTED|Washout Period 1||5||
48266044|NCT05262751|100975365|FG004|STARTED|Washout Period 1||5||
48266045|NCT05262751|100975366|FG005|STARTED|Washout Period 1||4||
48550869|NCT01821807|101683056|FG000|NOT COMPLETED|Overall Study||3||
48550870|NCT01821807|101683057|FG001|NOT COMPLETED|Overall Study||1||
48550871|NCT04289363|101683058|FG000|STARTED|Overall Study||53||
48550872|NCT04289363|101683059|FG001|STARTED|Overall Study||1489||
48550873|NCT04289363|101683058|FG000|COMPLETED|Overall Study||39||
48550874|NCT04289363|101683059|FG001|COMPLETED|Overall Study||1489||
48550875|NCT04289363|101683058|FG000|NOT COMPLETED|Overall Study||14||
48550876|NCT04289363|101683059|FG001|NOT COMPLETED|Overall Study||0||
48550877|NCT03624192|101683060|FG000|STARTED|Overall Study||3||3
48550878|NCT03624192|101683061|FG001|STARTED|Overall Study||3||3
48550879|NCT03624192|101683060|FG000|COMPLETED|Overall Study||2||2
48550880|NCT03624192|101683061|FG001|COMPLETED|Overall Study||2||2
48550881|NCT03624192|101683060|FG000|NOT COMPLETED|Overall Study||1||1
48550882|NCT03624192|101683061|FG001|NOT COMPLETED|Overall Study||1||1
48550883|NCT01056289|101683062|FG000|STARTED|Open-label Phase||480||
48550884|NCT01056289|101683063|FG001|STARTED|Open-label Phase||0||
48550885|NCT01056289|101683064|FG002|STARTED|Open-label Phase||0||
48550886|NCT01056289|101683065|FG003|STARTED|Open-label Phase||0||
48550887|NCT01056289|101683062|FG000|COMPLETED|Open-label Phase||361||
48550888|NCT01056289|101683063|FG001|COMPLETED|Open-label Phase||0||
48550889|NCT01056289|101683064|FG002|COMPLETED|Open-label Phase||0||
48266046|NCT05262751|100975361|FG000|COMPLETED|Washout Period 1||3||
48266047|NCT05262751|100975362|FG001|COMPLETED|Washout Period 1||2||
48266048|NCT05262751|100975363|FG002|COMPLETED|Washout Period 1||2||
48266049|NCT05262751|100975364|FG003|COMPLETED|Washout Period 1||5||
48266050|NCT05262751|100975365|FG004|COMPLETED|Washout Period 1||5||
48266051|NCT05262751|100975366|FG005|COMPLETED|Washout Period 1||4||
48391778|NCT01742078|101287730|FG003|COMPLETED|Overall Study||5||
48391779|NCT01742078|101287731|FG004|COMPLETED|Overall Study||6||
48391780|NCT01742078|101287732|FG005|COMPLETED|Overall Study||6||
48391781|NCT01742078|101287733|FG006|COMPLETED|Overall Study||6||
48391782|NCT01742078|101287734|FG007|COMPLETED|Overall Study||6||
48550890|NCT01056289|101683065|FG003|COMPLETED|Open-label Phase||0||
48550891|NCT01056289|101683062|FG000|NOT COMPLETED|Open-label Phase||119||
48550892|NCT01056289|101683063|FG001|NOT COMPLETED|Open-label Phase||0||
48550893|NCT01056289|101683064|FG002|NOT COMPLETED|Open-label Phase||0||
48550894|NCT01056289|101683065|FG003|NOT COMPLETED|Open-label Phase||0||
48550895|NCT01056289|101683062|FG000|STARTED|Double-blind Phase||0||
48550896|NCT01056289|101683063|FG001|STARTED|Double-blind Phase||73||
48550897|NCT01056289|101683064|FG002|STARTED|Double-blind Phase||140||
48550898|NCT01056289|101683065|FG003|STARTED|Double-blind Phase||148||
48550899|NCT01056289|101683062|FG000|COMPLETED|Double-blind Phase||0||
48550900|NCT01056289|101683063|FG001|COMPLETED|Double-blind Phase||69||
48550901|NCT01056289|101683064|FG002|COMPLETED|Double-blind Phase||127||
48550902|NCT01056289|101683065|FG003|COMPLETED|Double-blind Phase||138||
48550903|NCT01056289|101683062|FG000|NOT COMPLETED|Double-blind Phase||0||
48550904|NCT01056289|101683063|FG001|NOT COMPLETED|Double-blind Phase||4||
48550905|NCT01056289|101683064|FG002|NOT COMPLETED|Double-blind Phase||13||
48550906|NCT01056289|101683065|FG003|NOT COMPLETED|Double-blind Phase||10||
48550907|NCT04536376|101683066|FG000|STARTED|Overall Study||10||
48550908|NCT04536376|101683066|FG000|COMPLETED|Overall Study||10||
48550909|NCT04536376|101683066|FG000|NOT COMPLETED|Overall Study||0||
48550910|NCT00550459|101683067|FG000|STARTED|Overall Study||28||
48391783|NCT01742078|101287735|FG008|COMPLETED|Overall Study||12||
48391784|NCT01742078|101287727|FG000|NOT COMPLETED|Overall Study||0||
48391785|NCT01742078|101287728|FG001|NOT COMPLETED|Overall Study||0||
48391786|NCT01742078|101287729|FG002|NOT COMPLETED|Overall Study||0||
48266052|NCT05262751|100975361|FG000|NOT COMPLETED|Washout Period 1||0||
48266053|NCT05262751|100975362|FG001|NOT COMPLETED|Washout Period 1||0||
48266054|NCT05262751|100975363|FG002|NOT COMPLETED|Washout Period 1||0||
48266055|NCT05262751|100975364|FG003|NOT COMPLETED|Washout Period 1||0||
48266056|NCT05262751|100975365|FG004|NOT COMPLETED|Washout Period 1||0||
48550911|NCT00550459|101683068|FG001|STARTED|Overall Study||29||
48550912|NCT00550459|101683067|FG000|COMPLETED|Overall Study||27||
48550913|NCT00550459|101683068|FG001|COMPLETED|Overall Study||26||
48550914|NCT00550459|101683067|FG000|NOT COMPLETED|Overall Study||1||
48550915|NCT00550459|101683068|FG001|NOT COMPLETED|Overall Study||3||
48550916|NCT00403585|101683069|FG000|STARTED|Initial Treatment Phase||104||
48550917|NCT00403585|101683069|FG000|COMPLETED|Initial Treatment Phase||102||
48550918|NCT00403585|101683069|FG000|NOT COMPLETED|Initial Treatment Phase||2||
48550919|NCT00403585|101683069|FG000|STARTED|Open-Label Phase; Extension Study||80||
48550920|NCT00403585|101683069|FG000|COMPLETED|Open-Label Phase; Extension Study||74||
48550921|NCT00403585|101683069|FG000|NOT COMPLETED|Open-Label Phase; Extension Study||6||
48550922|NCT01371747|101683070|FG000|STARTED|Overall Study||74||
48550923|NCT01371747|101683071|FG001|STARTED|Overall Study||74||
48550924|NCT01371747|101683072|FG002|STARTED|Overall Study||74||
48550925|NCT01371747|101683073|FG003|STARTED|Overall Study||26||
48691879|NCT02933879|102029040|FG001|COMPLETED|Overall Study||48||
48550926|NCT01371747|101683074|FG004|STARTED|Overall Study||28||
48550927|NCT01371747|101683075|FG005|STARTED|Overall Study||30||
48550928|NCT01371747|101683070|FG000|COMPLETED|Overall Study||56||
48550929|NCT01371747|101683071|FG001|COMPLETED|Overall Study||51||
48550930|NCT01371747|101683072|FG002|COMPLETED|Overall Study||50||
48550931|NCT01371747|101683073|FG003|COMPLETED|Overall Study||17||
48550932|NCT01371747|101683074|FG004|COMPLETED|Overall Study||21||
48550933|NCT01371747|101683075|FG005|COMPLETED|Overall Study||16||
48550934|NCT01371747|101683070|FG000|NOT COMPLETED|Overall Study||18||
48550935|NCT01371747|101683071|FG001|NOT COMPLETED|Overall Study||23||
48550936|NCT01371747|101683072|FG002|NOT COMPLETED|Overall Study||24||
48550937|NCT01371747|101683073|FG003|NOT COMPLETED|Overall Study||9||
48550938|NCT01371747|101683074|FG004|NOT COMPLETED|Overall Study||7||
48550939|NCT01371747|101683075|FG005|NOT COMPLETED|Overall Study||14||
48550940|NCT00261950|101683076|FG000|STARTED|Overall Study||110||
48550941|NCT00261950|101683076|FG000|COMPLETED|Overall Study||84||
48550942|NCT00261950|101683076|FG000|NOT COMPLETED|Overall Study||26||
48550943|NCT04237272|101683077|FG000|STARTED|Overall Study||13||
48550944|NCT04237272|101683078|FG001|STARTED|Overall Study||12||
48550945|NCT04237272|101683079|FG002|STARTED|Overall Study||6||
48550946|NCT04237272|101683077|FG000|COMPLETED|Overall Study||13||
48550947|NCT04237272|101683078|FG001|COMPLETED|Overall Study||10||
48550948|NCT04237272|101683079|FG002|COMPLETED|Overall Study||3||
48550949|NCT04237272|101683077|FG000|NOT COMPLETED|Overall Study||0||
48550950|NCT04237272|101683078|FG001|NOT COMPLETED|Overall Study||2||
48550951|NCT04237272|101683079|FG002|NOT COMPLETED|Overall Study||3||
48550952|NCT02892149|101683080|FG000|STARTED|Overall Study||1777||
48550953|NCT02892149|101683081|FG001|STARTED|Overall Study||1777||
48550954|NCT02892149|101683080|FG000|COMPLETED|Overall Study||1425||
48550955|NCT02892149|101683081|FG001|COMPLETED|Overall Study||1421||
48550956|NCT02892149|101683080|FG000|NOT COMPLETED|Overall Study||352||
48550957|NCT02892149|101683081|FG001|NOT COMPLETED|Overall Study||356||
48550958|NCT00524420|101683082|FG000|STARTED|Overall Study||8||
48550959|NCT00524420|101683083|FG001|STARTED|Overall Study||11||
48550960|NCT00524420|101683082|FG000|COMPLETED|Overall Study||7||
48550961|NCT00524420|101683083|FG001|COMPLETED|Overall Study||11||
48550962|NCT00524420|101683082|FG000|NOT COMPLETED|Overall Study||1||
48550963|NCT00524420|101683083|FG001|NOT COMPLETED|Overall Study||0||
48550964|NCT02756208|101683084|FG000|STARTED|Overall Study||18||
48550965|NCT02756208|101683085|FG001|STARTED|Overall Study||16||
48550966|NCT02756208|101683086|FG002|STARTED|Overall Study||15||
48550967|NCT02756208|101683087|FG003|STARTED|Overall Study||16||
48550968|NCT02756208|101683084|FG000|COMPLETED|Overall Study||13||
48550969|NCT02756208|101683085|FG001|COMPLETED|Overall Study||14||
48550970|NCT02756208|101683086|FG002|COMPLETED|Overall Study||13||
48550971|NCT02756208|101683087|FG003|COMPLETED|Overall Study||12||
48550972|NCT02756208|101683084|FG000|NOT COMPLETED|Overall Study||5||
48550973|NCT02756208|101683085|FG001|NOT COMPLETED|Overall Study||2||
48550974|NCT02756208|101683086|FG002|NOT COMPLETED|Overall Study||2||
48550975|NCT02756208|101683087|FG003|NOT COMPLETED|Overall Study||4||
48550976|NCT01232452|101683088|FG000|STARTED|Overall Study||87||
48550977|NCT01232452|101683089|FG001|STARTED|Overall Study||85||
48550978|NCT01232452|101683088|FG000|Received at Least One Dose of Study Drug|Overall Study||85||
48550979|NCT01232452|101683089|FG001|Received at Least One Dose of Study Drug|Overall Study||81||
48550980|NCT01232452|101683088|FG000|COMPLETED|Overall Study||48||
48550981|NCT01232452|101683089|FG001|COMPLETED|Overall Study||46||
48550982|NCT01232452|101683088|FG000|NOT COMPLETED|Overall Study||39||
48550983|NCT01232452|101683089|FG001|NOT COMPLETED|Overall Study||39||
48550984|NCT00196326|101683090|FG000|STARTED|Overall Study||2235||
48550985|NCT00196326|101683090|FG000|Safety Population|Overall Study||2185||
48550986|NCT00196326|101683090|FG000|Pregnancy Intent-to-treat Cohort (PITT)|Overall Study||1735||
48550987|NCT00196326|101683090|FG000|COMPLETED|Overall Study||1249||
48550988|NCT00196326|101683090|FG000|NOT COMPLETED|Overall Study||986||
48550989|NCT01085760|101683091|FG000|STARTED|Overall Study||8||
48550990|NCT01085760|101683092|FG001|STARTED|Overall Study||9||
48550991|NCT01085760|101683093|FG002|STARTED|Overall Study||9||
48550992|NCT01085760|101683094|FG003|STARTED|Overall Study||9||
48550993|NCT01085760|101683091|FG000|COMPLETED|Overall Study||7||
48550994|NCT01085760|101683092|FG001|COMPLETED|Overall Study||8||
48550995|NCT01085760|101683093|FG002|COMPLETED|Overall Study||7||
48550996|NCT01085760|101683094|FG003|COMPLETED|Overall Study||6||
48550997|NCT01085760|101683091|FG000|NOT COMPLETED|Overall Study||1||
48550998|NCT01085760|101683092|FG001|NOT COMPLETED|Overall Study||1||
48550999|NCT01085760|101683093|FG002|NOT COMPLETED|Overall Study||2||
48551000|NCT01085760|101683094|FG003|NOT COMPLETED|Overall Study||3||
48551001|NCT03593395|101683095|FG000|STARTED|Overall Study||196||7
48551002|NCT03593395|101683096|FG001|STARTED|Overall Study||95||7
48551003|NCT03593395|101683095|FG000|COMPLETED|Overall Study||121||7
48551004|NCT03593395|101683096|FG001|COMPLETED|Overall Study||49||7
48551005|NCT03593395|101683095|FG000|NOT COMPLETED|Overall Study||75||0
48551006|NCT03593395|101683096|FG001|NOT COMPLETED|Overall Study||46||0
48551007|NCT00919126|101683097|FG000|STARTED|Overall Study||32||
48551008|NCT00919126|101683098|FG001|STARTED|Overall Study||37||
48551009|NCT00919126|101683099|FG002|STARTED|Overall Study||33||
48551010|NCT00919126|101683097|FG000|COMPLETED|Overall Study||31||
48551011|NCT00919126|101683098|FG001|COMPLETED|Overall Study||32||
48551012|NCT00919126|101683099|FG002|COMPLETED|Overall Study||32||
48551013|NCT00919126|101683097|FG000|NOT COMPLETED|Overall Study||1||
48551014|NCT00919126|101683098|FG001|NOT COMPLETED|Overall Study||5||
48551015|NCT00919126|101683099|FG002|NOT COMPLETED|Overall Study||1||
48551016|NCT01597778|101683100|FG000|STARTED|Overall Study||186||
48551017|NCT01597778|101683101|FG001|STARTED|Overall Study||182||
48551018|NCT01597778|101683100|FG000|COMPLETED|Overall Study||172||
48551019|NCT01597778|101683101|FG001|COMPLETED|Overall Study||153||
48551020|NCT01597778|101683100|FG000|NOT COMPLETED|Overall Study||14||
48551021|NCT01597778|101683101|FG001|NOT COMPLETED|Overall Study||29||
48551022|NCT00111241|101683102|FG000|STARTED|Overall Study||45||
48551023|NCT00111241|101683103|FG001|STARTED|Overall Study||70||
48551024|NCT00111241|101683102|FG000|COMPLETED|Overall Study||30||
48551025|NCT00111241|101683103|FG001|COMPLETED|Overall Study||62||
48551026|NCT00111241|101683102|FG000|NOT COMPLETED|Overall Study||15||
48551027|NCT00111241|101683103|FG001|NOT COMPLETED|Overall Study||8||
48551028|NCT01778634|101683104|FG000|STARTED|Overall Study||61||
48551029|NCT01778634|101683105|FG001|STARTED|Overall Study||60||
48551030|NCT01778634|101683104|FG000|COMPLETED|Overall Study||61||
48551031|NCT01778634|101683105|FG001|COMPLETED|Overall Study||60||
48551032|NCT01778634|101683104|FG000|NOT COMPLETED|Overall Study||0||
48551033|NCT01778634|101683105|FG001|NOT COMPLETED|Overall Study||0||
48551034|NCT03897634|101683106|FG000|STARTED|Overall Study||22||
48551035|NCT03897634|101683106|FG000|COMPLETED|Overall Study||22||
48551036|NCT03897634|101683106|FG000|NOT COMPLETED|Overall Study||0||
48551037|NCT02010645|101683107|FG000|STARTED|Overall Study||6||
48551038|NCT02010645|101683107|FG000|COMPLETED|Overall Study||6||
48551039|NCT02010645|101683107|FG000|NOT COMPLETED|Overall Study||0||
48551040|NCT01023035|101683108|FG000|STARTED|Treatment Period||249||
48551041|NCT01023035|101683109|FG001|STARTED|Treatment Period||251||
48551042|NCT01023035|101683110|FG002|STARTED|Treatment Period||187||
48551043|NCT01023035|101683108|FG000|COMPLETED|Treatment Period||177||
48551044|NCT01023035|101683109|FG001|COMPLETED|Treatment Period||166||
48551045|NCT01023035|101683110|FG002|COMPLETED|Treatment Period||69||
48551046|NCT01023035|101683108|FG000|NOT COMPLETED|Treatment Period||72||
48551047|NCT01023035|101683109|FG001|NOT COMPLETED|Treatment Period||85||
48551048|NCT01023035|101683110|FG002|NOT COMPLETED|Treatment Period||118||
48551049|NCT01023035|101683108|FG000|STARTED|Follow-up Period (up to Week 72)||238||
48551050|NCT01023035|101683109|FG001|STARTED|Follow-up Period (up to Week 72)||235||
48551051|NCT01023035|101683110|FG002|STARTED|Follow-up Period (up to Week 72)||147||
48551052|NCT01023035|101683108|FG000|COMPLETED|Follow-up Period (up to Week 72)||210||
48551053|NCT01023035|101683109|FG001|COMPLETED|Follow-up Period (up to Week 72)||207||
48551054|NCT01023035|101683110|FG002|COMPLETED|Follow-up Period (up to Week 72)||108||
48551055|NCT01023035|101683108|FG000|NOT COMPLETED|Follow-up Period (up to Week 72)||28||
48551056|NCT01023035|101683109|FG001|NOT COMPLETED|Follow-up Period (up to Week 72)||28||
48551057|NCT01023035|101683110|FG002|NOT COMPLETED|Follow-up Period (up to Week 72)||39||
48551058|NCT03567980|101683111|FG000|STARTED|Overall Study||30||
48551059|NCT03567980|101683111|FG000|COMPLETED|Overall Study||29||
48551060|NCT03567980|101683111|FG000|NOT COMPLETED|Overall Study||1||
48551061|NCT01757275|101683112|FG000|STARTED|Overall Study||111||
48551062|NCT01757275|101683113|FG001|STARTED|Overall Study||111||
48551063|NCT01757275|101683112|FG000|COMPLETED|Overall Study||102||
48551064|NCT01757275|101683113|FG001|COMPLETED|Overall Study||98||
48551065|NCT01757275|101683112|FG000|NOT COMPLETED|Overall Study||9||
48551066|NCT01757275|101683113|FG001|NOT COMPLETED|Overall Study||13||
48551067|NCT01739699|101683114|FG000|STARTED|Overall Study||70||
48551068|NCT01739699|101683115|FG001|STARTED|Overall Study||70||
48551069|NCT01739699|101683114|FG000|COMPLETED|Overall Study||66||
48551070|NCT01739699|101683115|FG001|COMPLETED|Overall Study||65||
48551071|NCT01739699|101683114|FG000|NOT COMPLETED|Overall Study||4||
48551072|NCT01739699|101683115|FG001|NOT COMPLETED|Overall Study||5||
48551073|NCT00770328|101683116|FG000|STARTED|Overall Study||22||
48551074|NCT00770328|101683117|FG001|STARTED|Overall Study||15||
48551075|NCT00770328|101683116|FG000|COMPLETED|Overall Study||9||
48551076|NCT00770328|101683117|FG001|COMPLETED|Overall Study||11||
48551077|NCT00770328|101683116|FG000|NOT COMPLETED|Overall Study||13||
48551078|NCT00770328|101683117|FG001|NOT COMPLETED|Overall Study||4||
48551079|NCT00356525|101683118|FG000|STARTED|Overall Study||14||
48691880|NCT02933879|102029041|FG002|COMPLETED|Overall Study||41||
48691881|NCT02933879|102029039|FG000|NOT COMPLETED|Overall Study||16||
48691882|NCT02933879|102029040|FG001|NOT COMPLETED|Overall Study||14||
48551080|NCT00356525|101683119|FG001|STARTED|Overall Study||11||
48551081|NCT00356525|101683120|FG002|STARTED|Overall Study||7||
48551082|NCT00356525|101683121|FG003|STARTED|Overall Study||9||
48551083|NCT00356525|101683118|FG000|COMPLETED|Overall Study||0||
48551084|NCT00356525|101683119|FG001|COMPLETED|Overall Study||0||
48551085|NCT00356525|101683120|FG002|COMPLETED|Overall Study||0||
48551086|NCT00356525|101683121|FG003|COMPLETED|Overall Study||0||
48551087|NCT00356525|101683118|FG000|NOT COMPLETED|Overall Study||14||
48551088|NCT00356525|101683119|FG001|NOT COMPLETED|Overall Study||11||
48551089|NCT00356525|101683120|FG002|NOT COMPLETED|Overall Study||7||
48551090|NCT00356525|101683121|FG003|NOT COMPLETED|Overall Study||9||
48551091|NCT02766335|101683122|FG000|STARTED|Initial Registration||68||
48551092|NCT02766335|101683123|FG001|STARTED|Initial Registration||30||
48551093|NCT02766335|101683124|FG002|STARTED|Initial Registration||0||
48551094|NCT02766335|101683122|FG000|Eligible Participants Enrolled Before Docetaxel Arm Closed|Initial Registration||32||
48551095|NCT02766335|101683123|FG001|Eligible Participants Enrolled Before Docetaxel Arm Closed|Initial Registration||30||
48551096|NCT02766335|101683124|FG002|Eligible Participants Enrolled Before Docetaxel Arm Closed|Initial Registration||0||
48551097|NCT02766335|101683122|FG000|COMPLETED|Initial Registration||10||
48551098|NCT02766335|101683123|FG001|COMPLETED|Initial Registration||0||
48551099|NCT02766335|101683124|FG002|COMPLETED|Initial Registration||0||
48551100|NCT02766335|101683122|FG000|NOT COMPLETED|Initial Registration||58||
48551101|NCT02766335|101683123|FG001|NOT COMPLETED|Initial Registration||30||
48551102|NCT02766335|101683124|FG002|NOT COMPLETED|Initial Registration||0||
48551103|NCT02766335|101683122|FG000|STARTED|Re-registration of Arm I to MEDI4738||0||
48551104|NCT02766335|101683123|FG001|STARTED|Re-registration of Arm I to MEDI4738||0||
48551105|NCT02766335|101683124|FG002|STARTED|Re-registration of Arm I to MEDI4738||4||
48551106|NCT02766335|101683122|FG000|COMPLETED|Re-registration of Arm I to MEDI4738||0||
48551107|NCT02766335|101683123|FG001|COMPLETED|Re-registration of Arm I to MEDI4738||0||
48551108|NCT02766335|101683124|FG002|COMPLETED|Re-registration of Arm I to MEDI4738||2||
48551109|NCT02766335|101683122|FG000|NOT COMPLETED|Re-registration of Arm I to MEDI4738||0||
48551110|NCT02766335|101683123|FG001|NOT COMPLETED|Re-registration of Arm I to MEDI4738||0||
48551111|NCT02766335|101683124|FG002|NOT COMPLETED|Re-registration of Arm I to MEDI4738||2||
48551112|NCT02443740|101683125|FG000|STARTED|Intervention Period 1 (3 Days)||2||
48551113|NCT02443740|101683126|FG001|STARTED|Intervention Period 1 (3 Days)||2||
48551114|NCT02443740|101683127|FG002|STARTED|Intervention Period 1 (3 Days)||2||
48551115|NCT02443740|101683128|FG003|STARTED|Intervention Period 1 (3 Days)||3||
48551116|NCT02443740|101683129|FG004|STARTED|Intervention Period 1 (3 Days)||2||
48551117|NCT02443740|101683130|FG005|STARTED|Intervention Period 1 (3 Days)||4||
48551118|NCT02443740|101683131|FG006|STARTED|Intervention Period 1 (3 Days)||3||
48551119|NCT02443740|101683132|FG007|STARTED|Intervention Period 1 (3 Days)||2||
48551120|NCT02443740|101683133|FG008|STARTED|Intervention Period 1 (3 Days)||6||
48551121|NCT02443740|101683134|FG009|STARTED|Intervention Period 1 (3 Days)||3||
48551122|NCT02443740|101683135|FG010|STARTED|Intervention Period 1 (3 Days)||3||
48551123|NCT02443740|101683125|FG000|COMPLETED|Intervention Period 1 (3 Days)||1||
48551124|NCT02443740|101683126|FG001|COMPLETED|Intervention Period 1 (3 Days)||2||
48551125|NCT02443740|101683127|FG002|COMPLETED|Intervention Period 1 (3 Days)||2||
48551126|NCT02443740|101683128|FG003|COMPLETED|Intervention Period 1 (3 Days)||3||
48551127|NCT02443740|101683129|FG004|COMPLETED|Intervention Period 1 (3 Days)||2||
48551128|NCT02443740|101683130|FG005|COMPLETED|Intervention Period 1 (3 Days)||2||
48551129|NCT02443740|101683131|FG006|COMPLETED|Intervention Period 1 (3 Days)||2||
48551130|NCT02443740|101683132|FG007|COMPLETED|Intervention Period 1 (3 Days)||2||
48551131|NCT02443740|101683133|FG008|COMPLETED|Intervention Period 1 (3 Days)||6||
48551132|NCT02443740|101683134|FG009|COMPLETED|Intervention Period 1 (3 Days)||3||
48551133|NCT02443740|101683135|FG010|COMPLETED|Intervention Period 1 (3 Days)||3||
48551134|NCT02443740|101683125|FG000|NOT COMPLETED|Intervention Period 1 (3 Days)||1||
48551135|NCT02443740|101683126|FG001|NOT COMPLETED|Intervention Period 1 (3 Days)||0||
48551136|NCT02443740|101683127|FG002|NOT COMPLETED|Intervention Period 1 (3 Days)||0||
48551137|NCT02443740|101683128|FG003|NOT COMPLETED|Intervention Period 1 (3 Days)||0||
48551138|NCT02443740|101683129|FG004|NOT COMPLETED|Intervention Period 1 (3 Days)||0||
48551139|NCT02443740|101683130|FG005|NOT COMPLETED|Intervention Period 1 (3 Days)||2||
48551140|NCT02443740|101683131|FG006|NOT COMPLETED|Intervention Period 1 (3 Days)||1||
48551141|NCT02443740|101683132|FG007|NOT COMPLETED|Intervention Period 1 (3 Days)||0||
48551142|NCT02443740|101683133|FG008|NOT COMPLETED|Intervention Period 1 (3 Days)||0||
48551143|NCT02443740|101683134|FG009|NOT COMPLETED|Intervention Period 1 (3 Days)||0||
48551144|NCT02443740|101683135|FG010|NOT COMPLETED|Intervention Period 1 (3 Days)||0||
48551145|NCT02443740|101683125|FG000|STARTED|Washout Period 1 (7 Days)||1||
48551146|NCT02443740|101683126|FG001|STARTED|Washout Period 1 (7 Days)||2||
48551147|NCT02443740|101683127|FG002|STARTED|Washout Period 1 (7 Days)||2||
48551148|NCT02443740|101683128|FG003|STARTED|Washout Period 1 (7 Days)||3||
48551149|NCT02443740|101683129|FG004|STARTED|Washout Period 1 (7 Days)||2||
48551150|NCT02443740|101683130|FG005|STARTED|Washout Period 1 (7 Days)||2||
48551151|NCT02443740|101683131|FG006|STARTED|Washout Period 1 (7 Days)||2||
48551152|NCT02443740|101683132|FG007|STARTED|Washout Period 1 (7 Days)||2||
48551153|NCT02443740|101683133|FG008|STARTED|Washout Period 1 (7 Days)||0||
48551154|NCT02443740|101683134|FG009|STARTED|Washout Period 1 (7 Days)||3||
48551155|NCT02443740|101683135|FG010|STARTED|Washout Period 1 (7 Days)||3||
48551156|NCT02443740|101683125|FG000|COMPLETED|Washout Period 1 (7 Days)||1||
48551157|NCT02443740|101683126|FG001|COMPLETED|Washout Period 1 (7 Days)||2||
48551158|NCT02443740|101683127|FG002|COMPLETED|Washout Period 1 (7 Days)||2||
48551159|NCT02443740|101683128|FG003|COMPLETED|Washout Period 1 (7 Days)||3||
48551160|NCT02443740|101683129|FG004|COMPLETED|Washout Period 1 (7 Days)||2||
48551161|NCT02443740|101683130|FG005|COMPLETED|Washout Period 1 (7 Days)||2||
48551162|NCT02443740|101683131|FG006|COMPLETED|Washout Period 1 (7 Days)||2||
48551163|NCT02443740|101683132|FG007|COMPLETED|Washout Period 1 (7 Days)||2||
48551164|NCT02443740|101683133|FG008|COMPLETED|Washout Period 1 (7 Days)||0||
48551165|NCT02443740|101683134|FG009|COMPLETED|Washout Period 1 (7 Days)||3||
48551166|NCT02443740|101683135|FG010|COMPLETED|Washout Period 1 (7 Days)||3||
48551167|NCT02443740|101683125|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48551168|NCT02443740|101683126|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48551169|NCT02443740|101683127|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48551170|NCT02443740|101683128|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48551171|NCT02443740|101683129|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48551172|NCT02443740|101683130|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48551173|NCT02443740|101683131|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48551174|NCT02443740|101683132|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48551175|NCT02443740|101683133|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48551176|NCT02443740|101683134|FG009|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48551177|NCT02443740|101683135|FG010|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48551178|NCT02443740|101683125|FG000|STARTED|Intervention Period 2 (3 Days)||1||
48551179|NCT02443740|101683126|FG001|STARTED|Intervention Period 2 (3 Days)||2||
48551180|NCT02443740|101683127|FG002|STARTED|Intervention Period 2 (3 Days)||2||
48551181|NCT02443740|101683128|FG003|STARTED|Intervention Period 2 (3 Days)||3||
48551182|NCT02443740|101683129|FG004|STARTED|Intervention Period 2 (3 Days)||2||
48551183|NCT02443740|101683130|FG005|STARTED|Intervention Period 2 (3 Days)||2||
48551184|NCT02443740|101683131|FG006|STARTED|Intervention Period 2 (3 Days)||2||
48551185|NCT02443740|101683132|FG007|STARTED|Intervention Period 2 (3 Days)||2||
48551186|NCT02443740|101683133|FG008|STARTED|Intervention Period 2 (3 Days)||0||
48551187|NCT02443740|101683134|FG009|STARTED|Intervention Period 2 (3 Days)||3||
48551188|NCT02443740|101683135|FG010|STARTED|Intervention Period 2 (3 Days)||3||
48551189|NCT02443740|101683125|FG000|COMPLETED|Intervention Period 2 (3 Days)||1||
48551190|NCT02443740|101683126|FG001|COMPLETED|Intervention Period 2 (3 Days)||2||
48551191|NCT02443740|101683127|FG002|COMPLETED|Intervention Period 2 (3 Days)||2||
48551192|NCT02443740|101683128|FG003|COMPLETED|Intervention Period 2 (3 Days)||3||
48266057|NCT05262751|100975366|FG005|NOT COMPLETED|Washout Period 1||0||
48266058|NCT05262751|100975361|FG000|STARTED|Treatment Period 2||3||
48266059|NCT05262751|100975362|FG001|STARTED|Treatment Period 2||2||
48266060|NCT05262751|100975363|FG002|STARTED|Treatment Period 2||2||
48266061|NCT05262751|100975364|FG003|STARTED|Treatment Period 2||5||
48266062|NCT05262751|100975365|FG004|STARTED|Treatment Period 2||5||
48266063|NCT05262751|100975366|FG005|STARTED|Treatment Period 2||4||
48266064|NCT05262751|100975361|FG000|COMPLETED|Treatment Period 2||3||
48266065|NCT05262751|100975362|FG001|COMPLETED|Treatment Period 2||2||
48266066|NCT05262751|100975363|FG002|COMPLETED|Treatment Period 2||2||
48266067|NCT05262751|100975364|FG003|COMPLETED|Treatment Period 2||5||
48266068|NCT05262751|100975365|FG004|COMPLETED|Treatment Period 2||5||
48266069|NCT05262751|100975366|FG005|COMPLETED|Treatment Period 2||4||
48266070|NCT05262751|100975361|FG000|NOT COMPLETED|Treatment Period 2||0||
48266071|NCT05262751|100975362|FG001|NOT COMPLETED|Treatment Period 2||0||
48266072|NCT05262751|100975363|FG002|NOT COMPLETED|Treatment Period 2||0||
48551193|NCT02443740|101683129|FG004|COMPLETED|Intervention Period 2 (3 Days)||2||
48551194|NCT02443740|101683130|FG005|COMPLETED|Intervention Period 2 (3 Days)||2||
48551195|NCT02443740|101683131|FG006|COMPLETED|Intervention Period 2 (3 Days)||2||
48551196|NCT02443740|101683132|FG007|COMPLETED|Intervention Period 2 (3 Days)||2||
48551197|NCT02443740|101683133|FG008|COMPLETED|Intervention Period 2 (3 Days)||0||
48551198|NCT02443740|101683134|FG009|COMPLETED|Intervention Period 2 (3 Days)||3||
48551199|NCT02443740|101683135|FG010|COMPLETED|Intervention Period 2 (3 Days)||3||
48551200|NCT02443740|101683125|FG000|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
48551201|NCT02443740|101683126|FG001|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
48551202|NCT02443740|101683127|FG002|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
48551203|NCT02443740|101683128|FG003|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
48551204|NCT02443740|101683129|FG004|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
48551205|NCT02443740|101683130|FG005|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
48266073|NCT05262751|100975364|FG003|NOT COMPLETED|Treatment Period 2||0||
48266074|NCT05262751|100975365|FG004|NOT COMPLETED|Treatment Period 2||0||
48266075|NCT05262751|100975366|FG005|NOT COMPLETED|Treatment Period 2||0||
48266076|NCT05262751|100975361|FG000|STARTED|Washout Period 2||3||
48266077|NCT05262751|100975362|FG001|STARTED|Washout Period 2||2||
48266078|NCT05262751|100975363|FG002|STARTED|Washout Period 2||2||
48551206|NCT02443740|101683131|FG006|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
48551207|NCT02443740|101683132|FG007|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
48551208|NCT02443740|101683133|FG008|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
48551209|NCT02443740|101683134|FG009|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
48551210|NCT02443740|101683135|FG010|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
48551211|NCT02443740|101683125|FG000|STARTED|Washout Period 2 (7 Days)||1||
48551212|NCT02443740|101683126|FG001|STARTED|Washout Period 2 (7 Days)||2||
48551213|NCT02443740|101683127|FG002|STARTED|Washout Period 2 (7 Days)||2||
48551214|NCT02443740|101683128|FG003|STARTED|Washout Period 2 (7 Days)||3||
48551215|NCT02443740|101683129|FG004|STARTED|Washout Period 2 (7 Days)||2||
48551216|NCT02443740|101683130|FG005|STARTED|Washout Period 2 (7 Days)||2||
48551217|NCT02443740|101683131|FG006|STARTED|Washout Period 2 (7 Days)||2||
48551218|NCT02443740|101683132|FG007|STARTED|Washout Period 2 (7 Days)||2||
48551219|NCT02443740|101683133|FG008|STARTED|Washout Period 2 (7 Days)||0||
48551220|NCT02443740|101683134|FG009|STARTED|Washout Period 2 (7 Days)||0||
48551221|NCT02443740|101683135|FG010|STARTED|Washout Period 2 (7 Days)||0||
48551222|NCT02443740|101683125|FG000|COMPLETED|Washout Period 2 (7 Days)||1||
48551223|NCT02443740|101683126|FG001|COMPLETED|Washout Period 2 (7 Days)||2||
48551224|NCT02443740|101683127|FG002|COMPLETED|Washout Period 2 (7 Days)||2||
48551225|NCT02443740|101683128|FG003|COMPLETED|Washout Period 2 (7 Days)||3||
48551226|NCT02443740|101683129|FG004|COMPLETED|Washout Period 2 (7 Days)||2||
48551227|NCT02443740|101683130|FG005|COMPLETED|Washout Period 2 (7 Days)||2||
48551228|NCT02443740|101683131|FG006|COMPLETED|Washout Period 2 (7 Days)||2||
48551229|NCT02443740|101683132|FG007|COMPLETED|Washout Period 2 (7 Days)||2||
48551230|NCT02443740|101683133|FG008|COMPLETED|Washout Period 2 (7 Days)||0||
48551231|NCT02443740|101683134|FG009|COMPLETED|Washout Period 2 (7 Days)||0||
48551232|NCT02443740|101683135|FG010|COMPLETED|Washout Period 2 (7 Days)||0||
48691883|NCT02933879|102029041|FG002|NOT COMPLETED|Overall Study||17||
48691884|NCT02482298|102029042|FG000|STARTED|Overall Study||30||
48691885|NCT02482298|102029043|FG001|STARTED|Overall Study||27||
48691886|NCT02482298|102029044|FG002|STARTED|Overall Study||30||
48691887|NCT02482298|102029042|FG000|COMPLETED|Overall Study||28||
48691888|NCT02482298|102029043|FG001|COMPLETED|Overall Study||24||
48691889|NCT02482298|102029044|FG002|COMPLETED|Overall Study||27||
48691890|NCT02482298|102029042|FG000|NOT COMPLETED|Overall Study||2||
48551233|NCT02443740|101683125|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48551234|NCT02443740|101683126|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48551235|NCT02443740|101683127|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48551236|NCT02443740|101683128|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48551237|NCT02443740|101683129|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48551238|NCT02443740|101683130|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48551239|NCT02443740|101683131|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48551240|NCT02443740|101683132|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48551241|NCT02443740|101683133|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48551242|NCT02443740|101683134|FG009|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48551243|NCT02443740|101683135|FG010|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48551244|NCT02443740|101683125|FG000|STARTED|Intervention Period 3 (3 Days)||1||
48551245|NCT02443740|101683126|FG001|STARTED|Intervention Period 3 (3 Days)||2||
48551246|NCT02443740|101683127|FG002|STARTED|Intervention Period 3 (3 Days)||2||
48551247|NCT02443740|101683128|FG003|STARTED|Intervention Period 3 (3 Days)||3||
48551248|NCT02443740|101683129|FG004|STARTED|Intervention Period 3 (3 Days)||2||
48551249|NCT02443740|101683130|FG005|STARTED|Intervention Period 3 (3 Days)||2||
48551250|NCT02443740|101683131|FG006|STARTED|Intervention Period 3 (3 Days)||2||
48551251|NCT02443740|101683132|FG007|STARTED|Intervention Period 3 (3 Days)||2||
48551252|NCT02443740|101683133|FG008|STARTED|Intervention Period 3 (3 Days)||0||
48551253|NCT02443740|101683134|FG009|STARTED|Intervention Period 3 (3 Days)||0||
48551254|NCT02443740|101683135|FG010|STARTED|Intervention Period 3 (3 Days)||0||
48551255|NCT02443740|101683125|FG000|COMPLETED|Intervention Period 3 (3 Days)||1||
48551256|NCT02443740|101683126|FG001|COMPLETED|Intervention Period 3 (3 Days)||2||
48551257|NCT02443740|101683127|FG002|COMPLETED|Intervention Period 3 (3 Days)||2||
48551258|NCT02443740|101683128|FG003|COMPLETED|Intervention Period 3 (3 Days)||3||
48691891|NCT02482298|102029043|FG001|NOT COMPLETED|Overall Study||3||
48691892|NCT02482298|102029044|FG002|NOT COMPLETED|Overall Study||3||
48551259|NCT02443740|101683129|FG004|COMPLETED|Intervention Period 3 (3 Days)||2||
48551260|NCT02443740|101683130|FG005|COMPLETED|Intervention Period 3 (3 Days)||2||
48551261|NCT02443740|101683131|FG006|COMPLETED|Intervention Period 3 (3 Days)||2||
48551262|NCT02443740|101683132|FG007|COMPLETED|Intervention Period 3 (3 Days)||2||
48551263|NCT02443740|101683133|FG008|COMPLETED|Intervention Period 3 (3 Days)||0||
48551264|NCT02443740|101683134|FG009|COMPLETED|Intervention Period 3 (3 Days)||0||
48551265|NCT02443740|101683135|FG010|COMPLETED|Intervention Period 3 (3 Days)||0||
48691893|NCT01823107|102029045|FG000|STARTED|Overall Study||25||
48691894|NCT01823107|102029045|FG000|COMPLETED|Overall Study||24||
48551266|NCT02443740|101683125|FG000|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
48691895|NCT01823107|102029045|FG000|NOT COMPLETED|Overall Study||1||
48691896|NCT04852055|102029046|FG000|STARTED|Overall Study||1270||80
48691897|NCT04852055|102029047|FG001|STARTED|Overall Study||1341||80
48551267|NCT02443740|101683126|FG001|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
48551268|NCT02443740|101683127|FG002|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
48551269|NCT02443740|101683128|FG003|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
48551270|NCT02443740|101683129|FG004|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
48551271|NCT02443740|101683130|FG005|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
48551272|NCT02443740|101683131|FG006|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
48551273|NCT02443740|101683132|FG007|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
48551274|NCT02443740|101683133|FG008|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
48551275|NCT02443740|101683134|FG009|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
48551276|NCT02443740|101683135|FG010|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
48551277|NCT02443740|101683125|FG000|STARTED|Washout Period 3 (7 Days)||1||
48551278|NCT02443740|101683126|FG001|STARTED|Washout Period 3 (7 Days)||2||
48551279|NCT02443740|101683127|FG002|STARTED|Washout Period 3 (7 Days)||2||
48551280|NCT02443740|101683128|FG003|STARTED|Washout Period 3 (7 Days)||3||
48551281|NCT02443740|101683129|FG004|STARTED|Washout Period 3 (7 Days)||2||
48551282|NCT02443740|101683130|FG005|STARTED|Washout Period 3 (7 Days)||2||
48551283|NCT02443740|101683131|FG006|STARTED|Washout Period 3 (7 Days)||2||
48551284|NCT02443740|101683132|FG007|STARTED|Washout Period 3 (7 Days)||2||
48551285|NCT02443740|101683133|FG008|STARTED|Washout Period 3 (7 Days)||0||
48551286|NCT02443740|101683134|FG009|STARTED|Washout Period 3 (7 Days)||0||
48551287|NCT02443740|101683135|FG010|STARTED|Washout Period 3 (7 Days)||0||
48551288|NCT02443740|101683125|FG000|COMPLETED|Washout Period 3 (7 Days)||1||
48551289|NCT02443740|101683126|FG001|COMPLETED|Washout Period 3 (7 Days)||2||
48551290|NCT02443740|101683127|FG002|COMPLETED|Washout Period 3 (7 Days)||2||
48551291|NCT02443740|101683128|FG003|COMPLETED|Washout Period 3 (7 Days)||3||
48266079|NCT05262751|100975364|FG003|STARTED|Washout Period 2||5||
48551292|NCT02443740|101683129|FG004|COMPLETED|Washout Period 3 (7 Days)||2||
48551293|NCT02443740|101683130|FG005|COMPLETED|Washout Period 3 (7 Days)||2||
48551294|NCT02443740|101683131|FG006|COMPLETED|Washout Period 3 (7 Days)||2||
48551295|NCT02443740|101683132|FG007|COMPLETED|Washout Period 3 (7 Days)||2||
48551296|NCT02443740|101683133|FG008|COMPLETED|Washout Period 3 (7 Days)||0||
48551297|NCT02443740|101683134|FG009|COMPLETED|Washout Period 3 (7 Days)||0||
48551298|NCT02443740|101683135|FG010|COMPLETED|Washout Period 3 (7 Days)||0||
48551299|NCT02443740|101683125|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48551300|NCT02443740|101683126|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48551301|NCT02443740|101683127|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48551302|NCT02443740|101683128|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48551303|NCT02443740|101683129|FG004|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48551304|NCT02443740|101683130|FG005|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48391787|NCT01742078|101287730|FG003|NOT COMPLETED|Overall Study||1||
48551305|NCT02443740|101683131|FG006|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48551306|NCT02443740|101683132|FG007|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48551307|NCT02443740|101683133|FG008|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48551308|NCT02443740|101683134|FG009|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48551309|NCT02443740|101683135|FG010|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48551310|NCT02443740|101683125|FG000|STARTED|Intervention Period 4 (3 Days)||1||
48551311|NCT02443740|101683126|FG001|STARTED|Intervention Period 4 (3 Days)||2||
48551312|NCT02443740|101683127|FG002|STARTED|Intervention Period 4 (3 Days)||2||
48551313|NCT02443740|101683128|FG003|STARTED|Intervention Period 4 (3 Days)||3||
48551314|NCT02443740|101683129|FG004|STARTED|Intervention Period 4 (3 Days)||2||
48551315|NCT02443740|101683130|FG005|STARTED|Intervention Period 4 (3 Days)||2||
48551316|NCT02443740|101683131|FG006|STARTED|Intervention Period 4 (3 Days)||2||
48551317|NCT02443740|101683132|FG007|STARTED|Intervention Period 4 (3 Days)||2||
48551318|NCT02443740|101683133|FG008|STARTED|Intervention Period 4 (3 Days)||0||
48551319|NCT02443740|101683134|FG009|STARTED|Intervention Period 4 (3 Days)||0||
48551320|NCT02443740|101683135|FG010|STARTED|Intervention Period 4 (3 Days)||0||
48551321|NCT02443740|101683125|FG000|COMPLETED|Intervention Period 4 (3 Days)||1||
48551322|NCT02443740|101683126|FG001|COMPLETED|Intervention Period 4 (3 Days)||2||
48551323|NCT02443740|101683127|FG002|COMPLETED|Intervention Period 4 (3 Days)||2||
48551324|NCT02443740|101683128|FG003|COMPLETED|Intervention Period 4 (3 Days)||3||
48551325|NCT02443740|101683129|FG004|COMPLETED|Intervention Period 4 (3 Days)||2||
48266080|NCT05262751|100975365|FG004|STARTED|Washout Period 2||5||
48266081|NCT05262751|100975366|FG005|STARTED|Washout Period 2||4||
48266082|NCT05262751|100975361|FG000|COMPLETED|Washout Period 2||2||
48266083|NCT05262751|100975362|FG001|COMPLETED|Washout Period 2||2||
48391788|NCT01742078|101287731|FG004|NOT COMPLETED|Overall Study||0||
48551326|NCT02443740|101683130|FG005|COMPLETED|Intervention Period 4 (3 Days)||2||
48551327|NCT02443740|101683131|FG006|COMPLETED|Intervention Period 4 (3 Days)||2||
48551328|NCT02443740|101683132|FG007|COMPLETED|Intervention Period 4 (3 Days)||2||
48551329|NCT02443740|101683133|FG008|COMPLETED|Intervention Period 4 (3 Days)||0||
48266084|NCT05262751|100975363|FG002|COMPLETED|Washout Period 2||2||
48266085|NCT05262751|100975364|FG003|COMPLETED|Washout Period 2||5||
48551330|NCT02443740|101683134|FG009|COMPLETED|Intervention Period 4 (3 Days)||0||
48551331|NCT02443740|101683135|FG010|COMPLETED|Intervention Period 4 (3 Days)||0||
48551332|NCT02443740|101683125|FG000|NOT COMPLETED|Intervention Period 4 (3 Days)||0||
48104380|NCT02113956|100582919|FG001|COMPLETED|Intervention End (5 Weeks Post Baseline)||148||
48104381|NCT02113956|100582918|FG000|NOT COMPLETED|Intervention End (5 Weeks Post Baseline)||9||
48104382|NCT02113956|100582919|FG001|NOT COMPLETED|Intervention End (5 Weeks Post Baseline)||4||
48104383|NCT02113956|100582918|FG000|STARTED|3 Month Post-intervention||141||
48104384|NCT02113956|100582919|FG001|STARTED|3 Month Post-intervention||148||
48104385|NCT02113956|100582918|FG000|COMPLETED|3 Month Post-intervention||137||
48104386|NCT02113956|100582919|FG001|COMPLETED|3 Month Post-intervention||146||
48104387|NCT02113956|100582918|FG000|NOT COMPLETED|3 Month Post-intervention||4||
48104388|NCT02113956|100582919|FG001|NOT COMPLETED|3 Month Post-intervention||2||
48104389|NCT01074164|100582920|FG000|STARTED|Overall Study||7||
48104390|NCT01074164|100582921|FG001|STARTED|Overall Study||8||
48104391|NCT01074164|100582920|FG000|COMPLETED|Overall Study||4||
48104392|NCT01074164|100582921|FG001|COMPLETED|Overall Study||7||
48104393|NCT01074164|100582920|FG000|NOT COMPLETED|Overall Study||3||
48104394|NCT01074164|100582921|FG001|NOT COMPLETED|Overall Study||1||
48104395|NCT01271868|100582922|FG000|STARTED|Pharmacokinetic Study||9||
48104396|NCT01271868|100582922|FG000|COMPLETED|Pharmacokinetic Study||9||
48104397|NCT01271868|100582922|FG000|NOT COMPLETED|Pharmacokinetic Study||0||
48104398|NCT01271868|100582922|FG000|STARTED|Treatment Study||9||
48104399|NCT01271868|100582922|FG000|COMPLETED|Treatment Study||9||
48104400|NCT01271868|100582922|FG000|NOT COMPLETED|Treatment Study||0||
48104401|NCT03001258|100582923|FG000|STARTED|Overall Study||765||
48104402|NCT03001258|100582924|FG001|STARTED|Overall Study||751||
48104403|NCT03001258|100582925|FG002|STARTED|Overall Study||485||
48104404|NCT03001258|100582923|FG000|COMPLETED|Overall Study||765||
48104405|NCT03001258|100582924|FG001|COMPLETED|Overall Study||751||
48104406|NCT03001258|100582925|FG002|COMPLETED|Overall Study||485||
48104407|NCT03001258|100582923|FG000|NOT COMPLETED|Overall Study||0||
48104408|NCT03001258|100582924|FG001|NOT COMPLETED|Overall Study||0||
48104409|NCT03001258|100582925|FG002|NOT COMPLETED|Overall Study||0||
48104410|NCT03037528|100582926|FG000|STARTED|Overall Study||15||
48104411|NCT03037528|100582927|FG001|STARTED|Overall Study||15||
48551333|NCT02443740|101683126|FG001|NOT COMPLETED|Intervention Period 4 (3 Days)||0||
48551334|NCT02443740|101683127|FG002|NOT COMPLETED|Intervention Period 4 (3 Days)||0||
48551335|NCT02443740|101683128|FG003|NOT COMPLETED|Intervention Period 4 (3 Days)||0||
48551336|NCT02443740|101683129|FG004|NOT COMPLETED|Intervention Period 4 (3 Days)||0||
48551337|NCT02443740|101683130|FG005|NOT COMPLETED|Intervention Period 4 (3 Days)||0||
48551338|NCT02443740|101683131|FG006|NOT COMPLETED|Intervention Period 4 (3 Days)||0||
48551339|NCT02443740|101683132|FG007|NOT COMPLETED|Intervention Period 4 (3 Days)||0||
48551340|NCT02443740|101683133|FG008|NOT COMPLETED|Intervention Period 4 (3 Days)||0||
48551341|NCT02443740|101683134|FG009|NOT COMPLETED|Intervention Period 4 (3 Days)||0||
48551342|NCT02443740|101683135|FG010|NOT COMPLETED|Intervention Period 4 (3 Days)||0||
48551343|NCT02969421|101683136|FG000|STARTED|Overall Study||33||
48551344|NCT02969421|101683137|FG001|STARTED|Overall Study||33||
48551345|NCT02969421|101683136|FG000|COMPLETED|Overall Study||33||
48551346|NCT02969421|101683137|FG001|COMPLETED|Overall Study||33||
48551347|NCT02969421|101683136|FG000|NOT COMPLETED|Overall Study||0||
48551348|NCT02969421|101683137|FG001|NOT COMPLETED|Overall Study||0||
48551349|NCT03220854|101683138|FG000|STARTED|Overall Study||4||
48551350|NCT03220854|101683139|FG001|STARTED|Overall Study||0||
48551351|NCT03220854|101683140|FG002|STARTED|Overall Study||1||
48551352|NCT03220854|101683138|FG000|COMPLETED|Overall Study||4||
48551353|NCT03220854|101683139|FG001|COMPLETED|Overall Study||0||
48551354|NCT03220854|101683140|FG002|COMPLETED|Overall Study||1||
48551355|NCT03220854|101683138|FG000|NOT COMPLETED|Overall Study||0||
48551356|NCT03220854|101683139|FG001|NOT COMPLETED|Overall Study||0||
48104412|NCT03037528|100582928|FG002|STARTED|Overall Study||13||
48104413|NCT03037528|100582929|FG003|STARTED|Overall Study||14||
48104414|NCT03037528|100582930|FG004|STARTED|Overall Study||13||
48104415|NCT03037528|100582931|FG005|STARTED|Overall Study||14||
48104416|NCT03037528|100582932|FG006|STARTED|Overall Study||15||
48104417|NCT03037528|100582933|FG007|STARTED|Overall Study||13||
48104418|NCT03037528|100582926|FG000|COMPLETED|Overall Study||12||
48104419|NCT03037528|100582927|FG001|COMPLETED|Overall Study||12||
48104420|NCT03037528|100582928|FG002|COMPLETED|Overall Study||11||
48104421|NCT03037528|100582929|FG003|COMPLETED|Overall Study||10||
48104422|NCT03037528|100582930|FG004|COMPLETED|Overall Study||8||
48104423|NCT03037528|100582931|FG005|COMPLETED|Overall Study||7||
48551357|NCT03220854|101683140|FG002|NOT COMPLETED|Overall Study||0||
48551358|NCT00637494|101683141|FG000|STARTED|Overall Study||141||
48551359|NCT00637494|101683142|FG001|STARTED|Overall Study||151||
48551360|NCT00637494|101683141|FG000|COMPLETED|Overall Study||109||
48104424|NCT03037528|100582932|FG006|COMPLETED|Overall Study||9||
48104425|NCT03037528|100582933|FG007|COMPLETED|Overall Study||5||
48104426|NCT03037528|100582926|FG000|NOT COMPLETED|Overall Study||3||
48104427|NCT03037528|100582927|FG001|NOT COMPLETED|Overall Study||3||
48104428|NCT03037528|100582928|FG002|NOT COMPLETED|Overall Study||2||
48104429|NCT03037528|100582929|FG003|NOT COMPLETED|Overall Study||4||
48104430|NCT03037528|100582930|FG004|NOT COMPLETED|Overall Study||5||
48104431|NCT03037528|100582931|FG005|NOT COMPLETED|Overall Study||7||
48104432|NCT03037528|100582932|FG006|NOT COMPLETED|Overall Study||6||
48104433|NCT03037528|100582933|FG007|NOT COMPLETED|Overall Study||8||
48104434|NCT01395329|100582934|FG000|STARTED|Overall Study||14||
48104435|NCT01395329|100582935|FG001|STARTED|Overall Study||14||
48104436|NCT01395329|100582936|FG002|STARTED|Overall Study||14||
48104437|NCT01395329|100582934|FG000|COMPLETED|Overall Study||14||
48104438|NCT01395329|100582935|FG001|COMPLETED|Overall Study||14||
48104439|NCT01395329|100582936|FG002|COMPLETED|Overall Study||14||
48104440|NCT01395329|100582934|FG000|NOT COMPLETED|Overall Study||0||
48104441|NCT01395329|100582935|FG001|NOT COMPLETED|Overall Study||0||
48104442|NCT01395329|100582936|FG002|NOT COMPLETED|Overall Study||0||
48104443|NCT02276872|100582937|FG000|STARTED|Overall Study||10||
48104444|NCT02276872|100582938|FG001|STARTED|Overall Study||10||
48104445|NCT02276872|100582939|FG002|STARTED|Overall Study||12||
48104446|NCT02276872|100582937|FG000|COMPLETED|Overall Study||9||
48104447|NCT02276872|100582938|FG001|COMPLETED|Overall Study||10||
48104448|NCT02276872|100582939|FG002|COMPLETED|Overall Study||12||
48104449|NCT02276872|100582937|FG000|NOT COMPLETED|Overall Study||1||
48104450|NCT02276872|100582938|FG001|NOT COMPLETED|Overall Study||0||
48104451|NCT02276872|100582939|FG002|NOT COMPLETED|Overall Study||0||
48104452|NCT02212587|100582940|FG000|STARTED|Overall Study||10||
48104453|NCT02212587|100582940|FG000|COMPLETED|Overall Study||9||
48104454|NCT02212587|100582940|FG000|NOT COMPLETED|Overall Study||1||
48104455|NCT02107599|100582941|FG000|STARTED|Overall Study||96||
48104456|NCT02107599|100582941|FG000|COMPLETED|Overall Study||96||
48104457|NCT02107599|100582941|FG000|NOT COMPLETED|Overall Study||0||
48104458|NCT03664752|100582942|FG000|STARTED|Overall Study||293||
48104459|NCT03664752|100582943|FG001|STARTED|Overall Study||292||
48104460|NCT03664752|100582942|FG000|COMPLETED|Overall Study||244||
48104461|NCT03664752|100582943|FG001|COMPLETED|Overall Study||241||
48104462|NCT03664752|100582942|FG000|NOT COMPLETED|Overall Study||49||
48104463|NCT03664752|100582943|FG001|NOT COMPLETED|Overall Study||51||
48104464|NCT02932904|100582944|FG000|STARTED|Overall Study||92||
48104465|NCT02932904|100582945|FG001|STARTED|Overall Study||85||
48104466|NCT02932904|100582946|FG002|STARTED|Overall Study||91||
48104467|NCT02932904|100582947|FG003|STARTED|Overall Study||93||
48104468|NCT02932904|100582944|FG000|Treated|Overall Study||91||
48104469|NCT02932904|100582945|FG001|Treated|Overall Study||84||
48104470|NCT02932904|100582946|FG002|Treated|Overall Study||91||
48104471|NCT02932904|100582947|FG003|Treated|Overall Study||91||
48104472|NCT02932904|100582944|FG000|COMPLETED|Overall Study||76||
48104473|NCT02932904|100582945|FG001|COMPLETED|Overall Study||67||
48104474|NCT02932904|100582946|FG002|COMPLETED|Overall Study||68||
48104475|NCT02932904|100582947|FG003|COMPLETED|Overall Study||79||
48104476|NCT02932904|100582944|FG000|NOT COMPLETED|Overall Study||16||
48104477|NCT02932904|100582945|FG001|NOT COMPLETED|Overall Study||18||
48104478|NCT02932904|100582946|FG002|NOT COMPLETED|Overall Study||23||
48104479|NCT02932904|100582947|FG003|NOT COMPLETED|Overall Study||14||
48104480|NCT04344314|100582948|FG000|STARTED|Overall Study||19||19
48104481|NCT04344314|100582949|FG001|STARTED|Overall Study||19||19
48104482|NCT04344314|100582950|FG002|STARTED|Overall Study||21||21
48266086|NCT05262751|100975365|FG004|COMPLETED|Washout Period 2||5||
48266087|NCT05262751|100975366|FG005|COMPLETED|Washout Period 2||4||
48266088|NCT05262751|100975361|FG000|NOT COMPLETED|Washout Period 2||1||
48551361|NCT00637494|101683142|FG001|COMPLETED|Overall Study||108||
48551362|NCT00637494|101683141|FG000|NOT COMPLETED|Overall Study||32||
48551363|NCT00637494|101683142|FG001|NOT COMPLETED|Overall Study||43||
48551364|NCT01301729|101683143|FG000|STARTED|Overall Study||32||
48266089|NCT05262751|100975362|FG001|NOT COMPLETED|Washout Period 2||0||
48266090|NCT05262751|100975363|FG002|NOT COMPLETED|Washout Period 2||0||
48266091|NCT05262751|100975364|FG003|NOT COMPLETED|Washout Period 2||0||
48266092|NCT05262751|100975365|FG004|NOT COMPLETED|Washout Period 2||0||
48551365|NCT01301729|101683143|FG000|COMPLETED|Overall Study||28||
48104483|NCT04344314|100582951|FG003|STARTED|Overall Study||21||21
48104484|NCT04344314|100582948|FG000|COMPLETED|Overall Study||19||19
48104485|NCT04344314|100582949|FG001|COMPLETED|Overall Study||19||19
48104486|NCT04344314|100582950|FG002|COMPLETED|Overall Study||21||21
48104487|NCT04344314|100582951|FG003|COMPLETED|Overall Study||21||21
48104488|NCT04344314|100582948|FG000|NOT COMPLETED|Overall Study||0||0
48551366|NCT01301729|101683143|FG000|NOT COMPLETED|Overall Study||4||
48551367|NCT02789137|101683144|FG000|STARTED|Overall Study||111||
48551368|NCT02789137|101683144|FG000|COMPLETED|Overall Study||53||
48104489|NCT04344314|100582949|FG001|NOT COMPLETED|Overall Study||0||0
48104490|NCT04344314|100582950|FG002|NOT COMPLETED|Overall Study||0||0
48104491|NCT04344314|100582951|FG003|NOT COMPLETED|Overall Study||0||0
48104492|NCT01652664|100582952|FG000|STARTED|Overall Study||77||
48104493|NCT01652664|100582953|FG001|STARTED|Overall Study||75||
48104494|NCT01652664|100582952|FG000|COMPLETED|Overall Study||71||
48104495|NCT01652664|100582953|FG001|COMPLETED|Overall Study||74||
48104496|NCT01652664|100582952|FG000|NOT COMPLETED|Overall Study||6||
48266093|NCT05262751|100975366|FG005|NOT COMPLETED|Washout Period 2||0||
48266094|NCT05262751|100975361|FG000|STARTED|Treatment Period 3||2||
48266095|NCT05262751|100975362|FG001|STARTED|Treatment Period 3||2||
48104497|NCT01652664|100582953|FG001|NOT COMPLETED|Overall Study||1||
48104498|NCT00802412|100582954|FG000|STARTED|Overall Study||65||
48266096|NCT05262751|100975363|FG002|STARTED|Treatment Period 3||2||
48551369|NCT02789137|101683144|FG000|NOT COMPLETED|Overall Study||58||
48551370|NCT00866359|101683145|FG000|STARTED|Treatment Phase (Days 1 to 85)||56||
48104499|NCT00802412|100582955|FG001|STARTED|Overall Study||67||
48104500|NCT00802412|100582954|FG000|COMPLETED|Overall Study||63||
48104501|NCT00802412|100582955|FG001|COMPLETED|Overall Study||66||
48104502|NCT00802412|100582954|FG000|NOT COMPLETED|Overall Study||2||
48104503|NCT00802412|100582955|FG001|NOT COMPLETED|Overall Study||1||
48104504|NCT00642668|100582956|FG000|STARTED|Overall Study||35||
48104505|NCT00642668|100582956|FG000|COMPLETED|Overall Study||21||
48104506|NCT00642668|100582956|FG000|NOT COMPLETED|Overall Study||14||
48104507|NCT00903617|100582957|FG000|STARTED|Overall Study||19||
48104508|NCT00903617|100582958|FG001|STARTED|Overall Study||20||
48104509|NCT00903617|100582959|FG002|STARTED|Overall Study||20||
48104510|NCT00903617|100582960|FG003|STARTED|Overall Study||21||
48104511|NCT00903617|100582957|FG000|COMPLETED|Overall Study||16||
48104512|NCT00903617|100582958|FG001|COMPLETED|Overall Study||15||
48104513|NCT00903617|100582959|FG002|COMPLETED|Overall Study||15||
48104514|NCT00903617|100582960|FG003|COMPLETED|Overall Study||20||
48104515|NCT00903617|100582957|FG000|NOT COMPLETED|Overall Study||3||
48551371|NCT00866359|101683146|FG001|STARTED|Treatment Phase (Days 1 to 85)||55||
48551372|NCT00866359|101683147|FG002|STARTED|Treatment Phase (Days 1 to 85)||0||
48551373|NCT00866359|101683148|FG003|STARTED|Treatment Phase (Days 1 to 85)||0||
48551374|NCT00866359|101683145|FG000|COMPLETED|Treatment Phase (Days 1 to 85)||45||
48551375|NCT00866359|101683146|FG001|COMPLETED|Treatment Phase (Days 1 to 85)||50||
48551376|NCT00866359|101683147|FG002|COMPLETED|Treatment Phase (Days 1 to 85)||0||
48551377|NCT00866359|101683148|FG003|COMPLETED|Treatment Phase (Days 1 to 85)||0||
48551378|NCT00866359|101683145|FG000|NOT COMPLETED|Treatment Phase (Days 1 to 85)||11||
48551379|NCT00866359|101683146|FG001|NOT COMPLETED|Treatment Phase (Days 1 to 85)||5||
48551380|NCT00866359|101683147|FG002|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0||
48551381|NCT00866359|101683148|FG003|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0||
48551382|NCT00866359|101683145|FG000|STARTED|Extension Phase (Day 86 to 169)||0||
48551383|NCT00866359|101683146|FG001|STARTED|Extension Phase (Day 86 to 169)||0||
48551384|NCT00866359|101683147|FG002|STARTED|Extension Phase (Day 86 to 169)||45||
48551385|NCT00866359|101683148|FG003|STARTED|Extension Phase (Day 86 to 169)||50||
48551386|NCT00866359|101683145|FG000|COMPLETED|Extension Phase (Day 86 to 169)||0||
48551387|NCT00866359|101683146|FG001|COMPLETED|Extension Phase (Day 86 to 169)||0||
48551388|NCT00866359|101683147|FG002|COMPLETED|Extension Phase (Day 86 to 169)||44||
48551389|NCT00866359|101683148|FG003|COMPLETED|Extension Phase (Day 86 to 169)||47||
48551390|NCT00866359|101683145|FG000|NOT COMPLETED|Extension Phase (Day 86 to 169)||0||
48551391|NCT00866359|101683146|FG001|NOT COMPLETED|Extension Phase (Day 86 to 169)||0||
48551392|NCT00866359|101683147|FG002|NOT COMPLETED|Extension Phase (Day 86 to 169)||1||
48551393|NCT00866359|101683148|FG003|NOT COMPLETED|Extension Phase (Day 86 to 169)||3||
48551394|NCT00866359|101683145|FG000|STARTED|Observational Follow-Up Phase||0||
48551395|NCT00866359|101683146|FG001|STARTED|Observational Follow-Up Phase||0||
48551396|NCT00866359|101683147|FG002|STARTED|Observational Follow-Up Phase||54||
48551397|NCT00866359|101683148|FG003|STARTED|Observational Follow-Up Phase||54||
48551398|NCT00866359|101683145|FG000|COMPLETED|Observational Follow-Up Phase||0||
48104516|NCT00903617|100582958|FG001|NOT COMPLETED|Overall Study||5||
48104517|NCT00903617|100582959|FG002|NOT COMPLETED|Overall Study||5||
48104518|NCT00903617|100582960|FG003|NOT COMPLETED|Overall Study||1||
48104519|NCT00699556|100582961|FG000|STARTED|First Intervention (1 Day)||11||
48104520|NCT00699556|100582962|FG001|STARTED|First Intervention (1 Day)||11||
48104521|NCT00699556|100582961|FG000|COMPLETED|First Intervention (1 Day)||11||
48104522|NCT00699556|100582962|FG001|COMPLETED|First Intervention (1 Day)||11||
48104523|NCT00699556|100582961|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48104524|NCT00699556|100582962|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48104525|NCT00699556|100582961|FG000|STARTED|Second Intervention (1 Day)||11||
48104526|NCT00699556|100582962|FG001|STARTED|Second Intervention (1 Day)||11||
48104527|NCT00699556|100582961|FG000|COMPLETED|Second Intervention (1 Day)||11||
48104528|NCT00699556|100582962|FG001|COMPLETED|Second Intervention (1 Day)||11||
48104529|NCT00699556|100582961|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48104530|NCT00699556|100582962|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48104531|NCT01076504|100582963|FG000|STARTED|Overall Study||80||
48104532|NCT01076504|100582963|FG000|COMPLETED|Overall Study||0||
48104533|NCT01076504|100582963|FG000|NOT COMPLETED|Overall Study||80||
48104534|NCT01883427|100582964|FG000|STARTED|Overall Study||20||
48104535|NCT01883427|100582965|FG001|STARTED|Overall Study||20||
48104536|NCT01883427|100582964|FG000|COMPLETED|Overall Study||20||
48104537|NCT01883427|100582965|FG001|COMPLETED|Overall Study||20||
48104538|NCT01883427|100582964|FG000|NOT COMPLETED|Overall Study||0||
48104539|NCT01883427|100582965|FG001|NOT COMPLETED|Overall Study||0||
48104540|NCT00297037|100582966|FG000|STARTED|Overall Study||10||
48104541|NCT00297037|100582967|FG001|STARTED|Overall Study||11||
48104542|NCT00297037|100582966|FG000|COMPLETED|Overall Study||8||
48104543|NCT00297037|100582967|FG001|COMPLETED|Overall Study||11||
48104544|NCT00297037|100582966|FG000|NOT COMPLETED|Overall Study||2||
48104545|NCT00297037|100582967|FG001|NOT COMPLETED|Overall Study||0||
48104546|NCT01894152|100582968|FG000|STARTED|Overall Study||2002||
48104547|NCT01894152|100582968|FG000|COMPLETED|Overall Study||1851||
48104548|NCT01894152|100582968|FG000|NOT COMPLETED|Overall Study||151||
48104549|NCT02803307|100582969|FG000|STARTED|Overall Study||20||
48104550|NCT02803307|100582970|FG001|STARTED|Overall Study||20||
48104551|NCT02803307|100582969|FG000|COMPLETED|Overall Study||20||
48104552|NCT02803307|100582970|FG001|COMPLETED|Overall Study||20||
48104553|NCT02803307|100582969|FG000|NOT COMPLETED|Overall Study||0||
48551399|NCT00866359|101683146|FG001|COMPLETED|Observational Follow-Up Phase||0||
48551400|NCT00866359|101683147|FG002|COMPLETED|Observational Follow-Up Phase||54||
48551401|NCT00866359|101683148|FG003|COMPLETED|Observational Follow-Up Phase||54||
48104554|NCT02803307|100582970|FG001|NOT COMPLETED|Overall Study||0||
48104555|NCT01241903|100582971|FG000|STARTED|Overall Study||27||
48104556|NCT01241903|100582972|FG001|STARTED|Overall Study||27||
48104557|NCT01241903|100582971|FG000|COMPLETED|Overall Study||26||
48104558|NCT01241903|100582972|FG001|COMPLETED|Overall Study||27||
48104559|NCT01241903|100582971|FG000|NOT COMPLETED|Overall Study||1||
48104560|NCT01241903|100582972|FG001|NOT COMPLETED|Overall Study||0||
48104561|NCT02141997|100582973|FG000|STARTED|Overall Study||56||
48104562|NCT02141997|100582974|FG001|STARTED|Overall Study||55||
48104563|NCT02141997|100582975|FG002|STARTED|Overall Study||56||
48104564|NCT02141997|100582976|FG003|STARTED|Overall Study||55||
48104565|NCT02141997|100582973|FG000|COMPLETED|Overall Study||53||
48104566|NCT02141997|100582974|FG001|COMPLETED|Overall Study||49||
48104567|NCT02141997|100582975|FG002|COMPLETED|Overall Study||53||
48104568|NCT02141997|100582976|FG003|COMPLETED|Overall Study||54||
48104569|NCT02141997|100582973|FG000|NOT COMPLETED|Overall Study||3||
48104570|NCT02141997|100582974|FG001|NOT COMPLETED|Overall Study||6||
48104571|NCT02141997|100582975|FG002|NOT COMPLETED|Overall Study||3||
48104572|NCT02141997|100582976|FG003|NOT COMPLETED|Overall Study||1||
48104573|NCT01104636|100582977|FG000|STARTED|Overall Study||1177||
48104574|NCT01104636|100582977|FG000|COMPLETED|Overall Study||999||
48551402|NCT00866359|101683145|FG000|NOT COMPLETED|Observational Follow-Up Phase||0||
48551403|NCT00866359|101683146|FG001|NOT COMPLETED|Observational Follow-Up Phase||0||
48551404|NCT00866359|101683147|FG002|NOT COMPLETED|Observational Follow-Up Phase||0||
48551405|NCT00866359|101683148|FG003|NOT COMPLETED|Observational Follow-Up Phase||0||
48551406|NCT00711880|101683149|FG000|STARTED|Overall Study||63||
48551407|NCT00711880|101683150|FG001|STARTED|Overall Study||62||
48551408|NCT00711880|101683149|FG000|COMPLETED|Overall Study||50||
48551409|NCT00711880|101683150|FG001|COMPLETED|Overall Study||55||
48551410|NCT00711880|101683149|FG000|NOT COMPLETED|Overall Study||13||
48104575|NCT01104636|100582977|FG000|NOT COMPLETED|Overall Study||178||
48104576|NCT02431754|100582978|FG000|STARTED|Period 1 (8 Weeks)||85||
48104577|NCT02431754|100582979|FG001|STARTED|Period 1 (8 Weeks)||86||
48104578|NCT02431754|100582978|FG000|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||85||
48104579|NCT02431754|100582979|FG001|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||86||
48104580|NCT02431754|100582978|FG000|COMPLETED|Period 1 (8 Weeks)||79||
48104581|NCT02431754|100582979|FG001|COMPLETED|Period 1 (8 Weeks)||82||
48104582|NCT02431754|100582978|FG000|NOT COMPLETED|Period 1 (8 Weeks)||6||
48104583|NCT02431754|100582979|FG001|NOT COMPLETED|Period 1 (8 Weeks)||4||
48104584|NCT02431754|100582978|FG000|STARTED|Wash-out Period (4 Weeks)||79||
48104585|NCT02431754|100582979|FG001|STARTED|Wash-out Period (4 Weeks)||82||
48104586|NCT02431754|100582978|FG000|COMPLETED|Wash-out Period (4 Weeks)||75||
48104587|NCT02431754|100582979|FG001|COMPLETED|Wash-out Period (4 Weeks)||82||
48104588|NCT02431754|100582978|FG000|NOT COMPLETED|Wash-out Period (4 Weeks)||4||
48104589|NCT02431754|100582979|FG001|NOT COMPLETED|Wash-out Period (4 Weeks)||0||
48104590|NCT02431754|100582978|FG000|STARTED|Period 2 (8 Weeks)||75||
48104591|NCT02431754|100582979|FG001|STARTED|Period 2 (8 Weeks)||82||
48104592|NCT02431754|100582978|FG000|COMPLETED|Period 2 (8 Weeks)||74||
48104593|NCT02431754|100582979|FG001|COMPLETED|Period 2 (8 Weeks)||78||
48104594|NCT02431754|100582978|FG000|NOT COMPLETED|Period 2 (8 Weeks)||1||
48104595|NCT02431754|100582979|FG001|NOT COMPLETED|Period 2 (8 Weeks)||4||
48104596|NCT01742338|100582980|FG000|STARTED|Overall Study||47||
48104597|NCT01742338|100582981|FG001|STARTED|Overall Study||42||
48551411|NCT00711880|101683150|FG001|NOT COMPLETED|Overall Study||7||
48551412|NCT00887289|101683151|FG000|STARTED|Overall Study||1504||
48551413|NCT00887289|101683151|FG000|COMPLETED|Overall Study||1409||
48104598|NCT01742338|100582980|FG000|COMPLETED|Overall Study||43||
48104599|NCT01742338|100582981|FG001|COMPLETED|Overall Study||39||
48551414|NCT00887289|101683151|FG000|NOT COMPLETED|Overall Study||95||
48551415|NCT00826007|101683152|FG000|STARTED|Overall Study||308||
48104600|NCT01742338|100582980|FG000|NOT COMPLETED|Overall Study||4||
48104601|NCT01742338|100582981|FG001|NOT COMPLETED|Overall Study||3||
48104602|NCT02488681|100582982|FG000|STARTED|Overall Study||276||
48104603|NCT02488681|100582982|FG000|COMPLETED|Overall Study||269||
48104604|NCT02488681|100582982|FG000|NOT COMPLETED|Overall Study||7||
48104605|NCT00615056|100582983|FG000|STARTED|Overall Study||49||
48104606|NCT00615056|100582984|FG001|STARTED|Overall Study||51||
48104607|NCT00615056|100582985|FG002|STARTED|Overall Study||36||
48104608|NCT00615056|100582986|FG003|STARTED|Overall Study||35||
48104609|NCT00615056|100582983|FG000|Treated|Overall Study||46||
48104610|NCT00615056|100582984|FG001|Treated|Overall Study||51||
48104611|NCT00615056|100582985|FG002|Treated|Overall Study||36||
48104612|NCT00615056|100582986|FG003|Treated|Overall Study||35||
48104613|NCT00615056|100582983|FG000|COMPLETED|Overall Study||0||
48104614|NCT00615056|100582984|FG001|COMPLETED|Overall Study||0||
48104615|NCT00615056|100582985|FG002|COMPLETED|Overall Study||0||
48104616|NCT00615056|100582986|FG003|COMPLETED|Overall Study||0||
48104617|NCT00615056|100582983|FG000|NOT COMPLETED|Overall Study||49||
48104618|NCT00615056|100582984|FG001|NOT COMPLETED|Overall Study||51||
48104619|NCT00615056|100582985|FG002|NOT COMPLETED|Overall Study||36||
48104620|NCT00615056|100582986|FG003|NOT COMPLETED|Overall Study||35||
48104621|NCT00858442|100582987|FG000|STARTED|From Surgery to Start Compression;||21||
48104622|NCT00858442|100582988|FG001|STARTED|From Surgery to Start Compression;||23||
48104623|NCT00858442|100582987|FG000|COMPLETED|From Surgery to Start Compression;||21||
48104624|NCT00858442|100582988|FG001|COMPLETED|From Surgery to Start Compression;||23||
48104625|NCT00858442|100582987|FG000|NOT COMPLETED|From Surgery to Start Compression;||0||
48104626|NCT00858442|100582988|FG001|NOT COMPLETED|From Surgery to Start Compression;||0||
48104627|NCT00858442|100582987|FG000|STARTED|Compression:Start to Finish||21||
48104628|NCT00858442|100582988|FG001|STARTED|Compression:Start to Finish||23||
48104629|NCT00858442|100582987|FG000|COMPLETED|Compression:Start to Finish||20||
48104630|NCT00858442|100582988|FG001|COMPLETED|Compression:Start to Finish||20||
48104631|NCT00858442|100582987|FG000|NOT COMPLETED|Compression:Start to Finish||1||
48104632|NCT00858442|100582988|FG001|NOT COMPLETED|Compression:Start to Finish||3||
48104633|NCT02063737|100582989|FG000|STARTED|Overall Study||52||
48104634|NCT02063737|100582990|FG001|STARTED|Overall Study||48||
48104635|NCT02063737|100582989|FG000|COMPLETED|Overall Study||41||
48104636|NCT02063737|100582990|FG001|COMPLETED|Overall Study||44||
48104637|NCT02063737|100582989|FG000|NOT COMPLETED|Overall Study||11||
48104638|NCT02063737|100582990|FG001|NOT COMPLETED|Overall Study||4||
48104639|NCT04536727|100582991|FG000|STARTED|Overall Study||13||
48104640|NCT04536727|100582992|FG001|STARTED|Overall Study||15||
48104641|NCT04536727|100582991|FG000|COMPLETED|Overall Study||12||
48104642|NCT04536727|100582992|FG001|COMPLETED|Overall Study||13||
48104643|NCT04536727|100582991|FG000|NOT COMPLETED|Overall Study||1||
48104644|NCT04536727|100582992|FG001|NOT COMPLETED|Overall Study||2||
48104645|NCT02138461|100582993|FG000|STARTED|Overall Study||101||
48104646|NCT02138461|100582994|FG001|STARTED|Overall Study||110||
48104647|NCT02138461|100582993|FG000|COMPLETED|Overall Study||101||
48104648|NCT02138461|100582994|FG001|COMPLETED|Overall Study||110||
48104649|NCT02138461|100582993|FG000|NOT COMPLETED|Overall Study||0||
48104650|NCT02138461|100582994|FG001|NOT COMPLETED|Overall Study||0||
48104651|NCT04640519|100582995|FG000|STARTED|Overall Study||25||
48104652|NCT04640519|100582996|FG001|STARTED|Overall Study||25||
48104653|NCT04640519|100582995|FG000|COMPLETED|Overall Study||25||
48104654|NCT04640519|100582996|FG001|COMPLETED|Overall Study||25||
48104655|NCT04640519|100582995|FG000|NOT COMPLETED|Overall Study||0||
48104656|NCT04640519|100582996|FG001|NOT COMPLETED|Overall Study||0||
48104657|NCT02910167|100582997|FG000|STARTED|Overall Study||360||
48104658|NCT02910167|100582997|FG000|COMPLETED|Overall Study||341||
48104659|NCT02910167|100582997|FG000|NOT COMPLETED|Overall Study||19||
48104660|NCT04859868|100582998|FG000|STARTED|First Experimental Visit (1.5 Hour)||5||
48104661|NCT04859868|100582999|FG001|STARTED|First Experimental Visit (1.5 Hour)||5||
48104662|NCT04859868|100583000|FG002|STARTED|First Experimental Visit (1.5 Hour)||5||
48551416|NCT00826007|101683153|FG001|STARTED|Overall Study||279||
48551417|NCT00826007|101683152|FG000|COMPLETED|Overall Study||308||
48551418|NCT00826007|101683153|FG001|COMPLETED|Overall Study||279||
48551419|NCT00826007|101683152|FG000|NOT COMPLETED|Overall Study||0||
48551420|NCT00826007|101683153|FG001|NOT COMPLETED|Overall Study||0||
48551421|NCT00805467|101683154|FG000|STARTED|Overall Study||1||
48551422|NCT00805467|101683155|FG001|STARTED|Overall Study||59||
48551423|NCT00805467|101683156|FG002|STARTED|Overall Study||183||
48104663|NCT04859868|100583001|FG003|STARTED|First Experimental Visit (1.5 Hour)||4||
48104664|NCT04859868|100583002|FG004|STARTED|First Experimental Visit (1.5 Hour)||5||
48104665|NCT04859868|100583003|FG005|STARTED|First Experimental Visit (1.5 Hour)||5||
48104666|NCT04859868|100582998|FG000|COMPLETED|First Experimental Visit (1.5 Hour)||5||
48104667|NCT04859868|100582999|FG001|COMPLETED|First Experimental Visit (1.5 Hour)||5||
48104668|NCT04859868|100583000|FG002|COMPLETED|First Experimental Visit (1.5 Hour)||5||
48104669|NCT04859868|100583001|FG003|COMPLETED|First Experimental Visit (1.5 Hour)||4||
48104670|NCT04859868|100583002|FG004|COMPLETED|First Experimental Visit (1.5 Hour)||5||
48551424|NCT00805467|101683157|FG003|STARTED|Overall Study||381||
48551425|NCT00805467|101683154|FG000|Enrolled But Did Not Receive Treatment|Overall Study||0||
48104671|NCT04859868|100583003|FG005|COMPLETED|First Experimental Visit (1.5 Hour)||5||
48104672|NCT04859868|100582998|FG000|NOT COMPLETED|First Experimental Visit (1.5 Hour)||0||
48104673|NCT04859868|100582999|FG001|NOT COMPLETED|First Experimental Visit (1.5 Hour)||0||
48104674|NCT04859868|100583000|FG002|NOT COMPLETED|First Experimental Visit (1.5 Hour)||0||
48104675|NCT04859868|100583001|FG003|NOT COMPLETED|First Experimental Visit (1.5 Hour)||0||
48104676|NCT04859868|100583002|FG004|NOT COMPLETED|First Experimental Visit (1.5 Hour)||0||
48104677|NCT04859868|100583003|FG005|NOT COMPLETED|First Experimental Visit (1.5 Hour)||0||
48104678|NCT04859868|100582998|FG000|STARTED|Second Experimental Visit (1.5 Hour)||4||
48104679|NCT04859868|100582999|FG001|STARTED|Second Experimental Visit (1.5 Hour)||5||
48691898|NCT04852055|102029046|FG000|COMPLETED|Overall Study||1138||79
48691899|NCT04852055|102029047|FG001|COMPLETED|Overall Study||1205||80
48691900|NCT04852055|102029046|FG000|NOT COMPLETED|Overall Study||132||1
48691901|NCT04852055|102029047|FG001|NOT COMPLETED|Overall Study||136||0
48691902|NCT00124072|102029048|FG000|STARTED|Overall Study||3017||
48691903|NCT00124072|102029049|FG001|STARTED|Overall Study||3016||
48691904|NCT00124072|102029050|FG002|STARTED|Overall Study||3016||
48691905|NCT00124072|102029051|FG003|STARTED|Overall Study||3015||
48691906|NCT00124072|102029048|FG000|COMPLETED|Overall Study||2503||
48691907|NCT00124072|102029049|FG001|COMPLETED|Overall Study||2504||
48691908|NCT00124072|102029050|FG002|COMPLETED|Overall Study||2524||
48691909|NCT00124072|102029051|FG003|COMPLETED|Overall Study||2515||
48691910|NCT00124072|102029048|FG000|NOT COMPLETED|Overall Study||514||
48691911|NCT00124072|102029049|FG001|NOT COMPLETED|Overall Study||512||
48691912|NCT00124072|102029050|FG002|NOT COMPLETED|Overall Study||492||
48691913|NCT00124072|102029051|FG003|NOT COMPLETED|Overall Study||500||
48691914|NCT00332579|102029052|FG000|STARTED|Overall Study||12||
48691915|NCT00332579|102029053|FG001|STARTED|Overall Study||13||
48691916|NCT00332579|102029052|FG000|COMPLETED|Overall Study||11||
48691917|NCT00332579|102029053|FG001|COMPLETED|Overall Study||12||
48691918|NCT00332579|102029052|FG000|NOT COMPLETED|Overall Study||1||
48691919|NCT00332579|102029053|FG001|NOT COMPLETED|Overall Study||1||
48691920|NCT00260832|102029054|FG000|STARTED|Overall Study||243||
48691921|NCT00260832|102029055|FG001|STARTED|Overall Study||242||
48691922|NCT00260832|102029054|FG000|COMPLETED|Overall Study||15||
48691923|NCT00260832|102029055|FG001|COMPLETED|Overall Study||31||
48691924|NCT00260832|102029054|FG000|NOT COMPLETED|Overall Study||228||
48691925|NCT00260832|102029055|FG001|NOT COMPLETED|Overall Study||211||
48691926|NCT01027559|102029056|FG000|STARTED|Overall Study||26||
48691927|NCT01027559|102029057|FG001|STARTED|Overall Study||34||
48691928|NCT01027559|102029058|FG002|STARTED|Overall Study||31||
48691929|NCT01027559|102029056|FG000|COMPLETED|Overall Study||20||
48104680|NCT04859868|100583000|FG002|STARTED|Second Experimental Visit (1.5 Hour)||5||
48104681|NCT04859868|100583001|FG003|STARTED|Second Experimental Visit (1.5 Hour)||4||
48691930|NCT01027559|102029057|FG001|COMPLETED|Overall Study||26||
48691931|NCT01027559|102029058|FG002|COMPLETED|Overall Study||22||
48691932|NCT01027559|102029056|FG000|NOT COMPLETED|Overall Study||6||
48104682|NCT04859868|100583002|FG004|STARTED|Second Experimental Visit (1.5 Hour)||4||
48691933|NCT01027559|102029057|FG001|NOT COMPLETED|Overall Study||8||
48691934|NCT01027559|102029058|FG002|NOT COMPLETED|Overall Study||9||
48691935|NCT01498692|102029059|FG000|STARTED|Overall Study||94||
48691936|NCT01498692|102029059|FG000|COMPLETED|Overall Study||86||
48104683|NCT04859868|100583003|FG005|STARTED|Second Experimental Visit (1.5 Hour)||5||
48104684|NCT04859868|100582998|FG000|COMPLETED|Second Experimental Visit (1.5 Hour)||4||
48104685|NCT04859868|100582999|FG001|COMPLETED|Second Experimental Visit (1.5 Hour)||5||
48104686|NCT04859868|100583000|FG002|COMPLETED|Second Experimental Visit (1.5 Hour)||5||
48104687|NCT04859868|100583001|FG003|COMPLETED|Second Experimental Visit (1.5 Hour)||4||
48104688|NCT04859868|100583002|FG004|COMPLETED|Second Experimental Visit (1.5 Hour)||4||
48104689|NCT04859868|100583003|FG005|COMPLETED|Second Experimental Visit (1.5 Hour)||5||
48104690|NCT04859868|100582998|FG000|NOT COMPLETED|Second Experimental Visit (1.5 Hour)||0||
48104691|NCT04859868|100582999|FG001|NOT COMPLETED|Second Experimental Visit (1.5 Hour)||0||
48104692|NCT04859868|100583000|FG002|NOT COMPLETED|Second Experimental Visit (1.5 Hour)||0||
48104693|NCT04859868|100583001|FG003|NOT COMPLETED|Second Experimental Visit (1.5 Hour)||0||
48104694|NCT04859868|100583002|FG004|NOT COMPLETED|Second Experimental Visit (1.5 Hour)||0||
48104695|NCT04859868|100583003|FG005|NOT COMPLETED|Second Experimental Visit (1.5 Hour)||0||
48104696|NCT04859868|100582998|FG000|STARTED|Third Experimental Visit (1.5 Hour)||4||
48104697|NCT04859868|100582999|FG001|STARTED|Third Experimental Visit (1.5 Hour)||5||
48104698|NCT04859868|100583000|FG002|STARTED|Third Experimental Visit (1.5 Hour)||5||
48104699|NCT04859868|100583001|FG003|STARTED|Third Experimental Visit (1.5 Hour)||4||
48104700|NCT04859868|100583002|FG004|STARTED|Third Experimental Visit (1.5 Hour)||4||
48104701|NCT04859868|100583003|FG005|STARTED|Third Experimental Visit (1.5 Hour)||5||
48104702|NCT04859868|100582998|FG000|COMPLETED|Third Experimental Visit (1.5 Hour)||4||
48104703|NCT04859868|100582999|FG001|COMPLETED|Third Experimental Visit (1.5 Hour)||5||
48104704|NCT04859868|100583000|FG002|COMPLETED|Third Experimental Visit (1.5 Hour)||5||
48104705|NCT04859868|100583001|FG003|COMPLETED|Third Experimental Visit (1.5 Hour)||4||
48104706|NCT04859868|100583002|FG004|COMPLETED|Third Experimental Visit (1.5 Hour)||4||
48104707|NCT04859868|100583003|FG005|COMPLETED|Third Experimental Visit (1.5 Hour)||5||
48104708|NCT04859868|100582998|FG000|NOT COMPLETED|Third Experimental Visit (1.5 Hour)||0||
48104709|NCT04859868|100582999|FG001|NOT COMPLETED|Third Experimental Visit (1.5 Hour)||0||
48104710|NCT04859868|100583000|FG002|NOT COMPLETED|Third Experimental Visit (1.5 Hour)||0||
48104711|NCT04859868|100583001|FG003|NOT COMPLETED|Third Experimental Visit (1.5 Hour)||0||
48104712|NCT04859868|100583002|FG004|NOT COMPLETED|Third Experimental Visit (1.5 Hour)||0||
48104713|NCT04859868|100583003|FG005|NOT COMPLETED|Third Experimental Visit (1.5 Hour)||0||
48104714|NCT02063516|100583004|FG000|STARTED|Overall Study||40||
48104715|NCT02063516|100583005|FG001|STARTED|Overall Study||40||
48104716|NCT02063516|100583004|FG000|COMPLETED|Overall Study||40||
48104717|NCT02063516|100583005|FG001|COMPLETED|Overall Study||40||
48104718|NCT02063516|100583004|FG000|NOT COMPLETED|Overall Study||0||
48104719|NCT02063516|100583005|FG001|NOT COMPLETED|Overall Study||0||
48104720|NCT04356963|100583006|FG000|STARTED|First Session||60||
48104721|NCT04356963|100583006|FG000|Completed VR Blu|First Session||21||
48104722|NCT04356963|100583006|FG000|Completed Tablet Blu|First Session||19||
48104723|NCT04356963|100583006|FG000|Completed VR Blank|First Session||19||
48104724|NCT04356963|100583006|FG000|COMPLETED|First Session||59||
48104725|NCT04356963|100583006|FG000|NOT COMPLETED|First Session||1||
48104726|NCT04356963|100583006|FG000|STARTED|Second Session||59||
48104727|NCT04356963|100583006|FG000|Completed VR Blu|Second Session||17||
48104728|NCT04356963|100583006|FG000|Completed Tablet Blu|Second Session||23||
48266097|NCT05262751|100975364|FG003|STARTED|Treatment Period 3||5||
48266098|NCT05262751|100975365|FG004|STARTED|Treatment Period 3||5||
48266099|NCT05262751|100975366|FG005|STARTED|Treatment Period 3||4||
48266100|NCT05262751|100975361|FG000|Treated|Treatment Period 3||2||
48266101|NCT05262751|100975362|FG001|Treated|Treatment Period 3||1||
48104729|NCT04356963|100583006|FG000|Completed VR Blank|Second Session||15||
48104730|NCT04356963|100583006|FG000|COMPLETED|Second Session||55||
48104731|NCT04356963|100583006|FG000|NOT COMPLETED|Second Session||4||
48104732|NCT04356963|100583006|FG000|STARTED|Third Session||55||
48266102|NCT05262751|100975363|FG002|Treated|Treatment Period 3||2||
48104733|NCT04356963|100583006|FG000|Completed VR Blu|Third Session||14||
48104734|NCT04356963|100583006|FG000|Completed Tablet Blu|Third Session||12||
48104735|NCT04356963|100583006|FG000|Completed VR Blank|Third Session||22||
48104736|NCT04356963|100583006|FG000|COMPLETED|Third Session||48||
48104737|NCT04356963|100583006|FG000|NOT COMPLETED|Third Session||7||
48104738|NCT02319005|100583007|FG000|STARTED|Overall Study||140||
48104739|NCT02319005|100583008|FG001|STARTED|Overall Study||66||
48104740|NCT02319005|100583007|FG000|COMPLETED|Overall Study||92||
48104741|NCT02319005|100583008|FG001|COMPLETED|Overall Study||51||
48104742|NCT02319005|100583007|FG000|NOT COMPLETED|Overall Study||48||
48104743|NCT02319005|100583008|FG001|NOT COMPLETED|Overall Study||15||
48104744|NCT02689258|100583009|FG000|STARTED|Overall Study||20||
48104745|NCT02689258|100583010|FG001|STARTED|Overall Study||63||
48104746|NCT02689258|100583011|FG002|STARTED|Overall Study||10||
48104747|NCT02689258|100583012|FG003|STARTED|Overall Study||11||
48104748|NCT02689258|100583013|FG004|STARTED|Overall Study||17||
48104749|NCT02689258|100583014|FG005|STARTED|Overall Study||10||
48104750|NCT02689258|100583015|FG006|STARTED|Overall Study||17||
48266103|NCT05262751|100975364|FG003|Treated|Treatment Period 3||5||
48266104|NCT05262751|100975365|FG004|Treated|Treatment Period 3||5||
48266105|NCT05262751|100975366|FG005|Treated|Treatment Period 3||4||
48104751|NCT02689258|100583016|FG007|STARTED|Overall Study||17||
48104752|NCT02689258|100583017|FG008|STARTED|Overall Study||27||
48104753|NCT02689258|100583018|FG009|STARTED|Overall Study||35||
48104754|NCT02689258|100583019|FG010|STARTED|Overall Study||17||
48104755|NCT02689258|100583020|FG011|STARTED|Overall Study||32||
48104756|NCT02689258|100583009|FG000|COMPLETED|Overall Study||20||
48104757|NCT02689258|100583010|FG001|COMPLETED|Overall Study||59||
48104758|NCT02689258|100583011|FG002|COMPLETED|Overall Study||10||
48104759|NCT02689258|100583012|FG003|COMPLETED|Overall Study||11||
48104760|NCT02689258|100583013|FG004|COMPLETED|Overall Study||16||
48104761|NCT02689258|100583014|FG005|COMPLETED|Overall Study||10||
48104762|NCT02689258|100583015|FG006|COMPLETED|Overall Study||17||
48104763|NCT02689258|100583016|FG007|COMPLETED|Overall Study||17||
48104764|NCT02689258|100583017|FG008|COMPLETED|Overall Study||25||
48104765|NCT02689258|100583018|FG009|COMPLETED|Overall Study||35||
48104766|NCT02689258|100583019|FG010|COMPLETED|Overall Study||17||
48104767|NCT02689258|100583020|FG011|COMPLETED|Overall Study||31||
48104768|NCT02689258|100583009|FG000|NOT COMPLETED|Overall Study||0||
48104769|NCT02689258|100583010|FG001|NOT COMPLETED|Overall Study||4||
48104770|NCT02689258|100583011|FG002|NOT COMPLETED|Overall Study||0||
48104771|NCT02689258|100583012|FG003|NOT COMPLETED|Overall Study||0||
48104772|NCT02689258|100583013|FG004|NOT COMPLETED|Overall Study||1||
48104773|NCT02689258|100583014|FG005|NOT COMPLETED|Overall Study||0||
48104774|NCT02689258|100583015|FG006|NOT COMPLETED|Overall Study||0||
48104775|NCT02689258|100583016|FG007|NOT COMPLETED|Overall Study||0||
48104776|NCT02689258|100583017|FG008|NOT COMPLETED|Overall Study||2||
48104777|NCT02689258|100583018|FG009|NOT COMPLETED|Overall Study||0||
48104778|NCT02689258|100583019|FG010|NOT COMPLETED|Overall Study||0||
48104779|NCT02689258|100583020|FG011|NOT COMPLETED|Overall Study||1||
48104780|NCT00531232|100583021|FG000|STARTED|Overall Study||4||
48104781|NCT00531232|100583022|FG001|STARTED|Overall Study||9||
48104782|NCT00531232|100583023|FG002|STARTED|Overall Study||25||
48104783|NCT00531232|100583021|FG000|Treated|Overall Study||4||
48104784|NCT00531232|100583022|FG001|Treated|Overall Study||8||
48104785|NCT00531232|100583023|FG002|Treated|Overall Study||24||
48104786|NCT00531232|100583021|FG000|COMPLETED|Overall Study||0||
48104787|NCT00531232|100583022|FG001|COMPLETED|Overall Study||0||
48104788|NCT00531232|100583023|FG002|COMPLETED|Overall Study||0||
48104789|NCT00531232|100583021|FG000|NOT COMPLETED|Overall Study||4||
48104790|NCT00531232|100583022|FG001|NOT COMPLETED|Overall Study||9||
48104791|NCT00531232|100583023|FG002|NOT COMPLETED|Overall Study||25||
48104792|NCT02753699|100583024|FG000|STARTED|Overall Study||164||
48104793|NCT02753699|100583025|FG001|STARTED|Overall Study||397||
48104794|NCT02753699|100583026|FG002|STARTED|Overall Study||162||
48104795|NCT02753699|100583024|FG000|COMPLETED|Overall Study||150||
48104796|NCT02753699|100583025|FG001|COMPLETED|Overall Study||354||
48104797|NCT02753699|100583026|FG002|COMPLETED|Overall Study||139||
48104798|NCT02753699|100583024|FG000|NOT COMPLETED|Overall Study||14||
48104799|NCT02753699|100583025|FG001|NOT COMPLETED|Overall Study||43||
48104800|NCT02753699|100583026|FG002|NOT COMPLETED|Overall Study||23||
48104801|NCT02586896|100583027|FG000|STARTED|Overall Study||150||
48104802|NCT02586896|100583028|FG001|STARTED|Overall Study||150||
48104803|NCT02586896|100583027|FG000|3-Month Follow-up|Overall Study||126||
48104804|NCT02586896|100583028|FG001|3-Month Follow-up|Overall Study||123||
48104805|NCT02586896|100583027|FG000|COMPLETED|Overall Study||131|6-Month Follow-Up|
48104806|NCT02586896|100583028|FG001|COMPLETED|Overall Study||133|6-Month Follow-Up|
48104807|NCT02586896|100583027|FG000|NOT COMPLETED|Overall Study||19||
48104808|NCT02586896|100583028|FG001|NOT COMPLETED|Overall Study||17||
48104809|NCT02124863|100583029|FG000|STARTED|Overall Study||67||
48104810|NCT02124863|100583029|FG000|COMPLETED|Overall Study||50||
48104811|NCT02124863|100583029|FG000|NOT COMPLETED|Overall Study||17||
48104812|NCT01113879|100583030|FG000|STARTED|Period 1: Block 1||7||
48104813|NCT01113879|100583031|FG001|STARTED|Period 1: Block 1||2||
48104814|NCT01113879|100583030|FG000|COMPLETED|Period 1: Block 1||5||
48104815|NCT01113879|100583031|FG001|COMPLETED|Period 1: Block 1||2||
48104816|NCT01113879|100583030|FG000|NOT COMPLETED|Period 1: Block 1||2||
48104817|NCT01113879|100583031|FG001|NOT COMPLETED|Period 1: Block 1||0||
48104818|NCT01113879|100583030|FG000|STARTED|Period 2: Block 2||5||
48104819|NCT01113879|100583031|FG001|STARTED|Period 2: Block 2||2||
48104820|NCT01113879|100583030|FG000|COMPLETED|Period 2: Block 2||5||
48104821|NCT01113879|100583031|FG001|COMPLETED|Period 2: Block 2||2||
48104822|NCT01113879|100583030|FG000|NOT COMPLETED|Period 2: Block 2||0||
48104823|NCT01113879|100583031|FG001|NOT COMPLETED|Period 2: Block 2||0||
48104824|NCT03022292|100583032|FG000|STARTED|Overall Study||26||
48104825|NCT03022292|100583032|FG000|COMPLETED|Overall Study||24||
48104826|NCT03022292|100583032|FG000|NOT COMPLETED|Overall Study||2||
48104827|NCT02442778|100583033|FG000|STARTED|Overall Study||210||
48104828|NCT02442778|100583034|FG001|STARTED|Overall Study||151||
48104829|NCT02442778|100583035|FG002|STARTED|Overall Study||161||
48104830|NCT02442778|100583033|FG000|Safety Population|Overall Study||210|Safety Population included all participants who received at least one dose of study medication. Participants were included in the treatment group based on the actual treatment received.|
48104831|NCT02442778|100583034|FG001|Safety Population|Overall Study||151|Safety Population included all participants who received at least one dose of study medication. Participants were included in the treatment group based on the actual treatment received.|
48104832|NCT02442778|100583035|FG002|Safety Population|Overall Study||160|Safety Population included all participants who received at least one dose of study medication. Participants were included in the treatment group based on the actual treatment received.|
48104833|NCT02442778|100583033|FG000|Modified Intent-to-Treat (mITT) Population|Overall Study||210|mITT Population included all randomized participants who had at least one post-baseline efficacy assessment. Participants were included in the treatment group to which they were randomized regardless of treatment received|
48104834|NCT02442778|100583034|FG001|Modified Intent-to-Treat (mITT) Population|Overall Study||150|mITT Population included all randomized participants who had at least one post-baseline efficacy assessment. Participants were included in the treatment group to which they were randomized regardless of treatment received|
48104835|NCT02442778|100583035|FG002|Modified Intent-to-Treat (mITT) Population|Overall Study||159|mITT Population included all randomized participants who had at least one post-baseline efficacy assessment. Participants were included in the treatment group to which they were randomized regardless of treatment received|
48104836|NCT02442778|100583033|FG000|COMPLETED|Overall Study||192||
48104837|NCT02442778|100583034|FG001|COMPLETED|Overall Study||121||
48104838|NCT02442778|100583035|FG002|COMPLETED|Overall Study||146||
48104839|NCT02442778|100583033|FG000|NOT COMPLETED|Overall Study||18||
48104840|NCT02442778|100583034|FG001|NOT COMPLETED|Overall Study||30||
48104841|NCT02442778|100583035|FG002|NOT COMPLETED|Overall Study||15||
48104842|NCT03913091|100583036|FG000|STARTED|Overall Study||92||
48104843|NCT03913091|100583037|FG001|STARTED|Overall Study||92||
48104844|NCT03913091|100583036|FG000|COMPLETED|Overall Study||72||
48104845|NCT03913091|100583037|FG001|COMPLETED|Overall Study||78||
48104846|NCT03913091|100583036|FG000|NOT COMPLETED|Overall Study||20||
48104847|NCT03913091|100583037|FG001|NOT COMPLETED|Overall Study||14||
48104848|NCT01015586|100583038|FG000|STARTED|Overall Study||21||
48104849|NCT01015586|100583039|FG001|STARTED|Overall Study||22||
48104850|NCT01015586|100583038|FG000|COMPLETED|Overall Study||14||
48104851|NCT01015586|100583039|FG001|COMPLETED|Overall Study||11||
48104852|NCT01015586|100583038|FG000|NOT COMPLETED|Overall Study||7||
48104853|NCT01015586|100583039|FG001|NOT COMPLETED|Overall Study||11||
48104854|NCT02876900|100583040|FG000|STARTED|Overall Study||205||
48104855|NCT02876900|100583041|FG001|STARTED|Overall Study||206||
48104856|NCT02876900|100583042|FG002|STARTED|Overall Study||206||
48551426|NCT00805467|101683155|FG001|Enrolled But Did Not Receive Treatment|Overall Study||0||
48551427|NCT00805467|101683156|FG002|Enrolled But Did Not Receive Treatment|Overall Study||0||
48551428|NCT00805467|101683157|FG003|Enrolled But Did Not Receive Treatment|Overall Study||0||
48691937|NCT01498692|102029059|FG000|NOT COMPLETED|Overall Study||8||
48551429|NCT00805467|101683154|FG000|COMPLETED|Overall Study||1||
48551430|NCT00805467|101683155|FG001|COMPLETED|Overall Study||25||
48551431|NCT00805467|101683156|FG002|COMPLETED|Overall Study||80||
48551432|NCT00805467|101683157|FG003|COMPLETED|Overall Study||144||
48551433|NCT00805467|101683154|FG000|NOT COMPLETED|Overall Study||0||
48551434|NCT00805467|101683155|FG001|NOT COMPLETED|Overall Study||34||
48691938|NCT01336712|102029060|FG000|STARTED|Overall Study||30||
48691939|NCT01336712|102029060|FG000|COMPLETED|Overall Study||27||
48691940|NCT01336712|102029060|FG000|NOT COMPLETED|Overall Study||3||
48691941|NCT00456755|102029061|FG000|STARTED|Overall Study||63||
48691942|NCT00456755|102029062|FG001|STARTED|Overall Study||63||
48691943|NCT00456755|102029061|FG000|COMPLETED|Overall Study||61||
48691944|NCT00456755|102029062|FG001|COMPLETED|Overall Study||62||
48691945|NCT00456755|102029061|FG000|NOT COMPLETED|Overall Study||2||
48691946|NCT00456755|102029062|FG001|NOT COMPLETED|Overall Study||1||
48691947|NCT00652743|102029063|FG000|STARTED|Months 12-18||219||
48691948|NCT00652743|102029064|FG001|STARTED|Months 12-18||188||
48691949|NCT00652743|102029065|FG002|STARTED|Months 12-18||437||
48691950|NCT00652743|102029063|FG000|COMPLETED|Months 12-18||218||
48691951|NCT00652743|102029064|FG001|COMPLETED|Months 12-18||186||
48691952|NCT00652743|102029065|FG002|COMPLETED|Months 12-18||430||
48691953|NCT00652743|102029063|FG000|NOT COMPLETED|Months 12-18||1||
48691954|NCT00652743|102029064|FG001|NOT COMPLETED|Months 12-18||2||
48691955|NCT00652743|102029065|FG002|NOT COMPLETED|Months 12-18||7||
48691956|NCT00652743|102029063|FG000|STARTED|Months 24-30||212||
48691957|NCT00652743|102029064|FG001|STARTED|Months 24-30||186||
48691958|NCT00652743|102029065|FG002|STARTED|Months 24-30||433||
48691959|NCT00652743|102029063|FG000|COMPLETED|Months 24-30||207||
48691960|NCT00652743|102029064|FG001|COMPLETED|Months 24-30||185||
48691961|NCT00652743|102029065|FG002|COMPLETED|Months 24-30||422||
48266106|NCT05262751|100975361|FG000|COMPLETED|Treatment Period 3||2||
48266107|NCT05262751|100975362|FG001|COMPLETED|Treatment Period 3||1||
48266108|NCT05262751|100975363|FG002|COMPLETED|Treatment Period 3||2||
48266109|NCT05262751|100975364|FG003|COMPLETED|Treatment Period 3||5||
48266110|NCT05262751|100975365|FG004|COMPLETED|Treatment Period 3||5||
48266111|NCT05262751|100975366|FG005|COMPLETED|Treatment Period 3||4||
48266112|NCT05262751|100975361|FG000|NOT COMPLETED|Treatment Period 3||0||
48266113|NCT05262751|100975362|FG001|NOT COMPLETED|Treatment Period 3||1||
48266114|NCT05262751|100975363|FG002|NOT COMPLETED|Treatment Period 3||0||
48266115|NCT05262751|100975364|FG003|NOT COMPLETED|Treatment Period 3||0||
48266116|NCT05262751|100975365|FG004|NOT COMPLETED|Treatment Period 3||0||
48266117|NCT05262751|100975366|FG005|NOT COMPLETED|Treatment Period 3||0||
48266118|NCT00412607|100975367|FG000|STARTED|Overall Study||249||
48266119|NCT00412607|100975367|FG000|Started Study Catheter|Overall Study||233||
48266120|NCT00412607|100975367|FG000|COMPLETED|Overall Study||145||
48266121|NCT00412607|100975367|FG000|NOT COMPLETED|Overall Study||104||
48266122|NCT03552523|100975368|FG000|STARTED|Overall Study||5||
48551435|NCT00805467|101683156|FG002|NOT COMPLETED|Overall Study||103||
48551436|NCT00805467|101683157|FG003|NOT COMPLETED|Overall Study||237||
48551437|NCT05013008|101683158|FG000|STARTED|Overall Study||483||
48551438|NCT05013008|101683159|FG001|STARTED|Overall Study||468||
48551439|NCT05013008|101683158|FG000|mBFAS|Overall Study||478|Modified biomarker full analysis set (mBFAS)|
48551440|NCT05013008|101683159|FG001|mBFAS|Overall Study||443|Modified biomarker full analysis set (mBFAS)|
48551441|NCT05013008|101683158|FG000|COMPLETED|Overall Study||478||
48551442|NCT05013008|101683159|FG001|COMPLETED|Overall Study||443||
48551443|NCT05013008|101683158|FG000|NOT COMPLETED|Overall Study||5||
48551444|NCT05013008|101683159|FG001|NOT COMPLETED|Overall Study||25||
48551445|NCT01570686|101683160|FG000|STARTED|Overall Study||296||
48551446|NCT01570686|101683161|FG001|STARTED|Overall Study||294||
48551447|NCT01570686|101683160|FG000|Safety and Full Analysis Set (FAS)|Overall Study||295||
48551448|NCT01570686|101683161|FG001|Safety and Full Analysis Set (FAS)|Overall Study||294||
48551449|NCT01570686|101683160|FG000|COMPLETED|Overall Study||274||
48551450|NCT01570686|101683161|FG001|COMPLETED|Overall Study||278||
48551451|NCT01570686|101683160|FG000|NOT COMPLETED|Overall Study||22||
48551452|NCT01570686|101683161|FG001|NOT COMPLETED|Overall Study||16||
48551453|NCT01103492|101683162|FG000|STARTED|Overall Study||1||
48551454|NCT01103492|101683162|FG000|COMPLETED|Overall Study||1||
48551455|NCT01103492|101683162|FG000|NOT COMPLETED|Overall Study||0||
48551456|NCT03908437|101683163|FG000|STARTED|Overall Study||55||
48551457|NCT03908437|101683164|FG001|STARTED|Overall Study||49||
48551458|NCT03908437|101683163|FG000|COMPLETED|Overall Study||24||
48551459|NCT03908437|101683164|FG001|COMPLETED|Overall Study||24||
48551460|NCT03908437|101683163|FG000|NOT COMPLETED|Overall Study||31||
48551461|NCT03908437|101683164|FG001|NOT COMPLETED|Overall Study||25||
48551462|NCT04721808|101683165|FG000|STARTED|Overall Study||1712||
48551463|NCT04721808|101683165|FG000|COMPLETED|Overall Study||1712||
48551464|NCT04721808|101683165|FG000|NOT COMPLETED|Overall Study||0||
48691962|NCT00652743|102029063|FG000|NOT COMPLETED|Months 24-30||5||
48691963|NCT00652743|102029064|FG001|NOT COMPLETED|Months 24-30||1||
48266123|NCT03552523|100975369|FG001|STARTED|Overall Study||2||
48266124|NCT03552523|100975368|FG000|COMPLETED|Overall Study||4||
48266125|NCT03552523|100975369|FG001|COMPLETED|Overall Study||1||
48266126|NCT03552523|100975368|FG000|NOT COMPLETED|Overall Study||1||
48266127|NCT03552523|100975369|FG001|NOT COMPLETED|Overall Study||1||
48266128|NCT01735175|100975370|FG000|STARTED|Overall Study||159|Allocated|
48266129|NCT01735175|100975371|FG001|STARTED|Overall Study||157|Allocated|
48266130|NCT01735175|100975370|FG000|Completed All Cycles|Overall Study||141||
48266131|NCT01735175|100975371|FG001|Completed All Cycles|Overall Study||150||
48266132|NCT01735175|100975370|FG000|Completed All Treatments as Planned|Overall Study||140||
48266133|NCT01735175|100975371|FG001|Completed All Treatments as Planned|Overall Study||150||
48266134|NCT01735175|100975370|FG000|Completed the 6-month SFU Visit|Overall Study||120|1 more patient, LA-EP06 arm died due to disease progression, not included in participant flow-death|
48266135|NCT01735175|100975371|FG001|Completed the 6-month SFU Visit|Overall Study||138|1 more patient, LA-EP06 arm died due to disease progression, not included in participant flow-death|
48551465|NCT02756611|101683166|FG000|STARTED|Overall Study||258||
48551466|NCT02756611|101683166|FG000|COMPLETED|Overall Study||124|Completed survival follow up period or beyond 108 weeks of treatment|
48551467|NCT02756611|101683166|FG000|NOT COMPLETED|Overall Study||134||
48551468|NCT00191191|101683167|FG000|STARTED|Overall Study||114||
48551469|NCT00191191|101683168|FG001|STARTED|Overall Study||112||
48551470|NCT00191191|101683167|FG000|Safety Analysis Population|Overall Study||114||
48551471|NCT00191191|101683168|FG001|Safety Analysis Population|Overall Study||111||
48551472|NCT00191191|101683167|FG000|Full Analysis Set Population|Overall Study||108||
48266136|NCT01735175|100975370|FG000|COMPLETED|Overall Study||130|Completed the study as planned (prior to Safety follow-up)|
48266137|NCT01735175|100975371|FG001|COMPLETED|Overall Study||144|Completed the study as planned (prior to Safety follow-up)|
48266138|NCT01735175|100975370|FG000|NOT COMPLETED|Overall Study||29||
48266139|NCT01735175|100975371|FG001|NOT COMPLETED|Overall Study||13||
48266140|NCT02833077|100975372|FG000|STARTED|Overall Study||144||
48266141|NCT02833077|100975373|FG001|STARTED|Overall Study||48||
48266142|NCT02833077|100975372|FG000|Participants Treated|Overall Study||144||
48104857|NCT02876900|100583040|FG000|COMPLETED|Overall Study||166||
48104858|NCT02876900|100583041|FG001|COMPLETED|Overall Study||158||
48104859|NCT02876900|100583042|FG002|COMPLETED|Overall Study||162||
48104860|NCT02876900|100583040|FG000|NOT COMPLETED|Overall Study||39||
48104861|NCT02876900|100583041|FG001|NOT COMPLETED|Overall Study||48||
48104862|NCT02876900|100583042|FG002|NOT COMPLETED|Overall Study||44||
48104863|NCT02106728|100583043|FG000|STARTED|Overall Study||70||
48104864|NCT02106728|100583044|FG001|STARTED|Overall Study||47||
48104865|NCT02106728|100583043|FG000|COMPLETED|Overall Study||70||
48104866|NCT02106728|100583044|FG001|COMPLETED|Overall Study||47||
48104867|NCT02106728|100583043|FG000|NOT COMPLETED|Overall Study||0||
48104868|NCT02106728|100583044|FG001|NOT COMPLETED|Overall Study||0||
48104869|NCT01716013|100583045|FG000|STARTED|Overall Study||108||
48104870|NCT01716013|100583046|FG001|STARTED|Overall Study||54||
48104871|NCT01716013|100583045|FG000|COMPLETED|Overall Study||105||
48104872|NCT01716013|100583046|FG001|COMPLETED|Overall Study||54||
48104873|NCT01716013|100583045|FG000|NOT COMPLETED|Overall Study||3||
48104874|NCT01716013|100583046|FG001|NOT COMPLETED|Overall Study||0||
48104875|NCT00291668|100583047|FG000|STARTED|Overall Study||32||
48104876|NCT00291668|100583048|FG001|STARTED|Overall Study||30||
48104877|NCT00291668|100583049|FG002|STARTED|Overall Study||32||
48104878|NCT00291668|100583047|FG000|COMPLETED|Overall Study||28||
48104879|NCT00291668|100583048|FG001|COMPLETED|Overall Study||29||
48104880|NCT00291668|100583049|FG002|COMPLETED|Overall Study||31||
48104881|NCT00291668|100583047|FG000|NOT COMPLETED|Overall Study||4||
48104882|NCT00291668|100583048|FG001|NOT COMPLETED|Overall Study||1||
48104883|NCT00291668|100583049|FG002|NOT COMPLETED|Overall Study||1||
48104884|NCT02818777|100583050|FG000|STARTED|Overall Study||13||
48104885|NCT02818777|100583050|FG000|COMPLETED|Overall Study||10||
48104886|NCT02818777|100583050|FG000|NOT COMPLETED|Overall Study||3||
48104887|NCT01644175|100583051|FG000|STARTED|Overall Study||107||
48104888|NCT01644175|100583052|FG001|STARTED|Overall Study||209||
48104889|NCT01644175|100583051|FG000|Treated|Overall Study||107||
48104890|NCT01644175|100583052|FG001|Treated|Overall Study||207||
48104891|NCT01644175|100583051|FG000|COMPLETED|Overall Study||75||
48104892|NCT01644175|100583052|FG001|COMPLETED|Overall Study||156||
48104893|NCT01644175|100583051|FG000|NOT COMPLETED|Overall Study||32||
48104894|NCT01644175|100583052|FG001|NOT COMPLETED|Overall Study||53||
48104895|NCT01859507|100583053|FG000|STARTED|Overall Study||32||
48104896|NCT01859507|100583053|FG000|COMPLETED|Overall Study||28||
48104897|NCT01859507|100583053|FG000|NOT COMPLETED|Overall Study||4||
48104898|NCT02159521|100583054|FG000|STARTED|Overall Study||81||85
48104899|NCT02159521|100583054|FG000|Received EkoSonic® Treatment|Overall Study||78||82
48104900|NCT02159521|100583054|FG000|COMPLETED|Overall Study||63||67
48104901|NCT02159521|100583054|FG000|NOT COMPLETED|Overall Study||18||18
48104902|NCT02780804|100583055|FG000|STARTED|Overall Study||6||
48104903|NCT02780804|100583056|FG001|STARTED|Overall Study||9||
48104904|NCT02780804|100583057|FG002|STARTED|Overall Study||6||
48104905|NCT02780804|100583055|FG000|COMPLETED|Overall Study||0||
48104906|NCT02780804|100583056|FG001|COMPLETED|Overall Study||0||
48104907|NCT02780804|100583057|FG002|COMPLETED|Overall Study||0||
48104908|NCT02780804|100583055|FG000|NOT COMPLETED|Overall Study||6||
48104909|NCT02780804|100583056|FG001|NOT COMPLETED|Overall Study||9||
48104910|NCT02780804|100583057|FG002|NOT COMPLETED|Overall Study||6||
48104911|NCT01549964|100583058|FG000|STARTED|24-Week Treatment Period||132||
48104912|NCT01549964|100583059|FG001|STARTED|24-Week Treatment Period||260||
48104913|NCT01549964|100583060|FG002|STARTED|24-Week Treatment Period||263||
48104914|NCT01549964|100583061|FG003|STARTED|24-Week Treatment Period||261||
48104915|NCT01549964|100583058|FG000|Safety Analysis Set=Received Treatment|24-Week Treatment Period||132||
48104916|NCT01549964|100583059|FG001|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260||
48104917|NCT01549964|100583060|FG002|Safety Analysis Set=Received Treatment|24-Week Treatment Period||263||
48104918|NCT01549964|100583061|FG003|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260||
48104919|NCT01549964|100583058|FG000|COMPLETED|24-Week Treatment Period||71||
48266143|NCT02833077|100975373|FG001|Participants Treated|Overall Study||38||
48266144|NCT02833077|100975372|FG000|COMPLETED|Overall Study||127||
48266145|NCT02833077|100975373|FG001|COMPLETED|Overall Study||40||
48104920|NCT01549964|100583059|FG001|COMPLETED|24-Week Treatment Period||149||
48104921|NCT01549964|100583060|FG002|COMPLETED|24-Week Treatment Period||147||
48104922|NCT01549964|100583061|FG003|COMPLETED|24-Week Treatment Period||140||
48104923|NCT01549964|100583058|FG000|NOT COMPLETED|24-Week Treatment Period||61||
48266146|NCT02833077|100975372|FG000|NOT COMPLETED|Overall Study||17||
48266147|NCT02833077|100975373|FG001|NOT COMPLETED|Overall Study||8||
48266148|NCT00940875|100975374|FG000|STARTED|Treatment Phase||31||
48104924|NCT01549964|100583059|FG001|NOT COMPLETED|24-Week Treatment Period||111||
48104925|NCT01549964|100583060|FG002|NOT COMPLETED|24-Week Treatment Period||116||
48104926|NCT01549964|100583061|FG003|NOT COMPLETED|24-Week Treatment Period||121||
48104927|NCT01549964|100583058|FG000|STARTED|80-Week Extension Period||66||
48104928|NCT01549964|100583059|FG001|STARTED|80-Week Extension Period||138||
48104929|NCT01549964|100583060|FG002|STARTED|80-Week Extension Period||140||
48104930|NCT01549964|100583061|FG003|STARTED|80-Week Extension Period||137||
48104931|NCT01549964|100583058|FG000|COMPLETED|80-Week Extension Period||0||
48266149|NCT00940875|100975375|FG001|STARTED|Treatment Phase||23||
48266150|NCT00940875|100975374|FG000|COMPLETED|Treatment Phase||5||
48266151|NCT00940875|100975375|FG001|COMPLETED|Treatment Phase||4||
48266152|NCT00940875|100975374|FG000|NOT COMPLETED|Treatment Phase||26||
48266153|NCT00940875|100975375|FG001|NOT COMPLETED|Treatment Phase||19||
48266154|NCT00940875|100975374|FG000|STARTED|Post-Study Treatment||0||
48266155|NCT00940875|100975375|FG001|STARTED|Post-Study Treatment||4||
48266156|NCT00940875|100975374|FG000|COMPLETED|Post-Study Treatment||0||
48266157|NCT00940875|100975375|FG001|COMPLETED|Post-Study Treatment||1||
48266158|NCT00940875|100975374|FG000|NOT COMPLETED|Post-Study Treatment||0||
48266159|NCT00940875|100975375|FG001|NOT COMPLETED|Post-Study Treatment||3||
48266160|NCT01154140|100975376|FG000|STARTED|Overall Study||172||
48266161|NCT01154140|100975377|FG001|STARTED|Overall Study||171||
48266162|NCT01154140|100975376|FG000|Treated|Overall Study||171||
48266163|NCT01154140|100975377|FG001|Treated|Overall Study||169||
48266164|NCT01154140|100975376|FG000|COMPLETED|Overall Study||81||
48266165|NCT01154140|100975377|FG001|COMPLETED|Overall Study||69||
48266166|NCT01154140|100975376|FG000|NOT COMPLETED|Overall Study||91||
48266167|NCT01154140|100975377|FG001|NOT COMPLETED|Overall Study||102||
48691964|NCT00652743|102029065|FG002|NOT COMPLETED|Months 24-30||11||
48691965|NCT00652743|102029063|FG000|STARTED|Months 36-42||216||
48691966|NCT00652743|102029064|FG001|STARTED|Months 36-42||185||
48691967|NCT00652743|102029065|FG002|STARTED|Months 36-42||390||
48691968|NCT00652743|102029063|FG000|COMPLETED|Months 36-42||210||
48691969|NCT00652743|102029064|FG001|COMPLETED|Months 36-42||180||
48104932|NCT01549964|100583059|FG001|COMPLETED|80-Week Extension Period||0||
48691970|NCT00652743|102029065|FG002|COMPLETED|Months 36-42||381||
48691971|NCT00652743|102029063|FG000|NOT COMPLETED|Months 36-42||6||
48691972|NCT00652743|102029064|FG001|NOT COMPLETED|Months 36-42||5||
48691973|NCT00652743|102029065|FG002|NOT COMPLETED|Months 36-42||9||
48691974|NCT00652743|102029063|FG000|STARTED|Months 42-48||196||
48691975|NCT00652743|102029064|FG001|STARTED|Months 42-48||170||
48691976|NCT00652743|102029065|FG002|STARTED|Months 42-48||367||
48691977|NCT00652743|102029063|FG000|COMPLETED|Months 42-48||196||
48691978|NCT00652743|102029064|FG001|COMPLETED|Months 42-48||170||
48691979|NCT00652743|102029065|FG002|COMPLETED|Months 42-48||367||
48691980|NCT00652743|102029063|FG000|NOT COMPLETED|Months 42-48||0||
48691981|NCT00652743|102029064|FG001|NOT COMPLETED|Months 42-48||0||
48691982|NCT00652743|102029065|FG002|NOT COMPLETED|Months 42-48||0||
48691983|NCT03951766|102029066|FG000|STARTED|Treatment Phase||100||
48691984|NCT03951766|102029066|FG000|COMPLETED|Treatment Phase||99||
48691985|NCT03951766|102029066|FG000|NOT COMPLETED|Treatment Phase||1||
48691986|NCT03951766|102029066|FG000|STARTED|Follow-up Phase||99||
48691987|NCT03951766|102029066|FG000|COMPLETED|Follow-up Phase||89||
48691988|NCT03951766|102029066|FG000|NOT COMPLETED|Follow-up Phase||10||
48691989|NCT02243371|102029067|FG000|STARTED|Overall Study||51||
48691990|NCT02243371|102029068|FG001|STARTED|Overall Study||42||
48104933|NCT01549964|100583060|FG002|COMPLETED|80-Week Extension Period||0||
48104934|NCT01549964|100583061|FG003|COMPLETED|80-Week Extension Period||0||
48104935|NCT01549964|100583058|FG000|NOT COMPLETED|80-Week Extension Period||66||
48104936|NCT01549964|100583059|FG001|NOT COMPLETED|80-Week Extension Period||138||
48104937|NCT01549964|100583060|FG002|NOT COMPLETED|80-Week Extension Period||140||
48691991|NCT02243371|102029067|FG000|COMPLETED|Overall Study||14||
48691992|NCT02243371|102029068|FG001|COMPLETED|Overall Study||10||
48104938|NCT01549964|100583061|FG003|NOT COMPLETED|80-Week Extension Period||137||
48691993|NCT02243371|102029067|FG000|NOT COMPLETED|Overall Study||37||
48691994|NCT02243371|102029068|FG001|NOT COMPLETED|Overall Study||32||
48104939|NCT00128921|100583062|FG000|STARTED|Overall Study||10||
48691995|NCT00082368|102029069|FG000|STARTED|Overall Study||12||
48691996|NCT00082368|102029069|FG000|COMPLETED|Overall Study||11||
48691997|NCT00082368|102029069|FG000|NOT COMPLETED|Overall Study||1||
48691998|NCT02720523|102029070|FG000|STARTED|Period 1: Placebo-controlled Period||49||
48104940|NCT00128921|100583063|FG001|STARTED|Overall Study||8||
48104941|NCT00128921|100583064|FG002|STARTED|Overall Study||0||
48104942|NCT00128921|100583062|FG000|Received Bortezomib|Overall Study||10||
48104943|NCT00128921|100583063|FG001|Received Bortezomib|Overall Study||6||
48104944|NCT00128921|100583064|FG002|Received Bortezomib|Overall Study||0||
48691999|NCT02720523|102029071|FG001|STARTED|Period 1: Placebo-controlled Period||49||
48692000|NCT02720523|102029072|FG002|STARTED|Period 1: Placebo-controlled Period||49||
48692001|NCT02720523|102029073|FG003|STARTED|Period 1: Placebo-controlled Period||50||
48104945|NCT00128921|100583062|FG000|COMPLETED|Overall Study||5||
48104946|NCT00128921|100583063|FG001|COMPLETED|Overall Study||3||
48266168|NCT01896557|100975378|FG000|STARTED|Clopidogrel Alone||44||
48266169|NCT01896557|100975379|FG001|STARTED|Clopidogrel Alone||48||
48266170|NCT01896557|100975378|FG000|COMPLETED|Clopidogrel Alone||43||
48266171|NCT01896557|100975379|FG001|COMPLETED|Clopidogrel Alone||48||
48266172|NCT01896557|100975378|FG000|NOT COMPLETED|Clopidogrel Alone||1||
48692002|NCT02720523|102029074|FG004|STARTED|Period 1: Placebo-controlled Period||0||
48692003|NCT02720523|102029075|FG005|STARTED|Period 1: Placebo-controlled Period||0||
48692004|NCT02720523|102029076|FG006|STARTED|Period 1: Placebo-controlled Period||0||
48692005|NCT02720523|102029070|FG000|COMPLETED|Period 1: Placebo-controlled Period||47||
48692006|NCT02720523|102029071|FG001|COMPLETED|Period 1: Placebo-controlled Period||49||
48692007|NCT02720523|102029072|FG002|COMPLETED|Period 1: Placebo-controlled Period||47||
48692008|NCT02720523|102029073|FG003|COMPLETED|Period 1: Placebo-controlled Period||44||
48692009|NCT02720523|102029074|FG004|COMPLETED|Period 1: Placebo-controlled Period||0||
48692010|NCT02720523|102029075|FG005|COMPLETED|Period 1: Placebo-controlled Period||0||
48692011|NCT02720523|102029076|FG006|COMPLETED|Period 1: Placebo-controlled Period||0||
48692012|NCT02720523|102029070|FG000|NOT COMPLETED|Period 1: Placebo-controlled Period||2||
48692013|NCT02720523|102029071|FG001|NOT COMPLETED|Period 1: Placebo-controlled Period||0||
48692014|NCT02720523|102029072|FG002|NOT COMPLETED|Period 1: Placebo-controlled Period||2||
48692015|NCT02720523|102029073|FG003|NOT COMPLETED|Period 1: Placebo-controlled Period||6||
48692016|NCT02720523|102029074|FG004|NOT COMPLETED|Period 1: Placebo-controlled Period||0||
48692017|NCT02720523|102029075|FG005|NOT COMPLETED|Period 1: Placebo-controlled Period||0||
48692018|NCT02720523|102029076|FG006|NOT COMPLETED|Period 1: Placebo-controlled Period||0||
48266173|NCT01896557|100975379|FG001|NOT COMPLETED|Clopidogrel Alone||0||
48266174|NCT01896557|100975378|FG000|STARTED|Clopidogrel + GI Protector||43||
48266175|NCT01896557|100975379|FG001|STARTED|Clopidogrel + GI Protector||48||
48266176|NCT01896557|100975378|FG000|COMPLETED|Clopidogrel + GI Protector||41||
48266177|NCT01896557|100975379|FG001|COMPLETED|Clopidogrel + GI Protector||44||
48266178|NCT01896557|100975378|FG000|NOT COMPLETED|Clopidogrel + GI Protector||2||
48266179|NCT01896557|100975379|FG001|NOT COMPLETED|Clopidogrel + GI Protector||4||
48266180|NCT02388347|100975380|FG000|STARTED|Overall Study||8||
48266181|NCT02388347|100975381|FG001|STARTED|Overall Study||6||
48266182|NCT02388347|100975382|FG002|STARTED|Overall Study||6||
48266183|NCT02388347|100975383|FG003|STARTED|Overall Study||6||
48391789|NCT01742078|101287732|FG005|NOT COMPLETED|Overall Study||0||
48391790|NCT01742078|101287733|FG006|NOT COMPLETED|Overall Study||0||
48391791|NCT01742078|101287734|FG007|NOT COMPLETED|Overall Study||0||
48391792|NCT01742078|101287735|FG008|NOT COMPLETED|Overall Study||0||
48391793|NCT03330041|101287736|FG000|STARTED|Overall Study||50||
48391794|NCT03330041|101287736|FG000|COMPLETED|Overall Study||48||
48391795|NCT03330041|101287736|FG000|NOT COMPLETED|Overall Study||2||
48391796|NCT03505749|101287737|FG000|STARTED|Overall Study||38||
48391797|NCT03505749|101287738|FG001|STARTED|Overall Study||45||
48391798|NCT03505749|101287737|FG000|COMPLETED|Overall Study||22||
48391799|NCT03505749|101287738|FG001|COMPLETED|Overall Study||28||
48391800|NCT03505749|101287737|FG000|NOT COMPLETED|Overall Study||16||
48391801|NCT03505749|101287738|FG001|NOT COMPLETED|Overall Study||17||
48391802|NCT01392378|101287739|FG000|STARTED|Infant Series||173||
48391803|NCT01392378|101287740|FG001|STARTED|Infant Series||176||
48391804|NCT01392378|101287741|FG002|STARTED|Infant Series||172||
48391805|NCT01392378|101287742|FG003|STARTED|Infant Series||177||
48391806|NCT01392378|101287743|FG004|STARTED|Infant Series||210||
48391807|NCT01392378|101287739|FG000|Vaccinated Dose 1|Infant Series||173||
48391808|NCT01392378|101287740|FG001|Vaccinated Dose 1|Infant Series||176||
48391809|NCT01392378|101287741|FG002|Vaccinated Dose 1|Infant Series||172||
48391810|NCT01392378|101287742|FG003|Vaccinated Dose 1|Infant Series||177||
48391811|NCT01392378|101287743|FG004|Vaccinated Dose 1|Infant Series||210||
48391812|NCT01392378|101287739|FG000|Vaccinated Dose 2|Infant Series||171||
48391813|NCT01392378|101287740|FG001|Vaccinated Dose 2|Infant Series||174||
48692019|NCT02720523|102029070|FG000|STARTED|Period 2: Long-term Extension Period||0||
48692020|NCT02720523|102029071|FG001|STARTED|Period 2: Long-term Extension Period||0||
48692021|NCT02720523|102029072|FG002|STARTED|Period 2: Long-term Extension Period||0||
48266184|NCT02388347|100975384|FG004|STARTED|Overall Study||6||
48266185|NCT02388347|100975380|FG000|COMPLETED|Overall Study||8||
48266186|NCT02388347|100975381|FG001|COMPLETED|Overall Study||6||
48266187|NCT02388347|100975382|FG002|COMPLETED|Overall Study||5||
48692022|NCT02720523|102029073|FG003|STARTED|Period 2: Long-term Extension Period||0||
48266188|NCT02388347|100975383|FG003|COMPLETED|Overall Study||6||
48266189|NCT02388347|100975384|FG004|COMPLETED|Overall Study||6||
48266190|NCT02388347|100975380|FG000|NOT COMPLETED|Overall Study||0||
48266191|NCT02388347|100975381|FG001|NOT COMPLETED|Overall Study||0||
48266192|NCT02388347|100975382|FG002|NOT COMPLETED|Overall Study||1||
48391814|NCT01392378|101287741|FG002|Vaccinated Dose 2|Infant Series||172||
48391815|NCT01392378|101287742|FG003|Vaccinated Dose 2|Infant Series||177||
48391816|NCT01392378|101287743|FG004|Vaccinated Dose 2|Infant Series||210||
48391817|NCT01392378|101287739|FG000|Vaccinated Dose 3|Infant Series||170||
48692023|NCT02720523|102029074|FG004|STARTED|Period 2: Long-term Extension Period||65||
48692024|NCT02720523|102029075|FG005|STARTED|Period 2: Long-term Extension Period||62||
48266193|NCT02388347|100975383|FG003|NOT COMPLETED|Overall Study||0||
48266194|NCT02388347|100975384|FG004|NOT COMPLETED|Overall Study||0||
48266195|NCT01736189|100975385|FG000|STARTED|Overall Study||346||
48266196|NCT01736189|100975385|FG000|COMPLETED|Overall Study||300||
48391818|NCT01392378|101287740|FG001|Vaccinated Dose 3|Infant Series||174||
48391819|NCT01392378|101287741|FG002|Vaccinated Dose 3|Infant Series||172||
48692025|NCT02720523|102029076|FG006|STARTED|Period 2: Long-term Extension Period||60||
48266197|NCT01736189|100975385|FG000|NOT COMPLETED|Overall Study||46||
48266198|NCT02358668|100975386|FG000|STARTED|Overall Study||24||
48266199|NCT02358668|100975387|FG001|STARTED|Overall Study||24||
48266200|NCT02358668|100975388|FG002|STARTED|Overall Study||12||
48266201|NCT02358668|100975386|FG000|COMPLETED|Overall Study||22||
48266202|NCT02358668|100975387|FG001|COMPLETED|Overall Study||23||
48391820|NCT01392378|101287742|FG003|Vaccinated Dose 3|Infant Series||176||
48692026|NCT02720523|102029070|FG000|COMPLETED|Period 2: Long-term Extension Period||0|Completed study as of the data cutoff date of 12 July 2018|
48692027|NCT02720523|102029071|FG001|COMPLETED|Period 2: Long-term Extension Period||0|Completed study as of the data cutoff date of 12 July 2018|
48692028|NCT02720523|102029072|FG002|COMPLETED|Period 2: Long-term Extension Period||0|Completed study as of the data cutoff date of 12 July 2018|
48692029|NCT02720523|102029073|FG003|COMPLETED|Period 2: Long-term Extension Period||0|Completed study as of the data cutoff date of 12 July 2018|
48692030|NCT02720523|102029074|FG004|COMPLETED|Period 2: Long-term Extension Period||0|Completed study as of the data cutoff date of 12 July 2018|
48692031|NCT02720523|102029075|FG005|COMPLETED|Period 2: Long-term Extension Period||0|Completed study as of the data cutoff date of 12 July 2018|
48692032|NCT02720523|102029076|FG006|COMPLETED|Period 2: Long-term Extension Period||0|Completed study as of the data cutoff date of 12 July 2018|
48692033|NCT02720523|102029070|FG000|NOT COMPLETED|Period 2: Long-term Extension Period||0||
48692034|NCT02720523|102029071|FG001|NOT COMPLETED|Period 2: Long-term Extension Period||0||
48692035|NCT02720523|102029072|FG002|NOT COMPLETED|Period 2: Long-term Extension Period||0||
48692036|NCT02720523|102029073|FG003|NOT COMPLETED|Period 2: Long-term Extension Period||0||
48692037|NCT02720523|102029074|FG004|NOT COMPLETED|Period 2: Long-term Extension Period||65||
48692038|NCT02720523|102029075|FG005|NOT COMPLETED|Period 2: Long-term Extension Period||62||
48551473|NCT00191191|101683168|FG001|Full Analysis Set Population|Overall Study||108||
48551474|NCT00191191|101683167|FG000|COMPLETED|Overall Study||0||
48551475|NCT00191191|101683168|FG001|COMPLETED|Overall Study||0||
48551476|NCT00191191|101683167|FG000|NOT COMPLETED|Overall Study||114||
48692039|NCT02720523|102029076|FG006|NOT COMPLETED|Period 2: Long-term Extension Period||60||
48692040|NCT02342288|102029077|FG000|STARTED|Overall Study||30||
48551477|NCT00191191|101683168|FG001|NOT COMPLETED|Overall Study||112||
48551478|NCT03105518|101683169|FG000|STARTED|Overall Study||100||
48551479|NCT03105518|101683169|FG000|COMPLETED|Overall Study||100||
48692041|NCT02342288|102029078|FG001|STARTED|Overall Study||33||
48692042|NCT02342288|102029077|FG000|COMPLETED|Overall Study||25||
48692043|NCT02342288|102029078|FG001|COMPLETED|Overall Study||27||
48692044|NCT02342288|102029077|FG000|NOT COMPLETED|Overall Study||5||
48692045|NCT02342288|102029078|FG001|NOT COMPLETED|Overall Study||6||
48692046|NCT02991898|102029079|FG000|STARTED|Overall Study||3||
48692047|NCT02991898|102029079|FG000|COMPLETED|Overall Study||3||
48692048|NCT02991898|102029079|FG000|NOT COMPLETED|Overall Study||0||
48692049|NCT02277691|102029080|FG000|STARTED|Overall Study||341||
48692050|NCT02277691|102029080|FG000|COMPLETED|Overall Study||295||
48104947|NCT00128921|100583064|FG002|COMPLETED|Overall Study||0||
48104948|NCT00128921|100583062|FG000|NOT COMPLETED|Overall Study||5||
48104949|NCT00128921|100583063|FG001|NOT COMPLETED|Overall Study||5||
48104950|NCT00128921|100583064|FG002|NOT COMPLETED|Overall Study||0||
48104951|NCT02771990|100583065|FG000|STARTED|Overall Study||11||
48104952|NCT02771990|100583066|FG001|STARTED|Overall Study||10||
48104953|NCT02771990|100583065|FG000|COMPLETED|Overall Study||11||
48104954|NCT02771990|100583066|FG001|COMPLETED|Overall Study||10||
48104955|NCT02771990|100583065|FG000|NOT COMPLETED|Overall Study||0||
48104956|NCT02771990|100583066|FG001|NOT COMPLETED|Overall Study||0||
48104957|NCT00265512|100583067|FG000|STARTED|Overall Study||213||
48104958|NCT00265512|100583068|FG001|STARTED|Overall Study||454||
48104959|NCT00265512|100583067|FG000|COMPLETED|Overall Study||168||
48692051|NCT02277691|102029080|FG000|NOT COMPLETED|Overall Study||46||
48692052|NCT00182078|102029081|FG000|STARTED|Overall Study||9||
48692053|NCT00182078|102029082|FG001|STARTED|Overall Study||17||
48104960|NCT00265512|100583068|FG001|COMPLETED|Overall Study||359||
48104961|NCT00265512|100583067|FG000|NOT COMPLETED|Overall Study||45||
48104962|NCT00265512|100583068|FG001|NOT COMPLETED|Overall Study||95||
48104963|NCT01701115|100583069|FG000|STARTED|Overall Study||77||
48104964|NCT01701115|100583070|FG001|STARTED|Overall Study||77||
48104965|NCT01701115|100583069|FG000|COMPLETED|Overall Study||75||
48266203|NCT02358668|100975388|FG002|COMPLETED|Overall Study||12||
48266204|NCT02358668|100975386|FG000|NOT COMPLETED|Overall Study||2||
48266205|NCT02358668|100975387|FG001|NOT COMPLETED|Overall Study||1||
48266206|NCT02358668|100975388|FG002|NOT COMPLETED|Overall Study||0||
48266207|NCT02357264|100975389|FG000|STARTED|Overall Study||56||
48266208|NCT02357264|100975390|FG001|STARTED|Overall Study||130||
48266209|NCT02357264|100975389|FG000|COMPLETED|Overall Study||56||
48266210|NCT02357264|100975390|FG001|COMPLETED|Overall Study||130||
48266211|NCT02357264|100975389|FG000|NOT COMPLETED|Overall Study||0||
48266212|NCT02357264|100975390|FG001|NOT COMPLETED|Overall Study||0||
48266213|NCT00243074|100975391|FG000|STARTED|Overall Study||54||
48266214|NCT00243074|100975391|FG000|COMPLETED|Overall Study||0||
48266215|NCT00243074|100975391|FG000|NOT COMPLETED|Overall Study||54||
48104966|NCT01701115|100583070|FG001|COMPLETED|Overall Study||77||
48104967|NCT01701115|100583069|FG000|NOT COMPLETED|Overall Study||2||
48104968|NCT01701115|100583070|FG001|NOT COMPLETED|Overall Study||0||
48104969|NCT01124604|100583071|FG000|STARTED|Overall Study||60||
48104970|NCT01124604|100583072|FG001|STARTED|Overall Study||31||
48104971|NCT01124604|100583071|FG000|COMPLETED|Overall Study||45||
48266216|NCT00401258|100975392|FG000|STARTED|Overall Study||15||
48266217|NCT00401258|100975392|FG000|COMPLETED|Overall Study||8||
48266218|NCT00401258|100975392|FG000|NOT COMPLETED|Overall Study||7||
48551480|NCT03105518|101683169|FG000|NOT COMPLETED|Overall Study||0||
48266219|NCT01730378|100975393|FG000|STARTED|Overall Study||84||
48266220|NCT01730378|100975394|FG001|STARTED|Overall Study||47||
48266221|NCT01730378|100975393|FG000|COMPLETED|Overall Study||83||
48266222|NCT01730378|100975394|FG001|COMPLETED|Overall Study||47||
48266223|NCT01730378|100975393|FG000|NOT COMPLETED|Overall Study||1||
48266224|NCT01730378|100975394|FG001|NOT COMPLETED|Overall Study||0||
48266225|NCT00281320|100975395|FG000|STARTED|Overall Study||61||
48266226|NCT00281320|100975396|FG001|STARTED|Overall Study||61||
48266227|NCT00281320|100975395|FG000|COMPLETED|Overall Study||36||
48266228|NCT00281320|100975396|FG001|COMPLETED|Overall Study||40||
48266229|NCT00281320|100975395|FG000|NOT COMPLETED|Overall Study||25||
48266230|NCT00281320|100975396|FG001|NOT COMPLETED|Overall Study||21||
48266231|NCT02567708|100975397|FG000|STARTED|Treatment Period 1 (Up to 4 Weeks)||24||
48551481|NCT00182325|101683170|FG000|STARTED|Overall Study||97||
48266232|NCT02567708|100975398|FG001|STARTED|Treatment Period 1 (Up to 4 Weeks)||26||
48266233|NCT02567708|100975397|FG000|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||22||
48391821|NCT01392378|101287743|FG004|Vaccinated Dose 3|Infant Series||210||
48391822|NCT01392378|101287739|FG000|COMPLETED|Infant Series||169||
48391823|NCT01392378|101287740|FG001|COMPLETED|Infant Series||174||
48391824|NCT01392378|101287741|FG002|COMPLETED|Infant Series||172||
48391825|NCT01392378|101287742|FG003|COMPLETED|Infant Series||175||
48391826|NCT01392378|101287743|FG004|COMPLETED|Infant Series||210||
48391827|NCT01392378|101287739|FG000|NOT COMPLETED|Infant Series||4||
48391828|NCT01392378|101287740|FG001|NOT COMPLETED|Infant Series||2||
48391829|NCT01392378|101287741|FG002|NOT COMPLETED|Infant Series||0||
48391830|NCT01392378|101287742|FG003|NOT COMPLETED|Infant Series||2||
48391831|NCT01392378|101287743|FG004|NOT COMPLETED|Infant Series||0||
48391832|NCT01392378|101287739|FG000|STARTED|After Infant Series||169||
48391833|NCT01392378|101287740|FG001|STARTED|After Infant Series||174||
48391834|NCT01392378|101287741|FG002|STARTED|After Infant Series||172||
48391835|NCT01392378|101287742|FG003|STARTED|After Infant Series||175||
48391836|NCT01392378|101287743|FG004|STARTED|After Infant Series||210||
48391837|NCT01392378|101287739|FG000|COMPLETED|After Infant Series||169||
48391838|NCT01392378|101287740|FG001|COMPLETED|After Infant Series||173||
48391839|NCT01392378|101287741|FG002|COMPLETED|After Infant Series||170||
48391840|NCT01392378|101287742|FG003|COMPLETED|After Infant Series||175||
48391841|NCT01392378|101287743|FG004|COMPLETED|After Infant Series||209||
48391842|NCT01392378|101287739|FG000|NOT COMPLETED|After Infant Series||0||
48391843|NCT01392378|101287740|FG001|NOT COMPLETED|After Infant Series||1||
48391844|NCT01392378|101287741|FG002|NOT COMPLETED|After Infant Series||2||
48391845|NCT01392378|101287742|FG003|NOT COMPLETED|After Infant Series||0||
48391846|NCT01392378|101287743|FG004|NOT COMPLETED|After Infant Series||1||
48391847|NCT01392378|101287739|FG000|STARTED|Toddler Dose||169||
48391848|NCT01392378|101287740|FG001|STARTED|Toddler Dose||173||
48391849|NCT01392378|101287741|FG002|STARTED|Toddler Dose||170||
48391850|NCT01392378|101287742|FG003|STARTED|Toddler Dose||175||
48391851|NCT01392378|101287743|FG004|STARTED|Toddler Dose||209||
48391852|NCT01392378|101287739|FG000|COMPLETED|Toddler Dose||169||
48391853|NCT01392378|101287740|FG001|COMPLETED|Toddler Dose||172||
48391854|NCT01392378|101287741|FG002|COMPLETED|Toddler Dose||170||
48391855|NCT01392378|101287742|FG003|COMPLETED|Toddler Dose||173||
48391856|NCT01392378|101287743|FG004|COMPLETED|Toddler Dose||208||
48551482|NCT00182325|101683171|FG001|STARTED|Overall Study||96||
48551483|NCT00182325|101683170|FG000|COMPLETED|Overall Study||63||
48266234|NCT02567708|100975398|FG001|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||23||
48266235|NCT02567708|100975397|FG000|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||2||
48266236|NCT02567708|100975398|FG001|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||3||
48266237|NCT02567708|100975397|FG000|STARTED|Washout Period (Up to 4 Weeks)||22||
48266238|NCT02567708|100975398|FG001|STARTED|Washout Period (Up to 4 Weeks)||23||
48266239|NCT02567708|100975397|FG000|COMPLETED|Washout Period (Up to 4 Weeks)||22||
48266240|NCT02567708|100975398|FG001|COMPLETED|Washout Period (Up to 4 Weeks)||23||
48266241|NCT02567708|100975397|FG000|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0||
48391857|NCT01392378|101287739|FG000|NOT COMPLETED|Toddler Dose||0||
48391858|NCT01392378|101287740|FG001|NOT COMPLETED|Toddler Dose||1||
48391859|NCT01392378|101287741|FG002|NOT COMPLETED|Toddler Dose||0||
48391860|NCT01392378|101287742|FG003|NOT COMPLETED|Toddler Dose||2||
48391861|NCT01392378|101287743|FG004|NOT COMPLETED|Toddler Dose||1||
48391862|NCT02553317|101287744|FG000|STARTED|Overall Treatment Period + Follow-up||72||
48391863|NCT02553317|101287745|FG001|STARTED|Overall Treatment Period + Follow-up||73||
48391864|NCT02553317|101287744|FG000|Received Study Drug|Overall Treatment Period + Follow-up||71||
48391865|NCT02553317|101287745|FG001|Received Study Drug|Overall Treatment Period + Follow-up||73||
48391866|NCT02553317|101287744|FG000|COMPLETED|Overall Treatment Period + Follow-up||58||
48391867|NCT02553317|101287745|FG001|COMPLETED|Overall Treatment Period + Follow-up||50||
48391868|NCT02553317|101287744|FG000|NOT COMPLETED|Overall Treatment Period + Follow-up||14||
48391869|NCT02553317|101287745|FG001|NOT COMPLETED|Overall Treatment Period + Follow-up||23||
48266242|NCT02567708|100975398|FG001|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0||
48266243|NCT02567708|100975397|FG000|STARTED|Treatment Period 2 (Up to 4 Weeks)||22||
48266244|NCT02567708|100975398|FG001|STARTED|Treatment Period 2 (Up to 4 Weeks)||23||
48391870|NCT02553317|101287744|FG000|STARTED|Double-blind (DB) Treatment Period||71||
48551484|NCT00182325|101683171|FG001|COMPLETED|Overall Study||43||
48266245|NCT02567708|100975397|FG000|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||22||
48551485|NCT00182325|101683170|FG000|NOT COMPLETED|Overall Study||34||
48551486|NCT00182325|101683171|FG001|NOT COMPLETED|Overall Study||53||
48551487|NCT01720225|101683172|FG000|STARTED|Overall Study||73||
48266246|NCT02567708|100975398|FG001|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||20||
48266247|NCT02567708|100975397|FG000|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0||
48266248|NCT02567708|100975398|FG001|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||3||
48266249|NCT02370251|100975399|FG000|STARTED|Overall Study||63||
48266250|NCT02370251|100975399|FG000|COMPLETED|Overall Study||52||
48266251|NCT02370251|100975399|FG000|NOT COMPLETED|Overall Study||11||
48266252|NCT01712061|100975400|FG000|STARTED|Overall Study||30||
48266253|NCT01712061|100975401|FG001|STARTED|Overall Study||140||
48266254|NCT01712061|100975402|FG002|STARTED|Overall Study||56||
48266255|NCT01712061|100975400|FG000|COMPLETED|Overall Study||20||
48266256|NCT01712061|100975401|FG001|COMPLETED|Overall Study||114||
48266257|NCT01712061|100975402|FG002|COMPLETED|Overall Study||45||
48266258|NCT01712061|100975400|FG000|NOT COMPLETED|Overall Study||10||
48266259|NCT01712061|100975401|FG001|NOT COMPLETED|Overall Study||26||
48266260|NCT01712061|100975402|FG002|NOT COMPLETED|Overall Study||11||
48266261|NCT01053247|100975403|FG000|STARTED|Overall Study||269||
48266262|NCT01053247|100975404|FG001|STARTED|Overall Study||260||
48266263|NCT01053247|100975405|FG002|STARTED|Overall Study||264||
48266264|NCT01053247|100975403|FG000|COMPLETED|Overall Study||249||
48266265|NCT01053247|100975404|FG001|COMPLETED|Overall Study||241||
48266266|NCT01053247|100975405|FG002|COMPLETED|Overall Study||236||
48266267|NCT01053247|100975403|FG000|NOT COMPLETED|Overall Study||20||
48266268|NCT01053247|100975404|FG001|NOT COMPLETED|Overall Study||19||
48266269|NCT01053247|100975405|FG002|NOT COMPLETED|Overall Study||28||
48266270|NCT03617835|100975406|FG000|STARTED|Overall Study||12||
48266271|NCT03617835|100975407|FG001|STARTED|Overall Study||12||
48266272|NCT03617835|100975408|FG002|STARTED|Overall Study||12||
48266273|NCT03617835|100975409|FG003|STARTED|Overall Study||12||
48266274|NCT03617835|100975406|FG000|COMPLETED|Overall Study||12||
48266275|NCT03617835|100975407|FG001|COMPLETED|Overall Study||12||
48266276|NCT03617835|100975408|FG002|COMPLETED|Overall Study||12||
48391871|NCT02553317|101287745|FG001|STARTED|Double-blind (DB) Treatment Period||73||
48391872|NCT02553317|101287744|FG000|COMPLETED|Double-blind (DB) Treatment Period||68||
48104972|NCT01124604|100583072|FG001|COMPLETED|Overall Study||29||
48391873|NCT02553317|101287745|FG001|COMPLETED|Double-blind (DB) Treatment Period||65||
48391874|NCT02553317|101287744|FG000|NOT COMPLETED|Double-blind (DB) Treatment Period||3||
48391875|NCT02553317|101287745|FG001|NOT COMPLETED|Double-blind (DB) Treatment Period||8||
48391876|NCT02553317|101287744|FG000|STARTED|Open-label (OL) Treatment Period||2||
48391877|NCT02553317|101287745|FG001|STARTED|Open-label (OL) Treatment Period||26||
48391878|NCT02553317|101287744|FG000|COMPLETED|Open-label (OL) Treatment Period||2||
48551488|NCT01720225|101683173|FG001|STARTED|Overall Study||40||
48104973|NCT01124604|100583071|FG000|NOT COMPLETED|Overall Study||15||
48104974|NCT01124604|100583072|FG001|NOT COMPLETED|Overall Study||2||
48104975|NCT03167879|100583073|FG000|STARTED|Overall Study||129||2
48104976|NCT03167879|100583074|FG001|STARTED|Overall Study||130||2
48104977|NCT03167879|100583075|FG002|STARTED|Overall Study||130||2
48104978|NCT03167879|100583073|FG000|COMPLETED|Overall Study||122||2
48104979|NCT03167879|100583074|FG001|COMPLETED|Overall Study||125||2
48104980|NCT03167879|100583075|FG002|COMPLETED|Overall Study||122||2
48104981|NCT03167879|100583073|FG000|NOT COMPLETED|Overall Study||7||0
48104982|NCT03167879|100583074|FG001|NOT COMPLETED|Overall Study||5||0
48104983|NCT03167879|100583075|FG002|NOT COMPLETED|Overall Study||8||0
48104984|NCT05516082|100583076|FG000|STARTED|Period 1: Lens A, 15 Minutes||41||
48104985|NCT05516082|100583077|FG001|STARTED|Period 1: Lens A, 15 Minutes||0||
48104986|NCT05516082|100583076|FG000|COMPLETED|Period 1: Lens A, 15 Minutes||41||
48104987|NCT05516082|100583077|FG001|COMPLETED|Period 1: Lens A, 15 Minutes||0||
48104988|NCT05516082|100583076|FG000|NOT COMPLETED|Period 1: Lens A, 15 Minutes||0||
48104989|NCT05516082|100583077|FG001|NOT COMPLETED|Period 1: Lens A, 15 Minutes||0||
48104990|NCT05516082|100583076|FG000|STARTED|Period 2: Lens B, 15 Minutes||0||
48104991|NCT05516082|100583077|FG001|STARTED|Period 2: Lens B, 15 Minutes||41||
48266277|NCT03617835|100975409|FG003|COMPLETED|Overall Study||12||
48266278|NCT03617835|100975406|FG000|NOT COMPLETED|Overall Study||0||
48266279|NCT03617835|100975407|FG001|NOT COMPLETED|Overall Study||0||
48266280|NCT03617835|100975408|FG002|NOT COMPLETED|Overall Study||0||
48266281|NCT03617835|100975409|FG003|NOT COMPLETED|Overall Study||0||
48266282|NCT00701909|100975410|FG000|STARTED|Overall Study||7||
48266283|NCT00701909|100975411|FG001|STARTED|Overall Study||5||
48266284|NCT00701909|100975410|FG000|COMPLETED|Overall Study||7||
48266285|NCT00701909|100975411|FG001|COMPLETED|Overall Study||4||
48266286|NCT00701909|100975410|FG000|NOT COMPLETED|Overall Study||0||
48551489|NCT01720225|101683172|FG000|COMPLETED|Overall Study||70||
48104992|NCT05516082|100583076|FG000|COMPLETED|Period 2: Lens B, 15 Minutes||0||
48266287|NCT00701909|100975411|FG001|NOT COMPLETED|Overall Study||1||
48266288|NCT03933462|100975412|FG000|STARTED|Overall Study||10||
48266289|NCT03933462|100975413|FG001|STARTED|Overall Study||10||
48266290|NCT03933462|100975412|FG000|Crossover|Overall Study||8||
48266291|NCT03933462|100975413|FG001|Crossover|Overall Study||10||
48266292|NCT03933462|100975412|FG000|COMPLETED|Overall Study||8||
48692054|NCT00182078|102029081|FG000|COMPLETED|Overall Study||8||
48692055|NCT00182078|102029082|FG001|COMPLETED|Overall Study||17||
48692056|NCT00182078|102029081|FG000|NOT COMPLETED|Overall Study||1||
48692057|NCT00182078|102029082|FG001|NOT COMPLETED|Overall Study||0||
48692058|NCT00588237|102029083|FG000|STARTED|Overall Study||42||
48692059|NCT00588237|102029083|FG000|COMPLETED|Overall Study||38||
48692060|NCT00588237|102029083|FG000|NOT COMPLETED|Overall Study||4||
48692061|NCT01846299|102029084|FG000|STARTED|Overall Study||118||
48692062|NCT01846299|102029085|FG001|STARTED|Overall Study||60||
48692063|NCT01846299|102029084|FG000|Full Analysis Set|Overall Study||117||
48692064|NCT01846299|102029085|FG001|Full Analysis Set|Overall Study||60||
48692065|NCT01846299|102029084|FG000|Safety Set|Overall Study||119||
48692066|NCT01846299|102029085|FG001|Safety Set|Overall Study||58||
48692067|NCT01846299|102029084|FG000|COMPLETED|Overall Study||106||
48692068|NCT01846299|102029085|FG001|COMPLETED|Overall Study||50||
48551490|NCT01720225|101683173|FG001|COMPLETED|Overall Study||39||
48551491|NCT01720225|101683172|FG000|NOT COMPLETED|Overall Study||3||
48551492|NCT01720225|101683173|FG001|NOT COMPLETED|Overall Study||1||
48551493|NCT00754650|101683174|FG000|STARTED|Overall Study||2||
48551494|NCT00754650|101683174|FG000|COMPLETED|Overall Study||0||
48551495|NCT00754650|101683174|FG000|NOT COMPLETED|Overall Study||2||
48551496|NCT03953612|101683175|FG000|STARTED|Overall Study||21||
48551497|NCT03953612|101683176|FG001|STARTED|Overall Study||18||
48551498|NCT03953612|101683177|FG002|STARTED|Overall Study||19||
48551499|NCT03953612|101683175|FG000|Intent to Treat Sample Included in Analyses|Overall Study||20||
48551500|NCT03953612|101683176|FG001|Intent to Treat Sample Included in Analyses|Overall Study||17||
48692069|NCT01846299|102029084|FG000|NOT COMPLETED|Overall Study||12||
48692070|NCT01846299|102029085|FG001|NOT COMPLETED|Overall Study||10||
48692071|NCT00902850|102029086|FG000|STARTED|Overall Study||14||
48692072|NCT00902850|102029087|FG001|STARTED|Overall Study||14||
48692073|NCT00902850|102029086|FG000|COMPLETED|Overall Study||12||
48692074|NCT00902850|102029087|FG001|COMPLETED|Overall Study||12||
48692075|NCT00902850|102029086|FG000|NOT COMPLETED|Overall Study||2||
48692076|NCT00902850|102029087|FG001|NOT COMPLETED|Overall Study||2||
48692077|NCT00656058|102029088|FG000|STARTED|Overall Study||25||
48692078|NCT00656058|102029088|FG000|COMPLETED|Overall Study||19||
48692079|NCT00656058|102029088|FG000|NOT COMPLETED|Overall Study||6||
48692080|NCT00682929|102029089|FG000|STARTED|Overall Study||13||
48692081|NCT00682929|102029090|FG001|STARTED|Overall Study||14||
48692082|NCT00682929|102029091|FG002|STARTED|Overall Study||14||
48692083|NCT00682929|102029089|FG000|COMPLETED|Overall Study||7||
48692084|NCT00682929|102029090|FG001|COMPLETED|Overall Study||9||
48692085|NCT00682929|102029091|FG002|COMPLETED|Overall Study||12||
48692086|NCT00682929|102029089|FG000|NOT COMPLETED|Overall Study||6||
48692087|NCT00682929|102029090|FG001|NOT COMPLETED|Overall Study||5||
48692088|NCT00682929|102029091|FG002|NOT COMPLETED|Overall Study||2||
48692089|NCT03163134|102029092|FG000|STARTED|Overall Study||85||
48692090|NCT03163134|102029093|FG001|STARTED|Overall Study||85||
48692091|NCT03163134|102029092|FG000|COMPLETED|Overall Study||85||
48692092|NCT03163134|102029093|FG001|COMPLETED|Overall Study||85||
48692093|NCT03163134|102029092|FG000|NOT COMPLETED|Overall Study||0||
48551501|NCT03953612|101683177|FG002|Intent to Treat Sample Included in Analyses|Overall Study||18||
48692094|NCT03163134|102029093|FG001|NOT COMPLETED|Overall Study||0||
48692095|NCT00851552|102029094|FG000|STARTED|Overall Study||9||
48692096|NCT00851552|102029094|FG000|COMPLETED|Overall Study||2||
48692097|NCT00851552|102029094|FG000|NOT COMPLETED|Overall Study||7||
48692098|NCT01848067|102029095|FG000|STARTED|Overall Study||9||
48692099|NCT01848067|102029095|FG000|COMPLETED|Overall Study||9||
48692100|NCT01848067|102029095|FG000|NOT COMPLETED|Overall Study||0||
48692101|NCT00688467|102029096|FG000|STARTED|Treatment Period 1||9||
48551502|NCT03953612|101683175|FG000|Dropout Weeks 1-3|Overall Study||1||
48551503|NCT03953612|101683176|FG001|Dropout Weeks 1-3|Overall Study||1||
48551504|NCT03953612|101683177|FG002|Dropout Weeks 1-3|Overall Study||0||
48551505|NCT03953612|101683175|FG000|Dropout Weeks 4-12|Overall Study||1||
48551506|NCT03953612|101683176|FG001|Dropout Weeks 4-12|Overall Study||0||
48551507|NCT03953612|101683177|FG002|Dropout Weeks 4-12|Overall Study||0||
48551508|NCT03953612|101683175|FG000|COMPLETED|Overall Study||18||
48551509|NCT03953612|101683176|FG001|COMPLETED|Overall Study||16||
48551510|NCT03953612|101683177|FG002|COMPLETED|Overall Study||18||
48551511|NCT03953612|101683175|FG000|NOT COMPLETED|Overall Study||3||
48551512|NCT03953612|101683176|FG001|NOT COMPLETED|Overall Study||2||
48551513|NCT03953612|101683177|FG002|NOT COMPLETED|Overall Study||1||
48551514|NCT01401452|101683178|FG000|STARTED|Overall Study||246||
48551515|NCT01401452|101683178|FG000|Visit 1 (Baseline)|Overall Study||246||
48692102|NCT00688467|102029097|FG001|STARTED|Treatment Period 1||10||
48692103|NCT00688467|102029096|FG000|COMPLETED|Treatment Period 1||7||
48692104|NCT00688467|102029097|FG001|COMPLETED|Treatment Period 1||8||
48692105|NCT00688467|102029096|FG000|NOT COMPLETED|Treatment Period 1||2||
48692106|NCT00688467|102029097|FG001|NOT COMPLETED|Treatment Period 1||2||
48692107|NCT00688467|102029096|FG000|STARTED|Treatment Period 2||7||
48692108|NCT00688467|102029097|FG001|STARTED|Treatment Period 2||8||
48692109|NCT00688467|102029096|FG000|COMPLETED|Treatment Period 2||7||
48692110|NCT00688467|102029097|FG001|COMPLETED|Treatment Period 2||6||
48692111|NCT00688467|102029096|FG000|NOT COMPLETED|Treatment Period 2||0||
48692112|NCT00688467|102029097|FG001|NOT COMPLETED|Treatment Period 2||2||
48692113|NCT02964273|102029098|FG000|STARTED|Phase A: Double-blind Period (12 Months)||48||
48692114|NCT02964273|102029099|FG001|STARTED|Phase A: Double-blind Period (12 Months)||43||
48692115|NCT02964273|102029100|FG002|STARTED|Phase A: Double-blind Period (12 Months)||0||
48692116|NCT02964273|102029101|FG003|STARTED|Phase A: Double-blind Period (12 Months)||0||
48692117|NCT02964273|102029098|FG000|Dense Pharmacokinetic/Pharmacodynamic (PK/PD) Population|Phase A: Double-blind Period (12 Months)||12|The Dense PK/PD Population included a subset of participants half on tolvaptan and half on placebo, in the 12 to 17 year old age group who had dense PK sampling after at least 1 month on IMP.|
48692118|NCT02964273|102029099|FG001|Dense Pharmacokinetic/Pharmacodynamic (PK/PD) Population|Phase A: Double-blind Period (12 Months)||8|The Dense PK/PD Population included a subset of participants half on tolvaptan and half on placebo, in the 12 to 17 year old age group who had dense PK sampling after at least 1 month on IMP.|
48692119|NCT02964273|102029100|FG002|Dense Pharmacokinetic/Pharmacodynamic (PK/PD) Population|Phase A: Double-blind Period (12 Months)||0|The Dense PK/PD Population included a subset of participants half on tolvaptan and half on placebo, in the 12 to 17 year old age group who had dense PK sampling after at least 1 month on IMP.|
48692120|NCT02964273|102029101|FG003|Dense Pharmacokinetic/Pharmacodynamic (PK/PD) Population|Phase A: Double-blind Period (12 Months)||0|The Dense PK/PD Population included a subset of participants half on tolvaptan and half on placebo, in the 12 to 17 year old age group who had dense PK sampling after at least 1 month on IMP.|
48692121|NCT02964273|102029098|FG000|COMPLETED|Phase A: Double-blind Period (12 Months)||44||
48692122|NCT02964273|102029099|FG001|COMPLETED|Phase A: Double-blind Period (12 Months)||40||
48692123|NCT02964273|102029100|FG002|COMPLETED|Phase A: Double-blind Period (12 Months)||0||
48692124|NCT02964273|102029101|FG003|COMPLETED|Phase A: Double-blind Period (12 Months)||0||
48692125|NCT02964273|102029098|FG000|NOT COMPLETED|Phase A: Double-blind Period (12 Months)||4||
48692126|NCT02964273|102029099|FG001|NOT COMPLETED|Phase A: Double-blind Period (12 Months)||3||
48692127|NCT02964273|102029100|FG002|NOT COMPLETED|Phase A: Double-blind Period (12 Months)||0||
48692128|NCT02964273|102029101|FG003|NOT COMPLETED|Phase A: Double-blind Period (12 Months)||0||
48692129|NCT02964273|102029098|FG000|STARTED|Phase B: Open-label Period (24 Months)||0||
48692130|NCT02964273|102029099|FG001|STARTED|Phase B: Open-label Period (24 Months)||0||
48692131|NCT02964273|102029100|FG002|STARTED|Phase B: Open-label Period (24 Months)||42||
48692132|NCT02964273|102029101|FG003|STARTED|Phase B: Open-label Period (24 Months)||39||
48692133|NCT02964273|102029098|FG000|COMPLETED|Phase B: Open-label Period (24 Months)||0||
48692134|NCT02964273|102029099|FG001|COMPLETED|Phase B: Open-label Period (24 Months)||0||
48551516|NCT01401452|101683178|FG000|Visit 2 (1 Month)|Overall Study||225||
48551517|NCT01401452|101683178|FG000|Visit 3 (3 Months)|Overall Study||217||
48551518|NCT01401452|101683178|FG000|Visit 4 (6 Months)|Overall Study||172||
48551519|NCT01401452|101683178|FG000|Visit 5 (9 Months)|Overall Study||175||
48551520|NCT01401452|101683178|FG000|COMPLETED|Overall Study||174||
48551521|NCT01401452|101683178|FG000|NOT COMPLETED|Overall Study||72||
48692135|NCT02964273|102029100|FG002|COMPLETED|Phase B: Open-label Period (24 Months)||36||
48692136|NCT02964273|102029101|FG003|COMPLETED|Phase B: Open-label Period (24 Months)||33||
48692137|NCT02964273|102029098|FG000|NOT COMPLETED|Phase B: Open-label Period (24 Months)||0||
48692138|NCT02964273|102029099|FG001|NOT COMPLETED|Phase B: Open-label Period (24 Months)||0||
48692139|NCT02964273|102029100|FG002|NOT COMPLETED|Phase B: Open-label Period (24 Months)||6||
48692140|NCT02964273|102029101|FG003|NOT COMPLETED|Phase B: Open-label Period (24 Months)||6||
48692141|NCT03583359|102029102|FG000|STARTED|Overall Study||123||
48266293|NCT03933462|100975413|FG001|COMPLETED|Overall Study||10||
48551522|NCT01924754|101683179|FG000|STARTED|Overall Study||50||
48551523|NCT01924754|101683180|FG001|STARTED|Overall Study||50||
48551524|NCT01924754|101683181|FG002|STARTED|Overall Study||50||
48551525|NCT01924754|101683179|FG000|COMPLETED|Overall Study||49||
48551526|NCT01924754|101683180|FG001|COMPLETED|Overall Study||47||
48266294|NCT03933462|100975412|FG000|NOT COMPLETED|Overall Study||2||
48266295|NCT03933462|100975413|FG001|NOT COMPLETED|Overall Study||0||
48266296|NCT03017742|100975414|FG000|STARTED|Overall Study||813||
48266297|NCT03017742|100975414|FG000|COMPLETED|Overall Study||740||
48266298|NCT03017742|100975414|FG000|NOT COMPLETED|Overall Study||73||
48266299|NCT00848484|100975415|FG000|STARTED|First Intervention (Treatment Period 1)||27||
48266300|NCT00848484|100975416|FG001|STARTED|First Intervention (Treatment Period 1)||27||
48551527|NCT01924754|101683181|FG002|COMPLETED|Overall Study||47||
48551528|NCT01924754|101683179|FG000|NOT COMPLETED|Overall Study||1||
48551529|NCT01924754|101683180|FG001|NOT COMPLETED|Overall Study||3||
48551530|NCT01924754|101683181|FG002|NOT COMPLETED|Overall Study||3||
48551531|NCT00369941|101683182|FG000|STARTED|Overall Study||282||
48551532|NCT00369941|101683183|FG001|STARTED|Overall Study||284||
48551533|NCT00369941|101683182|FG000|Treated|Overall Study||281||
48551534|NCT00369941|101683183|FG001|Treated|Overall Study||282||
48551535|NCT00369941|101683182|FG000|COMPLETED|Overall Study||210||
48551536|NCT00369941|101683183|FG001|COMPLETED|Overall Study||184||
48551537|NCT00369941|101683182|FG000|NOT COMPLETED|Overall Study||72||
48551538|NCT00369941|101683183|FG001|NOT COMPLETED|Overall Study||100||
48266301|NCT00848484|100975415|FG000|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||2||
48266302|NCT00848484|100975416|FG001|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||1||
48551539|NCT03086486|101683184|FG000|STARTED|Overall Study||45||
48551540|NCT03086486|101683185|FG001|STARTED|Overall Study||46||
48551541|NCT03086486|101683186|FG002|STARTED|Overall Study||45||
48266303|NCT00848484|100975415|FG000|COMPLETED|First Intervention (Treatment Period 1)||25||
48551542|NCT03086486|101683187|FG003|STARTED|Overall Study||45||
48551543|NCT03086486|101683184|FG000|COMPLETED|Overall Study||44|Treatment|
48551544|NCT03086486|101683185|FG001|COMPLETED|Overall Study||42|Treatment|
48266304|NCT00848484|100975416|FG001|COMPLETED|First Intervention (Treatment Period 1)||24||
48266305|NCT00848484|100975415|FG000|NOT COMPLETED|First Intervention (Treatment Period 1)||2||
48266306|NCT00848484|100975416|FG001|NOT COMPLETED|First Intervention (Treatment Period 1)||3||
48551545|NCT03086486|101683186|FG002|COMPLETED|Overall Study||43|Treatment|
48551546|NCT03086486|101683187|FG003|COMPLETED|Overall Study||40|Treatment|
48551547|NCT03086486|101683184|FG000|NOT COMPLETED|Overall Study||1||
48551548|NCT03086486|101683185|FG001|NOT COMPLETED|Overall Study||4||
48551549|NCT03086486|101683186|FG002|NOT COMPLETED|Overall Study||2||
48551550|NCT03086486|101683187|FG003|NOT COMPLETED|Overall Study||5||
48551551|NCT00444587|101683188|FG000|STARTED|Overall Study||93||
48551552|NCT00444587|101683189|FG001|STARTED|Overall Study||16||
48551553|NCT00444587|101683188|FG000|COMPLETED|Overall Study||10||
48551554|NCT00444587|101683189|FG001|COMPLETED|Overall Study||1||
48551555|NCT00444587|101683188|FG000|NOT COMPLETED|Overall Study||83||
48551556|NCT00444587|101683189|FG001|NOT COMPLETED|Overall Study||15||
48551557|NCT00584454|101683190|FG000|STARTED|Overall Study||10||
48551558|NCT00584454|101683190|FG000|COMPLETED|Overall Study||6||
48551559|NCT00584454|101683190|FG000|NOT COMPLETED|Overall Study||4||
48551560|NCT00504751|101683191|FG000|STARTED|Overall Study||15||
48551561|NCT00504751|101683191|FG000|COMPLETED|Overall Study||15||
48551562|NCT00504751|101683191|FG000|NOT COMPLETED|Overall Study||0||
48551563|NCT02797171|101683192|FG000|STARTED|Overall Study||23||
48551564|NCT02797171|101683193|FG001|STARTED|Overall Study||23||
48551565|NCT02797171|101683194|FG002|STARTED|Overall Study||7||
48104993|NCT05516082|100583077|FG001|COMPLETED|Period 2: Lens B, 15 Minutes||41||
48104994|NCT05516082|100583076|FG000|NOT COMPLETED|Period 2: Lens B, 15 Minutes||0||
48104995|NCT05516082|100583077|FG001|NOT COMPLETED|Period 2: Lens B, 15 Minutes||0||
48104996|NCT02018458|100583078|FG000|STARTED|Overall Study||10||
48266307|NCT00848484|100975415|FG000|STARTED|Washout Period of Two Weeks||25||
48266308|NCT00848484|100975416|FG001|STARTED|Washout Period of Two Weeks||24||
48266309|NCT00848484|100975415|FG000|COMPLETED|Washout Period of Two Weeks||25||
48266310|NCT00848484|100975416|FG001|COMPLETED|Washout Period of Two Weeks||21||
48266311|NCT00848484|100975415|FG000|NOT COMPLETED|Washout Period of Two Weeks||0||
48266312|NCT00848484|100975416|FG001|NOT COMPLETED|Washout Period of Two Weeks||3||
48266313|NCT00848484|100975415|FG000|STARTED|Second Intervention (Treatment Period 2)||25||
48551566|NCT02797171|101683195|FG003|STARTED|Overall Study||16||
48551567|NCT02797171|101683196|FG004|STARTED|Overall Study||10||
48551568|NCT02797171|101683197|FG005|STARTED|Overall Study||1||
48551569|NCT02797171|101683192|FG000|Safety Population|Overall Study||23||
48551570|NCT02797171|101683193|FG001|Safety Population|Overall Study||23||
48551571|NCT02797171|101683194|FG002|Safety Population|Overall Study||7||
48551572|NCT02797171|101683195|FG003|Safety Population|Overall Study||16||
48551573|NCT02797171|101683196|FG004|Safety Population|Overall Study||10||
48551574|NCT02797171|101683197|FG005|Safety Population|Overall Study||1||
48551575|NCT02797171|101683192|FG000|COMPLETED|Overall Study||19||
48551576|NCT02797171|101683193|FG001|COMPLETED|Overall Study||21||
48551577|NCT02797171|101683194|FG002|COMPLETED|Overall Study||5||
48551578|NCT02797171|101683195|FG003|COMPLETED|Overall Study||15||
48551579|NCT02797171|101683196|FG004|COMPLETED|Overall Study||8||
48551580|NCT02797171|101683197|FG005|COMPLETED|Overall Study||0||
48551581|NCT02797171|101683192|FG000|NOT COMPLETED|Overall Study||4||
48551582|NCT02797171|101683193|FG001|NOT COMPLETED|Overall Study||2||
48551583|NCT02797171|101683194|FG002|NOT COMPLETED|Overall Study||2||
48551584|NCT02797171|101683195|FG003|NOT COMPLETED|Overall Study||1||
48551585|NCT02797171|101683196|FG004|NOT COMPLETED|Overall Study||2||
48551586|NCT02797171|101683197|FG005|NOT COMPLETED|Overall Study||1||
48551587|NCT02281422|101683198|FG000|STARTED|Overall Study||8||
48551588|NCT02281422|101683199|FG001|STARTED|Overall Study||8||
48551589|NCT02281422|101683200|FG002|STARTED|Overall Study||8||
48551590|NCT02281422|101683201|FG003|STARTED|Overall Study||8||
48551591|NCT02281422|101683202|FG004|STARTED|Overall Study||8||
48551592|NCT02281422|101683198|FG000|COMPLETED|Overall Study||8||
48551593|NCT02281422|101683199|FG001|COMPLETED|Overall Study||8||
48551594|NCT02281422|101683200|FG002|COMPLETED|Overall Study||8||
48266314|NCT00848484|100975416|FG001|STARTED|Second Intervention (Treatment Period 2)||21||
48266315|NCT00848484|100975415|FG000|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0||
48551595|NCT02281422|101683201|FG003|COMPLETED|Overall Study||8||
48551596|NCT02281422|101683202|FG004|COMPLETED|Overall Study||8||
48551597|NCT02281422|101683198|FG000|NOT COMPLETED|Overall Study||0||
48551598|NCT02281422|101683199|FG001|NOT COMPLETED|Overall Study||0||
48551599|NCT02281422|101683200|FG002|NOT COMPLETED|Overall Study||0||
48551600|NCT02281422|101683201|FG003|NOT COMPLETED|Overall Study||0||
48551601|NCT02281422|101683202|FG004|NOT COMPLETED|Overall Study||0||
48551602|NCT03774407|101683203|FG000|STARTED|Overall Study||21||
48551603|NCT03774407|101683203|FG000|COMPLETED|Overall Study||12||
48551604|NCT03774407|101683203|FG000|NOT COMPLETED|Overall Study||9||
48551605|NCT02856802|101683204|FG000|STARTED|Double-Blind Treatment Period 1||50||
48692142|NCT03583359|102029103|FG001|STARTED|Overall Study||57||
48692143|NCT03583359|102029102|FG000|Treated Participants|Overall Study||122||
48692144|NCT03583359|102029103|FG001|Treated Participants|Overall Study||53||
48692145|NCT03583359|102029102|FG000|COMPLETED|Overall Study||94||
48692146|NCT03583359|102029103|FG001|COMPLETED|Overall Study||45||
48692147|NCT03583359|102029102|FG000|NOT COMPLETED|Overall Study||29||
48692148|NCT03583359|102029103|FG001|NOT COMPLETED|Overall Study||12||
48692149|NCT01995526|102029104|FG000|STARTED|Overall Study||11||
48692150|NCT01995526|102029104|FG000|Received One Dose of Study Drug|Overall Study||11||
48692151|NCT01995526|102029104|FG000|COMPLETED|Overall Study||10||
48692152|NCT01995526|102029104|FG000|NOT COMPLETED|Overall Study||1||
48692153|NCT01144416|102029105|FG000|STARTED|Intervention Period||694||
48692154|NCT01144416|102029106|FG001|STARTED|Intervention Period||696||
48266316|NCT00848484|100975416|FG001|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0||
48266317|NCT00848484|100975415|FG000|COMPLETED|Second Intervention (Treatment Period 2)||25||
48266318|NCT00848484|100975416|FG001|COMPLETED|Second Intervention (Treatment Period 2)||20||
48266319|NCT00848484|100975415|FG000|NOT COMPLETED|Second Intervention (Treatment Period 2)||0||
48266320|NCT00848484|100975416|FG001|NOT COMPLETED|Second Intervention (Treatment Period 2)||1||
48266321|NCT00983749|100975417|FG000|STARTED|Acute Phase (Enrollment to Hospital DC)||13||
48266322|NCT00983749|100975418|FG001|STARTED|Acute Phase (Enrollment to Hospital DC)||10||
48266323|NCT00983749|100975417|FG000|COMPLETED|Acute Phase (Enrollment to Hospital DC)||13||
48266324|NCT00983749|100975418|FG001|COMPLETED|Acute Phase (Enrollment to Hospital DC)||10||
48266325|NCT00983749|100975417|FG000|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0||
48266326|NCT00983749|100975418|FG001|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0||
48266327|NCT00983749|100975417|FG000|STARTED|Follow-up Phase (Hospital DC to 30 Days)||13||
48551606|NCT02856802|101683205|FG001|STARTED|Double-Blind Treatment Period 1||43||
48551607|NCT02856802|101683204|FG000|COMPLETED|Double-Blind Treatment Period 1||48||
48551608|NCT02856802|101683205|FG001|COMPLETED|Double-Blind Treatment Period 1||38||
48551609|NCT02856802|101683204|FG000|NOT COMPLETED|Double-Blind Treatment Period 1||2||
48551610|NCT02856802|101683205|FG001|NOT COMPLETED|Double-Blind Treatment Period 1||5||
48551611|NCT02856802|101683204|FG000|STARTED|Double-Blind Treatment Period 2||37|86 subjects completing double-blind treatment period 1, and still eligible, were re-randomized into double-blind treatment period 2|
48551612|NCT02856802|101683205|FG001|STARTED|Double-Blind Treatment Period 2||38|86 subjects completing double-blind treatment period 1, and still eligible, were re-randomized into double-blind treatment period 2|
48551613|NCT02856802|101683204|FG000|COMPLETED|Double-Blind Treatment Period 2||36||
48551614|NCT02856802|101683205|FG001|COMPLETED|Double-Blind Treatment Period 2||38||
48551615|NCT02856802|101683204|FG000|NOT COMPLETED|Double-Blind Treatment Period 2||1||
48551616|NCT02856802|101683205|FG001|NOT COMPLETED|Double-Blind Treatment Period 2||0||
48551617|NCT00626808|101683206|FG000|STARTED|Overall Study||254464||
48551618|NCT00626808|101683207|FG001|STARTED|Overall Study||34316||
48551619|NCT00626808|101683208|FG002|STARTED|Overall Study||30011||
48551620|NCT00626808|101683209|FG003|STARTED|Overall Study||2906||
48551621|NCT00626808|101683206|FG000|COMPLETED|Overall Study||254464||
48551622|NCT00626808|101683207|FG001|COMPLETED|Overall Study||34316||
48551623|NCT00626808|101683208|FG002|COMPLETED|Overall Study||30011||
48551624|NCT00626808|101683209|FG003|COMPLETED|Overall Study||2906||
48551625|NCT00626808|101683206|FG000|NOT COMPLETED|Overall Study||0||
48551626|NCT00626808|101683207|FG001|NOT COMPLETED|Overall Study||0||
48551627|NCT00626808|101683208|FG002|NOT COMPLETED|Overall Study||0||
48551628|NCT00626808|101683209|FG003|NOT COMPLETED|Overall Study||0||
48551629|NCT01245283|101683210|FG000|STARTED|Overall Study||32||
48551630|NCT01245283|101683211|FG001|STARTED|Overall Study||28||
48551631|NCT01245283|101683212|FG002|STARTED|Overall Study||30||
48551632|NCT01245283|101683210|FG000|COMPLETED|Overall Study||18||
48551633|NCT01245283|101683211|FG001|COMPLETED|Overall Study||17||
48551634|NCT01245283|101683212|FG002|COMPLETED|Overall Study||19||
48551635|NCT01245283|101683210|FG000|NOT COMPLETED|Overall Study||14||
48551636|NCT01245283|101683211|FG001|NOT COMPLETED|Overall Study||11||
48551637|NCT01245283|101683212|FG002|NOT COMPLETED|Overall Study||11||
48551638|NCT00395161|101683213|FG000|STARTED|Overall Study||149||
48551639|NCT00395161|101683214|FG001|STARTED|Overall Study||144||
48551640|NCT00395161|101683213|FG000|COMPLETED|Overall Study||149||
48551641|NCT00395161|101683214|FG001|COMPLETED|Overall Study||144||
48551642|NCT00395161|101683213|FG000|NOT COMPLETED|Overall Study||0||
48551643|NCT00395161|101683214|FG001|NOT COMPLETED|Overall Study||0||
48551644|NCT03757312|101683215|FG000|STARTED|Overall Study||5||
48551645|NCT03757312|101683216|FG001|STARTED|Overall Study||9||
48551646|NCT03757312|101683215|FG000|COMPLETED|Overall Study||5||
48551647|NCT03757312|101683216|FG001|COMPLETED|Overall Study||9||
48692155|NCT01144416|102029105|FG000|COMPLETED|Intervention Period||632||
48692156|NCT01144416|102029106|FG001|COMPLETED|Intervention Period||647||
48692157|NCT01144416|102029105|FG000|NOT COMPLETED|Intervention Period||62||
48692158|NCT01144416|102029106|FG001|NOT COMPLETED|Intervention Period||49||
48692159|NCT01144416|102029105|FG000|STARTED|Pregnancy Follow-up Period||154||
48551648|NCT03757312|101683215|FG000|NOT COMPLETED|Overall Study||0||
48692160|NCT01144416|102029106|FG001|STARTED|Pregnancy Follow-up Period||167||
48692161|NCT01144416|102029105|FG000|COMPLETED|Pregnancy Follow-up Period||146||
48551649|NCT03757312|101683216|FG001|NOT COMPLETED|Overall Study||0||
48551650|NCT04238650|101683217|FG000|STARTED|Overall Study||24||
48551651|NCT04238650|101683218|FG001|STARTED|Overall Study||25||
48551652|NCT04238650|101683217|FG000|COMPLETED|Overall Study||24||
48692162|NCT01144416|102029106|FG001|COMPLETED|Pregnancy Follow-up Period||157||
48692163|NCT01144416|102029105|FG000|NOT COMPLETED|Pregnancy Follow-up Period||8||
48266328|NCT00983749|100975418|FG001|STARTED|Follow-up Phase (Hospital DC to 30 Days)||10||
48551653|NCT04238650|101683218|FG001|COMPLETED|Overall Study||24||
48551654|NCT04238650|101683217|FG000|NOT COMPLETED|Overall Study||0||
48551655|NCT04238650|101683218|FG001|NOT COMPLETED|Overall Study||1||
48551656|NCT04043455|101683219|FG000|STARTED|Main Study Double-Blind Treatment Period||67||
48551657|NCT04043455|101683220|FG001|STARTED|Main Study Double-Blind Treatment Period||67||
48551658|NCT04043455|101683221|FG002|STARTED|Main Study Double-Blind Treatment Period||69||
48551659|NCT04043455|101683222|FG003|STARTED|Main Study Double-Blind Treatment Period||70||
48551660|NCT04043455|101683223|FG004|STARTED|Main Study Double-Blind Treatment Period||0||
48551661|NCT04043455|101683224|FG005|STARTED|Main Study Double-Blind Treatment Period||0||
48551662|NCT04043455|101683219|FG000|Received Treatment|Main Study Double-Blind Treatment Period||67||
48551663|NCT04043455|101683220|FG001|Received Treatment|Main Study Double-Blind Treatment Period||66||
48551664|NCT04043455|101683221|FG002|Received Treatment|Main Study Double-Blind Treatment Period||69||
48551665|NCT04043455|101683222|FG003|Received Treatment|Main Study Double-Blind Treatment Period||70||
48551666|NCT04043455|101683223|FG004|Received Treatment|Main Study Double-Blind Treatment Period||0||
48551667|NCT04043455|101683224|FG005|Received Treatment|Main Study Double-Blind Treatment Period||0||
48551668|NCT04043455|101683219|FG000|COMPLETED|Main Study Double-Blind Treatment Period||59||
48551669|NCT04043455|101683220|FG001|COMPLETED|Main Study Double-Blind Treatment Period||53||
48551670|NCT04043455|101683221|FG002|COMPLETED|Main Study Double-Blind Treatment Period||61||
48551671|NCT04043455|101683222|FG003|COMPLETED|Main Study Double-Blind Treatment Period||58||
48551672|NCT04043455|101683223|FG004|COMPLETED|Main Study Double-Blind Treatment Period||0||
48551673|NCT04043455|101683224|FG005|COMPLETED|Main Study Double-Blind Treatment Period||0||
48551674|NCT04043455|101683219|FG000|NOT COMPLETED|Main Study Double-Blind Treatment Period||8||
48551675|NCT04043455|101683220|FG001|NOT COMPLETED|Main Study Double-Blind Treatment Period||14||
48551676|NCT04043455|101683221|FG002|NOT COMPLETED|Main Study Double-Blind Treatment Period||8||
48551677|NCT04043455|101683222|FG003|NOT COMPLETED|Main Study Double-Blind Treatment Period||12||
48551678|NCT04043455|101683223|FG004|NOT COMPLETED|Main Study Double-Blind Treatment Period||0||
48551679|NCT04043455|101683224|FG005|NOT COMPLETED|Main Study Double-Blind Treatment Period||0||
48551680|NCT04043455|101683219|FG000|STARTED|Double-Blind LTE Treatment Period||0||
48551681|NCT04043455|101683220|FG001|STARTED|Double-Blind LTE Treatment Period||0||
48551682|NCT04043455|101683221|FG002|STARTED|Double-Blind LTE Treatment Period||0||
48551683|NCT04043455|101683222|FG003|STARTED|Double-Blind LTE Treatment Period||0||
48551684|NCT04043455|101683223|FG004|STARTED|Double-Blind LTE Treatment Period||53||
48551685|NCT04043455|101683224|FG005|STARTED|Double-Blind LTE Treatment Period||52||
48551686|NCT04043455|101683219|FG000|Received Treatment|Double-Blind LTE Treatment Period||0||
48551687|NCT04043455|101683220|FG001|Received Treatment|Double-Blind LTE Treatment Period||0||
48551688|NCT04043455|101683221|FG002|Received Treatment|Double-Blind LTE Treatment Period||0||
48551689|NCT04043455|101683222|FG003|Received Treatment|Double-Blind LTE Treatment Period||0||
48551690|NCT04043455|101683223|FG004|Received Treatment|Double-Blind LTE Treatment Period||53||
48551691|NCT04043455|101683224|FG005|Received Treatment|Double-Blind LTE Treatment Period||51||
48551692|NCT04043455|101683219|FG000|COMPLETED|Double-Blind LTE Treatment Period||0||
48551693|NCT04043455|101683220|FG001|COMPLETED|Double-Blind LTE Treatment Period||0||
48551694|NCT04043455|101683221|FG002|COMPLETED|Double-Blind LTE Treatment Period||0||
48551695|NCT04043455|101683222|FG003|COMPLETED|Double-Blind LTE Treatment Period||0||
48551696|NCT04043455|101683223|FG004|COMPLETED|Double-Blind LTE Treatment Period||0||
48551697|NCT04043455|101683224|FG005|COMPLETED|Double-Blind LTE Treatment Period||0||
48551698|NCT04043455|101683219|FG000|NOT COMPLETED|Double-Blind LTE Treatment Period||0||
48551699|NCT04043455|101683220|FG001|NOT COMPLETED|Double-Blind LTE Treatment Period||0||
48551700|NCT04043455|101683221|FG002|NOT COMPLETED|Double-Blind LTE Treatment Period||0||
48551701|NCT04043455|101683222|FG003|NOT COMPLETED|Double-Blind LTE Treatment Period||0||
48551702|NCT04043455|101683223|FG004|NOT COMPLETED|Double-Blind LTE Treatment Period||53||
48551703|NCT04043455|101683224|FG005|NOT COMPLETED|Double-Blind LTE Treatment Period||52||
48551704|NCT03404674|101683225|FG000|STARTED|Overall Study||5|Enrolled and received Dose 1|
48551705|NCT03404674|101683226|FG001|STARTED|Overall Study||5|Enrolled and received Dose 1|
48551706|NCT03404674|101683227|FG002|STARTED|Overall Study||10|Enrolled and received Dose 1|
48551707|NCT03404674|101683228|FG003|STARTED|Overall Study||10|Enrolled and received Dose 1|
48266329|NCT00983749|100975417|FG000|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||12||
48266330|NCT00983749|100975418|FG001|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||7||
48551708|NCT03404674|101683229|FG004|STARTED|Overall Study||10|Enrolled and received Dose 1|
48692164|NCT01144416|102029106|FG001|NOT COMPLETED|Pregnancy Follow-up Period||10||
48266331|NCT00983749|100975417|FG000|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||1||
48266332|NCT00983749|100975418|FG001|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||3||
48266333|NCT00965497|100975419|FG000|STARTED|Overall Study||14||
48266334|NCT00965497|100975419|FG000|COMPLETED|Overall Study||13||
48266335|NCT00965497|100975419|FG000|NOT COMPLETED|Overall Study||1||
48266336|NCT01673022|100975420|FG000|STARTED|Overall Study||430||
48266337|NCT01673022|100975420|FG000|COMPLETED|Overall Study||422||
48266338|NCT01673022|100975420|FG000|NOT COMPLETED|Overall Study||8||
48266339|NCT04198571|100975421|FG000|STARTED|Overall Study||185||
48266340|NCT04198571|100975422|FG001|STARTED|Overall Study||132||
48266341|NCT04198571|100975421|FG000|COMPLETED|Overall Study||185||
48266342|NCT04198571|100975422|FG001|COMPLETED|Overall Study||132||
48266343|NCT04198571|100975421|FG000|NOT COMPLETED|Overall Study||0||
48266344|NCT04198571|100975422|FG001|NOT COMPLETED|Overall Study||0||
48266345|NCT01454739|100975423|FG000|STARTED|Overall Study||61||
48266346|NCT01454739|100975424|FG001|STARTED|Overall Study||179||
48266347|NCT01454739|100975423|FG000|Tailored Prophylaxis|Overall Study||59||
48266348|NCT01454739|100975424|FG001|Tailored Prophylaxis|Overall Study||131||
48266349|NCT01454739|100975423|FG000|Weekly Prophylaxis|Overall Study||0||
48266350|NCT01454739|100975424|FG001|Weekly Prophylaxis|Overall Study||34||
48266351|NCT01454739|100975423|FG000|Personalized Prophylaxis|Overall Study||3||
48266352|NCT01454739|100975424|FG001|Personalized Prophylaxis|Overall Study||23||
48266353|NCT01454739|100975423|FG000|Episodic|Overall Study||0||
48266354|NCT01454739|100975424|FG001|Episodic|Overall Study||13||
48266355|NCT01454739|100975423|FG000|Surgery Subgroup|Overall Study||2|Participants who have undergone major surgery or have major surgical/rehabilitation period in study.|
48266356|NCT01454739|100975424|FG001|Surgery Subgroup|Overall Study||26|Participants who have undergone major surgery or have major surgical/rehabilitation period in study.|
48266357|NCT01454739|100975423|FG000|COMPLETED|Overall Study||54||
48266358|NCT01454739|100975424|FG001|COMPLETED|Overall Study||158||
48266359|NCT01454739|100975423|FG000|NOT COMPLETED|Overall Study||7||
48266360|NCT01454739|100975424|FG001|NOT COMPLETED|Overall Study||21||
48266361|NCT01589926|100975425|FG000|STARTED|Overall Study||0||
48266362|NCT01589926|100975426|FG001|STARTED|Overall Study||0||
48266363|NCT01589926|100975425|FG000|COMPLETED|Overall Study||0||
48266364|NCT01589926|100975426|FG001|COMPLETED|Overall Study||0||
48266365|NCT01589926|100975425|FG000|NOT COMPLETED|Overall Study||0||
48266366|NCT01589926|100975426|FG001|NOT COMPLETED|Overall Study||0||
48266367|NCT00972322|100975427|FG000|STARTED|Overall Study||28||
48266368|NCT00972322|100975428|FG001|STARTED|Overall Study||28||
48266369|NCT00972322|100975427|FG000|COMPLETED|Overall Study||25||
48266370|NCT00972322|100975428|FG001|COMPLETED|Overall Study||25||
48266371|NCT00972322|100975427|FG000|NOT COMPLETED|Overall Study||3||
48266372|NCT00972322|100975428|FG001|NOT COMPLETED|Overall Study||3||
48266373|NCT00402051|100975429|FG000|STARTED|Overall Study||66||
48266374|NCT00402051|100975430|FG001|STARTED|Overall Study||67||
48266375|NCT00402051|100975429|FG000|Received Treatment|Overall Study||65||
48266376|NCT00402051|100975430|FG001|Received Treatment|Overall Study||65||
48266377|NCT00402051|100975429|FG000|COMPLETED|Overall Study||28||
48266378|NCT00402051|100975430|FG001|COMPLETED|Overall Study||32||
48391879|NCT02553317|101287745|FG001|COMPLETED|Open-label (OL) Treatment Period||22||
48391880|NCT02553317|101287744|FG000|NOT COMPLETED|Open-label (OL) Treatment Period||0||
48391881|NCT02553317|101287745|FG001|NOT COMPLETED|Open-label (OL) Treatment Period||4||
48391882|NCT00904995|101287746|FG000|STARTED|Overall Study||10||
48391883|NCT00904995|101287747|FG001|STARTED|Overall Study||11||
48391884|NCT00904995|101287746|FG000|COMPLETED|Overall Study||10||
48391885|NCT00904995|101287747|FG001|COMPLETED|Overall Study||11||
48391886|NCT00904995|101287746|FG000|NOT COMPLETED|Overall Study||0||
48391887|NCT00904995|101287747|FG001|NOT COMPLETED|Overall Study||0||
48391888|NCT02581982|101287748|FG000|STARTED|Overall Study||27||
48391889|NCT02581982|101287748|FG000|COMPLETED|Overall Study||11||
48391890|NCT02581982|101287748|FG000|NOT COMPLETED|Overall Study||16||
48391891|NCT00889681|101287749|FG000|STARTED|Overall Study||81||
48266379|NCT00402051|100975429|FG000|NOT COMPLETED|Overall Study||38||
48266380|NCT00402051|100975430|FG001|NOT COMPLETED|Overall Study||35||
48266381|NCT01181492|100975431|FG000|STARTED|Overall Study||103||
48266382|NCT01181492|100975432|FG001|STARTED|Overall Study||66||
48266383|NCT01181492|100975433|FG002|STARTED|Overall Study||7||
48266384|NCT01181492|100975431|FG000|COMPLETED|Overall Study||103||
48391892|NCT00889681|101287749|FG000|Received Treatment|Overall Study||78||
48391893|NCT00889681|101287749|FG000|COMPLETED|Overall Study||78||
48391894|NCT00889681|101287749|FG000|NOT COMPLETED|Overall Study||3||
48391895|NCT04325906|101287750|FG000|STARTED|Overall Study||112||
48391896|NCT04325906|101287751|FG001|STARTED|Overall Study||112||
48266385|NCT01181492|100975432|FG001|COMPLETED|Overall Study||66||
48266386|NCT01181492|100975433|FG002|COMPLETED|Overall Study||7||
48266387|NCT01181492|100975431|FG000|NOT COMPLETED|Overall Study||0||
48266388|NCT01181492|100975432|FG001|NOT COMPLETED|Overall Study||0||
48266389|NCT01181492|100975433|FG002|NOT COMPLETED|Overall Study||0||
48266390|NCT02552147|100975434|FG000|STARTED|First Intervention (7 Days)||4||
48266391|NCT02552147|100975435|FG001|STARTED|First Intervention (7 Days)||4||
48391897|NCT04325906|101287750|FG000|COMPLETED|Overall Study||110||
48266392|NCT02552147|100975434|FG000|COMPLETED|First Intervention (7 Days)||3||
48266393|NCT02552147|100975435|FG001|COMPLETED|First Intervention (7 Days)||4||
48391898|NCT04325906|101287751|FG001|COMPLETED|Overall Study||112||
48391899|NCT04325906|101287750|FG000|NOT COMPLETED|Overall Study||2||
48266394|NCT02552147|100975434|FG000|NOT COMPLETED|First Intervention (7 Days)||1||
48692165|NCT01977729|102029107|FG000|STARTED|Overall Study||1||
48692166|NCT01977729|102029107|FG000|COMPLETED|Overall Study||0||
48692167|NCT01977729|102029107|FG000|NOT COMPLETED|Overall Study||1||
48692168|NCT04474197|102029108|FG000|STARTED|Overall Study||7||
48692169|NCT04474197|102029109|FG001|STARTED|Overall Study||10||
48692170|NCT04474197|102029110|FG002|STARTED|Overall Study||9||
48266395|NCT02552147|100975435|FG001|NOT COMPLETED|First Intervention (7 Days)||0||
48266396|NCT02552147|100975434|FG000|STARTED|Washout (7 Days)||3||
48266397|NCT02552147|100975435|FG001|STARTED|Washout (7 Days)||4||
48266398|NCT02552147|100975434|FG000|COMPLETED|Washout (7 Days)||3||
48266399|NCT02552147|100975435|FG001|COMPLETED|Washout (7 Days)||4||
48266400|NCT02552147|100975434|FG000|NOT COMPLETED|Washout (7 Days)||0||
48266401|NCT02552147|100975435|FG001|NOT COMPLETED|Washout (7 Days)||0||
48266402|NCT02552147|100975434|FG000|STARTED|Second Intervention (7 Days)||3||
48266403|NCT02552147|100975435|FG001|STARTED|Second Intervention (7 Days)||4||
48266404|NCT02552147|100975434|FG000|COMPLETED|Second Intervention (7 Days)||1||
48266405|NCT02552147|100975435|FG001|COMPLETED|Second Intervention (7 Days)||4||
48266406|NCT02552147|100975434|FG000|NOT COMPLETED|Second Intervention (7 Days)||2||
48266407|NCT02552147|100975435|FG001|NOT COMPLETED|Second Intervention (7 Days)||0||
48266408|NCT02523690|100975436|FG000|STARTED|Overall Study||3||
48266409|NCT02523690|100975437|FG001|STARTED|Overall Study||2||
48266410|NCT02523690|100975436|FG000|COMPLETED|Overall Study||3||
48266411|NCT02523690|100975437|FG001|COMPLETED|Overall Study||2||
48266412|NCT02523690|100975436|FG000|NOT COMPLETED|Overall Study||0||
48266413|NCT02523690|100975437|FG001|NOT COMPLETED|Overall Study||0||
48266414|NCT02406248|100975438|FG000|STARTED|Overall Study||108||
48266415|NCT02406248|100975438|FG000|COMPLETED|Overall Study||99||
48266416|NCT02406248|100975438|FG000|NOT COMPLETED|Overall Study||9||
48266417|NCT02034019|100975439|FG000|STARTED|Overall Study||164||
48266418|NCT02034019|100975440|FG001|STARTED|Overall Study||83||
48266419|NCT02034019|100975439|FG000|COMPLETED|Overall Study||163||
48266420|NCT02034019|100975440|FG001|COMPLETED|Overall Study||81||
48266421|NCT02034019|100975439|FG000|NOT COMPLETED|Overall Study||1||
48266422|NCT02034019|100975440|FG001|NOT COMPLETED|Overall Study||2||
48266423|NCT02866669|100975441|FG000|STARTED|Overall Study||406|Practices Randomized|18
48266424|NCT02866669|100975442|FG001|STARTED|Overall Study||382|Practices Randomized|16
48266425|NCT02866669|100975443|FG002|STARTED|Overall Study||424|Practices Randomized|19
48266426|NCT02866669|100975444|FG003|STARTED|Overall Study||380|Practices Randomized|16
48266427|NCT02866669|100975441|FG000|COMPLETED|Overall Study||342||16
48266428|NCT02866669|100975442|FG001|COMPLETED|Overall Study||260||12
48266429|NCT02866669|100975443|FG002|COMPLETED|Overall Study||332||17
48266430|NCT02866669|100975444|FG003|COMPLETED|Overall Study||275||15
48266431|NCT02866669|100975441|FG000|NOT COMPLETED|Overall Study||64||2
48266432|NCT02866669|100975442|FG001|NOT COMPLETED|Overall Study||122||4
48266433|NCT02866669|100975443|FG002|NOT COMPLETED|Overall Study||92||2
48266434|NCT02866669|100975444|FG003|NOT COMPLETED|Overall Study||105||1
48266435|NCT02353468|100975445|FG000|STARTED|Overall Study||3||
48266436|NCT02353468|100975445|FG000|COMPLETED|Overall Study||0||
48266437|NCT02353468|100975445|FG000|NOT COMPLETED|Overall Study||3||
48266438|NCT00762476|100975446|FG000|STARTED|Overall Study||206||
48266439|NCT00762476|100975447|FG001|STARTED|Overall Study||205||
48266440|NCT00762476|100975446|FG000|COMPLETED|Overall Study||183||
48266441|NCT00762476|100975447|FG001|COMPLETED|Overall Study||169||
48266442|NCT00762476|100975446|FG000|NOT COMPLETED|Overall Study||23||
48266443|NCT00762476|100975447|FG001|NOT COMPLETED|Overall Study||36||
48266444|NCT01516749|100975448|FG000|STARTED|Active Therapy||6||
48266445|NCT01516749|100975448|FG000|COMPLETED|Active Therapy||5||
48266446|NCT01516749|100975448|FG000|NOT COMPLETED|Active Therapy||1||
48266447|NCT01516749|100975448|FG000|STARTED|Follow-up Off Therapy||5||
48266448|NCT01516749|100975448|FG000|COMPLETED|Follow-up Off Therapy||4||
48266449|NCT01516749|100975448|FG000|NOT COMPLETED|Follow-up Off Therapy||1||
48266450|NCT00634842|100975449|FG000|STARTED|Overall Study||122||
48266451|NCT00634842|100975450|FG001|STARTED|Overall Study||122||
48266452|NCT00634842|100975449|FG000|COMPLETED|Overall Study||107||
48692171|NCT04474197|102029111|FG003|STARTED|Overall Study||18||
48692172|NCT04474197|102029108|FG000|COMPLETED|Overall Study||7||
48692173|NCT04474197|102029109|FG001|COMPLETED|Overall Study||9||
48692174|NCT04474197|102029110|FG002|COMPLETED|Overall Study||9||
48692175|NCT04474197|102029111|FG003|COMPLETED|Overall Study||18||
48266453|NCT00634842|100975450|FG001|COMPLETED|Overall Study||104||
48266454|NCT00634842|100975449|FG000|NOT COMPLETED|Overall Study||15||
48266455|NCT00634842|100975450|FG001|NOT COMPLETED|Overall Study||18||
48266456|NCT02270671|100975451|FG000|STARTED|Overall Study||64||
48266457|NCT02270671|100975452|FG001|STARTED|Overall Study||66||
48266458|NCT02270671|100975451|FG000|COMPLETED|Overall Study||59||
48692176|NCT04474197|102029108|FG000|NOT COMPLETED|Overall Study||0||
48266459|NCT02270671|100975452|FG001|COMPLETED|Overall Study||61||
48266460|NCT02270671|100975451|FG000|NOT COMPLETED|Overall Study||5||
48266461|NCT02270671|100975452|FG001|NOT COMPLETED|Overall Study||5||
48266462|NCT02769442|100975453|FG000|STARTED|Overall Study||309||
48692177|NCT04474197|102029109|FG001|NOT COMPLETED|Overall Study||1||
48692178|NCT04474197|102029110|FG002|NOT COMPLETED|Overall Study||0||
48266463|NCT02769442|100975454|FG001|STARTED|Overall Study||291||
48266464|NCT02769442|100975453|FG000|COMPLETED|Overall Study||309||
48266465|NCT02769442|100975454|FG001|COMPLETED|Overall Study||291||
48266466|NCT02769442|100975453|FG000|NOT COMPLETED|Overall Study||0||
48266467|NCT02769442|100975454|FG001|NOT COMPLETED|Overall Study||0||
48266468|NCT00775411|100975455|FG000|STARTED|Overall Study||44||
48266469|NCT00775411|100975455|FG000|COMPLETED|Overall Study||43||
48266470|NCT00775411|100975455|FG000|NOT COMPLETED|Overall Study||1||
48266471|NCT03809039|100975456|FG000|STARTED|Part 1||11||
48266472|NCT03809039|100975457|FG001|STARTED|Part 1||6||
48266473|NCT03809039|100975458|FG002|STARTED|Part 1||6||
48266474|NCT03809039|100975459|FG003|STARTED|Part 1||6||
48266475|NCT03809039|100975460|FG004|STARTED|Part 1||6||
48266476|NCT03809039|100975461|FG005|STARTED|Part 1||4||
48266477|NCT03809039|100975462|FG006|STARTED|Part 1||5||
48266478|NCT03809039|100975463|FG007|STARTED|Part 1||0||
48266479|NCT03809039|100975464|FG008|STARTED|Part 1||0||
48266480|NCT03809039|100975456|FG000|COMPLETED|Part 1||10||
48266481|NCT03809039|100975457|FG001|COMPLETED|Part 1||6||
48266482|NCT03809039|100975458|FG002|COMPLETED|Part 1||6||
48266483|NCT03809039|100975459|FG003|COMPLETED|Part 1||5||
48266484|NCT03809039|100975460|FG004|COMPLETED|Part 1||6||
48266485|NCT03809039|100975461|FG005|COMPLETED|Part 1||4||
48266486|NCT03809039|100975462|FG006|COMPLETED|Part 1||5||
48266487|NCT03809039|100975463|FG007|COMPLETED|Part 1||0||
48266488|NCT03809039|100975464|FG008|COMPLETED|Part 1||0||
48266489|NCT03809039|100975456|FG000|NOT COMPLETED|Part 1||1||
48266490|NCT03809039|100975457|FG001|NOT COMPLETED|Part 1||0||
48266491|NCT03809039|100975458|FG002|NOT COMPLETED|Part 1||0||
48266492|NCT03809039|100975459|FG003|NOT COMPLETED|Part 1||1||
48266493|NCT03809039|100975460|FG004|NOT COMPLETED|Part 1||0||
48266494|NCT03809039|100975461|FG005|NOT COMPLETED|Part 1||0||
48266495|NCT03809039|100975462|FG006|NOT COMPLETED|Part 1||0||
48266496|NCT03809039|100975463|FG007|NOT COMPLETED|Part 1||0||
48266497|NCT03809039|100975464|FG008|NOT COMPLETED|Part 1||0||
48266498|NCT03809039|100975456|FG000|STARTED|Part 2||1||
48266499|NCT03809039|100975457|FG001|STARTED|Part 2||0||
48266500|NCT03809039|100975458|FG002|STARTED|Part 2||0||
48266501|NCT03809039|100975459|FG003|STARTED|Part 2||5||
48266502|NCT03809039|100975460|FG004|STARTED|Part 2||0||
48551709|NCT03404674|101683230|FG005|STARTED|Overall Study||10|Enrolled and received Dose 1|
48551710|NCT03404674|101683225|FG000|Received Dose 2|Overall Study||5||
48266503|NCT03809039|100975461|FG005|STARTED|Part 2||0||
48266504|NCT03809039|100975462|FG006|STARTED|Part 2||0||
48266505|NCT03809039|100975463|FG007|STARTED|Part 2||0||
48266506|NCT03809039|100975464|FG008|STARTED|Part 2||0||
48266507|NCT03809039|100975456|FG000|COMPLETED|Part 2||1||
48266508|NCT03809039|100975457|FG001|COMPLETED|Part 2||0||
48266509|NCT03809039|100975458|FG002|COMPLETED|Part 2||0||
48266510|NCT03809039|100975459|FG003|COMPLETED|Part 2||5||
48266511|NCT03809039|100975460|FG004|COMPLETED|Part 2||0||
48266512|NCT03809039|100975461|FG005|COMPLETED|Part 2||0||
48266513|NCT03809039|100975462|FG006|COMPLETED|Part 2||0||
48266514|NCT03809039|100975463|FG007|COMPLETED|Part 2||0||
48266515|NCT03809039|100975464|FG008|COMPLETED|Part 2||0||
48266516|NCT03809039|100975456|FG000|NOT COMPLETED|Part 2||0||
48266517|NCT03809039|100975457|FG001|NOT COMPLETED|Part 2||0||
48266518|NCT03809039|100975458|FG002|NOT COMPLETED|Part 2||0||
48266519|NCT03809039|100975459|FG003|NOT COMPLETED|Part 2||0||
48266520|NCT03809039|100975460|FG004|NOT COMPLETED|Part 2||0||
48266521|NCT03809039|100975461|FG005|NOT COMPLETED|Part 2||0||
48266522|NCT03809039|100975462|FG006|NOT COMPLETED|Part 2||0||
48266523|NCT03809039|100975463|FG007|NOT COMPLETED|Part 2||0||
48266524|NCT03809039|100975464|FG008|NOT COMPLETED|Part 2||0||
48266525|NCT03809039|100975456|FG000|STARTED|Part 3||0||
48266526|NCT03809039|100975457|FG001|STARTED|Part 3||0||
48266527|NCT03809039|100975458|FG002|STARTED|Part 3||0||
48551711|NCT03404674|101683226|FG001|Received Dose 2|Overall Study||4||
48551712|NCT03404674|101683227|FG002|Received Dose 2|Overall Study||10||
48266528|NCT03809039|100975459|FG003|STARTED|Part 3||0||
48266529|NCT03809039|100975460|FG004|STARTED|Part 3||0||
48266530|NCT03809039|100975461|FG005|STARTED|Part 3||0||
48266531|NCT03809039|100975462|FG006|STARTED|Part 3||0||
48266532|NCT03809039|100975463|FG007|STARTED|Part 3||2||
48266533|NCT03809039|100975464|FG008|STARTED|Part 3||6||
48266534|NCT03809039|100975456|FG000|COMPLETED|Part 3||0||
48266535|NCT03809039|100975457|FG001|COMPLETED|Part 3||0||
48266536|NCT03809039|100975458|FG002|COMPLETED|Part 3||0||
48104997|NCT02018458|100583078|FG000|COMPLETED|Overall Study||6||
48104998|NCT02018458|100583078|FG000|NOT COMPLETED|Overall Study||4||
48104999|NCT00181207|100583079|FG000|STARTED|Overall Study||24||
48105000|NCT00181207|100583080|FG001|STARTED|Overall Study||26||
48105001|NCT00181207|100583079|FG000|COMPLETED|Overall Study||24||
48105002|NCT00181207|100583080|FG001|COMPLETED|Overall Study||26||
48105003|NCT00181207|100583079|FG000|NOT COMPLETED|Overall Study||0||
48105004|NCT00181207|100583080|FG001|NOT COMPLETED|Overall Study||0||
48105005|NCT01531387|100583081|FG000|STARTED|Overall Study||11||
48105006|NCT01531387|100583082|FG001|STARTED|Overall Study||11||
48105007|NCT01531387|100583081|FG000|COMPLETED|Overall Study||0||
48105008|NCT01531387|100583082|FG001|COMPLETED|Overall Study||0||
48105009|NCT01531387|100583081|FG000|NOT COMPLETED|Overall Study||11||
48105010|NCT01531387|100583082|FG001|NOT COMPLETED|Overall Study||11||
48105011|NCT03434041|100583083|FG000|STARTED|Double Blind Treatment Phase (4 Weeks)||126||
48105012|NCT03434041|100583084|FG001|STARTED|Double Blind Treatment Phase (4 Weeks)||126||
48105013|NCT03434041|100583083|FG000|Full Analysis Set|Double Blind Treatment Phase (4 Weeks)||124||
48105014|NCT03434041|100583084|FG001|Full Analysis Set|Double Blind Treatment Phase (4 Weeks)||126||
48105015|NCT03434041|100583083|FG000|COMPLETED|Double Blind Treatment Phase (4 Weeks)||108||
48105016|NCT03434041|100583084|FG001|COMPLETED|Double Blind Treatment Phase (4 Weeks)||106||
48105017|NCT03434041|100583083|FG000|NOT COMPLETED|Double Blind Treatment Phase (4 Weeks)||18||
48105018|NCT03434041|100583084|FG001|NOT COMPLETED|Double Blind Treatment Phase (4 Weeks)||20||
48105019|NCT03434041|100583083|FG000|STARTED|Follow-up Phase (Up to 8 Weeks)||106||
48105020|NCT03434041|100583084|FG001|STARTED|Follow-up Phase (Up to 8 Weeks)||103||
48105021|NCT03434041|100583083|FG000|COMPLETED|Follow-up Phase (Up to 8 Weeks)||99||
48105022|NCT03434041|100583084|FG001|COMPLETED|Follow-up Phase (Up to 8 Weeks)||100||
48105023|NCT03434041|100583083|FG000|NOT COMPLETED|Follow-up Phase (Up to 8 Weeks)||7||
48105024|NCT03434041|100583084|FG001|NOT COMPLETED|Follow-up Phase (Up to 8 Weeks)||3||
48105025|NCT00453999|100583085|FG000|STARTED|Overall Study||45||
48105026|NCT00453999|100583086|FG001|STARTED|Overall Study||46||
48105027|NCT00453999|100583087|FG002|STARTED|Overall Study||46||
48105028|NCT00453999|100583085|FG000|COMPLETED|Overall Study||40||
48105029|NCT00453999|100583086|FG001|COMPLETED|Overall Study||41||
48105030|NCT00453999|100583087|FG002|COMPLETED|Overall Study||43||
48105031|NCT00453999|100583085|FG000|NOT COMPLETED|Overall Study||5||
48105032|NCT00453999|100583086|FG001|NOT COMPLETED|Overall Study||5||
48105033|NCT00453999|100583087|FG002|NOT COMPLETED|Overall Study||3||
48105034|NCT03898349|100583088|FG000|STARTED|Overall Study||125||
48105035|NCT03898349|100583089|FG001|STARTED|Overall Study||625||
48105036|NCT03898349|100583088|FG000|COMPLETED|Overall Study||15||
48105037|NCT03898349|100583089|FG001|COMPLETED|Overall Study||15||
48105038|NCT03898349|100583088|FG000|NOT COMPLETED|Overall Study||110||
48105039|NCT03898349|100583089|FG001|NOT COMPLETED|Overall Study||610||
48105040|NCT03412084|100583090|FG000|STARTED|Overall Study||48||
48105041|NCT03412084|100583091|FG001|STARTED|Overall Study||36||
48105042|NCT03412084|100583090|FG000|COMPLETED|Overall Study||44||
48105043|NCT03412084|100583091|FG001|COMPLETED|Overall Study||35||
48105044|NCT03412084|100583090|FG000|NOT COMPLETED|Overall Study||4||
48105045|NCT03412084|100583091|FG001|NOT COMPLETED|Overall Study||1||
48105046|NCT00313612|100583092|FG000|STARTED|Overall Study||19||
48105047|NCT00313612|100583093|FG001|STARTED|Overall Study||20||
48105048|NCT00313612|100583092|FG000|COMPLETED|Overall Study||19||
48105049|NCT00313612|100583093|FG001|COMPLETED|Overall Study||19||
48105050|NCT00313612|100583092|FG000|NOT COMPLETED|Overall Study||0||
48105051|NCT00313612|100583093|FG001|NOT COMPLETED|Overall Study||1||
48105052|NCT01308450|100583094|FG000|STARTED|Overall Study||302||
48105053|NCT01308450|100583094|FG000|COMPLETED|Overall Study||300||
48105054|NCT01308450|100583094|FG000|NOT COMPLETED|Overall Study||2||
48105055|NCT00573755|100583095|FG000|STARTED|Overall Study||2||
48105056|NCT00573755|100583096|FG001|STARTED|Overall Study||2||
48105057|NCT00573755|100583095|FG000|COMPLETED|Overall Study||1||
48105058|NCT00573755|100583096|FG001|COMPLETED|Overall Study||2||
48551713|NCT03404674|101683228|FG003|Received Dose 2|Overall Study||9||
48551714|NCT03404674|101683229|FG004|Received Dose 2|Overall Study||10||
48551715|NCT03404674|101683230|FG005|Received Dose 2|Overall Study||10||
48551716|NCT03404674|101683225|FG000|Received Dose 3|Overall Study||5||
48551717|NCT03404674|101683226|FG001|Received Dose 3|Overall Study||4||
48551718|NCT03404674|101683227|FG002|Received Dose 3|Overall Study||9||
48105059|NCT00573755|100583095|FG000|NOT COMPLETED|Overall Study||1||
48105060|NCT00573755|100583096|FG001|NOT COMPLETED|Overall Study||0||
48105061|NCT00117559|100583097|FG000|STARTED|Overall Study||9||
48105062|NCT00117559|100583098|FG001|STARTED|Overall Study||10||
48391900|NCT04325906|101287751|FG001|NOT COMPLETED|Overall Study||0||
48105063|NCT00117559|100583097|FG000|COMPLETED|Overall Study||8||
48551719|NCT03404674|101683228|FG003|Received Dose 3|Overall Study||9||
48551720|NCT03404674|101683229|FG004|Received Dose 3|Overall Study||10||
48551721|NCT03404674|101683230|FG005|Received Dose 3|Overall Study||9||
48105064|NCT00117559|100583098|FG001|COMPLETED|Overall Study||9||
48105065|NCT00117559|100583097|FG000|NOT COMPLETED|Overall Study||1||
48105066|NCT00117559|100583098|FG001|NOT COMPLETED|Overall Study||1||
48105067|NCT03025828|100583099|FG000|STARTED|Overall Study||5||
48105068|NCT03025828|100583099|FG000|COMPLETED|Overall Study||4||
48551722|NCT03404674|101683225|FG000|COMPLETED|Overall Study||5||
48551723|NCT03404674|101683226|FG001|COMPLETED|Overall Study||4||
48551724|NCT03404674|101683227|FG002|COMPLETED|Overall Study||8||
48551725|NCT03404674|101683228|FG003|COMPLETED|Overall Study||9||
48551726|NCT03404674|101683229|FG004|COMPLETED|Overall Study||10||
48105069|NCT03025828|100583099|FG000|NOT COMPLETED|Overall Study||1||
48105070|NCT00603746|100583100|FG000|STARTED|Overall Study||103||
48266537|NCT03809039|100975459|FG003|COMPLETED|Part 3||0||
48266538|NCT03809039|100975460|FG004|COMPLETED|Part 3||0||
48266539|NCT03809039|100975461|FG005|COMPLETED|Part 3||0||
48105071|NCT00603746|100583101|FG001|STARTED|Overall Study||99||
48105072|NCT00603746|100583102|FG002|STARTED|Overall Study||101||
48105073|NCT00603746|100583103|FG003|STARTED|Overall Study||107||
48105074|NCT00603746|100583104|FG004|STARTED|Overall Study||102||
48105075|NCT00603746|100583105|FG005|STARTED|Overall Study||110||
48105076|NCT00603746|100583100|FG000|COMPLETED|Overall Study||65||
48105077|NCT00603746|100583101|FG001|COMPLETED|Overall Study||81||
48105078|NCT00603746|100583102|FG002|COMPLETED|Overall Study||93||
48105079|NCT00603746|100583103|FG003|COMPLETED|Overall Study||94||
48105080|NCT00603746|100583104|FG004|COMPLETED|Overall Study||85||
48105081|NCT00603746|100583105|FG005|COMPLETED|Overall Study||97||
48105082|NCT00603746|100583100|FG000|NOT COMPLETED|Overall Study||38||
48105083|NCT00603746|100583101|FG001|NOT COMPLETED|Overall Study||18||
48105084|NCT00603746|100583102|FG002|NOT COMPLETED|Overall Study||8||
48105085|NCT00603746|100583103|FG003|NOT COMPLETED|Overall Study||13||
48105086|NCT00603746|100583104|FG004|NOT COMPLETED|Overall Study||17||
48105087|NCT00603746|100583105|FG005|NOT COMPLETED|Overall Study||13||
48105088|NCT00811577|100583106|FG000|STARTED|Overall Study||126||
48105089|NCT00811577|100583107|FG001|STARTED|Overall Study||24||
48105090|NCT00811577|100583106|FG000|COMPLETED|Overall Study||116||
48105091|NCT00811577|100583107|FG001|COMPLETED|Overall Study||23||
48105092|NCT00811577|100583106|FG000|NOT COMPLETED|Overall Study||10||
48105093|NCT00811577|100583107|FG001|NOT COMPLETED|Overall Study||1||
48105094|NCT01948739|100583108|FG000|STARTED|Overall Study||18||
48105095|NCT01948739|100583108|FG000|Received Intervention|Overall Study||10||
48105096|NCT01948739|100583108|FG000|COMPLETED|Overall Study||10||
48105097|NCT01948739|100583108|FG000|NOT COMPLETED|Overall Study||8||
48105098|NCT02918851|100583109|FG000|STARTED|Overall Study||14||
48105099|NCT02918851|100583110|FG001|STARTED|Overall Study||14||
48105100|NCT02918851|100583111|FG002|STARTED|Overall Study||14||
48105101|NCT02918851|100583109|FG000|COMPLETED|Overall Study||10||
48105102|NCT02918851|100583110|FG001|COMPLETED|Overall Study||10||
48105103|NCT02918851|100583111|FG002|COMPLETED|Overall Study||10||
48105104|NCT02918851|100583109|FG000|NOT COMPLETED|Overall Study||4||
48105105|NCT02918851|100583110|FG001|NOT COMPLETED|Overall Study||4||
48105106|NCT02918851|100583111|FG002|NOT COMPLETED|Overall Study||4||
48105107|NCT02529137|100583112|FG000|STARTED|Overall Study||2000|Instead of participants, retrospective cases were enrolled in the study|
48105108|NCT02529137|100583112|FG000|COMPLETED|Overall Study||1992|Instead of participants, retrospective cases were enrolled in the study|
48105109|NCT02529137|100583112|FG000|NOT COMPLETED|Overall Study||8||
48105110|NCT00959842|100583113|FG000|STARTED|Overall Study||15||
48105111|NCT00959842|100583113|FG000|COMPLETED|Overall Study||15||
48105112|NCT00959842|100583113|FG000|NOT COMPLETED|Overall Study||0||
48105113|NCT00962104|100583114|FG000|STARTED|Overall Study||195||
48105114|NCT00962104|100583115|FG001|STARTED|Overall Study||196||
48105115|NCT00962104|100583114|FG000|Full Analysis Set|Overall Study||193||
48105116|NCT00962104|100583115|FG001|Full Analysis Set|Overall Study||195||
48105117|NCT00962104|100583114|FG000|COMPLETED|Overall Study||155||
48105118|NCT00962104|100583115|FG001|COMPLETED|Overall Study||171||
48105119|NCT00962104|100583114|FG000|NOT COMPLETED|Overall Study||40||
48105120|NCT00962104|100583115|FG001|NOT COMPLETED|Overall Study||25||
48266540|NCT03809039|100975462|FG006|COMPLETED|Part 3||0||
48266541|NCT03809039|100975463|FG007|COMPLETED|Part 3||0||
48551727|NCT03404674|101683230|FG005|COMPLETED|Overall Study||9||
48551728|NCT03404674|101683225|FG000|NOT COMPLETED|Overall Study||0||
48551729|NCT03404674|101683226|FG001|NOT COMPLETED|Overall Study||1||
48105121|NCT01251380|100583116|FG000|STARTED|Overall Study||216||
48105122|NCT01251380|100583116|FG000|Cycle 1|Overall Study||207||
48105123|NCT01251380|100583116|FG000|Cycle 2|Overall Study||175||
48105124|NCT01251380|100583116|FG000|Cycle 3|Overall Study||86||
48105125|NCT01251380|100583116|FG000|Cycle 4|Overall Study||11||
48105126|NCT01251380|100583116|FG000|COMPLETED|Overall Study||194||
48105127|NCT01251380|100583116|FG000|NOT COMPLETED|Overall Study||22||
48105128|NCT02641379|100583117|FG000|STARTED|Overall Study||142||
48105129|NCT02641379|100583118|FG001|STARTED|Overall Study||152||
48266542|NCT03809039|100975464|FG008|COMPLETED|Part 3||0||
48266543|NCT03809039|100975456|FG000|NOT COMPLETED|Part 3||0||
48266544|NCT03809039|100975457|FG001|NOT COMPLETED|Part 3||0||
48266545|NCT03809039|100975458|FG002|NOT COMPLETED|Part 3||0||
48266546|NCT03809039|100975459|FG003|NOT COMPLETED|Part 3||0||
48266547|NCT03809039|100975460|FG004|NOT COMPLETED|Part 3||0||
48266548|NCT03809039|100975461|FG005|NOT COMPLETED|Part 3||0||
48266549|NCT03809039|100975462|FG006|NOT COMPLETED|Part 3||0||
48105130|NCT02641379|100583119|FG002|STARTED|Overall Study||78||
48105131|NCT02641379|100583120|FG003|STARTED|Overall Study||156||
48105132|NCT02641379|100583121|FG004|STARTED|Overall Study||17||
48105133|NCT02641379|100583122|FG005|STARTED|Overall Study||36||
48105134|NCT02641379|100583123|FG006|STARTED|Overall Study||25||
48105135|NCT02641379|100583124|FG007|STARTED|Overall Study||20||
48105136|NCT02641379|100583125|FG008|STARTED|Overall Study||42||
48105137|NCT02641379|100583126|FG009|STARTED|Overall Study||45||
48105138|NCT02641379|100583127|FG010|STARTED|Overall Study||8||
48105139|NCT02641379|100583117|FG000|COMPLETED|Overall Study||107||
48105140|NCT02641379|100583118|FG001|COMPLETED|Overall Study||101||
48105141|NCT02641379|100583119|FG002|COMPLETED|Overall Study||7||
48105142|NCT02641379|100583120|FG003|COMPLETED|Overall Study||139||
48105143|NCT02641379|100583121|FG004|COMPLETED|Overall Study||0||
48105144|NCT02641379|100583122|FG005|COMPLETED|Overall Study||20||
48105145|NCT02641379|100583123|FG006|COMPLETED|Overall Study||12||
48105146|NCT02641379|100583124|FG007|COMPLETED|Overall Study||1||
48105147|NCT02641379|100583125|FG008|COMPLETED|Overall Study||36||
48105148|NCT02641379|100583126|FG009|COMPLETED|Overall Study||36||
48105149|NCT02641379|100583127|FG010|COMPLETED|Overall Study||0||
48105150|NCT02641379|100583117|FG000|NOT COMPLETED|Overall Study||35||
48105151|NCT02641379|100583118|FG001|NOT COMPLETED|Overall Study||51||
48105152|NCT02641379|100583119|FG002|NOT COMPLETED|Overall Study||71||
48105153|NCT02641379|100583120|FG003|NOT COMPLETED|Overall Study||17||
48105154|NCT02641379|100583121|FG004|NOT COMPLETED|Overall Study||17||
48105155|NCT02641379|100583122|FG005|NOT COMPLETED|Overall Study||16||
48105156|NCT02641379|100583123|FG006|NOT COMPLETED|Overall Study||13||
48105157|NCT02641379|100583124|FG007|NOT COMPLETED|Overall Study||19||
48105158|NCT02641379|100583125|FG008|NOT COMPLETED|Overall Study||6||
48105159|NCT02641379|100583126|FG009|NOT COMPLETED|Overall Study||9||
48105160|NCT02641379|100583127|FG010|NOT COMPLETED|Overall Study||8||
48105161|NCT03050619|100583128|FG000|STARTED|Overall Study||129||
48105162|NCT03050619|100583129|FG001|STARTED|Overall Study||3926||
48105163|NCT03050619|100583130|FG002|STARTED|Overall Study||6416||
48105164|NCT03050619|100583131|FG003|STARTED|Overall Study||14007||
48105165|NCT03050619|100583132|FG004|STARTED|Overall Study||6079||
48105166|NCT03050619|100583133|FG005|STARTED|Overall Study||1351||
48105167|NCT03050619|100583128|FG000|COMPLETED|Overall Study||129||
48105168|NCT03050619|100583129|FG001|COMPLETED|Overall Study||3926||
48105169|NCT03050619|100583130|FG002|COMPLETED|Overall Study||6416||
48105170|NCT03050619|100583131|FG003|COMPLETED|Overall Study||14007||
48105171|NCT03050619|100583132|FG004|COMPLETED|Overall Study||6079||
48105172|NCT03050619|100583133|FG005|COMPLETED|Overall Study||1351||
48105173|NCT03050619|100583128|FG000|NOT COMPLETED|Overall Study||0||
48105174|NCT03050619|100583129|FG001|NOT COMPLETED|Overall Study||0||
48105175|NCT03050619|100583130|FG002|NOT COMPLETED|Overall Study||0||
48105176|NCT03050619|100583131|FG003|NOT COMPLETED|Overall Study||0||
48105177|NCT03050619|100583132|FG004|NOT COMPLETED|Overall Study||0||
48105178|NCT03050619|100583133|FG005|NOT COMPLETED|Overall Study||0||
48105179|NCT04534764|100583134|FG000|STARTED|Period 1||18||
48105180|NCT04534764|100583135|FG001|STARTED|Period 1||17||
48105181|NCT04534764|100583134|FG000|COMPLETED|Period 1||18||
48105182|NCT04534764|100583135|FG001|COMPLETED|Period 1||17||
48105183|NCT04534764|100583134|FG000|NOT COMPLETED|Period 1||0||
48105184|NCT04534764|100583135|FG001|NOT COMPLETED|Period 1||0||
48105185|NCT04534764|100583134|FG000|STARTED|Period 2||18||
48105186|NCT04534764|100583135|FG001|STARTED|Period 2||17||
48105187|NCT04534764|100583134|FG000|COMPLETED|Period 2||18||
48105188|NCT04534764|100583135|FG001|COMPLETED|Period 2||17||
48105189|NCT04534764|100583134|FG000|NOT COMPLETED|Period 2||0||
48105190|NCT04534764|100583135|FG001|NOT COMPLETED|Period 2||0||
48105191|NCT02710890|100583136|FG000|STARTED|Overall Study||48||
48105192|NCT02710890|100583137|FG001|STARTED|Overall Study||55||
48105193|NCT02710890|100583136|FG000|COMPLETED|Overall Study||48||
48105194|NCT02710890|100583137|FG001|COMPLETED|Overall Study||55||
48105195|NCT02710890|100583136|FG000|NOT COMPLETED|Overall Study||0||
48105196|NCT02710890|100583137|FG001|NOT COMPLETED|Overall Study||0||
48105197|NCT03463889|100583138|FG000|STARTED|Overall Study||12||
48105198|NCT03463889|100583138|FG000|COMPLETED|Overall Study||12||
48105199|NCT03463889|100583138|FG000|NOT COMPLETED|Overall Study||0||
48105200|NCT02476968|100583139|FG000|STARTED|Overall Study||145|Enrolled and included in the full analysis set (FAS)|
48105201|NCT02476968|100583140|FG001|STARTED|Overall Study||33|Enrolled and included in the full analysis set (FAS)|
48105202|NCT02476968|100583141|FG002|STARTED|Overall Study||3|Enrolled and included in the full analysis set (FAS)|
48105203|NCT02476968|100583139|FG000|Received Treatment|Overall Study||143||
48105204|NCT02476968|100583140|FG001|Received Treatment|Overall Study||32||
48105205|NCT02476968|100583141|FG002|Received Treatment|Overall Study||2||
48105206|NCT02476968|100583139|FG000|COMPLETED|Overall Study||50||
48105207|NCT02476968|100583140|FG001|COMPLETED|Overall Study||15||
48105208|NCT02476968|100583141|FG002|COMPLETED|Overall Study||0||
48105209|NCT02476968|100583139|FG000|NOT COMPLETED|Overall Study||95||
48105210|NCT02476968|100583140|FG001|NOT COMPLETED|Overall Study||18||
48105211|NCT02476968|100583141|FG002|NOT COMPLETED|Overall Study||3||
48105212|NCT01124643|100583142|FG000|STARTED|Overall Study||35||
48105213|NCT01124643|100583142|FG000|COMPLETED|Overall Study||34||
48105214|NCT01124643|100583142|FG000|NOT COMPLETED|Overall Study||1||
48105215|NCT04222712|100583143|FG000|STARTED|Overall Study||8||
48105216|NCT04222712|100583144|FG001|STARTED|Overall Study||8||
48105217|NCT04222712|100583143|FG000|COMPLETED|Overall Study||8||
48105218|NCT04222712|100583144|FG001|COMPLETED|Overall Study||8||
48105219|NCT04222712|100583143|FG000|NOT COMPLETED|Overall Study||0||
48105220|NCT04222712|100583144|FG001|NOT COMPLETED|Overall Study||0||
48692179|NCT04474197|102029111|FG003|NOT COMPLETED|Overall Study||0||
48692180|NCT01057693|102029112|FG000|STARTED|Single-Blind Phase (Up to Week 6)||665||
48692181|NCT01057693|102029113|FG001|STARTED|Single-Blind Phase (Up to Week 6)||0||
48692182|NCT01057693|102029114|FG002|STARTED|Single-Blind Phase (Up to Week 6)||0||
48692183|NCT01057693|102029112|FG000|COMPLETED|Single-Blind Phase (Up to Week 6)||566||
48692184|NCT01057693|102029113|FG001|COMPLETED|Single-Blind Phase (Up to Week 6)||0||
48105221|NCT00449644|100583145|FG000|STARTED|Overall Study||23||
48105222|NCT00449644|100583146|FG001|STARTED|Overall Study||24||
48105223|NCT00449644|100583147|FG002|STARTED|Overall Study||79||
48105224|NCT00449644|100583148|FG003|STARTED|Overall Study||81||
48105225|NCT00449644|100583145|FG000|Rollover|Overall Study||0||
48105226|NCT00449644|100583146|FG001|Rollover|Overall Study||0||
48105227|NCT00449644|100583147|FG002|Rollover|Overall Study||0||
48105228|NCT00449644|100583148|FG003|Rollover|Overall Study||1||
48105229|NCT00449644|100583145|FG000|COMPLETED|Overall Study||13||
48692185|NCT01057693|102029114|FG002|COMPLETED|Single-Blind Phase (Up to Week 6)||0||
48692186|NCT01057693|102029112|FG000|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||99||
48692187|NCT01057693|102029113|FG001|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0||
48692188|NCT01057693|102029114|FG002|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0||
48692189|NCT01057693|102029112|FG000|STARTED|Between Single-Blind and Double-Blind||566||
48692190|NCT01057693|102029113|FG001|STARTED|Between Single-Blind and Double-Blind||0||
48692191|NCT01057693|102029114|FG002|STARTED|Between Single-Blind and Double-Blind||0||
48692192|NCT01057693|102029112|FG000|COMPLETED|Between Single-Blind and Double-Blind||296||
48692193|NCT01057693|102029113|FG001|COMPLETED|Between Single-Blind and Double-Blind||0||
48105230|NCT00449644|100583146|FG001|COMPLETED|Overall Study||11||
48105231|NCT00449644|100583147|FG002|COMPLETED|Overall Study||50||
48105232|NCT00449644|100583148|FG003|COMPLETED|Overall Study||49||
48105233|NCT00449644|100583145|FG000|NOT COMPLETED|Overall Study||10||
48105234|NCT00449644|100583146|FG001|NOT COMPLETED|Overall Study||13||
48105235|NCT00449644|100583147|FG002|NOT COMPLETED|Overall Study||29||
48105236|NCT00449644|100583148|FG003|NOT COMPLETED|Overall Study||32||
48105237|NCT01904604|100583149|FG000|STARTED|Overall Study||25||
48105238|NCT01904604|100583150|FG001|STARTED|Overall Study||25||
48105239|NCT01904604|100583151|FG002|STARTED|Overall Study||25||
48105240|NCT01904604|100583149|FG000|Completed Week 52 OFC|Overall Study||22|Completion of the Week 52 OFC was required to assess the primary endpoint of the study.|
48105241|NCT01904604|100583150|FG001|Completed Week 52 OFC|Overall Study||21|Completion of the Week 52 OFC was required to assess the primary endpoint of the study.|
48105242|NCT01904604|100583151|FG002|Completed Week 52 OFC|Overall Study||25|Completion of the Week 52 OFC was required to assess the primary endpoint of the study.|
48105243|NCT01904604|100583149|FG000|Began Crossover Treatment|Overall Study||20||
48105244|NCT01904604|100583150|FG001|Began Crossover Treatment|Overall Study||21||
48105245|NCT01904604|100583151|FG002|Began Crossover Treatment|Overall Study||0||
48105246|NCT01904604|100583149|FG000|Completed Week 130 OFC|Overall Study||18||
48105247|NCT01904604|100583150|FG001|Completed Week 130 OFC|Overall Study||18||
48105248|NCT01904604|100583151|FG002|Completed Week 130 OFC|Overall Study||23||
48105249|NCT01904604|100583149|FG000|COMPLETED|Overall Study||18||
48105250|NCT01904604|100583150|FG001|COMPLETED|Overall Study||18||
48105251|NCT01904604|100583151|FG002|COMPLETED|Overall Study||23||
48105252|NCT01904604|100583149|FG000|NOT COMPLETED|Overall Study||7||
48105253|NCT01904604|100583150|FG001|NOT COMPLETED|Overall Study||7||
48105254|NCT01904604|100583151|FG002|NOT COMPLETED|Overall Study||2||
48105255|NCT01514396|100583152|FG000|STARTED|Overall Study||8||
48105256|NCT01514396|100583152|FG000|COMPLETED|Overall Study||8||
48105257|NCT01514396|100583152|FG000|NOT COMPLETED|Overall Study||0||
48105258|NCT02276612|100586833|FG000|STARTED|Overall Study||50||
48692194|NCT01057693|102029114|FG002|COMPLETED|Between Single-Blind and Double-Blind||0||
48692195|NCT01057693|102029112|FG000|NOT COMPLETED|Between Single-Blind and Double-Blind||270||
48692196|NCT01057693|102029113|FG001|NOT COMPLETED|Between Single-Blind and Double-Blind||0||
48692197|NCT01057693|102029114|FG002|NOT COMPLETED|Between Single-Blind and Double-Blind||0||
48105259|NCT02276612|100586834|FG001|STARTED|Overall Study||10||
48105260|NCT02276612|100586833|FG000|COMPLETED|Overall Study||46||
48692198|NCT01057693|102029112|FG000|STARTED|Double-Blind Phase (Week 7 to Week 19)||0||
48105261|NCT02276612|100586834|FG001|COMPLETED|Overall Study||10||
48105262|NCT02276612|100586833|FG000|NOT COMPLETED|Overall Study||4||
48105263|NCT02276612|100586834|FG001|NOT COMPLETED|Overall Study||0||
48692199|NCT01057693|102029113|FG001|STARTED|Double-Blind Phase (Week 7 to Week 19)||147||
48105264|NCT02680639|100586835|FG000|STARTED|Screening Period||10||
48105265|NCT02680639|100586836|FG001|STARTED|Screening Period||0||
48105266|NCT02680639|100586837|FG002|STARTED|Screening Period||0||
48105267|NCT02680639|100586835|FG000|COMPLETED|Screening Period||3||
48105268|NCT02680639|100586836|FG001|COMPLETED|Screening Period||0||
48105269|NCT02680639|100586837|FG002|COMPLETED|Screening Period||0||
48105270|NCT02680639|100586835|FG000|NOT COMPLETED|Screening Period||7||
48105271|NCT02680639|100586836|FG001|NOT COMPLETED|Screening Period||0||
48105272|NCT02680639|100586837|FG002|NOT COMPLETED|Screening Period||0||
48105273|NCT02680639|100586835|FG000|STARTED|High Frequency Oscillation (HFO) Therapy||0||
48105274|NCT02680639|100586836|FG001|STARTED|High Frequency Oscillation (HFO) Therapy||2||
48105275|NCT02680639|100586837|FG002|STARTED|High Frequency Oscillation (HFO) Therapy||1||
48105276|NCT02680639|100586835|FG000|COMPLETED|High Frequency Oscillation (HFO) Therapy||0||
48105277|NCT02680639|100586836|FG001|COMPLETED|High Frequency Oscillation (HFO) Therapy||2||
48105278|NCT02680639|100586837|FG002|COMPLETED|High Frequency Oscillation (HFO) Therapy||1||
48105279|NCT02680639|100586835|FG000|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0||
48105280|NCT02680639|100586836|FG001|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0||
48105281|NCT02680639|100586837|FG002|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0||
48105282|NCT02290821|100586838|FG000|STARTED|Overall Study||109||
48105283|NCT02290821|100586839|FG001|STARTED|Overall Study||106||
48105284|NCT02290821|100586838|FG000|COMPLETED|Overall Study||103||
48105285|NCT02290821|100586839|FG001|COMPLETED|Overall Study||103||
48105286|NCT02290821|100586838|FG000|NOT COMPLETED|Overall Study||6||
48105287|NCT02290821|100586839|FG001|NOT COMPLETED|Overall Study||3||
48105288|NCT01025427|100586840|FG000|STARTED|Overall Study||16||
48105289|NCT01025427|100586840|FG000|COMPLETED|Overall Study||16||
48105290|NCT01025427|100586840|FG000|NOT COMPLETED|Overall Study||0||
48105291|NCT02357940|100586841|FG000|STARTED|Overall Study||9||
48105292|NCT02357940|100586842|FG001|STARTED|Overall Study||32||
48105293|NCT02357940|100586841|FG000|COMPLETED|Overall Study||9||
48105294|NCT02357940|100586842|FG001|COMPLETED|Overall Study||30||
48105295|NCT02357940|100586841|FG000|NOT COMPLETED|Overall Study||0||
48105296|NCT02357940|100586842|FG001|NOT COMPLETED|Overall Study||2||
48105297|NCT00506155|100586843|FG000|STARTED|Overall Study||60||
48105298|NCT00506155|100586843|FG000|COMPLETED|Overall Study||60||
48105299|NCT00506155|100586843|FG000|NOT COMPLETED|Overall Study||0||
48105300|NCT00344773|100586844|FG000|STARTED|Overall Study||46||
48105301|NCT00344773|100586844|FG000|COMPLETED|Overall Study||25||
48105302|NCT00344773|100586844|FG000|NOT COMPLETED|Overall Study||21||
48105303|NCT01649375|100586845|FG000|STARTED|Up to Week 16||73||
48105304|NCT01649375|100586846|FG001|STARTED|Up to Week 16||72||
48105305|NCT01649375|100586847|FG002|STARTED|Up to Week 16||74||
48105306|NCT01649375|100586848|FG003|STARTED|Up to Week 16||0||
48105307|NCT01649375|100586849|FG004|STARTED|Up to Week 16||0||
48105308|NCT01649375|100586845|FG000|COMPLETED|Up to Week 16||68||
48105309|NCT01649375|100586846|FG001|COMPLETED|Up to Week 16||66||
48105310|NCT01649375|100586847|FG002|COMPLETED|Up to Week 16||66||
48105311|NCT01649375|100586848|FG003|COMPLETED|Up to Week 16||0||
48105312|NCT01649375|100586849|FG004|COMPLETED|Up to Week 16||0||
48105313|NCT01649375|100586845|FG000|NOT COMPLETED|Up to Week 16||5||
48105314|NCT01649375|100586846|FG001|NOT COMPLETED|Up to Week 16||6||
48105315|NCT01649375|100586847|FG002|NOT COMPLETED|Up to Week 16||8||
48105316|NCT01649375|100586848|FG003|NOT COMPLETED|Up to Week 16||0||
48105317|NCT01649375|100586849|FG004|NOT COMPLETED|Up to Week 16||0||
48105318|NCT01649375|100586845|FG000|STARTED|Week 16 up to Week 260||68||
48105319|NCT01649375|100586846|FG001|STARTED|Week 16 up to Week 260||66||
48105320|NCT01649375|100586847|FG002|STARTED|Week 16 up to Week 260||0||
48105321|NCT01649375|100586848|FG003|STARTED|Week 16 up to Week 260||32||
48105322|NCT01649375|100586849|FG004|STARTED|Week 16 up to Week 260||34||
48105323|NCT01649375|100586845|FG000|COMPLETED|Week 16 up to Week 260||48||
48105324|NCT01649375|100586846|FG001|COMPLETED|Week 16 up to Week 260||53||
48105325|NCT01649375|100586847|FG002|COMPLETED|Week 16 up to Week 260||0||
48105326|NCT01649375|100586848|FG003|COMPLETED|Week 16 up to Week 260||20||
48105327|NCT01649375|100586849|FG004|COMPLETED|Week 16 up to Week 260||29||
48105328|NCT01649375|100586845|FG000|NOT COMPLETED|Week 16 up to Week 260||20||
48105329|NCT01649375|100586846|FG001|NOT COMPLETED|Week 16 up to Week 260||13||
48105330|NCT01649375|100586847|FG002|NOT COMPLETED|Week 16 up to Week 260||0||
48105331|NCT01649375|100586848|FG003|NOT COMPLETED|Week 16 up to Week 260||12||
48105332|NCT01649375|100586849|FG004|NOT COMPLETED|Week 16 up to Week 260||5||
48105333|NCT01462357|100586850|FG000|STARTED|Overall Study||359||
48105334|NCT01462357|100586851|FG001|STARTED|Overall Study||358||
48105335|NCT01462357|100586852|FG002|STARTED|Overall Study||358||
48105336|NCT01462357|100586850|FG000|COMPLETED|Overall Study||351||
48105337|NCT01462357|100586851|FG001|COMPLETED|Overall Study||339||
48105338|NCT01462357|100586852|FG002|COMPLETED|Overall Study||346||
48105339|NCT01462357|100586850|FG000|NOT COMPLETED|Overall Study||8||
48105340|NCT01462357|100586851|FG001|NOT COMPLETED|Overall Study||19||
48105341|NCT01462357|100586852|FG002|NOT COMPLETED|Overall Study||12||
48105342|NCT00048542|100586853|FG000|STARTED|Double-Blind Phase||38||
48105343|NCT00048542|100586854|FG001|STARTED|Double-Blind Phase||37||
48105344|NCT00048542|100586855|FG002|STARTED|Double-Blind Phase||30||
48105345|NCT00048542|100586856|FG003|STARTED|Double-Blind Phase||28||
48105346|NCT00048542|100586857|FG004|STARTED|Double-Blind Phase||0||
48105347|NCT00048542|100586858|FG005|STARTED|Double-Blind Phase||0||
48105348|NCT00048542|100586859|FG006|STARTED|Double-Blind Phase||0||
48105349|NCT00048542|100586860|FG007|STARTED|Double-Blind Phase||0||
48266550|NCT03809039|100975463|FG007|NOT COMPLETED|Part 3||2||
48266551|NCT03809039|100975464|FG008|NOT COMPLETED|Part 3||6||
48266552|NCT00730015|100975465|FG000|STARTED|Overall Study||217||
48266553|NCT00730015|100975466|FG001|STARTED|Overall Study||217||
48266554|NCT00730015|100975467|FG002|STARTED|Overall Study||209||
48266555|NCT00730015|100975465|FG000|COMPLETED|Overall Study||186||
48266556|NCT00730015|100975466|FG001|COMPLETED|Overall Study||177||
48266557|NCT00730015|100975467|FG002|COMPLETED|Overall Study||177||
48266558|NCT00730015|100975465|FG000|NOT COMPLETED|Overall Study||31||
48266559|NCT00730015|100975466|FG001|NOT COMPLETED|Overall Study||40||
48266560|NCT00730015|100975467|FG002|NOT COMPLETED|Overall Study||32||
48266561|NCT01535001|100975468|FG000|STARTED|Overall Study||50||
48266562|NCT01535001|100975469|FG001|STARTED|Overall Study||50||
48266563|NCT01535001|100975468|FG000|COMPLETED|Overall Study||47||
48105350|NCT00048542|100586853|FG000|COMPLETED|Double-Blind Phase||35||
48105351|NCT00048542|100586854|FG001|COMPLETED|Double-Blind Phase||36||
48105352|NCT00048542|100586855|FG002|COMPLETED|Double-Blind Phase||29||
48105353|NCT00048542|100586856|FG003|COMPLETED|Double-Blind Phase||28||
48105354|NCT00048542|100586857|FG004|COMPLETED|Double-Blind Phase||0||
48105355|NCT00048542|100586858|FG005|COMPLETED|Double-Blind Phase||0||
48105356|NCT00048542|100586859|FG006|COMPLETED|Double-Blind Phase||0||
48105357|NCT00048542|100586860|FG007|COMPLETED|Double-Blind Phase||0||
48105358|NCT00048542|100586853|FG000|NOT COMPLETED|Double-Blind Phase||3||
48105359|NCT00048542|100586854|FG001|NOT COMPLETED|Double-Blind Phase||1||
48105360|NCT00048542|100586855|FG002|NOT COMPLETED|Double-Blind Phase||1||
48105361|NCT00048542|100586856|FG003|NOT COMPLETED|Double-Blind Phase||0||
48105362|NCT00048542|100586857|FG004|NOT COMPLETED|Double-Blind Phase||0||
48105363|NCT00048542|100586858|FG005|NOT COMPLETED|Double-Blind Phase||0||
48105364|NCT00048542|100586859|FG006|NOT COMPLETED|Double-Blind Phase||0||
48105365|NCT00048542|100586860|FG007|NOT COMPLETED|Double-Blind Phase||0||
48105366|NCT00048542|100586853|FG000|STARTED|Open-Label Extension BSA Phase||0||
48105367|NCT00048542|100586854|FG001|STARTED|Open-Label Extension BSA Phase||0||
48105368|NCT00048542|100586855|FG002|STARTED|Open-Label Extension BSA Phase||0||
48105369|NCT00048542|100586856|FG003|STARTED|Open-Label Extension BSA Phase||0||
48105370|NCT00048542|100586857|FG004|STARTED|Open-Label Extension BSA Phase||71||
48105371|NCT00048542|100586858|FG005|STARTED|Open-Label Extension BSA Phase||57||
48105372|NCT00048542|100586859|FG006|STARTED|Open-Label Extension BSA Phase||0||
48105373|NCT00048542|100586860|FG007|STARTED|Open-Label Extension BSA Phase||0||
48105374|NCT00048542|100586853|FG000|COMPLETED|Open-Label Extension BSA Phase||0||
48105375|NCT00048542|100586854|FG001|COMPLETED|Open-Label Extension BSA Phase||0||
48105376|NCT00048542|100586855|FG002|COMPLETED|Open-Label Extension BSA Phase||0||
48105377|NCT00048542|100586856|FG003|COMPLETED|Open-Label Extension BSA Phase||0||
48105378|NCT00048542|100586857|FG004|COMPLETED|Open-Label Extension BSA Phase||59||
48105379|NCT00048542|100586858|FG005|COMPLETED|Open-Label Extension BSA Phase||47||
48105380|NCT00048542|100586859|FG006|COMPLETED|Open-Label Extension BSA Phase||0||
48105381|NCT00048542|100586860|FG007|COMPLETED|Open-Label Extension BSA Phase||0||
48105382|NCT00048542|100586853|FG000|NOT COMPLETED|Open-Label Extension BSA Phase||0||
48105383|NCT00048542|100586854|FG001|NOT COMPLETED|Open-Label Extension BSA Phase||0||
48105384|NCT00048542|100586855|FG002|NOT COMPLETED|Open-Label Extension BSA Phase||0||
48105385|NCT00048542|100586856|FG003|NOT COMPLETED|Open-Label Extension BSA Phase||0||
48105386|NCT00048542|100586857|FG004|NOT COMPLETED|Open-Label Extension BSA Phase||12||
48105387|NCT00048542|100586858|FG005|NOT COMPLETED|Open-Label Extension BSA Phase||10||
48105388|NCT00048542|100586859|FG006|NOT COMPLETED|Open-Label Extension BSA Phase||0||
48105389|NCT00048542|100586860|FG007|NOT COMPLETED|Open-Label Extension BSA Phase||0||
48105390|NCT00048542|100586853|FG000|STARTED|Open-Label Extension Fixed Dose Phase||0||
48105391|NCT00048542|100586854|FG001|STARTED|Open-Label Extension Fixed Dose Phase||0||
48105392|NCT00048542|100586855|FG002|STARTED|Open-Label Extension Fixed Dose Phase||0||
48105393|NCT00048542|100586856|FG003|STARTED|Open-Label Extension Fixed Dose Phase||0||
48105394|NCT00048542|100586857|FG004|STARTED|Open-Label Extension Fixed Dose Phase||0||
48105395|NCT00048542|100586858|FG005|STARTED|Open-Label Extension Fixed Dose Phase||0||
48105396|NCT00048542|100586859|FG006|STARTED|Open-Label Extension Fixed Dose Phase||59||
48105397|NCT00048542|100586860|FG007|STARTED|Open-Label Extension Fixed Dose Phase||47||
48105398|NCT00048542|100586853|FG000|COMPLETED|Open-Label Extension Fixed Dose Phase||0||
48105399|NCT00048542|100586854|FG001|COMPLETED|Open-Label Extension Fixed Dose Phase||0||
48105400|NCT00048542|100586855|FG002|COMPLETED|Open-Label Extension Fixed Dose Phase||0||
48105401|NCT00048542|100586856|FG003|COMPLETED|Open-Label Extension Fixed Dose Phase||0||
48105402|NCT00048542|100586857|FG004|COMPLETED|Open-Label Extension Fixed Dose Phase||0||
48105403|NCT00048542|100586858|FG005|COMPLETED|Open-Label Extension Fixed Dose Phase||0||
48105404|NCT00048542|100586859|FG006|COMPLETED|Open-Label Extension Fixed Dose Phase||37||
48105405|NCT00048542|100586860|FG007|COMPLETED|Open-Label Extension Fixed Dose Phase||25||
48266564|NCT01535001|100975469|FG001|COMPLETED|Overall Study||44||
48266565|NCT01535001|100975468|FG000|NOT COMPLETED|Overall Study||3||
48266566|NCT01535001|100975469|FG001|NOT COMPLETED|Overall Study||6||
48266567|NCT05071313|100975470|FG000|STARTED|Overall Study||389||
48266568|NCT05071313|100975471|FG001|STARTED|Overall Study||388||
48266569|NCT05071313|100975470|FG000|Received Ad26/Protein preF RSV Vaccine With Fluzone in CoAd Group at Day 1|Overall Study||385||
48266570|NCT05071313|100975471|FG001|Received Ad26/Protein preF RSV Vaccine With Fluzone in CoAd Group at Day 1|Overall Study||0||
48266571|NCT05071313|100975470|FG000|Received Placebo With Fluzone in Control Group at Day 1|Overall Study||0||
48266572|NCT05071313|100975471|FG001|Received Placebo With Fluzone in Control Group at Day 1|Overall Study||386||
48266573|NCT05071313|100975470|FG000|Received Placebo in CoAd Group at Day 29|Overall Study||357||
48266574|NCT05071313|100975471|FG001|Received Placebo in CoAd Group at Day 29|Overall Study||0||
48266575|NCT05071313|100975470|FG000|Received Ad26/Protein preF RSV Vaccine in Control Group at Day 29|Overall Study||0||
48266576|NCT05071313|100975471|FG001|Received Ad26/Protein preF RSV Vaccine in Control Group at Day 29|Overall Study||363||
48266577|NCT05071313|100975470|FG000|COMPLETED|Overall Study||355||
48266578|NCT05071313|100975471|FG001|COMPLETED|Overall Study||355||
48266579|NCT05071313|100975470|FG000|NOT COMPLETED|Overall Study||34||
48266580|NCT05071313|100975471|FG001|NOT COMPLETED|Overall Study||33||
48266581|NCT03358238|100975472|FG000|STARTED|Overall Study||23||
48266582|NCT03358238|100975473|FG001|STARTED|Overall Study||25||
48266583|NCT03358238|100975472|FG000|COMPLETED|Overall Study||23||
48551730|NCT03404674|101683227|FG002|NOT COMPLETED|Overall Study||2||
48551731|NCT03404674|101683228|FG003|NOT COMPLETED|Overall Study||1||
48551732|NCT03404674|101683229|FG004|NOT COMPLETED|Overall Study||0||
48105406|NCT00048542|100586853|FG000|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0||
48105407|NCT00048542|100586854|FG001|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0||
48105408|NCT00048542|100586855|FG002|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0||
48105409|NCT00048542|100586856|FG003|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0||
48266584|NCT03358238|100975473|FG001|COMPLETED|Overall Study||24||
48266585|NCT03358238|100975472|FG000|NOT COMPLETED|Overall Study||0||
48266586|NCT03358238|100975473|FG001|NOT COMPLETED|Overall Study||1||
48105410|NCT00048542|100586857|FG004|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0||
48105411|NCT00048542|100586858|FG005|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0||
48105412|NCT00048542|100586859|FG006|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22||
48105413|NCT00048542|100586860|FG007|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22||
48105414|NCT01527292|100586861|FG000|STARTED|Overall Study||0||
48105415|NCT01527292|100586862|FG001|STARTED|Overall Study||3||
48266587|NCT02614183|100975474|FG000|STARTED|Double Blind Treatment Phase||434||
48692200|NCT01057693|102029114|FG002|STARTED|Double-Blind Phase (Week 7 to Week 19)||149||
48692201|NCT01057693|102029112|FG000|Treated|Double-Blind Phase (Week 7 to Week 19)||0||
48692202|NCT01057693|102029113|FG001|Treated|Double-Blind Phase (Week 7 to Week 19)||147||
48692203|NCT01057693|102029114|FG002|Treated|Double-Blind Phase (Week 7 to Week 19)||147||
48692204|NCT01057693|102029112|FG000|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0||
48105416|NCT01527292|100586861|FG000|COMPLETED|Overall Study||0||
48266588|NCT02614183|100975475|FG001|STARTED|Double Blind Treatment Phase||214||
48266589|NCT02614183|100975476|FG002|STARTED|Double Blind Treatment Phase||214||
48551733|NCT03404674|101683230|FG005|NOT COMPLETED|Overall Study||1||
48551734|NCT04650217|101683231|FG000|STARTED|Overall Study||0||
48551735|NCT04650217|101683232|FG001|STARTED|Overall Study||0||
48551736|NCT04650217|101683233|FG002|STARTED|Overall Study||0||
48105417|NCT01527292|100586862|FG001|COMPLETED|Overall Study||0||
48105418|NCT01527292|100586861|FG000|NOT COMPLETED|Overall Study||0||
48105419|NCT01527292|100586862|FG001|NOT COMPLETED|Overall Study||3||
48105420|NCT03873987|100586863|FG000|STARTED|Overall Study||52||
48105421|NCT03873987|100586864|FG001|STARTED|Overall Study||50||
48266590|NCT02614183|100975474|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||433||
48266591|NCT02614183|100975475|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||213||
48266592|NCT02614183|100975476|FG002|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||212||
48551737|NCT04650217|101683234|FG003|STARTED|Overall Study||0||
48551738|NCT04650217|101683235|FG004|STARTED|Overall Study||1||
48551739|NCT04650217|101683231|FG000|COMPLETED|Overall Study||0||
48105422|NCT03873987|100586863|FG000|COMPLETED|Overall Study||50||
48551740|NCT04650217|101683232|FG001|COMPLETED|Overall Study||0||
48105423|NCT03873987|100586864|FG001|COMPLETED|Overall Study||49||
48105424|NCT03873987|100586863|FG000|NOT COMPLETED|Overall Study||2||
48266593|NCT02614183|100975474|FG000|Safety Population|Double Blind Treatment Phase||432||
48266594|NCT02614183|100975475|FG001|Safety Population|Double Blind Treatment Phase||206||
48266595|NCT02614183|100975476|FG002|Safety Population|Double Blind Treatment Phase||220||
48266596|NCT02614183|100975474|FG000|COMPLETED|Double Blind Treatment Phase||351||
48266597|NCT02614183|100975475|FG001|COMPLETED|Double Blind Treatment Phase||177||
48266598|NCT02614183|100975476|FG002|COMPLETED|Double Blind Treatment Phase||175||
48266599|NCT02614183|100975474|FG000|NOT COMPLETED|Double Blind Treatment Phase||83||
48266600|NCT02614183|100975475|FG001|NOT COMPLETED|Double Blind Treatment Phase||37||
48266601|NCT02614183|100975476|FG002|NOT COMPLETED|Double Blind Treatment Phase||39||
48266602|NCT02614183|100975474|FG000|STARTED|Post Treatment Follow-up Phase||372||
48391901|NCT05567393|101287752|FG000|STARTED|Overall Study||24||
48551741|NCT04650217|101683233|FG002|COMPLETED|Overall Study||0||
48551742|NCT04650217|101683234|FG003|COMPLETED|Overall Study||0||
48551743|NCT04650217|101683235|FG004|COMPLETED|Overall Study||0||
48105425|NCT03873987|100586864|FG001|NOT COMPLETED|Overall Study||1||
48105426|NCT01398956|100586865|FG000|STARTED|Overall Study||44||
48105427|NCT01398956|100586865|FG000|COMPLETED|Overall Study||34||
48105428|NCT01398956|100586865|FG000|NOT COMPLETED|Overall Study||10||
48105429|NCT03340337|100586866|FG000|STARTED|Overall Study||30||
48105430|NCT03340337|100586866|FG000|Received Neo-Russian|Overall Study||30|All the participants received this type of electrical stimulation, in a randomized order.|
48105431|NCT03340337|100586866|FG000|Received Aussie|Overall Study||30|All the participants received this type of electrical stimulation, in a randomized order.|
48105432|NCT03340337|100586866|FG000|Received RBS|Overall Study||30|All the participants received this type of electrical stimulation, in a randomized order.|
48105433|NCT03340337|100586866|FG000|COMPLETED|Overall Study||30||
48105434|NCT03340337|100586866|FG000|NOT COMPLETED|Overall Study||0||
48105435|NCT03662542|100586867|FG000|STARTED|Combination Phase ( Week 0- Week 12)||72||
48105436|NCT03662542|100586868|FG001|STARTED|Combination Phase ( Week 0- Week 12)||71||
48105437|NCT03662542|100586869|FG002|STARTED|Combination Phase ( Week 0- Week 12)||71||
48105438|NCT03662542|100586870|FG003|STARTED|Combination Phase ( Week 0- Week 12)||0||
48105439|NCT03662542|100586871|FG004|STARTED|Combination Phase ( Week 0- Week 12)||0||
48105440|NCT03662542|100586872|FG005|STARTED|Combination Phase ( Week 0- Week 12)||0||
48105441|NCT03662542|100586873|FG006|STARTED|Combination Phase ( Week 0- Week 12)||0||
48105442|NCT03662542|100586874|FG007|STARTED|Combination Phase ( Week 0- Week 12)||0||
48105443|NCT03662542|100586875|FG008|STARTED|Combination Phase ( Week 0- Week 12)||0||
48105444|NCT03662542|100586867|FG000|COMPLETED|Combination Phase ( Week 0- Week 12)||67||
48105445|NCT03662542|100586868|FG001|COMPLETED|Combination Phase ( Week 0- Week 12)||70||
48105446|NCT03662542|100586869|FG002|COMPLETED|Combination Phase ( Week 0- Week 12)||71||
48105447|NCT03662542|100586870|FG003|COMPLETED|Combination Phase ( Week 0- Week 12)||0||
48105448|NCT03662542|100586871|FG004|COMPLETED|Combination Phase ( Week 0- Week 12)||0||
48105449|NCT03662542|100586872|FG005|COMPLETED|Combination Phase ( Week 0- Week 12)||0||
48105450|NCT03662542|100586873|FG006|COMPLETED|Combination Phase ( Week 0- Week 12)||0||
48692205|NCT01057693|102029113|FG001|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||125||
48692206|NCT01057693|102029114|FG002|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||113||
48692207|NCT01057693|102029112|FG000|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0||
48692208|NCT01057693|102029113|FG001|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||22||
48692209|NCT01057693|102029114|FG002|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||36||
48692210|NCT01802580|102029115|FG000|STARTED|Overall Study||20||
48692211|NCT01802580|102029116|FG001|STARTED|Overall Study||20||
48105451|NCT03662542|100586874|FG007|COMPLETED|Combination Phase ( Week 0- Week 12)||0||
48105452|NCT03662542|100586875|FG008|COMPLETED|Combination Phase ( Week 0- Week 12)||0||
48105453|NCT03662542|100586867|FG000|NOT COMPLETED|Combination Phase ( Week 0- Week 12)||5||
48105454|NCT03662542|100586868|FG001|NOT COMPLETED|Combination Phase ( Week 0- Week 12)||1||
48105455|NCT03662542|100586869|FG002|NOT COMPLETED|Combination Phase ( Week 0- Week 12)||0||
48105456|NCT03662542|100586870|FG003|NOT COMPLETED|Combination Phase ( Week 0- Week 12)||0||
48105457|NCT03662542|100586871|FG004|NOT COMPLETED|Combination Phase ( Week 0- Week 12)||0||
48105458|NCT03662542|100586872|FG005|NOT COMPLETED|Combination Phase ( Week 0- Week 12)||0||
48105459|NCT03662542|100586873|FG006|NOT COMPLETED|Combination Phase ( Week 0- Week 12)||0||
48105460|NCT03662542|100586874|FG007|NOT COMPLETED|Combination Phase ( Week 0- Week 12)||0||
48105461|NCT03662542|100586875|FG008|NOT COMPLETED|Combination Phase ( Week 0- Week 12)||0||
48105462|NCT03662542|100586867|FG000|STARTED|Monotherapy Phase (Week 12-Week 38)||0||
48105463|NCT03662542|100586868|FG001|STARTED|Monotherapy Phase (Week 12-Week 38)||0||
48105464|NCT03662542|100586869|FG002|STARTED|Monotherapy Phase (Week 12-Week 38)||0||
48105465|NCT03662542|100586870|FG003|STARTED|Monotherapy Phase (Week 12-Week 38)||67||
48105466|NCT03662542|100586871|FG004|STARTED|Monotherapy Phase (Week 12-Week 38)||70||
48105467|NCT03662542|100586872|FG005|STARTED|Monotherapy Phase (Week 12-Week 38)||71||
48105468|NCT03662542|100586873|FG006|STARTED|Monotherapy Phase (Week 12-Week 38)||0||
48105469|NCT03662542|100586874|FG007|STARTED|Monotherapy Phase (Week 12-Week 38)||0||
48105470|NCT03662542|100586875|FG008|STARTED|Monotherapy Phase (Week 12-Week 38)||0||
48105471|NCT03662542|100586867|FG000|COMPLETED|Monotherapy Phase (Week 12-Week 38)||0||
48105472|NCT03662542|100586868|FG001|COMPLETED|Monotherapy Phase (Week 12-Week 38)||0||
48105473|NCT03662542|100586869|FG002|COMPLETED|Monotherapy Phase (Week 12-Week 38)||0||
48266603|NCT02614183|100975475|FG001|STARTED|Post Treatment Follow-up Phase||185||
48266604|NCT02614183|100975476|FG002|STARTED|Post Treatment Follow-up Phase||183||
48266605|NCT02614183|100975474|FG000|Safety Population|Post Treatment Follow-up Phase||372||
48266606|NCT02614183|100975475|FG001|Safety Population|Post Treatment Follow-up Phase||183||
48266607|NCT02614183|100975476|FG002|Safety Population|Post Treatment Follow-up Phase||185||
48266608|NCT02614183|100975474|FG000|COMPLETED|Post Treatment Follow-up Phase||354||
48105474|NCT03662542|100586870|FG003|COMPLETED|Monotherapy Phase (Week 12-Week 38)||62||
48105475|NCT03662542|100586871|FG004|COMPLETED|Monotherapy Phase (Week 12-Week 38)||67||
48266609|NCT02614183|100975475|FG001|COMPLETED|Post Treatment Follow-up Phase||179||
48105476|NCT03662542|100586872|FG005|COMPLETED|Monotherapy Phase (Week 12-Week 38)||65||
48266610|NCT02614183|100975476|FG002|COMPLETED|Post Treatment Follow-up Phase||171||
48266611|NCT02614183|100975474|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||18||
48266612|NCT02614183|100975475|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||6||
48266613|NCT02614183|100975476|FG002|NOT COMPLETED|Post Treatment Follow-up Phase||12||
48105477|NCT03662542|100586873|FG006|COMPLETED|Monotherapy Phase (Week 12-Week 38)||0||
48105478|NCT03662542|100586874|FG007|COMPLETED|Monotherapy Phase (Week 12-Week 38)||0||
48105479|NCT03662542|100586875|FG008|COMPLETED|Monotherapy Phase (Week 12-Week 38)||0||
48266614|NCT01663506|100975477|FG000|STARTED|Overall Study||23||
48105480|NCT03662542|100586867|FG000|NOT COMPLETED|Monotherapy Phase (Week 12-Week 38)||0||
48105481|NCT03662542|100586868|FG001|NOT COMPLETED|Monotherapy Phase (Week 12-Week 38)||0||
48141398|NCT01454583|100670420|FG001|COMPLETED|1st Year||2378||
48141399|NCT01454583|100670421|FG002|COMPLETED|1st Year||1933||
48692212|NCT01802580|102029115|FG000|COMPLETED|Overall Study||11||
48266615|NCT01663506|100975477|FG000|COMPLETED|Overall Study||15||
48266616|NCT01663506|100975477|FG000|NOT COMPLETED|Overall Study||8||
48266617|NCT01999972|100975478|FG000|STARTED|Dose Escalation Part||5||
48266618|NCT01999972|100975479|FG001|STARTED|Dose Escalation Part||3||
48266619|NCT01999972|100975480|FG002|STARTED|Dose Escalation Part||5||
48266620|NCT01999972|100975481|FG003|STARTED|Dose Escalation Part||11||
48266621|NCT01999972|100975482|FG004|STARTED|Dose Escalation Part||0||
48266622|NCT01999972|100975483|FG005|STARTED|Dose Escalation Part||0||
48266623|NCT01999972|100975478|FG000|Treated|Dose Escalation Part||5||
48266624|NCT01999972|100975479|FG001|Treated|Dose Escalation Part||3||
48266625|NCT01999972|100975480|FG002|Treated|Dose Escalation Part||4||
48266626|NCT01999972|100975481|FG003|Treated|Dose Escalation Part||10||
48266627|NCT01999972|100975482|FG004|Treated|Dose Escalation Part||0||
48266628|NCT01999972|100975483|FG005|Treated|Dose Escalation Part||0||
48266629|NCT01999972|100975478|FG000|COMPLETED|Dose Escalation Part||0||
48266630|NCT01999972|100975479|FG001|COMPLETED|Dose Escalation Part||0||
48266631|NCT01999972|100975480|FG002|COMPLETED|Dose Escalation Part||0||
48266632|NCT01999972|100975481|FG003|COMPLETED|Dose Escalation Part||0||
48266633|NCT01999972|100975482|FG004|COMPLETED|Dose Escalation Part||0||
48266634|NCT01999972|100975483|FG005|COMPLETED|Dose Escalation Part||0||
48266635|NCT01999972|100975478|FG000|NOT COMPLETED|Dose Escalation Part||5||
48266636|NCT01999972|100975479|FG001|NOT COMPLETED|Dose Escalation Part||3||
48266637|NCT01999972|100975480|FG002|NOT COMPLETED|Dose Escalation Part||5||
48266638|NCT01999972|100975481|FG003|NOT COMPLETED|Dose Escalation Part||11||
48266639|NCT01999972|100975482|FG004|NOT COMPLETED|Dose Escalation Part||0||
48266640|NCT01999972|100975483|FG005|NOT COMPLETED|Dose Escalation Part||0||
48266641|NCT01999972|100975478|FG000|STARTED|Dose Expansion Part||0||
48266642|NCT01999972|100975479|FG001|STARTED|Dose Expansion Part||0||
48266643|NCT01999972|100975480|FG002|STARTED|Dose Expansion Part||0||
48266644|NCT01999972|100975481|FG003|STARTED|Dose Expansion Part||0||
48266645|NCT01999972|100975482|FG004|STARTED|Dose Expansion Part||21||
48266646|NCT01999972|100975483|FG005|STARTED|Dose Expansion Part||7||
48266647|NCT01999972|100975478|FG000|Treated|Dose Expansion Part||0||
48266648|NCT01999972|100975479|FG001|Treated|Dose Expansion Part||0||
48266649|NCT01999972|100975480|FG002|Treated|Dose Expansion Part||0||
48266650|NCT01999972|100975481|FG003|Treated|Dose Expansion Part||0||
48266651|NCT01999972|100975482|FG004|Treated|Dose Expansion Part||21||
48266652|NCT01999972|100975483|FG005|Treated|Dose Expansion Part||7||
48266653|NCT01999972|100975478|FG000|COMPLETED|Dose Expansion Part||0||
48266654|NCT01999972|100975479|FG001|COMPLETED|Dose Expansion Part||0||
48266655|NCT01999972|100975480|FG002|COMPLETED|Dose Expansion Part||0||
48266656|NCT01999972|100975481|FG003|COMPLETED|Dose Expansion Part||0||
48266657|NCT01999972|100975482|FG004|COMPLETED|Dose Expansion Part||0||
48266658|NCT01999972|100975483|FG005|COMPLETED|Dose Expansion Part||0||
48266659|NCT01999972|100975478|FG000|NOT COMPLETED|Dose Expansion Part||0||
48266660|NCT01999972|100975479|FG001|NOT COMPLETED|Dose Expansion Part||0||
48266661|NCT01999972|100975480|FG002|NOT COMPLETED|Dose Expansion Part||0||
48266662|NCT01999972|100975481|FG003|NOT COMPLETED|Dose Expansion Part||0||
48266663|NCT01999972|100975482|FG004|NOT COMPLETED|Dose Expansion Part||21||
48266664|NCT01999972|100975483|FG005|NOT COMPLETED|Dose Expansion Part||7||
48266665|NCT00551746|100975484|FG000|STARTED|Overall Study||36||
48266666|NCT00551746|100975485|FG001|STARTED|Overall Study||34||
48266667|NCT00551746|100975484|FG000|COMPLETED|Overall Study||25||
48266668|NCT00551746|100975485|FG001|COMPLETED|Overall Study||26||
48266669|NCT00551746|100975484|FG000|NOT COMPLETED|Overall Study||11||
48266670|NCT00551746|100975485|FG001|NOT COMPLETED|Overall Study||8||
48391902|NCT05567393|101287753|FG001|STARTED|Overall Study||6||
48391903|NCT05567393|101287754|FG002|STARTED|Overall Study||6||
48391904|NCT05567393|101287755|FG003|STARTED|Overall Study||6||
48391905|NCT05567393|101287756|FG004|STARTED|Overall Study||6||
48391906|NCT05567393|101287757|FG005|STARTED|Overall Study||6||
48391907|NCT05567393|101287758|FG006|STARTED|Overall Study||6||
48391908|NCT05567393|101287759|FG007|STARTED|Overall Study||6||
48266671|NCT00971997|100975486|FG000|STARTED|Overall Study||135||
48266672|NCT00971997|100975486|FG000|COMPLETED|Overall Study||116||
48266673|NCT00971997|100975486|FG000|NOT COMPLETED|Overall Study||19||
48266674|NCT00570908|100975487|FG000|STARTED|Overall Study||12||
48266675|NCT00570908|100975487|FG000|COMPLETED|Overall Study||5||
48266676|NCT00570908|100975487|FG000|NOT COMPLETED|Overall Study||7||
48266677|NCT03786744|100975488|FG000|STARTED|Overall Study||10||
48266678|NCT03786744|100975489|FG001|STARTED|Overall Study||10||
48266679|NCT03786744|100975488|FG000|COMPLETED|Overall Study||10||
48266680|NCT03786744|100975489|FG001|COMPLETED|Overall Study||10||
48266681|NCT03786744|100975488|FG000|NOT COMPLETED|Overall Study||0||
48266682|NCT03786744|100975489|FG001|NOT COMPLETED|Overall Study||0||
48391909|NCT05567393|101287760|FG008|STARTED|Overall Study||6||
48391910|NCT05567393|101287761|FG009|STARTED|Overall Study||6||
48391911|NCT05567393|101287762|FG010|STARTED|Overall Study||6||
48391912|NCT05567393|101287763|FG011|STARTED|Overall Study||6||
48391913|NCT05567393|101287764|FG012|STARTED|Overall Study||6||
48391914|NCT05567393|101287765|FG013|STARTED|Overall Study||8||
48391915|NCT05567393|101287766|FG014|STARTED|Overall Study||6||
48692213|NCT01802580|102029116|FG001|COMPLETED|Overall Study||9||
48692214|NCT01802580|102029115|FG000|NOT COMPLETED|Overall Study||9||
48692215|NCT01802580|102029116|FG001|NOT COMPLETED|Overall Study||11||
48692216|NCT01732510|102029117|FG000|STARTED|Overall Study||9||
48692217|NCT01732510|102029118|FG001|STARTED|Overall Study||9||
48692218|NCT01732510|102029119|FG002|STARTED|Overall Study||8||
48692219|NCT01732510|102029120|FG003|STARTED|Overall Study||10||
48692220|NCT01732510|102029121|FG004|STARTED|Overall Study||8||
48692221|NCT01732510|102029122|FG005|STARTED|Overall Study||13||
48692222|NCT01732510|102029123|FG006|STARTED|Overall Study||8||
48692223|NCT01732510|102029117|FG000|COMPLETED|Overall Study||8||
48692224|NCT01732510|102029118|FG001|COMPLETED|Overall Study||4||
48692225|NCT01732510|102029119|FG002|COMPLETED|Overall Study||4||
48692226|NCT01732510|102029120|FG003|COMPLETED|Overall Study||5||
48692227|NCT01732510|102029121|FG004|COMPLETED|Overall Study||3||
48692228|NCT01732510|102029122|FG005|COMPLETED|Overall Study||0||
48692229|NCT01732510|102029123|FG006|COMPLETED|Overall Study||0||
48692230|NCT01732510|102029117|FG000|NOT COMPLETED|Overall Study||1||
48692231|NCT01732510|102029118|FG001|NOT COMPLETED|Overall Study||5||
48266683|NCT03836859|100975490|FG000|STARTED|Overall Study||20||
48266684|NCT03836859|100975491|FG001|STARTED|Overall Study||10||
48266685|NCT03836859|100975490|FG000|COMPLETED|Overall Study||20||
48266686|NCT03836859|100975491|FG001|COMPLETED|Overall Study||10||
48266687|NCT03836859|100975490|FG000|NOT COMPLETED|Overall Study||0||
48266688|NCT03836859|100975491|FG001|NOT COMPLETED|Overall Study||0||
48266689|NCT02336425|100975492|FG000|STARTED|Overall Study||2||
48266690|NCT02336425|100975493|FG001|STARTED|Overall Study||2||
48266691|NCT02336425|100975494|FG002|STARTED|Overall Study||3||
48266692|NCT02336425|100975495|FG003|STARTED|Overall Study||3||
48266693|NCT02336425|100975492|FG000|COMPLETED|Overall Study||0||
48266694|NCT02336425|100975493|FG001|COMPLETED|Overall Study||0||
48266695|NCT02336425|100975494|FG002|COMPLETED|Overall Study||0||
48266696|NCT02336425|100975495|FG003|COMPLETED|Overall Study||0||
48266697|NCT02336425|100975492|FG000|NOT COMPLETED|Overall Study||2||
48266698|NCT02336425|100975493|FG001|NOT COMPLETED|Overall Study||2||
48266699|NCT02336425|100975494|FG002|NOT COMPLETED|Overall Study||3||
48266700|NCT02336425|100975495|FG003|NOT COMPLETED|Overall Study||3||
48266701|NCT00955708|100975496|FG000|STARTED|Overall Study||1308||
48266702|NCT00955708|100975496|FG000|COMPLETED|Overall Study||250||
48266703|NCT00955708|100975496|FG000|NOT COMPLETED|Overall Study||1058||
48266704|NCT00847522|100975497|FG000|STARTED|Overall Study||90||
48266705|NCT00847522|100975497|FG000|Phase I|Overall Study||10||
48266706|NCT00847522|100975497|FG000|Phase II|Overall Study||80||
48266707|NCT00847522|100975497|FG000|COMPLETED|Overall Study||90||
48266708|NCT00847522|100975497|FG000|NOT COMPLETED|Overall Study||0||
48266709|NCT00399841|100975498|FG000|STARTED|Overall Study||13||
48266710|NCT00399841|100975499|FG001|STARTED|Overall Study||0||
48266711|NCT00399841|100975500|FG002|STARTED|Overall Study||0||
48266712|NCT00399841|100975498|FG000|Permanent Implant|Overall Study||6||
48266713|NCT00399841|100975499|FG001|Permanent Implant|Overall Study||0||
48266714|NCT00399841|100975500|FG002|Permanent Implant|Overall Study||0||
48266715|NCT00399841|100975498|FG000|12-week|Overall Study||2||
48266716|NCT00399841|100975499|FG001|12-week|Overall Study||0||
48266717|NCT00399841|100975500|FG002|12-week|Overall Study||0||
48266718|NCT00399841|100975498|FG000|COMPLETED|Overall Study||1||
48266719|NCT00399841|100975499|FG001|COMPLETED|Overall Study||0||
48692232|NCT01732510|102029119|FG002|NOT COMPLETED|Overall Study||4||
48692233|NCT01732510|102029120|FG003|NOT COMPLETED|Overall Study||5||
48692234|NCT01732510|102029121|FG004|NOT COMPLETED|Overall Study||5||
48692235|NCT01732510|102029122|FG005|NOT COMPLETED|Overall Study||13||
48692236|NCT01732510|102029123|FG006|NOT COMPLETED|Overall Study||8||
48692237|NCT02263326|102029124|FG000|STARTED|Overall Study||44||
48692238|NCT02263326|102029125|FG001|STARTED|Overall Study||45||
48692239|NCT02263326|102029124|FG000|COMPLETED|Overall Study||43||
48266720|NCT00399841|100975500|FG002|COMPLETED|Overall Study||0||
48266721|NCT00399841|100975498|FG000|NOT COMPLETED|Overall Study||12||
48266722|NCT00399841|100975499|FG001|NOT COMPLETED|Overall Study||0||
48266723|NCT00399841|100975500|FG002|NOT COMPLETED|Overall Study||0||
48266724|NCT00837590|100975501|FG000|STARTED|Overall Study||6||
48266725|NCT00837590|100975502|FG001|STARTED|Overall Study||5||
48266726|NCT00837590|100975503|FG002|STARTED|Overall Study||5||
48266727|NCT00837590|100975501|FG000|COMPLETED|Overall Study||6||
48692240|NCT02263326|102029125|FG001|COMPLETED|Overall Study||44||
48692241|NCT02263326|102029124|FG000|NOT COMPLETED|Overall Study||1||
48692242|NCT02263326|102029125|FG001|NOT COMPLETED|Overall Study||1||
48692243|NCT04294459|102029126|FG000|STARTED|Overall Study||12||
48266728|NCT00837590|100975502|FG001|COMPLETED|Overall Study||4||
48266729|NCT00837590|100975503|FG002|COMPLETED|Overall Study||4||
48266730|NCT00837590|100975501|FG000|NOT COMPLETED|Overall Study||0||
48266731|NCT00837590|100975502|FG001|NOT COMPLETED|Overall Study||1||
48266732|NCT00837590|100975503|FG002|NOT COMPLETED|Overall Study||1||
48266733|NCT01165177|100975504|FG000|STARTED|Overall Study||7695||
48692244|NCT04294459|102029127|FG001|STARTED|Overall Study||11||
48692245|NCT04294459|102029126|FG000|COMPLETED|Overall Study||12||
48692246|NCT04294459|102029127|FG001|COMPLETED|Overall Study||10||
48692247|NCT04294459|102029126|FG000|NOT COMPLETED|Overall Study||0||
48266734|NCT01165177|100975505|FG001|STARTED|Overall Study||7710||
48266735|NCT01165177|100975504|FG000|COMPLETED|Overall Study||6773||
48266736|NCT01165177|100975505|FG001|COMPLETED|Overall Study||6808||
48266737|NCT01165177|100975504|FG000|NOT COMPLETED|Overall Study||922||
48266738|NCT01165177|100975505|FG001|NOT COMPLETED|Overall Study||902||
48266739|NCT03614676|100975506|FG000|STARTED|Overall Study||2311||
48266740|NCT03614676|100975507|FG001|STARTED|Overall Study||2181||
48266741|NCT03614676|100975506|FG000|COMPLETED|Overall Study||2195||
48266742|NCT03614676|100975507|FG001|COMPLETED|Overall Study||2017||
48266743|NCT03614676|100975506|FG000|NOT COMPLETED|Overall Study||116||
48266744|NCT03614676|100975507|FG001|NOT COMPLETED|Overall Study||164||
48266745|NCT02579772|100975508|FG000|STARTED|Overall Study||8||
48266746|NCT02579772|100975509|FG001|STARTED|Overall Study||5||
48266747|NCT02579772|100975508|FG000|COMPLETED|Overall Study||6||
48266748|NCT02579772|100975509|FG001|COMPLETED|Overall Study||3||
48266749|NCT02579772|100975508|FG000|NOT COMPLETED|Overall Study||2||
48266750|NCT02579772|100975509|FG001|NOT COMPLETED|Overall Study||2||
48266751|NCT02838979|100975510|FG000|STARTED|Overall Study||6||
48266752|NCT02838979|100975511|FG001|STARTED|Overall Study||5||
48266753|NCT02838979|100975510|FG000|COMPLETED|Overall Study||6||
48266754|NCT02838979|100975511|FG001|COMPLETED|Overall Study||5||
48266755|NCT02838979|100975510|FG000|NOT COMPLETED|Overall Study||0||
48266756|NCT02838979|100975511|FG001|NOT COMPLETED|Overall Study||0||
48266757|NCT03690427|100975512|FG000|STARTED|Overall Study||9||
48266758|NCT03690427|100975513|FG001|STARTED|Overall Study||10||
48266759|NCT03690427|100975512|FG000|COMPLETED|Overall Study||9||
48266760|NCT03690427|100975513|FG001|COMPLETED|Overall Study||8||
48266761|NCT03690427|100975512|FG000|NOT COMPLETED|Overall Study||0||
48266762|NCT03690427|100975513|FG001|NOT COMPLETED|Overall Study||2||
48266763|NCT04206085|100975514|FG000|STARTED|Overall Study||13||
48266764|NCT04206085|100975515|FG001|STARTED|Overall Study||13||
48266765|NCT04206085|100975516|FG002|STARTED|Overall Study||12||
48266766|NCT04206085|100975514|FG000|COMPLETED|Overall Study||13||
48266767|NCT04206085|100975515|FG001|COMPLETED|Overall Study||12||
48266768|NCT04206085|100975516|FG002|COMPLETED|Overall Study||11||
48266769|NCT04206085|100975514|FG000|NOT COMPLETED|Overall Study||0||
48266770|NCT04206085|100975515|FG001|NOT COMPLETED|Overall Study||1||
48266771|NCT04206085|100975516|FG002|NOT COMPLETED|Overall Study||1||
48266772|NCT01592045|100975517|FG000|STARTED|Overall Study||14||
48266773|NCT01592045|100975518|FG001|STARTED|Overall Study||14||
48551744|NCT04650217|101683231|FG000|NOT COMPLETED|Overall Study||0||
48551745|NCT04650217|101683232|FG001|NOT COMPLETED|Overall Study||0||
48551746|NCT04650217|101683233|FG002|NOT COMPLETED|Overall Study||0||
48551747|NCT04650217|101683234|FG003|NOT COMPLETED|Overall Study||0||
48551748|NCT04650217|101683235|FG004|NOT COMPLETED|Overall Study||1||
48551749|NCT02413229|101683236|FG000|STARTED|Overall Study||25||
48266774|NCT01592045|100975517|FG000|Completed Course 1|Overall Study||13||
48266775|NCT01592045|100975518|FG001|Completed Course 1|Overall Study||14||
48266776|NCT01592045|100975517|FG000|Completed Course 2|Overall Study||13||
48266777|NCT01592045|100975518|FG001|Completed Course 2|Overall Study||13||
48266778|NCT01592045|100975517|FG000|Completed Course 3|Overall Study||11||
48551750|NCT02413229|101683237|FG001|STARTED|Overall Study||12||
48266779|NCT01592045|100975518|FG001|Completed Course 3|Overall Study||13||
48266780|NCT01592045|100975517|FG000|Completed Course 4|Overall Study||11||
48266781|NCT01592045|100975518|FG001|Completed Course 4|Overall Study||12||
48266782|NCT01592045|100975517|FG000|Completed Course 5|Overall Study||9||
48266783|NCT01592045|100975518|FG001|Completed Course 5|Overall Study||12||
48266784|NCT01592045|100975517|FG000|COMPLETED|Overall Study||9||
48266785|NCT01592045|100975518|FG001|COMPLETED|Overall Study||12||
48266786|NCT01592045|100975517|FG000|NOT COMPLETED|Overall Study||5||
48266787|NCT01592045|100975518|FG001|NOT COMPLETED|Overall Study||2||
48266788|NCT02743897|100975519|FG000|STARTED|Overall Study||62||
48266789|NCT02743897|100975519|FG000|COMPLETED|Overall Study||62||
48266790|NCT02743897|100975519|FG000|NOT COMPLETED|Overall Study||0||
48266791|NCT00203047|100975520|FG000|STARTED|Overall Study||204||
48266792|NCT00203047|100975521|FG001|STARTED|Overall Study||210||
48266793|NCT00203047|100975520|FG000|In Database as of January 29, 2009|Overall Study||199||
48266794|NCT00203047|100975521|FG001|In Database as of January 29, 2009|Overall Study||209||
48266795|NCT00203047|100975520|FG000|COMPLETED|Overall Study||13||
48266796|NCT00203047|100975521|FG001|COMPLETED|Overall Study||7||
48266797|NCT00203047|100975520|FG000|NOT COMPLETED|Overall Study||191||
48266798|NCT00203047|100975521|FG001|NOT COMPLETED|Overall Study||203||
48266799|NCT00497874|100975522|FG000|STARTED|Overall Study||443||
48266800|NCT00497874|100975523|FG001|STARTED|Overall Study||459||
48266801|NCT00497874|100975522|FG000|COMPLETED|Overall Study||296||
48266802|NCT00497874|100975523|FG001|COMPLETED|Overall Study||343||
48266803|NCT00497874|100975522|FG000|NOT COMPLETED|Overall Study||147||
48266804|NCT00497874|100975523|FG001|NOT COMPLETED|Overall Study||116||
48266805|NCT00658606|100975524|FG000|STARTED|Overall Study||49||
48266806|NCT00658606|100975525|FG001|STARTED|Overall Study||49||
48266807|NCT00658606|100975524|FG000|Completed Treatment|Overall Study||42||
48551751|NCT02413229|101683238|FG002|STARTED|Overall Study||26||
48551752|NCT02413229|101683239|FG003|STARTED|Overall Study||12||
48551753|NCT02413229|101683240|FG004|STARTED|Overall Study||24||
48551754|NCT02413229|101683241|FG005|STARTED|Overall Study||12||
48266808|NCT00658606|100975525|FG001|Completed Treatment|Overall Study||44||
48266809|NCT00658606|100975524|FG000|COMPLETED|Overall Study||33||
48266810|NCT00658606|100975525|FG001|COMPLETED|Overall Study||26||
48266811|NCT00658606|100975524|FG000|NOT COMPLETED|Overall Study||16||
48266812|NCT00658606|100975525|FG001|NOT COMPLETED|Overall Study||23||
48266813|NCT00760513|100975526|FG000|STARTED|Overall Study||51||
48266814|NCT00760513|100975527|FG001|STARTED|Overall Study||52||
48266815|NCT00760513|100975526|FG000|COMPLETED|Overall Study||46||
48266816|NCT00760513|100975527|FG001|COMPLETED|Overall Study||45||
48266817|NCT00760513|100975526|FG000|NOT COMPLETED|Overall Study||5||
48266818|NCT00760513|100975527|FG001|NOT COMPLETED|Overall Study||7||
48266819|NCT00486252|100975528|FG000|STARTED|Overall Study||996||
48266820|NCT00486252|100975528|FG000|COMPLETED|Overall Study||938||
48266821|NCT00486252|100975528|FG000|NOT COMPLETED|Overall Study||58||
48266822|NCT01012947|100975529|FG000|STARTED|Overall Study||212||
48266823|NCT01012947|100975530|FG001|STARTED|Overall Study||215||
48266824|NCT01012947|100975531|FG002|STARTED|Overall Study||241||
48266825|NCT01012947|100975532|FG003|STARTED|Overall Study||211||
48266826|NCT01012947|100975533|FG004|STARTED|Overall Study||236||
48391916|NCT05567393|101287767|FG015|STARTED|Overall Study||6||
48391917|NCT05567393|101287768|FG016|STARTED|Overall Study||6||
48391918|NCT05567393|101287769|FG017|STARTED|Overall Study||6||
48692248|NCT04294459|102029127|FG001|NOT COMPLETED|Overall Study||1||
48692249|NCT04169529|102029128|FG000|STARTED|Overall Study||40||
48692250|NCT04169529|102029128|FG000|COMPLETED|Overall Study||40||
48692251|NCT04169529|102029128|FG000|NOT COMPLETED|Overall Study||0||
48692252|NCT01822899|102029129|FG000|STARTED|Overall Study||358||
48692253|NCT01822899|102029130|FG001|STARTED|Overall Study||358||
48692254|NCT01822899|102029129|FG000|COMPLETED|Overall Study||334||
48692255|NCT01822899|102029130|FG001|COMPLETED|Overall Study||340||
48692256|NCT01822899|102029129|FG000|NOT COMPLETED|Overall Study||24||
48692257|NCT01822899|102029130|FG001|NOT COMPLETED|Overall Study||18||
48692258|NCT01667133|102029131|FG000|STARTED|Phase 1: Dose-escalation||1||
48266827|NCT01012947|100975529|FG000|COMPLETED|Overall Study||81||
48266828|NCT01012947|100975530|FG001|COMPLETED|Overall Study||80||
48266829|NCT01012947|100975531|FG002|COMPLETED|Overall Study||111||
48266830|NCT01012947|100975532|FG003|COMPLETED|Overall Study||93||
48266831|NCT01012947|100975533|FG004|COMPLETED|Overall Study||94||
48266832|NCT01012947|100975529|FG000|NOT COMPLETED|Overall Study||131||
48266833|NCT01012947|100975530|FG001|NOT COMPLETED|Overall Study||135||
48266834|NCT01012947|100975531|FG002|NOT COMPLETED|Overall Study||130||
48266835|NCT01012947|100975532|FG003|NOT COMPLETED|Overall Study||118||
48391919|NCT05567393|101287752|FG000|COMPLETED|Overall Study||24||
48391920|NCT05567393|101287753|FG001|COMPLETED|Overall Study||6||
48391921|NCT05567393|101287754|FG002|COMPLETED|Overall Study||6||
48266836|NCT01012947|100975533|FG004|NOT COMPLETED|Overall Study||142||
48266837|NCT02833805|100975534|FG000|STARTED|Overall Study||21||
48266838|NCT02833805|100975534|FG000|COMPLETED|Overall Study||21||
48266839|NCT02833805|100975534|FG000|NOT COMPLETED|Overall Study||0||
48266840|NCT02417441|100975535|FG000|STARTED|Overall Study||645||
48266841|NCT02417441|100975536|FG001|STARTED|Overall Study||325||
48266842|NCT02417441|100975535|FG000|COMPLETED|Overall Study||593||
48266843|NCT02417441|100975536|FG001|COMPLETED|Overall Study||306||
48266844|NCT02417441|100975535|FG000|NOT COMPLETED|Overall Study||52||
48266845|NCT02417441|100975536|FG001|NOT COMPLETED|Overall Study||19||
48266846|NCT01327846|100975537|FG000|STARTED|Core Phase||2263||
48266847|NCT01327846|100975538|FG001|STARTED|Core Phase||2284||
48266848|NCT01327846|100975539|FG002|STARTED|Core Phase||2170||
48266849|NCT01327846|100975540|FG003|STARTED|Core Phase||3344||
48266850|NCT01327846|100975537|FG000|COMPLETED|Core Phase||2235||
48266851|NCT01327846|100975538|FG001|COMPLETED|Core Phase||2252||
48266852|NCT01327846|100975539|FG002|COMPLETED|Core Phase||2144||
48266853|NCT01327846|100975540|FG003|COMPLETED|Core Phase||3311||
48266854|NCT01327846|100975537|FG000|NOT COMPLETED|Core Phase||28||
48266855|NCT01327846|100975538|FG001|NOT COMPLETED|Core Phase||32||
48266856|NCT01327846|100975539|FG002|NOT COMPLETED|Core Phase||26||
48266857|NCT01327846|100975540|FG003|NOT COMPLETED|Core Phase||33||
48266858|NCT01327846|100975537|FG000|STARTED|Extension Phase||1267||
48266859|NCT01327846|100975538|FG001|STARTED|Extension Phase||1287||
48266860|NCT01327846|100975539|FG002|STARTED|Extension Phase||1279||
48266861|NCT01327846|100975540|FG003|STARTED|Extension Phase||1944||
48266862|NCT01327846|100975537|FG000|Stopped/Discontinued Study at Washout|Extension Phase||127||
48266863|NCT01327846|100975538|FG001|Stopped/Discontinued Study at Washout|Extension Phase||97||
48266864|NCT01327846|100975539|FG002|Stopped/Discontinued Study at Washout|Extension Phase||137||
48266865|NCT01327846|100975540|FG003|Stopped/Discontinued Study at Washout|Extension Phase||178||
48266866|NCT01327846|100975537|FG000|Completed Treatment Period|Extension Phase||41||
48266867|NCT01327846|100975538|FG001|Completed Treatment Period|Extension Phase||45||
48266868|NCT01327846|100975539|FG002|Completed Treatment Period|Extension Phase||49||
48266869|NCT01327846|100975540|FG003|Completed Treatment Period|Extension Phase||60||
48266870|NCT01327846|100975537|FG000|Details Missing|Extension Phase||0||
48266871|NCT01327846|100975538|FG001|Details Missing|Extension Phase||1||
48266872|NCT01327846|100975539|FG002|Details Missing|Extension Phase||1||
48266873|NCT01327846|100975540|FG003|Details Missing|Extension Phase||0||
48266874|NCT01327846|100975537|FG000|COMPLETED|Extension Phase||168||
48266875|NCT01327846|100975538|FG001|COMPLETED|Extension Phase||143||
48266876|NCT01327846|100975539|FG002|COMPLETED|Extension Phase||187||
48266877|NCT01327846|100975540|FG003|COMPLETED|Extension Phase||238||
48266878|NCT01327846|100975537|FG000|NOT COMPLETED|Extension Phase||1099||
48266879|NCT01327846|100975538|FG001|NOT COMPLETED|Extension Phase||1144||
48266880|NCT01327846|100975539|FG002|NOT COMPLETED|Extension Phase||1092||
48266881|NCT01327846|100975540|FG003|NOT COMPLETED|Extension Phase||1706||
48266882|NCT04591171|100975541|FG000|STARTED|Overall Study||9||
48266883|NCT04591171|100975541|FG000|COMPLETED|Overall Study||9||
48266884|NCT04591171|100975541|FG000|NOT COMPLETED|Overall Study||0||
48266885|NCT03981939|100975542|FG000|STARTED|Overall Study||549||
48266886|NCT03981939|100975543|FG001|STARTED|Overall Study||1902||
48266887|NCT03981939|100975544|FG002|STARTED|Overall Study||581||
48266888|NCT03981939|100975542|FG000|COMPLETED|Overall Study||549||
48266889|NCT03981939|100975543|FG001|COMPLETED|Overall Study||1902||
48266890|NCT03981939|100975544|FG002|COMPLETED|Overall Study||581||
48266891|NCT03981939|100975542|FG000|NOT COMPLETED|Overall Study||0||
48266892|NCT03981939|100975543|FG001|NOT COMPLETED|Overall Study||0||
48266893|NCT03981939|100975544|FG002|NOT COMPLETED|Overall Study||0||
48266894|NCT03210519|100975545|FG000|STARTED|Overall Study||11||
48266895|NCT03210519|100975546|FG001|STARTED|Overall Study||10||
48266896|NCT03210519|100975545|FG000|COMPLETED|Overall Study||9||
48266897|NCT03210519|100975546|FG001|COMPLETED|Overall Study||10||
48266898|NCT03210519|100975545|FG000|NOT COMPLETED|Overall Study||2||
48266899|NCT03210519|100975546|FG001|NOT COMPLETED|Overall Study||0||
48266900|NCT02103114|100975547|FG000|STARTED|Overall Study||20||
48266901|NCT02103114|100975548|FG001|STARTED|Overall Study||20||
48266902|NCT02103114|100975547|FG000|COMPLETED|Overall Study||20||
48266903|NCT02103114|100975548|FG001|COMPLETED|Overall Study||19||
48266904|NCT02103114|100975547|FG000|NOT COMPLETED|Overall Study||0||
48266905|NCT02103114|100975548|FG001|NOT COMPLETED|Overall Study||1||
48266906|NCT00983853|100975549|FG000|STARTED|Overall Study||7||
48266907|NCT00983853|100975550|FG001|STARTED|Overall Study||7||
48266908|NCT00983853|100975551|FG002|STARTED|Overall Study||17||
48266909|NCT00983853|100975552|FG003|STARTED|Overall Study||8||
48266910|NCT00983853|100975553|FG004|STARTED|Overall Study||15||
48266911|NCT00983853|100975554|FG005|STARTED|Overall Study||8||
48266912|NCT00983853|100975549|FG000|COMPLETED|Overall Study||6||
48266913|NCT00983853|100975550|FG001|COMPLETED|Overall Study||5||
48266914|NCT00983853|100975551|FG002|COMPLETED|Overall Study||14||
48266915|NCT00983853|100975552|FG003|COMPLETED|Overall Study||6||
48266916|NCT00983853|100975553|FG004|COMPLETED|Overall Study||12||
48266917|NCT00983853|100975554|FG005|COMPLETED|Overall Study||7||
48266918|NCT00983853|100975549|FG000|NOT COMPLETED|Overall Study||1||
48266919|NCT00983853|100975550|FG001|NOT COMPLETED|Overall Study||2||
48266920|NCT00983853|100975551|FG002|NOT COMPLETED|Overall Study||3||
48266921|NCT00983853|100975552|FG003|NOT COMPLETED|Overall Study||2||
48266922|NCT00983853|100975553|FG004|NOT COMPLETED|Overall Study||3||
48266923|NCT00983853|100975554|FG005|NOT COMPLETED|Overall Study||1||
48266924|NCT03327831|100975555|FG000|STARTED|Overall Study||30||
48266925|NCT03327831|100975555|FG000|COMPLETED|Overall Study||28||
48266926|NCT03327831|100975555|FG000|NOT COMPLETED|Overall Study||2||
48266927|NCT00725543|100975556|FG000|STARTED|Overall Study||358||
48266928|NCT00725543|100975556|FG000|COMPLETED|Overall Study||205||
48266929|NCT00725543|100975556|FG000|NOT COMPLETED|Overall Study||153||
48391922|NCT05567393|101287755|FG003|COMPLETED|Overall Study||6||
48692259|NCT01667133|102029132|FG001|STARTED|Phase 1: Dose-escalation||1||
48692260|NCT01667133|102029133|FG002|STARTED|Phase 1: Dose-escalation||4||
48692261|NCT01667133|102029134|FG003|STARTED|Phase 1: Dose-escalation||3||
48692262|NCT01667133|102029135|FG004|STARTED|Phase 1: Dose-escalation||1||
48692263|NCT01667133|102029136|FG005|STARTED|Phase 1: Dose-escalation||1||
48692264|NCT01667133|102029137|FG006|STARTED|Phase 1: Dose-escalation||1||
48692265|NCT01667133|102029138|FG007|STARTED|Phase 1: Dose-escalation||0||
48692266|NCT01667133|102029139|FG008|STARTED|Phase 1: Dose-escalation||0||
48692267|NCT01667133|102029140|FG009|STARTED|Phase 1: Dose-escalation||0||
48692268|NCT01667133|102029141|FG010|STARTED|Phase 1: Dose-escalation||0||
48692269|NCT01667133|102029142|FG011|STARTED|Phase 1: Dose-escalation||0||
48692270|NCT01667133|102029131|FG000|COMPLETED|Phase 1: Dose-escalation||1||
48692271|NCT01667133|102029132|FG001|COMPLETED|Phase 1: Dose-escalation||0||
48692272|NCT01667133|102029133|FG002|COMPLETED|Phase 1: Dose-escalation||0||
48266930|NCT01371708|100975557|FG000|STARTED|Overall Study||92||
48266931|NCT01371708|100975558|FG001|STARTED|Overall Study||93||
48266932|NCT01371708|100975559|FG002|STARTED|Overall Study||98||
48266933|NCT01371708|100975557|FG000|Received Treatment|Overall Study||91||
48266934|NCT01371708|100975558|FG001|Received Treatment|Overall Study||93||
48266935|NCT01371708|100975559|FG002|Received Treatment|Overall Study||97||
48266936|NCT01371708|100975557|FG000|COMPLETED|Overall Study||66||
48266937|NCT01371708|100975558|FG001|COMPLETED|Overall Study||63||
48266938|NCT01371708|100975559|FG002|COMPLETED|Overall Study||59||
48266939|NCT01371708|100975557|FG000|NOT COMPLETED|Overall Study||26||
48266940|NCT01371708|100975558|FG001|NOT COMPLETED|Overall Study||30||
48266941|NCT01371708|100975559|FG002|NOT COMPLETED|Overall Study||39||
48266942|NCT01031498|100975560|FG000|STARTED|Overall Study||49||
48266943|NCT01031498|100975561|FG001|STARTED|Overall Study||51||
48266944|NCT01031498|100975562|FG002|STARTED|Overall Study||50||
48391923|NCT05567393|101287756|FG004|COMPLETED|Overall Study||6||
48692273|NCT01667133|102029134|FG003|COMPLETED|Phase 1: Dose-escalation||2||
48692274|NCT01667133|102029135|FG004|COMPLETED|Phase 1: Dose-escalation||0||
48692275|NCT01667133|102029136|FG005|COMPLETED|Phase 1: Dose-escalation||0||
48266945|NCT01031498|100975560|FG000|COMPLETED|Overall Study||47||
48266946|NCT01031498|100975561|FG001|COMPLETED|Overall Study||48||
48266947|NCT01031498|100975562|FG002|COMPLETED|Overall Study||48||
48266948|NCT01031498|100975560|FG000|NOT COMPLETED|Overall Study||2||
48266949|NCT01031498|100975561|FG001|NOT COMPLETED|Overall Study||3||
48692276|NCT01667133|102029137|FG006|COMPLETED|Phase 1: Dose-escalation||0||
48105482|NCT03662542|100586869|FG002|NOT COMPLETED|Monotherapy Phase (Week 12-Week 38)||0||
48105483|NCT03662542|100586870|FG003|NOT COMPLETED|Monotherapy Phase (Week 12-Week 38)||5||
48266950|NCT01031498|100975562|FG002|NOT COMPLETED|Overall Study||2||
48266951|NCT00794924|100975563|FG000|STARTED|Overall Study||174||
48266952|NCT00794924|100975564|FG001|STARTED|Overall Study||171||
48266953|NCT00794924|100975563|FG000|COMPLETED|Overall Study||114||
48266954|NCT00794924|100975564|FG001|COMPLETED|Overall Study||101||
48266955|NCT00794924|100975563|FG000|NOT COMPLETED|Overall Study||60||
48266956|NCT00794924|100975564|FG001|NOT COMPLETED|Overall Study||70||
48266957|NCT03937141|100975565|FG000|STARTED|Overall Study||16||
48266958|NCT03937141|100975565|FG000|COMPLETED|Overall Study||16||
48266959|NCT03937141|100975565|FG000|NOT COMPLETED|Overall Study||0||
48266960|NCT01174446|100975566|FG000|STARTED|Part 1 -Pharmacokinetic Crossover||14||
48266961|NCT01174446|100975567|FG001|STARTED|Part 1 -Pharmacokinetic Crossover||14||
48266962|NCT01174446|100975568|FG002|STARTED|Part 1 -Pharmacokinetic Crossover||0||
48266963|NCT01174446|100975569|FG003|STARTED|Part 1 -Pharmacokinetic Crossover||0||
48266964|NCT01174446|100975566|FG000|COMPLETED|Part 1 -Pharmacokinetic Crossover||14||
48266965|NCT01174446|100975567|FG001|COMPLETED|Part 1 -Pharmacokinetic Crossover||14||
48266966|NCT01174446|100975568|FG002|COMPLETED|Part 1 -Pharmacokinetic Crossover||0||
48266967|NCT01174446|100975569|FG003|COMPLETED|Part 1 -Pharmacokinetic Crossover||0||
48266968|NCT01174446|100975566|FG000|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0||
48266969|NCT01174446|100975567|FG001|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0||
48266970|NCT01174446|100975568|FG002|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0||
48266971|NCT01174446|100975569|FG003|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0||
48266972|NCT01174446|100975566|FG000|STARTED|Part 2 -BAX326 Prophylaxis and On-demand||14||
48266973|NCT01174446|100975567|FG001|STARTED|Part 2 -BAX326 Prophylaxis and On-demand||14||
48266974|NCT01174446|100975568|FG002|STARTED|Part 2 -BAX326 Prophylaxis and On-demand||31||
48266975|NCT01174446|100975569|FG003|STARTED|Part 2 -BAX326 Prophylaxis and On-demand||14||
48266976|NCT01174446|100975566|FG000|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14||
48266977|NCT01174446|100975567|FG001|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14||
48266978|NCT01174446|100975568|FG002|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||29||
48266979|NCT01174446|100975569|FG003|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14||
48266980|NCT01174446|100975566|FG000|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0||
48266981|NCT01174446|100975567|FG001|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0||
48266982|NCT01174446|100975568|FG002|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||2||
48266983|NCT01174446|100975569|FG003|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0||
48266984|NCT01174446|100975566|FG000|STARTED|Part 3 -Pharmacokinetic BAX326 Only||14||
48266985|NCT01174446|100975567|FG001|STARTED|Part 3 -Pharmacokinetic BAX326 Only||14||
48266986|NCT01174446|100975568|FG002|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0||
48266987|NCT01174446|100975569|FG003|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0||
48266988|NCT01174446|100975566|FG000|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13||
48266989|NCT01174446|100975567|FG001|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13||
48266990|NCT01174446|100975568|FG002|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0||
48266991|NCT01174446|100975569|FG003|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0||
48266992|NCT01174446|100975566|FG000|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1||
48551755|NCT02413229|101683242|FG006|STARTED|Overall Study||25||
48551756|NCT02413229|101683243|FG007|STARTED|Overall Study||15||
48551757|NCT02413229|101683236|FG000|COMPLETED|Overall Study||24||
48551758|NCT02413229|101683237|FG001|COMPLETED|Overall Study||11||
48551759|NCT02413229|101683238|FG002|COMPLETED|Overall Study||25||
48551760|NCT02413229|101683239|FG003|COMPLETED|Overall Study||11||
48551761|NCT02413229|101683240|FG004|COMPLETED|Overall Study||21||
48551762|NCT02413229|101683241|FG005|COMPLETED|Overall Study||12||
48551763|NCT02413229|101683242|FG006|COMPLETED|Overall Study||25||
48551764|NCT02413229|101683243|FG007|COMPLETED|Overall Study||11||
48551765|NCT02413229|101683236|FG000|NOT COMPLETED|Overall Study||1||
48551766|NCT02413229|101683237|FG001|NOT COMPLETED|Overall Study||1||
48551767|NCT02413229|101683238|FG002|NOT COMPLETED|Overall Study||1||
48551768|NCT02413229|101683239|FG003|NOT COMPLETED|Overall Study||1||
48551769|NCT02413229|101683240|FG004|NOT COMPLETED|Overall Study||3||
48551770|NCT02413229|101683241|FG005|NOT COMPLETED|Overall Study||0||
48105484|NCT03662542|100586871|FG004|NOT COMPLETED|Monotherapy Phase (Week 12-Week 38)||3||
48105485|NCT03662542|100586872|FG005|NOT COMPLETED|Monotherapy Phase (Week 12-Week 38)||6||
48105486|NCT03662542|100586873|FG006|NOT COMPLETED|Monotherapy Phase (Week 12-Week 38)||0||
48266993|NCT01174446|100975567|FG001|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1||
48266994|NCT01174446|100975568|FG002|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0||
48266995|NCT01174446|100975569|FG003|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0||
48266996|NCT01445327|100975570|FG000|STARTED|Overall Study||3||
48266997|NCT01445327|100975571|FG001|STARTED|Overall Study||1||
48266998|NCT01445327|100975572|FG002|STARTED|Overall Study||5||
48266999|NCT01445327|100975570|FG000|COMPLETED|Overall Study||3||
48267000|NCT01445327|100975571|FG001|COMPLETED|Overall Study||1||
48551771|NCT02413229|101683242|FG006|NOT COMPLETED|Overall Study||0||
48551772|NCT02413229|101683243|FG007|NOT COMPLETED|Overall Study||4||
48551773|NCT01108718|101683244|FG000|STARTED|Received First Intervention (2 Months)||5||
48551774|NCT01108718|101683245|FG001|STARTED|Received First Intervention (2 Months)||7||
48267001|NCT01445327|100975572|FG002|COMPLETED|Overall Study||5||
48267002|NCT01445327|100975570|FG000|NOT COMPLETED|Overall Study||0||
48267003|NCT01445327|100975571|FG001|NOT COMPLETED|Overall Study||0||
48267004|NCT01445327|100975572|FG002|NOT COMPLETED|Overall Study||0||
48267005|NCT02154906|100975573|FG000|STARTED|Overall Study||21||
48267006|NCT02154906|100975574|FG001|STARTED|Overall Study||20||
48267007|NCT02154906|100975573|FG000|COMPLETED|Overall Study||19||
48267008|NCT02154906|100975574|FG001|COMPLETED|Overall Study||17||
48267009|NCT02154906|100975573|FG000|NOT COMPLETED|Overall Study||2||
48267010|NCT02154906|100975574|FG001|NOT COMPLETED|Overall Study||3||
48267011|NCT00387959|100975575|FG000|STARTED|Overall Study||17||
48267012|NCT00387959|100975575|FG000|COMPLETED|Overall Study||16||
48267013|NCT00387959|100975575|FG000|NOT COMPLETED|Overall Study||1||
48267014|NCT03898700|100978434|FG000|STARTED|Overall Study||9||
48267015|NCT03898700|100978434|FG000|COMPLETED|Overall Study||7||
48267016|NCT03898700|100978434|FG000|NOT COMPLETED|Overall Study||2||
48267017|NCT01483144|100978435|FG000|STARTED|Overall Study||56||
48267018|NCT01483144|100978436|FG001|STARTED|Overall Study||57||
48267019|NCT01483144|100978437|FG002|STARTED|Overall Study||58||
48267020|NCT01483144|100978435|FG000|COMPLETED|Overall Study||41||
48692277|NCT01667133|102029138|FG007|COMPLETED|Phase 1: Dose-escalation||0||
48692278|NCT01667133|102029139|FG008|COMPLETED|Phase 1: Dose-escalation||0||
48692279|NCT01667133|102029140|FG009|COMPLETED|Phase 1: Dose-escalation||0||
48692280|NCT01667133|102029141|FG010|COMPLETED|Phase 1: Dose-escalation||0||
48692281|NCT01667133|102029142|FG011|COMPLETED|Phase 1: Dose-escalation||0||
48692282|NCT01667133|102029131|FG000|NOT COMPLETED|Phase 1: Dose-escalation||0||
48692283|NCT01667133|102029132|FG001|NOT COMPLETED|Phase 1: Dose-escalation||1||
48692284|NCT01667133|102029133|FG002|NOT COMPLETED|Phase 1: Dose-escalation||4||
48692285|NCT01667133|102029134|FG003|NOT COMPLETED|Phase 1: Dose-escalation||1||
48692286|NCT01667133|102029135|FG004|NOT COMPLETED|Phase 1: Dose-escalation||1||
48692287|NCT01667133|102029136|FG005|NOT COMPLETED|Phase 1: Dose-escalation||1||
48692288|NCT01667133|102029137|FG006|NOT COMPLETED|Phase 1: Dose-escalation||1||
48692289|NCT01667133|102029138|FG007|NOT COMPLETED|Phase 1: Dose-escalation||0||
48692290|NCT01667133|102029139|FG008|NOT COMPLETED|Phase 1: Dose-escalation||0||
48692291|NCT01667133|102029140|FG009|NOT COMPLETED|Phase 1: Dose-escalation||0||
48692292|NCT01667133|102029141|FG010|NOT COMPLETED|Phase 1: Dose-escalation||0||
48692293|NCT01667133|102029142|FG011|NOT COMPLETED|Phase 1: Dose-escalation||0||
48692294|NCT01667133|102029131|FG000|STARTED|Phase 2: Dose-expansion||0||
48692295|NCT01667133|102029132|FG001|STARTED|Phase 2: Dose-expansion||0||
48692296|NCT01667133|102029133|FG002|STARTED|Phase 2: Dose-expansion||0||
48692297|NCT01667133|102029134|FG003|STARTED|Phase 2: Dose-expansion||0||
48692298|NCT01667133|102029135|FG004|STARTED|Phase 2: Dose-expansion||0||
48692299|NCT01667133|102029136|FG005|STARTED|Phase 2: Dose-expansion||0||
48692300|NCT01667133|102029137|FG006|STARTED|Phase 2: Dose-expansion||0||
48692301|NCT01667133|102029138|FG007|STARTED|Phase 2: Dose-expansion||2||
48267021|NCT01483144|100978436|FG001|COMPLETED|Overall Study||44||
48267022|NCT01483144|100978437|FG002|COMPLETED|Overall Study||43||
48267023|NCT01483144|100978435|FG000|NOT COMPLETED|Overall Study||15||
48267024|NCT01483144|100978436|FG001|NOT COMPLETED|Overall Study||13||
48267025|NCT01483144|100978437|FG002|NOT COMPLETED|Overall Study||15||
48267026|NCT01667926|100978438|FG000|STARTED|Overall Study||13||
48267027|NCT01667926|100978439|FG001|STARTED|Overall Study||13||
48267028|NCT01667926|100978440|FG002|STARTED|Overall Study||11||
48267029|NCT01667926|100978438|FG000|COMPLETED|Overall Study||8||
48267030|NCT01667926|100978439|FG001|COMPLETED|Overall Study||9||
48267031|NCT01667926|100978440|FG002|COMPLETED|Overall Study||0||
48267032|NCT01667926|100978438|FG000|NOT COMPLETED|Overall Study||5||
48267033|NCT01667926|100978439|FG001|NOT COMPLETED|Overall Study||4||
48267034|NCT01667926|100978440|FG002|NOT COMPLETED|Overall Study||11||
48267035|NCT02185105|100978441|FG000|STARTED|Overall Study||30||
48267036|NCT02185105|100978441|FG000|COMPLETED|Overall Study||30||
48267037|NCT02185105|100978441|FG000|NOT COMPLETED|Overall Study||0||
48267038|NCT00350727|100978442|FG000|STARTED|Phase I: Dose Escalation||34||
48267039|NCT00350727|100978443|FG001|STARTED|Phase I: Dose Escalation||0||
48267040|NCT00350727|100978444|FG002|STARTED|Phase I: Dose Escalation||0||
48267041|NCT00350727|100978442|FG000|COMPLETED|Phase I: Dose Escalation||0||
48267042|NCT00350727|100978443|FG001|COMPLETED|Phase I: Dose Escalation||0||
48267043|NCT00350727|100978444|FG002|COMPLETED|Phase I: Dose Escalation||0||
48267044|NCT00350727|100978442|FG000|NOT COMPLETED|Phase I: Dose Escalation||34||
48267045|NCT00350727|100978443|FG001|NOT COMPLETED|Phase I: Dose Escalation||0||
48267046|NCT00350727|100978444|FG002|NOT COMPLETED|Phase I: Dose Escalation||0||
48267047|NCT00350727|100978442|FG000|STARTED|Phase II||0||
48267048|NCT00350727|100978443|FG001|STARTED|Phase II||19||
48692302|NCT01667133|102029139|FG008|STARTED|Phase 2: Dose-expansion||1||
48692303|NCT01667133|102029140|FG009|STARTED|Phase 2: Dose-expansion||11||
48692304|NCT01667133|102029141|FG010|STARTED|Phase 2: Dose-expansion||3||
48692305|NCT01667133|102029142|FG011|STARTED|Phase 2: Dose-expansion||6||
48267049|NCT00350727|100978444|FG002|STARTED|Phase II||22||
48267050|NCT00350727|100978442|FG000|COMPLETED|Phase II||0||
48267051|NCT00350727|100978443|FG001|COMPLETED|Phase II||0||
48267052|NCT00350727|100978444|FG002|COMPLETED|Phase II||0||
48267053|NCT00350727|100978442|FG000|NOT COMPLETED|Phase II||0||
48267054|NCT00350727|100978443|FG001|NOT COMPLETED|Phase II||19||
48267055|NCT00350727|100978444|FG002|NOT COMPLETED|Phase II||22||
48267056|NCT02489734|100978445|FG000|STARTED|Overall Study||56||
48267057|NCT02489734|100978446|FG001|STARTED|Overall Study||53||
48267058|NCT02489734|100978445|FG000|COMPLETED|Overall Study||39||
48267059|NCT02489734|100978446|FG001|COMPLETED|Overall Study||53||
48267060|NCT02489734|100978445|FG000|NOT COMPLETED|Overall Study||17||
48267061|NCT02489734|100978446|FG001|NOT COMPLETED|Overall Study||0||
48267062|NCT01246999|100978447|FG000|STARTED|Overall Study||11||
48267063|NCT01246999|100978448|FG001|STARTED|Overall Study||4||
48267064|NCT01246999|100978449|FG002|STARTED|Overall Study||2||
48267065|NCT01246999|100978450|FG003|STARTED|Overall Study||17||
48267066|NCT01246999|100978447|FG000|COMPLETED|Overall Study||11||
48267067|NCT01246999|100978448|FG001|COMPLETED|Overall Study||3||
48267068|NCT01246999|100978449|FG002|COMPLETED|Overall Study||2||
48267069|NCT01246999|100978450|FG003|COMPLETED|Overall Study||15||
48267070|NCT01246999|100978447|FG000|NOT COMPLETED|Overall Study||0||
48267071|NCT01246999|100978448|FG001|NOT COMPLETED|Overall Study||1||
48267072|NCT01246999|100978449|FG002|NOT COMPLETED|Overall Study||0||
48267073|NCT01246999|100978450|FG003|NOT COMPLETED|Overall Study||2||
48267074|NCT01439867|100978451|FG000|STARTED|Overall Study||8||
48267075|NCT01439867|100978452|FG001|STARTED|Overall Study||10||
48692306|NCT01667133|102029131|FG000|COMPLETED|Phase 2: Dose-expansion||0||
48692307|NCT01667133|102029132|FG001|COMPLETED|Phase 2: Dose-expansion||0||
48692308|NCT01667133|102029133|FG002|COMPLETED|Phase 2: Dose-expansion||0||
48692309|NCT01667133|102029134|FG003|COMPLETED|Phase 2: Dose-expansion||0||
48692310|NCT01667133|102029135|FG004|COMPLETED|Phase 2: Dose-expansion||0||
48267076|NCT01439867|100978451|FG000|Received Treatment|Overall Study||7||
48267077|NCT01439867|100978452|FG001|Received Treatment|Overall Study||10||
48267078|NCT01439867|100978451|FG000|COMPLETED|Overall Study||2||
48267079|NCT01439867|100978452|FG001|COMPLETED|Overall Study||2||
48267080|NCT01439867|100978451|FG000|NOT COMPLETED|Overall Study||6||
48267081|NCT01439867|100978452|FG001|NOT COMPLETED|Overall Study||8||
48267082|NCT00879775|100978453|FG000|STARTED|Overall Study||20||
48267083|NCT00879775|100978454|FG001|STARTED|Overall Study||21||
48267084|NCT00879775|100978453|FG000|COMPLETED|Overall Study||18||
48267085|NCT00879775|100978454|FG001|COMPLETED|Overall Study||20||
48267086|NCT00879775|100978453|FG000|NOT COMPLETED|Overall Study||2||
48267087|NCT00879775|100978454|FG001|NOT COMPLETED|Overall Study||1||
48267088|NCT04593823|100978455|FG000|STARTED|Overall Study||34||
48267089|NCT04593823|100978456|FG001|STARTED|Overall Study||17||
48267090|NCT04593823|100978455|FG000|COMPLETED|Overall Study||33||
48267091|NCT04593823|100978456|FG001|COMPLETED|Overall Study||15||
48267092|NCT04593823|100978455|FG000|NOT COMPLETED|Overall Study||1||
48267093|NCT04593823|100978456|FG001|NOT COMPLETED|Overall Study||2||
48267094|NCT03445533|100978457|FG000|STARTED|Overall Study||243||
48267095|NCT03445533|100978458|FG001|STARTED|Overall Study||238||
48267096|NCT03445533|100978457|FG000|COMPLETED|Overall Study||115||
48267097|NCT03445533|100978458|FG001|COMPLETED|Overall Study||45||
48267098|NCT03445533|100978457|FG000|NOT COMPLETED|Overall Study||128||
48267099|NCT03445533|100978458|FG001|NOT COMPLETED|Overall Study||193||
48692311|NCT01667133|102029136|FG005|COMPLETED|Phase 2: Dose-expansion||0||
48692312|NCT01667133|102029137|FG006|COMPLETED|Phase 2: Dose-expansion||0||
48692313|NCT01667133|102029138|FG007|COMPLETED|Phase 2: Dose-expansion||0||
48692314|NCT01667133|102029139|FG008|COMPLETED|Phase 2: Dose-expansion||0||
48692315|NCT01667133|102029140|FG009|COMPLETED|Phase 2: Dose-expansion||5||
48692316|NCT01667133|102029141|FG010|COMPLETED|Phase 2: Dose-expansion||0||
48692317|NCT01667133|102029142|FG011|COMPLETED|Phase 2: Dose-expansion||0||
48692318|NCT01667133|102029131|FG000|NOT COMPLETED|Phase 2: Dose-expansion||0||
48692319|NCT01667133|102029132|FG001|NOT COMPLETED|Phase 2: Dose-expansion||0||
48692320|NCT01667133|102029133|FG002|NOT COMPLETED|Phase 2: Dose-expansion||0||
48692321|NCT01667133|102029134|FG003|NOT COMPLETED|Phase 2: Dose-expansion||0||
48692322|NCT01667133|102029135|FG004|NOT COMPLETED|Phase 2: Dose-expansion||0||
48267100|NCT00994175|100978459|FG000|STARTED|First Intervention||6||
48267101|NCT00994175|100978460|FG001|STARTED|First Intervention||9||
48267102|NCT00994175|100978459|FG000|COMPLETED|First Intervention||4||
48267103|NCT00994175|100978460|FG001|COMPLETED|First Intervention||8||
48267104|NCT00994175|100978459|FG000|NOT COMPLETED|First Intervention||2||
48267105|NCT00994175|100978460|FG001|NOT COMPLETED|First Intervention||1||
48267106|NCT00994175|100978459|FG000|STARTED|Second Intervention||4||
48267107|NCT00994175|100978460|FG001|STARTED|Second Intervention||8||
48267108|NCT00994175|100978459|FG000|COMPLETED|Second Intervention||4||
48267109|NCT00994175|100978460|FG001|COMPLETED|Second Intervention||8||
48267110|NCT00994175|100978459|FG000|NOT COMPLETED|Second Intervention||0||
48267111|NCT00994175|100978460|FG001|NOT COMPLETED|Second Intervention||0||
48267112|NCT01475305|100978461|FG000|STARTED|Overall Study||4||
48267113|NCT01475305|100978462|FG001|STARTED|Overall Study||3||
48267114|NCT01475305|100978461|FG000|End of Quarantine, Day 15|Overall Study||4||
48267115|NCT01475305|100978462|FG001|End of Quarantine, Day 15|Overall Study||3||
48267116|NCT01475305|100978461|FG000|COMPLETED|Overall Study||4||
48267117|NCT01475305|100978462|FG001|COMPLETED|Overall Study||3||
48551775|NCT01108718|101683244|FG000|COMPLETED|Received First Intervention (2 Months)||5||
48551776|NCT01108718|101683245|FG001|COMPLETED|Received First Intervention (2 Months)||7||
48551777|NCT01108718|101683244|FG000|NOT COMPLETED|Received First Intervention (2 Months)||0||
48551778|NCT01108718|101683245|FG001|NOT COMPLETED|Received First Intervention (2 Months)||0||
48551779|NCT01108718|101683244|FG000|STARTED|Received Second Intervention (2 Months)||5||
48551780|NCT01108718|101683245|FG001|STARTED|Received Second Intervention (2 Months)||7||
48551781|NCT01108718|101683244|FG000|COMPLETED|Received Second Intervention (2 Months)||4||
48551782|NCT01108718|101683245|FG001|COMPLETED|Received Second Intervention (2 Months)||7||
48551783|NCT01108718|101683244|FG000|NOT COMPLETED|Received Second Intervention (2 Months)||1||
48551784|NCT01108718|101683245|FG001|NOT COMPLETED|Received Second Intervention (2 Months)||0||
48105487|NCT03662542|100586874|FG007|NOT COMPLETED|Monotherapy Phase (Week 12-Week 38)||0||
48105488|NCT03662542|100586875|FG008|NOT COMPLETED|Monotherapy Phase (Week 12-Week 38)||0||
48105489|NCT03662542|100586867|FG000|STARTED|Safety Follow-up (Week 38- Week 50)||0||
48105490|NCT03662542|100586868|FG001|STARTED|Safety Follow-up (Week 38- Week 50)||0||
48105491|NCT03662542|100586869|FG002|STARTED|Safety Follow-up (Week 38- Week 50)||0||
48105492|NCT03662542|100586870|FG003|STARTED|Safety Follow-up (Week 38- Week 50)||0||
48105493|NCT03662542|100586871|FG004|STARTED|Safety Follow-up (Week 38- Week 50)||0||
48105494|NCT03662542|100586872|FG005|STARTED|Safety Follow-up (Week 38- Week 50)||0||
48105495|NCT03662542|100586873|FG006|STARTED|Safety Follow-up (Week 38- Week 50)||58||
48105496|NCT03662542|100586874|FG007|STARTED|Safety Follow-up (Week 38- Week 50)||65||
48551785|NCT02211417|101683246|FG000|STARTED|Overall Study||51||
48551786|NCT02211417|101683247|FG001|STARTED|Overall Study||51||
48551787|NCT02211417|101683246|FG000|COMPLETED|Overall Study||36||
48551788|NCT02211417|101683247|FG001|COMPLETED|Overall Study||35||
48551789|NCT02211417|101683246|FG000|NOT COMPLETED|Overall Study||15||
48551790|NCT02211417|101683247|FG001|NOT COMPLETED|Overall Study||16||
48551791|NCT01068548|101683248|FG000|STARTED|Overall Study||66||
48551792|NCT01068548|101683249|FG001|STARTED|Overall Study||63||
48551793|NCT01068548|101683248|FG000|COMPLETED|Overall Study||66||
48551794|NCT01068548|101683249|FG001|COMPLETED|Overall Study||63||
48551795|NCT01068548|101683248|FG000|NOT COMPLETED|Overall Study||0||
48551796|NCT01068548|101683249|FG001|NOT COMPLETED|Overall Study||0||
48105497|NCT03662542|100586875|FG008|STARTED|Safety Follow-up (Week 38- Week 50)||60||
48105498|NCT03662542|100586867|FG000|COMPLETED|Safety Follow-up (Week 38- Week 50)||0||
48551797|NCT02685735|101683250|FG000|STARTED|Overall Study||124||
48551798|NCT02685735|101683251|FG001|STARTED|Overall Study||129||
48551799|NCT02685735|101683250|FG000|COMPLETED|Overall Study||101|These subjects completed and provide data for the primary analysis. The total completed for secondary analyses is 89 in the gabapentin group and 93 in the placebo group. The reason for not completing was failure to complete questionnaires on at least one of the three occasions that these were performed.|
48551800|NCT02685735|101683251|FG001|COMPLETED|Overall Study||107|These subjects completed and provide data for the primary analysis. The total completed for secondary analyses is 89 in the gabapentin group and 93 in the placebo group. The reason for not completing was failure to complete questionnaires on at least one of the three occasions that these were performed.|
48105499|NCT03662542|100586868|FG001|COMPLETED|Safety Follow-up (Week 38- Week 50)||0||
48551801|NCT02685735|101683250|FG000|NOT COMPLETED|Overall Study||23||
48551802|NCT02685735|101683251|FG001|NOT COMPLETED|Overall Study||22||
48551803|NCT02103855|101683252|FG000|STARTED|Overall Study||6||
48551804|NCT02103855|101683252|FG000|COMPLETED|Overall Study||4||
48551805|NCT02103855|101683252|FG000|NOT COMPLETED|Overall Study||2||
48551806|NCT00461253|101683253|FG000|STARTED|Overall Study||10093||
48551807|NCT00461253|101683254|FG001|STARTED|Overall Study||40250||
48551808|NCT00461253|101683253|FG000|COMPLETED|Overall Study||5113||
48551809|NCT00461253|101683254|FG001|COMPLETED|Overall Study||20452||
48105500|NCT03662542|100586869|FG002|COMPLETED|Safety Follow-up (Week 38- Week 50)||0||
48105501|NCT03662542|100586870|FG003|COMPLETED|Safety Follow-up (Week 38- Week 50)||0||
48105502|NCT03662542|100586871|FG004|COMPLETED|Safety Follow-up (Week 38- Week 50)||0||
48105503|NCT03662542|100586872|FG005|COMPLETED|Safety Follow-up (Week 38- Week 50)||0||
48105504|NCT03662542|100586873|FG006|COMPLETED|Safety Follow-up (Week 38- Week 50)||55||
48692323|NCT01667133|102029136|FG005|NOT COMPLETED|Phase 2: Dose-expansion||0||
48692324|NCT01667133|102029137|FG006|NOT COMPLETED|Phase 2: Dose-expansion||0||
48692325|NCT01667133|102029138|FG007|NOT COMPLETED|Phase 2: Dose-expansion||2||
48692326|NCT01667133|102029139|FG008|NOT COMPLETED|Phase 2: Dose-expansion||1||
48692327|NCT01667133|102029140|FG009|NOT COMPLETED|Phase 2: Dose-expansion||6||
48692328|NCT01667133|102029141|FG010|NOT COMPLETED|Phase 2: Dose-expansion||3||
48692329|NCT01667133|102029142|FG011|NOT COMPLETED|Phase 2: Dose-expansion||6||
48692330|NCT03292874|102029143|FG000|STARTED|Overall Study||64||
48692331|NCT03292874|102029143|FG000|COMPLETED|Overall Study||59||
48692332|NCT03292874|102029143|FG000|NOT COMPLETED|Overall Study||5||
48692333|NCT04136548|102029144|FG000|STARTED|Enrolled & Randomized||19||
48692334|NCT04136548|102029145|FG001|STARTED|Enrolled & Randomized||19||
48692335|NCT04136548|102029144|FG000|COMPLETED|Enrolled & Randomized||13||
48692336|NCT04136548|102029145|FG001|COMPLETED|Enrolled & Randomized||15||
48692337|NCT04136548|102029144|FG000|NOT COMPLETED|Enrolled & Randomized||6||
48692338|NCT04136548|102029145|FG001|NOT COMPLETED|Enrolled & Randomized||4||
48551810|NCT00461253|101683253|FG000|NOT COMPLETED|Overall Study||4980||
48551811|NCT00461253|101683254|FG001|NOT COMPLETED|Overall Study||19798||
48551812|NCT03629184|101683255|FG000|STARTED|Overall Study||115||
48551813|NCT03629184|101683256|FG001|STARTED|Overall Study||58||
48551814|NCT03629184|101683255|FG000|COMPLETED|Overall Study||112||
48551815|NCT03629184|101683256|FG001|COMPLETED|Overall Study||57||
48551816|NCT03629184|101683255|FG000|NOT COMPLETED|Overall Study||3||
48551817|NCT03629184|101683256|FG001|NOT COMPLETED|Overall Study||1||
48551818|NCT01651793|101683257|FG000|STARTED|Overall Study||6||
48551819|NCT01651793|101683258|FG001|STARTED|Overall Study||6||
48551820|NCT01651793|101683259|FG002|STARTED|Overall Study||6||
48551821|NCT01651793|101683260|FG003|STARTED|Overall Study||6||
48551822|NCT01651793|101683257|FG000|COMPLETED|Overall Study||6||
48551823|NCT01651793|101683258|FG001|COMPLETED|Overall Study||6||
48551824|NCT01651793|101683259|FG002|COMPLETED|Overall Study||6||
48551825|NCT01651793|101683260|FG003|COMPLETED|Overall Study||5||
48551826|NCT01651793|101683257|FG000|NOT COMPLETED|Overall Study||0||
48551827|NCT01651793|101683258|FG001|NOT COMPLETED|Overall Study||0||
48551828|NCT01651793|101683259|FG002|NOT COMPLETED|Overall Study||0||
48551829|NCT01651793|101683260|FG003|NOT COMPLETED|Overall Study||1||
48551830|NCT04841577|101683261|FG000|STARTED|Overall Study||442||
48551831|NCT04841577|101683262|FG001|STARTED|Overall Study||443||
48551832|NCT04841577|101683261|FG000|COMPLETED|Overall Study||429||
48551833|NCT04841577|101683262|FG001|COMPLETED|Overall Study||417||
48551834|NCT04841577|101683261|FG000|NOT COMPLETED|Overall Study||13||
48551835|NCT04841577|101683262|FG001|NOT COMPLETED|Overall Study||26||
48551836|NCT02396511|101683263|FG000|STARTED|Overall Study||2||
48551837|NCT02396511|101683263|FG000|COMPLETED|Overall Study||2||
48551838|NCT02396511|101683263|FG000|NOT COMPLETED|Overall Study||0||
48551839|NCT02348112|101683264|FG000|STARTED|Overall Study||213||
48551840|NCT02348112|101683265|FG001|STARTED|Overall Study||203||
48551841|NCT02348112|101683264|FG000|COMPLETED|Overall Study||140||
48551842|NCT02348112|101683265|FG001|COMPLETED|Overall Study||101||
48551843|NCT02348112|101683264|FG000|NOT COMPLETED|Overall Study||73||
48551844|NCT02348112|101683265|FG001|NOT COMPLETED|Overall Study||102||
48551845|NCT02208089|101683266|FG000|STARTED|Overall Study||47||
48551846|NCT02208089|101683267|FG001|STARTED|Overall Study||47||
48551847|NCT02208089|101683266|FG000|COMPLETED|Overall Study||40||
48551848|NCT02208089|101683267|FG001|COMPLETED|Overall Study||47||
48551849|NCT02208089|101683266|FG000|NOT COMPLETED|Overall Study||7||
48692339|NCT04136548|102029144|FG000|STARTED|First Visit||13||
48692340|NCT04136548|102029145|FG001|STARTED|First Visit||15||
48692341|NCT04136548|102029144|FG000|COMPLETED|First Visit||13||
48692342|NCT04136548|102029145|FG001|COMPLETED|First Visit||15||
48692343|NCT04136548|102029144|FG000|NOT COMPLETED|First Visit||0||
48692344|NCT04136548|102029145|FG001|NOT COMPLETED|First Visit||0||
48692345|NCT04136548|102029144|FG000|STARTED|Washout (at Least 48 Hours)||13||
48692346|NCT04136548|102029145|FG001|STARTED|Washout (at Least 48 Hours)||15||
48551850|NCT02208089|101683267|FG001|NOT COMPLETED|Overall Study||0||
48551851|NCT00193050|101683268|FG000|STARTED|Neoadjuvant Treatment||110||
48551852|NCT00193050|101683268|FG000|COMPLETED|Neoadjuvant Treatment||101||
48551853|NCT00193050|101683268|FG000|NOT COMPLETED|Neoadjuvant Treatment||9||
48551854|NCT00193050|101683268|FG000|STARTED|Surgery||103||
48551855|NCT00193050|101683268|FG000|COMPLETED|Surgery||103||
48551856|NCT00193050|101683268|FG000|NOT COMPLETED|Surgery||0||
48551857|NCT00193050|101683268|FG000|STARTED|Adjuvant||87||
48551858|NCT00193050|101683268|FG000|COMPLETED|Adjuvant||77||
48551859|NCT00193050|101683268|FG000|NOT COMPLETED|Adjuvant||10||
48551860|NCT03156504|101683269|FG000|STARTED|Overall Study||75||
48551861|NCT03156504|101683269|FG000|COMPLETED|Overall Study||74||
48692347|NCT04136548|102029144|FG000|COMPLETED|Washout (at Least 48 Hours)||13||
48692348|NCT04136548|102029145|FG001|COMPLETED|Washout (at Least 48 Hours)||15||
48692349|NCT04136548|102029144|FG000|NOT COMPLETED|Washout (at Least 48 Hours)||0||
48692350|NCT04136548|102029145|FG001|NOT COMPLETED|Washout (at Least 48 Hours)||0||
48692351|NCT04136548|102029144|FG000|STARTED|Second Visit||13||
48692352|NCT04136548|102029145|FG001|STARTED|Second Visit||15||
48692353|NCT04136548|102029144|FG000|COMPLETED|Second Visit||13||
48692354|NCT04136548|102029145|FG001|COMPLETED|Second Visit||15||
48692355|NCT04136548|102029144|FG000|NOT COMPLETED|Second Visit||0||
48692356|NCT04136548|102029145|FG001|NOT COMPLETED|Second Visit||0||
48692357|NCT02943070|102029146|FG000|STARTED|Overall Study||50||
48692358|NCT02943070|102029146|FG000|COMPLETED|Overall Study||7||
48105505|NCT03662542|100586874|FG007|COMPLETED|Safety Follow-up (Week 38- Week 50)||58||
48551862|NCT03156504|101683269|FG000|NOT COMPLETED|Overall Study||1||
48551863|NCT02864355|101683270|FG000|STARTED|Overall Study||25||
48551864|NCT02864355|101683271|FG001|STARTED|Overall Study||28||
48551865|NCT02864355|101683270|FG000|COMPLETED|Overall Study||23||
48551866|NCT02864355|101683271|FG001|COMPLETED|Overall Study||25||
48551867|NCT02864355|101683270|FG000|NOT COMPLETED|Overall Study||2||
48551868|NCT02864355|101683271|FG001|NOT COMPLETED|Overall Study||3||
48551869|NCT02683421|101683272|FG000|STARTED|Overall Study||5||
48551870|NCT02683421|101683273|FG001|STARTED|Overall Study||4||
48105506|NCT03662542|100586875|FG008|COMPLETED|Safety Follow-up (Week 38- Week 50)||55||
48105507|NCT03662542|100586867|FG000|NOT COMPLETED|Safety Follow-up (Week 38- Week 50)||0||
48105508|NCT03662542|100586868|FG001|NOT COMPLETED|Safety Follow-up (Week 38- Week 50)||0||
48551871|NCT02683421|101683274|FG002|STARTED|Overall Study||4||
48551872|NCT02683421|101683275|FG003|STARTED|Overall Study||5||
48551873|NCT02683421|101683272|FG000|COMPLETED|Overall Study||5||
48551874|NCT02683421|101683273|FG001|COMPLETED|Overall Study||4||
48551875|NCT02683421|101683274|FG002|COMPLETED|Overall Study||4||
48551876|NCT02683421|101683275|FG003|COMPLETED|Overall Study||5||
48105509|NCT03662542|100586869|FG002|NOT COMPLETED|Safety Follow-up (Week 38- Week 50)||0||
48105510|NCT03662542|100586870|FG003|NOT COMPLETED|Safety Follow-up (Week 38- Week 50)||0||
48105511|NCT03662542|100586871|FG004|NOT COMPLETED|Safety Follow-up (Week 38- Week 50)||0||
48105512|NCT03662542|100586872|FG005|NOT COMPLETED|Safety Follow-up (Week 38- Week 50)||0||
48105513|NCT03662542|100586873|FG006|NOT COMPLETED|Safety Follow-up (Week 38- Week 50)||3||
48105514|NCT03662542|100586874|FG007|NOT COMPLETED|Safety Follow-up (Week 38- Week 50)||7||
48105515|NCT03662542|100586875|FG008|NOT COMPLETED|Safety Follow-up (Week 38- Week 50)||5||
48105516|NCT00235872|100586876|FG000|STARTED|Overall Study||309||
48105517|NCT00235872|100586876|FG000|COMPLETED|Overall Study||162||
48105518|NCT00235872|100586876|FG000|NOT COMPLETED|Overall Study||147||
48105519|NCT01100242|100586877|FG000|STARTED|Overall Study||17||
48105520|NCT01100242|100586877|FG000|COMPLETED|Overall Study||17||
48105521|NCT01100242|100586877|FG000|NOT COMPLETED|Overall Study||0||
48105522|NCT03238911|100586878|FG000|STARTED|Overall Study||62||
48105523|NCT03238911|100586879|FG001|STARTED|Overall Study||61||
48105524|NCT03238911|100586878|FG000|Safety Analysis Set|Overall Study||63||
48105525|NCT03238911|100586879|FG001|Safety Analysis Set|Overall Study||60||
48105526|NCT03238911|100586878|FG000|COMPLETED|Overall Study||59||
48105527|NCT03238911|100586879|FG001|COMPLETED|Overall Study||58||
48105528|NCT03238911|100586878|FG000|NOT COMPLETED|Overall Study||3||
48105529|NCT03238911|100586879|FG001|NOT COMPLETED|Overall Study||3||
48105530|NCT02400723|100586880|FG000|STARTED|Overall Study||27||
48105531|NCT02400723|100586881|FG001|STARTED|Overall Study||29||
48551877|NCT02683421|101683272|FG000|NOT COMPLETED|Overall Study||0||
48551878|NCT02683421|101683273|FG001|NOT COMPLETED|Overall Study||0||
48551879|NCT02683421|101683274|FG002|NOT COMPLETED|Overall Study||0||
48692359|NCT02943070|102029146|FG000|NOT COMPLETED|Overall Study||43||
48692360|NCT01670279|102029147|FG000|STARTED|Overall Study||6||
48105532|NCT02400723|100586880|FG000|COMPLETED|Overall Study||22||
48551880|NCT02683421|101683275|FG003|NOT COMPLETED|Overall Study||0||
48551881|NCT00626561|101683276|FG000|STARTED|Overall Study||4||
48551882|NCT00626561|101683276|FG000|COMPLETED|Overall Study||0||
48551883|NCT00626561|101683276|FG000|NOT COMPLETED|Overall Study||4||
48551884|NCT01514461|101683277|FG000|STARTED|Overall Study||15||
48551885|NCT01514461|101683278|FG001|STARTED|Overall Study||15||
48551886|NCT01514461|101683279|FG002|STARTED|Overall Study||15||
48692361|NCT01670279|102029148|FG001|STARTED|Overall Study||7||
48692362|NCT01670279|102029149|FG002|STARTED|Overall Study||0||
48692363|NCT01670279|102029150|FG003|STARTED|Overall Study||5||
48692364|NCT01670279|102029147|FG000|COMPLETED|Overall Study||6||
48105533|NCT02400723|100586881|FG001|COMPLETED|Overall Study||24||
48105534|NCT02400723|100586880|FG000|NOT COMPLETED|Overall Study||5||
48105535|NCT02400723|100586881|FG001|NOT COMPLETED|Overall Study||5||
48105536|NCT01566448|100586882|FG000|STARTED|Overall Study||30||
48105537|NCT01566448|100586882|FG000|COMPLETED|Overall Study||30||
48105538|NCT01566448|100586882|FG000|NOT COMPLETED|Overall Study||0||
48105539|NCT01726738|100586883|FG000|STARTED|Overall Study||17||
48105540|NCT01726738|100586883|FG000|COMPLETED|Overall Study||17||
48105541|NCT01726738|100586883|FG000|NOT COMPLETED|Overall Study||0||
48105542|NCT02600637|100586884|FG000|STARTED|Overall Study||19||
48105543|NCT02600637|100586885|FG001|STARTED|Overall Study||18||
48105544|NCT02600637|100586884|FG000|COMPLETED|Overall Study||14||
48105545|NCT02600637|100586885|FG001|COMPLETED|Overall Study||13||
48105546|NCT02600637|100586884|FG000|NOT COMPLETED|Overall Study||5||
48105547|NCT02600637|100586885|FG001|NOT COMPLETED|Overall Study||5||
48105548|NCT01667978|100586886|FG000|STARTED|Overall Study||18||
48105549|NCT01667978|100586887|FG001|STARTED|Overall Study||17||
48105550|NCT01667978|100586886|FG000|COMPLETED|Overall Study||16||
48105551|NCT01667978|100586887|FG001|COMPLETED|Overall Study||17||
48105552|NCT01667978|100586886|FG000|NOT COMPLETED|Overall Study||2||
48105553|NCT01667978|100586887|FG001|NOT COMPLETED|Overall Study||0||
48105554|NCT02666183|100586888|FG000|STARTED|Overall Study||137||
48105555|NCT02666183|100586889|FG001|STARTED|Overall Study||141||
48105556|NCT02666183|100586890|FG002|STARTED|Overall Study||119||
48105557|NCT02666183|100586888|FG000|COMPLETED|Overall Study||103||
48105558|NCT02666183|100586889|FG001|COMPLETED|Overall Study||106||
48105559|NCT02666183|100586890|FG002|COMPLETED|Overall Study||93||
48105560|NCT02666183|100586888|FG000|NOT COMPLETED|Overall Study||34||
48105561|NCT02666183|100586889|FG001|NOT COMPLETED|Overall Study||35||
48105562|NCT02666183|100586890|FG002|NOT COMPLETED|Overall Study||26||
48105563|NCT00244712|100586891|FG000|STARTED|Overall Study||343||
48105564|NCT00244712|100586892|FG001|STARTED|Overall Study||345||
48105565|NCT00244712|100586891|FG000|COMPLETED|Overall Study||234||
48105566|NCT00244712|100586892|FG001|COMPLETED|Overall Study||221||
48105567|NCT00244712|100586891|FG000|NOT COMPLETED|Overall Study||109||
48105568|NCT00244712|100586892|FG001|NOT COMPLETED|Overall Study||124||
48105569|NCT01856790|100586893|FG000|STARTED|Closed Loop Control||15||
48105570|NCT01856790|100586893|FG000|COMPLETED|Closed Loop Control||13||
48105571|NCT01856790|100586893|FG000|NOT COMPLETED|Closed Loop Control||2||
48105572|NCT01856790|100586893|FG000|STARTED|Closed Loop Control + Liraglutide||13||
48105573|NCT01856790|100586893|FG000|COMPLETED|Closed Loop Control + Liraglutide||11||
48105574|NCT01856790|100586893|FG000|NOT COMPLETED|Closed Loop Control + Liraglutide||2||
48105575|NCT00449956|100586894|FG000|STARTED|Overall Study||189||
48105576|NCT00449956|100586895|FG001|STARTED|Overall Study||92||
48105577|NCT00449956|100586896|FG002|STARTED|Overall Study||193||
48105578|NCT00449956|100586894|FG000|COMPLETED|Overall Study||179||
48105579|NCT00449956|100586895|FG001|COMPLETED|Overall Study||88||
48105580|NCT00449956|100586896|FG002|COMPLETED|Overall Study||184||
48105581|NCT00449956|100586894|FG000|NOT COMPLETED|Overall Study||10||
48105582|NCT00449956|100586895|FG001|NOT COMPLETED|Overall Study||4||
48105583|NCT00449956|100586896|FG002|NOT COMPLETED|Overall Study||9||
48105584|NCT04649164|100586897|FG000|STARTED|Overall Study||19||
48267118|NCT01475305|100978461|FG000|NOT COMPLETED|Overall Study||0||
48267119|NCT01475305|100978462|FG001|NOT COMPLETED|Overall Study||0||
48267120|NCT01515943|100978463|FG000|STARTED|Overall Study||75||
48267121|NCT01515943|100978464|FG001|STARTED|Overall Study||85||
48267122|NCT01515943|100978465|FG002|STARTED|Overall Study||44||
48267123|NCT01515943|100978463|FG000|COMPLETED|Overall Study||69||
48267124|NCT01515943|100978464|FG001|COMPLETED|Overall Study||69||
48267125|NCT01515943|100978465|FG002|COMPLETED|Overall Study||31||
48267126|NCT01515943|100978463|FG000|NOT COMPLETED|Overall Study||6||
48267127|NCT01515943|100978464|FG001|NOT COMPLETED|Overall Study||16||
48267128|NCT01515943|100978465|FG002|NOT COMPLETED|Overall Study||13||
48105585|NCT04649164|100586898|FG001|STARTED|Overall Study||36||
48105586|NCT04649164|100586899|FG002|STARTED|Overall Study||32||
48105587|NCT04649164|100586897|FG000|COMPLETED|Overall Study||18||
48105588|NCT04649164|100586898|FG001|COMPLETED|Overall Study||35||
48105589|NCT04649164|100586899|FG002|COMPLETED|Overall Study||28||
48105590|NCT04649164|100586897|FG000|NOT COMPLETED|Overall Study||1||
48105591|NCT04649164|100586898|FG001|NOT COMPLETED|Overall Study||1||
48105592|NCT04649164|100586899|FG002|NOT COMPLETED|Overall Study||4||
48391924|NCT05567393|101287757|FG005|COMPLETED|Overall Study||6||
48391925|NCT05567393|101287758|FG006|COMPLETED|Overall Study||6||
48391926|NCT05567393|101287759|FG007|COMPLETED|Overall Study||6||
48391927|NCT05567393|101287760|FG008|COMPLETED|Overall Study||6||
48391928|NCT05567393|101287761|FG009|COMPLETED|Overall Study||6||
48105593|NCT02622828|100586900|FG000|STARTED|Overall Study||4||
48105594|NCT02622828|100586900|FG000|COMPLETED|Overall Study||1||
48391929|NCT05567393|101287762|FG010|COMPLETED|Overall Study||6||
48391930|NCT05567393|101287763|FG011|COMPLETED|Overall Study||6||
48105595|NCT02622828|100586900|FG000|NOT COMPLETED|Overall Study||3||
48105596|NCT05620576|100586901|FG000|STARTED|Overall Study||87||
48105597|NCT05620576|100586902|FG001|STARTED|Overall Study||44||
48105598|NCT05620576|100586901|FG000|Received at Least One Dose of Study Drug|Overall Study||87||
48391931|NCT05567393|101287764|FG012|COMPLETED|Overall Study||6||
48105599|NCT05620576|100586902|FG001|Received at Least One Dose of Study Drug|Overall Study||44||
48105600|NCT05620576|100586901|FG000|COMPLETED|Overall Study||80||
48105601|NCT05620576|100586902|FG001|COMPLETED|Overall Study||37||
48105602|NCT05620576|100586901|FG000|NOT COMPLETED|Overall Study||7||
48105603|NCT05620576|100586902|FG001|NOT COMPLETED|Overall Study||7||
48105604|NCT00914810|100586903|FG000|STARTED|Overall Study||20||
48105605|NCT00914810|100586904|FG001|STARTED|Overall Study||19||
48105606|NCT00914810|100586903|FG000|COMPLETED|Overall Study||18||
48105607|NCT00914810|100586904|FG001|COMPLETED|Overall Study||18||
48105608|NCT00914810|100586903|FG000|NOT COMPLETED|Overall Study||2||
48105609|NCT00914810|100586904|FG001|NOT COMPLETED|Overall Study||1||
48105610|NCT00264641|100586905|FG000|STARTED|Overall Study||10||
48105611|NCT00264641|100586906|FG001|STARTED|Overall Study||10||
48105612|NCT00264641|100586905|FG000|Initiation of the Study|Overall Study||10||
48105613|NCT00264641|100586906|FG001|Initiation of the Study|Overall Study||10||
48105614|NCT00264641|100586905|FG000|COMPLETED|Overall Study||10||
48105615|NCT00264641|100586906|FG001|COMPLETED|Overall Study||10||
48105616|NCT00264641|100586905|FG000|NOT COMPLETED|Overall Study||0||
48105617|NCT00264641|100586906|FG001|NOT COMPLETED|Overall Study||0||
48105618|NCT03034954|100586907|FG000|STARTED|Overall Study||21||
48105619|NCT03034954|100586908|FG001|STARTED|Overall Study||21||
48105620|NCT03034954|100586907|FG000|COMPLETED|Overall Study||20||
48105621|NCT03034954|100586908|FG001|COMPLETED|Overall Study||21||
48105622|NCT03034954|100586907|FG000|NOT COMPLETED|Overall Study||1||
48105623|NCT03034954|100586908|FG001|NOT COMPLETED|Overall Study||0||
48105624|NCT03373383|100586909|FG000|STARTED|Treatment Period: Wk0-16||83||
48105625|NCT03373383|100586910|FG001|STARTED|Treatment Period: Wk0-16||81||
48105626|NCT03373383|100586911|FG002|STARTED|Treatment Period: Wk0-16||83||
48105627|NCT03373383|100586912|FG003|STARTED|Treatment Period: Wk0-16||82||
48105628|NCT03373383|100586913|FG004|STARTED|Treatment Period: Wk0-16||82||
48105629|NCT03373383|100586909|FG000|Completed Titration and Stabilization|Treatment Period: Wk0-16||78||
48105630|NCT03373383|100586910|FG001|Completed Titration and Stabilization|Treatment Period: Wk0-16||72||
48105631|NCT03373383|100586911|FG002|Completed Titration and Stabilization|Treatment Period: Wk0-16||71||
48105632|NCT03373383|100586912|FG003|Completed Titration and Stabilization|Treatment Period: Wk0-16||68||
48105633|NCT03373383|100586913|FG004|Completed Titration and Stabilization|Treatment Period: Wk0-16||65||
48105634|NCT03373383|100586909|FG000|Completed Maintenance Period|Treatment Period: Wk0-16||70||
48105635|NCT03373383|100586910|FG001|Completed Maintenance Period|Treatment Period: Wk0-16||66||
48105636|NCT03373383|100586911|FG002|Completed Maintenance Period|Treatment Period: Wk0-16||68||
48105637|NCT03373383|100586912|FG003|Completed Maintenance Period|Treatment Period: Wk0-16||61||
48105638|NCT03373383|100586913|FG004|Completed Maintenance Period|Treatment Period: Wk0-16||58||
48105639|NCT03373383|100586909|FG000|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||6||
48105640|NCT03373383|100586910|FG001|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||11||
48105641|NCT03373383|100586911|FG002|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||8||
48267129|NCT03539068|100978466|FG000|STARTED|Overall Study||214||
48267130|NCT03539068|100978467|FG001|STARTED|Overall Study||102||
48267131|NCT03539068|100978466|FG000|COMPLETED|Overall Study||199||
48267132|NCT03539068|100978467|FG001|COMPLETED|Overall Study||102||
48267133|NCT03539068|100978466|FG000|NOT COMPLETED|Overall Study||15||
48267134|NCT03539068|100978467|FG001|NOT COMPLETED|Overall Study||0||
48267135|NCT02601209|100978468|FG000|STARTED|Initial Treatment (Up to 4 Months)||4||
48267136|NCT02601209|100978469|FG001|STARTED|Initial Treatment (Up to 4 Months)||4||
48267137|NCT02601209|100978470|FG002|STARTED|Initial Treatment (Up to 4 Months)||4||
48267138|NCT02601209|100978471|FG003|STARTED|Initial Treatment (Up to 4 Months)||6||
48267139|NCT02601209|100978472|FG004|STARTED|Initial Treatment (Up to 4 Months)||13||
48267140|NCT02601209|100978473|FG005|STARTED|Initial Treatment (Up to 4 Months)||15||
48267141|NCT02601209|100978474|FG006|STARTED|Initial Treatment (Up to 4 Months)||56||
48267142|NCT02601209|100978475|FG007|STARTED|Initial Treatment (Up to 4 Months)||6||
48267143|NCT02601209|100978476|FG008|STARTED|Initial Treatment (Up to 4 Months)||43||
48267144|NCT02601209|100978468|FG000|COMPLETED|Initial Treatment (Up to 4 Months)||3||
48267145|NCT02601209|100978469|FG001|COMPLETED|Initial Treatment (Up to 4 Months)||3||
48267146|NCT02601209|100978470|FG002|COMPLETED|Initial Treatment (Up to 4 Months)||3||
48267147|NCT02601209|100978471|FG003|COMPLETED|Initial Treatment (Up to 4 Months)||6||
48267148|NCT02601209|100978472|FG004|COMPLETED|Initial Treatment (Up to 4 Months)||12||
48267149|NCT02601209|100978473|FG005|COMPLETED|Initial Treatment (Up to 4 Months)||13||
48267150|NCT02601209|100978474|FG006|COMPLETED|Initial Treatment (Up to 4 Months)||55||
48267151|NCT02601209|100978475|FG007|COMPLETED|Initial Treatment (Up to 4 Months)||6||
48267152|NCT02601209|100978476|FG008|COMPLETED|Initial Treatment (Up to 4 Months)||43||
48267153|NCT02601209|100978468|FG000|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1||
48267154|NCT02601209|100978469|FG001|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1||
48267155|NCT02601209|100978470|FG002|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1||
48105642|NCT03373383|100586912|FG003|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||18||
48105643|NCT03373383|100586913|FG004|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||21||
48105644|NCT03373383|100586909|FG000|COMPLETED|Treatment Period: Wk0-16||70||
48105645|NCT03373383|100586910|FG001|COMPLETED|Treatment Period: Wk0-16||66||
48267156|NCT02601209|100978471|FG003|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0||
48105646|NCT03373383|100586911|FG002|COMPLETED|Treatment Period: Wk0-16||68||
48105647|NCT03373383|100586912|FG003|COMPLETED|Treatment Period: Wk0-16||61||
48105648|NCT03373383|100586913|FG004|COMPLETED|Treatment Period: Wk0-16||58||
48105649|NCT03373383|100586909|FG000|NOT COMPLETED|Treatment Period: Wk0-16||13||
48105650|NCT03373383|100586910|FG001|NOT COMPLETED|Treatment Period: Wk0-16||15||
48105651|NCT03373383|100586911|FG002|NOT COMPLETED|Treatment Period: Wk0-16||15||
48105652|NCT03373383|100586912|FG003|NOT COMPLETED|Treatment Period: Wk0-16||21||
48267157|NCT02601209|100978472|FG004|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1||
48267158|NCT02601209|100978473|FG005|NOT COMPLETED|Initial Treatment (Up to 4 Months)||2||
48267159|NCT02601209|100978474|FG006|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1||
48267160|NCT02601209|100978475|FG007|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0||
48105653|NCT03373383|100586913|FG004|NOT COMPLETED|Treatment Period: Wk0-16||24||
48105654|NCT03373383|100586909|FG000|STARTED|Post-Treatment Period: Wk16-23||70||
48105655|NCT03373383|100586910|FG001|STARTED|Post-Treatment Period: Wk16-23||66||
48105656|NCT03373383|100586911|FG002|STARTED|Post-Treatment Period: Wk16-23||68||
48105657|NCT03373383|100586912|FG003|STARTED|Post-Treatment Period: Wk16-23||61||
48267161|NCT02601209|100978476|FG008|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0||
48267162|NCT02601209|100978468|FG000|STARTED|Optional Crossover (Up to 2 Months)||0||
48267163|NCT02601209|100978469|FG001|STARTED|Optional Crossover (Up to 2 Months)||0||
48267164|NCT02601209|100978470|FG002|STARTED|Optional Crossover (Up to 2 Months)||0||
48267165|NCT02601209|100978471|FG003|STARTED|Optional Crossover (Up to 2 Months)||0||
48391932|NCT05567393|101287765|FG013|COMPLETED|Overall Study||7||
48105658|NCT03373383|100586913|FG004|STARTED|Post-Treatment Period: Wk16-23||58||
48105659|NCT03373383|100586909|FG000|Started Conversion Period|Post-Treatment Period: Wk16-23||69||
48105660|NCT03373383|100586910|FG001|Started Conversion Period|Post-Treatment Period: Wk16-23||64||
48105661|NCT03373383|100586911|FG002|Started Conversion Period|Post-Treatment Period: Wk16-23||66||
48105662|NCT03373383|100586912|FG003|Started Conversion Period|Post-Treatment Period: Wk16-23||55||
48105663|NCT03373383|100586913|FG004|Started Conversion Period|Post-Treatment Period: Wk16-23||57||
48105664|NCT03373383|100586909|FG000|Completed Conversion Period|Post-Treatment Period: Wk16-23||68||
48105665|NCT03373383|100586910|FG001|Completed Conversion Period|Post-Treatment Period: Wk16-23||64||
48105666|NCT03373383|100586911|FG002|Completed Conversion Period|Post-Treatment Period: Wk16-23||66||
48105667|NCT03373383|100586912|FG003|Completed Conversion Period|Post-Treatment Period: Wk16-23||55||
48105668|NCT03373383|100586913|FG004|Completed Conversion Period|Post-Treatment Period: Wk16-23||57||
48105669|NCT03373383|100586909|FG000|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||3||
48105670|NCT03373383|100586910|FG001|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||3||
48105671|NCT03373383|100586911|FG002|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||3||
48105672|NCT03373383|100586912|FG003|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||6||
48105673|NCT03373383|100586913|FG004|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||1||
48105674|NCT03373383|100586909|FG000|Enrolled in EP0093|Post-Treatment Period: Wk16-23||67||
48105675|NCT03373383|100586910|FG001|Enrolled in EP0093|Post-Treatment Period: Wk16-23||63||
48105676|NCT03373383|100586911|FG002|Enrolled in EP0093|Post-Treatment Period: Wk16-23||65||
48105677|NCT03373383|100586912|FG003|Enrolled in EP0093|Post-Treatment Period: Wk16-23||55||
48105678|NCT03373383|100586913|FG004|Enrolled in EP0093|Post-Treatment Period: Wk16-23||57||
48105679|NCT03373383|100586909|FG000|COMPLETED|Post-Treatment Period: Wk16-23||69||
48105680|NCT03373383|100586910|FG001|COMPLETED|Post-Treatment Period: Wk16-23||66||
48105681|NCT03373383|100586911|FG002|COMPLETED|Post-Treatment Period: Wk16-23||68||
48105682|NCT03373383|100586912|FG003|COMPLETED|Post-Treatment Period: Wk16-23||61||
48105683|NCT03373383|100586913|FG004|COMPLETED|Post-Treatment Period: Wk16-23||58||
48105684|NCT03373383|100586909|FG000|NOT COMPLETED|Post-Treatment Period: Wk16-23||1||
48105685|NCT03373383|100586910|FG001|NOT COMPLETED|Post-Treatment Period: Wk16-23||0||
48105686|NCT03373383|100586911|FG002|NOT COMPLETED|Post-Treatment Period: Wk16-23||0||
48105687|NCT03373383|100586912|FG003|NOT COMPLETED|Post-Treatment Period: Wk16-23||0||
48105688|NCT03373383|100586913|FG004|NOT COMPLETED|Post-Treatment Period: Wk16-23||0||
48105689|NCT01740596|100586914|FG000|STARTED|Overall Study||19||16
48105690|NCT01740596|100586915|FG001|STARTED|Overall Study||19||0
48105691|NCT01740596|100586914|FG000|COMPLETED|Overall Study||0||0
48105692|NCT01740596|100586915|FG001|COMPLETED|Overall Study||0||0
48105693|NCT01740596|100586914|FG000|NOT COMPLETED|Overall Study||19||16
48105694|NCT01740596|100586915|FG001|NOT COMPLETED|Overall Study||19||0
48105695|NCT03394768|100586916|FG000|STARTED|Overall Study||26||
48105696|NCT03394768|100586916|FG000|COMPLETED|Overall Study||26||
48105697|NCT03394768|100586916|FG000|NOT COMPLETED|Overall Study||0||
48105698|NCT02357147|100586917|FG000|STARTED|Combination Treatment Phase||52||
48267166|NCT02601209|100978472|FG004|STARTED|Optional Crossover (Up to 2 Months)||0||
48267167|NCT02601209|100978473|FG005|STARTED|Optional Crossover (Up to 2 Months)||0||
48267168|NCT02601209|100978474|FG006|STARTED|Optional Crossover (Up to 2 Months)||0||
48267169|NCT02601209|100978475|FG007|STARTED|Optional Crossover (Up to 2 Months)||6||
48267170|NCT02601209|100978476|FG008|STARTED|Optional Crossover (Up to 2 Months)||43||
48267171|NCT02601209|100978468|FG000|COMPLETED|Optional Crossover (Up to 2 Months)||0||
48267172|NCT02601209|100978469|FG001|COMPLETED|Optional Crossover (Up to 2 Months)||0||
48105699|NCT02357147|100586918|FG001|STARTED|Combination Treatment Phase||56||
48105700|NCT02357147|100586917|FG000|Treated|Combination Treatment Phase||52||
48105701|NCT02357147|100586918|FG001|Treated|Combination Treatment Phase||54||
48105702|NCT02357147|100586917|FG000|COMPLETED|Combination Treatment Phase||26||
48105703|NCT02357147|100586918|FG001|COMPLETED|Combination Treatment Phase||29||
48105704|NCT02357147|100586917|FG000|NOT COMPLETED|Combination Treatment Phase||26||
48105705|NCT02357147|100586918|FG001|NOT COMPLETED|Combination Treatment Phase||27||
48105706|NCT02357147|100586917|FG000|STARTED|Maintenance Treatment Phase||26||
48105707|NCT02357147|100586918|FG001|STARTED|Maintenance Treatment Phase||29||
48105708|NCT02357147|100586917|FG000|Treated|Maintenance Treatment Phase||25||
48105709|NCT02357147|100586918|FG001|Treated|Maintenance Treatment Phase||29||
48105710|NCT02357147|100586917|FG000|COMPLETED|Maintenance Treatment Phase||0||
48105711|NCT02357147|100586918|FG001|COMPLETED|Maintenance Treatment Phase||0||
48105712|NCT02357147|100586917|FG000|NOT COMPLETED|Maintenance Treatment Phase||26||
48105713|NCT02357147|100586918|FG001|NOT COMPLETED|Maintenance Treatment Phase||29||
48105714|NCT02558790|100586919|FG000|STARTED|Overall Study||20||
48105715|NCT02558790|100586919|FG000|Treated|Overall Study||15||
48105716|NCT02558790|100586919|FG000|COMPLETED|Overall Study||13||
48105717|NCT02558790|100586919|FG000|NOT COMPLETED|Overall Study||7||
48105718|NCT02552316|100586920|FG000|STARTED|Overall Study||34||
48105719|NCT02552316|100586920|FG000|COMPLETED|Overall Study||32||
48105720|NCT02552316|100586920|FG000|NOT COMPLETED|Overall Study||2||
48267173|NCT02601209|100978470|FG002|COMPLETED|Optional Crossover (Up to 2 Months)||0||
48105721|NCT04372602|100586921|FG000|STARTED|Overall Study||15||
48105722|NCT04372602|100586922|FG001|STARTED|Overall Study||13||
48105723|NCT04372602|100586921|FG000|COMPLETED|Overall Study||14||
48105724|NCT04372602|100586922|FG001|COMPLETED|Overall Study||10||
48105725|NCT04372602|100586921|FG000|NOT COMPLETED|Overall Study||1||
48105726|NCT04372602|100586922|FG001|NOT COMPLETED|Overall Study||3||
48105727|NCT00868712|100586923|FG000|STARTED|Overall Study||31||
48105728|NCT00868712|100586924|FG001|STARTED|Overall Study||11||
48105729|NCT00868712|100586925|FG002|STARTED|Overall Study||28||
48105730|NCT00868712|100586923|FG000|COMPLETED|Overall Study||31||
48105731|NCT00868712|100586924|FG001|COMPLETED|Overall Study||11||
48105732|NCT00868712|100586925|FG002|COMPLETED|Overall Study||28||
48105733|NCT00868712|100586923|FG000|NOT COMPLETED|Overall Study||0||
48105734|NCT00868712|100586924|FG001|NOT COMPLETED|Overall Study||0||
48105735|NCT00868712|100586925|FG002|NOT COMPLETED|Overall Study||0||
48105736|NCT01467999|100586926|FG000|STARTED|Overall Study||22||
48105737|NCT01467999|100586926|FG000|COMPLETED|Overall Study||9||
48105738|NCT01467999|100586926|FG000|NOT COMPLETED|Overall Study||13||
48105739|NCT04916795|100586927|FG000|STARTED|Overall Study||9||
48105740|NCT04916795|100586928|FG001|STARTED|Overall Study||9||
48105741|NCT04916795|100586927|FG000|COMPLETED|Overall Study||9||
48105742|NCT04916795|100586928|FG001|COMPLETED|Overall Study||9||
48105743|NCT04916795|100586927|FG000|NOT COMPLETED|Overall Study||0||
48105744|NCT04916795|100586928|FG001|NOT COMPLETED|Overall Study||0||
48105745|NCT02286193|100586929|FG000|STARTED|Overall Study||622||
48105746|NCT02286193|100586929|FG000|COMPLETED|Overall Study||418||
48105747|NCT02286193|100586929|FG000|NOT COMPLETED|Overall Study||204||
48105748|NCT00189228|100586930|FG000|STARTED|Overall Study||18||
48105749|NCT00189228|100586930|FG000|COMPLETED|Overall Study||18||
48105750|NCT00189228|100586930|FG000|NOT COMPLETED|Overall Study||0||
48105751|NCT02596854|100586931|FG000|STARTED|Overall Study||117||
48105752|NCT02596854|100586931|FG000|COMPLETED|Overall Study||109||
48105753|NCT02596854|100586931|FG000|NOT COMPLETED|Overall Study||8||
48105754|NCT00543764|100586932|FG000|STARTED|Overall Study||100||
48105755|NCT00543764|100586933|FG001|STARTED|Overall Study||50||
48105756|NCT00543764|100586932|FG000|COMPLETED|Overall Study||100||
48105757|NCT00543764|100586933|FG001|COMPLETED|Overall Study||50||
48105758|NCT00543764|100586932|FG000|NOT COMPLETED|Overall Study||0||
48105759|NCT00543764|100586933|FG001|NOT COMPLETED|Overall Study||0||
48105760|NCT00066066|100586934|FG000|STARTED|Overall Study||27||
48105761|NCT00066066|100586935|FG001|STARTED|Overall Study||22||
48105762|NCT00066066|100586936|FG002|STARTED|Overall Study||30||
48105763|NCT00066066|100586937|FG003|STARTED|Overall Study||20||
48105764|NCT00066066|100586938|FG004|STARTED|Overall Study||27||
48105765|NCT00066066|100586939|FG005|STARTED|Overall Study||20||
48105766|NCT00066066|100586934|FG000|Baseline|Overall Study||27||
48105767|NCT00066066|100586935|FG001|Baseline|Overall Study||22||
48105768|NCT00066066|100586936|FG002|Baseline|Overall Study||30||
48105769|NCT00066066|100586937|FG003|Baseline|Overall Study||20||
48105770|NCT00066066|100586938|FG004|Baseline|Overall Study||27||
48105771|NCT00066066|100586939|FG005|Baseline|Overall Study||20||
48105772|NCT00066066|100586934|FG000|3 Month|Overall Study||21||
48105773|NCT00066066|100586935|FG001|3 Month|Overall Study||17||
48105774|NCT00066066|100586936|FG002|3 Month|Overall Study||23||
48105775|NCT00066066|100586937|FG003|3 Month|Overall Study||16||
48105776|NCT00066066|100586938|FG004|3 Month|Overall Study||22||
48105777|NCT00066066|100586939|FG005|3 Month|Overall Study||15||
48105778|NCT00066066|100586934|FG000|6 Month|Overall Study||19||
48105779|NCT00066066|100586935|FG001|6 Month|Overall Study||13||
48105780|NCT00066066|100586936|FG002|6 Month|Overall Study||23||
48105781|NCT00066066|100586937|FG003|6 Month|Overall Study||13||
48105782|NCT00066066|100586938|FG004|6 Month|Overall Study||21||
48105783|NCT00066066|100586939|FG005|6 Month|Overall Study||14||
48105784|NCT00066066|100586934|FG000|12 Month|Overall Study||18||
48267174|NCT02601209|100978471|FG003|COMPLETED|Optional Crossover (Up to 2 Months)||0||
48267175|NCT02601209|100978472|FG004|COMPLETED|Optional Crossover (Up to 2 Months)||0||
48692365|NCT01670279|102029148|FG001|COMPLETED|Overall Study||5||
48692366|NCT01670279|102029149|FG002|COMPLETED|Overall Study||0||
48692367|NCT01670279|102029150|FG003|COMPLETED|Overall Study||4||
48692368|NCT01670279|102029147|FG000|NOT COMPLETED|Overall Study||0||
48105785|NCT00066066|100586935|FG001|12 Month|Overall Study||11||
48105786|NCT00066066|100586936|FG002|12 Month|Overall Study||21||
48105787|NCT00066066|100586937|FG003|12 Month|Overall Study||11||
48105788|NCT00066066|100586938|FG004|12 Month|Overall Study||19||
48105789|NCT00066066|100586939|FG005|12 Month|Overall Study||9||
48105790|NCT00066066|100586934|FG000|COMPLETED|Overall Study||21||
48692369|NCT01670279|102029148|FG001|NOT COMPLETED|Overall Study||2||
48692370|NCT01670279|102029149|FG002|NOT COMPLETED|Overall Study||0||
48692371|NCT01670279|102029150|FG003|NOT COMPLETED|Overall Study||1||
48692372|NCT02880228|102029151|FG000|STARTED|Overall Study||11||
48692373|NCT02880228|102029151|FG000|COMPLETED|Overall Study||11||
48692374|NCT02880228|102029151|FG000|NOT COMPLETED|Overall Study||0||
48692375|NCT00517010|102029152|FG000|STARTED|Overall Study||6||
48692376|NCT00517010|102029152|FG000|COMPLETED|Overall Study||5||
48692377|NCT00517010|102029152|FG000|NOT COMPLETED|Overall Study||1||
48692378|NCT02520388|102029153|FG000|STARTED|Overall Study||82||
48692379|NCT02520388|102029154|FG001|STARTED|Overall Study||81||
48692380|NCT02520388|102029153|FG000|Treated|Overall Study||81||
48692381|NCT02520388|102029154|FG001|Treated|Overall Study||80||
48692382|NCT02520388|102029153|FG000|COMPLETED|Overall Study||73||
48692383|NCT02520388|102029154|FG001|COMPLETED|Overall Study||65||
48692384|NCT02520388|102029153|FG000|NOT COMPLETED|Overall Study||9||
48692385|NCT02520388|102029154|FG001|NOT COMPLETED|Overall Study||16||
48692386|NCT00720356|102029155|FG000|STARTED|Registration to Study||115||
48692387|NCT00720356|102029155|FG000|Completed Registration Step 1|Registration to Study||115||
48692388|NCT00720356|102029155|FG000|Completed Registration Step 2|Registration to Study||48||
48692389|NCT00720356|102029155|FG000|COMPLETED|Registration to Study||48||
48692390|NCT00720356|102029155|FG000|NOT COMPLETED|Registration to Study||67||
48692391|NCT00720356|102029155|FG000|STARTED|Reached 1st Response/2 Cycles||48||
48692392|NCT00720356|102029155|FG000|COMPLETED|Reached 1st Response/2 Cycles||46||
48692393|NCT00720356|102029155|FG000|NOT COMPLETED|Reached 1st Response/2 Cycles||2||
48692394|NCT00720356|102029155|FG000|STARTED|Went on to be Treated Cycle 3||46||
48692395|NCT00720356|102029155|FG000|COMPLETED|Went on to be Treated Cycle 3||44||
48692396|NCT00720356|102029155|FG000|NOT COMPLETED|Went on to be Treated Cycle 3||2||
48692397|NCT00720356|102029155|FG000|STARTED|Follow up Until Death||48||
48692398|NCT00720356|102029155|FG000|COMPLETED|Follow up Until Death||43||
48692399|NCT00720356|102029155|FG000|NOT COMPLETED|Follow up Until Death||5||
48692400|NCT01864148|102029156|FG000|STARTED|Overall Study||93||
48692401|NCT01864148|102029157|FG001|STARTED|Overall Study||45||
48692402|NCT01864148|102029158|FG002|STARTED|Overall Study||95||
48692403|NCT01864148|102029159|FG003|STARTED|Overall Study||94||
48692404|NCT01864148|102029160|FG004|STARTED|Overall Study||92||
48692405|NCT01864148|102029156|FG000|Randomized and Dosed|Overall Study||93||
48105791|NCT00066066|100586935|FG001|COMPLETED|Overall Study||18||
48105792|NCT00066066|100586936|FG002|COMPLETED|Overall Study||23||
48105793|NCT00066066|100586937|FG003|COMPLETED|Overall Study||16||
48105794|NCT00066066|100586938|FG004|COMPLETED|Overall Study||24||
48105795|NCT00066066|100586939|FG005|COMPLETED|Overall Study||15||
48105796|NCT00066066|100586934|FG000|NOT COMPLETED|Overall Study||6||
48105797|NCT00066066|100586935|FG001|NOT COMPLETED|Overall Study||4||
48105798|NCT00066066|100586936|FG002|NOT COMPLETED|Overall Study||7||
48105799|NCT00066066|100586937|FG003|NOT COMPLETED|Overall Study||4||
48105800|NCT00066066|100586938|FG004|NOT COMPLETED|Overall Study||3||
48105801|NCT00066066|100586939|FG005|NOT COMPLETED|Overall Study||5||
48105802|NCT04656132|100586940|FG000|STARTED|Overall Study||63||
48105803|NCT04656132|100586940|FG000|COMPLETED|Overall Study||55||
48105804|NCT04656132|100586940|FG000|NOT COMPLETED|Overall Study||8||
48105805|NCT01446965|100586941|FG000|STARTED|Randominization||1554||
48267176|NCT02601209|100978473|FG005|COMPLETED|Optional Crossover (Up to 2 Months)||0||
48105806|NCT01446965|100586942|FG001|STARTED|Randominization||794||
48105807|NCT01446965|100586941|FG000|COMPLETED|Randominization||1524||
48267177|NCT02601209|100978474|FG006|COMPLETED|Optional Crossover (Up to 2 Months)||0||
48692406|NCT01864148|102029157|FG001|Randomized and Dosed|Overall Study||45||
48692407|NCT01864148|102029158|FG002|Randomized and Dosed|Overall Study||95||
48692408|NCT01864148|102029159|FG003|Randomized and Dosed|Overall Study||93||
48692409|NCT01864148|102029160|FG004|Randomized and Dosed|Overall Study||92||
48692410|NCT01864148|102029156|FG000|COMPLETED|Overall Study||73||
48692411|NCT01864148|102029157|FG001|COMPLETED|Overall Study||40||
48692412|NCT01864148|102029158|FG002|COMPLETED|Overall Study||84||
48692413|NCT01864148|102029159|FG003|COMPLETED|Overall Study||68||
48692414|NCT01864148|102029160|FG004|COMPLETED|Overall Study||69||
48692415|NCT01864148|102029156|FG000|NOT COMPLETED|Overall Study||20||
48692416|NCT01864148|102029157|FG001|NOT COMPLETED|Overall Study||5||
48105808|NCT01446965|100586942|FG001|COMPLETED|Randominization||778||
48105809|NCT01446965|100586941|FG000|NOT COMPLETED|Randominization||30||
48105810|NCT01446965|100586942|FG001|NOT COMPLETED|Randominization||16||
48105811|NCT01446965|100586941|FG000|STARTED|Participants Followed and Analyzed||1524||
48105812|NCT01446965|100586942|FG001|STARTED|Participants Followed and Analyzed||778||
48105813|NCT01446965|100586941|FG000|Received WCD|Participants Followed and Analyzed||1481||
48105814|NCT01446965|100586942|FG001|Received WCD|Participants Followed and Analyzed||0||
48105815|NCT01446965|100586941|FG000|Never Wore WCD|Participants Followed and Analyzed||43|n=43 participants in the treatment group withdrew consent prior to receiving WCD or refused WCD fitting|
48105816|NCT01446965|100586942|FG001|Never Wore WCD|Participants Followed and Analyzed||0|n=43 participants in the treatment group withdrew consent prior to receiving WCD or refused WCD fitting|
48105817|NCT01446965|100586941|FG000|Never Given WCD|Participants Followed and Analyzed||0||
48105818|NCT01446965|100586942|FG001|Never Given WCD|Participants Followed and Analyzed||758||
48105819|NCT01446965|100586941|FG000|Given WCD Out of Protocol|Participants Followed and Analyzed||0|n=20 participants in the control group received WCD by prescription outside of protocol by treating physician|
48105820|NCT01446965|100586942|FG001|Given WCD Out of Protocol|Participants Followed and Analyzed||20|n=20 participants in the control group received WCD by prescription outside of protocol by treating physician|
48267178|NCT02601209|100978475|FG007|COMPLETED|Optional Crossover (Up to 2 Months)||4||
48267179|NCT02601209|100978476|FG008|COMPLETED|Optional Crossover (Up to 2 Months)||26||
48267180|NCT02601209|100978468|FG000|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0||
48267181|NCT02601209|100978469|FG001|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0||
48267182|NCT02601209|100978470|FG002|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0||
48267183|NCT02601209|100978471|FG003|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0||
48267184|NCT02601209|100978472|FG004|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0||
48391933|NCT05567393|101287766|FG014|COMPLETED|Overall Study||6||
48391934|NCT05567393|101287767|FG015|COMPLETED|Overall Study||6||
48391935|NCT05567393|101287768|FG016|COMPLETED|Overall Study||6||
48391936|NCT05567393|101287769|FG017|COMPLETED|Overall Study||6||
48391937|NCT05567393|101287752|FG000|NOT COMPLETED|Overall Study||0||
48391938|NCT05567393|101287753|FG001|NOT COMPLETED|Overall Study||0||
48391939|NCT05567393|101287754|FG002|NOT COMPLETED|Overall Study||0||
48391940|NCT05567393|101287755|FG003|NOT COMPLETED|Overall Study||0||
48391941|NCT05567393|101287756|FG004|NOT COMPLETED|Overall Study||0||
48391942|NCT05567393|101287757|FG005|NOT COMPLETED|Overall Study||0||
48391943|NCT05567393|101287758|FG006|NOT COMPLETED|Overall Study||0||
48391944|NCT05567393|101287759|FG007|NOT COMPLETED|Overall Study||0||
48391945|NCT05567393|101287760|FG008|NOT COMPLETED|Overall Study||0||
48391946|NCT05567393|101287761|FG009|NOT COMPLETED|Overall Study||0||
48391947|NCT05567393|101287762|FG010|NOT COMPLETED|Overall Study||0||
48391948|NCT05567393|101287763|FG011|NOT COMPLETED|Overall Study||0||
48391949|NCT05567393|101287764|FG012|NOT COMPLETED|Overall Study||0||
48391950|NCT05567393|101287765|FG013|NOT COMPLETED|Overall Study||1||
48391951|NCT05567393|101287766|FG014|NOT COMPLETED|Overall Study||0||
48391952|NCT05567393|101287767|FG015|NOT COMPLETED|Overall Study||0||
48391953|NCT05567393|101287768|FG016|NOT COMPLETED|Overall Study||0||
48391954|NCT05567393|101287769|FG017|NOT COMPLETED|Overall Study||0||
48391955|NCT02871401|101287770|FG000|STARTED|Overall Study||20||
48391956|NCT02871401|101287771|FG001|STARTED|Overall Study||11||
48391957|NCT02871401|101287770|FG000|COMPLETED|Overall Study||19||
48391958|NCT02871401|101287771|FG001|COMPLETED|Overall Study||11||
48391959|NCT02871401|101287770|FG000|NOT COMPLETED|Overall Study||1||
48391960|NCT02871401|101287771|FG001|NOT COMPLETED|Overall Study||0||
48391961|NCT05351710|101287772|FG000|STARTED|Overall Study||43||
48105821|NCT01446965|100586941|FG000|COMPLETED|Participants Followed and Analyzed||1514||
48105822|NCT01446965|100586942|FG001|COMPLETED|Participants Followed and Analyzed||766||
48105823|NCT01446965|100586941|FG000|NOT COMPLETED|Participants Followed and Analyzed||10||
48105824|NCT01446965|100586942|FG001|NOT COMPLETED|Participants Followed and Analyzed||12||
48105825|NCT03161483|100586943|FG000|STARTED|Placebo Controlled Phase||83||
48267185|NCT02601209|100978473|FG005|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0||
48267186|NCT02601209|100978474|FG006|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0||
48391962|NCT05351710|101287773|FG001|STARTED|Overall Study||42||
48391963|NCT05351710|101287772|FG000|COMPLETED|Overall Study||35||
48391964|NCT05351710|101287773|FG001|COMPLETED|Overall Study||35||
48391965|NCT05351710|101287772|FG000|NOT COMPLETED|Overall Study||8||
48391966|NCT05351710|101287773|FG001|NOT COMPLETED|Overall Study||7||
48391967|NCT00618995|101287774|FG000|STARTED|Period 1||6||
48391968|NCT00618995|101287775|FG001|STARTED|Period 1||7||
48391969|NCT00618995|101287776|FG002|STARTED|Period 1||7||
48391970|NCT00618995|101287777|FG003|STARTED|Period 1||6||
48391971|NCT00618995|101287774|FG000|COMPLETED|Period 1||6||
48391972|NCT00618995|101287775|FG001|COMPLETED|Period 1||6||
48391973|NCT00618995|101287776|FG002|COMPLETED|Period 1||5||
48391974|NCT00618995|101287777|FG003|COMPLETED|Period 1||6||
48391975|NCT00618995|101287774|FG000|NOT COMPLETED|Period 1||0||
48391976|NCT00618995|101287775|FG001|NOT COMPLETED|Period 1||1||
48391977|NCT00618995|101287776|FG002|NOT COMPLETED|Period 1||2||
48391978|NCT00618995|101287777|FG003|NOT COMPLETED|Period 1||0||
48391979|NCT00618995|101287774|FG000|STARTED|Period 2||6||
48391980|NCT00618995|101287775|FG001|STARTED|Period 2||6||
48391981|NCT00618995|101287776|FG002|STARTED|Period 2||5||
48391982|NCT00618995|101287777|FG003|STARTED|Period 2||6||
48105826|NCT03161483|100586944|FG001|STARTED|Placebo Controlled Phase||82||
48105827|NCT03161483|100586945|FG002|STARTED|Placebo Controlled Phase||42||
48105828|NCT03161483|100586946|FG003|STARTED|Placebo Controlled Phase||82||
48105829|NCT03161483|100586943|FG000|COMPLETED|Placebo Controlled Phase||83||
48105830|NCT03161483|100586944|FG001|COMPLETED|Placebo Controlled Phase||81||
48105831|NCT03161483|100586945|FG002|COMPLETED|Placebo Controlled Phase||42||
48105832|NCT03161483|100586946|FG003|COMPLETED|Placebo Controlled Phase||82||
48105833|NCT03161483|100586943|FG000|NOT COMPLETED|Placebo Controlled Phase||0||
48105834|NCT03161483|100586944|FG001|NOT COMPLETED|Placebo Controlled Phase||1||
48267187|NCT02601209|100978475|FG007|NOT COMPLETED|Optional Crossover (Up to 2 Months)||2||
48267188|NCT02601209|100978476|FG008|NOT COMPLETED|Optional Crossover (Up to 2 Months)||17||
48267189|NCT01001390|100978477|FG000|STARTED|Overall Study||2||
48267190|NCT01001390|100978478|FG001|STARTED|Overall Study||0||
48267191|NCT01001390|100978477|FG000|COMPLETED|Overall Study||0||
48105835|NCT03161483|100586945|FG002|NOT COMPLETED|Placebo Controlled Phase||0||
48105836|NCT03161483|100586946|FG003|NOT COMPLETED|Placebo Controlled Phase||0||
48105837|NCT03161483|100586943|FG000|STARTED|Treatment Period||83|Started = Entered placebo-controlled phase|
48105838|NCT03161483|100586944|FG001|STARTED|Treatment Period||81|Started = Entered placebo-controlled phase|
48105839|NCT03161483|100586945|FG002|STARTED|Treatment Period||42|Started = Entered placebo-controlled phase|
48267192|NCT01001390|100978478|FG001|COMPLETED|Overall Study||0||
48391983|NCT00618995|101287774|FG000|COMPLETED|Period 2||6||
48391984|NCT00618995|101287775|FG001|COMPLETED|Period 2||6||
48391985|NCT00618995|101287776|FG002|COMPLETED|Period 2||4||
48391986|NCT00618995|101287777|FG003|COMPLETED|Period 2||6||
48391987|NCT00618995|101287774|FG000|NOT COMPLETED|Period 2||0||
48391988|NCT00618995|101287775|FG001|NOT COMPLETED|Period 2||0||
48391989|NCT00618995|101287776|FG002|NOT COMPLETED|Period 2||1||
48391990|NCT00618995|101287777|FG003|NOT COMPLETED|Period 2||0||
48551887|NCT01514461|101683277|FG000|COMPLETED|Overall Study||10||
48267193|NCT01001390|100978477|FG000|NOT COMPLETED|Overall Study||2||
48267194|NCT01001390|100978478|FG001|NOT COMPLETED|Overall Study||0||
48391991|NCT00618995|101287774|FG000|STARTED|Period 3||6||
48391992|NCT00618995|101287775|FG001|STARTED|Period 3||6||
48267195|NCT01976273|100978479|FG000|STARTED|Overall Study||10||
48267196|NCT01976273|100978480|FG001|STARTED|Overall Study||10||
48267197|NCT01976273|100978479|FG000|COMPLETED|Overall Study||9||
48267198|NCT01976273|100978480|FG001|COMPLETED|Overall Study||9||
48267199|NCT01976273|100978479|FG000|NOT COMPLETED|Overall Study||1||
48391993|NCT00618995|101287776|FG002|STARTED|Period 3||4||
48391994|NCT00618995|101287777|FG003|STARTED|Period 3||6||
48391995|NCT00618995|101287774|FG000|COMPLETED|Period 3||6||
48391996|NCT00618995|101287775|FG001|COMPLETED|Period 3||6||
48391997|NCT00618995|101287776|FG002|COMPLETED|Period 3||4||
48391998|NCT00618995|101287777|FG003|COMPLETED|Period 3||6||
48391999|NCT00618995|101287774|FG000|NOT COMPLETED|Period 3||0||
48392000|NCT00618995|101287775|FG001|NOT COMPLETED|Period 3||0||
48105840|NCT03161483|100586946|FG003|STARTED|Treatment Period||82|Started = Entered placebo-controlled phase|
48105841|NCT03161483|100586943|FG000|Going to 0.30mg After Week 24|Treatment Period||36|After Week 24|
48105842|NCT03161483|100586944|FG001|Going to 0.30mg After Week 24|Treatment Period||0|After Week 24|
48105843|NCT03161483|100586945|FG002|Going to 0.30mg After Week 24|Treatment Period||0|After Week 24|
48105844|NCT03161483|100586946|FG003|Going to 0.30mg After Week 24|Treatment Period||0|After Week 24|
48105845|NCT03161483|100586943|FG000|Going to 0.45mg After Week 24|Treatment Period||36||
48392001|NCT00618995|101287776|FG002|NOT COMPLETED|Period 3||0||
48392002|NCT00618995|101287777|FG003|NOT COMPLETED|Period 3||0||
48392003|NCT00618995|101287774|FG000|STARTED|Period 4||6||
48392004|NCT00618995|101287775|FG001|STARTED|Period 4||6||
48392005|NCT00618995|101287776|FG002|STARTED|Period 4||4||
48105846|NCT03161483|100586944|FG001|Going to 0.45mg After Week 24|Treatment Period||0||
48105847|NCT03161483|100586945|FG002|Going to 0.45mg After Week 24|Treatment Period||0||
48105848|NCT03161483|100586946|FG003|Going to 0.45mg After Week 24|Treatment Period||0||
48105849|NCT03161483|100586943|FG000|Staying on Placebo After Week 24|Treatment Period||11||
48105850|NCT03161483|100586944|FG001|Staying on Placebo After Week 24|Treatment Period||0||
48105851|NCT03161483|100586945|FG002|Staying on Placebo After Week 24|Treatment Period||0||
48105852|NCT03161483|100586946|FG003|Staying on Placebo After Week 24|Treatment Period||0||
48105853|NCT03161483|100586943|FG000|COMPLETED|Treatment Period||73|Completed = Finished placebo-controlled phase|
48267200|NCT01976273|100978480|FG001|NOT COMPLETED|Overall Study||1||
48267201|NCT03721172|100978481|FG000|STARTED|Placebo-controlled Phase||298||
48267202|NCT03721172|100978482|FG001|STARTED|Placebo-controlled Phase||297||
48267203|NCT03721172|100978483|FG002|STARTED|Placebo-controlled Phase||0||
48392006|NCT00618995|101287777|FG003|STARTED|Period 4||6||
48392007|NCT00618995|101287774|FG000|COMPLETED|Period 4||5||
48392008|NCT00618995|101287775|FG001|COMPLETED|Period 4||6||
48267204|NCT03721172|100978481|FG000|Received at Least 1 Dose of Treatment|Placebo-controlled Phase||297||
48392009|NCT00618995|101287776|FG002|COMPLETED|Period 4||4||
48267205|NCT03721172|100978482|FG001|Received at Least 1 Dose of Treatment|Placebo-controlled Phase||297||
48267206|NCT03721172|100978483|FG002|Received at Least 1 Dose of Treatment|Placebo-controlled Phase||0||
48267207|NCT03721172|100978481|FG000|COMPLETED|Placebo-controlled Phase||246||
48392010|NCT00618995|101287777|FG003|COMPLETED|Period 4||6||
48267208|NCT03721172|100978482|FG001|COMPLETED|Placebo-controlled Phase||258||
48267209|NCT03721172|100978483|FG002|COMPLETED|Placebo-controlled Phase||0||
48267210|NCT03721172|100978481|FG000|NOT COMPLETED|Placebo-controlled Phase||52||
48267211|NCT03721172|100978482|FG001|NOT COMPLETED|Placebo-controlled Phase||39||
48267212|NCT03721172|100978483|FG002|NOT COMPLETED|Placebo-controlled Phase||0||
48267213|NCT03721172|100978481|FG000|STARTED|Apremilast Extension Phase||0||
48267214|NCT03721172|100978482|FG001|STARTED|Apremilast Extension Phase||0||
48267215|NCT03721172|100978483|FG002|STARTED|Apremilast Extension Phase||503||
48267216|NCT03721172|100978481|FG000|Received at Least 1 Dose|Apremilast Extension Phase||0||
48267217|NCT03721172|100978482|FG001|Received at Least 1 Dose|Apremilast Extension Phase||0||
48267218|NCT03721172|100978483|FG002|Received at Least 1 Dose|Apremilast Extension Phase||503||
48267219|NCT03721172|100978481|FG000|COMPLETED|Apremilast Extension Phase||0||
48267220|NCT03721172|100978482|FG001|COMPLETED|Apremilast Extension Phase||0||
48551888|NCT01514461|101683278|FG001|COMPLETED|Overall Study||12||
48551889|NCT01514461|101683279|FG002|COMPLETED|Overall Study||11||
48551890|NCT01514461|101683277|FG000|NOT COMPLETED|Overall Study||5||
48267221|NCT03721172|100978483|FG002|COMPLETED|Apremilast Extension Phase||437||
48267222|NCT03721172|100978481|FG000|NOT COMPLETED|Apremilast Extension Phase||0||
48267223|NCT03721172|100978482|FG001|NOT COMPLETED|Apremilast Extension Phase||0||
48267224|NCT03721172|100978483|FG002|NOT COMPLETED|Apremilast Extension Phase||66||
48267225|NCT02402322|100978484|FG000|STARTED|Pretreatment||27||
48551891|NCT01514461|101683278|FG001|NOT COMPLETED|Overall Study||3||
48551892|NCT01514461|101683279|FG002|NOT COMPLETED|Overall Study||4||
48551893|NCT02543944|101683280|FG000|STARTED|Phase 1: GBN/BUP Induction and BUP Detox||60||
48551894|NCT02543944|101683281|FG001|STARTED|Phase 1: GBN/BUP Induction and BUP Detox||57||
48551895|NCT02543944|101683280|FG000|COMPLETED|Phase 1: GBN/BUP Induction and BUP Detox||41||
48551896|NCT02543944|101683281|FG001|COMPLETED|Phase 1: GBN/BUP Induction and BUP Detox||34||
48551897|NCT02543944|101683280|FG000|NOT COMPLETED|Phase 1: GBN/BUP Induction and BUP Detox||19||
48551898|NCT02543944|101683281|FG001|NOT COMPLETED|Phase 1: GBN/BUP Induction and BUP Detox||23||
48551899|NCT02543944|101683280|FG000|STARTED|Phase 2: Transition From BUP to XR-NTX||33||
48551900|NCT02543944|101683281|FG001|STARTED|Phase 2: Transition From BUP to XR-NTX||29||
48551901|NCT02543944|101683280|FG000|COMPLETED|Phase 2: Transition From BUP to XR-NTX||12||
48551902|NCT02543944|101683281|FG001|COMPLETED|Phase 2: Transition From BUP to XR-NTX||12||
48551903|NCT02543944|101683280|FG000|NOT COMPLETED|Phase 2: Transition From BUP to XR-NTX||21||
48551904|NCT02543944|101683281|FG001|NOT COMPLETED|Phase 2: Transition From BUP to XR-NTX||17||
48551905|NCT02543944|101683280|FG000|STARTED|Phase 3: XR-NTX Maintenance||12||
48551906|NCT02543944|101683281|FG001|STARTED|Phase 3: XR-NTX Maintenance||12||
48551907|NCT02543944|101683280|FG000|COMPLETED|Phase 3: XR-NTX Maintenance||7||
48551908|NCT02543944|101683281|FG001|COMPLETED|Phase 3: XR-NTX Maintenance||3||
48551909|NCT02543944|101683280|FG000|NOT COMPLETED|Phase 3: XR-NTX Maintenance||5||
48267226|NCT02402322|100978485|FG001|STARTED|Pretreatment||25||
48267227|NCT02402322|100978486|FG002|STARTED|Pretreatment||25||
48267228|NCT02402322|100978484|FG000|Posttreatment Measures|Pretreatment||24||
48267229|NCT02402322|100978485|FG001|Posttreatment Measures|Pretreatment||24||
48267230|NCT02402322|100978486|FG002|Posttreatment Measures|Pretreatment||24||
48267231|NCT02402322|100978484|FG000|COMPLETED|Pretreatment||24||
48267232|NCT02402322|100978485|FG001|COMPLETED|Pretreatment||24||
48551910|NCT02543944|101683281|FG001|NOT COMPLETED|Phase 3: XR-NTX Maintenance||9||
48551911|NCT01277211|101683282|FG000|STARTED|Overall Study||738||
48551912|NCT01277211|101683283|FG001|STARTED|Overall Study||245||
48551913|NCT01277211|101683282|FG000|Treated|Overall Study||714||
48551914|NCT01277211|101683283|FG001|Treated|Overall Study||232||
48551915|NCT01277211|101683282|FG000|COMPLETED|Overall Study||588||
48551916|NCT01277211|101683283|FG001|COMPLETED|Overall Study||182||
48551917|NCT01277211|101683282|FG000|NOT COMPLETED|Overall Study||150||
48551918|NCT01277211|101683283|FG001|NOT COMPLETED|Overall Study||63||
48551919|NCT02633787|101683284|FG000|STARTED|Overall Study||110||
48551920|NCT02633787|101683284|FG000|COMPLETED|Overall Study||109||
48551921|NCT02633787|101683284|FG000|NOT COMPLETED|Overall Study||1||
48267233|NCT02402322|100978486|FG002|COMPLETED|Pretreatment||24||
48267234|NCT02402322|100978484|FG000|NOT COMPLETED|Pretreatment||3||
48267235|NCT02402322|100978485|FG001|NOT COMPLETED|Pretreatment||1||
48267236|NCT02402322|100978486|FG002|NOT COMPLETED|Pretreatment||1||
48267237|NCT02402322|100978484|FG000|STARTED|Follow-up||24||
48267238|NCT02402322|100978485|FG001|STARTED|Follow-up||24||
48267239|NCT02402322|100978486|FG002|STARTED|Follow-up||24||
48267240|NCT02402322|100978484|FG000|COMPLETED|Follow-up||18||
48267241|NCT02402322|100978485|FG001|COMPLETED|Follow-up||21||
48267242|NCT02402322|100978486|FG002|COMPLETED|Follow-up||0||
48267243|NCT02402322|100978484|FG000|NOT COMPLETED|Follow-up||6||
48267244|NCT02402322|100978485|FG001|NOT COMPLETED|Follow-up||3||
48267245|NCT02402322|100978486|FG002|NOT COMPLETED|Follow-up||24||
48267246|NCT04829747|100978487|FG000|STARTED|Overall Study||3||
48267247|NCT04829747|100978487|FG000|COMPLETED|Overall Study||2||
48267248|NCT04829747|100978487|FG000|NOT COMPLETED|Overall Study||1||
48267249|NCT01432626|100978488|FG000|STARTED|Overall Study||10||
48551922|NCT00789035|101683285|FG000|STARTED|Overall Study||82||
48551923|NCT00789035|101683286|FG001|STARTED|Overall Study||81||
48551924|NCT00789035|101683287|FG002|STARTED|Overall Study||81||
48551925|NCT00789035|101683288|FG003|STARTED|Overall Study||82||
48551926|NCT00789035|101683289|FG004|STARTED|Overall Study||80||
48551927|NCT00789035|101683285|FG000|COMPLETED|Overall Study||76||
48551928|NCT00789035|101683286|FG001|COMPLETED|Overall Study||74||
48551929|NCT00789035|101683287|FG002|COMPLETED|Overall Study||80||
48551930|NCT00789035|101683288|FG003|COMPLETED|Overall Study||81||
48692417|NCT01864148|102029158|FG002|NOT COMPLETED|Overall Study||11||
48692418|NCT01864148|102029159|FG003|NOT COMPLETED|Overall Study||26||
48692419|NCT01864148|102029160|FG004|NOT COMPLETED|Overall Study||23||
48267250|NCT01432626|100978488|FG000|COMPLETED|Overall Study||3||
48267251|NCT01432626|100978488|FG000|NOT COMPLETED|Overall Study||7||
48267252|NCT03332784|100978489|FG000|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2||
48267253|NCT03332784|100978490|FG001|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2||
48551931|NCT00789035|101683289|FG004|COMPLETED|Overall Study||74||
48551932|NCT00789035|101683285|FG000|NOT COMPLETED|Overall Study||6||
48551933|NCT00789035|101683286|FG001|NOT COMPLETED|Overall Study||7||
48551934|NCT00789035|101683287|FG002|NOT COMPLETED|Overall Study||1||
48551935|NCT00789035|101683288|FG003|NOT COMPLETED|Overall Study||1||
48267254|NCT03332784|100978491|FG002|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2||
48267255|NCT03332784|100978492|FG003|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2||
48267256|NCT03332784|100978493|FG004|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2||
48267257|NCT03332784|100978494|FG005|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2||
48267258|NCT03332784|100978495|FG006|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2||
48267259|NCT03332784|100978496|FG007|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2||
48267260|NCT03332784|100978497|FG008|STARTED|Parts 1 and 2 - Period 1 (1 Day)||4||
48267261|NCT03332784|100978498|FG009|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6||
48267262|NCT03332784|100978499|FG010|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6||
48267263|NCT03332784|100978500|FG011|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2||
48267264|NCT03332784|100978501|FG012|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6||
48267265|NCT03332784|100978502|FG013|STARTED|Parts 1 and 2 - Period 1 (1 Day)||4||
48267266|NCT03332784|100978503|FG014|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2||
48267267|NCT03332784|100978504|FG015|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2||
48267268|NCT03332784|100978505|FG016|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2||
48267269|NCT03332784|100978506|FG017|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2||
48267270|NCT03332784|100978507|FG018|STARTED|Parts 1 and 2 - Period 1 (1 Day)||3||
48551936|NCT00789035|101683289|FG004|NOT COMPLETED|Overall Study||6||
48551937|NCT02430480|101683290|FG000|STARTED|Overall Study||39||
48551938|NCT02430480|101683290|FG000|COMPLETED|Overall Study||36||
48551939|NCT02430480|101683290|FG000|NOT COMPLETED|Overall Study||3||
48551940|NCT03123068|101683291|FG000|STARTED|Overall Study||22||
48267271|NCT03332784|100978508|FG019|STARTED|Parts 1 and 2 - Period 1 (1 Day)||3||
48551941|NCT03123068|101683292|FG001|STARTED|Overall Study||20||
48551942|NCT03123068|101683291|FG000|COMPLETED|Overall Study||22||
48551943|NCT03123068|101683292|FG001|COMPLETED|Overall Study||20||
48267272|NCT03332784|100978489|FG000|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2||
48267273|NCT03332784|100978490|FG001|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1||
48267274|NCT03332784|100978491|FG002|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2||
48267275|NCT03332784|100978492|FG003|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2||
48267276|NCT03332784|100978493|FG004|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2||
48267277|NCT03332784|100978494|FG005|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2||
48267278|NCT03332784|100978495|FG006|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2||
48267279|NCT03332784|100978496|FG007|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2||
48551944|NCT03123068|101683291|FG000|NOT COMPLETED|Overall Study||0||
48551945|NCT03123068|101683292|FG001|NOT COMPLETED|Overall Study||0||
48551946|NCT01957397|101683293|FG000|STARTED|Baseline Own Product||13||
48551947|NCT01957397|101683294|FG001|STARTED|Baseline Own Product||13||
48551948|NCT01957397|101683293|FG000|COMPLETED|Baseline Own Product||13||
48551949|NCT01957397|101683294|FG001|COMPLETED|Baseline Own Product||13||
48267280|NCT03332784|100978497|FG008|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||4||
48267281|NCT03332784|100978498|FG009|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6||
48267282|NCT03332784|100978499|FG010|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6||
48267283|NCT03332784|100978500|FG011|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2||
48267284|NCT03332784|100978501|FG012|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6||
48267285|NCT03332784|100978502|FG013|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||4||
48551950|NCT01957397|101683293|FG000|NOT COMPLETED|Baseline Own Product||0||
48551951|NCT01957397|101683294|FG001|NOT COMPLETED|Baseline Own Product||0||
48692420|NCT01014936|102032554|FG000|STARTED|Overall Study||42||
48692421|NCT01014936|102032555|FG001|STARTED|Overall Study||45||
48692422|NCT01014936|102032556|FG002|STARTED|Overall Study||62||
48692423|NCT01014936|102032554|FG000|COMPLETED|Overall Study||42||
48692424|NCT01014936|102032555|FG001|COMPLETED|Overall Study||45||
48551952|NCT01957397|101683293|FG000|STARTED|Test Period 1||13||
48551953|NCT01957397|101683294|FG001|STARTED|Test Period 1||13||
48551954|NCT01957397|101683293|FG000|COMPLETED|Test Period 1||11||
48551955|NCT01957397|101683294|FG001|COMPLETED|Test Period 1||12||
48551956|NCT01957397|101683293|FG000|NOT COMPLETED|Test Period 1||2||
48551957|NCT01957397|101683294|FG001|NOT COMPLETED|Test Period 1||1||
48551958|NCT01957397|101683293|FG000|STARTED|Test Period 2||11||
48551959|NCT01957397|101683294|FG001|STARTED|Test Period 2||12||
48551960|NCT01957397|101683293|FG000|COMPLETED|Test Period 2||11||
48551961|NCT01957397|101683294|FG001|COMPLETED|Test Period 2||11||
48551962|NCT01957397|101683293|FG000|NOT COMPLETED|Test Period 2||0||
48551963|NCT01957397|101683294|FG001|NOT COMPLETED|Test Period 2||1||
48551964|NCT01957397|101683293|FG000|STARTED|Test Period 3||11||
48551965|NCT01957397|101683294|FG001|STARTED|Test Period 3||11||
48551966|NCT01957397|101683293|FG000|COMPLETED|Test Period 3||9||
48551967|NCT01957397|101683294|FG001|COMPLETED|Test Period 3||9||
48551968|NCT01957397|101683293|FG000|NOT COMPLETED|Test Period 3||2||
48551969|NCT01957397|101683294|FG001|NOT COMPLETED|Test Period 3||2||
48551970|NCT02153983|101683295|FG000|STARTED|Overall Study||19||
48551971|NCT02153983|101683296|FG001|STARTED|Overall Study||21||
48551972|NCT02153983|101683297|FG002|STARTED|Overall Study||4||
48551973|NCT02153983|101683298|FG003|STARTED|Overall Study||13||
48551974|NCT02153983|101683299|FG004|STARTED|Overall Study||19||
48551975|NCT02153983|101683300|FG005|STARTED|Overall Study||1||
48551976|NCT02153983|101683295|FG000|COMPLETED|Overall Study||19||
48551977|NCT02153983|101683296|FG001|COMPLETED|Overall Study||18||
48551978|NCT02153983|101683297|FG002|COMPLETED|Overall Study||2||
48551979|NCT02153983|101683298|FG003|COMPLETED|Overall Study||13||
48551980|NCT02153983|101683299|FG004|COMPLETED|Overall Study||19||
48551981|NCT02153983|101683300|FG005|COMPLETED|Overall Study||1||
48551982|NCT02153983|101683295|FG000|NOT COMPLETED|Overall Study||0||
48551983|NCT02153983|101683296|FG001|NOT COMPLETED|Overall Study||3||
48551984|NCT02153983|101683297|FG002|NOT COMPLETED|Overall Study||2||
48551985|NCT02153983|101683298|FG003|NOT COMPLETED|Overall Study||0||
48551986|NCT02153983|101683299|FG004|NOT COMPLETED|Overall Study||0||
48551987|NCT02153983|101683300|FG005|NOT COMPLETED|Overall Study||0||
48551988|NCT01074944|101683301|FG000|STARTED|Lead-in Period (up to 78 Weeks)||170||
48551989|NCT01074944|101683302|FG001|STARTED|Lead-in Period (up to 78 Weeks)||0||
48551990|NCT01074944|101683303|FG002|STARTED|Lead-in Period (up to 78 Weeks)||0||
48551991|NCT01074944|101683304|FG003|STARTED|Lead-in Period (up to 78 Weeks)||0||
48551992|NCT01074944|101683305|FG004|STARTED|Lead-in Period (up to 78 Weeks)||0||
48551993|NCT01074944|101683301|FG000|COMPLETED|Lead-in Period (up to 78 Weeks)||157||
48551994|NCT01074944|101683302|FG001|COMPLETED|Lead-in Period (up to 78 Weeks)||0||
48551995|NCT01074944|101683303|FG002|COMPLETED|Lead-in Period (up to 78 Weeks)||0||
48551996|NCT01074944|101683304|FG003|COMPLETED|Lead-in Period (up to 78 Weeks)||0||
48551997|NCT01074944|101683305|FG004|COMPLETED|Lead-in Period (up to 78 Weeks)||0||
48551998|NCT01074944|101683301|FG000|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||13||
48551999|NCT01074944|101683302|FG001|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0||
48552000|NCT01074944|101683303|FG002|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0||
48552001|NCT01074944|101683304|FG003|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0||
48552002|NCT01074944|101683305|FG004|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0||
48552003|NCT01074944|101683301|FG000|STARTED|Primary Analysis Period (up to 52 Weeks)||0||
48552004|NCT01074944|101683302|FG001|STARTED|Primary Analysis Period (up to 52 Weeks)||65||
48552005|NCT01074944|101683303|FG002|STARTED|Primary Analysis Period (up to 52 Weeks)||66||
48552006|NCT01074944|101683304|FG003|STARTED|Primary Analysis Period (up to 52 Weeks)||0||
48552007|NCT01074944|101683305|FG004|STARTED|Primary Analysis Period (up to 52 Weeks)||0||
48552008|NCT01074944|101683301|FG000|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0||
48552009|NCT01074944|101683302|FG001|COMPLETED|Primary Analysis Period (up to 52 Weeks)||54||
48552010|NCT01074944|101683303|FG002|COMPLETED|Primary Analysis Period (up to 52 Weeks)||60||
48552011|NCT01074944|101683304|FG003|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0||
48552012|NCT01074944|101683305|FG004|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0||
48552013|NCT01074944|101683301|FG000|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0||
48552014|NCT01074944|101683302|FG001|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||11||
48552015|NCT01074944|101683303|FG002|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||6||
48552016|NCT01074944|101683304|FG003|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0||
48552017|NCT01074944|101683305|FG004|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0||
48552018|NCT01074944|101683301|FG000|STARTED|Long Term Treatment||0||
48692425|NCT01014936|102032556|FG002|COMPLETED|Overall Study||62||
48552019|NCT01074944|101683302|FG001|STARTED|Long Term Treatment||0||
48552020|NCT01074944|101683303|FG002|STARTED|Long Term Treatment||0||
48552021|NCT01074944|101683304|FG003|STARTED|Long Term Treatment||121||
48552022|NCT01074944|101683305|FG004|STARTED|Long Term Treatment||0||
48552023|NCT01074944|101683301|FG000|COMPLETED|Long Term Treatment||0||
48552024|NCT01074944|101683302|FG001|COMPLETED|Long Term Treatment||0||
48552025|NCT01074944|101683303|FG002|COMPLETED|Long Term Treatment||0||
48552026|NCT01074944|101683304|FG003|COMPLETED|Long Term Treatment||95||
48552027|NCT01074944|101683305|FG004|COMPLETED|Long Term Treatment||0||
48552028|NCT01074944|101683301|FG000|NOT COMPLETED|Long Term Treatment||0||
48105854|NCT03161483|100586944|FG001|COMPLETED|Treatment Period||73|Completed = Finished placebo-controlled phase|
48105855|NCT03161483|100586945|FG002|COMPLETED|Treatment Period||39|Completed = Finished placebo-controlled phase|
48105856|NCT03161483|100586946|FG003|COMPLETED|Treatment Period||62|Completed = Finished placebo-controlled phase|
48105857|NCT03161483|100586943|FG000|NOT COMPLETED|Treatment Period||10||
48105858|NCT03161483|100586944|FG001|NOT COMPLETED|Treatment Period||8||
48105859|NCT03161483|100586945|FG002|NOT COMPLETED|Treatment Period||3||
48105860|NCT03161483|100586946|FG003|NOT COMPLETED|Treatment Period||20||
48105861|NCT01982253|100586947|FG000|STARTED|Overall Study||2||
48105862|NCT01982253|100586948|FG001|STARTED|Overall Study||4||
48105863|NCT01982253|100586949|FG002|STARTED|Overall Study||4||
48105864|NCT01982253|100586947|FG000|COMPLETED|Overall Study||0||
48105865|NCT01982253|100586948|FG001|COMPLETED|Overall Study||0||
48105866|NCT01982253|100586949|FG002|COMPLETED|Overall Study||0||
48552029|NCT01074944|101683302|FG001|NOT COMPLETED|Long Term Treatment||0||
48552030|NCT01074944|101683303|FG002|NOT COMPLETED|Long Term Treatment||0||
48552031|NCT01074944|101683304|FG003|NOT COMPLETED|Long Term Treatment||26||
48552032|NCT01074944|101683305|FG004|NOT COMPLETED|Long Term Treatment||0||
48552033|NCT01074944|101683301|FG000|STARTED|Extended Treatment (up to 42 Months)||0||
48552034|NCT01074944|101683302|FG001|STARTED|Extended Treatment (up to 42 Months)||0||
48552035|NCT01074944|101683303|FG002|STARTED|Extended Treatment (up to 42 Months)||0||
48552036|NCT01074944|101683304|FG003|STARTED|Extended Treatment (up to 42 Months)||0||
48552037|NCT01074944|101683305|FG004|STARTED|Extended Treatment (up to 42 Months)||25||
48552038|NCT01074944|101683301|FG000|COMPLETED|Extended Treatment (up to 42 Months)||0||
48552039|NCT01074944|101683302|FG001|COMPLETED|Extended Treatment (up to 42 Months)||0||
48552040|NCT01074944|101683303|FG002|COMPLETED|Extended Treatment (up to 42 Months)||0||
48552041|NCT01074944|101683304|FG003|COMPLETED|Extended Treatment (up to 42 Months)||0||
48552042|NCT01074944|101683305|FG004|COMPLETED|Extended Treatment (up to 42 Months)||20||
48552043|NCT01074944|101683301|FG000|NOT COMPLETED|Extended Treatment (up to 42 Months)||0||
48552044|NCT01074944|101683302|FG001|NOT COMPLETED|Extended Treatment (up to 42 Months)||0||
48552045|NCT01074944|101683303|FG002|NOT COMPLETED|Extended Treatment (up to 42 Months)||0||
48552046|NCT01074944|101683304|FG003|NOT COMPLETED|Extended Treatment (up to 42 Months)||0||
48552047|NCT01074944|101683305|FG004|NOT COMPLETED|Extended Treatment (up to 42 Months)||5||
48552048|NCT02245412|101683306|FG000|STARTED|Treatment Period||17||
48552049|NCT02245412|101683307|FG001|STARTED|Treatment Period||6||
48552050|NCT02245412|101683308|FG002|STARTED|Treatment Period||2||
48552051|NCT02245412|101683306|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||17||
48552052|NCT02245412|101683307|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||6||
48552053|NCT02245412|101683308|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||2||
48552054|NCT02245412|101683306|FG000|Modified Full Analysis Set (mFAS)|Treatment Period||16|The mFAS included all participants who had at least 1 dose of ALXN1007 and had GI GVHD confirmed.|
48552055|NCT02245412|101683307|FG001|Modified Full Analysis Set (mFAS)|Treatment Period||6|The mFAS included all participants who had at least 1 dose of ALXN1007 and had GI GVHD confirmed.|
48552056|NCT02245412|101683308|FG002|Modified Full Analysis Set (mFAS)|Treatment Period||2|The mFAS included all participants who had at least 1 dose of ALXN1007 and had GI GVHD confirmed.|
48552057|NCT02245412|101683306|FG000|COMPLETED|Treatment Period||12||
48552058|NCT02245412|101683307|FG001|COMPLETED|Treatment Period||3||
48552059|NCT02245412|101683308|FG002|COMPLETED|Treatment Period||2||
48552060|NCT02245412|101683306|FG000|NOT COMPLETED|Treatment Period||5||
48552061|NCT02245412|101683307|FG001|NOT COMPLETED|Treatment Period||3||
48105867|NCT01982253|100586947|FG000|NOT COMPLETED|Overall Study||2||
48105868|NCT01982253|100586948|FG001|NOT COMPLETED|Overall Study||4||
48105869|NCT01982253|100586949|FG002|NOT COMPLETED|Overall Study||4||
48105870|NCT02678676|100586950|FG000|STARTED|Overall Study||1820||
48105871|NCT02678676|100586951|FG001|STARTED|Overall Study||1779||
48105872|NCT02678676|100586950|FG000|COMPLETED|Overall Study||932||
48105873|NCT02678676|100586951|FG001|COMPLETED|Overall Study||907||
48105874|NCT02678676|100586950|FG000|NOT COMPLETED|Overall Study||888||
48552062|NCT02245412|101683308|FG002|NOT COMPLETED|Treatment Period||0||
48552063|NCT02245412|101683306|FG000|STARTED|Follow-Up Period||13||
48552064|NCT02245412|101683307|FG001|STARTED|Follow-Up Period||4||
48552065|NCT02245412|101683308|FG002|STARTED|Follow-Up Period||2||
48552066|NCT02245412|101683306|FG000|COMPLETED|Follow-Up Period||8||
48552067|NCT02245412|101683307|FG001|COMPLETED|Follow-Up Period||2||
48552068|NCT02245412|101683308|FG002|COMPLETED|Follow-Up Period||0||
48105875|NCT02678676|100586951|FG001|NOT COMPLETED|Overall Study||872||
48105876|NCT02865915|100586952|FG000|STARTED|Overall Study||25||
48105877|NCT02865915|100586953|FG001|STARTED|Overall Study||30||
48105878|NCT02865915|100586952|FG000|COMPLETED|Overall Study||0||
48105879|NCT02865915|100586953|FG001|COMPLETED|Overall Study||0||
48105880|NCT02865915|100586952|FG000|NOT COMPLETED|Overall Study||25||
48552069|NCT02245412|101683306|FG000|NOT COMPLETED|Follow-Up Period||5||
48552070|NCT02245412|101683307|FG001|NOT COMPLETED|Follow-Up Period||2||
48552071|NCT02245412|101683308|FG002|NOT COMPLETED|Follow-Up Period||2||
48552072|NCT02139137|101683309|FG000|STARTED|Overall Study||22||
48105881|NCT02865915|100586953|FG001|NOT COMPLETED|Overall Study||30||
48105882|NCT00902564|100586954|FG000|STARTED|Overall Study||30||
48105883|NCT00902564|100586954|FG000|COMPLETED|Overall Study||28||
48552073|NCT02139137|101683310|FG001|STARTED|Overall Study||20||
48552074|NCT02139137|101683309|FG000|COMPLETED|Overall Study||15||
48552075|NCT02139137|101683310|FG001|COMPLETED|Overall Study||10||
48552076|NCT02139137|101683309|FG000|NOT COMPLETED|Overall Study||7||
48552077|NCT02139137|101683310|FG001|NOT COMPLETED|Overall Study||10||
48552078|NCT00958893|101683311|FG000|STARTED|Overall Study||4||
48552079|NCT00958893|101683311|FG000|COMPLETED|Overall Study||0||
48552080|NCT00958893|101683311|FG000|NOT COMPLETED|Overall Study||4||
48552081|NCT04138498|101683312|FG000|STARTED|Overall Study||11||
48552082|NCT04138498|101683313|FG001|STARTED|Overall Study||10||
48552083|NCT04138498|101683314|FG002|STARTED|Overall Study||12||
48552084|NCT04138498|101683315|FG003|STARTED|Overall Study||12||
48552085|NCT04138498|101683312|FG000|COMPLETED|Overall Study||10||
48552086|NCT04138498|101683313|FG001|COMPLETED|Overall Study||10||
48552087|NCT04138498|101683314|FG002|COMPLETED|Overall Study||10||
48552088|NCT04138498|101683315|FG003|COMPLETED|Overall Study||9||
48552089|NCT04138498|101683312|FG000|NOT COMPLETED|Overall Study||1||
48552090|NCT04138498|101683313|FG001|NOT COMPLETED|Overall Study||0||
48552091|NCT04138498|101683314|FG002|NOT COMPLETED|Overall Study||2||
48552092|NCT04138498|101683315|FG003|NOT COMPLETED|Overall Study||3||
48552093|NCT00978874|101683316|FG000|STARTED|Overall Study||0||
48552094|NCT00978874|101683316|FG000|COMPLETED|Overall Study||0||
48105884|NCT00902564|100586954|FG000|NOT COMPLETED|Overall Study||2||
48105885|NCT02061969|100586955|FG000|STARTED|Overall Study||73||
48105886|NCT02061969|100586956|FG001|STARTED|Overall Study||67||
48105887|NCT02061969|100586955|FG000|COMPLETED|Overall Study||73||
48105888|NCT02061969|100586956|FG001|COMPLETED|Overall Study||67||
48267286|NCT03332784|100978503|FG014|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1||
48267287|NCT03332784|100978504|FG015|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2||
48105889|NCT02061969|100586955|FG000|NOT COMPLETED|Overall Study||0||
48105890|NCT02061969|100586956|FG001|NOT COMPLETED|Overall Study||0||
48105891|NCT00779103|100586957|FG000|STARTED|Overall Study||36||
48105892|NCT00779103|100586957|FG000|Second & Third Implant|Overall Study||31||
48267288|NCT03332784|100978505|FG016|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2||
48267289|NCT03332784|100978506|FG017|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2||
48267290|NCT03332784|100978507|FG018|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||3||
48105893|NCT00779103|100586957|FG000|Fourth Implant|Overall Study||13||
48105894|NCT00779103|100586957|FG000|No Treatment|Overall Study||9||
48105895|NCT00779103|100586957|FG000|COMPLETED|Overall Study||36||
48105896|NCT00779103|100586957|FG000|NOT COMPLETED|Overall Study||0||
48267291|NCT03332784|100978508|FG019|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||3||
48267292|NCT03332784|100978489|FG000|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
48267293|NCT03332784|100978490|FG001|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1||
48267294|NCT03332784|100978491|FG002|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
48267295|NCT03332784|100978492|FG003|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
48267296|NCT03332784|100978493|FG004|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
48267297|NCT03332784|100978494|FG005|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
48267298|NCT03332784|100978495|FG006|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
48267299|NCT03332784|100978496|FG007|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
48267300|NCT03332784|100978497|FG008|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
48267301|NCT03332784|100978498|FG009|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
48267302|NCT03332784|100978499|FG010|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
48267303|NCT03332784|100978500|FG011|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
48267304|NCT03332784|100978501|FG012|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
48267305|NCT03332784|100978502|FG013|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
48267306|NCT03332784|100978503|FG014|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1||
48267307|NCT03332784|100978504|FG015|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
48267308|NCT03332784|100978505|FG016|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
48267309|NCT03332784|100978506|FG017|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
48267310|NCT03332784|100978507|FG018|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
48267311|NCT03332784|100978508|FG019|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
48267312|NCT03332784|100978489|FG000|STARTED|Parts 1 and 2- Period 2 (1 Day)||2||
48267313|NCT03332784|100978490|FG001|STARTED|Parts 1 and 2- Period 2 (1 Day)||1||
48267314|NCT03332784|100978491|FG002|STARTED|Parts 1 and 2- Period 2 (1 Day)||2||
48267315|NCT03332784|100978492|FG003|STARTED|Parts 1 and 2- Period 2 (1 Day)||2||
48267316|NCT03332784|100978493|FG004|STARTED|Parts 1 and 2- Period 2 (1 Day)||2||
48267317|NCT03332784|100978494|FG005|STARTED|Parts 1 and 2- Period 2 (1 Day)||2||
48552095|NCT00978874|101683316|FG000|NOT COMPLETED|Overall Study||0||
48552096|NCT01644617|101683317|FG000|STARTED|Overall Study||42||
48552097|NCT01644617|101683318|FG001|STARTED|Overall Study||41||
48552098|NCT01644617|101683319|FG002|STARTED|Overall Study||41||
48552099|NCT01644617|101683317|FG000|COMPLETED|Overall Study||36||
48552100|NCT01644617|101683318|FG001|COMPLETED|Overall Study||36||
48552101|NCT01644617|101683319|FG002|COMPLETED|Overall Study||34||
48552102|NCT01644617|101683317|FG000|NOT COMPLETED|Overall Study||6||
48105897|NCT01928862|100586958|FG000|STARTED|Overall Study||16||
48105898|NCT01928862|100586959|FG001|STARTED|Overall Study||16||
48105899|NCT01928862|100586960|FG002|STARTED|Overall Study||16||
48105900|NCT01928862|100586961|FG003|STARTED|Overall Study||16||
48105901|NCT01928862|100586962|FG004|STARTED|Overall Study||14||
48105902|NCT01928862|100586958|FG000|COMPLETED|Overall Study||15||
48105903|NCT01928862|100586959|FG001|COMPLETED|Overall Study||16||
48105904|NCT01928862|100586960|FG002|COMPLETED|Overall Study||16||
48105905|NCT01928862|100586961|FG003|COMPLETED|Overall Study||16||
48105906|NCT01928862|100586962|FG004|COMPLETED|Overall Study||13||
48105907|NCT01928862|100586958|FG000|NOT COMPLETED|Overall Study||1||
48105908|NCT01928862|100586959|FG001|NOT COMPLETED|Overall Study||0||
48105909|NCT01928862|100586960|FG002|NOT COMPLETED|Overall Study||0||
48267318|NCT03332784|100978495|FG006|STARTED|Parts 1 and 2- Period 2 (1 Day)||2||
48267319|NCT03332784|100978496|FG007|STARTED|Parts 1 and 2- Period 2 (1 Day)||2||
48267320|NCT03332784|100978497|FG008|STARTED|Parts 1 and 2- Period 2 (1 Day)||0||
48267321|NCT03332784|100978498|FG009|STARTED|Parts 1 and 2- Period 2 (1 Day)||0||
48267322|NCT03332784|100978499|FG010|STARTED|Parts 1 and 2- Period 2 (1 Day)||0||
48105910|NCT01928862|100586961|FG003|NOT COMPLETED|Overall Study||0||
48105911|NCT01928862|100586962|FG004|NOT COMPLETED|Overall Study||1||
48105912|NCT02734810|100586963|FG000|STARTED|Overall Study||15||
48105913|NCT02734810|100586964|FG001|STARTED|Overall Study||0||
48105914|NCT02734810|100586963|FG000|COMPLETED|Overall Study||13||
48105915|NCT02734810|100586964|FG001|COMPLETED|Overall Study||0||
48105916|NCT02734810|100586963|FG000|NOT COMPLETED|Overall Study||2||
48105917|NCT02734810|100586964|FG001|NOT COMPLETED|Overall Study||0||
48105918|NCT01251588|100586965|FG000|STARTED|Overall Study||65||
48105919|NCT01251588|100586966|FG001|STARTED|Overall Study||63||
48105920|NCT01251588|100586965|FG000|COMPLETED|Overall Study||65||
48105921|NCT01251588|100586966|FG001|COMPLETED|Overall Study||59||
48105922|NCT01251588|100586965|FG000|NOT COMPLETED|Overall Study||0||
48105923|NCT01251588|100586966|FG001|NOT COMPLETED|Overall Study||4||
48105924|NCT00004888|100586967|FG000|STARTED|Overall Study||38||
48105925|NCT00004888|100586968|FG001|STARTED|Overall Study||46||
48105926|NCT00004888|100586967|FG000|COMPLETED|Overall Study||27||
48105927|NCT00004888|100586968|FG001|COMPLETED|Overall Study||22||
48105928|NCT00004888|100586967|FG000|NOT COMPLETED|Overall Study||11||
48105929|NCT00004888|100586968|FG001|NOT COMPLETED|Overall Study||24||
48105930|NCT02871739|100586969|FG000|STARTED|Overall Study||6||
48105931|NCT02871739|100586970|FG001|STARTED|Overall Study||6||
48105932|NCT02871739|100586971|FG002|STARTED|Overall Study||4||
48105933|NCT02871739|100586972|FG003|STARTED|Overall Study||7||
48105934|NCT02871739|100586969|FG000|Completed First SPI|Overall Study||3||
48105935|NCT02871739|100586970|FG001|Completed First SPI|Overall Study||5||
48105936|NCT02871739|100586971|FG002|Completed First SPI|Overall Study||4||
48105937|NCT02871739|100586972|FG003|Completed First SPI|Overall Study||6||
48105938|NCT02871739|100586969|FG000|Completed Second SPI|Overall Study||3||
48105939|NCT02871739|100586970|FG001|Completed Second SPI|Overall Study||4||
48105940|NCT02871739|100586971|FG002|Completed Second SPI|Overall Study||4||
48105941|NCT02871739|100586972|FG003|Completed Second SPI|Overall Study||5||
48105942|NCT02871739|100586969|FG000|Complete Final Survey|Overall Study||3||
48105943|NCT02871739|100586970|FG001|Complete Final Survey|Overall Study||4||
48105944|NCT02871739|100586971|FG002|Complete Final Survey|Overall Study||4||
48105945|NCT02871739|100586972|FG003|Complete Final Survey|Overall Study||5||
48105946|NCT02871739|100586969|FG000|COMPLETED|Overall Study||3||
48105947|NCT02871739|100586970|FG001|COMPLETED|Overall Study||4||
48105948|NCT02871739|100586971|FG002|COMPLETED|Overall Study||4||
48105949|NCT02871739|100586972|FG003|COMPLETED|Overall Study||5||
48105950|NCT02871739|100586969|FG000|NOT COMPLETED|Overall Study||3||
48105951|NCT02871739|100586970|FG001|NOT COMPLETED|Overall Study||2||
48105952|NCT02871739|100586971|FG002|NOT COMPLETED|Overall Study||0||
48105953|NCT02871739|100586972|FG003|NOT COMPLETED|Overall Study||2||
48105954|NCT00314236|100586973|FG000|STARTED|Overall Study||41||
48105955|NCT00314236|100586974|FG001|STARTED|Overall Study||39||
48105956|NCT00314236|100586973|FG000|COMPLETED|Overall Study||41||
48105957|NCT00314236|100586974|FG001|COMPLETED|Overall Study||37||
48105958|NCT00314236|100586973|FG000|NOT COMPLETED|Overall Study||0||
48105959|NCT00314236|100586974|FG001|NOT COMPLETED|Overall Study||2||
48105960|NCT01182493|100586975|FG000|STARTED|Overall Study||168||
48105961|NCT01182493|100586976|FG001|STARTED|Overall Study||163||
48105962|NCT01182493|100586975|FG000|COMPLETED|Overall Study||152||
48105963|NCT01182493|100586976|FG001|COMPLETED|Overall Study||156||
48105964|NCT01182493|100586975|FG000|NOT COMPLETED|Overall Study||16||
48267323|NCT03332784|100978500|FG011|STARTED|Parts 1 and 2- Period 2 (1 Day)||0||
48267324|NCT03332784|100978501|FG012|STARTED|Parts 1 and 2- Period 2 (1 Day)||0||
48267325|NCT03332784|100978502|FG013|STARTED|Parts 1 and 2- Period 2 (1 Day)||0||
48267326|NCT03332784|100978503|FG014|STARTED|Parts 1 and 2- Period 2 (1 Day)||1||
48105965|NCT01182493|100586976|FG001|NOT COMPLETED|Overall Study||7||
48105966|NCT01498640|100586977|FG000|STARTED|Overall Study||52||
48105967|NCT01498640|100586977|FG000|COMPLETED|Overall Study||47||
48105968|NCT01498640|100586977|FG000|NOT COMPLETED|Overall Study||5||
48105969|NCT02515942|100586978|FG000|STARTED|Overall Study||36||
48105970|NCT02515942|100586979|FG001|STARTED|Overall Study||39||
48105971|NCT02515942|100586980|FG002|STARTED|Overall Study||39||
48267327|NCT03332784|100978504|FG015|STARTED|Parts 1 and 2- Period 2 (1 Day)||2||
48141400|NCT01454583|100670419|FG000|NOT COMPLETED|1st Year||1057||
48105972|NCT02515942|100586978|FG000|Safety Analysis Set|Overall Study||36|All subjects who received any study drug|
48105973|NCT02515942|100586979|FG001|Safety Analysis Set|Overall Study||39|All subjects who received any study drug|
48105974|NCT02515942|100586980|FG002|Safety Analysis Set|Overall Study||39|All subjects who received any study drug|
48105975|NCT02515942|100586978|FG000|Full Analysis Set (FAS)|Overall Study||35|Subjects who received study treatment \& at least 1 follow-up visit with assessment of GA lesion size|
48141401|NCT01454583|100670420|FG001|NOT COMPLETED|1st Year||318||
48692426|NCT01014936|102032554|FG000|NOT COMPLETED|Overall Study||0||
48692427|NCT01014936|102032555|FG001|NOT COMPLETED|Overall Study||0||
48692428|NCT01014936|102032556|FG002|NOT COMPLETED|Overall Study||0||
48692429|NCT01415583|102032557|FG000|STARTED|Overall Study||157||
48692430|NCT01415583|102032558|FG001|STARTED|Overall Study||157||
48692431|NCT01415583|102032557|FG000|COMPLETED|Overall Study||157||
48692432|NCT01415583|102032558|FG001|COMPLETED|Overall Study||157||
48692433|NCT01415583|102032557|FG000|NOT COMPLETED|Overall Study||0||
48692434|NCT01415583|102032558|FG001|NOT COMPLETED|Overall Study||0||
48692435|NCT01116466|102032559|FG000|STARTED|Overall Study||5||
48692436|NCT01116466|102032559|FG000|COMPLETED|Overall Study||5||
48692437|NCT01116466|102032559|FG000|NOT COMPLETED|Overall Study||0||
48692438|NCT04381052|102032560|FG000|STARTED|Overall Study||1||
48692439|NCT04381052|102032560|FG000|COMPLETED|Overall Study||1||
48692440|NCT04381052|102032560|FG000|NOT COMPLETED|Overall Study||0||
48692441|NCT02455336|102032561|FG000|STARTED|Overall Study||15||
48692442|NCT02455336|102032562|FG001|STARTED|Overall Study||8||
48692443|NCT02455336|102032561|FG000|COMPLETED|Overall Study||10||
48692444|NCT02455336|102032562|FG001|COMPLETED|Overall Study||6||
48692445|NCT02455336|102032561|FG000|NOT COMPLETED|Overall Study||5||
48692446|NCT02455336|102032562|FG001|NOT COMPLETED|Overall Study||2||
48692447|NCT02597452|102032563|FG000|STARTED|Overall Study||516||
48692448|NCT02597452|102032563|FG000|COMPLETED|Overall Study||486||
48692449|NCT02597452|102032563|FG000|NOT COMPLETED|Overall Study||30||
48692450|NCT04860869|102032564|FG000|STARTED|Overall Study||10||
48692451|NCT04860869|102032565|FG001|STARTED|Overall Study||13||
48692452|NCT04860869|102032564|FG000|COMPLETED|Overall Study||9||
48692453|NCT04860869|102032565|FG001|COMPLETED|Overall Study||13||
48692454|NCT04860869|102032564|FG000|NOT COMPLETED|Overall Study||1||
48692455|NCT04860869|102032565|FG001|NOT COMPLETED|Overall Study||0||
48692456|NCT02052661|102032566|FG000|STARTED|Overall Study||300||
48692457|NCT02052661|102032566|FG000|COMPLETED|Overall Study||300||
48692458|NCT02052661|102032566|FG000|NOT COMPLETED|Overall Study||0||
48692459|NCT02622295|102032567|FG000|STARTED|Overall Study||40||
48692460|NCT02622295|102032568|FG001|STARTED|Overall Study||31||
48692461|NCT02622295|102032567|FG000|COMPLETED|Overall Study||40||
48692462|NCT02622295|102032568|FG001|COMPLETED|Overall Study||31||
48692463|NCT02622295|102032567|FG000|NOT COMPLETED|Overall Study||0||
48692464|NCT02622295|102032568|FG001|NOT COMPLETED|Overall Study||0||
48692465|NCT02259725|102032569|FG000|STARTED|Overall Study||3||
48692466|NCT02259725|102032569|FG000|COMPLETED|Overall Study||3||
48692467|NCT02259725|102032569|FG000|NOT COMPLETED|Overall Study||0||
48692468|NCT02688829|102032570|FG000|STARTED|Overall Study||21||
48692469|NCT02688829|102032570|FG000|COMPLETED|Overall Study||19||
48692470|NCT02688829|102032570|FG000|NOT COMPLETED|Overall Study||2||
48692471|NCT00349349|102032571|FG000|STARTED|Overall Study||95||
48692472|NCT00349349|102032572|FG001|STARTED|Overall Study||112||
48692473|NCT00349349|102032573|FG002|STARTED|Overall Study||16||
48692474|NCT00349349|102032571|FG000|COMPLETED|Overall Study||42||
48692475|NCT00349349|102032572|FG001|COMPLETED|Overall Study||50||
48692476|NCT00349349|102032573|FG002|COMPLETED|Overall Study||10||
48692477|NCT00349349|102032571|FG000|NOT COMPLETED|Overall Study||53||
48692478|NCT00349349|102032572|FG001|NOT COMPLETED|Overall Study||62||
48692479|NCT00349349|102032573|FG002|NOT COMPLETED|Overall Study||6||
48692480|NCT03292640|102032574|FG000|STARTED|Overall Study||275||
48692481|NCT03292640|102032575|FG001|STARTED|Overall Study||272||
48692482|NCT03292640|102032574|FG000|COMPLETED|Overall Study||214||
48692483|NCT03292640|102032575|FG001|COMPLETED|Overall Study||230||
48692484|NCT03292640|102032574|FG000|NOT COMPLETED|Overall Study||61||
48692485|NCT03292640|102032575|FG001|NOT COMPLETED|Overall Study||42||
48692486|NCT03377816|102032576|FG000|STARTED|Overall Study||157||
48692487|NCT03377816|102032577|FG001|STARTED|Overall Study||161||
48692488|NCT03377816|102032576|FG000|COMPLETED|Overall Study||107||
48692489|NCT03377816|102032577|FG001|COMPLETED|Overall Study||108||
48692490|NCT03377816|102032576|FG000|NOT COMPLETED|Overall Study||50||
48692491|NCT03377816|102032577|FG001|NOT COMPLETED|Overall Study||53||
48692492|NCT00861757|102032578|FG000|STARTED|Overall Study||154||
48105976|NCT02515942|100586979|FG001|Full Analysis Set (FAS)|Overall Study||37|Subjects who received study treatment \& at least 1 follow-up visit with assessment of GA lesion size|
48105977|NCT02515942|100586980|FG002|Full Analysis Set (FAS)|Overall Study||38|Subjects who received study treatment \& at least 1 follow-up visit with assessment of GA lesion size|
48267328|NCT03332784|100978505|FG016|STARTED|Parts 1 and 2- Period 2 (1 Day)||2||
48267329|NCT03332784|100978506|FG017|STARTED|Parts 1 and 2- Period 2 (1 Day)||2||
48267330|NCT03332784|100978507|FG018|STARTED|Parts 1 and 2- Period 2 (1 Day)||3||
48267331|NCT03332784|100978508|FG019|STARTED|Parts 1 and 2- Period 2 (1 Day)||3||
48267332|NCT03332784|100978489|FG000|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2||
48105978|NCT02515942|100586978|FG000|Per Protocol Analysis Set (PPS)|Overall Study||30|FAS with no critical protocol deviations \& with a valid assessment of primary efficacy endpoint|
48105979|NCT02515942|100586979|FG001|Per Protocol Analysis Set (PPS)|Overall Study||35|FAS with no critical protocol deviations \& with a valid assessment of primary efficacy endpoint|
48105980|NCT02515942|100586980|FG002|Per Protocol Analysis Set (PPS)|Overall Study||34|FAS with no critical protocol deviations \& with a valid assessment of primary efficacy endpoint|
48105981|NCT02515942|100586978|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||36|Subjects in safety set with evaluable PK data \& no major protocol deviations that impacted PK data|
48105982|NCT02515942|100586979|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||39|Subjects in safety set with evaluable PK data \& no major protocol deviations that impacted PK data|
48105983|NCT02515942|100586980|FG002|Pharmacokinetics (PK) Analysis Set|Overall Study||0|Subjects in safety set with evaluable PK data \& no major protocol deviations that impacted PK data|
48105984|NCT02515942|100586978|FG000|Completed Day 85|Overall Study||35||
48105985|NCT02515942|100586979|FG001|Completed Day 85|Overall Study||38||
48105986|NCT02515942|100586980|FG002|Completed Day 85|Overall Study||37||
48105987|NCT02515942|100586978|FG000|Completed Day 169|Overall Study||32||
48105988|NCT02515942|100586979|FG001|Completed Day 169|Overall Study||37||
48105989|NCT02515942|100586980|FG002|Completed Day 169|Overall Study||37||
48105990|NCT02515942|100586978|FG000|Completed Day 253|Overall Study||29||
48105991|NCT02515942|100586979|FG001|Completed Day 253|Overall Study||37||
48105992|NCT02515942|100586980|FG002|Completed Day 253|Overall Study||36||
48105993|NCT02515942|100586978|FG000|Completed Day 337|Overall Study||30||
48105994|NCT02515942|100586979|FG001|Completed Day 337|Overall Study||36||
48105995|NCT02515942|100586980|FG002|Completed Day 337|Overall Study||35||
48105996|NCT02515942|100586978|FG000|COMPLETED|Overall Study||29||
48105997|NCT02515942|100586979|FG001|COMPLETED|Overall Study||36||
48105998|NCT02515942|100586980|FG002|COMPLETED|Overall Study||35||
48105999|NCT02515942|100586978|FG000|NOT COMPLETED|Overall Study||7||
48106000|NCT02515942|100586979|FG001|NOT COMPLETED|Overall Study||3||
48106001|NCT02515942|100586980|FG002|NOT COMPLETED|Overall Study||4||
48106002|NCT04052542|100586981|FG000|STARTED|Overall Study||116||
48106003|NCT04052542|100586982|FG001|STARTED|Overall Study||28||
48106004|NCT04052542|100586983|FG002|STARTED|Overall Study||146||
48106005|NCT04052542|100586984|FG003|STARTED|Overall Study||188||
48106006|NCT04052542|100586985|FG004|STARTED|Overall Study||24||
48106007|NCT04052542|100586986|FG005|STARTED|Overall Study||183||
48106008|NCT04052542|100586987|FG006|STARTED|Overall Study||275||
48106009|NCT04052542|100586988|FG007|STARTED|Overall Study||27||
48106010|NCT04052542|100586989|FG008|STARTED|Overall Study||276||
48106011|NCT04052542|100586990|FG009|STARTED|Overall Study||22||
48106012|NCT04052542|100586991|FG010|STARTED|Overall Study||31||
48106013|NCT04052542|100586992|FG011|STARTED|Overall Study||12||
48106014|NCT04052542|100586981|FG000|COMPLETED|Overall Study||116||
48106015|NCT04052542|100586982|FG001|COMPLETED|Overall Study||28||
48106016|NCT04052542|100586983|FG002|COMPLETED|Overall Study||146||
48106017|NCT04052542|100586984|FG003|COMPLETED|Overall Study||188||
48106018|NCT04052542|100586985|FG004|COMPLETED|Overall Study||24||
48106019|NCT04052542|100586986|FG005|COMPLETED|Overall Study||183||
48106020|NCT04052542|100586987|FG006|COMPLETED|Overall Study||275||
48106021|NCT04052542|100586988|FG007|COMPLETED|Overall Study||27||
48106022|NCT04052542|100586989|FG008|COMPLETED|Overall Study||276||
48267333|NCT03332784|100978490|FG001|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||1||
48267334|NCT03332784|100978491|FG002|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2||
48267335|NCT03332784|100978492|FG003|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2||
48267336|NCT03332784|100978493|FG004|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2||
48267337|NCT03332784|100978494|FG005|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2||
48267338|NCT03332784|100978495|FG006|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2||
48267339|NCT03332784|100978496|FG007|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2||
48267340|NCT03332784|100978497|FG008|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
48106023|NCT04052542|100586990|FG009|COMPLETED|Overall Study||22||
48106024|NCT04052542|100586991|FG010|COMPLETED|Overall Study||31||
48106025|NCT04052542|100586992|FG011|COMPLETED|Overall Study||12||
48106026|NCT04052542|100586981|FG000|NOT COMPLETED|Overall Study||0||
48106027|NCT04052542|100586982|FG001|NOT COMPLETED|Overall Study||0||
48106028|NCT04052542|100586983|FG002|NOT COMPLETED|Overall Study||0||
48106029|NCT04052542|100586984|FG003|NOT COMPLETED|Overall Study||0||
48106030|NCT04052542|100586985|FG004|NOT COMPLETED|Overall Study||0||
48267341|NCT03332784|100978498|FG009|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
48267342|NCT03332784|100978499|FG010|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
48267343|NCT03332784|100978500|FG011|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
48267344|NCT03332784|100978501|FG012|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
48267345|NCT03332784|100978502|FG013|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
48267346|NCT03332784|100978503|FG014|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||1||
48267347|NCT03332784|100978504|FG015|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2||
48692493|NCT00861757|102032579|FG001|STARTED|Overall Study||151||
48692494|NCT00861757|102032580|FG002|STARTED|Overall Study||155||
48692495|NCT00861757|102032581|FG003|STARTED|Overall Study||152||
48106031|NCT04052542|100586986|FG005|NOT COMPLETED|Overall Study||0||
48106032|NCT04052542|100586987|FG006|NOT COMPLETED|Overall Study||0||
48106033|NCT04052542|100586988|FG007|NOT COMPLETED|Overall Study||0||
48106034|NCT04052542|100586989|FG008|NOT COMPLETED|Overall Study||0||
48106035|NCT04052542|100586990|FG009|NOT COMPLETED|Overall Study||0||
48106036|NCT04052542|100586991|FG010|NOT COMPLETED|Overall Study||0||
48106037|NCT04052542|100586992|FG011|NOT COMPLETED|Overall Study||0||
48106038|NCT01334866|100586993|FG000|STARTED|Overall Study||91||
48106039|NCT01334866|100586993|FG000|COMPLETED|Overall Study||72||
48106040|NCT01334866|100586993|FG000|NOT COMPLETED|Overall Study||19||
48106041|NCT03239470|100586994|FG000|STARTED|Blood Donation||5||
48106042|NCT03239470|100586995|FG001|STARTED|Blood Donation||0||
48106043|NCT03239470|100586994|FG000|COMPLETED|Blood Donation||5||
48106044|NCT03239470|100586995|FG001|COMPLETED|Blood Donation||0||
48106045|NCT03239470|100586994|FG000|NOT COMPLETED|Blood Donation||0||
48106046|NCT03239470|100586995|FG001|NOT COMPLETED|Blood Donation||0||
48106047|NCT03239470|100586994|FG000|STARTED|Polyclonal Treg Infusion||5||
48106048|NCT03239470|100586995|FG001|STARTED|Polyclonal Treg Infusion||0||
48106049|NCT03239470|100586994|FG000|COMPLETED|Polyclonal Treg Infusion||4||
48106050|NCT03239470|100586995|FG001|COMPLETED|Polyclonal Treg Infusion||0||
48106051|NCT03239470|100586994|FG000|NOT COMPLETED|Polyclonal Treg Infusion||1||
48106052|NCT03239470|100586995|FG001|NOT COMPLETED|Polyclonal Treg Infusion||0||
48106053|NCT02323854|100586996|FG000|STARTED|Overall Study||15||
48106054|NCT02323854|100586996|FG000|COMPLETED|Overall Study||15||
48106055|NCT02323854|100586996|FG000|NOT COMPLETED|Overall Study||0||
48106056|NCT00581776|100586997|FG000|STARTED|Overall Study||30||
48106057|NCT00581776|100586997|FG000|COMPLETED|Overall Study||27||
48106058|NCT00581776|100586997|FG000|NOT COMPLETED|Overall Study||3||
48106059|NCT01851720|100586998|FG000|STARTED|Overall Study||0||
48106060|NCT01851720|100586999|FG001|STARTED|Overall Study||1||
48692496|NCT00861757|102032578|FG000|COMPLETED|Overall Study||145||
48692497|NCT00861757|102032579|FG001|COMPLETED|Overall Study||136||
48692498|NCT00861757|102032580|FG002|COMPLETED|Overall Study||137||
48692499|NCT00861757|102032581|FG003|COMPLETED|Overall Study||143||
48692500|NCT00861757|102032578|FG000|NOT COMPLETED|Overall Study||9||
48106061|NCT01851720|100586998|FG000|COMPLETED|Overall Study||0||
48106062|NCT01851720|100586999|FG001|COMPLETED|Overall Study||0||
48106063|NCT01851720|100586998|FG000|NOT COMPLETED|Overall Study||0||
48106064|NCT01851720|100586999|FG001|NOT COMPLETED|Overall Study||1||
48106065|NCT00283933|100587000|FG000|STARTED|Treatment Period||5||
48106066|NCT00283933|100587000|FG000|Safety Population|Treatment Period||5|Received at least 1 dose of study drug|
48106067|NCT00283933|100587000|FG000|Pharmacodynamic (PD) Population|Treatment Period||5|Received study drug and had at least 1 non-missing postbaseline PD parameter recorded|
48106068|NCT00283933|100587000|FG000|COMPLETED|Treatment Period||5||
48106069|NCT00283933|100587000|FG000|NOT COMPLETED|Treatment Period||0||
48106070|NCT00283933|100587000|FG000|STARTED|Extension Period||5||
48106071|NCT00283933|100587000|FG000|COMPLETED|Extension Period||5||
48267348|NCT03332784|100978505|FG016|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2||
48267349|NCT03332784|100978506|FG017|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2||
48267350|NCT03332784|100978507|FG018|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||3||
48267351|NCT03332784|100978508|FG019|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||3||
48106072|NCT00283933|100587000|FG000|NOT COMPLETED|Extension Period||0||
48106073|NCT03690388|100587001|FG000|STARTED|Overall Study||125||
48106074|NCT03690388|100587002|FG001|STARTED|Overall Study||62||
48106075|NCT03690388|100587001|FG000|COMPLETED|Overall Study||89||
48106076|NCT03690388|100587002|FG001|COMPLETED|Overall Study||26||
48106077|NCT03690388|100587001|FG000|NOT COMPLETED|Overall Study||36||
48106078|NCT03690388|100587002|FG001|NOT COMPLETED|Overall Study||36||
48106079|NCT01364428|100587003|FG000|STARTED|Overall Study||186||
48106080|NCT01364428|100587004|FG001|STARTED|Overall Study||187||
48106081|NCT01364428|100587003|FG000|Exposed|Overall Study||184||
48106082|NCT01364428|100587004|FG001|Exposed|Overall Study||187||
48106083|NCT01364428|100587003|FG000|COMPLETED|Overall Study||166||
48106084|NCT01364428|100587004|FG001|COMPLETED|Overall Study||172||
48267352|NCT03332784|100978489|FG000|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
48267353|NCT03332784|100978490|FG001|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
48692501|NCT00861757|102032579|FG001|NOT COMPLETED|Overall Study||15||
48692502|NCT00861757|102032580|FG002|NOT COMPLETED|Overall Study||18||
48692503|NCT00861757|102032581|FG003|NOT COMPLETED|Overall Study||9||
48692504|NCT03640507|102032582|FG000|STARTED|Overall Study||10||
48692505|NCT03640507|102032583|FG001|STARTED|Overall Study||9||
48692506|NCT03640507|102032584|FG002|STARTED|Overall Study||11||
48692507|NCT03640507|102032582|FG000|COMPLETED|Overall Study||10||
48692508|NCT03640507|102032583|FG001|COMPLETED|Overall Study||9||
48692509|NCT03640507|102032584|FG002|COMPLETED|Overall Study||10||
48692510|NCT03640507|102032582|FG000|NOT COMPLETED|Overall Study||0||
48692511|NCT03640507|102032583|FG001|NOT COMPLETED|Overall Study||0||
48106085|NCT01364428|100587003|FG000|NOT COMPLETED|Overall Study||20||
48106086|NCT01364428|100587004|FG001|NOT COMPLETED|Overall Study||15||
48106087|NCT00451035|100587005|FG000|STARTED|Overall Study||29||
48106088|NCT00451035|100587005|FG000|COMPLETED|Overall Study||12||
48106089|NCT00451035|100587005|FG000|NOT COMPLETED|Overall Study||17||
48106090|NCT01835743|100587006|FG000|STARTED|Overall Study||37||
48106091|NCT01835743|100587007|FG001|STARTED|Overall Study||32||
48106092|NCT01835743|100587006|FG000|COMPLETED|Overall Study||37||
48106093|NCT01835743|100587007|FG001|COMPLETED|Overall Study||32||
48106094|NCT01835743|100587006|FG000|NOT COMPLETED|Overall Study||0||
48106095|NCT01835743|100587007|FG001|NOT COMPLETED|Overall Study||0||
48106096|NCT02381418|100587008|FG000|STARTED|Overall Study||120||
48106097|NCT02381418|100587008|FG000|COMPLETED|Overall Study||120||
48106098|NCT02381418|100587008|FG000|NOT COMPLETED|Overall Study||0||
48106099|NCT01224639|100587009|FG000|STARTED|Overall Study||19||
48106100|NCT01224639|100587010|FG001|STARTED|Overall Study||5||
48106101|NCT01224639|100587011|FG002|STARTED|Overall Study||21||
48106102|NCT01224639|100587012|FG003|STARTED|Overall Study||3||
48106103|NCT01224639|100587013|FG004|STARTED|Overall Study||21||
48106104|NCT01224639|100587014|FG005|STARTED|Overall Study||4||
48106105|NCT01224639|100587015|FG006|STARTED|Overall Study||18||
48106106|NCT01224639|100587016|FG007|STARTED|Overall Study||5||
48106107|NCT01224639|100587009|FG000|COMPLETED|Overall Study||19||
48106108|NCT01224639|100587010|FG001|COMPLETED|Overall Study||5||
48106109|NCT01224639|100587011|FG002|COMPLETED|Overall Study||21||
48106110|NCT01224639|100587012|FG003|COMPLETED|Overall Study||3||
48106111|NCT01224639|100587013|FG004|COMPLETED|Overall Study||19||
48106112|NCT01224639|100587014|FG005|COMPLETED|Overall Study||4||
48106113|NCT01224639|100587015|FG006|COMPLETED|Overall Study||17||
48106114|NCT01224639|100587016|FG007|COMPLETED|Overall Study||3||
48106115|NCT01224639|100587009|FG000|NOT COMPLETED|Overall Study||0||
48106116|NCT01224639|100587010|FG001|NOT COMPLETED|Overall Study||0||
48106117|NCT01224639|100587011|FG002|NOT COMPLETED|Overall Study||0||
48106118|NCT01224639|100587012|FG003|NOT COMPLETED|Overall Study||0||
48106119|NCT01224639|100587013|FG004|NOT COMPLETED|Overall Study||2||
48106120|NCT01224639|100587014|FG005|NOT COMPLETED|Overall Study||0||
48106121|NCT01224639|100587015|FG006|NOT COMPLETED|Overall Study||1||
48106122|NCT01224639|100587016|FG007|NOT COMPLETED|Overall Study||2||
48106123|NCT00922766|100587017|FG000|STARTED|Overall Study||617||
48106124|NCT00922766|100587017|FG000|COMPLETED|Overall Study||610||
48106125|NCT00922766|100587017|FG000|NOT COMPLETED|Overall Study||7||
48106126|NCT00405548|100587018|FG000|STARTED|Overall Study||28||
48106127|NCT00405548|100587019|FG001|STARTED|Overall Study||13||
48106128|NCT00405548|100587018|FG000|COMPLETED|Overall Study||24||
48106129|NCT00405548|100587019|FG001|COMPLETED|Overall Study||12||
48106130|NCT00405548|100587018|FG000|NOT COMPLETED|Overall Study||4||
48106131|NCT00405548|100587019|FG001|NOT COMPLETED|Overall Study||1||
48106132|NCT00922883|100587020|FG000|STARTED|Overall Study||43||
48106133|NCT00922883|100587020|FG000|COMPLETED|Overall Study||43||
48692512|NCT03640507|102032584|FG002|NOT COMPLETED|Overall Study||1||
48692513|NCT00988052|102032585|FG000|STARTED|Overall Study||423||
48692514|NCT00988052|102032586|FG001|STARTED|Overall Study||416||
48106134|NCT00922883|100587020|FG000|NOT COMPLETED|Overall Study||0||
48106135|NCT02174848|100587021|FG000|STARTED|Overall Study||24||
48106136|NCT02174848|100587022|FG001|STARTED|Overall Study||44||
48106137|NCT02174848|100587021|FG000|Provided Post-baseline Efficacy Data|Overall Study||19||
48106138|NCT02174848|100587022|FG001|Provided Post-baseline Efficacy Data|Overall Study||43||
48106139|NCT02174848|100587021|FG000|COMPLETED|Overall Study||17||
48106140|NCT02174848|100587022|FG001|COMPLETED|Overall Study||38||
48106141|NCT02174848|100587021|FG000|NOT COMPLETED|Overall Study||7||
48106142|NCT02174848|100587022|FG001|NOT COMPLETED|Overall Study||6||
48106143|NCT01820416|100587023|FG000|STARTED|Overall Study||12||
48106144|NCT01820416|100587024|FG001|STARTED|Overall Study||12||
48106145|NCT01820416|100587025|FG002|STARTED|Overall Study||11||
48106146|NCT01820416|100587023|FG000|COMPLETED|Overall Study||9||
48106147|NCT01820416|100587024|FG001|COMPLETED|Overall Study||10||
48106148|NCT01820416|100587025|FG002|COMPLETED|Overall Study||11||
48106149|NCT01820416|100587023|FG000|NOT COMPLETED|Overall Study||3||
48267354|NCT03332784|100978491|FG002|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
48106150|NCT01820416|100587024|FG001|NOT COMPLETED|Overall Study||2||
48106151|NCT01820416|100587025|FG002|NOT COMPLETED|Overall Study||0||
48106152|NCT03317431|100587026|FG000|STARTED|Overall Study||46||
48106153|NCT03317431|100587026|FG000|COMPLETED|Overall Study||46||
48106154|NCT03317431|100587026|FG000|NOT COMPLETED|Overall Study||0||
48106155|NCT01203072|100587027|FG000|STARTED|Overall Study||105||
48106156|NCT01203072|100587028|FG001|STARTED|Overall Study||106||
48267355|NCT03332784|100978492|FG003|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
48106157|NCT01203072|100587029|FG002|STARTED|Overall Study||104||
48106158|NCT01203072|100587030|FG003|STARTED|Overall Study||106||
48692515|NCT00988052|102032585|FG000|COMPLETED|Overall Study||0||
48692516|NCT00988052|102032586|FG001|COMPLETED|Overall Study||0||
48692517|NCT00988052|102032585|FG000|NOT COMPLETED|Overall Study||423||
48692518|NCT00988052|102032586|FG001|NOT COMPLETED|Overall Study||416||
48692519|NCT03520920|102032587|FG000|STARTED|Overall Study||20||
48692520|NCT03520920|102032588|FG001|STARTED|Overall Study||16||
48106159|NCT01203072|100587031|FG004|STARTED|Overall Study||102||
48106160|NCT01203072|100587027|FG000|COMPLETED|Overall Study||95||
48106161|NCT01203072|100587028|FG001|COMPLETED|Overall Study||100||
48106162|NCT01203072|100587029|FG002|COMPLETED|Overall Study||101||
48106163|NCT01203072|100587030|FG003|COMPLETED|Overall Study||100||
48106164|NCT01203072|100587031|FG004|COMPLETED|Overall Study||96||
48106165|NCT01203072|100587027|FG000|NOT COMPLETED|Overall Study||10||
48106166|NCT01203072|100587028|FG001|NOT COMPLETED|Overall Study||6||
48106167|NCT01203072|100587029|FG002|NOT COMPLETED|Overall Study||3||
48106168|NCT01203072|100587030|FG003|NOT COMPLETED|Overall Study||6||
48106169|NCT01203072|100587031|FG004|NOT COMPLETED|Overall Study||6||
48106170|NCT01215227|100587032|FG000|STARTED|Overall Study||218||
48106171|NCT01215227|100587033|FG001|STARTED|Overall Study||215||
48106172|NCT01215227|100587034|FG002|STARTED|Overall Study||107||
48106173|NCT01215227|100587035|FG003|STARTED|Overall Study||97||
48106174|NCT01215227|100587036|FG004|STARTED|Overall Study||93||
48106175|NCT01215227|100587037|FG005|STARTED|Overall Study||109||
48106176|NCT01215227|100587032|FG000|Treated|Overall Study||218||
48106177|NCT01215227|100587033|FG001|Treated|Overall Study||215||
48106178|NCT01215227|100587034|FG002|Treated|Overall Study||106||
48106179|NCT01215227|100587035|FG003|Treated|Overall Study||96||
48106180|NCT01215227|100587036|FG004|Treated|Overall Study||93||
48106181|NCT01215227|100587037|FG005|Treated|Overall Study||108||
48106182|NCT01215227|100587032|FG000|COMPLETED|Overall Study||97||
48106183|NCT01215227|100587033|FG001|COMPLETED|Overall Study||96||
48106184|NCT01215227|100587034|FG002|COMPLETED|Overall Study||50||
48106185|NCT01215227|100587035|FG003|COMPLETED|Overall Study||48||
48106186|NCT01215227|100587036|FG004|COMPLETED|Overall Study||45||
48106187|NCT01215227|100587037|FG005|COMPLETED|Overall Study||51||
48106188|NCT01215227|100587032|FG000|NOT COMPLETED|Overall Study||121||
48106189|NCT01215227|100587033|FG001|NOT COMPLETED|Overall Study||119||
48106190|NCT01215227|100587034|FG002|NOT COMPLETED|Overall Study||57||
48106191|NCT01215227|100587035|FG003|NOT COMPLETED|Overall Study||49||
48106192|NCT01215227|100587036|FG004|NOT COMPLETED|Overall Study||48||
48106193|NCT01215227|100587037|FG005|NOT COMPLETED|Overall Study||58||
48106194|NCT02404350|100587038|FG000|STARTED|Overall Study||222||
48106195|NCT02404350|100587039|FG001|STARTED|Overall Study||220||
48106196|NCT02404350|100587040|FG002|STARTED|Overall Study||222||
48106197|NCT02404350|100587041|FG003|STARTED|Overall Study||332||
48106198|NCT02404350|100587038|FG000|COMPLETED|Overall Study||207|Completed Randomisation phase (up to week 24).|
48106199|NCT02404350|100587039|FG001|COMPLETED|Overall Study||214|Completed Randomisation phase (up to week 24).|
48106200|NCT02404350|100587040|FG002|COMPLETED|Overall Study||216|Completed Randomisation phase (up to week 24).|
48106201|NCT02404350|100587041|FG003|COMPLETED|Overall Study||295|Completed Randomisation phase (up to week 24).|
48106202|NCT02404350|100587038|FG000|NOT COMPLETED|Overall Study||15||
48106203|NCT02404350|100587039|FG001|NOT COMPLETED|Overall Study||6||
48106204|NCT02404350|100587040|FG002|NOT COMPLETED|Overall Study||6||
48106205|NCT02404350|100587041|FG003|NOT COMPLETED|Overall Study||37||
48106206|NCT02439320|100587042|FG000|STARTED|Overall Study||744||
48106207|NCT02439320|100587043|FG001|STARTED|Overall Study||745||
48106208|NCT02439320|100587044|FG002|STARTED|Overall Study||742||
48106209|NCT02439320|100587042|FG000|Confirmed Eligibility|Overall Study||710||
48106210|NCT02439320|100587043|FG001|Confirmed Eligibility|Overall Study||695||
48106211|NCT02439320|100587044|FG002|Confirmed Eligibility|Overall Study||705||
48106212|NCT02439320|100587042|FG000|1st Dose (by 4 Hours Migraine Onset)|Overall Study||630|Safety population based on the first dose. Participants received at least 1 dose of study drug.|
48106213|NCT02439320|100587043|FG001|1st Dose (by 4 Hours Migraine Onset)|Overall Study||609|Safety population based on the first dose. Participants received at least 1 dose of study drug.|
48106214|NCT02439320|100587044|FG002|1st Dose (by 4 Hours Migraine Onset)|Overall Study||617|Safety population based on the first dose. Participants received at least 1 dose of study drug.|
48106215|NCT02439320|100587042|FG000|2nd Dose (After 2 Hour Assessment)|Overall Study||289|Participants received second dose of study drug after 4 hours.|
48106216|NCT02439320|100587043|FG001|2nd Dose (After 2 Hour Assessment)|Overall Study||238|Participants received second dose of study drug after 4 hours.|
48552103|NCT01644617|101683318|FG001|NOT COMPLETED|Overall Study||5||
48106217|NCT02439320|100587044|FG002|2nd Dose (After 2 Hour Assessment)|Overall Study||401|Participants received second dose of study drug after 4 hours.|
48106218|NCT02439320|100587042|FG000|COMPLETED|Overall Study||648|Included participants who received study drug and participants who did not receive study drug.|
48106219|NCT02439320|100587043|FG001|COMPLETED|Overall Study||631|Included participants who received study drug and participants who did not receive study drug.|
48106220|NCT02439320|100587044|FG002|COMPLETED|Overall Study||643|Included participants who received study drug and participants who did not receive study drug.|
48106221|NCT02439320|100587042|FG000|NOT COMPLETED|Overall Study||96||
48106222|NCT02439320|100587043|FG001|NOT COMPLETED|Overall Study||114||
48106223|NCT02439320|100587044|FG002|NOT COMPLETED|Overall Study||99||
48106224|NCT01063764|100587045|FG000|STARTED|1st Period (From Week 8 to Week 22)||73||
48106225|NCT01063764|100587045|FG000|COMPLETED|1st Period (From Week 8 to Week 22)||62||
48106226|NCT01063764|100587045|FG000|NOT COMPLETED|1st Period (From Week 8 to Week 22)||11||
48106227|NCT01063764|100587045|FG000|STARTED|2nd Period (Week 22 to the End of Study)||55||
48106228|NCT01063764|100587045|FG000|COMPLETED|2nd Period (Week 22 to the End of Study)||35||
48106229|NCT01063764|100587045|FG000|NOT COMPLETED|2nd Period (Week 22 to the End of Study)||20||
48106230|NCT00129129|100587046|FG000|STARTED|Primary Phase||287||
48106231|NCT00129129|100587047|FG001|STARTED|Primary Phase||319||
48106232|NCT00129129|100587048|FG002|STARTED|Primary Phase||150||
48106233|NCT00129129|100587049|FG003|STARTED|Primary Phase||0||
48106234|NCT00129129|100587050|FG004|STARTED|Primary Phase||0||
48106235|NCT00129129|100587046|FG000|COMPLETED|Primary Phase||262||
48106236|NCT00129129|100587047|FG001|COMPLETED|Primary Phase||294||
48106237|NCT00129129|100587048|FG002|COMPLETED|Primary Phase||150||
48106238|NCT00129129|100587049|FG003|COMPLETED|Primary Phase||0||
48106239|NCT00129129|100587050|FG004|COMPLETED|Primary Phase||0||
48106240|NCT00129129|100587046|FG000|NOT COMPLETED|Primary Phase||25||
48106241|NCT00129129|100587047|FG001|NOT COMPLETED|Primary Phase||25||
48106242|NCT00129129|100587048|FG002|NOT COMPLETED|Primary Phase||0||
48106243|NCT00129129|100587049|FG003|NOT COMPLETED|Primary Phase||0||
48106244|NCT00129129|100587050|FG004|NOT COMPLETED|Primary Phase||0||
48106245|NCT00129129|100587046|FG000|STARTED|Fourth Dose Phase||236||
48106246|NCT00129129|100587047|FG001|STARTED|Fourth Dose Phase||0||
48106247|NCT00129129|100587048|FG002|STARTED|Fourth Dose Phase||0||
48106248|NCT00129129|100587049|FG003|STARTED|Fourth Dose Phase||132||
48106249|NCT00129129|100587050|FG004|STARTED|Fourth Dose Phase||130||
48106250|NCT00129129|100587046|FG000|COMPLETED|Fourth Dose Phase||232||
48106251|NCT00129129|100587047|FG001|COMPLETED|Fourth Dose Phase||0||
48106252|NCT00129129|100587048|FG002|COMPLETED|Fourth Dose Phase||0||
48106253|NCT00129129|100587049|FG003|COMPLETED|Fourth Dose Phase||128||
48106254|NCT00129129|100587050|FG004|COMPLETED|Fourth Dose Phase||124||
48106255|NCT00129129|100587046|FG000|NOT COMPLETED|Fourth Dose Phase||4||
48106256|NCT00129129|100587047|FG001|NOT COMPLETED|Fourth Dose Phase||0||
48106257|NCT00129129|100587048|FG002|NOT COMPLETED|Fourth Dose Phase||0||
48106258|NCT00129129|100587049|FG003|NOT COMPLETED|Fourth Dose Phase||4||
48106259|NCT00129129|100587050|FG004|NOT COMPLETED|Fourth Dose Phase||6||
48267356|NCT03332784|100978493|FG004|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
48267357|NCT03332784|100978494|FG005|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
48267358|NCT03332784|100978495|FG006|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
48267359|NCT03332784|100978496|FG007|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
48267360|NCT03332784|100978497|FG008|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
48267361|NCT03332784|100978498|FG009|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
48267362|NCT03332784|100978499|FG010|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
48267363|NCT03332784|100978500|FG011|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
48267364|NCT03332784|100978501|FG012|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
48267365|NCT03332784|100978502|FG013|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
48267366|NCT03332784|100978503|FG014|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
48267367|NCT03332784|100978504|FG015|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
48267368|NCT03332784|100978505|FG016|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
48552104|NCT01644617|101683319|FG002|NOT COMPLETED|Overall Study||7||
48552105|NCT00451178|101683320|FG000|STARTED|Chemotherapy (Up To Six 21-Day Cycles)||58||
48552106|NCT00451178|101683321|FG001|STARTED|Chemotherapy (Up To Six 21-Day Cycles)||43||
48552107|NCT00451178|101683320|FG000|Received At Least 1 Dose Study Treatment|Chemotherapy (Up To Six 21-Day Cycles)||57||
48552108|NCT00451178|101683321|FG001|Received At Least 1 Dose Study Treatment|Chemotherapy (Up To Six 21-Day Cycles)||43||
48552109|NCT00451178|101683320|FG000|COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||40||
48106260|NCT03168464|100587051|FG000|STARTED|Overall Study||15||
48106261|NCT03168464|100587051|FG000|COMPLETED|Overall Study||0||
48267369|NCT03332784|100978506|FG017|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
48267370|NCT03332784|100978507|FG018|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
48267371|NCT03332784|100978508|FG019|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
48552110|NCT00451178|101683321|FG001|COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||26||
48106262|NCT03168464|100587051|FG000|NOT COMPLETED|Overall Study||15||
48106263|NCT01209442|100587052|FG000|STARTED|Overall Study||30||
48106264|NCT01209442|100587052|FG000|COMPLETED|Overall Study||30||
48106265|NCT01209442|100587052|FG000|NOT COMPLETED|Overall Study||0||
48106266|NCT04681482|100587053|FG000|STARTED|Overall Study||35051||
48106267|NCT04681482|100587054|FG001|STARTED|Overall Study||38756||
48267372|NCT03332784|100978489|FG000|STARTED|Part 1- Period 3 (1 Day)||2||
48267373|NCT03332784|100978490|FG001|STARTED|Part 1- Period 3 (1 Day)||1||
48267374|NCT03332784|100978491|FG002|STARTED|Part 1- Period 3 (1 Day)||2||
48267375|NCT03332784|100978492|FG003|STARTED|Part 1- Period 3 (1 Day)||2||
48267376|NCT03332784|100978493|FG004|STARTED|Part 1- Period 3 (1 Day)||2||
48267377|NCT03332784|100978494|FG005|STARTED|Part 1- Period 3 (1 Day)||2||
48267378|NCT03332784|100978495|FG006|STARTED|Part 1- Period 3 (1 Day)||2||
48267379|NCT03332784|100978496|FG007|STARTED|Part 1- Period 3 (1 Day)||2||
48267380|NCT03332784|100978497|FG008|STARTED|Part 1- Period 3 (1 Day)||0||
48267381|NCT03332784|100978498|FG009|STARTED|Part 1- Period 3 (1 Day)||0||
48267382|NCT03332784|100978499|FG010|STARTED|Part 1- Period 3 (1 Day)||0||
48267383|NCT03332784|100978500|FG011|STARTED|Part 1- Period 3 (1 Day)||0||
48267384|NCT03332784|100978501|FG012|STARTED|Part 1- Period 3 (1 Day)||0||
48267385|NCT03332784|100978502|FG013|STARTED|Part 1- Period 3 (1 Day)||0||
48267386|NCT03332784|100978503|FG014|STARTED|Part 1- Period 3 (1 Day)||0||
48106268|NCT04681482|100587055|FG002|STARTED|Overall Study||12148||
48106269|NCT04681482|100587056|FG003|STARTED|Overall Study||21428||
48106270|NCT04681482|100587053|FG000|COMPLETED|Overall Study||35051||
48106271|NCT04681482|100587054|FG001|COMPLETED|Overall Study||38756||
48106272|NCT04681482|100587055|FG002|COMPLETED|Overall Study||12148||
48106273|NCT04681482|100587056|FG003|COMPLETED|Overall Study||21428||
48106274|NCT04681482|100587053|FG000|NOT COMPLETED|Overall Study||0||
48106275|NCT04681482|100587054|FG001|NOT COMPLETED|Overall Study||0||
48106276|NCT04681482|100587055|FG002|NOT COMPLETED|Overall Study||0||
48106277|NCT04681482|100587056|FG003|NOT COMPLETED|Overall Study||0||
48106278|NCT02482025|100587057|FG000|STARTED|Overall Study||122||
48106279|NCT02482025|100587058|FG001|STARTED|Overall Study||118||
48106280|NCT02482025|100587057|FG000|COMPLETED|Overall Study||122||
48106281|NCT02482025|100587058|FG001|COMPLETED|Overall Study||118||
48106282|NCT02482025|100587057|FG000|NOT COMPLETED|Overall Study||0||
48106283|NCT02482025|100587058|FG001|NOT COMPLETED|Overall Study||0||
48106284|NCT01516957|100587059|FG000|STARTED|Placebo-controlled Phase||55||
48106285|NCT01516957|100587060|FG001|STARTED|Placebo-controlled Phase||57||
48106286|NCT01516957|100587061|FG002|STARTED|Placebo-controlled Phase||56||
48106287|NCT01516957|100587062|FG003|STARTED|Placebo-controlled Phase||0||
48106288|NCT01516957|100587059|FG000|COMPLETED|Placebo-controlled Phase||52||
48106289|NCT01516957|100587060|FG001|COMPLETED|Placebo-controlled Phase||53||
48106290|NCT01516957|100587061|FG002|COMPLETED|Placebo-controlled Phase||51||
48106291|NCT01516957|100587062|FG003|COMPLETED|Placebo-controlled Phase||0||
48106292|NCT01516957|100587059|FG000|NOT COMPLETED|Placebo-controlled Phase||3||
48106293|NCT01516957|100587060|FG001|NOT COMPLETED|Placebo-controlled Phase||4||
48106294|NCT01516957|100587061|FG002|NOT COMPLETED|Placebo-controlled Phase||5||
48106295|NCT01516957|100587062|FG003|NOT COMPLETED|Placebo-controlled Phase||0||
48106296|NCT01516957|100587059|FG000|STARTED|Open-label Phase||0||
48106297|NCT01516957|100587060|FG001|STARTED|Open-label Phase||0||
48106298|NCT01516957|100587061|FG002|STARTED|Open-label Phase||0||
48106299|NCT01516957|100587062|FG003|STARTED|Open-label Phase||156||
48106300|NCT01516957|100587059|FG000|COMPLETED|Open-label Phase||0||
48106301|NCT01516957|100587060|FG001|COMPLETED|Open-label Phase||0||
48106302|NCT01516957|100587061|FG002|COMPLETED|Open-label Phase||0||
48106303|NCT01516957|100587062|FG003|COMPLETED|Open-label Phase||0||
48106304|NCT01516957|100587059|FG000|NOT COMPLETED|Open-label Phase||0||
48106305|NCT01516957|100587060|FG001|NOT COMPLETED|Open-label Phase||0||
48106306|NCT01516957|100587061|FG002|NOT COMPLETED|Open-label Phase||0||
48106307|NCT01516957|100587062|FG003|NOT COMPLETED|Open-label Phase||156||
48106308|NCT01675882|100587063|FG000|STARTED|Overall Study||53||
48267387|NCT03332784|100978504|FG015|STARTED|Part 1- Period 3 (1 Day)||0||
48106309|NCT01675882|100587064|FG001|STARTED|Overall Study||56||
48106310|NCT01675882|100587065|FG002|STARTED|Overall Study||56||
48106311|NCT01675882|100587066|FG003|STARTED|Overall Study||56||
48106312|NCT01675882|100587063|FG000|COMPLETED|Overall Study||51||
48106313|NCT01675882|100587064|FG001|COMPLETED|Overall Study||49||
48106314|NCT01675882|100587065|FG002|COMPLETED|Overall Study||53||
48267388|NCT03332784|100978505|FG016|STARTED|Part 1- Period 3 (1 Day)||0||
48106315|NCT01675882|100587066|FG003|COMPLETED|Overall Study||54||
48106316|NCT01675882|100587063|FG000|NOT COMPLETED|Overall Study||2||
48106317|NCT01675882|100587064|FG001|NOT COMPLETED|Overall Study||7||
48106318|NCT01675882|100587065|FG002|NOT COMPLETED|Overall Study||3||
48106319|NCT01675882|100587066|FG003|NOT COMPLETED|Overall Study||2||
48106320|NCT01183169|100587067|FG000|STARTED|Main Phase||121||
48106321|NCT01183169|100587068|FG001|STARTED|Main Phase||115||
48267389|NCT03332784|100978506|FG017|STARTED|Part 1- Period 3 (1 Day)||0||
48267390|NCT03332784|100978507|FG018|STARTED|Part 1- Period 3 (1 Day)||0||
48267391|NCT03332784|100978508|FG019|STARTED|Part 1- Period 3 (1 Day)||0||
48267392|NCT03332784|100978489|FG000|COMPLETED|Part 1- Period 3 (1 Day)||2||
48267393|NCT03332784|100978490|FG001|COMPLETED|Part 1- Period 3 (1 Day)||1||
48267394|NCT03332784|100978491|FG002|COMPLETED|Part 1- Period 3 (1 Day)||2||
48267395|NCT03332784|100978492|FG003|COMPLETED|Part 1- Period 3 (1 Day)||2||
48267396|NCT03332784|100978493|FG004|COMPLETED|Part 1- Period 3 (1 Day)||2||
48267397|NCT03332784|100978494|FG005|COMPLETED|Part 1- Period 3 (1 Day)||2||
48267398|NCT03332784|100978495|FG006|COMPLETED|Part 1- Period 3 (1 Day)||2||
48106322|NCT01183169|100587069|FG002|STARTED|Main Phase||59||
48106323|NCT01183169|100587070|FG003|STARTED|Main Phase||55||
48106324|NCT01183169|100587071|FG004|STARTED|Main Phase||109||
48106325|NCT01183169|100587072|FG005|STARTED|Main Phase||0||
48106326|NCT01183169|100587073|FG006|STARTED|Main Phase||0||
48267399|NCT03332784|100978496|FG007|COMPLETED|Part 1- Period 3 (1 Day)||2||
48267400|NCT03332784|100978497|FG008|COMPLETED|Part 1- Period 3 (1 Day)||0||
48267401|NCT03332784|100978498|FG009|COMPLETED|Part 1- Period 3 (1 Day)||0||
48267402|NCT03332784|100978499|FG010|COMPLETED|Part 1- Period 3 (1 Day)||0||
48267403|NCT03332784|100978500|FG011|COMPLETED|Part 1- Period 3 (1 Day)||0||
48267404|NCT03332784|100978501|FG012|COMPLETED|Part 1- Period 3 (1 Day)||0||
48106327|NCT01183169|100587067|FG000|Completed Treatment|Main Phase||72||
48106328|NCT01183169|100587068|FG001|Completed Treatment|Main Phase||78||
48106329|NCT01183169|100587069|FG002|Completed Treatment|Main Phase||17||
48106330|NCT01183169|100587070|FG003|Completed Treatment|Main Phase||17||
48106331|NCT01183169|100587071|FG004|Completed Treatment|Main Phase||77||
48106332|NCT01183169|100587072|FG005|Completed Treatment|Main Phase||0||
48106333|NCT01183169|100587073|FG006|Completed Treatment|Main Phase||0||
48106334|NCT01183169|100587067|FG000|Switched to ALV|Main Phase||0||
48106335|NCT01183169|100587068|FG001|Switched to ALV|Main Phase||0||
48106336|NCT01183169|100587069|FG002|Switched to ALV|Main Phase||35||
48106337|NCT01183169|100587070|FG003|Switched to ALV|Main Phase||30||
48106338|NCT01183169|100587071|FG004|Switched to ALV|Main Phase||0||
48106339|NCT01183169|100587072|FG005|Switched to ALV|Main Phase||0||
48106340|NCT01183169|100587073|FG006|Switched to ALV|Main Phase||0||
48106341|NCT01183169|100587067|FG000|COMPLETED|Main Phase||94||
48106342|NCT01183169|100587068|FG001|COMPLETED|Main Phase||93||
48106343|NCT01183169|100587069|FG002|COMPLETED|Main Phase||18||
48106344|NCT01183169|100587070|FG003|COMPLETED|Main Phase||18||
48106345|NCT01183169|100587071|FG004|COMPLETED|Main Phase||83||
48106346|NCT01183169|100587072|FG005|COMPLETED|Main Phase||0||
48106347|NCT01183169|100587073|FG006|COMPLETED|Main Phase||0||
48106348|NCT01183169|100587067|FG000|NOT COMPLETED|Main Phase||27||
48106349|NCT01183169|100587068|FG001|NOT COMPLETED|Main Phase||22||
48106350|NCT01183169|100587069|FG002|NOT COMPLETED|Main Phase||41||
48106351|NCT01183169|100587070|FG003|NOT COMPLETED|Main Phase||37||
48106352|NCT01183169|100587071|FG004|NOT COMPLETED|Main Phase||26||
48106353|NCT01183169|100587072|FG005|NOT COMPLETED|Main Phase||0||
48106354|NCT01183169|100587073|FG006|NOT COMPLETED|Main Phase||0||
48106355|NCT01183169|100587067|FG000|STARTED|Post-switch Phase||0||
48106356|NCT01183169|100587068|FG001|STARTED|Post-switch Phase||0||
48106357|NCT01183169|100587069|FG002|STARTED|Post-switch Phase||0||
48106358|NCT01183169|100587070|FG003|STARTED|Post-switch Phase||0||
48106359|NCT01183169|100587071|FG004|STARTED|Post-switch Phase||0||
48106360|NCT01183169|100587072|FG005|STARTED|Post-switch Phase||35||
48106361|NCT01183169|100587073|FG006|STARTED|Post-switch Phase||30||
48106362|NCT01183169|100587067|FG000|Completed Treatment|Post-switch Phase||0||
48106363|NCT01183169|100587068|FG001|Completed Treatment|Post-switch Phase||0||
48106364|NCT01183169|100587069|FG002|Completed Treatment|Post-switch Phase||0||
48106365|NCT01183169|100587070|FG003|Completed Treatment|Post-switch Phase||0||
48106366|NCT01183169|100587071|FG004|Completed Treatment|Post-switch Phase||0||
48106367|NCT01183169|100587072|FG005|Completed Treatment|Post-switch Phase||12||
48106368|NCT01183169|100587073|FG006|Completed Treatment|Post-switch Phase||13||
48106369|NCT01183169|100587067|FG000|COMPLETED|Post-switch Phase||0||
48106370|NCT01183169|100587068|FG001|COMPLETED|Post-switch Phase||0||
48106371|NCT01183169|100587069|FG002|COMPLETED|Post-switch Phase||0||
48106372|NCT01183169|100587070|FG003|COMPLETED|Post-switch Phase||0||
48106373|NCT01183169|100587071|FG004|COMPLETED|Post-switch Phase||0||
48106374|NCT01183169|100587072|FG005|COMPLETED|Post-switch Phase||21||
48106375|NCT01183169|100587073|FG006|COMPLETED|Post-switch Phase||21||
48106376|NCT01183169|100587067|FG000|NOT COMPLETED|Post-switch Phase||0||
48106377|NCT01183169|100587068|FG001|NOT COMPLETED|Post-switch Phase||0||
48106378|NCT01183169|100587069|FG002|NOT COMPLETED|Post-switch Phase||0||
48106379|NCT01183169|100587070|FG003|NOT COMPLETED|Post-switch Phase||0||
48106380|NCT01183169|100587071|FG004|NOT COMPLETED|Post-switch Phase||0||
48267405|NCT03332784|100978502|FG013|COMPLETED|Part 1- Period 3 (1 Day)||0||
48106381|NCT01183169|100587072|FG005|NOT COMPLETED|Post-switch Phase||14||
48106382|NCT01183169|100587073|FG006|NOT COMPLETED|Post-switch Phase||9||
48106383|NCT02996864|100587074|FG000|STARTED|Overall Study||150||
48106384|NCT02996864|100587075|FG001|STARTED|Overall Study||150||
48106385|NCT02996864|100587074|FG000|COMPLETED|Overall Study||142||
48106386|NCT02996864|100587075|FG001|COMPLETED|Overall Study||136||
48106387|NCT02996864|100587074|FG000|NOT COMPLETED|Overall Study||8||
48106388|NCT02996864|100587075|FG001|NOT COMPLETED|Overall Study||14||
48106389|NCT00578175|100587076|FG000|STARTED|Overall Study||705||
48106390|NCT00578175|100587077|FG001|STARTED|Overall Study||689||
48106391|NCT00578175|100587078|FG002|STARTED|Overall Study||389||
48106392|NCT00578175|100587076|FG000|COMPLETED|Overall Study||635||
48106393|NCT00578175|100587077|FG001|COMPLETED|Overall Study||646||
48267406|NCT03332784|100978503|FG014|COMPLETED|Part 1- Period 3 (1 Day)||0||
48267407|NCT03332784|100978504|FG015|COMPLETED|Part 1- Period 3 (1 Day)||0||
48267408|NCT03332784|100978505|FG016|COMPLETED|Part 1- Period 3 (1 Day)||0||
48267409|NCT03332784|100978506|FG017|COMPLETED|Part 1- Period 3 (1 Day)||0||
48106394|NCT00578175|100587078|FG002|COMPLETED|Overall Study||365||
48106395|NCT00578175|100587076|FG000|NOT COMPLETED|Overall Study||70||
48106396|NCT00578175|100587077|FG001|NOT COMPLETED|Overall Study||43||
48106397|NCT00578175|100587078|FG002|NOT COMPLETED|Overall Study||24||
48106398|NCT02659020|100587079|FG000|STARTED|Overall Study||21||
48106399|NCT02659020|100587080|FG001|STARTED|Overall Study||18||
48106400|NCT02659020|100587081|FG002|STARTED|Overall Study||15||
48106401|NCT02659020|100587082|FG003|STARTED|Overall Study||81||
48106402|NCT02659020|100587083|FG004|STARTED|Overall Study||46||
48106403|NCT02659020|100587084|FG005|STARTED|Overall Study||86||
48106404|NCT02659020|100587085|FG006|STARTED|Overall Study||43||
48106405|NCT02659020|100587079|FG000|Received at Least 1 Dose of Study Drug|Overall Study||21||
48106406|NCT02659020|100587080|FG001|Received at Least 1 Dose of Study Drug|Overall Study||18||
48106407|NCT02659020|100587081|FG002|Received at Least 1 Dose of Study Drug|Overall Study||15||
48106408|NCT02659020|100587082|FG003|Received at Least 1 Dose of Study Drug|Overall Study||81||
48106409|NCT02659020|100587083|FG004|Received at Least 1 Dose of Study Drug|Overall Study||45||
48106410|NCT02659020|100587084|FG005|Received at Least 1 Dose of Study Drug|Overall Study||86||
48106411|NCT02659020|100587085|FG006|Received at Least 1 Dose of Study Drug|Overall Study||43||
48106412|NCT02659020|100587079|FG000|COMPLETED|Overall Study||18||
48106413|NCT02659020|100587080|FG001|COMPLETED|Overall Study||15||
48106414|NCT02659020|100587081|FG002|COMPLETED|Overall Study||14||
48106415|NCT02659020|100587082|FG003|COMPLETED|Overall Study||65||
48106416|NCT02659020|100587083|FG004|COMPLETED|Overall Study||40||
48106417|NCT02659020|100587084|FG005|COMPLETED|Overall Study||75||
48106418|NCT02659020|100587085|FG006|COMPLETED|Overall Study||35||
48106419|NCT02659020|100587079|FG000|NOT COMPLETED|Overall Study||3||
48106420|NCT02659020|100587080|FG001|NOT COMPLETED|Overall Study||3||
48106421|NCT02659020|100587081|FG002|NOT COMPLETED|Overall Study||1||
48106422|NCT02659020|100587082|FG003|NOT COMPLETED|Overall Study||16||
48106423|NCT02659020|100587083|FG004|NOT COMPLETED|Overall Study||6||
48106424|NCT02659020|100587084|FG005|NOT COMPLETED|Overall Study||11||
48106425|NCT02659020|100587085|FG006|NOT COMPLETED|Overall Study||8||
48106426|NCT02028988|100587086|FG000|STARTED|Overall Study||64||
48106427|NCT02028988|100587086|FG000|Evaluable if Treatment Completed|Overall Study||62||
48106428|NCT02028988|100587086|FG000|COMPLETED|Overall Study||62||
48106429|NCT02028988|100587086|FG000|NOT COMPLETED|Overall Study||2||
48106430|NCT00666757|100587087|FG000|STARTED|Overall Study||372||
48106431|NCT00666757|100587088|FG001|STARTED|Overall Study||378||
48106432|NCT00666757|100587087|FG000|COMPLETED|Overall Study||272||
48106433|NCT00666757|100587088|FG001|COMPLETED|Overall Study||281||
48106434|NCT00666757|100587087|FG000|NOT COMPLETED|Overall Study||100||
48106435|NCT00666757|100587088|FG001|NOT COMPLETED|Overall Study||97||
48106436|NCT01188603|100587089|FG000|STARTED|Overall Study||24||
48106437|NCT01188603|100587089|FG000|COMPLETED|Overall Study||24||
48106438|NCT01188603|100587089|FG000|NOT COMPLETED|Overall Study||0||
48106439|NCT01272830|100587090|FG000|STARTED|Overall Study||25||
48106440|NCT01272830|100587091|FG001|STARTED|Overall Study||26||
48106441|NCT01272830|100587090|FG000|COMPLETED|Overall Study||17||
48106442|NCT01272830|100587091|FG001|COMPLETED|Overall Study||21||
48106443|NCT01272830|100587090|FG000|NOT COMPLETED|Overall Study||8||
48106444|NCT01272830|100587091|FG001|NOT COMPLETED|Overall Study||5||
48106445|NCT00980395|100587092|FG000|STARTED|Overall Study||24||
48106446|NCT00980395|100587092|FG000|COMPLETED|Overall Study||24||
48106447|NCT00980395|100587092|FG000|NOT COMPLETED|Overall Study||0||
48106448|NCT01449526|100587093|FG000|STARTED|Overall Study||83||
48106449|NCT01449526|100587094|FG001|STARTED|Overall Study||83||
48106450|NCT01449526|100587093|FG000|COMPLETED|Overall Study||81||
48106451|NCT01449526|100587094|FG001|COMPLETED|Overall Study||77||
48106452|NCT01449526|100587093|FG000|NOT COMPLETED|Overall Study||2||
48106453|NCT01449526|100587094|FG001|NOT COMPLETED|Overall Study||6||
48106454|NCT00907374|100587095|FG000|STARTED|Overall Study||14||
48106455|NCT00907374|100587096|FG001|STARTED|Overall Study||13||
48106456|NCT00907374|100587095|FG000|COMPLETED|Overall Study||12||
48106457|NCT00907374|100587096|FG001|COMPLETED|Overall Study||11||
48106458|NCT00907374|100587095|FG000|NOT COMPLETED|Overall Study||2||
48106459|NCT00907374|100587096|FG001|NOT COMPLETED|Overall Study||2||
48106460|NCT03578081|100587097|FG000|STARTED|Overall Study||346||
48106461|NCT03578081|100587098|FG001|STARTED|Overall Study||344||
48106462|NCT03578081|100587097|FG000|COMPLETED|Overall Study||326||
48106463|NCT03578081|100587098|FG001|COMPLETED|Overall Study||320||
48106464|NCT03578081|100587097|FG000|NOT COMPLETED|Overall Study||20||
48106465|NCT03578081|100587098|FG001|NOT COMPLETED|Overall Study||24||
48106466|NCT04434131|100587099|FG000|STARTED|Overall Study||12||
48106467|NCT04434131|100587099|FG000|COMPLETED|Overall Study||12||
48106468|NCT04434131|100587099|FG000|NOT COMPLETED|Overall Study||0||
48106469|NCT03240133|100587100|FG000|STARTED|Overall Study||33||
48106470|NCT03240133|100587101|FG001|STARTED|Overall Study||14||
48106471|NCT03240133|100587102|FG002|STARTED|Overall Study||11||
48106472|NCT03240133|100587100|FG000|Completed Period 1|Overall Study||33||
48106473|NCT03240133|100587101|FG001|Completed Period 1|Overall Study||14||
48106474|NCT03240133|100587102|FG002|Completed Period 1|Overall Study||11||
48106475|NCT03240133|100587100|FG000|Completed Period 2|Overall Study||32||
48106476|NCT03240133|100587101|FG001|Completed Period 2|Overall Study||11||
48106477|NCT03240133|100587102|FG002|Completed Period 2|Overall Study||11||
48106478|NCT03240133|100587100|FG000|Completed Period 3|Overall Study||30||
48106479|NCT03240133|100587101|FG001|Completed Period 3|Overall Study||11||
48106480|NCT03240133|100587102|FG002|Completed Period 3|Overall Study||11||
48106481|NCT03240133|100587100|FG000|COMPLETED|Overall Study||30||
48106482|NCT03240133|100587101|FG001|COMPLETED|Overall Study||11||
48106483|NCT03240133|100587102|FG002|COMPLETED|Overall Study||10||
48106484|NCT03240133|100587100|FG000|NOT COMPLETED|Overall Study||3||
48106485|NCT03240133|100587101|FG001|NOT COMPLETED|Overall Study||3||
48106486|NCT03240133|100587102|FG002|NOT COMPLETED|Overall Study||1||
48106487|NCT00834210|100587103|FG000|STARTED|Overall Study||86||
48106488|NCT00834210|100587104|FG001|STARTED|Overall Study||85||
48106489|NCT00834210|100587103|FG000|COMPLETED|Overall Study||83||
48106490|NCT00834210|100587104|FG001|COMPLETED|Overall Study||77||
48106491|NCT00834210|100587103|FG000|NOT COMPLETED|Overall Study||3||
48106492|NCT00834210|100587104|FG001|NOT COMPLETED|Overall Study||8||
48106493|NCT01023581|100587105|FG000|STARTED|Overall Study||109||
48106494|NCT01023581|100587106|FG001|STARTED|Overall Study||112||
48106495|NCT01023581|100587107|FG002|STARTED|Overall Study||113||
48106496|NCT01023581|100587108|FG003|STARTED|Overall Study||114||
48106497|NCT01023581|100587109|FG004|STARTED|Overall Study||111||
48106498|NCT01023581|100587110|FG005|STARTED|Overall Study||111||
48106499|NCT01023581|100587111|FG006|STARTED|Overall Study||114||
48106500|NCT01023581|100587105|FG000|Received Study Treatment|Overall Study||106||
48106501|NCT01023581|100587106|FG001|Received Study Treatment|Overall Study||112||
48106502|NCT01023581|100587107|FG002|Received Study Treatment|Overall Study||110||
48106503|NCT01023581|100587108|FG003|Received Study Treatment|Overall Study||109||
48106504|NCT01023581|100587109|FG004|Received Study Treatment|Overall Study||111||
48106505|NCT01023581|100587110|FG005|Received Study Treatment|Overall Study||106||
48106506|NCT01023581|100587111|FG006|Received Study Treatment|Overall Study||114||
48106507|NCT01023581|100587105|FG000|COMPLETED|Overall Study||74||
48106508|NCT01023581|100587106|FG001|COMPLETED|Overall Study||89||
48106509|NCT01023581|100587107|FG002|COMPLETED|Overall Study||71||
48106510|NCT01023581|100587108|FG003|COMPLETED|Overall Study||94||
48106511|NCT01023581|100587109|FG004|COMPLETED|Overall Study||95||
48106512|NCT01023581|100587110|FG005|COMPLETED|Overall Study||92||
48106513|NCT01023581|100587111|FG006|COMPLETED|Overall Study||94||
48106514|NCT01023581|100587105|FG000|NOT COMPLETED|Overall Study||35||
48106515|NCT01023581|100587106|FG001|NOT COMPLETED|Overall Study||23||
48106516|NCT01023581|100587107|FG002|NOT COMPLETED|Overall Study||42||
48106517|NCT01023581|100587108|FG003|NOT COMPLETED|Overall Study||20||
48106518|NCT01023581|100587109|FG004|NOT COMPLETED|Overall Study||16||
48106519|NCT01023581|100587110|FG005|NOT COMPLETED|Overall Study||19||
48106520|NCT01023581|100587111|FG006|NOT COMPLETED|Overall Study||20||
48106521|NCT00913744|100587112|FG000|STARTED|Overall Study||75||
48106522|NCT00913744|100587113|FG001|STARTED|Overall Study||25||
48106523|NCT00913744|100587112|FG000|COMPLETED|Overall Study||70||
48106524|NCT00913744|100587113|FG001|COMPLETED|Overall Study||24||
48106525|NCT00913744|100587112|FG000|NOT COMPLETED|Overall Study||5||
48106526|NCT00913744|100587113|FG001|NOT COMPLETED|Overall Study||1||
48106527|NCT02253810|100587114|FG000|STARTED|Overall Study||45||
48106528|NCT02253810|100587115|FG001|STARTED|Overall Study||44||
48106529|NCT02253810|100587114|FG000|COMPLETED|Overall Study||40||
48106530|NCT02253810|100587115|FG001|COMPLETED|Overall Study||41||
48106531|NCT02253810|100587114|FG000|NOT COMPLETED|Overall Study||5||
48106532|NCT02253810|100587115|FG001|NOT COMPLETED|Overall Study||3||
48106533|NCT01120756|100587116|FG000|STARTED|Overall Study||21||
48267410|NCT03332784|100978507|FG018|COMPLETED|Part 1- Period 3 (1 Day)||0||
48267411|NCT03332784|100978508|FG019|COMPLETED|Part 1- Period 3 (1 Day)||0||
48267412|NCT03332784|100978489|FG000|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
48267413|NCT03332784|100978490|FG001|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
48267414|NCT03332784|100978491|FG002|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
48267415|NCT03332784|100978492|FG003|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
48267416|NCT03332784|100978493|FG004|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
48267417|NCT03332784|100978494|FG005|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
48267418|NCT03332784|100978495|FG006|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
48267419|NCT03332784|100978496|FG007|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
48267420|NCT03332784|100978497|FG008|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
48106534|NCT01120756|100587117|FG001|STARTED|Overall Study||14||
48106535|NCT01120756|100587116|FG000|COMPLETED|Overall Study||20||
48106536|NCT01120756|100587117|FG001|COMPLETED|Overall Study||13||
48106537|NCT01120756|100587116|FG000|NOT COMPLETED|Overall Study||1||
48106538|NCT01120756|100587117|FG001|NOT COMPLETED|Overall Study||1||
48106539|NCT00594061|100587118|FG000|STARTED|Overall Study||9||
48106540|NCT00594061|100587118|FG000|COMPLETED|Overall Study||9||
48106541|NCT00594061|100587118|FG000|NOT COMPLETED|Overall Study||0||
48106542|NCT00394212|100587119|FG000|STARTED|Overall Study||50||
48106543|NCT00394212|100587120|FG001|STARTED|Overall Study||27||
48106544|NCT00394212|100587119|FG000|6 Week Follow-up|Overall Study||45||
48106545|NCT00394212|100587120|FG001|6 Week Follow-up|Overall Study||26||
48106546|NCT00394212|100587119|FG000|3 Month Follow-up|Overall Study||45||
48106547|NCT00394212|100587120|FG001|3 Month Follow-up|Overall Study||26||
48267421|NCT03332784|100978498|FG009|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
48106548|NCT00394212|100587119|FG000|6 Month Follow-up|Overall Study||43||
48106549|NCT00394212|100587120|FG001|6 Month Follow-up|Overall Study||26||
48106550|NCT00394212|100587119|FG000|COMPLETED|Overall Study||43||
48267422|NCT03332784|100978499|FG010|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
48267423|NCT03332784|100978500|FG011|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
48267424|NCT03332784|100978501|FG012|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
48267425|NCT03332784|100978502|FG013|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
48267426|NCT03332784|100978503|FG014|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
48267427|NCT03332784|100978504|FG015|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
48267428|NCT03332784|100978505|FG016|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
48267429|NCT03332784|100978506|FG017|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
48267430|NCT03332784|100978507|FG018|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
48267431|NCT03332784|100978508|FG019|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
48267432|NCT00953147|100978509|FG000|STARTED|Overall Study||298||
48267433|NCT00953147|100978510|FG001|STARTED|Overall Study||505||
48267434|NCT00953147|100978511|FG002|STARTED|Overall Study||307||
48267435|NCT00953147|100978509|FG000|COMPLETED|Overall Study||261||
48267436|NCT00953147|100978510|FG001|COMPLETED|Overall Study||439||
48267437|NCT00953147|100978511|FG002|COMPLETED|Overall Study||265||
48267438|NCT00953147|100978509|FG000|NOT COMPLETED|Overall Study||37||
48392011|NCT00618995|101287774|FG000|NOT COMPLETED|Period 4||1||
48392012|NCT00618995|101287775|FG001|NOT COMPLETED|Period 4||0||
48392013|NCT00618995|101287776|FG002|NOT COMPLETED|Period 4||0||
48106551|NCT00394212|100587120|FG001|COMPLETED|Overall Study||26||
48106552|NCT00394212|100587119|FG000|NOT COMPLETED|Overall Study||7||
48106553|NCT00394212|100587120|FG001|NOT COMPLETED|Overall Study||1||
48392014|NCT00618995|101287777|FG003|NOT COMPLETED|Period 4||0||
48392015|NCT00284739|101287778|FG000|STARTED|Overall Study||11||
48392016|NCT00284739|101287779|FG001|STARTED|Overall Study||9||
48392017|NCT00284739|101287778|FG000|COMPLETED|Overall Study||11||
48106554|NCT00694369|100587121|FG000|STARTED|Overall Study||46||
48106555|NCT00694369|100587122|FG001|STARTED|Overall Study||191||
48106556|NCT00694369|100587123|FG002|STARTED|Overall Study||97||
48106557|NCT00694369|100587124|FG003|STARTED|Overall Study||192||
48106558|NCT00694369|100587125|FG004|STARTED|Overall Study||62||
48106559|NCT00694369|100587121|FG000|COMPLETED|Overall Study||45||
48106560|NCT00694369|100587122|FG001|COMPLETED|Overall Study||188||
48106561|NCT00694369|100587123|FG002|COMPLETED|Overall Study||95||
48106562|NCT00694369|100587124|FG003|COMPLETED|Overall Study||189||
48106563|NCT00694369|100587125|FG004|COMPLETED|Overall Study||56||
48106564|NCT00694369|100587121|FG000|NOT COMPLETED|Overall Study||1||
48106565|NCT00694369|100587122|FG001|NOT COMPLETED|Overall Study||3||
48106566|NCT00694369|100587123|FG002|NOT COMPLETED|Overall Study||2||
48106567|NCT00694369|100587124|FG003|NOT COMPLETED|Overall Study||3||
48106568|NCT00694369|100587125|FG004|NOT COMPLETED|Overall Study||6||
48106569|NCT03090100|100587126|FG000|STARTED|Overall Study||534||
48267439|NCT00953147|100978510|FG001|NOT COMPLETED|Overall Study||66||
48267440|NCT00953147|100978511|FG002|NOT COMPLETED|Overall Study||42||
48267441|NCT01358331|100978512|FG000|STARTED|Overall Study||2||
48267442|NCT01358331|100978513|FG001|STARTED|Overall Study||3||
48267443|NCT01358331|100978514|FG002|STARTED|Overall Study||4||
48267444|NCT01358331|100978515|FG003|STARTED|Overall Study||3||
48267445|NCT01358331|100978516|FG004|STARTED|Overall Study||7||
48267446|NCT01358331|100978517|FG005|STARTED|Overall Study||6||
48267447|NCT01358331|100978512|FG000|COMPLETED|Overall Study||0||
48267448|NCT01358331|100978513|FG001|COMPLETED|Overall Study||0||
48267449|NCT01358331|100978514|FG002|COMPLETED|Overall Study||0||
48267450|NCT01358331|100978515|FG003|COMPLETED|Overall Study||0||
48267451|NCT01358331|100978516|FG004|COMPLETED|Overall Study||0||
48267452|NCT01358331|100978517|FG005|COMPLETED|Overall Study||0||
48267453|NCT01358331|100978512|FG000|NOT COMPLETED|Overall Study||2||
48267454|NCT01358331|100978513|FG001|NOT COMPLETED|Overall Study||3||
48392018|NCT00284739|101287779|FG001|COMPLETED|Overall Study||9||
48392019|NCT00284739|101287778|FG000|NOT COMPLETED|Overall Study||0||
48106570|NCT03090100|100587127|FG001|STARTED|Overall Study||514||
48106571|NCT03090100|100587126|FG000|Treated|Overall Study||534||
48106572|NCT03090100|100587127|FG001|Treated|Overall Study||511||
48106573|NCT03090100|100587126|FG000|COMPLETED|Overall Study||507||
48106574|NCT03090100|100587127|FG001|COMPLETED|Overall Study||466||
48106575|NCT03090100|100587126|FG000|NOT COMPLETED|Overall Study||27||
48106576|NCT03090100|100587127|FG001|NOT COMPLETED|Overall Study||48||
48106577|NCT03979638|100587128|FG000|STARTED|Period 1||33||
48106578|NCT03979638|100587129|FG001|STARTED|Period 1||35||
48106579|NCT03979638|100587128|FG000|COMPLETED|Period 1||26||
48106580|NCT03979638|100587129|FG001|COMPLETED|Period 1||28||
48267455|NCT01358331|100978514|FG002|NOT COMPLETED|Overall Study||4||
48267456|NCT01358331|100978515|FG003|NOT COMPLETED|Overall Study||3||
48392020|NCT00284739|101287779|FG001|NOT COMPLETED|Overall Study||0||
48392021|NCT03874351|101287780|FG000|STARTED|Overall Study||11||
48267457|NCT01358331|100978516|FG004|NOT COMPLETED|Overall Study||7||
48267458|NCT01358331|100978517|FG005|NOT COMPLETED|Overall Study||6||
48267459|NCT00414167|100978518|FG000|STARTED|Overall Study||31||
48267460|NCT00414167|100978519|FG001|STARTED|Overall Study||30||
48267461|NCT00414167|100978518|FG000|COMPLETED|Overall Study||27||
48267462|NCT00414167|100978519|FG001|COMPLETED|Overall Study||27||
48267463|NCT00414167|100978518|FG000|NOT COMPLETED|Overall Study||4||
48267464|NCT00414167|100978519|FG001|NOT COMPLETED|Overall Study||3||
48267465|NCT03603639|100978520|FG000|STARTED|Treatment Period 1 (Day 1)||1||
48267466|NCT03603639|100978521|FG001|STARTED|Treatment Period 1 (Day 1)||1||
48267467|NCT03603639|100978522|FG002|STARTED|Treatment Period 1 (Day 1)||1||
48267468|NCT03603639|100978523|FG003|STARTED|Treatment Period 1 (Day 1)||1||
48267469|NCT03603639|100978524|FG004|STARTED|Treatment Period 1 (Day 1)||1||
48267470|NCT03603639|100978525|FG005|STARTED|Treatment Period 1 (Day 1)||1||
48267471|NCT03603639|100978520|FG000|COMPLETED|Treatment Period 1 (Day 1)||1||
48267472|NCT03603639|100978521|FG001|COMPLETED|Treatment Period 1 (Day 1)||1||
48267473|NCT03603639|100978522|FG002|COMPLETED|Treatment Period 1 (Day 1)||1||
48267474|NCT03603639|100978523|FG003|COMPLETED|Treatment Period 1 (Day 1)||1||
48267475|NCT03603639|100978524|FG004|COMPLETED|Treatment Period 1 (Day 1)||1||
48267476|NCT03603639|100978525|FG005|COMPLETED|Treatment Period 1 (Day 1)||1||
48267477|NCT03603639|100978520|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48267478|NCT03603639|100978521|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48267479|NCT03603639|100978522|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48267480|NCT03603639|100978523|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48267481|NCT03603639|100978524|FG004|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48267482|NCT03603639|100978525|FG005|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48267483|NCT03603639|100978520|FG000|STARTED|Washout Period (at Least 3 Weeks)||1||
48267484|NCT03603639|100978521|FG001|STARTED|Washout Period (at Least 3 Weeks)||1||
48267485|NCT03603639|100978522|FG002|STARTED|Washout Period (at Least 3 Weeks)||1||
48267486|NCT03603639|100978523|FG003|STARTED|Washout Period (at Least 3 Weeks)||1||
48267487|NCT03603639|100978524|FG004|STARTED|Washout Period (at Least 3 Weeks)||1||
48267488|NCT03603639|100978525|FG005|STARTED|Washout Period (at Least 3 Weeks)||1||
48267489|NCT03603639|100978520|FG000|COMPLETED|Washout Period (at Least 3 Weeks)||1||
48267490|NCT03603639|100978521|FG001|COMPLETED|Washout Period (at Least 3 Weeks)||1||
48267491|NCT03603639|100978522|FG002|COMPLETED|Washout Period (at Least 3 Weeks)||1||
48267492|NCT03603639|100978523|FG003|COMPLETED|Washout Period (at Least 3 Weeks)||1||
48267493|NCT03603639|100978524|FG004|COMPLETED|Washout Period (at Least 3 Weeks)||1||
48267494|NCT03603639|100978525|FG005|COMPLETED|Washout Period (at Least 3 Weeks)||1||
48267495|NCT03603639|100978520|FG000|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0||
48267496|NCT03603639|100978521|FG001|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0||
48267497|NCT03603639|100978522|FG002|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0||
48267498|NCT03603639|100978523|FG003|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0||
48267499|NCT03603639|100978524|FG004|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0||
48267500|NCT03603639|100978525|FG005|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0||
48267501|NCT03603639|100978520|FG000|STARTED|Treatment Period 2 (Day 1)||1||
48267502|NCT03603639|100978521|FG001|STARTED|Treatment Period 2 (Day 1)||1||
48267503|NCT03603639|100978522|FG002|STARTED|Treatment Period 2 (Day 1)||1||
48267504|NCT03603639|100978523|FG003|STARTED|Treatment Period 2 (Day 1)||1||
48267505|NCT03603639|100978524|FG004|STARTED|Treatment Period 2 (Day 1)||1||
48267506|NCT03603639|100978525|FG005|STARTED|Treatment Period 2 (Day 1)||1||
48267507|NCT03603639|100978520|FG000|COMPLETED|Treatment Period 2 (Day 1)||1||
48267508|NCT03603639|100978521|FG001|COMPLETED|Treatment Period 2 (Day 1)||1||
48267509|NCT03603639|100978522|FG002|COMPLETED|Treatment Period 2 (Day 1)||1||
48267510|NCT03603639|100978523|FG003|COMPLETED|Treatment Period 2 (Day 1)||1||
48267511|NCT03603639|100978524|FG004|COMPLETED|Treatment Period 2 (Day 1)||1||
48267512|NCT03603639|100978525|FG005|COMPLETED|Treatment Period 2 (Day 1)||1||
48267513|NCT03603639|100978520|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
48267514|NCT03603639|100978521|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
48267515|NCT03603639|100978522|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
48267516|NCT03603639|100978523|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
48267517|NCT03603639|100978524|FG004|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
48267518|NCT03603639|100978525|FG005|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
48267519|NCT03603639|100978520|FG000|STARTED|Washout Period (at Least 3 Weeks)||1||
48267520|NCT03603639|100978521|FG001|STARTED|Washout Period (at Least 3 Weeks)||1||
48267521|NCT03603639|100978522|FG002|STARTED|Washout Period (at Least 3 Weeks)||1||
48267522|NCT03603639|100978523|FG003|STARTED|Washout Period (at Least 3 Weeks)||1||
48267523|NCT03603639|100978524|FG004|STARTED|Washout Period (at Least 3 Weeks)||1||
48267524|NCT03603639|100978525|FG005|STARTED|Washout Period (at Least 3 Weeks)||1||
48267525|NCT03603639|100978520|FG000|COMPLETED|Washout Period (at Least 3 Weeks)||1||
48267526|NCT03603639|100978521|FG001|COMPLETED|Washout Period (at Least 3 Weeks)||1||
48267527|NCT03603639|100978522|FG002|COMPLETED|Washout Period (at Least 3 Weeks)||0||
48267528|NCT03603639|100978523|FG003|COMPLETED|Washout Period (at Least 3 Weeks)||0||
48267529|NCT03603639|100978524|FG004|COMPLETED|Washout Period (at Least 3 Weeks)||0||
48267530|NCT03603639|100978525|FG005|COMPLETED|Washout Period (at Least 3 Weeks)||0||
48267531|NCT03603639|100978520|FG000|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0||
48267532|NCT03603639|100978521|FG001|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0||
48267533|NCT03603639|100978522|FG002|NOT COMPLETED|Washout Period (at Least 3 Weeks)||1||
48267534|NCT03603639|100978523|FG003|NOT COMPLETED|Washout Period (at Least 3 Weeks)||1||
48267535|NCT03603639|100978524|FG004|NOT COMPLETED|Washout Period (at Least 3 Weeks)||1||
48267536|NCT03603639|100978525|FG005|NOT COMPLETED|Washout Period (at Least 3 Weeks)||1||
48267537|NCT03603639|100978520|FG000|STARTED|Treatment Period 3 (Day 1)||1||
48267538|NCT03603639|100978521|FG001|STARTED|Treatment Period 3 (Day 1)||1||
48267539|NCT03603639|100978522|FG002|STARTED|Treatment Period 3 (Day 1)||0||
48267540|NCT03603639|100978523|FG003|STARTED|Treatment Period 3 (Day 1)||0||
48267541|NCT03603639|100978524|FG004|STARTED|Treatment Period 3 (Day 1)||0||
48267542|NCT03603639|100978525|FG005|STARTED|Treatment Period 3 (Day 1)||0||
48267543|NCT03603639|100978520|FG000|COMPLETED|Treatment Period 3 (Day 1)||1||
48106581|NCT03979638|100587128|FG000|NOT COMPLETED|Period 1||7||
48106582|NCT03979638|100587129|FG001|NOT COMPLETED|Period 1||7||
48106583|NCT03979638|100587128|FG000|STARTED|Period 2||26||
48106584|NCT03979638|100587129|FG001|STARTED|Period 2||28||
48106585|NCT03979638|100587128|FG000|COMPLETED|Period 2||25||
48106586|NCT03979638|100587129|FG001|COMPLETED|Period 2||27||
48106587|NCT03979638|100587128|FG000|NOT COMPLETED|Period 2||1||
48106588|NCT03979638|100587129|FG001|NOT COMPLETED|Period 2||1||
48267544|NCT03603639|100978521|FG001|COMPLETED|Treatment Period 3 (Day 1)||1||
48267545|NCT03603639|100978522|FG002|COMPLETED|Treatment Period 3 (Day 1)||0||
48267546|NCT03603639|100978523|FG003|COMPLETED|Treatment Period 3 (Day 1)||0||
48267547|NCT03603639|100978524|FG004|COMPLETED|Treatment Period 3 (Day 1)||0||
48267548|NCT03603639|100978525|FG005|COMPLETED|Treatment Period 3 (Day 1)||0||
48267549|NCT03603639|100978520|FG000|NOT COMPLETED|Treatment Period 3 (Day 1)||0||
48267550|NCT03603639|100978521|FG001|NOT COMPLETED|Treatment Period 3 (Day 1)||0||
48267551|NCT03603639|100978522|FG002|NOT COMPLETED|Treatment Period 3 (Day 1)||0||
48267552|NCT03603639|100978523|FG003|NOT COMPLETED|Treatment Period 3 (Day 1)||0||
48267553|NCT03603639|100978524|FG004|NOT COMPLETED|Treatment Period 3 (Day 1)||0||
48267554|NCT03603639|100978525|FG005|NOT COMPLETED|Treatment Period 3 (Day 1)||0||
48392022|NCT03874351|101287781|FG001|STARTED|Overall Study||11||
48392023|NCT03874351|101287780|FG000|COMPLETED|Overall Study||7||
48392024|NCT03874351|101287781|FG001|COMPLETED|Overall Study||9||
48392025|NCT03874351|101287780|FG000|NOT COMPLETED|Overall Study||4||
48392026|NCT03874351|101287781|FG001|NOT COMPLETED|Overall Study||2||
48392027|NCT00671723|101287782|FG000|STARTED|Overall Study||11||
48392028|NCT00671723|101287783|FG001|STARTED|Overall Study||11||
48392029|NCT00671723|101287784|FG002|STARTED|Overall Study||11||
48392030|NCT00671723|101287782|FG000|COMPLETED|Overall Study||11||
48392031|NCT00671723|101287783|FG001|COMPLETED|Overall Study||11||
48392032|NCT00671723|101287784|FG002|COMPLETED|Overall Study||11||
48392033|NCT00671723|101287782|FG000|NOT COMPLETED|Overall Study||0||
48392034|NCT00671723|101287783|FG001|NOT COMPLETED|Overall Study||0||
48392035|NCT00671723|101287784|FG002|NOT COMPLETED|Overall Study||0||
48392036|NCT03199638|101287785|FG000|STARTED|Overall Study||7||
48392037|NCT03199638|101287786|FG001|STARTED|Overall Study||7||
48392038|NCT03199638|101287785|FG000|COMPLETED|Overall Study||7||
48392039|NCT03199638|101287786|FG001|COMPLETED|Overall Study||5||
48392040|NCT03199638|101287785|FG000|NOT COMPLETED|Overall Study||0||
48392041|NCT03199638|101287786|FG001|NOT COMPLETED|Overall Study||2||
48392042|NCT01746940|101287787|FG000|STARTED|Safety and Efficacy First Phase||39||
48392043|NCT01746940|101287788|FG001|STARTED|Safety and Efficacy First Phase||41||
48392044|NCT01746940|101287789|FG002|STARTED|Safety and Efficacy First Phase||40||
48392045|NCT01746940|101287790|FG003|STARTED|Safety and Efficacy First Phase||3||
48392046|NCT01746940|101287787|FG000|COMPLETED|Safety and Efficacy First Phase||39||
48392047|NCT01746940|101287788|FG001|COMPLETED|Safety and Efficacy First Phase||41||
48392048|NCT01746940|101287789|FG002|COMPLETED|Safety and Efficacy First Phase||40||
48392049|NCT01746940|101287790|FG003|COMPLETED|Safety and Efficacy First Phase||0||
48392050|NCT01746940|101287787|FG000|NOT COMPLETED|Safety and Efficacy First Phase||0||
48392051|NCT01746940|101287788|FG001|NOT COMPLETED|Safety and Efficacy First Phase||0||
48392052|NCT01746940|101287789|FG002|NOT COMPLETED|Safety and Efficacy First Phase||0||
48392053|NCT01746940|101287790|FG003|NOT COMPLETED|Safety and Efficacy First Phase||3||
48392054|NCT01746940|101287787|FG000|STARTED|Safety Second Phase||18||
48392055|NCT01746940|101287788|FG001|STARTED|Safety Second Phase||18||
48392056|NCT01746940|101287789|FG002|STARTED|Safety Second Phase||0||
48392057|NCT01746940|101287790|FG003|STARTED|Safety Second Phase||0||
48392058|NCT01746940|101287787|FG000|COMPLETED|Safety Second Phase||18||
48392059|NCT01746940|101287788|FG001|COMPLETED|Safety Second Phase||18||
48267555|NCT00790400|100978526|FG000|STARTED|Double-blind Period (Core Phase)||79||
48392060|NCT01746940|101287789|FG002|COMPLETED|Safety Second Phase||0||
48392061|NCT01746940|101287790|FG003|COMPLETED|Safety Second Phase||0||
48392062|NCT01746940|101287787|FG000|NOT COMPLETED|Safety Second Phase||0||
48392063|NCT01746940|101287788|FG001|NOT COMPLETED|Safety Second Phase||0||
48392064|NCT01746940|101287789|FG002|NOT COMPLETED|Safety Second Phase||0||
48392065|NCT01746940|101287790|FG003|NOT COMPLETED|Safety Second Phase||0||
48106589|NCT00500292|100587130|FG000|STARTED|Overall Study||32||
48106590|NCT00500292|100587131|FG001|STARTED|Overall Study||35||
48106591|NCT00500292|100587132|FG002|STARTED|Overall Study||37||
48392066|NCT00387348|101287791|FG000|STARTED|Overall Study||8||
48267556|NCT00790400|100978527|FG001|STARTED|Double-blind Period (Core Phase)||39||
48267557|NCT00790400|100978526|FG000|COMPLETED|Double-blind Period (Core Phase)||72||
48267558|NCT00790400|100978527|FG001|COMPLETED|Double-blind Period (Core Phase)||26||
48392067|NCT00387348|101287792|FG001|STARTED|Overall Study||5||
48392068|NCT00387348|101287793|FG002|STARTED|Overall Study||11||
48267559|NCT00790400|100978526|FG000|NOT COMPLETED|Double-blind Period (Core Phase)||7||
48267560|NCT00790400|100978527|FG001|NOT COMPLETED|Double-blind Period (Core Phase)||13||
48267561|NCT00790400|100978526|FG000|STARTED|Everolimus Period (Core or Extension)||112||
48267562|NCT00790400|100978527|FG001|STARTED|Everolimus Period (Core or Extension)||0||
48267563|NCT00790400|100978526|FG000|COMPLETED|Everolimus Period (Core or Extension)||83||
48267564|NCT00790400|100978527|FG001|COMPLETED|Everolimus Period (Core or Extension)||0||
48267565|NCT00790400|100978526|FG000|NOT COMPLETED|Everolimus Period (Core or Extension)||29||
48267566|NCT00790400|100978527|FG001|NOT COMPLETED|Everolimus Period (Core or Extension)||0||
48267567|NCT02671500|100978528|FG000|STARTED|Overall Study||375||
48267568|NCT02671500|100978528|FG000|COMPLETED|Overall Study||361||
48267569|NCT02671500|100978528|FG000|NOT COMPLETED|Overall Study||14||
48267570|NCT02251236|100978529|FG000|STARTED|Overall Study||9||
48267571|NCT02251236|100978530|FG001|STARTED|Overall Study||5||
48267572|NCT02251236|100978531|FG002|STARTED|Overall Study||0||
48267573|NCT02251236|100978529|FG000|COMPLETED|Overall Study||9||
48267574|NCT02251236|100978530|FG001|COMPLETED|Overall Study||5||
48267575|NCT02251236|100978531|FG002|COMPLETED|Overall Study||0||
48267576|NCT02251236|100978529|FG000|NOT COMPLETED|Overall Study||0||
48267577|NCT02251236|100978530|FG001|NOT COMPLETED|Overall Study||0||
48267578|NCT02251236|100978531|FG002|NOT COMPLETED|Overall Study||0||
48267579|NCT03167151|100978532|FG000|STARTED|Overall Study||3||
48267580|NCT03167151|100978533|FG001|STARTED|Overall Study||3||
48267581|NCT03167151|100978534|FG002|STARTED|Overall Study||3||
48267582|NCT03167151|100978532|FG000|COMPLETED|Overall Study||2||
48267583|NCT03167151|100978533|FG001|COMPLETED|Overall Study||2||
48267584|NCT03167151|100978534|FG002|COMPLETED|Overall Study||2||
48267585|NCT03167151|100978532|FG000|NOT COMPLETED|Overall Study||1||
48267586|NCT03167151|100978533|FG001|NOT COMPLETED|Overall Study||1||
48267587|NCT03167151|100978534|FG002|NOT COMPLETED|Overall Study||1||
48267588|NCT01371825|100978535|FG000|STARTED|Overall Study||9||
48267589|NCT01371825|100978535|FG000|Received at Least 1 Dose of Study Drug|Overall Study||9||
48267590|NCT01371825|100978535|FG000|COMPLETED|Overall Study||5||
48267591|NCT01371825|100978535|FG000|NOT COMPLETED|Overall Study||4||
48267592|NCT02229578|100978536|FG000|STARTED|Overall Study||19||
48267593|NCT02229578|100978537|FG001|STARTED|Overall Study||15||
48267594|NCT02229578|100978536|FG000|COMPLETED|Overall Study||16||
48267595|NCT02229578|100978537|FG001|COMPLETED|Overall Study||12||
48267596|NCT02229578|100978536|FG000|NOT COMPLETED|Overall Study||3||
48267597|NCT02229578|100978537|FG001|NOT COMPLETED|Overall Study||3||
48267598|NCT01100606|100978538|FG000|STARTED|First Treatment Period||8||
48267599|NCT01100606|100978539|FG001|STARTED|First Treatment Period||7||
48267600|NCT01100606|100978538|FG000|COMPLETED|First Treatment Period||8||
48267601|NCT01100606|100978539|FG001|COMPLETED|First Treatment Period||7||
48267602|NCT01100606|100978538|FG000|NOT COMPLETED|First Treatment Period||0||
48267603|NCT01100606|100978539|FG001|NOT COMPLETED|First Treatment Period||0||
48267604|NCT01100606|100978538|FG000|STARTED|Second Treatment Period||8||
48267605|NCT01100606|100978539|FG001|STARTED|Second Treatment Period||7||
48267606|NCT01100606|100978538|FG000|COMPLETED|Second Treatment Period||8||
48267607|NCT01100606|100978539|FG001|COMPLETED|Second Treatment Period||7||
48267608|NCT01100606|100978538|FG000|NOT COMPLETED|Second Treatment Period||0||
48267609|NCT01100606|100978539|FG001|NOT COMPLETED|Second Treatment Period||0||
48267610|NCT04121897|100978540|FG000|STARTED|Overall Study||68||
48267611|NCT04121897|100978540|FG000|Parents|Overall Study||32||
48267612|NCT04121897|100978540|FG000|Infants|Overall Study||36||
48267613|NCT04121897|100978540|FG000|COMPLETED|Overall Study||37||
48267614|NCT04121897|100978540|FG000|NOT COMPLETED|Overall Study||31||
48267615|NCT02560753|100978541|FG000|STARTED|Overall Study||9||
48267616|NCT02560753|100978542|FG001|STARTED|Overall Study||9||
48267617|NCT02560753|100978543|FG002|STARTED|Overall Study||10||
48267618|NCT02560753|100978544|FG003|STARTED|Overall Study||8||
48267619|NCT02560753|100978541|FG000|COMPLETED|Overall Study||8||
48267620|NCT02560753|100978542|FG001|COMPLETED|Overall Study||9||
48267621|NCT02560753|100978543|FG002|COMPLETED|Overall Study||9||
48267622|NCT02560753|100978544|FG003|COMPLETED|Overall Study||8||
48267623|NCT02560753|100978541|FG000|NOT COMPLETED|Overall Study||1||
48267624|NCT02560753|100978542|FG001|NOT COMPLETED|Overall Study||0||
48267625|NCT02560753|100978543|FG002|NOT COMPLETED|Overall Study||1||
48267626|NCT02560753|100978544|FG003|NOT COMPLETED|Overall Study||0||
48267627|NCT04843579|100978545|FG000|STARTED|Overall Study||4||
48267628|NCT04843579|100978545|FG000|COMPLETED|Overall Study||2||
48267629|NCT04843579|100978545|FG000|NOT COMPLETED|Overall Study||2||
48267630|NCT00903760|100978546|FG000|STARTED|Overall Study||19||
48267631|NCT00903760|100978547|FG001|STARTED|Overall Study||18||
48267632|NCT00903760|100978546|FG000|COMPLETED|Overall Study||0||
48267633|NCT00903760|100978547|FG001|COMPLETED|Overall Study||2||
48267634|NCT00903760|100978546|FG000|NOT COMPLETED|Overall Study||19||
48267635|NCT00903760|100978547|FG001|NOT COMPLETED|Overall Study||16||
48267636|NCT01250509|100978548|FG000|STARTED|Overall Study||24||
48267637|NCT01250509|100978549|FG001|STARTED|Overall Study||23||
48267638|NCT01250509|100978548|FG000|COMPLETED|Overall Study||19||
48267639|NCT01250509|100978549|FG001|COMPLETED|Overall Study||21||
48267640|NCT01250509|100978548|FG000|NOT COMPLETED|Overall Study||5||
48267641|NCT01250509|100978549|FG001|NOT COMPLETED|Overall Study||2||
48106592|NCT00500292|100587130|FG000|COMPLETED|Overall Study||7||
48106593|NCT00500292|100587131|FG001|COMPLETED|Overall Study||4||
48106594|NCT00500292|100587132|FG002|COMPLETED|Overall Study||10||
48106595|NCT00500292|100587130|FG000|NOT COMPLETED|Overall Study||25||
48106596|NCT00500292|100587131|FG001|NOT COMPLETED|Overall Study||31||
48106597|NCT00500292|100587132|FG002|NOT COMPLETED|Overall Study||27||
48106598|NCT00314574|100587133|FG000|STARTED|Overall Study||423||
48106599|NCT00314574|100587134|FG001|STARTED|Overall Study||427||
48106600|NCT00314574|100587133|FG000|Received at Least One Dose of Study Drug|Overall Study||421||
48106601|NCT00314574|100587134|FG001|Received at Least One Dose of Study Drug|Overall Study||427||
48106602|NCT00314574|100587133|FG000|Safety Population|Overall Study||420||
48106603|NCT00314574|100587134|FG001|Safety Population|Overall Study||428||
48106604|NCT00314574|100587133|FG000|COMPLETED|Overall Study||329||
48106605|NCT00314574|100587134|FG001|COMPLETED|Overall Study||344||
48106606|NCT00314574|100587133|FG000|NOT COMPLETED|Overall Study||94||
48106607|NCT00314574|100587134|FG001|NOT COMPLETED|Overall Study||83||
48106608|NCT01965288|100587135|FG000|STARTED|Overall Study||30||
48106609|NCT01965288|100587136|FG001|STARTED|Overall Study||30||
48267642|NCT03994731|100978550|FG000|STARTED|Run-in Period (From Week -4 to Day 1)||100|Randomized|
48267643|NCT03994731|100978551|FG001|STARTED|Run-in Period (From Week -4 to Day 1)||52|Randomized|
48267644|NCT03994731|100978550|FG000|Took at Least 1 Dose of MTX or Placebo|Run-in Period (From Week -4 to Day 1)||98||
48267645|NCT03994731|100978551|FG001|Took at Least 1 Dose of MTX or Placebo|Run-in Period (From Week -4 to Day 1)||51||
48267646|NCT03994731|100978550|FG000|COMPLETED|Run-in Period (From Week -4 to Day 1)||96||
48267647|NCT03994731|100978551|FG001|COMPLETED|Run-in Period (From Week -4 to Day 1)||49||
48267648|NCT03994731|100978550|FG000|NOT COMPLETED|Run-in Period (From Week -4 to Day 1)||4||
48267649|NCT03994731|100978551|FG001|NOT COMPLETED|Run-in Period (From Week -4 to Day 1)||3||
48552111|NCT00451178|101683320|FG000|NOT COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||18||
48692521|NCT03520920|102032589|FG002|STARTED|Overall Study||5||
48692522|NCT03520920|102032587|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20||
48692523|NCT03520920|102032588|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16||
48692524|NCT03520920|102032589|FG002|Received at Least 1 Dose of Study Drug|Overall Study||5||
48692525|NCT03520920|102032587|FG000|COMPLETED|Overall Study||0||
48692526|NCT03520920|102032588|FG001|COMPLETED|Overall Study||0||
48692527|NCT03520920|102032589|FG002|COMPLETED|Overall Study||0||
48692528|NCT03520920|102032587|FG000|NOT COMPLETED|Overall Study||20||
48692529|NCT03520920|102032588|FG001|NOT COMPLETED|Overall Study||16||
48106610|NCT01965288|100587135|FG000|COMPLETED|Overall Study||30||
48106611|NCT01965288|100587136|FG001|COMPLETED|Overall Study||30||
48106612|NCT01965288|100587135|FG000|NOT COMPLETED|Overall Study||0||
48106613|NCT01965288|100587136|FG001|NOT COMPLETED|Overall Study||0||
48106614|NCT02321462|100587137|FG000|STARTED|Overall Study||147|Patients randomized to each arm|
48106615|NCT02321462|100587138|FG001|STARTED|Overall Study||149|Patients randomized to each arm|
48106616|NCT02321462|100587137|FG000|ITT Population|Overall Study||146|Patients assessed according to their randomised treatment, regardless of treatment they received|
48106617|NCT02321462|100587138|FG001|ITT Population|Overall Study||148|Patients assessed according to their randomised treatment, regardless of treatment they received|
48106618|NCT02321462|100587137|FG000|Treated Patients|Overall Study||147|Patients assessed according to actual treatment they received (See Limitations and Caveats section)|
48106619|NCT02321462|100587138|FG001|Treated Patients|Overall Study||147|Patients assessed according to actual treatment they received (See Limitations and Caveats section)|
48106620|NCT02321462|100587137|FG000|Safety Population|Overall Study||147|Patients assessed according to actual treatment they received (See Limitations and Caveats section)|
48106621|NCT02321462|100587138|FG001|Safety Population|Overall Study||147|Patients assessed according to actual treatment they received (See Limitations and Caveats section)|
48106622|NCT02321462|100587137|FG000|COMPLETED|Overall Study||141||
48692530|NCT03520920|102032589|FG002|NOT COMPLETED|Overall Study||5||
48692531|NCT01536561|102032590|FG000|STARTED|Dosimetric and Therapeutic Treatment||59||
48692532|NCT01536561|102032590|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0||
48692533|NCT01536561|102032590|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||59||
48692534|NCT01536561|102032590|FG000|STARTED|Long-Term Follow-Up||13||
48692535|NCT01536561|102032590|FG000|COMPLETED|Long-Term Follow-Up||13||
48692536|NCT01536561|102032590|FG000|NOT COMPLETED|Long-Term Follow-Up||0||
48692537|NCT03962894|102032591|FG000|STARTED|Overall Study||265||1
48692538|NCT03962894|102032592|FG001|STARTED|Overall Study||271||1
48692539|NCT03962894|102032593|FG002|STARTED|Overall Study||6||1
48692540|NCT03962894|102032594|FG003|STARTED|Overall Study||133||1
48106623|NCT02321462|100587138|FG001|COMPLETED|Overall Study||146||
48692541|NCT03962894|102032595|FG004|STARTED|Overall Study||14||1
48692542|NCT03962894|102032596|FG005|STARTED|Overall Study||99||1
48267650|NCT03994731|100978550|FG000|STARTED|Pegloticase + IMM Period||96||
48267651|NCT03994731|100978551|FG001|STARTED|Pegloticase + IMM Period||49||
48267652|NCT03994731|100978550|FG000|COMPLETED|Pegloticase + IMM Period||76||
48267653|NCT03994731|100978551|FG001|COMPLETED|Pegloticase + IMM Period||34||
48267654|NCT03994731|100978550|FG000|NOT COMPLETED|Pegloticase + IMM Period||20||
48267655|NCT03994731|100978551|FG001|NOT COMPLETED|Pegloticase + IMM Period||15||
48267656|NCT00485953|100978552|FG000|STARTED|Overall Study||55||
48267657|NCT00485953|100978553|FG001|STARTED|Overall Study||54||
48267658|NCT00485953|100978552|FG000|COMPLETED|Overall Study||48||
48267659|NCT00485953|100978553|FG001|COMPLETED|Overall Study||47||
48692543|NCT03962894|102032597|FG006|STARTED|Overall Study||46||1
48692544|NCT03962894|102032591|FG000|COMPLETED|Overall Study||265||1
48692545|NCT03962894|102032592|FG001|COMPLETED|Overall Study||271||1
48692546|NCT03962894|102032593|FG002|COMPLETED|Overall Study||6||1
48692547|NCT03962894|102032594|FG003|COMPLETED|Overall Study||133||1
48692548|NCT03962894|102032595|FG004|COMPLETED|Overall Study||14||1
48692549|NCT03962894|102032596|FG005|COMPLETED|Overall Study||99||1
48692550|NCT03962894|102032597|FG006|COMPLETED|Overall Study||46||1
48692551|NCT03962894|102032591|FG000|NOT COMPLETED|Overall Study||0||0
48692552|NCT03962894|102032592|FG001|NOT COMPLETED|Overall Study||0||0
48692553|NCT03962894|102032593|FG002|NOT COMPLETED|Overall Study||0||0
48106624|NCT02321462|100587137|FG000|NOT COMPLETED|Overall Study||6||
48106625|NCT02321462|100587138|FG001|NOT COMPLETED|Overall Study||3||
48106626|NCT03999892|100587139|FG000|STARTED|Overall Study||17||
48106627|NCT03999892|100587139|FG000|COMPLETED|Overall Study||16||
48106628|NCT03999892|100587139|FG000|NOT COMPLETED|Overall Study||1||
48106629|NCT02151526|100587140|FG000|STARTED|Overall Study||3||
48106630|NCT02151526|100587141|FG001|STARTED|Overall Study||4||
48106631|NCT02151526|100587140|FG000|COMPLETED|Overall Study||3||
48106632|NCT02151526|100587141|FG001|COMPLETED|Overall Study||4||
48106633|NCT02151526|100587140|FG000|NOT COMPLETED|Overall Study||0||
48106634|NCT02151526|100587141|FG001|NOT COMPLETED|Overall Study||0||
48106635|NCT02509065|100587142|FG000|STARTED|Overall Study||1||
48106636|NCT02509065|100587143|FG001|STARTED|Overall Study||1||
48106637|NCT02509065|100587144|FG002|STARTED|Overall Study||2||
48106638|NCT02509065|100587145|FG003|STARTED|Overall Study||1||
48106639|NCT02509065|100587146|FG004|STARTED|Overall Study||1||
48106640|NCT02509065|100587147|FG005|STARTED|Overall Study||1||
48106641|NCT02509065|100587148|FG006|STARTED|Overall Study||1||
48106642|NCT02509065|100587149|FG007|STARTED|Overall Study||1||
48106643|NCT02509065|100587150|FG008|STARTED|Overall Study||1||
48106644|NCT02509065|100587151|FG009|STARTED|Overall Study||1||
48106645|NCT02509065|100587152|FG010|STARTED|Overall Study||1||
48106646|NCT02509065|100587153|FG011|STARTED|Overall Study||1||
48106647|NCT02509065|100587154|FG012|STARTED|Overall Study||1||
48106648|NCT02509065|100587155|FG013|STARTED|Overall Study||1||
48106649|NCT02509065|100587156|FG014|STARTED|Overall Study||1||
48106650|NCT02509065|100587157|FG015|STARTED|Overall Study||1||
48106651|NCT02509065|100587158|FG016|STARTED|Overall Study||1||
48106652|NCT02509065|100587159|FG017|STARTED|Overall Study||1||
48106653|NCT02509065|100587160|FG018|STARTED|Overall Study||1||
48106654|NCT02509065|100587161|FG019|STARTED|Overall Study||1||
48106655|NCT02509065|100587162|FG020|STARTED|Overall Study||1||
48106656|NCT02509065|100587163|FG021|STARTED|Overall Study||1||
48106657|NCT02509065|100587164|FG022|STARTED|Overall Study||1||
48106658|NCT02509065|100587142|FG000|COMPLETED|Overall Study||1||
48267660|NCT00485953|100978552|FG000|NOT COMPLETED|Overall Study||7||
48267661|NCT00485953|100978553|FG001|NOT COMPLETED|Overall Study||7||
48267662|NCT03222505|100978554|FG000|STARTED|Overall Study||5||
48267663|NCT03222505|100978555|FG001|STARTED|Overall Study||7||
48692554|NCT03962894|102032594|FG003|NOT COMPLETED|Overall Study||0||0
48692555|NCT03962894|102032595|FG004|NOT COMPLETED|Overall Study||0||0
48692556|NCT03962894|102032596|FG005|NOT COMPLETED|Overall Study||0||0
48692557|NCT03962894|102032597|FG006|NOT COMPLETED|Overall Study||0||0
48692558|NCT00422448|102032598|FG000|STARTED|Overall Study||43||
48692559|NCT00422448|102032598|FG000|COMPLETED|Overall Study||43||
48692560|NCT00422448|102032598|FG000|NOT COMPLETED|Overall Study||0||
48692561|NCT05332392|102032599|FG000|STARTED|Overall Study||90||
48692562|NCT05332392|102032599|FG000|COMPLETED|Overall Study||46||
48692563|NCT05332392|102032599|FG000|NOT COMPLETED|Overall Study||44||
48692564|NCT00391053|102032600|FG000|STARTED|Overall Study||857||
48692565|NCT00391053|102032601|FG001|STARTED|Overall Study||848||
48692566|NCT00391053|102032602|FG002|STARTED|Overall Study||870||
48692567|NCT00391053|102032603|FG003|STARTED|Overall Study||1262||
48692568|NCT00391053|102032600|FG000|COMPLETED|Overall Study||848||
48692569|NCT00391053|102032601|FG001|COMPLETED|Overall Study||847||
48692570|NCT00391053|102032602|FG002|COMPLETED|Overall Study||868||
48692571|NCT00391053|102032603|FG003|COMPLETED|Overall Study||1252||
48692572|NCT00391053|102032600|FG000|NOT COMPLETED|Overall Study||9||
48692573|NCT00391053|102032601|FG001|NOT COMPLETED|Overall Study||1||
48692574|NCT00391053|102032602|FG002|NOT COMPLETED|Overall Study||2||
48692575|NCT00391053|102032603|FG003|NOT COMPLETED|Overall Study||10||
48106659|NCT02509065|100587143|FG001|COMPLETED|Overall Study||1||
48267664|NCT03222505|100978554|FG000|COMPLETED|Overall Study||5||
48267665|NCT03222505|100978555|FG001|COMPLETED|Overall Study||7||
48267666|NCT03222505|100978554|FG000|NOT COMPLETED|Overall Study||0||
48267667|NCT03222505|100978555|FG001|NOT COMPLETED|Overall Study||0||
48267668|NCT02947100|100978556|FG000|STARTED|Overall Study||4||
48267669|NCT02947100|100978556|FG000|COMPLETED|Overall Study||0||
48106660|NCT02509065|100587144|FG002|COMPLETED|Overall Study||2||
48106661|NCT02509065|100587145|FG003|COMPLETED|Overall Study||1||
48106662|NCT02509065|100587146|FG004|COMPLETED|Overall Study||1||
48106663|NCT02509065|100587147|FG005|COMPLETED|Overall Study||1||
48106664|NCT02509065|100587148|FG006|COMPLETED|Overall Study||1||
48106665|NCT02509065|100587149|FG007|COMPLETED|Overall Study||1||
48106666|NCT02509065|100587150|FG008|COMPLETED|Overall Study||1||
48106667|NCT02509065|100587151|FG009|COMPLETED|Overall Study||1||
48106668|NCT02509065|100587152|FG010|COMPLETED|Overall Study||1||
48106669|NCT02509065|100587153|FG011|COMPLETED|Overall Study||1||
48106670|NCT02509065|100587154|FG012|COMPLETED|Overall Study||1||
48106671|NCT02509065|100587155|FG013|COMPLETED|Overall Study||1||
48106672|NCT02509065|100587156|FG014|COMPLETED|Overall Study||1||
48106673|NCT02509065|100587157|FG015|COMPLETED|Overall Study||1||
48106674|NCT02509065|100587158|FG016|COMPLETED|Overall Study||1||
48106675|NCT02509065|100587159|FG017|COMPLETED|Overall Study||1||
48106676|NCT02509065|100587160|FG018|COMPLETED|Overall Study||1||
48106677|NCT02509065|100587161|FG019|COMPLETED|Overall Study||1||
48106678|NCT02509065|100587162|FG020|COMPLETED|Overall Study||1||
48106679|NCT02509065|100587163|FG021|COMPLETED|Overall Study||1||
48106680|NCT02509065|100587164|FG022|COMPLETED|Overall Study||1||
48106681|NCT02509065|100587142|FG000|NOT COMPLETED|Overall Study||0||
48106682|NCT02509065|100587143|FG001|NOT COMPLETED|Overall Study||0||
48106683|NCT02509065|100587144|FG002|NOT COMPLETED|Overall Study||0||
48106684|NCT02509065|100587145|FG003|NOT COMPLETED|Overall Study||0||
48106685|NCT02509065|100587146|FG004|NOT COMPLETED|Overall Study||0||
48106686|NCT02509065|100587147|FG005|NOT COMPLETED|Overall Study||0||
48106687|NCT02509065|100587148|FG006|NOT COMPLETED|Overall Study||0||
48106688|NCT02509065|100587149|FG007|NOT COMPLETED|Overall Study||0||
48106689|NCT02509065|100587150|FG008|NOT COMPLETED|Overall Study||0||
48106690|NCT02509065|100587151|FG009|NOT COMPLETED|Overall Study||0||
48106691|NCT02509065|100587152|FG010|NOT COMPLETED|Overall Study||0||
48106692|NCT02509065|100587153|FG011|NOT COMPLETED|Overall Study||0||
48106693|NCT02509065|100587154|FG012|NOT COMPLETED|Overall Study||0||
48106694|NCT02509065|100587155|FG013|NOT COMPLETED|Overall Study||0||
48106695|NCT02509065|100587156|FG014|NOT COMPLETED|Overall Study||0||
48106696|NCT02509065|100587157|FG015|NOT COMPLETED|Overall Study||0||
48106697|NCT02509065|100587158|FG016|NOT COMPLETED|Overall Study||0||
48106698|NCT02509065|100587159|FG017|NOT COMPLETED|Overall Study||0||
48106699|NCT02509065|100587160|FG018|NOT COMPLETED|Overall Study||0||
48106700|NCT02509065|100587161|FG019|NOT COMPLETED|Overall Study||0||
48106701|NCT02509065|100587162|FG020|NOT COMPLETED|Overall Study||0||
48106702|NCT02509065|100587163|FG021|NOT COMPLETED|Overall Study||0||
48106703|NCT02509065|100587164|FG022|NOT COMPLETED|Overall Study||0||
48106704|NCT00558103|100587165|FG000|STARTED|Randomized Treatment Phase||38||
48106705|NCT00558103|100587166|FG001|STARTED|Randomized Treatment Phase||38||
48106706|NCT00558103|100587167|FG002|STARTED|Randomized Treatment Phase||36||
48106707|NCT00558103|100587168|FG003|STARTED|Randomized Treatment Phase||13||
48106708|NCT00558103|100587169|FG004|STARTED|Randomized Treatment Phase||38||
48106709|NCT00558103|100587170|FG005|STARTED|Randomized Treatment Phase||0||
48106710|NCT00558103|100587165|FG000|COMPLETED|Randomized Treatment Phase||33||
48106711|NCT00558103|100587166|FG001|COMPLETED|Randomized Treatment Phase||34||
48106712|NCT00558103|100587167|FG002|COMPLETED|Randomized Treatment Phase||33||
48106713|NCT00558103|100587168|FG003|COMPLETED|Randomized Treatment Phase||11||
48106714|NCT00558103|100587169|FG004|COMPLETED|Randomized Treatment Phase||33||
48106715|NCT00558103|100587170|FG005|COMPLETED|Randomized Treatment Phase||0||
48106716|NCT00558103|100587165|FG000|NOT COMPLETED|Randomized Treatment Phase||5||
48106717|NCT00558103|100587166|FG001|NOT COMPLETED|Randomized Treatment Phase||4||
48106718|NCT00558103|100587167|FG002|NOT COMPLETED|Randomized Treatment Phase||3||
48106719|NCT00558103|100587168|FG003|NOT COMPLETED|Randomized Treatment Phase||2||
48106720|NCT00558103|100587169|FG004|NOT COMPLETED|Randomized Treatment Phase||5||
48106721|NCT00558103|100587170|FG005|NOT COMPLETED|Randomized Treatment Phase||0||
48106722|NCT00558103|100587165|FG000|STARTED|Monotherapy Extension Phase||0||
48106723|NCT00558103|100587166|FG001|STARTED|Monotherapy Extension Phase||0||
48106724|NCT00558103|100587167|FG002|STARTED|Monotherapy Extension Phase||0||
48106725|NCT00558103|100587168|FG003|STARTED|Monotherapy Extension Phase||0||
48106726|NCT00558103|100587169|FG004|STARTED|Monotherapy Extension Phase||0||
48267670|NCT02947100|100978556|FG000|NOT COMPLETED|Overall Study||4||
48552112|NCT00451178|101683321|FG001|NOT COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||17||
48106727|NCT00558103|100587170|FG005|STARTED|Monotherapy Extension Phase||9||
48106728|NCT00558103|100587165|FG000|COMPLETED|Monotherapy Extension Phase||0||
48267671|NCT01647945|100978557|FG000|STARTED|Overall Study||6||
48267672|NCT01647945|100978558|FG001|STARTED|Overall Study||6||
48106729|NCT00558103|100587166|FG001|COMPLETED|Monotherapy Extension Phase||0||
48106730|NCT00558103|100587167|FG002|COMPLETED|Monotherapy Extension Phase||0||
48106731|NCT00558103|100587168|FG003|COMPLETED|Monotherapy Extension Phase||0||
48106732|NCT00558103|100587169|FG004|COMPLETED|Monotherapy Extension Phase||0||
48106733|NCT00558103|100587170|FG005|COMPLETED|Monotherapy Extension Phase||0||
48106734|NCT00558103|100587165|FG000|NOT COMPLETED|Monotherapy Extension Phase||0||
48106735|NCT00558103|100587166|FG001|NOT COMPLETED|Monotherapy Extension Phase||0||
48106736|NCT00558103|100587167|FG002|NOT COMPLETED|Monotherapy Extension Phase||0||
48106737|NCT00558103|100587168|FG003|NOT COMPLETED|Monotherapy Extension Phase||0||
48106738|NCT00558103|100587169|FG004|NOT COMPLETED|Monotherapy Extension Phase||0||
48106739|NCT00558103|100587170|FG005|NOT COMPLETED|Monotherapy Extension Phase||9||
48106740|NCT00116558|100587171|FG000|STARTED|Overall Study||80||
48106741|NCT00116558|100587172|FG001|STARTED|Overall Study||26||
48106742|NCT00116558|100587173|FG002|STARTED|Overall Study||47||
48692576|NCT03073811|102032604|FG000|STARTED|Overall Study||26||
48692577|NCT03073811|102032605|FG001|STARTED|Overall Study||24||
48692578|NCT03073811|102032604|FG000|COMPLETED|Overall Study||19||
48692579|NCT03073811|102032605|FG001|COMPLETED|Overall Study||16||
48692580|NCT03073811|102032604|FG000|NOT COMPLETED|Overall Study||7||
48692581|NCT03073811|102032605|FG001|NOT COMPLETED|Overall Study||8||
48692582|NCT01713582|102032606|FG000|STARTED|Overall Study||3||
48106743|NCT00116558|100587171|FG000|COMPLETED|Overall Study||49||
48106744|NCT00116558|100587172|FG001|COMPLETED|Overall Study||11||
48106745|NCT00116558|100587173|FG002|COMPLETED|Overall Study||14||
48106746|NCT00116558|100587171|FG000|NOT COMPLETED|Overall Study||31||
48106747|NCT00116558|100587172|FG001|NOT COMPLETED|Overall Study||15||
48106748|NCT00116558|100587173|FG002|NOT COMPLETED|Overall Study||33||
48106749|NCT01554618|100587174|FG000|STARTED|Randomized Through Start of Treatment||59||
48106750|NCT01554618|100587175|FG001|STARTED|Randomized Through Start of Treatment||24||
48106751|NCT01554618|100587174|FG000|COMPLETED|Randomized Through Start of Treatment||58||
48106752|NCT01554618|100587175|FG001|COMPLETED|Randomized Through Start of Treatment||24||
48106753|NCT01554618|100587174|FG000|NOT COMPLETED|Randomized Through Start of Treatment||1||
48106754|NCT01554618|100587175|FG001|NOT COMPLETED|Randomized Through Start of Treatment||0||
48106755|NCT01554618|100587174|FG000|STARTED|Controlled Assessment Period||58|Received treatment during controlled assessment period|
48106756|NCT01554618|100587175|FG001|STARTED|Controlled Assessment Period||24|Received treatment during controlled assessment period|
48106757|NCT01554618|100587174|FG000|COMPLETED|Controlled Assessment Period||50|Completed controlled assessment period|
48106758|NCT01554618|100587175|FG001|COMPLETED|Controlled Assessment Period||23|Completed controlled assessment period|
48106759|NCT01554618|100587174|FG000|NOT COMPLETED|Controlled Assessment Period||8||
48106760|NCT01554618|100587175|FG001|NOT COMPLETED|Controlled Assessment Period||1||
48106761|NCT01554618|100587174|FG000|STARTED|Open-Label Extension Period||49|Received open-label exenatide treatment|
48106762|NCT01554618|100587175|FG001|STARTED|Open-Label Extension Period||23|Received open-label exenatide treatment|
48106763|NCT01554618|100587174|FG000|COMPLETED|Open-Label Extension Period||46|Completed extension period|
48106764|NCT01554618|100587175|FG001|COMPLETED|Open-Label Extension Period||18|Completed extension period|
48106765|NCT01554618|100587174|FG000|NOT COMPLETED|Open-Label Extension Period||3||
48106766|NCT01554618|100587175|FG001|NOT COMPLETED|Open-Label Extension Period||5||
48106767|NCT05179421|100587176|FG000|STARTED|First Infusion Day||14||
48106768|NCT05179421|100587177|FG001|STARTED|First Infusion Day||11||
48267673|NCT01647945|100978559|FG002|STARTED|Overall Study||5||
48267674|NCT01647945|100978560|FG003|STARTED|Overall Study||6||
48267675|NCT01647945|100978557|FG000|COMPLETED|Overall Study||6||
48267676|NCT01647945|100978558|FG001|COMPLETED|Overall Study||6||
48267677|NCT01647945|100978559|FG002|COMPLETED|Overall Study||3||
48692583|NCT01713582|102032607|FG001|STARTED|Overall Study||3||
48692584|NCT01713582|102032608|FG002|STARTED|Overall Study||4||
48692585|NCT01713582|102032609|FG003|STARTED|Overall Study||3||
48692586|NCT01713582|102032610|FG004|STARTED|Overall Study||4||
48692587|NCT01713582|102032611|FG005|STARTED|Overall Study||8||
48267678|NCT01647945|100978560|FG003|COMPLETED|Overall Study||5||
48692588|NCT01713582|102032612|FG006|STARTED|Overall Study||7||
48692589|NCT01713582|102032613|FG007|STARTED|Overall Study||6||
48267679|NCT01647945|100978557|FG000|NOT COMPLETED|Overall Study||0||
48267680|NCT01647945|100978558|FG001|NOT COMPLETED|Overall Study||0||
48267681|NCT01647945|100978559|FG002|NOT COMPLETED|Overall Study||2||
48267682|NCT01647945|100978560|FG003|NOT COMPLETED|Overall Study||1||
48267683|NCT04227145|100978561|FG000|STARTED|Baseline and Post-Intervention Surveys||48||
48267684|NCT04227145|100978562|FG001|STARTED|Baseline and Post-Intervention Surveys||50||
48267685|NCT04227145|100978561|FG000|COMPLETED|Baseline and Post-Intervention Surveys||48||
48267686|NCT04227145|100978562|FG001|COMPLETED|Baseline and Post-Intervention Surveys||50||
48692590|NCT01713582|102032614|FG008|STARTED|Overall Study||6||
48692591|NCT01713582|102032615|FG009|STARTED|Overall Study||18||
48692592|NCT01713582|102032616|FG010|STARTED|Overall Study||16||
48106769|NCT05179421|100587176|FG000|COMPLETED|First Infusion Day||13||
48106770|NCT05179421|100587177|FG001|COMPLETED|First Infusion Day||11||
48106771|NCT05179421|100587176|FG000|NOT COMPLETED|First Infusion Day||1||
48106772|NCT05179421|100587177|FG001|NOT COMPLETED|First Infusion Day||0||
48106773|NCT05179421|100587176|FG000|STARTED|At Least 5 Days Between Infusion Studies||13||
48106774|NCT05179421|100587177|FG001|STARTED|At Least 5 Days Between Infusion Studies||11||
48106775|NCT05179421|100587176|FG000|COMPLETED|At Least 5 Days Between Infusion Studies||13||
48106776|NCT05179421|100587177|FG001|COMPLETED|At Least 5 Days Between Infusion Studies||11||
48106777|NCT05179421|100587176|FG000|NOT COMPLETED|At Least 5 Days Between Infusion Studies||0||
48106778|NCT05179421|100587177|FG001|NOT COMPLETED|At Least 5 Days Between Infusion Studies||0||
48106779|NCT05179421|100587176|FG000|STARTED|Second Infusion Day||13||
48106780|NCT05179421|100587177|FG001|STARTED|Second Infusion Day||11||
48106781|NCT05179421|100587176|FG000|COMPLETED|Second Infusion Day||13||
48106782|NCT05179421|100587177|FG001|COMPLETED|Second Infusion Day||11||
48106783|NCT05179421|100587176|FG000|NOT COMPLETED|Second Infusion Day||0||
48106784|NCT05179421|100587177|FG001|NOT COMPLETED|Second Infusion Day||0||
48106785|NCT01727141|100587178|FG000|STARTED|Overall Study||260||
48106786|NCT01727141|100587179|FG001|STARTED|Overall Study||260||
48106787|NCT01727141|100587180|FG002|STARTED|Overall Study||261||
48106788|NCT01727141|100587181|FG003|STARTED|Overall Study||261||
48106789|NCT01727141|100587178|FG000|Safety Set|Overall Study||258||
48106790|NCT01727141|100587179|FG001|Safety Set|Overall Study||260||
48106791|NCT01727141|100587180|FG002|Safety Set|Overall Study||262||
48106792|NCT01727141|100587181|FG003|Safety Set|Overall Study||260||
48106793|NCT01727141|100587178|FG000|Full Analysis Set|Overall Study||258||
48106794|NCT01727141|100587179|FG001|Full Analysis Set|Overall Study||260||
48106795|NCT01727141|100587180|FG002|Full Analysis Set|Overall Study||261||
48106796|NCT01727141|100587181|FG003|Full Analysis Set|Overall Study||261||
48106797|NCT01727141|100587178|FG000|COMPLETED|Overall Study||255||
48106798|NCT01727141|100587179|FG001|COMPLETED|Overall Study||251||
48106799|NCT01727141|100587180|FG002|COMPLETED|Overall Study||258||
48106800|NCT01727141|100587181|FG003|COMPLETED|Overall Study||246||
48106801|NCT01727141|100587178|FG000|NOT COMPLETED|Overall Study||5||
48106802|NCT01727141|100587179|FG001|NOT COMPLETED|Overall Study||9||
48106803|NCT01727141|100587180|FG002|NOT COMPLETED|Overall Study||3||
48106804|NCT01727141|100587181|FG003|NOT COMPLETED|Overall Study||15||
48106805|NCT00747435|100587182|FG000|STARTED|Overall Study||73||
48106806|NCT00747435|100587182|FG000|COMPLETED|Overall Study||67||
48106807|NCT00747435|100587182|FG000|NOT COMPLETED|Overall Study||6||
48106808|NCT00663052|100587183|FG000|STARTED|Overall Study||136||
48106809|NCT00663052|100587184|FG001|STARTED|Overall Study||137||
48106810|NCT00663052|100587183|FG000|COMPLETED|Overall Study||124||
48106811|NCT00663052|100587184|FG001|COMPLETED|Overall Study||127||
48106812|NCT00663052|100587183|FG000|NOT COMPLETED|Overall Study||12||
48267687|NCT04227145|100978561|FG000|NOT COMPLETED|Baseline and Post-Intervention Surveys||0||
48267688|NCT04227145|100978562|FG001|NOT COMPLETED|Baseline and Post-Intervention Surveys||0||
48106813|NCT00663052|100587184|FG001|NOT COMPLETED|Overall Study||10||
48106814|NCT01350128|100587185|FG000|STARTED|Overall Study||103||
48106815|NCT01350128|100587185|FG000|GP MDI 36 µg BID|Overall Study||49||
48106816|NCT01350128|100587185|FG000|GP MDI 18 µg BID|Overall Study||49||
48106817|NCT01350128|100587185|FG000|GP MDI 9 µg BID|Overall Study||49||
48106818|NCT01350128|100587185|FG000|GP MDI 4.6 µg BID|Overall Study||45||
48106819|NCT01350128|100587185|FG000|Placebo MDI BID|Overall Study||48||
48106820|NCT01350128|100587185|FG000|Atrovent HFA 34 µg BID|Overall Study||48||
48106821|NCT01350128|100587185|FG000|COMPLETED|Overall Study||89||
48106822|NCT01350128|100587185|FG000|NOT COMPLETED|Overall Study||14||
48106823|NCT00870363|100587186|FG000|STARTED|Overall Study||10||
48106824|NCT00870363|100587187|FG001|STARTED|Overall Study||11||
48106825|NCT00870363|100587188|FG002|STARTED|Overall Study||11||
48267689|NCT04227145|100978561|FG000|STARTED|Two-week Follow-up||38||
48267690|NCT04227145|100978562|FG001|STARTED|Two-week Follow-up||31||
48267691|NCT04227145|100978561|FG000|COMPLETED|Two-week Follow-up||38||
48106826|NCT00870363|100587189|FG003|STARTED|Overall Study||12||
48106827|NCT00870363|100587186|FG000|COMPLETED|Overall Study||10||
48106828|NCT00870363|100587187|FG001|COMPLETED|Overall Study||8||
48106829|NCT00870363|100587188|FG002|COMPLETED|Overall Study||8||
48106830|NCT00870363|100587189|FG003|COMPLETED|Overall Study||12||
48106831|NCT00870363|100587186|FG000|NOT COMPLETED|Overall Study||0||
48106832|NCT00870363|100587187|FG001|NOT COMPLETED|Overall Study||3||
48267692|NCT04227145|100978562|FG001|COMPLETED|Two-week Follow-up||31||
48267693|NCT04227145|100978561|FG000|NOT COMPLETED|Two-week Follow-up||0||
48106833|NCT00870363|100587188|FG002|NOT COMPLETED|Overall Study||3||
48267694|NCT04227145|100978562|FG001|NOT COMPLETED|Two-week Follow-up||0||
48106834|NCT00870363|100587189|FG003|NOT COMPLETED|Overall Study||0||
48106835|NCT00579111|100587190|FG000|STARTED|Overall Study||3||
48106836|NCT00579111|100587191|FG001|STARTED|Overall Study||1||
48106837|NCT00579111|100587190|FG000|COMPLETED|Overall Study||1||
48106838|NCT00579111|100587191|FG001|COMPLETED|Overall Study||0||
48106839|NCT00579111|100587190|FG000|NOT COMPLETED|Overall Study||2||
48106840|NCT00579111|100587191|FG001|NOT COMPLETED|Overall Study||1||
48106841|NCT01268111|100587192|FG000|STARTED|Overall Study||6||
48106842|NCT01268111|100587193|FG001|STARTED|Overall Study||6||
48106843|NCT01268111|100587192|FG000|COMPLETED|Overall Study||6||
48106844|NCT01268111|100587193|FG001|COMPLETED|Overall Study||6||
48106845|NCT01268111|100587192|FG000|NOT COMPLETED|Overall Study||0||
48106846|NCT01268111|100587193|FG001|NOT COMPLETED|Overall Study||0||
48106847|NCT04448210|100587194|FG000|STARTED|Overall Study||22||
48106848|NCT04448210|100587195|FG001|STARTED|Overall Study||20||
48106849|NCT04448210|100587194|FG000|COMPLETED|Overall Study||22||
48106850|NCT04448210|100587195|FG001|COMPLETED|Overall Study||20||
48106851|NCT04448210|100587194|FG000|NOT COMPLETED|Overall Study||0||
48106852|NCT04448210|100587195|FG001|NOT COMPLETED|Overall Study||0||
48106853|NCT02204748|100587196|FG000|STARTED|Overall Study||5||
48106854|NCT02204748|100587196|FG000|COMPLETED|Overall Study||5||
48106855|NCT02204748|100587196|FG000|NOT COMPLETED|Overall Study||0||
48106856|NCT04087122|100587197|FG000|STARTED|Overall Study||20||
48106857|NCT04087122|100587197|FG000|COMPLETED|Overall Study||20||
48106858|NCT04087122|100587197|FG000|NOT COMPLETED|Overall Study||0||
48106859|NCT00868621|100587198|FG000|STARTED|Overall Study||20||
48106860|NCT00868621|100587199|FG001|STARTED|Overall Study||20||
48106861|NCT00868621|100587200|FG002|STARTED|Overall Study||20||
48106862|NCT00868621|100587198|FG000|COMPLETED|Overall Study||20||
48106863|NCT00868621|100587199|FG001|COMPLETED|Overall Study||20||
48106864|NCT00868621|100587200|FG002|COMPLETED|Overall Study||16||
48106865|NCT00868621|100587198|FG000|NOT COMPLETED|Overall Study||0||
48106866|NCT00868621|100587199|FG001|NOT COMPLETED|Overall Study||0||
48106867|NCT00868621|100587200|FG002|NOT COMPLETED|Overall Study||4||
48106868|NCT00805935|100590393|FG000|STARTED|Overall Study||25||
48106869|NCT00805935|100590394|FG001|STARTED|Overall Study||27||
48106870|NCT00805935|100590395|FG002|STARTED|Overall Study||28||
48106871|NCT00805935|100590396|FG003|STARTED|Overall Study||30||
48106872|NCT00805935|100590393|FG000|COMPLETED|Overall Study||12||
48106873|NCT00805935|100590394|FG001|COMPLETED|Overall Study||8||
48106874|NCT00805935|100590395|FG002|COMPLETED|Overall Study||13||
48106875|NCT00805935|100590396|FG003|COMPLETED|Overall Study||19||
48106876|NCT00805935|100590393|FG000|NOT COMPLETED|Overall Study||13||
48106877|NCT00805935|100590394|FG001|NOT COMPLETED|Overall Study||19||
48106878|NCT00805935|100590395|FG002|NOT COMPLETED|Overall Study||15||
48106879|NCT00805935|100590396|FG003|NOT COMPLETED|Overall Study||11||
48692593|NCT01713582|102032617|FG011|STARTED|Overall Study||5||
48106880|NCT00606892|100590397|FG000|STARTED|Adaptation||9||
48692594|NCT01713582|102032618|FG012|STARTED|Overall Study||3||
48692595|NCT01713582|102032619|FG013|STARTED|Overall Study||4||
48692596|NCT01713582|102032620|FG014|STARTED|Overall Study||7||
48692597|NCT01713582|102032621|FG015|STARTED|Overall Study||6||
48692598|NCT01713582|102032622|FG016|STARTED|Overall Study||7||
48692599|NCT01713582|102032623|FG017|STARTED|Overall Study||3||
48692600|NCT01713582|102032624|FG018|STARTED|Overall Study||5||
48692601|NCT01713582|102032625|FG019|STARTED|Overall Study||5||
48692602|NCT01713582|102032626|FG020|STARTED|Overall Study||15||
48692603|NCT01713582|102032606|FG000|COMPLETED|Overall Study||0||
48692604|NCT01713582|102032607|FG001|COMPLETED|Overall Study||0||
48692605|NCT01713582|102032608|FG002|COMPLETED|Overall Study||0||
48692606|NCT01713582|102032609|FG003|COMPLETED|Overall Study||0||
48692607|NCT01713582|102032610|FG004|COMPLETED|Overall Study||0||
48692608|NCT01713582|102032611|FG005|COMPLETED|Overall Study||0||
48692609|NCT01713582|102032612|FG006|COMPLETED|Overall Study||0||
48692610|NCT01713582|102032613|FG007|COMPLETED|Overall Study||0||
48692611|NCT01713582|102032614|FG008|COMPLETED|Overall Study||0||
48692612|NCT01713582|102032615|FG009|COMPLETED|Overall Study||0||
48692613|NCT01713582|102032616|FG010|COMPLETED|Overall Study||0||
48692614|NCT01713582|102032617|FG011|COMPLETED|Overall Study||0||
48692615|NCT01713582|102032618|FG012|COMPLETED|Overall Study||0||
48692616|NCT01713582|102032619|FG013|COMPLETED|Overall Study||0||
48692617|NCT01713582|102032620|FG014|COMPLETED|Overall Study||0||
48106881|NCT00606892|100590398|FG001|STARTED|Adaptation||8||
48106882|NCT00606892|100590397|FG000|COMPLETED|Adaptation||9||
48106883|NCT00606892|100590398|FG001|COMPLETED|Adaptation||8||
48106884|NCT00606892|100590397|FG000|NOT COMPLETED|Adaptation||0||
48106885|NCT00606892|100590398|FG001|NOT COMPLETED|Adaptation||0||
48106886|NCT00606892|100590397|FG000|STARTED|First Intervention||9||
48106887|NCT00606892|100590398|FG001|STARTED|First Intervention||8||
48106888|NCT00606892|100590397|FG000|COMPLETED|First Intervention||8||
48106889|NCT00606892|100590398|FG001|COMPLETED|First Intervention||4||
48106890|NCT00606892|100590397|FG000|NOT COMPLETED|First Intervention||1||
48106891|NCT00606892|100590398|FG001|NOT COMPLETED|First Intervention||4||
48106892|NCT00606892|100590397|FG000|STARTED|Washout Period||8||
48106893|NCT00606892|100590398|FG001|STARTED|Washout Period||4||
48106894|NCT00606892|100590397|FG000|COMPLETED|Washout Period||8||
48106895|NCT00606892|100590398|FG001|COMPLETED|Washout Period||4||
48692618|NCT01713582|102032621|FG015|COMPLETED|Overall Study||0||
48692619|NCT01713582|102032622|FG016|COMPLETED|Overall Study||0||
48692620|NCT01713582|102032623|FG017|COMPLETED|Overall Study||0||
48692621|NCT01713582|102032624|FG018|COMPLETED|Overall Study||0||
48692622|NCT01713582|102032625|FG019|COMPLETED|Overall Study||0||
48692623|NCT01713582|102032626|FG020|COMPLETED|Overall Study||0||
48692624|NCT01713582|102032606|FG000|NOT COMPLETED|Overall Study||3||
48106896|NCT00606892|100590397|FG000|NOT COMPLETED|Washout Period||0||
48106897|NCT00606892|100590398|FG001|NOT COMPLETED|Washout Period||0||
48106898|NCT00606892|100590397|FG000|STARTED|Second Intervention||8||
48106899|NCT00606892|100590398|FG001|STARTED|Second Intervention||4||
48106900|NCT00606892|100590397|FG000|COMPLETED|Second Intervention||8||
48106901|NCT00606892|100590398|FG001|COMPLETED|Second Intervention||4||
48106902|NCT00606892|100590397|FG000|NOT COMPLETED|Second Intervention||0||
48106903|NCT00606892|100590398|FG001|NOT COMPLETED|Second Intervention||0||
48106904|NCT03026257|100590399|FG000|STARTED|Overall Study||60|Randomized and treated, as randomized|
48106905|NCT03026257|100590400|FG001|STARTED|Overall Study||64|Randomized and treated, as randomized|
48106906|NCT03026257|100590401|FG002|STARTED|Overall Study||34|Randomized and treated, as randomized|
48106907|NCT03026257|100590402|FG003|STARTED|Overall Study||25|Randomized and treated, as randomized|
48106908|NCT03026257|100590403|FG004|STARTED|Overall Study||23|Randomized and treated, as randomized|
48106909|NCT03026257|100590404|FG005|STARTED|Overall Study||46|Randomized and treated, as randomized|
48106910|NCT03026257|100590399|FG000|Treated|Overall Study||58|Randomized and treated, as treated|
48106911|NCT03026257|100590400|FG001|Treated|Overall Study||65|Randomized and treated, as treated|
48106912|NCT03026257|100590401|FG002|Treated|Overall Study||35|Randomized and treated, as treated|
48106913|NCT03026257|100590402|FG003|Treated|Overall Study||24|Randomized and treated, as treated|
48106914|NCT03026257|100590403|FG004|Treated|Overall Study||23|Randomized and treated, as treated|
48106915|NCT03026257|100590404|FG005|Treated|Overall Study||47|Randomized and treated, as treated|
48106916|NCT03026257|100590399|FG000|COMPLETED|Overall Study||54||
48106917|NCT03026257|100590400|FG001|COMPLETED|Overall Study||63||
48106918|NCT03026257|100590401|FG002|COMPLETED|Overall Study||34||
48106919|NCT03026257|100590402|FG003|COMPLETED|Overall Study||24||
48106920|NCT03026257|100590403|FG004|COMPLETED|Overall Study||22||
48106921|NCT03026257|100590404|FG005|COMPLETED|Overall Study||46||
48106922|NCT03026257|100590399|FG000|NOT COMPLETED|Overall Study||6||
48106923|NCT03026257|100590400|FG001|NOT COMPLETED|Overall Study||1||
48106924|NCT03026257|100590401|FG002|NOT COMPLETED|Overall Study||0||
48106925|NCT03026257|100590402|FG003|NOT COMPLETED|Overall Study||1||
48106926|NCT03026257|100590403|FG004|NOT COMPLETED|Overall Study||1||
48106927|NCT03026257|100590404|FG005|NOT COMPLETED|Overall Study||0||
48106928|NCT02901951|100590405|FG000|STARTED|Overall Study||103||
48106929|NCT02901951|100590405|FG000|COMPLETED|Overall Study||103||
48106930|NCT02901951|100590405|FG000|NOT COMPLETED|Overall Study||0||
48106931|NCT01810666|100590406|FG000|STARTED|Overall Study||30||
48106932|NCT01810666|100590406|FG000|COMPLETED|Overall Study||30||
48106933|NCT01810666|100590406|FG000|NOT COMPLETED|Overall Study||0||
48106934|NCT00542919|100590407|FG000|STARTED|Overall Study||23||
48106935|NCT00542919|100590408|FG001|STARTED|Overall Study||19||
48106936|NCT00542919|100590409|FG002|STARTED|Overall Study||15||
48106937|NCT00542919|100590407|FG000|Received At Least One Dose of Study Drug|Overall Study||23||
48106938|NCT00542919|100590408|FG001|Received At Least One Dose of Study Drug|Overall Study||19||
48106939|NCT00542919|100590409|FG002|Received At Least One Dose of Study Drug|Overall Study||15||
48106940|NCT00542919|100590407|FG000|Progressive Disease|Overall Study||15||
48106941|NCT00542919|100590408|FG001|Progressive Disease|Overall Study||11||
48106942|NCT00542919|100590409|FG002|Progressive Disease|Overall Study||7||
48267695|NCT04227145|100978561|FG000|STARTED|One-month Follow-up||37||
48267696|NCT04227145|100978562|FG001|STARTED|One-month Follow-up||37||
48267697|NCT04227145|100978561|FG000|COMPLETED|One-month Follow-up||37||
48267698|NCT04227145|100978562|FG001|COMPLETED|One-month Follow-up||37||
48106943|NCT00542919|100590407|FG000|Death|Overall Study||1||
48106944|NCT00542919|100590408|FG001|Death|Overall Study||1||
48267699|NCT04227145|100978561|FG000|NOT COMPLETED|One-month Follow-up||0||
48267700|NCT04227145|100978562|FG001|NOT COMPLETED|One-month Follow-up||0||
48267701|NCT04227145|100978561|FG000|STARTED|Three-month Follow-up||36||
48267702|NCT04227145|100978562|FG001|STARTED|Three-month Follow-up||22||
48267703|NCT04227145|100978561|FG000|COMPLETED|Three-month Follow-up||36||
48267704|NCT04227145|100978562|FG001|COMPLETED|Three-month Follow-up||22||
48267705|NCT04227145|100978561|FG000|NOT COMPLETED|Three-month Follow-up||0||
48267706|NCT04227145|100978562|FG001|NOT COMPLETED|Three-month Follow-up||0||
48267707|NCT00600613|100978563|FG000|STARTED|Overall Study||6||
48267708|NCT00600613|100978563|FG000|COMPLETED|Overall Study||5||
48267709|NCT00600613|100978563|FG000|NOT COMPLETED|Overall Study||1||
48267710|NCT03041792|100978564|FG000|STARTED|Overall Study||32||
48267711|NCT03041792|100978565|FG001|STARTED|Overall Study||29||
48267712|NCT03041792|100978564|FG000|Received Treatment|Overall Study||32||
48267713|NCT03041792|100978565|FG001|Received Treatment|Overall Study||28||
48267714|NCT03041792|100978564|FG000|COMPLETED|Overall Study||28||
48267715|NCT03041792|100978565|FG001|COMPLETED|Overall Study||26||
48267716|NCT03041792|100978564|FG000|NOT COMPLETED|Overall Study||4||
48106945|NCT00542919|100590409|FG002|Death|Overall Study||2||
48106946|NCT00542919|100590407|FG000|COMPLETED|Overall Study||16||
48106947|NCT00542919|100590408|FG001|COMPLETED|Overall Study||12||
48106948|NCT00542919|100590409|FG002|COMPLETED|Overall Study||9||
48106949|NCT00542919|100590407|FG000|NOT COMPLETED|Overall Study||7||
48106950|NCT00542919|100590408|FG001|NOT COMPLETED|Overall Study||7||
48106951|NCT00542919|100590409|FG002|NOT COMPLETED|Overall Study||6||
48106952|NCT02535741|100590410|FG000|STARTED|Overall Study||168||
48106953|NCT02535741|100590410|FG000|COMPLETED|Overall Study||136||
48692625|NCT01713582|102032607|FG001|NOT COMPLETED|Overall Study||3||
48106954|NCT02535741|100590410|FG000|NOT COMPLETED|Overall Study||32||
48106955|NCT02130063|100590411|FG000|STARTED|Overall Study||342||
48106956|NCT02130063|100590412|FG001|STARTED|Overall Study||169||
48106957|NCT02130063|100590411|FG000|COMPLETED|Overall Study||317||
48106958|NCT02130063|100590412|FG001|COMPLETED|Overall Study||152||
48692626|NCT01713582|102032608|FG002|NOT COMPLETED|Overall Study||4||
48692627|NCT01713582|102032609|FG003|NOT COMPLETED|Overall Study||3||
48692628|NCT01713582|102032610|FG004|NOT COMPLETED|Overall Study||4||
48692629|NCT01713582|102032611|FG005|NOT COMPLETED|Overall Study||8||
48692630|NCT01713582|102032612|FG006|NOT COMPLETED|Overall Study||7||
48692631|NCT01713582|102032613|FG007|NOT COMPLETED|Overall Study||6||
48692632|NCT01713582|102032614|FG008|NOT COMPLETED|Overall Study||6||
48692633|NCT01713582|102032615|FG009|NOT COMPLETED|Overall Study||18||
48692634|NCT01713582|102032616|FG010|NOT COMPLETED|Overall Study||16||
48692635|NCT01713582|102032617|FG011|NOT COMPLETED|Overall Study||5||
48692636|NCT01713582|102032618|FG012|NOT COMPLETED|Overall Study||3||
48692637|NCT01713582|102032619|FG013|NOT COMPLETED|Overall Study||4||
48692638|NCT01713582|102032620|FG014|NOT COMPLETED|Overall Study||7||
48692639|NCT01713582|102032621|FG015|NOT COMPLETED|Overall Study||6||
48692640|NCT01713582|102032622|FG016|NOT COMPLETED|Overall Study||7||
48692641|NCT01713582|102032623|FG017|NOT COMPLETED|Overall Study||3||
48692642|NCT01713582|102032624|FG018|NOT COMPLETED|Overall Study||5||
48692643|NCT01713582|102032625|FG019|NOT COMPLETED|Overall Study||5||
48106959|NCT02130063|100590411|FG000|NOT COMPLETED|Overall Study||25||
48106960|NCT02130063|100590412|FG001|NOT COMPLETED|Overall Study||17||
48106961|NCT01495585|100590413|FG000|STARTED|Overall Study||4||
48106962|NCT01495585|100590414|FG001|STARTED|Overall Study||6||
48692644|NCT01713582|102032626|FG020|NOT COMPLETED|Overall Study||15||
48106963|NCT01495585|100590415|FG002|STARTED|Overall Study||4||
48106964|NCT01495585|100590413|FG000|Open Label Lonafarnib 200 mg|Overall Study||2||
48106965|NCT01495585|100590414|FG001|Open Label Lonafarnib 200 mg|Overall Study||0||
48106966|NCT01495585|100590415|FG002|Open Label Lonafarnib 200 mg|Overall Study||0||
48106967|NCT01495585|100590413|FG000|COMPLETED|Overall Study||4||
48106968|NCT01495585|100590414|FG001|COMPLETED|Overall Study||6||
48106969|NCT01495585|100590415|FG002|COMPLETED|Overall Study||4||
48692645|NCT00106119|102032627|FG000|STARTED|First Intervention||7||
48692646|NCT00106119|102032628|FG001|STARTED|First Intervention||7||
48106970|NCT01495585|100590413|FG000|NOT COMPLETED|Overall Study||0||
48106971|NCT01495585|100590414|FG001|NOT COMPLETED|Overall Study||0||
48106972|NCT01495585|100590415|FG002|NOT COMPLETED|Overall Study||0||
48106973|NCT01217060|100590416|FG000|STARTED|Overall Study||4||
48106974|NCT01217060|100590416|FG000|COMPLETED|Overall Study||3||
48106975|NCT01217060|100590416|FG000|NOT COMPLETED|Overall Study||1||
48692647|NCT00106119|102032627|FG000|COMPLETED|First Intervention||7||
48692648|NCT00106119|102032628|FG001|COMPLETED|First Intervention||7||
48692649|NCT00106119|102032627|FG000|NOT COMPLETED|First Intervention||0||
48692650|NCT00106119|102032628|FG001|NOT COMPLETED|First Intervention||0||
48106976|NCT00446147|100590417|FG000|STARTED|Overall Study||195||
48106977|NCT00446147|100590418|FG001|STARTED|Overall Study||194||
48106978|NCT00446147|100590417|FG000|COMPLETED|Overall Study||180||
48106979|NCT00446147|100590418|FG001|COMPLETED|Overall Study||180||
48106980|NCT00446147|100590417|FG000|NOT COMPLETED|Overall Study||15||
48106981|NCT00446147|100590418|FG001|NOT COMPLETED|Overall Study||14||
48106982|NCT04327986|100590419|FG000|STARTED|Overall Study||3||
48106983|NCT04327986|100590420|FG001|STARTED|Overall Study||0||
48106984|NCT04327986|100590421|FG002|STARTED|Overall Study||0||
48106985|NCT04327986|100590419|FG000|COMPLETED|Overall Study||0||
48106986|NCT04327986|100590420|FG001|COMPLETED|Overall Study||0||
48106987|NCT04327986|100590421|FG002|COMPLETED|Overall Study||0||
48106988|NCT04327986|100590419|FG000|NOT COMPLETED|Overall Study||3||
48106989|NCT04327986|100590420|FG001|NOT COMPLETED|Overall Study||0||
48106990|NCT04327986|100590421|FG002|NOT COMPLETED|Overall Study||0||
48106991|NCT00006489|100590422|FG000|STARTED|Overall Study||42||
48106992|NCT00006489|100590423|FG001|STARTED|Overall Study||40||
48106993|NCT00006489|100590424|FG002|STARTED|Overall Study||40||
48106994|NCT00006489|100590425|FG003|STARTED|Overall Study||43||
48106995|NCT00006489|100590422|FG000|COMPLETED|Overall Study||29||
48106996|NCT00006489|100590423|FG001|COMPLETED|Overall Study||26||
48692651|NCT00106119|102032627|FG000|STARTED|Washout Period of 30 Days||7||
48692652|NCT00106119|102032628|FG001|STARTED|Washout Period of 30 Days||7||
48106997|NCT00006489|100590424|FG002|COMPLETED|Overall Study||25||
48106998|NCT00006489|100590425|FG003|COMPLETED|Overall Study||32||
48106999|NCT00006489|100590422|FG000|NOT COMPLETED|Overall Study||13||
48107000|NCT00006489|100590423|FG001|NOT COMPLETED|Overall Study||14||
48107001|NCT00006489|100590424|FG002|NOT COMPLETED|Overall Study||15||
48107002|NCT00006489|100590425|FG003|NOT COMPLETED|Overall Study||11||
48107003|NCT03323658|100590426|FG000|STARTED|Overall Study||10||
48107004|NCT03323658|100590427|FG001|STARTED|Overall Study||4||
48107005|NCT03323658|100590428|FG002|STARTED|Overall Study||10||
48107006|NCT03323658|100590426|FG000|COMPLETED|Overall Study||10||
48107007|NCT03323658|100590427|FG001|COMPLETED|Overall Study||3||
48107008|NCT03323658|100590428|FG002|COMPLETED|Overall Study||10||
48267717|NCT03041792|100978565|FG001|NOT COMPLETED|Overall Study||3||
48267718|NCT00387244|100978566|FG000|STARTED|Overall Study||7||
48267719|NCT00387244|100978566|FG000|End of Trial|Overall Study||0||
48267720|NCT00387244|100978566|FG000|COMPLETED|Overall Study||0||
48267721|NCT00387244|100978566|FG000|NOT COMPLETED|Overall Study||7||
48267722|NCT00368875|100978567|FG000|STARTED|Overall Study||6||
48267723|NCT00368875|100978568|FG001|STARTED|Overall Study||48||
48267724|NCT00368875|100978567|FG000|COMPLETED|Overall Study||0||
48267725|NCT00368875|100978568|FG001|COMPLETED|Overall Study||0||
48267726|NCT00368875|100978567|FG000|NOT COMPLETED|Overall Study||6||
48692653|NCT00106119|102032627|FG000|COMPLETED|Washout Period of 30 Days||7||
48107009|NCT03323658|100590426|FG000|NOT COMPLETED|Overall Study||0||
48107010|NCT03323658|100590427|FG001|NOT COMPLETED|Overall Study||1||
48107011|NCT03323658|100590428|FG002|NOT COMPLETED|Overall Study||0||
48107012|NCT03829046|100590429|FG000|STARTED|Overall Study||20||
48107013|NCT03829046|100590430|FG001|STARTED|Overall Study||21||
48107014|NCT03829046|100590429|FG000|COMPLETED|Overall Study||19||
48107015|NCT03829046|100590430|FG001|COMPLETED|Overall Study||21||
48107016|NCT03829046|100590429|FG000|NOT COMPLETED|Overall Study||1||
48107017|NCT03829046|100590430|FG001|NOT COMPLETED|Overall Study||0||
48107018|NCT02579265|100590431|FG000|STARTED|Overall Study||83||
48107019|NCT02579265|100590432|FG001|STARTED|Overall Study||78||
48107020|NCT02579265|100590431|FG000|COMPLETED|Overall Study||33||
48107021|NCT02579265|100590432|FG001|COMPLETED|Overall Study||33||
48107022|NCT02579265|100590431|FG000|NOT COMPLETED|Overall Study||50||
48267727|NCT00368875|100978568|FG001|NOT COMPLETED|Overall Study||48||
48267728|NCT00108745|100978569|FG000|STARTED|Overall Study||387||
48267729|NCT00108745|100978570|FG001|STARTED|Overall Study||384||
48267730|NCT00108745|100978571|FG002|STARTED|Overall Study||386||
48267731|NCT00108745|100978569|FG000|COMPLETED|Overall Study||353||
48267732|NCT00108745|100978570|FG001|COMPLETED|Overall Study||349||
48267733|NCT00108745|100978571|FG002|COMPLETED|Overall Study||349||
48267734|NCT00108745|100978569|FG000|NOT COMPLETED|Overall Study||34||
48267735|NCT00108745|100978570|FG001|NOT COMPLETED|Overall Study||35||
48267736|NCT00108745|100978571|FG002|NOT COMPLETED|Overall Study||37||
48267737|NCT03548220|100978572|FG000|STARTED|Overall Study||40||
48267738|NCT03548220|100978573|FG001|STARTED|Overall Study||2||
48267739|NCT03548220|100978574|FG002|STARTED|Overall Study||3||
48267740|NCT03548220|100978575|FG003|STARTED|Overall Study||35||
48267741|NCT03548220|100978572|FG000|COMPLETED|Overall Study||39||
48267742|NCT03548220|100978573|FG001|COMPLETED|Overall Study||2||
48267743|NCT03548220|100978574|FG002|COMPLETED|Overall Study||3||
48267744|NCT03548220|100978575|FG003|COMPLETED|Overall Study||35||
48267745|NCT03548220|100978572|FG000|NOT COMPLETED|Overall Study||1||
48267746|NCT03548220|100978573|FG001|NOT COMPLETED|Overall Study||0||
48267747|NCT03548220|100978574|FG002|NOT COMPLETED|Overall Study||0||
48267748|NCT03548220|100978575|FG003|NOT COMPLETED|Overall Study||0||
48267749|NCT00842244|100978576|FG000|STARTED|Overall Study||22||
48267750|NCT00842244|100978576|FG000|COMPLETED|Overall Study||1||
48267751|NCT00842244|100978576|FG000|NOT COMPLETED|Overall Study||21||
48692654|NCT00106119|102032628|FG001|COMPLETED|Washout Period of 30 Days||7||
48107023|NCT02579265|100590432|FG001|NOT COMPLETED|Overall Study||45||
48107024|NCT01293240|100590433|FG000|STARTED|Overall Study||117||
48107025|NCT01293240|100590433|FG000|COMPLETED|Overall Study||115||
48107026|NCT01293240|100590433|FG000|NOT COMPLETED|Overall Study||2||
48267752|NCT00371176|100978577|FG000|STARTED|Overall Study||13||
48267753|NCT00371176|100978578|FG001|STARTED|Overall Study||13||
48267754|NCT00371176|100978577|FG000|Completed Treatment|Overall Study||10||
48267755|NCT00371176|100978578|FG001|Completed Treatment|Overall Study||9||
48267756|NCT00371176|100978577|FG000|COMPLETED|Overall Study||8||
48267757|NCT00371176|100978578|FG001|COMPLETED|Overall Study||5||
48267758|NCT00371176|100978577|FG000|NOT COMPLETED|Overall Study||5||
48267759|NCT00371176|100978578|FG001|NOT COMPLETED|Overall Study||8||
48267760|NCT03238963|100978579|FG000|STARTED|Overall Study||40||
48267761|NCT03238963|100978580|FG001|STARTED|Overall Study||39||
48267762|NCT03238963|100978579|FG000|COMPLETED|Overall Study||35||
48267763|NCT03238963|100978580|FG001|COMPLETED|Overall Study||37||
48267764|NCT03238963|100978579|FG000|NOT COMPLETED|Overall Study||5||
48267765|NCT03238963|100978580|FG001|NOT COMPLETED|Overall Study||2||
48267766|NCT04012619|100978581|FG000|STARTED|Overall Study||4||
48267767|NCT04012619|100978582|FG001|STARTED|Overall Study||4||
48692655|NCT00106119|102032627|FG000|NOT COMPLETED|Washout Period of 30 Days||0||
48107027|NCT01412866|100590434|FG000|STARTED|Overall Study||58||
48107028|NCT01412866|100590435|FG001|STARTED|Overall Study||66||
48107029|NCT01412866|100590434|FG000|COMPLETED|Overall Study||57||
48107030|NCT01412866|100590435|FG001|COMPLETED|Overall Study||64||
48107031|NCT01412866|100590434|FG000|NOT COMPLETED|Overall Study||1||
48107032|NCT01412866|100590435|FG001|NOT COMPLETED|Overall Study||2||
48107033|NCT02114879|100590436|FG000|STARTED|Overall Study||115||
48267768|NCT04012619|100978581|FG000|COMPLETED|Overall Study||4||
48267769|NCT04012619|100978582|FG001|COMPLETED|Overall Study||4||
48107034|NCT02114879|100590437|FG001|STARTED|Overall Study||114||
48107035|NCT02114879|100590436|FG000|COMPLETED|Overall Study||96||
48267770|NCT04012619|100978581|FG000|NOT COMPLETED|Overall Study||0||
48267771|NCT04012619|100978582|FG001|NOT COMPLETED|Overall Study||0||
48107036|NCT02114879|100590437|FG001|COMPLETED|Overall Study||90||
48107037|NCT02114879|100590436|FG000|NOT COMPLETED|Overall Study||19||
48107038|NCT02114879|100590437|FG001|NOT COMPLETED|Overall Study||24||
48107039|NCT01364090|100590438|FG000|STARTED|Overall Study||61||
48267772|NCT00609947|100978583|FG000|STARTED|Overall Study||241||
48267773|NCT00609947|100978583|FG000|COMPLETED|Overall Study||240||
48267774|NCT00609947|100978583|FG000|NOT COMPLETED|Overall Study||1||
48267775|NCT01183390|100978584|FG000|STARTED|First Intervention||11||
48267776|NCT01183390|100978585|FG001|STARTED|First Intervention||11||
48267777|NCT01183390|100978584|FG000|COMPLETED|First Intervention||11||
48267778|NCT01183390|100978585|FG001|COMPLETED|First Intervention||10||
48267779|NCT01183390|100978584|FG000|NOT COMPLETED|First Intervention||0||
48392069|NCT00387348|101287791|FG000|COMPLETED|Overall Study||5||
48392070|NCT00387348|101287792|FG001|COMPLETED|Overall Study||2||
48392071|NCT00387348|101287793|FG002|COMPLETED|Overall Study||7||
48392072|NCT00387348|101287791|FG000|NOT COMPLETED|Overall Study||3||
48392073|NCT00387348|101287792|FG001|NOT COMPLETED|Overall Study||3||
48392074|NCT00387348|101287793|FG002|NOT COMPLETED|Overall Study||4||
48392075|NCT01226706|101287794|FG000|STARTED|Overall Study||10||
48392076|NCT01226706|101287795|FG001|STARTED|Overall Study||11||
48392077|NCT01226706|101287794|FG000|COMPLETED|Overall Study||10||
48392078|NCT01226706|101287795|FG001|COMPLETED|Overall Study||11||
48692656|NCT00106119|102032628|FG001|NOT COMPLETED|Washout Period of 30 Days||0||
48692657|NCT00106119|102032627|FG000|STARTED|Second Intervention||7||
48692658|NCT00106119|102032628|FG001|STARTED|Second Intervention||7||
48267780|NCT01183390|100978585|FG001|NOT COMPLETED|First Intervention||1||
48267781|NCT01183390|100978584|FG000|STARTED|Washout of 21 Days||11||
48267782|NCT01183390|100978585|FG001|STARTED|Washout of 21 Days||10||
48267783|NCT01183390|100978584|FG000|COMPLETED|Washout of 21 Days||11||
48267784|NCT01183390|100978585|FG001|COMPLETED|Washout of 21 Days||10||
48692659|NCT00106119|102032627|FG000|COMPLETED|Second Intervention||7||
48692660|NCT00106119|102032628|FG001|COMPLETED|Second Intervention||7||
48692661|NCT00106119|102032627|FG000|NOT COMPLETED|Second Intervention||0||
48692662|NCT00106119|102032628|FG001|NOT COMPLETED|Second Intervention||0||
48692663|NCT05066750|102032629|FG000|STARTED|Overall Study||85||
48692664|NCT05066750|102032630|FG001|STARTED|Overall Study||85||
48692665|NCT05066750|102032629|FG000|Analysis Population|Overall Study||85||
48107040|NCT01364090|100590439|FG001|STARTED|Overall Study||26||
48107041|NCT01364090|100590440|FG002|STARTED|Overall Study||6||
48267785|NCT01183390|100978584|FG000|NOT COMPLETED|Washout of 21 Days||0||
48267786|NCT01183390|100978585|FG001|NOT COMPLETED|Washout of 21 Days||0||
48267787|NCT01183390|100978584|FG000|STARTED|Second Intervention||11||
48267788|NCT01183390|100978585|FG001|STARTED|Second Intervention||10||
48267789|NCT01183390|100978584|FG000|COMPLETED|Second Intervention||11||
48267790|NCT01183390|100978585|FG001|COMPLETED|Second Intervention||10||
48267791|NCT01183390|100978584|FG000|NOT COMPLETED|Second Intervention||0||
48267792|NCT01183390|100978585|FG001|NOT COMPLETED|Second Intervention||0||
48267793|NCT02227992|100978586|FG000|STARTED|Overall Study||20||
48267794|NCT02227992|100978587|FG001|STARTED|Overall Study||20||
48267795|NCT02227992|100978586|FG000|COMPLETED|Overall Study||19||
48267796|NCT02227992|100978587|FG001|COMPLETED|Overall Study||19||
48267797|NCT02227992|100978586|FG000|NOT COMPLETED|Overall Study||1||
48267798|NCT02227992|100978587|FG001|NOT COMPLETED|Overall Study||1||
48267799|NCT01989169|100978588|FG000|STARTED|Period 1||15||
48267800|NCT01989169|100978589|FG001|STARTED|Period 1||15||
48267801|NCT01989169|100978588|FG000|COMPLETED|Period 1||15||
48392079|NCT01226706|101287794|FG000|NOT COMPLETED|Overall Study||0||
48392080|NCT01226706|101287795|FG001|NOT COMPLETED|Overall Study||0||
48392081|NCT00842361|101287796|FG000|STARTED|Overall Study||33||
48392082|NCT00842361|101287797|FG001|STARTED|Overall Study||33||
48692666|NCT05066750|102032630|FG001|Analysis Population|Overall Study||83||
48107042|NCT01364090|100590438|FG000|COMPLETED|Overall Study||58||
48267802|NCT01989169|100978589|FG001|COMPLETED|Period 1||15||
48267803|NCT01989169|100978588|FG000|NOT COMPLETED|Period 1||0||
48267804|NCT01989169|100978589|FG001|NOT COMPLETED|Period 1||0||
48267805|NCT01989169|100978588|FG000|STARTED|Period 2||15||
48267806|NCT01989169|100978589|FG001|STARTED|Period 2||15||
48267807|NCT01989169|100978588|FG000|COMPLETED|Period 2||15||
48392083|NCT00842361|101287796|FG000|Exposed|Overall Study||33||
48392084|NCT00842361|101287797|FG001|Exposed|Overall Study||32||
48392085|NCT00842361|101287796|FG000|COMPLETED|Overall Study||32||
48692667|NCT05066750|102032629|FG000|COMPLETED|Overall Study||85||
48692668|NCT05066750|102032630|FG001|COMPLETED|Overall Study||85||
48692669|NCT05066750|102032629|FG000|NOT COMPLETED|Overall Study||0||
48107043|NCT01364090|100590439|FG001|COMPLETED|Overall Study||12||
48107044|NCT01364090|100590440|FG002|COMPLETED|Overall Study||0||
48267808|NCT01989169|100978589|FG001|COMPLETED|Period 2||14||
48267809|NCT01989169|100978588|FG000|NOT COMPLETED|Period 2||0||
48267810|NCT01989169|100978589|FG001|NOT COMPLETED|Period 2||1||
48267811|NCT01533753|100978590|FG000|STARTED|Overall Study||2||
48267812|NCT01533753|100978591|FG001|STARTED|Overall Study||3||
48267813|NCT01533753|100978590|FG000|COMPLETED|Overall Study||2||
48267814|NCT01533753|100978591|FG001|COMPLETED|Overall Study||3||
48267815|NCT01533753|100978590|FG000|NOT COMPLETED|Overall Study||0||
48267816|NCT01533753|100978591|FG001|NOT COMPLETED|Overall Study||0||
48267817|NCT01411241|100978592|FG000|STARTED|Overall Study||309||
48692670|NCT05066750|102032630|FG001|NOT COMPLETED|Overall Study||0||
48692671|NCT02684617|102032631|FG000|STARTED|Overall Study||18||
48692672|NCT02684617|102032632|FG001|STARTED|Overall Study||17||
48692673|NCT02684617|102032633|FG002|STARTED|Overall Study||40||
48692674|NCT02684617|102032631|FG000|Treated|Overall Study||17||
48692675|NCT02684617|102032632|FG001|Treated|Overall Study||17||
48692676|NCT02684617|102032633|FG002|Treated|Overall Study||38||
48692677|NCT02684617|102032631|FG000|COMPLETED|Overall Study||0||
48692678|NCT02684617|102032632|FG001|COMPLETED|Overall Study||0||
48692679|NCT02684617|102032633|FG002|COMPLETED|Overall Study||0||
48692680|NCT02684617|102032631|FG000|NOT COMPLETED|Overall Study||18||
48692681|NCT02684617|102032632|FG001|NOT COMPLETED|Overall Study||17||
48692682|NCT02684617|102032633|FG002|NOT COMPLETED|Overall Study||40||
48692683|NCT02974140|102032634|FG000|STARTED|Overall Study||39||78
48692684|NCT02974140|102032634|FG000|CRS (Left or Right Eye)|Overall Study||38|Cataract surgery using Cataract Refractive Suite, as randomized|38
48692685|NCT02974140|102032634|FG000|Manual (Fellow Eye)|Overall Study||38|Cataract surgery using standard manual technique|38
48692686|NCT02974140|102032634|FG000|COMPLETED|Overall Study||0||0
48692687|NCT02974140|102032634|FG000|NOT COMPLETED|Overall Study||39||78
48692688|NCT01812213|102032635|FG000|STARTED|Overall Study||76||
48692689|NCT01812213|102032635|FG000|COMPLETED|Overall Study||39||
48692690|NCT01812213|102032635|FG000|NOT COMPLETED|Overall Study||37||
48692691|NCT00662831|102032636|FG000|STARTED|Overall Study||184||
48692692|NCT00662831|102032637|FG001|STARTED|Overall Study||92||
48267818|NCT01411241|100978593|FG001|STARTED|Overall Study||315||
48267819|NCT01411241|100978592|FG000|COMPLETED|Overall Study||298||
48267820|NCT01411241|100978593|FG001|COMPLETED|Overall Study||293||
48267821|NCT01411241|100978592|FG000|NOT COMPLETED|Overall Study||11||
48267822|NCT01411241|100978593|FG001|NOT COMPLETED|Overall Study||22||
48267823|NCT02526498|100978594|FG000|STARTED|Overall Study||200||
48267824|NCT02526498|100978594|FG000|COMPLETED|Overall Study||200||
48267825|NCT02526498|100978594|FG000|NOT COMPLETED|Overall Study||0||
48267826|NCT01217437|100978595|FG000|STARTED|Overall Study||55||
48267827|NCT01217437|100978596|FG001|STARTED|Overall Study||53||
48267828|NCT01217437|100978595|FG000|COMPLETED|Overall Study||12||
48267829|NCT01217437|100978596|FG001|COMPLETED|Overall Study||12||
48267830|NCT01217437|100978595|FG000|NOT COMPLETED|Overall Study||43||
48267831|NCT01217437|100978596|FG001|NOT COMPLETED|Overall Study||41||
48267832|NCT00895895|100978597|FG000|STARTED|Period 1||107||
48267833|NCT00895895|100978598|FG001|STARTED|Period 1||105||
48267834|NCT00895895|100978599|FG002|STARTED|Period 1||104||
48267835|NCT00895895|100978600|FG003|STARTED|Period 1||104||
48267836|NCT00895895|100978601|FG004|STARTED|Period 1||106||
48267837|NCT00895895|100978597|FG000|Randomized But Not Treated|Period 1||1||
48267838|NCT00895895|100978598|FG001|Randomized But Not Treated|Period 1||3||
48267839|NCT00895895|100978599|FG002|Randomized But Not Treated|Period 1||1||
48267840|NCT00895895|100978600|FG003|Randomized But Not Treated|Period 1||1||
48267841|NCT00895895|100978601|FG004|Randomized But Not Treated|Period 1||2||
48267842|NCT00895895|100978597|FG000|COMPLETED|Period 1||86||
48267843|NCT00895895|100978598|FG001|COMPLETED|Period 1||84||
48267844|NCT00895895|100978599|FG002|COMPLETED|Period 1||84||
48267845|NCT00895895|100978600|FG003|COMPLETED|Period 1||91||
48267846|NCT00895895|100978601|FG004|COMPLETED|Period 1||86||
48267847|NCT00895895|100978597|FG000|NOT COMPLETED|Period 1||21||
48267848|NCT00895895|100978598|FG001|NOT COMPLETED|Period 1||21||
48267849|NCT00895895|100978599|FG002|NOT COMPLETED|Period 1||20||
48267850|NCT00895895|100978600|FG003|NOT COMPLETED|Period 1||13||
48267851|NCT00895895|100978601|FG004|NOT COMPLETED|Period 1||20||
48267852|NCT00895895|100978597|FG000|STARTED|After Period 1, Prior to Period 2||86||
48267853|NCT00895895|100978598|FG001|STARTED|After Period 1, Prior to Period 2||84||
48267854|NCT00895895|100978599|FG002|STARTED|After Period 1, Prior to Period 2||84||
48267855|NCT00895895|100978600|FG003|STARTED|After Period 1, Prior to Period 2||91||
48692693|NCT00662831|102032636|FG000|COMPLETED|Overall Study||78||
48692694|NCT00662831|102032637|FG001|COMPLETED|Overall Study||33||
48692695|NCT00662831|102032636|FG000|NOT COMPLETED|Overall Study||106||
48692696|NCT00662831|102032637|FG001|NOT COMPLETED|Overall Study||59||
48692697|NCT02561481|102032638|FG000|STARTED|Pilot Trial||10|Pilot study|
48692698|NCT02561481|102032639|FG001|STARTED|Pilot Trial||0|Pilot study|
48267856|NCT00895895|100978601|FG004|STARTED|After Period 1, Prior to Period 2||86||
48267857|NCT00895895|100978597|FG000|COMPLETED|After Period 1, Prior to Period 2||86||
48267858|NCT00895895|100978598|FG001|COMPLETED|After Period 1, Prior to Period 2||84||
48267859|NCT00895895|100978599|FG002|COMPLETED|After Period 1, Prior to Period 2||82||
48267860|NCT00895895|100978600|FG003|COMPLETED|After Period 1, Prior to Period 2||91||
48267861|NCT00895895|100978601|FG004|COMPLETED|After Period 1, Prior to Period 2||84||
48692699|NCT02561481|102032638|FG000|COMPLETED|Pilot Trial||10||
48692700|NCT02561481|102032639|FG001|COMPLETED|Pilot Trial||0||
48267862|NCT00895895|100978597|FG000|NOT COMPLETED|After Period 1, Prior to Period 2||0||
48267863|NCT00895895|100978598|FG001|NOT COMPLETED|After Period 1, Prior to Period 2||0||
48267864|NCT00895895|100978599|FG002|NOT COMPLETED|After Period 1, Prior to Period 2||2||
48267865|NCT00895895|100978600|FG003|NOT COMPLETED|After Period 1, Prior to Period 2||0||
48267866|NCT00895895|100978601|FG004|NOT COMPLETED|After Period 1, Prior to Period 2||2||
48267867|NCT00895895|100978597|FG000|STARTED|Period 2||86||
48267868|NCT00895895|100978598|FG001|STARTED|Period 2||84||
48267869|NCT00895895|100978599|FG002|STARTED|Period 2||82||
48267870|NCT00895895|100978600|FG003|STARTED|Period 2||91||
48267871|NCT00895895|100978601|FG004|STARTED|Period 2||84||
48267872|NCT00895895|100978597|FG000|COMPLETED|Period 2||30||
48267873|NCT00895895|100978598|FG001|COMPLETED|Period 2||31||
48267874|NCT00895895|100978599|FG002|COMPLETED|Period 2||33||
48267875|NCT00895895|100978600|FG003|COMPLETED|Period 2||37||
48267876|NCT00895895|100978601|FG004|COMPLETED|Period 2||35||
48267877|NCT00895895|100978597|FG000|NOT COMPLETED|Period 2||56||
48267878|NCT00895895|100978598|FG001|NOT COMPLETED|Period 2||53||
48267879|NCT00895895|100978599|FG002|NOT COMPLETED|Period 2||49||
48267880|NCT00895895|100978600|FG003|NOT COMPLETED|Period 2||54||
48267881|NCT00895895|100978601|FG004|NOT COMPLETED|Period 2||49||
48552113|NCT00451178|101683320|FG000|STARTED|Prior to Maintenance Therapy||40||
48552114|NCT00451178|101683321|FG001|STARTED|Prior to Maintenance Therapy||0||
48552115|NCT00451178|101683320|FG000|COMPLETED|Prior to Maintenance Therapy||36||
48552116|NCT00451178|101683321|FG001|COMPLETED|Prior to Maintenance Therapy||0||
48552117|NCT00451178|101683320|FG000|NOT COMPLETED|Prior to Maintenance Therapy||4||
48267882|NCT03006185|100978602|FG000|STARTED|Overall Study||18||36
48267883|NCT03006185|100978602|FG000|Number of Test Areas Recieving AFL|Overall Study||18||36
48267884|NCT03006185|100978602|FG000|Number of Test Areas Receiving MD|Overall Study||18||36
48267885|NCT03006185|100978602|FG000|COMPLETED|Overall Study||18||36
48267886|NCT03006185|100978602|FG000|NOT COMPLETED|Overall Study||0||0
48267887|NCT00078377|100978603|FG000|STARTED|Overall Study||67||
48267888|NCT00078377|100978604|FG001|STARTED|Overall Study||65||
48267889|NCT00078377|100978605|FG002|STARTED|Overall Study||64||
48267890|NCT00078377|100978603|FG000|COMPLETED|Overall Study||56||
48267891|NCT00078377|100978604|FG001|COMPLETED|Overall Study||49||
48267892|NCT00078377|100978605|FG002|COMPLETED|Overall Study||55||
48267893|NCT00078377|100978603|FG000|NOT COMPLETED|Overall Study||11||
48267894|NCT00078377|100978604|FG001|NOT COMPLETED|Overall Study||16||
48267895|NCT00078377|100978605|FG002|NOT COMPLETED|Overall Study||9||
48267896|NCT00980642|100978606|FG000|STARTED|Overall Study||36||
48267897|NCT00980642|100978607|FG001|STARTED|Overall Study||20||
48267898|NCT00980642|100978606|FG000|COMPLETED|Overall Study||36||
48267899|NCT00980642|100978607|FG001|COMPLETED|Overall Study||20||
48267900|NCT00980642|100978606|FG000|NOT COMPLETED|Overall Study||0||
48267901|NCT00980642|100978607|FG001|NOT COMPLETED|Overall Study||0||
48267902|NCT01240551|100978608|FG000|STARTED|Overall Study||30||
48267903|NCT01240551|100978609|FG001|STARTED|Overall Study||30||
48267904|NCT01240551|100978608|FG000|COMPLETED|Overall Study||26||
48267905|NCT01240551|100978609|FG001|COMPLETED|Overall Study||27||
48267906|NCT01240551|100978608|FG000|NOT COMPLETED|Overall Study||4||
48267907|NCT01240551|100978609|FG001|NOT COMPLETED|Overall Study||3||
48267908|NCT02993406|100978610|FG000|STARTED|Overall Study||6992||
48267909|NCT02993406|100978611|FG001|STARTED|Overall Study||6978||
48267910|NCT02993406|100978610|FG000|COMPLETED|Overall Study||6697||
48267911|NCT02993406|100978611|FG001|COMPLETED|Overall Study||6620||
48267912|NCT02993406|100978610|FG000|NOT COMPLETED|Overall Study||295||
48267913|NCT02993406|100978611|FG001|NOT COMPLETED|Overall Study||358||
48267914|NCT00822770|100978612|FG000|STARTED|Overall Study||18||
48267915|NCT00822770|100978613|FG001|STARTED|Overall Study||29||
48267916|NCT00822770|100978612|FG000|COMPLETED|Overall Study||15||
48267917|NCT00822770|100978613|FG001|COMPLETED|Overall Study||28||
48267918|NCT00822770|100978612|FG000|NOT COMPLETED|Overall Study||3||
48267919|NCT00822770|100978613|FG001|NOT COMPLETED|Overall Study||1||
48267920|NCT01028677|100978614|FG000|STARTED|Overall Study||10||
48267921|NCT01028677|100978615|FG001|STARTED|Overall Study||7||
48267922|NCT01028677|100978614|FG000|COMPLETED|Overall Study||8||
48267923|NCT01028677|100978615|FG001|COMPLETED|Overall Study||6||
48267924|NCT01028677|100978614|FG000|NOT COMPLETED|Overall Study||2||
48267925|NCT01028677|100978615|FG001|NOT COMPLETED|Overall Study||1||
48267926|NCT01250925|100978616|FG000|STARTED|Overall Study||31||
48267927|NCT01250925|100978617|FG001|STARTED|Overall Study||31||
48267928|NCT01250925|100978618|FG002|STARTED|Overall Study||32||
48267929|NCT01250925|100978616|FG000|COMPLETED|Overall Study||26||
48267930|NCT01250925|100978617|FG001|COMPLETED|Overall Study||28||
48267931|NCT01250925|100978618|FG002|COMPLETED|Overall Study||30||
48267932|NCT01250925|100978616|FG000|NOT COMPLETED|Overall Study||5||
48267933|NCT01250925|100978617|FG001|NOT COMPLETED|Overall Study||3||
48267934|NCT01250925|100978618|FG002|NOT COMPLETED|Overall Study||2||
48267935|NCT04155203|100978619|FG000|STARTED|Overall Study||219||
48267936|NCT04155203|100978620|FG001|STARTED|Overall Study||219||
48267937|NCT04155203|100978621|FG002|STARTED|Overall Study||219||
48552118|NCT00451178|101683321|FG001|NOT COMPLETED|Prior to Maintenance Therapy||0||
48552119|NCT00451178|101683320|FG000|STARTED|Maintenance Therapy (up to 3 Years)||36||
48552120|NCT00451178|101683321|FG001|STARTED|Maintenance Therapy (up to 3 Years)||0||
48267938|NCT04155203|100978619|FG000|COMPLETED|Overall Study||165||
48267939|NCT04155203|100978620|FG001|COMPLETED|Overall Study||184||
48267940|NCT04155203|100978621|FG002|COMPLETED|Overall Study||165||
48267941|NCT04155203|100978619|FG000|NOT COMPLETED|Overall Study||54||
48267942|NCT04155203|100978620|FG001|NOT COMPLETED|Overall Study||35||
48267943|NCT04155203|100978621|FG002|NOT COMPLETED|Overall Study||54||
48267944|NCT03053453|100978622|FG000|STARTED|Overall Study||26||
48267945|NCT03053453|100978623|FG001|STARTED|Overall Study||26||
48267946|NCT03053453|100978622|FG000|COMPLETED|Overall Study||26||
48267947|NCT03053453|100978623|FG001|COMPLETED|Overall Study||26||
48267948|NCT03053453|100978622|FG000|NOT COMPLETED|Overall Study||0||
48267949|NCT03053453|100978623|FG001|NOT COMPLETED|Overall Study||0||
48267950|NCT02125279|100978624|FG000|STARTED|Overall Study||54||
48267951|NCT02125279|100978624|FG000|COMPLETED|Overall Study||41||
48267952|NCT02125279|100978624|FG000|NOT COMPLETED|Overall Study||13||
48267953|NCT03382769|100978625|FG000|STARTED|Overall Study||0||
48267954|NCT03382769|100978626|FG001|STARTED|Overall Study||1||
48267955|NCT03382769|100978625|FG000|COMPLETED|Overall Study||0||
48267956|NCT03382769|100978626|FG001|COMPLETED|Overall Study||0||
48267957|NCT03382769|100978625|FG000|NOT COMPLETED|Overall Study||0||
48267958|NCT03382769|100978626|FG001|NOT COMPLETED|Overall Study||1||
48267959|NCT05454813|100978627|FG000|STARTED|Overall Study||56||
48267960|NCT05454813|100978627|FG000|COMPLETED|Overall Study||56||
48267961|NCT05454813|100978627|FG000|NOT COMPLETED|Overall Study||0||
48267962|NCT02637323|100978628|FG000|STARTED|Overall Study||63||
48267963|NCT02637323|100978629|FG001|STARTED|Overall Study||18||
48267964|NCT02637323|100978628|FG000|COMPLETED|Overall Study||61||
48267965|NCT02637323|100978629|FG001|COMPLETED|Overall Study||17||
48267966|NCT02637323|100978628|FG000|NOT COMPLETED|Overall Study||2||
48267967|NCT02637323|100978629|FG001|NOT COMPLETED|Overall Study||1||
48692701|NCT02561481|102032638|FG000|NOT COMPLETED|Pilot Trial||0||
48692702|NCT02561481|102032639|FG001|NOT COMPLETED|Pilot Trial||0||
48692703|NCT02561481|102032638|FG000|STARTED|Main Trial - Double Blind Phase||25||
48267968|NCT00504777|100978630|FG000|STARTED|Overall Study||36||
48267969|NCT00504777|100978630|FG000|COMPLETED|Overall Study||35||
48267970|NCT00504777|100978630|FG000|NOT COMPLETED|Overall Study||1||
48267971|NCT01040169|100978631|FG000|STARTED|Overall Study||35||
48267972|NCT01040169|100978632|FG001|STARTED|Overall Study||44||
48267973|NCT01040169|100978631|FG000|COMPLETED|Overall Study||32||
48267974|NCT01040169|100978632|FG001|COMPLETED|Overall Study||36||
48267975|NCT01040169|100978631|FG000|NOT COMPLETED|Overall Study||3||
48267976|NCT01040169|100978632|FG001|NOT COMPLETED|Overall Study||8||
48267977|NCT01932762|100978633|FG000|STARTED|Overall Study||30||
48267978|NCT01932762|100978634|FG001|STARTED|Overall Study||30||
48267979|NCT01932762|100978635|FG002|STARTED|Overall Study||19||
48267980|NCT01932762|100978636|FG003|STARTED|Overall Study||19||
48267981|NCT01932762|100978633|FG000|COMPLETED|Overall Study||24||
48267982|NCT01932762|100978634|FG001|COMPLETED|Overall Study||28||
48267983|NCT01932762|100978635|FG002|COMPLETED|Overall Study||19||
48267984|NCT01932762|100978636|FG003|COMPLETED|Overall Study||18||
48267985|NCT01932762|100978633|FG000|NOT COMPLETED|Overall Study||6||
48267986|NCT01932762|100978634|FG001|NOT COMPLETED|Overall Study||2||
48267987|NCT01932762|100978635|FG002|NOT COMPLETED|Overall Study||0||
48267988|NCT01932762|100978636|FG003|NOT COMPLETED|Overall Study||1||
48267989|NCT04887506|100978637|FG000|STARTED|Overall Study||54||
48267990|NCT04887506|100978638|FG001|STARTED|Overall Study||53||
48267991|NCT04887506|100978637|FG000|Modified Intent-to-treat (mITT) Population|Overall Study||54|Modified intent-to-treat (mITT) population included all randomized patients who received at least one dose of study medication|
48267992|NCT04887506|100978638|FG001|Modified Intent-to-treat (mITT) Population|Overall Study||49|Modified intent-to-treat (mITT) population included all randomized patients who received at least one dose of study medication|
48267993|NCT04887506|100978637|FG000|COMPLETED|Overall Study||48||
48267994|NCT04887506|100978638|FG001|COMPLETED|Overall Study||45||
48267995|NCT04887506|100978637|FG000|NOT COMPLETED|Overall Study||6||
48267996|NCT04887506|100978638|FG001|NOT COMPLETED|Overall Study||8||
48267997|NCT01791972|100978639|FG000|STARTED|Overall Study||19||
48267998|NCT01791972|100978640|FG001|STARTED|Overall Study||19||
48692704|NCT02561481|102032639|FG001|STARTED|Main Trial - Double Blind Phase||25||
48692705|NCT02561481|102032638|FG000|COMPLETED|Main Trial - Double Blind Phase||22||
48267999|NCT01791972|100978639|FG000|COMPLETED|Overall Study||19||
48268000|NCT01791972|100978640|FG001|COMPLETED|Overall Study||19||
48268001|NCT01791972|100978639|FG000|NOT COMPLETED|Overall Study||0||
48268002|NCT01791972|100978640|FG001|NOT COMPLETED|Overall Study||0||
48268003|NCT03834519|100978641|FG000|STARTED|Overall Study||529||
48392086|NCT00842361|101287797|FG001|COMPLETED|Overall Study||31||
48692706|NCT02561481|102032639|FG001|COMPLETED|Main Trial - Double Blind Phase||23||
48692707|NCT02561481|102032638|FG000|NOT COMPLETED|Main Trial - Double Blind Phase||3||
48268004|NCT03834519|100978642|FG001|STARTED|Overall Study||264||
48268005|NCT03834519|100978641|FG000|COMPLETED|Overall Study||0||
48268006|NCT03834519|100978642|FG001|COMPLETED|Overall Study||0||
48268007|NCT03834519|100978641|FG000|NOT COMPLETED|Overall Study||529||
48392087|NCT00842361|101287796|FG000|NOT COMPLETED|Overall Study||1||
48692708|NCT02561481|102032639|FG001|NOT COMPLETED|Main Trial - Double Blind Phase||2||
48268008|NCT03834519|100978642|FG001|NOT COMPLETED|Overall Study||264||
48268009|NCT03306420|100978643|FG000|STARTED|Overall Study||3||
48268010|NCT03306420|100978644|FG001|STARTED|Overall Study||3||
48268011|NCT03306420|100978645|FG002|STARTED|Overall Study||3||
48268012|NCT03306420|100978646|FG003|STARTED|Overall Study||3||
48268013|NCT03306420|100978647|FG004|STARTED|Overall Study||3||
48692709|NCT02561481|102032638|FG000|STARTED|Main Trial - Open Label Phase||45||
48692710|NCT02561481|102032639|FG001|STARTED|Main Trial - Open Label Phase||0||
48692711|NCT02561481|102032638|FG000|COMPLETED|Main Trial - Open Label Phase||32||
48692712|NCT02561481|102032639|FG001|COMPLETED|Main Trial - Open Label Phase||0||
48692713|NCT02561481|102032638|FG000|NOT COMPLETED|Main Trial - Open Label Phase||13||
48692714|NCT02561481|102032639|FG001|NOT COMPLETED|Main Trial - Open Label Phase||0||
48692715|NCT04928885|102032640|FG000|STARTED|Overall Study||152||
48692716|NCT04928885|102032641|FG001|STARTED|Overall Study||133||
48692717|NCT04928885|102032640|FG000|3 Months|Overall Study||130||
48692718|NCT04928885|102032641|FG001|3 Months|Overall Study||123||
48692719|NCT04928885|102032640|FG000|COMPLETED|Overall Study||123||
48692720|NCT04928885|102032641|FG001|COMPLETED|Overall Study||122||
48692721|NCT04928885|102032640|FG000|NOT COMPLETED|Overall Study||29||
48692722|NCT04928885|102032641|FG001|NOT COMPLETED|Overall Study||11||
48392088|NCT00842361|101287797|FG001|NOT COMPLETED|Overall Study||2||
48392089|NCT01925612|101287798|FG000|STARTED|Overall Study||29||
48392090|NCT01925612|101287799|FG001|STARTED|Overall Study||22||
48392091|NCT01925612|101287800|FG002|STARTED|Overall Study||11||
48392092|NCT01925612|101287801|FG003|STARTED|Overall Study||11||
48392093|NCT01925612|101287802|FG004|STARTED|Overall Study||12||
48392094|NCT01925612|101287798|FG000|COMPLETED|Overall Study||25||
48392095|NCT01925612|101287799|FG001|COMPLETED|Overall Study||18||
48392096|NCT01925612|101287800|FG002|COMPLETED|Overall Study||10||
48392097|NCT01925612|101287801|FG003|COMPLETED|Overall Study||10||
48392098|NCT01925612|101287802|FG004|COMPLETED|Overall Study||10||
48392099|NCT01925612|101287798|FG000|NOT COMPLETED|Overall Study||4||
48392100|NCT01925612|101287799|FG001|NOT COMPLETED|Overall Study||4||
48392101|NCT01925612|101287800|FG002|NOT COMPLETED|Overall Study||1||
48692723|NCT04345900|102032642|FG000|STARTED|Overall Study||13||
48692724|NCT04345900|102032643|FG001|STARTED|Overall Study||14||
48392102|NCT01925612|101287801|FG003|NOT COMPLETED|Overall Study||1||
48392103|NCT01925612|101287802|FG004|NOT COMPLETED|Overall Study||2||
48392104|NCT00628758|101287803|FG000|STARTED|Overall Study||209||
48392105|NCT00628758|101287804|FG001|STARTED|Overall Study||221||
48268014|NCT03306420|100978643|FG000|COMPLETED|Overall Study||3||
48268015|NCT03306420|100978644|FG001|COMPLETED|Overall Study||3||
48268016|NCT03306420|100978645|FG002|COMPLETED|Overall Study||3||
48268017|NCT03306420|100978646|FG003|COMPLETED|Overall Study||3||
48268018|NCT03306420|100978647|FG004|COMPLETED|Overall Study||3||
48268019|NCT03306420|100978643|FG000|NOT COMPLETED|Overall Study||0||
48268020|NCT03306420|100978644|FG001|NOT COMPLETED|Overall Study||0||
48268021|NCT03306420|100978645|FG002|NOT COMPLETED|Overall Study||0||
48268022|NCT03306420|100978646|FG003|NOT COMPLETED|Overall Study||0||
48268023|NCT03306420|100978647|FG004|NOT COMPLETED|Overall Study||0||
48268024|NCT00186017|100978648|FG000|STARTED|Overall Study||25||
48552121|NCT00451178|101683320|FG000|COMPLETED|Maintenance Therapy (up to 3 Years)||6||
48552122|NCT00451178|101683321|FG001|COMPLETED|Maintenance Therapy (up to 3 Years)||0||
48552123|NCT00451178|101683320|FG000|NOT COMPLETED|Maintenance Therapy (up to 3 Years)||30||
48552124|NCT00451178|101683321|FG001|NOT COMPLETED|Maintenance Therapy (up to 3 Years)||0||
48552125|NCT00451178|101683320|FG000|STARTED|Long-Term Follow-Up (Up to 2 Years)||6||
48552126|NCT00451178|101683321|FG001|STARTED|Long-Term Follow-Up (Up to 2 Years)||26||
48552127|NCT00451178|101683320|FG000|COMPLETED|Long-Term Follow-Up (Up to 2 Years)||0||
48552128|NCT00451178|101683321|FG001|COMPLETED|Long-Term Follow-Up (Up to 2 Years)||0||
48268025|NCT00186017|100978649|FG001|STARTED|Overall Study||25||
48268026|NCT00186017|100978648|FG000|COMPLETED|Overall Study||23||
48268027|NCT00186017|100978649|FG001|COMPLETED|Overall Study||22||
48268028|NCT00186017|100978648|FG000|NOT COMPLETED|Overall Study||2||
48268029|NCT00186017|100978649|FG001|NOT COMPLETED|Overall Study||3||
48268030|NCT02879383|100978650|FG000|STARTED|First 24 Weeks||39||
48268031|NCT02879383|100978651|FG001|STARTED|First 24 Weeks||37||
48268032|NCT02879383|100978652|FG002|STARTED|First 24 Weeks||17||
48268033|NCT02879383|100978653|FG003|STARTED|First 24 Weeks||16||
48268034|NCT02879383|100978650|FG000|COMPLETED|First 24 Weeks||39||
48268035|NCT02879383|100978651|FG001|COMPLETED|First 24 Weeks||36||
48268036|NCT02879383|100978652|FG002|COMPLETED|First 24 Weeks||17||
48268037|NCT02879383|100978653|FG003|COMPLETED|First 24 Weeks||16||
48268038|NCT02879383|100978650|FG000|NOT COMPLETED|First 24 Weeks||0||
48268039|NCT02879383|100978651|FG001|NOT COMPLETED|First 24 Weeks||1||
48268040|NCT02879383|100978652|FG002|NOT COMPLETED|First 24 Weeks||0||
48268041|NCT02879383|100978653|FG003|NOT COMPLETED|First 24 Weeks||0||
48268042|NCT02879383|100978650|FG000|STARTED|Second 24 Weeks (Crossover for Sham)||33||
48268043|NCT02879383|100978651|FG001|STARTED|Second 24 Weeks (Crossover for Sham)||0||
48268044|NCT02879383|100978652|FG002|STARTED|Second 24 Weeks (Crossover for Sham)||4||
48268045|NCT02879383|100978653|FG003|STARTED|Second 24 Weeks (Crossover for Sham)||0||
48268046|NCT02879383|100978650|FG000|COMPLETED|Second 24 Weeks (Crossover for Sham)||33||
48268047|NCT02879383|100978651|FG001|COMPLETED|Second 24 Weeks (Crossover for Sham)||0||
48268048|NCT02879383|100978652|FG002|COMPLETED|Second 24 Weeks (Crossover for Sham)||4||
48552129|NCT00451178|101683320|FG000|NOT COMPLETED|Long-Term Follow-Up (Up to 2 Years)||6||
48552130|NCT00451178|101683321|FG001|NOT COMPLETED|Long-Term Follow-Up (Up to 2 Years)||26||
48552131|NCT02928055|101683322|FG000|STARTED|Overall Study||8||
48552132|NCT02928055|101683323|FG001|STARTED|Overall Study||8||
48552133|NCT02928055|101683324|FG002|STARTED|Overall Study||7||
48552134|NCT02928055|101683322|FG000|End of Treatment|Overall Study||8||
48552135|NCT02928055|101683323|FG001|End of Treatment|Overall Study||8||
48552136|NCT02928055|101683324|FG002|End of Treatment|Overall Study||6||
48552137|NCT02928055|101683322|FG000|1 Month Follow up|Overall Study||7||
48552138|NCT02928055|101683323|FG001|1 Month Follow up|Overall Study||7||
48692725|NCT04345900|102032644|FG002|STARTED|Overall Study||14||
48692726|NCT04345900|102032645|FG003|STARTED|Overall Study||14||
48692727|NCT04345900|102032642|FG000|COMPLETED|Overall Study||11|l|
48268049|NCT02879383|100978653|FG003|COMPLETED|Second 24 Weeks (Crossover for Sham)||0||
48268050|NCT02879383|100978650|FG000|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0||
48268051|NCT02879383|100978651|FG001|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0||
48268052|NCT02879383|100978652|FG002|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0||
48268053|NCT02879383|100978653|FG003|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0||
48552139|NCT02928055|101683324|FG002|1 Month Follow up|Overall Study||6||
48552140|NCT02928055|101683322|FG000|2 Month Follow up|Overall Study||6||
48552141|NCT02928055|101683323|FG001|2 Month Follow up|Overall Study||7||
48552142|NCT02928055|101683324|FG002|2 Month Follow up|Overall Study||5||
48552143|NCT02928055|101683322|FG000|3 Month Follow up|Overall Study||5||
48552144|NCT02928055|101683323|FG001|3 Month Follow up|Overall Study||6||
48552145|NCT02928055|101683324|FG002|3 Month Follow up|Overall Study||5||
48552146|NCT02928055|101683322|FG000|COMPLETED|Overall Study||5|complete study(all milestones)|
48552147|NCT02928055|101683323|FG001|COMPLETED|Overall Study||6|complete study(all milestones)|
48552148|NCT02928055|101683324|FG002|COMPLETED|Overall Study||5|complete study(all milestones)|
48552149|NCT02928055|101683322|FG000|NOT COMPLETED|Overall Study||3||
48552150|NCT02928055|101683323|FG001|NOT COMPLETED|Overall Study||2||
48552151|NCT02928055|101683324|FG002|NOT COMPLETED|Overall Study||2||
48552152|NCT01275729|101683325|FG000|STARTED|Overall Study||96||
48552153|NCT01275729|101683325|FG000|COMPLETED|Overall Study||92||
48552154|NCT01275729|101683325|FG000|NOT COMPLETED|Overall Study||4||
48552155|NCT01776632|101683326|FG000|STARTED|Overall Study||217||
48552156|NCT01776632|101683327|FG001|STARTED|Overall Study||219||
48107045|NCT01364090|100590438|FG000|NOT COMPLETED|Overall Study||3||
48107046|NCT01364090|100590439|FG001|NOT COMPLETED|Overall Study||14||
48107047|NCT01364090|100590440|FG002|NOT COMPLETED|Overall Study||6||
48107048|NCT05300295|100590441|FG000|STARTED|Overall Study||13||
48107049|NCT05300295|100590441|FG000|COMPLETED|Overall Study||13||
48552157|NCT01776632|101683326|FG000|COMPLETED|Overall Study||190||
48552158|NCT01776632|101683327|FG001|COMPLETED|Overall Study||190||
48552159|NCT01776632|101683326|FG000|NOT COMPLETED|Overall Study||27||
48552160|NCT01776632|101683327|FG001|NOT COMPLETED|Overall Study||29||
48552161|NCT00442962|101683328|FG000|STARTED|Overall Study||54||
48552162|NCT00442962|101683328|FG000|Primary Outcome Evaluation|Overall Study||52||
48552163|NCT00442962|101683328|FG000|COMPLETED|Overall Study||46||
48692728|NCT04345900|102032643|FG001|COMPLETED|Overall Study||11|l|
48107050|NCT05300295|100590441|FG000|NOT COMPLETED|Overall Study||0||
48107051|NCT03249779|100590442|FG000|STARTED|Overall Study||8||
48107052|NCT03249779|100590442|FG000|COMPLETED|Overall Study||8||
48552164|NCT00442962|101683328|FG000|NOT COMPLETED|Overall Study||8||
48552165|NCT02755649|101683329|FG000|STARTED|Overall Study||108||
48552166|NCT02755649|101683330|FG001|STARTED|Overall Study||107||
48552167|NCT02755649|101683331|FG002|STARTED|Overall Study||110||
48552168|NCT02755649|101683329|FG000|Completed Treatment (Week 16)|Overall Study||107||
48552169|NCT02755649|101683330|FG001|Completed Treatment (Week 16)|Overall Study||106||
48552170|NCT02755649|101683331|FG002|Completed Treatment (Week 16)|Overall Study||109||
48692729|NCT04345900|102032644|FG002|COMPLETED|Overall Study||10|l|
48552171|NCT02755649|101683329|FG000|Completed Study (Week 28)|Overall Study||7||
48692730|NCT04345900|102032645|FG003|COMPLETED|Overall Study||9|l|
48692731|NCT04345900|102032642|FG000|NOT COMPLETED|Overall Study||2||
48692732|NCT04345900|102032643|FG001|NOT COMPLETED|Overall Study||3||
48692733|NCT04345900|102032644|FG002|NOT COMPLETED|Overall Study||4||
48692734|NCT04345900|102032645|FG003|NOT COMPLETED|Overall Study||5||
48692735|NCT02388165|102032646|FG000|STARTED|Overall Study||1726||
48692736|NCT02388165|102032647|FG001|STARTED|Overall Study||1724||
48692737|NCT02388165|102032646|FG000|Vaccinated (Safety Population)|Overall Study||1708||
48692738|NCT02388165|102032647|FG001|Vaccinated (Safety Population)|Overall Study||1709||
48692739|NCT02388165|102032646|FG000|COMPLETED|Overall Study||1599||
48692740|NCT02388165|102032647|FG001|COMPLETED|Overall Study||1594||
48692741|NCT02388165|102032646|FG000|NOT COMPLETED|Overall Study||127||
48692742|NCT02388165|102032647|FG001|NOT COMPLETED|Overall Study||130||
48692743|NCT03440463|102032648|FG000|STARTED|Baseline||201||
48692744|NCT03440463|102032649|FG001|STARTED|Baseline||163||
48692745|NCT03440463|102032650|FG002|STARTED|Baseline||164||
48692746|NCT03440463|102032648|FG000|COMPLETED|Baseline||201||
48692747|NCT03440463|102032649|FG001|COMPLETED|Baseline||163||
48692748|NCT03440463|102032650|FG002|COMPLETED|Baseline||164||
48692749|NCT03440463|102032648|FG000|NOT COMPLETED|Baseline||0||
48692750|NCT03440463|102032649|FG001|NOT COMPLETED|Baseline||0||
48692751|NCT03440463|102032650|FG002|NOT COMPLETED|Baseline||0||
48692752|NCT03440463|102032648|FG000|STARTED|1-month Follow-up||201||
48692753|NCT03440463|102032649|FG001|STARTED|1-month Follow-up||163||
48692754|NCT03440463|102032650|FG002|STARTED|1-month Follow-up||164||
48692755|NCT03440463|102032648|FG000|COMPLETED|1-month Follow-up||134||
48692756|NCT03440463|102032649|FG001|COMPLETED|1-month Follow-up||113||
48692757|NCT03440463|102032650|FG002|COMPLETED|1-month Follow-up||107||
48692758|NCT03440463|102032648|FG000|NOT COMPLETED|1-month Follow-up||67||
48692759|NCT03440463|102032649|FG001|NOT COMPLETED|1-month Follow-up||50||
48692760|NCT03440463|102032650|FG002|NOT COMPLETED|1-month Follow-up||57||
48692761|NCT03440463|102032648|FG000|STARTED|3-month Follow-up||201||
48692762|NCT03440463|102032649|FG001|STARTED|3-month Follow-up||163||
48692763|NCT03440463|102032650|FG002|STARTED|3-month Follow-up||164||
48692764|NCT03440463|102032648|FG000|COMPLETED|3-month Follow-up||117||
48692765|NCT03440463|102032649|FG001|COMPLETED|3-month Follow-up||89||
48692766|NCT03440463|102032650|FG002|COMPLETED|3-month Follow-up||96||
48692767|NCT03440463|102032648|FG000|NOT COMPLETED|3-month Follow-up||84||
48692768|NCT03440463|102032649|FG001|NOT COMPLETED|3-month Follow-up||74||
48692769|NCT03440463|102032650|FG002|NOT COMPLETED|3-month Follow-up||68||
48692770|NCT01841021|102032651|FG000|STARTED|Overall Study||1||
48692771|NCT01841021|102032651|FG000|COMPLETED|Overall Study||1||
48692772|NCT01841021|102032651|FG000|NOT COMPLETED|Overall Study||0||
48107053|NCT03249779|100590442|FG000|NOT COMPLETED|Overall Study||0||
48107054|NCT01001442|100590443|FG000|STARTED|Overall Study||4||
48692773|NCT00958360|102032652|FG000|STARTED|Overall Study||163||
48268054|NCT00681668|100978654|FG000|STARTED|Overall Study||5||
48268055|NCT00681668|100978654|FG000|COMPLETED|Overall Study||3||
48268056|NCT00681668|100978654|FG000|NOT COMPLETED|Overall Study||2||
48692774|NCT00958360|102032653|FG001|STARTED|Overall Study||160||
48692775|NCT00958360|102032652|FG000|COMPLETED|Overall Study||152||
48692776|NCT00958360|102032653|FG001|COMPLETED|Overall Study||150||
48692777|NCT00958360|102032652|FG000|NOT COMPLETED|Overall Study||11||
48692778|NCT00958360|102032653|FG001|NOT COMPLETED|Overall Study||10||
48692779|NCT02397915|102032654|FG000|STARTED|Period 1||150||
48692780|NCT02397915|102032655|FG001|STARTED|Period 1||150||
48692781|NCT02397915|102032656|FG002|STARTED|Period 1||0||
48692782|NCT02397915|102032657|FG003|STARTED|Period 1||0||
48692783|NCT02397915|102032654|FG000|COMPLETED|Period 1||149||
48692784|NCT02397915|102032655|FG001|COMPLETED|Period 1||149||
48692785|NCT02397915|102032656|FG002|COMPLETED|Period 1||0||
48692786|NCT02397915|102032657|FG003|COMPLETED|Period 1||0||
48692787|NCT02397915|102032654|FG000|NOT COMPLETED|Period 1||1||
48692788|NCT02397915|102032655|FG001|NOT COMPLETED|Period 1||1||
48692789|NCT02397915|102032656|FG002|NOT COMPLETED|Period 1||0||
48692790|NCT02397915|102032657|FG003|NOT COMPLETED|Period 1||0||
48692791|NCT02397915|102032654|FG000|STARTED|Period 2||0||
48692792|NCT02397915|102032655|FG001|STARTED|Period 2||0||
48692793|NCT02397915|102032656|FG002|STARTED|Period 2||149||
48692794|NCT02397915|102032657|FG003|STARTED|Period 2||149||
48692795|NCT02397915|102032654|FG000|COMPLETED|Period 2||0||
48692796|NCT02397915|102032655|FG001|COMPLETED|Period 2||0||
48692797|NCT02397915|102032656|FG002|COMPLETED|Period 2||149||
48692798|NCT02397915|102032657|FG003|COMPLETED|Period 2||149||
48692799|NCT02397915|102032654|FG000|NOT COMPLETED|Period 2||0||
48692800|NCT02397915|102032655|FG001|NOT COMPLETED|Period 2||0||
48692801|NCT02397915|102032656|FG002|NOT COMPLETED|Period 2||0||
48692802|NCT02397915|102032657|FG003|NOT COMPLETED|Period 2||0||
48692803|NCT03115827|102032658|FG000|STARTED|Overall Study||15||
48692804|NCT03115827|102032658|FG000|COMPLETED|Overall Study||12||
48692805|NCT03115827|102032658|FG000|NOT COMPLETED|Overall Study||3||
48692806|NCT00293813|102032659|FG000|STARTED|Overall Study||82||
48692807|NCT00293813|102032660|FG001|STARTED|Overall Study||83||
48692808|NCT00293813|102032661|FG002|STARTED|Overall Study||82||
48692809|NCT00293813|102032659|FG000|COMPLETED|Overall Study||69||
48692810|NCT00293813|102032660|FG001|COMPLETED|Overall Study||74||
48692811|NCT00293813|102032661|FG002|COMPLETED|Overall Study||74||
48692812|NCT00293813|102032659|FG000|NOT COMPLETED|Overall Study||13||
48692813|NCT00293813|102032660|FG001|NOT COMPLETED|Overall Study||9||
48692814|NCT00293813|102032661|FG002|NOT COMPLETED|Overall Study||8||
48692815|NCT02137447|102032662|FG000|STARTED|Overall Study||10||
48692816|NCT02137447|102032662|FG000|COMPLETED|Overall Study||10||
48692817|NCT02137447|102032662|FG000|NOT COMPLETED|Overall Study||0||
48692818|NCT00832598|102032663|FG000|STARTED|Overall Study||13||
48692819|NCT00832598|102032663|FG000|COMPLETED|Overall Study||13||
48692820|NCT00832598|102032663|FG000|NOT COMPLETED|Overall Study||0||
48692821|NCT00924612|102032664|FG000|STARTED|Overall Study||4||
48692822|NCT00924612|102032665|FG001|STARTED|Overall Study||4||
48692823|NCT00924612|102032666|FG002|STARTED|Overall Study||4||
48692824|NCT00924612|102032667|FG003|STARTED|Overall Study||4||
48692825|NCT00924612|102032664|FG000|COMPLETED|Overall Study||4||
48692826|NCT00924612|102032665|FG001|COMPLETED|Overall Study||4||
48692827|NCT00924612|102032666|FG002|COMPLETED|Overall Study||4||
48692828|NCT00924612|102032667|FG003|COMPLETED|Overall Study||4||
48692829|NCT00924612|102032664|FG000|NOT COMPLETED|Overall Study||0||
48692830|NCT00924612|102032665|FG001|NOT COMPLETED|Overall Study||0||
48692831|NCT00924612|102032666|FG002|NOT COMPLETED|Overall Study||0||
48692832|NCT00924612|102032667|FG003|NOT COMPLETED|Overall Study||0||
48692833|NCT01625416|102032668|FG000|STARTED|Overall Study||60||
48692834|NCT01625416|102032669|FG001|STARTED|Overall Study||61||
48268057|NCT01777334|100978655|FG000|STARTED|Overall Study||454||
48692835|NCT01625416|102032668|FG000|COMPLETED|Overall Study||51||
48692836|NCT01625416|102032669|FG001|COMPLETED|Overall Study||54||
48692837|NCT01625416|102032668|FG000|NOT COMPLETED|Overall Study||9||
48692838|NCT01625416|102032669|FG001|NOT COMPLETED|Overall Study||7||
48692839|NCT01208324|102032670|FG000|STARTED|Pre-randomization of Patch||14||
48692840|NCT01208324|102032671|FG001|STARTED|Pre-randomization of Patch||15||
48692841|NCT01208324|102032672|FG002|STARTED|Pre-randomization of Patch||10||
48268058|NCT01777334|100978656|FG001|STARTED|Overall Study||451||
48692842|NCT01208324|102032673|FG003|STARTED|Pre-randomization of Patch||8||
48692843|NCT01208324|102032670|FG000|Test Day 1|Pre-randomization of Patch||14|1 Sham Patch: Sham Tryptophan, then Active Tryptophan participant did not comp|
48692844|NCT01208324|102032671|FG001|Test Day 1|Pre-randomization of Patch||15|1 Sham Patch: Sham Tryptophan, then Active Tryptophan participant did not comp|
48692845|NCT01208324|102032672|FG002|Test Day 1|Pre-randomization of Patch||10|1 Sham Patch: Sham Tryptophan, then Active Tryptophan participant did not comp|
48268059|NCT01777334|100978655|FG000|COMPLETED|Overall Study||401||
48268060|NCT01777334|100978656|FG001|COMPLETED|Overall Study||388||
48692846|NCT01208324|102032673|FG003|Test Day 1|Pre-randomization of Patch||8|1 Sham Patch: Sham Tryptophan, then Active Tryptophan participant did not comp|
48692847|NCT01208324|102032670|FG000|Test Day 2|Pre-randomization of Patch||14||
48692848|NCT01208324|102032671|FG001|Test Day 2|Pre-randomization of Patch||15||
48552172|NCT02755649|101683330|FG001|Completed Study (Week 28)|Overall Study||8||
48552173|NCT02755649|101683331|FG002|Completed Study (Week 28)|Overall Study||8||
48552174|NCT02755649|101683329|FG000|COMPLETED|Overall Study||7||
48107055|NCT01001442|100590444|FG001|STARTED|Overall Study||3||
48107056|NCT01001442|100590445|FG002|STARTED|Overall Study||4||
48107057|NCT01001442|100590446|FG003|STARTED|Overall Study||3||
48107058|NCT01001442|100590447|FG004|STARTED|Overall Study||4||
48107059|NCT01001442|100590448|FG005|STARTED|Overall Study||3||
48107060|NCT01001442|100590449|FG006|STARTED|Overall Study||10||
48107061|NCT01001442|100590450|FG007|STARTED|Overall Study||4||
48107062|NCT01001442|100590443|FG000|COMPLETED|Overall Study||4||
48107063|NCT01001442|100590444|FG001|COMPLETED|Overall Study||3||
48552175|NCT02755649|101683330|FG001|COMPLETED|Overall Study||8||
48552176|NCT02755649|101683331|FG002|COMPLETED|Overall Study||8||
48552177|NCT02755649|101683329|FG000|NOT COMPLETED|Overall Study||101||
48552178|NCT02755649|101683330|FG001|NOT COMPLETED|Overall Study||99||
48552179|NCT02755649|101683331|FG002|NOT COMPLETED|Overall Study||102||
48552180|NCT05736861|101683332|FG000|STARTED|Overall Study||919||
48552181|NCT05736861|101683333|FG001|STARTED|Overall Study||881||
48552182|NCT05736861|101683332|FG000|COMPLETED|Overall Study||817||
48552183|NCT05736861|101683333|FG001|COMPLETED|Overall Study||774||
48552184|NCT05736861|101683332|FG000|NOT COMPLETED|Overall Study||102||
48552185|NCT05736861|101683333|FG001|NOT COMPLETED|Overall Study||107||
48552186|NCT03536884|101683334|FG000|STARTED|Double-Blind (DB) Period: ITP Wk 0-16||373||
48552187|NCT03536884|101683335|FG001|STARTED|Double-Blind (DB) Period: ITP Wk 0-16||370||
48552188|NCT03536884|101683336|FG002|STARTED|Double-Blind (DB) Period: ITP Wk 0-16||0||
48552189|NCT03536884|101683337|FG003|STARTED|Double-Blind (DB) Period: ITP Wk 0-16||0||
48552190|NCT03536884|101683338|FG004|STARTED|Double-Blind (DB) Period: ITP Wk 0-16||0||
48552191|NCT03536884|101683339|FG005|STARTED|Double-Blind (DB) Period: ITP Wk 0-16||0||
48552192|NCT03536884|101683340|FG006|STARTED|Double-Blind (DB) Period: ITP Wk 0-16||0||
48552193|NCT03536884|101683341|FG007|STARTED|Double-Blind (DB) Period: ITP Wk 0-16||0||
48552194|NCT03536884|101683342|FG008|STARTED|Double-Blind (DB) Period: ITP Wk 0-16||0||
48552195|NCT03536884|101683343|FG009|STARTED|Double-Blind (DB) Period: ITP Wk 0-16||0||
48552196|NCT03536884|101683344|FG010|STARTED|Double-Blind (DB) Period: ITP Wk 0-16||0||
48552197|NCT03536884|101683345|FG011|STARTED|Double-Blind (DB) Period: ITP Wk 0-16||0||
48552198|NCT03536884|101683334|FG000|COMPLETED|Double-Blind (DB) Period: ITP Wk 0-16||362||
48552199|NCT03536884|101683335|FG001|COMPLETED|Double-Blind (DB) Period: ITP Wk 0-16||354||
48552200|NCT03536884|101683336|FG002|COMPLETED|Double-Blind (DB) Period: ITP Wk 0-16||0||
48552201|NCT03536884|101683337|FG003|COMPLETED|Double-Blind (DB) Period: ITP Wk 0-16||0||
48552202|NCT03536884|101683338|FG004|COMPLETED|Double-Blind (DB) Period: ITP Wk 0-16||0||
48552203|NCT03536884|101683339|FG005|COMPLETED|Double-Blind (DB) Period: ITP Wk 0-16||0||
48552204|NCT03536884|101683340|FG006|COMPLETED|Double-Blind (DB) Period: ITP Wk 0-16||0||
48552205|NCT03536884|101683341|FG007|COMPLETED|Double-Blind (DB) Period: ITP Wk 0-16||0||
48552206|NCT03536884|101683342|FG008|COMPLETED|Double-Blind (DB) Period: ITP Wk 0-16||0||
48552207|NCT03536884|101683343|FG009|COMPLETED|Double-Blind (DB) Period: ITP Wk 0-16||0||
48107064|NCT01001442|100590445|FG002|COMPLETED|Overall Study||4||
48107065|NCT01001442|100590446|FG003|COMPLETED|Overall Study||3||
48107066|NCT01001442|100590447|FG004|COMPLETED|Overall Study||2||
48268061|NCT01777334|100978655|FG000|NOT COMPLETED|Overall Study||53||
48268062|NCT01777334|100978656|FG001|NOT COMPLETED|Overall Study||63||
48268063|NCT00607672|100978657|FG000|STARTED|Overall Study||32||
48268064|NCT00607672|100978658|FG001|STARTED|Overall Study||27||
48268065|NCT00607672|100978659|FG002|STARTED|Overall Study||27||
48268066|NCT00607672|100978657|FG000|COMPLETED|Overall Study||28||
48268067|NCT00607672|100978658|FG001|COMPLETED|Overall Study||24||
48268068|NCT00607672|100978659|FG002|COMPLETED|Overall Study||22||
48268069|NCT00607672|100978657|FG000|NOT COMPLETED|Overall Study||4||
48268070|NCT00607672|100978658|FG001|NOT COMPLETED|Overall Study||3||
48268071|NCT00607672|100978659|FG002|NOT COMPLETED|Overall Study||5||
48268072|NCT03510455|100978660|FG000|STARTED|Overall Study||4||
48268073|NCT03510455|100978660|FG000|Treated|Overall Study||4||
48268074|NCT03510455|100978660|FG000|Extension Phase|Overall Study||1||
48268075|NCT03510455|100978660|FG000|Screening Failures|Overall Study||0||
48268076|NCT03510455|100978660|FG000|COMPLETED|Overall Study||3||
48268077|NCT03510455|100978660|FG000|NOT COMPLETED|Overall Study||1||
48268078|NCT01736540|100978661|FG000|STARTED|Overall Study||243||
48268079|NCT01736540|100978661|FG000|COMPLETED|Overall Study||228||
48268080|NCT01736540|100978661|FG000|NOT COMPLETED|Overall Study||15||
48268081|NCT00126659|100978662|FG000|STARTED|Overall Study||3||
48268082|NCT00126659|100978663|FG001|STARTED|Overall Study||3||
48268083|NCT00126659|100978664|FG002|STARTED|Overall Study||4||
48268084|NCT00126659|100978662|FG000|COMPLETED|Overall Study||3||
48268085|NCT00126659|100978663|FG001|COMPLETED|Overall Study||3||
48268086|NCT00126659|100978664|FG002|COMPLETED|Overall Study||2||
48268087|NCT00126659|100978662|FG000|NOT COMPLETED|Overall Study||0||
48268088|NCT00126659|100978663|FG001|NOT COMPLETED|Overall Study||0||
48268089|NCT00126659|100978664|FG002|NOT COMPLETED|Overall Study||2||
48268090|NCT01081886|100978665|FG000|STARTED|Overall Study||11||
48268091|NCT01081886|100978666|FG001|STARTED|Overall Study||13||
48268092|NCT01081886|100978665|FG000|COMPLETED|Overall Study||0||
48268093|NCT01081886|100978666|FG001|COMPLETED|Overall Study||0||
48268094|NCT01081886|100978665|FG000|NOT COMPLETED|Overall Study||11||
48268095|NCT01081886|100978666|FG001|NOT COMPLETED|Overall Study||13||
48268096|NCT01234883|100978667|FG000|STARTED|Overall Study||51||
48268097|NCT01234883|100978668|FG001|STARTED|Overall Study||49||
48552208|NCT03536884|101683344|FG010|COMPLETED|Double-Blind (DB) Period: ITP Wk 0-16||0||
48552209|NCT03536884|101683345|FG011|COMPLETED|Double-Blind (DB) Period: ITP Wk 0-16||0||
48552210|NCT03536884|101683334|FG000|NOT COMPLETED|Double-Blind (DB) Period: ITP Wk 0-16||11||
48552211|NCT03536884|101683335|FG001|NOT COMPLETED|Double-Blind (DB) Period: ITP Wk 0-16||16||
48552212|NCT03536884|101683336|FG002|NOT COMPLETED|Double-Blind (DB) Period: ITP Wk 0-16||0||
48552213|NCT03536884|101683337|FG003|NOT COMPLETED|Double-Blind (DB) Period: ITP Wk 0-16||0||
48552214|NCT03536884|101683338|FG004|NOT COMPLETED|Double-Blind (DB) Period: ITP Wk 0-16||0||
48552215|NCT03536884|101683339|FG005|NOT COMPLETED|Double-Blind (DB) Period: ITP Wk 0-16||0||
48552216|NCT03536884|101683340|FG006|NOT COMPLETED|Double-Blind (DB) Period: ITP Wk 0-16||0||
48552217|NCT03536884|101683341|FG007|NOT COMPLETED|Double-Blind (DB) Period: ITP Wk 0-16||0||
48552218|NCT03536884|101683342|FG008|NOT COMPLETED|Double-Blind (DB) Period: ITP Wk 0-16||0||
48552219|NCT03536884|101683343|FG009|NOT COMPLETED|Double-Blind (DB) Period: ITP Wk 0-16||0||
48552220|NCT03536884|101683344|FG010|NOT COMPLETED|Double-Blind (DB) Period: ITP Wk 0-16||0||
48552221|NCT03536884|101683345|FG011|NOT COMPLETED|Double-Blind (DB) Period: ITP Wk 0-16||0||
48552222|NCT03536884|101683334|FG000|STARTED|Double-Blind Period: MTP Wk 16-48||0||
48552223|NCT03536884|101683335|FG001|STARTED|Double-Blind Period: MTP Wk 16-48||0||
48552224|NCT03536884|101683336|FG002|STARTED|Double-Blind Period: MTP Wk 16-48||215||
48552225|NCT03536884|101683337|FG003|STARTED|Double-Blind Period: MTP Wk 16-48||147||
48552226|NCT03536884|101683338|FG004|STARTED|Double-Blind Period: MTP Wk 16-48||354||
48552227|NCT03536884|101683339|FG005|STARTED|Double-Blind Period: MTP Wk 16-48||0||
48552228|NCT03536884|101683340|FG006|STARTED|Double-Blind Period: MTP Wk 16-48||0||
48552229|NCT03536884|101683341|FG007|STARTED|Double-Blind Period: MTP Wk 16-48||0||
48552230|NCT03536884|101683342|FG008|STARTED|Double-Blind Period: MTP Wk 16-48||0||
48552231|NCT03536884|101683343|FG009|STARTED|Double-Blind Period: MTP Wk 16-48||0||
48268098|NCT01234883|100978667|FG000|COMPLETED|Overall Study||41||
48268099|NCT01234883|100978668|FG001|COMPLETED|Overall Study||36||
48268100|NCT01234883|100978667|FG000|NOT COMPLETED|Overall Study||10||
48268101|NCT01234883|100978668|FG001|NOT COMPLETED|Overall Study||13||
48268102|NCT02035696|100978669|FG000|STARTED|Overall Study||174||
48268103|NCT02035696|100978670|FG001|STARTED|Overall Study||166||
48268104|NCT02035696|100978671|FG002|STARTED|Overall Study||167||
48268105|NCT02035696|100978672|FG003|STARTED|Overall Study||164||
48268106|NCT02035696|100978669|FG000|COMPLETED|Overall Study||171||
48268107|NCT02035696|100978670|FG001|COMPLETED|Overall Study||163||
48268108|NCT02035696|100978671|FG002|COMPLETED|Overall Study||164||
48268109|NCT02035696|100978672|FG003|COMPLETED|Overall Study||161||
48268110|NCT02035696|100978669|FG000|NOT COMPLETED|Overall Study||3||
48268111|NCT02035696|100978670|FG001|NOT COMPLETED|Overall Study||3||
48268112|NCT02035696|100978671|FG002|NOT COMPLETED|Overall Study||3||
48268113|NCT02035696|100978672|FG003|NOT COMPLETED|Overall Study||3||
48268114|NCT02204657|100978673|FG000|STARTED|Overall Study||32||
48268115|NCT02204657|100978674|FG001|STARTED|Overall Study||25||
48268116|NCT02204657|100978673|FG000|COMPLETED|Overall Study||25||
48107067|NCT01001442|100590448|FG005|COMPLETED|Overall Study||3||
48107068|NCT01001442|100590449|FG006|COMPLETED|Overall Study||6||
48107069|NCT01001442|100590450|FG007|COMPLETED|Overall Study||2||
48107070|NCT01001442|100590443|FG000|NOT COMPLETED|Overall Study||0||
48107071|NCT01001442|100590444|FG001|NOT COMPLETED|Overall Study||0||
48107072|NCT01001442|100590445|FG002|NOT COMPLETED|Overall Study||0||
48107073|NCT01001442|100590446|FG003|NOT COMPLETED|Overall Study||0||
48107074|NCT01001442|100590447|FG004|NOT COMPLETED|Overall Study||2||
48107075|NCT01001442|100590448|FG005|NOT COMPLETED|Overall Study||0||
48107076|NCT01001442|100590449|FG006|NOT COMPLETED|Overall Study||4||
48107077|NCT01001442|100590450|FG007|NOT COMPLETED|Overall Study||2||
48107078|NCT02155335|100590451|FG000|STARTED|Period 1||50||
48107079|NCT02155335|100590452|FG001|STARTED|Period 1||50||
48107080|NCT02155335|100590451|FG000|Treated|Period 1||50||
48107081|NCT02155335|100590452|FG001|Treated|Period 1||49||
48107082|NCT02155335|100590451|FG000|COMPLETED|Period 1||50||
48107083|NCT02155335|100590452|FG001|COMPLETED|Period 1||49||
48107084|NCT02155335|100590451|FG000|NOT COMPLETED|Period 1||0||
48107085|NCT02155335|100590452|FG001|NOT COMPLETED|Period 1||1||
48107086|NCT02155335|100590451|FG000|STARTED|Period 2||50||
48107087|NCT02155335|100590452|FG001|STARTED|Period 2||49||
48107088|NCT02155335|100590451|FG000|COMPLETED|Period 2||50||
48107089|NCT02155335|100590452|FG001|COMPLETED|Period 2||49||
48107090|NCT02155335|100590451|FG000|NOT COMPLETED|Period 2||0||
48107091|NCT02155335|100590452|FG001|NOT COMPLETED|Period 2||0||
48107092|NCT04033159|100590453|FG000|STARTED|Single Ascending Dose (Day 1)||6||
48107093|NCT04033159|100590454|FG001|STARTED|Single Ascending Dose (Day 1)||8||
48107094|NCT04033159|100590455|FG002|STARTED|Single Ascending Dose (Day 1)||0||
48107095|NCT04033159|100590453|FG000|COMPLETED|Single Ascending Dose (Day 1)||6||
48107096|NCT04033159|100590454|FG001|COMPLETED|Single Ascending Dose (Day 1)||8||
48107097|NCT04033159|100590455|FG002|COMPLETED|Single Ascending Dose (Day 1)||0||
48107098|NCT04033159|100590453|FG000|NOT COMPLETED|Single Ascending Dose (Day 1)||0||
48107099|NCT04033159|100590454|FG001|NOT COMPLETED|Single Ascending Dose (Day 1)||0||
48107100|NCT04033159|100590455|FG002|NOT COMPLETED|Single Ascending Dose (Day 1)||0||
48107101|NCT04033159|100590453|FG000|STARTED|Washout Period||6||
48107102|NCT04033159|100590454|FG001|STARTED|Washout Period||8||
48107103|NCT04033159|100590455|FG002|STARTED|Washout Period||0||
48107104|NCT04033159|100590453|FG000|COMPLETED|Washout Period||6||
48107105|NCT04033159|100590454|FG001|COMPLETED|Washout Period||0||
48107106|NCT04033159|100590455|FG002|COMPLETED|Washout Period||0||
48107107|NCT04033159|100590453|FG000|NOT COMPLETED|Washout Period||0||
48107108|NCT04033159|100590454|FG001|NOT COMPLETED|Washout Period||8||
48107109|NCT04033159|100590455|FG002|NOT COMPLETED|Washout Period||0||
48107110|NCT04033159|100590453|FG000|STARTED|Multiple Ascending Dose Period||6||
48107111|NCT04033159|100590454|FG001|STARTED|Multiple Ascending Dose Period||0||
48107112|NCT04033159|100590455|FG002|STARTED|Multiple Ascending Dose Period||0||
48107113|NCT04033159|100590453|FG000|COMPLETED|Multiple Ascending Dose Period||0||
48107114|NCT04033159|100590454|FG001|COMPLETED|Multiple Ascending Dose Period||0||
48107115|NCT04033159|100590455|FG002|COMPLETED|Multiple Ascending Dose Period||0||
48107116|NCT04033159|100590453|FG000|NOT COMPLETED|Multiple Ascending Dose Period||6||
48107117|NCT04033159|100590454|FG001|NOT COMPLETED|Multiple Ascending Dose Period||0||
48268117|NCT02204657|100978674|FG001|COMPLETED|Overall Study||25||
48268118|NCT02204657|100978673|FG000|NOT COMPLETED|Overall Study||7||
48268119|NCT02204657|100978674|FG001|NOT COMPLETED|Overall Study||0||
48692849|NCT01208324|102032672|FG002|Test Day 2|Pre-randomization of Patch||8||
48692850|NCT01208324|102032673|FG003|Test Day 2|Pre-randomization of Patch||5||
48692851|NCT01208324|102032670|FG000|COMPLETED|Pre-randomization of Patch||14|Five participants did not make it to Test Day 2|
48692852|NCT01208324|102032671|FG001|COMPLETED|Pre-randomization of Patch||15|Five participants did not make it to Test Day 2|
48692853|NCT01208324|102032672|FG002|COMPLETED|Pre-randomization of Patch||8|Five participants did not make it to Test Day 2|
48692854|NCT01208324|102032673|FG003|COMPLETED|Pre-randomization of Patch||5|Five participants did not make it to Test Day 2|
48692855|NCT01208324|102032670|FG000|NOT COMPLETED|Pre-randomization of Patch||0||
48692856|NCT01208324|102032671|FG001|NOT COMPLETED|Pre-randomization of Patch||0||
48107118|NCT04033159|100590455|FG002|NOT COMPLETED|Multiple Ascending Dose Period||0||
48107119|NCT01660412|100590456|FG000|STARTED|Overall Study||29||
48107120|NCT01660412|100590457|FG001|STARTED|Overall Study||31||
48107121|NCT01660412|100590456|FG000|Head|Overall Study||1||
48107122|NCT01660412|100590457|FG001|Head|Overall Study||4||
48107123|NCT01660412|100590456|FG000|Thorax|Overall Study||9|Including neck and buttocks|
48107124|NCT01660412|100590457|FG001|Thorax|Overall Study||9|Including neck and buttocks|
48107125|NCT01660412|100590456|FG000|Appendicular Structures|Overall Study||17|including shoulder to wrist, back of hand, and hip to ankle|
48107126|NCT01660412|100590457|FG001|Appendicular Structures|Overall Study||11|including shoulder to wrist, back of hand, and hip to ankle|
48107127|NCT01660412|100590456|FG000|Other|Overall Study||2|Remainder of the hand and feet|
48107128|NCT01660412|100590457|FG001|Other|Overall Study||4|Remainder of the hand and feet|
48268120|NCT01647542|100978675|FG000|STARTED|Overall Study||131||
48268121|NCT01647542|100978676|FG001|STARTED|Overall Study||131||
48268122|NCT01647542|100978677|FG002|STARTED|Overall Study||131||
48268123|NCT01647542|100978675|FG000|COMPLETED|Overall Study||55||
48268124|NCT01647542|100978676|FG001|COMPLETED|Overall Study||58||
48552232|NCT03536884|101683344|FG010|STARTED|Double-Blind Period: MTP Wk 16-48||0||
48552233|NCT03536884|101683345|FG011|STARTED|Double-Blind Period: MTP Wk 16-48||0||
48552234|NCT03536884|101683334|FG000|COMPLETED|Double-Blind Period: MTP Wk 16-48||0||
48552235|NCT03536884|101683335|FG001|COMPLETED|Double-Blind Period: MTP Wk 16-48||0||
48552236|NCT03536884|101683336|FG002|COMPLETED|Double-Blind Period: MTP Wk 16-48||205||
48552237|NCT03536884|101683337|FG003|COMPLETED|Double-Blind Period: MTP Wk 16-48||138||
48552238|NCT03536884|101683338|FG004|COMPLETED|Double-Blind Period: MTP Wk 16-48||325||
48552239|NCT03536884|101683339|FG005|COMPLETED|Double-Blind Period: MTP Wk 16-48||0||
48552240|NCT03536884|101683340|FG006|COMPLETED|Double-Blind Period: MTP Wk 16-48||0||
48552241|NCT03536884|101683341|FG007|COMPLETED|Double-Blind Period: MTP Wk 16-48||0||
48552242|NCT03536884|101683342|FG008|COMPLETED|Double-Blind Period: MTP Wk 16-48||0||
48552243|NCT03536884|101683343|FG009|COMPLETED|Double-Blind Period: MTP Wk 16-48||0||
48552244|NCT03536884|101683344|FG010|COMPLETED|Double-Blind Period: MTP Wk 16-48||0||
48552245|NCT03536884|101683345|FG011|COMPLETED|Double-Blind Period: MTP Wk 16-48||0||
48552246|NCT03536884|101683334|FG000|NOT COMPLETED|Double-Blind Period: MTP Wk 16-48||0||
48552247|NCT03536884|101683335|FG001|NOT COMPLETED|Double-Blind Period: MTP Wk 16-48||0||
48552248|NCT03536884|101683336|FG002|NOT COMPLETED|Double-Blind Period: MTP Wk 16-48||10||
48552249|NCT03536884|101683337|FG003|NOT COMPLETED|Double-Blind Period: MTP Wk 16-48||9||
48552250|NCT03536884|101683338|FG004|NOT COMPLETED|Double-Blind Period: MTP Wk 16-48||29||
48552251|NCT03536884|101683339|FG005|NOT COMPLETED|Double-Blind Period: MTP Wk 16-48||0||
48552252|NCT03536884|101683340|FG006|NOT COMPLETED|Double-Blind Period: MTP Wk 16-48||0||
48552253|NCT03536884|101683341|FG007|NOT COMPLETED|Double-Blind Period: MTP Wk 16-48||0||
48268125|NCT01647542|100978677|FG002|COMPLETED|Overall Study||59||
48268126|NCT01647542|100978675|FG000|NOT COMPLETED|Overall Study||76||
48268127|NCT01647542|100978676|FG001|NOT COMPLETED|Overall Study||73||
48268128|NCT01647542|100978677|FG002|NOT COMPLETED|Overall Study||72||
48268129|NCT01967069|100978678|FG000|STARTED|Overall Study||182||
48268130|NCT01967069|100978679|FG001|STARTED|Overall Study||95||
48268131|NCT01967069|100978678|FG000|COMPLETED|Overall Study||174||
48268132|NCT01967069|100978679|FG001|COMPLETED|Overall Study||87||
48268133|NCT01967069|100978678|FG000|NOT COMPLETED|Overall Study||8||
48268134|NCT01967069|100978679|FG001|NOT COMPLETED|Overall Study||8||
48268135|NCT01144377|100978680|FG000|STARTED|52 Week Treatment Period||31||
48268136|NCT01144377|100978681|FG001|STARTED|52 Week Treatment Period||30||
48268137|NCT01144377|100978682|FG002|STARTED|52 Week Treatment Period||30||
48268138|NCT01144377|100978683|FG003|STARTED|52 Week Treatment Period||26||
48268139|NCT01144377|100978684|FG004|STARTED|52 Week Treatment Period||37||
48268140|NCT01144377|100978680|FG000|Received at Least One Dose of Study Drug|52 Week Treatment Period||31||
48268141|NCT01144377|100978681|FG001|Received at Least One Dose of Study Drug|52 Week Treatment Period||30||
48268142|NCT01144377|100978682|FG002|Received at Least One Dose of Study Drug|52 Week Treatment Period||30||
48268143|NCT01144377|100978683|FG003|Received at Least One Dose of Study Drug|52 Week Treatment Period||25||
48552254|NCT03536884|101683342|FG008|NOT COMPLETED|Double-Blind Period: MTP Wk 16-48||0||
48552255|NCT03536884|101683343|FG009|NOT COMPLETED|Double-Blind Period: MTP Wk 16-48||0||
48552256|NCT03536884|101683344|FG010|NOT COMPLETED|Double-Blind Period: MTP Wk 16-48||0||
48552257|NCT03536884|101683345|FG011|NOT COMPLETED|Double-Blind Period: MTP Wk 16-48||0||
48552258|NCT03536884|101683334|FG000|STARTED|OLE Period: Wk48-Wk144||0||
48552259|NCT03536884|101683335|FG001|STARTED|OLE Period: Wk48-Wk144||0||
48552260|NCT03536884|101683336|FG002|STARTED|OLE Period: Wk48-Wk144||0||
48552261|NCT03536884|101683337|FG003|STARTED|OLE Period: Wk48-Wk144||0||
48552262|NCT03536884|101683338|FG004|STARTED|OLE Period: Wk48-Wk144||0||
48552263|NCT03536884|101683339|FG005|STARTED|OLE Period: Wk48-Wk144||238||
48552264|NCT03536884|101683340|FG006|STARTED|OLE Period: Wk48-Wk144||98||
48552265|NCT03536884|101683341|FG007|STARTED|OLE Period: Wk48-Wk144||122||
48552266|NCT03536884|101683342|FG008|STARTED|OLE Period: Wk48-Wk144||196||
48552267|NCT03536884|101683343|FG009|STARTED|OLE Period: Wk48-Wk144||0||
48552268|NCT03536884|101683344|FG010|STARTED|OLE Period: Wk48-Wk144||0||
48552269|NCT03536884|101683345|FG011|STARTED|OLE Period: Wk48-Wk144||0||
48552270|NCT03536884|101683334|FG000|COMPLETED|OLE Period: Wk48-Wk144||0||
48552271|NCT03536884|101683335|FG001|COMPLETED|OLE Period: Wk48-Wk144||0||
48552272|NCT03536884|101683336|FG002|COMPLETED|OLE Period: Wk48-Wk144||0||
48552273|NCT03536884|101683337|FG003|COMPLETED|OLE Period: Wk48-Wk144||0||
48268144|NCT01144377|100978684|FG004|Received at Least One Dose of Study Drug|52 Week Treatment Period||37||
48268145|NCT01144377|100978680|FG000|COMPLETED|52 Week Treatment Period||26||
48268146|NCT01144377|100978681|FG001|COMPLETED|52 Week Treatment Period||29||
48268147|NCT01144377|100978682|FG002|COMPLETED|52 Week Treatment Period||25||
48268148|NCT01144377|100978683|FG003|COMPLETED|52 Week Treatment Period||22||
48268149|NCT01144377|100978684|FG004|COMPLETED|52 Week Treatment Period||34||
48268150|NCT01144377|100978680|FG000|NOT COMPLETED|52 Week Treatment Period||5||
48268151|NCT01144377|100978681|FG001|NOT COMPLETED|52 Week Treatment Period||1||
48268152|NCT01144377|100978682|FG002|NOT COMPLETED|52 Week Treatment Period||5||
48107129|NCT01660412|100590456|FG000|Injection 1|Overall Study||29||
48107130|NCT01660412|100590457|FG001|Injection 1|Overall Study||31||
48107131|NCT01660412|100590456|FG000|Injection 2|Overall Study||29||
48107132|NCT01660412|100590457|FG001|Injection 2|Overall Study||31||
48107133|NCT01660412|100590456|FG000|Injection 3|Overall Study||29||
48107134|NCT01660412|100590457|FG001|Injection 3|Overall Study||31||
48107135|NCT01660412|100590456|FG000|Injection 4|Overall Study||29||
48107136|NCT01660412|100590457|FG001|Injection 4|Overall Study||31||
48107137|NCT01660412|100590456|FG000|COMPLETED|Overall Study||29||
48107138|NCT01660412|100590457|FG001|COMPLETED|Overall Study||28||
48107139|NCT01660412|100590456|FG000|NOT COMPLETED|Overall Study||0||
48107140|NCT01660412|100590457|FG001|NOT COMPLETED|Overall Study||3||
48107141|NCT02586493|100590458|FG000|STARTED|Overall Study||278||
48107142|NCT02586493|100590458|FG000|COMPLETED|Overall Study||266||
48107143|NCT02586493|100590458|FG000|NOT COMPLETED|Overall Study||12||
48107144|NCT03712410|100590459|FG000|STARTED|Overall Study||154||
48107145|NCT03712410|100590460|FG001|STARTED|Overall Study||152||
48107146|NCT03712410|100590461|FG002|STARTED|Overall Study||154||
48107147|NCT03712410|100590462|FG003|STARTED|Overall Study||63||
48107148|NCT03712410|100590459|FG000|COMPLETED|Overall Study||115||
48107149|NCT03712410|100590460|FG001|COMPLETED|Overall Study||106||
48107150|NCT03712410|100590461|FG002|COMPLETED|Overall Study||101||
48107151|NCT03712410|100590462|FG003|COMPLETED|Overall Study||46||
48107152|NCT03712410|100590459|FG000|NOT COMPLETED|Overall Study||39||
48107153|NCT03712410|100590460|FG001|NOT COMPLETED|Overall Study||46||
48107154|NCT03712410|100590461|FG002|NOT COMPLETED|Overall Study||53||
48107155|NCT03712410|100590462|FG003|NOT COMPLETED|Overall Study||17||
48107156|NCT02196324|100590463|FG000|STARTED|Overall Study||63||
48107157|NCT02196324|100590464|FG001|STARTED|Overall Study||65||
48107158|NCT02196324|100590463|FG000|COMPLETED|Overall Study||48||
48107159|NCT02196324|100590464|FG001|COMPLETED|Overall Study||57||
48107160|NCT02196324|100590463|FG000|NOT COMPLETED|Overall Study||15||
48107161|NCT02196324|100590464|FG001|NOT COMPLETED|Overall Study||8||
48107162|NCT01277354|100590465|FG000|STARTED|Overall Study||1||
48107163|NCT01277354|100590466|FG001|STARTED|Overall Study||1||
48107164|NCT01277354|100590465|FG000|COMPLETED|Overall Study||1||
48107165|NCT01277354|100590466|FG001|COMPLETED|Overall Study||1||
48107166|NCT01277354|100590465|FG000|NOT COMPLETED|Overall Study||0||
48107167|NCT01277354|100590466|FG001|NOT COMPLETED|Overall Study||0||
48107168|NCT04145895|100590467|FG000|STARTED|Overall Study||42||
48268153|NCT01144377|100978683|FG003|NOT COMPLETED|52 Week Treatment Period||4||
48268154|NCT01144377|100978684|FG004|NOT COMPLETED|52 Week Treatment Period||3||
48268155|NCT01144377|100978680|FG000|STARTED|12 Week Safety Follow-up Period||26||
48268156|NCT01144377|100978681|FG001|STARTED|12 Week Safety Follow-up Period||29||
48268157|NCT01144377|100978682|FG002|STARTED|12 Week Safety Follow-up Period||25||
48268158|NCT01144377|100978683|FG003|STARTED|12 Week Safety Follow-up Period||22||
48268159|NCT01144377|100978684|FG004|STARTED|12 Week Safety Follow-up Period||34||
48268160|NCT01144377|100978680|FG000|COMPLETED|12 Week Safety Follow-up Period||26||
48552274|NCT03536884|101683338|FG004|COMPLETED|OLE Period: Wk48-Wk144||0||
48552275|NCT03536884|101683339|FG005|COMPLETED|OLE Period: Wk48-Wk144||205||
48552276|NCT03536884|101683340|FG006|COMPLETED|OLE Period: Wk48-Wk144||80||
48552277|NCT03536884|101683341|FG007|COMPLETED|OLE Period: Wk48-Wk144||106||
48710802|NCT00380029|102078023|FG000|COMPLETED|Overall Study||20||
48107169|NCT04145895|100590468|FG001|STARTED|Overall Study||126||
48107170|NCT04145895|100590467|FG000|COMPLETED|Overall Study||40||
48107171|NCT04145895|100590468|FG001|COMPLETED|Overall Study||124||
48107172|NCT04145895|100590467|FG000|NOT COMPLETED|Overall Study||2||
48107173|NCT04145895|100590468|FG001|NOT COMPLETED|Overall Study||2||
48268161|NCT01144377|100978681|FG001|COMPLETED|12 Week Safety Follow-up Period||29||
48392106|NCT00628758|101287803|FG000|COMPLETED|Overall Study||165||
48552278|NCT03536884|101683342|FG008|COMPLETED|OLE Period: Wk48-Wk144||167||
48552279|NCT03536884|101683343|FG009|COMPLETED|OLE Period: Wk48-Wk144||0||
48552280|NCT03536884|101683344|FG010|COMPLETED|OLE Period: Wk48-Wk144||0||
48107174|NCT03072134|100590469|FG000|STARTED|Cohort 1: 0.5x10^8/NSCs/6.25x10^10 vp||3||
48107175|NCT03072134|100590469|FG000|COMPLETED|Cohort 1: 0.5x10^8/NSCs/6.25x10^10 vp||3||
48107176|NCT03072134|100590469|FG000|NOT COMPLETED|Cohort 1: 0.5x10^8/NSCs/6.25x10^10 vp||0||
48107177|NCT03072134|100590469|FG000|STARTED|Cohort 2: 1.0x10^8 NSCs/1.25x10^10 vp||3||
48107178|NCT03072134|100590469|FG000|COMPLETED|Cohort 2: 1.0x10^8 NSCs/1.25x10^10 vp||3||
48268162|NCT01144377|100978682|FG002|COMPLETED|12 Week Safety Follow-up Period||25||
48392107|NCT00628758|101287804|FG001|COMPLETED|Overall Study||179||
48552281|NCT03536884|101683345|FG011|COMPLETED|OLE Period: Wk48-Wk144||0||
48107179|NCT03072134|100590469|FG000|NOT COMPLETED|Cohort 2: 1.0x10^8 NSCs/1.25x10^10 vp||0||
48107180|NCT03072134|100590469|FG000|STARTED|Cohort 3: 1.5x10^8 NSCs/1.875x10^10 vp||6|An additional 3 subjects were added as one subject at this dose level experienced a DLT.|
48107181|NCT03072134|100590469|FG000|COMPLETED|Cohort 3: 1.5x10^8 NSCs/1.875x10^10 vp||6||
48107182|NCT03072134|100590469|FG000|NOT COMPLETED|Cohort 3: 1.5x10^8 NSCs/1.875x10^10 vp||0||
48107183|NCT02045511|100590470|FG000|STARTED|Overall Study||8||
48107184|NCT02045511|100590471|FG001|STARTED|Overall Study||7||
48107185|NCT02045511|100590470|FG000|COMPLETED|Overall Study||8||
48107186|NCT02045511|100590471|FG001|COMPLETED|Overall Study||7||
48552282|NCT03536884|101683334|FG000|NOT COMPLETED|OLE Period: Wk48-Wk144||0||
48268163|NCT01144377|100978683|FG003|COMPLETED|12 Week Safety Follow-up Period||22||
48107187|NCT02045511|100590470|FG000|NOT COMPLETED|Overall Study||0||
48107188|NCT02045511|100590471|FG001|NOT COMPLETED|Overall Study||0||
48107189|NCT02739269|100590472|FG000|STARTED|Overall Study||100||
48107190|NCT02739269|100590473|FG001|STARTED|Overall Study||100||
48107191|NCT02739269|100590472|FG000|COMPLETED|Overall Study||93||
48107192|NCT02739269|100590473|FG001|COMPLETED|Overall Study||96||
48107193|NCT02739269|100590472|FG000|NOT COMPLETED|Overall Study||7||
48107194|NCT02739269|100590473|FG001|NOT COMPLETED|Overall Study||4||
48107195|NCT01879228|100590474|FG000|STARTED|Overall Study||13||
48107196|NCT01879228|100590475|FG001|STARTED|Overall Study||13||
48107197|NCT01879228|100590474|FG000|COMPLETED|Overall Study||12||
48107198|NCT01879228|100590475|FG001|COMPLETED|Overall Study||12||
48107199|NCT01879228|100590474|FG000|NOT COMPLETED|Overall Study||1||
48107200|NCT01879228|100590475|FG001|NOT COMPLETED|Overall Study||1||
48107201|NCT01200797|100590476|FG000|STARTED|Overall Study||19||
48107202|NCT01200797|100590476|FG000|COMPLETED|Overall Study||0||
48107203|NCT01200797|100590476|FG000|NOT COMPLETED|Overall Study||19||
48268164|NCT01144377|100978684|FG004|COMPLETED|12 Week Safety Follow-up Period||34||
48268165|NCT01144377|100978680|FG000|NOT COMPLETED|12 Week Safety Follow-up Period||0||
48268166|NCT01144377|100978681|FG001|NOT COMPLETED|12 Week Safety Follow-up Period||0||
48107204|NCT00600756|100590477|FG000|STARTED|Analysis After 6 Months||395||
48107205|NCT00600756|100590478|FG001|STARTED|Analysis After 6 Months||403||
48107206|NCT00600756|100590477|FG000|COMPLETED|Analysis After 6 Months||264||
48107207|NCT00600756|100590478|FG001|COMPLETED|Analysis After 6 Months||283||
48268167|NCT01144377|100978682|FG002|NOT COMPLETED|12 Week Safety Follow-up Period||0||
48268168|NCT01144377|100978683|FG003|NOT COMPLETED|12 Week Safety Follow-up Period||0||
48268169|NCT01144377|100978684|FG004|NOT COMPLETED|12 Week Safety Follow-up Period||0||
48268170|NCT01144377|100978680|FG000|STARTED|Optional 40 Week Safety Follow-up Period||22||
48268171|NCT01144377|100978681|FG001|STARTED|Optional 40 Week Safety Follow-up Period||25||
48268172|NCT01144377|100978682|FG002|STARTED|Optional 40 Week Safety Follow-up Period||23||
48268173|NCT01144377|100978683|FG003|STARTED|Optional 40 Week Safety Follow-up Period||3||
48268174|NCT01144377|100978684|FG004|STARTED|Optional 40 Week Safety Follow-up Period||23||
48268175|NCT01144377|100978680|FG000|COMPLETED|Optional 40 Week Safety Follow-up Period||21||
48268176|NCT01144377|100978681|FG001|COMPLETED|Optional 40 Week Safety Follow-up Period||24||
48268177|NCT01144377|100978682|FG002|COMPLETED|Optional 40 Week Safety Follow-up Period||23||
48392108|NCT00628758|101287803|FG000|NOT COMPLETED|Overall Study||44||
48392109|NCT00628758|101287804|FG001|NOT COMPLETED|Overall Study||42||
48392110|NCT01804036|101287805|FG000|STARTED|Overall Study||31||
48392111|NCT01804036|101287806|FG001|STARTED|Overall Study||41||
48392112|NCT01804036|101287805|FG000|COMPLETED|Overall Study||18||
48392113|NCT01804036|101287806|FG001|COMPLETED|Overall Study||21||
48392114|NCT01804036|101287805|FG000|NOT COMPLETED|Overall Study||13||
48392115|NCT01804036|101287806|FG001|NOT COMPLETED|Overall Study||20||
48392116|NCT01957709|101287807|FG000|STARTED|Overall Study||8||
48107208|NCT00600756|100590477|FG000|NOT COMPLETED|Analysis After 6 Months||131||
48107209|NCT00600756|100590478|FG001|NOT COMPLETED|Analysis After 6 Months||120||
48107210|NCT00600756|100590477|FG000|STARTED|Overall Study Analysis After 12 Months||395||
48107211|NCT00600756|100590478|FG001|STARTED|Overall Study Analysis After 12 Months||403||
48107212|NCT00600756|100590477|FG000|Randomized Analysis|Overall Study Analysis After 12 Months||395||
48107213|NCT00600756|100590478|FG001|Randomized Analysis|Overall Study Analysis After 12 Months||403||
48107214|NCT00600756|100590477|FG000|Safety Analysis|Overall Study Analysis After 12 Months||391||
48107215|NCT00600756|100590478|FG001|Safety Analysis|Overall Study Analysis After 12 Months||402||
48107216|NCT00600756|100590477|FG000|ITT Analysis|Overall Study Analysis After 12 Months||379||
48107217|NCT00600756|100590478|FG001|ITT Analysis|Overall Study Analysis After 12 Months||392||
48107218|NCT00600756|100590477|FG000|COMPLETED|Overall Study Analysis After 12 Months||212||
48107219|NCT00600756|100590478|FG001|COMPLETED|Overall Study Analysis After 12 Months||227||
48107220|NCT00600756|100590477|FG000|NOT COMPLETED|Overall Study Analysis After 12 Months||183||
48107221|NCT00600756|100590478|FG001|NOT COMPLETED|Overall Study Analysis After 12 Months||176||
48107222|NCT00788827|100590479|FG000|STARTED|Overall Study||7||
48107223|NCT00788827|100590479|FG000|COMPLETED|Overall Study||5||
48107224|NCT00788827|100590479|FG000|NOT COMPLETED|Overall Study||2||
48107225|NCT01433107|100590480|FG000|STARTED|Overall Study||145||
48268178|NCT01144377|100978683|FG003|COMPLETED|Optional 40 Week Safety Follow-up Period||3||
48268179|NCT01144377|100978684|FG004|COMPLETED|Optional 40 Week Safety Follow-up Period||21||
48268180|NCT01144377|100978680|FG000|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1||
48268181|NCT01144377|100978681|FG001|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1||
48268182|NCT01144377|100978682|FG002|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0||
48268183|NCT01144377|100978683|FG003|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0||
48268184|NCT01144377|100978684|FG004|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||2||
48268185|NCT01564277|100978685|FG000|STARTED|Overall Study||12||
48268186|NCT01564277|100978686|FG001|STARTED|Overall Study||12||
48268187|NCT01564277|100978685|FG000|COMPLETED|Overall Study||11||
48268188|NCT01564277|100978686|FG001|COMPLETED|Overall Study||11||
48392117|NCT01957709|101287807|FG000|COMPLETED|Overall Study||7||
48392118|NCT01957709|101287807|FG000|NOT COMPLETED|Overall Study||1||
48392119|NCT01216397|101287808|FG000|STARTED|Period 1||20||
48692857|NCT01208324|102032672|FG002|NOT COMPLETED|Pre-randomization of Patch||2||
48692858|NCT01208324|102032673|FG003|NOT COMPLETED|Pre-randomization of Patch||3||
48692859|NCT01208324|102032670|FG000|STARTED|Post-randomization of Patch||14|One participant withdrew post Test Day 2|
48692860|NCT01208324|102032671|FG001|STARTED|Post-randomization of Patch||15|One participant withdrew post Test Day 2|
48692861|NCT01208324|102032672|FG002|STARTED|Post-randomization of Patch||8|One participant withdrew post Test Day 2|
48692862|NCT01208324|102032673|FG003|STARTED|Post-randomization of Patch||5|One participant withdrew post Test Day 2|
48692863|NCT01208324|102032670|FG000|Test Day 3|Post-randomization of Patch||13||
48692864|NCT01208324|102032671|FG001|Test Day 3|Post-randomization of Patch||15||
48692865|NCT01208324|102032672|FG002|Test Day 3|Post-randomization of Patch||8||
48692866|NCT01208324|102032673|FG003|Test Day 3|Post-randomization of Patch||5||
48692867|NCT01208324|102032670|FG000|Test Day 4|Post-randomization of Patch||13||
48692868|NCT01208324|102032671|FG001|Test Day 4|Post-randomization of Patch||15||
48692869|NCT01208324|102032672|FG002|Test Day 4|Post-randomization of Patch||8||
48692870|NCT01208324|102032673|FG003|Test Day 4|Post-randomization of Patch||5||
48107226|NCT01433107|100590481|FG001|STARTED|Overall Study||145||
48107227|NCT01433107|100590480|FG000|COMPLETED|Overall Study||118||
48107228|NCT01433107|100590481|FG001|COMPLETED|Overall Study||128||
48107229|NCT01433107|100590480|FG000|NOT COMPLETED|Overall Study||27||
48107230|NCT01433107|100590481|FG001|NOT COMPLETED|Overall Study||17||
48107231|NCT02972632|100590482|FG000|STARTED|Overall Study||123||
48107232|NCT02972632|100590482|FG000|Safety Analysis Set|Overall Study||122|All participants who received at least one dose study drug.|
48107233|NCT02972632|100590482|FG000|COMPLETED|Overall Study||106||
48107234|NCT02972632|100590482|FG000|NOT COMPLETED|Overall Study||17||
48107235|NCT01907828|100590483|FG000|STARTED|Overall Study||39||
48107236|NCT01907828|100590484|FG001|STARTED|Overall Study||22||
48107237|NCT01907828|100590483|FG000|Underwent Procedure|Overall Study||39||
48692871|NCT01208324|102032670|FG000|COMPLETED|Post-randomization of Patch||13||
48692872|NCT01208324|102032671|FG001|COMPLETED|Post-randomization of Patch||15||
48692873|NCT01208324|102032672|FG002|COMPLETED|Post-randomization of Patch||8||
48692874|NCT01208324|102032673|FG003|COMPLETED|Post-randomization of Patch||5||
48692875|NCT01208324|102032670|FG000|NOT COMPLETED|Post-randomization of Patch||1||
48692876|NCT01208324|102032671|FG001|NOT COMPLETED|Post-randomization of Patch||0||
48692877|NCT01208324|102032672|FG002|NOT COMPLETED|Post-randomization of Patch||0||
48692878|NCT01208324|102032673|FG003|NOT COMPLETED|Post-randomization of Patch||0||
48692879|NCT01523743|102032674|FG000|STARTED|Period 1||63||
48692880|NCT01523743|102032675|FG001|STARTED|Period 1||62||
48692881|NCT01523743|102032674|FG000|COMPLETED|Period 1||53||
48692882|NCT01523743|102032675|FG001|COMPLETED|Period 1||60||
48692883|NCT01523743|102032674|FG000|NOT COMPLETED|Period 1||10||
48692884|NCT01523743|102032675|FG001|NOT COMPLETED|Period 1||2||
48692885|NCT01523743|102032674|FG000|STARTED|Period 2||53||
48107238|NCT01907828|100590484|FG001|Underwent Procedure|Overall Study||20||
48107239|NCT01907828|100590483|FG000|1-month Follow-up|Overall Study||37||
48107240|NCT01907828|100590484|FG001|1-month Follow-up|Overall Study||17||
48107241|NCT01907828|100590483|FG000|3-month Follow-up|Overall Study||36||
48107242|NCT01907828|100590484|FG001|3-month Follow-up|Overall Study||16||
48107243|NCT01907828|100590483|FG000|6-month Follow-up|Overall Study||35||
48107244|NCT01907828|100590484|FG001|6-month Follow-up|Overall Study||16||
48107245|NCT01907828|100590483|FG000|12-month Follow-up|Overall Study||34||
48107246|NCT01907828|100590484|FG001|12-month Follow-up|Overall Study||16||
48107247|NCT01907828|100590483|FG000|24-month Follow-up|Overall Study||32||
48107248|NCT01907828|100590484|FG001|24-month Follow-up|Overall Study||16||
48107249|NCT01907828|100590483|FG000|COMPLETED|Overall Study||32||
48107250|NCT01907828|100590484|FG001|COMPLETED|Overall Study||16||
48107251|NCT01907828|100590483|FG000|NOT COMPLETED|Overall Study||7||
48107252|NCT01907828|100590484|FG001|NOT COMPLETED|Overall Study||6||
48107253|NCT02849548|100590485|FG000|STARTED|Overall Study||13||
48107254|NCT02849548|100590486|FG001|STARTED|Overall Study||14||
48107255|NCT02849548|100590485|FG000|COMPLETED|Overall Study||11||
48107256|NCT02849548|100590486|FG001|COMPLETED|Overall Study||12||
48107257|NCT02849548|100590485|FG000|NOT COMPLETED|Overall Study||2||
48107258|NCT02849548|100590486|FG001|NOT COMPLETED|Overall Study||2||
48107259|NCT02506816|100590487|FG000|STARTED|Overall Study||36||
48107260|NCT02506816|100590487|FG000|Samples Availability|Overall Study||31||
48107261|NCT02506816|100590487|FG000|COMPLETED|Overall Study||33||
48107262|NCT02506816|100590487|FG000|NOT COMPLETED|Overall Study||3||
48107263|NCT00613509|100590488|FG000|STARTED|Cycle 1||11||
48107264|NCT00613509|100590489|FG001|STARTED|Cycle 1||12||
48107265|NCT00613509|100590488|FG000|COMPLETED|Cycle 1||6||
48107266|NCT00613509|100590489|FG001|COMPLETED|Cycle 1||4||
48107267|NCT00613509|100590488|FG000|NOT COMPLETED|Cycle 1||5||
48107268|NCT00613509|100590489|FG001|NOT COMPLETED|Cycle 1||8||
48107269|NCT00613509|100590488|FG000|STARTED|Cycle 2 (Group 2 = Crossover)||11||
48107270|NCT00613509|100590489|FG001|STARTED|Cycle 2 (Group 2 = Crossover)||4||
48107271|NCT00613509|100590488|FG000|COMPLETED|Cycle 2 (Group 2 = Crossover)||11||
48107272|NCT00613509|100590489|FG001|COMPLETED|Cycle 2 (Group 2 = Crossover)||4||
48107273|NCT00613509|100590488|FG000|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0||
48107274|NCT00613509|100590489|FG001|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0||
48107275|NCT02766244|100590490|FG000|STARTED|Overall Study||3||
48107276|NCT02766244|100590490|FG000|COMPLETED|Overall Study||3||
48107277|NCT02766244|100590490|FG000|NOT COMPLETED|Overall Study||0||
48107278|NCT01640366|100590491|FG000|STARTED|Overall Study||200||
48268189|NCT01564277|100978685|FG000|NOT COMPLETED|Overall Study||1||
48268190|NCT01564277|100978686|FG001|NOT COMPLETED|Overall Study||1||
48268191|NCT02614547|100978687|FG000|STARTED|Overall Study||11||
48107279|NCT01640366|100590491|FG000|Day 21 Follow-up|Overall Study||185||
48107280|NCT01640366|100590491|FG000|Day 42 Follow-up|Overall Study||177||
48107281|NCT01640366|100590491|FG000|Day 90 Follow-up|Overall Study||178||
48107282|NCT01640366|100590491|FG000|COMPLETED|Overall Study||178||
48107283|NCT01640366|100590491|FG000|NOT COMPLETED|Overall Study||22||
48107284|NCT02800356|100590492|FG000|STARTED|Overall Study||20||
48107285|NCT02800356|100590492|FG000|COMPLETED|Overall Study||20||
48107286|NCT02800356|100590492|FG000|NOT COMPLETED|Overall Study||0||
48107287|NCT00966238|100590493|FG000|STARTED|Overall Study||20||
48107288|NCT00966238|100590494|FG001|STARTED|Overall Study||20||
48107289|NCT00966238|100590495|FG002|STARTED|Overall Study||20||
48107290|NCT00966238|100590496|FG003|STARTED|Overall Study||20||
48107291|NCT00966238|100590497|FG004|STARTED|Overall Study||20||
48107292|NCT00966238|100590498|FG005|STARTED|Overall Study||20||
48107293|NCT00966238|100590493|FG000|COMPLETED|Overall Study||20||
48107294|NCT00966238|100590494|FG001|COMPLETED|Overall Study||20||
48107295|NCT00966238|100590495|FG002|COMPLETED|Overall Study||20||
48107296|NCT00966238|100590496|FG003|COMPLETED|Overall Study||20||
48107297|NCT00966238|100590497|FG004|COMPLETED|Overall Study||20||
48107298|NCT00966238|100590498|FG005|COMPLETED|Overall Study||20||
48107299|NCT00966238|100590493|FG000|NOT COMPLETED|Overall Study||0||
48268192|NCT02614547|100978688|FG001|STARTED|Overall Study||10||
48268193|NCT02614547|100978687|FG000|COMPLETED|Overall Study||11||
48268194|NCT02614547|100978688|FG001|COMPLETED|Overall Study||10||
48107300|NCT00966238|100590494|FG001|NOT COMPLETED|Overall Study||0||
48107301|NCT00966238|100590495|FG002|NOT COMPLETED|Overall Study||0||
48107302|NCT00966238|100590496|FG003|NOT COMPLETED|Overall Study||0||
48107303|NCT00966238|100590497|FG004|NOT COMPLETED|Overall Study||0||
48107304|NCT00966238|100590498|FG005|NOT COMPLETED|Overall Study||0||
48107305|NCT01921179|100590499|FG000|STARTED|5 Week Randomized GOALS vs EDU Training||24||
48107306|NCT01921179|100590500|FG001|STARTED|5 Week Randomized GOALS vs EDU Training||22||
48107307|NCT01921179|100590499|FG000|COMPLETED|5 Week Randomized GOALS vs EDU Training||21||
48107308|NCT01921179|100590500|FG001|COMPLETED|5 Week Randomized GOALS vs EDU Training||19||
48268195|NCT02614547|100978687|FG000|NOT COMPLETED|Overall Study||0||
48268196|NCT02614547|100978688|FG001|NOT COMPLETED|Overall Study||0||
48107309|NCT01921179|100590499|FG000|NOT COMPLETED|5 Week Randomized GOALS vs EDU Training||3||
48107310|NCT01921179|100590500|FG001|NOT COMPLETED|5 Week Randomized GOALS vs EDU Training||3||
48268197|NCT01475461|100978689|FG000|STARTED|Run-in Period||376||
48268198|NCT01475461|100978690|FG001|STARTED|Run-in Period||0||
48268199|NCT01475461|100978691|FG002|STARTED|Run-in Period||0||
48268200|NCT01475461|100978692|FG003|STARTED|Run-in Period||0||
48692886|NCT01523743|102032675|FG001|STARTED|Period 2||60||
48692887|NCT01523743|102032674|FG000|COMPLETED|Period 2||52||
48692888|NCT01523743|102032675|FG001|COMPLETED|Period 2||58||
48268201|NCT01475461|100978693|FG004|STARTED|Run-in Period||0||
48692889|NCT01523743|102032674|FG000|NOT COMPLETED|Period 2||1||
48692890|NCT01523743|102032675|FG001|NOT COMPLETED|Period 2||2||
48692891|NCT01645735|102032676|FG000|STARTED|Overall Study||32||
48692892|NCT01645735|102032677|FG001|STARTED|Overall Study||17||
48692893|NCT01645735|102032676|FG000|COMPLETED|Overall Study||28||
48692894|NCT01645735|102032677|FG001|COMPLETED|Overall Study||16||
48692895|NCT01645735|102032676|FG000|NOT COMPLETED|Overall Study||4||
48692896|NCT01645735|102032677|FG001|NOT COMPLETED|Overall Study||1||
48692897|NCT02122666|102032678|FG000|STARTED|Overall Study||12||
48692898|NCT02122666|102032679|FG001|STARTED|Overall Study||15||
48692899|NCT02122666|102032678|FG000|COMPLETED|Overall Study||12||
48268202|NCT01475461|100978694|FG005|STARTED|Run-in Period||0||
48692900|NCT02122666|102032679|FG001|COMPLETED|Overall Study||15||
48692901|NCT02122666|102032678|FG000|NOT COMPLETED|Overall Study||0||
48268203|NCT01475461|100978695|FG006|STARTED|Run-in Period||0||
48268204|NCT01475461|100978689|FG000|COMPLETED|Run-in Period||335||
48268205|NCT01475461|100978690|FG001|COMPLETED|Run-in Period||0||
48692902|NCT02122666|102032679|FG001|NOT COMPLETED|Overall Study||0||
48692903|NCT01756573|102032680|FG000|STARTED|Overall Study||3||
48692904|NCT01756573|102032681|FG001|STARTED|Overall Study||1||
48692905|NCT01756573|102032682|FG002|STARTED|Overall Study||1||
48692906|NCT01756573|102032680|FG000|COMPLETED|Overall Study||3||
48692907|NCT01756573|102032681|FG001|COMPLETED|Overall Study||1||
48692908|NCT01756573|102032682|FG002|COMPLETED|Overall Study||1||
48692909|NCT01756573|102032680|FG000|NOT COMPLETED|Overall Study||0||
48692910|NCT01756573|102032681|FG001|NOT COMPLETED|Overall Study||0||
48692911|NCT01756573|102032682|FG002|NOT COMPLETED|Overall Study||0||
48692912|NCT04077424|102032683|FG000|STARTED|Overall Study||2||
48692913|NCT04077424|102032684|FG001|STARTED|Overall Study||2||
48692914|NCT04077424|102032685|FG002|STARTED|Overall Study||6||
48692915|NCT04077424|102032683|FG000|COMPLETED|Overall Study||2||
48692916|NCT04077424|102032684|FG001|COMPLETED|Overall Study||2||
48692917|NCT04077424|102032685|FG002|COMPLETED|Overall Study||6||
48692918|NCT04077424|102032683|FG000|NOT COMPLETED|Overall Study||0||
48692919|NCT04077424|102032684|FG001|NOT COMPLETED|Overall Study||0||
48692920|NCT04077424|102032685|FG002|NOT COMPLETED|Overall Study||0||
48692921|NCT03370419|102032686|FG000|STARTED|Overall Study||40||
48692922|NCT03370419|102032686|FG000|COMPLETED|Overall Study||24||
48692923|NCT03370419|102032686|FG000|NOT COMPLETED|Overall Study||16||
48692924|NCT01642901|102032687|FG000|STARTED|Intervention||10||
48692925|NCT01642901|102032688|FG001|STARTED|Intervention||5||
48692926|NCT01642901|102032687|FG000|COMPLETED|Intervention||10||
48692927|NCT01642901|102032688|FG001|COMPLETED|Intervention||5||
48692928|NCT01642901|102032687|FG000|NOT COMPLETED|Intervention||0||
48692929|NCT01642901|102032688|FG001|NOT COMPLETED|Intervention||0||
48692930|NCT01642901|102032687|FG000|STARTED|4-month Follow-up||10||
48692931|NCT01642901|102032688|FG001|STARTED|4-month Follow-up||5||
48692932|NCT01642901|102032687|FG000|COMPLETED|4-month Follow-up||10||
48692933|NCT01642901|102032688|FG001|COMPLETED|4-month Follow-up||5||
48692934|NCT01642901|102032687|FG000|NOT COMPLETED|4-month Follow-up||0||
48692935|NCT01642901|102032688|FG001|NOT COMPLETED|4-month Follow-up||0||
48692936|NCT01642901|102032687|FG000|STARTED|12-month Follow-up||10||
48692937|NCT01642901|102032688|FG001|STARTED|12-month Follow-up||5||
48692938|NCT01642901|102032687|FG000|COMPLETED|12-month Follow-up||9||
48692939|NCT01642901|102032688|FG001|COMPLETED|12-month Follow-up||5||
48692940|NCT01642901|102032687|FG000|NOT COMPLETED|12-month Follow-up||1||
48268206|NCT01475461|100978691|FG002|COMPLETED|Run-in Period||0||
48268207|NCT01475461|100978692|FG003|COMPLETED|Run-in Period||0||
48268208|NCT01475461|100978693|FG004|COMPLETED|Run-in Period||0||
48692941|NCT01642901|102032688|FG001|NOT COMPLETED|12-month Follow-up||0||
48692942|NCT03846427|102032689|FG000|STARTED|Overall Study||68||
48692943|NCT03846427|102032689|FG000|COMPLETED|Overall Study||51||
48692944|NCT03846427|102032689|FG000|NOT COMPLETED|Overall Study||17||
48692945|NCT00635349|102032690|FG000|STARTED|Overall Study||73||
48692946|NCT00635349|102032691|FG001|STARTED|Overall Study||67||
48692947|NCT00635349|102032690|FG000|COMPLETED|Overall Study||29||
48692948|NCT00635349|102032691|FG001|COMPLETED|Overall Study||19||
48692949|NCT00635349|102032690|FG000|NOT COMPLETED|Overall Study||44||
48692950|NCT00635349|102032691|FG001|NOT COMPLETED|Overall Study||48||
48692951|NCT00576628|102032692|FG000|STARTED|Overall Study||125||
48692952|NCT00576628|102032692|FG000|COMPLETED|Overall Study||82||
48692953|NCT00576628|102032692|FG000|NOT COMPLETED|Overall Study||43||
48692954|NCT02469701|102032693|FG000|STARTED|Overall Study||10||
48268209|NCT01475461|100978694|FG005|COMPLETED|Run-in Period||0||
48268210|NCT01475461|100978695|FG006|COMPLETED|Run-in Period||0||
48268211|NCT01475461|100978689|FG000|NOT COMPLETED|Run-in Period||41||
48268212|NCT01475461|100978690|FG001|NOT COMPLETED|Run-in Period||0||
48268213|NCT01475461|100978691|FG002|NOT COMPLETED|Run-in Period||0||
48268214|NCT01475461|100978692|FG003|NOT COMPLETED|Run-in Period||0||
48268215|NCT01475461|100978693|FG004|NOT COMPLETED|Run-in Period||0||
48268216|NCT01475461|100978694|FG005|NOT COMPLETED|Run-in Period||0||
48268217|NCT01475461|100978695|FG006|NOT COMPLETED|Run-in Period||0||
48268218|NCT01475461|100978689|FG000|STARTED|Treatment Period||0||
48268219|NCT01475461|100978690|FG001|STARTED|Treatment Period||57||
48692955|NCT02469701|102032693|FG000|COMPLETED|Overall Study||10||
48692956|NCT02469701|102032693|FG000|NOT COMPLETED|Overall Study||0||
48692957|NCT03569878|102032694|FG000|STARTED|Overall Study||225||
48692958|NCT03569878|102032695|FG001|STARTED|Overall Study||225||
48692959|NCT03569878|102032694|FG000|COMPLETED|Overall Study||225||
48692960|NCT03569878|102032695|FG001|COMPLETED|Overall Study||225||
48692961|NCT03569878|102032694|FG000|NOT COMPLETED|Overall Study||0||
48692962|NCT03569878|102032695|FG001|NOT COMPLETED|Overall Study||0||
48692963|NCT03802630|102032696|FG000|STARTED|Overall Study||226||
48692964|NCT03802630|102032697|FG001|STARTED|Overall Study||224||
48268220|NCT01475461|100978691|FG002|STARTED|Treatment Period||57||
48268221|NCT01475461|100978692|FG003|STARTED|Treatment Period||54||
48692965|NCT03802630|102032696|FG000|COMPLETED|Overall Study||73||
48692966|NCT03802630|102032697|FG001|COMPLETED|Overall Study||76||
48692967|NCT03802630|102032696|FG000|NOT COMPLETED|Overall Study||153||
48692968|NCT03802630|102032697|FG001|NOT COMPLETED|Overall Study||148||
48692969|NCT01221753|102032698|FG000|STARTED|Overall Study||7||
48692970|NCT01221753|102032698|FG000|COMPLETED|Overall Study||6||
48692971|NCT01221753|102032698|FG000|NOT COMPLETED|Overall Study||1||
48692972|NCT03604172|102032699|FG000|STARTED|Overall Study||20||
48692973|NCT03604172|102032700|FG001|STARTED|Overall Study||20||
48692974|NCT03604172|102032699|FG000|COMPLETED|Overall Study||19||
48692975|NCT03604172|102032700|FG001|COMPLETED|Overall Study||18||
48692976|NCT03604172|102032699|FG000|NOT COMPLETED|Overall Study||1||
48692977|NCT03604172|102032700|FG001|NOT COMPLETED|Overall Study||2||
48692978|NCT02097719|102032701|FG000|STARTED|Overall Study||49||
48692979|NCT02097719|102032702|FG001|STARTED|Overall Study||51||
48692980|NCT02097719|102032701|FG000|COMPLETED|Overall Study||46||
48692981|NCT02097719|102032702|FG001|COMPLETED|Overall Study||50||
48692982|NCT02097719|102032701|FG000|NOT COMPLETED|Overall Study||3||
48692983|NCT02097719|102032702|FG001|NOT COMPLETED|Overall Study||1||
48692984|NCT01958580|102032703|FG000|STARTED|Overall Study||3||
48692985|NCT01958580|102032703|FG000|COMPLETED|Overall Study||3||
48692986|NCT01958580|102032703|FG000|NOT COMPLETED|Overall Study||0||
48692987|NCT03617536|102032704|FG000|STARTED|Overall Study||69||
48692988|NCT03617536|102032705|FG001|STARTED|Overall Study||66||
48692989|NCT03617536|102032706|FG002|STARTED|Overall Study||67||
48692990|NCT03617536|102032707|FG003|STARTED|Overall Study||67||
48692991|NCT03617536|102032704|FG000|COMPLETED|Overall Study||60||
48692992|NCT03617536|102032705|FG001|COMPLETED|Overall Study||57||
48692993|NCT03617536|102032706|FG002|COMPLETED|Overall Study||54||
48692994|NCT03617536|102032707|FG003|COMPLETED|Overall Study||57||
48268222|NCT01475461|100978693|FG004|STARTED|Treatment Period||56||
48692995|NCT03617536|102032704|FG000|NOT COMPLETED|Overall Study||9||
48692996|NCT03617536|102032705|FG001|NOT COMPLETED|Overall Study||9||
48692997|NCT03617536|102032706|FG002|NOT COMPLETED|Overall Study||13||
48692998|NCT03617536|102032707|FG003|NOT COMPLETED|Overall Study||10||
48692999|NCT01701362|102032708|FG000|STARTED|Overall Study||275||
48693000|NCT01701362|102032709|FG001|STARTED|Overall Study||267||
48693001|NCT01701362|102032708|FG000|TREATED|Overall Study||274||
48693002|NCT01701362|102032709|FG001|TREATED|Overall Study||265||
48693003|NCT01701362|102032708|FG000|COMPLETED|Overall Study||233||
48107311|NCT01921179|100590499|FG000|STARTED|Long Term Follow-up After GOALS Training||34||
48107312|NCT01921179|100590500|FG001|STARTED|Long Term Follow-up After GOALS Training||0||
48107313|NCT01921179|100590499|FG000|COMPLETED|Long Term Follow-up After GOALS Training||32||
48107314|NCT01921179|100590500|FG001|COMPLETED|Long Term Follow-up After GOALS Training||0||
48107315|NCT01921179|100590499|FG000|NOT COMPLETED|Long Term Follow-up After GOALS Training||2||
48107316|NCT01921179|100590500|FG001|NOT COMPLETED|Long Term Follow-up After GOALS Training||0||
48107317|NCT02356783|100590501|FG000|STARTED|Overall Study||16||
48107318|NCT02356783|100590502|FG001|STARTED|Overall Study||17||
48107319|NCT02356783|100590501|FG000|COMPLETED|Overall Study||15||
48107320|NCT02356783|100590502|FG001|COMPLETED|Overall Study||14||
48107321|NCT02356783|100590501|FG000|NOT COMPLETED|Overall Study||1||
48107322|NCT02356783|100590502|FG001|NOT COMPLETED|Overall Study||3||
48107323|NCT00302133|100590503|FG000|STARTED|Overall Study||9||
48107324|NCT00302133|100590504|FG001|STARTED|Overall Study||9||
48107325|NCT00302133|100590503|FG000|COMPLETED|Overall Study||5||
48107326|NCT00302133|100590504|FG001|COMPLETED|Overall Study||5||
48107327|NCT00302133|100590503|FG000|NOT COMPLETED|Overall Study||4||
48107328|NCT00302133|100590504|FG001|NOT COMPLETED|Overall Study||4||
48107329|NCT00594464|100590505|FG000|STARTED|Overall Study||14||
48107330|NCT00594464|100590505|FG000|COMPLETED|Overall Study||11||
48107331|NCT00594464|100590505|FG000|NOT COMPLETED|Overall Study||3||
48107332|NCT03551210|100590506|FG000|STARTED|Overall Study||171||
48107333|NCT03551210|100590507|FG001|STARTED|Overall Study||171||
48107334|NCT03551210|100590506|FG000|COMPLETED|Overall Study||161||
48107335|NCT03551210|100590507|FG001|COMPLETED|Overall Study||151||
48107336|NCT03551210|100590506|FG000|NOT COMPLETED|Overall Study||10||
48107337|NCT03551210|100590507|FG001|NOT COMPLETED|Overall Study||20||
48107338|NCT00348556|100590508|FG000|STARTED|Overall Study||4||
48107339|NCT00348556|100590508|FG000|COMPLETED|Overall Study||3||
48107340|NCT00348556|100590508|FG000|NOT COMPLETED|Overall Study||1||
48107341|NCT00426283|100590509|FG000|STARTED|Overall Study||28||
48107342|NCT00426283|100590510|FG001|STARTED|Overall Study||14||
48107343|NCT00426283|100590509|FG000|COMPLETED|Overall Study||23||
48107344|NCT00426283|100590510|FG001|COMPLETED|Overall Study||13||
48107345|NCT00426283|100590509|FG000|NOT COMPLETED|Overall Study||5||
48107346|NCT00426283|100590510|FG001|NOT COMPLETED|Overall Study||1||
48107347|NCT02445027|100590511|FG000|STARTED|Overall Study||60||
48107348|NCT02445027|100590511|FG000|COMPLETED|Overall Study||45||
48107349|NCT02445027|100590511|FG000|NOT COMPLETED|Overall Study||15||
48107350|NCT04098458|100590512|FG000|STARTED|Overall Study||18||
48107351|NCT04098458|100590512|FG000|COMPLETED|Overall Study||14||
48107352|NCT04098458|100590512|FG000|NOT COMPLETED|Overall Study||4||
48107353|NCT03569371|100590513|FG000|STARTED|Overall Study||10||
48107354|NCT03569371|100590513|FG000|COMPLETED|Overall Study||7||
48107355|NCT03569371|100590513|FG000|NOT COMPLETED|Overall Study||3||
48107356|NCT02244580|100590514|FG000|STARTED|Overall Study||1010||
48107357|NCT02244580|100590514|FG000|COMPLETED|Overall Study||769||
48107358|NCT02244580|100590514|FG000|NOT COMPLETED|Overall Study||241||
48107359|NCT00677807|100590515|FG000|STARTED|Overall Study||144||
48107360|NCT00677807|100590516|FG001|STARTED|Overall Study||146||
48107361|NCT00677807|100590517|FG002|STARTED|Overall Study||125||
48107362|NCT00677807|100590515|FG000|Safety/ITT: Received Study Drug|Overall Study||144||
48107363|NCT00677807|100590516|FG001|Safety/ITT: Received Study Drug|Overall Study||146||
48107364|NCT00677807|100590517|FG002|Safety/ITT: Received Study Drug|Overall Study||124||
48107365|NCT00677807|100590515|FG000|COMPLETED|Overall Study||126||
48107366|NCT00677807|100590516|FG001|COMPLETED|Overall Study||135||
48107367|NCT00677807|100590517|FG002|COMPLETED|Overall Study||105||
48107368|NCT00677807|100590515|FG000|NOT COMPLETED|Overall Study||18||
48107369|NCT00677807|100590516|FG001|NOT COMPLETED|Overall Study||11||
48107370|NCT00677807|100590517|FG002|NOT COMPLETED|Overall Study||20||
48107371|NCT02904057|100590518|FG000|STARTED|Overall Study||19||
48107372|NCT02904057|100590519|FG001|STARTED|Overall Study||10||
48107373|NCT02904057|100590518|FG000|COMPLETED|Overall Study||19||
48107374|NCT02904057|100590519|FG001|COMPLETED|Overall Study||10||
48107375|NCT02904057|100590518|FG000|NOT COMPLETED|Overall Study||0||
48107376|NCT02904057|100590519|FG001|NOT COMPLETED|Overall Study||0||
48107377|NCT01874262|100590520|FG000|STARTED|Overall Study||91||
48107378|NCT01874262|100590521|FG001|STARTED|Overall Study||83||
48107379|NCT01874262|100590520|FG000|Not Correctly Randomised|Overall Study||2||
48107380|NCT01874262|100590521|FG001|Not Correctly Randomised|Overall Study||0||
48107381|NCT01874262|100590520|FG000|Not Included Due to Tehnical Issues|Overall Study||3||
48107382|NCT01874262|100590521|FG001|Not Included Due to Tehnical Issues|Overall Study||3||
48107383|NCT01874262|100590520|FG000|COMPLETED|Overall Study||86||
48693004|NCT01701362|102032709|FG001|COMPLETED|Overall Study||211||
48693005|NCT01701362|102032708|FG000|NOT COMPLETED|Overall Study||42||
48107384|NCT01874262|100590521|FG001|COMPLETED|Overall Study||80||
48107385|NCT01874262|100590520|FG000|NOT COMPLETED|Overall Study||5||
48107386|NCT01874262|100590521|FG001|NOT COMPLETED|Overall Study||3||
48107387|NCT00951093|100590522|FG000|STARTED|Before GBP||53||
48107388|NCT00951093|100590522|FG000|COMPLETED|Before GBP||53||
48107389|NCT00951093|100590522|FG000|NOT COMPLETED|Before GBP||0||
48107390|NCT00951093|100590522|FG000|STARTED|6 Months After GBP||53||
48107391|NCT00951093|100590522|FG000|COMPLETED|6 Months After GBP||53||
48107392|NCT00951093|100590522|FG000|NOT COMPLETED|6 Months After GBP||0||
48107393|NCT03221595|100590523|FG000|STARTED|Overall Study||51||
48107394|NCT03221595|100590524|FG001|STARTED|Overall Study||59||
48107395|NCT03221595|100590523|FG000|COMPLETED|Overall Study||51||
48107396|NCT03221595|100590524|FG001|COMPLETED|Overall Study||59||
48107397|NCT03221595|100590523|FG000|NOT COMPLETED|Overall Study||0||
48107398|NCT03221595|100590524|FG001|NOT COMPLETED|Overall Study||0||
48107399|NCT01188694|100590525|FG000|STARTED|Overall Study||15||
48107400|NCT01188694|100590526|FG001|STARTED|Overall Study||16||
48107401|NCT01188694|100590527|FG002|STARTED|Overall Study||11||
48107402|NCT01188694|100590525|FG000|COMPLETED|Overall Study||10||
48107403|NCT01188694|100590526|FG001|COMPLETED|Overall Study||15||
48107404|NCT01188694|100590527|FG002|COMPLETED|Overall Study||10||
48107405|NCT01188694|100590525|FG000|NOT COMPLETED|Overall Study||5||
48107406|NCT01188694|100590526|FG001|NOT COMPLETED|Overall Study||1||
48107407|NCT01188694|100590527|FG002|NOT COMPLETED|Overall Study||1||
48107408|NCT03595878|100590528|FG000|STARTED|Overall Study||29||
48107409|NCT03595878|100590529|FG001|STARTED|Overall Study||27||
48107410|NCT03595878|100590530|FG002|STARTED|Overall Study||4||
48107411|NCT03595878|100590528|FG000|COMPLETED|Overall Study||25||
48107412|NCT03595878|100590529|FG001|COMPLETED|Overall Study||25||
48107413|NCT03595878|100590530|FG002|COMPLETED|Overall Study||2||
48107414|NCT03595878|100590528|FG000|NOT COMPLETED|Overall Study||4||
48107415|NCT03595878|100590529|FG001|NOT COMPLETED|Overall Study||2||
48107416|NCT03595878|100590530|FG002|NOT COMPLETED|Overall Study||2||
48107417|NCT04056195|100590531|FG000|STARTED|Overall Study||26||
48107418|NCT04056195|100590532|FG001|STARTED|Overall Study||22||
48107419|NCT04056195|100590533|FG002|STARTED|Overall Study||12||
48107420|NCT04056195|100590531|FG000|COMPLETED|Overall Study||24||
48107421|NCT04056195|100590532|FG001|COMPLETED|Overall Study||20||
48107422|NCT04056195|100590533|FG002|COMPLETED|Overall Study||10||
48107423|NCT04056195|100590531|FG000|NOT COMPLETED|Overall Study||2||
48107424|NCT04056195|100590532|FG001|NOT COMPLETED|Overall Study||2||
48107425|NCT04056195|100590533|FG002|NOT COMPLETED|Overall Study||2||
48107426|NCT01933048|100590534|FG000|STARTED|Overall Study||548||
48107427|NCT01933048|100590535|FG001|STARTED|Overall Study||529||
48107428|NCT01933048|100590534|FG000|COMPLETED|Overall Study||523||
48107429|NCT01933048|100590535|FG001|COMPLETED|Overall Study||501||
48107430|NCT01933048|100590534|FG000|NOT COMPLETED|Overall Study||25||
48107431|NCT01933048|100590535|FG001|NOT COMPLETED|Overall Study||28||
48107432|NCT02767427|100590536|FG000|STARTED|Overall Study||21||
48107433|NCT02767427|100590537|FG001|STARTED|Overall Study||19||
48107434|NCT02767427|100590536|FG000|COMPLETED|Overall Study||21||
48107435|NCT02767427|100590537|FG001|COMPLETED|Overall Study||19||
48107436|NCT02767427|100590536|FG000|NOT COMPLETED|Overall Study||0||
48107437|NCT02767427|100590537|FG001|NOT COMPLETED|Overall Study||0||
48107438|NCT03509675|100590538|FG000|STARTED|First Intervention (7 Days)||11||
48107439|NCT03509675|100590539|FG001|STARTED|First Intervention (7 Days)||12||
48107440|NCT03509675|100590538|FG000|COMPLETED|First Intervention (7 Days)||6||
48107441|NCT03509675|100590539|FG001|COMPLETED|First Intervention (7 Days)||8||
48107442|NCT03509675|100590538|FG000|NOT COMPLETED|First Intervention (7 Days)||5||
48107443|NCT03509675|100590539|FG001|NOT COMPLETED|First Intervention (7 Days)||4||
48107444|NCT03509675|100590538|FG000|STARTED|Washout Period (7 Days)||6||
48107445|NCT03509675|100590539|FG001|STARTED|Washout Period (7 Days)||8||
48107446|NCT03509675|100590538|FG000|COMPLETED|Washout Period (7 Days)||6||
48107447|NCT03509675|100590539|FG001|COMPLETED|Washout Period (7 Days)||8||
48107448|NCT03509675|100590538|FG000|NOT COMPLETED|Washout Period (7 Days)||0||
48107449|NCT03509675|100590539|FG001|NOT COMPLETED|Washout Period (7 Days)||0||
48107450|NCT03509675|100590538|FG000|STARTED|Second Intervention )7 Days)||6||
48107451|NCT03509675|100590539|FG001|STARTED|Second Intervention )7 Days)||8||
48107452|NCT03509675|100590538|FG000|COMPLETED|Second Intervention )7 Days)||4||
48107453|NCT03509675|100590539|FG001|COMPLETED|Second Intervention )7 Days)||8||
48107454|NCT03509675|100590538|FG000|NOT COMPLETED|Second Intervention )7 Days)||2||
48107455|NCT03509675|100590539|FG001|NOT COMPLETED|Second Intervention )7 Days)||0||
48107456|NCT01168024|100590540|FG000|STARTED|Overall Study||13||
48107457|NCT01168024|100590541|FG001|STARTED|Overall Study||3||
48107458|NCT01168024|100590540|FG000|COMPLETED|Overall Study||13||
48107459|NCT01168024|100590541|FG001|COMPLETED|Overall Study||3||
48107460|NCT01168024|100590540|FG000|NOT COMPLETED|Overall Study||0||
48107461|NCT01168024|100590541|FG001|NOT COMPLETED|Overall Study||0||
48107462|NCT02603432|100590542|FG000|STARTED|Overall Study||350||
48107463|NCT02603432|100590543|FG001|STARTED|Overall Study||350||
48107464|NCT02603432|100590542|FG000|COMPLETED|Overall Study||16||
48107465|NCT02603432|100590543|FG001|COMPLETED|Overall Study||1||
48107466|NCT02603432|100590542|FG000|NOT COMPLETED|Overall Study||334||
48693006|NCT01701362|102032709|FG001|NOT COMPLETED|Overall Study||56||
48693007|NCT01692496|102032710|FG000|STARTED|Overall Study||52||
48693008|NCT01692496|102032710|FG000|3 Weeks Pazopanib (Per Protocol PP)|Overall Study||50||
48693009|NCT01692496|102032710|FG000|COMPLETED|Overall Study||52||
48693010|NCT01692496|102032710|FG000|NOT COMPLETED|Overall Study||0||
48693011|NCT05002985|102032711|FG000|STARTED|Overall Study||49||
48693012|NCT05002985|102032711|FG000|COMPLETED|Overall Study||48||
48693013|NCT05002985|102032711|FG000|NOT COMPLETED|Overall Study||1||
48107467|NCT02603432|100590543|FG001|NOT COMPLETED|Overall Study||349||
48107468|NCT01822132|100590544|FG000|STARTED|Overall Study||25||
48107469|NCT01822132|100590545|FG001|STARTED|Overall Study||27||
48107470|NCT01822132|100590544|FG000|COMPLETED|Overall Study||21||
48107471|NCT01822132|100590545|FG001|COMPLETED|Overall Study||25||
48107472|NCT01822132|100590544|FG000|NOT COMPLETED|Overall Study||4||
48107473|NCT01822132|100590545|FG001|NOT COMPLETED|Overall Study||2||
48107474|NCT03493828|100590546|FG000|STARTED|Overall Study||20||
48107475|NCT03493828|100590547|FG001|STARTED|Overall Study||20||
48107476|NCT03493828|100590548|FG002|STARTED|Overall Study||20||
48107477|NCT03493828|100590546|FG000|COMPLETED|Overall Study||20||
48107478|NCT03493828|100590547|FG001|COMPLETED|Overall Study||20||
48107479|NCT03493828|100590548|FG002|COMPLETED|Overall Study||20||
48107480|NCT03493828|100590546|FG000|NOT COMPLETED|Overall Study||0||
48107481|NCT03493828|100590547|FG001|NOT COMPLETED|Overall Study||0||
48107482|NCT03493828|100590548|FG002|NOT COMPLETED|Overall Study||0||
48107483|NCT01945489|100590549|FG000|STARTED|Cycle 1||129||
48107484|NCT01945489|100590550|FG001|STARTED|Cycle 1||125||
48107485|NCT01945489|100590549|FG000|COMPLETED|Cycle 1||116||
48107486|NCT01945489|100590550|FG001|COMPLETED|Cycle 1||121||
48107487|NCT01945489|100590549|FG000|NOT COMPLETED|Cycle 1||13||
48107488|NCT01945489|100590550|FG001|NOT COMPLETED|Cycle 1||4||
48107489|NCT01945489|100590549|FG000|STARTED|Cycle 2||88||
48107490|NCT01945489|100590550|FG001|STARTED|Cycle 2||107||
48107491|NCT01945489|100590549|FG000|COMPLETED|Cycle 2||87||
48107492|NCT01945489|100590550|FG001|COMPLETED|Cycle 2||106||
48107493|NCT01945489|100590549|FG000|NOT COMPLETED|Cycle 2||1||
48107494|NCT01945489|100590550|FG001|NOT COMPLETED|Cycle 2||1||
48268223|NCT01475461|100978694|FG005|STARTED|Treatment Period||56||
48268224|NCT01475461|100978695|FG006|STARTED|Treatment Period||55||
48693014|NCT01681186|102032712|FG000|STARTED|First Intervention||4||
48693015|NCT01681186|102032713|FG001|STARTED|First Intervention||2||
48693016|NCT01681186|102032714|FG002|STARTED|First Intervention||2||
48693017|NCT01681186|102032715|FG003|STARTED|First Intervention||3||
48107495|NCT04248816|100590551|FG000|STARTED|Overall Study||123||
48107496|NCT04248816|100590552|FG001|STARTED|Overall Study||245||
48107497|NCT04248816|100590553|FG002|STARTED|Overall Study||247||
48107498|NCT04248816|100590551|FG000|COMPLETED|Overall Study||116||
48107499|NCT04248816|100590552|FG001|COMPLETED|Overall Study||224||
48107500|NCT04248816|100590553|FG002|COMPLETED|Overall Study||222||
48107501|NCT04248816|100590551|FG000|NOT COMPLETED|Overall Study||7||
48107502|NCT04248816|100590552|FG001|NOT COMPLETED|Overall Study||21||
48107503|NCT04248816|100590553|FG002|NOT COMPLETED|Overall Study||25||
48107504|NCT02731729|100590554|FG000|STARTED|Overall Study||10||
48107505|NCT02731729|100590555|FG001|STARTED|Overall Study||10||
48107506|NCT02731729|100590554|FG000|COMPLETED|Overall Study||1||
48107507|NCT02731729|100590555|FG001|COMPLETED|Overall Study||2||
48107508|NCT02731729|100590554|FG000|NOT COMPLETED|Overall Study||9||
48107509|NCT02731729|100590555|FG001|NOT COMPLETED|Overall Study||8||
48107510|NCT04693585|100590556|FG000|STARTED|Overall Study||120||
48107511|NCT04693585|100590557|FG001|STARTED|Overall Study||40||
48107512|NCT04693585|100590558|FG002|STARTED|Overall Study||41||
48107513|NCT04693585|100590556|FG000|COMPLETED|Overall Study||94||
48107514|NCT04693585|100590557|FG001|COMPLETED|Overall Study||28||
48107515|NCT04693585|100590558|FG002|COMPLETED|Overall Study||13||
48107516|NCT04693585|100590556|FG000|NOT COMPLETED|Overall Study||26||
48107517|NCT04693585|100590557|FG001|NOT COMPLETED|Overall Study||12||
48107518|NCT04693585|100590558|FG002|NOT COMPLETED|Overall Study||28||
48107519|NCT00692770|100590559|FG000|STARTED|Overall Study||556||
48107520|NCT00692770|100590560|FG001|STARTED|Overall Study||558||
48693018|NCT01681186|102032716|FG004|STARTED|First Intervention||3||
48107521|NCT00692770|100590559|FG000|Participants Received Treatment|Overall Study||553||
48107522|NCT00692770|100590560|FG001|Participants Received Treatment|Overall Study||554||
48107523|NCT00692770|100590559|FG000|COMPLETED|Overall Study||0||
48107524|NCT00692770|100590560|FG001|COMPLETED|Overall Study||0||
48107525|NCT00692770|100590559|FG000|NOT COMPLETED|Overall Study||556||
48107526|NCT00692770|100590560|FG001|NOT COMPLETED|Overall Study||558||
48107527|NCT02155738|100590561|FG000|STARTED|Overall Study||50||
48107528|NCT02155738|100590562|FG001|STARTED|Overall Study||52||
48107529|NCT02155738|100590563|FG002|STARTED|Overall Study||51||
48107530|NCT02155738|100590564|FG003|STARTED|Overall Study||51||
48107531|NCT02155738|100590561|FG000|COMPLETED|Overall Study||49||
48107532|NCT02155738|100590562|FG001|COMPLETED|Overall Study||52||
48107533|NCT02155738|100590563|FG002|COMPLETED|Overall Study||51||
48107534|NCT02155738|100590564|FG003|COMPLETED|Overall Study||50||
48268225|NCT01475461|100978689|FG000|COMPLETED|Treatment Period||0||
48268226|NCT01475461|100978690|FG001|COMPLETED|Treatment Period||48||
48693019|NCT01681186|102032717|FG005|STARTED|First Intervention||2||
48268227|NCT01475461|100978691|FG002|COMPLETED|Treatment Period||53||
48268228|NCT01475461|100978692|FG003|COMPLETED|Treatment Period||46||
48268229|NCT01475461|100978693|FG004|COMPLETED|Treatment Period||52||
48268230|NCT01475461|100978694|FG005|COMPLETED|Treatment Period||51||
48268231|NCT01475461|100978695|FG006|COMPLETED|Treatment Period||53||
48268232|NCT01475461|100978689|FG000|NOT COMPLETED|Treatment Period||0||
48268233|NCT01475461|100978690|FG001|NOT COMPLETED|Treatment Period||9||
48268234|NCT01475461|100978691|FG002|NOT COMPLETED|Treatment Period||4||
48268235|NCT01475461|100978692|FG003|NOT COMPLETED|Treatment Period||8||
48268236|NCT01475461|100978693|FG004|NOT COMPLETED|Treatment Period||4||
48268237|NCT01475461|100978694|FG005|NOT COMPLETED|Treatment Period||5||
48268238|NCT01475461|100978695|FG006|NOT COMPLETED|Treatment Period||2||
48268239|NCT02643225|100978696|FG000|STARTED|Overall Study||40||
48268240|NCT02643225|100978697|FG001|STARTED|Overall Study||40||
48268241|NCT02643225|100978696|FG000|COMPLETED|Overall Study||40||
48268242|NCT02643225|100978697|FG001|COMPLETED|Overall Study||40||
48268243|NCT02643225|100978696|FG000|NOT COMPLETED|Overall Study||0||
48268244|NCT02643225|100978697|FG001|NOT COMPLETED|Overall Study||0||
48693020|NCT01681186|102032718|FG006|STARTED|First Intervention||7||
48693021|NCT01681186|102032719|FG007|STARTED|First Intervention||7||
48693022|NCT01681186|102032712|FG000|COMPLETED|First Intervention||4||
48693023|NCT01681186|102032713|FG001|COMPLETED|First Intervention||2||
48693024|NCT01681186|102032714|FG002|COMPLETED|First Intervention||2||
48693025|NCT01681186|102032715|FG003|COMPLETED|First Intervention||3||
48693026|NCT01681186|102032716|FG004|COMPLETED|First Intervention||3||
48693027|NCT01681186|102032717|FG005|COMPLETED|First Intervention||2||
48693028|NCT01681186|102032718|FG006|COMPLETED|First Intervention||7||
48268245|NCT02975102|100978698|FG000|STARTED|Overall Study||45|Randomized|
48268246|NCT02975102|100978699|FG001|STARTED|Overall Study||38|Randomized|
48268247|NCT02975102|100978698|FG000|Safety Population|Overall Study||45||
48268248|NCT02975102|100978699|FG001|Safety Population|Overall Study||38||
48268249|NCT02975102|100978698|FG000|Intention-to-treat Population|Overall Study||45||
48268250|NCT02975102|100978699|FG001|Intention-to-treat Population|Overall Study||38||
48268251|NCT02975102|100978698|FG000|Per Protocol Population Day 7|Overall Study||42||
48268252|NCT02975102|100978699|FG001|Per Protocol Population Day 7|Overall Study||34||
48268253|NCT02975102|100978698|FG000|Per Protocol Population Day 28|Overall Study||43||
48268254|NCT02975102|100978699|FG001|Per Protocol Population Day 28|Overall Study||35||
48268255|NCT02975102|100978698|FG000|Per Protocol Population Day 90|Overall Study||42||
48268256|NCT02975102|100978699|FG001|Per Protocol Population Day 90|Overall Study||34||
48268257|NCT02975102|100978698|FG000|COMPLETED|Overall Study||43||
48268258|NCT02975102|100978699|FG001|COMPLETED|Overall Study||37||
48268259|NCT02975102|100978698|FG000|NOT COMPLETED|Overall Study||2||
48268260|NCT02975102|100978699|FG001|NOT COMPLETED|Overall Study||1||
48268261|NCT01415934|100978700|FG000|STARTED|Overall Study||192||
48268262|NCT01415934|100978701|FG001|STARTED|Overall Study||189||
48268263|NCT01415934|100978700|FG000|COMPLETED|Overall Study||189||
48268264|NCT01415934|100978701|FG001|COMPLETED|Overall Study||182||
48268265|NCT01415934|100978700|FG000|NOT COMPLETED|Overall Study||3||
48268266|NCT01415934|100978701|FG001|NOT COMPLETED|Overall Study||7||
48268267|NCT01727505|100978702|FG000|STARTED|First 24 Hours||14||
48268268|NCT01727505|100978703|FG001|STARTED|First 24 Hours||12||
48268269|NCT01727505|100978702|FG000|COMPLETED|First 24 Hours||14||
48268270|NCT01727505|100978703|FG001|COMPLETED|First 24 Hours||11||
48268271|NCT01727505|100978702|FG000|NOT COMPLETED|First 24 Hours||0||
48392120|NCT01216397|101287809|FG001|STARTED|Period 1||20||
48392121|NCT01216397|101287808|FG000|COMPLETED|Period 1||20||
48392122|NCT01216397|101287809|FG001|COMPLETED|Period 1||20||
48392123|NCT01216397|101287808|FG000|NOT COMPLETED|Period 1||0||
48392124|NCT01216397|101287809|FG001|NOT COMPLETED|Period 1||0||
48392125|NCT01216397|101287808|FG000|STARTED|Washout (35 Days)||20||
48392126|NCT01216397|101287809|FG001|STARTED|Washout (35 Days)||20||
48392127|NCT01216397|101287808|FG000|COMPLETED|Washout (35 Days)||20||
48392128|NCT01216397|101287809|FG001|COMPLETED|Washout (35 Days)||20||
48392129|NCT01216397|101287808|FG000|NOT COMPLETED|Washout (35 Days)||0||
48392130|NCT01216397|101287809|FG001|NOT COMPLETED|Washout (35 Days)||0||
48392131|NCT01216397|101287808|FG000|STARTED|Period 2||20||
48392132|NCT01216397|101287809|FG001|STARTED|Period 2||20||
48693029|NCT01681186|102032719|FG007|COMPLETED|First Intervention||7||
48693030|NCT01681186|102032712|FG000|NOT COMPLETED|First Intervention||0||
48268272|NCT01727505|100978703|FG001|NOT COMPLETED|First 24 Hours||1||
48268273|NCT01727505|100978702|FG000|STARTED|Second 24 Hours||14||
48268274|NCT01727505|100978703|FG001|STARTED|Second 24 Hours||11||
48268275|NCT01727505|100978702|FG000|COMPLETED|Second 24 Hours||14||
48268276|NCT01727505|100978703|FG001|COMPLETED|Second 24 Hours||10||
48268277|NCT01727505|100978702|FG000|NOT COMPLETED|Second 24 Hours||0||
48268278|NCT01727505|100978703|FG001|NOT COMPLETED|Second 24 Hours||1||
48392133|NCT01216397|101287808|FG000|COMPLETED|Period 2||20||
48268279|NCT00558792|100978704|FG000|STARTED|Overall Study||68||
48268280|NCT00558792|100978705|FG001|STARTED|Overall Study||63||
48268281|NCT00558792|100978706|FG002|STARTED|Overall Study||60||
48268282|NCT00558792|100978704|FG000|COMPLETED|Overall Study||68||
48268283|NCT00558792|100978705|FG001|COMPLETED|Overall Study||63||
48392134|NCT01216397|101287809|FG001|COMPLETED|Period 2||20||
48268284|NCT00558792|100978706|FG002|COMPLETED|Overall Study||60||
48268285|NCT00558792|100978704|FG000|NOT COMPLETED|Overall Study||0||
48268286|NCT00558792|100978705|FG001|NOT COMPLETED|Overall Study||0||
48268287|NCT00558792|100978706|FG002|NOT COMPLETED|Overall Study||0||
48268288|NCT02172911|100978707|FG000|STARTED|Overall Study||7||
48268289|NCT02172911|100978708|FG001|STARTED|Overall Study||3||
48268290|NCT02172911|100978707|FG000|COMPLETED|Overall Study||6||
48268291|NCT02172911|100978708|FG001|COMPLETED|Overall Study||1||
48268292|NCT02172911|100978707|FG000|NOT COMPLETED|Overall Study||1||
48268293|NCT02172911|100978708|FG001|NOT COMPLETED|Overall Study||2||
48268294|NCT00758342|100978709|FG000|STARTED|Overall Study||19||
48268295|NCT00758342|100978710|FG001|STARTED|Overall Study||18||
48268296|NCT00758342|100978709|FG000|COMPLETED|Overall Study||15||
48268297|NCT00758342|100978710|FG001|COMPLETED|Overall Study||17||
48268298|NCT00758342|100978709|FG000|NOT COMPLETED|Overall Study||4||
48268299|NCT00758342|100978710|FG001|NOT COMPLETED|Overall Study||1||
48268300|NCT00862836|100978711|FG000|STARTED|Overall Study||15||
48268301|NCT00862836|100978711|FG000|Evaluable for Safety/Toxicity|Overall Study||14||
48268302|NCT00862836|100978711|FG000|Evaluable for Activity (Tumour Response)|Overall Study||10||
48268303|NCT00862836|100978711|FG000|COMPLETED|Overall Study||14||
48268304|NCT00862836|100978711|FG000|NOT COMPLETED|Overall Study||1||
48268305|NCT02588872|100978712|FG000|STARTED|Overall Study||59||
48268306|NCT02588872|100978713|FG001|STARTED|Overall Study||52||
48268307|NCT02588872|100978712|FG000|COMPLETED|Overall Study||59||
48268308|NCT02588872|100978713|FG001|COMPLETED|Overall Study||52||
48268309|NCT02588872|100978712|FG000|NOT COMPLETED|Overall Study||0||
48268310|NCT02588872|100978713|FG001|NOT COMPLETED|Overall Study||0||
48693031|NCT01681186|102032713|FG001|NOT COMPLETED|First Intervention||0||
48268311|NCT01228175|100978714|FG000|STARTED|Overall Study||119||
48268312|NCT01228175|100978715|FG001|STARTED|Overall Study||99||
48268313|NCT01228175|100978714|FG000|COMPLETED|Overall Study||53||
48268314|NCT01228175|100978715|FG001|COMPLETED|Overall Study||46||
48268315|NCT01228175|100978714|FG000|NOT COMPLETED|Overall Study||66||
48268316|NCT01228175|100978715|FG001|NOT COMPLETED|Overall Study||53||
48268317|NCT02870972|100978716|FG000|STARTED|Overall Study||18||
48268318|NCT02870972|100978717|FG001|STARTED|Overall Study||14||
48268319|NCT02870972|100978718|FG002|STARTED|Overall Study||14||
48268320|NCT02870972|100978719|FG003|STARTED|Overall Study||7||
48268321|NCT02870972|100978720|FG004|STARTED|Overall Study||22||
48268322|NCT02870972|100978716|FG000|COMPLETED|Overall Study||17||
48268323|NCT02870972|100978717|FG001|COMPLETED|Overall Study||14||
48268324|NCT02870972|100978718|FG002|COMPLETED|Overall Study||14||
48268325|NCT02870972|100978719|FG003|COMPLETED|Overall Study||7||
48268326|NCT02870972|100978720|FG004|COMPLETED|Overall Study||22||
48268327|NCT02870972|100978716|FG000|NOT COMPLETED|Overall Study||1||
48268328|NCT02870972|100978717|FG001|NOT COMPLETED|Overall Study||0||
48268329|NCT02870972|100978718|FG002|NOT COMPLETED|Overall Study||0||
48268330|NCT02870972|100978719|FG003|NOT COMPLETED|Overall Study||0||
48268331|NCT02870972|100978720|FG004|NOT COMPLETED|Overall Study||0||
48268332|NCT01460225|100978721|FG000|STARTED|Overall Study||19||
48268333|NCT01460225|100978721|FG000|COMPLETED|Overall Study||19||
48268334|NCT01460225|100978721|FG000|NOT COMPLETED|Overall Study||0||
48268335|NCT00664534|100978722|FG000|STARTED|Overall Study||173||
48268336|NCT00664534|100978723|FG001|STARTED|Overall Study||171||
48268337|NCT00664534|100978722|FG000|COMPLETED|Overall Study||132||
48268338|NCT00664534|100978723|FG001|COMPLETED|Overall Study||138||
48268339|NCT00664534|100978722|FG000|NOT COMPLETED|Overall Study||41||
48268340|NCT00664534|100978723|FG001|NOT COMPLETED|Overall Study||33||
48268341|NCT00129935|100981682|FG000|STARTED|Overall Study||669||
48268342|NCT00129935|100981683|FG001|STARTED|Overall Study||715||
48268343|NCT00129935|100981682|FG000|COMPLETED|Overall Study||633||
48268344|NCT00129935|100981683|FG001|COMPLETED|Overall Study||623||
48268345|NCT00129935|100981682|FG000|NOT COMPLETED|Overall Study||36||
48268346|NCT00129935|100981683|FG001|NOT COMPLETED|Overall Study||92||
48693032|NCT01681186|102032714|FG002|NOT COMPLETED|First Intervention||0||
48268347|NCT02638883|100981684|FG000|STARTED|Overall Study||6||
48268348|NCT02638883|100981684|FG000|COMPLETED|Overall Study||6||
48268349|NCT02638883|100981684|FG000|NOT COMPLETED|Overall Study||0||
48268350|NCT01907906|100981685|FG000|STARTED|Overall Study||16||
48268351|NCT01907906|100981686|FG001|STARTED|Overall Study||13||
48268352|NCT01907906|100981685|FG000|COMPLETED|Overall Study||12||
48268353|NCT01907906|100981686|FG001|COMPLETED|Overall Study||12||
48268354|NCT01907906|100981685|FG000|NOT COMPLETED|Overall Study||4||
48268355|NCT01907906|100981686|FG001|NOT COMPLETED|Overall Study||1||
48268356|NCT02920970|100981687|FG000|STARTED|First Intervention||38||
48268357|NCT02920970|100981688|FG001|STARTED|First Intervention||32||
48268358|NCT02920970|100981687|FG000|COMPLETED|First Intervention||38||
48268359|NCT02920970|100981688|FG001|COMPLETED|First Intervention||30||
48268360|NCT02920970|100981687|FG000|NOT COMPLETED|First Intervention||0||
48268361|NCT02920970|100981688|FG001|NOT COMPLETED|First Intervention||2||
48268362|NCT02920970|100981687|FG000|STARTED|Second Intervention||38||
48268363|NCT02920970|100981688|FG001|STARTED|Second Intervention||30||
48268364|NCT02920970|100981687|FG000|COMPLETED|Second Intervention||37||
48268365|NCT02920970|100981688|FG001|COMPLETED|Second Intervention||30||
48268366|NCT02920970|100981687|FG000|NOT COMPLETED|Second Intervention||1||
48268367|NCT02920970|100981688|FG001|NOT COMPLETED|Second Intervention||0||
48268368|NCT02473965|100981689|FG000|STARTED|Overall Study||30||
48268369|NCT02473965|100981690|FG001|STARTED|Overall Study||30||
48268370|NCT02473965|100981689|FG000|COMPLETED|Overall Study||18|Completed up to Week 45|
48268371|NCT02473965|100981690|FG001|COMPLETED|Overall Study||20|Completed up to Week 45|
48268372|NCT02473965|100981689|FG000|NOT COMPLETED|Overall Study||12||
48268373|NCT02473965|100981690|FG001|NOT COMPLETED|Overall Study||10||
48268374|NCT01825577|100981691|FG000|STARTED|Overall Study||14||
48268375|NCT01825577|100981691|FG000|COMPLETED|Overall Study||6||
48268376|NCT01825577|100981691|FG000|NOT COMPLETED|Overall Study||8||
48268377|NCT01594970|100981692|FG000|STARTED|Overall Study||295||
48268378|NCT01594970|100981693|FG001|STARTED|Overall Study||248||
48268379|NCT01594970|100981694|FG002|STARTED|Overall Study||257||
48268380|NCT01594970|100981692|FG000|COMPLETED|Overall Study||220||
48268381|NCT01594970|100981693|FG001|COMPLETED|Overall Study||166||
48268382|NCT01594970|100981694|FG002|COMPLETED|Overall Study||191||
48268383|NCT01594970|100981692|FG000|NOT COMPLETED|Overall Study||75||
48268384|NCT01594970|100981693|FG001|NOT COMPLETED|Overall Study||82||
48268385|NCT01594970|100981694|FG002|NOT COMPLETED|Overall Study||66||
48268386|NCT00554996|100981695|FG000|STARTED|Overall Study||10||
48268387|NCT00554996|100981695|FG000|COMPLETED|Overall Study||10||
48268388|NCT00554996|100981695|FG000|NOT COMPLETED|Overall Study||0||
48268389|NCT02336451|100981696|FG000|STARTED|Overall Study||42||
48268390|NCT02336451|100981697|FG001|STARTED|Overall Study||40||
48268391|NCT02336451|100981698|FG002|STARTED|Overall Study||12||
48268392|NCT02336451|100981699|FG003|STARTED|Overall Study||44||
48268393|NCT02336451|100981700|FG004|STARTED|Overall Study||18||
48268394|NCT02336451|100981696|FG000|COMPLETED|Overall Study||0||
48268395|NCT02336451|100981697|FG001|COMPLETED|Overall Study||0||
48268396|NCT02336451|100981698|FG002|COMPLETED|Overall Study||0||
48268397|NCT02336451|100981699|FG003|COMPLETED|Overall Study||0||
48268398|NCT02336451|100981700|FG004|COMPLETED|Overall Study||0||
48268399|NCT02336451|100981696|FG000|NOT COMPLETED|Overall Study||42||
48268400|NCT02336451|100981697|FG001|NOT COMPLETED|Overall Study||40||
48268401|NCT02336451|100981698|FG002|NOT COMPLETED|Overall Study||12||
48268402|NCT02336451|100981699|FG003|NOT COMPLETED|Overall Study||44||
48392135|NCT01216397|101287808|FG000|NOT COMPLETED|Period 2||0||
48392136|NCT01216397|101287809|FG001|NOT COMPLETED|Period 2||0||
48392137|NCT04031404|101287810|FG000|STARTED|Baseline||10|Randomized|
48392138|NCT04031404|101287811|FG001|STARTED|Baseline||13|Randomized|
48392139|NCT04031404|101287810|FG000|COMPLETED|Baseline||8||
48392140|NCT04031404|101287811|FG001|COMPLETED|Baseline||8||
48392141|NCT04031404|101287810|FG000|NOT COMPLETED|Baseline||2||
48392142|NCT04031404|101287811|FG001|NOT COMPLETED|Baseline||5||
48392143|NCT04031404|101287810|FG000|STARTED|Pre-randomization||8||
48392144|NCT04031404|101287811|FG001|STARTED|Pre-randomization||8||
48392145|NCT04031404|101287810|FG000|COMPLETED|Pre-randomization||6||
48392146|NCT04031404|101287811|FG001|COMPLETED|Pre-randomization||5||
48392147|NCT04031404|101287810|FG000|NOT COMPLETED|Pre-randomization||2||
48392148|NCT04031404|101287811|FG001|NOT COMPLETED|Pre-randomization||3||
48392149|NCT04031404|101287810|FG000|STARTED|First Drink Visit||6||
48392150|NCT04031404|101287811|FG001|STARTED|First Drink Visit||5||
48392151|NCT04031404|101287810|FG000|COMPLETED|First Drink Visit||6||
48392152|NCT04031404|101287811|FG001|COMPLETED|First Drink Visit||5||
48268403|NCT02336451|100981700|FG004|NOT COMPLETED|Overall Study||18||
48268404|NCT00763490|100981701|FG000|STARTED|Overall Study||20||
48268405|NCT00763490|100981701|FG000|COMPLETED|Overall Study||20||
48268406|NCT00763490|100981701|FG000|NOT COMPLETED|Overall Study||0||
48268407|NCT02980042|100981702|FG000|STARTED|Overall Study||100||
48268408|NCT02980042|100981703|FG001|STARTED|Overall Study||100||
48268409|NCT02980042|100981702|FG000|COMPLETED|Overall Study||93||
48268410|NCT02980042|100981703|FG001|COMPLETED|Overall Study||100||
48392153|NCT04031404|101287810|FG000|NOT COMPLETED|First Drink Visit||0||
48392154|NCT04031404|101287811|FG001|NOT COMPLETED|First Drink Visit||0||
48392155|NCT04031404|101287810|FG000|STARTED|Washout (5 Day Min)||6||
48392156|NCT04031404|101287811|FG001|STARTED|Washout (5 Day Min)||5||
48392157|NCT04031404|101287810|FG000|COMPLETED|Washout (5 Day Min)||5||
48392158|NCT04031404|101287811|FG001|COMPLETED|Washout (5 Day Min)||5||
48392159|NCT04031404|101287810|FG000|NOT COMPLETED|Washout (5 Day Min)||1||
48392160|NCT04031404|101287811|FG001|NOT COMPLETED|Washout (5 Day Min)||0||
48268411|NCT02980042|100981702|FG000|NOT COMPLETED|Overall Study||7||
48268412|NCT02980042|100981703|FG001|NOT COMPLETED|Overall Study||0||
48268413|NCT01490892|100981704|FG000|STARTED|Overall Study||219||
48268414|NCT01490892|100981704|FG000|COMPLETED|Overall Study||219||
48268415|NCT01490892|100981704|FG000|NOT COMPLETED|Overall Study||0||
48268416|NCT01226732|100981705|FG000|STARTED|Overall Study||3||
48268417|NCT01226732|100981706|FG001|STARTED|Overall Study||3||
48268418|NCT01226732|100981707|FG002|STARTED|Overall Study||3||
48392161|NCT04031404|101287810|FG000|STARTED|Second Drink Visit||5||
48392162|NCT04031404|101287811|FG001|STARTED|Second Drink Visit||5||
48392163|NCT04031404|101287810|FG000|COMPLETED|Second Drink Visit||5||
48268419|NCT01226732|100981708|FG003|STARTED|Overall Study||5||
48268420|NCT01226732|100981709|FG004|STARTED|Overall Study||3||
48268421|NCT01226732|100981710|FG005|STARTED|Overall Study||6||
48268422|NCT01226732|100981705|FG000|COMPLETED|Overall Study||0||
48268423|NCT01226732|100981706|FG001|COMPLETED|Overall Study||0||
48268424|NCT01226732|100981707|FG002|COMPLETED|Overall Study||0||
48268425|NCT01226732|100981708|FG003|COMPLETED|Overall Study||0||
48268426|NCT01226732|100981709|FG004|COMPLETED|Overall Study||0||
48268427|NCT01226732|100981710|FG005|COMPLETED|Overall Study||0||
48268428|NCT01226732|100981705|FG000|NOT COMPLETED|Overall Study||3||
48268429|NCT01226732|100981706|FG001|NOT COMPLETED|Overall Study||3||
48268430|NCT01226732|100981707|FG002|NOT COMPLETED|Overall Study||3||
48392164|NCT04031404|101287811|FG001|COMPLETED|Second Drink Visit||5||
48392165|NCT04031404|101287810|FG000|NOT COMPLETED|Second Drink Visit||0||
48392166|NCT04031404|101287811|FG001|NOT COMPLETED|Second Drink Visit||0||
48392167|NCT01019252|101287812|FG000|STARTED|Initial CBT for ADHD vs. Wait List||24||
48268431|NCT01226732|100981708|FG003|NOT COMPLETED|Overall Study||5||
48268432|NCT01226732|100981709|FG004|NOT COMPLETED|Overall Study||3||
48268433|NCT01226732|100981710|FG005|NOT COMPLETED|Overall Study||6||
48268434|NCT01241604|100981711|FG000|STARTED|Screening Period||11||
48268435|NCT01241604|100981712|FG001|STARTED|Screening Period||0||
48268436|NCT01241604|100981713|FG002|STARTED|Screening Period||0||
48268437|NCT01241604|100981711|FG000|COMPLETED|Screening Period||8||
48268438|NCT01241604|100981712|FG001|COMPLETED|Screening Period||0||
48268439|NCT01241604|100981713|FG002|COMPLETED|Screening Period||0||
48268440|NCT01241604|100981711|FG000|NOT COMPLETED|Screening Period||3||
48268441|NCT01241604|100981712|FG001|NOT COMPLETED|Screening Period||0||
48268442|NCT01241604|100981713|FG002|NOT COMPLETED|Screening Period||0||
48268443|NCT01241604|100981711|FG000|STARTED|Study Period||0||
48268444|NCT01241604|100981712|FG001|STARTED|Study Period||5||
48268445|NCT01241604|100981713|FG002|STARTED|Study Period||3||
48268446|NCT01241604|100981711|FG000|COMPLETED|Study Period||0||
48392168|NCT01019252|101287813|FG001|STARTED|Initial CBT for ADHD vs. Wait List||22||
48392169|NCT01019252|101287812|FG000|COMPLETED|Initial CBT for ADHD vs. Wait List||21||
48392170|NCT01019252|101287813|FG001|COMPLETED|Initial CBT for ADHD vs. Wait List||22||
48392171|NCT01019252|101287812|FG000|NOT COMPLETED|Initial CBT for ADHD vs. Wait List||3||
48552283|NCT03536884|101683335|FG001|NOT COMPLETED|OLE Period: Wk48-Wk144||0||
48552284|NCT03536884|101683336|FG002|NOT COMPLETED|OLE Period: Wk48-Wk144||0||
48268447|NCT01241604|100981712|FG001|COMPLETED|Study Period||5||
48268448|NCT01241604|100981713|FG002|COMPLETED|Study Period||3||
48268449|NCT01241604|100981711|FG000|NOT COMPLETED|Study Period||0||
48268450|NCT01241604|100981712|FG001|NOT COMPLETED|Study Period||0||
48268451|NCT01241604|100981713|FG002|NOT COMPLETED|Study Period||0||
48268452|NCT00245960|100981714|FG000|STARTED|Period 1 (Double Blind): 1-12 Weeks||379||
48268453|NCT00245960|100981715|FG001|STARTED|Period 1 (Double Blind): 1-12 Weeks||373||
48268454|NCT00245960|100981714|FG000|COMPLETED|Period 1 (Double Blind): 1-12 Weeks||364||
48268455|NCT00245960|100981715|FG001|COMPLETED|Period 1 (Double Blind): 1-12 Weeks||362||
48268456|NCT00245960|100981714|FG000|NOT COMPLETED|Period 1 (Double Blind): 1-12 Weeks||15||
48268457|NCT00245960|100981715|FG001|NOT COMPLETED|Period 1 (Double Blind): 1-12 Weeks||11||
48268458|NCT00245960|100981714|FG000|STARTED|Period 2 (Open Label): 13-24 Weeks||364||
48268459|NCT00245960|100981715|FG001|STARTED|Period 2 (Open Label): 13-24 Weeks||362||
48268460|NCT00245960|100981714|FG000|COMPLETED|Period 2 (Open Label): 13-24 Weeks||350||
48268461|NCT00245960|100981715|FG001|COMPLETED|Period 2 (Open Label): 13-24 Weeks||344||
48268462|NCT00245960|100981714|FG000|NOT COMPLETED|Period 2 (Open Label): 13-24 Weeks||14||
48268463|NCT00245960|100981715|FG001|NOT COMPLETED|Period 2 (Open Label): 13-24 Weeks||18||
48268464|NCT00476242|100981716|FG000|STARTED|Overall Study||27||
48268465|NCT00476242|100981717|FG001|STARTED|Overall Study||28||
48268466|NCT00476242|100981716|FG000|COMPLETED|Overall Study||19||
48268467|NCT00476242|100981717|FG001|COMPLETED|Overall Study||12||
48268468|NCT00476242|100981716|FG000|NOT COMPLETED|Overall Study||8||
48268469|NCT00476242|100981717|FG001|NOT COMPLETED|Overall Study||16||
48268470|NCT02193490|100981718|FG000|STARTED|Overall Study||25||
48268471|NCT02193490|100981719|FG001|STARTED|Overall Study||22||
48268472|NCT02193490|100981718|FG000|COMPLETED|Overall Study||21||
48268473|NCT02193490|100981719|FG001|COMPLETED|Overall Study||20||
48392172|NCT01019252|101287813|FG001|NOT COMPLETED|Initial CBT for ADHD vs. Wait List||0||
48392173|NCT01019252|101287812|FG000|STARTED|Wait List Cross-over to CBT for ADHD||21||
48392174|NCT01019252|101287813|FG001|STARTED|Wait List Cross-over to CBT for ADHD||22||
48392175|NCT01019252|101287812|FG000|COMPLETED|Wait List Cross-over to CBT for ADHD||21||
48392176|NCT01019252|101287813|FG001|COMPLETED|Wait List Cross-over to CBT for ADHD||15||
48392177|NCT01019252|101287812|FG000|NOT COMPLETED|Wait List Cross-over to CBT for ADHD||0||
48392178|NCT01019252|101287813|FG001|NOT COMPLETED|Wait List Cross-over to CBT for ADHD||7||
48392179|NCT01359046|101287814|FG000|STARTED|Overall Study||144||
48392180|NCT01359046|101287815|FG001|STARTED|Overall Study||144||
48392181|NCT01359046|101287814|FG000|COMPLETED|Overall Study||137||
48392182|NCT01359046|101287815|FG001|COMPLETED|Overall Study||127||
48392183|NCT01359046|101287814|FG000|NOT COMPLETED|Overall Study||7||
48392184|NCT01359046|101287815|FG001|NOT COMPLETED|Overall Study||17||
48392185|NCT00547898|101287816|FG000|STARTED|Overall Study||138||
48392186|NCT00547898|101287817|FG001|STARTED|Overall Study||136||
48392187|NCT00547898|101287818|FG002|STARTED|Overall Study||54||
48392188|NCT00547898|101287819|FG003|STARTED|Overall Study||46||
48392189|NCT00547898|101287816|FG000|COMPLETED|Overall Study||129||
48392190|NCT00547898|101287817|FG001|COMPLETED|Overall Study||126||
48392191|NCT00547898|101287818|FG002|COMPLETED|Overall Study||54||
48392192|NCT00547898|101287819|FG003|COMPLETED|Overall Study||40||
48392193|NCT00547898|101287816|FG000|NOT COMPLETED|Overall Study||9||
48392194|NCT00547898|101287817|FG001|NOT COMPLETED|Overall Study||10||
48392195|NCT00547898|101287818|FG002|NOT COMPLETED|Overall Study||0||
48392196|NCT00547898|101287819|FG003|NOT COMPLETED|Overall Study||6||
48392197|NCT00168324|101287820|FG000|STARTED|Double-Blind Period||201||
48392198|NCT00168324|101287821|FG001|STARTED|Double-Blind Period||196||
48392199|NCT00168324|101287822|FG002|STARTED|Double-Blind Period||202||
48392200|NCT00168324|101287820|FG000|COMPLETED|Double-Blind Period||189||
48392201|NCT00168324|101287821|FG001|COMPLETED|Double-Blind Period||189||
48392202|NCT00168324|101287822|FG002|COMPLETED|Double-Blind Period||189||
48392203|NCT00168324|101287820|FG000|NOT COMPLETED|Double-Blind Period||12||
48392204|NCT00168324|101287821|FG001|NOT COMPLETED|Double-Blind Period||7||
48392205|NCT00168324|101287822|FG002|NOT COMPLETED|Double-Blind Period||13||
48392206|NCT00168324|101287820|FG000|STARTED|Open-Label Period||164||
48392207|NCT00168324|101287821|FG001|STARTED|Open-Label Period||155||
48392208|NCT00168324|101287822|FG002|STARTED|Open-Label Period||158||
48392209|NCT00168324|101287820|FG000|COMPLETED|Open-Label Period||160||
48392210|NCT00168324|101287821|FG001|COMPLETED|Open-Label Period||147||
48392211|NCT00168324|101287822|FG002|COMPLETED|Open-Label Period||152||
48392212|NCT00168324|101287820|FG000|NOT COMPLETED|Open-Label Period||4||
48392213|NCT00168324|101287821|FG001|NOT COMPLETED|Open-Label Period||8||
48392214|NCT00168324|101287822|FG002|NOT COMPLETED|Open-Label Period||6||
48392215|NCT04129086|101287823|FG000|STARTED|Overall Study||144||
48392216|NCT04129086|101287824|FG001|STARTED|Overall Study||156||
48392217|NCT04129086|101287823|FG000|COMPLETED|Overall Study||144||
48392218|NCT04129086|101287824|FG001|COMPLETED|Overall Study||156||
48392219|NCT04129086|101287823|FG000|NOT COMPLETED|Overall Study||0||
48392220|NCT04129086|101287824|FG001|NOT COMPLETED|Overall Study||0||
48392221|NCT00356057|101287825|FG000|STARTED|Overall Study||58||
48392222|NCT00356057|101287826|FG001|STARTED|Overall Study||61||
48268474|NCT02193490|100981718|FG000|NOT COMPLETED|Overall Study||4||
48268475|NCT02193490|100981719|FG001|NOT COMPLETED|Overall Study||2||
48268476|NCT01575873|100981720|FG000|STARTED|Overall Study||145||
48268477|NCT01575873|100981721|FG001|STARTED|Overall Study||145||
48392223|NCT00356057|101287827|FG002|STARTED|Overall Study||34||
48392224|NCT00356057|101287825|FG000|IMPLANTED|Overall Study||49||
48392225|NCT00356057|101287826|FG001|IMPLANTED|Overall Study||52||
48392226|NCT00356057|101287827|FG002|IMPLANTED|Overall Study||25||
48268478|NCT01575873|100981722|FG002|STARTED|Overall Study||252||
48268479|NCT01575873|100981723|FG003|STARTED|Overall Study||253||
48268480|NCT01575873|100981720|FG000|Received Study Drug|Overall Study||140||
48268481|NCT01575873|100981721|FG001|Received Study Drug|Overall Study||142||
48268482|NCT01575873|100981722|FG002|Received Study Drug|Overall Study||246||
48693033|NCT01681186|102032715|FG003|NOT COMPLETED|First Intervention||0||
48693034|NCT01681186|102032716|FG004|NOT COMPLETED|First Intervention||0||
48268483|NCT01575873|100981723|FG003|Received Study Drug|Overall Study||251||
48268484|NCT01575873|100981720|FG000|COMPLETED|Overall Study||117||
48392227|NCT00356057|101287825|FG000|COMPLETED|Overall Study||45||
48392228|NCT00356057|101287826|FG001|COMPLETED|Overall Study||47||
48392229|NCT00356057|101287827|FG002|COMPLETED|Overall Study||22||
48392230|NCT00356057|101287825|FG000|NOT COMPLETED|Overall Study||13||
48392231|NCT00356057|101287826|FG001|NOT COMPLETED|Overall Study||14||
48392232|NCT00356057|101287827|FG002|NOT COMPLETED|Overall Study||12||
48392233|NCT01833741|101287828|FG000|STARTED|Overall Study||1137||
48392234|NCT01833741|101287828|FG000|COMPLETED|Overall Study||997||
48392235|NCT01833741|101287828|FG000|NOT COMPLETED|Overall Study||140||
48268485|NCT01575873|100981721|FG001|COMPLETED|Overall Study||109||
48268486|NCT01575873|100981722|FG002|COMPLETED|Overall Study||178||
48268487|NCT01575873|100981723|FG003|COMPLETED|Overall Study||186||
48268488|NCT01575873|100981720|FG000|NOT COMPLETED|Overall Study||28||
48268489|NCT01575873|100981721|FG001|NOT COMPLETED|Overall Study||36||
48268490|NCT01575873|100981722|FG002|NOT COMPLETED|Overall Study||74||
48268491|NCT01575873|100981723|FG003|NOT COMPLETED|Overall Study||67||
48268492|NCT02896075|100981724|FG000|STARTED|Overall Study||40||
48268493|NCT02896075|100981724|FG000|Leg Soreness|Overall Study||40||
48268494|NCT02896075|100981724|FG000|COMPLETED|Overall Study||40||
48268495|NCT02896075|100981724|FG000|NOT COMPLETED|Overall Study||0||
48268496|NCT01882413|100981725|FG000|STARTED|Overall Study||204||
48268497|NCT01882413|100981725|FG000|COMPLETED|Overall Study||204||
48268498|NCT01882413|100981725|FG000|NOT COMPLETED|Overall Study||0||
48268499|NCT01762904|100981726|FG000|STARTED|Overall Study||135||
48268500|NCT01762904|100981726|FG000|COMPLETED|Overall Study||135||
48268501|NCT01762904|100981726|FG000|NOT COMPLETED|Overall Study||0||
48268502|NCT00364377|100981727|FG000|STARTED|Overall Study||11||
48268503|NCT00364377|100981728|FG001|STARTED|Overall Study||11||
48268504|NCT00364377|100981727|FG000|COMPLETED|Overall Study||11||
48268505|NCT00364377|100981728|FG001|COMPLETED|Overall Study||11||
48268506|NCT00364377|100981727|FG000|NOT COMPLETED|Overall Study||0||
48268507|NCT00364377|100981728|FG001|NOT COMPLETED|Overall Study||0||
48268508|NCT05071586|100981729|FG000|STARTED|Overall Study||10||
48268509|NCT05071586|100981729|FG000|COMPLETED|Overall Study||10||
48268510|NCT05071586|100981729|FG000|NOT COMPLETED|Overall Study||0||
48268511|NCT01931098|100981730|FG000|STARTED|Overall Study||9||
48268512|NCT01931098|100981731|FG001|STARTED|Overall Study||26||
48268513|NCT01931098|100981730|FG000|COMPLETED|Overall Study||9||
48268514|NCT01931098|100981731|FG001|COMPLETED|Overall Study||22||
48268515|NCT01931098|100981730|FG000|NOT COMPLETED|Overall Study||0||
48268516|NCT01931098|100981731|FG001|NOT COMPLETED|Overall Study||4||
48268517|NCT00148668|100981732|FG000|STARTED|Overall Study||41||
48268518|NCT00148668|100981733|FG001|STARTED|Overall Study||40||
48268519|NCT00148668|100981732|FG000|COMPLETED|Overall Study||41||
48268520|NCT00148668|100981733|FG001|COMPLETED|Overall Study||40||
48268521|NCT00148668|100981732|FG000|NOT COMPLETED|Overall Study||0||
48268522|NCT00148668|100981733|FG001|NOT COMPLETED|Overall Study||0||
48268523|NCT03321253|100981734|FG000|STARTED|Overall Study||38||
48268524|NCT03321253|100981734|FG000|COMPLETED|Overall Study||38||
48268525|NCT03321253|100981734|FG000|NOT COMPLETED|Overall Study||0||
48268526|NCT01162486|100981735|FG000|STARTED|Overall Study||8||
48268527|NCT01162486|100981736|FG001|STARTED|Overall Study||6||
48392236|NCT02031432|101287829|FG000|STARTED|Overall Study||76||
48392237|NCT02031432|101287829|FG000|Completing the Titration Phase|Overall Study||67||
48392238|NCT02031432|101287829|FG000|Completing the Treatment|Overall Study||39||
48268528|NCT01162486|100981737|FG002|STARTED|Overall Study||6||
48268529|NCT01162486|100981738|FG003|STARTED|Overall Study||7||
48268530|NCT01162486|100981739|FG004|STARTED|Overall Study||6||
48268531|NCT01162486|100981735|FG000|Took at Least One Dose Study Drug|Overall Study||8||
48268532|NCT01162486|100981736|FG001|Took at Least One Dose Study Drug|Overall Study||6||
48268533|NCT01162486|100981737|FG002|Took at Least One Dose Study Drug|Overall Study||6||
48268534|NCT01162486|100981738|FG003|Took at Least One Dose Study Drug|Overall Study||7||
48268535|NCT01162486|100981739|FG004|Took at Least One Dose Study Drug|Overall Study||6||
48268536|NCT01162486|100981735|FG000|COMPLETED|Overall Study||6||
48268537|NCT01162486|100981736|FG001|COMPLETED|Overall Study||6||
48268538|NCT01162486|100981737|FG002|COMPLETED|Overall Study||5||
48268539|NCT01162486|100981738|FG003|COMPLETED|Overall Study||6||
48268540|NCT01162486|100981739|FG004|COMPLETED|Overall Study||6||
48268541|NCT01162486|100981735|FG000|NOT COMPLETED|Overall Study||2||
48392239|NCT02031432|101287829|FG000|COMPLETED|Overall Study||38||
48392240|NCT02031432|101287829|FG000|NOT COMPLETED|Overall Study||38||
48268542|NCT01162486|100981736|FG001|NOT COMPLETED|Overall Study||0||
48268543|NCT01162486|100981737|FG002|NOT COMPLETED|Overall Study||1||
48693035|NCT01681186|102032717|FG005|NOT COMPLETED|First Intervention||0||
48693036|NCT01681186|102032718|FG006|NOT COMPLETED|First Intervention||0||
48693037|NCT01681186|102032719|FG007|NOT COMPLETED|First Intervention||0||
48693038|NCT01681186|102032712|FG000|STARTED|Washout Period From First Intervention||4||
48693039|NCT01681186|102032713|FG001|STARTED|Washout Period From First Intervention||2||
48693040|NCT01681186|102032714|FG002|STARTED|Washout Period From First Intervention||2||
48693041|NCT01681186|102032715|FG003|STARTED|Washout Period From First Intervention||3||
48693042|NCT01681186|102032716|FG004|STARTED|Washout Period From First Intervention||3||
48693043|NCT01681186|102032717|FG005|STARTED|Washout Period From First Intervention||2||
48693044|NCT01681186|102032718|FG006|STARTED|Washout Period From First Intervention||7||
48693045|NCT01681186|102032719|FG007|STARTED|Washout Period From First Intervention||7||
48693046|NCT01681186|102032712|FG000|COMPLETED|Washout Period From First Intervention||4||
48693047|NCT01681186|102032713|FG001|COMPLETED|Washout Period From First Intervention||2||
48693048|NCT01681186|102032714|FG002|COMPLETED|Washout Period From First Intervention||2||
48693049|NCT01681186|102032715|FG003|COMPLETED|Washout Period From First Intervention||3||
48693050|NCT01681186|102032716|FG004|COMPLETED|Washout Period From First Intervention||3||
48693051|NCT01681186|102032717|FG005|COMPLETED|Washout Period From First Intervention||2||
48693052|NCT01681186|102032718|FG006|COMPLETED|Washout Period From First Intervention||7||
48693053|NCT01681186|102032719|FG007|COMPLETED|Washout Period From First Intervention||7||
48693054|NCT01681186|102032712|FG000|NOT COMPLETED|Washout Period From First Intervention||0||
48693055|NCT01681186|102032713|FG001|NOT COMPLETED|Washout Period From First Intervention||0||
48693056|NCT01681186|102032714|FG002|NOT COMPLETED|Washout Period From First Intervention||0||
48693057|NCT01681186|102032715|FG003|NOT COMPLETED|Washout Period From First Intervention||0||
48693058|NCT01681186|102032716|FG004|NOT COMPLETED|Washout Period From First Intervention||0||
48693059|NCT01681186|102032717|FG005|NOT COMPLETED|Washout Period From First Intervention||0||
48693060|NCT01681186|102032718|FG006|NOT COMPLETED|Washout Period From First Intervention||0||
48693061|NCT01681186|102032719|FG007|NOT COMPLETED|Washout Period From First Intervention||0||
48693062|NCT01681186|102032712|FG000|STARTED|Second Intervention||4||
48693063|NCT01681186|102032713|FG001|STARTED|Second Intervention||2||
48693064|NCT01681186|102032714|FG002|STARTED|Second Intervention||2||
48693065|NCT01681186|102032715|FG003|STARTED|Second Intervention||3||
48693066|NCT01681186|102032716|FG004|STARTED|Second Intervention||3||
48268544|NCT01162486|100981738|FG003|NOT COMPLETED|Overall Study||1||
48268545|NCT01162486|100981739|FG004|NOT COMPLETED|Overall Study||0||
48268546|NCT00581477|100981740|FG000|STARTED|Overall Study||8|Enrolled|
48268547|NCT00581477|100981740|FG000|Dose Selection Trial With Droxidopa|Overall Study||6||
48268548|NCT00581477|100981740|FG000|Droxidopa 25 mg|Overall Study||6||
48268549|NCT00581477|100981740|FG000|Droxidopa 50 mg|Overall Study||6||
48268550|NCT00581477|100981740|FG000|Droxidopa 100 mg|Overall Study||6||
48268551|NCT00581477|100981740|FG000|Droxidopa 200 mg|Overall Study||6||
48268552|NCT00581477|100981740|FG000|Droxidopa 250 mg|Overall Study||6||
48693067|NCT01681186|102032717|FG005|STARTED|Second Intervention||2||
48693068|NCT01681186|102032718|FG006|STARTED|Second Intervention||7||
48693069|NCT01681186|102032719|FG007|STARTED|Second Intervention||7||
48693070|NCT01681186|102032712|FG000|COMPLETED|Second Intervention||4||
48693071|NCT01681186|102032713|FG001|COMPLETED|Second Intervention||2||
48693072|NCT01681186|102032714|FG002|COMPLETED|Second Intervention||2||
48693073|NCT01681186|102032715|FG003|COMPLETED|Second Intervention||3||
48268553|NCT00581477|100981740|FG000|Droxidopa 300 mg|Overall Study||6||
48268554|NCT00581477|100981740|FG000|COMPLETED|Overall Study||6||
48268555|NCT00581477|100981740|FG000|NOT COMPLETED|Overall Study||2||
48268556|NCT01367847|100981741|FG000|STARTED|Overall Study||10||
48268557|NCT01367847|100981742|FG001|STARTED|Overall Study||9||
48268558|NCT01367847|100981741|FG000|COMPLETED|Overall Study||8||
48268559|NCT01367847|100981742|FG001|COMPLETED|Overall Study||7||
48268560|NCT01367847|100981741|FG000|NOT COMPLETED|Overall Study||2||
48268561|NCT01367847|100981742|FG001|NOT COMPLETED|Overall Study||2||
48268562|NCT02142153|100981743|FG000|STARTED|Overall Study||6||
48268563|NCT02142153|100981744|FG001|STARTED|Overall Study||2||
48268564|NCT02142153|100981745|FG002|STARTED|Overall Study||6||
48268565|NCT02142153|100981746|FG003|STARTED|Overall Study||2||
48268566|NCT02142153|100981747|FG004|STARTED|Overall Study||6||
48268567|NCT02142153|100981748|FG005|STARTED|Overall Study||2||
48268568|NCT02142153|100981749|FG006|STARTED|Overall Study||6||
48268569|NCT02142153|100981750|FG007|STARTED|Overall Study||2||
48392241|NCT03819218|101287830|FG000|STARTED|Overall Study||7||
48392242|NCT03819218|101287830|FG000|COMPLETED|Overall Study||6||
48552285|NCT03536884|101683337|FG003|NOT COMPLETED|OLE Period: Wk48-Wk144||0||
48552286|NCT03536884|101683338|FG004|NOT COMPLETED|OLE Period: Wk48-Wk144||0||
48552287|NCT03536884|101683339|FG005|NOT COMPLETED|OLE Period: Wk48-Wk144||33||
48552288|NCT03536884|101683340|FG006|NOT COMPLETED|OLE Period: Wk48-Wk144||18||
48552289|NCT03536884|101683341|FG007|NOT COMPLETED|OLE Period: Wk48-Wk144||16||
48552290|NCT03536884|101683342|FG008|NOT COMPLETED|OLE Period: Wk48-Wk144||29||
48552291|NCT03536884|101683343|FG009|NOT COMPLETED|OLE Period: Wk48-Wk144||0||
48552292|NCT03536884|101683344|FG010|NOT COMPLETED|OLE Period: Wk48-Wk144||0||
48552293|NCT03536884|101683345|FG011|NOT COMPLETED|OLE Period: Wk48-Wk144||0||
48552294|NCT03536884|101683334|FG000|STARTED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48552295|NCT03536884|101683335|FG001|STARTED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48552296|NCT03536884|101683336|FG002|STARTED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48552297|NCT03536884|101683337|FG003|STARTED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48552298|NCT03536884|101683338|FG004|STARTED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48552299|NCT03536884|101683339|FG005|STARTED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48552300|NCT03536884|101683340|FG006|STARTED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48552301|NCT03536884|101683341|FG007|STARTED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48552302|NCT03536884|101683342|FG008|STARTED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48552303|NCT03536884|101683343|FG009|STARTED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||9||
48552304|NCT03536884|101683344|FG010|STARTED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||66||
48552305|NCT03536884|101683345|FG011|STARTED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||59||
48552306|NCT03536884|101683334|FG000|COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48552307|NCT03536884|101683335|FG001|COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48552308|NCT03536884|101683336|FG002|COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48552309|NCT03536884|101683337|FG003|COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48552310|NCT03536884|101683338|FG004|COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48552311|NCT03536884|101683339|FG005|COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48552312|NCT03536884|101683340|FG006|COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48552313|NCT03536884|101683341|FG007|COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48552314|NCT03536884|101683342|FG008|COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48552315|NCT03536884|101683343|FG009|COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||6||
48552316|NCT03536884|101683344|FG010|COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||61||
48552317|NCT03536884|101683345|FG011|COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||52||
48552318|NCT03536884|101683334|FG000|NOT COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48552319|NCT03536884|101683335|FG001|NOT COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48552320|NCT03536884|101683336|FG002|NOT COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48552321|NCT03536884|101683337|FG003|NOT COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48552322|NCT03536884|101683338|FG004|NOT COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48552323|NCT03536884|101683339|FG005|NOT COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48552324|NCT03536884|101683340|FG006|NOT COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48552325|NCT03536884|101683341|FG007|NOT COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48552326|NCT03536884|101683342|FG008|NOT COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||0||
48552327|NCT03536884|101683343|FG009|NOT COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||3||
48552328|NCT03536884|101683344|FG010|NOT COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||5||
48552329|NCT03536884|101683345|FG011|NOT COMPLETED|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48||7||
48552330|NCT04778475|101683346|FG000|STARTED|Overall Study||50||
48552331|NCT04778475|101683347|FG001|STARTED|Overall Study||50||
48552332|NCT04778475|101683346|FG000|COMPLETED|Overall Study||46||
48552333|NCT04778475|101683347|FG001|COMPLETED|Overall Study||50||
48552334|NCT04778475|101683346|FG000|NOT COMPLETED|Overall Study||4||
48552335|NCT04778475|101683347|FG001|NOT COMPLETED|Overall Study||0||
48552336|NCT03560128|101683348|FG000|STARTED|Overall Study||306||
48268570|NCT02142153|100981751|FG008|STARTED|Overall Study||6||
48268571|NCT02142153|100981752|FG009|STARTED|Overall Study||2||
48268572|NCT02142153|100981743|FG000|COMPLETED|Overall Study||6||
48268573|NCT02142153|100981744|FG001|COMPLETED|Overall Study||2||
48392243|NCT03819218|101287830|FG000|NOT COMPLETED|Overall Study||1||
48268574|NCT02142153|100981745|FG002|COMPLETED|Overall Study||6||
48268575|NCT02142153|100981746|FG003|COMPLETED|Overall Study||2||
48268576|NCT02142153|100981747|FG004|COMPLETED|Overall Study||6||
48268577|NCT02142153|100981748|FG005|COMPLETED|Overall Study||2||
48268578|NCT02142153|100981749|FG006|COMPLETED|Overall Study||6||
48268579|NCT02142153|100981750|FG007|COMPLETED|Overall Study||2||
48268580|NCT02142153|100981751|FG008|COMPLETED|Overall Study||6||
48268581|NCT02142153|100981752|FG009|COMPLETED|Overall Study||2||
48268582|NCT02142153|100981743|FG000|NOT COMPLETED|Overall Study||0||
48268583|NCT02142153|100981744|FG001|NOT COMPLETED|Overall Study||0||
48268584|NCT02142153|100981745|FG002|NOT COMPLETED|Overall Study||0||
48268585|NCT02142153|100981746|FG003|NOT COMPLETED|Overall Study||0||
48268586|NCT02142153|100981747|FG004|NOT COMPLETED|Overall Study||0||
48268587|NCT02142153|100981748|FG005|NOT COMPLETED|Overall Study||0||
48268588|NCT02142153|100981749|FG006|NOT COMPLETED|Overall Study||0||
48552337|NCT03560128|101683349|FG001|STARTED|Overall Study||306||
48552338|NCT03560128|101683348|FG000|COMPLETED|Overall Study||294||
48552339|NCT03560128|101683349|FG001|COMPLETED|Overall Study||298||
48552340|NCT03560128|101683348|FG000|NOT COMPLETED|Overall Study||12||
48552341|NCT03560128|101683349|FG001|NOT COMPLETED|Overall Study||8||
48552342|NCT02925403|101683350|FG000|STARTED|Overall Study||8||
48552343|NCT02925403|101683351|FG001|STARTED|Overall Study||5||
48552344|NCT02925403|101683350|FG000|COMPLETED|Overall Study||8||
48552345|NCT02925403|101683351|FG001|COMPLETED|Overall Study||4||
48552346|NCT02925403|101683350|FG000|NOT COMPLETED|Overall Study||0||
48552347|NCT02925403|101683351|FG001|NOT COMPLETED|Overall Study||1||
48552348|NCT03295630|101686710|FG000|STARTED|Overall Study||20||
48552349|NCT03295630|101686710|FG000|COMPLETED|Overall Study||20||
48552350|NCT03295630|101686710|FG000|NOT COMPLETED|Overall Study||0||
48552351|NCT04442464|101686711|FG000|STARTED|Overall Study||1||1
48552352|NCT04442464|101686712|FG001|STARTED|Overall Study||1||1
48552353|NCT04442464|101686711|FG000|COMPLETED|Overall Study||1||1
48552354|NCT04442464|101686712|FG001|COMPLETED|Overall Study||1||1
48552355|NCT04442464|101686711|FG000|NOT COMPLETED|Overall Study||0||0
48552356|NCT04442464|101686712|FG001|NOT COMPLETED|Overall Study||0||0
48552357|NCT04912232|101686713|FG000|STARTED|Overall Study||1||
48552358|NCT04912232|101686713|FG000|COMPLETED|Overall Study||1||
48552359|NCT04912232|101686713|FG000|NOT COMPLETED|Overall Study||0||
48552360|NCT03100123|101686714|FG000|STARTED|Overall Study||0||
48552361|NCT03100123|101686715|FG001|STARTED|Overall Study||1||
48552362|NCT03100123|101686714|FG000|COMPLETED|Overall Study||0||
48552363|NCT03100123|101686715|FG001|COMPLETED|Overall Study||1||
48552364|NCT03100123|101686714|FG000|NOT COMPLETED|Overall Study||0||
48552365|NCT03100123|101686715|FG001|NOT COMPLETED|Overall Study||0||
48552366|NCT00743717|101686716|FG000|STARTED|Overall Study||2||
48552367|NCT00743717|101686717|FG001|STARTED|Overall Study||2||
48552368|NCT00743717|101686716|FG000|COMPLETED|Overall Study||2||
48552369|NCT00743717|101686717|FG001|COMPLETED|Overall Study||2||
48552370|NCT00743717|101686716|FG000|NOT COMPLETED|Overall Study||0||
48552371|NCT00743717|101686717|FG001|NOT COMPLETED|Overall Study||0||
48552372|NCT01651078|101686718|FG000|STARTED|Overall Study||42||
48552373|NCT01651078|101686718|FG000|COMPLETED|Overall Study||16||
48268589|NCT02142153|100981750|FG007|NOT COMPLETED|Overall Study||0||
48268590|NCT02142153|100981751|FG008|NOT COMPLETED|Overall Study||0||
48268591|NCT02142153|100981752|FG009|NOT COMPLETED|Overall Study||0||
48268592|NCT04276051|100981753|FG000|STARTED|Overall Study||2||
48268593|NCT04276051|100981754|FG001|STARTED|Overall Study||3||
48268594|NCT04276051|100981753|FG000|COMPLETED|Overall Study||1||
48268595|NCT04276051|100981754|FG001|COMPLETED|Overall Study||0||
48268596|NCT04276051|100981753|FG000|NOT COMPLETED|Overall Study||1||
48268597|NCT04276051|100981754|FG001|NOT COMPLETED|Overall Study||3||
48268598|NCT02808975|100981755|FG000|STARTED|Overall Study||103||
48268599|NCT02808975|100981756|FG001|STARTED|Overall Study||103||
48268600|NCT02808975|100981755|FG000|COMPLETED|Overall Study||81||
48268601|NCT02808975|100981756|FG001|COMPLETED|Overall Study||84||
48268602|NCT02808975|100981755|FG000|NOT COMPLETED|Overall Study||22||
48268603|NCT02808975|100981756|FG001|NOT COMPLETED|Overall Study||19||
48268604|NCT00719329|100981757|FG000|STARTED|Overall Study||705||
48268605|NCT00719329|100981758|FG001|STARTED|Overall Study||571||
48552374|NCT01651078|101686718|FG000|NOT COMPLETED|Overall Study||26||
48552375|NCT00307086|101686719|FG000|STARTED|Overall Study||30||
48552376|NCT00307086|101686719|FG000|COMPLETED|Overall Study||25||
48552377|NCT00307086|101686719|FG000|NOT COMPLETED|Overall Study||5||
48552378|NCT01221207|101686720|FG000|STARTED|Overall Study||75||
48552379|NCT01221207|101686721|FG001|STARTED|Overall Study||75||
48268606|NCT00719329|100981759|FG002|STARTED|Overall Study||647||
48268607|NCT00719329|100981757|FG000|Day 1 Swab|Overall Study||705||
48552380|NCT01221207|101686722|FG002|STARTED|Overall Study||75||
48552381|NCT01221207|101686720|FG000|COMPLETED|Overall Study||43||
48552382|NCT01221207|101686721|FG001|COMPLETED|Overall Study||66||
48268608|NCT00719329|100981758|FG001|Day 1 Swab|Overall Study||569||
48268609|NCT00719329|100981759|FG002|Day 1 Swab|Overall Study||646||
48268610|NCT00719329|100981757|FG000|Day 3 Swab|Overall Study||614||
48268611|NCT00719329|100981758|FG001|Day 3 Swab|Overall Study||501||
48268612|NCT00719329|100981759|FG002|Day 3 Swab|Overall Study||578||
48268613|NCT00719329|100981757|FG000|Day 7 Swab|Overall Study||593||
48552383|NCT01221207|101686722|FG002|COMPLETED|Overall Study||54||
48552384|NCT01221207|101686720|FG000|NOT COMPLETED|Overall Study||32||
48552385|NCT01221207|101686721|FG001|NOT COMPLETED|Overall Study||9||
48552386|NCT01221207|101686722|FG002|NOT COMPLETED|Overall Study||21||
48552387|NCT02501928|101686723|FG000|STARTED|Overall Study||0||
48552388|NCT02501928|101686724|FG001|STARTED|Overall Study||2||
48552389|NCT02501928|101686725|FG002|STARTED|Overall Study||0||
48552390|NCT02501928|101686726|FG003|STARTED|Overall Study||0||
48552391|NCT02501928|101686727|FG004|STARTED|Overall Study||7||
48552392|NCT02501928|101686728|FG005|STARTED|Overall Study||3||
48552393|NCT02501928|101686723|FG000|COMPLETED|Overall Study||0||
48552394|NCT02501928|101686724|FG001|COMPLETED|Overall Study||2||
48552395|NCT02501928|101686725|FG002|COMPLETED|Overall Study||0||
48552396|NCT02501928|101686726|FG003|COMPLETED|Overall Study||0||
48552397|NCT02501928|101686727|FG004|COMPLETED|Overall Study||6||
48552398|NCT02501928|101686728|FG005|COMPLETED|Overall Study||3||
48552399|NCT02501928|101686723|FG000|NOT COMPLETED|Overall Study||0||
48552400|NCT02501928|101686724|FG001|NOT COMPLETED|Overall Study||0||
48552401|NCT02501928|101686725|FG002|NOT COMPLETED|Overall Study||0||
48552402|NCT02501928|101686726|FG003|NOT COMPLETED|Overall Study||0||
48552403|NCT02501928|101686727|FG004|NOT COMPLETED|Overall Study||1||
48552404|NCT02501928|101686728|FG005|NOT COMPLETED|Overall Study||0||
48552405|NCT00934024|101686729|FG000|STARTED|Overall Study||10||
48552406|NCT00934024|101686730|FG001|STARTED|Overall Study||11||
48552407|NCT00934024|101686729|FG000|COMPLETED|Overall Study||10||
48552408|NCT00934024|101686730|FG001|COMPLETED|Overall Study||6||
48552409|NCT00934024|101686729|FG000|NOT COMPLETED|Overall Study||0||
48552410|NCT00934024|101686730|FG001|NOT COMPLETED|Overall Study||5||
48552411|NCT03296527|101686731|FG000|STARTED|Overall Study||500|Randomized (2 randomized participants were not exposed to the IMP)|
48552412|NCT03296527|101686732|FG001|STARTED|Overall Study||511|Randomized (2 randomized participants were not exposed to the IMP)|
48552413|NCT03296527|101686731|FG000|Full Analysis Set|Overall Study||499||
48552414|NCT03296527|101686732|FG001|Full Analysis Set|Overall Study||510||
48552415|NCT03296527|101686731|FG000|COMPLETED|Overall Study||465||
48552416|NCT03296527|101686732|FG001|COMPLETED|Overall Study||458||
48552417|NCT03296527|101686731|FG000|NOT COMPLETED|Overall Study||35||
48552418|NCT03296527|101686732|FG001|NOT COMPLETED|Overall Study||53||
48552419|NCT03971474|101686733|FG000|STARTED|Overall Study||67||
48552420|NCT03971474|101686734|FG001|STARTED|Overall Study||69||
48552421|NCT03971474|101686733|FG000|COMPLETED|Overall Study||0||
48552422|NCT03971474|101686734|FG001|COMPLETED|Overall Study||0||
48552423|NCT03971474|101686733|FG000|NOT COMPLETED|Overall Study||67||
48552424|NCT03971474|101686734|FG001|NOT COMPLETED|Overall Study||69||
48552425|NCT04320823|101686735|FG000|STARTED|Overall Study||1717||
48552426|NCT04320823|101686736|FG001|STARTED|Overall Study||1726||
48552427|NCT04320823|101686735|FG000|COMPLETED|Overall Study||1717||
48552428|NCT04320823|101686736|FG001|COMPLETED|Overall Study||1726||
48552429|NCT04320823|101686735|FG000|NOT COMPLETED|Overall Study||0||
48552430|NCT04320823|101686736|FG001|NOT COMPLETED|Overall Study||0||
48552431|NCT01917214|101686737|FG000|STARTED|Overall Study||212||
48552432|NCT01917214|101686737|FG000|COMPLETED|Overall Study||212||
48107535|NCT02155738|100590561|FG000|NOT COMPLETED|Overall Study||1||
48552433|NCT01917214|101686737|FG000|NOT COMPLETED|Overall Study||0||
48552434|NCT01937871|101686738|FG000|STARTED|Overall Study||361||
48552435|NCT01937871|101686739|FG001|STARTED|Overall Study||363||
48552436|NCT01937871|101686740|FG002|STARTED|Overall Study||185||
48552437|NCT01937871|101686738|FG000|Received at Least One Dose of Study Drug|Overall Study||361||
48552438|NCT01937871|101686739|FG001|Received at Least One Dose of Study Drug|Overall Study||362||
48552439|NCT01937871|101686740|FG002|Received at Least One Dose of Study Drug|Overall Study||185||
48552440|NCT01937871|101686738|FG000|COMPLETED|Overall Study||337||
48552441|NCT01937871|101686739|FG001|COMPLETED|Overall Study||346||
48552442|NCT01937871|101686740|FG002|COMPLETED|Overall Study||174||
48552443|NCT01937871|101686738|FG000|NOT COMPLETED|Overall Study||24||
48552444|NCT01937871|101686739|FG001|NOT COMPLETED|Overall Study||17||
48552445|NCT01937871|101686740|FG002|NOT COMPLETED|Overall Study||11||
48552446|NCT02574832|101686741|FG000|STARTED|Overall Study||2||
48552447|NCT02574832|101686741|FG000|COMPLETED|Overall Study||2||
48552448|NCT02574832|101686741|FG000|NOT COMPLETED|Overall Study||0||
48552449|NCT03901092|101686742|FG000|STARTED|Overall Study||83||
48552450|NCT03901092|101686743|FG001|STARTED|Overall Study||159||
48552451|NCT03901092|101686742|FG000|COMPLETED|Overall Study||83||
48552452|NCT03901092|101686743|FG001|COMPLETED|Overall Study||159||
48552453|NCT03901092|101686742|FG000|NOT COMPLETED|Overall Study||0||
48552454|NCT03901092|101686743|FG001|NOT COMPLETED|Overall Study||0||
48552455|NCT00247676|101686744|FG000|STARTED|Overall Study||37||
48552456|NCT00247676|101686744|FG000|COMPLETED|Overall Study||1||
48552457|NCT00247676|101686744|FG000|NOT COMPLETED|Overall Study||36||
48552458|NCT03366207|101686745|FG000|STARTED|Overall Study||250||
48552459|NCT03366207|101686745|FG000|COMPLETED|Overall Study||242||
48552460|NCT03366207|101686745|FG000|NOT COMPLETED|Overall Study||8||
48552461|NCT04552795|101686746|FG000|STARTED|Overall Study||12||
48552462|NCT04552795|101686746|FG000|COMPLETED|Overall Study||12||
48552463|NCT04552795|101686746|FG000|NOT COMPLETED|Overall Study||0||
48552464|NCT00580502|101686747|FG000|STARTED|Overall Study||50||
48552465|NCT00580502|101686747|FG000|COMPLETED|Overall Study||50||
48552466|NCT00580502|101686747|FG000|NOT COMPLETED|Overall Study||0||
48552467|NCT00261443|101686748|FG000|STARTED|1: Confirmation of Partial Nonresponse||1270||
48552468|NCT00261443|101686749|FG001|STARTED|1: Confirmation of Partial Nonresponse||0||
48552469|NCT00261443|101686750|FG002|STARTED|1: Confirmation of Partial Nonresponse||0||
48552470|NCT00261443|101686748|FG000|COMPLETED|1: Confirmation of Partial Nonresponse||686||
48552471|NCT00261443|101686749|FG001|COMPLETED|1: Confirmation of Partial Nonresponse||0||
48552472|NCT00261443|101686750|FG002|COMPLETED|1: Confirmation of Partial Nonresponse||0||
48552473|NCT00261443|101686748|FG000|NOT COMPLETED|1: Confirmation of Partial Nonresponse||584||
48552474|NCT00261443|101686749|FG001|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0||
48552475|NCT00261443|101686750|FG002|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0||
48552476|NCT00261443|101686748|FG000|STARTED|2: Stability & Maintenance of Stability||686||
48107536|NCT02155738|100590562|FG001|NOT COMPLETED|Overall Study||0||
48107537|NCT02155738|100590563|FG002|NOT COMPLETED|Overall Study||0||
48107538|NCT02155738|100590564|FG003|NOT COMPLETED|Overall Study||1||
48107539|NCT05124665|100590565|FG000|STARTED|Overall Study||364|Index participants randomized that agreed to participate in the study and then the household contacts that agreed to participate.|
48107540|NCT05124665|100590566|FG001|STARTED|Overall Study||248|Index participants randomized that agreed to participate in the study and then the household contacts that agreed to participate.|
48107541|NCT05124665|100590565|FG000|Index Patients|Overall Study||79||
48107542|NCT05124665|100590566|FG001|Index Patients|Overall Study||61||
48107543|NCT05124665|100590565|FG000|Household Contacts|Overall Study||285||
48107544|NCT05124665|100590566|FG001|Household Contacts|Overall Study||187||
48107545|NCT05124665|100590565|FG000|COMPLETED|Overall Study||364||
48107546|NCT05124665|100590566|FG001|COMPLETED|Overall Study||248||
48107547|NCT05124665|100590565|FG000|NOT COMPLETED|Overall Study||0||
48107548|NCT05124665|100590566|FG001|NOT COMPLETED|Overall Study||0||
48107549|NCT03523117|100590567|FG000|STARTED|Overall Study||40||
48107550|NCT03523117|100590568|FG001|STARTED|Overall Study||39||
48107551|NCT03523117|100590567|FG000|COMPLETED|Overall Study||39||
48107552|NCT03523117|100590568|FG001|COMPLETED|Overall Study||37||
48107553|NCT03523117|100590567|FG000|NOT COMPLETED|Overall Study||1||
48107554|NCT03523117|100590568|FG001|NOT COMPLETED|Overall Study||2||
48107555|NCT03999411|100590569|FG000|STARTED|Overall Study||13||
48552477|NCT00261443|101686749|FG001|STARTED|2: Stability & Maintenance of Stability||0||
48552478|NCT00261443|101686750|FG002|STARTED|2: Stability & Maintenance of Stability||0||
48552479|NCT00261443|101686748|FG000|COMPLETED|2: Stability & Maintenance of Stability||346||
48552480|NCT00261443|101686749|FG001|COMPLETED|2: Stability & Maintenance of Stability||0||
48552481|NCT00261443|101686750|FG002|COMPLETED|2: Stability & Maintenance of Stability||0||
48552482|NCT00261443|101686748|FG000|NOT COMPLETED|2: Stability & Maintenance of Stability||340||
48552483|NCT00261443|101686749|FG001|NOT COMPLETED|2: Stability & Maintenance of Stability||0||
48552484|NCT00261443|101686750|FG002|NOT COMPLETED|2: Stability & Maintenance of Stability||0||
48552485|NCT00261443|101686748|FG000|STARTED|3: Assessment of Relapse||0||
48552486|NCT00261443|101686749|FG001|STARTED|3: Assessment of Relapse||169||
48552487|NCT00261443|101686750|FG002|STARTED|3: Assessment of Relapse||168||
48552488|NCT00261443|101686748|FG000|COMPLETED|3: Assessment of Relapse||0||
48552489|NCT00261443|101686749|FG001|COMPLETED|3: Assessment of Relapse||89||
48552490|NCT00261443|101686750|FG002|COMPLETED|3: Assessment of Relapse||103||
48552491|NCT00261443|101686748|FG000|NOT COMPLETED|3: Assessment of Relapse||0||
48552492|NCT00261443|101686749|FG001|NOT COMPLETED|3: Assessment of Relapse||80||
48552493|NCT00261443|101686750|FG002|NOT COMPLETED|3: Assessment of Relapse||65||
48107556|NCT03999411|100590570|FG001|STARTED|Overall Study||13||
48107557|NCT03999411|100590571|FG002|STARTED|Overall Study||13||
48552494|NCT00261443|101686748|FG000|STARTED|4: Extension Phase||0||
48107558|NCT03999411|100590569|FG000|COMPLETED|Overall Study||12||
48107559|NCT03999411|100590570|FG001|COMPLETED|Overall Study||11||
48107560|NCT03999411|100590571|FG002|COMPLETED|Overall Study||13||
48107561|NCT03999411|100590569|FG000|NOT COMPLETED|Overall Study||1||
48107562|NCT03999411|100590570|FG001|NOT COMPLETED|Overall Study||2||
48107563|NCT03999411|100590571|FG002|NOT COMPLETED|Overall Study||0||
48552495|NCT00261443|101686749|FG001|STARTED|4: Extension Phase||19||
48552496|NCT00261443|101686750|FG002|STARTED|4: Extension Phase||23||
48552497|NCT00261443|101686748|FG000|COMPLETED|4: Extension Phase||0||
48552498|NCT00261443|101686749|FG001|COMPLETED|4: Extension Phase||16||
48107564|NCT00006916|100590572|FG000|STARTED|Overall Study||19||
48107565|NCT00006916|100590572|FG000|COMPLETED|Overall Study||14||
48107566|NCT00006916|100590572|FG000|NOT COMPLETED|Overall Study||5||
48107567|NCT02353247|100590573|FG000|STARTED|Overall Study||30||
48107568|NCT02353247|100590574|FG001|STARTED|Overall Study||23||
48107569|NCT02353247|100590575|FG002|STARTED|Overall Study||35||
48107570|NCT02353247|100590573|FG000|COMPLETED|Overall Study||21||
48107571|NCT02353247|100590574|FG001|COMPLETED|Overall Study||18||
48107572|NCT02353247|100590575|FG002|COMPLETED|Overall Study||0||
48107573|NCT02353247|100590573|FG000|NOT COMPLETED|Overall Study||9||
48107574|NCT02353247|100590574|FG001|NOT COMPLETED|Overall Study||5||
48107575|NCT02353247|100590575|FG002|NOT COMPLETED|Overall Study||35||
48107576|NCT01709695|100590576|FG000|STARTED|Overall Study||13||
48107577|NCT01709695|100590577|FG001|STARTED|Overall Study||14||
48107578|NCT01709695|100590576|FG000|COMPLETED|Overall Study||12||
48107579|NCT01709695|100590577|FG001|COMPLETED|Overall Study||13||
48107580|NCT01709695|100590576|FG000|NOT COMPLETED|Overall Study||1||
48268614|NCT00719329|100981758|FG001|Day 7 Swab|Overall Study||467||
48392244|NCT00830960|101287831|FG000|STARTED|Overall Study||124||
48392245|NCT00830960|101287832|FG001|STARTED|Overall Study||124||
48392246|NCT00830960|101287833|FG002|STARTED|Overall Study||137||
48392247|NCT00830960|101287834|FG003|STARTED|Overall Study||138||
48392248|NCT00830960|101287835|FG004|STARTED|Overall Study||96||
48392249|NCT00830960|101287836|FG005|STARTED|Overall Study||100||
48107581|NCT01709695|100590577|FG001|NOT COMPLETED|Overall Study||1||
48107582|NCT01869192|100590578|FG000|STARTED|Preoperative Chemotherapy to Surgery||37||
48107583|NCT01869192|100590579|FG001|STARTED|Preoperative Chemotherapy to Surgery||35||
48107584|NCT01869192|100590578|FG000|COMPLETED|Preoperative Chemotherapy to Surgery||35|2 did not go to surgery|
48107585|NCT01869192|100590579|FG001|COMPLETED|Preoperative Chemotherapy to Surgery||34|2 did not go to surgery|
48107586|NCT01869192|100590578|FG000|NOT COMPLETED|Preoperative Chemotherapy to Surgery||2||
48107587|NCT01869192|100590579|FG001|NOT COMPLETED|Preoperative Chemotherapy to Surgery||1||
48107588|NCT01869192|100590578|FG000|STARTED|Postoperative Chemotherapy||32||
48107589|NCT01869192|100590579|FG001|STARTED|Postoperative Chemotherapy||33||
48107590|NCT01869192|100590578|FG000|COMPLETED|Postoperative Chemotherapy||32||
48107591|NCT01869192|100590579|FG001|COMPLETED|Postoperative Chemotherapy||31||
48107592|NCT01869192|100590578|FG000|NOT COMPLETED|Postoperative Chemotherapy||0||
48107593|NCT01869192|100590579|FG001|NOT COMPLETED|Postoperative Chemotherapy||2||
48107594|NCT02469116|100590580|FG000|STARTED|Overall Study||18||
48107595|NCT02469116|100590580|FG000|COMPLETED|Overall Study||18||
48107596|NCT02469116|100590580|FG000|NOT COMPLETED|Overall Study||0||
48107597|NCT03848845|100590581|FG000|STARTED|Main Study Phase (Day 1 to Week 178)||6||
48107598|NCT03848845|100590582|FG001|STARTED|Main Study Phase (Day 1 to Week 178)||7||
48107599|NCT03848845|100590583|FG002|STARTED|Main Study Phase (Day 1 to Week 178)||28||
48107600|NCT03848845|100590584|FG003|STARTED|Main Study Phase (Day 1 to Week 178)||0||
48107601|NCT03848845|100590581|FG000|COMPLETED|Main Study Phase (Day 1 to Week 178)||3|Participants who completed follow-up or who died were considered to have completed the study.|
48107602|NCT03848845|100590582|FG001|COMPLETED|Main Study Phase (Day 1 to Week 178)||4|Participants who completed follow-up or who died were considered to have completed the study.|
48107603|NCT03848845|100590583|FG002|COMPLETED|Main Study Phase (Day 1 to Week 178)||19|Participants who completed follow-up or who died were considered to have completed the study.|
48107604|NCT03848845|100590584|FG003|COMPLETED|Main Study Phase (Day 1 to Week 178)||0|Participants who completed follow-up or who died were considered to have completed the study.|
48107605|NCT03848845|100590581|FG000|NOT COMPLETED|Main Study Phase (Day 1 to Week 178)||3||
48107606|NCT03848845|100590582|FG001|NOT COMPLETED|Main Study Phase (Day 1 to Week 178)||3||
48107607|NCT03848845|100590583|FG002|NOT COMPLETED|Main Study Phase (Day 1 to Week 178)||9||
48107608|NCT03848845|100590584|FG003|NOT COMPLETED|Main Study Phase (Day 1 to Week 178)||0||
48107609|NCT03848845|100590581|FG000|STARTED|PACT Phase (Week 178 to Week 221)||0||
48107610|NCT03848845|100590582|FG001|STARTED|PACT Phase (Week 178 to Week 221)||0||
48107611|NCT03848845|100590583|FG002|STARTED|PACT Phase (Week 178 to Week 221)||0||
48107612|NCT03848845|100590584|FG003|STARTED|PACT Phase (Week 178 to Week 221)||2||
48107613|NCT03848845|100590581|FG000|COMPLETED|PACT Phase (Week 178 to Week 221)||0||
48107614|NCT03848845|100590582|FG001|COMPLETED|PACT Phase (Week 178 to Week 221)||0||
48107615|NCT03848845|100590583|FG002|COMPLETED|PACT Phase (Week 178 to Week 221)||0||
48107616|NCT03848845|100590584|FG003|COMPLETED|PACT Phase (Week 178 to Week 221)||1||
48107617|NCT03848845|100590581|FG000|NOT COMPLETED|PACT Phase (Week 178 to Week 221)||0||
48107618|NCT03848845|100590582|FG001|NOT COMPLETED|PACT Phase (Week 178 to Week 221)||0||
48107619|NCT03848845|100590583|FG002|NOT COMPLETED|PACT Phase (Week 178 to Week 221)||0||
48107620|NCT03848845|100590584|FG003|NOT COMPLETED|PACT Phase (Week 178 to Week 221)||1||
48107621|NCT01831232|100590585|FG000|STARTED|Overall Study||24||
48107622|NCT01831232|100590585|FG000|COMPLETED|Overall Study||24||
48107623|NCT01831232|100590585|FG000|NOT COMPLETED|Overall Study||0||
48107624|NCT05402995|100590586|FG000|STARTED|Overall Study||0||
48107625|NCT05402995|100590587|FG001|STARTED|Overall Study||2||
48107626|NCT05402995|100590588|FG002|STARTED|Overall Study||2||
48107627|NCT05402995|100590589|FG003|STARTED|Overall Study||2||
48107628|NCT05402995|100590586|FG000|COMPLETED|Overall Study||0||
48392250|NCT00830960|101287831|FG000|Received at Least 1 Dose of Study Drug|Overall Study||117||
48107629|NCT05402995|100590587|FG001|COMPLETED|Overall Study||0||
48107630|NCT05402995|100590588|FG002|COMPLETED|Overall Study||0||
48268615|NCT00719329|100981759|FG002|Day 7 Swab|Overall Study||561||
48552499|NCT00261443|101686750|FG002|COMPLETED|4: Extension Phase||21||
48107631|NCT05402995|100590589|FG003|COMPLETED|Overall Study||0||
48107632|NCT05402995|100590586|FG000|NOT COMPLETED|Overall Study||0||
48107633|NCT05402995|100590587|FG001|NOT COMPLETED|Overall Study||2||
48107634|NCT05402995|100590588|FG002|NOT COMPLETED|Overall Study||2||
48107635|NCT05402995|100590589|FG003|NOT COMPLETED|Overall Study||2||
48107636|NCT01876485|100590590|FG000|STARTED|Overall Study||140||
48107637|NCT01876485|100590591|FG001|STARTED|Overall Study||140||
48107638|NCT01876485|100590590|FG000|Post-Intervention|Overall Study||125|4 months after baseline|
48107639|NCT01876485|100590591|FG001|Post-Intervention|Overall Study||129|4 months after baseline|
48107640|NCT01876485|100590590|FG000|Maintenance|Overall Study||116|10 months after baseline|
48107641|NCT01876485|100590591|FG001|Maintenance|Overall Study||114|10 months after baseline|
48107642|NCT01876485|100590590|FG000|COMPLETED|Overall Study||116||
48107643|NCT01876485|100590591|FG001|COMPLETED|Overall Study||114||
48107644|NCT01876485|100590590|FG000|NOT COMPLETED|Overall Study||24||
48107645|NCT01876485|100590591|FG001|NOT COMPLETED|Overall Study||26||
48107646|NCT02835274|100590592|FG000|STARTED|Overall Study||6||
48107647|NCT02835274|100590593|FG001|STARTED|Overall Study||6||
48107648|NCT02835274|100590592|FG000|COMPLETED|Overall Study||6||
48107649|NCT02835274|100590593|FG001|COMPLETED|Overall Study||6||
48107650|NCT02835274|100590592|FG000|NOT COMPLETED|Overall Study||0||
48107651|NCT02835274|100590593|FG001|NOT COMPLETED|Overall Study||0||
48107652|NCT00112242|100590594|FG000|STARTED|Overall Study||10||
48107653|NCT00112242|100590595|FG001|STARTED|Overall Study||5||
48107654|NCT00112242|100590596|FG002|STARTED|Overall Study||5||
48107655|NCT00112242|100590597|FG003|STARTED|Overall Study||10||
48107656|NCT00112242|100590598|FG004|STARTED|Overall Study||9||
48107657|NCT00112242|100590594|FG000|Cycle 1 Completed|Overall Study||10||
48107658|NCT00112242|100590595|FG001|Cycle 1 Completed|Overall Study||5||
48107659|NCT00112242|100590596|FG002|Cycle 1 Completed|Overall Study||5||
48107660|NCT00112242|100590597|FG003|Cycle 1 Completed|Overall Study||9||
48107661|NCT00112242|100590598|FG004|Cycle 1 Completed|Overall Study||7||
48107662|NCT00112242|100590594|FG000|Cycle 2 Completed|Overall Study||8||
48107663|NCT00112242|100590595|FG001|Cycle 2 Completed|Overall Study||3||
48107664|NCT00112242|100590596|FG002|Cycle 2 Completed|Overall Study||4||
48107665|NCT00112242|100590597|FG003|Cycle 2 Completed|Overall Study||8||
48107666|NCT00112242|100590598|FG004|Cycle 2 Completed|Overall Study||4||
48107667|NCT00112242|100590594|FG000|Cycle 3 Completed|Overall Study||5||
48107668|NCT00112242|100590595|FG001|Cycle 3 Completed|Overall Study||3||
48107669|NCT00112242|100590596|FG002|Cycle 3 Completed|Overall Study||4||
48107670|NCT00112242|100590597|FG003|Cycle 3 Completed|Overall Study||4||
48107671|NCT00112242|100590598|FG004|Cycle 3 Completed|Overall Study||2||
48107672|NCT00112242|100590594|FG000|COMPLETED|Overall Study||5|Received 3 cycles of treatment|
48107673|NCT00112242|100590595|FG001|COMPLETED|Overall Study||3|Received 3 cycles of treatment|
48107674|NCT00112242|100590596|FG002|COMPLETED|Overall Study||4|Received 3 cycles of treatment|
48107675|NCT00112242|100590597|FG003|COMPLETED|Overall Study||4|Received 3 cycles of treatment|
48107676|NCT00112242|100590598|FG004|COMPLETED|Overall Study||2|Received 3 cycles of treatment|
48107677|NCT00112242|100590594|FG000|NOT COMPLETED|Overall Study||5||
48107678|NCT00112242|100590595|FG001|NOT COMPLETED|Overall Study||2||
48107679|NCT00112242|100590596|FG002|NOT COMPLETED|Overall Study||1||
48107680|NCT00112242|100590597|FG003|NOT COMPLETED|Overall Study||6||
48107681|NCT00112242|100590598|FG004|NOT COMPLETED|Overall Study||7||
48107682|NCT00578942|100590599|FG000|STARTED|Overall Study||48||
48107683|NCT00578942|100590599|FG000|COMPLETED|Overall Study||47||
48107684|NCT00578942|100590599|FG000|NOT COMPLETED|Overall Study||1||
48107685|NCT04862156|100590600|FG000|STARTED|Overall Study||19||
48107686|NCT04862156|100590600|FG000|COMPLETED|Overall Study||14||
48107687|NCT04862156|100590600|FG000|NOT COMPLETED|Overall Study||5||
48107688|NCT02658890|100590601|FG000|STARTED|Pre-Treatment Phase||7||
48107689|NCT02658890|100590602|FG001|STARTED|Pre-Treatment Phase||11||
48107690|NCT02658890|100590603|FG002|STARTED|Pre-Treatment Phase||12||
48107691|NCT02658890|100590604|FG003|STARTED|Pre-Treatment Phase||18||
48268616|NCT00719329|100981757|FG000|COMPLETED|Overall Study||705||
48552500|NCT00261443|101686748|FG000|NOT COMPLETED|4: Extension Phase||0||
48552501|NCT00261443|101686749|FG001|NOT COMPLETED|4: Extension Phase||3||
48552502|NCT00261443|101686750|FG002|NOT COMPLETED|4: Extension Phase||2||
48552503|NCT01396512|101686751|FG000|STARTED|Overall Study||137||
48552504|NCT01396512|101686752|FG001|STARTED|Overall Study||137||
48107692|NCT02658890|100590605|FG004|STARTED|Pre-Treatment Phase||7||
48107693|NCT02658890|100590606|FG005|STARTED|Pre-Treatment Phase||18||
48107694|NCT02658890|100590607|FG006|STARTED|Pre-Treatment Phase||17||
48107695|NCT02658890|100590608|FG007|STARTED|Pre-Treatment Phase||22||
48107696|NCT02658890|100590609|FG008|STARTED|Pre-Treatment Phase||36||
48107697|NCT02658890|100590610|FG009|STARTED|Pre-Treatment Phase||15||
48107698|NCT02658890|100590611|FG010|STARTED|Pre-Treatment Phase||14||
48107699|NCT02658890|100590612|FG011|STARTED|Pre-Treatment Phase||14||
48107700|NCT02658890|100590613|FG012|STARTED|Pre-Treatment Phase||16||
48552505|NCT01396512|101686751|FG000|COMPLETED|Overall Study||137||
48107701|NCT02658890|100590614|FG013|STARTED|Pre-Treatment Phase||79||
48107702|NCT02658890|100590615|FG014|STARTED|Pre-Treatment Phase||9||
48107703|NCT02658890|100590616|FG015|STARTED|Pre-Treatment Phase||6||
48107704|NCT02658890|100590617|FG016|STARTED|Pre-Treatment Phase||37||
48107705|NCT02658890|100590618|FG017|STARTED|Pre-Treatment Phase||17||
48107706|NCT02658890|100590619|FG018|STARTED|Pre-Treatment Phase||80||
48107707|NCT02658890|100590620|FG019|STARTED|Pre-Treatment Phase||41||
48107708|NCT02658890|100590621|FG020|STARTED|Pre-Treatment Phase||32||
48107709|NCT02658890|100590622|FG021|STARTED|Pre-Treatment Phase||42||
48107710|NCT02658890|100590623|FG022|STARTED|Pre-Treatment Phase||41||
48107711|NCT02658890|100590624|FG023|STARTED|Pre-Treatment Phase||1||
48107712|NCT02658890|100590625|FG024|STARTED|Pre-Treatment Phase||1||
48107713|NCT02658890|100590626|FG025|STARTED|Pre-Treatment Phase||20||
48107714|NCT02658890|100590627|FG026|STARTED|Pre-Treatment Phase||14||
48107715|NCT02658890|100590601|FG000|COMPLETED|Pre-Treatment Phase||7||
48107716|NCT02658890|100590602|FG001|COMPLETED|Pre-Treatment Phase||11||
48107717|NCT02658890|100590603|FG002|COMPLETED|Pre-Treatment Phase||12||
48107718|NCT02658890|100590604|FG003|COMPLETED|Pre-Treatment Phase||18||
48107719|NCT02658890|100590605|FG004|COMPLETED|Pre-Treatment Phase||7||
48107720|NCT02658890|100590606|FG005|COMPLETED|Pre-Treatment Phase||18||
48107721|NCT02658890|100590607|FG006|COMPLETED|Pre-Treatment Phase||17||
48107722|NCT02658890|100590608|FG007|COMPLETED|Pre-Treatment Phase||22||
48107723|NCT02658890|100590609|FG008|COMPLETED|Pre-Treatment Phase||35||
48107724|NCT02658890|100590610|FG009|COMPLETED|Pre-Treatment Phase||15||
48107725|NCT02658890|100590611|FG010|COMPLETED|Pre-Treatment Phase||14||
48107726|NCT02658890|100590612|FG011|COMPLETED|Pre-Treatment Phase||14||
48107727|NCT02658890|100590613|FG012|COMPLETED|Pre-Treatment Phase||16||
48107728|NCT02658890|100590614|FG013|COMPLETED|Pre-Treatment Phase||79||
48107729|NCT02658890|100590615|FG014|COMPLETED|Pre-Treatment Phase||9||
48107730|NCT02658890|100590616|FG015|COMPLETED|Pre-Treatment Phase||6||
48107731|NCT02658890|100590617|FG016|COMPLETED|Pre-Treatment Phase||37||
48107732|NCT02658890|100590618|FG017|COMPLETED|Pre-Treatment Phase||17||
48107733|NCT02658890|100590619|FG018|COMPLETED|Pre-Treatment Phase||80||
48107734|NCT02658890|100590620|FG019|COMPLETED|Pre-Treatment Phase||41||
48107735|NCT02658890|100590621|FG020|COMPLETED|Pre-Treatment Phase||32||
48107736|NCT02658890|100590622|FG021|COMPLETED|Pre-Treatment Phase||42||
48107737|NCT02658890|100590623|FG022|COMPLETED|Pre-Treatment Phase||41||
48107738|NCT02658890|100590624|FG023|COMPLETED|Pre-Treatment Phase||1||
48107739|NCT02658890|100590625|FG024|COMPLETED|Pre-Treatment Phase||1||
48107740|NCT02658890|100590626|FG025|COMPLETED|Pre-Treatment Phase||20||
48107741|NCT02658890|100590627|FG026|COMPLETED|Pre-Treatment Phase||14||
48107742|NCT02658890|100590601|FG000|NOT COMPLETED|Pre-Treatment Phase||0||
48107743|NCT02658890|100590602|FG001|NOT COMPLETED|Pre-Treatment Phase||0||
48107744|NCT02658890|100590603|FG002|NOT COMPLETED|Pre-Treatment Phase||0||
48107745|NCT02658890|100590604|FG003|NOT COMPLETED|Pre-Treatment Phase||0||
48107746|NCT02658890|100590605|FG004|NOT COMPLETED|Pre-Treatment Phase||0||
48107747|NCT02658890|100590606|FG005|NOT COMPLETED|Pre-Treatment Phase||0||
48107748|NCT02658890|100590607|FG006|NOT COMPLETED|Pre-Treatment Phase||0||
48107749|NCT02658890|100590608|FG007|NOT COMPLETED|Pre-Treatment Phase||0||
48107750|NCT02658890|100590609|FG008|NOT COMPLETED|Pre-Treatment Phase||1||
48107751|NCT02658890|100590610|FG009|NOT COMPLETED|Pre-Treatment Phase||0||
48107752|NCT02658890|100590611|FG010|NOT COMPLETED|Pre-Treatment Phase||0||
48107753|NCT02658890|100590612|FG011|NOT COMPLETED|Pre-Treatment Phase||0||
48107754|NCT02658890|100590613|FG012|NOT COMPLETED|Pre-Treatment Phase||0||
48107755|NCT02658890|100590614|FG013|NOT COMPLETED|Pre-Treatment Phase||0||
48392251|NCT00830960|101287832|FG001|Received at Least 1 Dose of Study Drug|Overall Study||122||
48693074|NCT01681186|102032716|FG004|COMPLETED|Second Intervention||3||
48693075|NCT01681186|102032717|FG005|COMPLETED|Second Intervention||2||
48693076|NCT01681186|102032718|FG006|COMPLETED|Second Intervention||7||
48693077|NCT01681186|102032719|FG007|COMPLETED|Second Intervention||7||
48693078|NCT01681186|102032712|FG000|NOT COMPLETED|Second Intervention||0||
48107756|NCT02658890|100590615|FG014|NOT COMPLETED|Pre-Treatment Phase||0||
48107757|NCT02658890|100590616|FG015|NOT COMPLETED|Pre-Treatment Phase||0||
48107758|NCT02658890|100590617|FG016|NOT COMPLETED|Pre-Treatment Phase||0||
48107759|NCT02658890|100590618|FG017|NOT COMPLETED|Pre-Treatment Phase||0||
48107760|NCT02658890|100590619|FG018|NOT COMPLETED|Pre-Treatment Phase||0||
48268617|NCT00719329|100981758|FG001|COMPLETED|Overall Study||569||
48268618|NCT00719329|100981759|FG002|COMPLETED|Overall Study||646||
48392252|NCT00830960|101287833|FG002|Received at Least 1 Dose of Study Drug|Overall Study||133||
48693079|NCT01681186|102032713|FG001|NOT COMPLETED|Second Intervention||0||
48107761|NCT02658890|100590620|FG019|NOT COMPLETED|Pre-Treatment Phase||0||
48107762|NCT02658890|100590621|FG020|NOT COMPLETED|Pre-Treatment Phase||0||
48107763|NCT02658890|100590622|FG021|NOT COMPLETED|Pre-Treatment Phase||0||
48107764|NCT02658890|100590623|FG022|NOT COMPLETED|Pre-Treatment Phase||0||
48107765|NCT02658890|100590624|FG023|NOT COMPLETED|Pre-Treatment Phase||0||
48107766|NCT02658890|100590625|FG024|NOT COMPLETED|Pre-Treatment Phase||0||
48107767|NCT02658890|100590626|FG025|NOT COMPLETED|Pre-Treatment Phase||0||
48107768|NCT02658890|100590627|FG026|NOT COMPLETED|Pre-Treatment Phase||0||
48693080|NCT01681186|102032714|FG002|NOT COMPLETED|Second Intervention||0||
48107769|NCT02658890|100590601|FG000|STARTED|Treatment Phase||7||
48268619|NCT00719329|100981757|FG000|NOT COMPLETED|Overall Study||0||
48268620|NCT00719329|100981758|FG001|NOT COMPLETED|Overall Study||2||
48268621|NCT00719329|100981759|FG002|NOT COMPLETED|Overall Study||1||
48268622|NCT01920477|100981760|FG000|STARTED|Overall Study||17||
48268623|NCT01920477|100981761|FG001|STARTED|Overall Study||18||
48268624|NCT01920477|100981760|FG000|Requiried Individualized Follow-up|Overall Study||1||
48268625|NCT01920477|100981761|FG001|Requiried Individualized Follow-up|Overall Study||0||
48268626|NCT01920477|100981760|FG000|COMPLETED|Overall Study||2||
48268627|NCT01920477|100981761|FG001|COMPLETED|Overall Study||1||
48268628|NCT01920477|100981760|FG000|NOT COMPLETED|Overall Study||15||
48268629|NCT01920477|100981761|FG001|NOT COMPLETED|Overall Study||17||
48268630|NCT01607476|100981762|FG000|STARTED|Overall Study||25||
48268631|NCT01607476|100981763|FG001|STARTED|Overall Study||30||
48268632|NCT01607476|100981764|FG002|STARTED|Overall Study||33||
48268633|NCT01607476|100981762|FG000|COMPLETED|Overall Study||24||
48268634|NCT01607476|100981763|FG001|COMPLETED|Overall Study||30||
48268635|NCT01607476|100981764|FG002|COMPLETED|Overall Study||30||
48268636|NCT01607476|100981762|FG000|NOT COMPLETED|Overall Study||1||
48268637|NCT01607476|100981763|FG001|NOT COMPLETED|Overall Study||0||
48268638|NCT01607476|100981764|FG002|NOT COMPLETED|Overall Study||3||
48268639|NCT03149042|100981765|FG000|STARTED|Overall Study||75||
48268640|NCT03149042|100981765|FG000|COMPLETED|Overall Study||52||
48268641|NCT03149042|100981765|FG000|NOT COMPLETED|Overall Study||23||
48268642|NCT03564353|100981766|FG000|STARTED|Overall Study||10||
48268643|NCT03564353|100981767|FG001|STARTED|Overall Study||10||
48268644|NCT03564353|100981768|FG002|STARTED|Overall Study||10||
48268645|NCT03564353|100981769|FG003|STARTED|Overall Study||10||
48268646|NCT03564353|100981766|FG000|COMPLETED|Overall Study||10||
48268647|NCT03564353|100981767|FG001|COMPLETED|Overall Study||10||
48268648|NCT03564353|100981768|FG002|COMPLETED|Overall Study||10||
48268649|NCT03564353|100981769|FG003|COMPLETED|Overall Study||10||
48268650|NCT03564353|100981766|FG000|NOT COMPLETED|Overall Study||0||
48552506|NCT01396512|101686752|FG001|COMPLETED|Overall Study||136||
48552507|NCT01396512|101686751|FG000|NOT COMPLETED|Overall Study||0||
48268651|NCT03564353|100981767|FG001|NOT COMPLETED|Overall Study||0||
48268652|NCT03564353|100981768|FG002|NOT COMPLETED|Overall Study||0||
48268653|NCT03564353|100981769|FG003|NOT COMPLETED|Overall Study||0||
48268654|NCT01195623|100981770|FG000|STARTED|Overall Study||148||
48268655|NCT01195623|100981771|FG001|STARTED|Overall Study||145||
48268656|NCT01195623|100981770|FG000|COMPLETED|Overall Study||113||
48268657|NCT01195623|100981771|FG001|COMPLETED|Overall Study||108||
48268658|NCT01195623|100981770|FG000|NOT COMPLETED|Overall Study||35||
48552508|NCT01396512|101686752|FG001|NOT COMPLETED|Overall Study||1||
48268659|NCT01195623|100981771|FG001|NOT COMPLETED|Overall Study||37||
48268660|NCT04071301|100981772|FG000|STARTED|Overall Study||15||
48268661|NCT04071301|100981772|FG000|COMPLETED|Overall Study||8||
48268662|NCT04071301|100981772|FG000|NOT COMPLETED|Overall Study||7||
48268663|NCT02539459|100981773|FG000|STARTED|Overall Study||20||
48268664|NCT02539459|100981773|FG000|COMPLETED|Overall Study||18||
48268665|NCT02539459|100981773|FG000|NOT COMPLETED|Overall Study||2||
48268666|NCT00335140|100981774|FG000|STARTED|Overall Study||26||
48268667|NCT00335140|100981774|FG000|Eligible|Overall Study||25||
48268668|NCT00335140|100981774|FG000|Treated|Overall Study||25||
48268669|NCT00335140|100981774|FG000|COMPLETED|Overall Study||25||
48268670|NCT00335140|100981774|FG000|NOT COMPLETED|Overall Study||1||
48268671|NCT02221557|100981775|FG000|STARTED|Overall Study||8||
48268672|NCT02221557|100981775|FG000|COMPLETED|Overall Study||5||
48268673|NCT02221557|100981775|FG000|NOT COMPLETED|Overall Study||3||
48268674|NCT01747551|100981776|FG000|STARTED|Overall Study||43||
48268675|NCT01747551|100981777|FG001|STARTED|Overall Study||21||
48268676|NCT01747551|100981776|FG000|COMPLETED|Overall Study||0||
48268677|NCT01747551|100981777|FG001|COMPLETED|Overall Study||0||
48268678|NCT01747551|100981776|FG000|NOT COMPLETED|Overall Study||43||
48268679|NCT01747551|100981777|FG001|NOT COMPLETED|Overall Study||21||
48268680|NCT00769600|100981778|FG000|STARTED|Overall Study||15||
48268681|NCT00769600|100981779|FG001|STARTED|Overall Study||8||
48268682|NCT00769600|100981778|FG000|COMPLETED|Overall Study||15||
48268683|NCT00769600|100981779|FG001|COMPLETED|Overall Study||8||
48268684|NCT00769600|100981778|FG000|NOT COMPLETED|Overall Study||0||
48268685|NCT00769600|100981779|FG001|NOT COMPLETED|Overall Study||0||
48268686|NCT03984513|100981780|FG000|STARTED|Overall Study||29||
48268687|NCT03984513|100981781|FG001|STARTED|Overall Study||29||
48268688|NCT03984513|100981780|FG000|COMPLETED|Overall Study||26||
48552509|NCT01648530|101686753|FG000|STARTED|Overall Study||16789||
48552510|NCT01648530|101686753|FG000|COMPLETED|Overall Study||5915||
48552511|NCT01648530|101686753|FG000|NOT COMPLETED|Overall Study||10874||
48552512|NCT05584189|101686754|FG000|STARTED|Overall Study||53||
48552513|NCT05584189|101686755|FG001|STARTED|Overall Study||46||
48552514|NCT05584189|101686754|FG000|COMPLETED|Overall Study||53||
48552515|NCT05584189|101686755|FG001|COMPLETED|Overall Study||46||
48552516|NCT05584189|101686754|FG000|NOT COMPLETED|Overall Study||0||
48552517|NCT05584189|101686755|FG001|NOT COMPLETED|Overall Study||0||
48552518|NCT02324582|101686756|FG000|STARTED|Overall Study||3||
48552519|NCT02324582|101686757|FG001|STARTED|Overall Study||15||
48552520|NCT02324582|101686756|FG000|COMPLETED|Overall Study||3||
48552521|NCT02324582|101686757|FG001|COMPLETED|Overall Study||10||
48552522|NCT02324582|101686756|FG000|NOT COMPLETED|Overall Study||0||
48552523|NCT02324582|101686757|FG001|NOT COMPLETED|Overall Study||5||
48268689|NCT03984513|100981781|FG001|COMPLETED|Overall Study||22||
48268690|NCT03984513|100981780|FG000|NOT COMPLETED|Overall Study||3||
48268691|NCT03984513|100981781|FG001|NOT COMPLETED|Overall Study||7||
48268692|NCT01128270|100981782|FG000|STARTED|Environment Chloral Hydrate and DCA (1A)||7||
48268693|NCT01128270|100981782|FG000|COMPLETED|Environment Chloral Hydrate and DCA (1A)||7||
48268694|NCT01128270|100981782|FG000|NOT COMPLETED|Environment Chloral Hydrate and DCA (1A)||0||
48268695|NCT01128270|100981782|FG000|STARTED|Environmental Chloral Hydrate (1B)||8||
48268696|NCT01128270|100981782|FG000|COMPLETED|Environmental Chloral Hydrate (1B)||8||
48268697|NCT01128270|100981782|FG000|NOT COMPLETED|Environmental Chloral Hydrate (1B)||0||
48268698|NCT01128270|100981782|FG000|STARTED|Therapeutic Chloral Hydrate and DCA (2A)||8||
48268699|NCT01128270|100981782|FG000|COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||8||
48268700|NCT01128270|100981782|FG000|NOT COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||0||
48552524|NCT02016183|101686758|FG000|STARTED|Overall Study||3222||
48552525|NCT02016183|101686758|FG000|COMPLETED|Overall Study||3157||
48552526|NCT02016183|101686758|FG000|NOT COMPLETED|Overall Study||65||
48268701|NCT01128270|100981782|FG000|STARTED|Therapeutic Chloral Hydrate (2B)||8||
48268702|NCT01128270|100981782|FG000|COMPLETED|Therapeutic Chloral Hydrate (2B)||8||
48268703|NCT01128270|100981782|FG000|NOT COMPLETED|Therapeutic Chloral Hydrate (2B)||0||
48268704|NCT03406078|100981783|FG000|STARTED|Overall Study||74||
48268705|NCT03406078|100981784|FG001|STARTED|Overall Study||76||
48268706|NCT03406078|100981783|FG000|COMPLETED|Overall Study||68||
48268707|NCT03406078|100981784|FG001|COMPLETED|Overall Study||73||
48268708|NCT03406078|100981783|FG000|NOT COMPLETED|Overall Study||6||
48268709|NCT03406078|100981784|FG001|NOT COMPLETED|Overall Study||3||
48268710|NCT00078338|100981785|FG000|STARTED|Overall Study||386||
48268711|NCT00078338|100981786|FG001|STARTED|Overall Study||378||
48268712|NCT00078338|100981785|FG000|Safety Population|Overall Study||381||
48268713|NCT00078338|100981786|FG001|Safety Population|Overall Study||375||
48268714|NCT00078338|100981785|FG000|COMPLETED|Overall Study||301||
48268715|NCT00078338|100981786|FG001|COMPLETED|Overall Study||324||
48268716|NCT00078338|100981785|FG000|NOT COMPLETED|Overall Study||85||
48268717|NCT00078338|100981786|FG001|NOT COMPLETED|Overall Study||54||
48268718|NCT01031628|100981787|FG000|STARTED|Overall Study||0||
48552527|NCT01153425|101686759|FG000|STARTED|Overall Study||16||
48552528|NCT01153425|101686760|FG001|STARTED|Overall Study||17||
48552529|NCT01153425|101686759|FG000|COMPLETED|Overall Study||13||
48552530|NCT01153425|101686760|FG001|COMPLETED|Overall Study||14||
48552531|NCT01153425|101686759|FG000|NOT COMPLETED|Overall Study||3||
48268719|NCT01031628|100981788|FG001|STARTED|Overall Study||1||
48268720|NCT01031628|100981789|FG002|STARTED|Overall Study||3||
48268721|NCT01031628|100981790|FG003|STARTED|Overall Study||0||
48107770|NCT02658890|100590602|FG001|STARTED|Treatment Phase||11||
48107771|NCT02658890|100590603|FG002|STARTED|Treatment Phase||12||
48107772|NCT02658890|100590604|FG003|STARTED|Treatment Phase||18||
48268722|NCT01031628|100981787|FG000|COMPLETED|Overall Study||0||
48268723|NCT01031628|100981788|FG001|COMPLETED|Overall Study||0||
48268724|NCT01031628|100981789|FG002|COMPLETED|Overall Study||0||
48268725|NCT01031628|100981790|FG003|COMPLETED|Overall Study||0||
48268726|NCT01031628|100981787|FG000|NOT COMPLETED|Overall Study||0||
48268727|NCT01031628|100981788|FG001|NOT COMPLETED|Overall Study||1||
48107773|NCT02658890|100590605|FG004|STARTED|Treatment Phase||7||
48107774|NCT02658890|100590606|FG005|STARTED|Treatment Phase||18||
48107775|NCT02658890|100590607|FG006|STARTED|Treatment Phase||17||
48107776|NCT02658890|100590608|FG007|STARTED|Treatment Phase||22||
48268728|NCT01031628|100981789|FG002|NOT COMPLETED|Overall Study||3||
48268729|NCT01031628|100981790|FG003|NOT COMPLETED|Overall Study||0||
48268730|NCT00945672|100981791|FG000|STARTED|Overall Study||12||
48107777|NCT02658890|100590609|FG008|STARTED|Treatment Phase||35||
48268731|NCT00945672|100981792|FG001|STARTED|Overall Study||6||
48268732|NCT00945672|100981793|FG002|STARTED|Overall Study||12||
48107778|NCT02658890|100590610|FG009|STARTED|Treatment Phase||15||
48107779|NCT02658890|100590611|FG010|STARTED|Treatment Phase||14||
48268733|NCT00945672|100981794|FG003|STARTED|Overall Study||6||
48268734|NCT00945672|100981791|FG000|COMPLETED|Overall Study||12||
48268735|NCT00945672|100981792|FG001|COMPLETED|Overall Study||6||
48268736|NCT00945672|100981793|FG002|COMPLETED|Overall Study||12||
48268737|NCT00945672|100981794|FG003|COMPLETED|Overall Study||5||
48268738|NCT00945672|100981791|FG000|NOT COMPLETED|Overall Study||0||
48268739|NCT00945672|100981792|FG001|NOT COMPLETED|Overall Study||0||
48268740|NCT00945672|100981793|FG002|NOT COMPLETED|Overall Study||0||
48268741|NCT00945672|100981794|FG003|NOT COMPLETED|Overall Study||1||
48268742|NCT01008553|100981795|FG000|STARTED|Period 1 (Titration Period)||258||
48268743|NCT01008553|100981796|FG001|STARTED|Period 1 (Titration Period)||0||
48268744|NCT01008553|100981797|FG002|STARTED|Period 1 (Titration Period)||0||
48268745|NCT01008553|100981795|FG000|COMPLETED|Period 1 (Titration Period)||163||
48268746|NCT01008553|100981796|FG001|COMPLETED|Period 1 (Titration Period)||0||
48268747|NCT01008553|100981797|FG002|COMPLETED|Period 1 (Titration Period)||0||
48268748|NCT01008553|100981795|FG000|NOT COMPLETED|Period 1 (Titration Period)||95||
48268749|NCT01008553|100981796|FG001|NOT COMPLETED|Period 1 (Titration Period)||0||
48268750|NCT01008553|100981797|FG002|NOT COMPLETED|Period 1 (Titration Period)||0||
48268751|NCT01008553|100981795|FG000|STARTED|Period 2 (Double-Blind Period)||0||
48268752|NCT01008553|100981796|FG001|STARTED|Period 2 (Double-Blind Period)||84||
48268753|NCT01008553|100981797|FG002|STARTED|Period 2 (Double-Blind Period)||79||
48268754|NCT01008553|100981795|FG000|COMPLETED|Period 2 (Double-Blind Period)||0||
48268755|NCT01008553|100981796|FG001|COMPLETED|Period 2 (Double-Blind Period)||47||
48268756|NCT01008553|100981797|FG002|COMPLETED|Period 2 (Double-Blind Period)||28||
48268757|NCT01008553|100981795|FG000|NOT COMPLETED|Period 2 (Double-Blind Period)||0||
48268758|NCT01008553|100981796|FG001|NOT COMPLETED|Period 2 (Double-Blind Period)||37||
48268759|NCT01008553|100981797|FG002|NOT COMPLETED|Period 2 (Double-Blind Period)||51||
48268760|NCT01048697|100981798|FG000|STARTED|Overall Study||18||
48268761|NCT01048697|100981798|FG000|COMPLETED|Overall Study||18||
48268762|NCT01048697|100981798|FG000|NOT COMPLETED|Overall Study||0||
48268763|NCT00264303|100981799|FG000|STARTED|Overall Study||438||
48268764|NCT00264303|100981800|FG001|STARTED|Overall Study||448||
48268765|NCT00264303|100981799|FG000|COMPLETED|Overall Study||413||
48268766|NCT00264303|100981800|FG001|COMPLETED|Overall Study||419||
48268767|NCT00264303|100981799|FG000|NOT COMPLETED|Overall Study||25||
48268768|NCT00264303|100981800|FG001|NOT COMPLETED|Overall Study||29||
48268769|NCT02878603|100981801|FG000|STARTED|Overall Study||29||
48268770|NCT02878603|100981802|FG001|STARTED|Overall Study||75||
48268771|NCT02878603|100981801|FG000|COMPLETED|Overall Study||23||
48268772|NCT02878603|100981802|FG001|COMPLETED|Overall Study||70||
48268773|NCT02878603|100981801|FG000|NOT COMPLETED|Overall Study||6||
48552532|NCT01153425|101686760|FG001|NOT COMPLETED|Overall Study||3||
48552533|NCT02723344|101686761|FG000|STARTED|Overall Study||15||
48552534|NCT02723344|101686762|FG001|STARTED|Overall Study||16||
48552535|NCT02723344|101686761|FG000|COMPLETED|Overall Study||15||
48552536|NCT02723344|101686762|FG001|COMPLETED|Overall Study||12||
48552537|NCT02723344|101686761|FG000|NOT COMPLETED|Overall Study||0||
48552538|NCT02723344|101686762|FG001|NOT COMPLETED|Overall Study||4||
48552539|NCT00946920|101686763|FG000|STARTED|Overall Study||565||
48268774|NCT02878603|100981802|FG001|NOT COMPLETED|Overall Study||5||
48268775|NCT01528319|100981803|FG000|STARTED|Overall Study||24||
48268776|NCT01528319|100981803|FG000|12 Weeks After Surgery|Overall Study||24||
48268777|NCT01528319|100981803|FG000|COMPLETED|Overall Study||23||
48268778|NCT01528319|100981803|FG000|NOT COMPLETED|Overall Study||1||
48268779|NCT00680992|100981804|FG000|STARTED|Overall Study||268||
48268780|NCT00680992|100981805|FG001|STARTED|Overall Study||252||
48268781|NCT00680992|100981806|FG002|STARTED|Overall Study||12||
48268782|NCT00680992|100981804|FG000|Safety Analysis Set|Overall Study||265|Received ≥1 dose of denosumab|
48268783|NCT00680992|100981805|FG001|Safety Analysis Set|Overall Study||249|Received ≥1 dose of denosumab|
48268784|NCT00680992|100981806|FG002|Safety Analysis Set|Overall Study||12|Received ≥1 dose of denosumab|
48268785|NCT00680992|100981804|FG000|Efficacy Analysis Set|Overall Study||260|Eligible for study and received ≥1 dose of denosumab|
48268786|NCT00680992|100981805|FG001|Efficacy Analysis Set|Overall Study||242|Eligible for study and received ≥1 dose of denosumab|
48268787|NCT00680992|100981806|FG002|Efficacy Analysis Set|Overall Study||11|Eligible for study and received ≥1 dose of denosumab|
48268788|NCT00680992|100981804|FG000|COMPLETED|Overall Study||0|Completed the initial treatment phase|
48268789|NCT00680992|100981805|FG001|COMPLETED|Overall Study||0|Completed the initial treatment phase|
48268790|NCT00680992|100981806|FG002|COMPLETED|Overall Study||0|Completed the initial treatment phase|
48268791|NCT00680992|100981804|FG000|NOT COMPLETED|Overall Study||268||
48268792|NCT00680992|100981805|FG001|NOT COMPLETED|Overall Study||252||
48268793|NCT00680992|100981806|FG002|NOT COMPLETED|Overall Study||12||
48268794|NCT01701102|100981807|FG000|STARTED|Overall Study||22||
48552540|NCT00946920|101686764|FG001|STARTED|Overall Study||283||
48552541|NCT00946920|101686763|FG000|Full Analysis Set (FAS)|Overall Study||565||
48268795|NCT01701102|100981808|FG001|STARTED|Overall Study||6||
48268796|NCT01701102|100981809|FG002|STARTED|Overall Study||10||
48268797|NCT01701102|100981810|FG003|STARTED|Overall Study||18||
48268798|NCT01701102|100981807|FG000|COMPLETED|Overall Study||22||
48268799|NCT01701102|100981808|FG001|COMPLETED|Overall Study||6||
48268800|NCT01701102|100981809|FG002|COMPLETED|Overall Study||10||
48268801|NCT01701102|100981810|FG003|COMPLETED|Overall Study||18||
48268802|NCT01701102|100981807|FG000|NOT COMPLETED|Overall Study||0||
48268803|NCT01701102|100981808|FG001|NOT COMPLETED|Overall Study||0||
48268804|NCT01701102|100981809|FG002|NOT COMPLETED|Overall Study||0||
48268805|NCT01701102|100981810|FG003|NOT COMPLETED|Overall Study||0||
48268806|NCT01200290|100981811|FG000|STARTED|Treatment Period||18||
48268807|NCT01200290|100981811|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||18||
48268808|NCT01200290|100981811|FG000|COMPLETED|Treatment Period||17||
48268809|NCT01200290|100981811|FG000|NOT COMPLETED|Treatment Period||1||
48268810|NCT01200290|100981811|FG000|STARTED|Post-Treatment Follow-Up Period||18||
48268811|NCT01200290|100981811|FG000|COMPLETED|Post-Treatment Follow-Up Period||16||
48268812|NCT01200290|100981811|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||2||
48268813|NCT03296800|100981812|FG000|STARTED|Overall Study||16||
48268814|NCT03296800|100981813|FG001|STARTED|Overall Study||16||
48268815|NCT03296800|100981814|FG002|STARTED|Overall Study||16||
48268816|NCT03296800|100981812|FG000|COMPLETED|Overall Study||16||
48268817|NCT03296800|100981813|FG001|COMPLETED|Overall Study||16||
48268818|NCT03296800|100981814|FG002|COMPLETED|Overall Study||16||
48268819|NCT03296800|100981812|FG000|NOT COMPLETED|Overall Study||0||
48268820|NCT03296800|100981813|FG001|NOT COMPLETED|Overall Study||0||
48268821|NCT03296800|100981814|FG002|NOT COMPLETED|Overall Study||0||
48268822|NCT00953615|100981815|FG000|STARTED|Overall Study||1||
48268823|NCT00953615|100981815|FG000|COMPLETED|Overall Study||0||
48268824|NCT00953615|100981815|FG000|NOT COMPLETED|Overall Study||1||
48268825|NCT00346905|100981816|FG000|STARTED|Overall Study||16||
48268826|NCT00346905|100981816|FG000|COMPLETED|Overall Study||12||
48268827|NCT00346905|100981816|FG000|NOT COMPLETED|Overall Study||4||
48268828|NCT01252355|100981817|FG000|STARTED|Overall Study||177||
48268829|NCT01252355|100981818|FG001|STARTED|Overall Study||178||
48268830|NCT01252355|100981819|FG002|STARTED|Overall Study||179||
48268831|NCT01252355|100981817|FG000|Treated|Overall Study||175||
48268832|NCT01252355|100981818|FG001|Treated|Overall Study||178||
48268833|NCT01252355|100981819|FG002|Treated|Overall Study||179||
48268834|NCT01252355|100981817|FG000|COMPLETED|Overall Study||0||
48268835|NCT01252355|100981818|FG001|COMPLETED|Overall Study||0||
48268836|NCT01252355|100981819|FG002|COMPLETED|Overall Study||0||
48268837|NCT01252355|100981817|FG000|NOT COMPLETED|Overall Study||177||
48268838|NCT01252355|100981818|FG001|NOT COMPLETED|Overall Study||178||
48268839|NCT01252355|100981819|FG002|NOT COMPLETED|Overall Study||179||
48268840|NCT03670004|100981820|FG000|STARTED|Overall Study||13||
48268841|NCT03670004|100981821|FG001|STARTED|Overall Study||10||
48268842|NCT03670004|100981820|FG000|COMPLETED|Overall Study||13||
48268843|NCT03670004|100981821|FG001|COMPLETED|Overall Study||10||
48268844|NCT03670004|100981820|FG000|NOT COMPLETED|Overall Study||0||
48268845|NCT03670004|100981821|FG001|NOT COMPLETED|Overall Study||0||
48268846|NCT02737826|100981822|FG000|STARTED|Phase I - Buprenorphine Initiation||27||
48268847|NCT02737826|100981823|FG001|STARTED|Phase I - Buprenorphine Initiation||0||
48268848|NCT02737826|100981824|FG002|STARTED|Phase I - Buprenorphine Initiation||0||
48268849|NCT02737826|100981822|FG000|COMPLETED|Phase I - Buprenorphine Initiation||27||
48268850|NCT02737826|100981823|FG001|COMPLETED|Phase I - Buprenorphine Initiation||0||
48268851|NCT02737826|100981824|FG002|COMPLETED|Phase I - Buprenorphine Initiation||0||
48268852|NCT02737826|100981822|FG000|NOT COMPLETED|Phase I - Buprenorphine Initiation||0||
48268853|NCT02737826|100981823|FG001|NOT COMPLETED|Phase I - Buprenorphine Initiation||0||
48268854|NCT02737826|100981824|FG002|NOT COMPLETED|Phase I - Buprenorphine Initiation||0||
48268855|NCT02737826|100981822|FG000|STARTED|Phase II - Randomization + Taper||0||
48268856|NCT02737826|100981823|FG001|STARTED|Phase II - Randomization + Taper||13||
48268857|NCT02737826|100981824|FG002|STARTED|Phase II - Randomization + Taper||14||
48268858|NCT02737826|100981822|FG000|COMPLETED|Phase II - Randomization + Taper||0||
48268859|NCT02737826|100981823|FG001|COMPLETED|Phase II - Randomization + Taper||1||
48268860|NCT02737826|100981824|FG002|COMPLETED|Phase II - Randomization + Taper||0||
48268861|NCT02737826|100981822|FG000|NOT COMPLETED|Phase II - Randomization + Taper||0||
48268862|NCT02737826|100981823|FG001|NOT COMPLETED|Phase II - Randomization + Taper||12||
48268863|NCT02737826|100981824|FG002|NOT COMPLETED|Phase II - Randomization + Taper||14||
48268864|NCT02525692|100981825|FG000|STARTED|Overall Study||17||
48268865|NCT02525692|100981826|FG001|STARTED|Overall Study||19||
48268866|NCT02525692|100981827|FG002|STARTED|Overall Study||8||
48268867|NCT02525692|100981828|FG003|STARTED|Overall Study||30||
48268868|NCT02525692|100981829|FG004|STARTED|Overall Study||3||
48268869|NCT02525692|100981830|FG005|STARTED|Overall Study||7||
48268870|NCT02525692|100981825|FG000|COMPLETED|Overall Study||0||
48268871|NCT02525692|100981826|FG001|COMPLETED|Overall Study||0||
48268872|NCT02525692|100981827|FG002|COMPLETED|Overall Study||0||
48268873|NCT02525692|100981828|FG003|COMPLETED|Overall Study||0||
48268874|NCT02525692|100981829|FG004|COMPLETED|Overall Study||0||
48268875|NCT02525692|100981830|FG005|COMPLETED|Overall Study||0||
48268876|NCT02525692|100981825|FG000|NOT COMPLETED|Overall Study||17||
48268877|NCT02525692|100981826|FG001|NOT COMPLETED|Overall Study||19||
48268878|NCT02525692|100981827|FG002|NOT COMPLETED|Overall Study||8||
48268879|NCT02525692|100981828|FG003|NOT COMPLETED|Overall Study||30||
48268880|NCT02525692|100981829|FG004|NOT COMPLETED|Overall Study||3||
48268881|NCT02525692|100981830|FG005|NOT COMPLETED|Overall Study||7||
48268882|NCT01294436|100981831|FG000|STARTED|Overall Study||249||
48268883|NCT01294436|100981832|FG001|STARTED|Overall Study||479||
48268884|NCT01294436|100981831|FG000|COMPLETED|Overall Study||221||
48268885|NCT01294436|100981832|FG001|COMPLETED|Overall Study||409||
48268886|NCT01294436|100981831|FG000|NOT COMPLETED|Overall Study||28||
48268887|NCT01294436|100981832|FG001|NOT COMPLETED|Overall Study||70||
48268888|NCT05609604|100981833|FG000|STARTED|Overall Study||2||
48268889|NCT05609604|100981834|FG001|STARTED|Overall Study||2||
48268890|NCT05609604|100981833|FG000|COMPLETED|Overall Study||0||
48268891|NCT05609604|100981834|FG001|COMPLETED|Overall Study||0||
48268892|NCT05609604|100981833|FG000|NOT COMPLETED|Overall Study||2||
48268893|NCT05609604|100981834|FG001|NOT COMPLETED|Overall Study||2||
48268894|NCT01976572|100981835|FG000|STARTED|Overall Study||6||
48268895|NCT01976572|100981836|FG001|STARTED|Overall Study||6||
48268896|NCT01976572|100981837|FG002|STARTED|Overall Study||6||
48268897|NCT01976572|100981835|FG000|COMPLETED|Overall Study||6||
48268898|NCT01976572|100981836|FG001|COMPLETED|Overall Study||6||
48268899|NCT01976572|100981837|FG002|COMPLETED|Overall Study||6||
48268900|NCT01976572|100981835|FG000|NOT COMPLETED|Overall Study||0||
48268901|NCT01976572|100981836|FG001|NOT COMPLETED|Overall Study||0||
48268902|NCT01976572|100981837|FG002|NOT COMPLETED|Overall Study||0||
48268903|NCT03519204|100981838|FG000|STARTED|Overall Study||43||
48268904|NCT03519204|100981839|FG001|STARTED|Overall Study||133||
48268905|NCT03519204|100981838|FG000|mITT Population|Overall Study||33||
48268906|NCT03519204|100981839|FG001|mITT Population|Overall Study||130||
48268907|NCT03519204|100981838|FG000|Safety Population|Overall Study||40||
48268908|NCT03519204|100981839|FG001|Safety Population|Overall Study||136||
48268909|NCT03519204|100981838|FG000|COMPLETED|Overall Study||30||
48268910|NCT03519204|100981839|FG001|COMPLETED|Overall Study||118||
48268911|NCT03519204|100981838|FG000|NOT COMPLETED|Overall Study||13||
48107780|NCT02658890|100590612|FG011|STARTED|Treatment Phase||14||
48107781|NCT02658890|100590613|FG012|STARTED|Treatment Phase||16||
48107782|NCT02658890|100590614|FG013|STARTED|Treatment Phase||79||
48107783|NCT02658890|100590615|FG014|STARTED|Treatment Phase||9||
48107784|NCT02658890|100590616|FG015|STARTED|Treatment Phase||6||
48107785|NCT02658890|100590617|FG016|STARTED|Treatment Phase||37||
48268912|NCT03519204|100981839|FG001|NOT COMPLETED|Overall Study||15||
48268913|NCT01987895|100981840|FG000|STARTED|Overall Study||306||
48268914|NCT01987895|100981841|FG001|STARTED|Overall Study||326||
48268915|NCT01987895|100981840|FG000|COMPLETED|Overall Study||276|Include subjects who completed the main study + subjects who completed the re-treatment extension.|
48268916|NCT01987895|100981841|FG001|COMPLETED|Overall Study||296|Include subjects who completed the main study + subjects who completed the re-treatment extension.|
48268917|NCT01987895|100981840|FG000|NOT COMPLETED|Overall Study||30||
48268918|NCT01987895|100981841|FG001|NOT COMPLETED|Overall Study||30||
48268919|NCT01294397|100981842|FG000|STARTED|Overall Study||19||
48268920|NCT01294397|100981842|FG000|COMPLETED|Overall Study||17||
48268921|NCT01294397|100981842|FG000|NOT COMPLETED|Overall Study||2||
48268922|NCT04481568|100981843|FG000|STARTED|Overall Study||79||
48268923|NCT04481568|100981844|FG001|STARTED|Overall Study||79||
48268924|NCT04481568|100981843|FG000|COMPLETED|Overall Study||79||
48268925|NCT04481568|100981844|FG001|COMPLETED|Overall Study||79||
48268926|NCT04481568|100981843|FG000|NOT COMPLETED|Overall Study||0||
48268927|NCT04481568|100981844|FG001|NOT COMPLETED|Overall Study||0||
48268928|NCT01782690|100981845|FG000|STARTED|Overall Study||338||
48268929|NCT01782690|100981845|FG000|COMPLETED|Overall Study||39||
48268930|NCT01782690|100981845|FG000|NOT COMPLETED|Overall Study||299||
48268931|NCT00725270|100981846|FG000|STARTED|Overall Study||5||
48268932|NCT00725270|100981847|FG001|STARTED|Overall Study||7||
48268933|NCT00725270|100981846|FG000|COMPLETED|Overall Study||5||
48268934|NCT00725270|100981847|FG001|COMPLETED|Overall Study||7||
48268935|NCT00725270|100981846|FG000|NOT COMPLETED|Overall Study||0||
48268936|NCT00725270|100981847|FG001|NOT COMPLETED|Overall Study||0||
48268937|NCT00448201|100981848|FG000|STARTED|Overall Study||71||
48268938|NCT00448201|100981848|FG000|COMPLETED|Overall Study||71||
48268939|NCT00448201|100981848|FG000|NOT COMPLETED|Overall Study||0||
48268940|NCT02807883|100981849|FG000|STARTED|Overall Study||23||
48268941|NCT02807883|100981849|FG000|COMPLETED|Overall Study||21||
48268942|NCT02807883|100981849|FG000|NOT COMPLETED|Overall Study||2||
48268943|NCT03057847|100981850|FG000|STARTED|Overall Study||32||
48268944|NCT03057847|100981850|FG000|Treatment Initiation|Overall Study||21||
48268945|NCT03057847|100981850|FG000|COMPLETED|Overall Study||16||
48107786|NCT02658890|100590618|FG017|STARTED|Treatment Phase||17||
48107787|NCT02658890|100590619|FG018|STARTED|Treatment Phase||80||
48107788|NCT02658890|100590620|FG019|STARTED|Treatment Phase||41||
48107789|NCT02658890|100590621|FG020|STARTED|Treatment Phase||32||
48107790|NCT02658890|100590622|FG021|STARTED|Treatment Phase||42||
48107791|NCT02658890|100590623|FG022|STARTED|Treatment Phase||41||
48107792|NCT02658890|100590624|FG023|STARTED|Treatment Phase||1||
48107793|NCT02658890|100590625|FG024|STARTED|Treatment Phase||1||
48107794|NCT02658890|100590626|FG025|STARTED|Treatment Phase||20||
48107795|NCT02658890|100590627|FG026|STARTED|Treatment Phase||14||
48107796|NCT02658890|100590601|FG000|COMPLETED|Treatment Phase||1||
48107797|NCT02658890|100590602|FG001|COMPLETED|Treatment Phase||2||
48107798|NCT02658890|100590603|FG002|COMPLETED|Treatment Phase||1||
48107799|NCT02658890|100590604|FG003|COMPLETED|Treatment Phase||3||
48107800|NCT02658890|100590605|FG004|COMPLETED|Treatment Phase||0||
48107801|NCT02658890|100590606|FG005|COMPLETED|Treatment Phase||0||
48268946|NCT03057847|100981850|FG000|NOT COMPLETED|Overall Study||16||
48552542|NCT00946920|101686764|FG001|Full Analysis Set (FAS)|Overall Study||282||
48552543|NCT00946920|101686763|FG000|COMPLETED|Overall Study||455||
48552544|NCT00946920|101686764|FG001|COMPLETED|Overall Study||239||
48552545|NCT00946920|101686763|FG000|NOT COMPLETED|Overall Study||110||
48552546|NCT00946920|101686764|FG001|NOT COMPLETED|Overall Study||44||
48552547|NCT02540083|101686765|FG000|STARTED|Overall Study||94||
48552548|NCT02540083|101686765|FG000|COMPLETED|Overall Study||78||
48693081|NCT01681186|102032715|FG003|NOT COMPLETED|Second Intervention||0||
48693082|NCT01681186|102032716|FG004|NOT COMPLETED|Second Intervention||0||
48693083|NCT01681186|102032717|FG005|NOT COMPLETED|Second Intervention||0||
48693084|NCT01681186|102032718|FG006|NOT COMPLETED|Second Intervention||0||
48693085|NCT01681186|102032719|FG007|NOT COMPLETED|Second Intervention||0||
48693086|NCT01681186|102032712|FG000|STARTED|Washout Period From Second Intervention||0||
48552549|NCT02540083|101686765|FG000|NOT COMPLETED|Overall Study||16||
48552550|NCT03126435|101686766|FG000|STARTED|Overall Study||108||
48552551|NCT03126435|101686767|FG001|STARTED|Overall Study||110||
48552552|NCT03126435|101686766|FG000|COMPLETED|Overall Study||2||
48552553|NCT03126435|101686767|FG001|COMPLETED|Overall Study||6||
48552554|NCT03126435|101686766|FG000|NOT COMPLETED|Overall Study||106||
48552555|NCT03126435|101686767|FG001|NOT COMPLETED|Overall Study||104||
48107802|NCT02658890|100590607|FG006|COMPLETED|Treatment Phase||2||
48107803|NCT02658890|100590608|FG007|COMPLETED|Treatment Phase||1||
48552556|NCT02006732|101686768|FG000|STARTED|Overall Study||202||
48552557|NCT02006732|101686769|FG001|STARTED|Overall Study||203||
48552558|NCT02006732|101686770|FG002|STARTED|Overall Study||202||
48552559|NCT02006732|101686771|FG003|STARTED|Overall Study||202||
48552560|NCT02006732|101686768|FG000|COMPLETED|Overall Study||182||
48552561|NCT02006732|101686769|FG001|COMPLETED|Overall Study||191||
48552562|NCT02006732|101686770|FG002|COMPLETED|Overall Study||193||
48552563|NCT02006732|101686771|FG003|COMPLETED|Overall Study||198||
48552564|NCT02006732|101686768|FG000|NOT COMPLETED|Overall Study||20||
48552565|NCT02006732|101686769|FG001|NOT COMPLETED|Overall Study||12||
48552566|NCT02006732|101686770|FG002|NOT COMPLETED|Overall Study||9||
48552567|NCT02006732|101686771|FG003|NOT COMPLETED|Overall Study||4||
48552568|NCT02899962|101686772|FG000|STARTED|Open-label Phase||650||
48552569|NCT02899962|101686773|FG001|STARTED|Open-label Phase||0||
48107804|NCT02658890|100590609|FG008|COMPLETED|Treatment Phase||4||
48107805|NCT02658890|100590610|FG009|COMPLETED|Treatment Phase||3||
48693087|NCT01681186|102032713|FG001|STARTED|Washout Period From Second Intervention||0||
48693088|NCT01681186|102032714|FG002|STARTED|Washout Period From Second Intervention||0||
48693089|NCT01681186|102032715|FG003|STARTED|Washout Period From Second Intervention||0||
48693090|NCT01681186|102032716|FG004|STARTED|Washout Period From Second Intervention||0||
48693091|NCT01681186|102032717|FG005|STARTED|Washout Period From Second Intervention||0||
48693092|NCT01681186|102032718|FG006|STARTED|Washout Period From Second Intervention||7||
48552570|NCT02899962|101686774|FG002|STARTED|Open-label Phase||0||
48552571|NCT02899962|101686772|FG000|COMPLETED|Open-label Phase||623||
48552572|NCT02899962|101686773|FG001|COMPLETED|Open-label Phase||0||
48552573|NCT02899962|101686774|FG002|COMPLETED|Open-label Phase||0||
48107806|NCT02658890|100590611|FG010|COMPLETED|Treatment Phase||3||
48552574|NCT02899962|101686772|FG000|NOT COMPLETED|Open-label Phase||27||
48552575|NCT02899962|101686773|FG001|NOT COMPLETED|Open-label Phase||0||
48552576|NCT02899962|101686774|FG002|NOT COMPLETED|Open-label Phase||0||
48552577|NCT02899962|101686772|FG000|STARTED|Maintenance Phase||0||
48552578|NCT02899962|101686773|FG001|STARTED|Maintenance Phase||272||
48552579|NCT02899962|101686774|FG002|STARTED|Maintenance Phase||273||
48552580|NCT02899962|101686772|FG000|COMPLETED|Maintenance Phase||0||
48552581|NCT02899962|101686773|FG001|COMPLETED|Maintenance Phase||131||
48552582|NCT02899962|101686774|FG002|COMPLETED|Maintenance Phase||120||
48552583|NCT02899962|101686772|FG000|NOT COMPLETED|Maintenance Phase||0||
48552584|NCT02899962|101686773|FG001|NOT COMPLETED|Maintenance Phase||141||
48552585|NCT02899962|101686774|FG002|NOT COMPLETED|Maintenance Phase||153||
48552586|NCT01654315|101686775|FG000|STARTED|Overall Study||15||
48552587|NCT01654315|101686776|FG001|STARTED|Overall Study||10||
48552588|NCT01654315|101686777|FG002|STARTED|Overall Study||9||
48552589|NCT01654315|101686775|FG000|COMPLETED|Overall Study||15||
48552590|NCT01654315|101686776|FG001|COMPLETED|Overall Study||10||
48552591|NCT01654315|101686777|FG002|COMPLETED|Overall Study||9||
48552592|NCT01654315|101686775|FG000|NOT COMPLETED|Overall Study||0||
48552593|NCT01654315|101686776|FG001|NOT COMPLETED|Overall Study||0||
48552594|NCT01654315|101686777|FG002|NOT COMPLETED|Overall Study||0||
48552595|NCT02952586|101686778|FG000|STARTED|Lead-In Phase (7 Days)||350||
48552596|NCT02952586|101686779|FG001|STARTED|Lead-In Phase (7 Days)||347||
48552597|NCT02952586|101686778|FG000|Safety Analysis Set|Lead-In Phase (7 Days)||348||
48552598|NCT02952586|101686779|FG001|Safety Analysis Set|Lead-In Phase (7 Days)||344||
48552599|NCT02952586|101686778|FG000|COMPLETED|Lead-In Phase (7 Days)||345||
48552600|NCT02952586|101686779|FG001|COMPLETED|Lead-In Phase (7 Days)||343||
48552601|NCT02952586|101686778|FG000|NOT COMPLETED|Lead-In Phase (7 Days)||5||
48552602|NCT02952586|101686779|FG001|NOT COMPLETED|Lead-In Phase (7 Days)||4||
48552603|NCT02952586|101686778|FG000|STARTED|CRT for Avelumab or Placebo (63 Days)||345||
48552604|NCT02952586|101686779|FG001|STARTED|CRT for Avelumab or Placebo (63 Days)||340||
48107807|NCT02658890|100590612|FG011|COMPLETED|Treatment Phase||4||
48107808|NCT02658890|100590613|FG012|COMPLETED|Treatment Phase||4||
48107809|NCT02658890|100590614|FG013|COMPLETED|Treatment Phase||31||
48107810|NCT02658890|100590615|FG014|COMPLETED|Treatment Phase||3||
48107811|NCT02658890|100590616|FG015|COMPLETED|Treatment Phase||3||
48107812|NCT02658890|100590617|FG016|COMPLETED|Treatment Phase||3||
48107813|NCT02658890|100590618|FG017|COMPLETED|Treatment Phase||3||
48107814|NCT02658890|100590619|FG018|COMPLETED|Treatment Phase||18||
48107815|NCT02658890|100590620|FG019|COMPLETED|Treatment Phase||2||
48107816|NCT02658890|100590621|FG020|COMPLETED|Treatment Phase||8||
48107817|NCT02658890|100590622|FG021|COMPLETED|Treatment Phase||8||
48107818|NCT02658890|100590623|FG022|COMPLETED|Treatment Phase||9||
48107819|NCT02658890|100590624|FG023|COMPLETED|Treatment Phase||0||
48107820|NCT02658890|100590625|FG024|COMPLETED|Treatment Phase||0||
48107821|NCT02658890|100590626|FG025|COMPLETED|Treatment Phase||2||
48107822|NCT02658890|100590627|FG026|COMPLETED|Treatment Phase||1||
48107823|NCT02658890|100590601|FG000|NOT COMPLETED|Treatment Phase||6||
48107824|NCT02658890|100590602|FG001|NOT COMPLETED|Treatment Phase||9||
48107825|NCT02658890|100590603|FG002|NOT COMPLETED|Treatment Phase||11||
48268947|NCT00487825|100981851|FG000|STARTED|Overall Study||52||
48268948|NCT00487825|100981852|FG001|STARTED|Overall Study||26||
48268949|NCT00487825|100981851|FG000|COMPLETED|Overall Study||46||
48268950|NCT00487825|100981852|FG001|COMPLETED|Overall Study||21||
48268951|NCT00487825|100981851|FG000|NOT COMPLETED|Overall Study||6||
48268952|NCT00487825|100981852|FG001|NOT COMPLETED|Overall Study||5||
48552605|NCT02952586|101686778|FG000|COMPLETED|CRT for Avelumab or Placebo (63 Days)||312||
48552606|NCT02952586|101686779|FG001|COMPLETED|CRT for Avelumab or Placebo (63 Days)||313||
48552607|NCT02952586|101686778|FG000|NOT COMPLETED|CRT for Avelumab or Placebo (63 Days)||33||
48552608|NCT02952586|101686779|FG001|NOT COMPLETED|CRT for Avelumab or Placebo (63 Days)||27||
48552609|NCT02952586|101686778|FG000|STARTED|CRT for Cisplatin (63 Days)||345||
48552610|NCT02952586|101686779|FG001|STARTED|CRT for Cisplatin (63 Days)||340||
48552611|NCT02952586|101686778|FG000|COMPLETED|CRT for Cisplatin (63 Days)||234||
48552612|NCT02952586|101686779|FG001|COMPLETED|CRT for Cisplatin (63 Days)||236||
48552613|NCT02952586|101686778|FG000|NOT COMPLETED|CRT for Cisplatin (63 Days)||111||
48552614|NCT02952586|101686779|FG001|NOT COMPLETED|CRT for Cisplatin (63 Days)||104||
48552615|NCT02952586|101686778|FG000|STARTED|CRT for IMRT (63 Days)||345||
48552616|NCT02952586|101686779|FG001|STARTED|CRT for IMRT (63 Days)||340||
48552617|NCT02952586|101686778|FG000|COMPLETED|CRT for IMRT (63 Days)||322||
48552618|NCT02952586|101686779|FG001|COMPLETED|CRT for IMRT (63 Days)||320||
48552619|NCT02952586|101686778|FG000|NOT COMPLETED|CRT for IMRT (63 Days)||23||
48552620|NCT02952586|101686779|FG001|NOT COMPLETED|CRT for IMRT (63 Days)||20||
48552621|NCT02952586|101686778|FG000|STARTED|Maintenance Phase (12 Months)||291||
48693093|NCT01681186|102032719|FG007|STARTED|Washout Period From Second Intervention||7||
48693094|NCT01681186|102032712|FG000|COMPLETED|Washout Period From Second Intervention||0||
48693095|NCT01681186|102032713|FG001|COMPLETED|Washout Period From Second Intervention||0||
48693096|NCT01681186|102032714|FG002|COMPLETED|Washout Period From Second Intervention||0||
48693097|NCT01681186|102032715|FG003|COMPLETED|Washout Period From Second Intervention||0||
48693098|NCT01681186|102032716|FG004|COMPLETED|Washout Period From Second Intervention||0||
48107826|NCT02658890|100590604|FG003|NOT COMPLETED|Treatment Phase||15||
48693099|NCT01681186|102032717|FG005|COMPLETED|Washout Period From Second Intervention||0||
48693100|NCT01681186|102032718|FG006|COMPLETED|Washout Period From Second Intervention||6||
48693101|NCT01681186|102032719|FG007|COMPLETED|Washout Period From Second Intervention||6||
48693102|NCT01681186|102032712|FG000|NOT COMPLETED|Washout Period From Second Intervention||0||
48693103|NCT01681186|102032713|FG001|NOT COMPLETED|Washout Period From Second Intervention||0||
48693104|NCT01681186|102032714|FG002|NOT COMPLETED|Washout Period From Second Intervention||0||
48693105|NCT01681186|102032715|FG003|NOT COMPLETED|Washout Period From Second Intervention||0||
48107827|NCT02658890|100590605|FG004|NOT COMPLETED|Treatment Phase||7||
48268953|NCT05789576|100981853|FG000|STARTED|Overall Study||31||
48268954|NCT05789576|100981853|FG000|COMPLETED|Overall Study||24||
48268955|NCT05789576|100981853|FG000|NOT COMPLETED|Overall Study||7||
48552622|NCT02952586|101686779|FG001|STARTED|Maintenance Phase (12 Months)||304||
48552623|NCT02952586|101686778|FG000|COMPLETED|Maintenance Phase (12 Months)||139||
48552624|NCT02952586|101686779|FG001|COMPLETED|Maintenance Phase (12 Months)||177||
48552625|NCT02952586|101686778|FG000|NOT COMPLETED|Maintenance Phase (12 Months)||152||
48552626|NCT02952586|101686779|FG001|NOT COMPLETED|Maintenance Phase (12 Months)||127||
48552627|NCT02952586|101686778|FG000|STARTED|Follow-Up Phase (90 Days)||266||
48693106|NCT01681186|102032716|FG004|NOT COMPLETED|Washout Period From Second Intervention||0||
48693107|NCT01681186|102032717|FG005|NOT COMPLETED|Washout Period From Second Intervention||0||
48693108|NCT01681186|102032718|FG006|NOT COMPLETED|Washout Period From Second Intervention||1||
48107828|NCT02658890|100590606|FG005|NOT COMPLETED|Treatment Phase||18||
48107829|NCT02658890|100590607|FG006|NOT COMPLETED|Treatment Phase||15||
48107830|NCT02658890|100590608|FG007|NOT COMPLETED|Treatment Phase||21||
48107831|NCT02658890|100590609|FG008|NOT COMPLETED|Treatment Phase||31||
48107832|NCT02658890|100590610|FG009|NOT COMPLETED|Treatment Phase||12||
48107833|NCT02658890|100590611|FG010|NOT COMPLETED|Treatment Phase||11||
48107834|NCT02658890|100590612|FG011|NOT COMPLETED|Treatment Phase||10||
48107835|NCT02658890|100590613|FG012|NOT COMPLETED|Treatment Phase||12||
48268956|NCT02389764|100981854|FG000|STARTED|Overall Study||9||
48107836|NCT02658890|100590614|FG013|NOT COMPLETED|Treatment Phase||48||
48107837|NCT02658890|100590615|FG014|NOT COMPLETED|Treatment Phase||6||
48107838|NCT02658890|100590616|FG015|NOT COMPLETED|Treatment Phase||3||
48107839|NCT02658890|100590617|FG016|NOT COMPLETED|Treatment Phase||34||
48107840|NCT02658890|100590618|FG017|NOT COMPLETED|Treatment Phase||14||
48107841|NCT02658890|100590619|FG018|NOT COMPLETED|Treatment Phase||62||
48107842|NCT02658890|100590620|FG019|NOT COMPLETED|Treatment Phase||39||
48107843|NCT02658890|100590621|FG020|NOT COMPLETED|Treatment Phase||24||
48107844|NCT02658890|100590622|FG021|NOT COMPLETED|Treatment Phase||34||
48107845|NCT02658890|100590623|FG022|NOT COMPLETED|Treatment Phase||32||
48107846|NCT02658890|100590624|FG023|NOT COMPLETED|Treatment Phase||1||
48107847|NCT02658890|100590625|FG024|NOT COMPLETED|Treatment Phase||1||
48107848|NCT02658890|100590626|FG025|NOT COMPLETED|Treatment Phase||18||
48107849|NCT02658890|100590627|FG026|NOT COMPLETED|Treatment Phase||13||
48107850|NCT02076412|100590628|FG000|STARTED|Overall Study||50||
48107851|NCT02076412|100590629|FG001|STARTED|Overall Study||24||
48107852|NCT02076412|100590628|FG000|COMPLETED|Overall Study||13||
48107853|NCT02076412|100590629|FG001|COMPLETED|Overall Study||2||
48107854|NCT02076412|100590628|FG000|NOT COMPLETED|Overall Study||37||
48107855|NCT02076412|100590629|FG001|NOT COMPLETED|Overall Study||22||
48107856|NCT02531321|100590630|FG000|STARTED|Overall Study||7||
48107857|NCT02531321|100590631|FG001|STARTED|Overall Study||10||
48107858|NCT02531321|100590630|FG000|COMPLETED|Overall Study||5||
48107859|NCT02531321|100590631|FG001|COMPLETED|Overall Study||10||
48107860|NCT02531321|100590630|FG000|NOT COMPLETED|Overall Study||2||
48107861|NCT02531321|100590631|FG001|NOT COMPLETED|Overall Study||0||
48107862|NCT04907032|100590632|FG000|STARTED|Overall Study||27||
48107863|NCT04907032|100590633|FG001|STARTED|Overall Study||27||
48107864|NCT04907032|100590632|FG000|COMPLETED|Overall Study||20|withdrew because could not complete 12-week PTNS protocol.|
48107865|NCT04907032|100590633|FG001|COMPLETED|Overall Study||26|withdrew because could not complete 12-week PTNS protocol.|
48107866|NCT04907032|100590632|FG000|NOT COMPLETED|Overall Study||7||
48107867|NCT04907032|100590633|FG001|NOT COMPLETED|Overall Study||1||
48107868|NCT02027844|100590634|FG000|STARTED|Overall Study||39||
48107869|NCT02027844|100590635|FG001|STARTED|Overall Study||39||
48107870|NCT02027844|100590636|FG002|STARTED|Overall Study||39||
48107871|NCT02027844|100590634|FG000|COMPLETED|Overall Study||34||
48107872|NCT02027844|100590635|FG001|COMPLETED|Overall Study||33||
48107873|NCT02027844|100590636|FG002|COMPLETED|Overall Study||37||
48107874|NCT02027844|100590634|FG000|NOT COMPLETED|Overall Study||5||
48107875|NCT02027844|100590635|FG001|NOT COMPLETED|Overall Study||6||
48107876|NCT02027844|100590636|FG002|NOT COMPLETED|Overall Study||2||
48107877|NCT01723163|100590637|FG000|STARTED|Baseline||156||
48107878|NCT01723163|100590638|FG001|STARTED|Baseline||154||
48107879|NCT01723163|100590637|FG000|COMPLETED|Baseline||156||
48107880|NCT01723163|100590638|FG001|COMPLETED|Baseline||154||
48107881|NCT01723163|100590637|FG000|NOT COMPLETED|Baseline||0||
48107882|NCT01723163|100590638|FG001|NOT COMPLETED|Baseline||0||
48107883|NCT01723163|100590637|FG000|STARTED|Treatment Phase||156||
48107884|NCT01723163|100590638|FG001|STARTED|Treatment Phase||154||
48107885|NCT01723163|100590637|FG000|COMPLETED|Treatment Phase||137||
48107886|NCT01723163|100590638|FG001|COMPLETED|Treatment Phase||147||
48107887|NCT01723163|100590637|FG000|NOT COMPLETED|Treatment Phase||19||
48107888|NCT01723163|100590638|FG001|NOT COMPLETED|Treatment Phase||7||
48107889|NCT01723163|100590637|FG000|STARTED|3-Month Follow-up||137||
48107890|NCT01723163|100590638|FG001|STARTED|3-Month Follow-up||147||
48107891|NCT01723163|100590637|FG000|COMPLETED|3-Month Follow-up||124||
48107892|NCT01723163|100590638|FG001|COMPLETED|3-Month Follow-up||128||
48107893|NCT01723163|100590637|FG000|NOT COMPLETED|3-Month Follow-up||13||
48107894|NCT01723163|100590638|FG001|NOT COMPLETED|3-Month Follow-up||19||
48107895|NCT01723163|100590637|FG000|STARTED|6-Month Follow-up||136||
48107896|NCT01723163|100590638|FG001|STARTED|6-Month Follow-up||147||
48107897|NCT01723163|100590637|FG000|COMPLETED|6-Month Follow-up||118||
48107898|NCT01723163|100590638|FG001|COMPLETED|6-Month Follow-up||132||
48107899|NCT01723163|100590637|FG000|NOT COMPLETED|6-Month Follow-up||18||
48107900|NCT01723163|100590638|FG001|NOT COMPLETED|6-Month Follow-up||15||
48107901|NCT01723163|100590637|FG000|STARTED|12-Month Follow-up||135||
48107902|NCT01723163|100590638|FG001|STARTED|12-Month Follow-up||147||
48107903|NCT01723163|100590637|FG000|COMPLETED|12-Month Follow-up||111||
48107904|NCT01723163|100590638|FG001|COMPLETED|12-Month Follow-up||119||
48107905|NCT01723163|100590637|FG000|NOT COMPLETED|12-Month Follow-up||24||
48107906|NCT01723163|100590638|FG001|NOT COMPLETED|12-Month Follow-up||28||
48107907|NCT01116232|100590639|FG000|STARTED|Overall Study||4||
48107908|NCT01116232|100590639|FG000|COMPLETED|Overall Study||0||
48107909|NCT01116232|100590639|FG000|NOT COMPLETED|Overall Study||4||
48107910|NCT01520363|100590640|FG000|STARTED|Overall Study||26||
48107911|NCT01520363|100590641|FG001|STARTED|Overall Study||26||
48107912|NCT01520363|100590640|FG000|COMPLETED|Overall Study||24||
48107913|NCT01520363|100590641|FG001|COMPLETED|Overall Study||26||
48107914|NCT01520363|100590640|FG000|NOT COMPLETED|Overall Study||2||
48107915|NCT01520363|100590641|FG001|NOT COMPLETED|Overall Study||0||
48107916|NCT01556204|100590642|FG000|STARTED|Overall Study||35||
48107917|NCT01556204|100590643|FG001|STARTED|Overall Study||38||
48107918|NCT01556204|100590642|FG000|COMPLETED|Overall Study||35||
48107919|NCT01556204|100590643|FG001|COMPLETED|Overall Study||38||
48107920|NCT01556204|100590642|FG000|NOT COMPLETED|Overall Study||0||
48107921|NCT01556204|100590643|FG001|NOT COMPLETED|Overall Study||0||
48107922|NCT02281552|100590644|FG000|STARTED|Overall Study||104||
48107923|NCT02281552|100590645|FG001|STARTED|Overall Study||105||
48107924|NCT02281552|100590644|FG000|COMPLETED|Overall Study||100||
48107925|NCT02281552|100590645|FG001|COMPLETED|Overall Study||95||
48107926|NCT02281552|100590644|FG000|NOT COMPLETED|Overall Study||4||
48107927|NCT02281552|100590645|FG001|NOT COMPLETED|Overall Study||10||
48107928|NCT00136084|100590646|FG000|STARTED|Overall Study||109||
48107929|NCT00136084|100590647|FG001|STARTED|Overall Study||114||
48107930|NCT00136084|100590646|FG000|COMPLETED|Overall Study||61||
48107931|NCT00136084|100590647|FG001|COMPLETED|Overall Study||72||
48107932|NCT00136084|100590646|FG000|NOT COMPLETED|Overall Study||48||
48107933|NCT00136084|100590647|FG001|NOT COMPLETED|Overall Study||42||
48107934|NCT00422032|100590648|FG000|STARTED|Overall Study||37||
48107935|NCT00422032|100590649|FG001|STARTED|Overall Study||21||
48107936|NCT00422032|100590648|FG000|COMPLETED|Overall Study||37||
48107937|NCT00422032|100590649|FG001|COMPLETED|Overall Study||21||
48107938|NCT00422032|100590648|FG000|NOT COMPLETED|Overall Study||0||
48107939|NCT00422032|100590649|FG001|NOT COMPLETED|Overall Study||0||
48107940|NCT00854581|100590650|FG000|STARTED|Induction (Up to Day 21)||13||
48107941|NCT00854581|100590650|FG000|COMPLETED|Induction (Up to Day 21)||7||
48107942|NCT00854581|100590650|FG000|NOT COMPLETED|Induction (Up to Day 21)||6||
48107943|NCT00854581|100590650|FG000|STARTED|Part 1 Maintenance (Up to Day 60)||7||
48107944|NCT00854581|100590650|FG000|COMPLETED|Part 1 Maintenance (Up to Day 60)||5||
48107945|NCT00854581|100590650|FG000|NOT COMPLETED|Part 1 Maintenance (Up to Day 60)||2||
48107946|NCT00854581|100590650|FG000|STARTED|Part 2 Maintenance (Up to 12 Months)||5||
48107947|NCT00854581|100590650|FG000|COMPLETED|Part 2 Maintenance (Up to 12 Months)||2||
48107948|NCT00854581|100590650|FG000|NOT COMPLETED|Part 2 Maintenance (Up to 12 Months)||3||
48107949|NCT00486265|100590651|FG000|STARTED|Overall Study||9||
48107950|NCT00486265|100590651|FG000|COMPLETED|Overall Study||0||
48107951|NCT00486265|100590651|FG000|NOT COMPLETED|Overall Study||9||
48107952|NCT01752855|100590652|FG000|STARTED|Overall Study||44||
48107953|NCT01752855|100590653|FG001|STARTED|Overall Study||44||
48107954|NCT01752855|100590652|FG000|COMPLETED|Overall Study||43||
48107955|NCT01752855|100590653|FG001|COMPLETED|Overall Study||40||
48107956|NCT01752855|100590652|FG000|NOT COMPLETED|Overall Study||1||
48107957|NCT01752855|100590653|FG001|NOT COMPLETED|Overall Study||4||
48107958|NCT00249470|100590654|FG000|STARTED|Overall Study||28||
48107959|NCT00249470|100590655|FG001|STARTED|Overall Study||28||
48107960|NCT00249470|100590654|FG000|COMPLETED|Overall Study||28||
48107961|NCT00249470|100590655|FG001|COMPLETED|Overall Study||28||
48107962|NCT00249470|100590654|FG000|NOT COMPLETED|Overall Study||0||
48107963|NCT00249470|100590655|FG001|NOT COMPLETED|Overall Study||0||
48107964|NCT02382016|100590656|FG000|STARTED|Double-blind (DB) Treatment Period||43||
48107965|NCT02382016|100590657|FG001|STARTED|Double-blind (DB) Treatment Period||42||
48107966|NCT02382016|100590656|FG000|COMPLETED|Double-blind (DB) Treatment Period||39||
48107967|NCT02382016|100590657|FG001|COMPLETED|Double-blind (DB) Treatment Period||41||
48268957|NCT02389764|100981854|FG000|COMPLETED|Overall Study||0||
48268958|NCT02389764|100981854|FG000|NOT COMPLETED|Overall Study||9||
48268959|NCT02205034|100981855|FG000|STARTED|Overall Study||6||
48268960|NCT02205034|100981856|FG001|STARTED|Overall Study||6||
48107968|NCT02382016|100590656|FG000|NOT COMPLETED|Double-blind (DB) Treatment Period||4||
48107969|NCT02382016|100590657|FG001|NOT COMPLETED|Double-blind (DB) Treatment Period||1||
48107970|NCT02382016|100590656|FG000|STARTED|Open-label (OL) Treatment Period||80||
48107971|NCT02382016|100590657|FG001|STARTED|Open-label (OL) Treatment Period||0||
48107972|NCT02382016|100590656|FG000|COMPLETED|Open-label (OL) Treatment Period||71||
48107973|NCT02382016|100590657|FG001|COMPLETED|Open-label (OL) Treatment Period||0||
48107974|NCT02382016|100590656|FG000|NOT COMPLETED|Open-label (OL) Treatment Period||9||
48107975|NCT02382016|100590657|FG001|NOT COMPLETED|Open-label (OL) Treatment Period||0||
48107976|NCT02382016|100590656|FG000|STARTED|OL Extension Period||33||
48107977|NCT02382016|100590657|FG001|STARTED|OL Extension Period||0||
48107978|NCT02382016|100590656|FG000|COMPLETED|OL Extension Period||27||
48107979|NCT02382016|100590657|FG001|COMPLETED|OL Extension Period||0||
48107980|NCT02382016|100590656|FG000|NOT COMPLETED|OL Extension Period||6||
48107981|NCT02382016|100590657|FG001|NOT COMPLETED|OL Extension Period||0||
48107982|NCT00058825|100590658|FG000|STARTED|Overall Study||27||
48107983|NCT00058825|100590658|FG000|COMPLETED|Overall Study||5||
48107984|NCT00058825|100590658|FG000|NOT COMPLETED|Overall Study||22||
48107985|NCT00588445|100590659|FG000|STARTED|Overall Study||65||
48107986|NCT00588445|100590659|FG000|COMPLETED|Overall Study||50||
48107987|NCT00588445|100590659|FG000|NOT COMPLETED|Overall Study||15||
48107988|NCT01978314|100590660|FG000|STARTED|Overall Study||8||
48107989|NCT01978314|100590661|FG001|STARTED|Overall Study||8||
48107990|NCT01978314|100590662|FG002|STARTED|Overall Study||8||
48107991|NCT01978314|100590663|FG003|STARTED|Overall Study||1||
48107992|NCT01978314|100590664|FG004|STARTED|Overall Study||8||
48107993|NCT01978314|100590660|FG000|COMPLETED|Overall Study||8||
48107994|NCT01978314|100590661|FG001|COMPLETED|Overall Study||8||
48107995|NCT01978314|100590662|FG002|COMPLETED|Overall Study||8||
48107996|NCT01978314|100590663|FG003|COMPLETED|Overall Study||1||
48268961|NCT02205034|100981857|FG002|STARTED|Overall Study||6||
48268962|NCT02205034|100981855|FG000|COMPLETED|Overall Study||6||
48107997|NCT01978314|100590664|FG004|COMPLETED|Overall Study||8||
48107998|NCT01978314|100590660|FG000|NOT COMPLETED|Overall Study||0||
48107999|NCT01978314|100590661|FG001|NOT COMPLETED|Overall Study||0||
48108000|NCT01978314|100590662|FG002|NOT COMPLETED|Overall Study||0||
48108001|NCT01978314|100590663|FG003|NOT COMPLETED|Overall Study||0||
48108002|NCT01978314|100590664|FG004|NOT COMPLETED|Overall Study||0||
48108003|NCT00308711|100590665|FG000|STARTED|Overall Study||428||
48108004|NCT00308711|100590666|FG001|STARTED|Overall Study||444||
48108005|NCT00308711|100590667|FG002|STARTED|Overall Study||436||
48108006|NCT00308711|100590665|FG000|COMPLETED|Overall Study||426||
48108007|NCT00308711|100590666|FG001|COMPLETED|Overall Study||440||
48108008|NCT00308711|100590667|FG002|COMPLETED|Overall Study||431||
48108009|NCT00308711|100590665|FG000|NOT COMPLETED|Overall Study||2||
48108010|NCT00308711|100590666|FG001|NOT COMPLETED|Overall Study||4||
48108011|NCT00308711|100590667|FG002|NOT COMPLETED|Overall Study||5||
48108012|NCT01162382|100590668|FG000|STARTED|Overall Study||0|No data are available fo this study as the study was terminated and PI has left the institution.|
48108013|NCT01162382|100590668|FG000|COMPLETED|Overall Study||0|No data are available fo this study as the study was terminated and PI has left the institution.|
48108014|NCT01162382|100590668|FG000|NOT COMPLETED|Overall Study||0||
48108015|NCT00660348|100590669|FG000|STARTED|Overall Study||1||
48108016|NCT00660348|100590670|FG001|STARTED|Overall Study||0||
48108017|NCT00660348|100590669|FG000|COMPLETED|Overall Study||0||
48108018|NCT00660348|100590670|FG001|COMPLETED|Overall Study||0||
48108019|NCT00660348|100590669|FG000|NOT COMPLETED|Overall Study||1||
48108020|NCT00660348|100590670|FG001|NOT COMPLETED|Overall Study||0||
48108021|NCT01063595|100590671|FG000|STARTED|Enrolled in Study and Randomized||32||
48108022|NCT01063595|100590672|FG001|STARTED|Enrolled in Study and Randomized||31||
48108023|NCT01063595|100590671|FG000|Received Treatment|Enrolled in Study and Randomized||31||
48108024|NCT01063595|100590672|FG001|Received Treatment|Enrolled in Study and Randomized||29||
48268963|NCT02205034|100981856|FG001|COMPLETED|Overall Study||6||
48108025|NCT01063595|100590671|FG000|COMPLETED|Enrolled in Study and Randomized||31||
48108026|NCT01063595|100590672|FG001|COMPLETED|Enrolled in Study and Randomized||29||
48108027|NCT01063595|100590671|FG000|NOT COMPLETED|Enrolled in Study and Randomized||1||
48108028|NCT01063595|100590672|FG001|NOT COMPLETED|Enrolled in Study and Randomized||2||
48108029|NCT01063595|100590671|FG000|STARTED|First Intervention||31||
48108030|NCT01063595|100590672|FG001|STARTED|First Intervention||29||
48108031|NCT01063595|100590671|FG000|COMPLETED|First Intervention||29||
48108032|NCT01063595|100590672|FG001|COMPLETED|First Intervention||24||
48108033|NCT01063595|100590671|FG000|NOT COMPLETED|First Intervention||2||
48108034|NCT01063595|100590672|FG001|NOT COMPLETED|First Intervention||5||
48108035|NCT01063595|100590671|FG000|STARTED|Second Intervention||29||
48108036|NCT01063595|100590672|FG001|STARTED|Second Intervention||24||
48108037|NCT01063595|100590671|FG000|COMPLETED|Second Intervention||29||
48108038|NCT01063595|100590672|FG001|COMPLETED|Second Intervention||24||
48108039|NCT01063595|100590671|FG000|NOT COMPLETED|Second Intervention||0||
48108040|NCT01063595|100590672|FG001|NOT COMPLETED|Second Intervention||0||
48108041|NCT01132495|100590673|FG000|STARTED|Overall Study||447||
48108042|NCT01132495|100590674|FG001|STARTED|Overall Study||441||
48108043|NCT01132495|100590675|FG002|STARTED|Overall Study||166||
48108044|NCT01132495|100590676|FG003|STARTED|Overall Study||116||
48108045|NCT01132495|100590673|FG000|COMPLETED|Overall Study||407||
48108046|NCT01132495|100590674|FG001|COMPLETED|Overall Study||403||
48108047|NCT01132495|100590675|FG002|COMPLETED|Overall Study||146||
48108048|NCT01132495|100590676|FG003|COMPLETED|Overall Study||104||
48108049|NCT01132495|100590673|FG000|NOT COMPLETED|Overall Study||40||
48108050|NCT01132495|100590674|FG001|NOT COMPLETED|Overall Study||38||
48108051|NCT01132495|100590675|FG002|NOT COMPLETED|Overall Study||20||
48108052|NCT01132495|100590676|FG003|NOT COMPLETED|Overall Study||12||
48108053|NCT00955266|100590677|FG000|STARTED|Overall Study||4||
48108054|NCT00955266|100590678|FG001|STARTED|Overall Study||4||
48108055|NCT00955266|100590677|FG000|COMPLETED|Overall Study||4||
48108056|NCT00955266|100590678|FG001|COMPLETED|Overall Study||4||
48108057|NCT00955266|100590677|FG000|NOT COMPLETED|Overall Study||0||
48108058|NCT00955266|100590678|FG001|NOT COMPLETED|Overall Study||0||
48108059|NCT02064907|100590679|FG000|STARTED|Period 1||26||
48108060|NCT02064907|100590680|FG001|STARTED|Period 1||26||
48108061|NCT02064907|100590679|FG000|COMPLETED|Period 1||26||
48108062|NCT02064907|100590680|FG001|COMPLETED|Period 1||26||
48108063|NCT02064907|100590679|FG000|NOT COMPLETED|Period 1||0||
48108064|NCT02064907|100590680|FG001|NOT COMPLETED|Period 1||0||
48108065|NCT02064907|100590679|FG000|STARTED|Period 2||26||
48108066|NCT02064907|100590680|FG001|STARTED|Period 2||26||
48108067|NCT02064907|100590679|FG000|COMPLETED|Period 2||26||
48108068|NCT02064907|100590680|FG001|COMPLETED|Period 2||26||
48108069|NCT02064907|100590679|FG000|NOT COMPLETED|Period 2||0||
48108070|NCT02064907|100590680|FG001|NOT COMPLETED|Period 2||0||
48108071|NCT00743652|100590681|FG000|STARTED|Overall Study||151||
48108072|NCT00743652|100590682|FG001|STARTED|Overall Study||51||
48108073|NCT00743652|100590683|FG002|STARTED|Overall Study||25||
48108074|NCT00743652|100590684|FG003|STARTED|Overall Study||67||
48108075|NCT00743652|100590685|FG004|STARTED|Overall Study||79||
48108076|NCT00743652|100590681|FG000|Vaccinated Dose 1|Overall Study||151||
48108077|NCT00743652|100590682|FG001|Vaccinated Dose 1|Overall Study||51||
48552628|NCT02952586|101686779|FG001|STARTED|Follow-Up Phase (90 Days)||284||
48552629|NCT02952586|101686778|FG000|COMPLETED|Follow-Up Phase (90 Days)||208||
48552630|NCT02952586|101686779|FG001|COMPLETED|Follow-Up Phase (90 Days)||216||
48552631|NCT02952586|101686778|FG000|NOT COMPLETED|Follow-Up Phase (90 Days)||58||
48552632|NCT02952586|101686779|FG001|NOT COMPLETED|Follow-Up Phase (90 Days)||68||
48552633|NCT02952586|101686778|FG000|STARTED|LT Follow-up (up to 45 Months)||247||
48108078|NCT00743652|100590683|FG002|Vaccinated Dose 1|Overall Study||25||
48108079|NCT00743652|100590684|FG003|Vaccinated Dose 1|Overall Study||66||
48108080|NCT00743652|100590685|FG004|Vaccinated Dose 1|Overall Study||79||
48108081|NCT00743652|100590681|FG000|Vaccinated Dose 2|Overall Study||112||
48108082|NCT00743652|100590682|FG001|Vaccinated Dose 2|Overall Study||41||
48108083|NCT00743652|100590683|FG002|Vaccinated Dose 2|Overall Study||0||
48108084|NCT00743652|100590684|FG003|Vaccinated Dose 2|Overall Study||49||
48108085|NCT00743652|100590685|FG004|Vaccinated Dose 2|Overall Study||0||
48108086|NCT00743652|100590681|FG000|Vaccinated Dose 3|Overall Study||74||
48108087|NCT00743652|100590682|FG001|Vaccinated Dose 3|Overall Study||0||
48108088|NCT00743652|100590683|FG002|Vaccinated Dose 3|Overall Study||0||
48552634|NCT02952586|101686779|FG001|STARTED|LT Follow-up (up to 45 Months)||237||
48108089|NCT00743652|100590684|FG003|Vaccinated Dose 3|Overall Study||0||
48108090|NCT00743652|100590685|FG004|Vaccinated Dose 3|Overall Study||0||
48108091|NCT00743652|100590681|FG000|Toddler Dose|Overall Study||15||
48108092|NCT00743652|100590682|FG001|Toddler Dose|Overall Study||23||
48108093|NCT00743652|100590683|FG002|Toddler Dose|Overall Study||16||
48108094|NCT00743652|100590684|FG003|Toddler Dose|Overall Study||0||
48108095|NCT00743652|100590685|FG004|Toddler Dose|Overall Study||0||
48108096|NCT00743652|100590681|FG000|COMPLETED|Overall Study||141||
48552635|NCT02952586|101686778|FG000|COMPLETED|LT Follow-up (up to 45 Months)||0||
48108097|NCT00743652|100590682|FG001|COMPLETED|Overall Study||48||
48108098|NCT00743652|100590683|FG002|COMPLETED|Overall Study||23||
48108099|NCT00743652|100590684|FG003|COMPLETED|Overall Study||63||
48552636|NCT02952586|101686779|FG001|COMPLETED|LT Follow-up (up to 45 Months)||0||
48552637|NCT02952586|101686778|FG000|NOT COMPLETED|LT Follow-up (up to 45 Months)||247||
48552638|NCT02952586|101686779|FG001|NOT COMPLETED|LT Follow-up (up to 45 Months)||237||
48108100|NCT00743652|100590685|FG004|COMPLETED|Overall Study||79||
48268964|NCT02205034|100981857|FG002|COMPLETED|Overall Study||6||
48268965|NCT02205034|100981855|FG000|NOT COMPLETED|Overall Study||0||
48268966|NCT02205034|100981856|FG001|NOT COMPLETED|Overall Study||0||
48268967|NCT02205034|100981857|FG002|NOT COMPLETED|Overall Study||0||
48268968|NCT04560374|100981858|FG000|STARTED|Overall Study||50||
48268969|NCT04560374|100981859|FG001|STARTED|Overall Study||50||
48268970|NCT04560374|100981858|FG000|COMPLETED|Overall Study||50||
48268971|NCT04560374|100981859|FG001|COMPLETED|Overall Study||50||
48108101|NCT00743652|100590681|FG000|NOT COMPLETED|Overall Study||10||
48108102|NCT00743652|100590682|FG001|NOT COMPLETED|Overall Study||3||
48108103|NCT00743652|100590683|FG002|NOT COMPLETED|Overall Study||2||
48108104|NCT00743652|100590684|FG003|NOT COMPLETED|Overall Study||4||
48108105|NCT00743652|100590685|FG004|NOT COMPLETED|Overall Study||0||
48108106|NCT02347527|100590686|FG000|STARTED|Overall Study||25||
48108107|NCT02347527|100590687|FG001|STARTED|Overall Study||22||
48108108|NCT02347527|100590688|FG002|STARTED|Overall Study||23||
48108109|NCT02347527|100590689|FG003|STARTED|Overall Study||22||
48108110|NCT02347527|100590686|FG000|Completed Intervention|Overall Study||24||
48108111|NCT02347527|100590687|FG001|Completed Intervention|Overall Study||21||
48108112|NCT02347527|100590688|FG002|Completed Intervention|Overall Study||23||
48108113|NCT02347527|100590689|FG003|Completed Intervention|Overall Study||22||
48108114|NCT02347527|100590686|FG000|Included in Analyses|Overall Study||22||
48108115|NCT02347527|100590687|FG001|Included in Analyses|Overall Study||19||
48108116|NCT02347527|100590688|FG002|Included in Analyses|Overall Study||22||
48108117|NCT02347527|100590689|FG003|Included in Analyses|Overall Study||20||
48108118|NCT02347527|100590686|FG000|COMPLETED|Overall Study||22||
48108119|NCT02347527|100590687|FG001|COMPLETED|Overall Study||19||
48108120|NCT02347527|100590688|FG002|COMPLETED|Overall Study||22||
48108121|NCT02347527|100590689|FG003|COMPLETED|Overall Study||20||
48108122|NCT02347527|100590686|FG000|NOT COMPLETED|Overall Study||3||
48108123|NCT02347527|100590687|FG001|NOT COMPLETED|Overall Study||3||
48108124|NCT02347527|100590688|FG002|NOT COMPLETED|Overall Study||1||
48108125|NCT02347527|100590689|FG003|NOT COMPLETED|Overall Study||2||
48108126|NCT02086110|100590690|FG000|STARTED|Overall Study||5||
48108127|NCT02086110|100590691|FG001|STARTED|Overall Study||6||
48108128|NCT02086110|100590690|FG000|COMPLETED|Overall Study||4||
48108129|NCT02086110|100590691|FG001|COMPLETED|Overall Study||5||
48108130|NCT02086110|100590690|FG000|NOT COMPLETED|Overall Study||1||
48108131|NCT02086110|100590691|FG001|NOT COMPLETED|Overall Study||1||
48108132|NCT02508636|100590692|FG000|STARTED|Overall Study||11||
48108133|NCT02508636|100590692|FG000|COMPLETED|Overall Study||11||
48108134|NCT02508636|100590692|FG000|NOT COMPLETED|Overall Study||0||
48108135|NCT00856908|100590693|FG000|STARTED|Overall Study||15||
48108136|NCT00856908|100590694|FG001|STARTED|Overall Study||5||
48108137|NCT00856908|100590693|FG000|COMPLETED|Overall Study||14||
48108138|NCT00856908|100590694|FG001|COMPLETED|Overall Study||5||
48108139|NCT00856908|100590693|FG000|NOT COMPLETED|Overall Study||1||
48108140|NCT00856908|100590694|FG001|NOT COMPLETED|Overall Study||0||
48108141|NCT00265473|100590695|FG000|STARTED|Overall Study||5||
48108142|NCT00265473|100590695|FG000|COMPLETED|Overall Study||5||
48108143|NCT00265473|100590695|FG000|NOT COMPLETED|Overall Study||0||
48108144|NCT02310919|100590696|FG000|STARTED|Overall Study||54||
48108145|NCT02310919|100590697|FG001|STARTED|Overall Study||51||
48108146|NCT02310919|100590696|FG000|COMPLETED|Overall Study||54||
48108147|NCT02310919|100590697|FG001|COMPLETED|Overall Study||51||
48108148|NCT02310919|100590696|FG000|NOT COMPLETED|Overall Study||0||
48108149|NCT02310919|100590697|FG001|NOT COMPLETED|Overall Study||0||
48108150|NCT02581384|100590698|FG000|STARTED|Overall Study||3||
48108151|NCT02581384|100590699|FG001|STARTED|Overall Study||2||
48108152|NCT02581384|100590698|FG000|COMPLETED|Overall Study||3||
48268972|NCT04560374|100981858|FG000|NOT COMPLETED|Overall Study||0||
48268973|NCT04560374|100981859|FG001|NOT COMPLETED|Overall Study||0||
48268974|NCT03853551|100981860|FG000|STARTED|Overall Study||60|60 patients were enrolled and received at least 1 dose of the study drug.|
48392253|NCT00830960|101287834|FG003|Received at Least 1 Dose of Study Drug|Overall Study||135||
48552639|NCT03541317|101686780|FG000|STARTED|Stage 1 of the Implementation||6||5
48108153|NCT02581384|100590699|FG001|COMPLETED|Overall Study||2||
48108154|NCT02581384|100590698|FG000|NOT COMPLETED|Overall Study||0||
48108155|NCT02581384|100590699|FG001|NOT COMPLETED|Overall Study||0||
48108156|NCT02457403|100590700|FG000|STARTED|Overall Study||34||
48268975|NCT03853551|100981860|FG000|COMPLETED|Overall Study||51|"51 patients completed the study treatment (Cycle 1, Day 1 to Cycle 6, Day 21) and 28 days follow-up.~Each cycle consisting of 21 days."|
48552640|NCT03541317|101686781|FG001|STARTED|Stage 1 of the Implementation||37||21
48552641|NCT03541317|101686782|FG002|STARTED|Stage 1 of the Implementation||38||21
48108157|NCT02457403|100590701|FG001|STARTED|Overall Study||34||
48108158|NCT02457403|100590700|FG000|COMPLETED|Overall Study||34||
48108159|NCT02457403|100590701|FG001|COMPLETED|Overall Study||34||
48108160|NCT02457403|100590700|FG000|NOT COMPLETED|Overall Study||0||
48108161|NCT02457403|100590701|FG001|NOT COMPLETED|Overall Study||0||
48108162|NCT02268409|100590702|FG000|STARTED|Overall Study||51||
48268976|NCT03853551|100981860|FG000|NOT COMPLETED|Overall Study||9||
48108163|NCT02268409|100590702|FG000|COMPLETED|Overall Study||14||
48108164|NCT02268409|100590702|FG000|NOT COMPLETED|Overall Study||37||
48108165|NCT02016625|100590703|FG000|STARTED|Cyclo or Tac (Single Dose, Day 1)||16||
48108166|NCT02016625|100590704|FG001|STARTED|Cyclo or Tac (Single Dose, Day 1)||16||
48108167|NCT02016625|100590703|FG000|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||16||
48108168|NCT02016625|100590704|FG001|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||15||
48108169|NCT02016625|100590703|FG000|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||0||
48108170|NCT02016625|100590704|FG001|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||1||
48108171|NCT02016625|100590703|FG000|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||16||
48108172|NCT02016625|100590704|FG001|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15||
48108173|NCT02016625|100590703|FG000|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||13||
48108174|NCT02016625|100590704|FG001|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15||
48108175|NCT02016625|100590703|FG000|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||3||
48108176|NCT02016625|100590704|FG001|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||0||
48108177|NCT01538862|100590705|FG000|STARTED|Overall Study||7||
48108178|NCT01538862|100590705|FG000|COMPLETED|Overall Study||7||
48108179|NCT01538862|100590705|FG000|NOT COMPLETED|Overall Study||0||
48108180|NCT00805766|100590706|FG000|STARTED|Screening Period||45||
48108181|NCT00805766|100590706|FG000|COMPLETED|Screening Period||39||
48108182|NCT00805766|100590706|FG000|NOT COMPLETED|Screening Period||6||
48108183|NCT00805766|100590706|FG000|STARTED|Increased Dose Period||39||
48108184|NCT00805766|100590706|FG000|COMPLETED|Increased Dose Period||26||
48108185|NCT00805766|100590706|FG000|NOT COMPLETED|Increased Dose Period||13||
48108186|NCT03023085|100590707|FG000|STARTED|Overall Study||40||
48108187|NCT03023085|100590708|FG001|STARTED|Overall Study||37||
48108188|NCT03023085|100590709|FG002|STARTED|Overall Study||17||
48108189|NCT03023085|100590710|FG003|STARTED|Overall Study||20||
48108190|NCT03023085|100590707|FG000|COMPLETED|Overall Study||38||
48108191|NCT03023085|100590708|FG001|COMPLETED|Overall Study||26||
48108192|NCT03023085|100590709|FG002|COMPLETED|Overall Study||17||
48108193|NCT03023085|100590710|FG003|COMPLETED|Overall Study||19||
48108194|NCT03023085|100590707|FG000|NOT COMPLETED|Overall Study||2||
48108195|NCT03023085|100590708|FG001|NOT COMPLETED|Overall Study||11||
48108196|NCT03023085|100590709|FG002|NOT COMPLETED|Overall Study||0||
48108197|NCT03023085|100590710|FG003|NOT COMPLETED|Overall Study||1||
48108198|NCT02084628|100590711|FG000|STARTED|Overall Study||1||
48108199|NCT02084628|100590711|FG000|COMPLETED|Overall Study||1||
48108200|NCT02084628|100590711|FG000|NOT COMPLETED|Overall Study||0||
48108201|NCT01633320|100590712|FG000|STARTED|Overall Study||132||
48108202|NCT01633320|100590713|FG001|STARTED|Overall Study||68||
48108203|NCT01633320|100590712|FG000|COMPLETED|Overall Study||132||
48108204|NCT01633320|100590713|FG001|COMPLETED|Overall Study||68||
48108205|NCT01633320|100590712|FG000|NOT COMPLETED|Overall Study||0||
48108206|NCT01633320|100590713|FG001|NOT COMPLETED|Overall Study||0||
48108207|NCT01236755|100590714|FG000|STARTED|Spectacles Wearing Phase||91||
48108208|NCT01236755|100590714|FG000|COMPLETED|Spectacles Wearing Phase||74||
48108209|NCT01236755|100590714|FG000|NOT COMPLETED|Spectacles Wearing Phase||17||
48108210|NCT01236755|100590714|FG000|STARTED|Orthokeratology Wearing Phase||74||
48108211|NCT01236755|100590714|FG000|COMPLETED|Orthokeratology Wearing Phase||66||
48108212|NCT01236755|100590714|FG000|NOT COMPLETED|Orthokeratology Wearing Phase||8||
48108213|NCT04865432|100590715|FG000|STARTED|Overall Study||10||
48108214|NCT04865432|100590715|FG000|COMPLETED|Overall Study||10||
48108215|NCT04865432|100590715|FG000|NOT COMPLETED|Overall Study||0||
48108216|NCT01230931|100590716|FG000|STARTED|Overall Study||10||
48108217|NCT01230931|100590717|FG001|STARTED|Overall Study||10||
48108218|NCT01230931|100590716|FG000|COMPLETED|Overall Study||10||
48108219|NCT01230931|100590717|FG001|COMPLETED|Overall Study||10||
48108220|NCT01230931|100590716|FG000|NOT COMPLETED|Overall Study||0||
48108221|NCT01230931|100590717|FG001|NOT COMPLETED|Overall Study||0||
48108222|NCT02127632|100590718|FG000|STARTED|Overall Study||50||
48108223|NCT02127632|100590719|FG001|STARTED|Overall Study||50||
48108224|NCT02127632|100590718|FG000|COMPLETED|Overall Study||50||
48108225|NCT02127632|100590719|FG001|COMPLETED|Overall Study||50||
48108226|NCT02127632|100590718|FG000|NOT COMPLETED|Overall Study||0||
48108227|NCT02127632|100590719|FG001|NOT COMPLETED|Overall Study||0||
48108228|NCT00500370|100590720|FG000|STARTED|Overall Study||80||
48108229|NCT00500370|100590721|FG001|STARTED|Overall Study||83||
48108230|NCT00500370|100590720|FG000|Treatment Start-Baseline (Week 0)|Overall Study||73||
48108231|NCT00500370|100590721|FG001|Treatment Start-Baseline (Week 0)|Overall Study||79||
48108232|NCT00500370|100590720|FG000|Treatment Complete (Week 24)|Overall Study||48||
48108233|NCT00500370|100590721|FG001|Treatment Complete (Week 24)|Overall Study||54||
48108234|NCT00500370|100590720|FG000|COMPLETED|Overall Study||47||
48108235|NCT00500370|100590721|FG001|COMPLETED|Overall Study||49||
48108236|NCT00500370|100590720|FG000|NOT COMPLETED|Overall Study||33||
48108237|NCT00500370|100590721|FG001|NOT COMPLETED|Overall Study||34||
48108238|NCT00005669|100590722|FG000|STARTED|Overall Study||53||
48108239|NCT00005669|100590723|FG001|STARTED|Overall Study||47||
48108240|NCT00005669|100590722|FG000|COMPLETED|Overall Study||45||
48108241|NCT00005669|100590723|FG001|COMPLETED|Overall Study||40||
48108242|NCT00005669|100590722|FG000|NOT COMPLETED|Overall Study||8||
48268977|NCT01261000|100981861|FG000|STARTED|Overall Study||8||
48268978|NCT01261000|100981861|FG000|COMPLETED|Overall Study||7||
48268979|NCT01261000|100981861|FG000|NOT COMPLETED|Overall Study||1||
48268980|NCT01305408|100981862|FG000|STARTED|Overall Study||199||
48268981|NCT01305408|100981863|FG001|STARTED|Overall Study||200||
48268982|NCT01305408|100981862|FG000|Safety Population|Overall Study||198||
48268983|NCT01305408|100981863|FG001|Safety Population|Overall Study||200||
48268984|NCT01305408|100981862|FG000|Full Analysis Population|Overall Study||196||
48268985|NCT01305408|100981863|FG001|Full Analysis Population|Overall Study||197||
48268986|NCT01305408|100981862|FG000|COMPLETED|Overall Study||167||
48268987|NCT01305408|100981863|FG001|COMPLETED|Overall Study||169||
48268988|NCT01305408|100981862|FG000|NOT COMPLETED|Overall Study||32||
48268989|NCT01305408|100981863|FG001|NOT COMPLETED|Overall Study||31||
48268990|NCT00534495|100981864|FG000|STARTED|Double Blind Placebo Phase Week 0-4||36||
48268991|NCT00534495|100981865|FG001|STARTED|Double Blind Placebo Phase Week 0-4||35||
48268992|NCT00534495|100981866|FG002|STARTED|Double Blind Placebo Phase Week 0-4||0||
48268993|NCT00534495|100981864|FG000|COMPLETED|Double Blind Placebo Phase Week 0-4||36||
48268994|NCT00534495|100981865|FG001|COMPLETED|Double Blind Placebo Phase Week 0-4||34||
48268995|NCT00534495|100981866|FG002|COMPLETED|Double Blind Placebo Phase Week 0-4||0||
48268996|NCT00534495|100981864|FG000|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0||
48268997|NCT00534495|100981865|FG001|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||1||
48268998|NCT00534495|100981866|FG002|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0||
48268999|NCT00534495|100981864|FG000|STARTED|All Active Treatment Phase Week 4-24||36||
48269000|NCT00534495|100981865|FG001|STARTED|All Active Treatment Phase Week 4-24||34||
48269001|NCT00534495|100981866|FG002|STARTED|All Active Treatment Phase Week 4-24||0||
48269002|NCT00534495|100981864|FG000|COMPLETED|All Active Treatment Phase Week 4-24||32||
48269003|NCT00534495|100981865|FG001|COMPLETED|All Active Treatment Phase Week 4-24||25||
48269004|NCT00534495|100981866|FG002|COMPLETED|All Active Treatment Phase Week 4-24||0||
48269005|NCT00534495|100981864|FG000|NOT COMPLETED|All Active Treatment Phase Week 4-24||4||
48269006|NCT00534495|100981865|FG001|NOT COMPLETED|All Active Treatment Phase Week 4-24||9||
48269007|NCT00534495|100981866|FG002|NOT COMPLETED|All Active Treatment Phase Week 4-24||0||
48269008|NCT00534495|100981864|FG000|STARTED|Long Term Ext. Phase Week 24-month 21||0||
48269009|NCT00534495|100981865|FG001|STARTED|Long Term Ext. Phase Week 24-month 21||0||
48269010|NCT00534495|100981866|FG002|STARTED|Long Term Ext. Phase Week 24-month 21||40||
48269011|NCT00534495|100981864|FG000|COMPLETED|Long Term Ext. Phase Week 24-month 21||0||
48269012|NCT00534495|100981865|FG001|COMPLETED|Long Term Ext. Phase Week 24-month 21||0||
48269013|NCT00534495|100981866|FG002|COMPLETED|Long Term Ext. Phase Week 24-month 21||29||
48269014|NCT00534495|100981864|FG000|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0||
48269015|NCT00534495|100981865|FG001|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0||
48269016|NCT00534495|100981866|FG002|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||11||
48269017|NCT04486625|100981867|FG000|STARTED|Overall Study||6||
48269018|NCT04486625|100981868|FG001|STARTED|Overall Study||5||
48269019|NCT04486625|100981867|FG000|COMPLETED|Overall Study||6||
48269020|NCT04486625|100981868|FG001|COMPLETED|Overall Study||5||
48269021|NCT04486625|100981867|FG000|NOT COMPLETED|Overall Study||0||
48269022|NCT04486625|100981868|FG001|NOT COMPLETED|Overall Study||0||
48269023|NCT00416195|100981869|FG000|STARTED|Overall Study||10||
48269024|NCT00416195|100981870|FG001|STARTED|Overall Study||38||
48269025|NCT00416195|100981869|FG000|COMPLETED|Overall Study||8||
48269026|NCT00416195|100981870|FG001|COMPLETED|Overall Study||34||
48269027|NCT00416195|100981869|FG000|NOT COMPLETED|Overall Study||2||
48269028|NCT00416195|100981870|FG001|NOT COMPLETED|Overall Study||4||
48269029|NCT01375673|100981871|FG000|STARTED|Overall Study||7||
48269030|NCT01375673|100981872|FG001|STARTED|Overall Study||7||
48269031|NCT01375673|100981871|FG000|COMPLETED|Overall Study||7||
48269032|NCT01375673|100981872|FG001|COMPLETED|Overall Study||6||
48269033|NCT01375673|100981871|FG000|NOT COMPLETED|Overall Study||0||
48269034|NCT01375673|100981872|FG001|NOT COMPLETED|Overall Study||1||
48269035|NCT01780454|100981873|FG000|STARTED|Overall Study||2||
48269036|NCT01780454|100981873|FG000|COMPLETED|Overall Study||2||
48269037|NCT01780454|100981873|FG000|NOT COMPLETED|Overall Study||0||
48269038|NCT05288829|100981874|FG000|STARTED|Overall Study||24||
48269039|NCT05288829|100981875|FG001|STARTED|Overall Study||12||
48269040|NCT05288829|100981876|FG002|STARTED|Overall Study||6||
48269041|NCT05288829|100981874|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||24||
48269042|NCT05288829|100981875|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||12||
48269043|NCT05288829|100981876|FG002|Received At Least 1 Dose Of Study Drug|Overall Study||6||
48269044|NCT05288829|100981874|FG000|COMPLETED|Overall Study||24||
48269045|NCT05288829|100981875|FG001|COMPLETED|Overall Study||12||
48269046|NCT05288829|100981876|FG002|COMPLETED|Overall Study||6||
48269047|NCT05288829|100981874|FG000|NOT COMPLETED|Overall Study||0||
48269048|NCT05288829|100981875|FG001|NOT COMPLETED|Overall Study||0||
48269049|NCT05288829|100981876|FG002|NOT COMPLETED|Overall Study||0||
48269050|NCT01251770|100981877|FG000|STARTED|Overall Study||42||
48269051|NCT01251770|100981878|FG001|STARTED|Overall Study||36||
48269052|NCT01251770|100981877|FG000|COMPLETED|Overall Study||29||
48269053|NCT01251770|100981878|FG001|COMPLETED|Overall Study||29||
48269054|NCT01251770|100981877|FG000|NOT COMPLETED|Overall Study||13||
48269055|NCT01251770|100981878|FG001|NOT COMPLETED|Overall Study||7||
48269056|NCT00921947|100981879|FG000|STARTED|Day 0||30||
48269057|NCT00921947|100981880|FG001|STARTED|Day 0||30||
48269058|NCT00921947|100981879|FG000|COMPLETED|Day 0||30||
48269059|NCT00921947|100981880|FG001|COMPLETED|Day 0||30||
48269060|NCT00921947|100981879|FG000|NOT COMPLETED|Day 0||0||
48269061|NCT00921947|100981880|FG001|NOT COMPLETED|Day 0||0||
48269062|NCT00921947|100981879|FG000|STARTED|Day 28||28||
48269063|NCT00921947|100981880|FG001|STARTED|Day 28||30||
48269064|NCT00921947|100981879|FG000|COMPLETED|Day 28||28||
48269065|NCT00921947|100981880|FG001|COMPLETED|Day 28||30||
48269066|NCT00921947|100981879|FG000|NOT COMPLETED|Day 28||0||
48269067|NCT00921947|100981880|FG001|NOT COMPLETED|Day 28||0||
48269068|NCT01661205|100981881|FG000|STARTED|Overall Study||26||
48269069|NCT01661205|100981881|FG000|COMPLETED|Overall Study||24||
48269070|NCT01661205|100981881|FG000|NOT COMPLETED|Overall Study||2||
48269071|NCT02314689|100981882|FG000|STARTED|Overall Study||4||
48269072|NCT02314689|100981882|FG000|COMPLETED|Overall Study||4||
48269073|NCT02314689|100981882|FG000|NOT COMPLETED|Overall Study||0||
48269074|NCT01370655|100981883|FG000|STARTED|Period 1||7||
48269075|NCT01370655|100981884|FG001|STARTED|Period 1||7||
48269076|NCT01370655|100981885|FG002|STARTED|Period 1||3||
48269077|NCT01370655|100981886|FG003|STARTED|Period 1||3||
48269078|NCT01370655|100981887|FG004|STARTED|Period 1||3||
48269079|NCT01370655|100981888|FG005|STARTED|Period 1||4||
48269080|NCT01370655|100981889|FG006|STARTED|Period 1||4||
48269081|NCT01370655|100981890|FG007|STARTED|Period 1||4||
48269082|NCT01370655|100981891|FG008|STARTED|Period 1||3||
48269083|NCT01370655|100981892|FG009|STARTED|Period 1||2||
48269084|NCT01370655|100981893|FG010|STARTED|Period 1||3||
48269085|NCT01370655|100981894|FG011|STARTED|Period 1||3||
48269086|NCT01370655|100981883|FG000|COMPLETED|Period 1||5||
48269087|NCT01370655|100981884|FG001|COMPLETED|Period 1||7||
48269088|NCT01370655|100981885|FG002|COMPLETED|Period 1||3||
48269089|NCT01370655|100981886|FG003|COMPLETED|Period 1||3||
48269090|NCT01370655|100981887|FG004|COMPLETED|Period 1||3||
48269091|NCT01370655|100981888|FG005|COMPLETED|Period 1||4||
48269092|NCT01370655|100981889|FG006|COMPLETED|Period 1||3||
48269093|NCT01370655|100981890|FG007|COMPLETED|Period 1||4||
48269094|NCT01370655|100981891|FG008|COMPLETED|Period 1||3||
48269095|NCT01370655|100981892|FG009|COMPLETED|Period 1||2||
48269096|NCT01370655|100981893|FG010|COMPLETED|Period 1||3||
48269097|NCT01370655|100981894|FG011|COMPLETED|Period 1||3||
48269098|NCT01370655|100981883|FG000|NOT COMPLETED|Period 1||2||
48269099|NCT01370655|100981884|FG001|NOT COMPLETED|Period 1||0||
48269100|NCT01370655|100981885|FG002|NOT COMPLETED|Period 1||0||
48269101|NCT01370655|100981886|FG003|NOT COMPLETED|Period 1||0||
48269102|NCT01370655|100981887|FG004|NOT COMPLETED|Period 1||0||
48269103|NCT01370655|100981888|FG005|NOT COMPLETED|Period 1||0||
48269104|NCT01370655|100981889|FG006|NOT COMPLETED|Period 1||1||
48269105|NCT01370655|100981890|FG007|NOT COMPLETED|Period 1||0||
48269106|NCT01370655|100981891|FG008|NOT COMPLETED|Period 1||0||
48269107|NCT01370655|100981892|FG009|NOT COMPLETED|Period 1||0||
48269108|NCT01370655|100981893|FG010|NOT COMPLETED|Period 1||0||
48269109|NCT01370655|100981894|FG011|NOT COMPLETED|Period 1||0||
48269110|NCT01370655|100981883|FG000|STARTED|Period 2||5||
48269111|NCT01370655|100981884|FG001|STARTED|Period 2||7||
48269112|NCT01370655|100981885|FG002|STARTED|Period 2||3||
48269113|NCT01370655|100981886|FG003|STARTED|Period 2||3||
48269114|NCT01370655|100981887|FG004|STARTED|Period 2||3||
48269115|NCT01370655|100981888|FG005|STARTED|Period 2||4||
48269116|NCT01370655|100981889|FG006|STARTED|Period 2||3||
48269117|NCT01370655|100981890|FG007|STARTED|Period 2||4||
48269118|NCT01370655|100981891|FG008|STARTED|Period 2||3||
48269119|NCT01370655|100981892|FG009|STARTED|Period 2||2||
48269120|NCT01370655|100981893|FG010|STARTED|Period 2||3||
48269121|NCT01370655|100981894|FG011|STARTED|Period 2||3||
48269122|NCT01370655|100981883|FG000|COMPLETED|Period 2||5||
48269123|NCT01370655|100981884|FG001|COMPLETED|Period 2||7||
48269124|NCT01370655|100981885|FG002|COMPLETED|Period 2||1||
48269125|NCT01370655|100981886|FG003|COMPLETED|Period 2||3||
48269126|NCT01370655|100981887|FG004|COMPLETED|Period 2||2||
48269127|NCT01370655|100981888|FG005|COMPLETED|Period 2||4||
48269128|NCT01370655|100981889|FG006|COMPLETED|Period 2||2||
48693109|NCT01681186|102032719|FG007|NOT COMPLETED|Washout Period From Second Intervention||1||
48693110|NCT01681186|102032712|FG000|STARTED|Third Intervention||0||
48693111|NCT01681186|102032713|FG001|STARTED|Third Intervention||0||
48693112|NCT01681186|102032714|FG002|STARTED|Third Intervention||0||
48269129|NCT01370655|100981890|FG007|COMPLETED|Period 2||3||
48269130|NCT01370655|100981891|FG008|COMPLETED|Period 2||1||
48269131|NCT01370655|100981892|FG009|COMPLETED|Period 2||2||
48269132|NCT01370655|100981893|FG010|COMPLETED|Period 2||2||
48269133|NCT01370655|100981894|FG011|COMPLETED|Period 2||3||
48269134|NCT01370655|100981883|FG000|NOT COMPLETED|Period 2||0||
48269135|NCT01370655|100981884|FG001|NOT COMPLETED|Period 2||0||
48269136|NCT01370655|100981885|FG002|NOT COMPLETED|Period 2||2||
48269137|NCT01370655|100981886|FG003|NOT COMPLETED|Period 2||0||
48269138|NCT01370655|100981887|FG004|NOT COMPLETED|Period 2||1||
48269139|NCT01370655|100981888|FG005|NOT COMPLETED|Period 2||0||
48269140|NCT01370655|100981889|FG006|NOT COMPLETED|Period 2||1||
48693113|NCT01681186|102032715|FG003|STARTED|Third Intervention||0||
48269141|NCT01370655|100981890|FG007|NOT COMPLETED|Period 2||1||
48269142|NCT01370655|100981891|FG008|NOT COMPLETED|Period 2||2||
48269143|NCT01370655|100981892|FG009|NOT COMPLETED|Period 2||0||
48269144|NCT01370655|100981893|FG010|NOT COMPLETED|Period 2||1||
48269145|NCT01370655|100981894|FG011|NOT COMPLETED|Period 2||0||
48269146|NCT01441635|100981895|FG000|STARTED|Overall Study||32||
48269147|NCT01441635|100981896|FG001|STARTED|Overall Study||33||
48269148|NCT01441635|100981897|FG002|STARTED|Overall Study||16||
48269149|NCT01441635|100981898|FG003|STARTED|Overall Study||35||
48269150|NCT01441635|100981899|FG004|STARTED|Overall Study||18||
48269151|NCT01441635|100981900|FG005|STARTED|Overall Study||34||
48269152|NCT01441635|100981901|FG006|STARTED|Overall Study||30||
48269153|NCT01441635|100981902|FG007|STARTED|Overall Study||30||
48269154|NCT01441635|100981903|FG008|STARTED|Overall Study||16||
48269155|NCT01441635|100981904|FG009|STARTED|Overall Study||27||
48269156|NCT01441635|100981895|FG000|COMPLETED|Overall Study||26||
48269157|NCT01441635|100981896|FG001|COMPLETED|Overall Study||27||
48269158|NCT01441635|100981897|FG002|COMPLETED|Overall Study||13||
48269159|NCT01441635|100981898|FG003|COMPLETED|Overall Study||28||
48269160|NCT01441635|100981899|FG004|COMPLETED|Overall Study||16||
48269161|NCT01441635|100981900|FG005|COMPLETED|Overall Study||29||
48269162|NCT01441635|100981901|FG006|COMPLETED|Overall Study||24||
48269163|NCT01441635|100981902|FG007|COMPLETED|Overall Study||26||
48269164|NCT01441635|100981903|FG008|COMPLETED|Overall Study||14||
48269165|NCT01441635|100981904|FG009|COMPLETED|Overall Study||25||
48269166|NCT01441635|100981895|FG000|NOT COMPLETED|Overall Study||6||
48269167|NCT01441635|100981896|FG001|NOT COMPLETED|Overall Study||6||
48269168|NCT01441635|100981897|FG002|NOT COMPLETED|Overall Study||3||
48269169|NCT01441635|100981898|FG003|NOT COMPLETED|Overall Study||7||
48269170|NCT01441635|100981899|FG004|NOT COMPLETED|Overall Study||2||
48269171|NCT01441635|100981900|FG005|NOT COMPLETED|Overall Study||5||
48269172|NCT01441635|100981901|FG006|NOT COMPLETED|Overall Study||6||
48269173|NCT01441635|100981902|FG007|NOT COMPLETED|Overall Study||4||
48269174|NCT01441635|100981903|FG008|NOT COMPLETED|Overall Study||2||
48269175|NCT01441635|100981904|FG009|NOT COMPLETED|Overall Study||2||
48269176|NCT02694445|100981905|FG000|STARTED|Overall Study||3098||
48269177|NCT02694445|100981905|FG000|COMPLETED|Overall Study||3046||
48269178|NCT02694445|100981905|FG000|NOT COMPLETED|Overall Study||52||
48269179|NCT00340704|100981906|FG000|STARTED|PK Study||10||
48269180|NCT00340704|100981907|FG001|STARTED|PK Study||10||
48269181|NCT00340704|100981908|FG002|STARTED|PK Study||11||
48269182|NCT00340704|100981909|FG003|STARTED|PK Study||0||
48269183|NCT00340704|100981910|FG004|STARTED|PK Study||0||
48269184|NCT00340704|100981911|FG005|STARTED|PK Study||0||
48269185|NCT00340704|100981912|FG006|STARTED|PK Study||0||
48269186|NCT00340704|100981913|FG007|STARTED|PK Study||0||
48269187|NCT00340704|100981914|FG008|STARTED|PK Study||0||
48269188|NCT00340704|100981906|FG000|COMPLETED|PK Study||10||
48269189|NCT00340704|100981907|FG001|COMPLETED|PK Study||9||
48269190|NCT00340704|100981908|FG002|COMPLETED|PK Study||10||
48269191|NCT00340704|100981909|FG003|COMPLETED|PK Study||0||
48269192|NCT00340704|100981910|FG004|COMPLETED|PK Study||0||
48269193|NCT00340704|100981911|FG005|COMPLETED|PK Study||0||
48269194|NCT00340704|100981912|FG006|COMPLETED|PK Study||0||
48269195|NCT00340704|100981913|FG007|COMPLETED|PK Study||0||
48269196|NCT00340704|100981914|FG008|COMPLETED|PK Study||0||
48269197|NCT00340704|100981906|FG000|NOT COMPLETED|PK Study||0||
48269198|NCT00340704|100981907|FG001|NOT COMPLETED|PK Study||1||
48269199|NCT00340704|100981908|FG002|NOT COMPLETED|PK Study||1||
48269200|NCT00340704|100981909|FG003|NOT COMPLETED|PK Study||0||
48269201|NCT00340704|100981910|FG004|NOT COMPLETED|PK Study||0||
48269202|NCT00340704|100981911|FG005|NOT COMPLETED|PK Study||0||
48269203|NCT00340704|100981912|FG006|NOT COMPLETED|PK Study||0||
48269204|NCT00340704|100981913|FG007|NOT COMPLETED|PK Study||0||
48269205|NCT00340704|100981914|FG008|NOT COMPLETED|PK Study||0||
48269206|NCT00340704|100981906|FG000|STARTED|Group D- Denovo & 527.51 Rollover Study||0||
48269207|NCT00340704|100981907|FG001|STARTED|Group D- Denovo & 527.51 Rollover Study||0||
48269208|NCT00340704|100981908|FG002|STARTED|Group D- Denovo & 527.51 Rollover Study||0||
48269209|NCT00340704|100981909|FG003|STARTED|Group D- Denovo & 527.51 Rollover Study||29||
48269210|NCT00340704|100981910|FG004|STARTED|Group D- Denovo & 527.51 Rollover Study||21||
48269211|NCT00340704|100981911|FG005|STARTED|Group D- Denovo & 527.51 Rollover Study||37||
48269212|NCT00340704|100981912|FG006|STARTED|Group D- Denovo & 527.51 Rollover Study||54||
48269213|NCT00340704|100981913|FG007|STARTED|Group D- Denovo & 527.51 Rollover Study||13||
48269214|NCT00340704|100981914|FG008|STARTED|Group D- Denovo & 527.51 Rollover Study||29||
48269215|NCT00340704|100981906|FG000|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0||
48269216|NCT00340704|100981907|FG001|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0||
48269217|NCT00340704|100981908|FG002|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0||
48269218|NCT00340704|100981909|FG003|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||7||
48269219|NCT00340704|100981910|FG004|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||5||
48269220|NCT00340704|100981911|FG005|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||18||
48269221|NCT00340704|100981912|FG006|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0||
48269222|NCT00340704|100981913|FG007|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0||
48269223|NCT00340704|100981914|FG008|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0||
48269224|NCT00340704|100981906|FG000|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0||
48269225|NCT00340704|100981907|FG001|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0||
48269226|NCT00340704|100981908|FG002|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0||
48269227|NCT00340704|100981909|FG003|COMPLETED|Group D- Denovo & 527.51 Rollover Study||27||
48269228|NCT00340704|100981910|FG004|COMPLETED|Group D- Denovo & 527.51 Rollover Study||16||
48269229|NCT00340704|100981911|FG005|COMPLETED|Group D- Denovo & 527.51 Rollover Study||30||
48269230|NCT00340704|100981912|FG006|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1||
48269231|NCT00340704|100981913|FG007|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1||
48269232|NCT00340704|100981914|FG008|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0||
48269233|NCT00340704|100981906|FG000|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0||
48269234|NCT00340704|100981907|FG001|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0||
48269235|NCT00340704|100981908|FG002|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0||
48269236|NCT00340704|100981909|FG003|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||2||
48269237|NCT00340704|100981910|FG004|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||5||
48269238|NCT00340704|100981911|FG005|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||7||
48269239|NCT00340704|100981912|FG006|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||53||
48269240|NCT00340704|100981913|FG007|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||12||
48269241|NCT00340704|100981914|FG008|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||29||
48269242|NCT00332462|100981915|FG000|STARTED|Overall Study||34||
48269243|NCT00332462|100981915|FG000|Patients Treated With Sandimmun® i.v.|Overall Study||34||
48269244|NCT00332462|100981915|FG000|Patients Treated With Sandimmun® Optoral|Overall Study||29||
48269245|NCT00332462|100981915|FG000|COMPLETED|Overall Study||18||
48269246|NCT00332462|100981915|FG000|NOT COMPLETED|Overall Study||16||
48269247|NCT01426230|100981916|FG000|STARTED|Overall Study||86||
48269248|NCT01426230|100981917|FG001|STARTED|Overall Study||111||
48269249|NCT01426230|100981916|FG000|COMPLETED|Overall Study||55||
48269250|NCT01426230|100981917|FG001|COMPLETED|Overall Study||84||
48269251|NCT01426230|100981916|FG000|NOT COMPLETED|Overall Study||31||
48269252|NCT01426230|100981917|FG001|NOT COMPLETED|Overall Study||27||
48269253|NCT00167206|100981918|FG000|STARTED|Overall Study||16||
48269254|NCT00167206|100981918|FG000|COMPLETED|Overall Study||16||
48269255|NCT00167206|100981918|FG000|NOT COMPLETED|Overall Study||0||
48269256|NCT03995316|100981919|FG000|STARTED|Overall Study||96||
48269257|NCT03995316|100981920|FG001|STARTED|Overall Study||95||
48269258|NCT03995316|100981919|FG000|COMPLETED|Overall Study||86||
48269259|NCT03995316|100981920|FG001|COMPLETED|Overall Study||92||
48269260|NCT03995316|100981919|FG000|NOT COMPLETED|Overall Study||10||
48269261|NCT03995316|100981920|FG001|NOT COMPLETED|Overall Study||3||
48269262|NCT00246090|100981921|FG000|STARTED|Overall Study||298||
48269263|NCT00246090|100981921|FG000|COMPLETED|Overall Study||3||
48269264|NCT00246090|100981921|FG000|NOT COMPLETED|Overall Study||295||
48269265|NCT00643617|100981922|FG000|STARTED|Overall Study||112|Received CyberKnife treatment|
48269266|NCT00643617|100981923|FG001|STARTED|Overall Study||147|Received CyberKnife treatment|
48269267|NCT00643617|100981922|FG000|10-yr Follow up|Overall Study||36|Optional extension per protocol amendment|
48269268|NCT00643617|100981923|FG001|10-yr Follow up|Overall Study||33|Optional extension per protocol amendment|
48269269|NCT00643617|100981922|FG000|COMPLETED|Overall Study||64|Completed required 5-year follow up|
48269270|NCT00643617|100981923|FG001|COMPLETED|Overall Study||87|Completed required 5-year follow up|
48269271|NCT00643617|100981922|FG000|NOT COMPLETED|Overall Study||48||
48269272|NCT00643617|100981923|FG001|NOT COMPLETED|Overall Study||60||
48269273|NCT04243512|100981924|FG000|STARTED|Overall Study||39||
48269274|NCT04243512|100981924|FG000|COMPLETED|Overall Study||36||
48269275|NCT04243512|100981924|FG000|NOT COMPLETED|Overall Study||3||
48269276|NCT02202785|100981925|FG000|STARTED|Overall Study||11||
48269277|NCT02202785|100981926|FG001|STARTED|Overall Study||15||
48269278|NCT02202785|100981927|FG002|STARTED|Overall Study||17||
48269279|NCT02202785|100981925|FG000|COMPLETED|Overall Study||0||
48269280|NCT02202785|100981926|FG001|COMPLETED|Overall Study||0||
48269281|NCT02202785|100981927|FG002|COMPLETED|Overall Study||0||
48269282|NCT02202785|100981925|FG000|NOT COMPLETED|Overall Study||11||
48269283|NCT02202785|100981926|FG001|NOT COMPLETED|Overall Study||15||
48269284|NCT02202785|100981927|FG002|NOT COMPLETED|Overall Study||17||
48269285|NCT01885689|100981928|FG000|STARTED|Overall Study||52||
48269286|NCT01885689|100981928|FG000|COMPLETED|Overall Study||52||
48269287|NCT01885689|100981928|FG000|NOT COMPLETED|Overall Study||0||
48269288|NCT00527787|100981929|FG000|STARTED|Overall Study||218||
48269289|NCT00527787|100981930|FG001|STARTED|Overall Study||216||
48269290|NCT00527787|100981929|FG000|COMPLETED|Overall Study||180||
48269291|NCT00527787|100981930|FG001|COMPLETED|Overall Study||153||
48269292|NCT00527787|100981929|FG000|NOT COMPLETED|Overall Study||38||
48552642|NCT03541317|101686783|FG003|STARTED|Stage 1 of the Implementation||9||6
48269293|NCT00527787|100981930|FG001|NOT COMPLETED|Overall Study||63||
48269294|NCT00863512|100981931|FG000|STARTED|Overall Study||17||
48269295|NCT00863512|100981932|FG001|STARTED|Overall Study||17||
48269296|NCT00863512|100981931|FG000|COMPLETED|Overall Study||3||
48269297|NCT00863512|100981932|FG001|COMPLETED|Overall Study||17||
48269298|NCT00863512|100981931|FG000|NOT COMPLETED|Overall Study||14||
48269299|NCT00863512|100981932|FG001|NOT COMPLETED|Overall Study||0||
48269300|NCT00611975|100981933|FG000|STARTED|Overall Study||45||
48269301|NCT00611975|100981934|FG001|STARTED|Overall Study||38||
48269302|NCT00611975|100981933|FG000|COMPLETED|Overall Study||40||
48269303|NCT00611975|100981934|FG001|COMPLETED|Overall Study||30||
48269304|NCT00611975|100981933|FG000|NOT COMPLETED|Overall Study||5||
48269305|NCT00611975|100981934|FG001|NOT COMPLETED|Overall Study||8||
48269306|NCT02053610|100981935|FG000|STARTED|Overall Study||330||
48269307|NCT02053610|100981936|FG001|STARTED|Overall Study||333||
48269308|NCT02053610|100981935|FG000|Received Study Drug|Overall Study||326||
48269309|NCT02053610|100981936|FG001|Received Study Drug|Overall Study||331||
48269310|NCT02053610|100981935|FG000|COMPLETED|Overall Study||288||
48269311|NCT02053610|100981936|FG001|COMPLETED|Overall Study||266||
48269312|NCT02053610|100981935|FG000|NOT COMPLETED|Overall Study||42||
48269313|NCT02053610|100981936|FG001|NOT COMPLETED|Overall Study||67||
48269314|NCT02269423|100981937|FG000|STARTED|Overall Study||10||
48269315|NCT02269423|100981938|FG001|STARTED|Overall Study||10||
48269316|NCT02269423|100981939|FG002|STARTED|Overall Study||10||
48269317|NCT02269423|100981940|FG003|STARTED|Overall Study||9||
48269318|NCT02269423|100981937|FG000|COMPLETED|Overall Study||10||
48269319|NCT02269423|100981938|FG001|COMPLETED|Overall Study||9||
48269320|NCT02269423|100981939|FG002|COMPLETED|Overall Study||10||
48269321|NCT02269423|100981940|FG003|COMPLETED|Overall Study||8||
48269322|NCT02269423|100981937|FG000|NOT COMPLETED|Overall Study||0||
48269323|NCT02269423|100981938|FG001|NOT COMPLETED|Overall Study||1||
48269324|NCT02269423|100981939|FG002|NOT COMPLETED|Overall Study||0||
48269325|NCT02269423|100981940|FG003|NOT COMPLETED|Overall Study||1||
48269326|NCT01465763|100981941|FG000|STARTED|Overall Study||476||
48269327|NCT01465763|100981942|FG001|STARTED|Overall Study||16||
48269328|NCT01465763|100981943|FG002|STARTED|Overall Study||122||
48269329|NCT01465763|100981941|FG000|COMPLETED|Overall Study||445||
48269330|NCT01465763|100981942|FG001|COMPLETED|Overall Study||15||
48269331|NCT01465763|100981943|FG002|COMPLETED|Overall Study||118||
48269332|NCT01465763|100981941|FG000|NOT COMPLETED|Overall Study||31||
48269333|NCT01465763|100981942|FG001|NOT COMPLETED|Overall Study||1||
48269334|NCT01465763|100981943|FG002|NOT COMPLETED|Overall Study||4||
48269335|NCT03714659|100981944|FG000|STARTED|Overall Study||20||
48269336|NCT03714659|100981944|FG000|COMPLETED|Overall Study||19||
48269337|NCT03714659|100981944|FG000|NOT COMPLETED|Overall Study||1||
48269338|NCT03993210|100981945|FG000|STARTED|Overall Study||1||
48269339|NCT03993210|100981946|FG001|STARTED|Overall Study||0||
48269340|NCT03993210|100981945|FG000|COMPLETED|Overall Study||1||
48269341|NCT03993210|100981946|FG001|COMPLETED|Overall Study||0||
48269342|NCT03993210|100981945|FG000|NOT COMPLETED|Overall Study||0||
48269343|NCT03993210|100981946|FG001|NOT COMPLETED|Overall Study||0||
48269344|NCT00667394|100981947|FG000|STARTED|Overall Study||41||
48269345|NCT00667394|100981948|FG001|STARTED|Overall Study||1||
48269346|NCT00667394|100981947|FG000|COMPLETED|Overall Study||37||
48269347|NCT00667394|100981948|FG001|COMPLETED|Overall Study||1||
48269348|NCT00667394|100981947|FG000|NOT COMPLETED|Overall Study||4||
48269349|NCT00667394|100981948|FG001|NOT COMPLETED|Overall Study||0||
48269350|NCT02902770|100981949|FG000|STARTED|Overall Study||50||
48269351|NCT02902770|100981950|FG001|STARTED|Overall Study||50||
48269352|NCT02902770|100981951|FG002|STARTED|Overall Study||50||
48269353|NCT02902770|100981949|FG000|COMPLETED|Overall Study||50||
48269354|NCT02902770|100981950|FG001|COMPLETED|Overall Study||50||
48269355|NCT02902770|100981951|FG002|COMPLETED|Overall Study||50||
48269356|NCT02902770|100981949|FG000|NOT COMPLETED|Overall Study||0||
48269357|NCT02902770|100981950|FG001|NOT COMPLETED|Overall Study||0||
48269358|NCT02902770|100981951|FG002|NOT COMPLETED|Overall Study||0||
48269359|NCT02354651|100981952|FG000|STARTED|Overall Study||9||
48269360|NCT02354651|100981952|FG000|COMPLETED|Overall Study||6||
48269361|NCT02354651|100981952|FG000|NOT COMPLETED|Overall Study||3||
48269362|NCT01443403|100981953|FG000|STARTED|Overall Study||61||
48269363|NCT01443403|100981954|FG001|STARTED|Overall Study||61||
48269364|NCT01443403|100981955|FG002|STARTED|Overall Study||61||
48269365|NCT01443403|100981956|FG003|STARTED|Overall Study||61||
48269366|NCT01443403|100981953|FG000|Received Treatment|Overall Study||61||
48269367|NCT01443403|100981954|FG001|Received Treatment|Overall Study||61||
48269368|NCT01443403|100981955|FG002|Received Treatment|Overall Study||60||
48269369|NCT01443403|100981956|FG003|Received Treatment|Overall Study||61||
48269370|NCT01443403|100981953|FG000|COMPLETED|Overall Study||55||
48269371|NCT01443403|100981954|FG001|COMPLETED|Overall Study||55||
48269372|NCT01443403|100981955|FG002|COMPLETED|Overall Study||54||
48269373|NCT01443403|100981956|FG003|COMPLETED|Overall Study||52||
48269374|NCT01443403|100981953|FG000|NOT COMPLETED|Overall Study||6||
48269375|NCT01443403|100981954|FG001|NOT COMPLETED|Overall Study||6||
48269376|NCT01443403|100981955|FG002|NOT COMPLETED|Overall Study||7||
48269377|NCT01443403|100981956|FG003|NOT COMPLETED|Overall Study||9||
48269378|NCT01167452|100981957|FG000|STARTED|Overall Study||36||
48269379|NCT01167452|100981957|FG000|COMPLETED|Overall Study||36||
48269380|NCT01167452|100981957|FG000|NOT COMPLETED|Overall Study||0||
48269381|NCT03468478|100981958|FG000|STARTED|Overall Study||403||
48269382|NCT03468478|100981959|FG001|STARTED|Overall Study||403||
48269383|NCT03468478|100981960|FG002|STARTED|Overall Study||403||
48269384|NCT03468478|100981958|FG000|COMPLETED|Overall Study||86||
48269385|NCT03468478|100981959|FG001|COMPLETED|Overall Study||90||
48269386|NCT03468478|100981960|FG002|COMPLETED|Overall Study||90||
48269387|NCT03468478|100981958|FG000|NOT COMPLETED|Overall Study||317||
48269388|NCT03468478|100981959|FG001|NOT COMPLETED|Overall Study||313||
48269389|NCT03468478|100981960|FG002|NOT COMPLETED|Overall Study||313||
48269390|NCT01888874|100981961|FG000|STARTED|Period 1 (Baseline up to Week 12)||86||
48269391|NCT01888874|100981962|FG001|STARTED|Period 1 (Baseline up to Week 12)||82||
48269392|NCT01888874|100981963|FG002|STARTED|Period 1 (Baseline up to Week 12)||85||
48269393|NCT01888874|100981964|FG003|STARTED|Period 1 (Baseline up to Week 12)||86||
48269394|NCT01888874|100981965|FG004|STARTED|Period 1 (Baseline up to Week 12)||86||
48269395|NCT01888874|100981966|FG005|STARTED|Period 1 (Baseline up to Week 12)||85||
48269396|NCT01888874|100981967|FG006|STARTED|Period 1 (Baseline up to Week 12)||84||
48269397|NCT01888874|100981961|FG000|COMPLETED|Period 1 (Baseline up to Week 12)||83||
48269398|NCT01888874|100981962|FG001|COMPLETED|Period 1 (Baseline up to Week 12)||76||
48269399|NCT01888874|100981963|FG002|COMPLETED|Period 1 (Baseline up to Week 12)||78||
48269400|NCT01888874|100981964|FG003|COMPLETED|Period 1 (Baseline up to Week 12)||80||
48269401|NCT01888874|100981965|FG004|COMPLETED|Period 1 (Baseline up to Week 12)||77||
48269402|NCT01888874|100981966|FG005|COMPLETED|Period 1 (Baseline up to Week 12)||80||
48269403|NCT01888874|100981967|FG006|COMPLETED|Period 1 (Baseline up to Week 12)||83||
48269404|NCT01888874|100981961|FG000|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3||
48269405|NCT01888874|100981962|FG001|NOT COMPLETED|Period 1 (Baseline up to Week 12)||6||
48269406|NCT01888874|100981963|FG002|NOT COMPLETED|Period 1 (Baseline up to Week 12)||7||
48269407|NCT01888874|100981964|FG003|NOT COMPLETED|Period 1 (Baseline up to Week 12)||6||
48269408|NCT01888874|100981965|FG004|NOT COMPLETED|Period 1 (Baseline up to Week 12)||9||
48269409|NCT01888874|100981966|FG005|NOT COMPLETED|Period 1 (Baseline up to Week 12)||5||
48269410|NCT01888874|100981967|FG006|NOT COMPLETED|Period 1 (Baseline up to Week 12)||1||
48269411|NCT01888874|100981961|FG000|STARTED|Period 2 (Week 13 to Week 24)||53||
48269412|NCT01888874|100981962|FG001|STARTED|Period 2 (Week 13 to Week 24)||57||
48269413|NCT01888874|100981963|FG002|STARTED|Period 2 (Week 13 to Week 24)||112||
48269414|NCT01888874|100981964|FG003|STARTED|Period 2 (Week 13 to Week 24)||80||
48269415|NCT01888874|100981965|FG004|STARTED|Period 2 (Week 13 to Week 24)||60||
48269416|NCT01888874|100981966|FG005|STARTED|Period 2 (Week 13 to Week 24)||112||
48269417|NCT01888874|100981967|FG006|STARTED|Period 2 (Week 13 to Week 24)||83||
48269418|NCT01888874|100981961|FG000|COMPLETED|Period 2 (Week 13 to Week 24)||50||
48269419|NCT01888874|100981962|FG001|COMPLETED|Period 2 (Week 13 to Week 24)||55||
48269420|NCT01888874|100981963|FG002|COMPLETED|Period 2 (Week 13 to Week 24)||104||
48269421|NCT01888874|100981964|FG003|COMPLETED|Period 2 (Week 13 to Week 24)||78||
48269422|NCT01888874|100981965|FG004|COMPLETED|Period 2 (Week 13 to Week 24)||57||
48269423|NCT01888874|100981966|FG005|COMPLETED|Period 2 (Week 13 to Week 24)||109||
48269424|NCT01888874|100981967|FG006|COMPLETED|Period 2 (Week 13 to Week 24)||80||
48269425|NCT01888874|100981961|FG000|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3||
48269426|NCT01888874|100981962|FG001|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2||
48269427|NCT01888874|100981963|FG002|NOT COMPLETED|Period 2 (Week 13 to Week 24)||8||
48269428|NCT01888874|100981964|FG003|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2||
48269429|NCT01888874|100981965|FG004|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3||
48269430|NCT01888874|100981966|FG005|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3||
48269431|NCT01888874|100981967|FG006|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3||
48269432|NCT02817906|100981968|FG000|STARTED|Overall Study||86|Part A-Number of subjects treated|
48269433|NCT02817906|100981969|FG001|STARTED|Overall Study||89|Part A-Number of subjects treated|
48269434|NCT02817906|100981968|FG000|COMPLETED|Overall Study||70|Part A|
48269435|NCT02817906|100981969|FG001|COMPLETED|Overall Study||84|Part A|
48269436|NCT02817906|100981968|FG000|NOT COMPLETED|Overall Study||16||
48392254|NCT00830960|101287835|FG004|Received at Least 1 Dose of Study Drug|Overall Study||91||
48269437|NCT02817906|100981969|FG001|NOT COMPLETED|Overall Study||5||
48269438|NCT03274453|100981970|FG000|STARTED|Overall Study||38||
48269439|NCT03274453|100981971|FG001|STARTED|Overall Study||30||
48269440|NCT03274453|100981972|FG002|STARTED|Overall Study||32||
48269441|NCT03274453|100981973|FG003|STARTED|Overall Study||29||
48269442|NCT03274453|100981970|FG000|COMPLETED|Overall Study||34||
48269443|NCT03274453|100981971|FG001|COMPLETED|Overall Study||24||
48269444|NCT03274453|100981972|FG002|COMPLETED|Overall Study||28||
48392255|NCT00830960|101287836|FG005|Received at Least 1 Dose of Study Drug|Overall Study||93||
48269445|NCT03274453|100981973|FG003|COMPLETED|Overall Study||25||
48269446|NCT03274453|100981970|FG000|NOT COMPLETED|Overall Study||4||
48269447|NCT03274453|100981971|FG001|NOT COMPLETED|Overall Study||6||
48269448|NCT03274453|100981972|FG002|NOT COMPLETED|Overall Study||4||
48269449|NCT03274453|100981973|FG003|NOT COMPLETED|Overall Study||4||
48269450|NCT04263987|100981974|FG000|STARTED|Overall Study||30||
48269451|NCT04263987|100981975|FG001|STARTED|Overall Study||30||
48269452|NCT04263987|100981974|FG000|COMPLETED|Overall Study||30||
48269453|NCT04263987|100981975|FG001|COMPLETED|Overall Study||30||
48269454|NCT04263987|100981974|FG000|NOT COMPLETED|Overall Study||0||
48269455|NCT04263987|100981975|FG001|NOT COMPLETED|Overall Study||0||
48269456|NCT01825798|100981976|FG000|STARTED|Overall Study||32||
48269457|NCT01825798|100981977|FG001|STARTED|Overall Study||28||
48269458|NCT01825798|100981976|FG000|COMPLETED|Overall Study||30||
48269459|NCT01825798|100981977|FG001|COMPLETED|Overall Study||23||
48269460|NCT01825798|100981976|FG000|NOT COMPLETED|Overall Study||2||
48269461|NCT01825798|100981977|FG001|NOT COMPLETED|Overall Study||5||
48269462|NCT01691950|100981978|FG000|STARTED|Overall Study||20||
48269463|NCT01691950|100981979|FG001|STARTED|Overall Study||10||
48269464|NCT01691950|100981978|FG000|COMPLETED|Overall Study||10||
48269465|NCT01691950|100981979|FG001|COMPLETED|Overall Study||10||
48269466|NCT01691950|100981978|FG000|NOT COMPLETED|Overall Study||10||
48269467|NCT01691950|100981979|FG001|NOT COMPLETED|Overall Study||0||
48552643|NCT03541317|101686784|FG004|STARTED|Stage 1 of the Implementation||43||21
48552644|NCT03541317|101686785|FG005|STARTED|Stage 1 of the Implementation||36||20
48552645|NCT03541317|101686780|FG000|COMPLETED|Stage 1 of the Implementation||6||5
48552646|NCT03541317|101686781|FG001|COMPLETED|Stage 1 of the Implementation||37||21
48552647|NCT03541317|101686782|FG002|COMPLETED|Stage 1 of the Implementation||38||21
48552648|NCT03541317|101686783|FG003|COMPLETED|Stage 1 of the Implementation||9||6
48552649|NCT03541317|101686784|FG004|COMPLETED|Stage 1 of the Implementation||43||21
48552650|NCT03541317|101686785|FG005|COMPLETED|Stage 1 of the Implementation||36||20
48552651|NCT03541317|101686780|FG000|NOT COMPLETED|Stage 1 of the Implementation||0||0
48552652|NCT03541317|101686781|FG001|NOT COMPLETED|Stage 1 of the Implementation||0||0
48552653|NCT03541317|101686782|FG002|NOT COMPLETED|Stage 1 of the Implementation||0||0
48552654|NCT03541317|101686783|FG003|NOT COMPLETED|Stage 1 of the Implementation||0||0
48552655|NCT03541317|101686784|FG004|NOT COMPLETED|Stage 1 of the Implementation||0||0
48552656|NCT03541317|101686785|FG005|NOT COMPLETED|Stage 1 of the Implementation||0||0
48552657|NCT03541317|101686780|FG000|STARTED|Stage 2 of the Implementation||6||5
48552658|NCT03541317|101686781|FG001|STARTED|Stage 2 of the Implementation||37||21
48552659|NCT03541317|101686782|FG002|STARTED|Stage 2 of the Implementation||38||21
48552660|NCT03541317|101686783|FG003|STARTED|Stage 2 of the Implementation||9||6
48552661|NCT03541317|101686784|FG004|STARTED|Stage 2 of the Implementation||43||21
48552662|NCT03541317|101686785|FG005|STARTED|Stage 2 of the Implementation||36||20
48552663|NCT03541317|101686780|FG000|COMPLETED|Stage 2 of the Implementation||5||5
48552664|NCT03541317|101686781|FG001|COMPLETED|Stage 2 of the Implementation||37||21
48552665|NCT03541317|101686782|FG002|COMPLETED|Stage 2 of the Implementation||38||21
48552666|NCT03541317|101686783|FG003|COMPLETED|Stage 2 of the Implementation||9||6
48552667|NCT03541317|101686784|FG004|COMPLETED|Stage 2 of the Implementation||43||21
48552668|NCT03541317|101686785|FG005|COMPLETED|Stage 2 of the Implementation||36||20
48552669|NCT03541317|101686780|FG000|NOT COMPLETED|Stage 2 of the Implementation||1||0
48552670|NCT03541317|101686781|FG001|NOT COMPLETED|Stage 2 of the Implementation||0||0
48552671|NCT03541317|101686782|FG002|NOT COMPLETED|Stage 2 of the Implementation||0||0
48552672|NCT03541317|101686783|FG003|NOT COMPLETED|Stage 2 of the Implementation||0||0
48552673|NCT03541317|101686784|FG004|NOT COMPLETED|Stage 2 of the Implementation||0||0
48693114|NCT01681186|102032716|FG004|STARTED|Third Intervention||0||
48693115|NCT01681186|102032717|FG005|STARTED|Third Intervention||0||
48693116|NCT01681186|102032718|FG006|STARTED|Third Intervention||6||
48693117|NCT01681186|102032719|FG007|STARTED|Third Intervention||6||
48693118|NCT01681186|102032712|FG000|COMPLETED|Third Intervention||0||
48693119|NCT01681186|102032713|FG001|COMPLETED|Third Intervention||0||
48693120|NCT01681186|102032714|FG002|COMPLETED|Third Intervention||0||
48693121|NCT01681186|102032715|FG003|COMPLETED|Third Intervention||0||
48269468|NCT01850589|100981980|FG000|STARTED|Overall Study||22||
48269469|NCT01850589|100981981|FG001|STARTED|Overall Study||22||
48269470|NCT01850589|100981980|FG000|COMPLETED|Overall Study||14||
48269471|NCT01850589|100981981|FG001|COMPLETED|Overall Study||22||
48269472|NCT01850589|100981980|FG000|NOT COMPLETED|Overall Study||8||
48392256|NCT00830960|101287831|FG000|COMPLETED|Overall Study||91||
48693122|NCT01681186|102032716|FG004|COMPLETED|Third Intervention||0||
48269473|NCT01850589|100981981|FG001|NOT COMPLETED|Overall Study||0||
48269474|NCT03325790|100981982|FG000|STARTED|Overall Study||42||
48269475|NCT03325790|100981983|FG001|STARTED|Overall Study||42||
48269476|NCT03325790|100981984|FG002|STARTED|Overall Study||42||
48269477|NCT03325790|100981982|FG000|COMPLETED|Overall Study||41||
48392257|NCT00830960|101287832|FG001|COMPLETED|Overall Study||96||
48392258|NCT00830960|101287833|FG002|COMPLETED|Overall Study||108||
48693123|NCT01681186|102032717|FG005|COMPLETED|Third Intervention||0||
48693124|NCT01681186|102032718|FG006|COMPLETED|Third Intervention||6||
48693125|NCT01681186|102032719|FG007|COMPLETED|Third Intervention||6||
48693126|NCT01681186|102032712|FG000|NOT COMPLETED|Third Intervention||0||
48693127|NCT01681186|102032713|FG001|NOT COMPLETED|Third Intervention||0||
48269478|NCT03325790|100981983|FG001|COMPLETED|Overall Study||41||
48269479|NCT03325790|100981984|FG002|COMPLETED|Overall Study||38||
48269480|NCT03325790|100981982|FG000|NOT COMPLETED|Overall Study||1||
48392259|NCT00830960|101287834|FG003|COMPLETED|Overall Study||106||
48552674|NCT03541317|101686785|FG005|NOT COMPLETED|Stage 2 of the Implementation||0||0
48552675|NCT03337399|101686786|FG000|STARTED|Overall Study||250||
48552676|NCT03337399|101686787|FG001|STARTED|Overall Study||257||
48552677|NCT03337399|101686786|FG000|COMPLETED|Overall Study||250||
48552678|NCT03337399|101686787|FG001|COMPLETED|Overall Study||257||
48269481|NCT03325790|100981983|FG001|NOT COMPLETED|Overall Study||1||
48269482|NCT03325790|100981984|FG002|NOT COMPLETED|Overall Study||4||
48269483|NCT01055704|100981985|FG000|STARTED|Overall Study||16||
48269484|NCT01055704|100981986|FG001|STARTED|Overall Study||8||
48269485|NCT01055704|100981987|FG002|STARTED|Overall Study||16||
48269486|NCT01055704|100981988|FG003|STARTED|Overall Study||8||
48269487|NCT01055704|100981985|FG000|COMPLETED|Overall Study||16||
48269488|NCT01055704|100981986|FG001|COMPLETED|Overall Study||8||
48269489|NCT01055704|100981987|FG002|COMPLETED|Overall Study||16||
48269490|NCT01055704|100981988|FG003|COMPLETED|Overall Study||8||
48269491|NCT01055704|100981985|FG000|NOT COMPLETED|Overall Study||0||
48269492|NCT01055704|100981986|FG001|NOT COMPLETED|Overall Study||0||
48269493|NCT01055704|100981987|FG002|NOT COMPLETED|Overall Study||0||
48552679|NCT03337399|101686786|FG000|NOT COMPLETED|Overall Study||0||
48552680|NCT03337399|101686787|FG001|NOT COMPLETED|Overall Study||0||
48108243|NCT00005669|100590723|FG001|NOT COMPLETED|Overall Study||7||
48108244|NCT00277212|100590724|FG000|STARTED|Phase 1 - Single-Blind Treatment||787||
48108245|NCT00277212|100590725|FG001|STARTED|Phase 1 - Single-Blind Treatment||0||
48108246|NCT00277212|100590726|FG002|STARTED|Phase 1 - Single-Blind Treatment||0||
48108247|NCT00277212|100590724|FG000|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||787||
48108248|NCT00277212|100590725|FG001|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0||
48108249|NCT00277212|100590726|FG002|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0||
48108250|NCT00277212|100590724|FG000|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||756||
48108251|NCT00277212|100590725|FG001|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0||
48108252|NCT00277212|100590726|FG002|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0||
48108253|NCT00277212|100590724|FG000|COMPLETED|Phase 1 - Single-Blind Treatment||352||
48108254|NCT00277212|100590725|FG001|COMPLETED|Phase 1 - Single-Blind Treatment||0||
48108255|NCT00277212|100590726|FG002|COMPLETED|Phase 1 - Single-Blind Treatment||0||
48108256|NCT00277212|100590724|FG000|NOT COMPLETED|Phase 1 - Single-Blind Treatment||435||
48108257|NCT00277212|100590725|FG001|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0||
48108258|NCT00277212|100590726|FG002|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0||
48108259|NCT00277212|100590724|FG000|STARTED|Phase 2 - Double-Blind Treatment||0||
48108260|NCT00277212|100590725|FG001|STARTED|Phase 2 - Double-Blind Treatment||173||
48108261|NCT00277212|100590726|FG002|STARTED|Phase 2 - Double-Blind Treatment||178||
48108262|NCT00277212|100590724|FG000|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||0||
48108263|NCT00277212|100590725|FG001|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||165||
48108264|NCT00277212|100590726|FG002|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||176||
48108265|NCT00277212|100590724|FG000|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||0||
48108266|NCT00277212|100590725|FG001|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||164||
48269494|NCT01055704|100981988|FG003|NOT COMPLETED|Overall Study||0||
48269495|NCT04273139|100981989|FG000|STARTED|Overall Study||45||
48269496|NCT04273139|100981989|FG000|COMPLETED|Overall Study||45||
48269497|NCT04273139|100981989|FG000|NOT COMPLETED|Overall Study||0||
48269498|NCT00607724|100984588|FG000|STARTED|Stage 1: Dose Escalation||7||
48269499|NCT00607724|100984589|FG001|STARTED|Stage 1: Dose Escalation||9||
48269500|NCT00607724|100984590|FG002|STARTED|Stage 1: Dose Escalation||4||
48269501|NCT00607724|100984591|FG003|STARTED|Stage 1: Dose Escalation||0||
48269502|NCT00607724|100984592|FG004|STARTED|Stage 1: Dose Escalation||0||
48269503|NCT00607724|100984593|FG005|STARTED|Stage 1: Dose Escalation||0||
48269504|NCT00607724|100984594|FG006|STARTED|Stage 1: Dose Escalation||0||
48269505|NCT00607724|100984588|FG000|COMPLETED|Stage 1: Dose Escalation||0||
48392260|NCT00830960|101287835|FG004|COMPLETED|Overall Study||64||
48269506|NCT00607724|100984589|FG001|COMPLETED|Stage 1: Dose Escalation||1||
48269507|NCT00607724|100984590|FG002|COMPLETED|Stage 1: Dose Escalation||0||
48269508|NCT00607724|100984591|FG003|COMPLETED|Stage 1: Dose Escalation||0||
48269509|NCT00607724|100984592|FG004|COMPLETED|Stage 1: Dose Escalation||0||
48269510|NCT00607724|100984593|FG005|COMPLETED|Stage 1: Dose Escalation||0||
48269511|NCT00607724|100984594|FG006|COMPLETED|Stage 1: Dose Escalation||0||
48269512|NCT00607724|100984588|FG000|NOT COMPLETED|Stage 1: Dose Escalation||7||
48269513|NCT00607724|100984589|FG001|NOT COMPLETED|Stage 1: Dose Escalation||8||
48269514|NCT00607724|100984590|FG002|NOT COMPLETED|Stage 1: Dose Escalation||4||
48269515|NCT00607724|100984591|FG003|NOT COMPLETED|Stage 1: Dose Escalation||0||
48269516|NCT00607724|100984592|FG004|NOT COMPLETED|Stage 1: Dose Escalation||0||
48269517|NCT00607724|100984593|FG005|NOT COMPLETED|Stage 1: Dose Escalation||0||
48269518|NCT00607724|100984594|FG006|NOT COMPLETED|Stage 1: Dose Escalation||0||
48269519|NCT00607724|100984588|FG000|STARTED|Stage 2: Expanded Cohort||0||
48269520|NCT00607724|100984589|FG001|STARTED|Stage 2: Expanded Cohort||0||
48552681|NCT04446247|101686788|FG000|STARTED|Overall Study||14||
48552682|NCT04446247|101686788|FG000|COMPLETED|Overall Study||14||
48552683|NCT04446247|101686788|FG000|NOT COMPLETED|Overall Study||0||
48552684|NCT03092219|101686789|FG000|STARTED|Overall Study||150|Randomized|
48552685|NCT03092219|101686790|FG001|STARTED|Overall Study||52|Randomized|
48552686|NCT03092219|101686789|FG000|Baseline / ITT Population|Overall Study||150|Visit 1 - Week 0|
48693128|NCT01681186|102032714|FG002|NOT COMPLETED|Third Intervention||0||
48693129|NCT01681186|102032715|FG003|NOT COMPLETED|Third Intervention||0||
48693130|NCT01681186|102032716|FG004|NOT COMPLETED|Third Intervention||0||
48693131|NCT01681186|102032717|FG005|NOT COMPLETED|Third Intervention||0||
48693132|NCT01681186|102032718|FG006|NOT COMPLETED|Third Intervention||0||
48693133|NCT01681186|102032719|FG007|NOT COMPLETED|Third Intervention||0||
48693134|NCT01681186|102032712|FG000|STARTED|Washout Period From Third Intervention||0||
48693135|NCT01681186|102032713|FG001|STARTED|Washout Period From Third Intervention||0||
48693136|NCT01681186|102032714|FG002|STARTED|Washout Period From Third Intervention||0||
48693137|NCT01681186|102032715|FG003|STARTED|Washout Period From Third Intervention||0||
48108267|NCT00277212|100590726|FG002|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||174||
48108268|NCT00277212|100590724|FG000|COMPLETED|Phase 2 - Double-Blind Treatment||0||
48108269|NCT00277212|100590725|FG001|COMPLETED|Phase 2 - Double-Blind Treatment||53||
48108270|NCT00277212|100590726|FG002|COMPLETED|Phase 2 - Double-Blind Treatment||65||
48108271|NCT00277212|100590724|FG000|NOT COMPLETED|Phase 2 - Double-Blind Treatment||0||
48108272|NCT00277212|100590725|FG001|NOT COMPLETED|Phase 2 - Double-Blind Treatment||120||
48108273|NCT00277212|100590726|FG002|NOT COMPLETED|Phase 2 - Double-Blind Treatment||113||
48108274|NCT00862784|100590727|FG000|STARTED|Overall Study||48||
48108275|NCT00862784|100590727|FG000|Received Any Amount of Study Drug|Overall Study||48||
48108276|NCT00862784|100590727|FG000|COMPLETED|Overall Study||48||
48269521|NCT00607724|100984590|FG002|STARTED|Stage 2: Expanded Cohort||0||
48269522|NCT00607724|100984591|FG003|STARTED|Stage 2: Expanded Cohort||6||
48269523|NCT00607724|100984592|FG004|STARTED|Stage 2: Expanded Cohort||14||
48269524|NCT00607724|100984593|FG005|STARTED|Stage 2: Expanded Cohort||12||
48269525|NCT00607724|100984594|FG006|STARTED|Stage 2: Expanded Cohort||16||
48269526|NCT00607724|100984588|FG000|COMPLETED|Stage 2: Expanded Cohort||0||
48269527|NCT00607724|100984589|FG001|COMPLETED|Stage 2: Expanded Cohort||0||
48269528|NCT00607724|100984590|FG002|COMPLETED|Stage 2: Expanded Cohort||0||
48269529|NCT00607724|100984591|FG003|COMPLETED|Stage 2: Expanded Cohort||1||
48269530|NCT00607724|100984592|FG004|COMPLETED|Stage 2: Expanded Cohort||5||
48269531|NCT00607724|100984593|FG005|COMPLETED|Stage 2: Expanded Cohort||0||
48269532|NCT00607724|100984594|FG006|COMPLETED|Stage 2: Expanded Cohort||5||
48269533|NCT00607724|100984588|FG000|NOT COMPLETED|Stage 2: Expanded Cohort||0||
48269534|NCT00607724|100984589|FG001|NOT COMPLETED|Stage 2: Expanded Cohort||0||
48269535|NCT00607724|100984590|FG002|NOT COMPLETED|Stage 2: Expanded Cohort||0||
48269536|NCT00607724|100984591|FG003|NOT COMPLETED|Stage 2: Expanded Cohort||5||
48269537|NCT00607724|100984592|FG004|NOT COMPLETED|Stage 2: Expanded Cohort||9||
48269538|NCT00607724|100984593|FG005|NOT COMPLETED|Stage 2: Expanded Cohort||12||
48269539|NCT00607724|100984594|FG006|NOT COMPLETED|Stage 2: Expanded Cohort||11||
48269540|NCT00694109|100984595|FG000|STARTED|Overall Study||142||
48269541|NCT00694109|100984595|FG000|Treated|Overall Study||141||
48269542|NCT00694109|100984595|FG000|Consented 2 Years Additional Treatment|Overall Study||42||
48552687|NCT03092219|101686790|FG001|Baseline / ITT Population|Overall Study||51|Visit 1 - Week 0|
48552688|NCT03092219|101686789|FG000|Primary Analysis Endpoint|Overall Study||150|Visit 4 - Week 8 after last treatment|
48552689|NCT03092219|101686790|FG001|Primary Analysis Endpoint|Overall Study||51|Visit 4 - Week 8 after last treatment|
48552690|NCT03092219|101686789|FG000|Pooled SAFT Population|Overall Study||150|Visit 8 - Week 36 after last treatment|
48552691|NCT03092219|101686790|FG001|Pooled SAFT Population|Overall Study||50|Visit 8 - Week 36 after last treatment|
48552692|NCT03092219|101686789|FG000|COMPLETED|Overall Study||143|Per Protocol Population|
48552693|NCT03092219|101686790|FG001|COMPLETED|Overall Study||48|Per Protocol Population|
48552694|NCT03092219|101686789|FG000|NOT COMPLETED|Overall Study||7||
48552695|NCT03092219|101686790|FG001|NOT COMPLETED|Overall Study||4||
48693138|NCT01681186|102032716|FG004|STARTED|Washout Period From Third Intervention||0||
48108277|NCT00862784|100590727|FG000|NOT COMPLETED|Overall Study||0||
48552696|NCT02046603|101686791|FG000|STARTED|Overall Study||22||
48552697|NCT02046603|101686792|FG001|STARTED|Overall Study||140||
48552698|NCT02046603|101686791|FG000|Received at Least 1 Dose of Tocilizumab|Overall Study||21||
48552699|NCT02046603|101686792|FG001|Received at Least 1 Dose of Tocilizumab|Overall Study||140||
48552700|NCT02046603|101686791|FG000|COMPLETED|Overall Study||7||
48552701|NCT02046603|101686792|FG001|COMPLETED|Overall Study||65||
48552702|NCT02046603|101686791|FG000|NOT COMPLETED|Overall Study||15||
48552703|NCT02046603|101686792|FG001|NOT COMPLETED|Overall Study||75||
48552704|NCT04324021|101686793|FG000|STARTED|Overall Study||5||
48552705|NCT04324021|101686794|FG001|STARTED|Overall Study||5||
48552706|NCT04324021|101686795|FG002|STARTED|Overall Study||6||
48552707|NCT04324021|101686793|FG000|COMPLETED|Overall Study||3||
48552708|NCT04324021|101686794|FG001|COMPLETED|Overall Study||4||
48552709|NCT04324021|101686795|FG002|COMPLETED|Overall Study||5||
48552710|NCT04324021|101686793|FG000|NOT COMPLETED|Overall Study||2||
48552711|NCT04324021|101686794|FG001|NOT COMPLETED|Overall Study||1||
48552712|NCT04324021|101686795|FG002|NOT COMPLETED|Overall Study||1||
48552713|NCT01439581|101686796|FG000|STARTED|Overall Study||216||
48552714|NCT01439581|101686797|FG001|STARTED|Overall Study||212||
48552715|NCT01439581|101686796|FG000|COMPLETED|Overall Study||216||
48552716|NCT01439581|101686797|FG001|COMPLETED|Overall Study||212||
48552717|NCT01439581|101686796|FG000|NOT COMPLETED|Overall Study||0||
48552718|NCT01439581|101686797|FG001|NOT COMPLETED|Overall Study||0||
48552719|NCT00668317|101686798|FG000|STARTED|Overall Study||5||
48552720|NCT00668317|101686798|FG000|COMPLETED|Overall Study||3||
48552721|NCT00668317|101686798|FG000|NOT COMPLETED|Overall Study||2||
48552722|NCT05424679|101686799|FG000|STARTED|Overall Study||38||
48269543|NCT00694109|100984595|FG000|Completed Consented Length of Treatment|Overall Study||60||
48269544|NCT00694109|100984595|FG000|COMPLETED|Overall Study||25||
48269545|NCT00694109|100984595|FG000|NOT COMPLETED|Overall Study||117||
48269546|NCT00755105|100984596|FG000|STARTED|Overall Study||38||
48269547|NCT00755105|100984597|FG001|STARTED|Overall Study||30||
48269548|NCT00755105|100984598|FG002|STARTED|Overall Study||9||
48269549|NCT00755105|100984596|FG000|COMPLETED|Overall Study||29||
48269550|NCT00755105|100984597|FG001|COMPLETED|Overall Study||19||
48269551|NCT00755105|100984598|FG002|COMPLETED|Overall Study||5||
48269552|NCT00755105|100984596|FG000|NOT COMPLETED|Overall Study||9||
48269553|NCT00755105|100984597|FG001|NOT COMPLETED|Overall Study||11||
48269554|NCT00755105|100984598|FG002|NOT COMPLETED|Overall Study||4||
48269555|NCT01099917|100984599|FG000|STARTED|Overall Study||45||
48269556|NCT01099917|100984599|FG000|COMPLETED|Overall Study||18||
48269557|NCT01099917|100984599|FG000|NOT COMPLETED|Overall Study||27||
48269558|NCT02079025|100984600|FG000|STARTED|Overall Study||839||
48269559|NCT02079025|100984601|FG001|STARTED|Overall Study||837||
48269560|NCT02079025|100984600|FG000|COMPLETED|Overall Study||839||
48269561|NCT02079025|100984601|FG001|COMPLETED|Overall Study||837||
48269562|NCT02079025|100984600|FG000|NOT COMPLETED|Overall Study||0||
48269563|NCT02079025|100984601|FG001|NOT COMPLETED|Overall Study||0||
48269564|NCT02159040|100984602|FG000|STARTED|Overall Study||1||
48269565|NCT02159040|100984602|FG000|COMPLETED|Overall Study||0||
48269566|NCT02159040|100984602|FG000|NOT COMPLETED|Overall Study||1||
48269567|NCT01646177|100984603|FG000|STARTED|Blinded Induction Dosing (Week 0-12)||193||
48269568|NCT01646177|100984604|FG001|STARTED|Blinded Induction Dosing (Week 0-12)||382||
48269569|NCT01646177|100984605|FG002|STARTED|Blinded Induction Dosing (Week 0-12)||386||
48269570|NCT01646177|100984606|FG003|STARTED|Blinded Induction Dosing (Week 0-12)||385||
48269571|NCT01646177|100984607|FG004|STARTED|Blinded Induction Dosing (Week 0-12)||0||
48269572|NCT01646177|100984608|FG005|STARTED|Blinded Induction Dosing (Week 0-12)||0||
48269573|NCT01646177|100984609|FG006|STARTED|Blinded Induction Dosing (Week 0-12)||0||
48269574|NCT01646177|100984610|FG007|STARTED|Blinded Induction Dosing (Week 0-12)||0||
48269575|NCT01646177|100984611|FG008|STARTED|Blinded Induction Dosing (Week 0-12)||0||
48269576|NCT01646177|100984612|FG009|STARTED|Blinded Induction Dosing (Week 0-12)||0||
48269577|NCT01646177|100984613|FG010|STARTED|Blinded Induction Dosing (Week 0-12)||0||
48269578|NCT01646177|100984614|FG011|STARTED|Blinded Induction Dosing (Week 0-12)||0||
48392261|NCT00830960|101287836|FG005|COMPLETED|Overall Study||63||
48269579|NCT01646177|100984603|FG000|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||193||
48392262|NCT00830960|101287831|FG000|NOT COMPLETED|Overall Study||33||
48552723|NCT05424679|101686800|FG001|STARTED|Overall Study||36||
48552724|NCT05424679|101686799|FG000|Youth Participants|Overall Study||5|Two of these youth are older than 18. Our study considered 'youth' to be any child of a parent from a different study, who was recruited into the current study, regardless of age. By this definition, two adult children are considered 'youth'. This distinction will be reflected in the sample sizes for the Baseline Characteristics, where we report age based on the pre-defined disaggregations, in Primary Outcome 2 (youth only), Secondary Outcome 2 (adult only), and Secondary Outcome 3 (youth only).|
48592724|NCT02143791|101783167|FG000|COMPLETED|Any Programming (3-6 Months)||88||
48592725|NCT02143791|101783167|FG000|NOT COMPLETED|Any Programming (3-6 Months)||4||
48269580|NCT01646177|100984604|FG001|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||382||
48269581|NCT01646177|100984605|FG002|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||382||
48269582|NCT01646177|100984606|FG003|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||384||
48392263|NCT00830960|101287832|FG001|NOT COMPLETED|Overall Study||28||
48552725|NCT05424679|101686800|FG001|Youth Participants|Overall Study||4|Two of these youth are older than 18. Our study considered 'youth' to be any child of a parent from a different study, who was recruited into the current study, regardless of age. By this definition, two adult children are considered 'youth'. This distinction will be reflected in the sample sizes for the Baseline Characteristics, where we report age based on the pre-defined disaggregations, in Primary Outcome 2 (youth only), Secondary Outcome 2 (adult only), and Secondary Outcome 3 (youth only).|
48552726|NCT05424679|101686799|FG000|Adult Participants|Overall Study||33||
48552727|NCT05424679|101686800|FG001|Adult Participants|Overall Study||32||
48552728|NCT05424679|101686799|FG000|COMPLETED|Overall Study||21||
48552729|NCT05424679|101686800|FG001|COMPLETED|Overall Study||27||
48552730|NCT05424679|101686799|FG000|NOT COMPLETED|Overall Study||17||
48552731|NCT05424679|101686800|FG001|NOT COMPLETED|Overall Study||9||
48552732|NCT00687830|101686801|FG000|STARTED|Overall Study||68||
48552733|NCT00687830|101686802|FG001|STARTED|Overall Study||68||
48552734|NCT00687830|101686801|FG000|COMPLETED|Overall Study||68||
48552735|NCT00687830|101686802|FG001|COMPLETED|Overall Study||68||
48552736|NCT00687830|101686801|FG000|NOT COMPLETED|Overall Study||0||
48552737|NCT00687830|101686802|FG001|NOT COMPLETED|Overall Study||0||
48552738|NCT01526057|101686803|FG000|STARTED|Overall Study||73||
48552739|NCT01526057|101686804|FG001|STARTED|Overall Study||74||
48552740|NCT01526057|101686805|FG002|STARTED|Overall Study||73||
48552741|NCT01526057|101686803|FG000|COMPLETED|Overall Study||64||
48552742|NCT01526057|101686804|FG001|COMPLETED|Overall Study||71||
48552743|NCT01526057|101686805|FG002|COMPLETED|Overall Study||67||
48552744|NCT01526057|101686803|FG000|NOT COMPLETED|Overall Study||9||
48552745|NCT01526057|101686804|FG001|NOT COMPLETED|Overall Study||3||
48552746|NCT01526057|101686805|FG002|NOT COMPLETED|Overall Study||6||
48552747|NCT02585778|101686806|FG000|STARTED|Overall Study||345||
48552748|NCT02585778|101686807|FG001|STARTED|Overall Study||172||
48552749|NCT02585778|101686806|FG000|Treated (Safety Population)|Overall Study||344||
48552750|NCT02585778|101686807|FG001|Treated (Safety Population)|Overall Study||170||
48552751|NCT02585778|101686806|FG000|ITT Population|Overall Study||336||
48552752|NCT02585778|101686807|FG001|ITT Population|Overall Study||167||
48552753|NCT02585778|101686806|FG000|mITT Population|Overall Study||333||
48552754|NCT02585778|101686807|FG001|mITT Population|Overall Study||164||
48552755|NCT02585778|101686806|FG000|T1DM Participants|Overall Study||51|Randomized stratum: T1DM|
48552756|NCT02585778|101686807|FG001|T1DM Participants|Overall Study||25|Randomized stratum: T1DM|
48552757|NCT02585778|101686806|FG000|T2DM Participants|Overall Study||294|Randomized stratum: T2DM|
48552758|NCT02585778|101686807|FG001|T2DM Participants|Overall Study||147|Randomized stratum: T2DM|
48552759|NCT02585778|101686806|FG000|COMPLETED|Overall Study||312|Completed = treatment completion|
48552760|NCT02585778|101686807|FG001|COMPLETED|Overall Study||157|Completed = treatment completion|
48552761|NCT02585778|101686806|FG000|NOT COMPLETED|Overall Study||33||
48552762|NCT02585778|101686807|FG001|NOT COMPLETED|Overall Study||15||
48552763|NCT03022916|101686808|FG000|STARTED|Overall Study||5||5
48552764|NCT03022916|101686809|FG001|STARTED|Overall Study||5||5
48552765|NCT03022916|101686810|FG002|STARTED|Overall Study||5||5
48552766|NCT03022916|101686811|FG003|STARTED|Overall Study||5||5
48552767|NCT03022916|101686808|FG000|Nail Polish|Overall Study||5||5
48552768|NCT03022916|101686809|FG001|Nail Polish|Overall Study||5||5
48269583|NCT01646177|100984607|FG004|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0||
48269584|NCT01646177|100984608|FG005|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0||
48269585|NCT01646177|100984609|FG006|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0||
48269586|NCT01646177|100984610|FG007|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0||
48269587|NCT01646177|100984611|FG008|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0||
48269588|NCT01646177|100984612|FG009|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0||
48269589|NCT01646177|100984613|FG010|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0||
48552769|NCT03022916|101686810|FG002|Nail Polish|Overall Study||5||5
48108278|NCT04244786|100590728|FG000|STARTED|Overall Study||3||
48108279|NCT04244786|100590729|FG001|STARTED|Overall Study||3||
48108280|NCT04244786|100590730|FG002|STARTED|Overall Study||7||
48108281|NCT04244786|100590728|FG000|COMPLETED|Overall Study||3||
48108282|NCT04244786|100590729|FG001|COMPLETED|Overall Study||3||
48108283|NCT04244786|100590730|FG002|COMPLETED|Overall Study||0||
48108284|NCT04244786|100590728|FG000|NOT COMPLETED|Overall Study||0||
48108285|NCT04244786|100590729|FG001|NOT COMPLETED|Overall Study||0||
48108286|NCT04244786|100590730|FG002|NOT COMPLETED|Overall Study||7||
48392264|NCT00830960|101287833|FG002|NOT COMPLETED|Overall Study||29||
48552770|NCT03022916|101686811|FG003|Nail Polish|Overall Study||5||5
48552771|NCT03022916|101686808|FG000|Nail Polish, Base Coat|Overall Study||5||5
48552772|NCT03022916|101686809|FG001|Nail Polish, Base Coat|Overall Study||5||5
48552773|NCT03022916|101686810|FG002|Nail Polish, Base Coat|Overall Study||5||5
48552774|NCT03022916|101686811|FG003|Nail Polish, Base Coat|Overall Study||5||5
48552775|NCT03022916|101686808|FG000|Nail Polish, Top Coat|Overall Study||5||5
48552776|NCT03022916|101686809|FG001|Nail Polish, Top Coat|Overall Study||5||5
48141402|NCT01454583|100670421|FG002|NOT COMPLETED|1st Year||180||
48141403|NCT01454583|100670419|FG000|STARTED|2nd Year||10177||
48141404|NCT01454583|100670420|FG001|STARTED|2nd Year||2696||
48552777|NCT03022916|101686810|FG002|Nail Polish, Top Coat|Overall Study||5||5
48552778|NCT03022916|101686811|FG003|Nail Polish, Top Coat|Overall Study||5||5
48269590|NCT01646177|100984614|FG011|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0||
48269591|NCT01646177|100984603|FG000|COMPLETED|Blinded Induction Dosing (Week 0-12)||183||
48269592|NCT01646177|100984604|FG001|COMPLETED|Blinded Induction Dosing (Week 0-12)||369||
48269593|NCT01646177|100984605|FG002|COMPLETED|Blinded Induction Dosing (Week 0-12)||360||
48269594|NCT01646177|100984606|FG003|COMPLETED|Blinded Induction Dosing (Week 0-12)||363||
48269595|NCT01646177|100984607|FG004|COMPLETED|Blinded Induction Dosing (Week 0-12)||0||
48552779|NCT03022916|101686808|FG000|COMPLETED|Overall Study||5||5
48552780|NCT03022916|101686809|FG001|COMPLETED|Overall Study||5||5
48552781|NCT03022916|101686810|FG002|COMPLETED|Overall Study||5||5
48552782|NCT03022916|101686811|FG003|COMPLETED|Overall Study||5||5
48552783|NCT03022916|101686808|FG000|NOT COMPLETED|Overall Study||0||0
48552784|NCT03022916|101686809|FG001|NOT COMPLETED|Overall Study||0||0
48552785|NCT03022916|101686810|FG002|NOT COMPLETED|Overall Study||0||0
48552786|NCT03022916|101686811|FG003|NOT COMPLETED|Overall Study||0||0
48552787|NCT00599248|101686812|FG000|STARTED|Overall Study||3||
48269596|NCT01646177|100984608|FG005|COMPLETED|Blinded Induction Dosing (Week 0-12)||0||
48269597|NCT01646177|100984609|FG006|COMPLETED|Blinded Induction Dosing (Week 0-12)||0||
48269598|NCT01646177|100984610|FG007|COMPLETED|Blinded Induction Dosing (Week 0-12)||0||
48269599|NCT01646177|100984611|FG008|COMPLETED|Blinded Induction Dosing (Week 0-12)||0||
48269600|NCT01646177|100984612|FG009|COMPLETED|Blinded Induction Dosing (Week 0-12)||0||
48269601|NCT01646177|100984613|FG010|COMPLETED|Blinded Induction Dosing (Week 0-12)||0||
48269602|NCT01646177|100984614|FG011|COMPLETED|Blinded Induction Dosing (Week 0-12)||0||
48269603|NCT01646177|100984603|FG000|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||10||
48269604|NCT01646177|100984604|FG001|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||13||
48269605|NCT01646177|100984605|FG002|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||26||
48269606|NCT01646177|100984606|FG003|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||22||
48269607|NCT01646177|100984607|FG004|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0||
48269608|NCT01646177|100984608|FG005|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0||
48269609|NCT01646177|100984609|FG006|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0||
48269610|NCT01646177|100984610|FG007|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0||
48269611|NCT01646177|100984611|FG008|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0||
48552788|NCT00599248|101686813|FG001|STARTED|Overall Study||3||
48552789|NCT00599248|101686814|FG002|STARTED|Overall Study||3||
48552790|NCT00599248|101686815|FG003|STARTED|Overall Study||3||
48269612|NCT01646177|100984612|FG009|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0||
48269613|NCT01646177|100984613|FG010|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0||
48552791|NCT00599248|101686812|FG000|COMPLETED|Overall Study||3||
48552792|NCT00599248|101686813|FG001|COMPLETED|Overall Study||3||
48552793|NCT00599248|101686814|FG002|COMPLETED|Overall Study||3||
48552794|NCT00599248|101686815|FG003|COMPLETED|Overall Study||3||
48552795|NCT00599248|101686812|FG000|NOT COMPLETED|Overall Study||0||
48552796|NCT00599248|101686813|FG001|NOT COMPLETED|Overall Study||0||
48552797|NCT00599248|101686814|FG002|NOT COMPLETED|Overall Study||0||
48552798|NCT00599248|101686815|FG003|NOT COMPLETED|Overall Study||0||
48552799|NCT01286753|101686816|FG000|STARTED|Overall Study||26||
48552800|NCT01286753|101686817|FG001|STARTED|Overall Study||25||
48552801|NCT01286753|101686816|FG000|COMPLETED|Overall Study||0||
48552802|NCT01286753|101686817|FG001|COMPLETED|Overall Study||0||
48552803|NCT01286753|101686816|FG000|NOT COMPLETED|Overall Study||26||
48552804|NCT01286753|101686817|FG001|NOT COMPLETED|Overall Study||25||
48269614|NCT01646177|100984614|FG011|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0||
48269615|NCT01646177|100984603|FG000|STARTED|Long-Term Extension Period (Week 12-264)||0||
48552805|NCT03552380|101686818|FG000|STARTED|Study Treatment||5||
48552806|NCT03552380|101686819|FG001|STARTED|Study Treatment||7||
48552807|NCT03552380|101686818|FG000|COMPLETED|Study Treatment||0||
48552808|NCT03552380|101686819|FG001|COMPLETED|Study Treatment||1||
48552809|NCT03552380|101686818|FG000|NOT COMPLETED|Study Treatment||5||
48552810|NCT03552380|101686819|FG001|NOT COMPLETED|Study Treatment||6||
48552811|NCT03552380|101686818|FG000|STARTED|Follow up||5|Treatment and Follow up both are at different time period. Therefore, the number of subjects to start follow up is not equal to the number of subjects who have completed treatment.|
48552812|NCT03552380|101686819|FG001|STARTED|Follow up||7|Treatment and Follow up both are at different time period. Therefore, the number of subjects to start follow up is not equal to the number of subjects who have completed treatment.|
48552813|NCT03552380|101686818|FG000|COMPLETED|Follow up||0||
48552814|NCT03552380|101686819|FG001|COMPLETED|Follow up||0||
48552815|NCT03552380|101686818|FG000|NOT COMPLETED|Follow up||5||
48552816|NCT03552380|101686819|FG001|NOT COMPLETED|Follow up||7||
48552817|NCT01982955|101686820|FG000|STARTED|Overall Study||6||
48552818|NCT01982955|101686821|FG001|STARTED|Overall Study||12||
48552819|NCT01982955|101686822|FG002|STARTED|Overall Study||31||
48552820|NCT01982955|101686823|FG003|STARTED|Overall Study||24||
48552821|NCT01982955|101686824|FG004|STARTED|Overall Study||15||
48552822|NCT01982955|101686820|FG000|Treated|Overall Study||6||
48552823|NCT01982955|101686821|FG001|Treated|Overall Study||12||
48552824|NCT01982955|101686822|FG002|Treated|Overall Study||31||
48552825|NCT01982955|101686823|FG003|Treated|Overall Study||23||
48269616|NCT01646177|100984604|FG001|STARTED|Long-Term Extension Period (Week 12-264)||0||
48552826|NCT01982955|101686824|FG004|Treated|Overall Study||15||
48552827|NCT01982955|101686820|FG000|COMPLETED|Overall Study||6||
48552828|NCT01982955|101686821|FG001|COMPLETED|Overall Study||12||
48552829|NCT01982955|101686822|FG002|COMPLETED|Overall Study||31||
48552830|NCT01982955|101686823|FG003|COMPLETED|Overall Study||23||
48552831|NCT01982955|101686824|FG004|COMPLETED|Overall Study||15||
48552832|NCT01982955|101686820|FG000|NOT COMPLETED|Overall Study||0||
48552833|NCT01982955|101686821|FG001|NOT COMPLETED|Overall Study||0||
48552834|NCT01982955|101686822|FG002|NOT COMPLETED|Overall Study||0||
48552835|NCT01982955|101686823|FG003|NOT COMPLETED|Overall Study||1||
48552836|NCT01982955|101686824|FG004|NOT COMPLETED|Overall Study||0||
48552837|NCT03905694|101686825|FG000|STARTED|Primary Analysis Period||18||
48552838|NCT03905694|101686825|FG000|COMPLETED|Primary Analysis Period||18||
48552839|NCT03905694|101686825|FG000|NOT COMPLETED|Primary Analysis Period||0||
48552840|NCT03905694|101686825|FG000|STARTED|Long-term Extension Period||18||
48552841|NCT03905694|101686825|FG000|COMPLETED|Long-term Extension Period||0||
48552842|NCT03905694|101686825|FG000|NOT COMPLETED|Long-term Extension Period||18||
48552843|NCT02431364|101686826|FG000|STARTED|Overall Study||8||
48552844|NCT02431364|101686827|FG001|STARTED|Overall Study||6||
48269617|NCT01646177|100984605|FG002|STARTED|Long-Term Extension Period (Week 12-264)||0||
48269618|NCT01646177|100984606|FG003|STARTED|Long-Term Extension Period (Week 12-264)||0||
48269619|NCT01646177|100984607|FG004|STARTED|Long-Term Extension Period (Week 12-264)||183||
48269620|NCT01646177|100984608|FG005|STARTED|Long-Term Extension Period (Week 12-264)||369||
48269621|NCT01646177|100984609|FG006|STARTED|Long-Term Extension Period (Week 12-264)||360||
48269622|NCT01646177|100984610|FG007|STARTED|Long-Term Extension Period (Week 12-264)||362||
48269623|NCT01646177|100984611|FG008|STARTED|Long-Term Extension Period (Week 12-264)||0||
48269624|NCT01646177|100984612|FG009|STARTED|Long-Term Extension Period (Week 12-264)||0||
48269625|NCT01646177|100984613|FG010|STARTED|Long-Term Extension Period (Week 12-264)||0||
48269626|NCT01646177|100984614|FG011|STARTED|Long-Term Extension Period (Week 12-264)||0||
48552845|NCT02431364|101686828|FG002|STARTED|Overall Study||6||
48552846|NCT02431364|101686829|FG003|STARTED|Overall Study||7||
48552847|NCT02431364|101686830|FG004|STARTED|Overall Study||6||
48552848|NCT02431364|101686826|FG000|Treated|Overall Study||8||
48552849|NCT02431364|101686827|FG001|Treated|Overall Study||6||
48108287|NCT01418937|100594238|FG000|STARTED|Overall Study||164||
48552850|NCT02431364|101686828|FG002|Treated|Overall Study||6||
48552851|NCT02431364|101686829|FG003|Treated|Overall Study||6||
48108288|NCT01418937|100594238|FG000|COMPLETED|Overall Study||156||
48108289|NCT01418937|100594238|FG000|NOT COMPLETED|Overall Study||8||
48108290|NCT00586469|100594239|FG000|STARTED|Overall Study||500||
48108291|NCT00586469|100594240|FG001|STARTED|Overall Study||500||
48108292|NCT00586469|100594239|FG000|COMPLETED|Overall Study||500||
48108293|NCT00586469|100594240|FG001|COMPLETED|Overall Study||499||
48108294|NCT00586469|100594239|FG000|NOT COMPLETED|Overall Study||0||
48108295|NCT00586469|100594240|FG001|NOT COMPLETED|Overall Study||1||
48108296|NCT01157533|100594241|FG000|STARTED|Overall Study||1||
48108297|NCT01157533|100594241|FG000|COMPLETED|Overall Study||1||
48108298|NCT01157533|100594241|FG000|NOT COMPLETED|Overall Study||0||
48108299|NCT02340299|100594242|FG000|STARTED|Overall Study||4||
48108300|NCT02340299|100594243|FG001|STARTED|Overall Study||2||
48108301|NCT02340299|100594242|FG000|COMPLETED|Overall Study||4||
48108302|NCT02340299|100594243|FG001|COMPLETED|Overall Study||2||
48108303|NCT02340299|100594242|FG000|NOT COMPLETED|Overall Study||0||
48108304|NCT02340299|100594243|FG001|NOT COMPLETED|Overall Study||0||
48108305|NCT00850031|100594244|FG000|STARTED|Overall Study||118||
48108306|NCT00850031|100594244|FG000|COMPLETED|Overall Study||101||
48108307|NCT00850031|100594244|FG000|NOT COMPLETED|Overall Study||17||
48108308|NCT03856437|100594245|FG000|STARTED|Overall Study||380||
48108309|NCT03856437|100594246|FG001|STARTED|Overall Study||407||
48108310|NCT03856437|100594247|FG002|STARTED|Overall Study||383||
48108311|NCT03856437|100594245|FG000|COMPLETED|Overall Study||380||
48108312|NCT03856437|100594246|FG001|COMPLETED|Overall Study||407||
48108313|NCT03856437|100594247|FG002|COMPLETED|Overall Study||383||
48108314|NCT03856437|100594245|FG000|NOT COMPLETED|Overall Study||0||
48108315|NCT03856437|100594246|FG001|NOT COMPLETED|Overall Study||0||
48108316|NCT03856437|100594247|FG002|NOT COMPLETED|Overall Study||0||
48108317|NCT02881996|100594248|FG000|STARTED|Overall Study||45||
48108318|NCT02881996|100594249|FG001|STARTED|Overall Study||45||
48108319|NCT02881996|100594248|FG000|COMPLETED|Overall Study||39||
48108320|NCT02881996|100594249|FG001|COMPLETED|Overall Study||43||
48108321|NCT02881996|100594248|FG000|NOT COMPLETED|Overall Study||6||
48108322|NCT02881996|100594249|FG001|NOT COMPLETED|Overall Study||2||
48108323|NCT00082433|100594250|FG000|STARTED|Overall Study||609||
48108324|NCT00082433|100594251|FG001|STARTED|Overall Study||612||
48108325|NCT00082433|100594250|FG000|COMPLETED|Overall Study||15||
48108326|NCT00082433|100594251|FG001|COMPLETED|Overall Study||15||
48108327|NCT00082433|100594250|FG000|NOT COMPLETED|Overall Study||594||
48108328|NCT00082433|100594251|FG001|NOT COMPLETED|Overall Study||597||
48108329|NCT01365273|100594252|FG000|STARTED|Overall Study||22||
48108330|NCT01365273|100594253|FG001|STARTED|Overall Study||21||
48108331|NCT01365273|100594252|FG000|Compl. Pts, Not Evaluable for Pain.|Overall Study||2||
48108332|NCT01365273|100594253|FG001|Compl. Pts, Not Evaluable for Pain.|Overall Study||4||
48108333|NCT01365273|100594252|FG000|COMPLETED|Overall Study||20||
48108334|NCT01365273|100594253|FG001|COMPLETED|Overall Study||20||
48108335|NCT01365273|100594252|FG000|NOT COMPLETED|Overall Study||2||
48108336|NCT01365273|100594253|FG001|NOT COMPLETED|Overall Study||1||
48108337|NCT00590954|100594254|FG000|STARTED|Overall Study||32||
48108338|NCT00590954|100594254|FG000|COMPLETED|Overall Study||30||
48108339|NCT00590954|100594254|FG000|NOT COMPLETED|Overall Study||2||
48108340|NCT04292730|100594255|FG000|STARTED|Overall Study||199||
48108341|NCT04292730|100594256|FG001|STARTED|Overall Study||197||
48108342|NCT04292730|100594257|FG002|STARTED|Overall Study||200||
48108343|NCT04292730|100594258|FG003|STARTED|Overall Study||517||
48108344|NCT04292730|100594255|FG000|COMPLETED|Overall Study||179||
48108345|NCT04292730|100594256|FG001|COMPLETED|Overall Study||176||
48108346|NCT04292730|100594257|FG002|COMPLETED|Overall Study||178||
48108347|NCT04292730|100594258|FG003|COMPLETED|Overall Study||437||
48108348|NCT04292730|100594255|FG000|NOT COMPLETED|Overall Study||20||
48108349|NCT04292730|100594256|FG001|NOT COMPLETED|Overall Study||21||
48108350|NCT04292730|100594257|FG002|NOT COMPLETED|Overall Study||22||
48108351|NCT04292730|100594258|FG003|NOT COMPLETED|Overall Study||80||
48108352|NCT00806546|100594259|FG000|STARTED|Overall Study||514||
48108353|NCT00806546|100594259|FG000|COMPLETED|Overall Study||207||
48108354|NCT00806546|100594259|FG000|NOT COMPLETED|Overall Study||307||
48108355|NCT00097721|100594260|FG000|STARTED|Overall Study||71||
48108356|NCT00097721|100594261|FG001|STARTED|Overall Study||33||
48108357|NCT00097721|100594260|FG000|COMPLETED|Overall Study||0||
48108358|NCT00097721|100594261|FG001|COMPLETED|Overall Study||0||
48108359|NCT00097721|100594260|FG000|NOT COMPLETED|Overall Study||71||
48108360|NCT00097721|100594261|FG001|NOT COMPLETED|Overall Study||33||
48108361|NCT04538066|100594262|FG000|STARTED|Overall Study||61|Although 122 subjects were randomized, only 117 proceeded to participate.|
48108362|NCT04538066|100594263|FG001|STARTED|Overall Study||61|Although 122 subjects were randomized, only 117 proceeded to participate.|
48108363|NCT04538066|100594262|FG000|COMPLETED|Overall Study||33||
48108364|NCT04538066|100594263|FG001|COMPLETED|Overall Study||40||
48108365|NCT04538066|100594262|FG000|NOT COMPLETED|Overall Study||28||
48108366|NCT04538066|100594263|FG001|NOT COMPLETED|Overall Study||21||
48108367|NCT03961100|100594264|FG000|STARTED|Part 1||5||
48108368|NCT03961100|100594265|FG001|STARTED|Part 1||5||
48108369|NCT03961100|100594266|FG002|STARTED|Part 1||5||
48108370|NCT03961100|100594267|FG003|STARTED|Part 1||0||
48108371|NCT03961100|100594268|FG004|STARTED|Part 1||0||
48108372|NCT03961100|100594264|FG000|COMPLETED|Part 1||5||
48108373|NCT03961100|100594265|FG001|COMPLETED|Part 1||5||
48693139|NCT01681186|102032717|FG005|STARTED|Washout Period From Third Intervention||0||
48693140|NCT01681186|102032718|FG006|STARTED|Washout Period From Third Intervention||6||
48693141|NCT01681186|102032719|FG007|STARTED|Washout Period From Third Intervention||6||
48269627|NCT01646177|100984603|FG000|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0||
48269628|NCT01646177|100984604|FG001|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0||
48552852|NCT02431364|101686830|FG004|Treated|Overall Study||6||
48269629|NCT01646177|100984605|FG002|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0||
48269630|NCT01646177|100984606|FG003|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0||
48269631|NCT01646177|100984607|FG004|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||183||
48269632|NCT01646177|100984608|FG005|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||369||
48269633|NCT01646177|100984609|FG006|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||360||
48269634|NCT01646177|100984610|FG007|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||362||
48552853|NCT02431364|101686826|FG000|COMPLETED|Overall Study||8||
48269635|NCT01646177|100984611|FG008|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0||
48269636|NCT01646177|100984612|FG009|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0||
48269637|NCT01646177|100984613|FG010|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0||
48269638|NCT01646177|100984614|FG011|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0||
48269639|NCT01646177|100984603|FG000|COMPLETED|Long-Term Extension Period (Week 12-264)||0||
48269640|NCT01646177|100984604|FG001|COMPLETED|Long-Term Extension Period (Week 12-264)||0||
48269641|NCT01646177|100984605|FG002|COMPLETED|Long-Term Extension Period (Week 12-264)||0||
48269642|NCT01646177|100984606|FG003|COMPLETED|Long-Term Extension Period (Week 12-264)||0||
48269643|NCT01646177|100984607|FG004|COMPLETED|Long-Term Extension Period (Week 12-264)||135||
48552854|NCT02431364|101686827|FG001|COMPLETED|Overall Study||5||
48552855|NCT02431364|101686828|FG002|COMPLETED|Overall Study||6||
48269644|NCT01646177|100984608|FG005|COMPLETED|Long-Term Extension Period (Week 12-264)||256||
48269645|NCT01646177|100984609|FG006|COMPLETED|Long-Term Extension Period (Week 12-264)||244||
48269646|NCT01646177|100984610|FG007|COMPLETED|Long-Term Extension Period (Week 12-264)||255||
48269647|NCT01646177|100984611|FG008|COMPLETED|Long-Term Extension Period (Week 12-264)||0||
48269648|NCT01646177|100984612|FG009|COMPLETED|Long-Term Extension Period (Week 12-264)||0||
48269649|NCT01646177|100984613|FG010|COMPLETED|Long-Term Extension Period (Week 12-264)||0||
48269650|NCT01646177|100984614|FG011|COMPLETED|Long-Term Extension Period (Week 12-264)||0||
48269651|NCT01646177|100984603|FG000|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0||
48269652|NCT01646177|100984604|FG001|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0||
48269653|NCT01646177|100984605|FG002|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0||
48269654|NCT01646177|100984606|FG003|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0||
48269655|NCT01646177|100984607|FG004|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||48||
48269656|NCT01646177|100984608|FG005|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||113||
48269657|NCT01646177|100984609|FG006|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||116||
48552856|NCT02431364|101686829|FG003|COMPLETED|Overall Study||6||
48552857|NCT02431364|101686830|FG004|COMPLETED|Overall Study||6||
48552858|NCT02431364|101686826|FG000|NOT COMPLETED|Overall Study||0||
48552859|NCT02431364|101686827|FG001|NOT COMPLETED|Overall Study||1||
48552860|NCT02431364|101686828|FG002|NOT COMPLETED|Overall Study||0||
48552861|NCT02431364|101686829|FG003|NOT COMPLETED|Overall Study||1||
48552862|NCT02431364|101686830|FG004|NOT COMPLETED|Overall Study||0||
48552863|NCT02681510|101686831|FG000|STARTED|Overall Study||36||
48552864|NCT02681510|101686831|FG000|COMPLETED|Overall Study||26||
48552865|NCT02681510|101686831|FG000|NOT COMPLETED|Overall Study||10||
48552866|NCT01551030|101686832|FG000|STARTED|Overall Study||19||
48552867|NCT01551030|101686832|FG000|COMPLETED|Overall Study||19||
48552868|NCT01551030|101686832|FG000|NOT COMPLETED|Overall Study||0||
48552869|NCT00599053|101686833|FG000|STARTED|Overall Study||5||
48552870|NCT00599053|101686834|FG001|STARTED|Overall Study||2||
48552871|NCT00599053|101686833|FG000|COMPLETED|Overall Study||5||
48693142|NCT01681186|102032712|FG000|COMPLETED|Washout Period From Third Intervention||0||
48693143|NCT01681186|102032713|FG001|COMPLETED|Washout Period From Third Intervention||0||
48269658|NCT01646177|100984610|FG007|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||107||
48269659|NCT01646177|100984611|FG008|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0||
48269660|NCT01646177|100984612|FG009|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0||
48269661|NCT01646177|100984613|FG010|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0||
48269662|NCT01646177|100984614|FG011|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0||
48552872|NCT00599053|101686834|FG001|COMPLETED|Overall Study||2||
48552873|NCT00599053|101686833|FG000|NOT COMPLETED|Overall Study||0||
48552874|NCT00599053|101686834|FG001|NOT COMPLETED|Overall Study||0||
48552875|NCT02656069|101686835|FG000|STARTED|First Intervention||44||
48552876|NCT02656069|101686836|FG001|STARTED|First Intervention||36||
48552877|NCT02656069|101686835|FG000|COMPLETED|First Intervention||44||
48552878|NCT02656069|101686836|FG001|COMPLETED|First Intervention||36||
48552879|NCT02656069|101686835|FG000|NOT COMPLETED|First Intervention||0||
48552880|NCT02656069|101686836|FG001|NOT COMPLETED|First Intervention||0||
48269663|NCT01646177|100984603|FG000|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0||
48269664|NCT01646177|100984604|FG001|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0||
48269665|NCT01646177|100984605|FG002|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0||
48269666|NCT01646177|100984606|FG003|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0||
48693144|NCT01681186|102032714|FG002|COMPLETED|Washout Period From Third Intervention||0||
48693145|NCT01681186|102032715|FG003|COMPLETED|Washout Period From Third Intervention||0||
48693146|NCT01681186|102032716|FG004|COMPLETED|Washout Period From Third Intervention||0||
48269667|NCT01646177|100984607|FG004|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0||
48269668|NCT01646177|100984608|FG005|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0||
48269669|NCT01646177|100984609|FG006|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0||
48269670|NCT01646177|100984610|FG007|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0||
48269671|NCT01646177|100984611|FG008|STARTED|Follow-Up Period (Minimum of 12 Weeks)||157||
48269672|NCT01646177|100984612|FG009|STARTED|Follow-Up Period (Minimum of 12 Weeks)||309||
48269673|NCT01646177|100984613|FG010|STARTED|Follow-Up Period (Minimum of 12 Weeks)||305||
48269674|NCT01646177|100984614|FG011|STARTED|Follow-Up Period (Minimum of 12 Weeks)||313||
48269675|NCT01646177|100984603|FG000|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0||
48269676|NCT01646177|100984604|FG001|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0||
48269677|NCT01646177|100984605|FG002|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0||
48269678|NCT01646177|100984606|FG003|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0||
48269679|NCT01646177|100984607|FG004|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0||
48269680|NCT01646177|100984608|FG005|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0||
48269681|NCT01646177|100984609|FG006|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0||
48269682|NCT01646177|100984610|FG007|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0||
48269683|NCT01646177|100984611|FG008|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||157||
48269684|NCT01646177|100984612|FG009|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||309||
48269685|NCT01646177|100984613|FG010|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||305||
48269686|NCT01646177|100984614|FG011|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||313||
48269687|NCT01646177|100984603|FG000|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0||
48269688|NCT01646177|100984604|FG001|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0||
48269689|NCT01646177|100984605|FG002|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0||
48269690|NCT01646177|100984606|FG003|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0||
48269691|NCT01646177|100984607|FG004|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0||
48269692|NCT01646177|100984608|FG005|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0||
48269693|NCT01646177|100984609|FG006|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0||
48269694|NCT01646177|100984610|FG007|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0||
48269695|NCT01646177|100984611|FG008|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||126||
48269696|NCT01646177|100984612|FG009|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||233||
48269697|NCT01646177|100984613|FG010|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||225||
48269698|NCT01646177|100984614|FG011|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||230||
48269699|NCT01646177|100984603|FG000|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0||
48269700|NCT01646177|100984604|FG001|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0||
48269701|NCT01646177|100984605|FG002|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0||
48269702|NCT01646177|100984606|FG003|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0||
48269703|NCT01646177|100984607|FG004|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0||
48269704|NCT01646177|100984608|FG005|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0||
48269705|NCT01646177|100984609|FG006|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0||
48269706|NCT01646177|100984610|FG007|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0||
48269707|NCT01646177|100984611|FG008|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||31||
48269708|NCT01646177|100984612|FG009|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||76||
48269709|NCT01646177|100984613|FG010|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||80||
48693147|NCT01681186|102032717|FG005|COMPLETED|Washout Period From Third Intervention||0||
48693148|NCT01681186|102032718|FG006|COMPLETED|Washout Period From Third Intervention||5||
48693149|NCT01681186|102032719|FG007|COMPLETED|Washout Period From Third Intervention||6||
48693150|NCT01681186|102032712|FG000|NOT COMPLETED|Washout Period From Third Intervention||0||
48269710|NCT01646177|100984614|FG011|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||83||
48269711|NCT04662060|100984615|FG000|STARTED|Overall Study||60||
48269712|NCT04662060|100984616|FG001|STARTED|Overall Study||60||
48269713|NCT04662060|100984615|FG000|Received Allocated Treatment|Overall Study||59||
48269714|NCT04662060|100984616|FG001|Received Allocated Treatment|Overall Study||59||
48269715|NCT04662060|100984615|FG000|COMPLETED|Overall Study||55||
48269716|NCT04662060|100984616|FG001|COMPLETED|Overall Study||56||
48269717|NCT04662060|100984615|FG000|NOT COMPLETED|Overall Study||5||
48269718|NCT04662060|100984616|FG001|NOT COMPLETED|Overall Study||4||
48269719|NCT00763451|100984617|FG000|STARTED|Overall Study||80||
48269720|NCT00763451|100984618|FG001|STARTED|Overall Study||82||
48269721|NCT00763451|100984619|FG002|STARTED|Overall Study||161||
48269722|NCT00763451|100984620|FG003|STARTED|Overall Study||161||
48693151|NCT01681186|102032713|FG001|NOT COMPLETED|Washout Period From Third Intervention||0||
48693152|NCT01681186|102032714|FG002|NOT COMPLETED|Washout Period From Third Intervention||0||
48693153|NCT01681186|102032715|FG003|NOT COMPLETED|Washout Period From Third Intervention||0||
48693154|NCT01681186|102032716|FG004|NOT COMPLETED|Washout Period From Third Intervention||0||
48693155|NCT01681186|102032717|FG005|NOT COMPLETED|Washout Period From Third Intervention||0||
48693156|NCT01681186|102032718|FG006|NOT COMPLETED|Washout Period From Third Intervention||1||
48693157|NCT01681186|102032719|FG007|NOT COMPLETED|Washout Period From Third Intervention||0||
48693158|NCT01681186|102032712|FG000|STARTED|Fourth Intervention||0||
48693159|NCT01681186|102032713|FG001|STARTED|Fourth Intervention||0||
48693160|NCT01681186|102032714|FG002|STARTED|Fourth Intervention||0||
48693161|NCT01681186|102032715|FG003|STARTED|Fourth Intervention||0||
48693162|NCT01681186|102032716|FG004|STARTED|Fourth Intervention||0||
48693163|NCT01681186|102032717|FG005|STARTED|Fourth Intervention||0||
48693164|NCT01681186|102032718|FG006|STARTED|Fourth Intervention||5||
48693165|NCT01681186|102032719|FG007|STARTED|Fourth Intervention||6||
48269723|NCT00763451|100984617|FG000|Treated/Safety Population|Overall Study||79||
48269724|NCT00763451|100984618|FG001|Treated/Safety Population|Overall Study||81||
48269725|NCT00763451|100984619|FG002|Treated/Safety Population|Overall Study||161||
48269726|NCT00763451|100984620|FG003|Treated/Safety Population|Overall Study||161||
48269727|NCT00763451|100984617|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study||79||
48269728|NCT00763451|100984618|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||80||
48693166|NCT01681186|102032712|FG000|COMPLETED|Fourth Intervention||0||
48693167|NCT01681186|102032713|FG001|COMPLETED|Fourth Intervention||0||
48693168|NCT01681186|102032714|FG002|COMPLETED|Fourth Intervention||0||
48693169|NCT01681186|102032715|FG003|COMPLETED|Fourth Intervention||0||
48108374|NCT03961100|100594266|FG002|COMPLETED|Part 1||5||
48269729|NCT00763451|100984619|FG002|Modified Intent-to-Treat(mITT)Population|Overall Study||160||
48269730|NCT00763451|100984620|FG003|Modified Intent-to-Treat(mITT)Population|Overall Study||160||
48269731|NCT00763451|100984617|FG000|COMPLETED|Overall Study||67||
48269732|NCT00763451|100984618|FG001|COMPLETED|Overall Study||60||
48269733|NCT00763451|100984619|FG002|COMPLETED|Overall Study||121||
48269734|NCT00763451|100984620|FG003|COMPLETED|Overall Study||131||
48269735|NCT00763451|100984617|FG000|NOT COMPLETED|Overall Study||13||
48392265|NCT00830960|101287834|FG003|NOT COMPLETED|Overall Study||32||
48392266|NCT00830960|101287835|FG004|NOT COMPLETED|Overall Study||32||
48392267|NCT00830960|101287836|FG005|NOT COMPLETED|Overall Study||37||
48392268|NCT04685499|101287837|FG000|STARTED|Overall Study||1||
48392269|NCT04685499|101287837|FG000|COMPLETED|Overall Study||0||
48392270|NCT04685499|101287837|FG000|NOT COMPLETED|Overall Study||1||
48392271|NCT01637870|101287838|FG000|STARTED|Overall Study||110||
48392272|NCT01637870|101287838|FG000|COMPLETED|Overall Study||110||
48392273|NCT01637870|101287838|FG000|NOT COMPLETED|Overall Study||0||
48392274|NCT01539811|101287839|FG000|STARTED|Overall Study||0||
48392275|NCT01539811|101287840|FG001|STARTED|Overall Study||0||
48392276|NCT01539811|101287839|FG000|COMPLETED|Overall Study||0||
48392277|NCT01539811|101287840|FG001|COMPLETED|Overall Study||0||
48392278|NCT01539811|101287839|FG000|NOT COMPLETED|Overall Study||0||
48392279|NCT01539811|101287840|FG001|NOT COMPLETED|Overall Study||0||
48392280|NCT00871377|101287841|FG000|STARTED|First Intervention (10 Weeks)||3||
48392281|NCT00871377|101287842|FG001|STARTED|First Intervention (10 Weeks)||4||
48392282|NCT00871377|101287843|FG002|STARTED|First Intervention (10 Weeks)||4||
48392283|NCT00871377|101287844|FG003|STARTED|First Intervention (10 Weeks)||4||
48392284|NCT00871377|101287845|FG004|STARTED|First Intervention (10 Weeks)||4||
48392285|NCT00871377|101287846|FG005|STARTED|First Intervention (10 Weeks)||5||
48392286|NCT00871377|101287841|FG000|COMPLETED|First Intervention (10 Weeks)||3||
48392287|NCT00871377|101287842|FG001|COMPLETED|First Intervention (10 Weeks)||4||
48392288|NCT00871377|101287843|FG002|COMPLETED|First Intervention (10 Weeks)||3||
48392289|NCT00871377|101287844|FG003|COMPLETED|First Intervention (10 Weeks)||4||
48392290|NCT00871377|101287845|FG004|COMPLETED|First Intervention (10 Weeks)||4||
48392291|NCT00871377|101287846|FG005|COMPLETED|First Intervention (10 Weeks)||4||
48392292|NCT00871377|101287841|FG000|NOT COMPLETED|First Intervention (10 Weeks)||0||
48392293|NCT00871377|101287842|FG001|NOT COMPLETED|First Intervention (10 Weeks)||0||
48392294|NCT00871377|101287843|FG002|NOT COMPLETED|First Intervention (10 Weeks)||1||
48269736|NCT00763451|100984618|FG001|NOT COMPLETED|Overall Study||22||
48269737|NCT00763451|100984619|FG002|NOT COMPLETED|Overall Study||40||
48269738|NCT00763451|100984620|FG003|NOT COMPLETED|Overall Study||30||
48269739|NCT02387268|100984621|FG000|STARTED|Overall Study||10||
48269740|NCT02387268|100984621|FG000|COMPLETED|Overall Study||9||
48269741|NCT02387268|100984621|FG000|NOT COMPLETED|Overall Study||1||
48269742|NCT04664075|100984622|FG000|STARTED|Overall Study||8||
48392295|NCT00871377|101287844|FG003|NOT COMPLETED|First Intervention (10 Weeks)||0||
48269743|NCT04664075|100984622|FG000|COMPLETED|Overall Study||7||
48269744|NCT04664075|100984622|FG000|NOT COMPLETED|Overall Study||1||
48392296|NCT00871377|101287845|FG004|NOT COMPLETED|First Intervention (10 Weeks)||0||
48693170|NCT01681186|102032716|FG004|COMPLETED|Fourth Intervention||0||
48269745|NCT02931253|100984623|FG000|STARTED|Overall Study||2||
48269746|NCT02931253|100984624|FG001|STARTED|Overall Study||4||
48392297|NCT00871377|101287846|FG005|NOT COMPLETED|First Intervention (10 Weeks)||1||
48693171|NCT01681186|102032717|FG005|COMPLETED|Fourth Intervention||0||
48269747|NCT02931253|100984623|FG000|COMPLETED|Overall Study||2||
48269748|NCT02931253|100984624|FG001|COMPLETED|Overall Study||4||
48269749|NCT02931253|100984623|FG000|NOT COMPLETED|Overall Study||0||
48269750|NCT02931253|100984624|FG001|NOT COMPLETED|Overall Study||0||
48269751|NCT03289351|100984625|FG000|STARTED|Overall Study||80||
48269752|NCT03289351|100984626|FG001|STARTED|Overall Study||82||
48269753|NCT03289351|100984625|FG000|COMPLETED|Overall Study||80||
48269754|NCT03289351|100984626|FG001|COMPLETED|Overall Study||82||
48269755|NCT03289351|100984625|FG000|NOT COMPLETED|Overall Study||0||
48269756|NCT03289351|100984626|FG001|NOT COMPLETED|Overall Study||0||
48392298|NCT00871377|101287841|FG000|STARTED|Washout (6 Weeks)||3||
48392299|NCT00871377|101287842|FG001|STARTED|Washout (6 Weeks)||4||
48392300|NCT00871377|101287843|FG002|STARTED|Washout (6 Weeks)||3||
48392301|NCT00871377|101287844|FG003|STARTED|Washout (6 Weeks)||4||
48392302|NCT00871377|101287845|FG004|STARTED|Washout (6 Weeks)||4||
48392303|NCT00871377|101287846|FG005|STARTED|Washout (6 Weeks)||4||
48392304|NCT00871377|101287841|FG000|COMPLETED|Washout (6 Weeks)||2||
48392305|NCT00871377|101287842|FG001|COMPLETED|Washout (6 Weeks)||4||
48392306|NCT00871377|101287843|FG002|COMPLETED|Washout (6 Weeks)||3||
48392307|NCT00871377|101287844|FG003|COMPLETED|Washout (6 Weeks)||4||
48392308|NCT00871377|101287845|FG004|COMPLETED|Washout (6 Weeks)||4||
48693172|NCT01681186|102032718|FG006|COMPLETED|Fourth Intervention||5||
48693173|NCT01681186|102032719|FG007|COMPLETED|Fourth Intervention||5||
48693174|NCT01681186|102032712|FG000|NOT COMPLETED|Fourth Intervention||0||
48693175|NCT01681186|102032713|FG001|NOT COMPLETED|Fourth Intervention||0||
48693176|NCT01681186|102032714|FG002|NOT COMPLETED|Fourth Intervention||0||
48693177|NCT01681186|102032715|FG003|NOT COMPLETED|Fourth Intervention||0||
48693178|NCT01681186|102032716|FG004|NOT COMPLETED|Fourth Intervention||0||
48693179|NCT01681186|102032717|FG005|NOT COMPLETED|Fourth Intervention||0||
48693180|NCT01681186|102032718|FG006|NOT COMPLETED|Fourth Intervention||0||
48693181|NCT01681186|102032719|FG007|NOT COMPLETED|Fourth Intervention||1||
48693182|NCT03560102|102032720|FG000|STARTED|Overall Study||1||
48693183|NCT03560102|102032720|FG000|COMPLETED|Overall Study||1||
48693184|NCT03560102|102032720|FG000|NOT COMPLETED|Overall Study||0||
48693185|NCT04153981|102032721|FG000|STARTED|Overall Study||304||
48693186|NCT04153981|102032721|FG000|Participants Who Received At Least One Dose of Study Drug|Overall Study||259||
48693187|NCT04153981|102032721|FG000|COMPLETED|Overall Study||218||
48693188|NCT04153981|102032721|FG000|NOT COMPLETED|Overall Study||86||
48693189|NCT02901249|102032722|FG000|STARTED|Overall Study||68||
48693190|NCT02901249|102032722|FG000|COMPLETED|Overall Study||43||
48693191|NCT02901249|102032722|FG000|NOT COMPLETED|Overall Study||25||
48693192|NCT03316573|102032723|FG000|STARTED|Overall Study||18||
48693193|NCT03316573|102032723|FG000|COMPLETED|Overall Study||18||
48693194|NCT03316573|102032723|FG000|NOT COMPLETED|Overall Study||0||
48693195|NCT04154293|102032724|FG000|STARTED|Overall Study||12||
48108375|NCT03961100|100594267|FG003|COMPLETED|Part 1||0||
48108376|NCT03961100|100594268|FG004|COMPLETED|Part 1||0||
48108377|NCT03961100|100594264|FG000|NOT COMPLETED|Part 1||0||
48108378|NCT03961100|100594265|FG001|NOT COMPLETED|Part 1||0||
48108379|NCT03961100|100594266|FG002|NOT COMPLETED|Part 1||0||
48108380|NCT03961100|100594267|FG003|NOT COMPLETED|Part 1||0||
48108381|NCT03961100|100594268|FG004|NOT COMPLETED|Part 1||0||
48108382|NCT03961100|100594264|FG000|STARTED|Part 2||0||
48108383|NCT03961100|100594265|FG001|STARTED|Part 2||0||
48108384|NCT03961100|100594266|FG002|STARTED|Part 2||0||
48108385|NCT03961100|100594267|FG003|STARTED|Part 2||8||
48108386|NCT03961100|100594268|FG004|STARTED|Part 2||8||
48108387|NCT03961100|100594264|FG000|COMPLETED|Part 2||0||
48108388|NCT03961100|100594265|FG001|COMPLETED|Part 2||0||
48269757|NCT03285555|100984627|FG000|STARTED|Overall Study||30||
48269758|NCT03285555|100984628|FG001|STARTED|Overall Study||30||
48269759|NCT03285555|100984627|FG000|COMPLETED|Overall Study||30||
48269760|NCT03285555|100984628|FG001|COMPLETED|Overall Study||30||
48269761|NCT03285555|100984627|FG000|NOT COMPLETED|Overall Study||0||
48269762|NCT03285555|100984628|FG001|NOT COMPLETED|Overall Study||0||
48392309|NCT00871377|101287846|FG005|COMPLETED|Washout (6 Weeks)||4||
48392310|NCT00871377|101287841|FG000|NOT COMPLETED|Washout (6 Weeks)||1||
48392311|NCT00871377|101287842|FG001|NOT COMPLETED|Washout (6 Weeks)||0||
48392312|NCT00871377|101287843|FG002|NOT COMPLETED|Washout (6 Weeks)||0||
48392313|NCT00871377|101287844|FG003|NOT COMPLETED|Washout (6 Weeks)||0||
48392314|NCT00871377|101287845|FG004|NOT COMPLETED|Washout (6 Weeks)||0||
48392315|NCT00871377|101287846|FG005|NOT COMPLETED|Washout (6 Weeks)||0||
48392316|NCT00871377|101287841|FG000|STARTED|Second Intervention (10 Weeks)||2||
48693196|NCT04154293|102032725|FG001|STARTED|Overall Study||11||
48693197|NCT04154293|102032726|FG002|STARTED|Overall Study||11||
48693198|NCT04154293|102032724|FG000|Number Who Received at Least 1 Dose|Overall Study||12||
48693199|NCT04154293|102032725|FG001|Number Who Received at Least 1 Dose|Overall Study||11||
48693200|NCT04154293|102032726|FG002|Number Who Received at Least 1 Dose|Overall Study||10||
48108389|NCT03961100|100594266|FG002|COMPLETED|Part 2||0||
48108390|NCT03961100|100594267|FG003|COMPLETED|Part 2||8||
48392317|NCT00871377|101287842|FG001|STARTED|Second Intervention (10 Weeks)||4||
48392318|NCT00871377|101287843|FG002|STARTED|Second Intervention (10 Weeks)||3||
48269763|NCT01271504|100984629|FG000|STARTED|Overall Study||7||
48269764|NCT01271504|100984630|FG001|STARTED|Overall Study||8||
48269765|NCT01271504|100984631|FG002|STARTED|Overall Study||44||
48269766|NCT01271504|100984632|FG003|STARTED|Overall Study||43||
48269767|NCT01271504|100984629|FG000|Treated|Overall Study||7||
48269768|NCT01271504|100984630|FG001|Treated|Overall Study||7||
48269769|NCT01271504|100984631|FG002|Treated|Overall Study||42||
48269770|NCT01271504|100984632|FG003|Treated|Overall Study||42||
48269771|NCT01271504|100984629|FG000|COMPLETED|Overall Study||0||
48693201|NCT04154293|102032724|FG000|COMPLETED|Overall Study||10||
48693202|NCT04154293|102032725|FG001|COMPLETED|Overall Study||8||
48269772|NCT01271504|100984630|FG001|COMPLETED|Overall Study||0||
48269773|NCT01271504|100984631|FG002|COMPLETED|Overall Study||0||
48269774|NCT01271504|100984632|FG003|COMPLETED|Overall Study||0||
48269775|NCT01271504|100984629|FG000|NOT COMPLETED|Overall Study||7||
48269776|NCT01271504|100984630|FG001|NOT COMPLETED|Overall Study||8||
48269777|NCT01271504|100984631|FG002|NOT COMPLETED|Overall Study||44||
48269778|NCT01271504|100984632|FG003|NOT COMPLETED|Overall Study||43||
48269779|NCT02330094|100984633|FG000|STARTED|Overall Study||8||
48269780|NCT02330094|100984634|FG001|STARTED|Overall Study||8||
48269781|NCT02330094|100984633|FG000|COMPLETED|Overall Study||8||
48269782|NCT02330094|100984634|FG001|COMPLETED|Overall Study||8||
48269783|NCT02330094|100984633|FG000|NOT COMPLETED|Overall Study||0||
48269784|NCT02330094|100984634|FG001|NOT COMPLETED|Overall Study||0||
48269785|NCT02963090|100984635|FG000|STARTED|Non-cross Over Phase||3||
48269786|NCT02963090|100984636|FG001|STARTED|Non-cross Over Phase||6||
48269787|NCT02963090|100984635|FG000|COMPLETED|Non-cross Over Phase||2||
48269788|NCT02963090|100984636|FG001|COMPLETED|Non-cross Over Phase||6||
48269789|NCT02963090|100984635|FG000|NOT COMPLETED|Non-cross Over Phase||1||
48269790|NCT02963090|100984636|FG001|NOT COMPLETED|Non-cross Over Phase||0||
48269791|NCT02963090|100984635|FG000|STARTED|Cross Over Phase||2||
48269792|NCT02963090|100984636|FG001|STARTED|Cross Over Phase||0||
48269793|NCT02963090|100984635|FG000|COMPLETED|Cross Over Phase||2||
48269794|NCT02963090|100984636|FG001|COMPLETED|Cross Over Phase||0||
48269795|NCT02963090|100984635|FG000|NOT COMPLETED|Cross Over Phase||0||
48269796|NCT02963090|100984636|FG001|NOT COMPLETED|Cross Over Phase||0||
48269797|NCT00678301|100984637|FG000|STARTED|Overall Study||239||
48269798|NCT00678301|100984638|FG001|STARTED|Overall Study||118||
48269799|NCT00678301|100984637|FG000|COMPLETED|Overall Study||231||
48269800|NCT00678301|100984638|FG001|COMPLETED|Overall Study||116||
48269801|NCT00678301|100984637|FG000|NOT COMPLETED|Overall Study||8||
48269802|NCT00678301|100984638|FG001|NOT COMPLETED|Overall Study||2||
48269803|NCT04674189|100984639|FG000|STARTED|Overall Study||786||
48269804|NCT04674189|100984640|FG001|STARTED|Overall Study||786||
48269805|NCT04674189|100984641|FG002|STARTED|Overall Study||785||
48269806|NCT04674189|100984639|FG000|Safety Analysis Set|Overall Study||783||
48269807|NCT04674189|100984640|FG001|Safety Analysis Set|Overall Study||785||
48269808|NCT04674189|100984641|FG002|Safety Analysis Set|Overall Study||783||
48269809|NCT04674189|100984639|FG000|COMPLETED|Overall Study||617||
48269810|NCT04674189|100984640|FG001|COMPLETED|Overall Study||637||
48269811|NCT04674189|100984641|FG002|COMPLETED|Overall Study||372||
48269812|NCT04674189|100984639|FG000|NOT COMPLETED|Overall Study||169||
48269813|NCT04674189|100984640|FG001|NOT COMPLETED|Overall Study||149||
48269814|NCT04674189|100984641|FG002|NOT COMPLETED|Overall Study||413||
48269815|NCT00795275|100984642|FG000|STARTED|Overall Study||11||
48269816|NCT00795275|100984643|FG001|STARTED|Overall Study||15||
48269817|NCT00795275|100984642|FG000|COMPLETED|Overall Study||10||
48269818|NCT00795275|100984643|FG001|COMPLETED|Overall Study||13||
48269819|NCT00795275|100984642|FG000|NOT COMPLETED|Overall Study||1||
48269820|NCT00795275|100984643|FG001|NOT COMPLETED|Overall Study||2||
48269821|NCT03168542|100984644|FG000|STARTED|Overall Study||7||
48269822|NCT03168542|100984645|FG001|STARTED|Overall Study||5||
48269823|NCT03168542|100984646|FG002|STARTED|Overall Study||9||
48269824|NCT03168542|100984644|FG000|COMPLETED|Overall Study||7||
48269825|NCT03168542|100984645|FG001|COMPLETED|Overall Study||5||
48269826|NCT03168542|100984646|FG002|COMPLETED|Overall Study||9||
48269827|NCT03168542|100984644|FG000|NOT COMPLETED|Overall Study||0||
48552881|NCT02656069|101686835|FG000|STARTED|Second Intervention||44||
48552882|NCT02656069|101686836|FG001|STARTED|Second Intervention||36||
48552883|NCT02656069|101686835|FG000|COMPLETED|Second Intervention||43||
48552884|NCT02656069|101686836|FG001|COMPLETED|Second Intervention||35||
48552885|NCT02656069|101686835|FG000|NOT COMPLETED|Second Intervention||1||
48552886|NCT02656069|101686836|FG001|NOT COMPLETED|Second Intervention||1||
48552887|NCT02864992|101686837|FG000|STARTED|Overall Study||152||
48552888|NCT02864992|101686838|FG001|STARTED|Overall Study||24||
48552889|NCT02864992|101686839|FG002|STARTED|Overall Study||161||
48552890|NCT02864992|101686837|FG000|COMPLETED|Overall Study||137||
48552891|NCT02864992|101686838|FG001|COMPLETED|Overall Study||23||
48552892|NCT02864992|101686839|FG002|COMPLETED|Overall Study||128||
48693203|NCT04154293|102032726|FG002|COMPLETED|Overall Study||9||
48269828|NCT03168542|100984645|FG001|NOT COMPLETED|Overall Study||0||
48269829|NCT03168542|100984646|FG002|NOT COMPLETED|Overall Study||0||
48269830|NCT01464775|100984647|FG000|STARTED|Overall Study||123||
48269831|NCT01464775|100984648|FG001|STARTED|Overall Study||44||
48552893|NCT02864992|101686837|FG000|NOT COMPLETED|Overall Study||15||
48269832|NCT01464775|100984647|FG000|COMPLETED|Overall Study||112||
48269833|NCT01464775|100984648|FG001|COMPLETED|Overall Study||38||
48269834|NCT01464775|100984647|FG000|NOT COMPLETED|Overall Study||11||
48269835|NCT01464775|100984648|FG001|NOT COMPLETED|Overall Study||6||
48269836|NCT02412735|100984649|FG000|STARTED|Overall Study||143||
48269837|NCT02412735|100984650|FG001|STARTED|Overall Study||129||
48269838|NCT02412735|100984651|FG002|STARTED|Overall Study||132||
48269839|NCT02412735|100984649|FG000|Received Treatment|Overall Study||140||
48269840|NCT02412735|100984650|FG001|Received Treatment|Overall Study||128||
48269841|NCT02412735|100984651|FG002|Received Treatment|Overall Study||130||
48269842|NCT02412735|100984649|FG000|COMPLETED|Overall Study||97||
48269843|NCT02412735|100984650|FG001|COMPLETED|Overall Study||85||
48269844|NCT02412735|100984651|FG002|COMPLETED|Overall Study||86||
48269845|NCT02412735|100984649|FG000|NOT COMPLETED|Overall Study||46||
48269846|NCT02412735|100984650|FG001|NOT COMPLETED|Overall Study||44||
48392319|NCT00871377|101287844|FG003|STARTED|Second Intervention (10 Weeks)||4||
48552894|NCT02864992|101686838|FG001|NOT COMPLETED|Overall Study||1||
48552895|NCT02864992|101686839|FG002|NOT COMPLETED|Overall Study||33||
48552896|NCT02717455|101686840|FG000|STARTED|Overall Study||13||
48552897|NCT02717455|101686841|FG001|STARTED|Overall Study||6||
48552898|NCT02717455|101686842|FG002|STARTED|Overall Study||3||
48108391|NCT03961100|100594268|FG004|COMPLETED|Part 2||8||
48108392|NCT03961100|100594264|FG000|NOT COMPLETED|Part 2||0||
48108393|NCT03961100|100594265|FG001|NOT COMPLETED|Part 2||0||
48108394|NCT03961100|100594266|FG002|NOT COMPLETED|Part 2||0||
48108395|NCT03961100|100594267|FG003|NOT COMPLETED|Part 2||0||
48108396|NCT03961100|100594268|FG004|NOT COMPLETED|Part 2||0||
48108397|NCT02308735|100594269|FG000|STARTED|Overall Study||2||
48108398|NCT02308735|100594270|FG001|STARTED|Overall Study||0||
48108399|NCT02308735|100594271|FG002|STARTED|Overall Study||0||
48108400|NCT02308735|100594272|FG003|STARTED|Overall Study||2||
48108401|NCT02308735|100594269|FG000|COMPLETED|Overall Study||0||
48108402|NCT02308735|100594270|FG001|COMPLETED|Overall Study||0||
48108403|NCT02308735|100594271|FG002|COMPLETED|Overall Study||0||
48108404|NCT02308735|100594272|FG003|COMPLETED|Overall Study||0||
48108405|NCT02308735|100594269|FG000|NOT COMPLETED|Overall Study||2||
48108406|NCT02308735|100594270|FG001|NOT COMPLETED|Overall Study||0||
48108407|NCT02308735|100594271|FG002|NOT COMPLETED|Overall Study||0||
48108408|NCT02308735|100594272|FG003|NOT COMPLETED|Overall Study||2||
48108409|NCT00476021|100594273|FG000|STARTED|Overall Study||51||
48108410|NCT00476021|100594274|FG001|STARTED|Overall Study||51||
48108411|NCT00476021|100594273|FG000|COMPLETED|Overall Study||51||
48108412|NCT00476021|100594274|FG001|COMPLETED|Overall Study||51||
48108413|NCT00476021|100594273|FG000|NOT COMPLETED|Overall Study||0||
48108414|NCT00476021|100594274|FG001|NOT COMPLETED|Overall Study||0||
48108415|NCT02094716|100594275|FG000|STARTED|Overall Study||43||
48108416|NCT02094716|100594276|FG001|STARTED|Overall Study||43||
48108417|NCT02094716|100594277|FG002|STARTED|Overall Study||44||
48108418|NCT02094716|100594275|FG000|Received Second Dose at Day 14|Overall Study||15|Of 44 subjects who had a first dose of vehicle, 8 received a second treatment with 4% and 9 with 5%.|
48108419|NCT02094716|100594276|FG001|Received Second Dose at Day 14|Overall Study||10|Of 44 subjects who had a first dose of vehicle, 8 received a second treatment with 4% and 9 with 5%.|
48108420|NCT02094716|100594277|FG002|Received Second Dose at Day 14|Overall Study||17|Of 44 subjects who had a first dose of vehicle, 8 received a second treatment with 4% and 9 with 5%.|
48108421|NCT02094716|100594275|FG000|COMPLETED|Overall Study||41||
48108422|NCT02094716|100594276|FG001|COMPLETED|Overall Study||36||
48108423|NCT02094716|100594277|FG002|COMPLETED|Overall Study||40||
48108424|NCT02094716|100594275|FG000|NOT COMPLETED|Overall Study||2||
48108425|NCT02094716|100594276|FG001|NOT COMPLETED|Overall Study||7||
48108426|NCT02094716|100594277|FG002|NOT COMPLETED|Overall Study||4||
48108427|NCT01959542|100594278|FG000|STARTED|Overall Study||15|3 patients withdrew after initial consent.|
48108428|NCT01959542|100594278|FG000|Evaluable at Visit 1|Overall Study||12||
48108429|NCT01959542|100594278|FG000|Evaluable at Visit 2|Overall Study||12||
48108430|NCT01959542|100594278|FG000|COMPLETED|Overall Study||12||
48108431|NCT01959542|100594278|FG000|NOT COMPLETED|Overall Study||3||
48108432|NCT04200248|100594279|FG000|STARTED|Overall Study||32||
48108433|NCT04200248|100594280|FG001|STARTED|Overall Study||31||
48108434|NCT04200248|100594281|FG002|STARTED|Overall Study||31||
48108435|NCT04200248|100594279|FG000|COMPLETED|Overall Study||29||
48108436|NCT04200248|100594280|FG001|COMPLETED|Overall Study||28||
48108437|NCT04200248|100594281|FG002|COMPLETED|Overall Study||28||
48108438|NCT04200248|100594279|FG000|NOT COMPLETED|Overall Study||3||
48108439|NCT04200248|100594280|FG001|NOT COMPLETED|Overall Study||3||
48108440|NCT04200248|100594281|FG002|NOT COMPLETED|Overall Study||3||
48108441|NCT00579826|100594282|FG000|STARTED|Overall Study||29||
48108442|NCT00579826|100594283|FG001|STARTED|Overall Study||26||
48108443|NCT00579826|100594282|FG000|6 Months|Overall Study||28||
48108444|NCT00579826|100594283|FG001|6 Months|Overall Study||25||
48108445|NCT00579826|100594282|FG000|COMPLETED|Overall Study||24||
48108446|NCT00579826|100594283|FG001|COMPLETED|Overall Study||23||
48108447|NCT00579826|100594282|FG000|NOT COMPLETED|Overall Study||5||
48108448|NCT00579826|100594283|FG001|NOT COMPLETED|Overall Study||3||
48269847|NCT02412735|100984651|FG002|NOT COMPLETED|Overall Study||46||
48552899|NCT02717455|101686843|FG003|STARTED|Overall Study||12||
48269848|NCT00996606|100984652|FG000|STARTED|Overall Study||58||
48269849|NCT00996606|100984652|FG000|COMPLETED|Overall Study||50||
48269850|NCT00996606|100984652|FG000|NOT COMPLETED|Overall Study||8||
48269851|NCT01754753|100984653|FG000|STARTED|Overall Study||78||
48269852|NCT01754753|100984654|FG001|STARTED|Overall Study||79||
48269853|NCT01754753|100984653|FG000|COMPLETED|Overall Study||26||
48269854|NCT01754753|100984654|FG001|COMPLETED|Overall Study||30||
48269855|NCT01754753|100984653|FG000|NOT COMPLETED|Overall Study||52||
48269856|NCT01754753|100984654|FG001|NOT COMPLETED|Overall Study||49||
48269857|NCT01800890|100984655|FG000|STARTED|Test Period 1||3||
48269858|NCT01800890|100984656|FG001|STARTED|Test Period 1||3||
48269859|NCT01800890|100984657|FG002|STARTED|Test Period 1||3||
48269860|NCT01800890|100984658|FG003|STARTED|Test Period 1||3||
48269861|NCT01800890|100984659|FG004|STARTED|Test Period 1||4||
48269862|NCT01800890|100984660|FG005|STARTED|Test Period 1||4||
48269863|NCT01800890|100984661|FG006|STARTED|Test Period 1||3||
48269864|NCT01800890|100984662|FG007|STARTED|Test Period 1||3||
48269865|NCT01800890|100984663|FG008|STARTED|Test Period 1||3||
48269866|NCT01800890|100984655|FG000|COMPLETED|Test Period 1||3||
48269867|NCT01800890|100984656|FG001|COMPLETED|Test Period 1||3||
48269868|NCT01800890|100984657|FG002|COMPLETED|Test Period 1||3||
48269869|NCT01800890|100984658|FG003|COMPLETED|Test Period 1||2||
48269870|NCT01800890|100984659|FG004|COMPLETED|Test Period 1||4||
48269871|NCT01800890|100984660|FG005|COMPLETED|Test Period 1||4||
48269872|NCT01800890|100984661|FG006|COMPLETED|Test Period 1||3||
48269873|NCT01800890|100984662|FG007|COMPLETED|Test Period 1||3||
48269874|NCT01800890|100984663|FG008|COMPLETED|Test Period 1||3||
48269875|NCT01800890|100984655|FG000|NOT COMPLETED|Test Period 1||0||
48269876|NCT01800890|100984656|FG001|NOT COMPLETED|Test Period 1||0||
48269877|NCT01800890|100984657|FG002|NOT COMPLETED|Test Period 1||0||
48269878|NCT01800890|100984658|FG003|NOT COMPLETED|Test Period 1||1||
48269879|NCT01800890|100984659|FG004|NOT COMPLETED|Test Period 1||0||
48269880|NCT01800890|100984660|FG005|NOT COMPLETED|Test Period 1||0||
48693204|NCT04154293|102032724|FG000|NOT COMPLETED|Overall Study||2||
48693205|NCT04154293|102032725|FG001|NOT COMPLETED|Overall Study||3||
48693206|NCT04154293|102032726|FG002|NOT COMPLETED|Overall Study||2||
48693207|NCT00873821|102032727|FG000|STARTED|Overall Study||22||
48693208|NCT00873821|102032728|FG001|STARTED|Overall Study||22||
48693209|NCT00873821|102032727|FG000|COMPLETED|Overall Study||22||
48693210|NCT00873821|102032728|FG001|COMPLETED|Overall Study||22||
48693211|NCT00873821|102032727|FG000|NOT COMPLETED|Overall Study||0||
48269881|NCT01800890|100984661|FG006|NOT COMPLETED|Test Period 1||0||
48269882|NCT01800890|100984662|FG007|NOT COMPLETED|Test Period 1||0||
48269883|NCT01800890|100984663|FG008|NOT COMPLETED|Test Period 1||0||
48269884|NCT01800890|100984655|FG000|STARTED|Test Period 2||3||
48269885|NCT01800890|100984656|FG001|STARTED|Test Period 2||3||
48269886|NCT01800890|100984657|FG002|STARTED|Test Period 2||3||
48269887|NCT01800890|100984658|FG003|STARTED|Test Period 2||2||
48269888|NCT01800890|100984659|FG004|STARTED|Test Period 2||4||
48269889|NCT01800890|100984660|FG005|STARTED|Test Period 2||4||
48269890|NCT01800890|100984661|FG006|STARTED|Test Period 2||3||
48269891|NCT01800890|100984662|FG007|STARTED|Test Period 2||3||
48269892|NCT01800890|100984663|FG008|STARTED|Test Period 2||3||
48269893|NCT01800890|100984655|FG000|COMPLETED|Test Period 2||3||
48392320|NCT00871377|101287845|FG004|STARTED|Second Intervention (10 Weeks)||4||
48392321|NCT00871377|101287846|FG005|STARTED|Second Intervention (10 Weeks)||4||
48392322|NCT00871377|101287841|FG000|COMPLETED|Second Intervention (10 Weeks)||2||
48392323|NCT00871377|101287842|FG001|COMPLETED|Second Intervention (10 Weeks)||4||
48392324|NCT00871377|101287843|FG002|COMPLETED|Second Intervention (10 Weeks)||3||
48392325|NCT00871377|101287844|FG003|COMPLETED|Second Intervention (10 Weeks)||4||
48392326|NCT00871377|101287845|FG004|COMPLETED|Second Intervention (10 Weeks)||4||
48392327|NCT00871377|101287846|FG005|COMPLETED|Second Intervention (10 Weeks)||4||
48392328|NCT00871377|101287841|FG000|NOT COMPLETED|Second Intervention (10 Weeks)||0||
48392329|NCT00871377|101287842|FG001|NOT COMPLETED|Second Intervention (10 Weeks)||0||
48392330|NCT00871377|101287843|FG002|NOT COMPLETED|Second Intervention (10 Weeks)||0||
48552900|NCT02717455|101686844|FG004|STARTED|Overall Study||12||
48693212|NCT00873821|102032728|FG001|NOT COMPLETED|Overall Study||0||
48693213|NCT02952313|102032729|FG000|STARTED|Primary Endpoint||113||
48693214|NCT02952313|102032729|FG000|6 Months|Primary Endpoint||106||
48693215|NCT02952313|102032729|FG000|COMPLETED|Primary Endpoint||106||
48693216|NCT02952313|102032729|FG000|NOT COMPLETED|Primary Endpoint||7||
48269894|NCT01800890|100984656|FG001|COMPLETED|Test Period 2||3||
48552901|NCT02717455|101686845|FG005|STARTED|Overall Study||7||
48710705|NCT00846040|102077993|FG000|STARTED|Second Treatment: After Washout, 14 Day||9||
48269895|NCT01800890|100984657|FG002|COMPLETED|Test Period 2||3||
48269896|NCT01800890|100984658|FG003|COMPLETED|Test Period 2||2||
48269897|NCT01800890|100984659|FG004|COMPLETED|Test Period 2||4||
48269898|NCT01800890|100984660|FG005|COMPLETED|Test Period 2||4||
48269899|NCT01800890|100984661|FG006|COMPLETED|Test Period 2||3||
48269900|NCT01800890|100984662|FG007|COMPLETED|Test Period 2||3||
48269901|NCT01800890|100984663|FG008|COMPLETED|Test Period 2||3||
48269902|NCT01800890|100984655|FG000|NOT COMPLETED|Test Period 2||0||
48269903|NCT01800890|100984656|FG001|NOT COMPLETED|Test Period 2||0||
48552902|NCT02717455|101686840|FG000|COMPLETED|Overall Study||10||
48269904|NCT01800890|100984657|FG002|NOT COMPLETED|Test Period 2||0||
48269905|NCT01800890|100984658|FG003|NOT COMPLETED|Test Period 2||0||
48269906|NCT01800890|100984659|FG004|NOT COMPLETED|Test Period 2||0||
48269907|NCT01800890|100984660|FG005|NOT COMPLETED|Test Period 2||0||
48269908|NCT01800890|100984661|FG006|NOT COMPLETED|Test Period 2||0||
48269909|NCT01800890|100984662|FG007|NOT COMPLETED|Test Period 2||0||
48269910|NCT01800890|100984663|FG008|NOT COMPLETED|Test Period 2||0||
48269911|NCT01800890|100984655|FG000|STARTED|Test Period 3||3||
48269912|NCT01800890|100984656|FG001|STARTED|Test Period 3||3||
48269913|NCT01800890|100984657|FG002|STARTED|Test Period 3||3||
48269914|NCT01800890|100984658|FG003|STARTED|Test Period 3||2||
48269915|NCT01800890|100984659|FG004|STARTED|Test Period 3||4||
48269916|NCT01800890|100984660|FG005|STARTED|Test Period 3||4||
48269917|NCT01800890|100984661|FG006|STARTED|Test Period 3||3||
48269918|NCT01800890|100984662|FG007|STARTED|Test Period 3||3||
48269919|NCT01800890|100984663|FG008|STARTED|Test Period 3||3||
48269920|NCT01800890|100984655|FG000|COMPLETED|Test Period 3||3||
48269921|NCT01800890|100984656|FG001|COMPLETED|Test Period 3||3||
48269922|NCT01800890|100984657|FG002|COMPLETED|Test Period 3||3||
48269923|NCT01800890|100984658|FG003|COMPLETED|Test Period 3||2||
48269924|NCT01800890|100984659|FG004|COMPLETED|Test Period 3||4||
48269925|NCT01800890|100984660|FG005|COMPLETED|Test Period 3||4||
48269926|NCT01800890|100984661|FG006|COMPLETED|Test Period 3||3||
48269927|NCT01800890|100984662|FG007|COMPLETED|Test Period 3||3||
48269928|NCT01800890|100984663|FG008|COMPLETED|Test Period 3||3||
48269929|NCT01800890|100984655|FG000|NOT COMPLETED|Test Period 3||0||
48269930|NCT01800890|100984656|FG001|NOT COMPLETED|Test Period 3||0||
48269931|NCT01800890|100984657|FG002|NOT COMPLETED|Test Period 3||0||
48269932|NCT01800890|100984658|FG003|NOT COMPLETED|Test Period 3||0||
48269933|NCT01800890|100984659|FG004|NOT COMPLETED|Test Period 3||0||
48269934|NCT01800890|100984660|FG005|NOT COMPLETED|Test Period 3||0||
48269935|NCT01800890|100984661|FG006|NOT COMPLETED|Test Period 3||0||
48269936|NCT01800890|100984662|FG007|NOT COMPLETED|Test Period 3||0||
48269937|NCT01800890|100984663|FG008|NOT COMPLETED|Test Period 3||0||
48269938|NCT01102764|100984664|FG000|STARTED|Overall Study||64||
48269939|NCT01102764|100984665|FG001|STARTED|Overall Study||68||
48269940|NCT01102764|100984664|FG000|COMPLETED|Overall Study||43||
48269941|NCT01102764|100984665|FG001|COMPLETED|Overall Study||55||
48269942|NCT01102764|100984664|FG000|NOT COMPLETED|Overall Study||21||
48269943|NCT01102764|100984665|FG001|NOT COMPLETED|Overall Study||13||
48269944|NCT01689857|100984666|FG000|STARTED|Overall Study||20||
48269945|NCT01689857|100984667|FG001|STARTED|Overall Study||20||
48269946|NCT01689857|100984666|FG000|COMPLETED|Overall Study||15||
48269947|NCT01689857|100984667|FG001|COMPLETED|Overall Study||18||
48269948|NCT01689857|100984666|FG000|NOT COMPLETED|Overall Study||5||
48269949|NCT01689857|100984667|FG001|NOT COMPLETED|Overall Study||2||
48269950|NCT00426127|100984668|FG000|STARTED|Overall Study||2||
48269951|NCT00426127|100984668|FG000|COMPLETED|Overall Study||0||
48269952|NCT00426127|100984668|FG000|NOT COMPLETED|Overall Study||2||
48269953|NCT01068665|100984669|FG000|STARTED|Overall Study||230||
48269954|NCT01068665|100984670|FG001|STARTED|Overall Study||230||
48269955|NCT01068665|100984669|FG000|Full Analysis Set|Overall Study||228||
48269956|NCT01068665|100984670|FG001|Full Analysis Set|Overall Study||229||
48269957|NCT01068665|100984669|FG000|Exposed|Overall Study||228||
48269958|NCT01068665|100984670|FG001|Exposed|Overall Study||228||
48269959|NCT01068665|100984669|FG000|COMPLETED|Overall Study||200||
48269960|NCT01068665|100984670|FG001|COMPLETED|Overall Study||201||
48269961|NCT01068665|100984669|FG000|NOT COMPLETED|Overall Study||30||
48269962|NCT01068665|100984670|FG001|NOT COMPLETED|Overall Study||29||
48269963|NCT04091061|100984671|FG000|STARTED|Overall Study||6||
48269964|NCT04091061|100984672|FG001|STARTED|Overall Study||6||
48269965|NCT04091061|100984673|FG002|STARTED|Overall Study||6||
48269966|NCT04091061|100984674|FG003|STARTED|Overall Study||6||
48269967|NCT04091061|100984671|FG000|COMPLETED|Overall Study||6||
48269968|NCT04091061|100984672|FG001|COMPLETED|Overall Study||6||
48269969|NCT04091061|100984673|FG002|COMPLETED|Overall Study||6||
48269970|NCT04091061|100984674|FG003|COMPLETED|Overall Study||6||
48269971|NCT04091061|100984671|FG000|NOT COMPLETED|Overall Study||0||
48269972|NCT04091061|100984672|FG001|NOT COMPLETED|Overall Study||0||
48269973|NCT04091061|100984673|FG002|NOT COMPLETED|Overall Study||0||
48392331|NCT00871377|101287844|FG003|NOT COMPLETED|Second Intervention (10 Weeks)||0||
48269974|NCT04091061|100984674|FG003|NOT COMPLETED|Overall Study||0||
48269975|NCT05383508|100984675|FG000|STARTED|Overall Study||6||
48269976|NCT05383508|100984676|FG001|STARTED|Overall Study||6||
48269977|NCT05383508|100984677|FG002|STARTED|Overall Study||6||
48269978|NCT05383508|100984678|FG003|STARTED|Overall Study||6||
48269979|NCT05383508|100984679|FG004|STARTED|Overall Study||6||
48269980|NCT05383508|100984680|FG005|STARTED|Overall Study||6||
48269981|NCT05383508|100984675|FG000|COMPLETED|Overall Study||5||
48269982|NCT05383508|100984676|FG001|COMPLETED|Overall Study||6||
48269983|NCT05383508|100984677|FG002|COMPLETED|Overall Study||5||
48269984|NCT05383508|100984678|FG003|COMPLETED|Overall Study||5||
48269985|NCT05383508|100984679|FG004|COMPLETED|Overall Study||4||
48269986|NCT05383508|100984680|FG005|COMPLETED|Overall Study||6||
48269987|NCT05383508|100984675|FG000|NOT COMPLETED|Overall Study||1||
48269988|NCT05383508|100984676|FG001|NOT COMPLETED|Overall Study||0||
48269989|NCT05383508|100984677|FG002|NOT COMPLETED|Overall Study||1||
48269990|NCT05383508|100984678|FG003|NOT COMPLETED|Overall Study||1||
48269991|NCT05383508|100984679|FG004|NOT COMPLETED|Overall Study||2||
48269992|NCT05383508|100984680|FG005|NOT COMPLETED|Overall Study||0||
48269993|NCT03023553|100984681|FG000|STARTED|Overall Study||4||
48269994|NCT03023553|100984682|FG001|STARTED|Overall Study||9||
48269995|NCT03023553|100984681|FG000|COMPLETED|Overall Study||4||
48269996|NCT03023553|100984682|FG001|COMPLETED|Overall Study||8||
48269997|NCT03023553|100984681|FG000|NOT COMPLETED|Overall Study||0||
48269998|NCT03023553|100984682|FG001|NOT COMPLETED|Overall Study||1||
48269999|NCT03568643|100984683|FG000|STARTED|Overall Study||161||
48270000|NCT03568643|100984684|FG001|STARTED|Overall Study||140||
48270001|NCT03568643|100984683|FG000|COMPLETED|Overall Study||161||
48270002|NCT03568643|100984684|FG001|COMPLETED|Overall Study||140||
48270003|NCT03568643|100984683|FG000|NOT COMPLETED|Overall Study||0||
48270004|NCT03568643|100984684|FG001|NOT COMPLETED|Overall Study||0||
48270005|NCT01080326|100984685|FG000|STARTED|Overall Study||7||
48270006|NCT01080326|100984685|FG000|COMPLETED|Overall Study||3||
48270007|NCT01080326|100984685|FG000|NOT COMPLETED|Overall Study||4||
48270008|NCT03415243|100984686|FG000|STARTED|Overall Study||14||
48270009|NCT03415243|100984687|FG001|STARTED|Overall Study||14||
48270010|NCT03415243|100984686|FG000|COMPLETED|Overall Study||14||
48270011|NCT03415243|100984687|FG001|COMPLETED|Overall Study||14||
48270012|NCT03415243|100984686|FG000|NOT COMPLETED|Overall Study||0||
48270013|NCT03415243|100984687|FG001|NOT COMPLETED|Overall Study||0||
48270014|NCT00478192|100984688|FG000|STARTED|Overall Study||20||
48270015|NCT00478192|100984689|FG001|STARTED|Overall Study||20||
48552903|NCT02717455|101686841|FG001|COMPLETED|Overall Study||5||
48552904|NCT02717455|101686842|FG002|COMPLETED|Overall Study||3||
48552905|NCT02717455|101686843|FG003|COMPLETED|Overall Study||6||
48552906|NCT02717455|101686844|FG004|COMPLETED|Overall Study||7||
48552907|NCT02717455|101686845|FG005|COMPLETED|Overall Study||2||
48552908|NCT02717455|101686840|FG000|NOT COMPLETED|Overall Study||3||
48270016|NCT00478192|100984690|FG002|STARTED|Overall Study||10||
48270017|NCT00478192|100984688|FG000|Full Analysis Set / Safety Analysis Set|Overall Study||20||
48270018|NCT00478192|100984689|FG001|Full Analysis Set / Safety Analysis Set|Overall Study||20||
48270019|NCT00478192|100984690|FG002|Full Analysis Set / Safety Analysis Set|Overall Study||9||
48270020|NCT00478192|100984688|FG000|End of Treatment|Overall Study||18||
48270021|NCT00478192|100984689|FG001|End of Treatment|Overall Study||16||
48270022|NCT00478192|100984690|FG002|End of Treatment|Overall Study||8||
48270023|NCT00478192|100984688|FG000|COMPLETED|Overall Study||16||
48270024|NCT00478192|100984689|FG001|COMPLETED|Overall Study||15||
48270025|NCT00478192|100984690|FG002|COMPLETED|Overall Study||8||
48270026|NCT00478192|100984688|FG000|NOT COMPLETED|Overall Study||4||
48270027|NCT00478192|100984689|FG001|NOT COMPLETED|Overall Study||5||
48270028|NCT00478192|100984690|FG002|NOT COMPLETED|Overall Study||2||
48270029|NCT02145468|100984691|FG000|STARTED|Overall Study||1758||
48270030|NCT02145468|100984692|FG001|STARTED|Overall Study||1731||
48270031|NCT02145468|100984691|FG000|COMPLETED|Overall Study||1753||
48270032|NCT02145468|100984692|FG001|COMPLETED|Overall Study||1723||
48270033|NCT02145468|100984691|FG000|NOT COMPLETED|Overall Study||5||
48270034|NCT02145468|100984692|FG001|NOT COMPLETED|Overall Study||8||
48270035|NCT01810939|100984693|FG000|STARTED|Part A Treatment Period||243||
48270036|NCT01810939|100984694|FG001|STARTED|Part A Treatment Period||0||
48270037|NCT01810939|100984695|FG002|STARTED|Part A Treatment Period||0||
48270038|NCT01810939|100984693|FG000|COMPLETED|Part A Treatment Period||219||
48270039|NCT01810939|100984694|FG001|COMPLETED|Part A Treatment Period||0||
48270040|NCT01810939|100984695|FG002|COMPLETED|Part A Treatment Period||0||
48270041|NCT01810939|100984693|FG000|NOT COMPLETED|Part A Treatment Period||24||
48270042|NCT01810939|100984694|FG001|NOT COMPLETED|Part A Treatment Period||0||
48270043|NCT01810939|100984695|FG002|NOT COMPLETED|Part A Treatment Period||0||
48552909|NCT02717455|101686841|FG001|NOT COMPLETED|Overall Study||1||
48270044|NCT01810939|100984693|FG000|STARTED|Part B Placebo-Controlled Withdrawal||0||
48270045|NCT01810939|100984694|FG001|STARTED|Part B Placebo-Controlled Withdrawal||55||
48270046|NCT01810939|100984695|FG002|STARTED|Part B Placebo-Controlled Withdrawal||52||
48270047|NCT01810939|100984693|FG000|COMPLETED|Part B Placebo-Controlled Withdrawal||0||
48270048|NCT01810939|100984694|FG001|COMPLETED|Part B Placebo-Controlled Withdrawal||45||
48270049|NCT01810939|100984695|FG002|COMPLETED|Part B Placebo-Controlled Withdrawal||30||
48270050|NCT01810939|100984693|FG000|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||0||
48270051|NCT01810939|100984694|FG001|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||10||
48270052|NCT01810939|100984695|FG002|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||22||
48270053|NCT02693704|100984696|FG000|STARTED|Overall Study||10||
48552910|NCT02717455|101686842|FG002|NOT COMPLETED|Overall Study||0||
48552911|NCT02717455|101686843|FG003|NOT COMPLETED|Overall Study||6||
48552912|NCT02717455|101686844|FG004|NOT COMPLETED|Overall Study||5||
48108449|NCT01256593|100594284|FG000|STARTED|Overall Study||3827||
48108450|NCT01256593|100594284|FG000|COMPLETED|Overall Study||3613||
48108451|NCT01256593|100594284|FG000|NOT COMPLETED|Overall Study||214||
48108452|NCT00614913|100594285|FG000|STARTED|Overall Study||76||
48108453|NCT00614913|100594285|FG000|COMPLETED|Overall Study||76||
48108454|NCT00614913|100594285|FG000|NOT COMPLETED|Overall Study||0||
48108455|NCT01755416|100594286|FG000|STARTED|First Intervention ( Upto 2 Days)||9||
48108456|NCT01755416|100594287|FG001|STARTED|First Intervention ( Upto 2 Days)||9||
48108457|NCT01755416|100594286|FG000|COMPLETED|First Intervention ( Upto 2 Days)||8||
48108458|NCT01755416|100594287|FG001|COMPLETED|First Intervention ( Upto 2 Days)||7||
48108459|NCT01755416|100594286|FG000|NOT COMPLETED|First Intervention ( Upto 2 Days)||1||
48108460|NCT01755416|100594287|FG001|NOT COMPLETED|First Intervention ( Upto 2 Days)||2||
48108461|NCT01755416|100594286|FG000|STARTED|Second Intervention (Upto 2 Days)||8||
48108462|NCT01755416|100594287|FG001|STARTED|Second Intervention (Upto 2 Days)||7||
48108463|NCT01755416|100594286|FG000|COMPLETED|Second Intervention (Upto 2 Days)||8||
48108464|NCT01755416|100594287|FG001|COMPLETED|Second Intervention (Upto 2 Days)||7||
48108465|NCT01755416|100594286|FG000|NOT COMPLETED|Second Intervention (Upto 2 Days)||0||
48108466|NCT01755416|100594287|FG001|NOT COMPLETED|Second Intervention (Upto 2 Days)||0||
48108467|NCT01554891|100594288|FG000|STARTED|Overall Study||105||
48108468|NCT01554891|100594289|FG001|STARTED|Overall Study||120||
48108469|NCT01554891|100594290|FG002|STARTED|Overall Study||57||
48108470|NCT01554891|100594288|FG000|COMPLETED|Overall Study||98||
48108471|NCT01554891|100594289|FG001|COMPLETED|Overall Study||115||
48108472|NCT01554891|100594290|FG002|COMPLETED|Overall Study||55||
48108473|NCT01554891|100594288|FG000|NOT COMPLETED|Overall Study||7||
48108474|NCT01554891|100594289|FG001|NOT COMPLETED|Overall Study||5||
48108475|NCT01554891|100594290|FG002|NOT COMPLETED|Overall Study||2||
48108476|NCT04964453|100594291|FG000|STARTED|Overall Study||8||
48108477|NCT04964453|100594292|FG001|STARTED|Overall Study||6||
48108478|NCT04964453|100594293|FG002|STARTED|Overall Study||6||
48108479|NCT04964453|100594294|FG003|STARTED|Overall Study||6||
48108480|NCT04964453|100594295|FG004|STARTED|Overall Study||6||
48108481|NCT04964453|100594291|FG000|COMPLETED|Overall Study||8||
48108482|NCT04964453|100594292|FG001|COMPLETED|Overall Study||6||
48108483|NCT04964453|100594293|FG002|COMPLETED|Overall Study||6||
48108484|NCT04964453|100594294|FG003|COMPLETED|Overall Study||6||
48108485|NCT04964453|100594295|FG004|COMPLETED|Overall Study||6||
48108486|NCT04964453|100594291|FG000|NOT COMPLETED|Overall Study||0||
48108487|NCT04964453|100594292|FG001|NOT COMPLETED|Overall Study||0||
48108488|NCT04964453|100594293|FG002|NOT COMPLETED|Overall Study||0||
48108489|NCT04964453|100594294|FG003|NOT COMPLETED|Overall Study||0||
48108490|NCT04964453|100594295|FG004|NOT COMPLETED|Overall Study||0||
48108491|NCT03013543|100594296|FG000|STARTED|Overall Study||19||
48108492|NCT03013543|100594297|FG001|STARTED|Overall Study||4||
48108493|NCT03013543|100594298|FG002|STARTED|Overall Study||10||
48108494|NCT03013543|100594299|FG003|STARTED|Overall Study||49||
48108495|NCT03013543|100594300|FG004|STARTED|Overall Study||33||
48108496|NCT03013543|100594301|FG005|STARTED|Overall Study||5||
48108497|NCT03013543|100594302|FG006|STARTED|Overall Study||27||
48108498|NCT03013543|100594303|FG007|STARTED|Overall Study||22||
48108499|NCT03013543|100594304|FG008|STARTED|Overall Study||12||
48108500|NCT03013543|100594305|FG009|STARTED|Overall Study||32||
48108501|NCT03013543|100594296|FG000|COMPLETED|Overall Study||19||
48108502|NCT03013543|100594297|FG001|COMPLETED|Overall Study||2||
48108503|NCT03013543|100594298|FG002|COMPLETED|Overall Study||7||
48108504|NCT03013543|100594299|FG003|COMPLETED|Overall Study||37||
48108505|NCT03013543|100594300|FG004|COMPLETED|Overall Study||22||
48108506|NCT03013543|100594301|FG005|COMPLETED|Overall Study||2||
48108507|NCT03013543|100594302|FG006|COMPLETED|Overall Study||20||
48108508|NCT03013543|100594303|FG007|COMPLETED|Overall Study||13||
48108509|NCT03013543|100594304|FG008|COMPLETED|Overall Study||9||
48108510|NCT03013543|100594305|FG009|COMPLETED|Overall Study||22||
48108511|NCT03013543|100594296|FG000|NOT COMPLETED|Overall Study||0||
48108512|NCT03013543|100594297|FG001|NOT COMPLETED|Overall Study||2||
48108513|NCT03013543|100594298|FG002|NOT COMPLETED|Overall Study||3||
48108514|NCT03013543|100594299|FG003|NOT COMPLETED|Overall Study||12||
48108515|NCT03013543|100594300|FG004|NOT COMPLETED|Overall Study||11||
48108516|NCT03013543|100594301|FG005|NOT COMPLETED|Overall Study||3||
48108517|NCT03013543|100594302|FG006|NOT COMPLETED|Overall Study||7||
48108518|NCT03013543|100594303|FG007|NOT COMPLETED|Overall Study||9||
48108519|NCT03013543|100594304|FG008|NOT COMPLETED|Overall Study||3||
48108520|NCT03013543|100594305|FG009|NOT COMPLETED|Overall Study||10||
48108521|NCT02882321|100594306|FG000|STARTED|Overall Study||4||
48552913|NCT02717455|101686845|FG005|NOT COMPLETED|Overall Study||5||
48108522|NCT02882321|100594307|FG001|STARTED|Overall Study||3||
48108523|NCT02882321|100594308|FG002|STARTED|Overall Study||3||
48108524|NCT02882321|100594309|FG003|STARTED|Overall Study||7||
48108525|NCT02882321|100594306|FG000|COMPLETED|Overall Study||4||
48552914|NCT00490841|101686846|FG000|STARTED|Overall Study||202||
48552915|NCT00490841|101686846|FG000|COMPLETED|Overall Study||189||
48552916|NCT00490841|101686846|FG000|NOT COMPLETED|Overall Study||13||
48552917|NCT01579747|101686847|FG000|STARTED|Overall Study||12||
48552918|NCT01579747|101686848|FG001|STARTED|Overall Study||12||
48552919|NCT01579747|101686847|FG000|COMPLETED|Overall Study||12||
48552920|NCT01579747|101686848|FG001|COMPLETED|Overall Study||12||
48552921|NCT01579747|101686847|FG000|NOT COMPLETED|Overall Study||0||
48552922|NCT01579747|101686848|FG001|NOT COMPLETED|Overall Study||0||
48552923|NCT01027598|101686849|FG000|STARTED|Overall Study||134||
48552924|NCT01027598|101686850|FG001|STARTED|Overall Study||67||
48552925|NCT01027598|101686849|FG000|COMPLETED|Overall Study||0||
48552926|NCT01027598|101686850|FG001|COMPLETED|Overall Study||0||
48552927|NCT01027598|101686849|FG000|NOT COMPLETED|Overall Study||134||
48552928|NCT01027598|101686850|FG001|NOT COMPLETED|Overall Study||67||
48552929|NCT03617783|101686851|FG000|STARTED|Overall Study||9||
48552930|NCT03617783|101686852|FG001|STARTED|Overall Study||13||
48552931|NCT03617783|101686851|FG000|COMPLETED|Overall Study||8||
48552932|NCT03617783|101686852|FG001|COMPLETED|Overall Study||12||
48552933|NCT03617783|101686851|FG000|NOT COMPLETED|Overall Study||1||
48552934|NCT03617783|101686852|FG001|NOT COMPLETED|Overall Study||1||
48552935|NCT00587860|101686853|FG000|STARTED|Overall Study||35||
48552936|NCT00587860|101686854|FG001|STARTED|Overall Study||35||
48552937|NCT00587860|101686853|FG000|COMPLETED|Overall Study||30||
48552938|NCT00587860|101686854|FG001|COMPLETED|Overall Study||30||
48552939|NCT00587860|101686853|FG000|NOT COMPLETED|Overall Study||5||
48552940|NCT00587860|101686854|FG001|NOT COMPLETED|Overall Study||5||
48552941|NCT03519087|101686855|FG000|STARTED|Clinic Evaluation||55||
48552942|NCT03519087|101686856|FG001|STARTED|Clinic Evaluation||57||
48552943|NCT03519087|101686857|FG002|STARTED|Clinic Evaluation||0||
48552944|NCT03519087|101686858|FG003|STARTED|Clinic Evaluation||0||
48552945|NCT03519087|101686859|FG004|STARTED|Clinic Evaluation||0||
48552946|NCT03519087|101686855|FG000|Received Assigned Intervention|Clinic Evaluation||54||
48552947|NCT03519087|101686856|FG001|Received Assigned Intervention|Clinic Evaluation||57||
48552948|NCT03519087|101686857|FG002|Received Assigned Intervention|Clinic Evaluation||0||
48552949|NCT03519087|101686858|FG003|Received Assigned Intervention|Clinic Evaluation||0||
48552950|NCT03519087|101686859|FG004|Received Assigned Intervention|Clinic Evaluation||0||
48552951|NCT03519087|101686855|FG000|Confirmed Diagnosis by Physician|Clinic Evaluation||39||
48552952|NCT03519087|101686856|FG001|Confirmed Diagnosis by Physician|Clinic Evaluation||39||
48552953|NCT03519087|101686857|FG002|Confirmed Diagnosis by Physician|Clinic Evaluation||0||
48552954|NCT03519087|101686858|FG003|Confirmed Diagnosis by Physician|Clinic Evaluation||0||
48552955|NCT03519087|101686859|FG004|Confirmed Diagnosis by Physician|Clinic Evaluation||0||
48552956|NCT03519087|101686855|FG000|COMPLETED|Clinic Evaluation||39||
48552957|NCT03519087|101686856|FG001|COMPLETED|Clinic Evaluation||39||
48552958|NCT03519087|101686857|FG002|COMPLETED|Clinic Evaluation||0||
48552959|NCT03519087|101686858|FG003|COMPLETED|Clinic Evaluation||0||
48552960|NCT03519087|101686859|FG004|COMPLETED|Clinic Evaluation||0||
48552961|NCT03519087|101686855|FG000|NOT COMPLETED|Clinic Evaluation||16||
48552962|NCT03519087|101686856|FG001|NOT COMPLETED|Clinic Evaluation||18||
48552963|NCT03519087|101686857|FG002|NOT COMPLETED|Clinic Evaluation||0||
48552964|NCT03519087|101686858|FG003|NOT COMPLETED|Clinic Evaluation||0||
48552965|NCT03519087|101686859|FG004|NOT COMPLETED|Clinic Evaluation||0||
48552966|NCT03519087|101686855|FG000|STARTED|Re-randomization for Treatment||39||
48552967|NCT03519087|101686856|FG001|STARTED|Re-randomization for Treatment||39||
48552968|NCT03519087|101686857|FG002|STARTED|Re-randomization for Treatment||0||
48552969|NCT03519087|101686858|FG003|STARTED|Re-randomization for Treatment||0||
48552970|NCT03519087|101686859|FG004|STARTED|Re-randomization for Treatment||0||
48552971|NCT03519087|101686855|FG000|COMPLETED|Re-randomization for Treatment||12||
48552972|NCT03519087|101686856|FG001|COMPLETED|Re-randomization for Treatment||7||
48552973|NCT03519087|101686857|FG002|COMPLETED|Re-randomization for Treatment||0||
48552974|NCT03519087|101686858|FG003|COMPLETED|Re-randomization for Treatment||0||
48552975|NCT03519087|101686859|FG004|COMPLETED|Re-randomization for Treatment||0||
48552976|NCT03519087|101686855|FG000|NOT COMPLETED|Re-randomization for Treatment||27||
48552977|NCT03519087|101686856|FG001|NOT COMPLETED|Re-randomization for Treatment||32||
48552978|NCT03519087|101686857|FG002|NOT COMPLETED|Re-randomization for Treatment||0||
48552979|NCT03519087|101686858|FG003|NOT COMPLETED|Re-randomization for Treatment||0||
48552980|NCT03519087|101686859|FG004|NOT COMPLETED|Re-randomization for Treatment||0||
48552981|NCT03519087|101686855|FG000|STARTED|Laboratory Testing||0||
48552982|NCT03519087|101686856|FG001|STARTED|Laboratory Testing||0||
48552983|NCT03519087|101686857|FG002|STARTED|Laboratory Testing||6||
48552984|NCT03519087|101686858|FG003|STARTED|Laboratory Testing||6||
48552985|NCT03519087|101686859|FG004|STARTED|Laboratory Testing||7||
48552986|NCT03519087|101686855|FG000|Baseline Lab Testing|Laboratory Testing||0||
48552987|NCT03519087|101686856|FG001|Baseline Lab Testing|Laboratory Testing||0||
48552988|NCT03519087|101686857|FG002|Baseline Lab Testing|Laboratory Testing||5||
48552989|NCT03519087|101686858|FG003|Baseline Lab Testing|Laboratory Testing||4||
48552990|NCT03519087|101686859|FG004|Baseline Lab Testing|Laboratory Testing||3||
48270054|NCT02693704|100984697|FG001|STARTED|Overall Study||10||
48270055|NCT02693704|100984698|FG002|STARTED|Overall Study||10||
48270056|NCT02693704|100984699|FG003|STARTED|Overall Study||10||
48270057|NCT02693704|100984696|FG000|COMPLETED|Overall Study||10||
48270058|NCT02693704|100984697|FG001|COMPLETED|Overall Study||10||
48270059|NCT02693704|100984698|FG002|COMPLETED|Overall Study||10||
48552991|NCT03519087|101686855|FG000|COMPLETED|Laboratory Testing||0||
48552992|NCT03519087|101686856|FG001|COMPLETED|Laboratory Testing||0||
48552993|NCT03519087|101686857|FG002|COMPLETED|Laboratory Testing||4||
48552994|NCT03519087|101686858|FG003|COMPLETED|Laboratory Testing||2||
48552995|NCT03519087|101686859|FG004|COMPLETED|Laboratory Testing||1||
48552996|NCT03519087|101686855|FG000|NOT COMPLETED|Laboratory Testing||0||
48552997|NCT03519087|101686856|FG001|NOT COMPLETED|Laboratory Testing||0||
48270060|NCT02693704|100984699|FG003|COMPLETED|Overall Study||10||
48270061|NCT02693704|100984696|FG000|NOT COMPLETED|Overall Study||0||
48270062|NCT02693704|100984697|FG001|NOT COMPLETED|Overall Study||0||
48270063|NCT02693704|100984698|FG002|NOT COMPLETED|Overall Study||0||
48270064|NCT02693704|100984699|FG003|NOT COMPLETED|Overall Study||0||
48270065|NCT02222870|100984700|FG000|STARTED|Overall Study||30||
48270066|NCT02222870|100984701|FG001|STARTED|Overall Study||30||
48270067|NCT02222870|100984700|FG000|COMPLETED|Overall Study||30||
48270068|NCT02222870|100984701|FG001|COMPLETED|Overall Study||30||
48552998|NCT03519087|101686857|FG002|NOT COMPLETED|Laboratory Testing||2||
48552999|NCT03519087|101686858|FG003|NOT COMPLETED|Laboratory Testing||4||
48553000|NCT03519087|101686859|FG004|NOT COMPLETED|Laboratory Testing||6||
48270069|NCT02222870|100984700|FG000|NOT COMPLETED|Overall Study||0||
48270070|NCT02222870|100984701|FG001|NOT COMPLETED|Overall Study||0||
48553001|NCT02995408|101686860|FG000|STARTED|Overall Study||32||
48553002|NCT02995408|101686861|FG001|STARTED|Overall Study||32||
48553003|NCT02995408|101686860|FG000|COMPLETED|Overall Study||20||
48553004|NCT02995408|101686861|FG001|COMPLETED|Overall Study||22||
48553005|NCT02995408|101686860|FG000|NOT COMPLETED|Overall Study||12||
48553006|NCT02995408|101686861|FG001|NOT COMPLETED|Overall Study||10||
48553007|NCT03348163|101686862|FG000|STARTED|Overall Study||12||
48553008|NCT03348163|101686863|FG001|STARTED|Overall Study||9||
48553009|NCT03348163|101686862|FG000|COMPLETED|Overall Study||10||
48553010|NCT03348163|101686863|FG001|COMPLETED|Overall Study||9||
48553011|NCT03348163|101686862|FG000|NOT COMPLETED|Overall Study||2||
48553012|NCT03348163|101686863|FG001|NOT COMPLETED|Overall Study||0||
48553013|NCT01699815|101686864|FG000|STARTED|Overall Study||62||
48553014|NCT01699815|101686865|FG001|STARTED|Overall Study||64||
48553015|NCT01699815|101686864|FG000|COMPLETED|Overall Study||57||
48553016|NCT01699815|101686865|FG001|COMPLETED|Overall Study||56||
48553017|NCT01699815|101686864|FG000|NOT COMPLETED|Overall Study||5||
48553018|NCT01699815|101686865|FG001|NOT COMPLETED|Overall Study||8||
48270071|NCT03192462|100984702|FG000|STARTED|Overall Study||13||
48270072|NCT03192462|100984703|FG001|STARTED|Overall Study||12||
48270073|NCT03192462|100984704|FG002|STARTED|Overall Study||12||
48270074|NCT03192462|100984702|FG000|COMPLETED|Overall Study||0||
48270075|NCT03192462|100984703|FG001|COMPLETED|Overall Study||0||
48270076|NCT03192462|100984704|FG002|COMPLETED|Overall Study||0||
48270077|NCT03192462|100984702|FG000|NOT COMPLETED|Overall Study||13||
48270078|NCT03192462|100984703|FG001|NOT COMPLETED|Overall Study||12||
48270079|NCT03192462|100984704|FG002|NOT COMPLETED|Overall Study||12||
48270080|NCT02627118|100984705|FG000|STARTED|Overall Study||10||
48270081|NCT02627118|100984705|FG000|COMPLETED|Overall Study||10||
48270082|NCT02627118|100984705|FG000|NOT COMPLETED|Overall Study||0||
48553019|NCT01810302|101686866|FG000|STARTED|Overall Study||1||
48553020|NCT01810302|101686867|FG001|STARTED|Overall Study||1||
48553021|NCT01810302|101686866|FG000|COMPLETED|Overall Study||0||
48553022|NCT01810302|101686867|FG001|COMPLETED|Overall Study||0||
48553023|NCT01810302|101686866|FG000|NOT COMPLETED|Overall Study||1||
48553024|NCT01810302|101686867|FG001|NOT COMPLETED|Overall Study||1||
48553025|NCT03267212|101686868|FG000|STARTED|First Intervention||6||
48553026|NCT03267212|101686869|FG001|STARTED|First Intervention||9||
48270083|NCT02956837|100984706|FG000|STARTED|Overall Study||100||
48270084|NCT02956837|100984707|FG001|STARTED|Overall Study||99||
48270085|NCT02956837|100984708|FG002|STARTED|Overall Study||99||
48270086|NCT02956837|100984709|FG003|STARTED|Overall Study||102||
48270087|NCT02956837|100984706|FG000|COMPLETED|Overall Study||100||
48270088|NCT02956837|100984707|FG001|COMPLETED|Overall Study||96||
48270089|NCT02956837|100984708|FG002|COMPLETED|Overall Study||97||
48270090|NCT02956837|100984709|FG003|COMPLETED|Overall Study||99||
48270091|NCT02956837|100984706|FG000|NOT COMPLETED|Overall Study||0||
48270092|NCT02956837|100984707|FG001|NOT COMPLETED|Overall Study||3||
48270093|NCT02956837|100984708|FG002|NOT COMPLETED|Overall Study||2||
48270094|NCT02956837|100984709|FG003|NOT COMPLETED|Overall Study||3||
48270095|NCT01711853|100984710|FG000|STARTED|Overall Study||19||
48270096|NCT01711853|100984710|FG000|COMPLETED|Overall Study||16||
48270097|NCT01711853|100984710|FG000|NOT COMPLETED|Overall Study||3||
48270098|NCT03745898|100984711|FG000|STARTED|Overall Study||48||
48270099|NCT03745898|100984712|FG001|STARTED|Overall Study||50||
48270100|NCT03745898|100984711|FG000|COMPLETED|Overall Study||48||
48270101|NCT03745898|100984712|FG001|COMPLETED|Overall Study||50||
48553027|NCT03267212|101686868|FG000|High SCI|First Intervention||2||
48553028|NCT03267212|101686869|FG001|High SCI|First Intervention||5||
48553029|NCT03267212|101686868|FG000|Low SCI|First Intervention||4||
48553030|NCT03267212|101686869|FG001|Low SCI|First Intervention||4||
48553031|NCT03267212|101686868|FG000|COMPLETED|First Intervention||5||
48553032|NCT03267212|101686869|FG001|COMPLETED|First Intervention||6||
48553033|NCT03267212|101686868|FG000|NOT COMPLETED|First Intervention||1||
48553034|NCT03267212|101686869|FG001|NOT COMPLETED|First Intervention||3||
48270102|NCT03745898|100984711|FG000|NOT COMPLETED|Overall Study||0||
48553035|NCT03267212|101686868|FG000|STARTED|Washout (Min 2 Days / Max 7 Days)||5||
48553036|NCT03267212|101686869|FG001|STARTED|Washout (Min 2 Days / Max 7 Days)||6||
48553037|NCT03267212|101686868|FG000|COMPLETED|Washout (Min 2 Days / Max 7 Days)||4||
48553038|NCT03267212|101686869|FG001|COMPLETED|Washout (Min 2 Days / Max 7 Days)||6||
48553039|NCT03267212|101686868|FG000|NOT COMPLETED|Washout (Min 2 Days / Max 7 Days)||1||
48270103|NCT03745898|100984712|FG001|NOT COMPLETED|Overall Study||0||
48270104|NCT01696955|100984713|FG000|STARTED|Main Study||42||
48270105|NCT01696955|100984714|FG001|STARTED|Main Study||39||
48553040|NCT03267212|101686869|FG001|NOT COMPLETED|Washout (Min 2 Days / Max 7 Days)||0||
48553041|NCT03267212|101686868|FG000|STARTED|Second Intervention||4||
48553042|NCT03267212|101686869|FG001|STARTED|Second Intervention||6||
48553043|NCT03267212|101686868|FG000|COMPLETED|Second Intervention||4||
48553044|NCT03267212|101686869|FG001|COMPLETED|Second Intervention||6||
48553045|NCT03267212|101686868|FG000|NOT COMPLETED|Second Intervention||0||
48553046|NCT03267212|101686869|FG001|NOT COMPLETED|Second Intervention||0||
48553047|NCT02308124|101686870|FG000|STARTED|Overall Study||29||
48553048|NCT02308124|101686871|FG001|STARTED|Overall Study||29||
48553049|NCT02308124|101686872|FG002|STARTED|Overall Study||29||
48553050|NCT02308124|101686870|FG000|COMPLETED|Overall Study||23||
48553051|NCT02308124|101686871|FG001|COMPLETED|Overall Study||21||
48553052|NCT02308124|101686872|FG002|COMPLETED|Overall Study||21||
48553053|NCT02308124|101686870|FG000|NOT COMPLETED|Overall Study||6||
48553054|NCT02308124|101686871|FG001|NOT COMPLETED|Overall Study||8||
48553055|NCT02308124|101686872|FG002|NOT COMPLETED|Overall Study||8||
48553056|NCT01223378|101686873|FG000|STARTED|Overall Study||82||
48553057|NCT01223378|101686874|FG001|STARTED|Overall Study||85||
48553058|NCT01223378|101686875|FG002|STARTED|Overall Study||83||
48553059|NCT01223378|101686876|FG003|STARTED|Overall Study||81||
48553060|NCT01223378|101686877|FG004|STARTED|Overall Study||82||
48553061|NCT01223378|101686873|FG000|COMPLETED|Overall Study||76||
48553062|NCT01223378|101686874|FG001|COMPLETED|Overall Study||81||
48553063|NCT01223378|101686875|FG002|COMPLETED|Overall Study||80||
48553064|NCT01223378|101686876|FG003|COMPLETED|Overall Study||80||
48553065|NCT01223378|101686877|FG004|COMPLETED|Overall Study||79||
48553066|NCT01223378|101686873|FG000|NOT COMPLETED|Overall Study||6||
48553067|NCT01223378|101686874|FG001|NOT COMPLETED|Overall Study||4||
48553068|NCT01223378|101686875|FG002|NOT COMPLETED|Overall Study||3||
48553069|NCT01223378|101686876|FG003|NOT COMPLETED|Overall Study||1||
48553070|NCT01223378|101686877|FG004|NOT COMPLETED|Overall Study||3||
48553071|NCT04146012|101686878|FG000|STARTED|Overall Study||33||
48553072|NCT04146012|101686879|FG001|STARTED|Overall Study||17||
48553073|NCT04146012|101686878|FG000|COMPLETED|Overall Study||3||
48553074|NCT04146012|101686879|FG001|COMPLETED|Overall Study||2||
48553075|NCT04146012|101686878|FG000|NOT COMPLETED|Overall Study||30||
48553076|NCT04146012|101686879|FG001|NOT COMPLETED|Overall Study||15||
48553077|NCT03091179|101686880|FG000|STARTED|Overall Study||10||
48553078|NCT03091179|101686881|FG001|STARTED|Overall Study||10||
48553079|NCT03091179|101686880|FG000|COMPLETED|Overall Study||10||
48553080|NCT03091179|101686881|FG001|COMPLETED|Overall Study||10||
48553081|NCT03091179|101686880|FG000|NOT COMPLETED|Overall Study||0||
48553082|NCT03091179|101686881|FG001|NOT COMPLETED|Overall Study||0||
48553083|NCT03764618|101686882|FG000|STARTED|Overall Study||45||
48270106|NCT01696955|100984713|FG000|COMPLETED|Main Study||40||
48270107|NCT01696955|100984714|FG001|COMPLETED|Main Study||38||
48270108|NCT01696955|100984713|FG000|NOT COMPLETED|Main Study||2||
48270109|NCT01696955|100984714|FG001|NOT COMPLETED|Main Study||1||
48270110|NCT01696955|100984713|FG000|STARTED|Failure on Cetuximab-Received Tivantinib||0||
48553084|NCT03764618|101686883|FG001|STARTED|Overall Study||45||
48553085|NCT03764618|101686882|FG000|COMPLETED|Overall Study||38||
48553086|NCT03764618|101686883|FG001|COMPLETED|Overall Study||34||
48553087|NCT03764618|101686882|FG000|NOT COMPLETED|Overall Study||7||
48553088|NCT03764618|101686883|FG001|NOT COMPLETED|Overall Study||11||
48553089|NCT00200902|101686884|FG000|STARTED|Overall Study||39|Overall for this study, n=67 assessed for many measures in Results section.|
48553090|NCT00200902|101686885|FG001|STARTED|Overall Study||29|Overall for this study, n=67 assessed for many measures in Results section.|
48553091|NCT00200902|101686886|FG002|STARTED|Overall Study||20|Overall for this study, n=67 assessed for many measures in Results section.|
48553092|NCT00200902|101686884|FG000|COMPLETED|Overall Study||29||
48553093|NCT00200902|101686885|FG001|COMPLETED|Overall Study||26||
48270111|NCT01696955|100984714|FG001|STARTED|Failure on Cetuximab-Received Tivantinib||15||
48270112|NCT01696955|100984713|FG000|COMPLETED|Failure on Cetuximab-Received Tivantinib||0||
48270113|NCT01696955|100984714|FG001|COMPLETED|Failure on Cetuximab-Received Tivantinib||15||
48270114|NCT01696955|100984713|FG000|NOT COMPLETED|Failure on Cetuximab-Received Tivantinib||0||
48270115|NCT01696955|100984714|FG001|NOT COMPLETED|Failure on Cetuximab-Received Tivantinib||0||
48270116|NCT02416453|100984715|FG000|STARTED|Overall Study||10||
48270117|NCT02416453|100984716|FG001|STARTED|Overall Study||10||
48270118|NCT02416453|100984717|FG002|STARTED|Overall Study||10||
48270119|NCT02416453|100984718|FG003|STARTED|Overall Study||112||
48270120|NCT02416453|100984719|FG004|STARTED|Overall Study||13||
48270121|NCT02416453|100984720|FG005|STARTED|Overall Study||114||
48553094|NCT00200902|101686886|FG002|COMPLETED|Overall Study||12||
48553095|NCT00200902|101686884|FG000|NOT COMPLETED|Overall Study||10||
48553096|NCT00200902|101686885|FG001|NOT COMPLETED|Overall Study||3||
48553097|NCT00200902|101686886|FG002|NOT COMPLETED|Overall Study||8||
48553098|NCT05044195|101686887|FG000|STARTED|Overall Study||1027||
48553099|NCT05044195|101686888|FG001|STARTED|Overall Study||1017||
48553100|NCT05044195|101686887|FG000|Received Study Vaccine|Overall Study||1027||
48553101|NCT05044195|101686888|FG001|Received Study Vaccine|Overall Study||1016||
48553102|NCT05044195|101686887|FG000|COMPLETED|Overall Study||982||
48553103|NCT05044195|101686888|FG001|COMPLETED|Overall Study||989||
48553104|NCT05044195|101686887|FG000|NOT COMPLETED|Overall Study||45||
48553105|NCT05044195|101686888|FG001|NOT COMPLETED|Overall Study||28||
48553106|NCT02779166|101686889|FG000|STARTED|Overall Study||50||
48553107|NCT02779166|101686890|FG001|STARTED|Overall Study||48||
48553108|NCT02779166|101686889|FG000|COMPLETED|Overall Study||50||
48553109|NCT02779166|101686890|FG001|COMPLETED|Overall Study||48||
48553110|NCT02779166|101686889|FG000|NOT COMPLETED|Overall Study||0||
48553111|NCT02779166|101686890|FG001|NOT COMPLETED|Overall Study||0||
48553112|NCT02207634|101686891|FG000|STARTED|Overall Study||990||
48553113|NCT02207634|101686892|FG001|STARTED|Overall Study||984||
48553114|NCT02207634|101686891|FG000|Received Treatment|Overall Study||990||
48553115|NCT02207634|101686892|FG001|Received Treatment|Overall Study||983||
48553116|NCT02207634|101686891|FG000|COMPLETED|Overall Study||968||
48553117|NCT02207634|101686892|FG001|COMPLETED|Overall Study||953||
48553118|NCT02207634|101686891|FG000|NOT COMPLETED|Overall Study||22||
48553119|NCT02207634|101686892|FG001|NOT COMPLETED|Overall Study||31||
48553120|NCT00545714|101686893|FG000|STARTED|Induction Phase (6 Months)||86||
48553121|NCT00545714|101686893|FG000|Safety Population|Induction Phase (6 Months)||86||
48553122|NCT00545714|101686893|FG000|Intent-to-Treat (ITT) Population|Induction Phase (6 Months)||84||
48553123|NCT00545714|101686893|FG000|COMPLETED|Induction Phase (6 Months)||74||
48553124|NCT00545714|101686893|FG000|NOT COMPLETED|Induction Phase (6 Months)||12||
48553125|NCT00545714|101686893|FG000|STARTED|Maintenance Phase (36 Months)||74||
48553126|NCT00545714|101686893|FG000|COMPLETED|Maintenance Phase (36 Months)||42||
48270122|NCT02416453|100984721|FG006|STARTED|Overall Study||13||
48270123|NCT02416453|100984722|FG007|STARTED|Overall Study||106||
48270124|NCT02416453|100984723|FG008|STARTED|Overall Study||18||
48270125|NCT02416453|100984724|FG009|STARTED|Overall Study||13||
48270126|NCT02416453|100984725|FG010|STARTED|Overall Study||2||
48270127|NCT02416453|100984715|FG000|COMPLETED|Overall Study||7||
48270128|NCT02416453|100984716|FG001|COMPLETED|Overall Study||7||
48270129|NCT02416453|100984717|FG002|COMPLETED|Overall Study||9||
48270130|NCT02416453|100984718|FG003|COMPLETED|Overall Study||97||
48270131|NCT02416453|100984719|FG004|COMPLETED|Overall Study||12||
48270132|NCT02416453|100984720|FG005|COMPLETED|Overall Study||98||
48270133|NCT02416453|100984721|FG006|COMPLETED|Overall Study||11||
48270134|NCT02416453|100984722|FG007|COMPLETED|Overall Study||94||
48270135|NCT02416453|100984723|FG008|COMPLETED|Overall Study||13||
48270136|NCT02416453|100984724|FG009|COMPLETED|Overall Study||13||
48270137|NCT02416453|100984725|FG010|COMPLETED|Overall Study||2||
48270138|NCT02416453|100984715|FG000|NOT COMPLETED|Overall Study||3||
48270139|NCT02416453|100984716|FG001|NOT COMPLETED|Overall Study||3||
48270140|NCT02416453|100984717|FG002|NOT COMPLETED|Overall Study||1||
48270141|NCT02416453|100984718|FG003|NOT COMPLETED|Overall Study||15||
48270142|NCT02416453|100984719|FG004|NOT COMPLETED|Overall Study||1||
48270143|NCT02416453|100984720|FG005|NOT COMPLETED|Overall Study||16||
48270144|NCT02416453|100984721|FG006|NOT COMPLETED|Overall Study||2||
48270145|NCT02416453|100984722|FG007|NOT COMPLETED|Overall Study||12||
48270146|NCT02416453|100984723|FG008|NOT COMPLETED|Overall Study||5||
48270147|NCT02416453|100984724|FG009|NOT COMPLETED|Overall Study||0||
48270148|NCT02416453|100984725|FG010|NOT COMPLETED|Overall Study||0||
48270149|NCT01093469|100984726|FG000|STARTED|Overall Study||13||
48270150|NCT01093469|100984727|FG001|STARTED|Overall Study||13||
48270151|NCT01093469|100984728|FG002|STARTED|Overall Study||13||
48270152|NCT01093469|100984726|FG000|COMPLETED|Overall Study||13||
48392332|NCT00871377|101287845|FG004|NOT COMPLETED|Second Intervention (10 Weeks)||0||
48392333|NCT00871377|101287846|FG005|NOT COMPLETED|Second Intervention (10 Weeks)||0||
48392334|NCT00871377|101287841|FG000|STARTED|Washout (6 Weeks)||2||
48553127|NCT00545714|101686893|FG000|NOT COMPLETED|Maintenance Phase (36 Months)||32||
48553128|NCT00719186|101686894|FG000|STARTED|Overall Study||376||
48553129|NCT00719186|101686895|FG001|STARTED|Overall Study||374||
48553130|NCT00719186|101686894|FG000|COMPLETED|Overall Study||376||
48553131|NCT00719186|101686895|FG001|COMPLETED|Overall Study||374||
48553132|NCT00719186|101686894|FG000|NOT COMPLETED|Overall Study||0||
48553133|NCT00719186|101686895|FG001|NOT COMPLETED|Overall Study||0||
48553134|NCT00573261|101686896|FG000|STARTED|Overall Study||20||
48553135|NCT00573261|101686897|FG001|STARTED|Overall Study||20||
48270153|NCT01093469|100984727|FG001|COMPLETED|Overall Study||13||
48270154|NCT01093469|100984728|FG002|COMPLETED|Overall Study||12||
48270155|NCT01093469|100984726|FG000|NOT COMPLETED|Overall Study||0||
48553136|NCT00573261|101686896|FG000|COMPLETED|Overall Study||14||
48553137|NCT00573261|101686897|FG001|COMPLETED|Overall Study||15||
48553138|NCT00573261|101686896|FG000|NOT COMPLETED|Overall Study||6||
48553139|NCT00573261|101686897|FG001|NOT COMPLETED|Overall Study||5||
48270156|NCT01093469|100984727|FG001|NOT COMPLETED|Overall Study||0||
48553140|NCT01443728|101686898|FG000|STARTED|Overall Study||31||
48553141|NCT01443728|101686899|FG001|STARTED|Overall Study||31||
48553142|NCT01443728|101686898|FG000|COMPLETED|Overall Study||28||
48553143|NCT01443728|101686899|FG001|COMPLETED|Overall Study||28||
48553144|NCT01443728|101686898|FG000|NOT COMPLETED|Overall Study||3||
48553145|NCT01443728|101686899|FG001|NOT COMPLETED|Overall Study||3||
48553146|NCT02054338|101686900|FG000|STARTED|Overall Study||503||
48553147|NCT02054338|101686901|FG001|STARTED|Overall Study||501||
48553148|NCT02054338|101686900|FG000|COMPLETED|Overall Study||0||
48553149|NCT02054338|101686901|FG001|COMPLETED|Overall Study||0||
48553150|NCT02054338|101686900|FG000|NOT COMPLETED|Overall Study||503||
48553151|NCT02054338|101686901|FG001|NOT COMPLETED|Overall Study||501||
48553152|NCT00100828|101686902|FG000|STARTED|Overall Study||6||
48553153|NCT00100828|101686902|FG000|COMPLETED|Overall Study||0|Trial closed due to early stopping rule and low enrollment.|
48553154|NCT00100828|101686902|FG000|NOT COMPLETED|Overall Study||6||
48270157|NCT01093469|100984728|FG002|NOT COMPLETED|Overall Study||1||
48270158|NCT01706705|100984729|FG000|STARTED|Overall Study||57||
48270159|NCT01706705|100984729|FG000|COMPLETED|Overall Study||37||
48270160|NCT01706705|100984729|FG000|NOT COMPLETED|Overall Study||20||
48270161|NCT00567840|100984730|FG000|STARTED|Overall Study||15||
48270162|NCT00567840|100984731|FG001|STARTED|Overall Study||15||
48553155|NCT00645970|101686903|FG000|STARTED|Overall Study||141||
48553156|NCT00645970|101686904|FG001|STARTED|Overall Study||218||
48553157|NCT00645970|101686903|FG000|6 Months|Overall Study||58||
48553158|NCT00645970|101686904|FG001|6 Months|Overall Study||97||
48553159|NCT00645970|101686903|FG000|1 Year|Overall Study||37||
48553160|NCT00645970|101686904|FG001|1 Year|Overall Study||42||
48553161|NCT00645970|101686903|FG000|COMPLETED|Overall Study||32||
48553162|NCT00645970|101686904|FG001|COMPLETED|Overall Study||32||
48553163|NCT00645970|101686903|FG000|NOT COMPLETED|Overall Study||109||
48553164|NCT00645970|101686904|FG001|NOT COMPLETED|Overall Study||186||
48553165|NCT00613171|101686905|FG000|STARTED|Overall Study||27||
48553166|NCT00613171|101686905|FG000|COMPLETED|Overall Study||13||
48553167|NCT00613171|101686905|FG000|NOT COMPLETED|Overall Study||14||
48553168|NCT04782076|101686906|FG000|STARTED|Overall Study||36||
48553169|NCT04782076|101686906|FG000|Received at Least One Dose of Dabigatran on Day 1|Overall Study||36||
48553170|NCT04782076|101686906|FG000|Washout Period|Overall Study||36||
48553171|NCT04782076|101686906|FG000|Received at Least One Dose of Selpercatinib and Dabigatran on Day 8|Overall Study||35||
48553172|NCT04782076|101686906|FG000|COMPLETED|Overall Study||35||
48553173|NCT04782076|101686906|FG000|NOT COMPLETED|Overall Study||1||
48553174|NCT00246324|101686907|FG000|STARTED|Overall Study||16||
48270163|NCT00567840|100984732|FG002|STARTED|Overall Study||16||
48270164|NCT00567840|100984733|FG003|STARTED|Overall Study||15||
48270165|NCT00567840|100984734|FG004|STARTED|Overall Study||8||
48270166|NCT00567840|100984730|FG000|COMPLETED|Overall Study||13||
48270167|NCT00567840|100984731|FG001|COMPLETED|Overall Study||15||
48270168|NCT00567840|100984732|FG002|COMPLETED|Overall Study||15||
48270169|NCT00567840|100984733|FG003|COMPLETED|Overall Study||14||
48270170|NCT00567840|100984734|FG004|COMPLETED|Overall Study||8||
48270171|NCT00567840|100984730|FG000|NOT COMPLETED|Overall Study||2||
48553175|NCT00246324|101686907|FG000|COMPLETED|Overall Study||15||
48553176|NCT00246324|101686907|FG000|NOT COMPLETED|Overall Study||1||
48270172|NCT00567840|100984731|FG001|NOT COMPLETED|Overall Study||0||
48270173|NCT00567840|100984732|FG002|NOT COMPLETED|Overall Study||1||
48270174|NCT00567840|100984733|FG003|NOT COMPLETED|Overall Study||1||
48270175|NCT00567840|100984734|FG004|NOT COMPLETED|Overall Study||0||
48553177|NCT03889886|101686908|FG000|STARTED|Overall Study||76||
48553178|NCT03889886|101686909|FG001|STARTED|Overall Study||77||
48553179|NCT03889886|101686910|FG002|STARTED|Overall Study||76||
48553180|NCT03889886|101686911|FG003|STARTED|Overall Study||76||
48553181|NCT03889886|101686908|FG000|COMPLETED|Overall Study||76||
48553182|NCT03889886|101686909|FG001|COMPLETED|Overall Study||76||
48553183|NCT03889886|101686910|FG002|COMPLETED|Overall Study||75||
48553184|NCT03889886|101686911|FG003|COMPLETED|Overall Study||69||
48270176|NCT04707664|100984735|FG000|STARTED|Overall Study||301|All randomized patients|
48270177|NCT04707664|100984736|FG001|STARTED|Overall Study||299|All randomized patients|
48553185|NCT03889886|101686908|FG000|NOT COMPLETED|Overall Study||0||
48553186|NCT03889886|101686909|FG001|NOT COMPLETED|Overall Study||1||
48553187|NCT03889886|101686910|FG002|NOT COMPLETED|Overall Study||1||
48553188|NCT03889886|101686911|FG003|NOT COMPLETED|Overall Study||7||
48553189|NCT03288714|101686912|FG000|STARTED|Overall Study||59||
48270178|NCT04707664|100984735|FG000|Full Analysis Set|Overall Study||301|Patients evaluated for efficacy|
48270179|NCT04707664|100984736|FG001|Full Analysis Set|Overall Study||299|Patients evaluated for efficacy|
48270180|NCT04707664|100984735|FG000|Safety Population|Overall Study||297|Patients who had at least 1 dose of assigned study treatment|
48270181|NCT04707664|100984736|FG001|Safety Population|Overall Study||290|Patients who had at least 1 dose of assigned study treatment|
48270182|NCT04707664|100984735|FG000|COMPLETED|Overall Study||272||
48270183|NCT04707664|100984736|FG001|COMPLETED|Overall Study||263||
48270184|NCT04707664|100984735|FG000|NOT COMPLETED|Overall Study||29||
48270185|NCT04707664|100984736|FG001|NOT COMPLETED|Overall Study||36||
48270186|NCT01597843|100984737|FG000|STARTED|Overall Study||79||
48270187|NCT01597843|100984738|FG001|STARTED|Overall Study||122||
48270188|NCT01597843|100984739|FG002|STARTED|Overall Study||81||
48392335|NCT00871377|101287842|FG001|STARTED|Washout (6 Weeks)||4||
48392336|NCT00871377|101287843|FG002|STARTED|Washout (6 Weeks)||3||
48392337|NCT00871377|101287844|FG003|STARTED|Washout (6 Weeks)||4||
48392338|NCT00871377|101287845|FG004|STARTED|Washout (6 Weeks)||4||
48392339|NCT00871377|101287846|FG005|STARTED|Washout (6 Weeks)||4||
48392340|NCT00871377|101287841|FG000|COMPLETED|Washout (6 Weeks)||2||
48392341|NCT00871377|101287842|FG001|COMPLETED|Washout (6 Weeks)||4||
48392342|NCT00871377|101287843|FG002|COMPLETED|Washout (6 Weeks)||3||
48392343|NCT00871377|101287844|FG003|COMPLETED|Washout (6 Weeks)||4||
48392344|NCT00871377|101287845|FG004|COMPLETED|Washout (6 Weeks)||4||
48392345|NCT00871377|101287846|FG005|COMPLETED|Washout (6 Weeks)||3||
48392346|NCT00871377|101287841|FG000|NOT COMPLETED|Washout (6 Weeks)||0||
48392347|NCT00871377|101287842|FG001|NOT COMPLETED|Washout (6 Weeks)||0||
48392348|NCT00871377|101287843|FG002|NOT COMPLETED|Washout (6 Weeks)||0||
48392349|NCT00871377|101287844|FG003|NOT COMPLETED|Washout (6 Weeks)||0||
48392350|NCT00871377|101287845|FG004|NOT COMPLETED|Washout (6 Weeks)||0||
48392351|NCT00871377|101287846|FG005|NOT COMPLETED|Washout (6 Weeks)||1||
48392352|NCT00871377|101287841|FG000|STARTED|Third Intervention (10 Weeks)||2||
48392353|NCT00871377|101287842|FG001|STARTED|Third Intervention (10 Weeks)||4||
48392354|NCT00871377|101287843|FG002|STARTED|Third Intervention (10 Weeks)||3||
48392355|NCT00871377|101287844|FG003|STARTED|Third Intervention (10 Weeks)||4||
48392356|NCT00871377|101287845|FG004|STARTED|Third Intervention (10 Weeks)||4||
48392357|NCT00871377|101287846|FG005|STARTED|Third Intervention (10 Weeks)||3||
48392358|NCT00871377|101287841|FG000|COMPLETED|Third Intervention (10 Weeks)||2||
48392359|NCT00871377|101287842|FG001|COMPLETED|Third Intervention (10 Weeks)||4||
48392360|NCT00871377|101287843|FG002|COMPLETED|Third Intervention (10 Weeks)||3||
48392361|NCT00871377|101287844|FG003|COMPLETED|Third Intervention (10 Weeks)||3||
48392362|NCT00871377|101287845|FG004|COMPLETED|Third Intervention (10 Weeks)||4||
48392363|NCT00871377|101287846|FG005|COMPLETED|Third Intervention (10 Weeks)||3||
48392364|NCT00871377|101287841|FG000|NOT COMPLETED|Third Intervention (10 Weeks)||0||
48392365|NCT00871377|101287842|FG001|NOT COMPLETED|Third Intervention (10 Weeks)||0||
48392366|NCT00871377|101287843|FG002|NOT COMPLETED|Third Intervention (10 Weeks)||0||
48392367|NCT00871377|101287844|FG003|NOT COMPLETED|Third Intervention (10 Weeks)||1||
48392368|NCT00871377|101287845|FG004|NOT COMPLETED|Third Intervention (10 Weeks)||0||
48392369|NCT00871377|101287846|FG005|NOT COMPLETED|Third Intervention (10 Weeks)||0||
48392370|NCT01686958|101287847|FG000|STARTED|Overall Study||30||
48392371|NCT01686958|101287847|FG000|COMPLETED|Overall Study||29||
48392372|NCT01686958|101287847|FG000|NOT COMPLETED|Overall Study||1||
48392373|NCT01617655|101287848|FG000|STARTED|Overall Study||35||
48392374|NCT01617655|101287849|FG001|STARTED|Overall Study||72||
48392375|NCT01617655|101287848|FG000|Treated|Overall Study||35||
48392376|NCT01617655|101287849|FG001|Treated|Overall Study||72||
48392377|NCT01617655|101287848|FG000|COMPLETED|Overall Study||26||
48392378|NCT01617655|101287849|FG001|COMPLETED|Overall Study||43||
48392379|NCT01617655|101287848|FG000|NOT COMPLETED|Overall Study||9||
48392380|NCT01617655|101287849|FG001|NOT COMPLETED|Overall Study||29||
48392381|NCT01602549|101287850|FG000|STARTED|Overall Study||19||
48392382|NCT01602549|101287851|FG001|STARTED|Overall Study||38||
48392383|NCT01602549|101287850|FG000|COMPLETED|Overall Study||18||
48392384|NCT01602549|101287851|FG001|COMPLETED|Overall Study||37||
48392385|NCT01602549|101287850|FG000|NOT COMPLETED|Overall Study||1||
48392386|NCT01602549|101287851|FG001|NOT COMPLETED|Overall Study||1||
48392387|NCT00776555|101287852|FG000|STARTED|Overall Study||3||
48392388|NCT00776555|101287853|FG001|STARTED|Overall Study||0||
48392389|NCT00776555|101287852|FG000|COMPLETED|Overall Study||0||
48392390|NCT00776555|101287853|FG001|COMPLETED|Overall Study||0||
48392391|NCT00776555|101287852|FG000|NOT COMPLETED|Overall Study||3||
48392392|NCT00776555|101287853|FG001|NOT COMPLETED|Overall Study||0||
48392393|NCT04671615|101287854|FG000|STARTED|Overall Study||559||
48392394|NCT04671615|101287854|FG000|COMPLETED|Overall Study||559||
48270189|NCT01597843|100984737|FG000|Survey 1 Responses|Overall Study||45||
48270190|NCT01597843|100984738|FG001|Survey 1 Responses|Overall Study||71||
48270191|NCT01597843|100984739|FG002|Survey 1 Responses|Overall Study||59||
48392395|NCT04671615|101287854|FG000|NOT COMPLETED|Overall Study||0||
48392396|NCT02713789|101287855|FG000|STARTED|Overall Study||8||
48392397|NCT02713789|101287856|FG001|STARTED|Overall Study||10||
48392398|NCT02713789|101287857|FG002|STARTED|Overall Study||8||
48392399|NCT02713789|101287855|FG000|COMPLETED|Overall Study||8||
48392400|NCT02713789|101287856|FG001|COMPLETED|Overall Study||9||
48553190|NCT03288714|101686913|FG001|STARTED|Overall Study||62||
48553191|NCT03288714|101686912|FG000|COMPLETED|Overall Study||49||
48553192|NCT03288714|101686913|FG001|COMPLETED|Overall Study||59||
48553193|NCT03288714|101686912|FG000|NOT COMPLETED|Overall Study||10||
48553194|NCT03288714|101686913|FG001|NOT COMPLETED|Overall Study||3||
48270192|NCT01597843|100984737|FG000|Survey 2 Responses|Overall Study||52||
48270193|NCT01597843|100984738|FG001|Survey 2 Responses|Overall Study||42||
48270194|NCT01597843|100984739|FG002|Survey 2 Responses|Overall Study||58||
48270195|NCT01597843|100984737|FG000|Survey 3 Responses|Overall Study||65||
48270196|NCT01597843|100984738|FG001|Survey 3 Responses|Overall Study||56||
48270197|NCT01597843|100984739|FG002|Survey 3 Responses|Overall Study||76||
48270198|NCT01597843|100984737|FG000|COMPLETED|Overall Study||79||
48270199|NCT01597843|100984738|FG001|COMPLETED|Overall Study||122||
48270200|NCT01597843|100984739|FG002|COMPLETED|Overall Study||81||
48270201|NCT01597843|100984737|FG000|NOT COMPLETED|Overall Study||0||
48270202|NCT01597843|100984738|FG001|NOT COMPLETED|Overall Study||0||
48553195|NCT00398866|101686914|FG000|STARTED|Overall Study||66||
48553196|NCT00398866|101686915|FG001|STARTED|Overall Study||68||
48553197|NCT00398866|101686916|FG002|STARTED|Overall Study||66||
48553198|NCT00398866|101686914|FG000|COMPLETED|Overall Study||52||
48553199|NCT00398866|101686915|FG001|COMPLETED|Overall Study||60||
48553200|NCT00398866|101686916|FG002|COMPLETED|Overall Study||58||
48553201|NCT00398866|101686914|FG000|NOT COMPLETED|Overall Study||14||
48553202|NCT00398866|101686915|FG001|NOT COMPLETED|Overall Study||8||
48553203|NCT00398866|101686916|FG002|NOT COMPLETED|Overall Study||8||
48553204|NCT04584684|101686917|FG000|STARTED|Overall Study||21||
48553205|NCT04584684|101686918|FG001|STARTED|Overall Study||27||
48553206|NCT04584684|101686919|FG002|STARTED|Overall Study||22||
48553207|NCT04584684|101686920|FG003|STARTED|Overall Study||19||
48553208|NCT04584684|101686921|FG004|STARTED|Overall Study||20||
48553209|NCT04584684|101686922|FG005|STARTED|Overall Study||19||
48553210|NCT04584684|101686917|FG000|COMPLETED|Overall Study||21||
48553211|NCT04584684|101686918|FG001|COMPLETED|Overall Study||27||
48553212|NCT04584684|101686919|FG002|COMPLETED|Overall Study||22||
48553213|NCT04584684|101686920|FG003|COMPLETED|Overall Study||19||
48553214|NCT04584684|101686921|FG004|COMPLETED|Overall Study||19||
48553215|NCT04584684|101686922|FG005|COMPLETED|Overall Study||19||
48553216|NCT04584684|101686917|FG000|NOT COMPLETED|Overall Study||0||
48553217|NCT04584684|101686918|FG001|NOT COMPLETED|Overall Study||0||
48553218|NCT04584684|101686919|FG002|NOT COMPLETED|Overall Study||0||
48553219|NCT04584684|101686920|FG003|NOT COMPLETED|Overall Study||0||
48553220|NCT04584684|101686921|FG004|NOT COMPLETED|Overall Study||1||
48553221|NCT04584684|101686922|FG005|NOT COMPLETED|Overall Study||0||
48553222|NCT01262872|101686923|FG000|STARTED|Step 1||60||
48553223|NCT01262872|101686924|FG001|STARTED|Step 1||60||
48553224|NCT01262872|101686925|FG002|STARTED|Step 1||0||
48553225|NCT01262872|101686926|FG003|STARTED|Step 1||0||
48553226|NCT01262872|101686927|FG004|STARTED|Step 1||0||
48553227|NCT01262872|101686928|FG005|STARTED|Step 1||0||
48553228|NCT01262872|101686929|FG006|STARTED|Step 1||0||
48553229|NCT01262872|101686930|FG007|STARTED|Step 1||0||
48553230|NCT01262872|101686923|FG000|COMPLETED|Step 1||60||
48553231|NCT01262872|101686924|FG001|COMPLETED|Step 1||60||
48553232|NCT01262872|101686925|FG002|COMPLETED|Step 1||0||
48553233|NCT01262872|101686926|FG003|COMPLETED|Step 1||0||
48553234|NCT01262872|101686927|FG004|COMPLETED|Step 1||0||
48553235|NCT01262872|101686928|FG005|COMPLETED|Step 1||0||
48553236|NCT01262872|101686929|FG006|COMPLETED|Step 1||0||
48553237|NCT01262872|101686930|FG007|COMPLETED|Step 1||0||
48553238|NCT01262872|101686923|FG000|NOT COMPLETED|Step 1||0||
48553239|NCT01262872|101686924|FG001|NOT COMPLETED|Step 1||0||
48553240|NCT01262872|101686925|FG002|NOT COMPLETED|Step 1||0||
48553241|NCT01262872|101686926|FG003|NOT COMPLETED|Step 1||0||
48270203|NCT01597843|100984739|FG002|NOT COMPLETED|Overall Study||0||
48270204|NCT03752177|100984740|FG000|STARTED|Overall Study||3||
48270205|NCT03752177|100984741|FG001|STARTED|Overall Study||3||
48270206|NCT03752177|100984742|FG002|STARTED|Overall Study||3||
48270207|NCT03752177|100984743|FG003|STARTED|Overall Study||3||
48270208|NCT03752177|100984740|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
48270209|NCT03752177|100984741|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3||
48553242|NCT01262872|101686927|FG004|NOT COMPLETED|Step 1||0||
48553243|NCT01262872|101686928|FG005|NOT COMPLETED|Step 1||0||
48553244|NCT01262872|101686929|FG006|NOT COMPLETED|Step 1||0||
48270210|NCT03752177|100984742|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
48270211|NCT03752177|100984743|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3||
48270212|NCT03752177|100984740|FG000|COMPLETED|Overall Study||3||
48270213|NCT03752177|100984741|FG001|COMPLETED|Overall Study||3||
48270214|NCT03752177|100984742|FG002|COMPLETED|Overall Study||3||
48270215|NCT03752177|100984743|FG003|COMPLETED|Overall Study||3||
48553245|NCT01262872|101686930|FG007|NOT COMPLETED|Step 1||0||
48553246|NCT01262872|101686923|FG000|STARTED|Step 2||0||
48553247|NCT01262872|101686924|FG001|STARTED|Step 2||0||
48553248|NCT01262872|101686925|FG002|STARTED|Step 2||200||
48553249|NCT01262872|101686926|FG003|STARTED|Step 2||200||
48553250|NCT01262872|101686927|FG004|STARTED|Step 2||200||
48553251|NCT01262872|101686928|FG005|STARTED|Step 2||200||
48553252|NCT01262872|101686929|FG006|STARTED|Step 2||200||
48270216|NCT03752177|100984740|FG000|NOT COMPLETED|Overall Study||0||
48270217|NCT03752177|100984741|FG001|NOT COMPLETED|Overall Study||0||
48270218|NCT03752177|100984742|FG002|NOT COMPLETED|Overall Study||0||
48270219|NCT03752177|100984743|FG003|NOT COMPLETED|Overall Study||0||
48270220|NCT00911768|100984744|FG000|STARTED|Overall Study||50||
48270221|NCT00911768|100984745|FG001|STARTED|Overall Study||50||
48270222|NCT00911768|100984744|FG000|COMPLETED|Overall Study||44||
48270223|NCT00911768|100984745|FG001|COMPLETED|Overall Study||46||
48270224|NCT00911768|100984744|FG000|NOT COMPLETED|Overall Study||6||
48270225|NCT00911768|100984745|FG001|NOT COMPLETED|Overall Study||4||
48270226|NCT04954326|100984746|FG000|STARTED|Overall Study||44||
48270227|NCT04954326|100984747|FG001|STARTED|Overall Study||45||
48270228|NCT04954326|100984746|FG000|COMPLETED|Overall Study||44||
48270229|NCT04954326|100984747|FG001|COMPLETED|Overall Study||41||
48270230|NCT04954326|100984746|FG000|NOT COMPLETED|Overall Study||0||
48270231|NCT04954326|100984747|FG001|NOT COMPLETED|Overall Study||4||
48270232|NCT03559062|100984748|FG000|STARTED|Overall Study||10||
48270233|NCT03559062|100984749|FG001|STARTED|Overall Study||54||
48270234|NCT03559062|100984750|FG002|STARTED|Overall Study||3||
48270235|NCT03559062|100984748|FG000|COMPLETED|Overall Study||10||
48270236|NCT03559062|100984749|FG001|COMPLETED|Overall Study||53||
48270237|NCT03559062|100984750|FG002|COMPLETED|Overall Study||3||
48270238|NCT03559062|100984748|FG000|NOT COMPLETED|Overall Study||0||
48270239|NCT03559062|100984749|FG001|NOT COMPLETED|Overall Study||1||
48270240|NCT03559062|100984750|FG002|NOT COMPLETED|Overall Study||0||
48270241|NCT01637077|100984751|FG000|STARTED|Overall Study||23||
48270242|NCT01637077|100984752|FG001|STARTED|Overall Study||23||
48270243|NCT01637077|100984751|FG000|COMPLETED|Overall Study||19||
48270244|NCT01637077|100984752|FG001|COMPLETED|Overall Study||22||
48270245|NCT01637077|100984751|FG000|NOT COMPLETED|Overall Study||4||
48270246|NCT01637077|100984752|FG001|NOT COMPLETED|Overall Study||1||
48270247|NCT02402153|100984753|FG000|STARTED|Overall Study||18||
48270248|NCT02402153|100984753|FG000|COMPLETED|Overall Study||18||
48270249|NCT02402153|100984753|FG000|NOT COMPLETED|Overall Study||0||
48270250|NCT01133418|100984754|FG000|STARTED|Overall Study||34||
48270251|NCT01133418|100984755|FG001|STARTED|Overall Study||38||
48270252|NCT01133418|100984754|FG000|COMPLETED|Overall Study||29||
48270253|NCT01133418|100984755|FG001|COMPLETED|Overall Study||32||
48270254|NCT01133418|100984754|FG000|NOT COMPLETED|Overall Study||5||
48270255|NCT01133418|100984755|FG001|NOT COMPLETED|Overall Study||6||
48270256|NCT03381339|100984756|FG000|STARTED|Overall Study||27||
48270257|NCT03381339|100984757|FG001|STARTED|Overall Study||28||
48270258|NCT03381339|100984756|FG000|COMPLETED|Overall Study||23|Subjects who completed all 12 weeks|
48270259|NCT03381339|100984757|FG001|COMPLETED|Overall Study||24|Subjects who completed all 12 weeks|
48270260|NCT03381339|100984756|FG000|NOT COMPLETED|Overall Study||4||
48392401|NCT02713789|101287857|FG002|COMPLETED|Overall Study||7||
48392402|NCT02713789|101287855|FG000|NOT COMPLETED|Overall Study||0||
48392403|NCT02713789|101287856|FG001|NOT COMPLETED|Overall Study||1||
48392404|NCT02713789|101287857|FG002|NOT COMPLETED|Overall Study||1||
48392405|NCT03373110|101287858|FG000|STARTED|Overall Study||133||
48392406|NCT03373110|101287859|FG001|STARTED|Overall Study||137||
48392407|NCT03373110|101287860|FG002|STARTED|Overall Study||70||
48270261|NCT03381339|100984757|FG001|NOT COMPLETED|Overall Study||4||
48270262|NCT01385748|100984758|FG000|STARTED|Overall Study||56||
48270263|NCT01385748|100984759|FG001|STARTED|Overall Study||65||
48392408|NCT03373110|101287858|FG000|Provided Fitbit Data|Overall Study||123||
48392409|NCT03373110|101287859|FG001|Provided Fitbit Data|Overall Study||130||
48392410|NCT03373110|101287860|FG002|Provided Fitbit Data|Overall Study||63||
48392411|NCT03373110|101287858|FG000|COMPLETED|Overall Study||55||
48392412|NCT03373110|101287859|FG001|COMPLETED|Overall Study||58||
48392413|NCT03373110|101287860|FG002|COMPLETED|Overall Study||26||
48392414|NCT03373110|101287858|FG000|NOT COMPLETED|Overall Study||78||
48392415|NCT03373110|101287859|FG001|NOT COMPLETED|Overall Study||79||
48392416|NCT03373110|101287860|FG002|NOT COMPLETED|Overall Study||44||
48392417|NCT00108953|101287861|FG000|STARTED|Treatment Period||47||
48392418|NCT00108953|101287862|FG001|STARTED|Treatment Period||49||
48392419|NCT00108953|101287861|FG000|COMPLETED|Treatment Period||47||
48392420|NCT00108953|101287862|FG001|COMPLETED|Treatment Period||49||
48392421|NCT00108953|101287861|FG000|NOT COMPLETED|Treatment Period||0||
48270264|NCT01385748|100984760|FG002|STARTED|Overall Study||62||
48270265|NCT01385748|100984758|FG000|COMPLETED|Overall Study||41||
48270266|NCT01385748|100984759|FG001|COMPLETED|Overall Study||51||
48270267|NCT01385748|100984760|FG002|COMPLETED|Overall Study||49||
48270268|NCT01385748|100984758|FG000|NOT COMPLETED|Overall Study||15||
48392422|NCT00108953|101287862|FG001|NOT COMPLETED|Treatment Period||0||
48392423|NCT00108953|101287861|FG000|STARTED|Follow-up||40||
48270269|NCT01385748|100984759|FG001|NOT COMPLETED|Overall Study||14||
48270270|NCT01385748|100984760|FG002|NOT COMPLETED|Overall Study||13||
48270271|NCT02687035|100984761|FG000|STARTED|Overall Study||1822||
48270272|NCT02687035|100984761|FG000|COMPLETED|Overall Study||1638||
48270273|NCT02687035|100984761|FG000|NOT COMPLETED|Overall Study||184||
48392424|NCT00108953|101287862|FG001|STARTED|Follow-up||45||
48392425|NCT00108953|101287861|FG000|COMPLETED|Follow-up||11||
48392426|NCT00108953|101287862|FG001|COMPLETED|Follow-up||12||
48270274|NCT03941600|100984762|FG000|STARTED|Overall Study||27||
48270275|NCT03941600|100984763|FG001|STARTED|Overall Study||22||
48270276|NCT03941600|100984762|FG000|COMPLETED|Overall Study||15||
48270277|NCT03941600|100984763|FG001|COMPLETED|Overall Study||17||
48270278|NCT03941600|100984762|FG000|NOT COMPLETED|Overall Study||12||
48270279|NCT03941600|100984763|FG001|NOT COMPLETED|Overall Study||5||
48270280|NCT03838731|100984764|FG000|STARTED|Overall Study||27||
48270281|NCT03838731|100984765|FG001|STARTED|Overall Study||29||
48270282|NCT03838731|100984764|FG000|COMPLETED|Overall Study||26||
48270283|NCT03838731|100984765|FG001|COMPLETED|Overall Study||28||
48270284|NCT03838731|100984764|FG000|NOT COMPLETED|Overall Study||1||
48108526|NCT02882321|100594307|FG001|COMPLETED|Overall Study||3||
48108527|NCT02882321|100594308|FG002|COMPLETED|Overall Study||3||
48108528|NCT02882321|100594309|FG003|COMPLETED|Overall Study||7||
48108529|NCT02882321|100594306|FG000|NOT COMPLETED|Overall Study||0||
48108530|NCT02882321|100594307|FG001|NOT COMPLETED|Overall Study||0||
48108531|NCT02882321|100594308|FG002|NOT COMPLETED|Overall Study||0||
48108532|NCT02882321|100594309|FG003|NOT COMPLETED|Overall Study||0||
48108533|NCT02584504|100594310|FG000|STARTED|Double-blind Treatment||54||
48270285|NCT03838731|100984765|FG001|NOT COMPLETED|Overall Study||1||
48270286|NCT01436253|100984766|FG000|STARTED|Overall Study||2196||
48270287|NCT01436253|100984766|FG000|COMPLETED|Overall Study||1897||
48270288|NCT01436253|100984766|FG000|NOT COMPLETED|Overall Study||299||
48270289|NCT00561145|100984767|FG000|STARTED|Overall Study||15||
48270290|NCT00561145|100984768|FG001|STARTED|Overall Study||17||
48270291|NCT00561145|100984767|FG000|COMPLETED|Overall Study||15||
48270292|NCT00561145|100984768|FG001|COMPLETED|Overall Study||17||
48270293|NCT00561145|100984767|FG000|NOT COMPLETED|Overall Study||0||
48270294|NCT00561145|100984768|FG001|NOT COMPLETED|Overall Study||0||
48270295|NCT02489968|100984769|FG000|STARTED|Open-label Treatment Period||439||
48270296|NCT02489968|100984770|FG001|STARTED|Open-label Treatment Period||440||
48270297|NCT02489968|100984771|FG002|STARTED|Open-label Treatment Period||0||
48270298|NCT02489968|100984772|FG003|STARTED|Open-label Treatment Period||0||
48270299|NCT02489968|100984773|FG004|STARTED|Open-label Treatment Period||0||
48270300|NCT02489968|100984774|FG005|STARTED|Open-label Treatment Period||0||
48270301|NCT02489968|100984769|FG000|COMPLETED|Open-label Treatment Period||215||
48270302|NCT02489968|100984770|FG001|COMPLETED|Open-label Treatment Period||232||
48270303|NCT02489968|100984771|FG002|COMPLETED|Open-label Treatment Period||0||
48270304|NCT02489968|100984772|FG003|COMPLETED|Open-label Treatment Period||0||
48270305|NCT02489968|100984773|FG004|COMPLETED|Open-label Treatment Period||0||
48270306|NCT02489968|100984774|FG005|COMPLETED|Open-label Treatment Period||0||
48270307|NCT02489968|100984769|FG000|NOT COMPLETED|Open-label Treatment Period||224||
48270308|NCT02489968|100984770|FG001|NOT COMPLETED|Open-label Treatment Period||208||
48270309|NCT02489968|100984771|FG002|NOT COMPLETED|Open-label Treatment Period||0||
48693217|NCT02952313|102032729|FG000|STARTED|Long-term Follow-up||107|Participant with missed 6-month visit (primary endpoint) was included in later follow-up.|
48108534|NCT02584504|100594311|FG001|STARTED|Double-blind Treatment||53||
48108535|NCT02584504|100594312|FG002|STARTED|Double-blind Treatment||56||
48108536|NCT02584504|100594310|FG000|ITT Population|Double-blind Treatment||54||
48108537|NCT02584504|100594311|FG001|ITT Population|Double-blind Treatment||53||
48108538|NCT02584504|100594312|FG002|ITT Population|Double-blind Treatment||56||
48108539|NCT02584504|100594310|FG000|mITT Population|Double-blind Treatment||54||
48108540|NCT02584504|100594311|FG001|mITT Population|Double-blind Treatment||53||
48108541|NCT02584504|100594312|FG002|mITT Population|Double-blind Treatment||56||
48270310|NCT02489968|100984772|FG003|NOT COMPLETED|Open-label Treatment Period||0||
48270311|NCT02489968|100984773|FG004|NOT COMPLETED|Open-label Treatment Period||0||
48693218|NCT02952313|102032729|FG000|12-Month|Long-term Follow-up||93||
48693219|NCT02952313|102032729|FG000|18-Month|Long-term Follow-up||79||
48693220|NCT02952313|102032729|FG000|COMPLETED|Long-term Follow-up||75||
48693221|NCT02952313|102032729|FG000|NOT COMPLETED|Long-term Follow-up||32||
48693222|NCT04301934|102032730|FG000|STARTED|Overall Study||7||
48108542|NCT02584504|100594310|FG000|Safety Population|Double-blind Treatment||54||
48108543|NCT02584504|100594311|FG001|Safety Population|Double-blind Treatment||53||
48108544|NCT02584504|100594312|FG002|Safety Population|Double-blind Treatment||56||
48108545|NCT02584504|100594310|FG000|COMPLETED|Double-blind Treatment||54||
48108546|NCT02584504|100594311|FG001|COMPLETED|Double-blind Treatment||51||
48108547|NCT02584504|100594312|FG002|COMPLETED|Double-blind Treatment||55||
48108548|NCT02584504|100594310|FG000|NOT COMPLETED|Double-blind Treatment||0||
48108549|NCT02584504|100594311|FG001|NOT COMPLETED|Double-blind Treatment||2||
48270312|NCT02489968|100984774|FG005|NOT COMPLETED|Open-label Treatment Period||0||
48270313|NCT02489968|100984769|FG000|STARTED|Double-blind Treatment Period||0||
48270314|NCT02489968|100984770|FG001|STARTED|Double-blind Treatment Period||0||
48270315|NCT02489968|100984771|FG002|STARTED|Double-blind Treatment Period||107||
48270316|NCT02489968|100984772|FG003|STARTED|Double-blind Treatment Period||108||
48270317|NCT02489968|100984773|FG004|STARTED|Double-blind Treatment Period||116||
48270318|NCT02489968|100984774|FG005|STARTED|Double-blind Treatment Period||116||
48108550|NCT02584504|100594312|FG002|NOT COMPLETED|Double-blind Treatment||1||
48108551|NCT02584504|100594310|FG000|STARTED|Open-label Treatment||54||
48108552|NCT02584504|100594311|FG001|STARTED|Open-label Treatment||51||
48108553|NCT02584504|100594312|FG002|STARTED|Open-label Treatment||55||
48108554|NCT02584504|100594310|FG000|Treated|Open-label Treatment||54||
48108555|NCT02584504|100594311|FG001|Treated|Open-label Treatment||50||
48108556|NCT02584504|100594312|FG002|Treated|Open-label Treatment||54||
48108557|NCT02584504|100594310|FG000|COMPLETED|Open-label Treatment||52||
48108558|NCT02584504|100594311|FG001|COMPLETED|Open-label Treatment||47||
48108559|NCT02584504|100594312|FG002|COMPLETED|Open-label Treatment||47||
48108560|NCT02584504|100594310|FG000|NOT COMPLETED|Open-label Treatment||2||
48108561|NCT02584504|100594311|FG001|NOT COMPLETED|Open-label Treatment||4||
48108562|NCT02584504|100594312|FG002|NOT COMPLETED|Open-label Treatment||8||
48108563|NCT03388138|100594313|FG000|STARTED|Overall Study||94||
48108564|NCT03388138|100594314|FG001|STARTED|Overall Study||47||
48108565|NCT03388138|100594313|FG000|COMPLETED|Overall Study||93||
48108566|NCT03388138|100594314|FG001|COMPLETED|Overall Study||47||
48108567|NCT03388138|100594313|FG000|NOT COMPLETED|Overall Study||1||
48108568|NCT03388138|100594314|FG001|NOT COMPLETED|Overall Study||0||
48108569|NCT01845792|100594315|FG000|STARTED|Overall Study||5||
48108570|NCT01845792|100594316|FG001|STARTED|Overall Study||2||
48108571|NCT01845792|100594315|FG000|COMPLETED|Overall Study||5||
48270319|NCT02489968|100984769|FG000|COMPLETED|Double-blind Treatment Period||0||
48270320|NCT02489968|100984770|FG001|COMPLETED|Double-blind Treatment Period||0||
48270321|NCT02489968|100984771|FG002|COMPLETED|Double-blind Treatment Period||105||
48270322|NCT02489968|100984772|FG003|COMPLETED|Double-blind Treatment Period||100||
48270323|NCT02489968|100984773|FG004|COMPLETED|Double-blind Treatment Period||110||
48270324|NCT02489968|100984774|FG005|COMPLETED|Double-blind Treatment Period||108||
48270325|NCT02489968|100984769|FG000|NOT COMPLETED|Double-blind Treatment Period||0||
48270326|NCT02489968|100984770|FG001|NOT COMPLETED|Double-blind Treatment Period||0||
48270327|NCT02489968|100984771|FG002|NOT COMPLETED|Double-blind Treatment Period||2||
48270328|NCT02489968|100984772|FG003|NOT COMPLETED|Double-blind Treatment Period||8||
48270329|NCT02489968|100984773|FG004|NOT COMPLETED|Double-blind Treatment Period||6||
48270330|NCT02489968|100984774|FG005|NOT COMPLETED|Double-blind Treatment Period||8||
48270331|NCT00846807|100984775|FG000|STARTED|Overall Study||5292||
48270332|NCT00846807|100984775|FG000|COMPLETED|Overall Study||4660||
48270333|NCT00846807|100984775|FG000|NOT COMPLETED|Overall Study||632||
48270334|NCT02609672|100984776|FG000|STARTED|Overall Study||12||
48270335|NCT02609672|100984777|FG001|STARTED|Overall Study||12||
48270336|NCT02609672|100984776|FG000|COMPLETED|Overall Study||9||
48270337|NCT02609672|100984777|FG001|COMPLETED|Overall Study||11||
48270338|NCT02609672|100984776|FG000|NOT COMPLETED|Overall Study||3||
48270339|NCT02609672|100984777|FG001|NOT COMPLETED|Overall Study||1||
48270340|NCT00153985|100984778|FG000|STARTED|Overall Study||2||
48270341|NCT00153985|100984778|FG000|COMPLETED|Overall Study||2||
48270342|NCT00153985|100984778|FG000|NOT COMPLETED|Overall Study||0||
48270343|NCT05422053|100984779|FG000|STARTED|Overall Study||34||
48270344|NCT05422053|100984779|FG000|COMPLETED|Overall Study||34||
48270345|NCT05422053|100984779|FG000|NOT COMPLETED|Overall Study||0||
48270346|NCT02993523|100984780|FG000|STARTED|Overall Study||1||
48270347|NCT02993523|100984781|FG001|STARTED|Overall Study||1||
48270348|NCT02993523|100984782|FG002|STARTED|Overall Study||145||
48270349|NCT02993523|100984783|FG003|STARTED|Overall Study||286||
48270350|NCT02993523|100984784|FG004|STARTED|Overall Study||10||
48270351|NCT02993523|100984780|FG000|COMPLETED|Overall Study||0||
48270352|NCT02993523|100984781|FG001|COMPLETED|Overall Study||0||
48270353|NCT02993523|100984782|FG002|COMPLETED|Overall Study||1||
48270354|NCT02993523|100984783|FG003|COMPLETED|Overall Study||48||
48270355|NCT02993523|100984784|FG004|COMPLETED|Overall Study||4||
48270356|NCT02993523|100984780|FG000|NOT COMPLETED|Overall Study||1||
48270357|NCT02993523|100984781|FG001|NOT COMPLETED|Overall Study||1||
48270358|NCT02993523|100984782|FG002|NOT COMPLETED|Overall Study||144||
48270359|NCT02993523|100984783|FG003|NOT COMPLETED|Overall Study||238||
48270360|NCT02993523|100984784|FG004|NOT COMPLETED|Overall Study||6||
48270361|NCT01435772|100984785|FG000|STARTED|Overall Study||3||
48270362|NCT01435772|100984786|FG001|STARTED|Overall Study||3||
48270363|NCT01435772|100984787|FG002|STARTED|Overall Study||15||
48392427|NCT00108953|101287861|FG000|NOT COMPLETED|Follow-up||29||
48108572|NCT01845792|100594316|FG001|COMPLETED|Overall Study||2||
48108573|NCT01845792|100594315|FG000|NOT COMPLETED|Overall Study||0||
48108574|NCT01845792|100594316|FG001|NOT COMPLETED|Overall Study||0||
48108575|NCT00445328|100594317|FG000|STARTED|Overall Study||42||
48108576|NCT00445328|100594318|FG001|STARTED|Overall Study||42||
48108577|NCT00445328|100594317|FG000|Received Treatment|Overall Study||41||
48108578|NCT00445328|100594318|FG001|Received Treatment|Overall Study||42||
48108579|NCT00445328|100594317|FG000|COMPLETED|Overall Study||39||
48108580|NCT00445328|100594318|FG001|COMPLETED|Overall Study||36||
48108581|NCT00445328|100594317|FG000|NOT COMPLETED|Overall Study||3||
48108582|NCT00445328|100594318|FG001|NOT COMPLETED|Overall Study||6||
48108583|NCT04649775|100594319|FG000|STARTED|Overall Study||5||
48270364|NCT01435772|100984785|FG000|COMPLETED|Overall Study||0||
48270365|NCT01435772|100984786|FG001|COMPLETED|Overall Study||0||
48270366|NCT01435772|100984787|FG002|COMPLETED|Overall Study||0||
48270367|NCT01435772|100984785|FG000|NOT COMPLETED|Overall Study||3||
48270368|NCT01435772|100984786|FG001|NOT COMPLETED|Overall Study||3||
48270369|NCT01435772|100984787|FG002|NOT COMPLETED|Overall Study||15||
48108584|NCT04649775|100594320|FG001|STARTED|Overall Study||6||
48270370|NCT04343976|100984788|FG000|STARTED|Overall Study||7||
48270371|NCT04343976|100984789|FG001|STARTED|Overall Study||7||
48270372|NCT04343976|100984788|FG000|COMPLETED|Overall Study||7||
48270373|NCT04343976|100984789|FG001|COMPLETED|Overall Study||6||
48270374|NCT04343976|100984788|FG000|NOT COMPLETED|Overall Study||0||
48270375|NCT04343976|100984789|FG001|NOT COMPLETED|Overall Study||1||
48270376|NCT03019640|100984790|FG000|STARTED|Overall Study||22||
48270377|NCT03019640|100984790|FG000|COMPLETED|Overall Study||14||
48270378|NCT03019640|100984790|FG000|NOT COMPLETED|Overall Study||8||
48270379|NCT02493062|100984791|FG000|STARTED|Overall Study||35||
48270380|NCT02493062|100984791|FG000|COMPLETED|Overall Study||23||
48270381|NCT02493062|100984791|FG000|NOT COMPLETED|Overall Study||12||
48270382|NCT02028325|100984792|FG000|STARTED|Overall Study||136||
48270383|NCT02028325|100984792|FG000|COMPLETED|Overall Study||126||
48270384|NCT02028325|100984792|FG000|NOT COMPLETED|Overall Study||10||
48270385|NCT04043143|100984793|FG000|STARTED|Overall Study||29||
48270386|NCT04043143|100984794|FG001|STARTED|Overall Study||27||
48270387|NCT04043143|100984793|FG000|COMPLETED|Overall Study||23||
48270388|NCT04043143|100984794|FG001|COMPLETED|Overall Study||22||
48270389|NCT04043143|100984793|FG000|NOT COMPLETED|Overall Study||6||
48270390|NCT04043143|100984794|FG001|NOT COMPLETED|Overall Study||5||
48270391|NCT01110408|100984795|FG000|STARTED|Overall Study||31||
48270392|NCT01110408|100984796|FG001|STARTED|Overall Study||10||
48270393|NCT01110408|100984795|FG000|COMPLETED|Overall Study||30||
48270394|NCT01110408|100984796|FG001|COMPLETED|Overall Study||10||
48270395|NCT01110408|100984795|FG000|NOT COMPLETED|Overall Study||1||
48270396|NCT01110408|100984796|FG001|NOT COMPLETED|Overall Study||0||
48270397|NCT01638390|100984797|FG000|STARTED|Overall Study||357||
48270398|NCT01638390|100984797|FG000|COMPLETED|Overall Study||336||
48270399|NCT01638390|100984797|FG000|NOT COMPLETED|Overall Study||21||
48270400|NCT01132820|100984798|FG000|STARTED|Overall Study||53||
48270401|NCT01132820|100984798|FG000|COMPLETED|Overall Study||48||
48270402|NCT01132820|100984798|FG000|NOT COMPLETED|Overall Study||5||
48270403|NCT01016847|100984799|FG000|STARTED|Overall Study||1||
48270404|NCT01016847|100984800|FG001|STARTED|Overall Study||2||
48270405|NCT01016847|100984799|FG000|COMPLETED|Overall Study||1||
48270406|NCT01016847|100984800|FG001|COMPLETED|Overall Study||2||
48270407|NCT01016847|100984799|FG000|NOT COMPLETED|Overall Study||0||
48270408|NCT01016847|100984800|FG001|NOT COMPLETED|Overall Study||0||
48270409|NCT00515723|100984801|FG000|STARTED|Overall Study||25||
48270410|NCT00515723|100984802|FG001|STARTED|Overall Study||22||
48270411|NCT00515723|100984803|FG002|STARTED|Overall Study||22||
48270412|NCT00515723|100984804|FG003|STARTED|Overall Study||27||
48270413|NCT00515723|100984801|FG000|COMPLETED|Overall Study||20||
48270414|NCT00515723|100984802|FG001|COMPLETED|Overall Study||21||
48270415|NCT00515723|100984803|FG002|COMPLETED|Overall Study||21||
48270416|NCT00515723|100984804|FG003|COMPLETED|Overall Study||21||
48270417|NCT00515723|100984801|FG000|NOT COMPLETED|Overall Study||5||
48270418|NCT00515723|100984802|FG001|NOT COMPLETED|Overall Study||1||
48270419|NCT00515723|100984803|FG002|NOT COMPLETED|Overall Study||1||
48270420|NCT00515723|100984804|FG003|NOT COMPLETED|Overall Study||6||
48270421|NCT01495572|100984805|FG000|STARTED|Overall Study||0||
48270422|NCT01495572|100984806|FG001|STARTED|Overall Study||5||
48270423|NCT01495572|100984805|FG000|COMPLETED|Overall Study||0||
48270424|NCT01495572|100984806|FG001|COMPLETED|Overall Study||5||
48270425|NCT01495572|100984805|FG000|NOT COMPLETED|Overall Study||0||
48270426|NCT01495572|100984806|FG001|NOT COMPLETED|Overall Study||0||
48270427|NCT00458952|100984807|FG000|STARTED|Overall Study||7||
48270428|NCT00458952|100984808|FG001|STARTED|Overall Study||14||
48270429|NCT00458952|100984807|FG000|COMPLETED|Overall Study||5||
48270430|NCT00458952|100984808|FG001|COMPLETED|Overall Study||9||
48270431|NCT00458952|100984807|FG000|NOT COMPLETED|Overall Study||2||
48270432|NCT00458952|100984808|FG001|NOT COMPLETED|Overall Study||5||
48270433|NCT00513708|100984809|FG000|STARTED|Overall Study||50||
48270434|NCT00513708|100984810|FG001|STARTED|Overall Study||50||
48392428|NCT00108953|101287862|FG001|NOT COMPLETED|Follow-up||33||
48392429|NCT01170702|101287863|FG000|STARTED|Overall Study||34||
48270435|NCT00513708|100984811|FG002|STARTED|Overall Study||50||
48270436|NCT00513708|100984809|FG000|COMPLETED|Overall Study||46||
48270437|NCT00513708|100984810|FG001|COMPLETED|Overall Study||46||
48270438|NCT00513708|100984811|FG002|COMPLETED|Overall Study||46||
48270439|NCT00513708|100984809|FG000|NOT COMPLETED|Overall Study||4||
48270440|NCT00513708|100984810|FG001|NOT COMPLETED|Overall Study||4||
48270441|NCT00513708|100984811|FG002|NOT COMPLETED|Overall Study||4||
48270442|NCT01373580|100984812|FG000|STARTED|Overall Study||373||
48270443|NCT01373580|100984812|FG000|COMPLETED|Overall Study||317||
48270444|NCT01373580|100984812|FG000|NOT COMPLETED|Overall Study||56||
48392430|NCT01170702|101287864|FG001|STARTED|Overall Study||32||
48392431|NCT01170702|101287865|FG002|STARTED|Overall Study||25||
48270445|NCT01007110|100984813|FG000|STARTED|Allocation||32||
48270446|NCT01007110|100984814|FG001|STARTED|Allocation||35||
48270447|NCT01007110|100984813|FG000|COMPLETED|Allocation||25||
48270448|NCT01007110|100984814|FG001|COMPLETED|Allocation||27||
48270449|NCT01007110|100984813|FG000|NOT COMPLETED|Allocation||7||
48270450|NCT01007110|100984814|FG001|NOT COMPLETED|Allocation||8||
48270451|NCT01007110|100984813|FG000|STARTED|Follow-Up at 24 Weeks||25||
48270452|NCT01007110|100984814|FG001|STARTED|Follow-Up at 24 Weeks||27||
48270453|NCT01007110|100984813|FG000|COMPLETED|Follow-Up at 24 Weeks||25||
48270454|NCT01007110|100984814|FG001|COMPLETED|Follow-Up at 24 Weeks||23||
48270455|NCT01007110|100984813|FG000|NOT COMPLETED|Follow-Up at 24 Weeks||0||
48108585|NCT04649775|100594319|FG000|COMPLETED|Overall Study||5||
48108586|NCT04649775|100594320|FG001|COMPLETED|Overall Study||6||
48108587|NCT04649775|100594319|FG000|NOT COMPLETED|Overall Study||0||
48270456|NCT01007110|100984814|FG001|NOT COMPLETED|Follow-Up at 24 Weeks||4||
48270457|NCT01007110|100984813|FG000|STARTED|Follow-Up at 32 Weeks||25||
48270458|NCT01007110|100984814|FG001|STARTED|Follow-Up at 32 Weeks||23||
48270459|NCT01007110|100984813|FG000|COMPLETED|Follow-Up at 32 Weeks||24||
48270460|NCT01007110|100984814|FG001|COMPLETED|Follow-Up at 32 Weeks||22||
48108588|NCT04649775|100594320|FG001|NOT COMPLETED|Overall Study||0||
48108589|NCT02188485|100594321|FG000|STARTED|Overall Study||32|Randomization|
48270461|NCT01007110|100984813|FG000|NOT COMPLETED|Follow-Up at 32 Weeks||1||
48270462|NCT01007110|100984814|FG001|NOT COMPLETED|Follow-Up at 32 Weeks||1||
48270463|NCT01007110|100984813|FG000|STARTED|Follow-Up at 36 Weeks||24||
48270464|NCT01007110|100984814|FG001|STARTED|Follow-Up at 36 Weeks||22||
48270465|NCT01007110|100984813|FG000|COMPLETED|Follow-Up at 36 Weeks||24||
48270466|NCT01007110|100984814|FG001|COMPLETED|Follow-Up at 36 Weeks||20||
48270467|NCT01007110|100984813|FG000|NOT COMPLETED|Follow-Up at 36 Weeks||0||
48693223|NCT04301934|102032731|FG001|STARTED|Overall Study||5||
48693224|NCT04301934|102032730|FG000|COMPLETED|Overall Study||7||
48693225|NCT04301934|102032731|FG001|COMPLETED|Overall Study||5||
48693226|NCT04301934|102032730|FG000|NOT COMPLETED|Overall Study||0||
48693227|NCT04301934|102032731|FG001|NOT COMPLETED|Overall Study||0||
48693228|NCT02644096|102032732|FG000|STARTED|Overall Study||93||
48693229|NCT02644096|102032733|FG001|STARTED|Overall Study||82||
48693230|NCT02644096|102032732|FG000|2 Week Interview|Overall Study||0||
48693231|NCT02644096|102032733|FG001|2 Week Interview|Overall Study||68||
48693232|NCT02644096|102032732|FG000|10 Week Interview|Overall Study||0||
48693233|NCT02644096|102032733|FG001|10 Week Interview|Overall Study||59||
48693234|NCT02644096|102032732|FG000|12 Week SF-36 Questionnaire|Overall Study||68||
48693235|NCT02644096|102032733|FG001|12 Week SF-36 Questionnaire|Overall Study||59||
48693236|NCT02644096|102032732|FG000|9 Month SF-36 Questionnaire|Overall Study||65||
48693237|NCT02644096|102032733|FG001|9 Month SF-36 Questionnaire|Overall Study||57||
48693238|NCT02644096|102032732|FG000|COMPLETED|Overall Study||65||
48693239|NCT02644096|102032733|FG001|COMPLETED|Overall Study||57||
48693240|NCT02644096|102032732|FG000|NOT COMPLETED|Overall Study||28||
48693241|NCT02644096|102032733|FG001|NOT COMPLETED|Overall Study||25||
48693242|NCT01204905|102032734|FG000|STARTED|Overall Study||7||
48693243|NCT01204905|102032734|FG000|COMPLETED|Overall Study||5||
48270468|NCT01007110|100984814|FG001|NOT COMPLETED|Follow-Up at 36 Weeks||2||
48270469|NCT01007110|100984813|FG000|STARTED|Neonatal Behavioral Assessment Scale (NB||24||
48270470|NCT01007110|100984814|FG001|STARTED|Neonatal Behavioral Assessment Scale (NB||20||
48108590|NCT02188485|100594322|FG001|STARTED|Overall Study||30|Randomization|
48108591|NCT02188485|100594321|FG000|COMPLETED|Overall Study||30||
48108592|NCT02188485|100594322|FG001|COMPLETED|Overall Study||27||
48270471|NCT01007110|100984813|FG000|COMPLETED|Neonatal Behavioral Assessment Scale (NB||12||
48270472|NCT01007110|100984814|FG001|COMPLETED|Neonatal Behavioral Assessment Scale (NB||15||
48270473|NCT01007110|100984813|FG000|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||12||
48270474|NCT01007110|100984814|FG001|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||5||
48270475|NCT01413503|100984815|FG000|STARTED|Overall Study||50||
48270476|NCT01413503|100984815|FG000|COMPLETED|Overall Study||49||
48270477|NCT01413503|100984815|FG000|NOT COMPLETED|Overall Study||1||
48270478|NCT03101462|100984816|FG000|STARTED|Overall Study||19||
48270479|NCT03101462|100984817|FG001|STARTED|Overall Study||19||
48270480|NCT03101462|100984816|FG000|COMPLETED|Overall Study||18||
48270481|NCT03101462|100984817|FG001|COMPLETED|Overall Study||18||
48270482|NCT03101462|100984816|FG000|NOT COMPLETED|Overall Study||1||
48270483|NCT03101462|100984817|FG001|NOT COMPLETED|Overall Study||1||
48270484|NCT02658877|100984818|FG000|STARTED|Overall Study||3||
48270485|NCT02658877|100984819|FG001|STARTED|Overall Study||0||
48270486|NCT02658877|100984818|FG000|COMPLETED|Overall Study||3||
48270487|NCT02658877|100984819|FG001|COMPLETED|Overall Study||0||
48270488|NCT02658877|100984818|FG000|NOT COMPLETED|Overall Study||0||
48693244|NCT01204905|102032734|FG000|NOT COMPLETED|Overall Study||2||
48693245|NCT03989349|102032735|FG000|STARTED|Initial Treatment(Day 1-Week 16 Predose)||522||
48693246|NCT03989349|102032736|FG001|STARTED|Initial Treatment(Day 1-Week 16 Predose)||265||
48693247|NCT03989349|102032737|FG002|STARTED|Initial Treatment(Day 1-Week 16 Predose)||0||
48693248|NCT03989349|102032738|FG003|STARTED|Initial Treatment(Day 1-Week 16 Predose)||0||
48693249|NCT03989349|102032739|FG004|STARTED|Initial Treatment(Day 1-Week 16 Predose)||0||
48270489|NCT02658877|100984819|FG001|NOT COMPLETED|Overall Study||0||
48693250|NCT03989349|102032740|FG005|STARTED|Initial Treatment(Day 1-Week 16 Predose)||0||
48693251|NCT03989349|102032735|FG000|Treated|Initial Treatment(Day 1-Week 16 Predose)||519||
48693252|NCT03989349|102032736|FG001|Treated|Initial Treatment(Day 1-Week 16 Predose)||263||
48108593|NCT02188485|100594321|FG000|NOT COMPLETED|Overall Study||2||
48270490|NCT00757627|100984820|FG000|STARTED|Overall Study||500||
48270491|NCT00757627|100984820|FG000|COMPLETED|Overall Study||419||
48270492|NCT00757627|100984820|FG000|NOT COMPLETED|Overall Study||81||
48270493|NCT01715883|100984821|FG000|STARTED|Overall Study||3||
48270494|NCT01715883|100984821|FG000|COMPLETED|Overall Study||2||
48270495|NCT01715883|100984821|FG000|NOT COMPLETED|Overall Study||1||
48108594|NCT02188485|100594322|FG001|NOT COMPLETED|Overall Study||3||
48108595|NCT02342704|100594323|FG000|STARTED|Overall Study||54||
48108596|NCT02342704|100594324|FG001|STARTED|Overall Study||54||
48108597|NCT02342704|100594323|FG000|COMPLETED|Overall Study||1||
48108598|NCT02342704|100594324|FG001|COMPLETED|Overall Study||3||
48108599|NCT02342704|100594323|FG000|NOT COMPLETED|Overall Study||53||
48108600|NCT02342704|100594324|FG001|NOT COMPLETED|Overall Study||51||
48108601|NCT00714259|100594325|FG000|STARTED|Overall Study||5||
48108602|NCT00714259|100594325|FG000|COMPLETED|Overall Study||3||
48108603|NCT00714259|100594325|FG000|NOT COMPLETED|Overall Study||2||
48108604|NCT02759120|100594326|FG000|STARTED|Overall Study||254||
48108605|NCT02759120|100594327|FG001|STARTED|Overall Study||259||
48108606|NCT02759120|100594326|FG000|COMPLETED|Overall Study||169||
48108607|NCT02759120|100594327|FG001|COMPLETED|Overall Study||180||
48108608|NCT02759120|100594326|FG000|NOT COMPLETED|Overall Study||85||
48108609|NCT02759120|100594327|FG001|NOT COMPLETED|Overall Study||79||
48270496|NCT02472145|100984822|FG000|STARTED|Overall Study||10||
48270497|NCT02472145|100984823|FG001|STARTED|Overall Study||159||
48270498|NCT02472145|100984824|FG002|STARTED|Overall Study||157||
48270499|NCT02472145|100984822|FG000|Treated|Overall Study||10||
48270500|NCT02472145|100984823|FG001|Treated|Overall Study||156||
48270501|NCT02472145|100984824|FG002|Treated|Overall Study||156||
48270502|NCT02472145|100984822|FG000|Safety|Overall Study||10||
48270503|NCT02472145|100984823|FG001|Safety|Overall Study||165||
48270504|NCT02472145|100984824|FG002|Safety|Overall Study||147||
48270505|NCT02472145|100984822|FG000|COMPLETED|Overall Study||0||
48270506|NCT02472145|100984823|FG001|COMPLETED|Overall Study||0||
48270507|NCT02472145|100984824|FG002|COMPLETED|Overall Study||0||
48270508|NCT02472145|100984822|FG000|NOT COMPLETED|Overall Study||10||
48693253|NCT03989349|102032737|FG002|Treated|Initial Treatment(Day 1-Week 16 Predose)||0||
48693254|NCT03989349|102032738|FG003|Treated|Initial Treatment(Day 1-Week 16 Predose)||0||
48270509|NCT02472145|100984823|FG001|NOT COMPLETED|Overall Study||159||
48270510|NCT02472145|100984824|FG002|NOT COMPLETED|Overall Study||157||
48270511|NCT03392168|100984825|FG000|STARTED|Period 1: Cohort 1||8||
48270512|NCT03392168|100984826|FG001|STARTED|Period 1: Cohort 1||0||
48270513|NCT03392168|100984827|FG002|STARTED|Period 1: Cohort 1||0||
48270514|NCT03392168|100984828|FG003|STARTED|Period 1: Cohort 1||0||
48270515|NCT03392168|100984825|FG000|COMPLETED|Period 1: Cohort 1||8||
48270516|NCT03392168|100984826|FG001|COMPLETED|Period 1: Cohort 1||0||
48270517|NCT03392168|100984827|FG002|COMPLETED|Period 1: Cohort 1||0||
48270518|NCT03392168|100984828|FG003|COMPLETED|Period 1: Cohort 1||0||
48270519|NCT03392168|100984825|FG000|NOT COMPLETED|Period 1: Cohort 1||0||
48270520|NCT03392168|100984826|FG001|NOT COMPLETED|Period 1: Cohort 1||0||
48270521|NCT03392168|100984827|FG002|NOT COMPLETED|Period 1: Cohort 1||0||
48270522|NCT03392168|100984828|FG003|NOT COMPLETED|Period 1: Cohort 1||0||
48270523|NCT03392168|100984825|FG000|STARTED|Period 2: Cohort 2||0||
48270524|NCT03392168|100984826|FG001|STARTED|Period 2: Cohort 2||30||
48270525|NCT03392168|100984827|FG002|STARTED|Period 2: Cohort 2||28||
48270526|NCT03392168|100984828|FG003|STARTED|Period 2: Cohort 2||31||
48270527|NCT03392168|100984825|FG000|COMPLETED|Period 2: Cohort 2||0||
48270528|NCT03392168|100984826|FG001|COMPLETED|Period 2: Cohort 2||28||
48270529|NCT03392168|100984827|FG002|COMPLETED|Period 2: Cohort 2||27||
48270530|NCT03392168|100984828|FG003|COMPLETED|Period 2: Cohort 2||30||
48270531|NCT03392168|100984825|FG000|NOT COMPLETED|Period 2: Cohort 2||0||
48270532|NCT03392168|100984826|FG001|NOT COMPLETED|Period 2: Cohort 2||2||
48270533|NCT03392168|100984827|FG002|NOT COMPLETED|Period 2: Cohort 2||1||
48270534|NCT03392168|100984828|FG003|NOT COMPLETED|Period 2: Cohort 2||1||
48270535|NCT01424813|100984829|FG000|STARTED|Overall Study||79||
48270536|NCT01424813|100984830|FG001|STARTED|Overall Study||79||
48270537|NCT01424813|100984829|FG000|Treated|Overall Study||79||
48270538|NCT01424813|100984830|FG001|Treated|Overall Study||78||
48270539|NCT01424813|100984829|FG000|COMPLETED|Overall Study||74||
48270540|NCT01424813|100984830|FG001|COMPLETED|Overall Study||77||
48270541|NCT01424813|100984829|FG000|NOT COMPLETED|Overall Study||5||
48270542|NCT01424813|100984830|FG001|NOT COMPLETED|Overall Study||2||
48270543|NCT00863681|100984831|FG000|STARTED|Overall Study||231||
48270544|NCT00863681|100984832|FG001|STARTED|Overall Study||109||
48270545|NCT00863681|100984833|FG002|STARTED|Overall Study||56||
48270546|NCT00863681|100984831|FG000|COMPLETED|Overall Study||140||
48693255|NCT03989349|102032739|FG004|Treated|Initial Treatment(Day 1-Week 16 Predose)||0||
48270547|NCT00863681|100984832|FG001|COMPLETED|Overall Study||66||
48270548|NCT00863681|100984833|FG002|COMPLETED|Overall Study||38||
48108610|NCT04939727|100594328|FG000|STARTED|Overall Study||69||8
48108611|NCT04939727|100594329|FG001|STARTED|Overall Study||46||7
48108612|NCT04939727|100594328|FG000|COMPLETED|Overall Study||69||8
48108613|NCT04939727|100594329|FG001|COMPLETED|Overall Study||46||7
48270549|NCT00863681|100984831|FG000|NOT COMPLETED|Overall Study||91||
48270550|NCT00863681|100984832|FG001|NOT COMPLETED|Overall Study||43||
48270551|NCT00863681|100984833|FG002|NOT COMPLETED|Overall Study||18||
48270552|NCT00737477|100984834|FG000|STARTED|Overall Study||96||
48270553|NCT00737477|100984834|FG000|COMPLETED|Overall Study||62||
48270554|NCT00737477|100984834|FG000|NOT COMPLETED|Overall Study||34||
48270555|NCT03121820|100984835|FG000|STARTED|First Period||9||
48270556|NCT03121820|100984836|FG001|STARTED|First Period||9||
48270557|NCT03121820|100984835|FG000|COMPLETED|First Period||9||
48270558|NCT03121820|100984836|FG001|COMPLETED|First Period||9||
48270559|NCT03121820|100984835|FG000|NOT COMPLETED|First Period||0||
48270560|NCT03121820|100984836|FG001|NOT COMPLETED|First Period||0||
48270561|NCT03121820|100984835|FG000|STARTED|Second Period (After Washout)||9||
48270562|NCT03121820|100984836|FG001|STARTED|Second Period (After Washout)||9||
48270563|NCT03121820|100984835|FG000|COMPLETED|Second Period (After Washout)||9||
48270564|NCT03121820|100984836|FG001|COMPLETED|Second Period (After Washout)||9||
48270565|NCT03121820|100984835|FG000|NOT COMPLETED|Second Period (After Washout)||0||
48270566|NCT03121820|100984836|FG001|NOT COMPLETED|Second Period (After Washout)||0||
48270567|NCT00558844|100984837|FG000|STARTED|Overall Study||15||
48270568|NCT00558844|100984838|FG001|STARTED|Overall Study||7||
48270569|NCT00558844|100984839|FG002|STARTED|Overall Study||7||
48270570|NCT00558844|100984840|FG003|STARTED|Overall Study||5||
48270571|NCT00558844|100984841|FG004|STARTED|Overall Study||7||
48270572|NCT00558844|100984837|FG000|COMPLETED|Overall Study||12|completed follow up off treatment|
48270573|NCT00558844|100984838|FG001|COMPLETED|Overall Study||7|completed follow up off treatment|
48270574|NCT00558844|100984839|FG002|COMPLETED|Overall Study||6|completed follow up off treatment|
48270575|NCT00558844|100984840|FG003|COMPLETED|Overall Study||5|completed follow up off treatment|
48693256|NCT03989349|102032740|FG005|Treated|Initial Treatment(Day 1-Week 16 Predose)||0||
48693257|NCT03989349|102032735|FG000|Safety Population|Initial Treatment(Day 1-Week 16 Predose)||519|The safety population comprised all participants who received at least 1 dose of study drug.|
48693258|NCT03989349|102032736|FG001|Safety Population|Initial Treatment(Day 1-Week 16 Predose)||263|The safety population comprised all participants who received at least 1 dose of study drug.|
48693259|NCT03989349|102032737|FG002|Safety Population|Initial Treatment(Day 1-Week 16 Predose)||0|The safety population comprised all participants who received at least 1 dose of study drug.|
48693260|NCT03989349|102032738|FG003|Safety Population|Initial Treatment(Day 1-Week 16 Predose)||0|The safety population comprised all participants who received at least 1 dose of study drug.|
48693261|NCT03989349|102032739|FG004|Safety Population|Initial Treatment(Day 1-Week 16 Predose)||0|The safety population comprised all participants who received at least 1 dose of study drug.|
48693262|NCT03989349|102032740|FG005|Safety Population|Initial Treatment(Day 1-Week 16 Predose)||0|The safety population comprised all participants who received at least 1 dose of study drug.|
48693263|NCT03989349|102032735|FG000|COMPLETED|Initial Treatment(Day 1-Week 16 Predose)||470||
48693264|NCT03989349|102032736|FG001|COMPLETED|Initial Treatment(Day 1-Week 16 Predose)||241||
48693265|NCT03989349|102032737|FG002|COMPLETED|Initial Treatment(Day 1-Week 16 Predose)||0||
48693266|NCT03989349|102032738|FG003|COMPLETED|Initial Treatment(Day 1-Week 16 Predose)||0||
48693267|NCT03989349|102032739|FG004|COMPLETED|Initial Treatment(Day 1-Week 16 Predose)||0||
48693268|NCT03989349|102032740|FG005|COMPLETED|Initial Treatment(Day 1-Week 16 Predose)||0||
48693269|NCT03989349|102032735|FG000|NOT COMPLETED|Initial Treatment(Day 1-Week 16 Predose)||52||
48693270|NCT03989349|102032736|FG001|NOT COMPLETED|Initial Treatment(Day 1-Week 16 Predose)||24||
48108614|NCT04939727|100594328|FG000|NOT COMPLETED|Overall Study||0||0
48108615|NCT04939727|100594329|FG001|NOT COMPLETED|Overall Study||0||0
48108616|NCT00423891|100594330|FG000|STARTED|Enrolled||35||
48108617|NCT00423891|100594331|FG001|STARTED|Enrolled||21||
48108618|NCT00423891|100594332|FG002|STARTED|Enrolled||8||
48108619|NCT00423891|100594330|FG000|COMPLETED|Enrolled||24||
48108620|NCT00423891|100594331|FG001|COMPLETED|Enrolled||19||
48108621|NCT00423891|100594332|FG002|COMPLETED|Enrolled||5||
48108622|NCT00423891|100594330|FG000|NOT COMPLETED|Enrolled||11||
48108623|NCT00423891|100594331|FG001|NOT COMPLETED|Enrolled||2||
48108624|NCT00423891|100594332|FG002|NOT COMPLETED|Enrolled||3||
48108625|NCT00423891|100594330|FG000|STARTED|Treatment||24||
48108626|NCT00423891|100594331|FG001|STARTED|Treatment||19||
48108627|NCT00423891|100594332|FG002|STARTED|Treatment||5||
48108628|NCT00423891|100594330|FG000|COMPLETED|Treatment||22||
48108629|NCT00423891|100594331|FG001|COMPLETED|Treatment||19||
48108630|NCT00423891|100594332|FG002|COMPLETED|Treatment||5||
48108631|NCT00423891|100594330|FG000|NOT COMPLETED|Treatment||2||
48270576|NCT00558844|100984841|FG004|COMPLETED|Overall Study||6|completed follow up off treatment|
48270577|NCT00558844|100984837|FG000|NOT COMPLETED|Overall Study||3||
48270578|NCT00558844|100984838|FG001|NOT COMPLETED|Overall Study||0||
48270579|NCT00558844|100984839|FG002|NOT COMPLETED|Overall Study||1||
48270580|NCT00558844|100984840|FG003|NOT COMPLETED|Overall Study||0||
48270581|NCT00558844|100984841|FG004|NOT COMPLETED|Overall Study||1||
48270582|NCT00703339|100984842|FG000|STARTED|Overall Study||1||
48270583|NCT00703339|100984842|FG000|COMPLETED|Overall Study||1||
48270584|NCT00703339|100984842|FG000|NOT COMPLETED|Overall Study||0||
48270585|NCT01076244|100984843|FG000|STARTED|Overall Study||46||
48270586|NCT01076244|100984843|FG000|COMPLETED|Overall Study||42||
48270587|NCT01076244|100984843|FG000|NOT COMPLETED|Overall Study||4||
48108632|NCT00423891|100594331|FG001|NOT COMPLETED|Treatment||0||
48108633|NCT00423891|100594332|FG002|NOT COMPLETED|Treatment||0||
48108634|NCT00423891|100594330|FG000|STARTED|Post-Dosing Follow Up||22||
48108635|NCT00423891|100594331|FG001|STARTED|Post-Dosing Follow Up||18||
48108636|NCT00423891|100594332|FG002|STARTED|Post-Dosing Follow Up||5||
48270588|NCT03445793|100984844|FG000|STARTED|Overall Study||5||
48270589|NCT03445793|100984844|FG000|COMPLETED|Overall Study||5||
48270590|NCT03445793|100984844|FG000|NOT COMPLETED|Overall Study||0||
48270591|NCT01399918|100984845|FG000|STARTED|Overall Study||57||
48270592|NCT01399918|100984845|FG000|COMPLETED|Overall Study||55||
48693271|NCT03989349|102032737|FG002|NOT COMPLETED|Initial Treatment(Day 1-Week 16 Predose)||0||
48693272|NCT03989349|102032738|FG003|NOT COMPLETED|Initial Treatment(Day 1-Week 16 Predose)||0||
48693273|NCT03989349|102032739|FG004|NOT COMPLETED|Initial Treatment(Day 1-Week 16 Predose)||0||
48693274|NCT03989349|102032740|FG005|NOT COMPLETED|Initial Treatment(Day 1-Week 16 Predose)||0||
48693275|NCT03989349|102032735|FG000|STARTED|Maintenance Period (Week 16-Week 48)||0||
48693276|NCT03989349|102032736|FG001|STARTED|Maintenance Period (Week 16-Week 48)||0||
48693277|NCT03989349|102032737|FG002|STARTED|Maintenance Period (Week 16-Week 48)||79||
48693278|NCT03989349|102032738|FG003|STARTED|Maintenance Period (Week 16-Week 48)||78||
48693279|NCT03989349|102032739|FG004|STARTED|Maintenance Period (Week 16-Week 48)||78||
48693280|NCT03989349|102032740|FG005|STARTED|Maintenance Period (Week 16-Week 48)||85||
48693281|NCT03989349|102032735|FG000|Treated|Maintenance Period (Week 16-Week 48)||0||
48693282|NCT03989349|102032736|FG001|Treated|Maintenance Period (Week 16-Week 48)||0||
48270593|NCT01399918|100984845|FG000|NOT COMPLETED|Overall Study||2||
48270594|NCT00820170|100984846|FG000|STARTED|Overall Study||3||
48270595|NCT00820170|100984847|FG001|STARTED|Overall Study||5||
48270596|NCT00820170|100984848|FG002|STARTED|Overall Study||3||
48270597|NCT00820170|100984849|FG003|STARTED|Overall Study||40||
48270598|NCT00820170|100984850|FG004|STARTED|Overall Study||4||
48270599|NCT00820170|100984846|FG000|COMPLETED|Overall Study||3||
48270600|NCT00820170|100984847|FG001|COMPLETED|Overall Study||5||
48270601|NCT00820170|100984848|FG002|COMPLETED|Overall Study||3||
48270602|NCT00820170|100984849|FG003|COMPLETED|Overall Study||40||
48270603|NCT00820170|100984850|FG004|COMPLETED|Overall Study||0||
48270604|NCT00820170|100984846|FG000|NOT COMPLETED|Overall Study||0||
48693283|NCT03989349|102032737|FG002|Treated|Maintenance Period (Week 16-Week 48)||78||
48693284|NCT03989349|102032738|FG003|Treated|Maintenance Period (Week 16-Week 48)||78||
48693285|NCT03989349|102032739|FG004|Treated|Maintenance Period (Week 16-Week 48)||77||
48693286|NCT03989349|102032740|FG005|Treated|Maintenance Period (Week 16-Week 48)||84||
48693287|NCT03989349|102032735|FG000|Safety Population|Maintenance Period (Week 16-Week 48)||0||
48693288|NCT03989349|102032736|FG001|Safety Population|Maintenance Period (Week 16-Week 48)||0||
48693289|NCT03989349|102032737|FG002|Safety Population|Maintenance Period (Week 16-Week 48)||79||
48693290|NCT03989349|102032738|FG003|Safety Population|Maintenance Period (Week 16-Week 48)||77||
48693291|NCT03989349|102032739|FG004|Safety Population|Maintenance Period (Week 16-Week 48)||77||
48693292|NCT03989349|102032740|FG005|Safety Population|Maintenance Period (Week 16-Week 48)||84||
48693293|NCT03989349|102032735|FG000|COMPLETED|Maintenance Period (Week 16-Week 48)||0||
48270605|NCT00820170|100984847|FG001|NOT COMPLETED|Overall Study||0||
48693294|NCT03989349|102032736|FG001|COMPLETED|Maintenance Period (Week 16-Week 48)||0||
48693295|NCT03989349|102032737|FG002|COMPLETED|Maintenance Period (Week 16-Week 48)||65||
48693296|NCT03989349|102032738|FG003|COMPLETED|Maintenance Period (Week 16-Week 48)||68||
48693297|NCT03989349|102032739|FG004|COMPLETED|Maintenance Period (Week 16-Week 48)||65||
48693298|NCT03989349|102032740|FG005|COMPLETED|Maintenance Period (Week 16-Week 48)||74||
48693299|NCT03989349|102032735|FG000|NOT COMPLETED|Maintenance Period (Week 16-Week 48)||0||
48693300|NCT03989349|102032736|FG001|NOT COMPLETED|Maintenance Period (Week 16-Week 48)||0||
48693301|NCT03989349|102032737|FG002|NOT COMPLETED|Maintenance Period (Week 16-Week 48)||14||
48693302|NCT03989349|102032738|FG003|NOT COMPLETED|Maintenance Period (Week 16-Week 48)||10||
48693303|NCT03989349|102032739|FG004|NOT COMPLETED|Maintenance Period (Week 16-Week 48)||13||
48693304|NCT03989349|102032740|FG005|NOT COMPLETED|Maintenance Period (Week 16-Week 48)||11||
48693305|NCT02628600|102032741|FG000|STARTED|Overall Study||73||
48693306|NCT02628600|102032742|FG001|STARTED|Overall Study||90||
48693307|NCT02628600|102032741|FG000|Participant Discontinued the Study|Overall Study||24||
48693308|NCT02628600|102032742|FG001|Participant Discontinued the Study|Overall Study||32||
48693309|NCT02628600|102032741|FG000|COMPLETED|Overall Study||49||
48693310|NCT02628600|102032742|FG001|COMPLETED|Overall Study||58||
48693311|NCT02628600|102032741|FG000|NOT COMPLETED|Overall Study||24||
48693312|NCT02628600|102032742|FG001|NOT COMPLETED|Overall Study||32||
48108637|NCT00423891|100594330|FG000|COMPLETED|Post-Dosing Follow Up||20||
48270606|NCT00820170|100984848|FG002|NOT COMPLETED|Overall Study||0||
48270607|NCT00820170|100984849|FG003|NOT COMPLETED|Overall Study||0||
48270608|NCT00820170|100984850|FG004|NOT COMPLETED|Overall Study||4||
48270609|NCT00858689|100984851|FG000|STARTED|Overall Study||20||
48270610|NCT00858689|100984851|FG000|COMPLETED|Overall Study||19||
48270611|NCT00858689|100984851|FG000|NOT COMPLETED|Overall Study||1||
48270612|NCT01038427|100984852|FG000|STARTED|Overall Study||317||
48270613|NCT01038427|100984853|FG001|STARTED|Overall Study||320||
48270614|NCT01038427|100984854|FG002|STARTED|Overall Study||158||
48270615|NCT01038427|100984852|FG000|Per-Protocol (PPP) Population|Overall Study||306|All participants who satisfied the criteria set forth in the protocol in terms of dosing compliance, number of available post-randomization evaluations and absence of significant protocol violations.|
48294157|NCT02527343|101047537|FG001|STARTED|OLE Period-Year 2: Week 105 to 156||0||
48294158|NCT02527343|101047538|FG002|STARTED|OLE Period-Year 2: Week 105 to 156||0||
48270616|NCT01038427|100984853|FG001|Per-Protocol (PPP) Population|Overall Study||307|All participants who satisfied the criteria set forth in the protocol in terms of dosing compliance, number of available post-randomization evaluations and absence of significant protocol violations.|
48270617|NCT01038427|100984854|FG002|Per-Protocol (PPP) Population|Overall Study||150|All participants who satisfied the criteria set forth in the protocol in terms of dosing compliance, number of available post-randomization evaluations and absence of significant protocol violations.|
48270618|NCT01038427|100984852|FG000|Intent-to-Treat (ITT) Population|Overall Study||314|All participants in the PPP as well as all participants who administered at least one dose of randomized study drug and had at least one post-randomization evaluation.|
48270619|NCT01038427|100984853|FG001|Intent-to-Treat (ITT) Population|Overall Study||314|All participants in the PPP as well as all participants who administered at least one dose of randomized study drug and had at least one post-randomization evaluation.|
48270620|NCT01038427|100984854|FG002|Intent-to-Treat (ITT) Population|Overall Study||156|All participants in the PPP as well as all participants who administered at least one dose of randomized study drug and had at least one post-randomization evaluation.|
48270621|NCT01038427|100984852|FG000|COMPLETED|Overall Study||314||
48270622|NCT01038427|100984853|FG001|COMPLETED|Overall Study||314||
48270623|NCT01038427|100984854|FG002|COMPLETED|Overall Study||154||
48270624|NCT01038427|100984852|FG000|NOT COMPLETED|Overall Study||3||
48270625|NCT01038427|100984853|FG001|NOT COMPLETED|Overall Study||6||
48270626|NCT01038427|100984854|FG002|NOT COMPLETED|Overall Study||4||
48270627|NCT03037203|100984855|FG000|STARTED|Overall Study||28||
48270628|NCT03037203|100984856|FG001|STARTED|Overall Study||28||
48270629|NCT03037203|100984857|FG002|STARTED|Overall Study||10||
48270630|NCT03037203|100984855|FG000|COMPLETED|Overall Study||27||
48270631|NCT03037203|100984856|FG001|COMPLETED|Overall Study||26||
48270632|NCT03037203|100984857|FG002|COMPLETED|Overall Study||9||
48270633|NCT03037203|100984855|FG000|NOT COMPLETED|Overall Study||1||
48392432|NCT01170702|101287866|FG003|STARTED|Overall Study||29||
48392433|NCT01170702|101287863|FG000|COMPLETED|Overall Study||33||
48270634|NCT03037203|100984856|FG001|NOT COMPLETED|Overall Study||2||
48270635|NCT03037203|100984857|FG002|NOT COMPLETED|Overall Study||1||
48270636|NCT00589303|100984858|FG000|STARTED|Overall Study||14||
48270637|NCT00589303|100984859|FG001|STARTED|Overall Study||13||
48270638|NCT00589303|100984858|FG000|COMPLETED|Overall Study||12||
48270639|NCT00589303|100984859|FG001|COMPLETED|Overall Study||12||
48270640|NCT00589303|100984858|FG000|NOT COMPLETED|Overall Study||2||
48270641|NCT00589303|100984859|FG001|NOT COMPLETED|Overall Study||1||
48270642|NCT02271984|100984860|FG000|STARTED|First Intervention Period (1 Day)||3||
48270643|NCT02271984|100984861|FG001|STARTED|First Intervention Period (1 Day)||3||
48553253|NCT01262872|101686930|FG007|STARTED|Step 2||200||
48553254|NCT01262872|101686923|FG000|COMPLETED|Step 2||0||
48270644|NCT02271984|100984862|FG002|STARTED|First Intervention Period (1 Day)||3||
48553255|NCT01262872|101686924|FG001|COMPLETED|Step 2||0||
48553256|NCT01262872|101686925|FG002|COMPLETED|Step 2||191||
48270645|NCT02271984|100984863|FG003|STARTED|First Intervention Period (1 Day)||3||
48553257|NCT01262872|101686926|FG003|COMPLETED|Step 2||190||
48553258|NCT01262872|101686927|FG004|COMPLETED|Step 2||195||
48553259|NCT01262872|101686928|FG005|COMPLETED|Step 2||191||
48553260|NCT01262872|101686929|FG006|COMPLETED|Step 2||191||
48553261|NCT01262872|101686930|FG007|COMPLETED|Step 2||194||
48553262|NCT01262872|101686923|FG000|NOT COMPLETED|Step 2||0||
48553263|NCT01262872|101686924|FG001|NOT COMPLETED|Step 2||0||
48553264|NCT01262872|101686925|FG002|NOT COMPLETED|Step 2||9||
48553265|NCT01262872|101686926|FG003|NOT COMPLETED|Step 2||10||
48553266|NCT01262872|101686927|FG004|NOT COMPLETED|Step 2||5||
48553267|NCT01262872|101686928|FG005|NOT COMPLETED|Step 2||9||
48270646|NCT02271984|100984864|FG004|STARTED|First Intervention Period (1 Day)||3||
48270647|NCT02271984|100984865|FG005|STARTED|First Intervention Period (1 Day)||3||
48270648|NCT02271984|100984866|FG006|STARTED|First Intervention Period (1 Day)||3||
48270649|NCT02271984|100984867|FG007|STARTED|First Intervention Period (1 Day)||3||
48270650|NCT02271984|100984868|FG008|STARTED|First Intervention Period (1 Day)||3||
48270651|NCT02271984|100984869|FG009|STARTED|First Intervention Period (1 Day)||3||
48270652|NCT02271984|100984870|FG010|STARTED|First Intervention Period (1 Day)||3||
48270653|NCT02271984|100984871|FG011|STARTED|First Intervention Period (1 Day)||3||
48270654|NCT02271984|100984860|FG000|COMPLETED|First Intervention Period (1 Day)||3||
48270655|NCT02271984|100984861|FG001|COMPLETED|First Intervention Period (1 Day)||3||
48270656|NCT02271984|100984862|FG002|COMPLETED|First Intervention Period (1 Day)||3||
48270657|NCT02271984|100984863|FG003|COMPLETED|First Intervention Period (1 Day)||3||
48270658|NCT02271984|100984864|FG004|COMPLETED|First Intervention Period (1 Day)||3||
48553268|NCT01262872|101686929|FG006|NOT COMPLETED|Step 2||9||
48553269|NCT01262872|101686930|FG007|NOT COMPLETED|Step 2||6||
48553270|NCT01597973|101686931|FG000|STARTED|Overall Study||234|Started means randomized, here.|
48553271|NCT01597973|101686932|FG001|STARTED|Overall Study||230|Started means randomized, here.|
48553272|NCT01597973|101686931|FG000|Began First Dose|Overall Study||230||
48553273|NCT01597973|101686932|FG001|Began First Dose|Overall Study||228||
48553274|NCT01597973|101686931|FG000|COMPLETED|Overall Study||214||
48553275|NCT01597973|101686932|FG001|COMPLETED|Overall Study||211||
48553276|NCT01597973|101686931|FG000|NOT COMPLETED|Overall Study||20||
48553277|NCT01597973|101686932|FG001|NOT COMPLETED|Overall Study||19||
48108638|NCT00423891|100594331|FG001|COMPLETED|Post-Dosing Follow Up||15||
48108639|NCT00423891|100594332|FG002|COMPLETED|Post-Dosing Follow Up||3||
48108640|NCT00423891|100594330|FG000|NOT COMPLETED|Post-Dosing Follow Up||2||
48108641|NCT00423891|100594331|FG001|NOT COMPLETED|Post-Dosing Follow Up||3||
48108642|NCT00423891|100594332|FG002|NOT COMPLETED|Post-Dosing Follow Up||2||
48108643|NCT01466192|100594333|FG000|STARTED|Overall Study||108||
48108644|NCT01466192|100594333|FG000|COMPLETED|Overall Study||104||
48108645|NCT01466192|100594333|FG000|NOT COMPLETED|Overall Study||4||
48108646|NCT02549508|100594334|FG000|STARTED|Overall Study||47||
48108647|NCT02549508|100594335|FG001|STARTED|Overall Study||38||
48108648|NCT02549508|100594334|FG000|COMPLETED|Overall Study||33||
48108649|NCT02549508|100594335|FG001|COMPLETED|Overall Study||21||
48108650|NCT02549508|100594334|FG000|NOT COMPLETED|Overall Study||14||
48108651|NCT02549508|100594335|FG001|NOT COMPLETED|Overall Study||17||
48108652|NCT01354496|100594336|FG000|STARTED|Period 1||6||
48108653|NCT01354496|100594337|FG001|STARTED|Period 1||6||
48108654|NCT01354496|100594338|FG002|STARTED|Period 1||6||
48108655|NCT01354496|100594339|FG003|STARTED|Period 1||6||
48108656|NCT01354496|100594340|FG004|STARTED|Period 1||5||
48108657|NCT01354496|100594341|FG005|STARTED|Period 1||6||
48108658|NCT01354496|100594336|FG000|Received at Least 1 Dose of Study Drug|Period 1||6||
48108659|NCT01354496|100594337|FG001|Received at Least 1 Dose of Study Drug|Period 1||6||
48108660|NCT01354496|100594338|FG002|Received at Least 1 Dose of Study Drug|Period 1||6||
48108661|NCT01354496|100594339|FG003|Received at Least 1 Dose of Study Drug|Period 1||6||
48108662|NCT01354496|100594340|FG004|Received at Least 1 Dose of Study Drug|Period 1||5||
48108663|NCT01354496|100594341|FG005|Received at Least 1 Dose of Study Drug|Period 1||6||
48108664|NCT01354496|100594336|FG000|COMPLETED|Period 1||6||
48108665|NCT01354496|100594337|FG001|COMPLETED|Period 1||6||
48108666|NCT01354496|100594338|FG002|COMPLETED|Period 1||4||
48108667|NCT01354496|100594339|FG003|COMPLETED|Period 1||6||
48108668|NCT01354496|100594340|FG004|COMPLETED|Period 1||5||
48108669|NCT01354496|100594341|FG005|COMPLETED|Period 1||6||
48108670|NCT01354496|100594336|FG000|NOT COMPLETED|Period 1||0||
48553278|NCT03345420|101686933|FG000|STARTED|Overall Study||102||
48553279|NCT03345420|101686933|FG000|Hypofractionated Radiotherapy|Overall Study||102||
48553280|NCT03345420|101686933|FG000|COMPLETED|Overall Study||101||
48693313|NCT03107052|102032743|FG000|STARTED|Overall Study||145|Intent-to-treat (ITT) analysis set: all participants enrolled for long-term safety evaluation|
48693314|NCT03107052|102032744|FG001|STARTED|Overall Study||60|Intent-to-treat (ITT) analysis set: all participants enrolled for long-term safety evaluation|
48693315|NCT03107052|102032745|FG002|STARTED|Overall Study||70|Intent-to-treat (ITT) analysis set: all participants enrolled for long-term safety evaluation|
48693316|NCT03107052|102032743|FG000|Safety Analysis Set|Overall Study||144|All participants who received at least 1 dose of study drug|
48693317|NCT03107052|102032744|FG001|Safety Analysis Set|Overall Study||60|All participants who received at least 1 dose of study drug|
48693318|NCT03107052|102032745|FG002|Safety Analysis Set|Overall Study||71|All participants who received at least 1 dose of study drug|
48693319|NCT03107052|102032743|FG000|COMPLETED|Overall Study||26||
48693320|NCT03107052|102032744|FG001|COMPLETED|Overall Study||14||
48270659|NCT02271984|100984865|FG005|COMPLETED|First Intervention Period (1 Day)||3||
48270660|NCT02271984|100984866|FG006|COMPLETED|First Intervention Period (1 Day)||3||
48553281|NCT03345420|101686933|FG000|NOT COMPLETED|Overall Study||1||
48553282|NCT02498392|101686934|FG000|STARTED|Double-blind(DB) Lead-in Period(3 Weeks)||160||
48553283|NCT02498392|101686935|FG001|STARTED|Double-blind(DB) Lead-in Period(3 Weeks)||0||
48553284|NCT02498392|101686934|FG000|Treated|Double-blind(DB) Lead-in Period(3 Weeks)||153||
48553285|NCT02498392|101686935|FG001|Treated|Double-blind(DB) Lead-in Period(3 Weeks)||0||
48553286|NCT02498392|101686934|FG000|COMPLETED|Double-blind(DB) Lead-in Period(3 Weeks)||153||
48553287|NCT02498392|101686935|FG001|COMPLETED|Double-blind(DB) Lead-in Period(3 Weeks)||0||
48553288|NCT02498392|101686934|FG000|NOT COMPLETED|Double-blind(DB) Lead-in Period(3 Weeks)||7||
48553289|NCT02498392|101686935|FG001|NOT COMPLETED|Double-blind(DB) Lead-in Period(3 Weeks)||0||
48553290|NCT02498392|101686934|FG000|STARTED|DB Treatment (6 Weeks)+Withdrawal Period||76||
48553291|NCT02498392|101686935|FG001|STARTED|DB Treatment (6 Weeks)+Withdrawal Period||77||
48553292|NCT02498392|101686934|FG000|COMPLETED|DB Treatment (6 Weeks)+Withdrawal Period||70||
48553293|NCT02498392|101686935|FG001|COMPLETED|DB Treatment (6 Weeks)+Withdrawal Period||67||
48553294|NCT02498392|101686934|FG000|NOT COMPLETED|DB Treatment (6 Weeks)+Withdrawal Period||6||
48553295|NCT02498392|101686935|FG001|NOT COMPLETED|DB Treatment (6 Weeks)+Withdrawal Period||10||
48553296|NCT00451204|101686936|FG000|STARTED|Overall Study||82||
48553297|NCT00451204|101686937|FG001|STARTED|Overall Study||76||
48553298|NCT00451204|101686936|FG000|COMPLETED|Overall Study||60||
48553299|NCT00451204|101686937|FG001|COMPLETED|Overall Study||56||
48553300|NCT00451204|101686936|FG000|NOT COMPLETED|Overall Study||22||
48553301|NCT00451204|101686937|FG001|NOT COMPLETED|Overall Study||20||
48553302|NCT01268527|101686938|FG000|STARTED|Overall Study||15||
48553303|NCT01268527|101686939|FG001|STARTED|Overall Study||15||
48553304|NCT01268527|101686938|FG000|COMPLETED|Overall Study||15||
48553305|NCT01268527|101686939|FG001|COMPLETED|Overall Study||15||
48553306|NCT01268527|101686938|FG000|NOT COMPLETED|Overall Study||0||
48553307|NCT01268527|101686939|FG001|NOT COMPLETED|Overall Study||0||
48553308|NCT03416829|101686940|FG000|STARTED|Overall Study||10||
48553309|NCT03416829|101686941|FG001|STARTED|Overall Study||10||
48553310|NCT03416829|101686942|FG002|STARTED|Overall Study||9||
48553311|NCT03416829|101686940|FG000|COMPLETED|Overall Study||10||
48553312|NCT03416829|101686941|FG001|COMPLETED|Overall Study||10||
48553313|NCT03416829|101686942|FG002|COMPLETED|Overall Study||9||
48553314|NCT03416829|101686940|FG000|NOT COMPLETED|Overall Study||0||
48553315|NCT03416829|101686941|FG001|NOT COMPLETED|Overall Study||0||
48553316|NCT03416829|101686942|FG002|NOT COMPLETED|Overall Study||0||
48553317|NCT02121652|101686943|FG000|STARTED|Overall Study||20||
48553318|NCT02121652|101686944|FG001|STARTED|Overall Study||20||
48553319|NCT02121652|101686943|FG000|COMPLETED|Overall Study||14||
48270661|NCT02271984|100984867|FG007|COMPLETED|First Intervention Period (1 Day)||3||
48270662|NCT02271984|100984868|FG008|COMPLETED|First Intervention Period (1 Day)||3||
48270663|NCT02271984|100984869|FG009|COMPLETED|First Intervention Period (1 Day)||3||
48270664|NCT02271984|100984870|FG010|COMPLETED|First Intervention Period (1 Day)||3||
48270665|NCT02271984|100984871|FG011|COMPLETED|First Intervention Period (1 Day)||3||
48270666|NCT02271984|100984860|FG000|NOT COMPLETED|First Intervention Period (1 Day)||0||
48270667|NCT02271984|100984861|FG001|NOT COMPLETED|First Intervention Period (1 Day)||0||
48553320|NCT02121652|101686944|FG001|COMPLETED|Overall Study||16||
48553321|NCT02121652|101686943|FG000|NOT COMPLETED|Overall Study||6||
48693321|NCT03107052|102032745|FG002|COMPLETED|Overall Study||29||
48270668|NCT02271984|100984862|FG002|NOT COMPLETED|First Intervention Period (1 Day)||0||
48270669|NCT02271984|100984863|FG003|NOT COMPLETED|First Intervention Period (1 Day)||0||
48270670|NCT02271984|100984864|FG004|NOT COMPLETED|First Intervention Period (1 Day)||0||
48270671|NCT02271984|100984865|FG005|NOT COMPLETED|First Intervention Period (1 Day)||0||
48270672|NCT02271984|100984866|FG006|NOT COMPLETED|First Intervention Period (1 Day)||0||
48270673|NCT02271984|100984867|FG007|NOT COMPLETED|First Intervention Period (1 Day)||0||
48108671|NCT01354496|100594337|FG001|NOT COMPLETED|Period 1||0||
48108672|NCT01354496|100594338|FG002|NOT COMPLETED|Period 1||2||
48108673|NCT01354496|100594339|FG003|NOT COMPLETED|Period 1||0||
48108674|NCT01354496|100594340|FG004|NOT COMPLETED|Period 1||0||
48108675|NCT01354496|100594341|FG005|NOT COMPLETED|Period 1||0||
48108676|NCT01354496|100594336|FG000|STARTED|Washout (at Least 14 Days)||6||
48108677|NCT01354496|100594337|FG001|STARTED|Washout (at Least 14 Days)||6||
48392434|NCT01170702|101287864|FG001|COMPLETED|Overall Study||30||
48392435|NCT01170702|101287865|FG002|COMPLETED|Overall Study||25||
48392436|NCT01170702|101287866|FG003|COMPLETED|Overall Study||27||
48693322|NCT03107052|102032743|FG000|NOT COMPLETED|Overall Study||119||
48108678|NCT01354496|100594338|FG002|STARTED|Washout (at Least 14 Days)||4||
48108679|NCT01354496|100594339|FG003|STARTED|Washout (at Least 14 Days)||6||
48693323|NCT03107052|102032744|FG001|NOT COMPLETED|Overall Study||46||
48693324|NCT03107052|102032745|FG002|NOT COMPLETED|Overall Study||41||
48693325|NCT00606411|102032746|FG000|STARTED|Overall Study||16||
48693326|NCT00606411|102032747|FG001|STARTED|Overall Study||18||
48693327|NCT00606411|102032746|FG000|COMPLETED|Overall Study||10||
48693328|NCT00606411|102032747|FG001|COMPLETED|Overall Study||11||
48693329|NCT00606411|102032746|FG000|NOT COMPLETED|Overall Study||6||
48693330|NCT00606411|102032747|FG001|NOT COMPLETED|Overall Study||7||
48693331|NCT02297815|102032748|FG000|STARTED|Overall Study||1604||
48693332|NCT02297815|102032749|FG001|STARTED|Overall Study||868||
48693333|NCT02297815|102032748|FG000|5-10 Day Interview|Overall Study||1604||
48693334|NCT02297815|102032749|FG001|5-10 Day Interview|Overall Study||868||
48108680|NCT01354496|100594340|FG004|STARTED|Washout (at Least 14 Days)||5||
48108681|NCT01354496|100594341|FG005|STARTED|Washout (at Least 14 Days)||6||
48108682|NCT01354496|100594336|FG000|COMPLETED|Washout (at Least 14 Days)||6||
48108683|NCT01354496|100594337|FG001|COMPLETED|Washout (at Least 14 Days)||6||
48108684|NCT01354496|100594338|FG002|COMPLETED|Washout (at Least 14 Days)||4||
48693335|NCT02297815|102032748|FG000|14-20 Day Interview|Overall Study||1368||
48693336|NCT02297815|102032749|FG001|14-20 Day Interview|Overall Study||728||
48693337|NCT02297815|102032748|FG000|COMPLETED|Overall Study||1368||
48693338|NCT02297815|102032749|FG001|COMPLETED|Overall Study||728||
48693339|NCT02297815|102032748|FG000|NOT COMPLETED|Overall Study||236||
48693340|NCT02297815|102032749|FG001|NOT COMPLETED|Overall Study||140||
48693341|NCT00475085|102032750|FG000|STARTED|Overall Study||253||
48270674|NCT02271984|100984868|FG008|NOT COMPLETED|First Intervention Period (1 Day)||0||
48270675|NCT02271984|100984869|FG009|NOT COMPLETED|First Intervention Period (1 Day)||0||
48270676|NCT02271984|100984870|FG010|NOT COMPLETED|First Intervention Period (1 Day)||0||
48392437|NCT01170702|101287863|FG000|NOT COMPLETED|Overall Study||1||
48693342|NCT00475085|102032751|FG001|STARTED|Overall Study||254||
48108685|NCT01354496|100594339|FG003|COMPLETED|Washout (at Least 14 Days)||6||
48693343|NCT00475085|102032752|FG002|STARTED|Overall Study||260||
48693344|NCT00475085|102032753|FG003|STARTED|Overall Study||254||
48108686|NCT01354496|100594340|FG004|COMPLETED|Washout (at Least 14 Days)||5||
48693345|NCT00475085|102032750|FG000|COMPLETED|Overall Study||235||
48693346|NCT00475085|102032751|FG001|COMPLETED|Overall Study||234||
48693347|NCT00475085|102032752|FG002|COMPLETED|Overall Study||241||
48108687|NCT01354496|100594341|FG005|COMPLETED|Washout (at Least 14 Days)||6||
48108688|NCT01354496|100594336|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0||
48108689|NCT01354496|100594337|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0||
48108690|NCT01354496|100594338|FG002|NOT COMPLETED|Washout (at Least 14 Days)||0||
48108691|NCT01354496|100594339|FG003|NOT COMPLETED|Washout (at Least 14 Days)||0||
48108692|NCT01354496|100594340|FG004|NOT COMPLETED|Washout (at Least 14 Days)||0||
48108693|NCT01354496|100594341|FG005|NOT COMPLETED|Washout (at Least 14 Days)||0||
48108694|NCT01354496|100594336|FG000|STARTED|Period 2||6||
48108695|NCT01354496|100594337|FG001|STARTED|Period 2||6||
48108696|NCT01354496|100594338|FG002|STARTED|Period 2||4||
48108697|NCT01354496|100594339|FG003|STARTED|Period 2||6||
48108698|NCT01354496|100594340|FG004|STARTED|Period 2||5||
48108699|NCT01354496|100594341|FG005|STARTED|Period 2||6||
48108700|NCT01354496|100594336|FG000|COMPLETED|Period 2||6||
48108701|NCT01354496|100594337|FG001|COMPLETED|Period 2||6||
48108702|NCT01354496|100594338|FG002|COMPLETED|Period 2||4||
48108703|NCT01354496|100594339|FG003|COMPLETED|Period 2||5||
48108704|NCT01354496|100594340|FG004|COMPLETED|Period 2||5||
48108705|NCT01354496|100594341|FG005|COMPLETED|Period 2||6||
48108706|NCT01354496|100594336|FG000|NOT COMPLETED|Period 2||0||
48108707|NCT01354496|100594337|FG001|NOT COMPLETED|Period 2||0||
48108708|NCT01354496|100594338|FG002|NOT COMPLETED|Period 2||0||
48108709|NCT01354496|100594339|FG003|NOT COMPLETED|Period 2||1||
48108710|NCT01354496|100594340|FG004|NOT COMPLETED|Period 2||0||
48108711|NCT01354496|100594341|FG005|NOT COMPLETED|Period 2||0||
48108712|NCT01354496|100594336|FG000|STARTED|Washout (at Least 14 Days)||6||
48108713|NCT01354496|100594337|FG001|STARTED|Washout (at Least 14 Days)||6||
48108714|NCT01354496|100594338|FG002|STARTED|Washout (at Least 14 Days)||4||
48108715|NCT01354496|100594339|FG003|STARTED|Washout (at Least 14 Days)||5||
48108716|NCT01354496|100594340|FG004|STARTED|Washout (at Least 14 Days)||5||
48108717|NCT01354496|100594341|FG005|STARTED|Washout (at Least 14 Days)||6||
48108718|NCT01354496|100594336|FG000|COMPLETED|Washout (at Least 14 Days)||6||
48108719|NCT01354496|100594337|FG001|COMPLETED|Washout (at Least 14 Days)||5||
48108720|NCT01354496|100594338|FG002|COMPLETED|Washout (at Least 14 Days)||4||
48108721|NCT01354496|100594339|FG003|COMPLETED|Washout (at Least 14 Days)||4||
48108722|NCT01354496|100594340|FG004|COMPLETED|Washout (at Least 14 Days)||5||
48108723|NCT01354496|100594341|FG005|COMPLETED|Washout (at Least 14 Days)||6||
48108724|NCT01354496|100594336|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0||
48108725|NCT01354496|100594337|FG001|NOT COMPLETED|Washout (at Least 14 Days)||1||
48108726|NCT01354496|100594338|FG002|NOT COMPLETED|Washout (at Least 14 Days)||0||
48108727|NCT01354496|100594339|FG003|NOT COMPLETED|Washout (at Least 14 Days)||1||
48108728|NCT01354496|100594340|FG004|NOT COMPLETED|Washout (at Least 14 Days)||0||
48108729|NCT01354496|100594341|FG005|NOT COMPLETED|Washout (at Least 14 Days)||0||
48108730|NCT01354496|100594336|FG000|STARTED|Period 3||6||
48108731|NCT01354496|100594337|FG001|STARTED|Period 3||5||
48108732|NCT01354496|100594338|FG002|STARTED|Period 3||4||
48108733|NCT01354496|100594339|FG003|STARTED|Period 3||4||
48108734|NCT01354496|100594340|FG004|STARTED|Period 3||5||
48108735|NCT01354496|100594341|FG005|STARTED|Period 3||6||
48108736|NCT01354496|100594336|FG000|COMPLETED|Period 3||6||
48108737|NCT01354496|100594337|FG001|COMPLETED|Period 3||5||
48108738|NCT01354496|100594338|FG002|COMPLETED|Period 3||4||
48108739|NCT01354496|100594339|FG003|COMPLETED|Period 3||4||
48108740|NCT01354496|100594340|FG004|COMPLETED|Period 3||5||
48108741|NCT01354496|100594341|FG005|COMPLETED|Period 3||6||
48108742|NCT01354496|100594336|FG000|NOT COMPLETED|Period 3||0||
48108743|NCT01354496|100594337|FG001|NOT COMPLETED|Period 3||0||
48108744|NCT01354496|100594338|FG002|NOT COMPLETED|Period 3||0||
48108745|NCT01354496|100594339|FG003|NOT COMPLETED|Period 3||0||
48108746|NCT01354496|100594340|FG004|NOT COMPLETED|Period 3||0||
48108747|NCT01354496|100594341|FG005|NOT COMPLETED|Period 3||0||
48108748|NCT01344447|100594342|FG000|STARTED|Overall Study||479||
48108749|NCT01344447|100594342|FG000|Fulfilled Requirement of FAS Population|Overall Study||457||
48108750|NCT01344447|100594342|FG000|COMPLETED|Overall Study||471||
48693348|NCT00475085|102032753|FG003|COMPLETED|Overall Study||234||
48693349|NCT00475085|102032750|FG000|NOT COMPLETED|Overall Study||18||
48693350|NCT00475085|102032751|FG001|NOT COMPLETED|Overall Study||20||
48693351|NCT00475085|102032752|FG002|NOT COMPLETED|Overall Study||19||
48693352|NCT00475085|102032753|FG003|NOT COMPLETED|Overall Study||20||
48693353|NCT02342691|102032754|FG000|STARTED|Overall Study||50||
48693354|NCT02342691|102032755|FG001|STARTED|Overall Study||50||
48693355|NCT02342691|102032756|FG002|STARTED|Overall Study||27||
48693356|NCT02342691|102032754|FG000|COMPLETED|Overall Study||47||
48693357|NCT02342691|102032755|FG001|COMPLETED|Overall Study||49||
48693358|NCT02342691|102032756|FG002|COMPLETED|Overall Study||27||
48693359|NCT02342691|102032754|FG000|NOT COMPLETED|Overall Study||3||
48693360|NCT02342691|102032755|FG001|NOT COMPLETED|Overall Study||1||
48693361|NCT02342691|102032756|FG002|NOT COMPLETED|Overall Study||0||
48693362|NCT04209634|102032757|FG000|STARTED|Overall Study||10||
48693363|NCT04209634|102032757|FG000|COMPLETED|Overall Study||0||
48693364|NCT04209634|102032757|FG000|NOT COMPLETED|Overall Study||10||
48693365|NCT01700959|102032758|FG000|STARTED|Overall Study||89||
48693366|NCT01700959|102032759|FG001|STARTED|Overall Study||88||
48693367|NCT01700959|102032760|FG002|STARTED|Overall Study||105||
48693368|NCT01700959|102032761|FG003|STARTED|Overall Study||105||
48693369|NCT01700959|102032762|FG004|STARTED|Overall Study||96||
48693370|NCT01700959|102032763|FG005|STARTED|Overall Study||97||
48693371|NCT01700959|102032758|FG000|COMPLETED|Overall Study||62||
48270677|NCT02271984|100984871|FG011|NOT COMPLETED|First Intervention Period (1 Day)||0||
48270678|NCT02271984|100984860|FG000|STARTED|Washout Period 1 (7 Days)||3||
48270679|NCT02271984|100984861|FG001|STARTED|Washout Period 1 (7 Days)||3||
48270680|NCT02271984|100984862|FG002|STARTED|Washout Period 1 (7 Days)||3||
48270681|NCT02271984|100984863|FG003|STARTED|Washout Period 1 (7 Days)||3||
48270682|NCT02271984|100984864|FG004|STARTED|Washout Period 1 (7 Days)||3||
48270683|NCT02271984|100984865|FG005|STARTED|Washout Period 1 (7 Days)||3||
48270684|NCT02271984|100984866|FG006|STARTED|Washout Period 1 (7 Days)||3||
48270685|NCT02271984|100984867|FG007|STARTED|Washout Period 1 (7 Days)||3||
48270686|NCT02271984|100984868|FG008|STARTED|Washout Period 1 (7 Days)||3||
48270687|NCT02271984|100984869|FG009|STARTED|Washout Period 1 (7 Days)||3||
48270688|NCT02271984|100984870|FG010|STARTED|Washout Period 1 (7 Days)||3||
48270689|NCT02271984|100984871|FG011|STARTED|Washout Period 1 (7 Days)||3||
48270690|NCT02271984|100984860|FG000|COMPLETED|Washout Period 1 (7 Days)||3||
48270691|NCT02271984|100984861|FG001|COMPLETED|Washout Period 1 (7 Days)||3||
48270692|NCT02271984|100984862|FG002|COMPLETED|Washout Period 1 (7 Days)||3||
48270693|NCT02271984|100984863|FG003|COMPLETED|Washout Period 1 (7 Days)||3||
48693372|NCT01700959|102032759|FG001|COMPLETED|Overall Study||64||
48693373|NCT01700959|102032760|FG002|COMPLETED|Overall Study||65||
48693374|NCT01700959|102032761|FG003|COMPLETED|Overall Study||70||
48270694|NCT02271984|100984864|FG004|COMPLETED|Washout Period 1 (7 Days)||3||
48270695|NCT02271984|100984865|FG005|COMPLETED|Washout Period 1 (7 Days)||3||
48270696|NCT02271984|100984866|FG006|COMPLETED|Washout Period 1 (7 Days)||3||
48270697|NCT02271984|100984867|FG007|COMPLETED|Washout Period 1 (7 Days)||3||
48270698|NCT02271984|100984868|FG008|COMPLETED|Washout Period 1 (7 Days)||3||
48270699|NCT02271984|100984869|FG009|COMPLETED|Washout Period 1 (7 Days)||3||
48270700|NCT02271984|100984870|FG010|COMPLETED|Washout Period 1 (7 Days)||3||
48270701|NCT02271984|100984871|FG011|COMPLETED|Washout Period 1 (7 Days)||3||
48270702|NCT02271984|100984860|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48270703|NCT02271984|100984861|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48270704|NCT02271984|100984862|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48270705|NCT02271984|100984863|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48392438|NCT01170702|101287864|FG001|NOT COMPLETED|Overall Study||2||
48693375|NCT01700959|102032762|FG004|COMPLETED|Overall Study||69||
48693376|NCT01700959|102032763|FG005|COMPLETED|Overall Study||72||
48693377|NCT01700959|102032758|FG000|NOT COMPLETED|Overall Study||27||
48693378|NCT01700959|102032759|FG001|NOT COMPLETED|Overall Study||24||
48693379|NCT01700959|102032760|FG002|NOT COMPLETED|Overall Study||40||
48693380|NCT01700959|102032761|FG003|NOT COMPLETED|Overall Study||35||
48693381|NCT01700959|102032762|FG004|NOT COMPLETED|Overall Study||27||
48693382|NCT01700959|102032763|FG005|NOT COMPLETED|Overall Study||25||
48693383|NCT01234480|102032764|FG000|STARTED|Overall Study||5859||
48693384|NCT01234480|102032764|FG000|COMPLETED|Overall Study||5416||
48693385|NCT01234480|102032764|FG000|NOT COMPLETED|Overall Study||443||
48693386|NCT01076205|102032765|FG000|STARTED|Overall Study||7229||
48693387|NCT01076205|102032765|FG000|COMPLETED|Overall Study||1210|Participants who were ongoing at the 60 month visit.|
48693388|NCT01076205|102032765|FG000|NOT COMPLETED|Overall Study||6019||
48693389|NCT00399568|102032766|FG000|STARTED|Overall Study||166||
48693390|NCT00399568|102032767|FG001|STARTED|Overall Study||165||
48693391|NCT00399568|102032766|FG000|COMPLETED|Overall Study||154||
48693392|NCT00399568|102032767|FG001|COMPLETED|Overall Study||156||
48693393|NCT00399568|102032766|FG000|NOT COMPLETED|Overall Study||12||
48693394|NCT00399568|102032767|FG001|NOT COMPLETED|Overall Study||9||
48693395|NCT04660552|102032768|FG000|STARTED|Overall Study||19||
48693396|NCT04660552|102032769|FG001|STARTED|Overall Study||15||
48693397|NCT04660552|102032768|FG000|COMPLETED|Overall Study||16||
48270706|NCT02271984|100984864|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48693398|NCT04660552|102032769|FG001|COMPLETED|Overall Study||14||
48270707|NCT02271984|100984865|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48270708|NCT02271984|100984866|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48108751|NCT01344447|100594342|FG000|NOT COMPLETED|Overall Study||8||
48108752|NCT02984384|100594343|FG000|STARTED|Overall Study||6209||
48270709|NCT02271984|100984867|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48270710|NCT02271984|100984868|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48270711|NCT02271984|100984869|FG009|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48270712|NCT02271984|100984870|FG010|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48270713|NCT02271984|100984871|FG011|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48270714|NCT02271984|100984860|FG000|STARTED|Second Intervention Period (1 Day)||3||
48270715|NCT02271984|100984861|FG001|STARTED|Second Intervention Period (1 Day)||3||
48270716|NCT02271984|100984862|FG002|STARTED|Second Intervention Period (1 Day)||3||
48270717|NCT02271984|100984863|FG003|STARTED|Second Intervention Period (1 Day)||3||
48270718|NCT02271984|100984864|FG004|STARTED|Second Intervention Period (1 Day)||3||
48270719|NCT02271984|100984865|FG005|STARTED|Second Intervention Period (1 Day)||3||
48270720|NCT02271984|100984866|FG006|STARTED|Second Intervention Period (1 Day)||3||
48270721|NCT02271984|100984867|FG007|STARTED|Second Intervention Period (1 Day)||3||
48270722|NCT02271984|100984868|FG008|STARTED|Second Intervention Period (1 Day)||3||
48693399|NCT04660552|102032768|FG000|NOT COMPLETED|Overall Study||3||
48693400|NCT04660552|102032769|FG001|NOT COMPLETED|Overall Study||1||
48693401|NCT03645941|102032770|FG000|STARTED|Overall Study||30||
48693402|NCT03645941|102032771|FG001|STARTED|Overall Study||31||
48693403|NCT03645941|102032770|FG000|COMPLETED|Overall Study||16||
48693404|NCT03645941|102032771|FG001|COMPLETED|Overall Study||19||
48108753|NCT02984384|100594344|FG001|STARTED|Overall Study||6215||
48108754|NCT02984384|100594343|FG000|COMPLETED|Overall Study||6110||
48108755|NCT02984384|100594344|FG001|COMPLETED|Overall Study||6101||
48108756|NCT02984384|100594343|FG000|NOT COMPLETED|Overall Study||99||
48108757|NCT02984384|100594344|FG001|NOT COMPLETED|Overall Study||114||
48108758|NCT03591575|100594345|FG000|STARTED|Overall Study||32||
48108759|NCT03591575|100594346|FG001|STARTED|Overall Study||32||
48108760|NCT03591575|100594345|FG000|COMPLETED|Overall Study||26||
48108761|NCT03591575|100594346|FG001|COMPLETED|Overall Study||31||
48108762|NCT03591575|100594345|FG000|NOT COMPLETED|Overall Study||6||
48108763|NCT03591575|100594346|FG001|NOT COMPLETED|Overall Study||1||
48108764|NCT00534235|100594347|FG000|STARTED|Overall Study||107||
48108765|NCT00534235|100594348|FG001|STARTED|Overall Study||215||
48108766|NCT00534235|100594347|FG000|COMPLETED|Overall Study||91||
48108767|NCT00534235|100594348|FG001|COMPLETED|Overall Study||192||
48108768|NCT00534235|100594347|FG000|NOT COMPLETED|Overall Study||16||
48108769|NCT00534235|100594348|FG001|NOT COMPLETED|Overall Study||23||
48108770|NCT01147653|100594349|FG000|STARTED|Year 1||32||
48108771|NCT01147653|100594350|FG001|STARTED|Year 1||31||
48108772|NCT01147653|100594349|FG000|COMPLETED|Year 1||32||
48108773|NCT01147653|100594350|FG001|COMPLETED|Year 1||31||
48108774|NCT01147653|100594349|FG000|NOT COMPLETED|Year 1||0||
48108775|NCT01147653|100594350|FG001|NOT COMPLETED|Year 1||0||
48108776|NCT01147653|100594349|FG000|STARTED|Year 2||32||
48108777|NCT01147653|100594350|FG001|STARTED|Year 2||31||
48108778|NCT01147653|100594349|FG000|COMPLETED|Year 2||30||
48270723|NCT02271984|100984869|FG009|STARTED|Second Intervention Period (1 Day)||3||
48270724|NCT02271984|100984870|FG010|STARTED|Second Intervention Period (1 Day)||3||
48270725|NCT02271984|100984871|FG011|STARTED|Second Intervention Period (1 Day)||3||
48270726|NCT02271984|100984860|FG000|COMPLETED|Second Intervention Period (1 Day)||3||
48270727|NCT02271984|100984861|FG001|COMPLETED|Second Intervention Period (1 Day)||3||
48270728|NCT02271984|100984862|FG002|COMPLETED|Second Intervention Period (1 Day)||3||
48270729|NCT02271984|100984863|FG003|COMPLETED|Second Intervention Period (1 Day)||3||
48270730|NCT02271984|100984864|FG004|COMPLETED|Second Intervention Period (1 Day)||3||
48693405|NCT03645941|102032770|FG000|NOT COMPLETED|Overall Study||14||
48693406|NCT03645941|102032771|FG001|NOT COMPLETED|Overall Study||12||
48693407|NCT02685566|102032772|FG000|STARTED|First Reading Session||50||
48693408|NCT02685566|102032773|FG001|STARTED|First Reading Session||50||
48693409|NCT02685566|102032772|FG000|COMPLETED|First Reading Session||50||
48693410|NCT02685566|102032773|FG001|COMPLETED|First Reading Session||50||
48693411|NCT02685566|102032772|FG000|NOT COMPLETED|First Reading Session||0||
48693412|NCT02685566|102032773|FG001|NOT COMPLETED|First Reading Session||0||
48693413|NCT02685566|102032772|FG000|STARTED|4 Week Memory Washout Period||50||
48693414|NCT02685566|102032773|FG001|STARTED|4 Week Memory Washout Period||50||
48693415|NCT02685566|102032772|FG000|COMPLETED|4 Week Memory Washout Period||50||
48693416|NCT02685566|102032773|FG001|COMPLETED|4 Week Memory Washout Period||50||
48693417|NCT02685566|102032772|FG000|NOT COMPLETED|4 Week Memory Washout Period||0||
48693418|NCT02685566|102032773|FG001|NOT COMPLETED|4 Week Memory Washout Period||0||
48693419|NCT02685566|102032772|FG000|STARTED|Second Reading Session||50||
48108779|NCT01147653|100594350|FG001|COMPLETED|Year 2||28||
48693420|NCT02685566|102032773|FG001|STARTED|Second Reading Session||50||
48693421|NCT02685566|102032772|FG000|COMPLETED|Second Reading Session||50||
48693422|NCT02685566|102032773|FG001|COMPLETED|Second Reading Session||50||
48108780|NCT01147653|100594349|FG000|NOT COMPLETED|Year 2||2||
48108781|NCT01147653|100594350|FG001|NOT COMPLETED|Year 2||3||
48108782|NCT01071512|100594351|FG000|STARTED|Overall Study||20||
48108783|NCT01071512|100594351|FG000|COMPLETED|Overall Study||15||
48108784|NCT01071512|100594351|FG000|NOT COMPLETED|Overall Study||5||
48270731|NCT02271984|100984865|FG005|COMPLETED|Second Intervention Period (1 Day)||3||
48270732|NCT02271984|100984866|FG006|COMPLETED|Second Intervention Period (1 Day)||3||
48108785|NCT00380393|100594352|FG000|STARTED|Month 8 (Cross-sectional Visit)||447||
48108786|NCT00380393|100594353|FG001|STARTED|Month 8 (Cross-sectional Visit)||447||
48108787|NCT00380393|100594352|FG000|COMPLETED|Month 8 (Cross-sectional Visit)||398||
48108788|NCT00380393|100594353|FG001|COMPLETED|Month 8 (Cross-sectional Visit)||407||
48108789|NCT00380393|100594352|FG000|NOT COMPLETED|Month 8 (Cross-sectional Visit)||49||
48108790|NCT00380393|100594353|FG001|NOT COMPLETED|Month 8 (Cross-sectional Visit)||40||
48108791|NCT00380393|100594352|FG000|STARTED|Month 14||447||
48108792|NCT00380393|100594353|FG001|STARTED|Month 14||447||
48108793|NCT00380393|100594352|FG000|COMPLETED|Month 14||390||
48108794|NCT00380393|100594353|FG001|COMPLETED|Month 14||391||
48108795|NCT00380393|100594352|FG000|NOT COMPLETED|Month 14||57||
48108796|NCT00380393|100594353|FG001|NOT COMPLETED|Month 14||56||
48108797|NCT00983580|100594354|FG000|STARTED|Overall Study||54||
48108798|NCT00983580|100594355|FG001|STARTED|Overall Study||53||
48108799|NCT00983580|100594354|FG000|COMPLETED|Overall Study||49||
48108800|NCT00983580|100594355|FG001|COMPLETED|Overall Study||49||
48108801|NCT00983580|100594354|FG000|NOT COMPLETED|Overall Study||5||
48108802|NCT00983580|100594355|FG001|NOT COMPLETED|Overall Study||4||
48108803|NCT02462967|100594356|FG000|STARTED|Overall Study||54||
48108804|NCT02462967|100594357|FG001|STARTED|Overall Study||54||
48108805|NCT02462967|100594358|FG002|STARTED|Overall Study||54||
48108806|NCT02462967|100594356|FG000|COMPLETED|Overall Study||52||
48108807|NCT02462967|100594357|FG001|COMPLETED|Overall Study||48||
48108808|NCT02462967|100594358|FG002|COMPLETED|Overall Study||51||
48108809|NCT02462967|100594356|FG000|NOT COMPLETED|Overall Study||2||
48108810|NCT02462967|100594357|FG001|NOT COMPLETED|Overall Study||6||
48108811|NCT02462967|100594358|FG002|NOT COMPLETED|Overall Study||3||
48108812|NCT01734551|100594359|FG000|STARTED|Overall Study||15||
48108813|NCT01734551|100594360|FG001|STARTED|Overall Study||16||
48108814|NCT01734551|100594359|FG000|COMPLETED|Overall Study||15||
48108815|NCT01734551|100594360|FG001|COMPLETED|Overall Study||16||
48108816|NCT01734551|100594359|FG000|NOT COMPLETED|Overall Study||0||
48108817|NCT01734551|100594360|FG001|NOT COMPLETED|Overall Study||0||
48108818|NCT01192152|100594361|FG000|STARTED|Period 1||15||
48108819|NCT01192152|100594362|FG001|STARTED|Period 1||15||
48108820|NCT01192152|100594361|FG000|COMPLETED|Period 1||15||
48108821|NCT01192152|100594362|FG001|COMPLETED|Period 1||14||
48108822|NCT01192152|100594361|FG000|NOT COMPLETED|Period 1||0||
48108823|NCT01192152|100594362|FG001|NOT COMPLETED|Period 1||1||
48108824|NCT01192152|100594361|FG000|STARTED|Period 2||15||
48108825|NCT01192152|100594362|FG001|STARTED|Period 2||14||
48108826|NCT01192152|100594361|FG000|COMPLETED|Period 2||15||
48108827|NCT01192152|100594362|FG001|COMPLETED|Period 2||14||
48108828|NCT01192152|100594361|FG000|NOT COMPLETED|Period 2||0||
48108829|NCT01192152|100594362|FG001|NOT COMPLETED|Period 2||0||
48108830|NCT01192152|100594361|FG000|STARTED|Period 3||15||
48108831|NCT01192152|100594362|FG001|STARTED|Period 3||0||
48108832|NCT01192152|100594361|FG000|COMPLETED|Period 3||14||
48108833|NCT01192152|100594362|FG001|COMPLETED|Period 3||0||
48108834|NCT01192152|100594361|FG000|NOT COMPLETED|Period 3||1||
48108835|NCT01192152|100594362|FG001|NOT COMPLETED|Period 3||0||
48108836|NCT06076694|100594363|FG000|STARTED|Overall Study||20||
48108837|NCT06076694|100594364|FG001|STARTED|Overall Study||20||
48108838|NCT06076694|100594365|FG002|STARTED|Overall Study||10||
48108839|NCT06076694|100594366|FG003|STARTED|Overall Study||10||
48108840|NCT06076694|100594367|FG004|STARTED|Overall Study||20||
48108841|NCT06076694|100594363|FG000|COMPLETED|Overall Study||19||
48108842|NCT06076694|100594364|FG001|COMPLETED|Overall Study||18||
48108843|NCT06076694|100594365|FG002|COMPLETED|Overall Study||10||
48108844|NCT06076694|100594366|FG003|COMPLETED|Overall Study||10||
48108845|NCT06076694|100594367|FG004|COMPLETED|Overall Study||20||
48108846|NCT06076694|100594363|FG000|NOT COMPLETED|Overall Study||1||
48108847|NCT06076694|100594364|FG001|NOT COMPLETED|Overall Study||2||
48270733|NCT02271984|100984867|FG007|COMPLETED|Second Intervention Period (1 Day)||3||
48270734|NCT02271984|100984868|FG008|COMPLETED|Second Intervention Period (1 Day)||3||
48270735|NCT02271984|100984869|FG009|COMPLETED|Second Intervention Period (1 Day)||3||
48108848|NCT06076694|100594365|FG002|NOT COMPLETED|Overall Study||0||
48108849|NCT06076694|100594366|FG003|NOT COMPLETED|Overall Study||0||
48108850|NCT06076694|100594367|FG004|NOT COMPLETED|Overall Study||0||
48108851|NCT04753164|100594368|FG000|STARTED|Overall Study||68||
48108852|NCT04753164|100594369|FG001|STARTED|Overall Study||68||
48108853|NCT04753164|100594368|FG000|COMPLETED|Overall Study||41||
48108854|NCT04753164|100594369|FG001|COMPLETED|Overall Study||48||
48108855|NCT04753164|100594368|FG000|NOT COMPLETED|Overall Study||27||
48108856|NCT04753164|100594369|FG001|NOT COMPLETED|Overall Study||20||
48108857|NCT04371380|100594370|FG000|STARTED|Oral Lead-in Phase (Up to Day 28)||15||
48108858|NCT04371380|100594371|FG001|STARTED|Oral Lead-in Phase (Up to Day 28)||0||
48108859|NCT04371380|100594372|FG002|STARTED|Oral Lead-in Phase (Up to Day 28)||0||
48108860|NCT04371380|100594370|FG000|COMPLETED|Oral Lead-in Phase (Up to Day 28)||14||
48108861|NCT04371380|100594371|FG001|COMPLETED|Oral Lead-in Phase (Up to Day 28)||0||
48270736|NCT02271984|100984870|FG010|COMPLETED|Second Intervention Period (1 Day)||3||
48270737|NCT02271984|100984871|FG011|COMPLETED|Second Intervention Period (1 Day)||3||
48270738|NCT02271984|100984860|FG000|NOT COMPLETED|Second Intervention Period (1 Day)||0||
48270739|NCT02271984|100984861|FG001|NOT COMPLETED|Second Intervention Period (1 Day)||0||
48270740|NCT02271984|100984862|FG002|NOT COMPLETED|Second Intervention Period (1 Day)||0||
48270741|NCT02271984|100984863|FG003|NOT COMPLETED|Second Intervention Period (1 Day)||0||
48270742|NCT02271984|100984864|FG004|NOT COMPLETED|Second Intervention Period (1 Day)||0||
48270743|NCT02271984|100984865|FG005|NOT COMPLETED|Second Intervention Period (1 Day)||0||
48270744|NCT02271984|100984866|FG006|NOT COMPLETED|Second Intervention Period (1 Day)||0||
48270745|NCT02271984|100984867|FG007|NOT COMPLETED|Second Intervention Period (1 Day)||0||
48270746|NCT02271984|100984868|FG008|NOT COMPLETED|Second Intervention Period (1 Day)||0||
48270747|NCT02271984|100984869|FG009|NOT COMPLETED|Second Intervention Period (1 Day)||0||
48270748|NCT02271984|100984870|FG010|NOT COMPLETED|Second Intervention Period (1 Day)||0||
48270749|NCT02271984|100984871|FG011|NOT COMPLETED|Second Intervention Period (1 Day)||0||
48693423|NCT02685566|102032772|FG000|NOT COMPLETED|Second Reading Session||0||
48693424|NCT02685566|102032773|FG001|NOT COMPLETED|Second Reading Session||0||
48270750|NCT02271984|100984860|FG000|STARTED|Washout Period 2 (7 Days)||3||
48270751|NCT02271984|100984861|FG001|STARTED|Washout Period 2 (7 Days)||3||
48270752|NCT02271984|100984862|FG002|STARTED|Washout Period 2 (7 Days)||3||
48270753|NCT02271984|100984863|FG003|STARTED|Washout Period 2 (7 Days)||3||
48270754|NCT02271984|100984864|FG004|STARTED|Washout Period 2 (7 Days)||3||
48392439|NCT01170702|101287865|FG002|NOT COMPLETED|Overall Study||0||
48392440|NCT01170702|101287866|FG003|NOT COMPLETED|Overall Study||2||
48392441|NCT01646398|101287867|FG000|STARTED|Overall Study||382||
48392442|NCT01646398|101287868|FG001|STARTED|Overall Study||382||
48392443|NCT01646398|101287867|FG000|COMPLETED|Overall Study||381||
48392444|NCT01646398|101287868|FG001|COMPLETED|Overall Study||382||
48392445|NCT01646398|101287867|FG000|NOT COMPLETED|Overall Study||1||
48392446|NCT01646398|101287868|FG001|NOT COMPLETED|Overall Study||0||
48392447|NCT00992602|101287869|FG000|STARTED|Overall Study||3||
48392448|NCT00992602|101287869|FG000|COMPLETED|Overall Study||0||
48392449|NCT00992602|101287869|FG000|NOT COMPLETED|Overall Study||3||
48392450|NCT02017899|101287870|FG000|STARTED|Overall Study||8||
48392451|NCT02017899|101287871|FG001|STARTED|Overall Study||9||
48392452|NCT02017899|101287872|FG002|STARTED|Overall Study||8||
48392453|NCT02017899|101287873|FG003|STARTED|Overall Study||8||
48392454|NCT02017899|101287874|FG004|STARTED|Overall Study||9||
48392455|NCT02017899|101287875|FG005|STARTED|Overall Study||8||
48392456|NCT02017899|101287870|FG000|COMPLETED|Overall Study||8||
48392457|NCT02017899|101287871|FG001|COMPLETED|Overall Study||9||
48392458|NCT02017899|101287872|FG002|COMPLETED|Overall Study||8||
48392459|NCT02017899|101287873|FG003|COMPLETED|Overall Study||7||
48392460|NCT02017899|101287874|FG004|COMPLETED|Overall Study||8||
48392461|NCT02017899|101287875|FG005|COMPLETED|Overall Study||8||
48392462|NCT02017899|101287870|FG000|NOT COMPLETED|Overall Study||0||
48392463|NCT02017899|101287871|FG001|NOT COMPLETED|Overall Study||0||
48392464|NCT02017899|101287872|FG002|NOT COMPLETED|Overall Study||0||
48392465|NCT02017899|101287873|FG003|NOT COMPLETED|Overall Study||1||
48392466|NCT02017899|101287874|FG004|NOT COMPLETED|Overall Study||1||
48392467|NCT02017899|101287875|FG005|NOT COMPLETED|Overall Study||0||
48392468|NCT03371732|101287876|FG000|STARTED|Overall Study||51||
48392469|NCT03371732|101287877|FG001|STARTED|Overall Study||53||
48392470|NCT03371732|101287876|FG000|COMPLETED|Overall Study||39||
48392471|NCT03371732|101287877|FG001|COMPLETED|Overall Study||46||
48392472|NCT03371732|101287876|FG000|NOT COMPLETED|Overall Study||12||
48392473|NCT03371732|101287877|FG001|NOT COMPLETED|Overall Study||7||
48392474|NCT02584868|101287878|FG000|STARTED|Overall Study||44||
48392475|NCT02584868|101287879|FG001|STARTED|Overall Study||44||
48392476|NCT02584868|101287878|FG000|COMPLETED|Overall Study||44||
48270755|NCT02271984|100984865|FG005|STARTED|Washout Period 2 (7 Days)||3||
48270756|NCT02271984|100984866|FG006|STARTED|Washout Period 2 (7 Days)||3||
48270757|NCT02271984|100984867|FG007|STARTED|Washout Period 2 (7 Days)||3||
48270758|NCT02271984|100984868|FG008|STARTED|Washout Period 2 (7 Days)||3||
48270759|NCT02271984|100984869|FG009|STARTED|Washout Period 2 (7 Days)||3||
48270760|NCT02271984|100984870|FG010|STARTED|Washout Period 2 (7 Days)||3||
48270761|NCT02271984|100984871|FG011|STARTED|Washout Period 2 (7 Days)||3||
48270762|NCT02271984|100984860|FG000|COMPLETED|Washout Period 2 (7 Days)||3||
48392477|NCT02584868|101287879|FG001|COMPLETED|Overall Study||44||
48392478|NCT02584868|101287878|FG000|NOT COMPLETED|Overall Study||0||
48392479|NCT02584868|101287879|FG001|NOT COMPLETED|Overall Study||0||
48392480|NCT02790463|101287880|FG000|STARTED|Overall Study||782||
48392481|NCT02790463|101287881|FG001|STARTED|Overall Study||681||
48693425|NCT00814580|102032774|FG000|STARTED|Overall Study||194||
48693426|NCT00814580|102032775|FG001|STARTED|Overall Study||188||
48693427|NCT00814580|102032774|FG000|COMPLETED|Overall Study||163||
48270763|NCT02271984|100984861|FG001|COMPLETED|Washout Period 2 (7 Days)||3||
48392482|NCT02790463|101287880|FG000|COMPLETED|Overall Study||782||
48270764|NCT02271984|100984862|FG002|COMPLETED|Washout Period 2 (7 Days)||3||
48270765|NCT02271984|100984863|FG003|COMPLETED|Washout Period 2 (7 Days)||3||
48392483|NCT02790463|101287881|FG001|COMPLETED|Overall Study||372||
48392484|NCT02790463|101287880|FG000|NOT COMPLETED|Overall Study||0||
48108862|NCT04371380|100594372|FG002|COMPLETED|Oral Lead-in Phase (Up to Day 28)||0||
48108863|NCT04371380|100594370|FG000|NOT COMPLETED|Oral Lead-in Phase (Up to Day 28)||1||
48108864|NCT04371380|100594371|FG001|NOT COMPLETED|Oral Lead-in Phase (Up to Day 28)||0||
48108865|NCT04371380|100594372|FG002|NOT COMPLETED|Oral Lead-in Phase (Up to Day 28)||0||
48108866|NCT04371380|100594370|FG000|STARTED|Injection Phase (IP)-Day 1[IP] to Week 4||0||
48108867|NCT04371380|100594371|FG001|STARTED|Injection Phase (IP)-Day 1[IP] to Week 4||14||
48108868|NCT04371380|100594372|FG002|STARTED|Injection Phase (IP)-Day 1[IP] to Week 4||0||
48108869|NCT04371380|100594370|FG000|COMPLETED|Injection Phase (IP)-Day 1[IP] to Week 4||0||
48108870|NCT04371380|100594371|FG001|COMPLETED|Injection Phase (IP)-Day 1[IP] to Week 4||14||
48108871|NCT04371380|100594372|FG002|COMPLETED|Injection Phase (IP)-Day 1[IP] to Week 4||0||
48108872|NCT04371380|100594370|FG000|NOT COMPLETED|Injection Phase (IP)-Day 1[IP] to Week 4||0||
48108873|NCT04371380|100594371|FG001|NOT COMPLETED|Injection Phase (IP)-Day 1[IP] to Week 4||0||
48108874|NCT04371380|100594372|FG002|NOT COMPLETED|Injection Phase (IP)-Day 1[IP] to Week 4||0||
48108875|NCT04371380|100594370|FG000|STARTED|Follow-up Phase (Week 4 to Week 52)||0||
48108876|NCT04371380|100594371|FG001|STARTED|Follow-up Phase (Week 4 to Week 52)||0||
48108877|NCT04371380|100594372|FG002|STARTED|Follow-up Phase (Week 4 to Week 52)||14||
48108878|NCT04371380|100594370|FG000|COMPLETED|Follow-up Phase (Week 4 to Week 52)||0||
48108879|NCT04371380|100594371|FG001|COMPLETED|Follow-up Phase (Week 4 to Week 52)||0||
48108880|NCT04371380|100594372|FG002|COMPLETED|Follow-up Phase (Week 4 to Week 52)||14||
48108881|NCT04371380|100594370|FG000|NOT COMPLETED|Follow-up Phase (Week 4 to Week 52)||0||
48108882|NCT04371380|100594371|FG001|NOT COMPLETED|Follow-up Phase (Week 4 to Week 52)||0||
48108883|NCT04371380|100594372|FG002|NOT COMPLETED|Follow-up Phase (Week 4 to Week 52)||0||
48108884|NCT01431703|100594373|FG000|STARTED|Overall Study||326||
48108885|NCT01431703|100594373|FG000|COMPLETED|Overall Study||326||
48108886|NCT01431703|100594373|FG000|NOT COMPLETED|Overall Study||0||
48108887|NCT02679911|100594374|FG000|STARTED|Overall Study||20|This is an intraindividual study so only 20 subjecst are included in total|
48108888|NCT02679911|100594374|FG000|COMPLETED|Overall Study||20||
48108889|NCT02679911|100594374|FG000|NOT COMPLETED|Overall Study||0||
48108890|NCT00259090|100594375|FG000|STARTED|Overall Study||35||
48108891|NCT00259090|100594376|FG001|STARTED|Overall Study||31||
48108892|NCT00259090|100594377|FG002|STARTED|Overall Study||37||
48108893|NCT00259090|100594375|FG000|COMPLETED|Overall Study||35||
48108894|NCT00259090|100594376|FG001|COMPLETED|Overall Study||31||
48108895|NCT00259090|100594377|FG002|COMPLETED|Overall Study||37||
48108896|NCT00259090|100594375|FG000|NOT COMPLETED|Overall Study||0||
48108897|NCT00259090|100594376|FG001|NOT COMPLETED|Overall Study||0||
48108898|NCT00259090|100594377|FG002|NOT COMPLETED|Overall Study||0||
48108899|NCT04043312|100594378|FG000|STARTED|Overall Study||12||
48108900|NCT04043312|100594379|FG001|STARTED|Overall Study||14||
48108901|NCT04043312|100594378|FG000|COMPLETED|Overall Study||12||
48108902|NCT04043312|100594379|FG001|COMPLETED|Overall Study||14||
48108903|NCT04043312|100594378|FG000|NOT COMPLETED|Overall Study||0||
48108904|NCT04043312|100594379|FG001|NOT COMPLETED|Overall Study||0||
48108905|NCT01275066|100594380|FG000|STARTED|Overall Study||60||
48270766|NCT02271984|100984864|FG004|COMPLETED|Washout Period 2 (7 Days)||3||
48108906|NCT01275066|100594381|FG001|STARTED|Overall Study||59||
48108907|NCT01275066|100594382|FG002|STARTED|Overall Study||58||
48108908|NCT01275066|100594380|FG000|Treated|Overall Study||59||
48108909|NCT01275066|100594381|FG001|Treated|Overall Study||59||
48108910|NCT01275066|100594382|FG002|Treated|Overall Study||58||
48108911|NCT01275066|100594380|FG000|COMPLETED|Overall Study||59||
48108912|NCT01275066|100594381|FG001|COMPLETED|Overall Study||59||
48108913|NCT01275066|100594382|FG002|COMPLETED|Overall Study||57||
48108914|NCT01275066|100594380|FG000|NOT COMPLETED|Overall Study||1||
48108915|NCT01275066|100594381|FG001|NOT COMPLETED|Overall Study||0||
48108916|NCT01275066|100594382|FG002|NOT COMPLETED|Overall Study||1||
48108917|NCT01572038|100594383|FG000|STARTED|Overall Study||1436|Intent-to-Treat (ITT) Population|
48108918|NCT01572038|100594383|FG000|Received at Least One Dose of Study Drug|Overall Study||1436|Safety Population|
48108919|NCT01572038|100594383|FG000|COMPLETED|Overall Study||445||
48108920|NCT01572038|100594383|FG000|NOT COMPLETED|Overall Study||991||
48108921|NCT00262067|100594384|FG000|STARTED|Overall Study||415||
48108922|NCT00262067|100594385|FG001|STARTED|Overall Study||207||
48108923|NCT00262067|100594386|FG002|STARTED|Overall Study||409||
48108924|NCT00262067|100594387|FG003|STARTED|Overall Study||206||
48108925|NCT00262067|100594384|FG000|COMPLETED|Overall Study||196||
48108926|NCT00262067|100594385|FG001|COMPLETED|Overall Study||107||
48108927|NCT00262067|100594386|FG002|COMPLETED|Overall Study||193||
48108928|NCT00262067|100594387|FG003|COMPLETED|Overall Study||93||
48108929|NCT00262067|100594384|FG000|NOT COMPLETED|Overall Study||219||
48108930|NCT00262067|100594385|FG001|NOT COMPLETED|Overall Study||100||
48108931|NCT00262067|100594386|FG002|NOT COMPLETED|Overall Study||216||
48108932|NCT00262067|100594387|FG003|NOT COMPLETED|Overall Study||113||
48108933|NCT01161329|100594388|FG000|STARTED|Overall Study||33||
48108934|NCT01161329|100594389|FG001|STARTED|Overall Study||34||
48108935|NCT01161329|100594388|FG000|COMPLETED|Overall Study||29||
48108936|NCT01161329|100594389|FG001|COMPLETED|Overall Study||24||
48108937|NCT01161329|100594388|FG000|NOT COMPLETED|Overall Study||4||
48270767|NCT02271984|100984865|FG005|COMPLETED|Washout Period 2 (7 Days)||3||
48108938|NCT01161329|100594389|FG001|NOT COMPLETED|Overall Study||10||
48108939|NCT03925727|100594390|FG000|STARTED|Overall Study||263||
48108940|NCT03925727|100594391|FG001|STARTED|Overall Study||100||
48108941|NCT03925727|100594392|FG002|STARTED|Overall Study||260||
48108942|NCT03925727|100594390|FG000|COMPLETED|Overall Study||244||
48108943|NCT03925727|100594391|FG001|COMPLETED|Overall Study||94||
48108944|NCT03925727|100594392|FG002|COMPLETED|Overall Study||242||
48108945|NCT03925727|100594390|FG000|NOT COMPLETED|Overall Study||19||
48108946|NCT03925727|100594391|FG001|NOT COMPLETED|Overall Study||6||
48108947|NCT03925727|100594392|FG002|NOT COMPLETED|Overall Study||18||
48108948|NCT00834912|100594393|FG000|STARTED|Treatment Period 1||6||
48108949|NCT00834912|100594394|FG001|STARTED|Treatment Period 1||6||
48108950|NCT00834912|100594395|FG002|STARTED|Treatment Period 1||6||
48108951|NCT00834912|100594396|FG003|STARTED|Treatment Period 1||6||
48108952|NCT00834912|100594397|FG004|STARTED|Treatment Period 1||6||
48108953|NCT00834912|100594398|FG005|STARTED|Treatment Period 1||6||
48108954|NCT00834912|100594393|FG000|COMPLETED|Treatment Period 1||6||
48108955|NCT00834912|100594394|FG001|COMPLETED|Treatment Period 1||5||
48108956|NCT00834912|100594395|FG002|COMPLETED|Treatment Period 1||6||
48108957|NCT00834912|100594396|FG003|COMPLETED|Treatment Period 1||5||
48108958|NCT00834912|100594397|FG004|COMPLETED|Treatment Period 1||6||
48108959|NCT00834912|100594398|FG005|COMPLETED|Treatment Period 1||6||
48108960|NCT00834912|100594393|FG000|NOT COMPLETED|Treatment Period 1||0||
48108961|NCT00834912|100594394|FG001|NOT COMPLETED|Treatment Period 1||1||
48108962|NCT00834912|100594395|FG002|NOT COMPLETED|Treatment Period 1||0||
48108963|NCT00834912|100594396|FG003|NOT COMPLETED|Treatment Period 1||1||
48108964|NCT00834912|100594397|FG004|NOT COMPLETED|Treatment Period 1||0||
48108965|NCT00834912|100594398|FG005|NOT COMPLETED|Treatment Period 1||0||
48270768|NCT02271984|100984866|FG006|COMPLETED|Washout Period 2 (7 Days)||3||
48270769|NCT02271984|100984867|FG007|COMPLETED|Washout Period 2 (7 Days)||3||
48270770|NCT02271984|100984868|FG008|COMPLETED|Washout Period 2 (7 Days)||3||
48270771|NCT02271984|100984869|FG009|COMPLETED|Washout Period 2 (7 Days)||3||
48270772|NCT02271984|100984870|FG010|COMPLETED|Washout Period 2 (7 Days)||3||
48693428|NCT00814580|102032775|FG001|COMPLETED|Overall Study||141||
48693429|NCT00814580|102032774|FG000|NOT COMPLETED|Overall Study||31||
48693430|NCT00814580|102032775|FG001|NOT COMPLETED|Overall Study||47||
48693431|NCT01532921|102032776|FG000|STARTED|Overall Study||85|Enrolled and consented subjects|
48693432|NCT01532921|102032776|FG000|Implantation Procedure|Overall Study||76|Subjects with study device implanted|
48693433|NCT01532921|102032776|FG000|Discharge|Overall Study||75||
48693434|NCT01532921|102032776|FG000|6 Months Follow Up|Overall Study||68||
48693435|NCT01532921|102032776|FG000|COMPLETED|Overall Study||69||
48693436|NCT01532921|102032776|FG000|NOT COMPLETED|Overall Study||16||
48693437|NCT00778336|102032777|FG000|STARTED|Index Procedure-Discharge||198||
48693438|NCT00778336|102032778|FG001|STARTED|Index Procedure-Discharge||170||
48108966|NCT00834912|100594393|FG000|STARTED|Treatment Period 2||6||
48108967|NCT00834912|100594394|FG001|STARTED|Treatment Period 2||5||
48693439|NCT00778336|102032779|FG002|STARTED|Index Procedure-Discharge||72||
48693440|NCT00778336|102032780|FG003|STARTED|Index Procedure-Discharge||12||
48693441|NCT00778336|102032777|FG000|COMPLETED|Index Procedure-Discharge||192||
48108968|NCT00834912|100594395|FG002|STARTED|Treatment Period 2||6||
48108969|NCT00834912|100594396|FG003|STARTED|Treatment Period 2||5||
48108970|NCT00834912|100594397|FG004|STARTED|Treatment Period 2||6||
48108971|NCT00834912|100594398|FG005|STARTED|Treatment Period 2||6||
48108972|NCT00834912|100594393|FG000|COMPLETED|Treatment Period 2||6||
48108973|NCT00834912|100594394|FG001|COMPLETED|Treatment Period 2||5||
48108974|NCT00834912|100594395|FG002|COMPLETED|Treatment Period 2||5||
48108975|NCT00834912|100594396|FG003|COMPLETED|Treatment Period 2||5||
48108976|NCT00834912|100594397|FG004|COMPLETED|Treatment Period 2||5||
48693442|NCT00778336|102032778|FG001|COMPLETED|Index Procedure-Discharge||167||
48693443|NCT00778336|102032779|FG002|COMPLETED|Index Procedure-Discharge||70||
48693444|NCT00778336|102032780|FG003|COMPLETED|Index Procedure-Discharge||12||
48693445|NCT00778336|102032777|FG000|NOT COMPLETED|Index Procedure-Discharge||6||
48693446|NCT00778336|102032778|FG001|NOT COMPLETED|Index Procedure-Discharge||3||
48693447|NCT00778336|102032779|FG002|NOT COMPLETED|Index Procedure-Discharge||2||
48693448|NCT00778336|102032780|FG003|NOT COMPLETED|Index Procedure-Discharge||0||
48693449|NCT00778336|102032777|FG000|STARTED|3 Month Follow Up||192||
48693450|NCT00778336|102032778|FG001|STARTED|3 Month Follow Up||167||
48108977|NCT00834912|100594398|FG005|COMPLETED|Treatment Period 2||6||
48108978|NCT00834912|100594393|FG000|NOT COMPLETED|Treatment Period 2||0||
48108979|NCT00834912|100594394|FG001|NOT COMPLETED|Treatment Period 2||0||
48108980|NCT00834912|100594395|FG002|NOT COMPLETED|Treatment Period 2||1||
48108981|NCT00834912|100594396|FG003|NOT COMPLETED|Treatment Period 2||0||
48108982|NCT00834912|100594397|FG004|NOT COMPLETED|Treatment Period 2||1||
48108983|NCT00834912|100594398|FG005|NOT COMPLETED|Treatment Period 2||0||
48108984|NCT00834912|100594393|FG000|STARTED|Treatment Period 3||6||
48108985|NCT00834912|100594394|FG001|STARTED|Treatment Period 3||5||
48108986|NCT00834912|100594395|FG002|STARTED|Treatment Period 3||5||
48108987|NCT00834912|100594396|FG003|STARTED|Treatment Period 3||5||
48108988|NCT00834912|100594397|FG004|STARTED|Treatment Period 3||5||
48108989|NCT00834912|100594398|FG005|STARTED|Treatment Period 3||6||
48108990|NCT00834912|100594393|FG000|COMPLETED|Treatment Period 3||6||
48108991|NCT00834912|100594394|FG001|COMPLETED|Treatment Period 3||5||
48108992|NCT00834912|100594395|FG002|COMPLETED|Treatment Period 3||5||
48108993|NCT00834912|100594396|FG003|COMPLETED|Treatment Period 3||5||
48108994|NCT00834912|100594397|FG004|COMPLETED|Treatment Period 3||5||
48108995|NCT00834912|100594398|FG005|COMPLETED|Treatment Period 3||6||
48108996|NCT00834912|100594393|FG000|NOT COMPLETED|Treatment Period 3||0||
48108997|NCT00834912|100594394|FG001|NOT COMPLETED|Treatment Period 3||0||
48108998|NCT00834912|100594395|FG002|NOT COMPLETED|Treatment Period 3||0||
48108999|NCT00834912|100594396|FG003|NOT COMPLETED|Treatment Period 3||0||
48109000|NCT00834912|100594397|FG004|NOT COMPLETED|Treatment Period 3||0||
48109001|NCT00834912|100594398|FG005|NOT COMPLETED|Treatment Period 3||0||
48109002|NCT03616912|100594399|FG000|STARTED|Overall Study||257||
48109003|NCT03616912|100594400|FG001|STARTED|Overall Study||258||
48109004|NCT03616912|100594401|FG002|STARTED|Overall Study||254||
48109005|NCT03616912|100594402|FG003|STARTED|Overall Study||21||
48109006|NCT03616912|100594403|FG004|STARTED|Overall Study||20||
48109007|NCT03616912|100594404|FG005|STARTED|Overall Study||20||
48109008|NCT03616912|100594399|FG000|Received at Least One Dose of Study Drug|Overall Study||257||
48109009|NCT03616912|100594400|FG001|Received at Least One Dose of Study Drug|Overall Study||256||
48109010|NCT03616912|100594401|FG002|Received at Least One Dose of Study Drug|Overall Study||254||
48109011|NCT03616912|100594402|FG003|Received at Least One Dose of Study Drug|Overall Study||21||
48109012|NCT03616912|100594403|FG004|Received at Least One Dose of Study Drug|Overall Study||20||
48109013|NCT03616912|100594404|FG005|Received at Least One Dose of Study Drug|Overall Study||20||
48109014|NCT03616912|100594399|FG000|Excluded Due to Site Misconduct|Overall Study||4||
48109015|NCT03616912|100594400|FG001|Excluded Due to Site Misconduct|Overall Study||1||
48109016|NCT03616912|100594401|FG002|Excluded Due to Site Misconduct|Overall Study||2||
48109017|NCT03616912|100594402|FG003|Excluded Due to Site Misconduct|Overall Study||0||
48109018|NCT03616912|100594403|FG004|Excluded Due to Site Misconduct|Overall Study||0||
48109019|NCT03616912|100594404|FG005|Excluded Due to Site Misconduct|Overall Study||0||
48109020|NCT03616912|100594399|FG000|COMPLETED|Overall Study||204||
48109021|NCT03616912|100594400|FG001|COMPLETED|Overall Study||211||
48109022|NCT03616912|100594401|FG002|COMPLETED|Overall Study||208||
48109023|NCT03616912|100594402|FG003|COMPLETED|Overall Study||5||
48109024|NCT03616912|100594403|FG004|COMPLETED|Overall Study||5||
48109025|NCT03616912|100594404|FG005|COMPLETED|Overall Study||6||
48109026|NCT03616912|100594399|FG000|NOT COMPLETED|Overall Study||53||
48109027|NCT03616912|100594400|FG001|NOT COMPLETED|Overall Study||47||
48109028|NCT03616912|100594401|FG002|NOT COMPLETED|Overall Study||46||
48109029|NCT03616912|100594402|FG003|NOT COMPLETED|Overall Study||16||
48109030|NCT03616912|100594403|FG004|NOT COMPLETED|Overall Study||15||
48109031|NCT03616912|100594404|FG005|NOT COMPLETED|Overall Study||14||
48109032|NCT01802775|100594405|FG000|STARTED|Overall Study||102||
48109033|NCT01802775|100594406|FG001|STARTED|Overall Study||101||
48109034|NCT01802775|100594405|FG000|Received Drug (Safety Analysis Set)|Overall Study||101||
48109035|NCT01802775|100594406|FG001|Received Drug (Safety Analysis Set)|Overall Study||100||
48109036|NCT01802775|100594405|FG000|COMPLETED|Overall Study||96||
48109037|NCT01802775|100594406|FG001|COMPLETED|Overall Study||89||
48109038|NCT01802775|100594405|FG000|NOT COMPLETED|Overall Study||6||
48109039|NCT01802775|100594406|FG001|NOT COMPLETED|Overall Study||12||
48109040|NCT02214277|100594407|FG000|STARTED|Overall Study||123||
48109041|NCT02214277|100594408|FG001|STARTED|Overall Study||121||
48109042|NCT02214277|100594409|FG002|STARTED|Overall Study||119||
48109043|NCT02214277|100594407|FG000|COMPLETED|Overall Study||104||
48109044|NCT02214277|100594408|FG001|COMPLETED|Overall Study||96||
48109045|NCT02214277|100594409|FG002|COMPLETED|Overall Study||85||
48109046|NCT02214277|100594407|FG000|NOT COMPLETED|Overall Study||19||
48109047|NCT02214277|100594408|FG001|NOT COMPLETED|Overall Study||25||
48109048|NCT02214277|100594409|FG002|NOT COMPLETED|Overall Study||34||
48109049|NCT00994448|100594410|FG000|STARTED|Overall Study||12||
48109050|NCT00994448|100594411|FG001|STARTED|Overall Study||7||
48109051|NCT00994448|100594410|FG000|COMPLETED|Overall Study||4||
48109052|NCT00994448|100594411|FG001|COMPLETED|Overall Study||5||
48109053|NCT00994448|100594410|FG000|NOT COMPLETED|Overall Study||8||
48109054|NCT00994448|100594411|FG001|NOT COMPLETED|Overall Study||2||
48109055|NCT03661814|100594412|FG000|STARTED|Overall Study||2||
48109056|NCT03661814|100594413|FG001|STARTED|Overall Study||5||
48109057|NCT03661814|100594412|FG000|COMPLETED|Overall Study||2||
48270773|NCT02271984|100984871|FG011|COMPLETED|Washout Period 2 (7 Days)||3||
48270774|NCT02271984|100984860|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48270775|NCT02271984|100984861|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48270776|NCT02271984|100984862|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48270777|NCT02271984|100984863|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48270778|NCT02271984|100984864|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48270779|NCT02271984|100984865|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48270780|NCT02271984|100984866|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48270781|NCT02271984|100984867|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48270782|NCT02271984|100984868|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48270783|NCT02271984|100984869|FG009|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48270784|NCT02271984|100984870|FG010|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48270785|NCT02271984|100984871|FG011|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48270786|NCT02271984|100984860|FG000|STARTED|Third Intervention Period (1 Day)||3||
48270787|NCT02271984|100984861|FG001|STARTED|Third Intervention Period (1 Day)||3||
48270788|NCT02271984|100984862|FG002|STARTED|Third Intervention Period (1 Day)||3||
48270789|NCT02271984|100984863|FG003|STARTED|Third Intervention Period (1 Day)||3||
48270790|NCT02271984|100984864|FG004|STARTED|Third Intervention Period (1 Day)||3||
48270791|NCT02271984|100984865|FG005|STARTED|Third Intervention Period (1 Day)||3||
48270792|NCT02271984|100984866|FG006|STARTED|Third Intervention Period (1 Day)||3||
48270793|NCT02271984|100984867|FG007|STARTED|Third Intervention Period (1 Day)||3||
48270794|NCT02271984|100984868|FG008|STARTED|Third Intervention Period (1 Day)||3||
48270795|NCT02271984|100984869|FG009|STARTED|Third Intervention Period (1 Day)||3||
48270796|NCT02271984|100984870|FG010|STARTED|Third Intervention Period (1 Day)||3||
48270797|NCT02271984|100984871|FG011|STARTED|Third Intervention Period (1 Day)||3||
48270798|NCT02271984|100984860|FG000|COMPLETED|Third Intervention Period (1 Day)||3||
48270799|NCT02271984|100984861|FG001|COMPLETED|Third Intervention Period (1 Day)||3||
48270800|NCT02271984|100984862|FG002|COMPLETED|Third Intervention Period (1 Day)||3||
48270801|NCT02271984|100984863|FG003|COMPLETED|Third Intervention Period (1 Day)||3||
48270802|NCT02271984|100984864|FG004|COMPLETED|Third Intervention Period (1 Day)||3||
48270803|NCT02271984|100984865|FG005|COMPLETED|Third Intervention Period (1 Day)||3||
48270804|NCT02271984|100984866|FG006|COMPLETED|Third Intervention Period (1 Day)||3||
48270805|NCT02271984|100984867|FG007|COMPLETED|Third Intervention Period (1 Day)||3||
48270806|NCT02271984|100984868|FG008|COMPLETED|Third Intervention Period (1 Day)||3||
48270807|NCT02271984|100984869|FG009|COMPLETED|Third Intervention Period (1 Day)||3||
48270808|NCT02271984|100984870|FG010|COMPLETED|Third Intervention Period (1 Day)||3||
48270809|NCT02271984|100984871|FG011|COMPLETED|Third Intervention Period (1 Day)||3||
48270810|NCT02271984|100984860|FG000|NOT COMPLETED|Third Intervention Period (1 Day)||0||
48270811|NCT02271984|100984861|FG001|NOT COMPLETED|Third Intervention Period (1 Day)||0||
48270812|NCT02271984|100984862|FG002|NOT COMPLETED|Third Intervention Period (1 Day)||0||
48270813|NCT02271984|100984863|FG003|NOT COMPLETED|Third Intervention Period (1 Day)||0||
48270814|NCT02271984|100984864|FG004|NOT COMPLETED|Third Intervention Period (1 Day)||0||
48270815|NCT02271984|100984865|FG005|NOT COMPLETED|Third Intervention Period (1 Day)||0||
48270816|NCT02271984|100984866|FG006|NOT COMPLETED|Third Intervention Period (1 Day)||0||
48270817|NCT02271984|100984867|FG007|NOT COMPLETED|Third Intervention Period (1 Day)||0||
48270818|NCT02271984|100984868|FG008|NOT COMPLETED|Third Intervention Period (1 Day)||0||
48270819|NCT02271984|100984869|FG009|NOT COMPLETED|Third Intervention Period (1 Day)||0||
48270820|NCT02271984|100984870|FG010|NOT COMPLETED|Third Intervention Period (1 Day)||0||
48270821|NCT02271984|100984871|FG011|NOT COMPLETED|Third Intervention Period (1 Day)||0||
48270822|NCT02271984|100984860|FG000|STARTED|Washout Period 3 (7 Days)||3||
48270823|NCT02271984|100984861|FG001|STARTED|Washout Period 3 (7 Days)||3||
48270824|NCT02271984|100984862|FG002|STARTED|Washout Period 3 (7 Days)||3||
48270825|NCT02271984|100984863|FG003|STARTED|Washout Period 3 (7 Days)||3||
48270826|NCT02271984|100984864|FG004|STARTED|Washout Period 3 (7 Days)||3||
48270827|NCT02271984|100984865|FG005|STARTED|Washout Period 3 (7 Days)||3||
48270828|NCT02271984|100984866|FG006|STARTED|Washout Period 3 (7 Days)||3||
48270829|NCT02271984|100984867|FG007|STARTED|Washout Period 3 (7 Days)||3||
48270830|NCT02271984|100984868|FG008|STARTED|Washout Period 3 (7 Days)||3||
48270831|NCT02271984|100984869|FG009|STARTED|Washout Period 3 (7 Days)||3||
48270832|NCT02271984|100984870|FG010|STARTED|Washout Period 3 (7 Days)||3||
48270833|NCT02271984|100984871|FG011|STARTED|Washout Period 3 (7 Days)||3||
48270834|NCT02271984|100984860|FG000|COMPLETED|Washout Period 3 (7 Days)||3||
48270835|NCT02271984|100984861|FG001|COMPLETED|Washout Period 3 (7 Days)||3||
48270836|NCT02271984|100984862|FG002|COMPLETED|Washout Period 3 (7 Days)||3||
48270837|NCT02271984|100984863|FG003|COMPLETED|Washout Period 3 (7 Days)||3||
48270838|NCT02271984|100984864|FG004|COMPLETED|Washout Period 3 (7 Days)||3||
48270839|NCT02271984|100984865|FG005|COMPLETED|Washout Period 3 (7 Days)||3||
48270840|NCT02271984|100984866|FG006|COMPLETED|Washout Period 3 (7 Days)||3||
48270841|NCT02271984|100984867|FG007|COMPLETED|Washout Period 3 (7 Days)||3||
48270842|NCT02271984|100984868|FG008|COMPLETED|Washout Period 3 (7 Days)||3||
48270843|NCT02271984|100984869|FG009|COMPLETED|Washout Period 3 (7 Days)||3||
48270844|NCT02271984|100984870|FG010|COMPLETED|Washout Period 3 (7 Days)||3||
48392485|NCT02790463|101287881|FG001|NOT COMPLETED|Overall Study||309||
48270845|NCT02271984|100984871|FG011|COMPLETED|Washout Period 3 (7 Days)||3||
48270846|NCT02271984|100984860|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48270847|NCT02271984|100984861|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48270848|NCT02271984|100984862|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48270849|NCT02271984|100984863|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48270850|NCT02271984|100984864|FG004|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48270851|NCT02271984|100984865|FG005|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48270852|NCT02271984|100984866|FG006|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48270853|NCT02271984|100984867|FG007|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48270854|NCT02271984|100984868|FG008|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48270855|NCT02271984|100984869|FG009|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48270856|NCT02271984|100984870|FG010|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48270857|NCT02271984|100984871|FG011|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48270858|NCT02271984|100984860|FG000|STARTED|Fourth Intervention Period (Day 1)||3||
48270859|NCT02271984|100984861|FG001|STARTED|Fourth Intervention Period (Day 1)||3||
48270860|NCT02271984|100984862|FG002|STARTED|Fourth Intervention Period (Day 1)||3||
48270861|NCT02271984|100984863|FG003|STARTED|Fourth Intervention Period (Day 1)||3||
48270862|NCT02271984|100984864|FG004|STARTED|Fourth Intervention Period (Day 1)||3||
48270863|NCT02271984|100984865|FG005|STARTED|Fourth Intervention Period (Day 1)||3||
48270864|NCT02271984|100984866|FG006|STARTED|Fourth Intervention Period (Day 1)||3||
48270865|NCT02271984|100984867|FG007|STARTED|Fourth Intervention Period (Day 1)||3||
48270866|NCT02271984|100984868|FG008|STARTED|Fourth Intervention Period (Day 1)||3||
48270867|NCT02271984|100984869|FG009|STARTED|Fourth Intervention Period (Day 1)||3||
48270868|NCT02271984|100984870|FG010|STARTED|Fourth Intervention Period (Day 1)||3||
48270869|NCT02271984|100984871|FG011|STARTED|Fourth Intervention Period (Day 1)||3||
48270870|NCT02271984|100984860|FG000|COMPLETED|Fourth Intervention Period (Day 1)||3||
48270871|NCT02271984|100984861|FG001|COMPLETED|Fourth Intervention Period (Day 1)||3||
48270872|NCT02271984|100984862|FG002|COMPLETED|Fourth Intervention Period (Day 1)||3||
48270873|NCT02271984|100984863|FG003|COMPLETED|Fourth Intervention Period (Day 1)||3||
48270874|NCT02271984|100984864|FG004|COMPLETED|Fourth Intervention Period (Day 1)||3||
48270875|NCT02271984|100984865|FG005|COMPLETED|Fourth Intervention Period (Day 1)||3||
48270876|NCT02271984|100984866|FG006|COMPLETED|Fourth Intervention Period (Day 1)||3||
48270877|NCT02271984|100984867|FG007|COMPLETED|Fourth Intervention Period (Day 1)||3||
48270878|NCT02271984|100984868|FG008|COMPLETED|Fourth Intervention Period (Day 1)||3||
48270879|NCT02271984|100984869|FG009|COMPLETED|Fourth Intervention Period (Day 1)||3||
48270880|NCT02271984|100984870|FG010|COMPLETED|Fourth Intervention Period (Day 1)||3||
48270881|NCT02271984|100984871|FG011|COMPLETED|Fourth Intervention Period (Day 1)||3||
48270882|NCT02271984|100984860|FG000|NOT COMPLETED|Fourth Intervention Period (Day 1)||0||
48270883|NCT02271984|100984861|FG001|NOT COMPLETED|Fourth Intervention Period (Day 1)||0||
48270884|NCT02271984|100984862|FG002|NOT COMPLETED|Fourth Intervention Period (Day 1)||0||
48270885|NCT02271984|100984863|FG003|NOT COMPLETED|Fourth Intervention Period (Day 1)||0||
48270886|NCT02271984|100984864|FG004|NOT COMPLETED|Fourth Intervention Period (Day 1)||0||
48270887|NCT02271984|100984865|FG005|NOT COMPLETED|Fourth Intervention Period (Day 1)||0||
48270888|NCT02271984|100984866|FG006|NOT COMPLETED|Fourth Intervention Period (Day 1)||0||
48270889|NCT02271984|100984867|FG007|NOT COMPLETED|Fourth Intervention Period (Day 1)||0||
48270890|NCT02271984|100984868|FG008|NOT COMPLETED|Fourth Intervention Period (Day 1)||0||
48270891|NCT02271984|100984869|FG009|NOT COMPLETED|Fourth Intervention Period (Day 1)||0||
48270892|NCT02271984|100984870|FG010|NOT COMPLETED|Fourth Intervention Period (Day 1)||0||
48270893|NCT02271984|100984871|FG011|NOT COMPLETED|Fourth Intervention Period (Day 1)||0||
48270894|NCT02271984|100984860|FG000|STARTED|Washout Period 4 (7 Days)||3||
48270895|NCT02271984|100984861|FG001|STARTED|Washout Period 4 (7 Days)||3||
48270896|NCT02271984|100984862|FG002|STARTED|Washout Period 4 (7 Days)||3||
48270897|NCT02271984|100984863|FG003|STARTED|Washout Period 4 (7 Days)||3||
48270898|NCT02271984|100984864|FG004|STARTED|Washout Period 4 (7 Days)||3||
48270899|NCT02271984|100984865|FG005|STARTED|Washout Period 4 (7 Days)||3||
48270900|NCT02271984|100984866|FG006|STARTED|Washout Period 4 (7 Days)||3||
48270901|NCT02271984|100984867|FG007|STARTED|Washout Period 4 (7 Days)||3||
48270902|NCT02271984|100984868|FG008|STARTED|Washout Period 4 (7 Days)||3||
48270903|NCT02271984|100984869|FG009|STARTED|Washout Period 4 (7 Days)||3||
48270904|NCT02271984|100984870|FG010|STARTED|Washout Period 4 (7 Days)||3||
48270905|NCT02271984|100984871|FG011|STARTED|Washout Period 4 (7 Days)||3||
48270906|NCT02271984|100984860|FG000|COMPLETED|Washout Period 4 (7 Days)||3||
48270907|NCT02271984|100984861|FG001|COMPLETED|Washout Period 4 (7 Days)||3||
48270908|NCT02271984|100984862|FG002|COMPLETED|Washout Period 4 (7 Days)||3||
48270909|NCT02271984|100984863|FG003|COMPLETED|Washout Period 4 (7 Days)||3||
48270910|NCT02271984|100984864|FG004|COMPLETED|Washout Period 4 (7 Days)||3||
48270911|NCT02271984|100984865|FG005|COMPLETED|Washout Period 4 (7 Days)||2||
48270912|NCT02271984|100984866|FG006|COMPLETED|Washout Period 4 (7 Days)||3||
48270913|NCT02271984|100984867|FG007|COMPLETED|Washout Period 4 (7 Days)||2||
48270914|NCT02271984|100984868|FG008|COMPLETED|Washout Period 4 (7 Days)||3||
48270915|NCT02271984|100984869|FG009|COMPLETED|Washout Period 4 (7 Days)||3||
48270916|NCT02271984|100984870|FG010|COMPLETED|Washout Period 4 (7 Days)||3||
48270917|NCT02271984|100984871|FG011|COMPLETED|Washout Period 4 (7 Days)||3||
48270918|NCT02271984|100984860|FG000|NOT COMPLETED|Washout Period 4 (7 Days)||0||
48270919|NCT02271984|100984861|FG001|NOT COMPLETED|Washout Period 4 (7 Days)||0||
48270920|NCT02271984|100984862|FG002|NOT COMPLETED|Washout Period 4 (7 Days)||0||
48270921|NCT02271984|100984863|FG003|NOT COMPLETED|Washout Period 4 (7 Days)||0||
48270922|NCT02271984|100984864|FG004|NOT COMPLETED|Washout Period 4 (7 Days)||0||
48270923|NCT02271984|100984865|FG005|NOT COMPLETED|Washout Period 4 (7 Days)||1||
48270924|NCT02271984|100984866|FG006|NOT COMPLETED|Washout Period 4 (7 Days)||0||
48270925|NCT02271984|100984867|FG007|NOT COMPLETED|Washout Period 4 (7 Days)||1||
48270926|NCT02271984|100984868|FG008|NOT COMPLETED|Washout Period 4 (7 Days)||0||
48270927|NCT02271984|100984869|FG009|NOT COMPLETED|Washout Period 4 (7 Days)||0||
48270928|NCT02271984|100984870|FG010|NOT COMPLETED|Washout Period 4 (7 Days)||0||
48270929|NCT02271984|100984871|FG011|NOT COMPLETED|Washout Period 4 (7 Days)||0||
48270930|NCT02271984|100984860|FG000|STARTED|Fifth Intervention Period (1 Day)||3||
48270931|NCT02271984|100984861|FG001|STARTED|Fifth Intervention Period (1 Day)||3||
48270932|NCT02271984|100984862|FG002|STARTED|Fifth Intervention Period (1 Day)||3||
48270933|NCT02271984|100984863|FG003|STARTED|Fifth Intervention Period (1 Day)||3||
48270934|NCT02271984|100984864|FG004|STARTED|Fifth Intervention Period (1 Day)||3||
48270935|NCT02271984|100984865|FG005|STARTED|Fifth Intervention Period (1 Day)||2||
48270936|NCT02271984|100984866|FG006|STARTED|Fifth Intervention Period (1 Day)||3||
48270937|NCT02271984|100984867|FG007|STARTED|Fifth Intervention Period (1 Day)||2||
48270938|NCT02271984|100984868|FG008|STARTED|Fifth Intervention Period (1 Day)||3||
48270939|NCT02271984|100984869|FG009|STARTED|Fifth Intervention Period (1 Day)||3||
48270940|NCT02271984|100984870|FG010|STARTED|Fifth Intervention Period (1 Day)||3||
48270941|NCT02271984|100984871|FG011|STARTED|Fifth Intervention Period (1 Day)||3||
48270942|NCT02271984|100984860|FG000|COMPLETED|Fifth Intervention Period (1 Day)||3||
48270943|NCT02271984|100984861|FG001|COMPLETED|Fifth Intervention Period (1 Day)||3||
48270944|NCT02271984|100984862|FG002|COMPLETED|Fifth Intervention Period (1 Day)||3||
48270945|NCT02271984|100984863|FG003|COMPLETED|Fifth Intervention Period (1 Day)||3||
48270946|NCT02271984|100984864|FG004|COMPLETED|Fifth Intervention Period (1 Day)||3||
48270947|NCT02271984|100984865|FG005|COMPLETED|Fifth Intervention Period (1 Day)||2||
48270948|NCT02271984|100984866|FG006|COMPLETED|Fifth Intervention Period (1 Day)||3||
48270949|NCT02271984|100984867|FG007|COMPLETED|Fifth Intervention Period (1 Day)||2||
48270950|NCT02271984|100984868|FG008|COMPLETED|Fifth Intervention Period (1 Day)||3||
48270951|NCT02271984|100984869|FG009|COMPLETED|Fifth Intervention Period (1 Day)||3||
48270952|NCT02271984|100984870|FG010|COMPLETED|Fifth Intervention Period (1 Day)||3||
48270953|NCT02271984|100984871|FG011|COMPLETED|Fifth Intervention Period (1 Day)||3||
48270954|NCT02271984|100984860|FG000|NOT COMPLETED|Fifth Intervention Period (1 Day)||0||
48270955|NCT02271984|100984861|FG001|NOT COMPLETED|Fifth Intervention Period (1 Day)||0||
48270956|NCT02271984|100984862|FG002|NOT COMPLETED|Fifth Intervention Period (1 Day)||0||
48270957|NCT02271984|100984863|FG003|NOT COMPLETED|Fifth Intervention Period (1 Day)||0||
48270958|NCT02271984|100984864|FG004|NOT COMPLETED|Fifth Intervention Period (1 Day)||0||
48270959|NCT02271984|100984865|FG005|NOT COMPLETED|Fifth Intervention Period (1 Day)||0||
48270960|NCT02271984|100984866|FG006|NOT COMPLETED|Fifth Intervention Period (1 Day)||0||
48270961|NCT02271984|100984867|FG007|NOT COMPLETED|Fifth Intervention Period (1 Day)||0||
48270962|NCT02271984|100984868|FG008|NOT COMPLETED|Fifth Intervention Period (1 Day)||0||
48270963|NCT02271984|100984869|FG009|NOT COMPLETED|Fifth Intervention Period (1 Day)||0||
48270964|NCT02271984|100984870|FG010|NOT COMPLETED|Fifth Intervention Period (1 Day)||0||
48270965|NCT02271984|100984871|FG011|NOT COMPLETED|Fifth Intervention Period (1 Day)||0||
48270966|NCT04577001|100984872|FG000|STARTED|Overall Study||0||
48270967|NCT04577001|100984873|FG001|STARTED|Overall Study||1||
48270968|NCT04577001|100984872|FG000|COMPLETED|Overall Study||0||
48270969|NCT04577001|100984873|FG001|COMPLETED|Overall Study||0||
48270970|NCT04577001|100984872|FG000|NOT COMPLETED|Overall Study||0||
48270971|NCT04577001|100984873|FG001|NOT COMPLETED|Overall Study||1||
48270972|NCT00623805|100984874|FG000|STARTED|Overall Study||62||
48270973|NCT00623805|100984875|FG001|STARTED|Overall Study||61||
48270974|NCT00623805|100984874|FG000|COMPLETED|Overall Study||42||
48270975|NCT00623805|100984875|FG001|COMPLETED|Overall Study||39||
48270976|NCT00623805|100984874|FG000|NOT COMPLETED|Overall Study||20||
48270977|NCT00623805|100984875|FG001|NOT COMPLETED|Overall Study||22||
48270978|NCT01299480|100984876|FG000|STARTED|Overall Study||427||
48270979|NCT01299480|100984877|FG001|STARTED|Overall Study||430||
48270980|NCT01299480|100984878|FG002|STARTED|Overall Study||427||
48270981|NCT01299480|100984879|FG003|STARTED|Overall Study||286||
48270982|NCT01299480|100984880|FG004|STARTED|Overall Study||143||
48270983|NCT01299480|100984876|FG000|COMPLETED|Overall Study||385||
48270984|NCT01299480|100984877|FG001|COMPLETED|Overall Study||395||
48270985|NCT01299480|100984878|FG002|COMPLETED|Overall Study||386||
48270986|NCT01299480|100984879|FG003|COMPLETED|Overall Study||261||
48270987|NCT01299480|100984880|FG004|COMPLETED|Overall Study||123||
48270988|NCT01299480|100984876|FG000|NOT COMPLETED|Overall Study||42||
48270989|NCT01299480|100984877|FG001|NOT COMPLETED|Overall Study||35||
48270990|NCT01299480|100984878|FG002|NOT COMPLETED|Overall Study||41||
48270991|NCT01299480|100984879|FG003|NOT COMPLETED|Overall Study||25||
48270992|NCT01299480|100984880|FG004|NOT COMPLETED|Overall Study||20||
48270993|NCT00338962|100988298|FG000|STARTED|Overall Study||22||
48270994|NCT00338962|100988299|FG001|STARTED|Overall Study||20||
48270995|NCT00338962|100988300|FG002|STARTED|Overall Study||22||
48270996|NCT00338962|100988301|FG003|STARTED|Overall Study||24||
48270997|NCT00338962|100988298|FG000|COMPLETED|Overall Study||14||
48270998|NCT00338962|100988299|FG001|COMPLETED|Overall Study||16||
48270999|NCT00338962|100988300|FG002|COMPLETED|Overall Study||16||
48271000|NCT00338962|100988301|FG003|COMPLETED|Overall Study||21||
48271001|NCT00338962|100988298|FG000|NOT COMPLETED|Overall Study||8||
48271002|NCT00338962|100988299|FG001|NOT COMPLETED|Overall Study||4||
48271003|NCT00338962|100988300|FG002|NOT COMPLETED|Overall Study||6||
48271004|NCT00338962|100988301|FG003|NOT COMPLETED|Overall Study||3||
48271005|NCT02229851|100988302|FG000|STARTED|Main Phase (Double-blind Phase)||61||
48271006|NCT02229851|100988303|FG001|STARTED|Main Phase (Double-blind Phase)||119||
48271007|NCT02229851|100988304|FG002|STARTED|Main Phase (Double-blind Phase)||120||
48271008|NCT02229851|100988305|FG003|STARTED|Main Phase (Double-blind Phase)||0||
48271009|NCT02229851|100988306|FG004|STARTED|Main Phase (Double-blind Phase)||0||
48271010|NCT02229851|100988307|FG005|STARTED|Main Phase (Double-blind Phase)||0||
48271011|NCT02229851|100988308|FG006|STARTED|Main Phase (Double-blind Phase)||0||
48271012|NCT02229851|100988302|FG000|Full Analysis Set|Main Phase (Double-blind Phase)||61||
48271013|NCT02229851|100988303|FG001|Full Analysis Set|Main Phase (Double-blind Phase)||119||
48271014|NCT02229851|100988304|FG002|Full Analysis Set|Main Phase (Double-blind Phase)||120||
48271015|NCT02229851|100988305|FG003|Full Analysis Set|Main Phase (Double-blind Phase)||0||
48271016|NCT02229851|100988306|FG004|Full Analysis Set|Main Phase (Double-blind Phase)||0||
48271017|NCT02229851|100988307|FG005|Full Analysis Set|Main Phase (Double-blind Phase)||0||
48271018|NCT02229851|100988308|FG006|Full Analysis Set|Main Phase (Double-blind Phase)||0||
48271019|NCT02229851|100988302|FG000|Safety Analysis Set|Main Phase (Double-blind Phase)||61||
48271020|NCT02229851|100988303|FG001|Safety Analysis Set|Main Phase (Double-blind Phase)||119||
48271021|NCT02229851|100988304|FG002|Safety Analysis Set|Main Phase (Double-blind Phase)||120||
48271022|NCT02229851|100988305|FG003|Safety Analysis Set|Main Phase (Double-blind Phase)||0||
48271023|NCT02229851|100988306|FG004|Safety Analysis Set|Main Phase (Double-blind Phase)||0||
48271024|NCT02229851|100988307|FG005|Safety Analysis Set|Main Phase (Double-blind Phase)||0||
48271025|NCT02229851|100988308|FG006|Safety Analysis Set|Main Phase (Double-blind Phase)||0||
48271026|NCT02229851|100988302|FG000|COMPLETED|Main Phase (Double-blind Phase)||55||
48271027|NCT02229851|100988303|FG001|COMPLETED|Main Phase (Double-blind Phase)||103||
48271028|NCT02229851|100988304|FG002|COMPLETED|Main Phase (Double-blind Phase)||114||
48271029|NCT02229851|100988305|FG003|COMPLETED|Main Phase (Double-blind Phase)||0||
48271030|NCT02229851|100988306|FG004|COMPLETED|Main Phase (Double-blind Phase)||0||
48271031|NCT02229851|100988307|FG005|COMPLETED|Main Phase (Double-blind Phase)||0||
48271032|NCT02229851|100988308|FG006|COMPLETED|Main Phase (Double-blind Phase)||0||
48271033|NCT02229851|100988302|FG000|NOT COMPLETED|Main Phase (Double-blind Phase)||6||
48271034|NCT02229851|100988303|FG001|NOT COMPLETED|Main Phase (Double-blind Phase)||16||
48271035|NCT02229851|100988304|FG002|NOT COMPLETED|Main Phase (Double-blind Phase)||6||
48271036|NCT02229851|100988305|FG003|NOT COMPLETED|Main Phase (Double-blind Phase)||0||
48271037|NCT02229851|100988306|FG004|NOT COMPLETED|Main Phase (Double-blind Phase)||0||
48271038|NCT02229851|100988307|FG005|NOT COMPLETED|Main Phase (Double-blind Phase)||0||
48271039|NCT02229851|100988308|FG006|NOT COMPLETED|Main Phase (Double-blind Phase)||0||
48271040|NCT02229851|100988302|FG000|STARTED|Extension Phase (Open-label Phase)||0||
48271041|NCT02229851|100988303|FG001|STARTED|Extension Phase (Open-label Phase)||0||
48271042|NCT02229851|100988304|FG002|STARTED|Extension Phase (Open-label Phase)||0||
48271043|NCT02229851|100988305|FG003|STARTED|Extension Phase (Open-label Phase)||55||
48271044|NCT02229851|100988306|FG004|STARTED|Extension Phase (Open-label Phase)||114||
48271045|NCT02229851|100988307|FG005|STARTED|Extension Phase (Open-label Phase)||52||
48271046|NCT02229851|100988308|FG006|STARTED|Extension Phase (Open-label Phase)||51||
48271047|NCT02229851|100988302|FG000|COMPLETED|Extension Phase (Open-label Phase)||0||
48271048|NCT02229851|100988303|FG001|COMPLETED|Extension Phase (Open-label Phase)||0||
48271049|NCT02229851|100988304|FG002|COMPLETED|Extension Phase (Open-label Phase)||0||
48271050|NCT02229851|100988305|FG003|COMPLETED|Extension Phase (Open-label Phase)||53||
48271051|NCT02229851|100988306|FG004|COMPLETED|Extension Phase (Open-label Phase)||109||
48271052|NCT02229851|100988307|FG005|COMPLETED|Extension Phase (Open-label Phase)||47||
48271053|NCT02229851|100988308|FG006|COMPLETED|Extension Phase (Open-label Phase)||48||
48271054|NCT02229851|100988302|FG000|NOT COMPLETED|Extension Phase (Open-label Phase)||0||
48271055|NCT02229851|100988303|FG001|NOT COMPLETED|Extension Phase (Open-label Phase)||0||
48271056|NCT02229851|100988304|FG002|NOT COMPLETED|Extension Phase (Open-label Phase)||0||
48271057|NCT02229851|100988305|FG003|NOT COMPLETED|Extension Phase (Open-label Phase)||2||
48271058|NCT02229851|100988306|FG004|NOT COMPLETED|Extension Phase (Open-label Phase)||5||
48271059|NCT02229851|100988307|FG005|NOT COMPLETED|Extension Phase (Open-label Phase)||5||
48271060|NCT02229851|100988308|FG006|NOT COMPLETED|Extension Phase (Open-label Phase)||3||
48271061|NCT00477490|100988309|FG000|STARTED|Part I: 4 Week Efficacy||160||
48271062|NCT00477490|100988310|FG001|STARTED|Part I: 4 Week Efficacy||163||
48271063|NCT00477490|100988311|FG002|STARTED|Part I: 4 Week Efficacy||158||
48271064|NCT00477490|100988312|FG003|STARTED|Part I: 4 Week Efficacy||158||
48271065|NCT00477490|100988313|FG004|STARTED|Part I: 4 Week Efficacy||160||
48271066|NCT00477490|100988314|FG005|STARTED|Part I: 4 Week Efficacy||0||
48271067|NCT00477490|100988315|FG006|STARTED|Part I: 4 Week Efficacy||0||
48392486|NCT01324687|101287882|FG000|STARTED|Overall Study||1058||
48392487|NCT01324687|101287883|FG001|STARTED|Overall Study||494||
48392488|NCT01324687|101287882|FG000|COMPLETED|Overall Study||1058||
48392489|NCT01324687|101287883|FG001|COMPLETED|Overall Study||479||
48392490|NCT01324687|101287882|FG000|NOT COMPLETED|Overall Study||0||
48392491|NCT01324687|101287883|FG001|NOT COMPLETED|Overall Study||15||
48392492|NCT00187889|101287884|FG000|STARTED|Overall Study||25||
48392493|NCT00187889|101287885|FG001|STARTED|Overall Study||26||
48392494|NCT00187889|101287884|FG000|COMPLETED|Overall Study||19||
48693451|NCT00778336|102032779|FG002|STARTED|3 Month Follow Up||70||
48693452|NCT00778336|102032780|FG003|STARTED|3 Month Follow Up||12||
48271068|NCT00477490|100988316|FG007|STARTED|Part I: 4 Week Efficacy||0||
48271069|NCT00477490|100988317|FG008|STARTED|Part I: 4 Week Efficacy||0||
48271070|NCT00477490|100988309|FG000|ITT Population|Part I: 4 Week Efficacy||156||
48271071|NCT00477490|100988310|FG001|ITT Population|Part I: 4 Week Efficacy||155||
48271072|NCT00477490|100988311|FG002|ITT Population|Part I: 4 Week Efficacy||152||
48271073|NCT00477490|100988312|FG003|ITT Population|Part I: 4 Week Efficacy||148||
48271074|NCT00477490|100988313|FG004|ITT Population|Part I: 4 Week Efficacy||146||
48271075|NCT00477490|100988314|FG005|ITT Population|Part I: 4 Week Efficacy||0||
48271076|NCT00477490|100988315|FG006|ITT Population|Part I: 4 Week Efficacy||0||
48271077|NCT00477490|100988316|FG007|ITT Population|Part I: 4 Week Efficacy||0||
48271078|NCT00477490|100988317|FG008|ITT Population|Part I: 4 Week Efficacy||0||
48271079|NCT00477490|100988309|FG000|COMPLETED|Part I: 4 Week Efficacy||145||
48271080|NCT00477490|100988310|FG001|COMPLETED|Part I: 4 Week Efficacy||144||
48271081|NCT00477490|100988311|FG002|COMPLETED|Part I: 4 Week Efficacy||148||
48271082|NCT00477490|100988312|FG003|COMPLETED|Part I: 4 Week Efficacy||138||
48271083|NCT00477490|100988313|FG004|COMPLETED|Part I: 4 Week Efficacy||135||
48271084|NCT00477490|100988314|FG005|COMPLETED|Part I: 4 Week Efficacy||0||
48271085|NCT00477490|100988315|FG006|COMPLETED|Part I: 4 Week Efficacy||0||
48271086|NCT00477490|100988316|FG007|COMPLETED|Part I: 4 Week Efficacy||0||
48271087|NCT00477490|100988317|FG008|COMPLETED|Part I: 4 Week Efficacy||0||
48271088|NCT00477490|100988309|FG000|NOT COMPLETED|Part I: 4 Week Efficacy||15||
48271089|NCT00477490|100988310|FG001|NOT COMPLETED|Part I: 4 Week Efficacy||19||
48271090|NCT00477490|100988311|FG002|NOT COMPLETED|Part I: 4 Week Efficacy||10||
48271091|NCT00477490|100988312|FG003|NOT COMPLETED|Part I: 4 Week Efficacy||20||
48271092|NCT00477490|100988313|FG004|NOT COMPLETED|Part I: 4 Week Efficacy||25||
48271093|NCT00477490|100988314|FG005|NOT COMPLETED|Part I: 4 Week Efficacy||0||
48271094|NCT00477490|100988315|FG006|NOT COMPLETED|Part I: 4 Week Efficacy||0||
48271095|NCT00477490|100988316|FG007|NOT COMPLETED|Part I: 4 Week Efficacy||0||
48271096|NCT00477490|100988317|FG008|NOT COMPLETED|Part I: 4 Week Efficacy||0||
48271097|NCT00477490|100988309|FG000|STARTED|Part II: Extension Week 5 up to Day 169||0||
48271098|NCT00477490|100988310|FG001|STARTED|Part II: Extension Week 5 up to Day 169||135||
48271099|NCT00477490|100988311|FG002|STARTED|Part II: Extension Week 5 up to Day 169||135||
48271100|NCT00477490|100988312|FG003|STARTED|Part II: Extension Week 5 up to Day 169||132||
48271101|NCT00477490|100988313|FG004|STARTED|Part II: Extension Week 5 up to Day 169||127||
48271102|NCT00477490|100988314|FG005|STARTED|Part II: Extension Week 5 up to Day 169||31||
48271103|NCT00477490|100988315|FG006|STARTED|Part II: Extension Week 5 up to Day 169||37||
48271104|NCT00477490|100988316|FG007|STARTED|Part II: Extension Week 5 up to Day 169||34||
48271105|NCT00477490|100988317|FG008|STARTED|Part II: Extension Week 5 up to Day 169||34||
48271106|NCT00477490|100988309|FG000|COMPLETED|Part II: Extension Week 5 up to Day 169||0||
48271107|NCT00477490|100988310|FG001|COMPLETED|Part II: Extension Week 5 up to Day 169||107||
48271108|NCT00477490|100988311|FG002|COMPLETED|Part II: Extension Week 5 up to Day 169||120||
48271109|NCT00477490|100988312|FG003|COMPLETED|Part II: Extension Week 5 up to Day 169||120||
48271110|NCT00477490|100988313|FG004|COMPLETED|Part II: Extension Week 5 up to Day 169||107||
48271111|NCT00477490|100988314|FG005|COMPLETED|Part II: Extension Week 5 up to Day 169||25||
48271112|NCT00477490|100988315|FG006|COMPLETED|Part II: Extension Week 5 up to Day 169||32||
48271113|NCT00477490|100988316|FG007|COMPLETED|Part II: Extension Week 5 up to Day 169||29||
48271114|NCT00477490|100988317|FG008|COMPLETED|Part II: Extension Week 5 up to Day 169||26||
48271115|NCT00477490|100988309|FG000|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||0||
48271116|NCT00477490|100988310|FG001|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||28||
48271117|NCT00477490|100988311|FG002|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||15||
48271118|NCT00477490|100988312|FG003|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||12||
48392495|NCT00187889|101287885|FG001|COMPLETED|Overall Study||22||
48392496|NCT00187889|101287884|FG000|NOT COMPLETED|Overall Study||6||
48392497|NCT00187889|101287885|FG001|NOT COMPLETED|Overall Study||4||
48553322|NCT02121652|101686944|FG001|NOT COMPLETED|Overall Study||4||
48271119|NCT00477490|100988313|FG004|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||20||
48271120|NCT00477490|100988314|FG005|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||6||
48271121|NCT00477490|100988315|FG006|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5||
48392498|NCT02282982|101291364|FG000|STARTED|Overall Study||359||
48392499|NCT02282982|101291364|FG000|Attended Visit 1|Overall Study||359||
48553323|NCT00417170|101686945|FG000|STARTED|Overall Study||23||
48693453|NCT00778336|102032777|FG000|COMPLETED|3 Month Follow Up||169||
48392500|NCT02282982|101291364|FG000|Attended Visit 2|Overall Study||341||
48693454|NCT00778336|102032778|FG001|COMPLETED|3 Month Follow Up||144||
48693455|NCT00778336|102032779|FG002|COMPLETED|3 Month Follow Up||65||
48271122|NCT00477490|100988316|FG007|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5||
48271123|NCT00477490|100988317|FG008|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||8||
48271124|NCT01254747|100988318|FG000|STARTED|Overall Study||40||
48271125|NCT01254747|100988319|FG001|STARTED|Overall Study||29||
48392501|NCT02282982|101291364|FG000|Attended Visit 3|Overall Study||298||
48693456|NCT00778336|102032780|FG003|COMPLETED|3 Month Follow Up||12||
48693457|NCT00778336|102032777|FG000|NOT COMPLETED|3 Month Follow Up||23||
48693458|NCT00778336|102032778|FG001|NOT COMPLETED|3 Month Follow Up||23||
48693459|NCT00778336|102032779|FG002|NOT COMPLETED|3 Month Follow Up||5||
48693460|NCT00778336|102032780|FG003|NOT COMPLETED|3 Month Follow Up||0||
48693461|NCT03711370|102032781|FG000|STARTED|Overall Study||76||
48693462|NCT03711370|102032782|FG001|STARTED|Overall Study||76||
48693463|NCT03711370|102032781|FG000|Pre-Test: Clear Bottle Feeding Condition|Overall Study||76||
48693464|NCT03711370|102032782|FG001|Pre-Test: Clear Bottle Feeding Condition|Overall Study||76||
48693465|NCT03711370|102032781|FG000|Pre-Test: Opaque Bottle Feeding Condition|Overall Study||76||
48271126|NCT01254747|100988320|FG002|STARTED|Overall Study||30||
48271127|NCT01254747|100988321|FG003|STARTED|Overall Study||30||
48271128|NCT01254747|100988318|FG000|COMPLETED|Overall Study||40||
48271129|NCT01254747|100988319|FG001|COMPLETED|Overall Study||23||
48271130|NCT01254747|100988320|FG002|COMPLETED|Overall Study||26||
48271131|NCT01254747|100988321|FG003|COMPLETED|Overall Study||28||
48271132|NCT01254747|100988318|FG000|NOT COMPLETED|Overall Study||0||
48271133|NCT01254747|100988319|FG001|NOT COMPLETED|Overall Study||6||
48392502|NCT02282982|101291364|FG000|Attended Visit 4|Overall Study||194||
48392503|NCT02282982|101291364|FG000|Attended Visit 5|Overall Study||83||
48693466|NCT03711370|102032782|FG001|Pre-Test: Opaque Bottle Feeding Condition|Overall Study||76||
48693467|NCT03711370|102032781|FG000|Post-test: Clear Bottle Feeding Condition|Overall Study||60||
48693468|NCT03711370|102032782|FG001|Post-test: Clear Bottle Feeding Condition|Overall Study||66||
48693469|NCT03711370|102032781|FG000|Post-test: Opaque Bottle Feeding Condition|Overall Study||60||
48693470|NCT03711370|102032782|FG001|Post-test: Opaque Bottle Feeding Condition|Overall Study||66||
48693471|NCT03711370|102032781|FG000|COMPLETED|Overall Study||60||
48693472|NCT03711370|102032782|FG001|COMPLETED|Overall Study||60||
48693473|NCT03711370|102032781|FG000|NOT COMPLETED|Overall Study||16||
48693474|NCT03711370|102032782|FG001|NOT COMPLETED|Overall Study||16||
48693475|NCT04072835|102032783|FG000|STARTED|Overall Study||1116|Enrolled in the study but not all have experienced a PSVT episode and administered the study drug before the end of the study.|
48693476|NCT04072835|102032783|FG000|Participants Who Completed the Study With at Least 1 Treated Perceived PSVT Episode|Overall Study||503||
48693477|NCT04072835|102032783|FG000|Participants Who Treated 1 Perceived PSVT Episode in the Study|Overall Study||220||
48693478|NCT04072835|102032783|FG000|Participants Who Treated 2 Perceived PSVT Episodes in the Study|Overall Study||118||
48693479|NCT04072835|102032783|FG000|Participants Who Treated 3 Perceived PSVT Episodes in the Study|Overall Study||62||
48693480|NCT04072835|102032783|FG000|Participants Who Treated 4 Perceived PSVT Episodes in the Study|Overall Study||103||
48693481|NCT04072835|102032783|FG000|COMPLETED|Overall Study||103||
48693482|NCT04072835|102032783|FG000|NOT COMPLETED|Overall Study||1013||
48693483|NCT02579421|102032784|FG000|STARTED|Overall Study||23||
48693484|NCT02579421|102032785|FG001|STARTED|Overall Study||23||
48693485|NCT02579421|102032786|FG002|STARTED|Overall Study||6||
48693486|NCT02579421|102032787|FG003|STARTED|Overall Study||6||
48693487|NCT02579421|102032784|FG000|COMPLETED|Overall Study||17||
48693488|NCT02579421|102032785|FG001|COMPLETED|Overall Study||18||
48693489|NCT02579421|102032786|FG002|COMPLETED|Overall Study||5||
48693490|NCT02579421|102032787|FG003|COMPLETED|Overall Study||3||
48693491|NCT02579421|102032784|FG000|NOT COMPLETED|Overall Study||6||
48693492|NCT02579421|102032785|FG001|NOT COMPLETED|Overall Study||5||
48693493|NCT02579421|102032786|FG002|NOT COMPLETED|Overall Study||1||
48693494|NCT02579421|102032787|FG003|NOT COMPLETED|Overall Study||3||
48693495|NCT00915759|102032788|FG000|STARTED|Overall Study||40||
48693496|NCT00915759|102032788|FG000|COMPLETED|Overall Study||40||
48693497|NCT00915759|102032788|FG000|NOT COMPLETED|Overall Study||0||
48693498|NCT01498744|102032789|FG000|STARTED|Overall Study||22||
48693499|NCT01498744|102032790|FG001|STARTED|Overall Study||31||
48693500|NCT01498744|102032789|FG000|COMPLETED|Overall Study||22||
48693501|NCT01498744|102032790|FG001|COMPLETED|Overall Study||31||
48693502|NCT01498744|102032789|FG000|NOT COMPLETED|Overall Study||0||
48693503|NCT01498744|102032790|FG001|NOT COMPLETED|Overall Study||0||
48693504|NCT00342628|102032791|FG000|STARTED|Overall Study||100||
48693505|NCT00342628|102032792|FG001|STARTED|Overall Study||101||
48693506|NCT00342628|102032793|FG002|STARTED|Overall Study||100||
48693507|NCT00342628|102032791|FG000|COMPLETED|Overall Study||80||
48693508|NCT00342628|102032792|FG001|COMPLETED|Overall Study||80||
48271134|NCT01254747|100988320|FG002|NOT COMPLETED|Overall Study||4||
48271135|NCT01254747|100988321|FG003|NOT COMPLETED|Overall Study||2||
48271136|NCT01236378|100988322|FG000|STARTED|Overall Study||24||
48271137|NCT01236378|100988322|FG000|COMPLETED|Overall Study||24||
48271138|NCT01236378|100988322|FG000|NOT COMPLETED|Overall Study||0||
48693509|NCT00342628|102032793|FG002|COMPLETED|Overall Study||81||
48693510|NCT00342628|102032791|FG000|NOT COMPLETED|Overall Study||20||
48693511|NCT00342628|102032792|FG001|NOT COMPLETED|Overall Study||21||
48693512|NCT00342628|102032793|FG002|NOT COMPLETED|Overall Study||19||
48693513|NCT02013778|102032794|FG000|STARTED|Overall Study||8||
48109058|NCT03661814|100594413|FG001|COMPLETED|Overall Study||5||
48109059|NCT03661814|100594412|FG000|NOT COMPLETED|Overall Study||0||
48109060|NCT03661814|100594413|FG001|NOT COMPLETED|Overall Study||0||
48109061|NCT01489969|100594414|FG000|STARTED|Overall Study||45||
48109062|NCT01489969|100594415|FG001|STARTED|Overall Study||47||
48109063|NCT01489969|100594416|FG002|STARTED|Overall Study||45||
48109064|NCT01489969|100594414|FG000|COMPLETED|Overall Study||40||
48109065|NCT01489969|100594415|FG001|COMPLETED|Overall Study||43||
48109066|NCT01489969|100594416|FG002|COMPLETED|Overall Study||44||
48109067|NCT01489969|100594414|FG000|NOT COMPLETED|Overall Study||5||
48109068|NCT01489969|100594415|FG001|NOT COMPLETED|Overall Study||4||
48109069|NCT01489969|100594416|FG002|NOT COMPLETED|Overall Study||1||
48109070|NCT04010266|100594417|FG000|STARTED|Overall Study||32||
48109071|NCT04010266|100594418|FG001|STARTED|Overall Study||31||
48109072|NCT04010266|100594417|FG000|COMPLETED|Overall Study||24||
48109073|NCT04010266|100594418|FG001|COMPLETED|Overall Study||18||
48109074|NCT04010266|100594417|FG000|NOT COMPLETED|Overall Study||8||
48109075|NCT04010266|100594418|FG001|NOT COMPLETED|Overall Study||13||
48109076|NCT02129803|100594419|FG000|STARTED|Overall Study||12||
48109077|NCT02129803|100594420|FG001|STARTED|Overall Study||12||
48109078|NCT02129803|100594419|FG000|COMPLETED|Overall Study||6||
48109079|NCT02129803|100594420|FG001|COMPLETED|Overall Study||9||
48109080|NCT02129803|100594419|FG000|NOT COMPLETED|Overall Study||6||
48109081|NCT02129803|100594420|FG001|NOT COMPLETED|Overall Study||3||
48271139|NCT02460575|100988323|FG000|STARTED|Overall Study||40||
48271140|NCT02460575|100988324|FG001|STARTED|Overall Study||20||
48693514|NCT02013778|102032794|FG000|COMPLETED|Overall Study||1||
48693515|NCT02013778|102032794|FG000|NOT COMPLETED|Overall Study||7||
48693516|NCT02038777|102032795|FG000|STARTED|Overall Study||3||
48693517|NCT02038777|102032796|FG001|STARTED|Overall Study||5||
48271141|NCT02460575|100988323|FG000|COMPLETED|Overall Study||39||
48271142|NCT02460575|100988324|FG001|COMPLETED|Overall Study||20||
48271143|NCT02460575|100988323|FG000|NOT COMPLETED|Overall Study||1||
48271144|NCT02460575|100988324|FG001|NOT COMPLETED|Overall Study||0||
48271145|NCT02628028|100988325|FG000|STARTED|Dosing Period||9||
48271146|NCT02628028|100988326|FG001|STARTED|Dosing Period||9||
48271147|NCT02628028|100988327|FG002|STARTED|Dosing Period||10||
48271148|NCT02628028|100988328|FG003|STARTED|Dosing Period||8||
48109082|NCT00813358|100594421|FG000|STARTED|Overall Study||115||
48109083|NCT00813358|100594421|FG000|COMPLETED|Overall Study||46||
48109084|NCT00813358|100594421|FG000|NOT COMPLETED|Overall Study||69||
48109085|NCT01381861|100594422|FG000|STARTED|Overall Study||23||
48109086|NCT01381861|100594422|FG000|COMPLETED|Overall Study||23||
48109087|NCT01381861|100594422|FG000|NOT COMPLETED|Overall Study||0||
48109088|NCT02703636|100594423|FG000|STARTED|Overall Study||118||
48109089|NCT02703636|100594423|FG000|COMPLETED|Overall Study||102||
48109090|NCT02703636|100594423|FG000|NOT COMPLETED|Overall Study||16||
48109091|NCT00544076|100594424|FG000|STARTED|Overall Study||34||
48109092|NCT00544076|100594425|FG001|STARTED|Overall Study||35||
48109093|NCT00544076|100594426|FG002|STARTED|Overall Study||31||
48109094|NCT00544076|100594424|FG000|COMPLETED|Overall Study||17||
48109095|NCT00544076|100594425|FG001|COMPLETED|Overall Study||19||
48109096|NCT00544076|100594426|FG002|COMPLETED|Overall Study||20||
48109097|NCT00544076|100594424|FG000|NOT COMPLETED|Overall Study||17||
48109098|NCT00544076|100594425|FG001|NOT COMPLETED|Overall Study||16||
48109099|NCT00544076|100594426|FG002|NOT COMPLETED|Overall Study||11||
48109100|NCT02667483|100594427|FG000|STARTED|Overall Study||3||
48109101|NCT02667483|100594428|FG001|STARTED|Overall Study||5||
48109102|NCT02667483|100594427|FG000|COMPLETED|Overall Study||3||
48109103|NCT02667483|100594428|FG001|COMPLETED|Overall Study||5||
48109104|NCT02667483|100594427|FG000|NOT COMPLETED|Overall Study||0||
48109105|NCT02667483|100594428|FG001|NOT COMPLETED|Overall Study||0||
48109106|NCT02296112|100594429|FG000|STARTED|Overall Study||9||
48109107|NCT02296112|100594429|FG000|COMPLETED|Overall Study||0||
48109108|NCT02296112|100594429|FG000|NOT COMPLETED|Overall Study||9||
48109109|NCT02312726|100594430|FG000|STARTED|Overall Study||38||
48109110|NCT02312726|100594431|FG001|STARTED|Overall Study||30||
48109111|NCT02312726|100594432|FG002|STARTED|Overall Study||67||
48109112|NCT02312726|100594430|FG000|COMPLETED|Overall Study||38||
48109113|NCT02312726|100594431|FG001|COMPLETED|Overall Study||30||
48109114|NCT02312726|100594432|FG002|COMPLETED|Overall Study||0||
48109115|NCT02312726|100594430|FG000|NOT COMPLETED|Overall Study||0||
48109116|NCT02312726|100594431|FG001|NOT COMPLETED|Overall Study||0||
48109117|NCT02312726|100594432|FG002|NOT COMPLETED|Overall Study||67||
48109118|NCT00178191|100594433|FG000|STARTED|Overall Study||11||
48109119|NCT00178191|100594434|FG001|STARTED|Overall Study||10||
48109120|NCT00178191|100594435|FG002|STARTED|Overall Study||7||
48109121|NCT00178191|100594433|FG000|COMPLETED|Overall Study||11||
48109122|NCT00178191|100594434|FG001|COMPLETED|Overall Study||10||
48271149|NCT02628028|100988329|FG004|STARTED|Dosing Period||62||
48271150|NCT02628028|100988330|FG005|STARTED|Dosing Period||63||
48271151|NCT02628028|100988331|FG006|STARTED|Dosing Period||62||
48693518|NCT02038777|102032797|FG002|STARTED|Overall Study||6||
48109123|NCT00178191|100594435|FG002|COMPLETED|Overall Study||7||
48109124|NCT00178191|100594433|FG000|NOT COMPLETED|Overall Study||0||
48109125|NCT00178191|100594434|FG001|NOT COMPLETED|Overall Study||0||
48109126|NCT00178191|100594435|FG002|NOT COMPLETED|Overall Study||0||
48109127|NCT01488097|100594436|FG000|STARTED|Overall Study||8||
48109128|NCT01488097|100594436|FG000|Received Study Drug in Extension Study|Overall Study||8||
48109129|NCT01488097|100594436|FG000|COMPLETED|Overall Study||7||
48109130|NCT01488097|100594436|FG000|NOT COMPLETED|Overall Study||1||
48109131|NCT03670810|100594437|FG000|STARTED|Main Study||485||
48109132|NCT03670810|100594438|FG001|STARTED|Main Study||486||
48109133|NCT03670810|100594439|FG002|STARTED|Main Study||249||
48271152|NCT02628028|100988332|FG007|STARTED|Dosing Period||63||
48693519|NCT02038777|102032798|FG003|STARTED|Overall Study||6||
48693520|NCT02038777|102032799|FG004|STARTED|Overall Study||6||
48271153|NCT02628028|100988325|FG000|Received at Least 1dose of Study Drug|Dosing Period||9||
48693521|NCT02038777|102032800|FG005|STARTED|Overall Study||6||
48693522|NCT02038777|102032801|FG006|STARTED|Overall Study||1||
48693523|NCT02038777|102032802|FG007|STARTED|Overall Study||15||
48109134|NCT03670810|100594440|FG003|STARTED|Main Study||251||
48109135|NCT03670810|100594441|FG004|STARTED|Main Study||55||
48109136|NCT03670810|100594442|FG005|STARTED|Main Study||53||
48109137|NCT03670810|100594443|FG006|STARTED|Main Study||28||
48109138|NCT03670810|100594444|FG007|STARTED|Main Study||26||
48271154|NCT02628028|100988326|FG001|Received at Least 1dose of Study Drug|Dosing Period||9||
48271155|NCT02628028|100988327|FG002|Received at Least 1dose of Study Drug|Dosing Period||10||
48271156|NCT02628028|100988328|FG003|Received at Least 1dose of Study Drug|Dosing Period||8||
48271157|NCT02628028|100988329|FG004|Received at Least 1dose of Study Drug|Dosing Period||62||
48271158|NCT02628028|100988330|FG005|Received at Least 1dose of Study Drug|Dosing Period||63||
48271159|NCT02628028|100988331|FG006|Received at Least 1dose of Study Drug|Dosing Period||62||
48271160|NCT02628028|100988332|FG007|Received at Least 1dose of Study Drug|Dosing Period||63||
48271161|NCT02628028|100988325|FG000|COMPLETED|Dosing Period||9||
48271162|NCT02628028|100988326|FG001|COMPLETED|Dosing Period||9||
48271163|NCT02628028|100988327|FG002|COMPLETED|Dosing Period||9||
48271164|NCT02628028|100988328|FG003|COMPLETED|Dosing Period||8||
48271165|NCT02628028|100988329|FG004|COMPLETED|Dosing Period||46||
48271166|NCT02628028|100988330|FG005|COMPLETED|Dosing Period||49||
48271167|NCT02628028|100988331|FG006|COMPLETED|Dosing Period||46||
48271168|NCT02628028|100988332|FG007|COMPLETED|Dosing Period||48||
48271169|NCT02628028|100988325|FG000|NOT COMPLETED|Dosing Period||0||
48271170|NCT02628028|100988326|FG001|NOT COMPLETED|Dosing Period||0||
48271171|NCT02628028|100988327|FG002|NOT COMPLETED|Dosing Period||1||
48271172|NCT02628028|100988328|FG003|NOT COMPLETED|Dosing Period||0||
48271173|NCT02628028|100988329|FG004|NOT COMPLETED|Dosing Period||16||
48271174|NCT02628028|100988330|FG005|NOT COMPLETED|Dosing Period||14||
48271175|NCT02628028|100988331|FG006|NOT COMPLETED|Dosing Period||16||
48271176|NCT02628028|100988332|FG007|NOT COMPLETED|Dosing Period||15||
48271177|NCT02628028|100988325|FG000|STARTED|Long-term Extension (LTE) Period||0||
48271178|NCT02628028|100988326|FG001|STARTED|Long-term Extension (LTE) Period||0||
48271179|NCT02628028|100988327|FG002|STARTED|Long-term Extension (LTE) Period||0||
48271180|NCT02628028|100988328|FG003|STARTED|Long-term Extension (LTE) Period||0||
48271181|NCT02628028|100988329|FG004|STARTED|Long-term Extension (LTE) Period||0||
48271182|NCT02628028|100988330|FG005|STARTED|Long-term Extension (LTE) Period||61||
48271183|NCT02628028|100988331|FG006|STARTED|Long-term Extension (LTE) Period||58||
48271184|NCT02628028|100988332|FG007|STARTED|Long-term Extension (LTE) Period||61||
48271185|NCT02628028|100988325|FG000|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0||
48271186|NCT02628028|100988326|FG001|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0||
48271187|NCT02628028|100988327|FG002|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0||
48271188|NCT02628028|100988328|FG003|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0||
48271189|NCT02628028|100988329|FG004|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0||
48271190|NCT02628028|100988330|FG005|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14||
48271191|NCT02628028|100988331|FG006|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14||
48271192|NCT02628028|100988332|FG007|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14||
48271193|NCT02628028|100988325|FG000|COMPLETED|Long-term Extension (LTE) Period||0||
48271194|NCT02628028|100988326|FG001|COMPLETED|Long-term Extension (LTE) Period||0||
48271195|NCT02628028|100988327|FG002|COMPLETED|Long-term Extension (LTE) Period||0||
48271196|NCT02628028|100988328|FG003|COMPLETED|Long-term Extension (LTE) Period||0||
48271197|NCT02628028|100988329|FG004|COMPLETED|Long-term Extension (LTE) Period||0||
48271198|NCT02628028|100988330|FG005|COMPLETED|Long-term Extension (LTE) Period||1||
48271199|NCT02628028|100988331|FG006|COMPLETED|Long-term Extension (LTE) Period||0||
48553324|NCT00417170|101686946|FG001|STARTED|Overall Study||25||
48553325|NCT00417170|101686945|FG000|Pharmacodynamics Population|Overall Study||21||
48553326|NCT00417170|101686946|FG001|Pharmacodynamics Population|Overall Study||23||
48553327|NCT00417170|101686945|FG000|COMPLETED|Overall Study||21||
48553328|NCT00417170|101686946|FG001|COMPLETED|Overall Study||22||
48553329|NCT00417170|101686945|FG000|NOT COMPLETED|Overall Study||2||
48553330|NCT00417170|101686946|FG001|NOT COMPLETED|Overall Study||3||
48553331|NCT02553772|101686947|FG000|STARTED|Overall Study||120||
48553332|NCT02553772|101686948|FG001|STARTED|Overall Study||122||
48553333|NCT02553772|101686947|FG000|COMPLETED|Overall Study||114||
48553334|NCT02553772|101686948|FG001|COMPLETED|Overall Study||116||
48553335|NCT02553772|101686947|FG000|NOT COMPLETED|Overall Study||6||
48553336|NCT02553772|101686948|FG001|NOT COMPLETED|Overall Study||6||
48553337|NCT03112473|101686949|FG000|STARTED|Overall Study||30||
48553338|NCT03112473|101686950|FG001|STARTED|Overall Study||30||
48553339|NCT03112473|101686951|FG002|STARTED|Overall Study||30||
48553340|NCT03112473|101686952|FG003|STARTED|Overall Study||30||
48553341|NCT03112473|101686949|FG000|COMPLETED|Overall Study||30||
48553342|NCT03112473|101686950|FG001|COMPLETED|Overall Study||30||
48271200|NCT02628028|100988332|FG007|COMPLETED|Long-term Extension (LTE) Period||0||
48271201|NCT02628028|100988325|FG000|NOT COMPLETED|Long-term Extension (LTE) Period||0||
48271202|NCT02628028|100988326|FG001|NOT COMPLETED|Long-term Extension (LTE) Period||0||
48271203|NCT02628028|100988327|FG002|NOT COMPLETED|Long-term Extension (LTE) Period||0||
48271204|NCT02628028|100988328|FG003|NOT COMPLETED|Long-term Extension (LTE) Period||0||
48271205|NCT02628028|100988329|FG004|NOT COMPLETED|Long-term Extension (LTE) Period||0||
48271206|NCT02628028|100988330|FG005|NOT COMPLETED|Long-term Extension (LTE) Period||60||
48271207|NCT02628028|100988331|FG006|NOT COMPLETED|Long-term Extension (LTE) Period||58||
48553343|NCT03112473|101686951|FG002|COMPLETED|Overall Study||30||
48553344|NCT03112473|101686952|FG003|COMPLETED|Overall Study||30||
48553345|NCT03112473|101686949|FG000|NOT COMPLETED|Overall Study||0||
48693524|NCT02038777|102032795|FG000|Treated (Safety Set)|Overall Study||3||
48693525|NCT02038777|102032796|FG001|Treated (Safety Set)|Overall Study||4||
48693526|NCT02038777|102032797|FG002|Treated (Safety Set)|Overall Study||6||
48693527|NCT02038777|102032798|FG003|Treated (Safety Set)|Overall Study||6||
48693528|NCT02038777|102032799|FG004|Treated (Safety Set)|Overall Study||6||
48693529|NCT02038777|102032800|FG005|Treated (Safety Set)|Overall Study||6||
48693530|NCT02038777|102032801|FG006|Treated (Safety Set)|Overall Study||1||
48693531|NCT02038777|102032802|FG007|Treated (Safety Set)|Overall Study||15||
48693532|NCT02038777|102032795|FG000|COMPLETED|Overall Study||2||
48693533|NCT02038777|102032796|FG001|COMPLETED|Overall Study||1||
48693534|NCT02038777|102032797|FG002|COMPLETED|Overall Study||3||
48693535|NCT02038777|102032798|FG003|COMPLETED|Overall Study||2||
48693536|NCT02038777|102032799|FG004|COMPLETED|Overall Study||3||
48693537|NCT02038777|102032800|FG005|COMPLETED|Overall Study||2||
48693538|NCT02038777|102032801|FG006|COMPLETED|Overall Study||1||
48693539|NCT02038777|102032802|FG007|COMPLETED|Overall Study||5||
48109139|NCT03670810|100594445|FG008|STARTED|Main Study||0||
48109140|NCT03670810|100594437|FG000|Treated at Least One Migraine Attack|Main Study||485||
48109141|NCT03670810|100594438|FG001|Treated at Least One Migraine Attack|Main Study||486||
48553346|NCT03112473|101686950|FG001|NOT COMPLETED|Overall Study||0||
48553347|NCT03112473|101686951|FG002|NOT COMPLETED|Overall Study||0||
48553348|NCT03112473|101686952|FG003|NOT COMPLETED|Overall Study||0||
48109142|NCT03670810|100594439|FG002|Treated at Least One Migraine Attack|Main Study||249||
48109143|NCT03670810|100594440|FG003|Treated at Least One Migraine Attack|Main Study||251||
48109144|NCT03670810|100594441|FG004|Treated at Least One Migraine Attack|Main Study||55||
48109145|NCT03670810|100594442|FG005|Treated at Least One Migraine Attack|Main Study||53||
48109146|NCT03670810|100594443|FG006|Treated at Least One Migraine Attack|Main Study||28||
48553349|NCT02964247|101686953|FG000|STARTED|Overall Study||203||
48553350|NCT02964247|101686954|FG001|STARTED|Overall Study||100||
48553351|NCT02964247|101686953|FG000|Exposed to Trial Product|Overall Study||202||
48693540|NCT02038777|102032795|FG000|NOT COMPLETED|Overall Study||1||
48693541|NCT02038777|102032796|FG001|NOT COMPLETED|Overall Study||4||
48693542|NCT02038777|102032797|FG002|NOT COMPLETED|Overall Study||3||
48109147|NCT03670810|100594444|FG007|Treated at Least One Migraine Attack|Main Study||26||
48109148|NCT03670810|100594445|FG008|Treated at Least One Migraine Attack|Main Study||0||
48109149|NCT03670810|100594437|FG000|COMPLETED|Main Study||403||
48109150|NCT03670810|100594438|FG001|COMPLETED|Main Study||394||
48109151|NCT03670810|100594439|FG002|COMPLETED|Main Study||219||
48109152|NCT03670810|100594440|FG003|COMPLETED|Main Study||223||
48109153|NCT03670810|100594441|FG004|COMPLETED|Main Study||45||
48109154|NCT03670810|100594442|FG005|COMPLETED|Main Study||46||
48109155|NCT03670810|100594443|FG006|COMPLETED|Main Study||26||
48109156|NCT03670810|100594444|FG007|COMPLETED|Main Study||23||
48109157|NCT03670810|100594445|FG008|COMPLETED|Main Study||0||
48109158|NCT03670810|100594437|FG000|NOT COMPLETED|Main Study||82||
48109159|NCT03670810|100594438|FG001|NOT COMPLETED|Main Study||92||
48109160|NCT03670810|100594439|FG002|NOT COMPLETED|Main Study||30||
48109161|NCT03670810|100594440|FG003|NOT COMPLETED|Main Study||28||
48109162|NCT03670810|100594441|FG004|NOT COMPLETED|Main Study||10||
48109163|NCT03670810|100594442|FG005|NOT COMPLETED|Main Study||7||
48109164|NCT03670810|100594443|FG006|NOT COMPLETED|Main Study||2||
48109165|NCT03670810|100594444|FG007|NOT COMPLETED|Main Study||3||
48109166|NCT03670810|100594445|FG008|NOT COMPLETED|Main Study||0||
48109167|NCT03670810|100594437|FG000|STARTED|Open Label Extension||0||
48109168|NCT03670810|100594438|FG001|STARTED|Open Label Extension||0||
48109169|NCT03670810|100594439|FG002|STARTED|Open Label Extension||0||
48109170|NCT03670810|100594440|FG003|STARTED|Open Label Extension||0||
48109171|NCT03670810|100594441|FG004|STARTED|Open Label Extension||0||
48109172|NCT03670810|100594442|FG005|STARTED|Open Label Extension||0||
48109173|NCT03670810|100594443|FG006|STARTED|Open Label Extension||0||
48109174|NCT03670810|100594444|FG007|STARTED|Open Label Extension||0||
48109175|NCT03670810|100594445|FG008|STARTED|Open Label Extension||477||
48109176|NCT03670810|100594437|FG000|Treated at Least One Migraine Attack|Open Label Extension||0||
48109177|NCT03670810|100594438|FG001|Treated at Least One Migraine Attack|Open Label Extension||0||
48109178|NCT03670810|100594439|FG002|Treated at Least One Migraine Attack|Open Label Extension||0||
48553352|NCT02964247|101686954|FG001|Exposed to Trial Product|Overall Study||100||
48553353|NCT02964247|101686953|FG000|COMPLETED|Overall Study||200||
48553354|NCT02964247|101686954|FG001|COMPLETED|Overall Study||98||
48553355|NCT02964247|101686953|FG000|NOT COMPLETED|Overall Study||3||
48553356|NCT02964247|101686954|FG001|NOT COMPLETED|Overall Study||2||
48553357|NCT04825912|101686955|FG000|STARTED|Overall Study||18||
48553358|NCT04825912|101686955|FG000|COMPLETED|Overall Study||14||
48553359|NCT04825912|101686955|FG000|NOT COMPLETED|Overall Study||4||
48553360|NCT00709995|101686956|FG000|STARTED|Overall Study||11||
48553361|NCT00709995|101686957|FG001|STARTED|Overall Study||6||
48553362|NCT00709995|101686956|FG000|Progressive Disease|Overall Study||6||
48553363|NCT00709995|101686957|FG001|Progressive Disease|Overall Study||1||
48693543|NCT02038777|102032798|FG003|NOT COMPLETED|Overall Study||4||
48553364|NCT00709995|101686956|FG000|COMPLETED|Overall Study||6||
48553365|NCT00709995|101686957|FG001|COMPLETED|Overall Study||1||
48553366|NCT00709995|101686956|FG000|NOT COMPLETED|Overall Study||5||
48553367|NCT00709995|101686957|FG001|NOT COMPLETED|Overall Study||5||
48553368|NCT02276807|101686958|FG000|STARTED|Overall Study||68||
48553369|NCT02276807|101686959|FG001|STARTED|Overall Study||72||
48553370|NCT02276807|101686958|FG000|12-week Assessment|Overall Study||57|Participant completed the main outcome measure, but may not have completed all required measures.|
48553371|NCT02276807|101686959|FG001|12-week Assessment|Overall Study||63|Participant completed the main outcome measure, but may not have completed all required measures.|
48553372|NCT02276807|101686958|FG000|COMPLETED|Overall Study||50|Participant completed the main outcome measure, but may not have completed all required measures.|
48553373|NCT02276807|101686959|FG001|COMPLETED|Overall Study||55|Participant completed the main outcome measure, but may not have completed all required measures.|
48553374|NCT02276807|101686958|FG000|NOT COMPLETED|Overall Study||18||
48553375|NCT02276807|101686959|FG001|NOT COMPLETED|Overall Study||17||
48553376|NCT04071405|101690431|FG000|STARTED|Overall Study||110||
48553377|NCT04071405|101690431|FG000|Safety Population|Overall Study||107||
48553378|NCT04071405|101690431|FG000|COMPLETED|Overall Study||107||
48553379|NCT04071405|101690431|FG000|NOT COMPLETED|Overall Study||3||
48553380|NCT02252354|101690432|FG000|STARTED|Overall Study||6||
48553381|NCT02252354|101690433|FG001|STARTED|Overall Study||6||
48553382|NCT02252354|101690432|FG000|COMPLETED|Overall Study||6||
48553383|NCT02252354|101690433|FG001|COMPLETED|Overall Study||6||
48553384|NCT02252354|101690432|FG000|NOT COMPLETED|Overall Study||0||
48553385|NCT02252354|101690433|FG001|NOT COMPLETED|Overall Study||0||
48553386|NCT02269098|101690434|FG000|STARTED|Overall Study||51||
48553387|NCT02269098|101690435|FG001|STARTED|Overall Study||50||
48553388|NCT02269098|101690434|FG000|COMPLETED|Overall Study||37||
48553389|NCT02269098|101690435|FG001|COMPLETED|Overall Study||41||
48553390|NCT02269098|101690434|FG000|NOT COMPLETED|Overall Study||14||
48553391|NCT02269098|101690435|FG001|NOT COMPLETED|Overall Study||9||
48109179|NCT03670810|100594440|FG003|Treated at Least One Migraine Attack|Open Label Extension||0||
48553392|NCT00591773|101690436|FG000|STARTED|Overall Study||185||
48553393|NCT00591773|101690437|FG001|STARTED|Overall Study||182||
48553394|NCT00591773|101690438|FG002|STARTED|Overall Study||184||
48553395|NCT00591773|101690436|FG000|COMPLETED|Overall Study||169||
48553396|NCT00591773|101690437|FG001|COMPLETED|Overall Study||158||
48553397|NCT00591773|101690438|FG002|COMPLETED|Overall Study||168||
48553398|NCT00591773|101690436|FG000|NOT COMPLETED|Overall Study||16||
48553399|NCT00591773|101690437|FG001|NOT COMPLETED|Overall Study||24||
48553400|NCT00591773|101690438|FG002|NOT COMPLETED|Overall Study||16||
48553401|NCT04505969|101690439|FG000|STARTED|Overall Study||108||
48553402|NCT04505969|101690440|FG001|STARTED|Overall Study||84||
48553403|NCT04505969|101690439|FG000|COMPLETED|Overall Study||108||
48553404|NCT04505969|101690440|FG001|COMPLETED|Overall Study||84||
48553405|NCT04505969|101690439|FG000|NOT COMPLETED|Overall Study||0||
48553406|NCT04505969|101690440|FG001|NOT COMPLETED|Overall Study||0||
48553407|NCT01625091|101690441|FG000|STARTED|Intervention||96||
48693544|NCT02038777|102032799|FG004|NOT COMPLETED|Overall Study||3||
48693545|NCT02038777|102032800|FG005|NOT COMPLETED|Overall Study||4||
48693546|NCT02038777|102032801|FG006|NOT COMPLETED|Overall Study||0||
48693547|NCT02038777|102032802|FG007|NOT COMPLETED|Overall Study||10||
48693548|NCT00617058|102032803|FG000|STARTED|Overall Study||1||
48693549|NCT00617058|102032804|FG001|STARTED|Overall Study||0||
48693550|NCT00617058|102032805|FG002|STARTED|Overall Study||0||
48693551|NCT00617058|102032803|FG000|COMPLETED|Overall Study||1||
48693552|NCT00617058|102032804|FG001|COMPLETED|Overall Study||0||
48693553|NCT00617058|102032805|FG002|COMPLETED|Overall Study||0||
48693554|NCT00617058|102032803|FG000|NOT COMPLETED|Overall Study||0||
48109180|NCT03670810|100594441|FG004|Treated at Least One Migraine Attack|Open Label Extension||0||
48109181|NCT03670810|100594442|FG005|Treated at Least One Migraine Attack|Open Label Extension||0||
48109182|NCT03670810|100594443|FG006|Treated at Least One Migraine Attack|Open Label Extension||0||
48109183|NCT03670810|100594444|FG007|Treated at Least One Migraine Attack|Open Label Extension||0||
48109184|NCT03670810|100594445|FG008|Treated at Least One Migraine Attack|Open Label Extension||476||
48109185|NCT03670810|100594437|FG000|COMPLETED|Open Label Extension||0||
48109186|NCT03670810|100594438|FG001|COMPLETED|Open Label Extension||0||
48553408|NCT01625091|101690442|FG001|STARTED|Intervention||98||
48553409|NCT01625091|101690441|FG000|2 Months|Intervention||90||
48553410|NCT01625091|101690442|FG001|2 Months|Intervention||93||
48553411|NCT01625091|101690441|FG000|4 Months|Intervention||85||
48553412|NCT01625091|101690442|FG001|4 Months|Intervention||87||
48553413|NCT01625091|101690441|FG000|COMPLETED|Intervention||85||
48693555|NCT00617058|102032804|FG001|NOT COMPLETED|Overall Study||0||
48693556|NCT00617058|102032805|FG002|NOT COMPLETED|Overall Study||0||
48109187|NCT03670810|100594439|FG002|COMPLETED|Open Label Extension||0||
48109188|NCT03670810|100594440|FG003|COMPLETED|Open Label Extension||0||
48109189|NCT03670810|100594441|FG004|COMPLETED|Open Label Extension||0||
48109190|NCT03670810|100594442|FG005|COMPLETED|Open Label Extension||0||
48553414|NCT01625091|101690442|FG001|COMPLETED|Intervention||87||
48553415|NCT01625091|101690441|FG000|NOT COMPLETED|Intervention||11||
48553416|NCT01625091|101690442|FG001|NOT COMPLETED|Intervention||11||
48553417|NCT01625091|101690441|FG000|STARTED|Post-intervention||85||
48553418|NCT01625091|101690442|FG001|STARTED|Post-intervention||87||
48693557|NCT01270880|102032806|FG000|STARTED|Overall Study||18||
48553419|NCT01625091|101690441|FG000|7 Months|Post-intervention||81||
48693558|NCT01270880|102032806|FG000|COMPLETED|Overall Study||17||
48693559|NCT01270880|102032806|FG000|NOT COMPLETED|Overall Study||1||
48693560|NCT00118248|102032807|FG000|STARTED|Overall Study||17||
48693561|NCT00118248|102032808|FG001|STARTED|Overall Study||24||
48693562|NCT00118248|102032807|FG000|COMPLETED|Overall Study||17||
48693563|NCT00118248|102032808|FG001|COMPLETED|Overall Study||24||
48553420|NCT01625091|101690442|FG001|7 Months|Post-intervention||85||
48553421|NCT01625091|101690441|FG000|COMPLETED|Post-intervention||81||
48553422|NCT01625091|101690442|FG001|COMPLETED|Post-intervention||85||
48553423|NCT01625091|101690441|FG000|NOT COMPLETED|Post-intervention||4||
48553424|NCT01625091|101690442|FG001|NOT COMPLETED|Post-intervention||2||
48553425|NCT01433055|101690443|FG000|STARTED|Overall Study||29||
48553426|NCT01433055|101690444|FG001|STARTED|Overall Study||23||
48553427|NCT01433055|101690443|FG000|COMPLETED|Overall Study||27||
48693564|NCT00118248|102032807|FG000|NOT COMPLETED|Overall Study||0||
48693565|NCT00118248|102032808|FG001|NOT COMPLETED|Overall Study||0||
48693566|NCT02831855|102032809|FG000|STARTED|Open Label Phase (24 Weeks)||694||
48693567|NCT02831855|102032810|FG001|STARTED|Open Label Phase (24 Weeks)||0||
48109191|NCT03670810|100594443|FG006|COMPLETED|Open Label Extension||0||
48109192|NCT03670810|100594444|FG007|COMPLETED|Open Label Extension||0||
48109193|NCT03670810|100594445|FG008|COMPLETED|Open Label Extension||324||
48109194|NCT03670810|100594437|FG000|NOT COMPLETED|Open Label Extension||0||
48109195|NCT03670810|100594438|FG001|NOT COMPLETED|Open Label Extension||0||
48109196|NCT03670810|100594439|FG002|NOT COMPLETED|Open Label Extension||0||
48693568|NCT02831855|102032811|FG002|STARTED|Open Label Phase (24 Weeks)||0||
48693569|NCT02831855|102032809|FG000|COMPLETED|Open Label Phase (24 Weeks)||623||
48693570|NCT02831855|102032810|FG001|COMPLETED|Open Label Phase (24 Weeks)||0||
48693571|NCT02831855|102032811|FG002|COMPLETED|Open Label Phase (24 Weeks)||0||
48693572|NCT02831855|102032809|FG000|NOT COMPLETED|Open Label Phase (24 Weeks)||71||
48109197|NCT03670810|100594440|FG003|NOT COMPLETED|Open Label Extension||0||
48271208|NCT02628028|100988332|FG007|NOT COMPLETED|Long-term Extension (LTE) Period||61||
48271209|NCT00561431|100988333|FG000|STARTED|Overall Study||100||
48271210|NCT00561431|100988334|FG001|STARTED|Overall Study||100||
48109198|NCT03670810|100594441|FG004|NOT COMPLETED|Open Label Extension||0||
48109199|NCT03670810|100594442|FG005|NOT COMPLETED|Open Label Extension||0||
48109200|NCT03670810|100594443|FG006|NOT COMPLETED|Open Label Extension||0||
48109201|NCT03670810|100594444|FG007|NOT COMPLETED|Open Label Extension||0||
48109202|NCT03670810|100594445|FG008|NOT COMPLETED|Open Label Extension||153||
48109203|NCT00302003|100594446|FG000|STARTED|Overall Study||287||
48109204|NCT00302003|100594446|FG000|COMPLETED|Overall Study||207||
48109205|NCT00302003|100594446|FG000|NOT COMPLETED|Overall Study||80||
48109206|NCT03799484|100594447|FG000|STARTED|Overall Study||14||
48109207|NCT03799484|100594447|FG000|COMPLETED|Overall Study||14||
48109208|NCT03799484|100594447|FG000|NOT COMPLETED|Overall Study||0||
48109209|NCT02151448|100594448|FG000|STARTED|Phase 1||9||
48109210|NCT02151448|100594448|FG000|COMPLETED|Phase 1||9||
48109211|NCT02151448|100594448|FG000|NOT COMPLETED|Phase 1||0||
48109212|NCT02151448|100594448|FG000|STARTED|Phase 2||55||
48109213|NCT02151448|100594448|FG000|COMPLETED|Phase 2||55||
48109214|NCT02151448|100594448|FG000|NOT COMPLETED|Phase 2||0||
48109215|NCT02376946|100594449|FG000|STARTED|Overall Study||0||
48109216|NCT02376946|100594450|FG001|STARTED|Overall Study||0||
48109217|NCT02376946|100594449|FG000|COMPLETED|Overall Study||0||
48109218|NCT02376946|100594450|FG001|COMPLETED|Overall Study||0||
48109219|NCT02376946|100594449|FG000|NOT COMPLETED|Overall Study||0||
48109220|NCT02376946|100594450|FG001|NOT COMPLETED|Overall Study||0||
48109221|NCT00738972|100594451|FG000|STARTED|Overall Study||3||
48109222|NCT00738972|100594452|FG001|STARTED|Overall Study||3||
48109223|NCT00738972|100594453|FG002|STARTED|Overall Study||3||
48553428|NCT01433055|101690444|FG001|COMPLETED|Overall Study||23||
48553429|NCT01433055|101690443|FG000|NOT COMPLETED|Overall Study||2||
48553430|NCT01433055|101690444|FG001|NOT COMPLETED|Overall Study||0||
48553431|NCT00501995|101690445|FG000|STARTED|Overall Study||6||
48693573|NCT02831855|102032810|FG001|NOT COMPLETED|Open Label Phase (24 Weeks)||0||
48553432|NCT00501995|101690445|FG000|COMPLETED|Overall Study||5||
48553433|NCT00501995|101690445|FG000|NOT COMPLETED|Overall Study||1||
48693574|NCT02831855|102032811|FG002|NOT COMPLETED|Open Label Phase (24 Weeks)||0||
48693575|NCT02831855|102032809|FG000|STARTED|Double Blind Phase (24 Weeks)||0||
48693576|NCT02831855|102032810|FG001|STARTED|Double Blind Phase (24 Weeks)||267||
48693577|NCT02831855|102032811|FG002|STARTED|Double Blind Phase (24 Weeks)||266||
48693578|NCT02831855|102032809|FG000|Treated|Double Blind Phase (24 Weeks)||0||
48693579|NCT02831855|102032810|FG001|Treated|Double Blind Phase (24 Weeks)||264||
48109224|NCT00738972|100594454|FG003|STARTED|Overall Study||3||
48109225|NCT00738972|100594451|FG000|COMPLETED|Overall Study||3||
48109226|NCT00738972|100594452|FG001|COMPLETED|Overall Study||3||
48109227|NCT00738972|100594453|FG002|COMPLETED|Overall Study||3||
48109228|NCT00738972|100594454|FG003|COMPLETED|Overall Study||2||
48109229|NCT00738972|100594451|FG000|NOT COMPLETED|Overall Study||0||
48109230|NCT00738972|100594452|FG001|NOT COMPLETED|Overall Study||0||
48271211|NCT00561431|100988333|FG000|COMPLETED|Overall Study||100||
48271212|NCT00561431|100988334|FG001|COMPLETED|Overall Study||100||
48271213|NCT00561431|100988333|FG000|NOT COMPLETED|Overall Study||0||
48109231|NCT00738972|100594453|FG002|NOT COMPLETED|Overall Study||0||
48109232|NCT00738972|100594454|FG003|NOT COMPLETED|Overall Study||1||
48109233|NCT03299192|100594455|FG000|STARTED|Overall Study||28||
48109234|NCT03299192|100594456|FG001|STARTED|Overall Study||12||
48109235|NCT03299192|100594457|FG002|STARTED|Overall Study||17||
48109236|NCT03299192|100594455|FG000|COMPLETED|Overall Study||27||
48109237|NCT03299192|100594456|FG001|COMPLETED|Overall Study||10||
48109238|NCT03299192|100594457|FG002|COMPLETED|Overall Study||16||
48109239|NCT03299192|100594455|FG000|NOT COMPLETED|Overall Study||1||
48109240|NCT03299192|100594456|FG001|NOT COMPLETED|Overall Study||2||
48109241|NCT03299192|100594457|FG002|NOT COMPLETED|Overall Study||1||
48109242|NCT04765358|100594458|FG000|STARTED|Overall Study||235||
48109243|NCT04765358|100594458|FG000|COMPLETED|Overall Study||234||
48693580|NCT02831855|102032811|FG002|Treated|Double Blind Phase (24 Weeks)||266||
48693581|NCT02831855|102032809|FG000|COMPLETED|Double Blind Phase (24 Weeks)||0||
48693582|NCT02831855|102032810|FG001|COMPLETED|Double Blind Phase (24 Weeks)||238||
48109244|NCT04765358|100594458|FG000|NOT COMPLETED|Overall Study||1||
48553434|NCT01026194|101690446|FG000|STARTED|Period 1：Double Blind Period||101||
48553435|NCT01026194|101690447|FG001|STARTED|Period 1：Double Blind Period||103||
48109245|NCT03909009|100594459|FG000|STARTED|Overall Study||10||
48109246|NCT03909009|100594460|FG001|STARTED|Overall Study||10||
48109247|NCT03909009|100594459|FG000|COMPLETED|Overall Study||10||
48109248|NCT03909009|100594460|FG001|COMPLETED|Overall Study||10||
48109249|NCT03909009|100594459|FG000|NOT COMPLETED|Overall Study||0||
48109250|NCT03909009|100594460|FG001|NOT COMPLETED|Overall Study||0||
48109251|NCT06259331|100594461|FG000|STARTED|Overall Study||15||
48109252|NCT06259331|100594461|FG000|COMPLETED|Overall Study||15||
48109253|NCT06259331|100594461|FG000|NOT COMPLETED|Overall Study||0||
48109254|NCT01331694|100594462|FG000|STARTED|Overall Study||16684||
48109255|NCT01331694|100594463|FG001|STARTED|Overall Study||14449||
48109256|NCT01331694|100594464|FG002|STARTED|Overall Study||12659||
48109257|NCT01331694|100594465|FG003|STARTED|Overall Study||12595||
48109258|NCT01331694|100594466|FG004|STARTED|Overall Study||10617||
48109259|NCT01331694|100594467|FG005|STARTED|Overall Study||9126||
48109260|NCT01331694|100594462|FG000|COMPLETED|Overall Study||16684||
48109261|NCT01331694|100594463|FG001|COMPLETED|Overall Study||14449||
48109262|NCT01331694|100594464|FG002|COMPLETED|Overall Study||12659||
48109263|NCT01331694|100594465|FG003|COMPLETED|Overall Study||12595||
48109264|NCT01331694|100594466|FG004|COMPLETED|Overall Study||10617||
48109265|NCT01331694|100594467|FG005|COMPLETED|Overall Study||9126||
48109266|NCT01331694|100594462|FG000|NOT COMPLETED|Overall Study||0||
48109267|NCT01331694|100594463|FG001|NOT COMPLETED|Overall Study||0||
48109268|NCT01331694|100594464|FG002|NOT COMPLETED|Overall Study||0||
48109269|NCT01331694|100594465|FG003|NOT COMPLETED|Overall Study||0||
48553436|NCT01026194|101690446|FG000|COMPLETED|Period 1：Double Blind Period||98||
48553437|NCT01026194|101690447|FG001|COMPLETED|Period 1：Double Blind Period||98||
48553438|NCT01026194|101690446|FG000|NOT COMPLETED|Period 1：Double Blind Period||3||
48553439|NCT01026194|101690447|FG001|NOT COMPLETED|Period 1：Double Blind Period||5||
48553440|NCT01026194|101690446|FG000|STARTED|Period 2：Open-label Period||98||
48553441|NCT01026194|101690447|FG001|STARTED|Period 2：Open-label Period||98||
48553442|NCT01026194|101690446|FG000|COMPLETED|Period 2：Open-label Period||91||
48553443|NCT01026194|101690447|FG001|COMPLETED|Period 2：Open-label Period||88||
48553444|NCT01026194|101690446|FG000|NOT COMPLETED|Period 2：Open-label Period||7||
48553445|NCT01026194|101690447|FG001|NOT COMPLETED|Period 2：Open-label Period||10||
48553446|NCT00074308|101690448|FG000|STARTED|Overall Study||3||
48553447|NCT00074308|101690449|FG001|STARTED|Overall Study||3||
48553448|NCT00074308|101690450|FG002|STARTED|Overall Study||3||
48553449|NCT00074308|101690451|FG003|STARTED|Overall Study||8||
48109270|NCT01331694|100594466|FG004|NOT COMPLETED|Overall Study||0||
48109271|NCT01331694|100594467|FG005|NOT COMPLETED|Overall Study||0||
48109272|NCT02953990|100594468|FG000|STARTED|Overall Study||41||
48109273|NCT02953990|100594468|FG000|COMPLETED|Overall Study||27||
48109274|NCT02953990|100594468|FG000|NOT COMPLETED|Overall Study||14||
48109275|NCT04155008|100594469|FG000|STARTED|Overall Study||0||
48109276|NCT04155008|100594470|FG001|STARTED|Overall Study||1||
48109277|NCT04155008|100594469|FG000|COMPLETED|Overall Study||0||
48109278|NCT04155008|100594470|FG001|COMPLETED|Overall Study||1||
48109279|NCT04155008|100594469|FG000|NOT COMPLETED|Overall Study||0||
48109280|NCT04155008|100594470|FG001|NOT COMPLETED|Overall Study||0||
48109281|NCT02501096|100594471|FG000|STARTED|Overall Study||2||
48553450|NCT00074308|101690452|FG004|STARTED|Overall Study||23||
48553451|NCT00074308|101690448|FG000|COMPLETED|Overall Study||3||
48109282|NCT02501096|100594472|FG001|STARTED|Overall Study||1||
48553452|NCT00074308|101690449|FG001|COMPLETED|Overall Study||3||
48693583|NCT02831855|102032811|FG002|COMPLETED|Double Blind Phase (24 Weeks)||247||
48109283|NCT02501096|100594473|FG002|STARTED|Overall Study||124||
48109284|NCT02501096|100594474|FG003|STARTED|Overall Study||145||
48109285|NCT02501096|100594475|FG004|STARTED|Overall Study||21||
48109286|NCT02501096|100594476|FG005|STARTED|Overall Study||21||
48109287|NCT02501096|100594477|FG006|STARTED|Overall Study||22||
48109288|NCT02501096|100594478|FG007|STARTED|Overall Study||20||
48109289|NCT02501096|100594479|FG008|STARTED|Overall Study||1||
48109290|NCT02501096|100594471|FG000|Phase 1b Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg.|Overall Study||0||
48109291|NCT02501096|100594472|FG001|Phase 1b Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg.|Overall Study||0||
48109292|NCT02501096|100594473|FG002|Phase 1b Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg.|Overall Study||2||
48109293|NCT02501096|100594474|FG003|Phase 1b Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg.|Overall Study||6||
48109294|NCT02501096|100594475|FG004|Phase 1b Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg.|Overall Study||1||
48109295|NCT02501096|100594476|FG005|Phase 1b Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg.|Overall Study||1||
48109296|NCT02501096|100594477|FG006|Phase 1b Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg.|Overall Study||0||
48109297|NCT02501096|100594478|FG007|Phase 1b Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg.|Overall Study||0||
48109298|NCT02501096|100594479|FG008|Phase 1b Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg.|Overall Study||0||
48109299|NCT02501096|100594471|FG000|Phase 2 Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg|Overall Study||0||
48109300|NCT02501096|100594472|FG001|Phase 2 Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg|Overall Study||0||
48109301|NCT02501096|100594473|FG002|Phase 2 Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg|Overall Study||122||
48109302|NCT02501096|100594474|FG003|Phase 2 Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg|Overall Study||139||
48109303|NCT02501096|100594475|FG004|Phase 2 Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg|Overall Study||20||
48109304|NCT02501096|100594476|FG005|Phase 2 Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg|Overall Study||20||
48109305|NCT02501096|100594477|FG006|Phase 2 Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg|Overall Study||22||
48109306|NCT02501096|100594478|FG007|Phase 2 Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg|Overall Study||20||
48553453|NCT00074308|101690450|FG002|COMPLETED|Overall Study||3||
48553454|NCT00074308|101690451|FG003|COMPLETED|Overall Study||8||
48109307|NCT02501096|100594479|FG008|Phase 2 Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg|Overall Study||1||
48109308|NCT02501096|100594471|FG000|COMPLETED|Overall Study||0||
48109309|NCT02501096|100594472|FG001|COMPLETED|Overall Study||0||
48109310|NCT02501096|100594473|FG002|COMPLETED|Overall Study||0||
48109311|NCT02501096|100594474|FG003|COMPLETED|Overall Study||0||
48109312|NCT02501096|100594475|FG004|COMPLETED|Overall Study||0||
48109313|NCT02501096|100594476|FG005|COMPLETED|Overall Study||0||
48109314|NCT02501096|100594477|FG006|COMPLETED|Overall Study||0||
48109315|NCT02501096|100594478|FG007|COMPLETED|Overall Study||0||
48109316|NCT02501096|100594479|FG008|COMPLETED|Overall Study||0||
48109317|NCT02501096|100594471|FG000|NOT COMPLETED|Overall Study||2||
48109318|NCT02501096|100594472|FG001|NOT COMPLETED|Overall Study||1||
48109319|NCT02501096|100594473|FG002|NOT COMPLETED|Overall Study||124||
48109320|NCT02501096|100594474|FG003|NOT COMPLETED|Overall Study||145||
48109321|NCT02501096|100594475|FG004|NOT COMPLETED|Overall Study||21||
48109322|NCT02501096|100594476|FG005|NOT COMPLETED|Overall Study||21||
48109323|NCT02501096|100594477|FG006|NOT COMPLETED|Overall Study||22||
48109324|NCT02501096|100594478|FG007|NOT COMPLETED|Overall Study||20||
48109325|NCT02501096|100594479|FG008|NOT COMPLETED|Overall Study||1||
48109326|NCT00539838|100594480|FG000|STARTED|Overall Study||12||
48109327|NCT00539838|100594481|FG001|STARTED|Overall Study||11||
48109328|NCT00539838|100594482|FG002|STARTED|Overall Study||10||
48109329|NCT00539838|100594480|FG000|COMPLETED|Overall Study||5||
48109330|NCT00539838|100594481|FG001|COMPLETED|Overall Study||5||
48109331|NCT00539838|100594482|FG002|COMPLETED|Overall Study||1||
48109332|NCT00539838|100594480|FG000|NOT COMPLETED|Overall Study||7||
48109333|NCT00539838|100594481|FG001|NOT COMPLETED|Overall Study||6||
48109334|NCT00539838|100594482|FG002|NOT COMPLETED|Overall Study||9||
48109335|NCT01024296|100594483|FG000|STARTED|Overall Study||4||
48109336|NCT01024296|100594483|FG000|COMPLETED|Overall Study||4||
48109337|NCT01024296|100594483|FG000|NOT COMPLETED|Overall Study||0||
48109338|NCT00075335|100594484|FG000|STARTED|Overall Study||8||
48109339|NCT00075335|100594484|FG000|COMPLETED|Overall Study||8||
48109340|NCT00075335|100594484|FG000|NOT COMPLETED|Overall Study||0||
48109341|NCT00404352|100594485|FG000|STARTED|Double Blind (up to 24 Month)||171||
48109342|NCT00404352|100594486|FG001|STARTED|Double Blind (up to 24 Month)||175||
48109343|NCT00404352|100594487|FG002|STARTED|Double Blind (up to 24 Month)||171||
48109344|NCT00404352|100594488|FG003|STARTED|Double Blind (up to 24 Month)||0||
48109345|NCT00404352|100594489|FG004|STARTED|Double Blind (up to 24 Month)||0||
48109346|NCT00404352|100594490|FG005|STARTED|Double Blind (up to 24 Month)||0||
48109347|NCT00404352|100594491|FG006|STARTED|Double Blind (up to 24 Month)||0||
48392504|NCT02282982|101291364|FG000|Attended Follow-up Visit|Overall Study||349||
48392505|NCT02282982|101291364|FG000|COMPLETED|Overall Study||153||
48392506|NCT02282982|101291364|FG000|NOT COMPLETED|Overall Study||206||
48392507|NCT04010370|101291365|FG000|STARTED|Overall Study||25||
48392508|NCT04010370|101291365|FG000|COMPLETED|Overall Study||25||
48553455|NCT00074308|101690452|FG004|COMPLETED|Overall Study||23||
48553456|NCT00074308|101690448|FG000|NOT COMPLETED|Overall Study||0||
48553457|NCT00074308|101690449|FG001|NOT COMPLETED|Overall Study||0||
48553458|NCT00074308|101690450|FG002|NOT COMPLETED|Overall Study||0||
48553459|NCT00074308|101690451|FG003|NOT COMPLETED|Overall Study||0||
48553460|NCT00074308|101690452|FG004|NOT COMPLETED|Overall Study||0||
48553461|NCT00908544|101690453|FG000|STARTED|Overall Study||20||
48553462|NCT00908544|101690454|FG001|STARTED|Overall Study||22||
48392509|NCT04010370|101291365|FG000|NOT COMPLETED|Overall Study||0||
48392510|NCT00109772|101291366|FG000|STARTED|Double-blind Treatment||90||
48392511|NCT00109772|101291367|FG001|STARTED|Double-blind Treatment||94||
48392512|NCT00109772|101291366|FG000|Safety and ITT Population|Double-blind Treatment||87||
48392513|NCT00109772|101291367|FG001|Safety and ITT Population|Double-blind Treatment||93||
48392514|NCT00109772|101291366|FG000|COMPLETED|Double-blind Treatment||68||
48392515|NCT00109772|101291367|FG001|COMPLETED|Double-blind Treatment||79||
48392516|NCT00109772|101291366|FG000|NOT COMPLETED|Double-blind Treatment||22||
48109348|NCT00404352|100594492|FG007|STARTED|Double Blind (up to 24 Month)||0||
48109349|NCT00404352|100594493|FG008|STARTED|Double Blind (up to 24 Month)||0||
48109350|NCT00404352|100594485|FG000|Treated|Double Blind (up to 24 Month)||171||
48109351|NCT00404352|100594486|FG001|Treated|Double Blind (up to 24 Month)||173||
48109352|NCT00404352|100594487|FG002|Treated|Double Blind (up to 24 Month)||171||
48109353|NCT00404352|100594488|FG003|Treated|Double Blind (up to 24 Month)||0||
48109354|NCT00404352|100594489|FG004|Treated|Double Blind (up to 24 Month)||0||
48109355|NCT00404352|100594490|FG005|Treated|Double Blind (up to 24 Month)||0||
48109356|NCT00404352|100594491|FG006|Treated|Double Blind (up to 24 Month)||0||
48109357|NCT00404352|100594492|FG007|Treated|Double Blind (up to 24 Month)||0||
48109358|NCT00404352|100594493|FG008|Treated|Double Blind (up to 24 Month)||0||
48109359|NCT00404352|100594485|FG000|COMPLETED|Double Blind (up to 24 Month)||119||
48109360|NCT00404352|100594486|FG001|COMPLETED|Double Blind (up to 24 Month)||128||
48109361|NCT00404352|100594487|FG002|COMPLETED|Double Blind (up to 24 Month)||92||
48109362|NCT00404352|100594488|FG003|COMPLETED|Double Blind (up to 24 Month)||0||
48109363|NCT00404352|100594489|FG004|COMPLETED|Double Blind (up to 24 Month)||0||
48109364|NCT00404352|100594490|FG005|COMPLETED|Double Blind (up to 24 Month)||0||
48109365|NCT00404352|100594491|FG006|COMPLETED|Double Blind (up to 24 Month)||0||
48109366|NCT00404352|100594492|FG007|COMPLETED|Double Blind (up to 24 Month)||0||
48109367|NCT00404352|100594493|FG008|COMPLETED|Double Blind (up to 24 Month)||0||
48109368|NCT00404352|100594485|FG000|NOT COMPLETED|Double Blind (up to 24 Month)||52||
48109369|NCT00404352|100594486|FG001|NOT COMPLETED|Double Blind (up to 24 Month)||47||
48109370|NCT00404352|100594487|FG002|NOT COMPLETED|Double Blind (up to 24 Month)||79||
48109371|NCT00404352|100594488|FG003|NOT COMPLETED|Double Blind (up to 24 Month)||0||
48109372|NCT00404352|100594489|FG004|NOT COMPLETED|Double Blind (up to 24 Month)||0||
48109373|NCT00404352|100594490|FG005|NOT COMPLETED|Double Blind (up to 24 Month)||0||
48109374|NCT00404352|100594491|FG006|NOT COMPLETED|Double Blind (up to 24 Month)||0||
48109375|NCT00404352|100594492|FG007|NOT COMPLETED|Double Blind (up to 24 Month)||0||
48109376|NCT00404352|100594493|FG008|NOT COMPLETED|Double Blind (up to 24 Month)||0||
48109377|NCT00404352|100594485|FG000|STARTED|Open Label (up to 24 Month)||0||
48109378|NCT00404352|100594486|FG001|STARTED|Open Label (up to 24 Month)||0||
48109379|NCT00404352|100594487|FG002|STARTED|Open Label (up to 24 Month)||0||
48109380|NCT00404352|100594488|FG003|STARTED|Open Label (up to 24 Month)||31||
48109381|NCT00404352|100594489|FG004|STARTED|Open Label (up to 24 Month)||30||
48109382|NCT00404352|100594490|FG005|STARTED|Open Label (up to 24 Month)||59||
48109383|NCT00404352|100594491|FG006|STARTED|Open Label (up to 24 Month)||0||
48109384|NCT00404352|100594492|FG007|STARTED|Open Label (up to 24 Month)||0||
48109385|NCT00404352|100594493|FG008|STARTED|Open Label (up to 24 Month)||0||
48109386|NCT00404352|100594485|FG000|COMPLETED|Open Label (up to 24 Month)||0||
48109387|NCT00404352|100594486|FG001|COMPLETED|Open Label (up to 24 Month)||0||
48109388|NCT00404352|100594487|FG002|COMPLETED|Open Label (up to 24 Month)||0||
48109389|NCT00404352|100594488|FG003|COMPLETED|Open Label (up to 24 Month)||28||
48109390|NCT00404352|100594489|FG004|COMPLETED|Open Label (up to 24 Month)||28||
48109391|NCT00404352|100594490|FG005|COMPLETED|Open Label (up to 24 Month)||52||
48109392|NCT00404352|100594491|FG006|COMPLETED|Open Label (up to 24 Month)||0||
48109393|NCT00404352|100594492|FG007|COMPLETED|Open Label (up to 24 Month)||0||
48109394|NCT00404352|100594493|FG008|COMPLETED|Open Label (up to 24 Month)||0||
48109395|NCT00404352|100594485|FG000|NOT COMPLETED|Open Label (up to 24 Month)||0||
48109396|NCT00404352|100594486|FG001|NOT COMPLETED|Open Label (up to 24 Month)||0||
48109397|NCT00404352|100594487|FG002|NOT COMPLETED|Open Label (up to 24 Month)||0||
48109398|NCT00404352|100594488|FG003|NOT COMPLETED|Open Label (up to 24 Month)||3||
48109399|NCT00404352|100594489|FG004|NOT COMPLETED|Open Label (up to 24 Month)||2||
48109400|NCT00404352|100594490|FG005|NOT COMPLETED|Open Label (up to 24 Month)||7||
48109401|NCT00404352|100594491|FG006|NOT COMPLETED|Open Label (up to 24 Month)||0||
48392517|NCT00109772|101291367|FG001|NOT COMPLETED|Double-blind Treatment||15||
48109402|NCT00404352|100594492|FG007|NOT COMPLETED|Open Label (up to 24 Month)||0||
48109403|NCT00404352|100594493|FG008|NOT COMPLETED|Open Label (up to 24 Month)||0||
48109404|NCT00404352|100594485|FG000|STARTED|Open Label Extension (up to 36 Months)||0||
48109405|NCT00404352|100594486|FG001|STARTED|Open Label Extension (up to 36 Months)||0||
48109406|NCT00404352|100594487|FG002|STARTED|Open Label Extension (up to 36 Months)||0||
48109407|NCT00404352|100594488|FG003|STARTED|Open Label Extension (up to 36 Months)||0||
48109408|NCT00404352|100594489|FG004|STARTED|Open Label Extension (up to 36 Months)||0||
48109409|NCT00404352|100594490|FG005|STARTED|Open Label Extension (up to 36 Months)||0||
48109410|NCT00404352|100594491|FG006|STARTED|Open Label Extension (up to 36 Months)||4||
48109411|NCT00404352|100594492|FG007|STARTED|Open Label Extension (up to 36 Months)||5||
48109412|NCT00404352|100594493|FG008|STARTED|Open Label Extension (up to 36 Months)||11||
48109413|NCT00404352|100594485|FG000|COMPLETED|Open Label Extension (up to 36 Months)||0||
48109414|NCT00404352|100594486|FG001|COMPLETED|Open Label Extension (up to 36 Months)||0||
48109415|NCT00404352|100594487|FG002|COMPLETED|Open Label Extension (up to 36 Months)||0||
48109416|NCT00404352|100594488|FG003|COMPLETED|Open Label Extension (up to 36 Months)||0||
48109417|NCT00404352|100594489|FG004|COMPLETED|Open Label Extension (up to 36 Months)||0||
48109418|NCT00404352|100594490|FG005|COMPLETED|Open Label Extension (up to 36 Months)||0||
48109419|NCT00404352|100594491|FG006|COMPLETED|Open Label Extension (up to 36 Months)||3||
48109420|NCT00404352|100594492|FG007|COMPLETED|Open Label Extension (up to 36 Months)||4||
48392518|NCT00109772|101291366|FG000|STARTED|Open-label Extension||64||
48392519|NCT00109772|101291367|FG001|STARTED|Open-label Extension||78||
48392520|NCT00109772|101291366|FG000|COMPLETED|Open-label Extension||19||
48392521|NCT00109772|101291367|FG001|COMPLETED|Open-label Extension||29||
48392522|NCT00109772|101291366|FG000|NOT COMPLETED|Open-label Extension||45||
48392523|NCT00109772|101291367|FG001|NOT COMPLETED|Open-label Extension||49||
48392524|NCT00014911|101291368|FG000|STARTED|Overall Study||36||
48392525|NCT00014911|101291368|FG000|COMPLETED|Overall Study||25||
48392526|NCT00014911|101291368|FG000|NOT COMPLETED|Overall Study||11||
48392527|NCT03874754|101291369|FG000|STARTED|Overall Study||22||
48392528|NCT03874754|101291370|FG001|STARTED|Overall Study||12||
48392529|NCT03874754|101291369|FG000|COMPLETED|Overall Study||14||
48392530|NCT03874754|101291370|FG001|COMPLETED|Overall Study||6||
48392531|NCT03874754|101291369|FG000|NOT COMPLETED|Overall Study||8||
48392532|NCT03874754|101291370|FG001|NOT COMPLETED|Overall Study||6||
48392533|NCT01351064|101291371|FG000|STARTED|Overall Study||42||
48392534|NCT01351064|101291372|FG001|STARTED|Overall Study||42||
48392535|NCT01351064|101291371|FG000|COMPLETED|Overall Study||42||
48109421|NCT00404352|100594493|FG008|COMPLETED|Open Label Extension (up to 36 Months)||9||
48109422|NCT00404352|100594485|FG000|NOT COMPLETED|Open Label Extension (up to 36 Months)||0||
48553463|NCT00908544|101690453|FG000|COMPLETED|Overall Study||15||
48553464|NCT00908544|101690454|FG001|COMPLETED|Overall Study||16||
48553465|NCT00908544|101690453|FG000|NOT COMPLETED|Overall Study||5||
48553466|NCT00908544|101690454|FG001|NOT COMPLETED|Overall Study||6||
48553467|NCT01459783|101690455|FG000|STARTED|Baseline to 6 Months||71||
48553468|NCT01459783|101690456|FG001|STARTED|Baseline to 6 Months||73||
48553469|NCT01459783|101690455|FG000|COMPLETED|Baseline to 6 Months||39||
48553470|NCT01459783|101690456|FG001|COMPLETED|Baseline to 6 Months||53||
48553471|NCT01459783|101690455|FG000|NOT COMPLETED|Baseline to 6 Months||32||
48553472|NCT01459783|101690456|FG001|NOT COMPLETED|Baseline to 6 Months||20||
48553473|NCT01459783|101690455|FG000|STARTED|6 Months to 12 Months||39||
48553474|NCT01459783|101690456|FG001|STARTED|6 Months to 12 Months||53||
48693584|NCT02831855|102032809|FG000|NOT COMPLETED|Double Blind Phase (24 Weeks)||0||
48109423|NCT00404352|100594486|FG001|NOT COMPLETED|Open Label Extension (up to 36 Months)||0||
48553475|NCT01459783|101690455|FG000|COMPLETED|6 Months to 12 Months||20||
48553476|NCT01459783|101690456|FG001|COMPLETED|6 Months to 12 Months||23||
48109424|NCT00404352|100594487|FG002|NOT COMPLETED|Open Label Extension (up to 36 Months)||0||
48109425|NCT00404352|100594488|FG003|NOT COMPLETED|Open Label Extension (up to 36 Months)||0||
48109426|NCT00404352|100594489|FG004|NOT COMPLETED|Open Label Extension (up to 36 Months)||0||
48109427|NCT00404352|100594490|FG005|NOT COMPLETED|Open Label Extension (up to 36 Months)||0||
48109428|NCT00404352|100594491|FG006|NOT COMPLETED|Open Label Extension (up to 36 Months)||1||
48109429|NCT00404352|100594492|FG007|NOT COMPLETED|Open Label Extension (up to 36 Months)||1||
48109430|NCT00404352|100594493|FG008|NOT COMPLETED|Open Label Extension (up to 36 Months)||2||
48109431|NCT04889625|100594494|FG000|STARTED|Period 1||40||
48109432|NCT04889625|100594495|FG001|STARTED|Period 1||38||
48109433|NCT04889625|100594494|FG000|COMPLETED|Period 1||37||
48109434|NCT04889625|100594495|FG001|COMPLETED|Period 1||34||
48109435|NCT04889625|100594494|FG000|NOT COMPLETED|Period 1||3||
48109436|NCT04889625|100594495|FG001|NOT COMPLETED|Period 1||4||
48109437|NCT04889625|100594494|FG000|STARTED|Period 2||37||
48109438|NCT04889625|100594495|FG001|STARTED|Period 2||34||
48109439|NCT04889625|100594494|FG000|COMPLETED|Period 2||35||
48109440|NCT04889625|100594495|FG001|COMPLETED|Period 2||33||
48109441|NCT04889625|100594494|FG000|NOT COMPLETED|Period 2||2||
48109442|NCT04889625|100594495|FG001|NOT COMPLETED|Period 2||1||
48109443|NCT04889625|100594494|FG000|STARTED|Period 3||35||
48109444|NCT04889625|100594495|FG001|STARTED|Period 3||33||
48109445|NCT04889625|100594494|FG000|COMPLETED|Period 3||35||
48109446|NCT04889625|100594495|FG001|COMPLETED|Period 3||33||
48109447|NCT04889625|100594494|FG000|NOT COMPLETED|Period 3||0||
48109448|NCT04889625|100594495|FG001|NOT COMPLETED|Period 3||0||
48109449|NCT03200925|100594496|FG000|STARTED|Overall Study||120||
48109450|NCT03200925|100594497|FG001|STARTED|Overall Study||120||
48109451|NCT03200925|100594496|FG000|COMPLETED|Overall Study||120||
48109452|NCT03200925|100594497|FG001|COMPLETED|Overall Study||120||
48109453|NCT03200925|100594496|FG000|NOT COMPLETED|Overall Study||0||
48109454|NCT03200925|100594497|FG001|NOT COMPLETED|Overall Study||0||
48109455|NCT00547703|100594498|FG000|STARTED|Overall Study||4||
48109456|NCT00547703|100594499|FG001|STARTED|Overall Study||1||
48109457|NCT00547703|100594498|FG000|COMPLETED|Overall Study||3||
48109458|NCT00547703|100594499|FG001|COMPLETED|Overall Study||1||
48109459|NCT00547703|100594498|FG000|NOT COMPLETED|Overall Study||1||
48109460|NCT00547703|100594499|FG001|NOT COMPLETED|Overall Study||0||
48109461|NCT03149237|100594500|FG000|STARTED|Overall Study||1108||12
48109462|NCT03149237|100594501|FG001|STARTED|Overall Study||1052||12
48109463|NCT03149237|100594500|FG000|COMPLETED|Overall Study||1104||12
48109464|NCT03149237|100594501|FG001|COMPLETED|Overall Study||1047||12
48109465|NCT03149237|100594500|FG000|NOT COMPLETED|Overall Study||4||0
48109466|NCT03149237|100594501|FG001|NOT COMPLETED|Overall Study||5||0
48693585|NCT02831855|102032810|FG001|NOT COMPLETED|Double Blind Phase (24 Weeks)||29||
48109467|NCT02769702|100594502|FG000|STARTED|Overall Study||2||
48109468|NCT02769702|100594502|FG000|COMPLETED|Overall Study||2||
48553477|NCT01459783|101690455|FG000|NOT COMPLETED|6 Months to 12 Months||19||
48553478|NCT01459783|101690456|FG001|NOT COMPLETED|6 Months to 12 Months||30||
48553479|NCT02126826|101690457|FG000|STARTED|Overall Study||9||
48109469|NCT02769702|100594502|FG000|NOT COMPLETED|Overall Study||0||
48109470|NCT04568122|100594503|FG000|STARTED|Overall Study||94||
48109471|NCT04568122|100594504|FG001|STARTED|Overall Study||112||
48109472|NCT04568122|100594505|FG002|STARTED|Overall Study||135||
48109473|NCT04568122|100594506|FG003|STARTED|Overall Study||9||
48109474|NCT04568122|100594507|FG004|STARTED|Overall Study||3||
48553480|NCT02126826|101690458|FG001|STARTED|Overall Study||9||
48553481|NCT02126826|101690459|FG002|STARTED|Overall Study||9||
48109475|NCT04568122|100594503|FG000|Completed One Test|Overall Study||46||
48109476|NCT04568122|100594504|FG001|Completed One Test|Overall Study||68||
48109477|NCT04568122|100594505|FG002|Completed One Test|Overall Study||131||
48109478|NCT04568122|100594506|FG003|Completed One Test|Overall Study||9||
48553482|NCT02126826|101690460|FG003|STARTED|Overall Study||9||
48553483|NCT02126826|101690461|FG004|STARTED|Overall Study||5||
48553484|NCT02126826|101690462|FG005|STARTED|Overall Study||9||
48553485|NCT02126826|101690463|FG006|STARTED|Overall Study||8||
48271214|NCT00561431|100988334|FG001|NOT COMPLETED|Overall Study||0||
48271215|NCT01538966|100988335|FG000|STARTED|Overall Study||23||
48271216|NCT01538966|100988336|FG001|STARTED|Overall Study||26||
48271217|NCT01538966|100988337|FG002|STARTED|Overall Study||27||
48271218|NCT01538966|100988335|FG000|COMPLETED|Overall Study||15||
48271219|NCT01538966|100988336|FG001|COMPLETED|Overall Study||14||
48271220|NCT01538966|100988337|FG002|COMPLETED|Overall Study||23||
48271221|NCT01538966|100988335|FG000|NOT COMPLETED|Overall Study||8||
48271222|NCT01538966|100988336|FG001|NOT COMPLETED|Overall Study||12||
48271223|NCT01538966|100988337|FG002|NOT COMPLETED|Overall Study||4||
48271224|NCT02568397|100988338|FG000|STARTED|Period 1||60||
48271225|NCT02568397|100988339|FG001|STARTED|Period 1||0||
48271226|NCT02568397|100988338|FG000|Received at Least 1 Dose of Study Drug|Period 1||60||
48271227|NCT02568397|100988339|FG001|Received at Least 1 Dose of Study Drug|Period 1||0||
48271228|NCT02568397|100988338|FG000|COMPLETED|Period 1||60||
48271229|NCT02568397|100988339|FG001|COMPLETED|Period 1||0||
48271230|NCT02568397|100988338|FG000|NOT COMPLETED|Period 1||0||
48271231|NCT02568397|100988339|FG001|NOT COMPLETED|Period 1||0||
48271232|NCT02568397|100988338|FG000|STARTED|Period 2||0||
48271233|NCT02568397|100988339|FG001|STARTED|Period 2||60||
48271234|NCT02568397|100988338|FG000|COMPLETED|Period 2||0||
48271235|NCT02568397|100988339|FG001|COMPLETED|Period 2||58||
48271236|NCT02568397|100988338|FG000|NOT COMPLETED|Period 2||0||
48271237|NCT02568397|100988339|FG001|NOT COMPLETED|Period 2||2||
48271238|NCT01186705|100988340|FG000|STARTED|Overall Study||1||
48271239|NCT01186705|100988340|FG000|COMPLETED|Overall Study||1||
48553486|NCT02126826|101690457|FG000|COMPLETED|Overall Study||9||
48553487|NCT02126826|101690458|FG001|COMPLETED|Overall Study||9||
48553488|NCT02126826|101690459|FG002|COMPLETED|Overall Study||9||
48553489|NCT02126826|101690460|FG003|COMPLETED|Overall Study||8||
48553490|NCT02126826|101690461|FG004|COMPLETED|Overall Study||5||
48553491|NCT02126826|101690462|FG005|COMPLETED|Overall Study||9||
48553492|NCT02126826|101690463|FG006|COMPLETED|Overall Study||8||
48271240|NCT01186705|100988340|FG000|NOT COMPLETED|Overall Study||0||
48271241|NCT00633880|100988341|FG000|STARTED|Open Label Titration||181||
48271242|NCT00633880|100988342|FG001|STARTED|Open Label Titration||0||
48271243|NCT00633880|100988343|FG002|STARTED|Open Label Titration||0||
48271244|NCT00633880|100988341|FG000|COMPLETED|Open Label Titration||101||
48271245|NCT00633880|100988342|FG001|COMPLETED|Open Label Titration||0||
48271246|NCT00633880|100988343|FG002|COMPLETED|Open Label Titration||0||
48271247|NCT00633880|100988341|FG000|NOT COMPLETED|Open Label Titration||80||
48271248|NCT00633880|100988342|FG001|NOT COMPLETED|Open Label Titration||0||
48271249|NCT00633880|100988343|FG002|NOT COMPLETED|Open Label Titration||0||
48271250|NCT00633880|100988341|FG000|STARTED|Randomized Double Blind||0||
48271251|NCT00633880|100988342|FG001|STARTED|Randomized Double Blind||50||
48271252|NCT00633880|100988343|FG002|STARTED|Randomized Double Blind||51||
48271253|NCT00633880|100988341|FG000|COMPLETED|Randomized Double Blind||0||
48271254|NCT00633880|100988342|FG001|COMPLETED|Randomized Double Blind||50||
48271255|NCT00633880|100988343|FG002|COMPLETED|Randomized Double Blind||51||
48271256|NCT00633880|100988341|FG000|NOT COMPLETED|Randomized Double Blind||0||
48271257|NCT00633880|100988342|FG001|NOT COMPLETED|Randomized Double Blind||0||
48271258|NCT00633880|100988343|FG002|NOT COMPLETED|Randomized Double Blind||0||
48271259|NCT03064152|100988344|FG000|STARTED|Overall Study||26||
48271260|NCT03064152|100988345|FG001|STARTED|Overall Study||23||
48271261|NCT03064152|100988344|FG000|COMPLETED|Overall Study||26||
48271262|NCT03064152|100988345|FG001|COMPLETED|Overall Study||23||
48271263|NCT03064152|100988344|FG000|NOT COMPLETED|Overall Study||0||
48271264|NCT03064152|100988345|FG001|NOT COMPLETED|Overall Study||0||
48271265|NCT03551691|100988346|FG000|STARTED|Overall Study||9||
48271266|NCT03551691|100988347|FG001|STARTED|Overall Study||10||
48271267|NCT03551691|100988346|FG000|COMPLETED|Overall Study||6||
48271268|NCT03551691|100988347|FG001|COMPLETED|Overall Study||7||
48271269|NCT03551691|100988346|FG000|NOT COMPLETED|Overall Study||3||
48553493|NCT02126826|101690457|FG000|NOT COMPLETED|Overall Study||0||
48553494|NCT02126826|101690458|FG001|NOT COMPLETED|Overall Study||0||
48553495|NCT02126826|101690459|FG002|NOT COMPLETED|Overall Study||0||
48553496|NCT02126826|101690460|FG003|NOT COMPLETED|Overall Study||1||
48271270|NCT03551691|100988347|FG001|NOT COMPLETED|Overall Study||3||
48271271|NCT02734498|100988348|FG000|STARTED|Overall Study||2||
48271272|NCT02734498|100988349|FG001|STARTED|Overall Study||0||
48271273|NCT02734498|100988350|FG002|STARTED|Overall Study||0||
48271274|NCT02734498|100988348|FG000|COMPLETED|Overall Study||2||
48553497|NCT02126826|101690461|FG004|NOT COMPLETED|Overall Study||0||
48553498|NCT02126826|101690462|FG005|NOT COMPLETED|Overall Study||0||
48271275|NCT02734498|100988349|FG001|COMPLETED|Overall Study||0||
48271276|NCT02734498|100988350|FG002|COMPLETED|Overall Study||0||
48271277|NCT02734498|100988348|FG000|NOT COMPLETED|Overall Study||0||
48271278|NCT02734498|100988349|FG001|NOT COMPLETED|Overall Study||0||
48271279|NCT02734498|100988350|FG002|NOT COMPLETED|Overall Study||0||
48553499|NCT02126826|101690463|FG006|NOT COMPLETED|Overall Study||0||
48553500|NCT03225001|101690464|FG000|STARTED|Overall Study||197||
48553501|NCT03225001|101690464|FG000|Valve-Implanted|Overall Study||195||
48553502|NCT03225001|101690464|FG000|COMPLETED|Overall Study||188||
48553503|NCT03225001|101690464|FG000|NOT COMPLETED|Overall Study||9||
48553504|NCT04607135|101690465|FG000|STARTED|Overall Study||34||
48553505|NCT04607135|101690465|FG000|Acoustic Radiation Force Impulse (ARFI)|Overall Study||30||
48553506|NCT04607135|101690465|FG000|MR-ultrasound Fusion|Overall Study||29||
48553507|NCT04607135|101690465|FG000|Systematic Sampling|Overall Study||30||
48553508|NCT04607135|101690465|FG000|COMPLETED|Overall Study||29||
48553509|NCT04607135|101690465|FG000|NOT COMPLETED|Overall Study||5||
48553510|NCT02856555|101690466|FG000|STARTED|Overall Study||51||
48553511|NCT02856555|101690467|FG001|STARTED|Overall Study||50||
48553512|NCT02856555|101690468|FG002|STARTED|Overall Study||26||
48553513|NCT02856555|101690466|FG000|COMPLETED|Overall Study||46||
48553514|NCT02856555|101690467|FG001|COMPLETED|Overall Study||46||
48553515|NCT02856555|101690468|FG002|COMPLETED|Overall Study||26||
48553516|NCT02856555|101690466|FG000|NOT COMPLETED|Overall Study||5||
48553517|NCT02856555|101690467|FG001|NOT COMPLETED|Overall Study||4||
48553518|NCT02856555|101690468|FG002|NOT COMPLETED|Overall Study||0||
48553519|NCT01289678|101690469|FG000|STARTED|Overall Study||18||
48553520|NCT01289678|101690469|FG000|COMPLETED|Overall Study||12||
48553521|NCT01289678|101690469|FG000|NOT COMPLETED|Overall Study||6||
48553522|NCT00580788|101690470|FG000|STARTED|Overall Study||3||
48109479|NCT04568122|100594507|FG004|Completed One Test|Overall Study||3||
48109480|NCT04568122|100594503|FG000|Completed 2 Tests|Overall Study||32||
48109481|NCT04568122|100594504|FG001|Completed 2 Tests|Overall Study||53||
48109482|NCT04568122|100594505|FG002|Completed 2 Tests|Overall Study||0||
48109483|NCT04568122|100594506|FG003|Completed 2 Tests|Overall Study||0||
48109484|NCT04568122|100594507|FG004|Completed 2 Tests|Overall Study||0||
48109485|NCT04568122|100594503|FG000|COMPLETED|Overall Study||46||
48109486|NCT04568122|100594504|FG001|COMPLETED|Overall Study||68||
48109487|NCT04568122|100594505|FG002|COMPLETED|Overall Study||131||
48109488|NCT04568122|100594506|FG003|COMPLETED|Overall Study||9||
48109489|NCT04568122|100594507|FG004|COMPLETED|Overall Study||3||
48109490|NCT04568122|100594503|FG000|NOT COMPLETED|Overall Study||48||
48109491|NCT04568122|100594504|FG001|NOT COMPLETED|Overall Study||44||
48109492|NCT04568122|100594505|FG002|NOT COMPLETED|Overall Study||4||
48109493|NCT04568122|100594506|FG003|NOT COMPLETED|Overall Study||0||
48109494|NCT04568122|100594507|FG004|NOT COMPLETED|Overall Study||0||
48109495|NCT04382911|100594508|FG000|STARTED|Overall Study||8||
48109496|NCT04382911|100594508|FG000|COMPLETED|Overall Study||6||
48109497|NCT04382911|100594508|FG000|NOT COMPLETED|Overall Study||2||
48109498|NCT00735371|100594509|FG000|STARTED|Overall Study||78||
48109499|NCT00735371|100594510|FG001|STARTED|Overall Study||79||
48109500|NCT00735371|100594511|FG002|STARTED|Overall Study||78||
48109501|NCT00735371|100594512|FG003|STARTED|Overall Study||79||
48109502|NCT00735371|100594509|FG000|COMPLETED|Overall Study||63||
48109503|NCT00735371|100594510|FG001|COMPLETED|Overall Study||66||
48109504|NCT00735371|100594511|FG002|COMPLETED|Overall Study||67||
48109505|NCT00735371|100594512|FG003|COMPLETED|Overall Study||69||
48109506|NCT00735371|100594509|FG000|NOT COMPLETED|Overall Study||15||
48109507|NCT00735371|100594510|FG001|NOT COMPLETED|Overall Study||13||
48109508|NCT00735371|100594511|FG002|NOT COMPLETED|Overall Study||11||
48109509|NCT00735371|100594512|FG003|NOT COMPLETED|Overall Study||10||
48109510|NCT02385799|100594513|FG000|STARTED|Overall Study||26||
48109511|NCT02385799|100594514|FG001|STARTED|Overall Study||32||
48109512|NCT02385799|100594513|FG000|Completed End-of-Treatment Visit|Overall Study||21|Includes all subjects who returned for end-of-treatment study visit, including early terminations.|
48109513|NCT02385799|100594514|FG001|Completed End-of-Treatment Visit|Overall Study||26|Includes all subjects who returned for end-of-treatment study visit, including early terminations.|
48109514|NCT02385799|100594513|FG000|COMPLETED|Overall Study||21|Includes all subjects who completed 6-month treatment with study drug. Excludes early terminations.|
48109515|NCT02385799|100594514|FG001|COMPLETED|Overall Study||24|Includes all subjects who completed 6-month treatment with study drug. Excludes early terminations.|
48109516|NCT02385799|100594513|FG000|NOT COMPLETED|Overall Study||5||
48109517|NCT02385799|100594514|FG001|NOT COMPLETED|Overall Study||8||
48109518|NCT01574703|100594515|FG000|STARTED|Overall Study||1192||
48109519|NCT01574703|100594516|FG001|STARTED|Overall Study||1166||
48109520|NCT01574703|100594517|FG002|STARTED|Overall Study||1116||
48109521|NCT01574703|100594518|FG003|STARTED|Overall Study||1121||
48109522|NCT01574703|100594515|FG000|COMPLETED|Overall Study||1067||
48109523|NCT01574703|100594516|FG001|COMPLETED|Overall Study||1054||
48109524|NCT01574703|100594517|FG002|COMPLETED|Overall Study||1011||
48109525|NCT01574703|100594518|FG003|COMPLETED|Overall Study||1007||
48109526|NCT01574703|100594515|FG000|NOT COMPLETED|Overall Study||125||
48109527|NCT01574703|100594516|FG001|NOT COMPLETED|Overall Study||112||
48109528|NCT01574703|100594517|FG002|NOT COMPLETED|Overall Study||105||
48109529|NCT01574703|100594518|FG003|NOT COMPLETED|Overall Study||114||
48109530|NCT01660893|100594519|FG000|STARTED|Overall Study||10||
48109531|NCT01660893|100594520|FG001|STARTED|Overall Study||10||
48553523|NCT00580788|101690471|FG001|STARTED|Overall Study||6||
48553524|NCT00580788|101690472|FG002|STARTED|Overall Study||3||
48553525|NCT00580788|101690473|FG003|STARTED|Overall Study||2||
48553526|NCT00580788|101690470|FG000|COMPLETED|Overall Study||3||
48553527|NCT00580788|101690471|FG001|COMPLETED|Overall Study||6||
48553528|NCT00580788|101690472|FG002|COMPLETED|Overall Study||3||
48553529|NCT00580788|101690473|FG003|COMPLETED|Overall Study||1||
48553530|NCT00580788|101690470|FG000|NOT COMPLETED|Overall Study||0||
48553531|NCT00580788|101690471|FG001|NOT COMPLETED|Overall Study||0||
48553532|NCT00580788|101690472|FG002|NOT COMPLETED|Overall Study||0||
48553533|NCT00580788|101690473|FG003|NOT COMPLETED|Overall Study||1||
48553534|NCT00124917|101690474|FG000|STARTED|Overall Study||6||
48553535|NCT00124917|101690474|FG000|COMPLETED|Overall Study||3||
48553536|NCT00124917|101690474|FG000|NOT COMPLETED|Overall Study||3||
48553537|NCT01207583|101690475|FG000|STARTED|Overall Study||14||
48553538|NCT01207583|101690476|FG001|STARTED|Overall Study||31||
48553539|NCT01207583|101690477|FG002|STARTED|Overall Study||55||
48553540|NCT01207583|101690475|FG000|Dose 1|Overall Study||14||
48553541|NCT01207583|101690476|FG001|Dose 1|Overall Study||31||
48553542|NCT01207583|101690477|FG002|Dose 1|Overall Study||55||
48553543|NCT01207583|101690475|FG000|Dose 2|Overall Study||13||
48553544|NCT01207583|101690476|FG001|Dose 2|Overall Study||29||
48109532|NCT01660893|100594521|FG002|STARTED|Overall Study||6||
48109533|NCT01660893|100594519|FG000|COMPLETED|Overall Study||10||
48109534|NCT01660893|100594520|FG001|COMPLETED|Overall Study||10||
48109535|NCT01660893|100594521|FG002|COMPLETED|Overall Study||6||
48109536|NCT01660893|100594519|FG000|NOT COMPLETED|Overall Study||0||
48109537|NCT01660893|100594520|FG001|NOT COMPLETED|Overall Study||0||
48109538|NCT01660893|100594521|FG002|NOT COMPLETED|Overall Study||0||
48109539|NCT01914666|100594522|FG000|STARTED|Treatment Period||68||
48109540|NCT01914666|100594523|FG001|STARTED|Treatment Period||42||
48109541|NCT01914666|100594524|FG002|STARTED|Treatment Period||41||
48109542|NCT01914666|100594522|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||68||
48109543|NCT01914666|100594523|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||42||
48109544|NCT01914666|100594524|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||41||
48109545|NCT01914666|100594522|FG000|COMPLETED|Treatment Period||55||
48553545|NCT01207583|101690477|FG002|Dose 2|Overall Study||54||
48553546|NCT01207583|101690475|FG000|Dose 3|Overall Study||13||
48109546|NCT01914666|100594523|FG001|COMPLETED|Treatment Period||36||
48109547|NCT01914666|100594524|FG002|COMPLETED|Treatment Period||33||
48109548|NCT01914666|100594522|FG000|NOT COMPLETED|Treatment Period||13||
48109549|NCT01914666|100594523|FG001|NOT COMPLETED|Treatment Period||6||
48109550|NCT01914666|100594524|FG002|NOT COMPLETED|Treatment Period||8||
48109551|NCT01914666|100594522|FG000|STARTED|Tapering Period||59||
48109552|NCT01914666|100594523|FG001|STARTED|Tapering Period||39||
48109553|NCT01914666|100594524|FG002|STARTED|Tapering Period||40||
48109554|NCT01914666|100594522|FG000|COMPLETED|Tapering Period||59||
48109555|NCT01914666|100594523|FG001|COMPLETED|Tapering Period||39||
48109556|NCT01914666|100594524|FG002|COMPLETED|Tapering Period||40||
48109557|NCT01914666|100594522|FG000|NOT COMPLETED|Tapering Period||0||
48109558|NCT01914666|100594523|FG001|NOT COMPLETED|Tapering Period||0||
48109559|NCT01914666|100594524|FG002|NOT COMPLETED|Tapering Period||0||
48109560|NCT04150224|100594525|FG000|STARTED|Overall Study||10||
48109561|NCT04150224|100594526|FG001|STARTED|Overall Study||10||
48109562|NCT04150224|100594527|FG002|STARTED|Overall Study||10||
48109563|NCT04150224|100594528|FG003|STARTED|Overall Study||10||
48109564|NCT04150224|100594529|FG004|STARTED|Overall Study||10||
48109565|NCT04150224|100594530|FG005|STARTED|Overall Study||10||
48109566|NCT04150224|100594525|FG000|COMPLETED|Overall Study||10||
48109567|NCT04150224|100594526|FG001|COMPLETED|Overall Study||10||
48109568|NCT04150224|100594527|FG002|COMPLETED|Overall Study||10||
48109569|NCT04150224|100594528|FG003|COMPLETED|Overall Study||10||
48109570|NCT04150224|100594529|FG004|COMPLETED|Overall Study||10||
48109571|NCT04150224|100594530|FG005|COMPLETED|Overall Study||10||
48109572|NCT04150224|100594525|FG000|NOT COMPLETED|Overall Study||0||
48109573|NCT04150224|100594526|FG001|NOT COMPLETED|Overall Study||0||
48109574|NCT04150224|100594527|FG002|NOT COMPLETED|Overall Study||0||
48109575|NCT04150224|100594528|FG003|NOT COMPLETED|Overall Study||0||
48109576|NCT04150224|100594529|FG004|NOT COMPLETED|Overall Study||0||
48109577|NCT04150224|100594530|FG005|NOT COMPLETED|Overall Study||0||
48109578|NCT00323414|100594531|FG000|STARTED|Overall Study||18||
48109579|NCT00323414|100594532|FG001|STARTED|Overall Study||19||
48109580|NCT00323414|100594531|FG000|COMPLETED|Overall Study||18||
48109581|NCT00323414|100594532|FG001|COMPLETED|Overall Study||18||
48109582|NCT00323414|100594531|FG000|NOT COMPLETED|Overall Study||0||
48553547|NCT01207583|101690476|FG001|Dose 3|Overall Study||27||
48553548|NCT01207583|101690477|FG002|Dose 3|Overall Study||0||
48553549|NCT01207583|101690475|FG000|Dose 4|Overall Study||7||
48553550|NCT01207583|101690476|FG001|Dose 4|Overall Study||0||
48553551|NCT01207583|101690477|FG002|Dose 4|Overall Study||0||
48553552|NCT01207583|101690475|FG000|COMPLETED|Overall Study||13||
48553553|NCT01207583|101690476|FG001|COMPLETED|Overall Study||26||
48109583|NCT00323414|100594532|FG001|NOT COMPLETED|Overall Study||1||
48109584|NCT02149342|100594533|FG000|STARTED|Overall Study||14||
48109585|NCT02149342|100594533|FG000|COMPLETED|Overall Study||14||
48109586|NCT02149342|100594533|FG000|NOT COMPLETED|Overall Study||0||
48109587|NCT01574352|100594534|FG000|STARTED|Overall Study||55||
48109588|NCT01574352|100594535|FG001|STARTED|Overall Study||51||
48109589|NCT01574352|100594534|FG000|COMPLETED|Overall Study||48||
48693586|NCT02831855|102032811|FG002|NOT COMPLETED|Double Blind Phase (24 Weeks)||19||
48693587|NCT05420961|102032812|FG000|STARTED|Overall Study||231||
48693588|NCT05420961|102032813|FG001|STARTED|Overall Study||119||
48693589|NCT05420961|102032814|FG002|STARTED|Overall Study||176||
48693590|NCT05420961|102032815|FG003|STARTED|Overall Study||85||
48693591|NCT05420961|102032816|FG004|STARTED|Overall Study||106||
48693592|NCT05420961|102032812|FG000|Day 1 - Vaccinated With V116|Overall Study||229||
48693593|NCT05420961|102032813|FG001|Day 1 - Vaccinated With V116|Overall Study||1||
48693594|NCT05420961|102032814|FG002|Day 1 - Vaccinated With V116|Overall Study||174||
48693595|NCT05420961|102032815|FG003|Day 1 - Vaccinated With V116|Overall Study||0||
48693596|NCT05420961|102032816|FG004|Day 1 - Vaccinated With V116|Overall Study||105||
48693597|NCT05420961|102032812|FG000|Day 1 - Vaccinated With PCV15|Overall Study||0||
48693598|NCT05420961|102032813|FG001|Day 1 - Vaccinated With PCV15|Overall Study||117||
48693599|NCT05420961|102032814|FG002|Day 1 - Vaccinated With PCV15|Overall Study||0||
48693600|NCT05420961|102032815|FG003|Day 1 - Vaccinated With PCV15|Overall Study||0||
48693601|NCT05420961|102032816|FG004|Day 1 - Vaccinated With PCV15|Overall Study||0||
48693602|NCT05420961|102032812|FG000|Day 1 - Vaccinated With PPSV23|Overall Study||0||
48109590|NCT01574352|100594535|FG001|COMPLETED|Overall Study||38||
48109591|NCT01574352|100594534|FG000|NOT COMPLETED|Overall Study||7||
48109592|NCT01574352|100594535|FG001|NOT COMPLETED|Overall Study||13||
48109593|NCT02108821|100594536|FG000|STARTED|Overall Study||23|March 12, 2014|
48109594|NCT02108821|100594536|FG000|COMPLETED|Overall Study||23|September 30th, 2016|
48109595|NCT02108821|100594536|FG000|NOT COMPLETED|Overall Study||0||
48271280|NCT03512964|100988351|FG000|STARTED|Overall Study||32||
48271281|NCT03512964|100988351|FG000|COMPLETED|Overall Study||32||
48271282|NCT03512964|100988351|FG000|NOT COMPLETED|Overall Study||0||
48271283|NCT00567567|100988352|FG000|STARTED|Overall Study||210||
48271284|NCT00567567|100988353|FG001|STARTED|Overall Study||176||
48271285|NCT00567567|100988354|FG002|STARTED|Overall Study||279||
48271286|NCT00567567|100988352|FG000|COMPLETED|Overall Study||58||
48271287|NCT00567567|100988353|FG001|COMPLETED|Overall Study||42||
48271288|NCT00567567|100988354|FG002|COMPLETED|Overall Study||1||
48271289|NCT00567567|100988352|FG000|NOT COMPLETED|Overall Study||152||
48271290|NCT00567567|100988353|FG001|NOT COMPLETED|Overall Study||134||
48271291|NCT00567567|100988354|FG002|NOT COMPLETED|Overall Study||278||
48271292|NCT01606670|100988355|FG000|STARTED|Overall Study||93||
48271293|NCT01606670|100988355|FG000|Safety Set|Overall Study||93||
48271294|NCT01606670|100988355|FG000|Full Analysis Set|Overall Study||70||
48109596|NCT00508742|100594537|FG000|STARTED|Period 1: Infant Series||932||
48109597|NCT00508742|100594538|FG001|STARTED|Period 1: Infant Series||934||
48109598|NCT00508742|100594537|FG000|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||930||
48109599|NCT00508742|100594538|FG001|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||933||
48109600|NCT00508742|100594537|FG000|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||904||
48109601|NCT00508742|100594538|FG001|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||902||
48109602|NCT00508742|100594537|FG000|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||898||
48109603|NCT00508742|100594538|FG001|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||892||
48109604|NCT00508742|100594537|FG000|COMPLETED|Period 1: Infant Series||890||
48109605|NCT00508742|100594538|FG001|COMPLETED|Period 1: Infant Series||889||
48109606|NCT00508742|100594537|FG000|NOT COMPLETED|Period 1: Infant Series||42||
48109607|NCT00508742|100594538|FG001|NOT COMPLETED|Period 1: Infant Series||45||
48109608|NCT00508742|100594537|FG000|STARTED|Period 2: After Infant Series||890||
48271295|NCT01606670|100988355|FG000|COMPLETED|Overall Study||77||
48271296|NCT01606670|100988355|FG000|NOT COMPLETED|Overall Study||16||
48271297|NCT00919191|100988356|FG000|STARTED|Overall Study||26||
48271298|NCT00919191|100988356|FG000|COMPLETED|Overall Study||26||
48271299|NCT00919191|100988356|FG000|NOT COMPLETED|Overall Study||0||
48271300|NCT00671177|100988357|FG000|STARTED|Overall Study||114||
48271301|NCT00671177|100988358|FG001|STARTED|Overall Study||115||
48271302|NCT00671177|100988357|FG000|COMPLETED|Overall Study||112||
48271303|NCT00671177|100988358|FG001|COMPLETED|Overall Study||114||
48271304|NCT00671177|100988357|FG000|NOT COMPLETED|Overall Study||2||
48271305|NCT00671177|100988358|FG001|NOT COMPLETED|Overall Study||1||
48271306|NCT02349152|100988359|FG000|STARTED|Overall Study||60||
48271307|NCT02349152|100988360|FG001|STARTED|Overall Study||56||
48271308|NCT02349152|100988359|FG000|COMPLETED|Overall Study||54||
48109609|NCT00508742|100594538|FG001|STARTED|Period 2: After Infant Series||889||
48109610|NCT00508742|100594537|FG000|COMPLETED|Period 2: After Infant Series||883||
48109611|NCT00508742|100594538|FG001|COMPLETED|Period 2: After Infant Series||878||
48109612|NCT00508742|100594537|FG000|NOT COMPLETED|Period 2: After Infant Series||7||
48271309|NCT02349152|100988360|FG001|COMPLETED|Overall Study||52||
48271310|NCT02349152|100988359|FG000|NOT COMPLETED|Overall Study||6||
48271311|NCT02349152|100988360|FG001|NOT COMPLETED|Overall Study||4||
48693603|NCT05420961|102032813|FG001|Day 1 - Vaccinated With PPSV23|Overall Study||1||
48693604|NCT05420961|102032814|FG002|Day 1 - Vaccinated With PPSV23|Overall Study||0||
48693605|NCT05420961|102032815|FG003|Day 1 - Vaccinated With PPSV23|Overall Study||85||
48271312|NCT01147536|100988361|FG000|STARTED|Overall Study||12||
48271313|NCT01147536|100988361|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12||
48271314|NCT01147536|100988361|FG000|COMPLETED|Overall Study||9||
48392536|NCT01351064|101291372|FG001|COMPLETED|Overall Study||42||
48109613|NCT00508742|100594538|FG001|NOT COMPLETED|Period 2: After Infant Series||11||
48271315|NCT01147536|100988361|FG000|NOT COMPLETED|Overall Study||3||
48271316|NCT00968526|100988362|FG000|STARTED|Overall Study||138||
48271317|NCT00968526|100988363|FG001|STARTED|Overall Study||102||
48271318|NCT00968526|100988362|FG000|COMPLETED|Overall Study||135||
48392537|NCT01351064|101291371|FG000|NOT COMPLETED|Overall Study||0||
48392538|NCT01351064|101291372|FG001|NOT COMPLETED|Overall Study||0||
48392539|NCT01285791|101291373|FG000|STARTED|Overall Study||11||
48392540|NCT01285791|101291374|FG001|STARTED|Overall Study||15||
48392541|NCT01285791|101291375|FG002|STARTED|Overall Study||13||
48392542|NCT01285791|101291373|FG000|COMPLETED|Overall Study||11||
48392543|NCT01285791|101291374|FG001|COMPLETED|Overall Study||15||
48271319|NCT00968526|100988363|FG001|COMPLETED|Overall Study||102||
48271320|NCT00968526|100988362|FG000|NOT COMPLETED|Overall Study||3||
48271321|NCT00968526|100988363|FG001|NOT COMPLETED|Overall Study||0||
48271322|NCT02592876|100988364|FG000|STARTED|Overall Study||41||
48271323|NCT02592876|100988365|FG001|STARTED|Overall Study||40||
48271324|NCT02592876|100988364|FG000|Received Study Drug|Overall Study||40||
48271325|NCT02592876|100988365|FG001|Received Study Drug|Overall Study||40||
48271326|NCT02592876|100988364|FG000|Completed Treatment|Overall Study||34||
48271327|NCT02592876|100988365|FG001|Completed Treatment|Overall Study||32||
48271328|NCT02592876|100988364|FG000|COMPLETED|Overall Study||0||
48271329|NCT02592876|100988365|FG001|COMPLETED|Overall Study||0||
48271330|NCT02592876|100988364|FG000|NOT COMPLETED|Overall Study||41||
48271331|NCT02592876|100988365|FG001|NOT COMPLETED|Overall Study||40||
48271332|NCT01213524|100988366|FG000|STARTED|Baseline||75||
48271333|NCT01213524|100988366|FG000|COMPLETED|Baseline||68||
48271334|NCT01213524|100988366|FG000|NOT COMPLETED|Baseline||7||
48271335|NCT01213524|100988366|FG000|STARTED|Session 2||68||
48271336|NCT01213524|100988366|FG000|COMPLETED|Session 2||63||
48271337|NCT01213524|100988366|FG000|NOT COMPLETED|Session 2||5||
48271338|NCT01213524|100988366|FG000|STARTED|Session 3||63||
48271339|NCT01213524|100988366|FG000|COMPLETED|Session 3||59||
48271340|NCT01213524|100988366|FG000|NOT COMPLETED|Session 3||4||
48271341|NCT01213524|100988366|FG000|STARTED|Session 4||59||
48271342|NCT01213524|100988366|FG000|COMPLETED|Session 4||56||
48271343|NCT01213524|100988366|FG000|NOT COMPLETED|Session 4||3||
48271344|NCT01213524|100988366|FG000|STARTED|Session 5||56||
48271345|NCT01213524|100988366|FG000|COMPLETED|Session 5||56||
48271346|NCT01213524|100988366|FG000|NOT COMPLETED|Session 5||0||
48271347|NCT01213524|100988366|FG000|STARTED|Session 6||56||
48271348|NCT01213524|100988366|FG000|COMPLETED|Session 6||56||
48271349|NCT01213524|100988366|FG000|NOT COMPLETED|Session 6||0||
48271350|NCT01213524|100988366|FG000|STARTED|Session 7||56||
48271351|NCT01213524|100988366|FG000|COMPLETED|Session 7||56||
48271352|NCT01213524|100988366|FG000|NOT COMPLETED|Session 7||0||
48271353|NCT02056626|100988367|FG000|STARTED|Overall Study||13||
48271354|NCT02056626|100988368|FG001|STARTED|Overall Study||13||
48271355|NCT02056626|100988369|FG002|STARTED|Overall Study||4||
48271356|NCT02056626|100988370|FG003|STARTED|Overall Study||14||
48271357|NCT02056626|100988367|FG000|COMPLETED|Overall Study||10||
48271358|NCT02056626|100988368|FG001|COMPLETED|Overall Study||12||
48271359|NCT02056626|100988369|FG002|COMPLETED|Overall Study||4||
48271360|NCT02056626|100988370|FG003|COMPLETED|Overall Study||14||
48392544|NCT01285791|101291375|FG002|COMPLETED|Overall Study||13||
48392545|NCT01285791|101291373|FG000|NOT COMPLETED|Overall Study||0||
48271361|NCT02056626|100988367|FG000|NOT COMPLETED|Overall Study||3||
48271362|NCT02056626|100988368|FG001|NOT COMPLETED|Overall Study||1||
48271363|NCT02056626|100988369|FG002|NOT COMPLETED|Overall Study||0||
48271364|NCT02056626|100988370|FG003|NOT COMPLETED|Overall Study||0||
48392546|NCT01285791|101291374|FG001|NOT COMPLETED|Overall Study||0||
48392547|NCT01285791|101291375|FG002|NOT COMPLETED|Overall Study||0||
48392548|NCT01078558|101291376|FG000|STARTED|Overall Study||2836||
48392549|NCT01078558|101291377|FG001|STARTED|Overall Study||1127||
48392550|NCT01078558|101291378|FG002|STARTED|Overall Study||1957||
48392551|NCT01078558|101291376|FG000|Oligoarticular PsA|Overall Study||0||
48392552|NCT01078558|101291377|FG001|Oligoarticular PsA|Overall Study||197||
48392553|NCT01078558|101291378|FG002|Oligoarticular PsA|Overall Study||0||
48392554|NCT01078558|101291376|FG000|COMPLETED|Overall Study||818||
48392555|NCT01078558|101291377|FG001|COMPLETED|Overall Study||372||
48271365|NCT01346072|100988371|FG000|STARTED|Overall Study||11||
48271366|NCT01346072|100988372|FG001|STARTED|Overall Study||10||
48271367|NCT01346072|100988371|FG000|COMPLETED|Overall Study||11||
48271368|NCT01346072|100988372|FG001|COMPLETED|Overall Study||10||
48271369|NCT01346072|100988371|FG000|NOT COMPLETED|Overall Study||0||
48271370|NCT01346072|100988372|FG001|NOT COMPLETED|Overall Study||0||
48392556|NCT01078558|101291378|FG002|COMPLETED|Overall Study||596||
48271371|NCT02278484|100988373|FG000|STARTED|Overall Study||50||
48271372|NCT02278484|100988373|FG000|COMPLETED|Overall Study||50||
48271373|NCT02278484|100988373|FG000|NOT COMPLETED|Overall Study||0||
48553554|NCT01207583|101690477|FG002|COMPLETED|Overall Study||54||
48553555|NCT01207583|101690475|FG000|NOT COMPLETED|Overall Study||1||
48553556|NCT01207583|101690476|FG001|NOT COMPLETED|Overall Study||5||
48553557|NCT01207583|101690477|FG002|NOT COMPLETED|Overall Study||1||
48553558|NCT04447040|101690478|FG000|STARTED|Overall Study||53||
48553559|NCT04447040|101690479|FG001|STARTED|Overall Study||49||
48553560|NCT04447040|101690480|FG002|STARTED|Overall Study||53||
48553561|NCT04447040|101690481|FG003|STARTED|Overall Study||52||
48553562|NCT04447040|101690482|FG004|STARTED|Overall Study||51||
48553563|NCT04447040|101690483|FG005|STARTED|Overall Study||46||
48553564|NCT04447040|101690478|FG000|COMPLETED|Overall Study||51||
48553565|NCT04447040|101690479|FG001|COMPLETED|Overall Study||47||
48553566|NCT04447040|101690480|FG002|COMPLETED|Overall Study||49||
48553567|NCT04447040|101690481|FG003|COMPLETED|Overall Study||48||
48553568|NCT04447040|101690482|FG004|COMPLETED|Overall Study||50||
48553569|NCT04447040|101690483|FG005|COMPLETED|Overall Study||43||
48553570|NCT04447040|101690478|FG000|NOT COMPLETED|Overall Study||2||
48553571|NCT04447040|101690479|FG001|NOT COMPLETED|Overall Study||2||
48553572|NCT04447040|101690480|FG002|NOT COMPLETED|Overall Study||4||
48553573|NCT04447040|101690481|FG003|NOT COMPLETED|Overall Study||4||
48553574|NCT04447040|101690482|FG004|NOT COMPLETED|Overall Study||1||
48553575|NCT04447040|101690483|FG005|NOT COMPLETED|Overall Study||3||
48553576|NCT00725491|101690484|FG000|STARTED|Overall Study||113||
48553577|NCT00725491|101690485|FG001|STARTED|Overall Study||120||
48553578|NCT00725491|101690484|FG000|COMPLETED|Overall Study||104||
48553579|NCT00725491|101690485|FG001|COMPLETED|Overall Study||102||
48553580|NCT00725491|101690484|FG000|NOT COMPLETED|Overall Study||9||
48553581|NCT00725491|101690485|FG001|NOT COMPLETED|Overall Study||18||
48553582|NCT01090414|101690486|FG000|STARTED|Parent Studies||191||
48553583|NCT01090414|101690487|FG001|STARTED|Parent Studies||241||
48553584|NCT01090414|101690488|FG002|STARTED|Parent Studies||64||
48553585|NCT01090414|101690489|FG003|STARTED|Parent Studies||18||
48553586|NCT01090414|101690486|FG000|COMPLETED|Parent Studies||50|Study completion was defined as participants who completed through Week 48 of parent study.|
48553587|NCT01090414|101690487|FG001|COMPLETED|Parent Studies||114|Study completion was defined as participants who completed through Week 48 of parent study.|
48553588|NCT01090414|101690488|FG002|COMPLETED|Parent Studies||43|Study completion was defined as participants who completed through Week 48 of parent study.|
48553589|NCT01090414|101690489|FG003|COMPLETED|Parent Studies||5|Study completion was defined as participants who completed through Week 48 of parent study.|
48553590|NCT01090414|101690486|FG000|NOT COMPLETED|Parent Studies||141||
48553591|NCT01090414|101690487|FG001|NOT COMPLETED|Parent Studies||127||
48553592|NCT01090414|101690488|FG002|NOT COMPLETED|Parent Studies||21||
48553593|NCT01090414|101690489|FG003|NOT COMPLETED|Parent Studies||13||
48553594|NCT01090414|101690486|FG000|STARTED|Study 101-99||48||
48553595|NCT01090414|101690487|FG001|STARTED|Study 101-99||108||
48553596|NCT01090414|101690488|FG002|STARTED|Study 101-99||41||
48553597|NCT01090414|101690489|FG003|STARTED|Study 101-99||5||
48109614|NCT00508742|100594537|FG000|STARTED|Period 3: Toddler Dose||883||
48109615|NCT00508742|100594538|FG001|STARTED|Period 3: Toddler Dose||878||
48109616|NCT00508742|100594537|FG000|COMPLETED|Period 3: Toddler Dose||858||
48109617|NCT00508742|100594538|FG001|COMPLETED|Period 3: Toddler Dose||863||
48109618|NCT00508742|100594537|FG000|NOT COMPLETED|Period 3: Toddler Dose||25||
48109619|NCT00508742|100594538|FG001|NOT COMPLETED|Period 3: Toddler Dose||15||
48553598|NCT01090414|101690486|FG000|COMPLETED|Study 101-99||0||
48553599|NCT01090414|101690487|FG001|COMPLETED|Study 101-99||0||
48553600|NCT01090414|101690488|FG002|COMPLETED|Study 101-99||0||
48553601|NCT01090414|101690489|FG003|COMPLETED|Study 101-99||0||
48553602|NCT01090414|101690486|FG000|NOT COMPLETED|Study 101-99||48||
48553603|NCT01090414|101690487|FG001|NOT COMPLETED|Study 101-99||108||
48553604|NCT01090414|101690488|FG002|NOT COMPLETED|Study 101-99||41||
48553605|NCT01090414|101690489|FG003|NOT COMPLETED|Study 101-99||5||
48553606|NCT00064987|101690490|FG000|STARTED|Overall Study||10||
48553607|NCT00064987|101690491|FG001|STARTED|Overall Study||6||
48553608|NCT00064987|101690490|FG000|COMPLETED|Overall Study||7||
48553609|NCT00064987|101690491|FG001|COMPLETED|Overall Study||6||
48553610|NCT00064987|101690490|FG000|NOT COMPLETED|Overall Study||3||
48553611|NCT00064987|101690491|FG001|NOT COMPLETED|Overall Study||0||
48553612|NCT02524847|101690492|FG000|STARTED|Overall Study||29||
48553613|NCT02524847|101690492|FG000|Completed Treatment Up to Week 12|Overall Study||14|Includes participants who received ECP treatments up to and including Week 12|
48271374|NCT01114880|100988374|FG000|STARTED|Period 1 (Week 0 to Week 12)||229||
48271375|NCT01114880|100988375|FG001|STARTED|Period 1 (Week 0 to Week 12)||115||
48271376|NCT01114880|100988374|FG000|COMPLETED|Period 1 (Week 0 to Week 12)||224||
48271377|NCT01114880|100988375|FG001|COMPLETED|Period 1 (Week 0 to Week 12)||113||
48271378|NCT01114880|100988374|FG000|NOT COMPLETED|Period 1 (Week 0 to Week 12)||5||
48553614|NCT02524847|101690492|FG000|Started Second Line Treatment|Overall Study||5||
48271379|NCT01114880|100988375|FG001|NOT COMPLETED|Period 1 (Week 0 to Week 12)||2||
48271380|NCT01114880|100988374|FG000|STARTED|Period 2 (Week 12 to Week 24)||224||
48271381|NCT01114880|100988375|FG001|STARTED|Period 2 (Week 12 to Week 24)||113||
48271382|NCT01114880|100988374|FG000|COMPLETED|Period 2 (Week 12 to Week 24)||221||
48271383|NCT01114880|100988375|FG001|COMPLETED|Period 2 (Week 12 to Week 24)||111||
48271384|NCT01114880|100988374|FG000|NOT COMPLETED|Period 2 (Week 12 to Week 24)||3||
48271385|NCT01114880|100988375|FG001|NOT COMPLETED|Period 2 (Week 12 to Week 24)||2||
48271386|NCT03079297|100988376|FG000|STARTED|First Intervention (14 Days)||2||
48271387|NCT03079297|100988377|FG001|STARTED|First Intervention (14 Days)||2||
48553615|NCT02524847|101690492|FG000|COMPLETED|Overall Study||15||
48553616|NCT02524847|101690492|FG000|NOT COMPLETED|Overall Study||14||
48553617|NCT01565889|101690493|FG000|STARTED|Part A||12||
48553618|NCT01565889|101690494|FG001|STARTED|Part A||4||
48553619|NCT01565889|101690495|FG002|STARTED|Part A||8||
48553620|NCT01565889|101690496|FG003|STARTED|Part A||7||
48553621|NCT01565889|101690497|FG004|STARTED|Part A||7||
48553622|NCT01565889|101690498|FG005|STARTED|Part A||0||
48271388|NCT03079297|100988376|FG000|COMPLETED|First Intervention (14 Days)||2||
48271389|NCT03079297|100988377|FG001|COMPLETED|First Intervention (14 Days)||2||
48271390|NCT03079297|100988376|FG000|NOT COMPLETED|First Intervention (14 Days)||0||
48271391|NCT03079297|100988377|FG001|NOT COMPLETED|First Intervention (14 Days)||0||
48271392|NCT03079297|100988376|FG000|STARTED|Washout (14 Days)||2||
48271393|NCT03079297|100988377|FG001|STARTED|Washout (14 Days)||2||
48271394|NCT03079297|100988376|FG000|COMPLETED|Washout (14 Days)||2||
48271395|NCT03079297|100988377|FG001|COMPLETED|Washout (14 Days)||2||
48553623|NCT01565889|101690493|FG000|COMPLETED|Part A||11||
48693606|NCT05420961|102032816|FG004|Day 1 - Vaccinated With PPSV23|Overall Study||0||
48553624|NCT01565889|101690494|FG001|COMPLETED|Part A||4||
48553625|NCT01565889|101690495|FG002|COMPLETED|Part A||8||
48693607|NCT05420961|102032812|FG000|COMPLETED|Overall Study||229||
48693608|NCT05420961|102032813|FG001|COMPLETED|Overall Study||118||
48693609|NCT05420961|102032814|FG002|COMPLETED|Overall Study||173||
48693610|NCT05420961|102032815|FG003|COMPLETED|Overall Study||85||
48693611|NCT05420961|102032816|FG004|COMPLETED|Overall Study||105||
48693612|NCT05420961|102032812|FG000|NOT COMPLETED|Overall Study||2||
48693613|NCT05420961|102032813|FG001|NOT COMPLETED|Overall Study||1||
48693614|NCT05420961|102032814|FG002|NOT COMPLETED|Overall Study||3||
48693615|NCT05420961|102032815|FG003|NOT COMPLETED|Overall Study||0||
48693616|NCT05420961|102032816|FG004|NOT COMPLETED|Overall Study||1||
48693617|NCT00586716|102032817|FG000|STARTED|Overall Study||14||
48693618|NCT00586716|102032818|FG001|STARTED|Overall Study||8||
48693619|NCT00586716|102032817|FG000|COMPLETED|Overall Study||14||
48693620|NCT00586716|102032818|FG001|COMPLETED|Overall Study||8||
48693621|NCT00586716|102032817|FG000|NOT COMPLETED|Overall Study||0||
48693622|NCT00586716|102032818|FG001|NOT COMPLETED|Overall Study||0||
48693623|NCT00906178|102032819|FG000|STARTED|Overall Study||183||
48693624|NCT00906178|102032820|FG001|STARTED|Overall Study||183||
48693625|NCT00906178|102032819|FG000|COMPLETED|Overall Study||168||
48693626|NCT00906178|102032820|FG001|COMPLETED|Overall Study||167||
48271396|NCT03079297|100988376|FG000|NOT COMPLETED|Washout (14 Days)||0||
48553626|NCT01565889|101690496|FG003|COMPLETED|Part A||7||
48553627|NCT01565889|101690497|FG004|COMPLETED|Part A||7||
48553628|NCT01565889|101690498|FG005|COMPLETED|Part A||0||
48553629|NCT01565889|101690493|FG000|NOT COMPLETED|Part A||1||
48553630|NCT01565889|101690494|FG001|NOT COMPLETED|Part A||0||
48553631|NCT01565889|101690495|FG002|NOT COMPLETED|Part A||0||
48553632|NCT01565889|101690496|FG003|NOT COMPLETED|Part A||0||
48693627|NCT00906178|102032819|FG000|NOT COMPLETED|Overall Study||15||
48693628|NCT00906178|102032820|FG001|NOT COMPLETED|Overall Study||16||
48693629|NCT01017042|102032821|FG000|STARTED|Overall Study||13||
48693630|NCT01017042|102032821|FG000|COMPLETED|Overall Study||13||
48693631|NCT01017042|102032821|FG000|NOT COMPLETED|Overall Study||0||
48693632|NCT02057640|102032822|FG000|STARTED|Weeks 1-4||4||
48693633|NCT02057640|102032823|FG001|STARTED|Weeks 1-4||3||
48693634|NCT02057640|102032822|FG000|COMPLETED|Weeks 1-4||4||
48693635|NCT02057640|102032823|FG001|COMPLETED|Weeks 1-4||3||
48271397|NCT03079297|100988377|FG001|NOT COMPLETED|Washout (14 Days)||0||
48553633|NCT01565889|101690497|FG004|NOT COMPLETED|Part A||0||
48553634|NCT01565889|101690498|FG005|NOT COMPLETED|Part A||0||
48553635|NCT01565889|101690493|FG000|STARTED|Part B||0||
48553636|NCT01565889|101690494|FG001|STARTED|Part B||0||
48693636|NCT02057640|102032822|FG000|NOT COMPLETED|Weeks 1-4||0||
48693637|NCT02057640|102032823|FG001|NOT COMPLETED|Weeks 1-4||0||
48693638|NCT02057640|102032822|FG000|STARTED|Phase II Portion of Study at DL2||0||
48693639|NCT02057640|102032823|FG001|STARTED|Phase II Portion of Study at DL2||9||
48553637|NCT01565889|101690495|FG002|STARTED|Part B||0||
48553638|NCT01565889|101690496|FG003|STARTED|Part B||0||
48693640|NCT02057640|102032822|FG000|COMPLETED|Phase II Portion of Study at DL2||0||
48553639|NCT01565889|101690497|FG004|STARTED|Part B||0||
48553640|NCT01565889|101690498|FG005|STARTED|Part B||23||
48553641|NCT01565889|101690493|FG000|COMPLETED|Part B||0||
48553642|NCT01565889|101690494|FG001|COMPLETED|Part B||0||
48553643|NCT01565889|101690495|FG002|COMPLETED|Part B||0||
48553644|NCT01565889|101690496|FG003|COMPLETED|Part B||0||
48553645|NCT01565889|101690497|FG004|COMPLETED|Part B||0||
48553646|NCT01565889|101690498|FG005|COMPLETED|Part B||19||
48553647|NCT01565889|101690493|FG000|NOT COMPLETED|Part B||0||
48553648|NCT01565889|101690494|FG001|NOT COMPLETED|Part B||0||
48553649|NCT01565889|101690495|FG002|NOT COMPLETED|Part B||0||
48553650|NCT01565889|101690496|FG003|NOT COMPLETED|Part B||0||
48553651|NCT01565889|101690497|FG004|NOT COMPLETED|Part B||0||
48553652|NCT01565889|101690498|FG005|NOT COMPLETED|Part B||4||
48553653|NCT01895777|101690499|FG000|STARTED|Overall Study||177||
48553654|NCT01895777|101690500|FG001|STARTED|Overall Study||90||
48553655|NCT01895777|101690499|FG000|Treated|Overall Study||176||
48553656|NCT01895777|101690500|FG001|Treated|Overall Study||90||
48553657|NCT01895777|101690499|FG000|COMPLETED|Overall Study||168||
48553658|NCT01895777|101690500|FG001|COMPLETED|Overall Study||85||
48553659|NCT01895777|101690499|FG000|NOT COMPLETED|Overall Study||9||
48553660|NCT01895777|101690500|FG001|NOT COMPLETED|Overall Study||5||
48553661|NCT02107131|101690501|FG000|STARTED|Overall Study||20||
48553662|NCT02107131|101690502|FG001|STARTED|Overall Study||20||
48553663|NCT02107131|101690501|FG000|COMPLETED|Overall Study||12||
48553664|NCT02107131|101690502|FG001|COMPLETED|Overall Study||11||
48271398|NCT03079297|100988376|FG000|STARTED|Second Intervention (14 Days)||2||
48271399|NCT03079297|100988377|FG001|STARTED|Second Intervention (14 Days)||2||
48271400|NCT03079297|100988376|FG000|COMPLETED|Second Intervention (14 Days)||2||
48271401|NCT03079297|100988377|FG001|COMPLETED|Second Intervention (14 Days)||2||
48271402|NCT03079297|100988376|FG000|NOT COMPLETED|Second Intervention (14 Days)||0||
48271403|NCT03079297|100988377|FG001|NOT COMPLETED|Second Intervention (14 Days)||0||
48271404|NCT04055090|100988378|FG000|STARTED|Overall Study||65|Treatment assignments (Engensis or Placebo) for this study, VMDN-003b, are based on the treatment groups in the prior study, VMDN-003|
48271405|NCT04055090|100988379|FG001|STARTED|Overall Study||36|Treatment assignments (Engensis or Placebo) for this study, VMDN-003b, are based on the treatment groups in the prior study, VMDN-003|
48271406|NCT04055090|100988378|FG000|COMPLETED|Overall Study||63||
48271407|NCT04055090|100988379|FG001|COMPLETED|Overall Study||36||
48271408|NCT04055090|100988378|FG000|NOT COMPLETED|Overall Study||2||
48271409|NCT04055090|100988379|FG001|NOT COMPLETED|Overall Study||0||
48553665|NCT02107131|101690501|FG000|NOT COMPLETED|Overall Study||8||
48553666|NCT02107131|101690502|FG001|NOT COMPLETED|Overall Study||9||
48553667|NCT01626690|101690503|FG000|STARTED|Overall Study||49||
48553668|NCT01626690|101690504|FG001|STARTED|Overall Study||51||
48553669|NCT01626690|101690503|FG000|COMPLETED|Overall Study||47||
48553670|NCT01626690|101690504|FG001|COMPLETED|Overall Study||51||
48553671|NCT01626690|101690503|FG000|NOT COMPLETED|Overall Study||2||
48553672|NCT01626690|101690504|FG001|NOT COMPLETED|Overall Study||0||
48553673|NCT03417778|101690505|FG000|STARTED|Overall Study||10||
48553674|NCT03417778|101690506|FG001|STARTED|Overall Study||10||
48271410|NCT02922023|100988380|FG000|STARTED|Overall Study||2||
48553675|NCT03417778|101690505|FG000|COMPLETED|Overall Study||10||
48553676|NCT03417778|101690506|FG001|COMPLETED|Overall Study||10||
48553677|NCT03417778|101690505|FG000|NOT COMPLETED|Overall Study||0||
48553678|NCT03417778|101690506|FG001|NOT COMPLETED|Overall Study||0||
48553679|NCT00916383|101690507|FG000|STARTED|Overall Study||49||
48553680|NCT00916383|101690507|FG000|COMPLETED|Overall Study||46||
48553681|NCT00916383|101690507|FG000|NOT COMPLETED|Overall Study||3||
48553682|NCT03474874|101690508|FG000|STARTED|Overall Study||68||
48553683|NCT03474874|101690508|FG000|COMPLETED|Overall Study||54||
48553684|NCT03474874|101690508|FG000|NOT COMPLETED|Overall Study||14||
48553685|NCT02286843|101690509|FG000|STARTED|Overall Study||49||
48553686|NCT02286843|101690509|FG000|COMPLETED|Overall Study||43||
48553687|NCT02286843|101690509|FG000|NOT COMPLETED|Overall Study||6||
48553688|NCT01112059|101690510|FG000|STARTED|Overall Study||20||
48553689|NCT01112059|101690511|FG001|STARTED|Overall Study||20||
48553690|NCT01112059|101690510|FG000|COMPLETED|Overall Study||19||
48553691|NCT01112059|101690511|FG001|COMPLETED|Overall Study||20||
48553692|NCT01112059|101690510|FG000|NOT COMPLETED|Overall Study||1||
48553693|NCT01112059|101690511|FG001|NOT COMPLETED|Overall Study||0||
48553694|NCT01176513|101690512|FG000|STARTED|Overall Study||25||
48553695|NCT01176513|101690512|FG000|COMPLETED|Overall Study||22||
48553696|NCT01176513|101690512|FG000|NOT COMPLETED|Overall Study||3||
48553697|NCT01277783|101690513|FG000|STARTED|Overall Study||138||
48553698|NCT01277783|101690513|FG000|COMPLETED|Overall Study||138||
48553699|NCT01277783|101690513|FG000|NOT COMPLETED|Overall Study||0||
48553700|NCT04108299|101690514|FG000|STARTED|Overall Study||12||
48553701|NCT04108299|101690515|FG001|STARTED|Overall Study||11||
48553702|NCT04108299|101690516|FG002|STARTED|Overall Study||12||
48553703|NCT04108299|101690517|FG003|STARTED|Overall Study||11||
48553704|NCT04108299|101690514|FG000|COMPLETED|Overall Study||10||
48553705|NCT04108299|101690515|FG001|COMPLETED|Overall Study||10||
48553706|NCT04108299|101690516|FG002|COMPLETED|Overall Study||10||
48553707|NCT04108299|101690517|FG003|COMPLETED|Overall Study||10||
48553708|NCT04108299|101690514|FG000|NOT COMPLETED|Overall Study||2||
48553709|NCT04108299|101690515|FG001|NOT COMPLETED|Overall Study||1||
48553710|NCT04108299|101690516|FG002|NOT COMPLETED|Overall Study||2||
48553711|NCT04108299|101690517|FG003|NOT COMPLETED|Overall Study||1||
48553712|NCT01662778|101690518|FG000|STARTED|Period 1||6||
48553713|NCT01662778|101690519|FG001|STARTED|Period 1||5||
48553714|NCT01662778|101690520|FG002|STARTED|Period 1||6||
48553715|NCT01662778|101690521|FG003|STARTED|Period 1||4||
48553716|NCT01662778|101690518|FG000|COMPLETED|Period 1||6||
48553717|NCT01662778|101690519|FG001|COMPLETED|Period 1||5||
48553718|NCT01662778|101690520|FG002|COMPLETED|Period 1||6||
48553719|NCT01662778|101690521|FG003|COMPLETED|Period 1||4||
48271411|NCT02922023|100988381|FG001|STARTED|Overall Study||0||
48271412|NCT02922023|100988380|FG000|COMPLETED|Overall Study||0||
48271413|NCT02922023|100988381|FG001|COMPLETED|Overall Study||0||
48271414|NCT02922023|100988380|FG000|NOT COMPLETED|Overall Study||2||
48271415|NCT02922023|100988381|FG001|NOT COMPLETED|Overall Study||0||
48271416|NCT02473289|100988382|FG000|STARTED|Overall Study||99||
48271417|NCT02473289|100988383|FG001|STARTED|Overall Study||94||
48271418|NCT02473289|100988382|FG000|COMPLETED|Overall Study||88||
48271419|NCT02473289|100988383|FG001|COMPLETED|Overall Study||81||
48271420|NCT02473289|100988382|FG000|NOT COMPLETED|Overall Study||11||
48271421|NCT02473289|100988383|FG001|NOT COMPLETED|Overall Study||13||
48271422|NCT03812029|100988384|FG000|STARTED|Overall Study||7||
48271423|NCT03812029|100988385|FG001|STARTED|Overall Study||17||
48271424|NCT03812029|100988386|FG002|STARTED|Overall Study||32||
48271425|NCT03812029|100988387|FG003|STARTED|Overall Study||31||
48271426|NCT03812029|100988388|FG004|STARTED|Overall Study||33||
48271427|NCT03812029|100988384|FG000|COMPLETED|Overall Study||5||
48271428|NCT03812029|100988385|FG001|COMPLETED|Overall Study||7||
48271429|NCT03812029|100988386|FG002|COMPLETED|Overall Study||32||
48271430|NCT03812029|100988387|FG003|COMPLETED|Overall Study||25||
48271431|NCT03812029|100988388|FG004|COMPLETED|Overall Study||23||
48271432|NCT03812029|100988384|FG000|NOT COMPLETED|Overall Study||2||
48271433|NCT03812029|100988385|FG001|NOT COMPLETED|Overall Study||10||
48271434|NCT03812029|100988386|FG002|NOT COMPLETED|Overall Study||0||
48271435|NCT03812029|100988387|FG003|NOT COMPLETED|Overall Study||6||
48271436|NCT03812029|100988388|FG004|NOT COMPLETED|Overall Study||10||
48271437|NCT00214019|100988389|FG000|STARTED|Overall Study||36||
48553720|NCT01662778|101690518|FG000|NOT COMPLETED|Period 1||0||
48553721|NCT01662778|101690519|FG001|NOT COMPLETED|Period 1||0||
48553722|NCT01662778|101690520|FG002|NOT COMPLETED|Period 1||0||
48553723|NCT01662778|101690521|FG003|NOT COMPLETED|Period 1||0||
48553724|NCT01662778|101690518|FG000|STARTED|Period 2||6||
48553725|NCT01662778|101690519|FG001|STARTED|Period 2||5||
48553726|NCT01662778|101690520|FG002|STARTED|Period 2||6||
48553727|NCT01662778|101690521|FG003|STARTED|Period 2||4||
48553728|NCT01662778|101690518|FG000|COMPLETED|Period 2||6||
48553729|NCT01662778|101690519|FG001|COMPLETED|Period 2||5||
48553730|NCT01662778|101690520|FG002|COMPLETED|Period 2||6||
48553731|NCT01662778|101690521|FG003|COMPLETED|Period 2||4||
48553732|NCT01662778|101690518|FG000|NOT COMPLETED|Period 2||0||
48553733|NCT01662778|101690519|FG001|NOT COMPLETED|Period 2||0||
48553734|NCT01662778|101690520|FG002|NOT COMPLETED|Period 2||0||
48553735|NCT01662778|101690521|FG003|NOT COMPLETED|Period 2||0||
48553736|NCT01662778|101690518|FG000|STARTED|Period 3||6||
48553737|NCT01662778|101690519|FG001|STARTED|Period 3||5||
48553738|NCT01662778|101690520|FG002|STARTED|Period 3||6||
48553739|NCT01662778|101690521|FG003|STARTED|Period 3||4||
48553740|NCT01662778|101690518|FG000|COMPLETED|Period 3||6||
48553741|NCT01662778|101690519|FG001|COMPLETED|Period 3||5||
48553742|NCT01662778|101690520|FG002|COMPLETED|Period 3||6||
48553743|NCT01662778|101690521|FG003|COMPLETED|Period 3||4||
48553744|NCT01662778|101690518|FG000|NOT COMPLETED|Period 3||0||
48553745|NCT01662778|101690519|FG001|NOT COMPLETED|Period 3||0||
48553746|NCT01662778|101690520|FG002|NOT COMPLETED|Period 3||0||
48271438|NCT00214019|100988389|FG000|Placebo/Placebo Arm|Overall Study||6||
48271439|NCT00214019|100988389|FG000|Placebo/Salmeterol Arm|Overall Study||6||
48271440|NCT00214019|100988389|FG000|Fluticasone/Placebo Arm|Overall Study||6||
48271441|NCT00214019|100988389|FG000|Fluticason/Salmeterol Arm|Overall Study||6||
48271442|NCT00214019|100988389|FG000|COMPLETED|Overall Study||6||
48271443|NCT00214019|100988389|FG000|NOT COMPLETED|Overall Study||30||
48271444|NCT03258723|100988390|FG000|STARTED|Overall Study||114||
48553747|NCT01662778|101690521|FG003|NOT COMPLETED|Period 3||0||
48553748|NCT01662778|101690518|FG000|STARTED|Period 4||6||
48271445|NCT03258723|100988390|FG000|6 Month Follow up|Overall Study||80||
48271446|NCT03258723|100988390|FG000|12 Month Follow up|Overall Study||52||
48271447|NCT03258723|100988390|FG000|COMPLETED|Overall Study||52||
48271448|NCT03258723|100988390|FG000|NOT COMPLETED|Overall Study||62||
48271449|NCT02206061|100988391|FG000|STARTED|Overall Study||149||
48271450|NCT02206061|100988392|FG001|STARTED|Overall Study||142||
48271451|NCT02206061|100988393|FG002|STARTED|Overall Study||139||
48553749|NCT01662778|101690519|FG001|STARTED|Period 4||5||
48553750|NCT01662778|101690520|FG002|STARTED|Period 4||6||
48553751|NCT01662778|101690521|FG003|STARTED|Period 4||4||
48553752|NCT01662778|101690518|FG000|COMPLETED|Period 4||6||
48553753|NCT01662778|101690519|FG001|COMPLETED|Period 4||5||
48553754|NCT01662778|101690520|FG002|COMPLETED|Period 4||6||
48553755|NCT01662778|101690521|FG003|COMPLETED|Period 4||4||
48553756|NCT01662778|101690518|FG000|NOT COMPLETED|Period 4||0||
48553757|NCT01662778|101690519|FG001|NOT COMPLETED|Period 4||0||
48553758|NCT01662778|101690520|FG002|NOT COMPLETED|Period 4||0||
48553759|NCT01662778|101690521|FG003|NOT COMPLETED|Period 4||0||
48553760|NCT03551821|101690522|FG000|STARTED|Overall Study||1||
48553761|NCT03551821|101690522|FG000|COMPLETED|Overall Study||1||
48553762|NCT03551821|101690522|FG000|NOT COMPLETED|Overall Study||0||
48553763|NCT03073876|101690523|FG000|STARTED|Overall Study||12||
48553764|NCT03073876|101690524|FG001|STARTED|Overall Study||11||
48553765|NCT03073876|101690523|FG000|COMPLETED|Overall Study||12||
48553766|NCT03073876|101690524|FG001|COMPLETED|Overall Study||11||
48553767|NCT03073876|101690523|FG000|NOT COMPLETED|Overall Study||0||
48553768|NCT03073876|101690524|FG001|NOT COMPLETED|Overall Study||0||
48271452|NCT02206061|100988391|FG000|COMPLETED|Overall Study||131||
48271453|NCT02206061|100988392|FG001|COMPLETED|Overall Study||128||
48271454|NCT02206061|100988393|FG002|COMPLETED|Overall Study||118||
48271455|NCT02206061|100988391|FG000|NOT COMPLETED|Overall Study||18||
48271456|NCT02206061|100988392|FG001|NOT COMPLETED|Overall Study||14||
48271457|NCT02206061|100988393|FG002|NOT COMPLETED|Overall Study||21||
48271458|NCT01011868|100988394|FG000|STARTED|After Week 18 Follow-up||170||
48271459|NCT01011868|100988395|FG001|STARTED|After Week 18 Follow-up||169||
48271460|NCT01011868|100988396|FG002|STARTED|After Week 18 Follow-up||155||
48271461|NCT01011868|100988394|FG000|COMPLETED|After Week 18 Follow-up||147||
48271462|NCT01011868|100988395|FG001|COMPLETED|After Week 18 Follow-up||153||
48271463|NCT01011868|100988396|FG002|COMPLETED|After Week 18 Follow-up||129||
48271464|NCT01011868|100988394|FG000|NOT COMPLETED|After Week 18 Follow-up||23||
48271465|NCT01011868|100988395|FG001|NOT COMPLETED|After Week 18 Follow-up||16||
48271466|NCT01011868|100988396|FG002|NOT COMPLETED|After Week 18 Follow-up||26||
48553769|NCT02189837|101690525|FG000|STARTED|Overall Study||22||
48553770|NCT02189837|101690526|FG001|STARTED|Overall Study||23||
48553771|NCT02189837|101690527|FG002|STARTED|Overall Study||23||
48553772|NCT02189837|101690528|FG003|STARTED|Overall Study||21||
48553773|NCT02189837|101690525|FG000|Received Treatment|Overall Study||21||
48553774|NCT02189837|101690526|FG001|Received Treatment|Overall Study||22||
48553775|NCT02189837|101690527|FG002|Received Treatment|Overall Study||22||
48553776|NCT02189837|101690528|FG003|Received Treatment|Overall Study||20||
48553777|NCT02189837|101690525|FG000|COMPLETED|Overall Study||20||
48553778|NCT02189837|101690526|FG001|COMPLETED|Overall Study||22||
48553779|NCT02189837|101690527|FG002|COMPLETED|Overall Study||20||
48553780|NCT02189837|101690528|FG003|COMPLETED|Overall Study||19||
48553781|NCT02189837|101690525|FG000|NOT COMPLETED|Overall Study||2||
48553782|NCT02189837|101690526|FG001|NOT COMPLETED|Overall Study||1||
48693641|NCT02057640|102032823|FG001|COMPLETED|Phase II Portion of Study at DL2||9||
48693642|NCT02057640|102032822|FG000|NOT COMPLETED|Phase II Portion of Study at DL2||0||
48693643|NCT02057640|102032823|FG001|NOT COMPLETED|Phase II Portion of Study at DL2||0||
48271467|NCT01011868|100988394|FG000|STARTED|After Week 78 Follow-up||170||
48553783|NCT02189837|101690527|FG002|NOT COMPLETED|Overall Study||3||
48553784|NCT02189837|101690528|FG003|NOT COMPLETED|Overall Study||2||
48553785|NCT02665221|101690529|FG000|STARTED|Overall Study||15||
48553786|NCT02665221|101690530|FG001|STARTED|Overall Study||15||
48553787|NCT02665221|101690529|FG000|COMPLETED|Overall Study||0||
48553788|NCT02665221|101690530|FG001|COMPLETED|Overall Study||0||
48553789|NCT02665221|101690529|FG000|NOT COMPLETED|Overall Study||15||
48553790|NCT02665221|101690530|FG001|NOT COMPLETED|Overall Study||15||
48553791|NCT02562066|101690531|FG000|STARTED|Overall Study||8||
48553792|NCT02562066|101690532|FG001|STARTED|Overall Study||8||
48553793|NCT02562066|101690533|FG002|STARTED|Overall Study||4||
48553794|NCT02562066|101690531|FG000|COMPLETED|Overall Study||7||
48553795|NCT02562066|101690532|FG001|COMPLETED|Overall Study||7||
48553796|NCT02562066|101690533|FG002|COMPLETED|Overall Study||0||
48553797|NCT02562066|101690531|FG000|NOT COMPLETED|Overall Study||1||
48553798|NCT02562066|101690532|FG001|NOT COMPLETED|Overall Study||1||
48553799|NCT02562066|101690533|FG002|NOT COMPLETED|Overall Study||4||
48553800|NCT02203357|101690534|FG000|STARTED|Overall Study||117||
48553801|NCT02203357|101690535|FG001|STARTED|Overall Study||111||
48553802|NCT02203357|101690536|FG002|STARTED|Overall Study||125||
48553803|NCT02203357|101690534|FG000|mon7/2/3|Overall Study||114|mon 7 for 0-1-6 group, mon 2 for 0-1 group, mon 3 for 0-2 group|
48553804|NCT02203357|101690535|FG001|mon7/2/3|Overall Study||110|mon 7 for 0-1-6 group, mon 2 for 0-1 group, mon 3 for 0-2 group|
48553805|NCT02203357|101690536|FG002|mon7/2/3|Overall Study||124|mon 7 for 0-1-6 group, mon 2 for 0-1 group, mon 3 for 0-2 group|
48553806|NCT02203357|101690534|FG000|mon12|Overall Study||113||
48693644|NCT03809078|102032824|FG000|STARTED|First Scan||7||
48693645|NCT03809078|102032825|FG001|STARTED|First Scan||7||
48693646|NCT03809078|102032824|FG000|COMPLETED|First Scan||7||
48693647|NCT03809078|102032825|FG001|COMPLETED|First Scan||7||
48271468|NCT01011868|100988395|FG001|STARTED|After Week 78 Follow-up||169||
48271469|NCT01011868|100988396|FG002|STARTED|After Week 78 Follow-up||155||
48271470|NCT01011868|100988394|FG000|COMPLETED|After Week 78 Follow-up||118||
48553807|NCT02203357|101690535|FG001|mon12|Overall Study||101||
48553808|NCT02203357|101690536|FG002|mon12|Overall Study||122||
48553809|NCT02203357|101690534|FG000|mon24|Overall Study||59||
48553810|NCT02203357|101690535|FG001|mon24|Overall Study||45||
48553811|NCT02203357|101690536|FG002|mon24|Overall Study||55||
48553812|NCT02203357|101690534|FG000|COMPLETED|Overall Study||59||
48553813|NCT02203357|101690535|FG001|COMPLETED|Overall Study||45||
48553814|NCT02203357|101690536|FG002|COMPLETED|Overall Study||55||
48553815|NCT02203357|101690534|FG000|NOT COMPLETED|Overall Study||58||
48553816|NCT02203357|101690535|FG001|NOT COMPLETED|Overall Study||66||
48553817|NCT02203357|101690536|FG002|NOT COMPLETED|Overall Study||70||
48553818|NCT01609790|101690537|FG000|STARTED|Overall Study||7||
48553819|NCT01609790|101690538|FG001|STARTED|Overall Study||65||
48553820|NCT01609790|101690539|FG002|STARTED|Overall Study||65||
48553821|NCT01609790|101690537|FG000|COMPLETED|Overall Study||6||
48553822|NCT01609790|101690538|FG001|COMPLETED|Overall Study||58||
48553823|NCT01609790|101690539|FG002|COMPLETED|Overall Study||57||
48553824|NCT01609790|101690537|FG000|NOT COMPLETED|Overall Study||1||
48553825|NCT01609790|101690538|FG001|NOT COMPLETED|Overall Study||7||
48553826|NCT01609790|101690539|FG002|NOT COMPLETED|Overall Study||8||
48553827|NCT05262387|101690540|FG000|STARTED|Treatment Period 1||6||
48553828|NCT05262387|101690541|FG001|STARTED|Treatment Period 1||6||
48553829|NCT05262387|101690542|FG002|STARTED|Treatment Period 1||7||
48553830|NCT05262387|101690543|FG003|STARTED|Treatment Period 1||6||
48553831|NCT05262387|101690540|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||6||
48553832|NCT05262387|101690541|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||6||
48553833|NCT05262387|101690542|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1||7||
48553834|NCT05262387|101690543|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 1||6||
48553835|NCT05262387|101690540|FG000|COMPLETED|Treatment Period 1||6||
48553836|NCT05262387|101690541|FG001|COMPLETED|Treatment Period 1||6||
48553837|NCT05262387|101690542|FG002|COMPLETED|Treatment Period 1||7||
48553838|NCT05262387|101690543|FG003|COMPLETED|Treatment Period 1||6||
48553839|NCT05262387|101690540|FG000|NOT COMPLETED|Treatment Period 1||0||
48553840|NCT05262387|101690541|FG001|NOT COMPLETED|Treatment Period 1||0||
48553841|NCT05262387|101690542|FG002|NOT COMPLETED|Treatment Period 1||0||
48553842|NCT05262387|101690543|FG003|NOT COMPLETED|Treatment Period 1||0||
48553843|NCT05262387|101690540|FG000|STARTED|Treatment Period 2||6||
48553844|NCT05262387|101690541|FG001|STARTED|Treatment Period 2||6||
48553845|NCT05262387|101690542|FG002|STARTED|Treatment Period 2||7||
48553846|NCT05262387|101690543|FG003|STARTED|Treatment Period 2||6||
48553847|NCT05262387|101690540|FG000|COMPLETED|Treatment Period 2||6||
48553848|NCT05262387|101690541|FG001|COMPLETED|Treatment Period 2||6||
48553849|NCT05262387|101690542|FG002|COMPLETED|Treatment Period 2||7||
48553850|NCT05262387|101690543|FG003|COMPLETED|Treatment Period 2||6||
48553851|NCT05262387|101690540|FG000|NOT COMPLETED|Treatment Period 2||0||
48553852|NCT05262387|101690541|FG001|NOT COMPLETED|Treatment Period 2||0||
48553853|NCT05262387|101690542|FG002|NOT COMPLETED|Treatment Period 2||0||
48693648|NCT03809078|102032824|FG000|NOT COMPLETED|First Scan||0||
48693649|NCT03809078|102032825|FG001|NOT COMPLETED|First Scan||0||
48271471|NCT01011868|100988395|FG001|COMPLETED|After Week 78 Follow-up||131||
48271472|NCT01011868|100988396|FG002|COMPLETED|After Week 78 Follow-up||111||
48271473|NCT01011868|100988394|FG000|NOT COMPLETED|After Week 78 Follow-up||52||
48271474|NCT01011868|100988395|FG001|NOT COMPLETED|After Week 78 Follow-up||38||
48553854|NCT05262387|101690543|FG003|NOT COMPLETED|Treatment Period 2||0||
48553855|NCT05262387|101690540|FG000|STARTED|Treatment Period 3||6||
48553856|NCT05262387|101690541|FG001|STARTED|Treatment Period 3||6||
48553857|NCT05262387|101690542|FG002|STARTED|Treatment Period 3||7||
48553858|NCT05262387|101690543|FG003|STARTED|Treatment Period 3||6||
48553859|NCT05262387|101690540|FG000|COMPLETED|Treatment Period 3||6||
48553860|NCT05262387|101690541|FG001|COMPLETED|Treatment Period 3||6||
48553861|NCT05262387|101690542|FG002|COMPLETED|Treatment Period 3||7||
48553862|NCT05262387|101690543|FG003|COMPLETED|Treatment Period 3||6||
48553863|NCT05262387|101690540|FG000|NOT COMPLETED|Treatment Period 3||0||
48553864|NCT05262387|101690541|FG001|NOT COMPLETED|Treatment Period 3||0||
48553865|NCT05262387|101690542|FG002|NOT COMPLETED|Treatment Period 3||0||
48553866|NCT05262387|101690543|FG003|NOT COMPLETED|Treatment Period 3||0||
48553867|NCT05262387|101690540|FG000|STARTED|Treatment Period 4||6||
48271475|NCT01011868|100988396|FG002|NOT COMPLETED|After Week 78 Follow-up||44||
48553868|NCT05262387|101690541|FG001|STARTED|Treatment Period 4||6||
48553869|NCT05262387|101690542|FG002|STARTED|Treatment Period 4||7||
48553870|NCT05262387|101690543|FG003|STARTED|Treatment Period 4||6||
48553871|NCT05262387|101690540|FG000|COMPLETED|Treatment Period 4||6||
48553872|NCT05262387|101690541|FG001|COMPLETED|Treatment Period 4||6||
48553873|NCT05262387|101690542|FG002|COMPLETED|Treatment Period 4||7||
48553874|NCT05262387|101690543|FG003|COMPLETED|Treatment Period 4||6||
48553875|NCT05262387|101690540|FG000|NOT COMPLETED|Treatment Period 4||0||
48553876|NCT05262387|101690541|FG001|NOT COMPLETED|Treatment Period 4||0||
48553877|NCT05262387|101690542|FG002|NOT COMPLETED|Treatment Period 4||0||
48553878|NCT05262387|101690543|FG003|NOT COMPLETED|Treatment Period 4||0||
48553879|NCT00371436|101690544|FG000|STARTED|Overall Study||92||
48271476|NCT00737698|100988397|FG000|STARTED|Overall Study||23||
48553880|NCT00371436|101690545|FG001|STARTED|Overall Study||89||
48271477|NCT00737698|100988398|FG001|STARTED|Overall Study||42||
48271478|NCT00737698|100988399|FG002|STARTED|Overall Study||21||
48553881|NCT00371436|101690544|FG000|COMPLETED|Overall Study||58||
48553882|NCT00371436|101690545|FG001|COMPLETED|Overall Study||68||
48553883|NCT00371436|101690544|FG000|NOT COMPLETED|Overall Study||34||
48553884|NCT00371436|101690545|FG001|NOT COMPLETED|Overall Study||21||
48553885|NCT01482312|101690546|FG000|STARTED|Period 1, 90 Minutes of Wear||10||
48553886|NCT01482312|101690547|FG001|STARTED|Period 1, 90 Minutes of Wear||9||
48553887|NCT01482312|101690548|FG002|STARTED|Period 1, 90 Minutes of Wear||10||
48553888|NCT01482312|101690546|FG000|COMPLETED|Period 1, 90 Minutes of Wear||9||
48553889|NCT01482312|101690547|FG001|COMPLETED|Period 1, 90 Minutes of Wear||9||
48553890|NCT01482312|101690548|FG002|COMPLETED|Period 1, 90 Minutes of Wear||10||
48553891|NCT01482312|101690546|FG000|NOT COMPLETED|Period 1, 90 Minutes of Wear||1||
48553892|NCT01482312|101690547|FG001|NOT COMPLETED|Period 1, 90 Minutes of Wear||0||
48553893|NCT01482312|101690548|FG002|NOT COMPLETED|Period 1, 90 Minutes of Wear||0||
48553894|NCT01482312|101690546|FG000|STARTED|Period 2, 90 Minutes of Wear||9||
48553895|NCT01482312|101690547|FG001|STARTED|Period 2, 90 Minutes of Wear||9||
48553896|NCT01482312|101690548|FG002|STARTED|Period 2, 90 Minutes of Wear||9||
48553897|NCT01482312|101690546|FG000|COMPLETED|Period 2, 90 Minutes of Wear||8||
48553898|NCT01482312|101690547|FG001|COMPLETED|Period 2, 90 Minutes of Wear||9||
48553899|NCT01482312|101690548|FG002|COMPLETED|Period 2, 90 Minutes of Wear||9||
48553900|NCT01482312|101690546|FG000|NOT COMPLETED|Period 2, 90 Minutes of Wear||1||
48553901|NCT01482312|101690547|FG001|NOT COMPLETED|Period 2, 90 Minutes of Wear||0||
48553902|NCT01482312|101690548|FG002|NOT COMPLETED|Period 2, 90 Minutes of Wear||0||
48553903|NCT01482312|101690546|FG000|STARTED|Period 3, 90 Minutes of Wear||8||
48553904|NCT01482312|101690547|FG001|STARTED|Period 3, 90 Minutes of Wear||9||
48553905|NCT01482312|101690548|FG002|STARTED|Period 3, 90 Minutes of Wear||9||
48553906|NCT01482312|101690546|FG000|COMPLETED|Period 3, 90 Minutes of Wear||8||
48553907|NCT01482312|101690547|FG001|COMPLETED|Period 3, 90 Minutes of Wear||9||
48553908|NCT01482312|101690548|FG002|COMPLETED|Period 3, 90 Minutes of Wear||9||
48553909|NCT01482312|101690546|FG000|NOT COMPLETED|Period 3, 90 Minutes of Wear||0||
48553910|NCT01482312|101690547|FG001|NOT COMPLETED|Period 3, 90 Minutes of Wear||0||
48553911|NCT01482312|101690548|FG002|NOT COMPLETED|Period 3, 90 Minutes of Wear||0||
48553912|NCT00462904|101690549|FG000|STARTED|Overall Study||4||
48553913|NCT00462904|101690549|FG000|COMPLETED|Overall Study||3||
48553914|NCT00462904|101690549|FG000|NOT COMPLETED|Overall Study||1||
48553915|NCT02577991|101690550|FG000|STARTED|Overall Study||24||
48553916|NCT02577991|101690551|FG001|STARTED|Overall Study||27||
48553917|NCT02577991|101690552|FG002|STARTED|Overall Study||29||
48553918|NCT02577991|101690550|FG000|COMPLETED|Overall Study||21||
48553919|NCT02577991|101690551|FG001|COMPLETED|Overall Study||25||
48553920|NCT02577991|101690552|FG002|COMPLETED|Overall Study||29||
48553921|NCT02577991|101690550|FG000|NOT COMPLETED|Overall Study||3||
48553922|NCT02577991|101690551|FG001|NOT COMPLETED|Overall Study||2||
48553923|NCT02577991|101690552|FG002|NOT COMPLETED|Overall Study||0||
48553924|NCT02421055|101690553|FG000|STARTED|Overall Study||34||
48553925|NCT02421055|101690554|FG001|STARTED|Overall Study||50||
48553926|NCT02421055|101690555|FG002|STARTED|Overall Study||74||
48553927|NCT02421055|101690553|FG000|Pre-operative Serum Sample (Minimum)|Overall Study||34||
48553928|NCT02421055|101690554|FG001|Pre-operative Serum Sample (Minimum)|Overall Study||50||
48553929|NCT02421055|101690555|FG002|Pre-operative Serum Sample (Minimum)|Overall Study||74||
48553930|NCT02421055|101690553|FG000|Pre-operative Complete Sample Set|Overall Study||23|Complete sample set of serum, 24-hour urine and stool|
48553931|NCT02421055|101690554|FG001|Pre-operative Complete Sample Set|Overall Study||22|Complete sample set of serum, 24-hour urine and stool|
48553932|NCT02421055|101690555|FG002|Pre-operative Complete Sample Set|Overall Study||36|Complete sample set of serum, 24-hour urine and stool|
48553933|NCT02421055|101690553|FG000|Post-operative Serum Sample (Minimum)|Overall Study||0||
48553934|NCT02421055|101690554|FG001|Post-operative Serum Sample (Minimum)|Overall Study||23||
48553935|NCT02421055|101690555|FG002|Post-operative Serum Sample (Minimum)|Overall Study||26||
48553936|NCT02421055|101690553|FG000|Post-operative Complete Sample Set|Overall Study||0|Complete sample set of serum, 24-hour urine and stool|
48392557|NCT01078558|101291376|FG000|NOT COMPLETED|Overall Study||2018||
48392558|NCT01078558|101291377|FG001|NOT COMPLETED|Overall Study||755||
48553937|NCT02421055|101690554|FG001|Post-operative Complete Sample Set|Overall Study||13|Complete sample set of serum, 24-hour urine and stool|
48553938|NCT02421055|101690555|FG002|Post-operative Complete Sample Set|Overall Study||14|Complete sample set of serum, 24-hour urine and stool|
48553939|NCT02421055|101690553|FG000|COMPLETED|Overall Study||0|Clinical data collected at pre-operative and post-operative time points|
48553940|NCT02421055|101690554|FG001|COMPLETED|Overall Study||50|Clinical data collected at pre-operative and post-operative time points|
48553941|NCT02421055|101690555|FG002|COMPLETED|Overall Study||74|Clinical data collected at pre-operative and post-operative time points|
48553942|NCT02421055|101690553|FG000|NOT COMPLETED|Overall Study||34||
48553943|NCT02421055|101690554|FG001|NOT COMPLETED|Overall Study||0||
48553944|NCT02421055|101690555|FG002|NOT COMPLETED|Overall Study||0||
48553945|NCT02906670|101690556|FG000|STARTED|Cohort 1, QW||1||
48553946|NCT02906670|101690557|FG001|STARTED|Cohort 1, QW||0||
48553947|NCT02906670|101690558|FG002|STARTED|Cohort 1, QW||0||
48392559|NCT01078558|101291378|FG002|NOT COMPLETED|Overall Study||1361||
48392560|NCT01576406|101291379|FG000|STARTED|Overall Study||11||
48392561|NCT01576406|101291380|FG001|STARTED|Overall Study||15||
48553948|NCT02906670|101690559|FG003|STARTED|Cohort 1, QW||0||
48109620|NCT00829296|100594539|FG000|STARTED|Overall Study||34||
48109621|NCT00829296|100594540|FG001|STARTED|Overall Study||36||
48109622|NCT00829296|100594539|FG000|COMPLETED|Overall Study||29||
48109623|NCT00829296|100594540|FG001|COMPLETED|Overall Study||32||
48109624|NCT00829296|100594539|FG000|NOT COMPLETED|Overall Study||5||
48553949|NCT02906670|101690560|FG004|STARTED|Cohort 1, QW||0||
48553950|NCT02906670|101690561|FG005|STARTED|Cohort 1, QW||0||
48553951|NCT02906670|101690562|FG006|STARTED|Cohort 1, QW||0||
48553952|NCT02906670|101690563|FG007|STARTED|Cohort 1, QW||0||
48553953|NCT02906670|101690564|FG008|STARTED|Cohort 1, QW||0||
48553954|NCT02906670|101690565|FG009|STARTED|Cohort 1, QW||0||
48553955|NCT02906670|101690556|FG000|COMPLETED|Cohort 1, QW||0||
48553956|NCT02906670|101690557|FG001|COMPLETED|Cohort 1, QW||0||
48553957|NCT02906670|101690558|FG002|COMPLETED|Cohort 1, QW||0||
48553958|NCT02906670|101690559|FG003|COMPLETED|Cohort 1, QW||0||
48553959|NCT02906670|101690560|FG004|COMPLETED|Cohort 1, QW||0||
48553960|NCT02906670|101690561|FG005|COMPLETED|Cohort 1, QW||0||
48553961|NCT02906670|101690562|FG006|COMPLETED|Cohort 1, QW||0||
48553962|NCT02906670|101690563|FG007|COMPLETED|Cohort 1, QW||0||
48553963|NCT02906670|101690564|FG008|COMPLETED|Cohort 1, QW||0||
48553964|NCT02906670|101690565|FG009|COMPLETED|Cohort 1, QW||0||
48553965|NCT02906670|101690556|FG000|NOT COMPLETED|Cohort 1, QW||1||
48553966|NCT02906670|101690557|FG001|NOT COMPLETED|Cohort 1, QW||0||
48553967|NCT02906670|101690558|FG002|NOT COMPLETED|Cohort 1, QW||0||
48553968|NCT02906670|101690559|FG003|NOT COMPLETED|Cohort 1, QW||0||
48553969|NCT02906670|101690560|FG004|NOT COMPLETED|Cohort 1, QW||0||
48553970|NCT02906670|101690561|FG005|NOT COMPLETED|Cohort 1, QW||0||
48553971|NCT02906670|101690562|FG006|NOT COMPLETED|Cohort 1, QW||0||
48109625|NCT00829296|100594540|FG001|NOT COMPLETED|Overall Study||4||
48109626|NCT03055000|100594541|FG000|STARTED|Overall Study||16||
48109627|NCT03055000|100594542|FG001|STARTED|Overall Study||17||
48109628|NCT03055000|100594543|FG002|STARTED|Overall Study||16||
48109629|NCT03055000|100594541|FG000|COMPLETED|Overall Study||16||
48109630|NCT03055000|100594542|FG001|COMPLETED|Overall Study||17||
48109631|NCT03055000|100594543|FG002|COMPLETED|Overall Study||16||
48109632|NCT03055000|100594541|FG000|NOT COMPLETED|Overall Study||0||
48109633|NCT03055000|100594542|FG001|NOT COMPLETED|Overall Study||0||
48109634|NCT03055000|100594543|FG002|NOT COMPLETED|Overall Study||0||
48109635|NCT05409235|100594544|FG000|STARTED|Overall Study||75||
48109636|NCT05409235|100594545|FG001|STARTED|Overall Study||76||
48109637|NCT05409235|100594546|FG002|STARTED|Overall Study||38||
48109638|NCT05409235|100594547|FG003|STARTED|Overall Study||36||
48553972|NCT02906670|101690563|FG007|NOT COMPLETED|Cohort 1, QW||0||
48553973|NCT02906670|101690564|FG008|NOT COMPLETED|Cohort 1, QW||0||
48553974|NCT02906670|101690565|FG009|NOT COMPLETED|Cohort 1, QW||0||
48553975|NCT02906670|101690556|FG000|STARTED|Cohort 2, QW||0||
48553976|NCT02906670|101690557|FG001|STARTED|Cohort 2, QW||1||
48553977|NCT02906670|101690558|FG002|STARTED|Cohort 2, QW||0||
48553978|NCT02906670|101690559|FG003|STARTED|Cohort 2, QW||0||
48553979|NCT02906670|101690560|FG004|STARTED|Cohort 2, QW||0||
48553980|NCT02906670|101690561|FG005|STARTED|Cohort 2, QW||0||
48553981|NCT02906670|101690562|FG006|STARTED|Cohort 2, QW||0||
48553982|NCT02906670|101690563|FG007|STARTED|Cohort 2, QW||0||
48553983|NCT02906670|101690564|FG008|STARTED|Cohort 2, QW||0||
48553984|NCT02906670|101690565|FG009|STARTED|Cohort 2, QW||0||
48553985|NCT02906670|101690556|FG000|COMPLETED|Cohort 2, QW||0||
48553986|NCT02906670|101690557|FG001|COMPLETED|Cohort 2, QW||0||
48553987|NCT02906670|101690558|FG002|COMPLETED|Cohort 2, QW||0||
48553988|NCT02906670|101690559|FG003|COMPLETED|Cohort 2, QW||0||
48553989|NCT02906670|101690560|FG004|COMPLETED|Cohort 2, QW||0||
48553990|NCT02906670|101690561|FG005|COMPLETED|Cohort 2, QW||0||
48553991|NCT02906670|101690562|FG006|COMPLETED|Cohort 2, QW||0||
48553992|NCT02906670|101690563|FG007|COMPLETED|Cohort 2, QW||0||
48109639|NCT05409235|100594544|FG000|COMPLETED|Overall Study||70||
48109640|NCT05409235|100594545|FG001|COMPLETED|Overall Study||65||
48553993|NCT02906670|101690564|FG008|COMPLETED|Cohort 2, QW||0||
48553994|NCT02906670|101690565|FG009|COMPLETED|Cohort 2, QW||0||
48553995|NCT02906670|101690556|FG000|NOT COMPLETED|Cohort 2, QW||0||
48553996|NCT02906670|101690557|FG001|NOT COMPLETED|Cohort 2, QW||1||
48553997|NCT02906670|101690558|FG002|NOT COMPLETED|Cohort 2, QW||0||
48553998|NCT02906670|101690559|FG003|NOT COMPLETED|Cohort 2, QW||0||
48553999|NCT02906670|101690560|FG004|NOT COMPLETED|Cohort 2, QW||0||
48109641|NCT05409235|100594546|FG002|COMPLETED|Overall Study||34||
48554000|NCT02906670|101690561|FG005|NOT COMPLETED|Cohort 2, QW||0||
48554001|NCT02906670|101690562|FG006|NOT COMPLETED|Cohort 2, QW||0||
48554002|NCT02906670|101690563|FG007|NOT COMPLETED|Cohort 2, QW||0||
48554003|NCT02906670|101690564|FG008|NOT COMPLETED|Cohort 2, QW||0||
48554004|NCT02906670|101690565|FG009|NOT COMPLETED|Cohort 2, QW||0||
48554005|NCT02906670|101690556|FG000|STARTED|Cohort 3, QW||0||
48554006|NCT02906670|101690557|FG001|STARTED|Cohort 3, QW||0||
48109642|NCT05409235|100594547|FG003|COMPLETED|Overall Study||30||
48109643|NCT05409235|100594544|FG000|NOT COMPLETED|Overall Study||5||
48554007|NCT02906670|101690558|FG002|STARTED|Cohort 3, QW||4||
48554008|NCT02906670|101690559|FG003|STARTED|Cohort 3, QW||0||
48554009|NCT02906670|101690560|FG004|STARTED|Cohort 3, QW||0||
48554010|NCT02906670|101690561|FG005|STARTED|Cohort 3, QW||0||
48554011|NCT02906670|101690562|FG006|STARTED|Cohort 3, QW||0||
48554012|NCT02906670|101690563|FG007|STARTED|Cohort 3, QW||0||
48554013|NCT02906670|101690564|FG008|STARTED|Cohort 3, QW||0||
48554014|NCT02906670|101690565|FG009|STARTED|Cohort 3, QW||0||
48554015|NCT02906670|101690556|FG000|COMPLETED|Cohort 3, QW||0||
48554016|NCT02906670|101690557|FG001|COMPLETED|Cohort 3, QW||0||
48554017|NCT02906670|101690558|FG002|COMPLETED|Cohort 3, QW||0||
48554018|NCT02906670|101690559|FG003|COMPLETED|Cohort 3, QW||0||
48554019|NCT02906670|101690560|FG004|COMPLETED|Cohort 3, QW||0||
48554020|NCT02906670|101690561|FG005|COMPLETED|Cohort 3, QW||0||
48554021|NCT02906670|101690562|FG006|COMPLETED|Cohort 3, QW||0||
48554022|NCT02906670|101690563|FG007|COMPLETED|Cohort 3, QW||0||
48554023|NCT02906670|101690564|FG008|COMPLETED|Cohort 3, QW||0||
48554024|NCT02906670|101690565|FG009|COMPLETED|Cohort 3, QW||0||
48554025|NCT02906670|101690556|FG000|NOT COMPLETED|Cohort 3, QW||0||
48554026|NCT02906670|101690557|FG001|NOT COMPLETED|Cohort 3, QW||0||
48554027|NCT02906670|101690558|FG002|NOT COMPLETED|Cohort 3, QW||4||
48554028|NCT02906670|101690559|FG003|NOT COMPLETED|Cohort 3, QW||0||
48554029|NCT02906670|101690560|FG004|NOT COMPLETED|Cohort 3, QW||0||
48554030|NCT02906670|101690561|FG005|NOT COMPLETED|Cohort 3, QW||0||
48554031|NCT02906670|101690562|FG006|NOT COMPLETED|Cohort 3, QW||0||
48554032|NCT02906670|101690563|FG007|NOT COMPLETED|Cohort 3, QW||0||
48554033|NCT02906670|101690564|FG008|NOT COMPLETED|Cohort 3, QW||0||
48554034|NCT02906670|101690565|FG009|NOT COMPLETED|Cohort 3, QW||0||
48554035|NCT02906670|101690556|FG000|STARTED|Cohort 4, Q2W||0||
48554036|NCT02906670|101690557|FG001|STARTED|Cohort 4, Q2W||0||
48554037|NCT02906670|101690558|FG002|STARTED|Cohort 4, Q2W||0||
48554038|NCT02906670|101690559|FG003|STARTED|Cohort 4, Q2W||0||
48554039|NCT02906670|101690560|FG004|STARTED|Cohort 4, Q2W||0||
48554040|NCT02906670|101690561|FG005|STARTED|Cohort 4, Q2W||3||
48554041|NCT02906670|101690562|FG006|STARTED|Cohort 4, Q2W||0||
48554042|NCT02906670|101690563|FG007|STARTED|Cohort 4, Q2W||0||
48554043|NCT02906670|101690564|FG008|STARTED|Cohort 4, Q2W||0||
48554044|NCT02906670|101690565|FG009|STARTED|Cohort 4, Q2W||0||
48554045|NCT02906670|101690556|FG000|COMPLETED|Cohort 4, Q2W||0||
48554046|NCT02906670|101690557|FG001|COMPLETED|Cohort 4, Q2W||0||
48554047|NCT02906670|101690558|FG002|COMPLETED|Cohort 4, Q2W||0||
48554048|NCT02906670|101690559|FG003|COMPLETED|Cohort 4, Q2W||0||
48693650|NCT03809078|102032824|FG000|STARTED|Second Scan||6||
48693651|NCT03809078|102032825|FG001|STARTED|Second Scan||7||
48693652|NCT03809078|102032824|FG000|COMPLETED|Second Scan||6||
48693653|NCT03809078|102032825|FG001|COMPLETED|Second Scan||7||
48554049|NCT02906670|101690560|FG004|COMPLETED|Cohort 4, Q2W||0||
48554050|NCT02906670|101690561|FG005|COMPLETED|Cohort 4, Q2W||0||
48554051|NCT02906670|101690562|FG006|COMPLETED|Cohort 4, Q2W||0||
48554052|NCT02906670|101690563|FG007|COMPLETED|Cohort 4, Q2W||0||
48554053|NCT02906670|101690564|FG008|COMPLETED|Cohort 4, Q2W||0||
48554054|NCT02906670|101690565|FG009|COMPLETED|Cohort 4, Q2W||0||
48554055|NCT02906670|101690556|FG000|NOT COMPLETED|Cohort 4, Q2W||0||
48554056|NCT02906670|101690557|FG001|NOT COMPLETED|Cohort 4, Q2W||0||
48554057|NCT02906670|101690558|FG002|NOT COMPLETED|Cohort 4, Q2W||0||
48554058|NCT02906670|101690559|FG003|NOT COMPLETED|Cohort 4, Q2W||0||
48554059|NCT02906670|101690560|FG004|NOT COMPLETED|Cohort 4, Q2W||0||
48554060|NCT02906670|101690561|FG005|NOT COMPLETED|Cohort 4, Q2W||3||
48554061|NCT02906670|101690562|FG006|NOT COMPLETED|Cohort 4, Q2W||0||
48554062|NCT02906670|101690563|FG007|NOT COMPLETED|Cohort 4, Q2W||0||
48554063|NCT02906670|101690564|FG008|NOT COMPLETED|Cohort 4, Q2W||0||
48554064|NCT02906670|101690565|FG009|NOT COMPLETED|Cohort 4, Q2W||0||
48554065|NCT02906670|101690556|FG000|STARTED|Cohort 5, Q2W||0||
48554066|NCT02906670|101690557|FG001|STARTED|Cohort 5, Q2W||0||
48554067|NCT02906670|101690558|FG002|STARTED|Cohort 5, Q2W||0||
48554068|NCT02906670|101690559|FG003|STARTED|Cohort 5, Q2W||0||
48554069|NCT02906670|101690560|FG004|STARTED|Cohort 5, Q2W||0||
48554070|NCT02906670|101690561|FG005|STARTED|Cohort 5, Q2W||0||
48554071|NCT02906670|101690562|FG006|STARTED|Cohort 5, Q2W||7||
48554072|NCT02906670|101690563|FG007|STARTED|Cohort 5, Q2W||0||
48554073|NCT02906670|101690564|FG008|STARTED|Cohort 5, Q2W||0||
48554074|NCT02906670|101690565|FG009|STARTED|Cohort 5, Q2W||0||
48554075|NCT02906670|101690556|FG000|COMPLETED|Cohort 5, Q2W||0||
48554076|NCT02906670|101690557|FG001|COMPLETED|Cohort 5, Q2W||0||
48554077|NCT02906670|101690558|FG002|COMPLETED|Cohort 5, Q2W||0||
48554078|NCT02906670|101690559|FG003|COMPLETED|Cohort 5, Q2W||0||
48554079|NCT02906670|101690560|FG004|COMPLETED|Cohort 5, Q2W||0||
48554080|NCT02906670|101690561|FG005|COMPLETED|Cohort 5, Q2W||0||
48554081|NCT02906670|101690562|FG006|COMPLETED|Cohort 5, Q2W||0||
48554082|NCT02906670|101690563|FG007|COMPLETED|Cohort 5, Q2W||0||
48554083|NCT02906670|101690564|FG008|COMPLETED|Cohort 5, Q2W||0||
48554084|NCT02906670|101690565|FG009|COMPLETED|Cohort 5, Q2W||0||
48554085|NCT02906670|101690556|FG000|NOT COMPLETED|Cohort 5, Q2W||0||
48554086|NCT02906670|101690557|FG001|NOT COMPLETED|Cohort 5, Q2W||0||
48693654|NCT03809078|102032824|FG000|NOT COMPLETED|Second Scan||0||
48693655|NCT03809078|102032825|FG001|NOT COMPLETED|Second Scan||0||
48554087|NCT02906670|101690558|FG002|NOT COMPLETED|Cohort 5, Q2W||0||
48554088|NCT02906670|101690559|FG003|NOT COMPLETED|Cohort 5, Q2W||0||
48554089|NCT02906670|101690560|FG004|NOT COMPLETED|Cohort 5, Q2W||0||
48693656|NCT01001767|102032826|FG000|STARTED|Overall Study||18||
48693657|NCT01001767|102032827|FG001|STARTED|Overall Study||17||
48693658|NCT01001767|102032826|FG000|COMPLETED|Overall Study||14||
48554090|NCT02906670|101690561|FG005|NOT COMPLETED|Cohort 5, Q2W||0||
48554091|NCT02906670|101690562|FG006|NOT COMPLETED|Cohort 5, Q2W||7||
48554092|NCT02906670|101690563|FG007|NOT COMPLETED|Cohort 5, Q2W||0||
48554093|NCT02906670|101690564|FG008|NOT COMPLETED|Cohort 5, Q2W||0||
48554094|NCT02906670|101690565|FG009|NOT COMPLETED|Cohort 5, Q2W||0||
48554095|NCT02906670|101690556|FG000|STARTED|Cohort 5P, Q2W||0||
48554096|NCT02906670|101690557|FG001|STARTED|Cohort 5P, Q2W||0||
48554097|NCT02906670|101690558|FG002|STARTED|Cohort 5P, Q2W||0||
48554098|NCT02906670|101690559|FG003|STARTED|Cohort 5P, Q2W||0||
48554099|NCT02906670|101690560|FG004|STARTED|Cohort 5P, Q2W||0||
48554100|NCT02906670|101690561|FG005|STARTED|Cohort 5P, Q2W||0||
48554101|NCT02906670|101690562|FG006|STARTED|Cohort 5P, Q2W||0||
48554102|NCT02906670|101690563|FG007|STARTED|Cohort 5P, Q2W||3||
48554103|NCT02906670|101690564|FG008|STARTED|Cohort 5P, Q2W||0||
48554104|NCT02906670|101690565|FG009|STARTED|Cohort 5P, Q2W||0||
48554105|NCT02906670|101690556|FG000|COMPLETED|Cohort 5P, Q2W||0||
48554106|NCT02906670|101690557|FG001|COMPLETED|Cohort 5P, Q2W||0||
48554107|NCT02906670|101690558|FG002|COMPLETED|Cohort 5P, Q2W||0||
48554108|NCT02906670|101690559|FG003|COMPLETED|Cohort 5P, Q2W||0||
48554109|NCT02906670|101690560|FG004|COMPLETED|Cohort 5P, Q2W||0||
48554110|NCT02906670|101690561|FG005|COMPLETED|Cohort 5P, Q2W||0||
48554111|NCT02906670|101690562|FG006|COMPLETED|Cohort 5P, Q2W||0||
48554112|NCT02906670|101690563|FG007|COMPLETED|Cohort 5P, Q2W||0||
48554113|NCT02906670|101690564|FG008|COMPLETED|Cohort 5P, Q2W||0||
48554114|NCT02906670|101690565|FG009|COMPLETED|Cohort 5P, Q2W||0||
48554115|NCT02906670|101690556|FG000|NOT COMPLETED|Cohort 5P, Q2W||0||
48554116|NCT02906670|101690557|FG001|NOT COMPLETED|Cohort 5P, Q2W||0||
48554117|NCT02906670|101690558|FG002|NOT COMPLETED|Cohort 5P, Q2W||0||
48554118|NCT02906670|101690559|FG003|NOT COMPLETED|Cohort 5P, Q2W||0||
48554119|NCT02906670|101690560|FG004|NOT COMPLETED|Cohort 5P, Q2W||0||
48554120|NCT02906670|101690561|FG005|NOT COMPLETED|Cohort 5P, Q2W||0||
48554121|NCT02906670|101690562|FG006|NOT COMPLETED|Cohort 5P, Q2W||0||
48554122|NCT02906670|101690563|FG007|NOT COMPLETED|Cohort 5P, Q2W||3||
48554123|NCT02906670|101690564|FG008|NOT COMPLETED|Cohort 5P, Q2W||0||
48554124|NCT02906670|101690565|FG009|NOT COMPLETED|Cohort 5P, Q2W||0||
48554125|NCT02906670|101690556|FG000|STARTED|Cohort 6P, Q2W||0||
48554126|NCT02906670|101690557|FG001|STARTED|Cohort 6P, Q2W||0||
48554127|NCT02906670|101690558|FG002|STARTED|Cohort 6P, Q2W||0||
48554128|NCT02906670|101690559|FG003|STARTED|Cohort 6P, Q2W||0||
48554129|NCT02906670|101690560|FG004|STARTED|Cohort 6P, Q2W||0||
48554130|NCT02906670|101690561|FG005|STARTED|Cohort 6P, Q2W||0||
48554131|NCT02906670|101690562|FG006|STARTED|Cohort 6P, Q2W||0||
48554132|NCT02906670|101690563|FG007|STARTED|Cohort 6P, Q2W||0||
48554133|NCT02906670|101690564|FG008|STARTED|Cohort 6P, Q2W||4||
48554134|NCT02906670|101690565|FG009|STARTED|Cohort 6P, Q2W||0||
48554135|NCT02906670|101690556|FG000|COMPLETED|Cohort 6P, Q2W||0||
48554136|NCT02906670|101690557|FG001|COMPLETED|Cohort 6P, Q2W||0||
48554137|NCT02906670|101690558|FG002|COMPLETED|Cohort 6P, Q2W||0||
48554138|NCT02906670|101690559|FG003|COMPLETED|Cohort 6P, Q2W||0||
48554139|NCT02906670|101690560|FG004|COMPLETED|Cohort 6P, Q2W||0||
48554140|NCT02906670|101690561|FG005|COMPLETED|Cohort 6P, Q2W||0||
48554141|NCT02906670|101690562|FG006|COMPLETED|Cohort 6P, Q2W||0||
48554142|NCT02906670|101690563|FG007|COMPLETED|Cohort 6P, Q2W||0||
48554143|NCT02906670|101690564|FG008|COMPLETED|Cohort 6P, Q2W||0||
48554144|NCT02906670|101690565|FG009|COMPLETED|Cohort 6P, Q2W||0||
48554145|NCT02906670|101690556|FG000|NOT COMPLETED|Cohort 6P, Q2W||0||
48554146|NCT02906670|101690557|FG001|NOT COMPLETED|Cohort 6P, Q2W||0||
48554147|NCT02906670|101690558|FG002|NOT COMPLETED|Cohort 6P, Q2W||0||
48554148|NCT02906670|101690559|FG003|NOT COMPLETED|Cohort 6P, Q2W||0||
48554149|NCT02906670|101690560|FG004|NOT COMPLETED|Cohort 6P, Q2W||0||
48554150|NCT02906670|101690561|FG005|NOT COMPLETED|Cohort 6P, Q2W||0||
48554151|NCT02906670|101690562|FG006|NOT COMPLETED|Cohort 6P, Q2W||0||
48554152|NCT02906670|101690563|FG007|NOT COMPLETED|Cohort 6P, Q2W||0||
48554153|NCT02906670|101690564|FG008|NOT COMPLETED|Cohort 6P, Q2W||4||
48554154|NCT02906670|101690565|FG009|NOT COMPLETED|Cohort 6P, Q2W||0||
48554155|NCT02906670|101690556|FG000|STARTED|Cohort 4P, QW||0||
48554156|NCT02906670|101690557|FG001|STARTED|Cohort 4P, QW||0||
48554157|NCT02906670|101690558|FG002|STARTED|Cohort 4P, QW||0||
48554158|NCT02906670|101690559|FG003|STARTED|Cohort 4P, QW||3||
48554159|NCT02906670|101690560|FG004|STARTED|Cohort 4P, QW||0||
48554160|NCT02906670|101690561|FG005|STARTED|Cohort 4P, QW||0||
48554161|NCT02906670|101690562|FG006|STARTED|Cohort 4P, QW||0||
48554162|NCT02906670|101690563|FG007|STARTED|Cohort 4P, QW||0||
48554163|NCT02906670|101690564|FG008|STARTED|Cohort 4P, QW||0||
48693659|NCT01001767|102032827|FG001|COMPLETED|Overall Study||17||
48693660|NCT01001767|102032826|FG000|NOT COMPLETED|Overall Study||4||
48693661|NCT01001767|102032827|FG001|NOT COMPLETED|Overall Study||0||
48693662|NCT00783835|102032828|FG000|STARTED|Overall Study||60||
48693663|NCT00783835|102032828|FG000|COMPLETED|Overall Study||50||
48693664|NCT00783835|102032828|FG000|NOT COMPLETED|Overall Study||10||
48554164|NCT02906670|101690565|FG009|STARTED|Cohort 4P, QW||0||
48554165|NCT02906670|101690556|FG000|COMPLETED|Cohort 4P, QW||0||
48554166|NCT02906670|101690557|FG001|COMPLETED|Cohort 4P, QW||0||
48554167|NCT02906670|101690558|FG002|COMPLETED|Cohort 4P, QW||0||
48554168|NCT02906670|101690559|FG003|COMPLETED|Cohort 4P, QW||0||
48554169|NCT02906670|101690560|FG004|COMPLETED|Cohort 4P, QW||0||
48554170|NCT02906670|101690561|FG005|COMPLETED|Cohort 4P, QW||0||
48554171|NCT02906670|101690562|FG006|COMPLETED|Cohort 4P, QW||0||
48554172|NCT02906670|101690563|FG007|COMPLETED|Cohort 4P, QW||0||
48554173|NCT02906670|101690564|FG008|COMPLETED|Cohort 4P, QW||0||
48554174|NCT02906670|101690565|FG009|COMPLETED|Cohort 4P, QW||0||
48554175|NCT02906670|101690556|FG000|NOT COMPLETED|Cohort 4P, QW||0||
48554176|NCT02906670|101690557|FG001|NOT COMPLETED|Cohort 4P, QW||0||
48554177|NCT02906670|101690558|FG002|NOT COMPLETED|Cohort 4P, QW||0||
48554178|NCT02906670|101690559|FG003|NOT COMPLETED|Cohort 4P, QW||3||
48554179|NCT02906670|101690560|FG004|NOT COMPLETED|Cohort 4P, QW||0||
48554180|NCT02906670|101690561|FG005|NOT COMPLETED|Cohort 4P, QW||0||
48554181|NCT02906670|101690562|FG006|NOT COMPLETED|Cohort 4P, QW||0||
48554182|NCT02906670|101690563|FG007|NOT COMPLETED|Cohort 4P, QW||0||
48554183|NCT02906670|101690564|FG008|NOT COMPLETED|Cohort 4P, QW||0||
48554184|NCT02906670|101690565|FG009|NOT COMPLETED|Cohort 4P, QW||0||
48554185|NCT02906670|101690556|FG000|STARTED|Cohort 7P, Q2W||0||
48554186|NCT02906670|101690557|FG001|STARTED|Cohort 7P, Q2W||0||
48554187|NCT02906670|101690558|FG002|STARTED|Cohort 7P, Q2W||0||
48554188|NCT02906670|101690559|FG003|STARTED|Cohort 7P, Q2W||0||
48554189|NCT02906670|101690560|FG004|STARTED|Cohort 7P, Q2W||0||
48554190|NCT02906670|101690561|FG005|STARTED|Cohort 7P, Q2W||0||
48554191|NCT02906670|101690562|FG006|STARTED|Cohort 7P, Q2W||0||
48554192|NCT02906670|101690563|FG007|STARTED|Cohort 7P, Q2W||0||
48554193|NCT02906670|101690564|FG008|STARTED|Cohort 7P, Q2W||0||
48554194|NCT02906670|101690565|FG009|STARTED|Cohort 7P, Q2W||3||
48554195|NCT02906670|101690556|FG000|COMPLETED|Cohort 7P, Q2W||0||
48554196|NCT02906670|101690557|FG001|COMPLETED|Cohort 7P, Q2W||0||
48554197|NCT02906670|101690558|FG002|COMPLETED|Cohort 7P, Q2W||0||
48554198|NCT02906670|101690559|FG003|COMPLETED|Cohort 7P, Q2W||0||
48554199|NCT02906670|101690560|FG004|COMPLETED|Cohort 7P, Q2W||0||
48554200|NCT02906670|101690561|FG005|COMPLETED|Cohort 7P, Q2W||0||
48554201|NCT02906670|101690562|FG006|COMPLETED|Cohort 7P, Q2W||0||
48554202|NCT02906670|101690563|FG007|COMPLETED|Cohort 7P, Q2W||0||
48554203|NCT02906670|101690564|FG008|COMPLETED|Cohort 7P, Q2W||0||
48554204|NCT02906670|101690565|FG009|COMPLETED|Cohort 7P, Q2W||0||
48554205|NCT02906670|101690556|FG000|NOT COMPLETED|Cohort 7P, Q2W||0||
48554206|NCT02906670|101690557|FG001|NOT COMPLETED|Cohort 7P, Q2W||0||
48554207|NCT02906670|101690558|FG002|NOT COMPLETED|Cohort 7P, Q2W||0||
48554208|NCT02906670|101690559|FG003|NOT COMPLETED|Cohort 7P, Q2W||0||
48554209|NCT02906670|101690560|FG004|NOT COMPLETED|Cohort 7P, Q2W||0||
48554210|NCT02906670|101690561|FG005|NOT COMPLETED|Cohort 7P, Q2W||0||
48554211|NCT02906670|101690562|FG006|NOT COMPLETED|Cohort 7P, Q2W||0||
48554212|NCT02906670|101690563|FG007|NOT COMPLETED|Cohort 7P, Q2W||0||
48554213|NCT02906670|101690564|FG008|NOT COMPLETED|Cohort 7P, Q2W||0||
48554214|NCT02906670|101690565|FG009|NOT COMPLETED|Cohort 7P, Q2W||3||
48554215|NCT02906670|101690556|FG000|STARTED|Cohort 5P, QW||0||
48554216|NCT02906670|101690557|FG001|STARTED|Cohort 5P, QW||0||
48554217|NCT02906670|101690558|FG002|STARTED|Cohort 5P, QW||0||
48554218|NCT02906670|101690559|FG003|STARTED|Cohort 5P, QW||0||
48554219|NCT02906670|101690560|FG004|STARTED|Cohort 5P, QW||3||
48554220|NCT02906670|101690561|FG005|STARTED|Cohort 5P, QW||0||
48554221|NCT02906670|101690562|FG006|STARTED|Cohort 5P, QW||0||
48554222|NCT02906670|101690563|FG007|STARTED|Cohort 5P, QW||0||
48554223|NCT02906670|101690564|FG008|STARTED|Cohort 5P, QW||0||
48554224|NCT02906670|101690565|FG009|STARTED|Cohort 5P, QW||0||
48554225|NCT02906670|101690556|FG000|COMPLETED|Cohort 5P, QW||0||
48554226|NCT02906670|101690557|FG001|COMPLETED|Cohort 5P, QW||0||
48554227|NCT02906670|101690558|FG002|COMPLETED|Cohort 5P, QW||0||
48554228|NCT02906670|101690559|FG003|COMPLETED|Cohort 5P, QW||0||
48554229|NCT02906670|101690560|FG004|COMPLETED|Cohort 5P, QW||0||
48554230|NCT02906670|101690561|FG005|COMPLETED|Cohort 5P, QW||0||
48554231|NCT02906670|101690562|FG006|COMPLETED|Cohort 5P, QW||0||
48554232|NCT02906670|101690563|FG007|COMPLETED|Cohort 5P, QW||0||
48554233|NCT02906670|101690564|FG008|COMPLETED|Cohort 5P, QW||0||
48554234|NCT02906670|101690565|FG009|COMPLETED|Cohort 5P, QW||0||
48554235|NCT02906670|101690556|FG000|NOT COMPLETED|Cohort 5P, QW||0||
48554236|NCT02906670|101690557|FG001|NOT COMPLETED|Cohort 5P, QW||0||
48554237|NCT02906670|101690558|FG002|NOT COMPLETED|Cohort 5P, QW||0||
48554238|NCT02906670|101690559|FG003|NOT COMPLETED|Cohort 5P, QW||0||
48554239|NCT02906670|101690560|FG004|NOT COMPLETED|Cohort 5P, QW||3||
48554240|NCT02906670|101690561|FG005|NOT COMPLETED|Cohort 5P, QW||0||
48554241|NCT02906670|101690562|FG006|NOT COMPLETED|Cohort 5P, QW||0||
48554242|NCT02906670|101690563|FG007|NOT COMPLETED|Cohort 5P, QW||0||
48554243|NCT02906670|101690564|FG008|NOT COMPLETED|Cohort 5P, QW||0||
48554244|NCT02906670|101690565|FG009|NOT COMPLETED|Cohort 5P, QW||0||
48554245|NCT02037425|101690566|FG000|STARTED|Overall Study||44||
48554246|NCT02037425|101690566|FG000|Randomized to Treatment|Overall Study||32||
48554247|NCT02037425|101690566|FG000|COMPLETED|Overall Study||18||
48554248|NCT02037425|101690566|FG000|NOT COMPLETED|Overall Study||26||
48554249|NCT05373108|101690567|FG000|STARTED|Overall Study||19||
48554250|NCT05373108|101690567|FG000|COMPLETED|Overall Study||17||
48554251|NCT05373108|101690567|FG000|NOT COMPLETED|Overall Study||2||
48554252|NCT04564092|101690568|FG000|STARTED|Overall Study||9||
48554253|NCT04564092|101690568|FG000|Safety Population|Overall Study||8|The safety population included all participants who received ioflupane (123I) injection.|
48554254|NCT04564092|101690568|FG000|COMPLETED|Overall Study||8||
48554255|NCT04564092|101690568|FG000|NOT COMPLETED|Overall Study||1||
48554256|NCT03618017|101690569|FG000|STARTED|Overall Study||33|Enrolled|
48554257|NCT03618017|101690570|FG001|STARTED|Overall Study||33|Enrolled|
48554258|NCT03618017|101690569|FG000|COMPLETED|Overall Study||26|Completed the 3-month follow-up survey.|
48554259|NCT03618017|101690570|FG001|COMPLETED|Overall Study||28|Completed the 3-month follow-up survey.|
48554260|NCT03618017|101690569|FG000|NOT COMPLETED|Overall Study||7||
48554261|NCT03618017|101690570|FG001|NOT COMPLETED|Overall Study||5||
48554262|NCT03722589|101690571|FG000|STARTED|Year 1 (2018-19)||202||
48554263|NCT03722589|101690572|FG001|STARTED|Year 1 (2018-19)||283||
48554264|NCT03722589|101690573|FG002|STARTED|Year 1 (2018-19)||120||
48554265|NCT03722589|101690574|FG003|STARTED|Year 1 (2018-19)||122||
48554266|NCT03722589|101690575|FG004|STARTED|Year 1 (2018-19)||0||
48271479|NCT00737698|100988397|FG000|COMPLETED|Overall Study||17||
48271480|NCT00737698|100988398|FG001|COMPLETED|Overall Study||37||
48271481|NCT00737698|100988399|FG002|COMPLETED|Overall Study||17||
48271482|NCT00737698|100988397|FG000|NOT COMPLETED|Overall Study||6||
48554267|NCT03722589|101690571|FG000|COMPLETED|Year 1 (2018-19)||195||
48554268|NCT03722589|101690572|FG001|COMPLETED|Year 1 (2018-19)||279||
48554269|NCT03722589|101690573|FG002|COMPLETED|Year 1 (2018-19)||97||
48554270|NCT03722589|101690574|FG003|COMPLETED|Year 1 (2018-19)||86||
48554271|NCT03722589|101690575|FG004|COMPLETED|Year 1 (2018-19)||0||
48554272|NCT03722589|101690571|FG000|NOT COMPLETED|Year 1 (2018-19)||7||
48554273|NCT03722589|101690572|FG001|NOT COMPLETED|Year 1 (2018-19)||4||
48554274|NCT03722589|101690573|FG002|NOT COMPLETED|Year 1 (2018-19)||23||
48554275|NCT03722589|101690574|FG003|NOT COMPLETED|Year 1 (2018-19)||36||
48554276|NCT03722589|101690575|FG004|NOT COMPLETED|Year 1 (2018-19)||0||
48554277|NCT03722589|101690571|FG000|STARTED|Year 2 (2019-20)||292||
48554278|NCT03722589|101690572|FG001|STARTED|Year 2 (2019-20)||287||
48554279|NCT03722589|101690573|FG002|STARTED|Year 2 (2019-20)||0||
48554280|NCT03722589|101690574|FG003|STARTED|Year 2 (2019-20)||105||
48554281|NCT03722589|101690575|FG004|STARTED|Year 2 (2019-20)||79||
48554282|NCT03722589|101690571|FG000|COMPLETED|Year 2 (2019-20)||285||
48554283|NCT03722589|101690572|FG001|COMPLETED|Year 2 (2019-20)||281||
48554284|NCT03722589|101690573|FG002|COMPLETED|Year 2 (2019-20)||0||
48554285|NCT03722589|101690574|FG003|COMPLETED|Year 2 (2019-20)||103||
48554286|NCT03722589|101690575|FG004|COMPLETED|Year 2 (2019-20)||79||
48554287|NCT03722589|101690571|FG000|NOT COMPLETED|Year 2 (2019-20)||7||
48554288|NCT03722589|101690572|FG001|NOT COMPLETED|Year 2 (2019-20)||6||
48554289|NCT03722589|101690573|FG002|NOT COMPLETED|Year 2 (2019-20)||0||
48554290|NCT03722589|101690574|FG003|NOT COMPLETED|Year 2 (2019-20)||2||
48554291|NCT03722589|101690575|FG004|NOT COMPLETED|Year 2 (2019-20)||0||
48392562|NCT01576406|101291381|FG002|STARTED|Overall Study||20||
48392563|NCT01576406|101291382|FG003|STARTED|Overall Study||10||
48392564|NCT01576406|101291383|FG004|STARTED|Overall Study||16||
48392565|NCT01576406|101291384|FG005|STARTED|Overall Study||16||
48392566|NCT01576406|101291379|FG000|COMPLETED|Overall Study||5||
48392567|NCT01576406|101291380|FG001|COMPLETED|Overall Study||7||
48392568|NCT01576406|101291381|FG002|COMPLETED|Overall Study||4||
48271483|NCT00737698|100988398|FG001|NOT COMPLETED|Overall Study||5||
48271484|NCT00737698|100988399|FG002|NOT COMPLETED|Overall Study||4||
48271485|NCT02807272|100988400|FG000|STARTED|Overall Study||23||
48392569|NCT01576406|101291382|FG003|COMPLETED|Overall Study||1||
48392570|NCT01576406|101291383|FG004|COMPLETED|Overall Study||8||
48554292|NCT02719184|101690576|FG000|STARTED|Overall Study||62|"Started = Observed subjects set"|
48554293|NCT02719184|101690577|FG001|STARTED|Overall Study||123|"Started = Observed subjects set"|
48554294|NCT02719184|101690578|FG002|STARTED|Overall Study||130|"Started = Observed subjects set"|
48392571|NCT01576406|101291384|FG005|COMPLETED|Overall Study||4||
48392572|NCT01576406|101291379|FG000|NOT COMPLETED|Overall Study||6||
48392573|NCT01576406|101291380|FG001|NOT COMPLETED|Overall Study||8||
48392574|NCT01576406|101291381|FG002|NOT COMPLETED|Overall Study||16||
48392575|NCT01576406|101291382|FG003|NOT COMPLETED|Overall Study||9||
48554295|NCT02719184|101690579|FG003|STARTED|Overall Study||129|"Started = Observed subjects set"|
48554296|NCT02719184|101690580|FG004|STARTED|Overall Study||19|"Started = Observed subjects set"|
48554297|NCT02719184|101690576|FG000|Per-Protocol Set (Biomarker Subjects)|Overall Study||61||
48554298|NCT02719184|101690577|FG001|Per-Protocol Set (Biomarker Subjects)|Overall Study||122||
48271486|NCT02807272|100988401|FG001|STARTED|Overall Study||12||
48271487|NCT02807272|100988402|FG002|STARTED|Overall Study||2||
48554299|NCT02719184|101690578|FG002|Per-Protocol Set (Biomarker Subjects)|Overall Study||127||
48554300|NCT02719184|101690579|FG003|Per-Protocol Set (Biomarker Subjects)|Overall Study||127||
48109644|NCT05409235|100594545|FG001|NOT COMPLETED|Overall Study||11||
48109645|NCT05409235|100594546|FG002|NOT COMPLETED|Overall Study||4||
48109646|NCT05409235|100594547|FG003|NOT COMPLETED|Overall Study||6||
48109647|NCT02181556|100594548|FG000|STARTED|Overall Study||41||
48271488|NCT02807272|100988403|FG003|STARTED|Overall Study||3||
48271489|NCT02807272|100988404|FG004|STARTED|Overall Study||4||
48271490|NCT02807272|100988400|FG000|COMPLETED|Overall Study||3||
48554301|NCT02719184|101690580|FG004|Per-Protocol Set (Biomarker Subjects)|Overall Study||19||
48554302|NCT02719184|101690576|FG000|COMPLETED|Overall Study||56||
48554303|NCT02719184|101690577|FG001|COMPLETED|Overall Study||101||
48554304|NCT02719184|101690578|FG002|COMPLETED|Overall Study||110||
48554305|NCT02719184|101690579|FG003|COMPLETED|Overall Study||93||
48554306|NCT02719184|101690580|FG004|COMPLETED|Overall Study||10||
48554307|NCT02719184|101690576|FG000|NOT COMPLETED|Overall Study||6||
48554308|NCT02719184|101690577|FG001|NOT COMPLETED|Overall Study||22||
48554309|NCT02719184|101690578|FG002|NOT COMPLETED|Overall Study||20||
48554310|NCT02719184|101690579|FG003|NOT COMPLETED|Overall Study||36||
48271491|NCT02807272|100988401|FG001|COMPLETED|Overall Study||4||
48271492|NCT02807272|100988402|FG002|COMPLETED|Overall Study||0||
48554311|NCT02719184|101690580|FG004|NOT COMPLETED|Overall Study||9||
48554312|NCT01811472|101690581|FG000|STARTED|Overall Study||20||
48109648|NCT02181556|100594548|FG000|COMPLETED|Overall Study||40||
48109649|NCT02181556|100594548|FG000|NOT COMPLETED|Overall Study||1||
48109650|NCT00337103|100594549|FG000|STARTED|Overall Study||554||
48109651|NCT00337103|100594550|FG001|STARTED|Overall Study||548||
48109652|NCT00337103|100594549|FG000|Treated (Safety Population)|Overall Study||544||
48109653|NCT00337103|100594550|FG001|Treated (Safety Population)|Overall Study||546||
48109654|NCT00337103|100594549|FG000|COMPLETED|Overall Study||0||
48109655|NCT00337103|100594550|FG001|COMPLETED|Overall Study||0||
48109656|NCT00337103|100594549|FG000|NOT COMPLETED|Overall Study||554||
48109657|NCT00337103|100594550|FG001|NOT COMPLETED|Overall Study||548||
48109658|NCT03350503|100594551|FG000|STARTED|Overall Study||121||121
48109659|NCT03350503|100594551|FG000|Successful Implantation|Overall Study||120||120
48109660|NCT03350503|100594551|FG000|Implanted With SN6AT3|Overall Study||61||61
48109661|NCT03350503|100594551|FG000|Implanted With SN6AT4|Overall Study||27||27
48109662|NCT03350503|100594551|FG000|Implanted With SN6AT5|Overall Study||33||33
48109663|NCT03350503|100594551|FG000|COMPLETED|Overall Study||104||104
48109664|NCT03350503|100594551|FG000|NOT COMPLETED|Overall Study||17||17
48109665|NCT00283439|100594552|FG000|STARTED|Overall Study||8||
48109666|NCT00283439|100594553|FG001|STARTED|Overall Study||11||
48109667|NCT00283439|100594554|FG002|STARTED|Overall Study||11||
48109668|NCT00283439|100594555|FG003|STARTED|Overall Study||9||
48109669|NCT00283439|100594552|FG000|COMPLETED|Overall Study||0||
48109670|NCT00283439|100594553|FG001|COMPLETED|Overall Study||0||
48109671|NCT00283439|100594554|FG002|COMPLETED|Overall Study||0||
48109672|NCT00283439|100594555|FG003|COMPLETED|Overall Study||0||
48109673|NCT00283439|100594552|FG000|NOT COMPLETED|Overall Study||8||
48109674|NCT00283439|100594553|FG001|NOT COMPLETED|Overall Study||11||
48109675|NCT00283439|100594554|FG002|NOT COMPLETED|Overall Study||11||
48109676|NCT00283439|100594555|FG003|NOT COMPLETED|Overall Study||9||
48109677|NCT00706641|100594556|FG000|STARTED|Dasatinib Administration||25||
48109678|NCT00706641|100594556|FG000|Toxicity Evaluation|Dasatinib Administration||24||
48109679|NCT00706641|100594556|FG000|COMPLETED|Dasatinib Administration||23||
48271493|NCT02807272|100988403|FG003|COMPLETED|Overall Study||0||
48109680|NCT00706641|100594556|FG000|NOT COMPLETED|Dasatinib Administration||2||
48109681|NCT00706641|100594556|FG000|STARTED|Radical Cystectomy||23||
48109682|NCT00706641|100594556|FG000|COMPLETED|Radical Cystectomy||22||
48554313|NCT01811472|101690582|FG001|STARTED|Overall Study||11||
48554314|NCT01811472|101690583|FG002|STARTED|Overall Study||21||
48554315|NCT01811472|101690581|FG000|COMPLETED|Overall Study||18||
48554316|NCT01811472|101690582|FG001|COMPLETED|Overall Study||11||
48109683|NCT00706641|100594556|FG000|NOT COMPLETED|Radical Cystectomy||1||
48109684|NCT00908960|100594557|FG000|STARTED|Overall Study||24||
48109685|NCT00908960|100594558|FG001|STARTED|Overall Study||12||
48271494|NCT02807272|100988404|FG004|COMPLETED|Overall Study||0||
48554317|NCT01811472|101690583|FG002|COMPLETED|Overall Study||16||
48554318|NCT01811472|101690581|FG000|NOT COMPLETED|Overall Study||2||
48109686|NCT00908960|100594559|FG002|STARTED|Overall Study||34||
48109687|NCT00908960|100594557|FG000|Evaluable|Overall Study||23||
48109688|NCT00908960|100594558|FG001|Evaluable|Overall Study||11||
48109689|NCT00908960|100594559|FG002|Evaluable|Overall Study||32||
48109690|NCT00908960|100594557|FG000|COMPLETED|Overall Study||23||
48109691|NCT00908960|100594558|FG001|COMPLETED|Overall Study||11||
48109692|NCT00908960|100594559|FG002|COMPLETED|Overall Study||32||
48109693|NCT00908960|100594557|FG000|NOT COMPLETED|Overall Study||1||
48109694|NCT00908960|100594558|FG001|NOT COMPLETED|Overall Study||1||
48109695|NCT00908960|100594559|FG002|NOT COMPLETED|Overall Study||2||
48109696|NCT02042924|100594560|FG000|STARTED|Overall Study||2||
48271495|NCT02807272|100988400|FG000|NOT COMPLETED|Overall Study||20||
48109697|NCT02042924|100594560|FG000|COMPLETED|Overall Study||1||
48109698|NCT02042924|100594560|FG000|NOT COMPLETED|Overall Study||1||
48109699|NCT00254995|100594561|FG000|STARTED|Overall Study||31561||
48109700|NCT00254995|100594562|FG001|STARTED|Overall Study||31065||
48109701|NCT00254995|100594561|FG000|COMPLETED|Overall Study||31561||
48109702|NCT00254995|100594562|FG001|COMPLETED|Overall Study||31065||
48109703|NCT00254995|100594561|FG000|NOT COMPLETED|Overall Study||0||
48109704|NCT00254995|100594562|FG001|NOT COMPLETED|Overall Study||0||
48109705|NCT00836875|100594563|FG000|STARTED|Overall Study||11||
48109706|NCT00836875|100594564|FG001|STARTED|Overall Study||20||
48109707|NCT00836875|100594563|FG000|COMPLETED|Overall Study||8||
48109708|NCT00836875|100594564|FG001|COMPLETED|Overall Study||17||
48109709|NCT00836875|100594563|FG000|NOT COMPLETED|Overall Study||3||
48109710|NCT00836875|100594564|FG001|NOT COMPLETED|Overall Study||3||
48109711|NCT00489853|100594565|FG000|STARTED|Treatment Period 1||36||
48109712|NCT00489853|100594566|FG001|STARTED|Treatment Period 1||37||
48109713|NCT00489853|100594567|FG002|STARTED|Treatment Period 1||38||
48109714|NCT00489853|100594565|FG000|COMPLETED|Treatment Period 1||36||
48109715|NCT00489853|100594566|FG001|COMPLETED|Treatment Period 1||37||
48109716|NCT00489853|100594567|FG002|COMPLETED|Treatment Period 1||38||
48109717|NCT00489853|100594565|FG000|NOT COMPLETED|Treatment Period 1||0||
48392576|NCT01576406|101291383|FG004|NOT COMPLETED|Overall Study||8||
48392577|NCT01576406|101291384|FG005|NOT COMPLETED|Overall Study||12||
48392578|NCT00835003|101291385|FG000|STARTED|Overall Study||636||
48392579|NCT00835003|101291386|FG001|STARTED|Overall Study||638||
48392580|NCT00835003|101291385|FG000|COMPLETED|Overall Study||636||
48693665|NCT03148379|102032829|FG000|STARTED|Overall Study||21||
48693666|NCT03148379|102032830|FG001|STARTED|Overall Study||11||
48693667|NCT03148379|102032829|FG000|COMPLETED|Overall Study||20||
48693668|NCT03148379|102032830|FG001|COMPLETED|Overall Study||11||
48109718|NCT00489853|100594566|FG001|NOT COMPLETED|Treatment Period 1||0||
48109719|NCT00489853|100594567|FG002|NOT COMPLETED|Treatment Period 1||0||
48109720|NCT00489853|100594565|FG000|STARTED|Wash-out Period 1||36||
48109721|NCT00489853|100594566|FG001|STARTED|Wash-out Period 1||37||
48109722|NCT00489853|100594567|FG002|STARTED|Wash-out Period 1||38||
48392581|NCT00835003|101291386|FG001|COMPLETED|Overall Study||638||
48693669|NCT03148379|102032829|FG000|NOT COMPLETED|Overall Study||1||
48693670|NCT03148379|102032830|FG001|NOT COMPLETED|Overall Study||0||
48693671|NCT02371785|102032831|FG000|STARTED|Overall Study||20||
48693672|NCT02371785|102032831|FG000|COMPLETED|Overall Study||20||
48693673|NCT02371785|102032831|FG000|NOT COMPLETED|Overall Study||0||
48693674|NCT00810771|102032832|FG000|STARTED|Overall Study||232||
48693675|NCT00810771|102032833|FG001|STARTED|Overall Study||234||
48693676|NCT00810771|102032834|FG002|STARTED|Overall Study||84||
48109723|NCT00489853|100594565|FG000|COMPLETED|Wash-out Period 1||35||
48392582|NCT00835003|101291385|FG000|NOT COMPLETED|Overall Study||0||
48392583|NCT00835003|101291386|FG001|NOT COMPLETED|Overall Study||0||
48392584|NCT01116687|101291387|FG000|STARTED|Overall Study||37||
48693677|NCT00810771|102032832|FG000|COMPLETED|Overall Study||232||
48693678|NCT00810771|102032833|FG001|COMPLETED|Overall Study||234||
48693679|NCT00810771|102032834|FG002|COMPLETED|Overall Study||84||
48693680|NCT00810771|102032832|FG000|NOT COMPLETED|Overall Study||0||
48271496|NCT02807272|100988401|FG001|NOT COMPLETED|Overall Study||8||
48693681|NCT00810771|102032833|FG001|NOT COMPLETED|Overall Study||0||
48693682|NCT00810771|102032834|FG002|NOT COMPLETED|Overall Study||0||
48271497|NCT02807272|100988402|FG002|NOT COMPLETED|Overall Study||2||
48271498|NCT02807272|100988403|FG003|NOT COMPLETED|Overall Study||3||
48271499|NCT02807272|100988404|FG004|NOT COMPLETED|Overall Study||4||
48271500|NCT00384397|100988405|FG000|STARTED|Overall Study||407||
48271501|NCT00384397|100988406|FG001|STARTED|Overall Study||293||
48271502|NCT00384397|100988407|FG002|STARTED|Overall Study||418||
48392585|NCT01116687|101291387|FG000|COMPLETED|Overall Study||33||
48392586|NCT01116687|101291387|FG000|NOT COMPLETED|Overall Study||4||
48392587|NCT02999100|101291388|FG000|STARTED|Part 1 (up to 15 Days)||9||
48392588|NCT02999100|101291389|FG001|STARTED|Part 1 (up to 15 Days)||8||
48392589|NCT02999100|101291390|FG002|STARTED|Part 1 (up to 15 Days)||0||
48392590|NCT02999100|101291391|FG003|STARTED|Part 1 (up to 15 Days)||0||
48271503|NCT00384397|100988405|FG000|COMPLETED|Overall Study||375||
48271504|NCT00384397|100988406|FG001|COMPLETED|Overall Study||247||
48271505|NCT00384397|100988407|FG002|COMPLETED|Overall Study||385||
48271506|NCT00384397|100988405|FG000|NOT COMPLETED|Overall Study||32||
48271507|NCT00384397|100988406|FG001|NOT COMPLETED|Overall Study||46||
48271508|NCT00384397|100988407|FG002|NOT COMPLETED|Overall Study||33||
48271509|NCT00368927|100988408|FG000|STARTED|Overall Study||31||
48271510|NCT00368927|100988409|FG001|STARTED|Overall Study||30||
48271511|NCT00368927|100988408|FG000|COMPLETED|Overall Study||26||
48271512|NCT00368927|100988409|FG001|COMPLETED|Overall Study||27||
48271513|NCT00368927|100988408|FG000|NOT COMPLETED|Overall Study||5||
48271514|NCT00368927|100988409|FG001|NOT COMPLETED|Overall Study||3||
48271515|NCT00672737|100988410|FG000|STARTED|Overall Study||56||
48271516|NCT00672737|100988410|FG000|COMPLETED|Overall Study||48||
48271517|NCT00672737|100988410|FG000|NOT COMPLETED|Overall Study||8||
48271518|NCT00747227|100988411|FG000|STARTED|Overall Study||126||
48271519|NCT00747227|100988412|FG001|STARTED|Overall Study||124||
48271520|NCT00747227|100988411|FG000|COMPLETED|Overall Study||120||
48271521|NCT00747227|100988412|FG001|COMPLETED|Overall Study||120||
48271522|NCT00747227|100988411|FG000|NOT COMPLETED|Overall Study||6||
48271523|NCT00747227|100988412|FG001|NOT COMPLETED|Overall Study||4||
48271524|NCT03301155|100988413|FG000|STARTED|Overall Study||528||
48271525|NCT03301155|100988414|FG001|STARTED|Overall Study||508||
48271526|NCT03301155|100988413|FG000|COMPLETED|Overall Study||520||
48271527|NCT03301155|100988414|FG001|COMPLETED|Overall Study||501||
48271528|NCT03301155|100988413|FG000|NOT COMPLETED|Overall Study||8||
48271529|NCT03301155|100988414|FG001|NOT COMPLETED|Overall Study||7||
48271530|NCT03466047|100988415|FG000|STARTED|Protein Stomach (1day)||8||
48271531|NCT03466047|100988415|FG000|COMPLETED|Protein Stomach (1day)||8||
48271532|NCT03466047|100988415|FG000|NOT COMPLETED|Protein Stomach (1day)||0||
48271533|NCT03466047|100988415|FG000|STARTED|Protein Small Intestine (1 Day)||8||
48271534|NCT03466047|100988415|FG000|COMPLETED|Protein Small Intestine (1 Day)||8||
48271535|NCT03466047|100988415|FG000|NOT COMPLETED|Protein Small Intestine (1 Day)||0||
48271536|NCT03466047|100988415|FG000|STARTED|CHO Stomach (1 Day)||8||
48271537|NCT03466047|100988415|FG000|COMPLETED|CHO Stomach (1 Day)||8||
48271538|NCT03466047|100988415|FG000|NOT COMPLETED|CHO Stomach (1 Day)||0||
48271539|NCT03466047|100988415|FG000|STARTED|CHO Small Intestine (1 Day)||8||
48271540|NCT03466047|100988415|FG000|COMPLETED|CHO Small Intestine (1 Day)||8||
48392591|NCT02999100|101291392|FG004|STARTED|Part 1 (up to 15 Days)||0||
48693683|NCT01947283|102032835|FG000|STARTED|Overall Study||89||
48693684|NCT01947283|102032836|FG001|STARTED|Overall Study||68||
48693685|NCT01947283|102032837|FG002|STARTED|Overall Study||83||
48271541|NCT03466047|100988415|FG000|NOT COMPLETED|CHO Small Intestine (1 Day)||0||
48271542|NCT03466047|100988415|FG000|STARTED|Fat Stomach (1 Day)||8||
48271543|NCT03466047|100988415|FG000|COMPLETED|Fat Stomach (1 Day)||8||
48271544|NCT03466047|100988415|FG000|NOT COMPLETED|Fat Stomach (1 Day)||0||
48271545|NCT03466047|100988415|FG000|STARTED|Fat Small Intestine (1 Day)||8||
48271546|NCT03466047|100988415|FG000|COMPLETED|Fat Small Intestine (1 Day)||8||
48271547|NCT03466047|100988415|FG000|NOT COMPLETED|Fat Small Intestine (1 Day)||0||
48392592|NCT02999100|101291393|FG005|STARTED|Part 1 (up to 15 Days)||0||
48392593|NCT02999100|101291388|FG000|COMPLETED|Part 1 (up to 15 Days)||9||
48392594|NCT02999100|101291389|FG001|COMPLETED|Part 1 (up to 15 Days)||7||
48392595|NCT02999100|101291390|FG002|COMPLETED|Part 1 (up to 15 Days)||0||
48392596|NCT02999100|101291391|FG003|COMPLETED|Part 1 (up to 15 Days)||0||
48392597|NCT02999100|101291392|FG004|COMPLETED|Part 1 (up to 15 Days)||0||
48392598|NCT02999100|101291393|FG005|COMPLETED|Part 1 (up to 15 Days)||0||
48392599|NCT02999100|101291388|FG000|NOT COMPLETED|Part 1 (up to 15 Days)||0||
48392600|NCT02999100|101291389|FG001|NOT COMPLETED|Part 1 (up to 15 Days)||1||
48392601|NCT02999100|101291390|FG002|NOT COMPLETED|Part 1 (up to 15 Days)||0||
48392602|NCT02999100|101291391|FG003|NOT COMPLETED|Part 1 (up to 15 Days)||0||
48693686|NCT01947283|102032838|FG003|STARTED|Overall Study||72||
48271548|NCT01912404|100988416|FG000|STARTED|Overall Study||3||
48271549|NCT01912404|100988417|FG001|STARTED|Overall Study||2||
48271550|NCT01912404|100988416|FG000|COMPLETED|Overall Study||2||
48271551|NCT01912404|100988417|FG001|COMPLETED|Overall Study||2||
48271552|NCT01912404|100988416|FG000|NOT COMPLETED|Overall Study||1||
48271553|NCT01912404|100988417|FG001|NOT COMPLETED|Overall Study||0||
48271554|NCT01381575|100988418|FG000|STARTED|Overall Study||550||
48271555|NCT01381575|100988419|FG001|STARTED|Overall Study||482||
48271556|NCT01381575|100988420|FG002|STARTED|Overall Study||415||
48271557|NCT01381575|100988418|FG000|COMPLETED|Overall Study||524||
48271558|NCT01381575|100988419|FG001|COMPLETED|Overall Study||443||
48271559|NCT01381575|100988420|FG002|COMPLETED|Overall Study||395||
48271560|NCT01381575|100988418|FG000|NOT COMPLETED|Overall Study||26||
48271561|NCT01381575|100988419|FG001|NOT COMPLETED|Overall Study||39||
48271562|NCT01381575|100988420|FG002|NOT COMPLETED|Overall Study||20||
48271563|NCT00168389|100988421|FG000|STARTED|Overall Study||163||
48271564|NCT00168389|100988422|FG001|STARTED|Overall Study||166||
48271565|NCT00168389|100988423|FG002|STARTED|Overall Study||165||
48271566|NCT00168389|100988421|FG000|COMPLETED|Overall Study||107||
48271567|NCT00168389|100988422|FG001|COMPLETED|Overall Study||118||
48271568|NCT00168389|100988423|FG002|COMPLETED|Overall Study||70||
48271569|NCT00168389|100988421|FG000|NOT COMPLETED|Overall Study||56||
48271570|NCT00168389|100988422|FG001|NOT COMPLETED|Overall Study||48||
48271571|NCT00168389|100988423|FG002|NOT COMPLETED|Overall Study||95||
48271572|NCT03192475|100988424|FG000|STARTED|Overall Study||162||
48271573|NCT03192475|100988425|FG001|STARTED|Overall Study||160||
48271574|NCT03192475|100988424|FG000|COMPLETED|Overall Study||149||
48271575|NCT03192475|100988425|FG001|COMPLETED|Overall Study||151||
48271576|NCT03192475|100988424|FG000|NOT COMPLETED|Overall Study||13||
48271577|NCT03192475|100988425|FG001|NOT COMPLETED|Overall Study||9||
48271578|NCT00871286|100988426|FG000|STARTED|Overall Study||20||
48271579|NCT00871286|100988427|FG001|STARTED|Overall Study||20||
48271580|NCT00871286|100988426|FG000|COMPLETED|Overall Study||20||
48554319|NCT01811472|101690582|FG001|NOT COMPLETED|Overall Study||0||
48554320|NCT01811472|101690583|FG002|NOT COMPLETED|Overall Study||5||
48554321|NCT01168427|101690584|FG000|STARTED|Overall Study||66||
48554322|NCT01168427|101690584|FG000|COMPLETED|Overall Study||65||
48554323|NCT01168427|101690584|FG000|NOT COMPLETED|Overall Study||1||
48554324|NCT04123405|101690585|FG000|STARTED|Overall Study||235|Randomized|
48554325|NCT04123405|101690586|FG001|STARTED|Overall Study||238|Randomized|
48554326|NCT04123405|101690587|FG002|STARTED|Overall Study||238|Randomized|
48554327|NCT04123405|101690588|FG003|STARTED|Overall Study||233|Randomized|
48554328|NCT04123405|101690585|FG000|Full Analysis Set|Overall Study||235|all randomized patients who received at least one dose of the trial medication and who had at least one post-baseline assessment of MSS during the double-blind treatment period|
48554329|NCT04123405|101690586|FG001|Full Analysis Set|Overall Study||236|all randomized patients who received at least one dose of the trial medication and who had at least one post-baseline assessment of MSS during the double-blind treatment period|
48554330|NCT04123405|101690587|FG002|Full Analysis Set|Overall Study||238|all randomized patients who received at least one dose of the trial medication and who had at least one post-baseline assessment of MSS during the double-blind treatment period|
48554331|NCT04123405|101690588|FG003|Full Analysis Set|Overall Study||230|all randomized patients who received at least one dose of the trial medication and who had at least one post-baseline assessment of MSS during the double-blind treatment period|
48554332|NCT04123405|101690585|FG000|Per-protocol Set|Overall Study||213|all FAS-evaluable patients who completed the double-blind treatment period without major protocol violations that could affect the efficacy evaluation|
48554333|NCT04123405|101690586|FG001|Per-protocol Set|Overall Study||215|all FAS-evaluable patients who completed the double-blind treatment period without major protocol violations that could affect the efficacy evaluation|
48554334|NCT04123405|101690587|FG002|Per-protocol Set|Overall Study||212|all FAS-evaluable patients who completed the double-blind treatment period without major protocol violations that could affect the efficacy evaluation|
48554335|NCT04123405|101690588|FG003|Per-protocol Set|Overall Study||207|all FAS-evaluable patients who completed the double-blind treatment period without major protocol violations that could affect the efficacy evaluation|
48554336|NCT04123405|101690585|FG000|Safety Set|Overall Study||235|all randomized patients who received at least one dose of the trial medication|
48554337|NCT04123405|101690586|FG001|Safety Set|Overall Study||238|all randomized patients who received at least one dose of the trial medication|
48554338|NCT04123405|101690587|FG002|Safety Set|Overall Study||238|all randomized patients who received at least one dose of the trial medication|
48554339|NCT04123405|101690588|FG003|Safety Set|Overall Study||233|all randomized patients who received at least one dose of the trial medication|
48554340|NCT04123405|101690585|FG000|COMPLETED|Overall Study||231||
48554341|NCT04123405|101690586|FG001|COMPLETED|Overall Study||231||
48554342|NCT04123405|101690587|FG002|COMPLETED|Overall Study||235||
48554343|NCT04123405|101690588|FG003|COMPLETED|Overall Study||225||
48554344|NCT04123405|101690585|FG000|NOT COMPLETED|Overall Study||4||
48554345|NCT04123405|101690586|FG001|NOT COMPLETED|Overall Study||7||
48554346|NCT04123405|101690587|FG002|NOT COMPLETED|Overall Study||3||
48554347|NCT04123405|101690588|FG003|NOT COMPLETED|Overall Study||8||
48554348|NCT02500043|101690589|FG000|STARTED|Overall Study||337||
48271581|NCT00871286|100988427|FG001|COMPLETED|Overall Study||14||
48271582|NCT00871286|100988426|FG000|NOT COMPLETED|Overall Study||0||
48271583|NCT00871286|100988427|FG001|NOT COMPLETED|Overall Study||6||
48271584|NCT03794700|100988428|FG000|STARTED|Overall Study||43||
48271585|NCT03794700|100988429|FG001|STARTED|Overall Study||88||
48271586|NCT03794700|100988428|FG000|COMPLETED|Overall Study||43||
48271587|NCT03794700|100988429|FG001|COMPLETED|Overall Study||88||
48271588|NCT03794700|100988428|FG000|NOT COMPLETED|Overall Study||0||
48271589|NCT03794700|100988429|FG001|NOT COMPLETED|Overall Study||0||
48554349|NCT02500043|101690590|FG001|STARTED|Overall Study||170||
48554350|NCT02500043|101690589|FG000|As-Treated (AT) Population|Overall Study||335|All participants who received at least 1 dose of study treatment.|
48554351|NCT02500043|101690590|FG001|As-Treated (AT) Population|Overall Study||168|All participants who received at least 1 dose of study treatment.|
48554352|NCT02500043|101690589|FG000|COMPLETED|Overall Study||0||
48554353|NCT02500043|101690590|FG001|COMPLETED|Overall Study||0||
48554354|NCT02500043|101690589|FG000|NOT COMPLETED|Overall Study||337||
48554355|NCT02500043|101690590|FG001|NOT COMPLETED|Overall Study||170||
48554356|NCT04479787|101690591|FG000|STARTED|Overall Study||162||
48554357|NCT04479787|101690592|FG001|STARTED|Overall Study||107||
48554358|NCT04479787|101690591|FG000|Cross Over to Alternate Arm|Overall Study||0||
48554359|NCT04479787|101690592|FG001|Cross Over to Alternate Arm|Overall Study||70||
48554360|NCT04479787|101690591|FG000|COMPLETED|Overall Study||96||
48554361|NCT04479787|101690592|FG001|COMPLETED|Overall Study||56||
48554362|NCT04479787|101690591|FG000|NOT COMPLETED|Overall Study||66||
48554363|NCT04479787|101690592|FG001|NOT COMPLETED|Overall Study||51||
48554364|NCT01231646|101690593|FG000|STARTED|Overall Study||28||
48554365|NCT01231646|101690594|FG001|STARTED|Overall Study||10||
48554366|NCT01231646|101690593|FG000|COMPLETED|Overall Study||28||
48554367|NCT01231646|101690594|FG001|COMPLETED|Overall Study||10||
48554368|NCT01231646|101690593|FG000|NOT COMPLETED|Overall Study||0||
48554369|NCT01231646|101690594|FG001|NOT COMPLETED|Overall Study||0||
48554370|NCT00207883|101690595|FG000|STARTED|Overall Study||93||
48554371|NCT00207883|101690596|FG001|STARTED|Overall Study||119||
48554372|NCT00207883|101690595|FG000|COMPLETED|Overall Study||93||
48554373|NCT00207883|101690596|FG001|COMPLETED|Overall Study||119||
48554374|NCT00207883|101690595|FG000|NOT COMPLETED|Overall Study||0||
48554375|NCT00207883|101690596|FG001|NOT COMPLETED|Overall Study||0||
48554376|NCT02765256|101690597|FG000|STARTED|Overall Study||4||
48554377|NCT02765256|101690598|FG001|STARTED|Overall Study||4||
48554378|NCT02765256|101690597|FG000|COMPLETED|Overall Study||4||
48554379|NCT02765256|101690598|FG001|COMPLETED|Overall Study||4||
48271590|NCT00669877|100988430|FG000|STARTED|Overall Study||56||
48271591|NCT00669877|100988430|FG000|COMPLETED|Overall Study||52||
48271592|NCT00669877|100988430|FG000|NOT COMPLETED|Overall Study||4||
48271593|NCT03926195|100988431|FG000|STARTED|DB Treatment Phase (Through Week 13)||54||
48271594|NCT03926195|100988432|FG001|STARTED|DB Treatment Phase (Through Week 13)||55||
48271595|NCT03926195|100988431|FG000|COMPLETED|DB Treatment Phase (Through Week 13)||54||
48271596|NCT03926195|100988432|FG001|COMPLETED|DB Treatment Phase (Through Week 13)||53||
48271597|NCT03926195|100988431|FG000|NOT COMPLETED|DB Treatment Phase (Through Week 13)||0||
48271598|NCT03926195|100988432|FG001|NOT COMPLETED|DB Treatment Phase (Through Week 13)||2||
48271599|NCT03926195|100988431|FG000|STARTED|EXT Phase (Through Week 156)||46||
48271600|NCT03926195|100988432|FG001|STARTED|EXT Phase (Through Week 156)||49||
48271601|NCT03926195|100988431|FG000|COMPLETED|EXT Phase (Through Week 156)||24||
48271602|NCT03926195|100988432|FG001|COMPLETED|EXT Phase (Through Week 156)||26||
48271603|NCT03926195|100988431|FG000|NOT COMPLETED|EXT Phase (Through Week 156)||22||
48271604|NCT03926195|100988432|FG001|NOT COMPLETED|EXT Phase (Through Week 156)||23||
48271605|NCT03926195|100988431|FG000|STARTED|Monitoring Phase (52 Weeks)||27|At any visit, participants who had a ≥50% decrease in sperm concentration, and/or sperm motility, and/or sperm morphology compared with baseline entered the Monitoring Phase for evaluation of reversibility.|
48271606|NCT03926195|100988432|FG001|STARTED|Monitoring Phase (52 Weeks)||21|At any visit, participants who had a ≥50% decrease in sperm concentration, and/or sperm motility, and/or sperm morphology compared with baseline entered the Monitoring Phase for evaluation of reversibility.|
48554380|NCT02765256|101690597|FG000|NOT COMPLETED|Overall Study||0||
48554381|NCT02765256|101690598|FG001|NOT COMPLETED|Overall Study||0||
48271607|NCT03926195|100988431|FG000|COMPLETED|Monitoring Phase (52 Weeks)||27||
48271608|NCT03926195|100988432|FG001|COMPLETED|Monitoring Phase (52 Weeks)||20||
48554382|NCT03135015|101690599|FG000|STARTED|Overall Study||11||
48554383|NCT03135015|101690600|FG001|STARTED|Overall Study||11||
48554384|NCT03135015|101690599|FG000|Water Control|Overall Study||9||
48554385|NCT03135015|101690600|FG001|Water Control|Overall Study||11||
48554386|NCT03135015|101690599|FG000|Placebo Capsules|Overall Study||9||
48554387|NCT03135015|101690600|FG001|Placebo Capsules|Overall Study||11||
48554388|NCT03135015|101690599|FG000|2g Capsules|Overall Study||9||
48554389|NCT03135015|101690600|FG001|2g Capsules|Overall Study||11||
48554390|NCT03135015|101690599|FG000|4g Capsules|Overall Study||9||
48554391|NCT03135015|101690600|FG001|4g Capsules|Overall Study||11||
48554392|NCT03135015|101690599|FG000|2g Tablets|Overall Study||9||
48554393|NCT03135015|101690600|FG001|2g Tablets|Overall Study||11||
48554394|NCT03135015|101690599|FG000|4g Tablets|Overall Study||9||
48554395|NCT03135015|101690600|FG001|4g Tablets|Overall Study||11||
48554396|NCT03135015|101690599|FG000|COMPLETED|Overall Study||9||
48554397|NCT03135015|101690600|FG001|COMPLETED|Overall Study||11||
48554398|NCT03135015|101690599|FG000|NOT COMPLETED|Overall Study||2||
48554399|NCT03135015|101690600|FG001|NOT COMPLETED|Overall Study||0||
48554400|NCT01495000|101690601|FG000|STARTED|Overall Study||124||
48554401|NCT01495000|101690602|FG001|STARTED|Overall Study||126||
48554402|NCT01495000|101690601|FG000|COMPLETED|Overall Study||111||
48554403|NCT01495000|101690602|FG001|COMPLETED|Overall Study||114||
48554404|NCT01495000|101690601|FG000|NOT COMPLETED|Overall Study||13||
48554405|NCT01495000|101690602|FG001|NOT COMPLETED|Overall Study||12||
48271609|NCT03926195|100988431|FG000|NOT COMPLETED|Monitoring Phase (52 Weeks)||0||
48271610|NCT03926195|100988432|FG001|NOT COMPLETED|Monitoring Phase (52 Weeks)||1||
48271611|NCT01156376|100988433|FG000|STARTED|Overall Study||27||
48271612|NCT01156376|100988434|FG001|STARTED|Overall Study||26||
48271613|NCT01156376|100988435|FG002|STARTED|Overall Study||27||
48271614|NCT01156376|100988433|FG000|COMPLETED|Overall Study||26||
48271615|NCT01156376|100988434|FG001|COMPLETED|Overall Study||26||
48271616|NCT01156376|100988435|FG002|COMPLETED|Overall Study||23||
48271617|NCT01156376|100988433|FG000|NOT COMPLETED|Overall Study||1||
48271618|NCT01156376|100988434|FG001|NOT COMPLETED|Overall Study||0||
48271619|NCT01156376|100988435|FG002|NOT COMPLETED|Overall Study||4||
48271620|NCT01187381|100988436|FG000|STARTED|Overall Study||250||
48271621|NCT01187381|100988436|FG000|COMPLETED|Overall Study||250||
48271622|NCT01187381|100988436|FG000|NOT COMPLETED|Overall Study||0||
48271623|NCT01016262|100988437|FG000|STARTED|Double-blind Phase||41||
48271624|NCT01016262|100988438|FG001|STARTED|Double-blind Phase||39||
48271625|NCT01016262|100988439|FG002|STARTED|Double-blind Phase||39||
48271626|NCT01016262|100988440|FG003|STARTED|Double-blind Phase||0||
48271627|NCT01016262|100988441|FG004|STARTED|Double-blind Phase||0||
48271628|NCT01016262|100988442|FG005|STARTED|Double-blind Phase||0||
48271629|NCT01016262|100988437|FG000|COMPLETED|Double-blind Phase||40||
48271630|NCT01016262|100988438|FG001|COMPLETED|Double-blind Phase||38||
48271631|NCT01016262|100988439|FG002|COMPLETED|Double-blind Phase||30||
48271632|NCT01016262|100988440|FG003|COMPLETED|Double-blind Phase||0||
48271633|NCT01016262|100988441|FG004|COMPLETED|Double-blind Phase||0||
48271634|NCT01016262|100988442|FG005|COMPLETED|Double-blind Phase||0||
48271635|NCT01016262|100988437|FG000|NOT COMPLETED|Double-blind Phase||1||
48271636|NCT01016262|100988438|FG001|NOT COMPLETED|Double-blind Phase||1||
48271637|NCT01016262|100988439|FG002|NOT COMPLETED|Double-blind Phase||9||
48271638|NCT01016262|100988440|FG003|NOT COMPLETED|Double-blind Phase||0||
48271639|NCT01016262|100988441|FG004|NOT COMPLETED|Double-blind Phase||0||
48271640|NCT01016262|100988442|FG005|NOT COMPLETED|Double-blind Phase||0||
48271641|NCT01016262|100988437|FG000|STARTED|Open-Label Phase||0||
48271642|NCT01016262|100988438|FG001|STARTED|Open-Label Phase||0||
48271643|NCT01016262|100988439|FG002|STARTED|Open-Label Phase||0||
48271644|NCT01016262|100988440|FG003|STARTED|Open-Label Phase||44||
48271645|NCT01016262|100988441|FG004|STARTED|Open-Label Phase||52||
48271646|NCT01016262|100988442|FG005|STARTED|Open-Label Phase||20||
48554406|NCT02574598|101690603|FG000|STARTED|Overall Study||40||
48554407|NCT02574598|101690604|FG001|STARTED|Overall Study||38||
48271647|NCT01016262|100988437|FG000|COMPLETED|Open-Label Phase||0||
48271648|NCT01016262|100988438|FG001|COMPLETED|Open-Label Phase||0||
48271649|NCT01016262|100988439|FG002|COMPLETED|Open-Label Phase||0||
48271650|NCT01016262|100988440|FG003|COMPLETED|Open-Label Phase||42||
48271651|NCT01016262|100988441|FG004|COMPLETED|Open-Label Phase||50||
48271652|NCT01016262|100988442|FG005|COMPLETED|Open-Label Phase||20||
48271653|NCT01016262|100988437|FG000|NOT COMPLETED|Open-Label Phase||0||
48271654|NCT01016262|100988438|FG001|NOT COMPLETED|Open-Label Phase||0||
48271655|NCT01016262|100988439|FG002|NOT COMPLETED|Open-Label Phase||0||
48271656|NCT01016262|100988440|FG003|NOT COMPLETED|Open-Label Phase||2||
48271657|NCT01016262|100988441|FG004|NOT COMPLETED|Open-Label Phase||2||
48271658|NCT01016262|100988442|FG005|NOT COMPLETED|Open-Label Phase||0||
48271659|NCT00438672|100988443|FG000|STARTED|Overall Study||31||
48271660|NCT00438672|100988444|FG001|STARTED|Overall Study||33||
48271661|NCT00438672|100988443|FG000|COMPLETED|Overall Study||24||
48271662|NCT00438672|100988444|FG001|COMPLETED|Overall Study||24||
48271663|NCT00438672|100988443|FG000|NOT COMPLETED|Overall Study||7||
48271664|NCT00438672|100988444|FG001|NOT COMPLETED|Overall Study||9||
48271665|NCT00581893|100988445|FG000|STARTED|First Intervention (1 Month)||10||
48271666|NCT00581893|100988446|FG001|STARTED|First Intervention (1 Month)||10||
48271667|NCT00581893|100988445|FG000|COMPLETED|First Intervention (1 Month)||10||
48271668|NCT00581893|100988446|FG001|COMPLETED|First Intervention (1 Month)||10||
48271669|NCT00581893|100988445|FG000|NOT COMPLETED|First Intervention (1 Month)||0||
48271670|NCT00581893|100988446|FG001|NOT COMPLETED|First Intervention (1 Month)||0||
48271671|NCT00581893|100988445|FG000|STARTED|Washout (14 Days)||10||
48271672|NCT00581893|100988446|FG001|STARTED|Washout (14 Days)||10||
48554408|NCT02574598|101690603|FG000|COMPLETED|Overall Study||40||
48554409|NCT02574598|101690604|FG001|COMPLETED|Overall Study||38||
48554410|NCT02574598|101690603|FG000|NOT COMPLETED|Overall Study||0||
48554411|NCT02574598|101690604|FG001|NOT COMPLETED|Overall Study||0||
48271673|NCT00581893|100988445|FG000|COMPLETED|Washout (14 Days)||10||
48271674|NCT00581893|100988446|FG001|COMPLETED|Washout (14 Days)||10||
48271675|NCT00581893|100988445|FG000|NOT COMPLETED|Washout (14 Days)||0||
48271676|NCT00581893|100988446|FG001|NOT COMPLETED|Washout (14 Days)||0||
48271677|NCT00581893|100988445|FG000|STARTED|Second Intervention (1 Month)||10||
48271678|NCT00581893|100988446|FG001|STARTED|Second Intervention (1 Month)||10||
48271679|NCT00581893|100988445|FG000|COMPLETED|Second Intervention (1 Month)||7||
48271680|NCT00581893|100988446|FG001|COMPLETED|Second Intervention (1 Month)||8||
48271681|NCT00581893|100988445|FG000|NOT COMPLETED|Second Intervention (1 Month)||3||
48271682|NCT00581893|100988446|FG001|NOT COMPLETED|Second Intervention (1 Month)||2||
48271683|NCT02815579|100988447|FG000|STARTED|Overall Study||390||8
48554412|NCT03044028|101690605|FG000|STARTED|Overall Study||22||
48271684|NCT02815579|100988448|FG001|STARTED|Overall Study||356||8
48271685|NCT02815579|100988447|FG000|Started Study Activities|Overall Study||366||8
48271686|NCT02815579|100988448|FG001|Started Study Activities|Overall Study||354||8
48271687|NCT02815579|100988447|FG000|COMPLETED|Overall Study||344||8
48271688|NCT02815579|100988448|FG001|COMPLETED|Overall Study||333||8
48271689|NCT02815579|100988447|FG000|NOT COMPLETED|Overall Study||46||0
48271690|NCT02815579|100988448|FG001|NOT COMPLETED|Overall Study||23||0
48271691|NCT02852356|100988449|FG000|STARTED|Overall Study||31||
48271692|NCT02852356|100988450|FG001|STARTED|Overall Study||31||
48271693|NCT02852356|100988451|FG002|STARTED|Overall Study||0||
48271694|NCT02852356|100988452|FG003|STARTED|Overall Study||0||
48693687|NCT01947283|102032839|FG004|STARTED|Overall Study||95||
48693688|NCT01947283|102032840|FG005|STARTED|Overall Study||34||
48693689|NCT01947283|102032841|FG006|STARTED|Overall Study||40||
48693690|NCT01947283|102032835|FG000|Baseline Assessment|Overall Study||89||
48693691|NCT01947283|102032836|FG001|Baseline Assessment|Overall Study||68||
48271695|NCT02852356|100988449|FG000|COMPLETED|Overall Study||31||
48271696|NCT02852356|100988450|FG001|COMPLETED|Overall Study||31||
48271697|NCT02852356|100988451|FG002|COMPLETED|Overall Study||0||
48271698|NCT02852356|100988452|FG003|COMPLETED|Overall Study||0||
48271699|NCT02852356|100988449|FG000|NOT COMPLETED|Overall Study||0||
48271700|NCT02852356|100988450|FG001|NOT COMPLETED|Overall Study||0||
48271701|NCT02852356|100988451|FG002|NOT COMPLETED|Overall Study||0||
48271702|NCT02852356|100988452|FG003|NOT COMPLETED|Overall Study||0||
48271703|NCT03970538|100988453|FG000|STARTED|Overall Study||105||
48271704|NCT03970538|100988453|FG000|COMPLETED|Overall Study||105||
48271705|NCT03970538|100988453|FG000|NOT COMPLETED|Overall Study||0||
48271706|NCT00968071|100988454|FG000|STARTED|Overall Study||71||
48271707|NCT00968071|100988454|FG000|COMPLETED|Overall Study||71||
48271708|NCT00968071|100988454|FG000|NOT COMPLETED|Overall Study||0||
48271709|NCT00584077|100988455|FG000|STARTED|Overall Study||15||
48271710|NCT00584077|100988455|FG000|COMPLETED|Overall Study||15||
48271711|NCT00584077|100988455|FG000|NOT COMPLETED|Overall Study||0||
48271712|NCT02783573|100988456|FG000|STARTED|Placebo-Controlled Treatment Period||562||
48271713|NCT02783573|100988457|FG001|STARTED|Placebo-Controlled Treatment Period||590||
48271714|NCT02783573|100988458|FG002|STARTED|Placebo-Controlled Treatment Period||570||
48271715|NCT02783573|100988456|FG000|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||558||
48271716|NCT02783573|100988457|FG001|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||588||
48271717|NCT02783573|100988458|FG002|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||568||
48271718|NCT02783573|100988456|FG000|COMPLETED|Placebo-Controlled Treatment Period||26||
48271719|NCT02783573|100988457|FG001|COMPLETED|Placebo-Controlled Treatment Period||28||
48271720|NCT02783573|100988458|FG002|COMPLETED|Placebo-Controlled Treatment Period||22||
48271721|NCT02783573|100988456|FG000|NOT COMPLETED|Placebo-Controlled Treatment Period||536||
48271722|NCT02783573|100988457|FG001|NOT COMPLETED|Placebo-Controlled Treatment Period||562||
48271723|NCT02783573|100988458|FG002|NOT COMPLETED|Placebo-Controlled Treatment Period||548||
48271724|NCT02783573|100988456|FG000|STARTED|Delayed-Start Period||0||
48271725|NCT02783573|100988457|FG001|STARTED|Delayed-Start Period||17||
48271726|NCT02783573|100988458|FG002|STARTED|Delayed-Start Period||12||
48271727|NCT02783573|100988456|FG000|Received at Least 1 Dose of Study Drug|Delayed-Start Period||0||
48271728|NCT02783573|100988457|FG001|Received at Least 1 Dose of Study Drug|Delayed-Start Period||14||
48271729|NCT02783573|100988458|FG002|Received at Least 1 Dose of Study Drug|Delayed-Start Period||12||
48271730|NCT02783573|100988456|FG000|COMPLETED|Delayed-Start Period||0||
48271731|NCT02783573|100988457|FG001|COMPLETED|Delayed-Start Period||0||
48271732|NCT02783573|100988458|FG002|COMPLETED|Delayed-Start Period||0||
48271733|NCT02783573|100988456|FG000|NOT COMPLETED|Delayed-Start Period||0||
48271734|NCT02783573|100988457|FG001|NOT COMPLETED|Delayed-Start Period||17||
48271735|NCT02783573|100988458|FG002|NOT COMPLETED|Delayed-Start Period||12||
48271736|NCT00734591|100988459|FG000|STARTED|Retrospective Period||3875||
48271737|NCT00734591|100988460|FG001|STARTED|Retrospective Period||3564||
48271738|NCT00734591|100988459|FG000|COMPLETED|Retrospective Period||3875||
48271739|NCT00734591|100988460|FG001|COMPLETED|Retrospective Period||3564||
48271740|NCT00734591|100988459|FG000|NOT COMPLETED|Retrospective Period||0||
48271741|NCT00734591|100988460|FG001|NOT COMPLETED|Retrospective Period||0||
48271742|NCT00734591|100988459|FG000|STARTED|Screening for Prospective Period||3875||
48271743|NCT00734591|100988460|FG001|STARTED|Screening for Prospective Period||3564||
48693692|NCT01947283|102032837|FG002|Baseline Assessment|Overall Study||83||
48693693|NCT01947283|102032838|FG003|Baseline Assessment|Overall Study||72||
48693694|NCT01947283|102032839|FG004|Baseline Assessment|Overall Study||0||
48693695|NCT01947283|102032840|FG005|Baseline Assessment|Overall Study||34||
48693696|NCT01947283|102032841|FG006|Baseline Assessment|Overall Study||40||
48271744|NCT00734591|100988459|FG000|COMPLETED|Screening for Prospective Period||1358||
48271745|NCT00734591|100988460|FG001|COMPLETED|Screening for Prospective Period||1273||
48271746|NCT00734591|100988459|FG000|NOT COMPLETED|Screening for Prospective Period||2517||
48271747|NCT00734591|100988460|FG001|NOT COMPLETED|Screening for Prospective Period||2291||
48271748|NCT00734591|100988459|FG000|STARTED|Prospective Period||1358||
48271749|NCT00734591|100988460|FG001|STARTED|Prospective Period||1273||
48693697|NCT01947283|102032835|FG000|Follow-up Assessment|Overall Study||64||
48271750|NCT00734591|100988459|FG000|COMPLETED|Prospective Period||1307||
48271751|NCT00734591|100988460|FG001|COMPLETED|Prospective Period||1229||
48271752|NCT00734591|100988459|FG000|NOT COMPLETED|Prospective Period||51||
48271753|NCT00734591|100988460|FG001|NOT COMPLETED|Prospective Period||44||
48271754|NCT05262517|100988461|FG000|STARTED|Overall Study||44||
48271755|NCT05262517|100988462|FG001|STARTED|Overall Study||43||
48271756|NCT05262517|100988461|FG000|Treated|Overall Study||39||
48271757|NCT05262517|100988462|FG001|Treated|Overall Study||32||
48271758|NCT05262517|100988461|FG000|COMPLETED|Overall Study||39||
48271759|NCT05262517|100988462|FG001|COMPLETED|Overall Study||32||
48271760|NCT05262517|100988461|FG000|NOT COMPLETED|Overall Study||5||
48271761|NCT05262517|100988462|FG001|NOT COMPLETED|Overall Study||11||
48271762|NCT04646291|100988463|FG000|STARTED|Overall Study||272||
48271763|NCT04646291|100988464|FG001|STARTED|Overall Study||70||
48271764|NCT04646291|100988465|FG002|STARTED|Overall Study||8||
48271765|NCT04646291|100988463|FG000|COMPLETED|Overall Study||272||
48271766|NCT04646291|100988464|FG001|COMPLETED|Overall Study||70||
48271767|NCT04646291|100988465|FG002|COMPLETED|Overall Study||8||
48271768|NCT04646291|100988463|FG000|NOT COMPLETED|Overall Study||0||
48271769|NCT04646291|100988464|FG001|NOT COMPLETED|Overall Study||0||
48271770|NCT04646291|100988465|FG002|NOT COMPLETED|Overall Study||0||
48271771|NCT02368457|100988466|FG000|STARTED|Overall Study||12||
48271772|NCT02368457|100988467|FG001|STARTED|Overall Study||12||
48271773|NCT02368457|100988466|FG000|COMPLETED|Overall Study||12||
48693698|NCT01947283|102032836|FG001|Follow-up Assessment|Overall Study||51||
48693699|NCT01947283|102032837|FG002|Follow-up Assessment|Overall Study||65||
48693700|NCT01947283|102032838|FG003|Follow-up Assessment|Overall Study||59||
48693701|NCT01947283|102032839|FG004|Follow-up Assessment|Overall Study||0||
48271774|NCT02368457|100988467|FG001|COMPLETED|Overall Study||12||
48271775|NCT02368457|100988466|FG000|NOT COMPLETED|Overall Study||0||
48271776|NCT02368457|100988467|FG001|NOT COMPLETED|Overall Study||0||
48271777|NCT03697122|100988468|FG000|STARTED|Overall Study||14||
48271778|NCT03697122|100988468|FG000|COMPLETED|Overall Study||14||
48271779|NCT03697122|100988468|FG000|NOT COMPLETED|Overall Study||0||
48271780|NCT00777764|100988469|FG000|STARTED|Overall Study||30||
48271781|NCT00777764|100988470|FG001|STARTED|Overall Study||30||
48271782|NCT00777764|100988469|FG000|COMPLETED|Overall Study||30||
48271783|NCT00777764|100988470|FG001|COMPLETED|Overall Study||29||
48271784|NCT00777764|100988469|FG000|NOT COMPLETED|Overall Study||0||
48271785|NCT00777764|100988470|FG001|NOT COMPLETED|Overall Study||1||
48554413|NCT03044028|101690606|FG001|STARTED|Overall Study||22||
48554414|NCT03044028|101690607|FG002|STARTED|Overall Study||22||
48554415|NCT03044028|101690605|FG000|COMPLETED|Overall Study||12||
48554416|NCT03044028|101690606|FG001|COMPLETED|Overall Study||12||
48554417|NCT03044028|101690607|FG002|COMPLETED|Overall Study||22||
48271786|NCT04458922|100988471|FG000|STARTED|Overall Study||9||
48271787|NCT04458922|100988472|FG001|STARTED|Overall Study||9||
48271788|NCT04458922|100988473|FG002|STARTED|Overall Study||9||
48271789|NCT04458922|100988471|FG000|COMPLETED|Overall Study||0||
48271790|NCT04458922|100988472|FG001|COMPLETED|Overall Study||0||
48271791|NCT04458922|100988473|FG002|COMPLETED|Overall Study||1||
48271792|NCT04458922|100988471|FG000|NOT COMPLETED|Overall Study||9||
48271793|NCT04458922|100988472|FG001|NOT COMPLETED|Overall Study||9||
48271794|NCT04458922|100988473|FG002|NOT COMPLETED|Overall Study||8||
48271795|NCT03686423|100988474|FG000|STARTED|Overall Study||44||
48271796|NCT03686423|100988474|FG000|COMPLETED|Overall Study||29||
48271797|NCT03686423|100988474|FG000|NOT COMPLETED|Overall Study||15||
48271798|NCT02037620|100988475|FG000|STARTED|Overall Study||5||
48271799|NCT02037620|100988475|FG000|COMPLETED|Overall Study||4||
48271800|NCT02037620|100988475|FG000|NOT COMPLETED|Overall Study||1||
48271801|NCT02132832|100988476|FG000|STARTED|Overall Study||19||
48271802|NCT02132832|100988477|FG001|STARTED|Overall Study||23||
48271803|NCT02132832|100988476|FG000|COMPLETED|Overall Study||16||
48271804|NCT02132832|100988477|FG001|COMPLETED|Overall Study||16||
48271805|NCT02132832|100988476|FG000|NOT COMPLETED|Overall Study||3||
48554418|NCT03044028|101690605|FG000|NOT COMPLETED|Overall Study||10||
48554419|NCT03044028|101690606|FG001|NOT COMPLETED|Overall Study||10||
48554420|NCT03044028|101690607|FG002|NOT COMPLETED|Overall Study||0||
48554421|NCT03383523|101690608|FG000|STARTED|Overall Study||11||
48554422|NCT03383523|101690609|FG001|STARTED|Overall Study||11||
48271806|NCT02132832|100988477|FG001|NOT COMPLETED|Overall Study||7||
48271807|NCT01397422|100988478|FG000|STARTED|Overall Study||22||
48271808|NCT01397422|100988479|FG001|STARTED|Overall Study||20||
48271809|NCT01397422|100988480|FG002|STARTED|Overall Study||21||
48271810|NCT01397422|100988481|FG003|STARTED|Overall Study||20||
48271811|NCT01397422|100988478|FG000|COMPLETED|Overall Study||20||
48271812|NCT01397422|100988479|FG001|COMPLETED|Overall Study||17||
48271813|NCT01397422|100988480|FG002|COMPLETED|Overall Study||18||
48271814|NCT01397422|100988481|FG003|COMPLETED|Overall Study||12||
48271815|NCT01397422|100988478|FG000|NOT COMPLETED|Overall Study||2||
48271816|NCT01397422|100988479|FG001|NOT COMPLETED|Overall Study||3||
48271817|NCT01397422|100988480|FG002|NOT COMPLETED|Overall Study||3||
48271818|NCT01397422|100988481|FG003|NOT COMPLETED|Overall Study||8||
48271819|NCT02917603|100988482|FG000|STARTED|Overall Study||20||
48554423|NCT03383523|101690610|FG002|STARTED|Overall Study||10||
48271820|NCT02917603|100988483|FG001|STARTED|Overall Study||20||
48271821|NCT02917603|100988482|FG000|COMPLETED|Overall Study||19||
48271822|NCT02917603|100988483|FG001|COMPLETED|Overall Study||16||
48271823|NCT02917603|100988482|FG000|NOT COMPLETED|Overall Study||1||
48271824|NCT02917603|100988483|FG001|NOT COMPLETED|Overall Study||4||
48271825|NCT00630734|100988484|FG000|STARTED|Overall Study||11||
48271826|NCT00630734|100988485|FG001|STARTED|Overall Study||13||
48271827|NCT00630734|100988486|FG002|STARTED|Overall Study||8||
48271828|NCT00630734|100988484|FG000|COMPLETED|Overall Study||9||
48271829|NCT00630734|100988485|FG001|COMPLETED|Overall Study||12||
48271830|NCT00630734|100988486|FG002|COMPLETED|Overall Study||7||
48271831|NCT00630734|100988484|FG000|NOT COMPLETED|Overall Study||2||
48271832|NCT00630734|100988485|FG001|NOT COMPLETED|Overall Study||1||
48271833|NCT00630734|100988486|FG002|NOT COMPLETED|Overall Study||1||
48271834|NCT04497389|100988487|FG000|STARTED|Overall Study||23||
48271835|NCT04497389|100988488|FG001|STARTED|Overall Study||24||
48271836|NCT04497389|100988487|FG000|COMPLETED|Overall Study||22||
48271837|NCT04497389|100988488|FG001|COMPLETED|Overall Study||24||
48271838|NCT04497389|100988487|FG000|NOT COMPLETED|Overall Study||1||
48271839|NCT04497389|100988488|FG001|NOT COMPLETED|Overall Study||0||
48271840|NCT01208103|100988489|FG000|STARTED|Overall Study||30||
48271841|NCT01208103|100988489|FG000|COMPLETED|Overall Study||28||
48271842|NCT01208103|100988489|FG000|NOT COMPLETED|Overall Study||2||
48271843|NCT02979249|100988490|FG000|STARTED|Overall Study||16||
48271844|NCT02979249|100988490|FG000|COMPLETED|Overall Study||10||
48271845|NCT02979249|100988490|FG000|NOT COMPLETED|Overall Study||6||
48271846|NCT00756457|100988491|FG000|STARTED|Overall Study||20||
48271847|NCT00756457|100988492|FG001|STARTED|Overall Study||19||
48271848|NCT00756457|100988491|FG000|COMPLETED|Overall Study||19||
48271849|NCT00756457|100988492|FG001|COMPLETED|Overall Study||17||
48271850|NCT00756457|100988491|FG000|NOT COMPLETED|Overall Study||1||
48271851|NCT00756457|100988492|FG001|NOT COMPLETED|Overall Study||2||
48271852|NCT01353118|100988493|FG000|STARTED|Overall Study||21||
48271853|NCT01353118|100988494|FG001|STARTED|Overall Study||20||
48271854|NCT01353118|100988493|FG000|COMPLETED|Overall Study||21||
48271855|NCT01353118|100988494|FG001|COMPLETED|Overall Study||20||
48271856|NCT01353118|100988493|FG000|NOT COMPLETED|Overall Study||0||
48271857|NCT01353118|100988494|FG001|NOT COMPLETED|Overall Study||0||
48271858|NCT00604708|100988495|FG000|STARTED|Overall Study||430||
48271859|NCT00604708|100988496|FG001|STARTED|Overall Study||437||
48271860|NCT00604708|100988495|FG000|COMPLETED|Overall Study||399||
48271861|NCT00604708|100988496|FG001|COMPLETED|Overall Study||397||
48271862|NCT00604708|100988495|FG000|NOT COMPLETED|Overall Study||31||
48271863|NCT00604708|100988496|FG001|NOT COMPLETED|Overall Study||40||
48271864|NCT01277887|100988497|FG000|STARTED|Pre-Quit Treatment Phase||9||
48271865|NCT01277887|100988498|FG001|STARTED|Pre-Quit Treatment Phase||10||
48271866|NCT01277887|100988497|FG000|Entered Study|Pre-Quit Treatment Phase||7||
48554424|NCT03383523|101690611|FG003|STARTED|Overall Study||12||
48554425|NCT03383523|101690612|FG004|STARTED|Overall Study||11||
48693702|NCT01947283|102032840|FG005|Follow-up Assessment|Overall Study||27||
48271867|NCT01277887|100988498|FG001|Entered Study|Pre-Quit Treatment Phase||10||
48271868|NCT01277887|100988497|FG000|COMPLETED|Pre-Quit Treatment Phase||6||
48271869|NCT01277887|100988498|FG001|COMPLETED|Pre-Quit Treatment Phase||10||
48271870|NCT01277887|100988497|FG000|NOT COMPLETED|Pre-Quit Treatment Phase||3||
48271871|NCT01277887|100988498|FG001|NOT COMPLETED|Pre-Quit Treatment Phase||0||
48271872|NCT01277887|100988497|FG000|STARTED|Post-Quit Treatment Phase||6||
48271873|NCT01277887|100988498|FG001|STARTED|Post-Quit Treatment Phase||10||
48271874|NCT01277887|100988497|FG000|COMPLETED|Post-Quit Treatment Phase||3||
48554426|NCT03383523|101690613|FG005|STARTED|Overall Study||12||
48554427|NCT03383523|101690614|FG006|STARTED|Overall Study||10||
48554428|NCT03383523|101690608|FG000|COMPLETED|Overall Study||10||
48554429|NCT03383523|101690609|FG001|COMPLETED|Overall Study||11||
48554430|NCT03383523|101690610|FG002|COMPLETED|Overall Study||9||
48554431|NCT03383523|101690611|FG003|COMPLETED|Overall Study||12||
48554432|NCT03383523|101690612|FG004|COMPLETED|Overall Study||11||
48693703|NCT01947283|102032841|FG006|Follow-up Assessment|Overall Study||36||
48693704|NCT01947283|102032835|FG000|Clinical Recording|Overall Study||65||
48271875|NCT01277887|100988498|FG001|COMPLETED|Post-Quit Treatment Phase||5||
48271876|NCT01277887|100988497|FG000|NOT COMPLETED|Post-Quit Treatment Phase||3||
48271877|NCT01277887|100988498|FG001|NOT COMPLETED|Post-Quit Treatment Phase||5||
48271878|NCT00594880|100988499|FG000|STARTED|Overall Study||12||
48271879|NCT00594880|100988500|FG001|STARTED|Overall Study||11||
48271880|NCT00594880|100988499|FG000|COMPLETED|Overall Study||10||
48271881|NCT00594880|100988500|FG001|COMPLETED|Overall Study||10||
48271882|NCT00594880|100988499|FG000|NOT COMPLETED|Overall Study||2||
48271883|NCT00594880|100988500|FG001|NOT COMPLETED|Overall Study||1||
48271884|NCT04942366|100988501|FG000|STARTED|Overall Study||25||
48271885|NCT04942366|100988502|FG001|STARTED|Overall Study||25||
48271886|NCT04942366|100988501|FG000|COMPLETED|Overall Study||20||
48554433|NCT03383523|101690613|FG005|COMPLETED|Overall Study||12||
48554434|NCT03383523|101690614|FG006|COMPLETED|Overall Study||10||
48554435|NCT03383523|101690608|FG000|NOT COMPLETED|Overall Study||1||
48554436|NCT03383523|101690609|FG001|NOT COMPLETED|Overall Study||0||
48554437|NCT03383523|101690610|FG002|NOT COMPLETED|Overall Study||1||
48554438|NCT03383523|101690611|FG003|NOT COMPLETED|Overall Study||0||
48554439|NCT03383523|101690612|FG004|NOT COMPLETED|Overall Study||0||
48554440|NCT03383523|101690613|FG005|NOT COMPLETED|Overall Study||0||
48271887|NCT04942366|100988502|FG001|COMPLETED|Overall Study||20||
48271888|NCT04942366|100988501|FG000|NOT COMPLETED|Overall Study||5||
48271889|NCT04942366|100988502|FG001|NOT COMPLETED|Overall Study||5||
48271890|NCT05254080|100988503|FG000|STARTED|Overall Study||12||
48271891|NCT05254080|100988504|FG001|STARTED|Overall Study||12||
48271892|NCT05254080|100988503|FG000|COMPLETED|Overall Study||10||
48271893|NCT05254080|100988504|FG001|COMPLETED|Overall Study||11||
48271894|NCT05254080|100988503|FG000|NOT COMPLETED|Overall Study||2||
48271895|NCT05254080|100988504|FG001|NOT COMPLETED|Overall Study||1||
48271896|NCT02666664|100988505|FG000|STARTED|Overall Study||742||
48271897|NCT02666664|100988506|FG001|STARTED|Overall Study||1488||
48271898|NCT02666664|100988505|FG000|COMPLETED|Overall Study||706||
48271899|NCT02666664|100988506|FG001|COMPLETED|Overall Study||1404||
48271900|NCT02666664|100988505|FG000|NOT COMPLETED|Overall Study||36||
48271901|NCT02666664|100988506|FG001|NOT COMPLETED|Overall Study||84||
48271902|NCT00288639|100988507|FG000|STARTED|Overall Study||98||
48271903|NCT00288639|100988507|FG000|COMPLETED|Overall Study||86||
48271904|NCT00288639|100988507|FG000|NOT COMPLETED|Overall Study||12||
48271905|NCT01245374|100988508|FG000|STARTED|Overall Study||103||
48271906|NCT01245374|100988508|FG000|COMPLETED|Overall Study||99||
48271907|NCT01245374|100988508|FG000|NOT COMPLETED|Overall Study||4||
48271908|NCT04297631|100988509|FG000|STARTED|Overall Study||20||
48271909|NCT04297631|100988509|FG000|COMPLETED|Overall Study||20||
48271910|NCT04297631|100988509|FG000|NOT COMPLETED|Overall Study||0||
48271911|NCT01934790|100988510|FG000|STARTED|Treatment||45||
48271912|NCT01934790|100988510|FG000|Participants Received Study Treatment|Treatment||44||
48271913|NCT01934790|100988510|FG000|COMPLETED|Treatment||29||
48271914|NCT01934790|100988510|FG000|NOT COMPLETED|Treatment||16||
48271915|NCT01934790|100988510|FG000|STARTED|Active Follow up||34||
48271916|NCT01934790|100988510|FG000|COMPLETED|Active Follow up||10||
48271917|NCT01934790|100988510|FG000|NOT COMPLETED|Active Follow up||24||
48271918|NCT01934790|100988510|FG000|STARTED|Long Term Follow up||12||
48271919|NCT01934790|100988510|FG000|COMPLETED|Long Term Follow up||12||
48271920|NCT01934790|100988510|FG000|NOT COMPLETED|Long Term Follow up||0||
48271921|NCT02120287|100988511|FG000|STARTED|Overall Study||16||
48271922|NCT02120287|100988511|FG000|COMPLETED|Overall Study||16||
48271923|NCT02120287|100988511|FG000|NOT COMPLETED|Overall Study||0||
48271924|NCT03312023|100988512|FG000|STARTED|Overall Study||8||
48271925|NCT03312023|100988513|FG001|STARTED|Overall Study||5||
48271926|NCT03312023|100988514|FG002|STARTED|Overall Study||4||
48271927|NCT03312023|100988515|FG003|STARTED|Overall Study||4||
48271928|NCT03312023|100988512|FG000|Completed Week 12|Overall Study||8|(end of treatment)|
48271929|NCT03312023|100988513|FG001|Completed Week 12|Overall Study||5|(end of treatment)|
48271930|NCT03312023|100988514|FG002|Completed Week 12|Overall Study||4|(end of treatment)|
48271931|NCT03312023|100988515|FG003|Completed Week 12|Overall Study||4|(end of treatment)|
48271932|NCT03312023|100988512|FG000|COMPLETED|Overall Study||8||
48271933|NCT03312023|100988513|FG001|COMPLETED|Overall Study||5||
48271934|NCT03312023|100988514|FG002|COMPLETED|Overall Study||4||
48554441|NCT03383523|101690614|FG006|NOT COMPLETED|Overall Study||0||
48554442|NCT02604407|101690615|FG000|STARTED|Overall Study||91||
48554443|NCT02604407|101690616|FG001|STARTED|Overall Study||92||
48554444|NCT02604407|101690617|FG002|STARTED|Overall Study||92||
48554445|NCT02604407|101690615|FG000|TREATED|Overall Study||89||
48554446|NCT02604407|101690616|FG001|TREATED|Overall Study||92||
48554447|NCT02604407|101690617|FG002|TREATED|Overall Study||90||
48554448|NCT02604407|101690615|FG000|COMPLETED|Overall Study||80||
48554449|NCT02604407|101690616|FG001|COMPLETED|Overall Study||80||
48554450|NCT02604407|101690617|FG002|COMPLETED|Overall Study||76||
48554451|NCT02604407|101690615|FG000|NOT COMPLETED|Overall Study||11||
48554452|NCT02604407|101690616|FG001|NOT COMPLETED|Overall Study||12||
48271935|NCT03312023|100988515|FG003|COMPLETED|Overall Study||4||
48392603|NCT02999100|101291392|FG004|NOT COMPLETED|Part 1 (up to 15 Days)||0||
48392604|NCT02999100|101291393|FG005|NOT COMPLETED|Part 1 (up to 15 Days)||0||
48554453|NCT02604407|101690617|FG002|NOT COMPLETED|Overall Study||16||
48554454|NCT01613768|101690618|FG000|STARTED|Overall Study||29||
48554455|NCT01613768|101690618|FG000|COMPLETED|Overall Study||29||
48271936|NCT03312023|100988512|FG000|NOT COMPLETED|Overall Study||0||
48271937|NCT03312023|100988513|FG001|NOT COMPLETED|Overall Study||0||
48271938|NCT03312023|100988514|FG002|NOT COMPLETED|Overall Study||0||
48271939|NCT03312023|100988515|FG003|NOT COMPLETED|Overall Study||0||
48271940|NCT03031496|100988516|FG000|STARTED|Period 1||21||
48271941|NCT03031496|100988517|FG001|STARTED|Period 1||21||
48271942|NCT03031496|100988516|FG000|COMPLETED|Period 1||19||
48271943|NCT03031496|100988517|FG001|COMPLETED|Period 1||19||
48271944|NCT03031496|100988516|FG000|NOT COMPLETED|Period 1||2||
48271945|NCT03031496|100988517|FG001|NOT COMPLETED|Period 1||2||
48271946|NCT03031496|100988516|FG000|STARTED|Period 2||19||
48271947|NCT03031496|100988517|FG001|STARTED|Period 2||19||
48271948|NCT03031496|100988516|FG000|COMPLETED|Period 2||19||
48554456|NCT01613768|101690618|FG000|NOT COMPLETED|Overall Study||0||
48554457|NCT01439802|101690619|FG000|STARTED|6 Weeks Postpartum Status||90||
48554458|NCT01439802|101690619|FG000|COMPLETED|6 Weeks Postpartum Status||54||
48554459|NCT01439802|101690619|FG000|NOT COMPLETED|6 Weeks Postpartum Status||36||
48554460|NCT01439802|101690619|FG000|STARTED|6 Months Postpartum Status||54||
48554461|NCT01439802|101690619|FG000|COMPLETED|6 Months Postpartum Status||42||
48554462|NCT01439802|101690619|FG000|NOT COMPLETED|6 Months Postpartum Status||12||
48554463|NCT01243957|101690620|FG000|STARTED|Overall Study||20||
48554464|NCT01243957|101690620|FG000|COMPLETED|Overall Study||20||
48554465|NCT01243957|101690620|FG000|NOT COMPLETED|Overall Study||0||
48554466|NCT03473184|101690621|FG000|STARTED|Overall Study||34||170
48554467|NCT03473184|101690621|FG000|Diacerein 1% Ointment Irradiated|Overall Study||34||34
48554468|NCT03473184|101690621|FG000|Vehicle Ointment Irradiated|Overall Study||34||34
48554469|NCT03473184|101690621|FG000|Diacerein 1% Ointment Non-irradiated|Overall Study||34||34
48554470|NCT03473184|101690621|FG000|Vehicle Ointment Non-irradiated|Overall Study||34||34
48554471|NCT03473184|101690621|FG000|Untreated Irradiated|Overall Study||34||34
48554472|NCT03473184|101690621|FG000|COMPLETED|Overall Study||34||170
48554473|NCT03473184|101690621|FG000|NOT COMPLETED|Overall Study||0||0
48554474|NCT01070953|101690622|FG000|STARTED|Participants for Safety Evaluation||4467||
48554475|NCT01070953|101690622|FG000|COMPLETED|Participants for Safety Evaluation||3536||
48554476|NCT01070953|101690622|FG000|NOT COMPLETED|Participants for Safety Evaluation||931||
48554477|NCT01070953|101690622|FG000|STARTED|Participants for Efficacy Evaluation||3536||
48554478|NCT01070953|101690622|FG000|COMPLETED|Participants for Efficacy Evaluation||3309||
48554479|NCT01070953|101690622|FG000|NOT COMPLETED|Participants for Efficacy Evaluation||227||
48554480|NCT02152605|101690623|FG000|STARTED|Overall Study||248||
48554481|NCT02152605|101690624|FG001|STARTED|Overall Study||248||
48554482|NCT02152605|101690623|FG000|COMPLETED|Overall Study||229||
48554483|NCT02152605|101690624|FG001|COMPLETED|Overall Study||230||
48554484|NCT02152605|101690623|FG000|NOT COMPLETED|Overall Study||19||
48554485|NCT02152605|101690624|FG001|NOT COMPLETED|Overall Study||18||
48554486|NCT00185588|101690625|FG000|STARTED|Overall Study||6||
48554487|NCT00185588|101690626|FG001|STARTED|Overall Study||4||
48554488|NCT00185588|101690627|FG002|STARTED|Overall Study||6||
48554489|NCT00185588|101690628|FG003|STARTED|Overall Study||17||
48554490|NCT00185588|101690625|FG000|COMPLETED|Overall Study||3||
48554491|NCT00185588|101690626|FG001|COMPLETED|Overall Study||2||
48554492|NCT00185588|101690627|FG002|COMPLETED|Overall Study||0||
48554493|NCT00185588|101690628|FG003|COMPLETED|Overall Study||13||
48554494|NCT00185588|101690625|FG000|NOT COMPLETED|Overall Study||3||
48554495|NCT00185588|101690626|FG001|NOT COMPLETED|Overall Study||2||
48554496|NCT00185588|101690627|FG002|NOT COMPLETED|Overall Study||6||
48554497|NCT00185588|101690628|FG003|NOT COMPLETED|Overall Study||4||
48554498|NCT00890617|101690629|FG000|STARTED|Overall Study||9||
48554499|NCT00890617|101690629|FG000|COMPLETED|Overall Study||9||
48554500|NCT00890617|101690629|FG000|NOT COMPLETED|Overall Study||0||
48554501|NCT01994785|101690630|FG000|STARTED|Overall Study||109||
48554502|NCT01994785|101690631|FG001|STARTED|Overall Study||109||
48554503|NCT01994785|101690632|FG002|STARTED|Overall Study||117||
48554504|NCT01994785|101690633|FG003|STARTED|Overall Study||117||
48554505|NCT01994785|101690630|FG000|COMPLETED|Overall Study||101||
48554506|NCT01994785|101690631|FG001|COMPLETED|Overall Study||108||
48554507|NCT01994785|101690632|FG002|COMPLETED|Overall Study||117||
48554508|NCT01994785|101690633|FG003|COMPLETED|Overall Study||114||
48554509|NCT01994785|101690630|FG000|NOT COMPLETED|Overall Study||8||
48554510|NCT01994785|101690631|FG001|NOT COMPLETED|Overall Study||1||
48554511|NCT01994785|101690632|FG002|NOT COMPLETED|Overall Study||0||
48554512|NCT01994785|101690633|FG003|NOT COMPLETED|Overall Study||3||
48554513|NCT00312338|101690634|FG000|STARTED|Overall Study||105||
48554514|NCT00312338|101690635|FG001|STARTED|Overall Study||57||
48554515|NCT00312338|101690634|FG000|COMPLETED|Overall Study||83||
48554516|NCT00312338|101690635|FG001|COMPLETED|Overall Study||54||
48554517|NCT00312338|101690634|FG000|NOT COMPLETED|Overall Study||22||
48554518|NCT00312338|101690635|FG001|NOT COMPLETED|Overall Study||3||
48554519|NCT04247100|101690636|FG000|STARTED|Overall Study||5||
48554520|NCT04247100|101690637|FG001|STARTED|Overall Study||5||
48554521|NCT04247100|101690636|FG000|COMPLETED|Overall Study||4||
48554522|NCT04247100|101690637|FG001|COMPLETED|Overall Study||4||
48554523|NCT04247100|101690636|FG000|NOT COMPLETED|Overall Study||1||
48554524|NCT04247100|101690637|FG001|NOT COMPLETED|Overall Study||1||
48554525|NCT01808547|101690638|FG000|STARTED|Overall Study||174||
48554526|NCT01808547|101690639|FG001|STARTED|Overall Study||94||
48554527|NCT01808547|101690638|FG000|Safety Population|Overall Study||170||
48554528|NCT01808547|101690639|FG001|Safety Population|Overall Study||85||
48554529|NCT01808547|101690638|FG000|mITT Population|Overall Study||168||
48554530|NCT01808547|101690639|FG001|mITT Population|Overall Study||85||
48554531|NCT01808547|101690638|FG000|COMPLETED|Overall Study||137||
48554532|NCT01808547|101690639|FG001|COMPLETED|Overall Study||48||
48554533|NCT01808547|101690638|FG000|NOT COMPLETED|Overall Study||37||
48554534|NCT01808547|101690639|FG001|NOT COMPLETED|Overall Study||46||
48554535|NCT01451463|101690640|FG000|STARTED|Overall Study||11||
48554536|NCT01451463|101690640|FG000|COMPLETED|Overall Study||11||
48554537|NCT01451463|101690640|FG000|NOT COMPLETED|Overall Study||0||
48271949|NCT03031496|100988517|FG001|COMPLETED|Period 2||19||
48271950|NCT03031496|100988516|FG000|NOT COMPLETED|Period 2||0||
48271951|NCT03031496|100988517|FG001|NOT COMPLETED|Period 2||0||
48271952|NCT01886287|100988518|FG000|STARTED|Overall Study||2||
48271953|NCT01886287|100988518|FG000|COMPLETED|Overall Study||0||
48271954|NCT01886287|100988518|FG000|NOT COMPLETED|Overall Study||2||
48271955|NCT04148989|100988519|FG000|STARTED|Pre-implmentation Period||50437||1
48271956|NCT04148989|100988520|FG001|STARTED|Pre-implmentation Period||0||0
48271957|NCT04148989|100988521|FG002|STARTED|Pre-implmentation Period||56192||2
48271958|NCT04148989|100988522|FG003|STARTED|Pre-implmentation Period||0||0
48271959|NCT04148989|100988519|FG000|COMPLETED|Pre-implmentation Period||50437||1
48271960|NCT04148989|100988520|FG001|COMPLETED|Pre-implmentation Period||0||0
48271961|NCT04148989|100988521|FG002|COMPLETED|Pre-implmentation Period||56192||2
48271962|NCT04148989|100988522|FG003|COMPLETED|Pre-implmentation Period||0||0
48271963|NCT04148989|100988519|FG000|NOT COMPLETED|Pre-implmentation Period||0||0
48271964|NCT04148989|100988520|FG001|NOT COMPLETED|Pre-implmentation Period||0||0
48271965|NCT04148989|100988521|FG002|NOT COMPLETED|Pre-implmentation Period||0||0
48271966|NCT04148989|100988522|FG003|NOT COMPLETED|Pre-implmentation Period||0||0
48271967|NCT04148989|100988519|FG000|STARTED|Post-implmementation Period||0||0
48271968|NCT04148989|100988520|FG001|STARTED|Post-implmementation Period||33415||1
48271969|NCT04148989|100988521|FG002|STARTED|Post-implmementation Period||0||0
48271970|NCT04148989|100988522|FG003|STARTED|Post-implmementation Period||40358||2
48271971|NCT04148989|100988519|FG000|COMPLETED|Post-implmementation Period||0||0
48271972|NCT04148989|100988520|FG001|COMPLETED|Post-implmementation Period||33415||1
48271973|NCT04148989|100988521|FG002|COMPLETED|Post-implmementation Period||0||0
48271974|NCT04148989|100988522|FG003|COMPLETED|Post-implmementation Period||40358||2
48271975|NCT04148989|100988519|FG000|NOT COMPLETED|Post-implmementation Period||0||0
48271976|NCT04148989|100988520|FG001|NOT COMPLETED|Post-implmementation Period||0||0
48271977|NCT04148989|100988521|FG002|NOT COMPLETED|Post-implmementation Period||0||0
48271978|NCT04148989|100988522|FG003|NOT COMPLETED|Post-implmementation Period||0||0
48271979|NCT03232931|100988523|FG000|STARTED|Overall Study||126||
48271980|NCT03232931|100988524|FG001|STARTED|Overall Study||122||
48271981|NCT03232931|100988523|FG000|COMPLETED|Overall Study||112|Completed the NICU portion of the study lasting up to 42 weeks gestational age.|
48271982|NCT03232931|100988524|FG001|COMPLETED|Overall Study||116|Completed the NICU portion of the study lasting up to 42 weeks gestational age.|
48271983|NCT03232931|100988523|FG000|NOT COMPLETED|Overall Study||14||
48271984|NCT03232931|100988524|FG001|NOT COMPLETED|Overall Study||6||
48271985|NCT00780559|100988525|FG000|STARTED|Overall Study||32||
48271986|NCT00780559|100988526|FG001|STARTED|Overall Study||40||
48271987|NCT00780559|100988525|FG000|COMPLETED|Overall Study||29||
48271988|NCT00780559|100988526|FG001|COMPLETED|Overall Study||33||
48271989|NCT00780559|100988525|FG000|NOT COMPLETED|Overall Study||3||
48271990|NCT00780559|100988526|FG001|NOT COMPLETED|Overall Study||7||
48271991|NCT00728910|100988527|FG000|STARTED|Atorvastatin||25||
48271992|NCT00728910|100988527|FG000|COMPLETED|Atorvastatin||22||
48271993|NCT00728910|100988527|FG000|NOT COMPLETED|Atorvastatin||3||
48271994|NCT00728910|100988527|FG000|STARTED|Atorvastatin+ABT335||22||
48271995|NCT00728910|100988527|FG000|COMPLETED|Atorvastatin+ABT335||22||
48271996|NCT00728910|100988527|FG000|NOT COMPLETED|Atorvastatin+ABT335||0||
48271997|NCT00728910|100988527|FG000|STARTED|Atorvastatin+ABT335+ER Niacin||22||
48271998|NCT00728910|100988527|FG000|COMPLETED|Atorvastatin+ABT335+ER Niacin||22||
48271999|NCT00728910|100988527|FG000|NOT COMPLETED|Atorvastatin+ABT335+ER Niacin||0||
48272000|NCT04210427|100988528|FG000|STARTED|Overall Study||3||
48272001|NCT04210427|100988528|FG000|COMPLETED|Overall Study||3||
48272002|NCT04210427|100988528|FG000|NOT COMPLETED|Overall Study||0||
48272003|NCT01736943|100988529|FG000|STARTED|Overall Study||25||
48272004|NCT01736943|100988529|FG000|COMPLETED|Overall Study||25||
48272005|NCT01736943|100988529|FG000|NOT COMPLETED|Overall Study||0||
48272006|NCT02071290|100988530|FG000|STARTED|Overall Study||25||
48272007|NCT02071290|100988531|FG001|STARTED|Overall Study||25||
48272008|NCT02071290|100988530|FG000|COMPLETED|Overall Study||21||
48272009|NCT02071290|100988531|FG001|COMPLETED|Overall Study||18||
48272010|NCT02071290|100988530|FG000|NOT COMPLETED|Overall Study||4||
48272011|NCT02071290|100988531|FG001|NOT COMPLETED|Overall Study||7||
48272012|NCT00441259|100988532|FG000|STARTED|Overall Study||48||
48272013|NCT00441259|100988533|FG001|STARTED|Overall Study||48||
48272014|NCT00441259|100988532|FG000|COMPLETED|Overall Study||48||
48272015|NCT00441259|100988533|FG001|COMPLETED|Overall Study||48||
48272016|NCT00441259|100988532|FG000|NOT COMPLETED|Overall Study||0||
48272017|NCT00441259|100988533|FG001|NOT COMPLETED|Overall Study||0||
48272018|NCT01681992|100988534|FG000|STARTED|Overall Study||1493||
48272019|NCT01681992|100988535|FG001|STARTED|Overall Study||1497||
48272020|NCT01681992|100988536|FG002|STARTED|Overall Study||1526||
48272021|NCT01681992|100988534|FG000|COMPLETED|Overall Study||1427||
48272022|NCT01681992|100988535|FG001|COMPLETED|Overall Study||1427||
48272023|NCT01681992|100988536|FG002|COMPLETED|Overall Study||1443||
48272024|NCT01681992|100988534|FG000|NOT COMPLETED|Overall Study||66||
48272025|NCT01681992|100988535|FG001|NOT COMPLETED|Overall Study||70||
48272026|NCT01681992|100988536|FG002|NOT COMPLETED|Overall Study||83||
48272027|NCT00677534|100988537|FG000|STARTED|Washout (Weeks 1-4)||10||
48272028|NCT00677534|100988537|FG000|COMPLETED|Washout (Weeks 1-4)||7||
48272029|NCT00677534|100988537|FG000|NOT COMPLETED|Washout (Weeks 1-4)||3||
48272030|NCT00677534|100988537|FG000|STARTED|Cholecalciferol (Weeks 5-12)||7||
48272031|NCT00677534|100988537|FG000|COMPLETED|Cholecalciferol (Weeks 5-12)||7||
48272032|NCT00677534|100988537|FG000|NOT COMPLETED|Cholecalciferol (Weeks 5-12)||0||
48272033|NCT00677534|100988537|FG000|STARTED|After Paricalcitol Restart (Weeks 13-14)||7||
48272034|NCT00677534|100988537|FG000|COMPLETED|After Paricalcitol Restart (Weeks 13-14)||7||
48272035|NCT00677534|100988537|FG000|NOT COMPLETED|After Paricalcitol Restart (Weeks 13-14)||0||
48272036|NCT01824589|100988538|FG000|STARTED|Overall Study||1||
48272037|NCT01824589|100988539|FG001|STARTED|Overall Study||0||
48272038|NCT01824589|100988540|FG002|STARTED|Overall Study||0||
48272039|NCT01824589|100988541|FG003|STARTED|Overall Study||0||
48554538|NCT02370238|101690641|FG000|STARTED|Overall Study||62||
48554539|NCT02370238|101690642|FG001|STARTED|Overall Study||61||
48554540|NCT02370238|101690641|FG000|ITT Population|Overall Study||62||
48554541|NCT02370238|101690642|FG001|ITT Population|Overall Study||61||
48554542|NCT02370238|101690641|FG000|Safety Population|Overall Study||61||
48554543|NCT02370238|101690642|FG001|Safety Population|Overall Study||60||
48554544|NCT02370238|101690641|FG000|Responsable-evaluable Population|Overall Study||57||
48554545|NCT02370238|101690642|FG001|Responsable-evaluable Population|Overall Study||54||
48554546|NCT02370238|101690641|FG000|COMPLETED|Overall Study||15||
48554547|NCT02370238|101690642|FG001|COMPLETED|Overall Study||16||
48554548|NCT02370238|101690641|FG000|NOT COMPLETED|Overall Study||47||
48554549|NCT02370238|101690642|FG001|NOT COMPLETED|Overall Study||45||
48554550|NCT02896712|101690643|FG000|STARTED|Phase 1||18||
48554551|NCT02896712|101690644|FG001|STARTED|Phase 1||17||
48554552|NCT02896712|101690645|FG002|STARTED|Phase 1||19||
48554553|NCT02896712|101690646|FG003|STARTED|Phase 1||21||
48554554|NCT02896712|101690647|FG004|STARTED|Phase 1||23||
48554555|NCT02896712|101690648|FG005|STARTED|Phase 1||20||
48272040|NCT01824589|100988538|FG000|COMPLETED|Overall Study||1||
48272041|NCT01824589|100988539|FG001|COMPLETED|Overall Study||0||
48272042|NCT01824589|100988540|FG002|COMPLETED|Overall Study||0||
48272043|NCT01824589|100988541|FG003|COMPLETED|Overall Study||0||
48272044|NCT01824589|100988538|FG000|NOT COMPLETED|Overall Study||0||
48272045|NCT01824589|100988539|FG001|NOT COMPLETED|Overall Study||0||
48272046|NCT01824589|100988540|FG002|NOT COMPLETED|Overall Study||0||
48272047|NCT01824589|100988541|FG003|NOT COMPLETED|Overall Study||0||
48272048|NCT00799981|100988542|FG000|STARTED|Overall Study||10|It differs between subjects if they are catheterisized twice per visit or one catheterisation at each visit. The subjects that were catheterisized twice during one day had at least 2 hours between 2 catheterizations.|
48272049|NCT00799981|100988543|FG001|STARTED|Overall Study||9|It differs between subjects if they are catheterisized twice per visit or one catheterisation at each visit. The subjects that were catheterisized twice during one day had at least 2 hours between 2 catheterizations.|
48272050|NCT00799981|100988544|FG002|STARTED|Overall Study||10|It differs between subjects if they are catheterisized twice per visit or one catheterisation at each visit. The subjects that were catheterisized twice during one day had at least 2 hours between 2 catheterizations.|
48272051|NCT00799981|100988545|FG003|STARTED|Overall Study||10|It differs between subjects if they are catheterisized twice per visit or one catheterisation at each visit. The subjects that were catheterisized twice during one day had at least 2 hours between 2 catheterizations.|
48272052|NCT00799981|100988546|FG004|STARTED|Overall Study||11|It differs between subjects if they are catheterisized twice per visit or one catheterisation at each visit. The subjects that were catheterisized twice during one day had at least 2 hours between 2 catheterizations.|
48272053|NCT00799981|100988547|FG005|STARTED|Overall Study||10|It differs between subjects if they are catheterisized twice per visit or one catheterisation at each visit. The subjects that were catheterisized twice during one day had at least 2 hours between 2 catheterizations.|
48272054|NCT00799981|100988542|FG000|COMPLETED|Overall Study||10||
48272055|NCT00799981|100988543|FG001|COMPLETED|Overall Study||9||
48272056|NCT00799981|100988544|FG002|COMPLETED|Overall Study||10||
48272057|NCT00799981|100988545|FG003|COMPLETED|Overall Study||10||
48272058|NCT00799981|100988546|FG004|COMPLETED|Overall Study||11||
48272059|NCT00799981|100988547|FG005|COMPLETED|Overall Study||10||
48272060|NCT00799981|100988542|FG000|NOT COMPLETED|Overall Study||0||
48272061|NCT00799981|100988543|FG001|NOT COMPLETED|Overall Study||0||
48272062|NCT00799981|100988544|FG002|NOT COMPLETED|Overall Study||0||
48554556|NCT02896712|101690643|FG000|COMPLETED|Phase 1||14||
48554557|NCT02896712|101690644|FG001|COMPLETED|Phase 1||17||
48554558|NCT02896712|101690645|FG002|COMPLETED|Phase 1||19||
48272063|NCT00799981|100988545|FG003|NOT COMPLETED|Overall Study||0||
48272064|NCT00799981|100988546|FG004|NOT COMPLETED|Overall Study||0||
48554559|NCT02896712|101690646|FG003|COMPLETED|Phase 1||10||
48554560|NCT02896712|101690647|FG004|COMPLETED|Phase 1||23||
48554561|NCT02896712|101690648|FG005|COMPLETED|Phase 1||20||
48554562|NCT02896712|101690643|FG000|NOT COMPLETED|Phase 1||4||
48554563|NCT02896712|101690644|FG001|NOT COMPLETED|Phase 1||0||
48554564|NCT02896712|101690645|FG002|NOT COMPLETED|Phase 1||0||
48554565|NCT02896712|101690646|FG003|NOT COMPLETED|Phase 1||11||
48554566|NCT02896712|101690647|FG004|NOT COMPLETED|Phase 1||0||
48554567|NCT02896712|101690648|FG005|NOT COMPLETED|Phase 1||0||
48554568|NCT02896712|101690643|FG000|STARTED|Phase 2||14||
48554569|NCT02896712|101690644|FG001|STARTED|Phase 2||17||
48554570|NCT02896712|101690645|FG002|STARTED|Phase 2||19||
48554571|NCT02896712|101690646|FG003|STARTED|Phase 2||10||
48554572|NCT02896712|101690647|FG004|STARTED|Phase 2||23||
48272065|NCT00799981|100988547|FG005|NOT COMPLETED|Overall Study||0||
48272066|NCT03762200|100988548|FG000|STARTED|Overall Study||103||
48272067|NCT03762200|100988548|FG000|COMPLETED|Overall Study||101||
48272068|NCT03762200|100988548|FG000|NOT COMPLETED|Overall Study||2||
48272069|NCT03274895|100988549|FG000|STARTED|Overall Study||69||
48272070|NCT03274895|100988550|FG001|STARTED|Overall Study||65||
48272071|NCT03274895|100988549|FG000|COMPLETED|Overall Study||56||
48272072|NCT03274895|100988550|FG001|COMPLETED|Overall Study||54||
48272073|NCT03274895|100988549|FG000|NOT COMPLETED|Overall Study||13||
48272074|NCT03274895|100988550|FG001|NOT COMPLETED|Overall Study||11||
48272075|NCT01541384|100988551|FG000|STARTED|Overall Study||40||
48272076|NCT01541384|100988552|FG001|STARTED|Overall Study||40||
48272077|NCT01541384|100988553|FG002|STARTED|Overall Study||40||
48272078|NCT01541384|100988551|FG000|COMPLETED|Overall Study||40||
48272079|NCT01541384|100988552|FG001|COMPLETED|Overall Study||39||
48272080|NCT01541384|100988553|FG002|COMPLETED|Overall Study||38||
48272081|NCT01541384|100988551|FG000|NOT COMPLETED|Overall Study||0||
48272082|NCT01541384|100988552|FG001|NOT COMPLETED|Overall Study||1||
48272083|NCT01541384|100988553|FG002|NOT COMPLETED|Overall Study||2||
48272084|NCT03931746|100988554|FG000|STARTED|Overall Study||8||
48272085|NCT03931746|100988555|FG001|STARTED|Overall Study||6||
48272086|NCT03931746|100988554|FG000|COMPLETED|Overall Study||7||
48272087|NCT03931746|100988555|FG001|COMPLETED|Overall Study||4||
48272088|NCT03931746|100988554|FG000|NOT COMPLETED|Overall Study||1||
48272089|NCT03931746|100988555|FG001|NOT COMPLETED|Overall Study||2||
48392605|NCT02999100|101291388|FG000|STARTED|Part 2 (Day 1): Dosing Session 1||0||
48392606|NCT02999100|101291389|FG001|STARTED|Part 2 (Day 1): Dosing Session 1||0||
48392607|NCT02999100|101291390|FG002|STARTED|Part 2 (Day 1): Dosing Session 1||5||
48392608|NCT02999100|101291391|FG003|STARTED|Part 2 (Day 1): Dosing Session 1||3||
48392609|NCT02999100|101291392|FG004|STARTED|Part 2 (Day 1): Dosing Session 1||3||
48554573|NCT02896712|101690648|FG005|STARTED|Phase 2||20||
48554574|NCT02896712|101690643|FG000|COMPLETED|Phase 2||8||
48554575|NCT02896712|101690644|FG001|COMPLETED|Phase 2||11||
48554576|NCT02896712|101690645|FG002|COMPLETED|Phase 2||10||
48554577|NCT02896712|101690646|FG003|COMPLETED|Phase 2||9||
48693705|NCT01947283|102032836|FG001|Clinical Recording|Overall Study||54||
48693706|NCT01947283|102032837|FG002|Clinical Recording|Overall Study||68||
48693707|NCT01947283|102032838|FG003|Clinical Recording|Overall Study||57||
48693708|NCT01947283|102032839|FG004|Clinical Recording|Overall Study||0||
48693709|NCT01947283|102032840|FG005|Clinical Recording|Overall Study||0||
48392610|NCT02999100|101291393|FG005|STARTED|Part 2 (Day 1): Dosing Session 1||3||
48554578|NCT02896712|101690647|FG004|COMPLETED|Phase 2||13||
48554579|NCT02896712|101690648|FG005|COMPLETED|Phase 2||13||
48554580|NCT02896712|101690643|FG000|NOT COMPLETED|Phase 2||6||
48693710|NCT01947283|102032841|FG006|Clinical Recording|Overall Study||0||
48693711|NCT01947283|102032835|FG000|End-of-Intervention Assessment|Overall Study||74||
48693712|NCT01947283|102032836|FG001|End-of-Intervention Assessment|Overall Study||53||
48693713|NCT01947283|102032837|FG002|End-of-Intervention Assessment|Overall Study||73||
48693714|NCT01947283|102032838|FG003|End-of-Intervention Assessment|Overall Study||66||
48693715|NCT01947283|102032839|FG004|End-of-Intervention Assessment|Overall Study||0||
48693716|NCT01947283|102032840|FG005|End-of-Intervention Assessment|Overall Study||32||
48693717|NCT01947283|102032841|FG006|End-of-Intervention Assessment|Overall Study||33||
48693718|NCT01947283|102032835|FG000|In Analysis|Overall Study||89||
48693719|NCT01947283|102032836|FG001|In Analysis|Overall Study||68||
48693720|NCT01947283|102032837|FG002|In Analysis|Overall Study||83||
48693721|NCT01947283|102032838|FG003|In Analysis|Overall Study||72||
48693722|NCT01947283|102032839|FG004|In Analysis|Overall Study||95||
48272090|NCT01734239|100988556|FG000|STARTED|Overall Study||52||
48272091|NCT01734239|100988557|FG001|STARTED|Overall Study||50||
48272092|NCT01734239|100988556|FG000|COMPLETED|Overall Study||52||
48392611|NCT02999100|101291388|FG000|COMPLETED|Part 2 (Day 1): Dosing Session 1||0||
48392612|NCT02999100|101291389|FG001|COMPLETED|Part 2 (Day 1): Dosing Session 1||0||
48392613|NCT02999100|101291390|FG002|COMPLETED|Part 2 (Day 1): Dosing Session 1||4||
48392614|NCT02999100|101291391|FG003|COMPLETED|Part 2 (Day 1): Dosing Session 1||3||
48554581|NCT02896712|101690644|FG001|NOT COMPLETED|Phase 2||6||
48554582|NCT02896712|101690645|FG002|NOT COMPLETED|Phase 2||9||
48554583|NCT02896712|101690646|FG003|NOT COMPLETED|Phase 2||1||
48554584|NCT02896712|101690647|FG004|NOT COMPLETED|Phase 2||10||
48272093|NCT01734239|100988557|FG001|COMPLETED|Overall Study||50||
48272094|NCT01734239|100988556|FG000|NOT COMPLETED|Overall Study||0||
48272095|NCT01734239|100988557|FG001|NOT COMPLETED|Overall Study||0||
48272096|NCT00749957|100988558|FG000|STARTED|Overall Study||6||
48272097|NCT00749957|100988559|FG001|STARTED|Overall Study||6||
48272098|NCT00749957|100988558|FG000|COMPLETED|Overall Study||6||
48554585|NCT02896712|101690648|FG005|NOT COMPLETED|Phase 2||7||
48693723|NCT01947283|102032840|FG005|In Analysis|Overall Study||30||
48693724|NCT01947283|102032841|FG006|In Analysis|Overall Study||38||
48693725|NCT01947283|102032835|FG000|Completed NRCT Baseline Assessment|Overall Study||0||
48693726|NCT01947283|102032836|FG001|Completed NRCT Baseline Assessment|Overall Study||0||
48693727|NCT01947283|102032837|FG002|Completed NRCT Baseline Assessment|Overall Study||0||
48693728|NCT01947283|102032838|FG003|Completed NRCT Baseline Assessment|Overall Study||0||
48693729|NCT01947283|102032839|FG004|Completed NRCT Baseline Assessment|Overall Study||95||
48693730|NCT01947283|102032840|FG005|Completed NRCT Baseline Assessment|Overall Study||0||
48693731|NCT01947283|102032841|FG006|Completed NRCT Baseline Assessment|Overall Study||0||
48693732|NCT01947283|102032835|FG000|COMPLETED|Overall Study||60||
48693733|NCT01947283|102032836|FG001|COMPLETED|Overall Study||45||
48693734|NCT01947283|102032837|FG002|COMPLETED|Overall Study||62||
48693735|NCT01947283|102032838|FG003|COMPLETED|Overall Study||55||
48693736|NCT01947283|102032839|FG004|COMPLETED|Overall Study||95||
48693737|NCT01947283|102032840|FG005|COMPLETED|Overall Study||27||
48693738|NCT01947283|102032841|FG006|COMPLETED|Overall Study||32||
48693739|NCT01947283|102032835|FG000|NOT COMPLETED|Overall Study||29||
48693740|NCT01947283|102032836|FG001|NOT COMPLETED|Overall Study||23||
48693741|NCT01947283|102032837|FG002|NOT COMPLETED|Overall Study||21||
48693742|NCT01947283|102032838|FG003|NOT COMPLETED|Overall Study||17||
48693743|NCT01947283|102032839|FG004|NOT COMPLETED|Overall Study||0||
48693744|NCT01947283|102032840|FG005|NOT COMPLETED|Overall Study||7||
48109724|NCT00489853|100594566|FG001|COMPLETED|Wash-out Period 1||34||
48272099|NCT00749957|100988559|FG001|COMPLETED|Overall Study||6||
48272100|NCT00749957|100988558|FG000|NOT COMPLETED|Overall Study||0||
48272101|NCT00749957|100988559|FG001|NOT COMPLETED|Overall Study||0||
48272102|NCT04551677|100988560|FG000|STARTED|Overall Study||29||
48272103|NCT04551677|100988561|FG001|STARTED|Overall Study||31||
48272104|NCT04551677|100988562|FG002|STARTED|Overall Study||30||
48272105|NCT04551677|100988560|FG000|Vaccinated|Overall Study||29||
48272106|NCT04551677|100988561|FG001|Vaccinated|Overall Study||31||
48272107|NCT04551677|100988562|FG002|Vaccinated|Overall Study||30||
48272108|NCT04551677|100988560|FG000|COMPLETED|Overall Study||29||
48554586|NCT02854527|101690649|FG000|STARTED|Overall Study||3||
48554587|NCT02854527|101690650|FG001|STARTED|Overall Study||3||
48554588|NCT02854527|101690651|FG002|STARTED|Overall Study||3||
48554589|NCT02854527|101690652|FG003|STARTED|Overall Study||3||
48554590|NCT02854527|101690653|FG004|STARTED|Overall Study||3||
48554591|NCT02854527|101690654|FG005|STARTED|Overall Study||3||
48554592|NCT02854527|101690655|FG006|STARTED|Overall Study||3||
48554593|NCT02854527|101690656|FG007|STARTED|Overall Study||3||
48554594|NCT02854527|101690657|FG008|STARTED|Overall Study||3||
48554595|NCT02854527|101690658|FG009|STARTED|Overall Study||3||
48554596|NCT02854527|101690649|FG000|Received R1|Overall Study||3||
48554597|NCT02854527|101690650|FG001|Received R1|Overall Study||3||
48554598|NCT02854527|101690651|FG002|Received R1|Overall Study||3||
48554599|NCT02854527|101690652|FG003|Received R1|Overall Study||2||
48554600|NCT02854527|101690653|FG004|Received R1|Overall Study||2||
48554601|NCT02854527|101690654|FG005|Received R1|Overall Study||3||
48554602|NCT02854527|101690655|FG006|Received R1|Overall Study||3||
48554603|NCT02854527|101690656|FG007|Received R1|Overall Study||3||
48554604|NCT02854527|101690657|FG008|Received R1|Overall Study||3||
48554605|NCT02854527|101690658|FG009|Received R1|Overall Study||3||
48693745|NCT01947283|102032841|FG006|NOT COMPLETED|Overall Study||8||
48693746|NCT02314156|102032842|FG000|STARTED|Overall Study||33||
48693747|NCT02314156|102032843|FG001|STARTED|Overall Study||34||
48693748|NCT02314156|102032842|FG000|COMPLETED|Overall Study||31||
48693749|NCT02314156|102032843|FG001|COMPLETED|Overall Study||34||
48693750|NCT02314156|102032842|FG000|NOT COMPLETED|Overall Study||2||
48693751|NCT02314156|102032843|FG001|NOT COMPLETED|Overall Study||0||
48693752|NCT01221623|102032844|FG000|STARTED|Overall Study||274||
48693753|NCT01221623|102032845|FG001|STARTED|Overall Study||141||
48693754|NCT01221623|102032844|FG000|COMPLETED|Overall Study||236||
48693755|NCT01221623|102032845|FG001|COMPLETED|Overall Study||127||
48693756|NCT01221623|102032844|FG000|NOT COMPLETED|Overall Study||38||
48693757|NCT01221623|102032845|FG001|NOT COMPLETED|Overall Study||14||
48693758|NCT00854724|102032846|FG000|STARTED|First Intervention||8||
48693759|NCT00854724|102032847|FG001|STARTED|First Intervention||8||
48693760|NCT00854724|102032846|FG000|COMPLETED|First Intervention||7||
48693761|NCT00854724|102032847|FG001|COMPLETED|First Intervention||7||
48554606|NCT02854527|101690649|FG000|Received R2|Overall Study||3||
48554607|NCT02854527|101690650|FG001|Received R2|Overall Study||3||
48693762|NCT00854724|102032846|FG000|NOT COMPLETED|First Intervention||1||
48693763|NCT00854724|102032847|FG001|NOT COMPLETED|First Intervention||1||
48693764|NCT00854724|102032846|FG000|STARTED|Washout||7||
48272109|NCT04551677|100988561|FG001|COMPLETED|Overall Study||31||
48272110|NCT04551677|100988562|FG002|COMPLETED|Overall Study||30||
48554608|NCT02854527|101690651|FG002|Received R2|Overall Study||3||
48554609|NCT02854527|101690652|FG003|Received R2|Overall Study||3||
48554610|NCT02854527|101690653|FG004|Received R2|Overall Study||3||
48693765|NCT00854724|102032847|FG001|STARTED|Washout||7||
48693766|NCT00854724|102032846|FG000|COMPLETED|Washout||6||
48693767|NCT00854724|102032847|FG001|COMPLETED|Washout||6||
48693768|NCT00854724|102032846|FG000|NOT COMPLETED|Washout||1||
48693769|NCT00854724|102032847|FG001|NOT COMPLETED|Washout||1||
48272111|NCT04551677|100988560|FG000|NOT COMPLETED|Overall Study||0||
48693770|NCT00854724|102032846|FG000|STARTED|Second Intervention||6||
48554611|NCT02854527|101690654|FG005|Received R2|Overall Study||3||
48554612|NCT02854527|101690655|FG006|Received R2|Overall Study||3||
48554613|NCT02854527|101690656|FG007|Received R2|Overall Study||3||
48554614|NCT02854527|101690657|FG008|Received R2|Overall Study||3||
48554615|NCT02854527|101690658|FG009|Received R2|Overall Study||3||
48693771|NCT00854724|102032847|FG001|STARTED|Second Intervention||6||
48693772|NCT00854724|102032846|FG000|COMPLETED|Second Intervention||5||
48693773|NCT00854724|102032847|FG001|COMPLETED|Second Intervention||5||
48554616|NCT02854527|101690649|FG000|Received R3|Overall Study||3||
48554617|NCT02854527|101690650|FG001|Received R3|Overall Study||3||
48554618|NCT02854527|101690651|FG002|Received R3|Overall Study||3||
48554619|NCT02854527|101690652|FG003|Received R3|Overall Study||2||
48554620|NCT02854527|101690653|FG004|Received R3|Overall Study||3||
48554621|NCT02854527|101690654|FG005|Received R3|Overall Study||3||
48554622|NCT02854527|101690655|FG006|Received R3|Overall Study||3||
48554623|NCT02854527|101690656|FG007|Received R3|Overall Study||3||
48554624|NCT02854527|101690657|FG008|Received R3|Overall Study||3||
48554625|NCT02854527|101690658|FG009|Received R3|Overall Study||3||
48554626|NCT02854527|101690649|FG000|Received R4|Overall Study||3||
48554627|NCT02854527|101690650|FG001|Received R4|Overall Study||3||
48554628|NCT02854527|101690651|FG002|Received R4|Overall Study||3||
48554629|NCT02854527|101690652|FG003|Received R4|Overall Study||2||
48554630|NCT02854527|101690653|FG004|Received R4|Overall Study||3||
48554631|NCT02854527|101690654|FG005|Received R4|Overall Study||3||
48554632|NCT02854527|101690655|FG006|Received R4|Overall Study||3||
48554633|NCT02854527|101690656|FG007|Received R4|Overall Study||3||
48554634|NCT02854527|101690657|FG008|Received R4|Overall Study||3||
48554635|NCT02854527|101690658|FG009|Received R4|Overall Study||3||
48554636|NCT02854527|101690649|FG000|Received T|Overall Study||3||
48554637|NCT02854527|101690650|FG001|Received T|Overall Study||3||
48554638|NCT02854527|101690651|FG002|Received T|Overall Study||3||
48554639|NCT02854527|101690652|FG003|Received T|Overall Study||2||
48554640|NCT02854527|101690653|FG004|Received T|Overall Study||2||
48554641|NCT02854527|101690654|FG005|Received T|Overall Study||3||
48554642|NCT02854527|101690655|FG006|Received T|Overall Study||3||
48554643|NCT02854527|101690656|FG007|Received T|Overall Study||3||
48554644|NCT02854527|101690657|FG008|Received T|Overall Study||3||
48554645|NCT02854527|101690658|FG009|Received T|Overall Study||3||
48693774|NCT00854724|102032846|FG000|NOT COMPLETED|Second Intervention||1||
48554646|NCT02854527|101690649|FG000|COMPLETED|Overall Study||3||
48554647|NCT02854527|101690650|FG001|COMPLETED|Overall Study||3||
48554648|NCT02854527|101690651|FG002|COMPLETED|Overall Study||3||
48554649|NCT02854527|101690652|FG003|COMPLETED|Overall Study||2||
48554650|NCT02854527|101690653|FG004|COMPLETED|Overall Study||2||
48554651|NCT02854527|101690654|FG005|COMPLETED|Overall Study||3||
48554652|NCT02854527|101690655|FG006|COMPLETED|Overall Study||3||
48554653|NCT02854527|101690656|FG007|COMPLETED|Overall Study||3||
48554654|NCT02854527|101690657|FG008|COMPLETED|Overall Study||3||
48554655|NCT02854527|101690658|FG009|COMPLETED|Overall Study||3||
48554656|NCT02854527|101690649|FG000|NOT COMPLETED|Overall Study||0||
48554657|NCT02854527|101690650|FG001|NOT COMPLETED|Overall Study||0||
48554658|NCT02854527|101690651|FG002|NOT COMPLETED|Overall Study||0||
48554659|NCT02854527|101690652|FG003|NOT COMPLETED|Overall Study||1||
48554660|NCT02854527|101690653|FG004|NOT COMPLETED|Overall Study||1||
48554661|NCT02854527|101690654|FG005|NOT COMPLETED|Overall Study||0||
48554662|NCT02854527|101690655|FG006|NOT COMPLETED|Overall Study||0||
48554663|NCT02854527|101690656|FG007|NOT COMPLETED|Overall Study||0||
48554664|NCT02854527|101690657|FG008|NOT COMPLETED|Overall Study||0||
48693775|NCT00854724|102032847|FG001|NOT COMPLETED|Second Intervention||1||
48693776|NCT03333928|102032848|FG000|STARTED|Initial Dosing Period (Period 1)||16||
48693777|NCT03333928|102032849|FG001|STARTED|Initial Dosing Period (Period 1)||25||
48693778|NCT03333928|102032850|FG002|STARTED|Initial Dosing Period (Period 1)||18||
48693779|NCT03333928|102032848|FG000|COMPLETED|Initial Dosing Period (Period 1)||15||
48693780|NCT03333928|102032849|FG001|COMPLETED|Initial Dosing Period (Period 1)||21||
48554665|NCT02854527|101690658|FG009|NOT COMPLETED|Overall Study||0||
48554666|NCT00708110|101690659|FG000|STARTED|Overall Study||7||
48554667|NCT00708110|101690660|FG001|STARTED|Overall Study||9||
48554668|NCT00708110|101690661|FG002|STARTED|Overall Study||9||
48554669|NCT00708110|101690662|FG003|STARTED|Overall Study||10||
48554670|NCT00708110|101690659|FG000|COMPLETED|Overall Study||7||
48554671|NCT00708110|101690660|FG001|COMPLETED|Overall Study||9||
48554672|NCT00708110|101690661|FG002|COMPLETED|Overall Study||9||
48554673|NCT00708110|101690662|FG003|COMPLETED|Overall Study||10||
48554674|NCT00708110|101690659|FG000|NOT COMPLETED|Overall Study||0||
48554675|NCT00708110|101690660|FG001|NOT COMPLETED|Overall Study||0||
48693781|NCT03333928|102032850|FG002|COMPLETED|Initial Dosing Period (Period 1)||14||
48710803|NCT00380029|102078023|FG000|NOT COMPLETED|Overall Study||0||
48554676|NCT00708110|101690661|FG002|NOT COMPLETED|Overall Study||0||
48109725|NCT00489853|100594567|FG002|COMPLETED|Wash-out Period 1||32||
48554677|NCT00708110|101690662|FG003|NOT COMPLETED|Overall Study||0||
48554678|NCT01547390|101690663|FG000|STARTED|Overall Study||27||
48554679|NCT01547390|101690664|FG001|STARTED|Overall Study||26||
48554680|NCT01547390|101690663|FG000|COMPLETED|Overall Study||14||
48554681|NCT01547390|101690664|FG001|COMPLETED|Overall Study||16||
48554682|NCT01547390|101690663|FG000|NOT COMPLETED|Overall Study||13||
48554683|NCT01547390|101690664|FG001|NOT COMPLETED|Overall Study||10||
48554684|NCT04211831|101690665|FG000|STARTED|Overall Study||27||
48554685|NCT04211831|101690666|FG001|STARTED|Overall Study||26||
48554686|NCT04211831|101690667|FG002|STARTED|Overall Study||27||
48554687|NCT04211831|101690665|FG000|COMPLETED|Overall Study||23||
48554688|NCT04211831|101690666|FG001|COMPLETED|Overall Study||22||
48554689|NCT04211831|101690667|FG002|COMPLETED|Overall Study||22||
48554690|NCT04211831|101690665|FG000|NOT COMPLETED|Overall Study||4||
48554691|NCT04211831|101690666|FG001|NOT COMPLETED|Overall Study||4||
48554692|NCT04211831|101690667|FG002|NOT COMPLETED|Overall Study||5||
48554693|NCT04362670|101690668|FG000|STARTED|Overall Study||5||
48554694|NCT04362670|101690669|FG001|STARTED|Overall Study||42||
48554695|NCT04362670|101690670|FG002|STARTED|Overall Study||41||
48554696|NCT04362670|101690671|FG003|STARTED|Overall Study||43||
48554697|NCT04362670|101690672|FG004|STARTED|Overall Study||22||
48554698|NCT04362670|101690668|FG000|COMPLETED|Overall Study||5||
48554699|NCT04362670|101690669|FG001|COMPLETED|Overall Study||39||
48554700|NCT04362670|101690670|FG002|COMPLETED|Overall Study||39||
48554701|NCT04362670|101690671|FG003|COMPLETED|Overall Study||42||
48554702|NCT04362670|101690672|FG004|COMPLETED|Overall Study||22||
48554703|NCT04362670|101690668|FG000|NOT COMPLETED|Overall Study||0||
48554704|NCT04362670|101690669|FG001|NOT COMPLETED|Overall Study||3||
48554705|NCT04362670|101690670|FG002|NOT COMPLETED|Overall Study||2||
48554706|NCT04362670|101690671|FG003|NOT COMPLETED|Overall Study||1||
48554707|NCT04362670|101690672|FG004|NOT COMPLETED|Overall Study||0||
48554708|NCT01644240|101690673|FG000|STARTED|Overall Study||6||
48554709|NCT01644240|101690674|FG001|STARTED|Overall Study||4||
48554710|NCT01644240|101690675|FG002|STARTED|Overall Study||6||
48554711|NCT01644240|101690673|FG000|COMPLETED|Overall Study||6||
48554712|NCT01644240|101690674|FG001|COMPLETED|Overall Study||4||
48554713|NCT01644240|101690675|FG002|COMPLETED|Overall Study||6||
48554714|NCT01644240|101690673|FG000|NOT COMPLETED|Overall Study||0||
48554715|NCT01644240|101690674|FG001|NOT COMPLETED|Overall Study||0||
48554716|NCT01644240|101690675|FG002|NOT COMPLETED|Overall Study||0||
48554717|NCT01807065|101690676|FG000|STARTED|Overall Study||25||
48554718|NCT01807065|101690677|FG001|STARTED|Overall Study||26||
48554719|NCT01807065|101690676|FG000|COMPLETED|Overall Study||24||
48554720|NCT01807065|101690677|FG001|COMPLETED|Overall Study||25||
48554721|NCT01807065|101690676|FG000|NOT COMPLETED|Overall Study||1||
48109726|NCT00489853|100594565|FG000|NOT COMPLETED|Wash-out Period 1||1||
48109727|NCT00489853|100594566|FG001|NOT COMPLETED|Wash-out Period 1||3||
48554722|NCT01807065|101690677|FG001|NOT COMPLETED|Overall Study||1||
48554723|NCT01728844|101690678|FG000|STARTED|Overall Study||22||
48554724|NCT01728844|101690679|FG001|STARTED|Overall Study||21||
48554725|NCT01728844|101690680|FG002|STARTED|Overall Study||22||
48554726|NCT01728844|101690681|FG003|STARTED|Overall Study||23||
48554727|NCT01728844|101690678|FG000|COMPLETED|Overall Study||21||
48554728|NCT01728844|101690679|FG001|COMPLETED|Overall Study||21||
48554729|NCT01728844|101690680|FG002|COMPLETED|Overall Study||22||
48554730|NCT01728844|101690681|FG003|COMPLETED|Overall Study||21||
48554731|NCT01728844|101690678|FG000|NOT COMPLETED|Overall Study||1||
48554732|NCT01728844|101690679|FG001|NOT COMPLETED|Overall Study||0||
48554733|NCT01728844|101690680|FG002|NOT COMPLETED|Overall Study||0||
48272112|NCT04551677|100988561|FG001|NOT COMPLETED|Overall Study||0||
48272113|NCT04551677|100988562|FG002|NOT COMPLETED|Overall Study||0||
48272114|NCT00790205|100988563|FG000|STARTED|Overall Study||7332||
48272115|NCT00790205|100988564|FG001|STARTED|Overall Study||7339||
48272116|NCT00790205|100988563|FG000|Treated|Overall Study||7266||
48272117|NCT00790205|100988564|FG001|Treated|Overall Study||7274||
48272118|NCT00790205|100988563|FG000|COMPLETED|Overall Study||6972||
48272119|NCT00790205|100988564|FG001|COMPLETED|Overall Study||6905||
48272120|NCT00790205|100988563|FG000|NOT COMPLETED|Overall Study||360||
48272121|NCT00790205|100988564|FG001|NOT COMPLETED|Overall Study||434||
48554734|NCT01728844|101690681|FG003|NOT COMPLETED|Overall Study||2||
48554735|NCT01320293|101690682|FG000|STARTED|Overall Study||18||
48272122|NCT00874731|100988565|FG000|STARTED|Part 1, Day 1: Placebo||23||
48272123|NCT00874731|100988566|FG001|STARTED|Part 1, Day 1: Placebo||0||
48554736|NCT01320293|101690682|FG000|COMPLETED|Overall Study||16||
48554737|NCT01320293|101690682|FG000|NOT COMPLETED|Overall Study||2||
48554738|NCT02020278|101690683|FG000|STARTED|Core Safety Follow-up Component||3||
48554739|NCT02020278|101690683|FG000|COMPLETED|Core Safety Follow-up Component||3||
48554740|NCT02020278|101690683|FG000|NOT COMPLETED|Core Safety Follow-up Component||0||
48554741|NCT02020278|101690683|FG000|STARTED|Optional Tolvaptan Treatment Component||0||
48554742|NCT02020278|101690683|FG000|COMPLETED|Optional Tolvaptan Treatment Component||0||
48554743|NCT02020278|101690683|FG000|NOT COMPLETED|Optional Tolvaptan Treatment Component||0||
48554744|NCT01225250|101690684|FG000|STARTED|Overall Study||15||
48554745|NCT01225250|101690685|FG001|STARTED|Overall Study||15||
48554746|NCT01225250|101690684|FG000|COMPLETED|Overall Study||10||
48554747|NCT01225250|101690685|FG001|COMPLETED|Overall Study||10||
48554748|NCT01225250|101690684|FG000|NOT COMPLETED|Overall Study||5||
48554749|NCT01225250|101690685|FG001|NOT COMPLETED|Overall Study||5||
48693782|NCT03333928|102032848|FG000|NOT COMPLETED|Initial Dosing Period (Period 1)||1||
48693783|NCT03333928|102032849|FG001|NOT COMPLETED|Initial Dosing Period (Period 1)||4||
48693784|NCT03333928|102032850|FG002|NOT COMPLETED|Initial Dosing Period (Period 1)||4||
48710706|NCT00846040|102077994|FG001|STARTED|Second Treatment: After Washout, 14 Day||8||
48710707|NCT00846040|102077995|FG002|STARTED|Second Treatment: After Washout, 14 Day||0||
48272124|NCT00874731|100988567|FG002|STARTED|Part 1, Day 1: Placebo||0||
48272125|NCT00874731|100988565|FG000|COMPLETED|Part 1, Day 1: Placebo||22||
48272126|NCT00874731|100988566|FG001|COMPLETED|Part 1, Day 1: Placebo||0||
48272127|NCT00874731|100988567|FG002|COMPLETED|Part 1, Day 1: Placebo||0||
48272128|NCT00874731|100988565|FG000|NOT COMPLETED|Part 1, Day 1: Placebo||1||
48272129|NCT00874731|100988566|FG001|NOT COMPLETED|Part 1, Day 1: Placebo||0||
48272130|NCT00874731|100988567|FG002|NOT COMPLETED|Part 1, Day 1: Placebo||0||
48272131|NCT00874731|100988565|FG000|STARTED|Part 1, Day 2: Ridaforolimus 100 mg||0||
48272132|NCT00874731|100988566|FG001|STARTED|Part 1, Day 2: Ridaforolimus 100 mg||22||
48272133|NCT00874731|100988567|FG002|STARTED|Part 1, Day 2: Ridaforolimus 100 mg||0||
48272134|NCT00874731|100988565|FG000|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0||
48272135|NCT00874731|100988566|FG001|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||22||
48272136|NCT00874731|100988567|FG002|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0||
48272137|NCT00874731|100988565|FG000|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0||
48272138|NCT00874731|100988566|FG001|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0||
48272139|NCT00874731|100988567|FG002|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0||
48272140|NCT00874731|100988565|FG000|STARTED|Washout Period||0||
48272141|NCT00874731|100988566|FG001|STARTED|Washout Period||22||
48272142|NCT00874731|100988567|FG002|STARTED|Washout Period||0||
48272143|NCT00874731|100988565|FG000|COMPLETED|Washout Period||0||
48272144|NCT00874731|100988566|FG001|COMPLETED|Washout Period||22||
48272145|NCT00874731|100988567|FG002|COMPLETED|Washout Period||0||
48272146|NCT00874731|100988565|FG000|NOT COMPLETED|Washout Period||0||
48272147|NCT00874731|100988566|FG001|NOT COMPLETED|Washout Period||0||
48272148|NCT00874731|100988567|FG002|NOT COMPLETED|Washout Period||0||
48272149|NCT00874731|100988565|FG000|STARTED|Part 2: Ridaforolimus 40 mg||0||
48554750|NCT02091856|101690686|FG000|STARTED|Active Intervention Interval||34||
48554751|NCT02091856|101690687|FG001|STARTED|Active Intervention Interval||19||
48554752|NCT02091856|101690688|FG002|STARTED|Active Intervention Interval||26||
48554753|NCT02091856|101690686|FG000|COMPLETED|Active Intervention Interval||15||
48554754|NCT02091856|101690687|FG001|COMPLETED|Active Intervention Interval||12||
48554755|NCT02091856|101690688|FG002|COMPLETED|Active Intervention Interval||19||
48554756|NCT02091856|101690686|FG000|NOT COMPLETED|Active Intervention Interval||19||
48554757|NCT02091856|101690687|FG001|NOT COMPLETED|Active Intervention Interval||7||
48554758|NCT02091856|101690688|FG002|NOT COMPLETED|Active Intervention Interval||7||
48554759|NCT02091856|101690686|FG000|STARTED|Follow-up Assessment||15||
48554760|NCT02091856|101690687|FG001|STARTED|Follow-up Assessment||12||
48554761|NCT02091856|101690688|FG002|STARTED|Follow-up Assessment||0||
48554762|NCT02091856|101690686|FG000|COMPLETED|Follow-up Assessment||10||
48554763|NCT02091856|101690687|FG001|COMPLETED|Follow-up Assessment||9||
48554764|NCT02091856|101690688|FG002|COMPLETED|Follow-up Assessment||0||
48554765|NCT02091856|101690686|FG000|NOT COMPLETED|Follow-up Assessment||5||
48554766|NCT02091856|101690687|FG001|NOT COMPLETED|Follow-up Assessment||3||
48554767|NCT02091856|101690688|FG002|NOT COMPLETED|Follow-up Assessment||0||
48554768|NCT00370552|101690689|FG000|STARTED|Overall Study||46||
48554769|NCT00370552|101690690|FG001|STARTED|Overall Study||45||
48554770|NCT00370552|101690691|FG002|STARTED|Overall Study||32||
48554771|NCT00370552|101690689|FG000|COMPLETED|Overall Study||0||
48554772|NCT00370552|101690690|FG001|COMPLETED|Overall Study||0||
48554773|NCT00370552|101690691|FG002|COMPLETED|Overall Study||0||
48554774|NCT00370552|101690689|FG000|NOT COMPLETED|Overall Study||46||
48554775|NCT00370552|101690690|FG001|NOT COMPLETED|Overall Study||45||
48554776|NCT00370552|101690691|FG002|NOT COMPLETED|Overall Study||32||
48554777|NCT00445432|101690692|FG000|STARTED|Through Week 52 of NCT00445432 (M06-837)||25||
48554778|NCT00445432|101690693|FG001|STARTED|Through Week 52 of NCT00445432 (M06-837)||25||
48554779|NCT00445432|101690694|FG002|STARTED|Through Week 52 of NCT00445432 (M06-837)||32||
48554780|NCT00445432|101690695|FG003|STARTED|Through Week 52 of NCT00445432 (M06-837)||0||
48554781|NCT00445432|101690692|FG000|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||10||
48554782|NCT00445432|101690693|FG001|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||2||
48554783|NCT00445432|101690694|FG002|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||21||
48554784|NCT00445432|101690695|FG003|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0||
48554785|NCT00445432|101690692|FG000|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||15||
48554786|NCT00445432|101690693|FG001|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||23||
48554787|NCT00445432|101690694|FG002|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||11||
48554788|NCT00445432|101690695|FG003|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0||
48554789|NCT00445432|101690692|FG000|STARTED|148 Weeks of Adalimumab Treatment||0||
48554790|NCT00445432|101690693|FG001|STARTED|148 Weeks of Adalimumab Treatment||0||
48554791|NCT00445432|101690694|FG002|STARTED|148 Weeks of Adalimumab Treatment||0||
48554792|NCT00445432|101690695|FG003|STARTED|148 Weeks of Adalimumab Treatment||79||
48554793|NCT00445432|101690692|FG000|COMPLETED|148 Weeks of Adalimumab Treatment||0||
48554794|NCT00445432|101690693|FG001|COMPLETED|148 Weeks of Adalimumab Treatment||0||
48554795|NCT00445432|101690694|FG002|COMPLETED|148 Weeks of Adalimumab Treatment||0||
48554796|NCT00445432|101690695|FG003|COMPLETED|148 Weeks of Adalimumab Treatment||35||
48554797|NCT00445432|101690692|FG000|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0||
48554798|NCT00445432|101690693|FG001|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0||
48554799|NCT00445432|101690694|FG002|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0||
48554800|NCT00445432|101690695|FG003|NOT COMPLETED|148 Weeks of Adalimumab Treatment||44||
48554801|NCT02094417|101690696|FG000|STARTED|Overall Study||7||
48554802|NCT02094417|101690697|FG001|STARTED|Overall Study||9||
48554803|NCT02094417|101690698|FG002|STARTED|Overall Study||9||
48554804|NCT02094417|101690699|FG003|STARTED|Overall Study||10||
48554805|NCT02094417|101690696|FG000|COMPLETED|Overall Study||2||
48554806|NCT02094417|101690697|FG001|COMPLETED|Overall Study||1||
48554807|NCT02094417|101690698|FG002|COMPLETED|Overall Study||4||
48554808|NCT02094417|101690699|FG003|COMPLETED|Overall Study||3||
48554809|NCT02094417|101690696|FG000|NOT COMPLETED|Overall Study||5||
48554810|NCT02094417|101690697|FG001|NOT COMPLETED|Overall Study||8||
48554811|NCT02094417|101690698|FG002|NOT COMPLETED|Overall Study||5||
48554812|NCT02094417|101690699|FG003|NOT COMPLETED|Overall Study||7||
48554813|NCT01610492|101690700|FG000|STARTED|Overall Study||14||
48554814|NCT01610492|101690700|FG000|COMPLETED|Overall Study||8||
48554815|NCT01610492|101690700|FG000|NOT COMPLETED|Overall Study||6||
48554816|NCT03772717|101690701|FG000|STARTED|Overall Study||2||
48554817|NCT03772717|101690701|FG000|COMPLETED|Overall Study||0||
48554818|NCT03772717|101690701|FG000|NOT COMPLETED|Overall Study||2||
48554819|NCT00344448|101690702|FG000|STARTED|Screening||6||
48554820|NCT00344448|101690703|FG001|STARTED|Screening||4||
48554821|NCT00344448|101690702|FG000|COMPLETED|Screening||6||
48554822|NCT00344448|101690703|FG001|COMPLETED|Screening||3||
48554823|NCT00344448|101690702|FG000|NOT COMPLETED|Screening||0||
48554824|NCT00344448|101690703|FG001|NOT COMPLETED|Screening||1||
48554825|NCT00344448|101690702|FG000|STARTED|Double Blind, Placebo Controlled||6||
48554826|NCT00344448|101690703|FG001|STARTED|Double Blind, Placebo Controlled||3||
48554827|NCT00344448|101690702|FG000|COMPLETED|Double Blind, Placebo Controlled||4||
48554828|NCT00344448|101690703|FG001|COMPLETED|Double Blind, Placebo Controlled||3||
48554829|NCT00344448|101690702|FG000|NOT COMPLETED|Double Blind, Placebo Controlled||2||
48554830|NCT00344448|101690703|FG001|NOT COMPLETED|Double Blind, Placebo Controlled||0||
48554831|NCT00344448|101690702|FG000|STARTED|Open Label||4||
48554832|NCT00344448|101690703|FG001|STARTED|Open Label||3||
48554833|NCT00344448|101690702|FG000|COMPLETED|Open Label||2||
48554834|NCT00344448|101690703|FG001|COMPLETED|Open Label||2||
48554835|NCT00344448|101690702|FG000|NOT COMPLETED|Open Label||2||
48554836|NCT00344448|101690703|FG001|NOT COMPLETED|Open Label||1||
48554837|NCT02439216|101690704|FG000|STARTED|PartA(7 Day Open-Label Treatment Period)||5||
48554838|NCT02439216|101690705|FG001|STARTED|PartA(7 Day Open-Label Treatment Period)||6||
48554839|NCT02439216|101690706|FG002|STARTED|PartA(7 Day Open-Label Treatment Period)||6||
48554840|NCT02439216|101690707|FG003|STARTED|PartA(7 Day Open-Label Treatment Period)||0||
48554841|NCT02439216|101690708|FG004|STARTED|PartA(7 Day Open-Label Treatment Period)||0||
48554842|NCT02439216|101690709|FG005|STARTED|PartA(7 Day Open-Label Treatment Period)||0||
48554843|NCT02439216|101690710|FG006|STARTED|PartA(7 Day Open-Label Treatment Period)||0||
48554844|NCT02439216|101690711|FG007|STARTED|PartA(7 Day Open-Label Treatment Period)||0||
48554845|NCT02439216|101690712|FG008|STARTED|PartA(7 Day Open-Label Treatment Period)||0||
48554846|NCT02439216|101690704|FG000|COMPLETED|PartA(7 Day Open-Label Treatment Period)||4||
48554847|NCT02439216|101690705|FG001|COMPLETED|PartA(7 Day Open-Label Treatment Period)||6||
48554848|NCT02439216|101690706|FG002|COMPLETED|PartA(7 Day Open-Label Treatment Period)||6||
48554849|NCT02439216|101690707|FG003|COMPLETED|PartA(7 Day Open-Label Treatment Period)||0||
48554850|NCT02439216|101690708|FG004|COMPLETED|PartA(7 Day Open-Label Treatment Period)||0||
48554851|NCT02439216|101690709|FG005|COMPLETED|PartA(7 Day Open-Label Treatment Period)||0||
48554852|NCT02439216|101690710|FG006|COMPLETED|PartA(7 Day Open-Label Treatment Period)||0||
48554853|NCT02439216|101690711|FG007|COMPLETED|PartA(7 Day Open-Label Treatment Period)||0||
48554854|NCT02439216|101690712|FG008|COMPLETED|PartA(7 Day Open-Label Treatment Period)||0||
48554855|NCT02439216|101690704|FG000|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||1||
48554856|NCT02439216|101690705|FG001|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||0||
48554857|NCT02439216|101690706|FG002|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||0||
48554858|NCT02439216|101690707|FG003|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||0||
48554859|NCT02439216|101690708|FG004|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||0||
48554860|NCT02439216|101690709|FG005|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||0||
48554861|NCT02439216|101690710|FG006|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||0||
48554862|NCT02439216|101690711|FG007|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||0||
48554863|NCT02439216|101690712|FG008|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||0||
48554864|NCT02439216|101690704|FG000|STARTED|Part B (12-week Double Blind)||0|It includes 16 Subjects who completed Part A and continued to Part B plus 15 New subjects who entered Part B|
48554865|NCT02439216|101690705|FG001|STARTED|Part B (12-week Double Blind)||0|It includes 16 Subjects who completed Part A and continued to Part B plus 15 New subjects who entered Part B|
48554866|NCT02439216|101690706|FG002|STARTED|Part B (12-week Double Blind)||0|It includes 16 Subjects who completed Part A and continued to Part B plus 15 New subjects who entered Part B|
48554867|NCT02439216|101690707|FG003|STARTED|Part B (12-week Double Blind)||10|It includes 16 Subjects who completed Part A and continued to Part B plus 15 New subjects who entered Part B|
48554868|NCT02439216|101690708|FG004|STARTED|Part B (12-week Double Blind)||10|It includes 16 Subjects who completed Part A and continued to Part B plus 15 New subjects who entered Part B|
48554869|NCT02439216|101690709|FG005|STARTED|Part B (12-week Double Blind)||5|It includes 16 Subjects who completed Part A and continued to Part B plus 15 New subjects who entered Part B|
48554870|NCT02439216|101690710|FG006|STARTED|Part B (12-week Double Blind)||6|It includes 16 Subjects who completed Part A and continued to Part B plus 15 New subjects who entered Part B|
48554871|NCT02439216|101690711|FG007|STARTED|Part B (12-week Double Blind)||0|It includes 16 Subjects who completed Part A and continued to Part B plus 15 New subjects who entered Part B|
48554872|NCT02439216|101690712|FG008|STARTED|Part B (12-week Double Blind)||0|It includes 16 Subjects who completed Part A and continued to Part B plus 15 New subjects who entered Part B|
48554873|NCT02439216|101690704|FG000|COMPLETED|Part B (12-week Double Blind)||0||
48554874|NCT02439216|101690705|FG001|COMPLETED|Part B (12-week Double Blind)||0||
48554875|NCT02439216|101690706|FG002|COMPLETED|Part B (12-week Double Blind)||0||
48554876|NCT02439216|101690707|FG003|COMPLETED|Part B (12-week Double Blind)||10||
48554877|NCT02439216|101690708|FG004|COMPLETED|Part B (12-week Double Blind)||10||
48554878|NCT02439216|101690709|FG005|COMPLETED|Part B (12-week Double Blind)||5||
48554879|NCT02439216|101690710|FG006|COMPLETED|Part B (12-week Double Blind)||6||
48554880|NCT02439216|101690711|FG007|COMPLETED|Part B (12-week Double Blind)||0||
48554881|NCT02439216|101690712|FG008|COMPLETED|Part B (12-week Double Blind)||0||
48554882|NCT02439216|101690704|FG000|NOT COMPLETED|Part B (12-week Double Blind)||0||
48554883|NCT02439216|101690705|FG001|NOT COMPLETED|Part B (12-week Double Blind)||0||
48554884|NCT02439216|101690706|FG002|NOT COMPLETED|Part B (12-week Double Blind)||0||
48554885|NCT02439216|101690707|FG003|NOT COMPLETED|Part B (12-week Double Blind)||0||
48554886|NCT02439216|101690708|FG004|NOT COMPLETED|Part B (12-week Double Blind)||0||
48554887|NCT02439216|101690709|FG005|NOT COMPLETED|Part B (12-week Double Blind)||0||
48554888|NCT02439216|101690710|FG006|NOT COMPLETED|Part B (12-week Double Blind)||0||
48554889|NCT02439216|101690711|FG007|NOT COMPLETED|Part B (12-week Double Blind)||0||
48554890|NCT02439216|101690712|FG008|NOT COMPLETED|Part B (12-week Double Blind)||0||
48554891|NCT02439216|101690704|FG000|STARTED|Part C (138-week, Open-label Treatment)||0|It has Subjects completed Part B|
48554892|NCT02439216|101690705|FG001|STARTED|Part C (138-week, Open-label Treatment)||0|It has Subjects completed Part B|
48554893|NCT02439216|101690706|FG002|STARTED|Part C (138-week, Open-label Treatment)||0|It has Subjects completed Part B|
48554894|NCT02439216|101690707|FG003|STARTED|Part C (138-week, Open-label Treatment)||0|It has Subjects completed Part B|
48554895|NCT02439216|101690708|FG004|STARTED|Part C (138-week, Open-label Treatment)||0|It has Subjects completed Part B|
48554896|NCT02439216|101690709|FG005|STARTED|Part C (138-week, Open-label Treatment)||0|It has Subjects completed Part B|
48693785|NCT03333928|102032848|FG000|STARTED|Dose-controlled Extension (Period 2)||22|Subjects randomized to active treatment remained on their Period 1 dose. Subjects who had been randomized to Placebo during Period 1 were randomized 1:1 to either HTD1801 500 mg BID or HTD1801 1000 mg BID.|
48693786|NCT03333928|102032849|FG001|STARTED|Dose-controlled Extension (Period 2)||29|Subjects randomized to active treatment remained on their Period 1 dose. Subjects who had been randomized to Placebo during Period 1 were randomized 1:1 to either HTD1801 500 mg BID or HTD1801 1000 mg BID.|
48693787|NCT03333928|102032850|FG002|STARTED|Dose-controlled Extension (Period 2)||0|Subjects randomized to active treatment remained on their Period 1 dose. Subjects who had been randomized to Placebo during Period 1 were randomized 1:1 to either HTD1801 500 mg BID or HTD1801 1000 mg BID.|
48693788|NCT03333928|102032848|FG000|COMPLETED|Dose-controlled Extension (Period 2)||19||
48693789|NCT03333928|102032849|FG001|COMPLETED|Dose-controlled Extension (Period 2)||28||
48693790|NCT03333928|102032850|FG002|COMPLETED|Dose-controlled Extension (Period 2)||0||
48693791|NCT03333928|102032848|FG000|NOT COMPLETED|Dose-controlled Extension (Period 2)||3||
48693792|NCT03333928|102032849|FG001|NOT COMPLETED|Dose-controlled Extension (Period 2)||1||
48554897|NCT02439216|101690710|FG006|STARTED|Part C (138-week, Open-label Treatment)||0|It has Subjects completed Part B|
48554898|NCT02439216|101690711|FG007|STARTED|Part C (138-week, Open-label Treatment)||15|It has Subjects completed Part B|
48554899|NCT02439216|101690712|FG008|STARTED|Part C (138-week, Open-label Treatment)||16|It has Subjects completed Part B|
48554900|NCT02439216|101690704|FG000|COMPLETED|Part C (138-week, Open-label Treatment)||0||
48554901|NCT02439216|101690705|FG001|COMPLETED|Part C (138-week, Open-label Treatment)||0||
48554902|NCT02439216|101690706|FG002|COMPLETED|Part C (138-week, Open-label Treatment)||0||
48554903|NCT02439216|101690707|FG003|COMPLETED|Part C (138-week, Open-label Treatment)||0||
48554904|NCT02439216|101690708|FG004|COMPLETED|Part C (138-week, Open-label Treatment)||0||
48554905|NCT02439216|101690709|FG005|COMPLETED|Part C (138-week, Open-label Treatment)||0||
48554906|NCT02439216|101690710|FG006|COMPLETED|Part C (138-week, Open-label Treatment)||0||
48554907|NCT02439216|101690711|FG007|COMPLETED|Part C (138-week, Open-label Treatment)||8||
48554908|NCT02439216|101690712|FG008|COMPLETED|Part C (138-week, Open-label Treatment)||5||
48554909|NCT02439216|101690704|FG000|NOT COMPLETED|Part C (138-week, Open-label Treatment)||0||
48554910|NCT02439216|101690705|FG001|NOT COMPLETED|Part C (138-week, Open-label Treatment)||0||
48554911|NCT02439216|101690706|FG002|NOT COMPLETED|Part C (138-week, Open-label Treatment)||0||
48554912|NCT02439216|101690707|FG003|NOT COMPLETED|Part C (138-week, Open-label Treatment)||0||
48554913|NCT02439216|101690708|FG004|NOT COMPLETED|Part C (138-week, Open-label Treatment)||0||
48554914|NCT02439216|101690709|FG005|NOT COMPLETED|Part C (138-week, Open-label Treatment)||0||
48554915|NCT02439216|101690710|FG006|NOT COMPLETED|Part C (138-week, Open-label Treatment)||0||
48554916|NCT02439216|101690711|FG007|NOT COMPLETED|Part C (138-week, Open-label Treatment)||7||
48554917|NCT02439216|101690712|FG008|NOT COMPLETED|Part C (138-week, Open-label Treatment)||11||
48554918|NCT02521415|101690713|FG000|STARTED|Overall Study||43||
48554919|NCT02521415|101690714|FG001|STARTED|Overall Study||44||
48554920|NCT02521415|101690713|FG000|COMPLETED|Overall Study||43||
48554921|NCT02521415|101690714|FG001|COMPLETED|Overall Study||44||
48554922|NCT02521415|101690713|FG000|NOT COMPLETED|Overall Study||0||
48554923|NCT02521415|101690714|FG001|NOT COMPLETED|Overall Study||0||
48554924|NCT05048329|101690715|FG000|STARTED|Overall Study||11||
48554925|NCT05048329|101690715|FG000|COMPLETED|Overall Study||9||
48554926|NCT05048329|101690715|FG000|NOT COMPLETED|Overall Study||2||
48554927|NCT00577863|101690716|FG000|STARTED|Overall Study||92||
48554928|NCT00577863|101690717|FG001|STARTED|Overall Study||108||
48554929|NCT00577863|101690716|FG000|Received at Least One Injection|Overall Study||92||
48554930|NCT00577863|101690717|FG001|Received at Least One Injection|Overall Study||107||
48554931|NCT00577863|101690716|FG000|COMPLETED|Overall Study||82||
48554932|NCT00577863|101690717|FG001|COMPLETED|Overall Study||94||
48554933|NCT00577863|101690716|FG000|NOT COMPLETED|Overall Study||10||
48554934|NCT00577863|101690717|FG001|NOT COMPLETED|Overall Study||14||
48554935|NCT02493660|101690718|FG000|STARTED|Overall Study||93||
48554936|NCT02493660|101690719|FG001|STARTED|Overall Study||91||
48554937|NCT02493660|101690718|FG000|COMPLETED|Overall Study||83||
48554938|NCT02493660|101690719|FG001|COMPLETED|Overall Study||79||
48554939|NCT02493660|101690718|FG000|NOT COMPLETED|Overall Study||10||
48554940|NCT02493660|101690719|FG001|NOT COMPLETED|Overall Study||12||
48554941|NCT02072980|101690720|FG000|STARTED|Period 1, First Wear||7||
48554942|NCT02072980|101690721|FG001|STARTED|Period 1, First Wear||8||
48554943|NCT02072980|101690720|FG000|COMPLETED|Period 1, First Wear||7||
48554944|NCT02072980|101690721|FG001|COMPLETED|Period 1, First Wear||8||
48554945|NCT02072980|101690720|FG000|NOT COMPLETED|Period 1, First Wear||0||
48554946|NCT02072980|101690721|FG001|NOT COMPLETED|Period 1, First Wear||0||
48554947|NCT02072980|101690720|FG000|STARTED|Period 2, Second Wear||7||
48693793|NCT03333928|102032850|FG002|NOT COMPLETED|Dose-controlled Extension (Period 2)||0||
48693794|NCT03333928|102032848|FG000|STARTED|Randomized Withdrawal (Period 3)||10|Active subjects from Period 2 were re-randomized in Period 3 to receive either Placebo, HTD1801 500 mg BID or HTD 1000 mg BID.|
48693795|NCT03333928|102032849|FG001|STARTED|Randomized Withdrawal (Period 3)||14|Active subjects from Period 2 were re-randomized in Period 3 to receive either Placebo, HTD1801 500 mg BID or HTD 1000 mg BID.|
48693796|NCT03333928|102032850|FG002|STARTED|Randomized Withdrawal (Period 3)||26|Active subjects from Period 2 were re-randomized in Period 3 to receive either Placebo, HTD1801 500 mg BID or HTD 1000 mg BID.|
48554948|NCT02072980|101690721|FG001|STARTED|Period 2, Second Wear||8||
48554949|NCT02072980|101690720|FG000|COMPLETED|Period 2, Second Wear||7||
48554950|NCT02072980|101690721|FG001|COMPLETED|Period 2, Second Wear||7||
48554951|NCT02072980|101690720|FG000|NOT COMPLETED|Period 2, Second Wear||0||
48554952|NCT02072980|101690721|FG001|NOT COMPLETED|Period 2, Second Wear||1||
48554953|NCT01392963|101690722|FG000|STARTED|Week 0 (First Intervention)||11||
48693797|NCT03333928|102032848|FG000|COMPLETED|Randomized Withdrawal (Period 3)||8||
48693798|NCT03333928|102032849|FG001|COMPLETED|Randomized Withdrawal (Period 3)||14||
48554954|NCT01392963|101690723|FG001|STARTED|Week 0 (First Intervention)||19||
48554955|NCT01392963|101690722|FG000|COMPLETED|Week 0 (First Intervention)||11||
48554956|NCT01392963|101690723|FG001|COMPLETED|Week 0 (First Intervention)||17||
48554957|NCT01392963|101690722|FG000|NOT COMPLETED|Week 0 (First Intervention)||0||
48554958|NCT01392963|101690723|FG001|NOT COMPLETED|Week 0 (First Intervention)||2||
48554959|NCT01392963|101690722|FG000|STARTED|Week 12 (Second Intervention)||11||
48554960|NCT01392963|101690723|FG001|STARTED|Week 12 (Second Intervention)||17||
48554961|NCT01392963|101690722|FG000|COMPLETED|Week 12 (Second Intervention)||11||
48554962|NCT01392963|101690723|FG001|COMPLETED|Week 12 (Second Intervention)||17||
48554963|NCT01392963|101690722|FG000|NOT COMPLETED|Week 12 (Second Intervention)||0||
48554964|NCT01392963|101690723|FG001|NOT COMPLETED|Week 12 (Second Intervention)||0||
48554965|NCT01392963|101690722|FG000|STARTED|Week 24 Follow-up||11||
48554966|NCT01392963|101690723|FG001|STARTED|Week 24 Follow-up||17||
48554967|NCT01392963|101690722|FG000|COMPLETED|Week 24 Follow-up||9||
48554968|NCT01392963|101690723|FG001|COMPLETED|Week 24 Follow-up||17||
48554969|NCT01392963|101690722|FG000|NOT COMPLETED|Week 24 Follow-up||2||
48554970|NCT01392963|101690723|FG001|NOT COMPLETED|Week 24 Follow-up||0||
48554971|NCT03633825|101690724|FG000|STARTED|Enrollment||19838|Randomized and assessed for eligibility.|
48554972|NCT03633825|101690725|FG001|STARTED|Enrollment||19612|Randomized and assessed for eligibility.|
48554973|NCT03633825|101690724|FG000|COMPLETED|Enrollment||805||
48554974|NCT03633825|101690725|FG001|COMPLETED|Enrollment||775||
48554975|NCT03633825|101690724|FG000|NOT COMPLETED|Enrollment||19033||
48554976|NCT03633825|101690725|FG001|NOT COMPLETED|Enrollment||18837||
48554977|NCT03633825|101690724|FG000|STARTED|Allocation||805|Allocated and received intervention.|
48554978|NCT03633825|101690725|FG001|STARTED|Allocation||775|Allocated and received intervention.|
48554979|NCT03633825|101690724|FG000|COMPLETED|Allocation||805||
48554980|NCT03633825|101690725|FG001|COMPLETED|Allocation||775||
48554981|NCT03633825|101690724|FG000|NOT COMPLETED|Allocation||0||
48554982|NCT03633825|101690725|FG001|NOT COMPLETED|Allocation||0||
48554983|NCT03633825|101690724|FG000|STARTED|Follow up||805||
48554984|NCT03633825|101690725|FG001|STARTED|Follow up||775||
48554985|NCT03633825|101690724|FG000|COMPLETED|Follow up||327||
48554986|NCT03633825|101690725|FG001|COMPLETED|Follow up||325||
48554987|NCT03633825|101690724|FG000|NOT COMPLETED|Follow up||478||
48554988|NCT03633825|101690725|FG001|NOT COMPLETED|Follow up||450||
48554989|NCT03633825|101690724|FG000|STARTED|Analysis||327||
48554990|NCT03633825|101690725|FG001|STARTED|Analysis||325||
48554991|NCT03633825|101690724|FG000|COMPLETED|Analysis||327||
48554992|NCT03633825|101690725|FG001|COMPLETED|Analysis||325||
48554993|NCT03633825|101690724|FG000|NOT COMPLETED|Analysis||0||
48554994|NCT03633825|101690725|FG001|NOT COMPLETED|Analysis||0||
48554995|NCT02135614|101690726|FG000|STARTED|Overall Study||94||
48554996|NCT02135614|101690727|FG001|STARTED|Overall Study||95||
48554997|NCT02135614|101690726|FG000|COMPLETED|Overall Study||86||
48554998|NCT02135614|101690727|FG001|COMPLETED|Overall Study||90||
48554999|NCT02135614|101690726|FG000|NOT COMPLETED|Overall Study||8||
48555000|NCT02135614|101690727|FG001|NOT COMPLETED|Overall Study||5||
48555001|NCT00799058|101690728|FG000|STARTED|Overall Study||43||
48555002|NCT00799058|101690729|FG001|STARTED|Overall Study||43||
48555003|NCT00799058|101690730|FG002|STARTED|Overall Study||42||
48555004|NCT00799058|101690728|FG000|COMPLETED|Overall Study||33||
48555005|NCT00799058|101690729|FG001|COMPLETED|Overall Study||34||
48555006|NCT00799058|101690730|FG002|COMPLETED|Overall Study||36||
48555007|NCT00799058|101690728|FG000|NOT COMPLETED|Overall Study||10||
48555008|NCT00799058|101690729|FG001|NOT COMPLETED|Overall Study||9||
48555009|NCT00799058|101690730|FG002|NOT COMPLETED|Overall Study||6||
48109728|NCT00489853|100594567|FG002|NOT COMPLETED|Wash-out Period 1||6||
48109729|NCT00489853|100594565|FG000|STARTED|Treatment Period 2||33||
48109730|NCT00489853|100594566|FG001|STARTED|Treatment Period 2||35||
48109731|NCT00489853|100594567|FG002|STARTED|Treatment Period 2||33||
48109732|NCT00489853|100594565|FG000|COMPLETED|Treatment Period 2||33||
48109733|NCT00489853|100594566|FG001|COMPLETED|Treatment Period 2||35||
48109734|NCT00489853|100594567|FG002|COMPLETED|Treatment Period 2||33||
48109735|NCT00489853|100594565|FG000|NOT COMPLETED|Treatment Period 2||0||
48109736|NCT00489853|100594566|FG001|NOT COMPLETED|Treatment Period 2||0||
48555010|NCT03594071|101690731|FG000|STARTED|Overall Study||294||309
48555011|NCT03594071|101690731|FG000|COMPLETED|Overall Study||289||304
48555012|NCT03594071|101690731|FG000|NOT COMPLETED|Overall Study||5||5
48555013|NCT00974922|101690732|FG000|STARTED|Overall Study||40|Group assignment was never unblinded due to discontinuation of study; randomization info unavailable|
48109737|NCT00489853|100594567|FG002|NOT COMPLETED|Treatment Period 2||0||
48109738|NCT00489853|100594565|FG000|STARTED|Wash-out Period 2||33||
48109739|NCT00489853|100594566|FG001|STARTED|Wash-out Period 2||35||
48109740|NCT00489853|100594567|FG002|STARTED|Wash-out Period 2||33||
48109741|NCT00489853|100594565|FG000|COMPLETED|Wash-out Period 2||29||
48109742|NCT00489853|100594566|FG001|COMPLETED|Wash-out Period 2||32||
48109743|NCT00489853|100594567|FG002|COMPLETED|Wash-out Period 2||31||
48109744|NCT00489853|100594565|FG000|NOT COMPLETED|Wash-out Period 2||4||
48109745|NCT00489853|100594566|FG001|NOT COMPLETED|Wash-out Period 2||3||
48555014|NCT00974922|101690732|FG000|COMPLETED|Overall Study||16||
48555015|NCT00974922|101690732|FG000|NOT COMPLETED|Overall Study||24||
48555016|NCT02235454|101690733|FG000|STARTED|Overall Study||57||
48555017|NCT02235454|101690733|FG000|COMPLETED|Overall Study||55||
48693799|NCT03333928|102032850|FG002|COMPLETED|Randomized Withdrawal (Period 3)||25||
48693800|NCT03333928|102032848|FG000|NOT COMPLETED|Randomized Withdrawal (Period 3)||2||
48109746|NCT00489853|100594567|FG002|NOT COMPLETED|Wash-out Period 2||2||
48109747|NCT00489853|100594565|FG000|STARTED|Treatment Period 3||29||
48109748|NCT00489853|100594566|FG001|STARTED|Treatment Period 3||30||
48109749|NCT00489853|100594567|FG002|STARTED|Treatment Period 3||33||
48109750|NCT00489853|100594565|FG000|COMPLETED|Treatment Period 3||29||
48555018|NCT02235454|101690733|FG000|NOT COMPLETED|Overall Study||2||
48555019|NCT01147068|101690734|FG000|STARTED|Subjects That Received 1st Dose||60||
48555020|NCT01147068|101690735|FG001|STARTED|Subjects That Received 1st Dose||57||
48555021|NCT01147068|101690736|FG002|STARTED|Subjects That Received 1st Dose||55||
48555022|NCT01147068|101690737|FG003|STARTED|Subjects That Received 1st Dose||56||
48555023|NCT01147068|101690738|FG004|STARTED|Subjects That Received 1st Dose||56||
48555024|NCT01147068|101690739|FG005|STARTED|Subjects That Received 1st Dose||53||
48555025|NCT01147068|101690740|FG006|STARTED|Subjects That Received 1st Dose||55||
48109751|NCT00489853|100594566|FG001|COMPLETED|Treatment Period 3||29||
48109752|NCT00489853|100594567|FG002|COMPLETED|Treatment Period 3||33||
48109753|NCT00489853|100594565|FG000|NOT COMPLETED|Treatment Period 3||0||
48109754|NCT00489853|100594566|FG001|NOT COMPLETED|Treatment Period 3||1||
48109755|NCT00489853|100594567|FG002|NOT COMPLETED|Treatment Period 3||0||
48109756|NCT00489853|100594565|FG000|STARTED|Follow-up Period||29||
48109757|NCT00489853|100594566|FG001|STARTED|Follow-up Period||29||
48109758|NCT00489853|100594567|FG002|STARTED|Follow-up Period||33||
48109759|NCT00489853|100594565|FG000|COMPLETED|Follow-up Period||29||
48109760|NCT00489853|100594566|FG001|COMPLETED|Follow-up Period||29||
48109761|NCT00489853|100594567|FG002|COMPLETED|Follow-up Period||33||
48109762|NCT00489853|100594565|FG000|NOT COMPLETED|Follow-up Period||0||
48109763|NCT00489853|100594566|FG001|NOT COMPLETED|Follow-up Period||0||
48109764|NCT00489853|100594567|FG002|NOT COMPLETED|Follow-up Period||0||
48109765|NCT01070316|100594568|FG000|STARTED|Main Phase||20||
48109766|NCT01070316|100594568|FG000|COMPLETED|Main Phase||20||
48109767|NCT01070316|100594568|FG000|NOT COMPLETED|Main Phase||0||
48109768|NCT01070316|100594568|FG000|STARTED|Extension Phase||18||
48109769|NCT01070316|100594568|FG000|COMPLETED|Extension Phase||14||
48109770|NCT01070316|100594568|FG000|NOT COMPLETED|Extension Phase||4||
48109771|NCT01418209|100594569|FG000|STARTED|Overall Study||97||
48555026|NCT01147068|101690734|FG000|COMPLETED|Subjects That Received 1st Dose||60||
48555027|NCT01147068|101690735|FG001|COMPLETED|Subjects That Received 1st Dose||57||
48555028|NCT01147068|101690736|FG002|COMPLETED|Subjects That Received 1st Dose||55||
48555029|NCT01147068|101690737|FG003|COMPLETED|Subjects That Received 1st Dose||56||
48555030|NCT01147068|101690738|FG004|COMPLETED|Subjects That Received 1st Dose||56||
48555031|NCT01147068|101690739|FG005|COMPLETED|Subjects That Received 1st Dose||53||
48555032|NCT01147068|101690740|FG006|COMPLETED|Subjects That Received 1st Dose||55||
48555033|NCT01147068|101690734|FG000|NOT COMPLETED|Subjects That Received 1st Dose||0||
48555034|NCT01147068|101690735|FG001|NOT COMPLETED|Subjects That Received 1st Dose||0||
48555035|NCT01147068|101690736|FG002|NOT COMPLETED|Subjects That Received 1st Dose||0||
48555036|NCT01147068|101690737|FG003|NOT COMPLETED|Subjects That Received 1st Dose||0||
48555037|NCT01147068|101690738|FG004|NOT COMPLETED|Subjects That Received 1st Dose||0||
48555038|NCT01147068|101690739|FG005|NOT COMPLETED|Subjects That Received 1st Dose||0||
48555039|NCT01147068|101690740|FG006|NOT COMPLETED|Subjects That Received 1st Dose||0||
48555040|NCT01147068|101690734|FG000|STARTED|Subjects That Received 2nd Dose||60||
48555041|NCT01147068|101690735|FG001|STARTED|Subjects That Received 2nd Dose||57||
48555042|NCT01147068|101690736|FG002|STARTED|Subjects That Received 2nd Dose||55||
48555043|NCT01147068|101690737|FG003|STARTED|Subjects That Received 2nd Dose||56||
48693801|NCT03333928|102032849|FG001|NOT COMPLETED|Randomized Withdrawal (Period 3)||0||
48693802|NCT03333928|102032850|FG002|NOT COMPLETED|Randomized Withdrawal (Period 3)||1||
48109772|NCT01418209|100594570|FG001|STARTED|Overall Study||96||
48109773|NCT01418209|100594571|FG002|STARTED|Overall Study||146||
48109774|NCT01418209|100594569|FG000|COMPLETED|Overall Study||95||
48109775|NCT01418209|100594570|FG001|COMPLETED|Overall Study||93||
48555044|NCT01147068|101690738|FG004|STARTED|Subjects That Received 2nd Dose||56||
48693803|NCT01891396|102032851|FG000|STARTED|Overall Study||149||
48693804|NCT01891396|102032852|FG001|STARTED|Overall Study||150||
48555045|NCT01147068|101690739|FG005|STARTED|Subjects That Received 2nd Dose||53||
48693805|NCT01891396|102032853|FG002|STARTED|Overall Study||69||
48693806|NCT01891396|102032851|FG000|Received Study Injection|Overall Study||149||
48693807|NCT01891396|102032852|FG001|Received Study Injection|Overall Study||150||
48109776|NCT01418209|100594571|FG002|COMPLETED|Overall Study||142||
48109777|NCT01418209|100594569|FG000|NOT COMPLETED|Overall Study||2||
48109778|NCT01418209|100594570|FG001|NOT COMPLETED|Overall Study||3||
48109779|NCT01418209|100594571|FG002|NOT COMPLETED|Overall Study||4||
48555046|NCT01147068|101690740|FG006|STARTED|Subjects That Received 2nd Dose||55||
48555047|NCT01147068|101690734|FG000|COMPLETED|Subjects That Received 2nd Dose||59||
48555048|NCT01147068|101690735|FG001|COMPLETED|Subjects That Received 2nd Dose||52||
48555049|NCT01147068|101690736|FG002|COMPLETED|Subjects That Received 2nd Dose||52||
48555050|NCT01147068|101690737|FG003|COMPLETED|Subjects That Received 2nd Dose||56||
48555051|NCT01147068|101690738|FG004|COMPLETED|Subjects That Received 2nd Dose||55||
48555052|NCT01147068|101690739|FG005|COMPLETED|Subjects That Received 2nd Dose||51||
48555053|NCT01147068|101690740|FG006|COMPLETED|Subjects That Received 2nd Dose||55||
48555054|NCT01147068|101690734|FG000|NOT COMPLETED|Subjects That Received 2nd Dose||1||
48555055|NCT01147068|101690735|FG001|NOT COMPLETED|Subjects That Received 2nd Dose||5||
48555056|NCT01147068|101690736|FG002|NOT COMPLETED|Subjects That Received 2nd Dose||3||
48555057|NCT01147068|101690737|FG003|NOT COMPLETED|Subjects That Received 2nd Dose||0||
48555058|NCT01147068|101690738|FG004|NOT COMPLETED|Subjects That Received 2nd Dose||1||
48555059|NCT01147068|101690739|FG005|NOT COMPLETED|Subjects That Received 2nd Dose||2||
48555060|NCT01147068|101690740|FG006|NOT COMPLETED|Subjects That Received 2nd Dose||0||
48555061|NCT01147068|101690734|FG000|STARTED|Subjects That Completed Safety Follow-up||60||
48555062|NCT01147068|101690735|FG001|STARTED|Subjects That Completed Safety Follow-up||57||
48555063|NCT01147068|101690736|FG002|STARTED|Subjects That Completed Safety Follow-up||55||
48555064|NCT01147068|101690737|FG003|STARTED|Subjects That Completed Safety Follow-up||56||
48555065|NCT01147068|101690738|FG004|STARTED|Subjects That Completed Safety Follow-up||56||
48555066|NCT01147068|101690739|FG005|STARTED|Subjects That Completed Safety Follow-up||53||
48555067|NCT01147068|101690740|FG006|STARTED|Subjects That Completed Safety Follow-up||55||
48555068|NCT01147068|101690734|FG000|COMPLETED|Subjects That Completed Safety Follow-up||59||
48555069|NCT01147068|101690735|FG001|COMPLETED|Subjects That Completed Safety Follow-up||56||
48555070|NCT01147068|101690736|FG002|COMPLETED|Subjects That Completed Safety Follow-up||55||
48555071|NCT01147068|101690737|FG003|COMPLETED|Subjects That Completed Safety Follow-up||54||
48555072|NCT01147068|101690738|FG004|COMPLETED|Subjects That Completed Safety Follow-up||56||
48555073|NCT01147068|101690739|FG005|COMPLETED|Subjects That Completed Safety Follow-up||52||
48555074|NCT01147068|101690740|FG006|COMPLETED|Subjects That Completed Safety Follow-up||54||
48555075|NCT01147068|101690734|FG000|NOT COMPLETED|Subjects That Completed Safety Follow-up||1||
48555076|NCT01147068|101690735|FG001|NOT COMPLETED|Subjects That Completed Safety Follow-up||1||
48555077|NCT01147068|101690736|FG002|NOT COMPLETED|Subjects That Completed Safety Follow-up||0||
48693808|NCT01891396|102032853|FG002|Received Study Injection|Overall Study||69||
48693809|NCT01891396|102032851|FG000|COMPLETED|Overall Study||145||
48693810|NCT01891396|102032852|FG001|COMPLETED|Overall Study||145||
48272150|NCT00874731|100988566|FG001|STARTED|Part 2: Ridaforolimus 40 mg||0||
48272151|NCT00874731|100988567|FG002|STARTED|Part 2: Ridaforolimus 40 mg||22||
48555078|NCT01147068|101690737|FG003|NOT COMPLETED|Subjects That Completed Safety Follow-up||2||
48555079|NCT01147068|101690738|FG004|NOT COMPLETED|Subjects That Completed Safety Follow-up||0||
48555080|NCT01147068|101690739|FG005|NOT COMPLETED|Subjects That Completed Safety Follow-up||1||
48693811|NCT01891396|102032853|FG002|COMPLETED|Overall Study||66||
48693812|NCT01891396|102032851|FG000|NOT COMPLETED|Overall Study||4||
48693813|NCT01891396|102032852|FG001|NOT COMPLETED|Overall Study||5||
48693814|NCT01891396|102032853|FG002|NOT COMPLETED|Overall Study||3||
48693815|NCT00830375|102032854|FG000|STARTED|Overall Study||10||
48272152|NCT00874731|100988565|FG000|COMPLETED|Part 2: Ridaforolimus 40 mg||0||
48272153|NCT00874731|100988566|FG001|COMPLETED|Part 2: Ridaforolimus 40 mg||0||
48272154|NCT00874731|100988567|FG002|COMPLETED|Part 2: Ridaforolimus 40 mg||0||
48555081|NCT01147068|101690740|FG006|NOT COMPLETED|Subjects That Completed Safety Follow-up||1||
48555082|NCT02738138|101690741|FG000|STARTED|Overall Study||137||
48555083|NCT02738138|101690742|FG001|STARTED|Overall Study||16||
48555084|NCT02738138|101690741|FG000|COMPLETED|Overall Study||134||
48555085|NCT02738138|101690742|FG001|COMPLETED|Overall Study||15||
48555086|NCT02738138|101690741|FG000|NOT COMPLETED|Overall Study||3||
48555087|NCT02738138|101690742|FG001|NOT COMPLETED|Overall Study||1||
48555088|NCT03333941|101690743|FG000|STARTED|Overall Study||76||
48555089|NCT03333941|101690743|FG000|COMPLETED|Overall Study||63||
48555090|NCT03333941|101690743|FG000|NOT COMPLETED|Overall Study||13||
48555091|NCT01742897|101690744|FG000|STARTED|Overall Study||35||
48555092|NCT01742897|101690744|FG000|Treated|Overall Study||33||
48555093|NCT01742897|101690744|FG000|COMPLETED|Overall Study||30||
48555094|NCT01742897|101690744|FG000|NOT COMPLETED|Overall Study||5||
48555095|NCT01256879|101690745|FG000|STARTED|Overall Study||25||
48555096|NCT01256879|101690745|FG000|CimTest-A|Overall Study||25||
48555097|NCT01256879|101690745|FG000|CimTest-B|Overall Study||24||
48555098|NCT01256879|101690745|FG000|Sorbitol-free Cimetidine Solution|Overall Study||24||
48555099|NCT01256879|101690745|FG000|Commercial Cimetidine Solution|Overall Study||24||
48555100|NCT01256879|101690745|FG000|COMPLETED|Overall Study||24||
48555101|NCT01256879|101690745|FG000|NOT COMPLETED|Overall Study||1||
48555102|NCT03284723|101690746|FG000|STARTED|Overall Study||2||
48555103|NCT03284723|101690747|FG001|STARTED|Overall Study||2||
48555104|NCT03284723|101690748|FG002|STARTED|Overall Study||2||
48693816|NCT00830375|102032854|FG000|COMPLETED|Overall Study||9||
48693817|NCT00830375|102032854|FG000|NOT COMPLETED|Overall Study||1||
48555105|NCT03284723|101690749|FG003|STARTED|Overall Study||4||
48555106|NCT03284723|101690750|FG004|STARTED|Overall Study||16||
48272155|NCT00874731|100988565|FG000|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||0||
48272156|NCT00874731|100988566|FG001|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||0||
48272157|NCT00874731|100988567|FG002|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||22||
48272158|NCT02138786|100988568|FG000|STARTED|Overall Study||3||
48272159|NCT02138786|100988569|FG001|STARTED|Overall Study||15||
48272160|NCT02138786|100988570|FG002|STARTED|Overall Study||8||
48272161|NCT02138786|100988568|FG000|COMPLETED|Overall Study||0||
48272162|NCT02138786|100988569|FG001|COMPLETED|Overall Study||0||
48272163|NCT02138786|100988570|FG002|COMPLETED|Overall Study||0||
48272164|NCT02138786|100988568|FG000|NOT COMPLETED|Overall Study||3||
48272165|NCT02138786|100988569|FG001|NOT COMPLETED|Overall Study||15||
48272166|NCT02138786|100988570|FG002|NOT COMPLETED|Overall Study||8||
48272167|NCT04531904|100988571|FG000|STARTED|Overall Study||102|Enrolled, attempted and had EmboVAC procedure performed.|
48272168|NCT04531904|100988571|FG000|Attempted EmboVac Procedure But Not Performed|Overall Study||2||
48272169|NCT04531904|100988571|FG000|COMPLETED|Overall Study||87||
48272170|NCT04531904|100988571|FG000|NOT COMPLETED|Overall Study||15||
48272171|NCT00636805|100988572|FG000|STARTED|Overall Study||63||
48272172|NCT00636805|100988572|FG000|COMPLETED|Overall Study||63||
48272173|NCT00636805|100988572|FG000|NOT COMPLETED|Overall Study||0||
48272174|NCT02224404|100988573|FG000|STARTED|Overall Study||21||
48272175|NCT02224404|100988573|FG000|COMPLETED|Overall Study||21||
48272176|NCT02224404|100988573|FG000|NOT COMPLETED|Overall Study||0||
48272177|NCT01609062|100988574|FG000|STARTED|Primary Phase||15||
48272178|NCT01609062|100988575|FG001|STARTED|Primary Phase||10||
48272179|NCT01609062|100988574|FG000|COMPLETED|Primary Phase||15||
48272180|NCT01609062|100988575|FG001|COMPLETED|Primary Phase||10||
48272181|NCT01609062|100988574|FG000|NOT COMPLETED|Primary Phase||0||
48272182|NCT01609062|100988575|FG001|NOT COMPLETED|Primary Phase||0||
48272183|NCT01609062|100988574|FG000|STARTED|Extension Phase||15||
48272184|NCT01609062|100988575|FG001|STARTED|Extension Phase||10||
48272185|NCT01609062|100988574|FG000|COMPLETED|Extension Phase||0||
48272186|NCT01609062|100988575|FG001|COMPLETED|Extension Phase||0||
48272187|NCT01609062|100988574|FG000|NOT COMPLETED|Extension Phase||15||
48272188|NCT01609062|100988575|FG001|NOT COMPLETED|Extension Phase||10||
48272189|NCT03738475|100988576|FG000|STARTED|Overall Study||16||
48272190|NCT03738475|100988577|FG001|STARTED|Overall Study||18||
48272191|NCT03738475|100988576|FG000|COMPLETED|Overall Study||15||
48272192|NCT03738475|100988577|FG001|COMPLETED|Overall Study||18||
48272193|NCT03738475|100988576|FG000|NOT COMPLETED|Overall Study||1||
48272194|NCT03738475|100988577|FG001|NOT COMPLETED|Overall Study||0||
48272195|NCT03599687|100988578|FG000|STARTED|Overall Study||82||
48272196|NCT03599687|100988579|FG001|STARTED|Overall Study||82||
48272197|NCT03599687|100988578|FG000|COMPLETED|Overall Study||82||
48272198|NCT03599687|100988579|FG001|COMPLETED|Overall Study||82||
48272199|NCT03599687|100988578|FG000|NOT COMPLETED|Overall Study||0||
48272200|NCT03599687|100988579|FG001|NOT COMPLETED|Overall Study||0||
48272201|NCT00387426|100988580|FG000|STARTED|Overall Study||14||
48272202|NCT00387426|100988580|FG000|COMPLETED|Overall Study||0||
48272203|NCT00387426|100988580|FG000|NOT COMPLETED|Overall Study||14||
48555107|NCT03284723|101690751|FG005|STARTED|Overall Study||15||
48555108|NCT03284723|101690752|FG006|STARTED|Overall Study||6||
48555109|NCT03284723|101690753|FG007|STARTED|Overall Study||5||
48555110|NCT03284723|101690754|FG008|STARTED|Overall Study||14||
48555111|NCT03284723|101690755|FG009|STARTED|Overall Study||12||
48555112|NCT03284723|101690756|FG010|STARTED|Overall Study||15||
48555113|NCT03284723|101690757|FG011|STARTED|Overall Study||2||
48555114|NCT03284723|101690746|FG000|Received Treatment|Overall Study||2||
48555115|NCT03284723|101690747|FG001|Received Treatment|Overall Study||2||
48555116|NCT03284723|101690748|FG002|Received Treatment|Overall Study||2||
48555117|NCT03284723|101690749|FG003|Received Treatment|Overall Study||4||
48555118|NCT03284723|101690750|FG004|Received Treatment|Overall Study||16||
48555119|NCT03284723|101690751|FG005|Received Treatment|Overall Study||15||
48555120|NCT03284723|101690752|FG006|Received Treatment|Overall Study||6||
48555121|NCT03284723|101690753|FG007|Received Treatment|Overall Study||5||
48555122|NCT03284723|101690754|FG008|Received Treatment|Overall Study||14||
48555123|NCT03284723|101690755|FG009|Received Treatment|Overall Study||12||
48555124|NCT03284723|101690756|FG010|Received Treatment|Overall Study||15||
48555125|NCT03284723|101690757|FG011|Received Treatment|Overall Study||2||
48555126|NCT03284723|101690746|FG000|COMPLETED|Overall Study||1||
48272204|NCT01585155|100988581|FG000|STARTED|Overall Study||21||
48272205|NCT01585155|100988581|FG000|COMPLETED|Overall Study||16||
48272206|NCT01585155|100988581|FG000|NOT COMPLETED|Overall Study||5||
48272207|NCT04087811|100988582|FG000|STARTED|Overall Study||1674||
48272208|NCT04087811|100988582|FG000|COMPLETED|Overall Study||1594||
48272209|NCT04087811|100988582|FG000|NOT COMPLETED|Overall Study||80||
48272210|NCT00941070|100988583|FG000|STARTED|Overall Study||26||
48272211|NCT00941070|100988583|FG000|COMPLETED|Overall Study||25||
48272212|NCT00941070|100988583|FG000|NOT COMPLETED|Overall Study||1||
48555127|NCT03284723|101690747|FG001|COMPLETED|Overall Study||2||
48555128|NCT03284723|101690748|FG002|COMPLETED|Overall Study||1||
48272213|NCT01681277|100988584|FG000|STARTED|Overall Study||12||
48272214|NCT01681277|100988585|FG001|STARTED|Overall Study||9||
48272215|NCT01681277|100988586|FG002|STARTED|Overall Study||9||
48272216|NCT01681277|100988587|FG003|STARTED|Overall Study||9||
48392615|NCT02999100|101291392|FG004|COMPLETED|Part 2 (Day 1): Dosing Session 1||3||
48392616|NCT02999100|101291393|FG005|COMPLETED|Part 2 (Day 1): Dosing Session 1||2||
48392617|NCT02999100|101291388|FG000|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0||
48392618|NCT02999100|101291389|FG001|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0||
48392619|NCT02999100|101291390|FG002|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||1||
48392620|NCT02999100|101291391|FG003|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0||
48392621|NCT02999100|101291392|FG004|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0||
48392622|NCT02999100|101291393|FG005|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||1||
48693818|NCT02368093|102032855|FG000|STARTED|Overall Study||24||
48693819|NCT02368093|102032856|FG001|STARTED|Overall Study||24||
48693820|NCT02368093|102032855|FG000|COMPLETED|Overall Study||24||
48693821|NCT02368093|102032856|FG001|COMPLETED|Overall Study||24||
48693822|NCT02368093|102032855|FG000|NOT COMPLETED|Overall Study||0||
48693823|NCT02368093|102032856|FG001|NOT COMPLETED|Overall Study||0||
48109780|NCT02752191|100594572|FG000|STARTED|Overall Study||14||
48109781|NCT02752191|100594573|FG001|STARTED|Overall Study||3||
48109782|NCT02752191|100594572|FG000|COMPLETED|Overall Study||14||
48109783|NCT02752191|100594573|FG001|COMPLETED|Overall Study||3||
48109784|NCT02752191|100594572|FG000|NOT COMPLETED|Overall Study||0||
48109785|NCT02752191|100594573|FG001|NOT COMPLETED|Overall Study||0||
48109786|NCT04211337|100594574|FG000|STARTED|Overall Study||193||
48109787|NCT04211337|100594575|FG001|STARTED|Overall Study||98||
48109788|NCT04211337|100594574|FG000|Received at Least One Dose of Study Drug|Overall Study||193||
48109789|NCT04211337|100594575|FG001|Received at Least One Dose of Study Drug|Overall Study||97||
48109790|NCT04211337|100594574|FG000|COMPLETED|Overall Study||18||
48109791|NCT04211337|100594575|FG001|COMPLETED|Overall Study||56||
48109792|NCT04211337|100594574|FG000|NOT COMPLETED|Overall Study||175||
48109793|NCT04211337|100594575|FG001|NOT COMPLETED|Overall Study||42||
48109794|NCT02821962|100594576|FG000|STARTED|Overall Study||19||
48109795|NCT02821962|100594577|FG001|STARTED|Overall Study||21||
48109796|NCT02821962|100594576|FG000|COMPLETED|Overall Study||17||
48109797|NCT02821962|100594577|FG001|COMPLETED|Overall Study||21||
48109798|NCT02821962|100594576|FG000|NOT COMPLETED|Overall Study||2||
48109799|NCT02821962|100594577|FG001|NOT COMPLETED|Overall Study||0||
48109800|NCT02082210|100594578|FG000|STARTED|Overall Study||3||
48109801|NCT02082210|100594579|FG001|STARTED|Overall Study||3||
48109802|NCT02082210|100594580|FG002|STARTED|Overall Study||16||
48109803|NCT02082210|100594581|FG003|STARTED|Overall Study||45||
48109804|NCT02082210|100594582|FG004|STARTED|Overall Study||15||
48109805|NCT02082210|100594583|FG005|STARTED|Overall Study||15||
48109806|NCT02082210|100594578|FG000|Received at Least One Dose of Study Drug|Overall Study||3||
48109807|NCT02082210|100594579|FG001|Received at Least One Dose of Study Drug|Overall Study||3||
48109808|NCT02082210|100594580|FG002|Received at Least One Dose of Study Drug|Overall Study||16||
48109809|NCT02082210|100594581|FG003|Received at Least One Dose of Study Drug|Overall Study||45||
48109810|NCT02082210|100594582|FG004|Received at Least One Dose of Study Drug|Overall Study||15||
48109811|NCT02082210|100594583|FG005|Received at Least One Dose of Study Drug|Overall Study||15||
48109812|NCT02082210|100594578|FG000|COMPLETED|Overall Study||3||
48109813|NCT02082210|100594579|FG001|COMPLETED|Overall Study||3||
48109814|NCT02082210|100594580|FG002|COMPLETED|Overall Study||13||
48109815|NCT02082210|100594581|FG003|COMPLETED|Overall Study||39||
48109816|NCT02082210|100594582|FG004|COMPLETED|Overall Study||12||
48109817|NCT02082210|100594583|FG005|COMPLETED|Overall Study||13||
48109818|NCT02082210|100594578|FG000|NOT COMPLETED|Overall Study||0||
48109819|NCT02082210|100594579|FG001|NOT COMPLETED|Overall Study||0||
48109820|NCT02082210|100594580|FG002|NOT COMPLETED|Overall Study||3||
48109821|NCT02082210|100594581|FG003|NOT COMPLETED|Overall Study||6||
48109822|NCT02082210|100594582|FG004|NOT COMPLETED|Overall Study||3||
48109823|NCT02082210|100594583|FG005|NOT COMPLETED|Overall Study||2||
48109824|NCT02702401|100594584|FG000|STARTED|Overall Study||278||
48109825|NCT02702401|100594585|FG001|STARTED|Overall Study||135||
48109826|NCT02702401|100594584|FG000|Treated|Overall Study||278||
48109827|NCT02702401|100594585|FG001|Treated|Overall Study||135||
48109828|NCT02702401|100594584|FG000|Received Second Course|Overall Study||7||
48109829|NCT02702401|100594585|FG001|Received Second Course|Overall Study||0||
48109830|NCT02702401|100594584|FG000|COMPLETED|Overall Study||0||
48109831|NCT02702401|100594585|FG001|COMPLETED|Overall Study||0||
48109832|NCT02702401|100594584|FG000|NOT COMPLETED|Overall Study||278||
48109833|NCT02702401|100594585|FG001|NOT COMPLETED|Overall Study||135||
48109834|NCT00554671|100594586|FG000|STARTED|Overall Study||117||
48109835|NCT00554671|100594587|FG001|STARTED|Overall Study||133||
48109836|NCT00554671|100594586|FG000|COMPLETED|Overall Study||97||
48109837|NCT00554671|100594587|FG001|COMPLETED|Overall Study||117||
48109838|NCT00554671|100594586|FG000|NOT COMPLETED|Overall Study||20||
48109839|NCT00554671|100594587|FG001|NOT COMPLETED|Overall Study||16||
48109840|NCT00314366|100594588|FG000|STARTED|Overall Study||11||
48109841|NCT00314366|100594589|FG001|STARTED|Overall Study||10||
48109842|NCT00314366|100594588|FG000|COMPLETED|Overall Study||10||
48109843|NCT00314366|100594589|FG001|COMPLETED|Overall Study||10||
48109844|NCT00314366|100594588|FG000|NOT COMPLETED|Overall Study||1||
48109845|NCT00314366|100594589|FG001|NOT COMPLETED|Overall Study||0||
48109846|NCT00717769|100594590|FG000|STARTED|Overall Study||120||
48693824|NCT02574078|102032857|FG000|STARTED|Pre-Treatment Period||13|Started = Randomized (entering treatment)|
48693825|NCT02574078|102032858|FG001|STARTED|Pre-Treatment Period||6|Started = Randomized (entering treatment)|
48693826|NCT02574078|102032859|FG002|STARTED|Pre-Treatment Period||9|Started = Randomized (entering treatment)|
48693827|NCT02574078|102032860|FG003|STARTED|Pre-Treatment Period||35|Started = Randomized (entering treatment)|
48693828|NCT02574078|102032861|FG004|STARTED|Pre-Treatment Period||34|Started = Randomized (entering treatment)|
48272217|NCT01681277|100988588|FG004|STARTED|Overall Study||9||
48272218|NCT01681277|100988584|FG000|COMPLETED|Overall Study||11||
48272219|NCT01681277|100988585|FG001|COMPLETED|Overall Study||9||
48272220|NCT01681277|100988586|FG002|COMPLETED|Overall Study||9||
48272221|NCT01681277|100988587|FG003|COMPLETED|Overall Study||9||
48272222|NCT01681277|100988588|FG004|COMPLETED|Overall Study||9||
48272223|NCT01681277|100988584|FG000|NOT COMPLETED|Overall Study||1||
48272224|NCT01681277|100988585|FG001|NOT COMPLETED|Overall Study||0||
48272225|NCT01681277|100988586|FG002|NOT COMPLETED|Overall Study||0||
48272226|NCT01681277|100988587|FG003|NOT COMPLETED|Overall Study||0||
48272227|NCT01681277|100988588|FG004|NOT COMPLETED|Overall Study||0||
48272228|NCT02551653|100988589|FG000|STARTED|Overall Study||5||
48272229|NCT02551653|100988590|FG001|STARTED|Overall Study||5||
48272230|NCT02551653|100988589|FG000|COMPLETED|Overall Study||5||
48272231|NCT02551653|100988590|FG001|COMPLETED|Overall Study||5||
48272232|NCT02551653|100988589|FG000|NOT COMPLETED|Overall Study||0||
48272233|NCT02551653|100988590|FG001|NOT COMPLETED|Overall Study||0||
48272234|NCT01509547|100988591|FG000|STARTED|Overall Study||77||
48272235|NCT01509547|100988592|FG001|STARTED|Overall Study||80||
48272236|NCT01509547|100988591|FG000|COMPLETED|Overall Study||42||
48272237|NCT01509547|100988592|FG001|COMPLETED|Overall Study||41||
48272238|NCT01509547|100988591|FG000|NOT COMPLETED|Overall Study||35||
48272239|NCT01509547|100988592|FG001|NOT COMPLETED|Overall Study||39||
48272240|NCT01933243|100988593|FG000|STARTED|Overall Study||12||
48272241|NCT01933243|100988594|FG001|STARTED|Overall Study||12||
48272242|NCT01933243|100988593|FG000|COMPLETED|Overall Study||10||
48272243|NCT01933243|100988594|FG001|COMPLETED|Overall Study||8||
48272244|NCT01933243|100988593|FG000|NOT COMPLETED|Overall Study||2||
48272245|NCT01933243|100988594|FG001|NOT COMPLETED|Overall Study||4||
48272246|NCT01827046|100988595|FG000|STARTED|Overall Study||250||
48272247|NCT01827046|100988596|FG001|STARTED|Overall Study||249||
48272248|NCT01827046|100988595|FG000|COMPLETED|Overall Study||249||
48272249|NCT01827046|100988596|FG001|COMPLETED|Overall Study||240||
48272250|NCT01827046|100988595|FG000|NOT COMPLETED|Overall Study||1||
48272251|NCT01827046|100988596|FG001|NOT COMPLETED|Overall Study||9||
48272252|NCT03026075|100991930|FG000|STARTED|Overall Study||47||
48272253|NCT03026075|100991930|FG000|COMPLETED|Overall Study||46||
48272254|NCT03026075|100991930|FG000|NOT COMPLETED|Overall Study||1||
48272255|NCT04606901|100991931|FG000|STARTED|Overall Study||28||
48272256|NCT04606901|100991932|FG001|STARTED|Overall Study||30||
48272257|NCT04606901|100991931|FG000|COMPLETED|Overall Study||28||
48693829|NCT02574078|102032862|FG005|STARTED|Pre-Treatment Period||35|Started = Randomized (entering treatment)|
48693830|NCT02574078|102032863|FG006|STARTED|Pre-Treatment Period||18|Started = Randomized (entering treatment)|
48693831|NCT02574078|102032864|FG007|STARTED|Pre-Treatment Period||17|Started = Randomized (entering treatment)|
48109847|NCT00717769|100594591|FG001|STARTED|Overall Study||120||
48109848|NCT00717769|100594592|FG002|STARTED|Overall Study||30||
48109849|NCT00717769|100594590|FG000|COMPLETED|Overall Study||104||
48109850|NCT00717769|100594591|FG001|COMPLETED|Overall Study||102||
48272258|NCT04606901|100991932|FG001|COMPLETED|Overall Study||30||
48272259|NCT04606901|100991931|FG000|NOT COMPLETED|Overall Study||0||
48272260|NCT04606901|100991932|FG001|NOT COMPLETED|Overall Study||0||
48272261|NCT01621776|100991933|FG000|STARTED|Overall Study||41||
48272262|NCT01621776|100991934|FG001|STARTED|Overall Study||40||
48272263|NCT01621776|100991935|FG002|STARTED|Overall Study||18||
48109851|NCT00717769|100594592|FG002|COMPLETED|Overall Study||19||
48109852|NCT00717769|100594590|FG000|NOT COMPLETED|Overall Study||16||
48109853|NCT00717769|100594591|FG001|NOT COMPLETED|Overall Study||18||
48272264|NCT01621776|100991933|FG000|COMPLETED|Overall Study||41||
48272265|NCT01621776|100991934|FG001|COMPLETED|Overall Study||40||
48272266|NCT01621776|100991935|FG002|COMPLETED|Overall Study||18||
48272267|NCT01621776|100991933|FG000|NOT COMPLETED|Overall Study||0||
48272268|NCT01621776|100991934|FG001|NOT COMPLETED|Overall Study||0||
48272269|NCT01621776|100991935|FG002|NOT COMPLETED|Overall Study||0||
48272270|NCT02946853|100991936|FG000|STARTED|Overall Study||13||
48272271|NCT02946853|100991937|FG001|STARTED|Overall Study||13||
48272272|NCT02946853|100991936|FG000|COMPLETED|Overall Study||12||
48272273|NCT02946853|100991937|FG001|COMPLETED|Overall Study||13||
48710804|NCT01187446|102078024|FG000|STARTED|Overall Study||14||
48109854|NCT00717769|100594592|FG002|NOT COMPLETED|Overall Study||11||
48272274|NCT02946853|100991936|FG000|NOT COMPLETED|Overall Study||1||
48272275|NCT02946853|100991937|FG001|NOT COMPLETED|Overall Study||0||
48272276|NCT03149549|100991938|FG000|STARTED|Study Discontinuation--Treatment Period||1||
48272277|NCT03149549|100991939|FG001|STARTED|Study Discontinuation--Treatment Period||3||
48272278|NCT03149549|100991940|FG002|STARTED|Study Discontinuation--Treatment Period||3||
48272279|NCT03149549|100991941|FG003|STARTED|Study Discontinuation--Treatment Period||3||
48555129|NCT03284723|101690749|FG003|COMPLETED|Overall Study||3||
48392623|NCT02999100|101291388|FG000|STARTED|Part 2 (Day 14): Dosing Session 2||0||
48392624|NCT02999100|101291389|FG001|STARTED|Part 2 (Day 14): Dosing Session 2||0||
48392625|NCT02999100|101291390|FG002|STARTED|Part 2 (Day 14): Dosing Session 2||4||
48392626|NCT02999100|101291391|FG003|STARTED|Part 2 (Day 14): Dosing Session 2||3||
48392627|NCT02999100|101291392|FG004|STARTED|Part 2 (Day 14): Dosing Session 2||3||
48392628|NCT02999100|101291393|FG005|STARTED|Part 2 (Day 14): Dosing Session 2||2||
48392629|NCT02999100|101291388|FG000|COMPLETED|Part 2 (Day 14): Dosing Session 2||0||
48392630|NCT02999100|101291389|FG001|COMPLETED|Part 2 (Day 14): Dosing Session 2||0||
48392631|NCT02999100|101291390|FG002|COMPLETED|Part 2 (Day 14): Dosing Session 2||4||
48392632|NCT02999100|101291391|FG003|COMPLETED|Part 2 (Day 14): Dosing Session 2||3||
48555130|NCT03284723|101690750|FG004|COMPLETED|Overall Study||9||
48555131|NCT03284723|101690751|FG005|COMPLETED|Overall Study||10||
48555132|NCT03284723|101690752|FG006|COMPLETED|Overall Study||3||
48555133|NCT03284723|101690753|FG007|COMPLETED|Overall Study||5||
48555134|NCT03284723|101690754|FG008|COMPLETED|Overall Study||6||
48555135|NCT03284723|101690755|FG009|COMPLETED|Overall Study||7||
48555136|NCT03284723|101690756|FG010|COMPLETED|Overall Study||9||
48555137|NCT03284723|101690757|FG011|COMPLETED|Overall Study||0||
48555138|NCT03284723|101690746|FG000|NOT COMPLETED|Overall Study||1||
48693832|NCT02574078|102032865|FG008|STARTED|Pre-Treatment Period||26|Started = Randomized (entering treatment)|
48693833|NCT02574078|102032866|FG009|STARTED|Pre-Treatment Period||26|Started = Randomized (entering treatment)|
48693834|NCT02574078|102032867|FG010|STARTED|Pre-Treatment Period||53|Started = Randomized (entering treatment)|
48693835|NCT02574078|102032868|FG011|STARTED|Pre-Treatment Period||56|Started = Randomized (entering treatment)|
48693836|NCT02574078|102032869|FG012|STARTED|Pre-Treatment Period||13|Started = Randomized (entering treatment)|
48109855|NCT01232296|100594593|FG000|STARTED|Overall Study||82||
48109856|NCT01232296|100594594|FG001|STARTED|Overall Study||83||
48109857|NCT01232296|100594593|FG000|Full Analysis Set|Overall Study||82||
48109858|NCT01232296|100594594|FG001|Full Analysis Set|Overall Study||83||
48109859|NCT01232296|100594593|FG000|Safety Set|Overall Study||79||
48109860|NCT01232296|100594594|FG001|Safety Set|Overall Study||83||
48109861|NCT01232296|100594593|FG000|COMPLETED|Overall Study||0||
48109862|NCT01232296|100594594|FG001|COMPLETED|Overall Study||0||
48109863|NCT01232296|100594593|FG000|NOT COMPLETED|Overall Study||82||
48109864|NCT01232296|100594594|FG001|NOT COMPLETED|Overall Study||83||
48109865|NCT04492891|100594595|FG000|STARTED|Overall Study||30|Due to the decline of COVID-19 cases which led to slow accrual, the study was closed to enrollment on April 6, 2022. For this reason, the total number of participants reported in the Arm/Group Description and the number of participants who started in the Participant Flow of the Result Section have a discrepancy.|
48109866|NCT04492891|100594596|FG001|STARTED|Overall Study||17|Due to the decline of COVID-19 cases which led to slow accrual, the study was closed to enrollment on April 6, 2022. For this reason, the total number of participants reported in the Arm/Group Description and the number of participants who started in the Participant Flow of the Result Section have a discrepancy.|
48109867|NCT04492891|100594595|FG000|COMPLETED|Overall Study||30|Due to the decline of COVID-19 cases which led to slow accrual, the study was closed to enrollment on April 6, 2022. For this reason, the total number of participants reported in the Arm/Group Description and the number of participants who completed in the Participant Flow of the Result Section have a discrepancy.|
48109868|NCT04492891|100594596|FG001|COMPLETED|Overall Study||17|Due to the decline of COVID-19 cases which led to slow accrual, the study was closed to enrollment on April 6, 2022. For this reason, the total number of participants reported in the Arm/Group Description and the number of participants who completed in the Participant Flow of the Result Section have a discrepancy.|
48109869|NCT04492891|100594595|FG000|NOT COMPLETED|Overall Study||0||
48109870|NCT04492891|100594596|FG001|NOT COMPLETED|Overall Study||0||
48272280|NCT03149549|100991942|FG004|STARTED|Study Discontinuation--Treatment Period||10||
48272281|NCT03149549|100991943|FG005|STARTED|Study Discontinuation--Treatment Period||9||
48272282|NCT03149549|100991944|FG006|STARTED|Study Discontinuation--Treatment Period||9||
48272283|NCT03149549|100991945|FG007|STARTED|Study Discontinuation--Treatment Period||12||
48272284|NCT03149549|100991946|FG008|STARTED|Study Discontinuation--Treatment Period||22||
48272285|NCT03149549|100991947|FG009|STARTED|Study Discontinuation--Treatment Period||9||
48272286|NCT03149549|100991948|FG010|STARTED|Study Discontinuation--Treatment Period||8||
48272287|NCT03149549|100991949|FG011|STARTED|Study Discontinuation--Treatment Period||4||
48272288|NCT03149549|100991950|FG012|STARTED|Study Discontinuation--Treatment Period||6||
48392633|NCT02999100|101291392|FG004|COMPLETED|Part 2 (Day 14): Dosing Session 2||3||
48392634|NCT02999100|101291393|FG005|COMPLETED|Part 2 (Day 14): Dosing Session 2||2||
48392635|NCT02999100|101291388|FG000|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0||
48392636|NCT02999100|101291389|FG001|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0||
48392637|NCT02999100|101291390|FG002|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0||
48392638|NCT02999100|101291391|FG003|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0||
48392639|NCT02999100|101291392|FG004|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0||
48392640|NCT02999100|101291393|FG005|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0||
48555139|NCT03284723|101690747|FG001|NOT COMPLETED|Overall Study||0||
48555140|NCT03284723|101690748|FG002|NOT COMPLETED|Overall Study||1||
48555141|NCT03284723|101690749|FG003|NOT COMPLETED|Overall Study||1||
48555142|NCT03284723|101690750|FG004|NOT COMPLETED|Overall Study||7||
48555143|NCT03284723|101690751|FG005|NOT COMPLETED|Overall Study||5||
48555144|NCT03284723|101690752|FG006|NOT COMPLETED|Overall Study||3||
48555145|NCT03284723|101690753|FG007|NOT COMPLETED|Overall Study||0||
48109871|NCT00480779|100594597|FG000|STARTED|Overall Study||26||
48392641|NCT01666145|101291394|FG000|STARTED|Overall Study||14||
48392642|NCT01666145|101291394|FG000|COMPLETED|Overall Study||14||
48392643|NCT01666145|101291394|FG000|NOT COMPLETED|Overall Study||0||
48392644|NCT02988401|101291395|FG000|STARTED|Overall Study||37||
48710805|NCT01187446|102078025|FG001|STARTED|Overall Study||14||
48109872|NCT00480779|100594598|FG001|STARTED|Overall Study||22||
48109873|NCT00480779|100594597|FG000|COMPLETED|Overall Study||24||
48392645|NCT02988401|101291396|FG001|STARTED|Overall Study||33||
48392646|NCT02988401|101291397|FG002|STARTED|Overall Study||35||
48392647|NCT02988401|101291395|FG000|COMPLETED|Overall Study||24|There were 69 total participants that had at least one follow-up visit up until week 24.|
48392648|NCT02988401|101291396|FG001|COMPLETED|Overall Study||17|There were 69 total participants that had at least one follow-up visit up until week 24.|
48392649|NCT02988401|101291397|FG002|COMPLETED|Overall Study||28|There were 69 total participants that had at least one follow-up visit up until week 24.|
48392650|NCT02988401|101291395|FG000|NOT COMPLETED|Overall Study||13||
48392651|NCT02988401|101291396|FG001|NOT COMPLETED|Overall Study||16||
48392652|NCT02988401|101291397|FG002|NOT COMPLETED|Overall Study||7||
48392653|NCT01575899|101291398|FG000|STARTED|Overall Study||73||
48392654|NCT01575899|101291399|FG001|STARTED|Overall Study||73||
48392655|NCT01575899|101291400|FG002|STARTED|Overall Study||62||
48392656|NCT01575899|101291398|FG000|COMPLETED|Overall Study||68||
48392657|NCT01575899|101291399|FG001|COMPLETED|Overall Study||68||
48392658|NCT01575899|101291400|FG002|COMPLETED|Overall Study||60||
48392659|NCT01575899|101291398|FG000|NOT COMPLETED|Overall Study||5||
48392660|NCT01575899|101291399|FG001|NOT COMPLETED|Overall Study||5||
48392661|NCT01575899|101291400|FG002|NOT COMPLETED|Overall Study||2||
48392662|NCT02224638|101291401|FG000|STARTED|Overall Study||11||
48392663|NCT02224638|101291402|FG001|STARTED|Overall Study||10||
48392664|NCT02224638|101291401|FG000|COMPLETED|Overall Study||10||
48392665|NCT02224638|101291402|FG001|COMPLETED|Overall Study||9||
48392666|NCT02224638|101291401|FG000|NOT COMPLETED|Overall Study||1||
48392667|NCT02224638|101291402|FG001|NOT COMPLETED|Overall Study||1||
48392668|NCT00546429|101291403|FG000|STARTED|Overall Study||62||
48109874|NCT00480779|100594598|FG001|COMPLETED|Overall Study||19||
48109875|NCT00480779|100594597|FG000|NOT COMPLETED|Overall Study||2||
48392669|NCT00546429|101291403|FG000|COMPLETED|Overall Study||32||
48392670|NCT00546429|101291403|FG000|NOT COMPLETED|Overall Study||30||
48392671|NCT01183312|101291404|FG000|STARTED|First Intervention Day||5||
48392672|NCT01183312|101291405|FG001|STARTED|First Intervention Day||5||
48109876|NCT00480779|100594598|FG001|NOT COMPLETED|Overall Study||3||
48109877|NCT00577512|100594599|FG000|STARTED|Overall Study||4||
48109878|NCT00577512|100594599|FG000|COMPLETED|Overall Study||0||
48109879|NCT00577512|100594599|FG000|NOT COMPLETED|Overall Study||4||
48109880|NCT01102413|100594600|FG000|STARTED|Overall Study||233||
48109881|NCT01102413|100594601|FG001|STARTED|Overall Study||118||
48109882|NCT01102413|100594600|FG000|COMPLETED|Overall Study||208||
48109883|NCT01102413|100594601|FG001|COMPLETED|Overall Study||106||
48109884|NCT01102413|100594600|FG000|NOT COMPLETED|Overall Study||25||
48109885|NCT01102413|100594601|FG001|NOT COMPLETED|Overall Study||12||
48392673|NCT01183312|101291404|FG000|COMPLETED|First Intervention Day||5||
48392674|NCT01183312|101291405|FG001|COMPLETED|First Intervention Day||5||
48392675|NCT01183312|101291404|FG000|NOT COMPLETED|First Intervention Day||0||
48392676|NCT01183312|101291405|FG001|NOT COMPLETED|First Intervention Day||0||
48392677|NCT01183312|101291404|FG000|STARTED|Washout Period of at Least 1 Week||5||
48392678|NCT01183312|101291405|FG001|STARTED|Washout Period of at Least 1 Week||5||
48392679|NCT01183312|101291404|FG000|COMPLETED|Washout Period of at Least 1 Week||5||
48392680|NCT01183312|101291405|FG001|COMPLETED|Washout Period of at Least 1 Week||5||
48392681|NCT01183312|101291404|FG000|NOT COMPLETED|Washout Period of at Least 1 Week||0||
48392682|NCT01183312|101291405|FG001|NOT COMPLETED|Washout Period of at Least 1 Week||0||
48392683|NCT01183312|101291404|FG000|STARTED|Second Intervention Day||5||
48392684|NCT01183312|101291405|FG001|STARTED|Second Intervention Day||5||
48392685|NCT01183312|101291404|FG000|COMPLETED|Second Intervention Day||5||
48392686|NCT01183312|101291405|FG001|COMPLETED|Second Intervention Day||5||
48392687|NCT01183312|101291404|FG000|NOT COMPLETED|Second Intervention Day||0||
48392688|NCT01183312|101291405|FG001|NOT COMPLETED|Second Intervention Day||0||
48392689|NCT01879319|101291406|FG000|STARTED|Overall Study||82||
48392690|NCT01879319|101291407|FG001|STARTED|Overall Study||82||
48392691|NCT01879319|101291406|FG000|Received Treatment|Overall Study||82||
48392692|NCT01879319|101291407|FG001|Received Treatment|Overall Study||82||
48555146|NCT03284723|101690754|FG008|NOT COMPLETED|Overall Study||8||
48555147|NCT03284723|101690755|FG009|NOT COMPLETED|Overall Study||5||
48555148|NCT03284723|101690756|FG010|NOT COMPLETED|Overall Study||6||
48109886|NCT02418468|100594602|FG000|STARTED|Overall Study||13||
48109887|NCT02418468|100594603|FG001|STARTED|Overall Study||11||
48109888|NCT02418468|100594602|FG000|COMPLETED|Overall Study||11||
48109889|NCT02418468|100594603|FG001|COMPLETED|Overall Study||10||
48109890|NCT02418468|100594602|FG000|NOT COMPLETED|Overall Study||2||
48272289|NCT03149549|100991938|FG000|COMPLETED|Study Discontinuation--Treatment Period||1||
48109891|NCT02418468|100594603|FG001|NOT COMPLETED|Overall Study||1||
48109892|NCT05233566|100594604|FG000|STARTED|Overall Study||16||
48109893|NCT05233566|100594605|FG001|STARTED|Overall Study||16||
48272290|NCT03149549|100991939|FG001|COMPLETED|Study Discontinuation--Treatment Period||3||
48272291|NCT03149549|100991940|FG002|COMPLETED|Study Discontinuation--Treatment Period||3||
48272292|NCT03149549|100991941|FG003|COMPLETED|Study Discontinuation--Treatment Period||1||
48272293|NCT03149549|100991942|FG004|COMPLETED|Study Discontinuation--Treatment Period||6||
48272294|NCT03149549|100991943|FG005|COMPLETED|Study Discontinuation--Treatment Period||7||
48272295|NCT03149549|100991944|FG006|COMPLETED|Study Discontinuation--Treatment Period||6||
48272296|NCT03149549|100991945|FG007|COMPLETED|Study Discontinuation--Treatment Period||8||
48272297|NCT03149549|100991946|FG008|COMPLETED|Study Discontinuation--Treatment Period||16||
48272298|NCT03149549|100991947|FG009|COMPLETED|Study Discontinuation--Treatment Period||7||
48272299|NCT03149549|100991948|FG010|COMPLETED|Study Discontinuation--Treatment Period||8||
48272300|NCT03149549|100991949|FG011|COMPLETED|Study Discontinuation--Treatment Period||4||
48272301|NCT03149549|100991950|FG012|COMPLETED|Study Discontinuation--Treatment Period||4||
48272302|NCT03149549|100991938|FG000|NOT COMPLETED|Study Discontinuation--Treatment Period||0||
48272303|NCT03149549|100991939|FG001|NOT COMPLETED|Study Discontinuation--Treatment Period||0||
48272304|NCT03149549|100991940|FG002|NOT COMPLETED|Study Discontinuation--Treatment Period||0||
48272305|NCT03149549|100991941|FG003|NOT COMPLETED|Study Discontinuation--Treatment Period||2||
48272306|NCT03149549|100991942|FG004|NOT COMPLETED|Study Discontinuation--Treatment Period||4||
48272307|NCT03149549|100991943|FG005|NOT COMPLETED|Study Discontinuation--Treatment Period||2||
48272308|NCT03149549|100991944|FG006|NOT COMPLETED|Study Discontinuation--Treatment Period||3||
48272309|NCT03149549|100991945|FG007|NOT COMPLETED|Study Discontinuation--Treatment Period||4||
48272310|NCT03149549|100991946|FG008|NOT COMPLETED|Study Discontinuation--Treatment Period||6||
48272311|NCT03149549|100991947|FG009|NOT COMPLETED|Study Discontinuation--Treatment Period||2||
48272312|NCT03149549|100991948|FG010|NOT COMPLETED|Study Discontinuation--Treatment Period||0||
48272313|NCT03149549|100991949|FG011|NOT COMPLETED|Study Discontinuation--Treatment Period||0||
48272314|NCT03149549|100991950|FG012|NOT COMPLETED|Study Discontinuation--Treatment Period||2||
48272315|NCT03149549|100991938|FG000|STARTED|Study Discontinuation--Follow-Up Period||1||
48272316|NCT03149549|100991939|FG001|STARTED|Study Discontinuation--Follow-Up Period||3||
48272317|NCT03149549|100991940|FG002|STARTED|Study Discontinuation--Follow-Up Period||3||
48272318|NCT03149549|100991941|FG003|STARTED|Study Discontinuation--Follow-Up Period||1||
48272319|NCT03149549|100991942|FG004|STARTED|Study Discontinuation--Follow-Up Period||6||
48272320|NCT03149549|100991943|FG005|STARTED|Study Discontinuation--Follow-Up Period||7||
48272321|NCT03149549|100991944|FG006|STARTED|Study Discontinuation--Follow-Up Period||6||
48272322|NCT03149549|100991945|FG007|STARTED|Study Discontinuation--Follow-Up Period||8||
48272323|NCT03149549|100991946|FG008|STARTED|Study Discontinuation--Follow-Up Period||16||
48272324|NCT03149549|100991947|FG009|STARTED|Study Discontinuation--Follow-Up Period||7||
48272325|NCT03149549|100991948|FG010|STARTED|Study Discontinuation--Follow-Up Period||8||
48272326|NCT03149549|100991949|FG011|STARTED|Study Discontinuation--Follow-Up Period||4||
48272327|NCT03149549|100991950|FG012|STARTED|Study Discontinuation--Follow-Up Period||4||
48272328|NCT03149549|100991938|FG000|COMPLETED|Study Discontinuation--Follow-Up Period||0||
48272329|NCT03149549|100991939|FG001|COMPLETED|Study Discontinuation--Follow-Up Period||0||
48272330|NCT03149549|100991940|FG002|COMPLETED|Study Discontinuation--Follow-Up Period||0||
48272331|NCT03149549|100991941|FG003|COMPLETED|Study Discontinuation--Follow-Up Period||0||
48272332|NCT03149549|100991942|FG004|COMPLETED|Study Discontinuation--Follow-Up Period||0||
48272333|NCT03149549|100991943|FG005|COMPLETED|Study Discontinuation--Follow-Up Period||0||
48272334|NCT03149549|100991944|FG006|COMPLETED|Study Discontinuation--Follow-Up Period||0||
48272335|NCT03149549|100991945|FG007|COMPLETED|Study Discontinuation--Follow-Up Period||0||
48272336|NCT03149549|100991946|FG008|COMPLETED|Study Discontinuation--Follow-Up Period||0||
48272337|NCT03149549|100991947|FG009|COMPLETED|Study Discontinuation--Follow-Up Period||0||
48272338|NCT03149549|100991948|FG010|COMPLETED|Study Discontinuation--Follow-Up Period||0||
48272339|NCT03149549|100991949|FG011|COMPLETED|Study Discontinuation--Follow-Up Period||0||
48272340|NCT03149549|100991950|FG012|COMPLETED|Study Discontinuation--Follow-Up Period||0||
48272341|NCT03149549|100991938|FG000|NOT COMPLETED|Study Discontinuation--Follow-Up Period||1||
48272342|NCT03149549|100991939|FG001|NOT COMPLETED|Study Discontinuation--Follow-Up Period||3||
48272343|NCT03149549|100991940|FG002|NOT COMPLETED|Study Discontinuation--Follow-Up Period||3||
48392693|NCT01879319|101291406|FG000|COMPLETED|Overall Study||80||
48272344|NCT03149549|100991941|FG003|NOT COMPLETED|Study Discontinuation--Follow-Up Period||1||
48272345|NCT03149549|100991942|FG004|NOT COMPLETED|Study Discontinuation--Follow-Up Period||6||
48272346|NCT03149549|100991943|FG005|NOT COMPLETED|Study Discontinuation--Follow-Up Period||7||
48392694|NCT01879319|101291407|FG001|COMPLETED|Overall Study||77||
48392695|NCT01879319|101291406|FG000|NOT COMPLETED|Overall Study||2||
48392696|NCT01879319|101291407|FG001|NOT COMPLETED|Overall Study||5||
48392697|NCT02384395|101291408|FG000|STARTED|Overall Study||40||
48392698|NCT02384395|101291408|FG000|Enrolled|Overall Study||40|Pending HLA and Hepatitis B results|
48392699|NCT02384395|101291408|FG000|Initiated Treatment|Overall Study||37||
48392700|NCT02384395|101291408|FG000|Completed Week 24|Overall Study||34||
48392701|NCT02384395|101291408|FG000|Completed Week 48|Overall Study||33||
48392702|NCT02384395|101291408|FG000|Completed Week 96|Overall Study||30|Two participants had data collected outside of Week 96 window|
48392703|NCT02384395|101291408|FG000|COMPLETED|Overall Study||30||
48392704|NCT02384395|101291408|FG000|NOT COMPLETED|Overall Study||10||
48392705|NCT03713957|101291409|FG000|STARTED|Overall Study||53||
48392706|NCT03713957|101291410|FG001|STARTED|Overall Study||26||
48392707|NCT03713957|101291409|FG000|COMPLETED|Overall Study||35||
48392708|NCT03713957|101291410|FG001|COMPLETED|Overall Study||16||
48392709|NCT03713957|101291409|FG000|NOT COMPLETED|Overall Study||18||
48392710|NCT03713957|101291410|FG001|NOT COMPLETED|Overall Study||10||
48392711|NCT02924688|101291411|FG000|STARTED|Overall Study||407||
48555149|NCT03284723|101690757|FG011|NOT COMPLETED|Overall Study||2||
48555150|NCT00629018|101690758|FG000|STARTED|Overall Study||55||
48555151|NCT00629018|101690759|FG001|STARTED|Overall Study||55||
48392712|NCT02924688|101291412|FG001|STARTED|Overall Study||405||
48392713|NCT02924688|101291413|FG002|STARTED|Overall Study||406||
48392714|NCT02924688|101291414|FG003|STARTED|Overall Study||406||
48392715|NCT02924688|101291415|FG004|STARTED|Overall Study||404||
48392716|NCT02924688|101291416|FG005|STARTED|Overall Study||408||
48392717|NCT02924688|101291411|FG000|COMPLETED|Overall Study||374||
48392718|NCT02924688|101291412|FG001|COMPLETED|Overall Study||374||
48392719|NCT02924688|101291413|FG002|COMPLETED|Overall Study||383||
48392720|NCT02924688|101291414|FG003|COMPLETED|Overall Study||378||
48392721|NCT02924688|101291415|FG004|COMPLETED|Overall Study||381||
48392722|NCT02924688|101291416|FG005|COMPLETED|Overall Study||384||
48392723|NCT02924688|101291411|FG000|NOT COMPLETED|Overall Study||33||
48392724|NCT02924688|101291412|FG001|NOT COMPLETED|Overall Study||31||
48392725|NCT02924688|101291413|FG002|NOT COMPLETED|Overall Study||23||
48392726|NCT02924688|101291414|FG003|NOT COMPLETED|Overall Study||28||
48392727|NCT02924688|101291415|FG004|NOT COMPLETED|Overall Study||23||
48392728|NCT02924688|101291416|FG005|NOT COMPLETED|Overall Study||24||
48392729|NCT00877604|101291417|FG000|STARTED|Overall Study||17||
48392730|NCT00877604|101291418|FG001|STARTED|Overall Study||17||
48392731|NCT00877604|101291417|FG000|COMPLETED|Overall Study||15||
48392732|NCT00877604|101291418|FG001|COMPLETED|Overall Study||14||
48392733|NCT00877604|101291417|FG000|NOT COMPLETED|Overall Study||2||
48392734|NCT00877604|101291418|FG001|NOT COMPLETED|Overall Study||3||
48392735|NCT00180271|101291419|FG000|STARTED|Overall Study||1089||
48392736|NCT00180271|101291420|FG001|STARTED|Overall Study||731||
48392737|NCT00180271|101291419|FG000|COMPLETED|Overall Study||1089||
48392738|NCT00180271|101291420|FG001|COMPLETED|Overall Study||731||
48392739|NCT00180271|101291419|FG000|NOT COMPLETED|Overall Study||0||
48392740|NCT00180271|101291420|FG001|NOT COMPLETED|Overall Study||0||
48392741|NCT00505752|101291421|FG000|STARTED|Overall Study||132||
48392742|NCT00505752|101291422|FG001|STARTED|Overall Study||128||
48392743|NCT00505752|101291423|FG002|STARTED|Overall Study||128||
48392744|NCT00505752|101291424|FG003|STARTED|Overall Study||132||
48392745|NCT00505752|101291421|FG000|COMPLETED|Overall Study||126||
48392746|NCT00505752|101291422|FG001|COMPLETED|Overall Study||119||
48392747|NCT00505752|101291423|FG002|COMPLETED|Overall Study||120||
48392748|NCT00505752|101291424|FG003|COMPLETED|Overall Study||126||
48392749|NCT00505752|101291421|FG000|NOT COMPLETED|Overall Study||6||
48392750|NCT00505752|101291422|FG001|NOT COMPLETED|Overall Study||9||
48392751|NCT00505752|101291423|FG002|NOT COMPLETED|Overall Study||8||
48392752|NCT00505752|101291424|FG003|NOT COMPLETED|Overall Study||6||
48392753|NCT04350905|101291425|FG000|STARTED|Overall Study||42||
48392754|NCT04350905|101291425|FG000|COMPLETED|Overall Study||41||
48392755|NCT04350905|101291425|FG000|NOT COMPLETED|Overall Study||1||
48392756|NCT03162458|101291426|FG000|STARTED|Overall Study||71||
48392757|NCT03162458|101291427|FG001|STARTED|Overall Study||71||
48392758|NCT03162458|101291426|FG000|COMPLETED|Overall Study||71||
48392759|NCT03162458|101291427|FG001|COMPLETED|Overall Study||71||
48392760|NCT03162458|101291426|FG000|NOT COMPLETED|Overall Study||0||
48392761|NCT03162458|101291427|FG001|NOT COMPLETED|Overall Study||0||
48392762|NCT02273037|101291428|FG000|STARTED|Overall Study||987||
48392763|NCT02273037|101291429|FG001|STARTED|Overall Study||1000||
48392764|NCT02273037|101291428|FG000|COMPLETED|Overall Study||979||
48392765|NCT02273037|101291429|FG001|COMPLETED|Overall Study||992||
48392766|NCT02273037|101291428|FG000|NOT COMPLETED|Overall Study||8||
48555152|NCT00629018|101690758|FG000|COMPLETED|Overall Study||55||
48555153|NCT00629018|101690759|FG001|COMPLETED|Overall Study||55||
48555154|NCT00629018|101690758|FG000|NOT COMPLETED|Overall Study||0||
48693837|NCT02574078|102032857|FG000|COMPLETED|Pre-Treatment Period||13|Finished = Treated|
48693838|NCT02574078|102032858|FG001|COMPLETED|Pre-Treatment Period||6|Finished = Treated|
48693839|NCT02574078|102032859|FG002|COMPLETED|Pre-Treatment Period||9|Finished = Treated|
48693840|NCT02574078|102032860|FG003|COMPLETED|Pre-Treatment Period||35|Finished = Treated|
48693841|NCT02574078|102032861|FG004|COMPLETED|Pre-Treatment Period||34|Finished = Treated|
48693842|NCT02574078|102032862|FG005|COMPLETED|Pre-Treatment Period||34|Finished = Treated|
48693843|NCT02574078|102032863|FG006|COMPLETED|Pre-Treatment Period||14|Finished = Treated|
48693844|NCT02574078|102032864|FG007|COMPLETED|Pre-Treatment Period||14|Finished = Treated|
48693845|NCT02574078|102032865|FG008|COMPLETED|Pre-Treatment Period||25|Finished = Treated|
48693846|NCT02574078|102032866|FG009|COMPLETED|Pre-Treatment Period||26|Finished = Treated|
48392767|NCT02273037|101291429|FG001|NOT COMPLETED|Overall Study||8||
48392768|NCT03595384|101291430|FG000|STARTED|Overall Study||41||
48392769|NCT03595384|101291430|FG000|Completed Week 12 Assessment|Overall Study||37||
48392770|NCT03595384|101291430|FG000|COMPLETED|Overall Study||25|Completed Week 24 Assessment|
48392771|NCT03595384|101291430|FG000|NOT COMPLETED|Overall Study||16||
48392772|NCT00615914|101291431|FG000|STARTED|Overall Study||1645||
48392773|NCT00615914|101291431|FG000|COMPLETED|Overall Study||1008||
48392774|NCT00615914|101291431|FG000|NOT COMPLETED|Overall Study||637||
48392775|NCT03005041|101291432|FG000|STARTED|Period 1||28||
48392776|NCT03005041|101291433|FG001|STARTED|Period 1||27||
48392777|NCT03005041|101291432|FG000|COMPLETED|Period 1||28||
48392778|NCT03005041|101291433|FG001|COMPLETED|Period 1||27||
48392779|NCT03005041|101291432|FG000|NOT COMPLETED|Period 1||0||
48392780|NCT03005041|101291433|FG001|NOT COMPLETED|Period 1||0||
48392781|NCT03005041|101291432|FG000|STARTED|Washout Period 1||28||
48392782|NCT03005041|101291433|FG001|STARTED|Washout Period 1||27||
48392783|NCT03005041|101291432|FG000|COMPLETED|Washout Period 1||28||
48392784|NCT03005041|101291433|FG001|COMPLETED|Washout Period 1||27||
48392785|NCT03005041|101291432|FG000|NOT COMPLETED|Washout Period 1||0||
48392786|NCT03005041|101291433|FG001|NOT COMPLETED|Washout Period 1||0||
48392787|NCT03005041|101291432|FG000|STARTED|Period 2||28||
48392788|NCT03005041|101291433|FG001|STARTED|Period 2||27||
48392789|NCT03005041|101291432|FG000|COMPLETED|Period 2||28||
48392790|NCT03005041|101291433|FG001|COMPLETED|Period 2||27||
48392791|NCT03005041|101291432|FG000|NOT COMPLETED|Period 2||0||
48392792|NCT03005041|101291433|FG001|NOT COMPLETED|Period 2||0||
48392793|NCT02759861|101291434|FG000|STARTED|Overall Study||16||
48392794|NCT02759861|101291434|FG000|COMPLETED|Overall Study||15||
48392795|NCT02759861|101291434|FG000|NOT COMPLETED|Overall Study||1||
48392796|NCT00603733|101291435|FG000|STARTED|Active Phase ITT||95||
48392797|NCT00603733|101291436|FG001|STARTED|Active Phase ITT||95||
48392798|NCT00603733|101291435|FG000|COMPLETED|Active Phase ITT||84||
48392799|NCT00603733|101291436|FG001|COMPLETED|Active Phase ITT||78||
48392800|NCT00603733|101291435|FG000|NOT COMPLETED|Active Phase ITT||11||
48392801|NCT00603733|101291436|FG001|NOT COMPLETED|Active Phase ITT||17||
48392802|NCT00603733|101291435|FG000|STARTED|Run-In Phase - 4 Weeks||49||
48392803|NCT00603733|101291436|FG001|STARTED|Run-In Phase - 4 Weeks||49||
48693847|NCT02574078|102032867|FG010|COMPLETED|Pre-Treatment Period||49|Finished = Treated|
48693848|NCT02574078|102032868|FG011|COMPLETED|Pre-Treatment Period||55|Finished = Treated|
48693849|NCT02574078|102032869|FG012|COMPLETED|Pre-Treatment Period||13|Finished = Treated|
48693850|NCT02574078|102032857|FG000|NOT COMPLETED|Pre-Treatment Period||0||
48693851|NCT02574078|102032858|FG001|NOT COMPLETED|Pre-Treatment Period||0||
48693852|NCT02574078|102032859|FG002|NOT COMPLETED|Pre-Treatment Period||0||
48693853|NCT02574078|102032860|FG003|NOT COMPLETED|Pre-Treatment Period||0||
48693854|NCT02574078|102032861|FG004|NOT COMPLETED|Pre-Treatment Period||0||
48693855|NCT02574078|102032862|FG005|NOT COMPLETED|Pre-Treatment Period||1||
48693856|NCT02574078|102032863|FG006|NOT COMPLETED|Pre-Treatment Period||4||
48693857|NCT02574078|102032864|FG007|NOT COMPLETED|Pre-Treatment Period||3||
48693858|NCT02574078|102032865|FG008|NOT COMPLETED|Pre-Treatment Period||1||
48392804|NCT00603733|101291435|FG000|COMPLETED|Run-In Phase - 4 Weeks||35||
48392805|NCT00603733|101291436|FG001|COMPLETED|Run-In Phase - 4 Weeks||36||
48392806|NCT00603733|101291435|FG000|NOT COMPLETED|Run-In Phase - 4 Weeks||14||
48392807|NCT00603733|101291436|FG001|NOT COMPLETED|Run-In Phase - 4 Weeks||13||
48392808|NCT00603733|101291435|FG000|STARTED|Maintenance Phase ITT||71||
48392809|NCT00603733|101291436|FG001|STARTED|Maintenance Phase ITT||82||
48392810|NCT00603733|101291435|FG000|COMPLETED|Maintenance Phase ITT||61||
48693859|NCT02574078|102032866|FG009|NOT COMPLETED|Pre-Treatment Period||0||
48693860|NCT02574078|102032867|FG010|NOT COMPLETED|Pre-Treatment Period||4||
48693861|NCT02574078|102032868|FG011|NOT COMPLETED|Pre-Treatment Period||1||
48693862|NCT02574078|102032869|FG012|NOT COMPLETED|Pre-Treatment Period||0||
48693863|NCT02574078|102032857|FG000|STARTED|Treatment Period||13|Started = Treated|
48693864|NCT02574078|102032858|FG001|STARTED|Treatment Period||6|Started = Treated|
48392811|NCT00603733|101291436|FG001|COMPLETED|Maintenance Phase ITT||66||
48392812|NCT00603733|101291435|FG000|NOT COMPLETED|Maintenance Phase ITT||10||
48392813|NCT00603733|101291436|FG001|NOT COMPLETED|Maintenance Phase ITT||16||
48392814|NCT02679807|101291437|FG000|STARTED|Overall Study||165||
48392815|NCT02679807|101291438|FG001|STARTED|Overall Study||169||
48392816|NCT02679807|101291437|FG000|COMPLETED|Overall Study||143||
48392817|NCT02679807|101291438|FG001|COMPLETED|Overall Study||153||
48392818|NCT02679807|101291437|FG000|NOT COMPLETED|Overall Study||22||
48392819|NCT02679807|101291438|FG001|NOT COMPLETED|Overall Study||16||
48392820|NCT02528253|101291439|FG000|STARTED|Overall Study||205||
48392821|NCT02528253|101291440|FG001|STARTED|Overall Study||204||
48392822|NCT02528253|101291441|FG002|STARTED|Overall Study||407||
48392823|NCT02528253|101291442|FG003|STARTED|Overall Study||407||
48392824|NCT02528253|101291443|FG004|STARTED|Overall Study||602||
48392825|NCT02528253|101291439|FG000|Intent to Treat Population|Overall Study||202||
48392826|NCT02528253|101291440|FG001|Intent to Treat Population|Overall Study||204||
48392827|NCT02528253|101291441|FG002|Intent to Treat Population|Overall Study||407||
48392828|NCT02528253|101291442|FG003|Intent to Treat Population|Overall Study||407||
48392829|NCT02528253|101291443|FG004|Intent to Treat Population|Overall Study||605||
48392830|NCT02528253|101291439|FG000|Treated at Week 16|Overall Study||99||
48392831|NCT02528253|101291440|FG001|Treated at Week 16|Overall Study||95||
48392832|NCT02528253|101291441|FG002|Treated at Week 16|Overall Study||236||
48392833|NCT02528253|101291442|FG003|Treated at Week 16|Overall Study||242||
48392834|NCT02528253|101291443|FG004|Treated at Week 16|Overall Study||307||
48392835|NCT02528253|101291439|FG000|COMPLETED|Overall Study||130||
48392836|NCT02528253|101291440|FG001|COMPLETED|Overall Study||134||
48392837|NCT02528253|101291441|FG002|COMPLETED|Overall Study||267||
48392838|NCT02528253|101291442|FG003|COMPLETED|Overall Study||271||
48392839|NCT02528253|101291443|FG004|COMPLETED|Overall Study||379||
48392840|NCT02528253|101291439|FG000|NOT COMPLETED|Overall Study||75||
48392841|NCT02528253|101291440|FG001|NOT COMPLETED|Overall Study||70||
48392842|NCT02528253|101291441|FG002|NOT COMPLETED|Overall Study||140||
48392843|NCT02528253|101291442|FG003|NOT COMPLETED|Overall Study||136||
48392844|NCT02528253|101291443|FG004|NOT COMPLETED|Overall Study||223||
48693865|NCT02574078|102032859|FG002|STARTED|Treatment Period||9|Started = Treated|
48693866|NCT02574078|102032860|FG003|STARTED|Treatment Period||35|Started = Treated|
48693867|NCT02574078|102032861|FG004|STARTED|Treatment Period||34|Started = Treated|
48693868|NCT02574078|102032862|FG005|STARTED|Treatment Period||34|Started = Treated|
48693869|NCT02574078|102032863|FG006|STARTED|Treatment Period||14|Started = Treated|
48693870|NCT02574078|102032864|FG007|STARTED|Treatment Period||14|Started = Treated|
48693871|NCT02574078|102032865|FG008|STARTED|Treatment Period||25|Started = Treated|
48693872|NCT02574078|102032866|FG009|STARTED|Treatment Period||26|Started = Treated|
48693873|NCT02574078|102032867|FG010|STARTED|Treatment Period||49|Started = Treated|
48693874|NCT02574078|102032868|FG011|STARTED|Treatment Period||55|Started = Treated|
48693875|NCT02574078|102032869|FG012|STARTED|Treatment Period||13|Started = Treated|
48693876|NCT02574078|102032857|FG000|COMPLETED|Treatment Period||3||
48693877|NCT02574078|102032858|FG001|COMPLETED|Treatment Period||0||
48693878|NCT02574078|102032859|FG002|COMPLETED|Treatment Period||0||
48693879|NCT02574078|102032860|FG003|COMPLETED|Treatment Period||7||
48693880|NCT02574078|102032861|FG004|COMPLETED|Treatment Period||3||
48693881|NCT02574078|102032862|FG005|COMPLETED|Treatment Period||1||
48693882|NCT02574078|102032863|FG006|COMPLETED|Treatment Period||2||
48693883|NCT02574078|102032864|FG007|COMPLETED|Treatment Period||2||
48693884|NCT02574078|102032865|FG008|COMPLETED|Treatment Period||1||
48109894|NCT05233566|100594604|FG000|COMPLETED|Overall Study||16||
48392845|NCT03179410|101291444|FG000|STARTED|Overall Study||15||
48392846|NCT03179410|101291444|FG000|COMPLETED|Overall Study||15||
48693885|NCT02574078|102032866|FG009|COMPLETED|Treatment Period||9||
48109895|NCT05233566|100594605|FG001|COMPLETED|Overall Study||16||
48392847|NCT03179410|101291444|FG000|NOT COMPLETED|Overall Study||0||
48392848|NCT03271307|101291445|FG000|STARTED|Overall Study||1951||5
48392849|NCT03271307|101291446|FG001|STARTED|Overall Study||1837||5
48392850|NCT03271307|101291447|FG002|STARTED|Overall Study||2097||5
48392851|NCT03271307|101291448|FG003|STARTED|Overall Study||135||1
48392852|NCT03271307|101291449|FG004|STARTED|Overall Study||349||2
48693886|NCT02574078|102032867|FG010|COMPLETED|Treatment Period||4||
48693887|NCT02574078|102032868|FG011|COMPLETED|Treatment Period||8||
48109896|NCT05233566|100594604|FG000|NOT COMPLETED|Overall Study||0||
48392853|NCT03271307|101291445|FG000|COMPLETED|Overall Study||1951||5
48392854|NCT03271307|101291446|FG001|COMPLETED|Overall Study||1837||5
48392855|NCT03271307|101291447|FG002|COMPLETED|Overall Study||2097||5
48392856|NCT03271307|101291448|FG003|COMPLETED|Overall Study||107||1
48392857|NCT03271307|101291449|FG004|COMPLETED|Overall Study||258||2
48392858|NCT03271307|101291445|FG000|NOT COMPLETED|Overall Study||0||0
48693888|NCT02574078|102032869|FG012|COMPLETED|Treatment Period||0||
48693889|NCT02574078|102032857|FG000|NOT COMPLETED|Treatment Period||10||
48693890|NCT02574078|102032858|FG001|NOT COMPLETED|Treatment Period||6||
48693891|NCT02574078|102032859|FG002|NOT COMPLETED|Treatment Period||9||
48392859|NCT03271307|101291446|FG001|NOT COMPLETED|Overall Study||0||0
48392860|NCT03271307|101291447|FG002|NOT COMPLETED|Overall Study||0||0
48392861|NCT03271307|101291448|FG003|NOT COMPLETED|Overall Study||28||0
48392862|NCT03271307|101291449|FG004|NOT COMPLETED|Overall Study||91||0
48693892|NCT02574078|102032860|FG003|NOT COMPLETED|Treatment Period||28||
48693893|NCT02574078|102032861|FG004|NOT COMPLETED|Treatment Period||31||
48693894|NCT02574078|102032862|FG005|NOT COMPLETED|Treatment Period||33||
48392863|NCT03380624|101291450|FG000|STARTED|Overall Study||10||
48392864|NCT03380624|101291451|FG001|STARTED|Overall Study||9||
48392865|NCT03380624|101291450|FG000|COMPLETED|Overall Study||10||
48392866|NCT03380624|101291451|FG001|COMPLETED|Overall Study||9||
48392867|NCT03380624|101291450|FG000|NOT COMPLETED|Overall Study||0||
48392868|NCT03380624|101291451|FG001|NOT COMPLETED|Overall Study||0||
48392869|NCT01957787|101291452|FG000|STARTED|Overall Study||131||226
48392870|NCT01957787|101291452|FG000|Intent-to-Treat (ITT) Population|Overall Study||130|Participants for whom cryoablation via Galil Medical Cryoablation System was attempted or performed.|226
48392871|NCT01957787|101291452|FG000|Modified ITT (mITT) Population|Overall Study||128|Participants in the ITT population and met all study entry criteria.|224
48392872|NCT01957787|101291452|FG000|COMPLETED|Overall Study||95||170
48392873|NCT01957787|101291452|FG000|NOT COMPLETED|Overall Study||36||56
48392874|NCT01057134|101291453|FG000|STARTED|Overall Study||10||
48392875|NCT01057134|101291453|FG000|COMPLETED|Overall Study||9||
48392876|NCT01057134|101291453|FG000|NOT COMPLETED|Overall Study||1||
48392877|NCT02029638|101291454|FG000|STARTED|Overall Study||2||
48392878|NCT02029638|101291455|FG001|STARTED|Overall Study||1||
48392879|NCT02029638|101291456|FG002|STARTED|Overall Study||1||
48392880|NCT02029638|101291454|FG000|COMPLETED|Overall Study||0||
48392881|NCT02029638|101291455|FG001|COMPLETED|Overall Study||1||
48392882|NCT02029638|101291456|FG002|COMPLETED|Overall Study||0||
48392883|NCT02029638|101291454|FG000|NOT COMPLETED|Overall Study||2||
48392884|NCT02029638|101291455|FG001|NOT COMPLETED|Overall Study||0||
48392885|NCT02029638|101291456|FG002|NOT COMPLETED|Overall Study||1||
48392886|NCT03404518|101291457|FG000|STARTED|Overall Study||97||
48392887|NCT03404518|101291458|FG001|STARTED|Overall Study||88||
48392888|NCT03404518|101291457|FG000|COMPLETED|Overall Study||56||
48392889|NCT03404518|101291458|FG001|COMPLETED|Overall Study||52||
48392890|NCT03404518|101291457|FG000|NOT COMPLETED|Overall Study||41||
48392891|NCT03404518|101291458|FG001|NOT COMPLETED|Overall Study||36||
48693895|NCT02574078|102032863|FG006|NOT COMPLETED|Treatment Period||12||
48693896|NCT02574078|102032864|FG007|NOT COMPLETED|Treatment Period||12||
48693897|NCT02574078|102032865|FG008|NOT COMPLETED|Treatment Period||24||
48693898|NCT02574078|102032866|FG009|NOT COMPLETED|Treatment Period||17||
48693899|NCT02574078|102032867|FG010|NOT COMPLETED|Treatment Period||45||
48693900|NCT02574078|102032868|FG011|NOT COMPLETED|Treatment Period||47||
48693901|NCT02574078|102032869|FG012|NOT COMPLETED|Treatment Period||13||
48693902|NCT04188834|102032870|FG000|STARTED|Overall Study||23||
48693903|NCT04188834|102032870|FG000|COMPLETED|Overall Study||19||
48693904|NCT04188834|102032870|FG000|NOT COMPLETED|Overall Study||4||
48693905|NCT03726658|102032871|FG000|STARTED|Overall Study||26||
48693906|NCT03726658|102032872|FG001|STARTED|Overall Study||26||
48693907|NCT03726658|102032873|FG002|STARTED|Overall Study||26||
48693908|NCT03726658|102032874|FG003|STARTED|Overall Study||25||
48693909|NCT03726658|102032875|FG004|STARTED|Overall Study||40||
48693910|NCT03726658|102032876|FG005|STARTED|Overall Study||40||
48693911|NCT03726658|102032877|FG006|STARTED|Overall Study||41||
48693912|NCT03726658|102032871|FG000|COMPLETED|Overall Study||25||
48693913|NCT03726658|102032872|FG001|COMPLETED|Overall Study||26||
48693914|NCT03726658|102032873|FG002|COMPLETED|Overall Study||24||
48693915|NCT03726658|102032874|FG003|COMPLETED|Overall Study||25||
48693916|NCT03726658|102032875|FG004|COMPLETED|Overall Study||34||
48693917|NCT03726658|102032876|FG005|COMPLETED|Overall Study||35||
48693918|NCT03726658|102032877|FG006|COMPLETED|Overall Study||36||
48693919|NCT03726658|102032871|FG000|NOT COMPLETED|Overall Study||1||
48693920|NCT03726658|102032872|FG001|NOT COMPLETED|Overall Study||0||
48693921|NCT03726658|102032873|FG002|NOT COMPLETED|Overall Study||2||
48693922|NCT03726658|102032874|FG003|NOT COMPLETED|Overall Study||0||
48693923|NCT03726658|102032875|FG004|NOT COMPLETED|Overall Study||6||
48693924|NCT03726658|102032876|FG005|NOT COMPLETED|Overall Study||5||
48693925|NCT03726658|102032877|FG006|NOT COMPLETED|Overall Study||5||
48693926|NCT03786224|102032878|FG000|STARTED|Overall Study||6||
48693927|NCT03786224|102032878|FG000|COMPLETED|Overall Study||0||
48693928|NCT03786224|102032878|FG000|NOT COMPLETED|Overall Study||6||
48693929|NCT00893152|102032879|FG000|STARTED|Overall Study||47||
48693930|NCT00893152|102032880|FG001|STARTED|Overall Study||36||
48392892|NCT00871572|101291459|FG000|STARTED|Overall Study||10||
48693931|NCT00893152|102032879|FG000|COMPLETED|Overall Study||47||
48693932|NCT00893152|102032880|FG001|COMPLETED|Overall Study||36||
48693933|NCT00893152|102032879|FG000|NOT COMPLETED|Overall Study||0||
48693934|NCT00893152|102032880|FG001|NOT COMPLETED|Overall Study||0||
48693935|NCT03358355|102036254|FG000|STARTED|Overall Study||9||
48693936|NCT03358355|102036254|FG000|COMPLETED|Overall Study||9||
48693937|NCT03358355|102036254|FG000|NOT COMPLETED|Overall Study||0||
48693938|NCT04532294|102036255|FG000|STARTED|Overall Study||4||
48693939|NCT04532294|102036256|FG001|STARTED|Overall Study||6||
48693940|NCT04532294|102036257|FG002|STARTED|Overall Study||8||
48693941|NCT04532294|102036255|FG000|COMPLETED|Overall Study||4||
48693942|NCT04532294|102036256|FG001|COMPLETED|Overall Study||6||
48693943|NCT04532294|102036257|FG002|COMPLETED|Overall Study||5||
48693944|NCT04532294|102036255|FG000|NOT COMPLETED|Overall Study||0||
48693945|NCT04532294|102036256|FG001|NOT COMPLETED|Overall Study||0||
48693946|NCT04532294|102036257|FG002|NOT COMPLETED|Overall Study||3||
48693947|NCT01653587|102036258|FG000|STARTED|Overall Study||120||
48392893|NCT00871572|101291460|FG001|STARTED|Overall Study||17||
48392894|NCT00871572|101291461|FG002|STARTED|Overall Study||34||
48392895|NCT00871572|101291462|FG003|STARTED|Overall Study||26||
48392896|NCT00871572|101291459|FG000|≥1 Post Baseline Value by Assigned Group|Overall Study||9||
48392897|NCT00871572|101291460|FG001|≥1 Post Baseline Value by Assigned Group|Overall Study||17||
48392898|NCT00871572|101291461|FG002|≥1 Post Baseline Value by Assigned Group|Overall Study||34||
48392899|NCT00871572|101291462|FG003|≥1 Post Baseline Value by Assigned Group|Overall Study||25||
48392900|NCT00871572|101291459|FG000|Received at Least 1 Dose of Study Drug|Overall Study||9||
48392901|NCT00871572|101291460|FG001|Received at Least 1 Dose of Study Drug|Overall Study||17||
48392902|NCT00871572|101291461|FG002|Received at Least 1 Dose of Study Drug|Overall Study||34||
48392903|NCT00871572|101291462|FG003|Received at Least 1 Dose of Study Drug|Overall Study||25||
48392904|NCT00871572|101291459|FG000|COMPLETED|Overall Study||8||
48392905|NCT00871572|101291460|FG001|COMPLETED|Overall Study||11||
48109897|NCT05233566|100594605|FG001|NOT COMPLETED|Overall Study||0||
48109898|NCT01924169|100594606|FG000|STARTED|Overall Study||3||
48109899|NCT01924169|100594606|FG000|COMPLETED|Overall Study||3||
48392906|NCT00871572|101291461|FG002|COMPLETED|Overall Study||30||
48392907|NCT00871572|101291462|FG003|COMPLETED|Overall Study||19||
48392908|NCT00871572|101291459|FG000|NOT COMPLETED|Overall Study||2||
48392909|NCT00871572|101291460|FG001|NOT COMPLETED|Overall Study||6||
48392910|NCT00871572|101291461|FG002|NOT COMPLETED|Overall Study||4||
48392911|NCT00871572|101291462|FG003|NOT COMPLETED|Overall Study||7||
48392912|NCT01153841|101291463|FG000|STARTED|Overall Study||199||
48392913|NCT01153841|101291464|FG001|STARTED|Overall Study||99||
48109900|NCT01924169|100594606|FG000|NOT COMPLETED|Overall Study||0||
48109901|NCT02845752|100594607|FG000|STARTED|First Intervention (7 Days)||7||
48109902|NCT02845752|100594608|FG001|STARTED|First Intervention (7 Days)||7||
48109903|NCT02845752|100594607|FG000|COMPLETED|First Intervention (7 Days)||7||
48109904|NCT02845752|100594608|FG001|COMPLETED|First Intervention (7 Days)||7||
48392914|NCT01153841|101291463|FG000|COMPLETED|Overall Study||193||
48392915|NCT01153841|101291464|FG001|COMPLETED|Overall Study||99||
48392916|NCT01153841|101291463|FG000|NOT COMPLETED|Overall Study||6||
48392917|NCT01153841|101291464|FG001|NOT COMPLETED|Overall Study||0||
48392918|NCT04327518|101291465|FG000|STARTED|Overall Study||125||202
48392919|NCT04327518|101291465|FG000|COMPLETED|Overall Study||124||200
48392920|NCT04327518|101291465|FG000|NOT COMPLETED|Overall Study||1||2
48392921|NCT03517449|101291466|FG000|STARTED|Overall Study||411||
48392922|NCT03517449|101291467|FG001|STARTED|Overall Study||416||
48392923|NCT03517449|101291466|FG000|Treated|Overall Study||406||
48392924|NCT03517449|101291467|FG001|Treated|Overall Study||388||
48392925|NCT03517449|101291466|FG000|COMPLETED|Overall Study||0||
48392926|NCT03517449|101291467|FG001|COMPLETED|Overall Study||0||
48392927|NCT03517449|101291466|FG000|NOT COMPLETED|Overall Study||411||
48392928|NCT03517449|101291467|FG001|NOT COMPLETED|Overall Study||416||
48109905|NCT02845752|100594607|FG000|NOT COMPLETED|First Intervention (7 Days)||0||
48109906|NCT02845752|100594608|FG001|NOT COMPLETED|First Intervention (7 Days)||0||
48109907|NCT02845752|100594607|FG000|STARTED|Washout (14 Days)||7||
48109908|NCT02845752|100594608|FG001|STARTED|Washout (14 Days)||7||
48109909|NCT02845752|100594607|FG000|COMPLETED|Washout (14 Days)||7||
48109910|NCT02845752|100594608|FG001|COMPLETED|Washout (14 Days)||7||
48109911|NCT02845752|100594607|FG000|NOT COMPLETED|Washout (14 Days)||0||
48109912|NCT02845752|100594608|FG001|NOT COMPLETED|Washout (14 Days)||0||
48109913|NCT02845752|100594607|FG000|STARTED|Second Intervention (7 Days)||7||
48109914|NCT02845752|100594608|FG001|STARTED|Second Intervention (7 Days)||7||
48109915|NCT02845752|100594607|FG000|COMPLETED|Second Intervention (7 Days)||7||
48109916|NCT02845752|100594608|FG001|COMPLETED|Second Intervention (7 Days)||7||
48109917|NCT02845752|100594607|FG000|NOT COMPLETED|Second Intervention (7 Days)||0||
48109918|NCT02845752|100594608|FG001|NOT COMPLETED|Second Intervention (7 Days)||0||
48109919|NCT00582933|100594609|FG000|STARTED|Overall Study||95||
48392929|NCT02378883|101291468|FG000|STARTED|Enrollment||121||
48109920|NCT00582933|100594609|FG000|COMPLETED|Overall Study||92||
48109921|NCT00582933|100594609|FG000|NOT COMPLETED|Overall Study||3||
48392930|NCT02378883|101291468|FG000|COMPLETED|Enrollment||112||
48392931|NCT02378883|101291468|FG000|NOT COMPLETED|Enrollment||9||
48392932|NCT02378883|101291468|FG000|STARTED|Discharge||112||
48392933|NCT02378883|101291468|FG000|COMPLETED|Discharge||112||
48392934|NCT02378883|101291468|FG000|NOT COMPLETED|Discharge||0||
48109922|NCT02167256|100594610|FG000|STARTED|Overall Study||79||
48109923|NCT02167256|100594611|FG001|STARTED|Overall Study||80||
48109924|NCT02167256|100594610|FG000|COMPLETED|Overall Study||58||
48109925|NCT02167256|100594611|FG001|COMPLETED|Overall Study||70||
48392935|NCT02378883|101291468|FG000|STARTED|30 Day Follow-Up||112||
48392936|NCT02378883|101291468|FG000|COMPLETED|30 Day Follow-Up||106|Includes 66 subjects with no tip retained. Subjects eligible to exit study per protocol.|
48392937|NCT02378883|101291468|FG000|NOT COMPLETED|30 Day Follow-Up||6||
48272347|NCT03149549|100991944|FG006|NOT COMPLETED|Study Discontinuation--Follow-Up Period||6||
48272348|NCT03149549|100991945|FG007|NOT COMPLETED|Study Discontinuation--Follow-Up Period||8||
48272349|NCT03149549|100991946|FG008|NOT COMPLETED|Study Discontinuation--Follow-Up Period||16||
48392938|NCT02378883|101291468|FG000|STARTED|12 Months Follow-Up||46|As per protocol only 46 subjects were eligible for 12 month visit due to tip retention.|
48392939|NCT02378883|101291468|FG000|COMPLETED|12 Months Follow-Up||41||
48392940|NCT02378883|101291468|FG000|NOT COMPLETED|12 Months Follow-Up||5||
48392941|NCT01818986|101291469|FG000|STARTED|Overall Study||20||
48555155|NCT00629018|101690759|FG001|NOT COMPLETED|Overall Study||0||
48272350|NCT03149549|100991947|FG009|NOT COMPLETED|Study Discontinuation--Follow-Up Period||7||
48272351|NCT03149549|100991948|FG010|NOT COMPLETED|Study Discontinuation--Follow-Up Period||8||
48272352|NCT03149549|100991949|FG011|NOT COMPLETED|Study Discontinuation--Follow-Up Period||4||
48272353|NCT03149549|100991950|FG012|NOT COMPLETED|Study Discontinuation--Follow-Up Period||4||
48272354|NCT01006252|100991951|FG000|STARTED|Overall Study||168||
48272355|NCT01006252|100991952|FG001|STARTED|Overall Study||168||
48272356|NCT01006252|100991951|FG000|Received Treatment|Overall Study||164||
48272357|NCT01006252|100991952|FG001|Received Treatment|Overall Study||161||
48272358|NCT01006252|100991951|FG000|COMPLETED|Overall Study||168||
48272359|NCT01006252|100991952|FG001|COMPLETED|Overall Study||168||
48272360|NCT01006252|100991951|FG000|NOT COMPLETED|Overall Study||0||
48272361|NCT01006252|100991952|FG001|NOT COMPLETED|Overall Study||0||
48272362|NCT03433677|100991953|FG000|STARTED|Period 1||24||
48272363|NCT03433677|100991954|FG001|STARTED|Period 1||25||
48272364|NCT03433677|100991953|FG000|Received at Least 1 Dose of Study Drug|Period 1||24||
48272365|NCT03433677|100991954|FG001|Received at Least 1 Dose of Study Drug|Period 1||25||
48272366|NCT03433677|100991953|FG000|COMPLETED|Period 1||23||
48272367|NCT03433677|100991954|FG001|COMPLETED|Period 1||25||
48272368|NCT03433677|100991953|FG000|NOT COMPLETED|Period 1||1||
48272369|NCT03433677|100991954|FG001|NOT COMPLETED|Period 1||0||
48272370|NCT03433677|100991953|FG000|STARTED|Period 2||23||
48272371|NCT03433677|100991954|FG001|STARTED|Period 2||25||
48272372|NCT03433677|100991953|FG000|Received at Least 1 Dose of Study Drug|Period 2||23||
48272373|NCT03433677|100991954|FG001|Received at Least 1 Dose of Study Drug|Period 2||25||
48272374|NCT03433677|100991953|FG000|COMPLETED|Period 2||22||
48272375|NCT03433677|100991954|FG001|COMPLETED|Period 2||24||
48272376|NCT03433677|100991953|FG000|NOT COMPLETED|Period 2||1||
48272377|NCT03433677|100991954|FG001|NOT COMPLETED|Period 2||1||
48272378|NCT03750786|100991955|FG000|STARTED|Overall Study||245||
48272379|NCT03750786|100991956|FG001|STARTED|Overall Study||245||
48272380|NCT03750786|100991955|FG000|COMPLETED|Overall Study||0||
48272381|NCT03750786|100991956|FG001|COMPLETED|Overall Study||0||
48272382|NCT03750786|100991955|FG000|NOT COMPLETED|Overall Study||245||
48272383|NCT03750786|100991956|FG001|NOT COMPLETED|Overall Study||245||
48272384|NCT02631577|100991957|FG000|STARTED|Overall Study||4||
48272385|NCT02631577|100991958|FG001|STARTED|Overall Study||34||
48272386|NCT02631577|100991957|FG000|COMPLETED|Overall Study||3||
48272387|NCT02631577|100991958|FG001|COMPLETED|Overall Study||24||
48272388|NCT02631577|100991957|FG000|NOT COMPLETED|Overall Study||1||
48272389|NCT02631577|100991958|FG001|NOT COMPLETED|Overall Study||10||
48272390|NCT00422812|100991959|FG000|STARTED|Overall Study||98||
48272391|NCT00422812|100991960|FG001|STARTED|Overall Study||104||
48272392|NCT00422812|100991961|FG002|STARTED|Overall Study||93||
48272393|NCT00422812|100991962|FG003|STARTED|Overall Study||105||
48272394|NCT00422812|100991959|FG000|COMPLETED|Overall Study||98||
48272395|NCT00422812|100991960|FG001|COMPLETED|Overall Study||103||
48272396|NCT00422812|100991961|FG002|COMPLETED|Overall Study||91||
48272397|NCT00422812|100991962|FG003|COMPLETED|Overall Study||103||
48272398|NCT00422812|100991959|FG000|NOT COMPLETED|Overall Study||0||
48272399|NCT00422812|100991960|FG001|NOT COMPLETED|Overall Study||1||
48272400|NCT00422812|100991961|FG002|NOT COMPLETED|Overall Study||2||
48272401|NCT00422812|100991962|FG003|NOT COMPLETED|Overall Study||2||
48272402|NCT00552929|100991963|FG000|STARTED|Overall Study||9|Randomized Participants|
48272403|NCT00552929|100991964|FG001|STARTED|Overall Study||10|Randomized Participants|
48272404|NCT00552929|100991965|FG002|STARTED|Overall Study||10|Randomized Participants|
48272405|NCT00552929|100991966|FG003|STARTED|Overall Study||11|Randomized Participants|
48272406|NCT00552929|100991967|FG004|STARTED|Overall Study||10|Randomized Participants|
48272407|NCT00552929|100991968|FG005|STARTED|Overall Study||10|Randomized Participants|
48272408|NCT00552929|100991969|FG006|STARTED|Overall Study||10|Randomized Participants|
48272409|NCT00552929|100991970|FG007|STARTED|Overall Study||11|Randomized Participants|
48272410|NCT00552929|100991971|FG008|STARTED|Overall Study||10|Randomized Participants|
48272411|NCT00552929|100991972|FG009|STARTED|Overall Study||11|Randomized Participants|
48272412|NCT00552929|100991963|FG000|Participants as Treated|Overall Study||9||
48272413|NCT00552929|100991964|FG001|Participants as Treated|Overall Study||10||
48272414|NCT00552929|100991965|FG002|Participants as Treated|Overall Study||10||
48272415|NCT00552929|100991966|FG003|Participants as Treated|Overall Study||11||
48272416|NCT00552929|100991967|FG004|Participants as Treated|Overall Study||10||
48272417|NCT00552929|100991968|FG005|Participants as Treated|Overall Study||9||
48272418|NCT00552929|100991969|FG006|Participants as Treated|Overall Study||10||
48272419|NCT00552929|100991970|FG007|Participants as Treated|Overall Study||11||
48272420|NCT00552929|100991971|FG008|Participants as Treated|Overall Study||10||
48555156|NCT05084924|101690760|FG000|STARTED|Overall Study||11||
48555157|NCT05084924|101690761|FG001|STARTED|Overall Study||12||
48555158|NCT05084924|101690762|FG002|STARTED|Overall Study||12||
48555159|NCT05084924|101690760|FG000|COMPLETED|Overall Study||11||
48555160|NCT05084924|101690761|FG001|COMPLETED|Overall Study||12||
48555161|NCT05084924|101690762|FG002|COMPLETED|Overall Study||12||
48555162|NCT05084924|101690760|FG000|NOT COMPLETED|Overall Study||0||
48693948|NCT01653587|102036259|FG001|STARTED|Overall Study||120||
48693949|NCT01653587|102036258|FG000|COMPLETED|Overall Study||120||
48693950|NCT01653587|102036259|FG001|COMPLETED|Overall Study||120||
48693951|NCT01653587|102036258|FG000|NOT COMPLETED|Overall Study||0||
48693952|NCT01653587|102036259|FG001|NOT COMPLETED|Overall Study||0||
48693953|NCT03470194|102036260|FG000|STARTED|Overall Study||49||
48693954|NCT03470194|102036261|FG001|STARTED|Overall Study||57||
48693955|NCT03470194|102036260|FG000|COMPLETED|Overall Study||38||
48693956|NCT03470194|102036261|FG001|COMPLETED|Overall Study||40||
48693957|NCT03470194|102036260|FG000|NOT COMPLETED|Overall Study||11||
48109926|NCT02167256|100594610|FG000|NOT COMPLETED|Overall Study||21||
48272421|NCT00552929|100991972|FG009|Participants as Treated|Overall Study||11||
48272422|NCT00552929|100991963|FG000|COMPLETED|Overall Study||9||
48272423|NCT00552929|100991964|FG001|COMPLETED|Overall Study||10||
48109927|NCT02167256|100594611|FG001|NOT COMPLETED|Overall Study||10||
48109928|NCT02239536|100597804|FG000|STARTED|Overall Study||190||
48109929|NCT02239536|100597805|FG001|STARTED|Overall Study||172||
48109930|NCT02239536|100597804|FG000|COMPLETED|Overall Study||167||
48109931|NCT02239536|100597805|FG001|COMPLETED|Overall Study||155||
48109932|NCT02239536|100597804|FG000|NOT COMPLETED|Overall Study||23||
48109933|NCT02239536|100597805|FG001|NOT COMPLETED|Overall Study||17||
48109934|NCT02660918|100597806|FG000|STARTED|Overall Study||42||
48272424|NCT00552929|100991965|FG002|COMPLETED|Overall Study||10||
48272425|NCT00552929|100991966|FG003|COMPLETED|Overall Study||11||
48272426|NCT00552929|100991967|FG004|COMPLETED|Overall Study||10||
48272427|NCT00552929|100991968|FG005|COMPLETED|Overall Study||9||
48272428|NCT00552929|100991969|FG006|COMPLETED|Overall Study||10||
48272429|NCT00552929|100991970|FG007|COMPLETED|Overall Study||11||
48109935|NCT02660918|100597807|FG001|STARTED|Overall Study||42||
48109936|NCT02660918|100597806|FG000|COMPLETED|Overall Study||41||
48109937|NCT02660918|100597807|FG001|COMPLETED|Overall Study||41||
48272430|NCT00552929|100991971|FG008|COMPLETED|Overall Study||9||
48272431|NCT00552929|100991972|FG009|COMPLETED|Overall Study||11||
48272432|NCT00552929|100991963|FG000|NOT COMPLETED|Overall Study||0||
48272433|NCT00552929|100991964|FG001|NOT COMPLETED|Overall Study||0||
48272434|NCT00552929|100991965|FG002|NOT COMPLETED|Overall Study||0||
48272435|NCT00552929|100991966|FG003|NOT COMPLETED|Overall Study||0||
48272436|NCT00552929|100991967|FG004|NOT COMPLETED|Overall Study||0||
48272437|NCT00552929|100991968|FG005|NOT COMPLETED|Overall Study||1||
48272438|NCT00552929|100991969|FG006|NOT COMPLETED|Overall Study||0||
48272439|NCT00552929|100991970|FG007|NOT COMPLETED|Overall Study||0||
48272440|NCT00552929|100991971|FG008|NOT COMPLETED|Overall Study||1||
48272441|NCT00552929|100991972|FG009|NOT COMPLETED|Overall Study||0||
48272442|NCT03388268|100991973|FG000|STARTED|Overall Study||8||
48272443|NCT03388268|100991974|FG001|STARTED|Overall Study||7||
48272444|NCT03388268|100991973|FG000|COMPLETED|Overall Study||7||
48272445|NCT03388268|100991974|FG001|COMPLETED|Overall Study||4||
48272446|NCT03388268|100991973|FG000|NOT COMPLETED|Overall Study||1||
48272447|NCT03388268|100991974|FG001|NOT COMPLETED|Overall Study||3||
48272448|NCT01675453|100991975|FG000|STARTED|Overall Study||20||
48272449|NCT01675453|100991976|FG001|STARTED|Overall Study||20||
48272450|NCT01675453|100991975|FG000|COMPLETED|Overall Study||20||
48272451|NCT01675453|100991976|FG001|COMPLETED|Overall Study||20||
48272452|NCT01675453|100991975|FG000|NOT COMPLETED|Overall Study||0||
48272453|NCT01675453|100991976|FG001|NOT COMPLETED|Overall Study||0||
48272454|NCT00902746|100991977|FG000|STARTED|Overall Study||149||
48272455|NCT00902746|100991977|FG000|Initiation of Study Drug Administration|Overall Study||148||
48555163|NCT05084924|101690761|FG001|NOT COMPLETED|Overall Study||0||
48555164|NCT05084924|101690762|FG002|NOT COMPLETED|Overall Study||0||
48555165|NCT02185339|101690763|FG000|STARTED|Overall Study||30||
48555166|NCT02185339|101690764|FG001|STARTED|Overall Study||31||
48555167|NCT02185339|101690763|FG000|COMPLETED|Overall Study||30||
48555168|NCT02185339|101690764|FG001|COMPLETED|Overall Study||30||
48555169|NCT02185339|101690763|FG000|NOT COMPLETED|Overall Study||0||
48555170|NCT02185339|101690764|FG001|NOT COMPLETED|Overall Study||1||
48555171|NCT01549405|101690765|FG000|STARTED|Overall Study||20||
48555172|NCT01549405|101690766|FG001|STARTED|Overall Study||20||
48555173|NCT01549405|101690765|FG000|COMPLETED|Overall Study||20||
48555174|NCT01549405|101690766|FG001|COMPLETED|Overall Study||20||
48109938|NCT02660918|100597806|FG000|NOT COMPLETED|Overall Study||1||
48109939|NCT02660918|100597807|FG001|NOT COMPLETED|Overall Study||1||
48109940|NCT01466270|100597808|FG000|STARTED|Overall Study||31||
48109941|NCT01466270|100597809|FG001|STARTED|Overall Study||31||
48272456|NCT00902746|100991977|FG000|Transfer to Step 2|Overall Study||133||
48272457|NCT00902746|100991977|FG000|COMPLETED|Overall Study||113||
48693958|NCT03470194|102036261|FG001|NOT COMPLETED|Overall Study||17||
48693959|NCT00104728|102036262|FG000|STARTED|Overall Study||42||
48693960|NCT00104728|102036262|FG000|COMPLETED|Overall Study||23||
48109942|NCT01466270|100597808|FG000|COMPLETED|Overall Study||19||
48109943|NCT01466270|100597809|FG001|COMPLETED|Overall Study||25||
48109944|NCT01466270|100597808|FG000|NOT COMPLETED|Overall Study||12||
48109945|NCT01466270|100597809|FG001|NOT COMPLETED|Overall Study||6||
48109946|NCT03621878|100597810|FG000|STARTED|Overall Study||17|the data from subject whom completed the trials only was used in the statistical analysis and result|
48109947|NCT03621878|100597811|FG001|STARTED|Overall Study||17|the data from subject whom completed the trials only was used in the statistical analysis and result|
48109948|NCT03621878|100597812|FG002|STARTED|Overall Study||17|the data from subject whom completed the trials only was used in the statistical analysis and result|
48555175|NCT01549405|101690765|FG000|NOT COMPLETED|Overall Study||0||
48555176|NCT01549405|101690766|FG001|NOT COMPLETED|Overall Study||0||
48555177|NCT02635984|101690767|FG000|STARTED|Overall Study||53||
48693961|NCT00104728|102036262|FG000|NOT COMPLETED|Overall Study||19||
48710708|NCT00846040|102077993|FG000|COMPLETED|Second Treatment: After Washout, 14 Day||9||
48109949|NCT03621878|100597810|FG000|COMPLETED|Overall Study||17||
48109950|NCT03621878|100597811|FG001|COMPLETED|Overall Study||17||
48109951|NCT03621878|100597812|FG002|COMPLETED|Overall Study||17||
48109952|NCT03621878|100597810|FG000|NOT COMPLETED|Overall Study||0||
48109953|NCT03621878|100597811|FG001|NOT COMPLETED|Overall Study||0||
48109954|NCT03621878|100597812|FG002|NOT COMPLETED|Overall Study||0||
48109955|NCT05583903|100597813|FG000|STARTED|Overall Study||15||
48109956|NCT05583903|100597814|FG001|STARTED|Overall Study||15||
48109957|NCT05583903|100597813|FG000|COMPLETED|Overall Study||15||
48109958|NCT05583903|100597814|FG001|COMPLETED|Overall Study||15||
48109959|NCT05583903|100597813|FG000|NOT COMPLETED|Overall Study||0||
48109960|NCT05583903|100597814|FG001|NOT COMPLETED|Overall Study||0||
48109961|NCT03818516|100597815|FG000|STARTED|Overall Study||12||
48109962|NCT03818516|100597815|FG000|COMPLETED|Overall Study||11||
48109963|NCT03818516|100597815|FG000|NOT COMPLETED|Overall Study||1||
48109964|NCT01617603|100597816|FG000|STARTED|Overall Study||20||
48109965|NCT01617603|100597817|FG001|STARTED|Overall Study||21||
48109966|NCT01617603|100597818|FG002|STARTED|Overall Study||21||
48109967|NCT01617603|100597816|FG000|COMPLETED|Overall Study||17||
48109968|NCT01617603|100597817|FG001|COMPLETED|Overall Study||19||
48109969|NCT01617603|100597818|FG002|COMPLETED|Overall Study||20||
48109970|NCT01617603|100597816|FG000|NOT COMPLETED|Overall Study||3||
48109971|NCT01617603|100597817|FG001|NOT COMPLETED|Overall Study||2||
48109972|NCT01617603|100597818|FG002|NOT COMPLETED|Overall Study||1||
48109973|NCT00358462|100597819|FG000|STARTED|Overall Study||304||
48109974|NCT00358462|100597820|FG001|STARTED|Overall Study||302||
48109975|NCT00358462|100597819|FG000|COMPLETED|Overall Study||245||
48109976|NCT00358462|100597820|FG001|COMPLETED|Overall Study||238||
48109977|NCT00358462|100597819|FG000|NOT COMPLETED|Overall Study||59||
48109978|NCT00358462|100597820|FG001|NOT COMPLETED|Overall Study||64||
48109979|NCT01746784|100597821|FG000|STARTED|Overall Study||19||
48109980|NCT01746784|100597822|FG001|STARTED|Overall Study||10||
48109981|NCT01746784|100597823|FG002|STARTED|Overall Study||9||
48109982|NCT01746784|100597824|FG003|STARTED|Overall Study||9||
48109983|NCT01746784|100597825|FG004|STARTED|Overall Study||19||
48109984|NCT01746784|100597821|FG000|Enrolled|Overall Study||19||
48109985|NCT01746784|100597822|FG001|Enrolled|Overall Study||10||
48109986|NCT01746784|100597823|FG002|Enrolled|Overall Study||9||
48109987|NCT01746784|100597824|FG003|Enrolled|Overall Study||9||
48109988|NCT01746784|100597825|FG004|Enrolled|Overall Study||19||
48109989|NCT01746784|100597821|FG000|COMPLETED|Overall Study||19||
48109990|NCT01746784|100597822|FG001|COMPLETED|Overall Study||10||
48109991|NCT01746784|100597823|FG002|COMPLETED|Overall Study||9||
48109992|NCT01746784|100597824|FG003|COMPLETED|Overall Study||9||
48109993|NCT01746784|100597825|FG004|COMPLETED|Overall Study||19||
48109994|NCT01746784|100597821|FG000|NOT COMPLETED|Overall Study||0||
48109995|NCT01746784|100597822|FG001|NOT COMPLETED|Overall Study||0||
48109996|NCT01746784|100597823|FG002|NOT COMPLETED|Overall Study||0||
48109997|NCT01746784|100597824|FG003|NOT COMPLETED|Overall Study||0||
48109998|NCT01746784|100597825|FG004|NOT COMPLETED|Overall Study||0||
48109999|NCT03865329|100597826|FG000|STARTED|Overall Study||9||
48110000|NCT03865329|100597826|FG000|COMPLETED|Overall Study||9||
48110001|NCT03865329|100597826|FG000|NOT COMPLETED|Overall Study||0||
48110002|NCT03299842|100597827|FG000|STARTED|Overall Study||5||
48110003|NCT03299842|100597827|FG000|COMPLETED|Overall Study||0||
48110004|NCT03299842|100597827|FG000|NOT COMPLETED|Overall Study||5||
48110005|NCT00697346|100597828|FG000|STARTED|Overall Study||28||
48110006|NCT00697346|100597829|FG001|STARTED|Overall Study||28||
48555178|NCT02635984|101690768|FG001|STARTED|Overall Study||55||
48110007|NCT00697346|100597830|FG002|STARTED|Overall Study||2||
48110008|NCT00697346|100597828|FG000|COMPLETED|Overall Study||0||
48110009|NCT00697346|100597829|FG001|COMPLETED|Overall Study||2||
48110010|NCT00697346|100597830|FG002|COMPLETED|Overall Study||1||
48110011|NCT00697346|100597828|FG000|NOT COMPLETED|Overall Study||28||
48110012|NCT00697346|100597829|FG001|NOT COMPLETED|Overall Study||26||
48110013|NCT00697346|100597830|FG002|NOT COMPLETED|Overall Study||1||
48110014|NCT01188577|100597831|FG000|STARTED|Visit 1||11||
48555179|NCT02635984|101690767|FG000|COMPLETED|Overall Study||50||
48110015|NCT01188577|100597832|FG001|STARTED|Visit 1||12||
48110016|NCT01188577|100597831|FG000|COMPLETED|Visit 1||11||
48110017|NCT01188577|100597832|FG001|COMPLETED|Visit 1||12||
48110018|NCT01188577|100597831|FG000|NOT COMPLETED|Visit 1||0||
48110019|NCT01188577|100597832|FG001|NOT COMPLETED|Visit 1||0||
48110020|NCT01188577|100597831|FG000|STARTED|3-14 Day Washout||11||
48110021|NCT01188577|100597832|FG001|STARTED|3-14 Day Washout||12||
48110022|NCT01188577|100597831|FG000|COMPLETED|3-14 Day Washout||11||
48110023|NCT01188577|100597832|FG001|COMPLETED|3-14 Day Washout||12||
48110024|NCT01188577|100597831|FG000|NOT COMPLETED|3-14 Day Washout||0||
48110025|NCT01188577|100597832|FG001|NOT COMPLETED|3-14 Day Washout||0||
48110026|NCT01188577|100597831|FG000|STARTED|Visit 2||11||
48110027|NCT01188577|100597832|FG001|STARTED|Visit 2||12||
48110028|NCT01188577|100597831|FG000|COMPLETED|Visit 2||11||
48110029|NCT01188577|100597832|FG001|COMPLETED|Visit 2||12||
48110030|NCT01188577|100597831|FG000|NOT COMPLETED|Visit 2||0||
48110031|NCT01188577|100597832|FG001|NOT COMPLETED|Visit 2||0||
48110032|NCT04847674|100597833|FG000|STARTED|Overall Study||32||
48110033|NCT04847674|100597834|FG001|STARTED|Overall Study||33||
48110034|NCT04847674|100597835|FG002|STARTED|Overall Study||32||
48110035|NCT04847674|100597833|FG000|Received at Least 1 Dose of Study Drug as Randomized|Overall Study||31||
48110036|NCT04847674|100597834|FG001|Received at Least 1 Dose of Study Drug as Randomized|Overall Study||33||
48110037|NCT04847674|100597835|FG002|Received at Least 1 Dose of Study Drug as Randomized|Overall Study||32||
48110038|NCT04847674|100597833|FG000|Modified Intent-to-treat (mITT) Analysis Set|Overall Study||31|All randomized participants who received at least a partial dose of study drug.|
48110039|NCT04847674|100597834|FG001|Modified Intent-to-treat (mITT) Analysis Set|Overall Study||33|All randomized participants who received at least a partial dose of study drug.|
48110040|NCT04847674|100597835|FG002|Modified Intent-to-treat (mITT) Analysis Set|Overall Study||32|All randomized participants who received at least a partial dose of study drug.|
48110041|NCT04847674|100597833|FG000|Safety Analysis Set|Overall Study||31|All randomized participants who received at least 1 dose of study drug. In this set, data were summarized based upon the treatment actually received regardless of the assigned treatment.|
48110042|NCT04847674|100597834|FG001|Safety Analysis Set|Overall Study||34|All randomized participants who received at least 1 dose of study drug. In this set, data were summarized based upon the treatment actually received regardless of the assigned treatment.|
48110043|NCT04847674|100597835|FG002|Safety Analysis Set|Overall Study||31|All randomized participants who received at least 1 dose of study drug. In this set, data were summarized based upon the treatment actually received regardless of the assigned treatment.|
48272458|NCT00902746|100991977|FG000|NOT COMPLETED|Overall Study||36||
48272459|NCT00603525|100991978|FG000|STARTED|DB Treatment Period (24 Weeks)||84||
48272460|NCT00603525|100991979|FG001|STARTED|DB Treatment Period (24 Weeks)||85||
48272461|NCT00603525|100991980|FG002|STARTED|DB Treatment Period (24 Weeks)||0||
48272462|NCT00603525|100991978|FG000|COMPLETED|DB Treatment Period (24 Weeks)||67||
48555180|NCT02635984|101690768|FG001|COMPLETED|Overall Study||51||
48555181|NCT02635984|101690767|FG000|NOT COMPLETED|Overall Study||3||
48555182|NCT02635984|101690768|FG001|NOT COMPLETED|Overall Study||4||
48555183|NCT00825786|101690769|FG000|STARTED|Overall Study||52||
48555184|NCT00825786|101690770|FG001|STARTED|Overall Study||51||
48555185|NCT00825786|101690769|FG000|COMPLETED|Overall Study||52||
48555186|NCT00825786|101690770|FG001|COMPLETED|Overall Study||51||
48555187|NCT00825786|101690769|FG000|NOT COMPLETED|Overall Study||0||
48555188|NCT00825786|101690770|FG001|NOT COMPLETED|Overall Study||0||
48555189|NCT03301649|101690771|FG000|STARTED|Overall Study||399||
48555190|NCT03301649|101690772|FG001|STARTED|Overall Study||400||
48555191|NCT03301649|101690773|FG002|STARTED|Overall Study||112||
48555192|NCT03301649|101690771|FG000|Safety Population|Overall Study||399|Randomized participants who received the study drug.|
48555193|NCT03301649|101690772|FG001|Safety Population|Overall Study||400|Randomized participants who received the study drug.|
48555194|NCT03301649|101690773|FG002|Safety Population|Overall Study||112|Randomized participants who received the study drug.|
48555195|NCT03301649|101690771|FG000|Modified Intent-to-treat(mITT)Population|Overall Study||372|Randomized participants, met study criteria, applied study drug, ≥1 post-baseline evaluation visit.|
48555196|NCT03301649|101690772|FG001|Modified Intent-to-treat(mITT)Population|Overall Study||380|Randomized participants, met study criteria, applied study drug, ≥1 post-baseline evaluation visit.|
48555197|NCT03301649|101690773|FG002|Modified Intent-to-treat(mITT)Population|Overall Study||111|Randomized participants, met study criteria, applied study drug, ≥1 post-baseline evaluation visit.|
48555198|NCT03301649|101690771|FG000|Per-protocol (PP) Population|Overall Study||345|mITT, made final study visit (Day 15 ± 2 days), and had no significant protocol deviations.|
48555199|NCT03301649|101690772|FG001|Per-protocol (PP) Population|Overall Study||354|mITT, made final study visit (Day 15 ± 2 days), and had no significant protocol deviations.|
48555200|NCT03301649|101690773|FG002|Per-protocol (PP) Population|Overall Study||103|mITT, made final study visit (Day 15 ± 2 days), and had no significant protocol deviations.|
48555201|NCT03301649|101690771|FG000|COMPLETED|Overall Study||356||
48555202|NCT03301649|101690772|FG001|COMPLETED|Overall Study||356||
48555203|NCT03301649|101690773|FG002|COMPLETED|Overall Study||27||
48555204|NCT03301649|101690771|FG000|NOT COMPLETED|Overall Study||43||
48555205|NCT03301649|101690772|FG001|NOT COMPLETED|Overall Study||44||
48555206|NCT03301649|101690773|FG002|NOT COMPLETED|Overall Study||85||
48555207|NCT00858273|101690774|FG000|STARTED|Overall Study||20||
48110044|NCT04847674|100597833|FG000|COMPLETED|Overall Study||11||
48110045|NCT04847674|100597834|FG001|COMPLETED|Overall Study||12||
48110046|NCT04847674|100597835|FG002|COMPLETED|Overall Study||10||
48110047|NCT04847674|100597833|FG000|NOT COMPLETED|Overall Study||21||
48392942|NCT01818986|101291469|FG000|COMPLETED|Overall Study||20||
48272463|NCT00603525|100991979|FG001|COMPLETED|DB Treatment Period (24 Weeks)||63||
48272464|NCT00603525|100991980|FG002|COMPLETED|DB Treatment Period (24 Weeks)||0||
48272465|NCT00603525|100991978|FG000|NOT COMPLETED|DB Treatment Period (24 Weeks)||17||
48272466|NCT00603525|100991979|FG001|NOT COMPLETED|DB Treatment Period (24 Weeks)||22||
48110048|NCT04847674|100597834|FG001|NOT COMPLETED|Overall Study||21||
48110049|NCT04847674|100597835|FG002|NOT COMPLETED|Overall Study||22||
48110050|NCT01434290|100597836|FG000|STARTED|Overall Study||127||
48110051|NCT01434290|100597837|FG001|STARTED|Overall Study||128||
48110052|NCT01434290|100597836|FG000|COMPLETED|Overall Study||119||
48110053|NCT01434290|100597837|FG001|COMPLETED|Overall Study||121||
48110054|NCT01434290|100597836|FG000|NOT COMPLETED|Overall Study||8||
48110055|NCT01434290|100597837|FG001|NOT COMPLETED|Overall Study||7||
48110056|NCT01339390|100597838|FG000|STARTED|Overall Study||1571||
48110057|NCT01339390|100597839|FG001|STARTED|Overall Study||1598||
48110058|NCT01339390|100597838|FG000|COMPLETED|Overall Study||1414||
48110059|NCT01339390|100597839|FG001|COMPLETED|Overall Study||1442||
48110060|NCT01339390|100597838|FG000|NOT COMPLETED|Overall Study||157||
48110061|NCT01339390|100597839|FG001|NOT COMPLETED|Overall Study||156||
48110062|NCT00654069|100597840|FG000|STARTED|Overall Study||136||
48110063|NCT00654069|100597841|FG001|STARTED|Overall Study||135||
48272467|NCT00603525|100991980|FG002|NOT COMPLETED|DB Treatment Period (24 Weeks)||0||
48272468|NCT00603525|100991978|FG000|STARTED|OL Treatment Period (120 Weeks)||0||
48272469|NCT00603525|100991979|FG001|STARTED|OL Treatment Period (120 Weeks)||125||
48272470|NCT00603525|100991980|FG002|STARTED|OL Treatment Period (120 Weeks)||0||
48272471|NCT00603525|100991978|FG000|COMPLETED|OL Treatment Period (120 Weeks)||0||
48272472|NCT00603525|100991979|FG001|COMPLETED|OL Treatment Period (120 Weeks)||13||
48110064|NCT00654069|100597842|FG002|STARTED|Overall Study||134||
48110065|NCT00654069|100597840|FG000|COMPLETED|Overall Study||119||
48110066|NCT00654069|100597841|FG001|COMPLETED|Overall Study||124||
48110067|NCT00654069|100597842|FG002|COMPLETED|Overall Study||116||
48110068|NCT00654069|100597840|FG000|NOT COMPLETED|Overall Study||17||
48110069|NCT00654069|100597841|FG001|NOT COMPLETED|Overall Study||11||
48110070|NCT00654069|100597842|FG002|NOT COMPLETED|Overall Study||18||
48110071|NCT04187196|100597843|FG000|STARTED|Overall Study||35||
48110072|NCT04187196|100597844|FG001|STARTED|Overall Study||38||
48110073|NCT04187196|100597843|FG000|COMPLETED|Overall Study||33||
48110074|NCT04187196|100597844|FG001|COMPLETED|Overall Study||38||
48110075|NCT04187196|100597843|FG000|NOT COMPLETED|Overall Study||2||
48110076|NCT04187196|100597844|FG001|NOT COMPLETED|Overall Study||0||
48110077|NCT02540954|100597845|FG000|STARTED|Overall Study||168|Randomized|
48110078|NCT02540954|100597846|FG001|STARTED|Overall Study||168|Randomized|
48110079|NCT02540954|100597845|FG000|Treated|Overall Study||167||
48110080|NCT02540954|100597846|FG001|Treated|Overall Study||168||
48110081|NCT02540954|100597845|FG000|Post-baseline BCVA Assessment|Overall Study||165||
48110082|NCT02540954|100597846|FG001|Post-baseline BCVA Assessment|Overall Study||167||
48110083|NCT02540954|100597845|FG000|COMPLETED|Overall Study||149||
48110084|NCT02540954|100597846|FG001|COMPLETED|Overall Study||154||
48110085|NCT02540954|100597845|FG000|NOT COMPLETED|Overall Study||19||
48110086|NCT02540954|100597846|FG001|NOT COMPLETED|Overall Study||14||
48110087|NCT02633956|100597847|FG000|STARTED|Overall Study||20||
48110088|NCT02633956|100597848|FG001|STARTED|Overall Study||21||
48110089|NCT02633956|100597849|FG002|STARTED|Overall Study||22||
48110090|NCT02633956|100597850|FG003|STARTED|Overall Study||21||
48110091|NCT02633956|100597847|FG000|COMPLETED|Overall Study||19||
48110092|NCT02633956|100597848|FG001|COMPLETED|Overall Study||19||
48110093|NCT02633956|100597849|FG002|COMPLETED|Overall Study||20||
48110094|NCT02633956|100597850|FG003|COMPLETED|Overall Study||21||
48110095|NCT02633956|100597847|FG000|NOT COMPLETED|Overall Study||1||
48110096|NCT02633956|100597848|FG001|NOT COMPLETED|Overall Study||2||
48110097|NCT02633956|100597849|FG002|NOT COMPLETED|Overall Study||2||
48110098|NCT02633956|100597850|FG003|NOT COMPLETED|Overall Study||0||
48110099|NCT00794196|100597851|FG000|STARTED|Overall Study||92||
48110100|NCT00794196|100597852|FG001|STARTED|Overall Study||87||
48110101|NCT00794196|100597851|FG000|COMPLETED|Overall Study||87||
48110102|NCT00794196|100597852|FG001|COMPLETED|Overall Study||64||
48110103|NCT00794196|100597851|FG000|NOT COMPLETED|Overall Study||5||
48110104|NCT00794196|100597852|FG001|NOT COMPLETED|Overall Study||23||
48110105|NCT02623803|100597853|FG000|STARTED|Overall Study||25||
48110106|NCT02623803|100597854|FG001|STARTED|Overall Study||23||
48110107|NCT02623803|100597853|FG000|COMPLETED|Overall Study||25||
48110108|NCT02623803|100597854|FG001|COMPLETED|Overall Study||23||
48110109|NCT02623803|100597853|FG000|NOT COMPLETED|Overall Study||0||
48110110|NCT02623803|100597854|FG001|NOT COMPLETED|Overall Study||0||
48110111|NCT02920983|100597855|FG000|STARTED|Dispense 1||8||
48110112|NCT02920983|100597856|FG001|STARTED|Dispense 1||10||
48110113|NCT02920983|100597857|FG002|STARTED|Dispense 1||7||
48110114|NCT02920983|100597858|FG003|STARTED|Dispense 1||6||
48110115|NCT02920983|100597859|FG004|STARTED|Dispense 1||13||
48110116|NCT02920983|100597860|FG005|STARTED|Dispense 1||7||
48110117|NCT02920983|100597855|FG000|COMPLETED|Dispense 1||8||
48110118|NCT02920983|100597856|FG001|COMPLETED|Dispense 1||10||
48110119|NCT02920983|100597857|FG002|COMPLETED|Dispense 1||7||
48272473|NCT00603525|100991980|FG002|COMPLETED|OL Treatment Period (120 Weeks)||0||
48392943|NCT01818986|101291469|FG000|NOT COMPLETED|Overall Study||0||
48110120|NCT02920983|100597858|FG003|COMPLETED|Dispense 1||6||
48110121|NCT02920983|100597859|FG004|COMPLETED|Dispense 1||12||
48110122|NCT02920983|100597860|FG005|COMPLETED|Dispense 1||7||
48110123|NCT02920983|100597855|FG000|NOT COMPLETED|Dispense 1||0||
48110124|NCT02920983|100597856|FG001|NOT COMPLETED|Dispense 1||0||
48110125|NCT02920983|100597857|FG002|NOT COMPLETED|Dispense 1||0||
48110126|NCT02920983|100597858|FG003|NOT COMPLETED|Dispense 1||0||
48110127|NCT02920983|100597859|FG004|NOT COMPLETED|Dispense 1||1||
48110128|NCT02920983|100597860|FG005|NOT COMPLETED|Dispense 1||0||
48110129|NCT02920983|100597855|FG000|STARTED|Dispense 2||8||
48110130|NCT02920983|100597856|FG001|STARTED|Dispense 2||10||
48110131|NCT02920983|100597857|FG002|STARTED|Dispense 2||7||
48555208|NCT00858273|101690775|FG001|STARTED|Overall Study||20||
48555209|NCT00858273|101690774|FG000|COMPLETED|Overall Study||17||
48555210|NCT00858273|101690775|FG001|COMPLETED|Overall Study||15||
48555211|NCT00858273|101690774|FG000|NOT COMPLETED|Overall Study||3||
48555212|NCT00858273|101690775|FG001|NOT COMPLETED|Overall Study||5||
48555213|NCT00625820|101690776|FG000|STARTED|Overall Study||17||
48555214|NCT00625820|101690776|FG000|COMPLETED|Overall Study||16||
48555215|NCT00625820|101690776|FG000|NOT COMPLETED|Overall Study||1||
48555216|NCT03888066|101690777|FG000|STARTED|Run-in Phase||1195||
48555217|NCT03888066|101690778|FG001|STARTED|Run-in Phase||0||
48555218|NCT03888066|101690777|FG000|COMPLETED|Run-in Phase||878||
48555219|NCT03888066|101690778|FG001|COMPLETED|Run-in Phase||0||
48555220|NCT03888066|101690777|FG000|NOT COMPLETED|Run-in Phase||317||
48555221|NCT03888066|101690778|FG001|NOT COMPLETED|Run-in Phase||0||
48555222|NCT03888066|101690777|FG000|STARTED|Treatment Phase (Overall Study)||439||
48693962|NCT02620878|102036263|FG000|STARTED|Overall Study||16|"participants in CLOSED LOOP First are also being counted in the OPEN LOOP Second"|
48693963|NCT02620878|102036264|FG001|STARTED|Overall Study||16|"participants in CLOSED LOOP First are also being counted in the OPEN LOOP Second"|
48693964|NCT02620878|102036263|FG000|COMPLETED|Overall Study||16||
48693965|NCT02620878|102036264|FG001|COMPLETED|Overall Study||16||
48693966|NCT02620878|102036263|FG000|NOT COMPLETED|Overall Study||0||
48693967|NCT02620878|102036264|FG001|NOT COMPLETED|Overall Study||0||
48693968|NCT01521923|102036265|FG000|STARTED|Overall Study||66||
48693969|NCT01521923|102036266|FG001|STARTED|Overall Study||81||
48693970|NCT01521923|102036267|FG002|STARTED|Overall Study||127||
48693971|NCT01521923|102036268|FG003|STARTED|Overall Study||83||
48693972|NCT01521923|102036265|FG000|COMPLETED|Overall Study||59||
48693973|NCT01521923|102036266|FG001|COMPLETED|Overall Study||72||
48693974|NCT01521923|102036267|FG002|COMPLETED|Overall Study||112||
48693975|NCT01521923|102036268|FG003|COMPLETED|Overall Study||70||
48110132|NCT02920983|100597858|FG003|STARTED|Dispense 2||6||
48110133|NCT02920983|100597859|FG004|STARTED|Dispense 2||13||
48110134|NCT02920983|100597860|FG005|STARTED|Dispense 2||7||
48110135|NCT02920983|100597855|FG000|COMPLETED|Dispense 2||7||
48110136|NCT02920983|100597856|FG001|COMPLETED|Dispense 2||10||
48110137|NCT02920983|100597857|FG002|COMPLETED|Dispense 2||7||
48110138|NCT02920983|100597858|FG003|COMPLETED|Dispense 2||6||
48110139|NCT02920983|100597859|FG004|COMPLETED|Dispense 2||12||
48110140|NCT02920983|100597860|FG005|COMPLETED|Dispense 2||7||
48110141|NCT02920983|100597855|FG000|NOT COMPLETED|Dispense 2||1||
48110142|NCT02920983|100597856|FG001|NOT COMPLETED|Dispense 2||0||
48110143|NCT02920983|100597857|FG002|NOT COMPLETED|Dispense 2||0||
48110144|NCT02920983|100597858|FG003|NOT COMPLETED|Dispense 2||0||
48110145|NCT02920983|100597859|FG004|NOT COMPLETED|Dispense 2||1||
48555223|NCT03888066|101690778|FG001|STARTED|Treatment Phase (Overall Study)||439||
48110146|NCT02920983|100597860|FG005|NOT COMPLETED|Dispense 2||0||
48110147|NCT02920983|100597855|FG000|STARTED|Dispense 3||8||
48110148|NCT02920983|100597856|FG001|STARTED|Dispense 3||10||
48110149|NCT02920983|100597857|FG002|STARTED|Dispense 3||7||
48110150|NCT02920983|100597858|FG003|STARTED|Dispense 3||6||
48110151|NCT02920983|100597859|FG004|STARTED|Dispense 3||13||
48110152|NCT02920983|100597860|FG005|STARTED|Dispense 3||7||
48110153|NCT02920983|100597855|FG000|COMPLETED|Dispense 3||7||
48110154|NCT02920983|100597856|FG001|COMPLETED|Dispense 3||9||
48110155|NCT02920983|100597857|FG002|COMPLETED|Dispense 3||7||
48110156|NCT02920983|100597858|FG003|COMPLETED|Dispense 3||6||
48110157|NCT02920983|100597859|FG004|COMPLETED|Dispense 3||12||
48110158|NCT02920983|100597860|FG005|COMPLETED|Dispense 3||7||
48110159|NCT02920983|100597855|FG000|NOT COMPLETED|Dispense 3||1||
48110160|NCT02920983|100597856|FG001|NOT COMPLETED|Dispense 3||1||
48110161|NCT02920983|100597857|FG002|NOT COMPLETED|Dispense 3||0||
48110162|NCT02920983|100597858|FG003|NOT COMPLETED|Dispense 3||0||
48110163|NCT02920983|100597859|FG004|NOT COMPLETED|Dispense 3||1||
48110164|NCT02920983|100597860|FG005|NOT COMPLETED|Dispense 3||0||
48110165|NCT02146482|100597861|FG000|STARTED|Overall Study||21||
48110166|NCT02146482|100597862|FG001|STARTED|Overall Study||25||
48110167|NCT02146482|100597861|FG000|COMPLETED|Overall Study||21||
48110168|NCT02146482|100597862|FG001|COMPLETED|Overall Study||25||
48555224|NCT03888066|101690777|FG000|COMPLETED|Treatment Phase (Overall Study)||360||
48555225|NCT03888066|101690778|FG001|COMPLETED|Treatment Phase (Overall Study)||367||
48555226|NCT03888066|101690777|FG000|NOT COMPLETED|Treatment Phase (Overall Study)||79||
48555227|NCT03888066|101690778|FG001|NOT COMPLETED|Treatment Phase (Overall Study)||72||
48555228|NCT01564537|101690779|FG000|STARTED|Overall Study||360||
48110169|NCT02146482|100597861|FG000|NOT COMPLETED|Overall Study||0||
48110170|NCT02146482|100597862|FG001|NOT COMPLETED|Overall Study||0||
48110171|NCT00855309|100597863|FG000|STARTED|Overall Study||57||
48110172|NCT00855309|100597864|FG001|STARTED|Overall Study||55||
48110173|NCT00855309|100597863|FG000|COMPLETED|Overall Study||56||
48110174|NCT00855309|100597864|FG001|COMPLETED|Overall Study||55||
48110175|NCT00855309|100597863|FG000|NOT COMPLETED|Overall Study||1||
48110176|NCT00855309|100597864|FG001|NOT COMPLETED|Overall Study||0||
48110177|NCT01076985|100597865|FG000|STARTED|Overall Study||24||
48110178|NCT01076985|100597865|FG000|COMPLETED|Overall Study||24||
48272474|NCT00603525|100991978|FG000|NOT COMPLETED|OL Treatment Period (120 Weeks)||0||
48555229|NCT01564537|101690780|FG001|STARTED|Overall Study||362||
48555230|NCT01564537|101690779|FG000|Intent-to-Treat (ITT) Population|Overall Study||360|ITT population was defined as all randomized participants.|
48555231|NCT01564537|101690780|FG001|Intent-to-Treat (ITT) Population|Overall Study||362|ITT population was defined as all randomized participants.|
48555232|NCT01564537|101690779|FG000|Safety Population|Overall Study||361|Safety population included all randomized participants who received at least 1 dose of any study drug, regardless of their randomized treatment.|
48555233|NCT01564537|101690780|FG001|Safety Population|Overall Study||359|Safety population included all randomized participants who received at least 1 dose of any study drug, regardless of their randomized treatment.|
48592726|NCT02143791|101783167|FG000|STARTED|Any Program (6-12 Months)||88||
48272475|NCT00603525|100991979|FG001|NOT COMPLETED|OL Treatment Period (120 Weeks)||112||
48110179|NCT01076985|100597865|FG000|NOT COMPLETED|Overall Study||0||
48110180|NCT01482767|100597866|FG000|STARTED|Overall Study||135||
48110181|NCT01482767|100597867|FG001|STARTED|Overall Study||127||
48110182|NCT01482767|100597866|FG000|COMPLETED|Overall Study||81||
48110183|NCT01482767|100597867|FG001|COMPLETED|Overall Study||78||
48110184|NCT01482767|100597866|FG000|NOT COMPLETED|Overall Study||54||
48110185|NCT01482767|100597867|FG001|NOT COMPLETED|Overall Study||49||
48110186|NCT01110421|100597868|FG000|STARTED|Overall Study||5||
48110187|NCT01110421|100597869|FG001|STARTED|Overall Study||2||
48110188|NCT01110421|100597868|FG000|COMPLETED|Overall Study||5||
48272476|NCT00603525|100991980|FG002|NOT COMPLETED|OL Treatment Period (120 Weeks)||0||
48272477|NCT00603525|100991978|FG000|STARTED|Follow-up Period (Approximately 2 Years)||0||
48272478|NCT00603525|100991979|FG001|STARTED|Follow-up Period (Approximately 2 Years)||0||
48272479|NCT00603525|100991980|FG002|STARTED|Follow-up Period (Approximately 2 Years)||124||
48272480|NCT00603525|100991978|FG000|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0||
48272481|NCT00603525|100991979|FG001|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0||
48272482|NCT00603525|100991980|FG002|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||111||
48272483|NCT00603525|100991978|FG000|COMPLETED|Follow-up Period (Approximately 2 Years)||0||
48272484|NCT00603525|100991979|FG001|COMPLETED|Follow-up Period (Approximately 2 Years)||0||
48272485|NCT00603525|100991980|FG002|COMPLETED|Follow-up Period (Approximately 2 Years)||13||
48272486|NCT00603525|100991978|FG000|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0||
48272487|NCT00603525|100991979|FG001|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0||
48110189|NCT01110421|100597869|FG001|COMPLETED|Overall Study||2||
48110190|NCT01110421|100597868|FG000|NOT COMPLETED|Overall Study||0||
48110191|NCT01110421|100597869|FG001|NOT COMPLETED|Overall Study||0||
48110192|NCT00526058|100597870|FG000|STARTED|Period: First Intervention||9||
48110193|NCT00526058|100597871|FG001|STARTED|Period: First Intervention||9||
48110194|NCT00526058|100597870|FG000|COMPLETED|Period: First Intervention||9||
48110195|NCT00526058|100597871|FG001|COMPLETED|Period: First Intervention||9||
48272488|NCT00603525|100991980|FG002|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||111||
48272489|NCT02954198|100991981|FG000|STARTED|Overall Study||20||
48555234|NCT01564537|101690779|FG000|Response Evaluable Population|Overall Study||345|Response-Evaluable population included all participants who received at least 1 dose of study drug, had measurable disease at baseline, and at least 1 post-baseline response assessment.|
48555235|NCT01564537|101690780|FG001|Response Evaluable Population|Overall Study||348|Response-Evaluable population included all participants who received at least 1 dose of study drug, had measurable disease at baseline, and at least 1 post-baseline response assessment.|
48555236|NCT01564537|101690779|FG000|COMPLETED|Overall Study||259||
48555237|NCT01564537|101690780|FG001|COMPLETED|Overall Study||263||
48555238|NCT01564537|101690779|FG000|NOT COMPLETED|Overall Study||101||
48555239|NCT01564537|101690780|FG001|NOT COMPLETED|Overall Study||99||
48555240|NCT01917682|101690781|FG000|STARTED|Overall Study||754||
48555241|NCT01917682|101690781|FG000|COMPLETED|Overall Study||754||
48555242|NCT01917682|101690781|FG000|NOT COMPLETED|Overall Study||0||
48555243|NCT02350816|101690782|FG000|STARTED|Overall Study||7||
48555244|NCT02350816|101690783|FG001|STARTED|Overall Study||6||
48555245|NCT02350816|101690784|FG002|STARTED|Overall Study||2||
48555246|NCT02350816|101690785|FG003|STARTED|Overall Study||2||
48555247|NCT02350816|101690782|FG000|COMPLETED|Overall Study||7|Participants who completed treatment period.|
48555248|NCT02350816|101690783|FG001|COMPLETED|Overall Study||6|Participants who completed treatment period.|
48555249|NCT02350816|101690784|FG002|COMPLETED|Overall Study||2|Participants who completed treatment period.|
48110196|NCT00526058|100597870|FG000|NOT COMPLETED|Period: First Intervention||0||
48110197|NCT00526058|100597871|FG001|NOT COMPLETED|Period: First Intervention||0||
48110198|NCT00526058|100597870|FG000|STARTED|Period: Second Intervention||9||
48110199|NCT00526058|100597871|FG001|STARTED|Period: Second Intervention||9||
48110200|NCT00526058|100597870|FG000|COMPLETED|Period: Second Intervention||9||
48110201|NCT00526058|100597871|FG001|COMPLETED|Period: Second Intervention||9||
48110202|NCT00526058|100597870|FG000|NOT COMPLETED|Period: Second Intervention||0||
48110203|NCT00526058|100597871|FG001|NOT COMPLETED|Period: Second Intervention||0||
48110204|NCT00397982|100597872|FG000|STARTED|Overall Study||17||
48110205|NCT00397982|100597872|FG000|COMPLETED|Overall Study||13||
48110206|NCT00397982|100597872|FG000|NOT COMPLETED|Overall Study||4||
48110207|NCT01552772|100597873|FG000|STARTED|Overall Study||60||
48110208|NCT01552772|100597873|FG000|COMPLETED|Overall Study||56||
48110209|NCT01552772|100597873|FG000|NOT COMPLETED|Overall Study||4||
48110210|NCT02789176|100597874|FG000|STARTED|Overall Study||99||
48110211|NCT02789176|100597875|FG001|STARTED|Overall Study||55||
48110212|NCT02789176|100597876|FG002|STARTED|Overall Study||95||
48110213|NCT02789176|100597877|FG003|STARTED|Overall Study||54||
48110214|NCT02789176|100597874|FG000|COMPLETED|Overall Study||91||
48110215|NCT02789176|100597875|FG001|COMPLETED|Overall Study||53||
48110216|NCT02789176|100597876|FG002|COMPLETED|Overall Study||85||
48110217|NCT02789176|100597877|FG003|COMPLETED|Overall Study||53||
48110218|NCT02789176|100597874|FG000|NOT COMPLETED|Overall Study||8||
48110219|NCT02789176|100597875|FG001|NOT COMPLETED|Overall Study||2||
48110220|NCT02789176|100597876|FG002|NOT COMPLETED|Overall Study||10||
48110221|NCT02789176|100597877|FG003|NOT COMPLETED|Overall Study||1||
48110222|NCT01129141|100597878|FG000|STARTED|Overall Study||101||
48110223|NCT01129141|100597879|FG001|STARTED|Overall Study||104||
48110224|NCT01129141|100597878|FG000|COMPLETED|Overall Study||86||
48110225|NCT01129141|100597879|FG001|COMPLETED|Overall Study||91||
48110226|NCT01129141|100597878|FG000|NOT COMPLETED|Overall Study||15||
48110227|NCT01129141|100597879|FG001|NOT COMPLETED|Overall Study||13||
48110228|NCT01436279|100597880|FG000|STARTED|Overall Study||30||
48110229|NCT01436279|100597881|FG001|STARTED|Overall Study||20||
48110230|NCT01436279|100597880|FG000|COMPLETED|Overall Study||30||
48110231|NCT01436279|100597881|FG001|COMPLETED|Overall Study||20||
48110232|NCT01436279|100597880|FG000|NOT COMPLETED|Overall Study||0||
48110233|NCT01436279|100597881|FG001|NOT COMPLETED|Overall Study||0||
48110234|NCT02188576|100597882|FG000|STARTED|Overall Study||32||
48110235|NCT02188576|100597883|FG001|STARTED|Overall Study||34||
48110236|NCT02188576|100597882|FG000|COMPLETED|Overall Study||32||
48110237|NCT02188576|100597883|FG001|COMPLETED|Overall Study||34||
48110238|NCT02188576|100597882|FG000|NOT COMPLETED|Overall Study||0||
48110239|NCT02188576|100597883|FG001|NOT COMPLETED|Overall Study||0||
48110240|NCT01524770|100597884|FG000|STARTED|First Intervention||26||
48110241|NCT01524770|100597885|FG001|STARTED|First Intervention||24||
48110242|NCT01524770|100597884|FG000|Received at Least 1 Dose of Study Drug|First Intervention||26||
48272490|NCT02954198|100991982|FG001|STARTED|Overall Study||20||
48272491|NCT02954198|100991981|FG000|COMPLETED|Overall Study||20||
48555250|NCT02350816|101690785|FG003|COMPLETED|Overall Study||2|Participants who completed treatment period.|
48555251|NCT02350816|101690782|FG000|NOT COMPLETED|Overall Study||0||
48110243|NCT01524770|100597885|FG001|Received at Least 1 Dose of Study Drug|First Intervention||24||
48110244|NCT01524770|100597884|FG000|COMPLETED|First Intervention||23||
48110245|NCT01524770|100597885|FG001|COMPLETED|First Intervention||23||
48110246|NCT01524770|100597884|FG000|NOT COMPLETED|First Intervention||3||
48110247|NCT01524770|100597885|FG001|NOT COMPLETED|First Intervention||1||
48110248|NCT01524770|100597884|FG000|STARTED|Washout Period of at Least 28 Days||23||
48272492|NCT02954198|100991982|FG001|COMPLETED|Overall Study||20||
48555252|NCT02350816|101690783|FG001|NOT COMPLETED|Overall Study||0||
48110249|NCT01524770|100597885|FG001|STARTED|Washout Period of at Least 28 Days||23||
48110250|NCT01524770|100597884|FG000|COMPLETED|Washout Period of at Least 28 Days||23||
48110251|NCT01524770|100597885|FG001|COMPLETED|Washout Period of at Least 28 Days||23||
48110252|NCT01524770|100597884|FG000|NOT COMPLETED|Washout Period of at Least 28 Days||0||
48110253|NCT01524770|100597885|FG001|NOT COMPLETED|Washout Period of at Least 28 Days||0||
48110254|NCT01524770|100597884|FG000|STARTED|Second Intervention||23||
48110255|NCT01524770|100597885|FG001|STARTED|Second Intervention||23||
48110256|NCT01524770|100597884|FG000|COMPLETED|Second Intervention||23||
48110257|NCT01524770|100597885|FG001|COMPLETED|Second Intervention||23||
48110258|NCT01524770|100597884|FG000|NOT COMPLETED|Second Intervention||0||
48110259|NCT01524770|100597885|FG001|NOT COMPLETED|Second Intervention||0||
48110260|NCT00439556|100597886|FG000|STARTED|Overall Study||36||
48272493|NCT02954198|100991981|FG000|NOT COMPLETED|Overall Study||0||
48272494|NCT02954198|100991982|FG001|NOT COMPLETED|Overall Study||0||
48272495|NCT01840410|100991983|FG000|STARTED|Overall Study||119||
48272496|NCT01840410|100991984|FG001|STARTED|Overall Study||59||
48272497|NCT01840410|100991983|FG000|Safety Set|Overall Study||119||
48272498|NCT01840410|100991984|FG001|Safety Set|Overall Study||59||
48272499|NCT01840410|100991983|FG000|Full Analysis Set|Overall Study||119||
48555253|NCT02350816|101690784|FG002|NOT COMPLETED|Overall Study||0||
48555254|NCT02350816|101690785|FG003|NOT COMPLETED|Overall Study||0||
48555255|NCT01295320|101690786|FG000|STARTED|Overall Study||129||
48555256|NCT01295320|101690786|FG000|COMPLETED|Overall Study||119||
48555257|NCT01295320|101690786|FG000|NOT COMPLETED|Overall Study||10||
48555258|NCT00742209|101690787|FG000|STARTED|Overall Study||129||
48555259|NCT00742209|101690788|FG001|STARTED|Overall Study||67||
48555260|NCT00742209|101690789|FG002|STARTED|Overall Study||134||
48555261|NCT00742209|101690790|FG003|STARTED|Overall Study||134||
48555262|NCT00742209|101690791|FG004|STARTED|Overall Study||62||
48110261|NCT00439556|100597887|FG001|STARTED|Overall Study||4||
48110262|NCT00439556|100597888|FG002|STARTED|Overall Study||0||
48110263|NCT00439556|100597886|FG000|COMPLETED|Overall Study||36||
48110264|NCT00439556|100597887|FG001|COMPLETED|Overall Study||3||
48110265|NCT00439556|100597888|FG002|COMPLETED|Overall Study||0||
48110266|NCT00439556|100597886|FG000|NOT COMPLETED|Overall Study||0||
48110267|NCT00439556|100597887|FG001|NOT COMPLETED|Overall Study||1||
48110268|NCT00439556|100597888|FG002|NOT COMPLETED|Overall Study||0||
48110269|NCT00386256|100597889|FG000|STARTED|Overall Study||16||
48110270|NCT00386256|100597890|FG001|STARTED|Overall Study||15||
48110271|NCT00386256|100597891|FG002|STARTED|Overall Study||4||
48110272|NCT00386256|100597892|FG003|STARTED|Overall Study||3||
48110273|NCT00386256|100597889|FG000|COMPLETED|Overall Study||16||
48110274|NCT00386256|100597890|FG001|COMPLETED|Overall Study||15||
48272500|NCT01840410|100991984|FG001|Full Analysis Set|Overall Study||59||
48272501|NCT01840410|100991983|FG000|COMPLETED|Overall Study||112||
48272502|NCT01840410|100991984|FG001|COMPLETED|Overall Study||55||
48272503|NCT01840410|100991983|FG000|NOT COMPLETED|Overall Study||7||
48272504|NCT01840410|100991984|FG001|NOT COMPLETED|Overall Study||4||
48272505|NCT04176731|100991985|FG000|STARTED|Overall Study||36||
48555263|NCT00742209|101690787|FG000|COMPLETED|Overall Study||95||
48555264|NCT00742209|101690788|FG001|COMPLETED|Overall Study||49||
48555265|NCT00742209|101690789|FG002|COMPLETED|Overall Study||88||
48693976|NCT01521923|102036265|FG000|NOT COMPLETED|Overall Study||7||
48693977|NCT01521923|102036266|FG001|NOT COMPLETED|Overall Study||9||
48110275|NCT00386256|100597891|FG002|COMPLETED|Overall Study||4||
48110276|NCT00386256|100597892|FG003|COMPLETED|Overall Study||3||
48110277|NCT00386256|100597889|FG000|NOT COMPLETED|Overall Study||0||
48110278|NCT00386256|100597890|FG001|NOT COMPLETED|Overall Study||0||
48110279|NCT00386256|100597891|FG002|NOT COMPLETED|Overall Study||0||
48110280|NCT00386256|100597892|FG003|NOT COMPLETED|Overall Study||0||
48693978|NCT01521923|102036267|FG002|NOT COMPLETED|Overall Study||15||
48693979|NCT01521923|102036268|FG003|NOT COMPLETED|Overall Study||13||
48693980|NCT00107900|102036269|FG000|STARTED|Overall Study||85||
48693981|NCT00107900|102036270|FG001|STARTED|Overall Study||75||
48693982|NCT00107900|102036271|FG002|STARTED|Overall Study||129||
48693983|NCT00107900|102036272|FG003|STARTED|Overall Study||99||
48693984|NCT00107900|102036273|FG004|STARTED|Overall Study||115||
48693985|NCT00107900|102036274|FG005|STARTED|Overall Study||103||
48693986|NCT00107900|102036269|FG000|COMPLETED|Overall Study||75||
48693987|NCT00107900|102036270|FG001|COMPLETED|Overall Study||72||
48693988|NCT00107900|102036271|FG002|COMPLETED|Overall Study||104||
48693989|NCT00107900|102036272|FG003|COMPLETED|Overall Study||87||
48693990|NCT00107900|102036273|FG004|COMPLETED|Overall Study||94||
48693991|NCT00107900|102036274|FG005|COMPLETED|Overall Study||94||
48693992|NCT00107900|102036269|FG000|NOT COMPLETED|Overall Study||10||
48693993|NCT00107900|102036270|FG001|NOT COMPLETED|Overall Study||3||
48693994|NCT00107900|102036271|FG002|NOT COMPLETED|Overall Study||25||
48693995|NCT00107900|102036272|FG003|NOT COMPLETED|Overall Study||12||
48693996|NCT00107900|102036273|FG004|NOT COMPLETED|Overall Study||21||
48110281|NCT03851016|100597893|FG000|STARTED|First Intervention (3 Weeks)||12||
48110282|NCT03851016|100597894|FG001|STARTED|First Intervention (3 Weeks)||12||
48110283|NCT03851016|100597893|FG000|COMPLETED|First Intervention (3 Weeks)||11||
48110284|NCT03851016|100597894|FG001|COMPLETED|First Intervention (3 Weeks)||10||
48110285|NCT03851016|100597893|FG000|NOT COMPLETED|First Intervention (3 Weeks)||1||
48110286|NCT03851016|100597894|FG001|NOT COMPLETED|First Intervention (3 Weeks)||2||
48110287|NCT03851016|100597893|FG000|STARTED|Washout (1 Week)||11||
48110288|NCT03851016|100597894|FG001|STARTED|Washout (1 Week)||10||
48272506|NCT04176731|100991985|FG000|COMPLETED|Overall Study||36||
48272507|NCT04176731|100991985|FG000|NOT COMPLETED|Overall Study||0||
48693997|NCT00107900|102036274|FG005|NOT COMPLETED|Overall Study||9||
48693998|NCT00570778|102036275|FG000|STARTED|Overall Study||41||
48693999|NCT00570778|102036276|FG001|STARTED|Overall Study||38||
48694000|NCT00570778|102036277|FG002|STARTED|Overall Study||37||
48694001|NCT00570778|102036278|FG003|STARTED|Overall Study||38||
48694002|NCT00570778|102036275|FG000|Safety Population: Received Study Drug|Overall Study||41||
48110289|NCT03851016|100597893|FG000|COMPLETED|Washout (1 Week)||11||
48110290|NCT03851016|100597894|FG001|COMPLETED|Washout (1 Week)||10||
48110291|NCT03851016|100597893|FG000|NOT COMPLETED|Washout (1 Week)||0||
48110292|NCT03851016|100597894|FG001|NOT COMPLETED|Washout (1 Week)||0||
48110293|NCT03851016|100597893|FG000|STARTED|Second Intervention (3 Weeks)||11||
48110294|NCT03851016|100597894|FG001|STARTED|Second Intervention (3 Weeks)||10||
48110295|NCT03851016|100597893|FG000|COMPLETED|Second Intervention (3 Weeks)||11||
48110296|NCT03851016|100597894|FG001|COMPLETED|Second Intervention (3 Weeks)||10||
48110297|NCT03851016|100597893|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0||
48110298|NCT03851016|100597894|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0||
48110299|NCT01541930|100597895|FG000|STARTED|Overall Study||21||
48110300|NCT01541930|100597895|FG000|COMPLETED|Overall Study||20||
48110301|NCT01541930|100597895|FG000|NOT COMPLETED|Overall Study||1||
48110302|NCT02871128|100597896|FG000|STARTED|Overall Study||20||
48110303|NCT02871128|100597897|FG001|STARTED|Overall Study||20||
48110304|NCT02871128|100597898|FG002|STARTED|Overall Study||16||
48110305|NCT02871128|100597896|FG000|COMPLETED|Overall Study||20||
48110306|NCT02871128|100597897|FG001|COMPLETED|Overall Study||19||
48110307|NCT02871128|100597898|FG002|COMPLETED|Overall Study||15||
48110308|NCT02871128|100597896|FG000|NOT COMPLETED|Overall Study||0||
48110309|NCT02871128|100597897|FG001|NOT COMPLETED|Overall Study||1||
48110310|NCT02871128|100597898|FG002|NOT COMPLETED|Overall Study||1||
48110311|NCT02448875|100597899|FG000|STARTED|Overall Study||60|Includes dose selection phase and expansion phase|
48110312|NCT02448875|100597900|FG001|STARTED|Overall Study||21|Includes dose selection phase and expansion phase|
48110313|NCT02448875|100597901|FG002|STARTED|Overall Study||61|Includes dose selection phase and expansion phase|
48110314|NCT02448875|100597899|FG000|Completed Dose Selection Phase|Overall Study||20||
48110315|NCT02448875|100597900|FG001|Completed Dose Selection Phase|Overall Study||21||
48272508|NCT01661764|100991986|FG000|STARTED|Overall Study||26||
48272509|NCT01661764|100991987|FG001|STARTED|Overall Study||25||
48694003|NCT00570778|102036276|FG001|Safety Population: Received Study Drug|Overall Study||38||
48110316|NCT02448875|100597901|FG002|Completed Dose Selection Phase|Overall Study||20||
48110317|NCT02448875|100597899|FG000|Full Analysis Set|Overall Study||60||
48110318|NCT02448875|100597900|FG001|Full Analysis Set|Overall Study||21||
48694004|NCT00570778|102036277|FG002|Safety Population: Received Study Drug|Overall Study||36||
48694005|NCT00570778|102036278|FG003|Safety Population: Received Study Drug|Overall Study||38||
48694006|NCT00570778|102036275|FG000|Modified Intent-to-treat Population|Overall Study||40||
48710806|NCT01187446|102078024|FG000|COMPLETED|Overall Study||14||
48272510|NCT01661764|100991988|FG002|STARTED|Overall Study||25||
48272511|NCT01661764|100991989|FG003|STARTED|Overall Study||26||
48272512|NCT01661764|100991990|FG004|STARTED|Overall Study||19||
48272513|NCT01661764|100991991|FG005|STARTED|Overall Study||20||
48110319|NCT02448875|100597901|FG002|Full Analysis Set|Overall Study||61||
48110320|NCT02448875|100597899|FG000|Safety Analysis Set|Overall Study||60||
48110321|NCT02448875|100597900|FG001|Safety Analysis Set|Overall Study||21||
48110322|NCT02448875|100597901|FG002|Safety Analysis Set|Overall Study||61||
48110323|NCT02448875|100597899|FG000|COMPLETED|Overall Study||53|Completed expansion phase|
48110324|NCT02448875|100597900|FG001|COMPLETED|Overall Study||20|Completed expansion phase|
48110325|NCT02448875|100597901|FG002|COMPLETED|Overall Study||60|Completed expansion phase|
48110326|NCT02448875|100597899|FG000|NOT COMPLETED|Overall Study||7||
48110327|NCT02448875|100597900|FG001|NOT COMPLETED|Overall Study||1||
48110328|NCT02448875|100597901|FG002|NOT COMPLETED|Overall Study||1||
48110329|NCT01990677|100597902|FG000|STARTED|Overall Study||12||
48110330|NCT01990677|100597903|FG001|STARTED|Overall Study||6||
48110331|NCT01990677|100597902|FG000|COMPLETED|Overall Study||10||
48110332|NCT01990677|100597903|FG001|COMPLETED|Overall Study||5||
48110333|NCT01990677|100597902|FG000|NOT COMPLETED|Overall Study||2||
48110334|NCT01990677|100597903|FG001|NOT COMPLETED|Overall Study||1||
48110335|NCT04503564|100597904|FG000|STARTED|Achilles Infusion Set w/Saline- Week 1||20||
48110336|NCT04503564|100597904|FG000|COMPLETED|Achilles Infusion Set w/Saline- Week 1||20||
48110337|NCT04503564|100597904|FG000|NOT COMPLETED|Achilles Infusion Set w/Saline- Week 1||0||
48110338|NCT04503564|100597904|FG000|STARTED|Achilles Infusion Set w/Insulin Week 2||20||
48272514|NCT01661764|100991986|FG000|COMPLETED|Overall Study||24||
48272515|NCT01661764|100991987|FG001|COMPLETED|Overall Study||20||
48272516|NCT01661764|100991988|FG002|COMPLETED|Overall Study||22||
48272517|NCT01661764|100991989|FG003|COMPLETED|Overall Study||24||
48272518|NCT01661764|100991990|FG004|COMPLETED|Overall Study||16||
48272519|NCT01661764|100991991|FG005|COMPLETED|Overall Study||18||
48272520|NCT01661764|100991986|FG000|NOT COMPLETED|Overall Study||2||
48272521|NCT01661764|100991987|FG001|NOT COMPLETED|Overall Study||5||
48272522|NCT01661764|100991988|FG002|NOT COMPLETED|Overall Study||3||
48272523|NCT01661764|100991989|FG003|NOT COMPLETED|Overall Study||2||
48272524|NCT01661764|100991990|FG004|NOT COMPLETED|Overall Study||3||
48555266|NCT00742209|101690790|FG003|COMPLETED|Overall Study||97||
48555267|NCT00742209|101690791|FG004|COMPLETED|Overall Study||37||
48555268|NCT00742209|101690787|FG000|NOT COMPLETED|Overall Study||34||
48555269|NCT00742209|101690788|FG001|NOT COMPLETED|Overall Study||18||
48555270|NCT00742209|101690789|FG002|NOT COMPLETED|Overall Study||46||
48555271|NCT00742209|101690790|FG003|NOT COMPLETED|Overall Study||37||
48555272|NCT00742209|101690791|FG004|NOT COMPLETED|Overall Study||25||
48555273|NCT00470392|101690792|FG000|STARTED|Overall Study||7||
48555274|NCT00470392|101690793|FG001|STARTED|Overall Study||2||
48555275|NCT00470392|101690792|FG000|COMPLETED|Overall Study||7||
48555276|NCT00470392|101690793|FG001|COMPLETED|Overall Study||2||
48555277|NCT00470392|101690792|FG000|NOT COMPLETED|Overall Study||0||
48555278|NCT00470392|101690793|FG001|NOT COMPLETED|Overall Study||0||
48555279|NCT04599075|101690794|FG000|STARTED|Overall Study||35||
48555280|NCT04599075|101690795|FG001|STARTED|Overall Study||35||
48555281|NCT04599075|101690794|FG000|COMPLETED|Overall Study||35||
48555282|NCT04599075|101690795|FG001|COMPLETED|Overall Study||35||
48694007|NCT00570778|102036276|FG001|Modified Intent-to-treat Population|Overall Study||37||
48110339|NCT04503564|100597904|FG000|COMPLETED|Achilles Infusion Set w/Insulin Week 2||20||
48110340|NCT04503564|100597904|FG000|NOT COMPLETED|Achilles Infusion Set w/Insulin Week 2||0||
48110341|NCT04503564|100597904|FG000|STARTED|Achilles Infusion Set w/Insulin Week 3||20||
48110342|NCT04503564|100597904|FG000|COMPLETED|Achilles Infusion Set w/Insulin Week 3||20||
48110343|NCT04503564|100597904|FG000|NOT COMPLETED|Achilles Infusion Set w/Insulin Week 3||0||
48110344|NCT01143090|100597905|FG000|STARTED|Overall Study||149||
48110345|NCT01143090|100597905|FG000|COMPLETED|Overall Study||98||
48272525|NCT01661764|100991991|FG005|NOT COMPLETED|Overall Study||2||
48110346|NCT01143090|100597905|FG000|NOT COMPLETED|Overall Study||51||
48110347|NCT04334460|100597906|FG000|STARTED|Full Enrollment||81||
48110348|NCT04334460|100597907|FG001|STARTED|Full Enrollment||39||
48110349|NCT04334460|100597906|FG000|COMPLETED|Full Enrollment||81||
48110350|NCT04334460|100597907|FG001|COMPLETED|Full Enrollment||39||
48110351|NCT04334460|100597906|FG000|NOT COMPLETED|Full Enrollment||0||
48110352|NCT04334460|100597907|FG001|NOT COMPLETED|Full Enrollment||0||
48110353|NCT04334460|100597906|FG000|STARTED|Full Analysis Set (FAS)||81||
48110354|NCT04334460|100597907|FG001|STARTED|Full Analysis Set (FAS)||39||
48110355|NCT04334460|100597906|FG000|COMPLETED|Full Analysis Set (FAS)||77||
48272526|NCT02091206|100991992|FG000|STARTED|Treatment Period||10||
48272527|NCT02091206|100991993|FG001|STARTED|Treatment Period||8||
48272528|NCT02091206|100991994|FG002|STARTED|Treatment Period||9||
48555283|NCT04599075|101690794|FG000|NOT COMPLETED|Overall Study||0||
48555284|NCT04599075|101690795|FG001|NOT COMPLETED|Overall Study||0||
48555285|NCT04700137|101690796|FG000|STARTED|Overall Study||166|Randomized and consented.|
48555286|NCT04700137|101690797|FG001|STARTED|Overall Study||165|Randomized and consented.|
48555287|NCT04700137|101690798|FG002|STARTED|Overall Study||168|Randomized and consented.|
48555288|NCT04700137|101690799|FG003|STARTED|Overall Study||167|Randomized and consented.|
48710807|NCT01187446|102078025|FG001|COMPLETED|Overall Study||13||
48110356|NCT04334460|100597907|FG001|COMPLETED|Full Analysis Set (FAS)||38||
48110357|NCT04334460|100597906|FG000|NOT COMPLETED|Full Analysis Set (FAS)||4||
48110358|NCT04334460|100597907|FG001|NOT COMPLETED|Full Analysis Set (FAS)||1||
48110359|NCT04334460|100597906|FG000|STARTED|Safety Analysis Population||81||
48110360|NCT04334460|100597907|FG001|STARTED|Safety Analysis Population||39||
48110361|NCT04334460|100597906|FG000|COMPLETED|Safety Analysis Population||77||
48110362|NCT04334460|100597907|FG001|COMPLETED|Safety Analysis Population||38||
48110363|NCT04334460|100597906|FG000|NOT COMPLETED|Safety Analysis Population||4||
48110364|NCT04334460|100597907|FG001|NOT COMPLETED|Safety Analysis Population||1||
48110365|NCT01073865|100597908|FG000|STARTED|Overall Study||109||
48392944|NCT03032510|101291470|FG000|STARTED|Overall Study||603||
48392945|NCT03032510|101291471|FG001|STARTED|Overall Study||602||
48392946|NCT03032510|101291470|FG000|COMPLETED|Overall Study||576||
48392947|NCT03032510|101291471|FG001|COMPLETED|Overall Study||584||
48392948|NCT03032510|101291470|FG000|NOT COMPLETED|Overall Study||27||
48392949|NCT03032510|101291471|FG001|NOT COMPLETED|Overall Study||18||
48110366|NCT01073865|100597909|FG001|STARTED|Overall Study||113||
48110367|NCT01073865|100597908|FG000|Received Randomised Treatment|Overall Study||108||
48392950|NCT00125372|101291472|FG000|STARTED|Overall Study||12||
48392951|NCT00125372|101291472|FG000|COMPLETED|Overall Study||10||
48392952|NCT00125372|101291472|FG000|NOT COMPLETED|Overall Study||2||
48392953|NCT02151682|101291473|FG000|STARTED|Part 1: 14 Days Morphine or Tapentadol||24||
48392954|NCT02151682|101291474|FG001|STARTED|Part 1: 14 Days Morphine or Tapentadol||45||
48392955|NCT02151682|101291475|FG002|STARTED|Part 1: 14 Days Morphine or Tapentadol||0||
48392956|NCT02151682|101291476|FG003|STARTED|Part 1: 14 Days Morphine or Tapentadol||0||
48392957|NCT02151682|101291477|FG004|STARTED|Part 1: 14 Days Morphine or Tapentadol||0||
48392958|NCT02151682|101291478|FG005|STARTED|Part 1: 14 Days Morphine or Tapentadol||0||
48392959|NCT02151682|101291473|FG000|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||22||
48392960|NCT02151682|101291474|FG001|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||40||
48392961|NCT02151682|101291475|FG002|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0||
48392962|NCT02151682|101291476|FG003|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0||
48392963|NCT02151682|101291477|FG004|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0||
48392964|NCT02151682|101291478|FG005|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0||
48392965|NCT02151682|101291473|FG000|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||2||
48392966|NCT02151682|101291474|FG001|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||5||
48392967|NCT02151682|101291475|FG002|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0||
48392968|NCT02151682|101291476|FG003|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0||
48392969|NCT02151682|101291477|FG004|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0||
48392970|NCT02151682|101291478|FG005|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0||
48392971|NCT02151682|101291473|FG000|STARTED|Part 2: Tapent. Extension or Observation||0||
48392972|NCT02151682|101291474|FG001|STARTED|Part 2: Tapent. Extension or Observation||0||
48392973|NCT02151682|101291475|FG002|STARTED|Part 2: Tapent. Extension or Observation||36||
48392974|NCT02151682|101291476|FG003|STARTED|Part 2: Tapent. Extension or Observation||18||
48392975|NCT02151682|101291477|FG004|STARTED|Part 2: Tapent. Extension or Observation||14||
48392976|NCT02151682|101291478|FG005|STARTED|Part 2: Tapent. Extension or Observation||0||
48392977|NCT02151682|101291473|FG000|COMPLETED|Part 2: Tapent. Extension or Observation||0||
48392978|NCT02151682|101291474|FG001|COMPLETED|Part 2: Tapent. Extension or Observation||0||
48392979|NCT02151682|101291475|FG002|COMPLETED|Part 2: Tapent. Extension or Observation||8||
48392980|NCT02151682|101291476|FG003|COMPLETED|Part 2: Tapent. Extension or Observation||14||
48392981|NCT02151682|101291477|FG004|COMPLETED|Part 2: Tapent. Extension or Observation||14||
48392982|NCT02151682|101291478|FG005|COMPLETED|Part 2: Tapent. Extension or Observation||0||
48392983|NCT02151682|101291473|FG000|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0||
48392984|NCT02151682|101291474|FG001|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0||
48392985|NCT02151682|101291475|FG002|NOT COMPLETED|Part 2: Tapent. Extension or Observation||28||
48392986|NCT02151682|101291476|FG003|NOT COMPLETED|Part 2: Tapent. Extension or Observation||4||
48392987|NCT02151682|101291477|FG004|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0||
48392988|NCT02151682|101291478|FG005|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0||
48110368|NCT01073865|100597909|FG001|Received Randomised Treatment|Overall Study||113||
48110369|NCT01073865|100597908|FG000|COMPLETED|Overall Study||81||
48110370|NCT01073865|100597909|FG001|COMPLETED|Overall Study||74||
48392989|NCT02151682|101291473|FG000|STARTED|Part 2: Observ. Aft. Tapent. Extension||0||
48392990|NCT02151682|101291474|FG001|STARTED|Part 2: Observ. Aft. Tapent. Extension||0||
48392991|NCT02151682|101291475|FG002|STARTED|Part 2: Observ. Aft. Tapent. Extension||0||
48392992|NCT02151682|101291476|FG003|STARTED|Part 2: Observ. Aft. Tapent. Extension||0||
48392993|NCT02151682|101291477|FG004|STARTED|Part 2: Observ. Aft. Tapent. Extension||0||
48392994|NCT02151682|101291478|FG005|STARTED|Part 2: Observ. Aft. Tapent. Extension||26||
48392995|NCT02151682|101291473|FG000|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0||
48110371|NCT01073865|100597908|FG000|NOT COMPLETED|Overall Study||28||
48110372|NCT01073865|100597909|FG001|NOT COMPLETED|Overall Study||39||
48110373|NCT01088646|100597910|FG000|STARTED|Overall Study||25||
48110374|NCT01088646|100597910|FG000|COMPLETED|Overall Study||25||
48110375|NCT01088646|100597910|FG000|NOT COMPLETED|Overall Study||0||
48110376|NCT02809430|100597911|FG000|STARTED|Overall Study||90||
48555289|NCT04700137|101690796|FG000|COMPLETED|Overall Study||165|Completed the study, including the entire final outcome survey.|
48555290|NCT04700137|101690797|FG001|COMPLETED|Overall Study||159|Completed the study, including the entire final outcome survey.|
48555291|NCT04700137|101690798|FG002|COMPLETED|Overall Study||165|Completed the study, including the entire final outcome survey.|
48272529|NCT02091206|100991995|FG003|STARTED|Treatment Period||7||
48272530|NCT02091206|100991992|FG000|Safety Analysis Set|Treatment Period||10|All randomized participants who received at least 1 dose of IMP|
48272531|NCT02091206|100991993|FG001|Safety Analysis Set|Treatment Period||8|All randomized participants who received at least 1 dose of IMP|
48272532|NCT02091206|100991994|FG002|Safety Analysis Set|Treatment Period||9|All randomized participants who received at least 1 dose of IMP|
48272533|NCT02091206|100991995|FG003|Safety Analysis Set|Treatment Period||7|All randomized participants who received at least 1 dose of IMP|
48272534|NCT02091206|100991992|FG000|COMPLETED|Treatment Period||10||
48555292|NCT04700137|101690799|FG003|COMPLETED|Overall Study||166|Completed the study, including the entire final outcome survey.|
48555293|NCT04700137|101690796|FG000|NOT COMPLETED|Overall Study||1||
48555294|NCT04700137|101690797|FG001|NOT COMPLETED|Overall Study||6||
48272535|NCT02091206|100991993|FG001|COMPLETED|Treatment Period||7||
48272536|NCT02091206|100991994|FG002|COMPLETED|Treatment Period||8||
48272537|NCT02091206|100991995|FG003|COMPLETED|Treatment Period||7||
48272538|NCT02091206|100991992|FG000|NOT COMPLETED|Treatment Period||0||
48555295|NCT04700137|101690798|FG002|NOT COMPLETED|Overall Study||3||
48555296|NCT04700137|101690799|FG003|NOT COMPLETED|Overall Study||1||
48555297|NCT00181714|101690800|FG000|STARTED|Signed Consent/Enrolled||203||
48272539|NCT02091206|100991993|FG001|NOT COMPLETED|Treatment Period||1||
48272540|NCT02091206|100991994|FG002|NOT COMPLETED|Treatment Period||1||
48272541|NCT02091206|100991995|FG003|NOT COMPLETED|Treatment Period||0||
48272542|NCT02091206|100991992|FG000|STARTED|Taper Period||10||
48272543|NCT02091206|100991993|FG001|STARTED|Taper Period||7||
48272544|NCT02091206|100991994|FG002|STARTED|Taper Period||8||
48272545|NCT02091206|100991995|FG003|STARTED|Taper Period||7||
48272546|NCT02091206|100991992|FG000|COMPLETED|Taper Period||9||
48555298|NCT00181714|101690800|FG000|COMPLETED|Signed Consent/Enrolled||154||
48555299|NCT00181714|101690800|FG000|NOT COMPLETED|Signed Consent/Enrolled||49||
48555300|NCT00181714|101690800|FG000|STARTED|Began Treatment With OROS-MPH||154||
48555301|NCT00181714|101690800|FG000|COMPLETED|Began Treatment With OROS-MPH||30||
48555302|NCT00181714|101690800|FG000|NOT COMPLETED|Began Treatment With OROS-MPH||124||
48555303|NCT03525886|101693687|FG000|STARTED|Cohort 1 (50 mg QHS)||8||
48555304|NCT03525886|101693688|FG001|STARTED|Cohort 1 (50 mg QHS)||0||
48555305|NCT03525886|101693689|FG002|STARTED|Cohort 1 (50 mg QHS)||0||
48555306|NCT03525886|101693690|FG003|STARTED|Cohort 1 (50 mg QHS)||0||
48555307|NCT03525886|101693687|FG000|COMPLETED|Cohort 1 (50 mg QHS)||8||
48555308|NCT03525886|101693688|FG001|COMPLETED|Cohort 1 (50 mg QHS)||0||
48694008|NCT00570778|102036277|FG002|Modified Intent-to-treat Population|Overall Study||35||
48555309|NCT03525886|101693689|FG002|COMPLETED|Cohort 1 (50 mg QHS)||0||
48555310|NCT03525886|101693690|FG003|COMPLETED|Cohort 1 (50 mg QHS)||0||
48555311|NCT03525886|101693687|FG000|NOT COMPLETED|Cohort 1 (50 mg QHS)||0||
48555312|NCT03525886|101693688|FG001|NOT COMPLETED|Cohort 1 (50 mg QHS)||0||
48555313|NCT03525886|101693689|FG002|NOT COMPLETED|Cohort 1 (50 mg QHS)||0||
48555314|NCT03525886|101693690|FG003|NOT COMPLETED|Cohort 1 (50 mg QHS)||0||
48694009|NCT00570778|102036278|FG003|Modified Intent-to-treat Population|Overall Study||37||
48694010|NCT00570778|102036275|FG000|COMPLETED|Overall Study||37||
48694011|NCT00570778|102036276|FG001|COMPLETED|Overall Study||34||
48694012|NCT00570778|102036277|FG002|COMPLETED|Overall Study||30||
48694013|NCT00570778|102036278|FG003|COMPLETED|Overall Study||34||
48694014|NCT00570778|102036275|FG000|NOT COMPLETED|Overall Study||4||
48694015|NCT00570778|102036276|FG001|NOT COMPLETED|Overall Study||4||
48694016|NCT00570778|102036277|FG002|NOT COMPLETED|Overall Study||7||
48694017|NCT00570778|102036278|FG003|NOT COMPLETED|Overall Study||4||
48694018|NCT02363972|102036279|FG000|STARTED|Overall Study||103||
48694019|NCT02363972|102036279|FG000|COMPLETED|Overall Study||77||
48555315|NCT03525886|101693687|FG000|STARTED|Cohort 2 (100 mg QHS)||0||
48555316|NCT03525886|101693688|FG001|STARTED|Cohort 2 (100 mg QHS)||7||
48555317|NCT03525886|101693689|FG002|STARTED|Cohort 2 (100 mg QHS)||0||
48555318|NCT03525886|101693690|FG003|STARTED|Cohort 2 (100 mg QHS)||0||
48555319|NCT03525886|101693687|FG000|COMPLETED|Cohort 2 (100 mg QHS)||0||
48555320|NCT03525886|101693688|FG001|COMPLETED|Cohort 2 (100 mg QHS)||7||
48555321|NCT03525886|101693689|FG002|COMPLETED|Cohort 2 (100 mg QHS)||0||
48555322|NCT03525886|101693690|FG003|COMPLETED|Cohort 2 (100 mg QHS)||0||
48555323|NCT03525886|101693687|FG000|NOT COMPLETED|Cohort 2 (100 mg QHS)||0||
48694020|NCT02363972|102036279|FG000|NOT COMPLETED|Overall Study||26||
48694021|NCT01500252|102036280|FG000|STARTED|Overall Study||21||
48694022|NCT01500252|102036281|FG001|STARTED|Overall Study||17||
48694023|NCT01500252|102036280|FG000|One Years|Overall Study||20||
48694024|NCT01500252|102036281|FG001|One Years|Overall Study||16||
48272547|NCT02091206|100991993|FG001|COMPLETED|Taper Period||7||
48272548|NCT02091206|100991994|FG002|COMPLETED|Taper Period||8||
48272549|NCT02091206|100991995|FG003|COMPLETED|Taper Period||5||
48272550|NCT02091206|100991992|FG000|NOT COMPLETED|Taper Period||1||
48272551|NCT02091206|100991993|FG001|NOT COMPLETED|Taper Period||0||
48272552|NCT02091206|100991994|FG002|NOT COMPLETED|Taper Period||0||
48272553|NCT02091206|100991995|FG003|NOT COMPLETED|Taper Period||2||
48272554|NCT05172050|100991996|FG000|STARTED|Overall Study||22||
48272555|NCT05172050|100991997|FG001|STARTED|Overall Study||20||
48272556|NCT05172050|100991998|FG002|STARTED|Overall Study||19||
48272557|NCT05172050|100991996|FG000|Full Analysis Set Population (FAS)|Overall Study||22||
48272558|NCT05172050|100991997|FG001|Full Analysis Set Population (FAS)|Overall Study||20||
48272559|NCT05172050|100991998|FG002|Full Analysis Set Population (FAS)|Overall Study||19||
48272560|NCT05172050|100991996|FG000|Per-Protocol Population (PP)|Overall Study||18||
48272561|NCT05172050|100991997|FG001|Per-Protocol Population (PP)|Overall Study||17||
48272562|NCT05172050|100991998|FG002|Per-Protocol Population (PP)|Overall Study||17||
48272563|NCT05172050|100991996|FG000|Safety Population (SAF)|Overall Study||22||
48272564|NCT05172050|100991997|FG001|Safety Population (SAF)|Overall Study||20||
48272565|NCT05172050|100991998|FG002|Safety Population (SAF)|Overall Study||19||
48272566|NCT05172050|100991996|FG000|COMPLETED|Overall Study||10|treatment completion|
48272567|NCT05172050|100991997|FG001|COMPLETED|Overall Study||9|treatment completion|
48272568|NCT05172050|100991998|FG002|COMPLETED|Overall Study||8|treatment completion|
48392996|NCT02151682|101291474|FG001|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0||
48392997|NCT02151682|101291475|FG002|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0||
48392998|NCT02151682|101291476|FG003|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0||
48392999|NCT02151682|101291477|FG004|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0||
48393000|NCT02151682|101291478|FG005|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||19||
48393001|NCT02151682|101291473|FG000|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0||
48393002|NCT02151682|101291474|FG001|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0||
48393003|NCT02151682|101291475|FG002|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0||
48393004|NCT02151682|101291476|FG003|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0||
48393005|NCT02151682|101291477|FG004|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0||
48393006|NCT02151682|101291478|FG005|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||7||
48393007|NCT00903370|101291479|FG000|STARTED|Overall Study||127||
48393008|NCT00903370|101291480|FG001|STARTED|Overall Study||133||
48393009|NCT00903370|101291479|FG000|COMPLETED|Overall Study||99||
48393010|NCT00903370|101291480|FG001|COMPLETED|Overall Study||109||
48393011|NCT00903370|101291479|FG000|NOT COMPLETED|Overall Study||28||
48393012|NCT00903370|101291480|FG001|NOT COMPLETED|Overall Study||24||
48393013|NCT00411086|101291481|FG000|STARTED|Overall Study||52||
48393014|NCT00411086|101291481|FG000|COMPLETED|Overall Study||52||
48393015|NCT00411086|101291481|FG000|NOT COMPLETED|Overall Study||0||
48393016|NCT00676208|101291482|FG000|STARTED|Overall Study||14||
48393017|NCT00676208|101291483|FG001|STARTED|Overall Study||19||
48393018|NCT00676208|101291482|FG000|COMPLETED|Overall Study||12||
48393019|NCT00676208|101291483|FG001|COMPLETED|Overall Study||13||
48393020|NCT00676208|101291482|FG000|NOT COMPLETED|Overall Study||2||
48393021|NCT00676208|101291483|FG001|NOT COMPLETED|Overall Study||6||
48393022|NCT04390568|101291484|FG000|STARTED|Overall Study||10||
48393023|NCT04390568|101291485|FG001|STARTED|Overall Study||10||
48393024|NCT04390568|101291486|FG002|STARTED|Overall Study||10||
48393025|NCT04390568|101291487|FG003|STARTED|Overall Study||10||
48393026|NCT04390568|101291488|FG004|STARTED|Overall Study||10||
48393027|NCT04390568|101291484|FG000|Treated|Overall Study||10||
48393028|NCT04390568|101291485|FG001|Treated|Overall Study||10||
48393029|NCT04390568|101291486|FG002|Treated|Overall Study||10||
48393030|NCT04390568|101291487|FG003|Treated|Overall Study||10||
48393031|NCT04390568|101291488|FG004|Treated|Overall Study||10||
48393032|NCT04390568|101291484|FG000|COMPLETED|Overall Study||10||
48272569|NCT05172050|100991996|FG000|NOT COMPLETED|Overall Study||12||
48272570|NCT05172050|100991997|FG001|NOT COMPLETED|Overall Study||11||
48393033|NCT04390568|101291485|FG001|COMPLETED|Overall Study||10||
48393034|NCT04390568|101291486|FG002|COMPLETED|Overall Study||10||
48393035|NCT04390568|101291487|FG003|COMPLETED|Overall Study||10||
48393036|NCT04390568|101291488|FG004|COMPLETED|Overall Study||10||
48393037|NCT04390568|101291484|FG000|NOT COMPLETED|Overall Study||0||
48393038|NCT04390568|101291485|FG001|NOT COMPLETED|Overall Study||0||
48393039|NCT04390568|101291486|FG002|NOT COMPLETED|Overall Study||0||
48555324|NCT03525886|101693688|FG001|NOT COMPLETED|Cohort 2 (100 mg QHS)||0||
48555325|NCT03525886|101693689|FG002|NOT COMPLETED|Cohort 2 (100 mg QHS)||0||
48110377|NCT02809430|100597911|FG000|Failed 3-night run-in Because no Evidence of Obstructive Sleep Apnea|Overall Study||28||
48110378|NCT02809430|100597911|FG000|Stopped CPAP During Inpatient Rehabilitation|Overall Study||10||
48110379|NCT02809430|100597911|FG000|COMPLETED|Overall Study||52||
48110380|NCT02809430|100597911|FG000|NOT COMPLETED|Overall Study||38||
48110381|NCT00247728|100597912|FG000|STARTED|Overall Study||58||
48110382|NCT00247728|100597913|FG001|STARTED|Overall Study||57||
48110383|NCT00247728|100597914|FG002|STARTED|Overall Study||57||
48110384|NCT00247728|100597912|FG000|COMPLETED|Overall Study||55||
48110385|NCT00247728|100597913|FG001|COMPLETED|Overall Study||51||
48110386|NCT00247728|100597914|FG002|COMPLETED|Overall Study||43||
48110387|NCT00247728|100597912|FG000|NOT COMPLETED|Overall Study||3||
48110388|NCT00247728|100597913|FG001|NOT COMPLETED|Overall Study||6||
48110389|NCT00247728|100597914|FG002|NOT COMPLETED|Overall Study||14||
48110390|NCT02318693|100597915|FG000|STARTED|Overall Study||26||
48110391|NCT02318693|100597916|FG001|STARTED|Overall Study||27||
48110392|NCT02318693|100597915|FG000|Treated|Overall Study||26||
48110393|NCT02318693|100597916|FG001|Treated|Overall Study||26||
48110394|NCT02318693|100597915|FG000|COMPLETED|Overall Study||26||
48110395|NCT02318693|100597916|FG001|COMPLETED|Overall Study||26||
48110396|NCT02318693|100597915|FG000|NOT COMPLETED|Overall Study||0||
48110397|NCT02318693|100597916|FG001|NOT COMPLETED|Overall Study||1||
48110398|NCT01112293|100597917|FG000|STARTED|Overall Study||14||
48110399|NCT01112293|100597917|FG000|COMPLETED|Overall Study||14||
48110400|NCT01112293|100597917|FG000|NOT COMPLETED|Overall Study||0||
48110401|NCT00706836|100597918|FG000|STARTED|Overall Study||16||
48110402|NCT00706836|100597918|FG000|COMPLETED|Overall Study||16||
48110403|NCT00706836|100597918|FG000|NOT COMPLETED|Overall Study||0||
48110404|NCT03711162|100597919|FG000|STARTED|Overall Study||175||
48110405|NCT03711162|100597920|FG001|STARTED|Overall Study||175||
48110406|NCT03711162|100597921|FG002|STARTED|Overall Study||175||
48110407|NCT03711162|100597919|FG000|Treated|Overall Study||174||
48110408|NCT03711162|100597920|FG001|Treated|Overall Study||175||
48110409|NCT03711162|100597921|FG002|Treated|Overall Study||174||
48110410|NCT03711162|100597919|FG000|COMPLETED|Overall Study||0||
48110411|NCT03711162|100597920|FG001|COMPLETED|Overall Study||0||
48110412|NCT03711162|100597921|FG002|COMPLETED|Overall Study||0||
48110413|NCT03711162|100597919|FG000|NOT COMPLETED|Overall Study||175||
48110414|NCT03711162|100597920|FG001|NOT COMPLETED|Overall Study||175||
48393040|NCT04390568|101291487|FG003|NOT COMPLETED|Overall Study||0||
48393041|NCT04390568|101291488|FG004|NOT COMPLETED|Overall Study||0||
48555326|NCT03525886|101693690|FG003|NOT COMPLETED|Cohort 2 (100 mg QHS)||0||
48555327|NCT03525886|101693687|FG000|STARTED|Cohort 3 (100 mg QPM)||0|Cohort 3 included 8 subjects who had participated in other cohorts.|
48555328|NCT03525886|101693688|FG001|STARTED|Cohort 3 (100 mg QPM)||0|Cohort 3 included 8 subjects who had participated in other cohorts.|
48555329|NCT03525886|101693689|FG002|STARTED|Cohort 3 (100 mg QPM)||8|Cohort 3 included 8 subjects who had participated in other cohorts.|
48694025|NCT01500252|102036280|FG000|Five Years|Overall Study||17||
48110415|NCT03711162|100597921|FG002|NOT COMPLETED|Overall Study||175||
48110416|NCT04066426|100597922|FG000|STARTED|Overall Study||50||
48110417|NCT04066426|100597923|FG001|STARTED|Overall Study||50||
48110418|NCT04066426|100597924|FG002|STARTED|Overall Study||50||
48110419|NCT04066426|100597925|FG003|STARTED|Overall Study||50||
48110420|NCT04066426|100597922|FG000|COMPLETED|Overall Study||40||
48110421|NCT04066426|100597923|FG001|COMPLETED|Overall Study||40||
48110422|NCT04066426|100597924|FG002|COMPLETED|Overall Study||42||
48110423|NCT04066426|100597925|FG003|COMPLETED|Overall Study||47||
48110424|NCT04066426|100597922|FG000|NOT COMPLETED|Overall Study||10||
48110425|NCT04066426|100597923|FG001|NOT COMPLETED|Overall Study||10||
48110426|NCT04066426|100597924|FG002|NOT COMPLETED|Overall Study||8||
48110427|NCT04066426|100597925|FG003|NOT COMPLETED|Overall Study||3||
48110428|NCT01857063|100597926|FG000|STARTED|Period 1 (7 Days)||110||
48110429|NCT01857063|100597927|FG001|STARTED|Period 1 (7 Days)||110||
48110430|NCT01857063|100597926|FG000|COMPLETED|Period 1 (7 Days)||108||
48110431|NCT01857063|100597927|FG001|COMPLETED|Period 1 (7 Days)||106||
48110432|NCT01857063|100597926|FG000|NOT COMPLETED|Period 1 (7 Days)||2||
48110433|NCT01857063|100597927|FG001|NOT COMPLETED|Period 1 (7 Days)||4||
48110434|NCT01857063|100597926|FG000|STARTED|Period 2 (7 Days)||108||
48110435|NCT01857063|100597927|FG001|STARTED|Period 2 (7 Days)||106||
48110436|NCT01857063|100597926|FG000|COMPLETED|Period 2 (7 Days)||104||
48110437|NCT01857063|100597927|FG001|COMPLETED|Period 2 (7 Days)||104||
48110438|NCT01857063|100597926|FG000|NOT COMPLETED|Period 2 (7 Days)||4||
48110439|NCT01857063|100597927|FG001|NOT COMPLETED|Period 2 (7 Days)||2||
48110440|NCT03742141|100597928|FG000|STARTED|Overall Study||125||
48110441|NCT03742141|100597928|FG000|COMPLETED|Overall Study||75||
48110442|NCT03742141|100597928|FG000|NOT COMPLETED|Overall Study||50||
48110443|NCT04116710|100597929|FG000|STARTED|Overall Study||4||
48110444|NCT04116710|100597930|FG001|STARTED|Overall Study||6||
48110445|NCT04116710|100597931|FG002|STARTED|Overall Study||3||
48110446|NCT04116710|100597932|FG003|STARTED|Overall Study||2||
48110447|NCT04116710|100597929|FG000|Disease Progression|Overall Study||4||
48272571|NCT05172050|100991998|FG002|NOT COMPLETED|Overall Study||11||
48272572|NCT00479882|100991999|FG000|STARTED|Precrossover: Periods I/II (Weeks 1-12)||610||
48272573|NCT00479882|100992000|FG001|STARTED|Precrossover: Periods I/II (Weeks 1-12)||602||
48272574|NCT00479882|100992001|FG002|STARTED|Precrossover: Periods I/II (Weeks 1-12)||597||
48272575|NCT00479882|100992002|FG003|STARTED|Precrossover: Periods I/II (Weeks 1-12)||605||
48272576|NCT00479882|100991999|FG000|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||472||
48272577|NCT00479882|100992000|FG001|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440||
48272578|NCT00479882|100992001|FG002|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440||
48272579|NCT00479882|100992002|FG003|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||465||
48272580|NCT00479882|100991999|FG000|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||138||
48272581|NCT00479882|100992000|FG001|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||162||
48272582|NCT00479882|100992001|FG002|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||157||
48272583|NCT00479882|100992002|FG003|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||140||
48272584|NCT00479882|100991999|FG000|STARTED|Crossover: Period III (Weeks 13-20)||472||
48272585|NCT00479882|100992000|FG001|STARTED|Crossover: Period III (Weeks 13-20)||440||
48272586|NCT00479882|100992001|FG002|STARTED|Crossover: Period III (Weeks 13-20)||440||
48272587|NCT00479882|100992002|FG003|STARTED|Crossover: Period III (Weeks 13-20)||465||
48272588|NCT00479882|100991999|FG000|COMPLETED|Crossover: Period III (Weeks 13-20)||447||
48272589|NCT00479882|100992000|FG001|COMPLETED|Crossover: Period III (Weeks 13-20)||419||
48393042|NCT04655703|101291489|FG000|STARTED|Overall Study||8||
48393043|NCT04655703|101291490|FG001|STARTED|Overall Study||8||
48393044|NCT04655703|101291491|FG002|STARTED|Overall Study||0||
48393045|NCT04655703|101291492|FG003|STARTED|Overall Study||0||
48393046|NCT04655703|101291489|FG000|COMPLETED|Overall Study||5||
48393047|NCT04655703|101291490|FG001|COMPLETED|Overall Study||8||
48272590|NCT00479882|100992001|FG002|COMPLETED|Crossover: Period III (Weeks 13-20)||420||
48272591|NCT00479882|100992002|FG003|COMPLETED|Crossover: Period III (Weeks 13-20)||447||
48272592|NCT00479882|100991999|FG000|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||25||
48272593|NCT00479882|100992000|FG001|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||21||
48272594|NCT00479882|100992001|FG002|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||20||
48272595|NCT00479882|100992002|FG003|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||18||
48272596|NCT02440425|100992003|FG000|STARTED|Overall Study||42||
48272597|NCT02440425|100992003|FG000|COMPLETED|Overall Study||37||
48393048|NCT04655703|101291491|FG002|COMPLETED|Overall Study||0||
48393049|NCT04655703|101291492|FG003|COMPLETED|Overall Study||0||
48393050|NCT04655703|101291489|FG000|NOT COMPLETED|Overall Study||3||
48393051|NCT04655703|101291490|FG001|NOT COMPLETED|Overall Study||0||
48393052|NCT04655703|101291491|FG002|NOT COMPLETED|Overall Study||0||
48393053|NCT04655703|101291492|FG003|NOT COMPLETED|Overall Study||0||
48272598|NCT02440425|100992003|FG000|NOT COMPLETED|Overall Study||5||
48272599|NCT00201877|100992004|FG000|STARTED|Overall Study||25||
48272600|NCT00201877|100992004|FG000|COMPLETED|Overall Study||25||
48272601|NCT00201877|100992004|FG000|NOT COMPLETED|Overall Study||0||
48272602|NCT01254552|100992005|FG000|STARTED|Screening Visit||351||
48272603|NCT01254552|100992005|FG000|COMPLETED|Screening Visit||348||
48272604|NCT01254552|100992005|FG000|NOT COMPLETED|Screening Visit||3||
48272605|NCT01254552|100992005|FG000|STARTED|Delayed-enhanced MRI With Dotarem||348||
48272606|NCT01254552|100992005|FG000|COMPLETED|Delayed-enhanced MRI With Dotarem||328||
48272607|NCT01254552|100992005|FG000|NOT COMPLETED|Delayed-enhanced MRI With Dotarem||20||
48272608|NCT01254552|100992005|FG000|STARTED|CCTA With Xenetix 350||328||
48393054|NCT02293096|101291493|FG000|STARTED|Overall Study||140||
48393055|NCT02293096|101291493|FG000|COMPLETED|Overall Study||140||
48272609|NCT01254552|100992005|FG000|COMPLETED|CCTA With Xenetix 350||322||
48272610|NCT01254552|100992005|FG000|NOT COMPLETED|CCTA With Xenetix 350||6||
48272611|NCT03514277|100992006|FG000|STARTED|Overall Study||11||
48272612|NCT03514277|100992007|FG001|STARTED|Overall Study||4||
48272613|NCT03514277|100992008|FG002|STARTED|Overall Study||4||
48272614|NCT03514277|100992006|FG000|COMPLETED|Overall Study||11||
48272615|NCT03514277|100992007|FG001|COMPLETED|Overall Study||4||
48272616|NCT03514277|100992008|FG002|COMPLETED|Overall Study||4||
48272617|NCT03514277|100992006|FG000|NOT COMPLETED|Overall Study||0||
48272618|NCT03514277|100992007|FG001|NOT COMPLETED|Overall Study||0||
48272619|NCT03514277|100992008|FG002|NOT COMPLETED|Overall Study||0||
48272620|NCT01310231|100992009|FG000|STARTED|Overall Study||22||
48272621|NCT01310231|100992010|FG001|STARTED|Overall Study||18||
48272622|NCT01310231|100992009|FG000|Received Intervention|Overall Study||22||
48393056|NCT02293096|101291493|FG000|NOT COMPLETED|Overall Study||0||
48393057|NCT01747811|101291494|FG000|STARTED|Overall Study||16||
48272623|NCT01310231|100992010|FG001|Received Intervention|Overall Study||17||
48272624|NCT01310231|100992009|FG000|Discontinued Intervention|Overall Study||0||
48272625|NCT01310231|100992010|FG001|Discontinued Intervention|Overall Study||1||
48272626|NCT01310231|100992009|FG000|Analyzed for Survival|Overall Study||22||
48272627|NCT01310231|100992010|FG001|Analyzed for Survival|Overall Study||18||
48272628|NCT01310231|100992009|FG000|Analyzed for Response, Toxicity, QOL|Overall Study||22||
48393058|NCT01747811|101291495|FG001|STARTED|Overall Study||16||
48393059|NCT01747811|101291494|FG000|COMPLETED|Overall Study||14||
48393060|NCT01747811|101291495|FG001|COMPLETED|Overall Study||12||
48393061|NCT01747811|101291494|FG000|NOT COMPLETED|Overall Study||2||
48272629|NCT01310231|100992010|FG001|Analyzed for Response, Toxicity, QOL|Overall Study||17||
48272630|NCT01310231|100992009|FG000|COMPLETED|Overall Study||22||
48272631|NCT01310231|100992010|FG001|COMPLETED|Overall Study||17||
48272632|NCT01310231|100992009|FG000|NOT COMPLETED|Overall Study||0||
48272633|NCT01310231|100992010|FG001|NOT COMPLETED|Overall Study||1||
48272634|NCT02985840|100992011|FG000|STARTED|Overall Study||64||
48272635|NCT02985840|100992012|FG001|STARTED|Overall Study||63||
48272636|NCT02985840|100992011|FG000|COMPLETED|Overall Study||64||
48272637|NCT02985840|100992012|FG001|COMPLETED|Overall Study||63||
48272638|NCT02985840|100992011|FG000|NOT COMPLETED|Overall Study||0||
48272639|NCT02985840|100992012|FG001|NOT COMPLETED|Overall Study||0||
48272640|NCT03338296|100992013|FG000|STARTED|Overall Study||139||
48272641|NCT03338296|100992014|FG001|STARTED|Overall Study||139||
48272642|NCT03338296|100992013|FG000|Safety Analysis Set|Overall Study||139||
48272643|NCT03338296|100992014|FG001|Safety Analysis Set|Overall Study||136||
48272644|NCT03338296|100992013|FG000|COMPLETED|Overall Study||36||
48272645|NCT03338296|100992014|FG001|COMPLETED|Overall Study||31||
48393062|NCT01747811|101291495|FG001|NOT COMPLETED|Overall Study||4||
48393063|NCT01567891|101291496|FG000|STARTED|Overall Study||9||
48393064|NCT01567891|101291496|FG000|Received T-cell|Overall Study||6||
48393065|NCT01567891|101291496|FG000|COMPLETED|Overall Study||6||
48393066|NCT01567891|101291496|FG000|NOT COMPLETED|Overall Study||3||
48393067|NCT03819478|101291497|FG000|STARTED|Overall Study||62||
48393068|NCT03819478|101291498|FG001|STARTED|Overall Study||62||
48393069|NCT03819478|101291499|FG002|STARTED|Overall Study||63||
48393070|NCT03819478|101291497|FG000|COMPLETED|Overall Study||51||
48555330|NCT03525886|101693690|FG003|STARTED|Cohort 3 (100 mg QPM)||0|Cohort 3 included 8 subjects who had participated in other cohorts.|
48555331|NCT03525886|101693687|FG000|COMPLETED|Cohort 3 (100 mg QPM)||0||
48555332|NCT03525886|101693688|FG001|COMPLETED|Cohort 3 (100 mg QPM)||0||
48555333|NCT03525886|101693689|FG002|COMPLETED|Cohort 3 (100 mg QPM)||8||
48555334|NCT03525886|101693690|FG003|COMPLETED|Cohort 3 (100 mg QPM)||0||
48555335|NCT03525886|101693687|FG000|NOT COMPLETED|Cohort 3 (100 mg QPM)||0||
48555336|NCT03525886|101693688|FG001|NOT COMPLETED|Cohort 3 (100 mg QPM)||0||
48555337|NCT03525886|101693689|FG002|NOT COMPLETED|Cohort 3 (100 mg QPM)||0||
48555338|NCT03525886|101693690|FG003|NOT COMPLETED|Cohort 3 (100 mg QPM)||0||
48555339|NCT03525886|101693687|FG000|STARTED|Cohort 4 (100 mg BID)||0|Cohort 4 included 5 subjects who had participated in other cohorts.|
48555340|NCT03525886|101693688|FG001|STARTED|Cohort 4 (100 mg BID)||0|Cohort 4 included 5 subjects who had participated in other cohorts.|
48555341|NCT03525886|101693689|FG002|STARTED|Cohort 4 (100 mg BID)||0|Cohort 4 included 5 subjects who had participated in other cohorts.|
48555342|NCT03525886|101693690|FG003|STARTED|Cohort 4 (100 mg BID)||8|Cohort 4 included 5 subjects who had participated in other cohorts.|
48555343|NCT03525886|101693687|FG000|COMPLETED|Cohort 4 (100 mg BID)||0||
48555344|NCT03525886|101693688|FG001|COMPLETED|Cohort 4 (100 mg BID)||0||
48555345|NCT03525886|101693689|FG002|COMPLETED|Cohort 4 (100 mg BID)||0||
48555346|NCT03525886|101693690|FG003|COMPLETED|Cohort 4 (100 mg BID)||8||
48272646|NCT03338296|100992013|FG000|NOT COMPLETED|Overall Study||103||
48272647|NCT03338296|100992014|FG001|NOT COMPLETED|Overall Study||108||
48272648|NCT01430468|100992015|FG000|STARTED|Overall Study||22||
48272649|NCT01430468|100992016|FG001|STARTED|Overall Study||22||
48272650|NCT01430468|100992015|FG000|COMPLETED|Overall Study||15||
48272651|NCT01430468|100992016|FG001|COMPLETED|Overall Study||16||
48272652|NCT01430468|100992015|FG000|NOT COMPLETED|Overall Study||7||
48272653|NCT01430468|100992016|FG001|NOT COMPLETED|Overall Study||6||
48272654|NCT03361605|100992017|FG000|STARTED|Overall Study||29||
48272655|NCT03361605|100992017|FG000|COMPLETED|Overall Study||26||
48272656|NCT03361605|100992017|FG000|NOT COMPLETED|Overall Study||3||
48272657|NCT01696045|100992018|FG000|STARTED|Overall Study||4||
48272658|NCT01696045|100992019|FG001|STARTED|Overall Study||8||
48272659|NCT01696045|100992018|FG000|COMPLETED|Overall Study||1||
48272660|NCT01696045|100992019|FG001|COMPLETED|Overall Study||1||
48272661|NCT01696045|100992018|FG000|NOT COMPLETED|Overall Study||3||
48272662|NCT01696045|100992019|FG001|NOT COMPLETED|Overall Study||7||
48393071|NCT03819478|101291498|FG001|COMPLETED|Overall Study||50||
48393072|NCT03819478|101291499|FG002|COMPLETED|Overall Study||52||
48393073|NCT03819478|101291497|FG000|NOT COMPLETED|Overall Study||11||
48393074|NCT03819478|101291498|FG001|NOT COMPLETED|Overall Study||12||
48272663|NCT00047697|100992020|FG000|STARTED|Overall Study||18||
48272664|NCT00047697|100992021|FG001|STARTED|Overall Study||16||
48272665|NCT00047697|100992020|FG000|COMPLETED|Overall Study||18||
48272666|NCT00047697|100992021|FG001|COMPLETED|Overall Study||14||
48272667|NCT00047697|100992020|FG000|NOT COMPLETED|Overall Study||0||
48272668|NCT00047697|100992021|FG001|NOT COMPLETED|Overall Study||2||
48272669|NCT01023958|100992022|FG000|STARTED|Overall Study||50||
48272670|NCT01023958|100992022|FG000|COMPLETED|Overall Study||0||
48272671|NCT01023958|100992022|FG000|NOT COMPLETED|Overall Study||50||
48272672|NCT01200342|100992023|FG000|STARTED|Overall Study||7||
48272673|NCT01200342|100992023|FG000|COMPLETED|Overall Study||6||
48272674|NCT01200342|100992023|FG000|NOT COMPLETED|Overall Study||1||
48272675|NCT01730950|100992024|FG000|STARTED|Overall Study||90||
48272676|NCT01730950|100992025|FG001|STARTED|Overall Study||92||
48393075|NCT03819478|101291499|FG002|NOT COMPLETED|Overall Study||11||
48393076|NCT00369967|101291500|FG000|STARTED|Overall Study||31||
48272677|NCT01730950|100992024|FG000|Eligible Population|Overall Study||84||
48272678|NCT01730950|100992025|FG001|Eligible Population|Overall Study||86||
48272679|NCT01730950|100992024|FG000|Adverse Event Population|Overall Study||76|Eligible participants who started protocol treatment|
48272680|NCT01730950|100992025|FG001|Adverse Event Population|Overall Study||83|Eligible participants who started protocol treatment|
48272681|NCT01730950|100992024|FG000|Response Population|Overall Study||78|Eligible participants with response evaluations|
48272682|NCT01730950|100992025|FG001|Response Population|Overall Study||77|Eligible participants with response evaluations|
48272683|NCT01730950|100992024|FG000|6-month Progression-free Analysis|Overall Study||79|Eligible participants with data at 6 months|
48272684|NCT01730950|100992025|FG001|6-month Progression-free Analysis|Overall Study||81|Eligible participants with data at 6 months|
48272685|NCT01730950|100992024|FG000|Delayed Toxicity Population|Overall Study||0|Eligible participants on RT arm who started RT and were alive at least 91 days from the start of RT|
48272686|NCT01730950|100992025|FG001|Delayed Toxicity Population|Overall Study||83|Eligible participants on RT arm who started RT and were alive at least 91 days from the start of RT|
48555347|NCT03525886|101693687|FG000|NOT COMPLETED|Cohort 4 (100 mg BID)||0||
48555348|NCT03525886|101693688|FG001|NOT COMPLETED|Cohort 4 (100 mg BID)||0||
48555349|NCT03525886|101693689|FG002|NOT COMPLETED|Cohort 4 (100 mg BID)||0||
48555350|NCT03525886|101693690|FG003|NOT COMPLETED|Cohort 4 (100 mg BID)||0||
48555351|NCT05387889|101693691|FG000|STARTED|Overall Study||9||
48555352|NCT05387889|101693692|FG001|STARTED|Overall Study||6||
48555353|NCT05387889|101693691|FG000|COMPLETED|Overall Study||9||
48555354|NCT05387889|101693692|FG001|COMPLETED|Overall Study||6||
48555355|NCT05387889|101693691|FG000|NOT COMPLETED|Overall Study||0||
48555356|NCT05387889|101693692|FG001|NOT COMPLETED|Overall Study||0||
48555357|NCT03682107|101693693|FG000|STARTED|Overall Study||10||
48555358|NCT03682107|101693694|FG001|STARTED|Overall Study||10||
48555359|NCT03682107|101693695|FG002|STARTED|Overall Study||10||
48555360|NCT03682107|101693696|FG003|STARTED|Overall Study||10||
48555361|NCT03682107|101693697|FG004|STARTED|Overall Study||8||
48555362|NCT03682107|101693693|FG000|COMPLETED|Overall Study||10||
48555363|NCT03682107|101693694|FG001|COMPLETED|Overall Study||9||
48555364|NCT03682107|101693695|FG002|COMPLETED|Overall Study||10||
48555365|NCT03682107|101693696|FG003|COMPLETED|Overall Study||10||
48555366|NCT03682107|101693697|FG004|COMPLETED|Overall Study||8||
48555367|NCT03682107|101693693|FG000|NOT COMPLETED|Overall Study||0||
48555368|NCT03682107|101693694|FG001|NOT COMPLETED|Overall Study||1||
48555369|NCT03682107|101693695|FG002|NOT COMPLETED|Overall Study||0||
48555370|NCT03682107|101693696|FG003|NOT COMPLETED|Overall Study||0||
48555371|NCT03682107|101693697|FG004|NOT COMPLETED|Overall Study||0||
48555372|NCT04981717|101693698|FG000|STARTED|Overall Study||222||
48555373|NCT04981717|101693699|FG001|STARTED|Overall Study||224||
48555374|NCT04981717|101693698|FG000|COMPLETED|Overall Study||8||
48272687|NCT01730950|100992024|FG000|COMPLETED|Overall Study||84|Subjects contributing data to results are considered to have completed the study.|
48272688|NCT01730950|100992025|FG001|COMPLETED|Overall Study||86|Subjects contributing data to results are considered to have completed the study.|
48555375|NCT04981717|101693699|FG001|COMPLETED|Overall Study||4||
48555376|NCT04981717|101693698|FG000|NOT COMPLETED|Overall Study||214||
48555377|NCT04981717|101693699|FG001|NOT COMPLETED|Overall Study||220||
48555378|NCT03125798|101693700|FG000|STARTED|Overall Study||109||
48555379|NCT03125798|101693701|FG001|STARTED|Overall Study||107||
48555380|NCT03125798|101693700|FG000|COMPLETED|Overall Study||100||
48555381|NCT03125798|101693701|FG001|COMPLETED|Overall Study||100||
48555382|NCT03125798|101693700|FG000|NOT COMPLETED|Overall Study||9||
48555383|NCT03125798|101693701|FG001|NOT COMPLETED|Overall Study||7||
48555384|NCT00233948|101693702|FG000|STARTED|Overall Study||4||
48555385|NCT00233948|101693703|FG001|STARTED|Overall Study||3||
48555386|NCT00233948|101693704|FG002|STARTED|Overall Study||3||
48555387|NCT00233948|101693705|FG003|STARTED|Overall Study||3||
48555388|NCT00233948|101693706|FG004|STARTED|Overall Study||4||
48555389|NCT00233948|101693707|FG005|STARTED|Overall Study||12||
48555390|NCT00233948|101693702|FG000|COMPLETED|Overall Study||3||
48555391|NCT00233948|101693703|FG001|COMPLETED|Overall Study||3||
48555392|NCT00233948|101693704|FG002|COMPLETED|Overall Study||3||
48555393|NCT00233948|101693705|FG003|COMPLETED|Overall Study||3||
48555394|NCT00233948|101693706|FG004|COMPLETED|Overall Study||4||
48555395|NCT00233948|101693707|FG005|COMPLETED|Overall Study||12||
48555396|NCT00233948|101693702|FG000|NOT COMPLETED|Overall Study||1||
48555397|NCT00233948|101693703|FG001|NOT COMPLETED|Overall Study||0||
48555398|NCT00233948|101693704|FG002|NOT COMPLETED|Overall Study||0||
48555399|NCT00233948|101693705|FG003|NOT COMPLETED|Overall Study||0||
48555400|NCT00233948|101693706|FG004|NOT COMPLETED|Overall Study||0||
48555401|NCT00233948|101693707|FG005|NOT COMPLETED|Overall Study||0||
48555402|NCT03354598|101693708|FG000|STARTED|Overall Study||835||
48555403|NCT03354598|101693709|FG001|STARTED|Overall Study||836||
48555404|NCT03354598|101693708|FG000|Microbiologic Modified Intent to Treat Resistant (Micro-MITTR) Participants|Overall Study||147||
48555405|NCT03354598|101693709|FG001|Microbiologic Modified Intent to Treat Resistant (Micro-MITTR) Participants|Overall Study||139||
48555406|NCT03354598|101693708|FG000|Microbiologic Modified Intent to Treat Susceptible (Micro-MITTS) Participants|Overall Study||370||
48555407|NCT03354598|101693709|FG001|Microbiologic Modified Intent to Treat Susceptible (Micro-MITTS) Participants|Overall Study||415||
48110448|NCT04116710|100597930|FG001|Disease Progression|Overall Study||6||
48110449|NCT04116710|100597931|FG002|Disease Progression|Overall Study||2||
48110450|NCT04116710|100597932|FG003|Disease Progression|Overall Study||2||
48110451|NCT04116710|100597929|FG000|COMPLETED|Overall Study||0||
48110452|NCT04116710|100597930|FG001|COMPLETED|Overall Study||0||
48110453|NCT04116710|100597931|FG002|COMPLETED|Overall Study||0||
48272689|NCT01730950|100992024|FG000|NOT COMPLETED|Overall Study||6||
48272690|NCT01730950|100992025|FG001|NOT COMPLETED|Overall Study||6||
48272691|NCT00513305|100992026|FG000|STARTED|Overall Study||33||
48272692|NCT00513305|100992027|FG001|STARTED|Overall Study||34||
48272693|NCT00513305|100992026|FG000|COMPLETED|Overall Study||5||
48272694|NCT00513305|100992027|FG001|COMPLETED|Overall Study||7||
48272695|NCT00513305|100992026|FG000|NOT COMPLETED|Overall Study||28||
48555408|NCT03354598|101693708|FG000|Microbiologic Modified Intent to Treat (Micro-MITT) Participants|Overall Study||517||
48555409|NCT03354598|101693709|FG001|Microbiologic Modified Intent to Treat (Micro-MITT) Participants|Overall Study||554||
48555410|NCT03354598|101693708|FG000|Modified Intent to Treat (MITT) Participants|Overall Study||785||
48555411|NCT03354598|101693709|FG001|Modified Intent to Treat (MITT) Participants|Overall Study||794||
48555412|NCT03354598|101693708|FG000|Intent to Treat (ITT) Participants|Overall Study||787||
48555413|NCT03354598|101693709|FG001|Intent to Treat (ITT) Participants|Overall Study||803||
48555414|NCT03354598|101693708|FG000|Safety Participants|Overall Study||833||
48555415|NCT03354598|101693709|FG001|Safety Participants|Overall Study||827||
48555416|NCT03354598|101693708|FG000|COMPLETED|Overall Study||755||
48555417|NCT03354598|101693709|FG001|COMPLETED|Overall Study||761||
48555418|NCT03354598|101693708|FG000|NOT COMPLETED|Overall Study||80||
48555419|NCT03354598|101693709|FG001|NOT COMPLETED|Overall Study||75||
48555420|NCT01710787|101693710|FG000|STARTED|Overall Study||44||
48555421|NCT01710787|101693711|FG001|STARTED|Overall Study||44||
48555422|NCT01710787|101693712|FG002|STARTED|Overall Study||22||
48555423|NCT01710787|101693710|FG000|COMPLETED|Overall Study||44||
48555424|NCT01710787|101693711|FG001|COMPLETED|Overall Study||44||
48555425|NCT01710787|101693712|FG002|COMPLETED|Overall Study||22||
48694026|NCT01500252|102036281|FG001|Five Years|Overall Study||13||
48694027|NCT01500252|102036280|FG000|Ten Years|Overall Study||12||
48694028|NCT01500252|102036281|FG001|Ten Years|Overall Study||11||
48694029|NCT01500252|102036280|FG000|COMPLETED|Overall Study||12||
48694030|NCT01500252|102036281|FG001|COMPLETED|Overall Study||11||
48694031|NCT01500252|102036280|FG000|NOT COMPLETED|Overall Study||9||
48694032|NCT01500252|102036281|FG001|NOT COMPLETED|Overall Study||6||
48694033|NCT01843673|102036282|FG000|STARTED|Overall Study||16||
48694034|NCT01843673|102036282|FG000|COMPLETED|Overall Study||10||
48694035|NCT01843673|102036282|FG000|NOT COMPLETED|Overall Study||6||
48694036|NCT00943098|102036283|FG000|STARTED|Overall Study||70||
48694037|NCT00943098|102036284|FG001|STARTED|Overall Study||72||
48694038|NCT00943098|102036283|FG000|COMPLETED|Overall Study||70||
48694039|NCT00943098|102036284|FG001|COMPLETED|Overall Study||72||
48694040|NCT00943098|102036283|FG000|NOT COMPLETED|Overall Study||0||
48694041|NCT00943098|102036284|FG001|NOT COMPLETED|Overall Study||0||
48110454|NCT04116710|100597932|FG003|COMPLETED|Overall Study||0||
48110455|NCT04116710|100597929|FG000|NOT COMPLETED|Overall Study||4||
48110456|NCT04116710|100597930|FG001|NOT COMPLETED|Overall Study||6||
48555426|NCT01710787|101693710|FG000|NOT COMPLETED|Overall Study||0||
48555427|NCT01710787|101693711|FG001|NOT COMPLETED|Overall Study||0||
48555428|NCT01710787|101693712|FG002|NOT COMPLETED|Overall Study||0||
48555429|NCT04728802|101693713|FG000|STARTED|Overall Study||317||
48555430|NCT04728802|101693714|FG001|STARTED|Overall Study||328||
48555431|NCT04728802|101693713|FG000|COMPLETED|Overall Study||288|All randomized patients were included in analysis|
48555432|NCT04728802|101693714|FG001|COMPLETED|Overall Study||292|All randomized patients were included in analysis|
48555433|NCT04728802|101693713|FG000|NOT COMPLETED|Overall Study||29||
48555434|NCT04728802|101693714|FG001|NOT COMPLETED|Overall Study||36||
48555435|NCT00214383|101693715|FG000|STARTED|Overall Study||148||
48555436|NCT00214383|101693716|FG001|STARTED|Overall Study||153||
48555437|NCT00214383|101693715|FG000|COMPLETED|Overall Study||132||
48555438|NCT00214383|101693716|FG001|COMPLETED|Overall Study||127||
48555439|NCT00214383|101693715|FG000|NOT COMPLETED|Overall Study||16||
48555440|NCT00214383|101693716|FG001|NOT COMPLETED|Overall Study||26||
48555441|NCT02492867|101693717|FG000|STARTED|Overall Study||47||
48555442|NCT02492867|101693717|FG000|COMPLETED|Overall Study||42||
48694042|NCT00301262|102036285|FG000|STARTED|Double Blind Phase (DB)||94||
48694043|NCT00301262|102036286|FG001|STARTED|Double Blind Phase (DB)||82||
48694044|NCT00301262|102036285|FG000|COMPLETED|Double Blind Phase (DB)||84||
48110457|NCT04116710|100597931|FG002|NOT COMPLETED|Overall Study||3||
48110458|NCT04116710|100597932|FG003|NOT COMPLETED|Overall Study||2||
48110459|NCT02449239|100597933|FG000|STARTED|Induction Phase||133||
48694045|NCT00301262|102036286|FG001|COMPLETED|Double Blind Phase (DB)||69||
48710808|NCT01187446|102078024|FG000|NOT COMPLETED|Overall Study||0||
48555443|NCT02492867|101693717|FG000|NOT COMPLETED|Overall Study||5||
48555444|NCT02174627|101693718|FG000|STARTED|Overall Study||1384|Randomized and included in the analysis|
48555445|NCT02174627|101693719|FG001|STARTED|Overall Study||1377|Randomized and included in the analysis|
48555446|NCT02174627|101693718|FG000|Received Treatment|Overall Study||1384||
48555447|NCT02174627|101693719|FG001|Received Treatment|Overall Study||1376||
48110460|NCT02449239|100597933|FG000|COMPLETED|Induction Phase||63||
48110461|NCT02449239|100597933|FG000|NOT COMPLETED|Induction Phase||70||
48110462|NCT02449239|100597933|FG000|STARTED|Maintenance Month 3||63||
48110463|NCT02449239|100597933|FG000|COMPLETED|Maintenance Month 3||49||
48110464|NCT02449239|100597933|FG000|NOT COMPLETED|Maintenance Month 3||14||
48110465|NCT02449239|100597933|FG000|STARTED|Maintenance Month 6||49||
48110466|NCT02449239|100597933|FG000|COMPLETED|Maintenance Month 6||36||
48110467|NCT02449239|100597933|FG000|NOT COMPLETED|Maintenance Month 6||13||
48110468|NCT02449239|100597933|FG000|STARTED|Maintenance Month 9||36||
48110469|NCT02449239|100597933|FG000|COMPLETED|Maintenance Month 9||33||
48110470|NCT02449239|100597933|FG000|NOT COMPLETED|Maintenance Month 9||3||
48110471|NCT02449239|100597933|FG000|STARTED|Maintenance Month 12||33||
48110472|NCT02449239|100597933|FG000|COMPLETED|Maintenance Month 12||26||
48110473|NCT02449239|100597933|FG000|NOT COMPLETED|Maintenance Month 12||7||
48110474|NCT02449239|100597933|FG000|STARTED|Maintenance Month 15||26||
48110475|NCT02449239|100597933|FG000|COMPLETED|Maintenance Month 15||25||
48110476|NCT02449239|100597933|FG000|NOT COMPLETED|Maintenance Month 15||1||
48110477|NCT02449239|100597933|FG000|STARTED|Maintenance Month 18||25||
48110478|NCT02449239|100597933|FG000|COMPLETED|Maintenance Month 18||25||
48110479|NCT02449239|100597933|FG000|NOT COMPLETED|Maintenance Month 18||0||
48110480|NCT02449239|100597933|FG000|STARTED|Maintenance Month 21||25||
48110481|NCT02449239|100597933|FG000|COMPLETED|Maintenance Month 21||23||
48110482|NCT02449239|100597933|FG000|NOT COMPLETED|Maintenance Month 21||2||
48272696|NCT00513305|100992027|FG001|NOT COMPLETED|Overall Study||27||
48272697|NCT01468181|100992028|FG000|STARTED|Overall Study||131||
48272698|NCT01468181|100992029|FG001|STARTED|Overall Study||61||
48272699|NCT01468181|100992030|FG002|STARTED|Overall Study||65||
48272700|NCT01468181|100992031|FG003|STARTED|Overall Study||66||
48272701|NCT01468181|100992032|FG004|STARTED|Overall Study||71||
48272702|NCT01468181|100992028|FG000|Received at Least 1 Dose of Study Drug|Overall Study||131||
48555448|NCT02174627|101693718|FG000|Discontinued Treatment|Overall Study||499||
48555449|NCT02174627|101693719|FG001|Discontinued Treatment|Overall Study||801||
48555450|NCT02174627|101693718|FG000|COMPLETED|Overall Study||1300|Completed the study|
48555451|NCT02174627|101693719|FG001|COMPLETED|Overall Study||1247|Completed the study|
48555452|NCT02174627|101693718|FG000|NOT COMPLETED|Overall Study||84||
48555453|NCT02174627|101693719|FG001|NOT COMPLETED|Overall Study||130||
48555454|NCT01037452|101693720|FG000|STARTED|Overall Study||30||
48555455|NCT01037452|101693721|FG001|STARTED|Overall Study||30||
48272703|NCT01468181|100992029|FG001|Received at Least 1 Dose of Study Drug|Overall Study||61||
48555456|NCT01037452|101693722|FG002|STARTED|Overall Study||30||
48555457|NCT01037452|101693723|FG003|STARTED|Overall Study||30||
48555458|NCT01037452|101693720|FG000|COMPLETED|Overall Study||30||
48555459|NCT01037452|101693721|FG001|COMPLETED|Overall Study||30||
48555460|NCT01037452|101693722|FG002|COMPLETED|Overall Study||30||
48555461|NCT01037452|101693723|FG003|COMPLETED|Overall Study||30||
48555462|NCT01037452|101693720|FG000|NOT COMPLETED|Overall Study||0||
48555463|NCT01037452|101693721|FG001|NOT COMPLETED|Overall Study||0||
48555464|NCT01037452|101693722|FG002|NOT COMPLETED|Overall Study||0||
48555465|NCT01037452|101693723|FG003|NOT COMPLETED|Overall Study||0||
48555466|NCT01927120|101693724|FG000|STARTED|Overall Study||20||
48555467|NCT01927120|101693724|FG000|COMPLETED|Overall Study||10||
48555468|NCT01927120|101693724|FG000|NOT COMPLETED|Overall Study||10||
48555469|NCT00836407|101693725|FG000|STARTED|Overall Study||15||
48555470|NCT00836407|101693726|FG001|STARTED|Overall Study||15||
48272704|NCT01468181|100992030|FG002|Received at Least 1 Dose of Study Drug|Overall Study||65||
48272705|NCT01468181|100992031|FG003|Received at Least 1 Dose of Study Drug|Overall Study||66||
48272706|NCT01468181|100992032|FG004|Received at Least 1 Dose of Study Drug|Overall Study||71||
48272707|NCT01468181|100992028|FG000|COMPLETED|Overall Study||121||
48555471|NCT00836407|101693725|FG000|COMPLETED|Overall Study||4||
48555472|NCT00836407|101693726|FG001|COMPLETED|Overall Study||7||
48555473|NCT00836407|101693725|FG000|NOT COMPLETED|Overall Study||11||
48555474|NCT00836407|101693726|FG001|NOT COMPLETED|Overall Study||8||
48555475|NCT01060072|101693727|FG000|STARTED|Overall Study||206||
48555476|NCT01060072|101693728|FG001|STARTED|Overall Study||201||
48555477|NCT01060072|101693727|FG000|COMPLETED|Overall Study||204||
48110483|NCT02777125|100597934|FG000|STARTED|Overall Study||488||
48110484|NCT02777125|100597935|FG001|STARTED|Overall Study||492||
48110485|NCT02777125|100597934|FG000|COMPLETED|Overall Study||445||
48110486|NCT02777125|100597935|FG001|COMPLETED|Overall Study||445||
48110487|NCT02777125|100597934|FG000|NOT COMPLETED|Overall Study||43||
48272708|NCT01468181|100992029|FG001|COMPLETED|Overall Study||59||
48555478|NCT01060072|101693728|FG001|COMPLETED|Overall Study||196||
48555479|NCT01060072|101693727|FG000|NOT COMPLETED|Overall Study||2||
48555480|NCT01060072|101693728|FG001|NOT COMPLETED|Overall Study||5||
48555481|NCT01522456|101693729|FG000|STARTED|Overall Study||73||
48555482|NCT01522456|101693729|FG000|COMPLETED|Overall Study||65||
48555483|NCT01522456|101693729|FG000|NOT COMPLETED|Overall Study||8||
48555484|NCT00291317|101693730|FG000|STARTED|Overall Study||6||
48555485|NCT00291317|101693730|FG000|COMPLETED|Overall Study||6||
48555486|NCT00291317|101693730|FG000|NOT COMPLETED|Overall Study||0||
48555487|NCT04156581|101693731|FG000|STARTED|Overall Study||23||
48555488|NCT04156581|101693732|FG001|STARTED|Overall Study||23||
48555489|NCT04156581|101693731|FG000|COMPLETED|Overall Study||23||
48555490|NCT04156581|101693732|FG001|COMPLETED|Overall Study||23||
48555491|NCT04156581|101693731|FG000|NOT COMPLETED|Overall Study||0||
48555492|NCT04156581|101693732|FG001|NOT COMPLETED|Overall Study||0||
48555493|NCT02254265|101693733|FG000|STARTED|Overall Study||151||
48555494|NCT02254265|101693734|FG001|STARTED|Overall Study||152||
48555495|NCT02254265|101693735|FG002|STARTED|Overall Study||152||
48555496|NCT02254265|101693733|FG000|COMPLETED|Overall Study||142||
48555497|NCT02254265|101693734|FG001|COMPLETED|Overall Study||140||
48555498|NCT02254265|101693735|FG002|COMPLETED|Overall Study||144||
48555499|NCT02254265|101693733|FG000|NOT COMPLETED|Overall Study||9||
48555500|NCT02254265|101693734|FG001|NOT COMPLETED|Overall Study||12||
48555501|NCT02254265|101693735|FG002|NOT COMPLETED|Overall Study||8||
48555502|NCT01350271|101693736|FG000|STARTED|Overall Study||70||
48555503|NCT01350271|101693737|FG001|STARTED|Overall Study||70||
48555504|NCT01350271|101693738|FG002|STARTED|Overall Study||74||
48555505|NCT01350271|101693736|FG000|COMPLETED|Overall Study||49||
48555506|NCT01350271|101693737|FG001|COMPLETED|Overall Study||53||
48555507|NCT01350271|101693738|FG002|COMPLETED|Overall Study||48||
48555508|NCT01350271|101693736|FG000|NOT COMPLETED|Overall Study||21||
48555509|NCT01350271|101693737|FG001|NOT COMPLETED|Overall Study||17||
48555510|NCT01350271|101693738|FG002|NOT COMPLETED|Overall Study||26||
48555511|NCT03126448|101693739|FG000|STARTED|Overall Study||56||
48555512|NCT03126448|101693740|FG001|STARTED|Overall Study||49||
48555513|NCT03126448|101693741|FG002|STARTED|Overall Study||37||
48555514|NCT03126448|101693739|FG000|COMPLETED|Overall Study||43||
48555515|NCT03126448|101693740|FG001|COMPLETED|Overall Study||41||
48555516|NCT03126448|101693741|FG002|COMPLETED|Overall Study||27||
48555517|NCT03126448|101693739|FG000|NOT COMPLETED|Overall Study||13||
48555518|NCT03126448|101693740|FG001|NOT COMPLETED|Overall Study||8||
48555519|NCT03126448|101693741|FG002|NOT COMPLETED|Overall Study||10||
48555520|NCT01707290|101693742|FG000|STARTED|Overall Study||121||
48555521|NCT01707290|101693743|FG001|STARTED|Overall Study||4||
48555522|NCT01707290|101693742|FG000|COMPLETED|Overall Study||35||
48555523|NCT01707290|101693743|FG001|COMPLETED|Overall Study||3||
48555524|NCT01707290|101693742|FG000|NOT COMPLETED|Overall Study||86||
48555525|NCT01707290|101693743|FG001|NOT COMPLETED|Overall Study||1||
48555526|NCT01326845|101693744|FG000|STARTED|Overall Study||7||
48555527|NCT01326845|101693745|FG001|STARTED|Overall Study||5||
48555528|NCT01326845|101693744|FG000|COMPLETED|Overall Study||0||
48555529|NCT01326845|101693745|FG001|COMPLETED|Overall Study||0||
48555530|NCT01326845|101693744|FG000|NOT COMPLETED|Overall Study||7||
48555531|NCT01326845|101693745|FG001|NOT COMPLETED|Overall Study||5||
48555532|NCT00619723|101693746|FG000|STARTED|Overall Study||63||
48555533|NCT00619723|101693747|FG001|STARTED|Overall Study||67||
48555534|NCT00619723|101693746|FG000|COMPLETED|Overall Study||61||
48555535|NCT00619723|101693747|FG001|COMPLETED|Overall Study||61||
48555536|NCT00619723|101693746|FG000|NOT COMPLETED|Overall Study||2||
48555537|NCT00619723|101693747|FG001|NOT COMPLETED|Overall Study||6||
48555538|NCT02456740|101693748|FG000|STARTED|Double-blind Treatment Phase (24 Weeks)||319||
48555539|NCT02456740|101693749|FG001|STARTED|Double-blind Treatment Phase (24 Weeks)||317||
48555540|NCT02456740|101693750|FG002|STARTED|Double-blind Treatment Phase (24 Weeks)||319||
48555541|NCT02456740|101693751|FG003|STARTED|Double-blind Treatment Phase (24 Weeks)||0||
48555542|NCT02456740|101693752|FG004|STARTED|Double-blind Treatment Phase (24 Weeks)||0||
48555543|NCT02456740|101693753|FG005|STARTED|Double-blind Treatment Phase (24 Weeks)||0||
48555544|NCT02456740|101693754|FG006|STARTED|Double-blind Treatment Phase (24 Weeks)||0||
48555545|NCT02456740|101693755|FG007|STARTED|Double-blind Treatment Phase (24 Weeks)||0||
48555546|NCT02456740|101693756|FG008|STARTED|Double-blind Treatment Phase (24 Weeks)||0||
48555547|NCT02456740|101693748|FG000|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||319||
48555548|NCT02456740|101693749|FG001|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||314||
48555549|NCT02456740|101693750|FG002|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||319||
48555550|NCT02456740|101693751|FG003|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0||
48555551|NCT02456740|101693752|FG004|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0||
48555552|NCT02456740|101693753|FG005|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0||
48555553|NCT02456740|101693754|FG006|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0||
48555554|NCT02456740|101693755|FG007|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0||
48555555|NCT02456740|101693756|FG008|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0||
48555556|NCT02456740|101693748|FG000|COMPLETED|Double-blind Treatment Phase (24 Weeks)||282||
48555557|NCT02456740|101693749|FG001|COMPLETED|Double-blind Treatment Phase (24 Weeks)||284||
48555558|NCT02456740|101693750|FG002|COMPLETED|Double-blind Treatment Phase (24 Weeks)||292||
48555559|NCT02456740|101693751|FG003|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0||
48555560|NCT02456740|101693752|FG004|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0||
48555561|NCT02456740|101693753|FG005|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0||
48555562|NCT02456740|101693754|FG006|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0||
48555563|NCT02456740|101693755|FG007|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0||
48555564|NCT02456740|101693756|FG008|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0||
48555565|NCT02456740|101693748|FG000|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||37||
48555566|NCT02456740|101693749|FG001|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||33||
48555567|NCT02456740|101693750|FG002|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||27||
48555568|NCT02456740|101693751|FG003|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0||
48555569|NCT02456740|101693752|FG004|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0||
48272709|NCT01468181|100992030|FG002|COMPLETED|Overall Study||57||
48272710|NCT01468181|100992031|FG003|COMPLETED|Overall Study||63||
48272711|NCT01468181|100992032|FG004|COMPLETED|Overall Study||66||
48272712|NCT01468181|100992028|FG000|NOT COMPLETED|Overall Study||10||
48272713|NCT01468181|100992029|FG001|NOT COMPLETED|Overall Study||2||
48272714|NCT01468181|100992030|FG002|NOT COMPLETED|Overall Study||8||
48272715|NCT01468181|100992031|FG003|NOT COMPLETED|Overall Study||3||
48272716|NCT01468181|100992032|FG004|NOT COMPLETED|Overall Study||5||
48272717|NCT05110690|100992033|FG000|STARTED|Eligible for Consent and Enrollment||29||
48272718|NCT05110690|100992033|FG000|COMPLETED|Eligible for Consent and Enrollment||24||
48272719|NCT05110690|100992033|FG000|NOT COMPLETED|Eligible for Consent and Enrollment||5||
48272720|NCT05110690|100992033|FG000|STARTED|Enrolled||24||
48272721|NCT05110690|100992033|FG000|COMPLETED|Enrolled||24||
48272722|NCT05110690|100992033|FG000|NOT COMPLETED|Enrolled||0||
48272723|NCT05110690|100992033|FG000|STARTED|Started Intervention||24||
48272724|NCT05110690|100992033|FG000|COMPLETED|Started Intervention||23||
48272725|NCT05110690|100992033|FG000|NOT COMPLETED|Started Intervention||1||
48272726|NCT05110690|100992033|FG000|STARTED|Completion of Intervention||23||
48272727|NCT05110690|100992033|FG000|COMPLETED|Completion of Intervention||19||
48272728|NCT05110690|100992033|FG000|NOT COMPLETED|Completion of Intervention||4||
48555570|NCT02456740|101693753|FG005|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0||
48555571|NCT02456740|101693754|FG006|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0||
48555572|NCT02456740|101693755|FG007|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0||
48555573|NCT02456740|101693756|FG008|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0||
48555574|NCT02456740|101693748|FG000|STARTED|Active Treatment Phase (Weeks 24 - 52)||0|Fourteen participants who completed the DBTP did not continue onto the active treatment phase|
48555575|NCT02456740|101693749|FG001|STARTED|Active Treatment Phase (Weeks 24 - 52)||0|Fourteen participants who completed the DBTP did not continue onto the active treatment phase|
48555576|NCT02456740|101693750|FG002|STARTED|Active Treatment Phase (Weeks 24 - 52)||0|Fourteen participants who completed the DBTP did not continue onto the active treatment phase|
48555577|NCT02456740|101693751|FG003|STARTED|Active Treatment Phase (Weeks 24 - 52)||138|Fourteen participants who completed the DBTP did not continue onto the active treatment phase|
48555578|NCT02456740|101693752|FG004|STARTED|Active Treatment Phase (Weeks 24 - 52)||140|Fourteen participants who completed the DBTP did not continue onto the active treatment phase|
48592727|NCT02143791|101783167|FG000|COMPLETED|Any Program (6-12 Months)||86||
48110488|NCT02777125|100597935|FG001|NOT COMPLETED|Overall Study||47||
48110489|NCT03907683|100597936|FG000|STARTED|Overall Study||82||
48110490|NCT03907683|100597936|FG000|COMPLETED|Overall Study||80||
48110491|NCT03907683|100597936|FG000|NOT COMPLETED|Overall Study||2||
48110492|NCT00842348|100597937|FG000|STARTED|Patients Randomised in Study 726||101||
48110493|NCT00842348|100597938|FG001|STARTED|Patients Randomised in Study 726||103||
48110494|NCT00842348|100597937|FG000|COMPLETED|Patients Randomised in Study 726||42||
48110495|NCT00842348|100597938|FG001|COMPLETED|Patients Randomised in Study 726||47||
48110496|NCT00842348|100597937|FG000|NOT COMPLETED|Patients Randomised in Study 726||59||
48110497|NCT00842348|100597938|FG001|NOT COMPLETED|Patients Randomised in Study 726||56||
48110498|NCT00842348|100597937|FG000|STARTED|Study 729||42||
48110499|NCT00842348|100597938|FG001|STARTED|Study 729||47||
48272729|NCT02305277|100992034|FG000|STARTED|Overall Study||15||
48272730|NCT02305277|100992035|FG001|STARTED|Overall Study||14||
48110500|NCT00842348|100597937|FG000|COMPLETED|Study 729||16||
48110501|NCT00842348|100597938|FG001|COMPLETED|Study 729||9||
48110502|NCT00842348|100597937|FG000|NOT COMPLETED|Study 729||26||
48110503|NCT00842348|100597938|FG001|NOT COMPLETED|Study 729||38||
48110504|NCT00739752|100597939|FG000|STARTED|Overall Study||299||
48110505|NCT00739752|100597940|FG001|STARTED|Overall Study||284||
48110506|NCT00739752|100597941|FG002|STARTED|Overall Study||292||
48110507|NCT00739752|100597942|FG003|STARTED|Overall Study||288||
48272731|NCT02305277|100992036|FG002|STARTED|Overall Study||14||
48272732|NCT02305277|100992037|FG003|STARTED|Overall Study||14||
48272733|NCT02305277|100992038|FG004|STARTED|Overall Study||14||
48272734|NCT02305277|100992039|FG005|STARTED|Overall Study||14||
48272735|NCT02305277|100992034|FG000|Received CM|Overall Study||15||
48272736|NCT02305277|100992035|FG001|Received CM|Overall Study||14||
48110508|NCT00739752|100597943|FG004|STARTED|Overall Study||291||
48110509|NCT00739752|100597944|FG005|STARTED|Overall Study||293||
48110510|NCT00739752|100597939|FG000|COMPLETED|Overall Study||299||
48110511|NCT00739752|100597940|FG001|COMPLETED|Overall Study||284||
48110512|NCT00739752|100597941|FG002|COMPLETED|Overall Study||292||
48110513|NCT00739752|100597942|FG003|COMPLETED|Overall Study||288||
48110514|NCT00739752|100597943|FG004|COMPLETED|Overall Study||291||
48110515|NCT00739752|100597944|FG005|COMPLETED|Overall Study||293||
48110516|NCT00739752|100597939|FG000|NOT COMPLETED|Overall Study||0||
48110517|NCT00739752|100597940|FG001|NOT COMPLETED|Overall Study||0||
48110518|NCT00739752|100597941|FG002|NOT COMPLETED|Overall Study||0||
48110519|NCT00739752|100597942|FG003|NOT COMPLETED|Overall Study||0||
48110520|NCT00739752|100597943|FG004|NOT COMPLETED|Overall Study||0||
48110521|NCT00739752|100597944|FG005|NOT COMPLETED|Overall Study||0||
48110522|NCT00983216|100597945|FG000|STARTED|Colchicine Alone||24||
48110523|NCT00983216|100597945|FG000|COMPLETED|Colchicine Alone||24||
48110524|NCT00983216|100597945|FG000|NOT COMPLETED|Colchicine Alone||0||
48110525|NCT00983216|100597945|FG000|STARTED|14 Day Washout Period||24||
48110526|NCT00983216|100597945|FG000|COMPLETED|14 Day Washout Period||24||
48110527|NCT00983216|100597945|FG000|NOT COMPLETED|14 Day Washout Period||0||
48110528|NCT00983216|100597945|FG000|STARTED|Ketoconazole Alone||24||
48110529|NCT00983216|100597945|FG000|COMPLETED|Ketoconazole Alone||24||
48110530|NCT00983216|100597945|FG000|NOT COMPLETED|Ketoconazole Alone||0||
48110531|NCT00983216|100597945|FG000|STARTED|Colchicine With Ketoconazole||24||
48110532|NCT00983216|100597945|FG000|COMPLETED|Colchicine With Ketoconazole||24||
48110533|NCT00983216|100597945|FG000|NOT COMPLETED|Colchicine With Ketoconazole||0||
48110534|NCT03080961|100597946|FG000|STARTED|Overall Study||46||
48110535|NCT03080961|100597946|FG000|COMPLETED|Overall Study||43||
48110536|NCT03080961|100597946|FG000|NOT COMPLETED|Overall Study||3||
48110537|NCT04322396|100597947|FG000|STARTED|Overall Study||56||
48110538|NCT04322396|100597948|FG001|STARTED|Overall Study||61||
48110539|NCT04322396|100597947|FG000|COMPLETED|Overall Study||56||
48555579|NCT02456740|101693753|FG005|STARTED|Active Treatment Phase (Weeks 24 - 52)||143|Fourteen participants who completed the DBTP did not continue onto the active treatment phase|
48592728|NCT02143791|101783167|FG000|NOT COMPLETED|Any Program (6-12 Months)||2||
48110540|NCT04322396|100597948|FG001|COMPLETED|Overall Study||61||
48110541|NCT04322396|100597947|FG000|NOT COMPLETED|Overall Study||0||
48110542|NCT04322396|100597948|FG001|NOT COMPLETED|Overall Study||0||
48110543|NCT00499096|100597949|FG000|STARTED|Overall Study||58||
48110544|NCT00499096|100597950|FG001|STARTED|Overall Study||60||
48110545|NCT00499096|100597949|FG000|COMPLETED|Overall Study||35||
48110546|NCT00499096|100597950|FG001|COMPLETED|Overall Study||40||
48110547|NCT00499096|100597949|FG000|NOT COMPLETED|Overall Study||23||
48110548|NCT00499096|100597950|FG001|NOT COMPLETED|Overall Study||20||
48110549|NCT01052545|100597951|FG000|STARTED|Overall Study||867||
48110550|NCT01052545|100597952|FG001|STARTED|Overall Study||731||
48110551|NCT01052545|100597951|FG000|COMPLETED|Overall Study||867||
48110552|NCT01052545|100597952|FG001|COMPLETED|Overall Study||731||
48110553|NCT01052545|100597951|FG000|NOT COMPLETED|Overall Study||0||
48110554|NCT01052545|100597952|FG001|NOT COMPLETED|Overall Study||0||
48110555|NCT04206293|100597953|FG000|STARTED|Overall Study||11||
48110556|NCT04206293|100597953|FG000|COMPLETED|Overall Study||10||
48110557|NCT04206293|100597953|FG000|NOT COMPLETED|Overall Study||1||
48110558|NCT01569529|100597954|FG000|STARTED|Overall Study||2676||
48110559|NCT01569529|100597955|FG001|STARTED|Overall Study||394||
48110560|NCT01569529|100597954|FG000|COMPLETED|Overall Study||2676||
48110561|NCT01569529|100597955|FG001|COMPLETED|Overall Study||394||
48110562|NCT01569529|100597954|FG000|NOT COMPLETED|Overall Study||0||
48110563|NCT01569529|100597955|FG001|NOT COMPLETED|Overall Study||0||
48110564|NCT03007394|100597956|FG000|STARTED|Overall Study||118||
48110565|NCT03007394|100597957|FG001|STARTED|Overall Study||154||
48110566|NCT03007394|100597956|FG000|COMPLETED|Overall Study||91||
48110567|NCT03007394|100597957|FG001|COMPLETED|Overall Study||91||
48110568|NCT03007394|100597956|FG000|NOT COMPLETED|Overall Study||27||
48110569|NCT03007394|100597957|FG001|NOT COMPLETED|Overall Study||63||
48592729|NCT02678000|101783168|FG000|STARTED|PART 1||7||
48110570|NCT03023488|100597958|FG000|STARTED|Overall Study||46||
48110571|NCT03023488|100597958|FG000|COMPLETED|Overall Study||46||
48110572|NCT03023488|100597958|FG000|NOT COMPLETED|Overall Study||0||
48110573|NCT00838565|100597959|FG000|STARTED|Overall Study||9||
48110574|NCT00838565|100597960|FG001|STARTED|Overall Study||7||
48110575|NCT00838565|100597961|FG002|STARTED|Overall Study||6||
48110576|NCT00838565|100597962|FG003|STARTED|Overall Study||6||
48110577|NCT00838565|100597963|FG004|STARTED|Overall Study||6||
48110578|NCT00838565|100597964|FG005|STARTED|Overall Study||7||
48110579|NCT00838565|100597959|FG000|Treated|Overall Study||9||
48110580|NCT00838565|100597960|FG001|Treated|Overall Study||6||
48110581|NCT00838565|100597961|FG002|Treated|Overall Study||6||
48110582|NCT00838565|100597962|FG003|Treated|Overall Study||6||
48110583|NCT00838565|100597963|FG004|Treated|Overall Study||6||
48110584|NCT00838565|100597964|FG005|Treated|Overall Study||7||
48110585|NCT00838565|100597959|FG000|COMPLETED|Overall Study||9||
48110586|NCT00838565|100597960|FG001|COMPLETED|Overall Study||4||
48110587|NCT00838565|100597961|FG002|COMPLETED|Overall Study||5||
48110588|NCT00838565|100597962|FG003|COMPLETED|Overall Study||6||
48110589|NCT00838565|100597963|FG004|COMPLETED|Overall Study||6||
48110590|NCT00838565|100597964|FG005|COMPLETED|Overall Study||5||
48110591|NCT00838565|100597959|FG000|NOT COMPLETED|Overall Study||0||
48110592|NCT00838565|100597960|FG001|NOT COMPLETED|Overall Study||3||
48110593|NCT00838565|100597961|FG002|NOT COMPLETED|Overall Study||1||
48110594|NCT00838565|100597962|FG003|NOT COMPLETED|Overall Study||0||
48110595|NCT00838565|100597963|FG004|NOT COMPLETED|Overall Study||0||
48110596|NCT00838565|100597964|FG005|NOT COMPLETED|Overall Study||2||
48110597|NCT01346267|100597965|FG000|STARTED|Overall Study||93||
48110598|NCT01346267|100597966|FG001|STARTED|Overall Study||94||
48110599|NCT01346267|100597965|FG000|COMPLETED|Overall Study||70||
48110600|NCT01346267|100597966|FG001|COMPLETED|Overall Study||67||
48110601|NCT01346267|100597965|FG000|NOT COMPLETED|Overall Study||23||
48110602|NCT01346267|100597966|FG001|NOT COMPLETED|Overall Study||27||
48110603|NCT05005390|100597967|FG000|STARTED|Overall Study||76||
48110604|NCT05005390|100597968|FG001|STARTED|Overall Study||71||
48110605|NCT05005390|100597967|FG000|Successfully Completed First Ventilation (Step 1)|Overall Study||64||
48110606|NCT05005390|100597968|FG001|Successfully Completed First Ventilation (Step 1)|Overall Study||52||
48110607|NCT05005390|100597967|FG000|Successfully Completed Second Ventilation (Step 2)|Overall Study||63||
48110608|NCT05005390|100597968|FG001|Successfully Completed Second Ventilation (Step 2)|Overall Study||63||
48110609|NCT05005390|100597967|FG000|COMPLETED|Overall Study||57|Successfully Completed First and Second Ventilation|
48110610|NCT05005390|100597968|FG001|COMPLETED|Overall Study||50|Successfully Completed First and Second Ventilation|
48110611|NCT05005390|100597967|FG000|NOT COMPLETED|Overall Study||19||
48110612|NCT05005390|100597968|FG001|NOT COMPLETED|Overall Study||21||
48110613|NCT02346136|100597969|FG000|STARTED|Overall Study||93||
48110614|NCT02346136|100597970|FG001|STARTED|Overall Study||87||
48110615|NCT02346136|100597969|FG000|COMPLETED|Overall Study||71||
48110616|NCT02346136|100597970|FG001|COMPLETED|Overall Study||64||
48110617|NCT02346136|100597969|FG000|NOT COMPLETED|Overall Study||22||
48110618|NCT02346136|100597970|FG001|NOT COMPLETED|Overall Study||23||
48110619|NCT00414388|100597971|FG000|STARTED|Overall Study||22||
48110620|NCT00414388|100597971|FG000|COMPLETED|Overall Study||21||
48110621|NCT00414388|100597971|FG000|NOT COMPLETED|Overall Study||1||
48110622|NCT00531843|100597972|FG000|STARTED|Overall Study||81||
48110623|NCT00531843|100597973|FG001|STARTED|Overall Study||6||
48110624|NCT00531843|100597972|FG000|COMPLETED|Overall Study||81||
48110625|NCT00531843|100597973|FG001|COMPLETED|Overall Study||6||
48110626|NCT00531843|100597972|FG000|NOT COMPLETED|Overall Study||0||
48110627|NCT00531843|100597973|FG001|NOT COMPLETED|Overall Study||0||
48110628|NCT04796831|100597974|FG000|STARTED|Overall Study||8||
48110629|NCT04796831|100597974|FG000|COMPLETED|Overall Study||8||
48110630|NCT04796831|100597974|FG000|NOT COMPLETED|Overall Study||0||
48110631|NCT00712296|100597975|FG000|STARTED|Phase I ( 1 Week)||12||
48110632|NCT00712296|100597976|FG001|STARTED|Phase I ( 1 Week)||8||
48110633|NCT00712296|100597977|FG002|STARTED|Phase I ( 1 Week)||0||
48110634|NCT00712296|100597978|FG003|STARTED|Phase I ( 1 Week)||0||
48110635|NCT00712296|100597979|FG004|STARTED|Phase I ( 1 Week)||0||
48110636|NCT00712296|100597975|FG000|COMPLETED|Phase I ( 1 Week)||12||
48110637|NCT00712296|100597976|FG001|COMPLETED|Phase I ( 1 Week)||8||
48110638|NCT00712296|100597977|FG002|COMPLETED|Phase I ( 1 Week)||0||
48110639|NCT00712296|100597978|FG003|COMPLETED|Phase I ( 1 Week)||0||
48110640|NCT00712296|100597979|FG004|COMPLETED|Phase I ( 1 Week)||0||
48110641|NCT00712296|100597975|FG000|NOT COMPLETED|Phase I ( 1 Week)||0||
48110642|NCT00712296|100597976|FG001|NOT COMPLETED|Phase I ( 1 Week)||0||
48110643|NCT00712296|100597977|FG002|NOT COMPLETED|Phase I ( 1 Week)||0||
48110644|NCT00712296|100597978|FG003|NOT COMPLETED|Phase I ( 1 Week)||0||
48110645|NCT00712296|100597979|FG004|NOT COMPLETED|Phase I ( 1 Week)||0||
48110646|NCT00712296|100597975|FG000|STARTED|Phase II (28 Weeks)||0||
48110647|NCT00712296|100597976|FG001|STARTED|Phase II (28 Weeks)||0||
48110648|NCT00712296|100597977|FG002|STARTED|Phase II (28 Weeks)||15||
48110649|NCT00712296|100597978|FG003|STARTED|Phase II (28 Weeks)||16||
48110650|NCT00712296|100597979|FG004|STARTED|Phase II (28 Weeks)||15||
48110651|NCT00712296|100597975|FG000|COMPLETED|Phase II (28 Weeks)||0||
48110652|NCT00712296|100597976|FG001|COMPLETED|Phase II (28 Weeks)||0||
48110653|NCT00712296|100597977|FG002|COMPLETED|Phase II (28 Weeks)||2||
48110654|NCT00712296|100597978|FG003|COMPLETED|Phase II (28 Weeks)||1||
48110655|NCT00712296|100597979|FG004|COMPLETED|Phase II (28 Weeks)||3||
48110656|NCT00712296|100597975|FG000|NOT COMPLETED|Phase II (28 Weeks)||0||
48110657|NCT00712296|100597976|FG001|NOT COMPLETED|Phase II (28 Weeks)||0||
48110658|NCT00712296|100597977|FG002|NOT COMPLETED|Phase II (28 Weeks)||13||
48110659|NCT00712296|100597978|FG003|NOT COMPLETED|Phase II (28 Weeks)||15||
48110660|NCT00712296|100597979|FG004|NOT COMPLETED|Phase II (28 Weeks)||12||
48110661|NCT03012386|100597980|FG000|STARTED|Overall Study||8||
48110662|NCT03012386|100597981|FG001|STARTED|Overall Study||18||
48110663|NCT03012386|100597980|FG000|COMPLETED|Overall Study||8||
48110664|NCT03012386|100597981|FG001|COMPLETED|Overall Study||13||
48110665|NCT03012386|100597980|FG000|NOT COMPLETED|Overall Study||0||
48110666|NCT03012386|100597981|FG001|NOT COMPLETED|Overall Study||5||
48110667|NCT01465464|100597982|FG000|STARTED|Overall Study||444||
48110668|NCT01465464|100597983|FG001|STARTED|Overall Study||444||
48110669|NCT01465464|100597982|FG000|COMPLETED|Overall Study||0||
48110670|NCT01465464|100597983|FG001|COMPLETED|Overall Study||0||
48110671|NCT01465464|100597982|FG000|NOT COMPLETED|Overall Study||444||
48110672|NCT01465464|100597983|FG001|NOT COMPLETED|Overall Study||444||
48110673|NCT02643251|100597984|FG000|STARTED|Overall Study||69||
48110674|NCT02643251|100597985|FG001|STARTED|Overall Study||69||
48110675|NCT02643251|100597984|FG000|COMPLETED|Overall Study||58||
48110676|NCT02643251|100597985|FG001|COMPLETED|Overall Study||67||
48110677|NCT02643251|100597984|FG000|NOT COMPLETED|Overall Study||11||
48272737|NCT02305277|100992036|FG002|Received CM|Overall Study||14||
48272738|NCT02305277|100992037|FG003|Received CM|Overall Study||14||
48555580|NCT02456740|101693754|FG006|STARTED|Active Treatment Phase (Weeks 24 - 52)||140|Fourteen participants who completed the DBTP did not continue onto the active treatment phase|
48555581|NCT02456740|101693755|FG007|STARTED|Active Treatment Phase (Weeks 24 - 52)||140|Fourteen participants who completed the DBTP did not continue onto the active treatment phase|
48555582|NCT02456740|101693756|FG008|STARTED|Active Treatment Phase (Weeks 24 - 52)||144|Fourteen participants who completed the DBTP did not continue onto the active treatment phase|
48555583|NCT02456740|101693748|FG000|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0||
48555584|NCT02456740|101693749|FG001|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0||
48555585|NCT02456740|101693750|FG002|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0||
48555586|NCT02456740|101693751|FG003|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||124||
48555587|NCT02456740|101693752|FG004|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||123||
48555588|NCT02456740|101693753|FG005|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||130||
48555589|NCT02456740|101693754|FG006|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||131||
48555590|NCT02456740|101693755|FG007|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||128||
48555591|NCT02456740|101693756|FG008|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||126||
48555592|NCT02456740|101693748|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0||
48555593|NCT02456740|101693749|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0||
48555594|NCT02456740|101693750|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0||
48555595|NCT02456740|101693751|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||14||
48555596|NCT02456740|101693752|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||17||
48272739|NCT02305277|100992038|FG004|Received CM|Overall Study||14||
48272740|NCT02305277|100992039|FG005|Received CM|Overall Study||14||
48272741|NCT02305277|100992034|FG000|Received TBM|Overall Study||15||
48272742|NCT02305277|100992035|FG001|Received TBM|Overall Study||14||
48272743|NCT02305277|100992036|FG002|Received TBM|Overall Study||14||
48272744|NCT02305277|100992037|FG003|Received TBM|Overall Study||14||
48555597|NCT02456740|101693753|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||13||
48555598|NCT02456740|101693754|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||9||
48555599|NCT02456740|101693755|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12||
48555600|NCT02456740|101693756|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||18||
48555601|NCT05219448|101693757|FG000|STARTED|Overall Study||241||2
48555602|NCT05219448|101693758|FG001|STARTED|Overall Study||93||1
48272745|NCT02305277|100992038|FG004|Received TBM|Overall Study||14||
48272746|NCT02305277|100992039|FG005|Received TBM|Overall Study||14||
48272747|NCT02305277|100992034|FG000|COMPLETED|Overall Study||14||
48272748|NCT02305277|100992035|FG001|COMPLETED|Overall Study||14||
48272749|NCT02305277|100992036|FG002|COMPLETED|Overall Study||14||
48272750|NCT02305277|100992037|FG003|COMPLETED|Overall Study||14||
48272751|NCT02305277|100992038|FG004|COMPLETED|Overall Study||13||
48272752|NCT02305277|100992039|FG005|COMPLETED|Overall Study||14||
48272753|NCT02305277|100992034|FG000|NOT COMPLETED|Overall Study||1||
48272754|NCT02305277|100992035|FG001|NOT COMPLETED|Overall Study||0||
48272755|NCT02305277|100992036|FG002|NOT COMPLETED|Overall Study||0||
48272756|NCT02305277|100992037|FG003|NOT COMPLETED|Overall Study||0||
48272757|NCT02305277|100992038|FG004|NOT COMPLETED|Overall Study||1||
48272758|NCT02305277|100992039|FG005|NOT COMPLETED|Overall Study||0||
48272759|NCT04148651|100992040|FG000|STARTED|Overall Study||12||12
48272760|NCT04148651|100992040|FG000|COMPLETED|Overall Study||10||10
48272761|NCT04148651|100992040|FG000|NOT COMPLETED|Overall Study||2||2
48272762|NCT02476175|100992041|FG000|STARTED|Overall Study||35||
48272763|NCT02476175|100992041|FG000|COMPLETED|Overall Study||33||
48272764|NCT02476175|100992041|FG000|NOT COMPLETED|Overall Study||2||
48272765|NCT02677870|100992042|FG000|STARTED|Diet Treatment (4 Weeks)||4||
48110678|NCT02643251|100597985|FG001|NOT COMPLETED|Overall Study||2||
48110679|NCT00086580|100597986|FG000|STARTED|Treatment Period||168||
48110680|NCT00086580|100597987|FG001|STARTED|Treatment Period||167||
48110681|NCT00086580|100597986|FG000|Safety Population|Treatment Period||164||
48272766|NCT02677870|100992043|FG001|STARTED|Diet Treatment (4 Weeks)||3||
48272767|NCT02677870|100992042|FG000|COMPLETED|Diet Treatment (4 Weeks)||4||
48272768|NCT02677870|100992043|FG001|COMPLETED|Diet Treatment (4 Weeks)||3||
48272769|NCT02677870|100992042|FG000|NOT COMPLETED|Diet Treatment (4 Weeks)||0||
48272770|NCT02677870|100992043|FG001|NOT COMPLETED|Diet Treatment (4 Weeks)||0||
48110682|NCT00086580|100597987|FG001|Safety Population|Treatment Period||165||
48272771|NCT02677870|100992042|FG000|STARTED|First Saproterin Dihydrochloride tx||4||
48555603|NCT05219448|101693757|FG000|Baseline|Overall Study||220||2
48555604|NCT05219448|101693758|FG001|Baseline|Overall Study||85||1
48555605|NCT05219448|101693757|FG000|1-month Data Collection|Overall Study||231||2
48555606|NCT05219448|101693758|FG001|1-month Data Collection|Overall Study||91||1
48555607|NCT05219448|101693757|FG000|3-month Data Collection|Overall Study||234||2
48555608|NCT05219448|101693758|FG001|3-month Data Collection|Overall Study||93||1
48555609|NCT05219448|101693757|FG000|6-month Data Collection|Overall Study||231||2
48555610|NCT05219448|101693758|FG001|6-month Data Collection|Overall Study||93||1
48555611|NCT05219448|101693757|FG000|12-month Data Collection|Overall Study||232||2
48555612|NCT05219448|101693758|FG001|12-month Data Collection|Overall Study||93||1
48555613|NCT05219448|101693757|FG000|COMPLETED|Overall Study||232||2
48555614|NCT05219448|101693758|FG001|COMPLETED|Overall Study||93||1
48555615|NCT05219448|101693757|FG000|NOT COMPLETED|Overall Study||9||0
48555616|NCT05219448|101693758|FG001|NOT COMPLETED|Overall Study||0||0
48555617|NCT02280200|101693759|FG000|STARTED|Overall Study||15||
48555618|NCT02280200|101693760|FG001|STARTED|Overall Study||13||
48555619|NCT02280200|101693759|FG000|COMPLETED|Overall Study||12||
48555620|NCT02280200|101693760|FG001|COMPLETED|Overall Study||10||
48555621|NCT02280200|101693759|FG000|NOT COMPLETED|Overall Study||3||
48555622|NCT02280200|101693760|FG001|NOT COMPLETED|Overall Study||3||
48555623|NCT00678210|101693761|FG000|STARTED|Overall Study||49||
48555624|NCT00678210|101693762|FG001|STARTED|Overall Study||49||
48555625|NCT00678210|101693763|FG002|STARTED|Overall Study||49||
48555626|NCT00678210|101693764|FG003|STARTED|Overall Study||50||
48555627|NCT00678210|101693761|FG000|COMPLETED|Overall Study||38||
48555628|NCT00678210|101693762|FG001|COMPLETED|Overall Study||38||
48555629|NCT00678210|101693763|FG002|COMPLETED|Overall Study||43||
48555630|NCT00678210|101693764|FG003|COMPLETED|Overall Study||30||
48555631|NCT00678210|101693761|FG000|NOT COMPLETED|Overall Study||11||
48555632|NCT00678210|101693762|FG001|NOT COMPLETED|Overall Study||11||
48555633|NCT00678210|101693763|FG002|NOT COMPLETED|Overall Study||6||
48555634|NCT00678210|101693764|FG003|NOT COMPLETED|Overall Study||20||
48555635|NCT00266630|101693765|FG000|STARTED|Overall Study||100||
48555636|NCT00266630|101693766|FG001|STARTED|Overall Study||39||
48555637|NCT00266630|101693765|FG000|COMPLETED|Overall Study||58||
48555638|NCT00266630|101693766|FG001|COMPLETED|Overall Study||11||
48555639|NCT00266630|101693765|FG000|NOT COMPLETED|Overall Study||42||
48555640|NCT00266630|101693766|FG001|NOT COMPLETED|Overall Study||28||
48555641|NCT05289869|101693767|FG000|STARTED|Overall Study||10||
48555642|NCT05289869|101693768|FG001|STARTED|Overall Study||10||
48555643|NCT05289869|101693767|FG000|COMPLETED|Overall Study||10||
48555644|NCT05289869|101693768|FG001|COMPLETED|Overall Study||10||
48555645|NCT05289869|101693767|FG000|NOT COMPLETED|Overall Study||0||
48555646|NCT05289869|101693768|FG001|NOT COMPLETED|Overall Study||0||
48555647|NCT00867659|101693769|FG000|STARTED|Overall Study||20||
48555648|NCT00867659|101693769|FG000|COMPLETED|Overall Study||20||
48555649|NCT00867659|101693769|FG000|NOT COMPLETED|Overall Study||0||
48555650|NCT00473590|101693770|FG000|STARTED|Overall Study||53||
48555651|NCT00473590|101693771|FG001|STARTED|Overall Study||49||
48555652|NCT00473590|101693770|FG000|Treated|Overall Study||52||
48555653|NCT00473590|101693771|FG001|Treated|Overall Study||48||
48555654|NCT00473590|101693770|FG000|Safety Population|Overall Study||50||
48555655|NCT00473590|101693771|FG001|Safety Population|Overall Study||50||
48555656|NCT00473590|101693770|FG000|COMPLETED|Overall Study||8||
48555657|NCT00473590|101693771|FG001|COMPLETED|Overall Study||11||
48555658|NCT00473590|101693770|FG000|NOT COMPLETED|Overall Study||45||
48110683|NCT00086580|100597986|FG000|COMPLETED|Treatment Period||103||
48110684|NCT00086580|100597987|FG001|COMPLETED|Treatment Period||107||
48110685|NCT00086580|100597986|FG000|NOT COMPLETED|Treatment Period||65||
48110686|NCT00086580|100597987|FG001|NOT COMPLETED|Treatment Period||60||
48110687|NCT00086580|100597986|FG000|STARTED|Follow-up Period||141||
48110688|NCT00086580|100597987|FG001|STARTED|Follow-up Period||137||
48555659|NCT00473590|101693771|FG001|NOT COMPLETED|Overall Study||38||
48555660|NCT05244122|101693772|FG000|STARTED|Overall Study||1121|This is the number of individuals who started the online study|
48555661|NCT05244122|101693772|FG000|Completed a Full Block of Trials|Overall Study||630||
48555662|NCT05244122|101693772|FG000|COMPLETED|Overall Study||803|This is the number of participants who produced usable data. In an online study, participants often start a study but then decide they are not interested or don't have time. In any event, they do not complete the study.|
48555663|NCT05244122|101693772|FG000|NOT COMPLETED|Overall Study||318||
48555664|NCT04347993|101693773|FG000|STARTED|Overall Study||4588||
48555665|NCT04347993|101693773|FG000|COMPLETED|Overall Study||4588||
48555666|NCT04347993|101693773|FG000|NOT COMPLETED|Overall Study||0||
48555667|NCT03888469|101693774|FG000|STARTED|First Wear Period (8 -1/+2 Days)||46||
48555668|NCT03888469|101693775|FG001|STARTED|First Wear Period (8 -1/+2 Days)||46||
48555669|NCT03888469|101693774|FG000|COMPLETED|First Wear Period (8 -1/+2 Days)||46||
48555670|NCT03888469|101693775|FG001|COMPLETED|First Wear Period (8 -1/+2 Days)||46||
48555671|NCT03888469|101693774|FG000|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0||
48555672|NCT03888469|101693775|FG001|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0||
48555673|NCT03888469|101693774|FG000|STARTED|Second Wear Period (8 -1/+2 Days)||46||
48555674|NCT03888469|101693775|FG001|STARTED|Second Wear Period (8 -1/+2 Days)||46||
48555675|NCT03888469|101693774|FG000|COMPLETED|Second Wear Period (8 -1/+2 Days)||46||
48555676|NCT03888469|101693775|FG001|COMPLETED|Second Wear Period (8 -1/+2 Days)||46||
48555677|NCT03888469|101693774|FG000|NOT COMPLETED|Second Wear Period (8 -1/+2 Days)||0||
48555678|NCT03888469|101693775|FG001|NOT COMPLETED|Second Wear Period (8 -1/+2 Days)||0||
48555679|NCT05273411|101693776|FG000|STARTED|Intervention Period 1||2||
48555680|NCT05273411|101693777|FG001|STARTED|Intervention Period 1||2||
48555681|NCT05273411|101693778|FG002|STARTED|Intervention Period 1||2||
48555682|NCT05273411|101693779|FG003|STARTED|Intervention Period 1||2||
48555683|NCT05273411|101693780|FG004|STARTED|Intervention Period 1||2||
48555684|NCT05273411|101693781|FG005|STARTED|Intervention Period 1||2||
48555685|NCT05273411|101693776|FG000|COMPLETED|Intervention Period 1||2||
48555686|NCT05273411|101693777|FG001|COMPLETED|Intervention Period 1||2||
48555687|NCT05273411|101693778|FG002|COMPLETED|Intervention Period 1||2||
48555688|NCT05273411|101693779|FG003|COMPLETED|Intervention Period 1||2||
48555689|NCT05273411|101693780|FG004|COMPLETED|Intervention Period 1||2||
48555690|NCT05273411|101693781|FG005|COMPLETED|Intervention Period 1||2||
48555691|NCT05273411|101693776|FG000|NOT COMPLETED|Intervention Period 1||0||
48110689|NCT00086580|100597986|FG000|COMPLETED|Follow-up Period||37||
48272772|NCT02677870|100992043|FG001|STARTED|First Saproterin Dihydrochloride tx||3||
48272773|NCT02677870|100992042|FG000|COMPLETED|First Saproterin Dihydrochloride tx||4||
48272774|NCT02677870|100992043|FG001|COMPLETED|First Saproterin Dihydrochloride tx||3||
48272775|NCT02677870|100992042|FG000|NOT COMPLETED|First Saproterin Dihydrochloride tx||0||
48272776|NCT02677870|100992043|FG001|NOT COMPLETED|First Saproterin Dihydrochloride tx||0||
48272777|NCT02677870|100992042|FG000|STARTED|Washout (2 Weeks)||4||
48272778|NCT02677870|100992043|FG001|STARTED|Washout (2 Weeks)||3||
48272779|NCT02677870|100992042|FG000|COMPLETED|Washout (2 Weeks)||4||
48272780|NCT02677870|100992043|FG001|COMPLETED|Washout (2 Weeks)||3||
48272781|NCT02677870|100992042|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
48272782|NCT02677870|100992043|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
48272783|NCT02677870|100992042|FG000|STARTED|Second Saproterin Dihydrochloride tx||4||
48272784|NCT02677870|100992043|FG001|STARTED|Second Saproterin Dihydrochloride tx||3||
48272785|NCT02677870|100992042|FG000|COMPLETED|Second Saproterin Dihydrochloride tx||4||
48272786|NCT02677870|100992043|FG001|COMPLETED|Second Saproterin Dihydrochloride tx||3||
48272787|NCT02677870|100992042|FG000|NOT COMPLETED|Second Saproterin Dihydrochloride tx||0||
48272788|NCT02677870|100992043|FG001|NOT COMPLETED|Second Saproterin Dihydrochloride tx||0||
48272789|NCT01681121|100992044|FG000|STARTED|Overall Study||44||
48272790|NCT01681121|100992045|FG001|STARTED|Overall Study||49||
48272791|NCT01681121|100992044|FG000|COMPLETED|Overall Study||36||
48272792|NCT01681121|100992045|FG001|COMPLETED|Overall Study||38||
48272793|NCT01681121|100992044|FG000|NOT COMPLETED|Overall Study||8||
48272794|NCT01681121|100992045|FG001|NOT COMPLETED|Overall Study||11||
48272795|NCT00509249|100992046|FG000|STARTED|Overall Study||18||
48272796|NCT00509249|100992046|FG000|COMPLETED|Overall Study||18||
48272797|NCT00509249|100992046|FG000|NOT COMPLETED|Overall Study||0||
48272798|NCT03683823|100992047|FG000|STARTED|Post-treatment Assessment||11||
48555692|NCT05273411|101693777|FG001|NOT COMPLETED|Intervention Period 1||0||
48555693|NCT05273411|101693778|FG002|NOT COMPLETED|Intervention Period 1||0||
48555694|NCT05273411|101693779|FG003|NOT COMPLETED|Intervention Period 1||0||
48555695|NCT05273411|101693780|FG004|NOT COMPLETED|Intervention Period 1||0||
48555696|NCT05273411|101693781|FG005|NOT COMPLETED|Intervention Period 1||0||
48555697|NCT05273411|101693776|FG000|STARTED|Intervention Period 2||2||
48555698|NCT05273411|101693777|FG001|STARTED|Intervention Period 2||2||
48555699|NCT05273411|101693778|FG002|STARTED|Intervention Period 2||2||
48555700|NCT05273411|101693779|FG003|STARTED|Intervention Period 2||2||
48555701|NCT05273411|101693780|FG004|STARTED|Intervention Period 2||2||
48555702|NCT05273411|101693781|FG005|STARTED|Intervention Period 2||2||
48555703|NCT05273411|101693776|FG000|COMPLETED|Intervention Period 2||2||
48555704|NCT05273411|101693777|FG001|COMPLETED|Intervention Period 2||2||
48555705|NCT05273411|101693778|FG002|COMPLETED|Intervention Period 2||2||
48555706|NCT05273411|101693779|FG003|COMPLETED|Intervention Period 2||2||
48272799|NCT03683823|100992048|FG001|STARTED|Post-treatment Assessment||10||
48272800|NCT03683823|100992047|FG000|COMPLETED|Post-treatment Assessment||10||
48272801|NCT03683823|100992048|FG001|COMPLETED|Post-treatment Assessment||8||
48272802|NCT03683823|100992047|FG000|NOT COMPLETED|Post-treatment Assessment||1||
48272803|NCT03683823|100992048|FG001|NOT COMPLETED|Post-treatment Assessment||2||
48272804|NCT03683823|100992047|FG000|STARTED|1-week Follow-up||10||
48272805|NCT03683823|100992048|FG001|STARTED|1-week Follow-up||8||
48272806|NCT03683823|100992047|FG000|COMPLETED|1-week Follow-up||9||
48272807|NCT03683823|100992048|FG001|COMPLETED|1-week Follow-up||7||
48272808|NCT03683823|100992047|FG000|NOT COMPLETED|1-week Follow-up||1||
48272809|NCT03683823|100992048|FG001|NOT COMPLETED|1-week Follow-up||1||
48272810|NCT03232580|100992049|FG000|STARTED|Overall Study||5||
48272811|NCT03232580|100992049|FG000|COMPLETED|Overall Study||5||
48272812|NCT03232580|100992049|FG000|NOT COMPLETED|Overall Study||0||
48272813|NCT02235311|100992050|FG000|STARTED|Overall Study||1||
48272814|NCT02235311|100992051|FG001|STARTED|Overall Study||2||
48272815|NCT02235311|100992050|FG000|COMPLETED|Overall Study||1||
48272816|NCT02235311|100992051|FG001|COMPLETED|Overall Study||0||
48272817|NCT02235311|100992050|FG000|NOT COMPLETED|Overall Study||0||
48272818|NCT02235311|100992051|FG001|NOT COMPLETED|Overall Study||2||
48272819|NCT01969851|100992052|FG000|STARTED|Overall Study||10||
48272820|NCT01969851|100992053|FG001|STARTED|Overall Study||24||
48272821|NCT01969851|100992054|FG002|STARTED|Overall Study||21||
48555707|NCT05273411|101693780|FG004|COMPLETED|Intervention Period 2||2||
48555708|NCT05273411|101693781|FG005|COMPLETED|Intervention Period 2||2||
48555709|NCT05273411|101693776|FG000|NOT COMPLETED|Intervention Period 2||0||
48272822|NCT01969851|100992052|FG000|COMPLETED|Overall Study||9||
48272823|NCT01969851|100992053|FG001|COMPLETED|Overall Study||21||
48272824|NCT01969851|100992054|FG002|COMPLETED|Overall Study||14||
48272825|NCT01969851|100992052|FG000|NOT COMPLETED|Overall Study||1||
48272826|NCT01969851|100992053|FG001|NOT COMPLETED|Overall Study||3||
48272827|NCT01969851|100992054|FG002|NOT COMPLETED|Overall Study||7||
48272828|NCT00573859|100992055|FG000|STARTED|Medication Versus Placebo||27||
48272829|NCT00573859|100992055|FG000|COMPLETED|Medication Versus Placebo||15||
48272830|NCT00573859|100992055|FG000|NOT COMPLETED|Medication Versus Placebo||12||
48555710|NCT05273411|101693777|FG001|NOT COMPLETED|Intervention Period 2||0||
48555711|NCT05273411|101693778|FG002|NOT COMPLETED|Intervention Period 2||0||
48555712|NCT05273411|101693779|FG003|NOT COMPLETED|Intervention Period 2||0||
48555713|NCT05273411|101693780|FG004|NOT COMPLETED|Intervention Period 2||0||
48555714|NCT05273411|101693781|FG005|NOT COMPLETED|Intervention Period 2||0||
48555715|NCT05273411|101693776|FG000|STARTED|Intervention Period 3||2||
48555716|NCT05273411|101693777|FG001|STARTED|Intervention Period 3||2||
48555717|NCT05273411|101693778|FG002|STARTED|Intervention Period 3||2||
48555718|NCT05273411|101693779|FG003|STARTED|Intervention Period 3||2||
48555719|NCT05273411|101693780|FG004|STARTED|Intervention Period 3||2||
48555720|NCT05273411|101693781|FG005|STARTED|Intervention Period 3||2||
48555721|NCT05273411|101693776|FG000|COMPLETED|Intervention Period 3||2||
48555722|NCT05273411|101693777|FG001|COMPLETED|Intervention Period 3||2||
48555723|NCT05273411|101693778|FG002|COMPLETED|Intervention Period 3||2||
48555724|NCT05273411|101693779|FG003|COMPLETED|Intervention Period 3||2||
48555725|NCT05273411|101693780|FG004|COMPLETED|Intervention Period 3||2||
48555726|NCT05273411|101693781|FG005|COMPLETED|Intervention Period 3||2||
48555727|NCT05273411|101693776|FG000|NOT COMPLETED|Intervention Period 3||0||
48555728|NCT05273411|101693777|FG001|NOT COMPLETED|Intervention Period 3||0||
48555729|NCT05273411|101693778|FG002|NOT COMPLETED|Intervention Period 3||0||
48555730|NCT05273411|101693779|FG003|NOT COMPLETED|Intervention Period 3||0||
48555731|NCT05273411|101693780|FG004|NOT COMPLETED|Intervention Period 3||0||
48555732|NCT05273411|101693781|FG005|NOT COMPLETED|Intervention Period 3||0||
48555733|NCT01042093|101693782|FG000|STARTED|Overall Study||40||
48555734|NCT01042093|101693783|FG001|STARTED|Overall Study||40||
48555735|NCT01042093|101693784|FG002|STARTED|Overall Study||40||
48555736|NCT01042093|101693785|FG003|STARTED|Overall Study||40||
48555737|NCT01042093|101693782|FG000|COMPLETED|Overall Study||38||
48555738|NCT01042093|101693783|FG001|COMPLETED|Overall Study||38||
48555739|NCT01042093|101693784|FG002|COMPLETED|Overall Study||38||
48555740|NCT01042093|101693785|FG003|COMPLETED|Overall Study||36||
48555741|NCT01042093|101693782|FG000|NOT COMPLETED|Overall Study||2||
48555742|NCT01042093|101693783|FG001|NOT COMPLETED|Overall Study||2||
48555743|NCT01042093|101693784|FG002|NOT COMPLETED|Overall Study||2||
48555744|NCT01042093|101693785|FG003|NOT COMPLETED|Overall Study||4||
48555745|NCT03305848|101693786|FG000|STARTED|Overall Study||20||
48555746|NCT03305848|101693786|FG000|COMPLETED|Overall Study||17||
48555747|NCT03305848|101693786|FG000|NOT COMPLETED|Overall Study||3||
48272831|NCT00573859|100992055|FG000|STARTED|Smoking Versus Abstinence||27||
48272832|NCT00573859|100992055|FG000|COMPLETED|Smoking Versus Abstinence||15||
48272833|NCT00573859|100992055|FG000|NOT COMPLETED|Smoking Versus Abstinence||12||
48272834|NCT00709228|100992056|FG000|STARTED|Overall Study||496||
48272835|NCT00709228|100992056|FG000|COMPLETED|Overall Study||164||
48272836|NCT00709228|100992056|FG000|NOT COMPLETED|Overall Study||332||
48272837|NCT01365481|100992057|FG000|STARTED|Overall Study||23||
48272838|NCT01365481|100992058|FG001|STARTED|Overall Study||52||
48272839|NCT01365481|100992059|FG002|STARTED|Overall Study||18||
48272840|NCT01365481|100992060|FG003|STARTED|Overall Study||57||
48272841|NCT01365481|100992057|FG000|COMPLETED|Overall Study||16||
48272842|NCT01365481|100992058|FG001|COMPLETED|Overall Study||37||
48272843|NCT01365481|100992059|FG002|COMPLETED|Overall Study||14||
48272844|NCT01365481|100992060|FG003|COMPLETED|Overall Study||50||
48555748|NCT02698163|101693787|FG000|STARTED|Overall Study||1||
48555749|NCT02698163|101693788|FG001|STARTED|Overall Study||3||
48555750|NCT02698163|101693787|FG000|COMPLETED|Overall Study||1||
48555751|NCT02698163|101693788|FG001|COMPLETED|Overall Study||2||
48555752|NCT02698163|101693787|FG000|NOT COMPLETED|Overall Study||0||
48555753|NCT02698163|101693788|FG001|NOT COMPLETED|Overall Study||1||
48555754|NCT02490631|101693789|FG000|STARTED|Overall Study||79||
48555755|NCT02490631|101693790|FG001|STARTED|Overall Study||78||
48555756|NCT02490631|101693789|FG000|COMPLETED|Overall Study||76||
48555757|NCT02490631|101693790|FG001|COMPLETED|Overall Study||75||
48555758|NCT02490631|101693789|FG000|NOT COMPLETED|Overall Study||3||
48555759|NCT02490631|101693790|FG001|NOT COMPLETED|Overall Study||3||
48272845|NCT01365481|100992057|FG000|NOT COMPLETED|Overall Study||7||
48272846|NCT01365481|100992058|FG001|NOT COMPLETED|Overall Study||15||
48272847|NCT01365481|100992059|FG002|NOT COMPLETED|Overall Study||4||
48555760|NCT00462917|101693791|FG000|STARTED|Overall Study||72||
48555761|NCT00462917|101693792|FG001|STARTED|Overall Study||75||
48555762|NCT00462917|101693793|FG002|STARTED|Overall Study||66||
48555763|NCT00462917|101693794|FG003|STARTED|Overall Study||77||
48555764|NCT00462917|101693791|FG000|Met With Genetic Counselor|Overall Study||66||
48110690|NCT00086580|100597987|FG001|COMPLETED|Follow-up Period||18||
48110691|NCT00086580|100597986|FG000|NOT COMPLETED|Follow-up Period||104||
48110692|NCT00086580|100597987|FG001|NOT COMPLETED|Follow-up Period||119||
48110693|NCT00086580|100597986|FG000|STARTED|Observation Period||95||
48110694|NCT00086580|100597987|FG001|STARTED|Observation Period||121||
48110695|NCT00086580|100597986|FG000|COMPLETED|Observation Period||49||
48110696|NCT00086580|100597987|FG001|COMPLETED|Observation Period||56||
48110697|NCT00086580|100597986|FG000|NOT COMPLETED|Observation Period||46||
48272848|NCT01365481|100992060|FG003|NOT COMPLETED|Overall Study||7||
48272849|NCT03011567|100992061|FG000|STARTED|Overall Study||70||
48272850|NCT03011567|100992062|FG001|STARTED|Overall Study||31||
48272851|NCT03011567|100992063|FG002|STARTED|Overall Study||70||
48272852|NCT03011567|100992064|FG003|STARTED|Overall Study||31||
48272853|NCT03011567|100992061|FG000|Randomized|Overall Study||70||
48272854|NCT03011567|100992062|FG001|Randomized|Overall Study||31||
48272855|NCT03011567|100992063|FG002|Randomized|Overall Study||70||
48272856|NCT03011567|100992064|FG003|Randomized|Overall Study||31||
48272857|NCT03011567|100992061|FG000|COMPLETED|Overall Study||70||
48272858|NCT03011567|100992062|FG001|COMPLETED|Overall Study||31||
48272859|NCT03011567|100992063|FG002|COMPLETED|Overall Study||70||
48272860|NCT03011567|100992064|FG003|COMPLETED|Overall Study||30||
48272861|NCT03011567|100992061|FG000|NOT COMPLETED|Overall Study||0||
48272862|NCT03011567|100992062|FG001|NOT COMPLETED|Overall Study||0||
48272863|NCT03011567|100992063|FG002|NOT COMPLETED|Overall Study||0||
48272864|NCT03011567|100992064|FG003|NOT COMPLETED|Overall Study||1||
48272865|NCT00943852|100992065|FG000|STARTED|First Period of Treatment Intervention||2||
48272866|NCT00943852|100992066|FG001|STARTED|First Period of Treatment Intervention||1||
48272867|NCT00943852|100992067|FG002|STARTED|First Period of Treatment Intervention||1||
48272868|NCT00943852|100992068|FG003|STARTED|First Period of Treatment Intervention||2||
48272869|NCT00943852|100992069|FG004|STARTED|First Period of Treatment Intervention||1||
48272870|NCT00943852|100992070|FG005|STARTED|First Period of Treatment Intervention||1||
48272871|NCT00943852|100992071|FG006|STARTED|First Period of Treatment Intervention||2||
48272872|NCT00943852|100992072|FG007|STARTED|First Period of Treatment Intervention||1||
48272873|NCT00943852|100992073|FG008|STARTED|First Period of Treatment Intervention||1||
48272874|NCT00943852|100992074|FG009|STARTED|First Period of Treatment Intervention||1||
48272875|NCT00943852|100992065|FG000|COMPLETED|First Period of Treatment Intervention||2||
48272876|NCT00943852|100992066|FG001|COMPLETED|First Period of Treatment Intervention||1||
48555765|NCT00462917|101693792|FG001|Met With Genetic Counselor|Overall Study||71||
48555766|NCT00462917|101693793|FG002|Met With Genetic Counselor|Overall Study||56||
48555767|NCT00462917|101693794|FG003|Met With Genetic Counselor|Overall Study||71||
48555768|NCT00462917|101693791|FG000|Received Risk Information|Overall Study||64||
48555769|NCT00462917|101693792|FG001|Received Risk Information|Overall Study||70||
48555770|NCT00462917|101693793|FG002|Received Risk Information|Overall Study||55||
48555771|NCT00462917|101693794|FG003|Received Risk Information|Overall Study||68||
48555772|NCT00462917|101693791|FG000|Completed 6 Week Follow-up|Overall Study||63||
48555773|NCT00462917|101693792|FG001|Completed 6 Week Follow-up|Overall Study||70||
48555774|NCT00462917|101693793|FG002|Completed 6 Week Follow-up|Overall Study||55||
48555775|NCT00462917|101693794|FG003|Completed 6 Week Follow-up|Overall Study||68||
48555776|NCT00462917|101693791|FG000|Completed 6 Month Follow-up|Overall Study||63||
48555777|NCT00462917|101693792|FG001|Completed 6 Month Follow-up|Overall Study||68||
48555778|NCT00462917|101693793|FG002|Completed 6 Month Follow-up|Overall Study||55||
48555779|NCT00462917|101693794|FG003|Completed 6 Month Follow-up|Overall Study||66||
48555780|NCT00462917|101693791|FG000|COMPLETED|Overall Study||62||
48555781|NCT00462917|101693792|FG001|COMPLETED|Overall Study||65||
48555782|NCT00462917|101693793|FG002|COMPLETED|Overall Study||54||
48555783|NCT00462917|101693794|FG003|COMPLETED|Overall Study||66||
48555784|NCT00462917|101693791|FG000|NOT COMPLETED|Overall Study||10||
48555785|NCT00462917|101693792|FG001|NOT COMPLETED|Overall Study||10||
48555786|NCT00462917|101693793|FG002|NOT COMPLETED|Overall Study||12||
48555787|NCT00462917|101693794|FG003|NOT COMPLETED|Overall Study||11||
48555788|NCT02163057|101693795|FG000|STARTED|Overall Study||6||
48555789|NCT02163057|101693796|FG001|STARTED|Overall Study||16||
48555790|NCT02163057|101693795|FG000|COMPLETED|Overall Study||3||
48555791|NCT02163057|101693796|FG001|COMPLETED|Overall Study||11||
48555792|NCT02163057|101693795|FG000|NOT COMPLETED|Overall Study||3||
48555793|NCT02163057|101693796|FG001|NOT COMPLETED|Overall Study||5||
48555794|NCT01841593|101693797|FG000|STARTED|First Intervention (Days 1 to 7)||12||
48555795|NCT01841593|101693798|FG001|STARTED|First Intervention (Days 1 to 7)||7||
48555796|NCT01841593|101693797|FG000|COMPLETED|First Intervention (Days 1 to 7)||12||
48555797|NCT01841593|101693798|FG001|COMPLETED|First Intervention (Days 1 to 7)||6||
48272877|NCT00943852|100992067|FG002|COMPLETED|First Period of Treatment Intervention||1||
48555798|NCT01841593|101693797|FG000|NOT COMPLETED|First Intervention (Days 1 to 7)||0||
48555799|NCT01841593|101693798|FG001|NOT COMPLETED|First Intervention (Days 1 to 7)||1||
48555800|NCT01841593|101693797|FG000|STARTED|Second Intervention (Days 8 to 14)||12||
48555801|NCT01841593|101693798|FG001|STARTED|Second Intervention (Days 8 to 14)||6||
48555802|NCT01841593|101693797|FG000|COMPLETED|Second Intervention (Days 8 to 14)||11||
48555803|NCT01841593|101693798|FG001|COMPLETED|Second Intervention (Days 8 to 14)||6||
48272878|NCT00943852|100992068|FG003|COMPLETED|First Period of Treatment Intervention||2||
48272879|NCT00943852|100992069|FG004|COMPLETED|First Period of Treatment Intervention||1||
48272880|NCT00943852|100992070|FG005|COMPLETED|First Period of Treatment Intervention||1||
48555804|NCT01841593|101693797|FG000|NOT COMPLETED|Second Intervention (Days 8 to 14)||1||
48555805|NCT01841593|101693798|FG001|NOT COMPLETED|Second Intervention (Days 8 to 14)||0||
48555806|NCT01841593|101693797|FG000|STARTED|Third Intervention (Days 15 to 21)||11||
48272881|NCT00943852|100992071|FG006|COMPLETED|First Period of Treatment Intervention||2||
48272882|NCT00943852|100992072|FG007|COMPLETED|First Period of Treatment Intervention||1||
48694046|NCT00301262|102036285|FG000|NOT COMPLETED|Double Blind Phase (DB)||10||
48694047|NCT00301262|102036286|FG001|NOT COMPLETED|Double Blind Phase (DB)||13||
48694048|NCT00301262|102036285|FG000|STARTED|Open Label Phase (OL)||83||
48694049|NCT00301262|102036286|FG001|STARTED|Open Label Phase (OL)||69||
48694050|NCT00301262|102036285|FG000|COMPLETED|Open Label Phase (OL)||79||
48694051|NCT00301262|102036286|FG001|COMPLETED|Open Label Phase (OL)||67||
48694052|NCT00301262|102036285|FG000|NOT COMPLETED|Open Label Phase (OL)||4||
48694053|NCT00301262|102036286|FG001|NOT COMPLETED|Open Label Phase (OL)||2||
48272883|NCT00943852|100992073|FG008|COMPLETED|First Period of Treatment Intervention||1||
48272884|NCT00943852|100992074|FG009|COMPLETED|First Period of Treatment Intervention||1||
48272885|NCT00943852|100992065|FG000|NOT COMPLETED|First Period of Treatment Intervention||0||
48272886|NCT00943852|100992066|FG001|NOT COMPLETED|First Period of Treatment Intervention||0||
48272887|NCT00943852|100992067|FG002|NOT COMPLETED|First Period of Treatment Intervention||0||
48272888|NCT00943852|100992068|FG003|NOT COMPLETED|First Period of Treatment Intervention||0||
48272889|NCT00943852|100992069|FG004|NOT COMPLETED|First Period of Treatment Intervention||0||
48272890|NCT00943852|100992070|FG005|NOT COMPLETED|First Period of Treatment Intervention||0||
48272891|NCT00943852|100992071|FG006|NOT COMPLETED|First Period of Treatment Intervention||0||
48272892|NCT00943852|100992072|FG007|NOT COMPLETED|First Period of Treatment Intervention||0||
48272893|NCT00943852|100992073|FG008|NOT COMPLETED|First Period of Treatment Intervention||0||
48272894|NCT00943852|100992074|FG009|NOT COMPLETED|First Period of Treatment Intervention||0||
48272895|NCT00943852|100992065|FG000|STARTED|Washout Period After Period 1 Treatment||2||
48272896|NCT00943852|100992066|FG001|STARTED|Washout Period After Period 1 Treatment||1||
48272897|NCT00943852|100992067|FG002|STARTED|Washout Period After Period 1 Treatment||1||
48272898|NCT00943852|100992068|FG003|STARTED|Washout Period After Period 1 Treatment||2||
48272899|NCT00943852|100992069|FG004|STARTED|Washout Period After Period 1 Treatment||1||
48272900|NCT00943852|100992070|FG005|STARTED|Washout Period After Period 1 Treatment||1||
48272901|NCT00943852|100992071|FG006|STARTED|Washout Period After Period 1 Treatment||2||
48272902|NCT00943852|100992072|FG007|STARTED|Washout Period After Period 1 Treatment||1||
48272903|NCT00943852|100992073|FG008|STARTED|Washout Period After Period 1 Treatment||1||
48272904|NCT00943852|100992074|FG009|STARTED|Washout Period After Period 1 Treatment||1||
48272905|NCT00943852|100992065|FG000|COMPLETED|Washout Period After Period 1 Treatment||2||
48272906|NCT00943852|100992066|FG001|COMPLETED|Washout Period After Period 1 Treatment||1||
48272907|NCT00943852|100992067|FG002|COMPLETED|Washout Period After Period 1 Treatment||1||
48272908|NCT00943852|100992068|FG003|COMPLETED|Washout Period After Period 1 Treatment||1||
48272909|NCT00943852|100992069|FG004|COMPLETED|Washout Period After Period 1 Treatment||1||
48272910|NCT00943852|100992070|FG005|COMPLETED|Washout Period After Period 1 Treatment||1||
48272911|NCT00943852|100992071|FG006|COMPLETED|Washout Period After Period 1 Treatment||2||
48272912|NCT00943852|100992072|FG007|COMPLETED|Washout Period After Period 1 Treatment||1||
48272913|NCT00943852|100992073|FG008|COMPLETED|Washout Period After Period 1 Treatment||1||
48272914|NCT00943852|100992074|FG009|COMPLETED|Washout Period After Period 1 Treatment||1||
48272915|NCT00943852|100992065|FG000|NOT COMPLETED|Washout Period After Period 1 Treatment||0||
48272916|NCT00943852|100992066|FG001|NOT COMPLETED|Washout Period After Period 1 Treatment||0||
48272917|NCT00943852|100992067|FG002|NOT COMPLETED|Washout Period After Period 1 Treatment||0||
48272918|NCT00943852|100992068|FG003|NOT COMPLETED|Washout Period After Period 1 Treatment||1||
48272919|NCT00943852|100992069|FG004|NOT COMPLETED|Washout Period After Period 1 Treatment||0||
48272920|NCT00943852|100992070|FG005|NOT COMPLETED|Washout Period After Period 1 Treatment||0||
48272921|NCT00943852|100992071|FG006|NOT COMPLETED|Washout Period After Period 1 Treatment||0||
48272922|NCT00943852|100992072|FG007|NOT COMPLETED|Washout Period After Period 1 Treatment||0||
48272923|NCT00943852|100992073|FG008|NOT COMPLETED|Washout Period After Period 1 Treatment||0||
48272924|NCT00943852|100992074|FG009|NOT COMPLETED|Washout Period After Period 1 Treatment||0||
48272925|NCT00943852|100992065|FG000|STARTED|Second Period of Treatment Intervention||2||
48272926|NCT00943852|100992066|FG001|STARTED|Second Period of Treatment Intervention||1||
48393077|NCT00369967|101291501|FG001|STARTED|Overall Study||17||
48694054|NCT00879034|102036287|FG000|STARTED|Overall Study||5||
48694055|NCT00879034|102036287|FG000|Received Treatment|Overall Study||4|One patient did not receive a zoledronic acid infusion during study.|
48694056|NCT00879034|102036287|FG000|COMPLETED|Overall Study||5||
48272927|NCT00943852|100992067|FG002|STARTED|Second Period of Treatment Intervention||1||
48272928|NCT00943852|100992068|FG003|STARTED|Second Period of Treatment Intervention||1||
48272929|NCT00943852|100992069|FG004|STARTED|Second Period of Treatment Intervention||1||
48272930|NCT00943852|100992070|FG005|STARTED|Second Period of Treatment Intervention||1||
48555807|NCT01841593|101693798|FG001|STARTED|Third Intervention (Days 15 to 21)||6||
48555808|NCT01841593|101693797|FG000|COMPLETED|Third Intervention (Days 15 to 21)||11||
48555809|NCT01841593|101693798|FG001|COMPLETED|Third Intervention (Days 15 to 21)||6||
48555810|NCT01841593|101693797|FG000|NOT COMPLETED|Third Intervention (Days 15 to 21)||0||
48555811|NCT01841593|101693798|FG001|NOT COMPLETED|Third Intervention (Days 15 to 21)||0||
48555812|NCT03730207|101693799|FG000|STARTED|Overall Study||89||
48555813|NCT03730207|101693800|FG001|STARTED|Overall Study||91||
48555814|NCT03730207|101693799|FG000|COMPLETED|Overall Study||83||
48555815|NCT03730207|101693800|FG001|COMPLETED|Overall Study||88||
48555816|NCT03730207|101693799|FG000|NOT COMPLETED|Overall Study||6||
48555817|NCT03730207|101693800|FG001|NOT COMPLETED|Overall Study||3||
48555818|NCT00547586|101693801|FG000|STARTED|Overall Study||33||
48555819|NCT00547586|101693802|FG001|STARTED|Overall Study||7||
48555820|NCT00547586|101693803|FG002|STARTED|Overall Study||14||
48555821|NCT00547586|101693804|FG003|STARTED|Overall Study||33||
48555822|NCT00547586|101693805|FG004|STARTED|Overall Study||35||
48555823|NCT00547586|101693801|FG000|COMPLETED|Overall Study||28||
48555824|NCT00547586|101693802|FG001|COMPLETED|Overall Study||6||
48555825|NCT00547586|101693803|FG002|COMPLETED|Overall Study||13||
48555826|NCT00547586|101693804|FG003|COMPLETED|Overall Study||27||
48555827|NCT00547586|101693805|FG004|COMPLETED|Overall Study||32||
48555828|NCT00547586|101693801|FG000|NOT COMPLETED|Overall Study||5||
48555829|NCT00547586|101693802|FG001|NOT COMPLETED|Overall Study||1||
48555830|NCT00547586|101693803|FG002|NOT COMPLETED|Overall Study||1||
48555831|NCT00547586|101693804|FG003|NOT COMPLETED|Overall Study||6||
48555832|NCT00547586|101693805|FG004|NOT COMPLETED|Overall Study||3||
48555833|NCT04080739|101693806|FG000|STARTED|Overall Study||50||
48555834|NCT04080739|101693807|FG001|STARTED|Overall Study||50||
48555835|NCT04080739|101693806|FG000|COMPLETED|Overall Study||48||
48555836|NCT04080739|101693807|FG001|COMPLETED|Overall Study||50||
48555837|NCT04080739|101693806|FG000|NOT COMPLETED|Overall Study||2||
48555838|NCT04080739|101693807|FG001|NOT COMPLETED|Overall Study||0||
48555839|NCT03334435|101693808|FG000|STARTED|Treatment Period 1: Week 0 to Week 52||91||
48555840|NCT03334435|101693809|FG001|STARTED|Treatment Period 1: Week 0 to Week 52||45||
48555841|NCT03334435|101693810|FG002|STARTED|Treatment Period 1: Week 0 to Week 52||519||
48555842|NCT03334435|101693811|FG003|STARTED|Treatment Period 1: Week 0 to Week 52||743||
48555843|NCT03334435|101693812|FG004|STARTED|Treatment Period 1: Week 0 to Week 52||247||
48555844|NCT03334435|101693813|FG005|STARTED|Treatment Period 1: Week 0 to Week 52||0||
48555845|NCT03334435|101693814|FG006|STARTED|Treatment Period 1: Week 0 to Week 52||0||
48555846|NCT03334435|101693815|FG007|STARTED|Treatment Period 1: Week 0 to Week 52||0||
48555847|NCT03334435|101693816|FG008|STARTED|Treatment Period 1: Week 0 to Week 52||0||
48694057|NCT00879034|102036287|FG000|NOT COMPLETED|Overall Study||0||
48694058|NCT01032603|102036288|FG000|STARTED|Overall Study||101||
48694059|NCT01032603|102036289|FG001|STARTED|Overall Study||96||
48694060|NCT01032603|102036288|FG000|COMPLETED|Overall Study||86||
48694061|NCT01032603|102036289|FG001|COMPLETED|Overall Study||77||
48694062|NCT01032603|102036288|FG000|NOT COMPLETED|Overall Study||15||
48694063|NCT01032603|102036289|FG001|NOT COMPLETED|Overall Study||19||
48694064|NCT01301066|102036290|FG000|STARTED|Overall Study||126||
48694065|NCT01301066|102036291|FG001|STARTED|Overall Study||126||
48694066|NCT01301066|102036290|FG000|COMPLETED|Overall Study||99||
48694067|NCT01301066|102036291|FG001|COMPLETED|Overall Study||91||
48694068|NCT01301066|102036290|FG000|NOT COMPLETED|Overall Study||27||
48694069|NCT01301066|102036291|FG001|NOT COMPLETED|Overall Study||35||
48694070|NCT02120781|102036292|FG000|STARTED|Overall Study||15||
48694071|NCT02120781|102036293|FG001|STARTED|Overall Study||6||
48555848|NCT03334435|101693817|FG009|STARTED|Treatment Period 1: Week 0 to Week 52||0||
48555849|NCT03334435|101693818|FG010|STARTED|Treatment Period 1: Week 0 to Week 52||0||
48555850|NCT03334435|101693819|FG011|STARTED|Treatment Period 1: Week 0 to Week 52||0||
48555851|NCT03334435|101693820|FG012|STARTED|Treatment Period 1: Week 0 to Week 52||0||
48555852|NCT03334435|101693821|FG013|STARTED|Treatment Period 1: Week 0 to Week 52||0||
48555853|NCT03334435|101693822|FG014|STARTED|Treatment Period 1: Week 0 to Week 52||0||
48555854|NCT03334435|101693808|FG000|Received at Least 1 Dose of Investigational Product (IP)|Treatment Period 1: Week 0 to Week 52||91||
48555855|NCT03334435|101693809|FG001|Received at Least 1 Dose of Investigational Product (IP)|Treatment Period 1: Week 0 to Week 52||45||
48592730|NCT02678000|101783169|FG001|STARTED|PART 1||4||
48694072|NCT02120781|102036292|FG000|COMPLETED|Overall Study||11||
48694073|NCT02120781|102036293|FG001|COMPLETED|Overall Study||5||
48694074|NCT02120781|102036292|FG000|NOT COMPLETED|Overall Study||4||
48694075|NCT02120781|102036293|FG001|NOT COMPLETED|Overall Study||1||
48555856|NCT03334435|101693810|FG002|Received at Least 1 Dose of Investigational Product (IP)|Treatment Period 1: Week 0 to Week 52||519||
48555857|NCT03334435|101693811|FG003|Received at Least 1 Dose of Investigational Product (IP)|Treatment Period 1: Week 0 to Week 52||743||
48555858|NCT03334435|101693812|FG004|Received at Least 1 Dose of Investigational Product (IP)|Treatment Period 1: Week 0 to Week 52||247||
48555859|NCT03334435|101693813|FG005|Received at Least 1 Dose of Investigational Product (IP)|Treatment Period 1: Week 0 to Week 52||0||
48555860|NCT03334435|101693814|FG006|Received at Least 1 Dose of Investigational Product (IP)|Treatment Period 1: Week 0 to Week 52||0||
48555861|NCT03334435|101693815|FG007|Received at Least 1 Dose of Investigational Product (IP)|Treatment Period 1: Week 0 to Week 52||0||
48110698|NCT00086580|100597987|FG001|NOT COMPLETED|Observation Period||65||
48110699|NCT05091528|100597988|FG000|STARTED|Overall Study||0||
48110700|NCT05091528|100597989|FG001|STARTED|Overall Study||1||
48555862|NCT03334435|101693816|FG008|Received at Least 1 Dose of Investigational Product (IP)|Treatment Period 1: Week 0 to Week 52||0||
48555863|NCT03334435|101693817|FG009|Received at Least 1 Dose of Investigational Product (IP)|Treatment Period 1: Week 0 to Week 52||0||
48555864|NCT03334435|101693818|FG010|Received at Least 1 Dose of Investigational Product (IP)|Treatment Period 1: Week 0 to Week 52||0||
48555865|NCT03334435|101693819|FG011|Received at Least 1 Dose of Investigational Product (IP)|Treatment Period 1: Week 0 to Week 52||0||
48555866|NCT03334435|101693820|FG012|Received at Least 1 Dose of Investigational Product (IP)|Treatment Period 1: Week 0 to Week 52||0||
48555867|NCT03334435|101693821|FG013|Received at Least 1 Dose of Investigational Product (IP)|Treatment Period 1: Week 0 to Week 52||0||
48555868|NCT03334435|101693822|FG014|Received at Least 1 Dose of Investigational Product (IP)|Treatment Period 1: Week 0 to Week 52||0||
48555869|NCT03334435|101693808|FG000|RPR|Treatment Period 1: Week 0 to Week 52||91||
48555870|NCT03334435|101693809|FG001|RPR|Treatment Period 1: Week 0 to Week 52||45||
48555871|NCT03334435|101693810|FG002|RPR|Treatment Period 1: Week 0 to Week 52||108||
48110701|NCT05091528|100597990|FG002|STARTED|Overall Study||0||
48110702|NCT05091528|100597991|FG003|STARTED|Overall Study||1||
48110703|NCT05091528|100597988|FG000|COMPLETED|Overall Study||0||
48110704|NCT05091528|100597989|FG001|COMPLETED|Overall Study||0||
48555872|NCT03334435|101693811|FG003|RPR|Treatment Period 1: Week 0 to Week 52||134||
48555873|NCT03334435|101693812|FG004|RPR|Treatment Period 1: Week 0 to Week 52||0||
48555874|NCT03334435|101693813|FG005|RPR|Treatment Period 1: Week 0 to Week 52||0||
48555875|NCT03334435|101693814|FG006|RPR|Treatment Period 1: Week 0 to Week 52||0||
48555876|NCT03334435|101693815|FG007|RPR|Treatment Period 1: Week 0 to Week 52||0||
48555877|NCT03334435|101693816|FG008|RPR|Treatment Period 1: Week 0 to Week 52||0||
48555878|NCT03334435|101693817|FG009|RPR|Treatment Period 1: Week 0 to Week 52||0||
48110705|NCT05091528|100597990|FG002|COMPLETED|Overall Study||0||
48110706|NCT05091528|100597991|FG003|COMPLETED|Overall Study||0||
48110707|NCT05091528|100597988|FG000|NOT COMPLETED|Overall Study||0||
48272931|NCT00943852|100992071|FG006|STARTED|Second Period of Treatment Intervention||2||
48272932|NCT00943852|100992072|FG007|STARTED|Second Period of Treatment Intervention||1||
48272933|NCT00943852|100992073|FG008|STARTED|Second Period of Treatment Intervention||1||
48272934|NCT00943852|100992074|FG009|STARTED|Second Period of Treatment Intervention||1||
48272935|NCT00943852|100992065|FG000|COMPLETED|Second Period of Treatment Intervention||2||
48272936|NCT00943852|100992066|FG001|COMPLETED|Second Period of Treatment Intervention||1||
48272937|NCT00943852|100992067|FG002|COMPLETED|Second Period of Treatment Intervention||1||
48272938|NCT00943852|100992068|FG003|COMPLETED|Second Period of Treatment Intervention||1||
48272939|NCT00943852|100992069|FG004|COMPLETED|Second Period of Treatment Intervention||1||
48272940|NCT00943852|100992070|FG005|COMPLETED|Second Period of Treatment Intervention||1||
48272941|NCT00943852|100992071|FG006|COMPLETED|Second Period of Treatment Intervention||2||
48272942|NCT00943852|100992072|FG007|COMPLETED|Second Period of Treatment Intervention||1||
48272943|NCT00943852|100992073|FG008|COMPLETED|Second Period of Treatment Intervention||1||
48272944|NCT00943852|100992074|FG009|COMPLETED|Second Period of Treatment Intervention||1||
48272945|NCT00943852|100992065|FG000|NOT COMPLETED|Second Period of Treatment Intervention||0||
48272946|NCT00943852|100992066|FG001|NOT COMPLETED|Second Period of Treatment Intervention||0||
48272947|NCT00943852|100992067|FG002|NOT COMPLETED|Second Period of Treatment Intervention||0||
48272948|NCT00943852|100992068|FG003|NOT COMPLETED|Second Period of Treatment Intervention||0||
48272949|NCT00943852|100992069|FG004|NOT COMPLETED|Second Period of Treatment Intervention||0||
48272950|NCT00943852|100992070|FG005|NOT COMPLETED|Second Period of Treatment Intervention||0||
48272951|NCT00943852|100992071|FG006|NOT COMPLETED|Second Period of Treatment Intervention||0||
48272952|NCT00943852|100992072|FG007|NOT COMPLETED|Second Period of Treatment Intervention||0||
48272953|NCT00943852|100992073|FG008|NOT COMPLETED|Second Period of Treatment Intervention||0||
48272954|NCT00943852|100992074|FG009|NOT COMPLETED|Second Period of Treatment Intervention||0||
48272955|NCT00943852|100992065|FG000|STARTED|Washout Period After Period 2 Treatment||2||
48555879|NCT03334435|101693818|FG010|RPR|Treatment Period 1: Week 0 to Week 52||0||
48555880|NCT03334435|101693819|FG011|RPR|Treatment Period 1: Week 0 to Week 52||0||
48555881|NCT03334435|101693820|FG012|RPR|Treatment Period 1: Week 0 to Week 52||0||
48555882|NCT03334435|101693821|FG013|RPR|Treatment Period 1: Week 0 to Week 52||0||
48555883|NCT03334435|101693822|FG014|RPR|Treatment Period 1: Week 0 to Week 52||0||
48555884|NCT03334435|101693808|FG000|NR|Treatment Period 1: Week 0 to Week 52||0||
48555885|NCT03334435|101693809|FG001|NR|Treatment Period 1: Week 0 to Week 52||0||
48555886|NCT03334435|101693810|FG002|NR|Treatment Period 1: Week 0 to Week 52||411||
48555887|NCT03334435|101693811|FG003|NR|Treatment Period 1: Week 0 to Week 52||609||
48555888|NCT03334435|101693812|FG004|NR|Treatment Period 1: Week 0 to Week 52||0||
48555889|NCT03334435|101693813|FG005|NR|Treatment Period 1: Week 0 to Week 52||0||
48555890|NCT03334435|101693814|FG006|NR|Treatment Period 1: Week 0 to Week 52||0||
48555891|NCT03334435|101693815|FG007|NR|Treatment Period 1: Week 0 to Week 52||0||
48555892|NCT03334435|101693816|FG008|NR|Treatment Period 1: Week 0 to Week 52||0||
48555893|NCT03334435|101693817|FG009|NR|Treatment Period 1: Week 0 to Week 52||0||
48555894|NCT03334435|101693818|FG010|NR|Treatment Period 1: Week 0 to Week 52||0||
48555895|NCT03334435|101693819|FG011|NR|Treatment Period 1: Week 0 to Week 52||0||
48555896|NCT03334435|101693820|FG012|NR|Treatment Period 1: Week 0 to Week 52||0||
48555897|NCT03334435|101693821|FG013|NR|Treatment Period 1: Week 0 to Week 52||0||
48555898|NCT03334435|101693822|FG014|NR|Treatment Period 1: Week 0 to Week 52||0||
48555899|NCT03334435|101693808|FG000|COMPLETED|Treatment Period 1: Week 0 to Week 52||2||
48555900|NCT03334435|101693809|FG001|COMPLETED|Treatment Period 1: Week 0 to Week 52||2||
48555901|NCT03334435|101693810|FG002|COMPLETED|Treatment Period 1: Week 0 to Week 52||12||
48555902|NCT03334435|101693811|FG003|COMPLETED|Treatment Period 1: Week 0 to Week 52||15||
48555903|NCT03334435|101693812|FG004|COMPLETED|Treatment Period 1: Week 0 to Week 52||5||
48555904|NCT03334435|101693813|FG005|COMPLETED|Treatment Period 1: Week 0 to Week 52||0||
48555905|NCT03334435|101693814|FG006|COMPLETED|Treatment Period 1: Week 0 to Week 52||0||
48555906|NCT03334435|101693815|FG007|COMPLETED|Treatment Period 1: Week 0 to Week 52||0||
48555907|NCT03334435|101693816|FG008|COMPLETED|Treatment Period 1: Week 0 to Week 52||0||
48555908|NCT03334435|101693817|FG009|COMPLETED|Treatment Period 1: Week 0 to Week 52||0||
48555909|NCT03334435|101693818|FG010|COMPLETED|Treatment Period 1: Week 0 to Week 52||0||
48555910|NCT03334435|101693819|FG011|COMPLETED|Treatment Period 1: Week 0 to Week 52||0||
48555911|NCT03334435|101693820|FG012|COMPLETED|Treatment Period 1: Week 0 to Week 52||0||
48555912|NCT03334435|101693821|FG013|COMPLETED|Treatment Period 1: Week 0 to Week 52||0||
48555913|NCT03334435|101693822|FG014|COMPLETED|Treatment Period 1: Week 0 to Week 52||0||
48555914|NCT03334435|101693808|FG000|NOT COMPLETED|Treatment Period 1: Week 0 to Week 52||89||
48555915|NCT03334435|101693809|FG001|NOT COMPLETED|Treatment Period 1: Week 0 to Week 52||43||
48555916|NCT03334435|101693810|FG002|NOT COMPLETED|Treatment Period 1: Week 0 to Week 52||507||
48555917|NCT03334435|101693811|FG003|NOT COMPLETED|Treatment Period 1: Week 0 to Week 52||728||
48110708|NCT05091528|100597989|FG001|NOT COMPLETED|Overall Study||1||
48110709|NCT05091528|100597990|FG002|NOT COMPLETED|Overall Study||0||
48110710|NCT05091528|100597991|FG003|NOT COMPLETED|Overall Study||1||
48110711|NCT01652716|100597992|FG000|STARTED|Overall Study||229||
48110712|NCT01652716|100597993|FG001|STARTED|Overall Study||148||
48555918|NCT03334435|101693812|FG004|NOT COMPLETED|Treatment Period 1: Week 0 to Week 52||242||
48555919|NCT03334435|101693813|FG005|NOT COMPLETED|Treatment Period 1: Week 0 to Week 52||0||
48555920|NCT03334435|101693814|FG006|NOT COMPLETED|Treatment Period 1: Week 0 to Week 52||0||
48555921|NCT03334435|101693815|FG007|NOT COMPLETED|Treatment Period 1: Week 0 to Week 52||0||
48110713|NCT01652716|100597992|FG000|Completed 28-week|Overall Study||197||
48110714|NCT01652716|100597993|FG001|Completed 28-week|Overall Study||118||
48110715|NCT01652716|100597992|FG000|COMPLETED|Overall Study||173||
48110716|NCT01652716|100597993|FG001|COMPLETED|Overall Study||102||
48110717|NCT01652716|100597992|FG000|NOT COMPLETED|Overall Study||56||
48555922|NCT03334435|101693816|FG008|NOT COMPLETED|Treatment Period 1: Week 0 to Week 52||0||
48555923|NCT03334435|101693817|FG009|NOT COMPLETED|Treatment Period 1: Week 0 to Week 52||0||
48555924|NCT03334435|101693818|FG010|NOT COMPLETED|Treatment Period 1: Week 0 to Week 52||0||
48555925|NCT03334435|101693819|FG011|NOT COMPLETED|Treatment Period 1: Week 0 to Week 52||0||
48555926|NCT03334435|101693820|FG012|NOT COMPLETED|Treatment Period 1: Week 0 to Week 52||0||
48555927|NCT03334435|101693821|FG013|NOT COMPLETED|Treatment Period 1: Week 0 to Week 52||0||
48555928|NCT03334435|101693822|FG014|NOT COMPLETED|Treatment Period 1: Week 0 to Week 52||0||
48555929|NCT03334435|101693808|FG000|STARTED|Treatment Period 2: Week 52 to Week 200||0||
48555930|NCT03334435|101693809|FG001|STARTED|Treatment Period 2: Week 52 to Week 200||0||
48555931|NCT03334435|101693810|FG002|STARTED|Treatment Period 2: Week 52 to Week 200||0||
48555932|NCT03334435|101693811|FG003|STARTED|Treatment Period 2: Week 52 to Week 200||0||
48555933|NCT03334435|101693812|FG004|STARTED|Treatment Period 2: Week 52 to Week 200||0||
48555934|NCT03334435|101693813|FG005|STARTED|Treatment Period 2: Week 52 to Week 200||92||
48555935|NCT03334435|101693814|FG006|STARTED|Treatment Period 2: Week 52 to Week 200||91||
48555936|NCT03334435|101693815|FG007|STARTED|Treatment Period 2: Week 52 to Week 200||92||
48555937|NCT03334435|101693816|FG008|STARTED|Treatment Period 2: Week 52 to Week 200||84||
48555938|NCT03334435|101693817|FG009|STARTED|Treatment Period 2: Week 52 to Week 200||84||
48555939|NCT03334435|101693818|FG010|STARTED|Treatment Period 2: Week 52 to Week 200||84||
48555940|NCT03334435|101693819|FG011|STARTED|Treatment Period 2: Week 52 to Week 200||70||
48555941|NCT03334435|101693820|FG012|STARTED|Treatment Period 2: Week 52 to Week 200||32||
48555942|NCT03334435|101693821|FG013|STARTED|Treatment Period 2: Week 52 to Week 200||249||
48555943|NCT03334435|101693822|FG014|STARTED|Treatment Period 2: Week 52 to Week 200||264||
48555944|NCT03334435|101693808|FG000|Received at Least 1 Dose of IP|Treatment Period 2: Week 52 to Week 200||0||
48555945|NCT03334435|101693809|FG001|Received at Least 1 Dose of IP|Treatment Period 2: Week 52 to Week 200||0||
48555946|NCT03334435|101693810|FG002|Received at Least 1 Dose of IP|Treatment Period 2: Week 52 to Week 200||0||
48555947|NCT03334435|101693811|FG003|Received at Least 1 Dose of IP|Treatment Period 2: Week 52 to Week 200||0||
48555948|NCT03334435|101693812|FG004|Received at Least 1 Dose of IP|Treatment Period 2: Week 52 to Week 200||0||
48555949|NCT03334435|101693813|FG005|Received at Least 1 Dose of IP|Treatment Period 2: Week 52 to Week 200||92||
48555950|NCT03334435|101693814|FG006|Received at Least 1 Dose of IP|Treatment Period 2: Week 52 to Week 200||91||
48555951|NCT03334435|101693815|FG007|Received at Least 1 Dose of IP|Treatment Period 2: Week 52 to Week 200||92||
48555952|NCT03334435|101693816|FG008|Received at Least 1 Dose of IP|Treatment Period 2: Week 52 to Week 200||84||
48555953|NCT03334435|101693817|FG009|Received at Least 1 Dose of IP|Treatment Period 2: Week 52 to Week 200||84||
48555954|NCT03334435|101693818|FG010|Received at Least 1 Dose of IP|Treatment Period 2: Week 52 to Week 200||84||
48555955|NCT03334435|101693819|FG011|Received at Least 1 Dose of IP|Treatment Period 2: Week 52 to Week 200||70||
48555956|NCT03334435|101693820|FG012|Received at Least 1 Dose of IP|Treatment Period 2: Week 52 to Week 200||32||
48555957|NCT03334435|101693821|FG013|Received at Least 1 Dose of IP|Treatment Period 2: Week 52 to Week 200||249||
48555958|NCT03334435|101693822|FG014|Received at Least 1 Dose of IP|Treatment Period 2: Week 52 to Week 200||264||
48555959|NCT03334435|101693808|FG000|COMPLETED|Treatment Period 2: Week 52 to Week 200||0|"Regarding the participants who did not complete the study due to the reason study termination by sponsor. As pre-planned in the protocol, study termination may have occurred in a specific country or region when baricitinib was approved for the treatment of AD and became reimbursed or commercially available in that country or region, or a negative regulatory opinion was received in that country or region."|
48592731|NCT02678000|101783170|FG002|STARTED|PART 1||0||
48592732|NCT02678000|101783171|FG003|STARTED|PART 1||0||
48592733|NCT02678000|101783172|FG004|STARTED|PART 1||0||
48592734|NCT02678000|101783168|FG000|COMPLETED|PART 1||7||
48110718|NCT01652716|100597993|FG001|NOT COMPLETED|Overall Study||46||
48110719|NCT02884089|100597994|FG000|STARTED|Period 1||11||
48110720|NCT02884089|100597995|FG001|STARTED|Period 1||11||
48110721|NCT02884089|100597996|FG002|STARTED|Period 1||9||
48110722|NCT02884089|100597997|FG003|STARTED|Period 1||9||
48110723|NCT02884089|100597994|FG000|Received at Least One Dose of Study Drug|Period 1||11||
48110724|NCT02884089|100597995|FG001|Received at Least One Dose of Study Drug|Period 1||11||
48110725|NCT02884089|100597996|FG002|Received at Least One Dose of Study Drug|Period 1||9||
48110726|NCT02884089|100597997|FG003|Received at Least One Dose of Study Drug|Period 1||9||
48555960|NCT03334435|101693809|FG001|COMPLETED|Treatment Period 2: Week 52 to Week 200||0|"Regarding the participants who did not complete the study due to the reason study termination by sponsor. As pre-planned in the protocol, study termination may have occurred in a specific country or region when baricitinib was approved for the treatment of AD and became reimbursed or commercially available in that country or region, or a negative regulatory opinion was received in that country or region."|
48272956|NCT00943852|100992066|FG001|STARTED|Washout Period After Period 2 Treatment||1||
48272957|NCT00943852|100992067|FG002|STARTED|Washout Period After Period 2 Treatment||1||
48272958|NCT00943852|100992068|FG003|STARTED|Washout Period After Period 2 Treatment||1||
48555961|NCT03334435|101693810|FG002|COMPLETED|Treatment Period 2: Week 52 to Week 200||0|"Regarding the participants who did not complete the study due to the reason study termination by sponsor. As pre-planned in the protocol, study termination may have occurred in a specific country or region when baricitinib was approved for the treatment of AD and became reimbursed or commercially available in that country or region, or a negative regulatory opinion was received in that country or region."|
48555962|NCT03334435|101693811|FG003|COMPLETED|Treatment Period 2: Week 52 to Week 200||0|"Regarding the participants who did not complete the study due to the reason study termination by sponsor. As pre-planned in the protocol, study termination may have occurred in a specific country or region when baricitinib was approved for the treatment of AD and became reimbursed or commercially available in that country or region, or a negative regulatory opinion was received in that country or region."|
48555963|NCT03334435|101693812|FG004|COMPLETED|Treatment Period 2: Week 52 to Week 200||0|"Regarding the participants who did not complete the study due to the reason study termination by sponsor. As pre-planned in the protocol, study termination may have occurred in a specific country or region when baricitinib was approved for the treatment of AD and became reimbursed or commercially available in that country or region, or a negative regulatory opinion was received in that country or region."|
48555964|NCT03334435|101693813|FG005|COMPLETED|Treatment Period 2: Week 52 to Week 200||29|"Regarding the participants who did not complete the study due to the reason study termination by sponsor. As pre-planned in the protocol, study termination may have occurred in a specific country or region when baricitinib was approved for the treatment of AD and became reimbursed or commercially available in that country or region, or a negative regulatory opinion was received in that country or region."|
48555965|NCT03334435|101693814|FG006|COMPLETED|Treatment Period 2: Week 52 to Week 200||40|"Regarding the participants who did not complete the study due to the reason study termination by sponsor. As pre-planned in the protocol, study termination may have occurred in a specific country or region when baricitinib was approved for the treatment of AD and became reimbursed or commercially available in that country or region, or a negative regulatory opinion was received in that country or region."|
48555966|NCT03334435|101693815|FG007|COMPLETED|Treatment Period 2: Week 52 to Week 200||38|"Regarding the participants who did not complete the study due to the reason study termination by sponsor. As pre-planned in the protocol, study termination may have occurred in a specific country or region when baricitinib was approved for the treatment of AD and became reimbursed or commercially available in that country or region, or a negative regulatory opinion was received in that country or region."|
48555967|NCT03334435|101693816|FG008|COMPLETED|Treatment Period 2: Week 52 to Week 200||34|"Regarding the participants who did not complete the study due to the reason study termination by sponsor. As pre-planned in the protocol, study termination may have occurred in a specific country or region when baricitinib was approved for the treatment of AD and became reimbursed or commercially available in that country or region, or a negative regulatory opinion was received in that country or region."|
48555968|NCT03334435|101693817|FG009|COMPLETED|Treatment Period 2: Week 52 to Week 200||40|"Regarding the participants who did not complete the study due to the reason study termination by sponsor. As pre-planned in the protocol, study termination may have occurred in a specific country or region when baricitinib was approved for the treatment of AD and became reimbursed or commercially available in that country or region, or a negative regulatory opinion was received in that country or region."|
48592735|NCT02678000|101783169|FG001|COMPLETED|PART 1||4||
48592736|NCT02678000|101783170|FG002|COMPLETED|PART 1||0||
48694076|NCT03850093|102036294|FG000|STARTED|Overall Study||22||
48272959|NCT00943852|100992069|FG004|STARTED|Washout Period After Period 2 Treatment||1||
48272960|NCT00943852|100992070|FG005|STARTED|Washout Period After Period 2 Treatment||1||
48272961|NCT00943852|100992071|FG006|STARTED|Washout Period After Period 2 Treatment||2||
48272962|NCT00943852|100992072|FG007|STARTED|Washout Period After Period 2 Treatment||1||
48272963|NCT00943852|100992073|FG008|STARTED|Washout Period After Period 2 Treatment||1||
48272964|NCT00943852|100992074|FG009|STARTED|Washout Period After Period 2 Treatment||1||
48694077|NCT03850093|102036295|FG001|STARTED|Overall Study||22||
48694078|NCT03850093|102036296|FG002|STARTED|Overall Study||19||
48694079|NCT03850093|102036294|FG000|COMPLETED|Overall Study||21||
48694080|NCT03850093|102036295|FG001|COMPLETED|Overall Study||22||
48694081|NCT03850093|102036296|FG002|COMPLETED|Overall Study||17||
48694082|NCT03850093|102036294|FG000|NOT COMPLETED|Overall Study||1||
48694083|NCT03850093|102036295|FG001|NOT COMPLETED|Overall Study||0||
48694084|NCT03850093|102036296|FG002|NOT COMPLETED|Overall Study||2||
48694085|NCT01188551|102036297|FG000|STARTED|Overall Study||25||
48694086|NCT01188551|102036298|FG001|STARTED|Overall Study||25||
48694087|NCT01188551|102036299|FG002|STARTED|Overall Study||25||
48694088|NCT01188551|102036300|FG003|STARTED|Overall Study||25||
48694089|NCT01188551|102036297|FG000|COMPLETED|Overall Study||24||
48694090|NCT01188551|102036298|FG001|COMPLETED|Overall Study||25||
48694091|NCT01188551|102036299|FG002|COMPLETED|Overall Study||25||
48694092|NCT01188551|102036300|FG003|COMPLETED|Overall Study||25||
48694093|NCT01188551|102036297|FG000|NOT COMPLETED|Overall Study||1||
48694094|NCT01188551|102036298|FG001|NOT COMPLETED|Overall Study||0||
48272965|NCT00943852|100992065|FG000|COMPLETED|Washout Period After Period 2 Treatment||2||
48272966|NCT00943852|100992066|FG001|COMPLETED|Washout Period After Period 2 Treatment||1||
48110727|NCT02884089|100597994|FG000|COMPLETED|Period 1||9||
48110728|NCT02884089|100597995|FG001|COMPLETED|Period 1||9||
48110729|NCT02884089|100597996|FG002|COMPLETED|Period 1||9||
48110730|NCT02884089|100597997|FG003|COMPLETED|Period 1||9||
48110731|NCT02884089|100597994|FG000|NOT COMPLETED|Period 1||2||
48110732|NCT02884089|100597995|FG001|NOT COMPLETED|Period 1||2||
48110733|NCT02884089|100597996|FG002|NOT COMPLETED|Period 1||0||
48110734|NCT02884089|100597997|FG003|NOT COMPLETED|Period 1||0||
48110735|NCT02884089|100597994|FG000|STARTED|Washout Period 1||9||
48110736|NCT02884089|100597995|FG001|STARTED|Washout Period 1||9||
48110737|NCT02884089|100597996|FG002|STARTED|Washout Period 1||9||
48110738|NCT02884089|100597997|FG003|STARTED|Washout Period 1||9||
48110739|NCT02884089|100597994|FG000|COMPLETED|Washout Period 1||9||
48110740|NCT02884089|100597995|FG001|COMPLETED|Washout Period 1||7||
48110741|NCT02884089|100597996|FG002|COMPLETED|Washout Period 1||9||
48110742|NCT02884089|100597997|FG003|COMPLETED|Washout Period 1||8||
48555969|NCT03334435|101693818|FG010|COMPLETED|Treatment Period 2: Week 52 to Week 200||35|"Regarding the participants who did not complete the study due to the reason study termination by sponsor. As pre-planned in the protocol, study termination may have occurred in a specific country or region when baricitinib was approved for the treatment of AD and became reimbursed or commercially available in that country or region, or a negative regulatory opinion was received in that country or region."|
48555970|NCT03334435|101693819|FG011|COMPLETED|Treatment Period 2: Week 52 to Week 200||28|"Regarding the participants who did not complete the study due to the reason study termination by sponsor. As pre-planned in the protocol, study termination may have occurred in a specific country or region when baricitinib was approved for the treatment of AD and became reimbursed or commercially available in that country or region, or a negative regulatory opinion was received in that country or region."|
48555971|NCT03334435|101693820|FG012|COMPLETED|Treatment Period 2: Week 52 to Week 200||23|"Regarding the participants who did not complete the study due to the reason study termination by sponsor. As pre-planned in the protocol, study termination may have occurred in a specific country or region when baricitinib was approved for the treatment of AD and became reimbursed or commercially available in that country or region, or a negative regulatory opinion was received in that country or region."|
48555972|NCT03334435|101693821|FG013|COMPLETED|Treatment Period 2: Week 52 to Week 200||60|"Regarding the participants who did not complete the study due to the reason study termination by sponsor. As pre-planned in the protocol, study termination may have occurred in a specific country or region when baricitinib was approved for the treatment of AD and became reimbursed or commercially available in that country or region, or a negative regulatory opinion was received in that country or region."|
48555973|NCT03334435|101693822|FG014|COMPLETED|Treatment Period 2: Week 52 to Week 200||68|"Regarding the participants who did not complete the study due to the reason study termination by sponsor. As pre-planned in the protocol, study termination may have occurred in a specific country or region when baricitinib was approved for the treatment of AD and became reimbursed or commercially available in that country or region, or a negative regulatory opinion was received in that country or region."|
48555974|NCT03334435|101693808|FG000|NOT COMPLETED|Treatment Period 2: Week 52 to Week 200||0||
48555975|NCT03334435|101693809|FG001|NOT COMPLETED|Treatment Period 2: Week 52 to Week 200||0||
48555976|NCT03334435|101693810|FG002|NOT COMPLETED|Treatment Period 2: Week 52 to Week 200||0||
48555977|NCT03334435|101693811|FG003|NOT COMPLETED|Treatment Period 2: Week 52 to Week 200||0||
48555978|NCT03334435|101693812|FG004|NOT COMPLETED|Treatment Period 2: Week 52 to Week 200||0||
48555979|NCT03334435|101693813|FG005|NOT COMPLETED|Treatment Period 2: Week 52 to Week 200||63||
48110743|NCT02884089|100597994|FG000|NOT COMPLETED|Washout Period 1||0||
48110744|NCT02884089|100597995|FG001|NOT COMPLETED|Washout Period 1||2||
48110745|NCT02884089|100597996|FG002|NOT COMPLETED|Washout Period 1||0||
48110746|NCT02884089|100597997|FG003|NOT COMPLETED|Washout Period 1||1||
48110747|NCT02884089|100597994|FG000|STARTED|Period 2||9||
48110748|NCT02884089|100597995|FG001|STARTED|Period 2||7||
48110749|NCT02884089|100597996|FG002|STARTED|Period 2||9||
48110750|NCT02884089|100597997|FG003|STARTED|Period 2||8||
48110751|NCT02884089|100597994|FG000|COMPLETED|Period 2||8||
48110752|NCT02884089|100597995|FG001|COMPLETED|Period 2||7||
48110753|NCT02884089|100597996|FG002|COMPLETED|Period 2||9||
48110754|NCT02884089|100597997|FG003|COMPLETED|Period 2||8||
48110755|NCT02884089|100597994|FG000|NOT COMPLETED|Period 2||1||
48110756|NCT02884089|100597995|FG001|NOT COMPLETED|Period 2||0||
48110757|NCT02884089|100597996|FG002|NOT COMPLETED|Period 2||0||
48110758|NCT02884089|100597997|FG003|NOT COMPLETED|Period 2||0||
48110759|NCT02884089|100597994|FG000|STARTED|Washout Period 2||8||
48110760|NCT02884089|100597995|FG001|STARTED|Washout Period 2||7||
48110761|NCT02884089|100597996|FG002|STARTED|Washout Period 2||9||
48110762|NCT02884089|100597997|FG003|STARTED|Washout Period 2||8||
48110763|NCT02884089|100597994|FG000|COMPLETED|Washout Period 2||8||
48110764|NCT02884089|100597995|FG001|COMPLETED|Washout Period 2||7||
48110765|NCT02884089|100597996|FG002|COMPLETED|Washout Period 2||9||
48110766|NCT02884089|100597997|FG003|COMPLETED|Washout Period 2||8||
48110767|NCT02884089|100597994|FG000|NOT COMPLETED|Washout Period 2||0||
48110768|NCT02884089|100597995|FG001|NOT COMPLETED|Washout Period 2||0||
48110769|NCT02884089|100597996|FG002|NOT COMPLETED|Washout Period 2||0||
48110770|NCT02884089|100597997|FG003|NOT COMPLETED|Washout Period 2||0||
48555980|NCT03334435|101693814|FG006|NOT COMPLETED|Treatment Period 2: Week 52 to Week 200||51||
48555981|NCT03334435|101693815|FG007|NOT COMPLETED|Treatment Period 2: Week 52 to Week 200||54||
48555982|NCT03334435|101693816|FG008|NOT COMPLETED|Treatment Period 2: Week 52 to Week 200||50||
48555983|NCT03334435|101693817|FG009|NOT COMPLETED|Treatment Period 2: Week 52 to Week 200||44||
48555984|NCT03334435|101693818|FG010|NOT COMPLETED|Treatment Period 2: Week 52 to Week 200||49||
48555985|NCT03334435|101693819|FG011|NOT COMPLETED|Treatment Period 2: Week 52 to Week 200||42||
48110771|NCT02884089|100597994|FG000|STARTED|Period 3||8||
48110772|NCT02884089|100597995|FG001|STARTED|Period 3||7||
48110773|NCT02884089|100597996|FG002|STARTED|Period 3||9||
48110774|NCT02884089|100597997|FG003|STARTED|Period 3||8||
48110775|NCT02884089|100597994|FG000|COMPLETED|Period 3||8||
48110776|NCT02884089|100597995|FG001|COMPLETED|Period 3||7||
48110777|NCT02884089|100597996|FG002|COMPLETED|Period 3||8||
48110778|NCT02884089|100597997|FG003|COMPLETED|Period 3||8||
48110779|NCT02884089|100597994|FG000|NOT COMPLETED|Period 3||0||
48110780|NCT02884089|100597995|FG001|NOT COMPLETED|Period 3||0||
48110781|NCT02884089|100597996|FG002|NOT COMPLETED|Period 3||1||
48110782|NCT02884089|100597997|FG003|NOT COMPLETED|Period 3||0||
48110783|NCT02884089|100597994|FG000|STARTED|Washout Period 3||8||
48110784|NCT02884089|100597995|FG001|STARTED|Washout Period 3||7||
48110785|NCT02884089|100597996|FG002|STARTED|Washout Period 3||8||
48110786|NCT02884089|100597997|FG003|STARTED|Washout Period 3||8||
48110787|NCT02884089|100597994|FG000|COMPLETED|Washout Period 3||8||
48110788|NCT02884089|100597995|FG001|COMPLETED|Washout Period 3||7||
48110789|NCT02884089|100597996|FG002|COMPLETED|Washout Period 3||7||
48110790|NCT02884089|100597997|FG003|COMPLETED|Washout Period 3||7||
48110791|NCT02884089|100597994|FG000|NOT COMPLETED|Washout Period 3||0||
48110792|NCT02884089|100597995|FG001|NOT COMPLETED|Washout Period 3||0||
48110793|NCT02884089|100597996|FG002|NOT COMPLETED|Washout Period 3||1||
48555986|NCT03334435|101693820|FG012|NOT COMPLETED|Treatment Period 2: Week 52 to Week 200||9||
48555987|NCT03334435|101693821|FG013|NOT COMPLETED|Treatment Period 2: Week 52 to Week 200||189||
48555988|NCT03334435|101693822|FG014|NOT COMPLETED|Treatment Period 2: Week 52 to Week 200||196||
48555989|NCT01375946|101693823|FG000|STARTED|Overall Study||4||
48555990|NCT01375946|101693824|FG001|STARTED|Overall Study||4||
48555991|NCT01375946|101693825|FG002|STARTED|Overall Study||4||
48555992|NCT01375946|101693826|FG003|STARTED|Overall Study||4||
48555993|NCT01375946|101693827|FG004|STARTED|Overall Study||4||
48555994|NCT01375946|101693828|FG005|STARTED|Overall Study||4||
48555995|NCT01375946|101693823|FG000|COMPLETED|Overall Study||4||
48555996|NCT01375946|101693824|FG001|COMPLETED|Overall Study||4||
48555997|NCT01375946|101693825|FG002|COMPLETED|Overall Study||4||
48555998|NCT01375946|101693826|FG003|COMPLETED|Overall Study||4||
48110794|NCT02884089|100597997|FG003|NOT COMPLETED|Washout Period 3||1||
48110795|NCT02884089|100597994|FG000|STARTED|Period 4||8||
48110796|NCT02884089|100597995|FG001|STARTED|Period 4||7||
48110797|NCT02884089|100597996|FG002|STARTED|Period 4||7||
48110798|NCT02884089|100597997|FG003|STARTED|Period 4||7||
48110799|NCT02884089|100597994|FG000|COMPLETED|Period 4||7||
48110800|NCT02884089|100597995|FG001|COMPLETED|Period 4||6||
48110801|NCT02884089|100597996|FG002|COMPLETED|Period 4||7||
48110802|NCT02884089|100597997|FG003|COMPLETED|Period 4||7||
48110803|NCT02884089|100597994|FG000|NOT COMPLETED|Period 4||1||
48110804|NCT02884089|100597995|FG001|NOT COMPLETED|Period 4||1||
48110805|NCT02884089|100597996|FG002|NOT COMPLETED|Period 4||0||
48110806|NCT02884089|100597997|FG003|NOT COMPLETED|Period 4||0||
48110807|NCT02884089|100597994|FG000|STARTED|Follow-up Visit||7||
48110808|NCT02884089|100597995|FG001|STARTED|Follow-up Visit||6||
48110809|NCT02884089|100597996|FG002|STARTED|Follow-up Visit||7||
48110810|NCT02884089|100597997|FG003|STARTED|Follow-up Visit||7||
48110811|NCT02884089|100597994|FG000|COMPLETED|Follow-up Visit||6||
48555999|NCT01375946|101693827|FG004|COMPLETED|Overall Study||4||
48556000|NCT01375946|101693828|FG005|COMPLETED|Overall Study||4||
48556001|NCT01375946|101693823|FG000|NOT COMPLETED|Overall Study||0||
48556002|NCT01375946|101693824|FG001|NOT COMPLETED|Overall Study||0||
48110812|NCT02884089|100597995|FG001|COMPLETED|Follow-up Visit||6||
48110813|NCT02884089|100597996|FG002|COMPLETED|Follow-up Visit||7||
48110814|NCT02884089|100597997|FG003|COMPLETED|Follow-up Visit||6||
48110815|NCT02884089|100597994|FG000|NOT COMPLETED|Follow-up Visit||1||
48110816|NCT02884089|100597995|FG001|NOT COMPLETED|Follow-up Visit||0||
48110817|NCT02884089|100597996|FG002|NOT COMPLETED|Follow-up Visit||0||
48110818|NCT02884089|100597997|FG003|NOT COMPLETED|Follow-up Visit||1||
48110819|NCT03925324|100597998|FG000|STARTED|Overall Study||2||
48110820|NCT03925324|100597999|FG001|STARTED|Overall Study||2||
48110821|NCT03925324|100597998|FG000|COMPLETED|Overall Study||1||
48110822|NCT03925324|100597999|FG001|COMPLETED|Overall Study||1||
48110823|NCT03925324|100597998|FG000|NOT COMPLETED|Overall Study||1||
48110824|NCT03925324|100597999|FG001|NOT COMPLETED|Overall Study||1||
48110825|NCT02619409|100598000|FG000|STARTED|Overall Study||6||
48110826|NCT02619409|100598001|FG001|STARTED|Overall Study||6||
48110827|NCT02619409|100598002|FG002|STARTED|Overall Study||6||
48110828|NCT02619409|100598003|FG003|STARTED|Overall Study||6||
48110829|NCT02619409|100598004|FG004|STARTED|Overall Study||6||
48110830|NCT02619409|100598000|FG000|COMPLETED|Overall Study||6||
48110831|NCT02619409|100598001|FG001|COMPLETED|Overall Study||6||
48110832|NCT02619409|100598002|FG002|COMPLETED|Overall Study||6||
48110833|NCT02619409|100598003|FG003|COMPLETED|Overall Study||6||
48110834|NCT02619409|100598004|FG004|COMPLETED|Overall Study||6||
48110835|NCT02619409|100598000|FG000|NOT COMPLETED|Overall Study||0||
48110836|NCT02619409|100598001|FG001|NOT COMPLETED|Overall Study||0||
48110837|NCT02619409|100598002|FG002|NOT COMPLETED|Overall Study||0||
48110838|NCT02619409|100598003|FG003|NOT COMPLETED|Overall Study||0||
48110839|NCT02619409|100598004|FG004|NOT COMPLETED|Overall Study||0||
48110840|NCT03450707|100598005|FG000|STARTED|Overall Study||47|"93 is the total number of patients who were randomized to either thiamine or placebo:47 randomized to thiamine, 46 randomized to placebo.~But 7/47 randomized to thiamine did not receive the intervention, and 10/46 randomized to placebo did not receive the placebo, resulting in final numbers of 40 patients who received thiamine and 36 patients who received placebo.~A granular breakdown of the reasons for not having received the intervention is given in the reason not completed field."|
48110841|NCT03450707|100598006|FG001|STARTED|Overall Study||46|"93 is the total number of patients who were randomized to either thiamine or placebo:47 randomized to thiamine, 46 randomized to placebo.~But 7/47 randomized to thiamine did not receive the intervention, and 10/46 randomized to placebo did not receive the placebo, resulting in final numbers of 40 patients who received thiamine and 36 patients who received placebo.~A granular breakdown of the reasons for not having received the intervention is given in the reason not completed field."|
48110842|NCT03450707|100598005|FG000|COMPLETED|Overall Study||40||
48110843|NCT03450707|100598006|FG001|COMPLETED|Overall Study||36||
48110844|NCT03450707|100598005|FG000|NOT COMPLETED|Overall Study||7||
48110845|NCT03450707|100598006|FG001|NOT COMPLETED|Overall Study||10||
48110846|NCT03761732|100598007|FG000|STARTED|Overall Study||26||
48110847|NCT03761732|100598007|FG000|COMPLETED|Overall Study||26||
48110848|NCT03761732|100598007|FG000|NOT COMPLETED|Overall Study||0||
48110849|NCT00418691|100598008|FG000|STARTED|Overall Study||11||
48110850|NCT00418691|100598009|FG001|STARTED|Overall Study||12||
48556003|NCT01375946|101693825|FG002|NOT COMPLETED|Overall Study||0||
48556004|NCT01375946|101693826|FG003|NOT COMPLETED|Overall Study||0||
48556005|NCT01375946|101693827|FG004|NOT COMPLETED|Overall Study||0||
48556006|NCT01375946|101693828|FG005|NOT COMPLETED|Overall Study||0||
48556007|NCT01121250|101693829|FG000|STARTED|Overall Study||76||
48556008|NCT01121250|101693830|FG001|STARTED|Overall Study||76||
48556009|NCT01121250|101693831|FG002|STARTED|Overall Study||76||
48556010|NCT01121250|101693829|FG000|COMPLETED|Overall Study||76||
48556011|NCT01121250|101693830|FG001|COMPLETED|Overall Study||76||
48556012|NCT01121250|101693831|FG002|COMPLETED|Overall Study||75||
48556013|NCT01121250|101693829|FG000|NOT COMPLETED|Overall Study||0||
48556014|NCT01121250|101693830|FG001|NOT COMPLETED|Overall Study||0||
48556015|NCT01121250|101693831|FG002|NOT COMPLETED|Overall Study||1||
48556016|NCT01306305|101693832|FG000|STARTED|Overall Study||55||
48556017|NCT01306305|101693833|FG001|STARTED|Overall Study||55||
48556018|NCT01306305|101693832|FG000|COMPLETED|Overall Study||53||
48556019|NCT01306305|101693833|FG001|COMPLETED|Overall Study||55||
48556020|NCT01306305|101693832|FG000|NOT COMPLETED|Overall Study||2||
48556021|NCT01306305|101693833|FG001|NOT COMPLETED|Overall Study||0||
48556022|NCT01027702|101693834|FG000|STARTED|Overall Study||4||
48556023|NCT01027702|101693835|FG001|STARTED|Overall Study||4||
48556024|NCT01027702|101693836|FG002|STARTED|Overall Study||3||
48556025|NCT01027702|101693837|FG003|STARTED|Overall Study||14||
48556026|NCT01027702|101693838|FG004|STARTED|Overall Study||10||
48556027|NCT01027702|101693839|FG005|STARTED|Overall Study||1||
48556028|NCT01027702|101693840|FG006|STARTED|Overall Study||2||
48556029|NCT01027702|101693834|FG000|COMPLETED|Overall Study||3||
48556030|NCT01027702|101693835|FG001|COMPLETED|Overall Study||2||
48556031|NCT01027702|101693836|FG002|COMPLETED|Overall Study||2||
48556032|NCT01027702|101693837|FG003|COMPLETED|Overall Study||10||
48556033|NCT01027702|101693838|FG004|COMPLETED|Overall Study||9||
48556034|NCT01027702|101693839|FG005|COMPLETED|Overall Study||1||
48556035|NCT01027702|101693840|FG006|COMPLETED|Overall Study||1||
48110851|NCT00418691|100598010|FG002|STARTED|Overall Study||10||
48110852|NCT00418691|100598008|FG000|COMPLETED|Overall Study||9||
48110853|NCT00418691|100598009|FG001|COMPLETED|Overall Study||10||
48556036|NCT01027702|101693834|FG000|NOT COMPLETED|Overall Study||1||
48556037|NCT01027702|101693835|FG001|NOT COMPLETED|Overall Study||2||
48556038|NCT01027702|101693836|FG002|NOT COMPLETED|Overall Study||1||
48556039|NCT01027702|101693837|FG003|NOT COMPLETED|Overall Study||4||
48272967|NCT00943852|100992067|FG002|COMPLETED|Washout Period After Period 2 Treatment||1||
48272968|NCT00943852|100992068|FG003|COMPLETED|Washout Period After Period 2 Treatment||1||
48272969|NCT00943852|100992069|FG004|COMPLETED|Washout Period After Period 2 Treatment||1||
48272970|NCT00943852|100992070|FG005|COMPLETED|Washout Period After Period 2 Treatment||0||
48272971|NCT00943852|100992071|FG006|COMPLETED|Washout Period After Period 2 Treatment||2||
48272972|NCT00943852|100992072|FG007|COMPLETED|Washout Period After Period 2 Treatment||1||
48272973|NCT00943852|100992073|FG008|COMPLETED|Washout Period After Period 2 Treatment||1||
48272974|NCT00943852|100992074|FG009|COMPLETED|Washout Period After Period 2 Treatment||1||
48272975|NCT00943852|100992065|FG000|NOT COMPLETED|Washout Period After Period 2 Treatment||0||
48272976|NCT00943852|100992066|FG001|NOT COMPLETED|Washout Period After Period 2 Treatment||0||
48272977|NCT00943852|100992067|FG002|NOT COMPLETED|Washout Period After Period 2 Treatment||0||
48272978|NCT00943852|100992068|FG003|NOT COMPLETED|Washout Period After Period 2 Treatment||0||
48272979|NCT00943852|100992069|FG004|NOT COMPLETED|Washout Period After Period 2 Treatment||0||
48556040|NCT01027702|101693838|FG004|NOT COMPLETED|Overall Study||1||
48556041|NCT01027702|101693839|FG005|NOT COMPLETED|Overall Study||0||
48556042|NCT01027702|101693840|FG006|NOT COMPLETED|Overall Study||1||
48556043|NCT03223350|101693841|FG000|STARTED|Overall Study||17||
48556044|NCT03223350|101693842|FG001|STARTED|Overall Study||13||
48556045|NCT03223350|101693841|FG000|COMPLETED|Overall Study||17||
48556046|NCT03223350|101693842|FG001|COMPLETED|Overall Study||13||
48556047|NCT03223350|101693841|FG000|NOT COMPLETED|Overall Study||0||
48556048|NCT03223350|101693842|FG001|NOT COMPLETED|Overall Study||0||
48556049|NCT01750190|101693843|FG000|STARTED|Overall Study||616|Intent-to-Treat (ITT) Population: All randomized/enrolled participants.|
48556050|NCT01750190|101693844|FG001|STARTED|Overall Study||306|Intent-to-Treat (ITT) Population: All randomized/enrolled participants.|
48556051|NCT01750190|101693843|FG000|Safety Population|Overall Study||611|All randomized/enrolled participants who received at least 1 dose of study drug.|
48556052|NCT01750190|101693844|FG001|Safety Population|Overall Study||305|All randomized/enrolled participants who received at least 1 dose of study drug.|
48556053|NCT01750190|101693843|FG000|Full Analysis Set (FAS)|Overall Study||608|All randomized/enrolled participants who received at least 1 dose of study drug and have baseline and at least 1 postdose Hb assessment.|
48556054|NCT01750190|101693844|FG001|Full Analysis Set (FAS)|Overall Study||305|All randomized/enrolled participants who received at least 1 dose of study drug and have baseline and at least 1 postdose Hb assessment.|
48556055|NCT01750190|101693843|FG000|COMPLETED|Overall Study||349||
48556056|NCT01750190|101693844|FG001|COMPLETED|Overall Study||98||
48556057|NCT01750190|101693843|FG000|NOT COMPLETED|Overall Study||267||
48556058|NCT01750190|101693844|FG001|NOT COMPLETED|Overall Study||208||
48556059|NCT00661193|101693845|FG000|STARTED|Overall Study||33||
48556060|NCT00661193|101693846|FG001|STARTED|Overall Study||26||
48556061|NCT00661193|101693845|FG000|COMPLETED|Overall Study||0||
48556062|NCT00661193|101693846|FG001|COMPLETED|Overall Study||0||
48556063|NCT00661193|101693845|FG000|NOT COMPLETED|Overall Study||33||
48556064|NCT00661193|101693846|FG001|NOT COMPLETED|Overall Study||26||
48556065|NCT02263963|101693847|FG000|STARTED|Overall Study||25||
48556066|NCT02263963|101693848|FG001|STARTED|Overall Study||25||
48556067|NCT02263963|101693847|FG000|COMPLETED|Overall Study||25||
48556068|NCT02263963|101693848|FG001|COMPLETED|Overall Study||25||
48556069|NCT02263963|101693847|FG000|NOT COMPLETED|Overall Study||0||
48556070|NCT02263963|101693848|FG001|NOT COMPLETED|Overall Study||0||
48556071|NCT02435524|101693849|FG000|STARTED|Baseline Survey||1111||18
48556072|NCT02435524|101693850|FG001|STARTED|Baseline Survey||1177||19
48556073|NCT02435524|101693849|FG000|COMPLETED|Baseline Survey||1111||18
48556074|NCT02435524|101693850|FG001|COMPLETED|Baseline Survey||1177||19
48556075|NCT02435524|101693849|FG000|NOT COMPLETED|Baseline Survey||0||0
48556076|NCT02435524|101693850|FG001|NOT COMPLETED|Baseline Survey||0||0
48556077|NCT02435524|101693849|FG000|STARTED|Endline Survey||1092||18
48556078|NCT02435524|101693850|FG001|STARTED|Endline Survey||1161||19
48556079|NCT02435524|101693849|FG000|COMPLETED|Endline Survey||1092||18
48556080|NCT02435524|101693850|FG001|COMPLETED|Endline Survey||1161||19
48556081|NCT02435524|101693849|FG000|NOT COMPLETED|Endline Survey||0||0
48556082|NCT02435524|101693850|FG001|NOT COMPLETED|Endline Survey||0||0
48556083|NCT01569295|101693851|FG000|STARTED|Overall Study||207||
48556084|NCT01569295|101693852|FG001|STARTED|Overall Study||209||
48556085|NCT01569295|101693851|FG000|Long-Term Follow-up|Overall Study||109||
48556086|NCT01569295|101693852|FG001|Long-Term Follow-up|Overall Study||161||
48556087|NCT01569295|101693851|FG000|COMPLETED|Overall Study||0||
48556088|NCT01569295|101693852|FG001|COMPLETED|Overall Study||0||
48556089|NCT01569295|101693851|FG000|NOT COMPLETED|Overall Study||207||
48556090|NCT01569295|101693852|FG001|NOT COMPLETED|Overall Study||209||
48556091|NCT02288312|101693853|FG000|STARTED|Overall Study||6||
48556092|NCT02288312|101693854|FG001|STARTED|Overall Study||6||
48556093|NCT02288312|101693855|FG002|STARTED|Overall Study||6||
48556094|NCT02288312|101693853|FG000|COMPLETED|Overall Study||5||
48556095|NCT02288312|101693854|FG001|COMPLETED|Overall Study||6||
48556096|NCT02288312|101693855|FG002|COMPLETED|Overall Study||6||
48556097|NCT02288312|101693853|FG000|NOT COMPLETED|Overall Study||1||
48556098|NCT02288312|101693854|FG001|NOT COMPLETED|Overall Study||0||
48556099|NCT02288312|101693855|FG002|NOT COMPLETED|Overall Study||0||
48556100|NCT00153179|101693856|FG000|STARTED|Study Visit Day 1||10||
48393078|NCT00369967|101291500|FG000|COMPLETED|Overall Study||8||
48272980|NCT00943852|100992070|FG005|NOT COMPLETED|Washout Period After Period 2 Treatment||1||
48272981|NCT00943852|100992071|FG006|NOT COMPLETED|Washout Period After Period 2 Treatment||0||
48272982|NCT00943852|100992072|FG007|NOT COMPLETED|Washout Period After Period 2 Treatment||0||
48272983|NCT00943852|100992073|FG008|NOT COMPLETED|Washout Period After Period 2 Treatment||0||
48272984|NCT00943852|100992074|FG009|NOT COMPLETED|Washout Period After Period 2 Treatment||0||
48272985|NCT00943852|100992065|FG000|STARTED|Third Period of Treatment Intervention||2||
48272986|NCT00943852|100992066|FG001|STARTED|Third Period of Treatment Intervention||1||
48272987|NCT00943852|100992067|FG002|STARTED|Third Period of Treatment Intervention||1||
48272988|NCT00943852|100992068|FG003|STARTED|Third Period of Treatment Intervention||1||
48272989|NCT00943852|100992069|FG004|STARTED|Third Period of Treatment Intervention||1||
48272990|NCT00943852|100992070|FG005|STARTED|Third Period of Treatment Intervention||0||
48272991|NCT00943852|100992071|FG006|STARTED|Third Period of Treatment Intervention||2||
48272992|NCT00943852|100992072|FG007|STARTED|Third Period of Treatment Intervention||1||
48272993|NCT00943852|100992073|FG008|STARTED|Third Period of Treatment Intervention||1||
48272994|NCT00943852|100992074|FG009|STARTED|Third Period of Treatment Intervention||1||
48272995|NCT00943852|100992065|FG000|COMPLETED|Third Period of Treatment Intervention||2||
48272996|NCT00943852|100992066|FG001|COMPLETED|Third Period of Treatment Intervention||1||
48272997|NCT00943852|100992067|FG002|COMPLETED|Third Period of Treatment Intervention||1||
48272998|NCT00943852|100992068|FG003|COMPLETED|Third Period of Treatment Intervention||1||
48272999|NCT00943852|100992069|FG004|COMPLETED|Third Period of Treatment Intervention||1||
48273000|NCT00943852|100992070|FG005|COMPLETED|Third Period of Treatment Intervention||0||
48273001|NCT00943852|100992071|FG006|COMPLETED|Third Period of Treatment Intervention||2||
48273002|NCT00943852|100992072|FG007|COMPLETED|Third Period of Treatment Intervention||1||
48273003|NCT00943852|100992073|FG008|COMPLETED|Third Period of Treatment Intervention||1||
48273004|NCT00943852|100992074|FG009|COMPLETED|Third Period of Treatment Intervention||1||
48273005|NCT00943852|100992065|FG000|NOT COMPLETED|Third Period of Treatment Intervention||0||
48273006|NCT00943852|100992066|FG001|NOT COMPLETED|Third Period of Treatment Intervention||0||
48273007|NCT00943852|100992067|FG002|NOT COMPLETED|Third Period of Treatment Intervention||0||
48273008|NCT00943852|100992068|FG003|NOT COMPLETED|Third Period of Treatment Intervention||0||
48273009|NCT00943852|100992069|FG004|NOT COMPLETED|Third Period of Treatment Intervention||0||
48273010|NCT00943852|100992070|FG005|NOT COMPLETED|Third Period of Treatment Intervention||0||
48273011|NCT00943852|100992071|FG006|NOT COMPLETED|Third Period of Treatment Intervention||0||
48273012|NCT00943852|100992072|FG007|NOT COMPLETED|Third Period of Treatment Intervention||0||
48273013|NCT00943852|100992073|FG008|NOT COMPLETED|Third Period of Treatment Intervention||0||
48273014|NCT00943852|100992074|FG009|NOT COMPLETED|Third Period of Treatment Intervention||0||
48273015|NCT00943852|100992065|FG000|STARTED|Washout Period After Period 3 Treatment||2||
48273016|NCT00943852|100992066|FG001|STARTED|Washout Period After Period 3 Treatment||1||
48273017|NCT00943852|100992067|FG002|STARTED|Washout Period After Period 3 Treatment||1||
48273018|NCT00943852|100992068|FG003|STARTED|Washout Period After Period 3 Treatment||1||
48273019|NCT00943852|100992069|FG004|STARTED|Washout Period After Period 3 Treatment||1||
48273020|NCT00943852|100992070|FG005|STARTED|Washout Period After Period 3 Treatment||0||
48273021|NCT00943852|100992071|FG006|STARTED|Washout Period After Period 3 Treatment||2||
48273022|NCT00943852|100992072|FG007|STARTED|Washout Period After Period 3 Treatment||1||
48273023|NCT00943852|100992073|FG008|STARTED|Washout Period After Period 3 Treatment||1||
48273024|NCT00943852|100992074|FG009|STARTED|Washout Period After Period 3 Treatment||1||
48273025|NCT00943852|100992065|FG000|COMPLETED|Washout Period After Period 3 Treatment||2||
48273026|NCT00943852|100992066|FG001|COMPLETED|Washout Period After Period 3 Treatment||1||
48273027|NCT00943852|100992067|FG002|COMPLETED|Washout Period After Period 3 Treatment||1||
48273028|NCT00943852|100992068|FG003|COMPLETED|Washout Period After Period 3 Treatment||1||
48273029|NCT00943852|100992069|FG004|COMPLETED|Washout Period After Period 3 Treatment||1||
48273030|NCT00943852|100992070|FG005|COMPLETED|Washout Period After Period 3 Treatment||0||
48273031|NCT00943852|100992071|FG006|COMPLETED|Washout Period After Period 3 Treatment||1||
48273032|NCT00943852|100992072|FG007|COMPLETED|Washout Period After Period 3 Treatment||1||
48273033|NCT00943852|100992073|FG008|COMPLETED|Washout Period After Period 3 Treatment||1||
48273034|NCT00943852|100992074|FG009|COMPLETED|Washout Period After Period 3 Treatment||1||
48273035|NCT00943852|100992065|FG000|NOT COMPLETED|Washout Period After Period 3 Treatment||0||
48273036|NCT00943852|100992066|FG001|NOT COMPLETED|Washout Period After Period 3 Treatment||0||
48273037|NCT00943852|100992067|FG002|NOT COMPLETED|Washout Period After Period 3 Treatment||0||
48273038|NCT00943852|100992068|FG003|NOT COMPLETED|Washout Period After Period 3 Treatment||0||
48273039|NCT00943852|100992069|FG004|NOT COMPLETED|Washout Period After Period 3 Treatment||0||
48273040|NCT00943852|100992070|FG005|NOT COMPLETED|Washout Period After Period 3 Treatment||0||
48273041|NCT00943852|100992071|FG006|NOT COMPLETED|Washout Period After Period 3 Treatment||1||
48273042|NCT00943852|100992072|FG007|NOT COMPLETED|Washout Period After Period 3 Treatment||0||
48273043|NCT00943852|100992073|FG008|NOT COMPLETED|Washout Period After Period 3 Treatment||0||
48273044|NCT00943852|100992074|FG009|NOT COMPLETED|Washout Period After Period 3 Treatment||0||
48273045|NCT00943852|100992065|FG000|STARTED|Fourth Period of Treatment Intervention||2||
48273046|NCT00943852|100992066|FG001|STARTED|Fourth Period of Treatment Intervention||1||
48273047|NCT00943852|100992067|FG002|STARTED|Fourth Period of Treatment Intervention||1||
48273048|NCT00943852|100992068|FG003|STARTED|Fourth Period of Treatment Intervention||1||
48273049|NCT00943852|100992069|FG004|STARTED|Fourth Period of Treatment Intervention||1||
48273050|NCT00943852|100992070|FG005|STARTED|Fourth Period of Treatment Intervention||0||
48273051|NCT00943852|100992071|FG006|STARTED|Fourth Period of Treatment Intervention||1||
48273052|NCT00943852|100992072|FG007|STARTED|Fourth Period of Treatment Intervention||1||
48273053|NCT00943852|100992073|FG008|STARTED|Fourth Period of Treatment Intervention||1||
48273054|NCT00943852|100992074|FG009|STARTED|Fourth Period of Treatment Intervention||1||
48273055|NCT00943852|100992065|FG000|COMPLETED|Fourth Period of Treatment Intervention||2||
48273056|NCT00943852|100992066|FG001|COMPLETED|Fourth Period of Treatment Intervention||1||
48273057|NCT00943852|100992067|FG002|COMPLETED|Fourth Period of Treatment Intervention||1||
48273058|NCT00943852|100992068|FG003|COMPLETED|Fourth Period of Treatment Intervention||1||
48273059|NCT00943852|100992069|FG004|COMPLETED|Fourth Period of Treatment Intervention||1||
48273060|NCT00943852|100992070|FG005|COMPLETED|Fourth Period of Treatment Intervention||0||
48273061|NCT00943852|100992071|FG006|COMPLETED|Fourth Period of Treatment Intervention||1||
48273062|NCT00943852|100992072|FG007|COMPLETED|Fourth Period of Treatment Intervention||1||
48273063|NCT00943852|100992073|FG008|COMPLETED|Fourth Period of Treatment Intervention||1||
48273064|NCT00943852|100992074|FG009|COMPLETED|Fourth Period of Treatment Intervention||1||
48273065|NCT00943852|100992065|FG000|NOT COMPLETED|Fourth Period of Treatment Intervention||0||
48273066|NCT00943852|100992066|FG001|NOT COMPLETED|Fourth Period of Treatment Intervention||0||
48556101|NCT00153179|101693857|FG001|STARTED|Study Visit Day 1||8||
48110854|NCT00418691|100598010|FG002|COMPLETED|Overall Study||5||
48110855|NCT00418691|100598008|FG000|NOT COMPLETED|Overall Study||2||
48110856|NCT00418691|100598009|FG001|NOT COMPLETED|Overall Study||2||
48110857|NCT00418691|100598010|FG002|NOT COMPLETED|Overall Study||5||
48110858|NCT02806726|100598011|FG000|STARTED|Overall Study||7||14
48110859|NCT02806726|100598011|FG000|COMPLETED|Overall Study||6||12
48110860|NCT02806726|100598011|FG000|NOT COMPLETED|Overall Study||1||2
48110861|NCT00850395|100598012|FG000|STARTED|Overall Study||79||
48110862|NCT00850395|100598012|FG000|COMPLETED|Overall Study||69||
48110863|NCT00850395|100598012|FG000|NOT COMPLETED|Overall Study||10||
48110864|NCT01226719|100598013|FG000|STARTED|Overall Study||15||
48110865|NCT01226719|100598013|FG000|COMPLETED|Overall Study||2||
48110866|NCT01226719|100598013|FG000|NOT COMPLETED|Overall Study||13||
48110867|NCT02953821|100598014|FG000|STARTED|Overall Study||86||
48110868|NCT02953821|100598015|FG001|STARTED|Overall Study||86||
48110869|NCT02953821|100598014|FG000|Safety Population|Overall Study||86||
48110870|NCT02953821|100598015|FG001|Safety Population|Overall Study||86||
48110871|NCT02953821|100598014|FG000|Modified Intent to Treat (mITT) Populati|Overall Study||85||
48110872|NCT02953821|100598015|FG001|Modified Intent to Treat (mITT) Populati|Overall Study||84||
48110873|NCT02953821|100598014|FG000|Per Protocol (PP) Population|Overall Study||72||
48110874|NCT02953821|100598015|FG001|Per Protocol (PP) Population|Overall Study||75||
48110875|NCT02953821|100598014|FG000|Completed Week 16 Visit|Overall Study||76||
48110876|NCT02953821|100598015|FG001|Completed Week 16 Visit|Overall Study||77||
48110877|NCT02953821|100598014|FG000|Completed Study Treatment (Week 24)|Overall Study||73||
48110878|NCT02953821|100598015|FG001|Completed Study Treatment (Week 24)|Overall Study||76||
48110879|NCT02953821|100598014|FG000|COMPLETED|Overall Study||71|including follow-up|
48110880|NCT02953821|100598015|FG001|COMPLETED|Overall Study||73|including follow-up|
48110881|NCT02953821|100598014|FG000|NOT COMPLETED|Overall Study||15||
48110882|NCT02953821|100598015|FG001|NOT COMPLETED|Overall Study||13||
48110883|NCT02350309|100598016|FG000|STARTED|Treatment Period 1 (2 Days)||12||
48110884|NCT02350309|100598017|FG001|STARTED|Treatment Period 1 (2 Days)||11||
48110885|NCT02350309|100598018|FG002|STARTED|Treatment Period 1 (2 Days)||11||
48110886|NCT02350309|100598019|FG003|STARTED|Treatment Period 1 (2 Days)||11||
48110887|NCT02350309|100598020|FG004|STARTED|Treatment Period 1 (2 Days)||12||
48273067|NCT00943852|100992067|FG002|NOT COMPLETED|Fourth Period of Treatment Intervention||0||
48273068|NCT00943852|100992068|FG003|NOT COMPLETED|Fourth Period of Treatment Intervention||0||
48273069|NCT00943852|100992069|FG004|NOT COMPLETED|Fourth Period of Treatment Intervention||0||
48273070|NCT00943852|100992070|FG005|NOT COMPLETED|Fourth Period of Treatment Intervention||0||
48273071|NCT00943852|100992071|FG006|NOT COMPLETED|Fourth Period of Treatment Intervention||0||
48273072|NCT00943852|100992072|FG007|NOT COMPLETED|Fourth Period of Treatment Intervention||0||
48273073|NCT00943852|100992073|FG008|NOT COMPLETED|Fourth Period of Treatment Intervention||0||
48556102|NCT00153179|101693858|FG002|STARTED|Study Visit Day 1||13||
48556103|NCT00153179|101693859|FG003|STARTED|Study Visit Day 1||9||
48556104|NCT00153179|101693856|FG000|COMPLETED|Study Visit Day 1||10||
48556105|NCT00153179|101693857|FG001|COMPLETED|Study Visit Day 1||8||
48556106|NCT00153179|101693858|FG002|COMPLETED|Study Visit Day 1||13||
48556107|NCT00153179|101693859|FG003|COMPLETED|Study Visit Day 1||9||
48556108|NCT00153179|101693856|FG000|NOT COMPLETED|Study Visit Day 1||0||
48556109|NCT00153179|101693857|FG001|NOT COMPLETED|Study Visit Day 1||0||
48110888|NCT02350309|100598021|FG005|STARTED|Treatment Period 1 (2 Days)||12||
48110889|NCT02350309|100598016|FG000|COMPLETED|Treatment Period 1 (2 Days)||12||
48556110|NCT00153179|101693858|FG002|NOT COMPLETED|Study Visit Day 1||0||
48556111|NCT00153179|101693859|FG003|NOT COMPLETED|Study Visit Day 1||0||
48110890|NCT02350309|100598017|FG001|COMPLETED|Treatment Period 1 (2 Days)||11||
48110891|NCT02350309|100598018|FG002|COMPLETED|Treatment Period 1 (2 Days)||10||
48694095|NCT01188551|102036299|FG002|NOT COMPLETED|Overall Study||0||
48694096|NCT01188551|102036300|FG003|NOT COMPLETED|Overall Study||0||
48694097|NCT03470740|102036301|FG000|STARTED|Overall Study||112||
48694098|NCT03470740|102036302|FG001|STARTED|Overall Study||112||
48694099|NCT03470740|102036301|FG000|COMPLETED|Overall Study||108||
48694100|NCT03470740|102036302|FG001|COMPLETED|Overall Study||106||
48694101|NCT03470740|102036301|FG000|NOT COMPLETED|Overall Study||4||
48694102|NCT03470740|102036302|FG001|NOT COMPLETED|Overall Study||6||
48694103|NCT03177512|102036303|FG000|STARTED|Overall Study||40||
48694104|NCT03177512|102036304|FG001|STARTED|Overall Study||21||
48694105|NCT03177512|102036303|FG000|COMPLETED|Overall Study||31||
48694106|NCT03177512|102036304|FG001|COMPLETED|Overall Study||18||
48694107|NCT03177512|102036303|FG000|NOT COMPLETED|Overall Study||9||
48694108|NCT03177512|102036304|FG001|NOT COMPLETED|Overall Study||3||
48694109|NCT01849692|102036305|FG000|STARTED|Overall Study||10||
48694110|NCT01849692|102036306|FG001|STARTED|Overall Study||3||
48273074|NCT00943852|100992074|FG009|NOT COMPLETED|Fourth Period of Treatment Intervention||0||
48273075|NCT00943852|100992065|FG000|STARTED|Washout Period After Period 4 Treatment||2||
48273076|NCT00943852|100992066|FG001|STARTED|Washout Period After Period 4 Treatment||1||
48273077|NCT00943852|100992067|FG002|STARTED|Washout Period After Period 4 Treatment||1||
48273078|NCT00943852|100992068|FG003|STARTED|Washout Period After Period 4 Treatment||1||
48273079|NCT00943852|100992069|FG004|STARTED|Washout Period After Period 4 Treatment||1||
48273080|NCT00943852|100992070|FG005|STARTED|Washout Period After Period 4 Treatment||0||
48273081|NCT00943852|100992071|FG006|STARTED|Washout Period After Period 4 Treatment||1||
48273082|NCT00943852|100992072|FG007|STARTED|Washout Period After Period 4 Treatment||1||
48273083|NCT00943852|100992073|FG008|STARTED|Washout Period After Period 4 Treatment||1||
48273084|NCT00943852|100992074|FG009|STARTED|Washout Period After Period 4 Treatment||1||
48273085|NCT00943852|100992065|FG000|COMPLETED|Washout Period After Period 4 Treatment||1||
48273086|NCT00943852|100992066|FG001|COMPLETED|Washout Period After Period 4 Treatment||1||
48110892|NCT02350309|100598019|FG003|COMPLETED|Treatment Period 1 (2 Days)||11||
48110893|NCT02350309|100598020|FG004|COMPLETED|Treatment Period 1 (2 Days)||12||
48110894|NCT02350309|100598021|FG005|COMPLETED|Treatment Period 1 (2 Days)||12||
48393079|NCT00369967|101291501|FG001|COMPLETED|Overall Study||5||
48694111|NCT01849692|102036307|FG002|STARTED|Overall Study||10||
48694112|NCT01849692|102036308|FG003|STARTED|Overall Study||3||
48110895|NCT02350309|100598016|FG000|NOT COMPLETED|Treatment Period 1 (2 Days)||0||
48110896|NCT02350309|100598017|FG001|NOT COMPLETED|Treatment Period 1 (2 Days)||0||
48110897|NCT02350309|100598018|FG002|NOT COMPLETED|Treatment Period 1 (2 Days)||1||
48110898|NCT02350309|100598019|FG003|NOT COMPLETED|Treatment Period 1 (2 Days)||0||
48110899|NCT02350309|100598020|FG004|NOT COMPLETED|Treatment Period 1 (2 Days)||0||
48110900|NCT02350309|100598021|FG005|NOT COMPLETED|Treatment Period 1 (2 Days)||0||
48110901|NCT02350309|100598016|FG000|STARTED|Washout Period 1 (12-16 Days)||12||
48110902|NCT02350309|100598017|FG001|STARTED|Washout Period 1 (12-16 Days)||11||
48110903|NCT02350309|100598018|FG002|STARTED|Washout Period 1 (12-16 Days)||10||
48110904|NCT02350309|100598019|FG003|STARTED|Washout Period 1 (12-16 Days)||11||
48110905|NCT02350309|100598020|FG004|STARTED|Washout Period 1 (12-16 Days)||12||
48110906|NCT02350309|100598021|FG005|STARTED|Washout Period 1 (12-16 Days)||12||
48110907|NCT02350309|100598016|FG000|COMPLETED|Washout Period 1 (12-16 Days)||12||
48110908|NCT02350309|100598017|FG001|COMPLETED|Washout Period 1 (12-16 Days)||11||
48110909|NCT02350309|100598018|FG002|COMPLETED|Washout Period 1 (12-16 Days)||10||
48110910|NCT02350309|100598019|FG003|COMPLETED|Washout Period 1 (12-16 Days)||11||
48273087|NCT00943852|100992067|FG002|COMPLETED|Washout Period After Period 4 Treatment||0||
48273088|NCT00943852|100992068|FG003|COMPLETED|Washout Period After Period 4 Treatment||0||
48273089|NCT00943852|100992069|FG004|COMPLETED|Washout Period After Period 4 Treatment||1||
48273090|NCT00943852|100992070|FG005|COMPLETED|Washout Period After Period 4 Treatment||0||
48273091|NCT00943852|100992071|FG006|COMPLETED|Washout Period After Period 4 Treatment||0||
48273092|NCT00943852|100992072|FG007|COMPLETED|Washout Period After Period 4 Treatment||0||
48694113|NCT01849692|102036309|FG004|STARTED|Overall Study||10||
48694114|NCT01849692|102036310|FG005|STARTED|Overall Study||3||
48694115|NCT01849692|102036311|FG006|STARTED|Overall Study||10||
48694116|NCT01849692|102036312|FG007|STARTED|Overall Study||3||
48273093|NCT00943852|100992073|FG008|COMPLETED|Washout Period After Period 4 Treatment||1||
48273094|NCT00943852|100992074|FG009|COMPLETED|Washout Period After Period 4 Treatment||1||
48273095|NCT00943852|100992065|FG000|NOT COMPLETED|Washout Period After Period 4 Treatment||1||
48273096|NCT00943852|100992066|FG001|NOT COMPLETED|Washout Period After Period 4 Treatment||0||
48273097|NCT00943852|100992067|FG002|NOT COMPLETED|Washout Period After Period 4 Treatment||1||
48273098|NCT00943852|100992068|FG003|NOT COMPLETED|Washout Period After Period 4 Treatment||1||
48393080|NCT00369967|101291500|FG000|NOT COMPLETED|Overall Study||23||
48694117|NCT01849692|102036305|FG000|COMPLETED|Overall Study||10||
48694118|NCT01849692|102036306|FG001|COMPLETED|Overall Study||3||
48694119|NCT01849692|102036307|FG002|COMPLETED|Overall Study||10||
48694120|NCT01849692|102036308|FG003|COMPLETED|Overall Study||3||
48694121|NCT01849692|102036309|FG004|COMPLETED|Overall Study||10||
48694122|NCT01849692|102036310|FG005|COMPLETED|Overall Study||3||
48694123|NCT01849692|102036311|FG006|COMPLETED|Overall Study||10||
48694124|NCT01849692|102036312|FG007|COMPLETED|Overall Study||3||
48694125|NCT01849692|102036305|FG000|NOT COMPLETED|Overall Study||0||
48694126|NCT01849692|102036306|FG001|NOT COMPLETED|Overall Study||0||
48694127|NCT01849692|102036307|FG002|NOT COMPLETED|Overall Study||0||
48694128|NCT01849692|102036308|FG003|NOT COMPLETED|Overall Study||0||
48694129|NCT01849692|102036309|FG004|NOT COMPLETED|Overall Study||0||
48694130|NCT01849692|102036310|FG005|NOT COMPLETED|Overall Study||0||
48694131|NCT01849692|102036311|FG006|NOT COMPLETED|Overall Study||0||
48694132|NCT01849692|102036312|FG007|NOT COMPLETED|Overall Study||0||
48694133|NCT02798315|102036313|FG000|STARTED|Overall Study||40||
48694134|NCT02798315|102036313|FG000|COMPLETED|Overall Study||39||
48694135|NCT02798315|102036313|FG000|NOT COMPLETED|Overall Study||1||
48694136|NCT05445921|102036314|FG000|STARTED|Overall Study||20||
48694137|NCT05445921|102036314|FG000|COMPLETED|Overall Study||20||
48694138|NCT05445921|102036314|FG000|NOT COMPLETED|Overall Study||0||
48694139|NCT04644276|102036315|FG000|STARTED|Overall Study||2||
48694140|NCT04644276|102036316|FG001|STARTED|Overall Study||3||
48694141|NCT04644276|102036317|FG002|STARTED|Overall Study||2||
48694142|NCT04644276|102036315|FG000|COMPLETED|Overall Study||2||
48694143|NCT04644276|102036316|FG001|COMPLETED|Overall Study||3||
48694144|NCT04644276|102036317|FG002|COMPLETED|Overall Study||1||
48694145|NCT04644276|102036315|FG000|NOT COMPLETED|Overall Study||0||
48694146|NCT04644276|102036316|FG001|NOT COMPLETED|Overall Study||0||
48694147|NCT04644276|102036317|FG002|NOT COMPLETED|Overall Study||1||
48694148|NCT01437111|102036318|FG000|STARTED|Overall Study||200||
48694149|NCT01437111|102036318|FG000|Treated Participants|Overall Study||198||
48694150|NCT01437111|102036318|FG000|COMPLETED|Overall Study||182||
48694151|NCT01437111|102036318|FG000|NOT COMPLETED|Overall Study||18||
48694152|NCT02817594|102036319|FG000|STARTED|Overall Study||51||
48694153|NCT02817594|102036319|FG000|Received Treatment|Overall Study||50||
48694154|NCT02817594|102036319|FG000|COMPLETED|Overall Study||48|Completed defined as having an HCV RNA assessment performed at least 10 weeks post-treatment|
48694155|NCT02817594|102036319|FG000|NOT COMPLETED|Overall Study||3||
48694156|NCT02858440|102036320|FG000|STARTED|Overall Study||235||
48694157|NCT02858440|102036320|FG000|COMPLETED|Overall Study||223||
48694158|NCT02858440|102036320|FG000|NOT COMPLETED|Overall Study||12||
48694159|NCT00807586|102036321|FG000|STARTED|Overall Study||60||
48694160|NCT00807586|102036322|FG001|STARTED|Overall Study||59||
48694161|NCT00807586|102036321|FG000|COMPLETED|Overall Study||54||
48694162|NCT00807586|102036322|FG001|COMPLETED|Overall Study||58||
48694163|NCT00807586|102036321|FG000|NOT COMPLETED|Overall Study||6||
48694164|NCT00807586|102036322|FG001|NOT COMPLETED|Overall Study||1||
48694165|NCT00005947|102036323|FG000|STARTED|Overall Study||82||
48694166|NCT00005947|102036324|FG001|STARTED|Overall Study||45||
48694167|NCT00005947|102036323|FG000|COMPLETED|Overall Study||25||
48694168|NCT00005947|102036324|FG001|COMPLETED|Overall Study||4||
48694169|NCT00005947|102036323|FG000|NOT COMPLETED|Overall Study||57||
48694170|NCT00005947|102036324|FG001|NOT COMPLETED|Overall Study||41||
48694171|NCT03818607|102036325|FG000|STARTED|Period 1 (Week 1 to Week 52)||20||
48694172|NCT03818607|102036326|FG001|STARTED|Period 1 (Week 1 to Week 52)||22||
48694173|NCT03818607|102036325|FG000|Participants Treated|Period 1 (Week 1 to Week 52)||20||
48694174|NCT03818607|102036326|FG001|Participants Treated|Period 1 (Week 1 to Week 52)||22||
48694175|NCT03818607|102036325|FG000|COMPLETED|Period 1 (Week 1 to Week 52)||20||
48694176|NCT03818607|102036326|FG001|COMPLETED|Period 1 (Week 1 to Week 52)||21||
48694177|NCT03818607|102036325|FG000|NOT COMPLETED|Period 1 (Week 1 to Week 52)||0||
48273099|NCT00943852|100992069|FG004|NOT COMPLETED|Washout Period After Period 4 Treatment||0||
48273100|NCT00943852|100992070|FG005|NOT COMPLETED|Washout Period After Period 4 Treatment||0||
48273101|NCT00943852|100992071|FG006|NOT COMPLETED|Washout Period After Period 4 Treatment||1||
48273102|NCT00943852|100992072|FG007|NOT COMPLETED|Washout Period After Period 4 Treatment||1||
48273103|NCT00943852|100992073|FG008|NOT COMPLETED|Washout Period After Period 4 Treatment||0||
48694178|NCT03818607|102036326|FG001|NOT COMPLETED|Period 1 (Week 1 to Week 52)||1||
48694179|NCT03818607|102036325|FG000|STARTED|Period 2 (Week 53 to Week 79)||20||
48694180|NCT03818607|102036326|FG001|STARTED|Period 2 (Week 53 to Week 79)||21||
48694181|NCT03818607|102036325|FG000|Participants Treated|Period 2 (Week 53 to Week 79)||20||
48694182|NCT03818607|102036326|FG001|Participants Treated|Period 2 (Week 53 to Week 79)||21||
48694183|NCT03818607|102036325|FG000|COMPLETED|Period 2 (Week 53 to Week 79)||19||
48694184|NCT03818607|102036326|FG001|COMPLETED|Period 2 (Week 53 to Week 79)||20||
48694185|NCT03818607|102036325|FG000|NOT COMPLETED|Period 2 (Week 53 to Week 79)||1||
48694186|NCT03818607|102036326|FG001|NOT COMPLETED|Period 2 (Week 53 to Week 79)||1||
48694187|NCT03994211|102036327|FG000|STARTED|Core Phase||12||
48694188|NCT03994211|102036328|FG001|STARTED|Core Phase||13||
48694189|NCT03994211|102036329|FG002|STARTED|Core Phase||0||
48694190|NCT03994211|102036327|FG000|COMPLETED|Core Phase||12||
48694191|NCT03994211|102036328|FG001|COMPLETED|Core Phase||12||
48694192|NCT03994211|102036329|FG002|COMPLETED|Core Phase||0||
48694193|NCT03994211|102036327|FG000|NOT COMPLETED|Core Phase||0||
48694194|NCT03994211|102036328|FG001|NOT COMPLETED|Core Phase||1||
48694195|NCT03994211|102036329|FG002|NOT COMPLETED|Core Phase||0||
48694196|NCT03994211|102036327|FG000|STARTED|Extension Phase||0||
48694197|NCT03994211|102036328|FG001|STARTED|Extension Phase||0||
48694198|NCT03994211|102036329|FG002|STARTED|Extension Phase||24||
48694199|NCT03994211|102036327|FG000|COMPLETED|Extension Phase||0||
48694200|NCT03994211|102036328|FG001|COMPLETED|Extension Phase||0||
48694201|NCT03994211|102036329|FG002|COMPLETED|Extension Phase||0||
48694202|NCT03994211|102036327|FG000|NOT COMPLETED|Extension Phase||0||
48110911|NCT02350309|100598020|FG004|COMPLETED|Washout Period 1 (12-16 Days)||12||
48110912|NCT02350309|100598021|FG005|COMPLETED|Washout Period 1 (12-16 Days)||12||
48110913|NCT02350309|100598016|FG000|NOT COMPLETED|Washout Period 1 (12-16 Days)||0||
48110914|NCT02350309|100598017|FG001|NOT COMPLETED|Washout Period 1 (12-16 Days)||0||
48110915|NCT02350309|100598018|FG002|NOT COMPLETED|Washout Period 1 (12-16 Days)||0||
48110916|NCT02350309|100598019|FG003|NOT COMPLETED|Washout Period 1 (12-16 Days)||0||
48110917|NCT02350309|100598020|FG004|NOT COMPLETED|Washout Period 1 (12-16 Days)||0||
48110918|NCT02350309|100598021|FG005|NOT COMPLETED|Washout Period 1 (12-16 Days)||0||
48110919|NCT02350309|100598016|FG000|STARTED|Treatment Period 2 (2 Days)||12||
48110920|NCT02350309|100598017|FG001|STARTED|Treatment Period 2 (2 Days)||11||
48110921|NCT02350309|100598018|FG002|STARTED|Treatment Period 2 (2 Days)||10||
48110922|NCT02350309|100598019|FG003|STARTED|Treatment Period 2 (2 Days)||11||
48110923|NCT02350309|100598020|FG004|STARTED|Treatment Period 2 (2 Days)||12||
48273104|NCT00943852|100992074|FG009|NOT COMPLETED|Washout Period After Period 4 Treatment||0||
48273105|NCT00943852|100992065|FG000|STARTED|Fifth Period of Treatment Intervention||1||
48273106|NCT00943852|100992066|FG001|STARTED|Fifth Period of Treatment Intervention||1||
48556112|NCT00153179|101693856|FG000|STARTED|Study Visit Day 2||10||
48556113|NCT00153179|101693857|FG001|STARTED|Study Visit Day 2||8||
48556114|NCT00153179|101693858|FG002|STARTED|Study Visit Day 2||13||
48556115|NCT00153179|101693859|FG003|STARTED|Study Visit Day 2||9||
48556116|NCT00153179|101693856|FG000|COMPLETED|Study Visit Day 2||9||
48556117|NCT00153179|101693857|FG001|COMPLETED|Study Visit Day 2||8||
48556118|NCT00153179|101693858|FG002|COMPLETED|Study Visit Day 2||11||
48556119|NCT00153179|101693859|FG003|COMPLETED|Study Visit Day 2||7||
48556120|NCT00153179|101693856|FG000|NOT COMPLETED|Study Visit Day 2||1||
48556121|NCT00153179|101693857|FG001|NOT COMPLETED|Study Visit Day 2||0||
48556122|NCT00153179|101693858|FG002|NOT COMPLETED|Study Visit Day 2||2||
48556123|NCT00153179|101693859|FG003|NOT COMPLETED|Study Visit Day 2||2||
48556124|NCT02618759|101693860|FG000|STARTED|Overall Study||60||
48556125|NCT02618759|101693861|FG001|STARTED|Overall Study||59||
48556126|NCT02618759|101693860|FG000|COMPLETED|Overall Study||58||
48556127|NCT02618759|101693861|FG001|COMPLETED|Overall Study||54||
48556128|NCT02618759|101693860|FG000|NOT COMPLETED|Overall Study||2||
48556129|NCT02618759|101693861|FG001|NOT COMPLETED|Overall Study||5||
48556130|NCT01565356|101693862|FG000|STARTED|Overall Study||41||
48556131|NCT01565356|101693862|FG000|COMPLETED|Overall Study||41||
48556132|NCT01565356|101693862|FG000|NOT COMPLETED|Overall Study||0||
48556133|NCT02064296|101693863|FG000|STARTED|Eligibility to Baseline Data Collection||27||
48556134|NCT02064296|101693864|FG001|STARTED|Eligibility to Baseline Data Collection||39||
48556135|NCT02064296|101693865|FG002|STARTED|Eligibility to Baseline Data Collection||40||
48556136|NCT02064296|101693863|FG000|COMPLETED|Eligibility to Baseline Data Collection||26||
48110924|NCT02350309|100598021|FG005|STARTED|Treatment Period 2 (2 Days)||12||
48110925|NCT02350309|100598016|FG000|COMPLETED|Treatment Period 2 (2 Days)||12||
48110926|NCT02350309|100598017|FG001|COMPLETED|Treatment Period 2 (2 Days)||11||
48110927|NCT02350309|100598018|FG002|COMPLETED|Treatment Period 2 (2 Days)||10||
48110928|NCT02350309|100598019|FG003|COMPLETED|Treatment Period 2 (2 Days)||11||
48110929|NCT02350309|100598020|FG004|COMPLETED|Treatment Period 2 (2 Days)||12||
48273107|NCT00943852|100992067|FG002|STARTED|Fifth Period of Treatment Intervention||0||
48556137|NCT02064296|101693864|FG001|COMPLETED|Eligibility to Baseline Data Collection||39||
48556138|NCT02064296|101693865|FG002|COMPLETED|Eligibility to Baseline Data Collection||40||
48556139|NCT02064296|101693863|FG000|NOT COMPLETED|Eligibility to Baseline Data Collection||1||
48556140|NCT02064296|101693864|FG001|NOT COMPLETED|Eligibility to Baseline Data Collection||0||
48592737|NCT02678000|101783171|FG003|COMPLETED|PART 1||0||
48694203|NCT03994211|102036328|FG001|NOT COMPLETED|Extension Phase||0||
48694204|NCT03994211|102036329|FG002|NOT COMPLETED|Extension Phase||24||
48694205|NCT05081167|102036330|FG000|STARTED|Overall Study||116||
48694206|NCT05081167|102036331|FG001|STARTED|Overall Study||116||
48694207|NCT05081167|102036330|FG000|COMPLETED|Overall Study||108||
48694208|NCT05081167|102036331|FG001|COMPLETED|Overall Study||102||
48273108|NCT00943852|100992068|FG003|STARTED|Fifth Period of Treatment Intervention||0||
48110930|NCT02350309|100598021|FG005|COMPLETED|Treatment Period 2 (2 Days)||12||
48110931|NCT02350309|100598016|FG000|NOT COMPLETED|Treatment Period 2 (2 Days)||0||
48110932|NCT02350309|100598017|FG001|NOT COMPLETED|Treatment Period 2 (2 Days)||0||
48110933|NCT02350309|100598018|FG002|NOT COMPLETED|Treatment Period 2 (2 Days)||0||
48110934|NCT02350309|100598019|FG003|NOT COMPLETED|Treatment Period 2 (2 Days)||0||
48110935|NCT02350309|100598020|FG004|NOT COMPLETED|Treatment Period 2 (2 Days)||0||
48110936|NCT02350309|100598021|FG005|NOT COMPLETED|Treatment Period 2 (2 Days)||0||
48110937|NCT02350309|100598016|FG000|STARTED|Washout Period 2 (12-16 Days)||12||
48110938|NCT02350309|100598017|FG001|STARTED|Washout Period 2 (12-16 Days)||11||
48110939|NCT02350309|100598018|FG002|STARTED|Washout Period 2 (12-16 Days)||10||
48110940|NCT02350309|100598019|FG003|STARTED|Washout Period 2 (12-16 Days)||11||
48110941|NCT02350309|100598020|FG004|STARTED|Washout Period 2 (12-16 Days)||12||
48110942|NCT02350309|100598021|FG005|STARTED|Washout Period 2 (12-16 Days)||12||
48110943|NCT02350309|100598016|FG000|COMPLETED|Washout Period 2 (12-16 Days)||12||
48110944|NCT02350309|100598017|FG001|COMPLETED|Washout Period 2 (12-16 Days)||11||
48694209|NCT05081167|102036330|FG000|NOT COMPLETED|Overall Study||8||
48694210|NCT05081167|102036331|FG001|NOT COMPLETED|Overall Study||14||
48694211|NCT02591537|102036332|FG000|STARTED|Overall Study||8||32
48694212|NCT02591537|102036333|FG001|STARTED|Overall Study||8||32
48694213|NCT02591537|102036332|FG000|COMPLETED|Overall Study||8||32
48694214|NCT02591537|102036333|FG001|COMPLETED|Overall Study||8||32
48694215|NCT02591537|102036332|FG000|NOT COMPLETED|Overall Study||0||0
48694216|NCT02591537|102036333|FG001|NOT COMPLETED|Overall Study||0||0
48694217|NCT05040971|102036334|FG000|STARTED|Overall Study||138||
48694218|NCT05040971|102036335|FG001|STARTED|Overall Study||69||
48694219|NCT05040971|102036334|FG000|Full Analysis Set (FAS)|Overall Study||138||
48694220|NCT05040971|102036335|FG001|Full Analysis Set (FAS)|Overall Study||69||
48694221|NCT05040971|102036334|FG000|Safety Analysis Set (SAS)|Overall Study||138||
48694222|NCT05040971|102036335|FG001|Safety Analysis Set (SAS)|Overall Study||69||
48694223|NCT05040971|102036334|FG000|COMPLETED|Overall Study||128||
48694224|NCT05040971|102036335|FG001|COMPLETED|Overall Study||64||
48694225|NCT05040971|102036334|FG000|NOT COMPLETED|Overall Study||10||
48694226|NCT05040971|102036335|FG001|NOT COMPLETED|Overall Study||5||
48694227|NCT02091362|102036336|FG000|STARTED|Period 1||133||
48694228|NCT02091362|102036337|FG001|STARTED|Period 1||137||
48694229|NCT02091362|102036336|FG000|COMPLETED|Period 1||128||
48694230|NCT02091362|102036337|FG001|COMPLETED|Period 1||133||
48694231|NCT02091362|102036336|FG000|NOT COMPLETED|Period 1||5||
48694232|NCT02091362|102036337|FG001|NOT COMPLETED|Period 1||4||
48694233|NCT02091362|102036336|FG000|STARTED|Wash-out||128||
48694234|NCT02091362|102036337|FG001|STARTED|Wash-out||133||
48694235|NCT02091362|102036336|FG000|COMPLETED|Wash-out||127||
48694236|NCT02091362|102036337|FG001|COMPLETED|Wash-out||130||
48694237|NCT02091362|102036336|FG000|NOT COMPLETED|Wash-out||1||
48694238|NCT02091362|102036337|FG001|NOT COMPLETED|Wash-out||3||
48694239|NCT02091362|102036336|FG000|STARTED|Period 2||127||
48694240|NCT02091362|102036337|FG001|STARTED|Period 2||130||
48694241|NCT02091362|102036336|FG000|COMPLETED|Period 2||125||
48110945|NCT02350309|100598018|FG002|COMPLETED|Washout Period 2 (12-16 Days)||10||
48110946|NCT02350309|100598019|FG003|COMPLETED|Washout Period 2 (12-16 Days)||11||
48110947|NCT02350309|100598020|FG004|COMPLETED|Washout Period 2 (12-16 Days)||12||
48110948|NCT02350309|100598021|FG005|COMPLETED|Washout Period 2 (12-16 Days)||12||
48110949|NCT02350309|100598016|FG000|NOT COMPLETED|Washout Period 2 (12-16 Days)||0||
48110950|NCT02350309|100598017|FG001|NOT COMPLETED|Washout Period 2 (12-16 Days)||0||
48110951|NCT02350309|100598018|FG002|NOT COMPLETED|Washout Period 2 (12-16 Days)||0||
48110952|NCT02350309|100598019|FG003|NOT COMPLETED|Washout Period 2 (12-16 Days)||0||
48110953|NCT02350309|100598020|FG004|NOT COMPLETED|Washout Period 2 (12-16 Days)||0||
48110954|NCT02350309|100598021|FG005|NOT COMPLETED|Washout Period 2 (12-16 Days)||0||
48110955|NCT02350309|100598016|FG000|STARTED|Treatment Period 3 (2 Days)||12||
48110956|NCT02350309|100598017|FG001|STARTED|Treatment Period 3 (2 Days)||11||
48110957|NCT02350309|100598018|FG002|STARTED|Treatment Period 3 (2 Days)||10||
48110958|NCT02350309|100598019|FG003|STARTED|Treatment Period 3 (2 Days)||11||
48110959|NCT02350309|100598020|FG004|STARTED|Treatment Period 3 (2 Days)||12||
48110960|NCT02350309|100598021|FG005|STARTED|Treatment Period 3 (2 Days)||12||
48110961|NCT02350309|100598016|FG000|COMPLETED|Treatment Period 3 (2 Days)||12||
48110962|NCT02350309|100598017|FG001|COMPLETED|Treatment Period 3 (2 Days)||11||
48110963|NCT02350309|100598018|FG002|COMPLETED|Treatment Period 3 (2 Days)||10||
48694242|NCT02091362|102036337|FG001|COMPLETED|Period 2||128||
48694243|NCT02091362|102036336|FG000|NOT COMPLETED|Period 2||2||
48694244|NCT02091362|102036337|FG001|NOT COMPLETED|Period 2||2||
48694245|NCT00889603|102036338|FG000|STARTED|Overall Study||370||
48694246|NCT00889603|102036338|FG000|COMPLETED|Overall Study||333||
48694247|NCT00889603|102036338|FG000|NOT COMPLETED|Overall Study||37||
48694248|NCT02438683|102036339|FG000|STARTED|Overall Study||4||
48694249|NCT02438683|102036340|FG001|STARTED|Overall Study||3||
48694250|NCT02438683|102036341|FG002|STARTED|Overall Study||2||
48694251|NCT02438683|102036342|FG003|STARTED|Overall Study||3||
48694252|NCT02438683|102036343|FG004|STARTED|Overall Study||4||
48694253|NCT02438683|102036344|FG005|STARTED|Overall Study||4||
48694254|NCT02438683|102036339|FG000|COMPLETED|Overall Study||3||
48694255|NCT02438683|102036340|FG001|COMPLETED|Overall Study||3||
48273109|NCT00943852|100992069|FG004|STARTED|Fifth Period of Treatment Intervention||1||
48273110|NCT00943852|100992070|FG005|STARTED|Fifth Period of Treatment Intervention||0||
48273111|NCT00943852|100992071|FG006|STARTED|Fifth Period of Treatment Intervention||0||
48273112|NCT00943852|100992072|FG007|STARTED|Fifth Period of Treatment Intervention||0||
48273113|NCT00943852|100992073|FG008|STARTED|Fifth Period of Treatment Intervention||1||
48273114|NCT00943852|100992074|FG009|STARTED|Fifth Period of Treatment Intervention||1||
48273115|NCT00943852|100992065|FG000|COMPLETED|Fifth Period of Treatment Intervention||1||
48393081|NCT00369967|101291501|FG001|NOT COMPLETED|Overall Study||12||
48393082|NCT03920865|101291502|FG000|STARTED|Overall Study||8||
48556141|NCT02064296|101693865|FG002|NOT COMPLETED|Eligibility to Baseline Data Collection||0||
48556142|NCT02064296|101693863|FG000|STARTED|Baseline Data Collection||26||
48556143|NCT02064296|101693864|FG001|STARTED|Baseline Data Collection||39||
48556144|NCT02064296|101693865|FG002|STARTED|Baseline Data Collection||40||
48556145|NCT02064296|101693863|FG000|COMPLETED|Baseline Data Collection||26||
48556146|NCT02064296|101693864|FG001|COMPLETED|Baseline Data Collection||39||
48556147|NCT02064296|101693865|FG002|COMPLETED|Baseline Data Collection||40||
48556148|NCT02064296|101693863|FG000|NOT COMPLETED|Baseline Data Collection||0||
48556149|NCT02064296|101693864|FG001|NOT COMPLETED|Baseline Data Collection||0||
48556150|NCT02064296|101693865|FG002|NOT COMPLETED|Baseline Data Collection||0||
48556151|NCT02064296|101693863|FG000|STARTED|Intervention||0||
48556152|NCT02064296|101693864|FG001|STARTED|Intervention||39||
48556153|NCT02064296|101693865|FG002|STARTED|Intervention||40||
48556154|NCT02064296|101693863|FG000|COMPLETED|Intervention||0||
48556155|NCT02064296|101693864|FG001|COMPLETED|Intervention||38||
48556156|NCT02064296|101693865|FG002|COMPLETED|Intervention||38||
48556157|NCT02064296|101693863|FG000|NOT COMPLETED|Intervention||0||
48556158|NCT02064296|101693864|FG001|NOT COMPLETED|Intervention||1||
48556159|NCT02064296|101693865|FG002|NOT COMPLETED|Intervention||2||
48556160|NCT03817190|101693866|FG000|STARTED|Overall Study||110||
48556161|NCT03817190|101693867|FG001|STARTED|Overall Study||109||
48556162|NCT03817190|101693866|FG000|COMPLETED|Overall Study||50||
48556163|NCT03817190|101693867|FG001|COMPLETED|Overall Study||50||
48556164|NCT03817190|101693866|FG000|NOT COMPLETED|Overall Study||60||
48556165|NCT03817190|101693867|FG001|NOT COMPLETED|Overall Study||59||
48556166|NCT01200069|101693868|FG000|STARTED|Overall Study||8||
48556167|NCT01200069|101693869|FG001|STARTED|Overall Study||6||
48556168|NCT01200069|101693868|FG000|COMPLETED|Overall Study||8||
48556169|NCT01200069|101693869|FG001|COMPLETED|Overall Study||5||
48556170|NCT01200069|101693868|FG000|NOT COMPLETED|Overall Study||0||
48556171|NCT01200069|101693869|FG001|NOT COMPLETED|Overall Study||1||
48556172|NCT01133067|101693870|FG000|STARTED|Overall Study||200||
48556173|NCT01133067|101693870|FG000|COMPLETED|Overall Study||61||
48556174|NCT01133067|101693870|FG000|NOT COMPLETED|Overall Study||139||
48556175|NCT02009722|101693871|FG000|STARTED|Overall Study||41||
48556176|NCT02009722|101693872|FG001|STARTED|Overall Study||43||
48556177|NCT02009722|101693871|FG000|Received Intervention|Overall Study||41||
48556178|NCT02009722|101693872|FG001|Received Intervention|Overall Study||42||
48556179|NCT02009722|101693871|FG000|COMPLETED|Overall Study||40||
48556180|NCT02009722|101693872|FG001|COMPLETED|Overall Study||40||
48556181|NCT02009722|101693871|FG000|NOT COMPLETED|Overall Study||1||
48556182|NCT02009722|101693872|FG001|NOT COMPLETED|Overall Study||3||
48556183|NCT00573378|101693873|FG000|STARTED|Overall Study||12||
48556184|NCT00573378|101693873|FG000|Evaluable for Primary Outcome Measure|Overall Study||1||
48556185|NCT00573378|101693873|FG000|COMPLETED|Overall Study||0||
48556186|NCT00573378|101693873|FG000|NOT COMPLETED|Overall Study||12||
48556187|NCT04428034|101693874|FG000|STARTED|Enrollment to Intervention Completion||41||
48556188|NCT04428034|101693874|FG000|Attended at Least 2 Intervention Sessions in One Cohort|Enrollment to Intervention Completion||35||
48556189|NCT04428034|101693874|FG000|COMPLETED|Enrollment to Intervention Completion||35||
48556190|NCT04428034|101693874|FG000|NOT COMPLETED|Enrollment to Intervention Completion||6||
48556191|NCT04428034|101693874|FG000|STARTED|4-Week Follow Up Survey||35||
48556192|NCT04428034|101693874|FG000|COMPLETED|4-Week Follow Up Survey||29||
48556193|NCT04428034|101693874|FG000|NOT COMPLETED|4-Week Follow Up Survey||6||
48556194|NCT04428034|101693874|FG000|STARTED|8-Week Follow Up Survey||29||
48556195|NCT04428034|101693874|FG000|COMPLETED|8-Week Follow Up Survey||27||
48556196|NCT04428034|101693874|FG000|NOT COMPLETED|8-Week Follow Up Survey||2||
48556197|NCT00673439|101693875|FG000|STARTED|Overall Study||3||
48556198|NCT00673439|101693875|FG000|COMPLETED|Overall Study||3||
48556199|NCT00673439|101693875|FG000|NOT COMPLETED|Overall Study||0||
48556200|NCT00925704|101693876|FG000|STARTED|First Intervention||6||
48556201|NCT00925704|101693877|FG001|STARTED|First Intervention||7||
48556202|NCT00925704|101693878|FG002|STARTED|First Intervention||7||
48556203|NCT00925704|101693879|FG003|STARTED|First Intervention||7||
48556204|NCT00925704|101693880|FG004|STARTED|First Intervention||7||
48273116|NCT00943852|100992066|FG001|COMPLETED|Fifth Period of Treatment Intervention||1||
48273117|NCT00943852|100992067|FG002|COMPLETED|Fifth Period of Treatment Intervention||0||
48273118|NCT00943852|100992068|FG003|COMPLETED|Fifth Period of Treatment Intervention||0||
48273119|NCT00943852|100992069|FG004|COMPLETED|Fifth Period of Treatment Intervention||1||
48273120|NCT00943852|100992070|FG005|COMPLETED|Fifth Period of Treatment Intervention||0||
48393083|NCT03920865|101291503|FG001|STARTED|Overall Study||8||
48556205|NCT00925704|101693881|FG005|STARTED|First Intervention||7||
48556206|NCT00925704|101693876|FG000|COMPLETED|First Intervention||6||
48556207|NCT00925704|101693877|FG001|COMPLETED|First Intervention||7||
48694256|NCT02438683|102036341|FG002|COMPLETED|Overall Study||2||
48694257|NCT02438683|102036342|FG003|COMPLETED|Overall Study||3||
48694258|NCT02438683|102036343|FG004|COMPLETED|Overall Study||4||
48556208|NCT00925704|101693878|FG002|COMPLETED|First Intervention||7||
48556209|NCT00925704|101693879|FG003|COMPLETED|First Intervention||6||
48556210|NCT00925704|101693880|FG004|COMPLETED|First Intervention||6||
48556211|NCT00925704|101693881|FG005|COMPLETED|First Intervention||7||
48556212|NCT00925704|101693876|FG000|NOT COMPLETED|First Intervention||0||
48556213|NCT00925704|101693877|FG001|NOT COMPLETED|First Intervention||0||
48556214|NCT00925704|101693878|FG002|NOT COMPLETED|First Intervention||0||
48556215|NCT00925704|101693879|FG003|NOT COMPLETED|First Intervention||1||
48556216|NCT00925704|101693880|FG004|NOT COMPLETED|First Intervention||1||
48556217|NCT00925704|101693881|FG005|NOT COMPLETED|First Intervention||0||
48556218|NCT00925704|101693876|FG000|STARTED|Washout||6||
48556219|NCT00925704|101693877|FG001|STARTED|Washout||7||
48556220|NCT00925704|101693878|FG002|STARTED|Washout||7||
48556221|NCT00925704|101693879|FG003|STARTED|Washout||6||
48556222|NCT00925704|101693880|FG004|STARTED|Washout||6||
48556223|NCT00925704|101693881|FG005|STARTED|Washout||7||
48556224|NCT00925704|101693876|FG000|COMPLETED|Washout||6||
48556225|NCT00925704|101693877|FG001|COMPLETED|Washout||7||
48556226|NCT00925704|101693878|FG002|COMPLETED|Washout||7||
48556227|NCT00925704|101693879|FG003|COMPLETED|Washout||6||
48556228|NCT00925704|101693880|FG004|COMPLETED|Washout||6||
48556229|NCT00925704|101693881|FG005|COMPLETED|Washout||7||
48556230|NCT00925704|101693876|FG000|NOT COMPLETED|Washout||0||
48556231|NCT00925704|101693877|FG001|NOT COMPLETED|Washout||0||
48556232|NCT00925704|101693878|FG002|NOT COMPLETED|Washout||0||
48556233|NCT00925704|101693879|FG003|NOT COMPLETED|Washout||0||
48556234|NCT00925704|101693880|FG004|NOT COMPLETED|Washout||0||
48556235|NCT00925704|101693881|FG005|NOT COMPLETED|Washout||0||
48556236|NCT00925704|101693876|FG000|STARTED|Second Intervention||6||
48556237|NCT00925704|101693877|FG001|STARTED|Second Intervention||7||
48556238|NCT00925704|101693878|FG002|STARTED|Second Intervention||7||
48556239|NCT00925704|101693879|FG003|STARTED|Second Intervention||6||
48556240|NCT00925704|101693880|FG004|STARTED|Second Intervention||6||
48556241|NCT00925704|101693881|FG005|STARTED|Second Intervention||7||
48556242|NCT00925704|101693876|FG000|COMPLETED|Second Intervention||5||
48556243|NCT00925704|101693877|FG001|COMPLETED|Second Intervention||7||
48556244|NCT00925704|101693878|FG002|COMPLETED|Second Intervention||7||
48556245|NCT00925704|101693879|FG003|COMPLETED|Second Intervention||6||
48556246|NCT00925704|101693880|FG004|COMPLETED|Second Intervention||5||
48556247|NCT00925704|101693881|FG005|COMPLETED|Second Intervention||7||
48556248|NCT00925704|101693876|FG000|NOT COMPLETED|Second Intervention||1||
48556249|NCT00925704|101693877|FG001|NOT COMPLETED|Second Intervention||0||
48556250|NCT00925704|101693878|FG002|NOT COMPLETED|Second Intervention||0||
48556251|NCT00925704|101693879|FG003|NOT COMPLETED|Second Intervention||0||
48556252|NCT00925704|101693880|FG004|NOT COMPLETED|Second Intervention||1||
48556253|NCT00925704|101693881|FG005|NOT COMPLETED|Second Intervention||0||
48556254|NCT00925704|101693876|FG000|STARTED|Washout||5||
48556255|NCT00925704|101693877|FG001|STARTED|Washout||7||
48556256|NCT00925704|101693878|FG002|STARTED|Washout||7||
48556257|NCT00925704|101693879|FG003|STARTED|Washout||6||
48556258|NCT00925704|101693880|FG004|STARTED|Washout||5||
48556259|NCT00925704|101693881|FG005|STARTED|Washout||7||
48556260|NCT00925704|101693876|FG000|COMPLETED|Washout||5||
48556261|NCT00925704|101693877|FG001|COMPLETED|Washout||7||
48556262|NCT00925704|101693878|FG002|COMPLETED|Washout||7||
48556263|NCT00925704|101693879|FG003|COMPLETED|Washout||6||
48556264|NCT00925704|101693880|FG004|COMPLETED|Washout||5||
48694259|NCT02438683|102036344|FG005|COMPLETED|Overall Study||4||
48694260|NCT02438683|102036339|FG000|NOT COMPLETED|Overall Study||1||
48694261|NCT02438683|102036340|FG001|NOT COMPLETED|Overall Study||0||
48556265|NCT00925704|101693881|FG005|COMPLETED|Washout||7||
48556266|NCT00925704|101693876|FG000|NOT COMPLETED|Washout||0||
48556267|NCT00925704|101693877|FG001|NOT COMPLETED|Washout||0||
48556268|NCT00925704|101693878|FG002|NOT COMPLETED|Washout||0||
48556269|NCT00925704|101693879|FG003|NOT COMPLETED|Washout||0||
48556270|NCT00925704|101693880|FG004|NOT COMPLETED|Washout||0||
48556271|NCT00925704|101693881|FG005|NOT COMPLETED|Washout||0||
48556272|NCT00925704|101693876|FG000|STARTED|Third Intervention||5||
48556273|NCT00925704|101693877|FG001|STARTED|Third Intervention||7||
48556274|NCT00925704|101693878|FG002|STARTED|Third Intervention||7||
48556275|NCT00925704|101693879|FG003|STARTED|Third Intervention||6||
48556276|NCT00925704|101693880|FG004|STARTED|Third Intervention||5||
48556277|NCT00925704|101693881|FG005|STARTED|Third Intervention||7||
48556278|NCT00925704|101693876|FG000|COMPLETED|Third Intervention||5||
48556279|NCT00925704|101693877|FG001|COMPLETED|Third Intervention||7||
48556280|NCT00925704|101693878|FG002|COMPLETED|Third Intervention||7||
48556281|NCT00925704|101693879|FG003|COMPLETED|Third Intervention||6||
48556282|NCT00925704|101693880|FG004|COMPLETED|Third Intervention||5||
48694262|NCT02438683|102036341|FG002|NOT COMPLETED|Overall Study||0||
48694263|NCT02438683|102036342|FG003|NOT COMPLETED|Overall Study||0||
48556283|NCT00925704|101693881|FG005|COMPLETED|Third Intervention||6||
48556284|NCT00925704|101693876|FG000|NOT COMPLETED|Third Intervention||0||
48556285|NCT00925704|101693877|FG001|NOT COMPLETED|Third Intervention||0||
48556286|NCT00925704|101693878|FG002|NOT COMPLETED|Third Intervention||0||
48556287|NCT00925704|101693879|FG003|NOT COMPLETED|Third Intervention||0||
48556288|NCT00925704|101693880|FG004|NOT COMPLETED|Third Intervention||0||
48556289|NCT00925704|101693881|FG005|NOT COMPLETED|Third Intervention||1||
48556290|NCT01602068|101693882|FG000|STARTED|Overall Study||23||
48556291|NCT01602068|101693883|FG001|STARTED|Overall Study||22||
48694264|NCT02438683|102036343|FG004|NOT COMPLETED|Overall Study||0||
48694265|NCT02438683|102036344|FG005|NOT COMPLETED|Overall Study||0||
48694266|NCT02253433|102036345|FG000|STARTED|Overall Study||130||
48694267|NCT02253433|102036346|FG001|STARTED|Overall Study||134||
48694268|NCT02253433|102036345|FG000|COMPLETED|Overall Study||114||
48556292|NCT01602068|101693882|FG000|COMPLETED|Overall Study||23||
48556293|NCT01602068|101693883|FG001|COMPLETED|Overall Study||22||
48556294|NCT01602068|101693882|FG000|NOT COMPLETED|Overall Study||0||
48556295|NCT01602068|101693883|FG001|NOT COMPLETED|Overall Study||0||
48556296|NCT00838526|101693884|FG000|STARTED|Overall Study||59||
48556297|NCT00838526|101693885|FG001|STARTED|Overall Study||176||
48556298|NCT00838526|101693884|FG000|COMPLETED|Overall Study||35||
48556299|NCT00838526|101693885|FG001|COMPLETED|Overall Study||137||
48556300|NCT00838526|101693884|FG000|NOT COMPLETED|Overall Study||24||
48556301|NCT00838526|101693885|FG001|NOT COMPLETED|Overall Study||39||
48556302|NCT02383017|101693886|FG000|STARTED|Overall Study||15||
48556303|NCT02383017|101693887|FG001|STARTED|Overall Study||13||
48556304|NCT02383017|101693886|FG000|COMPLETED|Overall Study||10||
48556305|NCT02383017|101693887|FG001|COMPLETED|Overall Study||11||
48556306|NCT02383017|101693886|FG000|NOT COMPLETED|Overall Study||5||
48556307|NCT02383017|101693887|FG001|NOT COMPLETED|Overall Study||2||
48556308|NCT02245516|101693888|FG000|STARTED|Overall Study||9||
48556309|NCT02245516|101693889|FG001|STARTED|Overall Study||7||
48556310|NCT02245516|101693888|FG000|COMPLETED|Overall Study||9||
48556311|NCT02245516|101693889|FG001|COMPLETED|Overall Study||4||
48556312|NCT02245516|101693888|FG000|NOT COMPLETED|Overall Study||0||
48556313|NCT02245516|101693889|FG001|NOT COMPLETED|Overall Study||3||
48556314|NCT02601014|101693890|FG000|STARTED|Overall Study||15||
48556315|NCT02601014|101693891|FG001|STARTED|Overall Study||15||
48556316|NCT02601014|101693890|FG000|COMPLETED|Overall Study||5||
48556317|NCT02601014|101693891|FG001|COMPLETED|Overall Study||3||
48556318|NCT02601014|101693890|FG000|NOT COMPLETED|Overall Study||10||
48694269|NCT02253433|102036346|FG001|COMPLETED|Overall Study||79||
48694270|NCT02253433|102036345|FG000|NOT COMPLETED|Overall Study||16||
48694271|NCT02253433|102036346|FG001|NOT COMPLETED|Overall Study||55||
48694272|NCT01267864|102036347|FG000|STARTED|Overall Study||110||
48694273|NCT01267864|102036348|FG001|STARTED|Overall Study||110||
48694274|NCT01267864|102036349|FG002|STARTED|Overall Study||110||
48694275|NCT01267864|102036347|FG000|COMPLETED|Overall Study||110||
48694276|NCT01267864|102036348|FG001|COMPLETED|Overall Study||110||
48694277|NCT01267864|102036349|FG002|COMPLETED|Overall Study||110||
48694278|NCT01267864|102036347|FG000|NOT COMPLETED|Overall Study||0||
48694279|NCT01267864|102036348|FG001|NOT COMPLETED|Overall Study||0||
48694280|NCT01267864|102036349|FG002|NOT COMPLETED|Overall Study||0||
48694281|NCT02470585|102036350|FG000|STARTED|Overall Study||375||
48694282|NCT02470585|102036351|FG001|STARTED|Overall Study||383||
48694283|NCT02470585|102036352|FG002|STARTED|Overall Study||382||
48694284|NCT02470585|102036350|FG000|COMPLETED|Overall Study||0||
48694285|NCT02470585|102036351|FG001|COMPLETED|Overall Study||0||
48694286|NCT02470585|102036352|FG002|COMPLETED|Overall Study||0||
48694287|NCT02470585|102036350|FG000|NOT COMPLETED|Overall Study||375||
48694288|NCT02470585|102036351|FG001|NOT COMPLETED|Overall Study||383||
48694289|NCT02470585|102036352|FG002|NOT COMPLETED|Overall Study||382||
48694290|NCT04254692|102036353|FG000|STARTED|Overall Study||1||
48694291|NCT04254692|102036354|FG001|STARTED|Overall Study||1||
48694292|NCT04254692|102036353|FG000|COMPLETED|Overall Study||1||
48694293|NCT04254692|102036354|FG001|COMPLETED|Overall Study||1||
48694294|NCT04254692|102036353|FG000|NOT COMPLETED|Overall Study||0||
48694295|NCT04254692|102036354|FG001|NOT COMPLETED|Overall Study||0||
48556319|NCT02601014|101693891|FG001|NOT COMPLETED|Overall Study||12||
48556320|NCT03051672|101693892|FG000|STARTED|Overall Study||8||
48556321|NCT03051672|101693892|FG000|Began Treatment|Overall Study||8||
48556322|NCT03051672|101693892|FG000|COMPLETED|Overall Study||8||
48556323|NCT03051672|101693892|FG000|NOT COMPLETED|Overall Study||0||
48694296|NCT02248649|102036355|FG000|STARTED|Overall Study||80||
48694297|NCT02248649|102036356|FG001|STARTED|Overall Study||80||
48694298|NCT02248649|102036355|FG000|COMPLETED|Overall Study||59||
48694299|NCT02248649|102036356|FG001|COMPLETED|Overall Study||59||
48694300|NCT02248649|102036355|FG000|NOT COMPLETED|Overall Study||21||
48556324|NCT00618371|101693893|FG000|STARTED|Overall Study||12||
48556325|NCT00618371|101693893|FG000|COMPLETED|Overall Study||10||
48556326|NCT00618371|101693893|FG000|NOT COMPLETED|Overall Study||2||
48694301|NCT02248649|102036356|FG001|NOT COMPLETED|Overall Study||21||
48694302|NCT00958347|102036357|FG000|STARTED|Overall Study||226||
48694303|NCT00958347|102036357|FG000|COMPLETED|Overall Study||0||
48694304|NCT00958347|102036357|FG000|NOT COMPLETED|Overall Study||226||
48556327|NCT03052751|101693894|FG000|STARTED|Dosing Period 1||22||
48556328|NCT03052751|101693895|FG001|STARTED|Dosing Period 1||21||
48556329|NCT03052751|101693896|FG002|STARTED|Dosing Period 1||0||
48556330|NCT03052751|101693897|FG003|STARTED|Dosing Period 1||0||
48556331|NCT03052751|101693898|FG004|STARTED|Dosing Period 1||0||
48556332|NCT03052751|101693899|FG005|STARTED|Dosing Period 1||0||
48556333|NCT03052751|101693894|FG000|Completed Period 1|Dosing Period 1||22||
48556334|NCT03052751|101693895|FG001|Completed Period 1|Dosing Period 1||21||
48556335|NCT03052751|101693896|FG002|Completed Period 1|Dosing Period 1||0||
48556336|NCT03052751|101693897|FG003|Completed Period 1|Dosing Period 1||0||
48556337|NCT03052751|101693898|FG004|Completed Period 1|Dosing Period 1||0||
48556338|NCT03052751|101693899|FG005|Completed Period 1|Dosing Period 1||0||
48556339|NCT03052751|101693894|FG000|Completed Period 1 and Started Period 2|Dosing Period 1||22||
48556340|NCT03052751|101693895|FG001|Completed Period 1 and Started Period 2|Dosing Period 1||20||
48556341|NCT03052751|101693896|FG002|Completed Period 1 and Started Period 2|Dosing Period 1||0||
48556342|NCT03052751|101693897|FG003|Completed Period 1 and Started Period 2|Dosing Period 1||0||
48556343|NCT03052751|101693898|FG004|Completed Period 1 and Started Period 2|Dosing Period 1||0||
48556344|NCT03052751|101693899|FG005|Completed Period 1 and Started Period 2|Dosing Period 1||0||
48556345|NCT03052751|101693894|FG000|COMPLETED|Dosing Period 1||22||
48556346|NCT03052751|101693895|FG001|COMPLETED|Dosing Period 1||20||
48556347|NCT03052751|101693896|FG002|COMPLETED|Dosing Period 1||0||
48556348|NCT03052751|101693897|FG003|COMPLETED|Dosing Period 1||0||
48556349|NCT03052751|101693898|FG004|COMPLETED|Dosing Period 1||0||
48556350|NCT03052751|101693899|FG005|COMPLETED|Dosing Period 1||0||
48556351|NCT03052751|101693894|FG000|NOT COMPLETED|Dosing Period 1||0||
48556352|NCT03052751|101693895|FG001|NOT COMPLETED|Dosing Period 1||1||
48556353|NCT03052751|101693896|FG002|NOT COMPLETED|Dosing Period 1||0||
48556354|NCT03052751|101693897|FG003|NOT COMPLETED|Dosing Period 1||0||
48556355|NCT03052751|101693898|FG004|NOT COMPLETED|Dosing Period 1||0||
48556356|NCT03052751|101693899|FG005|NOT COMPLETED|Dosing Period 1||0||
48556357|NCT03052751|101693894|FG000|STARTED|Dosing Period 2||0||
48556358|NCT03052751|101693895|FG001|STARTED|Dosing Period 2||0||
48556359|NCT03052751|101693896|FG002|STARTED|Dosing Period 2||11||
48556360|NCT03052751|101693897|FG003|STARTED|Dosing Period 2||11||
48556361|NCT03052751|101693898|FG004|STARTED|Dosing Period 2||10||
48556362|NCT03052751|101693899|FG005|STARTED|Dosing Period 2||10||
48556363|NCT03052751|101693894|FG000|COMPLETED|Dosing Period 2||0||
48556364|NCT03052751|101693895|FG001|COMPLETED|Dosing Period 2||0||
48556365|NCT03052751|101693896|FG002|COMPLETED|Dosing Period 2||8||
48556366|NCT03052751|101693897|FG003|COMPLETED|Dosing Period 2||11||
48556367|NCT03052751|101693898|FG004|COMPLETED|Dosing Period 2||10||
48556368|NCT03052751|101693899|FG005|COMPLETED|Dosing Period 2||10||
48556369|NCT03052751|101693894|FG000|NOT COMPLETED|Dosing Period 2||0||
48556370|NCT03052751|101693895|FG001|NOT COMPLETED|Dosing Period 2||0||
48556371|NCT03052751|101693896|FG002|NOT COMPLETED|Dosing Period 2||3||
48556372|NCT03052751|101693897|FG003|NOT COMPLETED|Dosing Period 2||0||
48556373|NCT03052751|101693898|FG004|NOT COMPLETED|Dosing Period 2||0||
48556374|NCT03052751|101693899|FG005|NOT COMPLETED|Dosing Period 2||0||
48556375|NCT03052751|101693894|FG000|STARTED|Observation Period||22||
48556376|NCT03052751|101693895|FG001|STARTED|Observation Period||21||
48556377|NCT03052751|101693896|FG002|STARTED|Observation Period||11||
48556378|NCT03052751|101693897|FG003|STARTED|Observation Period||11||
48556379|NCT03052751|101693898|FG004|STARTED|Observation Period||10||
48556380|NCT03052751|101693899|FG005|STARTED|Observation Period||10||
48556381|NCT03052751|101693894|FG000|COMPLETED|Observation Period||22||
48556382|NCT03052751|101693895|FG001|COMPLETED|Observation Period||21||
48556383|NCT03052751|101693896|FG002|COMPLETED|Observation Period||11||
48556384|NCT03052751|101693897|FG003|COMPLETED|Observation Period||11||
48556385|NCT03052751|101693898|FG004|COMPLETED|Observation Period||9||
48556386|NCT03052751|101693899|FG005|COMPLETED|Observation Period||10||
48556387|NCT03052751|101693894|FG000|NOT COMPLETED|Observation Period||0||
48556388|NCT03052751|101693895|FG001|NOT COMPLETED|Observation Period||0||
48556389|NCT03052751|101693896|FG002|NOT COMPLETED|Observation Period||0||
48556390|NCT03052751|101693897|FG003|NOT COMPLETED|Observation Period||0||
48556391|NCT03052751|101693898|FG004|NOT COMPLETED|Observation Period||1||
48556392|NCT03052751|101693899|FG005|NOT COMPLETED|Observation Period||0||
48556393|NCT00218387|101693900|FG000|STARTED|Overall Study||40||
48556394|NCT00218387|101693901|FG001|STARTED|Overall Study||43||
48556395|NCT00218387|101693902|FG002|STARTED|Overall Study||40||
48556396|NCT00218387|101693900|FG000|COMPLETED|Overall Study||25||
48556397|NCT00218387|101693901|FG001|COMPLETED|Overall Study||25||
48556398|NCT00218387|101693902|FG002|COMPLETED|Overall Study||17||
48556399|NCT00218387|101693900|FG000|NOT COMPLETED|Overall Study||15||
48556400|NCT00218387|101693901|FG001|NOT COMPLETED|Overall Study||18||
48556401|NCT00218387|101693902|FG002|NOT COMPLETED|Overall Study||23||
48556402|NCT03238651|101693903|FG000|STARTED|Overall Study||3||
48556403|NCT03238651|101693904|FG001|STARTED|Overall Study||6||
48556404|NCT03238651|101693905|FG002|STARTED|Overall Study||4||
48556405|NCT03238651|101693906|FG003|STARTED|Overall Study||3||
48556406|NCT03238651|101693907|FG004|STARTED|Overall Study||1||
48556407|NCT03238651|101693903|FG000|COMPLETED|Overall Study||0||
48556408|NCT03238651|101693904|FG001|COMPLETED|Overall Study||0||
48556409|NCT03238651|101693905|FG002|COMPLETED|Overall Study||0||
48556410|NCT03238651|101693906|FG003|COMPLETED|Overall Study||0||
48556411|NCT03238651|101693907|FG004|COMPLETED|Overall Study||0||
48556412|NCT03238651|101693903|FG000|NOT COMPLETED|Overall Study||3||
48556413|NCT03238651|101693904|FG001|NOT COMPLETED|Overall Study||6||
48556414|NCT03238651|101693905|FG002|NOT COMPLETED|Overall Study||4||
48556415|NCT03238651|101693906|FG003|NOT COMPLETED|Overall Study||3||
48556416|NCT03238651|101693907|FG004|NOT COMPLETED|Overall Study||1||
48556417|NCT04132973|101693908|FG000|STARTED|Overall Study||34||
48556418|NCT04132973|101693908|FG000|Completed Intervention|Overall Study||11||
48556419|NCT04132973|101693908|FG000|COMPLETED|Overall Study||8||
48556420|NCT04132973|101693908|FG000|NOT COMPLETED|Overall Study||26||
48556421|NCT01385189|101693909|FG000|STARTED|Overall Study||12||
48556422|NCT01385189|101693910|FG001|STARTED|Overall Study||12||
48556423|NCT01385189|101693911|FG002|STARTED|Overall Study||4||
48556424|NCT01385189|101693912|FG003|STARTED|Overall Study||4||
48556425|NCT01385189|101693913|FG004|STARTED|Overall Study||8||
48556426|NCT01385189|101693909|FG000|COMPLETED|Overall Study||11||
48556427|NCT01385189|101693910|FG001|COMPLETED|Overall Study||11||
48556428|NCT01385189|101693911|FG002|COMPLETED|Overall Study||4||
48556429|NCT01385189|101693912|FG003|COMPLETED|Overall Study||3||
48556430|NCT01385189|101693913|FG004|COMPLETED|Overall Study||6||
48556431|NCT01385189|101693909|FG000|NOT COMPLETED|Overall Study||1||
48556432|NCT01385189|101693910|FG001|NOT COMPLETED|Overall Study||1||
48556433|NCT01385189|101693911|FG002|NOT COMPLETED|Overall Study||0||
48556434|NCT01385189|101693912|FG003|NOT COMPLETED|Overall Study||1||
48556435|NCT01385189|101693913|FG004|NOT COMPLETED|Overall Study||2||
48556436|NCT04937881|101693914|FG000|STARTED|Overall Study||20||
48556437|NCT04937881|101693915|FG001|STARTED|Overall Study||19||
48556438|NCT04937881|101693914|FG000|COMPLETED|Overall Study||20||
48556439|NCT04937881|101693915|FG001|COMPLETED|Overall Study||19||
48556440|NCT04937881|101693914|FG000|NOT COMPLETED|Overall Study||0||
48556441|NCT04937881|101693915|FG001|NOT COMPLETED|Overall Study||0||
48556442|NCT02115607|101693916|FG000|STARTED|Overall Study||17||
48556443|NCT02115607|101693916|FG000|COMPLETED|Overall Study||16||
48556444|NCT02115607|101693916|FG000|NOT COMPLETED|Overall Study||1||
48556445|NCT00725920|101693917|FG000|STARTED|Overall Study||17||
48556446|NCT00725920|101693918|FG001|STARTED|Overall Study||18||
48556447|NCT00725920|101693917|FG000|COMPLETED|Overall Study||14||
48556448|NCT00725920|101693918|FG001|COMPLETED|Overall Study||12||
48556449|NCT00725920|101693917|FG000|NOT COMPLETED|Overall Study||3||
48556450|NCT00725920|101693918|FG001|NOT COMPLETED|Overall Study||6||
48694305|NCT04343534|102036358|FG000|STARTED|Overall Study||230||
48694306|NCT04343534|102036359|FG001|STARTED|Overall Study||264||
48694307|NCT04343534|102036358|FG000|COMPLETED|Overall Study||230||
48694308|NCT04343534|102036359|FG001|COMPLETED|Overall Study||264||
48694309|NCT04343534|102036358|FG000|NOT COMPLETED|Overall Study||0||
48694310|NCT04343534|102036359|FG001|NOT COMPLETED|Overall Study||0||
48694311|NCT04075513|102036360|FG000|STARTED|Overall Study||172||
48694312|NCT04075513|102036361|FG001|STARTED|Overall Study||171||
48694313|NCT04075513|102036360|FG000|COMPLETED|Overall Study||164||
48694314|NCT04075513|102036361|FG001|COMPLETED|Overall Study||167||
48694315|NCT04075513|102036360|FG000|NOT COMPLETED|Overall Study||8||
48694316|NCT04075513|102036361|FG001|NOT COMPLETED|Overall Study||4||
48694317|NCT03248167|102036362|FG000|STARTED|Overall Study||17||
48694318|NCT03248167|102036363|FG001|STARTED|Overall Study||13||
48694319|NCT03248167|102036362|FG000|COMPLETED|Overall Study||12||
48556451|NCT02654054|101693919|FG000|STARTED|Treatment Period||102|randomized|
48556452|NCT02654054|101693920|FG001|STARTED|Treatment Period||104|randomized|
48556453|NCT02654054|101693921|FG002|STARTED|Treatment Period||207|randomized|
48556454|NCT02654054|101693919|FG000|Randomized and Treated|Treatment Period||102||
48556455|NCT02654054|101693920|FG001|Randomized and Treated|Treatment Period||104||
48556456|NCT02654054|101693921|FG002|Randomized and Treated|Treatment Period||206||
48556457|NCT02654054|101693919|FG000|COMPLETED|Treatment Period||83|completed treatment period|
48556458|NCT02654054|101693920|FG001|COMPLETED|Treatment Period||81|completed treatment period|
48556459|NCT02654054|101693921|FG002|COMPLETED|Treatment Period||164|completed treatment period|
48556460|NCT02654054|101693919|FG000|NOT COMPLETED|Treatment Period||19||
48556461|NCT02654054|101693920|FG001|NOT COMPLETED|Treatment Period||23||
48556462|NCT02654054|101693921|FG002|NOT COMPLETED|Treatment Period||43||
48694320|NCT03248167|102036363|FG001|COMPLETED|Overall Study||9||
48694321|NCT03248167|102036362|FG000|NOT COMPLETED|Overall Study||5||
48694322|NCT03248167|102036363|FG001|NOT COMPLETED|Overall Study||4||
48694323|NCT02200757|102036364|FG000|STARTED|Overall Study||67||
48694324|NCT02200757|102036365|FG001|STARTED|Overall Study||63||
48694325|NCT02200757|102036364|FG000|COMPLETED|Overall Study||67||
48694326|NCT02200757|102036365|FG001|COMPLETED|Overall Study||63||
48694327|NCT02200757|102036364|FG000|NOT COMPLETED|Overall Study||0||
48694328|NCT02200757|102036365|FG001|NOT COMPLETED|Overall Study||0||
48694329|NCT00090779|102036366|FG000|STARTED|Step 1||66||
48694330|NCT00090779|102036367|FG001|STARTED|Step 1||64||
48694331|NCT00090779|102036366|FG000|COMPLETED|Step 1||55||
48694332|NCT00090779|102036367|FG001|COMPLETED|Step 1||49||
48694333|NCT00090779|102036366|FG000|NOT COMPLETED|Step 1||11||
48694334|NCT00090779|102036367|FG001|NOT COMPLETED|Step 1||15||
48556463|NCT02654054|101693919|FG000|STARTED|Post-Treatment Follow-Up Period||25||
48556464|NCT02654054|101693920|FG001|STARTED|Post-Treatment Follow-Up Period||32||
48556465|NCT02654054|101693921|FG002|STARTED|Post-Treatment Follow-Up Period||59||
48556466|NCT02654054|101693919|FG000|COMPLETED|Post-Treatment Follow-Up Period||17||
48556467|NCT02654054|101693920|FG001|COMPLETED|Post-Treatment Follow-Up Period||24||
48556468|NCT02654054|101693921|FG002|COMPLETED|Post-Treatment Follow-Up Period||29||
48556469|NCT02654054|101693919|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||8||
48556470|NCT02654054|101693920|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||8||
48556471|NCT02654054|101693921|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||30||
48556472|NCT02556801|101693922|FG000|STARTED|Overall Study||42||
48273121|NCT00943852|100992071|FG006|COMPLETED|Fifth Period of Treatment Intervention||0||
48273122|NCT00943852|100992072|FG007|COMPLETED|Fifth Period of Treatment Intervention||0||
48273123|NCT00943852|100992073|FG008|COMPLETED|Fifth Period of Treatment Intervention||1||
48556473|NCT02556801|101693923|FG001|STARTED|Overall Study||42||
48556474|NCT02556801|101693924|FG002|STARTED|Overall Study||42||
48556475|NCT02556801|101693925|FG003|STARTED|Overall Study||42||
48556476|NCT02556801|101693922|FG000|COMPLETED|Overall Study||40||
48556477|NCT02556801|101693923|FG001|COMPLETED|Overall Study||35||
48556478|NCT02556801|101693924|FG002|COMPLETED|Overall Study||38||
48556479|NCT02556801|101693925|FG003|COMPLETED|Overall Study||37||
48556480|NCT02556801|101693922|FG000|NOT COMPLETED|Overall Study||2||
48556481|NCT02556801|101693923|FG001|NOT COMPLETED|Overall Study||7||
48556482|NCT02556801|101693924|FG002|NOT COMPLETED|Overall Study||4||
48556483|NCT02556801|101693925|FG003|NOT COMPLETED|Overall Study||5||
48556484|NCT01651117|101693926|FG000|STARTED|Overall Study||156||
48556485|NCT01651117|101693927|FG001|STARTED|Overall Study||205||
48556486|NCT01651117|101693928|FG002|STARTED|Overall Study||49||
48556487|NCT01651117|101693929|FG003|STARTED|Overall Study||70||
48556488|NCT01651117|101693926|FG000|COMPLETED|Overall Study||154||
48556489|NCT01651117|101693927|FG001|COMPLETED|Overall Study||202||
48556490|NCT01651117|101693928|FG002|COMPLETED|Overall Study||47||
48556491|NCT01651117|101693929|FG003|COMPLETED|Overall Study||68||
48556492|NCT01651117|101693926|FG000|NOT COMPLETED|Overall Study||2||
48556493|NCT01651117|101693927|FG001|NOT COMPLETED|Overall Study||3||
48556494|NCT01651117|101693928|FG002|NOT COMPLETED|Overall Study||2||
48556495|NCT01651117|101693929|FG003|NOT COMPLETED|Overall Study||2||
48556496|NCT01276860|101693930|FG000|STARTED|Overall Study||5||
48556497|NCT01276860|101693931|FG001|STARTED|Overall Study||2||
48556498|NCT01276860|101693930|FG000|COMPLETED|Overall Study||5||
48556499|NCT01276860|101693931|FG001|COMPLETED|Overall Study||2||
48556500|NCT01276860|101693930|FG000|NOT COMPLETED|Overall Study||0||
48556501|NCT01276860|101693931|FG001|NOT COMPLETED|Overall Study||0||
48556502|NCT04507464|101693932|FG000|STARTED|Overall Study||20||
48556503|NCT04507464|101693933|FG001|STARTED|Overall Study||19||
48556504|NCT04507464|101693932|FG000|COMPLETED|Overall Study||19||
48556505|NCT04507464|101693933|FG001|COMPLETED|Overall Study||19||
48556506|NCT04507464|101693932|FG000|NOT COMPLETED|Overall Study||1||
48556507|NCT04507464|101693933|FG001|NOT COMPLETED|Overall Study||0||
48556508|NCT02792517|101693934|FG000|STARTED|Overall Study||41||
48556509|NCT02792517|101693934|FG000|Received Erenumab|Overall Study||24||
48110964|NCT02350309|100598019|FG003|COMPLETED|Treatment Period 3 (2 Days)||11||
48110965|NCT02350309|100598020|FG004|COMPLETED|Treatment Period 3 (2 Days)||12||
48556510|NCT02792517|101693934|FG000|COMPLETED|Overall Study||21||
48556511|NCT02792517|101693934|FG000|NOT COMPLETED|Overall Study||20||
48556512|NCT02566889|101693935|FG000|STARTED|Overall Study||45||
48556513|NCT02566889|101693936|FG001|STARTED|Overall Study||8||
48556514|NCT02566889|101693935|FG000|Cross-over to Dose Escalation Group|Overall Study||1|This participant was counted in both arms for safety analysis.|
48556515|NCT02566889|101693936|FG001|Cross-over to Dose Escalation Group|Overall Study||0|This participant was counted in both arms for safety analysis.|
48556516|NCT02566889|101693935|FG000|COMPLETED|Overall Study||32||
48556517|NCT02566889|101693936|FG001|COMPLETED|Overall Study||3||
48556518|NCT02566889|101693935|FG000|NOT COMPLETED|Overall Study||13||
48556519|NCT02566889|101693936|FG001|NOT COMPLETED|Overall Study||5||
48556520|NCT02790437|101693937|FG000|STARTED|Overall Study||16||
48556521|NCT02790437|101693938|FG001|STARTED|Overall Study||3||
48556522|NCT02790437|101693937|FG000|COMPLETED|Overall Study||13||
48556523|NCT02790437|101693938|FG001|COMPLETED|Overall Study||3||
48273124|NCT00943852|100992074|FG009|COMPLETED|Fifth Period of Treatment Intervention||1||
48556524|NCT02790437|101693937|FG000|NOT COMPLETED|Overall Study||3||
48556525|NCT02790437|101693938|FG001|NOT COMPLETED|Overall Study||0||
48556526|NCT00729937|101693939|FG000|STARTED|Overall Study||629||
48556527|NCT00729937|101693940|FG001|STARTED|Overall Study||636||
48556528|NCT00729937|101693941|FG002|STARTED|Overall Study||251||
48556529|NCT00729937|101693942|FG003|STARTED|Overall Study||249||
48556530|NCT00729937|101693943|FG004|STARTED|Overall Study||249||
48556531|NCT00729937|101693944|FG005|STARTED|Overall Study||251||
48556532|NCT00729937|101693939|FG000|COMPLETED|Overall Study||555||
48556533|NCT00729937|101693940|FG001|COMPLETED|Overall Study||548||
48273125|NCT00943852|100992065|FG000|NOT COMPLETED|Fifth Period of Treatment Intervention||0||
48556534|NCT00729937|101693941|FG002|COMPLETED|Overall Study||222||
48556535|NCT00729937|101693942|FG003|COMPLETED|Overall Study||215||
48556536|NCT00729937|101693943|FG004|COMPLETED|Overall Study||221||
48556537|NCT00729937|101693944|FG005|COMPLETED|Overall Study||214||
48556538|NCT00729937|101693939|FG000|NOT COMPLETED|Overall Study||74||
48556539|NCT00729937|101693940|FG001|NOT COMPLETED|Overall Study||88||
48556540|NCT00729937|101693941|FG002|NOT COMPLETED|Overall Study||29||
48556541|NCT00729937|101693942|FG003|NOT COMPLETED|Overall Study||34||
48556542|NCT00729937|101693943|FG004|NOT COMPLETED|Overall Study||28||
48556543|NCT00729937|101693944|FG005|NOT COMPLETED|Overall Study||37||
48556544|NCT03452943|101693945|FG000|STARTED|Titration Period (7 Weeks)||59|Intent-to-treat (ITT) analysis set: all randomized participants|
48556545|NCT03452943|101693946|FG001|STARTED|Titration Period (7 Weeks)||60|Intent-to-treat (ITT) analysis set: all randomized participants|
48556546|NCT03452943|101693945|FG000|Safety Analysis Set|Titration Period (7 Weeks)||58|Received at least 1 dose of study drug|
48556547|NCT03452943|101693946|FG001|Safety Analysis Set|Titration Period (7 Weeks)||59|Received at least 1 dose of study drug|
48556548|NCT03452943|101693945|FG000|Modified ITT (mITT) Analysis Set|Titration Period (7 Weeks)||58|Received at least 1 dose of study drug; had both baseline \& at least 1 postbaseline YGTSS assessment|
48556549|NCT03452943|101693946|FG001|Modified ITT (mITT) Analysis Set|Titration Period (7 Weeks)||59|Received at least 1 dose of study drug; had both baseline \& at least 1 postbaseline YGTSS assessment|
48556550|NCT03452943|101693945|FG000|COMPLETED|Titration Period (7 Weeks)||54||
48556551|NCT03452943|101693946|FG001|COMPLETED|Titration Period (7 Weeks)||56||
48556552|NCT03452943|101693945|FG000|NOT COMPLETED|Titration Period (7 Weeks)||5||
48556553|NCT03452943|101693946|FG001|NOT COMPLETED|Titration Period (7 Weeks)||4||
48556554|NCT03452943|101693945|FG000|STARTED|Maintenance Period (5 Weeks)||54||
48556555|NCT03452943|101693946|FG001|STARTED|Maintenance Period (5 Weeks)||56||
48556556|NCT03452943|101693945|FG000|COMPLETED|Maintenance Period (5 Weeks)||51||
48556557|NCT03452943|101693946|FG001|COMPLETED|Maintenance Period (5 Weeks)||56||
48556558|NCT03452943|101693945|FG000|NOT COMPLETED|Maintenance Period (5 Weeks)||3||
48556559|NCT03452943|101693946|FG001|NOT COMPLETED|Maintenance Period (5 Weeks)||0||
48556560|NCT01173120|101693947|FG000|STARTED|Overall Study||62||
48556561|NCT01173120|101693947|FG000|Switched Back to Main Study|Overall Study||57||
48556562|NCT01173120|101693947|FG000|Discontinued ACP Substudy and Main Study|Overall Study||5||
48556563|NCT01173120|101693947|FG000|COMPLETED|Overall Study||0||
48556564|NCT01173120|101693947|FG000|NOT COMPLETED|Overall Study||62||
48556565|NCT03410056|101693948|FG000|STARTED|Overall Study||8||
48556566|NCT03410056|101693949|FG001|STARTED|Overall Study||6||
48556567|NCT03410056|101693950|FG002|STARTED|Overall Study||11||
48556568|NCT03410056|101693951|FG003|STARTED|Overall Study||11||
48556569|NCT03410056|101693952|FG004|STARTED|Overall Study||0||
48556570|NCT03410056|101693953|FG005|STARTED|Overall Study||0||
48556571|NCT03410056|101693954|FG006|STARTED|Overall Study||0||
48556572|NCT03410056|101693948|FG000|Received Treatment|Overall Study||8||
48556573|NCT03410056|101693949|FG001|Received Treatment|Overall Study||6||
48556574|NCT03410056|101693950|FG002|Received Treatment|Overall Study||11||
48556575|NCT03410056|101693951|FG003|Received Treatment|Overall Study||11||
48556576|NCT03410056|101693952|FG004|Received Treatment|Overall Study||0||
48556577|NCT03410056|101693953|FG005|Received Treatment|Overall Study||0||
48556578|NCT03410056|101693954|FG006|Received Treatment|Overall Study||0||
48556579|NCT03410056|101693948|FG000|COMPLETED|Overall Study||8||
48556580|NCT03410056|101693949|FG001|COMPLETED|Overall Study||4||
48556581|NCT03410056|101693950|FG002|COMPLETED|Overall Study||3||
48556582|NCT03410056|101693951|FG003|COMPLETED|Overall Study||6||
48556583|NCT03410056|101693952|FG004|COMPLETED|Overall Study||0||
48556584|NCT03410056|101693953|FG005|COMPLETED|Overall Study||0||
48556585|NCT03410056|101693954|FG006|COMPLETED|Overall Study||0||
48556586|NCT03410056|101693948|FG000|NOT COMPLETED|Overall Study||0||
48556587|NCT03410056|101693949|FG001|NOT COMPLETED|Overall Study||2||
48556588|NCT03410056|101693950|FG002|NOT COMPLETED|Overall Study||8||
48556589|NCT03410056|101693951|FG003|NOT COMPLETED|Overall Study||5||
48556590|NCT03410056|101693952|FG004|NOT COMPLETED|Overall Study||0||
48556591|NCT03410056|101693953|FG005|NOT COMPLETED|Overall Study||0||
48556592|NCT03410056|101693954|FG006|NOT COMPLETED|Overall Study||0||
48556593|NCT05024747|101693955|FG000|STARTED|Period 1 (Day 1 to 2)||11||
48556594|NCT05024747|101693956|FG001|STARTED|Period 1 (Day 1 to 2)||10||
48556595|NCT05024747|101693955|FG000|COMPLETED|Period 1 (Day 1 to 2)||10||
48556596|NCT05024747|101693956|FG001|COMPLETED|Period 1 (Day 1 to 2)||5||
48556597|NCT05024747|101693955|FG000|NOT COMPLETED|Period 1 (Day 1 to 2)||1||
48556598|NCT05024747|101693956|FG001|NOT COMPLETED|Period 1 (Day 1 to 2)||5||
48556599|NCT05024747|101693955|FG000|STARTED|Wash-out (Day 3)||10||
48556600|NCT05024747|101693956|FG001|STARTED|Wash-out (Day 3)||5||
48556601|NCT05024747|101693955|FG000|COMPLETED|Wash-out (Day 3)||10||
48556602|NCT05024747|101693956|FG001|COMPLETED|Wash-out (Day 3)||5||
48556603|NCT05024747|101693955|FG000|NOT COMPLETED|Wash-out (Day 3)||0||
48556604|NCT05024747|101693956|FG001|NOT COMPLETED|Wash-out (Day 3)||0||
48556605|NCT05024747|101693955|FG000|STARTED|Period 2 (Day 4 to 6)||10||
48556606|NCT05024747|101693956|FG001|STARTED|Period 2 (Day 4 to 6)||5||
48556607|NCT05024747|101693955|FG000|COMPLETED|Period 2 (Day 4 to 6)||10||
48556608|NCT05024747|101693956|FG001|COMPLETED|Period 2 (Day 4 to 6)||5||
48556609|NCT05024747|101693955|FG000|NOT COMPLETED|Period 2 (Day 4 to 6)||0||
48556610|NCT05024747|101693956|FG001|NOT COMPLETED|Period 2 (Day 4 to 6)||0||
48556611|NCT00662649|101693957|FG000|STARTED|Core Study (24 Months)||429||
48556612|NCT00662649|101693958|FG001|STARTED|Core Study (24 Months)||425||
48556613|NCT00662649|101693959|FG002|STARTED|Core Study (24 Months)||418||
48556614|NCT00662649|101693960|FG003|STARTED|Core Study (24 Months)||0||
48556615|NCT00662649|101693961|FG004|STARTED|Core Study (24 Months)||0||
48556616|NCT00662649|101693957|FG000|Intent to Treat (ITT)|Core Study (24 Months)||429||
48556617|NCT00662649|101693958|FG001|Intent to Treat (ITT)|Core Study (24 Months)||425||
48556618|NCT00662649|101693959|FG002|Intent to Treat (ITT)|Core Study (24 Months)||418||
48556619|NCT00662649|101693960|FG003|Intent to Treat (ITT)|Core Study (24 Months)||0||
48556620|NCT00662649|101693961|FG004|Intent to Treat (ITT)|Core Study (24 Months)||0||
48556621|NCT00662649|101693957|FG000|COMPLETED|Core Study (24 Months)||332||
48556622|NCT00662649|101693958|FG001|COMPLETED|Core Study (24 Months)||369||
48556623|NCT00662649|101693959|FG002|COMPLETED|Core Study (24 Months)||332||
48556624|NCT00662649|101693960|FG003|COMPLETED|Core Study (24 Months)||0||
48556625|NCT00662649|101693961|FG004|COMPLETED|Core Study (24 Months)||0||
48556626|NCT00662649|101693957|FG000|NOT COMPLETED|Core Study (24 Months)||97||
48556627|NCT00662649|101693958|FG001|NOT COMPLETED|Core Study (24 Months)||56||
48556628|NCT00662649|101693959|FG002|NOT COMPLETED|Core Study (24 Months)||86||
48556629|NCT00662649|101693960|FG003|NOT COMPLETED|Core Study (24 Months)||0||
48556630|NCT00662649|101693961|FG004|NOT COMPLETED|Core Study (24 Months)||0||
48556631|NCT00662649|101693957|FG000|STARTED|Extension Study (Month 24 to 60)||289||
48556632|NCT00662649|101693958|FG001|STARTED|Extension Study (Month 24 to 60)||331||
48556633|NCT00662649|101693959|FG002|STARTED|Extension Study (Month 24 to 60)||0||
48556634|NCT00662649|101693960|FG003|STARTED|Extension Study (Month 24 to 60)||145||
48556635|NCT00662649|101693961|FG004|STARTED|Extension Study (Month 24 to 60)||155||
48556636|NCT00662649|101693957|FG000|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||287||
48556637|NCT00662649|101693958|FG001|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||330||
48556638|NCT00662649|101693959|FG002|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||0||
48556639|NCT00662649|101693960|FG003|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||145||
48556640|NCT00662649|101693961|FG004|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||154||
48556641|NCT00662649|101693957|FG000|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||289||
48556642|NCT00662649|101693958|FG001|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||331||
48556643|NCT00662649|101693959|FG002|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||0||
48556644|NCT00662649|101693960|FG003|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||145||
48556645|NCT00662649|101693961|FG004|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||155||
48556646|NCT00662649|101693957|FG000|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||276||
48556647|NCT00662649|101693958|FG001|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||324||
48556648|NCT00662649|101693959|FG002|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||0||
48556649|NCT00662649|101693960|FG003|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||136||
48556650|NCT00662649|101693961|FG004|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||152||
48556651|NCT00662649|101693957|FG000|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||270||
48556652|NCT00662649|101693958|FG001|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||311||
48556653|NCT00662649|101693959|FG002|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||0||
48556654|NCT00662649|101693960|FG003|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||130||
48273126|NCT00943852|100992066|FG001|NOT COMPLETED|Fifth Period of Treatment Intervention||0||
48273127|NCT00943852|100992067|FG002|NOT COMPLETED|Fifth Period of Treatment Intervention||0||
48273128|NCT00943852|100992068|FG003|NOT COMPLETED|Fifth Period of Treatment Intervention||0||
48273129|NCT00943852|100992069|FG004|NOT COMPLETED|Fifth Period of Treatment Intervention||0||
48273130|NCT00943852|100992070|FG005|NOT COMPLETED|Fifth Period of Treatment Intervention||0||
48273131|NCT00943852|100992071|FG006|NOT COMPLETED|Fifth Period of Treatment Intervention||0||
48273132|NCT00943852|100992072|FG007|NOT COMPLETED|Fifth Period of Treatment Intervention||0||
48273133|NCT00943852|100992073|FG008|NOT COMPLETED|Fifth Period of Treatment Intervention||0||
48273134|NCT00943852|100992074|FG009|NOT COMPLETED|Fifth Period of Treatment Intervention||0||
48273135|NCT02470780|100992075|FG000|STARTED|Phase 1||2||
48273136|NCT02470780|100992076|FG001|STARTED|Phase 1||2||
48273137|NCT02470780|100992075|FG000|COMPLETED|Phase 1||2||
48556655|NCT00662649|101693961|FG004|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||145||
48393084|NCT03920865|101291504|FG002|STARTED|Overall Study||10||
48393085|NCT03920865|101291502|FG000|COMPLETED|Overall Study||8||
48273138|NCT02470780|100992076|FG001|COMPLETED|Phase 1||2||
48273139|NCT02470780|100992075|FG000|NOT COMPLETED|Phase 1||0||
48273140|NCT02470780|100992076|FG001|NOT COMPLETED|Phase 1||0||
48273141|NCT02470780|100992075|FG000|STARTED|Phase 2||0||
48273142|NCT02470780|100992076|FG001|STARTED|Phase 2||2||
48273143|NCT02470780|100992075|FG000|COMPLETED|Phase 2||0||
48273144|NCT02470780|100992076|FG001|COMPLETED|Phase 2||2||
48273145|NCT02470780|100992075|FG000|NOT COMPLETED|Phase 2||0||
48273146|NCT02470780|100992076|FG001|NOT COMPLETED|Phase 2||0||
48294159|NCT02527343|101047539|FG003|STARTED|OLE Period-Year 2: Week 105 to 156||0||
48393086|NCT03920865|101291503|FG001|COMPLETED|Overall Study||8||
48273147|NCT03724253|100992077|FG000|STARTED|Overall Study||5|Full Analysis Set (FAS) = all subjects who enter the study and receive the \[68Ga\]-NeoBOMB1 dose|
48273148|NCT03724253|100992078|FG001|STARTED|Overall Study||5|Full Analysis Set (FAS) = all subjects who enter the study and receive the \[68Ga\]-NeoBOMB1 dose|
48273149|NCT03724253|100992079|FG002|STARTED|Overall Study||5|Full Analysis Set (FAS) = all subjects who enter the study and receive the \[68Ga\]-NeoBOMB1 dose|
48273150|NCT03724253|100992080|FG003|STARTED|Overall Study||3|Full Analysis Set (FAS) = all subjects who enter the study and receive the \[68Ga\]-NeoBOMB1 dose|
48273151|NCT03724253|100992081|FG004|STARTED|Overall Study||1|Full Analysis Set (FAS) = all subjects who enter the study and receive the \[68Ga\]-NeoBOMB1 dose|
48556656|NCT00662649|101693957|FG000|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||254||
48556657|NCT00662649|101693958|FG001|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||301||
48556658|NCT00662649|101693959|FG002|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||0||
48556659|NCT00662649|101693960|FG003|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||120||
48556660|NCT00662649|101693961|FG004|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||136||
48556661|NCT00662649|101693957|FG000|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||125||
48556662|NCT00662649|101693958|FG001|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||152||
48556663|NCT00662649|101693959|FG002|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||0||
48556664|NCT00662649|101693960|FG003|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||58||
48556665|NCT00662649|101693961|FG004|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||67||
48556666|NCT00662649|101693957|FG000|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||31||
48556667|NCT00662649|101693958|FG001|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||32||
48556668|NCT00662649|101693959|FG002|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||0||
48556669|NCT00662649|101693960|FG003|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||11||
48556670|NCT00662649|101693961|FG004|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||13||
48556671|NCT00662649|101693957|FG000|COMPLETED|Extension Study (Month 24 to 60)||245||
48556672|NCT00662649|101693958|FG001|COMPLETED|Extension Study (Month 24 to 60)||290||
48556673|NCT00662649|101693959|FG002|COMPLETED|Extension Study (Month 24 to 60)||0||
48556674|NCT00662649|101693960|FG003|COMPLETED|Extension Study (Month 24 to 60)||112||
48556675|NCT00662649|101693961|FG004|COMPLETED|Extension Study (Month 24 to 60)||126||
48556676|NCT00662649|101693957|FG000|NOT COMPLETED|Extension Study (Month 24 to 60)||44||
48556677|NCT00662649|101693958|FG001|NOT COMPLETED|Extension Study (Month 24 to 60)||41||
48556678|NCT00662649|101693959|FG002|NOT COMPLETED|Extension Study (Month 24 to 60)||0||
48556679|NCT00662649|101693960|FG003|NOT COMPLETED|Extension Study (Month 24 to 60)||33||
48556680|NCT00662649|101693961|FG004|NOT COMPLETED|Extension Study (Month 24 to 60)||29||
48556681|NCT00768248|101693962|FG000|STARTED|Overall Study||1||
48556682|NCT00768248|101693963|FG001|STARTED|Overall Study||1||
48556683|NCT00768248|101693962|FG000|COMPLETED|Overall Study||0||
48556684|NCT00768248|101693963|FG001|COMPLETED|Overall Study||0||
48556685|NCT00768248|101693962|FG000|NOT COMPLETED|Overall Study||1||
48556686|NCT00768248|101693963|FG001|NOT COMPLETED|Overall Study||1||
48556687|NCT00524940|101693964|FG000|STARTED|Overall Study||124||
48556688|NCT00524940|101693964|FG000|COMPLETED|Overall Study||124||
48556689|NCT00524940|101693964|FG000|NOT COMPLETED|Overall Study||0||
48556690|NCT00560391|101693965|FG000|STARTED|Overall Study||6||
48556691|NCT00560391|101693966|FG001|STARTED|Overall Study||3||
48556692|NCT00560391|101693967|FG002|STARTED|Overall Study||3||
48556693|NCT00560391|101693968|FG003|STARTED|Overall Study||6||
48556694|NCT00560391|101693969|FG004|STARTED|Overall Study||17||
48556695|NCT00560391|101693965|FG000|COMPLETED|Overall Study||6||
48556696|NCT00560391|101693966|FG001|COMPLETED|Overall Study||3||
48556697|NCT00560391|101693967|FG002|COMPLETED|Overall Study||3||
48556698|NCT00560391|101693968|FG003|COMPLETED|Overall Study||5||
48556699|NCT00560391|101693969|FG004|COMPLETED|Overall Study||15||
48556700|NCT00560391|101693965|FG000|NOT COMPLETED|Overall Study||0||
48556701|NCT00560391|101693966|FG001|NOT COMPLETED|Overall Study||0||
48556702|NCT00560391|101693967|FG002|NOT COMPLETED|Overall Study||0||
48556703|NCT00560391|101693968|FG003|NOT COMPLETED|Overall Study||1||
48556704|NCT00560391|101693969|FG004|NOT COMPLETED|Overall Study||2||
48556705|NCT00423878|101693970|FG000|STARTED|Overall Study||109||
48556706|NCT00423878|101693971|FG001|STARTED|Overall Study||106||
48556707|NCT00423878|101693970|FG000|COMPLETED|Overall Study||89||
48556708|NCT00423878|101693971|FG001|COMPLETED|Overall Study||98||
48556709|NCT00423878|101693970|FG000|NOT COMPLETED|Overall Study||20||
48556710|NCT00423878|101693971|FG001|NOT COMPLETED|Overall Study||8||
48556711|NCT02575833|101693972|FG000|STARTED|Overall Study||44||
48556712|NCT02575833|101693973|FG001|STARTED|Overall Study||45||
48556713|NCT02575833|101693972|FG000|Received Study Drug|Overall Study||44||
48556714|NCT02575833|101693973|FG001|Received Study Drug|Overall Study||44||
48556715|NCT02575833|101693972|FG000|COMPLETED|Overall Study||43||
48556716|NCT02575833|101693973|FG001|COMPLETED|Overall Study||44||
48556717|NCT02575833|101693972|FG000|NOT COMPLETED|Overall Study||1||
48556718|NCT02575833|101693973|FG001|NOT COMPLETED|Overall Study||1||
48273152|NCT03724253|100992077|FG000|COMPLETED|Overall Study||5||
48273153|NCT03724253|100992078|FG001|COMPLETED|Overall Study||5||
48273154|NCT03724253|100992079|FG002|COMPLETED|Overall Study||5||
48273155|NCT03724253|100992080|FG003|COMPLETED|Overall Study||3||
48273156|NCT03724253|100992081|FG004|COMPLETED|Overall Study||1||
48273157|NCT03724253|100992077|FG000|NOT COMPLETED|Overall Study||0||
48273158|NCT03724253|100992078|FG001|NOT COMPLETED|Overall Study||0||
48273159|NCT03724253|100992079|FG002|NOT COMPLETED|Overall Study||0||
48273160|NCT03724253|100992080|FG003|NOT COMPLETED|Overall Study||0||
48273161|NCT03724253|100992081|FG004|NOT COMPLETED|Overall Study||0||
48273162|NCT03015129|100992082|FG000|STARTED|Overall Study||40||
48273163|NCT03015129|100992083|FG001|STARTED|Overall Study||40||
48273164|NCT03015129|100992082|FG000|COMPLETED|Overall Study||0||
48273165|NCT03015129|100992083|FG001|COMPLETED|Overall Study||0||
48273166|NCT03015129|100992082|FG000|NOT COMPLETED|Overall Study||40||
48273167|NCT03015129|100992083|FG001|NOT COMPLETED|Overall Study||40||
48273168|NCT00461981|100992084|FG000|STARTED|Overall Study||50||
48273169|NCT00461981|100992085|FG001|STARTED|Overall Study||51||
48273170|NCT00461981|100992084|FG000|COMPLETED|Overall Study||39||
48273171|NCT00461981|100992085|FG001|COMPLETED|Overall Study||42||
48273172|NCT00461981|100992084|FG000|NOT COMPLETED|Overall Study||11||
48273173|NCT00461981|100992085|FG001|NOT COMPLETED|Overall Study||9||
48273174|NCT03211117|100992086|FG000|STARTED|Overall Study||0||
48694335|NCT00090779|102036366|FG000|STARTED|Step 2||6||
48273175|NCT03211117|100992087|FG001|STARTED|Overall Study||3||
48273176|NCT03211117|100992086|FG000|COMPLETED|Overall Study||0||
48273177|NCT03211117|100992087|FG001|COMPLETED|Overall Study||3||
48273178|NCT03211117|100992086|FG000|NOT COMPLETED|Overall Study||0||
48273179|NCT03211117|100992087|FG001|NOT COMPLETED|Overall Study||0||
48273180|NCT04079634|100992088|FG000|STARTED|Overall Study||23||
48273181|NCT04079634|100992089|FG001|STARTED|Overall Study||19||
48273182|NCT04079634|100992088|FG000|COMPLETED|Overall Study||23||
48273183|NCT04079634|100992089|FG001|COMPLETED|Overall Study||19||
48273184|NCT04079634|100992088|FG000|NOT COMPLETED|Overall Study||0||
48273185|NCT04079634|100992089|FG001|NOT COMPLETED|Overall Study||0||
48273186|NCT02179177|100992090|FG000|STARTED|Overall Study||8||
48273187|NCT02179177|100992091|FG001|STARTED|Overall Study||8||
48273188|NCT02179177|100992090|FG000|COMPLETED|Overall Study||6||
48273189|NCT02179177|100992091|FG001|COMPLETED|Overall Study||6||
48694336|NCT00090779|102036367|FG001|STARTED|Step 2||19||
48694337|NCT00090779|102036366|FG000|COMPLETED|Step 2||0||
48273190|NCT02179177|100992090|FG000|NOT COMPLETED|Overall Study||2||
48273191|NCT02179177|100992091|FG001|NOT COMPLETED|Overall Study||2||
48273192|NCT03417570|100992092|FG000|STARTED|Overall Study||50||
48273193|NCT03417570|100992093|FG001|STARTED|Overall Study||50||
48273194|NCT03417570|100992092|FG000|COMPLETED|Overall Study||50||
48273195|NCT03417570|100992093|FG001|COMPLETED|Overall Study||50||
48273196|NCT03417570|100992092|FG000|NOT COMPLETED|Overall Study||0||
48273197|NCT03417570|100992093|FG001|NOT COMPLETED|Overall Study||0||
48273198|NCT00406692|100992094|FG000|STARTED|Overall Study||16||
48273199|NCT00406692|100992094|FG000|COMPLETED|Overall Study||9||
48273200|NCT00406692|100992094|FG000|NOT COMPLETED|Overall Study||7||
48273201|NCT00523640|100992095|FG000|STARTED|Overall Study||30||
48273202|NCT00523640|100992095|FG000|COMPLETED|Overall Study||29||
48273203|NCT00523640|100992095|FG000|NOT COMPLETED|Overall Study||1||
48273204|NCT01228318|100992096|FG000|STARTED|Overall Study||34||
48273205|NCT01228318|100992097|FG001|STARTED|Overall Study||29||
48273206|NCT01228318|100992096|FG000|COMPLETED|Overall Study||30||
48273207|NCT01228318|100992097|FG001|COMPLETED|Overall Study||22||
48273208|NCT01228318|100992096|FG000|NOT COMPLETED|Overall Study||4||
48273209|NCT01228318|100992097|FG001|NOT COMPLETED|Overall Study||7||
48273210|NCT02703259|100992098|FG000|STARTED|24 Hours Postoperative Assessment||70||
48273211|NCT02703259|100992099|FG001|STARTED|24 Hours Postoperative Assessment||67||
48273212|NCT02703259|100992098|FG000|COMPLETED|24 Hours Postoperative Assessment||68||
48273213|NCT02703259|100992099|FG001|COMPLETED|24 Hours Postoperative Assessment||61||
48273214|NCT02703259|100992098|FG000|NOT COMPLETED|24 Hours Postoperative Assessment||2||
48273215|NCT02703259|100992099|FG001|NOT COMPLETED|24 Hours Postoperative Assessment||6||
48273216|NCT02703259|100992098|FG000|STARTED|2 Weeks Postoperative Assessment||68||
48273217|NCT02703259|100992099|FG001|STARTED|2 Weeks Postoperative Assessment||61||
48273218|NCT02703259|100992098|FG000|COMPLETED|2 Weeks Postoperative Assessment||58||
48273219|NCT02703259|100992099|FG001|COMPLETED|2 Weeks Postoperative Assessment||51||
48273220|NCT02703259|100992098|FG000|NOT COMPLETED|2 Weeks Postoperative Assessment||10||
48273221|NCT02703259|100992099|FG001|NOT COMPLETED|2 Weeks Postoperative Assessment||10||
48273222|NCT00667225|100992100|FG000|STARTED|Overall Study||16||
48273223|NCT00667225|100992101|FG001|STARTED|Overall Study||13||
48273224|NCT00667225|100992100|FG000|COMPLETED|Overall Study||15||
48273225|NCT00667225|100992101|FG001|COMPLETED|Overall Study||12||
48273226|NCT00667225|100992100|FG000|NOT COMPLETED|Overall Study||1||
48273227|NCT00667225|100992101|FG001|NOT COMPLETED|Overall Study||1||
48273228|NCT02839889|100992102|FG000|STARTED|Randomization Period||2||
48273229|NCT02839889|100992103|FG001|STARTED|Randomization Period||3||
48694338|NCT00090779|102036367|FG001|COMPLETED|Step 2||1||
48694339|NCT00090779|102036366|FG000|NOT COMPLETED|Step 2||6||
48694340|NCT00090779|102036367|FG001|NOT COMPLETED|Step 2||18||
48694341|NCT00090779|102036366|FG000|STARTED|Step 3||7||
48273230|NCT02839889|100992102|FG000|COMPLETED|Randomization Period||2||
48273231|NCT02839889|100992103|FG001|COMPLETED|Randomization Period||3||
48273232|NCT02839889|100992102|FG000|NOT COMPLETED|Randomization Period||0||
48273233|NCT02839889|100992103|FG001|NOT COMPLETED|Randomization Period||0||
48273234|NCT02839889|100992102|FG000|STARTED|Open-Label Period||0||
48273235|NCT02839889|100992103|FG001|STARTED|Open-Label Period||5||
48273236|NCT02839889|100992102|FG000|COMPLETED|Open-Label Period||0||
48273237|NCT02839889|100992103|FG001|COMPLETED|Open-Label Period||4||
48273238|NCT02839889|100992102|FG000|NOT COMPLETED|Open-Label Period||0||
48273239|NCT02839889|100992103|FG001|NOT COMPLETED|Open-Label Period||1||
48273240|NCT00710905|100992104|FG000|STARTED|Overall Study||50||
48273241|NCT00710905|100992104|FG000|COMPLETED|Overall Study||34||
48273242|NCT00710905|100992104|FG000|NOT COMPLETED|Overall Study||16||
48273243|NCT03174431|100992105|FG000|STARTED|Overall Study||25||
48273244|NCT03174431|100992106|FG001|STARTED|Overall Study||25||
48273245|NCT03174431|100992105|FG000|COMPLETED|Overall Study||8||
48273246|NCT03174431|100992106|FG001|COMPLETED|Overall Study||9||
48273247|NCT03174431|100992105|FG000|NOT COMPLETED|Overall Study||17||
48273248|NCT03174431|100992106|FG001|NOT COMPLETED|Overall Study||16||
48273249|NCT01868425|100992107|FG000|STARTED|Overall Study||55||
48273250|NCT01868425|100992108|FG001|STARTED|Overall Study||57||
48273251|NCT01868425|100992107|FG000|COMPLETED|Overall Study||55||
48273252|NCT01868425|100992108|FG001|COMPLETED|Overall Study||57||
48273253|NCT01868425|100992107|FG000|NOT COMPLETED|Overall Study||0||
48273254|NCT01868425|100992108|FG001|NOT COMPLETED|Overall Study||0||
48556719|NCT00606632|101693974|FG000|STARTED|Overall Study||226||
48556720|NCT00606632|101693974|FG000|COMPLETED|Overall Study||204||
48273255|NCT00133809|100992109|FG000|STARTED|Overall Study||8||
48273256|NCT00133809|100992109|FG000|COMPLETED|Overall Study||8||
48273257|NCT00133809|100992109|FG000|NOT COMPLETED|Overall Study||0||
48273258|NCT01021618|100992110|FG000|STARTED|Overall Study||44||
48273259|NCT01021618|100992111|FG001|STARTED|Overall Study||96||
48273260|NCT01021618|100992110|FG000|COMPLETED|Overall Study||44||
48273261|NCT01021618|100992111|FG001|COMPLETED|Overall Study||96||
48273262|NCT01021618|100992110|FG000|NOT COMPLETED|Overall Study||0||
48273263|NCT01021618|100992111|FG001|NOT COMPLETED|Overall Study||0||
48273264|NCT02385240|100992112|FG000|STARTED|Overall Study||183||
48273265|NCT02385240|100992113|FG001|STARTED|Overall Study||184||
48273266|NCT02385240|100992114|FG002|STARTED|Overall Study||185||
48273267|NCT02385240|100992112|FG000|COMPLETED|Overall Study||182||
48556721|NCT00606632|101693974|FG000|NOT COMPLETED|Overall Study||22||
48556722|NCT01288079|101693975|FG000|STARTED|Overall Study||37||
48273268|NCT02385240|100992113|FG001|COMPLETED|Overall Study||178||
48273269|NCT02385240|100992114|FG002|COMPLETED|Overall Study||184||
48273270|NCT02385240|100992112|FG000|NOT COMPLETED|Overall Study||1||
48273271|NCT02385240|100992113|FG001|NOT COMPLETED|Overall Study||6||
48273272|NCT02385240|100992114|FG002|NOT COMPLETED|Overall Study||1||
48273273|NCT03241459|100992115|FG000|STARTED|Randomization||222||
48273274|NCT03241459|100992116|FG001|STARTED|Randomization||224||
48273275|NCT03241459|100992115|FG000|COMPLETED|Randomization||222||
48556723|NCT01288079|101693976|FG001|STARTED|Overall Study||36||
48556724|NCT01288079|101693977|FG002|STARTED|Overall Study||37||
48556725|NCT01288079|101693978|FG003|STARTED|Overall Study||35||
48556726|NCT01288079|101693975|FG000|COMPLETED|Overall Study||17||
48556727|NCT01288079|101693976|FG001|COMPLETED|Overall Study||9||
48556728|NCT01288079|101693977|FG002|COMPLETED|Overall Study||18||
48556729|NCT01288079|101693978|FG003|COMPLETED|Overall Study||18||
48556730|NCT01288079|101693975|FG000|NOT COMPLETED|Overall Study||20||
48273276|NCT03241459|100992116|FG001|COMPLETED|Randomization||224||
48273277|NCT03241459|100992115|FG000|NOT COMPLETED|Randomization||0||
48273278|NCT03241459|100992116|FG001|NOT COMPLETED|Randomization||0||
48273279|NCT03241459|100992115|FG000|STARTED|1-Month Visit (30 Days, - 2 to +15 Days)||222||
48273280|NCT03241459|100992116|FG001|STARTED|1-Month Visit (30 Days, - 2 to +15 Days)||224||
48273281|NCT03241459|100992115|FG000|COMPLETED|1-Month Visit (30 Days, - 2 to +15 Days)||215||
48273282|NCT03241459|100992116|FG001|COMPLETED|1-Month Visit (30 Days, - 2 to +15 Days)||224||
48273283|NCT03241459|100992115|FG000|NOT COMPLETED|1-Month Visit (30 Days, - 2 to +15 Days)||7||
48273284|NCT03241459|100992116|FG001|NOT COMPLETED|1-Month Visit (30 Days, - 2 to +15 Days)||0||
48273285|NCT03241459|100992115|FG000|STARTED|6-Month Visit (180 Days +/- 30 Days)||215||
48273286|NCT03241459|100992116|FG001|STARTED|6-Month Visit (180 Days +/- 30 Days)||224||
48273287|NCT03241459|100992115|FG000|COMPLETED|6-Month Visit (180 Days +/- 30 Days)||209||
48273288|NCT03241459|100992116|FG001|COMPLETED|6-Month Visit (180 Days +/- 30 Days)||223||
48273289|NCT03241459|100992115|FG000|NOT COMPLETED|6-Month Visit (180 Days +/- 30 Days)||6||
48273290|NCT03241459|100992116|FG001|NOT COMPLETED|6-Month Visit (180 Days +/- 30 Days)||1||
48273291|NCT03241459|100992115|FG000|STARTED|12-Month Visit (365 Days +/- 30 Days)||209||
48273292|NCT03241459|100992116|FG001|STARTED|12-Month Visit (365 Days +/- 30 Days)||223||
48273293|NCT03241459|100992115|FG000|COMPLETED|12-Month Visit (365 Days +/- 30 Days)||198||
48273294|NCT03241459|100992116|FG001|COMPLETED|12-Month Visit (365 Days +/- 30 Days)||214||
48273295|NCT03241459|100992115|FG000|NOT COMPLETED|12-Month Visit (365 Days +/- 30 Days)||11||
48273296|NCT03241459|100992116|FG001|NOT COMPLETED|12-Month Visit (365 Days +/- 30 Days)||9||
48393087|NCT03920865|101291504|FG002|COMPLETED|Overall Study||10||
48556731|NCT01288079|101693976|FG001|NOT COMPLETED|Overall Study||27||
48273297|NCT03241459|100992115|FG000|STARTED|24-Month Visit (730 Days +/- 60 Days)||198||
48273298|NCT03241459|100992116|FG001|STARTED|24-Month Visit (730 Days +/- 60 Days)||214||
48273299|NCT03241459|100992115|FG000|COMPLETED|24-Month Visit (730 Days +/- 60 Days)||184||
48273300|NCT03241459|100992116|FG001|COMPLETED|24-Month Visit (730 Days +/- 60 Days)||200||
48273301|NCT03241459|100992115|FG000|NOT COMPLETED|24-Month Visit (730 Days +/- 60 Days)||14||
48273302|NCT03241459|100992116|FG001|NOT COMPLETED|24-Month Visit (730 Days +/- 60 Days)||14||
48273303|NCT02406677|100992117|FG000|STARTED|Overall Study||6436|Total Patients Enrolled|
48556732|NCT01288079|101693977|FG002|NOT COMPLETED|Overall Study||19||
48694342|NCT00090779|102036367|FG001|STARTED|Step 3||5||
48273304|NCT02406677|100992118|FG001|STARTED|Overall Study||4565|Total Patients Enrolled|
48273305|NCT02406677|100992117|FG000|COMPLETED|Overall Study||6135||
48273306|NCT02406677|100992118|FG001|COMPLETED|Overall Study||3967||
48273307|NCT02406677|100992117|FG000|NOT COMPLETED|Overall Study||301||
48273308|NCT02406677|100992118|FG001|NOT COMPLETED|Overall Study||598||
48273309|NCT01259089|100992119|FG000|STARTED|Reached First Response at 4 Weeks||3||
48273310|NCT01259089|100992120|FG001|STARTED|Reached First Response at 4 Weeks||3||
48273311|NCT01259089|100992121|FG002|STARTED|Reached First Response at 4 Weeks||3||
48556733|NCT01288079|101693978|FG003|NOT COMPLETED|Overall Study||17||
48556734|NCT02040805|101693979|FG000|STARTED|Overall Study||160||
48556735|NCT02040805|101693980|FG001|STARTED|Overall Study||163||
48556736|NCT02040805|101693979|FG000|COMPLETED|Overall Study||118||
48556737|NCT02040805|101693980|FG001|COMPLETED|Overall Study||113||
48556738|NCT02040805|101693979|FG000|NOT COMPLETED|Overall Study||42||
48556739|NCT02040805|101693980|FG001|NOT COMPLETED|Overall Study||50||
48556740|NCT04586673|101693981|FG000|STARTED|Overall Study||3||
48556741|NCT04586673|101693982|FG001|STARTED|Overall Study||10||
48556742|NCT04586673|101693981|FG000|COMPLETED|Overall Study||3||
48556743|NCT04586673|101693982|FG001|COMPLETED|Overall Study||10||
48556744|NCT04586673|101693981|FG000|NOT COMPLETED|Overall Study||0||
48556745|NCT04586673|101693982|FG001|NOT COMPLETED|Overall Study||0||
48556746|NCT03639779|101693983|FG000|STARTED|Overall Study||5||10
48556747|NCT03639779|101693983|FG000|Baseline|Overall Study||5||10
48556748|NCT03639779|101693983|FG000|Month 1|Overall Study||5||10
48556749|NCT03639779|101693983|FG000|Month 2|Overall Study||4||8
48556750|NCT03639779|101693983|FG000|Month 3|Overall Study||4||8
48556751|NCT03639779|101693983|FG000|COMPLETED|Overall Study||4||8
48273312|NCT01259089|100992122|FG003|STARTED|Reached First Response at 4 Weeks||3||
48273313|NCT01259089|100992123|FG004|STARTED|Reached First Response at 4 Weeks||6||
48273314|NCT01259089|100992124|FG005|STARTED|Reached First Response at 4 Weeks||20||
48273315|NCT01259089|100992119|FG000|Started Treatment on Study|Reached First Response at 4 Weeks||3||
48273316|NCT01259089|100992120|FG001|Started Treatment on Study|Reached First Response at 4 Weeks||3||
48393088|NCT03920865|101291502|FG000|NOT COMPLETED|Overall Study||0||
48556752|NCT03639779|101693983|FG000|NOT COMPLETED|Overall Study||1||2
48556753|NCT03307226|101693984|FG000|STARTED|Overall Study||471||
48556754|NCT03307226|101693985|FG001|STARTED|Overall Study||381||
48556755|NCT03307226|101693986|FG002|STARTED|Overall Study||408||
48556756|NCT03307226|101693984|FG000|COMPLETED|Overall Study||441||
48556757|NCT03307226|101693985|FG001|COMPLETED|Overall Study||344||
48556758|NCT03307226|101693986|FG002|COMPLETED|Overall Study||380||
48556759|NCT03307226|101693984|FG000|NOT COMPLETED|Overall Study||30||
48556760|NCT03307226|101693985|FG001|NOT COMPLETED|Overall Study||37||
48556761|NCT03307226|101693986|FG002|NOT COMPLETED|Overall Study||28||
48556762|NCT01526655|101693987|FG000|STARTED|Overall Study||25||
48556763|NCT01526655|101693988|FG001|STARTED|Overall Study||25||
48556764|NCT01526655|101693987|FG000|COMPLETED|Overall Study||25||
48556765|NCT01526655|101693988|FG001|COMPLETED|Overall Study||24||
48556766|NCT01526655|101693987|FG000|NOT COMPLETED|Overall Study||0||
48556767|NCT01526655|101693988|FG001|NOT COMPLETED|Overall Study||1||
48556768|NCT01276041|101693989|FG000|STARTED|Overall Study||70||
48556769|NCT01276041|101693989|FG000|COMPLETED|Overall Study||67||
48556770|NCT01276041|101693989|FG000|NOT COMPLETED|Overall Study||3||
48556771|NCT01995513|101693990|FG000|STARTED|Period 1: First Open Label Treatment||509||
48556772|NCT01995513|101693991|FG001|STARTED|Period 1: First Open Label Treatment||0||
48556773|NCT01995513|101693992|FG002|STARTED|Period 1: First Open Label Treatment||0||
48556774|NCT01995513|101693993|FG003|STARTED|Period 1: First Open Label Treatment||0||
48694343|NCT00090779|102036366|FG000|COMPLETED|Step 3||0||
48694344|NCT00090779|102036367|FG001|COMPLETED|Step 3||0||
48694345|NCT00090779|102036366|FG000|NOT COMPLETED|Step 3||7||
48694346|NCT00090779|102036367|FG001|NOT COMPLETED|Step 3||5||
48393089|NCT03920865|101291503|FG001|NOT COMPLETED|Overall Study||0||
48556775|NCT01995513|101693990|FG000|COMPLETED|Period 1: First Open Label Treatment||264||
48556776|NCT01995513|101693991|FG001|COMPLETED|Period 1: First Open Label Treatment||0||
48556777|NCT01995513|101693992|FG002|COMPLETED|Period 1: First Open Label Treatment||0||
48556778|NCT01995513|101693993|FG003|COMPLETED|Period 1: First Open Label Treatment||0||
48556779|NCT01995513|101693990|FG000|NOT COMPLETED|Period 1: First Open Label Treatment||245||
48694347|NCT01140867|102036368|FG000|STARTED|Overall Study||121||
48556780|NCT01995513|101693991|FG001|NOT COMPLETED|Period 1: First Open Label Treatment||0||
48556781|NCT01995513|101693992|FG002|NOT COMPLETED|Period 1: First Open Label Treatment||0||
48556782|NCT01995513|101693993|FG003|NOT COMPLETED|Period 1: First Open Label Treatment||0||
48556783|NCT01995513|101693990|FG000|STARTED|Period 1: Second Open Label Treatment||0||
48556784|NCT01995513|101693991|FG001|STARTED|Period 1: Second Open Label Treatment||13||
48556785|NCT01995513|101693992|FG002|STARTED|Period 1: Second Open Label Treatment||0||
48556786|NCT01995513|101693993|FG003|STARTED|Period 1: Second Open Label Treatment||0||
48556787|NCT01995513|101693990|FG000|COMPLETED|Period 1: Second Open Label Treatment||0||
48556788|NCT01995513|101693991|FG001|COMPLETED|Period 1: Second Open Label Treatment||0||
48556789|NCT01995513|101693992|FG002|COMPLETED|Period 1: Second Open Label Treatment||0||
48556790|NCT01995513|101693993|FG003|COMPLETED|Period 1: Second Open Label Treatment||0||
48556791|NCT01995513|101693990|FG000|NOT COMPLETED|Period 1: Second Open Label Treatment||0||
48556792|NCT01995513|101693991|FG001|NOT COMPLETED|Period 1: Second Open Label Treatment||13||
48556793|NCT01995513|101693992|FG002|NOT COMPLETED|Period 1: Second Open Label Treatment||0||
48556794|NCT01995513|101693993|FG003|NOT COMPLETED|Period 1: Second Open Label Treatment||0||
48556795|NCT01995513|101693990|FG000|STARTED|Period 2: Double Blind Treatment||0||
48556796|NCT01995513|101693991|FG001|STARTED|Period 2: Double Blind Treatment||0||
48556797|NCT01995513|101693992|FG002|STARTED|Period 2: Double Blind Treatment||126||
48556798|NCT01995513|101693993|FG003|STARTED|Period 2: Double Blind Treatment||125||
48556799|NCT01995513|101693990|FG000|Treated|Period 2: Double Blind Treatment||0||
48556800|NCT01995513|101693991|FG001|Treated|Period 2: Double Blind Treatment||0||
48556801|NCT01995513|101693992|FG002|Treated|Period 2: Double Blind Treatment||125||
48556802|NCT01995513|101693993|FG003|Treated|Period 2: Double Blind Treatment||124||
48556803|NCT01995513|101693990|FG000|COMPLETED|Period 2: Double Blind Treatment||0||
48556804|NCT01995513|101693991|FG001|COMPLETED|Period 2: Double Blind Treatment||0||
48556805|NCT01995513|101693992|FG002|COMPLETED|Period 2: Double Blind Treatment||0||
48556806|NCT01995513|101693993|FG003|COMPLETED|Period 2: Double Blind Treatment||0||
48556807|NCT01995513|101693990|FG000|NOT COMPLETED|Period 2: Double Blind Treatment||0||
48556808|NCT01995513|101693991|FG001|NOT COMPLETED|Period 2: Double Blind Treatment||0||
48556809|NCT01995513|101693992|FG002|NOT COMPLETED|Period 2: Double Blind Treatment||126||
48556810|NCT01995513|101693993|FG003|NOT COMPLETED|Period 2: Double Blind Treatment||125||
48556811|NCT02404805|101693994|FG000|STARTED|Overall Study||5||
48556812|NCT02404805|101693995|FG001|STARTED|Overall Study||3||
48556813|NCT02404805|101693996|FG002|STARTED|Overall Study||5||
48556814|NCT02404805|101693997|FG003|STARTED|Overall Study||5||
48556815|NCT02404805|101693998|FG004|STARTED|Overall Study||3||
48556816|NCT02404805|101693999|FG005|STARTED|Overall Study||4||
48556817|NCT02404805|101693994|FG000|COMPLETED|Overall Study||4||
48556818|NCT02404805|101693995|FG001|COMPLETED|Overall Study||3||
48556819|NCT02404805|101693996|FG002|COMPLETED|Overall Study||5||
48556820|NCT02404805|101693997|FG003|COMPLETED|Overall Study||5||
48556821|NCT02404805|101693998|FG004|COMPLETED|Overall Study||3||
48556822|NCT02404805|101693999|FG005|COMPLETED|Overall Study||4||
48556823|NCT02404805|101693994|FG000|NOT COMPLETED|Overall Study||1||
48556824|NCT02404805|101693995|FG001|NOT COMPLETED|Overall Study||0||
48556825|NCT02404805|101693996|FG002|NOT COMPLETED|Overall Study||0||
48556826|NCT02404805|101693997|FG003|NOT COMPLETED|Overall Study||0||
48556827|NCT02404805|101693998|FG004|NOT COMPLETED|Overall Study||0||
48556828|NCT02404805|101693999|FG005|NOT COMPLETED|Overall Study||0||
48556829|NCT04583735|101694000|FG000|STARTED|Double-masked Treatment Period||42||
48556830|NCT04583735|101694001|FG001|STARTED|Double-masked Treatment Period||20||
48556831|NCT04583735|101694000|FG000|Intent-to-treat Populaton|Double-masked Treatment Period||42||
48556832|NCT04583735|101694001|FG001|Intent-to-treat Populaton|Double-masked Treatment Period||20||
48556833|NCT04583735|101694000|FG000|Safety Analysis Population|Double-masked Treatment Period||41||
48556834|NCT04583735|101694001|FG001|Safety Analysis Population|Double-masked Treatment Period||20||
48110966|NCT02350309|100598021|FG005|COMPLETED|Treatment Period 3 (2 Days)||12||
48556835|NCT04583735|101694000|FG000|COMPLETED|Double-masked Treatment Period||39||
48556836|NCT04583735|101694001|FG001|COMPLETED|Double-masked Treatment Period||19||
48556837|NCT04583735|101694000|FG000|NOT COMPLETED|Double-masked Treatment Period||3||
48110967|NCT02350309|100598016|FG000|NOT COMPLETED|Treatment Period 3 (2 Days)||0||
48110968|NCT02350309|100598017|FG001|NOT COMPLETED|Treatment Period 3 (2 Days)||0||
48556838|NCT04583735|101694001|FG001|NOT COMPLETED|Double-masked Treatment Period||1||
48556839|NCT04583735|101694000|FG000|STARTED|Open-label Treatment Period||12||
48110969|NCT02350309|100598018|FG002|NOT COMPLETED|Treatment Period 3 (2 Days)||0||
48556840|NCT04583735|101694001|FG001|STARTED|Open-label Treatment Period||12||
48556841|NCT04583735|101694000|FG000|COMPLETED|Open-label Treatment Period||10||
48556842|NCT04583735|101694001|FG001|COMPLETED|Open-label Treatment Period||10||
48556843|NCT04583735|101694000|FG000|NOT COMPLETED|Open-label Treatment Period||2||
48556844|NCT04583735|101694001|FG001|NOT COMPLETED|Open-label Treatment Period||2||
48556845|NCT04352101|101694002|FG000|STARTED|Overall Study||10||
48556846|NCT04352101|101694003|FG001|STARTED|Overall Study||8||
48556847|NCT04352101|101694002|FG000|COMPLETED|Overall Study||8||
48556848|NCT04352101|101694003|FG001|COMPLETED|Overall Study||7||
48556849|NCT04352101|101694002|FG000|NOT COMPLETED|Overall Study||2||
48556850|NCT04352101|101694003|FG001|NOT COMPLETED|Overall Study||1||
48556851|NCT01640249|101694004|FG000|STARTED|Period 1||3||
48556852|NCT01640249|101694005|FG001|STARTED|Period 1||2||
48556853|NCT01640249|101694006|FG002|STARTED|Period 1||2||
48556854|NCT01640249|101694007|FG003|STARTED|Period 1||2||
48556855|NCT01640249|101694008|FG004|STARTED|Period 1||2||
48556856|NCT01640249|101694009|FG005|STARTED|Period 1||5||
48556857|NCT01640249|101694010|FG006|STARTED|Period 1||2||
48556858|NCT01640249|101694004|FG000|Received at Least 1 Dose of Study Drug|Period 1||3||
48556859|NCT01640249|101694005|FG001|Received at Least 1 Dose of Study Drug|Period 1||2||
48556860|NCT01640249|101694006|FG002|Received at Least 1 Dose of Study Drug|Period 1||2||
48556861|NCT01640249|101694007|FG003|Received at Least 1 Dose of Study Drug|Period 1||2||
48556862|NCT01640249|101694008|FG004|Received at Least 1 Dose of Study Drug|Period 1||2||
48556863|NCT01640249|101694009|FG005|Received at Least 1 Dose of Study Drug|Period 1||5||
48556864|NCT01640249|101694010|FG006|Received at Least 1 Dose of Study Drug|Period 1||2||
48556865|NCT01640249|101694004|FG000|COMPLETED|Period 1||2||
48556866|NCT01640249|101694005|FG001|COMPLETED|Period 1||2||
48556867|NCT01640249|101694006|FG002|COMPLETED|Period 1||2||
48556868|NCT01640249|101694007|FG003|COMPLETED|Period 1||2||
48556869|NCT01640249|101694008|FG004|COMPLETED|Period 1||2||
48556870|NCT01640249|101694009|FG005|COMPLETED|Period 1||4||
48556871|NCT01640249|101694010|FG006|COMPLETED|Period 1||2||
48556872|NCT01640249|101694004|FG000|NOT COMPLETED|Period 1||1||
48556873|NCT01640249|101694005|FG001|NOT COMPLETED|Period 1||0||
48556874|NCT01640249|101694006|FG002|NOT COMPLETED|Period 1||0||
48556875|NCT01640249|101694007|FG003|NOT COMPLETED|Period 1||0||
48556876|NCT01640249|101694008|FG004|NOT COMPLETED|Period 1||0||
48556877|NCT01640249|101694009|FG005|NOT COMPLETED|Period 1||1||
48110970|NCT02350309|100598019|FG003|NOT COMPLETED|Treatment Period 3 (2 Days)||0||
48556878|NCT01640249|101694010|FG006|NOT COMPLETED|Period 1||0||
48694348|NCT01140867|102036368|FG000|COMPLETED|Overall Study||88||
48694349|NCT01140867|102036368|FG000|NOT COMPLETED|Overall Study||33||
48110971|NCT02350309|100598020|FG004|NOT COMPLETED|Treatment Period 3 (2 Days)||0||
48110972|NCT02350309|100598021|FG005|NOT COMPLETED|Treatment Period 3 (2 Days)||0||
48110973|NCT02350309|100598016|FG000|STARTED|Washout Period 3 (12-16 Days)||12||
48556879|NCT01640249|101694004|FG000|STARTED|Period 2||2||
48556880|NCT01640249|101694005|FG001|STARTED|Period 2||2||
48556881|NCT01640249|101694006|FG002|STARTED|Period 2||2||
48694350|NCT01832493|102036369|FG000|STARTED|Overall Study||50||
48694351|NCT01832493|102036369|FG000|COMPLETED|Overall Study||42||
48694352|NCT01832493|102036369|FG000|NOT COMPLETED|Overall Study||8||
48694353|NCT00416494|102036370|FG000|STARTED|Overall Study||19||
48694354|NCT00416494|102036371|FG001|STARTED|Overall Study||31||
48694355|NCT00416494|102036370|FG000|COMPLETED|Overall Study||19||
48694356|NCT00416494|102036371|FG001|COMPLETED|Overall Study||31||
48694357|NCT00416494|102036370|FG000|NOT COMPLETED|Overall Study||0||
48694358|NCT00416494|102036371|FG001|NOT COMPLETED|Overall Study||0||
48694359|NCT00617097|102036372|FG000|STARTED|Overall Study||25||
48556882|NCT01640249|101694007|FG003|STARTED|Period 2||2||
48556883|NCT01640249|101694008|FG004|STARTED|Period 2||2||
48556884|NCT01640249|101694009|FG005|STARTED|Period 2||4||
48556885|NCT01640249|101694010|FG006|STARTED|Period 2||2||
48556886|NCT01640249|101694004|FG000|COMPLETED|Period 2||2||
48556887|NCT01640249|101694005|FG001|COMPLETED|Period 2||2||
48556888|NCT01640249|101694006|FG002|COMPLETED|Period 2||2||
48556889|NCT01640249|101694007|FG003|COMPLETED|Period 2||2||
48556890|NCT01640249|101694008|FG004|COMPLETED|Period 2||2||
48556891|NCT01640249|101694009|FG005|COMPLETED|Period 2||4||
48556892|NCT01640249|101694010|FG006|COMPLETED|Period 2||2||
48556893|NCT01640249|101694004|FG000|NOT COMPLETED|Period 2||0||
48556894|NCT01640249|101694005|FG001|NOT COMPLETED|Period 2||0||
48556895|NCT01640249|101694006|FG002|NOT COMPLETED|Period 2||0||
48556896|NCT01640249|101694007|FG003|NOT COMPLETED|Period 2||0||
48556897|NCT01640249|101694008|FG004|NOT COMPLETED|Period 2||0||
48556898|NCT01640249|101694009|FG005|NOT COMPLETED|Period 2||0||
48556899|NCT01640249|101694010|FG006|NOT COMPLETED|Period 2||0||
48556900|NCT01640249|101694004|FG000|STARTED|Period 3||2||
48556901|NCT01640249|101694005|FG001|STARTED|Period 3||2||
48556902|NCT01640249|101694006|FG002|STARTED|Period 3||2||
48556903|NCT01640249|101694007|FG003|STARTED|Period 3||2||
48556904|NCT01640249|101694008|FG004|STARTED|Period 3||0||
48556905|NCT01640249|101694009|FG005|STARTED|Period 3||0||
48556906|NCT01640249|101694010|FG006|STARTED|Period 3||0||
48556907|NCT01640249|101694004|FG000|COMPLETED|Period 3||2||
48556908|NCT01640249|101694005|FG001|COMPLETED|Period 3||2||
48556909|NCT01640249|101694006|FG002|COMPLETED|Period 3||2||
48556910|NCT01640249|101694007|FG003|COMPLETED|Period 3||1||
48556911|NCT01640249|101694008|FG004|COMPLETED|Period 3||0||
48556912|NCT01640249|101694009|FG005|COMPLETED|Period 3||0||
48556913|NCT01640249|101694010|FG006|COMPLETED|Period 3||0||
48556914|NCT01640249|101694004|FG000|NOT COMPLETED|Period 3||0||
48556915|NCT01640249|101694005|FG001|NOT COMPLETED|Period 3||0||
48694360|NCT00617097|102036373|FG001|STARTED|Overall Study||25||
48694361|NCT00617097|102036372|FG000|COMPLETED|Overall Study||25||
48694362|NCT00617097|102036373|FG001|COMPLETED|Overall Study||25||
48694363|NCT00617097|102036372|FG000|NOT COMPLETED|Overall Study||0||
48694364|NCT00617097|102036373|FG001|NOT COMPLETED|Overall Study||0||
48694365|NCT00431444|102036374|FG000|STARTED|Overall Study||56||
48694366|NCT00431444|102036375|FG001|STARTED|Overall Study||53||
48110974|NCT02350309|100598017|FG001|STARTED|Washout Period 3 (12-16 Days)||11||
48110975|NCT02350309|100598018|FG002|STARTED|Washout Period 3 (12-16 Days)||10||
48110976|NCT02350309|100598019|FG003|STARTED|Washout Period 3 (12-16 Days)||11||
48694367|NCT00431444|102036374|FG000|COMPLETED|Overall Study||51||
48694368|NCT00431444|102036375|FG001|COMPLETED|Overall Study||46||
48694369|NCT00431444|102036374|FG000|NOT COMPLETED|Overall Study||5||
48556916|NCT01640249|101694006|FG002|NOT COMPLETED|Period 3||0||
48556917|NCT01640249|101694007|FG003|NOT COMPLETED|Period 3||1||
48556918|NCT01640249|101694008|FG004|NOT COMPLETED|Period 3||0||
48556919|NCT01640249|101694009|FG005|NOT COMPLETED|Period 3||0||
48556920|NCT01640249|101694010|FG006|NOT COMPLETED|Period 3||0||
48556921|NCT02454933|101694011|FG000|STARTED|Overall Study||17|Actual treatment received|
48556922|NCT02454933|101694012|FG001|STARTED|Overall Study||12|Actual treatment received|
48556923|NCT02454933|101694011|FG000|Treatment Group Randomised to|Overall Study||15||
48556924|NCT02454933|101694012|FG001|Treatment Group Randomised to|Overall Study||14||
48556925|NCT02454933|101694011|FG000|Ongoing at Primary Analysis Data Cut-off|Overall Study||9||
48694370|NCT00431444|102036375|FG001|NOT COMPLETED|Overall Study||7||
48110977|NCT02350309|100598020|FG004|STARTED|Washout Period 3 (12-16 Days)||12||
48110978|NCT02350309|100598021|FG005|STARTED|Washout Period 3 (12-16 Days)||12||
48110979|NCT02350309|100598016|FG000|COMPLETED|Washout Period 3 (12-16 Days)||12||
48110980|NCT02350309|100598017|FG001|COMPLETED|Washout Period 3 (12-16 Days)||11||
48110981|NCT02350309|100598018|FG002|COMPLETED|Washout Period 3 (12-16 Days)||10||
48556926|NCT02454933|101694012|FG001|Ongoing at Primary Analysis Data Cut-off|Overall Study||4||
48556927|NCT02454933|101694011|FG000|COMPLETED|Overall Study||5|Subjects completing study at final analysis data cut-off|
48556928|NCT02454933|101694012|FG001|COMPLETED|Overall Study||1|Subjects completing study at final analysis data cut-off|
48556929|NCT02454933|101694011|FG000|NOT COMPLETED|Overall Study||12||
48556930|NCT02454933|101694012|FG001|NOT COMPLETED|Overall Study||11||
48556931|NCT01197911|101694013|FG000|STARTED|Overall Study||18||
48556932|NCT01197911|101694014|FG001|STARTED|Overall Study||10||
48556933|NCT01197911|101694015|FG002|STARTED|Overall Study||10||
48556934|NCT01197911|101694013|FG000|COMPLETED|Overall Study||18||
48556935|NCT01197911|101694014|FG001|COMPLETED|Overall Study||10||
48556936|NCT01197911|101694015|FG002|COMPLETED|Overall Study||9||
48556937|NCT01197911|101694013|FG000|NOT COMPLETED|Overall Study||0||
48556938|NCT01197911|101694014|FG001|NOT COMPLETED|Overall Study||0||
48556939|NCT01197911|101694015|FG002|NOT COMPLETED|Overall Study||1||
48556940|NCT00470535|101694016|FG000|STARTED|Overall Study||18||
48556941|NCT00470535|101694016|FG000|COMPLETED|Overall Study||0||
48556942|NCT00470535|101694016|FG000|NOT COMPLETED|Overall Study||18||
48556943|NCT03597295|101697990|FG000|STARTED|Overall Study||94||
48556944|NCT03597295|101697990|FG000|COMPLETED|Overall Study||17||
48556945|NCT03597295|101697990|FG000|NOT COMPLETED|Overall Study||77||
48556946|NCT01759602|101697991|FG000|STARTED|Overall Study||10||
48556947|NCT01759602|101697991|FG000|COMPLETED|Overall Study||10||
48556948|NCT01759602|101697991|FG000|NOT COMPLETED|Overall Study||0||
48556949|NCT00652340|101697992|FG000|STARTED|Overall Study||78||
48556950|NCT00652340|101697993|FG001|STARTED|Overall Study||42||
48556951|NCT00652340|101697992|FG000|COMPLETED|Overall Study||74||
48556952|NCT00652340|101697993|FG001|COMPLETED|Overall Study||39||
48556953|NCT00652340|101697992|FG000|NOT COMPLETED|Overall Study||4||
48556954|NCT00652340|101697993|FG001|NOT COMPLETED|Overall Study||3||
48556955|NCT00124748|101697994|FG000|STARTED|Overall Study||157||
48556956|NCT00124748|101697995|FG001|STARTED|Overall Study||319||
48556957|NCT00124748|101697994|FG000|Safety Population|Overall Study||157||
48556958|NCT00124748|101697995|FG001|Safety Population|Overall Study||316||
48556959|NCT00124748|101697994|FG000|COMPLETED|Overall Study||14||
48556960|NCT00124748|101697995|FG001|COMPLETED|Overall Study||35||
48556961|NCT00124748|101697994|FG000|NOT COMPLETED|Overall Study||143||
48556962|NCT00124748|101697995|FG001|NOT COMPLETED|Overall Study||284||
48556963|NCT04342819|101697996|FG000|STARTED|Overall Study||25||
48556964|NCT04342819|101697996|FG000|COMPLETED|Overall Study||20||
48556965|NCT04342819|101697996|FG000|NOT COMPLETED|Overall Study||5||
48556966|NCT02071225|101697997|FG000|STARTED|Overall Study||72||
48556967|NCT02071225|101697997|FG000|COMPLETED|Overall Study||42||
48556968|NCT02071225|101697997|FG000|NOT COMPLETED|Overall Study||30||
48556969|NCT00858494|101697998|FG000|STARTED|Overall Study||49||
48556970|NCT00858494|101697998|FG000|COMPLETED|Overall Study||45||
48556971|NCT00858494|101697998|FG000|NOT COMPLETED|Overall Study||4||
48556972|NCT02094300|101697999|FG000|STARTED|Overall Study||26||
48556973|NCT02094300|101697999|FG000|30 Days|Overall Study||24||
48556974|NCT02094300|101697999|FG000|COMPLETED|Overall Study||6||
48556975|NCT02094300|101697999|FG000|NOT COMPLETED|Overall Study||20||
48556976|NCT00638508|101698000|FG000|STARTED|Overall Study||35||
48556977|NCT00638508|101698001|FG001|STARTED|Overall Study||32||
48556978|NCT00638508|101698000|FG000|COMPLETED|Overall Study||30||
48556979|NCT00638508|101698001|FG001|COMPLETED|Overall Study||30||
48556980|NCT00638508|101698000|FG000|NOT COMPLETED|Overall Study||5||
48110982|NCT02350309|100598019|FG003|COMPLETED|Washout Period 3 (12-16 Days)||11||
48110983|NCT02350309|100598020|FG004|COMPLETED|Washout Period 3 (12-16 Days)||12||
48556981|NCT00638508|101698001|FG001|NOT COMPLETED|Overall Study||2||
48556982|NCT04720053|101698002|FG000|STARTED|Overall Study||40||
48556983|NCT04720053|101698002|FG000|COMPLETED|Overall Study||28||
48556984|NCT04720053|101698002|FG000|NOT COMPLETED|Overall Study||12||
48556985|NCT02321111|101698003|FG000|STARTED|Infusion1||1||
48556986|NCT02321111|101698004|FG001|STARTED|Infusion1||4||
48556987|NCT02321111|101698005|FG002|STARTED|Infusion1||4||
48110984|NCT02350309|100598021|FG005|COMPLETED|Washout Period 3 (12-16 Days)||12||
48110985|NCT02350309|100598016|FG000|NOT COMPLETED|Washout Period 3 (12-16 Days)||0||
48556988|NCT02321111|101698006|FG003|STARTED|Infusion1||1||
48556989|NCT02321111|101698007|FG004|STARTED|Infusion1||0||
48556990|NCT02321111|101698008|FG005|STARTED|Infusion1||0||
48556991|NCT02321111|101698003|FG000|COMPLETED|Infusion1||1||
48556992|NCT02321111|101698004|FG001|COMPLETED|Infusion1||4||
48556993|NCT02321111|101698005|FG002|COMPLETED|Infusion1||4||
48556994|NCT02321111|101698006|FG003|COMPLETED|Infusion1||1||
48556995|NCT02321111|101698007|FG004|COMPLETED|Infusion1||0||
48556996|NCT02321111|101698008|FG005|COMPLETED|Infusion1||0||
48556997|NCT02321111|101698003|FG000|NOT COMPLETED|Infusion1||0||
48556998|NCT02321111|101698004|FG001|NOT COMPLETED|Infusion1||0||
48556999|NCT02321111|101698005|FG002|NOT COMPLETED|Infusion1||0||
48557000|NCT02321111|101698006|FG003|NOT COMPLETED|Infusion1||0||
48557001|NCT02321111|101698007|FG004|NOT COMPLETED|Infusion1||0||
48557002|NCT02321111|101698008|FG005|NOT COMPLETED|Infusion1||0||
48557003|NCT02321111|101698003|FG000|STARTED|Washout1 (3-4weeks Between Infusions)||1||
48557004|NCT02321111|101698004|FG001|STARTED|Washout1 (3-4weeks Between Infusions)||4||
48557005|NCT02321111|101698005|FG002|STARTED|Washout1 (3-4weeks Between Infusions)||4||
48557006|NCT02321111|101698006|FG003|STARTED|Washout1 (3-4weeks Between Infusions)||1||
48557007|NCT02321111|101698007|FG004|STARTED|Washout1 (3-4weeks Between Infusions)||0||
48557008|NCT02321111|101698008|FG005|STARTED|Washout1 (3-4weeks Between Infusions)||0||
48557009|NCT02321111|101698003|FG000|COMPLETED|Washout1 (3-4weeks Between Infusions)||1||
48557010|NCT02321111|101698004|FG001|COMPLETED|Washout1 (3-4weeks Between Infusions)||4||
48557011|NCT02321111|101698005|FG002|COMPLETED|Washout1 (3-4weeks Between Infusions)||4||
48557012|NCT02321111|101698006|FG003|COMPLETED|Washout1 (3-4weeks Between Infusions)||1||
48557013|NCT02321111|101698007|FG004|COMPLETED|Washout1 (3-4weeks Between Infusions)||0||
48557014|NCT02321111|101698008|FG005|COMPLETED|Washout1 (3-4weeks Between Infusions)||0||
48557015|NCT02321111|101698003|FG000|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0||
48557016|NCT02321111|101698004|FG001|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0||
48557017|NCT02321111|101698005|FG002|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0||
48557018|NCT02321111|101698006|FG003|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0||
48557019|NCT02321111|101698007|FG004|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0||
48557020|NCT02321111|101698008|FG005|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0||
48557021|NCT02321111|101698003|FG000|STARTED|Infusion2||1||
48557022|NCT02321111|101698004|FG001|STARTED|Infusion2||4||
48557023|NCT02321111|101698005|FG002|STARTED|Infusion2||4||
48557024|NCT02321111|101698006|FG003|STARTED|Infusion2||1||
48557025|NCT02321111|101698007|FG004|STARTED|Infusion2||0||
48557026|NCT02321111|101698008|FG005|STARTED|Infusion2||0||
48557027|NCT02321111|101698003|FG000|COMPLETED|Infusion2||1||
48557028|NCT02321111|101698004|FG001|COMPLETED|Infusion2||4||
48557029|NCT02321111|101698005|FG002|COMPLETED|Infusion2||4||
48557030|NCT02321111|101698006|FG003|COMPLETED|Infusion2||1||
48557031|NCT02321111|101698007|FG004|COMPLETED|Infusion2||0||
48557032|NCT02321111|101698008|FG005|COMPLETED|Infusion2||0||
48557033|NCT02321111|101698003|FG000|NOT COMPLETED|Infusion2||0||
48557034|NCT02321111|101698004|FG001|NOT COMPLETED|Infusion2||0||
48557035|NCT02321111|101698005|FG002|NOT COMPLETED|Infusion2||0||
48557036|NCT02321111|101698006|FG003|NOT COMPLETED|Infusion2||0||
48557037|NCT02321111|101698007|FG004|NOT COMPLETED|Infusion2||0||
48557038|NCT02321111|101698008|FG005|NOT COMPLETED|Infusion2||0||
48557039|NCT02321111|101698003|FG000|STARTED|Washout2 (3-4weeks Between Infusions)||1||
48557040|NCT02321111|101698004|FG001|STARTED|Washout2 (3-4weeks Between Infusions)||4||
48557041|NCT02321111|101698005|FG002|STARTED|Washout2 (3-4weeks Between Infusions)||4||
48557042|NCT02321111|101698006|FG003|STARTED|Washout2 (3-4weeks Between Infusions)||1||
48557043|NCT02321111|101698007|FG004|STARTED|Washout2 (3-4weeks Between Infusions)||0||
48557044|NCT02321111|101698008|FG005|STARTED|Washout2 (3-4weeks Between Infusions)||0||
48557045|NCT02321111|101698003|FG000|COMPLETED|Washout2 (3-4weeks Between Infusions)||1||
48557046|NCT02321111|101698004|FG001|COMPLETED|Washout2 (3-4weeks Between Infusions)||4||
48557047|NCT02321111|101698005|FG002|COMPLETED|Washout2 (3-4weeks Between Infusions)||4||
48557048|NCT02321111|101698006|FG003|COMPLETED|Washout2 (3-4weeks Between Infusions)||1||
48557049|NCT02321111|101698007|FG004|COMPLETED|Washout2 (3-4weeks Between Infusions)||0||
48557050|NCT02321111|101698008|FG005|COMPLETED|Washout2 (3-4weeks Between Infusions)||0||
48557051|NCT02321111|101698003|FG000|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0||
48557052|NCT02321111|101698004|FG001|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0||
48557053|NCT02321111|101698005|FG002|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0||
48557054|NCT02321111|101698006|FG003|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0||
48557055|NCT02321111|101698007|FG004|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0||
48557056|NCT02321111|101698008|FG005|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0||
48557057|NCT02321111|101698003|FG000|STARTED|Infusion3||1||
48557058|NCT02321111|101698004|FG001|STARTED|Infusion3||4||
48557059|NCT02321111|101698005|FG002|STARTED|Infusion3||4||
48557060|NCT02321111|101698006|FG003|STARTED|Infusion3||1||
48557061|NCT02321111|101698007|FG004|STARTED|Infusion3||0||
48557062|NCT02321111|101698008|FG005|STARTED|Infusion3||0||
48557063|NCT02321111|101698003|FG000|COMPLETED|Infusion3||1||
48557064|NCT02321111|101698004|FG001|COMPLETED|Infusion3||4||
48557065|NCT02321111|101698005|FG002|COMPLETED|Infusion3||4||
48557066|NCT02321111|101698006|FG003|COMPLETED|Infusion3||1||
48557067|NCT02321111|101698007|FG004|COMPLETED|Infusion3||0||
48557068|NCT02321111|101698008|FG005|COMPLETED|Infusion3||0||
48557069|NCT02321111|101698003|FG000|NOT COMPLETED|Infusion3||0||
48557070|NCT02321111|101698004|FG001|NOT COMPLETED|Infusion3||0||
48557071|NCT02321111|101698005|FG002|NOT COMPLETED|Infusion3||0||
48557072|NCT02321111|101698006|FG003|NOT COMPLETED|Infusion3||0||
48557073|NCT02321111|101698007|FG004|NOT COMPLETED|Infusion3||0||
48557074|NCT02321111|101698008|FG005|NOT COMPLETED|Infusion3||0||
48557075|NCT02548832|101698009|FG000|STARTED|Overall Study||12||
48557076|NCT02548832|101698010|FG001|STARTED|Overall Study||12||
48557077|NCT02548832|101698011|FG002|STARTED|Overall Study||12||
48557078|NCT02548832|101698009|FG000|COMPLETED|Overall Study||10||
48557079|NCT02548832|101698010|FG001|COMPLETED|Overall Study||10||
48557080|NCT02548832|101698011|FG002|COMPLETED|Overall Study||10||
48557081|NCT02548832|101698009|FG000|NOT COMPLETED|Overall Study||2||
48557082|NCT02548832|101698010|FG001|NOT COMPLETED|Overall Study||2||
48557083|NCT02548832|101698011|FG002|NOT COMPLETED|Overall Study||2||
48557084|NCT03500198|101698012|FG000|STARTED|Overall Study||110||
48694371|NCT02950155|102036376|FG000|STARTED|Overall Study||25||
48694372|NCT02950155|102036377|FG001|STARTED|Overall Study||22||
48694373|NCT02950155|102036376|FG000|COMPLETED|Overall Study||25||
48557085|NCT03500198|101698013|FG001|STARTED|Overall Study||108||
48557086|NCT03500198|101698012|FG000|First Eye|Overall Study||110||
48557087|NCT03500198|101698013|FG001|First Eye|Overall Study||108||
48557088|NCT03500198|101698012|FG000|Second Eye|Overall Study||109||
48557089|NCT03500198|101698013|FG001|Second Eye|Overall Study||108||
48557090|NCT03500198|101698012|FG000|COMPLETED|Overall Study||110||
48557091|NCT03500198|101698013|FG001|COMPLETED|Overall Study||107||
48557092|NCT03500198|101698012|FG000|NOT COMPLETED|Overall Study||0||
48557093|NCT03500198|101698013|FG001|NOT COMPLETED|Overall Study||1||
48557094|NCT02001987|101698014|FG000|STARTED|Core Study Period (24 Weeks)||139||
48557095|NCT02001987|101698014|FG000|COMPLETED|Core Study Period (24 Weeks)||116||
48557096|NCT02001987|101698014|FG000|NOT COMPLETED|Core Study Period (24 Weeks)||23||
48557097|NCT02001987|101698014|FG000|STARTED|LTE Period (52 Weeks)||116||
48557098|NCT02001987|101698014|FG000|COMPLETED|LTE Period (52 Weeks)||107||
48557099|NCT02001987|101698014|FG000|NOT COMPLETED|LTE Period (52 Weeks)||9||
48557100|NCT01050530|101698015|FG000|STARTED|Overall Study||82||
48557101|NCT01050530|101698016|FG001|STARTED|Overall Study||80||
48557102|NCT01050530|101698015|FG000|COMPLETED|Overall Study||74||
48557103|NCT01050530|101698016|FG001|COMPLETED|Overall Study||70||
48557104|NCT01050530|101698015|FG000|NOT COMPLETED|Overall Study||8||
48557105|NCT01050530|101698016|FG001|NOT COMPLETED|Overall Study||10||
48557106|NCT03565900|101698017|FG000|STARTED|Overall Study||139||
48557107|NCT03565900|101698018|FG001|STARTED|Overall Study||138||
48557108|NCT03565900|101698017|FG000|Vaccination 1 With V114 or Prevnar 13™ (PCV) (Day 1)|Overall Study||139||
48557109|NCT03565900|101698018|FG001|Vaccination 1 With V114 or Prevnar 13™ (PCV) (Day 1)|Overall Study||135||
48557110|NCT03565900|101698017|FG000|Vaccination 2 With PCV (Day 30)|Overall Study||135||
48557111|NCT03565900|101698018|FG001|Vaccination 2 With PCV (Day 30)|Overall Study||128||
48557112|NCT03565900|101698017|FG000|Vaccination 3 With PCV (Day 60)|Overall Study||130||
48557113|NCT03565900|101698018|FG001|Vaccination 3 With PCV (Day 60)|Overall Study||124||
48557114|NCT03565900|101698017|FG000|Vaccination 4 With PNEUMOVAX™23 (PPV23) (12 Months After Allo-HSCT, Without Chronic GVHD)|Overall Study||89||
48557115|NCT03565900|101698018|FG001|Vaccination 4 With PNEUMOVAX™23 (PPV23) (12 Months After Allo-HSCT, Without Chronic GVHD)|Overall Study||75||
48557116|NCT03565900|101698017|FG000|Vaccination 4 With PCV (12 Months After Allo-HSCT, With Chronic GVHD)|Overall Study||29||
48557117|NCT03565900|101698018|FG001|Vaccination 4 With PCV (12 Months After Allo-HSCT, With Chronic GVHD)|Overall Study||37||
48557118|NCT03565900|101698017|FG000|COMPLETED|Overall Study||115||
48557119|NCT03565900|101698018|FG001|COMPLETED|Overall Study||111||
48557120|NCT03565900|101698017|FG000|NOT COMPLETED|Overall Study||24||
48557121|NCT03565900|101698018|FG001|NOT COMPLETED|Overall Study||27||
48557122|NCT01762800|101698019|FG000|STARTED|Overall Study||202||
48557123|NCT01762800|101698020|FG001|STARTED|Overall Study||204||
48557124|NCT01762800|101698019|FG000|COMPLETED|Overall Study||183||
48694374|NCT02950155|102036377|FG001|COMPLETED|Overall Study||22||
48694375|NCT02950155|102036376|FG000|NOT COMPLETED|Overall Study||0||
48694376|NCT02950155|102036377|FG001|NOT COMPLETED|Overall Study||0||
48694377|NCT03332173|102036378|FG000|STARTED|Overall Study||44||
48557125|NCT01762800|101698020|FG001|COMPLETED|Overall Study||183||
48557126|NCT01762800|101698019|FG000|NOT COMPLETED|Overall Study||19||
48694378|NCT03332173|102036378|FG000|COMPLETED|Overall Study||0||
48694379|NCT03332173|102036378|FG000|NOT COMPLETED|Overall Study||44||
48694380|NCT04723355|102036379|FG000|STARTED|Overall Study||231||
48694381|NCT04723355|102036379|FG000|COMPLETED|Overall Study||179||
48694382|NCT04723355|102036379|FG000|NOT COMPLETED|Overall Study||52||
48694383|NCT02249091|102036380|FG000|STARTED|Overall Study||27||
48694384|NCT02249091|102036381|FG001|STARTED|Overall Study||15||
48694385|NCT02249091|102036380|FG000|COMPLETED|Overall Study||7||
48694386|NCT02249091|102036381|FG001|COMPLETED|Overall Study||2||
48694387|NCT02249091|102036380|FG000|NOT COMPLETED|Overall Study||20||
48557127|NCT01762800|101698020|FG001|NOT COMPLETED|Overall Study||21||
48557128|NCT02969044|101698021|FG000|STARTED|Overall Study||42||
48694388|NCT02249091|102036381|FG001|NOT COMPLETED|Overall Study||13||
48694389|NCT03053440|102036382|FG000|STARTED|Overall Study||99||
48694390|NCT03053440|102036383|FG001|STARTED|Overall Study||102||
48694391|NCT03053440|102036382|FG000|COMPLETED|Overall Study||0||
48694392|NCT03053440|102036383|FG001|COMPLETED|Overall Study||0||
48557129|NCT02969044|101698022|FG001|STARTED|Overall Study||28||
48557130|NCT02969044|101698021|FG000|COMPLETED|Overall Study||37||
48557131|NCT02969044|101698022|FG001|COMPLETED|Overall Study||22||
48557132|NCT02969044|101698021|FG000|NOT COMPLETED|Overall Study||5||
48557133|NCT02969044|101698022|FG001|NOT COMPLETED|Overall Study||6||
48557134|NCT02301169|101698023|FG000|STARTED|Overall Study||21||
48557135|NCT02301169|101698024|FG001|STARTED|Overall Study||21||
48557136|NCT02301169|101698023|FG000|COMPLETED|Overall Study||20||
48557137|NCT02301169|101698024|FG001|COMPLETED|Overall Study||21||
48557138|NCT02301169|101698023|FG000|NOT COMPLETED|Overall Study||1||
48557139|NCT02301169|101698024|FG001|NOT COMPLETED|Overall Study||0||
48557140|NCT01870778|101698025|FG000|STARTED|Overall Study||3274||
48557141|NCT01870778|101698026|FG001|STARTED|Overall Study||3271||
48557142|NCT01870778|101698025|FG000|Safety Set|Overall Study||3257||
48557143|NCT01870778|101698026|FG001|Safety Set|Overall Study||3248||
48557144|NCT01870778|101698025|FG000|Full Analysis Set|Overall Study||3274||
48557145|NCT01870778|101698026|FG001|Full Analysis Set|Overall Study||3271||
48557146|NCT01870778|101698025|FG000|Biomarker Analysis Set|Overall Study||521||
48557147|NCT01870778|101698026|FG001|Biomarker Analysis Set|Overall Study||510||
48557148|NCT01870778|101698025|FG000|COMPLETED|Overall Study||3266||
48557149|NCT01870778|101698026|FG001|COMPLETED|Overall Study||3262||
48557150|NCT01870778|101698025|FG000|NOT COMPLETED|Overall Study||8||
48557151|NCT01870778|101698026|FG001|NOT COMPLETED|Overall Study||9||
48557152|NCT01311687|101698027|FG000|STARTED|Treatment Phase||302||
48557153|NCT01311687|101698028|FG001|STARTED|Treatment Phase||153||
48557154|NCT01311687|101698027|FG000|Received Study Drug|Treatment Phase||300||
48694393|NCT03053440|102036382|FG000|NOT COMPLETED|Overall Study||99||
48694394|NCT03053440|102036383|FG001|NOT COMPLETED|Overall Study||102||
48694395|NCT02308163|102036384|FG000|STARTED|Overall Study||104||
48694396|NCT02308163|102036385|FG001|STARTED|Overall Study||102||
48694397|NCT02308163|102036386|FG002|STARTED|Overall Study||50||
48694398|NCT02308163|102036387|FG003|STARTED|Overall Study||52||
48557155|NCT01311687|101698028|FG001|Received Study Drug|Treatment Phase||150||
48557156|NCT01311687|101698027|FG000|Crossed-over to Pomalidomide|Treatment Phase||0||
48557157|NCT01311687|101698028|FG001|Crossed-over to Pomalidomide|Treatment Phase||11||
48557158|NCT01311687|101698027|FG000|COMPLETED|Treatment Phase||302|Completed represents participants who discontinued from study treatment|
48557159|NCT01311687|101698028|FG001|COMPLETED|Treatment Phase||153|Completed represents participants who discontinued from study treatment|
48557160|NCT01311687|101698027|FG000|NOT COMPLETED|Treatment Phase||0||
48557161|NCT01311687|101698028|FG001|NOT COMPLETED|Treatment Phase||0||
48557162|NCT01311687|101698027|FG000|STARTED|PFS Follow-up Phase||11||
48557163|NCT01311687|101698028|FG001|STARTED|PFS Follow-up Phase||8||
48557164|NCT01311687|101698027|FG000|Crossed-over to Pomalidomide|PFS Follow-up Phase||11|After Amendment 4 participants still on HD-Dex treatment were permitted to crossover to pomalidomide|
48694399|NCT02308163|102036388|FG004|STARTED|Overall Study||201||
48694400|NCT02308163|102036384|FG000|COMPLETED|Overall Study||73||
48694401|NCT02308163|102036385|FG001|COMPLETED|Overall Study||84||
48694402|NCT02308163|102036386|FG002|COMPLETED|Overall Study||36||
48694403|NCT02308163|102036387|FG003|COMPLETED|Overall Study||39||
48694404|NCT02308163|102036388|FG004|COMPLETED|Overall Study||167||
48694405|NCT02308163|102036384|FG000|NOT COMPLETED|Overall Study||31||
48694406|NCT02308163|102036385|FG001|NOT COMPLETED|Overall Study||18||
48694407|NCT02308163|102036386|FG002|NOT COMPLETED|Overall Study||14||
48694408|NCT02308163|102036387|FG003|NOT COMPLETED|Overall Study||13||
48694409|NCT02308163|102036388|FG004|NOT COMPLETED|Overall Study||34||
48694410|NCT00904670|102036389|FG000|STARTED|Open Label Phase||23||
48694411|NCT00904670|102036390|FG001|STARTED|Open Label Phase||22||
48694412|NCT00904670|102036389|FG000|COMPLETED|Open Label Phase||17||
48694413|NCT00904670|102036390|FG001|COMPLETED|Open Label Phase||22||
48694414|NCT00904670|102036389|FG000|NOT COMPLETED|Open Label Phase||6||
48694415|NCT00904670|102036390|FG001|NOT COMPLETED|Open Label Phase||0||
48694416|NCT00904670|102036389|FG000|STARTED|First Intervention Period||17||
48694417|NCT00904670|102036390|FG001|STARTED|First Intervention Period||22||
48694418|NCT00904670|102036389|FG000|COMPLETED|First Intervention Period||17||
48694419|NCT00904670|102036390|FG001|COMPLETED|First Intervention Period||22||
48694420|NCT00904670|102036389|FG000|NOT COMPLETED|First Intervention Period||0||
48694421|NCT00904670|102036390|FG001|NOT COMPLETED|First Intervention Period||0||
48694422|NCT00904670|102036389|FG000|STARTED|Second Intervention Period||17||
48694423|NCT00904670|102036390|FG001|STARTED|Second Intervention Period||22||
48710809|NCT01187446|102078025|FG001|NOT COMPLETED|Overall Study||1||
48694424|NCT00904670|102036389|FG000|COMPLETED|Second Intervention Period||17||
48694425|NCT00904670|102036390|FG001|COMPLETED|Second Intervention Period||22||
48694426|NCT00904670|102036389|FG000|NOT COMPLETED|Second Intervention Period||0||
48694427|NCT00904670|102036390|FG001|NOT COMPLETED|Second Intervention Period||0||
48694428|NCT01271907|102036391|FG000|STARTED|Overall Study||3||
48694429|NCT01271907|102036392|FG001|STARTED|Overall Study||0||
48694430|NCT01271907|102036393|FG002|STARTED|Overall Study||0||
48694431|NCT01271907|102036391|FG000|COMPLETED|Overall Study||3||
48694432|NCT01271907|102036392|FG001|COMPLETED|Overall Study||0||
48694433|NCT01271907|102036393|FG002|COMPLETED|Overall Study||0||
48694434|NCT01271907|102036391|FG000|NOT COMPLETED|Overall Study||0||
48694435|NCT01271907|102036392|FG001|NOT COMPLETED|Overall Study||0||
48694436|NCT01271907|102036393|FG002|NOT COMPLETED|Overall Study||0||
48694437|NCT01576939|102036394|FG000|STARTED|Overall Study||30||
48557165|NCT01311687|101698028|FG001|Crossed-over to Pomalidomide|PFS Follow-up Phase||0|After Amendment 4 participants still on HD-Dex treatment were permitted to crossover to pomalidomide|
48557166|NCT01311687|101698027|FG000|COMPLETED|PFS Follow-up Phase||11|Completed represents participants who discontinued from PFS follow-up|
48557167|NCT01311687|101698028|FG001|COMPLETED|PFS Follow-up Phase||8|Completed represents participants who discontinued from PFS follow-up|
48557168|NCT01311687|101698027|FG000|NOT COMPLETED|PFS Follow-up Phase||0||
48557169|NCT01311687|101698028|FG001|NOT COMPLETED|PFS Follow-up Phase||0||
48557170|NCT00262028|101698029|FG000|STARTED|Overall Study||152||
48557171|NCT00262028|101698030|FG001|STARTED|Overall Study||153||
48557172|NCT00262028|101698031|FG002|STARTED|Overall Study||157||
48557173|NCT00262028|101698032|FG003|STARTED|Overall Study||157||
48557174|NCT00262028|101698033|FG004|STARTED|Overall Study||74||
48557175|NCT00262028|101698034|FG005|STARTED|Overall Study||73||
48557176|NCT00262028|101698035|FG006|STARTED|Overall Study||71||
48557177|NCT00262028|101698036|FG007|STARTED|Overall Study||73||
48557178|NCT00262028|101698037|FG008|STARTED|Overall Study||100||
48557179|NCT00262028|101698029|FG000|COMPLETED|Overall Study||128||
48557180|NCT00262028|101698030|FG001|COMPLETED|Overall Study||126||
48557181|NCT00262028|101698031|FG002|COMPLETED|Overall Study||137||
48557182|NCT00262028|101698032|FG003|COMPLETED|Overall Study||134||
48557183|NCT00262028|101698033|FG004|COMPLETED|Overall Study||62||
48557184|NCT00262028|101698034|FG005|COMPLETED|Overall Study||60||
48557185|NCT00262028|101698035|FG006|COMPLETED|Overall Study||59||
48557186|NCT00262028|101698036|FG007|COMPLETED|Overall Study||55||
48557187|NCT00262028|101698037|FG008|COMPLETED|Overall Study||81||
48557188|NCT00262028|101698029|FG000|NOT COMPLETED|Overall Study||24||
48694438|NCT01576939|102036394|FG000|COMPLETED|Overall Study||30||
48694439|NCT01576939|102036394|FG000|NOT COMPLETED|Overall Study||0||
48557189|NCT00262028|101698030|FG001|NOT COMPLETED|Overall Study||27||
48557190|NCT00262028|101698031|FG002|NOT COMPLETED|Overall Study||20||
48557191|NCT00262028|101698032|FG003|NOT COMPLETED|Overall Study||23||
48557192|NCT00262028|101698033|FG004|NOT COMPLETED|Overall Study||12||
48557193|NCT00262028|101698034|FG005|NOT COMPLETED|Overall Study||13||
48694440|NCT04904744|102036395|FG000|STARTED|Overall Study||412||
48694441|NCT04904744|102036396|FG001|STARTED|Overall Study||412||
48694442|NCT04904744|102036397|FG002|STARTED|Overall Study||411||
48694443|NCT04904744|102036395|FG000|COMPLETED|Overall Study||412||
48694444|NCT04904744|102036396|FG001|COMPLETED|Overall Study||412||
48694445|NCT04904744|102036397|FG002|COMPLETED|Overall Study||411||
48694446|NCT04904744|102036395|FG000|NOT COMPLETED|Overall Study||0||
48694447|NCT04904744|102036396|FG001|NOT COMPLETED|Overall Study||0||
48694448|NCT04904744|102036397|FG002|NOT COMPLETED|Overall Study||0||
48694449|NCT05069597|102036398|FG000|STARTED|Run-in Period (Day -28 to Day 0)||30||
48694450|NCT05069597|102036399|FG001|STARTED|Run-in Period (Day -28 to Day 0)||0||
48694451|NCT05069597|102036398|FG000|COMPLETED|Run-in Period (Day -28 to Day 0)||30||
48557194|NCT00262028|101698035|FG006|NOT COMPLETED|Overall Study||12||
48557195|NCT00262028|101698036|FG007|NOT COMPLETED|Overall Study||18||
48557196|NCT00262028|101698037|FG008|NOT COMPLETED|Overall Study||19||
48557197|NCT00097448|101698038|FG000|STARTED|Overall Study||125||
48694452|NCT05069597|102036399|FG001|COMPLETED|Run-in Period (Day -28 to Day 0)||0||
48694453|NCT05069597|102036398|FG000|NOT COMPLETED|Run-in Period (Day -28 to Day 0)||0||
48694454|NCT05069597|102036399|FG001|NOT COMPLETED|Run-in Period (Day -28 to Day 0)||0||
48557198|NCT00097448|101698039|FG001|STARTED|Overall Study||130||
48557199|NCT00097448|101698038|FG000|COMPLETED|Overall Study||121||
48557200|NCT00097448|101698039|FG001|COMPLETED|Overall Study||129||
48273317|NCT01259089|100992121|FG002|Started Treatment on Study|Reached First Response at 4 Weeks||3||
48273318|NCT01259089|100992122|FG003|Started Treatment on Study|Reached First Response at 4 Weeks||3||
48273319|NCT01259089|100992123|FG004|Started Treatment on Study|Reached First Response at 4 Weeks||6||
48557201|NCT00097448|101698038|FG000|NOT COMPLETED|Overall Study||4||
48557202|NCT00097448|101698039|FG001|NOT COMPLETED|Overall Study||1||
48557203|NCT03901313|101698040|FG000|STARTED|Overall Study||4||
48557204|NCT03901313|101698041|FG001|STARTED|Overall Study||4||
48557205|NCT03901313|101698042|FG002|STARTED|Overall Study||4||
48273320|NCT01259089|100992124|FG005|Started Treatment on Study|Reached First Response at 4 Weeks||19||
48273321|NCT01259089|100992119|FG000|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3||
48273322|NCT01259089|100992120|FG001|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3||
48273323|NCT01259089|100992121|FG002|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3||
48273324|NCT01259089|100992122|FG003|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3||
48273325|NCT01259089|100992123|FG004|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||6||
48273326|NCT01259089|100992124|FG005|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||18||
48273327|NCT01259089|100992119|FG000|COMPLETED|Reached First Response at 4 Weeks||3||
48273328|NCT01259089|100992120|FG001|COMPLETED|Reached First Response at 4 Weeks||3||
48273329|NCT01259089|100992121|FG002|COMPLETED|Reached First Response at 4 Weeks||3||
48557206|NCT03901313|101698043|FG003|STARTED|Overall Study||4||
48557207|NCT03901313|101698044|FG004|STARTED|Overall Study||4||
48557208|NCT03901313|101698045|FG005|STARTED|Overall Study||4||
48557209|NCT03901313|101698040|FG000|COMPLETED|Overall Study||4||
48557210|NCT03901313|101698041|FG001|COMPLETED|Overall Study||4||
48557211|NCT03901313|101698042|FG002|COMPLETED|Overall Study||4||
48557212|NCT03901313|101698043|FG003|COMPLETED|Overall Study||4||
48557213|NCT03901313|101698044|FG004|COMPLETED|Overall Study||4||
48557214|NCT03901313|101698045|FG005|COMPLETED|Overall Study||4||
48557215|NCT03901313|101698040|FG000|NOT COMPLETED|Overall Study||0||
48557216|NCT03901313|101698041|FG001|NOT COMPLETED|Overall Study||0||
48557217|NCT03901313|101698042|FG002|NOT COMPLETED|Overall Study||0||
48557218|NCT03901313|101698043|FG003|NOT COMPLETED|Overall Study||0||
48557219|NCT03901313|101698044|FG004|NOT COMPLETED|Overall Study||0||
48557220|NCT03901313|101698045|FG005|NOT COMPLETED|Overall Study||0||
48557221|NCT01339403|101698046|FG000|STARTED|Overall Study||24768||
48557222|NCT01339403|101698047|FG001|STARTED|Overall Study||257600||
48557223|NCT01339403|101698046|FG000|COMPLETED|Overall Study||24768||
48557224|NCT01339403|101698047|FG001|COMPLETED|Overall Study||257600||
48557225|NCT01339403|101698046|FG000|NOT COMPLETED|Overall Study||0||
48557226|NCT01339403|101698047|FG001|NOT COMPLETED|Overall Study||0||
48557227|NCT02839772|101698048|FG000|STARTED|Overall Study||97||
48557228|NCT02839772|101698049|FG001|STARTED|Overall Study||96||
48557229|NCT02839772|101698048|FG000|COMPLETED|Overall Study||96||
48557230|NCT02839772|101698049|FG001|COMPLETED|Overall Study||96||
48557231|NCT02839772|101698048|FG000|NOT COMPLETED|Overall Study||1||
48557232|NCT02839772|101698049|FG001|NOT COMPLETED|Overall Study||0||
48557233|NCT00711243|101698050|FG000|STARTED|Registed and Started Treatment||3||
48557234|NCT00711243|101698051|FG001|STARTED|Registed and Started Treatment||3||
48557235|NCT00711243|101698052|FG002|STARTED|Registed and Started Treatment||3||
48557236|NCT00711243|101698053|FG003|STARTED|Registed and Started Treatment||3||
48557237|NCT00711243|101698054|FG004|STARTED|Registed and Started Treatment||3||
48557238|NCT00711243|101698055|FG005|STARTED|Registed and Started Treatment||44||
48557239|NCT00711243|101698050|FG000|Registered to Study|Registed and Started Treatment||3||
48557240|NCT00711243|101698051|FG001|Registered to Study|Registed and Started Treatment||3||
48557241|NCT00711243|101698052|FG002|Registered to Study|Registed and Started Treatment||3||
48557242|NCT00711243|101698053|FG003|Registered to Study|Registed and Started Treatment||3||
48557243|NCT00711243|101698054|FG004|Registered to Study|Registed and Started Treatment||3||
48557244|NCT00711243|101698055|FG005|Registered to Study|Registed and Started Treatment||44||
48557245|NCT00711243|101698050|FG000|Started Treatment|Registed and Started Treatment||3||
48273330|NCT01259089|100992122|FG003|COMPLETED|Reached First Response at 4 Weeks||3||
48273331|NCT01259089|100992123|FG004|COMPLETED|Reached First Response at 4 Weeks||6||
48273332|NCT01259089|100992124|FG005|COMPLETED|Reached First Response at 4 Weeks||18||
48273333|NCT01259089|100992119|FG000|NOT COMPLETED|Reached First Response at 4 Weeks||0||
48273334|NCT01259089|100992120|FG001|NOT COMPLETED|Reached First Response at 4 Weeks||0||
48273335|NCT01259089|100992121|FG002|NOT COMPLETED|Reached First Response at 4 Weeks||0||
48273336|NCT01259089|100992122|FG003|NOT COMPLETED|Reached First Response at 4 Weeks||0||
48273337|NCT01259089|100992123|FG004|NOT COMPLETED|Reached First Response at 4 Weeks||0||
48273338|NCT01259089|100992124|FG005|NOT COMPLETED|Reached First Response at 4 Weeks||2||
48273339|NCT01259089|100992119|FG000|STARTED|Confirmed Response at 8 Weeks||3||
48273340|NCT01259089|100992120|FG001|STARTED|Confirmed Response at 8 Weeks||3||
48273341|NCT01259089|100992121|FG002|STARTED|Confirmed Response at 8 Weeks||3||
48273342|NCT01259089|100992122|FG003|STARTED|Confirmed Response at 8 Weeks||3||
48273343|NCT01259089|100992123|FG004|STARTED|Confirmed Response at 8 Weeks||6||
48273344|NCT01259089|100992124|FG005|STARTED|Confirmed Response at 8 Weeks||18||
48273345|NCT01259089|100992119|FG000|COMPLETED|Confirmed Response at 8 Weeks||3||
48273346|NCT01259089|100992120|FG001|COMPLETED|Confirmed Response at 8 Weeks||3||
48273347|NCT01259089|100992121|FG002|COMPLETED|Confirmed Response at 8 Weeks||2||
48273348|NCT01259089|100992122|FG003|COMPLETED|Confirmed Response at 8 Weeks||2||
48273349|NCT01259089|100992123|FG004|COMPLETED|Confirmed Response at 8 Weeks||2||
48273350|NCT01259089|100992124|FG005|COMPLETED|Confirmed Response at 8 Weeks||8||
48273351|NCT01259089|100992119|FG000|NOT COMPLETED|Confirmed Response at 8 Weeks||0||
48273352|NCT01259089|100992120|FG001|NOT COMPLETED|Confirmed Response at 8 Weeks||0||
48273353|NCT01259089|100992121|FG002|NOT COMPLETED|Confirmed Response at 8 Weeks||1||
48557246|NCT00711243|101698051|FG001|Started Treatment|Registed and Started Treatment||3||
48557247|NCT00711243|101698052|FG002|Started Treatment|Registed and Started Treatment||3||
48273354|NCT01259089|100992122|FG003|NOT COMPLETED|Confirmed Response at 8 Weeks||1||
48273355|NCT01259089|100992123|FG004|NOT COMPLETED|Confirmed Response at 8 Weeks||4||
48273356|NCT01259089|100992124|FG005|NOT COMPLETED|Confirmed Response at 8 Weeks||10||
48273357|NCT01259089|100992119|FG000|STARTED|Continued Treatment After 8 Weeks||3||
48273358|NCT01259089|100992120|FG001|STARTED|Continued Treatment After 8 Weeks||3||
48273359|NCT01259089|100992121|FG002|STARTED|Continued Treatment After 8 Weeks||2||
48273360|NCT01259089|100992122|FG003|STARTED|Continued Treatment After 8 Weeks||2||
48273361|NCT01259089|100992123|FG004|STARTED|Continued Treatment After 8 Weeks||2||
48273362|NCT01259089|100992124|FG005|STARTED|Continued Treatment After 8 Weeks||8||
48273363|NCT01259089|100992119|FG000|COMPLETED|Continued Treatment After 8 Weeks||1||
48273364|NCT01259089|100992120|FG001|COMPLETED|Continued Treatment After 8 Weeks||2||
48273365|NCT01259089|100992121|FG002|COMPLETED|Continued Treatment After 8 Weeks||1||
48273366|NCT01259089|100992122|FG003|COMPLETED|Continued Treatment After 8 Weeks||1||
48273367|NCT01259089|100992123|FG004|COMPLETED|Continued Treatment After 8 Weeks||0||
48273368|NCT01259089|100992124|FG005|COMPLETED|Continued Treatment After 8 Weeks||7||
48273369|NCT01259089|100992119|FG000|NOT COMPLETED|Continued Treatment After 8 Weeks||2||
48273370|NCT01259089|100992120|FG001|NOT COMPLETED|Continued Treatment After 8 Weeks||1||
48273371|NCT01259089|100992121|FG002|NOT COMPLETED|Continued Treatment After 8 Weeks||1||
48273372|NCT01259089|100992122|FG003|NOT COMPLETED|Continued Treatment After 8 Weeks||1||
48273373|NCT01259089|100992123|FG004|NOT COMPLETED|Continued Treatment After 8 Weeks||2||
48273374|NCT01259089|100992124|FG005|NOT COMPLETED|Continued Treatment After 8 Weeks||1||
48273375|NCT01259089|100992119|FG000|STARTED|Survival Follow up for Two Years||3|All patients that are treated on study go into follow up once they finish treatment.|
48273376|NCT01259089|100992120|FG001|STARTED|Survival Follow up for Two Years||3|All patients that are treated on study go into follow up once they finish treatment.|
48273377|NCT01259089|100992121|FG002|STARTED|Survival Follow up for Two Years||3|All patients that are treated on study go into follow up once they finish treatment.|
48273378|NCT01259089|100992122|FG003|STARTED|Survival Follow up for Two Years||3|All patients that are treated on study go into follow up once they finish treatment.|
48273379|NCT01259089|100992123|FG004|STARTED|Survival Follow up for Two Years||6|All patients that are treated on study go into follow up once they finish treatment.|
48273380|NCT01259089|100992124|FG005|STARTED|Survival Follow up for Two Years||19|All patients that are treated on study go into follow up once they finish treatment.|
48557248|NCT00711243|101698053|FG003|Started Treatment|Registed and Started Treatment||3||
48557249|NCT00711243|101698054|FG004|Started Treatment|Registed and Started Treatment||3||
48557250|NCT00711243|101698055|FG005|Started Treatment|Registed and Started Treatment||43||
48273381|NCT01259089|100992119|FG000|COMPLETED|Survival Follow up for Two Years||0||
48273382|NCT01259089|100992120|FG001|COMPLETED|Survival Follow up for Two Years||1||
48273383|NCT01259089|100992121|FG002|COMPLETED|Survival Follow up for Two Years||1||
48273384|NCT01259089|100992122|FG003|COMPLETED|Survival Follow up for Two Years||0||
48273385|NCT01259089|100992123|FG004|COMPLETED|Survival Follow up for Two Years||0||
48273386|NCT01259089|100992124|FG005|COMPLETED|Survival Follow up for Two Years||0||
48273387|NCT01259089|100992119|FG000|NOT COMPLETED|Survival Follow up for Two Years||3||
48273388|NCT01259089|100992120|FG001|NOT COMPLETED|Survival Follow up for Two Years||2||
48273389|NCT01259089|100992121|FG002|NOT COMPLETED|Survival Follow up for Two Years||2||
48273390|NCT01259089|100992122|FG003|NOT COMPLETED|Survival Follow up for Two Years||3||
48273391|NCT01259089|100992123|FG004|NOT COMPLETED|Survival Follow up for Two Years||6||
48273392|NCT01259089|100992124|FG005|NOT COMPLETED|Survival Follow up for Two Years||19||
48273393|NCT01495598|100992125|FG000|STARTED|Overall Study||28||
48273394|NCT01495598|100992125|FG000|COMPLETED|Overall Study||14||
48273395|NCT01495598|100992125|FG000|NOT COMPLETED|Overall Study||14||
48273396|NCT01593787|100992126|FG000|STARTED|Overall Study||6||
48273397|NCT01593787|100992127|FG001|STARTED|Overall Study||8||
48273398|NCT01593787|100992128|FG002|STARTED|Overall Study||18||
48273399|NCT01593787|100992126|FG000|COMPLETED|Overall Study||5||
48273400|NCT01593787|100992127|FG001|COMPLETED|Overall Study||8||
48273401|NCT01593787|100992128|FG002|COMPLETED|Overall Study||18||
48273402|NCT01593787|100992126|FG000|NOT COMPLETED|Overall Study||1||
48273403|NCT01593787|100992127|FG001|NOT COMPLETED|Overall Study||0||
48273404|NCT01593787|100992128|FG002|NOT COMPLETED|Overall Study||0||
48273405|NCT04400487|100992129|FG000|STARTED|Screening Period (28 Days)||25||
48273406|NCT04400487|100992129|FG000|COMPLETED|Screening Period (28 Days)||25||
48273407|NCT04400487|100992129|FG000|NOT COMPLETED|Screening Period (28 Days)||0||
48273408|NCT04400487|100992129|FG000|STARTED|Run-in Period (14 Days)||25||
48273409|NCT04400487|100992129|FG000|COMPLETED|Run-in Period (14 Days)||25||
48273410|NCT04400487|100992129|FG000|NOT COMPLETED|Run-in Period (14 Days)||0||
48273411|NCT04400487|100992129|FG000|STARTED|Treatment Period (24 Weeks)||25||
48273412|NCT04400487|100992129|FG000|Treated (With at Least 1 Dose of Study Treatment)|Treatment Period (24 Weeks)||25||
48273413|NCT04400487|100992129|FG000|COMPLETED|Treatment Period (24 Weeks)||23||
48273414|NCT04400487|100992129|FG000|NOT COMPLETED|Treatment Period (24 Weeks)||2||
48273415|NCT04400487|100992129|FG000|STARTED|Follow-up Period (28 Days)||23||
48273416|NCT04400487|100992129|FG000|COMPLETED|Follow-up Period (28 Days)||21||
48273417|NCT04400487|100992129|FG000|NOT COMPLETED|Follow-up Period (28 Days)||2||
48273418|NCT02037477|100992130|FG000|STARTED|Treatment Period 1||5||
48273419|NCT02037477|100992131|FG001|STARTED|Treatment Period 1||5||
48273420|NCT02037477|100992132|FG002|STARTED|Treatment Period 1||5||
48273421|NCT02037477|100992133|FG003|STARTED|Treatment Period 1||5||
48273422|NCT02037477|100992130|FG000|COMPLETED|Treatment Period 1||5||
48273423|NCT02037477|100992131|FG001|COMPLETED|Treatment Period 1||5||
48273424|NCT02037477|100992132|FG002|COMPLETED|Treatment Period 1||4||
48273425|NCT02037477|100992133|FG003|COMPLETED|Treatment Period 1||5||
48273426|NCT02037477|100992130|FG000|NOT COMPLETED|Treatment Period 1||0||
48273427|NCT02037477|100992131|FG001|NOT COMPLETED|Treatment Period 1||0||
48273428|NCT02037477|100992132|FG002|NOT COMPLETED|Treatment Period 1||1||
48273429|NCT02037477|100992133|FG003|NOT COMPLETED|Treatment Period 1||0||
48273430|NCT02037477|100992130|FG000|STARTED|Treatment Period 2||5||
48273431|NCT02037477|100992131|FG001|STARTED|Treatment Period 2||5||
48273432|NCT02037477|100992132|FG002|STARTED|Treatment Period 2||4||
48273433|NCT02037477|100992133|FG003|STARTED|Treatment Period 2||5||
48273434|NCT02037477|100992130|FG000|COMPLETED|Treatment Period 2||5||
48273435|NCT02037477|100992131|FG001|COMPLETED|Treatment Period 2||5||
48273436|NCT02037477|100992132|FG002|COMPLETED|Treatment Period 2||4||
48273437|NCT02037477|100992133|FG003|COMPLETED|Treatment Period 2||5||
48273438|NCT02037477|100992130|FG000|NOT COMPLETED|Treatment Period 2||0||
48273439|NCT02037477|100992131|FG001|NOT COMPLETED|Treatment Period 2||0||
48273440|NCT02037477|100992132|FG002|NOT COMPLETED|Treatment Period 2||0||
48273441|NCT02037477|100992133|FG003|NOT COMPLETED|Treatment Period 2||0||
48557251|NCT00711243|101698050|FG000|COMPLETED|Registed and Started Treatment||3||
48557252|NCT00711243|101698051|FG001|COMPLETED|Registed and Started Treatment||3||
48557253|NCT00711243|101698052|FG002|COMPLETED|Registed and Started Treatment||3||
48557254|NCT00711243|101698053|FG003|COMPLETED|Registed and Started Treatment||3||
48557255|NCT00711243|101698054|FG004|COMPLETED|Registed and Started Treatment||3||
48557256|NCT00711243|101698055|FG005|COMPLETED|Registed and Started Treatment||43||
48273442|NCT02018653|100992134|FG000|STARTED|Overall Study||1||
48557257|NCT00711243|101698050|FG000|NOT COMPLETED|Registed and Started Treatment||0||
48557258|NCT00711243|101698051|FG001|NOT COMPLETED|Registed and Started Treatment||0||
48557259|NCT00711243|101698052|FG002|NOT COMPLETED|Registed and Started Treatment||0||
48557260|NCT00711243|101698053|FG003|NOT COMPLETED|Registed and Started Treatment||0||
48557261|NCT00711243|101698054|FG004|NOT COMPLETED|Registed and Started Treatment||0||
48557262|NCT00711243|101698055|FG005|NOT COMPLETED|Registed and Started Treatment||1||
48557263|NCT00711243|101698050|FG000|STARTED|Reached First Response/4 Cycles||3||
48557264|NCT00711243|101698051|FG001|STARTED|Reached First Response/4 Cycles||3||
48557265|NCT00711243|101698052|FG002|STARTED|Reached First Response/4 Cycles||3||
48273443|NCT02018653|100992135|FG001|STARTED|Overall Study||1||
48273444|NCT02018653|100992134|FG000|COMPLETED|Overall Study||1||
48273445|NCT02018653|100992135|FG001|COMPLETED|Overall Study||0||
48273446|NCT02018653|100992134|FG000|NOT COMPLETED|Overall Study||0||
48273447|NCT02018653|100992135|FG001|NOT COMPLETED|Overall Study||1||
48273448|NCT04655027|100992136|FG000|STARTED|Overall Study||13||
48273449|NCT04655027|100992137|FG001|STARTED|Overall Study||12||
48273450|NCT04655027|100992136|FG000|COMPLETED|Overall Study||12||
48273451|NCT04655027|100992137|FG001|COMPLETED|Overall Study||12||
48273452|NCT04655027|100992136|FG000|NOT COMPLETED|Overall Study||1||
48273453|NCT04655027|100992137|FG001|NOT COMPLETED|Overall Study||0||
48273454|NCT04678505|100992138|FG000|STARTED|Overall Study||4||
48273455|NCT04678505|100992139|FG001|STARTED|Overall Study||5||
48273456|NCT04678505|100992140|FG002|STARTED|Overall Study||0||
48273457|NCT04678505|100992141|FG003|STARTED|Overall Study||0||
48273458|NCT04678505|100992142|FG004|STARTED|Overall Study||0||
48273459|NCT04678505|100992138|FG000|COMPLETED|Overall Study||4||
48273460|NCT04678505|100992139|FG001|COMPLETED|Overall Study||5||
48273461|NCT04678505|100992140|FG002|COMPLETED|Overall Study||0||
48557266|NCT00711243|101698053|FG003|STARTED|Reached First Response/4 Cycles||3||
48557267|NCT00711243|101698054|FG004|STARTED|Reached First Response/4 Cycles||3||
48557268|NCT00711243|101698055|FG005|STARTED|Reached First Response/4 Cycles||43||
48557269|NCT00711243|101698050|FG000|COMPLETED|Reached First Response/4 Cycles||3||
48557270|NCT00711243|101698051|FG001|COMPLETED|Reached First Response/4 Cycles||3||
48273462|NCT04678505|100992141|FG003|COMPLETED|Overall Study||0||
48273463|NCT04678505|100992142|FG004|COMPLETED|Overall Study||0||
48273464|NCT04678505|100992138|FG000|NOT COMPLETED|Overall Study||0||
48273465|NCT04678505|100992139|FG001|NOT COMPLETED|Overall Study||0||
48273466|NCT04678505|100992140|FG002|NOT COMPLETED|Overall Study||0||
48273467|NCT04678505|100992141|FG003|NOT COMPLETED|Overall Study||0||
48273468|NCT04678505|100992142|FG004|NOT COMPLETED|Overall Study||0||
48273469|NCT01214642|100992143|FG000|STARTED|Overall Study||3||
48694455|NCT05069597|102036398|FG000|STARTED|Treatment Period (Day 1 to Day 85)||0||
48694456|NCT05069597|102036399|FG001|STARTED|Treatment Period (Day 1 to Day 85)||29||
48694457|NCT05069597|102036398|FG000|COMPLETED|Treatment Period (Day 1 to Day 85)||0||
48694458|NCT05069597|102036399|FG001|COMPLETED|Treatment Period (Day 1 to Day 85)||28||
48557271|NCT00711243|101698052|FG002|COMPLETED|Reached First Response/4 Cycles||3||
48273470|NCT01214642|100992144|FG001|STARTED|Overall Study||3||
48273471|NCT01214642|100992145|FG002|STARTED|Overall Study||6||
48273472|NCT01214642|100992146|FG003|STARTED|Overall Study||6||
48273473|NCT01214642|100992147|FG004|STARTED|Overall Study||6||
48273474|NCT01214642|100992148|FG005|STARTED|Overall Study||3||
48273475|NCT01214642|100992149|FG006|STARTED|Overall Study||6||
48273476|NCT01214642|100992150|FG007|STARTED|Overall Study||3||
48273477|NCT01214642|100992151|FG008|STARTED|Overall Study||13||
48273478|NCT01214642|100992152|FG009|STARTED|Overall Study||4||
48273479|NCT01214642|100992153|FG010|STARTED|Overall Study||4||
48273480|NCT01214642|100992154|FG011|STARTED|Overall Study||6||
48273481|NCT01214642|100992143|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
48273482|NCT01214642|100992144|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3||
48273483|NCT01214642|100992145|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
48273484|NCT01214642|100992146|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6||
48273485|NCT01214642|100992147|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6||
48557272|NCT00711243|101698053|FG003|COMPLETED|Reached First Response/4 Cycles||2||
48557273|NCT00711243|101698054|FG004|COMPLETED|Reached First Response/4 Cycles||3||
48557274|NCT00711243|101698055|FG005|COMPLETED|Reached First Response/4 Cycles||41||
48557275|NCT00711243|101698050|FG000|NOT COMPLETED|Reached First Response/4 Cycles||0||
48557276|NCT00711243|101698051|FG001|NOT COMPLETED|Reached First Response/4 Cycles||0||
48557277|NCT00711243|101698052|FG002|NOT COMPLETED|Reached First Response/4 Cycles||0||
48557278|NCT00711243|101698053|FG003|NOT COMPLETED|Reached First Response/4 Cycles||1||
48557279|NCT00711243|101698054|FG004|NOT COMPLETED|Reached First Response/4 Cycles||0||
48557280|NCT00711243|101698055|FG005|NOT COMPLETED|Reached First Response/4 Cycles||2||
48557281|NCT00711243|101698050|FG000|STARTED|Treated Cycle 5 After First Response||3||
48694459|NCT05069597|102036398|FG000|NOT COMPLETED|Treatment Period (Day 1 to Day 85)||0||
48694460|NCT05069597|102036399|FG001|NOT COMPLETED|Treatment Period (Day 1 to Day 85)||1||
48694461|NCT02485639|102036400|FG000|STARTED|Overall Study||27||
48694462|NCT02485639|102036400|FG000|COMPLETED|Overall Study||11||
48694463|NCT02485639|102036400|FG000|NOT COMPLETED|Overall Study||16||
48694464|NCT02836717|102036401|FG000|STARTED|Test Phase||73||
48694465|NCT02836717|102036402|FG001|STARTED|Test Phase||16||
48694466|NCT02836717|102036403|FG002|STARTED|Test Phase||12||
48694467|NCT02836717|102036401|FG000|COMPLETED|Test Phase||59||
48273486|NCT01214642|100992148|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3||
48557282|NCT00711243|101698051|FG001|STARTED|Treated Cycle 5 After First Response||3||
48557283|NCT00711243|101698052|FG002|STARTED|Treated Cycle 5 After First Response||3||
48694468|NCT02836717|102036402|FG001|COMPLETED|Test Phase||8||
48273487|NCT01214642|100992149|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6||
48273488|NCT01214642|100992150|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3||
48273489|NCT01214642|100992151|FG008|Received at Least 1 Dose of Study Drug|Overall Study||13||
48273490|NCT01214642|100992152|FG009|Received at Least 1 Dose of Study Drug|Overall Study||4||
48273491|NCT01214642|100992153|FG010|Received at Least 1 Dose of Study Drug|Overall Study||4||
48273492|NCT01214642|100992154|FG011|Received at Least 1 Dose of Study Drug|Overall Study||6||
48273493|NCT01214642|100992143|FG000|Complete at Least 2 Cycles of Study Drug|Overall Study||3||
48273494|NCT01214642|100992144|FG001|Complete at Least 2 Cycles of Study Drug|Overall Study||1||
48273495|NCT01214642|100992145|FG002|Complete at Least 2 Cycles of Study Drug|Overall Study||5||
48273496|NCT01214642|100992146|FG003|Complete at Least 2 Cycles of Study Drug|Overall Study||4||
48273497|NCT01214642|100992147|FG004|Complete at Least 2 Cycles of Study Drug|Overall Study||6||
48273498|NCT01214642|100992148|FG005|Complete at Least 2 Cycles of Study Drug|Overall Study||1||
48273499|NCT01214642|100992149|FG006|Complete at Least 2 Cycles of Study Drug|Overall Study||6||
48273500|NCT01214642|100992150|FG007|Complete at Least 2 Cycles of Study Drug|Overall Study||3||
48273501|NCT01214642|100992151|FG008|Complete at Least 2 Cycles of Study Drug|Overall Study||12||
48273502|NCT01214642|100992152|FG009|Complete at Least 2 Cycles of Study Drug|Overall Study||2||
48557284|NCT00711243|101698053|FG003|STARTED|Treated Cycle 5 After First Response||2||
48273503|NCT01214642|100992153|FG010|Complete at Least 2 Cycles of Study Drug|Overall Study||2||
48273504|NCT01214642|100992154|FG011|Complete at Least 2 Cycles of Study Drug|Overall Study||5||
48273505|NCT01214642|100992143|FG000|COMPLETED|Overall Study||0||
48273506|NCT01214642|100992144|FG001|COMPLETED|Overall Study||0||
48273507|NCT01214642|100992145|FG002|COMPLETED|Overall Study||0||
48273508|NCT01214642|100992146|FG003|COMPLETED|Overall Study||0||
48273509|NCT01214642|100992147|FG004|COMPLETED|Overall Study||0||
48273510|NCT01214642|100992148|FG005|COMPLETED|Overall Study||0||
48273511|NCT01214642|100992149|FG006|COMPLETED|Overall Study||0||
48273512|NCT01214642|100992150|FG007|COMPLETED|Overall Study||0||
48273513|NCT01214642|100992151|FG008|COMPLETED|Overall Study||0||
48273514|NCT01214642|100992152|FG009|COMPLETED|Overall Study||0||
48273515|NCT01214642|100992153|FG010|COMPLETED|Overall Study||0||
48273516|NCT01214642|100992154|FG011|COMPLETED|Overall Study||0||
48273517|NCT01214642|100992143|FG000|NOT COMPLETED|Overall Study||3||
48273518|NCT01214642|100992144|FG001|NOT COMPLETED|Overall Study||3||
48273519|NCT01214642|100992145|FG002|NOT COMPLETED|Overall Study||6||
48557285|NCT00711243|101698054|FG004|STARTED|Treated Cycle 5 After First Response||3||
48557286|NCT00711243|101698055|FG005|STARTED|Treated Cycle 5 After First Response||41||
48557287|NCT00711243|101698050|FG000|COMPLETED|Treated Cycle 5 After First Response||2||
48557288|NCT00711243|101698051|FG001|COMPLETED|Treated Cycle 5 After First Response||1||
48557289|NCT00711243|101698052|FG002|COMPLETED|Treated Cycle 5 After First Response||3||
48557290|NCT00711243|101698053|FG003|COMPLETED|Treated Cycle 5 After First Response||2||
48557291|NCT00711243|101698054|FG004|COMPLETED|Treated Cycle 5 After First Response||2||
48557292|NCT00711243|101698055|FG005|COMPLETED|Treated Cycle 5 After First Response||37||
48557293|NCT00711243|101698050|FG000|NOT COMPLETED|Treated Cycle 5 After First Response||1||
48557294|NCT00711243|101698051|FG001|NOT COMPLETED|Treated Cycle 5 After First Response||2||
48557295|NCT00711243|101698052|FG002|NOT COMPLETED|Treated Cycle 5 After First Response||0||
48557296|NCT00711243|101698053|FG003|NOT COMPLETED|Treated Cycle 5 After First Response||0||
48557297|NCT00711243|101698054|FG004|NOT COMPLETED|Treated Cycle 5 After First Response||1||
48557298|NCT00711243|101698055|FG005|NOT COMPLETED|Treated Cycle 5 After First Response||4||
48557299|NCT00711243|101698050|FG000|STARTED|Follow up Every 3 Months Until Death||3|All patients that are treated on study go into follow up|
48557300|NCT00711243|101698051|FG001|STARTED|Follow up Every 3 Months Until Death||3|All patients that are treated on study go into follow up|
48557301|NCT00711243|101698052|FG002|STARTED|Follow up Every 3 Months Until Death||3|All patients that are treated on study go into follow up|
48557302|NCT00711243|101698053|FG003|STARTED|Follow up Every 3 Months Until Death||3|All patients that are treated on study go into follow up|
48557303|NCT00711243|101698054|FG004|STARTED|Follow up Every 3 Months Until Death||3|All patients that are treated on study go into follow up|
48557304|NCT00711243|101698055|FG005|STARTED|Follow up Every 3 Months Until Death||39|All patients that are treated on study go into follow up|
48557305|NCT00711243|101698050|FG000|COMPLETED|Follow up Every 3 Months Until Death||3||
48557306|NCT00711243|101698051|FG001|COMPLETED|Follow up Every 3 Months Until Death||3||
48557307|NCT00711243|101698052|FG002|COMPLETED|Follow up Every 3 Months Until Death||3||
48557308|NCT00711243|101698053|FG003|COMPLETED|Follow up Every 3 Months Until Death||3||
48557309|NCT00711243|101698054|FG004|COMPLETED|Follow up Every 3 Months Until Death||3||
48557310|NCT00711243|101698055|FG005|COMPLETED|Follow up Every 3 Months Until Death||37||
48557311|NCT00711243|101698050|FG000|NOT COMPLETED|Follow up Every 3 Months Until Death||0||
48557312|NCT00711243|101698051|FG001|NOT COMPLETED|Follow up Every 3 Months Until Death||0||
48557313|NCT00711243|101698052|FG002|NOT COMPLETED|Follow up Every 3 Months Until Death||0||
48557314|NCT00711243|101698053|FG003|NOT COMPLETED|Follow up Every 3 Months Until Death||0||
48557315|NCT00711243|101698054|FG004|NOT COMPLETED|Follow up Every 3 Months Until Death||0||
48557316|NCT00711243|101698055|FG005|NOT COMPLETED|Follow up Every 3 Months Until Death||2||
48557317|NCT01525329|101698056|FG000|STARTED|Overall Study||4||
48557318|NCT01525329|101698057|FG001|STARTED|Overall Study||14||
48557319|NCT01525329|101698056|FG000|COMPLETED|Overall Study||4||
48557320|NCT01525329|101698057|FG001|COMPLETED|Overall Study||14||
48557321|NCT01525329|101698056|FG000|NOT COMPLETED|Overall Study||0||
48557322|NCT01525329|101698057|FG001|NOT COMPLETED|Overall Study||0||
48557323|NCT01318317|101698058|FG000|STARTED|Overall Study||1||
48557324|NCT01318317|101698059|FG001|STARTED|Overall Study||4||
48557325|NCT01318317|101698060|FG002|STARTED|Overall Study||3||
48557326|NCT01318317|101698058|FG000|COMPLETED|Overall Study||1||
48557327|NCT01318317|101698059|FG001|COMPLETED|Overall Study||4||
48557328|NCT01318317|101698060|FG002|COMPLETED|Overall Study||3||
48557329|NCT01318317|101698058|FG000|NOT COMPLETED|Overall Study||0||
48557330|NCT01318317|101698059|FG001|NOT COMPLETED|Overall Study||0||
48557331|NCT01318317|101698060|FG002|NOT COMPLETED|Overall Study||0||
48557332|NCT00982657|101698061|FG000|STARTED|Overall Study||12||
48557333|NCT00982657|101698062|FG001|STARTED|Overall Study||3||
48557334|NCT00982657|101698063|FG002|STARTED|Overall Study||3||
48273520|NCT01214642|100992146|FG003|NOT COMPLETED|Overall Study||6||
48273521|NCT01214642|100992147|FG004|NOT COMPLETED|Overall Study||6||
48273522|NCT01214642|100992148|FG005|NOT COMPLETED|Overall Study||3||
48273523|NCT01214642|100992149|FG006|NOT COMPLETED|Overall Study||6||
48273524|NCT01214642|100992150|FG007|NOT COMPLETED|Overall Study||3||
48273525|NCT01214642|100992151|FG008|NOT COMPLETED|Overall Study||13||
48557335|NCT00982657|101698064|FG003|STARTED|Overall Study||16||
48557336|NCT00982657|101698061|FG000|COMPLETED|Overall Study||11||
48557337|NCT00982657|101698062|FG001|COMPLETED|Overall Study||3||
48557338|NCT00982657|101698063|FG002|COMPLETED|Overall Study||1||
48557339|NCT00982657|101698064|FG003|COMPLETED|Overall Study||7||
48557340|NCT00982657|101698061|FG000|NOT COMPLETED|Overall Study||1||
48557341|NCT00982657|101698062|FG001|NOT COMPLETED|Overall Study||0||
48557342|NCT00982657|101698063|FG002|NOT COMPLETED|Overall Study||2||
48694469|NCT02836717|102036403|FG002|COMPLETED|Test Phase||12||
48694470|NCT02836717|102036401|FG000|NOT COMPLETED|Test Phase||14||
48694471|NCT02836717|102036402|FG001|NOT COMPLETED|Test Phase||8||
48694472|NCT02836717|102036403|FG002|NOT COMPLETED|Test Phase||0||
48694473|NCT02836717|102036401|FG000|STARTED|Study Phase||59||
48694474|NCT02836717|102036402|FG001|STARTED|Study Phase||8||
48694475|NCT02836717|102036403|FG002|STARTED|Study Phase||12||
48273526|NCT01214642|100992152|FG009|NOT COMPLETED|Overall Study||4||
48273527|NCT01214642|100992153|FG010|NOT COMPLETED|Overall Study||4||
48273528|NCT01214642|100992154|FG011|NOT COMPLETED|Overall Study||6||
48557343|NCT00982657|101698064|FG003|NOT COMPLETED|Overall Study||9||
48557344|NCT01154231|101698065|FG000|STARTED|Overall Study||314||
48557345|NCT01154231|101698065|FG000|COMPLETED|Overall Study||312||
48557346|NCT01154231|101698065|FG000|NOT COMPLETED|Overall Study||2||
48557347|NCT01607450|101698066|FG000|STARTED|Overall Study||6||
48694476|NCT02836717|102036401|FG000|COMPLETED|Study Phase||45||
48694477|NCT02836717|102036402|FG001|COMPLETED|Study Phase||1||
48694478|NCT02836717|102036403|FG002|COMPLETED|Study Phase||11||
48694479|NCT02836717|102036401|FG000|NOT COMPLETED|Study Phase||14||
48694480|NCT02836717|102036402|FG001|NOT COMPLETED|Study Phase||7||
48694481|NCT02836717|102036403|FG002|NOT COMPLETED|Study Phase||1||
48694482|NCT01638013|102036404|FG000|STARTED|Overall Study||201||
48110986|NCT02350309|100598017|FG001|NOT COMPLETED|Washout Period 3 (12-16 Days)||0||
48557348|NCT01607450|101698067|FG001|STARTED|Overall Study||8||
48557349|NCT01607450|101698068|FG002|STARTED|Overall Study||7||
48557350|NCT01607450|101698069|FG003|STARTED|Overall Study||11||
48557351|NCT01607450|101698070|FG004|STARTED|Overall Study||1||
48557352|NCT01607450|101698071|FG005|STARTED|Overall Study||0||
48557353|NCT01607450|101698072|FG006|STARTED|Overall Study||0||
48557354|NCT01607450|101698066|FG000|COMPLETED|Overall Study||6||
48557355|NCT01607450|101698067|FG001|COMPLETED|Overall Study||8||
48694483|NCT01638013|102036405|FG001|STARTED|Overall Study||225||
48694484|NCT01638013|102036406|FG002|STARTED|Overall Study||417||
48694485|NCT01638013|102036404|FG000|COMPLETED|Overall Study||70||
48110987|NCT02350309|100598018|FG002|NOT COMPLETED|Washout Period 3 (12-16 Days)||0||
48110988|NCT02350309|100598019|FG003|NOT COMPLETED|Washout Period 3 (12-16 Days)||0||
48110989|NCT02350309|100598020|FG004|NOT COMPLETED|Washout Period 3 (12-16 Days)||0||
48110990|NCT02350309|100598021|FG005|NOT COMPLETED|Washout Period 3 (12-16 Days)||0||
48110991|NCT02350309|100598016|FG000|STARTED|Treatment Period 4 (2 Days)||12||
48110992|NCT02350309|100598017|FG001|STARTED|Treatment Period 4 (2 Days)||11||
48110993|NCT02350309|100598018|FG002|STARTED|Treatment Period 4 (2 Days)||10||
48110994|NCT02350309|100598019|FG003|STARTED|Treatment Period 4 (2 Days)||11||
48110995|NCT02350309|100598020|FG004|STARTED|Treatment Period 4 (2 Days)||12||
48110996|NCT02350309|100598021|FG005|STARTED|Treatment Period 4 (2 Days)||12||
48110997|NCT02350309|100598016|FG000|COMPLETED|Treatment Period 4 (2 Days)||12||
48110998|NCT02350309|100598017|FG001|COMPLETED|Treatment Period 4 (2 Days)||11||
48110999|NCT02350309|100598018|FG002|COMPLETED|Treatment Period 4 (2 Days)||10||
48111000|NCT02350309|100598019|FG003|COMPLETED|Treatment Period 4 (2 Days)||11||
48111001|NCT02350309|100598020|FG004|COMPLETED|Treatment Period 4 (2 Days)||12||
48111002|NCT02350309|100598021|FG005|COMPLETED|Treatment Period 4 (2 Days)||11||
48111003|NCT02350309|100598016|FG000|NOT COMPLETED|Treatment Period 4 (2 Days)||0||
48273529|NCT00878826|100992155|FG000|STARTED|Overall Study||3||
48557356|NCT01607450|101698068|FG002|COMPLETED|Overall Study||7||
48557357|NCT01607450|101698069|FG003|COMPLETED|Overall Study||11||
48557358|NCT01607450|101698070|FG004|COMPLETED|Overall Study||1||
48557359|NCT01607450|101698071|FG005|COMPLETED|Overall Study||0||
48557360|NCT01607450|101698072|FG006|COMPLETED|Overall Study||0||
48557361|NCT01607450|101698066|FG000|NOT COMPLETED|Overall Study||0||
48694486|NCT01638013|102036405|FG001|COMPLETED|Overall Study||147||
48694487|NCT01638013|102036406|FG002|COMPLETED|Overall Study||296||
48694488|NCT01638013|102036404|FG000|NOT COMPLETED|Overall Study||131||
48694489|NCT01638013|102036405|FG001|NOT COMPLETED|Overall Study||78||
48694490|NCT01638013|102036406|FG002|NOT COMPLETED|Overall Study||121||
48694491|NCT01404559|102036407|FG000|STARTED|Overall Study||5||
48694492|NCT01404559|102036408|FG001|STARTED|Overall Study||5||
48694493|NCT01404559|102036409|FG002|STARTED|Overall Study||4||
48694494|NCT01404559|102036410|FG003|STARTED|Overall Study||14||
48694495|NCT01404559|102036407|FG000|COMPLETED|Overall Study||5||
48694496|NCT01404559|102036408|FG001|COMPLETED|Overall Study||5||
48694497|NCT01404559|102036409|FG002|COMPLETED|Overall Study||4||
48694498|NCT01404559|102036410|FG003|COMPLETED|Overall Study||14||
48694499|NCT01404559|102036407|FG000|NOT COMPLETED|Overall Study||0||
48694500|NCT01404559|102036408|FG001|NOT COMPLETED|Overall Study||0||
48694501|NCT01404559|102036409|FG002|NOT COMPLETED|Overall Study||0||
48694502|NCT01404559|102036410|FG003|NOT COMPLETED|Overall Study||0||
48694503|NCT02972606|102036411|FG000|STARTED|Overall Study||26||
48694504|NCT02972606|102036411|FG000|COMPLETED|Overall Study||26||
48694505|NCT02972606|102036411|FG000|NOT COMPLETED|Overall Study||0||
48694506|NCT02982772|102036412|FG000|STARTED|Enrollment||245||
48694507|NCT02982772|102036413|FG001|STARTED|Enrollment||243||
48694508|NCT02982772|102036412|FG000|COMPLETED|Enrollment||245||
48694509|NCT02982772|102036413|FG001|COMPLETED|Enrollment||243||
48694510|NCT02982772|102036412|FG000|NOT COMPLETED|Enrollment||0||
48694511|NCT02982772|102036413|FG001|NOT COMPLETED|Enrollment||0||
48694512|NCT02982772|102036412|FG000|STARTED|Intervention||245||
48694513|NCT02982772|102036413|FG001|STARTED|Intervention||243||
48694514|NCT02982772|102036412|FG000|COMPLETED|Intervention||226||
48694515|NCT02982772|102036413|FG001|COMPLETED|Intervention||230||
48694516|NCT02982772|102036412|FG000|NOT COMPLETED|Intervention||19||
48694517|NCT02982772|102036413|FG001|NOT COMPLETED|Intervention||13||
48694518|NCT02982772|102036412|FG000|STARTED|1M Follow-Up||226||
48694519|NCT02982772|102036413|FG001|STARTED|1M Follow-Up||230||
48694520|NCT02982772|102036412|FG000|COMPLETED|1M Follow-Up||205||
48694521|NCT02982772|102036413|FG001|COMPLETED|1M Follow-Up||212||
48694522|NCT02982772|102036412|FG000|NOT COMPLETED|1M Follow-Up||21||
48694523|NCT02982772|102036413|FG001|NOT COMPLETED|1M Follow-Up||18||
48694524|NCT02982772|102036412|FG000|STARTED|3M Follow-Up||205||
48694525|NCT02982772|102036413|FG001|STARTED|3M Follow-Up||212||
48694526|NCT02982772|102036412|FG000|COMPLETED|3M Follow-Up||188||
48694527|NCT02982772|102036413|FG001|COMPLETED|3M Follow-Up||201||
48694528|NCT02982772|102036412|FG000|NOT COMPLETED|3M Follow-Up||17||
48694529|NCT02982772|102036413|FG001|NOT COMPLETED|3M Follow-Up||11||
48694530|NCT02982772|102036412|FG000|STARTED|6M Follow-Up||188||
48694531|NCT02982772|102036413|FG001|STARTED|6M Follow-Up||201||
48694532|NCT02982772|102036412|FG000|COMPLETED|6M Follow-Up||177||
48694533|NCT02982772|102036413|FG001|COMPLETED|6M Follow-Up||192||
48694534|NCT02982772|102036412|FG000|NOT COMPLETED|6M Follow-Up||11||
48694535|NCT02982772|102036413|FG001|NOT COMPLETED|6M Follow-Up||9||
48694536|NCT02982772|102036412|FG000|STARTED|12M Follow-Up||177||
48694537|NCT02982772|102036413|FG001|STARTED|12M Follow-Up||192||
48694538|NCT02982772|102036412|FG000|COMPLETED|12M Follow-Up||166||
48694539|NCT02982772|102036413|FG001|COMPLETED|12M Follow-Up||187||
48694540|NCT02982772|102036412|FG000|NOT COMPLETED|12M Follow-Up||11||
48694541|NCT02982772|102036413|FG001|NOT COMPLETED|12M Follow-Up||5||
48694542|NCT00412958|102036414|FG000|STARTED|Overall Study||29||
48694543|NCT00412958|102036415|FG001|STARTED|Overall Study||33||
48694544|NCT00412958|102036416|FG002|STARTED|Overall Study||32||
48694545|NCT00412958|102036417|FG003|STARTED|Overall Study||31||
48694546|NCT00412958|102036414|FG000|COMPLETED|Overall Study||26||
48694547|NCT00412958|102036415|FG001|COMPLETED|Overall Study||29||
48694548|NCT00412958|102036416|FG002|COMPLETED|Overall Study||32||
48694549|NCT00412958|102036417|FG003|COMPLETED|Overall Study||30||
48694550|NCT00412958|102036414|FG000|NOT COMPLETED|Overall Study||3||
48694551|NCT00412958|102036415|FG001|NOT COMPLETED|Overall Study||4||
48694552|NCT00412958|102036416|FG002|NOT COMPLETED|Overall Study||0||
48694553|NCT00412958|102036417|FG003|NOT COMPLETED|Overall Study||1||
48694554|NCT02923830|102036418|FG000|STARTED|Overall Study||13||
48694555|NCT02923830|102036419|FG001|STARTED|Overall Study||15||
48694556|NCT02923830|102036418|FG000|COMPLETED|Overall Study||0||
48694557|NCT02923830|102036419|FG001|COMPLETED|Overall Study||0||
48694558|NCT02923830|102036418|FG000|NOT COMPLETED|Overall Study||13||
48694559|NCT02923830|102036419|FG001|NOT COMPLETED|Overall Study||15||
48694560|NCT02642393|102036420|FG000|STARTED|Overall Study||149||
48694561|NCT02642393|102036421|FG001|STARTED|Overall Study||149||
48694562|NCT02642393|102036420|FG000|COMPLETED|Overall Study||50||
48694563|NCT02642393|102036421|FG001|COMPLETED|Overall Study||57||
48694564|NCT02642393|102036420|FG000|NOT COMPLETED|Overall Study||99||
48694565|NCT02642393|102036421|FG001|NOT COMPLETED|Overall Study||92||
48694566|NCT02476032|102036422|FG000|STARTED|Overall Study||20||
48694567|NCT02476032|102036423|FG001|STARTED|Overall Study||20||
48694568|NCT02476032|102036424|FG002|STARTED|Overall Study||20||
48694569|NCT02476032|102036422|FG000|COMPLETED|Overall Study||20||
48694570|NCT02476032|102036423|FG001|COMPLETED|Overall Study||19||
48694571|NCT02476032|102036424|FG002|COMPLETED|Overall Study||19||
48694572|NCT02476032|102036422|FG000|NOT COMPLETED|Overall Study||0||
48694573|NCT02476032|102036423|FG001|NOT COMPLETED|Overall Study||1||
48694574|NCT02476032|102036424|FG002|NOT COMPLETED|Overall Study||1||
48694575|NCT03462927|102036425|FG000|STARTED|Overall Study||32||
48694576|NCT03462927|102036426|FG001|STARTED|Overall Study||31||
48694577|NCT03462927|102036425|FG000|COMPLETED|Overall Study||26||
48694578|NCT03462927|102036426|FG001|COMPLETED|Overall Study||29||
48694579|NCT03462927|102036425|FG000|NOT COMPLETED|Overall Study||6||
48694580|NCT03462927|102036426|FG001|NOT COMPLETED|Overall Study||2||
48694581|NCT01312805|102036427|FG000|STARTED|Overall Study||1016||
48694582|NCT01312805|102036428|FG001|STARTED|Overall Study||1082||
48694583|NCT01312805|102036427|FG000|COMPLETED|Overall Study||1016||
48694584|NCT01312805|102036428|FG001|COMPLETED|Overall Study||1082||
48694585|NCT01312805|102036427|FG000|NOT COMPLETED|Overall Study||0||
48694586|NCT01312805|102036428|FG001|NOT COMPLETED|Overall Study||0||
48694587|NCT01309997|102036429|FG000|STARTED|Overall Study||35||
48694588|NCT01309997|102036430|FG001|STARTED|Overall Study||37||
48694589|NCT01309997|102036429|FG000|Remained on First Arm Only|Overall Study||16||
48694590|NCT01309997|102036430|FG001|Remained on First Arm Only|Overall Study||14||
48694591|NCT01309997|102036429|FG000|Crossed Over to Second Arm|Overall Study||19||
48694592|NCT01309997|102036430|FG001|Crossed Over to Second Arm|Overall Study||23||
48273530|NCT00878826|100992156|FG001|STARTED|Overall Study||6||
48273531|NCT00878826|100992157|FG002|STARTED|Overall Study||2||
48273532|NCT00878826|100992155|FG000|COMPLETED|Overall Study||3||
48273533|NCT00878826|100992156|FG001|COMPLETED|Overall Study||6||
48694593|NCT01309997|102036429|FG000|COMPLETED|Overall Study||30||
48694594|NCT01309997|102036430|FG001|COMPLETED|Overall Study||31||
48694595|NCT01309997|102036429|FG000|NOT COMPLETED|Overall Study||5||
48694596|NCT01309997|102036430|FG001|NOT COMPLETED|Overall Study||6||
48694597|NCT01905943|102036431|FG000|STARTED|Overall Study||972||
48694598|NCT01905943|102036431|FG000|COMPLETED|Overall Study||658||
48694599|NCT01905943|102036431|FG000|NOT COMPLETED|Overall Study||314||
48694600|NCT00438360|102036432|FG000|STARTED|Overall Study||162||
48694601|NCT00438360|102036433|FG001|STARTED|Overall Study||81||
48694602|NCT00438360|102036432|FG000|Intention to Treat (ITT) Population|Overall Study||160||
48694603|NCT00438360|102036433|FG001|Intention to Treat (ITT) Population|Overall Study||79||
48694604|NCT00438360|102036432|FG000|COMPLETED|Overall Study||90||
48694605|NCT00438360|102036433|FG001|COMPLETED|Overall Study||38||
48694606|NCT00438360|102036432|FG000|NOT COMPLETED|Overall Study||72||
48694607|NCT00438360|102036433|FG001|NOT COMPLETED|Overall Study||43||
48694608|NCT03205358|102036434|FG000|STARTED|Overall Study||94||
48694609|NCT03205358|102036435|FG001|STARTED|Overall Study||94||
48694610|NCT03205358|102036434|FG000|COMPLETED|Overall Study||94||
48694611|NCT03205358|102036435|FG001|COMPLETED|Overall Study||94||
48694612|NCT03205358|102036434|FG000|NOT COMPLETED|Overall Study||0||
48694613|NCT03205358|102036435|FG001|NOT COMPLETED|Overall Study||0||
48694614|NCT00883168|102036436|FG000|STARTED|Overall Study||448||
48694615|NCT00883168|102036437|FG001|STARTED|Overall Study||445||
48694616|NCT00883168|102036438|FG002|STARTED|Overall Study||450||
48694617|NCT00883168|102036439|FG003|STARTED|Overall Study||448||
48694618|NCT00883168|102036436|FG000|COMPLETED|Overall Study||434||
48694619|NCT00883168|102036437|FG001|COMPLETED|Overall Study||430||
48694620|NCT00883168|102036438|FG002|COMPLETED|Overall Study||431||
48694621|NCT00883168|102036439|FG003|COMPLETED|Overall Study||433||
48694622|NCT00883168|102036436|FG000|NOT COMPLETED|Overall Study||14||
48694623|NCT00883168|102036437|FG001|NOT COMPLETED|Overall Study||15||
48694624|NCT00883168|102036438|FG002|NOT COMPLETED|Overall Study||19||
48694625|NCT00883168|102036439|FG003|NOT COMPLETED|Overall Study||15||
48694626|NCT00253513|102036440|FG000|STARTED|Overall Study||60||
48694627|NCT00253513|102036440|FG000|COMPLETED|Overall Study||60||
48694628|NCT00253513|102036440|FG000|NOT COMPLETED|Overall Study||0||
48694629|NCT01258790|102036441|FG000|STARTED|Overall Study||6||
48694630|NCT01258790|102036442|FG001|STARTED|Overall Study||6||
48694631|NCT01258790|102036441|FG000|COMPLETED|Overall Study||6||
48694632|NCT01258790|102036442|FG001|COMPLETED|Overall Study||6||
48273534|NCT00878826|100992157|FG002|COMPLETED|Overall Study||2||
48273535|NCT00878826|100992155|FG000|NOT COMPLETED|Overall Study||0||
48273536|NCT00878826|100992156|FG001|NOT COMPLETED|Overall Study||0||
48273537|NCT00878826|100992157|FG002|NOT COMPLETED|Overall Study||0||
48273538|NCT01020877|100992158|FG000|STARTED|First Intervention||19||
48694633|NCT01258790|102036441|FG000|NOT COMPLETED|Overall Study||0||
48694634|NCT01258790|102036442|FG001|NOT COMPLETED|Overall Study||0||
48694635|NCT01939977|102036443|FG000|STARTED|Overall Study||46||
48694636|NCT01939977|102036444|FG001|STARTED|Overall Study||48||
48694637|NCT01939977|102036443|FG000|COMPLETED|Overall Study||37||
48694638|NCT01939977|102036444|FG001|COMPLETED|Overall Study||41||
48694639|NCT01939977|102036443|FG000|NOT COMPLETED|Overall Study||9||
48694640|NCT01939977|102036444|FG001|NOT COMPLETED|Overall Study||7||
48694641|NCT02323126|102036445|FG000|STARTED|Overall Study||18||
48694642|NCT02323126|102036446|FG001|STARTED|Overall Study||16||
48557362|NCT01607450|101698067|FG001|NOT COMPLETED|Overall Study||0||
48557363|NCT01607450|101698068|FG002|NOT COMPLETED|Overall Study||0||
48557364|NCT01607450|101698069|FG003|NOT COMPLETED|Overall Study||0||
48557365|NCT01607450|101698070|FG004|NOT COMPLETED|Overall Study||0||
48557366|NCT01607450|101698071|FG005|NOT COMPLETED|Overall Study||0||
48557367|NCT01607450|101698072|FG006|NOT COMPLETED|Overall Study||0||
48557368|NCT01012336|101698073|FG000|STARTED|Overall Study||85||
48557369|NCT01012336|101698073|FG000|COMPLETED|Overall Study||85||
48557370|NCT01012336|101698073|FG000|NOT COMPLETED|Overall Study||0||
48557371|NCT02058069|101698074|FG000|STARTED|Overall Study||100||
48557372|NCT02058069|101698074|FG000|COMPLETED|Overall Study||89||
48557373|NCT02058069|101698074|FG000|NOT COMPLETED|Overall Study||11||
48557374|NCT03831711|101698075|FG000|STARTED|Overall Study||5||
48557375|NCT03831711|101698075|FG000|COMPLETED|Overall Study||5||
48557376|NCT03831711|101698075|FG000|NOT COMPLETED|Overall Study||0||
48557377|NCT01008605|101698076|FG000|STARTED|Overall Study||48||
48557378|NCT01008605|101698076|FG000|COMPLETED|Overall Study||48||
48557379|NCT01008605|101698076|FG000|NOT COMPLETED|Overall Study||0||
48557380|NCT00460603|101698077|FG000|STARTED|Phase 1||6||
48557381|NCT00460603|101698078|FG001|STARTED|Phase 1||6||
48557382|NCT00460603|101698079|FG002|STARTED|Phase 1||4||
48557383|NCT00460603|101698080|FG003|STARTED|Phase 1||8||
48557384|NCT00460603|101698081|FG004|STARTED|Phase 1||6||
48557385|NCT00460603|101698082|FG005|STARTED|Phase 1||4||
48557386|NCT00460603|101698083|FG006|STARTED|Phase 1||6||
48557387|NCT00460603|101698084|FG007|STARTED|Phase 1||3||
48557388|NCT00460603|101698085|FG008|STARTED|Phase 1||18||
48557389|NCT00460603|101698086|FG009|STARTED|Phase 1||0||
48557390|NCT00460603|101698087|FG010|STARTED|Phase 1||0||
48557391|NCT00460603|101698088|FG011|STARTED|Phase 1||0||
48557392|NCT00460603|101698077|FG000|COMPLETED|Phase 1||0||
48557393|NCT00460603|101698078|FG001|COMPLETED|Phase 1||0||
48557394|NCT00460603|101698079|FG002|COMPLETED|Phase 1||0||
48557395|NCT00460603|101698080|FG003|COMPLETED|Phase 1||0||
48557396|NCT00460603|101698081|FG004|COMPLETED|Phase 1||0||
48557397|NCT00460603|101698082|FG005|COMPLETED|Phase 1||0||
48557398|NCT00460603|101698083|FG006|COMPLETED|Phase 1||0||
48557399|NCT00460603|101698084|FG007|COMPLETED|Phase 1||0||
48557400|NCT00460603|101698085|FG008|COMPLETED|Phase 1||0||
48557401|NCT00460603|101698086|FG009|COMPLETED|Phase 1||0||
48557402|NCT00460603|101698087|FG010|COMPLETED|Phase 1||0||
48557403|NCT00460603|101698088|FG011|COMPLETED|Phase 1||0||
48557404|NCT00460603|101698077|FG000|NOT COMPLETED|Phase 1||6||
48557405|NCT00460603|101698078|FG001|NOT COMPLETED|Phase 1||6||
48557406|NCT00460603|101698079|FG002|NOT COMPLETED|Phase 1||4||
48557407|NCT00460603|101698080|FG003|NOT COMPLETED|Phase 1||8||
48557408|NCT00460603|101698081|FG004|NOT COMPLETED|Phase 1||6||
48557409|NCT00460603|101698082|FG005|NOT COMPLETED|Phase 1||4||
48557410|NCT00460603|101698083|FG006|NOT COMPLETED|Phase 1||6||
48557411|NCT00460603|101698084|FG007|NOT COMPLETED|Phase 1||3||
48557412|NCT00460603|101698085|FG008|NOT COMPLETED|Phase 1||18||
48557413|NCT00460603|101698086|FG009|NOT COMPLETED|Phase 1||0||
48557414|NCT00460603|101698087|FG010|NOT COMPLETED|Phase 1||0||
48557415|NCT00460603|101698088|FG011|NOT COMPLETED|Phase 1||0||
48557416|NCT00460603|101698077|FG000|STARTED|Phase 2||0||
48557417|NCT00460603|101698078|FG001|STARTED|Phase 2||0||
48557418|NCT00460603|101698079|FG002|STARTED|Phase 2||0||
48557419|NCT00460603|101698080|FG003|STARTED|Phase 2||0||
48557420|NCT00460603|101698081|FG004|STARTED|Phase 2||0||
48557421|NCT00460603|101698082|FG005|STARTED|Phase 2||0||
48557422|NCT00460603|101698083|FG006|STARTED|Phase 2||0||
48557423|NCT00460603|101698084|FG007|STARTED|Phase 2||0||
48557424|NCT00460603|101698085|FG008|STARTED|Phase 2||0||
48557425|NCT00460603|101698086|FG009|STARTED|Phase 2||42||
48557426|NCT00460603|101698087|FG010|STARTED|Phase 2||43||
48557427|NCT00460603|101698088|FG011|STARTED|Phase 2||41||
48557428|NCT00460603|101698077|FG000|Treated|Phase 2||0||
48557429|NCT00460603|101698078|FG001|Treated|Phase 2||0||
48557430|NCT00460603|101698079|FG002|Treated|Phase 2||0||
48557431|NCT00460603|101698080|FG003|Treated|Phase 2||0||
48557432|NCT00460603|101698081|FG004|Treated|Phase 2||0||
48557433|NCT00460603|101698082|FG005|Treated|Phase 2||0||
48557434|NCT00460603|101698083|FG006|Treated|Phase 2||0||
48557435|NCT00460603|101698084|FG007|Treated|Phase 2||0||
48557436|NCT00460603|101698085|FG008|Treated|Phase 2||0||
48557437|NCT00460603|101698086|FG009|Treated|Phase 2||39||
48557438|NCT00460603|101698087|FG010|Treated|Phase 2||43||
48557439|NCT00460603|101698088|FG011|Treated|Phase 2||41||
48557440|NCT00460603|101698077|FG000|COMPLETED|Phase 2||0||
48557441|NCT00460603|101698078|FG001|COMPLETED|Phase 2||0||
48557442|NCT00460603|101698079|FG002|COMPLETED|Phase 2||0||
48557443|NCT00460603|101698080|FG003|COMPLETED|Phase 2||0||
48557444|NCT00460603|101698081|FG004|COMPLETED|Phase 2||0||
48557445|NCT00460603|101698082|FG005|COMPLETED|Phase 2||0||
48557446|NCT00460603|101698083|FG006|COMPLETED|Phase 2||0||
48557447|NCT00460603|101698084|FG007|COMPLETED|Phase 2||0||
48557448|NCT00460603|101698085|FG008|COMPLETED|Phase 2||0||
48557449|NCT00460603|101698086|FG009|COMPLETED|Phase 2||0||
48557450|NCT00460603|101698087|FG010|COMPLETED|Phase 2||0||
48557451|NCT00460603|101698088|FG011|COMPLETED|Phase 2||0||
48557452|NCT00460603|101698077|FG000|NOT COMPLETED|Phase 2||0||
48557453|NCT00460603|101698078|FG001|NOT COMPLETED|Phase 2||0||
48557454|NCT00460603|101698079|FG002|NOT COMPLETED|Phase 2||0||
48694643|NCT02323126|102036447|FG002|STARTED|Overall Study||30||
48694644|NCT02323126|102036445|FG000|COMPLETED|Overall Study||0||
48694645|NCT02323126|102036446|FG001|COMPLETED|Overall Study||0||
48694646|NCT02323126|102036447|FG002|COMPLETED|Overall Study||0||
48694647|NCT02323126|102036445|FG000|NOT COMPLETED|Overall Study||18||
48694648|NCT02323126|102036446|FG001|NOT COMPLETED|Overall Study||16||
48694649|NCT02323126|102036447|FG002|NOT COMPLETED|Overall Study||30||
48694650|NCT02032758|102036448|FG000|STARTED|Overall Study||27||
48694651|NCT02032758|102036449|FG001|STARTED|Overall Study||11||
48694652|NCT02032758|102036448|FG000|COMPLETED|Overall Study||27||
48694653|NCT02032758|102036449|FG001|COMPLETED|Overall Study||11||
48694654|NCT02032758|102036448|FG000|NOT COMPLETED|Overall Study||0||
48694655|NCT02032758|102036449|FG001|NOT COMPLETED|Overall Study||0||
48694656|NCT01334216|102036450|FG000|STARTED|Overall Study||168||
48694657|NCT01334216|102036451|FG001|STARTED|Overall Study||194||
48694658|NCT01334216|102036450|FG000|COMPLETED|Overall Study||168||
48694659|NCT01334216|102036451|FG001|COMPLETED|Overall Study||194||
48694660|NCT01334216|102036450|FG000|NOT COMPLETED|Overall Study||0||
48694661|NCT01334216|102036451|FG001|NOT COMPLETED|Overall Study||0||
48694662|NCT04222699|102036452|FG000|STARTED|Overall Study||28||
48694663|NCT04222699|102036452|FG000|COMPLETED|Overall Study||26||
48694664|NCT04222699|102036452|FG000|NOT COMPLETED|Overall Study||2||
48694665|NCT00136695|102036453|FG000|STARTED|Overall Study||45||
48694666|NCT00136695|102036454|FG001|STARTED|Overall Study||43||
48694667|NCT00136695|102036453|FG000|COMPLETED|Overall Study||34||
48694668|NCT00136695|102036454|FG001|COMPLETED|Overall Study||35||
48694669|NCT00136695|102036453|FG000|NOT COMPLETED|Overall Study||11||
48694670|NCT00136695|102036454|FG001|NOT COMPLETED|Overall Study||8||
48694671|NCT04601532|102036455|FG000|STARTED|Overall Study||13||
48111004|NCT02350309|100598017|FG001|NOT COMPLETED|Treatment Period 4 (2 Days)||0||
48694672|NCT04601532|102036456|FG001|STARTED|Overall Study||13||
48694673|NCT04601532|102036455|FG000|COMPLETED|Overall Study||11||
48694674|NCT04601532|102036456|FG001|COMPLETED|Overall Study||11||
48694675|NCT04601532|102036455|FG000|NOT COMPLETED|Overall Study||2||
48694676|NCT04601532|102036456|FG001|NOT COMPLETED|Overall Study||2||
48694677|NCT02752633|102036457|FG000|STARTED|Overall Study||9||
48694678|NCT02752633|102036457|FG000|COMPLETED|Overall Study||8||
48694679|NCT02752633|102036457|FG000|NOT COMPLETED|Overall Study||1||
48694680|NCT01260688|102036458|FG000|STARTED|Overall Study||11||
48694681|NCT01260688|102036459|FG001|STARTED|Overall Study||11||
48694682|NCT01260688|102036458|FG000|COMPLETED|Overall Study||11||
48694683|NCT01260688|102036459|FG001|COMPLETED|Overall Study||11||
48694684|NCT01260688|102036458|FG000|NOT COMPLETED|Overall Study||0||
48694685|NCT01260688|102036459|FG001|NOT COMPLETED|Overall Study||0||
48694686|NCT01951586|102036460|FG000|STARTED|Overall Study||78||
48694687|NCT01951586|102036461|FG001|STARTED|Overall Study||148||
48694688|NCT01951586|102036460|FG000|Received Study Drug|Overall Study||76||
48694689|NCT01951586|102036461|FG001|Received Study Drug|Overall Study||145||
48694690|NCT01951586|102036460|FG000|COMPLETED|Overall Study||0||
48694691|NCT01951586|102036461|FG001|COMPLETED|Overall Study||0||
48694692|NCT01951586|102036460|FG000|NOT COMPLETED|Overall Study||78||
48694693|NCT01951586|102036461|FG001|NOT COMPLETED|Overall Study||148||
48694694|NCT03832322|102036462|FG000|STARTED|Overall Study||89||
48694695|NCT03832322|102036463|FG001|STARTED|Overall Study||87||
48694696|NCT03832322|102036462|FG000|COMPLETED|Overall Study||86||
48694697|NCT03832322|102036463|FG001|COMPLETED|Overall Study||86||
48694698|NCT03832322|102036462|FG000|NOT COMPLETED|Overall Study||3||
48694699|NCT03832322|102036463|FG001|NOT COMPLETED|Overall Study||1||
48694700|NCT04599803|102036464|FG000|STARTED|Overall Study||187||
48694701|NCT04599803|102036464|FG000|COMPLETED|Overall Study||156||
48694702|NCT04599803|102036464|FG000|NOT COMPLETED|Overall Study||31||
48694703|NCT01308814|102036465|FG000|STARTED|Overall Study||86||
48694704|NCT01308814|102036466|FG001|STARTED|Overall Study||86||
48694705|NCT01308814|102036465|FG000|COMPLETED|Overall Study||69||
48694706|NCT01308814|102036466|FG001|COMPLETED|Overall Study||63||
48694707|NCT01308814|102036465|FG000|NOT COMPLETED|Overall Study||17||
48694708|NCT01308814|102036466|FG001|NOT COMPLETED|Overall Study||23||
48694709|NCT03248531|102036467|FG000|STARTED|Overall Study||22|Completed screening period (2-4 Weeks) and Randomized|
48694710|NCT03248531|102036468|FG001|STARTED|Overall Study||22|Completed screening period (2-4 Weeks) and Randomized|
48694711|NCT03248531|102036469|FG002|STARTED|Overall Study||46|Completed screening period (2-4 Weeks) and Randomized|
48694712|NCT03248531|102036467|FG000|Completed Week 12|Overall Study||19|Completed treatment period (12 Weeks)|
48694713|NCT03248531|102036468|FG001|Completed Week 12|Overall Study||18|Completed treatment period (12 Weeks)|
48694714|NCT03248531|102036469|FG002|Completed Week 12|Overall Study||42|Completed treatment period (12 Weeks)|
48694715|NCT03248531|102036467|FG000|COMPLETED|Overall Study||18|Study completed (including safety follow-up period \[20 weeks after last dose\])|
48694716|NCT03248531|102036468|FG001|COMPLETED|Overall Study||17|Study completed (including safety follow-up period \[20 weeks after last dose\])|
48694717|NCT03248531|102036469|FG002|COMPLETED|Overall Study||38|Study completed (including safety follow-up period \[20 weeks after last dose\])|
48694718|NCT03248531|102036467|FG000|NOT COMPLETED|Overall Study||4||
48694719|NCT03248531|102036468|FG001|NOT COMPLETED|Overall Study||5||
48694720|NCT03248531|102036469|FG002|NOT COMPLETED|Overall Study||8||
48694721|NCT00392834|102036470|FG000|STARTED|Overall Study||2||
48111005|NCT02350309|100598018|FG002|NOT COMPLETED|Treatment Period 4 (2 Days)||0||
48111006|NCT02350309|100598019|FG003|NOT COMPLETED|Treatment Period 4 (2 Days)||0||
48111007|NCT02350309|100598020|FG004|NOT COMPLETED|Treatment Period 4 (2 Days)||0||
48111008|NCT02350309|100598021|FG005|NOT COMPLETED|Treatment Period 4 (2 Days)||1||
48111009|NCT01009099|100598022|FG000|STARTED|Overall Study||58||
48111010|NCT01009099|100598023|FG001|STARTED|Overall Study||61||
48111011|NCT01009099|100598022|FG000|COMPLETED|Overall Study||53||
48111012|NCT01009099|100598023|FG001|COMPLETED|Overall Study||57||
48111013|NCT01009099|100598022|FG000|NOT COMPLETED|Overall Study||5||
48111014|NCT01009099|100598023|FG001|NOT COMPLETED|Overall Study||4||
48111015|NCT01231581|100598024|FG000|STARTED|Overall Study||80||
48111016|NCT01231581|100598025|FG001|STARTED|Overall Study||80||
48111017|NCT01231581|100598024|FG000|Ongoing|Overall Study||1||
48111018|NCT01231581|100598025|FG001|Ongoing|Overall Study||0||
48111019|NCT01231581|100598024|FG000|COMPLETED|Overall Study||0||
48111020|NCT01231581|100598025|FG001|COMPLETED|Overall Study||0||
48111021|NCT01231581|100598024|FG000|NOT COMPLETED|Overall Study||80||
48111022|NCT01231581|100598025|FG001|NOT COMPLETED|Overall Study||80||
48273539|NCT01020877|100992159|FG001|STARTED|First Intervention||19||
48557455|NCT00460603|101698080|FG003|NOT COMPLETED|Phase 2||0||
48557456|NCT00460603|101698081|FG004|NOT COMPLETED|Phase 2||0||
48557457|NCT00460603|101698082|FG005|NOT COMPLETED|Phase 2||0||
48557458|NCT00460603|101698083|FG006|NOT COMPLETED|Phase 2||0||
48557459|NCT00460603|101698084|FG007|NOT COMPLETED|Phase 2||0||
48557460|NCT00460603|101698085|FG008|NOT COMPLETED|Phase 2||0||
48557461|NCT00460603|101698086|FG009|NOT COMPLETED|Phase 2||42||
48557462|NCT00460603|101698087|FG010|NOT COMPLETED|Phase 2||43||
48557463|NCT00460603|101698088|FG011|NOT COMPLETED|Phase 2||41||
48557464|NCT04004481|101698089|FG000|STARTED|Overall Study||50||
48557465|NCT04004481|101698089|FG000|COMPLETED|Overall Study||47||
48557466|NCT04004481|101698089|FG000|NOT COMPLETED|Overall Study||3||
48557467|NCT02762929|101698090|FG000|STARTED|Overall Study||32||
48557468|NCT02762929|101698091|FG001|STARTED|Overall Study||175||
48557469|NCT02762929|101698092|FG002|STARTED|Overall Study||25||
48557470|NCT02762929|101698093|FG003|STARTED|Overall Study||104||
48557471|NCT02762929|101698094|FG004|STARTED|Overall Study||64||
48557472|NCT02762929|101698095|FG005|STARTED|Overall Study||30||
48557473|NCT02762929|101698090|FG000|COMPLETED|Overall Study||31||
48557474|NCT02762929|101698091|FG001|COMPLETED|Overall Study||172||
48557475|NCT02762929|101698092|FG002|COMPLETED|Overall Study||25||
48557476|NCT02762929|101698093|FG003|COMPLETED|Overall Study||101||
48557477|NCT02762929|101698094|FG004|COMPLETED|Overall Study||64||
48557478|NCT02762929|101698095|FG005|COMPLETED|Overall Study||30||
48557479|NCT02762929|101698090|FG000|NOT COMPLETED|Overall Study||1||
48557480|NCT02762929|101698091|FG001|NOT COMPLETED|Overall Study||3||
48557481|NCT02762929|101698092|FG002|NOT COMPLETED|Overall Study||0||
48111023|NCT01158222|100598026|FG000|STARTED|Overall Study||37||
48111024|NCT01158222|100598026|FG000|COMPLETED|Overall Study||20||
48111025|NCT01158222|100598026|FG000|NOT COMPLETED|Overall Study||17||
48111026|NCT03608488|100598027|FG000|STARTED|Overall Study||22||
48111027|NCT03608488|100598028|FG001|STARTED|Overall Study||21||
48111028|NCT03608488|100598029|FG002|STARTED|Overall Study||22||
48111029|NCT03608488|100598030|FG003|STARTED|Overall Study||45||
48111030|NCT03608488|100598027|FG000|COMPLETED|Overall Study||21||
48111031|NCT03608488|100598028|FG001|COMPLETED|Overall Study||18||
48111032|NCT03608488|100598029|FG002|COMPLETED|Overall Study||20||
48111033|NCT03608488|100598030|FG003|COMPLETED|Overall Study||40||
48111034|NCT03608488|100598027|FG000|NOT COMPLETED|Overall Study||1||
48111035|NCT03608488|100598028|FG001|NOT COMPLETED|Overall Study||3||
48111036|NCT03608488|100598029|FG002|NOT COMPLETED|Overall Study||2||
48111037|NCT03608488|100598030|FG003|NOT COMPLETED|Overall Study||5||
48111038|NCT01557400|100598031|FG000|STARTED|Overall Study||94||
48111039|NCT01557400|100598031|FG000|Received at Least 1 Dose of Study Drug|Overall Study||94||
48111040|NCT01557400|100598031|FG000|COMPLETED|Overall Study||37||
48111041|NCT01557400|100598031|FG000|NOT COMPLETED|Overall Study||57||
48111042|NCT04138615|100598032|FG000|STARTED|Overall Study||19||
48111043|NCT04138615|100598033|FG001|STARTED|Overall Study||25||
48111044|NCT04138615|100598032|FG000|COMPLETED|Overall Study||14||
48111045|NCT04138615|100598033|FG001|COMPLETED|Overall Study||16||
48111046|NCT04138615|100598032|FG000|NOT COMPLETED|Overall Study||5||
48111047|NCT04138615|100598033|FG001|NOT COMPLETED|Overall Study||9||
48557482|NCT02762929|101698093|FG003|NOT COMPLETED|Overall Study||3||
48557483|NCT02762929|101698094|FG004|NOT COMPLETED|Overall Study||0||
48557484|NCT02762929|101698095|FG005|NOT COMPLETED|Overall Study||0||
48111048|NCT02607514|100598034|FG000|STARTED|Overall Study||40||
48111049|NCT02607514|100598035|FG001|STARTED|Overall Study||40||
48111050|NCT02607514|100598034|FG000|COMPLETED|Overall Study||22||
48111051|NCT02607514|100598035|FG001|COMPLETED|Overall Study||26||
48111052|NCT02607514|100598034|FG000|NOT COMPLETED|Overall Study||18||
48111053|NCT02607514|100598035|FG001|NOT COMPLETED|Overall Study||14||
48111054|NCT03212963|100598036|FG000|STARTED|Overall Study||16||
48111055|NCT03212963|100598036|FG000|COMPLETED|Overall Study||16||
48111056|NCT03212963|100598036|FG000|NOT COMPLETED|Overall Study||0||
48273540|NCT01020877|100992158|FG000|COMPLETED|First Intervention||19||
48557485|NCT00235755|101698096|FG000|STARTED|4-Week Titration Phase||179||
48557486|NCT00235755|101698097|FG001|STARTED|4-Week Titration Phase||181||
48557487|NCT00235755|101698098|FG002|STARTED|4-Week Titration Phase||179||
48557488|NCT00235755|101698096|FG000|COMPLETED|4-Week Titration Phase||168||
48557489|NCT00235755|101698097|FG001|COMPLETED|4-Week Titration Phase||162||
48557490|NCT00235755|101698098|FG002|COMPLETED|4-Week Titration Phase||153||
48694722|NCT00392834|102036471|FG001|STARTED|Overall Study||32||
48694723|NCT00392834|102036470|FG000|COMPLETED|Overall Study||2||
48694724|NCT00392834|102036471|FG001|COMPLETED|Overall Study||32||
48694725|NCT00392834|102036470|FG000|NOT COMPLETED|Overall Study||0||
48694726|NCT00392834|102036471|FG001|NOT COMPLETED|Overall Study||0||
48694727|NCT02516982|102036472|FG000|STARTED|Overall Study||305||
48111057|NCT01451775|100598037|FG000|STARTED|Overall Study||3||
48111058|NCT01451775|100598038|FG001|STARTED|Overall Study||3||
48111059|NCT01451775|100598039|FG002|STARTED|Overall Study||3||
48111060|NCT01451775|100598040|FG003|STARTED|Overall Study||3||
48111061|NCT01451775|100598041|FG004|STARTED|Overall Study||3||
48111062|NCT01451775|100598042|FG005|STARTED|Overall Study||3||
48111063|NCT01451775|100598037|FG000|COMPLETED|Overall Study||3||
48111064|NCT01451775|100598038|FG001|COMPLETED|Overall Study||3||
48111065|NCT01451775|100598039|FG002|COMPLETED|Overall Study||3||
48111066|NCT01451775|100598040|FG003|COMPLETED|Overall Study||3||
48111067|NCT01451775|100598041|FG004|COMPLETED|Overall Study||3||
48111068|NCT01451775|100598042|FG005|COMPLETED|Overall Study||3||
48694728|NCT02516982|102036473|FG001|STARTED|Overall Study||292||
48694729|NCT02516982|102036474|FG002|STARTED|Overall Study||174||
48694730|NCT02516982|102036475|FG003|STARTED|Overall Study||175||
48694731|NCT02516982|102036472|FG000|COMPLETED|Overall Study||273||
48694732|NCT02516982|102036473|FG001|COMPLETED|Overall Study||257||
48694733|NCT02516982|102036474|FG002|COMPLETED|Overall Study||126||
48694734|NCT02516982|102036475|FG003|COMPLETED|Overall Study||125||
48694735|NCT02516982|102036472|FG000|NOT COMPLETED|Overall Study||32||
48694736|NCT02516982|102036473|FG001|NOT COMPLETED|Overall Study||35||
48694737|NCT02516982|102036474|FG002|NOT COMPLETED|Overall Study||48||
48694738|NCT02516982|102036475|FG003|NOT COMPLETED|Overall Study||50||
48557491|NCT00235755|101698096|FG000|NOT COMPLETED|4-Week Titration Phase||11||
48557492|NCT00235755|101698097|FG001|NOT COMPLETED|4-Week Titration Phase||19||
48557493|NCT00235755|101698098|FG002|NOT COMPLETED|4-Week Titration Phase||26||
48557494|NCT00235755|101698096|FG000|STARTED|12-Week Maintenance Phase||168||
48557495|NCT00235755|101698097|FG001|STARTED|12-Week Maintenance Phase||162||
48557496|NCT00235755|101698098|FG002|STARTED|12-Week Maintenance Phase||153||
48694739|NCT02661737|102036476|FG000|STARTED|Overall Study||503||
48694740|NCT02661737|102036476|FG000|COMPLETED|Overall Study||469||
48694741|NCT02661737|102036476|FG000|NOT COMPLETED|Overall Study||34||
48694742|NCT00610857|102036477|FG000|STARTED|Overall Study||37||
48694743|NCT00610857|102036477|FG000|COMPLETED|Overall Study||35||
48694744|NCT00610857|102036477|FG000|NOT COMPLETED|Overall Study||2||
48694745|NCT00559104|102036478|FG000|STARTED|Overall Study||55||
48694746|NCT00559104|102036479|FG001|STARTED|Overall Study||5||
48694747|NCT00559104|102036478|FG000|COMPLETED|Overall Study||46||
48694748|NCT00559104|102036479|FG001|COMPLETED|Overall Study||5||
48111069|NCT01451775|100598037|FG000|NOT COMPLETED|Overall Study||0||
48111070|NCT01451775|100598038|FG001|NOT COMPLETED|Overall Study||0||
48111071|NCT01451775|100598039|FG002|NOT COMPLETED|Overall Study||0||
48111072|NCT01451775|100598040|FG003|NOT COMPLETED|Overall Study||0||
48111073|NCT01451775|100598041|FG004|NOT COMPLETED|Overall Study||0||
48111074|NCT01451775|100598042|FG005|NOT COMPLETED|Overall Study||0||
48111075|NCT02774681|100598043|FG000|STARTED|Treatment on Study||12||
48111076|NCT02774681|100598043|FG000|Reached 1st Response/2 Cycles|Treatment on Study||10||
48111077|NCT02774681|100598043|FG000|Went on to Start Cycle 3|Treatment on Study||5||
48111078|NCT02774681|100598043|FG000|COMPLETED|Treatment on Study||5||
48111079|NCT02774681|100598043|FG000|NOT COMPLETED|Treatment on Study||7||
48111080|NCT02774681|100598043|FG000|STARTED|Follow-Up for 3 Years||12||
48557497|NCT00235755|101698096|FG000|COMPLETED|12-Week Maintenance Phase||152||
48557498|NCT00235755|101698097|FG001|COMPLETED|12-Week Maintenance Phase||135||
48557499|NCT00235755|101698098|FG002|COMPLETED|12-Week Maintenance Phase||122||
48557500|NCT00235755|101698096|FG000|NOT COMPLETED|12-Week Maintenance Phase||16||
48557501|NCT00235755|101698097|FG001|NOT COMPLETED|12-Week Maintenance Phase||27||
48557502|NCT00235755|101698098|FG002|NOT COMPLETED|12-Week Maintenance Phase||31||
48557503|NCT03290378|101698099|FG000|STARTED|Overall Study||140||
48557504|NCT03290378|101698100|FG001|STARTED|Overall Study||133||
48557505|NCT03290378|101698101|FG002|STARTED|Overall Study||136||
48557506|NCT03290378|101698099|FG000|COMPLETED|Overall Study||137||
48557507|NCT03290378|101698100|FG001|COMPLETED|Overall Study||123||
48694749|NCT00559104|102036478|FG000|NOT COMPLETED|Overall Study||9||
48694750|NCT00559104|102036479|FG001|NOT COMPLETED|Overall Study||0||
48111081|NCT02774681|100598043|FG000|COMPLETED|Follow-Up for 3 Years||0||
48273541|NCT01020877|100992159|FG001|COMPLETED|First Intervention||19||
48694751|NCT03143153|102036480|FG000|STARTED|Pre-Treatment||325|Started=Randomized|
48694752|NCT03143153|102036481|FG001|STARTED|Pre-Treatment||321|Started=Randomized|
48111082|NCT02774681|100598043|FG000|NOT COMPLETED|Follow-Up for 3 Years||12||
48111083|NCT04590495|100598044|FG000|STARTED|Overall Study||21||
48111084|NCT04590495|100598045|FG001|STARTED|Overall Study||19||
48111085|NCT04590495|100598044|FG000|COMPLETED|Overall Study||21||
48111086|NCT04590495|100598045|FG001|COMPLETED|Overall Study||19||
48111087|NCT04590495|100598044|FG000|NOT COMPLETED|Overall Study||0||
48111088|NCT04590495|100598045|FG001|NOT COMPLETED|Overall Study||0||
48111089|NCT02603809|100598046|FG000|STARTED|Overall Study||82||
48111090|NCT02603809|100598047|FG001|STARTED|Overall Study||82||
48111091|NCT02603809|100598048|FG002|STARTED|Overall Study||82||
48694753|NCT03143153|102036482|FG002|STARTED|Pre-Treatment||324|Started=Randomized|
48694754|NCT03143153|102036480|FG000|COMPLETED|Pre-Treatment||322|Completed=Treated|
48694755|NCT03143153|102036481|FG001|COMPLETED|Pre-Treatment||310|Completed=Treated|
48111092|NCT02603809|100598049|FG003|STARTED|Overall Study||82||
48111093|NCT02603809|100598050|FG004|STARTED|Overall Study||81||
48111094|NCT02603809|100598051|FG005|STARTED|Overall Study||81||
48111095|NCT02603809|100598046|FG000|Per-protocol Set|Overall Study||67||
48111096|NCT02603809|100598047|FG001|Per-protocol Set|Overall Study||68||
48111097|NCT02603809|100598048|FG002|Per-protocol Set|Overall Study||71||
48111098|NCT02603809|100598049|FG003|Per-protocol Set|Overall Study||67||
48111099|NCT02603809|100598050|FG004|Per-protocol Set|Overall Study||68||
48111100|NCT02603809|100598051|FG005|Per-protocol Set|Overall Study||69||
48111101|NCT02603809|100598046|FG000|Modified Per-Protocol Set|Overall Study||66||
48111102|NCT02603809|100598047|FG001|Modified Per-Protocol Set|Overall Study||68||
48111103|NCT02603809|100598048|FG002|Modified Per-Protocol Set|Overall Study||71||
48111104|NCT02603809|100598049|FG003|Modified Per-Protocol Set|Overall Study||67||
48111105|NCT02603809|100598050|FG004|Modified Per-Protocol Set|Overall Study||68||
48111106|NCT02603809|100598051|FG005|Modified Per-Protocol Set|Overall Study||69||
48111107|NCT02603809|100598046|FG000|Completed Study|Overall Study||75|Participants that completed the 30-day follow-up telephone call / visit (i.e., End-of-Study).|
48111108|NCT02603809|100598047|FG001|Completed Study|Overall Study||79|Participants that completed the 30-day follow-up telephone call / visit (i.e., End-of-Study).|
48111109|NCT02603809|100598048|FG002|Completed Study|Overall Study||79|Participants that completed the 30-day follow-up telephone call / visit (i.e., End-of-Study).|
48111110|NCT02603809|100598049|FG003|Completed Study|Overall Study||76|Participants that completed the 30-day follow-up telephone call / visit (i.e., End-of-Study).|
48111111|NCT02603809|100598050|FG004|Completed Study|Overall Study||78|Participants that completed the 30-day follow-up telephone call / visit (i.e., End-of-Study).|
48111112|NCT02603809|100598051|FG005|Completed Study|Overall Study||75|Participants that completed the 30-day follow-up telephone call / visit (i.e., End-of-Study).|
48111113|NCT02603809|100598046|FG000|COMPLETED|Overall Study||70|Participants that completed the 8-week treatment period.|
48111114|NCT02603809|100598047|FG001|COMPLETED|Overall Study||74|Participants that completed the 8-week treatment period.|
48111115|NCT02603809|100598048|FG002|COMPLETED|Overall Study||75|Participants that completed the 8-week treatment period.|
48111116|NCT02603809|100598049|FG003|COMPLETED|Overall Study||70|Participants that completed the 8-week treatment period.|
48111117|NCT02603809|100598050|FG004|COMPLETED|Overall Study||70|Participants that completed the 8-week treatment period.|
48111118|NCT02603809|100598051|FG005|COMPLETED|Overall Study||71|Participants that completed the 8-week treatment period.|
48111119|NCT02603809|100598046|FG000|NOT COMPLETED|Overall Study||12||
48111120|NCT02603809|100598047|FG001|NOT COMPLETED|Overall Study||8||
48111121|NCT02603809|100598048|FG002|NOT COMPLETED|Overall Study||7||
48111122|NCT02603809|100598049|FG003|NOT COMPLETED|Overall Study||12||
48111123|NCT02603809|100598050|FG004|NOT COMPLETED|Overall Study||11||
48111124|NCT02603809|100598051|FG005|NOT COMPLETED|Overall Study||10||
48111125|NCT02214121|100598052|FG000|STARTED|Part A||46||
48111126|NCT02214121|100598053|FG001|STARTED|Part A||0||
48111127|NCT02214121|100598054|FG002|STARTED|Part A||0||
48111128|NCT02214121|100598052|FG000|COMPLETED|Part A||39||
48111129|NCT02214121|100598053|FG001|COMPLETED|Part A||0||
48111130|NCT02214121|100598054|FG002|COMPLETED|Part A||0||
48111131|NCT02214121|100598052|FG000|NOT COMPLETED|Part A||7||
48111132|NCT02214121|100598053|FG001|NOT COMPLETED|Part A||0||
48111133|NCT02214121|100598054|FG002|NOT COMPLETED|Part A||0||
48111134|NCT02214121|100598052|FG000|STARTED|Part B||0||
48111135|NCT02214121|100598053|FG001|STARTED|Part B||17||
48111136|NCT02214121|100598054|FG002|STARTED|Part B||8||
48111137|NCT02214121|100598052|FG000|COMPLETED|Part B||0||
48111138|NCT02214121|100598053|FG001|COMPLETED|Part B||14||
48111139|NCT02214121|100598054|FG002|COMPLETED|Part B||7||
48111140|NCT02214121|100598052|FG000|NOT COMPLETED|Part B||0||
48111141|NCT02214121|100598053|FG001|NOT COMPLETED|Part B||3||
48111142|NCT02214121|100598054|FG002|NOT COMPLETED|Part B||1||
48111143|NCT05093699|100598055|FG000|STARTED|Overall Study||50||
48694756|NCT03143153|102036482|FG002|COMPLETED|Pre-Treatment||304|Completed=Treated|
48694757|NCT03143153|102036480|FG000|NOT COMPLETED|Pre-Treatment||3||
48694758|NCT03143153|102036481|FG001|NOT COMPLETED|Pre-Treatment||11||
48111144|NCT05093699|100598056|FG001|STARTED|Overall Study||48||
48111145|NCT05093699|100598055|FG000|COMPLETED|Overall Study||50||
48111146|NCT05093699|100598056|FG001|COMPLETED|Overall Study||48||
48694759|NCT03143153|102036482|FG002|NOT COMPLETED|Pre-Treatment||20||
48694760|NCT03143153|102036480|FG000|STARTED|Treatment||322||
48111147|NCT05093699|100598055|FG000|NOT COMPLETED|Overall Study||0||
48111148|NCT05093699|100598056|FG001|NOT COMPLETED|Overall Study||0||
48111149|NCT01467076|100598057|FG000|STARTED|Overall Study||3||
48111150|NCT01467076|100598058|FG001|STARTED|Overall Study||2||
48273542|NCT01020877|100992158|FG000|NOT COMPLETED|First Intervention||0||
48273543|NCT01020877|100992159|FG001|NOT COMPLETED|First Intervention||0||
48273544|NCT01020877|100992158|FG000|STARTED|Washout of 7 Days||19||
48273545|NCT01020877|100992159|FG001|STARTED|Washout of 7 Days||19||
48273546|NCT01020877|100992158|FG000|COMPLETED|Washout of 7 Days||19||
48273547|NCT01020877|100992159|FG001|COMPLETED|Washout of 7 Days||19||
48273548|NCT01020877|100992158|FG000|NOT COMPLETED|Washout of 7 Days||0||
48557508|NCT03290378|101698101|FG002|COMPLETED|Overall Study||120||
48557509|NCT03290378|101698099|FG000|NOT COMPLETED|Overall Study||3||
48557510|NCT03290378|101698100|FG001|NOT COMPLETED|Overall Study||10||
48557511|NCT03290378|101698101|FG002|NOT COMPLETED|Overall Study||16||
48557512|NCT03440840|101698102|FG000|STARTED|Overall Study||16||
48557513|NCT03440840|101698103|FG001|STARTED|Overall Study||15||
48557514|NCT03440840|101698104|FG002|STARTED|Overall Study||15||
48557515|NCT03440840|101698102|FG000|COMPLETED|Overall Study||15||
48557516|NCT03440840|101698103|FG001|COMPLETED|Overall Study||14||
48557517|NCT03440840|101698104|FG002|COMPLETED|Overall Study||15||
48557518|NCT03440840|101698102|FG000|NOT COMPLETED|Overall Study||1||
48557519|NCT03440840|101698103|FG001|NOT COMPLETED|Overall Study||1||
48557520|NCT03440840|101698104|FG002|NOT COMPLETED|Overall Study||0||
48557521|NCT02319317|101698105|FG000|STARTED|Overall Study||31||
48557522|NCT02319317|101698106|FG001|STARTED|Overall Study||29||
48557523|NCT02319317|101698105|FG000|COMPLETED|Overall Study||31||
48557524|NCT02319317|101698106|FG001|COMPLETED|Overall Study||29||
48557525|NCT02319317|101698105|FG000|NOT COMPLETED|Overall Study||0||
48557526|NCT02319317|101698106|FG001|NOT COMPLETED|Overall Study||0||
48557527|NCT03484702|101698107|FG000|STARTED|Pre-Treatment Period - Leukapheresis||45|Underwent Leukapheresis|
48557528|NCT03484702|101698108|FG001|STARTED|Pre-Treatment Period - Leukapheresis||32|Underwent Leukapheresis|
48557529|NCT03484702|101698109|FG002|STARTED|Pre-Treatment Period - Leukapheresis||14|Underwent Leukapheresis|
48557530|NCT03484702|101698110|FG003|STARTED|Pre-Treatment Period - Leukapheresis||4|Underwent Leukapheresis|
48557531|NCT03484702|101698111|FG004|STARTED|Pre-Treatment Period - Leukapheresis||7|Underwent Leukapheresis|
48557532|NCT03484702|101698112|FG005|STARTED|Pre-Treatment Period - Leukapheresis||11|Underwent Leukapheresis|
48557533|NCT03484702|101698107|FG000|COMPLETED|Pre-Treatment Period - Leukapheresis||43||
48557534|NCT03484702|101698108|FG001|COMPLETED|Pre-Treatment Period - Leukapheresis||27||
48557535|NCT03484702|101698109|FG002|COMPLETED|Pre-Treatment Period - Leukapheresis||12||
48557536|NCT03484702|101698110|FG003|COMPLETED|Pre-Treatment Period - Leukapheresis||1||
48557537|NCT03484702|101698111|FG004|COMPLETED|Pre-Treatment Period - Leukapheresis||5||
48557538|NCT03484702|101698112|FG005|COMPLETED|Pre-Treatment Period - Leukapheresis||10||
48557539|NCT03484702|101698107|FG000|NOT COMPLETED|Pre-Treatment Period - Leukapheresis||2||
48557540|NCT03484702|101698108|FG001|NOT COMPLETED|Pre-Treatment Period - Leukapheresis||5||
48557541|NCT03484702|101698109|FG002|NOT COMPLETED|Pre-Treatment Period - Leukapheresis||2||
48557542|NCT03484702|101698110|FG003|NOT COMPLETED|Pre-Treatment Period - Leukapheresis||3||
48557543|NCT03484702|101698111|FG004|NOT COMPLETED|Pre-Treatment Period - Leukapheresis||2||
48557544|NCT03484702|101698112|FG005|NOT COMPLETED|Pre-Treatment Period - Leukapheresis||1||
48557545|NCT03484702|101698107|FG000|STARTED|Treatment Period||43|Started lymphodepleting chemotherapy.|
48557546|NCT03484702|101698108|FG001|STARTED|Treatment Period||27|Started lymphodepleting chemotherapy.|
48557547|NCT03484702|101698109|FG002|STARTED|Treatment Period||12|Started lymphodepleting chemotherapy.|
48557548|NCT03484702|101698110|FG003|STARTED|Treatment Period||1|Started lymphodepleting chemotherapy.|
48557549|NCT03484702|101698111|FG004|STARTED|Treatment Period||5|Started lymphodepleting chemotherapy.|
48557550|NCT03484702|101698112|FG005|STARTED|Treatment Period||10|Started lymphodepleting chemotherapy.|
48557551|NCT03484702|101698107|FG000|JCAR017 Treated Set|Treatment Period||36|Received conforming JCAR017 cell product.|
48557552|NCT03484702|101698108|FG001|JCAR017 Treated Set|Treatment Period||27|Received conforming JCAR017 cell product.|
48557553|NCT03484702|101698109|FG002|JCAR017 Treated Set|Treatment Period||10|Received conforming JCAR017 cell product.|
48592738|NCT02678000|101783172|FG004|COMPLETED|PART 1||0||
48273549|NCT01020877|100992159|FG001|NOT COMPLETED|Washout of 7 Days||0||
48273550|NCT01020877|100992158|FG000|STARTED|Second Intervention||19||
48273551|NCT01020877|100992159|FG001|STARTED|Second Intervention||19||
48273552|NCT01020877|100992158|FG000|COMPLETED|Second Intervention||18||
48273553|NCT01020877|100992159|FG001|COMPLETED|Second Intervention||19||
48273554|NCT01020877|100992158|FG000|NOT COMPLETED|Second Intervention||1||
48273555|NCT01020877|100992159|FG001|NOT COMPLETED|Second Intervention||0||
48273556|NCT01152814|100992160|FG000|STARTED|Overall Study||64||
48273557|NCT01152814|100992160|FG000|COMPLETED|Overall Study||62||
48273558|NCT01152814|100992160|FG000|NOT COMPLETED|Overall Study||2||
48273559|NCT02797522|100992161|FG000|STARTED|Overall Study||4||
48273560|NCT02797522|100992162|FG001|STARTED|Overall Study||4||
48273561|NCT02797522|100992163|FG002|STARTED|Overall Study||4||
48273562|NCT02797522|100992164|FG003|STARTED|Overall Study||4||
48273563|NCT02797522|100992165|FG004|STARTED|Overall Study||4||
48273564|NCT02797522|100992166|FG005|STARTED|Overall Study||4||
48273565|NCT02797522|100992167|FG006|STARTED|Overall Study||12||
48273566|NCT02797522|100992168|FG007|STARTED|Overall Study||4||
48273567|NCT02797522|100992169|FG008|STARTED|Overall Study||2||
48273568|NCT02797522|100992170|FG009|STARTED|Overall Study||4||
48273569|NCT02797522|100992171|FG010|STARTED|Overall Study||1||
48111151|NCT01467076|100598059|FG002|STARTED|Overall Study||2||
48111152|NCT01467076|100598057|FG000|COMPLETED|Overall Study||2||
48111153|NCT01467076|100598058|FG001|COMPLETED|Overall Study||2||
48111154|NCT01467076|100598059|FG002|COMPLETED|Overall Study||2||
48111155|NCT01467076|100598057|FG000|NOT COMPLETED|Overall Study||1||
48111156|NCT01467076|100598058|FG001|NOT COMPLETED|Overall Study||0||
48111157|NCT01467076|100598059|FG002|NOT COMPLETED|Overall Study||0||
48111158|NCT02227485|100598060|FG000|STARTED|First Follow-up||40||
48273570|NCT02797522|100992161|FG000|COMPLETED|Overall Study||4||
48273571|NCT02797522|100992162|FG001|COMPLETED|Overall Study||4||
48273572|NCT02797522|100992163|FG002|COMPLETED|Overall Study||4||
48273573|NCT02797522|100992164|FG003|COMPLETED|Overall Study||4||
48557554|NCT03484702|101698110|FG003|JCAR017 Treated Set|Treatment Period||1|Received conforming JCAR017 cell product.|
48557555|NCT03484702|101698111|FG004|JCAR017 Treated Set|Treatment Period||5|Received conforming JCAR017 cell product.|
48557556|NCT03484702|101698112|FG005|JCAR017 Treated Set|Treatment Period||9|Received conforming JCAR017 cell product.|
48557557|NCT03484702|101698107|FG000|COMPLETED|Treatment Period||39||
48557558|NCT03484702|101698108|FG001|COMPLETED|Treatment Period||24||
48557559|NCT03484702|101698109|FG002|COMPLETED|Treatment Period||12||
48557560|NCT03484702|101698110|FG003|COMPLETED|Treatment Period||1||
48557561|NCT03484702|101698111|FG004|COMPLETED|Treatment Period||5||
48557562|NCT03484702|101698112|FG005|COMPLETED|Treatment Period||9||
48557563|NCT03484702|101698107|FG000|NOT COMPLETED|Treatment Period||4||
48557564|NCT03484702|101698108|FG001|NOT COMPLETED|Treatment Period||3||
48111159|NCT02227485|100598061|FG001|STARTED|First Follow-up||40||
48111160|NCT02227485|100598060|FG000|COMPLETED|First Follow-up||36||
48111161|NCT02227485|100598061|FG001|COMPLETED|First Follow-up||38||
48111162|NCT02227485|100598060|FG000|NOT COMPLETED|First Follow-up||4||
48111163|NCT02227485|100598061|FG001|NOT COMPLETED|First Follow-up||2||
48111164|NCT02227485|100598060|FG000|STARTED|Second Follow-up||36||
48111165|NCT02227485|100598061|FG001|STARTED|Second Follow-up||38||
48111166|NCT02227485|100598060|FG000|COMPLETED|Second Follow-up||34||
48111167|NCT02227485|100598061|FG001|COMPLETED|Second Follow-up||36||
48111168|NCT02227485|100598060|FG000|NOT COMPLETED|Second Follow-up||2||
48111169|NCT02227485|100598061|FG001|NOT COMPLETED|Second Follow-up||2||
48111170|NCT03367312|100598062|FG000|STARTED|Overall Study||11||
48111171|NCT03367312|100598062|FG000|COMPLETED|Overall Study||11||
48111172|NCT03367312|100598062|FG000|NOT COMPLETED|Overall Study||0||
48111173|NCT02153944|100598063|FG000|STARTED|Behavioral Sub-study||20||
48111174|NCT02153944|100598064|FG001|STARTED|Behavioral Sub-study||20||
48111175|NCT02153944|100598065|FG002|STARTED|Behavioral Sub-study||20||
48111176|NCT02153944|100598066|FG003|STARTED|Behavioral Sub-study||0||
48111177|NCT02153944|100598067|FG004|STARTED|Behavioral Sub-study||0||
48111178|NCT02153944|100598063|FG000|COMPLETED|Behavioral Sub-study||20||
48111179|NCT02153944|100598064|FG001|COMPLETED|Behavioral Sub-study||20||
48111180|NCT02153944|100598065|FG002|COMPLETED|Behavioral Sub-study||20||
48111181|NCT02153944|100598066|FG003|COMPLETED|Behavioral Sub-study||0||
48111182|NCT02153944|100598067|FG004|COMPLETED|Behavioral Sub-study||0||
48273574|NCT02797522|100992165|FG004|COMPLETED|Overall Study||4||
48273575|NCT02797522|100992166|FG005|COMPLETED|Overall Study||4||
48273576|NCT02797522|100992167|FG006|COMPLETED|Overall Study||12||
48273577|NCT02797522|100992168|FG007|COMPLETED|Overall Study||0||
48273578|NCT02797522|100992169|FG008|COMPLETED|Overall Study||0||
48273579|NCT02797522|100992170|FG009|COMPLETED|Overall Study||0||
48273580|NCT02797522|100992171|FG010|COMPLETED|Overall Study||0||
48273581|NCT02797522|100992161|FG000|NOT COMPLETED|Overall Study||0||
48273582|NCT02797522|100992162|FG001|NOT COMPLETED|Overall Study||0||
48273583|NCT02797522|100992163|FG002|NOT COMPLETED|Overall Study||0||
48273584|NCT02797522|100992164|FG003|NOT COMPLETED|Overall Study||0||
48557565|NCT03484702|101698109|FG002|NOT COMPLETED|Treatment Period||0||
48557566|NCT03484702|101698110|FG003|NOT COMPLETED|Treatment Period||0||
48557567|NCT03484702|101698111|FG004|NOT COMPLETED|Treatment Period||0||
48557568|NCT03484702|101698112|FG005|NOT COMPLETED|Treatment Period||1||
48557569|NCT00071110|101698113|FG000|STARTED|Overall Study||28||
48111183|NCT02153944|100598063|FG000|NOT COMPLETED|Behavioral Sub-study||0||
48111184|NCT02153944|100598064|FG001|NOT COMPLETED|Behavioral Sub-study||0||
48111185|NCT02153944|100598065|FG002|NOT COMPLETED|Behavioral Sub-study||0||
48111186|NCT02153944|100598066|FG003|NOT COMPLETED|Behavioral Sub-study||0||
48111187|NCT02153944|100598067|FG004|NOT COMPLETED|Behavioral Sub-study||0||
48111188|NCT02153944|100598063|FG000|STARTED|fMRI Sub-study||0||
48111189|NCT02153944|100598064|FG001|STARTED|fMRI Sub-study||0||
48111190|NCT02153944|100598065|FG002|STARTED|fMRI Sub-study||0||
48273585|NCT02797522|100992165|FG004|NOT COMPLETED|Overall Study||0||
48273586|NCT02797522|100992166|FG005|NOT COMPLETED|Overall Study||0||
48273587|NCT02797522|100992167|FG006|NOT COMPLETED|Overall Study||0||
48273588|NCT02797522|100992168|FG007|NOT COMPLETED|Overall Study||4||
48557570|NCT00071110|101698114|FG001|STARTED|Overall Study||29||
48557571|NCT00071110|101698113|FG000|COMPLETED|Overall Study||28||
48111191|NCT02153944|100598066|FG003|STARTED|fMRI Sub-study||34||
48111192|NCT02153944|100598067|FG004|STARTED|fMRI Sub-study||35||
48111193|NCT02153944|100598063|FG000|COMPLETED|fMRI Sub-study||0||
48111194|NCT02153944|100598064|FG001|COMPLETED|fMRI Sub-study||0||
48273589|NCT02797522|100992169|FG008|NOT COMPLETED|Overall Study||2||
48111195|NCT02153944|100598065|FG002|COMPLETED|fMRI Sub-study||0||
48111196|NCT02153944|100598066|FG003|COMPLETED|fMRI Sub-study||34||
48111197|NCT02153944|100598067|FG004|COMPLETED|fMRI Sub-study||35||
48111198|NCT02153944|100598063|FG000|NOT COMPLETED|fMRI Sub-study||0||
48111199|NCT02153944|100598064|FG001|NOT COMPLETED|fMRI Sub-study||0||
48694761|NCT03143153|102036481|FG001|STARTED|Treatment||310||
48694762|NCT03143153|102036482|FG002|STARTED|Treatment||304||
48694763|NCT03143153|102036480|FG000|COMPLETED|Treatment||21|Completed=continuing treatment|
48694764|NCT03143153|102036481|FG001|COMPLETED|Treatment||25|Completed=continuing treatment|
48694765|NCT03143153|102036482|FG002|COMPLETED|Treatment||4|Completed=continuing treatment|
48694766|NCT03143153|102036480|FG000|NOT COMPLETED|Treatment||301||
48694767|NCT03143153|102036481|FG001|NOT COMPLETED|Treatment||285||
48694768|NCT03143153|102036482|FG002|NOT COMPLETED|Treatment||300||
48273590|NCT02797522|100992170|FG009|NOT COMPLETED|Overall Study||4||
48694769|NCT01282242|102036483|FG000|STARTED|Overall Study||80||
48111200|NCT02153944|100598065|FG002|NOT COMPLETED|fMRI Sub-study||0||
48111201|NCT02153944|100598066|FG003|NOT COMPLETED|fMRI Sub-study||0||
48694770|NCT01282242|102036484|FG001|STARTED|Overall Study||8||
48111202|NCT02153944|100598067|FG004|NOT COMPLETED|fMRI Sub-study||0||
48111203|NCT00843713|100598068|FG000|STARTED|Overall Study||30||
48111204|NCT00843713|100598069|FG001|STARTED|Overall Study||26||
48111205|NCT00843713|100598068|FG000|COMPLETED|Overall Study||30||
48694771|NCT01282242|102036483|FG000|COMPLETED|Overall Study||80||
48694772|NCT01282242|102036484|FG001|COMPLETED|Overall Study||8||
48694773|NCT01282242|102036483|FG000|NOT COMPLETED|Overall Study||0||
48694774|NCT01282242|102036484|FG001|NOT COMPLETED|Overall Study||0||
48694775|NCT02222688|102036485|FG000|STARTED|Overall Study||4||
48694776|NCT02222688|102036486|FG001|STARTED|Overall Study||3||
48694777|NCT02222688|102036487|FG002|STARTED|Overall Study||3||
48694778|NCT02222688|102036488|FG003|STARTED|Overall Study||5||
48694779|NCT02222688|102036489|FG004|STARTED|Overall Study||3||
48694780|NCT02222688|102036490|FG005|STARTED|Overall Study||3||
48694781|NCT02222688|102036491|FG006|STARTED|Overall Study||6||
48694782|NCT02222688|102036485|FG000|COMPLETED|Overall Study||3||
48694783|NCT02222688|102036486|FG001|COMPLETED|Overall Study||3||
48694784|NCT02222688|102036487|FG002|COMPLETED|Overall Study||3||
48111206|NCT00843713|100598069|FG001|COMPLETED|Overall Study||26||
48111207|NCT00843713|100598068|FG000|NOT COMPLETED|Overall Study||0||
48111208|NCT00843713|100598069|FG001|NOT COMPLETED|Overall Study||0||
48111209|NCT00684424|100598070|FG000|STARTED|Overall Study||199||
48111210|NCT00684424|100598070|FG000|COMPLETED|Overall Study||194||
48111211|NCT00684424|100598070|FG000|NOT COMPLETED|Overall Study||5||
48111212|NCT00411619|100598071|FG000|STARTED|Overall Study||28||
48111213|NCT00411619|100598071|FG000|COMPLETED|Overall Study||22||
48111214|NCT00411619|100598071|FG000|NOT COMPLETED|Overall Study||6||
48111215|NCT03395314|100598072|FG000|STARTED|Overall Study||12||
48111216|NCT03395314|100598073|FG001|STARTED|Overall Study||10||
48111217|NCT03395314|100598072|FG000|COMPLETED|Overall Study||12||
48111218|NCT03395314|100598073|FG001|COMPLETED|Overall Study||10||
48111219|NCT03395314|100598072|FG000|NOT COMPLETED|Overall Study||0||
48111220|NCT03395314|100598073|FG001|NOT COMPLETED|Overall Study||0||
48111221|NCT03467425|100598074|FG000|STARTED|Overall Study||1545||
48111222|NCT03467425|100598075|FG001|STARTED|Overall Study||1547||
48111223|NCT03467425|100598074|FG000|Randomized But Did Not Start IP|Overall Study||1||
48111224|NCT03467425|100598075|FG001|Randomized But Did Not Start IP|Overall Study||0||
48111225|NCT03467425|100598074|FG000|Completed IP|Overall Study||1256||
48111226|NCT03467425|100598075|FG001|Completed IP|Overall Study||1359||
48111227|NCT03467425|100598074|FG000|Not Completed IP|Overall Study||288||
48111228|NCT03467425|100598075|FG001|Not Completed IP|Overall Study||188||
48111229|NCT03467425|100598074|FG000|Withdrew IP (WIP): Lost to Follow-up|Overall Study||15||
48111230|NCT03467425|100598075|FG001|Withdrew IP (WIP): Lost to Follow-up|Overall Study||24||
48111231|NCT03467425|100598074|FG000|WIP: Protocol Deviation|Overall Study||0||
48111232|NCT03467425|100598075|FG001|WIP: Protocol Deviation|Overall Study||2||
48111233|NCT03467425|100598074|FG000|WIP: Adverse Event|Overall Study||112||
48111234|NCT03467425|100598075|FG001|WIP: Adverse Event|Overall Study||29||
48111235|NCT03467425|100598074|FG000|WIP: Lack of Efficacy|Overall Study||56||
48273591|NCT02797522|100992171|FG010|NOT COMPLETED|Overall Study||1||
48694785|NCT02222688|102036488|FG003|COMPLETED|Overall Study||3||
48694786|NCT02222688|102036489|FG004|COMPLETED|Overall Study||2||
48111236|NCT03467425|100598075|FG001|WIP: Lack of Efficacy|Overall Study||28||
48111237|NCT03467425|100598074|FG000|WIP: Physician Decision|Overall Study||14||
48694787|NCT02222688|102036490|FG005|COMPLETED|Overall Study||3||
48694788|NCT02222688|102036491|FG006|COMPLETED|Overall Study||5||
48694789|NCT02222688|102036485|FG000|NOT COMPLETED|Overall Study||1||
48694790|NCT02222688|102036486|FG001|NOT COMPLETED|Overall Study||0||
48694791|NCT02222688|102036487|FG002|NOT COMPLETED|Overall Study||0||
48694792|NCT02222688|102036488|FG003|NOT COMPLETED|Overall Study||2||
48694793|NCT02222688|102036489|FG004|NOT COMPLETED|Overall Study||1||
48111238|NCT03467425|100598075|FG001|WIP: Physician Decision|Overall Study||27||
48111239|NCT03467425|100598074|FG000|WIP: Withdrawal by Participant|Overall Study||91||
48111240|NCT03467425|100598075|FG001|WIP: Withdrawal by Participant|Overall Study||78||
48111241|NCT03467425|100598074|FG000|COMPLETED|Overall Study||1498||
48111242|NCT03467425|100598075|FG001|COMPLETED|Overall Study||1493||
48111243|NCT03467425|100598074|FG000|NOT COMPLETED|Overall Study||47||
48111244|NCT03467425|100598075|FG001|NOT COMPLETED|Overall Study||54||
48111245|NCT01565330|100598076|FG000|STARTED|Overall Study||5||
48111246|NCT01565330|100598077|FG001|STARTED|Overall Study||4||
48111247|NCT01565330|100598078|FG002|STARTED|Overall Study||4||
48111248|NCT01565330|100598079|FG003|STARTED|Overall Study||7||
48111249|NCT01565330|100598076|FG000|COMPLETED|Overall Study||5||
48111250|NCT01565330|100598077|FG001|COMPLETED|Overall Study||4||
48694794|NCT02222688|102036490|FG005|NOT COMPLETED|Overall Study||0||
48694795|NCT02222688|102036491|FG006|NOT COMPLETED|Overall Study||1||
48111251|NCT01565330|100598078|FG002|COMPLETED|Overall Study||4||
48111252|NCT01565330|100598079|FG003|COMPLETED|Overall Study||7||
48111253|NCT01565330|100598076|FG000|NOT COMPLETED|Overall Study||0||
48111254|NCT01565330|100598077|FG001|NOT COMPLETED|Overall Study||0||
48694796|NCT00405392|102036492|FG000|STARTED|Overall Study||183||
48694797|NCT00405392|102036493|FG001|STARTED|Overall Study||182||
48694798|NCT00405392|102036492|FG000|COMPLETED|Overall Study||153||
48694799|NCT00405392|102036493|FG001|COMPLETED|Overall Study||155||
48273592|NCT04145700|100992172|FG000|STARTED|Overall Study||16||
48273593|NCT04145700|100992173|FG001|STARTED|Overall Study||7||
48273594|NCT04145700|100992172|FG000|Received at Least One Dose of Study Drug|Overall Study||16||
48557572|NCT00071110|101698114|FG001|COMPLETED|Overall Study||25||
48557573|NCT00071110|101698113|FG000|NOT COMPLETED|Overall Study||0||
48557574|NCT00071110|101698114|FG001|NOT COMPLETED|Overall Study||4||
48557575|NCT00276484|101698115|FG000|STARTED|Overall Study||288||
48557576|NCT00276484|101698116|FG001|STARTED|Overall Study||291||
48557577|NCT00276484|101698115|FG000|COMPLETED|Overall Study||279||
48557578|NCT00276484|101698116|FG001|COMPLETED|Overall Study||278||
48557579|NCT00276484|101698115|FG000|NOT COMPLETED|Overall Study||9||
48557580|NCT00276484|101698116|FG001|NOT COMPLETED|Overall Study||13||
48557581|NCT03499067|101698117|FG000|STARTED|First Intervention||27||
48557582|NCT03499067|101698118|FG001|STARTED|First Intervention||31||
48557583|NCT03499067|101698117|FG000|COMPLETED|First Intervention||22||
48557584|NCT03499067|101698118|FG001|COMPLETED|First Intervention||24||
48557585|NCT03499067|101698117|FG000|NOT COMPLETED|First Intervention||5||
48557586|NCT03499067|101698118|FG001|NOT COMPLETED|First Intervention||7||
48557587|NCT03499067|101698117|FG000|STARTED|Second Intervention||22||
48557588|NCT03499067|101698118|FG001|STARTED|Second Intervention||24||
48557589|NCT03499067|101698117|FG000|COMPLETED|Second Intervention||22||
48557590|NCT03499067|101698118|FG001|COMPLETED|Second Intervention||24||
48557591|NCT03499067|101698117|FG000|NOT COMPLETED|Second Intervention||0||
48557592|NCT03499067|101698118|FG001|NOT COMPLETED|Second Intervention||0||
48557593|NCT04707573|101698119|FG000|STARTED|Overall Study||10||
48557594|NCT04707573|101698120|FG001|STARTED|Overall Study||12||
48557595|NCT04707573|101698119|FG000|COMPLETED|Overall Study||10||
48557596|NCT04707573|101698120|FG001|COMPLETED|Overall Study||12||
48557597|NCT04707573|101698119|FG000|NOT COMPLETED|Overall Study||0||
48557598|NCT04707573|101698120|FG001|NOT COMPLETED|Overall Study||0||
48557599|NCT00758524|101698121|FG000|STARTED|Core Period (Week 0 to Week 8)||92||
48557600|NCT00758524|101698122|FG001|STARTED|Core Period (Week 0 to Week 8)||88||
48557601|NCT00758524|101698123|FG002|STARTED|Core Period (Week 0 to Week 8)||86||
48557602|NCT00758524|101698124|FG003|STARTED|Core Period (Week 0 to Week 8)||97||
48557603|NCT00758524|101698125|FG004|STARTED|Core Period (Week 0 to Week 8)||84||
48557604|NCT00758524|101698126|FG005|STARTED|Core Period (Week 0 to Week 8)||77||
48557605|NCT00758524|101698127|FG006|STARTED|Core Period (Week 0 to Week 8)||0||
48557606|NCT00758524|101698128|FG007|STARTED|Core Period (Week 0 to Week 8)||0||
48557607|NCT00758524|101698129|FG008|STARTED|Core Period (Week 0 to Week 8)||0||
48557608|NCT00758524|101698130|FG009|STARTED|Core Period (Week 0 to Week 8)||0||
48557609|NCT00758524|101698131|FG010|STARTED|Core Period (Week 0 to Week 8)||0||
48694800|NCT00405392|102036492|FG000|NOT COMPLETED|Overall Study||30||
48273595|NCT04145700|100992173|FG001|Received at Least One Dose of Study Drug|Overall Study||6||
48273596|NCT04145700|100992172|FG000|COMPLETED|Overall Study||8||
48273597|NCT04145700|100992173|FG001|COMPLETED|Overall Study||4||
48273598|NCT04145700|100992172|FG000|NOT COMPLETED|Overall Study||8||
48273599|NCT04145700|100992173|FG001|NOT COMPLETED|Overall Study||3||
48273600|NCT02748889|100992174|FG000|STARTED|Overall Study||0||
48273601|NCT02748889|100992175|FG001|STARTED|Overall Study||1||
48273602|NCT02748889|100992174|FG000|COMPLETED|Overall Study||0||
48273603|NCT02748889|100992175|FG001|COMPLETED|Overall Study||1||
48273604|NCT02748889|100992174|FG000|NOT COMPLETED|Overall Study||0||
48273605|NCT02748889|100992175|FG001|NOT COMPLETED|Overall Study||0||
48273606|NCT01146600|100992176|FG000|STARTED|Period 1 (Weeks 1 & 2)||13||
48273607|NCT01146600|100992177|FG001|STARTED|Period 1 (Weeks 1 & 2)||10||
48557610|NCT00758524|101698132|FG011|STARTED|Core Period (Week 0 to Week 8)||0||
48557611|NCT00758524|101698133|FG012|STARTED|Core Period (Week 0 to Week 8)||0||
48557612|NCT00758524|101698134|FG013|STARTED|Core Period (Week 0 to Week 8)||0||
48557613|NCT00758524|101698135|FG014|STARTED|Core Period (Week 0 to Week 8)||0||
48557614|NCT00758524|101698136|FG015|STARTED|Core Period (Week 0 to Week 8)||0||
48557615|NCT00758524|101698137|FG016|STARTED|Core Period (Week 0 to Week 8)||0||
48557616|NCT00758524|101698121|FG000|Treated|Core Period (Week 0 to Week 8)||92|Safety Set included participants who received at least 1 dose of study drug.|
48557617|NCT00758524|101698122|FG001|Treated|Core Period (Week 0 to Week 8)||87|Safety Set included participants who received at least 1 dose of study drug.|
48557618|NCT00758524|101698123|FG002|Treated|Core Period (Week 0 to Week 8)||87|Safety Set included participants who received at least 1 dose of study drug.|
48557619|NCT00758524|101698124|FG003|Treated|Core Period (Week 0 to Week 8)||97|Safety Set included participants who received at least 1 dose of study drug.|
48557620|NCT00758524|101698125|FG004|Treated|Core Period (Week 0 to Week 8)||84|Safety Set included participants who received at least 1 dose of study drug.|
48557621|NCT00758524|101698126|FG005|Treated|Core Period (Week 0 to Week 8)||76|Safety Set included participants who received at least 1 dose of study drug.|
48557622|NCT00758524|101698127|FG006|Treated|Core Period (Week 0 to Week 8)||0|Safety Set included participants who received at least 1 dose of study drug.|
48557623|NCT00758524|101698128|FG007|Treated|Core Period (Week 0 to Week 8)||0|Safety Set included participants who received at least 1 dose of study drug.|
48557624|NCT00758524|101698129|FG008|Treated|Core Period (Week 0 to Week 8)||0|Safety Set included participants who received at least 1 dose of study drug.|
48557625|NCT00758524|101698130|FG009|Treated|Core Period (Week 0 to Week 8)||0|Safety Set included participants who received at least 1 dose of study drug.|
48592739|NCT02678000|101783168|FG000|NOT COMPLETED|PART 1||0||
48273608|NCT01146600|100992176|FG000|COMPLETED|Period 1 (Weeks 1 & 2)||10||
48273609|NCT01146600|100992177|FG001|COMPLETED|Period 1 (Weeks 1 & 2)||10||
48273610|NCT01146600|100992176|FG000|NOT COMPLETED|Period 1 (Weeks 1 & 2)||3||
48273611|NCT01146600|100992177|FG001|NOT COMPLETED|Period 1 (Weeks 1 & 2)||0||
48273612|NCT01146600|100992176|FG000|STARTED|Washout (Week 3)||10||
48273613|NCT01146600|100992177|FG001|STARTED|Washout (Week 3)||10||
48273614|NCT01146600|100992176|FG000|COMPLETED|Washout (Week 3)||10||
48273615|NCT01146600|100992177|FG001|COMPLETED|Washout (Week 3)||10||
48273616|NCT01146600|100992176|FG000|NOT COMPLETED|Washout (Week 3)||0||
48273617|NCT01146600|100992177|FG001|NOT COMPLETED|Washout (Week 3)||0||
48273618|NCT01146600|100992176|FG000|STARTED|Period 2 (Weeks 4 & 5)||10||
48273619|NCT01146600|100992177|FG001|STARTED|Period 2 (Weeks 4 & 5)||10||
48273620|NCT01146600|100992176|FG000|COMPLETED|Period 2 (Weeks 4 & 5)||10||
48273621|NCT01146600|100992177|FG001|COMPLETED|Period 2 (Weeks 4 & 5)||10||
48273622|NCT01146600|100992176|FG000|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0||
48273623|NCT01146600|100992177|FG001|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0||
48273624|NCT03248882|100992178|FG000|STARTED|Overall Study||61||
48273625|NCT03248882|100992179|FG001|STARTED|Overall Study||63||
48273626|NCT03248882|100992180|FG002|STARTED|Overall Study||62||
48273627|NCT03248882|100992181|FG003|STARTED|Overall Study||58||
48273628|NCT03248882|100992182|FG004|STARTED|Overall Study||61||
48111255|NCT01565330|100598078|FG002|NOT COMPLETED|Overall Study||0||
48273629|NCT03248882|100992178|FG000|Received Treatment|Overall Study||61||
48273630|NCT03248882|100992179|FG001|Received Treatment|Overall Study||63||
48273631|NCT03248882|100992180|FG002|Received Treatment|Overall Study||62||
48557626|NCT00758524|101698131|FG010|Treated|Core Period (Week 0 to Week 8)||0|Safety Set included participants who received at least 1 dose of study drug.|
48557627|NCT00758524|101698132|FG011|Treated|Core Period (Week 0 to Week 8)||0|Safety Set included participants who received at least 1 dose of study drug.|
48557628|NCT00758524|101698133|FG012|Treated|Core Period (Week 0 to Week 8)||0|Safety Set included participants who received at least 1 dose of study drug.|
48557629|NCT00758524|101698134|FG013|Treated|Core Period (Week 0 to Week 8)||0|Safety Set included participants who received at least 1 dose of study drug.|
48557630|NCT00758524|101698135|FG014|Treated|Core Period (Week 0 to Week 8)||0|Safety Set included participants who received at least 1 dose of study drug.|
48273632|NCT03248882|100992181|FG003|Received Treatment|Overall Study||58||
48273633|NCT03248882|100992182|FG004|Received Treatment|Overall Study||61||
48273634|NCT03248882|100992178|FG000|COMPLETED|Overall Study||54||
48273635|NCT03248882|100992179|FG001|COMPLETED|Overall Study||58||
48273636|NCT03248882|100992180|FG002|COMPLETED|Overall Study||55||
48273637|NCT03248882|100992181|FG003|COMPLETED|Overall Study||48||
48273638|NCT03248882|100992182|FG004|COMPLETED|Overall Study||48||
48273639|NCT03248882|100992178|FG000|NOT COMPLETED|Overall Study||7||
48273640|NCT03248882|100992179|FG001|NOT COMPLETED|Overall Study||5||
48273641|NCT03248882|100992180|FG002|NOT COMPLETED|Overall Study||7||
48273642|NCT03248882|100992181|FG003|NOT COMPLETED|Overall Study||10||
48273643|NCT03248882|100992182|FG004|NOT COMPLETED|Overall Study||13||
48273644|NCT01923467|100992183|FG000|STARTED|Overall Study||767||
48273645|NCT01923467|100992183|FG000|Baseline Completed, Enrolled|Overall Study||288||
48557631|NCT00758524|101698136|FG015|Treated|Core Period (Week 0 to Week 8)||0|Safety Set included participants who received at least 1 dose of study drug.|
48557632|NCT00758524|101698137|FG016|Treated|Core Period (Week 0 to Week 8)||0|Safety Set included participants who received at least 1 dose of study drug.|
48557633|NCT00758524|101698121|FG000|COMPLETED|Core Period (Week 0 to Week 8)||84||
48557634|NCT00758524|101698122|FG001|COMPLETED|Core Period (Week 0 to Week 8)||81||
48557635|NCT00758524|101698123|FG002|COMPLETED|Core Period (Week 0 to Week 8)||77||
48557636|NCT00758524|101698124|FG003|COMPLETED|Core Period (Week 0 to Week 8)||90||
48557637|NCT00758524|101698125|FG004|COMPLETED|Core Period (Week 0 to Week 8)||75||
48557638|NCT00758524|101698126|FG005|COMPLETED|Core Period (Week 0 to Week 8)||67||
48557639|NCT00758524|101698127|FG006|COMPLETED|Core Period (Week 0 to Week 8)||0||
48592740|NCT02678000|101783169|FG001|NOT COMPLETED|PART 1||0||
48273646|NCT01923467|100992183|FG000|COMPLETED|Overall Study||226||
48273647|NCT01923467|100992183|FG000|NOT COMPLETED|Overall Study||541||
48273648|NCT02574845|100992184|FG000|STARTED|Overall Study||3||
48273649|NCT02574845|100992185|FG001|STARTED|Overall Study||3||
48273650|NCT02574845|100992186|FG002|STARTED|Overall Study||3||
48273651|NCT02574845|100992187|FG003|STARTED|Overall Study||3||
48273652|NCT02574845|100992188|FG004|STARTED|Overall Study||3||
48273653|NCT02574845|100992189|FG005|STARTED|Overall Study||3||
48273654|NCT02574845|100992184|FG000|Received T1|Overall Study||3||
48273655|NCT02574845|100992185|FG001|Received T1|Overall Study||2||
48273656|NCT02574845|100992186|FG002|Received T1|Overall Study||3||
48111256|NCT01565330|100598079|FG003|NOT COMPLETED|Overall Study||0||
48273657|NCT02574845|100992187|FG003|Received T1|Overall Study||3||
48273658|NCT02574845|100992188|FG004|Received T1|Overall Study||2||
48273659|NCT02574845|100992189|FG005|Received T1|Overall Study||2||
48273660|NCT02574845|100992184|FG000|Received T2|Overall Study||3||
48273661|NCT02574845|100992185|FG001|Received T2|Overall Study||3||
48273662|NCT02574845|100992186|FG002|Received T2|Overall Study||3||
48273663|NCT02574845|100992187|FG003|Received T2|Overall Study||3||
48273664|NCT02574845|100992188|FG004|Received T2|Overall Study||2||
48273665|NCT02574845|100992189|FG005|Received T2|Overall Study||3||
48273666|NCT02574845|100992184|FG000|Received T3|Overall Study||2||
48273667|NCT02574845|100992185|FG001|Received T3|Overall Study||2||
48273668|NCT02574845|100992186|FG002|Received T3|Overall Study||3||
48273669|NCT02574845|100992187|FG003|Received T3|Overall Study||3||
48273670|NCT02574845|100992188|FG004|Received T3|Overall Study||2||
48273671|NCT02574845|100992189|FG005|Received T3|Overall Study||3||
48273672|NCT02574845|100992184|FG000|Received T4|Overall Study||3||
48273673|NCT02574845|100992185|FG001|Received T4|Overall Study||2||
48273674|NCT02574845|100992186|FG002|Received T4|Overall Study||3||
48273675|NCT02574845|100992187|FG003|Received T4|Overall Study||3||
48273676|NCT02574845|100992188|FG004|Received T4|Overall Study||2||
48273677|NCT02574845|100992189|FG005|Received T4|Overall Study||2||
48273678|NCT02574845|100992184|FG000|Received T5|Overall Study||3||
48557640|NCT00758524|101698128|FG007|COMPLETED|Core Period (Week 0 to Week 8)||0||
48557641|NCT00758524|101698129|FG008|COMPLETED|Core Period (Week 0 to Week 8)||0||
48557642|NCT00758524|101698130|FG009|COMPLETED|Core Period (Week 0 to Week 8)||0||
48557643|NCT00758524|101698131|FG010|COMPLETED|Core Period (Week 0 to Week 8)||0||
48557644|NCT00758524|101698132|FG011|COMPLETED|Core Period (Week 0 to Week 8)||0||
48557645|NCT00758524|101698133|FG012|COMPLETED|Core Period (Week 0 to Week 8)||0||
48557646|NCT00758524|101698134|FG013|COMPLETED|Core Period (Week 0 to Week 8)||0||
48557647|NCT00758524|101698135|FG014|COMPLETED|Core Period (Week 0 to Week 8)||0||
48557648|NCT00758524|101698136|FG015|COMPLETED|Core Period (Week 0 to Week 8)||0||
48557649|NCT00758524|101698137|FG016|COMPLETED|Core Period (Week 0 to Week 8)||0||
48557650|NCT00758524|101698121|FG000|NOT COMPLETED|Core Period (Week 0 to Week 8)||8||
48557651|NCT00758524|101698122|FG001|NOT COMPLETED|Core Period (Week 0 to Week 8)||7||
48557652|NCT00758524|101698123|FG002|NOT COMPLETED|Core Period (Week 0 to Week 8)||9||
48557653|NCT00758524|101698124|FG003|NOT COMPLETED|Core Period (Week 0 to Week 8)||7||
48557654|NCT00758524|101698125|FG004|NOT COMPLETED|Core Period (Week 0 to Week 8)||9||
48557655|NCT00758524|101698126|FG005|NOT COMPLETED|Core Period (Week 0 to Week 8)||10||
48557656|NCT00758524|101698127|FG006|NOT COMPLETED|Core Period (Week 0 to Week 8)||0||
48557657|NCT00758524|101698128|FG007|NOT COMPLETED|Core Period (Week 0 to Week 8)||0||
48557658|NCT00758524|101698129|FG008|NOT COMPLETED|Core Period (Week 0 to Week 8)||0||
48557659|NCT00758524|101698130|FG009|NOT COMPLETED|Core Period (Week 0 to Week 8)||0||
48557660|NCT00758524|101698131|FG010|NOT COMPLETED|Core Period (Week 0 to Week 8)||0||
48557661|NCT00758524|101698132|FG011|NOT COMPLETED|Core Period (Week 0 to Week 8)||0||
48557662|NCT00758524|101698133|FG012|NOT COMPLETED|Core Period (Week 0 to Week 8)||0||
48557663|NCT00758524|101698134|FG013|NOT COMPLETED|Core Period (Week 0 to Week 8)||0||
48557664|NCT00758524|101698135|FG014|NOT COMPLETED|Core Period (Week 0 to Week 8)||0||
48557665|NCT00758524|101698136|FG015|NOT COMPLETED|Core Period (Week 0 to Week 8)||0||
48557666|NCT00758524|101698137|FG016|NOT COMPLETED|Core Period (Week 0 to Week 8)||0||
48557667|NCT00758524|101698121|FG000|STARTED|Withdrawal Period (Week 8 to Week 9)||0|Participants that started the withdrawal period included those who received at least one dose of the study drug from Week 8 to Week 9 (Randomized Withdrawal Safety Set).|
48557668|NCT00758524|101698122|FG001|STARTED|Withdrawal Period (Week 8 to Week 9)||0|Participants that started the withdrawal period included those who received at least one dose of the study drug from Week 8 to Week 9 (Randomized Withdrawal Safety Set).|
48557669|NCT00758524|101698123|FG002|STARTED|Withdrawal Period (Week 8 to Week 9)||0|Participants that started the withdrawal period included those who received at least one dose of the study drug from Week 8 to Week 9 (Randomized Withdrawal Safety Set).|
48557670|NCT00758524|101698124|FG003|STARTED|Withdrawal Period (Week 8 to Week 9)||0|Participants that started the withdrawal period included those who received at least one dose of the study drug from Week 8 to Week 9 (Randomized Withdrawal Safety Set).|
48592741|NCT02678000|101783170|FG002|NOT COMPLETED|PART 1||0||
48694801|NCT00405392|102036493|FG001|NOT COMPLETED|Overall Study||27||
48694802|NCT00933608|102036494|FG000|STARTED|Overall Study||7||
48694803|NCT00933608|102036495|FG001|STARTED|Overall Study||10||
48694804|NCT00933608|102036494|FG000|COMPLETED|Overall Study||2||
48273679|NCT02574845|100992185|FG001|Received T5|Overall Study||2||
48273680|NCT02574845|100992186|FG002|Received T5|Overall Study||3||
48273681|NCT02574845|100992187|FG003|Received T5|Overall Study||3||
48694805|NCT00933608|102036495|FG001|COMPLETED|Overall Study||8||
48273682|NCT02574845|100992188|FG004|Received T5|Overall Study||3||
48273683|NCT02574845|100992189|FG005|Received T5|Overall Study||2||
48273684|NCT02574845|100992184|FG000|Received R|Overall Study||3||
48273685|NCT02574845|100992185|FG001|Received R|Overall Study||2||
48273686|NCT02574845|100992186|FG002|Received R|Overall Study||3||
48273687|NCT02574845|100992187|FG003|Received R|Overall Study||3||
48273688|NCT02574845|100992188|FG004|Received R|Overall Study||2||
48273689|NCT02574845|100992189|FG005|Received R|Overall Study||3||
48273690|NCT02574845|100992184|FG000|COMPLETED|Overall Study||3||
48273691|NCT02574845|100992185|FG001|COMPLETED|Overall Study||2||
48273692|NCT02574845|100992186|FG002|COMPLETED|Overall Study||3||
48694806|NCT00933608|102036494|FG000|NOT COMPLETED|Overall Study||5||
48273693|NCT02574845|100992187|FG003|COMPLETED|Overall Study||3||
48273694|NCT02574845|100992188|FG004|COMPLETED|Overall Study||2||
48273695|NCT02574845|100992189|FG005|COMPLETED|Overall Study||2||
48273696|NCT02574845|100992184|FG000|NOT COMPLETED|Overall Study||0||
48273697|NCT02574845|100992185|FG001|NOT COMPLETED|Overall Study||1||
48273698|NCT02574845|100992186|FG002|NOT COMPLETED|Overall Study||0||
48273699|NCT02574845|100992187|FG003|NOT COMPLETED|Overall Study||0||
48273700|NCT02574845|100992188|FG004|NOT COMPLETED|Overall Study||1||
48273701|NCT02574845|100992189|FG005|NOT COMPLETED|Overall Study||1||
48273702|NCT03106753|100992190|FG000|STARTED|Overall Study||17||
48273703|NCT03106753|100992191|FG001|STARTED|Overall Study||17||
48273704|NCT03106753|100992190|FG000|COMPLETED|Overall Study||17||
48273705|NCT03106753|100992191|FG001|COMPLETED|Overall Study||16||
48273706|NCT03106753|100992190|FG000|NOT COMPLETED|Overall Study||0||
48273707|NCT03106753|100992191|FG001|NOT COMPLETED|Overall Study||1||
48273708|NCT03491891|100992192|FG000|STARTED|Overall Study||6038||
48273709|NCT03491891|100992193|FG001|STARTED|Overall Study||2438||
48273710|NCT03491891|100992192|FG000|COMPLETED|Overall Study||5185||
48273711|NCT03491891|100992193|FG001|COMPLETED|Overall Study||2058||
48273712|NCT03491891|100992192|FG000|NOT COMPLETED|Overall Study||853||
48694807|NCT00933608|102036495|FG001|NOT COMPLETED|Overall Study||2||
48694808|NCT00600106|102036496|FG000|STARTED|Overall Study||18||
48694809|NCT00600106|102036497|FG001|STARTED|Overall Study||19||
48694810|NCT00600106|102036496|FG000|COMPLETED|Overall Study||17||
48694811|NCT00600106|102036497|FG001|COMPLETED|Overall Study||18||
48273713|NCT03491891|100992193|FG001|NOT COMPLETED|Overall Study||380||
48273714|NCT01006980|100992194|FG000|STARTED|Vemurafenib and Dacarbazine||337||
48273715|NCT01006980|100992195|FG001|STARTED|Vemurafenib and Dacarbazine||338||
48273716|NCT01006980|100992194|FG000|Treated|Vemurafenib and Dacarbazine||336||
48273717|NCT01006980|100992195|FG001|Treated|Vemurafenib and Dacarbazine||293||
48273718|NCT01006980|100992194|FG000|COMPLETED|Vemurafenib and Dacarbazine||0||
48273719|NCT01006980|100992195|FG001|COMPLETED|Vemurafenib and Dacarbazine||0||
48273720|NCT01006980|100992194|FG000|NOT COMPLETED|Vemurafenib and Dacarbazine||337||
48273721|NCT01006980|100992195|FG001|NOT COMPLETED|Vemurafenib and Dacarbazine||338||
48111257|NCT02256891|100598080|FG000|STARTED|Overall Study||55||
48273722|NCT01006980|100992194|FG000|STARTED|Crossover: Dacarbazine to Vemurafenib||0||
48273723|NCT01006980|100992195|FG001|STARTED|Crossover: Dacarbazine to Vemurafenib||84||
48273724|NCT01006980|100992194|FG000|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0||
48273725|NCT01006980|100992195|FG001|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0||
48273726|NCT01006980|100992194|FG000|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||0||
48273727|NCT01006980|100992195|FG001|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||84||
48273728|NCT00472849|100992196|FG000|STARTED|Overall Study||12||
48273729|NCT00472849|100992197|FG001|STARTED|Overall Study||78||
48273730|NCT00472849|100992196|FG000|COMPLETED|Overall Study||12||
48273731|NCT00472849|100992197|FG001|COMPLETED|Overall Study||78||
48273732|NCT00472849|100992196|FG000|NOT COMPLETED|Overall Study||0||
48694812|NCT00600106|102036496|FG000|NOT COMPLETED|Overall Study||1||
48694813|NCT00600106|102036497|FG001|NOT COMPLETED|Overall Study||1||
48694814|NCT00224120|102036498|FG000|STARTED|Overall Study||233||
48694815|NCT00224120|102036499|FG001|STARTED|Overall Study||229||
48694816|NCT00224120|102036498|FG000|COMPLETED|Overall Study||211||
48694817|NCT00224120|102036499|FG001|COMPLETED|Overall Study||205||
48694818|NCT00224120|102036498|FG000|NOT COMPLETED|Overall Study||22||
48694819|NCT00224120|102036499|FG001|NOT COMPLETED|Overall Study||24||
48694820|NCT01318135|102036500|FG000|STARTED|Enrolled - Long-Term Extension Study||99||
48694821|NCT01318135|102036501|FG001|STARTED|Enrolled - Long-Term Extension Study||102||
48111258|NCT02256891|100598081|FG001|STARTED|Overall Study||42||
48273733|NCT00472849|100992197|FG001|NOT COMPLETED|Overall Study||0||
48273734|NCT04617275|100992198|FG000|STARTED|Treatment Period||16||
48273735|NCT04617275|100992199|FG001|STARTED|Treatment Period||20||
48273736|NCT04617275|100992200|FG002|STARTED|Treatment Period||22||
48273737|NCT04617275|100992201|FG003|STARTED|Treatment Period||22||
48273738|NCT04617275|100992202|FG004|STARTED|Treatment Period||22||
48273739|NCT04617275|100992203|FG005|STARTED|Treatment Period||21||
48273740|NCT04617275|100992204|FG006|STARTED|Treatment Period||6||
48273741|NCT04617275|100992205|FG007|STARTED|Treatment Period||22||
48273742|NCT04617275|100992198|FG000|COMPLETED|Treatment Period||13||
48273743|NCT04617275|100992199|FG001|COMPLETED|Treatment Period||13||
48273744|NCT04617275|100992200|FG002|COMPLETED|Treatment Period||16||
48273745|NCT04617275|100992201|FG003|COMPLETED|Treatment Period||13||
48273746|NCT04617275|100992202|FG004|COMPLETED|Treatment Period||13||
48273747|NCT04617275|100992203|FG005|COMPLETED|Treatment Period||10||
48694822|NCT01318135|102036502|FG002|STARTED|Enrolled - Long-Term Extension Study||46||
48273748|NCT04617275|100992204|FG006|COMPLETED|Treatment Period||5||
48273749|NCT04617275|100992205|FG007|COMPLETED|Treatment Period||6||
48273750|NCT04617275|100992198|FG000|NOT COMPLETED|Treatment Period||3||
48273751|NCT04617275|100992199|FG001|NOT COMPLETED|Treatment Period||7||
48273752|NCT04617275|100992200|FG002|NOT COMPLETED|Treatment Period||6||
48273753|NCT04617275|100992201|FG003|NOT COMPLETED|Treatment Period||9||
48273754|NCT04617275|100992202|FG004|NOT COMPLETED|Treatment Period||9||
48273755|NCT04617275|100992203|FG005|NOT COMPLETED|Treatment Period||11||
48273756|NCT04617275|100992204|FG006|NOT COMPLETED|Treatment Period||1||
48273757|NCT04617275|100992205|FG007|NOT COMPLETED|Treatment Period||16||
48273758|NCT04617275|100992198|FG000|STARTED|Follow-up Period||16||
48273759|NCT04617275|100992199|FG001|STARTED|Follow-up Period||20||
48557671|NCT00758524|101698125|FG004|STARTED|Withdrawal Period (Week 8 to Week 9)||0|Participants that started the withdrawal period included those who received at least one dose of the study drug from Week 8 to Week 9 (Randomized Withdrawal Safety Set).|
48557672|NCT00758524|101698126|FG005|STARTED|Withdrawal Period (Week 8 to Week 9)||0|Participants that started the withdrawal period included those who received at least one dose of the study drug from Week 8 to Week 9 (Randomized Withdrawal Safety Set).|
48557673|NCT00758524|101698127|FG006|STARTED|Withdrawal Period (Week 8 to Week 9)||46|Participants that started the withdrawal period included those who received at least one dose of the study drug from Week 8 to Week 9 (Randomized Withdrawal Safety Set).|
48557674|NCT00758524|101698128|FG007|STARTED|Withdrawal Period (Week 8 to Week 9)||38|Participants that started the withdrawal period included those who received at least one dose of the study drug from Week 8 to Week 9 (Randomized Withdrawal Safety Set).|
48557675|NCT00758524|101698129|FG008|STARTED|Withdrawal Period (Week 8 to Week 9)||44|Participants that started the withdrawal period included those who received at least one dose of the study drug from Week 8 to Week 9 (Randomized Withdrawal Safety Set).|
48694823|NCT01318135|102036503|FG003|STARTED|Enrolled - Long-Term Extension Study||49||
48694824|NCT01318135|102036504|FG004|STARTED|Enrolled - Long-Term Extension Study||91||
48694825|NCT01318135|102036505|FG005|STARTED|Enrolled - Long-Term Extension Study||90||
48694826|NCT01318135|102036506|FG006|STARTED|Enrolled - Long-Term Extension Study||50||
48694827|NCT01318135|102036507|FG007|STARTED|Enrolled - Long-Term Extension Study||49||
48694828|NCT01318135|102036500|FG000|COMPLETED|Enrolled - Long-Term Extension Study||97||
48694829|NCT01318135|102036501|FG001|COMPLETED|Enrolled - Long-Term Extension Study||102||
48694830|NCT01318135|102036502|FG002|COMPLETED|Enrolled - Long-Term Extension Study||46||
48694831|NCT01318135|102036503|FG003|COMPLETED|Enrolled - Long-Term Extension Study||49||
48694832|NCT01318135|102036504|FG004|COMPLETED|Enrolled - Long-Term Extension Study||91||
48694833|NCT01318135|102036505|FG005|COMPLETED|Enrolled - Long-Term Extension Study||90||
48694834|NCT01318135|102036506|FG006|COMPLETED|Enrolled - Long-Term Extension Study||50||
48694835|NCT01318135|102036507|FG007|COMPLETED|Enrolled - Long-Term Extension Study||49||
48694836|NCT01318135|102036500|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||2||
48273760|NCT04617275|100992200|FG002|STARTED|Follow-up Period||22||
48273761|NCT04617275|100992201|FG003|STARTED|Follow-up Period||22||
48273762|NCT04617275|100992202|FG004|STARTED|Follow-up Period||22||
48273763|NCT04617275|100992203|FG005|STARTED|Follow-up Period||21||
48273764|NCT04617275|100992204|FG006|STARTED|Follow-up Period||6||
48273765|NCT04617275|100992205|FG007|STARTED|Follow-up Period||22||
48273766|NCT04617275|100992198|FG000|COMPLETED|Follow-up Period||13||
48273767|NCT04617275|100992199|FG001|COMPLETED|Follow-up Period||17||
48273768|NCT04617275|100992200|FG002|COMPLETED|Follow-up Period||18||
48273769|NCT04617275|100992201|FG003|COMPLETED|Follow-up Period||16||
48273770|NCT04617275|100992202|FG004|COMPLETED|Follow-up Period||16||
48273771|NCT04617275|100992203|FG005|COMPLETED|Follow-up Period||14||
48273772|NCT04617275|100992204|FG006|COMPLETED|Follow-up Period||5||
48273773|NCT04617275|100992205|FG007|COMPLETED|Follow-up Period||14||
48273774|NCT04617275|100992198|FG000|NOT COMPLETED|Follow-up Period||3||
48694837|NCT01318135|102036501|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
48694838|NCT01318135|102036502|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
48694839|NCT01318135|102036503|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
48694840|NCT01318135|102036504|FG004|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
48694841|NCT01318135|102036505|FG005|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
48694842|NCT01318135|102036506|FG006|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
48694843|NCT01318135|102036507|FG007|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
48694844|NCT01318135|102036500|FG000|STARTED|Entered - Long-Term Extension Study||97||
48694845|NCT01318135|102036501|FG001|STARTED|Entered - Long-Term Extension Study||102||
48694846|NCT01318135|102036502|FG002|STARTED|Entered - Long-Term Extension Study||46||
48694847|NCT01318135|102036503|FG003|STARTED|Entered - Long-Term Extension Study||49||
48694848|NCT01318135|102036504|FG004|STARTED|Entered - Long-Term Extension Study||90||
48694849|NCT01318135|102036505|FG005|STARTED|Entered - Long-Term Extension Study||87||
48710810|NCT01767493|102078026|FG000|STARTED|Overall Study||19||
48273775|NCT04617275|100992199|FG001|NOT COMPLETED|Follow-up Period||3||
48393090|NCT03920865|101291504|FG002|NOT COMPLETED|Overall Study||0||
48273776|NCT04617275|100992200|FG002|NOT COMPLETED|Follow-up Period||4||
48273777|NCT04617275|100992201|FG003|NOT COMPLETED|Follow-up Period||6||
48273778|NCT04617275|100992202|FG004|NOT COMPLETED|Follow-up Period||6||
48273779|NCT04617275|100992203|FG005|NOT COMPLETED|Follow-up Period||7||
48557676|NCT00758524|101698130|FG009|STARTED|Withdrawal Period (Week 8 to Week 9)||37|Participants that started the withdrawal period included those who received at least one dose of the study drug from Week 8 to Week 9 (Randomized Withdrawal Safety Set).|
48557677|NCT00758524|101698131|FG010|STARTED|Withdrawal Period (Week 8 to Week 9)||41|Participants that started the withdrawal period included those who received at least one dose of the study drug from Week 8 to Week 9 (Randomized Withdrawal Safety Set).|
48557678|NCT00758524|101698132|FG011|STARTED|Withdrawal Period (Week 8 to Week 9)||37|Participants that started the withdrawal period included those who received at least one dose of the study drug from Week 8 to Week 9 (Randomized Withdrawal Safety Set).|
48592742|NCT02678000|101783171|FG003|NOT COMPLETED|PART 1||0||
48694850|NCT01318135|102036506|FG006|STARTED|Entered - Long-Term Extension Study||50||
48694851|NCT01318135|102036507|FG007|STARTED|Entered - Long-Term Extension Study||49||
48694852|NCT01318135|102036500|FG000|COMPLETED|Entered - Long-Term Extension Study||80||
48694853|NCT01318135|102036501|FG001|COMPLETED|Entered - Long-Term Extension Study||89||
48694854|NCT01318135|102036502|FG002|COMPLETED|Entered - Long-Term Extension Study||38||
48694855|NCT01318135|102036503|FG003|COMPLETED|Entered - Long-Term Extension Study||42||
48694856|NCT01318135|102036504|FG004|COMPLETED|Entered - Long-Term Extension Study||81||
48694857|NCT01318135|102036505|FG005|COMPLETED|Entered - Long-Term Extension Study||83||
48694858|NCT01318135|102036506|FG006|COMPLETED|Entered - Long-Term Extension Study||49||
48694859|NCT01318135|102036507|FG007|COMPLETED|Entered - Long-Term Extension Study||46||
48694860|NCT01318135|102036500|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||17||
48694861|NCT01318135|102036501|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||13||
48694862|NCT01318135|102036502|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||8||
48694863|NCT01318135|102036503|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||7||
48694864|NCT01318135|102036504|FG004|NOT COMPLETED|Entered - Long-Term Extension Study||9||
48694865|NCT01318135|102036505|FG005|NOT COMPLETED|Entered - Long-Term Extension Study||4||
48694866|NCT01318135|102036506|FG006|NOT COMPLETED|Entered - Long-Term Extension Study||1||
48694867|NCT01318135|102036507|FG007|NOT COMPLETED|Entered - Long-Term Extension Study||3||
48694868|NCT00361231|102036508|FG000|STARTED|Overall Study||35||
48694869|NCT00361231|102036508|FG000|COMPLETED|Overall Study||1||
48694870|NCT00361231|102036508|FG000|NOT COMPLETED|Overall Study||34||
48694871|NCT03206918|102036509|FG000|STARTED|Overall Study||91||
48694872|NCT03206918|102036509|FG000|COMPLETED|Overall Study||0||
48694873|NCT03206918|102036509|FG000|NOT COMPLETED|Overall Study||91||
48694874|NCT01734785|102036510|FG000|STARTED|Open-Label Period||0||
48694875|NCT01734785|102036511|FG001|STARTED|Open-Label Period||0||
48694876|NCT01734785|102036512|FG002|STARTED|Open-Label Period||0||
48694877|NCT01734785|102036513|FG003|STARTED|Open-Label Period||606||
48694878|NCT01734785|102036510|FG000|COMPLETED|Open-Label Period||0||
48694879|NCT01734785|102036511|FG001|COMPLETED|Open-Label Period||0||
48694880|NCT01734785|102036512|FG002|COMPLETED|Open-Label Period||0||
48694881|NCT01734785|102036513|FG003|COMPLETED|Open-Label Period||333||
48694882|NCT01734785|102036510|FG000|NOT COMPLETED|Open-Label Period||0||
48694883|NCT01734785|102036511|FG001|NOT COMPLETED|Open-Label Period||0||
48694884|NCT01734785|102036512|FG002|NOT COMPLETED|Open-Label Period||0||
48694885|NCT01734785|102036513|FG003|NOT COMPLETED|Open-Label Period||273||
48694886|NCT01734785|102036510|FG000|STARTED|Double-Blind Period||111||
48694887|NCT01734785|102036511|FG001|STARTED|Double-Blind Period||112||
48694888|NCT01734785|102036512|FG002|STARTED|Double-Blind Period||110||
48694889|NCT01734785|102036513|FG003|STARTED|Double-Blind Period||0||
48694890|NCT01734785|102036510|FG000|COMPLETED|Double-Blind Period||106||
48694891|NCT01734785|102036511|FG001|COMPLETED|Double-Blind Period||103||
48694892|NCT01734785|102036512|FG002|COMPLETED|Double-Blind Period||105||
48694893|NCT01734785|102036513|FG003|COMPLETED|Double-Blind Period||0||
48694894|NCT01734785|102036510|FG000|NOT COMPLETED|Double-Blind Period||5||
48694895|NCT01734785|102036511|FG001|NOT COMPLETED|Double-Blind Period||9||
48694896|NCT01734785|102036512|FG002|NOT COMPLETED|Double-Blind Period||5||
48694897|NCT01734785|102036513|FG003|NOT COMPLETED|Double-Blind Period||0||
48694898|NCT00191945|102036514|FG000|STARTED|Double-Blind Acute Treatment||100||
48694899|NCT00191945|102036515|FG001|STARTED|Double-Blind Acute Treatment||51||
48694900|NCT00191945|102036514|FG000|COMPLETED|Double-Blind Acute Treatment||94||
48694901|NCT00191945|102036515|FG001|COMPLETED|Double-Blind Acute Treatment||48||
48694902|NCT00191945|102036514|FG000|NOT COMPLETED|Double-Blind Acute Treatment||6||
48694903|NCT00191945|102036515|FG001|NOT COMPLETED|Double-Blind Acute Treatment||3||
48694904|NCT00191945|102036514|FG000|STARTED|Open-Label Treatment Extension||94||
48694905|NCT00191945|102036515|FG001|STARTED|Open-Label Treatment Extension||48||
48694906|NCT00191945|102036514|FG000|COMPLETED|Open-Label Treatment Extension||94||
48694907|NCT00191945|102036515|FG001|COMPLETED|Open-Label Treatment Extension||48||
48694908|NCT00191945|102036514|FG000|NOT COMPLETED|Open-Label Treatment Extension||0||
48694909|NCT00191945|102036515|FG001|NOT COMPLETED|Open-Label Treatment Extension||0||
48694910|NCT02159898|102036516|FG000|STARTED|Overall Study||30||
48694911|NCT02159898|102036517|FG001|STARTED|Overall Study||30||
48694912|NCT02159898|102036516|FG000|COMPLETED|Overall Study||29||
48694913|NCT02159898|102036517|FG001|COMPLETED|Overall Study||30||
48694914|NCT02159898|102036516|FG000|NOT COMPLETED|Overall Study||1||
48694915|NCT02159898|102036517|FG001|NOT COMPLETED|Overall Study||0||
48694916|NCT01703091|102036518|FG000|STARTED|Overall Study||98||
48694917|NCT01703091|102036519|FG001|STARTED|Overall Study||99||
48694918|NCT01703091|102036518|FG000|Received at Least One Dose of Study Drug|Overall Study||94||
48694919|NCT01703091|102036519|FG001|Received at Least One Dose of Study Drug|Overall Study||98||
48694920|NCT01703091|102036518|FG000|COMPLETED|Overall Study||89||
48694921|NCT01703091|102036519|FG001|COMPLETED|Overall Study||95||
48694922|NCT01703091|102036518|FG000|NOT COMPLETED|Overall Study||9||
48694923|NCT01703091|102036519|FG001|NOT COMPLETED|Overall Study||4||
48694924|NCT03490292|102036520|FG000|STARTED|Treatment: Run-In Phase (June-Oct 2018)||6||
48694925|NCT03490292|102036521|FG001|STARTED|Treatment: Run-In Phase (June-Oct 2018)||0||
48694926|NCT03490292|102036520|FG000|COMPLETED|Treatment: Run-In Phase (June-Oct 2018)||6||
48694927|NCT03490292|102036521|FG001|COMPLETED|Treatment: Run-In Phase (June-Oct 2018)||0||
48694928|NCT03490292|102036520|FG000|NOT COMPLETED|Treatment: Run-In Phase (June-Oct 2018)||0||
48694929|NCT03490292|102036521|FG001|NOT COMPLETED|Treatment: Run-In Phase (June-Oct 2018)||0||
48694930|NCT03490292|102036520|FG000|STARTED|Interim Analysis||6|Run-In Phase Participants analyzed for Dose Limiting Toxicities|
48694931|NCT03490292|102036521|FG001|STARTED|Interim Analysis||0|Run-In Phase Participants analyzed for Dose Limiting Toxicities|
48694932|NCT03490292|102036520|FG000|COMPLETED|Interim Analysis||6||
48694933|NCT03490292|102036521|FG001|COMPLETED|Interim Analysis||0||
48694934|NCT03490292|102036520|FG000|NOT COMPLETED|Interim Analysis||0||
48694935|NCT03490292|102036521|FG001|NOT COMPLETED|Interim Analysis||0||
48694936|NCT03490292|102036520|FG000|STARTED|Treatment: Expansion (Feb 2019-Dec 2021)||0||
48694937|NCT03490292|102036521|FG001|STARTED|Treatment: Expansion (Feb 2019-Dec 2021)||16||
48694938|NCT03490292|102036520|FG000|COMPLETED|Treatment: Expansion (Feb 2019-Dec 2021)||0||
48694939|NCT03490292|102036521|FG001|COMPLETED|Treatment: Expansion (Feb 2019-Dec 2021)||9||
48557679|NCT00758524|101698133|FG012|STARTED|Withdrawal Period (Week 8 to Week 9)||45|Participants that started the withdrawal period included those who received at least one dose of the study drug from Week 8 to Week 9 (Randomized Withdrawal Safety Set).|
48557680|NCT00758524|101698134|FG013|STARTED|Withdrawal Period (Week 8 to Week 9)||45|Participants that started the withdrawal period included those who received at least one dose of the study drug from Week 8 to Week 9 (Randomized Withdrawal Safety Set).|
48557681|NCT00758524|101698135|FG014|STARTED|Withdrawal Period (Week 8 to Week 9)||39|Participants that started the withdrawal period included those who received at least one dose of the study drug from Week 8 to Week 9 (Randomized Withdrawal Safety Set).|
48557682|NCT00758524|101698136|FG015|STARTED|Withdrawal Period (Week 8 to Week 9)||36|Participants that started the withdrawal period included those who received at least one dose of the study drug from Week 8 to Week 9 (Randomized Withdrawal Safety Set).|
48557683|NCT00758524|101698137|FG016|STARTED|Withdrawal Period (Week 8 to Week 9)||66|Participants that started the withdrawal period included those who received at least one dose of the study drug from Week 8 to Week 9 (Randomized Withdrawal Safety Set).|
48557684|NCT00758524|101698121|FG000|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0|Randomized Withdrawal Set included all participants with post-baseline blood pressure measurements from Week 8 to Week 9 only.|
48557685|NCT00758524|101698122|FG001|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0|Randomized Withdrawal Set included all participants with post-baseline blood pressure measurements from Week 8 to Week 9 only.|
48557686|NCT00758524|101698123|FG002|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0|Randomized Withdrawal Set included all participants with post-baseline blood pressure measurements from Week 8 to Week 9 only.|
48557687|NCT00758524|101698124|FG003|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0|Randomized Withdrawal Set included all participants with post-baseline blood pressure measurements from Week 8 to Week 9 only.|
48557688|NCT00758524|101698125|FG004|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0|Randomized Withdrawal Set included all participants with post-baseline blood pressure measurements from Week 8 to Week 9 only.|
48557689|NCT00758524|101698126|FG005|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0|Randomized Withdrawal Set included all participants with post-baseline blood pressure measurements from Week 8 to Week 9 only.|
48557690|NCT00758524|101698127|FG006|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||45|Randomized Withdrawal Set included all participants with post-baseline blood pressure measurements from Week 8 to Week 9 only.|
48557691|NCT00758524|101698128|FG007|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||38|Randomized Withdrawal Set included all participants with post-baseline blood pressure measurements from Week 8 to Week 9 only.|
48557692|NCT00758524|101698129|FG008|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||43|Randomized Withdrawal Set included all participants with post-baseline blood pressure measurements from Week 8 to Week 9 only.|
48592743|NCT02678000|101783172|FG004|NOT COMPLETED|PART 1||0||
48557693|NCT00758524|101698130|FG009|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||37|Randomized Withdrawal Set included all participants with post-baseline blood pressure measurements from Week 8 to Week 9 only.|
48557694|NCT00758524|101698131|FG010|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||41|Randomized Withdrawal Set included all participants with post-baseline blood pressure measurements from Week 8 to Week 9 only.|
48557695|NCT00758524|101698132|FG011|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||36|Randomized Withdrawal Set included all participants with post-baseline blood pressure measurements from Week 8 to Week 9 only.|
48557696|NCT00758524|101698133|FG012|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||45|Randomized Withdrawal Set included all participants with post-baseline blood pressure measurements from Week 8 to Week 9 only.|
48557697|NCT00758524|101698134|FG013|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||44|Randomized Withdrawal Set included all participants with post-baseline blood pressure measurements from Week 8 to Week 9 only.|
48557698|NCT00758524|101698135|FG014|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||39|Randomized Withdrawal Set included all participants with post-baseline blood pressure measurements from Week 8 to Week 9 only.|
48557699|NCT00758524|101698136|FG015|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||36|Randomized Withdrawal Set included all participants with post-baseline blood pressure measurements from Week 8 to Week 9 only.|
48557700|NCT00758524|101698137|FG016|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||67|Randomized Withdrawal Set included all participants with post-baseline blood pressure measurements from Week 8 to Week 9 only.|
48557701|NCT00758524|101698121|FG000|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
48557702|NCT00758524|101698122|FG001|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
48557703|NCT00758524|101698123|FG002|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
48557704|NCT00758524|101698124|FG003|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
48557705|NCT00758524|101698125|FG004|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
48557706|NCT00758524|101698126|FG005|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
48557707|NCT00758524|101698127|FG006|COMPLETED|Withdrawal Period (Week 8 to Week 9)||45||
48557708|NCT00758524|101698128|FG007|COMPLETED|Withdrawal Period (Week 8 to Week 9)||38||
48557709|NCT00758524|101698129|FG008|COMPLETED|Withdrawal Period (Week 8 to Week 9)||42||
48557710|NCT00758524|101698130|FG009|COMPLETED|Withdrawal Period (Week 8 to Week 9)||37||
48557711|NCT00758524|101698131|FG010|COMPLETED|Withdrawal Period (Week 8 to Week 9)||41||
48557712|NCT00758524|101698132|FG011|COMPLETED|Withdrawal Period (Week 8 to Week 9)||37||
48557713|NCT00758524|101698133|FG012|COMPLETED|Withdrawal Period (Week 8 to Week 9)||45||
48557714|NCT00758524|101698134|FG013|COMPLETED|Withdrawal Period (Week 8 to Week 9)||45||
48557715|NCT00758524|101698135|FG014|COMPLETED|Withdrawal Period (Week 8 to Week 9)||39||
48557716|NCT00758524|101698136|FG015|COMPLETED|Withdrawal Period (Week 8 to Week 9)||36||
48557717|NCT00758524|101698137|FG016|COMPLETED|Withdrawal Period (Week 8 to Week 9)||66||
48557718|NCT00758524|101698121|FG000|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
48557719|NCT00758524|101698122|FG001|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
48557720|NCT00758524|101698123|FG002|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
48557721|NCT00758524|101698124|FG003|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
48557722|NCT00758524|101698125|FG004|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
48557723|NCT00758524|101698126|FG005|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
48557724|NCT00758524|101698127|FG006|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||1||
48557725|NCT00758524|101698128|FG007|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
48557726|NCT00758524|101698129|FG008|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||2||
48557727|NCT00758524|101698130|FG009|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
48557728|NCT00758524|101698131|FG010|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
48557729|NCT00758524|101698132|FG011|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
48557730|NCT00758524|101698133|FG012|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
48557731|NCT00758524|101698134|FG013|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
48557732|NCT00758524|101698135|FG014|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
48557733|NCT00758524|101698136|FG015|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
48557734|NCT00758524|101698137|FG016|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
48557735|NCT02892331|101698138|FG000|STARTED|Overall Study||18||
48557736|NCT02892331|101698139|FG001|STARTED|Overall Study||16||
48557737|NCT02892331|101698140|FG002|STARTED|Overall Study||18||
48557738|NCT02892331|101698138|FG000|COMPLETED|Overall Study||16||
48557739|NCT02892331|101698139|FG001|COMPLETED|Overall Study||13||
48557740|NCT02892331|101698140|FG002|COMPLETED|Overall Study||14||
48557741|NCT02892331|101698138|FG000|NOT COMPLETED|Overall Study||2||
48557742|NCT02892331|101698139|FG001|NOT COMPLETED|Overall Study||3||
48557743|NCT02892331|101698140|FG002|NOT COMPLETED|Overall Study||4||
48557744|NCT02232984|101698141|FG000|STARTED|Overall Study||749||
48557745|NCT02232984|101698141|FG000|Successfully Implanted|Overall Study||675||
48557746|NCT02232984|101698141|FG000|COMPLETED|Overall Study||672||
48557747|NCT02232984|101698141|FG000|NOT COMPLETED|Overall Study||77||
48557748|NCT02287922|101698142|FG000|STARTED|Overall Study||62||
48557749|NCT02287922|101698143|FG001|STARTED|Overall Study||62||
48557750|NCT02287922|101698144|FG002|STARTED|Overall Study||63||
48557751|NCT02287922|101698145|FG003|STARTED|Overall Study||64||
48557752|NCT02287922|101698142|FG000|COMPLETED|Overall Study||59||
48557753|NCT02287922|101698143|FG001|COMPLETED|Overall Study||60||
48557754|NCT02287922|101698144|FG002|COMPLETED|Overall Study||56||
48557755|NCT02287922|101698145|FG003|COMPLETED|Overall Study||57||
48557756|NCT02287922|101698142|FG000|NOT COMPLETED|Overall Study||3||
48557757|NCT02287922|101698143|FG001|NOT COMPLETED|Overall Study||2||
48557758|NCT02287922|101698144|FG002|NOT COMPLETED|Overall Study||7||
48557759|NCT02287922|101698145|FG003|NOT COMPLETED|Overall Study||7||
48557760|NCT03022084|101698146|FG000|STARTED|Overall Study||29||
48557761|NCT03022084|101698147|FG001|STARTED|Overall Study||32||
48557762|NCT03022084|101698146|FG000|COMPLETED|Overall Study||27||
48557763|NCT03022084|101698147|FG001|COMPLETED|Overall Study||29||
48557764|NCT03022084|101698146|FG000|NOT COMPLETED|Overall Study||2||
48557765|NCT03022084|101698147|FG001|NOT COMPLETED|Overall Study||3||
48557766|NCT02392481|101698148|FG000|STARTED|Overall Study||10||
48557767|NCT02392481|101698149|FG001|STARTED|Overall Study||12||
48557768|NCT02392481|101698150|FG002|STARTED|Overall Study||20||
48557769|NCT02392481|101698151|FG003|STARTED|Overall Study||27||
48557770|NCT02392481|101698148|FG000|COMPLETED|Overall Study||10||
48557771|NCT02392481|101698149|FG001|COMPLETED|Overall Study||12||
48557772|NCT02392481|101698150|FG002|COMPLETED|Overall Study||18||
48557773|NCT02392481|101698151|FG003|COMPLETED|Overall Study||25||
48557774|NCT02392481|101698148|FG000|NOT COMPLETED|Overall Study||0||
48557775|NCT02392481|101698149|FG001|NOT COMPLETED|Overall Study||0||
48557776|NCT02392481|101698150|FG002|NOT COMPLETED|Overall Study||2||
48557777|NCT02392481|101698151|FG003|NOT COMPLETED|Overall Study||2||
48557778|NCT03408639|101698152|FG000|STARTED|Overall Study||78||
48557779|NCT03408639|101698153|FG001|STARTED|Overall Study||78||
48557780|NCT03408639|101698152|FG000|COMPLETED|Overall Study||67||
48557781|NCT03408639|101698153|FG001|COMPLETED|Overall Study||56||
48557782|NCT03408639|101698152|FG000|NOT COMPLETED|Overall Study||11||
48557783|NCT03408639|101698153|FG001|NOT COMPLETED|Overall Study||22||
48557784|NCT03182933|101698154|FG000|STARTED|Overall Study||32||
48557785|NCT03182933|101698155|FG001|STARTED|Overall Study||32||
48557786|NCT03182933|101698154|FG000|COMPLETED|Overall Study||31||
48557787|NCT03182933|101698155|FG001|COMPLETED|Overall Study||32||
48557788|NCT03182933|101698154|FG000|NOT COMPLETED|Overall Study||1||
48557789|NCT03182933|101698155|FG001|NOT COMPLETED|Overall Study||0||
48557790|NCT02002221|101698156|FG000|STARTED|Overall Study||78||
48557791|NCT02002221|101698157|FG001|STARTED|Overall Study||78||
48557792|NCT02002221|101698156|FG000|COMPLETED|Overall Study||76||
48557793|NCT02002221|101698157|FG001|COMPLETED|Overall Study||75||
48557794|NCT02002221|101698156|FG000|NOT COMPLETED|Overall Study||2||
48557795|NCT02002221|101698157|FG001|NOT COMPLETED|Overall Study||3||
48557796|NCT00495391|101698158|FG000|STARTED|Overall Study||42||
48557797|NCT00495391|101698159|FG001|STARTED|Overall Study||22||
48557798|NCT00495391|101698158|FG000|From Baseline to Week 8|Overall Study||31||
48557799|NCT00495391|101698159|FG001|From Baseline to Week 8|Overall Study||20||
48557800|NCT00495391|101698158|FG000|From Baseline to Week 16|Overall Study||24||
48557801|NCT00495391|101698159|FG001|From Baseline to Week 16|Overall Study||11||
48557802|NCT00495391|101698158|FG000|From Baseline to End of Treatment|Overall Study||6||
48557803|NCT00495391|101698159|FG001|From Baseline to End of Treatment|Overall Study||1||
48557804|NCT00495391|101698158|FG000|From Baseline to End of Follow up|Overall Study||6||
48557805|NCT00495391|101698159|FG001|From Baseline to End of Follow up|Overall Study||1||
48557806|NCT00495391|101698158|FG000|COMPLETED|Overall Study||6||
48557807|NCT00495391|101698159|FG001|COMPLETED|Overall Study||1||
48557808|NCT00495391|101698158|FG000|NOT COMPLETED|Overall Study||36||
48557809|NCT00495391|101698159|FG001|NOT COMPLETED|Overall Study||21||
48557810|NCT02423200|101698160|FG000|STARTED|Overall Study||8||
48694940|NCT03490292|102036520|FG000|NOT COMPLETED|Treatment: Expansion (Feb 2019-Dec 2021)||0||
48694941|NCT03490292|102036521|FG001|NOT COMPLETED|Treatment: Expansion (Feb 2019-Dec 2021)||7||
48694942|NCT03490292|102036520|FG000|STARTED|1 Year Follow Up Post Last Dose||6||
48694943|NCT03490292|102036521|FG001|STARTED|1 Year Follow Up Post Last Dose||9||
48694944|NCT03490292|102036520|FG000|COMPLETED|1 Year Follow Up Post Last Dose||5||
48694945|NCT03490292|102036521|FG001|COMPLETED|1 Year Follow Up Post Last Dose||8||
48694946|NCT03490292|102036520|FG000|NOT COMPLETED|1 Year Follow Up Post Last Dose||1||
48694947|NCT03490292|102036521|FG001|NOT COMPLETED|1 Year Follow Up Post Last Dose||1||
48694948|NCT03490292|102036520|FG000|STARTED|Survival Follow up 4 Yr Post Last Dose||5||
48694949|NCT03490292|102036521|FG001|STARTED|Survival Follow up 4 Yr Post Last Dose||8||
48111259|NCT02256891|100598080|FG000|COMPLETED|Overall Study||43||
48557811|NCT02423200|101698161|FG001|STARTED|Overall Study||1||
48557812|NCT02423200|101698160|FG000|COMPLETED|Overall Study||7||
48694950|NCT03490292|102036520|FG000|COMPLETED|Survival Follow up 4 Yr Post Last Dose||5||
48694951|NCT03490292|102036521|FG001|COMPLETED|Survival Follow up 4 Yr Post Last Dose||8||
48694952|NCT03490292|102036520|FG000|NOT COMPLETED|Survival Follow up 4 Yr Post Last Dose||0||
48694953|NCT03490292|102036521|FG001|NOT COMPLETED|Survival Follow up 4 Yr Post Last Dose||0||
48557813|NCT02423200|101698161|FG001|COMPLETED|Overall Study||1||
48557814|NCT02423200|101698160|FG000|NOT COMPLETED|Overall Study||1||
48557815|NCT02423200|101698161|FG001|NOT COMPLETED|Overall Study||0||
48557816|NCT04173507|101698162|FG000|STARTED|Overall Study||42||
48557817|NCT04173507|101698162|FG000|COMPLETED|Overall Study||0||
48557818|NCT04173507|101698162|FG000|NOT COMPLETED|Overall Study||42||
48557819|NCT00443729|101698163|FG000|STARTED|Overall Study||176||
48557820|NCT00443729|101698164|FG001|STARTED|Overall Study||179||
48557821|NCT00443729|101698163|FG000|Treated|Overall Study||176||
48694954|NCT00595881|102036522|FG000|STARTED|Overall Study||420||
48694955|NCT00595881|102036522|FG000|COMPLETED|Overall Study||420||
48694956|NCT00595881|102036522|FG000|NOT COMPLETED|Overall Study||0||
48694957|NCT00577707|102036523|FG000|STARTED|Overall Study||9||
48694958|NCT00577707|102036523|FG000|COMPLETED|Overall Study||6||
48694959|NCT00577707|102036523|FG000|NOT COMPLETED|Overall Study||3||
48694960|NCT01591954|102036524|FG000|STARTED|Overall Study||1||
48694961|NCT01591954|102036524|FG000|COMPLETED|Overall Study||1||
48694962|NCT01591954|102036524|FG000|NOT COMPLETED|Overall Study||0||
48694963|NCT00841776|102036525|FG000|STARTED|Overall Study||27||
48694964|NCT00841776|102036526|FG001|STARTED|Overall Study||27||
48694965|NCT00841776|102036525|FG000|COMPLETED|Overall Study||25||
48694966|NCT00841776|102036526|FG001|COMPLETED|Overall Study||24||
48694967|NCT00841776|102036525|FG000|NOT COMPLETED|Overall Study||2||
48111260|NCT02256891|100598081|FG001|COMPLETED|Overall Study||29||
48111261|NCT02256891|100598080|FG000|NOT COMPLETED|Overall Study||12||
48111262|NCT02256891|100598081|FG001|NOT COMPLETED|Overall Study||13||
48694968|NCT00841776|102036526|FG001|NOT COMPLETED|Overall Study||3||
48694969|NCT03308968|102036527|FG000|STARTED|Double-Blind Period (12 Weeks)||279|Intent-to-treat (ITT) analysis set: all randomized participants.|
48710811|NCT01767493|102078026|FG000|COMPLETED|Overall Study||16||
48557822|NCT00443729|101698164|FG001|Treated|Overall Study||178||
48557823|NCT00443729|101698163|FG000|COMPLETED|Overall Study||166||
48557824|NCT00443729|101698164|FG001|COMPLETED|Overall Study||172||
48557825|NCT00443729|101698163|FG000|NOT COMPLETED|Overall Study||10||
48557826|NCT00443729|101698164|FG001|NOT COMPLETED|Overall Study||7||
48557827|NCT04650204|101698165|FG000|STARTED|Overall Study||3||
48557828|NCT04650204|101698166|FG001|STARTED|Overall Study||1||
48557829|NCT04650204|101698165|FG000|COMPLETED|Overall Study||1||
48694970|NCT03308968|102036528|FG001|STARTED|Double-Blind Period (12 Weeks)||276|Intent-to-treat (ITT) analysis set: all randomized participants.|
48694971|NCT03308968|102036529|FG002|STARTED|Double-Blind Period (12 Weeks)||283|Intent-to-treat (ITT) analysis set: all randomized participants.|
48694972|NCT03308968|102036527|FG000|DB Safety Analysis Set|Double-Blind Period (12 Weeks)||277|Participants who received at least 1 dose of study drug during DB period.|
48694973|NCT03308968|102036528|FG001|DB Safety Analysis Set|Double-Blind Period (12 Weeks)||276|Participants who received at least 1 dose of study drug during DB period.|
48694974|NCT03308968|102036529|FG002|DB Safety Analysis Set|Double-Blind Period (12 Weeks)||285|Participants who received at least 1 dose of study drug during DB period.|
48694975|NCT03308968|102036527|FG000|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||278|Received ≥1 dose of study drug;had ≥10 days of postbaseline efficacy assessment on primary endpoint.|
48694976|NCT03308968|102036528|FG001|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||276|Received ≥1 dose of study drug;had ≥10 days of postbaseline efficacy assessment on primary endpoint.|
48694977|NCT03308968|102036529|FG002|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||283|Received ≥1 dose of study drug;had ≥10 days of postbaseline efficacy assessment on primary endpoint.|
48694978|NCT03308968|102036527|FG000|COMPLETED|Double-Blind Period (12 Weeks)||264||
48694979|NCT03308968|102036528|FG001|COMPLETED|Double-Blind Period (12 Weeks)||271||
48694980|NCT03308968|102036529|FG002|COMPLETED|Double-Blind Period (12 Weeks)||272||
48694981|NCT03308968|102036527|FG000|NOT COMPLETED|Double-Blind Period (12 Weeks)||15||
48694982|NCT03308968|102036528|FG001|NOT COMPLETED|Double-Blind Period (12 Weeks)||5||
48694983|NCT03308968|102036529|FG002|NOT COMPLETED|Double-Blind Period (12 Weeks)||11||
48694984|NCT03308968|102036527|FG000|STARTED|Open-Label Period (12 Weeks)||264|OL Safety analysis set: Participants who received at least 1 dose of study drug during OL period.|
48694985|NCT03308968|102036528|FG001|STARTED|Open-Label Period (12 Weeks)||271|OL Safety analysis set: Participants who received at least 1 dose of study drug during OL period.|
48694986|NCT03308968|102036529|FG002|STARTED|Open-Label Period (12 Weeks)||272|OL Safety analysis set: Participants who received at least 1 dose of study drug during OL period.|
48694987|NCT03308968|102036527|FG000|OL mITT Analysis Set|Open-Label Period (12 Weeks)||263|Received ≥1 dose of study drug in OL period;had ≥10 days of postbaseline diary entries in OL period.|
48694988|NCT03308968|102036528|FG001|OL mITT Analysis Set|Open-Label Period (12 Weeks)||271|Received ≥1 dose of study drug in OL period;had ≥10 days of postbaseline diary entries in OL period.|
48694989|NCT03308968|102036529|FG002|OL mITT Analysis Set|Open-Label Period (12 Weeks)||272|Received ≥1 dose of study drug in OL period;had ≥10 days of postbaseline diary entries in OL period.|
48694990|NCT03308968|102036527|FG000|COMPLETED|Open-Label Period (12 Weeks)||253||
48694991|NCT03308968|102036528|FG001|COMPLETED|Open-Label Period (12 Weeks)||259||
48694992|NCT03308968|102036529|FG002|COMPLETED|Open-Label Period (12 Weeks)||260||
48694993|NCT03308968|102036527|FG000|NOT COMPLETED|Open-Label Period (12 Weeks)||11||
48694994|NCT03308968|102036528|FG001|NOT COMPLETED|Open-Label Period (12 Weeks)||12||
48694995|NCT03308968|102036529|FG002|NOT COMPLETED|Open-Label Period (12 Weeks)||12||
48694996|NCT02767869|102036530|FG000|STARTED|Overall Study||12||
48694997|NCT02767869|102036531|FG001|STARTED|Overall Study||12||
48694998|NCT02767869|102036530|FG000|COMPLETED|Overall Study||12||
48694999|NCT02767869|102036531|FG001|COMPLETED|Overall Study||12||
48695000|NCT02767869|102036530|FG000|NOT COMPLETED|Overall Study||0||
48695001|NCT02767869|102036531|FG001|NOT COMPLETED|Overall Study||0||
48695002|NCT03573206|102036532|FG000|STARTED|Overall Study||168||
48695003|NCT03573206|102036532|FG000|COMPLETED|Overall Study||168||
48695004|NCT03573206|102036532|FG000|NOT COMPLETED|Overall Study||0||
48695005|NCT00602225|102036533|FG000|STARTED|Overall Study||50||
48695006|NCT00602225|102036533|FG000|COMPLETED|Overall Study||50||
48695007|NCT00602225|102036533|FG000|NOT COMPLETED|Overall Study||0||
48695008|NCT01147250|102036534|FG000|STARTED|Overall Study||3034||
48695009|NCT01147250|102036535|FG001|STARTED|Overall Study||3034||
48695010|NCT01147250|102036534|FG000|Treated|Overall Study||3032||
48695011|NCT01147250|102036535|FG001|Treated|Overall Study||3031||
48695012|NCT01147250|102036534|FG000|COMPLETED|Overall Study||2924||
48695013|NCT01147250|102036535|FG001|COMPLETED|Overall Study||2929||
48695014|NCT01147250|102036534|FG000|NOT COMPLETED|Overall Study||110||
48695015|NCT01147250|102036535|FG001|NOT COMPLETED|Overall Study||105||
48695016|NCT00700882|102038426|FG000|STARTED|Overall Study||81||
48695017|NCT00700882|102038426|FG000|Received Protocol Therapy|Overall Study||75||
48695018|NCT00700882|102038426|FG000|Eligible and Treated Patients|Overall Study||73||
48695019|NCT00700882|102038426|FG000|Eligible, Treated and KIT+ Patients|Overall Study||22||
48695020|NCT00700882|102038426|FG000|Eligible and Treated Patients With Objective Response|Overall Study||7||
48111263|NCT02365636|100598082|FG000|STARTED|Overall Study||100||
48557830|NCT04650204|101698166|FG001|COMPLETED|Overall Study||0||
48557831|NCT04650204|101698165|FG000|NOT COMPLETED|Overall Study||2||
48557832|NCT04650204|101698166|FG001|NOT COMPLETED|Overall Study||1||
48111264|NCT02365636|100598083|FG001|STARTED|Overall Study||100||
48557833|NCT01216735|101698167|FG000|STARTED|First Intervention (3 Weeks)||8||
48557834|NCT01216735|101698168|FG001|STARTED|First Intervention (3 Weeks)||7||
48557835|NCT01216735|101698167|FG000|COMPLETED|First Intervention (3 Weeks)||8||
48557836|NCT01216735|101698168|FG001|COMPLETED|First Intervention (3 Weeks)||7||
48557837|NCT01216735|101698167|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0||
48557838|NCT01216735|101698168|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0||
48557839|NCT01216735|101698167|FG000|STARTED|Washout (3 Weeks)||8||
48557840|NCT01216735|101698168|FG001|STARTED|Washout (3 Weeks)||7||
48695021|NCT00700882|102038426|FG000|COMPLETED|Overall Study||22||
48695022|NCT00700882|102038426|FG000|NOT COMPLETED|Overall Study||59||
48695023|NCT04603495|102038427|FG000|STARTED|Overall Study||214||
48695024|NCT04603495|102038428|FG001|STARTED|Overall Study||216||
48695025|NCT04603495|102038427|FG000|Received Both Pela/Placebo and RUX|Overall Study||212||
48695026|NCT04603495|102038428|FG001|Received Both Pela/Placebo and RUX|Overall Study||214||
48695027|NCT04603495|102038427|FG000|COMPLETED|Overall Study||181|Completed Week 24|
48695028|NCT04603495|102038428|FG001|COMPLETED|Overall Study||193|Completed Week 24|
48695029|NCT04603495|102038427|FG000|NOT COMPLETED|Overall Study||33||
48695030|NCT04603495|102038428|FG001|NOT COMPLETED|Overall Study||23||
48695031|NCT01375127|102038429|FG000|STARTED|Overall Study||1||
48695032|NCT01375127|102038430|FG001|STARTED|Overall Study||1||
48695033|NCT01375127|102038431|FG002|STARTED|Overall Study||40||
48695034|NCT01375127|102038432|FG003|STARTED|Overall Study||33||
48695035|NCT01375127|102038433|FG004|STARTED|Overall Study||5||
48695036|NCT01375127|102038434|FG005|STARTED|Overall Study||3||
48695037|NCT01375127|102038429|FG000|COMPLETED|Overall Study||1||
48695038|NCT01375127|102038430|FG001|COMPLETED|Overall Study||1||
48695039|NCT01375127|102038431|FG002|COMPLETED|Overall Study||40||
48695040|NCT01375127|102038432|FG003|COMPLETED|Overall Study||33||
48695041|NCT01375127|102038433|FG004|COMPLETED|Overall Study||5||
48695042|NCT01375127|102038434|FG005|COMPLETED|Overall Study||3||
48695043|NCT01375127|102038429|FG000|NOT COMPLETED|Overall Study||0||
48695044|NCT01375127|102038430|FG001|NOT COMPLETED|Overall Study||0||
48695045|NCT01375127|102038431|FG002|NOT COMPLETED|Overall Study||0||
48695046|NCT01375127|102038432|FG003|NOT COMPLETED|Overall Study||0||
48695047|NCT01375127|102038433|FG004|NOT COMPLETED|Overall Study||0||
48695048|NCT01375127|102038434|FG005|NOT COMPLETED|Overall Study||0||
48695049|NCT01153711|102038435|FG000|STARTED|Overall Study||32||
48695050|NCT01153711|102038435|FG000|COMPLETED|Overall Study||32||
48695051|NCT01153711|102038435|FG000|NOT COMPLETED|Overall Study||0||
48695052|NCT00624468|102038436|FG000|STARTED|Double-blind Period||17||
48695053|NCT00624468|102038437|FG001|STARTED|Double-blind Period||17||
48695054|NCT00624468|102038438|FG002|STARTED|Double-blind Period||0||
48695055|NCT00624468|102038439|FG003|STARTED|Double-blind Period||0||
48695056|NCT00624468|102038436|FG000|COMPLETED|Double-blind Period||3||
48695057|NCT00624468|102038437|FG001|COMPLETED|Double-blind Period||4||
48695058|NCT00624468|102038438|FG002|COMPLETED|Double-blind Period||0||
48695059|NCT00624468|102038439|FG003|COMPLETED|Double-blind Period||0||
48695060|NCT00624468|102038436|FG000|NOT COMPLETED|Double-blind Period||14||
48695061|NCT00624468|102038437|FG001|NOT COMPLETED|Double-blind Period||13||
48695062|NCT00624468|102038438|FG002|NOT COMPLETED|Double-blind Period||0||
48695063|NCT00624468|102038439|FG003|NOT COMPLETED|Double-blind Period||0||
48695064|NCT00624468|102038436|FG000|STARTED|Safety Follow-up (SFU) Period||0||
48695065|NCT00624468|102038437|FG001|STARTED|Safety Follow-up (SFU) Period||0||
48695066|NCT00624468|102038438|FG002|STARTED|Safety Follow-up (SFU) Period||13||
48695067|NCT00624468|102038439|FG003|STARTED|Safety Follow-up (SFU) Period||14||
48695068|NCT00624468|102038436|FG000|COMPLETED|Safety Follow-up (SFU) Period||0||
48695069|NCT00624468|102038437|FG001|COMPLETED|Safety Follow-up (SFU) Period||0||
48695070|NCT00624468|102038438|FG002|COMPLETED|Safety Follow-up (SFU) Period||11||
48695071|NCT00624468|102038439|FG003|COMPLETED|Safety Follow-up (SFU) Period||11||
48695072|NCT00624468|102038436|FG000|NOT COMPLETED|Safety Follow-up (SFU) Period||0||
48695073|NCT00624468|102038437|FG001|NOT COMPLETED|Safety Follow-up (SFU) Period||0||
48695074|NCT00624468|102038438|FG002|NOT COMPLETED|Safety Follow-up (SFU) Period||2||
48695075|NCT00624468|102038439|FG003|NOT COMPLETED|Safety Follow-up (SFU) Period||3||
48695076|NCT02584452|102038440|FG000|STARTED|Overall Study||34||
48695077|NCT02584452|102038441|FG001|STARTED|Overall Study||23||
48695078|NCT02584452|102038440|FG000|COMPLETED|Overall Study||32||
48695079|NCT02584452|102038441|FG001|COMPLETED|Overall Study||21||
48695080|NCT02584452|102038440|FG000|NOT COMPLETED|Overall Study||2||
48695081|NCT02584452|102038441|FG001|NOT COMPLETED|Overall Study||2||
48695082|NCT03718884|102038442|FG000|STARTED|Period 1 (6 Days)||29||
48695083|NCT03718884|102038443|FG001|STARTED|Period 1 (6 Days)||0||
48695084|NCT03718884|102038442|FG000|Received at Least One Dose of Study Drug|Period 1 (6 Days)||29||
48695085|NCT03718884|102038443|FG001|Received at Least One Dose of Study Drug|Period 1 (6 Days)||0||
48557841|NCT01216735|101698167|FG000|COMPLETED|Washout (3 Weeks)||8||
48557842|NCT01216735|101698168|FG001|COMPLETED|Washout (3 Weeks)||7||
48557843|NCT01216735|101698167|FG000|NOT COMPLETED|Washout (3 Weeks)||0||
48557844|NCT01216735|101698168|FG001|NOT COMPLETED|Washout (3 Weeks)||0||
48557845|NCT01216735|101698167|FG000|STARTED|Second Intervention (3 Weeks)||8||
48557846|NCT01216735|101698168|FG001|STARTED|Second Intervention (3 Weeks)||7||
48273780|NCT04617275|100992204|FG006|NOT COMPLETED|Follow-up Period||1||
48273781|NCT04617275|100992205|FG007|NOT COMPLETED|Follow-up Period||8||
48273782|NCT00436605|100992206|FG000|STARTED|Overall Study||39||
48273783|NCT00436605|100992206|FG000|COMPLETED|Overall Study||36||
48273784|NCT00436605|100992206|FG000|NOT COMPLETED|Overall Study||3||
48273785|NCT03117998|100992207|FG000|STARTED|Overall Study||25||
48273786|NCT03117998|100992208|FG001|STARTED|Overall Study||25||
48273787|NCT03117998|100992209|FG002|STARTED|Overall Study||25||
48557847|NCT01216735|101698167|FG000|COMPLETED|Second Intervention (3 Weeks)||8||
48557848|NCT01216735|101698168|FG001|COMPLETED|Second Intervention (3 Weeks)||7||
48557849|NCT01216735|101698167|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0||
48557850|NCT01216735|101698168|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0||
48557851|NCT02749617|101698169|FG000|STARTED|Overall Study||2||
48557852|NCT02749617|101698169|FG000|COMPLETED|Overall Study||2||
48557853|NCT02749617|101698169|FG000|NOT COMPLETED|Overall Study||0||
48557854|NCT01199146|101698170|FG000|STARTED|Overall Study||42||
48557855|NCT01199146|101698170|FG000|COMPLETED|Overall Study||39||
48557856|NCT01199146|101698170|FG000|NOT COMPLETED|Overall Study||3||
48557857|NCT01127256|101698171|FG000|STARTED|Overall Study||96||
48557858|NCT01127256|101698172|FG001|STARTED|Overall Study||104||
48557859|NCT01127256|101698171|FG000|COMPLETED|Overall Study||57||
48557860|NCT01127256|101698172|FG001|COMPLETED|Overall Study||65||
48557861|NCT01127256|101698171|FG000|NOT COMPLETED|Overall Study||39||
48557862|NCT01127256|101698172|FG001|NOT COMPLETED|Overall Study||39||
48273788|NCT03117998|100992210|FG003|STARTED|Overall Study||26||
48273789|NCT03117998|100992211|FG004|STARTED|Overall Study||26||
48273790|NCT03117998|100992212|FG005|STARTED|Overall Study||27||
48273791|NCT03117998|100992207|FG000|COMPLETED|Overall Study||24||
48273792|NCT03117998|100992208|FG001|COMPLETED|Overall Study||24||
48273793|NCT03117998|100992209|FG002|COMPLETED|Overall Study||21||
48557863|NCT05027308|101698173|FG000|STARTED|Overall Study||3||
48557864|NCT05027308|101698173|FG000|COMPLETED|Overall Study||3||
48557865|NCT05027308|101698173|FG000|NOT COMPLETED|Overall Study||0||
48557866|NCT01342081|101698174|FG000|STARTED|Overall Study||161||
48273794|NCT03117998|100992210|FG003|COMPLETED|Overall Study||22||
48557867|NCT01342081|101698175|FG001|STARTED|Overall Study||164||
48557868|NCT01342081|101698176|FG002|STARTED|Overall Study||164||
48557869|NCT01342081|101698174|FG000|COMPLETED|Overall Study||159||
48557870|NCT01342081|101698175|FG001|COMPLETED|Overall Study||162||
48557871|NCT01342081|101698176|FG002|COMPLETED|Overall Study||163||
48557872|NCT01342081|101698174|FG000|NOT COMPLETED|Overall Study||2||
48557873|NCT01342081|101698175|FG001|NOT COMPLETED|Overall Study||2||
48557874|NCT01342081|101698176|FG002|NOT COMPLETED|Overall Study||1||
48557875|NCT00615199|101698177|FG000|STARTED|Overall Study||34||
48557876|NCT00615199|101698178|FG001|STARTED|Overall Study||36||
48273795|NCT03117998|100992211|FG004|COMPLETED|Overall Study||19||
48557877|NCT00615199|101698179|FG002|STARTED|Overall Study||34||
48273796|NCT03117998|100992212|FG005|COMPLETED|Overall Study||24||
48557878|NCT00615199|101698180|FG003|STARTED|Overall Study||35||
48557879|NCT00615199|101698177|FG000|COMPLETED|Overall Study||26||
48557880|NCT00615199|101698178|FG001|COMPLETED|Overall Study||34||
48273797|NCT03117998|100992207|FG000|NOT COMPLETED|Overall Study||1||
48273798|NCT03117998|100992208|FG001|NOT COMPLETED|Overall Study||1||
48273799|NCT03117998|100992209|FG002|NOT COMPLETED|Overall Study||4||
48273800|NCT03117998|100992210|FG003|NOT COMPLETED|Overall Study||4||
48557881|NCT00615199|101698179|FG002|COMPLETED|Overall Study||33||
48557882|NCT00615199|101698180|FG003|COMPLETED|Overall Study||33||
48557883|NCT00615199|101698177|FG000|NOT COMPLETED|Overall Study||8||
48557884|NCT00615199|101698178|FG001|NOT COMPLETED|Overall Study||2||
48557885|NCT00615199|101698179|FG002|NOT COMPLETED|Overall Study||1||
48557886|NCT00615199|101698180|FG003|NOT COMPLETED|Overall Study||2||
48557887|NCT04143373|101698181|FG000|STARTED|Overall Study||20||20
48557888|NCT04143373|101698182|FG001|STARTED|Overall Study||20||20
48557889|NCT04143373|101698181|FG000|COMPLETED|Overall Study||20||20
48557890|NCT04143373|101698182|FG001|COMPLETED|Overall Study||20||20
48557891|NCT04143373|101698181|FG000|NOT COMPLETED|Overall Study||0||0
48557892|NCT04143373|101698182|FG001|NOT COMPLETED|Overall Study||0||0
48557893|NCT02860546|101698183|FG000|STARTED|Overall Study||18||
48557894|NCT02860546|101698183|FG000|COMPLETED|Overall Study||0||
48557895|NCT02860546|101698183|FG000|NOT COMPLETED|Overall Study||18||
48557896|NCT00485264|101698184|FG000|STARTED|Overall Study||71||
48557897|NCT00485264|101698185|FG001|STARTED|Overall Study||16||
48273801|NCT03117998|100992211|FG004|NOT COMPLETED|Overall Study||7||
48273802|NCT03117998|100992212|FG005|NOT COMPLETED|Overall Study||3||
48273803|NCT05319912|100992213|FG000|STARTED|Overall Study||3||
48273804|NCT05319912|100992214|FG001|STARTED|Overall Study||3||
48557898|NCT00485264|101698186|FG002|STARTED|Overall Study||18||
48557899|NCT00485264|101698187|FG003|STARTED|Overall Study||21||
48557900|NCT00485264|101698188|FG004|STARTED|Overall Study||15||
48273805|NCT05319912|100992215|FG002|STARTED|Overall Study||3||
48273806|NCT05319912|100992216|FG003|STARTED|Overall Study||3||
48273807|NCT05319912|100992217|FG004|STARTED|Overall Study||3||
48557901|NCT00485264|101698189|FG005|STARTED|Overall Study||12||
48557902|NCT00485264|101698184|FG000|Completed Week 24|Overall Study||67||
48273808|NCT05319912|100992218|FG005|STARTED|Overall Study||3||
48557903|NCT00485264|101698185|FG001|Completed Week 24|Overall Study||16||
48557904|NCT00485264|101698186|FG002|Completed Week 24|Overall Study||18||
48557905|NCT00485264|101698187|FG003|Completed Week 24|Overall Study||21||
48557906|NCT00485264|101698188|FG004|Completed Week 24|Overall Study||14||
48557907|NCT00485264|101698189|FG005|Completed Week 24|Overall Study||11||
48557908|NCT00485264|101698184|FG000|COMPLETED|Overall Study||35||
48557909|NCT00485264|101698185|FG001|COMPLETED|Overall Study||9||
48557910|NCT00485264|101698186|FG002|COMPLETED|Overall Study||12||
48557911|NCT00485264|101698187|FG003|COMPLETED|Overall Study||17||
48557912|NCT00485264|101698188|FG004|COMPLETED|Overall Study||9||
48557913|NCT00485264|101698189|FG005|COMPLETED|Overall Study||5||
48557914|NCT00485264|101698184|FG000|NOT COMPLETED|Overall Study||36||
48557915|NCT00485264|101698185|FG001|NOT COMPLETED|Overall Study||7||
48557916|NCT00485264|101698186|FG002|NOT COMPLETED|Overall Study||6||
48557917|NCT00485264|101698187|FG003|NOT COMPLETED|Overall Study||4||
48557918|NCT00485264|101698188|FG004|NOT COMPLETED|Overall Study||6||
48557919|NCT00485264|101698189|FG005|NOT COMPLETED|Overall Study||7||
48557920|NCT01130532|101698190|FG000|STARTED|Period III (Weeks 0-12)||207||
48557921|NCT01130532|101698191|FG001|STARTED|Period III (Weeks 0-12)||207||
48557922|NCT01130532|101698192|FG002|STARTED|Period III (Weeks 0-12)||209||
48557923|NCT01130532|101698193|FG003|STARTED|Period III (Weeks 0-12)||0||
48557924|NCT01130532|101698190|FG000|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205||
48557925|NCT01130532|101698191|FG001|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205||
48557926|NCT01130532|101698192|FG002|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||207||
48557927|NCT01130532|101698193|FG003|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||0||
48557928|NCT01130532|101698190|FG000|COMPLETED|Period III (Weeks 0-12)||186||
48557929|NCT01130532|101698191|FG001|COMPLETED|Period III (Weeks 0-12)||189||
48557930|NCT01130532|101698192|FG002|COMPLETED|Period III (Weeks 0-12)||190||
48557931|NCT01130532|101698193|FG003|COMPLETED|Period III (Weeks 0-12)||0||
48557932|NCT01130532|101698190|FG000|NOT COMPLETED|Period III (Weeks 0-12)||21||
48557933|NCT01130532|101698191|FG001|NOT COMPLETED|Period III (Weeks 0-12)||18||
48557934|NCT01130532|101698192|FG002|NOT COMPLETED|Period III (Weeks 0-12)||19||
48557935|NCT01130532|101698193|FG003|NOT COMPLETED|Period III (Weeks 0-12)||0||
48557936|NCT01130532|101698190|FG000|STARTED|Period IV (Weeks 13-16)||0||
48557937|NCT01130532|101698191|FG001|STARTED|Period IV (Weeks 13-16)||0||
48557938|NCT01130532|101698192|FG002|STARTED|Period IV (Weeks 13-16)||0||
48557939|NCT01130532|101698193|FG003|STARTED|Period IV (Weeks 13-16)||562||
48557940|NCT01130532|101698190|FG000|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0||
48557941|NCT01130532|101698191|FG001|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0||
48557942|NCT01130532|101698192|FG002|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0||
48557943|NCT01130532|101698193|FG003|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||546||
48557944|NCT01130532|101698190|FG000|COMPLETED|Period IV (Weeks 13-16)||0||
48557945|NCT01130532|101698191|FG001|COMPLETED|Period IV (Weeks 13-16)||0||
48557946|NCT01130532|101698192|FG002|COMPLETED|Period IV (Weeks 13-16)||0||
48557947|NCT01130532|101698193|FG003|COMPLETED|Period IV (Weeks 13-16)||552||
48557948|NCT01130532|101698190|FG000|NOT COMPLETED|Period IV (Weeks 13-16)||0||
48557949|NCT01130532|101698191|FG001|NOT COMPLETED|Period IV (Weeks 13-16)||0||
48557950|NCT01130532|101698192|FG002|NOT COMPLETED|Period IV (Weeks 13-16)||0||
48557951|NCT01130532|101698193|FG003|NOT COMPLETED|Period IV (Weeks 13-16)||10||
48557952|NCT00967330|101698194|FG000|STARTED|Overall Study||122||
48557953|NCT00967330|101698195|FG001|STARTED|Overall Study||60||
48557954|NCT00967330|101698194|FG000|COMPLETED|Overall Study||0||
48557955|NCT00967330|101698195|FG001|COMPLETED|Overall Study||0||
48557956|NCT00967330|101698194|FG000|NOT COMPLETED|Overall Study||122||
48557957|NCT00967330|101698195|FG001|NOT COMPLETED|Overall Study||60||
48557958|NCT02387840|101698196|FG000|STARTED|Overall Study||4||
48557959|NCT02387840|101698197|FG001|STARTED|Overall Study||6||
48557960|NCT02387840|101698198|FG002|STARTED|Overall Study||6||
48557961|NCT02387840|101698199|FG003|STARTED|Overall Study||8||
48557962|NCT02387840|101698200|FG004|STARTED|Overall Study||4||
48557963|NCT02387840|101698201|FG005|STARTED|Overall Study||6||
48557964|NCT02387840|101698196|FG000|COMPLETED|Overall Study||4||
48557965|NCT02387840|101698197|FG001|COMPLETED|Overall Study||6||
48557966|NCT02387840|101698198|FG002|COMPLETED|Overall Study||6||
48557967|NCT02387840|101698199|FG003|COMPLETED|Overall Study||8||
48557968|NCT02387840|101698200|FG004|COMPLETED|Overall Study||4||
48557969|NCT02387840|101698201|FG005|COMPLETED|Overall Study||5||
48557970|NCT02387840|101698196|FG000|NOT COMPLETED|Overall Study||0||
48557971|NCT02387840|101698197|FG001|NOT COMPLETED|Overall Study||0||
48557972|NCT02387840|101698198|FG002|NOT COMPLETED|Overall Study||0||
48557973|NCT02387840|101698199|FG003|NOT COMPLETED|Overall Study||0||
48557974|NCT02387840|101698200|FG004|NOT COMPLETED|Overall Study||0||
48695086|NCT03718884|102038442|FG000|COMPLETED|Period 1 (6 Days)||29||
48695087|NCT03718884|102038443|FG001|COMPLETED|Period 1 (6 Days)||0||
48695088|NCT03718884|102038442|FG000|NOT COMPLETED|Period 1 (6 Days)||0||
48695089|NCT03718884|102038443|FG001|NOT COMPLETED|Period 1 (6 Days)||0||
48695090|NCT03718884|102038442|FG000|STARTED|Period 2 (120 Days)||0||
48695091|NCT03718884|102038443|FG001|STARTED|Period 2 (120 Days)||29||
48695092|NCT03718884|102038442|FG000|COMPLETED|Period 2 (120 Days)||0||
48557975|NCT02387840|101698201|FG005|NOT COMPLETED|Overall Study||1||
48557976|NCT04747470|101698202|FG000|STARTED|Overall Study||0||
48557977|NCT04747470|101698203|FG001|STARTED|Overall Study||3||
48557978|NCT04747470|101698204|FG002|STARTED|Overall Study||3||
48557979|NCT04747470|101698205|FG003|STARTED|Overall Study||3||
48557980|NCT04747470|101698206|FG004|STARTED|Overall Study||4||
48557981|NCT04747470|101698207|FG005|STARTED|Overall Study||0||
48557982|NCT04747470|101698208|FG006|STARTED|Overall Study||0||
48557983|NCT04747470|101698209|FG007|STARTED|Overall Study||0||
48557984|NCT04747470|101698210|FG008|STARTED|Overall Study||0||
48557985|NCT04747470|101698211|FG009|STARTED|Overall Study||0||
48557986|NCT04747470|101698212|FG010|STARTED|Overall Study||0||
48557987|NCT04747470|101698202|FG000|COMPLETED|Overall Study||0||
48557988|NCT04747470|101698203|FG001|COMPLETED|Overall Study||0||
48557989|NCT04747470|101698204|FG002|COMPLETED|Overall Study||0||
48557990|NCT04747470|101698205|FG003|COMPLETED|Overall Study||0||
48557991|NCT04747470|101698206|FG004|COMPLETED|Overall Study||0||
48557992|NCT04747470|101698207|FG005|COMPLETED|Overall Study||0||
48557993|NCT04747470|101698208|FG006|COMPLETED|Overall Study||0||
48557994|NCT04747470|101698209|FG007|COMPLETED|Overall Study||0||
48557995|NCT04747470|101698210|FG008|COMPLETED|Overall Study||0||
48557996|NCT04747470|101698211|FG009|COMPLETED|Overall Study||0||
48557997|NCT04747470|101698212|FG010|COMPLETED|Overall Study||0||
48557998|NCT04747470|101698202|FG000|NOT COMPLETED|Overall Study||0||
48557999|NCT04747470|101698203|FG001|NOT COMPLETED|Overall Study||3||
48558000|NCT04747470|101698204|FG002|NOT COMPLETED|Overall Study||3||
48558001|NCT04747470|101698205|FG003|NOT COMPLETED|Overall Study||3||
48558002|NCT04747470|101698206|FG004|NOT COMPLETED|Overall Study||4||
48558003|NCT04747470|101698207|FG005|NOT COMPLETED|Overall Study||0||
48558004|NCT04747470|101698208|FG006|NOT COMPLETED|Overall Study||0||
48558005|NCT04747470|101698209|FG007|NOT COMPLETED|Overall Study||0||
48558006|NCT04747470|101698210|FG008|NOT COMPLETED|Overall Study||0||
48558007|NCT04747470|101698211|FG009|NOT COMPLETED|Overall Study||0||
48558008|NCT04747470|101698212|FG010|NOT COMPLETED|Overall Study||0||
48695093|NCT03718884|102038443|FG001|COMPLETED|Period 2 (120 Days)||26||
48695094|NCT03718884|102038442|FG000|NOT COMPLETED|Period 2 (120 Days)||0||
48695095|NCT03718884|102038443|FG001|NOT COMPLETED|Period 2 (120 Days)||3||
48695096|NCT01178944|102038444|FG000|STARTED|Overall Study||35||
48695097|NCT01178944|102038444|FG000|COMPLETED|Overall Study||35||
48695098|NCT01178944|102038444|FG000|NOT COMPLETED|Overall Study||0||
48695099|NCT01145001|102038445|FG000|STARTED|Overall Study||36||
48695100|NCT01145001|102038446|FG001|STARTED|Overall Study||37||
48695101|NCT01145001|102038447|FG002|STARTED|Overall Study||44||
48695102|NCT01145001|102038448|FG003|STARTED|Overall Study||37||
48695103|NCT01145001|102038445|FG000|COMPLETED|Overall Study||28||
48695104|NCT01145001|102038446|FG001|COMPLETED|Overall Study||31||
48695105|NCT01145001|102038447|FG002|COMPLETED|Overall Study||39||
48695106|NCT01145001|102038448|FG003|COMPLETED|Overall Study||31||
48558009|NCT01891864|101698213|FG000|STARTED|Treatment Period 1||264||
48558010|NCT01891864|101698214|FG001|STARTED|Treatment Period 1||267||
48558011|NCT01891864|101698215|FG002|STARTED|Treatment Period 1||0||
48695107|NCT01145001|102038445|FG000|NOT COMPLETED|Overall Study||8||
48695108|NCT01145001|102038446|FG001|NOT COMPLETED|Overall Study||6||
48558012|NCT01891864|101698216|FG003|STARTED|Treatment Period 1||0||
48558013|NCT01891864|101698217|FG004|STARTED|Treatment Period 1||0||
48558014|NCT01891864|101698218|FG005|STARTED|Treatment Period 1||0||
48273809|NCT05319912|100992213|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
48273810|NCT05319912|100992214|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3||
48273811|NCT05319912|100992215|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
48273812|NCT05319912|100992216|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3||
48273813|NCT05319912|100992217|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3||
48273814|NCT05319912|100992218|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3||
48273815|NCT05319912|100992213|FG000|COMPLETED|Overall Study||3||
48273816|NCT05319912|100992214|FG001|COMPLETED|Overall Study||3||
48273817|NCT05319912|100992215|FG002|COMPLETED|Overall Study||3||
48273818|NCT05319912|100992216|FG003|COMPLETED|Overall Study||3||
48273819|NCT05319912|100992217|FG004|COMPLETED|Overall Study||3||
48273820|NCT05319912|100992218|FG005|COMPLETED|Overall Study||3||
48273821|NCT05319912|100992213|FG000|NOT COMPLETED|Overall Study||0||
48273822|NCT05319912|100992214|FG001|NOT COMPLETED|Overall Study||0||
48273823|NCT05319912|100992215|FG002|NOT COMPLETED|Overall Study||0||
48273824|NCT05319912|100992216|FG003|NOT COMPLETED|Overall Study||0||
48273825|NCT05319912|100992217|FG004|NOT COMPLETED|Overall Study||0||
48273826|NCT05319912|100992218|FG005|NOT COMPLETED|Overall Study||0||
48273827|NCT00158197|100992219|FG000|STARTED|Overall Study||32||
48273828|NCT00158197|100992220|FG001|STARTED|Overall Study||30||
48558015|NCT01891864|101698213|FG000|COMPLETED|Treatment Period 1||256||
48558016|NCT01891864|101698214|FG001|COMPLETED|Treatment Period 1||255||
48558017|NCT01891864|101698215|FG002|COMPLETED|Treatment Period 1||0||
48273829|NCT00158197|100992221|FG002|STARTED|Overall Study||28||
48558018|NCT01891864|101698216|FG003|COMPLETED|Treatment Period 1||0||
48558019|NCT01891864|101698217|FG004|COMPLETED|Treatment Period 1||0||
48558020|NCT01891864|101698218|FG005|COMPLETED|Treatment Period 1||0||
48558021|NCT01891864|101698213|FG000|NOT COMPLETED|Treatment Period 1||8||
48558022|NCT01891864|101698214|FG001|NOT COMPLETED|Treatment Period 1||12||
48558023|NCT01891864|101698215|FG002|NOT COMPLETED|Treatment Period 1||0||
48273830|NCT00158197|100992222|FG003|STARTED|Overall Study||29||
48273831|NCT00158197|100992219|FG000|COMPLETED|Overall Study||32||
48273832|NCT00158197|100992220|FG001|COMPLETED|Overall Study||30||
48558024|NCT01891864|101698216|FG003|NOT COMPLETED|Treatment Period 1||0||
48558025|NCT01891864|101698217|FG004|NOT COMPLETED|Treatment Period 1||0||
48558026|NCT01891864|101698218|FG005|NOT COMPLETED|Treatment Period 1||0||
48558027|NCT01891864|101698213|FG000|STARTED|Treatment Period 2||0||
48558028|NCT01891864|101698214|FG001|STARTED|Treatment Period 2||0||
48558029|NCT01891864|101698215|FG002|STARTED|Treatment Period 2||150||
48558030|NCT01891864|101698216|FG003|STARTED|Treatment Period 2||151||
48558031|NCT01891864|101698217|FG004|STARTED|Treatment Period 2||100||
48558032|NCT01891864|101698218|FG005|STARTED|Treatment Period 2||96||
48558033|NCT01891864|101698213|FG000|COMPLETED|Treatment Period 2||0||
48558034|NCT01891864|101698214|FG001|COMPLETED|Treatment Period 2||0||
48273833|NCT00158197|100992221|FG002|COMPLETED|Overall Study||28||
48273834|NCT00158197|100992222|FG003|COMPLETED|Overall Study||29||
48273835|NCT00158197|100992219|FG000|NOT COMPLETED|Overall Study||0||
48273836|NCT00158197|100992220|FG001|NOT COMPLETED|Overall Study||0||
48273837|NCT00158197|100992221|FG002|NOT COMPLETED|Overall Study||0||
48273838|NCT00158197|100992222|FG003|NOT COMPLETED|Overall Study||0||
48273839|NCT00384774|100992223|FG000|STARTED|Overall Study||42||
48558035|NCT01891864|101698215|FG002|COMPLETED|Treatment Period 2||143||
48558036|NCT01891864|101698216|FG003|COMPLETED|Treatment Period 2||142||
48558037|NCT01891864|101698217|FG004|COMPLETED|Treatment Period 2||96||
48558038|NCT01891864|101698218|FG005|COMPLETED|Treatment Period 2||91||
48558039|NCT01891864|101698213|FG000|NOT COMPLETED|Treatment Period 2||0||
48558040|NCT01891864|101698214|FG001|NOT COMPLETED|Treatment Period 2||0||
48558041|NCT01891864|101698215|FG002|NOT COMPLETED|Treatment Period 2||7||
48558042|NCT01891864|101698216|FG003|NOT COMPLETED|Treatment Period 2||9||
48558043|NCT01891864|101698217|FG004|NOT COMPLETED|Treatment Period 2||4||
48558044|NCT01891864|101698218|FG005|NOT COMPLETED|Treatment Period 2||5||
48558045|NCT01891864|101698213|FG000|STARTED|Extension Period||0||
48558046|NCT01891864|101698214|FG001|STARTED|Extension Period||0||
48558047|NCT01891864|101698215|FG002|STARTED|Extension Period||140||
48558048|NCT01891864|101698216|FG003|STARTED|Extension Period||142||
48558049|NCT01891864|101698217|FG004|STARTED|Extension Period||95||
48558050|NCT01891864|101698218|FG005|STARTED|Extension Period||90||
48558051|NCT01891864|101698213|FG000|COMPLETED|Extension Period||0||
48273840|NCT00384774|100992224|FG001|STARTED|Overall Study||4||
48273841|NCT00384774|100992225|FG002|STARTED|Overall Study||12||
48273842|NCT00384774|100992226|FG003|STARTED|Overall Study||24||
48558052|NCT01891864|101698214|FG001|COMPLETED|Extension Period||0||
48558053|NCT01891864|101698215|FG002|COMPLETED|Extension Period||132||
48558054|NCT01891864|101698216|FG003|COMPLETED|Extension Period||137||
48558055|NCT01891864|101698217|FG004|COMPLETED|Extension Period||88||
48273843|NCT00384774|100992227|FG004|STARTED|Overall Study||28||
48273844|NCT00384774|100992228|FG005|STARTED|Overall Study||16||
48273845|NCT00384774|100992229|FG006|STARTED|Overall Study||4||
48273846|NCT00384774|100992223|FG000|Received at Least 1 Dose of Study Drug|Overall Study||42||
48558056|NCT01891864|101698218|FG005|COMPLETED|Extension Period||90||
48273847|NCT00384774|100992224|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4||
48273848|NCT00384774|100992225|FG002|Received at Least 1 Dose of Study Drug|Overall Study||12||
48273849|NCT00384774|100992226|FG003|Received at Least 1 Dose of Study Drug|Overall Study||24||
48273850|NCT00384774|100992227|FG004|Received at Least 1 Dose of Study Drug|Overall Study||28||
48558057|NCT01891864|101698213|FG000|NOT COMPLETED|Extension Period||0||
48558058|NCT01891864|101698214|FG001|NOT COMPLETED|Extension Period||0||
48558059|NCT01891864|101698215|FG002|NOT COMPLETED|Extension Period||8||
48558060|NCT01891864|101698216|FG003|NOT COMPLETED|Extension Period||5||
48558061|NCT01891864|101698217|FG004|NOT COMPLETED|Extension Period||7||
48558062|NCT01891864|101698218|FG005|NOT COMPLETED|Extension Period||0||
48558063|NCT02548156|101698219|FG000|STARTED|Period 1||5||
48558064|NCT02548156|101698220|FG001|STARTED|Period 1||5||
48558065|NCT02548156|101698221|FG002|STARTED|Period 1||4||
48273851|NCT00384774|100992228|FG005|Received at Least 1 Dose of Study Drug|Overall Study||16||
48273852|NCT00384774|100992229|FG006|Received at Least 1 Dose of Study Drug|Overall Study||4||
48273853|NCT00384774|100992223|FG000|COMPLETED|Overall Study||42||
48273854|NCT00384774|100992224|FG001|COMPLETED|Overall Study||4||
48273855|NCT00384774|100992225|FG002|COMPLETED|Overall Study||12||
48273856|NCT00384774|100992226|FG003|COMPLETED|Overall Study||24||
48558066|NCT02548156|101698222|FG003|STARTED|Period 1||5||
48558067|NCT02548156|101698223|FG004|STARTED|Period 1||5||
48558068|NCT02548156|101698224|FG005|STARTED|Period 1||5||
48558069|NCT02548156|101698219|FG000|COMPLETED|Period 1||5||
48558070|NCT02548156|101698220|FG001|COMPLETED|Period 1||5||
48558071|NCT02548156|101698221|FG002|COMPLETED|Period 1||4||
48558072|NCT02548156|101698222|FG003|COMPLETED|Period 1||5||
48558073|NCT02548156|101698223|FG004|COMPLETED|Period 1||5||
48273857|NCT00384774|100992227|FG004|COMPLETED|Overall Study||28||
48273858|NCT00384774|100992228|FG005|COMPLETED|Overall Study||16||
48273859|NCT00384774|100992229|FG006|COMPLETED|Overall Study||4||
48273860|NCT00384774|100992223|FG000|NOT COMPLETED|Overall Study||0||
48273861|NCT00384774|100992224|FG001|NOT COMPLETED|Overall Study||0||
48273862|NCT00384774|100992225|FG002|NOT COMPLETED|Overall Study||0||
48273863|NCT00384774|100992226|FG003|NOT COMPLETED|Overall Study||0||
48273864|NCT00384774|100992227|FG004|NOT COMPLETED|Overall Study||0||
48273865|NCT00384774|100992228|FG005|NOT COMPLETED|Overall Study||0||
48273866|NCT00384774|100992229|FG006|NOT COMPLETED|Overall Study||0||
48273867|NCT01818531|100992230|FG000|STARTED|Overall Study||75||
48273868|NCT01818531|100992231|FG001|STARTED|Overall Study||75||
48273869|NCT01818531|100992230|FG000|COMPLETED|Overall Study||74||
48273870|NCT01818531|100992231|FG001|COMPLETED|Overall Study||73||
48273871|NCT01818531|100992230|FG000|NOT COMPLETED|Overall Study||1||
48273872|NCT01818531|100992231|FG001|NOT COMPLETED|Overall Study||2||
48273873|NCT01390870|100992232|FG000|STARTED|Overall Study||400||
48273874|NCT01390870|100992232|FG000|COMPLETED|Overall Study||400||
48273875|NCT01390870|100992232|FG000|NOT COMPLETED|Overall Study||0||
48273876|NCT02224703|100992233|FG000|STARTED|Overall Study||67||
48273877|NCT02224703|100992234|FG001|STARTED|Overall Study||67||
48273878|NCT02224703|100992235|FG002|STARTED|Overall Study||65||
48273879|NCT02224703|100992233|FG000|Received at Least 1 Dose of Study Drug|Overall Study||66||
48273880|NCT02224703|100992234|FG001|Received at Least 1 Dose of Study Drug|Overall Study||67||
48273881|NCT02224703|100992235|FG002|Received at Least 1 Dose of Study Drug|Overall Study||65||
48273882|NCT02224703|100992233|FG000|Safety Analysis Set|Overall Study||64|Received at least 1 dose of study drug and analyzed as per actual treatment received|
48273883|NCT02224703|100992234|FG001|Safety Analysis Set|Overall Study||69|Received at least 1 dose of study drug and analyzed as per actual treatment received|
48273884|NCT02224703|100992235|FG002|Safety Analysis Set|Overall Study||65|Received at least 1 dose of study drug and analyzed as per actual treatment received|
48273885|NCT02224703|100992233|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||66|Randomized, received study drug, and had post-baseline efficacy data|
48273886|NCT02224703|100992234|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||67|Randomized, received study drug, and had post-baseline efficacy data|
48273887|NCT02224703|100992235|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||65|Randomized, received study drug, and had post-baseline efficacy data|
48273888|NCT02224703|100992233|FG000|COMPLETED|Overall Study||64||
48273889|NCT02224703|100992234|FG001|COMPLETED|Overall Study||61||
48273890|NCT02224703|100992235|FG002|COMPLETED|Overall Study||65||
48273891|NCT02224703|100992233|FG000|NOT COMPLETED|Overall Study||3||
48273892|NCT02224703|100992234|FG001|NOT COMPLETED|Overall Study||6||
48273893|NCT02224703|100992235|FG002|NOT COMPLETED|Overall Study||0||
48273894|NCT03560752|100992236|FG000|STARTED|Overall Study||17||
48558074|NCT02548156|101698224|FG005|COMPLETED|Period 1||5||
48558075|NCT02548156|101698219|FG000|NOT COMPLETED|Period 1||0||
48558076|NCT02548156|101698220|FG001|NOT COMPLETED|Period 1||0||
48558077|NCT02548156|101698221|FG002|NOT COMPLETED|Period 1||0||
48558078|NCT02548156|101698222|FG003|NOT COMPLETED|Period 1||0||
48273895|NCT03560752|100992237|FG001|STARTED|Overall Study||17||
48558079|NCT02548156|101698223|FG004|NOT COMPLETED|Period 1||0||
48558080|NCT02548156|101698224|FG005|NOT COMPLETED|Period 1||0||
48558081|NCT02548156|101698219|FG000|STARTED|Washout Period 1||5||
48558082|NCT02548156|101698220|FG001|STARTED|Washout Period 1||5||
48558083|NCT02548156|101698221|FG002|STARTED|Washout Period 1||4||
48558084|NCT02548156|101698222|FG003|STARTED|Washout Period 1||5||
48558085|NCT02548156|101698223|FG004|STARTED|Washout Period 1||5||
48558086|NCT02548156|101698224|FG005|STARTED|Washout Period 1||5||
48558087|NCT02548156|101698219|FG000|COMPLETED|Washout Period 1||5||
48558088|NCT02548156|101698220|FG001|COMPLETED|Washout Period 1||5||
48558089|NCT02548156|101698221|FG002|COMPLETED|Washout Period 1||4||
48558090|NCT02548156|101698222|FG003|COMPLETED|Washout Period 1||5||
48111265|NCT02365636|100598084|FG002|STARTED|Overall Study||100||
48111266|NCT02365636|100598082|FG000|Safety Population|Overall Study||100||
48111267|NCT02365636|100598083|FG001|Safety Population|Overall Study||98||
48111268|NCT02365636|100598084|FG002|Safety Population|Overall Study||100||
48111269|NCT02365636|100598082|FG000|Full Analysis Set|Overall Study||100||
48111270|NCT02365636|100598083|FG001|Full Analysis Set|Overall Study||98||
48111271|NCT02365636|100598084|FG002|Full Analysis Set|Overall Study||100||
48111272|NCT02365636|100598082|FG000|COMPLETED|Overall Study||94||
48111273|NCT02365636|100598083|FG001|COMPLETED|Overall Study||93||
48111274|NCT02365636|100598084|FG002|COMPLETED|Overall Study||97||
48111275|NCT02365636|100598082|FG000|NOT COMPLETED|Overall Study||6||
48111276|NCT02365636|100598083|FG001|NOT COMPLETED|Overall Study||7||
48111277|NCT02365636|100598084|FG002|NOT COMPLETED|Overall Study||3||
48111278|NCT02510794|100598085|FG000|STARTED|Overall Study||59||
48111279|NCT02510794|100598086|FG001|STARTED|Overall Study||62||
48111280|NCT02510794|100598087|FG002|STARTED|Overall Study||63||
48111281|NCT02510794|100598088|FG003|STARTED|Overall Study||41||
48111282|NCT02510794|100598085|FG000|COMPLETED|Overall Study||51||
48273896|NCT03560752|100992236|FG000|COMPLETED|Overall Study||17||
48393091|NCT01998438|101291505|FG000|STARTED|Overall Study||319||
48558091|NCT02548156|101698223|FG004|COMPLETED|Washout Period 1||4||
48558092|NCT02548156|101698224|FG005|COMPLETED|Washout Period 1||5||
48558093|NCT02548156|101698219|FG000|NOT COMPLETED|Washout Period 1||0||
48558094|NCT02548156|101698220|FG001|NOT COMPLETED|Washout Period 1||0||
48558095|NCT02548156|101698221|FG002|NOT COMPLETED|Washout Period 1||0||
48558096|NCT02548156|101698222|FG003|NOT COMPLETED|Washout Period 1||0||
48558097|NCT02548156|101698223|FG004|NOT COMPLETED|Washout Period 1||1||
48558098|NCT02548156|101698224|FG005|NOT COMPLETED|Washout Period 1||0||
48558099|NCT02548156|101698219|FG000|STARTED|Period 2||5||
48558100|NCT02548156|101698220|FG001|STARTED|Period 2||5||
48558101|NCT02548156|101698221|FG002|STARTED|Period 2||4||
48558102|NCT02548156|101698222|FG003|STARTED|Period 2||5||
48558103|NCT02548156|101698223|FG004|STARTED|Period 2||4||
48558104|NCT02548156|101698224|FG005|STARTED|Period 2||5||
48558105|NCT02548156|101698219|FG000|COMPLETED|Period 2||5||
48558106|NCT02548156|101698220|FG001|COMPLETED|Period 2||5||
48558107|NCT02548156|101698221|FG002|COMPLETED|Period 2||4||
48558108|NCT02548156|101698222|FG003|COMPLETED|Period 2||5||
48558109|NCT02548156|101698223|FG004|COMPLETED|Period 2||4||
48558110|NCT02548156|101698224|FG005|COMPLETED|Period 2||5||
48558111|NCT02548156|101698219|FG000|NOT COMPLETED|Period 2||0||
48558112|NCT02548156|101698220|FG001|NOT COMPLETED|Period 2||0||
48558113|NCT02548156|101698221|FG002|NOT COMPLETED|Period 2||0||
48558114|NCT02548156|101698222|FG003|NOT COMPLETED|Period 2||0||
48111283|NCT02510794|100598086|FG001|COMPLETED|Overall Study||56||
48111284|NCT02510794|100598087|FG002|COMPLETED|Overall Study||56||
48111285|NCT02510794|100598088|FG003|COMPLETED|Overall Study||36||
48111286|NCT02510794|100598085|FG000|NOT COMPLETED|Overall Study||8||
48111287|NCT02510794|100598086|FG001|NOT COMPLETED|Overall Study||6||
48111288|NCT02510794|100598087|FG002|NOT COMPLETED|Overall Study||7||
48111289|NCT02510794|100598088|FG003|NOT COMPLETED|Overall Study||5||
48111290|NCT01642238|100598089|FG000|STARTED|First Intervention (1 Day)||7||
48111291|NCT01642238|100598090|FG001|STARTED|First Intervention (1 Day)||8||
48111292|NCT01642238|100598089|FG000|COMPLETED|First Intervention (1 Day)||7||
48111293|NCT01642238|100598090|FG001|COMPLETED|First Intervention (1 Day)||8||
48111294|NCT01642238|100598089|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48111295|NCT01642238|100598090|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48111296|NCT01642238|100598089|FG000|STARTED|Washout (1-2 Weeks)||7||
48111297|NCT01642238|100598090|FG001|STARTED|Washout (1-2 Weeks)||8||
48111298|NCT01642238|100598089|FG000|COMPLETED|Washout (1-2 Weeks)||7||
48111299|NCT01642238|100598090|FG001|COMPLETED|Washout (1-2 Weeks)||8||
48111300|NCT01642238|100598089|FG000|NOT COMPLETED|Washout (1-2 Weeks)||0||
48111301|NCT01642238|100598090|FG001|NOT COMPLETED|Washout (1-2 Weeks)||0||
48111302|NCT01642238|100598089|FG000|STARTED|Second Intervention (1 Day)||7||
48111303|NCT01642238|100598090|FG001|STARTED|Second Intervention (1 Day)||8||
48111304|NCT01642238|100598089|FG000|COMPLETED|Second Intervention (1 Day)||7||
48111305|NCT01642238|100598090|FG001|COMPLETED|Second Intervention (1 Day)||8||
48111306|NCT01642238|100598089|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48111307|NCT01642238|100598090|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48273897|NCT03560752|100992237|FG001|COMPLETED|Overall Study||17||
48558115|NCT02548156|101698223|FG004|NOT COMPLETED|Period 2||0||
48558116|NCT02548156|101698224|FG005|NOT COMPLETED|Period 2||0||
48558117|NCT02548156|101698219|FG000|STARTED|Washout Period 2||5||
48558118|NCT02548156|101698220|FG001|STARTED|Washout Period 2||5||
48558119|NCT02548156|101698221|FG002|STARTED|Washout Period 2||4||
48558120|NCT02548156|101698222|FG003|STARTED|Washout Period 2||5||
48558121|NCT02548156|101698223|FG004|STARTED|Washout Period 2||4||
48558122|NCT02548156|101698224|FG005|STARTED|Washout Period 2||5||
48558123|NCT02548156|101698219|FG000|COMPLETED|Washout Period 2||5||
48558124|NCT02548156|101698220|FG001|COMPLETED|Washout Period 2||5||
48558125|NCT02548156|101698221|FG002|COMPLETED|Washout Period 2||4||
48558126|NCT02548156|101698222|FG003|COMPLETED|Washout Period 2||5||
48273898|NCT03560752|100992236|FG000|NOT COMPLETED|Overall Study||0||
48273899|NCT03560752|100992237|FG001|NOT COMPLETED|Overall Study||0||
48273900|NCT02597712|100992238|FG000|STARTED|Overall Study||13||
48273901|NCT02597712|100992239|FG001|STARTED|Overall Study||11||
48273902|NCT02597712|100992238|FG000|COMPLETED|Overall Study||10||
48273903|NCT02597712|100992239|FG001|COMPLETED|Overall Study||10||
48273904|NCT02597712|100992238|FG000|NOT COMPLETED|Overall Study||3||
48273905|NCT02597712|100992239|FG001|NOT COMPLETED|Overall Study||1||
48273906|NCT03752970|100992240|FG000|STARTED|Screening Cohort||6||
48273907|NCT03752970|100992241|FG001|STARTED|Screening Cohort||0||
48273908|NCT03752970|100992242|FG002|STARTED|Screening Cohort||0||
48273909|NCT03752970|100992240|FG000|COMPLETED|Screening Cohort||6||
48273910|NCT03752970|100992241|FG001|COMPLETED|Screening Cohort||0||
48273911|NCT03752970|100992242|FG002|COMPLETED|Screening Cohort||0||
48273912|NCT03752970|100992240|FG000|NOT COMPLETED|Screening Cohort||0||
48273913|NCT03752970|100992241|FG001|NOT COMPLETED|Screening Cohort||0||
48273914|NCT03752970|100992242|FG002|NOT COMPLETED|Screening Cohort||0||
48273915|NCT03752970|100992240|FG000|STARTED|Study Cohort Period 1 (Week 1 - <week12)||0|Subjects in the screening and study cohorts are mutually exclusive.|
48273916|NCT03752970|100992241|FG001|STARTED|Study Cohort Period 1 (Week 1 - <week12)||10|Subjects in the screening and study cohorts are mutually exclusive.|
48273917|NCT03752970|100992242|FG002|STARTED|Study Cohort Period 1 (Week 1 - <week12)||11|Subjects in the screening and study cohorts are mutually exclusive.|
48273918|NCT03752970|100992240|FG000|COMPLETED|Study Cohort Period 1 (Week 1 - <week12)||0||
48273919|NCT03752970|100992241|FG001|COMPLETED|Study Cohort Period 1 (Week 1 - <week12)||9||
48273920|NCT03752970|100992242|FG002|COMPLETED|Study Cohort Period 1 (Week 1 - <week12)||9||
48273921|NCT03752970|100992240|FG000|NOT COMPLETED|Study Cohort Period 1 (Week 1 - <week12)||0||
48273922|NCT03752970|100992241|FG001|NOT COMPLETED|Study Cohort Period 1 (Week 1 - <week12)||1||
48273923|NCT03752970|100992242|FG002|NOT COMPLETED|Study Cohort Period 1 (Week 1 - <week12)||2||
48273924|NCT03752970|100992240|FG000|STARTED|Study Cohort Week 12 Assignment||0||
48273925|NCT03752970|100992241|FG001|STARTED|Study Cohort Week 12 Assignment||9||
48273926|NCT03752970|100992242|FG002|STARTED|Study Cohort Week 12 Assignment||9||
48273927|NCT03752970|100992240|FG000|Switching Patients|Study Cohort Week 12 Assignment||0|Patients switching to Spesolimab|
48273928|NCT03752970|100992241|FG001|Switching Patients|Study Cohort Week 12 Assignment||4|Patients switching to Spesolimab|
48273929|NCT03752970|100992242|FG002|Switching Patients|Study Cohort Week 12 Assignment||0|Patients switching to Spesolimab|
48273930|NCT03752970|100992240|FG000|COMPLETED|Study Cohort Week 12 Assignment||0||
48273931|NCT03752970|100992241|FG001|COMPLETED|Study Cohort Week 12 Assignment||5||
48273932|NCT03752970|100992242|FG002|COMPLETED|Study Cohort Week 12 Assignment||9||
48273933|NCT03752970|100992240|FG000|NOT COMPLETED|Study Cohort Week 12 Assignment||0||
48273934|NCT03752970|100992241|FG001|NOT COMPLETED|Study Cohort Week 12 Assignment||4||
48273935|NCT03752970|100992242|FG002|NOT COMPLETED|Study Cohort Week 12 Assignment||0||
48273936|NCT03752970|100992240|FG000|STARTED|Study Cohort - Period 2 (>=Week 12 - 24)||0||
48273937|NCT03752970|100992241|FG001|STARTED|Study Cohort - Period 2 (>=Week 12 - 24)||5||
48273938|NCT03752970|100992242|FG002|STARTED|Study Cohort - Period 2 (>=Week 12 - 24)||13||
48273939|NCT03752970|100992240|FG000|COMPLETED|Study Cohort - Period 2 (>=Week 12 - 24)||0||
48273940|NCT03752970|100992241|FG001|COMPLETED|Study Cohort - Period 2 (>=Week 12 - 24)||5||
48558127|NCT02548156|101698223|FG004|COMPLETED|Washout Period 2||4||
48558128|NCT02548156|101698224|FG005|COMPLETED|Washout Period 2||5||
48558129|NCT02548156|101698219|FG000|NOT COMPLETED|Washout Period 2||0||
48558130|NCT02548156|101698220|FG001|NOT COMPLETED|Washout Period 2||0||
48558131|NCT02548156|101698221|FG002|NOT COMPLETED|Washout Period 2||0||
48558132|NCT02548156|101698222|FG003|NOT COMPLETED|Washout Period 2||0||
48558133|NCT02548156|101698223|FG004|NOT COMPLETED|Washout Period 2||0||
48558134|NCT02548156|101698224|FG005|NOT COMPLETED|Washout Period 2||0||
48558135|NCT02548156|101698219|FG000|STARTED|Period 3||5||
48558136|NCT02548156|101698220|FG001|STARTED|Period 3||5||
48558137|NCT02548156|101698221|FG002|STARTED|Period 3||4||
48558138|NCT02548156|101698222|FG003|STARTED|Period 3||5||
48558139|NCT02548156|101698223|FG004|STARTED|Period 3||4||
48558140|NCT02548156|101698224|FG005|STARTED|Period 3||5||
48558141|NCT02548156|101698219|FG000|COMPLETED|Period 3||5||
48558142|NCT02548156|101698220|FG001|COMPLETED|Period 3||5||
48558143|NCT02548156|101698221|FG002|COMPLETED|Period 3||4||
48558144|NCT02548156|101698222|FG003|COMPLETED|Period 3||5||
48558145|NCT02548156|101698223|FG004|COMPLETED|Period 3||4||
48273941|NCT03752970|100992242|FG002|COMPLETED|Study Cohort - Period 2 (>=Week 12 - 24)||12||
48273942|NCT03752970|100992240|FG000|NOT COMPLETED|Study Cohort - Period 2 (>=Week 12 - 24)||0||
48558146|NCT02548156|101698224|FG005|COMPLETED|Period 3||5||
48558147|NCT02548156|101698219|FG000|NOT COMPLETED|Period 3||0||
48558148|NCT02548156|101698220|FG001|NOT COMPLETED|Period 3||0||
48695109|NCT01145001|102038447|FG002|NOT COMPLETED|Overall Study||5||
48695110|NCT01145001|102038448|FG003|NOT COMPLETED|Overall Study||6||
48695111|NCT03427814|102038449|FG000|STARTED|Overall Study||71||
48695112|NCT03427814|102038450|FG001|STARTED|Overall Study||65||
48695113|NCT03427814|102038449|FG000|COMPLETED|Overall Study||0||
48695114|NCT03427814|102038450|FG001|COMPLETED|Overall Study||0||
48695115|NCT03427814|102038449|FG000|NOT COMPLETED|Overall Study||71||
48695116|NCT03427814|102038450|FG001|NOT COMPLETED|Overall Study||65||
48695117|NCT00443053|102038451|FG000|STARTED|Overall Study||1502||
48695118|NCT00443053|102038452|FG001|STARTED|Overall Study||1500||
48695119|NCT00443053|102038451|FG000|COMPLETED|Overall Study||1481||
48695120|NCT00443053|102038452|FG001|COMPLETED|Overall Study||1467||
48695121|NCT00443053|102038451|FG000|NOT COMPLETED|Overall Study||21||
48695122|NCT00443053|102038452|FG001|NOT COMPLETED|Overall Study||33||
48695123|NCT03800537|102038453|FG000|STARTED|Overall Study||14||
48695124|NCT03800537|102038453|FG000|COMPLETED|Overall Study||10||
48695125|NCT03800537|102038453|FG000|NOT COMPLETED|Overall Study||4||
48273943|NCT03752970|100992241|FG001|NOT COMPLETED|Study Cohort - Period 2 (>=Week 12 - 24)||0||
48273944|NCT03752970|100992242|FG002|NOT COMPLETED|Study Cohort - Period 2 (>=Week 12 - 24)||1||
48273945|NCT01498887|100992243|FG000|STARTED|Overall Study||200||
48273946|NCT01498887|100992244|FG001|STARTED|Overall Study||147||
48558149|NCT02548156|101698221|FG002|NOT COMPLETED|Period 3||0||
48558150|NCT02548156|101698222|FG003|NOT COMPLETED|Period 3||0||
48558151|NCT02548156|101698223|FG004|NOT COMPLETED|Period 3||0||
48558152|NCT02548156|101698224|FG005|NOT COMPLETED|Period 3||0||
48558153|NCT01071915|101698225|FG000|STARTED|Overall Study||157||
48558154|NCT01071915|101698225|FG000|Full Analysis Set (FAS)|Overall Study||155||
48273947|NCT01498887|100992243|FG000|Safety Set|Overall Study||200||
48273948|NCT01498887|100992244|FG001|Safety Set|Overall Study||147||
48273949|NCT01498887|100992243|FG000|Intent-to-treat|Overall Study||185||
48273950|NCT01498887|100992244|FG001|Intent-to-treat|Overall Study||135||
48273951|NCT01498887|100992243|FG000|COMPLETED|Overall Study||184||
48273952|NCT01498887|100992244|FG001|COMPLETED|Overall Study||136||
48273953|NCT01498887|100992243|FG000|NOT COMPLETED|Overall Study||16||
48273954|NCT01498887|100992244|FG001|NOT COMPLETED|Overall Study||11||
48273955|NCT04546425|100992245|FG000|STARTED|Overall Study||601||
48558155|NCT01071915|101698225|FG000|Safety Analysis Set|Overall Study||156||
48558156|NCT01071915|101698225|FG000|COMPLETED|Overall Study||148||
48558157|NCT01071915|101698225|FG000|NOT COMPLETED|Overall Study||9||
48558158|NCT02664181|101698226|FG000|STARTED|Overall Study||8||
48558159|NCT02664181|101698227|FG001|STARTED|Overall Study||5||
48558160|NCT02664181|101698226|FG000|COMPLETED|Overall Study||8||
48695126|NCT03158740|102038454|FG000|STARTED|Overall Study||15||
48695127|NCT03158740|102038455|FG001|STARTED|Overall Study||8||
48695128|NCT03158740|102038454|FG000|COMPLETED|Overall Study||11||
48695129|NCT03158740|102038455|FG001|COMPLETED|Overall Study||7||
48695130|NCT03158740|102038454|FG000|NOT COMPLETED|Overall Study||4||
48558161|NCT02664181|101698227|FG001|COMPLETED|Overall Study||5||
48695131|NCT03158740|102038455|FG001|NOT COMPLETED|Overall Study||1||
48695132|NCT02731820|102038456|FG000|STARTED|Overall Study||20||
48695133|NCT02731820|102038457|FG001|STARTED|Overall Study||20||
48558162|NCT02664181|101698226|FG000|NOT COMPLETED|Overall Study||0||
48558163|NCT02664181|101698227|FG001|NOT COMPLETED|Overall Study||0||
48558164|NCT02968576|101698228|FG000|STARTED|Overall Study||11||
48558165|NCT02968576|101698229|FG001|STARTED|Overall Study||14||
48558166|NCT02968576|101698228|FG000|COMPLETED|Overall Study||11||
48558167|NCT02968576|101698229|FG001|COMPLETED|Overall Study||13||
48695134|NCT02731820|102038456|FG000|COMPLETED|Overall Study||17||
48695135|NCT02731820|102038457|FG001|COMPLETED|Overall Study||18||
48695136|NCT02731820|102038456|FG000|NOT COMPLETED|Overall Study||3||
48695137|NCT02731820|102038457|FG001|NOT COMPLETED|Overall Study||2||
48695138|NCT03814382|102038458|FG000|STARTED|Overall Study||10||
48695139|NCT03814382|102038458|FG000|COMPLETED|Overall Study||10||
48695140|NCT03814382|102038458|FG000|NOT COMPLETED|Overall Study||0||
48695141|NCT04674111|102038459|FG000|STARTED|Overall Study||5||
48695142|NCT04674111|102038459|FG000|COMPLETED|Overall Study||5||
48695143|NCT04674111|102038459|FG000|NOT COMPLETED|Overall Study||0||
48695144|NCT02488135|102038460|FG000|STARTED|Overall Study||13||
48695145|NCT02488135|102038461|FG001|STARTED|Overall Study||13||
48695146|NCT02488135|102038460|FG000|COMPLETED|Overall Study||13||
48273956|NCT04546425|100992246|FG001|STARTED|Overall Study||603||
48273957|NCT04546425|100992247|FG002|STARTED|Overall Study||24||
48273958|NCT04546425|100992248|FG003|STARTED|Overall Study||27||
48273959|NCT04546425|100992245|FG000|Dose 1|Overall Study||601||
48273960|NCT04546425|100992246|FG001|Dose 1|Overall Study||603||
48273961|NCT04546425|100992247|FG002|Dose 1|Overall Study||24||
48273962|NCT04546425|100992248|FG003|Dose 1|Overall Study||27||
48273963|NCT04546425|100992245|FG000|Dose 2|Overall Study||593||
48273964|NCT04546425|100992246|FG001|Dose 2|Overall Study||598||
48273965|NCT04546425|100992247|FG002|Dose 2|Overall Study||24||
48273966|NCT04546425|100992248|FG003|Dose 2|Overall Study||27||
48558168|NCT02968576|101698228|FG000|NOT COMPLETED|Overall Study||0||
48558169|NCT02968576|101698229|FG001|NOT COMPLETED|Overall Study||1||
48558170|NCT02955212|101698230|FG000|STARTED|Period 1: Double-blind Treatment Period||169||
48695147|NCT02488135|102038461|FG001|COMPLETED|Overall Study||13||
48558171|NCT02955212|101698231|FG001|STARTED|Period 1: Double-blind Treatment Period||169||
48273967|NCT04546425|100992245|FG000|Dose 3|Overall Study||588||
48273968|NCT04546425|100992246|FG001|Dose 3|Overall Study||594||
48273969|NCT04546425|100992247|FG002|Dose 3|Overall Study||22||
48273970|NCT04546425|100992248|FG003|Dose 3|Overall Study||25||
48273971|NCT04546425|100992245|FG000|COMPLETED|Overall Study||583||
48273972|NCT04546425|100992246|FG001|COMPLETED|Overall Study||590||
48558172|NCT02955212|101698230|FG000|COMPLETED|Period 1: Double-blind Treatment Period||153|Completed Period 1 (Week 12) study drug|
48273973|NCT04546425|100992247|FG002|COMPLETED|Overall Study||22||
48273974|NCT04546425|100992248|FG003|COMPLETED|Overall Study||25||
48273975|NCT04546425|100992245|FG000|NOT COMPLETED|Overall Study||18||
48273976|NCT04546425|100992246|FG001|NOT COMPLETED|Overall Study||13||
48273977|NCT04546425|100992247|FG002|NOT COMPLETED|Overall Study||2||
48273978|NCT04546425|100992248|FG003|NOT COMPLETED|Overall Study||2||
48273979|NCT02378038|100992249|FG000|STARTED|Overall Study||5||
48273980|NCT02378038|100992249|FG000|COMPLETED|Overall Study||0||
48273981|NCT02378038|100992249|FG000|NOT COMPLETED|Overall Study||5||
48273982|NCT02088957|100992250|FG000|STARTED|Overall Study||1||
48273983|NCT02088957|100992251|FG001|STARTED|Overall Study||0||
48273984|NCT02088957|100992250|FG000|COMPLETED|Overall Study||0||
48273985|NCT02088957|100992251|FG001|COMPLETED|Overall Study||0||
48273986|NCT02088957|100992250|FG000|NOT COMPLETED|Overall Study||1||
48273987|NCT02088957|100992251|FG001|NOT COMPLETED|Overall Study||0||
48273988|NCT01877148|100992252|FG000|STARTED|Overall Study||6||
48273989|NCT01877148|100992253|FG001|STARTED|Overall Study||6||
48273990|NCT01877148|100992252|FG000|COMPLETED|Overall Study||5||
48273991|NCT01877148|100992253|FG001|COMPLETED|Overall Study||5||
48273992|NCT01877148|100992252|FG000|NOT COMPLETED|Overall Study||1||
48273993|NCT01877148|100992253|FG001|NOT COMPLETED|Overall Study||1||
48273994|NCT01607879|100992254|FG000|STARTED|Overall Study||24||
48273995|NCT01607879|100992255|FG001|STARTED|Overall Study||24||
48558173|NCT02955212|101698231|FG001|COMPLETED|Period 1: Double-blind Treatment Period||157|Completed Period 1 (Week 12) study drug|
48558174|NCT02955212|101698230|FG000|NOT COMPLETED|Period 1: Double-blind Treatment Period||16||
48558175|NCT02955212|101698231|FG001|NOT COMPLETED|Period 1: Double-blind Treatment Period||12||
48558176|NCT02955212|101698230|FG000|STARTED|Period 2: Open-label Extension||153||
48558177|NCT02955212|101698231|FG001|STARTED|Period 2: Open-label Extension||157||
48558178|NCT02955212|101698230|FG000|COMPLETED|Period 2: Open-label Extension||136||
48273996|NCT01607879|100992254|FG000|COMPLETED|Overall Study||23||
48273997|NCT01607879|100992255|FG001|COMPLETED|Overall Study||24||
48273998|NCT01607879|100992254|FG000|NOT COMPLETED|Overall Study||1||
48273999|NCT01607879|100992255|FG001|NOT COMPLETED|Overall Study||0||
48274000|NCT02097303|100992256|FG000|STARTED|Overall Study||36||
48274001|NCT02097303|100992256|FG000|COMPLETED|Overall Study||31||
48274002|NCT02097303|100992256|FG000|NOT COMPLETED|Overall Study||5||
48274003|NCT01559129|100992257|FG000|STARTED|Treatment Phase||12||
48274004|NCT01559129|100992258|FG001|STARTED|Treatment Phase||11||
48274005|NCT01559129|100992257|FG000|Received Treatment|Treatment Phase||12||
48274006|NCT01559129|100992258|FG001|Received Treatment|Treatment Phase||10||
48274007|NCT01559129|100992257|FG000|COMPLETED|Treatment Phase||7||
48274008|NCT01559129|100992258|FG001|COMPLETED|Treatment Phase||4||
48274009|NCT01559129|100992257|FG000|NOT COMPLETED|Treatment Phase||5||
48274010|NCT01559129|100992258|FG001|NOT COMPLETED|Treatment Phase||7||
48274011|NCT01559129|100992257|FG000|STARTED|Open-label Extension Period||6||
48274012|NCT01559129|100992258|FG001|STARTED|Open-label Extension Period||2||
48274013|NCT01559129|100992257|FG000|COMPLETED|Open-label Extension Period||0||
48274014|NCT01559129|100992258|FG001|COMPLETED|Open-label Extension Period||0||
48274015|NCT01559129|100992257|FG000|NOT COMPLETED|Open-label Extension Period||6||
48274016|NCT01559129|100992258|FG001|NOT COMPLETED|Open-label Extension Period||2||
48274017|NCT00515671|100992259|FG000|STARTED|Overall Study||60||
48274018|NCT00515671|100992260|FG001|STARTED|Overall Study||58||
48274019|NCT00515671|100992259|FG000|COMPLETED|Overall Study||43||
48274020|NCT00515671|100992260|FG001|COMPLETED|Overall Study||41||
48274021|NCT00515671|100992259|FG000|NOT COMPLETED|Overall Study||17||
48274022|NCT00515671|100992260|FG001|NOT COMPLETED|Overall Study||17||
48274023|NCT00542542|100992261|FG000|STARTED|Overall Study||44||
48274024|NCT00542542|100992262|FG001|STARTED|Overall Study||44||
48274025|NCT00542542|100992261|FG000|COMPLETED|Overall Study||44||
48274026|NCT00542542|100992262|FG001|COMPLETED|Overall Study||44||
48274027|NCT00542542|100992261|FG000|NOT COMPLETED|Overall Study||0||
48274028|NCT00542542|100992262|FG001|NOT COMPLETED|Overall Study||0||
48274029|NCT00974259|100992263|FG000|STARTED|Overall Study||59||
48274030|NCT00974259|100992264|FG001|STARTED|Overall Study||63||
48274031|NCT00974259|100992263|FG000|COMPLETED|Overall Study||57||
48274032|NCT00974259|100992264|FG001|COMPLETED|Overall Study||62||
48274033|NCT00974259|100992263|FG000|NOT COMPLETED|Overall Study||2||
48274034|NCT00974259|100992264|FG001|NOT COMPLETED|Overall Study||1||
48274035|NCT00283244|100992265|FG000|STARTED|Overall Study||44||
48274036|NCT00283244|100992266|FG001|STARTED|Overall Study||51||
48558179|NCT02955212|101698231|FG001|COMPLETED|Period 2: Open-label Extension||139||
48558180|NCT02955212|101698230|FG000|NOT COMPLETED|Period 2: Open-label Extension||17||
48274037|NCT00283244|100992267|FG002|STARTED|Overall Study||51||
48274038|NCT00283244|100992265|FG000|COMPLETED|Overall Study||26||
48274039|NCT00283244|100992266|FG001|COMPLETED|Overall Study||0||
48274040|NCT00283244|100992267|FG002|COMPLETED|Overall Study||0||
48274041|NCT00283244|100992265|FG000|NOT COMPLETED|Overall Study||18||
48274042|NCT00283244|100992266|FG001|NOT COMPLETED|Overall Study||51||
48274043|NCT00283244|100992267|FG002|NOT COMPLETED|Overall Study||51||
48274044|NCT00568178|100992268|FG000|STARTED|Double Blind Base Study||122||
48274045|NCT00568178|100992269|FG001|STARTED|Double Blind Base Study||124||
48274046|NCT00568178|100992270|FG002|STARTED|Double Blind Base Study||30||
48274047|NCT00568178|100992271|FG003|STARTED|Double Blind Base Study||30||
48274048|NCT00568178|100992272|FG004|STARTED|Double Blind Base Study||0||
48274049|NCT00568178|100992273|FG005|STARTED|Double Blind Base Study||0||
48274050|NCT00568178|100992268|FG000|COMPLETED|Double Blind Base Study||116||
48274051|NCT00568178|100992269|FG001|COMPLETED|Double Blind Base Study||118||
48274052|NCT00568178|100992270|FG002|COMPLETED|Double Blind Base Study||29||
48274053|NCT00568178|100992271|FG003|COMPLETED|Double Blind Base Study||25||
48274054|NCT00568178|100992272|FG004|COMPLETED|Double Blind Base Study||0||
48274055|NCT00568178|100992273|FG005|COMPLETED|Double Blind Base Study||0||
48274056|NCT00568178|100992268|FG000|NOT COMPLETED|Double Blind Base Study||6||
48274057|NCT00568178|100992269|FG001|NOT COMPLETED|Double Blind Base Study||6||
48274058|NCT00568178|100992270|FG002|NOT COMPLETED|Double Blind Base Study||1||
48274059|NCT00568178|100992271|FG003|NOT COMPLETED|Double Blind Base Study||5||
48274060|NCT00568178|100992272|FG004|NOT COMPLETED|Double Blind Base Study||0||
48274061|NCT00568178|100992273|FG005|NOT COMPLETED|Double Blind Base Study||0||
48274062|NCT00568178|100992268|FG000|STARTED|Open Label Extension||0||
48274063|NCT00568178|100992269|FG001|STARTED|Open Label Extension||0||
48274064|NCT00568178|100992270|FG002|STARTED|Open Label Extension||0||
48274065|NCT00568178|100992271|FG003|STARTED|Open Label Extension||0||
48274066|NCT00568178|100992272|FG004|STARTED|Open Label Extension||134||
48274067|NCT00568178|100992273|FG005|STARTED|Open Label Extension||134||
48274068|NCT00568178|100992268|FG000|COMPLETED|Open Label Extension||0||
48274069|NCT00568178|100992269|FG001|COMPLETED|Open Label Extension||0||
48274070|NCT00568178|100992270|FG002|COMPLETED|Open Label Extension||0||
48274071|NCT00568178|100992271|FG003|COMPLETED|Open Label Extension||0||
48274072|NCT00568178|100992272|FG004|COMPLETED|Open Label Extension||55||
48558181|NCT02955212|101698231|FG001|NOT COMPLETED|Period 2: Open-label Extension||18||
48558182|NCT00927589|101698232|FG000|STARTED|Overall Study||59||
48558183|NCT00927589|101698232|FG000|COMPLETED|Overall Study||43||
48558184|NCT00927589|101698232|FG000|NOT COMPLETED|Overall Study||16||
48558185|NCT02144714|101698233|FG000|STARTED|Overall Study||63||
48558186|NCT02144714|101698234|FG001|STARTED|Overall Study||63||
48558187|NCT02144714|101698235|FG002|STARTED|Overall Study||63||
48274073|NCT00568178|100992273|FG005|COMPLETED|Open Label Extension||54||
48274074|NCT00568178|100992268|FG000|NOT COMPLETED|Open Label Extension||0||
48274075|NCT00568178|100992269|FG001|NOT COMPLETED|Open Label Extension||0||
48274076|NCT00568178|100992270|FG002|NOT COMPLETED|Open Label Extension||0||
48274077|NCT00568178|100992271|FG003|NOT COMPLETED|Open Label Extension||0||
48274078|NCT00568178|100992272|FG004|NOT COMPLETED|Open Label Extension||79||
48274079|NCT00568178|100992273|FG005|NOT COMPLETED|Open Label Extension||80||
48274080|NCT00635661|100992274|FG000|STARTED|Overall Study||34||
48274081|NCT00635661|100992274|FG000|COMPLETED|Overall Study||30||
48558188|NCT02144714|101698233|FG000|COMPLETED|Overall Study||63||
48558189|NCT02144714|101698234|FG001|COMPLETED|Overall Study||63||
48558190|NCT02144714|101698235|FG002|COMPLETED|Overall Study||63||
48558191|NCT02144714|101698233|FG000|NOT COMPLETED|Overall Study||0||
48558192|NCT02144714|101698234|FG001|NOT COMPLETED|Overall Study||0||
48558193|NCT02144714|101698235|FG002|NOT COMPLETED|Overall Study||0||
48558194|NCT00610129|101698236|FG000|STARTED|Overall Study||28||
48558195|NCT00610129|101698236|FG000|COMPLETED|Overall Study||25||
48558196|NCT00610129|101698236|FG000|NOT COMPLETED|Overall Study||3||
48558197|NCT02696291|101698237|FG000|STARTED|Overall Study||5||
48558198|NCT02696291|101698238|FG001|STARTED|Overall Study||2||
48558199|NCT02696291|101698237|FG000|COMPLETED|Overall Study||5||
48558200|NCT02696291|101698238|FG001|COMPLETED|Overall Study||2||
48558201|NCT02696291|101698237|FG000|NOT COMPLETED|Overall Study||0||
48558202|NCT02696291|101698238|FG001|NOT COMPLETED|Overall Study||0||
48558203|NCT00567008|101698239|FG000|STARTED|Overall Study||18||
48558204|NCT00567008|101698240|FG001|STARTED|Overall Study||19||
48558205|NCT00567008|101698239|FG000|COMPLETED|Overall Study||17||
48558206|NCT00567008|101698240|FG001|COMPLETED|Overall Study||18||
48558207|NCT00567008|101698239|FG000|NOT COMPLETED|Overall Study||1||
48558208|NCT00567008|101698240|FG001|NOT COMPLETED|Overall Study||1||
48558209|NCT02932462|101698241|FG000|STARTED|Overall Study||184||
48558210|NCT02932462|101698242|FG001|STARTED|Overall Study||189||
48558211|NCT02932462|101698241|FG000|COMPLETED|Overall Study||177||
48558212|NCT02932462|101698242|FG001|COMPLETED|Overall Study||176||
48558213|NCT02932462|101698241|FG000|NOT COMPLETED|Overall Study||7||
48558214|NCT02932462|101698242|FG001|NOT COMPLETED|Overall Study||13||
48558215|NCT00268450|101698243|FG000|STARTED|Overall Study||21||
48558216|NCT00268450|101698243|FG000|COMPLETED|Overall Study||21||
48558217|NCT00268450|101698243|FG000|NOT COMPLETED|Overall Study||0||
48558218|NCT01530464|101698244|FG000|STARTED|First Intervention (24h)||10||
48558219|NCT01530464|101698245|FG001|STARTED|First Intervention (24h)||8||
48558220|NCT01530464|101698244|FG000|COMPLETED|First Intervention (24h)||10||
48558221|NCT01530464|101698245|FG001|COMPLETED|First Intervention (24h)||8||
48558222|NCT01530464|101698244|FG000|NOT COMPLETED|First Intervention (24h)||0||
48558223|NCT01530464|101698245|FG001|NOT COMPLETED|First Intervention (24h)||0||
48558224|NCT01530464|101698244|FG000|STARTED|Washout (24h)||10||
48558225|NCT01530464|101698245|FG001|STARTED|Washout (24h)||8||
48558226|NCT01530464|101698244|FG000|COMPLETED|Washout (24h)||10||
48558227|NCT01530464|101698245|FG001|COMPLETED|Washout (24h)||8||
48558228|NCT01530464|101698244|FG000|NOT COMPLETED|Washout (24h)||0||
48558229|NCT01530464|101698245|FG001|NOT COMPLETED|Washout (24h)||0||
48558230|NCT01530464|101698244|FG000|STARTED|Second Intervention (24h)||10||
48558231|NCT01530464|101698245|FG001|STARTED|Second Intervention (24h)||8||
48558232|NCT01530464|101698244|FG000|COMPLETED|Second Intervention (24h)||10||
48558233|NCT01530464|101698245|FG001|COMPLETED|Second Intervention (24h)||8||
48558234|NCT01530464|101698244|FG000|NOT COMPLETED|Second Intervention (24h)||0||
48558235|NCT01530464|101698245|FG001|NOT COMPLETED|Second Intervention (24h)||0||
48558236|NCT01530464|101698244|FG000|STARTED|Washout (24h)||10||
48558237|NCT01530464|101698245|FG001|STARTED|Washout (24h)||8||
48558238|NCT01530464|101698244|FG000|COMPLETED|Washout (24h)||9||
48558239|NCT01530464|101698245|FG001|COMPLETED|Washout (24h)||8||
48558240|NCT01530464|101698244|FG000|NOT COMPLETED|Washout (24h)||1||
48558241|NCT01530464|101698245|FG001|NOT COMPLETED|Washout (24h)||0||
48558242|NCT01530464|101698244|FG000|STARTED|Third Intervention (24h)||9||
48558243|NCT01530464|101698245|FG001|STARTED|Third Intervention (24h)||8||
48558244|NCT01530464|101698244|FG000|COMPLETED|Third Intervention (24h)||9||
48558245|NCT01530464|101698245|FG001|COMPLETED|Third Intervention (24h)||8||
48558246|NCT01530464|101698244|FG000|NOT COMPLETED|Third Intervention (24h)||0||
48558247|NCT01530464|101698245|FG001|NOT COMPLETED|Third Intervention (24h)||0||
48558248|NCT01530464|101698244|FG000|STARTED|Washout (24h)||9||
48558249|NCT01530464|101698245|FG001|STARTED|Washout (24h)||8||
48558250|NCT01530464|101698244|FG000|COMPLETED|Washout (24h)||9||
48558251|NCT01530464|101698245|FG001|COMPLETED|Washout (24h)||7||
48558252|NCT01530464|101698244|FG000|NOT COMPLETED|Washout (24h)||0||
48558253|NCT01530464|101698245|FG001|NOT COMPLETED|Washout (24h)||1||
48558254|NCT01403051|101698246|FG000|STARTED|Overall Study||81||
48558255|NCT01403051|101698247|FG001|STARTED|Overall Study||86||
48558256|NCT01403051|101698246|FG000|Initiated Study Treatment|Overall Study||81||
48558257|NCT01403051|101698247|FG001|Initiated Study Treatment|Overall Study||86||
48558258|NCT01403051|101698246|FG000|COMPLETED|Overall Study||71||
48558259|NCT01403051|101698247|FG001|COMPLETED|Overall Study||80||
48558260|NCT01403051|101698246|FG000|NOT COMPLETED|Overall Study||10||
48558261|NCT01403051|101698247|FG001|NOT COMPLETED|Overall Study||6||
48558262|NCT03367819|101698248|FG000|STARTED|Overall Study||24||
48558263|NCT03367819|101698249|FG001|STARTED|Overall Study||20||
48558264|NCT03367819|101698248|FG000|COMPLETED|Overall Study||0||
48558265|NCT03367819|101698249|FG001|COMPLETED|Overall Study||1||
48558266|NCT03367819|101698248|FG000|NOT COMPLETED|Overall Study||24||
48558267|NCT03367819|101698249|FG001|NOT COMPLETED|Overall Study||19||
48558268|NCT02811965|101698250|FG000|STARTED|Overall Study||21||
48558269|NCT02811965|101698250|FG000|COMPLETED|Overall Study||21||
48558270|NCT02811965|101698250|FG000|NOT COMPLETED|Overall Study||0||
48558271|NCT01215136|101698251|FG000|STARTED|Overall Study||7||
48558272|NCT01215136|101698252|FG001|STARTED|Overall Study||29||
48558273|NCT01215136|101698251|FG000|COMPLETED|Overall Study||1||
48558274|NCT01215136|101698252|FG001|COMPLETED|Overall Study||2||
48558275|NCT01215136|101698251|FG000|NOT COMPLETED|Overall Study||6||
48558276|NCT01215136|101698252|FG001|NOT COMPLETED|Overall Study||27||
48558277|NCT04709562|101698253|FG000|STARTED|Overall Study||36||
48558278|NCT04709562|101698254|FG001|STARTED|Overall Study||32||
48558279|NCT04709562|101698253|FG000|COMPLETED|Overall Study||36||
48558280|NCT04709562|101698254|FG001|COMPLETED|Overall Study||32||
48558281|NCT04709562|101698253|FG000|NOT COMPLETED|Overall Study||0||
48558282|NCT04709562|101698254|FG001|NOT COMPLETED|Overall Study||0||
48558283|NCT00879086|101698255|FG000|STARTED|Overall Study||52||
48558284|NCT00879086|101698256|FG001|STARTED|Overall Study||52||
48558285|NCT00879086|101698255|FG000|Safety Analysis Set (SAS)|Overall Study||51||
48558286|NCT00879086|101698256|FG001|Safety Analysis Set (SAS)|Overall Study||50||
48558287|NCT00879086|101698255|FG000|COMPLETED|Overall Study||0||
48558288|NCT00879086|101698256|FG001|COMPLETED|Overall Study||0||
48558289|NCT00879086|101698255|FG000|NOT COMPLETED|Overall Study||52||
48558290|NCT00879086|101698256|FG001|NOT COMPLETED|Overall Study||52||
48558291|NCT03860974|101698257|FG000|STARTED|Overall Study||49||
48558292|NCT03860974|101698258|FG001|STARTED|Overall Study||51||
48695148|NCT02488135|102038460|FG000|NOT COMPLETED|Overall Study||0||
48695149|NCT02488135|102038461|FG001|NOT COMPLETED|Overall Study||0||
48695150|NCT03478254|102038462|FG000|STARTED|Overall Study||300||
48558293|NCT03860974|101698257|FG000|COMPLETED|Overall Study||49||
48558294|NCT03860974|101698258|FG001|COMPLETED|Overall Study||51||
48558295|NCT03860974|101698257|FG000|NOT COMPLETED|Overall Study||0||
48558296|NCT03860974|101698258|FG001|NOT COMPLETED|Overall Study||0||
48558297|NCT03982511|101698259|FG000|STARTED|Overall Study||41||
48558298|NCT03982511|101698260|FG001|STARTED|Overall Study||18||
48558299|NCT03982511|101698259|FG000|COMPLETED|Overall Study||30||
48558300|NCT03982511|101698260|FG001|COMPLETED|Overall Study||15||
48558301|NCT03982511|101698259|FG000|NOT COMPLETED|Overall Study||11||
48558302|NCT03982511|101698260|FG001|NOT COMPLETED|Overall Study||3||
48558303|NCT02500589|101698261|FG000|STARTED|Overall Study||175||
48695151|NCT03478254|102038462|FG000|COMPLETED|Overall Study||300||
48695152|NCT03478254|102038462|FG000|NOT COMPLETED|Overall Study||0||
48695153|NCT00316706|102038463|FG000|STARTED|Overall Study||626||
48695154|NCT00316706|102038464|FG001|STARTED|Overall Study||619||
48695155|NCT00316706|102038463|FG000|COMPLETED|Overall Study||588||
48695156|NCT00316706|102038464|FG001|COMPLETED|Overall Study||571||
48695157|NCT00316706|102038463|FG000|NOT COMPLETED|Overall Study||38||
48695158|NCT00316706|102038464|FG001|NOT COMPLETED|Overall Study||48||
48695159|NCT04699032|102038465|FG000|STARTED|Overall Study||8||
48695160|NCT04699032|102038466|FG001|STARTED|Overall Study||8||
48695161|NCT04699032|102038465|FG000|COMPLETED|Overall Study||8||
48558304|NCT02500589|101698262|FG001|STARTED|Overall Study||175||
48558305|NCT02500589|101698261|FG000|COMPLETED|Overall Study||147||
48558306|NCT02500589|101698262|FG001|COMPLETED|Overall Study||143||
48558307|NCT02500589|101698261|FG000|NOT COMPLETED|Overall Study||28||
48558308|NCT02500589|101698262|FG001|NOT COMPLETED|Overall Study||32||
48558309|NCT01214655|101698263|FG000|STARTED|Part A||10||
48558310|NCT01214655|101698264|FG001|STARTED|Part A||0||
48558311|NCT01214655|101698265|FG002|STARTED|Part A||0||
48558312|NCT01214655|101698263|FG000|Received 2 mg Study Drug|Part A||3||
48558313|NCT01214655|101698264|FG001|Received 2 mg Study Drug|Part A||0||
48558314|NCT01214655|101698265|FG002|Received 2 mg Study Drug|Part A||0||
48695162|NCT04699032|102038466|FG001|COMPLETED|Overall Study||8||
48274082|NCT00635661|100992274|FG000|NOT COMPLETED|Overall Study||4||
48274083|NCT03846453|100992275|FG000|STARTED|Placebo Run-in (14 Days)||1108||
48274084|NCT03846453|100992276|FG001|STARTED|Placebo Run-in (14 Days)||0||
48274085|NCT03846453|100992277|FG002|STARTED|Placebo Run-in (14 Days)||0||
48274086|NCT03846453|100992275|FG000|COMPLETED|Placebo Run-in (14 Days)||637||
48274087|NCT03846453|100992276|FG001|COMPLETED|Placebo Run-in (14 Days)||0||
48274088|NCT03846453|100992277|FG002|COMPLETED|Placebo Run-in (14 Days)||0||
48274089|NCT03846453|100992275|FG000|NOT COMPLETED|Placebo Run-in (14 Days)||471||
48274090|NCT03846453|100992276|FG001|NOT COMPLETED|Placebo Run-in (14 Days)||0||
48274091|NCT03846453|100992277|FG002|NOT COMPLETED|Placebo Run-in (14 Days)||0||
48274092|NCT03846453|100992275|FG000|STARTED|Randomized Treatment Period (Days 57±3)||0||
48274093|NCT03846453|100992276|FG001|STARTED|Randomized Treatment Period (Days 57±3)||318||
48274094|NCT03846453|100992277|FG002|STARTED|Randomized Treatment Period (Days 57±3)||319||
48274095|NCT03846453|100992275|FG000|COMPLETED|Randomized Treatment Period (Days 57±3)||0||
48558315|NCT01214655|101698263|FG000|Escalated From 2 to 4 mg/m²/Day|Part A||3||
48558316|NCT01214655|101698264|FG001|Escalated From 2 to 4 mg/m²/Day|Part A||0||
48558317|NCT01214655|101698265|FG002|Escalated From 2 to 4 mg/m²/Day|Part A||0||
48558318|NCT01214655|101698263|FG000|Joined 4 mg Group|Part A||1|4 participants received 4 mg/m²/day|
48558319|NCT01214655|101698264|FG001|Joined 4 mg Group|Part A||0|4 participants received 4 mg/m²/day|
48558320|NCT01214655|101698265|FG002|Joined 4 mg Group|Part A||0|4 participants received 4 mg/m²/day|
48558321|NCT01214655|101698263|FG000|Escalated From 4 mg Study Drug|Part A||0||
48558322|NCT01214655|101698264|FG001|Escalated From 4 mg Study Drug|Part A||0||
48558323|NCT01214655|101698265|FG002|Escalated From 4 mg Study Drug|Part A||0||
48558324|NCT01214655|101698263|FG000|Joined 5 mg Study Drug|Part A||2|2 participants received 5 mg/m²/day|
48558325|NCT01214655|101698264|FG001|Joined 5 mg Study Drug|Part A||0|2 participants received 5 mg/m²/day|
48558326|NCT01214655|101698265|FG002|Joined 5 mg Study Drug|Part A||0|2 participants received 5 mg/m²/day|
48558327|NCT01214655|101698263|FG000|Escalated From 5 mg Study Drug|Part A||1||
48558328|NCT01214655|101698264|FG001|Escalated From 5 mg Study Drug|Part A||0||
48558329|NCT01214655|101698265|FG002|Escalated From 5 mg Study Drug|Part A||0||
48558330|NCT01214655|101698263|FG000|Joined 6 mg Group|Part A||4||
48558331|NCT01214655|101698264|FG001|Joined 6 mg Group|Part A||0||
48558332|NCT01214655|101698265|FG002|Joined 6 mg Group|Part A||0||
48558333|NCT01214655|101698263|FG000|Received 6 mg Study Drug|Part A||5||
48558334|NCT01214655|101698264|FG001|Received 6 mg Study Drug|Part A||0||
48558335|NCT01214655|101698265|FG002|Received 6 mg Study Drug|Part A||0||
48558336|NCT01214655|101698263|FG000|COMPLETED|Part A||2||
48558337|NCT01214655|101698264|FG001|COMPLETED|Part A||0||
48558338|NCT01214655|101698265|FG002|COMPLETED|Part A||0||
48558339|NCT01214655|101698263|FG000|NOT COMPLETED|Part A||8||
48695163|NCT04699032|102038465|FG000|NOT COMPLETED|Overall Study||0||
48695164|NCT04699032|102038466|FG001|NOT COMPLETED|Overall Study||0||
48695165|NCT03657134|102038467|FG000|STARTED|Overall Study||20||
48695166|NCT03657134|102038467|FG000|COMPLETED|Overall Study||20||
48695167|NCT03657134|102038467|FG000|NOT COMPLETED|Overall Study||0||
48695168|NCT00632827|102038468|FG000|STARTED|Overall Study||21||
48695169|NCT00632827|102038468|FG000|Received GVD|Overall Study||21||
48695170|NCT00632827|102038468|FG000|Received M-CHOP|Overall Study||18||
48695171|NCT00632827|102038468|FG000|Evaluated Post Stem Cell Transplant|Overall Study||16||
48695172|NCT00632827|102038468|FG000|COMPLETED|Overall Study||11||
48695173|NCT00632827|102038468|FG000|NOT COMPLETED|Overall Study||10||
48695174|NCT00294671|102038469|FG000|STARTED|Overall Study||64||
48695175|NCT00294671|102038470|FG001|STARTED|Overall Study||66||
48695176|NCT00294671|102038469|FG000|COMPLETED|Overall Study||37||
48695177|NCT00294671|102038470|FG001|COMPLETED|Overall Study||26||
48695178|NCT00294671|102038469|FG000|NOT COMPLETED|Overall Study||27||
48695179|NCT00294671|102038470|FG001|NOT COMPLETED|Overall Study||40||
48695180|NCT02547038|102038471|FG000|STARTED|Overall Study||176||
48695181|NCT02547038|102038472|FG001|STARTED|Overall Study||176||
48695182|NCT02547038|102038471|FG000|COMPLETED|Overall Study||173||
48695183|NCT02547038|102038472|FG001|COMPLETED|Overall Study||174||
48695184|NCT02547038|102038471|FG000|NOT COMPLETED|Overall Study||3||
48695185|NCT02547038|102038472|FG001|NOT COMPLETED|Overall Study||2||
48695186|NCT01534351|102038473|FG000|STARTED|Overall Study||1||
48695187|NCT01534351|102038474|FG001|STARTED|Overall Study||0||
48695188|NCT01534351|102038475|FG002|STARTED|Overall Study||0||
48695189|NCT01534351|102038473|FG000|COMPLETED|Overall Study||0||
48695190|NCT01534351|102038474|FG001|COMPLETED|Overall Study||0||
48695191|NCT01534351|102038475|FG002|COMPLETED|Overall Study||0||
48695192|NCT01534351|102038473|FG000|NOT COMPLETED|Overall Study||1||
48695193|NCT01534351|102038474|FG001|NOT COMPLETED|Overall Study||0||
48695194|NCT01534351|102038475|FG002|NOT COMPLETED|Overall Study||0||
48695195|NCT03594747|102038476|FG000|STARTED|Overall Study||120||
48695196|NCT03594747|102038477|FG001|STARTED|Overall Study||119||
48695197|NCT03594747|102038478|FG002|STARTED|Overall Study||121||
48695198|NCT03594747|102038476|FG000|Randomized But Not Treated|Overall Study||0||
48695199|NCT03594747|102038477|FG001|Randomized But Not Treated|Overall Study||1||
48695200|NCT03594747|102038478|FG002|Randomized But Not Treated|Overall Study||4||
48695201|NCT03594747|102038476|FG000|COMPLETED|Overall Study||0||
48695202|NCT03594747|102038477|FG001|COMPLETED|Overall Study||0||
48558340|NCT01214655|101698264|FG001|NOT COMPLETED|Part A||0||
48558341|NCT01214655|101698265|FG002|NOT COMPLETED|Part A||0||
48558342|NCT01214655|101698263|FG000|STARTED|Part B||0||
48558343|NCT01214655|101698264|FG001|STARTED|Part B||15||
48558344|NCT01214655|101698265|FG002|STARTED|Part B||0||
48558345|NCT01214655|101698263|FG000|Received at Least 1 Dose of Study Drug|Part B||0||
48558346|NCT01214655|101698264|FG001|Received at Least 1 Dose of Study Drug|Part B||15||
48558347|NCT01214655|101698265|FG002|Received at Least 1 Dose of Study Drug|Part B||0||
48558348|NCT01214655|101698263|FG000|Recieved 8 mg/m²/Day Study Drug|Part B||0||
48558349|NCT01214655|101698264|FG001|Recieved 8 mg/m²/Day Study Drug|Part B||4||
48558350|NCT01214655|101698265|FG002|Recieved 8 mg/m²/Day Study Drug|Part B||0||
48558351|NCT01214655|101698263|FG000|Escalated From 8 to 10 mg/m²/Day|Part B||0||
48558352|NCT01214655|101698264|FG001|Escalated From 8 to 10 mg/m²/Day|Part B||2||
48558353|NCT01214655|101698265|FG002|Escalated From 8 to 10 mg/m²/Day|Part B||0||
48558354|NCT01214655|101698263|FG000|Joined 10 mg/m²/Day Study D|Part B||0|5 participants received 10 mg/m²/day Study Drug|
48695203|NCT03594747|102038478|FG002|COMPLETED|Overall Study||0||
48695204|NCT03594747|102038476|FG000|NOT COMPLETED|Overall Study||120||
48695205|NCT03594747|102038477|FG001|NOT COMPLETED|Overall Study||119||
48695206|NCT03594747|102038478|FG002|NOT COMPLETED|Overall Study||121||
48695207|NCT02482428|102038479|FG000|STARTED|Overall Study||24||
48695208|NCT02482428|102038480|FG001|STARTED|Overall Study||22||
48695209|NCT02482428|102038481|FG002|STARTED|Overall Study||10||
48695210|NCT02482428|102038482|FG003|STARTED|Overall Study||10||
48695211|NCT02482428|102038483|FG004|STARTED|Overall Study||22||
48558355|NCT01214655|101698264|FG001|Joined 10 mg/m²/Day Study D|Part B||3|5 participants received 10 mg/m²/day Study Drug|
48695212|NCT02482428|102038479|FG000|COMPLETED|Overall Study||15||
48695213|NCT02482428|102038480|FG001|COMPLETED|Overall Study||10||
48695214|NCT02482428|102038481|FG002|COMPLETED|Overall Study||9||
48695215|NCT02482428|102038482|FG003|COMPLETED|Overall Study||8||
48695216|NCT02482428|102038483|FG004|COMPLETED|Overall Study||15||
48695217|NCT02482428|102038479|FG000|NOT COMPLETED|Overall Study||9||
48695218|NCT02482428|102038480|FG001|NOT COMPLETED|Overall Study||12||
48695219|NCT02482428|102038481|FG002|NOT COMPLETED|Overall Study||1||
48695220|NCT02482428|102038482|FG003|NOT COMPLETED|Overall Study||2||
48695221|NCT02482428|102038483|FG004|NOT COMPLETED|Overall Study||7||
48695222|NCT00960401|102038484|FG000|STARTED|Overall Study||9||
48558356|NCT01214655|101698265|FG002|Joined 10 mg/m²/Day Study D|Part B||0|5 participants received 10 mg/m²/day Study Drug|
48558357|NCT01214655|101698263|FG000|Escalated to 12 mg/m²/Day|Part B||0||
48558358|NCT01214655|101698264|FG001|Escalated to 12 mg/m²/Day|Part B||2||
48558359|NCT01214655|101698265|FG002|Escalated to 12 mg/m²/Day|Part B||0||
48558360|NCT01214655|101698263|FG000|Joined 12 mg/m²/Day|Part B||0|7 participants received 12 mg/m²/day Study Drug|
48558361|NCT01214655|101698264|FG001|Joined 12 mg/m²/Day|Part B||5|7 participants received 12 mg/m²/day Study Drug|
48558362|NCT01214655|101698265|FG002|Joined 12 mg/m²/Day|Part B||0|7 participants received 12 mg/m²/day Study Drug|
48558363|NCT01214655|101698263|FG000|Escalated From 12 to 14 mg/m²/Day|Part B||0||
48558364|NCT01214655|101698264|FG001|Escalated From 12 to 14 mg/m²/Day|Part B||1||
48558365|NCT01214655|101698265|FG002|Escalated From 12 to 14 mg/m²/Day|Part B||0||
48558366|NCT01214655|101698263|FG000|Joined 14 mg/m²/Day|Part B||0|4 participants received 14 mg/m²/day Study Drug|
48558367|NCT01214655|101698264|FG001|Joined 14 mg/m²/Day|Part B||3|4 participants received 14 mg/m²/day Study Drug|
48558368|NCT01214655|101698265|FG002|Joined 14 mg/m²/Day|Part B||0|4 participants received 14 mg/m²/day Study Drug|
48558369|NCT01214655|101698263|FG000|COMPLETED|Part B||0||
48558370|NCT01214655|101698264|FG001|COMPLETED|Part B||2||
48558371|NCT01214655|101698265|FG002|COMPLETED|Part B||0||
48558372|NCT01214655|101698263|FG000|NOT COMPLETED|Part B||0||
48558373|NCT01214655|101698264|FG001|NOT COMPLETED|Part B||13||
48558374|NCT01214655|101698265|FG002|NOT COMPLETED|Part B||0||
48558375|NCT01214655|101698263|FG000|STARTED|Part C||0||
48558376|NCT01214655|101698264|FG001|STARTED|Part C||0||
48558377|NCT01214655|101698265|FG002|STARTED|Part C||8||
48558378|NCT01214655|101698263|FG000|Received at Least 1 Dose of 5 mg/m²/Day|Part C||0||
48558379|NCT01214655|101698264|FG001|Received at Least 1 Dose of 5 mg/m²/Day|Part C||0||
48558380|NCT01214655|101698265|FG002|Received at Least 1 Dose of 5 mg/m²/Day|Part C||8||
48558381|NCT01214655|101698263|FG000|COMPLETED|Part C||0||
48558382|NCT01214655|101698264|FG001|COMPLETED|Part C||0||
48558383|NCT01214655|101698265|FG002|COMPLETED|Part C||1||
48558384|NCT01214655|101698263|FG000|NOT COMPLETED|Part C||0||
48558385|NCT01214655|101698264|FG001|NOT COMPLETED|Part C||0||
48558386|NCT01214655|101698265|FG002|NOT COMPLETED|Part C||7||
48558387|NCT01328184|101698266|FG000|STARTED|Overall Study||18||
48558388|NCT01328184|101698266|FG000|COMPLETED|Overall Study||18||
48558389|NCT01328184|101698266|FG000|NOT COMPLETED|Overall Study||0||
48558390|NCT03871543|101698267|FG000|STARTED|Period 1||184||
48558391|NCT03871543|101698267|FG000|COMPLETED|Period 1||48||
48558392|NCT03871543|101698267|FG000|NOT COMPLETED|Period 1||136||
48558393|NCT03871543|101698267|FG000|STARTED|Period 2||48||
48558394|NCT03871543|101698267|FG000|COMPLETED|Period 2||46||
48558395|NCT03871543|101698267|FG000|NOT COMPLETED|Period 2||2||
48558396|NCT01213966|101698268|FG000|STARTED|Overall Study||20||
48558397|NCT01213966|101698269|FG001|STARTED|Overall Study||20||
48558398|NCT01213966|101698270|FG002|STARTED|Overall Study||20||
48558399|NCT01213966|101698271|FG003|STARTED|Overall Study||21||
48558400|NCT01213966|101698268|FG000|COMPLETED|Overall Study||19||
48558401|NCT01213966|101698269|FG001|COMPLETED|Overall Study||20||
48558402|NCT01213966|101698270|FG002|COMPLETED|Overall Study||17||
48558403|NCT01213966|101698271|FG003|COMPLETED|Overall Study||20||
48558404|NCT01213966|101698268|FG000|NOT COMPLETED|Overall Study||1||
48558405|NCT01213966|101698269|FG001|NOT COMPLETED|Overall Study||0||
48558406|NCT01213966|101698270|FG002|NOT COMPLETED|Overall Study||3||
48558407|NCT01213966|101698271|FG003|NOT COMPLETED|Overall Study||1||
48558408|NCT03832686|101698272|FG000|STARTED|Overall Study||44||
48558409|NCT03832686|101698273|FG001|STARTED|Overall Study||47||
48558410|NCT03832686|101698272|FG000|COMPLETED|Overall Study||33||
48558411|NCT03832686|101698273|FG001|COMPLETED|Overall Study||34||
48558412|NCT03832686|101698272|FG000|NOT COMPLETED|Overall Study||11||
48558413|NCT03832686|101698273|FG001|NOT COMPLETED|Overall Study||13||
48558414|NCT01197534|101698274|FG000|STARTED|Overall Study||308||
48558415|NCT01197534|101698275|FG001|STARTED|Overall Study||298||
48558416|NCT01197534|101698276|FG002|STARTED|Overall Study||302||
48558417|NCT01197534|101698274|FG000|Randomised But Did Not Receive Treatment|Overall Study||0||
48558418|NCT01197534|101698275|FG001|Randomised But Did Not Receive Treatment|Overall Study||2||
48558419|NCT01197534|101698276|FG002|Randomised But Did Not Receive Treatment|Overall Study||3||
48558420|NCT01197534|101698274|FG000|COMPLETED|Overall Study||174||
48558421|NCT01197534|101698275|FG001|COMPLETED|Overall Study||168||
48558422|NCT01197534|101698276|FG002|COMPLETED|Overall Study||129||
48558423|NCT01197534|101698274|FG000|NOT COMPLETED|Overall Study||134||
48558424|NCT01197534|101698275|FG001|NOT COMPLETED|Overall Study||130||
48558425|NCT01197534|101698276|FG002|NOT COMPLETED|Overall Study||173||
48558426|NCT00266279|101698277|FG000|STARTED|Overall Study||17||
48558427|NCT00266279|101698277|FG000|COMPLETED|Overall Study||15||
48558428|NCT00266279|101698277|FG000|NOT COMPLETED|Overall Study||2||
48558429|NCT03207776|101698278|FG000|STARTED|Overall Study||2479|All patients with the diagnosis were to receive the intervention|
48558430|NCT03207776|101698279|FG001|STARTED|Overall Study||2353|All patients with the diagnosis were to receive the intervention|
48558431|NCT03207776|101698278|FG000|COMPLETED|Overall Study||2479||
48558432|NCT03207776|101698279|FG001|COMPLETED|Overall Study||2353||
48558433|NCT03207776|101698278|FG000|NOT COMPLETED|Overall Study||0||
48558434|NCT03207776|101698279|FG001|NOT COMPLETED|Overall Study||0||
48558435|NCT01692626|101698280|FG000|STARTED|Overall Study||6||
48558436|NCT01692626|101698281|FG001|STARTED|Overall Study||7||
48558437|NCT01692626|101698280|FG000|COMPLETED|Overall Study||2||
48558438|NCT01692626|101698281|FG001|COMPLETED|Overall Study||1||
48558439|NCT01692626|101698280|FG000|NOT COMPLETED|Overall Study||4||
48558440|NCT01692626|101698281|FG001|NOT COMPLETED|Overall Study||6||
48558441|NCT00674739|101698282|FG000|STARTED|Overall Study||178||
48558442|NCT00674739|101698283|FG001|STARTED|Overall Study||195||
48558443|NCT00674739|101698284|FG002|STARTED|Overall Study||97||
48558444|NCT00674739|101698282|FG000|COMPLETED|Overall Study||121||
48558445|NCT00674739|101698283|FG001|COMPLETED|Overall Study||136||
48558446|NCT00674739|101698284|FG002|COMPLETED|Overall Study||65||
48558447|NCT00674739|101698282|FG000|NOT COMPLETED|Overall Study||57||
48558448|NCT00674739|101698283|FG001|NOT COMPLETED|Overall Study||59||
48558449|NCT00674739|101698284|FG002|NOT COMPLETED|Overall Study||32||
48558450|NCT02692859|101698285|FG000|STARTED|Overall Study||996||
48558451|NCT02692859|101698286|FG001|STARTED|Overall Study||996||
48558452|NCT02692859|101698285|FG000|COMPLETED|Overall Study||912||
48558453|NCT02692859|101698286|FG001|COMPLETED|Overall Study||901||
48558454|NCT02692859|101698285|FG000|NOT COMPLETED|Overall Study||84||
48558455|NCT02692859|101698286|FG001|NOT COMPLETED|Overall Study||95||
48558456|NCT00118157|101698287|FG000|STARTED|Overall Study||19||
48558457|NCT00118157|101698287|FG000|COMPLETED|Overall Study||7||
48558458|NCT00118157|101698287|FG000|NOT COMPLETED|Overall Study||12||
48558459|NCT02969382|101698288|FG000|STARTED|Overall Study||125||
48558460|NCT02969382|101698289|FG001|STARTED|Overall Study||120||
48558461|NCT02969382|101698288|FG000|Subjects Continued Into Extension Study|Overall Study||79||
48558462|NCT02969382|101698289|FG001|Subjects Continued Into Extension Study|Overall Study||78||
48558463|NCT02969382|101698288|FG000|COMPLETED|Overall Study||99||
48558464|NCT02969382|101698289|FG001|COMPLETED|Overall Study||94||
48558465|NCT02969382|101698288|FG000|NOT COMPLETED|Overall Study||26||
48558466|NCT02969382|101698289|FG001|NOT COMPLETED|Overall Study||26||
48558467|NCT01499095|101698290|FG000|STARTED|Overall Study||404||
48558468|NCT01499095|101698291|FG001|STARTED|Overall Study||407||
48558469|NCT01499095|101698290|FG000|Treated|Overall Study||403||
48558470|NCT01499095|101698291|FG001|Treated|Overall Study||406||
48558471|NCT01499095|101698290|FG000|Participated in Substudy|Overall Study||89||
48558472|NCT01499095|101698291|FG001|Participated in Substudy|Overall Study||0||
48558473|NCT01499095|101698290|FG000|Modified Intent-to-Treat Population|Overall Study||403||
48558474|NCT01499095|101698291|FG001|Modified Intent-to-Treat Population|Overall Study||405||
48274096|NCT03846453|100992276|FG001|COMPLETED|Randomized Treatment Period (Days 57±3)||291||
48274097|NCT03846453|100992277|FG002|COMPLETED|Randomized Treatment Period (Days 57±3)||294||
48274098|NCT03846453|100992275|FG000|NOT COMPLETED|Randomized Treatment Period (Days 57±3)||0||
48274099|NCT03846453|100992276|FG001|NOT COMPLETED|Randomized Treatment Period (Days 57±3)||27||
48274100|NCT03846453|100992277|FG002|NOT COMPLETED|Randomized Treatment Period (Days 57±3)||25||
48274101|NCT01461811|100992278|FG000|STARTED|Overall Study||95||
48274102|NCT01461811|100992279|FG001|STARTED|Overall Study||49||
48274103|NCT01461811|100992278|FG000|COMPLETED|Overall Study||91||
48274104|NCT01461811|100992279|FG001|COMPLETED|Overall Study||46||
48274105|NCT01461811|100992278|FG000|NOT COMPLETED|Overall Study||4||
48274106|NCT01461811|100992279|FG001|NOT COMPLETED|Overall Study||3||
48274107|NCT01865747|100992280|FG000|STARTED|Overall Study (ITT)||330|Randomized|
48274108|NCT01865747|100992281|FG001|STARTED|Overall Study (ITT)||328|Randomized|
48274109|NCT01865747|100992280|FG000|COMPLETED|Overall Study (ITT)||132|Continuing study treatment at the time of data cut-off|
48274110|NCT01865747|100992281|FG001|COMPLETED|Overall Study (ITT)||73|Continuing study treatment at the time of data cut-off|
48274111|NCT01865747|100992280|FG000|NOT COMPLETED|Overall Study (ITT)||198||
48274112|NCT01865747|100992281|FG001|NOT COMPLETED|Overall Study (ITT)||255||
48274113|NCT01865747|100992280|FG000|STARTED|Primary Intent to Treat (PITT)||187|PITT population consisted of the first 375 subjects randomized to received study treatment.|
48274114|NCT01865747|100992281|FG001|STARTED|Primary Intent to Treat (PITT)||188|PITT population consisted of the first 375 subjects randomized to received study treatment.|
48274115|NCT01865747|100992280|FG000|COMPLETED|Primary Intent to Treat (PITT)||56|Continuing study treatment at the time of data cut-off|
48274116|NCT01865747|100992281|FG001|COMPLETED|Primary Intent to Treat (PITT)||36|Continuing study treatment at the time of data cut-off|
48274117|NCT01865747|100992280|FG000|NOT COMPLETED|Primary Intent to Treat (PITT)||131||
48274118|NCT01865747|100992281|FG001|NOT COMPLETED|Primary Intent to Treat (PITT)||152||
48558475|NCT01499095|101698290|FG000|COMPLETED|Overall Study||315||
48558476|NCT01499095|101698291|FG001|COMPLETED|Overall Study||314||
48558477|NCT01499095|101698290|FG000|NOT COMPLETED|Overall Study||89||
48558478|NCT01499095|101698291|FG001|NOT COMPLETED|Overall Study||93||
48558479|NCT02105987|101698292|FG000|STARTED|Early Switch Phase (24 Weeks)||275||
48558480|NCT02105987|101698293|FG001|STARTED|Early Switch Phase (24 Weeks)||278||
48558481|NCT02105987|101698294|FG002|STARTED|Early Switch Phase (24 Weeks)||0||
48558482|NCT02105987|101698295|FG003|STARTED|Early Switch Phase (24 Weeks)||0||
48558483|NCT02105987|101698296|FG004|STARTED|Early Switch Phase (24 Weeks)||0||
48558484|NCT02105987|101698297|FG005|STARTED|Early Switch Phase (24 Weeks)||0||
48558485|NCT02105987|101698292|FG000|COMPLETED|Early Switch Phase (24 Weeks)||239||
48558486|NCT02105987|101698293|FG001|COMPLETED|Early Switch Phase (24 Weeks)||244||
48558487|NCT02105987|101698294|FG002|COMPLETED|Early Switch Phase (24 Weeks)||0||
48558488|NCT02105987|101698295|FG003|COMPLETED|Early Switch Phase (24 Weeks)||0||
48558489|NCT02105987|101698296|FG004|COMPLETED|Early Switch Phase (24 Weeks)||0||
48558490|NCT02105987|101698297|FG005|COMPLETED|Early Switch Phase (24 Weeks)||0||
48274119|NCT02510040|100992282|FG000|STARTED|Overall Study||81||
48274120|NCT02510040|100992283|FG001|STARTED|Overall Study||114||
48274121|NCT02510040|100992284|FG002|STARTED|Overall Study||22||
48274122|NCT02510040|100992282|FG000|COMPLETED|Overall Study||63||
48274123|NCT02510040|100992283|FG001|COMPLETED|Overall Study||111||
48274124|NCT02510040|100992284|FG002|COMPLETED|Overall Study||21||
48558491|NCT02105987|101698292|FG000|NOT COMPLETED|Early Switch Phase (24 Weeks)||36||
48558492|NCT02105987|101698293|FG001|NOT COMPLETED|Early Switch Phase (24 Weeks)||34||
48558493|NCT02105987|101698294|FG002|NOT COMPLETED|Early Switch Phase (24 Weeks)||0||
48558494|NCT02105987|101698295|FG003|NOT COMPLETED|Early Switch Phase (24 Weeks)||0||
48558495|NCT02105987|101698296|FG004|NOT COMPLETED|Early Switch Phase (24 Weeks)||0||
48558496|NCT02105987|101698297|FG005|NOT COMPLETED|Early Switch Phase (24 Weeks)||0||
48558497|NCT02105987|101698292|FG000|STARTED|Late Switch Phase (24 Weeks)||0||
48558498|NCT02105987|101698293|FG001|STARTED|Late Switch Phase (24 Weeks)||0||
48558499|NCT02105987|101698294|FG002|STARTED|Late Switch Phase (24 Weeks)||275||
48558500|NCT02105987|101698295|FG003|STARTED|Late Switch Phase (24 Weeks)||244||
48558501|NCT02105987|101698296|FG004|STARTED|Late Switch Phase (24 Weeks)||0||
48274125|NCT02510040|100992282|FG000|NOT COMPLETED|Overall Study||18||
48274126|NCT02510040|100992283|FG001|NOT COMPLETED|Overall Study||3||
48274127|NCT02510040|100992284|FG002|NOT COMPLETED|Overall Study||1||
48274128|NCT02731690|100992285|FG000|STARTED|Overall Study||42||
48274129|NCT02731690|100992285|FG000|COMPLETED|Overall Study||12||
48274130|NCT02731690|100992285|FG000|NOT COMPLETED|Overall Study||30||
48274131|NCT01245140|100992286|FG000|STARTED|Overall Study||9||
48274132|NCT01245140|100992287|FG001|STARTED|Overall Study||24||
48274133|NCT01245140|100992286|FG000|COMPLETED|Overall Study||6||
48274134|NCT01245140|100992287|FG001|COMPLETED|Overall Study||14||
48274135|NCT01245140|100992286|FG000|NOT COMPLETED|Overall Study||3||
48274136|NCT01245140|100992287|FG001|NOT COMPLETED|Overall Study||10||
48274137|NCT03789175|100992288|FG000|STARTED|Week 0 to Week 12 of NR||1||
48274138|NCT03789175|100992288|FG000|COMPLETED|Week 0 to Week 12 of NR||1||
48274139|NCT03789175|100992288|FG000|NOT COMPLETED|Week 0 to Week 12 of NR||0||
48274140|NCT03789175|100992288|FG000|STARTED|Week 12 to Week 24 of NR||1||
48274141|NCT03789175|100992288|FG000|COMPLETED|Week 12 to Week 24 of NR||1||
48274142|NCT03789175|100992288|FG000|NOT COMPLETED|Week 12 to Week 24 of NR||0||
48274143|NCT02297100|100992289|FG000|STARTED|Overall Study||13||
48274144|NCT02297100|100992290|FG001|STARTED|Overall Study||14||
48274145|NCT02297100|100992289|FG000|COMPLETED|Overall Study||13||
48274146|NCT02297100|100992290|FG001|COMPLETED|Overall Study||14||
48274147|NCT02297100|100992289|FG000|NOT COMPLETED|Overall Study||0||
48274148|NCT02297100|100992290|FG001|NOT COMPLETED|Overall Study||0||
48274149|NCT02033083|100996154|FG000|STARTED|Overall Study||90||
48274150|NCT02033083|100996155|FG001|STARTED|Overall Study||90||
48274151|NCT02033083|100996154|FG000|COMPLETED|Overall Study||89||
48274152|NCT02033083|100996155|FG001|COMPLETED|Overall Study||89||
48274153|NCT02033083|100996154|FG000|NOT COMPLETED|Overall Study||1||
48274154|NCT02033083|100996155|FG001|NOT COMPLETED|Overall Study||1||
48274155|NCT04157400|100996156|FG000|STARTED|Overall Study||5||
48274156|NCT04157400|100996156|FG000|COMPLETED|Overall Study||1||
48274157|NCT04157400|100996156|FG000|NOT COMPLETED|Overall Study||4||
48558502|NCT02105987|101698297|FG005|STARTED|Late Switch Phase (24 Weeks)||0||
48558503|NCT02105987|101698292|FG000|COMPLETED|Late Switch Phase (24 Weeks)||0||
48558504|NCT02105987|101698293|FG001|COMPLETED|Late Switch Phase (24 Weeks)||0||
48558505|NCT02105987|101698294|FG002|COMPLETED|Late Switch Phase (24 Weeks)||230||
48558506|NCT02105987|101698295|FG003|COMPLETED|Late Switch Phase (24 Weeks)||230||
48558507|NCT02105987|101698296|FG004|COMPLETED|Late Switch Phase (24 Weeks)||0||
48558508|NCT02105987|101698297|FG005|COMPLETED|Late Switch Phase (24 Weeks)||0||
48558509|NCT02105987|101698292|FG000|NOT COMPLETED|Late Switch Phase (24 Weeks)||0||
48558510|NCT02105987|101698293|FG001|NOT COMPLETED|Late Switch Phase (24 Weeks)||0||
48558511|NCT02105987|101698294|FG002|NOT COMPLETED|Late Switch Phase (24 Weeks)||45||
48695223|NCT00960401|102038485|FG001|STARTED|Overall Study||11||
48695224|NCT00960401|102038484|FG000|COMPLETED|Overall Study||9||
48695225|NCT00960401|102038485|FG001|COMPLETED|Overall Study||11||
48695226|NCT00960401|102038484|FG000|NOT COMPLETED|Overall Study||0||
48695227|NCT00960401|102038485|FG001|NOT COMPLETED|Overall Study||0||
48695228|NCT04097028|102038486|FG000|STARTED|Overall Study||22||
48274158|NCT03621787|100996157|FG000|STARTED|Overall Study||9||
48274159|NCT03621787|100996157|FG000|COMPLETED|Overall Study||9||
48274160|NCT03621787|100996157|FG000|NOT COMPLETED|Overall Study||0||
48274161|NCT00233480|100996158|FG000|STARTED|Overall Study||14||
48558512|NCT02105987|101698295|FG003|NOT COMPLETED|Late Switch Phase (24 Weeks)||14||
48558513|NCT02105987|101698296|FG004|NOT COMPLETED|Late Switch Phase (24 Weeks)||0||
48558514|NCT02105987|101698297|FG005|NOT COMPLETED|Late Switch Phase (24 Weeks)||0||
48558515|NCT02105987|101698292|FG000|STARTED|Continuation Phase||0||
48558516|NCT02105987|101698293|FG001|STARTED|Continuation Phase||0||
48558517|NCT02105987|101698294|FG002|STARTED|Continuation Phase||0||
48558518|NCT02105987|101698295|FG003|STARTED|Continuation Phase||0||
48558519|NCT02105987|101698296|FG004|STARTED|Continuation Phase||14||
48558520|NCT02105987|101698297|FG005|STARTED|Continuation Phase||23||
48558521|NCT02105987|101698292|FG000|COMPLETED|Continuation Phase||0||
48558522|NCT02105987|101698293|FG001|COMPLETED|Continuation Phase||0||
48558523|NCT02105987|101698294|FG002|COMPLETED|Continuation Phase||0||
48558524|NCT02105987|101698295|FG003|COMPLETED|Continuation Phase||0||
48558525|NCT02105987|101698296|FG004|COMPLETED|Continuation Phase||13||
48695229|NCT04097028|102038486|FG000|COMPLETED|Overall Study||15||
48695230|NCT04097028|102038486|FG000|NOT COMPLETED|Overall Study||7||
48695231|NCT03125031|102038487|FG000|STARTED|Overall Study||44||
48695232|NCT03125031|102038488|FG001|STARTED|Overall Study||44||
48695233|NCT03125031|102038487|FG000|COMPLETED|Overall Study||44||
48695234|NCT03125031|102038488|FG001|COMPLETED|Overall Study||44||
48695235|NCT03125031|102038487|FG000|NOT COMPLETED|Overall Study||0||
48695236|NCT03125031|102038488|FG001|NOT COMPLETED|Overall Study||0||
48274162|NCT00233480|100996159|FG001|STARTED|Overall Study||13||
48274163|NCT00233480|100996158|FG000|COMPLETED|Overall Study||14||
48274164|NCT00233480|100996159|FG001|COMPLETED|Overall Study||12||
48274165|NCT00233480|100996158|FG000|NOT COMPLETED|Overall Study||0||
48274166|NCT00233480|100996159|FG001|NOT COMPLETED|Overall Study||1||
48274167|NCT03480932|100996160|FG000|STARTED|Overall Study||50||
48274168|NCT03480932|100996161|FG001|STARTED|Overall Study||50||
48274169|NCT03480932|100996162|FG002|STARTED|Overall Study||50||
48274170|NCT03480932|100996160|FG000|COMPLETED|Overall Study||47||
48695237|NCT01238991|102038489|FG000|STARTED|Overall Study||7||
48695238|NCT01238991|102038490|FG001|STARTED|Overall Study||3||
48274171|NCT03480932|100996161|FG001|COMPLETED|Overall Study||45||
48274172|NCT03480932|100996162|FG002|COMPLETED|Overall Study||45||
48558526|NCT02105987|101698297|FG005|COMPLETED|Continuation Phase||23||
48558527|NCT02105987|101698292|FG000|NOT COMPLETED|Continuation Phase||0||
48558528|NCT02105987|101698293|FG001|NOT COMPLETED|Continuation Phase||0||
48695239|NCT01238991|102038491|FG002|STARTED|Overall Study||11||
48695240|NCT01238991|102038492|FG003|STARTED|Overall Study||6||
48695241|NCT01238991|102038493|FG004|STARTED|Overall Study||5||
48695242|NCT01238991|102038494|FG005|STARTED|Overall Study||2||
48695243|NCT01238991|102038495|FG006|STARTED|Overall Study||8||
48695244|NCT01238991|102038496|FG007|STARTED|Overall Study||5||
48695245|NCT01238991|102038497|FG008|STARTED|Overall Study||4||
48695246|NCT01238991|102038498|FG009|STARTED|Overall Study||2||
48695247|NCT01238991|102038489|FG000|Received Treatment|Overall Study||7||
48695248|NCT01238991|102038490|FG001|Received Treatment|Overall Study||3||
48695249|NCT01238991|102038491|FG002|Received Treatment|Overall Study||11||
48695250|NCT01238991|102038492|FG003|Received Treatment|Overall Study||6||
48558529|NCT02105987|101698294|FG002|NOT COMPLETED|Continuation Phase||0||
48558530|NCT02105987|101698295|FG003|NOT COMPLETED|Continuation Phase||0||
48558531|NCT02105987|101698296|FG004|NOT COMPLETED|Continuation Phase||1||
48558532|NCT02105987|101698297|FG005|NOT COMPLETED|Continuation Phase||0||
48558533|NCT05192239|101698298|FG000|STARTED|Overall Study||5||
48558534|NCT05192239|101698299|FG001|STARTED|Overall Study||5||
48558535|NCT05192239|101698298|FG000|COMPLETED|Overall Study||5||
48558536|NCT05192239|101698299|FG001|COMPLETED|Overall Study||5||
48558537|NCT05192239|101698298|FG000|NOT COMPLETED|Overall Study||0||
48558538|NCT05192239|101698299|FG001|NOT COMPLETED|Overall Study||0||
48558539|NCT01866826|101698300|FG000|STARTED|Phase I -Initial Randomization - 4 Weeks||23||
48558540|NCT01866826|101698301|FG001|STARTED|Phase I -Initial Randomization - 4 Weeks||23||
48558541|NCT01866826|101698300|FG000|COMPLETED|Phase I -Initial Randomization - 4 Weeks||22||
48558542|NCT01866826|101698301|FG001|COMPLETED|Phase I -Initial Randomization - 4 Weeks||23||
48558543|NCT01866826|101698300|FG000|NOT COMPLETED|Phase I -Initial Randomization - 4 Weeks||1||
48558544|NCT01866826|101698301|FG001|NOT COMPLETED|Phase I -Initial Randomization - 4 Weeks||0||
48558545|NCT01866826|101698300|FG000|STARTED|Wash-Out Period - 4 -6 Weeks||22||
48558546|NCT01866826|101698301|FG001|STARTED|Wash-Out Period - 4 -6 Weeks||23||
48558547|NCT01866826|101698300|FG000|COMPLETED|Wash-Out Period - 4 -6 Weeks||22||
48558548|NCT01866826|101698301|FG001|COMPLETED|Wash-Out Period - 4 -6 Weeks||20||
48558549|NCT01866826|101698300|FG000|NOT COMPLETED|Wash-Out Period - 4 -6 Weeks||0||
48558550|NCT01866826|101698301|FG001|NOT COMPLETED|Wash-Out Period - 4 -6 Weeks||3||
48558551|NCT01866826|101698300|FG000|STARTED|Second Intervention - 4 Weeks||22||
48558552|NCT01866826|101698301|FG001|STARTED|Second Intervention - 4 Weeks||20||
48558553|NCT01866826|101698300|FG000|COMPLETED|Second Intervention - 4 Weeks||22||
48558554|NCT01866826|101698301|FG001|COMPLETED|Second Intervention - 4 Weeks||20||
48558555|NCT01866826|101698300|FG000|NOT COMPLETED|Second Intervention - 4 Weeks||0||
48558556|NCT01866826|101698301|FG001|NOT COMPLETED|Second Intervention - 4 Weeks||0||
48558557|NCT02152137|101698302|FG000|STARTED|Overall Study||19|Enrolled|
48558558|NCT02152137|101698302|FG000|Originally Assigned to Arm A|Overall Study||16||
48558559|NCT02152137|101698302|FG000|Originally Assigned to Arm B|Overall Study||3||
48695251|NCT01238991|102038493|FG004|Received Treatment|Overall Study||5||
48695252|NCT01238991|102038494|FG005|Received Treatment|Overall Study||2||
48274173|NCT03480932|100996160|FG000|NOT COMPLETED|Overall Study||3||
48558560|NCT02152137|101698302|FG000|COMPLETED|Overall Study||15|received efatutazone and paclitaxel combination and were included in safety and efficacy analyses|
48558561|NCT02152137|101698302|FG000|NOT COMPLETED|Overall Study||4||
48695253|NCT01238991|102038495|FG006|Received Treatment|Overall Study||8||
48695254|NCT01238991|102038496|FG007|Received Treatment|Overall Study||5||
48695255|NCT01238991|102038497|FG008|Received Treatment|Overall Study||4||
48274174|NCT03480932|100996161|FG001|NOT COMPLETED|Overall Study||5||
48274175|NCT03480932|100996162|FG002|NOT COMPLETED|Overall Study||5||
48274176|NCT02546921|100996163|FG000|STARTED|Overall Study||2||
48274177|NCT02546921|100996164|FG001|STARTED|Overall Study||8||
48274178|NCT02546921|100996165|FG002|STARTED|Overall Study||6||
48274179|NCT02546921|100996166|FG003|STARTED|Overall Study||3||
48274180|NCT02546921|100996167|FG004|STARTED|Overall Study||3||
48274181|NCT02546921|100996168|FG005|STARTED|Overall Study||3||
48274182|NCT02546921|100996169|FG006|STARTED|Overall Study||1||
48274183|NCT02546921|100996163|FG000|COMPLETED|Overall Study||1||
48558562|NCT01875978|101698303|FG000|STARTED|Study 4weeks||20||
48558563|NCT01875978|101698304|FG001|STARTED|Study 4weeks||20||
48558564|NCT01875978|101698303|FG000|COMPLETED|Study 4weeks||20||
48558565|NCT01875978|101698304|FG001|COMPLETED|Study 4weeks||20||
48558566|NCT01875978|101698303|FG000|NOT COMPLETED|Study 4weeks||0||
48558567|NCT01875978|101698304|FG001|NOT COMPLETED|Study 4weeks||0||
48558568|NCT01875978|101698303|FG000|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20||
48695256|NCT01238991|102038498|FG009|Received Treatment|Overall Study||2||
48695257|NCT01238991|102038489|FG000|COMPLETED|Overall Study||5||
48274184|NCT02546921|100996164|FG001|COMPLETED|Overall Study||2||
48274185|NCT02546921|100996165|FG002|COMPLETED|Overall Study||4||
48274186|NCT02546921|100996166|FG003|COMPLETED|Overall Study||3||
48274187|NCT02546921|100996167|FG004|COMPLETED|Overall Study||2||
48695258|NCT01238991|102038490|FG001|COMPLETED|Overall Study||3||
48695259|NCT01238991|102038491|FG002|COMPLETED|Overall Study||5||
48695260|NCT01238991|102038492|FG003|COMPLETED|Overall Study||4||
48695261|NCT01238991|102038493|FG004|COMPLETED|Overall Study||3||
48695262|NCT01238991|102038494|FG005|COMPLETED|Overall Study||2||
48274188|NCT02546921|100996168|FG005|COMPLETED|Overall Study||2||
48274189|NCT02546921|100996169|FG006|COMPLETED|Overall Study||1||
48274190|NCT02546921|100996163|FG000|NOT COMPLETED|Overall Study||1||
48274191|NCT02546921|100996164|FG001|NOT COMPLETED|Overall Study||6||
48274192|NCT02546921|100996165|FG002|NOT COMPLETED|Overall Study||2||
48274193|NCT02546921|100996166|FG003|NOT COMPLETED|Overall Study||0||
48695263|NCT01238991|102038495|FG006|COMPLETED|Overall Study||0||
48695264|NCT01238991|102038496|FG007|COMPLETED|Overall Study||0||
48274194|NCT02546921|100996167|FG004|NOT COMPLETED|Overall Study||1||
48274195|NCT02546921|100996168|FG005|NOT COMPLETED|Overall Study||1||
48558569|NCT01875978|101698304|FG001|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20||
48558570|NCT01875978|101698303|FG000|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20||
48558571|NCT01875978|101698304|FG001|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20||
48558572|NCT01875978|101698303|FG000|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0||
48558573|NCT01875978|101698304|FG001|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0||
48558574|NCT03759392|101698305|FG000|STARTED|Overall Study||185||
48558575|NCT03759392|101698306|FG001|STARTED|Overall Study||91||
48558576|NCT03759392|101698305|FG000|COMPLETED|Overall Study||164||
48558577|NCT03759392|101698306|FG001|COMPLETED|Overall Study||85||
48558578|NCT03759392|101698305|FG000|NOT COMPLETED|Overall Study||21||
48558579|NCT03759392|101698306|FG001|NOT COMPLETED|Overall Study||6||
48558580|NCT02142608|101698307|FG000|STARTED|Overall Study||18||
48558581|NCT02142608|101698307|FG000|COMPLETED|Overall Study||18||
48558582|NCT02142608|101698307|FG000|NOT COMPLETED|Overall Study||0||
48558583|NCT02440464|101698308|FG000|STARTED|Overall Study||21||
48558584|NCT02440464|101698309|FG001|STARTED|Overall Study||22||
48558585|NCT02440464|101698308|FG000|COMPLETED|Overall Study||18||
48558586|NCT02440464|101698309|FG001|COMPLETED|Overall Study||20||
48558587|NCT02440464|101698308|FG000|NOT COMPLETED|Overall Study||3||
48558588|NCT02440464|101698309|FG001|NOT COMPLETED|Overall Study||2||
48558589|NCT01330303|101698310|FG000|STARTED|Period 1||20||
48558590|NCT01330303|101698311|FG001|STARTED|Period 1||20||
48558591|NCT01330303|101698310|FG000|COMPLETED|Period 1||19||
48558592|NCT01330303|101698311|FG001|COMPLETED|Period 1||18||
48558593|NCT01330303|101698310|FG000|NOT COMPLETED|Period 1||1||
48558594|NCT01330303|101698311|FG001|NOT COMPLETED|Period 1||2||
48558595|NCT01330303|101698310|FG000|STARTED|7-Day Washout Period||19||
48558596|NCT01330303|101698311|FG001|STARTED|7-Day Washout Period||18||
48558597|NCT01330303|101698310|FG000|COMPLETED|7-Day Washout Period||19||
48558598|NCT01330303|101698311|FG001|COMPLETED|7-Day Washout Period||18||
48558599|NCT01330303|101698310|FG000|NOT COMPLETED|7-Day Washout Period||0||
48558600|NCT01330303|101698311|FG001|NOT COMPLETED|7-Day Washout Period||0||
48558601|NCT01330303|101698310|FG000|STARTED|Period 2||19||
48558602|NCT01330303|101698311|FG001|STARTED|Period 2||18||
48558603|NCT01330303|101698310|FG000|COMPLETED|Period 2||19||
48558604|NCT01330303|101698311|FG001|COMPLETED|Period 2||18||
48695265|NCT01238991|102038497|FG008|COMPLETED|Overall Study||0||
48695266|NCT01238991|102038498|FG009|COMPLETED|Overall Study||0||
48695267|NCT01238991|102038489|FG000|NOT COMPLETED|Overall Study||2||
48695268|NCT01238991|102038490|FG001|NOT COMPLETED|Overall Study||0||
48274196|NCT02546921|100996169|FG006|NOT COMPLETED|Overall Study||0||
48274197|NCT03478904|100996170|FG000|STARTED|Overall Study||1||
48274198|NCT03478904|100996170|FG000|COMPLETED|Overall Study||1||
48274199|NCT03478904|100996170|FG000|NOT COMPLETED|Overall Study||0||
48274200|NCT02277054|100996171|FG000|STARTED|Overall Study||5||
48558605|NCT01330303|101698310|FG000|NOT COMPLETED|Period 2||0||
48558606|NCT01330303|101698311|FG001|NOT COMPLETED|Period 2||0||
48695269|NCT01238991|102038491|FG002|NOT COMPLETED|Overall Study||6||
48695270|NCT01238991|102038492|FG003|NOT COMPLETED|Overall Study||2||
48695271|NCT01238991|102038493|FG004|NOT COMPLETED|Overall Study||2||
48558607|NCT05317312|101698312|FG000|STARTED|Overall Study||28||
48558608|NCT05317312|101698313|FG001|STARTED|Overall Study||28||
48558609|NCT05317312|101698314|FG002|STARTED|Overall Study||27||
48558610|NCT05317312|101698315|FG003|STARTED|Overall Study||27||
48558611|NCT05317312|101698312|FG000|COMPLETED|Overall Study||28||
48558612|NCT05317312|101698313|FG001|COMPLETED|Overall Study||27||
48558613|NCT05317312|101698314|FG002|COMPLETED|Overall Study||26||
48558614|NCT05317312|101698315|FG003|COMPLETED|Overall Study||26||
48558615|NCT05317312|101698312|FG000|NOT COMPLETED|Overall Study||0||
48558616|NCT05317312|101698313|FG001|NOT COMPLETED|Overall Study||1||
48558617|NCT05317312|101698314|FG002|NOT COMPLETED|Overall Study||1||
48558618|NCT05317312|101698315|FG003|NOT COMPLETED|Overall Study||1||
48558619|NCT03154125|101698316|FG000|STARTED|Overall Study||355||
48558620|NCT03154125|101698317|FG001|STARTED|Overall Study||355||
48558621|NCT03154125|101698318|FG002|STARTED|Overall Study||40||
48558622|NCT03154125|101698316|FG000|Randomized to PK Cohort|Overall Study||40||
48558623|NCT03154125|101698317|FG001|Randomized to PK Cohort|Overall Study||40||
48558624|NCT03154125|101698318|FG002|Randomized to PK Cohort|Overall Study||40||
48558625|NCT03154125|101698316|FG000|PK Population|Overall Study||35||
48558626|NCT03154125|101698317|FG001|PK Population|Overall Study||33||
48558627|NCT03154125|101698318|FG002|PK Population|Overall Study||32||
48558628|NCT03154125|101698316|FG000|Excluded From PK Population|Overall Study||5||
48558629|NCT03154125|101698317|FG001|Excluded From PK Population|Overall Study||7||
48558630|NCT03154125|101698318|FG002|Excluded From PK Population|Overall Study||8||
48558631|NCT03154125|101698316|FG000|COMPLETED|Overall Study||279||
48558632|NCT03154125|101698317|FG001|COMPLETED|Overall Study||278||
48558633|NCT03154125|101698318|FG002|COMPLETED|Overall Study||32||
48558634|NCT03154125|101698316|FG000|NOT COMPLETED|Overall Study||76||
48558635|NCT03154125|101698317|FG001|NOT COMPLETED|Overall Study||77||
48558636|NCT03154125|101698318|FG002|NOT COMPLETED|Overall Study||8||
48558637|NCT01894087|101698319|FG000|STARTED|Overall Study||102||
48558638|NCT01894087|101698320|FG001|STARTED|Overall Study||102||
48558639|NCT01894087|101698319|FG000|COMPLETED|Overall Study||96||
48558640|NCT01894087|101698320|FG001|COMPLETED|Overall Study||102||
48558641|NCT01894087|101698319|FG000|NOT COMPLETED|Overall Study||6||
48558642|NCT01894087|101698320|FG001|NOT COMPLETED|Overall Study||0||
48558643|NCT03644342|101698321|FG000|STARTED|Overall Study||3||
48558644|NCT03644342|101698322|FG001|STARTED|Overall Study||1||
48558645|NCT03644342|101698321|FG000|COMPLETED|Overall Study||1||
48558646|NCT03644342|101698322|FG001|COMPLETED|Overall Study||0||
48558647|NCT03644342|101698321|FG000|NOT COMPLETED|Overall Study||2||
48558648|NCT03644342|101698322|FG001|NOT COMPLETED|Overall Study||1||
48558649|NCT00752128|101698323|FG000|STARTED|Overall Study||2349||
48558650|NCT00752128|101698323|FG000|COMPLETED|Overall Study||2345||
48558651|NCT00752128|101698323|FG000|NOT COMPLETED|Overall Study||4||
48558652|NCT03805386|101698324|FG000|STARTED|Overall Study||32||
48558653|NCT03805386|101698325|FG001|STARTED|Overall Study||33||
48558654|NCT03805386|101698324|FG000|COMPLETED|Overall Study||32||
48558655|NCT03805386|101698325|FG001|COMPLETED|Overall Study||33||
48558656|NCT03805386|101698324|FG000|NOT COMPLETED|Overall Study||0||
48558657|NCT03805386|101698325|FG001|NOT COMPLETED|Overall Study||0||
48558658|NCT02847260|101698326|FG000|STARTED|Overall Study||39||
48558659|NCT02847260|101698326|FG000|COMPLETED|Overall Study||32||
48558660|NCT02847260|101698326|FG000|NOT COMPLETED|Overall Study||7||
48558661|NCT01250210|101698327|FG000|STARTED|Overall Study||45|Number of participants enrolled.|
48558662|NCT01250210|101698328|FG001|STARTED|Overall Study||45|Number of participants enrolled.|
48558663|NCT01250210|101698329|FG002|STARTED|Overall Study||33|Number of participants enrolled.|
48558664|NCT01250210|101698327|FG000|COMPLETED|Overall Study||41||
48558665|NCT01250210|101698328|FG001|COMPLETED|Overall Study||41||
48558666|NCT01250210|101698329|FG002|COMPLETED|Overall Study||25||
48558667|NCT01250210|101698327|FG000|NOT COMPLETED|Overall Study||4||
48558668|NCT01250210|101698328|FG001|NOT COMPLETED|Overall Study||4||
48558669|NCT01250210|101698329|FG002|NOT COMPLETED|Overall Study||8||
48558670|NCT03571828|101698330|FG000|STARTED|Overall Study||9||
48558671|NCT03571828|101698331|FG001|STARTED|Overall Study||1||
48558672|NCT03571828|101698330|FG000|Received Investigational Product|Overall Study||8||
48558673|NCT03571828|101698331|FG001|Received Investigational Product|Overall Study||1||
48558674|NCT03571828|101698330|FG000|COMPLETED|Overall Study||1||
48558675|NCT03571828|101698331|FG001|COMPLETED|Overall Study||0||
48558676|NCT03571828|101698330|FG000|NOT COMPLETED|Overall Study||8||
48558677|NCT03571828|101698331|FG001|NOT COMPLETED|Overall Study||1||
48558678|NCT02961595|101698332|FG000|STARTED|Overall Study||251||
48558679|NCT02961595|101698333|FG001|STARTED|Overall Study||64||
48558680|NCT02961595|101698332|FG000|COMPLETED|Overall Study||251||
48558681|NCT02961595|101698333|FG001|COMPLETED|Overall Study||64||
48558682|NCT02961595|101698332|FG000|NOT COMPLETED|Overall Study||0||
48558683|NCT02961595|101698333|FG001|NOT COMPLETED|Overall Study||0||
48558684|NCT01000155|101698334|FG000|STARTED|Overall Study||5||
48558685|NCT01000155|101698334|FG000|COMPLETED|Overall Study||3||
48558686|NCT01000155|101698334|FG000|NOT COMPLETED|Overall Study||2||
48558687|NCT03411863|101698335|FG000|STARTED|Overall Study||8||
48558688|NCT03411863|101698336|FG001|STARTED|Overall Study||11||
48558689|NCT03411863|101698335|FG000|COMPLETED|Overall Study||5||
48558690|NCT03411863|101698336|FG001|COMPLETED|Overall Study||9||
48558691|NCT03411863|101698335|FG000|NOT COMPLETED|Overall Study||3||
48558692|NCT03411863|101698336|FG001|NOT COMPLETED|Overall Study||2||
48558693|NCT00065156|101698337|FG000|STARTED|Overall Study||148||
48558694|NCT00065156|101698337|FG000|Modified Intent to Treat Population|Overall Study||94||
48558695|NCT00065156|101698337|FG000|COMPLETED|Overall Study||24||
48558696|NCT00065156|101698337|FG000|NOT COMPLETED|Overall Study||124||
48558697|NCT02810873|101698338|FG000|STARTED|Overall Study||6||
48558698|NCT02810873|101698339|FG001|STARTED|Overall Study||13||
48558699|NCT02810873|101698338|FG000|COMPLETED|Overall Study||6||
48558700|NCT02810873|101698339|FG001|COMPLETED|Overall Study||13||
48558701|NCT02810873|101698338|FG000|NOT COMPLETED|Overall Study||0||
48558702|NCT02810873|101698339|FG001|NOT COMPLETED|Overall Study||0||
48558703|NCT04067050|101698340|FG000|STARTED|One Month||32||
48558704|NCT04067050|101698341|FG001|STARTED|One Month||29||
48558705|NCT04067050|101698340|FG000|COMPLETED|One Month||28||
48558706|NCT04067050|101698341|FG001|COMPLETED|One Month||29||
48695272|NCT01238991|102038494|FG005|NOT COMPLETED|Overall Study||0||
48695273|NCT01238991|102038495|FG006|NOT COMPLETED|Overall Study||8||
48695274|NCT01238991|102038496|FG007|NOT COMPLETED|Overall Study||5||
48695275|NCT01238991|102038497|FG008|NOT COMPLETED|Overall Study||4||
48111308|NCT02281136|100598091|FG000|STARTED|Overall Study||29||
48111309|NCT02281136|100598091|FG000|COMPLETED|Overall Study||29||
48111310|NCT02281136|100598091|FG000|NOT COMPLETED|Overall Study||0||
48111311|NCT01067768|100598092|FG000|STARTED|Overall Study||604||
48111312|NCT01067768|100598093|FG001|STARTED|Overall Study||605||
48111313|NCT01067768|100598092|FG000|COMPLETED|Overall Study||604||
48111314|NCT01067768|100598093|FG001|COMPLETED|Overall Study||605||
48111315|NCT01067768|100598092|FG000|NOT COMPLETED|Overall Study||0||
48111316|NCT01067768|100598093|FG001|NOT COMPLETED|Overall Study||0||
48111317|NCT01458327|100598094|FG000|STARTED|Overall Study||3||
48111318|NCT01458327|100598094|FG000|COMPLETED|Overall Study||3||
48111319|NCT01458327|100598094|FG000|NOT COMPLETED|Overall Study||0||
48111320|NCT02272413|100598095|FG000|STARTED|Randomized Through Treatment Start||338|Started are randomized|
48111321|NCT02272413|100598096|FG001|STARTED|Randomized Through Treatment Start||333|Started are randomized|
48111322|NCT02272413|100598095|FG000|Treated|Randomized Through Treatment Start||335||
48111323|NCT02272413|100598096|FG001|Treated|Randomized Through Treatment Start||328||
48111324|NCT02272413|100598095|FG000|COMPLETED|Randomized Through Treatment Start||335|Completed are treated|
48111325|NCT02272413|100598096|FG001|COMPLETED|Randomized Through Treatment Start||328|Completed are treated|
48111326|NCT02272413|100598095|FG000|NOT COMPLETED|Randomized Through Treatment Start||3||
48111327|NCT02272413|100598096|FG001|NOT COMPLETED|Randomized Through Treatment Start||5||
48111328|NCT02272413|100598095|FG000|STARTED|Pre-switch Period||335|Started are treated|
48111329|NCT02272413|100598096|FG001|STARTED|Pre-switch Period||328|Started are treated|
48111330|NCT02272413|100598095|FG000|COMPLETED|Pre-switch Period||42||
48111331|NCT02272413|100598096|FG001|COMPLETED|Pre-switch Period||46||
48111332|NCT02272413|100598095|FG000|NOT COMPLETED|Pre-switch Period||293||
48111333|NCT02272413|100598096|FG001|NOT COMPLETED|Pre-switch Period||282||
48111334|NCT02272413|100598095|FG000|STARTED|Post-switch Period||42||
48111335|NCT02272413|100598096|FG001|STARTED|Post-switch Period||46||
48111336|NCT02272413|100598095|FG000|COMPLETED|Post-switch Period||0||
48111337|NCT02272413|100598096|FG001|COMPLETED|Post-switch Period||0||
48111338|NCT02272413|100598095|FG000|NOT COMPLETED|Post-switch Period||42||
48111339|NCT02272413|100598096|FG001|NOT COMPLETED|Post-switch Period||46||
48111340|NCT02547129|100598097|FG000|STARTED|Overall Study||2||
48558707|NCT04067050|101698340|FG000|NOT COMPLETED|One Month||4||
48558708|NCT04067050|101698341|FG001|NOT COMPLETED|One Month||0||
48695276|NCT01238991|102038498|FG009|NOT COMPLETED|Overall Study||2||
48695277|NCT04528017|102038499|FG000|STARTED|First Wear Period (8 -0/+3 Days)||27||54
48695278|NCT04528017|102038500|FG001|STARTED|First Wear Period (8 -0/+3 Days)||28||56
48695279|NCT04528017|102038499|FG000|COMPLETED|First Wear Period (8 -0/+3 Days)||27||54
48695280|NCT04528017|102038500|FG001|COMPLETED|First Wear Period (8 -0/+3 Days)||28||56
48695281|NCT04528017|102038499|FG000|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0||0
48695282|NCT04528017|102038500|FG001|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0||0
48695283|NCT04528017|102038499|FG000|STARTED|Second Wear Period (8 -0/+3 Days)||27||54
48695284|NCT04528017|102038500|FG001|STARTED|Second Wear Period (8 -0/+3 Days)||28||56
48558709|NCT04067050|101698340|FG000|STARTED|Two Month||22||
48558710|NCT04067050|101698341|FG001|STARTED|Two Month||29||
48558711|NCT04067050|101698340|FG000|COMPLETED|Two Month||20||
48558712|NCT04067050|101698341|FG001|COMPLETED|Two Month||29||
48558713|NCT04067050|101698340|FG000|NOT COMPLETED|Two Month||2||
48558714|NCT04067050|101698341|FG001|NOT COMPLETED|Two Month||0||
48558715|NCT03668808|101698342|FG000|STARTED|First Intervention||13||
48111341|NCT02547129|100598098|FG001|STARTED|Overall Study||2||
48111342|NCT02547129|100598097|FG000|COMPLETED|Overall Study||1||
48111343|NCT02547129|100598098|FG001|COMPLETED|Overall Study||2||
48111344|NCT02547129|100598097|FG000|NOT COMPLETED|Overall Study||1||
48111345|NCT02547129|100598098|FG001|NOT COMPLETED|Overall Study||0||
48111346|NCT04365699|100598099|FG000|STARTED|Overall Study||10||
48111347|NCT04365699|100598100|FG001|STARTED|Overall Study||16||
48111348|NCT04365699|100598101|FG002|STARTED|Overall Study||55||
48111349|NCT04365699|100598099|FG000|COMPLETED|Overall Study||8||
48111350|NCT04365699|100598100|FG001|COMPLETED|Overall Study||11||
48111351|NCT04365699|100598101|FG002|COMPLETED|Overall Study||40||
48111352|NCT04365699|100598099|FG000|NOT COMPLETED|Overall Study||2||
48111353|NCT04365699|100598100|FG001|NOT COMPLETED|Overall Study||5||
48111354|NCT04365699|100598101|FG002|NOT COMPLETED|Overall Study||15||
48111355|NCT01577758|100598102|FG000|STARTED|Dose Escalation Phase||2||
48111356|NCT01577758|100598103|FG001|STARTED|Dose Escalation Phase||2||
48111357|NCT01577758|100598104|FG002|STARTED|Dose Escalation Phase||2||
48111358|NCT01577758|100598105|FG003|STARTED|Dose Escalation Phase||2||
48111359|NCT01577758|100598106|FG004|STARTED|Dose Escalation Phase||6||
48111360|NCT01577758|100598107|FG005|STARTED|Dose Escalation Phase||4||
48111361|NCT01577758|100598108|FG006|STARTED|Dose Escalation Phase||1||
48111362|NCT01577758|100598109|FG007|STARTED|Dose Escalation Phase||0||
48111363|NCT01577758|100598102|FG000|COMPLETED|Dose Escalation Phase||0||
48111364|NCT01577758|100598103|FG001|COMPLETED|Dose Escalation Phase||0||
48111365|NCT01577758|100598104|FG002|COMPLETED|Dose Escalation Phase||0||
48111366|NCT01577758|100598105|FG003|COMPLETED|Dose Escalation Phase||0||
48111367|NCT01577758|100598106|FG004|COMPLETED|Dose Escalation Phase||0||
48111368|NCT01577758|100598107|FG005|COMPLETED|Dose Escalation Phase||0||
48111369|NCT01577758|100598108|FG006|COMPLETED|Dose Escalation Phase||0||
48111370|NCT01577758|100598109|FG007|COMPLETED|Dose Escalation Phase||0||
48111371|NCT01577758|100598102|FG000|NOT COMPLETED|Dose Escalation Phase||2||
48111372|NCT01577758|100598103|FG001|NOT COMPLETED|Dose Escalation Phase||2||
48111373|NCT01577758|100598104|FG002|NOT COMPLETED|Dose Escalation Phase||2||
48111374|NCT01577758|100598105|FG003|NOT COMPLETED|Dose Escalation Phase||2||
48111375|NCT01577758|100598106|FG004|NOT COMPLETED|Dose Escalation Phase||6||
48111376|NCT01577758|100598107|FG005|NOT COMPLETED|Dose Escalation Phase||4||
48111377|NCT01577758|100598108|FG006|NOT COMPLETED|Dose Escalation Phase||1||
48111378|NCT01577758|100598109|FG007|NOT COMPLETED|Dose Escalation Phase||0||
48111379|NCT01577758|100598102|FG000|STARTED|mCRC Expansion Phase||0||
48111380|NCT01577758|100598103|FG001|STARTED|mCRC Expansion Phase||0||
48111381|NCT01577758|100598104|FG002|STARTED|mCRC Expansion Phase||0||
48111382|NCT01577758|100598105|FG003|STARTED|mCRC Expansion Phase||0||
48111383|NCT01577758|100598106|FG004|STARTED|mCRC Expansion Phase||0||
48111384|NCT01577758|100598107|FG005|STARTED|mCRC Expansion Phase||0||
48111385|NCT01577758|100598108|FG006|STARTED|mCRC Expansion Phase||0||
48111386|NCT01577758|100598109|FG007|STARTED|mCRC Expansion Phase||25||
48111387|NCT01577758|100598102|FG000|COMPLETED|mCRC Expansion Phase||0||
48111388|NCT01577758|100598103|FG001|COMPLETED|mCRC Expansion Phase||0||
48111389|NCT01577758|100598104|FG002|COMPLETED|mCRC Expansion Phase||0||
48111390|NCT01577758|100598105|FG003|COMPLETED|mCRC Expansion Phase||0||
48111391|NCT01577758|100598106|FG004|COMPLETED|mCRC Expansion Phase||0||
48111392|NCT01577758|100598107|FG005|COMPLETED|mCRC Expansion Phase||0||
48111393|NCT01577758|100598108|FG006|COMPLETED|mCRC Expansion Phase||0||
48111394|NCT01577758|100598109|FG007|COMPLETED|mCRC Expansion Phase||0||
48111395|NCT01577758|100598102|FG000|NOT COMPLETED|mCRC Expansion Phase||0||
48111396|NCT01577758|100598103|FG001|NOT COMPLETED|mCRC Expansion Phase||0||
48111397|NCT01577758|100598104|FG002|NOT COMPLETED|mCRC Expansion Phase||0||
48111398|NCT01577758|100598105|FG003|NOT COMPLETED|mCRC Expansion Phase||0||
48111399|NCT01577758|100598106|FG004|NOT COMPLETED|mCRC Expansion Phase||0||
48111400|NCT01577758|100598107|FG005|NOT COMPLETED|mCRC Expansion Phase||0||
48111401|NCT01577758|100598108|FG006|NOT COMPLETED|mCRC Expansion Phase||0||
48111402|NCT01577758|100598109|FG007|NOT COMPLETED|mCRC Expansion Phase||25||
48111403|NCT00952341|100598110|FG000|STARTED|Cycle 1||209||
48111404|NCT00952341|100598111|FG001|STARTED|Cycle 1||212||
48111405|NCT00952341|100598110|FG000|COMPLETED|Cycle 1||189||
48111406|NCT00952341|100598111|FG001|COMPLETED|Cycle 1||199||
48111407|NCT00952341|100598110|FG000|NOT COMPLETED|Cycle 1||20||
48111408|NCT00952341|100598111|FG001|NOT COMPLETED|Cycle 1||13||
48111409|NCT00952341|100598110|FG000|STARTED|Cycle 2||110||
48111410|NCT00952341|100598111|FG001|STARTED|Cycle 2||130||
48111411|NCT00952341|100598110|FG000|COMPLETED|Cycle 2||101||
48111412|NCT00952341|100598111|FG001|COMPLETED|Cycle 2||118||
48111413|NCT00952341|100598110|FG000|NOT COMPLETED|Cycle 2||9||
48111414|NCT00952341|100598111|FG001|NOT COMPLETED|Cycle 2||12||
48111415|NCT04174313|100598112|FG000|STARTED|Overall Study||15||
48111416|NCT04174313|100598113|FG001|STARTED|Overall Study||50||
48111417|NCT04174313|100598112|FG000|COMPLETED|Overall Study||15||
48111418|NCT04174313|100598113|FG001|COMPLETED|Overall Study||50||
48111419|NCT04174313|100598112|FG000|NOT COMPLETED|Overall Study||0||
48111420|NCT04174313|100598113|FG001|NOT COMPLETED|Overall Study||0||
48111421|NCT04238728|100598114|FG000|STARTED|Overall Study||31||
48111422|NCT04238728|100598114|FG000|COMPLETED|Overall Study||28||
48111423|NCT04238728|100598114|FG000|NOT COMPLETED|Overall Study||3||
48111424|NCT01190254|100598115|FG000|STARTED|Overall Study||102||
48111425|NCT01190254|100598116|FG001|STARTED|Overall Study||98||
48111426|NCT01190254|100598117|FG002|STARTED|Overall Study||106||
48111427|NCT01190254|100598115|FG000|Treated|Overall Study||102||
48111428|NCT01190254|100598116|FG001|Treated|Overall Study||98||
48111429|NCT01190254|100598117|FG002|Treated|Overall Study||106||
48111430|NCT01190254|100598115|FG000|COMPLETED|Overall Study||81||
48111431|NCT01190254|100598116|FG001|COMPLETED|Overall Study||81||
48274201|NCT02277054|100996171|FG000|COMPLETED|Overall Study||5||
48274202|NCT02277054|100996171|FG000|NOT COMPLETED|Overall Study||0||
48274203|NCT01504477|100996172|FG000|STARTED|Overall Study||6||
48274204|NCT01504477|100996172|FG000|COMPLETED|Overall Study||6||
48558716|NCT03668808|101698343|FG001|STARTED|First Intervention||12||
48558717|NCT03668808|101698342|FG000|COMPLETED|First Intervention||11||
48558718|NCT03668808|101698343|FG001|COMPLETED|First Intervention||10||
48558719|NCT03668808|101698342|FG000|NOT COMPLETED|First Intervention||2||
48558720|NCT03668808|101698343|FG001|NOT COMPLETED|First Intervention||2||
48558721|NCT03668808|101698342|FG000|STARTED|Washout Period||11||
48558722|NCT03668808|101698343|FG001|STARTED|Washout Period||10||
48558723|NCT03668808|101698342|FG000|COMPLETED|Washout Period||11||
48558724|NCT03668808|101698343|FG001|COMPLETED|Washout Period||10||
48558725|NCT03668808|101698342|FG000|NOT COMPLETED|Washout Period||0||
48558726|NCT03668808|101698343|FG001|NOT COMPLETED|Washout Period||0||
48558727|NCT03668808|101698342|FG000|STARTED|Second Intervention||11||
48274205|NCT01504477|100996172|FG000|NOT COMPLETED|Overall Study||0||
48274206|NCT02310100|100996173|FG000|STARTED|Overall Study||178|FDA approval|
48274207|NCT02310100|100996173|FG000|COMPLETED|Overall Study||160||
48274208|NCT02310100|100996173|FG000|NOT COMPLETED|Overall Study||18||
48274209|NCT04531098|100996174|FG000|STARTED|Stage I||0||
48274210|NCT04531098|100996175|FG001|STARTED|Stage I||67||
48274211|NCT04531098|100996176|FG002|STARTED|Stage I||134||
48274212|NCT04531098|100996174|FG000|COMPLETED|Stage I||0||
48274213|NCT04531098|100996175|FG001|COMPLETED|Stage I||62||
48274214|NCT04531098|100996176|FG002|COMPLETED|Stage I||116||
48274215|NCT04531098|100996174|FG000|NOT COMPLETED|Stage I||0||
48274216|NCT04531098|100996175|FG001|NOT COMPLETED|Stage I||5||
48274217|NCT04531098|100996176|FG002|NOT COMPLETED|Stage I||18||
48274218|NCT04531098|100996174|FG000|STARTED|Stage II||134||
48274219|NCT04531098|100996175|FG001|STARTED|Stage II||67||
48274220|NCT04531098|100996176|FG002|STARTED|Stage II||0||
48274221|NCT04531098|100996174|FG000|COMPLETED|Stage II||121||
48274222|NCT04531098|100996175|FG001|COMPLETED|Stage II||57||
48274223|NCT04531098|100996176|FG002|COMPLETED|Stage II||0||
48274224|NCT04531098|100996174|FG000|NOT COMPLETED|Stage II||13||
48274225|NCT04531098|100996175|FG001|NOT COMPLETED|Stage II||10||
48558728|NCT03668808|101698343|FG001|STARTED|Second Intervention||10||
48558729|NCT03668808|101698342|FG000|COMPLETED|Second Intervention||11||
48558730|NCT03668808|101698343|FG001|COMPLETED|Second Intervention||10||
48558731|NCT03668808|101698342|FG000|NOT COMPLETED|Second Intervention||0||
48558732|NCT03668808|101698343|FG001|NOT COMPLETED|Second Intervention||0||
48558733|NCT00793455|101698344|FG000|STARTED|Overall Study||314||
48558734|NCT00793455|101698345|FG001|STARTED|Overall Study||314||
48558735|NCT00793455|101698344|FG000|COMPLETED|Overall Study||314||
48558736|NCT00793455|101698345|FG001|COMPLETED|Overall Study||314||
48558737|NCT00793455|101698344|FG000|NOT COMPLETED|Overall Study||0||
48558738|NCT00793455|101698345|FG001|NOT COMPLETED|Overall Study||0||
48558739|NCT03022370|101698346|FG000|STARTED|Overall Study||677||
48111432|NCT01190254|100598117|FG002|COMPLETED|Overall Study||84||
48111433|NCT01190254|100598115|FG000|NOT COMPLETED|Overall Study||21||
48111434|NCT01190254|100598116|FG001|NOT COMPLETED|Overall Study||17||
48111435|NCT01190254|100598117|FG002|NOT COMPLETED|Overall Study||22||
48111436|NCT03483935|100598118|FG000|STARTED|Stage 1: Dose Setting Study||7||34
48274226|NCT04531098|100996176|FG002|NOT COMPLETED|Stage II||0||
48274227|NCT01118013|100996177|FG000|STARTED|Overall Study||6||
48558740|NCT03022370|101698347|FG001|STARTED|Overall Study||674||
48558741|NCT03022370|101698346|FG000|COMPLETED|Overall Study||497||
48274228|NCT01118013|100996177|FG000|COMPLETED|Overall Study||6||
48274229|NCT01118013|100996177|FG000|NOT COMPLETED|Overall Study||0||
48274230|NCT04276415|100996178|FG000|STARTED|Overall Study||4||
48274231|NCT04276415|100996179|FG001|STARTED|Overall Study||4||
48274232|NCT04276415|100996180|FG002|STARTED|Overall Study||5||
48274233|NCT04276415|100996181|FG003|STARTED|Overall Study||13||
48274234|NCT04276415|100996182|FG004|STARTED|Overall Study||6||
48558742|NCT03022370|101698347|FG001|COMPLETED|Overall Study||553||
48558743|NCT03022370|101698346|FG000|NOT COMPLETED|Overall Study||180||
48111437|NCT03483935|100598118|FG000|COMPLETED|Stage 1: Dose Setting Study||7|7 participants were recruited to the stage 1, dose finding study|34
48111438|NCT03483935|100598118|FG000|NOT COMPLETED|Stage 1: Dose Setting Study||0||0
48274235|NCT04276415|100996183|FG005|STARTED|Overall Study||2||
48558744|NCT03022370|101698347|FG001|NOT COMPLETED|Overall Study||121||
48274236|NCT04276415|100996178|FG000|COMPLETED|Overall Study||0||
48274237|NCT04276415|100996179|FG001|COMPLETED|Overall Study||0||
48274238|NCT04276415|100996180|FG002|COMPLETED|Overall Study||0||
48274239|NCT04276415|100996181|FG003|COMPLETED|Overall Study||0||
48274240|NCT04276415|100996182|FG004|COMPLETED|Overall Study||0||
48274241|NCT04276415|100996183|FG005|COMPLETED|Overall Study||0||
48274242|NCT04276415|100996178|FG000|NOT COMPLETED|Overall Study||4||
48274243|NCT04276415|100996179|FG001|NOT COMPLETED|Overall Study||4||
48558745|NCT03793608|101698348|FG000|STARTED|Overall Study||1||
48558746|NCT03793608|101698349|FG001|STARTED|Overall Study||24||
48558747|NCT03793608|101698348|FG000|Treated|Overall Study||1||
48274244|NCT04276415|100996180|FG002|NOT COMPLETED|Overall Study||5||
48274245|NCT04276415|100996181|FG003|NOT COMPLETED|Overall Study||13||
48558748|NCT03793608|101698349|FG001|Treated|Overall Study||24||
48558749|NCT03793608|101698348|FG000|Safety Analysis Set (SAF)|Overall Study||0|The safety analysis set (SAF) included all participants who received dupilumab. All efficacy and safety variables were analyzed using SAF.|
48558750|NCT03793608|101698349|FG001|Safety Analysis Set (SAF)|Overall Study||24|The safety analysis set (SAF) included all participants who received dupilumab. All efficacy and safety variables were analyzed using SAF.|
48558751|NCT03793608|101698348|FG000|COMPLETED|Overall Study||1||
48558752|NCT03793608|101698349|FG001|COMPLETED|Overall Study||24||
48558753|NCT03793608|101698348|FG000|NOT COMPLETED|Overall Study||0||
48558754|NCT03793608|101698349|FG001|NOT COMPLETED|Overall Study||0||
48558755|NCT01202175|101698350|FG000|STARTED|Overall Study||50||
48558756|NCT01202175|101698350|FG000|Nebivolol|Overall Study||25||
48558757|NCT01202175|101698350|FG000|Pacebo|Overall Study||25||
48558758|NCT01202175|101698350|FG000|COMPLETED|Overall Study||45||
48558759|NCT01202175|101698350|FG000|NOT COMPLETED|Overall Study||5||
48558760|NCT03103087|101698351|FG000|STARTED|Overall Study||126||
48558761|NCT03103087|101698352|FG001|STARTED|Overall Study||127||
48558762|NCT03103087|101698353|FG002|STARTED|Overall Study||129||
48558763|NCT03103087|101698351|FG000|COMPLETED|Overall Study||102||
48558764|NCT03103087|101698352|FG001|COMPLETED|Overall Study||98||
48558765|NCT03103087|101698353|FG002|COMPLETED|Overall Study||102||
48558766|NCT03103087|101698351|FG000|NOT COMPLETED|Overall Study||24||
48558767|NCT03103087|101698352|FG001|NOT COMPLETED|Overall Study||29||
48558768|NCT03103087|101698353|FG002|NOT COMPLETED|Overall Study||27||
48558769|NCT02414958|101698354|FG000|STARTED|Overall Study||243||
48558770|NCT02414958|101698355|FG001|STARTED|Overall Study||243||
48558771|NCT02414958|101698356|FG002|STARTED|Overall Study||244||
48558772|NCT02414958|101698354|FG000|COMPLETED|Overall Study||211||
48558773|NCT02414958|101698355|FG001|COMPLETED|Overall Study||223||
48558774|NCT02414958|101698356|FG002|COMPLETED|Overall Study||230||
48558775|NCT02414958|101698354|FG000|NOT COMPLETED|Overall Study||32||
48558776|NCT02414958|101698355|FG001|NOT COMPLETED|Overall Study||20||
48558777|NCT02414958|101698356|FG002|NOT COMPLETED|Overall Study||14||
48558778|NCT01125917|101698357|FG000|STARTED|Overall Study||354||
48558779|NCT01125917|101698357|FG000|COMPLETED|Overall Study||15||
48558780|NCT01125917|101698357|FG000|NOT COMPLETED|Overall Study||339||
48558781|NCT02115269|101698358|FG000|STARTED|Overall Study||759||
48558782|NCT02115269|101698358|FG000|COMPLETED|Overall Study||702||
48558783|NCT02115269|101698358|FG000|NOT COMPLETED|Overall Study||57||
48558784|NCT00513240|101698359|FG000|STARTED|Overall Study||35||
48558785|NCT00513240|101698360|FG001|STARTED|Overall Study||27||
48558786|NCT00513240|101698359|FG000|Clinical Data Collection &Pre/Postop MRI|Overall Study||32||
48558787|NCT00513240|101698360|FG001|Clinical Data Collection &Pre/Postop MRI|Overall Study||27||
48558788|NCT00513240|101698359|FG000|COMPLETED|Overall Study||22||
48558789|NCT00513240|101698360|FG001|COMPLETED|Overall Study||20||
48558790|NCT00513240|101698359|FG000|NOT COMPLETED|Overall Study||13||
48558791|NCT00513240|101698360|FG001|NOT COMPLETED|Overall Study||7||
48558792|NCT00523939|101698361|FG000|STARTED|Overall Study||2||
48558793|NCT00523939|101698362|FG001|STARTED|Overall Study||2||
48558794|NCT00523939|101698361|FG000|COMPLETED|Overall Study||2||
48558795|NCT00523939|101698362|FG001|COMPLETED|Overall Study||2||
48274246|NCT04276415|100996182|FG004|NOT COMPLETED|Overall Study||6||
48274247|NCT04276415|100996183|FG005|NOT COMPLETED|Overall Study||2||
48274248|NCT03284203|100996184|FG000|STARTED|Overall Study||8||
48274249|NCT03284203|100996184|FG000|COMPLETED|Overall Study||5||
48558796|NCT00523939|101698361|FG000|NOT COMPLETED|Overall Study||0||
48558797|NCT00523939|101698362|FG001|NOT COMPLETED|Overall Study||0||
48558798|NCT00470470|101698363|FG000|STARTED|Overall Study||30||
48558799|NCT00470470|101698363|FG000|COMPLETED|Overall Study||25||
48558800|NCT00470470|101698363|FG000|NOT COMPLETED|Overall Study||5||
48558801|NCT00075816|101698364|FG000|STARTED|Overall Study||278||
48558802|NCT00075816|101698365|FG001|STARTED|Overall Study||273||
48274250|NCT03284203|100996184|FG000|NOT COMPLETED|Overall Study||3||
48274251|NCT02420951|100996185|FG000|STARTED|Overall Study||25||
48558803|NCT00075816|101698364|FG000|COMPLETED|Overall Study||264||
48558804|NCT00075816|101698365|FG001|COMPLETED|Overall Study||262||
48558805|NCT00075816|101698364|FG000|NOT COMPLETED|Overall Study||14||
48274252|NCT02420951|100996186|FG001|STARTED|Overall Study||25||
48274253|NCT02420951|100996185|FG000|COMPLETED|Overall Study||25||
48558806|NCT00075816|101698365|FG001|NOT COMPLETED|Overall Study||11||
48558807|NCT01977417|101698366|FG000|STARTED|Overall Study||8||
48558808|NCT01977417|101698367|FG001|STARTED|Overall Study||13||
48558809|NCT01977417|101698366|FG000|COMPLETED|Overall Study||5||
48558810|NCT01977417|101698367|FG001|COMPLETED|Overall Study||7||
48558811|NCT01977417|101698366|FG000|NOT COMPLETED|Overall Study||3||
48558812|NCT01977417|101698367|FG001|NOT COMPLETED|Overall Study||6||
48274254|NCT02420951|100996186|FG001|COMPLETED|Overall Study||25||
48274255|NCT02420951|100996185|FG000|NOT COMPLETED|Overall Study||0||
48274256|NCT02420951|100996186|FG001|NOT COMPLETED|Overall Study||0||
48274257|NCT03449901|100996187|FG000|STARTED|Overall Study||82||
48274258|NCT03449901|100996188|FG001|STARTED|Overall Study||15||
48274259|NCT03449901|100996187|FG000|COMPLETED|Overall Study||1||
48274260|NCT03449901|100996188|FG001|COMPLETED|Overall Study||0||
48274261|NCT03449901|100996187|FG000|NOT COMPLETED|Overall Study||81||
48274262|NCT03449901|100996188|FG001|NOT COMPLETED|Overall Study||15||
48274263|NCT00293059|100996189|FG000|STARTED|Overall Study||120||
48274264|NCT00293059|100996190|FG001|STARTED|Overall Study||70||
48274265|NCT00293059|100996189|FG000|Subjects Received Treatment|Overall Study||119||
48274266|NCT00293059|100996190|FG001|Subjects Received Treatment|Overall Study||66||
48274267|NCT00293059|100996189|FG000|Cycle 1/Treatment Day 28|Overall Study||115||
48274268|NCT00293059|100996190|FG001|Cycle 1/Treatment Day 28|Overall Study||64||
48274269|NCT00293059|100996189|FG000|Cycle 3/Treatment Day 84|Overall Study||100||
48274270|NCT00293059|100996190|FG001|Cycle 3/Treatment Day 84|Overall Study||55||
48274271|NCT00293059|100996189|FG000|Cycle 7/Treatment Day 196|Overall Study||113||
48274272|NCT00293059|100996190|FG001|Cycle 7/Treatment Day 196|Overall Study||62||
48274273|NCT00293059|100996189|FG000|COMPLETED|Overall Study||85||
48274274|NCT00293059|100996190|FG001|COMPLETED|Overall Study||51||
48274275|NCT00293059|100996189|FG000|NOT COMPLETED|Overall Study||35||
48393092|NCT01998438|101291506|FG001|STARTED|Overall Study||318||
48393093|NCT01998438|101291507|FG002|STARTED|Overall Study||318||
48558813|NCT01009814|101698368|FG000|STARTED|Overall Study||10||
48558814|NCT01009814|101698369|FG001|STARTED|Overall Study||10||
48558815|NCT01009814|101698370|FG002|STARTED|Overall Study||10||
48558816|NCT01009814|101698371|FG003|STARTED|Overall Study||10||
48558817|NCT01009814|101698372|FG004|STARTED|Overall Study||10||
48558818|NCT01009814|101698368|FG000|COMPLETED|Overall Study||9||
48558819|NCT01009814|101698369|FG001|COMPLETED|Overall Study||9||
48558820|NCT01009814|101698370|FG002|COMPLETED|Overall Study||10||
48558821|NCT01009814|101698371|FG003|COMPLETED|Overall Study||10||
48558822|NCT01009814|101698372|FG004|COMPLETED|Overall Study||10||
48558823|NCT01009814|101698368|FG000|NOT COMPLETED|Overall Study||1||
48558824|NCT01009814|101698369|FG001|NOT COMPLETED|Overall Study||1||
48558825|NCT01009814|101698370|FG002|NOT COMPLETED|Overall Study||0||
48558826|NCT01009814|101698371|FG003|NOT COMPLETED|Overall Study||0||
48558827|NCT01009814|101698372|FG004|NOT COMPLETED|Overall Study||0||
48558828|NCT01280643|101702197|FG000|STARTED|Overall Study||0||
48558829|NCT01280643|101702198|FG001|STARTED|Overall Study||1||
48558830|NCT01280643|101702199|FG002|STARTED|Overall Study||1||
48558831|NCT01280643|101702200|FG003|STARTED|Overall Study||1||
48558832|NCT01280643|101702201|FG004|STARTED|Overall Study||0||
48558833|NCT01280643|101702202|FG005|STARTED|Overall Study||0||
48558834|NCT01280643|101702203|FG006|STARTED|Overall Study||0||
48558835|NCT01280643|101702204|FG007|STARTED|Overall Study||0||
48558836|NCT01280643|101702205|FG008|STARTED|Overall Study||0||
48558837|NCT01280643|101702197|FG000|COMPLETED|Overall Study||0||
48558838|NCT01280643|101702198|FG001|COMPLETED|Overall Study||0||
48558839|NCT01280643|101702199|FG002|COMPLETED|Overall Study||1||
48558840|NCT01280643|101702200|FG003|COMPLETED|Overall Study||1||
48558841|NCT01280643|101702201|FG004|COMPLETED|Overall Study||0||
48558842|NCT01280643|101702202|FG005|COMPLETED|Overall Study||0||
48558843|NCT01280643|101702203|FG006|COMPLETED|Overall Study||0||
48558844|NCT01280643|101702204|FG007|COMPLETED|Overall Study||0||
48558845|NCT01280643|101702205|FG008|COMPLETED|Overall Study||0||
48558846|NCT01280643|101702197|FG000|NOT COMPLETED|Overall Study||0||
48558847|NCT01280643|101702198|FG001|NOT COMPLETED|Overall Study||1||
48558848|NCT01280643|101702199|FG002|NOT COMPLETED|Overall Study||0||
48558849|NCT01280643|101702200|FG003|NOT COMPLETED|Overall Study||0||
48558850|NCT01280643|101702201|FG004|NOT COMPLETED|Overall Study||0||
48558851|NCT01280643|101702202|FG005|NOT COMPLETED|Overall Study||0||
48558852|NCT01280643|101702203|FG006|NOT COMPLETED|Overall Study||0||
48558853|NCT01280643|101702204|FG007|NOT COMPLETED|Overall Study||0||
48558854|NCT01280643|101702205|FG008|NOT COMPLETED|Overall Study||0||
48274276|NCT00293059|100996190|FG001|NOT COMPLETED|Overall Study||19||
48558855|NCT04688671|101702206|FG000|STARTED|Overall Study||83||
48558856|NCT04688671|101702207|FG001|STARTED|Overall Study||84||
48558857|NCT04688671|101702206|FG000|COMPLETED|Overall Study||75||
48558858|NCT04688671|101702207|FG001|COMPLETED|Overall Study||80||
48558859|NCT04688671|101702206|FG000|NOT COMPLETED|Overall Study||8||
48558860|NCT04688671|101702207|FG001|NOT COMPLETED|Overall Study||4||
48558861|NCT02640482|101702208|FG000|STARTED|Overall Study||202||
48558862|NCT02640482|101702209|FG001|STARTED|Overall Study||100||
48558863|NCT02640482|101702208|FG000|COMPLETED|Overall Study||199||
48558864|NCT02640482|101702209|FG001|COMPLETED|Overall Study||100||
48558865|NCT02640482|101702208|FG000|NOT COMPLETED|Overall Study||3||
48558866|NCT02640482|101702209|FG001|NOT COMPLETED|Overall Study||0||
48558867|NCT00280735|101702210|FG000|STARTED|Overall Study||75||
48558868|NCT00280735|101702210|FG000|Received Treatment|Overall Study||72||
48558869|NCT00280735|101702210|FG000|Received Adequate Exposure|Overall Study||57|Defined as receiving 4 cycles of therapy within 12 weeks of initiating the first dose.|
48558870|NCT00280735|101702210|FG000|COMPLETED|Overall Study||57||
48558871|NCT00280735|101702210|FG000|NOT COMPLETED|Overall Study||18||
48558872|NCT02199964|101702211|FG000|STARTED|Overall Study||2||
48558873|NCT02199964|101702212|FG001|STARTED|Overall Study||2||
48558874|NCT02199964|101702211|FG000|COMPLETED|Overall Study||2||
48558875|NCT02199964|101702212|FG001|COMPLETED|Overall Study||2||
48558876|NCT02199964|101702211|FG000|NOT COMPLETED|Overall Study||0||
48558877|NCT02199964|101702212|FG001|NOT COMPLETED|Overall Study||0||
48558878|NCT03170544|101702213|FG000|STARTED|Part 1||10||
48558879|NCT03170544|101702214|FG001|STARTED|Part 1||6||
48558880|NCT03170544|101702215|FG002|STARTED|Part 1||6||
48558881|NCT03170544|101702216|FG003|STARTED|Part 1||7||
48558882|NCT03170544|101702217|FG004|STARTED|Part 1||6||
48558883|NCT03170544|101702218|FG005|STARTED|Part 1||6||
48558884|NCT03170544|101702219|FG006|STARTED|Part 1||0||
48558885|NCT03170544|101702220|FG007|STARTED|Part 1||0||
48558886|NCT03170544|101702221|FG008|STARTED|Part 1||0||
48558887|NCT03170544|101702222|FG009|STARTED|Part 1||0||
48558888|NCT03170544|101702223|FG010|STARTED|Part 1||0||
48558889|NCT03170544|101702224|FG011|STARTED|Part 1||0||
48558890|NCT03170544|101702213|FG000|COMPLETED|Part 1||9||
48558891|NCT03170544|101702214|FG001|COMPLETED|Part 1||6||
48558892|NCT03170544|101702215|FG002|COMPLETED|Part 1||6||
48558893|NCT03170544|101702216|FG003|COMPLETED|Part 1||6||
48558894|NCT03170544|101702217|FG004|COMPLETED|Part 1||6||
48558895|NCT03170544|101702218|FG005|COMPLETED|Part 1||6||
48558896|NCT03170544|101702219|FG006|COMPLETED|Part 1||0||
48558897|NCT03170544|101702220|FG007|COMPLETED|Part 1||0||
48558898|NCT03170544|101702221|FG008|COMPLETED|Part 1||0||
48558899|NCT03170544|101702222|FG009|COMPLETED|Part 1||0||
48558900|NCT03170544|101702223|FG010|COMPLETED|Part 1||0||
48558901|NCT03170544|101702224|FG011|COMPLETED|Part 1||0||
48558902|NCT03170544|101702213|FG000|NOT COMPLETED|Part 1||1||
48558903|NCT03170544|101702214|FG001|NOT COMPLETED|Part 1||0||
48558904|NCT03170544|101702215|FG002|NOT COMPLETED|Part 1||0||
48558905|NCT03170544|101702216|FG003|NOT COMPLETED|Part 1||1||
48558906|NCT03170544|101702217|FG004|NOT COMPLETED|Part 1||0||
48558907|NCT03170544|101702218|FG005|NOT COMPLETED|Part 1||0||
48558908|NCT03170544|101702219|FG006|NOT COMPLETED|Part 1||0||
48558909|NCT03170544|101702220|FG007|NOT COMPLETED|Part 1||0||
48558910|NCT03170544|101702221|FG008|NOT COMPLETED|Part 1||0||
48558911|NCT03170544|101702222|FG009|NOT COMPLETED|Part 1||0||
48558912|NCT03170544|101702223|FG010|NOT COMPLETED|Part 1||0||
48558913|NCT03170544|101702224|FG011|NOT COMPLETED|Part 1||0||
48558914|NCT03170544|101702213|FG000|STARTED|Part 2||0||
48558915|NCT03170544|101702214|FG001|STARTED|Part 2||0||
48558916|NCT03170544|101702215|FG002|STARTED|Part 2||0||
48558917|NCT03170544|101702216|FG003|STARTED|Part 2||0||
48558918|NCT03170544|101702217|FG004|STARTED|Part 2||0||
48558919|NCT03170544|101702218|FG005|STARTED|Part 2||0||
48558920|NCT03170544|101702219|FG006|STARTED|Part 2||4||
48558921|NCT03170544|101702220|FG007|STARTED|Part 2||0||
48558922|NCT03170544|101702221|FG008|STARTED|Part 2||0||
48558923|NCT03170544|101702222|FG009|STARTED|Part 2||0||
48558924|NCT03170544|101702223|FG010|STARTED|Part 2||0||
48558925|NCT03170544|101702224|FG011|STARTED|Part 2||0||
48558926|NCT03170544|101702213|FG000|COMPLETED|Part 2||0||
48558927|NCT03170544|101702214|FG001|COMPLETED|Part 2||0||
48558928|NCT03170544|101702215|FG002|COMPLETED|Part 2||0||
48558929|NCT03170544|101702216|FG003|COMPLETED|Part 2||0||
48558930|NCT03170544|101702217|FG004|COMPLETED|Part 2||0||
48558931|NCT03170544|101702218|FG005|COMPLETED|Part 2||0||
48558932|NCT03170544|101702219|FG006|COMPLETED|Part 2||4||
48558933|NCT03170544|101702220|FG007|COMPLETED|Part 2||0||
48558934|NCT03170544|101702221|FG008|COMPLETED|Part 2||0||
48558935|NCT03170544|101702222|FG009|COMPLETED|Part 2||0||
48558936|NCT03170544|101702223|FG010|COMPLETED|Part 2||0||
48558937|NCT03170544|101702224|FG011|COMPLETED|Part 2||0||
48558938|NCT03170544|101702213|FG000|NOT COMPLETED|Part 2||0||
48558939|NCT03170544|101702214|FG001|NOT COMPLETED|Part 2||0||
48558940|NCT03170544|101702215|FG002|NOT COMPLETED|Part 2||0||
48558941|NCT03170544|101702216|FG003|NOT COMPLETED|Part 2||0||
48558942|NCT03170544|101702217|FG004|NOT COMPLETED|Part 2||0||
48558943|NCT03170544|101702218|FG005|NOT COMPLETED|Part 2||0||
48558944|NCT03170544|101702219|FG006|NOT COMPLETED|Part 2||0||
48558945|NCT03170544|101702220|FG007|NOT COMPLETED|Part 2||0||
48558946|NCT03170544|101702221|FG008|NOT COMPLETED|Part 2||0||
48558947|NCT03170544|101702222|FG009|NOT COMPLETED|Part 2||0||
48558948|NCT03170544|101702223|FG010|NOT COMPLETED|Part 2||0||
48558949|NCT03170544|101702224|FG011|NOT COMPLETED|Part 2||0||
48558950|NCT03170544|101702213|FG000|STARTED|Part 3||0||
48558951|NCT03170544|101702214|FG001|STARTED|Part 3||0||
48558952|NCT03170544|101702215|FG002|STARTED|Part 3||0||
48558953|NCT03170544|101702216|FG003|STARTED|Part 3||0||
48558954|NCT03170544|101702217|FG004|STARTED|Part 3||0||
48558955|NCT03170544|101702218|FG005|STARTED|Part 3||0||
48558956|NCT03170544|101702219|FG006|STARTED|Part 3||0||
48558957|NCT03170544|101702220|FG007|STARTED|Part 3||4||
48558958|NCT03170544|101702221|FG008|STARTED|Part 3||6||
48558959|NCT03170544|101702222|FG009|STARTED|Part 3||6||
48558960|NCT03170544|101702223|FG010|STARTED|Part 3||0||
48558961|NCT03170544|101702224|FG011|STARTED|Part 3||0||
48558962|NCT03170544|101702213|FG000|COMPLETED|Part 3||0||
48558963|NCT03170544|101702214|FG001|COMPLETED|Part 3||0||
48558964|NCT03170544|101702215|FG002|COMPLETED|Part 3||0||
48558965|NCT03170544|101702216|FG003|COMPLETED|Part 3||0||
48695285|NCT04528017|102038499|FG000|COMPLETED|Second Wear Period (8 -0/+3 Days)||27||54
48695286|NCT04528017|102038500|FG001|COMPLETED|Second Wear Period (8 -0/+3 Days)||28||56
48695287|NCT04528017|102038499|FG000|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0||0
48695288|NCT04528017|102038500|FG001|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0||0
48274277|NCT04076943|100996191|FG000|STARTED|Overall Study||92||
48274278|NCT04076943|100996191|FG000|Received at Least 1 Dose of Study Drug|Overall Study||92||
48274279|NCT04076943|100996191|FG000|COMPLETED|Overall Study||58||
48274280|NCT04076943|100996191|FG000|NOT COMPLETED|Overall Study||34||
48274281|NCT01232738|100996192|FG000|STARTED|Overall Study||36||
48274282|NCT01232738|100996192|FG000|COMPLETED|Overall Study||23||
48274283|NCT01232738|100996192|FG000|NOT COMPLETED|Overall Study||13||
48274284|NCT03916458|100996193|FG000|STARTED|Overall Study||62||
48274285|NCT03916458|100996193|FG000|COMPLETED|Overall Study||62||
48274286|NCT03916458|100996193|FG000|NOT COMPLETED|Overall Study||0||
48274287|NCT00685698|100996194|FG000|STARTED|Overall Study||38||
48558966|NCT03170544|101702217|FG004|COMPLETED|Part 3||0||
48558967|NCT03170544|101702218|FG005|COMPLETED|Part 3||0||
48558968|NCT03170544|101702219|FG006|COMPLETED|Part 3||0||
48558969|NCT03170544|101702220|FG007|COMPLETED|Part 3||4||
48274288|NCT00685698|100996194|FG000|COMPLETED|Overall Study||25||
48274289|NCT00685698|100996194|FG000|NOT COMPLETED|Overall Study||13||
48274290|NCT00392925|100996195|FG000|STARTED|4 Week Lead-In Period - Non-Randomized||177||
48274291|NCT00392925|100996196|FG001|STARTED|4 Week Lead-In Period - Non-Randomized||0||
48274292|NCT00392925|100996197|FG002|STARTED|4 Week Lead-In Period - Non-Randomized||0||
48274293|NCT00392925|100996198|FG003|STARTED|4 Week Lead-In Period - Non-Randomized||0||
48274294|NCT00392925|100996195|FG000|COMPLETED|4 Week Lead-In Period - Non-Randomized||139||
48274295|NCT00392925|100996196|FG001|COMPLETED|4 Week Lead-In Period - Non-Randomized||0||
48274296|NCT00392925|100996197|FG002|COMPLETED|4 Week Lead-In Period - Non-Randomized||0||
48274297|NCT00392925|100996198|FG003|COMPLETED|4 Week Lead-In Period - Non-Randomized||0||
48274298|NCT00392925|100996195|FG000|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||38||
48274299|NCT00392925|100996196|FG001|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0||
48274300|NCT00392925|100996197|FG002|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0||
48274301|NCT00392925|100996198|FG003|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0||
48274302|NCT00392925|100996195|FG000|STARTED|Randomization to Treatment Group Period||0||
48274303|NCT00392925|100996196|FG001|STARTED|Randomization to Treatment Group Period||27||
48274304|NCT00392925|100996197|FG002|STARTED|Randomization to Treatment Group Period||56||
48274305|NCT00392925|100996198|FG003|STARTED|Randomization to Treatment Group Period||56||
48274306|NCT00392925|100996195|FG000|COMPLETED|Randomization to Treatment Group Period||0||
48274307|NCT00392925|100996196|FG001|COMPLETED|Randomization to Treatment Group Period||19||
48274308|NCT00392925|100996197|FG002|COMPLETED|Randomization to Treatment Group Period||37||
48274309|NCT00392925|100996198|FG003|COMPLETED|Randomization to Treatment Group Period||38||
48274310|NCT00392925|100996195|FG000|NOT COMPLETED|Randomization to Treatment Group Period||0||
48274311|NCT00392925|100996196|FG001|NOT COMPLETED|Randomization to Treatment Group Period||8||
48274312|NCT00392925|100996197|FG002|NOT COMPLETED|Randomization to Treatment Group Period||19||
48274313|NCT00392925|100996198|FG003|NOT COMPLETED|Randomization to Treatment Group Period||18||
48274314|NCT01088984|100996199|FG000|STARTED|Phase 1||5||
48274315|NCT01088984|100996200|FG001|STARTED|Phase 1||6||
48274316|NCT01088984|100996199|FG000|COMPLETED|Phase 1||0||
48274317|NCT01088984|100996200|FG001|COMPLETED|Phase 1||0||
48274318|NCT01088984|100996199|FG000|NOT COMPLETED|Phase 1||5||
48274319|NCT01088984|100996200|FG001|NOT COMPLETED|Phase 1||6||
48274320|NCT01088984|100996199|FG000|STARTED|Phase 2||0||
48274321|NCT01088984|100996200|FG001|STARTED|Phase 2||32||
48274322|NCT01088984|100996199|FG000|COMPLETED|Phase 2||0||
48274323|NCT01088984|100996200|FG001|COMPLETED|Phase 2||0||
48274324|NCT01088984|100996199|FG000|NOT COMPLETED|Phase 2||0||
48274325|NCT01088984|100996200|FG001|NOT COMPLETED|Phase 2||32||
48558970|NCT03170544|101702221|FG008|COMPLETED|Part 3||6||
48558971|NCT03170544|101702222|FG009|COMPLETED|Part 3||6||
48558972|NCT03170544|101702223|FG010|COMPLETED|Part 3||0||
48558973|NCT03170544|101702224|FG011|COMPLETED|Part 3||0||
48558974|NCT03170544|101702213|FG000|NOT COMPLETED|Part 3||0||
48558975|NCT03170544|101702214|FG001|NOT COMPLETED|Part 3||0||
48695289|NCT06219967|102038501|FG000|STARTED|Study Day 1||3||
48695290|NCT06219967|102038502|FG001|STARTED|Study Day 1||2||
48695291|NCT06219967|102038501|FG000|COMPLETED|Study Day 1||3||
48695292|NCT06219967|102038502|FG001|COMPLETED|Study Day 1||2||
48695293|NCT06219967|102038501|FG000|NOT COMPLETED|Study Day 1||0||
48695294|NCT06219967|102038502|FG001|NOT COMPLETED|Study Day 1||0||
48695295|NCT06219967|102038501|FG000|STARTED|Washout (at Least 7 Days)||3||
48695296|NCT06219967|102038502|FG001|STARTED|Washout (at Least 7 Days)||2||
48695297|NCT06219967|102038501|FG000|COMPLETED|Washout (at Least 7 Days)||3||
48695298|NCT06219967|102038502|FG001|COMPLETED|Washout (at Least 7 Days)||2||
48695299|NCT06219967|102038501|FG000|NOT COMPLETED|Washout (at Least 7 Days)||0||
48695300|NCT06219967|102038502|FG001|NOT COMPLETED|Washout (at Least 7 Days)||0||
48274326|NCT01728337|100996201|FG000|STARTED|Overall Study||80||
48558976|NCT03170544|101702215|FG002|NOT COMPLETED|Part 3||0||
48695301|NCT06219967|102038501|FG000|STARTED|Study Day 2||3||
48695302|NCT06219967|102038502|FG001|STARTED|Study Day 2||2||
48274327|NCT01728337|100996201|FG000|COMPLETED|Overall Study||80||
48695303|NCT06219967|102038501|FG000|COMPLETED|Study Day 2||3||
48695304|NCT06219967|102038502|FG001|COMPLETED|Study Day 2||2||
48274328|NCT01728337|100996201|FG000|NOT COMPLETED|Overall Study||0||
48274329|NCT01940939|100996202|FG000|STARTED|Overall Study||35||
48274330|NCT01940939|100996203|FG001|STARTED|Overall Study||35||
48274331|NCT01940939|100996202|FG000|COMPLETED|Overall Study||33||
48274332|NCT01940939|100996203|FG001|COMPLETED|Overall Study||27||
48274333|NCT01940939|100996202|FG000|NOT COMPLETED|Overall Study||2||
48274334|NCT01940939|100996203|FG001|NOT COMPLETED|Overall Study||8||
48274335|NCT02988050|100996204|FG000|STARTED|Overall Study||30||
48274336|NCT02988050|100996205|FG001|STARTED|Overall Study||30||
48274337|NCT02988050|100996204|FG000|COMPLETED|Overall Study||30||
48274338|NCT02988050|100996205|FG001|COMPLETED|Overall Study||30||
48274339|NCT02988050|100996204|FG000|NOT COMPLETED|Overall Study||0||
48558977|NCT03170544|101702216|FG003|NOT COMPLETED|Part 3||0||
48558978|NCT03170544|101702217|FG004|NOT COMPLETED|Part 3||0||
48558979|NCT03170544|101702218|FG005|NOT COMPLETED|Part 3||0||
48558980|NCT03170544|101702219|FG006|NOT COMPLETED|Part 3||0||
48558981|NCT03170544|101702220|FG007|NOT COMPLETED|Part 3||0||
48695305|NCT06219967|102038501|FG000|NOT COMPLETED|Study Day 2||0||
48695306|NCT06219967|102038502|FG001|NOT COMPLETED|Study Day 2||0||
48695307|NCT00956007|102038503|FG000|STARTED|Overall Study||314||
48695308|NCT00956007|102038504|FG001|STARTED|Overall Study||313||
48558982|NCT03170544|101702221|FG008|NOT COMPLETED|Part 3||0||
48558983|NCT03170544|101702222|FG009|NOT COMPLETED|Part 3||0||
48558984|NCT03170544|101702223|FG010|NOT COMPLETED|Part 3||0||
48558985|NCT03170544|101702224|FG011|NOT COMPLETED|Part 3||0||
48558986|NCT03170544|101702213|FG000|STARTED|Part 4||0||
48558987|NCT03170544|101702214|FG001|STARTED|Part 4||0||
48558988|NCT03170544|101702215|FG002|STARTED|Part 4||0||
48695309|NCT00956007|102038503|FG000|Eligible|Overall Study||287||
48695310|NCT00956007|102038504|FG001|Eligible|Overall Study||290||
48695311|NCT00956007|102038503|FG000|Eligible and Started Protocol Treatment|Overall Study||282|Adverse event population|
48695312|NCT00956007|102038504|FG001|Eligible and Started Protocol Treatment|Overall Study||276|Adverse event population|
48695313|NCT00956007|102038503|FG000|COMPLETED|Overall Study||287|Participants contributing data to results are considered to have completed the study.|
48695314|NCT00956007|102038504|FG001|COMPLETED|Overall Study||290|Participants contributing data to results are considered to have completed the study.|
48695315|NCT00956007|102038503|FG000|NOT COMPLETED|Overall Study||27||
48695316|NCT00956007|102038504|FG001|NOT COMPLETED|Overall Study||23||
48695317|NCT00516906|102038505|FG000|STARTED|Overall Study||36||
48695318|NCT00516906|102038506|FG001|STARTED|Overall Study||32||
48558989|NCT03170544|101702216|FG003|STARTED|Part 4||0||
48558990|NCT03170544|101702217|FG004|STARTED|Part 4||0||
48558991|NCT03170544|101702218|FG005|STARTED|Part 4||0||
48558992|NCT03170544|101702219|FG006|STARTED|Part 4||0||
48558993|NCT03170544|101702220|FG007|STARTED|Part 4||0||
48695319|NCT00516906|102038505|FG000|COMPLETED|Overall Study||30||
48695320|NCT00516906|102038506|FG001|COMPLETED|Overall Study||30||
48695321|NCT00516906|102038505|FG000|NOT COMPLETED|Overall Study||6||
48695322|NCT00516906|102038506|FG001|NOT COMPLETED|Overall Study||2||
48695323|NCT03654040|102038507|FG000|STARTED|Overall Study||30||
48695324|NCT03654040|102038508|FG001|STARTED|Overall Study||12||
48695325|NCT03654040|102038507|FG000|COMPLETED|Overall Study||0||
48695326|NCT03654040|102038508|FG001|COMPLETED|Overall Study||5||
48695327|NCT03654040|102038507|FG000|NOT COMPLETED|Overall Study||30||
48695328|NCT03654040|102038508|FG001|NOT COMPLETED|Overall Study||7||
48695329|NCT01555073|102038509|FG000|STARTED|Overall Study||7||
48695330|NCT01555073|102038510|FG001|STARTED|Overall Study||3||
48695331|NCT01555073|102038511|FG002|STARTED|Overall Study||7||
48695332|NCT01555073|102038512|FG003|STARTED|Overall Study||6||
48695333|NCT01555073|102038509|FG000|COMPLETED|Overall Study||6||
48695334|NCT01555073|102038510|FG001|COMPLETED|Overall Study||1||
48695335|NCT01555073|102038511|FG002|COMPLETED|Overall Study||7||
48695336|NCT01555073|102038512|FG003|COMPLETED|Overall Study||1||
48695337|NCT01555073|102038509|FG000|NOT COMPLETED|Overall Study||1||
48695338|NCT01555073|102038510|FG001|NOT COMPLETED|Overall Study||2||
48274340|NCT02988050|100996205|FG001|NOT COMPLETED|Overall Study||0||
48274341|NCT03635099|100996206|FG000|STARTED|Period 1||20||
48274342|NCT03635099|100996207|FG001|STARTED|Period 1||40||
48274343|NCT03635099|100996208|FG002|STARTED|Period 1||39||
48274344|NCT03635099|100996209|FG003|STARTED|Period 1||39||
48274345|NCT03635099|100996210|FG004|STARTED|Period 1||40||
48393094|NCT01998438|101291505|FG000|COMPLETED|Overall Study||319||
48558994|NCT03170544|101702221|FG008|STARTED|Part 4||0||
48558995|NCT03170544|101702222|FG009|STARTED|Part 4||0||
48558996|NCT03170544|101702223|FG010|STARTED|Part 4||3||
48695339|NCT01555073|102038511|FG002|NOT COMPLETED|Overall Study||0||
48695340|NCT01555073|102038512|FG003|NOT COMPLETED|Overall Study||5||
48695341|NCT03734016|102038513|FG000|STARTED|Overall Study||327||
48695342|NCT03734016|102038514|FG001|STARTED|Overall Study||325||
48695343|NCT03734016|102038513|FG000|COMPLETED|Overall Study||0||
48695344|NCT03734016|102038514|FG001|COMPLETED|Overall Study||0||
48695345|NCT03734016|102038513|FG000|NOT COMPLETED|Overall Study||327||
48695346|NCT03734016|102038514|FG001|NOT COMPLETED|Overall Study||325||
48695347|NCT00778375|102038515|FG000|STARTED|Overall Study||122||
48695348|NCT00778375|102038515|FG000|COMPLETED|Overall Study||119||
48695349|NCT00778375|102038515|FG000|NOT COMPLETED|Overall Study||3||
48695350|NCT01133756|102038516|FG000|STARTED|Overall Study||2||
48695351|NCT01133756|102038517|FG001|STARTED|Overall Study||3||
48558997|NCT03170544|101702224|FG011|STARTED|Part 4||6||
48558998|NCT03170544|101702213|FG000|COMPLETED|Part 4||0||
48558999|NCT03170544|101702214|FG001|COMPLETED|Part 4||0||
48559000|NCT03170544|101702215|FG002|COMPLETED|Part 4||0||
48559001|NCT03170544|101702216|FG003|COMPLETED|Part 4||0||
48559002|NCT03170544|101702217|FG004|COMPLETED|Part 4||0||
48559003|NCT03170544|101702218|FG005|COMPLETED|Part 4||0||
48559004|NCT03170544|101702219|FG006|COMPLETED|Part 4||0||
48559005|NCT03170544|101702220|FG007|COMPLETED|Part 4||0||
48559006|NCT03170544|101702221|FG008|COMPLETED|Part 4||0||
48559007|NCT03170544|101702222|FG009|COMPLETED|Part 4||0||
48559008|NCT03170544|101702223|FG010|COMPLETED|Part 4||3||
48695352|NCT01133756|102038518|FG002|STARTED|Overall Study||2||
48695353|NCT01133756|102038516|FG000|Completed 6 Cycles|Overall Study||1||
48695354|NCT01133756|102038517|FG001|Completed 6 Cycles|Overall Study||0||
48695355|NCT01133756|102038518|FG002|Completed 6 Cycles|Overall Study||0||
48695356|NCT01133756|102038516|FG000|COMPLETED|Overall Study||0||
48695357|NCT01133756|102038517|FG001|COMPLETED|Overall Study||0||
48274346|NCT03635099|100996211|FG005|STARTED|Period 1||10||
48274347|NCT03635099|100996212|FG006|STARTED|Period 1||44||
48274348|NCT03635099|100996213|FG007|STARTED|Period 1||42||
48274349|NCT03635099|100996206|FG000|Full Analysis Set (FAS)|Period 1||20||
48274350|NCT03635099|100996207|FG001|Full Analysis Set (FAS)|Period 1||40||
48559009|NCT03170544|101702224|FG011|COMPLETED|Part 4||6||
48559010|NCT03170544|101702213|FG000|NOT COMPLETED|Part 4||0||
48559011|NCT03170544|101702214|FG001|NOT COMPLETED|Part 4||0||
48559012|NCT03170544|101702215|FG002|NOT COMPLETED|Part 4||0||
48559013|NCT03170544|101702216|FG003|NOT COMPLETED|Part 4||0||
48559014|NCT03170544|101702217|FG004|NOT COMPLETED|Part 4||0||
48559015|NCT03170544|101702218|FG005|NOT COMPLETED|Part 4||0||
48559016|NCT03170544|101702219|FG006|NOT COMPLETED|Part 4||0||
48559017|NCT03170544|101702220|FG007|NOT COMPLETED|Part 4||0||
48559018|NCT03170544|101702221|FG008|NOT COMPLETED|Part 4||0||
48559019|NCT03170544|101702222|FG009|NOT COMPLETED|Part 4||0||
48559020|NCT03170544|101702223|FG010|NOT COMPLETED|Part 4||0||
48559021|NCT03170544|101702224|FG011|NOT COMPLETED|Part 4||0||
48559022|NCT02573597|101702225|FG000|STARTED|Overall Study||8||
48559023|NCT02573597|101702226|FG001|STARTED|Overall Study||6||
48559024|NCT02573597|101702227|FG002|STARTED|Overall Study||9||
48559025|NCT02573597|101702228|FG003|STARTED|Overall Study||8||
48559026|NCT02573597|101702225|FG000|Met Reject Critera|Overall Study||4||
48559027|NCT02573597|101702226|FG001|Met Reject Critera|Overall Study||1||
48559028|NCT02573597|101702227|FG002|Met Reject Critera|Overall Study||3||
48559029|NCT02573597|101702228|FG003|Met Reject Critera|Overall Study||2||
48559030|NCT02573597|101702225|FG000|Analyzable Data Set|Overall Study||4||
48559031|NCT02573597|101702226|FG001|Analyzable Data Set|Overall Study||5||
48559032|NCT02573597|101702227|FG002|Analyzable Data Set|Overall Study||6||
48559033|NCT02573597|101702228|FG003|Analyzable Data Set|Overall Study||6||
48559034|NCT02573597|101702225|FG000|COMPLETED|Overall Study||8||
48559035|NCT02573597|101702226|FG001|COMPLETED|Overall Study||6||
48559036|NCT02573597|101702227|FG002|COMPLETED|Overall Study||9||
48559037|NCT02573597|101702228|FG003|COMPLETED|Overall Study||8||
48559038|NCT02573597|101702225|FG000|NOT COMPLETED|Overall Study||0||
48559039|NCT02573597|101702226|FG001|NOT COMPLETED|Overall Study||0||
48695358|NCT01133756|102038518|FG002|COMPLETED|Overall Study||0||
48695359|NCT01133756|102038516|FG000|NOT COMPLETED|Overall Study||2||
48559040|NCT02573597|101702227|FG002|NOT COMPLETED|Overall Study||0||
48559041|NCT02573597|101702228|FG003|NOT COMPLETED|Overall Study||0||
48559042|NCT02687451|101702229|FG000|STARTED|Overall Study||6||
48559043|NCT02687451|101702230|FG001|STARTED|Overall Study||5||
48559044|NCT02687451|101702231|FG002|STARTED|Overall Study||5||
48559045|NCT02687451|101702232|FG003|STARTED|Overall Study||5||
48559046|NCT02687451|101702233|FG004|STARTED|Overall Study||4||
48559047|NCT02687451|101702234|FG005|STARTED|Overall Study||3||
48559048|NCT02687451|101702229|FG000|COMPLETED|Overall Study||5||
48695360|NCT01133756|102038517|FG001|NOT COMPLETED|Overall Study||3||
48695361|NCT01133756|102038518|FG002|NOT COMPLETED|Overall Study||2||
48695362|NCT03650413|102038519|FG000|STARTED|Overall Study||143||
48274351|NCT03635099|100996208|FG002|Full Analysis Set (FAS)|Period 1||39||
48559049|NCT02687451|101702230|FG001|COMPLETED|Overall Study||5||
48559050|NCT02687451|101702231|FG002|COMPLETED|Overall Study||5||
48559051|NCT02687451|101702232|FG003|COMPLETED|Overall Study||5||
48559052|NCT02687451|101702233|FG004|COMPLETED|Overall Study||4||
48559053|NCT02687451|101702234|FG005|COMPLETED|Overall Study||2||
48559054|NCT02687451|101702229|FG000|NOT COMPLETED|Overall Study||1||
48695363|NCT03650413|102038519|FG000|COMPLETED|Overall Study||82||
48695364|NCT03650413|102038519|FG000|NOT COMPLETED|Overall Study||61||
48695365|NCT03028415|102038520|FG000|STARTED|Overall Study||39||
48695366|NCT03028415|102038521|FG001|STARTED|Overall Study||17||
48559055|NCT02687451|101702230|FG001|NOT COMPLETED|Overall Study||0||
48559056|NCT02687451|101702231|FG002|NOT COMPLETED|Overall Study||0||
48559057|NCT02687451|101702232|FG003|NOT COMPLETED|Overall Study||0||
48559058|NCT02687451|101702233|FG004|NOT COMPLETED|Overall Study||0||
48559059|NCT02687451|101702234|FG005|NOT COMPLETED|Overall Study||1||
48559060|NCT00920439|101702235|FG000|STARTED|Overall Study||25||
48559061|NCT00920439|101702235|FG000|COMPLETED|Overall Study||25||
48559062|NCT00920439|101702235|FG000|NOT COMPLETED|Overall Study||0||
48559063|NCT02677753|101702236|FG000|STARTED|Overall Study||37||
48559064|NCT02677753|101702237|FG001|STARTED|Overall Study||38||
48559065|NCT02677753|101702236|FG000|COMPLETED|Overall Study||36||
48559066|NCT02677753|101702237|FG001|COMPLETED|Overall Study||38||
48559067|NCT02677753|101702236|FG000|NOT COMPLETED|Overall Study||1||
48559068|NCT02677753|101702237|FG001|NOT COMPLETED|Overall Study||0||
48559069|NCT00595621|101702238|FG000|STARTED|Open Label Run in||22||
48559070|NCT00595621|101702239|FG001|STARTED|Open Label Run in||0||
48559071|NCT00595621|101702238|FG000|COMPLETED|Open Label Run in||19||
48695367|NCT03028415|102038520|FG000|Modified Intention-to-treat (mITT) Population|Overall Study||39||
48695368|NCT03028415|102038521|FG001|Modified Intention-to-treat (mITT) Population|Overall Study||17||
48695369|NCT03028415|102038520|FG000|COMPLETED|Overall Study||31||
48695370|NCT03028415|102038521|FG001|COMPLETED|Overall Study||14||
48695371|NCT03028415|102038520|FG000|NOT COMPLETED|Overall Study||8||
48695372|NCT03028415|102038521|FG001|NOT COMPLETED|Overall Study||3||
48695373|NCT01581021|102038522|FG000|STARTED|Overall Study||29||
48695374|NCT01581021|102038523|FG001|STARTED|Overall Study||29||
48695375|NCT01581021|102038522|FG000|COMPLETED|Overall Study||19||
48695376|NCT01581021|102038523|FG001|COMPLETED|Overall Study||18||
48695377|NCT01581021|102038522|FG000|NOT COMPLETED|Overall Study||10||
48695378|NCT01581021|102038523|FG001|NOT COMPLETED|Overall Study||11||
48695379|NCT02771574|102038524|FG000|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||3||
48695380|NCT02771574|102038525|FG001|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0||
48695381|NCT02771574|102038526|FG002|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0||
48695382|NCT02771574|102038527|FG003|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0||
48695383|NCT02771574|102038528|FG004|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0||
48695384|NCT02771574|102038524|FG000|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||3||
48695385|NCT02771574|102038525|FG001|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0||
48695386|NCT02771574|102038526|FG002|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0||
48695387|NCT02771574|102038527|FG003|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0||
48695388|NCT02771574|102038528|FG004|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0||
48695389|NCT02771574|102038524|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0||
48695390|NCT02771574|102038525|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0||
48695391|NCT02771574|102038526|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0||
48695392|NCT02771574|102038527|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0||
48695393|NCT02771574|102038528|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0||
48695394|NCT02771574|102038524|FG000|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0||
48695395|NCT02771574|102038525|FG001|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||5||
48695396|NCT02771574|102038526|FG002|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0||
48695397|NCT02771574|102038527|FG003|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0||
48695398|NCT02771574|102038528|FG004|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0||
48695399|NCT02771574|102038524|FG000|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0||
48695400|NCT02771574|102038525|FG001|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||5||
48695401|NCT02771574|102038526|FG002|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0||
48695402|NCT02771574|102038527|FG003|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0||
48695403|NCT02771574|102038528|FG004|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0||
48695404|NCT02771574|102038524|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0||
48695405|NCT02771574|102038525|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0||
48695406|NCT02771574|102038526|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0||
48111439|NCT03483935|100598118|FG000|STARTED|Stage 2: Randomised Controlled Trial||11|Eleven participants were recruited and randomized to Stage 2. 179 AKs (93 treated, 86 untreated) were assessed.|179
48111440|NCT03483935|100598118|FG000|AKs Treated|Stage 2: Randomised Controlled Trial||11||93
48111441|NCT03483935|100598118|FG000|AKs Not Treated|Stage 2: Randomised Controlled Trial||11||86
48111442|NCT03483935|100598118|FG000|COMPLETED|Stage 2: Randomised Controlled Trial||11||179
48111443|NCT03483935|100598118|FG000|NOT COMPLETED|Stage 2: Randomised Controlled Trial||0||0
48559072|NCT00595621|101702239|FG001|COMPLETED|Open Label Run in||0||
48559073|NCT00595621|101702238|FG000|NOT COMPLETED|Open Label Run in||3||
48559074|NCT00595621|101702239|FG001|NOT COMPLETED|Open Label Run in||0||
48111444|NCT01106456|100598119|FG000|STARTED|Overall Study||243||
48111445|NCT01106456|100598120|FG001|STARTED|Overall Study||220||
48111446|NCT01106456|100598119|FG000|COMPLETED|Overall Study||140||
48111447|NCT01106456|100598120|FG001|COMPLETED|Overall Study||96||
48559075|NCT00595621|101702238|FG000|STARTED|Randomization and Study||10||
48559076|NCT00595621|101702239|FG001|STARTED|Randomization and Study||9||
48559077|NCT00595621|101702238|FG000|COMPLETED|Randomization and Study||8||
48695407|NCT02771574|102038527|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0||
48559078|NCT00595621|101702239|FG001|COMPLETED|Randomization and Study||8||
48559079|NCT00595621|101702238|FG000|NOT COMPLETED|Randomization and Study||2||
48559080|NCT00595621|101702239|FG001|NOT COMPLETED|Randomization and Study||1||
48559081|NCT01629511|101702240|FG000|STARTED|Overall Study||4||
48559082|NCT01629511|101702241|FG001|STARTED|Overall Study||0||
48559083|NCT01629511|101702242|FG002|STARTED|Overall Study||8||
48559084|NCT01629511|101702243|FG003|STARTED|Overall Study||3||
48559085|NCT01629511|101702240|FG000|COMPLETED|Overall Study||4||
48559086|NCT01629511|101702241|FG001|COMPLETED|Overall Study||0||
48559087|NCT01629511|101702242|FG002|COMPLETED|Overall Study||8||
48559088|NCT01629511|101702243|FG003|COMPLETED|Overall Study||3||
48559089|NCT01629511|101702240|FG000|NOT COMPLETED|Overall Study||0||
48559090|NCT01629511|101702241|FG001|NOT COMPLETED|Overall Study||0||
48559091|NCT01629511|101702242|FG002|NOT COMPLETED|Overall Study||0||
48559092|NCT01629511|101702243|FG003|NOT COMPLETED|Overall Study||0||
48559093|NCT02676882|101702244|FG000|STARTED|Overall Study||13||
48559094|NCT02676882|101702245|FG001|STARTED|Overall Study||7||
48559095|NCT02676882|101702244|FG000|Evaluable|Overall Study||11|Received study drug; completed minimum 1 follow-up visit; if Group 1, discontinued antidepressants.|
48559096|NCT02676882|101702245|FG001|Evaluable|Overall Study||6|Received study drug; completed minimum 1 follow-up visit; if Group 1, discontinued antidepressants.|
48559097|NCT02676882|101702244|FG000|COMPLETED|Overall Study||10||
48559098|NCT02676882|101702245|FG001|COMPLETED|Overall Study||5||
48559099|NCT02676882|101702244|FG000|NOT COMPLETED|Overall Study||3||
48559100|NCT02676882|101702245|FG001|NOT COMPLETED|Overall Study||2||
48559101|NCT00610428|101702246|FG000|STARTED|Overall Study||24||
48559102|NCT00610428|101702247|FG001|STARTED|Overall Study||24||
48559103|NCT00610428|101702248|FG002|STARTED|Overall Study||27||
48559104|NCT00610428|101702246|FG000|COMPLETED|Overall Study||24||
48559105|NCT00610428|101702247|FG001|COMPLETED|Overall Study||23||
48559106|NCT00610428|101702248|FG002|COMPLETED|Overall Study||25||
48559107|NCT00610428|101702246|FG000|NOT COMPLETED|Overall Study||0||
48559108|NCT00610428|101702247|FG001|NOT COMPLETED|Overall Study||1||
48559109|NCT00610428|101702248|FG002|NOT COMPLETED|Overall Study||2||
48559110|NCT02038010|101702249|FG000|STARTED|Completed 1st Cycle and Started Cycle 2||11||
48559111|NCT02038010|101702250|FG001|STARTED|Completed 1st Cycle and Started Cycle 2||6||
48559112|NCT02038010|101702251|FG002|STARTED|Completed 1st Cycle and Started Cycle 2||0||
48559113|NCT02038010|101702252|FG003|STARTED|Completed 1st Cycle and Started Cycle 2||0||
48559114|NCT02038010|101702249|FG000|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||11||
48559115|NCT02038010|101702250|FG001|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||5||
48559116|NCT02038010|101702251|FG002|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||0||
48559117|NCT02038010|101702252|FG003|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||0||
48559118|NCT02038010|101702249|FG000|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||10||
48559119|NCT02038010|101702250|FG001|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||4||
48559120|NCT02038010|101702251|FG002|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||0||
48559121|NCT02038010|101702252|FG003|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||0||
48559122|NCT02038010|101702249|FG000|COMPLETED|Completed 1st Cycle and Started Cycle 2||10||
48559123|NCT02038010|101702250|FG001|COMPLETED|Completed 1st Cycle and Started Cycle 2||4||
48559124|NCT02038010|101702251|FG002|COMPLETED|Completed 1st Cycle and Started Cycle 2||0||
48559125|NCT02038010|101702252|FG003|COMPLETED|Completed 1st Cycle and Started Cycle 2||0||
48559126|NCT02038010|101702249|FG000|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||1||
48559127|NCT02038010|101702250|FG001|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||2||
48559128|NCT02038010|101702251|FG002|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||0||
48559129|NCT02038010|101702252|FG003|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||0||
48559130|NCT02038010|101702249|FG000|STARTED|Completed 3 Cycles/Reached 1st Response||10||
48559131|NCT02038010|101702250|FG001|STARTED|Completed 3 Cycles/Reached 1st Response||4||
48559132|NCT02038010|101702251|FG002|STARTED|Completed 3 Cycles/Reached 1st Response||0||
48559133|NCT02038010|101702252|FG003|STARTED|Completed 3 Cycles/Reached 1st Response||0||
48559134|NCT02038010|101702249|FG000|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||10||
48559135|NCT02038010|101702250|FG001|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||4||
48559136|NCT02038010|101702251|FG002|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||0||
48559137|NCT02038010|101702252|FG003|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||0||
48559138|NCT02038010|101702249|FG000|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||9||
48559139|NCT02038010|101702250|FG001|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||3||
48559140|NCT02038010|101702251|FG002|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||0||
48559141|NCT02038010|101702252|FG003|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||0||
48274352|NCT03635099|100996209|FG003|Full Analysis Set (FAS)|Period 1||39||
48274353|NCT03635099|100996210|FG004|Full Analysis Set (FAS)|Period 1||40||
48274354|NCT03635099|100996211|FG005|Full Analysis Set (FAS)|Period 1||10||
48274355|NCT03635099|100996212|FG006|Full Analysis Set (FAS)|Period 1||43||
48559142|NCT02038010|101702249|FG000|COMPLETED|Completed 3 Cycles/Reached 1st Response||9||
48559143|NCT02038010|101702250|FG001|COMPLETED|Completed 3 Cycles/Reached 1st Response||3||
48559144|NCT02038010|101702251|FG002|COMPLETED|Completed 3 Cycles/Reached 1st Response||0||
48274356|NCT03635099|100996213|FG007|Full Analysis Set (FAS)|Period 1||42||
48559145|NCT02038010|101702252|FG003|COMPLETED|Completed 3 Cycles/Reached 1st Response||0||
48559146|NCT02038010|101702249|FG000|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||1||
48559147|NCT02038010|101702250|FG001|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||1||
48559148|NCT02038010|101702251|FG002|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||0||
48559149|NCT02038010|101702252|FG003|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||0||
48559150|NCT02038010|101702249|FG000|STARTED|Follow Up||11||
48559151|NCT02038010|101702250|FG001|STARTED|Follow Up||6||
48559152|NCT02038010|101702251|FG002|STARTED|Follow Up||0||
48559153|NCT02038010|101702252|FG003|STARTED|Follow Up||0||
48559154|NCT02038010|101702249|FG000|COMPLETED|Follow Up||4||
48559155|NCT02038010|101702250|FG001|COMPLETED|Follow Up||3||
48559156|NCT02038010|101702251|FG002|COMPLETED|Follow Up||0||
48559157|NCT02038010|101702252|FG003|COMPLETED|Follow Up||0||
48559158|NCT02038010|101702249|FG000|NOT COMPLETED|Follow Up||7||
48559159|NCT02038010|101702250|FG001|NOT COMPLETED|Follow Up||3||
48559160|NCT02038010|101702251|FG002|NOT COMPLETED|Follow Up||0||
48559161|NCT02038010|101702252|FG003|NOT COMPLETED|Follow Up||0||
48559162|NCT03631706|101702253|FG000|STARTED|Overall Study||152||
48559163|NCT03631706|101702254|FG001|STARTED|Overall Study||152||
48559164|NCT03631706|101702253|FG000|Treated|Overall Study||151||
48559165|NCT03631706|101702254|FG001|Treated|Overall Study||152||
48559166|NCT03631706|101702253|FG000|COMPLETED|Overall Study||60||
48559167|NCT03631706|101702254|FG001|COMPLETED|Overall Study||54||
48559168|NCT03631706|101702253|FG000|NOT COMPLETED|Overall Study||92||
48559169|NCT03631706|101702254|FG001|NOT COMPLETED|Overall Study||98||
48274357|NCT03635099|100996206|FG000|COMPLETED|Period 1||16|Completed period 1: completed 12 weeks of treatment.|
48559170|NCT01254643|101702255|FG000|STARTED|Overall Study||100||
48559171|NCT01254643|101702255|FG000|Vaccination 1|Overall Study||100||
48559172|NCT01254643|101702255|FG000|Vaccination 2|Overall Study||99||
48559173|NCT01254643|101702255|FG000|Vaccination 3|Overall Study||99||
48559174|NCT01254643|101702255|FG000|COMPLETED|Overall Study||99||
48559175|NCT01254643|101702255|FG000|NOT COMPLETED|Overall Study||1||
48559176|NCT01321879|101702256|FG000|STARTED|Overall Study||39||
48559177|NCT01321879|101702256|FG000|COMPLETED|Overall Study||25||
48559178|NCT01321879|101702256|FG000|NOT COMPLETED|Overall Study||14||
48559179|NCT01823861|101702257|FG000|STARTED|4 Month Follow up||249||
48559180|NCT01823861|101702258|FG001|STARTED|4 Month Follow up||251||
48559181|NCT01823861|101702257|FG000|COMPLETED|4 Month Follow up||211||
48559182|NCT01823861|101702258|FG001|COMPLETED|4 Month Follow up||220||
48559183|NCT01823861|101702257|FG000|NOT COMPLETED|4 Month Follow up||38||
48559184|NCT01823861|101702258|FG001|NOT COMPLETED|4 Month Follow up||31||
48559185|NCT01823861|101702257|FG000|STARTED|12 Month Follow up||211||
48559186|NCT01823861|101702258|FG001|STARTED|12 Month Follow up||220||
48559187|NCT01823861|101702257|FG000|COMPLETED|12 Month Follow up||169||
48559188|NCT01823861|101702258|FG001|COMPLETED|12 Month Follow up||159||
48559189|NCT01823861|101702257|FG000|NOT COMPLETED|12 Month Follow up||42||
48559190|NCT01823861|101702258|FG001|NOT COMPLETED|12 Month Follow up||61||
48559191|NCT01786993|101702259|FG000|STARTED|Overall Study||201||
48559192|NCT01786993|101702260|FG001|STARTED|Overall Study||180||
48559193|NCT01786993|101702259|FG000|Per Protocol Population at 9 Months|Overall Study||189||
48559194|NCT01786993|101702260|FG001|Per Protocol Population at 9 Months|Overall Study||170||
48559195|NCT01786993|101702259|FG000|COMPLETED|Overall Study||189||
48559196|NCT01786993|101702260|FG001|COMPLETED|Overall Study||170||
48559197|NCT01786993|101702259|FG000|NOT COMPLETED|Overall Study||12||
48559198|NCT01786993|101702260|FG001|NOT COMPLETED|Overall Study||10||
48559199|NCT03830333|101702261|FG000|STARTED|Overall Study||134||
48559200|NCT03830333|101702262|FG001|STARTED|Overall Study||134||
48559201|NCT03830333|101702261|FG000|Clinically Evaluable Population|Overall Study||105||
48559202|NCT03830333|101702262|FG001|Clinically Evaluable Population|Overall Study||116||
48559203|NCT03830333|101702261|FG000|COMPLETED|Overall Study||126||
48559204|NCT03830333|101702262|FG001|COMPLETED|Overall Study||130||
48559205|NCT03830333|101702261|FG000|NOT COMPLETED|Overall Study||8||
48559206|NCT03830333|101702262|FG001|NOT COMPLETED|Overall Study||4||
48559207|NCT01561716|101702263|FG000|STARTED|Overall Study||5||
48559208|NCT01561716|101702264|FG001|STARTED|Overall Study||5||
48559209|NCT01561716|101702265|FG002|STARTED|Overall Study||5||
48559210|NCT01561716|101702266|FG003|STARTED|Overall Study||5||
48559211|NCT01561716|101702267|FG004|STARTED|Overall Study||5||
48559212|NCT01561716|101702268|FG005|STARTED|Overall Study||5||
48559213|NCT01561716|101702263|FG000|COMPLETED|Overall Study||5||
48559214|NCT01561716|101702264|FG001|COMPLETED|Overall Study||5||
48559215|NCT01561716|101702265|FG002|COMPLETED|Overall Study||5||
48559216|NCT01561716|101702266|FG003|COMPLETED|Overall Study||5||
48559217|NCT01561716|101702267|FG004|COMPLETED|Overall Study||5||
48559218|NCT01561716|101702268|FG005|COMPLETED|Overall Study||5||
48559219|NCT01561716|101702263|FG000|NOT COMPLETED|Overall Study||0||
48559220|NCT01561716|101702264|FG001|NOT COMPLETED|Overall Study||0||
48559221|NCT01561716|101702265|FG002|NOT COMPLETED|Overall Study||0||
48559222|NCT01561716|101702266|FG003|NOT COMPLETED|Overall Study||0||
48559223|NCT01561716|101702267|FG004|NOT COMPLETED|Overall Study||0||
48559224|NCT01561716|101702268|FG005|NOT COMPLETED|Overall Study||0||
48559225|NCT02614924|101702269|FG000|STARTED|Overall Study||20||
48559226|NCT02614924|101702270|FG001|STARTED|Overall Study||20||
48559227|NCT02614924|101702269|FG000|COMPLETED|Overall Study||20||
48559228|NCT02614924|101702270|FG001|COMPLETED|Overall Study||20||
48559229|NCT02614924|101702269|FG000|NOT COMPLETED|Overall Study||0||
48559230|NCT02614924|101702270|FG001|NOT COMPLETED|Overall Study||0||
48559231|NCT00570063|101702271|FG000|STARTED|Overall Study||24||
48559232|NCT00570063|101702272|FG001|STARTED|Overall Study||11||
48559233|NCT00570063|101702271|FG000|COMPLETED|Overall Study||9||
48559234|NCT00570063|101702272|FG001|COMPLETED|Overall Study||3||
48559235|NCT00570063|101702271|FG000|NOT COMPLETED|Overall Study||15||
48559236|NCT00570063|101702272|FG001|NOT COMPLETED|Overall Study||8||
48559237|NCT00607321|101702273|FG000|STARTED|Overall Study||60||
48559238|NCT00607321|101702273|FG000|COMPLETED|Overall Study||60||
48559239|NCT00607321|101702273|FG000|NOT COMPLETED|Overall Study||0||
48559240|NCT01753570|101702274|FG000|STARTED|Overall Study||30||
48559241|NCT01753570|101702275|FG001|STARTED|Overall Study||30||
48559242|NCT01753570|101702276|FG002|STARTED|Overall Study||14||
48559243|NCT01753570|101702274|FG000|COMPLETED|Overall Study||28||
48559244|NCT01753570|101702275|FG001|COMPLETED|Overall Study||25||
48559245|NCT01753570|101702276|FG002|COMPLETED|Overall Study||13||
48559246|NCT01753570|101702274|FG000|NOT COMPLETED|Overall Study||2||
48559247|NCT01753570|101702275|FG001|NOT COMPLETED|Overall Study||5||
48559248|NCT01753570|101702276|FG002|NOT COMPLETED|Overall Study||1||
48559249|NCT00931411|101702277|FG000|STARTED|First Intervention - 42 Days||35||
48559250|NCT00931411|101702278|FG001|STARTED|First Intervention - 42 Days||38||
48559251|NCT00931411|101702277|FG000|COMPLETED|First Intervention - 42 Days||31||
48559252|NCT00931411|101702278|FG001|COMPLETED|First Intervention - 42 Days||35||
48559253|NCT00931411|101702277|FG000|NOT COMPLETED|First Intervention - 42 Days||4||
48559254|NCT00931411|101702278|FG001|NOT COMPLETED|First Intervention - 42 Days||3||
48559255|NCT00931411|101702277|FG000|STARTED|After Crossover - 14 Days (up to Day 56)||31||
48559256|NCT00931411|101702278|FG001|STARTED|After Crossover - 14 Days (up to Day 56)||35||
48559257|NCT00931411|101702277|FG000|COMPLETED|After Crossover - 14 Days (up to Day 56)||31||
48592744|NCT02678000|101783168|FG000|STARTED|PART 2||0||
48559258|NCT00931411|101702278|FG001|COMPLETED|After Crossover - 14 Days (up to Day 56)||34||
48559259|NCT00931411|101702277|FG000|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||0||
48559260|NCT00931411|101702278|FG001|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||1||
48559261|NCT01302743|101702279|FG000|STARTED|Overall Study||7||
48559262|NCT01302743|101702280|FG001|STARTED|Overall Study||8||
48559263|NCT01302743|101702281|FG002|STARTED|Overall Study||10||
48559264|NCT01302743|101702279|FG000|COMPLETED|Overall Study||6||
48559265|NCT01302743|101702280|FG001|COMPLETED|Overall Study||7||
48559266|NCT01302743|101702281|FG002|COMPLETED|Overall Study||8||
48559267|NCT01302743|101702279|FG000|NOT COMPLETED|Overall Study||1||
48559268|NCT01302743|101702280|FG001|NOT COMPLETED|Overall Study||1||
48559269|NCT01302743|101702281|FG002|NOT COMPLETED|Overall Study||2||
48559270|NCT03447639|101702282|FG000|STARTED|Overall Study||0||
48559271|NCT03447639|101702283|FG001|STARTED|Overall Study||3||
48559272|NCT03447639|101702282|FG000|COMPLETED|Overall Study||0||
48559273|NCT03447639|101702283|FG001|COMPLETED|Overall Study||1||
48559274|NCT03447639|101702282|FG000|NOT COMPLETED|Overall Study||0||
48559275|NCT03447639|101702283|FG001|NOT COMPLETED|Overall Study||2||
48559276|NCT02974686|101702284|FG000|STARTED|Overall Study||0||
48559277|NCT02974686|101702285|FG001|STARTED|Overall Study||0||
48559278|NCT02974686|101702284|FG000|COMPLETED|Overall Study||0||
48559279|NCT02974686|101702285|FG001|COMPLETED|Overall Study||0||
48559280|NCT02974686|101702284|FG000|NOT COMPLETED|Overall Study||0||
48559281|NCT02974686|101702285|FG001|NOT COMPLETED|Overall Study||0||
48559282|NCT01299103|101702286|FG000|STARTED|Overall Study||15||
48559283|NCT01299103|101702287|FG001|STARTED|Overall Study||15||
48559284|NCT01299103|101702288|FG002|STARTED|Overall Study||10||
48559285|NCT01299103|101702286|FG000|COMPLETED|Overall Study||15||
48559286|NCT01299103|101702287|FG001|COMPLETED|Overall Study||13||
48559287|NCT01299103|101702288|FG002|COMPLETED|Overall Study||8||
48559288|NCT01299103|101702286|FG000|NOT COMPLETED|Overall Study||0||
48559289|NCT01299103|101702287|FG001|NOT COMPLETED|Overall Study||2||
48559290|NCT01299103|101702288|FG002|NOT COMPLETED|Overall Study||2||
48559291|NCT01383720|101702289|FG000|STARTED|Overall Study||11||
48559292|NCT01383720|101702289|FG000|Primary Endpoint (Discharge/7 Days)|Overall Study||11||
48559293|NCT01383720|101702289|FG000|COMPLETED|Overall Study||11||
48559294|NCT01383720|101702289|FG000|NOT COMPLETED|Overall Study||0||
48559295|NCT03111940|101702290|FG000|STARTED|Overall Study||21||
48559296|NCT03111940|101702291|FG001|STARTED|Overall Study||14||
48559297|NCT03111940|101702290|FG000|COMPLETED|Overall Study||21||
48559298|NCT03111940|101702291|FG001|COMPLETED|Overall Study||14||
48559299|NCT03111940|101702290|FG000|NOT COMPLETED|Overall Study||0||
48559300|NCT03111940|101702291|FG001|NOT COMPLETED|Overall Study||0||
48559301|NCT01383174|101702292|FG000|STARTED|Baseline Assessment||76||
48559302|NCT01383174|101702293|FG001|STARTED|Baseline Assessment||75||
48559303|NCT01383174|101702292|FG000|COMPLETED|Baseline Assessment||76||
48559304|NCT01383174|101702293|FG001|COMPLETED|Baseline Assessment||75||
48559305|NCT01383174|101702292|FG000|NOT COMPLETED|Baseline Assessment||0||
48559306|NCT01383174|101702293|FG001|NOT COMPLETED|Baseline Assessment||0||
48559307|NCT01383174|101702292|FG000|STARTED|3 Month Assessment||76||
48559308|NCT01383174|101702293|FG001|STARTED|3 Month Assessment||75||
48559309|NCT01383174|101702292|FG000|COMPLETED|3 Month Assessment||70||
48559310|NCT01383174|101702293|FG001|COMPLETED|3 Month Assessment||74||
48559311|NCT01383174|101702292|FG000|NOT COMPLETED|3 Month Assessment||6||
48559312|NCT01383174|101702293|FG001|NOT COMPLETED|3 Month Assessment||1||
48559313|NCT01383174|101702292|FG000|STARTED|6 Month Assessment||76||
48559314|NCT01383174|101702293|FG001|STARTED|6 Month Assessment||74||
48559315|NCT01383174|101702292|FG000|COMPLETED|6 Month Assessment||71||
48559316|NCT01383174|101702293|FG001|COMPLETED|6 Month Assessment||73||
48559317|NCT01383174|101702292|FG000|NOT COMPLETED|6 Month Assessment||5||
48559318|NCT01383174|101702293|FG001|NOT COMPLETED|6 Month Assessment||1||
48559319|NCT02342678|101702294|FG000|STARTED|Overall Study||28||
48559320|NCT02342678|101702295|FG001|STARTED|Overall Study||28||
48559321|NCT02342678|101702294|FG000|COMPLETED|Overall Study||27||
48559322|NCT02342678|101702295|FG001|COMPLETED|Overall Study||23||
48559323|NCT02342678|101702294|FG000|NOT COMPLETED|Overall Study||1||
48559324|NCT02342678|101702295|FG001|NOT COMPLETED|Overall Study||5||
48559325|NCT00450437|101702296|FG000|STARTED|Overall Study||1640||
48559326|NCT00450437|101702297|FG001|STARTED|Overall Study||540||
48559327|NCT00450437|101702298|FG002|STARTED|Overall Study||1023||
48559328|NCT00450437|101702299|FG003|STARTED|Overall Study||336||
48559329|NCT00450437|101702296|FG000|COMPLETED|Overall Study||1594||
48559330|NCT00450437|101702297|FG001|COMPLETED|Overall Study||524||
48559331|NCT00450437|101702298|FG002|COMPLETED|Overall Study||999||
48559332|NCT00450437|101702299|FG003|COMPLETED|Overall Study||325||
48559333|NCT00450437|101702296|FG000|NOT COMPLETED|Overall Study||46||
48559334|NCT00450437|101702297|FG001|NOT COMPLETED|Overall Study||16||
48559335|NCT00450437|101702298|FG002|NOT COMPLETED|Overall Study||24||
48559336|NCT00450437|101702299|FG003|NOT COMPLETED|Overall Study||11||
48559337|NCT03347110|101702300|FG000|STARTED|Overall Study||183||
48559338|NCT03347110|101702300|FG000|COMPLETED|Overall Study||161||
48559339|NCT03347110|101702300|FG000|NOT COMPLETED|Overall Study||22||
48274358|NCT03635099|100996207|FG001|COMPLETED|Period 1||37|Completed period 1: completed 12 weeks of treatment.|
48274359|NCT03635099|100996208|FG002|COMPLETED|Period 1||31|Completed period 1: completed 12 weeks of treatment.|
48274360|NCT03635099|100996209|FG003|COMPLETED|Period 1||34|Completed period 1: completed 12 weeks of treatment.|
48274361|NCT03635099|100996210|FG004|COMPLETED|Period 1||37|Completed period 1: completed 12 weeks of treatment.|
48274362|NCT03635099|100996211|FG005|COMPLETED|Period 1||9|Completed period 1: completed 12 weeks of treatment.|
48274363|NCT03635099|100996212|FG006|COMPLETED|Period 1||40|Completed period 1: completed 12 weeks of treatment.|
48274364|NCT03635099|100996213|FG007|COMPLETED|Period 1||40|Completed period 1: completed 12 weeks of treatment.|
48274365|NCT03635099|100996206|FG000|NOT COMPLETED|Period 1||4||
48274366|NCT03635099|100996207|FG001|NOT COMPLETED|Period 1||3||
48274367|NCT03635099|100996208|FG002|NOT COMPLETED|Period 1||8||
48274368|NCT03635099|100996209|FG003|NOT COMPLETED|Period 1||5||
48274369|NCT03635099|100996210|FG004|NOT COMPLETED|Period 1||3||
48274370|NCT03635099|100996211|FG005|NOT COMPLETED|Period 1||1||
48274371|NCT03635099|100996212|FG006|NOT COMPLETED|Period 1||4||
48274372|NCT03635099|100996213|FG007|NOT COMPLETED|Period 1||2||
48274373|NCT03635099|100996206|FG000|STARTED|Not Eligible for Period 2||16||
48274374|NCT03635099|100996207|FG001|STARTED|Not Eligible for Period 2||37||
48559340|NCT04535141|101702301|FG000|STARTED|Overall Study||46||
48559341|NCT04535141|101702302|FG001|STARTED|Overall Study||45||
48559342|NCT04535141|101702301|FG000|COMPLETED|Overall Study||46||
48559343|NCT04535141|101702302|FG001|COMPLETED|Overall Study||45||
48559344|NCT04535141|101702301|FG000|NOT COMPLETED|Overall Study||0||
48559345|NCT04535141|101702302|FG001|NOT COMPLETED|Overall Study||0||
48559346|NCT01199939|101702303|FG000|STARTED|Overall Study||54||
48559347|NCT01199939|101702303|FG000|COMPLETED|Overall Study||41||
48274375|NCT03635099|100996208|FG002|STARTED|Not Eligible for Period 2||31||
48274376|NCT03635099|100996209|FG003|STARTED|Not Eligible for Period 2||34||
48274377|NCT03635099|100996210|FG004|STARTED|Not Eligible for Period 2||37||
48274378|NCT03635099|100996211|FG005|STARTED|Not Eligible for Period 2||9||
48274379|NCT03635099|100996212|FG006|STARTED|Not Eligible for Period 2||40||
48274380|NCT03635099|100996213|FG007|STARTED|Not Eligible for Period 2||40||
48274381|NCT03635099|100996206|FG000|COMPLETED|Not Eligible for Period 2||15|Completed subjects moved to period 2. Not completed did not move to period 2.|
48274382|NCT03635099|100996207|FG001|COMPLETED|Not Eligible for Period 2||37|Completed subjects moved to period 2. Not completed did not move to period 2.|
48274383|NCT03635099|100996208|FG002|COMPLETED|Not Eligible for Period 2||31|Completed subjects moved to period 2. Not completed did not move to period 2.|
48274384|NCT03635099|100996209|FG003|COMPLETED|Not Eligible for Period 2||33|Completed subjects moved to period 2. Not completed did not move to period 2.|
48274385|NCT03635099|100996210|FG004|COMPLETED|Not Eligible for Period 2||37|Completed subjects moved to period 2. Not completed did not move to period 2.|
48274386|NCT03635099|100996211|FG005|COMPLETED|Not Eligible for Period 2||0|Completed subjects moved to period 2. Not completed did not move to period 2.|
48274387|NCT03635099|100996212|FG006|COMPLETED|Not Eligible for Period 2||0|Completed subjects moved to period 2. Not completed did not move to period 2.|
48274388|NCT03635099|100996213|FG007|COMPLETED|Not Eligible for Period 2||0|Completed subjects moved to period 2. Not completed did not move to period 2.|
48274389|NCT03635099|100996206|FG000|NOT COMPLETED|Not Eligible for Period 2||1||
48274390|NCT03635099|100996207|FG001|NOT COMPLETED|Not Eligible for Period 2||0||
48274391|NCT03635099|100996208|FG002|NOT COMPLETED|Not Eligible for Period 2||0||
48274392|NCT03635099|100996209|FG003|NOT COMPLETED|Not Eligible for Period 2||1||
48274393|NCT03635099|100996210|FG004|NOT COMPLETED|Not Eligible for Period 2||0||
48274394|NCT03635099|100996211|FG005|NOT COMPLETED|Not Eligible for Period 2||9||
48274395|NCT03635099|100996212|FG006|NOT COMPLETED|Not Eligible for Period 2||40||
48274396|NCT03635099|100996213|FG007|NOT COMPLETED|Not Eligible for Period 2||40||
48274397|NCT03635099|100996206|FG000|STARTED|Eligible for Period 2||15||
48274398|NCT03635099|100996207|FG001|STARTED|Eligible for Period 2||37||
48274399|NCT03635099|100996208|FG002|STARTED|Eligible for Period 2||31||
48393095|NCT01998438|101291506|FG001|COMPLETED|Overall Study||318||
48393096|NCT01998438|101291507|FG002|COMPLETED|Overall Study||318||
48393097|NCT01998438|101291505|FG000|NOT COMPLETED|Overall Study||0||
48393098|NCT01998438|101291506|FG001|NOT COMPLETED|Overall Study||0||
48393099|NCT01998438|101291507|FG002|NOT COMPLETED|Overall Study||0||
48393100|NCT02703987|101291508|FG000|STARTED|Visit 3 Intervention (1 Day)||14||
48559348|NCT01199939|101702303|FG000|NOT COMPLETED|Overall Study||13||
48559349|NCT03498612|101702304|FG000|STARTED|Overall Study||9||
48559350|NCT03498612|101702304|FG000|COMPLETED|Overall Study||9||
48559351|NCT03498612|101702304|FG000|NOT COMPLETED|Overall Study||0||
48559352|NCT03757819|101702305|FG000|STARTED|Overall Study||3||
48559353|NCT03757819|101702306|FG001|STARTED|Overall Study||3||
48559354|NCT03757819|101702307|FG002|STARTED|Overall Study||3||
48559355|NCT03757819|101702308|FG003|STARTED|Overall Study||3||
48559356|NCT03757819|101702305|FG000|COMPLETED|Overall Study||3||
48559357|NCT03757819|101702306|FG001|COMPLETED|Overall Study||3||
48559358|NCT03757819|101702307|FG002|COMPLETED|Overall Study||3||
48559359|NCT03757819|101702308|FG003|COMPLETED|Overall Study||3||
48559360|NCT03757819|101702305|FG000|NOT COMPLETED|Overall Study||0||
48559361|NCT03757819|101702306|FG001|NOT COMPLETED|Overall Study||0||
48559362|NCT03757819|101702307|FG002|NOT COMPLETED|Overall Study||0||
48559363|NCT03757819|101702308|FG003|NOT COMPLETED|Overall Study||0||
48559364|NCT01777282|101702309|FG000|STARTED|Overall Study||120||
48559365|NCT01777282|101702310|FG001|STARTED|Overall Study||67||
48559366|NCT01777282|101702311|FG002|STARTED|Overall Study||65||
48559367|NCT01777282|101702312|FG003|STARTED|Overall Study||61||
48559368|NCT01777282|101702313|FG004|STARTED|Overall Study||61||
48559369|NCT01777282|101702309|FG000|Completing Treatment Period|Overall Study||109||
48559370|NCT01777282|101702310|FG001|Completing Treatment Period|Overall Study||63||
48559371|NCT01777282|101702311|FG002|Completing Treatment Period|Overall Study||59||
48559372|NCT01777282|101702312|FG003|Completing Treatment Period|Overall Study||59||
48559373|NCT01777282|101702313|FG004|Completing Treatment Period|Overall Study||54||
48559374|NCT01777282|101702309|FG000|Completing Follow-up Period|Overall Study||109||
48559375|NCT01777282|101702310|FG001|Completing Follow-up Period|Overall Study||63||
48559376|NCT01777282|101702311|FG002|Completing Follow-up Period|Overall Study||59||
48559377|NCT01777282|101702312|FG003|Completing Follow-up Period|Overall Study||59||
48559378|NCT01777282|101702313|FG004|Completing Follow-up Period|Overall Study||54||
48559379|NCT01777282|101702309|FG000|COMPLETED|Overall Study||109||
48559380|NCT01777282|101702310|FG001|COMPLETED|Overall Study||63||
48559381|NCT01777282|101702311|FG002|COMPLETED|Overall Study||59||
48559382|NCT01777282|101702312|FG003|COMPLETED|Overall Study||59||
48559383|NCT01777282|101702313|FG004|COMPLETED|Overall Study||54||
48559384|NCT01777282|101702309|FG000|NOT COMPLETED|Overall Study||11||
48559385|NCT01777282|101702310|FG001|NOT COMPLETED|Overall Study||4||
48559386|NCT01777282|101702311|FG002|NOT COMPLETED|Overall Study||6||
48559387|NCT01777282|101702312|FG003|NOT COMPLETED|Overall Study||2||
48559388|NCT01777282|101702313|FG004|NOT COMPLETED|Overall Study||7||
48559389|NCT00991887|101702314|FG000|STARTED|Overall Study||26||
48559390|NCT00991887|101702315|FG001|STARTED|Overall Study||22||
48559391|NCT00991887|101702314|FG000|COMPLETED|Overall Study||24||
48559392|NCT00991887|101702315|FG001|COMPLETED|Overall Study||21||
48559393|NCT00991887|101702314|FG000|NOT COMPLETED|Overall Study||2||
48559394|NCT00991887|101702315|FG001|NOT COMPLETED|Overall Study||1||
48559395|NCT02976129|101702316|FG000|STARTED|Overall Study||82||
48559396|NCT02976129|101702317|FG001|STARTED|Overall Study||43||
48559397|NCT02976129|101702316|FG000|COMPLETED|Overall Study||77||
48559398|NCT02976129|101702317|FG001|COMPLETED|Overall Study||41||
48559399|NCT02976129|101702316|FG000|NOT COMPLETED|Overall Study||5||
48559400|NCT02976129|101702317|FG001|NOT COMPLETED|Overall Study||2||
48559401|NCT02291237|101702318|FG000|STARTED|Overall Study||86||
48559402|NCT02291237|101702319|FG001|STARTED|Overall Study||86||
48559403|NCT02291237|101702318|FG000|COMPLETED|Overall Study||0||
48559404|NCT02291237|101702319|FG001|COMPLETED|Overall Study||0||
48559405|NCT02291237|101702318|FG000|NOT COMPLETED|Overall Study||86||
48559406|NCT02291237|101702319|FG001|NOT COMPLETED|Overall Study||86||
48559407|NCT02623725|101702320|FG000|STARTED|Overall Study||187||
48559408|NCT02623725|101702321|FG001|STARTED|Overall Study||64||
48559409|NCT02623725|101702320|FG000|COMPLETED|Overall Study||171||
48559410|NCT02623725|101702321|FG001|COMPLETED|Overall Study||58||
48559411|NCT02623725|101702320|FG000|NOT COMPLETED|Overall Study||16||
48559412|NCT02623725|101702321|FG001|NOT COMPLETED|Overall Study||6||
48559413|NCT01433471|101702322|FG000|STARTED|Overall Study||2||
48559414|NCT01433471|101702323|FG001|STARTED|Overall Study||2||
48559415|NCT01433471|101702322|FG000|COMPLETED|Overall Study||2||
48559416|NCT01433471|101702323|FG001|COMPLETED|Overall Study||1||
48559417|NCT01433471|101702322|FG000|NOT COMPLETED|Overall Study||0||
48559418|NCT01433471|101702323|FG001|NOT COMPLETED|Overall Study||1||
48559419|NCT03477006|101702324|FG000|STARTED|Overall Study||40||
48559420|NCT03477006|101702325|FG001|STARTED|Overall Study||46||
48559421|NCT03477006|101702324|FG000|COMPLETED|Overall Study||40||
48559422|NCT03477006|101702325|FG001|COMPLETED|Overall Study||46||
48559423|NCT03477006|101702324|FG000|NOT COMPLETED|Overall Study||0||
48559424|NCT03477006|101702325|FG001|NOT COMPLETED|Overall Study||0||
48559425|NCT03523520|101702326|FG000|STARTED|Overall Study||4||
48559426|NCT03523520|101702327|FG001|STARTED|Overall Study||3||
48559427|NCT03523520|101702328|FG002|STARTED|Overall Study||5||
48559428|NCT03523520|101702326|FG000|COMPLETED|Overall Study||4||
48559429|NCT03523520|101702327|FG001|COMPLETED|Overall Study||3||
48559430|NCT03523520|101702328|FG002|COMPLETED|Overall Study||5||
48559431|NCT03523520|101702326|FG000|NOT COMPLETED|Overall Study||0||
48559432|NCT03523520|101702327|FG001|NOT COMPLETED|Overall Study||0||
48559433|NCT03523520|101702328|FG002|NOT COMPLETED|Overall Study||0||
48559434|NCT02409927|101702329|FG000|STARTED|Overall Study||10||
48559435|NCT02409927|101702329|FG000|COMPLETED|Overall Study||10||
48559436|NCT02409927|101702329|FG000|NOT COMPLETED|Overall Study||0||
48559437|NCT00226577|101702330|FG000|STARTED|Overall Study||52||
48559438|NCT00226577|101702330|FG000|COMPLETED|Overall Study||52||
48559439|NCT00226577|101702330|FG000|NOT COMPLETED|Overall Study||0||
48559440|NCT03657797|101702331|FG000|STARTED|Overall Study||111||111
48559441|NCT03657797|101702332|FG001|STARTED|Overall Study||108||108
48559442|NCT03657797|101702333|FG002|STARTED|Overall Study||107||107
48559443|NCT03657797|101702334|FG003|STARTED|Overall Study||107||107
48559444|NCT03657797|101702331|FG000|COMPLETED|Overall Study||111||111
48559445|NCT03657797|101702332|FG001|COMPLETED|Overall Study||105||105
48559446|NCT03657797|101702333|FG002|COMPLETED|Overall Study||102||102
48559447|NCT03657797|101702334|FG003|COMPLETED|Overall Study||107||107
48559448|NCT03657797|101702331|FG000|NOT COMPLETED|Overall Study||0||0
48559449|NCT03657797|101702332|FG001|NOT COMPLETED|Overall Study||3||3
48559450|NCT03657797|101702333|FG002|NOT COMPLETED|Overall Study||5||5
48111448|NCT01106456|100598119|FG000|NOT COMPLETED|Overall Study||103||
48111449|NCT01106456|100598120|FG001|NOT COMPLETED|Overall Study||124||
48111450|NCT04019041|100598121|FG000|STARTED|Placebo Controlled Period (Weeks 0-16)||52||
48274400|NCT03635099|100996209|FG003|STARTED|Eligible for Period 2||33||
48274401|NCT03635099|100996210|FG004|STARTED|Eligible for Period 2||37||
48274402|NCT03635099|100996211|FG005|STARTED|Eligible for Period 2||0||
48559451|NCT03657797|101702334|FG003|NOT COMPLETED|Overall Study||0||0
48559452|NCT00245518|101702335|FG000|STARTED|Overall Study||17||
48111451|NCT04019041|100598122|FG001|STARTED|Placebo Controlled Period (Weeks 0-16)||50||
48111452|NCT04019041|100598123|FG002|STARTED|Placebo Controlled Period (Weeks 0-16)||51||
48111453|NCT04019041|100598124|FG003|STARTED|Placebo Controlled Period (Weeks 0-16)||0||
48111454|NCT04019041|100598125|FG004|STARTED|Placebo Controlled Period (Weeks 0-16)||0||
48111455|NCT04019041|100598126|FG005|STARTED|Placebo Controlled Period (Weeks 0-16)||0||
48274403|NCT03635099|100996212|FG006|STARTED|Eligible for Period 2||0||
48559453|NCT00245518|101702336|FG001|STARTED|Overall Study||16||
48111456|NCT04019041|100598121|FG000|COMPLETED|Placebo Controlled Period (Weeks 0-16)||48||
48111457|NCT04019041|100598122|FG001|COMPLETED|Placebo Controlled Period (Weeks 0-16)||43||
48111458|NCT04019041|100598123|FG002|COMPLETED|Placebo Controlled Period (Weeks 0-16)||43||
48111459|NCT04019041|100598124|FG003|COMPLETED|Placebo Controlled Period (Weeks 0-16)||0||
48111460|NCT04019041|100598125|FG004|COMPLETED|Placebo Controlled Period (Weeks 0-16)||0||
48111461|NCT04019041|100598126|FG005|COMPLETED|Placebo Controlled Period (Weeks 0-16)||0||
48111462|NCT04019041|100598121|FG000|NOT COMPLETED|Placebo Controlled Period (Weeks 0-16)||4||
48111463|NCT04019041|100598122|FG001|NOT COMPLETED|Placebo Controlled Period (Weeks 0-16)||7||
48111464|NCT04019041|100598123|FG002|NOT COMPLETED|Placebo Controlled Period (Weeks 0-16)||8||
48111465|NCT04019041|100598124|FG003|NOT COMPLETED|Placebo Controlled Period (Weeks 0-16)||0||
48111466|NCT04019041|100598125|FG004|NOT COMPLETED|Placebo Controlled Period (Weeks 0-16)||0||
48111467|NCT04019041|100598126|FG005|NOT COMPLETED|Placebo Controlled Period (Weeks 0-16)||0||
48111468|NCT04019041|100598121|FG000|STARTED|Active Treatment+Safety F-U (Week 17-36)||0||
48111469|NCT04019041|100598122|FG001|STARTED|Active Treatment+Safety F-U (Week 17-36)||0||
48111470|NCT04019041|100598123|FG002|STARTED|Active Treatment+Safety F-U (Week 17-36)||0||
48111471|NCT04019041|100598124|FG003|STARTED|Active Treatment+Safety F-U (Week 17-36)||48||
48111472|NCT04019041|100598125|FG004|STARTED|Active Treatment+Safety F-U (Week 17-36)||43||
48111473|NCT04019041|100598126|FG005|STARTED|Active Treatment+Safety F-U (Week 17-36)||43||
48111474|NCT04019041|100598121|FG000|COMPLETED|Active Treatment+Safety F-U (Week 17-36)||0||
48111475|NCT04019041|100598122|FG001|COMPLETED|Active Treatment+Safety F-U (Week 17-36)||0||
48111476|NCT04019041|100598123|FG002|COMPLETED|Active Treatment+Safety F-U (Week 17-36)||0||
48111477|NCT04019041|100598124|FG003|COMPLETED|Active Treatment+Safety F-U (Week 17-36)||42||
48111478|NCT04019041|100598125|FG004|COMPLETED|Active Treatment+Safety F-U (Week 17-36)||35||
48111479|NCT04019041|100598126|FG005|COMPLETED|Active Treatment+Safety F-U (Week 17-36)||38||
48111480|NCT04019041|100598121|FG000|NOT COMPLETED|Active Treatment+Safety F-U (Week 17-36)||0||
48111481|NCT04019041|100598122|FG001|NOT COMPLETED|Active Treatment+Safety F-U (Week 17-36)||0||
48111482|NCT04019041|100598123|FG002|NOT COMPLETED|Active Treatment+Safety F-U (Week 17-36)||0||
48111483|NCT04019041|100598124|FG003|NOT COMPLETED|Active Treatment+Safety F-U (Week 17-36)||6||
48111484|NCT04019041|100598125|FG004|NOT COMPLETED|Active Treatment+Safety F-U (Week 17-36)||8||
48111485|NCT04019041|100598126|FG005|NOT COMPLETED|Active Treatment+Safety F-U (Week 17-36)||5||
48111486|NCT00025883|100598127|FG000|STARTED|Overall Study||103||
48111487|NCT00025883|100598127|FG000|Generalized Lipodystrophy|Overall Study||63||
48111488|NCT00025883|100598127|FG000|Partial Lipodystrophy|Overall Study||40||
48111489|NCT00025883|100598127|FG000|COMPLETED|Overall Study||86||
48111490|NCT00025883|100598127|FG000|NOT COMPLETED|Overall Study||17||
48111491|NCT01247090|100598128|FG000|STARTED|Overall Study||4||
48111492|NCT01247090|100598129|FG001|STARTED|Overall Study||4||
48111493|NCT01247090|100598130|FG002|STARTED|Overall Study||4||
48111494|NCT01247090|100598128|FG000|COMPLETED|Overall Study||3||
48111495|NCT01247090|100598129|FG001|COMPLETED|Overall Study||3||
48111496|NCT01247090|100598130|FG002|COMPLETED|Overall Study||4||
48111497|NCT01247090|100598128|FG000|NOT COMPLETED|Overall Study||1||
48111498|NCT01247090|100598129|FG001|NOT COMPLETED|Overall Study||1||
48111499|NCT01247090|100598130|FG002|NOT COMPLETED|Overall Study||0||
48111500|NCT00749775|100598131|FG000|STARTED|Overall Study||3317||
48111501|NCT00749775|100598131|FG000|COMPLETED|Overall Study||3210||
48111502|NCT00749775|100598131|FG000|NOT COMPLETED|Overall Study||107||
48111503|NCT03730948|100598132|FG000|STARTED|Overall Study||4||
48111504|NCT03730948|100598132|FG000|COMPLETED|Overall Study||2||
48111505|NCT03730948|100598132|FG000|NOT COMPLETED|Overall Study||2||
48111506|NCT00151814|100598133|FG000|STARTED|Overall Study||4||
48111507|NCT00151814|100598134|FG001|STARTED|Overall Study||10||
48111508|NCT00151814|100598135|FG002|STARTED|Overall Study||10||
48111509|NCT00151814|100598133|FG000|COMPLETED|Overall Study||4||
48111510|NCT00151814|100598134|FG001|COMPLETED|Overall Study||10||
48111511|NCT00151814|100598135|FG002|COMPLETED|Overall Study||10||
48111512|NCT00151814|100598133|FG000|NOT COMPLETED|Overall Study||0||
48111513|NCT00151814|100598134|FG001|NOT COMPLETED|Overall Study||0||
48111514|NCT00151814|100598135|FG002|NOT COMPLETED|Overall Study||0||
48111515|NCT01399593|100598136|FG000|STARTED|Overall Study||51||
48111516|NCT01399593|100598137|FG001|STARTED|Overall Study||51||
48111517|NCT01399593|100598136|FG000|COMPLETED|Overall Study||48||
48111518|NCT01399593|100598137|FG001|COMPLETED|Overall Study||49||
48111519|NCT01399593|100598136|FG000|NOT COMPLETED|Overall Study||3||
48111520|NCT01399593|100598137|FG001|NOT COMPLETED|Overall Study||2||
48111521|NCT01120210|100598138|FG000|STARTED|MAIN INFUSION||16||
48111522|NCT01120210|100598139|FG001|STARTED|MAIN INFUSION||46||
48111523|NCT01120210|100598138|FG000|COMPLETED|MAIN INFUSION||15||
48111524|NCT01120210|100598139|FG001|COMPLETED|MAIN INFUSION||45||
48111525|NCT01120210|100598138|FG000|NOT COMPLETED|MAIN INFUSION||1||
48111526|NCT01120210|100598139|FG001|NOT COMPLETED|MAIN INFUSION||1||
48111527|NCT01120210|100598138|FG000|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||3||
48111528|NCT01120210|100598139|FG001|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||7||
48111529|NCT01120210|100598138|FG000|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||3||
48111530|NCT01120210|100598139|FG001|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||7||
48111531|NCT01120210|100598138|FG000|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0||
48111532|NCT01120210|100598139|FG001|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0||
48111533|NCT04091646|100598140|FG000|STARTED|Overall Study||154||
48111534|NCT04091646|100598141|FG001|STARTED|Overall Study||72||
48111535|NCT04091646|100598140|FG000|COMPLETED|Overall Study||141||
48111536|NCT04091646|100598141|FG001|COMPLETED|Overall Study||67||
48111537|NCT04091646|100598140|FG000|NOT COMPLETED|Overall Study||13||
48111538|NCT04091646|100598141|FG001|NOT COMPLETED|Overall Study||5||
48111539|NCT02487394|100598142|FG000|STARTED|Phase 1||8||
48111540|NCT02487394|100598143|FG001|STARTED|Phase 1||1||
48111541|NCT02487394|100598142|FG000|COMPLETED|Phase 1||8|One subject was withdrawn|
48111542|NCT02487394|100598143|FG001|COMPLETED|Phase 1||0|One subject was withdrawn|
48111543|NCT02487394|100598142|FG000|NOT COMPLETED|Phase 1||0||
48111544|NCT02487394|100598143|FG001|NOT COMPLETED|Phase 1||1||
48111545|NCT02487394|100598142|FG000|STARTED|Phase 2||4|Only 4 subjects who completed phase I enrolled in phase II of asthmatics. None of the COPD subjects who completed phase 1 enrolled in phase II.|
48111546|NCT02487394|100598143|FG001|STARTED|Phase 2||0|Only 4 subjects who completed phase I enrolled in phase II of asthmatics. None of the COPD subjects who completed phase 1 enrolled in phase II.|
48111547|NCT02487394|100598142|FG000|COMPLETED|Phase 2||4||
48111548|NCT02487394|100598143|FG001|COMPLETED|Phase 2||0||
48111549|NCT02487394|100598142|FG000|NOT COMPLETED|Phase 2||0||
48111550|NCT02487394|100598143|FG001|NOT COMPLETED|Phase 2||0||
48111551|NCT01344369|100598144|FG000|STARTED|First Intervention||18||
48111552|NCT01344369|100598145|FG001|STARTED|First Intervention||18||
48111553|NCT01344369|100598144|FG000|COMPLETED|First Intervention||18||
48111554|NCT01344369|100598145|FG001|COMPLETED|First Intervention||18||
48111555|NCT01344369|100598144|FG000|NOT COMPLETED|First Intervention||0||
48111556|NCT01344369|100598145|FG001|NOT COMPLETED|First Intervention||0||
48111557|NCT01344369|100598144|FG000|STARTED|Washout of 28 Days||18||
48111558|NCT01344369|100598145|FG001|STARTED|Washout of 28 Days||18||
48274404|NCT03635099|100996213|FG007|STARTED|Eligible for Period 2||0||
48111559|NCT01344369|100598144|FG000|COMPLETED|Washout of 28 Days||17||
48111560|NCT01344369|100598145|FG001|COMPLETED|Washout of 28 Days||17||
48111561|NCT01344369|100598144|FG000|NOT COMPLETED|Washout of 28 Days||1||
48111562|NCT01344369|100598145|FG001|NOT COMPLETED|Washout of 28 Days||1||
48111563|NCT01344369|100598144|FG000|STARTED|Second Intervention||17||
48111564|NCT01344369|100598145|FG001|STARTED|Second Intervention||17||
48111565|NCT01344369|100598144|FG000|COMPLETED|Second Intervention||17||
48111566|NCT01344369|100598145|FG001|COMPLETED|Second Intervention||16||
48111567|NCT01344369|100598144|FG000|NOT COMPLETED|Second Intervention||0||
48111568|NCT01344369|100598145|FG001|NOT COMPLETED|Second Intervention||1||
48111569|NCT02367599|100598146|FG000|STARTED|Overall Study||48||
48111570|NCT02367599|100598147|FG001|STARTED|Overall Study||48||
48111571|NCT02367599|100598146|FG000|COMPLETED|Overall Study||48||
48111572|NCT02367599|100598147|FG001|COMPLETED|Overall Study||48||
48111573|NCT02367599|100598146|FG000|NOT COMPLETED|Overall Study||0||
48111574|NCT02367599|100598147|FG001|NOT COMPLETED|Overall Study||0||
48111575|NCT01200875|100598148|FG000|STARTED|Overall Study||25||
48111576|NCT01200875|100598148|FG000|COMPLETED|Overall Study||25||
48111577|NCT01200875|100598148|FG000|NOT COMPLETED|Overall Study||0||
48111578|NCT00245765|100598149|FG000|STARTED|Overall Study||59||
48111579|NCT00245765|100598150|FG001|STARTED|Overall Study||59||
48111580|NCT00245765|100598151|FG002|STARTED|Overall Study||58||
48111581|NCT00245765|100598149|FG000|Safety Population|Overall Study||58|The safety population consisted of all subjects who were exposed to study medication.|
48111582|NCT00245765|100598150|FG001|Safety Population|Overall Study||60|The safety population consisted of all subjects who were exposed to study medication.|
48111583|NCT00245765|100598151|FG002|Safety Population|Overall Study||57|The safety population consisted of all subjects who were exposed to study medication.|
48111584|NCT00245765|100598149|FG000|COMPLETED|Overall Study||27||
48111585|NCT00245765|100598150|FG001|COMPLETED|Overall Study||45||
48111586|NCT00245765|100598151|FG002|COMPLETED|Overall Study||50||
48111587|NCT00245765|100598149|FG000|NOT COMPLETED|Overall Study||32||
48111588|NCT00245765|100598150|FG001|NOT COMPLETED|Overall Study||14||
48111589|NCT00245765|100598151|FG002|NOT COMPLETED|Overall Study||8||
48111590|NCT04413929|100598152|FG000|STARTED|Overall Study||8411||
48111591|NCT04413929|100598152|FG000|COMPLETED|Overall Study||8411||
48111592|NCT04413929|100598152|FG000|NOT COMPLETED|Overall Study||0||
48111593|NCT02353091|100601336|FG000|STARTED|Overall Study||13||
48111594|NCT02353091|100601337|FG001|STARTED|Overall Study||13||
48111595|NCT02353091|100601336|FG000|COMPLETED|Overall Study||13||
48111596|NCT02353091|100601337|FG001|COMPLETED|Overall Study||13||
48111597|NCT02353091|100601336|FG000|NOT COMPLETED|Overall Study||0||
48111598|NCT02353091|100601337|FG001|NOT COMPLETED|Overall Study||0||
48111599|NCT00159588|100601338|FG000|STARTED|5 Month Follow-up||19||
48111600|NCT00159588|100601339|FG001|STARTED|5 Month Follow-up||22||
48111601|NCT00159588|100601340|FG002|STARTED|5 Month Follow-up||20||
48111602|NCT00159588|100601338|FG000|COMPLETED|5 Month Follow-up||17|Fulfilled the 5-month visit|
48111603|NCT00159588|100601339|FG001|COMPLETED|5 Month Follow-up||18|Fulfilled the 5-month visit|
48111604|NCT00159588|100601340|FG002|COMPLETED|5 Month Follow-up||18|Fulfilled the 5-month visit|
48111605|NCT00159588|100601338|FG000|NOT COMPLETED|5 Month Follow-up||2||
48111606|NCT00159588|100601339|FG001|NOT COMPLETED|5 Month Follow-up||4||
48111607|NCT00159588|100601340|FG002|NOT COMPLETED|5 Month Follow-up||2||
48111608|NCT00159588|100601338|FG000|STARTED|1-year Follow-up for Group 1 and 2||17||
48111609|NCT00159588|100601339|FG001|STARTED|1-year Follow-up for Group 1 and 2||18||
48111610|NCT00159588|100601340|FG002|STARTED|1-year Follow-up for Group 1 and 2||18||
48111611|NCT00159588|100601338|FG000|COMPLETED|1-year Follow-up for Group 1 and 2||16||
48111612|NCT00159588|100601339|FG001|COMPLETED|1-year Follow-up for Group 1 and 2||14||
48111613|NCT00159588|100601340|FG002|COMPLETED|1-year Follow-up for Group 1 and 2||18||
48111614|NCT00159588|100601338|FG000|NOT COMPLETED|1-year Follow-up for Group 1 and 2||1||
48111615|NCT00159588|100601339|FG001|NOT COMPLETED|1-year Follow-up for Group 1 and 2||4||
48111616|NCT00159588|100601340|FG002|NOT COMPLETED|1-year Follow-up for Group 1 and 2||0||
48111617|NCT00430092|100601341|FG000|STARTED|Overall Study||54||
48111618|NCT00430092|100601342|FG001|STARTED|Overall Study||52||
48111619|NCT00430092|100601343|FG002|STARTED|Overall Study||113||
48111620|NCT00430092|100601341|FG000|COMPLETED|Overall Study||48||
48111621|NCT00430092|100601342|FG001|COMPLETED|Overall Study||48||
48111622|NCT00430092|100601343|FG002|COMPLETED|Overall Study||56||
48111623|NCT00430092|100601341|FG000|NOT COMPLETED|Overall Study||6||
48111624|NCT00430092|100601342|FG001|NOT COMPLETED|Overall Study||4||
48111625|NCT00430092|100601343|FG002|NOT COMPLETED|Overall Study||57||
48111626|NCT04999111|100601344|FG000|STARTED|Overall Study||331|Enrolled Participants|
48111627|NCT04999111|100601345|FG001|STARTED|Overall Study||328|Enrolled Participants|
48111628|NCT04999111|100601346|FG002|STARTED|Overall Study||116|Enrolled Participants|
48111629|NCT04999111|100601347|FG003|STARTED|Overall Study||329|Enrolled Participants|
48111630|NCT04999111|100601348|FG004|STARTED|Overall Study||331|Enrolled Participants|
48111631|NCT04999111|100601349|FG005|STARTED|Overall Study||106|Enrolled Participants|
48111632|NCT04999111|100601344|FG000|Randomized and Vaccinated|Overall Study||330||
48111633|NCT04999111|100601345|FG001|Randomized and Vaccinated|Overall Study||326||
48111634|NCT04999111|100601346|FG002|Randomized and Vaccinated|Overall Study||116||
48111635|NCT04999111|100601347|FG003|Randomized and Vaccinated|Overall Study||326||
48111636|NCT04999111|100601348|FG004|Randomized and Vaccinated|Overall Study||328||
48111637|NCT04999111|100601349|FG005|Randomized and Vaccinated|Overall Study||106||
48111638|NCT04999111|100601344|FG000|COMPLETED|Overall Study||277||
48111639|NCT04999111|100601345|FG001|COMPLETED|Overall Study||271||
48111640|NCT04999111|100601346|FG002|COMPLETED|Overall Study||96||
48111641|NCT04999111|100601347|FG003|COMPLETED|Overall Study||260||
48111642|NCT04999111|100601348|FG004|COMPLETED|Overall Study||251||
48111643|NCT04999111|100601349|FG005|COMPLETED|Overall Study||84||
48111644|NCT04999111|100601344|FG000|NOT COMPLETED|Overall Study||54||
48111645|NCT04999111|100601345|FG001|NOT COMPLETED|Overall Study||57||
48111646|NCT04999111|100601346|FG002|NOT COMPLETED|Overall Study||20||
48111647|NCT04999111|100601347|FG003|NOT COMPLETED|Overall Study||69||
48111648|NCT04999111|100601348|FG004|NOT COMPLETED|Overall Study||80||
48111649|NCT04999111|100601349|FG005|NOT COMPLETED|Overall Study||22||
48111650|NCT00701129|100601350|FG000|STARTED|Overall Study||4||
48111651|NCT00701129|100601350|FG000|Full Analysis Set (FAS)|Overall Study||4||
48111652|NCT00701129|100601350|FG000|COMPLETED|Overall Study||2||
48111653|NCT00701129|100601350|FG000|NOT COMPLETED|Overall Study||2||
48111654|NCT03554291|100601351|FG000|STARTED|Overall Study||41||
48111655|NCT03554291|100601352|FG001|STARTED|Overall Study||39||
48111656|NCT03554291|100601351|FG000|COMPLETED|Overall Study||34||
48111657|NCT03554291|100601352|FG001|COMPLETED|Overall Study||38||
48111658|NCT03554291|100601351|FG000|NOT COMPLETED|Overall Study||7||
48111659|NCT03554291|100601352|FG001|NOT COMPLETED|Overall Study||1||
48111660|NCT00699010|100601353|FG000|STARTED|Overall Study||15||
48111661|NCT00699010|100601354|FG001|STARTED|Overall Study||15||
48111662|NCT00699010|100601353|FG000|COMPLETED|Overall Study||15||
48111663|NCT00699010|100601354|FG001|COMPLETED|Overall Study||15||
48111664|NCT00699010|100601353|FG000|NOT COMPLETED|Overall Study||0||
48111665|NCT00699010|100601354|FG001|NOT COMPLETED|Overall Study||0||
48111666|NCT03993938|100601355|FG000|STARTED|Overall Study||30||
48111667|NCT03993938|100601355|FG000|COMPLETED|Overall Study||30||
48111668|NCT03993938|100601355|FG000|NOT COMPLETED|Overall Study||0||
48111669|NCT03216850|100601356|FG000|STARTED|Overall Study||15||
48111670|NCT03216850|100601356|FG000|COMPLETED|Overall Study||9||
48111671|NCT03216850|100601356|FG000|NOT COMPLETED|Overall Study||6||
48111672|NCT00637195|100601357|FG000|STARTED|Overall Study||76||
48111673|NCT00637195|100601358|FG001|STARTED|Overall Study||76||
48111674|NCT00637195|100601357|FG000|COMPLETED|Overall Study||73||
48111675|NCT00637195|100601358|FG001|COMPLETED|Overall Study||75||
48111676|NCT00637195|100601357|FG000|NOT COMPLETED|Overall Study||3||
48111677|NCT00637195|100601358|FG001|NOT COMPLETED|Overall Study||1||
48111678|NCT03854916|100601359|FG000|STARTED|Overall Study||38||
48111679|NCT03854916|100601360|FG001|STARTED|Overall Study||40||
48111680|NCT03854916|100601359|FG000|COMPLETED|Overall Study||38||
48111681|NCT03854916|100601360|FG001|COMPLETED|Overall Study||40||
48111682|NCT03854916|100601359|FG000|NOT COMPLETED|Overall Study||0||
48111683|NCT03854916|100601360|FG001|NOT COMPLETED|Overall Study||0||
48111684|NCT02383667|100601361|FG000|STARTED|Overall Study||20||
48111685|NCT02383667|100601361|FG000|COMPLETED|Overall Study||20||
48111686|NCT02383667|100601361|FG000|NOT COMPLETED|Overall Study||0||
48111687|NCT01446731|100601362|FG000|STARTED|Overall Study||22||
48111688|NCT01446731|100601363|FG001|STARTED|Overall Study||21||
48111689|NCT01446731|100601362|FG000|COMPLETED|Overall Study||21||
48111690|NCT01446731|100601363|FG001|COMPLETED|Overall Study||19||
48111691|NCT01446731|100601362|FG000|NOT COMPLETED|Overall Study||1||
48111692|NCT01446731|100601363|FG001|NOT COMPLETED|Overall Study||2||
48111693|NCT00096044|100601364|FG000|STARTED|Overall Study||45||
48111694|NCT00096044|100601364|FG000|COMPLETED|Overall Study||11||
48111695|NCT00096044|100601364|FG000|NOT COMPLETED|Overall Study||34||
48111696|NCT03735862|100601365|FG000|STARTED|Overall Study||73||
48111697|NCT03735862|100601365|FG000|COMPLETED|Overall Study||73||
48111698|NCT03735862|100601365|FG000|NOT COMPLETED|Overall Study||0||
48111699|NCT03385239|100601366|FG000|STARTED|Overall Study||24||
48111700|NCT03385239|100601367|FG001|STARTED|Overall Study||22||
48111701|NCT03385239|100601368|FG002|STARTED|Overall Study||23||
48111702|NCT03385239|100601369|FG003|STARTED|Overall Study||23||
48111703|NCT03385239|100601370|FG004|STARTED|Overall Study||22||
48111704|NCT03385239|100601366|FG000|COMPLETED|Overall Study||22|Completed here refers to participants who completed post-treatment follow-up.|
48111705|NCT03385239|100601367|FG001|COMPLETED|Overall Study||19|Completed here refers to participants who completed post-treatment follow-up.|
48111706|NCT03385239|100601368|FG002|COMPLETED|Overall Study||20|Completed here refers to participants who completed post-treatment follow-up.|
48111707|NCT03385239|100601369|FG003|COMPLETED|Overall Study||19|Completed here refers to participants who completed post-treatment follow-up.|
48559454|NCT00245518|101702335|FG000|COMPLETED|Overall Study||17||
48559455|NCT00245518|101702336|FG001|COMPLETED|Overall Study||16||
48559456|NCT00245518|101702335|FG000|NOT COMPLETED|Overall Study||0||
48559457|NCT00245518|101702336|FG001|NOT COMPLETED|Overall Study||0||
48559458|NCT00254592|101702337|FG000|STARTED|Overall Study||43||
48559459|NCT00254592|101702337|FG000|COMPLETED|Overall Study||41||
48559460|NCT00254592|101702337|FG000|NOT COMPLETED|Overall Study||2||
48559461|NCT03036657|101702338|FG000|STARTED|Overall Study||20||
48559462|NCT03036657|101702339|FG001|STARTED|Overall Study||20||
48559463|NCT03036657|101702340|FG002|STARTED|Overall Study||20||
48695408|NCT02771574|102038528|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0||
48695409|NCT02771574|102038524|FG000|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0||
48695410|NCT02771574|102038525|FG001|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0||
48695411|NCT02771574|102038526|FG002|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||3||
48559464|NCT03036657|101702338|FG000|COMPLETED|Overall Study||20||
48111708|NCT03385239|100601370|FG004|COMPLETED|Overall Study||22|Completed here refers to participants who completed post-treatment follow-up.|
48111709|NCT03385239|100601366|FG000|NOT COMPLETED|Overall Study||2||
48111710|NCT03385239|100601367|FG001|NOT COMPLETED|Overall Study||3||
48111711|NCT03385239|100601368|FG002|NOT COMPLETED|Overall Study||3||
48111712|NCT03385239|100601369|FG003|NOT COMPLETED|Overall Study||4||
48111713|NCT03385239|100601370|FG004|NOT COMPLETED|Overall Study||0||
48111714|NCT01957475|100601371|FG000|STARTED|Test Period 1||10||
48111715|NCT01957475|100601372|FG001|STARTED|Test Period 1||10||
48111716|NCT01957475|100601371|FG000|COMPLETED|Test Period 1||8||
48111717|NCT01957475|100601372|FG001|COMPLETED|Test Period 1||9||
48111718|NCT01957475|100601371|FG000|NOT COMPLETED|Test Period 1||2||
48111719|NCT01957475|100601372|FG001|NOT COMPLETED|Test Period 1||1||
48710812|NCT01767493|102078026|FG000|NOT COMPLETED|Overall Study||3||
48559465|NCT03036657|101702339|FG001|COMPLETED|Overall Study||20||
48559466|NCT03036657|101702340|FG002|COMPLETED|Overall Study||20||
48559467|NCT03036657|101702338|FG000|NOT COMPLETED|Overall Study||0||
48559468|NCT03036657|101702339|FG001|NOT COMPLETED|Overall Study||0||
48559469|NCT03036657|101702340|FG002|NOT COMPLETED|Overall Study||0||
48559470|NCT04753216|101702341|FG000|STARTED|Screening - 1st Response Assessment||3||
48559471|NCT04753216|101702341|FG000|Cycle 1|Screening - 1st Response Assessment||3||
48559472|NCT04753216|101702341|FG000|Cycle 2|Screening - 1st Response Assessment||3||
48559473|NCT04753216|101702341|FG000|1st Response Assessment|Screening - 1st Response Assessment||2||
48559474|NCT04753216|101702341|FG000|COMPLETED|Screening - 1st Response Assessment||2||
48559475|NCT04753216|101702341|FG000|NOT COMPLETED|Screening - 1st Response Assessment||1||
48274405|NCT03635099|100996206|FG000|Switching Patients|Eligible for Period 2||15|Non-responding patients in dose groups were switched at the end of period 1 to a higher dose group.|
48274406|NCT03635099|100996207|FG001|Switching Patients|Eligible for Period 2||35|Non-responding patients in dose groups were switched at the end of period 1 to a higher dose group.|
48274407|NCT03635099|100996208|FG002|Switching Patients|Eligible for Period 2||21|Non-responding patients in dose groups were switched at the end of period 1 to a higher dose group.|
48274408|NCT03635099|100996209|FG003|Switching Patients|Eligible for Period 2||25|Non-responding patients in dose groups were switched at the end of period 1 to a higher dose group.|
48274409|NCT03635099|100996210|FG004|Switching Patients|Eligible for Period 2||0|Non-responding patients in dose groups were switched at the end of period 1 to a higher dose group.|
48274410|NCT03635099|100996211|FG005|Switching Patients|Eligible for Period 2||0|Non-responding patients in dose groups were switched at the end of period 1 to a higher dose group.|
48274411|NCT03635099|100996212|FG006|Switching Patients|Eligible for Period 2||0|Non-responding patients in dose groups were switched at the end of period 1 to a higher dose group.|
48274412|NCT03635099|100996213|FG007|Switching Patients|Eligible for Period 2||0|Non-responding patients in dose groups were switched at the end of period 1 to a higher dose group.|
48274413|NCT03635099|100996206|FG000|Non Switching Patients|Eligible for Period 2||0|Patients stayed in initially randomized treatment group.|
48274414|NCT03635099|100996207|FG001|Non Switching Patients|Eligible for Period 2||2|Patients stayed in initially randomized treatment group.|
48274415|NCT03635099|100996208|FG002|Non Switching Patients|Eligible for Period 2||10|Patients stayed in initially randomized treatment group.|
48274416|NCT03635099|100996209|FG003|Non Switching Patients|Eligible for Period 2||8|Patients stayed in initially randomized treatment group.|
48274417|NCT03635099|100996210|FG004|Non Switching Patients|Eligible for Period 2||37|Patients stayed in initially randomized treatment group.|
48274418|NCT03635099|100996211|FG005|Non Switching Patients|Eligible for Period 2||0|Patients stayed in initially randomized treatment group.|
48274419|NCT03635099|100996212|FG006|Non Switching Patients|Eligible for Period 2||0|Patients stayed in initially randomized treatment group.|
48274420|NCT03635099|100996213|FG007|Non Switching Patients|Eligible for Period 2||0|Patients stayed in initially randomized treatment group.|
48274421|NCT03635099|100996206|FG000|COMPLETED|Eligible for Period 2||0||
48274422|NCT03635099|100996207|FG001|COMPLETED|Eligible for Period 2||2||
48274423|NCT03635099|100996208|FG002|COMPLETED|Eligible for Period 2||10||
48274424|NCT03635099|100996209|FG003|COMPLETED|Eligible for Period 2||8||
48274425|NCT03635099|100996210|FG004|COMPLETED|Eligible for Period 2||37||
48274426|NCT03635099|100996211|FG005|COMPLETED|Eligible for Period 2||0||
48274427|NCT03635099|100996212|FG006|COMPLETED|Eligible for Period 2||0||
48274428|NCT03635099|100996213|FG007|COMPLETED|Eligible for Period 2||0||
48274429|NCT03635099|100996206|FG000|NOT COMPLETED|Eligible for Period 2||15||
48274430|NCT03635099|100996207|FG001|NOT COMPLETED|Eligible for Period 2||35||
48274431|NCT03635099|100996208|FG002|NOT COMPLETED|Eligible for Period 2||21||
48274432|NCT03635099|100996209|FG003|NOT COMPLETED|Eligible for Period 2||25||
48274433|NCT03635099|100996210|FG004|NOT COMPLETED|Eligible for Period 2||0||
48274434|NCT03635099|100996211|FG005|NOT COMPLETED|Eligible for Period 2||0||
48274435|NCT03635099|100996212|FG006|NOT COMPLETED|Eligible for Period 2||0||
48274436|NCT03635099|100996213|FG007|NOT COMPLETED|Eligible for Period 2||0||
48274437|NCT03635099|100996206|FG000|STARTED|Period 2||0||
48274438|NCT03635099|100996207|FG001|STARTED|Period 2||2||
48274439|NCT03635099|100996208|FG002|STARTED|Period 2||45||
48274440|NCT03635099|100996209|FG003|STARTED|Period 2||29||
48274441|NCT03635099|100996210|FG004|STARTED|Period 2||77||
48274442|NCT03635099|100996211|FG005|STARTED|Period 2||0||
48274443|NCT03635099|100996212|FG006|STARTED|Period 2||0||
48274444|NCT03635099|100996213|FG007|STARTED|Period 2||0||
48274445|NCT03635099|100996206|FG000|COMPLETED|Period 2||0||
48274446|NCT03635099|100996207|FG001|COMPLETED|Period 2||2||
48274447|NCT03635099|100996208|FG002|COMPLETED|Period 2||36||
48274448|NCT03635099|100996209|FG003|COMPLETED|Period 2||25||
48274449|NCT03635099|100996210|FG004|COMPLETED|Period 2||65||
48274450|NCT03635099|100996211|FG005|COMPLETED|Period 2||0||
48274451|NCT03635099|100996212|FG006|COMPLETED|Period 2||0||
48274452|NCT03635099|100996213|FG007|COMPLETED|Period 2||0||
48274453|NCT03635099|100996206|FG000|NOT COMPLETED|Period 2||0||
48274454|NCT03635099|100996207|FG001|NOT COMPLETED|Period 2||0||
48274455|NCT03635099|100996208|FG002|NOT COMPLETED|Period 2||9||
48559476|NCT04753216|101702341|FG000|STARTED|Cycle 3 - 2nd Response Assessment||2||
48559477|NCT04753216|101702341|FG000|Cycle 3|Cycle 3 - 2nd Response Assessment||2||
48559478|NCT04753216|101702341|FG000|Cycle 4|Cycle 3 - 2nd Response Assessment||2||
48559479|NCT04753216|101702341|FG000|2nd Response Assessment|Cycle 3 - 2nd Response Assessment||2||
48592745|NCT02678000|101783169|FG001|STARTED|PART 2||0||
48274456|NCT03635099|100996209|FG003|NOT COMPLETED|Period 2||4||
48274457|NCT03635099|100996210|FG004|NOT COMPLETED|Period 2||12||
48274458|NCT03635099|100996211|FG005|NOT COMPLETED|Period 2||0||
48274459|NCT03635099|100996212|FG006|NOT COMPLETED|Period 2||0||
48274460|NCT03635099|100996213|FG007|NOT COMPLETED|Period 2||0||
48274461|NCT03772587|100996214|FG000|STARTED|Overall Study||14||
48274462|NCT03772587|100996215|FG001|STARTED|Overall Study||14||
48274463|NCT03772587|100996216|FG002|STARTED|Overall Study||13||
48274464|NCT03772587|100996217|FG003|STARTED|Overall Study||13||
48274465|NCT03772587|100996218|FG004|STARTED|Overall Study||14||
48274466|NCT03772587|100996214|FG000|COMPLETED|Overall Study||13||
48111720|NCT01957475|100601371|FG000|STARTED|Test Period 2||9||
48559480|NCT04753216|101702341|FG000|COMPLETED|Cycle 3 - 2nd Response Assessment||1||
48559481|NCT04753216|101702341|FG000|NOT COMPLETED|Cycle 3 - 2nd Response Assessment||1||
48559482|NCT04753216|101702341|FG000|STARTED|Cycle 5 - 3rd Response Assessment||1||
48559483|NCT04753216|101702341|FG000|Cycle 5|Cycle 5 - 3rd Response Assessment||1||
48559484|NCT04753216|101702341|FG000|Cycle 6|Cycle 5 - 3rd Response Assessment||1||
48111721|NCT01957475|100601372|FG001|STARTED|Test Period 2||8||
48111722|NCT01957475|100601371|FG000|COMPLETED|Test Period 2||8||
48111723|NCT01957475|100601372|FG001|COMPLETED|Test Period 2||8||
48111724|NCT01957475|100601371|FG000|NOT COMPLETED|Test Period 2||1||
48111725|NCT01957475|100601372|FG001|NOT COMPLETED|Test Period 2||0||
48111726|NCT03663283|100601373|FG000|STARTED|Overall Study||52||
48111727|NCT03663283|100601374|FG001|STARTED|Overall Study||52||
48559485|NCT04753216|101702341|FG000|3rd Response Assessment|Cycle 5 - 3rd Response Assessment||0||
48559486|NCT04753216|101702341|FG000|COMPLETED|Cycle 5 - 3rd Response Assessment||0||
48559487|NCT04753216|101702341|FG000|NOT COMPLETED|Cycle 5 - 3rd Response Assessment||1||
48559488|NCT04753216|101702341|FG000|STARTED|Survival Follow-Up||3||
48559489|NCT04753216|101702341|FG000|COMPLETED|Survival Follow-Up||3||
48559490|NCT04753216|101702341|FG000|NOT COMPLETED|Survival Follow-Up||0||
48559491|NCT00699816|101702342|FG000|STARTED|Overall Study||115||
48559492|NCT00699816|101702343|FG001|STARTED|Overall Study||115||
48559493|NCT00699816|101702342|FG000|COMPLETED|Overall Study||114||
48111728|NCT03663283|100601373|FG000|COMPLETED|Overall Study||52||
48111729|NCT03663283|100601374|FG001|COMPLETED|Overall Study||52||
48111730|NCT03663283|100601373|FG000|NOT COMPLETED|Overall Study||0||
48111731|NCT03663283|100601374|FG001|NOT COMPLETED|Overall Study||0||
48111732|NCT04855643|100601375|FG000|STARTED|Overall Study||1||
48111733|NCT04855643|100601376|FG001|STARTED|Overall Study||2||
48559494|NCT00699816|101702343|FG001|COMPLETED|Overall Study||112||
48111734|NCT04855643|100601375|FG000|COMPLETED|Overall Study||1||
48111735|NCT04855643|100601376|FG001|COMPLETED|Overall Study||2||
48111736|NCT04855643|100601375|FG000|NOT COMPLETED|Overall Study||0||
48111737|NCT04855643|100601376|FG001|NOT COMPLETED|Overall Study||0||
48559495|NCT00699816|101702342|FG000|NOT COMPLETED|Overall Study||1||
48111738|NCT03277261|100601377|FG000|STARTED|Overall Study||274||
48111739|NCT03277261|100601378|FG001|STARTED|Overall Study||275||
48559496|NCT00699816|101702343|FG001|NOT COMPLETED|Overall Study||3||
48141405|NCT01454583|100670421|FG002|STARTED|2nd Year||2113||
48141406|NCT01454583|100670419|FG000|COMPLETED|2nd Year||6212||
48274467|NCT03772587|100996215|FG001|COMPLETED|Overall Study||14||
48274468|NCT03772587|100996216|FG002|COMPLETED|Overall Study||12||
48274469|NCT03772587|100996217|FG003|COMPLETED|Overall Study||12||
48274470|NCT03772587|100996218|FG004|COMPLETED|Overall Study||14||
48274471|NCT03772587|100996214|FG000|NOT COMPLETED|Overall Study||1||
48274472|NCT03772587|100996215|FG001|NOT COMPLETED|Overall Study||0||
48274473|NCT03772587|100996216|FG002|NOT COMPLETED|Overall Study||1||
48274474|NCT03772587|100996217|FG003|NOT COMPLETED|Overall Study||1||
48274475|NCT03772587|100996218|FG004|NOT COMPLETED|Overall Study||0||
48274476|NCT01255631|100996219|FG000|STARTED|Overall Study||13||
48274477|NCT01255631|100996220|FG001|STARTED|Overall Study||9||
48274478|NCT01255631|100996219|FG000|COMPLETED|Overall Study||4||
48274479|NCT01255631|100996220|FG001|COMPLETED|Overall Study||3||
48274480|NCT01255631|100996219|FG000|NOT COMPLETED|Overall Study||9||
48274481|NCT01255631|100996220|FG001|NOT COMPLETED|Overall Study||6||
48274482|NCT04445987|100996221|FG000|STARTED|Overall Study||52||
48274483|NCT04445987|100996222|FG001|STARTED|Overall Study||23||
48274484|NCT04445987|100996223|FG002|STARTED|Overall Study||41||
48274485|NCT04445987|100996224|FG003|STARTED|Overall Study||17||
48274486|NCT04445987|100996225|FG004|STARTED|Overall Study||267||
48274487|NCT04445987|100996226|FG005|STARTED|Overall Study||8||
48274488|NCT04445987|100996221|FG000|COMPLETED|Overall Study||43||
48274489|NCT04445987|100996222|FG001|COMPLETED|Overall Study||20||
48274490|NCT04445987|100996223|FG002|COMPLETED|Overall Study||37||
48274491|NCT04445987|100996224|FG003|COMPLETED|Overall Study||16||
48274492|NCT04445987|100996225|FG004|COMPLETED|Overall Study||211||
48274493|NCT04445987|100996226|FG005|COMPLETED|Overall Study||7||
48274494|NCT04445987|100996221|FG000|NOT COMPLETED|Overall Study||9||
48274495|NCT04445987|100996222|FG001|NOT COMPLETED|Overall Study||3||
48274496|NCT04445987|100996223|FG002|NOT COMPLETED|Overall Study||4||
48274497|NCT04445987|100996224|FG003|NOT COMPLETED|Overall Study||1||
48274498|NCT04445987|100996225|FG004|NOT COMPLETED|Overall Study||56||
48274499|NCT04445987|100996226|FG005|NOT COMPLETED|Overall Study||1||
48559497|NCT01062425|101702344|FG000|STARTED|Overall Study||55||
48111740|NCT03277261|100601377|FG000|COMPLETED|Overall Study||240|The completed number of participants denote the population who completed the 96 weeks Treatment Period.|
48274500|NCT02535091|100996227|FG000|STARTED|Overall Study||83||
48274501|NCT02535091|100996228|FG001|STARTED|Overall Study||37||
48274502|NCT02535091|100996229|FG002|STARTED|Overall Study||1220||
48274503|NCT02535091|100996227|FG000|COMPLETED|Overall Study||22||
48274504|NCT02535091|100996228|FG001|COMPLETED|Overall Study||5||
48274505|NCT02535091|100996229|FG002|COMPLETED|Overall Study||236||
48274506|NCT02535091|100996227|FG000|NOT COMPLETED|Overall Study||61||
48274507|NCT02535091|100996228|FG001|NOT COMPLETED|Overall Study||32||
48274508|NCT02535091|100996229|FG002|NOT COMPLETED|Overall Study||984||
48274509|NCT00320528|100996230|FG000|STARTED|Study Period II||98||
48274510|NCT00320528|100996231|FG001|STARTED|Study Period II||41||
48274511|NCT00320528|100996232|FG002|STARTED|Study Period II||130||
48274512|NCT00320528|100996230|FG000|Received at Least One Dose of Study Drug|Study Period II||97||
48274513|NCT00320528|100996231|FG001|Received at Least One Dose of Study Drug|Study Period II||38||
48274514|NCT00320528|100996232|FG002|Received at Least One Dose of Study Drug|Study Period II||128||
48274515|NCT00320528|100996230|FG000|COMPLETED|Study Period II||87||
48274516|NCT00320528|100996231|FG001|COMPLETED|Study Period II||31||
48274517|NCT00320528|100996232|FG002|COMPLETED|Study Period II||108||
48111741|NCT03277261|100601378|FG001|COMPLETED|Overall Study||252|The completed number of participants denote the population who completed the 96 weeks Treatment Period.|
48111742|NCT03277261|100601377|FG000|NOT COMPLETED|Overall Study||34||
48111743|NCT03277261|100601378|FG001|NOT COMPLETED|Overall Study||23||
48111744|NCT01600586|100601379|FG000|STARTED|Overall Study||49||
48111745|NCT01600586|100601380|FG001|STARTED|Overall Study||51||
48111746|NCT01600586|100601379|FG000|COMPLETED|Overall Study||46||
48111747|NCT01600586|100601380|FG001|COMPLETED|Overall Study||48||
48111748|NCT01600586|100601379|FG000|NOT COMPLETED|Overall Study||3||
48111749|NCT01600586|100601380|FG001|NOT COMPLETED|Overall Study||3||
48111750|NCT02547662|100601381|FG000|STARTED|Overall Study||17||
48274518|NCT00320528|100996230|FG000|NOT COMPLETED|Study Period II||11||
48274519|NCT00320528|100996231|FG001|NOT COMPLETED|Study Period II||10||
48274520|NCT00320528|100996232|FG002|NOT COMPLETED|Study Period II||22||
48274521|NCT00320528|100996230|FG000|STARTED|Study Period III||87||
48274522|NCT00320528|100996231|FG001|STARTED|Study Period III||31||
48274523|NCT00320528|100996232|FG002|STARTED|Study Period III||108||
48111751|NCT02547662|100601381|FG000|COMPLETED|Overall Study||17||
48111752|NCT02547662|100601381|FG000|NOT COMPLETED|Overall Study||0||
48111753|NCT00934544|100601382|FG000|STARTED|Primary Endpoint Analysis (Interim)||146||
48111754|NCT00934544|100601383|FG001|STARTED|Primary Endpoint Analysis (Interim)||73||
48111755|NCT00934544|100601384|FG002|STARTED|Primary Endpoint Analysis (Interim)||0||
48111756|NCT00934544|100601382|FG000|COMPLETED|Primary Endpoint Analysis (Interim)||91||
48111757|NCT00934544|100601383|FG001|COMPLETED|Primary Endpoint Analysis (Interim)||31||
48111758|NCT00934544|100601384|FG002|COMPLETED|Primary Endpoint Analysis (Interim)||0||
48274524|NCT00320528|100996230|FG000|COMPLETED|Study Period III||0||
48274525|NCT00320528|100996231|FG001|COMPLETED|Study Period III||0||
48274526|NCT00320528|100996232|FG002|COMPLETED|Study Period III||2||
48274527|NCT00320528|100996230|FG000|NOT COMPLETED|Study Period III||87||
48695412|NCT02771574|102038527|FG003|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0||
48695413|NCT02771574|102038528|FG004|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0||
48274528|NCT00320528|100996231|FG001|NOT COMPLETED|Study Period III||31||
48274529|NCT00320528|100996232|FG002|NOT COMPLETED|Study Period III||106||
48274530|NCT02327351|100996233|FG000|STARTED|Overall Study||98||
48274531|NCT02327351|100996233|FG000|COMPLETED|Overall Study||98||
48274532|NCT02327351|100996233|FG000|NOT COMPLETED|Overall Study||0||
48274533|NCT03682302|100996234|FG000|STARTED|Overall Study||31||
48274534|NCT03682302|100996235|FG001|STARTED|Overall Study||30||
48274535|NCT03682302|100996236|FG002|STARTED|Overall Study||6||
48274536|NCT03682302|100996237|FG003|STARTED|Overall Study||30||
48274537|NCT03682302|100996234|FG000|COMPLETED|Overall Study||30||
48274538|NCT03682302|100996235|FG001|COMPLETED|Overall Study||28||
48274539|NCT03682302|100996236|FG002|COMPLETED|Overall Study||5||
48695414|NCT02771574|102038524|FG000|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0||
48695415|NCT02771574|102038525|FG001|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0||
48695416|NCT02771574|102038526|FG002|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||3||
48695417|NCT02771574|102038527|FG003|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0||
48274540|NCT03682302|100996237|FG003|COMPLETED|Overall Study||28||
48274541|NCT03682302|100996234|FG000|NOT COMPLETED|Overall Study||1||
48274542|NCT03682302|100996235|FG001|NOT COMPLETED|Overall Study||2||
48274543|NCT03682302|100996236|FG002|NOT COMPLETED|Overall Study||1||
48274544|NCT03682302|100996237|FG003|NOT COMPLETED|Overall Study||2||
48274545|NCT02233803|100996238|FG000|STARTED|Treatment Period 1 (4-Wks)||100||
48274546|NCT02233803|100996239|FG001|STARTED|Treatment Period 1 (4-Wks)||99||
48274547|NCT02233803|100996238|FG000|COMPLETED|Treatment Period 1 (4-Wks)||97||
48274548|NCT02233803|100996239|FG001|COMPLETED|Treatment Period 1 (4-Wks)||95||
48274549|NCT02233803|100996238|FG000|NOT COMPLETED|Treatment Period 1 (4-Wks)||3||
48274550|NCT02233803|100996239|FG001|NOT COMPLETED|Treatment Period 1 (4-Wks)||4||
48274551|NCT02233803|100996238|FG000|STARTED|Washout Period (4-Wks)||97||
48274552|NCT02233803|100996239|FG001|STARTED|Washout Period (4-Wks)||95||
48274553|NCT02233803|100996238|FG000|COMPLETED|Washout Period (4-Wks)||95||
48274554|NCT02233803|100996239|FG001|COMPLETED|Washout Period (4-Wks)||93||
48274555|NCT02233803|100996238|FG000|NOT COMPLETED|Washout Period (4-Wks)||2||
48274556|NCT02233803|100996239|FG001|NOT COMPLETED|Washout Period (4-Wks)||2||
48274557|NCT02233803|100996238|FG000|STARTED|Treatment Period 2 (4-Wks)||95||
48274558|NCT02233803|100996239|FG001|STARTED|Treatment Period 2 (4-Wks)||93||
48274559|NCT02233803|100996238|FG000|COMPLETED|Treatment Period 2 (4-Wks)||93||
48274560|NCT02233803|100996239|FG001|COMPLETED|Treatment Period 2 (4-Wks)||91||
48274561|NCT02233803|100996238|FG000|NOT COMPLETED|Treatment Period 2 (4-Wks)||2||
48274562|NCT02233803|100996239|FG001|NOT COMPLETED|Treatment Period 2 (4-Wks)||2||
48274563|NCT02626455|100996240|FG000|STARTED|Overall Study||3||
48274564|NCT02626455|100996241|FG001|STARTED|Overall Study||7||
48274565|NCT02626455|100996242|FG002|STARTED|Overall Study||5||
48274566|NCT02626455|100996243|FG003|STARTED|Overall Study||6||
48274567|NCT02626455|100996244|FG004|STARTED|Overall Study||6||
48274568|NCT02626455|100996245|FG005|STARTED|Overall Study||262||
48274569|NCT02626455|100996246|FG006|STARTED|Overall Study||262||
48274570|NCT02626455|100996240|FG000|COMPLETED|Overall Study||0||
48274571|NCT02626455|100996241|FG001|COMPLETED|Overall Study||2||
48274572|NCT02626455|100996242|FG002|COMPLETED|Overall Study||3||
48274573|NCT02626455|100996243|FG003|COMPLETED|Overall Study||2||
48274574|NCT02626455|100996244|FG004|COMPLETED|Overall Study||3||
48274575|NCT02626455|100996245|FG005|COMPLETED|Overall Study||108||
48274576|NCT02626455|100996246|FG006|COMPLETED|Overall Study||153||
48274577|NCT02626455|100996240|FG000|NOT COMPLETED|Overall Study||3||
48393101|NCT02703987|101291509|FG001|STARTED|Visit 3 Intervention (1 Day)||14||
48695418|NCT02771574|102038528|FG004|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0||
48695419|NCT02771574|102038524|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0||
48695420|NCT02771574|102038525|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0||
48695421|NCT02771574|102038526|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0||
48695422|NCT02771574|102038527|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0||
48695423|NCT02771574|102038528|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0||
48710813|NCT03837665|102078027|FG000|STARTED|Overall Study||1||
48274578|NCT02626455|100996241|FG001|NOT COMPLETED|Overall Study||5||
48274579|NCT02626455|100996242|FG002|NOT COMPLETED|Overall Study||2||
48274580|NCT02626455|100996243|FG003|NOT COMPLETED|Overall Study||4||
48274581|NCT02626455|100996244|FG004|NOT COMPLETED|Overall Study||3||
48274582|NCT02626455|100996245|FG005|NOT COMPLETED|Overall Study||154||
48274583|NCT02626455|100996246|FG006|NOT COMPLETED|Overall Study||109||
48274584|NCT00403767|100996247|FG000|STARTED|Overall Study||7111||
48274585|NCT00403767|100996248|FG001|STARTED|Overall Study||7125||
48274586|NCT00403767|100996247|FG000|COMPLETED|Overall Study||4591||
48274587|NCT00403767|100996248|FG001|COMPLETED|Overall Study||4657||
48274588|NCT00403767|100996247|FG000|NOT COMPLETED|Overall Study||2520||
48274589|NCT00403767|100996248|FG001|NOT COMPLETED|Overall Study||2468||
48274590|NCT02354820|100996249|FG000|STARTED|Overall Study||9667||
48274591|NCT02354820|100996250|FG001|STARTED|Overall Study||6597||
48274592|NCT02354820|100996249|FG000|COMPLETED|Overall Study||9667||
48274593|NCT02354820|100996250|FG001|COMPLETED|Overall Study||6597||
48274594|NCT02354820|100996249|FG000|NOT COMPLETED|Overall Study||0||
48695424|NCT02771574|102038524|FG000|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0||
48695425|NCT02771574|102038525|FG001|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0||
48695426|NCT02771574|102038526|FG002|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0||
48695427|NCT02771574|102038527|FG003|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||3||
48695428|NCT02771574|102038528|FG004|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0||
48695429|NCT02771574|102038524|FG000|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0||
48695430|NCT02771574|102038525|FG001|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0||
48695431|NCT02771574|102038526|FG002|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0||
48695432|NCT02771574|102038527|FG003|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||3||
48695433|NCT02771574|102038528|FG004|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0||
48695434|NCT02771574|102038524|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0||
48695435|NCT02771574|102038525|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0||
48695436|NCT02771574|102038526|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0||
48695437|NCT02771574|102038527|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0||
48695438|NCT02771574|102038528|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0||
48695439|NCT02771574|102038524|FG000|STARTED|Liq Avexitide (3 Days)||0||
48695440|NCT02771574|102038525|FG001|STARTED|Liq Avexitide (3 Days)||0||
48695441|NCT02771574|102038526|FG002|STARTED|Liq Avexitide (3 Days)||0||
48695442|NCT02771574|102038527|FG003|STARTED|Liq Avexitide (3 Days)||0||
48695443|NCT02771574|102038528|FG004|STARTED|Liq Avexitide (3 Days)||5||
48695444|NCT02771574|102038524|FG000|COMPLETED|Liq Avexitide (3 Days)||0||
48695445|NCT02771574|102038525|FG001|COMPLETED|Liq Avexitide (3 Days)||0||
48695446|NCT02771574|102038526|FG002|COMPLETED|Liq Avexitide (3 Days)||0||
48695447|NCT02771574|102038527|FG003|COMPLETED|Liq Avexitide (3 Days)||0||
48695448|NCT02771574|102038528|FG004|COMPLETED|Liq Avexitide (3 Days)||5||
48695449|NCT02771574|102038524|FG000|NOT COMPLETED|Liq Avexitide (3 Days)||0||
48695450|NCT02771574|102038525|FG001|NOT COMPLETED|Liq Avexitide (3 Days)||0||
48695451|NCT02771574|102038526|FG002|NOT COMPLETED|Liq Avexitide (3 Days)||0||
48695452|NCT02771574|102038527|FG003|NOT COMPLETED|Liq Avexitide (3 Days)||0||
48111759|NCT00934544|100601382|FG000|NOT COMPLETED|Primary Endpoint Analysis (Interim)||55||
48111760|NCT00934544|100601383|FG001|NOT COMPLETED|Primary Endpoint Analysis (Interim)||42||
48111761|NCT00934544|100601384|FG002|NOT COMPLETED|Primary Endpoint Analysis (Interim)||0||
48111762|NCT00934544|100601382|FG000|STARTED|Overall Disposition at 5 Year Follow-up||146||
48111763|NCT00934544|100601383|FG001|STARTED|Overall Disposition at 5 Year Follow-up||28||
48111764|NCT00934544|100601384|FG002|STARTED|Overall Disposition at 5 Year Follow-up||45||
48111765|NCT00934544|100601382|FG000|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||0||
48111766|NCT00934544|100601383|FG001|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||0||
48111767|NCT00934544|100601384|FG002|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||27||
48111768|NCT00934544|100601382|FG000|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||0||
48111769|NCT00934544|100601383|FG001|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||0||
48111770|NCT00934544|100601384|FG002|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||12||
48111771|NCT00934544|100601382|FG000|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||0||
48111772|NCT00934544|100601383|FG001|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||0||
48111773|NCT00934544|100601384|FG002|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||6||
48111774|NCT00934544|100601382|FG000|COMPLETED|Overall Disposition at 5 Year Follow-up||39||
48111775|NCT00934544|100601383|FG001|COMPLETED|Overall Disposition at 5 Year Follow-up||0||
48111776|NCT00934544|100601384|FG002|COMPLETED|Overall Disposition at 5 Year Follow-up||11||
48111777|NCT00934544|100601382|FG000|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||107||
48111778|NCT00934544|100601383|FG001|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||28||
48111779|NCT00934544|100601384|FG002|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||34||
48111780|NCT02023151|100601385|FG000|STARTED|Overall Study||17||
48111781|NCT02023151|100601385|FG000|COMPLETED|Overall Study||13||
48111782|NCT02023151|100601385|FG000|NOT COMPLETED|Overall Study||4||
48111783|NCT04033003|100601386|FG000|STARTED|T0 (Baseline at Recruitment)||877||7
48111784|NCT04033003|100601387|FG001|STARTED|T0 (Baseline at Recruitment)||884||7
48111785|NCT04033003|100601386|FG000|COMPLETED|T0 (Baseline at Recruitment)||877||7
48111786|NCT04033003|100601387|FG001|COMPLETED|T0 (Baseline at Recruitment)||884||7
48111787|NCT04033003|100601386|FG000|NOT COMPLETED|T0 (Baseline at Recruitment)||0||0
48111788|NCT04033003|100601387|FG001|NOT COMPLETED|T0 (Baseline at Recruitment)||0||0
48111789|NCT04033003|100601386|FG000|STARTED|T1 (34 Wks Gestation - 3 Wks Postpartum)||877||7
48111790|NCT04033003|100601387|FG001|STARTED|T1 (34 Wks Gestation - 3 Wks Postpartum)||884||7
48111791|NCT04033003|100601386|FG000|COMPLETED|T1 (34 Wks Gestation - 3 Wks Postpartum)||617||7
48111792|NCT04033003|100601387|FG001|COMPLETED|T1 (34 Wks Gestation - 3 Wks Postpartum)||668||7
48111793|NCT04033003|100601386|FG000|NOT COMPLETED|T1 (34 Wks Gestation - 3 Wks Postpartum)||260||0
48111794|NCT04033003|100601387|FG001|NOT COMPLETED|T1 (34 Wks Gestation - 3 Wks Postpartum)||216||0
48111795|NCT04033003|100601386|FG000|STARTED|T2 (6 - 12 Weeks Postpartum)||730||7
48111796|NCT04033003|100601387|FG001|STARTED|T2 (6 - 12 Weeks Postpartum)||858||7
48111797|NCT04033003|100601386|FG000|COMPLETED|T2 (6 - 12 Weeks Postpartum)||585||7
48111798|NCT04033003|100601387|FG001|COMPLETED|T2 (6 - 12 Weeks Postpartum)||596||7
48695453|NCT02771574|102038528|FG004|NOT COMPLETED|Liq Avexitide (3 Days)||0||
48695454|NCT03660865|102038529|FG000|STARTED|Overall Study||105||105
48695455|NCT03660865|102038530|FG001|STARTED|Overall Study||105||105
48695456|NCT03660865|102038529|FG000|COMPLETED|Overall Study||105||105
48695457|NCT03660865|102038530|FG001|COMPLETED|Overall Study||105||105
48695458|NCT03660865|102038529|FG000|NOT COMPLETED|Overall Study||0||0
48695459|NCT03660865|102038530|FG001|NOT COMPLETED|Overall Study||0||0
48695460|NCT02063867|102038531|FG000|STARTED|Overall Study||156889||26
48559498|NCT01062425|101702345|FG001|STARTED|Overall Study||103||
48559499|NCT01062425|101702344|FG000|COMPLETED|Overall Study||52||
48559500|NCT01062425|101702345|FG001|COMPLETED|Overall Study||97||
48559501|NCT01062425|101702344|FG000|NOT COMPLETED|Overall Study||3||
48559502|NCT01062425|101702345|FG001|NOT COMPLETED|Overall Study||6||
48559503|NCT00942084|101702346|FG000|STARTED|Overall Study||32||
48559504|NCT00942084|101702346|FG000|COMPLETED|Overall Study||30||
48559505|NCT00942084|101702346|FG000|NOT COMPLETED|Overall Study||2||
48559506|NCT00503698|101702347|FG000|STARTED|Overall Study||357||
48111799|NCT04033003|100601386|FG000|NOT COMPLETED|T2 (6 - 12 Weeks Postpartum)||145||0
48111800|NCT04033003|100601387|FG001|NOT COMPLETED|T2 (6 - 12 Weeks Postpartum)||262||0
48111801|NCT04033003|100601386|FG000|STARTED|T3 (5 - 8 Month Postpartum)||718|The participants lost-to-follow up in T 2 are eligible to participate in T3 survey, which is why the number of participants started in T3 does not equal those who completed T2. The number started T3 is the sum of T2 completed + T2 lost-to-follow-up.|7
48274595|NCT02354820|100996250|FG001|NOT COMPLETED|Overall Study||0||
48274596|NCT00415051|100996251|FG000|STARTED|Overall Study||20||
48274597|NCT00415051|100996251|FG000|COMPLETED|Overall Study||19||
48274598|NCT00415051|100996251|FG000|NOT COMPLETED|Overall Study||1||
48274599|NCT02579135|100996252|FG000|STARTED|Overall Study||107||
48274600|NCT02579135|100996253|FG001|STARTED|Overall Study||115||
48274601|NCT02579135|100996252|FG000|COMPLETED|Overall Study||105||
48559507|NCT00503698|101702348|FG001|STARTED|Overall Study||355||
48559508|NCT00503698|101702347|FG000|Exposed to Trial Drug|Overall Study||346||
48559509|NCT00503698|101702348|FG001|Exposed to Trial Drug|Overall Study||349||
48111802|NCT04033003|100601387|FG001|STARTED|T3 (5 - 8 Month Postpartum)||843|The participants lost-to-follow up in T 2 are eligible to participate in T3 survey, which is why the number of participants started in T3 does not equal those who completed T2. The number started T3 is the sum of T2 completed + T2 lost-to-follow-up.|7
48111803|NCT04033003|100601386|FG000|COMPLETED|T3 (5 - 8 Month Postpartum)||619||7
48111804|NCT04033003|100601387|FG001|COMPLETED|T3 (5 - 8 Month Postpartum)||673||7
48111805|NCT04033003|100601386|FG000|NOT COMPLETED|T3 (5 - 8 Month Postpartum)||99||0
48111806|NCT04033003|100601387|FG001|NOT COMPLETED|T3 (5 - 8 Month Postpartum)||170||0
48111807|NCT04033003|100601386|FG000|STARTED|T4 (11 -14 Months Postpartum)||715|The participants lost-to-follow up in T3 are eligible to participate in T4 survey, which is why the number of participants started in T4 does not equal those who completed T3. The number started T4 is the sum of T3 completed + T3 lost-to-follow-up.|7
48274602|NCT02579135|100996253|FG001|COMPLETED|Overall Study||106||
48274603|NCT02579135|100996252|FG000|NOT COMPLETED|Overall Study||2||
48274604|NCT02579135|100996253|FG001|NOT COMPLETED|Overall Study||9||
48274605|NCT00357110|100996254|FG000|STARTED|Overall Study||6||
48695461|NCT02063867|102038532|FG001|STARTED|Overall Study||183013||27
48695462|NCT02063867|102038531|FG000|COMPLETED|Overall Study||152598||24
48274606|NCT00357110|100996255|FG001|STARTED|Overall Study||7||
48274607|NCT00357110|100996254|FG000|COMPLETED|Overall Study||1||
48274608|NCT00357110|100996255|FG001|COMPLETED|Overall Study||2||
48393102|NCT02703987|101291508|FG000|COMPLETED|Visit 3 Intervention (1 Day)||13||
48393103|NCT02703987|101291509|FG001|COMPLETED|Visit 3 Intervention (1 Day)||11||
48393104|NCT02703987|101291508|FG000|NOT COMPLETED|Visit 3 Intervention (1 Day)||1||
48559510|NCT00503698|101702347|FG000|COMPLETED|Overall Study||0||
48695463|NCT02063867|102038532|FG001|COMPLETED|Overall Study||180048||24
48274609|NCT00357110|100996254|FG000|NOT COMPLETED|Overall Study||5||
48274610|NCT00357110|100996255|FG001|NOT COMPLETED|Overall Study||5||
48559511|NCT00503698|101702348|FG001|COMPLETED|Overall Study||0||
48559512|NCT00503698|101702347|FG000|NOT COMPLETED|Overall Study||357||
48559513|NCT00503698|101702348|FG001|NOT COMPLETED|Overall Study||355||
48559514|NCT01103180|101702349|FG000|STARTED|Overall Study||35||
48559515|NCT01103180|101702350|FG001|STARTED|Overall Study||35||
48559516|NCT01103180|101702349|FG000|COMPLETED|Overall Study||13||
48559517|NCT01103180|101702350|FG001|COMPLETED|Overall Study||14||
48695464|NCT02063867|102038531|FG000|NOT COMPLETED|Overall Study||4291||2
48695465|NCT02063867|102038532|FG001|NOT COMPLETED|Overall Study||2965||3
48695466|NCT01925040|102038533|FG000|STARTED|Overall Study||85||90
48559518|NCT01103180|101702349|FG000|NOT COMPLETED|Overall Study||22||
48559519|NCT01103180|101702350|FG001|NOT COMPLETED|Overall Study||21||
48559520|NCT03307252|101702351|FG000|STARTED|Part 1, Period 1||4||
48559521|NCT03307252|101702352|FG001|STARTED|Part 1, Period 1||4||
48559522|NCT03307252|101702353|FG002|STARTED|Part 1, Period 1||4||
48559523|NCT03307252|101702354|FG003|STARTED|Part 1, Period 1||0||
48559524|NCT03307252|101702355|FG004|STARTED|Part 1, Period 1||0||
48559525|NCT03307252|101702356|FG005|STARTED|Part 1, Period 1||0||
48559526|NCT03307252|101702357|FG006|STARTED|Part 1, Period 1||0||
48559527|NCT03307252|101702358|FG007|STARTED|Part 1, Period 1||0||
48559528|NCT03307252|101702359|FG008|STARTED|Part 1, Period 1||0||
48559529|NCT03307252|101702360|FG009|STARTED|Part 1, Period 1||0||
48559530|NCT03307252|101702361|FG010|STARTED|Part 1, Period 1||0||
48559531|NCT03307252|101702351|FG000|COMPLETED|Part 1, Period 1||4||
48559532|NCT03307252|101702352|FG001|COMPLETED|Part 1, Period 1||4||
48559533|NCT03307252|101702353|FG002|COMPLETED|Part 1, Period 1||4||
48559534|NCT03307252|101702354|FG003|COMPLETED|Part 1, Period 1||0||
48559535|NCT03307252|101702355|FG004|COMPLETED|Part 1, Period 1||0||
48559536|NCT03307252|101702356|FG005|COMPLETED|Part 1, Period 1||0||
48559537|NCT03307252|101702357|FG006|COMPLETED|Part 1, Period 1||0||
48559538|NCT03307252|101702358|FG007|COMPLETED|Part 1, Period 1||0||
48559539|NCT03307252|101702359|FG008|COMPLETED|Part 1, Period 1||0||
48559540|NCT03307252|101702360|FG009|COMPLETED|Part 1, Period 1||0||
48559541|NCT03307252|101702361|FG010|COMPLETED|Part 1, Period 1||0||
48559542|NCT03307252|101702351|FG000|NOT COMPLETED|Part 1, Period 1||0||
48559543|NCT03307252|101702352|FG001|NOT COMPLETED|Part 1, Period 1||0||
48559544|NCT03307252|101702353|FG002|NOT COMPLETED|Part 1, Period 1||0||
48559545|NCT03307252|101702354|FG003|NOT COMPLETED|Part 1, Period 1||0||
48559546|NCT03307252|101702355|FG004|NOT COMPLETED|Part 1, Period 1||0||
48559547|NCT03307252|101702356|FG005|NOT COMPLETED|Part 1, Period 1||0||
48695467|NCT01925040|102038534|FG001|STARTED|Overall Study||83||90
48695468|NCT01925040|102038533|FG000|COMPLETED|Overall Study||49||55
48695469|NCT01925040|102038534|FG001|COMPLETED|Overall Study||48||53
48695470|NCT01925040|102038533|FG000|NOT COMPLETED|Overall Study||36||35
48695471|NCT01925040|102038534|FG001|NOT COMPLETED|Overall Study||35||37
48695472|NCT05327660|102038535|FG000|STARTED|Overall Study||73||
48695473|NCT05327660|102038536|FG001|STARTED|Overall Study||76||
48695474|NCT05327660|102038537|FG002|STARTED|Overall Study||80||
48695475|NCT05327660|102038535|FG000|COMPLETED|Overall Study||73||
48695476|NCT05327660|102038536|FG001|COMPLETED|Overall Study||76||
48695477|NCT05327660|102038537|FG002|COMPLETED|Overall Study||80||
48695478|NCT05327660|102038535|FG000|NOT COMPLETED|Overall Study||0||
48695479|NCT05327660|102038536|FG001|NOT COMPLETED|Overall Study||0||
48695480|NCT05327660|102038537|FG002|NOT COMPLETED|Overall Study||0||
48695481|NCT03980743|102038538|FG000|STARTED|Overall Study||33||
48695482|NCT03980743|102038539|FG001|STARTED|Overall Study||17||
48695483|NCT03980743|102038538|FG000|COMPLETED|Overall Study||18||
48695484|NCT03980743|102038539|FG001|COMPLETED|Overall Study||9||
48695485|NCT03980743|102038538|FG000|NOT COMPLETED|Overall Study||15||
48695486|NCT03980743|102038539|FG001|NOT COMPLETED|Overall Study||8||
48695487|NCT00799227|102038540|FG000|STARTED|Overall Study||56||
48695488|NCT00799227|102038540|FG000|COMPLETED|Overall Study||53||
48695489|NCT00799227|102038540|FG000|NOT COMPLETED|Overall Study||3||
48695490|NCT02791516|102038541|FG000|STARTED|Overall Study||33||
48695491|NCT02791516|102038542|FG001|STARTED|Overall Study||34||
48559548|NCT03307252|101702357|FG006|NOT COMPLETED|Part 1, Period 1||0||
48559549|NCT03307252|101702358|FG007|NOT COMPLETED|Part 1, Period 1||0||
48559550|NCT03307252|101702359|FG008|NOT COMPLETED|Part 1, Period 1||0||
48559551|NCT03307252|101702360|FG009|NOT COMPLETED|Part 1, Period 1||0||
48559552|NCT03307252|101702361|FG010|NOT COMPLETED|Part 1, Period 1||0||
48559553|NCT03307252|101702351|FG000|STARTED|Part 1, Washout Period 1 (13 Days)||4||
48559554|NCT03307252|101702352|FG001|STARTED|Part 1, Washout Period 1 (13 Days)||4||
48559555|NCT03307252|101702353|FG002|STARTED|Part 1, Washout Period 1 (13 Days)||4||
48559556|NCT03307252|101702354|FG003|STARTED|Part 1, Washout Period 1 (13 Days)||0||
48559557|NCT03307252|101702355|FG004|STARTED|Part 1, Washout Period 1 (13 Days)||0||
48559558|NCT03307252|101702356|FG005|STARTED|Part 1, Washout Period 1 (13 Days)||0||
48559559|NCT03307252|101702357|FG006|STARTED|Part 1, Washout Period 1 (13 Days)||0||
48695492|NCT02791516|102038541|FG000|Completed 6-month Treatment Period|Overall Study||33||
48695493|NCT02791516|102038542|FG001|Completed 6-month Treatment Period|Overall Study||33||
48695494|NCT02791516|102038541|FG000|COMPLETED|Overall Study||32|Completed 9-month study period|
48695495|NCT02791516|102038542|FG001|COMPLETED|Overall Study||33|Completed 9-month study period|
48695496|NCT02791516|102038541|FG000|NOT COMPLETED|Overall Study||1||
48559560|NCT03307252|101702358|FG007|STARTED|Part 1, Washout Period 1 (13 Days)||0||
48559561|NCT03307252|101702359|FG008|STARTED|Part 1, Washout Period 1 (13 Days)||0||
48559562|NCT03307252|101702360|FG009|STARTED|Part 1, Washout Period 1 (13 Days)||0||
48559563|NCT03307252|101702361|FG010|STARTED|Part 1, Washout Period 1 (13 Days)||0||
48559564|NCT03307252|101702351|FG000|COMPLETED|Part 1, Washout Period 1 (13 Days)||4||
48559565|NCT03307252|101702352|FG001|COMPLETED|Part 1, Washout Period 1 (13 Days)||4||
48559566|NCT03307252|101702353|FG002|COMPLETED|Part 1, Washout Period 1 (13 Days)||4||
48559567|NCT03307252|101702354|FG003|COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
48559568|NCT03307252|101702355|FG004|COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
48559569|NCT03307252|101702356|FG005|COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
48559570|NCT03307252|101702357|FG006|COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
48559571|NCT03307252|101702358|FG007|COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
48559572|NCT03307252|101702359|FG008|COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
48559573|NCT03307252|101702360|FG009|COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
48559574|NCT03307252|101702361|FG010|COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
48559575|NCT03307252|101702351|FG000|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
48559576|NCT03307252|101702352|FG001|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
48695497|NCT02791516|102038542|FG001|NOT COMPLETED|Overall Study||1||
48695498|NCT03015363|102038543|FG000|STARTED|Overall Study||37||
48695499|NCT03015363|102038543|FG000|COMPLETED|Overall Study||20||
48695500|NCT03015363|102038543|FG000|NOT COMPLETED|Overall Study||17||
48695501|NCT04556591|102038544|FG000|STARTED|Overall Study||36||
48695502|NCT04556591|102038545|FG001|STARTED|Overall Study||36||
48695503|NCT04556591|102038544|FG000|COMPLETED|Overall Study||33||
48695504|NCT04556591|102038545|FG001|COMPLETED|Overall Study||36||
48695505|NCT04556591|102038544|FG000|NOT COMPLETED|Overall Study||3||
48695506|NCT04556591|102038545|FG001|NOT COMPLETED|Overall Study||0||
48695507|NCT01191736|102038546|FG000|STARTED|Overall Study||51||
48695508|NCT01191736|102038547|FG001|STARTED|Overall Study||47||
48695509|NCT01191736|102038548|FG002|STARTED|Overall Study||49||
48695510|NCT01191736|102038549|FG003|STARTED|Overall Study||46||
48695511|NCT01191736|102038550|FG004|STARTED|Overall Study||48||
48695512|NCT01191736|102038551|FG005|STARTED|Overall Study||50||
48695513|NCT01191736|102038552|FG006|STARTED|Overall Study||45||
48695514|NCT01191736|102038546|FG000|COMPLETED|Overall Study||51||
48695515|NCT01191736|102038547|FG001|COMPLETED|Overall Study||47||
48695516|NCT01191736|102038548|FG002|COMPLETED|Overall Study||49||
48695517|NCT01191736|102038549|FG003|COMPLETED|Overall Study||46||
48695518|NCT01191736|102038550|FG004|COMPLETED|Overall Study||48||
48393105|NCT02703987|101291509|FG001|NOT COMPLETED|Visit 3 Intervention (1 Day)||3||
48393106|NCT02703987|101291508|FG000|STARTED|Washout (Minimum 5 Days)||13||
48559577|NCT03307252|101702353|FG002|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
48559578|NCT03307252|101702354|FG003|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
48559579|NCT03307252|101702355|FG004|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
48559580|NCT03307252|101702356|FG005|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
48393107|NCT02703987|101291509|FG001|STARTED|Washout (Minimum 5 Days)||11||
48592746|NCT02678000|101783170|FG002|STARTED|PART 2||28||
48695519|NCT01191736|102038551|FG005|COMPLETED|Overall Study||50||
48695520|NCT01191736|102038552|FG006|COMPLETED|Overall Study||45||
48695521|NCT01191736|102038546|FG000|NOT COMPLETED|Overall Study||0||
48695522|NCT01191736|102038547|FG001|NOT COMPLETED|Overall Study||0||
48695523|NCT01191736|102038548|FG002|NOT COMPLETED|Overall Study||0||
48695524|NCT01191736|102038549|FG003|NOT COMPLETED|Overall Study||0||
48695525|NCT01191736|102038550|FG004|NOT COMPLETED|Overall Study||0||
48559581|NCT03307252|101702357|FG006|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
48559582|NCT03307252|101702358|FG007|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
48559583|NCT03307252|101702359|FG008|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
48559584|NCT03307252|101702360|FG009|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
48559585|NCT03307252|101702361|FG010|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
48559586|NCT03307252|101702351|FG000|STARTED|Part 1, Period 2||4||
48559587|NCT03307252|101702352|FG001|STARTED|Part 1, Period 2||4||
48559588|NCT03307252|101702353|FG002|STARTED|Part 1, Period 2||4||
48559589|NCT03307252|101702354|FG003|STARTED|Part 1, Period 2||0||
48559590|NCT03307252|101702355|FG004|STARTED|Part 1, Period 2||0||
48274611|NCT01641159|100996256|FG000|STARTED|Overall Study||35||
48274612|NCT01641159|100996257|FG001|STARTED|Overall Study||27||
48274613|NCT01641159|100996256|FG000|COMPLETED|Overall Study||33||
48274614|NCT01641159|100996257|FG001|COMPLETED|Overall Study||25||
48274615|NCT01641159|100996256|FG000|NOT COMPLETED|Overall Study||2||
48274616|NCT01641159|100996257|FG001|NOT COMPLETED|Overall Study||2||
48274617|NCT05330676|100996258|FG000|STARTED|Overall Study||38||
48274618|NCT05330676|100996259|FG001|STARTED|Overall Study||104||
48274619|NCT05330676|100996258|FG000|COMPLETED|Overall Study||36||
48274620|NCT05330676|100996259|FG001|COMPLETED|Overall Study||95||
48274621|NCT05330676|100996258|FG000|NOT COMPLETED|Overall Study||2||
48274622|NCT05330676|100996259|FG001|NOT COMPLETED|Overall Study||9||
48559591|NCT03307252|101702356|FG005|STARTED|Part 1, Period 2||0||
48559592|NCT03307252|101702357|FG006|STARTED|Part 1, Period 2||0||
48559593|NCT03307252|101702358|FG007|STARTED|Part 1, Period 2||0||
48559594|NCT03307252|101702359|FG008|STARTED|Part 1, Period 2||0||
48559595|NCT03307252|101702360|FG009|STARTED|Part 1, Period 2||0||
48559596|NCT03307252|101702361|FG010|STARTED|Part 1, Period 2||0||
48559597|NCT03307252|101702351|FG000|COMPLETED|Part 1, Period 2||4||
48559598|NCT03307252|101702352|FG001|COMPLETED|Part 1, Period 2||4||
48559599|NCT03307252|101702353|FG002|COMPLETED|Part 1, Period 2||4||
48559600|NCT03307252|101702354|FG003|COMPLETED|Part 1, Period 2||0||
48559601|NCT03307252|101702355|FG004|COMPLETED|Part 1, Period 2||0||
48559602|NCT03307252|101702356|FG005|COMPLETED|Part 1, Period 2||0||
48559603|NCT03307252|101702357|FG006|COMPLETED|Part 1, Period 2||0||
48559604|NCT03307252|101702358|FG007|COMPLETED|Part 1, Period 2||0||
48559605|NCT03307252|101702359|FG008|COMPLETED|Part 1, Period 2||0||
48559606|NCT03307252|101702360|FG009|COMPLETED|Part 1, Period 2||0||
48559607|NCT03307252|101702361|FG010|COMPLETED|Part 1, Period 2||0||
48559608|NCT03307252|101702351|FG000|NOT COMPLETED|Part 1, Period 2||0||
48559609|NCT03307252|101702352|FG001|NOT COMPLETED|Part 1, Period 2||0||
48559610|NCT03307252|101702353|FG002|NOT COMPLETED|Part 1, Period 2||0||
48559611|NCT03307252|101702354|FG003|NOT COMPLETED|Part 1, Period 2||0||
48559612|NCT03307252|101702355|FG004|NOT COMPLETED|Part 1, Period 2||0||
48559613|NCT03307252|101702356|FG005|NOT COMPLETED|Part 1, Period 2||0||
48559614|NCT03307252|101702357|FG006|NOT COMPLETED|Part 1, Period 2||0||
48559615|NCT03307252|101702358|FG007|NOT COMPLETED|Part 1, Period 2||0||
48559616|NCT03307252|101702359|FG008|NOT COMPLETED|Part 1, Period 2||0||
48559617|NCT03307252|101702360|FG009|NOT COMPLETED|Part 1, Period 2||0||
48559618|NCT03307252|101702361|FG010|NOT COMPLETED|Part 1, Period 2||0||
48559619|NCT03307252|101702351|FG000|STARTED|Part 1, Washout Period 2 (13 Days)||4||
48559620|NCT03307252|101702352|FG001|STARTED|Part 1, Washout Period 2 (13 Days)||4||
48559621|NCT03307252|101702353|FG002|STARTED|Part 1, Washout Period 2 (13 Days)||4||
48559622|NCT03307252|101702354|FG003|STARTED|Part 1, Washout Period 2 (13 Days)||0||
48559623|NCT03307252|101702355|FG004|STARTED|Part 1, Washout Period 2 (13 Days)||0||
48274623|NCT00789360|100996260|FG000|STARTED|Overall Study||15||
48274624|NCT00789360|100996261|FG001|STARTED|Overall Study||15||
48274625|NCT00789360|100996260|FG000|COMPLETED|Overall Study||12||
48274626|NCT00789360|100996261|FG001|COMPLETED|Overall Study||14||
48274627|NCT00789360|100996260|FG000|NOT COMPLETED|Overall Study||3||
48559624|NCT03307252|101702356|FG005|STARTED|Part 1, Washout Period 2 (13 Days)||0||
48559625|NCT03307252|101702357|FG006|STARTED|Part 1, Washout Period 2 (13 Days)||0||
48559626|NCT03307252|101702358|FG007|STARTED|Part 1, Washout Period 2 (13 Days)||0||
48559627|NCT03307252|101702359|FG008|STARTED|Part 1, Washout Period 2 (13 Days)||0||
48559628|NCT03307252|101702360|FG009|STARTED|Part 1, Washout Period 2 (13 Days)||0||
48559629|NCT03307252|101702361|FG010|STARTED|Part 1, Washout Period 2 (13 Days)||0||
48559630|NCT03307252|101702351|FG000|COMPLETED|Part 1, Washout Period 2 (13 Days)||4||
48559631|NCT03307252|101702352|FG001|COMPLETED|Part 1, Washout Period 2 (13 Days)||4||
48559632|NCT03307252|101702353|FG002|COMPLETED|Part 1, Washout Period 2 (13 Days)||4||
48111808|NCT04033003|100601387|FG001|STARTED|T4 (11 -14 Months Postpartum)||838|The participants lost-to-follow up in T3 are eligible to participate in T4 survey, which is why the number of participants started in T4 does not equal those who completed T3. The number started T4 is the sum of T3 completed + T3 lost-to-follow-up.|7
48111809|NCT04033003|100601386|FG000|COMPLETED|T4 (11 -14 Months Postpartum)||626||7
48111810|NCT04033003|100601387|FG001|COMPLETED|T4 (11 -14 Months Postpartum)||688||7
48111811|NCT04033003|100601386|FG000|NOT COMPLETED|T4 (11 -14 Months Postpartum)||89||0
48111812|NCT04033003|100601387|FG001|NOT COMPLETED|T4 (11 -14 Months Postpartum)||150||0
48111813|NCT00378703|100601388|FG000|STARTED|Overall Study||89||
48111814|NCT00378703|100601389|FG001|STARTED|Overall Study||91||
48111815|NCT00378703|100601390|FG002|STARTED|Overall Study||90||
48111816|NCT00378703|100601391|FG003|STARTED|Overall Study||91||
48111817|NCT00378703|100601388|FG000|Treated|Overall Study||88||
48111818|NCT00378703|100601389|FG001|Treated|Overall Study||86||
48111819|NCT00378703|100601390|FG002|Treated|Overall Study||90||
48111820|NCT00378703|100601391|FG003|Treated|Overall Study||91||
48111821|NCT00378703|100601388|FG000|Eligible and Treated|Overall Study||84||
48111822|NCT00378703|100601389|FG001|Eligible and Treated|Overall Study||80||
48111823|NCT00378703|100601390|FG002|Eligible and Treated|Overall Study||83||
48111824|NCT00378703|100601391|FG003|Eligible and Treated|Overall Study||84||
48111825|NCT00378703|100601388|FG000|COMPLETED|Overall Study||0||
48111826|NCT00378703|100601389|FG001|COMPLETED|Overall Study||0||
48111827|NCT00378703|100601390|FG002|COMPLETED|Overall Study||0||
48111828|NCT00378703|100601391|FG003|COMPLETED|Overall Study||0||
48111829|NCT00378703|100601388|FG000|NOT COMPLETED|Overall Study||89||
48111830|NCT00378703|100601389|FG001|NOT COMPLETED|Overall Study||91||
48111831|NCT00378703|100601390|FG002|NOT COMPLETED|Overall Study||90||
48111832|NCT00378703|100601391|FG003|NOT COMPLETED|Overall Study||91||
48111833|NCT02267629|100601392|FG000|STARTED|Overall Study||7||
48111834|NCT02267629|100601392|FG000|COMPLETED|Overall Study||7||
48111835|NCT02267629|100601392|FG000|NOT COMPLETED|Overall Study||0||
48111836|NCT03044197|100601393|FG000|STARTED|Overall Study||12||
48111837|NCT03044197|100601394|FG001|STARTED|Overall Study||12||
48111838|NCT03044197|100601393|FG000|COMPLETED|Overall Study||9||
48111839|NCT03044197|100601394|FG001|COMPLETED|Overall Study||11||
48111840|NCT03044197|100601393|FG000|NOT COMPLETED|Overall Study||3||
48111841|NCT03044197|100601394|FG001|NOT COMPLETED|Overall Study||1||
48111842|NCT00715793|100601395|FG000|STARTED|Phase 1 RP2D DAC + TMZ||4||
48111843|NCT00715793|100601396|FG001|STARTED|Phase 1 RP2D DAC + TMZ||6||
48111844|NCT00715793|100601395|FG000|COMPLETED|Phase 1 RP2D DAC + TMZ||3||
48111845|NCT00715793|100601396|FG001|COMPLETED|Phase 1 RP2D DAC + TMZ||6||
48111846|NCT00715793|100601395|FG000|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||1||
48111847|NCT00715793|100601396|FG001|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||0||
48111848|NCT00715793|100601395|FG000|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||0||
48111849|NCT00715793|100601396|FG001|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||29||
48111850|NCT00715793|100601395|FG000|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0||
48111851|NCT00715793|100601396|FG001|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||27||
48111852|NCT00715793|100601395|FG000|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0||
48111853|NCT00715793|100601396|FG001|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||2||
48111854|NCT02126969|100601397|FG000|STARTED|Overall Study||23||
48111855|NCT02126969|100601398|FG001|STARTED|Overall Study||22||
48111856|NCT02126969|100601397|FG000|COMPLETED|Overall Study||22||
48111857|NCT02126969|100601398|FG001|COMPLETED|Overall Study||20||
48111858|NCT02126969|100601397|FG000|NOT COMPLETED|Overall Study||1||
48111859|NCT02126969|100601398|FG001|NOT COMPLETED|Overall Study||2||
48111860|NCT02003625|100601399|FG000|STARTED|Overall Study||15||
48111861|NCT02003625|100601400|FG001|STARTED|Overall Study||15||
48111862|NCT02003625|100601399|FG000|Received Transplant|Overall Study||14||
48111863|NCT02003625|100601400|FG001|Received Transplant|Overall Study||12||
48111864|NCT02003625|100601399|FG000|COMPLETED|Overall Study||14||
48111865|NCT02003625|100601400|FG001|COMPLETED|Overall Study||12||
48111866|NCT02003625|100601399|FG000|NOT COMPLETED|Overall Study||1||
48111867|NCT02003625|100601400|FG001|NOT COMPLETED|Overall Study||3||
48111868|NCT02404311|100601401|FG000|STARTED|Part A: Month 0-18||210||
48111869|NCT02404311|100601402|FG001|STARTED|Part A: Month 0-18||42||
48111870|NCT02404311|100601403|FG002|STARTED|Part A: Month 0-18||0||
48111871|NCT02404311|100601404|FG003|STARTED|Part A: Month 0-18||0||
48111872|NCT02404311|100601405|FG004|STARTED|Part A: Month 0-18||0||
48111873|NCT02404311|100601401|FG000|Per Protocol|Part A: Month 0-18||185||
48111874|NCT02404311|100601402|FG001|Per Protocol|Part A: Month 0-18||37||
48111875|NCT02404311|100601403|FG002|Per Protocol|Part A: Month 0-18||0||
48111876|NCT02404311|100601404|FG003|Per Protocol|Part A: Month 0-18||0||
48111877|NCT02404311|100601405|FG004|Per Protocol|Part A: Month 0-18||0||
48111878|NCT02404311|100601401|FG000|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||194||
48111879|NCT02404311|100601402|FG001|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||37||
48111880|NCT02404311|100601403|FG002|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0||
48111881|NCT02404311|100601404|FG003|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0||
48559633|NCT03307252|101702354|FG003|COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
48559634|NCT03307252|101702355|FG004|COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
48559635|NCT03307252|101702356|FG005|COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
48559636|NCT03307252|101702357|FG006|COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
48559637|NCT03307252|101702358|FG007|COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
48559638|NCT03307252|101702359|FG008|COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
48559639|NCT03307252|101702360|FG009|COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
48559640|NCT03307252|101702361|FG010|COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
48559641|NCT03307252|101702351|FG000|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
48559642|NCT03307252|101702352|FG001|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
48559643|NCT03307252|101702353|FG002|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
48559644|NCT03307252|101702354|FG003|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
48559645|NCT03307252|101702355|FG004|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
48559646|NCT03307252|101702356|FG005|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
48559647|NCT03307252|101702357|FG006|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
48559648|NCT03307252|101702358|FG007|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
48559649|NCT03307252|101702359|FG008|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
48559650|NCT03307252|101702360|FG009|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
48559651|NCT03307252|101702361|FG010|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
48559652|NCT03307252|101702351|FG000|STARTED|Part 1, Period 3||4||
48559653|NCT03307252|101702352|FG001|STARTED|Part 1, Period 3||4||
48559654|NCT03307252|101702353|FG002|STARTED|Part 1, Period 3||4||
48559655|NCT03307252|101702354|FG003|STARTED|Part 1, Period 3||0||
48559656|NCT03307252|101702355|FG004|STARTED|Part 1, Period 3||0||
48559657|NCT03307252|101702356|FG005|STARTED|Part 1, Period 3||0||
48559658|NCT03307252|101702357|FG006|STARTED|Part 1, Period 3||0||
48559659|NCT03307252|101702358|FG007|STARTED|Part 1, Period 3||0||
48559660|NCT03307252|101702359|FG008|STARTED|Part 1, Period 3||0||
48559661|NCT03307252|101702360|FG009|STARTED|Part 1, Period 3||0||
48559662|NCT03307252|101702361|FG010|STARTED|Part 1, Period 3||0||
48559663|NCT03307252|101702351|FG000|COMPLETED|Part 1, Period 3||4||
48559664|NCT03307252|101702352|FG001|COMPLETED|Part 1, Period 3||4||
48559665|NCT03307252|101702353|FG002|COMPLETED|Part 1, Period 3||4||
48559666|NCT03307252|101702354|FG003|COMPLETED|Part 1, Period 3||0||
48559667|NCT03307252|101702355|FG004|COMPLETED|Part 1, Period 3||0||
48559668|NCT03307252|101702356|FG005|COMPLETED|Part 1, Period 3||0||
48559669|NCT03307252|101702357|FG006|COMPLETED|Part 1, Period 3||0||
48559670|NCT03307252|101702358|FG007|COMPLETED|Part 1, Period 3||0||
48559671|NCT03307252|101702359|FG008|COMPLETED|Part 1, Period 3||0||
48559672|NCT03307252|101702360|FG009|COMPLETED|Part 1, Period 3||0||
48559673|NCT03307252|101702361|FG010|COMPLETED|Part 1, Period 3||0||
48559674|NCT03307252|101702351|FG000|NOT COMPLETED|Part 1, Period 3||0||
48559675|NCT03307252|101702352|FG001|NOT COMPLETED|Part 1, Period 3||0||
48559676|NCT03307252|101702353|FG002|NOT COMPLETED|Part 1, Period 3||0||
48559677|NCT03307252|101702354|FG003|NOT COMPLETED|Part 1, Period 3||0||
48559678|NCT03307252|101702355|FG004|NOT COMPLETED|Part 1, Period 3||0||
48559679|NCT03307252|101702356|FG005|NOT COMPLETED|Part 1, Period 3||0||
48559680|NCT03307252|101702357|FG006|NOT COMPLETED|Part 1, Period 3||0||
48559681|NCT03307252|101702358|FG007|NOT COMPLETED|Part 1, Period 3||0||
48559682|NCT03307252|101702359|FG008|NOT COMPLETED|Part 1, Period 3||0||
48559683|NCT03307252|101702360|FG009|NOT COMPLETED|Part 1, Period 3||0||
48559684|NCT03307252|101702361|FG010|NOT COMPLETED|Part 1, Period 3||0||
48559685|NCT03307252|101702351|FG000|STARTED|Part 2, Period 1||0||
48559686|NCT03307252|101702352|FG001|STARTED|Part 2, Period 1||0||
48559687|NCT03307252|101702353|FG002|STARTED|Part 2, Period 1||0||
48559688|NCT03307252|101702354|FG003|STARTED|Part 2, Period 1||4||
48559689|NCT03307252|101702355|FG004|STARTED|Part 2, Period 1||4||
48559690|NCT03307252|101702356|FG005|STARTED|Part 2, Period 1||4||
48559691|NCT03307252|101702357|FG006|STARTED|Part 2, Period 1||5||
48559692|NCT03307252|101702358|FG007|STARTED|Part 2, Period 1||0||
48559693|NCT03307252|101702359|FG008|STARTED|Part 2, Period 1||0||
48559694|NCT03307252|101702360|FG009|STARTED|Part 2, Period 1||0||
48559695|NCT03307252|101702361|FG010|STARTED|Part 2, Period 1||0||
48559696|NCT03307252|101702351|FG000|COMPLETED|Part 2, Period 1||0||
48559697|NCT03307252|101702352|FG001|COMPLETED|Part 2, Period 1||0||
48559698|NCT03307252|101702353|FG002|COMPLETED|Part 2, Period 1||0||
48559699|NCT03307252|101702354|FG003|COMPLETED|Part 2, Period 1||4||
48559700|NCT03307252|101702355|FG004|COMPLETED|Part 2, Period 1||4||
48559701|NCT03307252|101702356|FG005|COMPLETED|Part 2, Period 1||3||
48559702|NCT03307252|101702357|FG006|COMPLETED|Part 2, Period 1||5||
48559703|NCT03307252|101702358|FG007|COMPLETED|Part 2, Period 1||0||
48559704|NCT03307252|101702359|FG008|COMPLETED|Part 2, Period 1||0||
48559705|NCT03307252|101702360|FG009|COMPLETED|Part 2, Period 1||0||
48559706|NCT03307252|101702361|FG010|COMPLETED|Part 2, Period 1||0||
48559707|NCT03307252|101702351|FG000|NOT COMPLETED|Part 2, Period 1||0||
48559708|NCT03307252|101702352|FG001|NOT COMPLETED|Part 2, Period 1||0||
48559709|NCT03307252|101702353|FG002|NOT COMPLETED|Part 2, Period 1||0||
48559710|NCT03307252|101702354|FG003|NOT COMPLETED|Part 2, Period 1||0||
48559711|NCT03307252|101702355|FG004|NOT COMPLETED|Part 2, Period 1||0||
48559712|NCT03307252|101702356|FG005|NOT COMPLETED|Part 2, Period 1||1||
48559713|NCT03307252|101702357|FG006|NOT COMPLETED|Part 2, Period 1||0||
48559714|NCT03307252|101702358|FG007|NOT COMPLETED|Part 2, Period 1||0||
48559715|NCT03307252|101702359|FG008|NOT COMPLETED|Part 2, Period 1||0||
48559716|NCT03307252|101702360|FG009|NOT COMPLETED|Part 2, Period 1||0||
48559717|NCT03307252|101702361|FG010|NOT COMPLETED|Part 2, Period 1||0||
48559718|NCT03307252|101702351|FG000|STARTED|Part 2, Washout Period 1 (7 Days)||0||
48559719|NCT03307252|101702352|FG001|STARTED|Part 2, Washout Period 1 (7 Days)||0||
48559720|NCT03307252|101702353|FG002|STARTED|Part 2, Washout Period 1 (7 Days)||0||
48559721|NCT03307252|101702354|FG003|STARTED|Part 2, Washout Period 1 (7 Days)||4||
48559722|NCT03307252|101702355|FG004|STARTED|Part 2, Washout Period 1 (7 Days)||4||
48559723|NCT03307252|101702356|FG005|STARTED|Part 2, Washout Period 1 (7 Days)||3||
48559724|NCT03307252|101702357|FG006|STARTED|Part 2, Washout Period 1 (7 Days)||5||
48559725|NCT03307252|101702358|FG007|STARTED|Part 2, Washout Period 1 (7 Days)||0||
48559726|NCT03307252|101702359|FG008|STARTED|Part 2, Washout Period 1 (7 Days)||0||
48559727|NCT03307252|101702360|FG009|STARTED|Part 2, Washout Period 1 (7 Days)||0||
48559728|NCT03307252|101702361|FG010|STARTED|Part 2, Washout Period 1 (7 Days)||0||
48559729|NCT03307252|101702351|FG000|COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
48559730|NCT03307252|101702352|FG001|COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
48559731|NCT03307252|101702353|FG002|COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
48559732|NCT03307252|101702354|FG003|COMPLETED|Part 2, Washout Period 1 (7 Days)||4||
48559733|NCT03307252|101702355|FG004|COMPLETED|Part 2, Washout Period 1 (7 Days)||4||
48559734|NCT03307252|101702356|FG005|COMPLETED|Part 2, Washout Period 1 (7 Days)||3||
48559735|NCT03307252|101702357|FG006|COMPLETED|Part 2, Washout Period 1 (7 Days)||5||
48559736|NCT03307252|101702358|FG007|COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
48559737|NCT03307252|101702359|FG008|COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
48559738|NCT03307252|101702360|FG009|COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
48559739|NCT03307252|101702361|FG010|COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
48559740|NCT03307252|101702351|FG000|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
48559741|NCT03307252|101702352|FG001|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
48559742|NCT03307252|101702353|FG002|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
48559743|NCT03307252|101702354|FG003|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
48559744|NCT03307252|101702355|FG004|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
48559745|NCT03307252|101702356|FG005|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
48559746|NCT03307252|101702357|FG006|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
48559747|NCT03307252|101702358|FG007|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
48559748|NCT03307252|101702359|FG008|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
48559749|NCT03307252|101702360|FG009|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
48559750|NCT03307252|101702361|FG010|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
48559751|NCT03307252|101702351|FG000|STARTED|Part 2, Period 2||0||
48559752|NCT03307252|101702352|FG001|STARTED|Part 2, Period 2||0||
48559753|NCT03307252|101702353|FG002|STARTED|Part 2, Period 2||0||
48559754|NCT03307252|101702354|FG003|STARTED|Part 2, Period 2||4||
48559755|NCT03307252|101702355|FG004|STARTED|Part 2, Period 2||4||
48559756|NCT03307252|101702356|FG005|STARTED|Part 2, Period 2||3||
48559757|NCT03307252|101702357|FG006|STARTED|Part 2, Period 2||5||
48559758|NCT03307252|101702358|FG007|STARTED|Part 2, Period 2||0||
48559759|NCT03307252|101702359|FG008|STARTED|Part 2, Period 2||0||
48559760|NCT03307252|101702360|FG009|STARTED|Part 2, Period 2||0||
48559761|NCT03307252|101702361|FG010|STARTED|Part 2, Period 2||0||
48559762|NCT03307252|101702351|FG000|COMPLETED|Part 2, Period 2||0||
48559763|NCT03307252|101702352|FG001|COMPLETED|Part 2, Period 2||0||
48559764|NCT03307252|101702353|FG002|COMPLETED|Part 2, Period 2||0||
48559765|NCT03307252|101702354|FG003|COMPLETED|Part 2, Period 2||4||
48559766|NCT03307252|101702355|FG004|COMPLETED|Part 2, Period 2||4||
48559767|NCT03307252|101702356|FG005|COMPLETED|Part 2, Period 2||3||
48559768|NCT03307252|101702357|FG006|COMPLETED|Part 2, Period 2||5||
48559769|NCT03307252|101702358|FG007|COMPLETED|Part 2, Period 2||0||
48559770|NCT03307252|101702359|FG008|COMPLETED|Part 2, Period 2||0||
48559771|NCT03307252|101702360|FG009|COMPLETED|Part 2, Period 2||0||
48559772|NCT03307252|101702361|FG010|COMPLETED|Part 2, Period 2||0||
48559773|NCT03307252|101702351|FG000|NOT COMPLETED|Part 2, Period 2||0||
48559774|NCT03307252|101702352|FG001|NOT COMPLETED|Part 2, Period 2||0||
48559775|NCT03307252|101702353|FG002|NOT COMPLETED|Part 2, Period 2||0||
48559776|NCT03307252|101702354|FG003|NOT COMPLETED|Part 2, Period 2||0||
48559777|NCT03307252|101702355|FG004|NOT COMPLETED|Part 2, Period 2||0||
48559778|NCT03307252|101702356|FG005|NOT COMPLETED|Part 2, Period 2||0||
48559779|NCT03307252|101702357|FG006|NOT COMPLETED|Part 2, Period 2||0||
48559780|NCT03307252|101702358|FG007|NOT COMPLETED|Part 2, Period 2||0||
48559781|NCT03307252|101702359|FG008|NOT COMPLETED|Part 2, Period 2||0||
48559782|NCT03307252|101702360|FG009|NOT COMPLETED|Part 2, Period 2||0||
48559783|NCT03307252|101702361|FG010|NOT COMPLETED|Part 2, Period 2||0||
48559784|NCT03307252|101702351|FG000|STARTED|Part 2, Washout Period 2 (7 Days)||0||
48559785|NCT03307252|101702352|FG001|STARTED|Part 2, Washout Period 2 (7 Days)||0||
48559786|NCT03307252|101702353|FG002|STARTED|Part 2, Washout Period 2 (7 Days)||0||
48559787|NCT03307252|101702354|FG003|STARTED|Part 2, Washout Period 2 (7 Days)||4||
48559788|NCT03307252|101702355|FG004|STARTED|Part 2, Washout Period 2 (7 Days)||4||
48559789|NCT03307252|101702356|FG005|STARTED|Part 2, Washout Period 2 (7 Days)||3||
48559790|NCT03307252|101702357|FG006|STARTED|Part 2, Washout Period 2 (7 Days)||5||
48559791|NCT03307252|101702358|FG007|STARTED|Part 2, Washout Period 2 (7 Days)||0||
48559792|NCT03307252|101702359|FG008|STARTED|Part 2, Washout Period 2 (7 Days)||0||
48559793|NCT03307252|101702360|FG009|STARTED|Part 2, Washout Period 2 (7 Days)||0||
48559794|NCT03307252|101702361|FG010|STARTED|Part 2, Washout Period 2 (7 Days)||0||
48559795|NCT03307252|101702351|FG000|COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
48559796|NCT03307252|101702352|FG001|COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
48559797|NCT03307252|101702353|FG002|COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
48559798|NCT03307252|101702354|FG003|COMPLETED|Part 2, Washout Period 2 (7 Days)||4||
48559799|NCT03307252|101702355|FG004|COMPLETED|Part 2, Washout Period 2 (7 Days)||4||
48559800|NCT03307252|101702356|FG005|COMPLETED|Part 2, Washout Period 2 (7 Days)||3||
48559801|NCT03307252|101702357|FG006|COMPLETED|Part 2, Washout Period 2 (7 Days)||5||
48559802|NCT03307252|101702358|FG007|COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
48559803|NCT03307252|101702359|FG008|COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
48559804|NCT03307252|101702360|FG009|COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
48559805|NCT03307252|101702361|FG010|COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
48559806|NCT03307252|101702351|FG000|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
48559807|NCT03307252|101702352|FG001|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
48559808|NCT03307252|101702353|FG002|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
48559809|NCT03307252|101702354|FG003|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
48559810|NCT03307252|101702355|FG004|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
48559811|NCT03307252|101702356|FG005|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
48559812|NCT03307252|101702357|FG006|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
48559813|NCT03307252|101702358|FG007|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
48559814|NCT03307252|101702359|FG008|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
48559815|NCT03307252|101702360|FG009|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
48559816|NCT03307252|101702361|FG010|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
48559817|NCT03307252|101702351|FG000|STARTED|Part 2, Period 3||0||
48559818|NCT03307252|101702352|FG001|STARTED|Part 2, Period 3||0||
48559819|NCT03307252|101702353|FG002|STARTED|Part 2, Period 3||0||
48559820|NCT03307252|101702354|FG003|STARTED|Part 2, Period 3||4||
48559821|NCT03307252|101702355|FG004|STARTED|Part 2, Period 3||4||
48559822|NCT03307252|101702356|FG005|STARTED|Part 2, Period 3||3||
48559823|NCT03307252|101702357|FG006|STARTED|Part 2, Period 3||5||
48559824|NCT03307252|101702358|FG007|STARTED|Part 2, Period 3||0||
48559825|NCT03307252|101702359|FG008|STARTED|Part 2, Period 3||0||
48559826|NCT03307252|101702360|FG009|STARTED|Part 2, Period 3||0||
48559827|NCT03307252|101702361|FG010|STARTED|Part 2, Period 3||0||
48559828|NCT03307252|101702351|FG000|COMPLETED|Part 2, Period 3||0||
48559829|NCT03307252|101702352|FG001|COMPLETED|Part 2, Period 3||0||
48559830|NCT03307252|101702353|FG002|COMPLETED|Part 2, Period 3||0||
48559831|NCT03307252|101702354|FG003|COMPLETED|Part 2, Period 3||4||
48559832|NCT03307252|101702355|FG004|COMPLETED|Part 2, Period 3||3||
48559833|NCT03307252|101702356|FG005|COMPLETED|Part 2, Period 3||3||
48559834|NCT03307252|101702357|FG006|COMPLETED|Part 2, Period 3||5||
48559835|NCT03307252|101702358|FG007|COMPLETED|Part 2, Period 3||0||
48559836|NCT03307252|101702359|FG008|COMPLETED|Part 2, Period 3||0||
48559837|NCT03307252|101702360|FG009|COMPLETED|Part 2, Period 3||0||
48559838|NCT03307252|101702361|FG010|COMPLETED|Part 2, Period 3||0||
48559839|NCT03307252|101702351|FG000|NOT COMPLETED|Part 2, Period 3||0||
48559840|NCT03307252|101702352|FG001|NOT COMPLETED|Part 2, Period 3||0||
48559841|NCT03307252|101702353|FG002|NOT COMPLETED|Part 2, Period 3||0||
48559842|NCT03307252|101702354|FG003|NOT COMPLETED|Part 2, Period 3||0||
48559843|NCT03307252|101702355|FG004|NOT COMPLETED|Part 2, Period 3||1||
48559844|NCT03307252|101702356|FG005|NOT COMPLETED|Part 2, Period 3||0||
48559845|NCT03307252|101702357|FG006|NOT COMPLETED|Part 2, Period 3||0||
48559846|NCT03307252|101702358|FG007|NOT COMPLETED|Part 2, Period 3||0||
48559847|NCT03307252|101702359|FG008|NOT COMPLETED|Part 2, Period 3||0||
48559848|NCT03307252|101702360|FG009|NOT COMPLETED|Part 2, Period 3||0||
48559849|NCT03307252|101702361|FG010|NOT COMPLETED|Part 2, Period 3||0||
48559850|NCT03307252|101702351|FG000|STARTED|Part 2, Washout Period 3 (7 Days)||0||
48559851|NCT03307252|101702352|FG001|STARTED|Part 2, Washout Period 3 (7 Days)||0||
48559852|NCT03307252|101702353|FG002|STARTED|Part 2, Washout Period 3 (7 Days)||0||
48559853|NCT03307252|101702354|FG003|STARTED|Part 2, Washout Period 3 (7 Days)||4||
48559854|NCT03307252|101702355|FG004|STARTED|Part 2, Washout Period 3 (7 Days)||3||
48559855|NCT03307252|101702356|FG005|STARTED|Part 2, Washout Period 3 (7 Days)||3||
48559856|NCT03307252|101702357|FG006|STARTED|Part 2, Washout Period 3 (7 Days)||5||
48559857|NCT03307252|101702358|FG007|STARTED|Part 2, Washout Period 3 (7 Days)||0||
48559858|NCT03307252|101702359|FG008|STARTED|Part 2, Washout Period 3 (7 Days)||0||
48559859|NCT03307252|101702360|FG009|STARTED|Part 2, Washout Period 3 (7 Days)||0||
48559860|NCT03307252|101702361|FG010|STARTED|Part 2, Washout Period 3 (7 Days)||0||
48559861|NCT03307252|101702351|FG000|COMPLETED|Part 2, Washout Period 3 (7 Days)||0||
48559862|NCT03307252|101702352|FG001|COMPLETED|Part 2, Washout Period 3 (7 Days)||0||
48559863|NCT03307252|101702353|FG002|COMPLETED|Part 2, Washout Period 3 (7 Days)||0||
48559864|NCT03307252|101702354|FG003|COMPLETED|Part 2, Washout Period 3 (7 Days)||4||
48559865|NCT03307252|101702355|FG004|COMPLETED|Part 2, Washout Period 3 (7 Days)||3||
48559866|NCT03307252|101702356|FG005|COMPLETED|Part 2, Washout Period 3 (7 Days)||3||
48559867|NCT03307252|101702357|FG006|COMPLETED|Part 2, Washout Period 3 (7 Days)||4||
48559868|NCT03307252|101702358|FG007|COMPLETED|Part 2, Washout Period 3 (7 Days)||0||
48559869|NCT03307252|101702359|FG008|COMPLETED|Part 2, Washout Period 3 (7 Days)||0||
48559870|NCT03307252|101702360|FG009|COMPLETED|Part 2, Washout Period 3 (7 Days)||0||
48559871|NCT03307252|101702361|FG010|COMPLETED|Part 2, Washout Period 3 (7 Days)||0||
48559872|NCT03307252|101702351|FG000|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0||
48559873|NCT03307252|101702352|FG001|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0||
48559874|NCT03307252|101702353|FG002|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0||
48559875|NCT03307252|101702354|FG003|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0||
48559876|NCT03307252|101702355|FG004|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0||
48559877|NCT03307252|101702356|FG005|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0||
48559878|NCT03307252|101702357|FG006|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||1||
48559879|NCT03307252|101702358|FG007|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0||
48559880|NCT03307252|101702359|FG008|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0||
48559881|NCT03307252|101702360|FG009|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0||
48559882|NCT03307252|101702361|FG010|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0||
48559883|NCT03307252|101702351|FG000|STARTED|Part 2, Period 4||0||
48559884|NCT03307252|101702352|FG001|STARTED|Part 2, Period 4||0||
48559885|NCT03307252|101702353|FG002|STARTED|Part 2, Period 4||0||
48559886|NCT03307252|101702354|FG003|STARTED|Part 2, Period 4||4||
48559887|NCT03307252|101702355|FG004|STARTED|Part 2, Period 4||3||
48559888|NCT03307252|101702356|FG005|STARTED|Part 2, Period 4||3||
48559889|NCT03307252|101702357|FG006|STARTED|Part 2, Period 4||5||
48559890|NCT03307252|101702358|FG007|STARTED|Part 2, Period 4||0||
48559891|NCT03307252|101702359|FG008|STARTED|Part 2, Period 4||0||
48559892|NCT03307252|101702360|FG009|STARTED|Part 2, Period 4||0||
48559893|NCT03307252|101702361|FG010|STARTED|Part 2, Period 4||0||
48559894|NCT03307252|101702351|FG000|COMPLETED|Part 2, Period 4||0||
48559895|NCT03307252|101702352|FG001|COMPLETED|Part 2, Period 4||0||
48559896|NCT03307252|101702353|FG002|COMPLETED|Part 2, Period 4||0||
48559897|NCT03307252|101702354|FG003|COMPLETED|Part 2, Period 4||4||
48559898|NCT03307252|101702355|FG004|COMPLETED|Part 2, Period 4||3||
48559899|NCT03307252|101702356|FG005|COMPLETED|Part 2, Period 4||3||
48559900|NCT03307252|101702357|FG006|COMPLETED|Part 2, Period 4||4||
48559901|NCT03307252|101702358|FG007|COMPLETED|Part 2, Period 4||0||
48559902|NCT03307252|101702359|FG008|COMPLETED|Part 2, Period 4||0||
48559903|NCT03307252|101702360|FG009|COMPLETED|Part 2, Period 4||0||
48559904|NCT03307252|101702361|FG010|COMPLETED|Part 2, Period 4||0||
48559905|NCT03307252|101702351|FG000|NOT COMPLETED|Part 2, Period 4||0||
48559906|NCT03307252|101702352|FG001|NOT COMPLETED|Part 2, Period 4||0||
48559907|NCT03307252|101702353|FG002|NOT COMPLETED|Part 2, Period 4||0||
48559908|NCT03307252|101702354|FG003|NOT COMPLETED|Part 2, Period 4||0||
48559909|NCT03307252|101702355|FG004|NOT COMPLETED|Part 2, Period 4||0||
48559910|NCT03307252|101702356|FG005|NOT COMPLETED|Part 2, Period 4||0||
48559911|NCT03307252|101702357|FG006|NOT COMPLETED|Part 2, Period 4||1||
48559912|NCT03307252|101702358|FG007|NOT COMPLETED|Part 2, Period 4||0||
48559913|NCT03307252|101702359|FG008|NOT COMPLETED|Part 2, Period 4||0||
48559914|NCT03307252|101702360|FG009|NOT COMPLETED|Part 2, Period 4||0||
48559915|NCT03307252|101702361|FG010|NOT COMPLETED|Part 2, Period 4||0||
48559916|NCT03307252|101702351|FG000|STARTED|Part 3, Period 1||0||
48559917|NCT03307252|101702352|FG001|STARTED|Part 3, Period 1||0||
48559918|NCT03307252|101702353|FG002|STARTED|Part 3, Period 1||0||
48559919|NCT03307252|101702354|FG003|STARTED|Part 3, Period 1||0||
48559920|NCT03307252|101702355|FG004|STARTED|Part 3, Period 1||0||
48559921|NCT03307252|101702356|FG005|STARTED|Part 3, Period 1||0||
48559922|NCT03307252|101702357|FG006|STARTED|Part 3, Period 1||0||
48559923|NCT03307252|101702358|FG007|STARTED|Part 3, Period 1||4||
48559924|NCT03307252|101702359|FG008|STARTED|Part 3, Period 1||4||
48559925|NCT03307252|101702360|FG009|STARTED|Part 3, Period 1||4||
48559926|NCT03307252|101702361|FG010|STARTED|Part 3, Period 1||4||
48559927|NCT03307252|101702351|FG000|COMPLETED|Part 3, Period 1||0||
48559928|NCT03307252|101702352|FG001|COMPLETED|Part 3, Period 1||0||
48559929|NCT03307252|101702353|FG002|COMPLETED|Part 3, Period 1||0||
48559930|NCT03307252|101702354|FG003|COMPLETED|Part 3, Period 1||0||
48559931|NCT03307252|101702355|FG004|COMPLETED|Part 3, Period 1||0||
48274628|NCT00789360|100996261|FG001|NOT COMPLETED|Overall Study||1||
48274629|NCT02451176|100996262|FG000|STARTED|Overall Study||126||
48274630|NCT02451176|100996263|FG001|STARTED|Overall Study||127||
48274631|NCT02451176|100996262|FG000|COMPLETED|Overall Study||126||
48274632|NCT02451176|100996263|FG001|COMPLETED|Overall Study||127||
48274633|NCT02451176|100996262|FG000|NOT COMPLETED|Overall Study||0||
48274634|NCT02451176|100996263|FG001|NOT COMPLETED|Overall Study||0||
48274635|NCT00632489|100996264|FG000|STARTED|Overall Study||15||
48274636|NCT00632489|100996265|FG001|STARTED|Overall Study||5||
48274637|NCT00632489|100996266|FG002|STARTED|Overall Study||0||
48274638|NCT00632489|100996264|FG000|COMPLETED|Overall Study||0||
48274639|NCT00632489|100996265|FG001|COMPLETED|Overall Study||0||
48274640|NCT00632489|100996266|FG002|COMPLETED|Overall Study||0||
48274641|NCT00632489|100996264|FG000|NOT COMPLETED|Overall Study||15||
48274642|NCT00632489|100996265|FG001|NOT COMPLETED|Overall Study||5||
48274643|NCT00632489|100996266|FG002|NOT COMPLETED|Overall Study||0||
48274644|NCT03030859|100996267|FG000|STARTED|Overall Study||20||
48559932|NCT03307252|101702356|FG005|COMPLETED|Part 3, Period 1||0||
48559933|NCT03307252|101702357|FG006|COMPLETED|Part 3, Period 1||0||
48559934|NCT03307252|101702358|FG007|COMPLETED|Part 3, Period 1||4||
48559935|NCT03307252|101702359|FG008|COMPLETED|Part 3, Period 1||4||
48559936|NCT03307252|101702360|FG009|COMPLETED|Part 3, Period 1||4||
48559937|NCT03307252|101702361|FG010|COMPLETED|Part 3, Period 1||4||
48559938|NCT03307252|101702351|FG000|NOT COMPLETED|Part 3, Period 1||0||
48559939|NCT03307252|101702352|FG001|NOT COMPLETED|Part 3, Period 1||0||
48559940|NCT03307252|101702353|FG002|NOT COMPLETED|Part 3, Period 1||0||
48559941|NCT03307252|101702354|FG003|NOT COMPLETED|Part 3, Period 1||0||
48559942|NCT03307252|101702355|FG004|NOT COMPLETED|Part 3, Period 1||0||
48559943|NCT03307252|101702356|FG005|NOT COMPLETED|Part 3, Period 1||0||
48559944|NCT03307252|101702357|FG006|NOT COMPLETED|Part 3, Period 1||0||
48559945|NCT03307252|101702358|FG007|NOT COMPLETED|Part 3, Period 1||0||
48559946|NCT03307252|101702359|FG008|NOT COMPLETED|Part 3, Period 1||0||
48559947|NCT03307252|101702360|FG009|NOT COMPLETED|Part 3, Period 1||0||
48559948|NCT03307252|101702361|FG010|NOT COMPLETED|Part 3, Period 1||0||
48559949|NCT03307252|101702351|FG000|STARTED|Part 3, Washout Period 1 (7 Days)||0||
48559950|NCT03307252|101702352|FG001|STARTED|Part 3, Washout Period 1 (7 Days)||0||
48559951|NCT03307252|101702353|FG002|STARTED|Part 3, Washout Period 1 (7 Days)||0||
48559952|NCT03307252|101702354|FG003|STARTED|Part 3, Washout Period 1 (7 Days)||0||
48559953|NCT03307252|101702355|FG004|STARTED|Part 3, Washout Period 1 (7 Days)||0||
48559954|NCT03307252|101702356|FG005|STARTED|Part 3, Washout Period 1 (7 Days)||0||
48559955|NCT03307252|101702357|FG006|STARTED|Part 3, Washout Period 1 (7 Days)||0||
48559956|NCT03307252|101702358|FG007|STARTED|Part 3, Washout Period 1 (7 Days)||4||
48559957|NCT03307252|101702359|FG008|STARTED|Part 3, Washout Period 1 (7 Days)||4||
48559958|NCT03307252|101702360|FG009|STARTED|Part 3, Washout Period 1 (7 Days)||4||
48559959|NCT03307252|101702361|FG010|STARTED|Part 3, Washout Period 1 (7 Days)||4||
48559960|NCT03307252|101702351|FG000|COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
48559961|NCT03307252|101702352|FG001|COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
48559962|NCT03307252|101702353|FG002|COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
48559963|NCT03307252|101702354|FG003|COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
48559964|NCT03307252|101702355|FG004|COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
48559965|NCT03307252|101702356|FG005|COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
48559966|NCT03307252|101702357|FG006|COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
48559967|NCT03307252|101702358|FG007|COMPLETED|Part 3, Washout Period 1 (7 Days)||4||
48559968|NCT03307252|101702359|FG008|COMPLETED|Part 3, Washout Period 1 (7 Days)||4||
48559969|NCT03307252|101702360|FG009|COMPLETED|Part 3, Washout Period 1 (7 Days)||4||
48559970|NCT03307252|101702361|FG010|COMPLETED|Part 3, Washout Period 1 (7 Days)||4||
48559971|NCT03307252|101702351|FG000|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
48559972|NCT03307252|101702352|FG001|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
48559973|NCT03307252|101702353|FG002|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
48559974|NCT03307252|101702354|FG003|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
48559975|NCT03307252|101702355|FG004|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
48559976|NCT03307252|101702356|FG005|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
48559977|NCT03307252|101702357|FG006|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
48559978|NCT03307252|101702358|FG007|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
48559979|NCT03307252|101702359|FG008|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
48274645|NCT03030859|100996268|FG001|STARTED|Overall Study||20||
48274646|NCT03030859|100996269|FG002|STARTED|Overall Study||19||
48274647|NCT03030859|100996267|FG000|COMPLETED|Overall Study||19||
48274648|NCT03030859|100996268|FG001|COMPLETED|Overall Study||17||
48274649|NCT03030859|100996269|FG002|COMPLETED|Overall Study||13||
48559980|NCT03307252|101702360|FG009|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
48559981|NCT03307252|101702361|FG010|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
48559982|NCT03307252|101702351|FG000|STARTED|Part 3, Period 2||0||
48559983|NCT03307252|101702352|FG001|STARTED|Part 3, Period 2||0||
48559984|NCT03307252|101702353|FG002|STARTED|Part 3, Period 2||0||
48559985|NCT03307252|101702354|FG003|STARTED|Part 3, Period 2||0||
48559986|NCT03307252|101702355|FG004|STARTED|Part 3, Period 2||0||
48559987|NCT03307252|101702356|FG005|STARTED|Part 3, Period 2||0||
48559988|NCT03307252|101702357|FG006|STARTED|Part 3, Period 2||0||
48559989|NCT03307252|101702358|FG007|STARTED|Part 3, Period 2||4||
48559990|NCT03307252|101702359|FG008|STARTED|Part 3, Period 2||4||
48559991|NCT03307252|101702360|FG009|STARTED|Part 3, Period 2||4||
48559992|NCT03307252|101702361|FG010|STARTED|Part 3, Period 2||4||
48559993|NCT03307252|101702351|FG000|COMPLETED|Part 3, Period 2||0||
48559994|NCT03307252|101702352|FG001|COMPLETED|Part 3, Period 2||0||
48559995|NCT03307252|101702353|FG002|COMPLETED|Part 3, Period 2||0||
48559996|NCT03307252|101702354|FG003|COMPLETED|Part 3, Period 2||0||
48274650|NCT03030859|100996267|FG000|NOT COMPLETED|Overall Study||1||
48274651|NCT03030859|100996268|FG001|NOT COMPLETED|Overall Study||3||
48559997|NCT03307252|101702355|FG004|COMPLETED|Part 3, Period 2||0||
48559998|NCT03307252|101702356|FG005|COMPLETED|Part 3, Period 2||0||
48559999|NCT03307252|101702357|FG006|COMPLETED|Part 3, Period 2||0||
48560000|NCT03307252|101702358|FG007|COMPLETED|Part 3, Period 2||4||
48111882|NCT02404311|100601405|FG004|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0||
48111883|NCT02404311|100601401|FG000|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||186||
48111884|NCT02404311|100601402|FG001|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||33||
48111885|NCT02404311|100601403|FG002|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0||
48111886|NCT02404311|100601404|FG003|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0||
48111887|NCT02404311|100601405|FG004|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0||
48111888|NCT02404311|100601401|FG000|COMPLETED|Part A: Month 0-18||184||
48111889|NCT02404311|100601402|FG001|COMPLETED|Part A: Month 0-18||36||
48111890|NCT02404311|100601403|FG002|COMPLETED|Part A: Month 0-18||0||
48111891|NCT02404311|100601404|FG003|COMPLETED|Part A: Month 0-18||0||
48111892|NCT02404311|100601405|FG004|COMPLETED|Part A: Month 0-18||0||
48111893|NCT02404311|100601401|FG000|NOT COMPLETED|Part A: Month 0-18||26||
48111894|NCT02404311|100601402|FG001|NOT COMPLETED|Part A: Month 0-18||6||
48111895|NCT02404311|100601403|FG002|NOT COMPLETED|Part A: Month 0-18||0||
48111896|NCT02404311|100601404|FG003|NOT COMPLETED|Part A: Month 0-18||0||
48111897|NCT02404311|100601405|FG004|NOT COMPLETED|Part A: Month 0-18||0||
48274652|NCT03030859|100996269|FG002|NOT COMPLETED|Overall Study||6||
48274653|NCT04230122|100996270|FG000|STARTED|Overall Study||3||
48274654|NCT04230122|100996271|FG001|STARTED|Overall Study||1||
48274655|NCT04230122|100996270|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
48274656|NCT04230122|100996271|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1||
48274657|NCT04230122|100996270|FG000|COMPLETED|Overall Study||2||
48560001|NCT03307252|101702359|FG008|COMPLETED|Part 3, Period 2||4||
48560002|NCT03307252|101702360|FG009|COMPLETED|Part 3, Period 2||4||
48560003|NCT03307252|101702361|FG010|COMPLETED|Part 3, Period 2||4||
48695526|NCT01191736|102038551|FG005|NOT COMPLETED|Overall Study||0||
48695527|NCT01191736|102038552|FG006|NOT COMPLETED|Overall Study||0||
48695528|NCT01907321|102038553|FG000|STARTED|Overall Study||14||
48111898|NCT02404311|100601401|FG000|STARTED|Part B: Month 30-36||0||
48111899|NCT02404311|100601402|FG001|STARTED|Part B: Month 30-36||0||
48111900|NCT02404311|100601403|FG002|STARTED|Part B: Month 30-36||32||
48111901|NCT02404311|100601404|FG003|STARTED|Part B: Month 30-36||31||
48111902|NCT02404311|100601405|FG004|STARTED|Part B: Month 30-36||7||
48111903|NCT02404311|100601401|FG000|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||0||
48111904|NCT02404311|100601402|FG001|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||0||
48111905|NCT02404311|100601403|FG002|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||28||
48111906|NCT02404311|100601404|FG003|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||30||
48111907|NCT02404311|100601405|FG004|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||6||
48111908|NCT02404311|100601401|FG000|COMPLETED|Part B: Month 30-36||0||
48111909|NCT02404311|100601402|FG001|COMPLETED|Part B: Month 30-36||0||
48111910|NCT02404311|100601403|FG002|COMPLETED|Part B: Month 30-36||32||
48111911|NCT02404311|100601404|FG003|COMPLETED|Part B: Month 30-36||31||
48111912|NCT02404311|100601405|FG004|COMPLETED|Part B: Month 30-36||7||
48111913|NCT02404311|100601401|FG000|NOT COMPLETED|Part B: Month 30-36||0||
48111914|NCT02404311|100601402|FG001|NOT COMPLETED|Part B: Month 30-36||0||
48111915|NCT02404311|100601403|FG002|NOT COMPLETED|Part B: Month 30-36||0||
48111916|NCT02404311|100601404|FG003|NOT COMPLETED|Part B: Month 30-36||0||
48111917|NCT02404311|100601405|FG004|NOT COMPLETED|Part B: Month 30-36||0||
48111918|NCT02553746|100601406|FG000|STARTED|Overall Study||80||
48111919|NCT02553746|100601407|FG001|STARTED|Overall Study||66||
48111920|NCT02553746|100601406|FG000|COMPLETED|Overall Study||77||
48111921|NCT02553746|100601407|FG001|COMPLETED|Overall Study||64||
48111922|NCT02553746|100601406|FG000|NOT COMPLETED|Overall Study||3||
48111923|NCT02553746|100601407|FG001|NOT COMPLETED|Overall Study||2||
48111924|NCT03277846|100601408|FG000|STARTED|Overall Study||50||
48111925|NCT03277846|100601409|FG001|STARTED|Overall Study||51||
48111926|NCT03277846|100601408|FG000|COMPLETED|Overall Study||38||
48111927|NCT03277846|100601409|FG001|COMPLETED|Overall Study||40||
48111928|NCT03277846|100601408|FG000|NOT COMPLETED|Overall Study||12||
48111929|NCT03277846|100601409|FG001|NOT COMPLETED|Overall Study||11||
48111930|NCT01578044|100601410|FG000|STARTED|Overall Study||6||
48111931|NCT01578044|100601411|FG001|STARTED|Overall Study||6||
48560004|NCT03307252|101702351|FG000|NOT COMPLETED|Part 3, Period 2||0||
48560005|NCT03307252|101702352|FG001|NOT COMPLETED|Part 3, Period 2||0||
48560006|NCT03307252|101702353|FG002|NOT COMPLETED|Part 3, Period 2||0||
48560007|NCT03307252|101702354|FG003|NOT COMPLETED|Part 3, Period 2||0||
48560008|NCT03307252|101702355|FG004|NOT COMPLETED|Part 3, Period 2||0||
48560009|NCT03307252|101702356|FG005|NOT COMPLETED|Part 3, Period 2||0||
48560010|NCT03307252|101702357|FG006|NOT COMPLETED|Part 3, Period 2||0||
48560011|NCT03307252|101702358|FG007|NOT COMPLETED|Part 3, Period 2||0||
48560012|NCT03307252|101702359|FG008|NOT COMPLETED|Part 3, Period 2||0||
48560013|NCT03307252|101702360|FG009|NOT COMPLETED|Part 3, Period 2||0||
48560014|NCT03307252|101702361|FG010|NOT COMPLETED|Part 3, Period 2||0||
48560015|NCT03307252|101702351|FG000|STARTED|Part 3, Washout Period 2 (7 Days)||0||
48560016|NCT03307252|101702352|FG001|STARTED|Part 3, Washout Period 2 (7 Days)||0||
48560017|NCT03307252|101702353|FG002|STARTED|Part 3, Washout Period 2 (7 Days)||0||
48560018|NCT03307252|101702354|FG003|STARTED|Part 3, Washout Period 2 (7 Days)||0||
48560019|NCT03307252|101702355|FG004|STARTED|Part 3, Washout Period 2 (7 Days)||0||
48560020|NCT03307252|101702356|FG005|STARTED|Part 3, Washout Period 2 (7 Days)||0||
48560021|NCT03307252|101702357|FG006|STARTED|Part 3, Washout Period 2 (7 Days)||0||
48560022|NCT03307252|101702358|FG007|STARTED|Part 3, Washout Period 2 (7 Days)||4||
48560023|NCT03307252|101702359|FG008|STARTED|Part 3, Washout Period 2 (7 Days)||4||
48560024|NCT03307252|101702360|FG009|STARTED|Part 3, Washout Period 2 (7 Days)||4||
48560025|NCT03307252|101702361|FG010|STARTED|Part 3, Washout Period 2 (7 Days)||4||
48560026|NCT03307252|101702351|FG000|COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
48560027|NCT03307252|101702352|FG001|COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
48560028|NCT03307252|101702353|FG002|COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
48560029|NCT03307252|101702354|FG003|COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
48560030|NCT03307252|101702355|FG004|COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
48560031|NCT03307252|101702356|FG005|COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
48560032|NCT03307252|101702357|FG006|COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
48560033|NCT03307252|101702358|FG007|COMPLETED|Part 3, Washout Period 2 (7 Days)||4||
48560034|NCT03307252|101702359|FG008|COMPLETED|Part 3, Washout Period 2 (7 Days)||4||
48560035|NCT03307252|101702360|FG009|COMPLETED|Part 3, Washout Period 2 (7 Days)||4||
48560036|NCT03307252|101702361|FG010|COMPLETED|Part 3, Washout Period 2 (7 Days)||4||
48560037|NCT03307252|101702351|FG000|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
48560038|NCT03307252|101702352|FG001|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
48560039|NCT03307252|101702353|FG002|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
48560040|NCT03307252|101702354|FG003|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
48560041|NCT03307252|101702355|FG004|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
48560042|NCT03307252|101702356|FG005|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
48560043|NCT03307252|101702357|FG006|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
48560044|NCT03307252|101702358|FG007|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
48560045|NCT03307252|101702359|FG008|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
48560046|NCT03307252|101702360|FG009|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
48560047|NCT03307252|101702361|FG010|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
48560048|NCT03307252|101702351|FG000|STARTED|Part 3, Period 3||0||
48560049|NCT03307252|101702352|FG001|STARTED|Part 3, Period 3||0||
48560050|NCT03307252|101702353|FG002|STARTED|Part 3, Period 3||0||
48560051|NCT03307252|101702354|FG003|STARTED|Part 3, Period 3||0||
48560052|NCT03307252|101702355|FG004|STARTED|Part 3, Period 3||0||
48560053|NCT03307252|101702356|FG005|STARTED|Part 3, Period 3||0||
48560054|NCT03307252|101702357|FG006|STARTED|Part 3, Period 3||0||
48560055|NCT03307252|101702358|FG007|STARTED|Part 3, Period 3||4||
48560056|NCT03307252|101702359|FG008|STARTED|Part 3, Period 3||4||
48560057|NCT03307252|101702360|FG009|STARTED|Part 3, Period 3||4||
48560058|NCT03307252|101702361|FG010|STARTED|Part 3, Period 3||4||
48560059|NCT03307252|101702351|FG000|COMPLETED|Part 3, Period 3||0||
48560060|NCT03307252|101702352|FG001|COMPLETED|Part 3, Period 3||0||
48560061|NCT03307252|101702353|FG002|COMPLETED|Part 3, Period 3||0||
48560062|NCT03307252|101702354|FG003|COMPLETED|Part 3, Period 3||0||
48560063|NCT03307252|101702355|FG004|COMPLETED|Part 3, Period 3||0||
48560064|NCT03307252|101702356|FG005|COMPLETED|Part 3, Period 3||0||
48560065|NCT03307252|101702357|FG006|COMPLETED|Part 3, Period 3||0||
48560066|NCT03307252|101702358|FG007|COMPLETED|Part 3, Period 3||4||
48695529|NCT01907321|102038553|FG000|COMPLETED|Overall Study||12||
48111932|NCT01578044|100601410|FG000|COMPLETED|Overall Study||6||
48111933|NCT01578044|100601411|FG001|COMPLETED|Overall Study||6||
48111934|NCT01578044|100601410|FG000|NOT COMPLETED|Overall Study||0||
48111935|NCT01578044|100601411|FG001|NOT COMPLETED|Overall Study||0||
48111936|NCT01536496|100601412|FG000|STARTED|Overall Study||57||
48111937|NCT01536496|100601413|FG001|STARTED|Overall Study||57||
48111938|NCT01536496|100601412|FG000|COMPLETED|Overall Study||55||
48111939|NCT01536496|100601413|FG001|COMPLETED|Overall Study||56||
48560067|NCT03307252|101702359|FG008|COMPLETED|Part 3, Period 3||4||
48560068|NCT03307252|101702360|FG009|COMPLETED|Part 3, Period 3||4||
48560069|NCT03307252|101702361|FG010|COMPLETED|Part 3, Period 3||4||
48560070|NCT03307252|101702351|FG000|NOT COMPLETED|Part 3, Period 3||0||
48560071|NCT03307252|101702352|FG001|NOT COMPLETED|Part 3, Period 3||0||
48560072|NCT03307252|101702353|FG002|NOT COMPLETED|Part 3, Period 3||0||
48560073|NCT03307252|101702354|FG003|NOT COMPLETED|Part 3, Period 3||0||
48560074|NCT03307252|101702355|FG004|NOT COMPLETED|Part 3, Period 3||0||
48560075|NCT03307252|101702356|FG005|NOT COMPLETED|Part 3, Period 3||0||
48560076|NCT03307252|101702357|FG006|NOT COMPLETED|Part 3, Period 3||0||
48560077|NCT03307252|101702358|FG007|NOT COMPLETED|Part 3, Period 3||0||
48560078|NCT03307252|101702359|FG008|NOT COMPLETED|Part 3, Period 3||0||
48560079|NCT03307252|101702360|FG009|NOT COMPLETED|Part 3, Period 3||0||
48560080|NCT03307252|101702361|FG010|NOT COMPLETED|Part 3, Period 3||0||
48560081|NCT03307252|101702351|FG000|STARTED|Part 3, Washout Period 3 (7 Days)||0||
48560082|NCT03307252|101702352|FG001|STARTED|Part 3, Washout Period 3 (7 Days)||0||
48560083|NCT03307252|101702353|FG002|STARTED|Part 3, Washout Period 3 (7 Days)||0||
48560084|NCT03307252|101702354|FG003|STARTED|Part 3, Washout Period 3 (7 Days)||0||
48560085|NCT03307252|101702355|FG004|STARTED|Part 3, Washout Period 3 (7 Days)||0||
48560086|NCT03307252|101702356|FG005|STARTED|Part 3, Washout Period 3 (7 Days)||0||
48560087|NCT03307252|101702357|FG006|STARTED|Part 3, Washout Period 3 (7 Days)||0||
48560088|NCT03307252|101702358|FG007|STARTED|Part 3, Washout Period 3 (7 Days)||4||
48560089|NCT03307252|101702359|FG008|STARTED|Part 3, Washout Period 3 (7 Days)||4||
48560090|NCT03307252|101702360|FG009|STARTED|Part 3, Washout Period 3 (7 Days)||4||
48560091|NCT03307252|101702361|FG010|STARTED|Part 3, Washout Period 3 (7 Days)||4||
48560092|NCT03307252|101702351|FG000|COMPLETED|Part 3, Washout Period 3 (7 Days)||0||
48560093|NCT03307252|101702352|FG001|COMPLETED|Part 3, Washout Period 3 (7 Days)||0||
48560094|NCT03307252|101702353|FG002|COMPLETED|Part 3, Washout Period 3 (7 Days)||0||
48560095|NCT03307252|101702354|FG003|COMPLETED|Part 3, Washout Period 3 (7 Days)||0||
48560096|NCT03307252|101702355|FG004|COMPLETED|Part 3, Washout Period 3 (7 Days)||0||
48560097|NCT03307252|101702356|FG005|COMPLETED|Part 3, Washout Period 3 (7 Days)||0||
48560098|NCT03307252|101702357|FG006|COMPLETED|Part 3, Washout Period 3 (7 Days)||0||
48560099|NCT03307252|101702358|FG007|COMPLETED|Part 3, Washout Period 3 (7 Days)||4||
48560100|NCT03307252|101702359|FG008|COMPLETED|Part 3, Washout Period 3 (7 Days)||4||
48560101|NCT03307252|101702360|FG009|COMPLETED|Part 3, Washout Period 3 (7 Days)||4||
48560102|NCT03307252|101702361|FG010|COMPLETED|Part 3, Washout Period 3 (7 Days)||3||
48560103|NCT03307252|101702351|FG000|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0||
48560104|NCT03307252|101702352|FG001|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0||
48560105|NCT03307252|101702353|FG002|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0||
48560106|NCT03307252|101702354|FG003|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0||
48560107|NCT03307252|101702355|FG004|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0||
48560108|NCT03307252|101702356|FG005|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0||
48560109|NCT03307252|101702357|FG006|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0||
48695530|NCT01907321|102038553|FG000|NOT COMPLETED|Overall Study||2||
48695531|NCT02569476|102038554|FG000|STARTED|Overall Study||119||
48695532|NCT02569476|102038554|FG000|COMPLETED|Overall Study||0||
48695533|NCT02569476|102038554|FG000|NOT COMPLETED|Overall Study||119||
48695534|NCT03286543|102038555|FG000|STARTED|Consented||47||
48560110|NCT03307252|101702358|FG007|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0||
48560111|NCT03307252|101702359|FG008|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0||
48560112|NCT03307252|101702360|FG009|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0||
48560113|NCT03307252|101702361|FG010|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||1||
48560114|NCT03307252|101702351|FG000|STARTED|Part 3, Period 4||0||
48560115|NCT03307252|101702352|FG001|STARTED|Part 3, Period 4||0||
48560116|NCT03307252|101702353|FG002|STARTED|Part 3, Period 4||0||
48560117|NCT03307252|101702354|FG003|STARTED|Part 3, Period 4||0||
48560118|NCT03307252|101702355|FG004|STARTED|Part 3, Period 4||0||
48560119|NCT03307252|101702356|FG005|STARTED|Part 3, Period 4||0||
48560120|NCT03307252|101702357|FG006|STARTED|Part 3, Period 4||0||
48560121|NCT03307252|101702358|FG007|STARTED|Part 3, Period 4||4||
48560122|NCT03307252|101702359|FG008|STARTED|Part 3, Period 4||4||
48560123|NCT03307252|101702360|FG009|STARTED|Part 3, Period 4||4||
48560124|NCT03307252|101702361|FG010|STARTED|Part 3, Period 4||3||
48560125|NCT03307252|101702351|FG000|COMPLETED|Part 3, Period 4||0||
48560126|NCT03307252|101702352|FG001|COMPLETED|Part 3, Period 4||0||
48695535|NCT03286543|102038556|FG001|STARTED|Consented||0||
48560127|NCT03307252|101702353|FG002|COMPLETED|Part 3, Period 4||0||
48560128|NCT03307252|101702354|FG003|COMPLETED|Part 3, Period 4||0||
48695536|NCT03286543|102038557|FG002|STARTED|Consented||0||
48560129|NCT03307252|101702355|FG004|COMPLETED|Part 3, Period 4||0||
48560130|NCT03307252|101702356|FG005|COMPLETED|Part 3, Period 4||0||
48560131|NCT03307252|101702357|FG006|COMPLETED|Part 3, Period 4||0||
48560132|NCT03307252|101702358|FG007|COMPLETED|Part 3, Period 4||4||
48560133|NCT03307252|101702359|FG008|COMPLETED|Part 3, Period 4||4||
48560134|NCT03307252|101702360|FG009|COMPLETED|Part 3, Period 4||4||
48695537|NCT03286543|102038555|FG000|Randomized|Consented||45|All subjects who were consented, met eligibility criteria, and were randomized.|
48560135|NCT03307252|101702361|FG010|COMPLETED|Part 3, Period 4||3||
48560136|NCT03307252|101702351|FG000|NOT COMPLETED|Part 3, Period 4||0||
48560137|NCT03307252|101702352|FG001|NOT COMPLETED|Part 3, Period 4||0||
48560138|NCT03307252|101702353|FG002|NOT COMPLETED|Part 3, Period 4||0||
48560139|NCT03307252|101702354|FG003|NOT COMPLETED|Part 3, Period 4||0||
48560140|NCT03307252|101702355|FG004|NOT COMPLETED|Part 3, Period 4||0||
48560141|NCT03307252|101702356|FG005|NOT COMPLETED|Part 3, Period 4||0||
48560142|NCT03307252|101702357|FG006|NOT COMPLETED|Part 3, Period 4||0||
48560143|NCT03307252|101702358|FG007|NOT COMPLETED|Part 3, Period 4||0||
48560144|NCT03307252|101702359|FG008|NOT COMPLETED|Part 3, Period 4||0||
48560145|NCT03307252|101702360|FG009|NOT COMPLETED|Part 3, Period 4||0||
48560146|NCT03307252|101702361|FG010|NOT COMPLETED|Part 3, Period 4||0||
48560147|NCT03093259|101702362|FG000|STARTED|Overall Study||23||
48560148|NCT03093259|101702363|FG001|STARTED|Overall Study||9||
48560149|NCT03093259|101702362|FG000|COMPLETED|Overall Study||21||
48560150|NCT03093259|101702363|FG001|COMPLETED|Overall Study||9||
48560151|NCT03093259|101702362|FG000|NOT COMPLETED|Overall Study||2||
48560152|NCT03093259|101702363|FG001|NOT COMPLETED|Overall Study||0||
48560153|NCT01690117|101702364|FG000|STARTED|Overall Study||47||
48560154|NCT01690117|101702365|FG001|STARTED|Overall Study||45||
48560155|NCT01690117|101702364|FG000|Post-Measurement|Overall Study||41||
48560156|NCT01690117|101702365|FG001|Post-Measurement|Overall Study||40||
48560157|NCT01690117|101702364|FG000|COMPLETED|Overall Study||31||
48560158|NCT01690117|101702365|FG001|COMPLETED|Overall Study||31||
48560159|NCT01690117|101702364|FG000|NOT COMPLETED|Overall Study||16||
48560160|NCT01690117|101702365|FG001|NOT COMPLETED|Overall Study||14||
48560161|NCT04090125|101702366|FG000|STARTED|Overall Study||30||
48560162|NCT04090125|101702367|FG001|STARTED|Overall Study||30||
48560163|NCT04090125|101702366|FG000|Completed 3-month Follow-up|Overall Study||23||
48560164|NCT04090125|101702367|FG001|Completed 3-month Follow-up|Overall Study||24||
48560165|NCT04090125|101702366|FG000|COMPLETED|Overall Study||20|Completed 6-month follow-up assessment|
48560166|NCT04090125|101702367|FG001|COMPLETED|Overall Study||24|Completed 6-month follow-up assessment|
48560167|NCT04090125|101702366|FG000|NOT COMPLETED|Overall Study||10||
48560168|NCT04090125|101702367|FG001|NOT COMPLETED|Overall Study||6||
48560169|NCT01416636|101702368|FG000|STARTED|Overall Study||53||
48560170|NCT01416636|101702369|FG001|STARTED|Overall Study||52||
48560171|NCT01416636|101702368|FG000|COMPLETED|Overall Study||45||
48560172|NCT01416636|101702369|FG001|COMPLETED|Overall Study||46||
48560173|NCT01416636|101702368|FG000|NOT COMPLETED|Overall Study||8||
48560174|NCT01416636|101702369|FG001|NOT COMPLETED|Overall Study||6||
48560175|NCT02023983|101702370|FG000|STARTED|Overall Study||76||
48560176|NCT02023983|101702371|FG001|STARTED|Overall Study||75||
48560177|NCT02023983|101702370|FG000|COMPLETED|Overall Study||76||
48560178|NCT02023983|101702371|FG001|COMPLETED|Overall Study||75||
48560179|NCT02023983|101702370|FG000|NOT COMPLETED|Overall Study||0||
48560180|NCT02023983|101702371|FG001|NOT COMPLETED|Overall Study||0||
48560181|NCT01769248|101702372|FG000|STARTED|Overall Study||70||
48560182|NCT01769248|101702373|FG001|STARTED|Overall Study||70||
48560183|NCT01769248|101702372|FG000|Participants Who Crossed-over|Overall Study||28||
48560184|NCT01769248|101702373|FG001|Participants Who Crossed-over|Overall Study||12||
48560185|NCT01769248|101702372|FG000|COMPLETED|Overall Study||42||
48560186|NCT01769248|101702373|FG001|COMPLETED|Overall Study||58||
48560187|NCT01769248|101702372|FG000|NOT COMPLETED|Overall Study||28||
48560188|NCT01769248|101702373|FG001|NOT COMPLETED|Overall Study||12||
48560189|NCT01342471|101702374|FG000|STARTED|Overall Study||29||
48560190|NCT01342471|101702375|FG001|STARTED|Overall Study||29||
48560191|NCT01342471|101702374|FG000|COMPLETED|Overall Study||24||
48560192|NCT01342471|101702375|FG001|COMPLETED|Overall Study||23||
48560193|NCT01342471|101702374|FG000|NOT COMPLETED|Overall Study||5||
48560194|NCT01342471|101702375|FG001|NOT COMPLETED|Overall Study||6||
48560195|NCT00122382|101702376|FG000|STARTED|Double-Blind Study||256||
48560196|NCT00122382|101702377|FG001|STARTED|Double-Blind Study||255||
48560197|NCT00122382|101702378|FG002|STARTED|Double-Blind Study||0||
48560198|NCT00122382|101702376|FG000|Treated|Double-Blind Study||256||
48560199|NCT00122382|101702377|FG001|Treated|Double-Blind Study||253||
48560200|NCT00122382|101702378|FG002|Treated|Double-Blind Study||0||
48560201|NCT00122382|101702376|FG000|COMPLETED|Double-Blind Study||232||
48560202|NCT00122382|101702377|FG001|COMPLETED|Double-Blind Study||227||
48560203|NCT00122382|101702378|FG002|COMPLETED|Double-Blind Study||0||
48560204|NCT00122382|101702376|FG000|NOT COMPLETED|Double-Blind Study||24||
48560205|NCT00122382|101702377|FG001|NOT COMPLETED|Double-Blind Study||28||
48560206|NCT00122382|101702378|FG002|NOT COMPLETED|Double-Blind Study||0||
48560207|NCT00122382|101702376|FG000|STARTED|Open-Label Study||0||
48560208|NCT00122382|101702377|FG001|STARTED|Open-Label Study||0||
48560209|NCT00122382|101702378|FG002|STARTED|Open-Label Study||459||
48560210|NCT00122382|101702376|FG000|COMPLETED|Open-Label Study||0||
48560211|NCT00122382|101702377|FG001|COMPLETED|Open-Label Study||0||
48560212|NCT00122382|101702378|FG002|COMPLETED|Open-Label Study||433||
48560213|NCT00122382|101702376|FG000|NOT COMPLETED|Open-Label Study||0||
48560214|NCT00122382|101702377|FG001|NOT COMPLETED|Open-Label Study||0||
48560215|NCT00122382|101702378|FG002|NOT COMPLETED|Open-Label Study||26||
48560216|NCT03103438|101702379|FG000|STARTED|Overall Study||1||
48560217|NCT03103438|101702380|FG001|STARTED|Overall Study||3||
48695538|NCT03286543|102038556|FG001|Randomized|Consented||0|All subjects who were consented, met eligibility criteria, and were randomized.|
48695539|NCT03286543|102038557|FG002|Randomized|Consented||0|All subjects who were consented, met eligibility criteria, and were randomized.|
48695540|NCT03286543|102038555|FG000|Enrolled|Consented||41|Treatment Group subjects who were consented, randomized, and underwent Lead placement, AND Control Group subjects who were consented and randomized.|
48111940|NCT01536496|100601412|FG000|NOT COMPLETED|Overall Study||2||
48111941|NCT01536496|100601413|FG001|NOT COMPLETED|Overall Study||1||
48111942|NCT01720069|100601414|FG000|STARTED|Overall Study||62||
48560218|NCT03103438|101702381|FG002|STARTED|Overall Study||3||
48560219|NCT03103438|101702382|FG003|STARTED|Overall Study||3||
48560220|NCT03103438|101702383|FG004|STARTED|Overall Study||3||
48560221|NCT03103438|101702384|FG005|STARTED|Overall Study||3||
48560222|NCT03103438|101702385|FG006|STARTED|Overall Study||3||
48560223|NCT03103438|101702379|FG000|COMPLETED|Overall Study||1||
48111943|NCT01720069|100601415|FG001|STARTED|Overall Study||71||
48111944|NCT01720069|100601416|FG002|STARTED|Overall Study||63||
48111945|NCT01720069|100601414|FG000|Full Anaylsis Set|Overall Study||62||
48111946|NCT01720069|100601415|FG001|Full Anaylsis Set|Overall Study||71||
48111947|NCT01720069|100601416|FG002|Full Anaylsis Set|Overall Study||63||
48111948|NCT01720069|100601414|FG000|COMPLETED|Overall Study||57||
48111949|NCT01720069|100601415|FG001|COMPLETED|Overall Study||56||
48111950|NCT01720069|100601416|FG002|COMPLETED|Overall Study||48||
48111951|NCT01720069|100601414|FG000|NOT COMPLETED|Overall Study||5||
48111952|NCT01720069|100601415|FG001|NOT COMPLETED|Overall Study||15||
48111953|NCT01720069|100601416|FG002|NOT COMPLETED|Overall Study||15||
48111954|NCT03102918|100601417|FG000|STARTED|Overall Study||5||
48111955|NCT03102918|100601418|FG001|STARTED|Overall Study||5||
48111956|NCT03102918|100601417|FG000|COMPLETED|Overall Study||4||
48111957|NCT03102918|100601418|FG001|COMPLETED|Overall Study||5||
48111958|NCT03102918|100601417|FG000|NOT COMPLETED|Overall Study||1||
48111959|NCT03102918|100601418|FG001|NOT COMPLETED|Overall Study||0||
48111960|NCT02299050|100601419|FG000|STARTED|Overall Study||23||
48111961|NCT02299050|100601419|FG000|COMPLETED|Overall Study||15||
48111962|NCT02299050|100601419|FG000|NOT COMPLETED|Overall Study||8||
48111963|NCT00820612|100601420|FG000|STARTED|Overall Study||307||
48111964|NCT00820612|100601421|FG001|STARTED|Overall Study||295||
48111965|NCT00820612|100601420|FG000|COMPLETED|Overall Study||307||
48111966|NCT00820612|100601421|FG001|COMPLETED|Overall Study||295||
48111967|NCT00820612|100601420|FG000|NOT COMPLETED|Overall Study||0||
48111968|NCT00820612|100601421|FG001|NOT COMPLETED|Overall Study||0||
48111969|NCT00482391|100601422|FG000|STARTED|Overall Study||95||
48111970|NCT00482391|100601422|FG000|COMPLETED|Overall Study||92||
48111971|NCT00482391|100601422|FG000|NOT COMPLETED|Overall Study||3||
48560224|NCT03103438|101702380|FG001|COMPLETED|Overall Study||3||
48560225|NCT03103438|101702381|FG002|COMPLETED|Overall Study||3||
48560226|NCT03103438|101702382|FG003|COMPLETED|Overall Study||3||
48560227|NCT03103438|101702383|FG004|COMPLETED|Overall Study||3||
48560228|NCT03103438|101702384|FG005|COMPLETED|Overall Study||3||
48695541|NCT03286543|102038556|FG001|Enrolled|Consented||0|Treatment Group subjects who were consented, randomized, and underwent Lead placement, AND Control Group subjects who were consented and randomized.|
48560229|NCT03103438|101702385|FG006|COMPLETED|Overall Study||3||
48560230|NCT03103438|101702379|FG000|NOT COMPLETED|Overall Study||0||
48560231|NCT03103438|101702380|FG001|NOT COMPLETED|Overall Study||0||
48560232|NCT03103438|101702381|FG002|NOT COMPLETED|Overall Study||0||
48111972|NCT02915744|100601423|FG000|STARTED|Overall Study||92||
48111973|NCT02915744|100601424|FG001|STARTED|Overall Study||86||
48111974|NCT02915744|100601423|FG000|COMPLETED|Overall Study||13||
48111975|NCT02915744|100601424|FG001|COMPLETED|Overall Study||9||
48111976|NCT02915744|100601423|FG000|NOT COMPLETED|Overall Study||79||
48111977|NCT02915744|100601424|FG001|NOT COMPLETED|Overall Study||77||
48111978|NCT03900299|100601425|FG000|STARTED|Overall Study||56||
48111979|NCT03900299|100601426|FG001|STARTED|Overall Study||58||
48111980|NCT03900299|100601425|FG000|COMPLETED|Overall Study||56||
48111981|NCT03900299|100601426|FG001|COMPLETED|Overall Study||58||
48111982|NCT03900299|100601425|FG000|NOT COMPLETED|Overall Study||0||
48111983|NCT03900299|100601426|FG001|NOT COMPLETED|Overall Study||0||
48111984|NCT02346240|100601427|FG000|STARTED|Initial Period (Baseline to Week 16)||57||
48111985|NCT02346240|100601428|FG001|STARTED|Initial Period (Baseline to Week 16)||170||
48111986|NCT02346240|100601429|FG002|STARTED|Initial Period (Baseline to Week 16)||165||
48111987|NCT02346240|100601430|FG003|STARTED|Initial Period (Baseline to Week 16)||167||
48111988|NCT02346240|100601431|FG004|STARTED|Initial Period (Baseline to Week 16)||0||
48111989|NCT02346240|100601432|FG005|STARTED|Initial Period (Baseline to Week 16)||0||
48111990|NCT02346240|100601433|FG006|STARTED|Initial Period (Baseline to Week 16)||0||
48111991|NCT02346240|100601434|FG007|STARTED|Initial Period (Baseline to Week 16)||0||
48111992|NCT02346240|100601435|FG008|STARTED|Initial Period (Baseline to Week 16)||0||
48111993|NCT02346240|100601436|FG009|STARTED|Initial Period (Baseline to Week 16)||0||
48111994|NCT02346240|100601437|FG010|STARTED|Initial Period (Baseline to Week 16)||0||
48111995|NCT02346240|100601438|FG011|STARTED|Initial Period (Baseline to Week 16)||0||
48111996|NCT02346240|100601439|FG012|STARTED|Initial Period (Baseline to Week 16)||0||
48111997|NCT02346240|100601440|FG013|STARTED|Initial Period (Baseline to Week 16)||0||
48111998|NCT02346240|100601441|FG014|STARTED|Initial Period (Baseline to Week 16)||0||
48111999|NCT02346240|100601442|FG015|STARTED|Initial Period (Baseline to Week 16)||0||
48112000|NCT02346240|100601443|FG016|STARTED|Initial Period (Baseline to Week 16)||0||
48112001|NCT02346240|100601444|FG017|STARTED|Initial Period (Baseline to Week 16)||0||
48112002|NCT02346240|100601445|FG018|STARTED|Initial Period (Baseline to Week 16)||0||
48112003|NCT02346240|100601446|FG019|STARTED|Initial Period (Baseline to Week 16)||0||
48112004|NCT02346240|100601447|FG020|STARTED|Initial Period (Baseline to Week 16)||0||
48112005|NCT02346240|100601448|FG021|STARTED|Initial Period (Baseline to Week 16)||0||
48112006|NCT02346240|100601449|FG022|STARTED|Initial Period (Baseline to Week 16)||0||
48112007|NCT02346240|100601450|FG023|STARTED|Initial Period (Baseline to Week 16)||0||
48112008|NCT02346240|100601427|FG000|Completed Week 16|Initial Period (Baseline to Week 16)||55||
48112009|NCT02346240|100601428|FG001|Completed Week 16|Initial Period (Baseline to Week 16)||159||
48112010|NCT02346240|100601429|FG002|Completed Week 16|Initial Period (Baseline to Week 16)||159||
48112011|NCT02346240|100601430|FG003|Completed Week 16|Initial Period (Baseline to Week 16)||162||
48112012|NCT02346240|100601431|FG004|Completed Week 16|Initial Period (Baseline to Week 16)||0||
48112013|NCT02346240|100601432|FG005|Completed Week 16|Initial Period (Baseline to Week 16)||0||
48112014|NCT02346240|100601433|FG006|Completed Week 16|Initial Period (Baseline to Week 16)||0||
48112015|NCT02346240|100601434|FG007|Completed Week 16|Initial Period (Baseline to Week 16)||0||
48112016|NCT02346240|100601435|FG008|Completed Week 16|Initial Period (Baseline to Week 16)||0||
48112017|NCT02346240|100601436|FG009|Completed Week 16|Initial Period (Baseline to Week 16)||0||
48112018|NCT02346240|100601437|FG010|Completed Week 16|Initial Period (Baseline to Week 16)||0||
48112019|NCT02346240|100601438|FG011|Completed Week 16|Initial Period (Baseline to Week 16)||0||
48112020|NCT02346240|100601439|FG012|Completed Week 16|Initial Period (Baseline to Week 16)||0||
48112021|NCT02346240|100601440|FG013|Completed Week 16|Initial Period (Baseline to Week 16)||0||
48112022|NCT02346240|100601441|FG014|Completed Week 16|Initial Period (Baseline to Week 16)||0||
48112023|NCT02346240|100601442|FG015|Completed Week 16|Initial Period (Baseline to Week 16)||0||
48112024|NCT02346240|100601443|FG016|Completed Week 16|Initial Period (Baseline to Week 16)||0||
48112025|NCT02346240|100601444|FG017|Completed Week 16|Initial Period (Baseline to Week 16)||0||
48112026|NCT02346240|100601445|FG018|Completed Week 16|Initial Period (Baseline to Week 16)||0||
48112027|NCT02346240|100601446|FG019|Completed Week 16|Initial Period (Baseline to Week 16)||0||
48112028|NCT02346240|100601447|FG020|Completed Week 16|Initial Period (Baseline to Week 16)||0||
48112029|NCT02346240|100601448|FG021|Completed Week 16|Initial Period (Baseline to Week 16)||0||
48112030|NCT02346240|100601449|FG022|Completed Week 16|Initial Period (Baseline to Week 16)||0||
48112031|NCT02346240|100601450|FG023|Completed Week 16|Initial Period (Baseline to Week 16)||0||
48112032|NCT02346240|100601427|FG000|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||55||
48112033|NCT02346240|100601428|FG001|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||159||
48112034|NCT02346240|100601429|FG002|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||159||
48112035|NCT02346240|100601430|FG003|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||160||
48112036|NCT02346240|100601431|FG004|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
48112037|NCT02346240|100601432|FG005|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
48112038|NCT02346240|100601433|FG006|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
48112039|NCT02346240|100601434|FG007|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
48112040|NCT02346240|100601435|FG008|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
48112041|NCT02346240|100601436|FG009|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
48112042|NCT02346240|100601437|FG010|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
48112043|NCT02346240|100601438|FG011|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
48112044|NCT02346240|100601439|FG012|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
48112045|NCT02346240|100601440|FG013|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
48112046|NCT02346240|100601441|FG014|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
48695542|NCT03286543|102038557|FG002|Enrolled|Consented||0|Treatment Group subjects who were consented, randomized, and underwent Lead placement, AND Control Group subjects who were consented and randomized.|
48695543|NCT03286543|102038555|FG000|Intent to Treat Set|Consented||37|Subjects that were consented, randomized, enrolled, and progressed in study to designated randomization assignment therapy.|
48695544|NCT03286543|102038556|FG001|Intent to Treat Set|Consented||0|Subjects that were consented, randomized, enrolled, and progressed in study to designated randomization assignment therapy.|
48695545|NCT03286543|102038557|FG002|Intent to Treat Set|Consented||0|Subjects that were consented, randomized, enrolled, and progressed in study to designated randomization assignment therapy.|
48710709|NCT00846040|102077994|FG001|COMPLETED|Second Treatment: After Washout, 14 Day||8||
48710710|NCT00846040|102077995|FG002|COMPLETED|Second Treatment: After Washout, 14 Day||0||
48710711|NCT00846040|102077993|FG000|NOT COMPLETED|Second Treatment: After Washout, 14 Day||0||
48112047|NCT02346240|100601442|FG015|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
48695546|NCT03286543|102038555|FG000|Per Protocol Set|Consented||23|Subjects that were consented, randomized, enrolled, have adequate diary completion, and continued study eligibility. Additionally, Treatment Group subjects must have received a Lead and experienced stimulation-evoked comfortable sensations or a reduction in pain with stimulation in the target area during Visit 2 (original or unscheduled) or Visit 4.|
48695547|NCT03286543|102038556|FG001|Per Protocol Set|Consented||0|Subjects that were consented, randomized, enrolled, have adequate diary completion, and continued study eligibility. Additionally, Treatment Group subjects must have received a Lead and experienced stimulation-evoked comfortable sensations or a reduction in pain with stimulation in the target area during Visit 2 (original or unscheduled) or Visit 4.|
48695548|NCT03286543|102038557|FG002|Per Protocol Set|Consented||0|Subjects that were consented, randomized, enrolled, have adequate diary completion, and continued study eligibility. Additionally, Treatment Group subjects must have received a Lead and experienced stimulation-evoked comfortable sensations or a reduction in pain with stimulation in the target area during Visit 2 (original or unscheduled) or Visit 4.|
48695549|NCT03286543|102038555|FG000|COMPLETED|Consented||28||
48695550|NCT03286543|102038556|FG001|COMPLETED|Consented||0||
48695551|NCT03286543|102038557|FG002|COMPLETED|Consented||0||
48695552|NCT03286543|102038555|FG000|NOT COMPLETED|Consented||19||
48695553|NCT03286543|102038556|FG001|NOT COMPLETED|Consented||0||
48695554|NCT03286543|102038557|FG002|NOT COMPLETED|Consented||0||
48695555|NCT03286543|102038555|FG000|STARTED|Study Enrollment||0||
48695556|NCT03286543|102038556|FG001|STARTED|Study Enrollment||18||
48695557|NCT03286543|102038557|FG002|STARTED|Study Enrollment||23||
48695558|NCT03286543|102038555|FG000|Intent to Treat Set|Study Enrollment||0|Subjects that were consented, randomized, and enrolled.|
48695559|NCT03286543|102038556|FG001|Intent to Treat Set|Study Enrollment||18|Subjects that were consented, randomized, and enrolled.|
48695560|NCT03286543|102038557|FG002|Intent to Treat Set|Study Enrollment||19|Subjects that were consented, randomized, and enrolled.|
48695561|NCT03286543|102038555|FG000|Per Protocol Set|Study Enrollment||0|Subjects that were consented, randomized, enrolled, have adequate diary completion, and continued study eligibility. Additionally, Treatment Group subjects must have received a Lead and experienced stimulation-evoked comfortable sensations or a reduction in pain with stimulation in the target area during Visit 2 (original or unscheduled) or Visit 4.|
48112048|NCT02346240|100601443|FG016|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
48112049|NCT02346240|100601444|FG017|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
48112050|NCT02346240|100601445|FG018|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
48112051|NCT02346240|100601446|FG019|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
48112052|NCT02346240|100601447|FG020|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
48112053|NCT02346240|100601448|FG021|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
48695562|NCT03286543|102038556|FG001|Per Protocol Set|Study Enrollment||7|Subjects that were consented, randomized, enrolled, have adequate diary completion, and continued study eligibility. Additionally, Treatment Group subjects must have received a Lead and experienced stimulation-evoked comfortable sensations or a reduction in pain with stimulation in the target area during Visit 2 (original or unscheduled) or Visit 4.|
48695563|NCT03286543|102038557|FG002|Per Protocol Set|Study Enrollment||16|Subjects that were consented, randomized, enrolled, have adequate diary completion, and continued study eligibility. Additionally, Treatment Group subjects must have received a Lead and experienced stimulation-evoked comfortable sensations or a reduction in pain with stimulation in the target area during Visit 2 (original or unscheduled) or Visit 4.|
48695564|NCT03286543|102038555|FG000|COMPLETED|Study Enrollment||0||
48695565|NCT03286543|102038556|FG001|COMPLETED|Study Enrollment||12||
48695566|NCT03286543|102038557|FG002|COMPLETED|Study Enrollment||16||
48695567|NCT03286543|102038555|FG000|NOT COMPLETED|Study Enrollment||0||
48695568|NCT03286543|102038556|FG001|NOT COMPLETED|Study Enrollment||6||
48695569|NCT03286543|102038557|FG002|NOT COMPLETED|Study Enrollment||7||
48695570|NCT01545934|102038558|FG000|STARTED|Overall Study||132||
48695571|NCT01545934|102038559|FG001|STARTED|Overall Study||132||
48695572|NCT01545934|102038558|FG000|COMPLETED|Overall Study||127||
48695573|NCT01545934|102038559|FG001|COMPLETED|Overall Study||129||
48695574|NCT01545934|102038558|FG000|NOT COMPLETED|Overall Study||5||
48695575|NCT01545934|102038559|FG001|NOT COMPLETED|Overall Study||3||
48695576|NCT00780143|102038560|FG000|STARTED|Overall Study||3||
48112054|NCT02346240|100601449|FG022|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
48112055|NCT02346240|100601450|FG023|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
48112056|NCT02346240|100601427|FG000|COMPLETED|Initial Period (Baseline to Week 16)||55||
48112057|NCT02346240|100601428|FG001|COMPLETED|Initial Period (Baseline to Week 16)||159||
48112058|NCT02346240|100601429|FG002|COMPLETED|Initial Period (Baseline to Week 16)||159||
48112059|NCT02346240|100601430|FG003|COMPLETED|Initial Period (Baseline to Week 16)||160||
48274658|NCT04230122|100996271|FG001|COMPLETED|Overall Study||1||
48274659|NCT04230122|100996270|FG000|NOT COMPLETED|Overall Study||1||
48274660|NCT04230122|100996271|FG001|NOT COMPLETED|Overall Study||0||
48274661|NCT02758847|100996272|FG000|STARTED|Overall Study||50||
48274662|NCT02758847|100996272|FG000|COMPLETED|Overall Study||50||
48274663|NCT02758847|100996272|FG000|NOT COMPLETED|Overall Study||0||
48274664|NCT01525238|100996273|FG000|STARTED|Overall Study||8||
48274665|NCT01525238|100996274|FG001|STARTED|Overall Study||8||
48274666|NCT01525238|100996275|FG002|STARTED|Overall Study||8||
48274667|NCT01525238|100996273|FG000|COMPLETED|Overall Study||7||
48274668|NCT01525238|100996274|FG001|COMPLETED|Overall Study||8||
48274669|NCT01525238|100996275|FG002|COMPLETED|Overall Study||8||
48560233|NCT03103438|101702382|FG003|NOT COMPLETED|Overall Study||0||
48560234|NCT03103438|101702383|FG004|NOT COMPLETED|Overall Study||0||
48560235|NCT03103438|101702384|FG005|NOT COMPLETED|Overall Study||0||
48560236|NCT03103438|101702385|FG006|NOT COMPLETED|Overall Study||0||
48560237|NCT01853215|101702386|FG000|STARTED|Overall Study||24||
48560238|NCT01853215|101702386|FG000|COMPLETED|Overall Study||24||
48560239|NCT01853215|101702386|FG000|NOT COMPLETED|Overall Study||0||
48560240|NCT00322712|101702387|FG000|STARTED|Overall Study||12||
48560241|NCT00322712|101702387|FG000|COMPLETED|Overall Study||11||
48560242|NCT00322712|101702387|FG000|NOT COMPLETED|Overall Study||1||
48560243|NCT01349192|101702388|FG000|STARTED|Overall Study||24||
48560244|NCT01349192|101702389|FG001|STARTED|Overall Study||23||
48560245|NCT01349192|101702388|FG000|Evaluable for Primary Endpoint|Overall Study||22||
48560246|NCT01349192|101702389|FG001|Evaluable for Primary Endpoint|Overall Study||19||
48560247|NCT01349192|101702388|FG000|Withdrawals|Overall Study||3||
48560248|NCT01349192|101702389|FG001|Withdrawals|Overall Study||6||
48560249|NCT01349192|101702388|FG000|COMPLETED|Overall Study||21||
48560250|NCT01349192|101702389|FG001|COMPLETED|Overall Study||17||
48560251|NCT01349192|101702388|FG000|NOT COMPLETED|Overall Study||3||
48560252|NCT01349192|101702389|FG001|NOT COMPLETED|Overall Study||6||
48560253|NCT01845441|101702390|FG000|STARTED|Overall Study||4||
48560254|NCT01845441|101702391|FG001|STARTED|Overall Study||3||
48560255|NCT01845441|101702390|FG000|COMPLETED|Overall Study||4||
48560256|NCT01845441|101702391|FG001|COMPLETED|Overall Study||3||
48560257|NCT01845441|101702390|FG000|NOT COMPLETED|Overall Study||0||
48560258|NCT01845441|101702391|FG001|NOT COMPLETED|Overall Study||0||
48560259|NCT02286713|101702392|FG000|STARTED|One Week Follow-Up||259||
48560260|NCT02286713|101702393|FG001|STARTED|One Week Follow-Up||257||
48560261|NCT02286713|101702392|FG000|COMPLETED|One Week Follow-Up||235||
48695577|NCT00780143|102038560|FG000|COMPLETED|Overall Study||0||
48695578|NCT00780143|102038560|FG000|NOT COMPLETED|Overall Study||3||
48695579|NCT04908384|102038561|FG000|STARTED|Overall Study||21||
48695580|NCT04908384|102038562|FG001|STARTED|Overall Study||21||
48695581|NCT04908384|102038563|FG002|STARTED|Overall Study||31||
48695582|NCT04908384|102038564|FG003|STARTED|Overall Study||31||
48695583|NCT04908384|102038561|FG000|COMPLETED|Overall Study||17||
48695584|NCT04908384|102038562|FG001|COMPLETED|Overall Study||17||
48695585|NCT04908384|102038563|FG002|COMPLETED|Overall Study||31||
48695586|NCT04908384|102038564|FG003|COMPLETED|Overall Study||31||
48695587|NCT04908384|102038561|FG000|NOT COMPLETED|Overall Study||4||
48695588|NCT04908384|102038562|FG001|NOT COMPLETED|Overall Study||4||
48695589|NCT04908384|102038563|FG002|NOT COMPLETED|Overall Study||0||
48695590|NCT04908384|102038564|FG003|NOT COMPLETED|Overall Study||0||
48695591|NCT04004221|102038565|FG000|STARTED|Overall Study||113||
48695592|NCT04004221|102038565|FG000|COMPLETED|Overall Study||0||
48695593|NCT04004221|102038565|FG000|NOT COMPLETED|Overall Study||113||
48695594|NCT00744380|102038566|FG000|STARTED|Overall Study||12||
48695595|NCT00744380|102038567|FG001|STARTED|Overall Study||11||
48695596|NCT00744380|102038566|FG000|COMPLETED|Overall Study||12||
48274670|NCT01525238|100996273|FG000|NOT COMPLETED|Overall Study||1||
48274671|NCT01525238|100996274|FG001|NOT COMPLETED|Overall Study||0||
48274672|NCT01525238|100996275|FG002|NOT COMPLETED|Overall Study||0||
48274673|NCT03795753|100996276|FG000|STARTED|Overall Study||23||
48274674|NCT03795753|100996277|FG001|STARTED|Overall Study||13||
48274675|NCT03795753|100996276|FG000|COMPLETED|Overall Study||23||
48274676|NCT03795753|100996277|FG001|COMPLETED|Overall Study||13||
48274677|NCT03795753|100996276|FG000|NOT COMPLETED|Overall Study||0||
48274678|NCT03795753|100996277|FG001|NOT COMPLETED|Overall Study||0||
48274679|NCT02745353|100996278|FG000|STARTED|First Intervention (2 Weeks)||4||
48274680|NCT02745353|100996279|FG001|STARTED|First Intervention (2 Weeks)||3||
48274681|NCT02745353|100996278|FG000|COMPLETED|First Intervention (2 Weeks)||1||
48560262|NCT02286713|101702393|FG001|COMPLETED|One Week Follow-Up||233||
48560263|NCT02286713|101702392|FG000|NOT COMPLETED|One Week Follow-Up||24||
48695597|NCT00744380|102038567|FG001|COMPLETED|Overall Study||11||
48695598|NCT00744380|102038566|FG000|NOT COMPLETED|Overall Study||0||
48695599|NCT00744380|102038567|FG001|NOT COMPLETED|Overall Study||0||
48695600|NCT02680041|102038568|FG000|STARTED|Overall Study||221||
48560264|NCT02286713|101702393|FG001|NOT COMPLETED|One Week Follow-Up||24||
48560265|NCT02286713|101702392|FG000|STARTED|Three Month Follow-Up||252||
48560266|NCT02286713|101702393|FG001|STARTED|Three Month Follow-Up||254||
48560267|NCT02286713|101702392|FG000|COMPLETED|Three Month Follow-Up||224||
48560268|NCT02286713|101702393|FG001|COMPLETED|Three Month Follow-Up||228||
48560269|NCT02286713|101702392|FG000|NOT COMPLETED|Three Month Follow-Up||28||
48274682|NCT02745353|100996279|FG001|COMPLETED|First Intervention (2 Weeks)||1||
48274683|NCT02745353|100996278|FG000|NOT COMPLETED|First Intervention (2 Weeks)||3||
48274684|NCT02745353|100996279|FG001|NOT COMPLETED|First Intervention (2 Weeks)||2||
48274685|NCT02745353|100996278|FG000|STARTED|Washout (3 Days)||1||
48560270|NCT02286713|101702393|FG001|NOT COMPLETED|Three Month Follow-Up||26||
48560271|NCT02286713|101702392|FG000|STARTED|Six Month Follow-Up||250||
48695601|NCT02680041|102038568|FG000|Received 18F-fluciclovine|Overall Study||213||
48695602|NCT02680041|102038568|FG000|COMPLETED|Overall Study||211||
48695603|NCT02680041|102038568|FG000|NOT COMPLETED|Overall Study||10||
48695604|NCT01231334|102038569|FG000|STARTED|Overall Study||145||
48274686|NCT02745353|100996279|FG001|STARTED|Washout (3 Days)||1||
48274687|NCT02745353|100996278|FG000|COMPLETED|Washout (3 Days)||1||
48274688|NCT02745353|100996279|FG001|COMPLETED|Washout (3 Days)||1||
48695605|NCT01231334|102038570|FG001|STARTED|Overall Study||141||
48695606|NCT01231334|102038569|FG000|COMPLETED|Overall Study||126||
48695607|NCT01231334|102038570|FG001|COMPLETED|Overall Study||120||
48695608|NCT01231334|102038569|FG000|NOT COMPLETED|Overall Study||19||
48695609|NCT01231334|102038570|FG001|NOT COMPLETED|Overall Study||21||
48274689|NCT02745353|100996278|FG000|NOT COMPLETED|Washout (3 Days)||0||
48274690|NCT02745353|100996279|FG001|NOT COMPLETED|Washout (3 Days)||0||
48274691|NCT02745353|100996278|FG000|STARTED|Second Intervention (2 Weeks)||1||
48274692|NCT02745353|100996279|FG001|STARTED|Second Intervention (2 Weeks)||1||
48274693|NCT02745353|100996278|FG000|COMPLETED|Second Intervention (2 Weeks)||1||
48274694|NCT02745353|100996279|FG001|COMPLETED|Second Intervention (2 Weeks)||0||
48274695|NCT02745353|100996278|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48274696|NCT02745353|100996279|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||1||
48560272|NCT02286713|101702393|FG001|STARTED|Six Month Follow-Up||252||
48560273|NCT02286713|101702392|FG000|COMPLETED|Six Month Follow-Up||218||
48274697|NCT03046121|100996280|FG000|STARTED|Overall Study||229||3
48274698|NCT03046121|100996281|FG001|STARTED|Overall Study||232||3
48274699|NCT03046121|100996280|FG000|Hospital 1|Overall Study||89||1
48274700|NCT03046121|100996281|FG001|Hospital 1|Overall Study||86||1
48274701|NCT03046121|100996280|FG000|Hospital 2|Overall Study||73||1
48274702|NCT03046121|100996281|FG001|Hospital 2|Overall Study||73||1
48274703|NCT03046121|100996280|FG000|Hospital 3|Overall Study||67||1
48274704|NCT03046121|100996281|FG001|Hospital 3|Overall Study||73||1
48274705|NCT03046121|100996280|FG000|COMPLETED|Overall Study||183||3
48274706|NCT03046121|100996281|FG001|COMPLETED|Overall Study||160||3
48274707|NCT03046121|100996280|FG000|NOT COMPLETED|Overall Study||46||0
48274708|NCT03046121|100996281|FG001|NOT COMPLETED|Overall Study||72||0
48274709|NCT03065075|100996282|FG000|STARTED|Overall Study||76||
48274710|NCT03065075|100996283|FG001|STARTED|Overall Study||76||
48274711|NCT03065075|100996282|FG000|Intent-to-treat Analysis|Overall Study||72||
48274712|NCT03065075|100996283|FG001|Intent-to-treat Analysis|Overall Study||74||
48274713|NCT03065075|100996282|FG000|As-treated Analysis|Overall Study||69||
48274714|NCT03065075|100996283|FG001|As-treated Analysis|Overall Study||77||
48274715|NCT03065075|100996282|FG000|COMPLETED|Overall Study||76||
48274716|NCT03065075|100996283|FG001|COMPLETED|Overall Study||76||
48274717|NCT03065075|100996282|FG000|NOT COMPLETED|Overall Study||0||
48274718|NCT03065075|100996283|FG001|NOT COMPLETED|Overall Study||0||
48274719|NCT01374568|100996284|FG000|STARTED|Overall Study||2||
48274720|NCT01374568|100996285|FG001|STARTED|Overall Study||3||
48274721|NCT01374568|100996284|FG000|COMPLETED|Overall Study||2||
48274722|NCT01374568|100996285|FG001|COMPLETED|Overall Study||1||
48274723|NCT01374568|100996284|FG000|NOT COMPLETED|Overall Study||0||
48274724|NCT01374568|100996285|FG001|NOT COMPLETED|Overall Study||2||
48274725|NCT01182441|100996286|FG000|STARTED|Overall Study||269||
48274726|NCT01182441|100996287|FG001|STARTED|Overall Study||138||
48274727|NCT01182441|100996286|FG000|COMPLETED|Overall Study||49||
48274728|NCT01182441|100996287|FG001|COMPLETED|Overall Study||19||
48274729|NCT01182441|100996286|FG000|NOT COMPLETED|Overall Study||220||
48274730|NCT01182441|100996287|FG001|NOT COMPLETED|Overall Study||119||
48560274|NCT02286713|101702393|FG001|COMPLETED|Six Month Follow-Up||225||
48560275|NCT02286713|101702392|FG000|NOT COMPLETED|Six Month Follow-Up||32||
48560276|NCT02286713|101702393|FG001|NOT COMPLETED|Six Month Follow-Up||27||
48560277|NCT01169350|101702394|FG000|STARTED|Overall Study||8||
48560278|NCT01169350|101702394|FG000|COMPLETED|Overall Study||3||
48560279|NCT01169350|101702394|FG000|NOT COMPLETED|Overall Study||5||
48560280|NCT04720105|101702395|FG000|STARTED|Overall Study||22||
48560281|NCT04720105|101702395|FG000|COMPLETED|Overall Study||17||
48560282|NCT04720105|101702395|FG000|NOT COMPLETED|Overall Study||5||
48560283|NCT00273182|101702396|FG000|STARTED|Overall Study||1999||
48560284|NCT00273182|101702396|FG000|COMPLETED|Overall Study||1014||
48560285|NCT00273182|101702396|FG000|NOT COMPLETED|Overall Study||985||
48274731|NCT00565773|100996288|FG000|STARTED|Overall Study||40||
48274732|NCT00565773|100996288|FG000|COMPLETED|Overall Study||38||
48695610|NCT04270682|102038571|FG000|STARTED|Overall Study||6||
48274733|NCT00565773|100996288|FG000|NOT COMPLETED|Overall Study||2||
48695611|NCT04270682|102038572|FG001|STARTED|Overall Study||7||
48695612|NCT04270682|102038573|FG002|STARTED|Overall Study||5||
48695613|NCT04270682|102038571|FG000|COMPLETED|Overall Study||6||
48695614|NCT04270682|102038572|FG001|COMPLETED|Overall Study||7||
48695615|NCT04270682|102038573|FG002|COMPLETED|Overall Study||4||
48112060|NCT02346240|100601431|FG004|COMPLETED|Initial Period (Baseline to Week 16)||0||
48112061|NCT02346240|100601432|FG005|COMPLETED|Initial Period (Baseline to Week 16)||0||
48274734|NCT02136134|100996289|FG000|STARTED|Overall Study||247||
48274735|NCT02136134|100996290|FG001|STARTED|Overall Study||251||
48274736|NCT02136134|100996289|FG000|Daratumumab Monotherapy|Overall Study||87||
48560286|NCT04573322|101702397|FG000|STARTED|Overall Study||6||
48560287|NCT04573322|101702398|FG001|STARTED|Overall Study||6||
48695616|NCT04270682|102038571|FG000|NOT COMPLETED|Overall Study||0||
48695617|NCT04270682|102038572|FG001|NOT COMPLETED|Overall Study||0||
48695618|NCT04270682|102038573|FG002|NOT COMPLETED|Overall Study||1||
48560288|NCT04573322|101702399|FG002|STARTED|Overall Study||7||
48560289|NCT04573322|101702400|FG003|STARTED|Overall Study||6||
48560290|NCT04573322|101702397|FG000|COMPLETED|Overall Study||5||
48560291|NCT04573322|101702398|FG001|COMPLETED|Overall Study||4||
48560292|NCT04573322|101702399|FG002|COMPLETED|Overall Study||5||
48560293|NCT04573322|101702400|FG003|COMPLETED|Overall Study||3||
48560294|NCT04573322|101702397|FG000|NOT COMPLETED|Overall Study||1||
48560295|NCT04573322|101702398|FG001|NOT COMPLETED|Overall Study||2||
48560296|NCT04573322|101702399|FG002|NOT COMPLETED|Overall Study||2||
48560297|NCT04573322|101702400|FG003|NOT COMPLETED|Overall Study||3||
48560298|NCT01368653|101702401|FG000|STARTED|Overall Study||47||
48560299|NCT01368653|101702402|FG001|STARTED|Overall Study||46||
48560300|NCT01368653|101702401|FG000|Completed 4-week Follow-up|Overall Study||44||
48560301|NCT01368653|101702402|FG001|Completed 4-week Follow-up|Overall Study||37||
48560302|NCT01368653|101702401|FG000|Smoked in Past 7 Days at 4-weeks|Overall Study||29||
48560303|NCT01368653|101702402|FG001|Smoked in Past 7 Days at 4-weeks|Overall Study||20||
48560304|NCT01368653|101702401|FG000|Randomized to Phase 2|Overall Study||21||
48560305|NCT01368653|101702402|FG001|Randomized to Phase 2|Overall Study||19||
48560306|NCT01368653|101702401|FG000|Randomized to VLNC in Phase 2|Overall Study||11||
48560307|NCT01368653|101702402|FG001|Randomized to VLNC in Phase 2|Overall Study||9||
48560308|NCT01368653|101702401|FG000|Randomized to Advice Only in Phase 2|Overall Study||10||
48560309|NCT01368653|101702402|FG001|Randomized to Advice Only in Phase 2|Overall Study||10||
48560310|NCT01368653|101702401|FG000|COMPLETED|Overall Study||41||
48560311|NCT01368653|101702402|FG001|COMPLETED|Overall Study||37||
48560312|NCT01368653|101702401|FG000|NOT COMPLETED|Overall Study||6||
48560313|NCT01368653|101702402|FG001|NOT COMPLETED|Overall Study||9||
48560314|NCT02003404|101702403|FG000|STARTED|Overall Study||17||
48560315|NCT02003404|101702403|FG000|COMPLETED|Overall Study||17||
48560316|NCT02003404|101702403|FG000|NOT COMPLETED|Overall Study||0||
48560317|NCT00955617|101702404|FG000|STARTED|First MRA (Between Day0 and Day21)||10||
48560318|NCT00955617|101702405|FG001|STARTED|First MRA (Between Day0 and Day21)||10||
48560319|NCT00955617|101702404|FG000|COMPLETED|First MRA (Between Day0 and Day21)||10||
48560320|NCT00955617|101702405|FG001|COMPLETED|First MRA (Between Day0 and Day21)||10||
48560321|NCT00955617|101702404|FG000|NOT COMPLETED|First MRA (Between Day0 and Day21)||0||
48560322|NCT00955617|101702405|FG001|NOT COMPLETED|First MRA (Between Day0 and Day21)||0||
48560323|NCT00955617|101702404|FG000|STARTED|Second MRA (Between Day 1 and Day 51)||10||
48695619|NCT02836470|102038574|FG000|STARTED|Overall Study||57||
48695620|NCT02836470|102038575|FG001|STARTED|Overall Study||55||
48695621|NCT02836470|102038574|FG000|COMPLETED|Overall Study||52||
48695622|NCT02836470|102038575|FG001|COMPLETED|Overall Study||49||
48695623|NCT02836470|102038574|FG000|NOT COMPLETED|Overall Study||5||
48695624|NCT02836470|102038575|FG001|NOT COMPLETED|Overall Study||6||
48695625|NCT03088930|102038576|FG000|STARTED|Overall Study||3||
48695626|NCT03088930|102038576|FG000|COMPLETED|Overall Study||3||
48695627|NCT03088930|102038576|FG000|NOT COMPLETED|Overall Study||0||
48695628|NCT01781806|102038577|FG000|STARTED|Overall Study||297||
48695629|NCT01781806|102038578|FG001|STARTED|Overall Study||4||
48695630|NCT01781806|102038577|FG000|Week 0|Overall Study||297||
48560324|NCT00955617|101702405|FG001|STARTED|Second MRA (Between Day 1 and Day 51)||10||
48560325|NCT00955617|101702404|FG000|COMPLETED|Second MRA (Between Day 1 and Day 51)||7||
48560326|NCT00955617|101702405|FG001|COMPLETED|Second MRA (Between Day 1 and Day 51)||7||
48560327|NCT00955617|101702404|FG000|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3||
48560328|NCT00955617|101702405|FG001|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3||
48560329|NCT02526667|101702406|FG000|STARTED|Abdomen||284||568
48560330|NCT02526667|101702407|FG001|STARTED|Abdomen||56||112
48560331|NCT02526667|101702408|FG002|STARTED|Abdomen||281||562
48560332|NCT02526667|101702406|FG000|COMPLETED|Abdomen||284||307
48560333|NCT02526667|101702407|FG001|COMPLETED|Abdomen||56||59
48695631|NCT01781806|102038578|FG001|Week 0|Overall Study||4||
48695632|NCT01781806|102038577|FG000|Week 4|Overall Study||284||
48695633|NCT01781806|102038578|FG001|Week 4|Overall Study||4||
48695634|NCT01781806|102038577|FG000|Week 8|Overall Study||278||
48695635|NCT01781806|102038578|FG001|Week 8|Overall Study||4||
48695636|NCT01781806|102038577|FG000|Week 12|Overall Study||272||
48695637|NCT01781806|102038578|FG001|Week 12|Overall Study||2||
48695638|NCT01781806|102038577|FG000|Week 24|Overall Study||260||
48560334|NCT02526667|101702408|FG002|COMPLETED|Abdomen||281||314
48560335|NCT02526667|101702406|FG000|NOT COMPLETED|Abdomen||0||261
48560336|NCT02526667|101702407|FG001|NOT COMPLETED|Abdomen||0||53
48560337|NCT02526667|101702408|FG002|NOT COMPLETED|Abdomen||0||248
48695639|NCT01781806|102038578|FG001|Week 24|Overall Study||1||
48560338|NCT02526667|101702406|FG000|STARTED|Groin||290||580
48560339|NCT02526667|101702407|FG001|STARTED|Groin||56||112
48560340|NCT02526667|101702408|FG002|STARTED|Groin||294||588
48560341|NCT02526667|101702406|FG000|COMPLETED|Groin||290||291
48695640|NCT01781806|102038577|FG000|Week 36|Overall Study||247||
48695641|NCT01781806|102038578|FG001|Week 36|Overall Study||1||
48560342|NCT02526667|101702407|FG001|COMPLETED|Groin||56||55
48274737|NCT02136134|100996290|FG001|Daratumumab Monotherapy|Overall Study||0||
48274738|NCT02136134|100996289|FG000|COMPLETED|Overall Study||0||
48274739|NCT02136134|100996290|FG001|COMPLETED|Overall Study||0||
48274740|NCT02136134|100996289|FG000|NOT COMPLETED|Overall Study||247||
48274741|NCT02136134|100996290|FG001|NOT COMPLETED|Overall Study||251||
48274742|NCT01951352|100996291|FG000|STARTED|Overall Study||10||
48274743|NCT01951352|100996291|FG000|COMPLETED|Overall Study||10||
48274744|NCT01951352|100996291|FG000|NOT COMPLETED|Overall Study||0||
48274745|NCT05141500|100996292|FG000|STARTED|Overall Study||12||
48274746|NCT05141500|100996292|FG000|COMPLETED|Overall Study||12||
48274747|NCT05141500|100996292|FG000|NOT COMPLETED|Overall Study||0||
48274748|NCT02949362|100996293|FG000|STARTED|Retrospective Period||24||
48274749|NCT02949362|100996294|FG001|STARTED|Retrospective Period||5||
48274750|NCT02949362|100996295|FG002|STARTED|Retrospective Period||0||
48274751|NCT02949362|100996296|FG003|STARTED|Retrospective Period||0||
48274752|NCT02949362|100996293|FG000|COMPLETED|Retrospective Period||20||
48274753|NCT02949362|100996294|FG001|COMPLETED|Retrospective Period||4||
48274754|NCT02949362|100996295|FG002|COMPLETED|Retrospective Period||0||
48274755|NCT02949362|100996296|FG003|COMPLETED|Retrospective Period||0||
48274756|NCT02949362|100996293|FG000|NOT COMPLETED|Retrospective Period||4||
48274757|NCT02949362|100996294|FG001|NOT COMPLETED|Retrospective Period||1||
48274758|NCT02949362|100996295|FG002|NOT COMPLETED|Retrospective Period||0||
48274759|NCT02949362|100996296|FG003|NOT COMPLETED|Retrospective Period||0||
48274760|NCT02949362|100996293|FG000|STARTED|Prospective Period||0||
48274761|NCT02949362|100996294|FG001|STARTED|Prospective Period||0||
48274762|NCT02949362|100996295|FG002|STARTED|Prospective Period||5||
48274763|NCT02949362|100996296|FG003|STARTED|Prospective Period||19||
48274764|NCT02949362|100996293|FG000|COMPLETED|Prospective Period||0||
48274765|NCT02949362|100996294|FG001|COMPLETED|Prospective Period||0||
48274766|NCT02949362|100996295|FG002|COMPLETED|Prospective Period||4||
48274767|NCT02949362|100996296|FG003|COMPLETED|Prospective Period||15||
48274768|NCT02949362|100996293|FG000|NOT COMPLETED|Prospective Period||0||
48274769|NCT02949362|100996294|FG001|NOT COMPLETED|Prospective Period||0||
48274770|NCT02949362|100996295|FG002|NOT COMPLETED|Prospective Period||1||
48274771|NCT02949362|100996296|FG003|NOT COMPLETED|Prospective Period||4||
48274772|NCT01892540|100996297|FG000|STARTED|Overall Study||15||
48274773|NCT01892540|100996298|FG001|STARTED|Overall Study||0||
48274774|NCT01892540|100996299|FG002|STARTED|Overall Study||28||
48274775|NCT01892540|100996297|FG000|COMPLETED|Overall Study||15||
48274776|NCT01892540|100996298|FG001|COMPLETED|Overall Study||0||
48274777|NCT01892540|100996299|FG002|COMPLETED|Overall Study||25||
48274778|NCT01892540|100996297|FG000|NOT COMPLETED|Overall Study||0||
48274779|NCT01892540|100996298|FG001|NOT COMPLETED|Overall Study||0||
48274780|NCT01892540|100996299|FG002|NOT COMPLETED|Overall Study||3||
48274781|NCT02175641|100996300|FG000|STARTED|Overall Study||157||
48274782|NCT02175641|100996301|FG001|STARTED|Overall Study||157||
48274783|NCT02175641|100996300|FG000|6-month Follow up|Overall Study||144||
48560343|NCT02526667|101702408|FG002|COMPLETED|Groin||294||294
48560344|NCT02526667|101702406|FG000|NOT COMPLETED|Groin||0||289
48560345|NCT02526667|101702407|FG001|NOT COMPLETED|Groin||0||57
48560346|NCT02526667|101702408|FG002|NOT COMPLETED|Groin||0||294
48560347|NCT04358081|101702409|FG000|STARTED|Treatment Phase of Study||7||
48695642|NCT01781806|102038577|FG000|Week 48|Overall Study||222||
48695643|NCT01781806|102038578|FG001|Week 48|Overall Study||1||
48695644|NCT01781806|102038577|FG000|COMPLETED|Overall Study||218||
48274784|NCT02175641|100996301|FG001|6-month Follow up|Overall Study||149||
48274785|NCT02175641|100996300|FG000|12-month Follow up|Overall Study||129||
48274786|NCT02175641|100996301|FG001|12-month Follow up|Overall Study||136||
48560348|NCT04358081|101702410|FG001|STARTED|Treatment Phase of Study||7||
48560349|NCT04358081|101702411|FG002|STARTED|Treatment Phase of Study||5||
48560350|NCT04358081|101702409|FG000|COMPLETED|Treatment Phase of Study||3||
48560351|NCT04358081|101702410|FG001|COMPLETED|Treatment Phase of Study||6||
48560352|NCT04358081|101702411|FG002|COMPLETED|Treatment Phase of Study||2||
48560353|NCT04358081|101702409|FG000|NOT COMPLETED|Treatment Phase of Study||4||
48560354|NCT04358081|101702410|FG001|NOT COMPLETED|Treatment Phase of Study||1||
48695645|NCT01781806|102038578|FG001|COMPLETED|Overall Study||1||
48695646|NCT01781806|102038577|FG000|NOT COMPLETED|Overall Study||79||
48274787|NCT02175641|100996300|FG000|18-month Follow up|Overall Study||122||
48560355|NCT04358081|101702411|FG002|NOT COMPLETED|Treatment Phase of Study||3||
48560356|NCT04358081|101702409|FG000|STARTED|Study Completion Phase||7||
48560357|NCT04358081|101702410|FG001|STARTED|Study Completion Phase||7||
48560358|NCT04358081|101702411|FG002|STARTED|Study Completion Phase||5||
48560359|NCT04358081|101702409|FG000|COMPLETED|Study Completion Phase||6||
48695647|NCT01781806|102038578|FG001|NOT COMPLETED|Overall Study||3||
48695648|NCT03869385|102038579|FG000|STARTED|Overall Study||222||
48274788|NCT02175641|100996301|FG001|18-month Follow up|Overall Study||130||
48274789|NCT02175641|100996300|FG000|COMPLETED|Overall Study||122||
48274790|NCT02175641|100996301|FG001|COMPLETED|Overall Study||130||
48560360|NCT04358081|101702410|FG001|COMPLETED|Study Completion Phase||7||
48560361|NCT04358081|101702411|FG002|COMPLETED|Study Completion Phase||3||
48560362|NCT04358081|101702409|FG000|NOT COMPLETED|Study Completion Phase||1||
48274791|NCT02175641|100996300|FG000|NOT COMPLETED|Overall Study||35||
48274792|NCT02175641|100996301|FG001|NOT COMPLETED|Overall Study||27||
48274793|NCT02186600|100996302|FG000|STARTED|Overall Study||93||
48274794|NCT02186600|100996303|FG001|STARTED|Overall Study||91||
48274795|NCT02186600|100996304|FG002|STARTED|Overall Study||92||
48560363|NCT04358081|101702410|FG001|NOT COMPLETED|Study Completion Phase||0||
48560364|NCT04358081|101702411|FG002|NOT COMPLETED|Study Completion Phase||2||
48560365|NCT00882518|101702412|FG000|STARTED|Overall Study||196||
48560366|NCT00882518|101702413|FG001|STARTED|Overall Study||192||
48560367|NCT00882518|101702412|FG000|COMPLETED|Overall Study||158||
48560368|NCT00882518|101702413|FG001|COMPLETED|Overall Study||148||
48560369|NCT00882518|101702412|FG000|NOT COMPLETED|Overall Study||38||
48560370|NCT00882518|101702413|FG001|NOT COMPLETED|Overall Study||44||
48695649|NCT03869385|102038580|FG001|STARTED|Overall Study||218||
48695650|NCT03869385|102038579|FG000|COMPLETED|Overall Study||222||
48112062|NCT02346240|100601433|FG006|COMPLETED|Initial Period (Baseline to Week 16)||0||
48112063|NCT02346240|100601434|FG007|COMPLETED|Initial Period (Baseline to Week 16)||0||
48112064|NCT02346240|100601435|FG008|COMPLETED|Initial Period (Baseline to Week 16)||0||
48112065|NCT02346240|100601436|FG009|COMPLETED|Initial Period (Baseline to Week 16)||0||
48112066|NCT02346240|100601437|FG010|COMPLETED|Initial Period (Baseline to Week 16)||0||
48112067|NCT02346240|100601438|FG011|COMPLETED|Initial Period (Baseline to Week 16)||0||
48112068|NCT02346240|100601439|FG012|COMPLETED|Initial Period (Baseline to Week 16)||0||
48112069|NCT02346240|100601440|FG013|COMPLETED|Initial Period (Baseline to Week 16)||0||
48112070|NCT02346240|100601441|FG014|COMPLETED|Initial Period (Baseline to Week 16)||0||
48112071|NCT02346240|100601442|FG015|COMPLETED|Initial Period (Baseline to Week 16)||0||
48112072|NCT02346240|100601443|FG016|COMPLETED|Initial Period (Baseline to Week 16)||0||
48112073|NCT02346240|100601444|FG017|COMPLETED|Initial Period (Baseline to Week 16)||0||
48274796|NCT02186600|100996302|FG000|COMPLETED|Overall Study||77||
48274797|NCT02186600|100996303|FG001|COMPLETED|Overall Study||78||
48274798|NCT02186600|100996304|FG002|COMPLETED|Overall Study||72||
48274799|NCT02186600|100996302|FG000|NOT COMPLETED|Overall Study||16||
48274800|NCT02186600|100996303|FG001|NOT COMPLETED|Overall Study||13||
48274801|NCT02186600|100996304|FG002|NOT COMPLETED|Overall Study||20||
48274802|NCT02248818|100996305|FG000|STARTED|Screening||0||
48274803|NCT02248818|100996306|FG001|STARTED|Screening||0||
48274804|NCT02248818|100996307|FG002|STARTED|Screening||0||
48274805|NCT02248818|100996308|FG003|STARTED|Screening||0||
48274806|NCT02248818|100996309|FG004|STARTED|Screening||0||
48274807|NCT02248818|100996310|FG005|STARTED|Screening||0||
48274808|NCT02248818|100996311|FG006|STARTED|Screening||0||
48274809|NCT02248818|100996312|FG007|STARTED|Screening||0||
48274810|NCT02248818|100996313|FG008|STARTED|Screening||155||
48274811|NCT02248818|100996305|FG000|COMPLETED|Screening||0||
48274812|NCT02248818|100996306|FG001|COMPLETED|Screening||0||
48274813|NCT02248818|100996307|FG002|COMPLETED|Screening||0||
48274814|NCT02248818|100996308|FG003|COMPLETED|Screening||0||
48274815|NCT02248818|100996309|FG004|COMPLETED|Screening||0||
48274816|NCT02248818|100996310|FG005|COMPLETED|Screening||0||
48274817|NCT02248818|100996311|FG006|COMPLETED|Screening||0||
48274818|NCT02248818|100996312|FG007|COMPLETED|Screening||0||
48274819|NCT02248818|100996313|FG008|COMPLETED|Screening||48||
48274820|NCT02248818|100996305|FG000|NOT COMPLETED|Screening||0||
48274821|NCT02248818|100996306|FG001|NOT COMPLETED|Screening||0||
48274822|NCT02248818|100996307|FG002|NOT COMPLETED|Screening||0||
48274823|NCT02248818|100996308|FG003|NOT COMPLETED|Screening||0||
48274824|NCT02248818|100996309|FG004|NOT COMPLETED|Screening||0||
48274825|NCT02248818|100996310|FG005|NOT COMPLETED|Screening||0||
48560371|NCT04135937|101702414|FG000|STARTED|Overall Study||12||
48560372|NCT04135937|101702414|FG000|COMPLETED|Overall Study||9||
48560373|NCT04135937|101702414|FG000|NOT COMPLETED|Overall Study||3||
48560374|NCT02273388|101702415|FG000|STARTED|Overall Study||4|Started are treated|
48560375|NCT02273388|101702416|FG001|STARTED|Overall Study||3|Started are treated|
48560376|NCT02273388|101702417|FG002|STARTED|Overall Study||3|Started are treated|
48560377|NCT02273388|101702418|FG003|STARTED|Overall Study||2|Started are treated|
48560378|NCT02273388|101702419|FG004|STARTED|Overall Study||4|Started are treated|
48560379|NCT02273388|101702420|FG005|STARTED|Overall Study||3|Started are treated|
48560380|NCT02273388|101702421|FG006|STARTED|Overall Study||15|Started are treated|
48560381|NCT02273388|101702422|FG007|STARTED|Overall Study||8|Started are treated|
48560382|NCT02273388|101702423|FG008|STARTED|Overall Study||6|Started are treated|
48560383|NCT02273388|101702424|FG009|STARTED|Overall Study||5|Started are treated|
48112074|NCT02346240|100601445|FG018|COMPLETED|Initial Period (Baseline to Week 16)||0||
48274826|NCT02248818|100996311|FG006|NOT COMPLETED|Screening||0||
48274827|NCT02248818|100996312|FG007|NOT COMPLETED|Screening||0||
48274828|NCT02248818|100996313|FG008|NOT COMPLETED|Screening||107||
48274829|NCT02248818|100996305|FG000|STARTED|Randomised Study||6||
48274830|NCT02248818|100996306|FG001|STARTED|Randomised Study||6||
48112075|NCT02346240|100601446|FG019|COMPLETED|Initial Period (Baseline to Week 16)||0||
48274831|NCT02248818|100996307|FG002|STARTED|Randomised Study||6||
48274832|NCT02248818|100996308|FG003|STARTED|Randomised Study||6||
48560384|NCT02273388|101702425|FG010|STARTED|Overall Study||10|Started are treated|
48560385|NCT02273388|101702426|FG011|STARTED|Overall Study||2|Started are treated|
48560386|NCT02273388|101702415|FG000|COMPLETED|Overall Study||0||
48560387|NCT02273388|101702416|FG001|COMPLETED|Overall Study||0||
48560388|NCT02273388|101702417|FG002|COMPLETED|Overall Study||0||
48560389|NCT02273388|101702418|FG003|COMPLETED|Overall Study||0||
48560390|NCT02273388|101702419|FG004|COMPLETED|Overall Study||0||
48560391|NCT02273388|101702420|FG005|COMPLETED|Overall Study||0||
48560392|NCT02273388|101702421|FG006|COMPLETED|Overall Study||0||
48560393|NCT02273388|101702422|FG007|COMPLETED|Overall Study||0||
48560394|NCT02273388|101702423|FG008|COMPLETED|Overall Study||0||
48560395|NCT02273388|101702424|FG009|COMPLETED|Overall Study||0||
48560396|NCT02273388|101702425|FG010|COMPLETED|Overall Study||0||
48560397|NCT02273388|101702426|FG011|COMPLETED|Overall Study||0||
48695651|NCT03869385|102038580|FG001|COMPLETED|Overall Study||218||
48695652|NCT03869385|102038579|FG000|NOT COMPLETED|Overall Study||0||
48695653|NCT03869385|102038580|FG001|NOT COMPLETED|Overall Study||0||
48695654|NCT00485758|102038581|FG000|STARTED|Overall Study||454||
48695655|NCT00485758|102038582|FG001|STARTED|Overall Study||342||
48695656|NCT00485758|102038581|FG000|COMPLETED|Overall Study||298||
48695657|NCT00485758|102038582|FG001|COMPLETED|Overall Study||277||
48695658|NCT00485758|102038581|FG000|NOT COMPLETED|Overall Study||156||
48695659|NCT00485758|102038582|FG001|NOT COMPLETED|Overall Study||65||
48695660|NCT02231892|102038583|FG000|STARTED|Overall Study||17||
48695661|NCT02231892|102038584|FG001|STARTED|Overall Study||17||
48695662|NCT02231892|102038585|FG002|STARTED|Overall Study||70||
48695663|NCT02231892|102038583|FG000|Sham|Overall Study||8|All participants were randomly assigned to sham, 100% MT, or 110% MT on each of 3 Study Days.|
48695664|NCT02231892|102038584|FG001|Sham|Overall Study||5|All participants were randomly assigned to sham, 100% MT, or 110% MT on each of 3 Study Days.|
48695665|NCT02231892|102038585|FG002|Sham|Overall Study||26|All participants were randomly assigned to sham, 100% MT, or 110% MT on each of 3 Study Days.|
48695666|NCT02231892|102038583|FG000|100% MT|Overall Study||7|All participants were randomly assigned to sham, 100% MT, or 110% MT on each of 3 Study Days.|
48695667|NCT02231892|102038584|FG001|100% MT|Overall Study||6|All participants were randomly assigned to sham, 100% MT, or 110% MT on each of 3 Study Days.|
48695668|NCT02231892|102038585|FG002|100% MT|Overall Study||25|All participants were randomly assigned to sham, 100% MT, or 110% MT on each of 3 Study Days.|
48695669|NCT02231892|102038583|FG000|110% MT|Overall Study||7|All participants were randomly assigned to sham, 100% MT, or 110% MT on each of 3 Study Days.|
48695670|NCT02231892|102038584|FG001|110% MT|Overall Study||5|All participants were randomly assigned to sham, 100% MT, or 110% MT on each of 3 Study Days.|
48695671|NCT02231892|102038585|FG002|110% MT|Overall Study||27|All participants were randomly assigned to sham, 100% MT, or 110% MT on each of 3 Study Days.|
48695672|NCT02231892|102038583|FG000|COMPLETED|Overall Study||6||
48695673|NCT02231892|102038584|FG001|COMPLETED|Overall Study||5||
48695674|NCT02231892|102038585|FG002|COMPLETED|Overall Study||25||
48695675|NCT02231892|102038583|FG000|NOT COMPLETED|Overall Study||11||
48560398|NCT02273388|101702415|FG000|NOT COMPLETED|Overall Study||4||
48560399|NCT02273388|101702416|FG001|NOT COMPLETED|Overall Study||3||
48560400|NCT02273388|101702417|FG002|NOT COMPLETED|Overall Study||3||
48560401|NCT02273388|101702418|FG003|NOT COMPLETED|Overall Study||2||
48560402|NCT02273388|101702419|FG004|NOT COMPLETED|Overall Study||4||
48560403|NCT02273388|101702420|FG005|NOT COMPLETED|Overall Study||3||
48560404|NCT02273388|101702421|FG006|NOT COMPLETED|Overall Study||15||
48560405|NCT02273388|101702422|FG007|NOT COMPLETED|Overall Study||8||
48560406|NCT02273388|101702423|FG008|NOT COMPLETED|Overall Study||6||
48560407|NCT02273388|101702424|FG009|NOT COMPLETED|Overall Study||5||
48560408|NCT02273388|101702425|FG010|NOT COMPLETED|Overall Study||10||
48560409|NCT02273388|101702426|FG011|NOT COMPLETED|Overall Study||2||
48560410|NCT01366417|101702427|FG000|STARTED|Overall Study||43||
48560411|NCT01366417|101702427|FG000|Signed Informed Consent|Overall Study||43||
48560412|NCT01366417|101702427|FG000|Completed Screen Visit|Overall Study||33||
48560413|NCT01366417|101702427|FG000|Completed Treatment Visit|Overall Study||28||
48560414|NCT01366417|101702427|FG000|Completed the Study|Overall Study||28||
48560415|NCT01366417|101702427|FG000|Discontinued Prior to Treatment|Overall Study||5||
48560416|NCT01366417|101702427|FG000|Excluded From Analysis|Overall Study||3||
48560417|NCT01366417|101702427|FG000|COMPLETED|Overall Study||25||
48560418|NCT01366417|101702427|FG000|NOT COMPLETED|Overall Study||18||
48560419|NCT01153815|101702428|FG000|STARTED|Overall Study||83||
48560420|NCT01153815|101702429|FG001|STARTED|Overall Study||87||
48560421|NCT01153815|101702428|FG000|COMPLETED|Overall Study||74||
48695676|NCT02231892|102038584|FG001|NOT COMPLETED|Overall Study||12||
48695677|NCT02231892|102038585|FG002|NOT COMPLETED|Overall Study||45||
48695678|NCT04552041|102038586|FG000|STARTED|Overall Study||204||
48560422|NCT01153815|101702429|FG001|COMPLETED|Overall Study||82||
48560423|NCT01153815|101702428|FG000|NOT COMPLETED|Overall Study||9||
48560424|NCT01153815|101702429|FG001|NOT COMPLETED|Overall Study||5||
48560425|NCT03440229|101702430|FG000|STARTED|Overall Study||9||
48560426|NCT03440229|101702431|FG001|STARTED|Overall Study||7||
48560427|NCT03440229|101702430|FG000|COMPLETED|Overall Study||9||
48560428|NCT03440229|101702431|FG001|COMPLETED|Overall Study||7||
48560429|NCT03440229|101702430|FG000|NOT COMPLETED|Overall Study||0||
48560430|NCT03440229|101702431|FG001|NOT COMPLETED|Overall Study||0||
48560431|NCT02763046|101702432|FG000|STARTED|Overall Study||71||
48560432|NCT02763046|101702433|FG001|STARTED|Overall Study||70||
48560433|NCT02763046|101702434|FG002|STARTED|Overall Study||70||
48560434|NCT02763046|101702432|FG000|COMPLETED|Overall Study||62||
48274833|NCT02248818|100996309|FG004|STARTED|Randomised Study||6||
48274834|NCT02248818|100996310|FG005|STARTED|Randomised Study||8||
48274835|NCT02248818|100996311|FG006|STARTED|Randomised Study||6||
48274836|NCT02248818|100996312|FG007|STARTED|Randomised Study||4||
48274837|NCT02248818|100996313|FG008|STARTED|Randomised Study||0||
48274838|NCT02248818|100996305|FG000|COMPLETED|Randomised Study||6||
48274839|NCT02248818|100996306|FG001|COMPLETED|Randomised Study||6||
48274840|NCT02248818|100996307|FG002|COMPLETED|Randomised Study||6||
48274841|NCT02248818|100996308|FG003|COMPLETED|Randomised Study||6||
48274842|NCT02248818|100996309|FG004|COMPLETED|Randomised Study||6||
48274843|NCT02248818|100996310|FG005|COMPLETED|Randomised Study||0||
48274844|NCT02248818|100996311|FG006|COMPLETED|Randomised Study||6||
48274845|NCT02248818|100996312|FG007|COMPLETED|Randomised Study||4||
48274846|NCT02248818|100996313|FG008|COMPLETED|Randomised Study||0||
48274847|NCT02248818|100996305|FG000|NOT COMPLETED|Randomised Study||0||
48274848|NCT02248818|100996306|FG001|NOT COMPLETED|Randomised Study||0||
48274849|NCT02248818|100996307|FG002|NOT COMPLETED|Randomised Study||0||
48274850|NCT02248818|100996308|FG003|NOT COMPLETED|Randomised Study||0||
48274851|NCT02248818|100996309|FG004|NOT COMPLETED|Randomised Study||0||
48274852|NCT02248818|100996310|FG005|NOT COMPLETED|Randomised Study||8||
48274853|NCT02248818|100996311|FG006|NOT COMPLETED|Randomised Study||0||
48274854|NCT02248818|100996312|FG007|NOT COMPLETED|Randomised Study||0||
48274855|NCT02248818|100996313|FG008|NOT COMPLETED|Randomised Study||0||
48274856|NCT03098563|100996314|FG000|STARTED|Experimental Session 1||58||
48274857|NCT03098563|100996315|FG001|STARTED|Experimental Session 1||0||
48274858|NCT03098563|100996316|FG002|STARTED|Experimental Session 1||0||
48274859|NCT03098563|100996317|FG003|STARTED|Experimental Session 1||0||
48274860|NCT03098563|100996314|FG000|COMPLETED|Experimental Session 1||58||
48274861|NCT03098563|100996315|FG001|COMPLETED|Experimental Session 1||0||
48274862|NCT03098563|100996316|FG002|COMPLETED|Experimental Session 1||0||
48274863|NCT03098563|100996317|FG003|COMPLETED|Experimental Session 1||0||
48274864|NCT03098563|100996314|FG000|NOT COMPLETED|Experimental Session 1||0||
48274865|NCT03098563|100996315|FG001|NOT COMPLETED|Experimental Session 1||0||
48274866|NCT03098563|100996316|FG002|NOT COMPLETED|Experimental Session 1||0||
48274867|NCT03098563|100996317|FG003|NOT COMPLETED|Experimental Session 1||0||
48274868|NCT03098563|100996314|FG000|STARTED|Experimental Sessions 2-4||0||
48274869|NCT03098563|100996315|FG001|STARTED|Experimental Sessions 2-4||58||
48274870|NCT03098563|100996316|FG002|STARTED|Experimental Sessions 2-4||0||
48274871|NCT03098563|100996317|FG003|STARTED|Experimental Sessions 2-4||0||
48274872|NCT03098563|100996314|FG000|COMPLETED|Experimental Sessions 2-4||0||
48274873|NCT03098563|100996315|FG001|COMPLETED|Experimental Sessions 2-4||58||
48274874|NCT03098563|100996316|FG002|COMPLETED|Experimental Sessions 2-4||0||
48274875|NCT03098563|100996317|FG003|COMPLETED|Experimental Sessions 2-4||0||
48274876|NCT03098563|100996314|FG000|NOT COMPLETED|Experimental Sessions 2-4||0||
48274877|NCT03098563|100996315|FG001|NOT COMPLETED|Experimental Sessions 2-4||0||
48274878|NCT03098563|100996316|FG002|NOT COMPLETED|Experimental Sessions 2-4||0||
48274879|NCT03098563|100996317|FG003|NOT COMPLETED|Experimental Sessions 2-4||0||
48274880|NCT03098563|100996314|FG000|STARTED|Experimental Sessions 2-4||0||
48274881|NCT03098563|100996315|FG001|STARTED|Experimental Sessions 2-4||0||
48274882|NCT03098563|100996316|FG002|STARTED|Experimental Sessions 2-4||58||
48274883|NCT03098563|100996317|FG003|STARTED|Experimental Sessions 2-4||0||
48274884|NCT03098563|100996314|FG000|COMPLETED|Experimental Sessions 2-4||0||
48274885|NCT03098563|100996315|FG001|COMPLETED|Experimental Sessions 2-4||0||
48274886|NCT03098563|100996316|FG002|COMPLETED|Experimental Sessions 2-4||58||
48274887|NCT03098563|100996317|FG003|COMPLETED|Experimental Sessions 2-4||0||
48274888|NCT03098563|100996314|FG000|NOT COMPLETED|Experimental Sessions 2-4||0||
48274889|NCT03098563|100996315|FG001|NOT COMPLETED|Experimental Sessions 2-4||0||
48274890|NCT03098563|100996316|FG002|NOT COMPLETED|Experimental Sessions 2-4||0||
48274891|NCT03098563|100996317|FG003|NOT COMPLETED|Experimental Sessions 2-4||0||
48274892|NCT03098563|100996314|FG000|STARTED|Experimental Sessions 2-4||0||
48274893|NCT03098563|100996315|FG001|STARTED|Experimental Sessions 2-4||0||
48274894|NCT03098563|100996316|FG002|STARTED|Experimental Sessions 2-4||0||
48274895|NCT03098563|100996317|FG003|STARTED|Experimental Sessions 2-4||58||
48274896|NCT03098563|100996314|FG000|COMPLETED|Experimental Sessions 2-4||0||
48274897|NCT03098563|100996315|FG001|COMPLETED|Experimental Sessions 2-4||0||
48274898|NCT03098563|100996316|FG002|COMPLETED|Experimental Sessions 2-4||0||
48274899|NCT03098563|100996317|FG003|COMPLETED|Experimental Sessions 2-4||58||
48274900|NCT03098563|100996314|FG000|NOT COMPLETED|Experimental Sessions 2-4||0||
48274901|NCT03098563|100996315|FG001|NOT COMPLETED|Experimental Sessions 2-4||0||
48274902|NCT03098563|100996316|FG002|NOT COMPLETED|Experimental Sessions 2-4||0||
48274903|NCT03098563|100996317|FG003|NOT COMPLETED|Experimental Sessions 2-4||0||
48274904|NCT01281839|100996318|FG000|STARTED|Overall Study||260||
48274905|NCT01281839|100996319|FG001|STARTED|Overall Study||133||
48274906|NCT01281839|100996318|FG000|COMPLETED|Overall Study||250||
48274907|NCT01281839|100996319|FG001|COMPLETED|Overall Study||119||
48274908|NCT01281839|100996318|FG000|NOT COMPLETED|Overall Study||10||
48274909|NCT01281839|100996319|FG001|NOT COMPLETED|Overall Study||14||
48274910|NCT02783027|100996320|FG000|STARTED|Overall Study||39||
48274911|NCT02783027|100996321|FG001|STARTED|Overall Study||44||
48274912|NCT02783027|100996320|FG000|COMPLETED|Overall Study||16||
48274913|NCT02783027|100996321|FG001|COMPLETED|Overall Study||27||
48274914|NCT02783027|100996320|FG000|NOT COMPLETED|Overall Study||23||
48274915|NCT02783027|100996321|FG001|NOT COMPLETED|Overall Study||17||
48274916|NCT01305239|100996322|FG000|STARTED|Overall Study||398||
48274917|NCT01305239|100996322|FG000|Safety Set|Overall Study||397||
48274918|NCT01305239|100996322|FG000|Intent to Treat Population|Overall Study||287||
48274919|NCT01305239|100996322|FG000|COMPLETED|Overall Study||375||
48695679|NCT04552041|102038587|FG001|STARTED|Overall Study||195||
48695680|NCT04552041|102038586|FG000|COMPLETED|Overall Study||204||
48695681|NCT04552041|102038587|FG001|COMPLETED|Overall Study||195||
48695682|NCT04552041|102038586|FG000|NOT COMPLETED|Overall Study||0||
48695683|NCT04552041|102038587|FG001|NOT COMPLETED|Overall Study||0||
48695684|NCT01679600|102038588|FG000|STARTED|Overall Study||7||
48695685|NCT01679600|102038589|FG001|STARTED|Overall Study||7||
48695686|NCT01679600|102038588|FG000|COMPLETED|Overall Study||7||
48695687|NCT01679600|102038589|FG001|COMPLETED|Overall Study||7||
48695688|NCT01679600|102038588|FG000|NOT COMPLETED|Overall Study||0||
48695689|NCT01679600|102038589|FG001|NOT COMPLETED|Overall Study||0||
48695690|NCT04470050|102038590|FG000|STARTED|Opioid Maintenance Phase||29||
48695691|NCT04470050|102038591|FG001|STARTED|Opioid Maintenance Phase||35||
48695692|NCT04470050|102038592|FG002|STARTED|Opioid Maintenance Phase||31||
48695693|NCT04470050|102038593|FG003|STARTED|Opioid Maintenance Phase||32||
48695694|NCT04470050|102038594|FG004|STARTED|Opioid Maintenance Phase||40||
48695695|NCT04470050|102038595|FG005|STARTED|Opioid Maintenance Phase||33||
48695696|NCT04470050|102038596|FG006|STARTED|Opioid Maintenance Phase||25||
48695697|NCT04470050|102038590|FG000|COMPLETED|Opioid Maintenance Phase||17||
48695698|NCT04470050|102038591|FG001|COMPLETED|Opioid Maintenance Phase||17||
48695699|NCT04470050|102038592|FG002|COMPLETED|Opioid Maintenance Phase||21||
48695700|NCT04470050|102038593|FG003|COMPLETED|Opioid Maintenance Phase||19||
48695701|NCT04470050|102038594|FG004|COMPLETED|Opioid Maintenance Phase||21||
48695702|NCT04470050|102038595|FG005|COMPLETED|Opioid Maintenance Phase||15||
48695703|NCT04470050|102038596|FG006|COMPLETED|Opioid Maintenance Phase||25||
48695704|NCT04470050|102038590|FG000|NOT COMPLETED|Opioid Maintenance Phase||12||
48695705|NCT04470050|102038591|FG001|NOT COMPLETED|Opioid Maintenance Phase||18||
48695706|NCT04470050|102038592|FG002|NOT COMPLETED|Opioid Maintenance Phase||10||
48695707|NCT04470050|102038593|FG003|NOT COMPLETED|Opioid Maintenance Phase||13||
48695708|NCT04470050|102038594|FG004|NOT COMPLETED|Opioid Maintenance Phase||19||
48695709|NCT04470050|102038595|FG005|NOT COMPLETED|Opioid Maintenance Phase||18||
48695710|NCT04470050|102038596|FG006|NOT COMPLETED|Opioid Maintenance Phase||0||
48695711|NCT04470050|102038590|FG000|STARTED|Double-blind Treatment Phase||17||
48695712|NCT04470050|102038591|FG001|STARTED|Double-blind Treatment Phase||17||
48695713|NCT04470050|102038592|FG002|STARTED|Double-blind Treatment Phase||21||
48695714|NCT04470050|102038593|FG003|STARTED|Double-blind Treatment Phase||19||
48695715|NCT04470050|102038594|FG004|STARTED|Double-blind Treatment Phase||21||
48695716|NCT04470050|102038595|FG005|STARTED|Double-blind Treatment Phase||15||
48695717|NCT04470050|102038596|FG006|STARTED|Double-blind Treatment Phase||25||
48695718|NCT04470050|102038590|FG000|COMPLETED|Double-blind Treatment Phase||7||
48695719|NCT04470050|102038591|FG001|COMPLETED|Double-blind Treatment Phase||5||
48112076|NCT02346240|100601447|FG020|COMPLETED|Initial Period (Baseline to Week 16)||0||
48112077|NCT02346240|100601448|FG021|COMPLETED|Initial Period (Baseline to Week 16)||0||
48112078|NCT02346240|100601449|FG022|COMPLETED|Initial Period (Baseline to Week 16)||0||
48112079|NCT02346240|100601450|FG023|COMPLETED|Initial Period (Baseline to Week 16)||0||
48112080|NCT02346240|100601427|FG000|NOT COMPLETED|Initial Period (Baseline to Week 16)||2||
48112081|NCT02346240|100601428|FG001|NOT COMPLETED|Initial Period (Baseline to Week 16)||11||
48112082|NCT02346240|100601429|FG002|NOT COMPLETED|Initial Period (Baseline to Week 16)||6||
48112083|NCT02346240|100601430|FG003|NOT COMPLETED|Initial Period (Baseline to Week 16)||7||
48112084|NCT02346240|100601431|FG004|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
48112085|NCT02346240|100601432|FG005|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
48141407|NCT01454583|100670420|FG001|COMPLETED|2nd Year||1647||
48141408|NCT01454583|100670421|FG002|COMPLETED|2nd Year||1376||
48141409|NCT01454583|100670419|FG000|NOT COMPLETED|2nd Year||3965||
48695720|NCT04470050|102038592|FG002|COMPLETED|Double-blind Treatment Phase||6||
48695721|NCT04470050|102038593|FG003|COMPLETED|Double-blind Treatment Phase||7||
48141410|NCT01454583|100670420|FG001|NOT COMPLETED|2nd Year||1049||
48695722|NCT04470050|102038594|FG004|COMPLETED|Double-blind Treatment Phase||5||
48695723|NCT04470050|102038595|FG005|COMPLETED|Double-blind Treatment Phase||6||
48695724|NCT04470050|102038596|FG006|COMPLETED|Double-blind Treatment Phase||6||
48695725|NCT04470050|102038590|FG000|NOT COMPLETED|Double-blind Treatment Phase||10||
48695726|NCT04470050|102038591|FG001|NOT COMPLETED|Double-blind Treatment Phase||12||
48695727|NCT04470050|102038592|FG002|NOT COMPLETED|Double-blind Treatment Phase||15||
48695728|NCT04470050|102038593|FG003|NOT COMPLETED|Double-blind Treatment Phase||12||
48141411|NCT01454583|100670421|FG002|NOT COMPLETED|2nd Year||737||
48141412|NCT01454583|100670419|FG000|STARTED|3rd Year||3791||
48141413|NCT01454583|100670420|FG001|STARTED|3rd Year||982||
48141414|NCT01454583|100670421|FG002|STARTED|3rd Year||582||
48141415|NCT01454583|100670419|FG000|COMPLETED|3rd Year||1832||
48141416|NCT01454583|100670420|FG001|COMPLETED|3rd Year||470||
48141417|NCT01454583|100670421|FG002|COMPLETED|3rd Year||285||
48695729|NCT04470050|102038594|FG004|NOT COMPLETED|Double-blind Treatment Phase||16||
48695730|NCT04470050|102038595|FG005|NOT COMPLETED|Double-blind Treatment Phase||9||
48695731|NCT04470050|102038596|FG006|NOT COMPLETED|Double-blind Treatment Phase||19||
48695732|NCT03783442|102038597|FG000|STARTED|Overall Study||326||
48695733|NCT03783442|102038598|FG001|STARTED|Overall Study||323||
48695734|NCT03783442|102038597|FG000|Treated|Overall Study||324||
48695735|NCT03783442|102038598|FG001|Treated|Overall Study||321||
48560435|NCT02763046|101702433|FG001|COMPLETED|Overall Study||65||
48560436|NCT02763046|101702434|FG002|COMPLETED|Overall Study||62||
48560437|NCT02763046|101702432|FG000|NOT COMPLETED|Overall Study||9||
48560438|NCT02763046|101702433|FG001|NOT COMPLETED|Overall Study||5||
48560439|NCT02763046|101702434|FG002|NOT COMPLETED|Overall Study||8||
48560440|NCT03359850|101702435|FG000|STARTED|PK Phase (Up to Day 8)||9||
48560441|NCT03359850|101702436|FG001|STARTED|PK Phase (Up to Day 8)||8||
48560442|NCT03359850|101702435|FG000|COMPLETED|PK Phase (Up to Day 8)||8||
48560443|NCT03359850|101702436|FG001|COMPLETED|PK Phase (Up to Day 8)||7||
48560444|NCT03359850|101702435|FG000|NOT COMPLETED|PK Phase (Up to Day 8)||1||
48560445|NCT03359850|101702436|FG001|NOT COMPLETED|PK Phase (Up to Day 8)||1||
48560446|NCT03359850|101702435|FG000|STARTED|Extension Phase (Up to 28 Months)||8||
48560447|NCT03359850|101702436|FG001|STARTED|Extension Phase (Up to 28 Months)||7||
48560448|NCT03359850|101702435|FG000|COMPLETED|Extension Phase (Up to 28 Months)||0||
48560449|NCT03359850|101702436|FG001|COMPLETED|Extension Phase (Up to 28 Months)||1||
48560450|NCT03359850|101702435|FG000|NOT COMPLETED|Extension Phase (Up to 28 Months)||8||
48560451|NCT03359850|101702436|FG001|NOT COMPLETED|Extension Phase (Up to 28 Months)||6||
48560452|NCT00289848|101702437|FG000|STARTED|Overall Study||352||
48560453|NCT00289848|101702438|FG001|STARTED|Overall Study||178||
48560454|NCT00289848|101702437|FG000|COMPLETED|Overall Study||306||
48560455|NCT00289848|101702438|FG001|COMPLETED|Overall Study||133||
48560456|NCT00289848|101702437|FG000|NOT COMPLETED|Overall Study||46||
48560457|NCT00289848|101702438|FG001|NOT COMPLETED|Overall Study||45||
48560458|NCT03875508|101702439|FG000|STARTED|Overall Study||108||
48560459|NCT03875508|101702439|FG000|COMPLETED|Overall Study||96||
48560460|NCT03875508|101702439|FG000|NOT COMPLETED|Overall Study||12||
48560461|NCT03104192|101702440|FG000|STARTED|Overall Study||9||
48560462|NCT03104192|101702441|FG001|STARTED|Overall Study||27||
48560463|NCT03104192|101702442|FG002|STARTED|Overall Study||16||
48560464|NCT03104192|101702443|FG003|STARTED|Overall Study||17||
48560465|NCT03104192|101702440|FG000|COMPLETED|Overall Study||9||
48560466|NCT03104192|101702441|FG001|COMPLETED|Overall Study||23||
48560467|NCT03104192|101702442|FG002|COMPLETED|Overall Study||14||
48560468|NCT03104192|101702443|FG003|COMPLETED|Overall Study||14||
48560469|NCT03104192|101702440|FG000|NOT COMPLETED|Overall Study||0||
48560470|NCT03104192|101702441|FG001|NOT COMPLETED|Overall Study||4||
48560471|NCT03104192|101702442|FG002|NOT COMPLETED|Overall Study||2||
48560472|NCT03104192|101702443|FG003|NOT COMPLETED|Overall Study||3||
48560473|NCT03134248|101702444|FG000|STARTED|Week 1||7||
48695736|NCT03783442|102038597|FG000|COMPLETED|Overall Study||0||
48112086|NCT02346240|100601433|FG006|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
48112087|NCT02346240|100601434|FG007|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
48112088|NCT02346240|100601435|FG008|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
48112089|NCT02346240|100601436|FG009|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
48112090|NCT02346240|100601437|FG010|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
48112091|NCT02346240|100601438|FG011|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
48112092|NCT02346240|100601439|FG012|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
48112093|NCT02346240|100601440|FG013|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
48560474|NCT03134248|101702445|FG001|STARTED|Week 1||8||
48560475|NCT03134248|101702446|FG002|STARTED|Week 1||9||
48560476|NCT03134248|101702447|FG003|STARTED|Week 1||7||
48560477|NCT03134248|101702448|FG004|STARTED|Week 1||9||
48560478|NCT03134248|101702449|FG005|STARTED|Week 1||9||
48560479|NCT03134248|101702444|FG000|COMPLETED|Week 1||7||
48560480|NCT03134248|101702445|FG001|COMPLETED|Week 1||8||
48560481|NCT03134248|101702446|FG002|COMPLETED|Week 1||9||
48560482|NCT03134248|101702447|FG003|COMPLETED|Week 1||7||
48560483|NCT03134248|101702448|FG004|COMPLETED|Week 1||9||
48560484|NCT03134248|101702449|FG005|COMPLETED|Week 1||9||
48112094|NCT02346240|100601441|FG014|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
48141418|NCT01454583|100670419|FG000|NOT COMPLETED|3rd Year||1959||
48560485|NCT03134248|101702444|FG000|NOT COMPLETED|Week 1||0||
48560486|NCT03134248|101702445|FG001|NOT COMPLETED|Week 1||0||
48560487|NCT03134248|101702446|FG002|NOT COMPLETED|Week 1||0||
48560488|NCT03134248|101702447|FG003|NOT COMPLETED|Week 1||0||
48560489|NCT03134248|101702448|FG004|NOT COMPLETED|Week 1||0||
48560490|NCT03134248|101702449|FG005|NOT COMPLETED|Week 1||0||
48560491|NCT03134248|101702444|FG000|STARTED|Week 2||7||
48560492|NCT03134248|101702445|FG001|STARTED|Week 2||8||
48560493|NCT03134248|101702446|FG002|STARTED|Week 2||9||
48560494|NCT03134248|101702447|FG003|STARTED|Week 2||7||
48560495|NCT03134248|101702448|FG004|STARTED|Week 2||9||
48560496|NCT03134248|101702449|FG005|STARTED|Week 2||9||
48560497|NCT03134248|101702444|FG000|COMPLETED|Week 2||7||
48560498|NCT03134248|101702445|FG001|COMPLETED|Week 2||8||
48560499|NCT03134248|101702446|FG002|COMPLETED|Week 2||9||
48560500|NCT03134248|101702447|FG003|COMPLETED|Week 2||7||
48560501|NCT03134248|101702448|FG004|COMPLETED|Week 2||9||
48560502|NCT03134248|101702449|FG005|COMPLETED|Week 2||9||
48560503|NCT03134248|101702444|FG000|NOT COMPLETED|Week 2||0||
48560504|NCT03134248|101702445|FG001|NOT COMPLETED|Week 2||0||
48560505|NCT03134248|101702446|FG002|NOT COMPLETED|Week 2||0||
48560506|NCT03134248|101702447|FG003|NOT COMPLETED|Week 2||0||
48274920|NCT01305239|100996322|FG000|NOT COMPLETED|Overall Study||23||
48274921|NCT00324116|100996323|FG000|STARTED|Overall Study||81||
48274922|NCT00324116|100996323|FG000|COMPLETED|Overall Study||49||
48274923|NCT00324116|100996323|FG000|NOT COMPLETED|Overall Study||32||
48274924|NCT02119442|100996324|FG000|STARTED|Overall Study||90||
48274925|NCT02119442|100996324|FG000|COMPLETED|Overall Study||90||
48274926|NCT02119442|100996324|FG000|NOT COMPLETED|Overall Study||0||
48274927|NCT03921723|100996325|FG000|STARTED|Period 1 (4 Days)||22||
48274928|NCT03921723|100996325|FG000|COMPLETED|Period 1 (4 Days)||22||
48560507|NCT03134248|101702448|FG004|NOT COMPLETED|Week 2||0||
48274929|NCT03921723|100996325|FG000|NOT COMPLETED|Period 1 (4 Days)||0||
48274930|NCT03921723|100996325|FG000|STARTED|Period 2 (4 Days)||22||
48274931|NCT03921723|100996325|FG000|COMPLETED|Period 2 (4 Days)||19||
48274932|NCT03921723|100996325|FG000|NOT COMPLETED|Period 2 (4 Days)||3||
48274933|NCT03921723|100996325|FG000|STARTED|Period 3 (4 Days)||19||
48274934|NCT03921723|100996325|FG000|COMPLETED|Period 3 (4 Days)||18||
48274935|NCT03921723|100996325|FG000|NOT COMPLETED|Period 3 (4 Days)||1||
48274936|NCT00951015|100996326|FG000|STARTED|Randomization Phase 96 Week||53||
48274937|NCT00951015|100996327|FG001|STARTED|Randomization Phase 96 Week||51||
48274938|NCT00951015|100996328|FG002|STARTED|Randomization Phase 96 Week||51||
48274939|NCT00951015|100996329|FG003|STARTED|Randomization Phase 96 Week||50||
48274940|NCT00951015|100996330|FG004|STARTED|Randomization Phase 96 Week||0||
48274941|NCT00951015|100996326|FG000|COMPLETED|Randomization Phase 96 Week||48||
48274942|NCT00951015|100996327|FG001|COMPLETED|Randomization Phase 96 Week||44||
48274943|NCT00951015|100996328|FG002|COMPLETED|Randomization Phase 96 Week||46||
48274944|NCT00951015|100996329|FG003|COMPLETED|Randomization Phase 96 Week||40||
48274945|NCT00951015|100996330|FG004|COMPLETED|Randomization Phase 96 Week||0||
48274946|NCT00951015|100996326|FG000|NOT COMPLETED|Randomization Phase 96 Week||5||
48274947|NCT00951015|100996327|FG001|NOT COMPLETED|Randomization Phase 96 Week||7||
48274948|NCT00951015|100996328|FG002|NOT COMPLETED|Randomization Phase 96 Week||5||
48274949|NCT00951015|100996329|FG003|NOT COMPLETED|Randomization Phase 96 Week||10||
48274950|NCT00951015|100996330|FG004|NOT COMPLETED|Randomization Phase 96 Week||0||
48274951|NCT00951015|100996326|FG000|STARTED|Open-label Phase||0||
48274952|NCT00951015|100996327|FG001|STARTED|Open-label Phase||0||
48274953|NCT00951015|100996328|FG002|STARTED|Open-label Phase||0||
48274954|NCT00951015|100996329|FG003|STARTED|Open-label Phase||0||
48274955|NCT00951015|100996330|FG004|STARTED|Open-label Phase||138||
48274956|NCT00951015|100996326|FG000|COMPLETED|Open-label Phase||0||
48274957|NCT00951015|100996327|FG001|COMPLETED|Open-label Phase||0||
48274958|NCT00951015|100996328|FG002|COMPLETED|Open-label Phase||0||
48274959|NCT00951015|100996329|FG003|COMPLETED|Open-label Phase||0||
48274960|NCT00951015|100996330|FG004|COMPLETED|Open-label Phase||88||
48274961|NCT00951015|100996326|FG000|NOT COMPLETED|Open-label Phase||0||
48274962|NCT00951015|100996327|FG001|NOT COMPLETED|Open-label Phase||0||
48274963|NCT00951015|100996328|FG002|NOT COMPLETED|Open-label Phase||0||
48274964|NCT00951015|100996329|FG003|NOT COMPLETED|Open-label Phase||0||
48274965|NCT00951015|100996330|FG004|NOT COMPLETED|Open-label Phase||50||
48274966|NCT02971761|100996331|FG000|STARTED|Overall Study||18||
48274967|NCT02971761|100996331|FG000|COMPLETED|Overall Study||16||
48274968|NCT02971761|100996331|FG000|NOT COMPLETED|Overall Study||2||
48274969|NCT04927247|100996332|FG000|STARTED|Overall Study||37||
48274970|NCT04927247|100996333|FG001|STARTED|Overall Study||35||
48274971|NCT04927247|100996332|FG000|COMPLETED|Overall Study||34||
48393108|NCT02703987|101291508|FG000|COMPLETED|Washout (Minimum 5 Days)||13||
48560508|NCT03134248|101702449|FG005|NOT COMPLETED|Week 2||0||
48560509|NCT03134248|101702444|FG000|STARTED|Week 3||7||
48560510|NCT03134248|101702445|FG001|STARTED|Week 3||8||
48560511|NCT03134248|101702446|FG002|STARTED|Week 3||9||
48560512|NCT03134248|101702447|FG003|STARTED|Week 3||7||
48274972|NCT04927247|100996333|FG001|COMPLETED|Overall Study||33||
48560513|NCT03134248|101702448|FG004|STARTED|Week 3||9||
48560514|NCT03134248|101702449|FG005|STARTED|Week 3||9||
48560515|NCT03134248|101702444|FG000|COMPLETED|Week 3||7||
48274973|NCT04927247|100996332|FG000|NOT COMPLETED|Overall Study||3||
48274974|NCT04927247|100996333|FG001|NOT COMPLETED|Overall Study||2||
48274975|NCT01399697|100996334|FG000|STARTED|Overall Study||96||
48274976|NCT01399697|100996335|FG001|STARTED|Overall Study||83||
48274977|NCT01399697|100996336|FG002|STARTED|Overall Study||82||
48274978|NCT01399697|100996334|FG000|COMPLETED|Overall Study||55||
48274979|NCT01399697|100996335|FG001|COMPLETED|Overall Study||80||
48560516|NCT03134248|101702445|FG001|COMPLETED|Week 3||8||
48560517|NCT03134248|101702446|FG002|COMPLETED|Week 3||9||
48560518|NCT03134248|101702447|FG003|COMPLETED|Week 3||7||
48560519|NCT03134248|101702448|FG004|COMPLETED|Week 3||9||
48560520|NCT03134248|101702449|FG005|COMPLETED|Week 3||9||
48274980|NCT01399697|100996336|FG002|COMPLETED|Overall Study||78||
48112095|NCT02346240|100601442|FG015|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
48112096|NCT02346240|100601443|FG016|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
48112097|NCT02346240|100601444|FG017|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
48112098|NCT02346240|100601445|FG018|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
48112099|NCT02346240|100601446|FG019|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
48112100|NCT02346240|100601447|FG020|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
48112101|NCT02346240|100601448|FG021|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
48112102|NCT02346240|100601449|FG022|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
48112103|NCT02346240|100601450|FG023|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
48112104|NCT02346240|100601427|FG000|STARTED|Maintenance Period (Week 16 to Week 48)||0||
48112105|NCT02346240|100601428|FG001|STARTED|Maintenance Period (Week 16 to Week 48)||0||
48112106|NCT02346240|100601429|FG002|STARTED|Maintenance Period (Week 16 to Week 48)||0||
48112107|NCT02346240|100601430|FG003|STARTED|Maintenance Period (Week 16 to Week 48)||0||
48112108|NCT02346240|100601431|FG004|STARTED|Maintenance Period (Week 16 to Week 48)||2||
48112109|NCT02346240|100601432|FG005|STARTED|Maintenance Period (Week 16 to Week 48)||24||
48112110|NCT02346240|100601433|FG006|STARTED|Maintenance Period (Week 16 to Week 48)||50||
48112111|NCT02346240|100601434|FG007|STARTED|Maintenance Period (Week 16 to Week 48)||22||
48112112|NCT02346240|100601435|FG008|STARTED|Maintenance Period (Week 16 to Week 48)||44||
48112113|NCT02346240|100601436|FG009|STARTED|Maintenance Period (Week 16 to Week 48)||44||
48112114|NCT02346240|100601437|FG010|STARTED|Maintenance Period (Week 16 to Week 48)||25||
48112115|NCT02346240|100601438|FG011|STARTED|Maintenance Period (Week 16 to Week 48)||50||
48112116|NCT02346240|100601439|FG012|STARTED|Maintenance Period (Week 16 to Week 48)||49||
48112117|NCT02346240|100601440|FG013|STARTED|Maintenance Period (Week 16 to Week 48)||53||
48112118|NCT02346240|100601441|FG014|STARTED|Maintenance Period (Week 16 to Week 48)||85||
48560521|NCT03134248|101702444|FG000|NOT COMPLETED|Week 3||0||
48560522|NCT03134248|101702445|FG001|NOT COMPLETED|Week 3||0||
48560523|NCT03134248|101702446|FG002|NOT COMPLETED|Week 3||0||
48560524|NCT03134248|101702447|FG003|NOT COMPLETED|Week 3||0||
48560525|NCT03134248|101702448|FG004|NOT COMPLETED|Week 3||0||
48274981|NCT01399697|100996334|FG000|NOT COMPLETED|Overall Study||41||
48274982|NCT01399697|100996335|FG001|NOT COMPLETED|Overall Study||3||
48274983|NCT01399697|100996336|FG002|NOT COMPLETED|Overall Study||4||
48274984|NCT00127205|100996337|FG000|STARTED|Overall Study||2262||
48274985|NCT00127205|100996338|FG001|STARTED|Overall Study||2268||
48560526|NCT03134248|101702449|FG005|NOT COMPLETED|Week 3||0||
48560527|NCT01269918|101702450|FG000|STARTED|Overall Study||71||
48560528|NCT01269918|101702451|FG001|STARTED|Overall Study||71||
48560529|NCT01269918|101702450|FG000|COMPLETED|Overall Study||71||
48560530|NCT01269918|101702451|FG001|COMPLETED|Overall Study||68||
48560531|NCT01269918|101702450|FG000|NOT COMPLETED|Overall Study||0||
48112119|NCT02346240|100601442|FG015|STARTED|Maintenance Period (Week 16 to Week 48)||49||
48560532|NCT01269918|101702451|FG001|NOT COMPLETED|Overall Study||3||
48560533|NCT00764881|101702452|FG000|STARTED|Overall Study||108||
48560534|NCT00764881|101702453|FG001|STARTED|Overall Study||109||
48560535|NCT00764881|101702452|FG000|Subjects Received Treatment|Overall Study||106||
48560536|NCT00764881|101702453|FG001|Subjects Received Treatment|Overall Study||107||
48560537|NCT00764881|101702452|FG000|COMPLETED|Overall Study||92||
48560538|NCT00764881|101702453|FG001|COMPLETED|Overall Study||99||
48560539|NCT00764881|101702452|FG000|NOT COMPLETED|Overall Study||16||
48560540|NCT00764881|101702453|FG001|NOT COMPLETED|Overall Study||10||
48560541|NCT01766076|101702454|FG000|STARTED|Overall Study||15||
48112120|NCT02346240|100601443|FG016|STARTED|Maintenance Period (Week 16 to Week 48)||36||
48274986|NCT00127205|100996339|FG002|STARTED|Overall Study||1567||
48274987|NCT00127205|100996337|FG000|COMPLETED|Overall Study||1433||
48393109|NCT02703987|101291509|FG001|COMPLETED|Washout (Minimum 5 Days)||11||
48393110|NCT02703987|101291508|FG000|NOT COMPLETED|Washout (Minimum 5 Days)||0||
48112121|NCT02346240|100601444|FG017|STARTED|Maintenance Period (Week 16 to Week 48)||0||
48112122|NCT02346240|100601445|FG018|STARTED|Maintenance Period (Week 16 to Week 48)||0||
48112123|NCT02346240|100601446|FG019|STARTED|Maintenance Period (Week 16 to Week 48)||0||
48274988|NCT00127205|100996338|FG001|COMPLETED|Overall Study||1295||
48274989|NCT00127205|100996339|FG002|COMPLETED|Overall Study||955||
48274990|NCT00127205|100996337|FG000|NOT COMPLETED|Overall Study||829||
48393111|NCT02703987|101291509|FG001|NOT COMPLETED|Washout (Minimum 5 Days)||0||
48393112|NCT02703987|101291508|FG000|STARTED|Visit 4 Intervention (1 Day)||13||
48393113|NCT02703987|101291509|FG001|STARTED|Visit 4 Intervention (1 Day)||11||
48560542|NCT01766076|101702455|FG001|STARTED|Overall Study||15||
48560543|NCT01766076|101702454|FG000|COMPLETED|Overall Study||15||
48274991|NCT00127205|100996338|FG001|NOT COMPLETED|Overall Study||973||
48274992|NCT00127205|100996339|FG002|NOT COMPLETED|Overall Study||612||
48393114|NCT02703987|101291508|FG000|COMPLETED|Visit 4 Intervention (1 Day)||12||
48560544|NCT01766076|101702455|FG001|COMPLETED|Overall Study||15||
48560545|NCT01766076|101702454|FG000|NOT COMPLETED|Overall Study||0||
48560546|NCT01766076|101702455|FG001|NOT COMPLETED|Overall Study||0||
48393115|NCT02703987|101291509|FG001|COMPLETED|Visit 4 Intervention (1 Day)||10||
48393116|NCT02703987|101291508|FG000|NOT COMPLETED|Visit 4 Intervention (1 Day)||1||
48393117|NCT02703987|101291509|FG001|NOT COMPLETED|Visit 4 Intervention (1 Day)||1||
48393118|NCT00966693|101291510|FG000|STARTED|Overall Study||3||
48560547|NCT02090088|101702456|FG000|STARTED|Overall Study||4||
48560548|NCT02090088|101702456|FG000|Gave Birth|Overall Study||4||
48560549|NCT02090088|101702456|FG000|COMPLETED|Overall Study||4||
48560550|NCT02090088|101702456|FG000|NOT COMPLETED|Overall Study||0||
48560551|NCT03983980|101702457|FG000|STARTED|Overall Study||343||
48560552|NCT03983980|101702458|FG001|STARTED|Overall Study||172||
48560553|NCT03983980|101702457|FG000|COMPLETED|Overall Study||282||
48560554|NCT03983980|101702458|FG001|COMPLETED|Overall Study||142||
48560555|NCT03983980|101702457|FG000|NOT COMPLETED|Overall Study||61||
48560556|NCT03983980|101702458|FG001|NOT COMPLETED|Overall Study||30||
48560557|NCT00459355|101702459|FG000|STARTED|Overall Study||140||
48560558|NCT00459355|101702460|FG001|STARTED|Overall Study||114||
48560559|NCT00459355|101702459|FG000|COMPLETED|Overall Study||120||
48560560|NCT00459355|101702460|FG001|COMPLETED|Overall Study||96||
48560561|NCT00459355|101702459|FG000|NOT COMPLETED|Overall Study||20||
48560562|NCT00459355|101702460|FG001|NOT COMPLETED|Overall Study||18||
48560563|NCT02044380|101702461|FG000|STARTED|Overall Study||14||
48560564|NCT02044380|101702461|FG000|COMPLETED|Overall Study||14||
48560565|NCT02044380|101702461|FG000|NOT COMPLETED|Overall Study||0||
48560566|NCT02817763|101702462|FG000|STARTED|Overall Study||20||
48560567|NCT02817763|101702463|FG001|STARTED|Overall Study||20||
48560568|NCT02817763|101702462|FG000|COMPLETED|Overall Study||20||
48560569|NCT02817763|101702463|FG001|COMPLETED|Overall Study||20||
48560570|NCT02817763|101702462|FG000|NOT COMPLETED|Overall Study||0||
48560571|NCT02817763|101702463|FG001|NOT COMPLETED|Overall Study||0||
48560572|NCT03866577|101702464|FG000|STARTED|Overall Study||7||
48560573|NCT03866577|101702465|FG001|STARTED|Overall Study||3||
48393119|NCT00966693|101291511|FG001|STARTED|Overall Study||3||
48393120|NCT00966693|101291512|FG002|STARTED|Overall Study||9||
48393121|NCT00966693|101291513|FG003|STARTED|Overall Study||49||
48560574|NCT03866577|101702466|FG002|STARTED|Overall Study||3||
48560575|NCT03866577|101702467|FG003|STARTED|Overall Study||3||
48560576|NCT03866577|101702468|FG004|STARTED|Overall Study||3||
48560577|NCT03866577|101702469|FG005|STARTED|Overall Study||3||
48560578|NCT03866577|101702470|FG006|STARTED|Overall Study||3||
48560579|NCT03866577|101702471|FG007|STARTED|Overall Study||2||
48560580|NCT03866577|101702472|FG008|STARTED|Overall Study||5||
48560581|NCT03866577|101702473|FG009|STARTED|Overall Study||5||
48560582|NCT03866577|101702474|FG010|STARTED|Overall Study||2||
48560583|NCT03866577|101702475|FG011|STARTED|Overall Study||6||
48560584|NCT03866577|101702476|FG012|STARTED|Overall Study||5||
48560585|NCT03866577|101702464|FG000|COMPLETED|Overall Study||7||
48560586|NCT03866577|101702465|FG001|COMPLETED|Overall Study||3||
48560587|NCT03866577|101702466|FG002|COMPLETED|Overall Study||3||
48560588|NCT03866577|101702467|FG003|COMPLETED|Overall Study||3||
48560589|NCT03866577|101702468|FG004|COMPLETED|Overall Study||3||
48560590|NCT03866577|101702469|FG005|COMPLETED|Overall Study||3||
48560591|NCT03866577|101702470|FG006|COMPLETED|Overall Study||3||
48560592|NCT03866577|101702471|FG007|COMPLETED|Overall Study||2||
48560593|NCT03866577|101702472|FG008|COMPLETED|Overall Study||4||
48560594|NCT03866577|101702473|FG009|COMPLETED|Overall Study||3||
48560595|NCT03866577|101702474|FG010|COMPLETED|Overall Study||2||
48560596|NCT03866577|101702475|FG011|COMPLETED|Overall Study||5||
48560597|NCT03866577|101702476|FG012|COMPLETED|Overall Study||5||
48560598|NCT03866577|101702464|FG000|NOT COMPLETED|Overall Study||0||
48560599|NCT03866577|101702465|FG001|NOT COMPLETED|Overall Study||0||
48393122|NCT00966693|101291510|FG000|Phase 1 Completed|Overall Study||2||
48560600|NCT03866577|101702466|FG002|NOT COMPLETED|Overall Study||0||
48560601|NCT03866577|101702467|FG003|NOT COMPLETED|Overall Study||0||
48560602|NCT03866577|101702468|FG004|NOT COMPLETED|Overall Study||0||
48560603|NCT03866577|101702469|FG005|NOT COMPLETED|Overall Study||0||
48560604|NCT03866577|101702470|FG006|NOT COMPLETED|Overall Study||0||
48560605|NCT03866577|101702471|FG007|NOT COMPLETED|Overall Study||0||
48560606|NCT03866577|101702472|FG008|NOT COMPLETED|Overall Study||1||
48560607|NCT03866577|101702473|FG009|NOT COMPLETED|Overall Study||2||
48560608|NCT03866577|101702474|FG010|NOT COMPLETED|Overall Study||0||
48560609|NCT03866577|101702475|FG011|NOT COMPLETED|Overall Study||1||
48560610|NCT03866577|101702476|FG012|NOT COMPLETED|Overall Study||0||
48560611|NCT00987337|101702477|FG000|STARTED|Overall Study||96||
48560612|NCT00987337|101702478|FG001|STARTED|Overall Study||96||
48560613|NCT00987337|101702479|FG002|STARTED|Overall Study||96||
48560614|NCT00987337|101702477|FG000|COMPLETED|Overall Study||39||
48560615|NCT00987337|101702478|FG001|COMPLETED|Overall Study||41||
48560616|NCT00987337|101702479|FG002|COMPLETED|Overall Study||45||
48560617|NCT00987337|101702477|FG000|NOT COMPLETED|Overall Study||57||
48560618|NCT00987337|101702478|FG001|NOT COMPLETED|Overall Study||55||
48560619|NCT00987337|101702479|FG002|NOT COMPLETED|Overall Study||51||
48560620|NCT00129389|101702480|FG000|STARTED|Overall Study||974||
48560621|NCT00129389|101702481|FG001|STARTED|Overall Study||951||
48560622|NCT00129389|101702480|FG000|COMPLETED|Overall Study||941||
48560623|NCT00129389|101702481|FG001|COMPLETED|Overall Study||811||
48560624|NCT00129389|101702480|FG000|NOT COMPLETED|Overall Study||33||
48560625|NCT00129389|101702481|FG001|NOT COMPLETED|Overall Study||140||
48560626|NCT02923232|101702482|FG000|STARTED|Overall Study||52||
48560627|NCT02923232|101702482|FG000|COMPLETED|Overall Study||52||
48560628|NCT02923232|101702482|FG000|NOT COMPLETED|Overall Study||0||
48560629|NCT03514459|101702483|FG000|STARTED|Overall Study||0||10
48560630|NCT03514459|101702484|FG001|STARTED|Overall Study||0||10
48560631|NCT03514459|101702483|FG000|COMPLETED|Overall Study||0||10
48560632|NCT03514459|101702484|FG001|COMPLETED|Overall Study||0||10
48560633|NCT03514459|101702483|FG000|NOT COMPLETED|Overall Study||0||0
48560634|NCT03514459|101702484|FG001|NOT COMPLETED|Overall Study||0||0
48560635|NCT01431079|101702485|FG000|STARTED|Overall Study||45||
48560636|NCT01431079|101702486|FG001|STARTED|Overall Study||45||
48560637|NCT01431079|101702485|FG000|Post-test|Overall Study||45||
48560638|NCT01431079|101702486|FG001|Post-test|Overall Study||45||
48560639|NCT01431079|101702485|FG000|COMPLETED|Overall Study||10||
48560640|NCT01431079|101702486|FG001|COMPLETED|Overall Study||6||
48560641|NCT01431079|101702485|FG000|NOT COMPLETED|Overall Study||35||
48560642|NCT01431079|101702486|FG001|NOT COMPLETED|Overall Study||39||
48560643|NCT01608100|101702487|FG000|STARTED|Overall Study||1101||
48112124|NCT02346240|100601447|FG020|STARTED|Maintenance Period (Week 16 to Week 48)||0||
48112125|NCT02346240|100601448|FG021|STARTED|Maintenance Period (Week 16 to Week 48)||0||
48112126|NCT02346240|100601449|FG022|STARTED|Maintenance Period (Week 16 to Week 48)||0||
48112127|NCT02346240|100601450|FG023|STARTED|Maintenance Period (Week 16 to Week 48)||0||
48112128|NCT02346240|100601427|FG000|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0||
48560644|NCT01608100|101702487|FG000|COMPLETED|Overall Study||1101||
48560645|NCT01608100|101702487|FG000|NOT COMPLETED|Overall Study||0||
48560646|NCT00204490|101702488|FG000|STARTED|Enrollment/Allocation of Qualified Women||99||
48560647|NCT00204490|101702489|FG001|STARTED|Enrollment/Allocation of Qualified Women||98||
48560648|NCT00204490|101702488|FG000|COMPLETED|Enrollment/Allocation of Qualified Women||99||
48112129|NCT02346240|100601428|FG001|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0||
48112130|NCT02346240|100601429|FG002|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0||
48112131|NCT02346240|100601430|FG003|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0||
48112132|NCT02346240|100601431|FG004|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||2||
48112133|NCT02346240|100601432|FG005|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||23||
48112134|NCT02346240|100601433|FG006|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||48||
48560649|NCT00204490|101702489|FG001|COMPLETED|Enrollment/Allocation of Qualified Women||98||
48560650|NCT00204490|101702488|FG000|NOT COMPLETED|Enrollment/Allocation of Qualified Women||0||
48560651|NCT00204490|101702489|FG001|NOT COMPLETED|Enrollment/Allocation of Qualified Women||0||
48560652|NCT00204490|101702488|FG000|STARTED|Follow-up <1 Year||99||
48560653|NCT00204490|101702489|FG001|STARTED|Follow-up <1 Year||98||
48560654|NCT00204490|101702488|FG000|COMPLETED|Follow-up <1 Year||83||
48560655|NCT00204490|101702489|FG001|COMPLETED|Follow-up <1 Year||83||
48560656|NCT00204490|101702488|FG000|NOT COMPLETED|Follow-up <1 Year||16||
48560657|NCT00204490|101702489|FG001|NOT COMPLETED|Follow-up <1 Year||15||
48560658|NCT00204490|101702488|FG000|STARTED|Follow-up >1 to <2 Years||83||
48560659|NCT00204490|101702489|FG001|STARTED|Follow-up >1 to <2 Years||83||
48560660|NCT00204490|101702488|FG000|COMPLETED|Follow-up >1 to <2 Years||68||
48560661|NCT00204490|101702489|FG001|COMPLETED|Follow-up >1 to <2 Years||67||
48560662|NCT00204490|101702488|FG000|NOT COMPLETED|Follow-up >1 to <2 Years||15||
48560663|NCT00204490|101702489|FG001|NOT COMPLETED|Follow-up >1 to <2 Years||16||
48560664|NCT00204490|101702488|FG000|STARTED|Follow-up 2 Years||68||
48560665|NCT00204490|101702489|FG001|STARTED|Follow-up 2 Years||67||
48560666|NCT00204490|101702488|FG000|COMPLETED|Follow-up 2 Years||50||
48560667|NCT00204490|101702489|FG001|COMPLETED|Follow-up 2 Years||47||
48560668|NCT00204490|101702488|FG000|NOT COMPLETED|Follow-up 2 Years||18||
48560669|NCT00204490|101702489|FG001|NOT COMPLETED|Follow-up 2 Years||20||
48560670|NCT02090725|101702490|FG000|STARTED|Overall Study||4||
48560671|NCT02090725|101702490|FG000|COMPLETED|Overall Study||0||
48560672|NCT02090725|101702490|FG000|NOT COMPLETED|Overall Study||4||
48560673|NCT00115076|101702491|FG000|STARTED|Overall Study||30||
48560674|NCT00115076|101702491|FG000|COMPLETED|Overall Study||30||
48560675|NCT00115076|101702491|FG000|NOT COMPLETED|Overall Study||0||
48560676|NCT03055624|101702492|FG000|STARTED|Overall Study||9|9 patients enrolled in the study and underwent the PAE procedure.|
48560677|NCT03055624|101702492|FG000|COMPLETED|Overall Study||0|The device received FDA IDE approval during the study. The study was closed at that time.|
48560678|NCT03055624|101702492|FG000|NOT COMPLETED|Overall Study||9||
48560679|NCT04055740|101702493|FG000|STARTED|Overall Study||31||
48560680|NCT04055740|101702493|FG000|COMPLETED|Overall Study||31||
48274993|NCT02001064|100996340|FG000|STARTED|Overall Study||30||
48274994|NCT02001064|100996341|FG001|STARTED|Overall Study||30||
48274995|NCT02001064|100996340|FG000|COMPLETED|Overall Study||28||
48274996|NCT02001064|100996341|FG001|COMPLETED|Overall Study||29||
48274997|NCT02001064|100996340|FG000|NOT COMPLETED|Overall Study||2||
48274998|NCT02001064|100996341|FG001|NOT COMPLETED|Overall Study||1||
48274999|NCT02369068|100996342|FG000|STARTED|1 Month||10||
48275000|NCT02369068|100996343|FG001|STARTED|1 Month||11||
48275001|NCT02369068|100996342|FG000|COMPLETED|1 Month||9||
48275002|NCT02369068|100996343|FG001|COMPLETED|1 Month||10||
48275003|NCT02369068|100996342|FG000|NOT COMPLETED|1 Month||1||
48275004|NCT02369068|100996343|FG001|NOT COMPLETED|1 Month||1||
48275005|NCT02369068|100996342|FG000|STARTED|3 Months||9||
48560681|NCT04055740|101702493|FG000|NOT COMPLETED|Overall Study||0||
48560682|NCT03627546|101702494|FG000|STARTED|Overall Study||15||
48560683|NCT03627546|101702495|FG001|STARTED|Overall Study||11||
48560684|NCT03627546|101702496|FG002|STARTED|Overall Study||13||
48560685|NCT03627546|101702494|FG000|COMPLETED|Overall Study||14||
48560686|NCT03627546|101702495|FG001|COMPLETED|Overall Study||11||
48560687|NCT03627546|101702496|FG002|COMPLETED|Overall Study||0||
48560688|NCT03627546|101702494|FG000|NOT COMPLETED|Overall Study||1||
48560689|NCT03627546|101702495|FG001|NOT COMPLETED|Overall Study||0||
48560690|NCT03627546|101702496|FG002|NOT COMPLETED|Overall Study||13||
48560691|NCT03640312|101702497|FG000|STARTED|Overall Study||32||
48560692|NCT03640312|101702498|FG001|STARTED|Overall Study||30||
48560693|NCT03640312|101702497|FG000|6 Week Follow Up|Overall Study||32||
48560694|NCT03640312|101702498|FG001|6 Week Follow Up|Overall Study||28||
48560695|NCT03640312|101702497|FG000|COMPLETED|Overall Study||29||
48560696|NCT03640312|101702498|FG001|COMPLETED|Overall Study||24||
48560697|NCT03640312|101702497|FG000|NOT COMPLETED|Overall Study||3||
48112135|NCT02346240|100601434|FG007|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||20||
48112136|NCT02346240|100601435|FG008|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||40||
48112137|NCT02346240|100601436|FG009|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||43||
48112138|NCT02346240|100601437|FG010|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||23||
48112139|NCT02346240|100601438|FG011|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||47||
48112140|NCT02346240|100601439|FG012|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||49||
48112141|NCT02346240|100601440|FG013|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||46||
48112142|NCT02346240|100601441|FG014|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||71||
48560698|NCT03640312|101702498|FG001|NOT COMPLETED|Overall Study||6||
48560699|NCT01487525|101702499|FG000|STARTED|Overall Study||22||
48560700|NCT01487525|101702500|FG001|STARTED|Overall Study||20||
48560701|NCT01487525|101702499|FG000|COMPLETED|Overall Study||22||
48695737|NCT03783442|102038598|FG001|COMPLETED|Overall Study||0||
48695738|NCT03783442|102038597|FG000|NOT COMPLETED|Overall Study||326||
48695739|NCT03783442|102038598|FG001|NOT COMPLETED|Overall Study||323||
48695740|NCT00309985|102038599|FG000|STARTED|Overall Study||397||
48695741|NCT00309985|102038600|FG001|STARTED|Overall Study||393||
48695742|NCT00309985|102038599|FG000|Toxicity Analysis|Overall Study||390||
48695743|NCT00309985|102038600|FG001|Toxicity Analysis|Overall Study||392||
48695744|NCT00309985|102038599|FG000|Both Baseline and 3-month FACT-P Evals|Overall Study||334||
48695745|NCT00309985|102038600|FG001|Both Baseline and 3-month FACT-P Evals|Overall Study||299||
48695746|NCT00309985|102038599|FG000|COMPLETED|Overall Study||335||
48695747|NCT00309985|102038600|FG001|COMPLETED|Overall Study||392||
48695748|NCT00309985|102038599|FG000|NOT COMPLETED|Overall Study||62||
48695749|NCT00309985|102038600|FG001|NOT COMPLETED|Overall Study||1||
48275006|NCT02369068|100996343|FG001|STARTED|3 Months||10||
48275007|NCT02369068|100996342|FG000|COMPLETED|3 Months||9||
48695750|NCT01530178|102038601|FG000|STARTED|Overall Study||2||
48275008|NCT02369068|100996343|FG001|COMPLETED|3 Months||8||
48275009|NCT02369068|100996342|FG000|NOT COMPLETED|3 Months||0||
48275010|NCT02369068|100996343|FG001|NOT COMPLETED|3 Months||2||
48275011|NCT02369068|100996342|FG000|STARTED|6 Months||9||
48275012|NCT02369068|100996343|FG001|STARTED|6 Months||8||
48275013|NCT02369068|100996342|FG000|COMPLETED|6 Months||9||
48275014|NCT02369068|100996343|FG001|COMPLETED|6 Months||7||
48275015|NCT02369068|100996342|FG000|NOT COMPLETED|6 Months||0||
48560702|NCT01487525|101702500|FG001|COMPLETED|Overall Study||19||
48560703|NCT01487525|101702499|FG000|NOT COMPLETED|Overall Study||0||
48695751|NCT01530178|102038602|FG001|STARTED|Overall Study||6||
48695752|NCT01530178|102038601|FG000|COMPLETED|Overall Study||2||
48560704|NCT01487525|101702500|FG001|NOT COMPLETED|Overall Study||1||
48560705|NCT01288807|101702501|FG000|STARTED|Overall Study||8||
48560706|NCT01288807|101702501|FG000|COMPLETED|Overall Study||8||
48560707|NCT01288807|101702501|FG000|NOT COMPLETED|Overall Study||0||
48560708|NCT00897715|101702502|FG000|STARTED|Overall Study||8||
48560709|NCT00897715|101702503|FG001|STARTED|Overall Study||7||
48560710|NCT00897715|101702502|FG000|COMPLETED|Overall Study||6||
48560711|NCT00897715|101702503|FG001|COMPLETED|Overall Study||6||
48560712|NCT00897715|101702502|FG000|NOT COMPLETED|Overall Study||2||
48560713|NCT00897715|101702503|FG001|NOT COMPLETED|Overall Study||1||
48560714|NCT01622673|101702504|FG000|STARTED|Treatment Period 1||4||
48560715|NCT01622673|101702505|FG001|STARTED|Treatment Period 1||5||
48560716|NCT01622673|101702506|FG002|STARTED|Treatment Period 1||4||
48560717|NCT01622673|101702507|FG003|STARTED|Treatment Period 1||6||
48560718|NCT01622673|101702508|FG004|STARTED|Treatment Period 1||4||
48560719|NCT01622673|101702509|FG005|STARTED|Treatment Period 1||4||
48560720|NCT01622673|101702504|FG000|COMPLETED|Treatment Period 1||4||
48560721|NCT01622673|101702505|FG001|COMPLETED|Treatment Period 1||4||
48560722|NCT01622673|101702506|FG002|COMPLETED|Treatment Period 1||4||
48560723|NCT01622673|101702507|FG003|COMPLETED|Treatment Period 1||5||
48560724|NCT01622673|101702508|FG004|COMPLETED|Treatment Period 1||4||
48560725|NCT01622673|101702509|FG005|COMPLETED|Treatment Period 1||4||
48560726|NCT01622673|101702504|FG000|NOT COMPLETED|Treatment Period 1||0||
48560727|NCT01622673|101702505|FG001|NOT COMPLETED|Treatment Period 1||1||
48560728|NCT01622673|101702506|FG002|NOT COMPLETED|Treatment Period 1||0||
48560729|NCT01622673|101702507|FG003|NOT COMPLETED|Treatment Period 1||1||
48560730|NCT01622673|101702508|FG004|NOT COMPLETED|Treatment Period 1||0||
48560731|NCT01622673|101702509|FG005|NOT COMPLETED|Treatment Period 1||0||
48560732|NCT01622673|101702504|FG000|STARTED|Treatment Period 2||4||
48560733|NCT01622673|101702505|FG001|STARTED|Treatment Period 2||4||
48560734|NCT01622673|101702506|FG002|STARTED|Treatment Period 2||4||
48560735|NCT01622673|101702507|FG003|STARTED|Treatment Period 2||5||
48560736|NCT01622673|101702508|FG004|STARTED|Treatment Period 2||4||
48560737|NCT01622673|101702509|FG005|STARTED|Treatment Period 2||4||
48560738|NCT01622673|101702504|FG000|COMPLETED|Treatment Period 2||4||
48560739|NCT01622673|101702505|FG001|COMPLETED|Treatment Period 2||4||
48560740|NCT01622673|101702506|FG002|COMPLETED|Treatment Period 2||4||
48560741|NCT01622673|101702507|FG003|COMPLETED|Treatment Period 2||4||
48560742|NCT01622673|101702508|FG004|COMPLETED|Treatment Period 2||4||
48560743|NCT01622673|101702509|FG005|COMPLETED|Treatment Period 2||4||
48560744|NCT01622673|101702504|FG000|NOT COMPLETED|Treatment Period 2||0||
48560745|NCT01622673|101702505|FG001|NOT COMPLETED|Treatment Period 2||0||
48560746|NCT01622673|101702506|FG002|NOT COMPLETED|Treatment Period 2||0||
48560747|NCT01622673|101702507|FG003|NOT COMPLETED|Treatment Period 2||1||
48560748|NCT01622673|101702508|FG004|NOT COMPLETED|Treatment Period 2||0||
48560749|NCT01622673|101702509|FG005|NOT COMPLETED|Treatment Period 2||0||
48560750|NCT01622673|101702504|FG000|STARTED|Treatment Period 3||4||
48560751|NCT01622673|101702505|FG001|STARTED|Treatment Period 3||4||
48560752|NCT01622673|101702506|FG002|STARTED|Treatment Period 3||4||
48560753|NCT01622673|101702507|FG003|STARTED|Treatment Period 3||4||
48560754|NCT01622673|101702508|FG004|STARTED|Treatment Period 3||4||
48560755|NCT01622673|101702509|FG005|STARTED|Treatment Period 3||4||
48560756|NCT01622673|101702504|FG000|COMPLETED|Treatment Period 3||4||
48560757|NCT01622673|101702505|FG001|COMPLETED|Treatment Period 3||3||
48560758|NCT01622673|101702506|FG002|COMPLETED|Treatment Period 3||4||
48275016|NCT02369068|100996343|FG001|NOT COMPLETED|6 Months||1||
48275017|NCT00821951|100996344|FG000|STARTED|Overall Study||17||
48275018|NCT00821951|100996344|FG000|COMPLETED|Overall Study||12||
48560759|NCT01622673|101702507|FG003|COMPLETED|Treatment Period 3||4||
48560760|NCT01622673|101702508|FG004|COMPLETED|Treatment Period 3||4||
48560761|NCT01622673|101702509|FG005|COMPLETED|Treatment Period 3||4||
48560762|NCT01622673|101702504|FG000|NOT COMPLETED|Treatment Period 3||0||
48560763|NCT01622673|101702505|FG001|NOT COMPLETED|Treatment Period 3||1||
48560764|NCT01622673|101702506|FG002|NOT COMPLETED|Treatment Period 3||0||
48560765|NCT01622673|101702507|FG003|NOT COMPLETED|Treatment Period 3||0||
48560766|NCT01622673|101702508|FG004|NOT COMPLETED|Treatment Period 3||0||
48560767|NCT01622673|101702509|FG005|NOT COMPLETED|Treatment Period 3||0||
48560768|NCT01622673|101702504|FG000|STARTED|Treatment Period 4||4||
48560769|NCT01622673|101702505|FG001|STARTED|Treatment Period 4||3||
48560770|NCT01622673|101702506|FG002|STARTED|Treatment Period 4||4||
48560771|NCT01622673|101702507|FG003|STARTED|Treatment Period 4||4||
48560772|NCT01622673|101702508|FG004|STARTED|Treatment Period 4||4||
48560773|NCT01622673|101702509|FG005|STARTED|Treatment Period 4||4||
48560774|NCT01622673|101702504|FG000|COMPLETED|Treatment Period 4||4||
48560775|NCT01622673|101702505|FG001|COMPLETED|Treatment Period 4||3||
48560776|NCT01622673|101702506|FG002|COMPLETED|Treatment Period 4||4||
48560777|NCT01622673|101702507|FG003|COMPLETED|Treatment Period 4||4||
48560778|NCT01622673|101702508|FG004|COMPLETED|Treatment Period 4||4||
48560779|NCT01622673|101702509|FG005|COMPLETED|Treatment Period 4||4||
48275019|NCT00821951|100996344|FG000|NOT COMPLETED|Overall Study||5||
48560780|NCT01622673|101702504|FG000|NOT COMPLETED|Treatment Period 4||0||
48560781|NCT01622673|101702505|FG001|NOT COMPLETED|Treatment Period 4||0||
48560782|NCT01622673|101702506|FG002|NOT COMPLETED|Treatment Period 4||0||
48560783|NCT01622673|101702507|FG003|NOT COMPLETED|Treatment Period 4||0||
48560784|NCT01622673|101702508|FG004|NOT COMPLETED|Treatment Period 4||0||
48560785|NCT01622673|101702509|FG005|NOT COMPLETED|Treatment Period 4||0||
48560786|NCT01622673|101702504|FG000|STARTED|Treatment Period 5||4||
48560787|NCT01622673|101702505|FG001|STARTED|Treatment Period 5||3||
48560788|NCT01622673|101702506|FG002|STARTED|Treatment Period 5||4||
48560789|NCT01622673|101702507|FG003|STARTED|Treatment Period 5||4||
48560790|NCT01622673|101702508|FG004|STARTED|Treatment Period 5||4||
48560791|NCT01622673|101702509|FG005|STARTED|Treatment Period 5||4||
48560792|NCT01622673|101702504|FG000|COMPLETED|Treatment Period 5||4||
48560793|NCT01622673|101702505|FG001|COMPLETED|Treatment Period 5||3||
48560794|NCT01622673|101702506|FG002|COMPLETED|Treatment Period 5||4||
48560795|NCT01622673|101702507|FG003|COMPLETED|Treatment Period 5||4||
48275020|NCT01401153|100996345|FG000|STARTED|First Test Day||66||
48275021|NCT01401153|100996346|FG001|STARTED|First Test Day||55||
48275022|NCT01401153|100996345|FG000|COMPLETED|First Test Day||65||
48275023|NCT01401153|100996346|FG001|COMPLETED|First Test Day||45||
48275024|NCT01401153|100996345|FG000|NOT COMPLETED|First Test Day||1||
48275025|NCT01401153|100996346|FG001|NOT COMPLETED|First Test Day||10||
48275026|NCT01401153|100996345|FG000|STARTED|Second Test Day||45||
48275027|NCT01401153|100996346|FG001|STARTED|Second Test Day||65||
48695753|NCT01530178|102038602|FG001|COMPLETED|Overall Study||6||
48695754|NCT01530178|102038601|FG000|NOT COMPLETED|Overall Study||0||
48695755|NCT01530178|102038602|FG001|NOT COMPLETED|Overall Study||0||
48695756|NCT01814397|102038603|FG000|STARTED|Overall Study||50||
48695757|NCT01814397|102038603|FG000|3 Month Evaluation|Overall Study||43||
48695758|NCT01814397|102038603|FG000|COMPLETED|Overall Study||36||
48275028|NCT01401153|100996345|FG000|COMPLETED|Second Test Day||45||
48275029|NCT01401153|100996346|FG001|COMPLETED|Second Test Day||60||
48275030|NCT01401153|100996345|FG000|NOT COMPLETED|Second Test Day||0||
48275031|NCT01401153|100996346|FG001|NOT COMPLETED|Second Test Day||5||
48275032|NCT03085836|100996347|FG000|STARTED|Overall Study||12||
48275033|NCT03085836|100996348|FG001|STARTED|Overall Study||11||
48275034|NCT03085836|100996349|FG002|STARTED|Overall Study||10||
48275035|NCT03085836|100996347|FG000|COMPLETED|Overall Study||12||
48275036|NCT03085836|100996348|FG001|COMPLETED|Overall Study||11||
48275037|NCT03085836|100996349|FG002|COMPLETED|Overall Study||10||
48275038|NCT03085836|100996347|FG000|NOT COMPLETED|Overall Study||0||
48275039|NCT03085836|100996348|FG001|NOT COMPLETED|Overall Study||0||
48275040|NCT03085836|100996349|FG002|NOT COMPLETED|Overall Study||0||
48275041|NCT00974818|100996350|FG000|STARTED|Overall Study||25||
48275042|NCT00974818|100996351|FG001|STARTED|Overall Study||25||
48275043|NCT00974818|100996350|FG000|COMPLETED|Overall Study||25||
48275044|NCT00974818|100996351|FG001|COMPLETED|Overall Study||25||
48275045|NCT00974818|100996350|FG000|NOT COMPLETED|Overall Study||0||
48275046|NCT00974818|100996351|FG001|NOT COMPLETED|Overall Study||0||
48275047|NCT01693900|100996352|FG000|STARTED|Overall Study||25||
48275048|NCT01693900|100996353|FG001|STARTED|Overall Study||25||
48275049|NCT01693900|100996352|FG000|COMPLETED|Overall Study||25||
48275050|NCT01693900|100996353|FG001|COMPLETED|Overall Study||25||
48275051|NCT01693900|100996352|FG000|NOT COMPLETED|Overall Study||0||
48275052|NCT01693900|100996353|FG001|NOT COMPLETED|Overall Study||0||
48275053|NCT03868787|100996354|FG000|STARTED|Overall Study||37||
48275054|NCT03868787|100996355|FG001|STARTED|Overall Study||37||
48275055|NCT03868787|100996354|FG000|COMPLETED|Overall Study||35||
48275056|NCT03868787|100996355|FG001|COMPLETED|Overall Study||36||
48275057|NCT03868787|100996354|FG000|NOT COMPLETED|Overall Study||2||
48275058|NCT03868787|100996355|FG001|NOT COMPLETED|Overall Study||1||
48695759|NCT01814397|102038603|FG000|NOT COMPLETED|Overall Study||14||
48695760|NCT03629223|102038604|FG000|STARTED|Treatment Period 1 (21 Days)||20||
48695761|NCT03629223|102038605|FG001|STARTED|Treatment Period 1 (21 Days)||20||
48695762|NCT03629223|102038606|FG002|STARTED|Treatment Period 1 (21 Days)||6||
48275059|NCT02734953|100996356|FG000|STARTED|Overall Study||10||
48275060|NCT02734953|100996356|FG000|COMPLETED|Overall Study||10||
48695763|NCT03629223|102038607|FG003|STARTED|Treatment Period 1 (21 Days)||8||
48275061|NCT02734953|100996356|FG000|NOT COMPLETED|Overall Study||0||
48275062|NCT04041037|100996357|FG000|STARTED|Overall Study||2||
48275063|NCT04041037|100996357|FG000|COMPLETED|Overall Study||2||
48275064|NCT04041037|100996357|FG000|NOT COMPLETED|Overall Study||0||
48275065|NCT01977677|100996358|FG000|STARTED|Overall Study||3||
48275066|NCT01977677|100996359|FG001|STARTED|Overall Study||6||
48560796|NCT01622673|101702508|FG004|COMPLETED|Treatment Period 5||4||
48560797|NCT01622673|101702509|FG005|COMPLETED|Treatment Period 5||4||
48560798|NCT01622673|101702504|FG000|NOT COMPLETED|Treatment Period 5||0||
48560799|NCT01622673|101702505|FG001|NOT COMPLETED|Treatment Period 5||0||
48560800|NCT01622673|101702506|FG002|NOT COMPLETED|Treatment Period 5||0||
48275067|NCT01977677|100996360|FG002|STARTED|Overall Study||21||
48695764|NCT03629223|102038608|FG004|STARTED|Treatment Period 1 (21 Days)||6||
48695765|NCT03629223|102038609|FG005|STARTED|Treatment Period 1 (21 Days)||6||
48275068|NCT01977677|100996358|FG000|COMPLETED|Overall Study||3||
48275069|NCT01977677|100996359|FG001|COMPLETED|Overall Study||6||
48275070|NCT01977677|100996360|FG002|COMPLETED|Overall Study||20||
48275071|NCT01977677|100996358|FG000|NOT COMPLETED|Overall Study||0||
48560801|NCT01622673|101702507|FG003|NOT COMPLETED|Treatment Period 5||0||
48560802|NCT01622673|101702508|FG004|NOT COMPLETED|Treatment Period 5||0||
48560803|NCT01622673|101702509|FG005|NOT COMPLETED|Treatment Period 5||0||
48560804|NCT01560975|101702510|FG000|STARTED|Overall Study||10||
48560805|NCT01560975|101702510|FG000|COMPLETED|Overall Study||10||
48560806|NCT01560975|101702510|FG000|NOT COMPLETED|Overall Study||0||
48560807|NCT00955929|101702511|FG000|STARTED|Overall Study||13||
48560808|NCT00955929|101702512|FG001|STARTED|Overall Study||30||
48560809|NCT00955929|101702513|FG002|STARTED|Overall Study||33||
48560810|NCT00955929|101702511|FG000|COMPLETED|Overall Study||13||
48560811|NCT00955929|101702512|FG001|COMPLETED|Overall Study||30||
48560812|NCT00955929|101702513|FG002|COMPLETED|Overall Study||33||
48560813|NCT00955929|101702511|FG000|NOT COMPLETED|Overall Study||0||
48560814|NCT00955929|101702512|FG001|NOT COMPLETED|Overall Study||0||
48560815|NCT00955929|101702513|FG002|NOT COMPLETED|Overall Study||0||
48560816|NCT05274178|101702514|FG000|STARTED|Overall Study||10||
48560817|NCT05274178|101702515|FG001|STARTED|Overall Study||10||
48560818|NCT05274178|101702514|FG000|"Tested With OTC Labeled Devices"|Overall Study||10||
48560819|NCT05274178|101702515|FG001|"Tested With OTC Labeled Devices"|Overall Study||10||
48560820|NCT05274178|101702514|FG000|"Tested With Prescriptive Laeled Devices"|Overall Study||10||
48560821|NCT05274178|101702515|FG001|"Tested With Prescriptive Laeled Devices"|Overall Study||10||
48560822|NCT05274178|101702514|FG000|COMPLETED|Overall Study||10||
48560823|NCT05274178|101702515|FG001|COMPLETED|Overall Study||10||
48695766|NCT03629223|102038604|FG000|COMPLETED|Treatment Period 1 (21 Days)||20||
48695767|NCT03629223|102038605|FG001|COMPLETED|Treatment Period 1 (21 Days)||18||
48695768|NCT03629223|102038606|FG002|COMPLETED|Treatment Period 1 (21 Days)||6||
48695769|NCT03629223|102038607|FG003|COMPLETED|Treatment Period 1 (21 Days)||6||
48695770|NCT03629223|102038608|FG004|COMPLETED|Treatment Period 1 (21 Days)||6||
48695771|NCT03629223|102038609|FG005|COMPLETED|Treatment Period 1 (21 Days)||6||
48695772|NCT03629223|102038604|FG000|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
48695773|NCT03629223|102038605|FG001|NOT COMPLETED|Treatment Period 1 (21 Days)||2||
48695774|NCT03629223|102038606|FG002|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
48695775|NCT03629223|102038607|FG003|NOT COMPLETED|Treatment Period 1 (21 Days)||2||
48695776|NCT03629223|102038608|FG004|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
48695777|NCT03629223|102038609|FG005|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
48695778|NCT03629223|102038604|FG000|STARTED|Treatment Period 2 (21 Days)||20||
48695779|NCT03629223|102038605|FG001|STARTED|Treatment Period 2 (21 Days)||18||
48695780|NCT03629223|102038606|FG002|STARTED|Treatment Period 2 (21 Days)||6||
48695781|NCT03629223|102038607|FG003|STARTED|Treatment Period 2 (21 Days)||6||
48695782|NCT03629223|102038608|FG004|STARTED|Treatment Period 2 (21 Days)||6||
48695783|NCT03629223|102038609|FG005|STARTED|Treatment Period 2 (21 Days)||6||
48695784|NCT03629223|102038604|FG000|COMPLETED|Treatment Period 2 (21 Days)||19||
48695785|NCT03629223|102038605|FG001|COMPLETED|Treatment Period 2 (21 Days)||18||
48695786|NCT03629223|102038606|FG002|COMPLETED|Treatment Period 2 (21 Days)||6||
48695787|NCT03629223|102038607|FG003|COMPLETED|Treatment Period 2 (21 Days)||6||
48695788|NCT03629223|102038608|FG004|COMPLETED|Treatment Period 2 (21 Days)||6||
48695789|NCT03629223|102038609|FG005|COMPLETED|Treatment Period 2 (21 Days)||6||
48695790|NCT03629223|102038604|FG000|NOT COMPLETED|Treatment Period 2 (21 Days)||1||
48560824|NCT05274178|101702514|FG000|NOT COMPLETED|Overall Study||0||
48695791|NCT03629223|102038605|FG001|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
48695792|NCT03629223|102038606|FG002|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
48695793|NCT03629223|102038607|FG003|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
48695794|NCT03629223|102038608|FG004|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
48695795|NCT03629223|102038609|FG005|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
48695796|NCT01849575|102038610|FG000|STARTED|Overall Study||1749||
48695797|NCT01849575|102038611|FG001|STARTED|Overall Study||1783||
48695798|NCT01849575|102038610|FG000|COMPLETED|Overall Study||1599||
48695799|NCT01849575|102038611|FG001|COMPLETED|Overall Study||1576||
48695800|NCT01849575|102038610|FG000|NOT COMPLETED|Overall Study||150||
48695801|NCT01849575|102038611|FG001|NOT COMPLETED|Overall Study||207||
48695802|NCT03316118|102038612|FG000|STARTED|Overall Study||2||
48560825|NCT05274178|101702515|FG001|NOT COMPLETED|Overall Study||0||
48560826|NCT02380612|101702516|FG000|STARTED|Overall Study||30||
48560827|NCT02380612|101702516|FG000|COMPLETED|Overall Study||27||
48560828|NCT02380612|101702516|FG000|NOT COMPLETED|Overall Study||3||
48560829|NCT00489866|101702517|FG000|STARTED|Overall Study||7||
48560830|NCT00489866|101702518|FG001|STARTED|Overall Study||7||
48560831|NCT00489866|101702517|FG000|COMPLETED|Overall Study||5||
48560832|NCT00489866|101702518|FG001|COMPLETED|Overall Study||7||
48560833|NCT00489866|101702517|FG000|NOT COMPLETED|Overall Study||2||
48560834|NCT00489866|101702518|FG001|NOT COMPLETED|Overall Study||0||
48695803|NCT03316118|102038613|FG001|STARTED|Overall Study||0||
48695804|NCT03316118|102038612|FG000|COMPLETED|Overall Study||2||
48695805|NCT03316118|102038613|FG001|COMPLETED|Overall Study||0||
48695806|NCT03316118|102038612|FG000|NOT COMPLETED|Overall Study||0||
48695807|NCT03316118|102038613|FG001|NOT COMPLETED|Overall Study||0||
48695808|NCT01158820|102038614|FG000|STARTED|Overall Study||25||
48695809|NCT01158820|102038615|FG001|STARTED|Overall Study||25||
48695810|NCT01158820|102038614|FG000|COMPLETED|Overall Study||25||
48560835|NCT01207687|101702519|FG000|STARTED|Overall Study||14||
48560836|NCT01207687|101702519|FG000|COMPLETED|Overall Study||12||
48560837|NCT01207687|101702519|FG000|NOT COMPLETED|Overall Study||2||
48560838|NCT02656303|101702520|FG000|STARTED|Overall Study||67||
48560839|NCT02656303|101702521|FG001|STARTED|Overall Study||31||
48560840|NCT02656303|101702522|FG002|STARTED|Overall Study||18||
48560841|NCT02656303|101702520|FG000|COMPLETED|Overall Study||0||
48560842|NCT02656303|101702521|FG001|COMPLETED|Overall Study||0||
48560843|NCT02656303|101702522|FG002|COMPLETED|Overall Study||0||
48560844|NCT02656303|101702520|FG000|NOT COMPLETED|Overall Study||67||
48560845|NCT02656303|101702521|FG001|NOT COMPLETED|Overall Study||31||
48560846|NCT02656303|101702522|FG002|NOT COMPLETED|Overall Study||18||
48560847|NCT01149863|101702523|FG000|STARTED|Overall Study||34||
48560848|NCT01149863|101702523|FG000|COMPLETED|Overall Study||31||
48560849|NCT01149863|101702523|FG000|NOT COMPLETED|Overall Study||3||
48560850|NCT03859427|101702524|FG000|STARTED|Overall Study||226||
48560851|NCT03859427|101702525|FG001|STARTED|Overall Study||228||
48560852|NCT03859427|101702524|FG000|Received Carfilzomib|Overall Study||226||
48560853|NCT03859427|101702525|FG001|Received Carfilzomib|Overall Study||228||
48560854|NCT03859427|101702524|FG000|Completed 12 Cycles Carfilzomib|Overall Study||152||
48560855|NCT03859427|101702525|FG001|Completed 12 Cycles Carfilzomib|Overall Study||150||
48560856|NCT03859427|101702524|FG000|Received Lenalidomide|Overall Study||226||
48560857|NCT03859427|101702525|FG001|Received Lenalidomide|Overall Study||228||
48560858|NCT03859427|101702524|FG000|Received Dexamethasone|Overall Study||226||
48560859|NCT03859427|101702525|FG001|Received Dexamethasone|Overall Study||228||
48560860|NCT03859427|101702524|FG000|Safety Population|Overall Study||231|Participants were analyzed according to the treatment arm corresponding to the actual treatment received.|
48560861|NCT03859427|101702525|FG001|Safety Population|Overall Study||223|Participants were analyzed according to the treatment arm corresponding to the actual treatment received.|
48560862|NCT03859427|101702524|FG000|COMPLETED|Overall Study||197||
48560863|NCT03859427|101702525|FG001|COMPLETED|Overall Study||191||
48560864|NCT03859427|101702524|FG000|NOT COMPLETED|Overall Study||29||
48560865|NCT03859427|101702525|FG001|NOT COMPLETED|Overall Study||37||
48560866|NCT01709500|101702526|FG000|STARTED|Overall Study||167||
48560867|NCT01709500|101702527|FG001|STARTED|Overall Study||82||
48560868|NCT01709500|101702526|FG000|Treated|Overall Study||167||
48560869|NCT01709500|101702527|FG001|Treated|Overall Study||81||
48560870|NCT01709500|101702526|FG000|COMPLETED|Overall Study||0||
48560871|NCT01709500|101702527|FG001|COMPLETED|Overall Study||0||
48560872|NCT01709500|101702526|FG000|NOT COMPLETED|Overall Study||167||
48560873|NCT01709500|101702527|FG001|NOT COMPLETED|Overall Study||82||
48560874|NCT04176250|101702528|FG000|STARTED|Overall Study||15||
48560875|NCT04176250|101702529|FG001|STARTED|Overall Study||15||
48560876|NCT04176250|101702530|FG002|STARTED|Overall Study||15||
48560877|NCT04176250|101702531|FG003|STARTED|Overall Study||17||
48560878|NCT04176250|101702532|FG004|STARTED|Overall Study||16||
48560879|NCT04176250|101702533|FG005|STARTED|Overall Study||15||
48695811|NCT01158820|102038615|FG001|COMPLETED|Overall Study||25||
48695812|NCT01158820|102038614|FG000|NOT COMPLETED|Overall Study||0||
48695813|NCT01158820|102038615|FG001|NOT COMPLETED|Overall Study||0||
48695814|NCT00564733|102038616|FG000|STARTED|Overall Study||55||
48695815|NCT00564733|102038616|FG000|COMPLETED|Overall Study||46||
48695816|NCT00564733|102038616|FG000|NOT COMPLETED|Overall Study||9||
48695817|NCT03530995|102038617|FG000|STARTED|Part 1 Period 1; Part 2 Period 1||35||
48695818|NCT03530995|102038618|FG001|STARTED|Part 1 Period 1; Part 2 Period 1||38||
48112143|NCT02346240|100601442|FG015|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||36||
48112144|NCT02346240|100601443|FG016|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||30||
48560880|NCT04176250|101702528|FG000|COMPLETED|Overall Study||15||
48560881|NCT04176250|101702529|FG001|COMPLETED|Overall Study||14||
48560882|NCT04176250|101702530|FG002|COMPLETED|Overall Study||14||
48560883|NCT04176250|101702531|FG003|COMPLETED|Overall Study||15||
48560884|NCT04176250|101702532|FG004|COMPLETED|Overall Study||15||
48560885|NCT04176250|101702533|FG005|COMPLETED|Overall Study||13||
48560886|NCT04176250|101702528|FG000|NOT COMPLETED|Overall Study||0||
48560887|NCT04176250|101702529|FG001|NOT COMPLETED|Overall Study||1||
48560888|NCT04176250|101702530|FG002|NOT COMPLETED|Overall Study||1||
48560889|NCT04176250|101702531|FG003|NOT COMPLETED|Overall Study||2||
48560890|NCT04176250|101702532|FG004|NOT COMPLETED|Overall Study||1||
48560891|NCT04176250|101702533|FG005|NOT COMPLETED|Overall Study||2||
48560892|NCT04495829|101702534|FG000|STARTED|Overall Study||70||
48560893|NCT04495829|101702534|FG000|COMPLETED|Overall Study||65||
48560894|NCT04495829|101702534|FG000|NOT COMPLETED|Overall Study||5||
48560895|NCT01894919|101702535|FG000|STARTED|Overall Study||98||
48560896|NCT01894919|101702536|FG001|STARTED|Overall Study||47||
48560897|NCT01894919|101702537|FG002|STARTED|Overall Study||89||
48560898|NCT01894919|101702538|FG003|STARTED|Overall Study||43||
48560899|NCT01894919|101702539|FG004|STARTED|Overall Study||81||
48695819|NCT03530995|102038617|FG000|COMPLETED|Part 1 Period 1; Part 2 Period 1||35||
48560900|NCT01894919|101702540|FG005|STARTED|Overall Study||39||
48560901|NCT01894919|101702541|FG006|STARTED|Overall Study||32||
48560902|NCT01894919|101702542|FG007|STARTED|Overall Study||36||
48560903|NCT01894919|101702543|FG008|STARTED|Overall Study||91||
48560904|NCT01894919|101702544|FG009|STARTED|Overall Study||90||
48560905|NCT01894919|101702545|FG010|STARTED|Overall Study||100||
48560906|NCT01894919|101702546|FG011|STARTED|Overall Study||55||
48560907|NCT01894919|101702547|FG012|STARTED|Overall Study||50||
48560908|NCT01894919|101702535|FG000|COMPLETED|Overall Study||96||
48560909|NCT01894919|101702536|FG001|COMPLETED|Overall Study||47||
48560910|NCT01894919|101702537|FG002|COMPLETED|Overall Study||89||
48560911|NCT01894919|101702538|FG003|COMPLETED|Overall Study||43||
48560912|NCT01894919|101702539|FG004|COMPLETED|Overall Study||78||
48275072|NCT01977677|100996359|FG001|NOT COMPLETED|Overall Study||0||
48275073|NCT01977677|100996360|FG002|NOT COMPLETED|Overall Study||1||
48275074|NCT01692951|100996361|FG000|STARTED|Overall Study||37||
48275075|NCT01692951|100996362|FG001|STARTED|Overall Study||111||
48275076|NCT01692951|100996363|FG002|STARTED|Overall Study||18||
48275077|NCT01692951|100996364|FG003|STARTED|Overall Study||54||
48275078|NCT01692951|100996361|FG000|COMPLETED|Overall Study||37||
48112145|NCT02346240|100601444|FG017|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0||
48112146|NCT02346240|100601445|FG018|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0||
48112147|NCT02346240|100601446|FG019|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0||
48112148|NCT02346240|100601447|FG020|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0||
48112149|NCT02346240|100601448|FG021|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0||
48112150|NCT02346240|100601449|FG022|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0||
48112151|NCT02346240|100601450|FG023|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0||
48112152|NCT02346240|100601427|FG000|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
48112153|NCT02346240|100601428|FG001|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
48112154|NCT02346240|100601429|FG002|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
48141419|NCT01454583|100670420|FG001|NOT COMPLETED|3rd Year||512||
48275079|NCT01692951|100996362|FG001|COMPLETED|Overall Study||111||
48275080|NCT01692951|100996363|FG002|COMPLETED|Overall Study||18||
48560913|NCT01894919|101702540|FG005|COMPLETED|Overall Study||39||
48560914|NCT01894919|101702541|FG006|COMPLETED|Overall Study||32||
48560915|NCT01894919|101702542|FG007|COMPLETED|Overall Study||36||
48560916|NCT01894919|101702543|FG008|COMPLETED|Overall Study||91||
48560917|NCT01894919|101702544|FG009|COMPLETED|Overall Study||89||
48560918|NCT01894919|101702545|FG010|COMPLETED|Overall Study||98||
48560919|NCT01894919|101702546|FG011|COMPLETED|Overall Study||55||
48560920|NCT01894919|101702547|FG012|COMPLETED|Overall Study||50||
48560921|NCT01894919|101702535|FG000|NOT COMPLETED|Overall Study||2||
48560922|NCT01894919|101702536|FG001|NOT COMPLETED|Overall Study||0||
48560923|NCT01894919|101702537|FG002|NOT COMPLETED|Overall Study||0||
48560924|NCT01894919|101702538|FG003|NOT COMPLETED|Overall Study||0||
48560925|NCT01894919|101702539|FG004|NOT COMPLETED|Overall Study||3||
48560926|NCT01894919|101702540|FG005|NOT COMPLETED|Overall Study||0||
48560927|NCT01894919|101702541|FG006|NOT COMPLETED|Overall Study||0||
48560928|NCT01894919|101702542|FG007|NOT COMPLETED|Overall Study||0||
48560929|NCT01894919|101702543|FG008|NOT COMPLETED|Overall Study||0||
48560930|NCT01894919|101702544|FG009|NOT COMPLETED|Overall Study||1||
48560931|NCT01894919|101702545|FG010|NOT COMPLETED|Overall Study||2||
48560932|NCT01894919|101702546|FG011|NOT COMPLETED|Overall Study||0||
48560933|NCT01894919|101702547|FG012|NOT COMPLETED|Overall Study||0||
48560934|NCT01332487|101702548|FG000|STARTED|Overall Study||5554||
48560935|NCT01332487|101702549|FG001|STARTED|Overall Study||3063||
48560936|NCT01332487|101702548|FG000|COMPLETED|Overall Study||5554||
48560937|NCT01332487|101702549|FG001|COMPLETED|Overall Study||3063||
48560938|NCT01332487|101702548|FG000|NOT COMPLETED|Overall Study||0||
48560939|NCT01332487|101702549|FG001|NOT COMPLETED|Overall Study||0||
48560940|NCT00720213|101702550|FG000|STARTED|Screening Phase With Diagnostic PSG||44||
48560941|NCT00720213|101702551|FG001|STARTED|Screening Phase With Diagnostic PSG||0||
48560942|NCT00720213|101702552|FG002|STARTED|Screening Phase With Diagnostic PSG||0||
48560943|NCT00720213|101702550|FG000|COMPLETED|Screening Phase With Diagnostic PSG||37||
48560944|NCT00720213|101702551|FG001|COMPLETED|Screening Phase With Diagnostic PSG||0||
48560945|NCT00720213|101702552|FG002|COMPLETED|Screening Phase With Diagnostic PSG||0||
48560946|NCT00720213|101702550|FG000|NOT COMPLETED|Screening Phase With Diagnostic PSG||7||
48560947|NCT00720213|101702551|FG001|NOT COMPLETED|Screening Phase With Diagnostic PSG||0||
48560948|NCT00720213|101702552|FG002|NOT COMPLETED|Screening Phase With Diagnostic PSG||0||
48560949|NCT00720213|101702550|FG000|STARTED|Treatment Period||0||
48560950|NCT00720213|101702551|FG001|STARTED|Treatment Period||20||
48275081|NCT01692951|100996364|FG003|COMPLETED|Overall Study||54||
48560951|NCT00720213|101702552|FG002|STARTED|Treatment Period||17||
48560952|NCT00720213|101702550|FG000|COMPLETED|Treatment Period||0||
48560953|NCT00720213|101702551|FG001|COMPLETED|Treatment Period||20||
48560954|NCT00720213|101702552|FG002|COMPLETED|Treatment Period||17||
48560955|NCT00720213|101702550|FG000|NOT COMPLETED|Treatment Period||0||
48560956|NCT00720213|101702551|FG001|NOT COMPLETED|Treatment Period||0||
48112155|NCT02346240|100601430|FG003|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
48112156|NCT02346240|100601431|FG004|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||2||
48112157|NCT02346240|100601432|FG005|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||23||
48112158|NCT02346240|100601433|FG006|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||48||
48112159|NCT02346240|100601434|FG007|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||20||
48112160|NCT02346240|100601435|FG008|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||40||
48112161|NCT02346240|100601436|FG009|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||43||
48112162|NCT02346240|100601437|FG010|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||23||
48112163|NCT02346240|100601438|FG011|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||47||
48112164|NCT02346240|100601439|FG012|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||49||
48112165|NCT02346240|100601440|FG013|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||45||
48112166|NCT02346240|100601441|FG014|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||68||
48112167|NCT02346240|100601442|FG015|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||35||
48112168|NCT02346240|100601443|FG016|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||29||
48112169|NCT02346240|100601444|FG017|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
48112170|NCT02346240|100601445|FG018|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
48112171|NCT02346240|100601446|FG019|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
48112172|NCT02346240|100601447|FG020|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
48112173|NCT02346240|100601448|FG021|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
48112174|NCT02346240|100601449|FG022|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
48112175|NCT02346240|100601450|FG023|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
48112176|NCT02346240|100601427|FG000|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48112177|NCT02346240|100601428|FG001|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48112178|NCT02346240|100601429|FG002|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48112179|NCT02346240|100601430|FG003|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48112180|NCT02346240|100601431|FG004|COMPLETED|Maintenance Period (Week 16 to Week 48)||2||
48112181|NCT02346240|100601432|FG005|COMPLETED|Maintenance Period (Week 16 to Week 48)||23||
48112182|NCT02346240|100601433|FG006|COMPLETED|Maintenance Period (Week 16 to Week 48)||48||
48112183|NCT02346240|100601434|FG007|COMPLETED|Maintenance Period (Week 16 to Week 48)||20||
48112184|NCT02346240|100601435|FG008|COMPLETED|Maintenance Period (Week 16 to Week 48)||40||
48112185|NCT02346240|100601436|FG009|COMPLETED|Maintenance Period (Week 16 to Week 48)||43||
48112186|NCT02346240|100601437|FG010|COMPLETED|Maintenance Period (Week 16 to Week 48)||23||
48112187|NCT02346240|100601438|FG011|COMPLETED|Maintenance Period (Week 16 to Week 48)||47||
48112188|NCT02346240|100601439|FG012|COMPLETED|Maintenance Period (Week 16 to Week 48)||49||
48112189|NCT02346240|100601440|FG013|COMPLETED|Maintenance Period (Week 16 to Week 48)||45||
48112190|NCT02346240|100601441|FG014|COMPLETED|Maintenance Period (Week 16 to Week 48)||68||
48112191|NCT02346240|100601442|FG015|COMPLETED|Maintenance Period (Week 16 to Week 48)||35||
48112192|NCT02346240|100601443|FG016|COMPLETED|Maintenance Period (Week 16 to Week 48)||29||
48112193|NCT02346240|100601444|FG017|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48112194|NCT02346240|100601445|FG018|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48112195|NCT02346240|100601446|FG019|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48112196|NCT02346240|100601447|FG020|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48112197|NCT02346240|100601448|FG021|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48112198|NCT02346240|100601449|FG022|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48112199|NCT02346240|100601450|FG023|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48112200|NCT02346240|100601427|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48112201|NCT02346240|100601428|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48112202|NCT02346240|100601429|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48560957|NCT00720213|101702552|FG002|NOT COMPLETED|Treatment Period||0||
48560958|NCT04846400|101702553|FG000|STARTED|Overall Study||2||
48560959|NCT04846400|101702553|FG000|COMPLETED|Overall Study||2||
48112203|NCT02346240|100601430|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48112204|NCT02346240|100601431|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48393123|NCT00966693|101291511|FG001|Phase 1 Completed|Overall Study||3||
48393124|NCT00966693|101291512|FG002|Phase 1 Completed|Overall Study||6||
48393125|NCT00966693|101291513|FG003|Phase 1 Completed|Overall Study||0||
48393126|NCT00966693|101291510|FG000|Phase 2 Completed|Overall Study||0||
48393127|NCT00966693|101291511|FG001|Phase 2 Completed|Overall Study||0||
48393128|NCT00966693|101291512|FG002|Phase 2 Completed|Overall Study||0||
48560960|NCT04846400|101702553|FG000|NOT COMPLETED|Overall Study||0||
48560961|NCT02070965|101702554|FG000|STARTED|Overall Study||27||
48560962|NCT02070965|101702555|FG001|STARTED|Overall Study||23||
48560963|NCT02070965|101702556|FG002|STARTED|Overall Study||25||
48560964|NCT02070965|101702554|FG000|COMPLETED|Overall Study||25||
48560965|NCT02070965|101702555|FG001|COMPLETED|Overall Study||21||
48560966|NCT02070965|101702556|FG002|COMPLETED|Overall Study||24||
48560967|NCT02070965|101702554|FG000|NOT COMPLETED|Overall Study||2||
48112205|NCT02346240|100601432|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1||
48112206|NCT02346240|100601433|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2||
48112207|NCT02346240|100601434|FG007|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2||
48112208|NCT02346240|100601435|FG008|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||4||
48112209|NCT02346240|100601436|FG009|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1||
48112210|NCT02346240|100601437|FG010|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2||
48275082|NCT01692951|100996361|FG000|NOT COMPLETED|Overall Study||0||
48275083|NCT01692951|100996362|FG001|NOT COMPLETED|Overall Study||0||
48275084|NCT01692951|100996363|FG002|NOT COMPLETED|Overall Study||0||
48112211|NCT02346240|100601438|FG011|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||3||
48112212|NCT02346240|100601439|FG012|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48112213|NCT02346240|100601440|FG013|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||8||
48112214|NCT02346240|100601441|FG014|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||17||
48112215|NCT02346240|100601442|FG015|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||14||
48112216|NCT02346240|100601443|FG016|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7||
48275085|NCT01692951|100996364|FG003|NOT COMPLETED|Overall Study||0||
48275086|NCT01137578|100996365|FG000|STARTED|Overall Study||77||
48275087|NCT01137578|100996366|FG001|STARTED|Overall Study||14||
48275088|NCT01137578|100996367|FG002|STARTED|Overall Study||43||
48275089|NCT01137578|100996365|FG000|COMPLETED|Overall Study||61||
48275090|NCT01137578|100996366|FG001|COMPLETED|Overall Study||12||
48112217|NCT02346240|100601444|FG017|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48112218|NCT02346240|100601445|FG018|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48112219|NCT02346240|100601446|FG019|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48112220|NCT02346240|100601447|FG020|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48112221|NCT02346240|100601448|FG021|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48112222|NCT02346240|100601449|FG022|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48275091|NCT01137578|100996367|FG002|COMPLETED|Overall Study||37||
48275092|NCT01137578|100996365|FG000|NOT COMPLETED|Overall Study||16||
48275093|NCT01137578|100996366|FG001|NOT COMPLETED|Overall Study||2||
48275094|NCT01137578|100996367|FG002|NOT COMPLETED|Overall Study||6||
48275095|NCT01882543|100996368|FG000|STARTED|Overall Study||37||
48275096|NCT01882543|100996369|FG001|STARTED|Overall Study||32||
48275097|NCT01882543|100996368|FG000|COMPLETED|Overall Study||33||
48275098|NCT01882543|100996369|FG001|COMPLETED|Overall Study||29||
48275099|NCT01882543|100996368|FG000|NOT COMPLETED|Overall Study||4||
48275100|NCT01882543|100996369|FG001|NOT COMPLETED|Overall Study||3||
48275101|NCT00834626|100996370|FG000|STARTED|Overall Study||30||
48275102|NCT00834626|100996370|FG000|1 Year Follow-up|Overall Study||30||
48275103|NCT00834626|100996370|FG000|COMPLETED|Overall Study||30||
48275104|NCT00834626|100996370|FG000|NOT COMPLETED|Overall Study||0||
48112223|NCT02346240|100601450|FG023|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48112224|NCT02346240|100601427|FG000|STARTED|Open-Label Period (Week 48 to Week 144)||0||
48112225|NCT02346240|100601428|FG001|STARTED|Open-Label Period (Week 48 to Week 144)||0||
48112226|NCT02346240|100601429|FG002|STARTED|Open-Label Period (Week 48 to Week 144)||0||
48112227|NCT02346240|100601430|FG003|STARTED|Open-Label Period (Week 48 to Week 144)||0||
48275105|NCT01598662|100996371|FG000|STARTED|Overall Study||11||
48275106|NCT01598662|100996372|FG001|STARTED|Overall Study||21||
48275107|NCT01598662|100996371|FG000|Patients Who Received IUD|Overall Study||0||
48275108|NCT01598662|100996372|FG001|Patients Who Received IUD|Overall Study||18||
48275109|NCT01598662|100996371|FG000|Patients Returned for 6 wk Postpartum|Overall Study||0||
48275110|NCT01598662|100996372|FG001|Patients Returned for 6 wk Postpartum|Overall Study||2||
48275111|NCT01598662|100996371|FG000|COMPLETED|Overall Study||0||
48560968|NCT02070965|101702555|FG001|NOT COMPLETED|Overall Study||2||
48275112|NCT01598662|100996372|FG001|COMPLETED|Overall Study||0||
48275113|NCT01598662|100996371|FG000|NOT COMPLETED|Overall Study||11||
48275114|NCT01598662|100996372|FG001|NOT COMPLETED|Overall Study||21||
48275115|NCT03738423|100996373|FG000|STARTED|Overall Study||25||
48275116|NCT03738423|100996374|FG001|STARTED|Overall Study||26||
48275117|NCT03738423|100996375|FG002|STARTED|Overall Study||27||
48275118|NCT03738423|100996376|FG003|STARTED|Overall Study||25||
48275119|NCT03738423|100996377|FG004|STARTED|Overall Study||26||
48275120|NCT03738423|100996373|FG000|Treated|Overall Study||25||
48275121|NCT03738423|100996374|FG001|Treated|Overall Study||26||
48560969|NCT02070965|101702556|FG002|NOT COMPLETED|Overall Study||1||
48560970|NCT01863667|101702557|FG000|STARTED|Overall Study||33||
48112228|NCT02346240|100601431|FG004|STARTED|Open-Label Period (Week 48 to Week 144)||0||
48112229|NCT02346240|100601432|FG005|STARTED|Open-Label Period (Week 48 to Week 144)||0||
48112230|NCT02346240|100601433|FG006|STARTED|Open-Label Period (Week 48 to Week 144)||0||
48112231|NCT02346240|100601434|FG007|STARTED|Open-Label Period (Week 48 to Week 144)||0||
48560971|NCT01863667|101702558|FG001|STARTED|Overall Study||32||
48112232|NCT02346240|100601435|FG008|STARTED|Open-Label Period (Week 48 to Week 144)||0||
48112233|NCT02346240|100601436|FG009|STARTED|Open-Label Period (Week 48 to Week 144)||0||
48275122|NCT03738423|100996375|FG002|Treated|Overall Study||26||
48275123|NCT03738423|100996376|FG003|Treated|Overall Study||24||
48275124|NCT03738423|100996377|FG004|Treated|Overall Study||26||
48560972|NCT01863667|101702557|FG000|COMPLETED|Overall Study||0||
48275125|NCT03738423|100996373|FG000|COMPLETED|Overall Study||11||
48275126|NCT03738423|100996374|FG001|COMPLETED|Overall Study||13||
48275127|NCT03738423|100996375|FG002|COMPLETED|Overall Study||14||
48275128|NCT03738423|100996376|FG003|COMPLETED|Overall Study||10||
48275129|NCT03738423|100996377|FG004|COMPLETED|Overall Study||11||
48275130|NCT03738423|100996373|FG000|NOT COMPLETED|Overall Study||14||
48275131|NCT03738423|100996374|FG001|NOT COMPLETED|Overall Study||13||
48275132|NCT03738423|100996375|FG002|NOT COMPLETED|Overall Study||13||
48275133|NCT03738423|100996376|FG003|NOT COMPLETED|Overall Study||15||
48275134|NCT03738423|100996377|FG004|NOT COMPLETED|Overall Study||15||
48275135|NCT03776539|100996378|FG000|STARTED|Overall Study||6||
48275136|NCT03776539|100996379|FG001|STARTED|Overall Study||6||
48275137|NCT03776539|100996380|FG002|STARTED|Overall Study||6||
48275138|NCT03776539|100996381|FG003|STARTED|Overall Study||6||
48275139|NCT03776539|100996378|FG000|COMPLETED|Overall Study||6||
48275140|NCT03776539|100996379|FG001|COMPLETED|Overall Study||6||
48275141|NCT03776539|100996380|FG002|COMPLETED|Overall Study||6||
48275142|NCT03776539|100996381|FG003|COMPLETED|Overall Study||6||
48275143|NCT03776539|100996378|FG000|NOT COMPLETED|Overall Study||0||
48560973|NCT01863667|101702558|FG001|COMPLETED|Overall Study||0||
48560974|NCT01863667|101702557|FG000|NOT COMPLETED|Overall Study||33||
48560975|NCT01863667|101702558|FG001|NOT COMPLETED|Overall Study||32||
48592747|NCT02678000|101783171|FG003|STARTED|PART 2||27||
48592748|NCT02678000|101783172|FG004|STARTED|PART 2||18||
48592749|NCT02678000|101783168|FG000|COMPLETED|PART 2||0||
48592750|NCT02678000|101783169|FG001|COMPLETED|PART 2||0||
48592751|NCT02678000|101783170|FG002|COMPLETED|PART 2||25||
48592752|NCT02678000|101783171|FG003|COMPLETED|PART 2||26||
48592753|NCT02678000|101783172|FG004|COMPLETED|PART 2||18||
48592754|NCT02678000|101783168|FG000|NOT COMPLETED|PART 2||0||
48275144|NCT03776539|100996379|FG001|NOT COMPLETED|Overall Study||0||
48275145|NCT03776539|100996380|FG002|NOT COMPLETED|Overall Study||0||
48275146|NCT03776539|100996381|FG003|NOT COMPLETED|Overall Study||0||
48275147|NCT01725126|100996382|FG000|STARTED|Overall Study||4||
48592755|NCT02678000|101783169|FG001|NOT COMPLETED|PART 2||0||
48592756|NCT02678000|101783170|FG002|NOT COMPLETED|PART 2||3||
48592757|NCT02678000|101783171|FG003|NOT COMPLETED|PART 2||1||
48275148|NCT01725126|100996383|FG001|STARTED|Overall Study||11||
48275149|NCT01725126|100996384|FG002|STARTED|Overall Study||6||
48275150|NCT01725126|100996385|FG003|STARTED|Overall Study||14||
48275151|NCT01725126|100996386|FG004|STARTED|Overall Study||6||
48275152|NCT01725126|100996387|FG005|STARTED|Overall Study||12||
48275153|NCT01725126|100996382|FG000|COMPLETED|Overall Study||4||
48275154|NCT01725126|100996383|FG001|COMPLETED|Overall Study||10||
48275155|NCT01725126|100996384|FG002|COMPLETED|Overall Study||6||
48275156|NCT01725126|100996385|FG003|COMPLETED|Overall Study||13||
48275157|NCT01725126|100996386|FG004|COMPLETED|Overall Study||6||
48275158|NCT01725126|100996387|FG005|COMPLETED|Overall Study||12||
48275159|NCT01725126|100996382|FG000|NOT COMPLETED|Overall Study||0||
48275160|NCT01725126|100996383|FG001|NOT COMPLETED|Overall Study||1||
48275161|NCT01725126|100996384|FG002|NOT COMPLETED|Overall Study||0||
48275162|NCT01725126|100996385|FG003|NOT COMPLETED|Overall Study||1||
48275163|NCT01725126|100996386|FG004|NOT COMPLETED|Overall Study||0||
48275164|NCT01725126|100996387|FG005|NOT COMPLETED|Overall Study||0||
48275165|NCT02591953|100996388|FG000|STARTED|Overall Study||12||
48275166|NCT02591953|100996389|FG001|STARTED|Overall Study||10||
48275167|NCT02591953|100996388|FG000|COMPLETED|Overall Study||6||
48592758|NCT02678000|101783172|FG004|NOT COMPLETED|PART 2||0||
48592759|NCT04489381|101783173|FG000|STARTED|Overall Study||104||
48592760|NCT04489381|101783174|FG001|STARTED|Overall Study||110||
48592761|NCT04489381|101783173|FG000|COMPLETED|Overall Study||101||
48592762|NCT04489381|101783174|FG001|COMPLETED|Overall Study||107||
48592763|NCT04489381|101783173|FG000|NOT COMPLETED|Overall Study||3||
48592764|NCT04489381|101783174|FG001|NOT COMPLETED|Overall Study||3||
48592765|NCT02570139|101783175|FG000|STARTED|Overall Study||24||
48592766|NCT02570139|101783176|FG001|STARTED|Overall Study||21||
48592767|NCT02570139|101783175|FG000|COMPLETED|Overall Study||24||
48592768|NCT02570139|101783176|FG001|COMPLETED|Overall Study||21||
48592769|NCT02570139|101783175|FG000|NOT COMPLETED|Overall Study||0||
48592770|NCT02570139|101783176|FG001|NOT COMPLETED|Overall Study||0||
48592771|NCT02292186|101783177|FG000|STARTED|Overall Study||25||
48592772|NCT02292186|101783177|FG000|COMPLETED|Overall Study||7||
48275168|NCT02591953|100996389|FG001|COMPLETED|Overall Study||4||
48275169|NCT02591953|100996388|FG000|NOT COMPLETED|Overall Study||6||
48275170|NCT02591953|100996389|FG001|NOT COMPLETED|Overall Study||6||
48275171|NCT01464840|100996390|FG000|STARTED|Overall Study||10||
48275172|NCT01464840|100996391|FG001|STARTED|Overall Study||10||
48592773|NCT02292186|101783177|FG000|NOT COMPLETED|Overall Study||18||
48592774|NCT01777295|101783178|FG000|STARTED|Overall Study||40||
48592775|NCT01777295|101783179|FG001|STARTED|Overall Study||41||
48592776|NCT01777295|101783178|FG000|COMPLETED|Overall Study||36||
48592777|NCT01777295|101783179|FG001|COMPLETED|Overall Study||38||
48592778|NCT01777295|101783178|FG000|NOT COMPLETED|Overall Study||4||
48592779|NCT01777295|101783179|FG001|NOT COMPLETED|Overall Study||3||
48592780|NCT02847182|101783180|FG000|STARTED|Overall Study||119||
48592781|NCT02847182|101783181|FG001|STARTED|Overall Study||61||
48710814|NCT03837665|102078027|FG000|COMPLETED|Overall Study||1||
48275173|NCT01464840|100996392|FG002|STARTED|Overall Study||10||
48275174|NCT01464840|100996390|FG000|COMPLETED|Overall Study||10||
48275175|NCT01464840|100996391|FG001|COMPLETED|Overall Study||10||
48275176|NCT01464840|100996392|FG002|COMPLETED|Overall Study||10||
48275177|NCT01464840|100996390|FG000|NOT COMPLETED|Overall Study||0||
48275178|NCT01464840|100996391|FG001|NOT COMPLETED|Overall Study||0||
48275179|NCT01464840|100996392|FG002|NOT COMPLETED|Overall Study||0||
48275180|NCT02190903|100996393|FG000|STARTED|Overall Study||6||
48275181|NCT02190903|100996394|FG001|STARTED|Overall Study||6||
48275182|NCT02190903|100996393|FG000|COMPLETED|Overall Study||6||
48275183|NCT02190903|100996394|FG001|COMPLETED|Overall Study||6||
48275184|NCT02190903|100996393|FG000|NOT COMPLETED|Overall Study||0||
48275185|NCT02190903|100996394|FG001|NOT COMPLETED|Overall Study||0||
48275186|NCT02383940|100996395|FG000|STARTED|Overall Study||44||
48275187|NCT02383940|100996396|FG001|STARTED|Overall Study||43||
48275188|NCT02383940|100996395|FG000|Treated|Overall Study||42||
48275189|NCT02383940|100996396|FG001|Treated|Overall Study||43||
48275190|NCT02383940|100996395|FG000|COMPLETED|Overall Study||35||
48275191|NCT02383940|100996396|FG001|COMPLETED|Overall Study||40||
48275192|NCT02383940|100996395|FG000|NOT COMPLETED|Overall Study||9||
48275193|NCT02383940|100996396|FG001|NOT COMPLETED|Overall Study||3||
48275194|NCT01484431|100996397|FG000|STARTED|Period 1: Low Dose||6||
48275195|NCT01484431|100996398|FG001|STARTED|Period 1: Low Dose||7||
48275196|NCT01484431|100996399|FG002|STARTED|Period 1: Low Dose||6||
48275197|NCT01484431|100996397|FG000|Received 2 mg|Period 1: Low Dose||1||
48275198|NCT01484431|100996398|FG001|Received 2 mg|Period 1: Low Dose||0||
48275199|NCT01484431|100996399|FG002|Received 2 mg|Period 1: Low Dose||0||
48275200|NCT01484431|100996397|FG000|Received 4 mg|Period 1: Low Dose||5||
48275201|NCT01484431|100996398|FG001|Received 4 mg|Period 1: Low Dose||0||
48275202|NCT01484431|100996399|FG002|Received 4 mg|Period 1: Low Dose||0||
48275203|NCT01484431|100996397|FG000|Received 5 mg|Period 1: Low Dose||0||
48275204|NCT01484431|100996398|FG001|Received 5 mg|Period 1: Low Dose||7||
48275205|NCT01484431|100996399|FG002|Received 5 mg|Period 1: Low Dose||0||
48275206|NCT01484431|100996397|FG000|Received 10 mg|Period 1: Low Dose||0||
48275207|NCT01484431|100996398|FG001|Received 10 mg|Period 1: Low Dose||0||
48275208|NCT01484431|100996399|FG002|Received 10 mg|Period 1: Low Dose||6||
48275209|NCT01484431|100996397|FG000|COMPLETED|Period 1: Low Dose||6||
48275210|NCT01484431|100996398|FG001|COMPLETED|Period 1: Low Dose||7||
48275211|NCT01484431|100996399|FG002|COMPLETED|Period 1: Low Dose||6||
48275212|NCT01484431|100996397|FG000|NOT COMPLETED|Period 1: Low Dose||0||
48275213|NCT01484431|100996398|FG001|NOT COMPLETED|Period 1: Low Dose||0||
48275214|NCT01484431|100996399|FG002|NOT COMPLETED|Period 1: Low Dose||0||
48275215|NCT01484431|100996397|FG000|STARTED|Period 1: High Dose||6||
48275216|NCT01484431|100996398|FG001|STARTED|Period 1: High Dose||7||
48275217|NCT01484431|100996399|FG002|STARTED|Period 1: High Dose||6||
48275218|NCT01484431|100996397|FG000|Received 8 mg|Period 1: High Dose||1||
48275219|NCT01484431|100996398|FG001|Received 8 mg|Period 1: High Dose||0||
48275220|NCT01484431|100996399|FG002|Received 8 mg|Period 1: High Dose||0||
48275221|NCT01484431|100996397|FG000|Received 10 mg|Period 1: High Dose||1||
48275222|NCT01484431|100996398|FG001|Received 10 mg|Period 1: High Dose||1||
48275223|NCT01484431|100996399|FG002|Received 10 mg|Period 1: High Dose||0||
48275224|NCT01484431|100996397|FG000|Received 15 mg|Period 1: High Dose||1||
48275225|NCT01484431|100996398|FG001|Received 15 mg|Period 1: High Dose||1||
48275226|NCT01484431|100996399|FG002|Received 15 mg|Period 1: High Dose||0||
48275227|NCT01484431|100996397|FG000|Received 20 mg|Period 1: High Dose||3||
48275228|NCT01484431|100996398|FG001|Received 20 mg|Period 1: High Dose||5||
48275229|NCT01484431|100996399|FG002|Received 20 mg|Period 1: High Dose||1||
48275230|NCT01484431|100996397|FG000|Received 40 mg|Period 1: High Dose||0||
48275231|NCT01484431|100996398|FG001|Received 40 mg|Period 1: High Dose||0||
48275232|NCT01484431|100996399|FG002|Received 40 mg|Period 1: High Dose||5||
48275233|NCT01484431|100996397|FG000|COMPLETED|Period 1: High Dose||6||
48275234|NCT01484431|100996398|FG001|COMPLETED|Period 1: High Dose||6||
48275235|NCT01484431|100996399|FG002|COMPLETED|Period 1: High Dose||6||
48275236|NCT01484431|100996397|FG000|NOT COMPLETED|Period 1: High Dose||0||
48275237|NCT01484431|100996398|FG001|NOT COMPLETED|Period 1: High Dose||1||
48275238|NCT01484431|100996399|FG002|NOT COMPLETED|Period 1: High Dose||0||
48275239|NCT01484431|100996397|FG000|STARTED|Period 2||6||
48275240|NCT01484431|100996398|FG001|STARTED|Period 2||6||
48275241|NCT01484431|100996399|FG002|STARTED|Period 2||6||
48275242|NCT01484431|100996397|FG000|Received 7 mg|Period 2||1||
48275243|NCT01484431|100996398|FG001|Received 7 mg|Period 2||0||
48275244|NCT01484431|100996399|FG002|Received 7 mg|Period 2||0||
48275245|NCT01484431|100996397|FG000|Received 7.5 mg|Period 2||0||
48275246|NCT01484431|100996398|FG001|Received 7.5 mg|Period 2||2||
48275247|NCT01484431|100996399|FG002|Received 7.5 mg|Period 2||0||
48275248|NCT01484431|100996397|FG000|Received 8 mg|Period 2||1||
48275249|NCT01484431|100996398|FG001|Received 8 mg|Period 2||0||
48275250|NCT01484431|100996399|FG002|Received 8 mg|Period 2||0||
48275251|NCT01484431|100996397|FG000|Received 10 mg|Period 2||0||
48275252|NCT01484431|100996398|FG001|Received 10 mg|Period 2||1||
48275253|NCT01484431|100996399|FG002|Received 10 mg|Period 2||0||
48275254|NCT01484431|100996397|FG000|Received 15 mg|Period 2||1||
48275255|NCT01484431|100996398|FG001|Received 15 mg|Period 2||2||
48275256|NCT01484431|100996399|FG002|Received 15 mg|Period 2||1||
48275257|NCT01484431|100996397|FG000|Received 20 mg|Period 2||3||
48275258|NCT01484431|100996398|FG001|Received 20 mg|Period 2||1||
48275259|NCT01484431|100996399|FG002|Received 20 mg|Period 2||4||
48275260|NCT01484431|100996397|FG000|Received 40 mg|Period 2||0||
48275261|NCT01484431|100996398|FG001|Received 40 mg|Period 2||0||
48275262|NCT01484431|100996399|FG002|Received 40 mg|Period 2||1||
48560976|NCT03591874|101705843|FG000|STARTED|Overall Study||40||
48112234|NCT02346240|100601437|FG010|STARTED|Open-Label Period (Week 48 to Week 144)||0||
48275263|NCT01484431|100996397|FG000|COMPLETED|Period 2||5||
48275264|NCT01484431|100996398|FG001|COMPLETED|Period 2||5||
48275265|NCT01484431|100996399|FG002|COMPLETED|Period 2||4||
48275266|NCT01484431|100996397|FG000|NOT COMPLETED|Period 2||1||
48275267|NCT01484431|100996398|FG001|NOT COMPLETED|Period 2||1||
48112235|NCT02346240|100601438|FG011|STARTED|Open-Label Period (Week 48 to Week 144)||0||
48112236|NCT02346240|100601439|FG012|STARTED|Open-Label Period (Week 48 to Week 144)||0||
48112237|NCT02346240|100601440|FG013|STARTED|Open-Label Period (Week 48 to Week 144)||0||
48112238|NCT02346240|100601441|FG014|STARTED|Open-Label Period (Week 48 to Week 144)||0||
48112239|NCT02346240|100601442|FG015|STARTED|Open-Label Period (Week 48 to Week 144)||0||
48112240|NCT02346240|100601443|FG016|STARTED|Open-Label Period (Week 48 to Week 144)||0||
48112241|NCT02346240|100601444|FG017|STARTED|Open-Label Period (Week 48 to Week 144)||34||
48112242|NCT02346240|100601445|FG018|STARTED|Open-Label Period (Week 48 to Week 144)||122||
48112243|NCT02346240|100601446|FG019|STARTED|Open-Label Period (Week 48 to Week 144)||41||
48112244|NCT02346240|100601447|FG020|STARTED|Open-Label Period (Week 48 to Week 144)||48||
48112245|NCT02346240|100601448|FG021|STARTED|Open-Label Period (Week 48 to Week 144)||177||
48112246|NCT02346240|100601449|FG022|STARTED|Open-Label Period (Week 48 to Week 144)||34||
48112247|NCT02346240|100601450|FG023|STARTED|Open-Label Period (Week 48 to Week 144)||16||
48275268|NCT01484431|100996399|FG002|NOT COMPLETED|Period 2||2||
48275269|NCT00588900|100996400|FG000|STARTED|Overall Study||5||
48275270|NCT00588900|100996400|FG000|COMPLETED|Overall Study||5||
48275271|NCT00588900|100996400|FG000|NOT COMPLETED|Overall Study||0||
48275272|NCT00316017|100996401|FG000|STARTED|Overall Study||231||
48275273|NCT00316017|100996402|FG001|STARTED|Overall Study||269||
48275274|NCT00316017|100996403|FG002|STARTED|Overall Study||395||
48275275|NCT00316017|100996401|FG000|COMPLETED|Overall Study||220||
48275276|NCT00316017|100996402|FG001|COMPLETED|Overall Study||256||
48275277|NCT00316017|100996403|FG002|COMPLETED|Overall Study||376||
48393129|NCT00966693|101291513|FG003|Phase 2 Completed|Overall Study||46||
48393130|NCT00966693|101291510|FG000|COMPLETED|Overall Study||2||
48393131|NCT00966693|101291511|FG001|COMPLETED|Overall Study||3||
48393132|NCT00966693|101291512|FG002|COMPLETED|Overall Study||6||
48393133|NCT00966693|101291513|FG003|COMPLETED|Overall Study||26||
48393134|NCT00966693|101291510|FG000|NOT COMPLETED|Overall Study||1||
48393135|NCT00966693|101291511|FG001|NOT COMPLETED|Overall Study||0||
48393136|NCT00966693|101291512|FG002|NOT COMPLETED|Overall Study||3||
48393137|NCT00966693|101291513|FG003|NOT COMPLETED|Overall Study||23||
48393138|NCT02939599|101291514|FG000|STARTED|Overall Study||3||
48393139|NCT02939599|101291515|FG001|STARTED|Overall Study||2||
48393140|NCT02939599|101291514|FG000|COMPLETED|Overall Study||0||
48112248|NCT02346240|100601427|FG000|COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
48112249|NCT02346240|100601428|FG001|COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
48112250|NCT02346240|100601429|FG002|COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
48112251|NCT02346240|100601430|FG003|COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
48275278|NCT00316017|100996401|FG000|NOT COMPLETED|Overall Study||11||
48275279|NCT00316017|100996402|FG001|NOT COMPLETED|Overall Study||13||
48275280|NCT00316017|100996403|FG002|NOT COMPLETED|Overall Study||19||
48275281|NCT02311673|100996404|FG000|STARTED|Placebo Run-in Period 1 (2 Weeks)||0||
48275282|NCT02311673|100996405|FG001|STARTED|Placebo Run-in Period 1 (2 Weeks)||0||
48275283|NCT02311673|100996406|FG002|STARTED|Placebo Run-in Period 1 (2 Weeks)||0||
48275284|NCT02311673|100996407|FG003|STARTED|Placebo Run-in Period 1 (2 Weeks)||40||
48275285|NCT02311673|100996404|FG000|COMPLETED|Placebo Run-in Period 1 (2 Weeks)||0||
48275286|NCT02311673|100996405|FG001|COMPLETED|Placebo Run-in Period 1 (2 Weeks)||0||
48393141|NCT02939599|101291515|FG001|COMPLETED|Overall Study||0||
48393142|NCT02939599|101291514|FG000|NOT COMPLETED|Overall Study||3||
48112252|NCT02346240|100601431|FG004|COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
48112253|NCT02346240|100601432|FG005|COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
48275287|NCT02311673|100996406|FG002|COMPLETED|Placebo Run-in Period 1 (2 Weeks)||0||
48275288|NCT02311673|100996407|FG003|COMPLETED|Placebo Run-in Period 1 (2 Weeks)||40||
48275289|NCT02311673|100996404|FG000|NOT COMPLETED|Placebo Run-in Period 1 (2 Weeks)||0||
48275290|NCT02311673|100996405|FG001|NOT COMPLETED|Placebo Run-in Period 1 (2 Weeks)||0||
48275291|NCT02311673|100996406|FG002|NOT COMPLETED|Placebo Run-in Period 1 (2 Weeks)||0||
48275292|NCT02311673|100996407|FG003|NOT COMPLETED|Placebo Run-in Period 1 (2 Weeks)||0||
48275293|NCT02311673|100996404|FG000|STARTED|Double-blind Randomized Period 2 (4 Wks)||4|Forty participants who completed placebo single-blind run-in period entered the double-blind randomized treatment period. Fifteen participants continued placebo and 25 participants were randomized to other treatment groups in the double-blind randomized treatment period.|
48393143|NCT02939599|101291515|FG001|NOT COMPLETED|Overall Study||2||
48393144|NCT02198651|101291516|FG000|STARTED|Lead-in Period||149||
48393145|NCT02198651|101291517|FG001|STARTED|Lead-in Period||0||
48275294|NCT02311673|100996405|FG001|STARTED|Double-blind Randomized Period 2 (4 Wks)||13|Forty participants who completed placebo single-blind run-in period entered the double-blind randomized treatment period. Fifteen participants continued placebo and 25 participants were randomized to other treatment groups in the double-blind randomized treatment period.|
48275295|NCT02311673|100996406|FG002|STARTED|Double-blind Randomized Period 2 (4 Wks)||8|Forty participants who completed placebo single-blind run-in period entered the double-blind randomized treatment period. Fifteen participants continued placebo and 25 participants were randomized to other treatment groups in the double-blind randomized treatment period.|
48393146|NCT02198651|101291518|FG002|STARTED|Lead-in Period||0||
48560977|NCT03591874|101705844|FG001|STARTED|Overall Study||19||
48560978|NCT03591874|101705843|FG000|Received at Least 1 Study Treatment|Overall Study||29||
48560979|NCT03591874|101705844|FG001|Received at Least 1 Study Treatment|Overall Study||16||
48560980|NCT03591874|101705843|FG000|COMPLETED|Overall Study||21||
48560981|NCT03591874|101705844|FG001|COMPLETED|Overall Study||12||
48560982|NCT03591874|101705843|FG000|NOT COMPLETED|Overall Study||19||
48560983|NCT03591874|101705844|FG001|NOT COMPLETED|Overall Study||7||
48560984|NCT02515331|101705845|FG000|STARTED|Overall Study||17||
48112254|NCT02346240|100601433|FG006|COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
48112255|NCT02346240|100601434|FG007|COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
48112256|NCT02346240|100601435|FG008|COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
48112257|NCT02346240|100601436|FG009|COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
48112258|NCT02346240|100601437|FG010|COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
48112259|NCT02346240|100601438|FG011|COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
48112260|NCT02346240|100601439|FG012|COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
48112261|NCT02346240|100601440|FG013|COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
48112262|NCT02346240|100601441|FG014|COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
48112263|NCT02346240|100601442|FG015|COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
48112264|NCT02346240|100601443|FG016|COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
48112265|NCT02346240|100601444|FG017|COMPLETED|Open-Label Period (Week 48 to Week 144)||31||
48112266|NCT02346240|100601445|FG018|COMPLETED|Open-Label Period (Week 48 to Week 144)||105||
48112267|NCT02346240|100601446|FG019|COMPLETED|Open-Label Period (Week 48 to Week 144)||34||
48112268|NCT02346240|100601447|FG020|COMPLETED|Open-Label Period (Week 48 to Week 144)||45||
48112269|NCT02346240|100601448|FG021|COMPLETED|Open-Label Period (Week 48 to Week 144)||146||
48112270|NCT02346240|100601449|FG022|COMPLETED|Open-Label Period (Week 48 to Week 144)||27||
48112271|NCT02346240|100601450|FG023|COMPLETED|Open-Label Period (Week 48 to Week 144)||8||
48112272|NCT02346240|100601427|FG000|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
48112273|NCT02346240|100601428|FG001|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
48112274|NCT02346240|100601429|FG002|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
48112275|NCT02346240|100601430|FG003|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
48112276|NCT02346240|100601431|FG004|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
48112277|NCT02346240|100601432|FG005|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
48112278|NCT02346240|100601433|FG006|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
48112279|NCT02346240|100601434|FG007|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
48112280|NCT02346240|100601435|FG008|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
48112281|NCT02346240|100601436|FG009|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
48112282|NCT02346240|100601437|FG010|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
48112283|NCT02346240|100601438|FG011|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
48112284|NCT02346240|100601439|FG012|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
48112285|NCT02346240|100601440|FG013|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
48112286|NCT02346240|100601441|FG014|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
48112287|NCT02346240|100601442|FG015|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
48112288|NCT02346240|100601443|FG016|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
48112289|NCT02346240|100601444|FG017|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||3||
48112290|NCT02346240|100601445|FG018|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||17||
48112291|NCT02346240|100601446|FG019|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||7||
48112292|NCT02346240|100601447|FG020|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||3||
48112293|NCT02346240|100601448|FG021|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||31||
48112294|NCT02346240|100601449|FG022|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||7||
48112295|NCT02346240|100601450|FG023|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||8||
48112296|NCT02840877|100601451|FG000|STARTED|Baseline to 12 Weeks||303||
48112297|NCT02840877|100601451|FG000|COMPLETED|Baseline to 12 Weeks||282||
48112298|NCT02840877|100601451|FG000|NOT COMPLETED|Baseline to 12 Weeks||21||
48112299|NCT02840877|100601451|FG000|STARTED|12 Weeks to 6 Months||282||
48112300|NCT02840877|100601451|FG000|COMPLETED|12 Weeks to 6 Months||271||
48112301|NCT02840877|100601451|FG000|NOT COMPLETED|12 Weeks to 6 Months||11||
48112302|NCT02840877|100601451|FG000|STARTED|6 Months to 18 Months||271||
48112303|NCT02840877|100601451|FG000|COMPLETED|6 Months to 18 Months||205||
48112304|NCT02840877|100601451|FG000|NOT COMPLETED|6 Months to 18 Months||66||
48112305|NCT03019627|100601452|FG000|STARTED|Overall Study||100||
48560985|NCT02515331|101705846|FG001|STARTED|Overall Study||15||
48560986|NCT02515331|101705847|FG002|STARTED|Overall Study||32||
48560987|NCT02515331|101705845|FG000|Primary Pharmacodynamic Analysis Set|Overall Study||15||
48393147|NCT02198651|101291519|FG003|STARTED|Lead-in Period||0||
48393148|NCT02198651|101291520|FG004|STARTED|Lead-in Period||0||
48393149|NCT02198651|101291516|FG000|Participants Treated in Lead-In Period|Lead-in Period||146||
48112306|NCT03019627|100601453|FG001|STARTED|Overall Study||50||
48112307|NCT03019627|100601452|FG000|COMPLETED|Overall Study||85||
48112308|NCT03019627|100601453|FG001|COMPLETED|Overall Study||42||
48112309|NCT03019627|100601452|FG000|NOT COMPLETED|Overall Study||15||
48112310|NCT03019627|100601453|FG001|NOT COMPLETED|Overall Study||8||
48112311|NCT02927457|100601454|FG000|STARTED|Overall Study||0||
48112312|NCT02927457|100601455|FG001|STARTED|Overall Study||11||
48112313|NCT02927457|100601454|FG000|COMPLETED|Overall Study||0||
48112314|NCT02927457|100601455|FG001|COMPLETED|Overall Study||11||
48112315|NCT02927457|100601454|FG000|NOT COMPLETED|Overall Study||0||
48112316|NCT02927457|100601455|FG001|NOT COMPLETED|Overall Study||0||
48112317|NCT00542750|100601456|FG000|STARTED|Overall Study||24||
48112318|NCT00542750|100601456|FG000|COMPLETED|Overall Study||24||
48112319|NCT00542750|100601456|FG000|NOT COMPLETED|Overall Study||0||
48112320|NCT03945981|100601457|FG000|STARTED|Overall Study||131||
48112321|NCT03945981|100601457|FG000|COMPLETED|Overall Study||108||
48112322|NCT03945981|100601457|FG000|NOT COMPLETED|Overall Study||23||
48112323|NCT01393743|100601458|FG000|STARTED|Core Study||82||
48112324|NCT01393743|100601459|FG001|STARTED|Core Study||81||
48112325|NCT01393743|100601460|FG002|STARTED|Core Study||0||
48112326|NCT01393743|100601458|FG000|COMPLETED|Core Study||72||
48112327|NCT01393743|100601459|FG001|COMPLETED|Core Study||68||
48112328|NCT01393743|100601460|FG002|COMPLETED|Core Study||0||
48112329|NCT01393743|100601458|FG000|NOT COMPLETED|Core Study||10||
48112330|NCT01393743|100601459|FG001|NOT COMPLETED|Core Study||13||
48112331|NCT01393743|100601460|FG002|NOT COMPLETED|Core Study||0||
48112332|NCT01393743|100601458|FG000|STARTED|Extension Phase||0||
48112333|NCT01393743|100601459|FG001|STARTED|Extension Phase||0||
48112334|NCT01393743|100601460|FG002|STARTED|Extension Phase||138||
48112335|NCT01393743|100601458|FG000|COMPLETED|Extension Phase||0||
48112336|NCT01393743|100601459|FG001|COMPLETED|Extension Phase||0||
48112337|NCT01393743|100601460|FG002|COMPLETED|Extension Phase||78||
48112338|NCT01393743|100601458|FG000|NOT COMPLETED|Extension Phase||0||
48112339|NCT01393743|100601459|FG001|NOT COMPLETED|Extension Phase||0||
48112340|NCT01393743|100601460|FG002|NOT COMPLETED|Extension Phase||60||
48112341|NCT01762943|100601461|FG000|STARTED|Overall Study||19||
48112342|NCT01762943|100601462|FG001|STARTED|Overall Study||17||
48112343|NCT01762943|100601461|FG000|Hypogonadism|Overall Study||18||
48112344|NCT01762943|100601462|FG001|Hypogonadism|Overall Study||15||
48112345|NCT01762943|100601461|FG000|Addback|Overall Study||16||
48112346|NCT01762943|100601462|FG001|Addback|Overall Study||15||
48112347|NCT01762943|100601461|FG000|Withdrawal|Overall Study||15||
48112348|NCT01762943|100601462|FG001|Withdrawal|Overall Study||15||
48112349|NCT01762943|100601461|FG000|COMPLETED|Overall Study||15||
48112350|NCT01762943|100601462|FG001|COMPLETED|Overall Study||15||
48112351|NCT01762943|100601461|FG000|NOT COMPLETED|Overall Study||4||
48112352|NCT01762943|100601462|FG001|NOT COMPLETED|Overall Study||2||
48112353|NCT00742313|100601463|FG000|STARTED|Overall Study||25||
48112354|NCT00742313|100601464|FG001|STARTED|Overall Study||19||
48112355|NCT00742313|100601463|FG000|COMPLETED|Overall Study||24||
48112356|NCT00742313|100601464|FG001|COMPLETED|Overall Study||19||
48393150|NCT02198651|101291517|FG001|Participants Treated in Lead-In Period|Lead-in Period||0||
48112357|NCT00742313|100601463|FG000|NOT COMPLETED|Overall Study||1||
48112358|NCT00742313|100601464|FG001|NOT COMPLETED|Overall Study||0||
48112359|NCT00655564|100601465|FG000|STARTED|Overall Study||15||
48112360|NCT00655564|100601465|FG000|COMPLETED|Overall Study||12||
48112361|NCT00655564|100601465|FG000|NOT COMPLETED|Overall Study||3||
48112362|NCT04076644|100601466|FG000|STARTED|Overall Study||11||
48112363|NCT04076644|100601466|FG000|COMPLETED|Overall Study||7||
48112364|NCT04076644|100601466|FG000|NOT COMPLETED|Overall Study||4||
48112365|NCT02002494|100601467|FG000|STARTED|Overall Study||27||
48112366|NCT02002494|100601467|FG000|COMPLETED|Overall Study||27||
48112367|NCT02002494|100601467|FG000|NOT COMPLETED|Overall Study||0||
48112368|NCT02016963|100601468|FG000|STARTED|Overall Study||20||
48112369|NCT02016963|100601468|FG000|COMPLETED|Overall Study||20||
48112370|NCT02016963|100601468|FG000|NOT COMPLETED|Overall Study||0||
48112371|NCT00499603|100601469|FG000|STARTED|Overall Study||27||
48112372|NCT00499603|100601470|FG001|STARTED|Overall Study||23||
48112373|NCT00499603|100601469|FG000|COMPLETED|Overall Study||27||
48112374|NCT00499603|100601470|FG001|COMPLETED|Overall Study||22||
48112375|NCT00499603|100601469|FG000|NOT COMPLETED|Overall Study||0||
48112376|NCT00499603|100601470|FG001|NOT COMPLETED|Overall Study||1||
48112377|NCT02281851|100601471|FG000|STARTED|Overall Study||4||
48112378|NCT02281851|100601472|FG001|STARTED|Overall Study||10||
48112379|NCT02281851|100601471|FG000|COMPLETED|Overall Study||4||
48112380|NCT02281851|100601472|FG001|COMPLETED|Overall Study||10||
48112381|NCT02281851|100601471|FG000|NOT COMPLETED|Overall Study||0||
48112382|NCT02281851|100601472|FG001|NOT COMPLETED|Overall Study||0||
48112383|NCT02457325|100601473|FG000|STARTED|First Intervention (1 Day)||25||
48112384|NCT02457325|100601474|FG001|STARTED|First Intervention (1 Day)||25||
48112385|NCT02457325|100601473|FG000|COMPLETED|First Intervention (1 Day)||23||
48112386|NCT02457325|100601474|FG001|COMPLETED|First Intervention (1 Day)||23||
48275296|NCT02311673|100996407|FG003|STARTED|Double-blind Randomized Period 2 (4 Wks)||15|Forty participants who completed placebo single-blind run-in period entered the double-blind randomized treatment period. Fifteen participants continued placebo and 25 participants were randomized to other treatment groups in the double-blind randomized treatment period.|
48275297|NCT02311673|100996404|FG000|COMPLETED|Double-blind Randomized Period 2 (4 Wks)||4||
48275298|NCT02311673|100996405|FG001|COMPLETED|Double-blind Randomized Period 2 (4 Wks)||13||
48275299|NCT02311673|100996406|FG002|COMPLETED|Double-blind Randomized Period 2 (4 Wks)||7||
48275300|NCT02311673|100996407|FG003|COMPLETED|Double-blind Randomized Period 2 (4 Wks)||15||
48275301|NCT02311673|100996404|FG000|NOT COMPLETED|Double-blind Randomized Period 2 (4 Wks)||0||
48275302|NCT02311673|100996405|FG001|NOT COMPLETED|Double-blind Randomized Period 2 (4 Wks)||0||
48275303|NCT02311673|100996406|FG002|NOT COMPLETED|Double-blind Randomized Period 2 (4 Wks)||1||
48275304|NCT02311673|100996407|FG003|NOT COMPLETED|Double-blind Randomized Period 2 (4 Wks)||0||
48275305|NCT02311673|100996404|FG000|STARTED|Randomized Withdrawal Period 3 (2 Weeks)||3|After completion of Period 2, a randomized withdrawal (Period 3) was initiated; participants within each of the setmelanotide groups were randomized 1:1; participants who had received setmelanotide were either continued at the current active dose, or switched to placebo treatment. Participants administered placebo during Period 2 were randomized 1:1 in Period 3 and either continued to receive placebo or began to receive setmelanotide.|
48275306|NCT02311673|100996405|FG001|STARTED|Randomized Withdrawal Period 3 (2 Weeks)||10|After completion of Period 2, a randomized withdrawal (Period 3) was initiated; participants within each of the setmelanotide groups were randomized 1:1; participants who had received setmelanotide were either continued at the current active dose, or switched to placebo treatment. Participants administered placebo during Period 2 were randomized 1:1 in Period 3 and either continued to receive placebo or began to receive setmelanotide.|
48294160|NCT02527343|101047540|FG004|STARTED|OLE Period-Year 2: Week 105 to 156||1||
48294161|NCT02527343|101047541|FG005|STARTED|OLE Period-Year 2: Week 105 to 156||2||
48294162|NCT02527343|101047536|FG000|COMPLETED|OLE Period-Year 2: Week 105 to 156||0||
48294163|NCT02527343|101047537|FG001|COMPLETED|OLE Period-Year 2: Week 105 to 156||0||
48560988|NCT02515331|101705846|FG001|Primary Pharmacodynamic Analysis Set|Overall Study||14||
48560989|NCT02515331|101705847|FG002|Primary Pharmacodynamic Analysis Set|Overall Study||29||
48560990|NCT02515331|101705845|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||17||
48560991|NCT02515331|101705846|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||15||
48560992|NCT02515331|101705847|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||0||
48560993|NCT02515331|101705845|FG000|COMPLETED|Overall Study||15||
48560994|NCT02515331|101705846|FG001|COMPLETED|Overall Study||15||
48560995|NCT02515331|101705847|FG002|COMPLETED|Overall Study||28||
48560996|NCT02515331|101705845|FG000|NOT COMPLETED|Overall Study||2||
48560997|NCT02515331|101705846|FG001|NOT COMPLETED|Overall Study||0||
48560998|NCT02515331|101705847|FG002|NOT COMPLETED|Overall Study||4||
48560999|NCT05271175|101705848|FG000|STARTED|Treatment||34||
48561000|NCT05271175|101705849|FG001|STARTED|Treatment||33||
48561001|NCT05271175|101705850|FG002|STARTED|Treatment||37||
48561002|NCT05271175|101705848|FG000|COMPLETED|Treatment||29||
48561003|NCT05271175|101705849|FG001|COMPLETED|Treatment||30||
48112387|NCT02457325|100601473|FG000|NOT COMPLETED|First Intervention (1 Day)||2||
48112388|NCT02457325|100601474|FG001|NOT COMPLETED|First Intervention (1 Day)||2||
48112389|NCT02457325|100601473|FG000|STARTED|Washout (1-2 Months)||23||
48112390|NCT02457325|100601474|FG001|STARTED|Washout (1-2 Months)||23||
48112391|NCT02457325|100601473|FG000|COMPLETED|Washout (1-2 Months)||23||
48112392|NCT02457325|100601474|FG001|COMPLETED|Washout (1-2 Months)||23||
48112393|NCT02457325|100601473|FG000|NOT COMPLETED|Washout (1-2 Months)||0||
48112394|NCT02457325|100601474|FG001|NOT COMPLETED|Washout (1-2 Months)||0||
48112395|NCT02457325|100601473|FG000|STARTED|Second Intervention (1 Day)||23||
48112396|NCT02457325|100601474|FG001|STARTED|Second Intervention (1 Day)||23||
48112397|NCT02457325|100601473|FG000|COMPLETED|Second Intervention (1 Day)||23||
48112398|NCT02457325|100601474|FG001|COMPLETED|Second Intervention (1 Day)||23||
48112399|NCT02457325|100601473|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48112400|NCT02457325|100601474|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48112401|NCT01971346|100601475|FG000|STARTED|Overall Study||50||
48112402|NCT01971346|100601475|FG000|COMPLETED|Overall Study||42||
48112403|NCT01971346|100601475|FG000|NOT COMPLETED|Overall Study||8||
48112404|NCT02561130|100601476|FG000|STARTED|Overall Study||77||
48112405|NCT02561130|100601477|FG001|STARTED|Overall Study||77||
48112406|NCT02561130|100601476|FG000|COMPLETED|Overall Study||76||
48112407|NCT02561130|100601477|FG001|COMPLETED|Overall Study||76||
48112408|NCT02561130|100601476|FG000|NOT COMPLETED|Overall Study||1||
48112409|NCT02561130|100601477|FG001|NOT COMPLETED|Overall Study||1||
48112410|NCT01691027|100601478|FG000|STARTED|Scotoma Awareness||4||
48112411|NCT01691027|100601478|FG000|COMPLETED|Scotoma Awareness||4||
48112412|NCT01691027|100601478|FG000|NOT COMPLETED|Scotoma Awareness||0||
48112413|NCT01691027|100601478|FG000|STARTED|Line and Circle Tracing Training||4||
48112414|NCT01691027|100601478|FG000|COMPLETED|Line and Circle Tracing Training||4||
48112415|NCT01691027|100601478|FG000|NOT COMPLETED|Line and Circle Tracing Training||0||
48112416|NCT01691027|100601478|FG000|STARTED|Video Games Training||4||
48112417|NCT01691027|100601478|FG000|COMPLETED|Video Games Training||4||
48112418|NCT01691027|100601478|FG000|NOT COMPLETED|Video Games Training||0||
48112419|NCT05091307|100601479|FG000|STARTED|Overall Study||382|Randomized participants|
48112420|NCT05091307|100601480|FG001|STARTED|Overall Study||386|Randomized participants|
48275307|NCT02311673|100996406|FG002|STARTED|Randomized Withdrawal Period 3 (2 Weeks)||5|After completion of Period 2, a randomized withdrawal (Period 3) was initiated; participants within each of the setmelanotide groups were randomized 1:1; participants who had received setmelanotide were either continued at the current active dose, or switched to placebo treatment. Participants administered placebo during Period 2 were randomized 1:1 in Period 3 and either continued to receive placebo or began to receive setmelanotide.|
48275308|NCT02311673|100996407|FG003|STARTED|Randomized Withdrawal Period 3 (2 Weeks)||20|After completion of Period 2, a randomized withdrawal (Period 3) was initiated; participants within each of the setmelanotide groups were randomized 1:1; participants who had received setmelanotide were either continued at the current active dose, or switched to placebo treatment. Participants administered placebo during Period 2 were randomized 1:1 in Period 3 and either continued to receive placebo or began to receive setmelanotide.|
48275309|NCT02311673|100996404|FG000|COMPLETED|Randomized Withdrawal Period 3 (2 Weeks)||3||
48275310|NCT02311673|100996405|FG001|COMPLETED|Randomized Withdrawal Period 3 (2 Weeks)||10||
48275311|NCT02311673|100996406|FG002|COMPLETED|Randomized Withdrawal Period 3 (2 Weeks)||5||
48695820|NCT03530995|102038618|FG001|COMPLETED|Part 1 Period 1; Part 2 Period 1||38||
48695821|NCT03530995|102038617|FG000|NOT COMPLETED|Part 1 Period 1; Part 2 Period 1||0||
48695822|NCT03530995|102038618|FG001|NOT COMPLETED|Part 1 Period 1; Part 2 Period 1||0||
48695823|NCT03530995|102038617|FG000|STARTED|Part 1 Period 2; Part 2 Period 2||35||
48695824|NCT03530995|102038618|FG001|STARTED|Part 1 Period 2; Part 2 Period 2||38||
48695825|NCT03530995|102038617|FG000|COMPLETED|Part 1 Period 2; Part 2 Period 2||35||
48695826|NCT03530995|102038618|FG001|COMPLETED|Part 1 Period 2; Part 2 Period 2||38||
48695827|NCT03530995|102038617|FG000|NOT COMPLETED|Part 1 Period 2; Part 2 Period 2||0||
48695828|NCT03530995|102038618|FG001|NOT COMPLETED|Part 1 Period 2; Part 2 Period 2||0||
48695829|NCT03530995|102038617|FG000|STARTED|Part 1 Period 3||35||
48695830|NCT03530995|102038618|FG001|STARTED|Part 1 Period 3||0||
48695831|NCT03530995|102038617|FG000|COMPLETED|Part 1 Period 3||32||
48695832|NCT03530995|102038618|FG001|COMPLETED|Part 1 Period 3||0||
48695833|NCT03530995|102038617|FG000|NOT COMPLETED|Part 1 Period 3||3||
48695834|NCT03530995|102038618|FG001|NOT COMPLETED|Part 1 Period 3||0||
48695835|NCT03530995|102038617|FG000|STARTED|Part 1 Period 4||32||
48561004|NCT05271175|101705850|FG002|COMPLETED|Treatment||30||
48695836|NCT03530995|102038618|FG001|STARTED|Part 1 Period 4||0||
48695837|NCT03530995|102038617|FG000|COMPLETED|Part 1 Period 4||30||
48695838|NCT03530995|102038618|FG001|COMPLETED|Part 1 Period 4||0||
48695839|NCT03530995|102038617|FG000|NOT COMPLETED|Part 1 Period 4||2||
48695840|NCT03530995|102038618|FG001|NOT COMPLETED|Part 1 Period 4||0||
48695841|NCT02027311|102038619|FG000|STARTED|Overall Study||33||
48695842|NCT02027311|102038620|FG001|STARTED|Overall Study||35||
48695843|NCT02027311|102038619|FG000|COMPLETED|Overall Study||30||
48695844|NCT02027311|102038620|FG001|COMPLETED|Overall Study||33||
48275312|NCT02311673|100996407|FG003|COMPLETED|Randomized Withdrawal Period 3 (2 Weeks)||20||
48561005|NCT05271175|101705848|FG000|NOT COMPLETED|Treatment||5||
48561006|NCT05271175|101705849|FG001|NOT COMPLETED|Treatment||3||
48561007|NCT05271175|101705850|FG002|NOT COMPLETED|Treatment||7||
48561008|NCT05271175|101705848|FG000|STARTED|One Week Follow up||29||
48561009|NCT05271175|101705849|FG001|STARTED|One Week Follow up||30||
48561010|NCT05271175|101705850|FG002|STARTED|One Week Follow up||30||
48561011|NCT05271175|101705848|FG000|COMPLETED|One Week Follow up||19||
48561012|NCT05271175|101705849|FG001|COMPLETED|One Week Follow up||23||
48561013|NCT05271175|101705850|FG002|COMPLETED|One Week Follow up||25||
48561014|NCT05271175|101705848|FG000|NOT COMPLETED|One Week Follow up||10||
48561015|NCT05271175|101705849|FG001|NOT COMPLETED|One Week Follow up||7||
48561016|NCT05271175|101705850|FG002|NOT COMPLETED|One Week Follow up||5||
48561017|NCT05271175|101705848|FG000|STARTED|One Month Follow up||29|Αll participants who completed the study (n=89) were asked to complete the one-month follow-up, regardless of whether they completed the one-week follow-up.|
48561018|NCT05271175|101705849|FG001|STARTED|One Month Follow up||30|Αll participants who completed the study (n=89) were asked to complete the one-month follow-up, regardless of whether they completed the one-week follow-up.|
48695845|NCT02027311|102038619|FG000|NOT COMPLETED|Overall Study||3||
48695846|NCT02027311|102038620|FG001|NOT COMPLETED|Overall Study||2||
48695847|NCT01591837|102038621|FG000|STARTED|Overall Study||60||
48695848|NCT01591837|102038622|FG001|STARTED|Overall Study||60||
48695849|NCT01591837|102038621|FG000|COMPLETED|Overall Study||60||
48695850|NCT01591837|102038622|FG001|COMPLETED|Overall Study||60||
48695851|NCT01591837|102038621|FG000|NOT COMPLETED|Overall Study||0||
48695852|NCT01591837|102038622|FG001|NOT COMPLETED|Overall Study||0||
48695853|NCT04493424|102038623|FG000|STARTED|Overall Study||108||
48695854|NCT04493424|102038623|FG000|COMPLETED|Overall Study||0||
48695855|NCT04493424|102038623|FG000|NOT COMPLETED|Overall Study||108||
48695856|NCT01006655|102038624|FG000|STARTED|First Intervention||11||
48695857|NCT01006655|102038625|FG001|STARTED|First Intervention||10||
48695858|NCT01006655|102038624|FG000|COMPLETED|First Intervention||11||
48695859|NCT01006655|102038625|FG001|COMPLETED|First Intervention||10||
48695860|NCT01006655|102038624|FG000|NOT COMPLETED|First Intervention||0||
48275313|NCT02311673|100996404|FG000|NOT COMPLETED|Randomized Withdrawal Period 3 (2 Weeks)||0||
48275314|NCT02311673|100996405|FG001|NOT COMPLETED|Randomized Withdrawal Period 3 (2 Weeks)||0||
48275315|NCT02311673|100996406|FG002|NOT COMPLETED|Randomized Withdrawal Period 3 (2 Weeks)||0||
48275316|NCT02311673|100996407|FG003|NOT COMPLETED|Randomized Withdrawal Period 3 (2 Weeks)||0||
48275317|NCT02311673|100996404|FG000|STARTED|Open-label Extension Period 4 (2 Weeks)||0|Period 4 was a follow-up, open-label extension available to participants who completed the first 3 periods and wanted to continue treatment. In Period 4, all participants were to receive either setmelanotide 1.5 mg or setmelanotide 2.5 mg.|
48275318|NCT02311673|100996405|FG001|STARTED|Open-label Extension Period 4 (2 Weeks)||22|Period 4 was a follow-up, open-label extension available to participants who completed the first 3 periods and wanted to continue treatment. In Period 4, all participants were to receive either setmelanotide 1.5 mg or setmelanotide 2.5 mg.|
48275319|NCT02311673|100996406|FG002|STARTED|Open-label Extension Period 4 (2 Weeks)||16|Period 4 was a follow-up, open-label extension available to participants who completed the first 3 periods and wanted to continue treatment. In Period 4, all participants were to receive either setmelanotide 1.5 mg or setmelanotide 2.5 mg.|
48275320|NCT02311673|100996407|FG003|STARTED|Open-label Extension Period 4 (2 Weeks)||1|Period 4 was a follow-up, open-label extension available to participants who completed the first 3 periods and wanted to continue treatment. In Period 4, all participants were to receive either setmelanotide 1.5 mg or setmelanotide 2.5 mg.|
48275321|NCT02311673|100996404|FG000|COMPLETED|Open-label Extension Period 4 (2 Weeks)||0||
48275322|NCT02311673|100996405|FG001|COMPLETED|Open-label Extension Period 4 (2 Weeks)||22||
48275323|NCT02311673|100996406|FG002|COMPLETED|Open-label Extension Period 4 (2 Weeks)||16||
48561019|NCT05271175|101705850|FG002|STARTED|One Month Follow up||30|Αll participants who completed the study (n=89) were asked to complete the one-month follow-up, regardless of whether they completed the one-week follow-up.|
48561020|NCT05271175|101705848|FG000|COMPLETED|One Month Follow up||17||
48561021|NCT05271175|101705849|FG001|COMPLETED|One Month Follow up||23||
48561022|NCT05271175|101705850|FG002|COMPLETED|One Month Follow up||21||
48561023|NCT05271175|101705848|FG000|NOT COMPLETED|One Month Follow up||12||
48275324|NCT02311673|100996407|FG003|COMPLETED|Open-label Extension Period 4 (2 Weeks)||1||
48275325|NCT02311673|100996404|FG000|NOT COMPLETED|Open-label Extension Period 4 (2 Weeks)||0||
48275326|NCT02311673|100996405|FG001|NOT COMPLETED|Open-label Extension Period 4 (2 Weeks)||0||
48275327|NCT02311673|100996406|FG002|NOT COMPLETED|Open-label Extension Period 4 (2 Weeks)||0||
48275328|NCT02311673|100996407|FG003|NOT COMPLETED|Open-label Extension Period 4 (2 Weeks)||0||
48275329|NCT01685229|100996408|FG000|STARTED|Overall Study||146||
48275330|NCT01685229|100996409|FG001|STARTED|Overall Study||52||
48275331|NCT01685229|100996408|FG000|COMPLETED|Overall Study||120||
48275332|NCT01685229|100996409|FG001|COMPLETED|Overall Study||36||
48275333|NCT01685229|100996408|FG000|NOT COMPLETED|Overall Study||26||
48275334|NCT01685229|100996409|FG001|NOT COMPLETED|Overall Study||16||
48275335|NCT01476449|100996410|FG000|STARTED|Overall Study||10||
48275336|NCT01476449|100996411|FG001|STARTED|Overall Study||10||
48275337|NCT01476449|100996410|FG000|COMPLETED|Overall Study||8||
48561024|NCT05271175|101705849|FG001|NOT COMPLETED|One Month Follow up||7||
48561025|NCT05271175|101705850|FG002|NOT COMPLETED|One Month Follow up||9||
48561026|NCT05271175|101705848|FG000|STARTED|Six Months Follow up||29|Αll participants who completed the study (n=89) were asked to complete the six-months follow-up, regardless of whether they completed the one-month follow-up.|
48561027|NCT05271175|101705849|FG001|STARTED|Six Months Follow up||30|Αll participants who completed the study (n=89) were asked to complete the six-months follow-up, regardless of whether they completed the one-month follow-up.|
48561028|NCT05271175|101705850|FG002|STARTED|Six Months Follow up||30|Αll participants who completed the study (n=89) were asked to complete the six-months follow-up, regardless of whether they completed the one-month follow-up.|
48275338|NCT01476449|100996411|FG001|COMPLETED|Overall Study||8||
48275339|NCT01476449|100996410|FG000|NOT COMPLETED|Overall Study||2||
48275340|NCT01476449|100996411|FG001|NOT COMPLETED|Overall Study||2||
48275341|NCT02120001|100996412|FG000|STARTED|Overall Study||17||
48275342|NCT02120001|100996413|FG001|STARTED|Overall Study||19||
48275343|NCT02120001|100996412|FG000|COMPLETED|Overall Study||17||
48275344|NCT02120001|100996413|FG001|COMPLETED|Overall Study||19||
48275345|NCT02120001|100996412|FG000|NOT COMPLETED|Overall Study||0||
48275346|NCT02120001|100996413|FG001|NOT COMPLETED|Overall Study||0||
48275347|NCT04307940|100996414|FG000|STARTED|Overall Study||90||
48275348|NCT04307940|100996415|FG001|STARTED|Overall Study||87||
48275349|NCT04307940|100996416|FG002|STARTED|Overall Study||44||
48275350|NCT04307940|100996414|FG000|COMPLETED|Overall Study||85||
48275351|NCT04307940|100996415|FG001|COMPLETED|Overall Study||84||
48275352|NCT04307940|100996416|FG002|COMPLETED|Overall Study||42||
48275353|NCT04307940|100996414|FG000|NOT COMPLETED|Overall Study||5||
48275354|NCT04307940|100996415|FG001|NOT COMPLETED|Overall Study||3||
48275355|NCT04307940|100996416|FG002|NOT COMPLETED|Overall Study||2||
48275356|NCT02706405|100996417|FG000|STARTED|Overall Study||5||
48275357|NCT02706405|100996418|FG001|STARTED|Overall Study||3||
48275358|NCT02706405|100996419|FG002|STARTED|Overall Study||3||
48275359|NCT02706405|100996420|FG003|STARTED|Overall Study||1||
48275360|NCT02706405|100996421|FG004|STARTED|Overall Study||1||
48275361|NCT02706405|100996422|FG005|STARTED|Overall Study||3||
48275362|NCT02706405|100996423|FG006|STARTED|Overall Study||6||
48275363|NCT02706405|100996424|FG007|STARTED|Overall Study||7||
48275364|NCT02706405|100996417|FG000|COMPLETED|Overall Study||1||
48275365|NCT02706405|100996418|FG001|COMPLETED|Overall Study||1||
48275366|NCT02706405|100996419|FG002|COMPLETED|Overall Study||3||
48561029|NCT05271175|101705848|FG000|COMPLETED|Six Months Follow up||21||
48561030|NCT05271175|101705849|FG001|COMPLETED|Six Months Follow up||28||
48561031|NCT05271175|101705850|FG002|COMPLETED|Six Months Follow up||28||
48561032|NCT05271175|101705848|FG000|NOT COMPLETED|Six Months Follow up||8||
48561033|NCT05271175|101705849|FG001|NOT COMPLETED|Six Months Follow up||2||
48561034|NCT05271175|101705850|FG002|NOT COMPLETED|Six Months Follow up||2||
48561035|NCT00692692|101705851|FG000|STARTED|Overall Study||20||
48561036|NCT00692692|101705852|FG001|STARTED|Overall Study||16||
48561037|NCT00692692|101705851|FG000|COMPLETED|Overall Study||20||
48561038|NCT00692692|101705852|FG001|COMPLETED|Overall Study||16||
48561039|NCT00692692|101705851|FG000|NOT COMPLETED|Overall Study||0||
48275367|NCT02706405|100996420|FG003|COMPLETED|Overall Study||0||
48275368|NCT02706405|100996421|FG004|COMPLETED|Overall Study||1||
48275369|NCT02706405|100996422|FG005|COMPLETED|Overall Study||2||
48275370|NCT02706405|100996423|FG006|COMPLETED|Overall Study||3||
48275371|NCT02706405|100996424|FG007|COMPLETED|Overall Study||1||
48275372|NCT02706405|100996417|FG000|NOT COMPLETED|Overall Study||4||
48275373|NCT02706405|100996418|FG001|NOT COMPLETED|Overall Study||2||
48561040|NCT00692692|101705852|FG001|NOT COMPLETED|Overall Study||0||
48561041|NCT00659711|101705853|FG000|STARTED|Overall Study||12||
48561042|NCT00659711|101705854|FG001|STARTED|Overall Study||10||
48561043|NCT00659711|101705853|FG000|COMPLETED|Overall Study||12||
48561044|NCT00659711|101705854|FG001|COMPLETED|Overall Study||10||
48561045|NCT00659711|101705853|FG000|NOT COMPLETED|Overall Study||0||
48561046|NCT00659711|101705854|FG001|NOT COMPLETED|Overall Study||0||
48561047|NCT03468218|101705855|FG000|STARTED|Overall Study||36||
48561048|NCT03468218|101705855|FG000|COMPLETED|Overall Study||11||
48561049|NCT03468218|101705855|FG000|NOT COMPLETED|Overall Study||25||
48561050|NCT00942357|101705856|FG000|STARTED|Overall Study||407||
48561051|NCT00942357|101705857|FG001|STARTED|Overall Study||406||
48561052|NCT00942357|101705856|FG000|COMPLETED|Overall Study||370||
48561053|NCT00942357|101705857|FG001|COMPLETED|Overall Study||366||
48561054|NCT00942357|101705856|FG000|NOT COMPLETED|Overall Study||37||
48561055|NCT00942357|101705857|FG001|NOT COMPLETED|Overall Study||40||
48561056|NCT01252095|101705858|FG000|STARTED|Overall Study||3||
48695861|NCT01006655|102038625|FG001|NOT COMPLETED|First Intervention||0||
48275374|NCT02706405|100996419|FG002|NOT COMPLETED|Overall Study||0||
48275375|NCT02706405|100996420|FG003|NOT COMPLETED|Overall Study||1||
48275376|NCT02706405|100996421|FG004|NOT COMPLETED|Overall Study||0||
48561057|NCT01252095|101705859|FG001|STARTED|Overall Study||1||
48561058|NCT01252095|101705858|FG000|COMPLETED|Overall Study||2||
48561059|NCT01252095|101705859|FG001|COMPLETED|Overall Study||1||
48561060|NCT01252095|101705858|FG000|NOT COMPLETED|Overall Study||1||
48561061|NCT01252095|101705859|FG001|NOT COMPLETED|Overall Study||0||
48561062|NCT03805412|101705860|FG000|STARTED|Overall Study||15||
48561063|NCT03805412|101705861|FG001|STARTED|Overall Study||8||
48561064|NCT03805412|101705860|FG000|COMPLETED|Overall Study||15||
48561065|NCT03805412|101705861|FG001|COMPLETED|Overall Study||7||
48561066|NCT03805412|101705860|FG000|NOT COMPLETED|Overall Study||0||
48561067|NCT03805412|101705861|FG001|NOT COMPLETED|Overall Study||1||
48561068|NCT00815880|101705862|FG000|STARTED|Overall Study||21|The first implantation was on April 15, 2009. The last implantation was on December 21, 2010.|
48561069|NCT00815880|101705862|FG000|COMPLETED|Overall Study||3||
48561070|NCT00815880|101705862|FG000|NOT COMPLETED|Overall Study||18||
48561071|NCT02607046|101705863|FG000|STARTED|Overall Study||22||
48275377|NCT02706405|100996422|FG005|NOT COMPLETED|Overall Study||1||
48275378|NCT02706405|100996423|FG006|NOT COMPLETED|Overall Study||3||
48275379|NCT02706405|100996424|FG007|NOT COMPLETED|Overall Study||6||
48275380|NCT00635128|100996425|FG000|STARTED|Overall Study||351||
48275381|NCT00635128|100996426|FG001|STARTED|Overall Study||64||
48275382|NCT00635128|100996425|FG000|COMPLETED|Overall Study||351||
48275383|NCT00635128|100996426|FG001|COMPLETED|Overall Study||64||
48275384|NCT00635128|100996425|FG000|NOT COMPLETED|Overall Study||0||
48275385|NCT00635128|100996426|FG001|NOT COMPLETED|Overall Study||0||
48275386|NCT01404429|100996427|FG000|STARTED|Overall Study||47||
48275387|NCT01404429|100996428|FG001|STARTED|Overall Study||53||
48275388|NCT01404429|100996427|FG000|COMPLETED|Overall Study||38||
48275389|NCT01404429|100996428|FG001|COMPLETED|Overall Study||46||
48275390|NCT01404429|100996427|FG000|NOT COMPLETED|Overall Study||9||
48561072|NCT02607046|101705864|FG001|STARTED|Overall Study||13||
48561073|NCT02607046|101705863|FG000|COMPLETED|Overall Study||14||
48561074|NCT02607046|101705864|FG001|COMPLETED|Overall Study||10||
48561075|NCT02607046|101705863|FG000|NOT COMPLETED|Overall Study||8||
48561076|NCT02607046|101705864|FG001|NOT COMPLETED|Overall Study||3||
48561077|NCT00634036|101705865|FG000|STARTED|Overall Study||12||
48561078|NCT00634036|101705866|FG001|STARTED|Overall Study||11||
48561079|NCT00634036|101705865|FG000|COMPLETED|Overall Study||10||
48561080|NCT00634036|101705866|FG001|COMPLETED|Overall Study||9||
48561081|NCT00634036|101705865|FG000|NOT COMPLETED|Overall Study||2||
48561082|NCT00634036|101705866|FG001|NOT COMPLETED|Overall Study||2||
48561083|NCT01368497|101705867|FG000|STARTED|Overall Study||60||
48275391|NCT01404429|100996428|FG001|NOT COMPLETED|Overall Study||7||
48275392|NCT02242097|100996429|FG000|STARTED|Ibrutinib Treatment||37||
48561084|NCT01368497|101705867|FG000|End of Treatment|Overall Study||60||
48561085|NCT01368497|101705867|FG000|COMPLETED|Overall Study||58||
48561086|NCT01368497|101705867|FG000|NOT COMPLETED|Overall Study||2||
48561087|NCT02045446|101705868|FG000|STARTED|Overall Study||15||
48561088|NCT02045446|101705869|FG001|STARTED|Overall Study||14||
48561089|NCT02045446|101705868|FG000|COMPLETED|Overall Study||15||
48561090|NCT02045446|101705869|FG001|COMPLETED|Overall Study||14||
48561091|NCT02045446|101705868|FG000|NOT COMPLETED|Overall Study||0||
48561092|NCT02045446|101705869|FG001|NOT COMPLETED|Overall Study||0||
48561093|NCT04020887|101705870|FG000|STARTED|Overall Study||304||
48561094|NCT04020887|101705871|FG001|STARTED|Overall Study||256||
48561095|NCT04020887|101705870|FG000|COMPLETED|Overall Study||304||
48561096|NCT04020887|101705871|FG001|COMPLETED|Overall Study||256||
48561097|NCT04020887|101705870|FG000|NOT COMPLETED|Overall Study||0||
48561098|NCT04020887|101705871|FG001|NOT COMPLETED|Overall Study||0||
48561099|NCT01662492|101705872|FG000|STARTED|Overall Study||45||
48561100|NCT01662492|101705873|FG001|STARTED|Overall Study||43||
48561101|NCT01662492|101705874|FG002|STARTED|Overall Study||37||
48561102|NCT01662492|101705872|FG000|COMPLETED|Overall Study||42||
48561103|NCT01662492|101705873|FG001|COMPLETED|Overall Study||42||
48561104|NCT01662492|101705874|FG002|COMPLETED|Overall Study||31||
48561105|NCT01662492|101705872|FG000|NOT COMPLETED|Overall Study||3||
48561106|NCT01662492|101705873|FG001|NOT COMPLETED|Overall Study||1||
48561107|NCT01662492|101705874|FG002|NOT COMPLETED|Overall Study||6||
48561108|NCT01129557|101705875|FG000|STARTED|Overall Study||15||
48561109|NCT01129557|101705876|FG001|STARTED|Overall Study||17||
48561110|NCT01129557|101705877|FG002|STARTED|Overall Study||14||
48561111|NCT01129557|101705875|FG000|COMPLETED|Overall Study||11||
48275393|NCT02242097|100996429|FG000|Cycle 1|Ibrutinib Treatment||36||
48275394|NCT02242097|100996429|FG000|Cycle 2|Ibrutinib Treatment||36||
48275395|NCT02242097|100996429|FG000|Cycle 4|Ibrutinib Treatment||34||
48275396|NCT02242097|100996429|FG000|Cycle 7|Ibrutinib Treatment||33||
48275397|NCT02242097|100996429|FG000|Cycle 13|Ibrutinib Treatment||30||
48275398|NCT02242097|100996429|FG000|Cycle 19|Ibrutinib Treatment||26||
48112421|NCT05091307|100601481|FG002|STARTED|Overall Study||47|Randomized participants|
48561112|NCT01129557|101705876|FG001|COMPLETED|Overall Study||12||
48561113|NCT01129557|101705877|FG002|COMPLETED|Overall Study||10||
48561114|NCT01129557|101705875|FG000|NOT COMPLETED|Overall Study||4||
48561115|NCT01129557|101705876|FG001|NOT COMPLETED|Overall Study||5||
48561116|NCT01129557|101705877|FG002|NOT COMPLETED|Overall Study||4||
48561117|NCT03817125|101705878|FG000|STARTED|Overall Study||6||
48561118|NCT03817125|101705879|FG001|STARTED|Overall Study||8||
48561119|NCT03817125|101705878|FG000|COMPLETED|Overall Study||4||
48112422|NCT05091307|100601482|FG003|STARTED|Overall Study||46|Randomized participants|
48112423|NCT05091307|100601479|FG000|Treated|Overall Study||382|Vaccinated participants|
48275399|NCT02242097|100996429|FG000|Cycle 25|Ibrutinib Treatment||25||
48275400|NCT02242097|100996429|FG000|Cycle 37|Ibrutinib Treatment||18||
48275401|NCT02242097|100996429|FG000|Cycle 49|Ibrutinib Treatment||17||
48275402|NCT02242097|100996429|FG000|COMPLETED|Ibrutinib Treatment||17||
48275403|NCT02242097|100996429|FG000|NOT COMPLETED|Ibrutinib Treatment||20||
48112424|NCT05091307|100601480|FG001|Treated|Overall Study||384|Vaccinated participants|
48112425|NCT05091307|100601481|FG002|Treated|Overall Study||47|Vaccinated participants|
48112426|NCT05091307|100601482|FG003|Treated|Overall Study||46|Vaccinated participants|
48112427|NCT05091307|100601479|FG000|COMPLETED|Overall Study||312||
48112428|NCT05091307|100601480|FG001|COMPLETED|Overall Study||316||
48275404|NCT02242097|100996429|FG000|STARTED|Post Therapy Follow Up||36||
48561120|NCT03817125|101705879|FG001|COMPLETED|Overall Study||2||
48561121|NCT03817125|101705878|FG000|NOT COMPLETED|Overall Study||2||
48561122|NCT03817125|101705879|FG001|NOT COMPLETED|Overall Study||6||
48561123|NCT01372618|101705880|FG000|STARTED|Overall Study||9||
48561124|NCT01372618|101705880|FG000|COMPLETED|Overall Study||0||
48112429|NCT05091307|100601481|FG002|COMPLETED|Overall Study||43||
48275405|NCT02242097|100996429|FG000|COMPLETED|Post Therapy Follow Up||32||
48275406|NCT02242097|100996429|FG000|NOT COMPLETED|Post Therapy Follow Up||4||
48561125|NCT01372618|101705880|FG000|NOT COMPLETED|Overall Study||9||
48561126|NCT00162981|101705881|FG000|STARTED|Overall Study||32||
48695862|NCT01006655|102038624|FG000|STARTED|Washout Period of 2 Weeks||11||
48695863|NCT01006655|102038625|FG001|STARTED|Washout Period of 2 Weeks||10||
48695864|NCT01006655|102038624|FG000|COMPLETED|Washout Period of 2 Weeks||11||
48695865|NCT01006655|102038625|FG001|COMPLETED|Washout Period of 2 Weeks||10||
48695866|NCT01006655|102038624|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0||
48695867|NCT01006655|102038625|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0||
48695868|NCT01006655|102038624|FG000|STARTED|Second Intervention||11||
48275407|NCT02672852|100996430|FG000|STARTED|Part A1||100||
48275408|NCT02672852|100996431|FG001|STARTED|Part A1||407||
48275409|NCT02672852|100996432|FG002|STARTED|Part A1||0||
48275410|NCT02672852|100996433|FG003|STARTED|Part A1||0||
48275411|NCT02672852|100996434|FG004|STARTED|Part A1||0||
48275412|NCT02672852|100996435|FG005|STARTED|Part A1||0||
48275413|NCT02672852|100996436|FG006|STARTED|Part A1||0||
48275414|NCT02672852|100996430|FG000|COMPLETED|Part A1||97||
48275415|NCT02672852|100996431|FG001|COMPLETED|Part A1||403||
48275416|NCT02672852|100996432|FG002|COMPLETED|Part A1||0||
48275417|NCT02672852|100996433|FG003|COMPLETED|Part A1||0||
48275418|NCT02672852|100996434|FG004|COMPLETED|Part A1||0||
48275419|NCT02672852|100996435|FG005|COMPLETED|Part A1||0||
48275420|NCT02672852|100996436|FG006|COMPLETED|Part A1||0||
48275421|NCT02672852|100996430|FG000|NOT COMPLETED|Part A1||3||
48275422|NCT02672852|100996431|FG001|NOT COMPLETED|Part A1||4||
48275423|NCT02672852|100996432|FG002|NOT COMPLETED|Part A1||0||
48275424|NCT02672852|100996433|FG003|NOT COMPLETED|Part A1||0||
48275425|NCT02672852|100996434|FG004|NOT COMPLETED|Part A1||0||
48275426|NCT02672852|100996435|FG005|NOT COMPLETED|Part A1||0||
48275427|NCT02672852|100996436|FG006|NOT COMPLETED|Part A1||0||
48275428|NCT02672852|100996430|FG000|STARTED|Part A2||0||
48275429|NCT02672852|100996431|FG001|STARTED|Part A2||0||
48275430|NCT02672852|100996432|FG002|STARTED|Part A2||93||
48275431|NCT02672852|100996433|FG003|STARTED|Part A2||403||
48275432|NCT02672852|100996434|FG004|STARTED|Part A2||0||
48275433|NCT02672852|100996435|FG005|STARTED|Part A2||0||
48275434|NCT02672852|100996436|FG006|STARTED|Part A2||0||
48275435|NCT02672852|100996430|FG000|COMPLETED|Part A2||0||
48275436|NCT02672852|100996431|FG001|COMPLETED|Part A2||0||
48275437|NCT02672852|100996432|FG002|COMPLETED|Part A2||83||
48275438|NCT02672852|100996433|FG003|COMPLETED|Part A2||399||
48275439|NCT02672852|100996434|FG004|COMPLETED|Part A2||0||
48275440|NCT02672852|100996435|FG005|COMPLETED|Part A2||0||
48275441|NCT02672852|100996436|FG006|COMPLETED|Part A2||0||
48275442|NCT02672852|100996430|FG000|NOT COMPLETED|Part A2||0||
48275443|NCT02672852|100996431|FG001|NOT COMPLETED|Part A2||0||
48275444|NCT02672852|100996432|FG002|NOT COMPLETED|Part A2||10||
48275445|NCT02672852|100996433|FG003|NOT COMPLETED|Part A2||4||
48275446|NCT02672852|100996434|FG004|NOT COMPLETED|Part A2||0||
48275447|NCT02672852|100996435|FG005|NOT COMPLETED|Part A2||0||
48275448|NCT02672852|100996436|FG006|NOT COMPLETED|Part A2||0||
48275449|NCT02672852|100996430|FG000|STARTED|Part B||0||
48275450|NCT02672852|100996431|FG001|STARTED|Part B||0||
48275451|NCT02672852|100996432|FG002|STARTED|Part B||0||
48275452|NCT02672852|100996433|FG003|STARTED|Part B||0||
48275453|NCT02672852|100996434|FG004|STARTED|Part B||225||
48275454|NCT02672852|100996435|FG005|STARTED|Part B||111||
48275455|NCT02672852|100996436|FG006|STARTED|Part B||63||
48275456|NCT02672852|100996430|FG000|COMPLETED|Part B||0||
48275457|NCT02672852|100996431|FG001|COMPLETED|Part B||0||
48275458|NCT02672852|100996432|FG002|COMPLETED|Part B||0||
48275459|NCT02672852|100996433|FG003|COMPLETED|Part B||0||
48275460|NCT02672852|100996434|FG004|COMPLETED|Part B||209||
48275461|NCT02672852|100996435|FG005|COMPLETED|Part B||100||
48275462|NCT02672852|100996436|FG006|COMPLETED|Part B||51||
48275463|NCT02672852|100996430|FG000|NOT COMPLETED|Part B||0||
48275464|NCT02672852|100996431|FG001|NOT COMPLETED|Part B||0||
48275465|NCT02672852|100996432|FG002|NOT COMPLETED|Part B||0||
48275466|NCT02672852|100996433|FG003|NOT COMPLETED|Part B||0||
48275467|NCT02672852|100996434|FG004|NOT COMPLETED|Part B||16||
48275468|NCT02672852|100996435|FG005|NOT COMPLETED|Part B||11||
48275469|NCT02672852|100996436|FG006|NOT COMPLETED|Part B||12||
48695869|NCT01006655|102038625|FG001|STARTED|Second Intervention||10||
48275470|NCT01605019|100996437|FG000|STARTED|Overall Study||4||
48275471|NCT01605019|100996438|FG001|STARTED|Overall Study||0||
48275472|NCT01605019|100996437|FG000|COMPLETED|Overall Study||1||
48275473|NCT01605019|100996438|FG001|COMPLETED|Overall Study||0||
48275474|NCT01605019|100996437|FG000|NOT COMPLETED|Overall Study||3||
48275475|NCT01605019|100996438|FG001|NOT COMPLETED|Overall Study||0||
48275476|NCT01519089|100996439|FG000|STARTED|Overall Study||47||
48275477|NCT01519089|100996440|FG001|STARTED|Overall Study||48||
48275478|NCT01519089|100996439|FG000|Received Treatment|Overall Study||47||
48275479|NCT01519089|100996440|FG001|Received Treatment|Overall Study||47||
48275480|NCT01519089|100996439|FG000|COMPLETED|Overall Study||40||
48275481|NCT01519089|100996440|FG001|COMPLETED|Overall Study||33||
48275482|NCT01519089|100996439|FG000|NOT COMPLETED|Overall Study||7||
48275483|NCT01519089|100996440|FG001|NOT COMPLETED|Overall Study||15||
48275484|NCT03538938|100996441|FG000|STARTED|Overall Study||83||
48275485|NCT03538938|100996442|FG001|STARTED|Overall Study||84||
48275486|NCT03538938|100996443|FG002|STARTED|Overall Study||80||
48275487|NCT03538938|100996444|FG003|STARTED|Overall Study||85||
48275488|NCT03538938|100996445|FG004|STARTED|Overall Study||82||
48275489|NCT03538938|100996446|FG005|STARTED|Overall Study||82||
48275490|NCT03538938|100996447|FG006|STARTED|Overall Study||84||
48275491|NCT03538938|100996448|FG007|STARTED|Overall Study||82||
48275492|NCT03538938|100996449|FG008|STARTED|Overall Study||80||
48275493|NCT03538938|100996450|FG009|STARTED|Overall Study||81||
48275494|NCT03538938|100996451|FG010|STARTED|Overall Study||81||
48275495|NCT03538938|100996452|FG011|STARTED|Overall Study||80||
48275496|NCT03538938|100996453|FG012|STARTED|Overall Study||82||
48275497|NCT03538938|100996454|FG013|STARTED|Overall Study||85||
48561127|NCT00162981|101705882|FG001|STARTED|Overall Study||36||
48561128|NCT00162981|101705881|FG000|COMPLETED|Overall Study||28||
48561129|NCT00162981|101705882|FG001|COMPLETED|Overall Study||30||
48561130|NCT00162981|101705881|FG000|NOT COMPLETED|Overall Study||4||
48561131|NCT00162981|101705882|FG001|NOT COMPLETED|Overall Study||6||
48561132|NCT00413699|101705883|FG000|STARTED|Initial Period||1123||
48275498|NCT03538938|100996455|FG014|STARTED|Overall Study||82||
48275499|NCT03538938|100996456|FG015|STARTED|Overall Study||83||
48561133|NCT00413699|101705884|FG001|STARTED|Initial Period||3358||
48561134|NCT00413699|101705885|FG002|STARTED|Initial Period||0||
48561135|NCT00413699|101705883|FG000|COMPLETED|Initial Period||484||
48561136|NCT00413699|101705884|FG001|COMPLETED|Initial Period||1653||
48561137|NCT00413699|101705885|FG002|COMPLETED|Initial Period||0||
48561138|NCT00413699|101705883|FG000|NOT COMPLETED|Initial Period||639||
48561139|NCT00413699|101705884|FG001|NOT COMPLETED|Initial Period||1705||
48561140|NCT00413699|101705885|FG002|NOT COMPLETED|Initial Period||0||
48561141|NCT00413699|101705883|FG000|STARTED|Extension Period||0||
48561142|NCT00413699|101705884|FG001|STARTED|Extension Period||0||
48561143|NCT00413699|101705885|FG002|STARTED|Extension Period||48||
48561144|NCT00413699|101705883|FG000|COMPLETED|Extension Period||0||
48561145|NCT00413699|101705884|FG001|COMPLETED|Extension Period||0||
48561146|NCT00413699|101705885|FG002|COMPLETED|Extension Period||43||
48561147|NCT00413699|101705883|FG000|NOT COMPLETED|Extension Period||0||
48561148|NCT00413699|101705884|FG001|NOT COMPLETED|Extension Period||0||
48561149|NCT00413699|101705885|FG002|NOT COMPLETED|Extension Period||5||
48561150|NCT03660930|101705886|FG000|STARTED|Overall Study||2||
48561151|NCT03660930|101705887|FG001|STARTED|Overall Study||2||
48561152|NCT03660930|101705888|FG002|STARTED|Overall Study||2||
48561153|NCT03660930|101705889|FG003|STARTED|Overall Study||2||
48561154|NCT03660930|101705890|FG004|STARTED|Overall Study||2||
48561155|NCT03660930|101705891|FG005|STARTED|Overall Study||3||
48561156|NCT03660930|101705892|FG006|STARTED|Overall Study||3||
48561157|NCT03660930|101705893|FG007|STARTED|Overall Study||3||
48561158|NCT03660930|101705886|FG000|COMPLETED|Overall Study||2||
48561159|NCT03660930|101705887|FG001|COMPLETED|Overall Study||2||
48561160|NCT03660930|101705888|FG002|COMPLETED|Overall Study||2||
48561161|NCT03660930|101705889|FG003|COMPLETED|Overall Study||0||
48695870|NCT01006655|102038624|FG000|COMPLETED|Second Intervention||11||
48695871|NCT01006655|102038625|FG001|COMPLETED|Second Intervention||10||
48695872|NCT01006655|102038624|FG000|NOT COMPLETED|Second Intervention||0||
48695873|NCT01006655|102038625|FG001|NOT COMPLETED|Second Intervention||0||
48695874|NCT03645096|102038626|FG000|STARTED|First Treatment (21 Days)||4||
48695875|NCT03645096|102038627|FG001|STARTED|First Treatment (21 Days)||4||
48695876|NCT03645096|102038628|FG002|STARTED|First Treatment (21 Days)||7||
48695877|NCT03645096|102038629|FG003|STARTED|First Treatment (21 Days)||7||
48695878|NCT03645096|102038630|FG004|STARTED|First Treatment (21 Days)||5||
48695879|NCT03645096|102038631|FG005|STARTED|First Treatment (21 Days)||2||
48695880|NCT03645096|102038626|FG000|COMPLETED|First Treatment (21 Days)||4||
48695881|NCT03645096|102038627|FG001|COMPLETED|First Treatment (21 Days)||3||
48695882|NCT03645096|102038628|FG002|COMPLETED|First Treatment (21 Days)||5||
48695883|NCT03645096|102038629|FG003|COMPLETED|First Treatment (21 Days)||7||
48695884|NCT03645096|102038630|FG004|COMPLETED|First Treatment (21 Days)||3||
48695885|NCT03645096|102038631|FG005|COMPLETED|First Treatment (21 Days)||2||
48275500|NCT03538938|100996441|FG000|COMPLETED|Overall Study||79||
48275501|NCT03538938|100996442|FG001|COMPLETED|Overall Study||78||
48561162|NCT03660930|101705890|FG004|COMPLETED|Overall Study||2||
48561163|NCT03660930|101705891|FG005|COMPLETED|Overall Study||1||
48561164|NCT03660930|101705892|FG006|COMPLETED|Overall Study||2||
48695886|NCT03645096|102038626|FG000|NOT COMPLETED|First Treatment (21 Days)||0||
48695887|NCT03645096|102038627|FG001|NOT COMPLETED|First Treatment (21 Days)||1||
48695888|NCT03645096|102038628|FG002|NOT COMPLETED|First Treatment (21 Days)||2||
48695889|NCT03645096|102038629|FG003|NOT COMPLETED|First Treatment (21 Days)||0||
48695890|NCT03645096|102038630|FG004|NOT COMPLETED|First Treatment (21 Days)||2||
48695891|NCT03645096|102038631|FG005|NOT COMPLETED|First Treatment (21 Days)||0||
48695892|NCT03645096|102038626|FG000|STARTED|Second Treatment (21 Days)||4||
48275502|NCT03538938|100996443|FG002|COMPLETED|Overall Study||73||
48561165|NCT03660930|101705893|FG007|COMPLETED|Overall Study||0||
48561166|NCT03660930|101705886|FG000|NOT COMPLETED|Overall Study||0||
48695893|NCT03645096|102038627|FG001|STARTED|Second Treatment (21 Days)||3||
48561167|NCT03660930|101705887|FG001|NOT COMPLETED|Overall Study||0||
48561168|NCT03660930|101705888|FG002|NOT COMPLETED|Overall Study||0||
48561169|NCT03660930|101705889|FG003|NOT COMPLETED|Overall Study||2||
48112430|NCT05091307|100601482|FG003|COMPLETED|Overall Study||44||
48112431|NCT05091307|100601479|FG000|NOT COMPLETED|Overall Study||70||
48112432|NCT05091307|100601480|FG001|NOT COMPLETED|Overall Study||70||
48112433|NCT05091307|100601481|FG002|NOT COMPLETED|Overall Study||4||
48275503|NCT03538938|100996444|FG003|COMPLETED|Overall Study||82||
48275504|NCT03538938|100996445|FG004|COMPLETED|Overall Study||82||
48112434|NCT05091307|100601482|FG003|NOT COMPLETED|Overall Study||2||
48275505|NCT03538938|100996446|FG005|COMPLETED|Overall Study||81||
48275506|NCT03538938|100996447|FG006|COMPLETED|Overall Study||81||
48561170|NCT03660930|101705890|FG004|NOT COMPLETED|Overall Study||0||
48561171|NCT03660930|101705891|FG005|NOT COMPLETED|Overall Study||2||
48561172|NCT03660930|101705892|FG006|NOT COMPLETED|Overall Study||1||
48561173|NCT03660930|101705893|FG007|NOT COMPLETED|Overall Study||3||
48561174|NCT01234350|101705894|FG000|STARTED|Overall Study||1000||
48561175|NCT01234350|101705895|FG001|STARTED|Overall Study||493||
48561176|NCT01234350|101705894|FG000|COMPLETED|Overall Study||313||
48561177|NCT01234350|101705895|FG001|COMPLETED|Overall Study||226||
48561178|NCT01234350|101705894|FG000|NOT COMPLETED|Overall Study||687||
48561179|NCT01234350|101705895|FG001|NOT COMPLETED|Overall Study||267||
48561180|NCT00397462|101705896|FG000|STARTED|Overall Study||16||
48561181|NCT00397462|101705897|FG001|STARTED|Overall Study||13||
48561182|NCT00397462|101705898|FG002|STARTED|Overall Study||15||
48561183|NCT00397462|101705896|FG000|COMPLETED|Overall Study||16||
48561184|NCT00397462|101705897|FG001|COMPLETED|Overall Study||13||
48561185|NCT00397462|101705898|FG002|COMPLETED|Overall Study||15||
48561186|NCT00397462|101705896|FG000|NOT COMPLETED|Overall Study||0||
48561187|NCT00397462|101705897|FG001|NOT COMPLETED|Overall Study||0||
48561188|NCT00397462|101705898|FG002|NOT COMPLETED|Overall Study||0||
48561189|NCT02771977|101705899|FG000|STARTED|Overall Study||2528||
48561190|NCT02771977|101705900|FG001|STARTED|Overall Study||2532||
48561191|NCT02771977|101705899|FG000|COMPLETED|Overall Study||2528||
48561192|NCT02771977|101705900|FG001|COMPLETED|Overall Study||2532||
48561193|NCT02771977|101705899|FG000|NOT COMPLETED|Overall Study||0||
48561194|NCT02771977|101705900|FG001|NOT COMPLETED|Overall Study||0||
48561195|NCT01965860|101705901|FG000|STARTED|Overall Study||11||
48561196|NCT01965860|101705902|FG001|STARTED|Overall Study||10||
48561197|NCT01965860|101705903|FG002|STARTED|Overall Study||11||
48561198|NCT01965860|101705901|FG000|COMPLETED|Overall Study||9||
48561199|NCT01965860|101705902|FG001|COMPLETED|Overall Study||10||
48561200|NCT01965860|101705903|FG002|COMPLETED|Overall Study||10||
48561201|NCT01965860|101705901|FG000|NOT COMPLETED|Overall Study||2||
48561202|NCT01965860|101705902|FG001|NOT COMPLETED|Overall Study||0||
48561203|NCT01965860|101705903|FG002|NOT COMPLETED|Overall Study||1||
48561204|NCT02548143|101705904|FG000|STARTED|Overall Study||6||
48561205|NCT02548143|101705905|FG001|STARTED|Overall Study||6||
48561206|NCT02548143|101705904|FG000|COMPLETED|Overall Study||5||
48561207|NCT02548143|101705905|FG001|COMPLETED|Overall Study||5||
48561208|NCT02548143|101705904|FG000|NOT COMPLETED|Overall Study||1||
48561209|NCT02548143|101705905|FG001|NOT COMPLETED|Overall Study||1||
48561210|NCT00517881|101705906|FG000|STARTED|Overall Study||29||
48561211|NCT00517881|101705906|FG000|COMPLETED|Overall Study||24||
48275507|NCT03538938|100996448|FG007|COMPLETED|Overall Study||80||
48275508|NCT03538938|100996449|FG008|COMPLETED|Overall Study||74||
48275509|NCT03538938|100996450|FG009|COMPLETED|Overall Study||79||
48275510|NCT03538938|100996451|FG010|COMPLETED|Overall Study||79||
48275511|NCT03538938|100996452|FG011|COMPLETED|Overall Study||78||
48275512|NCT03538938|100996453|FG012|COMPLETED|Overall Study||78||
48561212|NCT00517881|101705906|FG000|NOT COMPLETED|Overall Study||5||
48561213|NCT03361306|101705907|FG000|STARTED|Overall Study||15||
48561214|NCT03361306|101705907|FG000|COMPLETED|Overall Study||0||
48561215|NCT03361306|101705907|FG000|NOT COMPLETED|Overall Study||15||
48561216|NCT04030299|101705908|FG000|STARTED|Overall Study||34||
48561217|NCT04030299|101705908|FG000|COMPLETED|Overall Study||24||
48561218|NCT04030299|101705908|FG000|NOT COMPLETED|Overall Study||10||
48561219|NCT03214224|101705909|FG000|STARTED|Overall Study||49||
48561220|NCT03214224|101705909|FG000|COMPLETED|Overall Study||40||
48112435|NCT03405142|100601483|FG000|STARTED|Overall Study||2||
48112436|NCT03405142|100601484|FG001|STARTED|Overall Study||1||
48112437|NCT03405142|100601483|FG000|COMPLETED|Overall Study||2||
48275513|NCT03538938|100996454|FG013|COMPLETED|Overall Study||84||
48275514|NCT03538938|100996455|FG014|COMPLETED|Overall Study||80||
48561221|NCT03214224|101705909|FG000|NOT COMPLETED|Overall Study||9||
48561222|NCT03896022|101705910|FG000|STARTED|Overall Study||74||
48561223|NCT03896022|101705911|FG001|STARTED|Overall Study||51||
48561224|NCT03896022|101705912|FG002|STARTED|Overall Study||52||
48561225|NCT03896022|101705910|FG000|COMPLETED|Overall Study||70||
48561226|NCT03896022|101705911|FG001|COMPLETED|Overall Study||51||
48561227|NCT03896022|101705912|FG002|COMPLETED|Overall Study||52||
48561228|NCT03896022|101705910|FG000|NOT COMPLETED|Overall Study||4||
48561229|NCT03896022|101705911|FG001|NOT COMPLETED|Overall Study||0||
48393151|NCT02198651|101291518|FG002|Participants Treated in Lead-In Period|Lead-in Period||0||
48393152|NCT02198651|101291519|FG003|Participants Treated in Lead-In Period|Lead-in Period||0||
48393153|NCT02198651|101291520|FG004|Participants Treated in Lead-In Period|Lead-in Period||0||
48393154|NCT02198651|101291516|FG000|COMPLETED|Lead-in Period||112||
48393155|NCT02198651|101291517|FG001|COMPLETED|Lead-in Period||0||
48393156|NCT02198651|101291518|FG002|COMPLETED|Lead-in Period||0||
48112438|NCT03405142|100601484|FG001|COMPLETED|Overall Study||1||
48112439|NCT03405142|100601483|FG000|NOT COMPLETED|Overall Study||0||
48393157|NCT02198651|101291519|FG003|COMPLETED|Lead-in Period||0||
48393158|NCT02198651|101291520|FG004|COMPLETED|Lead-in Period||0||
48393159|NCT02198651|101291516|FG000|NOT COMPLETED|Lead-in Period||37||
48393160|NCT02198651|101291517|FG001|NOT COMPLETED|Lead-in Period||0||
48112440|NCT03405142|100601484|FG001|NOT COMPLETED|Overall Study||0||
48112441|NCT00838201|100601485|FG000|STARTED|Overall Study||186||
48112442|NCT00838201|100601486|FG001|STARTED|Overall Study||198||
48112443|NCT00838201|100601485|FG000|COMPLETED|Overall Study||144||
48112444|NCT00838201|100601486|FG001|COMPLETED|Overall Study||145||
48112445|NCT00838201|100601485|FG000|NOT COMPLETED|Overall Study||42||
48112446|NCT00838201|100601486|FG001|NOT COMPLETED|Overall Study||53||
48112447|NCT02100007|100601487|FG000|STARTED|Overall Study||46||
48112448|NCT02100007|100601487|FG000|COMPLETED|Overall Study||46||
48112449|NCT02100007|100601487|FG000|NOT COMPLETED|Overall Study||0||
48112450|NCT04630093|100601488|FG000|STARTED|Overall Study||100||
48112451|NCT04630093|100601488|FG000|COMPLETED|Overall Study||99||
48112452|NCT04630093|100601488|FG000|NOT COMPLETED|Overall Study||1||
48112453|NCT00265616|100601489|FG000|STARTED|Overall Study||14||
48112454|NCT00265616|100601490|FG001|STARTED|Overall Study||9||
48112455|NCT00265616|100601489|FG000|COMPLETED|Overall Study||14||
48112456|NCT00265616|100601490|FG001|COMPLETED|Overall Study||9||
48112457|NCT00265616|100601489|FG000|NOT COMPLETED|Overall Study||0||
48112458|NCT00265616|100601490|FG001|NOT COMPLETED|Overall Study||0||
48112459|NCT01849588|100601491|FG000|STARTED|Overall Study||3||
48112460|NCT01849588|100601491|FG000|COMPLETED|Overall Study||0||
48112461|NCT01849588|100601491|FG000|NOT COMPLETED|Overall Study||3||
48112462|NCT00354172|100601492|FG000|STARTED|Overall Study||16||
48112463|NCT00354172|100601492|FG000|COMPLETED|Overall Study||15||
48112464|NCT00354172|100601492|FG000|NOT COMPLETED|Overall Study||1||
48112465|NCT00205712|100601493|FG000|STARTED|Overall Study||20||
48112466|NCT00205712|100601494|FG001|STARTED|Overall Study||20||
48112467|NCT00205712|100601493|FG000|COMPLETED|Overall Study||20||
48112468|NCT00205712|100601494|FG001|COMPLETED|Overall Study||19||
48112469|NCT00205712|100601493|FG000|NOT COMPLETED|Overall Study||0||
48112470|NCT00205712|100601494|FG001|NOT COMPLETED|Overall Study||1||
48112471|NCT00360334|100601495|FG000|STARTED|Overall Study||118||
48112472|NCT00360334|100601496|FG001|STARTED|Overall Study||117||
48112473|NCT00360334|100601495|FG000|Full Analysis Set (FAS)|Overall Study||118||
48112474|NCT00360334|100601496|FG001|Full Analysis Set (FAS)|Overall Study||116||
48112475|NCT00360334|100601495|FG000|COMPLETED|Overall Study||99||
48112476|NCT00360334|100601496|FG001|COMPLETED|Overall Study||104||
48112477|NCT00360334|100601495|FG000|NOT COMPLETED|Overall Study||19||
48112478|NCT00360334|100601496|FG001|NOT COMPLETED|Overall Study||13||
48112479|NCT04013191|100601497|FG000|STARTED|Overall Study||10||
48112480|NCT04013191|100601498|FG001|STARTED|Overall Study||18||
48112481|NCT04013191|100601497|FG000|Completed Period 1A (Single Dose)|Overall Study||10||
48112482|NCT04013191|100601498|FG001|Completed Period 1A (Single Dose)|Overall Study||18||
48112483|NCT04013191|100601497|FG000|Completed Period 1B (Multiple Dose)|Overall Study||9||
48112484|NCT04013191|100601498|FG001|Completed Period 1B (Multiple Dose)|Overall Study||18||
48112485|NCT04013191|100601497|FG000|COMPLETED|Overall Study||9||
48112486|NCT04013191|100601498|FG001|COMPLETED|Overall Study||18||
48112487|NCT04013191|100601497|FG000|NOT COMPLETED|Overall Study||1||
48112488|NCT04013191|100601498|FG001|NOT COMPLETED|Overall Study||0||
48112489|NCT01603875|100601499|FG000|STARTED|Overall Study||35||
48112490|NCT01603875|100601500|FG001|STARTED|Overall Study||35||
48112491|NCT01603875|100601501|FG002|STARTED|Overall Study||35||
48112492|NCT01603875|100601499|FG000|COMPLETED|Overall Study||28||
48112493|NCT01603875|100601500|FG001|COMPLETED|Overall Study||27||
48112494|NCT01603875|100601501|FG002|COMPLETED|Overall Study||26||
48112495|NCT01603875|100601499|FG000|NOT COMPLETED|Overall Study||7||
48112496|NCT01603875|100601500|FG001|NOT COMPLETED|Overall Study||8||
48112497|NCT01603875|100601501|FG002|NOT COMPLETED|Overall Study||9||
48112498|NCT00720941|100601502|FG000|STARTED|Overall Study||557||
48112499|NCT00720941|100601503|FG001|STARTED|Overall Study||553||
48112500|NCT00720941|100601502|FG000|Ongoing|Overall Study||34||
48112501|NCT00720941|100601503|FG001|Ongoing|Overall Study||23||
48112502|NCT00720941|100601502|FG000|COMPLETED|Overall Study||144||
48112503|NCT00720941|100601503|FG001|COMPLETED|Overall Study||138||
48112504|NCT00720941|100601502|FG000|NOT COMPLETED|Overall Study||413||
48112505|NCT00720941|100601503|FG001|NOT COMPLETED|Overall Study||415||
48112506|NCT01218516|100601504|FG000|STARTED|Combination Therapy (up to 4.5 Months)||67||
48112507|NCT01218516|100601505|FG001|STARTED|Combination Therapy (up to 4.5 Months)||63||
48112508|NCT01218516|100601506|FG002|STARTED|Combination Therapy (up to 4.5 Months)||0||
48393161|NCT02198651|101291518|FG002|NOT COMPLETED|Lead-in Period||0||
48112509|NCT01218516|100601507|FG003|STARTED|Combination Therapy (up to 4.5 Months)||0||
48561230|NCT03896022|101705912|FG002|NOT COMPLETED|Overall Study||0||
48561231|NCT02554682|101705913|FG000|STARTED|Overall Study||40||
48561232|NCT02554682|101705914|FG001|STARTED|Overall Study||40||
48561233|NCT02554682|101705915|FG002|STARTED|Overall Study||40||
48561234|NCT02554682|101705916|FG003|STARTED|Overall Study||40||
48561235|NCT02554682|101705917|FG004|STARTED|Overall Study||40||
48561236|NCT02554682|101705918|FG005|STARTED|Overall Study||40||
48561237|NCT02554682|101705919|FG006|STARTED|Overall Study||28||
48561238|NCT02554682|101705920|FG007|STARTED|Overall Study||28||
48561239|NCT02554682|101705921|FG008|STARTED|Overall Study||26||
48561240|NCT02554682|101705922|FG009|STARTED|Overall Study||26||
48561241|NCT02554682|101705913|FG000|COMPLETED|Overall Study||25||
48561242|NCT02554682|101705914|FG001|COMPLETED|Overall Study||28||
48561243|NCT02554682|101705915|FG002|COMPLETED|Overall Study||36||
48561244|NCT02554682|101705916|FG003|COMPLETED|Overall Study||37||
48561245|NCT02554682|101705917|FG004|COMPLETED|Overall Study||38||
48561246|NCT02554682|101705918|FG005|COMPLETED|Overall Study||39||
48561247|NCT02554682|101705919|FG006|COMPLETED|Overall Study||22||
48561248|NCT02554682|101705920|FG007|COMPLETED|Overall Study||22||
48561249|NCT02554682|101705921|FG008|COMPLETED|Overall Study||24||
48561250|NCT02554682|101705922|FG009|COMPLETED|Overall Study||24||
48561251|NCT02554682|101705913|FG000|NOT COMPLETED|Overall Study||15||
48561252|NCT02554682|101705914|FG001|NOT COMPLETED|Overall Study||12||
48561253|NCT02554682|101705915|FG002|NOT COMPLETED|Overall Study||4||
48561254|NCT02554682|101705916|FG003|NOT COMPLETED|Overall Study||3||
48561255|NCT02554682|101705917|FG004|NOT COMPLETED|Overall Study||2||
48561256|NCT02554682|101705918|FG005|NOT COMPLETED|Overall Study||1||
48561257|NCT02554682|101705919|FG006|NOT COMPLETED|Overall Study||6||
48561258|NCT02554682|101705920|FG007|NOT COMPLETED|Overall Study||6||
48561259|NCT02554682|101705921|FG008|NOT COMPLETED|Overall Study||2||
48561260|NCT02554682|101705922|FG009|NOT COMPLETED|Overall Study||2||
48561261|NCT01139775|101705923|FG000|STARTED|Overall Study||14||
48561262|NCT01139775|101705924|FG001|STARTED|Overall Study||39||
48561263|NCT01139775|101705925|FG002|STARTED|Overall Study||23||
48561264|NCT01139775|101705923|FG000|Received at Least 1 Dose of Study Drug|Overall Study||14||
48561265|NCT01139775|101705924|FG001|Received at Least 1 Dose of Study Drug|Overall Study||39||
48561266|NCT01139775|101705925|FG002|Received at Least 1 Dose of Study Drug|Overall Study||22||
48561267|NCT01139775|101705923|FG000|COMPLETED|Overall Study||13||
48561268|NCT01139775|101705924|FG001|COMPLETED|Overall Study||26||
48561269|NCT01139775|101705925|FG002|COMPLETED|Overall Study||17||
48561270|NCT01139775|101705923|FG000|NOT COMPLETED|Overall Study||1||
48561271|NCT01139775|101705924|FG001|NOT COMPLETED|Overall Study||13||
48561272|NCT01139775|101705925|FG002|NOT COMPLETED|Overall Study||6||
48561273|NCT02747108|101705926|FG000|STARTED|Overall Study||253||
48561274|NCT02747108|101705927|FG001|STARTED|Overall Study||62||
48561275|NCT02747108|101705926|FG000|COMPLETED|Overall Study||248||
48561276|NCT02747108|101705927|FG001|COMPLETED|Overall Study||60||
48561277|NCT02747108|101705926|FG000|NOT COMPLETED|Overall Study||5||
48561278|NCT02747108|101705927|FG001|NOT COMPLETED|Overall Study||2||
48561279|NCT01119859|101705928|FG000|STARTED|Overall Study||163||
48561280|NCT01119859|101705929|FG001|STARTED|Overall Study||163||
48561281|NCT01119859|101705928|FG000|COMPLETED|Overall Study||139||
48561282|NCT01119859|101705929|FG001|COMPLETED|Overall Study||133||
48561283|NCT01119859|101705928|FG000|NOT COMPLETED|Overall Study||24||
48561284|NCT01119859|101705929|FG001|NOT COMPLETED|Overall Study||30||
48561285|NCT03534687|101705930|FG000|STARTED|Overall Study||20||
48561286|NCT03534687|101705931|FG001|STARTED|Overall Study||13||
48561287|NCT03534687|101705930|FG000|COMPLETED|Overall Study||13||
48561288|NCT03534687|101705931|FG001|COMPLETED|Overall Study||11||
48561289|NCT03534687|101705930|FG000|NOT COMPLETED|Overall Study||7||
48561290|NCT03534687|101705931|FG001|NOT COMPLETED|Overall Study||2||
48561291|NCT00478062|101705932|FG000|STARTED|Overall Study||1||
48561292|NCT00478062|101705932|FG000|COMPLETED|Overall Study||1||
48561293|NCT00478062|101705932|FG000|NOT COMPLETED|Overall Study||0||
48561294|NCT01701011|101705933|FG000|STARTED|Overall Study||127||
48561295|NCT01701011|101705934|FG001|STARTED|Overall Study||126||
48561296|NCT01701011|101705935|FG002|STARTED|Overall Study||124||
48561297|NCT01701011|101705933|FG000|COMPLETED|Overall Study||92||
48561298|NCT01701011|101705934|FG001|COMPLETED|Overall Study||102||
48561299|NCT01701011|101705935|FG002|COMPLETED|Overall Study||90||
48561300|NCT01701011|101705933|FG000|NOT COMPLETED|Overall Study||35||
48561301|NCT01701011|101705934|FG001|NOT COMPLETED|Overall Study||24||
48561302|NCT01701011|101705935|FG002|NOT COMPLETED|Overall Study||34||
48561303|NCT01827111|101705936|FG000|STARTED|Overall Study||19||
48561304|NCT01827111|101705936|FG000|COMPLETED|Overall Study||18||
48561305|NCT01827111|101705936|FG000|NOT COMPLETED|Overall Study||1||
48561306|NCT00711087|101705937|FG000|STARTED|Overall Study||1||
48561307|NCT00711087|101705938|FG001|STARTED|Overall Study||0||
48561308|NCT00711087|101705937|FG000|COMPLETED|Overall Study||0||
48561309|NCT00711087|101705938|FG001|COMPLETED|Overall Study||0||
48561310|NCT00711087|101705937|FG000|NOT COMPLETED|Overall Study||1||
48561311|NCT00711087|101705938|FG001|NOT COMPLETED|Overall Study||0||
48561312|NCT01578239|101705939|FG000|STARTED|Treatment Period||117|All patients who received a randomization number, regardless of receiving study medication were included in the Randomized Set|
48561313|NCT01578239|101705940|FG001|STARTED|Treatment Period||114|All patients who received a randomization number, regardless of receiving study medication were included in the Randomized Set|
48561314|NCT01578239|101705939|FG000|Full Analysis Set (FAS)|Treatment Period||117|All randomized participant were analyzed according to randomized treatment, regardless of the actual treatment received.|
48561315|NCT01578239|101705940|FG001|Full Analysis Set (FAS)|Treatment Period||114|All randomized participant were analyzed according to randomized treatment, regardless of the actual treatment received.|
48561316|NCT01578239|101705939|FG000|Safety Analysis Set (SAF)|Treatment Period||111|All randomized patients who received at least one dose of active study medication. In the SAF, patients were analyzed based on actual treatment received.|
48561317|NCT01578239|101705940|FG001|Safety Analysis Set (SAF)|Treatment Period||112|All randomized patients who received at least one dose of active study medication. In the SAF, patients were analyzed based on actual treatment received.|
48561318|NCT01578239|101705939|FG000|FAS-Entered Long-term Follow-up|Treatment Period||101||
48561319|NCT01578239|101705940|FG001|FAS-Entered Long-term Follow-up|Treatment Period||99||
48561320|NCT01578239|101705939|FG000|COMPLETED|Treatment Period||50|refers to completion of a minimum of 72 weeks of treatment.|
48561321|NCT01578239|101705940|FG001|COMPLETED|Treatment Period||13|refers to completion of a minimum of 72 weeks of treatment.|
48561322|NCT01578239|101705939|FG000|NOT COMPLETED|Treatment Period||67||
48561323|NCT01578239|101705940|FG001|NOT COMPLETED|Treatment Period||101||
48561324|NCT01578239|101705939|FG000|STARTED|Long-term Follow-Up Period||101||
48112510|NCT01218516|100601504|FG000|COMPLETED|Combination Therapy (up to 4.5 Months)||38||
48112511|NCT01218516|100601505|FG001|COMPLETED|Combination Therapy (up to 4.5 Months)||28||
48112512|NCT01218516|100601506|FG002|COMPLETED|Combination Therapy (up to 4.5 Months)||0||
48112513|NCT01218516|100601507|FG003|COMPLETED|Combination Therapy (up to 4.5 Months)||0||
48112514|NCT01218516|100601504|FG000|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||29||
48112515|NCT01218516|100601505|FG001|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||35||
48112516|NCT01218516|100601506|FG002|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||0||
48275515|NCT03538938|100996456|FG015|COMPLETED|Overall Study||78||
48275516|NCT03538938|100996441|FG000|NOT COMPLETED|Overall Study||4||
48561325|NCT01578239|101705940|FG001|STARTED|Long-term Follow-Up Period||99||
48561326|NCT01578239|101705939|FG000|COMPLETED|Long-term Follow-Up Period||24|Study ended 5 years from randomization of last participant or 158 deaths in the study achieved|
48275517|NCT03538938|100996442|FG001|NOT COMPLETED|Overall Study||6||
48275518|NCT03538938|100996443|FG002|NOT COMPLETED|Overall Study||7||
48275519|NCT03538938|100996444|FG003|NOT COMPLETED|Overall Study||3||
48275520|NCT03538938|100996445|FG004|NOT COMPLETED|Overall Study||0||
48275521|NCT03538938|100996446|FG005|NOT COMPLETED|Overall Study||1||
48275522|NCT03538938|100996447|FG006|NOT COMPLETED|Overall Study||3||
48275523|NCT03538938|100996448|FG007|NOT COMPLETED|Overall Study||2||
48561327|NCT01578239|101705940|FG001|COMPLETED|Long-term Follow-Up Period||19|Study ended 5 years from randomization of last participant or 158 deaths in the study achieved|
48561328|NCT01578239|101705939|FG000|NOT COMPLETED|Long-term Follow-Up Period||77||
48561329|NCT01578239|101705940|FG001|NOT COMPLETED|Long-term Follow-Up Period||80||
48561330|NCT01774760|101705941|FG000|STARTED|Overall Study||10||
48561331|NCT01774760|101705941|FG000|COMPLETED|Overall Study||10||
48561332|NCT01774760|101705941|FG000|NOT COMPLETED|Overall Study||0||
48561333|NCT01936844|101705942|FG000|STARTED|Overall Study||15||
48561334|NCT01936844|101705943|FG001|STARTED|Overall Study||15||
48561335|NCT01936844|101705942|FG000|COMPLETED|Overall Study||9||
48561336|NCT01936844|101705943|FG001|COMPLETED|Overall Study||8||
48561337|NCT01936844|101705942|FG000|NOT COMPLETED|Overall Study||6||
48561338|NCT01936844|101705943|FG001|NOT COMPLETED|Overall Study||7||
48561339|NCT01938092|101705944|FG000|STARTED|Overall Study||25||
48561340|NCT01938092|101705945|FG001|STARTED|Overall Study||24||
48561341|NCT01938092|101705944|FG000|COMPLETED|Overall Study||25||
48561342|NCT01938092|101705945|FG001|COMPLETED|Overall Study||24||
48561343|NCT01938092|101705944|FG000|NOT COMPLETED|Overall Study||0||
48561344|NCT01938092|101705945|FG001|NOT COMPLETED|Overall Study||0||
48112517|NCT01218516|100601507|FG003|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||0||
48112518|NCT01218516|100601504|FG000|STARTED|Monotherapy (up to 23.5 Months)||0||
48112519|NCT01218516|100601505|FG001|STARTED|Monotherapy (up to 23.5 Months)||0||
48112520|NCT01218516|100601506|FG002|STARTED|Monotherapy (up to 23.5 Months)||38||
48112521|NCT01218516|100601507|FG003|STARTED|Monotherapy (up to 23.5 Months)||28||
48112522|NCT01218516|100601504|FG000|Safety Analysis Set|Monotherapy (up to 23.5 Months)||0||
48112523|NCT01218516|100601505|FG001|Safety Analysis Set|Monotherapy (up to 23.5 Months)||0||
48112524|NCT01218516|100601506|FG002|Safety Analysis Set|Monotherapy (up to 23.5 Months)||35||
48112525|NCT01218516|100601507|FG003|Safety Analysis Set|Monotherapy (up to 23.5 Months)||31||
48275524|NCT03538938|100996449|FG008|NOT COMPLETED|Overall Study||6||
48275525|NCT03538938|100996450|FG009|NOT COMPLETED|Overall Study||2||
48275526|NCT03538938|100996451|FG010|NOT COMPLETED|Overall Study||2||
48275527|NCT03538938|100996452|FG011|NOT COMPLETED|Overall Study||2||
48275528|NCT03538938|100996453|FG012|NOT COMPLETED|Overall Study||4||
48275529|NCT03538938|100996454|FG013|NOT COMPLETED|Overall Study||1||
48275530|NCT03538938|100996455|FG014|NOT COMPLETED|Overall Study||2||
48275531|NCT03538938|100996456|FG015|NOT COMPLETED|Overall Study||5||
48275532|NCT02299414|100996457|FG000|STARTED|Overall Study||1208||
48275533|NCT02299414|100996458|FG001|STARTED|Overall Study||1200||
48275534|NCT02299414|100996457|FG000|COMPLETED|Overall Study||1208||
48561345|NCT04509076|101705946|FG000|STARTED|Overall Study||40||
48561346|NCT04509076|101705947|FG001|STARTED|Overall Study||40||
48561347|NCT04509076|101705946|FG000|COMPLETED|Overall Study||38||
48561348|NCT04509076|101705947|FG001|COMPLETED|Overall Study||36||
48561349|NCT04509076|101705946|FG000|NOT COMPLETED|Overall Study||2||
48561350|NCT04509076|101705947|FG001|NOT COMPLETED|Overall Study||4||
48561351|NCT03175536|101705948|FG000|STARTED|Overall Study||6087||
48561352|NCT03175536|101705949|FG001|STARTED|Overall Study||6151||
48561353|NCT03175536|101705948|FG000|COMPLETED|Overall Study||6087||
48561354|NCT03175536|101705949|FG001|COMPLETED|Overall Study||6151||
48561355|NCT03175536|101705948|FG000|NOT COMPLETED|Overall Study||0||
48561356|NCT03175536|101705949|FG001|NOT COMPLETED|Overall Study||0||
48561357|NCT04460911|101705950|FG000|STARTED|Overall Study||317||
48561358|NCT04460911|101705950|FG000|COMPLETED|Overall Study||317||
48561359|NCT04460911|101705950|FG000|NOT COMPLETED|Overall Study||0||
48561360|NCT01753999|101705951|FG000|STARTED|Period 1 - Initial Assignment||155||
48561361|NCT01753999|101705952|FG001|STARTED|Period 1 - Initial Assignment||162||
48561362|NCT01753999|101705951|FG000|Received Intervention|Period 1 - Initial Assignment||144||
48275535|NCT02299414|100996458|FG001|COMPLETED|Overall Study||1200||
48275536|NCT02299414|100996457|FG000|NOT COMPLETED|Overall Study||0||
48275537|NCT02299414|100996458|FG001|NOT COMPLETED|Overall Study||0||
48275538|NCT00604825|100996459|FG000|STARTED|Overall Study||90||
48275539|NCT00604825|100996460|FG001|STARTED|Overall Study||87||
48275540|NCT00604825|100996461|FG002|STARTED|Overall Study||89||
48275541|NCT00604825|100996462|FG003|STARTED|Overall Study||90||
48275542|NCT00604825|100996459|FG000|COMPLETED|Overall Study||81||
48275543|NCT00604825|100996460|FG001|COMPLETED|Overall Study||72||
48275544|NCT00604825|100996461|FG002|COMPLETED|Overall Study||73||
48275545|NCT00604825|100996462|FG003|COMPLETED|Overall Study||79||
48275546|NCT00604825|100996459|FG000|NOT COMPLETED|Overall Study||9||
48275547|NCT00604825|100996460|FG001|NOT COMPLETED|Overall Study||15||
48275548|NCT00604825|100996461|FG002|NOT COMPLETED|Overall Study||16||
48275549|NCT00604825|100996462|FG003|NOT COMPLETED|Overall Study||11||
48393162|NCT02198651|101291519|FG003|NOT COMPLETED|Lead-in Period||0||
48393163|NCT02198651|101291520|FG004|NOT COMPLETED|Lead-in Period||0||
48393164|NCT02198651|101291516|FG000|STARTED|Double-blind Period||0||
48393165|NCT02198651|101291517|FG001|STARTED|Double-blind Period||102||
48393166|NCT02198651|101291518|FG002|STARTED|Double-blind Period||20||
48393167|NCT02198651|101291519|FG003|STARTED|Double-blind Period||0||
48393168|NCT02198651|101291520|FG004|STARTED|Double-blind Period||0||
48561363|NCT01753999|101705952|FG001|Received Intervention|Period 1 - Initial Assignment||146||
48561364|NCT01753999|101705951|FG000|COMPLETED|Period 1 - Initial Assignment||116||
48561365|NCT01753999|101705952|FG001|COMPLETED|Period 1 - Initial Assignment||112||
48561366|NCT01753999|101705951|FG000|NOT COMPLETED|Period 1 - Initial Assignment||39||
48561367|NCT01753999|101705952|FG001|NOT COMPLETED|Period 1 - Initial Assignment||50||
48561368|NCT01753999|101705951|FG000|STARTED|Period 2 -Cross to Alternate Arm||116||
48561369|NCT01753999|101705952|FG001|STARTED|Period 2 -Cross to Alternate Arm||112||
48561370|NCT01753999|101705951|FG000|Received Intervention|Period 2 -Cross to Alternate Arm||103||
48561371|NCT01753999|101705952|FG001|Received Intervention|Period 2 -Cross to Alternate Arm||95||
48561372|NCT01753999|101705951|FG000|COMPLETED|Period 2 -Cross to Alternate Arm||99||
48561373|NCT01753999|101705952|FG001|COMPLETED|Period 2 -Cross to Alternate Arm||89||
48561374|NCT01753999|101705951|FG000|NOT COMPLETED|Period 2 -Cross to Alternate Arm||17||
48561375|NCT01753999|101705952|FG001|NOT COMPLETED|Period 2 -Cross to Alternate Arm||23||
48561376|NCT01839708|101705953|FG000|STARTED|Overall Study||387||
48561377|NCT01839708|101705954|FG001|STARTED|Overall Study||182||
48561378|NCT01839708|101705953|FG000|COMPLETED|Overall Study||311||
48112526|NCT01218516|100601504|FG000|COMPLETED|Monotherapy (up to 23.5 Months)||0||
48112527|NCT01218516|100601505|FG001|COMPLETED|Monotherapy (up to 23.5 Months)||0||
48112528|NCT01218516|100601506|FG002|COMPLETED|Monotherapy (up to 23.5 Months)||38||
48561379|NCT01839708|101705954|FG001|COMPLETED|Overall Study||115||
48561380|NCT01839708|101705953|FG000|NOT COMPLETED|Overall Study||76||
48561381|NCT01839708|101705954|FG001|NOT COMPLETED|Overall Study||67||
48561382|NCT02347813|101705955|FG000|STARTED|First Intervention, 24 Weeks||6||
48561383|NCT02347813|101705956|FG001|STARTED|First Intervention, 24 Weeks||6||
48112529|NCT01218516|100601507|FG003|COMPLETED|Monotherapy (up to 23.5 Months)||28||
48112530|NCT01218516|100601504|FG000|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0||
48112531|NCT01218516|100601505|FG001|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0||
48112532|NCT01218516|100601506|FG002|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0||
48112533|NCT01218516|100601507|FG003|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0||
48275550|NCT00702962|100996463|FG000|STARTED|Overall Study||1||
48275551|NCT00702962|100996464|FG001|STARTED|Overall Study||3||
48275552|NCT00702962|100996463|FG000|COMPLETED|Overall Study||0||
48561384|NCT02347813|101705955|FG000|COMPLETED|First Intervention, 24 Weeks||4||
48561385|NCT02347813|101705956|FG001|COMPLETED|First Intervention, 24 Weeks||4||
48393169|NCT02198651|101291516|FG000|COMPLETED|Double-blind Period||0||
48393170|NCT02198651|101291517|FG001|COMPLETED|Double-blind Period||93||
48393171|NCT02198651|101291518|FG002|COMPLETED|Double-blind Period||19||
48112534|NCT00645333|100601508|FG000|STARTED|Overall Study||30||
48275553|NCT00702962|100996464|FG001|COMPLETED|Overall Study||2||
48275554|NCT00702962|100996463|FG000|NOT COMPLETED|Overall Study||1||
48561386|NCT02347813|101705955|FG000|NOT COMPLETED|First Intervention, 24 Weeks||2||
48561387|NCT02347813|101705956|FG001|NOT COMPLETED|First Intervention, 24 Weeks||2||
48561388|NCT02347813|101705955|FG000|STARTED|Second Intervention, 24 Weeks||4||
48561389|NCT02347813|101705956|FG001|STARTED|Second Intervention, 24 Weeks||4||
48561390|NCT02347813|101705955|FG000|COMPLETED|Second Intervention, 24 Weeks||4||
48561391|NCT02347813|101705956|FG001|COMPLETED|Second Intervention, 24 Weeks||4||
48561392|NCT02347813|101705955|FG000|NOT COMPLETED|Second Intervention, 24 Weeks||0||
48561393|NCT02347813|101705956|FG001|NOT COMPLETED|Second Intervention, 24 Weeks||0||
48561394|NCT03606343|101705957|FG000|STARTED|Overall Study||21||
48561395|NCT03606343|101705957|FG000|COMPLETED|Overall Study||21||
48561396|NCT03606343|101705957|FG000|NOT COMPLETED|Overall Study||0||
48561397|NCT01131169|101705958|FG000|STARTED|Overall Study||47||
48561398|NCT01131169|101705959|FG001|STARTED|Overall Study||19||
48561399|NCT01131169|101705958|FG000|COMPLETED|Overall Study||47||
48561400|NCT01131169|101705959|FG001|COMPLETED|Overall Study||19||
48561401|NCT01131169|101705958|FG000|NOT COMPLETED|Overall Study||0||
48561402|NCT01131169|101705959|FG001|NOT COMPLETED|Overall Study||0||
48561403|NCT01831635|101705960|FG000|STARTED|Overall Study||106||
48561404|NCT01831635|101705961|FG001|STARTED|Overall Study||47||
48561405|NCT01831635|101705962|FG002|STARTED|Overall Study||81||
48561406|NCT01831635|101705960|FG000|Methodological Pens|Overall Study||69|number of those receiving pens|
48561407|NCT01831635|101705961|FG001|Methodological Pens|Overall Study||29|number of those receiving pens|
48561408|NCT01831635|101705962|FG002|Methodological Pens|Overall Study||54|number of those receiving pens|
48561409|NCT01831635|101705960|FG000|Methodological Trolley Token|Overall Study||51||
48561410|NCT01831635|101705961|FG001|Methodological Trolley Token|Overall Study||16||
48561411|NCT01831635|101705962|FG002|Methodological Trolley Token|Overall Study||0||
48561412|NCT01831635|101705960|FG000|Methodological - £10 Cheque|Overall Study||57||
48561413|NCT01831635|101705961|FG001|Methodological - £10 Cheque|Overall Study||23||
48561414|NCT01831635|101705962|FG002|Methodological - £10 Cheque|Overall Study||42||
48561415|NCT01831635|101705960|FG000|Initial Contact - Consent|Overall Study||84|Initial contact was via letter from clinician (cases), GP (GP controls) or info sheet (FF control)|
48561416|NCT01831635|101705961|FG001|Initial Contact - Consent|Overall Study||35|Initial contact was via letter from clinician (cases), GP (GP controls) or info sheet (FF control)|
48561417|NCT01831635|101705962|FG002|Initial Contact - Consent|Overall Study||81|Initial contact was via letter from clinician (cases), GP (GP controls) or info sheet (FF control)|
48561418|NCT01831635|101705960|FG000|Second Invite - Consent|Overall Study||22|Either telephone or letter as second means of contact|
48561419|NCT01831635|101705961|FG001|Second Invite - Consent|Overall Study||11|Either telephone or letter as second means of contact|
48561420|NCT01831635|101705962|FG002|Second Invite - Consent|Overall Study||0|Either telephone or letter as second means of contact|
48561421|NCT01831635|101705960|FG000|COMPLETED|Overall Study||106||
48561422|NCT01831635|101705961|FG001|COMPLETED|Overall Study||45||
48561423|NCT01831635|101705962|FG002|COMPLETED|Overall Study||81||
48561424|NCT01831635|101705960|FG000|NOT COMPLETED|Overall Study||0||
48561425|NCT01831635|101705961|FG001|NOT COMPLETED|Overall Study||2||
48561426|NCT01831635|101705962|FG002|NOT COMPLETED|Overall Study||0||
48561427|NCT02111798|101705963|FG000|STARTED|Overall Study||31||
48561428|NCT02111798|101705964|FG001|STARTED|Overall Study||32||
48561429|NCT02111798|101705965|FG002|STARTED|Overall Study||10||
48561430|NCT02111798|101705966|FG003|STARTED|Overall Study||10||
48561431|NCT02111798|101705963|FG000|COMPLETED|Overall Study||20||
48561432|NCT02111798|101705964|FG001|COMPLETED|Overall Study||16||
48561433|NCT02111798|101705965|FG002|COMPLETED|Overall Study||10||
48561434|NCT02111798|101705966|FG003|COMPLETED|Overall Study||7||
48561435|NCT02111798|101705963|FG000|NOT COMPLETED|Overall Study||11||
48561436|NCT02111798|101705964|FG001|NOT COMPLETED|Overall Study||16||
48561437|NCT02111798|101705965|FG002|NOT COMPLETED|Overall Study||0||
48561438|NCT02111798|101705966|FG003|NOT COMPLETED|Overall Study||3||
48561439|NCT04054765|101705967|FG000|STARTED|Baseline||155||
48561440|NCT04054765|101705968|FG001|STARTED|Baseline||132||
48561441|NCT04054765|101705967|FG000|COMPLETED|Baseline||150||
48561442|NCT04054765|101705968|FG001|COMPLETED|Baseline||129||
48561443|NCT04054765|101705967|FG000|NOT COMPLETED|Baseline||5||
48561444|NCT04054765|101705968|FG001|NOT COMPLETED|Baseline||3||
48561445|NCT04054765|101705967|FG000|STARTED|Post-Gameplay / 1-week Follow up||150||
48561446|NCT04054765|101705968|FG001|STARTED|Post-Gameplay / 1-week Follow up||129||
48561447|NCT04054765|101705967|FG000|COMPLETED|Post-Gameplay / 1-week Follow up||142||
48561448|NCT04054765|101705968|FG001|COMPLETED|Post-Gameplay / 1-week Follow up||126||
48561449|NCT04054765|101705967|FG000|NOT COMPLETED|Post-Gameplay / 1-week Follow up||8||
48561450|NCT04054765|101705968|FG001|NOT COMPLETED|Post-Gameplay / 1-week Follow up||3||
48561451|NCT04054765|101705967|FG000|STARTED|3-month Follow up||142||
48561452|NCT04054765|101705968|FG001|STARTED|3-month Follow up||126||
48561453|NCT04054765|101705967|FG000|COMPLETED|3-month Follow up||142||
48561454|NCT04054765|101705968|FG001|COMPLETED|3-month Follow up||123||
48561455|NCT04054765|101705967|FG000|NOT COMPLETED|3-month Follow up||0||
48561456|NCT04054765|101705968|FG001|NOT COMPLETED|3-month Follow up||3||
48561457|NCT04054765|101705967|FG000|STARTED|6-month Follow up||142||
48561458|NCT04054765|101705968|FG001|STARTED|6-month Follow up||123||
48561459|NCT04054765|101705967|FG000|COMPLETED|6-month Follow up||110||
48561460|NCT04054765|101705968|FG001|COMPLETED|6-month Follow up||91||
48561461|NCT04054765|101705967|FG000|NOT COMPLETED|6-month Follow up||32||
48561462|NCT04054765|101705968|FG001|NOT COMPLETED|6-month Follow up||32||
48695894|NCT03645096|102038628|FG002|STARTED|Second Treatment (21 Days)||5||
48695895|NCT03645096|102038629|FG003|STARTED|Second Treatment (21 Days)||7||
48695896|NCT03645096|102038630|FG004|STARTED|Second Treatment (21 Days)||3||
48695897|NCT03645096|102038631|FG005|STARTED|Second Treatment (21 Days)||2||
48695898|NCT03645096|102038626|FG000|COMPLETED|Second Treatment (21 Days)||3||
48695899|NCT03645096|102038627|FG001|COMPLETED|Second Treatment (21 Days)||2||
48561463|NCT00740636|101705969|FG000|STARTED|Overall Study||25||
48561464|NCT00740636|101705970|FG001|STARTED|Overall Study||67||
48561465|NCT00740636|101705969|FG000|COMPLETED|Overall Study||23||
48695900|NCT03645096|102038628|FG002|COMPLETED|Second Treatment (21 Days)||5||
48695901|NCT03645096|102038629|FG003|COMPLETED|Second Treatment (21 Days)||5||
48695902|NCT03645096|102038630|FG004|COMPLETED|Second Treatment (21 Days)||3||
48561466|NCT00740636|101705970|FG001|COMPLETED|Overall Study||63||
48561467|NCT00740636|101705969|FG000|NOT COMPLETED|Overall Study||2||
48561468|NCT00740636|101705970|FG001|NOT COMPLETED|Overall Study||4||
48561469|NCT03380429|101705971|FG000|STARTED|Overall Study||87||
48561470|NCT03380429|101705972|FG001|STARTED|Overall Study||88||
48561471|NCT03380429|101705973|FG002|STARTED|Overall Study||88||
48561472|NCT03380429|101705974|FG003|STARTED|Overall Study||88||
48561473|NCT03380429|101705975|FG004|STARTED|Overall Study||86||
48561474|NCT03380429|101705971|FG000|COMPLETED|Overall Study||82||
48561475|NCT03380429|101705972|FG001|COMPLETED|Overall Study||81||
48561476|NCT03380429|101705973|FG002|COMPLETED|Overall Study||77||
48561477|NCT03380429|101705974|FG003|COMPLETED|Overall Study||78||
48561478|NCT03380429|101705975|FG004|COMPLETED|Overall Study||81||
48561479|NCT03380429|101705971|FG000|NOT COMPLETED|Overall Study||5||
48561480|NCT03380429|101705972|FG001|NOT COMPLETED|Overall Study||7||
48561481|NCT03380429|101705973|FG002|NOT COMPLETED|Overall Study||11||
48561482|NCT03380429|101705974|FG003|NOT COMPLETED|Overall Study||10||
48561483|NCT03380429|101705975|FG004|NOT COMPLETED|Overall Study||5||
48561484|NCT05377749|101705976|FG000|STARTED|Baseline Assessments||24||
48695903|NCT03645096|102038631|FG005|COMPLETED|Second Treatment (21 Days)||2||
48275555|NCT00702962|100996464|FG001|NOT COMPLETED|Overall Study||1||
48275556|NCT01997905|100996465|FG000|STARTED|Overall Study||13||
48275557|NCT01997905|100996465|FG000|Baseline Completed|Overall Study||11||
48275558|NCT01997905|100996465|FG000|COMPLETED|Overall Study||10||
48275559|NCT01997905|100996465|FG000|NOT COMPLETED|Overall Study||3||
48275560|NCT01012297|100996466|FG000|STARTED|Overall Study||54||
48275561|NCT01012297|100996467|FG001|STARTED|Overall Study||53||
48275562|NCT01012297|100996466|FG000|COMPLETED|Overall Study||54||
48275563|NCT01012297|100996467|FG001|COMPLETED|Overall Study||53||
48275564|NCT01012297|100996466|FG000|NOT COMPLETED|Overall Study||0||
48275565|NCT01012297|100996467|FG001|NOT COMPLETED|Overall Study||0||
48275566|NCT00925353|100996468|FG000|STARTED|Overall Study||13||
48561485|NCT05377749|101705977|FG001|STARTED|Baseline Assessments||23||
48561486|NCT05377749|101705976|FG000|COMPLETED|Baseline Assessments||24||
48561487|NCT05377749|101705977|FG001|COMPLETED|Baseline Assessments||23||
48561488|NCT05377749|101705976|FG000|NOT COMPLETED|Baseline Assessments||0||
48695904|NCT03645096|102038626|FG000|NOT COMPLETED|Second Treatment (21 Days)||1||
48695905|NCT03645096|102038627|FG001|NOT COMPLETED|Second Treatment (21 Days)||1||
48695906|NCT03645096|102038628|FG002|NOT COMPLETED|Second Treatment (21 Days)||0||
48695907|NCT03645096|102038629|FG003|NOT COMPLETED|Second Treatment (21 Days)||2||
48695908|NCT03645096|102038630|FG004|NOT COMPLETED|Second Treatment (21 Days)||0||
48695909|NCT03645096|102038631|FG005|NOT COMPLETED|Second Treatment (21 Days)||0||
48695910|NCT03645096|102038626|FG000|STARTED|Third Treatment (21 Days)||3||
48695911|NCT03645096|102038627|FG001|STARTED|Third Treatment (21 Days)||2||
48695912|NCT03645096|102038628|FG002|STARTED|Third Treatment (21 Days)||5||
48695913|NCT03645096|102038629|FG003|STARTED|Third Treatment (21 Days)||5||
48695914|NCT03645096|102038630|FG004|STARTED|Third Treatment (21 Days)||3||
48695915|NCT03645096|102038631|FG005|STARTED|Third Treatment (21 Days)||2||
48561489|NCT05377749|101705977|FG001|NOT COMPLETED|Baseline Assessments||0||
48561490|NCT05377749|101705976|FG000|STARTED|3 Weeks||24||
48695916|NCT03645096|102038626|FG000|COMPLETED|Third Treatment (21 Days)||3||
48275567|NCT00925353|100996468|FG000|COMPLETED|Overall Study||10||
48275568|NCT00925353|100996468|FG000|NOT COMPLETED|Overall Study||3||
48275569|NCT03653208|100996469|FG000|STARTED|Overall Study||3||
48561491|NCT05377749|101705977|FG001|STARTED|3 Weeks||23||
48275570|NCT03653208|100996470|FG001|STARTED|Overall Study||3||
48275571|NCT03653208|100996471|FG002|STARTED|Overall Study||6||
48275572|NCT03653208|100996472|FG003|STARTED|Overall Study||6||
48275573|NCT03653208|100996473|FG004|STARTED|Overall Study||6||
48275574|NCT03653208|100996474|FG005|STARTED|Overall Study||6||
48561492|NCT05377749|101705976|FG000|COMPLETED|3 Weeks||21||
48561493|NCT05377749|101705977|FG001|COMPLETED|3 Weeks||18||
48275575|NCT03653208|100996475|FG006|STARTED|Overall Study||6||
48561494|NCT05377749|101705976|FG000|NOT COMPLETED|3 Weeks||3||
48561495|NCT05377749|101705977|FG001|NOT COMPLETED|3 Weeks||5||
48561496|NCT00708461|101705978|FG000|STARTED|Overall Study||752||
48695917|NCT03645096|102038627|FG001|COMPLETED|Third Treatment (21 Days)||1||
48695918|NCT03645096|102038628|FG002|COMPLETED|Third Treatment (21 Days)||4||
48695919|NCT03645096|102038629|FG003|COMPLETED|Third Treatment (21 Days)||3||
48695920|NCT03645096|102038630|FG004|COMPLETED|Third Treatment (21 Days)||3||
48695921|NCT03645096|102038631|FG005|COMPLETED|Third Treatment (21 Days)||2||
48275576|NCT03653208|100996476|FG007|STARTED|Overall Study||6||
48275577|NCT03653208|100996477|FG008|STARTED|Overall Study||14||
48695922|NCT03645096|102038626|FG000|NOT COMPLETED|Third Treatment (21 Days)||0||
48695923|NCT03645096|102038627|FG001|NOT COMPLETED|Third Treatment (21 Days)||1||
48695924|NCT03645096|102038628|FG002|NOT COMPLETED|Third Treatment (21 Days)||1||
48695925|NCT03645096|102038629|FG003|NOT COMPLETED|Third Treatment (21 Days)||2||
48695926|NCT03645096|102038630|FG004|NOT COMPLETED|Third Treatment (21 Days)||0||
48695927|NCT03645096|102038631|FG005|NOT COMPLETED|Third Treatment (21 Days)||0||
48695928|NCT00869791|102038632|FG000|STARTED|Period 1 Treatment for 7 Days||14||
48695929|NCT00869791|102038633|FG001|STARTED|Period 1 Treatment for 7 Days||13||
48695930|NCT00869791|102038632|FG000|COMPLETED|Period 1 Treatment for 7 Days||14||
48275578|NCT03653208|100996469|FG000|COMPLETED|Overall Study||3||
48275579|NCT03653208|100996470|FG001|COMPLETED|Overall Study||3||
48275580|NCT03653208|100996471|FG002|COMPLETED|Overall Study||6||
48275581|NCT03653208|100996472|FG003|COMPLETED|Overall Study||6||
48275582|NCT03653208|100996473|FG004|COMPLETED|Overall Study||5||
48275583|NCT03653208|100996474|FG005|COMPLETED|Overall Study||6||
48275584|NCT03653208|100996475|FG006|COMPLETED|Overall Study||6||
48275585|NCT03653208|100996476|FG007|COMPLETED|Overall Study||5||
48275586|NCT03653208|100996477|FG008|COMPLETED|Overall Study||13||
48275587|NCT03653208|100996469|FG000|NOT COMPLETED|Overall Study||0||
48275588|NCT03653208|100996470|FG001|NOT COMPLETED|Overall Study||0||
48275589|NCT03653208|100996471|FG002|NOT COMPLETED|Overall Study||0||
48393172|NCT02198651|101291519|FG003|COMPLETED|Double-blind Period||0||
48393173|NCT02198651|101291520|FG004|COMPLETED|Double-blind Period||0||
48393174|NCT02198651|101291516|FG000|NOT COMPLETED|Double-blind Period||0||
48393175|NCT02198651|101291517|FG001|NOT COMPLETED|Double-blind Period||9||
48393176|NCT02198651|101291518|FG002|NOT COMPLETED|Double-blind Period||1||
48393177|NCT02198651|101291519|FG003|NOT COMPLETED|Double-blind Period||0||
48695931|NCT00869791|102038633|FG001|COMPLETED|Period 1 Treatment for 7 Days||13||
48695932|NCT00869791|102038632|FG000|NOT COMPLETED|Period 1 Treatment for 7 Days||0||
48695933|NCT00869791|102038633|FG001|NOT COMPLETED|Period 1 Treatment for 7 Days||0||
48695934|NCT00869791|102038632|FG000|STARTED|Period 2 Treatment for 7 Days||14||
48695935|NCT00869791|102038633|FG001|STARTED|Period 2 Treatment for 7 Days||13||
48695936|NCT00869791|102038632|FG000|COMPLETED|Period 2 Treatment for 7 Days||14||
48695937|NCT00869791|102038633|FG001|COMPLETED|Period 2 Treatment for 7 Days||13||
48695938|NCT00869791|102038632|FG000|NOT COMPLETED|Period 2 Treatment for 7 Days||0||
48695939|NCT00869791|102038633|FG001|NOT COMPLETED|Period 2 Treatment for 7 Days||0||
48695940|NCT02237001|102038634|FG000|STARTED|Overall Study||30||
48695941|NCT02237001|102038634|FG000|6 Month Follow-up|Overall Study||27||
48695942|NCT02237001|102038634|FG000|12 Month Follow-up|Overall Study||21||
48393178|NCT02198651|101291520|FG004|NOT COMPLETED|Double-blind Period||0||
48393179|NCT02198651|101291516|FG000|STARTED|Open-label Rescue Period||0||
48695943|NCT02237001|102038634|FG000|24 Month Follow-up|Overall Study||19||
48695944|NCT02237001|102038634|FG000|COMPLETED|Overall Study||19||
48393180|NCT02198651|101291517|FG001|STARTED|Open-label Rescue Period||0||
48393181|NCT02198651|101291518|FG002|STARTED|Open-label Rescue Period||0||
48393182|NCT02198651|101291519|FG003|STARTED|Open-label Rescue Period||31||
48393183|NCT02198651|101291520|FG004|STARTED|Open-label Rescue Period||8||
48393184|NCT02198651|101291516|FG000|Correctly Entered Open-label Rescue|Open-label Rescue Period||0||
48695945|NCT02237001|102038634|FG000|NOT COMPLETED|Overall Study||11||
48275590|NCT03653208|100996472|FG003|NOT COMPLETED|Overall Study||0||
48393185|NCT02198651|101291517|FG001|Correctly Entered Open-label Rescue|Open-label Rescue Period||0||
48393186|NCT02198651|101291518|FG002|Correctly Entered Open-label Rescue|Open-label Rescue Period||0||
48393187|NCT02198651|101291519|FG003|Correctly Entered Open-label Rescue|Open-label Rescue Period||30||
48393188|NCT02198651|101291520|FG004|Correctly Entered Open-label Rescue|Open-label Rescue Period||8||
48393189|NCT02198651|101291516|FG000|COMPLETED|Open-label Rescue Period||0||
48695946|NCT02907216|102038635|FG000|STARTED|Overall Study||147||
48695947|NCT02907216|102038636|FG001|STARTED|Overall Study||145||
48695948|NCT02907216|102038635|FG000|COMPLETED|Overall Study||146||
48695949|NCT02907216|102038636|FG001|COMPLETED|Overall Study||144||
48275591|NCT03653208|100996473|FG004|NOT COMPLETED|Overall Study||1||
48275592|NCT03653208|100996474|FG005|NOT COMPLETED|Overall Study||0||
48275593|NCT03653208|100996475|FG006|NOT COMPLETED|Overall Study||0||
48275594|NCT03653208|100996476|FG007|NOT COMPLETED|Overall Study||1||
48275595|NCT03653208|100996477|FG008|NOT COMPLETED|Overall Study||1||
48393190|NCT02198651|101291517|FG001|COMPLETED|Open-label Rescue Period||0||
48275596|NCT02643472|100996478|FG000|STARTED|Overall Study||150||
48695950|NCT02907216|102038635|FG000|NOT COMPLETED|Overall Study||1||
48393191|NCT02198651|101291518|FG002|COMPLETED|Open-label Rescue Period||0||
48393192|NCT02198651|101291519|FG003|COMPLETED|Open-label Rescue Period||28||
48393193|NCT02198651|101291520|FG004|COMPLETED|Open-label Rescue Period||8||
48393194|NCT02198651|101291516|FG000|NOT COMPLETED|Open-label Rescue Period||0||
48393195|NCT02198651|101291517|FG001|NOT COMPLETED|Open-label Rescue Period||0||
48393196|NCT02198651|101291518|FG002|NOT COMPLETED|Open-label Rescue Period||0||
48393197|NCT02198651|101291519|FG003|NOT COMPLETED|Open-label Rescue Period||3||
48393198|NCT02198651|101291520|FG004|NOT COMPLETED|Open-label Rescue Period||0||
48393199|NCT01315002|101291521|FG000|STARTED|Overall Study||61||
48393200|NCT01315002|101291522|FG001|STARTED|Overall Study||60||
48393201|NCT01315002|101291521|FG000|COMPLETED|Overall Study||56||
48393202|NCT01315002|101291522|FG001|COMPLETED|Overall Study||55||
48393203|NCT01315002|101291521|FG000|NOT COMPLETED|Overall Study||5||
48393204|NCT01315002|101291522|FG001|NOT COMPLETED|Overall Study||5||
48393205|NCT00340834|101291523|FG000|STARTED|Core Phase of Study||426||
48393206|NCT00340834|101291524|FG001|STARTED|Core Phase of Study||431||
48393207|NCT00340834|101291525|FG002|STARTED|Core Phase of Study||435||
48393208|NCT00340834|101291526|FG003|STARTED|Core Phase of Study||0||
48393209|NCT00340834|101291527|FG004|STARTED|Core Phase of Study||0||
48393210|NCT00340834|101291523|FG000|COMPLETED|Core Phase of Study||369||
48393211|NCT00340834|101291524|FG001|COMPLETED|Core Phase of Study||398||
48393212|NCT00340834|101291525|FG002|COMPLETED|Core Phase of Study||386||
48393213|NCT00340834|101291526|FG003|COMPLETED|Core Phase of Study||0||
48393214|NCT00340834|101291527|FG004|COMPLETED|Core Phase of Study||0||
48393215|NCT00340834|101291523|FG000|NOT COMPLETED|Core Phase of Study||57||
48393216|NCT00340834|101291524|FG001|NOT COMPLETED|Core Phase of Study||33||
48393217|NCT00340834|101291525|FG002|NOT COMPLETED|Core Phase of Study||49||
48393218|NCT00340834|101291526|FG003|NOT COMPLETED|Core Phase of Study||0||
48393219|NCT00340834|101291527|FG004|NOT COMPLETED|Core Phase of Study||0||
48393220|NCT00340834|101291523|FG000|STARTED|Extension Phase of Study||330||
48393221|NCT00340834|101291524|FG001|STARTED|Extension Phase of Study||357||
48393222|NCT00340834|101291525|FG002|STARTED|Extension Phase of Study||0||
48393223|NCT00340834|101291526|FG003|STARTED|Extension Phase of Study||176||
48393224|NCT00340834|101291527|FG004|STARTED|Extension Phase of Study||167||
48393225|NCT00340834|101291523|FG000|Received Study Drug|Extension Phase of Study||330||
48393226|NCT00340834|101291524|FG001|Received Study Drug|Extension Phase of Study||356||
48393227|NCT00340834|101291525|FG002|Received Study Drug|Extension Phase of Study||0||
48393228|NCT00340834|101291526|FG003|Received Study Drug|Extension Phase of Study||174||
48393229|NCT00340834|101291527|FG004|Received Study Drug|Extension Phase of Study||167||
48393230|NCT00340834|101291523|FG000|COMPLETED|Extension Phase of Study||245||
48393231|NCT00340834|101291524|FG001|COMPLETED|Extension Phase of Study||281||
48393232|NCT00340834|101291525|FG002|COMPLETED|Extension Phase of Study||0||
48393233|NCT00340834|101291526|FG003|COMPLETED|Extension Phase of Study||123||
48393234|NCT00340834|101291527|FG004|COMPLETED|Extension Phase of Study||123||
48393235|NCT00340834|101291523|FG000|NOT COMPLETED|Extension Phase of Study||85||
48393236|NCT00340834|101291524|FG001|NOT COMPLETED|Extension Phase of Study||76||
48393237|NCT00340834|101291525|FG002|NOT COMPLETED|Extension Phase of Study||0||
48393238|NCT00340834|101291526|FG003|NOT COMPLETED|Extension Phase of Study||53||
48393239|NCT00340834|101291527|FG004|NOT COMPLETED|Extension Phase of Study||44||
48561497|NCT00708461|101705979|FG001|STARTED|Overall Study||995||
48561498|NCT00708461|101705978|FG000|COMPLETED|Overall Study||611||
48561499|NCT00708461|101705979|FG001|COMPLETED|Overall Study||795||
48561500|NCT00708461|101705978|FG000|NOT COMPLETED|Overall Study||141||
48561501|NCT00708461|101705979|FG001|NOT COMPLETED|Overall Study||200||
48561502|NCT02653625|101705980|FG000|STARTED|Overall Study||24||
48561503|NCT02653625|101705980|FG000|COMPLETED|Overall Study||20||
48561504|NCT02653625|101705980|FG000|NOT COMPLETED|Overall Study||4||
48561505|NCT01334229|101705981|FG000|STARTED|Overall Study||11||
48393240|NCT04578015|101291528|FG000|STARTED|Overall Study||8||
48393241|NCT04578015|101291529|FG001|STARTED|Overall Study||8||
48561506|NCT01334229|101705982|FG001|STARTED|Overall Study||11||
48561507|NCT01334229|101705981|FG000|COMPLETED|Overall Study||11||
48561508|NCT01334229|101705982|FG001|COMPLETED|Overall Study||11||
48112535|NCT00645333|100601508|FG000|COMPLETED|Overall Study||30||
48112536|NCT00645333|100601508|FG000|NOT COMPLETED|Overall Study||0||
48112537|NCT00997503|100601509|FG000|STARTED|Overall Study||4199||
48112538|NCT00997503|100601509|FG000|12 Months|Overall Study||4059||
48112539|NCT00997503|100601509|FG000|COMPLETED|Overall Study||3926||
48112540|NCT00997503|100601509|FG000|NOT COMPLETED|Overall Study||273||
48275597|NCT02643472|100996479|FG001|STARTED|Overall Study||150||
48275598|NCT02643472|100996478|FG000|COMPLETED|Overall Study||123||
48275599|NCT02643472|100996479|FG001|COMPLETED|Overall Study||116||
48275600|NCT02643472|100996478|FG000|NOT COMPLETED|Overall Study||27||
48275601|NCT02643472|100996479|FG001|NOT COMPLETED|Overall Study||34||
48275602|NCT02654652|100996480|FG000|STARTED|Overall Study||19||
48275603|NCT02654652|100996481|FG001|STARTED|Overall Study||21||
48275604|NCT02654652|100996480|FG000|COMPLETED|Overall Study||18||
48275605|NCT02654652|100996481|FG001|COMPLETED|Overall Study||18||
48275606|NCT02654652|100996480|FG000|NOT COMPLETED|Overall Study||1||
48275607|NCT02654652|100996481|FG001|NOT COMPLETED|Overall Study||3||
48275608|NCT04608773|100996482|FG000|STARTED|First Wash Out (1 Week)||69||
48275609|NCT04608773|100996483|FG001|STARTED|First Wash Out (1 Week)||60||
48275610|NCT04608773|100996482|FG000|COMPLETED|First Wash Out (1 Week)||57||
48393242|NCT04578015|101291528|FG000|COMPLETED|Overall Study||0||
48393243|NCT04578015|101291529|FG001|COMPLETED|Overall Study||0||
48393244|NCT04578015|101291528|FG000|NOT COMPLETED|Overall Study||8||
48393245|NCT04578015|101291529|FG001|NOT COMPLETED|Overall Study||8||
48393246|NCT01688635|101291530|FG000|STARTED|Period 1||45||
48393247|NCT01688635|101291531|FG001|STARTED|Period 1||46||
48393248|NCT01688635|101291530|FG000|Received at Least 1 Dose of Study Drug|Period 1||45||
48393249|NCT01688635|101291531|FG001|Received at Least 1 Dose of Study Drug|Period 1||46||
48393250|NCT01688635|101291530|FG000|COMPLETED|Period 1||45||
48393251|NCT01688635|101291531|FG001|COMPLETED|Period 1||46||
48393252|NCT01688635|101291530|FG000|NOT COMPLETED|Period 1||0||
48393253|NCT01688635|101291531|FG001|NOT COMPLETED|Period 1||0||
48393254|NCT01688635|101291530|FG000|STARTED|Washout 1||45||
48393255|NCT01688635|101291531|FG001|STARTED|Washout 1||46||
48393256|NCT01688635|101291530|FG000|COMPLETED|Washout 1||44||
48561509|NCT01334229|101705981|FG000|NOT COMPLETED|Overall Study||0||
48393257|NCT01688635|101291531|FG001|COMPLETED|Washout 1||44||
48393258|NCT01688635|101291530|FG000|NOT COMPLETED|Washout 1||1||
48393259|NCT01688635|101291531|FG001|NOT COMPLETED|Washout 1||2||
48393260|NCT01688635|101291530|FG000|STARTED|Period 2||44||
48393261|NCT01688635|101291531|FG001|STARTED|Period 2||44||
48393262|NCT01688635|101291530|FG000|COMPLETED|Period 2||44||
48393263|NCT01688635|101291531|FG001|COMPLETED|Period 2||44||
48393264|NCT01688635|101291530|FG000|NOT COMPLETED|Period 2||0||
48393265|NCT01688635|101291531|FG001|NOT COMPLETED|Period 2||0||
48393266|NCT01688635|101291530|FG000|STARTED|Washout 2||44||
48393267|NCT01688635|101291531|FG001|STARTED|Washout 2||44||
48393268|NCT01688635|101291530|FG000|COMPLETED|Washout 2||41||
48393269|NCT01688635|101291531|FG001|COMPLETED|Washout 2||42||
48393270|NCT01688635|101291530|FG000|NOT COMPLETED|Washout 2||3||
48393271|NCT01688635|101291531|FG001|NOT COMPLETED|Washout 2||2||
48393272|NCT01688635|101291530|FG000|STARTED|Period 3||41||
48393273|NCT01688635|101291531|FG001|STARTED|Period 3||42||
48393274|NCT01688635|101291530|FG000|COMPLETED|Period 3||41||
48393275|NCT01688635|101291531|FG001|COMPLETED|Period 3||42||
48561510|NCT01334229|101705982|FG001|NOT COMPLETED|Overall Study||0||
48561511|NCT01641640|101705983|FG000|STARTED|Overall Study||328||
48561512|NCT01641640|101705983|FG000|Enrolled and Treated|Overall Study||327||
48275611|NCT04608773|100996483|FG001|COMPLETED|First Wash Out (1 Week)||54||
48112541|NCT03325166|100601510|FG000|STARTED|Overall Study||2||
48275612|NCT04608773|100996482|FG000|NOT COMPLETED|First Wash Out (1 Week)||12||
48112542|NCT03325166|100601510|FG000|COMPLETED|Overall Study||1||
48275613|NCT04608773|100996483|FG001|NOT COMPLETED|First Wash Out (1 Week)||6||
48275614|NCT04608773|100996482|FG000|STARTED|First Intervention (2 Weeks)||57||
48393276|NCT01688635|101291530|FG000|NOT COMPLETED|Period 3||0||
48393277|NCT01688635|101291531|FG001|NOT COMPLETED|Period 3||0||
48393278|NCT01688635|101291530|FG000|STARTED|Washout 3||41||
48393279|NCT01688635|101291531|FG001|STARTED|Washout 3||42||
48393280|NCT01688635|101291530|FG000|COMPLETED|Washout 3||40||
48393281|NCT01688635|101291531|FG001|COMPLETED|Washout 3||42||
48393282|NCT01688635|101291530|FG000|NOT COMPLETED|Washout 3||1||
48393283|NCT01688635|101291531|FG001|NOT COMPLETED|Washout 3||0||
48561513|NCT01641640|101705983|FG000|COMPLETED|Overall Study||292||
48561514|NCT01641640|101705983|FG000|NOT COMPLETED|Overall Study||36||
48275615|NCT04608773|100996483|FG001|STARTED|First Intervention (2 Weeks)||54||
48275616|NCT04608773|100996482|FG000|COMPLETED|First Intervention (2 Weeks)||53||
48275617|NCT04608773|100996483|FG001|COMPLETED|First Intervention (2 Weeks)||50||
48275618|NCT04608773|100996482|FG000|NOT COMPLETED|First Intervention (2 Weeks)||4||
48275619|NCT04608773|100996483|FG001|NOT COMPLETED|First Intervention (2 Weeks)||4||
48275620|NCT04608773|100996482|FG000|STARTED|Second Wash Out (1 Week)||53||
48275621|NCT04608773|100996483|FG001|STARTED|Second Wash Out (1 Week)||50||
48275622|NCT04608773|100996482|FG000|COMPLETED|Second Wash Out (1 Week)||53||
48393284|NCT01688635|101291530|FG000|STARTED|Period 4||40||
48393285|NCT01688635|101291531|FG001|STARTED|Period 4||42||
48393286|NCT01688635|101291530|FG000|COMPLETED|Period 4||40||
48393287|NCT01688635|101291531|FG001|COMPLETED|Period 4||42||
48393288|NCT01688635|101291530|FG000|NOT COMPLETED|Period 4||0||
48393289|NCT01688635|101291531|FG001|NOT COMPLETED|Period 4||0||
48393290|NCT04526067|101291532|FG000|STARTED|Overall Study||35|Completers had baseline and at least one follow-up assessment|
48393291|NCT04526067|101291533|FG001|STARTED|Overall Study||21|Completers had baseline and at least one follow-up assessment|
48393292|NCT04526067|101291532|FG000|COMPLETED|Overall Study||35|Completers had baseline and at least one follow up assessment|
48393293|NCT04526067|101291533|FG001|COMPLETED|Overall Study||21|Completers had baseline and at least one follow up assessment|
48393294|NCT04526067|101291532|FG000|NOT COMPLETED|Overall Study||0||
48393295|NCT04526067|101291533|FG001|NOT COMPLETED|Overall Study||0||
48393296|NCT01583985|101291534|FG000|STARTED|Overall Study||120||
48393297|NCT01583985|101291535|FG001|STARTED|Overall Study||120||
48393298|NCT01583985|101291534|FG000|Included in Primary Analysis|Overall Study||119|Provided patient-reported outcomes at least one post-randomization follow-up timepoint|
48393299|NCT01583985|101291535|FG001|Included in Primary Analysis|Overall Study||119|Provided patient-reported outcomes at least one post-randomization follow-up timepoint|
48393300|NCT01583985|101291534|FG000|COMPLETED|Overall Study||117|Main patient-reported outcomes at 12 months|
48393301|NCT01583985|101291535|FG001|COMPLETED|Overall Study||117|Main patient-reported outcomes at 12 months|
48393302|NCT01583985|101291534|FG000|NOT COMPLETED|Overall Study||3||
48393303|NCT01583985|101291535|FG001|NOT COMPLETED|Overall Study||3||
48393304|NCT00004732|101291536|FG000|STARTED|Overall Study||1262||
48393305|NCT00004732|101291537|FG001|STARTED|Overall Study||1240||
48393306|NCT00004732|101291536|FG000|COMPLETED|Overall Study||1193||
48393307|NCT00004732|101291537|FG001|COMPLETED|Overall Study||1129||
48393308|NCT00004732|101291536|FG000|NOT COMPLETED|Overall Study||69||
48393309|NCT00004732|101291537|FG001|NOT COMPLETED|Overall Study||111||
48393310|NCT01962688|101291538|FG000|STARTED|Overall Study||19||
48393311|NCT01962688|101291539|FG001|STARTED|Overall Study||18||
48393312|NCT01962688|101291538|FG000|COMPLETED|Overall Study||19||
48393313|NCT01962688|101291539|FG001|COMPLETED|Overall Study||18||
48393314|NCT01962688|101291538|FG000|NOT COMPLETED|Overall Study||0||
48393315|NCT01962688|101291539|FG001|NOT COMPLETED|Overall Study||0||
48393316|NCT02810951|101291540|FG000|STARTED|Overall Study||6||
48695951|NCT02907216|102038636|FG001|NOT COMPLETED|Overall Study||1||
48695952|NCT03928418|102038637|FG000|STARTED|Overall Study||91||
48695953|NCT03928418|102038638|FG001|STARTED|Overall Study||91||
48695954|NCT03928418|102038639|FG002|STARTED|Overall Study||90||
48275623|NCT04608773|100996483|FG001|COMPLETED|Second Wash Out (1 Week)||50||
48275624|NCT04608773|100996482|FG000|NOT COMPLETED|Second Wash Out (1 Week)||0||
48275625|NCT04608773|100996483|FG001|NOT COMPLETED|Second Wash Out (1 Week)||0||
48393317|NCT02810951|101291540|FG000|FCX-007 Injection|Overall Study||6||
48393318|NCT02810951|101291540|FG000|No FCX-007 Injection|Overall Study||6||
48393319|NCT02810951|101291540|FG000|COMPLETED|Overall Study||5||
48393320|NCT02810951|101291540|FG000|NOT COMPLETED|Overall Study||1||
48393321|NCT02806947|101291541|FG000|STARTED|Overall Study||58||
48393322|NCT02806947|101291542|FG001|STARTED|Overall Study||64||
48393323|NCT02806947|101291541|FG000|COMPLETED|Overall Study||53||
48393324|NCT02806947|101291542|FG001|COMPLETED|Overall Study||63||
48393325|NCT02806947|101291541|FG000|NOT COMPLETED|Overall Study||5||
48393326|NCT02806947|101291542|FG001|NOT COMPLETED|Overall Study||1||
48393327|NCT01760187|101291543|FG000|STARTED|Overall Study||20||
48393328|NCT01760187|101291544|FG001|STARTED|Overall Study||12||
48393329|NCT01760187|101291545|FG002|STARTED|Overall Study||12||
48393330|NCT01760187|101291546|FG003|STARTED|Overall Study||12||
48393331|NCT01760187|101291547|FG004|STARTED|Overall Study||16||
48393332|NCT01760187|101291543|FG000|COMPLETED|Overall Study||19||
48393333|NCT01760187|101291544|FG001|COMPLETED|Overall Study||12||
48393334|NCT01760187|101291545|FG002|COMPLETED|Overall Study||12||
48393335|NCT01760187|101291546|FG003|COMPLETED|Overall Study||10||
48393336|NCT01760187|101291547|FG004|COMPLETED|Overall Study||16||
48710815|NCT03837665|102078027|FG000|NOT COMPLETED|Overall Study||0||
48275626|NCT04608773|100996482|FG000|STARTED|Second Intervention (2 Week)||53||
48275627|NCT04608773|100996483|FG001|STARTED|Second Intervention (2 Week)||50||
48275628|NCT04608773|100996482|FG000|COMPLETED|Second Intervention (2 Week)||51||
48275629|NCT04608773|100996483|FG001|COMPLETED|Second Intervention (2 Week)||45||
48275630|NCT04608773|100996482|FG000|NOT COMPLETED|Second Intervention (2 Week)||2||
48275631|NCT04608773|100996483|FG001|NOT COMPLETED|Second Intervention (2 Week)||5||
48275632|NCT00953771|100996484|FG000|STARTED|Overall Study||9||
48275633|NCT00953771|100996485|FG001|STARTED|Overall Study||20||
48275634|NCT00953771|100996484|FG000|COMPLETED|Overall Study||8||
48275635|NCT00953771|100996485|FG001|COMPLETED|Overall Study||20||
48275636|NCT00953771|100996484|FG000|NOT COMPLETED|Overall Study||1||
48275637|NCT00953771|100996485|FG001|NOT COMPLETED|Overall Study||0||
48275638|NCT00743431|100996486|FG000|STARTED|Overall Study||224||
48275639|NCT00743431|100996486|FG000|COMPLETED|Overall Study||98||
48275640|NCT00743431|100996486|FG000|NOT COMPLETED|Overall Study||126||
48275641|NCT00137969|100996487|FG000|STARTED|Overall Study||174||
48275642|NCT00137969|100996488|FG001|STARTED|Overall Study||88||
48275643|NCT00137969|100996487|FG000|Received Study Drug|Overall Study||169||
48275644|NCT00137969|100996488|FG001|Received Study Drug|Overall Study||88||
48275645|NCT00137969|100996487|FG000|COMPLETED|Overall Study||107||
48275646|NCT00137969|100996488|FG001|COMPLETED|Overall Study||67||
48275647|NCT00137969|100996487|FG000|NOT COMPLETED|Overall Study||67||
48275648|NCT00137969|100996488|FG001|NOT COMPLETED|Overall Study||21||
48275649|NCT01125046|100996489|FG000|STARTED|First 6 Months of Treatment||50||
48275650|NCT01125046|100996489|FG000|COMPLETED|First 6 Months of Treatment||36||
48275651|NCT01125046|100996489|FG000|NOT COMPLETED|First 6 Months of Treatment||14||
48275652|NCT01125046|100996489|FG000|STARTED|Continued Treatment After 6 Months||36||
48275653|NCT01125046|100996489|FG000|COMPLETED|Continued Treatment After 6 Months||33||
48275654|NCT01125046|100996489|FG000|NOT COMPLETED|Continued Treatment After 6 Months||3||
48561515|NCT05653479|101705984|FG000|STARTED|Overall Study||8||
48561516|NCT05653479|101705985|FG001|STARTED|Overall Study||8||
48561517|NCT05653479|101705986|FG002|STARTED|Overall Study||8||
48561518|NCT05653479|101705987|FG003|STARTED|Overall Study||8||
48561519|NCT05653479|101705984|FG000|COMPLETED|Overall Study||8||
48561520|NCT05653479|101705985|FG001|COMPLETED|Overall Study||8||
48561521|NCT05653479|101705986|FG002|COMPLETED|Overall Study||8||
48561522|NCT05653479|101705987|FG003|COMPLETED|Overall Study||8||
48561523|NCT05653479|101705984|FG000|NOT COMPLETED|Overall Study||0||
48561524|NCT05653479|101705985|FG001|NOT COMPLETED|Overall Study||0||
48561525|NCT05653479|101705986|FG002|NOT COMPLETED|Overall Study||0||
48561526|NCT05653479|101705987|FG003|NOT COMPLETED|Overall Study||0||
48561527|NCT01982682|101705988|FG000|STARTED|Overall Study||41||
48561528|NCT01982682|101705988|FG000|COMPLETED|Overall Study||40||
48561529|NCT01982682|101705988|FG000|NOT COMPLETED|Overall Study||1||
48561530|NCT02942017|101705989|FG000|STARTED|Overall Study||54||
48561531|NCT02942017|101705990|FG001|STARTED|Overall Study||54||
48561532|NCT02942017|101705989|FG000|Treated|Overall Study||53||
48561533|NCT02942017|101705990|FG001|Treated|Overall Study||51||
48561534|NCT02942017|101705989|FG000|COMPLETED|Overall Study||52||
48561535|NCT02942017|101705990|FG001|COMPLETED|Overall Study||48||
48561536|NCT02942017|101705989|FG000|NOT COMPLETED|Overall Study||2||
48561537|NCT02942017|101705990|FG001|NOT COMPLETED|Overall Study||6||
48561538|NCT01518322|101705991|FG000|STARTED|Overall Study||235||
48561539|NCT01518322|101705991|FG000|COMPLETED|Overall Study||222||
48561540|NCT01518322|101705991|FG000|NOT COMPLETED|Overall Study||13||
48561541|NCT01545648|101705992|FG000|STARTED|Overall Study||4||
48561542|NCT01545648|101705992|FG000|6 Months of Treatment|Overall Study||4||
48561543|NCT01545648|101705992|FG000|COMPLETED|Overall Study||4|12 months of treatment|
48275655|NCT01125046|100996489|FG000|STARTED|Follow-up/Data Cut Off Point||49|All patients treated on the study go into follow up period.|
48275656|NCT01125046|100996489|FG000|COMPLETED|Follow-up/Data Cut Off Point||16||
48275657|NCT01125046|100996489|FG000|NOT COMPLETED|Follow-up/Data Cut Off Point||33||
48275658|NCT00126503|100999647|FG000|STARTED|Overall Study||48||
48561544|NCT01545648|101705992|FG000|NOT COMPLETED|Overall Study||0||
48561545|NCT00733005|101705993|FG000|STARTED|Overall Study||162||
48561546|NCT00733005|101705994|FG001|STARTED|Overall Study||162||
48561547|NCT00733005|101705993|FG000|COMPLETED|Overall Study||160||
48561548|NCT00733005|101705994|FG001|COMPLETED|Overall Study||159||
48561549|NCT00733005|101705993|FG000|NOT COMPLETED|Overall Study||2||
48561550|NCT00733005|101705994|FG001|NOT COMPLETED|Overall Study||3||
48561551|NCT00856492|101705995|FG000|STARTED|Overall Study||99||
48561552|NCT00856492|101705996|FG001|STARTED|Overall Study||63||
48561553|NCT00856492|101705997|FG002|STARTED|Overall Study||53||
48275659|NCT00126503|100999648|FG001|STARTED|Overall Study||21||
48275660|NCT00126503|100999647|FG000|COMPLETED|Overall Study||1||
48275661|NCT00126503|100999648|FG001|COMPLETED|Overall Study||0||
48275662|NCT00126503|100999647|FG000|NOT COMPLETED|Overall Study||47||
48275663|NCT00126503|100999648|FG001|NOT COMPLETED|Overall Study||21||
48275664|NCT01643044|100999649|FG000|STARTED|Overall Study||24||
48561554|NCT00856492|101705995|FG000|Toxicity Eval|Overall Study||96|Fewer pts evaluable for toxicity vs arm totals b/c 2 pts on each arm did not receive any treatment|
48561555|NCT00856492|101705996|FG001|Toxicity Eval|Overall Study||60|Fewer pts evaluable for toxicity vs arm totals b/c 2 pts on each arm did not receive any treatment|
48695955|NCT03928418|102038637|FG000|Pilot Participant|Overall Study||1|The first 3 participants enrolled in the study were pilot participants - they are included in the total number started, but were excluded from all analyses.|
48695956|NCT03928418|102038638|FG001|Pilot Participant|Overall Study||1|The first 3 participants enrolled in the study were pilot participants - they are included in the total number started, but were excluded from all analyses.|
48695957|NCT03928418|102038639|FG002|Pilot Participant|Overall Study||1|The first 3 participants enrolled in the study were pilot participants - they are included in the total number started, but were excluded from all analyses.|
48695958|NCT03928418|102038637|FG000|6-month Visit|Overall Study||83|(excluding pilot participants)|
48275665|NCT01643044|100999650|FG001|STARTED|Overall Study||24||
48275666|NCT01643044|100999649|FG000|COMPLETED|Overall Study||20||
48275667|NCT01643044|100999650|FG001|COMPLETED|Overall Study||19||
48275668|NCT01643044|100999649|FG000|NOT COMPLETED|Overall Study||4||
48275669|NCT01643044|100999650|FG001|NOT COMPLETED|Overall Study||5||
48275670|NCT03697551|100999651|FG000|STARTED|Overall Study||4||
48695959|NCT03928418|102038638|FG001|6-month Visit|Overall Study||86|(excluding pilot participants)|
48695960|NCT03928418|102038639|FG002|6-month Visit|Overall Study||85|(excluding pilot participants)|
48695961|NCT03928418|102038637|FG000|COMPLETED|Overall Study||85|(excluding pilot participants)|
48695962|NCT03928418|102038638|FG001|COMPLETED|Overall Study||87|(excluding pilot participants)|
48695963|NCT03928418|102038639|FG002|COMPLETED|Overall Study||84|(excluding pilot participants)|
48695964|NCT03928418|102038637|FG000|NOT COMPLETED|Overall Study||6||
48695965|NCT03928418|102038638|FG001|NOT COMPLETED|Overall Study||4||
48695966|NCT03928418|102038639|FG002|NOT COMPLETED|Overall Study||6||
48695967|NCT00809835|102038640|FG000|STARTED|Overall Study||28||
48695968|NCT00809835|102038641|FG001|STARTED|Overall Study||27||
48695969|NCT00809835|102038642|FG002|STARTED|Overall Study||38||
48275671|NCT03697551|100999651|FG000|COMPLETED|Overall Study||4||
48275672|NCT03697551|100999651|FG000|NOT COMPLETED|Overall Study||0||
48275673|NCT01717742|100999652|FG000|STARTED|Overall Study||48||
48275674|NCT01717742|100999653|FG001|STARTED|Overall Study||49||
48275675|NCT01717742|100999652|FG000|COMPLETED|Overall Study||43||
48275676|NCT01717742|100999653|FG001|COMPLETED|Overall Study||47||
48275677|NCT01717742|100999652|FG000|NOT COMPLETED|Overall Study||5||
48275678|NCT01717742|100999653|FG001|NOT COMPLETED|Overall Study||2||
48275679|NCT00821587|100999654|FG000|STARTED|Overall Study||20||
48275680|NCT00821587|100999655|FG001|STARTED|Overall Study||19||
48275681|NCT00821587|100999654|FG000|COMPLETED|Overall Study||20||
48275682|NCT00821587|100999655|FG001|COMPLETED|Overall Study||18||
48275683|NCT00821587|100999654|FG000|NOT COMPLETED|Overall Study||0||
48275684|NCT00821587|100999655|FG001|NOT COMPLETED|Overall Study||1||
48275685|NCT01677767|100999656|FG000|STARTED|Overall Study||124||
48275686|NCT01677767|100999656|FG000|COMPLETED|Overall Study||102||
48275687|NCT01677767|100999656|FG000|NOT COMPLETED|Overall Study||22||
48275688|NCT02898077|100999657|FG000|STARTED|Overall Study||294||
48275689|NCT02898077|100999658|FG001|STARTED|Overall Study||146||
48275690|NCT02898077|100999657|FG000|Received at Least 1 Dose of Study Drug|Overall Study||293||
48275691|NCT02898077|100999658|FG001|Received at Least 1 Dose of Study Drug|Overall Study||145||
48275692|NCT02898077|100999657|FG000|COMPLETED|Overall Study||246||
48275693|NCT02898077|100999658|FG001|COMPLETED|Overall Study||123||
48275694|NCT02898077|100999657|FG000|NOT COMPLETED|Overall Study||48||
48561556|NCT00856492|101705997|FG002|Toxicity Eval|Overall Study||51|Fewer pts evaluable for toxicity vs arm totals b/c 2 pts on each arm did not receive any treatment|
48561557|NCT00856492|101705995|FG000|COMPLETED|Overall Study||98||
48561558|NCT00856492|101705996|FG001|COMPLETED|Overall Study||62||
48561559|NCT00856492|101705997|FG002|COMPLETED|Overall Study||51||
48561560|NCT00856492|101705995|FG000|NOT COMPLETED|Overall Study||1||
48561561|NCT00856492|101705996|FG001|NOT COMPLETED|Overall Study||1||
48561562|NCT00856492|101705997|FG002|NOT COMPLETED|Overall Study||2||
48561563|NCT00180661|101705998|FG000|STARTED|Overall Study||19||
48561564|NCT00180661|101705999|FG001|STARTED|Overall Study||20||
48561565|NCT00180661|101705998|FG000|COMPLETED|Overall Study||19||
48275695|NCT02898077|100999658|FG001|NOT COMPLETED|Overall Study||23||
48561566|NCT00180661|101705999|FG001|COMPLETED|Overall Study||20||
48561567|NCT00180661|101705998|FG000|NOT COMPLETED|Overall Study||0||
48695970|NCT00809835|102038643|FG003|STARTED|Overall Study||27||
48695971|NCT00809835|102038640|FG000|COMPLETED|Overall Study||20||
48695972|NCT00809835|102038641|FG001|COMPLETED|Overall Study||20||
48695973|NCT00809835|102038642|FG002|COMPLETED|Overall Study||27||
48695974|NCT00809835|102038643|FG003|COMPLETED|Overall Study||25||
48695975|NCT00809835|102038640|FG000|NOT COMPLETED|Overall Study||8||
48695976|NCT00809835|102038641|FG001|NOT COMPLETED|Overall Study||7||
48695977|NCT00809835|102038642|FG002|NOT COMPLETED|Overall Study||11||
48695978|NCT00809835|102038643|FG003|NOT COMPLETED|Overall Study||2||
48695979|NCT00553436|102038644|FG000|STARTED|Overall Study||7||
48695980|NCT00553436|102038644|FG000|COMPLETED|Overall Study||6||
48275696|NCT03122691|100999659|FG000|STARTED|Overall Study||23||
48275697|NCT03122691|100999659|FG000|Oral 0mg|Overall Study||22||
48275698|NCT03122691|100999659|FG000|Oral 10mg|Overall Study||22||
48275699|NCT03122691|100999659|FG000|Oral 25mg|Overall Study||21||
48275700|NCT03122691|100999659|FG000|Vape 0mg|Overall Study||20||
48275701|NCT03122691|100999659|FG000|Vape 5mg|Overall Study||21||
48275702|NCT03122691|100999659|FG000|Vape 20mg|Overall Study||21||
48275703|NCT03122691|100999659|FG000|COMPLETED|Overall Study||20||
48561568|NCT00180661|101705999|FG001|NOT COMPLETED|Overall Study||0||
48561569|NCT00314327|101706000|FG000|STARTED|Overall Study||1||
48561570|NCT00314327|101706000|FG000|COMPLETED|Overall Study||0||
48561571|NCT00314327|101706000|FG000|NOT COMPLETED|Overall Study||1||
48561572|NCT03717155|101706001|FG000|STARTED|Overall Study||43||
48561573|NCT03717155|101706001|FG000|COMPLETED|Overall Study||43||
48561574|NCT03717155|101706001|FG000|NOT COMPLETED|Overall Study||0||
48561575|NCT00879255|101706002|FG000|STARTED|Overall Study||61||
48561576|NCT00879255|101706003|FG001|STARTED|Overall Study||64||
48275704|NCT03122691|100999659|FG000|NOT COMPLETED|Overall Study||3||
48275705|NCT00918879|100999660|FG000|STARTED|Overall Study||107||
48275706|NCT00918879|100999661|FG001|STARTED|Overall Study||106||
48561577|NCT00879255|101706002|FG000|Received Allocated Intervention:|Overall Study||51||
48561578|NCT00879255|101706003|FG001|Received Allocated Intervention:|Overall Study||56||
48561579|NCT00879255|101706002|FG000|Completed Posttreatment Follow-up|Overall Study||50||
48561580|NCT00879255|101706003|FG001|Completed Posttreatment Follow-up|Overall Study||55||
48561581|NCT00879255|101706002|FG000|Completed 3-mo Follow-up|Overall Study||48||
48561582|NCT00879255|101706003|FG001|Completed 3-mo Follow-up|Overall Study||49||
48561583|NCT00879255|101706002|FG000|COMPLETED|Overall Study||45||
48561584|NCT00879255|101706003|FG001|COMPLETED|Overall Study||45||
48561585|NCT00879255|101706002|FG000|NOT COMPLETED|Overall Study||16||
48561586|NCT00879255|101706003|FG001|NOT COMPLETED|Overall Study||19||
48561587|NCT03807544|101706004|FG000|STARTED|Overall Study||17||
48561588|NCT03807544|101706004|FG000|COMPLETED|Overall Study||17||
48561589|NCT03807544|101706004|FG000|NOT COMPLETED|Overall Study||0||
48561590|NCT01015534|101706005|FG000|STARTED|Overall Study||28||
48561591|NCT01015534|101706006|FG001|STARTED|Overall Study||27||
48561592|NCT01015534|101706005|FG000|COMPLETED|Overall Study||27||
48561593|NCT01015534|101706006|FG001|COMPLETED|Overall Study||27||
48561594|NCT01015534|101706005|FG000|NOT COMPLETED|Overall Study||1||
48561595|NCT01015534|101706006|FG001|NOT COMPLETED|Overall Study||0||
48561596|NCT04314037|101706007|FG000|STARTED|Treatment Period 1||18||
48561597|NCT04314037|101706008|FG001|STARTED|Treatment Period 1||18||
48561598|NCT04314037|101706007|FG000|COMPLETED|Treatment Period 1||18||
48561599|NCT04314037|101706008|FG001|COMPLETED|Treatment Period 1||18||
48561600|NCT04314037|101706007|FG000|NOT COMPLETED|Treatment Period 1||0||
48561601|NCT04314037|101706008|FG001|NOT COMPLETED|Treatment Period 1||0||
48561602|NCT04314037|101706007|FG000|STARTED|Treatment Period 2||18||
48275707|NCT00918879|100999660|FG000|COMPLETED|Overall Study||101||
48275708|NCT00918879|100999661|FG001|COMPLETED|Overall Study||100||
48275709|NCT00918879|100999660|FG000|NOT COMPLETED|Overall Study||6||
48275710|NCT00918879|100999661|FG001|NOT COMPLETED|Overall Study||6||
48275711|NCT01846494|100999662|FG000|STARTED|Overall Study||50||
48275712|NCT01846494|100999663|FG001|STARTED|Overall Study||63||
48275713|NCT01846494|100999662|FG000|COMPLETED|Overall Study||20||
48275714|NCT01846494|100999663|FG001|COMPLETED|Overall Study||25||
48275715|NCT01846494|100999662|FG000|NOT COMPLETED|Overall Study||30||
48275716|NCT01846494|100999663|FG001|NOT COMPLETED|Overall Study||38||
48275717|NCT02225132|100999664|FG000|STARTED|Overall Study||10||
48275718|NCT02225132|100999664|FG000|COMPLETED|Overall Study||10||
48275719|NCT02225132|100999664|FG000|NOT COMPLETED|Overall Study||0||
48275720|NCT01669577|100999665|FG000|STARTED|Overall Study||334||
48275721|NCT01669577|100999665|FG000|COMPLETED|Overall Study||200||
48275722|NCT01669577|100999665|FG000|NOT COMPLETED|Overall Study||134||
48275723|NCT00742326|100999666|FG000|STARTED|Overall Study||6||
48275724|NCT00742326|100999667|FG001|STARTED|Overall Study||7||
48275725|NCT00742326|100999666|FG000|COMPLETED|Overall Study||6||
48275726|NCT00742326|100999667|FG001|COMPLETED|Overall Study||6||
48275727|NCT00742326|100999666|FG000|NOT COMPLETED|Overall Study||0||
48275728|NCT00742326|100999667|FG001|NOT COMPLETED|Overall Study||1||
48275729|NCT00224887|100999668|FG000|STARTED|Overall Study||154||
48275730|NCT00224887|100999669|FG001|STARTED|Overall Study||153||
48275731|NCT00224887|100999668|FG000|COMPLETED|Overall Study||148||
48275732|NCT00224887|100999669|FG001|COMPLETED|Overall Study||147||
48561603|NCT04314037|101706008|FG001|STARTED|Treatment Period 2||18||
48561604|NCT04314037|101706007|FG000|COMPLETED|Treatment Period 2||17||
48695981|NCT00553436|102038644|FG000|NOT COMPLETED|Overall Study||1||
48275733|NCT00224887|100999668|FG000|NOT COMPLETED|Overall Study||6||
48275734|NCT00224887|100999669|FG001|NOT COMPLETED|Overall Study||6||
48275735|NCT02232243|100999670|FG000|STARTED|First Dose (200mg HCQ Twice Daily)||3||
48275736|NCT02232243|100999671|FG001|STARTED|First Dose (200mg HCQ Twice Daily)||0||
48561605|NCT04314037|101706008|FG001|COMPLETED|Treatment Period 2||18||
48561606|NCT04314037|101706007|FG000|NOT COMPLETED|Treatment Period 2||1||
48561607|NCT04314037|101706008|FG001|NOT COMPLETED|Treatment Period 2||0||
48561608|NCT04314037|101706007|FG000|STARTED|Treatment Period 3||17||
48695982|NCT00372619|102038645|FG000|STARTED|Overall Study||8||
48695983|NCT00372619|102038646|FG001|STARTED|Overall Study||2||
48695984|NCT00372619|102038647|FG002|STARTED|Overall Study||3||
48275737|NCT02232243|100999672|FG002|STARTED|First Dose (200mg HCQ Twice Daily)||0||
48275738|NCT02232243|100999670|FG000|COMPLETED|First Dose (200mg HCQ Twice Daily)||3||
48275739|NCT02232243|100999671|FG001|COMPLETED|First Dose (200mg HCQ Twice Daily)||0||
48275740|NCT02232243|100999672|FG002|COMPLETED|First Dose (200mg HCQ Twice Daily)||0||
48561609|NCT04314037|101706008|FG001|STARTED|Treatment Period 3||18||
48561610|NCT04314037|101706007|FG000|COMPLETED|Treatment Period 3||16||
48561611|NCT04314037|101706008|FG001|COMPLETED|Treatment Period 3||17||
48561612|NCT04314037|101706007|FG000|NOT COMPLETED|Treatment Period 3||1||
48561613|NCT04314037|101706008|FG001|NOT COMPLETED|Treatment Period 3||1||
48561614|NCT04314037|101706007|FG000|STARTED|Treatment Period 4||16||
48561615|NCT04314037|101706008|FG001|STARTED|Treatment Period 4||17||
48561616|NCT04314037|101706007|FG000|COMPLETED|Treatment Period 4||16||
48561617|NCT04314037|101706008|FG001|COMPLETED|Treatment Period 4||17||
48561618|NCT04314037|101706007|FG000|NOT COMPLETED|Treatment Period 4||0||
48561619|NCT04314037|101706008|FG001|NOT COMPLETED|Treatment Period 4||0||
48561620|NCT02568072|101706009|FG000|STARTED|Overall Study||120||
48561621|NCT02568072|101706009|FG000|COMPLETED|Overall Study||68||
48561622|NCT02568072|101706009|FG000|NOT COMPLETED|Overall Study||52||
48561623|NCT00380874|101706010|FG000|STARTED|Overall Study||32||
48561624|NCT00380874|101706011|FG001|STARTED|Overall Study||29||
48561625|NCT00380874|101706010|FG000|COMPLETED|Overall Study||19||
48561626|NCT00380874|101706011|FG001|COMPLETED|Overall Study||19||
48561627|NCT00380874|101706010|FG000|NOT COMPLETED|Overall Study||13||
48561628|NCT00380874|101706011|FG001|NOT COMPLETED|Overall Study||10||
48561629|NCT00682786|101706012|FG000|STARTED|Overall Study||98||
48561630|NCT00682786|101706013|FG001|STARTED|Overall Study||37||
48275741|NCT02232243|100999670|FG000|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0||
48275742|NCT02232243|100999671|FG001|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0||
48275743|NCT02232243|100999672|FG002|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0||
48275744|NCT02232243|100999670|FG000|STARTED|Second Dose (400mg HCQ Twice Daily)||0||
48275745|NCT02232243|100999671|FG001|STARTED|Second Dose (400mg HCQ Twice Daily)||4||
48275746|NCT02232243|100999672|FG002|STARTED|Second Dose (400mg HCQ Twice Daily)||0||
48275747|NCT02232243|100999670|FG000|COMPLETED|Second Dose (400mg HCQ Twice Daily)||0||
48275748|NCT02232243|100999671|FG001|COMPLETED|Second Dose (400mg HCQ Twice Daily)||3||
48275749|NCT02232243|100999672|FG002|COMPLETED|Second Dose (400mg HCQ Twice Daily)||0||
48275750|NCT02232243|100999670|FG000|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||0||
48275751|NCT02232243|100999671|FG001|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||1||
48275752|NCT02232243|100999672|FG002|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||0||
48275753|NCT02232243|100999670|FG000|STARTED|Third Dose(200mg HCQ Twice Daily)||0||
48561631|NCT00682786|101706012|FG000|COMPLETED|Overall Study||96||
48561632|NCT00682786|101706013|FG001|COMPLETED|Overall Study||34||
48561633|NCT00682786|101706012|FG000|NOT COMPLETED|Overall Study||2||
48561634|NCT00682786|101706013|FG001|NOT COMPLETED|Overall Study||3||
48561635|NCT00116779|101706014|FG000|STARTED|Overall Study||63||
48561636|NCT00116779|101706015|FG001|STARTED|Overall Study||64||
48561637|NCT00116779|101706014|FG000|COMPLETED|Overall Study||42||
48561638|NCT00116779|101706015|FG001|COMPLETED|Overall Study||45||
48561639|NCT00116779|101706014|FG000|NOT COMPLETED|Overall Study||21||
48561640|NCT00116779|101706015|FG001|NOT COMPLETED|Overall Study||19||
48561641|NCT05266053|101706016|FG000|STARTED|Overall Study||12||
48561642|NCT05266053|101706017|FG001|STARTED|Overall Study||12||
48561643|NCT05266053|101706016|FG000|COMPLETED|Overall Study||4||
48561644|NCT05266053|101706017|FG001|COMPLETED|Overall Study||8||
48561645|NCT05266053|101706016|FG000|NOT COMPLETED|Overall Study||8||
48561646|NCT05266053|101706017|FG001|NOT COMPLETED|Overall Study||4||
48561647|NCT03539302|101706018|FG000|STARTED|Overall Study||10||
48561648|NCT03539302|101706019|FG001|STARTED|Overall Study||22||
48561649|NCT03539302|101706020|FG002|STARTED|Overall Study||21||
48561650|NCT03539302|101706021|FG003|STARTED|Overall Study||19||
48561651|NCT03539302|101706022|FG004|STARTED|Overall Study||29||
48561652|NCT03539302|101706023|FG005|STARTED|Overall Study||26||
48561653|NCT03539302|101706024|FG006|STARTED|Overall Study||45||
48561654|NCT03539302|101706018|FG000|COMPLETED|Overall Study||10||
48561655|NCT03539302|101706019|FG001|COMPLETED|Overall Study||22||
48561656|NCT03539302|101706020|FG002|COMPLETED|Overall Study||21||
48561657|NCT03539302|101706021|FG003|COMPLETED|Overall Study||19||
48275754|NCT02232243|100999671|FG001|STARTED|Third Dose(200mg HCQ Twice Daily)||0||
48275755|NCT02232243|100999672|FG002|STARTED|Third Dose(200mg HCQ Twice Daily)||3||
48275756|NCT02232243|100999670|FG000|COMPLETED|Third Dose(200mg HCQ Twice Daily)||0||
48275757|NCT02232243|100999671|FG001|COMPLETED|Third Dose(200mg HCQ Twice Daily)||0||
48275758|NCT02232243|100999672|FG002|COMPLETED|Third Dose(200mg HCQ Twice Daily)||3||
48275759|NCT02232243|100999670|FG000|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0||
48275760|NCT02232243|100999671|FG001|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0||
48275761|NCT02232243|100999672|FG002|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0||
48275762|NCT01499303|100999673|FG000|STARTED|Overall Study||21||
48275763|NCT01499303|100999674|FG001|STARTED|Overall Study||47||
48275764|NCT01499303|100999673|FG000|COMPLETED|Overall Study||18||
48275765|NCT01499303|100999674|FG001|COMPLETED|Overall Study||40||
48275766|NCT01499303|100999673|FG000|NOT COMPLETED|Overall Study||3||
48275767|NCT01499303|100999674|FG001|NOT COMPLETED|Overall Study||7||
48275768|NCT02006251|100999675|FG000|STARTED|Overall Study||12||
48275769|NCT02006251|100999676|FG001|STARTED|Overall Study||12||
48275770|NCT02006251|100999675|FG000|COMPLETED|Overall Study||10||
48275771|NCT02006251|100999676|FG001|COMPLETED|Overall Study||11||
48275772|NCT02006251|100999675|FG000|NOT COMPLETED|Overall Study||2||
48275773|NCT02006251|100999676|FG001|NOT COMPLETED|Overall Study||1||
48275774|NCT01022112|100999677|FG000|STARTED|Overall Study||82||
48275775|NCT01022112|100999678|FG001|STARTED|Overall Study||74||
48275776|NCT01022112|100999679|FG002|STARTED|Overall Study||77||
48275777|NCT01022112|100999680|FG003|STARTED|Overall Study||75||
48275778|NCT01022112|100999681|FG004|STARTED|Overall Study||75||
48275779|NCT01022112|100999677|FG000|COMPLETED|Overall Study||79||
48275780|NCT01022112|100999678|FG001|COMPLETED|Overall Study||71||
48275781|NCT01022112|100999679|FG002|COMPLETED|Overall Study||74||
48275782|NCT01022112|100999680|FG003|COMPLETED|Overall Study||72||
48275783|NCT01022112|100999681|FG004|COMPLETED|Overall Study||65||
48275784|NCT01022112|100999677|FG000|NOT COMPLETED|Overall Study||3||
48275785|NCT01022112|100999678|FG001|NOT COMPLETED|Overall Study||3||
48275786|NCT01022112|100999679|FG002|NOT COMPLETED|Overall Study||3||
48275787|NCT01022112|100999680|FG003|NOT COMPLETED|Overall Study||3||
48275788|NCT01022112|100999681|FG004|NOT COMPLETED|Overall Study||10||
48275789|NCT00663702|100999682|FG000|STARTED|Overall Study||52||
48275790|NCT00663702|100999683|FG001|STARTED|Overall Study||71||
48275791|NCT00663702|100999682|FG000|COMPLETED|Overall Study||34||
48275792|NCT00663702|100999683|FG001|COMPLETED|Overall Study||61||
48275793|NCT00663702|100999682|FG000|NOT COMPLETED|Overall Study||18||
48275794|NCT00663702|100999683|FG001|NOT COMPLETED|Overall Study||10||
48275795|NCT02530970|100999684|FG000|STARTED|Overall Study||1025||
48275796|NCT02530970|100999684|FG000|COMPLETED|Overall Study||891||
48275797|NCT02530970|100999684|FG000|NOT COMPLETED|Overall Study||134||
48275798|NCT02757872|100999685|FG000|STARTED|Overall Study||545||
48275799|NCT02757872|100999686|FG001|STARTED|Overall Study||570||
48275800|NCT02757872|100999687|FG002|STARTED|Overall Study||576||
48275801|NCT02757872|100999688|FG003|STARTED|Overall Study||541||
48275802|NCT02757872|100999685|FG000|COMPLETED|Overall Study||545||
48275803|NCT02757872|100999686|FG001|COMPLETED|Overall Study||570||
48275804|NCT02757872|100999687|FG002|COMPLETED|Overall Study||576||
48275805|NCT02757872|100999688|FG003|COMPLETED|Overall Study||541||
48275806|NCT02757872|100999685|FG000|NOT COMPLETED|Overall Study||0||
48275807|NCT02757872|100999686|FG001|NOT COMPLETED|Overall Study||0||
48275808|NCT02757872|100999687|FG002|NOT COMPLETED|Overall Study||0||
48275809|NCT02757872|100999688|FG003|NOT COMPLETED|Overall Study||0||
48275810|NCT05917470|100999689|FG000|STARTED|Overall Study||1||
48275811|NCT05917470|100999690|FG001|STARTED|Overall Study||1||
48275812|NCT05917470|100999691|FG002|STARTED|Overall Study||4||
48275813|NCT05917470|100999692|FG003|STARTED|Overall Study||3||
48275814|NCT05917470|100999693|FG004|STARTED|Overall Study||3||
48275815|NCT05917470|100999694|FG005|STARTED|Overall Study||3||
48275816|NCT05917470|100999695|FG006|STARTED|Overall Study||3||
48695985|NCT00372619|102038648|FG003|STARTED|Overall Study||10||
48695986|NCT00372619|102038649|FG004|STARTED|Overall Study||7||
48275817|NCT05917470|100999696|FG007|STARTED|Overall Study||3||
48275818|NCT05917470|100999689|FG000|Safety Population|Overall Study||1||
48275819|NCT05917470|100999690|FG001|Safety Population|Overall Study||1||
48275820|NCT05917470|100999691|FG002|Safety Population|Overall Study||4||
48275821|NCT05917470|100999692|FG003|Safety Population|Overall Study||3||
48275822|NCT05917470|100999693|FG004|Safety Population|Overall Study||3||
48275823|NCT05917470|100999694|FG005|Safety Population|Overall Study||3||
48275824|NCT05917470|100999695|FG006|Safety Population|Overall Study||3||
48275825|NCT05917470|100999696|FG007|Safety Population|Overall Study||3||
48275826|NCT05917470|100999689|FG000|DLT-evaluable Pop|Overall Study||1||
48695987|NCT00372619|102038650|FG005|STARTED|Overall Study||42||
48695988|NCT00372619|102038651|FG006|STARTED|Overall Study||2||
48695989|NCT00372619|102038645|FG000|COMPLETED|Overall Study||8||
48695990|NCT00372619|102038646|FG001|COMPLETED|Overall Study||2||
48695991|NCT00372619|102038647|FG002|COMPLETED|Overall Study||3||
48275827|NCT05917470|100999690|FG001|DLT-evaluable Pop|Overall Study||1||
48275828|NCT05917470|100999691|FG002|DLT-evaluable Pop|Overall Study||3||
48275829|NCT05917470|100999692|FG003|DLT-evaluable Pop|Overall Study||3||
48275830|NCT05917470|100999693|FG004|DLT-evaluable Pop|Overall Study||3||
48275831|NCT05917470|100999694|FG005|DLT-evaluable Pop|Overall Study||3||
48275832|NCT05917470|100999695|FG006|DLT-evaluable Pop|Overall Study||3||
48275833|NCT05917470|100999696|FG007|DLT-evaluable Pop|Overall Study||3||
48275834|NCT05917470|100999689|FG000|Efficacy-evaluable Population|Overall Study||1||
48275835|NCT05917470|100999690|FG001|Efficacy-evaluable Population|Overall Study||1||
48275836|NCT05917470|100999691|FG002|Efficacy-evaluable Population|Overall Study||3||
48275837|NCT05917470|100999692|FG003|Efficacy-evaluable Population|Overall Study||3||
48275838|NCT05917470|100999693|FG004|Efficacy-evaluable Population|Overall Study||3||
48275839|NCT05917470|100999694|FG005|Efficacy-evaluable Population|Overall Study||3||
48275840|NCT05917470|100999695|FG006|Efficacy-evaluable Population|Overall Study||3||
48275841|NCT05917470|100999696|FG007|Efficacy-evaluable Population|Overall Study||3||
48275842|NCT05917470|100999689|FG000|COMPLETED|Overall Study||0||
48275843|NCT05917470|100999690|FG001|COMPLETED|Overall Study||0||
48695992|NCT00372619|102038648|FG003|COMPLETED|Overall Study||10||
48275844|NCT05917470|100999691|FG002|COMPLETED|Overall Study||0||
48275845|NCT05917470|100999692|FG003|COMPLETED|Overall Study||0||
48275846|NCT05917470|100999693|FG004|COMPLETED|Overall Study||0||
48275847|NCT05917470|100999694|FG005|COMPLETED|Overall Study||0||
48275848|NCT05917470|100999695|FG006|COMPLETED|Overall Study||0||
48275849|NCT05917470|100999696|FG007|COMPLETED|Overall Study||0||
48275850|NCT05917470|100999689|FG000|NOT COMPLETED|Overall Study||1||
48275851|NCT05917470|100999690|FG001|NOT COMPLETED|Overall Study||1||
48275852|NCT05917470|100999691|FG002|NOT COMPLETED|Overall Study||4||
48275853|NCT05917470|100999692|FG003|NOT COMPLETED|Overall Study||3||
48275854|NCT05917470|100999693|FG004|NOT COMPLETED|Overall Study||3||
48275855|NCT05917470|100999694|FG005|NOT COMPLETED|Overall Study||3||
48275856|NCT05917470|100999695|FG006|NOT COMPLETED|Overall Study||3||
48275857|NCT05917470|100999696|FG007|NOT COMPLETED|Overall Study||3||
48393337|NCT01760187|101291543|FG000|NOT COMPLETED|Overall Study||1||
48393338|NCT01760187|101291544|FG001|NOT COMPLETED|Overall Study||0||
48393339|NCT01760187|101291545|FG002|NOT COMPLETED|Overall Study||0||
48393340|NCT01760187|101291546|FG003|NOT COMPLETED|Overall Study||2||
48393341|NCT01760187|101291547|FG004|NOT COMPLETED|Overall Study||0||
48393342|NCT01828099|101291548|FG000|STARTED|Overall Study||189||
48393343|NCT01828099|101291549|FG001|STARTED|Overall Study||187||
48275858|NCT03425097|100999697|FG000|STARTED|Treatment Period 1 (2 Weeks)||6||
48275859|NCT03425097|100999698|FG001|STARTED|Treatment Period 1 (2 Weeks)||5||
48275860|NCT03425097|100999697|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||6||
48275861|NCT03425097|100999698|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||5||
48275862|NCT03425097|100999697|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0||
48275863|NCT03425097|100999698|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0||
48275864|NCT03425097|100999697|FG000|STARTED|Washout Period (1 Week)||6||
48275865|NCT03425097|100999698|FG001|STARTED|Washout Period (1 Week)||5||
48275866|NCT03425097|100999697|FG000|COMPLETED|Washout Period (1 Week)||6||
48275867|NCT03425097|100999698|FG001|COMPLETED|Washout Period (1 Week)||5||
48275868|NCT03425097|100999697|FG000|NOT COMPLETED|Washout Period (1 Week)||0||
48275869|NCT03425097|100999698|FG001|NOT COMPLETED|Washout Period (1 Week)||0||
48275870|NCT03425097|100999697|FG000|STARTED|Second Treatment Period (2 Weeks)||6||
48275871|NCT03425097|100999698|FG001|STARTED|Second Treatment Period (2 Weeks)||5||
48275872|NCT03425097|100999697|FG000|COMPLETED|Second Treatment Period (2 Weeks)||6||
48275873|NCT03425097|100999698|FG001|COMPLETED|Second Treatment Period (2 Weeks)||5||
48275874|NCT03425097|100999697|FG000|NOT COMPLETED|Second Treatment Period (2 Weeks)||0||
48275875|NCT03425097|100999698|FG001|NOT COMPLETED|Second Treatment Period (2 Weeks)||0||
48275876|NCT00685139|100999699|FG000|STARTED|First Intervention||17||
48275877|NCT00685139|100999700|FG001|STARTED|First Intervention||17||
48275878|NCT00685139|100999699|FG000|COMPLETED|First Intervention||17||
48275879|NCT00685139|100999700|FG001|COMPLETED|First Intervention||17||
48275880|NCT00685139|100999699|FG000|NOT COMPLETED|First Intervention||0||
48275881|NCT00685139|100999700|FG001|NOT COMPLETED|First Intervention||0||
48275882|NCT00685139|100999699|FG000|STARTED|Washout Period of 28 Days||17||
48275883|NCT00685139|100999700|FG001|STARTED|Washout Period of 28 Days||17||
48275884|NCT00685139|100999699|FG000|COMPLETED|Washout Period of 28 Days||17||
48275885|NCT00685139|100999700|FG001|COMPLETED|Washout Period of 28 Days||17||
48275886|NCT00685139|100999699|FG000|NOT COMPLETED|Washout Period of 28 Days||0||
48275887|NCT00685139|100999700|FG001|NOT COMPLETED|Washout Period of 28 Days||0||
48275888|NCT00685139|100999699|FG000|STARTED|Second Intervention||17||
48275889|NCT00685139|100999700|FG001|STARTED|Second Intervention||17||
48275890|NCT00685139|100999699|FG000|COMPLETED|Second Intervention||17||
48275891|NCT00685139|100999700|FG001|COMPLETED|Second Intervention||17||
48275892|NCT00685139|100999699|FG000|NOT COMPLETED|Second Intervention||0||
48275893|NCT00685139|100999700|FG001|NOT COMPLETED|Second Intervention||0||
48275894|NCT00772330|100999701|FG000|STARTED|Overall Study||23||
48275895|NCT00772330|100999701|FG000|COMPLETED|Overall Study||20||
48275896|NCT00772330|100999701|FG000|NOT COMPLETED|Overall Study||3||
48275897|NCT01546675|100999702|FG000|STARTED|Overall Study||1||
48275898|NCT01546675|100999703|FG001|STARTED|Overall Study||1||
48275899|NCT01546675|100999702|FG000|COMPLETED|Overall Study||1||
48275900|NCT01546675|100999703|FG001|COMPLETED|Overall Study||1||
48275901|NCT01546675|100999702|FG000|NOT COMPLETED|Overall Study||0||
48275902|NCT01546675|100999703|FG001|NOT COMPLETED|Overall Study||0||
48275903|NCT01098318|100999704|FG000|STARTED|Overall Study||20||
48275904|NCT01098318|100999705|FG001|STARTED|Overall Study||19||
48275905|NCT01098318|100999706|FG002|STARTED|Overall Study||18||
48275906|NCT01098318|100999704|FG000|COMPLETED|Overall Study||17||
48275907|NCT01098318|100999705|FG001|COMPLETED|Overall Study||12||
48275908|NCT01098318|100999706|FG002|COMPLETED|Overall Study||15||
48393344|NCT01828099|101291548|FG000|Untreated Patients|Overall Study||0||
48393345|NCT01828099|101291549|FG001|Untreated Patients|Overall Study||12||
48393346|NCT01828099|101291548|FG000|Treated|Overall Study||189||
48393347|NCT01828099|101291549|FG001|Treated|Overall Study||175||
48393348|NCT01828099|101291548|FG000|Discontinued From Treatment Phase|Overall Study||94||
48393349|NCT01828099|101291549|FG001|Discontinued From Treatment Phase|Overall Study||157||
48393350|NCT01828099|101291548|FG000|Entered Extension-treatment Phase|Overall Study||0||
48393351|NCT01828099|101291549|FG001|Entered Extension-treatment Phase|Overall Study||81||
48393352|NCT01828099|101291548|FG000|Entered Post-treatment Follow-up Phase|Overall Study||10||
48393353|NCT01828099|101291549|FG001|Entered Post-treatment Follow-up Phase|Overall Study||16||
48275909|NCT01098318|100999704|FG000|NOT COMPLETED|Overall Study||3||
48275910|NCT01098318|100999705|FG001|NOT COMPLETED|Overall Study||7||
48695993|NCT00372619|102038649|FG004|COMPLETED|Overall Study||7||
48695994|NCT00372619|102038650|FG005|COMPLETED|Overall Study||39||
48695995|NCT00372619|102038651|FG006|COMPLETED|Overall Study||2||
48112543|NCT03325166|100601510|FG000|NOT COMPLETED|Overall Study||1||
48561658|NCT03539302|101706022|FG004|COMPLETED|Overall Study||29||
48561659|NCT03539302|101706023|FG005|COMPLETED|Overall Study||25||
48561660|NCT03539302|101706024|FG006|COMPLETED|Overall Study||44||
48561661|NCT03539302|101706018|FG000|NOT COMPLETED|Overall Study||0||
48561662|NCT03539302|101706019|FG001|NOT COMPLETED|Overall Study||0||
48561663|NCT03539302|101706020|FG002|NOT COMPLETED|Overall Study||0||
48561664|NCT03539302|101706021|FG003|NOT COMPLETED|Overall Study||0||
48561665|NCT03539302|101706022|FG004|NOT COMPLETED|Overall Study||0||
48561666|NCT03539302|101706023|FG005|NOT COMPLETED|Overall Study||1||
48561667|NCT03539302|101706024|FG006|NOT COMPLETED|Overall Study||1||
48561668|NCT03839628|101706025|FG000|STARTED|Overall Study||9||
48561669|NCT03839628|101706025|FG000|COMPLETED|Overall Study||8||
48561670|NCT03839628|101706025|FG000|NOT COMPLETED|Overall Study||1||
48561671|NCT02200055|101706026|FG000|STARTED|Overall Study||86||
48561672|NCT02200055|101706026|FG000|COMPLETED|Overall Study||86||
48561673|NCT02200055|101706026|FG000|NOT COMPLETED|Overall Study||0||
48561674|NCT01992172|101706027|FG000|STARTED|Overall Study||7||
48561675|NCT01992172|101706028|FG001|STARTED|Overall Study||0||
48561676|NCT01992172|101706027|FG000|COMPLETED|Overall Study||7||
48561677|NCT01992172|101706028|FG001|COMPLETED|Overall Study||0||
48561678|NCT01992172|101706027|FG000|NOT COMPLETED|Overall Study||0||
48561679|NCT01992172|101706028|FG001|NOT COMPLETED|Overall Study||0||
48561680|NCT00287586|101706029|FG000|STARTED|Overall Study||156||
48561681|NCT00287586|101706030|FG001|STARTED|Overall Study||152||
48561682|NCT00287586|101706029|FG000|Intent-to-treat: Received Study Drug|Overall Study||155||
48561683|NCT00287586|101706030|FG001|Intent-to-treat: Received Study Drug|Overall Study||151||
48561684|NCT00287586|101706029|FG000|COMPLETED|Overall Study||111||
48561685|NCT00287586|101706030|FG001|COMPLETED|Overall Study||100||
48561686|NCT00287586|101706029|FG000|NOT COMPLETED|Overall Study||45||
48561687|NCT00287586|101706030|FG001|NOT COMPLETED|Overall Study||52||
48561688|NCT04263311|101706031|FG000|STARTED|Overall Study||97||
48561689|NCT04263311|101706032|FG001|STARTED|Overall Study||93||
48561690|NCT04263311|101706033|FG002|STARTED|Overall Study||5||
48561691|NCT04263311|101706031|FG000|COMPLETED|Overall Study||92||
48561692|NCT04263311|101706032|FG001|COMPLETED|Overall Study||91||
48561693|NCT04263311|101706033|FG002|COMPLETED|Overall Study||0||
48561694|NCT04263311|101706031|FG000|NOT COMPLETED|Overall Study||5||
48561695|NCT04263311|101706032|FG001|NOT COMPLETED|Overall Study||2||
48561696|NCT04263311|101706033|FG002|NOT COMPLETED|Overall Study||5||
48561697|NCT01370629|101706034|FG000|STARTED|Overall Study||2015||
48561698|NCT01370629|101706034|FG000|COMPLETED|Overall Study||2009||
48561699|NCT01370629|101706034|FG000|NOT COMPLETED|Overall Study||6||
48561700|NCT00663793|101706035|FG000|STARTED|Overall Study||8||
48561701|NCT00663793|101706036|FG001|STARTED|Overall Study||8||
48561702|NCT00663793|101706035|FG000|COMPLETED|Overall Study||8||
48561703|NCT00663793|101706036|FG001|COMPLETED|Overall Study||8||
48561704|NCT00663793|101706035|FG000|NOT COMPLETED|Overall Study||0||
48561705|NCT00663793|101706036|FG001|NOT COMPLETED|Overall Study||0||
48561706|NCT01422213|101706037|FG000|STARTED|Overall Study||196||
48561707|NCT01422213|101706038|FG001|STARTED|Overall Study||195||
48695996|NCT00372619|102038645|FG000|NOT COMPLETED|Overall Study||0||
48112544|NCT01032135|100601511|FG000|STARTED|2 Week Randomization||311||
48112545|NCT01032135|100601512|FG001|STARTED|2 Week Randomization||93||
48112546|NCT01032135|100601513|FG002|STARTED|2 Week Randomization||96||
48112547|NCT01032135|100601514|FG003|STARTED|2 Week Randomization||0||
48112548|NCT01032135|100601515|FG004|STARTED|2 Week Randomization||0||
48561708|NCT01422213|101706039|FG002|STARTED|Overall Study||207||
48561709|NCT01422213|101706037|FG000|COMPLETED|Overall Study||163||
48561710|NCT01422213|101706038|FG001|COMPLETED|Overall Study||173||
48561711|NCT01422213|101706039|FG002|COMPLETED|Overall Study||178||
48561712|NCT01422213|101706037|FG000|NOT COMPLETED|Overall Study||33||
48561713|NCT01422213|101706038|FG001|NOT COMPLETED|Overall Study||22||
48561714|NCT01422213|101706039|FG002|NOT COMPLETED|Overall Study||29||
48561715|NCT00745901|101706040|FG000|STARTED|Overall Study||178||
48561716|NCT00745901|101706041|FG001|STARTED|Overall Study||177||
48561717|NCT00745901|101706040|FG000|COMPLETED|Overall Study||154||
48561718|NCT00745901|101706041|FG001|COMPLETED|Overall Study||156||
48561719|NCT00745901|101706040|FG000|NOT COMPLETED|Overall Study||24||
48561720|NCT00745901|101706041|FG001|NOT COMPLETED|Overall Study||21||
48561721|NCT03472014|101706042|FG000|STARTED|Overall Study||22||
48561722|NCT03472014|101706042|FG000|COMPLETED|Overall Study||18|active trial phase|
48561723|NCT03472014|101706042|FG000|NOT COMPLETED|Overall Study||4||
48561724|NCT02816736|101706043|FG000|STARTED|Overall Study||179|Started is defined as randomized|
48695997|NCT00372619|102038646|FG001|NOT COMPLETED|Overall Study||0||
48561725|NCT02816736|101706044|FG001|STARTED|Overall Study||186|Started is defined as randomized|
48561726|NCT02816736|101706043|FG000|COMPLETED|Overall Study||164|Completed is defined as all patients that died or completed follow-up.|
48561727|NCT02816736|101706044|FG001|COMPLETED|Overall Study||166|Completed is defined as all patients that died or completed follow-up.|
48561728|NCT02816736|101706043|FG000|NOT COMPLETED|Overall Study||15||
48561729|NCT02816736|101706044|FG001|NOT COMPLETED|Overall Study||20||
48112549|NCT01032135|100601516|FG005|STARTED|2 Week Randomization||0||
48561730|NCT01004354|101706045|FG000|STARTED|Overall Study||12||
48561731|NCT01004354|101706045|FG000|COMPLETED|Overall Study||12||
48561732|NCT01004354|101706045|FG000|NOT COMPLETED|Overall Study||0||
48561733|NCT01779440|101706046|FG000|STARTED|Overall Study||30||
48561734|NCT01779440|101706047|FG001|STARTED|Overall Study||28||
48561735|NCT01779440|101706046|FG000|COMPLETED|Overall Study||27||
48561736|NCT01779440|101706047|FG001|COMPLETED|Overall Study||23||
48561737|NCT01779440|101706046|FG000|NOT COMPLETED|Overall Study||3||
48561738|NCT01779440|101706047|FG001|NOT COMPLETED|Overall Study||5||
48561739|NCT01113723|101706048|FG000|STARTED|Overall Study||70||
48561740|NCT01113723|101706049|FG001|STARTED|Overall Study||70||
48561741|NCT01113723|101706048|FG000|COMPLETED|Overall Study||70||
48561742|NCT01113723|101706049|FG001|COMPLETED|Overall Study||70||
48561743|NCT01113723|101706048|FG000|NOT COMPLETED|Overall Study||0||
48561744|NCT01113723|101706049|FG001|NOT COMPLETED|Overall Study||0||
48561745|NCT00837148|101706050|FG000|STARTED|Overall Study||37||
48561746|NCT00837148|101706050|FG000|COMPLETED|Overall Study||35||
48561747|NCT00837148|101706050|FG000|NOT COMPLETED|Overall Study||2||
48112550|NCT01032135|100601517|FG006|STARTED|2 Week Randomization||0||
48561748|NCT05021900|101706051|FG000|STARTED|Overall Study||20||
48112551|NCT01032135|100601511|FG000|COMPLETED|2 Week Randomization||311||
48561749|NCT05021900|101706052|FG001|STARTED|Overall Study||20||
48561750|NCT05021900|101706051|FG000|COMPLETED|Overall Study||20||
48561751|NCT05021900|101706052|FG001|COMPLETED|Overall Study||20||
48561752|NCT05021900|101706051|FG000|NOT COMPLETED|Overall Study||0||
48561753|NCT05021900|101706052|FG001|NOT COMPLETED|Overall Study||0||
48561754|NCT01942993|101706053|FG000|STARTED|Overall Study||3||
48561755|NCT01942993|101706053|FG000|COMPLETED|Overall Study||1||
48561756|NCT01942993|101706053|FG000|NOT COMPLETED|Overall Study||2||
48561757|NCT03203473|101706054|FG000|STARTED|Induction Phase||85||
48561758|NCT03203473|101706055|FG001|STARTED|Induction Phase||0||
48561759|NCT03203473|101706056|FG002|STARTED|Induction Phase||0||
48561760|NCT03203473|101706054|FG000|COMPLETED|Induction Phase||69||
48561761|NCT03203473|101706055|FG001|COMPLETED|Induction Phase||0||
48561762|NCT03203473|101706056|FG002|COMPLETED|Induction Phase||0||
48561763|NCT03203473|101706054|FG000|NOT COMPLETED|Induction Phase||16||
48561764|NCT03203473|101706055|FG001|NOT COMPLETED|Induction Phase||0||
48561765|NCT03203473|101706056|FG002|NOT COMPLETED|Induction Phase||0||
48561766|NCT03203473|101706054|FG000|STARTED|Arm Allocation Phase||0|All 85 patients were off primary treatment (induction phase), of whom, 69 patients entered the 2nd period (12 were allocated to Arm A and 57 were allocated to Arm B).|
48561767|NCT03203473|101706055|FG001|STARTED|Arm Allocation Phase||12|All 85 patients were off primary treatment (induction phase), of whom, 69 patients entered the 2nd period (12 were allocated to Arm A and 57 were allocated to Arm B).|
48561768|NCT03203473|101706056|FG002|STARTED|Arm Allocation Phase||57|All 85 patients were off primary treatment (induction phase), of whom, 69 patients entered the 2nd period (12 were allocated to Arm A and 57 were allocated to Arm B).|
48561769|NCT03203473|101706054|FG000|COMPLETED|Arm Allocation Phase||0||
48561770|NCT03203473|101706055|FG001|COMPLETED|Arm Allocation Phase||0||
48561771|NCT03203473|101706056|FG002|COMPLETED|Arm Allocation Phase||0||
48561772|NCT03203473|101706054|FG000|NOT COMPLETED|Arm Allocation Phase||0||
48561773|NCT03203473|101706055|FG001|NOT COMPLETED|Arm Allocation Phase||12||
48561774|NCT03203473|101706056|FG002|NOT COMPLETED|Arm Allocation Phase||57||
48561775|NCT01656460|101706057|FG000|STARTED|Overall Study||3||
48112552|NCT01032135|100601512|FG001|COMPLETED|2 Week Randomization||93||
48112553|NCT01032135|100601513|FG002|COMPLETED|2 Week Randomization||96||
48112554|NCT01032135|100601514|FG003|COMPLETED|2 Week Randomization||0||
48112555|NCT01032135|100601515|FG004|COMPLETED|2 Week Randomization||0||
48112556|NCT01032135|100601516|FG005|COMPLETED|2 Week Randomization||0||
48275911|NCT01098318|100999706|FG002|NOT COMPLETED|Overall Study||3||
48561776|NCT01656460|101706058|FG001|STARTED|Overall Study||3||
48561777|NCT01656460|101706059|FG002|STARTED|Overall Study||3||
48561778|NCT01656460|101706060|FG003|STARTED|Overall Study||3||
48561779|NCT01656460|101706057|FG000|COMPLETED|Overall Study||3||
48561780|NCT01656460|101706058|FG001|COMPLETED|Overall Study||3||
48561781|NCT01656460|101706059|FG002|COMPLETED|Overall Study||3||
48561782|NCT01656460|101706060|FG003|COMPLETED|Overall Study||3||
48561783|NCT01656460|101706057|FG000|NOT COMPLETED|Overall Study||0||
48561784|NCT01656460|101706058|FG001|NOT COMPLETED|Overall Study||0||
48561785|NCT01656460|101706059|FG002|NOT COMPLETED|Overall Study||0||
48561786|NCT01656460|101706060|FG003|NOT COMPLETED|Overall Study||0||
48561787|NCT00979654|101706061|FG000|STARTED|Overall Study||103||
48561788|NCT00979654|101706061|FG000|COMPLETED|Overall Study||67||
48561789|NCT00979654|101706061|FG000|NOT COMPLETED|Overall Study||36||
48561790|NCT03456102|101706062|FG000|STARTED|Overall Study||10||
48561791|NCT03456102|101706063|FG001|STARTED|Overall Study||6||
48561792|NCT03456102|101706064|FG002|STARTED|Overall Study||0||
48561793|NCT03456102|101706065|FG003|STARTED|Overall Study||0||
48561794|NCT03456102|101706062|FG000|COMPLETED|Overall Study||10||
48561795|NCT03456102|101706063|FG001|COMPLETED|Overall Study||6||
48561796|NCT03456102|101706064|FG002|COMPLETED|Overall Study||0||
48561797|NCT03456102|101706065|FG003|COMPLETED|Overall Study||0||
48561798|NCT03456102|101706062|FG000|NOT COMPLETED|Overall Study||0||
48561799|NCT03456102|101706063|FG001|NOT COMPLETED|Overall Study||0||
48561800|NCT03456102|101706064|FG002|NOT COMPLETED|Overall Study||0||
48561801|NCT03456102|101706065|FG003|NOT COMPLETED|Overall Study||0||
48561802|NCT02727478|101706066|FG000|STARTED|Overall Study||61||
48561803|NCT02727478|101706067|FG001|STARTED|Overall Study||56||
48561804|NCT02727478|101706066|FG000|COMPLETED|Overall Study||53||
48561805|NCT02727478|101706067|FG001|COMPLETED|Overall Study||46||
48561806|NCT02727478|101706066|FG000|NOT COMPLETED|Overall Study||8||
48561807|NCT02727478|101706067|FG001|NOT COMPLETED|Overall Study||10||
48561808|NCT05966584|101706068|FG000|STARTED|Overall Study||1||
48561809|NCT05966584|101706068|FG000|COMPLETED|Overall Study||0||
48561810|NCT05966584|101706068|FG000|NOT COMPLETED|Overall Study||1||
48561811|NCT00529373|101706069|FG000|STARTED|Base Study||8043||
48561812|NCT00529373|101706070|FG001|STARTED|Base Study||8028||
48561813|NCT00529373|101706069|FG000|COMPLETED|Base Study||4297||
48561814|NCT00529373|101706070|FG001|COMPLETED|Base Study||3960||
48561815|NCT00529373|101706069|FG000|NOT COMPLETED|Base Study||3746||
48561816|NCT00529373|101706070|FG001|NOT COMPLETED|Base Study||4068||
48561817|NCT00529373|101706069|FG000|STARTED|First Extension Study||4297||
48561818|NCT00529373|101706070|FG001|STARTED|First Extension Study||3960||
48561819|NCT00529373|101706069|FG000|COMPLETED|First Extension Study||3144||
48561820|NCT00529373|101706070|FG001|COMPLETED|First Extension Study||2309||
48561821|NCT00529373|101706069|FG000|NOT COMPLETED|First Extension Study||1153||
48561822|NCT00529373|101706070|FG001|NOT COMPLETED|First Extension Study||1651||
48561823|NCT00529373|101706069|FG000|STARTED|Second Extension Study||3144||
48561824|NCT00529373|101706070|FG001|STARTED|Second Extension Study||2309||
48112557|NCT01032135|100601517|FG006|COMPLETED|2 Week Randomization||0||
48393354|NCT01828099|101291548|FG000|Entered Survival Follow-up Phase|Overall Study||64||
48561825|NCT00529373|101706069|FG000|COMPLETED|Second Extension Study||2844||
48561826|NCT00529373|101706070|FG001|COMPLETED|Second Extension Study||2112||
48561827|NCT00529373|101706069|FG000|NOT COMPLETED|Second Extension Study||300||
48561828|NCT00529373|101706070|FG001|NOT COMPLETED|Second Extension Study||197||
48561829|NCT00221338|101706071|FG000|STARTED|Overall Study||374||
48561830|NCT00221338|101706072|FG001|STARTED|Overall Study||376||
48561831|NCT00221338|101706071|FG000|COMPLETED|Overall Study||350||
48561832|NCT00221338|101706072|FG001|COMPLETED|Overall Study||347||
48561833|NCT00221338|101706071|FG000|NOT COMPLETED|Overall Study||24||
48561834|NCT00221338|101706072|FG001|NOT COMPLETED|Overall Study||29||
48561835|NCT01941615|101706073|FG000|STARTED|Run in Treatment: Microgynon®||16||
48561836|NCT01941615|101706073|FG000|COMPLETED|Run in Treatment: Microgynon®||16||
48561837|NCT01941615|101706073|FG000|NOT COMPLETED|Run in Treatment: Microgynon®||0||
48561838|NCT01941615|101706073|FG000|STARTED|Reference Treatment: Microgynon®||0||
48561839|NCT01941615|101706073|FG000|COMPLETED|Reference Treatment: Microgynon®||0||
48561840|NCT01941615|101706073|FG000|NOT COMPLETED|Reference Treatment: Microgynon®||0||
48561841|NCT01941615|101706073|FG000|STARTED|Microgynon® Plus Deleobuvir+Faldaprevir||0||
48561842|NCT01941615|101706073|FG000|COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0||
48561843|NCT01941615|101706073|FG000|NOT COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0||
48561844|NCT01924689|101706074|FG000|STARTED|Overall Study||3||
48561845|NCT01924689|101706075|FG001|STARTED|Overall Study||3||
48561846|NCT01924689|101706076|FG002|STARTED|Overall Study||4||
48561847|NCT01924689|101706077|FG003|STARTED|Overall Study||6||
48561848|NCT01924689|101706078|FG004|STARTED|Overall Study||6||
48561849|NCT01924689|101706079|FG005|STARTED|Overall Study||2||
48561850|NCT01924689|101706074|FG000|COMPLETED|Overall Study||0||
48561851|NCT01924689|101706075|FG001|COMPLETED|Overall Study||0||
48561852|NCT01924689|101706076|FG002|COMPLETED|Overall Study||0||
48561853|NCT01924689|101706077|FG003|COMPLETED|Overall Study||0||
48561854|NCT01924689|101706078|FG004|COMPLETED|Overall Study||0||
48561855|NCT01924689|101706079|FG005|COMPLETED|Overall Study||0||
48561856|NCT01924689|101706074|FG000|NOT COMPLETED|Overall Study||3||
48561857|NCT01924689|101706075|FG001|NOT COMPLETED|Overall Study||3||
48561858|NCT01924689|101706076|FG002|NOT COMPLETED|Overall Study||4||
48561859|NCT01924689|101706077|FG003|NOT COMPLETED|Overall Study||6||
48561860|NCT01924689|101706078|FG004|NOT COMPLETED|Overall Study||6||
48561861|NCT01924689|101706079|FG005|NOT COMPLETED|Overall Study||2||
48561862|NCT02810457|101706080|FG000|STARTED|Overall Study||364||
48561863|NCT02810457|101706081|FG001|STARTED|Overall Study||367||
48393355|NCT01828099|101291549|FG001|Entered Survival Follow-up Phase|Overall Study||31||
48393356|NCT01828099|101291548|FG000|Discontinued From Study|Overall Study||20||
48393357|NCT01828099|101291549|FG001|Discontinued From Study|Overall Study||29||
48393358|NCT01828099|101291548|FG000|COMPLETED|Overall Study||95||
48393359|NCT01828099|101291549|FG001|COMPLETED|Overall Study||30||
48393360|NCT01828099|101291548|FG000|NOT COMPLETED|Overall Study||94||
48393361|NCT01828099|101291549|FG001|NOT COMPLETED|Overall Study||157||
48393362|NCT00880763|101291550|FG000|STARTED|Initial Treatment Period (Part 1)||23||
48393363|NCT00880763|101291551|FG001|STARTED|Initial Treatment Period (Part 1)||22||
48393364|NCT00880763|101291552|FG002|STARTED|Initial Treatment Period (Part 1)||23||
48393365|NCT00880763|101291553|FG003|STARTED|Initial Treatment Period (Part 1)||22||
48393366|NCT00880763|101291550|FG000|COMPLETED|Initial Treatment Period (Part 1)||23||
48393367|NCT00880763|101291551|FG001|COMPLETED|Initial Treatment Period (Part 1)||22||
48393368|NCT00880763|101291552|FG002|COMPLETED|Initial Treatment Period (Part 1)||23||
48393369|NCT00880763|101291553|FG003|COMPLETED|Initial Treatment Period (Part 1)||22||
48393370|NCT00880763|101291550|FG000|NOT COMPLETED|Initial Treatment Period (Part 1)||0||
48393371|NCT00880763|101291551|FG001|NOT COMPLETED|Initial Treatment Period (Part 1)||0||
48393372|NCT00880763|101291552|FG002|NOT COMPLETED|Initial Treatment Period (Part 1)||0||
48393373|NCT00880763|101291553|FG003|NOT COMPLETED|Initial Treatment Period (Part 1)||0||
48393374|NCT00880763|101291550|FG000|STARTED|Extension Period (Part 2)||23||
48393375|NCT00880763|101291551|FG001|STARTED|Extension Period (Part 2)||22||
48393376|NCT00880763|101291552|FG002|STARTED|Extension Period (Part 2)||23||
48393377|NCT00880763|101291553|FG003|STARTED|Extension Period (Part 2)||22||
48393378|NCT00880763|101291550|FG000|COMPLETED|Extension Period (Part 2)||23||
48393379|NCT00880763|101291551|FG001|COMPLETED|Extension Period (Part 2)||19||
48393380|NCT00880763|101291552|FG002|COMPLETED|Extension Period (Part 2)||20||
48393381|NCT00880763|101291553|FG003|COMPLETED|Extension Period (Part 2)||19||
48393382|NCT00880763|101291550|FG000|NOT COMPLETED|Extension Period (Part 2)||0||
48393383|NCT00880763|101291551|FG001|NOT COMPLETED|Extension Period (Part 2)||3||
48393384|NCT00880763|101291552|FG002|NOT COMPLETED|Extension Period (Part 2)||3||
48393385|NCT00880763|101291553|FG003|NOT COMPLETED|Extension Period (Part 2)||3||
48393386|NCT02670928|101291554|FG000|STARTED|Overall Study||100|All enrolled patients (Full Analysis Set and Safety Population)|
48393387|NCT02670928|101291555|FG001|STARTED|Overall Study||30|All enrolled patients (Full Analysis Set and Safety Population)|
48393388|NCT02670928|101291554|FG000|COMPLETED|Overall Study||90||
48393389|NCT02670928|101291555|FG001|COMPLETED|Overall Study||29||
48393390|NCT02670928|101291554|FG000|NOT COMPLETED|Overall Study||10||
48393391|NCT02670928|101291555|FG001|NOT COMPLETED|Overall Study||1||
48393392|NCT01425749|101291556|FG000|STARTED|Overall Study||13||
48393393|NCT01425749|101291557|FG001|STARTED|Overall Study||12||
48393394|NCT01425749|101291556|FG000|COMPLETED|Overall Study||13||
48393395|NCT01425749|101291557|FG001|COMPLETED|Overall Study||11||
48393396|NCT01425749|101291556|FG000|NOT COMPLETED|Overall Study||0||
48393397|NCT01425749|101291557|FG001|NOT COMPLETED|Overall Study||1||
48393398|NCT00050960|101291558|FG000|STARTED|Overall Study||306||
48112558|NCT01032135|100601511|FG000|NOT COMPLETED|2 Week Randomization||0||
48112559|NCT01032135|100601512|FG001|NOT COMPLETED|2 Week Randomization||0||
48112560|NCT01032135|100601513|FG002|NOT COMPLETED|2 Week Randomization||0||
48112561|NCT01032135|100601514|FG003|NOT COMPLETED|2 Week Randomization||0||
48112562|NCT01032135|100601515|FG004|NOT COMPLETED|2 Week Randomization||0||
48112563|NCT01032135|100601516|FG005|NOT COMPLETED|2 Week Randomization||0||
48112564|NCT01032135|100601517|FG006|NOT COMPLETED|2 Week Randomization||0||
48393399|NCT00050960|101291559|FG001|STARTED|Overall Study||306||
48393400|NCT00050960|101291558|FG000|COMPLETED|Overall Study||4||
48393401|NCT00050960|101291559|FG001|COMPLETED|Overall Study||2||
48393402|NCT00050960|101291558|FG000|NOT COMPLETED|Overall Study||302||
48393403|NCT00050960|101291559|FG001|NOT COMPLETED|Overall Study||304||
48393404|NCT02084069|101291560|FG000|STARTED|Overall Study||29||
48393405|NCT02084069|101291561|FG001|STARTED|Overall Study||29||
48393406|NCT02084069|101291560|FG000|COMPLETED|Overall Study||29||
48393407|NCT02084069|101291561|FG001|COMPLETED|Overall Study||29||
48393408|NCT02084069|101291560|FG000|NOT COMPLETED|Overall Study||0||
48393409|NCT02084069|101291561|FG001|NOT COMPLETED|Overall Study||0||
48393410|NCT02016898|101291562|FG000|STARTED|Overall Study||50||
48393411|NCT02016898|101291563|FG001|STARTED|Overall Study||45||
48393412|NCT02016898|101291562|FG000|COMPLETED|Overall Study||45||
48393413|NCT02016898|101291563|FG001|COMPLETED|Overall Study||40||
48393414|NCT02016898|101291562|FG000|NOT COMPLETED|Overall Study||5||
48393415|NCT02016898|101291563|FG001|NOT COMPLETED|Overall Study||5||
48393416|NCT04254796|101291564|FG000|STARTED|Overall Study||50||
48393417|NCT04254796|101291565|FG001|STARTED|Overall Study||50||
48393418|NCT04254796|101291564|FG000|COMPLETED|Overall Study||45||
48393419|NCT04254796|101291565|FG001|COMPLETED|Overall Study||49||
48393420|NCT04254796|101291564|FG000|NOT COMPLETED|Overall Study||5||
48393421|NCT04254796|101291565|FG001|NOT COMPLETED|Overall Study||1||
48393422|NCT00769808|101291566|FG000|STARTED|Overall Study||72||
48393423|NCT00769808|101291566|FG000|COMPLETED|Overall Study||64||
48393424|NCT00769808|101291566|FG000|NOT COMPLETED|Overall Study||8||
48393425|NCT00873288|101291567|FG000|STARTED|Overall Study||127||
48393426|NCT00873288|101291568|FG001|STARTED|Overall Study||127||
48561864|NCT02810457|101706080|FG000|COMPLETED|Overall Study||37|Patients still in the study at DCO|
48275912|NCT00769652|100999707|FG000|STARTED|Overall Study||6||
48561865|NCT02810457|101706081|FG001|COMPLETED|Overall Study||38|Patients still in the study at DCO|
48561866|NCT02810457|101706080|FG000|NOT COMPLETED|Overall Study||327||
48561867|NCT02810457|101706081|FG001|NOT COMPLETED|Overall Study||329||
48561868|NCT04784091|101706082|FG000|STARTED|Overall Study||203||
48561869|NCT04784091|101706083|FG001|STARTED|Overall Study||209||
48561870|NCT04784091|101706082|FG000|COMPLETED|Overall Study||193||
48561871|NCT04784091|101706083|FG001|COMPLETED|Overall Study||200||
48561872|NCT04784091|101706082|FG000|NOT COMPLETED|Overall Study||10||
48561873|NCT04784091|101706083|FG001|NOT COMPLETED|Overall Study||9||
48561874|NCT02222922|101706084|FG000|STARTED|Overall Study||2||
48561875|NCT02222922|101706085|FG001|STARTED|Overall Study||2||
48561876|NCT02222922|101706086|FG002|STARTED|Overall Study||2||
48275913|NCT00769652|100999708|FG001|STARTED|Overall Study||1||
48561877|NCT02222922|101706087|FG003|STARTED|Overall Study||5||
48561878|NCT02222922|101706088|FG004|STARTED|Overall Study||96||
48561879|NCT02222922|101706089|FG005|STARTED|Overall Study||6||
48561880|NCT02222922|101706090|FG006|STARTED|Overall Study||3||
48561881|NCT02222922|101706091|FG007|STARTED|Overall Study||10||
48561882|NCT02222922|101706092|FG008|STARTED|Overall Study||12||
48561883|NCT02222922|101706084|FG000|Received Treatment|Overall Study||2||
48112565|NCT01032135|100601511|FG000|STARTED|8 Week Randomization||227||
48275914|NCT00769652|100999707|FG000|COMPLETED|Overall Study||6||
48275915|NCT00769652|100999708|FG001|COMPLETED|Overall Study||1||
48561884|NCT02222922|101706085|FG001|Received Treatment|Overall Study||2||
48561885|NCT02222922|101706086|FG002|Received Treatment|Overall Study||2||
48561886|NCT02222922|101706087|FG003|Received Treatment|Overall Study||4||
48561887|NCT02222922|101706088|FG004|Received Treatment|Overall Study||96||
48561888|NCT02222922|101706089|FG005|Received Treatment|Overall Study||6||
48561889|NCT02222922|101706090|FG006|Received Treatment|Overall Study||3||
48561890|NCT02222922|101706091|FG007|Received Treatment|Overall Study||10||
48561891|NCT02222922|101706092|FG008|Received Treatment|Overall Study||12||
48561892|NCT02222922|101706084|FG000|COMPLETED|Overall Study||1||
48561893|NCT02222922|101706085|FG001|COMPLETED|Overall Study||2||
48275916|NCT00769652|100999707|FG000|NOT COMPLETED|Overall Study||0||
48275917|NCT00769652|100999708|FG001|NOT COMPLETED|Overall Study||0||
48275918|NCT03562975|100999709|FG000|STARTED|Overall Study||18||
48275919|NCT03562975|100999709|FG000|COMPLETED|Overall Study||15||
48275920|NCT03562975|100999709|FG000|NOT COMPLETED|Overall Study||3||
48275921|NCT04949243|100999710|FG000|STARTED|Overall Study||338||
48275922|NCT04949243|100999710|FG000|COMPLETED|Overall Study||263||
48561894|NCT02222922|101706086|FG002|COMPLETED|Overall Study||1||
48561895|NCT02222922|101706087|FG003|COMPLETED|Overall Study||2||
48561896|NCT02222922|101706088|FG004|COMPLETED|Overall Study||58||
48561897|NCT02222922|101706089|FG005|COMPLETED|Overall Study||3||
48561898|NCT02222922|101706090|FG006|COMPLETED|Overall Study||1||
48561899|NCT02222922|101706091|FG007|COMPLETED|Overall Study||6||
48561900|NCT02222922|101706092|FG008|COMPLETED|Overall Study||6||
48561901|NCT02222922|101706084|FG000|NOT COMPLETED|Overall Study||1||
48561902|NCT02222922|101706085|FG001|NOT COMPLETED|Overall Study||0||
48561903|NCT02222922|101706086|FG002|NOT COMPLETED|Overall Study||1||
48561904|NCT02222922|101706087|FG003|NOT COMPLETED|Overall Study||3||
48561905|NCT02222922|101706088|FG004|NOT COMPLETED|Overall Study||38||
48561906|NCT02222922|101706089|FG005|NOT COMPLETED|Overall Study||3||
48561907|NCT02222922|101706090|FG006|NOT COMPLETED|Overall Study||2||
48275923|NCT04949243|100999710|FG000|NOT COMPLETED|Overall Study||75||
48275924|NCT04491877|100999711|FG000|STARTED|Overall Study||18||
48561908|NCT02222922|101706091|FG007|NOT COMPLETED|Overall Study||4||
48561909|NCT02222922|101706092|FG008|NOT COMPLETED|Overall Study||6||
48561910|NCT01615367|101706093|FG000|STARTED|Overall Study||19||
48561911|NCT01615367|101706094|FG001|STARTED|Overall Study||19||
48561912|NCT01615367|101706093|FG000|COMPLETED|Overall Study||14||
48561913|NCT01615367|101706094|FG001|COMPLETED|Overall Study||13||
48275925|NCT04491877|100999712|FG001|STARTED|Overall Study||18||
48275926|NCT04491877|100999713|FG002|STARTED|Overall Study||11||
48561914|NCT01615367|101706093|FG000|NOT COMPLETED|Overall Study||5||
48561915|NCT01615367|101706094|FG001|NOT COMPLETED|Overall Study||6||
48561916|NCT03723850|101706095|FG000|STARTED|Overall Study||49||
48561917|NCT03723850|101706096|FG001|STARTED|Overall Study||45||
48112566|NCT01032135|100601512|FG001|STARTED|8 Week Randomization||0||
48275927|NCT04491877|100999714|FG003|STARTED|Overall Study||10||
48561918|NCT03723850|101706097|FG002|STARTED|Overall Study||54||
48561919|NCT03723850|101706098|FG003|STARTED|Overall Study||52||
48561920|NCT03723850|101706099|FG004|STARTED|Overall Study||51||
48561921|NCT03723850|101706095|FG000|COMPLETED|Overall Study||46||
48561922|NCT03723850|101706096|FG001|COMPLETED|Overall Study||45||
48561923|NCT03723850|101706097|FG002|COMPLETED|Overall Study||51||
48561924|NCT03723850|101706098|FG003|COMPLETED|Overall Study||51||
48561925|NCT03723850|101706099|FG004|COMPLETED|Overall Study||48||
48561926|NCT03723850|101706095|FG000|NOT COMPLETED|Overall Study||3||
48561927|NCT03723850|101706096|FG001|NOT COMPLETED|Overall Study||0||
48561928|NCT03723850|101706097|FG002|NOT COMPLETED|Overall Study||3||
48561929|NCT03723850|101706098|FG003|NOT COMPLETED|Overall Study||1||
48561930|NCT03723850|101706099|FG004|NOT COMPLETED|Overall Study||3||
48561931|NCT02143128|101706100|FG000|STARTED|Overall Study||409||
48561932|NCT02143128|101706101|FG001|STARTED|Overall Study||417||
48561933|NCT02143128|101706102|FG002|STARTED|Overall Study||326||
48393427|NCT00873288|101291567|FG000|COMPLETED|Overall Study||127||
48393428|NCT00873288|101291568|FG001|COMPLETED|Overall Study||127||
48393429|NCT00873288|101291567|FG000|NOT COMPLETED|Overall Study||0||
48393430|NCT00873288|101291568|FG001|NOT COMPLETED|Overall Study||0||
48393431|NCT01412060|101291569|FG000|STARTED|Open-label Run-in Period (RIP)||765||
48393432|NCT01412060|101291570|FG001|STARTED|Open-label Run-in Period (RIP)||0||
48393433|NCT01412060|101291571|FG002|STARTED|Open-label Run-in Period (RIP)||0||
48393434|NCT01412060|101291569|FG000|COMPLETED|Open-label Run-in Period (RIP)||418||
48393435|NCT01412060|101291570|FG001|COMPLETED|Open-label Run-in Period (RIP)||0||
48561934|NCT02143128|101706100|FG000|COMPLETED|Overall Study||409||
48561935|NCT02143128|101706101|FG001|COMPLETED|Overall Study||417||
48561936|NCT02143128|101706102|FG002|COMPLETED|Overall Study||326||
48561937|NCT02143128|101706100|FG000|NOT COMPLETED|Overall Study||0||
48561938|NCT02143128|101706101|FG001|NOT COMPLETED|Overall Study||0||
48561939|NCT02143128|101706102|FG002|NOT COMPLETED|Overall Study||0||
48561940|NCT00918866|101706103|FG000|STARTED|Overall Study||16||
48561941|NCT00918866|101706104|FG001|STARTED|Overall Study||16||
48561942|NCT00918866|101706103|FG000|COMPLETED|Overall Study||16||
48561943|NCT00918866|101706104|FG001|COMPLETED|Overall Study||16||
48561944|NCT00918866|101706103|FG000|NOT COMPLETED|Overall Study||0||
48561945|NCT00918866|101706104|FG001|NOT COMPLETED|Overall Study||0||
48561946|NCT01267019|101706105|FG000|STARTED|Overall Study||47||
48561947|NCT01267019|101706106|FG001|STARTED|Overall Study||53||
48561948|NCT01267019|101706107|FG002|STARTED|Overall Study||53||
48561949|NCT01267019|101706105|FG000|COMPLETED|Overall Study||41||
48561950|NCT01267019|101706106|FG001|COMPLETED|Overall Study||47||
48561951|NCT01267019|101706107|FG002|COMPLETED|Overall Study||47||
48561952|NCT01267019|101706105|FG000|NOT COMPLETED|Overall Study||6||
48561953|NCT01267019|101706106|FG001|NOT COMPLETED|Overall Study||6||
48561954|NCT01267019|101706107|FG002|NOT COMPLETED|Overall Study||6||
48561955|NCT02462603|101706108|FG000|STARTED|Overall Study||44||
48561956|NCT02462603|101706108|FG000|Received at Least 1 Dose of Study Drug|Overall Study||41||
48561957|NCT02462603|101706108|FG000|EITT Population|Overall Study||40|participant who received at least 1 dose of PTC589 and had a minimum of Month 3 assessment.|
48561958|NCT02462603|101706108|FG000|COMPLETED|Overall Study||40||
48561959|NCT02462603|101706108|FG000|NOT COMPLETED|Overall Study||4||
48275928|NCT04491877|100999715|FG004|STARTED|Overall Study||10||
48275929|NCT04491877|100999716|FG005|STARTED|Overall Study||12||
48275930|NCT04491877|100999717|FG006|STARTED|Overall Study||61||
48275931|NCT04491877|100999718|FG007|STARTED|Overall Study||58||
48275932|NCT04491877|100999719|FG008|STARTED|Overall Study||61||
48275933|NCT04491877|100999711|FG000|COMPLETED|Overall Study||17||
48275934|NCT04491877|100999712|FG001|COMPLETED|Overall Study||16||
48275935|NCT04491877|100999713|FG002|COMPLETED|Overall Study||9||
48275936|NCT04491877|100999714|FG003|COMPLETED|Overall Study||8||
48275937|NCT04491877|100999715|FG004|COMPLETED|Overall Study||10||
48275938|NCT04491877|100999716|FG005|COMPLETED|Overall Study||10||
48275939|NCT04491877|100999717|FG006|COMPLETED|Overall Study||56||
48275940|NCT04491877|100999718|FG007|COMPLETED|Overall Study||51||
48275941|NCT04491877|100999719|FG008|COMPLETED|Overall Study||57||
48275942|NCT04491877|100999711|FG000|NOT COMPLETED|Overall Study||1||
48275943|NCT04491877|100999712|FG001|NOT COMPLETED|Overall Study||2||
48275944|NCT04491877|100999713|FG002|NOT COMPLETED|Overall Study||2||
48275945|NCT04491877|100999714|FG003|NOT COMPLETED|Overall Study||2||
48275946|NCT04491877|100999715|FG004|NOT COMPLETED|Overall Study||0||
48393436|NCT01412060|101291571|FG002|COMPLETED|Open-label Run-in Period (RIP)||0||
48561960|NCT00586703|101706109|FG000|STARTED|Overall Study||16||
48561961|NCT00586703|101706109|FG000|COMPLETED|Overall Study||4||
48561962|NCT00586703|101706109|FG000|NOT COMPLETED|Overall Study||12||
48561963|NCT01087918|101706110|FG000|STARTED|Overall Study||5||
48561964|NCT01087918|101706111|FG001|STARTED|Overall Study||4||
48561965|NCT01087918|101706110|FG000|COMPLETED|Overall Study||5||
48561966|NCT01087918|101706111|FG001|COMPLETED|Overall Study||4||
48561967|NCT01087918|101706110|FG000|NOT COMPLETED|Overall Study||0||
48561968|NCT01087918|101706111|FG001|NOT COMPLETED|Overall Study||0||
48275947|NCT04491877|100999716|FG005|NOT COMPLETED|Overall Study||2||
48275948|NCT04491877|100999717|FG006|NOT COMPLETED|Overall Study||5||
48275949|NCT04491877|100999718|FG007|NOT COMPLETED|Overall Study||7||
48275950|NCT04491877|100999719|FG008|NOT COMPLETED|Overall Study||4||
48275951|NCT00798590|100999720|FG000|STARTED|Overall Study||11||
48275952|NCT00798590|100999721|FG001|STARTED|Overall Study||8||
48275953|NCT00798590|100999720|FG000|COMPLETED|Overall Study||0||
48275954|NCT00798590|100999721|FG001|COMPLETED|Overall Study||0||
48275955|NCT00798590|100999720|FG000|NOT COMPLETED|Overall Study||11||
48561969|NCT02550561|101706112|FG000|STARTED|Overall Study||16||
48561970|NCT02550561|101706112|FG000|COMPLETED|Overall Study||10||
48561971|NCT02550561|101706112|FG000|NOT COMPLETED|Overall Study||6||
48561972|NCT03564119|101706113|FG000|STARTED|Overall Study||250||
48112567|NCT01032135|100601513|FG002|STARTED|8 Week Randomization||0||
48112568|NCT01032135|100601514|FG003|STARTED|8 Week Randomization||41||
48112569|NCT01032135|100601515|FG004|STARTED|8 Week Randomization||43||
48112570|NCT01032135|100601516|FG005|STARTED|8 Week Randomization||48||
48112571|NCT01032135|100601517|FG006|STARTED|8 Week Randomization||54||
48112572|NCT01032135|100601511|FG000|12 Week Follow up|8 Week Randomization||217||
48112573|NCT01032135|100601512|FG001|12 Week Follow up|8 Week Randomization||0||
48112574|NCT01032135|100601513|FG002|12 Week Follow up|8 Week Randomization||0||
48112575|NCT01032135|100601514|FG003|12 Week Follow up|8 Week Randomization||34||
48112576|NCT01032135|100601515|FG004|12 Week Follow up|8 Week Randomization||38||
48112577|NCT01032135|100601516|FG005|12 Week Follow up|8 Week Randomization||36||
48112578|NCT01032135|100601517|FG006|12 Week Follow up|8 Week Randomization||41||
48112579|NCT01032135|100601511|FG000|COMPLETED|8 Week Randomization||201||
48112580|NCT01032135|100601512|FG001|COMPLETED|8 Week Randomization||0||
48112581|NCT01032135|100601513|FG002|COMPLETED|8 Week Randomization||0||
48112582|NCT01032135|100601514|FG003|COMPLETED|8 Week Randomization||30||
48112583|NCT01032135|100601515|FG004|COMPLETED|8 Week Randomization||34||
48112584|NCT01032135|100601516|FG005|COMPLETED|8 Week Randomization||31||
48112585|NCT01032135|100601517|FG006|COMPLETED|8 Week Randomization||36||
48112586|NCT01032135|100601511|FG000|NOT COMPLETED|8 Week Randomization||26||
48112587|NCT01032135|100601512|FG001|NOT COMPLETED|8 Week Randomization||0||
48112588|NCT01032135|100601513|FG002|NOT COMPLETED|8 Week Randomization||0||
48112589|NCT01032135|100601514|FG003|NOT COMPLETED|8 Week Randomization||11||
48112590|NCT01032135|100601515|FG004|NOT COMPLETED|8 Week Randomization||9||
48112591|NCT01032135|100601516|FG005|NOT COMPLETED|8 Week Randomization||17||
48112592|NCT01032135|100601517|FG006|NOT COMPLETED|8 Week Randomization||18||
48112593|NCT00613028|100601518|FG000|STARTED|Overall Study||10||
48112594|NCT00613028|100601519|FG001|STARTED|Overall Study||13||
48112595|NCT00613028|100601518|FG000|COMPLETED|Overall Study||10||
48112596|NCT00613028|100601519|FG001|COMPLETED|Overall Study||12||
48112597|NCT00613028|100601518|FG000|NOT COMPLETED|Overall Study||0||
48112598|NCT00613028|100601519|FG001|NOT COMPLETED|Overall Study||1||
48112599|NCT00004412|100601520|FG000|STARTED|Randomized Period||11||
48112600|NCT00004412|100601521|FG001|STARTED|Randomized Period||12||
48112601|NCT00004412|100601522|FG002|STARTED|Randomized Period||0||
48112602|NCT00004412|100601520|FG000|COMPLETED|Randomized Period||8||
48112603|NCT00004412|100601521|FG001|COMPLETED|Randomized Period||12||
48112604|NCT00004412|100601522|FG002|COMPLETED|Randomized Period||0||
48112605|NCT00004412|100601520|FG000|NOT COMPLETED|Randomized Period||3||
48112606|NCT00004412|100601521|FG001|NOT COMPLETED|Randomized Period||0||
48275956|NCT00798590|100999721|FG001|NOT COMPLETED|Overall Study||8||
48275957|NCT05435482|100999722|FG000|STARTED|Overall Study||109||
48275958|NCT05435482|100999723|FG001|STARTED|Overall Study||111||
48275959|NCT05435482|100999722|FG000|COMPLETED|Overall Study||102||
48275960|NCT05435482|100999723|FG001|COMPLETED|Overall Study||106||
48275961|NCT05435482|100999722|FG000|NOT COMPLETED|Overall Study||7||
48275962|NCT05435482|100999723|FG001|NOT COMPLETED|Overall Study||5||
48275963|NCT05330988|100999724|FG000|STARTED|Overall Study||6||
48275964|NCT05330988|100999725|FG001|STARTED|Overall Study||6||
48561973|NCT03564119|101706114|FG001|STARTED|Overall Study||122||
48561974|NCT03564119|101706113|FG000|Received at Least 1 Dose of Study Drug|Overall Study||249||
48561975|NCT03564119|101706114|FG001|Received at Least 1 Dose of Study Drug|Overall Study||120||
48275965|NCT05330988|100999724|FG000|COMPLETED|Overall Study||6||
48561976|NCT03564119|101706113|FG000|COMPLETED|Overall Study||235||
48112607|NCT00004412|100601522|FG002|NOT COMPLETED|Randomized Period||0||
48112608|NCT00004412|100601520|FG000|STARTED|Crossover Period||8||
48112609|NCT00004412|100601521|FG001|STARTED|Crossover Period||12||
48112610|NCT00004412|100601522|FG002|STARTED|Crossover Period||3||
48275966|NCT05330988|100999725|FG001|COMPLETED|Overall Study||6||
48112611|NCT00004412|100601520|FG000|COMPLETED|Crossover Period||8||
48112612|NCT00004412|100601521|FG001|COMPLETED|Crossover Period||12||
48561977|NCT03564119|101706114|FG001|COMPLETED|Overall Study||113||
48561978|NCT03564119|101706113|FG000|NOT COMPLETED|Overall Study||15||
48112613|NCT00004412|100601522|FG002|COMPLETED|Crossover Period||3||
48275967|NCT05330988|100999724|FG000|NOT COMPLETED|Overall Study||0||
48275968|NCT05330988|100999725|FG001|NOT COMPLETED|Overall Study||0||
48275969|NCT01809834|100999726|FG000|STARTED|Overall Study||44||
48561979|NCT03564119|101706114|FG001|NOT COMPLETED|Overall Study||9||
48561980|NCT02695446|101706115|FG000|STARTED|Overall Study||12||
48561981|NCT02695446|101706115|FG000|COMPLETED|Overall Study||12||
48561982|NCT02695446|101706115|FG000|NOT COMPLETED|Overall Study||0||
48112614|NCT00004412|100601520|FG000|NOT COMPLETED|Crossover Period||0||
48112615|NCT00004412|100601521|FG001|NOT COMPLETED|Crossover Period||0||
48112616|NCT00004412|100601522|FG002|NOT COMPLETED|Crossover Period||0||
48112617|NCT00111228|100601523|FG000|STARTED|Overall Study||54||
48112618|NCT00111228|100601524|FG001|STARTED|Overall Study||54||
48112619|NCT00111228|100601525|FG002|STARTED|Overall Study||54||
48112620|NCT00111228|100601523|FG000|COMPLETED|Overall Study||49||
48112621|NCT00111228|100601524|FG001|COMPLETED|Overall Study||53||
48112622|NCT00111228|100601525|FG002|COMPLETED|Overall Study||54||
48112623|NCT00111228|100601523|FG000|NOT COMPLETED|Overall Study||5||
48112624|NCT00111228|100601524|FG001|NOT COMPLETED|Overall Study||1||
48112625|NCT00111228|100601525|FG002|NOT COMPLETED|Overall Study||0||
48112626|NCT01371656|100601526|FG000|STARTED|Overall Study||314||
48112627|NCT01371656|100601527|FG001|STARTED|Overall Study||310||
48112628|NCT01371656|100601526|FG000|COMPLETED|Overall Study||250||
48112629|NCT01371656|100601527|FG001|COMPLETED|Overall Study||296||
48112630|NCT01371656|100601526|FG000|NOT COMPLETED|Overall Study||64||
48112631|NCT01371656|100601527|FG001|NOT COMPLETED|Overall Study||14||
48112632|NCT01539226|100601528|FG000|STARTED|Overall Study||652||
48112633|NCT01539226|100601529|FG001|STARTED|Overall Study||1307||
48112634|NCT01539226|100601528|FG000|COMPLETED|Overall Study||435|A number of completed participants rolled over to the open-label extension of this trial (IPM 032, NCT02862171)|
48112635|NCT01539226|100601529|FG001|COMPLETED|Overall Study||902|A number of completed participants rolled over to the open-label extension of this trial (IPM 032, NCT02862171)|
48112636|NCT01539226|100601528|FG000|NOT COMPLETED|Overall Study||217||
48112637|NCT01539226|100601529|FG001|NOT COMPLETED|Overall Study||405||
48112638|NCT02915029|100601530|FG000|STARTED|Overall Study||63||24
48112639|NCT02915029|100601531|FG001|STARTED|Overall Study||62||0
48112640|NCT02915029|100601530|FG000|COMPLETED|Overall Study||50||24
48112641|NCT02915029|100601531|FG001|COMPLETED|Overall Study||48||0
48112642|NCT02915029|100601530|FG000|NOT COMPLETED|Overall Study||13||0
48275970|NCT01809834|100999726|FG000|COMPLETED|Overall Study||44||
48275971|NCT01809834|100999726|FG000|NOT COMPLETED|Overall Study||0||
48275972|NCT04045964|100999727|FG000|STARTED|Overall Study||16||
48112643|NCT02915029|100601531|FG001|NOT COMPLETED|Overall Study||14||0
48112644|NCT04074317|100601532|FG000|STARTED|First Period||3||
48112645|NCT04074317|100601533|FG001|STARTED|First Period||3||
48112646|NCT04074317|100601534|FG002|STARTED|First Period||3||
48112647|NCT04074317|100601535|FG003|STARTED|First Period||3||
48112648|NCT04074317|100601536|FG004|STARTED|First Period||3||
48112649|NCT04074317|100601537|FG005|STARTED|First Period||3||
48112650|NCT04074317|100601532|FG000|COMPLETED|First Period||3||
48112651|NCT04074317|100601533|FG001|COMPLETED|First Period||3||
48112652|NCT04074317|100601534|FG002|COMPLETED|First Period||3||
48112653|NCT04074317|100601535|FG003|COMPLETED|First Period||3||
48112654|NCT04074317|100601536|FG004|COMPLETED|First Period||3||
48112655|NCT04074317|100601537|FG005|COMPLETED|First Period||3||
48112656|NCT04074317|100601532|FG000|NOT COMPLETED|First Period||0||
48112657|NCT04074317|100601533|FG001|NOT COMPLETED|First Period||0||
48112658|NCT04074317|100601534|FG002|NOT COMPLETED|First Period||0||
48112659|NCT04074317|100601535|FG003|NOT COMPLETED|First Period||0||
48112660|NCT04074317|100601536|FG004|NOT COMPLETED|First Period||0||
48112661|NCT04074317|100601537|FG005|NOT COMPLETED|First Period||0||
48112662|NCT04074317|100601532|FG000|STARTED|Second Period||3||
48112663|NCT04074317|100601533|FG001|STARTED|Second Period||3||
48112664|NCT04074317|100601534|FG002|STARTED|Second Period||3||
48112665|NCT04074317|100601535|FG003|STARTED|Second Period||3||
48112666|NCT04074317|100601536|FG004|STARTED|Second Period||3||
48112667|NCT04074317|100601537|FG005|STARTED|Second Period||3||
48112668|NCT04074317|100601532|FG000|COMPLETED|Second Period||3||
48112669|NCT04074317|100601533|FG001|COMPLETED|Second Period||3||
48112670|NCT04074317|100601534|FG002|COMPLETED|Second Period||3||
48112671|NCT04074317|100601535|FG003|COMPLETED|Second Period||3||
48112672|NCT04074317|100601536|FG004|COMPLETED|Second Period||3||
48112673|NCT04074317|100601537|FG005|COMPLETED|Second Period||3||
48112674|NCT04074317|100601532|FG000|NOT COMPLETED|Second Period||0||
48112675|NCT04074317|100601533|FG001|NOT COMPLETED|Second Period||0||
48112676|NCT04074317|100601534|FG002|NOT COMPLETED|Second Period||0||
48112677|NCT04074317|100601535|FG003|NOT COMPLETED|Second Period||0||
48112678|NCT04074317|100601536|FG004|NOT COMPLETED|Second Period||0||
48112679|NCT04074317|100601537|FG005|NOT COMPLETED|Second Period||0||
48112680|NCT04074317|100601532|FG000|STARTED|Third Period||3||
48112681|NCT04074317|100601533|FG001|STARTED|Third Period||3||
48112682|NCT04074317|100601534|FG002|STARTED|Third Period||3||
48112683|NCT04074317|100601535|FG003|STARTED|Third Period||3||
48112684|NCT04074317|100601536|FG004|STARTED|Third Period||3||
48112685|NCT04074317|100601537|FG005|STARTED|Third Period||3||
48275973|NCT04045964|100999728|FG001|STARTED|Overall Study||16||
48275974|NCT04045964|100999727|FG000|Intervention Visit(s)|Overall Study||15||
48112686|NCT04074317|100601532|FG000|COMPLETED|Third Period||3||
48112687|NCT04074317|100601533|FG001|COMPLETED|Third Period||3||
48112688|NCT04074317|100601534|FG002|COMPLETED|Third Period||3||
48112689|NCT04074317|100601535|FG003|COMPLETED|Third Period||2||
48112690|NCT04074317|100601536|FG004|COMPLETED|Third Period||3||
48112691|NCT04074317|100601537|FG005|COMPLETED|Third Period||3||
48112692|NCT04074317|100601532|FG000|NOT COMPLETED|Third Period||0||
48275975|NCT04045964|100999728|FG001|Intervention Visit(s)|Overall Study||16||
48112693|NCT04074317|100601533|FG001|NOT COMPLETED|Third Period||0||
48112694|NCT04074317|100601534|FG002|NOT COMPLETED|Third Period||0||
48112695|NCT04074317|100601535|FG003|NOT COMPLETED|Third Period||1||
48112696|NCT04074317|100601536|FG004|NOT COMPLETED|Third Period||0||
48112697|NCT04074317|100601537|FG005|NOT COMPLETED|Third Period||0||
48112698|NCT01069289|100601538|FG000|STARTED|Overall Study||636||
48112699|NCT01069289|100601539|FG001|STARTED|Overall Study||657||
48112700|NCT01069289|100601538|FG000|COMPLETED|Overall Study||594||
48112701|NCT01069289|100601539|FG001|COMPLETED|Overall Study||601||
48112702|NCT01069289|100601538|FG000|NOT COMPLETED|Overall Study||42||
48112703|NCT01069289|100601539|FG001|NOT COMPLETED|Overall Study||56||
48112704|NCT00419562|100601540|FG000|STARTED|Overall Study||283||
48112705|NCT00419562|100601541|FG001|STARTED|Overall Study||277||
48112706|NCT00419562|100601540|FG000|COMPLETED|Overall Study||250||
48112707|NCT00419562|100601541|FG001|COMPLETED|Overall Study||246||
48112708|NCT00419562|100601540|FG000|NOT COMPLETED|Overall Study||33||
48112709|NCT00419562|100601541|FG001|NOT COMPLETED|Overall Study||31||
48112710|NCT02694315|100601542|FG000|STARTED|Overall Study||200||
48112711|NCT02694315|100601542|FG000|COMPLETED|Overall Study||200||
48112712|NCT02694315|100601542|FG000|NOT COMPLETED|Overall Study||0||
48112713|NCT01565291|100601543|FG000|STARTED|Overall Study||16||
48112714|NCT01565291|100601544|FG001|STARTED|Overall Study||16||
48112715|NCT01565291|100601543|FG000|COMPLETED|Overall Study||15||
48112716|NCT01565291|100601544|FG001|COMPLETED|Overall Study||16||
48112717|NCT01565291|100601543|FG000|NOT COMPLETED|Overall Study||1||
48112718|NCT01565291|100601544|FG001|NOT COMPLETED|Overall Study||0||
48112719|NCT04709575|100601545|FG000|STARTED|Overall Study||176||
48112720|NCT04709575|100601546|FG001|STARTED|Overall Study||177||
48112721|NCT04709575|100601545|FG000|COMPLETED|Overall Study||166||
48112722|NCT04709575|100601546|FG001|COMPLETED|Overall Study||172||
48112723|NCT04709575|100601545|FG000|NOT COMPLETED|Overall Study||10||
48112724|NCT04709575|100601546|FG001|NOT COMPLETED|Overall Study||5||
48112725|NCT00218543|100601547|FG000|STARTED|Overall Study||20||
48112726|NCT00218543|100601547|FG000|COMPLETED|Overall Study||5||
48112727|NCT00218543|100601547|FG000|NOT COMPLETED|Overall Study||15||
48112728|NCT00654381|100601548|FG000|STARTED|1st Stage||39||
48112729|NCT00654381|100601549|FG001|STARTED|1st Stage||41||
48112730|NCT00654381|100601550|FG002|STARTED|1st Stage||159||
48112731|NCT00654381|100601551|FG003|STARTED|1st Stage||160||
48112732|NCT00654381|100601552|FG004|STARTED|1st Stage||81||
48112733|NCT00654381|100601553|FG005|STARTED|1st Stage||81||
48112734|NCT00654381|100601548|FG000|COMPLETED|1st Stage||36||
48112735|NCT00654381|100601549|FG001|COMPLETED|1st Stage||38||
48112736|NCT00654381|100601550|FG002|COMPLETED|1st Stage||156||
48112737|NCT00654381|100601551|FG003|COMPLETED|1st Stage||155||
48112738|NCT00654381|100601552|FG004|COMPLETED|1st Stage||79||
48112739|NCT00654381|100601553|FG005|COMPLETED|1st Stage||79||
48112740|NCT00654381|100601548|FG000|NOT COMPLETED|1st Stage||3||
48112741|NCT00654381|100601549|FG001|NOT COMPLETED|1st Stage||3||
48112742|NCT00654381|100601550|FG002|NOT COMPLETED|1st Stage||3||
48112743|NCT00654381|100601551|FG003|NOT COMPLETED|1st Stage||5||
48112744|NCT00654381|100601552|FG004|NOT COMPLETED|1st Stage||2||
48112745|NCT00654381|100601553|FG005|NOT COMPLETED|1st Stage||2||
48112746|NCT00654381|100601548|FG000|STARTED|2nd Stage||36||
48112747|NCT00654381|100601549|FG001|STARTED|2nd Stage||38||
48112748|NCT00654381|100601550|FG002|STARTED|2nd Stage||156||
48112749|NCT00654381|100601551|FG003|STARTED|2nd Stage||155||
48112750|NCT00654381|100601552|FG004|STARTED|2nd Stage||79||
48112751|NCT00654381|100601553|FG005|STARTED|2nd Stage||79||
48112752|NCT00654381|100601548|FG000|COMPLETED|2nd Stage||34||
48112753|NCT00654381|100601549|FG001|COMPLETED|2nd Stage||38||
48112754|NCT00654381|100601550|FG002|COMPLETED|2nd Stage||153||
48112755|NCT00654381|100601551|FG003|COMPLETED|2nd Stage||151||
48112756|NCT00654381|100601552|FG004|COMPLETED|2nd Stage||71||
48112757|NCT00654381|100601553|FG005|COMPLETED|2nd Stage||76||
48112758|NCT00654381|100601548|FG000|NOT COMPLETED|2nd Stage||2||
48112759|NCT00654381|100601549|FG001|NOT COMPLETED|2nd Stage||0||
48112760|NCT00654381|100601550|FG002|NOT COMPLETED|2nd Stage||3||
48112761|NCT00654381|100601551|FG003|NOT COMPLETED|2nd Stage||4||
48112762|NCT00654381|100601552|FG004|NOT COMPLETED|2nd Stage||8||
48112763|NCT00654381|100601553|FG005|NOT COMPLETED|2nd Stage||3||
48112764|NCT00654381|100601548|FG000|STARTED|Extension Stage||34||
48112765|NCT00654381|100601549|FG001|STARTED|Extension Stage||38||
48112766|NCT00654381|100601550|FG002|STARTED|Extension Stage||153||
48112767|NCT00654381|100601551|FG003|STARTED|Extension Stage||151||
48112768|NCT00654381|100601552|FG004|STARTED|Extension Stage||71||
48112769|NCT00654381|100601553|FG005|STARTED|Extension Stage||76||
48112770|NCT00654381|100601548|FG000|COMPLETED|Extension Stage||33||
48112771|NCT00654381|100601549|FG001|COMPLETED|Extension Stage||36||
48112772|NCT00654381|100601550|FG002|COMPLETED|Extension Stage||142||
48112773|NCT00654381|100601551|FG003|COMPLETED|Extension Stage||142||
48112774|NCT00654381|100601552|FG004|COMPLETED|Extension Stage||68||
48112775|NCT00654381|100601553|FG005|COMPLETED|Extension Stage||73||
48112776|NCT00654381|100601548|FG000|NOT COMPLETED|Extension Stage||1||
48112777|NCT00654381|100601549|FG001|NOT COMPLETED|Extension Stage||2||
48112778|NCT00654381|100601550|FG002|NOT COMPLETED|Extension Stage||11||
48112779|NCT00654381|100601551|FG003|NOT COMPLETED|Extension Stage||9||
48112780|NCT00654381|100601552|FG004|NOT COMPLETED|Extension Stage||3||
48112781|NCT00654381|100601553|FG005|NOT COMPLETED|Extension Stage||3||
48112782|NCT01442363|100601554|FG000|STARTED|Overall Study||2||
48112783|NCT01442363|100601555|FG001|STARTED|Overall Study||2||
48112784|NCT01442363|100601556|FG002|STARTED|Overall Study||0||
48112785|NCT01442363|100601554|FG000|COMPLETED|Overall Study||2||
48561983|NCT00300235|101706116|FG000|STARTED|Overall Study||208||
48561984|NCT00300235|101706117|FG001|STARTED|Overall Study||240||
48112786|NCT01442363|100601555|FG001|COMPLETED|Overall Study||1||
48112787|NCT01442363|100601556|FG002|COMPLETED|Overall Study||0||
48112788|NCT01442363|100601554|FG000|NOT COMPLETED|Overall Study||0||
48112789|NCT01442363|100601555|FG001|NOT COMPLETED|Overall Study||1||
48112790|NCT01442363|100601556|FG002|NOT COMPLETED|Overall Study||0||
48112791|NCT00640510|100601557|FG000|STARTED|Overall Study||17||
48112792|NCT00640510|100601558|FG001|STARTED|Overall Study||17||
48112793|NCT00640510|100601557|FG000|COMPLETED|Overall Study||16||
48112794|NCT00640510|100601558|FG001|COMPLETED|Overall Study||15||
48112795|NCT00640510|100601557|FG000|NOT COMPLETED|Overall Study||1||
48112796|NCT00640510|100601558|FG001|NOT COMPLETED|Overall Study||2||
48112797|NCT03090256|100601559|FG000|STARTED|Overall Study||68||
48112798|NCT03090256|100601559|FG000|COMPLETED|Overall Study||68||
48112799|NCT03090256|100601559|FG000|NOT COMPLETED|Overall Study||0||
48112800|NCT01176292|100601560|FG000|STARTED|Overall Study||71||
48112801|NCT01176292|100601561|FG001|STARTED|Overall Study||71||
48112802|NCT01176292|100601560|FG000|COMPLETED|Overall Study||66||
48112803|NCT01176292|100601561|FG001|COMPLETED|Overall Study||62||
48112804|NCT01176292|100601560|FG000|NOT COMPLETED|Overall Study||5||
48112805|NCT01176292|100601561|FG001|NOT COMPLETED|Overall Study||9||
48112806|NCT03077165|100601562|FG000|STARTED|Overall Study||21||
48112807|NCT03077165|100601563|FG001|STARTED|Overall Study||22||
48112808|NCT03077165|100601564|FG002|STARTED|Overall Study||20||
48112809|NCT03077165|100601565|FG003|STARTED|Overall Study||19||
48112810|NCT03077165|100601566|FG004|STARTED|Overall Study||19||
48112811|NCT03077165|100601567|FG005|STARTED|Overall Study||20||
48112812|NCT03077165|100601562|FG000|COMPLETED|Overall Study||20||
48112813|NCT03077165|100601563|FG001|COMPLETED|Overall Study||22||
48112814|NCT03077165|100601564|FG002|COMPLETED|Overall Study||20||
48112815|NCT03077165|100601565|FG003|COMPLETED|Overall Study||19||
48112816|NCT03077165|100601566|FG004|COMPLETED|Overall Study||16||
48112817|NCT03077165|100601567|FG005|COMPLETED|Overall Study||20||
48112818|NCT03077165|100601562|FG000|NOT COMPLETED|Overall Study||1||
48112819|NCT03077165|100601563|FG001|NOT COMPLETED|Overall Study||0||
48112820|NCT03077165|100601564|FG002|NOT COMPLETED|Overall Study||0||
48112821|NCT03077165|100601565|FG003|NOT COMPLETED|Overall Study||0||
48112822|NCT03077165|100601566|FG004|NOT COMPLETED|Overall Study||3||
48112823|NCT03077165|100601567|FG005|NOT COMPLETED|Overall Study||0||
48112824|NCT00207142|100601568|FG000|STARTED|Induction Phase||252||
48112825|NCT00207142|100601569|FG001|STARTED|Induction Phase||0||
48112826|NCT00207142|100601570|FG002|STARTED|Induction Phase||0||
48112827|NCT00207142|100601571|FG003|STARTED|Induction Phase||0||
48112828|NCT00207142|100601568|FG000|COMPLETED|Induction Phase||222||
48112829|NCT00207142|100601569|FG001|COMPLETED|Induction Phase||0||
48112830|NCT00207142|100601570|FG002|COMPLETED|Induction Phase||0||
48112831|NCT00207142|100601571|FG003|COMPLETED|Induction Phase||0||
48112832|NCT00207142|100601568|FG000|NOT COMPLETED|Induction Phase||30||
48112833|NCT00207142|100601569|FG001|NOT COMPLETED|Induction Phase||0||
48112834|NCT00207142|100601570|FG002|NOT COMPLETED|Induction Phase||0||
48112835|NCT00207142|100601571|FG003|NOT COMPLETED|Induction Phase||0||
48112836|NCT00207142|100601568|FG000|STARTED|Maintenance Phase/Rescue Phase||0||
48112837|NCT00207142|100601569|FG001|STARTED|Maintenance Phase/Rescue Phase||87||
48112838|NCT00207142|100601570|FG002|STARTED|Maintenance Phase/Rescue Phase||85||
48561985|NCT00300235|101706118|FG002|STARTED|Overall Study||398||
48112839|NCT00207142|100601571|FG003|STARTED|Maintenance Phase/Rescue Phase||50||
48112840|NCT00207142|100601568|FG000|COMPLETED|Maintenance Phase/Rescue Phase||0||
48112841|NCT00207142|100601569|FG001|COMPLETED|Maintenance Phase/Rescue Phase||78||
48112842|NCT00207142|100601570|FG002|COMPLETED|Maintenance Phase/Rescue Phase||72||
48112843|NCT00207142|100601571|FG003|COMPLETED|Maintenance Phase/Rescue Phase||41||
48112844|NCT00207142|100601568|FG000|NOT COMPLETED|Maintenance Phase/Rescue Phase||0||
48112845|NCT00207142|100601569|FG001|NOT COMPLETED|Maintenance Phase/Rescue Phase||9||
48112846|NCT00207142|100601570|FG002|NOT COMPLETED|Maintenance Phase/Rescue Phase||13||
48561986|NCT00300235|101706119|FG003|STARTED|Overall Study||362||
48561987|NCT00300235|101706120|FG004|STARTED|Overall Study||251||
48112847|NCT00207142|100601571|FG003|NOT COMPLETED|Maintenance Phase/Rescue Phase||9||
48112848|NCT01067352|100601572|FG000|STARTED|Overall Study||9||
48112849|NCT01067352|100601573|FG001|STARTED|Overall Study||6||
48112850|NCT01067352|100601574|FG002|STARTED|Overall Study||10||
48112851|NCT01067352|100601572|FG000|COMPLETED|Overall Study||8||
48112852|NCT01067352|100601573|FG001|COMPLETED|Overall Study||3||
48112853|NCT01067352|100601574|FG002|COMPLETED|Overall Study||9||
48112854|NCT01067352|100601572|FG000|NOT COMPLETED|Overall Study||1||
48112855|NCT01067352|100601573|FG001|NOT COMPLETED|Overall Study||3||
48112856|NCT01067352|100601574|FG002|NOT COMPLETED|Overall Study||1||
48112857|NCT02963493|100601575|FG000|STARTED|Overall Study||157||
48561988|NCT00300235|101706116|FG000|COMPLETED|Overall Study||208||
48561989|NCT00300235|101706117|FG001|COMPLETED|Overall Study||240||
48112858|NCT02963493|100601575|FG000|COMPLETED|Overall Study||157|Study completion for assessment of endpoints|
48112859|NCT02963493|100601575|FG000|NOT COMPLETED|Overall Study||0||
48112860|NCT00515827|100601576|FG000|STARTED|First Intervention (12 Weeks)||27||
48112861|NCT00515827|100601577|FG001|STARTED|First Intervention (12 Weeks)||26||
48112862|NCT00515827|100601576|FG000|COMPLETED|First Intervention (12 Weeks)||26||
48112863|NCT00515827|100601577|FG001|COMPLETED|First Intervention (12 Weeks)||25||
48112864|NCT00515827|100601576|FG000|NOT COMPLETED|First Intervention (12 Weeks)||1||
48112865|NCT00515827|100601577|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1||
48112866|NCT00515827|100601576|FG000|STARTED|Second Intervention (12 Weeks)||26||
48112867|NCT00515827|100601577|FG001|STARTED|Second Intervention (12 Weeks)||25||
48112868|NCT00515827|100601576|FG000|COMPLETED|Second Intervention (12 Weeks)||25||
48112869|NCT00515827|100601577|FG001|COMPLETED|Second Intervention (12 Weeks)||25||
48112870|NCT00515827|100601576|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||1||
48112871|NCT00515827|100601577|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0||
48112872|NCT04737538|100601578|FG000|STARTED|Overall Study||36||
48112873|NCT04737538|100601579|FG001|STARTED|Overall Study||36||
48112874|NCT04737538|100601580|FG002|STARTED|Overall Study||38||
48112875|NCT04737538|100601578|FG000|COMPLETED|Overall Study||36||
48112876|NCT04737538|100601579|FG001|COMPLETED|Overall Study||36||
48112877|NCT04737538|100601580|FG002|COMPLETED|Overall Study||38||
48112878|NCT04737538|100601578|FG000|NOT COMPLETED|Overall Study||0||
48112879|NCT04737538|100601579|FG001|NOT COMPLETED|Overall Study||0||
48112880|NCT04737538|100601580|FG002|NOT COMPLETED|Overall Study||0||
48112881|NCT02586012|100601581|FG000|STARTED|Overall Study||5||
48112882|NCT02586012|100601582|FG001|STARTED|Overall Study||5||
48112883|NCT02586012|100601583|FG002|STARTED|Overall Study||5||
48112884|NCT02586012|100601584|FG003|STARTED|Overall Study||5||
48112885|NCT02586012|100601585|FG004|STARTED|Overall Study||5||
48112886|NCT02586012|100601586|FG005|STARTED|Overall Study||5||
48112887|NCT02586012|100601581|FG000|COMPLETED|Overall Study||4||
48112888|NCT02586012|100601582|FG001|COMPLETED|Overall Study||2||
48112889|NCT02586012|100601583|FG002|COMPLETED|Overall Study||4||
48112890|NCT02586012|100601584|FG003|COMPLETED|Overall Study||3||
48112891|NCT02586012|100601585|FG004|COMPLETED|Overall Study||4||
48112892|NCT02586012|100601586|FG005|COMPLETED|Overall Study||2||
48393437|NCT01412060|101291569|FG000|NOT COMPLETED|Open-label Run-in Period (RIP)||347||
48393438|NCT01412060|101291570|FG001|NOT COMPLETED|Open-label Run-in Period (RIP)||0||
48393439|NCT01412060|101291571|FG002|NOT COMPLETED|Open-label Run-in Period (RIP)||0||
48393440|NCT01412060|101291569|FG000|STARTED|Period Between RIP and SP||418||
48393441|NCT01412060|101291570|FG001|STARTED|Period Between RIP and SP||0||
48393442|NCT01412060|101291571|FG002|STARTED|Period Between RIP and SP||0||
48393443|NCT01412060|101291569|FG000|COMPLETED|Period Between RIP and SP||364||
48393444|NCT01412060|101291570|FG001|COMPLETED|Period Between RIP and SP||0||
48393445|NCT01412060|101291571|FG002|COMPLETED|Period Between RIP and SP||0||
48393446|NCT01412060|101291569|FG000|NOT COMPLETED|Period Between RIP and SP||54||
48393447|NCT01412060|101291570|FG001|NOT COMPLETED|Period Between RIP and SP||0||
48393448|NCT01412060|101291571|FG002|NOT COMPLETED|Period Between RIP and SP||0||
48561990|NCT00300235|101706118|FG002|COMPLETED|Overall Study||398||
48561991|NCT00300235|101706119|FG003|COMPLETED|Overall Study||362||
48561992|NCT00300235|101706120|FG004|COMPLETED|Overall Study||251||
48561993|NCT00300235|101706116|FG000|NOT COMPLETED|Overall Study||0||
48561994|NCT00300235|101706117|FG001|NOT COMPLETED|Overall Study||0||
48561995|NCT00300235|101706118|FG002|NOT COMPLETED|Overall Study||0||
48393449|NCT01412060|101291569|FG000|STARTED|Open-label Stabilization Period (SP)||364||
48393450|NCT01412060|101291570|FG001|STARTED|Open-label Stabilization Period (SP)||0||
48393451|NCT01412060|101291571|FG002|STARTED|Open-label Stabilization Period (SP)||0||
48393452|NCT01412060|101291569|FG000|COMPLETED|Open-label Stabilization Period (SP)||264||
48393453|NCT01412060|101291570|FG001|COMPLETED|Open-label Stabilization Period (SP)||0||
48393454|NCT01412060|101291571|FG002|COMPLETED|Open-label Stabilization Period (SP)||0||
48561996|NCT00300235|101706119|FG003|NOT COMPLETED|Overall Study||0||
48112893|NCT02586012|100601581|FG000|NOT COMPLETED|Overall Study||1||
48393455|NCT01412060|101291569|FG000|NOT COMPLETED|Open-label Stabilization Period (SP)||100||
48393456|NCT01412060|101291570|FG001|NOT COMPLETED|Open-label Stabilization Period (SP)||0||
48393457|NCT01412060|101291571|FG002|NOT COMPLETED|Open-label Stabilization Period (SP)||0||
48393458|NCT01412060|101291569|FG000|STARTED|Period Between SP and DBP||264||
48393459|NCT01412060|101291570|FG001|STARTED|Period Between SP and DBP||0||
48393460|NCT01412060|101291571|FG002|STARTED|Period Between SP and DBP||0||
48393461|NCT01412060|101291569|FG000|COMPLETED|Period Between SP and DBP||200||
48393462|NCT01412060|101291570|FG001|COMPLETED|Period Between SP and DBP||0||
48393463|NCT01412060|101291571|FG002|COMPLETED|Period Between SP and DBP||0||
48393464|NCT01412060|101291569|FG000|NOT COMPLETED|Period Between SP and DBP||64||
48561997|NCT00300235|101706120|FG004|NOT COMPLETED|Overall Study||0||
48561998|NCT00468819|101706121|FG000|STARTED|Overall Study||48||
48561999|NCT00468819|101706122|FG001|STARTED|Overall Study||44||
48112894|NCT02586012|100601582|FG001|NOT COMPLETED|Overall Study||3||
48112895|NCT02586012|100601583|FG002|NOT COMPLETED|Overall Study||1||
48112896|NCT02586012|100601584|FG003|NOT COMPLETED|Overall Study||2||
48112897|NCT02586012|100601585|FG004|NOT COMPLETED|Overall Study||1||
48562000|NCT00468819|101706123|FG002|STARTED|Overall Study||48||
48562001|NCT00468819|101706121|FG000|Treatment Received/ Safety Follow-up|Overall Study||46||
48562002|NCT00468819|101706122|FG001|Treatment Received/ Safety Follow-up|Overall Study||44||
48562003|NCT00468819|101706123|FG002|Treatment Received/ Safety Follow-up|Overall Study||48||
48562004|NCT00468819|101706121|FG000|COMPLETED|Overall Study||42||
48562005|NCT00468819|101706122|FG001|COMPLETED|Overall Study||44||
48562006|NCT00468819|101706123|FG002|COMPLETED|Overall Study||46||
48112898|NCT02586012|100601586|FG005|NOT COMPLETED|Overall Study||3||
48112899|NCT00935428|100601587|FG000|STARTED|Overall Study||231||
48112900|NCT00935428|100601587|FG000|COMPLETED|Overall Study||231||
48112901|NCT00935428|100601587|FG000|NOT COMPLETED|Overall Study||0||
48112902|NCT02722928|100601588|FG000|STARTED|Overall Study||49||
48112903|NCT02722928|100601589|FG001|STARTED|Overall Study||51||
48112904|NCT02722928|100601588|FG000|COMPLETED|Overall Study||39||
48112905|NCT02722928|100601589|FG001|COMPLETED|Overall Study||31||
48112906|NCT02722928|100601588|FG000|NOT COMPLETED|Overall Study||10||
48112907|NCT02722928|100601589|FG001|NOT COMPLETED|Overall Study||20||
48112908|NCT01256710|100601590|FG000|STARTED|Overall Study||1151||
48112909|NCT01256710|100601590|FG000|COMPLETED|Overall Study||227||
48112910|NCT01256710|100601590|FG000|NOT COMPLETED|Overall Study||924||
48112911|NCT03548584|100601591|FG000|STARTED|Overall Study||75||
48112912|NCT03548584|100601592|FG001|STARTED|Overall Study||153||
48112913|NCT03548584|100601593|FG002|STARTED|Overall Study||117||
48112914|NCT03548584|100601591|FG000|Intent-to-treat Population|Overall Study||73|Intent-to-treat (ITT) Population consisted of all participants in the randomized sample, who took at least 1 dose of investigational medical product (IMP) and had a baseline and at least one post-baseline evaluation for the Cohen-Mansfield Agitation Inventory (CMAI) total score.|
48112915|NCT03548584|100601592|FG001|Intent-to-treat Population|Overall Study||153|Intent-to-treat (ITT) Population consisted of all participants in the randomized sample, who took at least 1 dose of investigational medical product (IMP) and had a baseline and at least one post-baseline evaluation for the Cohen-Mansfield Agitation Inventory (CMAI) total score.|
48112916|NCT03548584|100601593|FG002|Intent-to-treat Population|Overall Study||116|Intent-to-treat (ITT) Population consisted of all participants in the randomized sample, who took at least 1 dose of investigational medical product (IMP) and had a baseline and at least one post-baseline evaluation for the Cohen-Mansfield Agitation Inventory (CMAI) total score.|
48112917|NCT03548584|100601591|FG000|COMPLETED|Overall Study||68||
48112918|NCT03548584|100601592|FG001|COMPLETED|Overall Study||130||
48112919|NCT03548584|100601593|FG002|COMPLETED|Overall Study||104||
48393465|NCT01412060|101291570|FG001|NOT COMPLETED|Period Between SP and DBP||0||
48393466|NCT01412060|101291571|FG002|NOT COMPLETED|Period Between SP and DBP||0||
48393467|NCT01412060|101291569|FG000|STARTED|Double-blind Treatment Phase (DBP)||0||
48393468|NCT01412060|101291570|FG001|STARTED|Double-blind Treatment Phase (DBP)||99||
48393469|NCT01412060|101291571|FG002|STARTED|Double-blind Treatment Phase (DBP)||101||
48393470|NCT01412060|101291569|FG000|COMPLETED|Double-blind Treatment Phase (DBP)||0||
48393471|NCT01412060|101291570|FG001|COMPLETED|Double-blind Treatment Phase (DBP)||16||
48393472|NCT01412060|101291571|FG002|COMPLETED|Double-blind Treatment Phase (DBP)||18||
48393473|NCT01412060|101291569|FG000|NOT COMPLETED|Double-blind Treatment Phase (DBP)||0||
48393474|NCT01412060|101291570|FG001|NOT COMPLETED|Double-blind Treatment Phase (DBP)||83||
48393475|NCT01412060|101291571|FG002|NOT COMPLETED|Double-blind Treatment Phase (DBP)||83||
48393476|NCT00209170|101291572|FG000|STARTED|Overall Study||7||
48112920|NCT03548584|100601591|FG000|NOT COMPLETED|Overall Study||7||
48112921|NCT03548584|100601592|FG001|NOT COMPLETED|Overall Study||23||
48112922|NCT03548584|100601593|FG002|NOT COMPLETED|Overall Study||13||
48112923|NCT03643562|100601594|FG000|STARTED|Overall Study||9||
48112924|NCT03643562|100601595|FG001|STARTED|Overall Study||18||
48112925|NCT03643562|100601594|FG000|Received at Least 1 Dose of Study Drug|Overall Study||9||
48112926|NCT03643562|100601595|FG001|Received at Least 1 Dose of Study Drug|Overall Study||18||
48112927|NCT03643562|100601594|FG000|COMPLETED|Overall Study||1||
48393477|NCT00209170|101291573|FG001|STARTED|Overall Study||7||
48393478|NCT00209170|101291572|FG000|COMPLETED|Overall Study||5||
48393479|NCT00209170|101291573|FG001|COMPLETED|Overall Study||4||
48393480|NCT00209170|101291572|FG000|NOT COMPLETED|Overall Study||2||
48393481|NCT00209170|101291573|FG001|NOT COMPLETED|Overall Study||3||
48393482|NCT02219997|101291574|FG000|STARTED|First Filter||33||
48393483|NCT02219997|101291575|FG001|STARTED|First Filter||17||
48393484|NCT02219997|101291576|FG002|STARTED|First Filter||18||
48393485|NCT02219997|101291574|FG000|COMPLETED|First Filter||33||
48393486|NCT02219997|101291575|FG001|COMPLETED|First Filter||17||
48562007|NCT00468819|101706121|FG000|NOT COMPLETED|Overall Study||6||
48562008|NCT00468819|101706122|FG001|NOT COMPLETED|Overall Study||0||
48393487|NCT02219997|101291576|FG002|COMPLETED|First Filter||18||
48393488|NCT02219997|101291574|FG000|NOT COMPLETED|First Filter||0||
48393489|NCT02219997|101291575|FG001|NOT COMPLETED|First Filter||0||
48393490|NCT02219997|101291576|FG002|NOT COMPLETED|First Filter||0||
48562009|NCT00468819|101706123|FG002|NOT COMPLETED|Overall Study||2||
48562010|NCT02105467|101706124|FG000|STARTED|Period 1||316||
48562011|NCT02105467|101706125|FG001|STARTED|Period 1||105||
48562012|NCT02105467|101706124|FG000|COMPLETED|Period 1||314||
48562013|NCT02105467|101706125|FG001|COMPLETED|Period 1||105||
48562014|NCT02105467|101706124|FG000|NOT COMPLETED|Period 1||2||
48562015|NCT02105467|101706125|FG001|NOT COMPLETED|Period 1||0||
48562016|NCT02105467|101706124|FG000|STARTED|Period 2||314||
48393491|NCT02219997|101291574|FG000|STARTED|Second Filter||0||
48393492|NCT02219997|101291575|FG001|STARTED|Second Filter||17||
48393493|NCT02219997|101291576|FG002|STARTED|Second Filter||18||
48393494|NCT02219997|101291574|FG000|COMPLETED|Second Filter||0||
48275976|NCT04045964|100999727|FG000|Follow up Visit 1|Overall Study||15||
48275977|NCT04045964|100999728|FG001|Follow up Visit 1|Overall Study||15||
48275978|NCT04045964|100999727|FG000|Follow up Visit 2|Overall Study||15||
48275979|NCT04045964|100999728|FG001|Follow up Visit 2|Overall Study||15||
48275980|NCT04045964|100999727|FG000|COMPLETED|Overall Study||15||
48275981|NCT04045964|100999728|FG001|COMPLETED|Overall Study||15||
48275982|NCT04045964|100999727|FG000|NOT COMPLETED|Overall Study||1||
48275983|NCT04045964|100999728|FG001|NOT COMPLETED|Overall Study||1||
48275984|NCT01370590|100999729|FG000|STARTED|Period 1||203||
48275985|NCT01370590|100999730|FG001|STARTED|Period 1||203||
48275986|NCT01370590|100999729|FG000|COMPLETED|Period 1||187||
48275987|NCT01370590|100999730|FG001|COMPLETED|Period 1||192||
48393495|NCT02219997|101291575|FG001|COMPLETED|Second Filter||17||
48393496|NCT02219997|101291576|FG002|COMPLETED|Second Filter||18||
48393497|NCT02219997|101291574|FG000|NOT COMPLETED|Second Filter||0||
48393498|NCT02219997|101291575|FG001|NOT COMPLETED|Second Filter||0||
48393499|NCT02219997|101291576|FG002|NOT COMPLETED|Second Filter||0||
48393500|NCT03803202|101291577|FG000|STARTED|Overall Study||30|Started = All enrolled participants|
48393501|NCT03803202|101291578|FG001|STARTED|Overall Study||32|Started = All enrolled participants|
48393502|NCT03803202|101291579|FG002|STARTED|Overall Study||32|Started = All enrolled participants|
48393503|NCT03803202|101291580|FG003|STARTED|Overall Study||33|Started = All enrolled participants|
48393504|NCT03803202|101291581|FG004|STARTED|Overall Study||100|Started = All enrolled participants|
48393505|NCT03803202|101291582|FG005|STARTED|Overall Study||107|Started = All enrolled participants|
48393506|NCT03803202|101291583|FG006|STARTED|Overall Study||86|Started = All enrolled participants|
48393507|NCT03803202|101291584|FG007|STARTED|Overall Study||97|Started = All enrolled participants|
48393508|NCT03803202|101291585|FG008|STARTED|Overall Study||113|Started = All enrolled participants|
48393509|NCT03803202|101291577|FG000|Vaccinated|Overall Study||30|Vaccinated = number of participants who completed the vaccination|
48393510|NCT03803202|101291578|FG001|Vaccinated|Overall Study||31|Vaccinated = number of participants who completed the vaccination|
48393511|NCT03803202|101291579|FG002|Vaccinated|Overall Study||32|Vaccinated = number of participants who completed the vaccination|
48393512|NCT03803202|101291580|FG003|Vaccinated|Overall Study||33|Vaccinated = number of participants who completed the vaccination|
48393513|NCT03803202|101291581|FG004|Vaccinated|Overall Study||100|Vaccinated = number of participants who completed the vaccination|
48393514|NCT03803202|101291582|FG005|Vaccinated|Overall Study||107|Vaccinated = number of participants who completed the vaccination|
48393515|NCT03803202|101291583|FG006|Vaccinated|Overall Study||86|Vaccinated = number of participants who completed the vaccination|
48393516|NCT03803202|101291584|FG007|Vaccinated|Overall Study||97|Vaccinated = number of participants who completed the vaccination|
48393517|NCT03803202|101291585|FG008|Vaccinated|Overall Study||113|Vaccinated = number of participants who completed the vaccination|
48393518|NCT03803202|101291577|FG000|COMPLETED|Overall Study||30||
48393519|NCT03803202|101291578|FG001|COMPLETED|Overall Study||31||
48393520|NCT03803202|101291579|FG002|COMPLETED|Overall Study||31||
48393521|NCT03803202|101291580|FG003|COMPLETED|Overall Study||32||
48393522|NCT03803202|101291581|FG004|COMPLETED|Overall Study||99||
48393523|NCT03803202|101291582|FG005|COMPLETED|Overall Study||106||
48393524|NCT03803202|101291583|FG006|COMPLETED|Overall Study||85||
48393525|NCT03803202|101291584|FG007|COMPLETED|Overall Study||96||
48393526|NCT03803202|101291585|FG008|COMPLETED|Overall Study||113||
48393527|NCT03803202|101291577|FG000|NOT COMPLETED|Overall Study||0||
48393528|NCT03803202|101291578|FG001|NOT COMPLETED|Overall Study||1||
48393529|NCT03803202|101291579|FG002|NOT COMPLETED|Overall Study||1||
48393530|NCT03803202|101291580|FG003|NOT COMPLETED|Overall Study||1||
48393531|NCT03803202|101291581|FG004|NOT COMPLETED|Overall Study||1||
48393532|NCT03803202|101291582|FG005|NOT COMPLETED|Overall Study||1||
48393533|NCT03803202|101291583|FG006|NOT COMPLETED|Overall Study||1||
48393534|NCT03803202|101291584|FG007|NOT COMPLETED|Overall Study||1||
48393535|NCT03803202|101291585|FG008|NOT COMPLETED|Overall Study||0||
48393536|NCT02146833|101291586|FG000|STARTED|Overall Study||20||
48393537|NCT02146833|101291586|FG000|COMPLETED|Overall Study||9||
48393538|NCT02146833|101291586|FG000|NOT COMPLETED|Overall Study||11||
48393539|NCT00719862|101291587|FG000|STARTED|Overall Study||242||
48393540|NCT00719862|101291588|FG001|STARTED|Overall Study||239||
48393541|NCT00719862|101291587|FG000|COMPLETED|Overall Study||234||
48393542|NCT00719862|101291588|FG001|COMPLETED|Overall Study||233||
48393543|NCT00719862|101291587|FG000|NOT COMPLETED|Overall Study||8||
48393544|NCT00719862|101291588|FG001|NOT COMPLETED|Overall Study||6||
48393545|NCT01787799|101291589|FG000|STARTED|Overall Study||100||
48393546|NCT01787799|101291589|FG000|COMPLETED|Overall Study||100||
48393547|NCT01787799|101291589|FG000|NOT COMPLETED|Overall Study||0||
48393548|NCT01309867|101291590|FG000|STARTED|Overall Study||151||
48393549|NCT01309867|101291591|FG001|STARTED|Overall Study||151||
48393550|NCT01309867|101291590|FG000|COMPLETED|Overall Study||148||
48393551|NCT01309867|101291591|FG001|COMPLETED|Overall Study||139||
48275988|NCT01370590|100999729|FG000|NOT COMPLETED|Period 1||16||
48275989|NCT01370590|100999730|FG001|NOT COMPLETED|Period 1||11||
48275990|NCT01370590|100999729|FG000|STARTED|Crossover Washout Period||187||
48112928|NCT03643562|100601595|FG001|COMPLETED|Overall Study||2||
48562017|NCT02105467|101706125|FG001|STARTED|Period 2||104||
48562018|NCT02105467|101706124|FG000|COMPLETED|Period 2||312||
48112929|NCT03643562|100601594|FG000|NOT COMPLETED|Overall Study||8||
48112930|NCT03643562|100601595|FG001|NOT COMPLETED|Overall Study||16||
48112931|NCT01096784|100601596|FG000|STARTED|Overall Study||61||
48112932|NCT01096784|100601597|FG001|STARTED|Overall Study||60||
48112933|NCT01096784|100601596|FG000|COMPLETED|Overall Study||46||
48112934|NCT01096784|100601597|FG001|COMPLETED|Overall Study||46||
48112935|NCT01096784|100601596|FG000|NOT COMPLETED|Overall Study||15||
48112936|NCT01096784|100601597|FG001|NOT COMPLETED|Overall Study||14||
48112937|NCT03460587|100601598|FG000|STARTED|Overall Study||13||
48112938|NCT03460587|100601598|FG000|COMPLETED|Overall Study||13||
48112939|NCT03460587|100601598|FG000|NOT COMPLETED|Overall Study||0||
48112940|NCT03029624|100601599|FG000|STARTED|Overall Study||46|Recruited|
48112941|NCT03029624|100601599|FG000|Primary Endpoint (3 Months)|Overall Study||44||
48112942|NCT03029624|100601599|FG000|COMPLETED|Overall Study||41||
48112943|NCT03029624|100601599|FG000|NOT COMPLETED|Overall Study||5||
48112944|NCT02563028|100601600|FG000|STARTED|Overall Study||20||
48112945|NCT02563028|100601600|FG000|COMPLETED|Overall Study||18||
48112946|NCT02563028|100601600|FG000|NOT COMPLETED|Overall Study||2||
48112947|NCT00727714|100601601|FG000|STARTED|Overall Study||95||
48112948|NCT00727714|100601601|FG000|COMPLETED|Overall Study||93||
48112949|NCT00727714|100601601|FG000|NOT COMPLETED|Overall Study||2||
48112950|NCT02696096|100601602|FG000|STARTED|Overall Study||21||
48112951|NCT02696096|100601602|FG000|Opioid Abstinence During Study Period|Overall Study||11||
48112952|NCT02696096|100601602|FG000|COMPLETED|Overall Study||19||
48112953|NCT02696096|100601602|FG000|NOT COMPLETED|Overall Study||2||
48275991|NCT01370590|100999730|FG001|STARTED|Crossover Washout Period||192||
48275992|NCT01370590|100999729|FG000|COMPLETED|Crossover Washout Period||181||
48275993|NCT01370590|100999730|FG001|COMPLETED|Crossover Washout Period||186||
48275994|NCT01370590|100999729|FG000|NOT COMPLETED|Crossover Washout Period||6||
48275995|NCT01370590|100999730|FG001|NOT COMPLETED|Crossover Washout Period||6||
48275996|NCT01370590|100999729|FG000|STARTED|Period 2||181||
48275997|NCT01370590|100999730|FG001|STARTED|Period 2||186||
48275998|NCT01370590|100999729|FG000|COMPLETED|Period 2||180||
48275999|NCT01370590|100999730|FG001|COMPLETED|Period 2||184||
48276000|NCT01370590|100999729|FG000|NOT COMPLETED|Period 2||1||
48276001|NCT01370590|100999730|FG001|NOT COMPLETED|Period 2||2||
48276002|NCT01507987|100999731|FG000|STARTED|Overall Study||982||982
48276003|NCT01507987|100999732|FG001|STARTED|Overall Study||670||670
48276004|NCT01507987|100999733|FG002|STARTED|Overall Study||458||458
48276005|NCT01507987|100999734|FG003|STARTED|Overall Study||737||737
48276006|NCT01507987|100999731|FG000|COMPLETED|Overall Study||618||618
48276007|NCT01507987|100999732|FG001|COMPLETED|Overall Study||335||335
48276008|NCT01507987|100999733|FG002|COMPLETED|Overall Study||252||252
48276009|NCT01507987|100999734|FG003|COMPLETED|Overall Study||480||480
48276010|NCT01507987|100999731|FG000|NOT COMPLETED|Overall Study||364||364
48276011|NCT01507987|100999732|FG001|NOT COMPLETED|Overall Study||335||335
48276012|NCT01507987|100999733|FG002|NOT COMPLETED|Overall Study||206||206
48276013|NCT01507987|100999734|FG003|NOT COMPLETED|Overall Study||257||257
48276014|NCT03387137|100999735|FG000|STARTED|Overall Study||10||
48276015|NCT03387137|100999736|FG001|STARTED|Overall Study||5||
48276016|NCT03387137|100999737|FG002|STARTED|Overall Study||20||
48276017|NCT03387137|100999738|FG003|STARTED|Overall Study||10||
48276018|NCT03387137|100999735|FG000|COMPLETED|Overall Study||10||
48276019|NCT03387137|100999736|FG001|COMPLETED|Overall Study||5||
48276020|NCT03387137|100999737|FG002|COMPLETED|Overall Study||20||
48276021|NCT03387137|100999738|FG003|COMPLETED|Overall Study||10||
48276022|NCT03387137|100999735|FG000|NOT COMPLETED|Overall Study||0||
48276023|NCT03387137|100999736|FG001|NOT COMPLETED|Overall Study||0||
48276024|NCT03387137|100999737|FG002|NOT COMPLETED|Overall Study||0||
48276025|NCT03387137|100999738|FG003|NOT COMPLETED|Overall Study||0||
48276026|NCT03829475|100999739|FG000|STARTED|Overall Study||30||
48276027|NCT03829475|100999740|FG001|STARTED|Overall Study||31||
48562019|NCT02105467|101706125|FG001|COMPLETED|Period 2||102||
48112954|NCT01428193|100601603|FG000|STARTED|Overall Study||4||
48276028|NCT03829475|100999739|FG000|COMPLETED|Overall Study||30||
48276029|NCT03829475|100999740|FG001|COMPLETED|Overall Study||31||
48276030|NCT03829475|100999739|FG000|NOT COMPLETED|Overall Study||0||
48276031|NCT03829475|100999740|FG001|NOT COMPLETED|Overall Study||0||
48276032|NCT01099475|100999741|FG000|STARTED|Overall Study||10||
48276033|NCT01099475|100999742|FG001|STARTED|Overall Study||10||
48276034|NCT01099475|100999741|FG000|COMPLETED|Overall Study||10||
48276035|NCT01099475|100999742|FG001|COMPLETED|Overall Study||10||
48276036|NCT01099475|100999741|FG000|NOT COMPLETED|Overall Study||0||
48562020|NCT02105467|101706124|FG000|NOT COMPLETED|Period 2||2||
48562021|NCT02105467|101706125|FG001|NOT COMPLETED|Period 2||2||
48112955|NCT01428193|100601603|FG000|COMPLETED|Overall Study||2||
48112956|NCT01428193|100601603|FG000|NOT COMPLETED|Overall Study||2||
48276037|NCT01099475|100999742|FG001|NOT COMPLETED|Overall Study||0||
48276038|NCT04910139|100999743|FG000|STARTED|Overall Study||50||
48112957|NCT01265446|100601604|FG000|STARTED|Overall Study||125||
48112958|NCT01265446|100601605|FG001|STARTED|Overall Study||125||
48112959|NCT01265446|100601604|FG000|COMPLETED|Overall Study||124||
48562022|NCT02105467|101706124|FG000|STARTED|Period 3||0||
48562023|NCT02105467|101706125|FG001|STARTED|Period 3||103||
48562024|NCT02105467|101706124|FG000|COMPLETED|Period 3||0||
48562025|NCT02105467|101706125|FG001|COMPLETED|Period 3||102||
48562026|NCT02105467|101706124|FG000|NOT COMPLETED|Period 3||0||
48562027|NCT02105467|101706125|FG001|NOT COMPLETED|Period 3||1||
48562028|NCT03808948|101706126|FG000|STARTED|Overall Study||50||
48276039|NCT04910139|100999743|FG000|COMPLETED|Overall Study||50||
48276040|NCT04910139|100999743|FG000|NOT COMPLETED|Overall Study||0||
48276041|NCT03541200|100999744|FG000|STARTED|Overall Study||190||
48276042|NCT03541200|100999744|FG000|COMPLETED|Overall Study||77||
48276043|NCT03541200|100999744|FG000|NOT COMPLETED|Overall Study||113||
48276044|NCT00589121|100999745|FG000|STARTED|Overall Study||12||
48276045|NCT00589121|100999746|FG001|STARTED|Overall Study||86||
48276046|NCT00589121|100999745|FG000|COMPLETED|Overall Study||10||
48276047|NCT00589121|100999746|FG001|COMPLETED|Overall Study||79||
48276048|NCT00589121|100999745|FG000|NOT COMPLETED|Overall Study||2||
48276049|NCT00589121|100999746|FG001|NOT COMPLETED|Overall Study||7||
48276050|NCT02766777|100999747|FG000|STARTED|Overall Study||87||
48276051|NCT02766777|100999747|FG000|Treated (Safety [SAF] Population)|Overall Study||87||
48276052|NCT02766777|100999747|FG000|COMPLETED|Overall Study||53||
48276053|NCT02766777|100999747|FG000|NOT COMPLETED|Overall Study||34||
48276054|NCT00299494|100999748|FG000|STARTED|Overall Study||5||
48276055|NCT00299494|100999749|FG001|STARTED|Overall Study||3||
48276056|NCT00299494|100999750|FG002|STARTED|Overall Study||7||
48562029|NCT03808948|101706126|FG000|COMPLETED|Overall Study||50||
48562030|NCT03808948|101706126|FG000|NOT COMPLETED|Overall Study||0||
48562031|NCT00459862|101706127|FG000|STARTED|Overall Study||34||
48562032|NCT00459862|101706127|FG000|COMPLETED|Overall Study||34||
48562033|NCT00459862|101706127|FG000|NOT COMPLETED|Overall Study||0||
48562034|NCT00697463|101706128|FG000|STARTED|Overall Study||22||
48562035|NCT00697463|101706128|FG000|COMPLETED|Overall Study||21||
48562036|NCT00697463|101706128|FG000|NOT COMPLETED|Overall Study||1||
48562037|NCT02633293|101706129|FG000|STARTED|Overall Study||243||
48562038|NCT02633293|101706129|FG000|Received Inhaled Treprostinil in RIN-PH-202 (Safety Population)|Overall Study||242||
48562039|NCT02633293|101706129|FG000|COMPLETED|Overall Study||70||
48562040|NCT02633293|101706129|FG000|NOT COMPLETED|Overall Study||173||
48276057|NCT00299494|100999751|FG003|STARTED|Overall Study||34||
48276058|NCT00299494|100999752|FG004|STARTED|Overall Study||40||
48276059|NCT00299494|100999753|FG005|STARTED|Overall Study||30||
48276060|NCT00299494|100999748|FG000|COMPLETED|Overall Study||2||
48276061|NCT00299494|100999749|FG001|COMPLETED|Overall Study||2||
48276062|NCT00299494|100999750|FG002|COMPLETED|Overall Study||3||
48562041|NCT02483676|101706130|FG000|STARTED|Overall Study||23||
48562042|NCT02483676|101706131|FG001|STARTED|Overall Study||22||
48562043|NCT02483676|101706130|FG000|COMPLETED|Overall Study||17||
48562044|NCT02483676|101706131|FG001|COMPLETED|Overall Study||17||
48276063|NCT00299494|100999751|FG003|COMPLETED|Overall Study||24||
48276064|NCT00299494|100999752|FG004|COMPLETED|Overall Study||13||
48276065|NCT00299494|100999753|FG005|COMPLETED|Overall Study||4||
48276066|NCT00299494|100999748|FG000|NOT COMPLETED|Overall Study||3||
48276067|NCT00299494|100999749|FG001|NOT COMPLETED|Overall Study||1||
48276068|NCT00299494|100999750|FG002|NOT COMPLETED|Overall Study||4||
48276069|NCT00299494|100999751|FG003|NOT COMPLETED|Overall Study||10||
48276070|NCT00299494|100999752|FG004|NOT COMPLETED|Overall Study||27||
48276071|NCT00299494|100999753|FG005|NOT COMPLETED|Overall Study||26||
48276072|NCT02760498|100999754|FG000|STARTED|Overall Study||59||
48276073|NCT02760498|100999755|FG001|STARTED|Overall Study||78||
48393552|NCT01309867|101291590|FG000|NOT COMPLETED|Overall Study||3||
48562045|NCT02483676|101706130|FG000|NOT COMPLETED|Overall Study||6||
48562046|NCT02483676|101706131|FG001|NOT COMPLETED|Overall Study||5||
48562047|NCT00349973|101706132|FG000|STARTED|Overall Study||12||
48562048|NCT00349973|101706133|FG001|STARTED|Overall Study||8||
48562049|NCT00349973|101706132|FG000|COMPLETED|Overall Study||8||
48562050|NCT00349973|101706133|FG001|COMPLETED|Overall Study||5||
48562051|NCT00349973|101706132|FG000|NOT COMPLETED|Overall Study||4||
48562052|NCT00349973|101706133|FG001|NOT COMPLETED|Overall Study||3||
48562053|NCT00972374|101706134|FG000|STARTED|Overall Study||15||
48562054|NCT00972374|101706135|FG001|STARTED|Overall Study||15||
48562055|NCT00972374|101706136|FG002|STARTED|Overall Study||14||
48562056|NCT00972374|101706134|FG000|COMPLETED|Overall Study||13||
48276074|NCT02760498|100999756|FG002|STARTED|Overall Study||56||
48276075|NCT02760498|100999757|FG003|STARTED|Overall Study||63||
48276076|NCT02760498|100999758|FG004|STARTED|Overall Study||9||
48276077|NCT02760498|100999759|FG005|STARTED|Overall Study||167||
48276078|NCT02760498|100999754|FG000|Received at Least 1 Dose of Study Drug|Overall Study||59||
48393553|NCT01309867|101291591|FG001|NOT COMPLETED|Overall Study||12||
48276079|NCT02760498|100999755|FG001|Received at Least 1 Dose of Study Drug|Overall Study||78||
48276080|NCT02760498|100999756|FG002|Received at Least 1 Dose of Study Drug|Overall Study||56||
48276081|NCT02760498|100999757|FG003|Received at Least 1 Dose of Study Drug|Overall Study||63||
48276082|NCT02760498|100999758|FG004|Received at Least 1 Dose of Study Drug|Overall Study||9||
48276083|NCT02760498|100999759|FG005|Received at Least 1 Dose of Study Drug|Overall Study||165||
48276084|NCT02760498|100999754|FG000|Completed Treatment|Overall Study||24||
48276085|NCT02760498|100999755|FG001|Completed Treatment|Overall Study||20||
48276086|NCT02760498|100999756|FG002|Completed Treatment|Overall Study||22||
48276087|NCT02760498|100999757|FG003|Completed Treatment|Overall Study||27||
48276088|NCT02760498|100999758|FG004|Completed Treatment|Overall Study||5||
48276089|NCT02760498|100999759|FG005|Completed Treatment|Overall Study||50||
48276090|NCT02760498|100999754|FG000|COMPLETED|Overall Study||19|Completed Study|
48276091|NCT02760498|100999755|FG001|COMPLETED|Overall Study||28|Completed Study|
48276092|NCT02760498|100999756|FG002|COMPLETED|Overall Study||22|Completed Study|
48276093|NCT02760498|100999757|FG003|COMPLETED|Overall Study||24|Completed Study|
48276094|NCT02760498|100999758|FG004|COMPLETED|Overall Study||3|Completed Study|
48276095|NCT02760498|100999759|FG005|COMPLETED|Overall Study||64|Completed Study|
48276096|NCT02760498|100999754|FG000|NOT COMPLETED|Overall Study||40||
48276097|NCT02760498|100999755|FG001|NOT COMPLETED|Overall Study||50||
48276098|NCT02760498|100999756|FG002|NOT COMPLETED|Overall Study||34||
48276099|NCT02760498|100999757|FG003|NOT COMPLETED|Overall Study||39||
48276100|NCT02760498|100999758|FG004|NOT COMPLETED|Overall Study||6||
48276101|NCT02760498|100999759|FG005|NOT COMPLETED|Overall Study||103||
48276102|NCT05000931|100999760|FG000|STARTED|Overall Study||50||
48276103|NCT05000931|100999760|FG000|COMPLETED|Overall Study||49||
48276104|NCT05000931|100999760|FG000|NOT COMPLETED|Overall Study||1||
48112960|NCT01265446|100601605|FG001|COMPLETED|Overall Study||125||
48112961|NCT01265446|100601604|FG000|NOT COMPLETED|Overall Study||1||
48112962|NCT01265446|100601605|FG001|NOT COMPLETED|Overall Study||0||
48112963|NCT00969553|100601606|FG000|STARTED|Overall Study||3||
48112964|NCT00969553|100601607|FG001|STARTED|Overall Study||3||
48112965|NCT00969553|100601608|FG002|STARTED|Overall Study||6||
48112966|NCT00969553|100601609|FG003|STARTED|Overall Study||17||
48695998|NCT00372619|102038647|FG002|NOT COMPLETED|Overall Study||0||
48695999|NCT00372619|102038648|FG003|NOT COMPLETED|Overall Study||0||
48696000|NCT00372619|102038649|FG004|NOT COMPLETED|Overall Study||0||
48696001|NCT00372619|102038650|FG005|NOT COMPLETED|Overall Study||3||
48696002|NCT00372619|102038651|FG006|NOT COMPLETED|Overall Study||0||
48696003|NCT04818216|102038652|FG000|STARTED|Overall Study||13||
48112967|NCT00969553|100601610|FG004|STARTED|Overall Study||3||
48112968|NCT00969553|100601611|FG005|STARTED|Overall Study||4||
48276105|NCT04806373|100999761|FG000|STARTED|Overall Study||12||
48696004|NCT04818216|102038653|FG001|STARTED|Overall Study||15||
48696005|NCT04818216|102038652|FG000|COMPLETED|Overall Study||9||
48696006|NCT04818216|102038653|FG001|COMPLETED|Overall Study||13||
48696007|NCT04818216|102038652|FG000|NOT COMPLETED|Overall Study||4||
48696008|NCT04818216|102038653|FG001|NOT COMPLETED|Overall Study||2||
48112969|NCT00969553|100601612|FG006|STARTED|Overall Study||4||
48276106|NCT04806373|100999762|FG001|STARTED|Overall Study||15||
48276107|NCT04806373|100999761|FG000|COMPLETED|Overall Study||11||
48276108|NCT04806373|100999762|FG001|COMPLETED|Overall Study||14||
48276109|NCT04806373|100999761|FG000|NOT COMPLETED|Overall Study||1||
48276110|NCT04806373|100999762|FG001|NOT COMPLETED|Overall Study||1||
48696009|NCT00617084|102038654|FG000|STARTED|Overall Study||1140||
48696010|NCT00617084|102038655|FG001|STARTED|Overall Study||1152||
48276111|NCT02550938|100999763|FG000|STARTED|Overall Study||44||
48276112|NCT02550938|100999764|FG001|STARTED|Overall Study||85||
48276113|NCT02550938|100999765|FG002|STARTED|Overall Study||43||
48276114|NCT02550938|100999766|FG003|STARTED|Overall Study||81||
48276115|NCT02550938|100999763|FG000|COMPLETED|Overall Study||36||
48276116|NCT02550938|100999764|FG001|COMPLETED|Overall Study||78||
48276117|NCT02550938|100999765|FG002|COMPLETED|Overall Study||31||
48276118|NCT02550938|100999766|FG003|COMPLETED|Overall Study||70||
48276119|NCT02550938|100999763|FG000|NOT COMPLETED|Overall Study||8||
48276120|NCT02550938|100999764|FG001|NOT COMPLETED|Overall Study||7||
48276121|NCT02550938|100999765|FG002|NOT COMPLETED|Overall Study||12||
48276122|NCT02550938|100999766|FG003|NOT COMPLETED|Overall Study||11||
48276123|NCT03211234|100999767|FG000|STARTED|Overall Study||17||
48276124|NCT03211234|100999768|FG001|STARTED|Overall Study||31||
48276125|NCT03211234|100999769|FG002|STARTED|Overall Study||28||
48276126|NCT03211234|100999767|FG000|COMPLETED|Overall Study||16||
48276127|NCT03211234|100999768|FG001|COMPLETED|Overall Study||30||
48276128|NCT03211234|100999769|FG002|COMPLETED|Overall Study||25||
48276129|NCT03211234|100999767|FG000|NOT COMPLETED|Overall Study||1||
48276130|NCT03211234|100999768|FG001|NOT COMPLETED|Overall Study||1||
48276131|NCT03211234|100999769|FG002|NOT COMPLETED|Overall Study||3||
48276132|NCT02842151|100999770|FG000|STARTED|Overall Study||150|All subjects with attempted implantation (successful or aborted) (Safety Analysis Set)|
48276133|NCT02842151|100999770|FG000|COMPLETED|Overall Study||148||
48276134|NCT02842151|100999770|FG000|NOT COMPLETED|Overall Study||2||
48276135|NCT00964886|100999771|FG000|STARTED|Overall Study||38||
48276136|NCT00964886|100999772|FG001|STARTED|Overall Study||34||
48276137|NCT00964886|100999773|FG002|STARTED|Overall Study||37||
48276138|NCT00964886|100999774|FG003|STARTED|Overall Study||33||
48276139|NCT00964886|100999771|FG000|COMPLETED|Overall Study||27||
48276140|NCT00964886|100999772|FG001|COMPLETED|Overall Study||27||
48276141|NCT00964886|100999773|FG002|COMPLETED|Overall Study||21||
48276142|NCT00964886|100999774|FG003|COMPLETED|Overall Study||24||
48276143|NCT00964886|100999771|FG000|NOT COMPLETED|Overall Study||11||
48276144|NCT00964886|100999772|FG001|NOT COMPLETED|Overall Study||7||
48276145|NCT00964886|100999773|FG002|NOT COMPLETED|Overall Study||16||
48276146|NCT00964886|100999774|FG003|NOT COMPLETED|Overall Study||9||
48112970|NCT00969553|100601613|FG007|STARTED|Overall Study||16||
48112971|NCT00969553|100601614|FG008|STARTED|Overall Study||3||
48112972|NCT00969553|100601606|FG000|COMPLETED|Overall Study||0||
48112973|NCT00969553|100601607|FG001|COMPLETED|Overall Study||0||
48112974|NCT00969553|100601608|FG002|COMPLETED|Overall Study||0||
48112975|NCT00969553|100601609|FG003|COMPLETED|Overall Study||1||
48112976|NCT00969553|100601610|FG004|COMPLETED|Overall Study||0||
48112977|NCT00969553|100601611|FG005|COMPLETED|Overall Study||0||
48112978|NCT00969553|100601612|FG006|COMPLETED|Overall Study||0||
48112979|NCT00969553|100601613|FG007|COMPLETED|Overall Study||2||
48112980|NCT00969553|100601614|FG008|COMPLETED|Overall Study||0||
48112981|NCT00969553|100601606|FG000|NOT COMPLETED|Overall Study||3||
48112982|NCT00969553|100601607|FG001|NOT COMPLETED|Overall Study||3||
48112983|NCT00969553|100601608|FG002|NOT COMPLETED|Overall Study||6||
48112984|NCT00969553|100601609|FG003|NOT COMPLETED|Overall Study||16||
48112985|NCT00969553|100601610|FG004|NOT COMPLETED|Overall Study||3||
48112986|NCT00969553|100601611|FG005|NOT COMPLETED|Overall Study||4||
48112987|NCT00969553|100601612|FG006|NOT COMPLETED|Overall Study||4||
48276147|NCT04869358|100999775|FG000|STARTED|Overall Study||6||
48276148|NCT04869358|100999776|FG001|STARTED|Overall Study||8||
48276149|NCT04869358|100999777|FG002|STARTED|Overall Study||5||
48276150|NCT04869358|100999778|FG003|STARTED|Overall Study||15||
48276151|NCT04869358|100999775|FG000|COMPLETED|Overall Study||5||
48276152|NCT04869358|100999776|FG001|COMPLETED|Overall Study||8||
48276153|NCT04869358|100999777|FG002|COMPLETED|Overall Study||5||
48276154|NCT04869358|100999778|FG003|COMPLETED|Overall Study||15||
48276155|NCT04869358|100999775|FG000|NOT COMPLETED|Overall Study||1||
48276156|NCT04869358|100999776|FG001|NOT COMPLETED|Overall Study||0||
48276157|NCT04869358|100999777|FG002|NOT COMPLETED|Overall Study||0||
48276158|NCT04869358|100999778|FG003|NOT COMPLETED|Overall Study||0||
48276159|NCT04889209|100999779|FG000|STARTED|All Cohorts Except 15E||53||
48112988|NCT00969553|100601613|FG007|NOT COMPLETED|Overall Study||14||
48112989|NCT00969553|100601614|FG008|NOT COMPLETED|Overall Study||3||
48112990|NCT02129075|100601615|FG000|STARTED|Overall Study||30||
48112991|NCT02129075|100601616|FG001|STARTED|Overall Study||30||
48276160|NCT04889209|100999780|FG001|STARTED|All Cohorts Except 15E||51||
48276161|NCT04889209|100999781|FG002|STARTED|All Cohorts Except 15E||50||
48276162|NCT04889209|100999782|FG003|STARTED|All Cohorts Except 15E||50||
48276163|NCT04889209|100999783|FG004|STARTED|All Cohorts Except 15E||49||
48276164|NCT04889209|100999784|FG005|STARTED|All Cohorts Except 15E||51||
48276165|NCT04889209|100999785|FG006|STARTED|All Cohorts Except 15E||53||
48276166|NCT04889209|100999786|FG007|STARTED|All Cohorts Except 15E||51||
48276167|NCT04889209|100999787|FG008|STARTED|All Cohorts Except 15E||50||
48276168|NCT04889209|100999788|FG009|STARTED|All Cohorts Except 15E||43||
48276169|NCT04889209|100999789|FG010|STARTED|All Cohorts Except 15E||50||
48276170|NCT04889209|100999790|FG011|STARTED|All Cohorts Except 15E||47||
48276171|NCT04889209|100999791|FG012|STARTED|All Cohorts Except 15E||50||
48276172|NCT04889209|100999792|FG013|STARTED|All Cohorts Except 15E||46||
48276173|NCT04889209|100999793|FG014|STARTED|All Cohorts Except 15E||0||
48276174|NCT04889209|100999794|FG015|STARTED|All Cohorts Except 15E||16||
48696011|NCT00617084|102038654|FG000|COMPLETED|Overall Study||1119||
48696012|NCT00617084|102038655|FG001|COMPLETED|Overall Study||1126||
48696013|NCT00617084|102038654|FG000|NOT COMPLETED|Overall Study||21||
48696014|NCT00617084|102038655|FG001|NOT COMPLETED|Overall Study||26||
48696015|NCT02241733|102038656|FG000|STARTED|Overall Study||40||
48696016|NCT02241733|102038657|FG001|STARTED|Overall Study||40||
48276175|NCT04889209|100999795|FG016|STARTED|All Cohorts Except 15E||31||
48276176|NCT04889209|100999796|FG017|STARTED|All Cohorts Except 15E||106||
48276177|NCT04889209|100999779|FG000|COMPLETED|All Cohorts Except 15E||50||
48276178|NCT04889209|100999780|FG001|COMPLETED|All Cohorts Except 15E||47||
48276179|NCT04889209|100999781|FG002|COMPLETED|All Cohorts Except 15E||47||
48276180|NCT04889209|100999782|FG003|COMPLETED|All Cohorts Except 15E||31||
48276181|NCT04889209|100999783|FG004|COMPLETED|All Cohorts Except 15E||41||
48276182|NCT04889209|100999784|FG005|COMPLETED|All Cohorts Except 15E||46||
48276183|NCT04889209|100999785|FG006|COMPLETED|All Cohorts Except 15E||48||
48696017|NCT02241733|102038656|FG000|COMPLETED|Overall Study||25||
48696018|NCT02241733|102038657|FG001|COMPLETED|Overall Study||30||
48696019|NCT02241733|102038656|FG000|NOT COMPLETED|Overall Study||15||
48696020|NCT02241733|102038657|FG001|NOT COMPLETED|Overall Study||10||
48112992|NCT02129075|100601615|FG000|COMPLETED|Overall Study||30||
48112993|NCT02129075|100601616|FG001|COMPLETED|Overall Study||30||
48276184|NCT04889209|100999786|FG007|COMPLETED|All Cohorts Except 15E||46||
48276185|NCT04889209|100999787|FG008|COMPLETED|All Cohorts Except 15E||45||
48276186|NCT04889209|100999788|FG009|COMPLETED|All Cohorts Except 15E||35||
48276187|NCT04889209|100999789|FG010|COMPLETED|All Cohorts Except 15E||44||
48276188|NCT04889209|100999790|FG011|COMPLETED|All Cohorts Except 15E||39||
48276189|NCT04889209|100999791|FG012|COMPLETED|All Cohorts Except 15E||43||
48276190|NCT04889209|100999792|FG013|COMPLETED|All Cohorts Except 15E||44||
48276191|NCT04889209|100999793|FG014|COMPLETED|All Cohorts Except 15E||0||
48276192|NCT04889209|100999794|FG015|COMPLETED|All Cohorts Except 15E||10||
48276193|NCT04889209|100999795|FG016|COMPLETED|All Cohorts Except 15E||22||
48276194|NCT04889209|100999796|FG017|COMPLETED|All Cohorts Except 15E||56||
48276195|NCT04889209|100999779|FG000|NOT COMPLETED|All Cohorts Except 15E||3||
48276196|NCT04889209|100999780|FG001|NOT COMPLETED|All Cohorts Except 15E||4||
48276197|NCT04889209|100999781|FG002|NOT COMPLETED|All Cohorts Except 15E||3||
48276198|NCT04889209|100999782|FG003|NOT COMPLETED|All Cohorts Except 15E||19||
48276199|NCT04889209|100999783|FG004|NOT COMPLETED|All Cohorts Except 15E||8||
48276200|NCT04889209|100999784|FG005|NOT COMPLETED|All Cohorts Except 15E||5||
48276201|NCT04889209|100999785|FG006|NOT COMPLETED|All Cohorts Except 15E||5||
48276202|NCT04889209|100999786|FG007|NOT COMPLETED|All Cohorts Except 15E||5||
48276203|NCT04889209|100999787|FG008|NOT COMPLETED|All Cohorts Except 15E||5||
48276204|NCT04889209|100999788|FG009|NOT COMPLETED|All Cohorts Except 15E||8||
48276205|NCT04889209|100999789|FG010|NOT COMPLETED|All Cohorts Except 15E||6||
48276206|NCT04889209|100999790|FG011|NOT COMPLETED|All Cohorts Except 15E||8||
48276207|NCT04889209|100999791|FG012|NOT COMPLETED|All Cohorts Except 15E||7||
48276208|NCT04889209|100999792|FG013|NOT COMPLETED|All Cohorts Except 15E||2||
48276209|NCT04889209|100999793|FG014|NOT COMPLETED|All Cohorts Except 15E||0||
48276210|NCT04889209|100999794|FG015|NOT COMPLETED|All Cohorts Except 15E||6||
48276211|NCT04889209|100999795|FG016|NOT COMPLETED|All Cohorts Except 15E||9||
48276212|NCT04889209|100999796|FG017|NOT COMPLETED|All Cohorts Except 15E||50||
48276213|NCT04889209|100999779|FG000|STARTED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276214|NCT04889209|100999780|FG001|STARTED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276215|NCT04889209|100999781|FG002|STARTED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276216|NCT04889209|100999782|FG003|STARTED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276217|NCT04889209|100999783|FG004|STARTED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48696021|NCT02817776|102038658|FG000|STARTED|Overall Study||381||
48276218|NCT04889209|100999784|FG005|STARTED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48696022|NCT02817776|102038658|FG000|COMPLETED|Overall Study||293||
48696023|NCT02817776|102038658|FG000|NOT COMPLETED|Overall Study||88||
48696024|NCT01685242|102038659|FG000|STARTED|Overall Study||50||
48696025|NCT01685242|102038660|FG001|STARTED|Overall Study||50||
48696026|NCT01685242|102038659|FG000|COMPLETED|Overall Study||49||
48696027|NCT01685242|102038660|FG001|COMPLETED|Overall Study||47||
48696028|NCT01685242|102038659|FG000|NOT COMPLETED|Overall Study||1||
48696029|NCT01685242|102038660|FG001|NOT COMPLETED|Overall Study||3||
48696030|NCT04952597|102041657|FG000|STARTED|Overall Study||41||
48696031|NCT04952597|102041658|FG001|STARTED|Overall Study||42||
48276219|NCT04889209|100999785|FG006|STARTED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276220|NCT04889209|100999786|FG007|STARTED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276221|NCT04889209|100999787|FG008|STARTED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276222|NCT04889209|100999788|FG009|STARTED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276223|NCT04889209|100999789|FG010|STARTED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276224|NCT04889209|100999790|FG011|STARTED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276225|NCT04889209|100999791|FG012|STARTED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276226|NCT04889209|100999792|FG013|STARTED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276227|NCT04889209|100999793|FG014|STARTED|Direct Enroll, Rollover to Co 1 Gr 15E||20||
48276228|NCT04889209|100999794|FG015|STARTED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276229|NCT04889209|100999795|FG016|STARTED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276230|NCT04889209|100999796|FG017|STARTED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276231|NCT04889209|100999779|FG000|COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276232|NCT04889209|100999780|FG001|COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276233|NCT04889209|100999781|FG002|COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276234|NCT04889209|100999782|FG003|COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276235|NCT04889209|100999783|FG004|COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276236|NCT04889209|100999784|FG005|COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276237|NCT04889209|100999785|FG006|COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276238|NCT04889209|100999786|FG007|COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276239|NCT04889209|100999787|FG008|COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276240|NCT04889209|100999788|FG009|COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276241|NCT04889209|100999789|FG010|COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276242|NCT04889209|100999790|FG011|COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276243|NCT04889209|100999791|FG012|COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276244|NCT04889209|100999792|FG013|COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276245|NCT04889209|100999793|FG014|COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||18||
48276246|NCT04889209|100999794|FG015|COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276247|NCT04889209|100999795|FG016|COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276248|NCT04889209|100999796|FG017|COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276249|NCT04889209|100999779|FG000|NOT COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48562057|NCT00972374|101706135|FG001|COMPLETED|Overall Study||15||
48562058|NCT00972374|101706136|FG002|COMPLETED|Overall Study||13||
48562059|NCT00972374|101706134|FG000|NOT COMPLETED|Overall Study||2||
48562060|NCT00972374|101706135|FG001|NOT COMPLETED|Overall Study||0||
48696032|NCT04952597|102041659|FG002|STARTED|Overall Study||43||
48112994|NCT02129075|100601615|FG000|NOT COMPLETED|Overall Study||0||
48112995|NCT02129075|100601616|FG001|NOT COMPLETED|Overall Study||0||
48112996|NCT00816101|100601617|FG000|STARTED|Overall Study||13||
48112997|NCT00816101|100601618|FG001|STARTED|Overall Study||8||
48112998|NCT00816101|100601619|FG002|STARTED|Overall Study||5||
48112999|NCT00816101|100601617|FG000|COMPLETED|Overall Study||13||
48113000|NCT00816101|100601618|FG001|COMPLETED|Overall Study||8||
48113001|NCT00816101|100601619|FG002|COMPLETED|Overall Study||5||
48113002|NCT00816101|100601617|FG000|NOT COMPLETED|Overall Study||0||
48113003|NCT00816101|100601618|FG001|NOT COMPLETED|Overall Study||0||
48113004|NCT00816101|100601619|FG002|NOT COMPLETED|Overall Study||0||
48113005|NCT03254134|100601620|FG000|STARTED|Overall Study||5745||
48113006|NCT03254134|100601621|FG001|STARTED|Overall Study||16745||
48113007|NCT03254134|100601620|FG000|COMPLETED|Overall Study||5146||
48113008|NCT03254134|100601621|FG001|COMPLETED|Overall Study||13115||
48113009|NCT03254134|100601620|FG000|NOT COMPLETED|Overall Study||599||
48113010|NCT03254134|100601621|FG001|NOT COMPLETED|Overall Study||3630||
48113011|NCT03078946|100601622|FG000|STARTED|Overall Study||30||
48113012|NCT03078946|100601623|FG001|STARTED|Overall Study||30||
48113013|NCT03078946|100601622|FG000|COMPLETED|Overall Study||30||
48113014|NCT03078946|100601623|FG001|COMPLETED|Overall Study||30||
48113015|NCT03078946|100601622|FG000|NOT COMPLETED|Overall Study||0||
48113016|NCT03078946|100601623|FG001|NOT COMPLETED|Overall Study||0||
48113017|NCT00358527|100601624|FG000|STARTED|Overall Study||267||
48113018|NCT00358527|100601625|FG001|STARTED|Overall Study||134||
48113019|NCT00358527|100601624|FG000|COMPLETED|Overall Study||254||
48113020|NCT00358527|100601625|FG001|COMPLETED|Overall Study||131||
48113021|NCT00358527|100601624|FG000|NOT COMPLETED|Overall Study||13||
48113022|NCT00358527|100601625|FG001|NOT COMPLETED|Overall Study||3||
48113023|NCT03765736|100601626|FG000|STARTED|Overall Study||197||
48113024|NCT03765736|100601626|FG000|COMPLETED|Overall Study||197||
48113025|NCT03765736|100601626|FG000|NOT COMPLETED|Overall Study||0||
48113026|NCT00964392|100601627|FG000|STARTED|Overall Study||125||
48113027|NCT00964392|100601628|FG001|STARTED|Overall Study||282||
48113028|NCT00964392|100601627|FG000|COMPLETED|Overall Study||72||
48113029|NCT00964392|100601628|FG001|COMPLETED|Overall Study||92||
48113030|NCT00964392|100601627|FG000|NOT COMPLETED|Overall Study||53||
48113031|NCT00964392|100601628|FG001|NOT COMPLETED|Overall Study||190||
48113032|NCT02674412|100601629|FG000|STARTED|Overall Study||5||
48113033|NCT02674412|100601630|FG001|STARTED|Overall Study||5||
48113034|NCT02674412|100601629|FG000|COMPLETED|Overall Study||5||
48113035|NCT02674412|100601630|FG001|COMPLETED|Overall Study||5||
48113036|NCT02674412|100601629|FG000|NOT COMPLETED|Overall Study||0||
48113037|NCT02674412|100601630|FG001|NOT COMPLETED|Overall Study||0||
48113038|NCT00748956|100601631|FG000|STARTED|Overall Study||0||
48113039|NCT00748956|100601632|FG001|STARTED|Overall Study||5||
48113040|NCT00748956|100601633|FG002|STARTED|Overall Study||5||
48113041|NCT00748956|100601631|FG000|COMPLETED|Overall Study||0||
48113042|NCT00748956|100601632|FG001|COMPLETED|Overall Study||5||
48113043|NCT00748956|100601633|FG002|COMPLETED|Overall Study||5||
48113044|NCT00748956|100601631|FG000|NOT COMPLETED|Overall Study||0||
48113045|NCT00748956|100601632|FG001|NOT COMPLETED|Overall Study||0||
48113046|NCT00748956|100601633|FG002|NOT COMPLETED|Overall Study||0||
48113047|NCT01077960|100601634|FG000|STARTED|Overall Study||126||
48113048|NCT01077960|100601634|FG000|COMPLETED|Overall Study||110||
48562061|NCT00972374|101706136|FG002|NOT COMPLETED|Overall Study||1||
48562062|NCT03918629|101706137|FG000|STARTED|Overall Study||996||
48562063|NCT03918629|101706138|FG001|STARTED|Overall Study||998||
48562064|NCT03918629|101706137|FG000|Vaccinated With Dose 1|Overall Study||994||
48562065|NCT03918629|101706138|FG001|Vaccinated With Dose 1|Overall Study||997||
48113049|NCT01077960|100601634|FG000|NOT COMPLETED|Overall Study||16||
48113050|NCT01239368|100601635|FG000|STARTED|Overall Study||2||
48113051|NCT01239368|100601636|FG001|STARTED|Overall Study||1||
48113052|NCT01239368|100601637|FG002|STARTED|Overall Study||1||
48113053|NCT01239368|100601638|FG003|STARTED|Overall Study||2||
48113054|NCT01239368|100601639|FG004|STARTED|Overall Study||7||
48113055|NCT01239368|100601640|FG005|STARTED|Overall Study||5||
48113056|NCT01239368|100601641|FG006|STARTED|Overall Study||7||
48113057|NCT01239368|100601642|FG007|STARTED|Overall Study||0||
48113058|NCT01239368|100601643|FG008|STARTED|Overall Study||1||
48113059|NCT01239368|100601644|FG009|STARTED|Overall Study||5||
48113060|NCT01239368|100601635|FG000|COMPLETED|Overall Study||0||
48113061|NCT01239368|100601636|FG001|COMPLETED|Overall Study||0||
48113062|NCT01239368|100601637|FG002|COMPLETED|Overall Study||0||
48562066|NCT03918629|101706137|FG000|Vaccinated With Dose 2|Overall Study||961||
48113063|NCT01239368|100601638|FG003|COMPLETED|Overall Study||1||
48113064|NCT01239368|100601639|FG004|COMPLETED|Overall Study||2||
48113065|NCT01239368|100601640|FG005|COMPLETED|Overall Study||1||
48113066|NCT01239368|100601641|FG006|COMPLETED|Overall Study||1||
48696033|NCT04952597|102041657|FG000|COMPLETED|Overall Study||28||
48113067|NCT01239368|100601642|FG007|COMPLETED|Overall Study||0||
48696034|NCT04952597|102041658|FG001|COMPLETED|Overall Study||28||
48696035|NCT04952597|102041659|FG002|COMPLETED|Overall Study||25||
48696036|NCT04952597|102041657|FG000|NOT COMPLETED|Overall Study||13||
48696037|NCT04952597|102041658|FG001|NOT COMPLETED|Overall Study||14||
48113068|NCT01239368|100601643|FG008|COMPLETED|Overall Study||1||
48113069|NCT01239368|100601644|FG009|COMPLETED|Overall Study||1||
48113070|NCT01239368|100601635|FG000|NOT COMPLETED|Overall Study||2||
48113071|NCT01239368|100601636|FG001|NOT COMPLETED|Overall Study||1||
48393554|NCT01946412|101291592|FG000|STARTED|Overall Study||33||
48393555|NCT01946412|101291592|FG000|COMPLETED|Overall Study||28||
48393556|NCT01946412|101291592|FG000|NOT COMPLETED|Overall Study||5||
48393557|NCT02670915|101291593|FG000|STARTED|Overall Study||260||
48393558|NCT02670915|101291594|FG001|STARTED|Overall Study||259||
48393559|NCT02670915|101291595|FG002|STARTED|Overall Study||258||
48393560|NCT02670915|101291593|FG000|COMPLETED|Overall Study||256||
48393561|NCT02670915|101291594|FG001|COMPLETED|Overall Study||251||
48393562|NCT02670915|101291595|FG002|COMPLETED|Overall Study||253||
48393563|NCT02670915|101291593|FG000|NOT COMPLETED|Overall Study||4||
48393564|NCT02670915|101291594|FG001|NOT COMPLETED|Overall Study||8||
48696038|NCT04952597|102041659|FG002|NOT COMPLETED|Overall Study||18||
48696039|NCT00810277|102041660|FG000|STARTED|Overall Study||14||
48393565|NCT02670915|101291595|FG002|NOT COMPLETED|Overall Study||5||
48393566|NCT00605696|101291596|FG000|STARTED|Overall Study||7||
48393567|NCT00605696|101291597|FG001|STARTED|Overall Study||11||
48393568|NCT00605696|101291596|FG000|COMPLETED|Overall Study||7||
48562067|NCT03918629|101706138|FG001|Vaccinated With Dose 2|Overall Study||964||
48562068|NCT03918629|101706137|FG000|Vaccinated With Dose 3|Overall Study||897||
48562069|NCT03918629|101706138|FG001|Vaccinated With Dose 3|Overall Study||917||
48562070|NCT03918629|101706137|FG000|COMPLETED|Overall Study||863||
48562071|NCT03918629|101706138|FG001|COMPLETED|Overall Study||880||
48562072|NCT03918629|101706137|FG000|NOT COMPLETED|Overall Study||133||
48562073|NCT03918629|101706138|FG001|NOT COMPLETED|Overall Study||118||
48562074|NCT02077140|101706139|FG000|STARTED|Overall Study||36||
48562075|NCT02077140|101706140|FG001|STARTED|Overall Study||36||
48562076|NCT02077140|101706141|FG002|STARTED|Overall Study||36||
48562077|NCT02077140|101706142|FG003|STARTED|Overall Study||36||
48562078|NCT02077140|101706143|FG004|STARTED|Overall Study||48||
48562079|NCT02077140|101706139|FG000|COMPLETED|Overall Study||32||
48562080|NCT02077140|101706140|FG001|COMPLETED|Overall Study||34||
48562081|NCT02077140|101706141|FG002|COMPLETED|Overall Study||34||
48562082|NCT02077140|101706142|FG003|COMPLETED|Overall Study||32||
48562083|NCT02077140|101706143|FG004|COMPLETED|Overall Study||43||
48562084|NCT02077140|101706139|FG000|NOT COMPLETED|Overall Study||4||
48562085|NCT02077140|101706140|FG001|NOT COMPLETED|Overall Study||2||
48562086|NCT02077140|101706141|FG002|NOT COMPLETED|Overall Study||2||
48562087|NCT02077140|101706142|FG003|NOT COMPLETED|Overall Study||4||
48562088|NCT02077140|101706143|FG004|NOT COMPLETED|Overall Study||5||
48562089|NCT01323517|101706144|FG000|STARTED|Overall Study||26||
48562090|NCT01323517|101706144|FG000|COMPLETED|Overall Study||26||
48696040|NCT00810277|102041660|FG000|COMPLETED|Overall Study||13||
48696041|NCT00810277|102041660|FG000|NOT COMPLETED|Overall Study||1||
48696042|NCT00368745|102041661|FG000|STARTED|Randomized to Double-blind Treatment||57||
48696043|NCT00368745|102041662|FG001|STARTED|Randomized to Double-blind Treatment||51||
48696044|NCT00368745|102041661|FG000|COMPLETED|Randomized to Double-blind Treatment||56||
48113072|NCT01239368|100601637|FG002|NOT COMPLETED|Overall Study||1||
48393569|NCT00605696|101291597|FG001|COMPLETED|Overall Study||11||
48393570|NCT00605696|101291596|FG000|NOT COMPLETED|Overall Study||0||
48393571|NCT00605696|101291597|FG001|NOT COMPLETED|Overall Study||0||
48393572|NCT02540772|101291598|FG000|STARTED|Overall Study||10||
48393573|NCT02540772|101291599|FG001|STARTED|Overall Study||10||
48393574|NCT02540772|101291598|FG000|COMPLETED|Overall Study||10||
48696045|NCT00368745|102041662|FG001|COMPLETED|Randomized to Double-blind Treatment||50||
48696046|NCT00368745|102041661|FG000|NOT COMPLETED|Randomized to Double-blind Treatment||1||
48696047|NCT00368745|102041662|FG001|NOT COMPLETED|Randomized to Double-blind Treatment||1||
48696048|NCT00368745|102041661|FG000|STARTED|Double-blind Treatment Period||56||
48696049|NCT00368745|102041662|FG001|STARTED|Double-blind Treatment Period||50||
48113073|NCT01239368|100601638|FG003|NOT COMPLETED|Overall Study||1||
48113074|NCT01239368|100601639|FG004|NOT COMPLETED|Overall Study||5||
48113075|NCT01239368|100601640|FG005|NOT COMPLETED|Overall Study||4||
48113076|NCT01239368|100601641|FG006|NOT COMPLETED|Overall Study||6||
48113077|NCT01239368|100601642|FG007|NOT COMPLETED|Overall Study||0||
48113078|NCT01239368|100601643|FG008|NOT COMPLETED|Overall Study||0||
48113079|NCT01239368|100601644|FG009|NOT COMPLETED|Overall Study||4||
48113080|NCT00989833|100601645|FG000|STARTED|Overall Study||21||
48393575|NCT02540772|101291599|FG001|COMPLETED|Overall Study||10||
48393576|NCT02540772|101291598|FG000|NOT COMPLETED|Overall Study||0||
48393577|NCT02540772|101291599|FG001|NOT COMPLETED|Overall Study||0||
48562091|NCT01323517|101706144|FG000|NOT COMPLETED|Overall Study||0||
48562092|NCT00666328|101706145|FG000|STARTED|Overall Study||35||
48562093|NCT00666328|101706145|FG000|Modified Intent To Treat (mITT)|Overall Study||33||
48696050|NCT00368745|102041661|FG000|COMPLETED|Double-blind Treatment Period||30||
48562094|NCT00666328|101706145|FG000|COMPLETED|Overall Study||30||
48562095|NCT00666328|101706145|FG000|NOT COMPLETED|Overall Study||5||
48562096|NCT01400477|101706146|FG000|STARTED|Overall Study||40||
48276250|NCT04889209|100999780|FG001|NOT COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276251|NCT04889209|100999781|FG002|NOT COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276252|NCT04889209|100999782|FG003|NOT COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276253|NCT04889209|100999783|FG004|NOT COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48562097|NCT01400477|101706147|FG001|STARTED|Overall Study||40||
48562098|NCT01400477|101706146|FG000|COMPLETED|Overall Study||38||
48562099|NCT01400477|101706147|FG001|COMPLETED|Overall Study||40||
48562100|NCT01400477|101706146|FG000|NOT COMPLETED|Overall Study||2||
48562101|NCT01400477|101706147|FG001|NOT COMPLETED|Overall Study||0||
48562102|NCT04933383|101706148|FG000|STARTED|Overall Study||11||
48562103|NCT04933383|101706149|FG001|STARTED|Overall Study||12||
48562104|NCT04933383|101706148|FG000|COMPLETED|Overall Study||11||
48562105|NCT04933383|101706149|FG001|COMPLETED|Overall Study||12||
48562106|NCT04933383|101706148|FG000|NOT COMPLETED|Overall Study||0||
48562107|NCT04933383|101706149|FG001|NOT COMPLETED|Overall Study||0||
48562108|NCT06160609|101706150|FG000|STARTED|Overall Study||6||
48562109|NCT06160609|101706151|FG001|STARTED|Overall Study||3||
48562110|NCT06160609|101706150|FG000|COMPLETED|Overall Study||6|Participants who completed follow-up or who died were considered to have completed the study.|
48696051|NCT00368745|102041662|FG001|COMPLETED|Double-blind Treatment Period||19||
48696052|NCT00368745|102041661|FG000|NOT COMPLETED|Double-blind Treatment Period||26||
48696053|NCT00368745|102041662|FG001|NOT COMPLETED|Double-blind Treatment Period||31||
48696054|NCT01961297|102041663|FG000|STARTED|Overall Study||30||
48696055|NCT01961297|102041664|FG001|STARTED|Overall Study||23||
48696056|NCT01961297|102041663|FG000|COMPLETED|Overall Study||28||
48696057|NCT01961297|102041664|FG001|COMPLETED|Overall Study||22||
48696058|NCT01961297|102041663|FG000|NOT COMPLETED|Overall Study||2||
48696059|NCT01961297|102041664|FG001|NOT COMPLETED|Overall Study||1||
48696060|NCT01262638|102041665|FG000|STARTED|Overall Study||45||
48696061|NCT01262638|102041666|FG001|STARTED|Overall Study||44||
48696062|NCT01262638|102041667|FG002|STARTED|Overall Study||44||
48696063|NCT01262638|102041668|FG003|STARTED|Overall Study||44||
48696064|NCT01262638|102041665|FG000|COMPLETED|Overall Study||38||
48696065|NCT01262638|102041666|FG001|COMPLETED|Overall Study||38||
48696066|NCT01262638|102041667|FG002|COMPLETED|Overall Study||38||
48696067|NCT01262638|102041668|FG003|COMPLETED|Overall Study||37||
48696068|NCT01262638|102041665|FG000|NOT COMPLETED|Overall Study||7||
48696069|NCT01262638|102041666|FG001|NOT COMPLETED|Overall Study||6||
48696070|NCT01262638|102041667|FG002|NOT COMPLETED|Overall Study||6||
48696071|NCT01262638|102041668|FG003|NOT COMPLETED|Overall Study||7||
48696072|NCT00158249|102041669|FG000|STARTED|Overall Study||11||
48696073|NCT00158249|102041670|FG001|STARTED|Overall Study||10||
48696074|NCT00158249|102041669|FG000|COMPLETED|Overall Study||9||
48696075|NCT00158249|102041670|FG001|COMPLETED|Overall Study||10||
48696076|NCT00158249|102041669|FG000|NOT COMPLETED|Overall Study||2||
48696077|NCT00158249|102041670|FG001|NOT COMPLETED|Overall Study||0||
48696078|NCT01814046|102041671|FG000|STARTED|Drug Administration||22||
48696079|NCT01814046|102041672|FG001|STARTED|Drug Administration||2||
48696080|NCT01814046|102041673|FG002|STARTED|Drug Administration||0||
48276254|NCT04889209|100999784|FG005|NOT COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48562111|NCT06160609|101706151|FG001|COMPLETED|Overall Study||3|Participants who completed follow-up or who died were considered to have completed the study.|
48562112|NCT06160609|101706150|FG000|NOT COMPLETED|Overall Study||0||
48562113|NCT06160609|101706151|FG001|NOT COMPLETED|Overall Study||0||
48696081|NCT01814046|102041671|FG000|COMPLETED|Drug Administration||21||
48696082|NCT01814046|102041672|FG001|COMPLETED|Drug Administration||2||
48696083|NCT01814046|102041673|FG002|COMPLETED|Drug Administration||0||
48696084|NCT01814046|102041671|FG000|NOT COMPLETED|Drug Administration||1||
48696085|NCT01814046|102041672|FG001|NOT COMPLETED|Drug Administration||0||
48696086|NCT01814046|102041673|FG002|NOT COMPLETED|Drug Administration||0||
48696087|NCT01814046|102041671|FG000|STARTED|Retreatment||0||
48696088|NCT01814046|102041672|FG001|STARTED|Retreatment||0||
48696089|NCT01814046|102041673|FG002|STARTED|Retreatment||3||
48696090|NCT01814046|102041671|FG000|COMPLETED|Retreatment||0||
48696091|NCT01814046|102041672|FG001|COMPLETED|Retreatment||0||
48696092|NCT01814046|102041673|FG002|COMPLETED|Retreatment||3||
48696093|NCT01814046|102041671|FG000|NOT COMPLETED|Retreatment||0||
48696094|NCT01814046|102041672|FG001|NOT COMPLETED|Retreatment||0||
48696095|NCT01814046|102041673|FG002|NOT COMPLETED|Retreatment||0||
48696096|NCT03206970|102041674|FG000|STARTED|Overall Study||86||
48696097|NCT03206970|102041674|FG000|Received at Least 1 Dose of Study Drug|Overall Study||86|Safety Analysis Set|
48562114|NCT03642262|101709882|FG000|STARTED|Period 1||12||
48562115|NCT03642262|101709883|FG001|STARTED|Period 1||18||
48562116|NCT03642262|101709882|FG000|COMPLETED|Period 1||11||
48562117|NCT03642262|101709883|FG001|COMPLETED|Period 1||16||
48562118|NCT03642262|101709882|FG000|NOT COMPLETED|Period 1||1||
48562119|NCT03642262|101709883|FG001|NOT COMPLETED|Period 1||2||
48696098|NCT03206970|102041674|FG000|COMPLETED|Overall Study||0||
48562120|NCT03642262|101709882|FG000|STARTED|Washout: 7 Days||11||
48696099|NCT03206970|102041674|FG000|NOT COMPLETED|Overall Study||86||
48562121|NCT03642262|101709883|FG001|STARTED|Washout: 7 Days||16||
48562122|NCT03642262|101709882|FG000|COMPLETED|Washout: 7 Days||11||
48562123|NCT03642262|101709883|FG001|COMPLETED|Washout: 7 Days||16||
48696100|NCT00759876|102041675|FG000|STARTED|Overall Study||36||
48696101|NCT00759876|102041675|FG000|As-Treated Population|Overall Study||36|All participants who received at least 1 dose of study drug in this study.|
48696102|NCT00759876|102041675|FG000|Evaluable Population|Overall Study||35|Participants in the As-Treated Population with Baseline and on-treatment data in this study.|
48696103|NCT00759876|102041675|FG000|Ambulatory Evaluable Population|Overall Study||24|Participants with the ability to walk ≥75 meters unassisted at screening.|
48276255|NCT04889209|100999785|FG006|NOT COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276256|NCT04889209|100999786|FG007|NOT COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276257|NCT04889209|100999787|FG008|NOT COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276258|NCT04889209|100999788|FG009|NOT COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276259|NCT04889209|100999789|FG010|NOT COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276260|NCT04889209|100999790|FG011|NOT COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48562124|NCT03642262|101709882|FG000|NOT COMPLETED|Washout: 7 Days||0||
48562125|NCT03642262|101709883|FG001|NOT COMPLETED|Washout: 7 Days||0||
48562126|NCT03642262|101709882|FG000|STARTED|Period 2||11||
48562127|NCT03642262|101709883|FG001|STARTED|Period 2||16||
48562128|NCT03642262|101709882|FG000|COMPLETED|Period 2||11||
48562129|NCT03642262|101709883|FG001|COMPLETED|Period 2||16||
48562130|NCT03642262|101709882|FG000|NOT COMPLETED|Period 2||0||
48562131|NCT03642262|101709883|FG001|NOT COMPLETED|Period 2||0||
48562132|NCT01385137|101709884|FG000|STARTED|Evaluable at Baseline||131|9 patients on arm 1 and 4 patients on arm 2 found ineligible after registration|
48562133|NCT01385137|101709885|FG001|STARTED|Evaluable at Baseline||131|9 patients on arm 1 and 4 patients on arm 2 found ineligible after registration|
48562134|NCT01385137|101709884|FG000|COMPLETED|Evaluable at Baseline||122||
48562135|NCT01385137|101709885|FG001|COMPLETED|Evaluable at Baseline||127||
48562136|NCT01385137|101709884|FG000|NOT COMPLETED|Evaluable at Baseline||9||
48562137|NCT01385137|101709885|FG001|NOT COMPLETED|Evaluable at Baseline||4||
48562138|NCT01385137|101709884|FG000|STARTED|Evaluable for Primary Endpoint||131||
48562139|NCT01385137|101709885|FG001|STARTED|Evaluable for Primary Endpoint||131||
48562140|NCT01385137|101709884|FG000|COMPLETED|Evaluable for Primary Endpoint||102||
48562141|NCT01385137|101709885|FG001|COMPLETED|Evaluable for Primary Endpoint||107||
48562142|NCT01385137|101709884|FG000|NOT COMPLETED|Evaluable for Primary Endpoint||29||
48562143|NCT01385137|101709885|FG001|NOT COMPLETED|Evaluable for Primary Endpoint||24||
48562144|NCT03345771|101709886|FG000|STARTED|Overall Study||115||
48562145|NCT03345771|101709887|FG001|STARTED|Overall Study||115||
48562146|NCT03345771|101709886|FG000|COMPLETED|Overall Study||115||
48562147|NCT03345771|101709887|FG001|COMPLETED|Overall Study||115||
48562148|NCT03345771|101709886|FG000|NOT COMPLETED|Overall Study||0||
48562149|NCT03345771|101709887|FG001|NOT COMPLETED|Overall Study||0||
48562150|NCT01983566|101709888|FG000|STARTED|Test Period 1||4||
48562151|NCT01983566|101709889|FG001|STARTED|Test Period 1||4||
48562152|NCT01983566|101709890|FG002|STARTED|Test Period 1||4||
48562153|NCT01983566|101709891|FG003|STARTED|Test Period 1||4||
48696104|NCT00759876|102041675|FG000|COMPLETED|Overall Study||0||
48696105|NCT00759876|102041675|FG000|NOT COMPLETED|Overall Study||36||
48276261|NCT04889209|100999791|FG012|NOT COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276262|NCT04889209|100999792|FG013|NOT COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276263|NCT04889209|100999793|FG014|NOT COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||2||
48696106|NCT01932372|102041676|FG000|STARTED|Overall Study||7054|Number of participants for whom CRFs were collected|
48276264|NCT04889209|100999794|FG015|NOT COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276265|NCT04889209|100999795|FG016|NOT COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276266|NCT04889209|100999796|FG017|NOT COMPLETED|Direct Enroll, Rollover to Co 1 Gr 15E||0||
48276267|NCT03139604|100999797|FG000|STARTED|Overall Study||219||
48276268|NCT03139604|100999798|FG001|STARTED|Overall Study||220||
48276269|NCT03139604|100999797|FG000|COMPLETED|Overall Study||0||
48276270|NCT03139604|100999798|FG001|COMPLETED|Overall Study||0||
48276271|NCT03139604|100999797|FG000|NOT COMPLETED|Overall Study||219||
48276272|NCT03139604|100999798|FG001|NOT COMPLETED|Overall Study||220||
48276273|NCT03816761|100999799|FG000|STARTED|First Treatment Period (7 Days)||4||
48562154|NCT01983566|101709888|FG000|COMPLETED|Test Period 1||4||
48562155|NCT01983566|101709889|FG001|COMPLETED|Test Period 1||4||
48276274|NCT03816761|100999800|FG001|STARTED|First Treatment Period (7 Days)||4||
48276275|NCT03816761|100999801|FG002|STARTED|First Treatment Period (7 Days)||4||
48276276|NCT03816761|100999802|FG003|STARTED|First Treatment Period (7 Days)||4||
48276277|NCT03816761|100999803|FG004|STARTED|First Treatment Period (7 Days)||4||
48276278|NCT03816761|100999804|FG005|STARTED|First Treatment Period (7 Days)||4||
48276279|NCT03816761|100999799|FG000|COMPLETED|First Treatment Period (7 Days)||4||
48276280|NCT03816761|100999800|FG001|COMPLETED|First Treatment Period (7 Days)||4||
48276281|NCT03816761|100999801|FG002|COMPLETED|First Treatment Period (7 Days)||4||
48562156|NCT01983566|101709890|FG002|COMPLETED|Test Period 1||4||
48276282|NCT03816761|100999802|FG003|COMPLETED|First Treatment Period (7 Days)||4||
48276283|NCT03816761|100999803|FG004|COMPLETED|First Treatment Period (7 Days)||4||
48562157|NCT01983566|101709891|FG003|COMPLETED|Test Period 1||4||
48562158|NCT01983566|101709888|FG000|NOT COMPLETED|Test Period 1||0||
48276284|NCT03816761|100999804|FG005|COMPLETED|First Treatment Period (7 Days)||3||
48276285|NCT03816761|100999799|FG000|NOT COMPLETED|First Treatment Period (7 Days)||0||
48276286|NCT03816761|100999800|FG001|NOT COMPLETED|First Treatment Period (7 Days)||0||
48276287|NCT03816761|100999801|FG002|NOT COMPLETED|First Treatment Period (7 Days)||0||
48562159|NCT01983566|101709889|FG001|NOT COMPLETED|Test Period 1||0||
48562160|NCT01983566|101709890|FG002|NOT COMPLETED|Test Period 1||0||
48562161|NCT01983566|101709891|FG003|NOT COMPLETED|Test Period 1||0||
48276288|NCT03816761|100999802|FG003|NOT COMPLETED|First Treatment Period (7 Days)||0||
48276289|NCT03816761|100999803|FG004|NOT COMPLETED|First Treatment Period (7 Days)||0||
48276290|NCT03816761|100999804|FG005|NOT COMPLETED|First Treatment Period (7 Days)||1||
48276291|NCT03816761|100999799|FG000|STARTED|Second Treatment Period (7 Days)||4||
48276292|NCT03816761|100999800|FG001|STARTED|Second Treatment Period (7 Days)||4||
48276293|NCT03816761|100999801|FG002|STARTED|Second Treatment Period (7 Days)||4||
48276294|NCT03816761|100999802|FG003|STARTED|Second Treatment Period (7 Days)||4||
48562162|NCT01983566|101709888|FG000|STARTED|Wash-Out 1||4||
48562163|NCT01983566|101709889|FG001|STARTED|Wash-Out 1||4||
48562164|NCT01983566|101709890|FG002|STARTED|Wash-Out 1||4||
48562165|NCT01983566|101709891|FG003|STARTED|Wash-Out 1||4||
48562166|NCT01983566|101709888|FG000|COMPLETED|Wash-Out 1||4||
48562167|NCT01983566|101709889|FG001|COMPLETED|Wash-Out 1||4||
48562168|NCT01983566|101709890|FG002|COMPLETED|Wash-Out 1||4||
48562169|NCT01983566|101709891|FG003|COMPLETED|Wash-Out 1||4||
48562170|NCT01983566|101709888|FG000|NOT COMPLETED|Wash-Out 1||0||
48276295|NCT03816761|100999803|FG004|STARTED|Second Treatment Period (7 Days)||4||
48276296|NCT03816761|100999804|FG005|STARTED|Second Treatment Period (7 Days)||3||
48276297|NCT03816761|100999799|FG000|COMPLETED|Second Treatment Period (7 Days)||4||
48562171|NCT01983566|101709889|FG001|NOT COMPLETED|Wash-Out 1||0||
48562172|NCT01983566|101709890|FG002|NOT COMPLETED|Wash-Out 1||0||
48562173|NCT01983566|101709891|FG003|NOT COMPLETED|Wash-Out 1||0||
48562174|NCT01983566|101709888|FG000|STARTED|Test Period 2||4||
48562175|NCT01983566|101709889|FG001|STARTED|Test Period 2||4||
48562176|NCT01983566|101709890|FG002|STARTED|Test Period 2||4||
48562177|NCT01983566|101709891|FG003|STARTED|Test Period 2||4||
48562178|NCT01983566|101709888|FG000|COMPLETED|Test Period 2||4||
48562179|NCT01983566|101709889|FG001|COMPLETED|Test Period 2||4||
48276298|NCT03816761|100999800|FG001|COMPLETED|Second Treatment Period (7 Days)||4||
48276299|NCT03816761|100999801|FG002|COMPLETED|Second Treatment Period (7 Days)||4||
48276300|NCT03816761|100999802|FG003|COMPLETED|Second Treatment Period (7 Days)||3||
48276301|NCT03816761|100999803|FG004|COMPLETED|Second Treatment Period (7 Days)||4||
48276302|NCT03816761|100999804|FG005|COMPLETED|Second Treatment Period (7 Days)||3||
48276303|NCT03816761|100999799|FG000|NOT COMPLETED|Second Treatment Period (7 Days)||0||
48276304|NCT03816761|100999800|FG001|NOT COMPLETED|Second Treatment Period (7 Days)||0||
48276305|NCT03816761|100999801|FG002|NOT COMPLETED|Second Treatment Period (7 Days)||0||
48276306|NCT03816761|100999802|FG003|NOT COMPLETED|Second Treatment Period (7 Days)||1||
48276307|NCT03816761|100999803|FG004|NOT COMPLETED|Second Treatment Period (7 Days)||0||
48276308|NCT03816761|100999804|FG005|NOT COMPLETED|Second Treatment Period (7 Days)||0||
48276309|NCT06264128|100999805|FG000|STARTED|Overall Study||74||
48276310|NCT06264128|100999806|FG001|STARTED|Overall Study||76||
48276311|NCT06264128|100999805|FG000|COMPLETED|Overall Study||74||
48276312|NCT06264128|100999806|FG001|COMPLETED|Overall Study||76||
48276313|NCT06264128|100999805|FG000|NOT COMPLETED|Overall Study||0||
48276314|NCT06264128|100999806|FG001|NOT COMPLETED|Overall Study||0||
48276315|NCT05061472|100999807|FG000|STARTED|Month 0 (Baseline)||10||
48276316|NCT05061472|100999808|FG001|STARTED|Month 0 (Baseline)||10||
48276317|NCT05061472|100999807|FG000|COMPLETED|Month 0 (Baseline)||10||
48276318|NCT05061472|100999808|FG001|COMPLETED|Month 0 (Baseline)||10||
48276319|NCT05061472|100999807|FG000|NOT COMPLETED|Month 0 (Baseline)||0||
48276320|NCT05061472|100999808|FG001|NOT COMPLETED|Month 0 (Baseline)||0||
48276321|NCT05061472|100999807|FG000|STARTED|Month 3||10||
48276322|NCT05061472|100999808|FG001|STARTED|Month 3||10||
48276323|NCT05061472|100999807|FG000|COMPLETED|Month 3||10|One participant completed 3-month measures and then withdrew due to worsening mental health after completion of outcome measures at this timepoint.|
48276324|NCT05061472|100999808|FG001|COMPLETED|Month 3||10|One participant completed 3-month measures and then withdrew due to worsening mental health after completion of outcome measures at this timepoint.|
48276325|NCT05061472|100999807|FG000|NOT COMPLETED|Month 3||0||
48276326|NCT05061472|100999808|FG001|NOT COMPLETED|Month 3||0||
48276327|NCT05061472|100999807|FG000|STARTED|Month 6 (Final)||9||
48276328|NCT05061472|100999808|FG001|STARTED|Month 6 (Final)||10||
48276329|NCT05061472|100999807|FG000|COMPLETED|Month 6 (Final)||9||
48276330|NCT05061472|100999808|FG001|COMPLETED|Month 6 (Final)||10||
48562180|NCT01983566|101709890|FG002|COMPLETED|Test Period 2||4||
48276331|NCT05061472|100999807|FG000|NOT COMPLETED|Month 6 (Final)||0||
48276332|NCT05061472|100999808|FG001|NOT COMPLETED|Month 6 (Final)||0||
48562181|NCT01983566|101709891|FG003|COMPLETED|Test Period 2||4||
48562182|NCT01983566|101709888|FG000|NOT COMPLETED|Test Period 2||0||
48562183|NCT01983566|101709889|FG001|NOT COMPLETED|Test Period 2||0||
48562184|NCT01983566|101709890|FG002|NOT COMPLETED|Test Period 2||0||
48562185|NCT01983566|101709891|FG003|NOT COMPLETED|Test Period 2||0||
48562186|NCT01983566|101709888|FG000|STARTED|Wash-Out 2||2||
48562187|NCT01983566|101709889|FG001|STARTED|Wash-Out 2||3||
48562188|NCT01983566|101709890|FG002|STARTED|Wash-Out 2||2||
48562189|NCT01983566|101709891|FG003|STARTED|Wash-Out 2||4||
48562190|NCT01983566|101709888|FG000|COMPLETED|Wash-Out 2||2||
48562191|NCT01983566|101709889|FG001|COMPLETED|Wash-Out 2||3||
48562192|NCT01983566|101709890|FG002|COMPLETED|Wash-Out 2||2||
48562193|NCT01983566|101709891|FG003|COMPLETED|Wash-Out 2||4||
48562194|NCT01983566|101709888|FG000|NOT COMPLETED|Wash-Out 2||0||
48562195|NCT01983566|101709889|FG001|NOT COMPLETED|Wash-Out 2||0||
48562196|NCT01983566|101709890|FG002|NOT COMPLETED|Wash-Out 2||0||
48562197|NCT01983566|101709891|FG003|NOT COMPLETED|Wash-Out 2||0||
48562198|NCT01983566|101709888|FG000|STARTED|Test Period 3||2||
48562199|NCT01983566|101709889|FG001|STARTED|Test Period 3||3||
48562200|NCT01983566|101709890|FG002|STARTED|Test Period 3||2||
48562201|NCT01983566|101709891|FG003|STARTED|Test Period 3||4||
48562202|NCT01983566|101709888|FG000|COMPLETED|Test Period 3||2||
48562203|NCT01983566|101709889|FG001|COMPLETED|Test Period 3||3||
48562204|NCT01983566|101709890|FG002|COMPLETED|Test Period 3||2||
48562205|NCT01983566|101709891|FG003|COMPLETED|Test Period 3||4||
48562206|NCT01983566|101709888|FG000|NOT COMPLETED|Test Period 3||0||
48562207|NCT01983566|101709889|FG001|NOT COMPLETED|Test Period 3||0||
48562208|NCT01983566|101709890|FG002|NOT COMPLETED|Test Period 3||0||
48276333|NCT01413087|100999809|FG000|STARTED|Overall Study||6||
48276334|NCT01413087|100999810|FG001|STARTED|Overall Study||6||
48276335|NCT01413087|100999809|FG000|COMPLETED|Overall Study||6||
48276336|NCT01413087|100999810|FG001|COMPLETED|Overall Study||6||
48276337|NCT01413087|100999809|FG000|NOT COMPLETED|Overall Study||0||
48276338|NCT01413087|100999810|FG001|NOT COMPLETED|Overall Study||0||
48276339|NCT01142115|100999811|FG000|STARTED|First Intervention||21||
48276340|NCT01142115|100999812|FG001|STARTED|First Intervention||20||
48276341|NCT01142115|100999811|FG000|COMPLETED|First Intervention||19||
48276342|NCT01142115|100999812|FG001|COMPLETED|First Intervention||19||
48276343|NCT01142115|100999811|FG000|NOT COMPLETED|First Intervention||2||
48276344|NCT01142115|100999812|FG001|NOT COMPLETED|First Intervention||1||
48562209|NCT01983566|101709891|FG003|NOT COMPLETED|Test Period 3||0||
48562210|NCT01983566|101709888|FG000|STARTED|Wash-Out 3||0||
48562211|NCT01983566|101709889|FG001|STARTED|Wash-Out 3||0||
48562212|NCT01983566|101709890|FG002|STARTED|Wash-Out 3||0||
48562213|NCT01983566|101709891|FG003|STARTED|Wash-Out 3||0||
48562214|NCT01983566|101709888|FG000|COMPLETED|Wash-Out 3||0||
48562215|NCT01983566|101709889|FG001|COMPLETED|Wash-Out 3||0||
48562216|NCT01983566|101709890|FG002|COMPLETED|Wash-Out 3||0||
48276345|NCT01142115|100999811|FG000|STARTED|Second Intervention||19||
48276346|NCT01142115|100999812|FG001|STARTED|Second Intervention||19||
48276347|NCT01142115|100999811|FG000|COMPLETED|Second Intervention||19||
48276348|NCT01142115|100999812|FG001|COMPLETED|Second Intervention||19||
48276349|NCT01142115|100999811|FG000|NOT COMPLETED|Second Intervention||0||
48276350|NCT01142115|100999812|FG001|NOT COMPLETED|Second Intervention||0||
48276351|NCT01803282|100999813|FG000|STARTED|Overall Study||4||
48276352|NCT01803282|100999814|FG001|STARTED|Overall Study||3||
48276353|NCT01803282|100999815|FG002|STARTED|Overall Study||6||
48276354|NCT01803282|100999816|FG003|STARTED|Overall Study||36||
48276355|NCT01803282|100999817|FG004|STARTED|Overall Study||11||
48276356|NCT01803282|100999818|FG005|STARTED|Overall Study||10||
48276357|NCT01803282|100999819|FG006|STARTED|Overall Study||41||
48276358|NCT01803282|100999820|FG007|STARTED|Overall Study||46||
48276359|NCT01803282|100999821|FG008|STARTED|Overall Study||11||
48276360|NCT01803282|100999822|FG009|STARTED|Overall Study||45||
48276361|NCT01803282|100999823|FG010|STARTED|Overall Study||8||
48276362|NCT01803282|100999824|FG011|STARTED|Overall Study||15||
48276363|NCT01803282|100999813|FG000|COMPLETED|Overall Study||0||
48276364|NCT01803282|100999814|FG001|COMPLETED|Overall Study||0||
48276365|NCT01803282|100999815|FG002|COMPLETED|Overall Study||0||
48276366|NCT01803282|100999816|FG003|COMPLETED|Overall Study||0||
48276367|NCT01803282|100999817|FG004|COMPLETED|Overall Study||0||
48276368|NCT01803282|100999818|FG005|COMPLETED|Overall Study||0||
48276369|NCT01803282|100999819|FG006|COMPLETED|Overall Study||0||
48276370|NCT01803282|100999820|FG007|COMPLETED|Overall Study||0||
48276371|NCT01803282|100999821|FG008|COMPLETED|Overall Study||0||
48276372|NCT01803282|100999822|FG009|COMPLETED|Overall Study||0||
48276373|NCT01803282|100999823|FG010|COMPLETED|Overall Study||0||
48276374|NCT01803282|100999824|FG011|COMPLETED|Overall Study||0||
48276375|NCT01803282|100999813|FG000|NOT COMPLETED|Overall Study||4||
48276376|NCT01803282|100999814|FG001|NOT COMPLETED|Overall Study||3||
48562217|NCT01983566|101709891|FG003|COMPLETED|Wash-Out 3||0||
48562218|NCT01983566|101709888|FG000|NOT COMPLETED|Wash-Out 3||0||
48562219|NCT01983566|101709889|FG001|NOT COMPLETED|Wash-Out 3||0||
48562220|NCT01983566|101709890|FG002|NOT COMPLETED|Wash-Out 3||0||
48562221|NCT01983566|101709891|FG003|NOT COMPLETED|Wash-Out 3||0||
48562222|NCT01983566|101709888|FG000|STARTED|Test Period 4||0||
48562223|NCT01983566|101709889|FG001|STARTED|Test Period 4||0||
48562224|NCT01983566|101709890|FG002|STARTED|Test Period 4||0||
48562225|NCT01983566|101709891|FG003|STARTED|Test Period 4||0||
48562226|NCT01983566|101709888|FG000|COMPLETED|Test Period 4||0||
48276377|NCT01803282|100999815|FG002|NOT COMPLETED|Overall Study||6||
48276378|NCT01803282|100999816|FG003|NOT COMPLETED|Overall Study||36||
48276379|NCT01803282|100999817|FG004|NOT COMPLETED|Overall Study||11||
48276380|NCT01803282|100999818|FG005|NOT COMPLETED|Overall Study||10||
48562227|NCT01983566|101709889|FG001|COMPLETED|Test Period 4||0||
48562228|NCT01983566|101709890|FG002|COMPLETED|Test Period 4||0||
48562229|NCT01983566|101709891|FG003|COMPLETED|Test Period 4||0||
48562230|NCT01983566|101709888|FG000|NOT COMPLETED|Test Period 4||0||
48562231|NCT01983566|101709889|FG001|NOT COMPLETED|Test Period 4||0||
48562232|NCT01983566|101709890|FG002|NOT COMPLETED|Test Period 4||0||
48562233|NCT01983566|101709891|FG003|NOT COMPLETED|Test Period 4||0||
48562234|NCT03194542|101709892|FG000|STARTED|Overall Study||22||
48562235|NCT03194542|101709893|FG001|STARTED|Overall Study||21||
48562236|NCT03194542|101709894|FG002|STARTED|Overall Study||14||
48562237|NCT03194542|101709895|FG003|STARTED|Overall Study||38||
48562238|NCT03194542|101709892|FG000|COMPLETED|Overall Study||0|Treatment ongoing|
48562239|NCT03194542|101709893|FG001|COMPLETED|Overall Study||0|Treatment ongoing|
48562240|NCT03194542|101709894|FG002|COMPLETED|Overall Study||0|Treatment ongoing|
48562241|NCT03194542|101709895|FG003|COMPLETED|Overall Study||0|Treatment ongoing|
48562242|NCT03194542|101709892|FG000|NOT COMPLETED|Overall Study||22||
48562243|NCT03194542|101709893|FG001|NOT COMPLETED|Overall Study||21||
48562244|NCT03194542|101709894|FG002|NOT COMPLETED|Overall Study||14||
48113081|NCT00989833|100601646|FG001|STARTED|Overall Study||22||
48113082|NCT00989833|100601647|FG002|STARTED|Overall Study||23||
48113083|NCT00989833|100601645|FG000|COMPLETED|Overall Study||19||
48113084|NCT00989833|100601646|FG001|COMPLETED|Overall Study||19||
48113085|NCT00989833|100601647|FG002|COMPLETED|Overall Study||21||
48113086|NCT00989833|100601645|FG000|NOT COMPLETED|Overall Study||2||
48113087|NCT00989833|100601646|FG001|NOT COMPLETED|Overall Study||3||
48113088|NCT00989833|100601647|FG002|NOT COMPLETED|Overall Study||2||
48113089|NCT03878134|100601648|FG000|STARTED|Overall Study||67||
48113090|NCT03878134|100601648|FG000|COMPLETED|Overall Study||56||
48113091|NCT03878134|100601648|FG000|NOT COMPLETED|Overall Study||11||
48113092|NCT01494610|100601649|FG000|STARTED|Period 1||31||
48113093|NCT01494610|100601650|FG001|STARTED|Period 1||29||
48113094|NCT01494610|100601649|FG000|COMPLETED|Period 1||30||
48113095|NCT01494610|100601650|FG001|COMPLETED|Period 1||28||
48113096|NCT01494610|100601649|FG000|NOT COMPLETED|Period 1||1||
48113097|NCT01494610|100601650|FG001|NOT COMPLETED|Period 1||1||
48113098|NCT01494610|100601649|FG000|STARTED|Period 2||30||
48113099|NCT01494610|100601650|FG001|STARTED|Period 2||28||
48113100|NCT01494610|100601649|FG000|COMPLETED|Period 2||30||
48113101|NCT01494610|100601650|FG001|COMPLETED|Period 2||28||
48113102|NCT01494610|100601649|FG000|NOT COMPLETED|Period 2||0||
48113103|NCT01494610|100601650|FG001|NOT COMPLETED|Period 2||0||
48113104|NCT01494610|100601649|FG000|STARTED|Period 3||30||
48113105|NCT01494610|100601650|FG001|STARTED|Period 3||28||
48113106|NCT01494610|100601649|FG000|COMPLETED|Period 3||28||
48113107|NCT01494610|100601650|FG001|COMPLETED|Period 3||28||
48113108|NCT01494610|100601649|FG000|NOT COMPLETED|Period 3||2||
48113109|NCT01494610|100601650|FG001|NOT COMPLETED|Period 3||0||
48113110|NCT01494610|100601649|FG000|STARTED|Period 4||28||
48113111|NCT01494610|100601650|FG001|STARTED|Period 4||28||
48113112|NCT01494610|100601649|FG000|COMPLETED|Period 4||27||
48113113|NCT01494610|100601650|FG001|COMPLETED|Period 4||28||
48113114|NCT01494610|100601649|FG000|NOT COMPLETED|Period 4||1||
48113115|NCT01494610|100601650|FG001|NOT COMPLETED|Period 4||0||
48113116|NCT04027218|100601651|FG000|STARTED|Overall Study||10||
48113117|NCT04027218|100601652|FG001|STARTED|Overall Study||11||
48113118|NCT04027218|100601653|FG002|STARTED|Overall Study||9||
48113119|NCT04027218|100601654|FG003|STARTED|Overall Study||11||
48113120|NCT04027218|100601655|FG004|STARTED|Overall Study||10||
48113121|NCT04027218|100601656|FG005|STARTED|Overall Study||11||
48113122|NCT04027218|100601651|FG000|COMPLETED|Overall Study||10||
48113123|NCT04027218|100601652|FG001|COMPLETED|Overall Study||8||
48113124|NCT04027218|100601653|FG002|COMPLETED|Overall Study||9||
48276381|NCT01803282|100999819|FG006|NOT COMPLETED|Overall Study||41||
48276382|NCT01803282|100999820|FG007|NOT COMPLETED|Overall Study||46||
48276383|NCT01803282|100999821|FG008|NOT COMPLETED|Overall Study||11||
48562245|NCT03194542|101709895|FG003|NOT COMPLETED|Overall Study||38||
48562246|NCT01125189|101709896|FG000|STARTED|Treatment Period||159||
48562247|NCT01125189|101709897|FG001|STARTED|Treatment Period||158||
48562248|NCT01125189|101709898|FG002|STARTED|Treatment Period||78||
48113125|NCT04027218|100601654|FG003|COMPLETED|Overall Study||11||
48113126|NCT04027218|100601655|FG004|COMPLETED|Overall Study||10||
48113127|NCT04027218|100601656|FG005|COMPLETED|Overall Study||11||
48113128|NCT04027218|100601651|FG000|NOT COMPLETED|Overall Study||0||
48113129|NCT04027218|100601652|FG001|NOT COMPLETED|Overall Study||3||
48113130|NCT04027218|100601653|FG002|NOT COMPLETED|Overall Study||0||
48113131|NCT04027218|100601654|FG003|NOT COMPLETED|Overall Study||0||
48113132|NCT04027218|100601655|FG004|NOT COMPLETED|Overall Study||0||
48113133|NCT04027218|100601656|FG005|NOT COMPLETED|Overall Study||0||
48276384|NCT01803282|100999822|FG009|NOT COMPLETED|Overall Study||45||
48562249|NCT01125189|101709896|FG000|COMPLETED|Treatment Period||128||
48562250|NCT01125189|101709897|FG001|COMPLETED|Treatment Period||123||
48113134|NCT02673775|100601657|FG000|STARTED|First Exposure||25||
48113135|NCT02673775|100601658|FG001|STARTED|First Exposure||37||
48113136|NCT02673775|100601657|FG000|COMPLETED|First Exposure||25||
48113137|NCT02673775|100601658|FG001|COMPLETED|First Exposure||37||
48113138|NCT02673775|100601657|FG000|NOT COMPLETED|First Exposure||0||
48113139|NCT02673775|100601658|FG001|NOT COMPLETED|First Exposure||0||
48113140|NCT02673775|100601657|FG000|STARTED|Washout (at Least 2 Weeks)||25||
48113141|NCT02673775|100601658|FG001|STARTED|Washout (at Least 2 Weeks)||37||
48113142|NCT02673775|100601657|FG000|COMPLETED|Washout (at Least 2 Weeks)||21||
48113143|NCT02673775|100601658|FG001|COMPLETED|Washout (at Least 2 Weeks)||33||
48113144|NCT02673775|100601657|FG000|NOT COMPLETED|Washout (at Least 2 Weeks)||4||
48113145|NCT02673775|100601658|FG001|NOT COMPLETED|Washout (at Least 2 Weeks)||4||
48113146|NCT02673775|100601657|FG000|STARTED|Second Exposure||21||
48113147|NCT02673775|100601658|FG001|STARTED|Second Exposure||33||
48113148|NCT02673775|100601657|FG000|COMPLETED|Second Exposure||21||
48113149|NCT02673775|100601658|FG001|COMPLETED|Second Exposure||33||
48113150|NCT02673775|100601657|FG000|NOT COMPLETED|Second Exposure||0||
48113151|NCT02673775|100601658|FG001|NOT COMPLETED|Second Exposure||0||
48113152|NCT02969928|100601659|FG000|STARTED|Overall Study||23||
48113153|NCT02969928|100601660|FG001|STARTED|Overall Study||23||
48113154|NCT02969928|100601659|FG000|COMPLETED|Overall Study||23||
48113155|NCT02969928|100601660|FG001|COMPLETED|Overall Study||23||
48113156|NCT02969928|100601659|FG000|NOT COMPLETED|Overall Study||0||
48113157|NCT02969928|100601660|FG001|NOT COMPLETED|Overall Study||0||
48113158|NCT03458130|100601661|FG000|STARTED|Overall Study||16||
48113159|NCT03458130|100601662|FG001|STARTED|Overall Study||16||
48113160|NCT03458130|100601663|FG002|STARTED|Overall Study||17||
48113161|NCT03458130|100601661|FG000|Screening|Overall Study||16||
48113162|NCT03458130|100601662|FG001|Screening|Overall Study||16||
48113163|NCT03458130|100601663|FG002|Screening|Overall Study||17||
48113164|NCT03458130|100601661|FG000|Double Blind Treatment|Overall Study||16||
48113165|NCT03458130|100601662|FG001|Double Blind Treatment|Overall Study||16||
48113166|NCT03458130|100601663|FG002|Double Blind Treatment|Overall Study||17||
48113167|NCT03458130|100601661|FG000|Follow-Up|Overall Study||16||
48113168|NCT03458130|100601662|FG001|Follow-Up|Overall Study||16||
48113169|NCT03458130|100601663|FG002|Follow-Up|Overall Study||17||
48113170|NCT03458130|100601661|FG000|COMPLETED|Overall Study||16||
48113171|NCT03458130|100601662|FG001|COMPLETED|Overall Study||16||
48113172|NCT03458130|100601663|FG002|COMPLETED|Overall Study||17||
48113173|NCT03458130|100601661|FG000|NOT COMPLETED|Overall Study||0||
48113174|NCT03458130|100601662|FG001|NOT COMPLETED|Overall Study||0||
48113175|NCT03458130|100601663|FG002|NOT COMPLETED|Overall Study||0||
48113176|NCT02377089|100601664|FG000|STARTED|Overall Study||31||
48113177|NCT02377089|100601665|FG001|STARTED|Overall Study||29||
48113178|NCT02377089|100601664|FG000|COMPLETED|Overall Study||22||
48113179|NCT02377089|100601665|FG001|COMPLETED|Overall Study||24||
48113180|NCT02377089|100601664|FG000|NOT COMPLETED|Overall Study||9||
48113181|NCT02377089|100601665|FG001|NOT COMPLETED|Overall Study||5||
48696107|NCT01932372|102041677|FG001|STARTED|Overall Study||2598|Number of participants for whom CRFs were collected|
48696108|NCT01932372|102041676|FG000|XELJANZ (Safety Analysis Set)|Overall Study||7021|Participants who received XELJANZ Tablets 5 mg as indicated in the approved local product document were observed for a scheduled period of 36 months or 6 months. The dosage can be adjusted as per physician's discretion. Participants who did not meet the eligibility criteria and/or were not assessable for safety were excluded.|
48696109|NCT01932372|102041677|FG001|XELJANZ (Safety Analysis Set)|Overall Study||2419|Participants who received XELJANZ Tablets 5 mg as indicated in the approved local product document were observed for a scheduled period of 36 months or 6 months. The dosage can be adjusted as per physician's discretion. Participants who did not meet the eligibility criteria and/or were not assessable for safety were excluded.|
48113182|NCT03291613|100601666|FG000|STARTED|Overall Study||13||
48113183|NCT03291613|100601666|FG000|COMPLETED|Overall Study||12||
48276385|NCT01803282|100999823|FG010|NOT COMPLETED|Overall Study||8||
48276386|NCT01803282|100999824|FG011|NOT COMPLETED|Overall Study||15||
48710712|NCT00846040|102077994|FG001|NOT COMPLETED|Second Treatment: After Washout, 14 Day||0||
48710713|NCT00846040|102077995|FG002|NOT COMPLETED|Second Treatment: After Washout, 14 Day||0||
48710714|NCT01861925|102077996|FG000|STARTED|Overall Study||34||
48276387|NCT01769326|100999825|FG000|STARTED|Overall Study||11||
48710715|NCT01861925|102077997|FG001|STARTED|Overall Study||8||
48710716|NCT01861925|102077998|FG002|STARTED|Overall Study||8||
48113184|NCT03291613|100601666|FG000|NOT COMPLETED|Overall Study||1||
48113185|NCT01786629|100601667|FG000|STARTED|Overall Study||169||
48113186|NCT01786629|100601668|FG001|STARTED|Overall Study||169||
48113187|NCT01786629|100601667|FG000|COMPLETED|Overall Study||169||
48113188|NCT01786629|100601668|FG001|COMPLETED|Overall Study||164||
48113189|NCT01786629|100601667|FG000|NOT COMPLETED|Overall Study||0||
48113190|NCT01786629|100601668|FG001|NOT COMPLETED|Overall Study||5||
48113191|NCT00436748|100601669|FG000|STARTED|Overall Study||59||
48113192|NCT00436748|100601670|FG001|STARTED|Overall Study||57||
48113193|NCT00436748|100601669|FG000|Received Treatment|Overall Study||58||
48113194|NCT00436748|100601670|FG001|Received Treatment|Overall Study||56||
48113195|NCT00436748|100601669|FG000|COMPLETED|Overall Study||48||
48113196|NCT00436748|100601670|FG001|COMPLETED|Overall Study||45||
48113197|NCT00436748|100601669|FG000|NOT COMPLETED|Overall Study||11||
48276388|NCT01769326|100999826|FG001|STARTED|Overall Study||12||
48696110|NCT01932372|102041676|FG000|XELJANZ (MTX Adherent Safety Analysis Set)|Overall Study||4574|Participants who received XELJANZ Tablets 5 mg as indicated in the approved local product document were observed for a scheduled period of 36 months or 6 months. The dosage can be adjusted as per physician's discretion. The MTX adherent safety analysis set was defined as the participants within the safety analysis set who have been poorly controlled even though MTX was used continuously dose of more than 8 mg/week for 3 months or longer.|
48113198|NCT00436748|100601670|FG001|NOT COMPLETED|Overall Study||12||
48113199|NCT01276314|100601671|FG000|STARTED|Overall Study||48||
48113200|NCT01276314|100601672|FG001|STARTED|Overall Study||43||
48113201|NCT01276314|100601673|FG002|STARTED|Overall Study||22||
48113202|NCT01276314|100601674|FG003|STARTED|Overall Study||22||
48113203|NCT01276314|100601671|FG000|COMPLETED|Overall Study||38||
48113204|NCT01276314|100601672|FG001|COMPLETED|Overall Study||33||
48113205|NCT01276314|100601673|FG002|COMPLETED|Overall Study||18||
48113206|NCT01276314|100601674|FG003|COMPLETED|Overall Study||17||
48113207|NCT01276314|100601671|FG000|NOT COMPLETED|Overall Study||10||
48113208|NCT01276314|100601672|FG001|NOT COMPLETED|Overall Study||10||
48113209|NCT01276314|100601673|FG002|NOT COMPLETED|Overall Study||4||
48113210|NCT01276314|100601674|FG003|NOT COMPLETED|Overall Study||5||
48113211|NCT00326612|100601675|FG000|STARTED|Overall Study||179||
48113212|NCT00326612|100601676|FG001|STARTED|Overall Study||179||
48113213|NCT00326612|100601675|FG000|COMPLETED|Overall Study||50||
48113214|NCT00326612|100601676|FG001|COMPLETED|Overall Study||42||
48113215|NCT00326612|100601675|FG000|NOT COMPLETED|Overall Study||129||
48113216|NCT00326612|100601676|FG001|NOT COMPLETED|Overall Study||137||
48113217|NCT01103934|100601677|FG000|STARTED|Overall Study||17||
48113218|NCT01103934|100601678|FG001|STARTED|Overall Study||18||
48113219|NCT01103934|100601677|FG000|COMPLETED|Overall Study||17||
48113220|NCT01103934|100601678|FG001|COMPLETED|Overall Study||18||
48113221|NCT01103934|100601677|FG000|NOT COMPLETED|Overall Study||0||
48113222|NCT01103934|100601678|FG001|NOT COMPLETED|Overall Study||0||
48113223|NCT01153581|100601679|FG000|STARTED|Overall Study||109||
48113224|NCT01153581|100601679|FG000|COMPLETED|Overall Study||109||
48113225|NCT01153581|100601679|FG000|NOT COMPLETED|Overall Study||0||
48113226|NCT01537783|100601680|FG000|STARTED|Overall Study||25||
48113227|NCT01537783|100601681|FG001|STARTED|Overall Study||25||
48113228|NCT01537783|100601680|FG000|COMPLETED|Overall Study||14||
48113229|NCT01537783|100601681|FG001|COMPLETED|Overall Study||23||
48113230|NCT01537783|100601680|FG000|NOT COMPLETED|Overall Study||11||
48113231|NCT01537783|100601681|FG001|NOT COMPLETED|Overall Study||2||
48113232|NCT00733343|100601682|FG000|STARTED|Overall Study||666||
48113233|NCT00733343|100601683|FG001|STARTED|Overall Study||659||
48113234|NCT00733343|100601682|FG000|COMPLETED|Overall Study||583||
48113235|NCT00733343|100601683|FG001|COMPLETED|Overall Study||578||
48113236|NCT00733343|100601682|FG000|NOT COMPLETED|Overall Study||83||
48113237|NCT00733343|100601683|FG001|NOT COMPLETED|Overall Study||81||
48113238|NCT02940691|100601684|FG000|STARTED|Overall Study||32||
48113239|NCT02940691|100601684|FG000|COMPLETED|Overall Study||26||
48113240|NCT02940691|100601684|FG000|NOT COMPLETED|Overall Study||6||
48113241|NCT00213148|100601685|FG000|STARTED|Cycle 1 (1 Month)||77||
48113242|NCT00213148|100601686|FG001|STARTED|Cycle 1 (1 Month)||0||
48113243|NCT00213148|100601687|FG002|STARTED|Cycle 1 (1 Month)||79||
48113244|NCT00213148|100601688|FG003|STARTED|Cycle 1 (1 Month)||76||
48113245|NCT00213148|100601689|FG004|STARTED|Cycle 1 (1 Month)||39||
48696111|NCT01932372|102041677|FG001|XELJANZ (MTX Adherent Safety Analysis Set)|Overall Study||0|Participants who received XELJANZ Tablets 5 mg as indicated in the approved local product document were observed for a scheduled period of 36 months or 6 months. The dosage can be adjusted as per physician's discretion. The MTX adherent safety analysis set was defined as the participants within the safety analysis set who have been poorly controlled even though MTX was used continuously dose of more than 8 mg/week for 3 months or longer.|
48710717|NCT01861925|102077996|FG000|COMPLETED|Overall Study||34||
48710718|NCT01861925|102077997|FG001|COMPLETED|Overall Study||8||
48710719|NCT01861925|102077998|FG002|COMPLETED|Overall Study||8||
48710720|NCT01861925|102077996|FG000|NOT COMPLETED|Overall Study||0||
48710721|NCT01861925|102077997|FG001|NOT COMPLETED|Overall Study||0||
48113246|NCT00213148|100601685|FG000|COMPLETED|Cycle 1 (1 Month)||53||
48113247|NCT00213148|100601686|FG001|COMPLETED|Cycle 1 (1 Month)||0||
48113248|NCT00213148|100601687|FG002|COMPLETED|Cycle 1 (1 Month)||60||
48113249|NCT00213148|100601688|FG003|COMPLETED|Cycle 1 (1 Month)||58||
48113250|NCT00213148|100601689|FG004|COMPLETED|Cycle 1 (1 Month)||17||
48113251|NCT00213148|100601685|FG000|NOT COMPLETED|Cycle 1 (1 Month)||24||
48113252|NCT00213148|100601686|FG001|NOT COMPLETED|Cycle 1 (1 Month)||0||
48113253|NCT00213148|100601687|FG002|NOT COMPLETED|Cycle 1 (1 Month)||19||
48113254|NCT00213148|100601688|FG003|NOT COMPLETED|Cycle 1 (1 Month)||18||
48113255|NCT00213148|100601689|FG004|NOT COMPLETED|Cycle 1 (1 Month)||22||
48113256|NCT00213148|100601685|FG000|STARTED|Cycle 2 (1 Month)||43||
48113257|NCT00213148|100601686|FG001|STARTED|Cycle 2 (1 Month)||10||
48113258|NCT00213148|100601687|FG002|STARTED|Cycle 2 (1 Month)||42||
48113259|NCT00213148|100601688|FG003|STARTED|Cycle 2 (1 Month)||52||
48113260|NCT00213148|100601689|FG004|STARTED|Cycle 2 (1 Month)||41||
48113261|NCT00213148|100601685|FG000|COMPLETED|Cycle 2 (1 Month)||29||
48113262|NCT00213148|100601686|FG001|COMPLETED|Cycle 2 (1 Month)||4||
48113263|NCT00213148|100601687|FG002|COMPLETED|Cycle 2 (1 Month)||28||
48113264|NCT00213148|100601688|FG003|COMPLETED|Cycle 2 (1 Month)||33||
48113265|NCT00213148|100601689|FG004|COMPLETED|Cycle 2 (1 Month)||11||
48113266|NCT00213148|100601685|FG000|NOT COMPLETED|Cycle 2 (1 Month)||14||
48696112|NCT01932372|102041676|FG000|XELJANZ (MTX Adherent Comparative Safety Analysis Set)|Overall Study||3731|Participants who received XELJANZ Tablets 5 mg as indicated in the approved local product document were observed for a scheduled period of 36 months. The dosage can be adjusted as per physician's discretion. The MTX adherent comparative safety analysis set was defined as the participants with RA who have been poorly controlled even though MTX was used continuously at a dose of more than 8 mg/week for 3 months or longer, excluding the participants with observation for 6 months or shorter.|
48710722|NCT01861925|102077998|FG002|NOT COMPLETED|Overall Study||0||
48113267|NCT00213148|100601686|FG001|NOT COMPLETED|Cycle 2 (1 Month)||6||
48113268|NCT00213148|100601687|FG002|NOT COMPLETED|Cycle 2 (1 Month)||14||
48113269|NCT00213148|100601688|FG003|NOT COMPLETED|Cycle 2 (1 Month)||19||
48113270|NCT00213148|100601689|FG004|NOT COMPLETED|Cycle 2 (1 Month)||30||
48113271|NCT00213148|100601685|FG000|STARTED|Cycle 3 (1 Month)||23||
48113272|NCT00213148|100601686|FG001|STARTED|Cycle 3 (1 Month)||10||
48113273|NCT00213148|100601687|FG002|STARTED|Cycle 3 (1 Month)||26||
48113274|NCT00213148|100601688|FG003|STARTED|Cycle 3 (1 Month)||24||
48113275|NCT00213148|100601689|FG004|STARTED|Cycle 3 (1 Month)||22||
48113276|NCT00213148|100601685|FG000|COMPLETED|Cycle 3 (1 Month)||23||
48113277|NCT00213148|100601686|FG001|COMPLETED|Cycle 3 (1 Month)||8||
48113278|NCT00213148|100601687|FG002|COMPLETED|Cycle 3 (1 Month)||25||
48113279|NCT00213148|100601688|FG003|COMPLETED|Cycle 3 (1 Month)||23||
48113280|NCT00213148|100601689|FG004|COMPLETED|Cycle 3 (1 Month)||21||
48113281|NCT00213148|100601685|FG000|NOT COMPLETED|Cycle 3 (1 Month)||0||
48113282|NCT00213148|100601686|FG001|NOT COMPLETED|Cycle 3 (1 Month)||2||
48113283|NCT00213148|100601687|FG002|NOT COMPLETED|Cycle 3 (1 Month)||1||
48113284|NCT00213148|100601688|FG003|NOT COMPLETED|Cycle 3 (1 Month)||1||
48113285|NCT00213148|100601689|FG004|NOT COMPLETED|Cycle 3 (1 Month)||1||
48113286|NCT04061694|100601690|FG000|STARTED|Overall Study||21||
48113287|NCT04061694|100601691|FG001|STARTED|Overall Study||25||
48562251|NCT01125189|101709898|FG002|COMPLETED|Treatment Period||37||
48562252|NCT01125189|101709896|FG000|NOT COMPLETED|Treatment Period||31||
48562253|NCT01125189|101709897|FG001|NOT COMPLETED|Treatment Period||35||
48562254|NCT01125189|101709898|FG002|NOT COMPLETED|Treatment Period||41||
48562255|NCT01125189|101709896|FG000|STARTED|Follow up Period||152||
48562256|NCT01125189|101709897|FG001|STARTED|Follow up Period||153||
48562257|NCT01125189|101709898|FG002|STARTED|Follow up Period||74||
48562258|NCT01125189|101709896|FG000|COMPLETED|Follow up Period||132||
48562259|NCT01125189|101709897|FG001|COMPLETED|Follow up Period||138||
48562260|NCT01125189|101709898|FG002|COMPLETED|Follow up Period||58||
48562261|NCT01125189|101709896|FG000|NOT COMPLETED|Follow up Period||20||
48562262|NCT01125189|101709897|FG001|NOT COMPLETED|Follow up Period||15||
48562263|NCT01125189|101709898|FG002|NOT COMPLETED|Follow up Period||16||
48562264|NCT01094704|101709899|FG000|STARTED|Overall Study||8||
48562265|NCT01094704|101709900|FG001|STARTED|Overall Study||8||
48562266|NCT01094704|101709899|FG000|COMPLETED|Overall Study||8||
48562267|NCT01094704|101709900|FG001|COMPLETED|Overall Study||8||
48562268|NCT01094704|101709899|FG000|NOT COMPLETED|Overall Study||0||
48562269|NCT01094704|101709900|FG001|NOT COMPLETED|Overall Study||0||
48562270|NCT02438423|101709901|FG000|STARTED|Overall Study||25||
48562271|NCT02438423|101709902|FG001|STARTED|Overall Study||25||
48562272|NCT02438423|101709903|FG002|STARTED|Overall Study||25||
48562273|NCT02438423|101709904|FG003|STARTED|Overall Study||25||
48562274|NCT02438423|101709901|FG000|COMPLETED|Overall Study||25||
48562275|NCT02438423|101709902|FG001|COMPLETED|Overall Study||25||
48562276|NCT02438423|101709903|FG002|COMPLETED|Overall Study||25||
48562277|NCT02438423|101709904|FG003|COMPLETED|Overall Study||25||
48562278|NCT02438423|101709901|FG000|NOT COMPLETED|Overall Study||0||
48562279|NCT02438423|101709902|FG001|NOT COMPLETED|Overall Study||0||
48562280|NCT02438423|101709903|FG002|NOT COMPLETED|Overall Study||0||
48562281|NCT02438423|101709904|FG003|NOT COMPLETED|Overall Study||0||
48562282|NCT02949973|101709905|FG000|STARTED|Overall Study||10||
48562283|NCT02949973|101709905|FG000|COMPLETED|Overall Study||9||
48562284|NCT02949973|101709905|FG000|NOT COMPLETED|Overall Study||1||
48562285|NCT03743415|101709906|FG000|STARTED|Overall Study||166||
48562286|NCT03743415|101709907|FG001|STARTED|Overall Study||44||
48562287|NCT03743415|101709908|FG002|STARTED|Overall Study||44||
48562288|NCT03743415|101709909|FG003|STARTED|Overall Study||97||
48113288|NCT04061694|100601690|FG000|COMPLETED|Overall Study||19||
48562289|NCT03743415|101709910|FG004|STARTED|Overall Study||166||
48562290|NCT03743415|101709911|FG005|STARTED|Overall Study||44||
48113289|NCT04061694|100601691|FG001|COMPLETED|Overall Study||25||
48113290|NCT04061694|100601690|FG000|NOT COMPLETED|Overall Study||2||
48113291|NCT04061694|100601691|FG001|NOT COMPLETED|Overall Study||0||
48113292|NCT03181542|100601692|FG000|STARTED|Overall Study||80||
48113293|NCT03181542|100601693|FG001|STARTED|Overall Study||80||
48562291|NCT03743415|101709912|FG006|STARTED|Overall Study||44||
48562292|NCT03743415|101709913|FG007|STARTED|Overall Study||97||
48562293|NCT03743415|101709914|FG008|STARTED|Overall Study||23||
48562294|NCT03743415|101709915|FG009|STARTED|Overall Study||23||
48562295|NCT03743415|101709906|FG000|COMPLETED|Overall Study||158||
48562296|NCT03743415|101709907|FG001|COMPLETED|Overall Study||41||
48562297|NCT03743415|101709908|FG002|COMPLETED|Overall Study||37||
48562298|NCT03743415|101709909|FG003|COMPLETED|Overall Study||87||
48562299|NCT03743415|101709910|FG004|COMPLETED|Overall Study||160||
48696113|NCT01932372|102041677|FG001|XELJANZ (MTX Adherent Comparative Safety Analysis Set)|Overall Study||0|Participants who received XELJANZ Tablets 5 mg as indicated in the approved local product document were observed for a scheduled period of 36 months. The dosage can be adjusted as per physician's discretion. The MTX adherent comparative safety analysis set was defined as the participants with RA who have been poorly controlled even though MTX was used continuously at a dose of more than 8 mg/week for 3 months or longer, excluding the participants with observation for 6 months or shorter.|
48696114|NCT01932372|102041676|FG000|COMPLETED|Overall Study||7021||
48696115|NCT01932372|102041677|FG001|COMPLETED|Overall Study||2419||
48696116|NCT01932372|102041676|FG000|NOT COMPLETED|Overall Study||33||
48696117|NCT01932372|102041677|FG001|NOT COMPLETED|Overall Study||179||
48696118|NCT04382586|102041678|FG000|STARTED|Overall Study||30||
48696119|NCT04382586|102041679|FG001|STARTED|Overall Study||33||
48696120|NCT04382586|102041678|FG000|COMPLETED|Overall Study||13||
48696121|NCT04382586|102041679|FG001|COMPLETED|Overall Study||17||
48696122|NCT04382586|102041678|FG000|NOT COMPLETED|Overall Study||17||
48696123|NCT04382586|102041679|FG001|NOT COMPLETED|Overall Study||16||
48696124|NCT01463696|102041680|FG000|STARTED|Overall Study||1||
48696125|NCT01463696|102041681|FG001|STARTED|Overall Study||6||
48696126|NCT01463696|102041682|FG002|STARTED|Overall Study||3||
48696127|NCT01463696|102041683|FG003|STARTED|Overall Study||7||
48696128|NCT01463696|102041684|FG004|STARTED|Overall Study||3||
48696129|NCT01463696|102041685|FG005|STARTED|Overall Study||6||
48696130|NCT01463696|102041686|FG006|STARTED|Overall Study||16||
48113294|NCT03181542|100601692|FG000|COMPLETED|Overall Study||79||
48113295|NCT03181542|100601693|FG001|COMPLETED|Overall Study||80||
48276389|NCT01769326|100999827|FG002|STARTED|Overall Study||9||
48276390|NCT01769326|100999828|FG003|STARTED|Overall Study||8||
48276391|NCT01769326|100999825|FG000|COMPLETED|Overall Study||9||
48113296|NCT03181542|100601692|FG000|NOT COMPLETED|Overall Study||1||
48113297|NCT03181542|100601693|FG001|NOT COMPLETED|Overall Study||0||
48113298|NCT01966926|100604907|FG000|STARTED|Overall Study||15||
48113299|NCT01966926|100604908|FG001|STARTED|Overall Study||15||
48113300|NCT01966926|100604907|FG000|COMPLETED|Overall Study||15||
48113301|NCT01966926|100604908|FG001|COMPLETED|Overall Study||15||
48113302|NCT01966926|100604907|FG000|NOT COMPLETED|Overall Study||0||
48113303|NCT01966926|100604908|FG001|NOT COMPLETED|Overall Study||0||
48113304|NCT01127503|100604909|FG000|STARTED|Overall Study||1||
48113305|NCT01127503|100604910|FG001|STARTED|Overall Study||1||
48276392|NCT01769326|100999826|FG001|COMPLETED|Overall Study||8||
48276393|NCT01769326|100999827|FG002|COMPLETED|Overall Study||8||
48276394|NCT01769326|100999828|FG003|COMPLETED|Overall Study||8||
48276395|NCT01769326|100999825|FG000|NOT COMPLETED|Overall Study||2||
48276396|NCT01769326|100999826|FG001|NOT COMPLETED|Overall Study||4||
48276397|NCT01769326|100999827|FG002|NOT COMPLETED|Overall Study||1||
48276398|NCT01769326|100999828|FG003|NOT COMPLETED|Overall Study||0||
48276399|NCT01223352|100999829|FG000|STARTED|Overall Study||31||
48276400|NCT01223352|100999830|FG001|STARTED|Overall Study||33||
48276401|NCT01223352|100999829|FG000|COMPLETED|Overall Study||31||
48276402|NCT01223352|100999830|FG001|COMPLETED|Overall Study||33||
48276403|NCT01223352|100999829|FG000|NOT COMPLETED|Overall Study||0||
48276404|NCT01223352|100999830|FG001|NOT COMPLETED|Overall Study||0||
48276405|NCT00586612|100999831|FG000|STARTED|Primary Phase||163||
48276406|NCT00586612|100999832|FG001|STARTED|Primary Phase||150||
48393578|NCT00376246|101291600|FG000|STARTED|First Intervention (2 Weeks)||14||
48113306|NCT01127503|100604909|FG000|COMPLETED|Overall Study||1||
48113307|NCT01127503|100604910|FG001|COMPLETED|Overall Study||1||
48113308|NCT01127503|100604909|FG000|NOT COMPLETED|Overall Study||0||
48113309|NCT01127503|100604910|FG001|NOT COMPLETED|Overall Study||0||
48113310|NCT01944059|100604911|FG000|STARTED|Overall Study||31||
48113311|NCT01944059|100604911|FG000|COMPLETED|Overall Study||24||
48113312|NCT01944059|100604911|FG000|NOT COMPLETED|Overall Study||7||
48113313|NCT00811564|100604912|FG000|STARTED|Overall Study||73||
48113314|NCT00811564|100604913|FG001|STARTED|Overall Study||75||
48113315|NCT00811564|100604912|FG000|COMPLETED|Overall Study||64||
48113316|NCT00811564|100604913|FG001|COMPLETED|Overall Study||73||
48113317|NCT00811564|100604912|FG000|NOT COMPLETED|Overall Study||9||
48113318|NCT00811564|100604913|FG001|NOT COMPLETED|Overall Study||2||
48113319|NCT00330551|100604914|FG000|STARTED|Overall Study||40||
48113320|NCT00330551|100604915|FG001|STARTED|Overall Study||43||
48276407|NCT00586612|100999831|FG000|COMPLETED|Primary Phase||162||
48276408|NCT00586612|100999832|FG001|COMPLETED|Primary Phase||147||
48276409|NCT00586612|100999831|FG000|NOT COMPLETED|Primary Phase||1||
48276410|NCT00586612|100999832|FG001|NOT COMPLETED|Primary Phase||3||
48276411|NCT00586612|100999831|FG000|STARTED|Booster Phase||154||
48393579|NCT00376246|101291601|FG001|STARTED|First Intervention (2 Weeks)||14||
48113321|NCT00330551|100604914|FG000|COMPLETED|Overall Study||30||
48113322|NCT00330551|100604915|FG001|COMPLETED|Overall Study||27||
48276412|NCT00586612|100999832|FG001|STARTED|Booster Phase||144||
48113323|NCT00330551|100604914|FG000|NOT COMPLETED|Overall Study||10||
48276413|NCT00586612|100999831|FG000|COMPLETED|Booster Phase||151||
48562300|NCT03743415|101709911|FG005|COMPLETED|Overall Study||42||
48562301|NCT03743415|101709912|FG006|COMPLETED|Overall Study||41||
48562302|NCT03743415|101709913|FG007|COMPLETED|Overall Study||88||
48562303|NCT03743415|101709914|FG008|COMPLETED|Overall Study||0||
48562304|NCT03743415|101709915|FG009|COMPLETED|Overall Study||0||
48562305|NCT03743415|101709906|FG000|NOT COMPLETED|Overall Study||8||
48562306|NCT03743415|101709907|FG001|NOT COMPLETED|Overall Study||3||
48562307|NCT03743415|101709908|FG002|NOT COMPLETED|Overall Study||7||
48696131|NCT01463696|102041687|FG007|STARTED|Overall Study||6||
48562308|NCT03743415|101709909|FG003|NOT COMPLETED|Overall Study||10||
48562309|NCT03743415|101709910|FG004|NOT COMPLETED|Overall Study||6||
48562310|NCT03743415|101709911|FG005|NOT COMPLETED|Overall Study||2||
48562311|NCT03743415|101709912|FG006|NOT COMPLETED|Overall Study||3||
48562312|NCT03743415|101709913|FG007|NOT COMPLETED|Overall Study||9||
48562313|NCT03743415|101709914|FG008|NOT COMPLETED|Overall Study||23||
48562314|NCT03743415|101709915|FG009|NOT COMPLETED|Overall Study||23||
48562315|NCT03802825|101709916|FG000|STARTED|Overall Study||54||
48562316|NCT03802825|101709917|FG001|STARTED|Overall Study||56||
48562317|NCT03802825|101709916|FG000|COMPLETED|Overall Study||42||
48562318|NCT03802825|101709917|FG001|COMPLETED|Overall Study||40||
48562319|NCT03802825|101709916|FG000|NOT COMPLETED|Overall Study||12||
48562320|NCT03802825|101709917|FG001|NOT COMPLETED|Overall Study||16||
48562321|NCT03743532|101709918|FG000|STARTED|Overall Study||30||
48562322|NCT03743532|101709919|FG001|STARTED|Overall Study||30||
48562323|NCT03743532|101709918|FG000|COMPLETED|Overall Study||14||
48562324|NCT03743532|101709919|FG001|COMPLETED|Overall Study||13||
48562325|NCT03743532|101709918|FG000|NOT COMPLETED|Overall Study||16||
48562326|NCT03743532|101709919|FG001|NOT COMPLETED|Overall Study||17||
48562327|NCT00780338|101709920|FG000|STARTED|Baseline to Mid (1 Year)||174||
48562328|NCT00780338|101709921|FG001|STARTED|Baseline to Mid (1 Year)||202||
48562329|NCT00780338|101709920|FG000|COMPLETED|Baseline to Mid (1 Year)||169||
48562330|NCT00780338|101709921|FG001|COMPLETED|Baseline to Mid (1 Year)||164||
48562331|NCT00780338|101709920|FG000|NOT COMPLETED|Baseline to Mid (1 Year)||5||
48562332|NCT00780338|101709921|FG001|NOT COMPLETED|Baseline to Mid (1 Year)||38||
48562333|NCT00780338|101709920|FG000|STARTED|Mid to Post (1 Year; 2 Years in Total)||169||
48562334|NCT00780338|101709921|FG001|STARTED|Mid to Post (1 Year; 2 Years in Total)||164||
48562335|NCT00780338|101709920|FG000|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||156||
48562336|NCT00780338|101709921|FG001|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||159||
48562337|NCT00780338|101709920|FG000|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||13||
48562338|NCT00780338|101709921|FG001|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||5||
48562339|NCT00886015|101709922|FG000|STARTED|Overall Study||1674||
48562340|NCT00886015|101709923|FG001|STARTED|Overall Study||1671||
48562341|NCT00886015|101709922|FG000|COMPLETED|Overall Study||1674||
48562342|NCT00886015|101709923|FG001|COMPLETED|Overall Study||1669||
48562343|NCT00886015|101709922|FG000|NOT COMPLETED|Overall Study||0||
48562344|NCT00886015|101709923|FG001|NOT COMPLETED|Overall Study||2||
48562345|NCT04268771|101709924|FG000|STARTED|Overall Study||70||
48562346|NCT04268771|101709925|FG001|STARTED|Overall Study||70||
48562347|NCT04268771|101709924|FG000|COMPLETED|Overall Study||66||
48562348|NCT04268771|101709925|FG001|COMPLETED|Overall Study||68||
48562349|NCT04268771|101709924|FG000|NOT COMPLETED|Overall Study||4||
48562350|NCT04268771|101709925|FG001|NOT COMPLETED|Overall Study||2||
48562351|NCT01805089|101709926|FG000|STARTED|Overall Study||48||
48562352|NCT01805089|101709927|FG001|STARTED|Overall Study||47||
48562353|NCT01805089|101709926|FG000|COMPLETED|Overall Study||43||
48562354|NCT01805089|101709927|FG001|COMPLETED|Overall Study||43||
48562355|NCT01805089|101709926|FG000|NOT COMPLETED|Overall Study||5||
48562356|NCT01805089|101709927|FG001|NOT COMPLETED|Overall Study||4||
48562357|NCT02750618|101709928|FG000|STARTED|Overall Study||13||
48562358|NCT02750618|101709928|FG000|Completed Week 40|Overall Study||13||
48562359|NCT02750618|101709928|FG000|Completed Week 64|Overall Study||13||
48562360|NCT02750618|101709928|FG000|COMPLETED|Overall Study||12||
48562361|NCT02750618|101709928|FG000|NOT COMPLETED|Overall Study||1||
48562362|NCT03193684|101709929|FG000|STARTED|Overall Study||36||
48562363|NCT03193684|101709930|FG001|STARTED|Overall Study||36||
48562364|NCT03193684|101709929|FG000|COMPLETED|Overall Study||36||
48562365|NCT03193684|101709930|FG001|COMPLETED|Overall Study||35||
48562366|NCT03193684|101709929|FG000|NOT COMPLETED|Overall Study||0||
48562367|NCT03193684|101709930|FG001|NOT COMPLETED|Overall Study||1||
48562368|NCT00811733|101709931|FG000|STARTED|Overall Study||15||
48562369|NCT00811733|101709932|FG001|STARTED|Overall Study||22||
48562370|NCT00811733|101709931|FG000|COMPLETED|Overall Study||4||
48562371|NCT00811733|101709932|FG001|COMPLETED|Overall Study||12||
48562372|NCT00811733|101709931|FG000|NOT COMPLETED|Overall Study||11||
48562373|NCT00811733|101709932|FG001|NOT COMPLETED|Overall Study||10||
48562374|NCT00985504|101709933|FG000|STARTED|Acute Treatment Period||244||
48562375|NCT00985504|101709934|FG001|STARTED|Acute Treatment Period||239||
48562376|NCT00985504|101709933|FG000|COMPLETED|Acute Treatment Period||229||
48696132|NCT01463696|102041680|FG000|Treated|Overall Study||1||
48696133|NCT01463696|102041681|FG001|Treated|Overall Study||6||
48696134|NCT01463696|102041682|FG002|Treated|Overall Study||3||
48562377|NCT00985504|101709934|FG001|COMPLETED|Acute Treatment Period||227||
48562378|NCT00985504|101709933|FG000|NOT COMPLETED|Acute Treatment Period||15||
48562379|NCT00985504|101709934|FG001|NOT COMPLETED|Acute Treatment Period||12||
48562380|NCT00985504|101709933|FG000|STARTED|Optimization Period||229||
48562381|NCT00985504|101709934|FG001|STARTED|Optimization Period||227||
48562382|NCT00985504|101709933|FG000|COMPLETED|Optimization Period||203||
48562383|NCT00985504|101709934|FG001|COMPLETED|Optimization Period||204||
48562384|NCT00985504|101709933|FG000|NOT COMPLETED|Optimization Period||26||
48562385|NCT00985504|101709934|FG001|NOT COMPLETED|Optimization Period||23||
48562386|NCT02174419|101709935|FG000|STARTED|Overall Study||22||
48562387|NCT02174419|101709936|FG001|STARTED|Overall Study||18||
48562388|NCT02174419|101709937|FG002|STARTED|Overall Study||22||
48562389|NCT02174419|101709935|FG000|COMPLETED|Overall Study||18||
48562390|NCT02174419|101709936|FG001|COMPLETED|Overall Study||12||
48562391|NCT02174419|101709937|FG002|COMPLETED|Overall Study||20||
48562392|NCT02174419|101709935|FG000|NOT COMPLETED|Overall Study||4||
48562393|NCT02174419|101709936|FG001|NOT COMPLETED|Overall Study||6||
48562394|NCT02174419|101709937|FG002|NOT COMPLETED|Overall Study||2||
48562395|NCT04341363|101709938|FG000|STARTED|Overall Study||8||
48562396|NCT04341363|101709938|FG000|COMPLETED|Overall Study||6||
48562397|NCT04341363|101709938|FG000|NOT COMPLETED|Overall Study||2||
48562398|NCT01808066|101709939|FG000|STARTED|Overall Study||21||
48562399|NCT01808066|101709939|FG000|COMPLETED|Overall Study||6||
48562400|NCT01808066|101709939|FG000|NOT COMPLETED|Overall Study||15||
48562401|NCT03517540|101709940|FG000|STARTED|Overall Study||50||
48562402|NCT03517540|101709941|FG001|STARTED|Overall Study||48||
48562403|NCT03517540|101709942|FG002|STARTED|Overall Study||47||
48562404|NCT03517540|101709943|FG003|STARTED|Overall Study||48||
48562405|NCT03517540|101709940|FG000|COMPLETED|Overall Study||36||
48562406|NCT03517540|101709941|FG001|COMPLETED|Overall Study||41||
48562407|NCT03517540|101709942|FG002|COMPLETED|Overall Study||38||
48562408|NCT03517540|101709943|FG003|COMPLETED|Overall Study||43||
48562409|NCT03517540|101709940|FG000|NOT COMPLETED|Overall Study||14||
48562410|NCT03517540|101709941|FG001|NOT COMPLETED|Overall Study||7||
48562411|NCT03517540|101709942|FG002|NOT COMPLETED|Overall Study||9||
48562412|NCT03517540|101709943|FG003|NOT COMPLETED|Overall Study||5||
48562413|NCT01052480|101709944|FG000|STARTED|Overall Study||49||
48562414|NCT01052480|101709945|FG001|STARTED|Overall Study||49||
48562415|NCT01052480|101709944|FG000|COMPLETED|Overall Study||41||
48562416|NCT01052480|101709945|FG001|COMPLETED|Overall Study||32||
48562417|NCT01052480|101709944|FG000|NOT COMPLETED|Overall Study||8||
48562418|NCT01052480|101709945|FG001|NOT COMPLETED|Overall Study||17||
48562419|NCT02689154|101709946|FG000|STARTED|Overall Study||18||
48562420|NCT02689154|101709946|FG000|COMPLETED|Overall Study||18||
48562421|NCT02689154|101709946|FG000|NOT COMPLETED|Overall Study||0||
48562422|NCT04982575|101709947|FG000|STARTED|Overall Study||31||
48562423|NCT04982575|101709948|FG001|STARTED|Overall Study||30||
48562424|NCT04982575|101709949|FG002|STARTED|Overall Study||31||
48562425|NCT04982575|101709947|FG000|COMPLETED|Overall Study||29||
48562426|NCT04982575|101709948|FG001|COMPLETED|Overall Study||30||
48562427|NCT04982575|101709949|FG002|COMPLETED|Overall Study||29||
48562428|NCT04982575|101709947|FG000|NOT COMPLETED|Overall Study||2||
48562429|NCT04982575|101709948|FG001|NOT COMPLETED|Overall Study||0||
48562430|NCT04982575|101709949|FG002|NOT COMPLETED|Overall Study||2||
48562431|NCT01422200|101709950|FG000|STARTED|Overall Study||11||
48562432|NCT01422200|101709951|FG001|STARTED|Overall Study||11||
48562433|NCT01422200|101709950|FG000|COMPLETED|Overall Study||11||
48562434|NCT01422200|101709951|FG001|COMPLETED|Overall Study||11||
48562435|NCT01422200|101709950|FG000|NOT COMPLETED|Overall Study||0||
48562436|NCT01422200|101709951|FG001|NOT COMPLETED|Overall Study||0||
48562437|NCT04390113|101709952|FG000|STARTED|Overall Study||57||
48562438|NCT04390113|101709953|FG001|STARTED|Overall Study||40||
48562439|NCT04390113|101709952|FG000|COMPLETED|Overall Study||37||
48562440|NCT04390113|101709953|FG001|COMPLETED|Overall Study||26||
48562441|NCT04390113|101709952|FG000|NOT COMPLETED|Overall Study||20||
48562442|NCT04390113|101709953|FG001|NOT COMPLETED|Overall Study||14||
48562443|NCT00765102|101709954|FG000|STARTED|Overall Study||32||
48562444|NCT00765102|101709954|FG000|COMPLETED|Overall Study||1||
48562445|NCT00765102|101709954|FG000|NOT COMPLETED|Overall Study||31||
48562446|NCT03989102|101709955|FG000|STARTED|Year 1||100||
48696135|NCT01463696|102041683|FG003|Treated|Overall Study||7||
48696136|NCT01463696|102041684|FG004|Treated|Overall Study||3||
48562447|NCT03989102|101709956|FG001|STARTED|Year 1||100||
48562448|NCT03989102|101709957|FG002|STARTED|Year 1||100||
48562449|NCT03989102|101709955|FG000|COMPLETED|Year 1||88||
48562450|NCT03989102|101709956|FG001|COMPLETED|Year 1||96||
48562451|NCT03989102|101709957|FG002|COMPLETED|Year 1||87||
48562452|NCT03989102|101709955|FG000|NOT COMPLETED|Year 1||12||
48562453|NCT03989102|101709956|FG001|NOT COMPLETED|Year 1||4||
48562454|NCT03989102|101709957|FG002|NOT COMPLETED|Year 1||13||
48562455|NCT03989102|101709955|FG000|STARTED|Year 2||85||
48562456|NCT03989102|101709956|FG001|STARTED|Year 2||92||
48562457|NCT03989102|101709957|FG002|STARTED|Year 2||84||
48562458|NCT03989102|101709955|FG000|COMPLETED|Year 2||66||
48562459|NCT03989102|101709956|FG001|COMPLETED|Year 2||78||
48562460|NCT03989102|101709957|FG002|COMPLETED|Year 2||68||
48562461|NCT03989102|101709955|FG000|NOT COMPLETED|Year 2||19||
48562462|NCT03989102|101709956|FG001|NOT COMPLETED|Year 2||14||
48562463|NCT03989102|101709957|FG002|NOT COMPLETED|Year 2||16||
48562464|NCT03989102|101709955|FG000|STARTED|Post-Year 3 (up to 3 Years, 8 Months)||68||
48562465|NCT03989102|101709956|FG001|STARTED|Post-Year 3 (up to 3 Years, 8 Months)||79||
48562466|NCT03989102|101709957|FG002|STARTED|Post-Year 3 (up to 3 Years, 8 Months)||71||
48562467|NCT03989102|101709955|FG000|COMPLETED|Post-Year 3 (up to 3 Years, 8 Months)||63||
48562468|NCT03989102|101709956|FG001|COMPLETED|Post-Year 3 (up to 3 Years, 8 Months)||72||
48562469|NCT03989102|101709957|FG002|COMPLETED|Post-Year 3 (up to 3 Years, 8 Months)||67||
48562470|NCT03989102|101709955|FG000|NOT COMPLETED|Post-Year 3 (up to 3 Years, 8 Months)||5||
48562471|NCT03989102|101709956|FG001|NOT COMPLETED|Post-Year 3 (up to 3 Years, 8 Months)||7||
48562472|NCT03989102|101709957|FG002|NOT COMPLETED|Post-Year 3 (up to 3 Years, 8 Months)||4||
48562473|NCT00413582|101709958|FG000|STARTED|Overall Study||55||
48562474|NCT00413582|101709959|FG001|STARTED|Overall Study||55||
48562475|NCT00413582|101709958|FG000|Completion of Study|Overall Study||55||
48562476|NCT00413582|101709959|FG001|Completion of Study|Overall Study||55||
48562477|NCT00413582|101709958|FG000|COMPLETED|Overall Study||55||
48562478|NCT00413582|101709959|FG001|COMPLETED|Overall Study||55||
48562479|NCT00413582|101709958|FG000|NOT COMPLETED|Overall Study||0||
48562480|NCT00413582|101709959|FG001|NOT COMPLETED|Overall Study||0||
48562481|NCT00884117|101709960|FG000|STARTED|Overall Study||4561||
48562482|NCT00884117|101709960|FG000|COMPLETED|Overall Study||4312||
48562483|NCT00884117|101709960|FG000|NOT COMPLETED|Overall Study||249||
48562484|NCT02954432|101709961|FG000|STARTED|Overall Study||20||
48696137|NCT01463696|102041685|FG005|Treated|Overall Study||6||
48696138|NCT01463696|102041686|FG006|Treated|Overall Study||15||
48696139|NCT01463696|102041687|FG007|Treated|Overall Study||6||
48696140|NCT01463696|102041680|FG000|COMPLETED|Overall Study||1||
48696141|NCT01463696|102041681|FG001|COMPLETED|Overall Study||4||
48696142|NCT01463696|102041682|FG002|COMPLETED|Overall Study||2||
48562485|NCT02954432|101709962|FG001|STARTED|Overall Study||20||
48276414|NCT00586612|100999832|FG001|COMPLETED|Booster Phase||143||
48276415|NCT00586612|100999831|FG000|NOT COMPLETED|Booster Phase||3||
48276416|NCT00586612|100999832|FG001|NOT COMPLETED|Booster Phase||1||
48276417|NCT02106962|100999833|FG000|STARTED|Overall Study||8||
48562486|NCT02954432|101709961|FG000|COMPLETED|Overall Study||12||
48562487|NCT02954432|101709962|FG001|COMPLETED|Overall Study||11||
48562488|NCT02954432|101709961|FG000|NOT COMPLETED|Overall Study||8||
48562489|NCT02954432|101709962|FG001|NOT COMPLETED|Overall Study||9||
48562490|NCT02535026|101709963|FG000|STARTED|Overall Study||580||
48562491|NCT02535026|101709963|FG000|COMPLETED|Overall Study||580||
48562492|NCT02535026|101709963|FG000|NOT COMPLETED|Overall Study||0||
48562493|NCT03395288|101709964|FG000|STARTED|Overall Study||28||
48562494|NCT03395288|101709965|FG001|STARTED|Overall Study||29||
48562495|NCT03395288|101709966|FG002|STARTED|Overall Study||4||
48562496|NCT03395288|101709964|FG000|COMPLETED|Overall Study||19||
48562497|NCT03395288|101709965|FG001|COMPLETED|Overall Study||25||
48562498|NCT03395288|101709966|FG002|COMPLETED|Overall Study||3||
48276418|NCT02106962|100999834|FG001|STARTED|Overall Study||9||
48562499|NCT03395288|101709964|FG000|NOT COMPLETED|Overall Study||9||
48562500|NCT03395288|101709965|FG001|NOT COMPLETED|Overall Study||4||
48562501|NCT03395288|101709966|FG002|NOT COMPLETED|Overall Study||1||
48562502|NCT02547012|101709967|FG000|STARTED|Overall Study||24||
48562503|NCT02547012|101709968|FG001|STARTED|Overall Study||27||
48562504|NCT02547012|101709967|FG000|COMPLETED|Overall Study||24||
48562505|NCT02547012|101709968|FG001|COMPLETED|Overall Study||27||
48562506|NCT02547012|101709967|FG000|NOT COMPLETED|Overall Study||0||
48562507|NCT02547012|101709968|FG001|NOT COMPLETED|Overall Study||0||
48562508|NCT02741076|101709969|FG000|STARTED|Overall Study||13||
48562509|NCT02741076|101709970|FG001|STARTED|Overall Study||12||
48562510|NCT02741076|101709971|FG002|STARTED|Overall Study||3||
48562511|NCT02741076|101709972|FG003|STARTED|Overall Study||4||
48562512|NCT02741076|101709969|FG000|COMPLETED|Overall Study||10||
48562513|NCT02741076|101709970|FG001|COMPLETED|Overall Study||7||
48562514|NCT02741076|101709971|FG002|COMPLETED|Overall Study||1||
48276419|NCT02106962|100999833|FG000|COMPLETED|Overall Study||8||
48276420|NCT02106962|100999834|FG001|COMPLETED|Overall Study||9||
48276421|NCT02106962|100999833|FG000|NOT COMPLETED|Overall Study||0||
48562515|NCT02741076|101709972|FG003|COMPLETED|Overall Study||2||
48562516|NCT02741076|101709969|FG000|NOT COMPLETED|Overall Study||3||
48696143|NCT01463696|102041683|FG003|COMPLETED|Overall Study||3||
48696144|NCT01463696|102041684|FG004|COMPLETED|Overall Study||2||
48696145|NCT01463696|102041685|FG005|COMPLETED|Overall Study||3||
48696146|NCT01463696|102041686|FG006|COMPLETED|Overall Study||6||
48696147|NCT01463696|102041687|FG007|COMPLETED|Overall Study||2||
48696148|NCT01463696|102041680|FG000|NOT COMPLETED|Overall Study||0||
48696149|NCT01463696|102041681|FG001|NOT COMPLETED|Overall Study||2||
48562517|NCT02741076|101709970|FG001|NOT COMPLETED|Overall Study||5||
48562518|NCT02741076|101709971|FG002|NOT COMPLETED|Overall Study||2||
48562519|NCT02741076|101709972|FG003|NOT COMPLETED|Overall Study||2||
48562520|NCT02329015|101709973|FG000|STARTED|Overall Study||48||
48562521|NCT02329015|101709974|FG001|STARTED|Overall Study||64||
48562522|NCT02329015|101709973|FG000|COMPLETED|Overall Study||48||
48562523|NCT02329015|101709974|FG001|COMPLETED|Overall Study||64||
48562524|NCT02329015|101709973|FG000|NOT COMPLETED|Overall Study||0||
48276422|NCT02106962|100999834|FG001|NOT COMPLETED|Overall Study||0||
48276423|NCT00831753|100999835|FG000|STARTED|Overall Study||132||
48276424|NCT00831753|100999836|FG001|STARTED|Overall Study||131||
48696150|NCT01463696|102041682|FG002|NOT COMPLETED|Overall Study||1||
48696151|NCT01463696|102041683|FG003|NOT COMPLETED|Overall Study||4||
48696152|NCT01463696|102041684|FG004|NOT COMPLETED|Overall Study||1||
48696153|NCT01463696|102041685|FG005|NOT COMPLETED|Overall Study||3||
48696154|NCT01463696|102041686|FG006|NOT COMPLETED|Overall Study||10||
48696155|NCT01463696|102041687|FG007|NOT COMPLETED|Overall Study||4||
48696156|NCT02675751|102041688|FG000|STARTED|Overall Study||167|"Participants 167~Units (eyes) 334"|334
48696157|NCT02675751|102041688|FG000|COMPLETED|Overall Study||151|"Participants 151~Units (eyes) 302"|302
48696158|NCT02675751|102041688|FG000|NOT COMPLETED|Overall Study||16||32
48696159|NCT01691105|102041689|FG000|STARTED|Baseline||477||
48696160|NCT01691105|102041690|FG001|STARTED|Baseline||567||
48696161|NCT01691105|102041689|FG000|COMPLETED|Baseline||477||
48696162|NCT01691105|102041690|FG001|COMPLETED|Baseline||567||
48696163|NCT01691105|102041689|FG000|NOT COMPLETED|Baseline||0||
48696164|NCT01691105|102041690|FG001|NOT COMPLETED|Baseline||0||
48696165|NCT01691105|102041689|FG000|STARTED|1 Month Follow-up||477||
48696166|NCT01691105|102041690|FG001|STARTED|1 Month Follow-up||567||
48696167|NCT01691105|102041689|FG000|COMPLETED|1 Month Follow-up||434||
48696168|NCT01691105|102041690|FG001|COMPLETED|1 Month Follow-up||526||
48696169|NCT01691105|102041689|FG000|NOT COMPLETED|1 Month Follow-up||43||
48696170|NCT01691105|102041690|FG001|NOT COMPLETED|1 Month Follow-up||41||
48696171|NCT01691105|102041689|FG000|STARTED|6 Month Follow-up||477||
48696172|NCT01691105|102041690|FG001|STARTED|6 Month Follow-up||567||
48696173|NCT01691105|102041689|FG000|COMPLETED|6 Month Follow-up||425||
48696174|NCT01691105|102041690|FG001|COMPLETED|6 Month Follow-up||496||
48696175|NCT01691105|102041689|FG000|NOT COMPLETED|6 Month Follow-up||52||
48696176|NCT01691105|102041690|FG001|NOT COMPLETED|6 Month Follow-up||71||
48696177|NCT01691105|102041689|FG000|STARTED|12 Month Follow-up||477||
48696178|NCT01691105|102041690|FG001|STARTED|12 Month Follow-up||567||
48696179|NCT01691105|102041689|FG000|COMPLETED|12 Month Follow-up||405||
48696180|NCT01691105|102041690|FG001|COMPLETED|12 Month Follow-up||466||
48696181|NCT01691105|102041689|FG000|NOT COMPLETED|12 Month Follow-up||72||
48696182|NCT01691105|102041690|FG001|NOT COMPLETED|12 Month Follow-up||101||
48696183|NCT01691105|102041689|FG000|STARTED|12 Month Biochemical Verification||477||
48696184|NCT01691105|102041690|FG001|STARTED|12 Month Biochemical Verification||567||
48696185|NCT01691105|102041689|FG000|COMPLETED|12 Month Biochemical Verification||53||
48696186|NCT01691105|102041690|FG001|COMPLETED|12 Month Biochemical Verification||65||
48696187|NCT01691105|102041689|FG000|NOT COMPLETED|12 Month Biochemical Verification||424||
48696188|NCT01691105|102041690|FG001|NOT COMPLETED|12 Month Biochemical Verification||502||
48696189|NCT01232504|102041691|FG000|STARTED|Overall Study||68||
48696190|NCT01232504|102041692|FG001|STARTED|Overall Study||69||
48696191|NCT01232504|102041693|FG002|STARTED|Overall Study||69||
48696192|NCT01232504|102041691|FG000|COMPLETED|Overall Study||59||
48696193|NCT01232504|102041692|FG001|COMPLETED|Overall Study||67||
48696194|NCT01232504|102041693|FG002|COMPLETED|Overall Study||61||
48696195|NCT01232504|102041691|FG000|NOT COMPLETED|Overall Study||9||
48696196|NCT01232504|102041692|FG001|NOT COMPLETED|Overall Study||2||
48276425|NCT00831753|100999835|FG000|COMPLETED|Overall Study||132||
48276426|NCT00831753|100999836|FG001|COMPLETED|Overall Study||131||
48276427|NCT00831753|100999835|FG000|NOT COMPLETED|Overall Study||0||
48276428|NCT00831753|100999836|FG001|NOT COMPLETED|Overall Study||0||
48276429|NCT02683785|100999837|FG000|STARTED|Overall Study||22||
48276430|NCT02683785|100999838|FG001|STARTED|Overall Study||22||
48276431|NCT02683785|100999837|FG000|COMPLETED|Overall Study||21||
48276432|NCT02683785|100999838|FG001|COMPLETED|Overall Study||18||
48276433|NCT02683785|100999837|FG000|NOT COMPLETED|Overall Study||1||
48276434|NCT02683785|100999838|FG001|NOT COMPLETED|Overall Study||4||
48276435|NCT00890695|100999839|FG000|STARTED|Overall Study||32||
48276436|NCT00890695|100999840|FG001|STARTED|Overall Study||33||
48276437|NCT00890695|100999839|FG000|COMPLETED|Overall Study||31||
48276438|NCT00890695|100999840|FG001|COMPLETED|Overall Study||33||
48696197|NCT01232504|102041693|FG002|NOT COMPLETED|Overall Study||8||
48276439|NCT00890695|100999839|FG000|NOT COMPLETED|Overall Study||1||
48276440|NCT00890695|100999840|FG001|NOT COMPLETED|Overall Study||0||
48696198|NCT03333252|102041694|FG000|STARTED|Overall Study||89||
48696199|NCT03333252|102041695|FG001|STARTED|Overall Study||87||
48696200|NCT03333252|102041696|FG002|STARTED|Overall Study||89||
48696201|NCT03333252|102041697|FG003|STARTED|Overall Study||87||
48696202|NCT03333252|102041694|FG000|COMPLETED|Overall Study||56||
48696203|NCT03333252|102041695|FG001|COMPLETED|Overall Study||45||
48696204|NCT03333252|102041696|FG002|COMPLETED|Overall Study||64||
48696205|NCT03333252|102041697|FG003|COMPLETED|Overall Study||58||
48276441|NCT01518153|100999841|FG000|STARTED|Stem Cell Transplant||16||
48276442|NCT01518153|100999842|FG001|STARTED|Stem Cell Transplant||0||
48696206|NCT03333252|102041694|FG000|NOT COMPLETED|Overall Study||33||
48696207|NCT03333252|102041695|FG001|NOT COMPLETED|Overall Study||42||
48696208|NCT03333252|102041696|FG002|NOT COMPLETED|Overall Study||25||
48696209|NCT03333252|102041697|FG003|NOT COMPLETED|Overall Study||29||
48696210|NCT05145322|102041698|FG000|STARTED|Overall Study||18||
48276443|NCT01518153|100999843|FG002|STARTED|Stem Cell Transplant||0||
48276444|NCT01518153|100999841|FG000|COMPLETED|Stem Cell Transplant||7||
48276445|NCT01518153|100999842|FG001|COMPLETED|Stem Cell Transplant||0||
48562525|NCT02329015|101709974|FG001|NOT COMPLETED|Overall Study||0||
48562526|NCT01037218|101709975|FG000|STARTED|Overall Study||147||
48562527|NCT01037218|101709976|FG001|STARTED|Overall Study||149||
48276446|NCT01518153|100999843|FG002|COMPLETED|Stem Cell Transplant||0||
48276447|NCT01518153|100999841|FG000|NOT COMPLETED|Stem Cell Transplant||9||
48276448|NCT01518153|100999842|FG001|NOT COMPLETED|Stem Cell Transplant||0||
48276449|NCT01518153|100999843|FG002|NOT COMPLETED|Stem Cell Transplant||0||
48276450|NCT01518153|100999841|FG000|STARTED|Donor Lymphocyte Infusion||0||
48276451|NCT01518153|100999842|FG001|STARTED|Donor Lymphocyte Infusion||3||
48276452|NCT01518153|100999843|FG002|STARTED|Donor Lymphocyte Infusion||4||
48276453|NCT01518153|100999841|FG000|COMPLETED|Donor Lymphocyte Infusion||0||
48276454|NCT01518153|100999842|FG001|COMPLETED|Donor Lymphocyte Infusion||1||
48276455|NCT01518153|100999843|FG002|COMPLETED|Donor Lymphocyte Infusion||3||
48276456|NCT01518153|100999841|FG000|NOT COMPLETED|Donor Lymphocyte Infusion||0||
48276457|NCT01518153|100999842|FG001|NOT COMPLETED|Donor Lymphocyte Infusion||2||
48276458|NCT01518153|100999843|FG002|NOT COMPLETED|Donor Lymphocyte Infusion||1||
48276459|NCT00668265|100999844|FG000|STARTED|Overall Study||9||
48276460|NCT00668265|100999845|FG001|STARTED|Overall Study||5||
48276461|NCT00668265|100999844|FG000|COMPLETED|Overall Study||0||
48276462|NCT00668265|100999845|FG001|COMPLETED|Overall Study||0||
48276463|NCT00668265|100999844|FG000|NOT COMPLETED|Overall Study||9||
48276464|NCT00668265|100999845|FG001|NOT COMPLETED|Overall Study||5||
48276465|NCT02060370|100999846|FG000|STARTED|Overall Study||60||
48276466|NCT02060370|100999846|FG000|COMPLETED|Overall Study||59||
48276467|NCT02060370|100999846|FG000|NOT COMPLETED|Overall Study||1||
48276468|NCT03377699|100999847|FG000|STARTED|Overall Study||111|Full analysis set for all women (FASall)|
48276469|NCT03377699|100999848|FG001|STARTED|Overall Study||114|Full analysis set for all women (FASall)|
48276470|NCT03377699|100999847|FG000|Treated|Overall Study||110|Safety analysis set for all women (SASall)|
48276471|NCT03377699|100999848|FG001|Treated|Overall Study||112|Safety analysis set for all women (SASall)|
48276472|NCT03377699|100999847|FG000|SASpregnant|Overall Study||91|Safety analysis set for pregnant women (SASpregnant)|
48276473|NCT03377699|100999848|FG001|SASpregnant|Overall Study||94|Safety analysis set for pregnant women (SASpregnant)|
48276474|NCT03377699|100999847|FG000|FASpregnant|Overall Study||92|Full analysis set for pregnant women (FASpregnant)|
48276475|NCT03377699|100999848|FG001|FASpregnant|Overall Study||96|Full analysis set for pregnant women (FASpregnant)|
48276476|NCT03377699|100999847|FG000|COMPLETED|Overall Study||89||
48276477|NCT03377699|100999848|FG001|COMPLETED|Overall Study||89||
48276478|NCT03377699|100999847|FG000|NOT COMPLETED|Overall Study||22||
48276479|NCT03377699|100999848|FG001|NOT COMPLETED|Overall Study||25||
48276480|NCT00954187|100999849|FG000|STARTED|Overall Study||0||
48276481|NCT00954187|100999850|FG001|STARTED|Overall Study||0||
48562528|NCT01037218|101709977|FG002|STARTED|Overall Study||155||
48562529|NCT01037218|101709978|FG003|STARTED|Overall Study||150||
48562530|NCT01037218|101709975|FG000|Safety Population|Overall Study||147||
48276482|NCT00954187|100999849|FG000|COMPLETED|Overall Study||0||
48276483|NCT00954187|100999850|FG001|COMPLETED|Overall Study||0||
48276484|NCT00954187|100999849|FG000|NOT COMPLETED|Overall Study||0||
48276485|NCT00954187|100999850|FG001|NOT COMPLETED|Overall Study||0||
48276486|NCT00383110|100999851|FG000|STARTED|Overall Study||150||
48276487|NCT00383110|100999852|FG001|STARTED|Overall Study||150||
48276488|NCT00383110|100999851|FG000|COMPLETED|Overall Study||150||
48276489|NCT00383110|100999852|FG001|COMPLETED|Overall Study||150||
48276490|NCT00383110|100999851|FG000|NOT COMPLETED|Overall Study||0||
48276491|NCT00383110|100999852|FG001|NOT COMPLETED|Overall Study||0||
48276492|NCT05467293|100999853|FG000|STARTED|Overall Study||85||
48276493|NCT05467293|100999854|FG001|STARTED|Overall Study||86||
48276494|NCT05467293|100999855|FG002|STARTED|Overall Study||86||
48276495|NCT05467293|100999853|FG000|COMPLETED|Overall Study||77||
48276496|NCT05467293|100999854|FG001|COMPLETED|Overall Study||81||
48276497|NCT05467293|100999855|FG002|COMPLETED|Overall Study||84||
48276498|NCT05467293|100999853|FG000|NOT COMPLETED|Overall Study||8||
48276499|NCT05467293|100999854|FG001|NOT COMPLETED|Overall Study||5||
48276500|NCT05467293|100999855|FG002|NOT COMPLETED|Overall Study||2||
48276501|NCT01905150|100999856|FG000|STARTED|Overall Study||14|Disease Progrression|
48276502|NCT01905150|100999857|FG001|STARTED|Overall Study||18|Disease Progrression|
48276503|NCT01905150|100999856|FG000|COMPLETED|Overall Study||12|Disease Progression|
48276504|NCT01905150|100999857|FG001|COMPLETED|Overall Study||18|Disease Progression|
48562531|NCT01037218|101709976|FG001|Safety Population|Overall Study||148||
48562532|NCT01037218|101709977|FG002|Safety Population|Overall Study||154||
48276505|NCT01905150|100999856|FG000|NOT COMPLETED|Overall Study||2||
48276506|NCT01905150|100999857|FG001|NOT COMPLETED|Overall Study||0||
48562533|NCT01037218|101709978|FG003|Safety Population|Overall Study||150||
48562534|NCT01037218|101709975|FG000|mITT Population|Overall Study||141||
48562535|NCT01037218|101709976|FG001|mITT Population|Overall Study||140||
48562536|NCT01037218|101709977|FG002|mITT Population|Overall Study||147||
48562537|NCT01037218|101709978|FG003|mITT Population|Overall Study||141||
48562538|NCT01037218|101709975|FG000|COMPLETED|Overall Study||131||
48562539|NCT01037218|101709976|FG001|COMPLETED|Overall Study||128||
48562540|NCT01037218|101709977|FG002|COMPLETED|Overall Study||134||
48696211|NCT05145322|102041699|FG001|STARTED|Overall Study||18||
48696212|NCT05145322|102041698|FG000|Restoration Placement|Overall Study||18||
48696213|NCT05145322|102041699|FG001|Restoration Placement|Overall Study||18||
48696214|NCT05145322|102041698|FG000|6-months Follow up|Overall Study||16||
48696215|NCT05145322|102041699|FG001|6-months Follow up|Overall Study||17||
48696216|NCT05145322|102041698|FG000|COMPLETED|Overall Study||14|Completion is defined as having attended the 18-months follow-up visit.|
48696217|NCT05145322|102041699|FG001|COMPLETED|Overall Study||13|Completion is defined as having attended the 18-months follow-up visit.|
48696218|NCT05145322|102041698|FG000|NOT COMPLETED|Overall Study||4||
48696219|NCT05145322|102041699|FG001|NOT COMPLETED|Overall Study||5||
48696220|NCT03300024|102041700|FG000|STARTED|Overall Study||4||
48696221|NCT03300024|102041701|FG001|STARTED|Overall Study||6||
48696222|NCT03300024|102041700|FG000|COMPLETED|Overall Study||0||
48696223|NCT03300024|102041701|FG001|COMPLETED|Overall Study||0||
48696224|NCT03300024|102041700|FG000|NOT COMPLETED|Overall Study||4||
48696225|NCT03300024|102041701|FG001|NOT COMPLETED|Overall Study||6||
48696226|NCT01825512|102041702|FG000|STARTED|Baseline||194||
48696227|NCT01825512|102041703|FG001|STARTED|Baseline||199||
48696228|NCT01825512|102041702|FG000|COMPLETED|Baseline||193||
48696229|NCT01825512|102041703|FG001|COMPLETED|Baseline||197||
48113324|NCT00330551|100604915|FG001|NOT COMPLETED|Overall Study||16||
48113325|NCT01686646|100604916|FG000|STARTED|Overall Study||45||
48113326|NCT01686646|100604917|FG001|STARTED|Overall Study||45||
48113327|NCT01686646|100604918|FG002|STARTED|Overall Study||75||
48113328|NCT01686646|100604919|FG003|STARTED|Overall Study||75||
48113329|NCT01686646|100604916|FG000|Intent to Treat Population|Overall Study||45||
48113330|NCT01686646|100604917|FG001|Intent to Treat Population|Overall Study||45||
48113331|NCT01686646|100604918|FG002|Intent to Treat Population|Overall Study||75||
48113332|NCT01686646|100604919|FG003|Intent to Treat Population|Overall Study||75||
48113333|NCT01686646|100604916|FG000|Safety Population|Overall Study||46||
48113334|NCT01686646|100604917|FG001|Safety Population|Overall Study||45||
48393580|NCT00376246|101291600|FG000|COMPLETED|First Intervention (2 Weeks)||10||
48393581|NCT00376246|101291601|FG001|COMPLETED|First Intervention (2 Weeks)||12||
48393582|NCT00376246|101291600|FG000|NOT COMPLETED|First Intervention (2 Weeks)||4||
48393583|NCT00376246|101291601|FG001|NOT COMPLETED|First Intervention (2 Weeks)||2||
48562541|NCT01037218|101709978|FG003|COMPLETED|Overall Study||134||
48562542|NCT01037218|101709975|FG000|NOT COMPLETED|Overall Study||16||
48562543|NCT01037218|101709976|FG001|NOT COMPLETED|Overall Study||21||
48562544|NCT01037218|101709977|FG002|NOT COMPLETED|Overall Study||21||
48562545|NCT01037218|101709978|FG003|NOT COMPLETED|Overall Study||16||
48562546|NCT01769573|101709979|FG000|STARTED|Overall Study||10||
48696230|NCT01825512|102041702|FG000|NOT COMPLETED|Baseline||1||
48696231|NCT01825512|102041703|FG001|NOT COMPLETED|Baseline||2||
48113335|NCT01686646|100604918|FG002|Safety Population|Overall Study||74||
48696232|NCT01825512|102041702|FG000|STARTED|Treatment||193||
48113336|NCT01686646|100604919|FG003|Safety Population|Overall Study||75||
48113337|NCT01686646|100604916|FG000|COMPLETED|Overall Study||45||
48113338|NCT01686646|100604917|FG001|COMPLETED|Overall Study||45||
48113339|NCT01686646|100604918|FG002|COMPLETED|Overall Study||75||
48113340|NCT01686646|100604919|FG003|COMPLETED|Overall Study||75||
48113341|NCT01686646|100604916|FG000|NOT COMPLETED|Overall Study||0||
48113342|NCT01686646|100604917|FG001|NOT COMPLETED|Overall Study||0||
48393584|NCT00376246|101291600|FG000|STARTED|Washout (2 Weeks)||10||
48393585|NCT00376246|101291601|FG001|STARTED|Washout (2 Weeks)||12||
48393586|NCT00376246|101291600|FG000|COMPLETED|Washout (2 Weeks)||10||
48393587|NCT00376246|101291601|FG001|COMPLETED|Washout (2 Weeks)||12||
48562547|NCT01769573|101709980|FG001|STARTED|Overall Study||6||
48562548|NCT01769573|101709981|FG002|STARTED|Overall Study||10||
48562549|NCT01769573|101709982|FG003|STARTED|Overall Study||0||
48562550|NCT01769573|101709983|FG004|STARTED|Overall Study||10||
48562551|NCT01769573|101709979|FG000|COMPLETED|Overall Study||10||
48696233|NCT01825512|102041703|FG001|STARTED|Treatment||197||
48696234|NCT01825512|102041702|FG000|COMPLETED|Treatment||140||
48696235|NCT01825512|102041703|FG001|COMPLETED|Treatment||170||
48696236|NCT01825512|102041702|FG000|NOT COMPLETED|Treatment||53||
48696237|NCT01825512|102041703|FG001|NOT COMPLETED|Treatment||27||
48696238|NCT03624478|102041704|FG000|STARTED|Overall Study||25||
48696239|NCT03624478|102041704|FG000|COMPLETED|Overall Study||24||
48696240|NCT03624478|102041704|FG000|NOT COMPLETED|Overall Study||1||
48696241|NCT05479097|102041705|FG000|STARTED|Overall Study||32||
48696242|NCT05479097|102041705|FG000|COMPLETED|Overall Study||30||
48696243|NCT05479097|102041705|FG000|NOT COMPLETED|Overall Study||2||
48696244|NCT01202188|102041706|FG000|STARTED|Overall Study||475||
48696245|NCT01202188|102041707|FG001|STARTED|Overall Study||477||
48696246|NCT01202188|102041708|FG002|STARTED|Overall Study||475||
48696247|NCT01202188|102041709|FG003|STARTED|Overall Study||483||
48696248|NCT01202188|102041710|FG004|STARTED|Overall Study||234||
48562552|NCT01769573|101709980|FG001|COMPLETED|Overall Study||6||
48113343|NCT01686646|100604918|FG002|NOT COMPLETED|Overall Study||0||
48113344|NCT01686646|100604919|FG003|NOT COMPLETED|Overall Study||0||
48113345|NCT01227512|100604920|FG000|STARTED|Overall Study||66||
48113346|NCT01227512|100604921|FG001|STARTED|Overall Study||58||
48113347|NCT01227512|100604920|FG000|COMPLETED|Overall Study||53||
48393588|NCT00376246|101291600|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
48696249|NCT01202188|102041706|FG000|Safety Set; Received Study Drug|Overall Study||474||
48276507|NCT00468559|100999858|FG000|STARTED|Open-label Treatment Phase||98||
48276508|NCT00468559|100999859|FG001|STARTED|Open-label Treatment Phase||0||
48276509|NCT00468559|100999860|FG002|STARTED|Open-label Treatment Phase||0||
48276510|NCT00468559|100999858|FG000|COMPLETED|Open-label Treatment Phase||80||
48276511|NCT00468559|100999859|FG001|COMPLETED|Open-label Treatment Phase||0||
48276512|NCT00468559|100999860|FG002|COMPLETED|Open-label Treatment Phase||0||
48276513|NCT00468559|100999858|FG000|NOT COMPLETED|Open-label Treatment Phase||18||
48276514|NCT00468559|100999859|FG001|NOT COMPLETED|Open-label Treatment Phase||0||
48276515|NCT00468559|100999860|FG002|NOT COMPLETED|Open-label Treatment Phase||0||
48276516|NCT00468559|100999858|FG000|STARTED|Double-blind, Treatment-withdrawal Phase||0||
48276517|NCT00468559|100999859|FG001|STARTED|Double-blind, Treatment-withdrawal Phase||39||
48276518|NCT00468559|100999860|FG002|STARTED|Double-blind, Treatment-withdrawal Phase||41||
48276519|NCT00468559|100999858|FG000|COMPLETED|Double-blind, Treatment-withdrawal Phase||0||
48276520|NCT00468559|100999859|FG001|COMPLETED|Double-blind, Treatment-withdrawal Phase||29||
48276521|NCT00468559|100999860|FG002|COMPLETED|Double-blind, Treatment-withdrawal Phase||24||
48276522|NCT00468559|100999858|FG000|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||0||
48276523|NCT00468559|100999859|FG001|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||10||
48276524|NCT00468559|100999860|FG002|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||17||
48276525|NCT03878277|100999861|FG000|STARTED|Overall Study||10||
48276526|NCT03878277|100999861|FG000|COMPLETED|Overall Study||10||
48276527|NCT03878277|100999861|FG000|NOT COMPLETED|Overall Study||0||
48276528|NCT01333813|100999862|FG000|STARTED|Overall Study||297||
48276529|NCT01333813|100999862|FG000|COMPLETED|Overall Study||297||
48276530|NCT01333813|100999862|FG000|NOT COMPLETED|Overall Study||0||
48276531|NCT01075958|100999863|FG000|STARTED|Overall Study||283||
48276532|NCT01075958|100999863|FG000|COMPLETED|Overall Study||239||
48276533|NCT01075958|100999863|FG000|NOT COMPLETED|Overall Study||44||
48276534|NCT00095056|100999864|FG000|STARTED|Phase A (Weeks 0-12)||65||
48276535|NCT00095056|100999865|FG001|STARTED|Phase A (Weeks 0-12)||26||
48276536|NCT00095056|100999864|FG000|COMPLETED|Phase A (Weeks 0-12)||58||
48276537|NCT00095056|100999865|FG001|COMPLETED|Phase A (Weeks 0-12)||25||
48276538|NCT00095056|100999864|FG000|NOT COMPLETED|Phase A (Weeks 0-12)||7||
48276539|NCT00095056|100999865|FG001|NOT COMPLETED|Phase A (Weeks 0-12)||1||
48276540|NCT00095056|100999864|FG000|STARTED|Phase B (Weeks 12-54)||56||
48276541|NCT00095056|100999865|FG001|STARTED|Phase B (Weeks 12-54)||25||
48276542|NCT00095056|100999864|FG000|COMPLETED|Phase B (Weeks 12-54)||46||
48276543|NCT00095056|100999865|FG001|COMPLETED|Phase B (Weeks 12-54)||20||
48276544|NCT00095056|100999864|FG000|NOT COMPLETED|Phase B (Weeks 12-54)||10||
48276545|NCT00095056|100999865|FG001|NOT COMPLETED|Phase B (Weeks 12-54)||5||
48276546|NCT03014479|100999866|FG000|STARTED|Overall Study||110||
48696250|NCT01202188|102041707|FG001|Safety Set; Received Study Drug|Overall Study||476||
48276547|NCT03014479|100999867|FG001|STARTED|Overall Study||109||
48276548|NCT03014479|100999866|FG000|COMPLETED|Overall Study||110||
48276549|NCT03014479|100999867|FG001|COMPLETED|Overall Study||105||
48276550|NCT03014479|100999866|FG000|NOT COMPLETED|Overall Study||0||
48276551|NCT03014479|100999867|FG001|NOT COMPLETED|Overall Study||4||
48276552|NCT01562041|100999868|FG000|STARTED|Overall Study||14||
48276553|NCT01562041|100999868|FG000|COMPLETED|Overall Study||14||
48276554|NCT01562041|100999868|FG000|NOT COMPLETED|Overall Study||0||
48276555|NCT04828837|100999869|FG000|STARTED|Overall Study||13||
48276556|NCT04828837|100999870|FG001|STARTED|Overall Study||14||
48276557|NCT04828837|100999869|FG000|COMPLETED|Overall Study||8||
48276558|NCT04828837|100999870|FG001|COMPLETED|Overall Study||4||
48276559|NCT04828837|100999869|FG000|NOT COMPLETED|Overall Study||5||
48276560|NCT04828837|100999870|FG001|NOT COMPLETED|Overall Study||10||
48276561|NCT04246021|100999871|FG000|STARTED|Overall Study||84||
48276562|NCT04246021|100999871|FG000|COMPLETED|Overall Study||84||
48276563|NCT04246021|100999871|FG000|NOT COMPLETED|Overall Study||0||
48276564|NCT01280357|100999872|FG000|STARTED|Overall Study||60||
48276565|NCT01280357|100999872|FG000|COMPLETED|Overall Study||34||
48276566|NCT01280357|100999872|FG000|NOT COMPLETED|Overall Study||26||
48276567|NCT00359983|100999873|FG000|STARTED|Year 1 Persistence Follow-up||138||
48276568|NCT00359983|100999874|FG001|STARTED|Year 1 Persistence Follow-up||70||
48696251|NCT01202188|102041708|FG002|Safety Set; Received Study Drug|Overall Study||473||
48696252|NCT01202188|102041709|FG003|Safety Set; Received Study Drug|Overall Study||480||
48276569|NCT00359983|100999875|FG002|STARTED|Year 1 Persistence Follow-up||62||
48276570|NCT00359983|100999873|FG000|COMPLETED|Year 1 Persistence Follow-up||138||
48276571|NCT00359983|100999874|FG001|COMPLETED|Year 1 Persistence Follow-up||70||
48276572|NCT00359983|100999875|FG002|COMPLETED|Year 1 Persistence Follow-up||62||
48276573|NCT00359983|100999873|FG000|NOT COMPLETED|Year 1 Persistence Follow-up||0||
48276574|NCT00359983|100999874|FG001|NOT COMPLETED|Year 1 Persistence Follow-up||0||
48276575|NCT00359983|100999875|FG002|NOT COMPLETED|Year 1 Persistence Follow-up||0||
48276576|NCT00359983|100999873|FG000|STARTED|Year 3 Persistence Follow-up||103||
48276577|NCT00359983|100999874|FG001|STARTED|Year 3 Persistence Follow-up||47||
48276578|NCT00359983|100999875|FG002|STARTED|Year 3 Persistence Follow-up||51||
48276579|NCT00359983|100999873|FG000|COMPLETED|Year 3 Persistence Follow-up||103||
48276580|NCT00359983|100999874|FG001|COMPLETED|Year 3 Persistence Follow-up||47||
48562553|NCT01769573|101709981|FG002|COMPLETED|Overall Study||10||
48562554|NCT01769573|101709982|FG003|COMPLETED|Overall Study||0||
48562555|NCT01769573|101709983|FG004|COMPLETED|Overall Study||10||
48562556|NCT01769573|101709979|FG000|NOT COMPLETED|Overall Study||0||
48562557|NCT01769573|101709980|FG001|NOT COMPLETED|Overall Study||0||
48562558|NCT01769573|101709981|FG002|NOT COMPLETED|Overall Study||0||
48562559|NCT01769573|101709982|FG003|NOT COMPLETED|Overall Study||0||
48562560|NCT01769573|101709983|FG004|NOT COMPLETED|Overall Study||0||
48562561|NCT01953302|101709984|FG000|STARTED|Overall Study||124||
48562562|NCT01953302|101709984|FG000|COMPLETED|Overall Study||124||
48562563|NCT01953302|101709984|FG000|NOT COMPLETED|Overall Study||0||
48562564|NCT03146806|101709985|FG000|STARTED|Overall Study||10||
48562565|NCT03146806|101709985|FG000|COMPLETED|Overall Study||10||
48562566|NCT03146806|101709985|FG000|NOT COMPLETED|Overall Study||0||
48562567|NCT01836471|101709986|FG000|STARTED|Overall Study||93||
48562568|NCT01836471|101709987|FG001|STARTED|Overall Study||94||
48562569|NCT01836471|101709988|FG002|STARTED|Overall Study||51||
48562570|NCT01836471|101709989|FG003|STARTED|Overall Study||42||
48562571|NCT01836471|101709990|FG004|STARTED|Overall Study||54||
48562572|NCT01836471|101709986|FG000|COMPLETED|Overall Study||82||
48562573|NCT01836471|101709987|FG001|COMPLETED|Overall Study||85||
48562574|NCT01836471|101709988|FG002|COMPLETED|Overall Study||49||
48562575|NCT01836471|101709989|FG003|COMPLETED|Overall Study||40||
48562576|NCT01836471|101709990|FG004|COMPLETED|Overall Study||49||
48562577|NCT01836471|101709986|FG000|NOT COMPLETED|Overall Study||11||
48562578|NCT01836471|101709987|FG001|NOT COMPLETED|Overall Study||9||
48696253|NCT01202188|102041710|FG004|Safety Set; Received Study Drug|Overall Study||232||
48696254|NCT01202188|102041706|FG000|COMPLETED|Overall Study||437||
48696255|NCT01202188|102041707|FG001|COMPLETED|Overall Study||421||
48696256|NCT01202188|102041708|FG002|COMPLETED|Overall Study||422||
48393589|NCT00376246|101291601|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
48393590|NCT00376246|101291600|FG000|STARTED|Second Intervention (2 Weeks)||10||
48393591|NCT00376246|101291601|FG001|STARTED|Second Intervention (2 Weeks)||12||
48393592|NCT00376246|101291600|FG000|COMPLETED|Second Intervention (2 Weeks)||10||
48393593|NCT00376246|101291601|FG001|COMPLETED|Second Intervention (2 Weeks)||12||
48393594|NCT00376246|101291600|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48393595|NCT00376246|101291601|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48393596|NCT01896856|101291602|FG000|STARTED|Overall Study||6||
48393597|NCT01896856|101291603|FG001|STARTED|Overall Study||3||
48393598|NCT01896856|101291604|FG002|STARTED|Overall Study||7||
48562579|NCT01836471|101709988|FG002|NOT COMPLETED|Overall Study||2||
48562580|NCT01836471|101709989|FG003|NOT COMPLETED|Overall Study||2||
48562581|NCT01836471|101709990|FG004|NOT COMPLETED|Overall Study||5||
48696257|NCT01202188|102041709|FG003|COMPLETED|Overall Study||441||
48696258|NCT01202188|102041710|FG004|COMPLETED|Overall Study||189||
48276581|NCT00359983|100999875|FG002|COMPLETED|Year 3 Persistence Follow-up||51||
48276582|NCT00359983|100999873|FG000|NOT COMPLETED|Year 3 Persistence Follow-up||0||
48276583|NCT00359983|100999874|FG001|NOT COMPLETED|Year 3 Persistence Follow-up||0||
48276584|NCT00359983|100999875|FG002|NOT COMPLETED|Year 3 Persistence Follow-up||0||
48696259|NCT01202188|102041706|FG000|NOT COMPLETED|Overall Study||38||
48696260|NCT01202188|102041707|FG001|NOT COMPLETED|Overall Study||56||
48276585|NCT00359983|100999873|FG000|STARTED|Year 5 Persistence Follow-up||95||
48276586|NCT00359983|100999874|FG001|STARTED|Year 5 Persistence Follow-up||44||
48276587|NCT00359983|100999875|FG002|STARTED|Year 5 Persistence Follow-up||42||
48276588|NCT00359983|100999873|FG000|COMPLETED|Year 5 Persistence Follow-up||95||
48276589|NCT00359983|100999874|FG001|COMPLETED|Year 5 Persistence Follow-up||44||
48276590|NCT00359983|100999875|FG002|COMPLETED|Year 5 Persistence Follow-up||42||
48276591|NCT00359983|100999873|FG000|NOT COMPLETED|Year 5 Persistence Follow-up||0||
48393599|NCT01896856|101291605|FG003|STARTED|Overall Study||6||
48393600|NCT01896856|101291606|FG004|STARTED|Overall Study||62||
48393601|NCT01896856|101291607|FG005|STARTED|Overall Study||34||
48393602|NCT01896856|101291602|FG000|COMPLETED|Overall Study||6||
48393603|NCT01896856|101291603|FG001|COMPLETED|Overall Study||3||
48393604|NCT01896856|101291604|FG002|COMPLETED|Overall Study||6||
48562582|NCT02288325|101709991|FG000|STARTED|Run-in Period||644||
48276592|NCT00359983|100999874|FG001|NOT COMPLETED|Year 5 Persistence Follow-up||0||
48276593|NCT00359983|100999875|FG002|NOT COMPLETED|Year 5 Persistence Follow-up||0||
48393605|NCT01896856|101291605|FG003|COMPLETED|Overall Study||6||
48562583|NCT02288325|101709992|FG001|STARTED|Run-in Period||0||
48562584|NCT02288325|101709993|FG002|STARTED|Run-in Period||0||
48562585|NCT02288325|101709991|FG000|COMPLETED|Run-in Period||499||
48562586|NCT02288325|101709992|FG001|COMPLETED|Run-in Period||0||
48562587|NCT02288325|101709993|FG002|COMPLETED|Run-in Period||0||
48562588|NCT02288325|101709991|FG000|NOT COMPLETED|Run-in Period||145||
48562589|NCT02288325|101709992|FG001|NOT COMPLETED|Run-in Period||0||
48562590|NCT02288325|101709993|FG002|NOT COMPLETED|Run-in Period||0||
48562591|NCT02288325|101709991|FG000|STARTED|Stabilization Period||429||
48562592|NCT02288325|101709992|FG001|STARTED|Stabilization Period||0||
48696261|NCT01202188|102041708|FG002|NOT COMPLETED|Overall Study||53||
48562593|NCT02288325|101709993|FG002|STARTED|Stabilization Period||0||
48393606|NCT01896856|101291606|FG004|COMPLETED|Overall Study||62||
48393607|NCT01896856|101291607|FG005|COMPLETED|Overall Study||34||
48276594|NCT05543707|100999876|FG000|STARTED|Overall Study||162||
48276595|NCT05543707|100999877|FG001|STARTED|Overall Study||80||
48276596|NCT05543707|100999876|FG000|COMPLETED|Overall Study||154||
48276597|NCT05543707|100999877|FG001|COMPLETED|Overall Study||77||
48276598|NCT05543707|100999876|FG000|NOT COMPLETED|Overall Study||8||
48276599|NCT05543707|100999877|FG001|NOT COMPLETED|Overall Study||3||
48276600|NCT02299089|100999878|FG000|STARTED|Overall Study||3||
48276601|NCT02299089|100999879|FG001|STARTED|Overall Study||4||
48276602|NCT02299089|100999880|FG002|STARTED|Overall Study||1||
48276603|NCT02299089|100999881|FG003|STARTED|Overall Study||4||
48276604|NCT02299089|100999878|FG000|COMPLETED|Overall Study||3||
48276605|NCT02299089|100999879|FG001|COMPLETED|Overall Study||4||
48276606|NCT02299089|100999880|FG002|COMPLETED|Overall Study||1||
48276607|NCT02299089|100999881|FG003|COMPLETED|Overall Study||4||
48276608|NCT02299089|100999878|FG000|NOT COMPLETED|Overall Study||0||
48276609|NCT02299089|100999879|FG001|NOT COMPLETED|Overall Study||0||
48276610|NCT02299089|100999880|FG002|NOT COMPLETED|Overall Study||0||
48276611|NCT02299089|100999881|FG003|NOT COMPLETED|Overall Study||0||
48276612|NCT01427725|100999882|FG000|STARTED|Overall Study||579||
48276613|NCT01427725|100999882|FG000|Collected CRFs|Overall Study||562||
48276614|NCT01427725|100999882|FG000|Safety Analysis Set|Overall Study||553||
48276615|NCT01427725|100999882|FG000|COMPLETED|Overall Study||378||
48276616|NCT01427725|100999882|FG000|NOT COMPLETED|Overall Study||201||
48276617|NCT01249027|100999883|FG000|STARTED|1 Year Clinical Follow up||2482||
48276618|NCT01249027|100999883|FG000|COMPLETED|1 Year Clinical Follow up||2391||
48276619|NCT01249027|100999883|FG000|NOT COMPLETED|1 Year Clinical Follow up||91||
48276620|NCT01249027|100999883|FG000|STARTED|2 Years Clinical Follow up||2391||
48276621|NCT01249027|100999883|FG000|COMPLETED|2 Years Clinical Follow up||2254||
48276622|NCT01249027|100999883|FG000|NOT COMPLETED|2 Years Clinical Follow up||137||
48562594|NCT02288325|101709991|FG000|COMPLETED|Stabilization Period||331||
48562595|NCT02288325|101709992|FG001|COMPLETED|Stabilization Period||0||
48562596|NCT02288325|101709993|FG002|COMPLETED|Stabilization Period||0||
48562597|NCT02288325|101709991|FG000|NOT COMPLETED|Stabilization Period||98||
48562598|NCT02288325|101709992|FG001|NOT COMPLETED|Stabilization Period||0||
48562599|NCT02288325|101709993|FG002|NOT COMPLETED|Stabilization Period||0||
48562600|NCT02288325|101709991|FG000|STARTED|Double-blind Treatment Period||0||
48562601|NCT02288325|101709992|FG001|STARTED|Double-blind Treatment Period||159||
48562602|NCT02288325|101709993|FG002|STARTED|Double-blind Treatment Period||165||
48562603|NCT02288325|101709991|FG000|COMPLETED|Double-blind Treatment Period||0||
48562604|NCT02288325|101709992|FG001|COMPLETED|Double-blind Treatment Period||135||
48562605|NCT02288325|101709993|FG002|COMPLETED|Double-blind Treatment Period||139||
48562606|NCT02288325|101709991|FG000|NOT COMPLETED|Double-blind Treatment Period||0||
48562607|NCT02288325|101709992|FG001|NOT COMPLETED|Double-blind Treatment Period||24||
48562608|NCT02288325|101709993|FG002|NOT COMPLETED|Double-blind Treatment Period||26||
48562609|NCT01960257|101709994|FG000|STARTED|Stage 1 (1-3 Weeks)||77||
48562610|NCT01960257|101709995|FG001|STARTED|Stage 1 (1-3 Weeks)||0||
48562611|NCT01960257|101709996|FG002|STARTED|Stage 1 (1-3 Weeks)||0||
48562612|NCT01960257|101709994|FG000|COMPLETED|Stage 1 (1-3 Weeks)||61||
48276623|NCT01249027|100999883|FG000|STARTED|3 Years Clinical Follow up||2254||
48276624|NCT01249027|100999883|FG000|COMPLETED|3 Years Clinical Follow up||2223||
48276625|NCT01249027|100999883|FG000|NOT COMPLETED|3 Years Clinical Follow up||31||
48276626|NCT01249027|100999883|FG000|STARTED|4 Years Clinical Follow up||2223||
48276627|NCT01249027|100999883|FG000|COMPLETED|4 Years Clinical Follow up||2210||
48276628|NCT01249027|100999883|FG000|NOT COMPLETED|4 Years Clinical Follow up||13||
48393608|NCT01896856|101291602|FG000|NOT COMPLETED|Overall Study||0||
48393609|NCT01896856|101291603|FG001|NOT COMPLETED|Overall Study||0||
48393610|NCT01896856|101291604|FG002|NOT COMPLETED|Overall Study||1||
48393611|NCT01896856|101291605|FG003|NOT COMPLETED|Overall Study||0||
48393612|NCT01896856|101291606|FG004|NOT COMPLETED|Overall Study||0||
48393613|NCT01896856|101291607|FG005|NOT COMPLETED|Overall Study||0||
48276629|NCT01249027|100999883|FG000|STARTED|5 Years Clinical Follow up||2210||
48276630|NCT01249027|100999883|FG000|COMPLETED|5 Years Clinical Follow up||2142||
48393614|NCT03258632|101291608|FG000|STARTED|Overall Study||82||
48393615|NCT03258632|101291609|FG001|STARTED|Overall Study||73||
48393616|NCT03258632|101291608|FG000|COMPLETED|Overall Study||70||
48393617|NCT03258632|101291609|FG001|COMPLETED|Overall Study||60||
48562613|NCT01960257|101709995|FG001|COMPLETED|Stage 1 (1-3 Weeks)||0||
48562614|NCT01960257|101709996|FG002|COMPLETED|Stage 1 (1-3 Weeks)||0||
48562615|NCT01960257|101709994|FG000|NOT COMPLETED|Stage 1 (1-3 Weeks)||16||
48276631|NCT01249027|100999883|FG000|NOT COMPLETED|5 Years Clinical Follow up||68||
48276632|NCT02108964|100999884|FG000|STARTED|Overall Study||17||
48276633|NCT02108964|100999885|FG001|STARTED|Overall Study||38||
48276634|NCT02108964|100999886|FG002|STARTED|Overall Study||73||
48276635|NCT02108964|100999887|FG003|STARTED|Overall Study||8||
48276636|NCT02108964|100999888|FG004|STARTED|Overall Study||28||
48393618|NCT03258632|101291608|FG000|NOT COMPLETED|Overall Study||12||
48276637|NCT02108964|100999889|FG005|STARTED|Overall Study||5||
48276638|NCT02108964|100999890|FG006|STARTED|Overall Study||11||
48393619|NCT03258632|101291609|FG001|NOT COMPLETED|Overall Study||13||
48276639|NCT02108964|100999891|FG007|STARTED|Overall Study||45||
48276640|NCT02108964|100999884|FG000|COMPLETED|Overall Study||0||
48696262|NCT01202188|102041709|FG003|NOT COMPLETED|Overall Study||42||
48696263|NCT01202188|102041710|FG004|NOT COMPLETED|Overall Study||45||
48696264|NCT04003207|102041711|FG000|STARTED|Overall Study||6||
48696265|NCT04003207|102041711|FG000|COMPLETED|Overall Study||5||
48696266|NCT04003207|102041711|FG000|NOT COMPLETED|Overall Study||1||
48696267|NCT03941873|102041712|FG000|STARTED|Overall Study||3||
48696268|NCT03941873|102041713|FG001|STARTED|Overall Study||24||
48696269|NCT03941873|102041714|FG002|STARTED|Overall Study||3||
48696270|NCT03941873|102041715|FG003|STARTED|Overall Study||81||
48696271|NCT03941873|102041712|FG000|COMPLETED|Overall Study||1||
48696272|NCT03941873|102041713|FG001|COMPLETED|Overall Study||3||
48696273|NCT03941873|102041714|FG002|COMPLETED|Overall Study||1||
48696274|NCT03941873|102041715|FG003|COMPLETED|Overall Study||8||
48696275|NCT03941873|102041712|FG000|NOT COMPLETED|Overall Study||2||
48696276|NCT03941873|102041713|FG001|NOT COMPLETED|Overall Study||21||
48696277|NCT03941873|102041714|FG002|NOT COMPLETED|Overall Study||2||
48696278|NCT03941873|102041715|FG003|NOT COMPLETED|Overall Study||73||
48276641|NCT02108964|100999885|FG001|COMPLETED|Overall Study||0||
48276642|NCT02108964|100999886|FG002|COMPLETED|Overall Study||0||
48276643|NCT02108964|100999887|FG003|COMPLETED|Overall Study||0||
48276644|NCT02108964|100999888|FG004|COMPLETED|Overall Study||0||
48276645|NCT02108964|100999889|FG005|COMPLETED|Overall Study||0||
48276646|NCT02108964|100999890|FG006|COMPLETED|Overall Study||0||
48276647|NCT02108964|100999891|FG007|COMPLETED|Overall Study||0||
48276648|NCT02108964|100999884|FG000|NOT COMPLETED|Overall Study||17||
48276649|NCT02108964|100999885|FG001|NOT COMPLETED|Overall Study||38||
48276650|NCT02108964|100999886|FG002|NOT COMPLETED|Overall Study||73||
48393620|NCT00806078|101291610|FG000|STARTED|First Intervention||9||
48393621|NCT00806078|101291611|FG001|STARTED|First Intervention||9||
48393622|NCT00806078|101291610|FG000|COMPLETED|First Intervention||9||
48393623|NCT00806078|101291611|FG001|COMPLETED|First Intervention||9||
48393624|NCT00806078|101291610|FG000|NOT COMPLETED|First Intervention||0||
48393625|NCT00806078|101291611|FG001|NOT COMPLETED|First Intervention||0||
48562616|NCT01960257|101709995|FG001|NOT COMPLETED|Stage 1 (1-3 Weeks)||0||
48562617|NCT01960257|101709996|FG002|NOT COMPLETED|Stage 1 (1-3 Weeks)||0||
48562618|NCT01960257|101709994|FG000|STARTED|Stage 2(1-4 Months, Not to Exceed 12wks)||0||
48562619|NCT01960257|101709995|FG001|STARTED|Stage 2(1-4 Months, Not to Exceed 12wks)||41||
48562620|NCT01960257|101709996|FG002|STARTED|Stage 2(1-4 Months, Not to Exceed 12wks)||20||
48562621|NCT01960257|101709994|FG000|COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0||
48562622|NCT01960257|101709995|FG001|COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||41||
48562623|NCT01960257|101709996|FG002|COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||20||
48562624|NCT01960257|101709994|FG000|NOT COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0||
48562625|NCT01960257|101709995|FG001|NOT COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0||
48393626|NCT00806078|101291610|FG000|STARTED|7 Day Washout Period||9||
48393627|NCT00806078|101291611|FG001|STARTED|7 Day Washout Period||9||
48393628|NCT00806078|101291610|FG000|COMPLETED|7 Day Washout Period||9||
48393629|NCT00806078|101291611|FG001|COMPLETED|7 Day Washout Period||9||
48393630|NCT00806078|101291610|FG000|NOT COMPLETED|7 Day Washout Period||0||
48393631|NCT00806078|101291611|FG001|NOT COMPLETED|7 Day Washout Period||0||
48393632|NCT00806078|101291610|FG000|STARTED|Second Intervention||9||
48393633|NCT00806078|101291611|FG001|STARTED|Second Intervention||9||
48393634|NCT00806078|101291610|FG000|COMPLETED|Second Intervention||9||
48393635|NCT00806078|101291611|FG001|COMPLETED|Second Intervention||9||
48393636|NCT00806078|101291610|FG000|NOT COMPLETED|Second Intervention||0||
48393637|NCT00806078|101291611|FG001|NOT COMPLETED|Second Intervention||0||
48393638|NCT01181778|101291612|FG000|STARTED|Overall Study||1919||
48393639|NCT01181778|101291612|FG000|COMPLETED|Overall Study||1871||
48393640|NCT01181778|101291612|FG000|NOT COMPLETED|Overall Study||48||
48393641|NCT02447458|101291613|FG000|STARTED|Overall Study||5||
48393642|NCT02447458|101291614|FG001|STARTED|Overall Study||6||
48393643|NCT02447458|101291615|FG002|STARTED|Overall Study||6||
48393644|NCT02447458|101291616|FG003|STARTED|Overall Study||6||
48393645|NCT02447458|101291617|FG004|STARTED|Overall Study||6||
48393646|NCT02447458|101291618|FG005|STARTED|Overall Study||10||
48562626|NCT01960257|101709996|FG002|NOT COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0||
48696279|NCT00964002|102041716|FG000|STARTED|Overall Study||61||
48696280|NCT00964002|102041716|FG000|Assessable for Safety|Overall Study||59||
48696281|NCT00964002|102041716|FG000|COMPLETED|Overall Study||53||
48696282|NCT00964002|102041716|FG000|NOT COMPLETED|Overall Study||8||
48696283|NCT02499900|102041717|FG000|STARTED|Core Study Period||430|Intent to treat|
48696284|NCT02499900|102041718|FG001|STARTED|Core Study Period||431|Intent to treat|
48696285|NCT02499900|102041717|FG000|Safety Analysis Set|Core Study Period||427||
48696286|NCT02499900|102041718|FG001|Safety Analysis Set|Core Study Period||430||
48696287|NCT02499900|102041717|FG000|COMPLETED|Core Study Period||395|Completed core phase of the study|
48696288|NCT02499900|102041718|FG001|COMPLETED|Core Study Period||399|Completed core phase of the study|
48276651|NCT02108964|100999887|FG003|NOT COMPLETED|Overall Study||8||
48276652|NCT02108964|100999888|FG004|NOT COMPLETED|Overall Study||28||
48393647|NCT02447458|101291613|FG000|COMPLETED|Overall Study||5||
48393648|NCT02447458|101291614|FG001|COMPLETED|Overall Study||6||
48393649|NCT02447458|101291615|FG002|COMPLETED|Overall Study||5||
48696289|NCT02499900|102041717|FG000|NOT COMPLETED|Core Study Period||35||
48696290|NCT02499900|102041718|FG001|NOT COMPLETED|Core Study Period||32||
48696291|NCT02499900|102041717|FG000|STARTED|Completed Core, Continued Into Extension||395||
48696292|NCT02499900|102041718|FG001|STARTED|Completed Core, Continued Into Extension||399||
48696293|NCT02499900|102041717|FG000|COMPLETED|Completed Core, Continued Into Extension||392||
48696294|NCT02499900|102041718|FG001|COMPLETED|Completed Core, Continued Into Extension||397||
48696295|NCT02499900|102041717|FG000|NOT COMPLETED|Completed Core, Continued Into Extension||3||
48696296|NCT02499900|102041718|FG001|NOT COMPLETED|Completed Core, Continued Into Extension||2||
48696297|NCT02499900|102041717|FG000|STARTED|Extension Study Period||392||
48393650|NCT02447458|101291616|FG003|COMPLETED|Overall Study||6||
48393651|NCT02447458|101291617|FG004|COMPLETED|Overall Study||6||
48393652|NCT02447458|101291618|FG005|COMPLETED|Overall Study||10||
48393653|NCT02447458|101291613|FG000|NOT COMPLETED|Overall Study||0||
48393654|NCT02447458|101291614|FG001|NOT COMPLETED|Overall Study||0||
48562627|NCT03164551|101709997|FG000|STARTED|Overall Study||200||
48562628|NCT03164551|101709998|FG001|STARTED|Overall Study||208||
48562629|NCT03164551|101709997|FG000|COMPLETED|Overall Study||171||
48562630|NCT03164551|101709998|FG001|COMPLETED|Overall Study||192||
48562631|NCT03164551|101709997|FG000|NOT COMPLETED|Overall Study||29||
48562632|NCT03164551|101709998|FG001|NOT COMPLETED|Overall Study||16||
48562633|NCT02069015|101709999|FG000|STARTED|Overall Study||71||
48562634|NCT02069015|101710000|FG001|STARTED|Overall Study||68||
48562635|NCT02069015|101709999|FG000|7 Day|Overall Study||44||
48562636|NCT02069015|101710000|FG001|7 Day|Overall Study||45||
48562637|NCT02069015|101709999|FG000|30 Day|Overall Study||38||
48562638|NCT02069015|101710000|FG001|30 Day|Overall Study||43||
48562639|NCT02069015|101709999|FG000|90 Day|Overall Study||32||
48562640|NCT02069015|101710000|FG001|90 Day|Overall Study||35||
48562641|NCT02069015|101709999|FG000|COMPLETED|Overall Study||31|Follow-up: 180 day post ED discharge|
48562642|NCT02069015|101710000|FG001|COMPLETED|Overall Study||35|Follow-up: 180 day post ED discharge|
48562643|NCT02069015|101709999|FG000|NOT COMPLETED|Overall Study||40||
48562644|NCT02069015|101710000|FG001|NOT COMPLETED|Overall Study||33||
48562645|NCT02832687|101710001|FG000|STARTED|Overall Study||41||
48562646|NCT02832687|101710002|FG001|STARTED|Overall Study||47||
48562647|NCT02832687|101710001|FG000|Participants Who Were Included in the Analysis|Overall Study||31||
48562648|NCT02832687|101710002|FG001|Participants Who Were Included in the Analysis|Overall Study||34||
48562649|NCT02832687|101710001|FG000|COMPLETED|Overall Study||41||
48562650|NCT02832687|101710002|FG001|COMPLETED|Overall Study||45||
48562651|NCT02832687|101710001|FG000|NOT COMPLETED|Overall Study||0||
48562652|NCT02832687|101710002|FG001|NOT COMPLETED|Overall Study||2||
48562653|NCT03473925|101710003|FG000|STARTED|Overall Study||52|Randomized|
48562654|NCT03473925|101710004|FG001|STARTED|Overall Study||55|Randomized|
48562655|NCT03473925|101710003|FG000|Treated|Overall Study||51||
48562656|NCT03473925|101710004|FG001|Treated|Overall Study||54||
48562657|NCT03473925|101710003|FG000|COMPLETED|Overall Study||0||
48562658|NCT03473925|101710004|FG001|COMPLETED|Overall Study||0||
48562659|NCT03473925|101710003|FG000|NOT COMPLETED|Overall Study||52||
48562660|NCT03473925|101710004|FG001|NOT COMPLETED|Overall Study||55||
48562661|NCT01991743|101710005|FG000|STARTED|Overall Study||60||
48562662|NCT01991743|101710006|FG001|STARTED|Overall Study||60||
48562663|NCT01991743|101710007|FG002|STARTED|Overall Study||60||
48562664|NCT01991743|101710008|FG003|STARTED|Overall Study||60||
48562665|NCT01991743|101710005|FG000|COMPLETED|Overall Study||60||
48562666|NCT01991743|101710006|FG001|COMPLETED|Overall Study||60||
48562667|NCT01991743|101710007|FG002|COMPLETED|Overall Study||59||
48696298|NCT02499900|102041718|FG001|STARTED|Extension Study Period||397||
48696299|NCT02499900|102041717|FG000|Safety Analysis Set|Extension Study Period||392||
48696300|NCT02499900|102041718|FG001|Safety Analysis Set|Extension Study Period||396||
48696301|NCT02499900|102041717|FG000|COMPLETED|Extension Study Period||380||
48696302|NCT02499900|102041718|FG001|COMPLETED|Extension Study Period||377||
48696303|NCT02499900|102041717|FG000|NOT COMPLETED|Extension Study Period||12||
48696304|NCT02499900|102041718|FG001|NOT COMPLETED|Extension Study Period||20||
48696305|NCT01071252|102041719|FG000|STARTED|Overall Study||29||
48696306|NCT01071252|102041720|FG001|STARTED|Overall Study||26||
48696307|NCT01071252|102041721|FG002|STARTED|Overall Study||21||
48696308|NCT01071252|102041722|FG003|STARTED|Overall Study||27||
48696309|NCT01071252|102041723|FG004|STARTED|Overall Study||22||
48696310|NCT01071252|102041719|FG000|COMPLETED|Overall Study||14||
48696311|NCT01071252|102041720|FG001|COMPLETED|Overall Study||16||
48696312|NCT01071252|102041721|FG002|COMPLETED|Overall Study||17||
48696313|NCT01071252|102041722|FG003|COMPLETED|Overall Study||20||
48696314|NCT01071252|102041723|FG004|COMPLETED|Overall Study||11||
48696315|NCT01071252|102041719|FG000|NOT COMPLETED|Overall Study||15||
48696316|NCT01071252|102041720|FG001|NOT COMPLETED|Overall Study||10||
48696317|NCT01071252|102041721|FG002|NOT COMPLETED|Overall Study||4||
48696318|NCT01071252|102041722|FG003|NOT COMPLETED|Overall Study||7||
48696319|NCT01071252|102041723|FG004|NOT COMPLETED|Overall Study||11||
48562668|NCT01991743|101710008|FG003|COMPLETED|Overall Study||60||
48562669|NCT01991743|101710005|FG000|NOT COMPLETED|Overall Study||0||
48562670|NCT01991743|101710006|FG001|NOT COMPLETED|Overall Study||0||
48562671|NCT01991743|101710007|FG002|NOT COMPLETED|Overall Study||1||
48562672|NCT01991743|101710008|FG003|NOT COMPLETED|Overall Study||0||
48562673|NCT02291510|101710009|FG000|STARTED|Overall Study||5||
48562674|NCT02291510|101710010|FG001|STARTED|Overall Study||5||
48562675|NCT02291510|101710011|FG002|STARTED|Overall Study||5||
48562676|NCT02291510|101710012|FG003|STARTED|Overall Study||5||
48562677|NCT02291510|101710009|FG000|Completed Treatment A|Overall Study||5||
48562678|NCT02291510|101710010|FG001|Completed Treatment A|Overall Study||5||
48562679|NCT02291510|101710011|FG002|Completed Treatment A|Overall Study||5||
48562680|NCT02291510|101710012|FG003|Completed Treatment A|Overall Study||5||
48562681|NCT02291510|101710009|FG000|Completed Treatment B|Overall Study||5||
48562682|NCT02291510|101710010|FG001|Completed Treatment B|Overall Study||5||
48562683|NCT02291510|101710011|FG002|Completed Treatment B|Overall Study||5||
48562684|NCT02291510|101710012|FG003|Completed Treatment B|Overall Study||4||
48562685|NCT02291510|101710009|FG000|Completed Treatment C|Overall Study||5||
48562686|NCT02291510|101710010|FG001|Completed Treatment C|Overall Study||5||
48562687|NCT02291510|101710011|FG002|Completed Treatment C|Overall Study||5||
48276653|NCT02108964|100999889|FG005|NOT COMPLETED|Overall Study||5||
48276654|NCT02108964|100999890|FG006|NOT COMPLETED|Overall Study||11||
48276655|NCT02108964|100999891|FG007|NOT COMPLETED|Overall Study||45||
48393655|NCT02447458|101291615|FG002|NOT COMPLETED|Overall Study||1||
48393656|NCT02447458|101291616|FG003|NOT COMPLETED|Overall Study||0||
48393657|NCT02447458|101291617|FG004|NOT COMPLETED|Overall Study||0||
48393658|NCT02447458|101291618|FG005|NOT COMPLETED|Overall Study||0||
48393659|NCT01335698|101291619|FG000|STARTED|Treatment Stage 1||23||
48393660|NCT01335698|101291620|FG001|STARTED|Treatment Stage 1||12||
48393661|NCT01335698|101291621|FG002|STARTED|Treatment Stage 1||21||
48393662|NCT01335698|101291622|FG003|STARTED|Treatment Stage 1||35||
48393663|NCT01335698|101291623|FG004|STARTED|Treatment Stage 1||8||
48393664|NCT01335698|101291619|FG000|COMPLETED|Treatment Stage 1||15||
48393665|NCT01335698|101291620|FG001|COMPLETED|Treatment Stage 1||4||
48393666|NCT01335698|101291621|FG002|COMPLETED|Treatment Stage 1||16||
48393667|NCT01335698|101291622|FG003|COMPLETED|Treatment Stage 1||26||
48393668|NCT01335698|101291623|FG004|COMPLETED|Treatment Stage 1||6||
48393669|NCT01335698|101291619|FG000|NOT COMPLETED|Treatment Stage 1||8||
48393670|NCT01335698|101291620|FG001|NOT COMPLETED|Treatment Stage 1||8||
48393671|NCT01335698|101291621|FG002|NOT COMPLETED|Treatment Stage 1||5||
48393672|NCT01335698|101291622|FG003|NOT COMPLETED|Treatment Stage 1||9||
48393673|NCT01335698|101291623|FG004|NOT COMPLETED|Treatment Stage 1||2||
48393674|NCT01335698|101291619|FG000|STARTED|Treatment Stage 2||15||
48113348|NCT01227512|100604921|FG001|COMPLETED|Overall Study||48||
48276656|NCT03940703|100999892|FG000|STARTED|Overall Study||128||
48276657|NCT03940703|100999893|FG001|STARTED|Overall Study||12||
48276658|NCT03940703|100999892|FG000|Full Analysis Set (FAS)|Overall Study||128|FAS included all participants who were administered any dose of any study treatment.|
48393675|NCT01335698|101291620|FG001|STARTED|Treatment Stage 2||4||
48393676|NCT01335698|101291621|FG002|STARTED|Treatment Stage 2||16||
48393677|NCT01335698|101291622|FG003|STARTED|Treatment Stage 2||26||
48393678|NCT01335698|101291623|FG004|STARTED|Treatment Stage 2||6||
48393679|NCT01335698|101291619|FG000|COMPLETED|Treatment Stage 2||4||
48393680|NCT01335698|101291620|FG001|COMPLETED|Treatment Stage 2||1||
48393681|NCT01335698|101291621|FG002|COMPLETED|Treatment Stage 2||11||
48562688|NCT02291510|101710012|FG003|Completed Treatment C|Overall Study||4||
48562689|NCT02291510|101710009|FG000|Completed Treatment D|Overall Study||5||
48562690|NCT02291510|101710010|FG001|Completed Treatment D|Overall Study||5||
48562691|NCT02291510|101710011|FG002|Completed Treatment D|Overall Study||5||
48562692|NCT02291510|101710012|FG003|Completed Treatment D|Overall Study||5||
48562693|NCT02291510|101710009|FG000|COMPLETED|Overall Study||5||
48562694|NCT02291510|101710010|FG001|COMPLETED|Overall Study||5||
48562695|NCT02291510|101710011|FG002|COMPLETED|Overall Study||5||
48562696|NCT02291510|101710012|FG003|COMPLETED|Overall Study||4||
48276659|NCT03940703|100999893|FG001|Full Analysis Set (FAS)|Overall Study||12|FAS included all participants who were administered any dose of any study treatment.|
48393682|NCT01335698|101291622|FG003|COMPLETED|Treatment Stage 2||18||
48393683|NCT01335698|101291623|FG004|COMPLETED|Treatment Stage 2||5||
48393684|NCT01335698|101291619|FG000|NOT COMPLETED|Treatment Stage 2||11||
48393685|NCT01335698|101291620|FG001|NOT COMPLETED|Treatment Stage 2||3||
48393686|NCT01335698|101291621|FG002|NOT COMPLETED|Treatment Stage 2||5||
48393687|NCT01335698|101291622|FG003|NOT COMPLETED|Treatment Stage 2||8||
48393688|NCT01335698|101291623|FG004|NOT COMPLETED|Treatment Stage 2||1||
48393689|NCT00074802|101291624|FG000|STARTED|Overall Study||29|Patients included here were the subset of enrollees completing the open trial as partial responders.|
48294164|NCT02527343|101047538|FG002|COMPLETED|OLE Period-Year 2: Week 105 to 156||0||
48393690|NCT00074802|101291625|FG001|STARTED|Overall Study||32|Patients included here were the subset of enrollees completing the open trial as partial responders.|
48393691|NCT00074802|101291624|FG000|COMPLETED|Overall Study||20||
48393692|NCT00074802|101291625|FG001|COMPLETED|Overall Study||25||
48562697|NCT02291510|101710009|FG000|NOT COMPLETED|Overall Study||0||
48562698|NCT02291510|101710010|FG001|NOT COMPLETED|Overall Study||0||
48562699|NCT02291510|101710011|FG002|NOT COMPLETED|Overall Study||0||
48562700|NCT02291510|101710012|FG003|NOT COMPLETED|Overall Study||1||
48113349|NCT01227512|100604920|FG000|NOT COMPLETED|Overall Study||13||
48393693|NCT00074802|101291624|FG000|NOT COMPLETED|Overall Study||9||
48276660|NCT03940703|100999892|FG000|Safety (SAF) Analysis Set|Overall Study||128|SAF analysis set included all participants who were administered any dose of any study treatment.|
48276661|NCT03940703|100999893|FG001|Safety (SAF) Analysis Set|Overall Study||12|SAF analysis set included all participants who were administered any dose of any study treatment.|
48276662|NCT03940703|100999892|FG000|Modified Full Analysis Set (mFAS)|Overall Study||105|mFAS: All FAS/SAF participants who started study treatment on or before the 08 July 2022 (that is \[i.e.\] date of completion of global enrollment), tested positive for MET amplification by either central test on tumor tissue or liquid biopsy or both, and progressed on first-line osimertinib as the only prior line of therapy in the noncurative advanced or metastatic NSCLC setting. T+ participants also belong to the Primary Analysis Set for Efficacy.|
48276663|NCT03940703|100999893|FG001|Modified Full Analysis Set (mFAS)|Overall Study||12|mFAS: All FAS/SAF participants who started study treatment on or before the 08 July 2022 (that is \[i.e.\] date of completion of global enrollment), tested positive for MET amplification by either central test on tumor tissue or liquid biopsy or both, and progressed on first-line osimertinib as the only prior line of therapy in the noncurative advanced or metastatic NSCLC setting. T+ participants also belong to the Primary Analysis Set for Efficacy.|
48276664|NCT03940703|100999892|FG000|Safety run-in Analysis Set (SRIAS)|Overall Study||9|SRIAS included all FAS/SAF participants treated during the safety run-in period who received at least 75 percent (% )of the tepotinib and osimertinib planned dose and completed the Dose-Limiting Toxicity (DLT) period (3 weeks after start of study treatment), or who experienced a DLT during the DLT period regardless of the received amount of each study treatment component.|
48276665|NCT03940703|100999893|FG001|Safety run-in Analysis Set (SRIAS)|Overall Study||0|SRIAS included all FAS/SAF participants treated during the safety run-in period who received at least 75 percent (% )of the tepotinib and osimertinib planned dose and completed the Dose-Limiting Toxicity (DLT) period (3 weeks after start of study treatment), or who experienced a DLT during the DLT period regardless of the received amount of each study treatment component.|
48276666|NCT03940703|100999892|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||120|PK analysis set included all FAS/SAF participants who have no important events affecting PK and provide at least one measurable post-dose concentration.|
48276667|NCT03940703|100999893|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||11|PK analysis set included all FAS/SAF participants who have no important events affecting PK and provide at least one measurable post-dose concentration.|
48276668|NCT03940703|100999892|FG000|COMPLETED|Overall Study||97||
48276669|NCT03940703|100999893|FG001|COMPLETED|Overall Study||12||
48276670|NCT03940703|100999892|FG000|NOT COMPLETED|Overall Study||31||
48276671|NCT03940703|100999893|FG001|NOT COMPLETED|Overall Study||0||
48276672|NCT01949389|100999894|FG000|STARTED|Overall Study||51||
48276673|NCT01949389|100999894|FG000|COMPLETED|Overall Study||51||
48276674|NCT01949389|100999894|FG000|NOT COMPLETED|Overall Study||0||
48276675|NCT02589275|100999895|FG000|STARTED|Overall Study||177||
48276676|NCT02589275|100999896|FG001|STARTED|Overall Study||198||
48276677|NCT02589275|100999895|FG000|COMPLETED|Overall Study||143||
48276678|NCT02589275|100999896|FG001|COMPLETED|Overall Study||142||
48276679|NCT02589275|100999895|FG000|NOT COMPLETED|Overall Study||34||
48276680|NCT02589275|100999896|FG001|NOT COMPLETED|Overall Study||56||
48276681|NCT03882177|100999897|FG000|STARTED|Overall Study||10||
48276682|NCT03882177|100999898|FG001|STARTED|Overall Study||6||
48276683|NCT03882177|100999899|FG002|STARTED|Overall Study||0||
48276684|NCT03882177|100999900|FG003|STARTED|Overall Study||0||
48276685|NCT03882177|100999897|FG000|COMPLETED|Overall Study||10||
48276686|NCT03882177|100999898|FG001|COMPLETED|Overall Study||6||
48276687|NCT03882177|100999899|FG002|COMPLETED|Overall Study||0||
48276688|NCT03882177|100999900|FG003|COMPLETED|Overall Study||0||
48276689|NCT03882177|100999897|FG000|NOT COMPLETED|Overall Study||0||
48276690|NCT03882177|100999898|FG001|NOT COMPLETED|Overall Study||0||
48276691|NCT03882177|100999899|FG002|NOT COMPLETED|Overall Study||0||
48276692|NCT03882177|100999900|FG003|NOT COMPLETED|Overall Study||0||
48276693|NCT04939701|100999901|FG000|STARTED|Phase 1: Dose Escalation (168 Days)||4||
48276694|NCT04939701|100999902|FG001|STARTED|Phase 1: Dose Escalation (168 Days)||7||
48393694|NCT00074802|101291625|FG001|NOT COMPLETED|Overall Study||7||
48562701|NCT04533737|101710013|FG000|STARTED|Overall Study||56||
48562702|NCT04533737|101710014|FG001|STARTED|Overall Study||57||
48562703|NCT04533737|101710013|FG000|COMPLETED|Overall Study||50||
48562704|NCT04533737|101710014|FG001|COMPLETED|Overall Study||50||
48562705|NCT04533737|101710013|FG000|NOT COMPLETED|Overall Study||6||
48562706|NCT04533737|101710014|FG001|NOT COMPLETED|Overall Study||7||
48562707|NCT01998919|101710015|FG000|STARTED|Overall Study||79||
48562708|NCT01998919|101710016|FG001|STARTED|Overall Study||74||
48562709|NCT01998919|101710015|FG000|Randomized|Overall Study||78||
48562710|NCT01998919|101710016|FG001|Randomized|Overall Study||76||
48562711|NCT01998919|101710015|FG000|COMPLETED|Overall Study||37||
48562712|NCT01998919|101710016|FG001|COMPLETED|Overall Study||39||
48562713|NCT01998919|101710015|FG000|NOT COMPLETED|Overall Study||42||
48562714|NCT01998919|101710016|FG001|NOT COMPLETED|Overall Study||35||
48562715|NCT03000010|101710017|FG000|STARTED|Overall Study||21||
48562716|NCT03000010|101710018|FG001|STARTED|Overall Study||20||
48393695|NCT00877006|101291626|FG000|STARTED|Treatment Period||224||
48393696|NCT00877006|101291627|FG001|STARTED|Treatment Period||223||
48562717|NCT03000010|101710017|FG000|COMPLETED|Overall Study||21||
48562718|NCT03000010|101710018|FG001|COMPLETED|Overall Study||20||
48562719|NCT03000010|101710017|FG000|NOT COMPLETED|Overall Study||0||
48562720|NCT03000010|101710018|FG001|NOT COMPLETED|Overall Study||0||
48562721|NCT01486446|101710019|FG000|STARTED|Overall Study||7||
48562722|NCT01486446|101710020|FG001|STARTED|Overall Study||1||
48562723|NCT01486446|101710019|FG000|COMPLETED|Overall Study||6||
48562724|NCT01486446|101710020|FG001|COMPLETED|Overall Study||1||
48562725|NCT01486446|101710019|FG000|NOT COMPLETED|Overall Study||1||
48562726|NCT01486446|101710020|FG001|NOT COMPLETED|Overall Study||0||
48276695|NCT04939701|100999903|FG002|STARTED|Phase 1: Dose Escalation (168 Days)||0||
48276696|NCT04939701|100999901|FG000|COMPLETED|Phase 1: Dose Escalation (168 Days)||1||
48276697|NCT04939701|100999902|FG001|COMPLETED|Phase 1: Dose Escalation (168 Days)||0||
48276698|NCT04939701|100999903|FG002|COMPLETED|Phase 1: Dose Escalation (168 Days)||0||
48276699|NCT04939701|100999901|FG000|NOT COMPLETED|Phase 1: Dose Escalation (168 Days)||3||
48562727|NCT01275846|101710021|FG000|STARTED|Overall Study||26||
48696320|NCT01974206|102041724|FG000|STARTED|Overall Study||74||
48562728|NCT01275846|101710021|FG000|COMPLETED|Overall Study||25||
48562729|NCT01275846|101710021|FG000|NOT COMPLETED|Overall Study||1||
48562730|NCT01365819|101710022|FG000|STARTED|Overall Study||25||
48696321|NCT01974206|102041725|FG001|STARTED|Overall Study||76||
48696322|NCT01974206|102041724|FG000|Received Treatment|Overall Study||74||
48696323|NCT01974206|102041725|FG001|Received Treatment|Overall Study||75||
48696324|NCT01974206|102041724|FG000|COMPLETED|Overall Study||68||
48696325|NCT01974206|102041725|FG001|COMPLETED|Overall Study||75||
48696326|NCT01974206|102041724|FG000|NOT COMPLETED|Overall Study||6||
48696327|NCT01974206|102041725|FG001|NOT COMPLETED|Overall Study||1||
48696328|NCT01132651|102041726|FG000|STARTED|Overall Study||4||
48696329|NCT01132651|102041727|FG001|STARTED|Overall Study||5||
48696330|NCT01132651|102041726|FG000|COMPLETED|Overall Study||3||
48696331|NCT01132651|102041727|FG001|COMPLETED|Overall Study||4||
48696332|NCT01132651|102041726|FG000|NOT COMPLETED|Overall Study||1||
48696333|NCT01132651|102041727|FG001|NOT COMPLETED|Overall Study||1||
48696334|NCT04551898|102041728|FG000|STARTED|Overall Study||47||
48696335|NCT04551898|102041729|FG001|STARTED|Overall Study||45||
48696336|NCT04551898|102041730|FG002|STARTED|Overall Study||43||
48696337|NCT04551898|102041731|FG003|STARTED|Overall Study||46||
48113350|NCT01227512|100604921|FG001|NOT COMPLETED|Overall Study||10||
48113351|NCT03592121|100604922|FG000|STARTED|Overall Study||3||
48113352|NCT03592121|100604923|FG001|STARTED|Overall Study||0||
48113353|NCT03592121|100604922|FG000|COMPLETED|Overall Study||3||
48113354|NCT03592121|100604923|FG001|COMPLETED|Overall Study||0||
48113355|NCT03592121|100604922|FG000|NOT COMPLETED|Overall Study||0||
48113356|NCT03592121|100604923|FG001|NOT COMPLETED|Overall Study||0||
48113357|NCT01027793|100604924|FG000|STARTED|Overall Study||17||
48113358|NCT01027793|100604925|FG001|STARTED|Overall Study||15||
48113359|NCT01027793|100604924|FG000|COMPLETED|Overall Study||10||
48113360|NCT01027793|100604925|FG001|COMPLETED|Overall Study||12||
48113361|NCT01027793|100604924|FG000|NOT COMPLETED|Overall Study||7||
48113362|NCT01027793|100604925|FG001|NOT COMPLETED|Overall Study||3||
48113363|NCT00403273|100604926|FG000|STARTED|Overall Study||25||
48113364|NCT00403273|100604927|FG001|STARTED|Overall Study||29||
48562731|NCT01365819|101710023|FG001|STARTED|Overall Study||27||
48562732|NCT01365819|101710022|FG000|COMPLETED|Overall Study||12||
48562733|NCT01365819|101710023|FG001|COMPLETED|Overall Study||14||
48113365|NCT00403273|100604926|FG000|COMPLETED|Overall Study||22||
48113366|NCT00403273|100604927|FG001|COMPLETED|Overall Study||25||
48113367|NCT00403273|100604926|FG000|NOT COMPLETED|Overall Study||3||
48113368|NCT00403273|100604927|FG001|NOT COMPLETED|Overall Study||4||
48113369|NCT02554656|100604928|FG000|STARTED|Overall Study||89||
48113370|NCT02554656|100604928|FG000|COMPLETED|Overall Study||86||
48113371|NCT02554656|100604928|FG000|NOT COMPLETED|Overall Study||3||
48113372|NCT02852265|100604929|FG000|STARTED|1-month Follow-up||10||
48113373|NCT02852265|100604930|FG001|STARTED|1-month Follow-up||10||
48393697|NCT00877006|101291626|FG000|COMPLETED|Treatment Period||199||
48562734|NCT01365819|101710022|FG000|NOT COMPLETED|Overall Study||13||
48696338|NCT04551898|102041728|FG000|COMPLETED|Overall Study||39||
48696339|NCT04551898|102041729|FG001|COMPLETED|Overall Study||42||
48696340|NCT04551898|102041730|FG002|COMPLETED|Overall Study||35||
48696341|NCT04551898|102041731|FG003|COMPLETED|Overall Study||41||
48696342|NCT04551898|102041728|FG000|NOT COMPLETED|Overall Study||8||
48696343|NCT04551898|102041729|FG001|NOT COMPLETED|Overall Study||3||
48696344|NCT04551898|102041730|FG002|NOT COMPLETED|Overall Study||8||
48696345|NCT04551898|102041731|FG003|NOT COMPLETED|Overall Study||5||
48696346|NCT03931382|102041732|FG000|STARTED|Overall Study||32||
48696347|NCT03931382|102041733|FG001|STARTED|Overall Study||31||
48696348|NCT03931382|102041734|FG002|STARTED|Overall Study||26||
48696349|NCT03931382|102041732|FG000|COMPLETED|Overall Study||30||
48696350|NCT03931382|102041733|FG001|COMPLETED|Overall Study||30||
48696351|NCT03931382|102041734|FG002|COMPLETED|Overall Study||24||
48696352|NCT03931382|102041732|FG000|NOT COMPLETED|Overall Study||2||
48696353|NCT03931382|102041733|FG001|NOT COMPLETED|Overall Study||1||
48696354|NCT03931382|102041734|FG002|NOT COMPLETED|Overall Study||2||
48562735|NCT01365819|101710023|FG001|NOT COMPLETED|Overall Study||13||
48562736|NCT00860795|101710024|FG000|STARTED|Overall Study||10||
48113374|NCT02852265|100604929|FG000|COMPLETED|1-month Follow-up||10||
48113375|NCT02852265|100604930|FG001|COMPLETED|1-month Follow-up||10||
48113376|NCT02852265|100604929|FG000|NOT COMPLETED|1-month Follow-up||0||
48113377|NCT02852265|100604930|FG001|NOT COMPLETED|1-month Follow-up||0||
48562737|NCT00860795|101710025|FG001|STARTED|Overall Study||10||
48113378|NCT02852265|100604929|FG000|STARTED|3-month Follow-up||10||
48113379|NCT02852265|100604930|FG001|STARTED|3-month Follow-up||10||
48113380|NCT02852265|100604929|FG000|COMPLETED|3-month Follow-up||9||
48113381|NCT02852265|100604930|FG001|COMPLETED|3-month Follow-up||9||
48113382|NCT02852265|100604929|FG000|NOT COMPLETED|3-month Follow-up||1||
48696355|NCT03985943|102041735|FG000|STARTED|Initial Treatment(Day 1-Week 16 Predose)||321||
48696356|NCT03985943|102041736|FG001|STARTED|Initial Treatment(Day 1-Week 16 Predose)||620||
48696357|NCT03985943|102041737|FG002|STARTED|Initial Treatment(Day 1-Week 16 Predose)||0||
48696358|NCT03985943|102041738|FG003|STARTED|Initial Treatment(Day 1-Week 16 Predose)||0||
48696359|NCT03985943|102041739|FG004|STARTED|Initial Treatment(Day 1-Week 16 Predose)||0||
48696360|NCT03985943|102041740|FG005|STARTED|Initial Treatment(Day 1-Week 16 Predose)||0||
48696361|NCT03985943|102041735|FG000|Safety Population|Initial Treatment(Day 1-Week 16 Predose)||321|Safety population (SP) consisted of all participants who received at least 1 dose of study drug.|
48696362|NCT03985943|102041736|FG001|Safety Population|Initial Treatment(Day 1-Week 16 Predose)||616|Safety population (SP) consisted of all participants who received at least 1 dose of study drug.|
48696363|NCT03985943|102041737|FG002|Safety Population|Initial Treatment(Day 1-Week 16 Predose)||0|Safety population (SP) consisted of all participants who received at least 1 dose of study drug.|
48696364|NCT03985943|102041738|FG003|Safety Population|Initial Treatment(Day 1-Week 16 Predose)||0|Safety population (SP) consisted of all participants who received at least 1 dose of study drug.|
48696365|NCT03985943|102041739|FG004|Safety Population|Initial Treatment(Day 1-Week 16 Predose)||0|Safety population (SP) consisted of all participants who received at least 1 dose of study drug.|
48696366|NCT03985943|102041740|FG005|Safety Population|Initial Treatment(Day 1-Week 16 Predose)||0|Safety population (SP) consisted of all participants who received at least 1 dose of study drug.|
48696367|NCT03985943|102041735|FG000|COMPLETED|Initial Treatment(Day 1-Week 16 Predose)||296||
48696368|NCT03985943|102041736|FG001|COMPLETED|Initial Treatment(Day 1-Week 16 Predose)||560||
48696369|NCT03985943|102041737|FG002|COMPLETED|Initial Treatment(Day 1-Week 16 Predose)||0||
48696370|NCT03985943|102041738|FG003|COMPLETED|Initial Treatment(Day 1-Week 16 Predose)||0||
48696371|NCT03985943|102041739|FG004|COMPLETED|Initial Treatment(Day 1-Week 16 Predose)||0||
48696372|NCT03985943|102041740|FG005|COMPLETED|Initial Treatment(Day 1-Week 16 Predose)||0||
48696373|NCT03985943|102041735|FG000|NOT COMPLETED|Initial Treatment(Day 1-Week 16 Predose)||25||
48696374|NCT03985943|102041736|FG001|NOT COMPLETED|Initial Treatment(Day 1-Week 16 Predose)||60||
48696375|NCT03985943|102041737|FG002|NOT COMPLETED|Initial Treatment(Day 1-Week 16 Predose)||0||
48696376|NCT03985943|102041738|FG003|NOT COMPLETED|Initial Treatment(Day 1-Week 16 Predose)||0||
48696377|NCT03985943|102041739|FG004|NOT COMPLETED|Initial Treatment(Day 1-Week 16 Predose)||0||
48696378|NCT03985943|102041740|FG005|NOT COMPLETED|Initial Treatment(Day 1-Week 16 Predose)||0||
48696379|NCT03985943|102041735|FG000|STARTED|Maintenance Period (Week 16-Week 48)||0||
48696380|NCT03985943|102041736|FG001|STARTED|Maintenance Period (Week 16-Week 48)||0||
48696381|NCT03985943|102041737|FG002|STARTED|Maintenance Period (Week 16-Week 48)||90||
48696382|NCT03985943|102041738|FG003|STARTED|Maintenance Period (Week 16-Week 48)||91||
48696383|NCT03985943|102041739|FG004|STARTED|Maintenance Period (Week 16-Week 48)||91||
48696384|NCT03985943|102041740|FG005|STARTED|Maintenance Period (Week 16-Week 48)||100||
48696385|NCT03985943|102041735|FG000|Safety Population|Maintenance Period (Week 16-Week 48)||0||
48696386|NCT03985943|102041736|FG001|Safety Population|Maintenance Period (Week 16-Week 48)||0||
48696387|NCT03985943|102041737|FG002|Safety Population|Maintenance Period (Week 16-Week 48)||91||
48696388|NCT03985943|102041738|FG003|Safety Population|Maintenance Period (Week 16-Week 48)||90||
48696389|NCT03985943|102041739|FG004|Safety Population|Maintenance Period (Week 16-Week 48)||91||
48696390|NCT03985943|102041740|FG005|Safety Population|Maintenance Period (Week 16-Week 48)||100||
48696391|NCT03985943|102041735|FG000|COMPLETED|Maintenance Period (Week 16-Week 48)||0||
48696392|NCT03985943|102041736|FG001|COMPLETED|Maintenance Period (Week 16-Week 48)||0||
48696393|NCT03985943|102041737|FG002|COMPLETED|Maintenance Period (Week 16-Week 48)||76||
48696394|NCT03985943|102041738|FG003|COMPLETED|Maintenance Period (Week 16-Week 48)||79||
48696395|NCT03985943|102041739|FG004|COMPLETED|Maintenance Period (Week 16-Week 48)||69||
48696396|NCT03985943|102041740|FG005|COMPLETED|Maintenance Period (Week 16-Week 48)||82||
48696397|NCT03985943|102041735|FG000|NOT COMPLETED|Maintenance Period (Week 16-Week 48)||0||
48696398|NCT03985943|102041736|FG001|NOT COMPLETED|Maintenance Period (Week 16-Week 48)||0||
48696399|NCT03985943|102041737|FG002|NOT COMPLETED|Maintenance Period (Week 16-Week 48)||14||
48696400|NCT03985943|102041738|FG003|NOT COMPLETED|Maintenance Period (Week 16-Week 48)||12||
48696401|NCT03985943|102041739|FG004|NOT COMPLETED|Maintenance Period (Week 16-Week 48)||22||
48696402|NCT03985943|102041740|FG005|NOT COMPLETED|Maintenance Period (Week 16-Week 48)||18||
48113383|NCT02852265|100604930|FG001|NOT COMPLETED|3-month Follow-up||1||
48113384|NCT02852265|100604929|FG000|STARTED|6-month Follow-up||9||
48113385|NCT02852265|100604930|FG001|STARTED|6-month Follow-up||9||
48113386|NCT02852265|100604929|FG000|COMPLETED|6-month Follow-up||9||
48113387|NCT02852265|100604930|FG001|COMPLETED|6-month Follow-up||9||
48113388|NCT02852265|100604929|FG000|NOT COMPLETED|6-month Follow-up||0||
48113389|NCT02852265|100604930|FG001|NOT COMPLETED|6-month Follow-up||0||
48113390|NCT01072201|100604931|FG000|STARTED|Overall Study||30||
48113391|NCT01072201|100604932|FG001|STARTED|Overall Study||30||
48113392|NCT01072201|100604931|FG000|COMPLETED|Overall Study||30||
48113393|NCT01072201|100604932|FG001|COMPLETED|Overall Study||29||
48113394|NCT01072201|100604931|FG000|NOT COMPLETED|Overall Study||0||
48696403|NCT01108731|102041741|FG000|STARTED|Overall Study||17||
48696404|NCT01108731|102041742|FG001|STARTED|Overall Study||17||
48696405|NCT01108731|102041741|FG000|COMPLETED|Overall Study||13||
48696406|NCT01108731|102041742|FG001|COMPLETED|Overall Study||13||
48696407|NCT01108731|102041741|FG000|NOT COMPLETED|Overall Study||4||
48696408|NCT01108731|102041742|FG001|NOT COMPLETED|Overall Study||4||
48696409|NCT05507567|102041743|FG000|STARTED|Randomised and Received Challenge Virus||32||
48696410|NCT05507567|102041744|FG001|STARTED|Randomised and Received Challenge Virus||31||
48696411|NCT05507567|102041745|FG002|STARTED|Randomised and Received Challenge Virus||41||
48696412|NCT05507567|102041743|FG000|COMPLETED|Randomised and Received Challenge Virus||30||
48696413|NCT05507567|102041744|FG001|COMPLETED|Randomised and Received Challenge Virus||31||
48696414|NCT05507567|102041745|FG002|COMPLETED|Randomised and Received Challenge Virus||40||
48696415|NCT05507567|102041743|FG000|NOT COMPLETED|Randomised and Received Challenge Virus||2||
48696416|NCT05507567|102041744|FG001|NOT COMPLETED|Randomised and Received Challenge Virus||0||
48696417|NCT05507567|102041745|FG002|NOT COMPLETED|Randomised and Received Challenge Virus||1||
48696418|NCT05507567|102041743|FG000|STARTED|From Challenge Virus to End of Study||30||
48696419|NCT05507567|102041744|FG001|STARTED|From Challenge Virus to End of Study||31||
48696420|NCT05507567|102041745|FG002|STARTED|From Challenge Virus to End of Study||40||
48696421|NCT05507567|102041743|FG000|COMPLETED|From Challenge Virus to End of Study||30||
48393698|NCT00877006|101291627|FG001|COMPLETED|Treatment Period||196||
48393699|NCT00877006|101291626|FG000|NOT COMPLETED|Treatment Period||25||
48393700|NCT00877006|101291627|FG001|NOT COMPLETED|Treatment Period||27||
48393701|NCT00877006|101291626|FG000|STARTED|Long-Term Follow-up Period||210||
48393702|NCT00877006|101291627|FG001|STARTED|Long-Term Follow-up Period||209||
48393703|NCT00877006|101291626|FG000|COMPLETED|Long-Term Follow-up Period||157||
48393704|NCT00877006|101291627|FG001|COMPLETED|Long-Term Follow-up Period||154||
48393705|NCT00877006|101291626|FG000|NOT COMPLETED|Long-Term Follow-up Period||53||
48393706|NCT00877006|101291627|FG001|NOT COMPLETED|Long-Term Follow-up Period||55||
48393707|NCT02514772|101291628|FG000|STARTED|Overall Study||53||
48393708|NCT02514772|101291629|FG001|STARTED|Overall Study||54||
48393709|NCT02514772|101291628|FG000|COMPLETED|Overall Study||50||
48393710|NCT02514772|101291629|FG001|COMPLETED|Overall Study||52||
48393711|NCT02514772|101291628|FG000|NOT COMPLETED|Overall Study||3||
48393712|NCT02514772|101291629|FG001|NOT COMPLETED|Overall Study||2||
48393713|NCT01263314|101291630|FG000|STARTED|Period 1||2||
48393714|NCT01263314|101291631|FG001|STARTED|Period 1||2||
48393715|NCT01263314|101291632|FG002|STARTED|Period 1||2||
48393716|NCT01263314|101291633|FG003|STARTED|Period 1||2||
48393717|NCT01263314|101291634|FG004|STARTED|Period 1||2||
48393718|NCT01263314|101291635|FG005|STARTED|Period 1||2||
48393719|NCT01263314|101291636|FG006|STARTED|Period 1||2||
48562738|NCT00860795|101710024|FG000|Number to Complete Study Medication|Overall Study||9||
48562739|NCT00860795|101710025|FG001|Number to Complete Study Medication|Overall Study||10||
48562740|NCT00860795|101710024|FG000|COMPLETED|Overall Study||10||
48562741|NCT00860795|101710025|FG001|COMPLETED|Overall Study||10||
48696422|NCT05507567|102041744|FG001|COMPLETED|From Challenge Virus to End of Study||29||
48696423|NCT05507567|102041745|FG002|COMPLETED|From Challenge Virus to End of Study||40||
48696424|NCT05507567|102041743|FG000|NOT COMPLETED|From Challenge Virus to End of Study||0||
48696425|NCT05507567|102041744|FG001|NOT COMPLETED|From Challenge Virus to End of Study||2||
48696426|NCT05507567|102041745|FG002|NOT COMPLETED|From Challenge Virus to End of Study||0||
48562742|NCT00860795|101710024|FG000|NOT COMPLETED|Overall Study||0||
48562743|NCT00860795|101710025|FG001|NOT COMPLETED|Overall Study||0||
48562744|NCT02705365|101710026|FG000|STARTED|Overall Study||400||
48562745|NCT02705365|101710027|FG001|STARTED|Overall Study||800||
48562746|NCT02705365|101710026|FG000|COMPLETED|Overall Study||400||
48393720|NCT01263314|101291637|FG007|STARTED|Period 1||2||
48393721|NCT01263314|101291630|FG000|COMPLETED|Period 1||2||
48393722|NCT01263314|101291631|FG001|COMPLETED|Period 1||2||
48393723|NCT01263314|101291632|FG002|COMPLETED|Period 1||2||
48393724|NCT01263314|101291633|FG003|COMPLETED|Period 1||2||
48393725|NCT01263314|101291634|FG004|COMPLETED|Period 1||2||
48393726|NCT01263314|101291635|FG005|COMPLETED|Period 1||2||
48393727|NCT01263314|101291636|FG006|COMPLETED|Period 1||2||
48562747|NCT02705365|101710027|FG001|COMPLETED|Overall Study||800||
48562748|NCT02705365|101710026|FG000|NOT COMPLETED|Overall Study||0||
48562749|NCT02705365|101710027|FG001|NOT COMPLETED|Overall Study||0||
48696427|NCT00053677|102041746|FG000|STARTED|Overall Study||58||
48696428|NCT00053677|102041747|FG001|STARTED|Overall Study||19||
48696429|NCT00053677|102041746|FG000|COMPLETED|Overall Study||36||
48696430|NCT00053677|102041747|FG001|COMPLETED|Overall Study||13||
48696431|NCT00053677|102041746|FG000|NOT COMPLETED|Overall Study||22||
48696432|NCT00053677|102041747|FG001|NOT COMPLETED|Overall Study||6||
48393728|NCT01263314|101291637|FG007|COMPLETED|Period 1||2||
48393729|NCT01263314|101291630|FG000|NOT COMPLETED|Period 1||0||
48393730|NCT01263314|101291631|FG001|NOT COMPLETED|Period 1||0||
48393731|NCT01263314|101291632|FG002|NOT COMPLETED|Period 1||0||
48393732|NCT01263314|101291633|FG003|NOT COMPLETED|Period 1||0||
48393733|NCT01263314|101291634|FG004|NOT COMPLETED|Period 1||0||
48393734|NCT01263314|101291635|FG005|NOT COMPLETED|Period 1||0||
48696433|NCT01639339|102041748|FG000|STARTED|Double-blind Period (Up to Week 104)||224||
48696434|NCT01639339|102041749|FG001|STARTED|Double-blind Period (Up to Week 104)||224||
48562750|NCT02816346|101710028|FG000|STARTED|Overall Study||10||
48562751|NCT02816346|101710029|FG001|STARTED|Overall Study||10||
48562752|NCT02816346|101710030|FG002|STARTED|Overall Study||10||
48562753|NCT02816346|101710031|FG003|STARTED|Overall Study||10||
48562754|NCT02816346|101710032|FG004|STARTED|Overall Study||16||
48562755|NCT02816346|101710028|FG000|COMPLETED|Overall Study||10||
48562756|NCT02816346|101710029|FG001|COMPLETED|Overall Study||10||
48562757|NCT02816346|101710030|FG002|COMPLETED|Overall Study||10||
48562758|NCT02816346|101710031|FG003|COMPLETED|Overall Study||10||
48562759|NCT02816346|101710032|FG004|COMPLETED|Overall Study||16||
48562760|NCT02816346|101710028|FG000|NOT COMPLETED|Overall Study||0||
48562761|NCT02816346|101710029|FG001|NOT COMPLETED|Overall Study||0||
48696435|NCT01639339|102041748|FG000|COMPLETED|Double-blind Period (Up to Week 104)||170||
48113395|NCT01072201|100604932|FG001|NOT COMPLETED|Overall Study||1||
48113396|NCT01481116|100604933|FG000|STARTED|Overall Study||824||
48113397|NCT01481116|100604934|FG001|STARTED|Overall Study||817||
48276700|NCT04939701|100999902|FG001|NOT COMPLETED|Phase 1: Dose Escalation (168 Days)||7||
48276701|NCT04939701|100999903|FG002|NOT COMPLETED|Phase 1: Dose Escalation (168 Days)||0||
48276702|NCT04939701|100999901|FG000|STARTED|Phase 2: Dose Expansion (168 Days)||0||
48276703|NCT04939701|100999902|FG001|STARTED|Phase 2: Dose Expansion (168 Days)||0||
48276704|NCT04939701|100999903|FG002|STARTED|Phase 2: Dose Expansion (168 Days)||5||
48276705|NCT04939701|100999901|FG000|COMPLETED|Phase 2: Dose Expansion (168 Days)||0||
48276706|NCT04939701|100999902|FG001|COMPLETED|Phase 2: Dose Expansion (168 Days)||0||
48276707|NCT04939701|100999903|FG002|COMPLETED|Phase 2: Dose Expansion (168 Days)||1||
48276708|NCT04939701|100999901|FG000|NOT COMPLETED|Phase 2: Dose Expansion (168 Days)||0||
48276709|NCT04939701|100999902|FG001|NOT COMPLETED|Phase 2: Dose Expansion (168 Days)||0||
48276710|NCT04939701|100999903|FG002|NOT COMPLETED|Phase 2: Dose Expansion (168 Days)||4||
48276711|NCT02992691|100999904|FG000|STARTED|Overall Study||56||
48276712|NCT02992691|100999904|FG000|Received Test Product 1|Overall Study||55||
48276713|NCT02992691|100999904|FG000|Received Test Product 2|Overall Study||55||
48276714|NCT02992691|100999904|FG000|Received Test Product 3|Overall Study||52||
48276715|NCT02992691|100999904|FG000|Received Positive Control|Overall Study||55||
48276716|NCT02992691|100999904|FG000|Received Negative Control|Overall Study||55||
48276717|NCT02992691|100999904|FG000|COMPLETED|Overall Study||53||
48276718|NCT02992691|100999904|FG000|NOT COMPLETED|Overall Study||3||
48276719|NCT04193436|100999905|FG000|STARTED|Overall Study||6||
48276720|NCT04193436|100999906|FG001|STARTED|Overall Study||6||
48276721|NCT04193436|100999907|FG002|STARTED|Overall Study||6||
48276722|NCT04193436|100999908|FG003|STARTED|Overall Study||5||
48276723|NCT04193436|100999905|FG000|COMPLETED|Overall Study||6||
48276724|NCT04193436|100999906|FG001|COMPLETED|Overall Study||6||
48276725|NCT04193436|100999907|FG002|COMPLETED|Overall Study||6||
48276726|NCT04193436|100999908|FG003|COMPLETED|Overall Study||5||
48276727|NCT04193436|100999905|FG000|NOT COMPLETED|Overall Study||0||
48276728|NCT04193436|100999906|FG001|NOT COMPLETED|Overall Study||0||
48276729|NCT04193436|100999907|FG002|NOT COMPLETED|Overall Study||0||
48276730|NCT04193436|100999908|FG003|NOT COMPLETED|Overall Study||0||
48276731|NCT01638429|100999909|FG000|STARTED|Overall Study||12||
48276732|NCT01638429|100999909|FG000|Pre-treatment Testing|Overall Study||11||
48276733|NCT01638429|100999909|FG000|Antibiotic Treatment|Overall Study||11||
48276734|NCT01638429|100999909|FG000|Post-treatment Testing|Overall Study||11||
48276735|NCT01638429|100999909|FG000|COMPLETED|Overall Study||11||
48276736|NCT01638429|100999909|FG000|NOT COMPLETED|Overall Study||1||
48276737|NCT00818779|101002974|FG000|STARTED|Overall Study||22||
48276738|NCT00818779|101002975|FG001|STARTED|Overall Study||16||
48276739|NCT00818779|101002974|FG000|COMPLETED|Overall Study||16||
48276740|NCT00818779|101002975|FG001|COMPLETED|Overall Study||15||
48276741|NCT00818779|101002974|FG000|NOT COMPLETED|Overall Study||6||
48276742|NCT00818779|101002975|FG001|NOT COMPLETED|Overall Study||1||
48276743|NCT02218606|101002976|FG000|STARTED|Overall Study||42||
48276744|NCT02218606|101002977|FG001|STARTED|Overall Study||39||
48276745|NCT02218606|101002976|FG000|COMPLETED|Overall Study||17||
48276746|NCT02218606|101002977|FG001|COMPLETED|Overall Study||7||
48276747|NCT02218606|101002976|FG000|NOT COMPLETED|Overall Study||25||
48276748|NCT02218606|101002977|FG001|NOT COMPLETED|Overall Study||32||
48276749|NCT03054051|101002978|FG000|STARTED|Overall Study||30||
48276750|NCT03054051|101002979|FG001|STARTED|Overall Study||30||
48276751|NCT03054051|101002978|FG000|COMPLETED|Overall Study||30||
48276752|NCT03054051|101002979|FG001|COMPLETED|Overall Study||30||
48276753|NCT03054051|101002978|FG000|NOT COMPLETED|Overall Study||0||
48113398|NCT01481116|100604935|FG002|STARTED|Overall Study||813||
48113399|NCT01481116|100604933|FG000|Treated|Overall Study||822||
48562762|NCT02816346|101710030|FG002|NOT COMPLETED|Overall Study||0||
48562763|NCT02816346|101710031|FG003|NOT COMPLETED|Overall Study||0||
48113400|NCT01481116|100604934|FG001|Treated|Overall Study||816||
48276754|NCT03054051|101002979|FG001|NOT COMPLETED|Overall Study||0||
48276755|NCT03002220|101002980|FG000|STARTED|Overall Study||52||
48276756|NCT03002220|101002980|FG000|COMPLETED|Overall Study||31||
48562764|NCT02816346|101710032|FG004|NOT COMPLETED|Overall Study||0||
48276757|NCT03002220|101002980|FG000|NOT COMPLETED|Overall Study||21||
48276758|NCT02797080|101002981|FG000|STARTED|Overall Study||38||
48276759|NCT02797080|101002981|FG000|COMPLETED|Overall Study||36||
48393735|NCT01263314|101291636|FG006|NOT COMPLETED|Period 1||0||
48113401|NCT01481116|100604935|FG002|Treated|Overall Study||813||
48113402|NCT01481116|100604933|FG000|COMPLETED|Overall Study||0||
48113403|NCT01481116|100604934|FG001|COMPLETED|Overall Study||0||
48113404|NCT01481116|100604935|FG002|COMPLETED|Overall Study||0||
48113405|NCT01481116|100604933|FG000|NOT COMPLETED|Overall Study||824||
48113406|NCT01481116|100604934|FG001|NOT COMPLETED|Overall Study||817||
48113407|NCT01481116|100604935|FG002|NOT COMPLETED|Overall Study||813||
48113408|NCT04352140|100604936|FG000|STARTED|Overall Study||30||
48113409|NCT04352140|100604937|FG001|STARTED|Overall Study||30||
48113410|NCT04352140|100604936|FG000|COMPLETED|Overall Study||30||
48113411|NCT04352140|100604937|FG001|COMPLETED|Overall Study||30||
48113412|NCT04352140|100604936|FG000|NOT COMPLETED|Overall Study||0||
48113413|NCT04352140|100604937|FG001|NOT COMPLETED|Overall Study||0||
48113414|NCT01397695|100604938|FG000|STARTED|Overall Study||0||
48113415|NCT01397695|100604938|FG000|COMPLETED|Overall Study||0||
48113416|NCT01397695|100604938|FG000|NOT COMPLETED|Overall Study||0||
48113417|NCT04147442|100604939|FG000|STARTED|Overall Study||20||
48562765|NCT04231825|101710033|FG000|STARTED|Overall Study||23||
48562766|NCT04231825|101710034|FG001|STARTED|Overall Study||24||
48562767|NCT04231825|101710033|FG000|COMPLETED|Overall Study||20||
48562768|NCT04231825|101710034|FG001|COMPLETED|Overall Study||20||
48562769|NCT04231825|101710033|FG000|NOT COMPLETED|Overall Study||3||
48562770|NCT04231825|101710034|FG001|NOT COMPLETED|Overall Study||4||
48562771|NCT00691444|101710035|FG000|STARTED|Overall Study||0||
48562772|NCT00691444|101710036|FG001|STARTED|Overall Study||0||
48562773|NCT00691444|101710037|FG002|STARTED|Overall Study||0||
48562774|NCT00691444|101710035|FG000|COMPLETED|Overall Study||0||
48562775|NCT00691444|101710036|FG001|COMPLETED|Overall Study||0||
48562776|NCT00691444|101710037|FG002|COMPLETED|Overall Study||0||
48562777|NCT00691444|101710035|FG000|NOT COMPLETED|Overall Study||0||
48562778|NCT00691444|101710036|FG001|NOT COMPLETED|Overall Study||0||
48562779|NCT00691444|101710037|FG002|NOT COMPLETED|Overall Study||0||
48562780|NCT00725283|101710038|FG000|STARTED|Overall Study||34||
48562781|NCT00725283|101710038|FG000|COMPLETED|Overall Study||10||
48562782|NCT00725283|101710038|FG000|NOT COMPLETED|Overall Study||24||
48562783|NCT00707239|101710039|FG000|STARTED|Overall Study||37||
48562784|NCT00707239|101710040|FG001|STARTED|Overall Study||36||
48562785|NCT00707239|101710041|FG002|STARTED|Overall Study||35||
48562786|NCT00707239|101710039|FG000|Treated|Overall Study||36||
48562787|NCT00707239|101710040|FG001|Treated|Overall Study||35||
48562788|NCT00707239|101710041|FG002|Treated|Overall Study||34||
48562789|NCT00707239|101710039|FG000|COMPLETED|Overall Study||18||
48562790|NCT00707239|101710040|FG001|COMPLETED|Overall Study||25||
48562791|NCT00707239|101710041|FG002|COMPLETED|Overall Study||21||
48562792|NCT00707239|101710039|FG000|NOT COMPLETED|Overall Study||19||
48562793|NCT00707239|101710040|FG001|NOT COMPLETED|Overall Study||11||
48562794|NCT00707239|101710041|FG002|NOT COMPLETED|Overall Study||14||
48562795|NCT02013817|101710042|FG000|STARTED|Overall Study||43||
48113418|NCT04147442|100604939|FG000|COMPLETED|Overall Study||20||
48113419|NCT04147442|100604939|FG000|NOT COMPLETED|Overall Study||0||
48113420|NCT00706966|100604940|FG000|STARTED|Overall Study||10||
48113421|NCT00706966|100604940|FG000|COMPLETED|Overall Study||9||
48113422|NCT00706966|100604940|FG000|NOT COMPLETED|Overall Study||1||
48113423|NCT03139916|100604941|FG000|STARTED|Overall Study||36||
48113424|NCT03139916|100604941|FG000|COMPLETED|Overall Study||33||
48113425|NCT03139916|100604941|FG000|NOT COMPLETED|Overall Study||3||
48276760|NCT02797080|101002981|FG000|NOT COMPLETED|Overall Study||2||
48276761|NCT01072630|101002982|FG000|STARTED|Overall Study||230||
48562796|NCT02013817|101710042|FG000|COMPLETED|Overall Study||16||
48562797|NCT02013817|101710042|FG000|NOT COMPLETED|Overall Study||27||
48562798|NCT00556946|101710043|FG000|STARTED|Overall Study||17||
48562799|NCT00556946|101710043|FG000|COMPLETED|Overall Study||16||
48562800|NCT00556946|101710043|FG000|NOT COMPLETED|Overall Study||1||
48562801|NCT02968602|101710044|FG000|STARTED|Overall Study||16||
48562802|NCT02968602|101710045|FG001|STARTED|Overall Study||16||
48562803|NCT02968602|101710044|FG000|COMPLETED|Overall Study||16||
48562804|NCT02968602|101710045|FG001|COMPLETED|Overall Study||16||
48562805|NCT02968602|101710044|FG000|NOT COMPLETED|Overall Study||0||
48562806|NCT02968602|101710045|FG001|NOT COMPLETED|Overall Study||0||
48562807|NCT02166333|101710046|FG000|STARTED|Stage 1||262||
48562808|NCT02166333|101710047|FG001|STARTED|Stage 1||0||
48562809|NCT02166333|101710048|FG002|STARTED|Stage 1||130||
48562810|NCT02166333|101710049|FG003|STARTED|Stage 1||0||
48710816|NCT00884910|102078028|FG000|STARTED|Overall Study||33||
48562811|NCT02166333|101710050|FG004|STARTED|Stage 1||68||
48562812|NCT02166333|101710051|FG005|STARTED|Stage 1||69||
48562813|NCT02166333|101710046|FG000|COMPLETED|Stage 1||242|In Stage 1, completed = started Stage 2|
48562814|NCT02166333|101710047|FG001|COMPLETED|Stage 1||0|In Stage 1, completed = started Stage 2|
48113426|NCT00958776|100604942|FG000|STARTED|Overall Study||137||
48113427|NCT00958776|100604943|FG001|STARTED|Overall Study||268||
48113428|NCT00958776|100604942|FG000|COMPLETED|Overall Study||121||
48113429|NCT00958776|100604943|FG001|COMPLETED|Overall Study||239||
48113430|NCT00958776|100604942|FG000|NOT COMPLETED|Overall Study||16||
48113431|NCT00958776|100604943|FG001|NOT COMPLETED|Overall Study||29||
48393736|NCT01263314|101291637|FG007|NOT COMPLETED|Period 1||0||
48276762|NCT01072630|101002983|FG001|STARTED|Overall Study||232||
48276763|NCT01072630|101002984|FG002|STARTED|Overall Study||30||
48276764|NCT01072630|101002982|FG000|Safety Population|Overall Study||229||
48276765|NCT01072630|101002983|FG001|Safety Population|Overall Study||231||
48276766|NCT01072630|101002984|FG002|Safety Population|Overall Study||30||
48276767|NCT01072630|101002982|FG000|Full Analysis Population|Overall Study||224||
48276768|NCT01072630|101002983|FG001|Full Analysis Population|Overall Study||230||
48276769|NCT01072630|101002984|FG002|Full Analysis Population|Overall Study||28||
48276770|NCT01072630|101002982|FG000|COMPLETED|Overall Study||175||
48276771|NCT01072630|101002983|FG001|COMPLETED|Overall Study||172||
48276772|NCT01072630|101002984|FG002|COMPLETED|Overall Study||17||
48562815|NCT02166333|101710048|FG002|COMPLETED|Stage 1||122|In Stage 1, completed = started Stage 2|
48562816|NCT02166333|101710049|FG003|COMPLETED|Stage 1||0|In Stage 1, completed = started Stage 2|
48562817|NCT02166333|101710050|FG004|COMPLETED|Stage 1||59|In Stage 1, completed = started Stage 2|
48562818|NCT02166333|101710051|FG005|COMPLETED|Stage 1||63|In Stage 1, completed = started Stage 2|
48562819|NCT02166333|101710046|FG000|NOT COMPLETED|Stage 1||20||
48562820|NCT02166333|101710047|FG001|NOT COMPLETED|Stage 1||0||
48562821|NCT02166333|101710048|FG002|NOT COMPLETED|Stage 1||8||
48562822|NCT02166333|101710049|FG003|NOT COMPLETED|Stage 1||0||
48562823|NCT02166333|101710050|FG004|NOT COMPLETED|Stage 1||9||
48562824|NCT02166333|101710051|FG005|NOT COMPLETED|Stage 1||6||
48562825|NCT02166333|101710046|FG000|STARTED|Stage 2||242||
48562826|NCT02166333|101710047|FG001|STARTED|Stage 2||77||
48562827|NCT02166333|101710048|FG002|STARTED|Stage 2||122||
48562828|NCT02166333|101710049|FG003|STARTED|Stage 2||82||
48562829|NCT02166333|101710050|FG004|STARTED|Stage 2||59||
48562830|NCT02166333|101710051|FG005|STARTED|Stage 2||63||
48562831|NCT02166333|101710046|FG000|COMPLETED|Stage 2||35|In Stage 2, completed = participated in closeout (April-May 2019)|
48562832|NCT02166333|101710047|FG001|COMPLETED|Stage 2||71|In Stage 2, completed = participated in closeout (April-May 2019)|
48562833|NCT02166333|101710048|FG002|COMPLETED|Stage 2||47|In Stage 2, completed = participated in closeout (April-May 2019)|
48562834|NCT02166333|101710049|FG003|COMPLETED|Stage 2||73|In Stage 2, completed = participated in closeout (April-May 2019)|
48562835|NCT02166333|101710050|FG004|COMPLETED|Stage 2||2|In Stage 2, completed = participated in closeout (April-May 2019)|
48562836|NCT02166333|101710051|FG005|COMPLETED|Stage 2||4|In Stage 2, completed = participated in closeout (April-May 2019)|
48562837|NCT02166333|101710046|FG000|NOT COMPLETED|Stage 2||207||
48562838|NCT02166333|101710047|FG001|NOT COMPLETED|Stage 2||6||
48562839|NCT02166333|101710048|FG002|NOT COMPLETED|Stage 2||75||
48562840|NCT02166333|101710049|FG003|NOT COMPLETED|Stage 2||9||
48562841|NCT02166333|101710050|FG004|NOT COMPLETED|Stage 2||57||
48562842|NCT02166333|101710051|FG005|NOT COMPLETED|Stage 2||59||
48562843|NCT04846569|101710052|FG000|STARTED|Overall Study||23||
48276773|NCT01072630|101002982|FG000|NOT COMPLETED|Overall Study||55||
48276774|NCT01072630|101002983|FG001|NOT COMPLETED|Overall Study||60||
48276775|NCT01072630|101002984|FG002|NOT COMPLETED|Overall Study||13||
48276776|NCT00669279|101002985|FG000|STARTED|Overall Study||22||
48276777|NCT00669279|101002986|FG001|STARTED|Overall Study||19||
48562844|NCT04846569|101710053|FG001|STARTED|Overall Study||20||
48562845|NCT04846569|101710052|FG000|COMPLETED|Overall Study||20||
48562846|NCT04846569|101710053|FG001|COMPLETED|Overall Study||19||
48562847|NCT04846569|101710052|FG000|NOT COMPLETED|Overall Study||3||
48562848|NCT04846569|101710053|FG001|NOT COMPLETED|Overall Study||1||
48562849|NCT01622257|101710054|FG000|STARTED|Overall Study||66||
48562850|NCT01622257|101710055|FG001|STARTED|Overall Study||66||
48276778|NCT00669279|101002985|FG000|COMPLETED|Overall Study||22||
48113432|NCT02485912|100604944|FG000|STARTED|Overall Study||20||
48113433|NCT02485912|100604945|FG001|STARTED|Overall Study||20||
48113434|NCT02485912|100604944|FG000|COMPLETED|Overall Study||20||
48113435|NCT02485912|100604945|FG001|COMPLETED|Overall Study||20||
48113436|NCT02485912|100604944|FG000|NOT COMPLETED|Overall Study||0||
48113437|NCT02485912|100604945|FG001|NOT COMPLETED|Overall Study||0||
48113438|NCT01559311|100604946|FG000|STARTED|Overall Study||30||
48113439|NCT01559311|100604947|FG001|STARTED|Overall Study||34||
48113440|NCT01559311|100604948|FG002|STARTED|Overall Study||34||
48696436|NCT01639339|102041749|FG001|COMPLETED|Double-blind Period (Up to Week 104)||186||
48696437|NCT01639339|102041748|FG000|NOT COMPLETED|Double-blind Period (Up to Week 104)||54||
48696438|NCT01639339|102041749|FG001|NOT COMPLETED|Double-blind Period (Up to Week 104)||38||
48696439|NCT01639339|102041748|FG000|STARTED|Open-label Period (Up to Week 28)||123||
48696440|NCT01639339|102041749|FG001|STARTED|Open-label Period (Up to Week 28)||132||
48696441|NCT01639339|102041748|FG000|COMPLETED|Open-label Period (Up to Week 28)||122||
48696442|NCT01639339|102041749|FG001|COMPLETED|Open-label Period (Up to Week 28)||124||
48696443|NCT01639339|102041748|FG000|NOT COMPLETED|Open-label Period (Up to Week 28)||1||
48696444|NCT01639339|102041749|FG001|NOT COMPLETED|Open-label Period (Up to Week 28)||8||
48696445|NCT00425698|102041750|FG000|STARTED|Overall Study||44||
48696446|NCT00425698|102041751|FG001|STARTED|Overall Study||44||
48696447|NCT00425698|102041750|FG000|COMPLETED|Overall Study||41||
48696448|NCT00425698|102041751|FG001|COMPLETED|Overall Study||42||
48696449|NCT00425698|102041750|FG000|NOT COMPLETED|Overall Study||3||
48696450|NCT00425698|102041751|FG001|NOT COMPLETED|Overall Study||2||
48696451|NCT03641716|102041752|FG000|STARTED|Overall Study||20||
48696452|NCT03641716|102041752|FG000|COMPLETED|Overall Study||15||
48696453|NCT03641716|102041752|FG000|NOT COMPLETED|Overall Study||5||
48696454|NCT00606034|102041753|FG000|STARTED|Overall Study||21||
48113441|NCT01559311|100604946|FG000|Implant|Overall Study||28||
48113442|NCT01559311|100604947|FG001|Implant|Overall Study||34||
48113443|NCT01559311|100604948|FG002|Implant|Overall Study||32||
48113444|NCT01559311|100604946|FG000|1-Month|Overall Study||27||
48113445|NCT01559311|100604947|FG001|1-Month|Overall Study||34||
48113446|NCT01559311|100604948|FG002|1-Month|Overall Study||29||
48113447|NCT01559311|100604946|FG000|3-Month|Overall Study||27||
48113448|NCT01559311|100604947|FG001|3-Month|Overall Study||34||
48113449|NCT01559311|100604948|FG002|3-Month|Overall Study||29||
48113450|NCT01559311|100604946|FG000|6-Month|Overall Study||27||
48113451|NCT01559311|100604947|FG001|6-Month|Overall Study||33||
48113452|NCT01559311|100604948|FG002|6-Month|Overall Study||28||
48276779|NCT00669279|101002986|FG001|COMPLETED|Overall Study||19||
48276780|NCT00669279|101002985|FG000|NOT COMPLETED|Overall Study||0||
48276781|NCT00669279|101002986|FG001|NOT COMPLETED|Overall Study||0||
48276782|NCT03047395|101002987|FG000|STARTED|Overall Study||2170||
48276783|NCT03047395|101002987|FG000|COMPLETED|Overall Study||1601||
48276784|NCT03047395|101002987|FG000|NOT COMPLETED|Overall Study||569||
48113453|NCT01559311|100604946|FG000|COMPLETED|Overall Study||27||
48113454|NCT01559311|100604947|FG001|COMPLETED|Overall Study||28||
48113455|NCT01559311|100604948|FG002|COMPLETED|Overall Study||26||
48113456|NCT01559311|100604946|FG000|NOT COMPLETED|Overall Study||3||
48113457|NCT01559311|100604947|FG001|NOT COMPLETED|Overall Study||6||
48276785|NCT03596762|101002988|FG000|STARTED|Overall Study||47||
48276786|NCT03596762|101002989|FG001|STARTED|Overall Study||31||
48276787|NCT03596762|101002990|FG002|STARTED|Overall Study||17||
48276788|NCT03596762|101002991|FG003|STARTED|Overall Study||52||
48113458|NCT01559311|100604948|FG002|NOT COMPLETED|Overall Study||8||
48113459|NCT01302392|100604949|FG000|STARTED|Overall Study||158||
48113460|NCT01302392|100604950|FG001|STARTED|Overall Study||157||
48113461|NCT01302392|100604949|FG000|Treated|Overall Study||153||
48276789|NCT03596762|101002992|FG004|STARTED|Overall Study||52||
48276790|NCT03596762|101002988|FG000|COMPLETED|Overall Study||43||
48393737|NCT01263314|101291630|FG000|STARTED|Period 2||2||
48113462|NCT01302392|100604950|FG001|Treated|Overall Study||157||
48113463|NCT01302392|100604949|FG000|COMPLETED|Overall Study||151||
48113464|NCT01302392|100604950|FG001|COMPLETED|Overall Study||156||
48276791|NCT03596762|101002989|FG001|COMPLETED|Overall Study||30||
48276792|NCT03596762|101002990|FG002|COMPLETED|Overall Study||16||
48393738|NCT01263314|101291631|FG001|STARTED|Period 2||2||
48113465|NCT01302392|100604949|FG000|NOT COMPLETED|Overall Study||7||
48276793|NCT03596762|101002991|FG003|COMPLETED|Overall Study||51||
48113466|NCT01302392|100604950|FG001|NOT COMPLETED|Overall Study||1||
48113467|NCT01940120|100604951|FG000|STARTED|Overall Study||78||
48113468|NCT01940120|100604951|FG000|COMPLETED|Overall Study||30||
48113469|NCT01940120|100604951|FG000|NOT COMPLETED|Overall Study||48||
48113470|NCT00833924|100604952|FG000|STARTED|Overall Study||120||
48113471|NCT00833924|100604952|FG000|30-day|Overall Study||120||
48113472|NCT00833924|100604952|FG000|12-month|Overall Study||113||
48113473|NCT00833924|100604952|FG000|COMPLETED|Overall Study||11||
48276794|NCT03596762|101002992|FG004|COMPLETED|Overall Study||45||
48276795|NCT03596762|101002988|FG000|NOT COMPLETED|Overall Study||4||
48276796|NCT03596762|101002989|FG001|NOT COMPLETED|Overall Study||1||
48276797|NCT03596762|101002990|FG002|NOT COMPLETED|Overall Study||1||
48393739|NCT01263314|101291632|FG002|STARTED|Period 2||2||
48696455|NCT00606034|102041753|FG000|COMPLETED|Overall Study||20||
48696456|NCT00606034|102041753|FG000|NOT COMPLETED|Overall Study||1||
48113474|NCT00833924|100604952|FG000|NOT COMPLETED|Overall Study||109||
48113475|NCT00915798|100604953|FG000|STARTED|Overall Study||19||
48113476|NCT00915798|100604954|FG001|STARTED|Overall Study||21||
48113477|NCT00915798|100604955|FG002|STARTED|Overall Study||23||
48113478|NCT00915798|100604956|FG003|STARTED|Overall Study||26||
48113479|NCT00915798|100604953|FG000|COMPLETED|Overall Study||19||
48113480|NCT00915798|100604954|FG001|COMPLETED|Overall Study||21||
48113481|NCT00915798|100604955|FG002|COMPLETED|Overall Study||23||
48113482|NCT00915798|100604956|FG003|COMPLETED|Overall Study||26||
48113483|NCT00915798|100604953|FG000|NOT COMPLETED|Overall Study||0||
48113484|NCT00915798|100604954|FG001|NOT COMPLETED|Overall Study||0||
48113485|NCT00915798|100604955|FG002|NOT COMPLETED|Overall Study||0||
48113486|NCT00915798|100604956|FG003|NOT COMPLETED|Overall Study||0||
48113487|NCT01828034|100604957|FG000|STARTED|Overall Study||3||
48113488|NCT01828034|100604958|FG001|STARTED|Overall Study||6||
48113489|NCT01828034|100604959|FG002|STARTED|Overall Study||3||
48113490|NCT01828034|100604960|FG003|STARTED|Overall Study||30||
48113491|NCT01828034|100604957|FG000|COMPLETED|Overall Study||3||
48113492|NCT01828034|100604958|FG001|COMPLETED|Overall Study||6||
48113493|NCT01828034|100604959|FG002|COMPLETED|Overall Study||3||
48393740|NCT01263314|101291633|FG003|STARTED|Period 2||2||
48393741|NCT01263314|101291634|FG004|STARTED|Period 2||2||
48393742|NCT01263314|101291635|FG005|STARTED|Period 2||2||
48393743|NCT01263314|101291636|FG006|STARTED|Period 2||2||
48393744|NCT01263314|101291637|FG007|STARTED|Period 2||2||
48393745|NCT01263314|101291630|FG000|COMPLETED|Period 2||2||
48393746|NCT01263314|101291631|FG001|COMPLETED|Period 2||2||
48393747|NCT01263314|101291632|FG002|COMPLETED|Period 2||2||
48393748|NCT01263314|101291633|FG003|COMPLETED|Period 2||2||
48393749|NCT01263314|101291634|FG004|COMPLETED|Period 2||2||
48393750|NCT01263314|101291635|FG005|COMPLETED|Period 2||2||
48393751|NCT01263314|101291636|FG006|COMPLETED|Period 2||2||
48393752|NCT01263314|101291637|FG007|COMPLETED|Period 2||2||
48393753|NCT01263314|101291630|FG000|NOT COMPLETED|Period 2||0||
48393754|NCT01263314|101291631|FG001|NOT COMPLETED|Period 2||0||
48393755|NCT01263314|101291632|FG002|NOT COMPLETED|Period 2||0||
48393756|NCT01263314|101291633|FG003|NOT COMPLETED|Period 2||0||
48393757|NCT01263314|101291634|FG004|NOT COMPLETED|Period 2||0||
48393758|NCT01263314|101291635|FG005|NOT COMPLETED|Period 2||0||
48393759|NCT01263314|101291636|FG006|NOT COMPLETED|Period 2||0||
48393760|NCT01263314|101291637|FG007|NOT COMPLETED|Period 2||0||
48393761|NCT01263314|101291630|FG000|STARTED|Period 3||2||
48393762|NCT01263314|101291631|FG001|STARTED|Period 3||2||
48393763|NCT01263314|101291632|FG002|STARTED|Period 3||2||
48393764|NCT01263314|101291633|FG003|STARTED|Period 3||2||
48393765|NCT01263314|101291634|FG004|STARTED|Period 3||2||
48393766|NCT01263314|101291635|FG005|STARTED|Period 3||2||
48393767|NCT01263314|101291636|FG006|STARTED|Period 3||2||
48393768|NCT01263314|101291637|FG007|STARTED|Period 3||2||
48393769|NCT01263314|101291630|FG000|COMPLETED|Period 3||2||
48393770|NCT01263314|101291631|FG001|COMPLETED|Period 3||2||
48393771|NCT01263314|101291632|FG002|COMPLETED|Period 3||2||
48393772|NCT01263314|101291633|FG003|COMPLETED|Period 3||2||
48393773|NCT01263314|101291634|FG004|COMPLETED|Period 3||2||
48393774|NCT01263314|101291635|FG005|COMPLETED|Period 3||2||
48393775|NCT01263314|101291636|FG006|COMPLETED|Period 3||2||
48393776|NCT01263314|101291637|FG007|COMPLETED|Period 3||2||
48393777|NCT01263314|101291630|FG000|NOT COMPLETED|Period 3||0||
48393778|NCT01263314|101291631|FG001|NOT COMPLETED|Period 3||0||
48393779|NCT01263314|101291632|FG002|NOT COMPLETED|Period 3||0||
48393780|NCT01263314|101291633|FG003|NOT COMPLETED|Period 3||0||
48393781|NCT01263314|101291634|FG004|NOT COMPLETED|Period 3||0||
48393782|NCT01263314|101291635|FG005|NOT COMPLETED|Period 3||0||
48393783|NCT01263314|101291636|FG006|NOT COMPLETED|Period 3||0||
48393784|NCT01263314|101291637|FG007|NOT COMPLETED|Period 3||0||
48562851|NCT01622257|101710056|FG002|STARTED|Overall Study||66||
48562852|NCT01622257|101710054|FG000|COMPLETED|Overall Study||66||
48562853|NCT01622257|101710055|FG001|COMPLETED|Overall Study||66||
48562854|NCT01622257|101710056|FG002|COMPLETED|Overall Study||66||
48562855|NCT01622257|101710054|FG000|NOT COMPLETED|Overall Study||0||
48562856|NCT01622257|101710055|FG001|NOT COMPLETED|Overall Study||0||
48562857|NCT01622257|101710056|FG002|NOT COMPLETED|Overall Study||0||
48113494|NCT01828034|100604960|FG003|COMPLETED|Overall Study||29||
48113495|NCT01828034|100604957|FG000|NOT COMPLETED|Overall Study||0||
48393785|NCT01179347|101291638|FG000|STARTED|Double-blind Period (12 Weeks)||155||
48393786|NCT01179347|101291639|FG001|STARTED|Double-blind Period (12 Weeks)||308||
48562858|NCT00564850|101710057|FG000|STARTED|Overall Study||37||
48113496|NCT01828034|100604958|FG001|NOT COMPLETED|Overall Study||0||
48393787|NCT01179347|101291638|FG000|COMPLETED|Double-blind Period (12 Weeks)||147||
48562859|NCT00564850|101710057|FG000|COMPLETED|Overall Study||35||
48562860|NCT00564850|101710057|FG000|NOT COMPLETED|Overall Study||2||
48562861|NCT02220764|101710058|FG000|STARTED|Overall Study||24||
48113497|NCT01828034|100604959|FG002|NOT COMPLETED|Overall Study||0||
48393788|NCT01179347|101291639|FG001|COMPLETED|Double-blind Period (12 Weeks)||294||
48393789|NCT01179347|101291638|FG000|NOT COMPLETED|Double-blind Period (12 Weeks)||8||
48393790|NCT01179347|101291639|FG001|NOT COMPLETED|Double-blind Period (12 Weeks)||14||
48393791|NCT01179347|101291638|FG000|STARTED|Open-label Period (12 Weeks)||147||
48562862|NCT02220764|101710059|FG001|STARTED|Overall Study||8||
48562863|NCT02220764|101710058|FG000|COMPLETED|Overall Study||20||
48113498|NCT01828034|100604960|FG003|NOT COMPLETED|Overall Study||1||
48113499|NCT00670228|100604961|FG000|STARTED|Overall Study||18||
48113500|NCT00670228|100604962|FG001|STARTED|Overall Study||15||
48113501|NCT00670228|100604961|FG000|COMPLETED|Overall Study||13||
48113502|NCT00670228|100604962|FG001|COMPLETED|Overall Study||12||
48113503|NCT00670228|100604961|FG000|NOT COMPLETED|Overall Study||5||
48113504|NCT00670228|100604962|FG001|NOT COMPLETED|Overall Study||3||
48113505|NCT01541826|100604963|FG000|STARTED|Overall Study||28||
48113506|NCT01541826|100604964|FG001|STARTED|Overall Study||28||
48113507|NCT01541826|100604965|FG002|STARTED|Overall Study||6||
48113508|NCT01541826|100604963|FG000|COMPLETED|Overall Study||24||
48562864|NCT02220764|101710059|FG001|COMPLETED|Overall Study||7||
48562865|NCT02220764|101710058|FG000|NOT COMPLETED|Overall Study||4||
48562866|NCT02220764|101710059|FG001|NOT COMPLETED|Overall Study||1||
48562867|NCT04429945|101710060|FG000|STARTED|Overall Study||10||
48562868|NCT04429945|101710060|FG000|COMPLETED|Overall Study||10||
48562869|NCT04429945|101710060|FG000|NOT COMPLETED|Overall Study||0||
48562870|NCT04515147|101710061|FG000|STARTED|Overall Study||12||
48562871|NCT04515147|101710062|FG001|STARTED|Overall Study||11||
48562872|NCT04515147|101710063|FG002|STARTED|Overall Study||289||
48562873|NCT04515147|101710064|FG003|STARTED|Overall Study||295||
48562874|NCT04515147|101710065|FG004|STARTED|Overall Study||31||
48113509|NCT01541826|100604964|FG001|COMPLETED|Overall Study||25||
48113510|NCT01541826|100604965|FG002|COMPLETED|Overall Study||6||
48113511|NCT01541826|100604963|FG000|NOT COMPLETED|Overall Study||4||
48113512|NCT01541826|100604964|FG001|NOT COMPLETED|Overall Study||3||
48113513|NCT01541826|100604965|FG002|NOT COMPLETED|Overall Study||0||
48562875|NCT04515147|101710066|FG005|STARTED|Overall Study||30||
48562876|NCT04515147|101710061|FG000|COMPLETED|Overall Study||11||
48562877|NCT04515147|101710062|FG001|COMPLETED|Overall Study||10||
48562878|NCT04515147|101710063|FG002|COMPLETED|Overall Study||274||
48562879|NCT04515147|101710064|FG003|COMPLETED|Overall Study||268||
48562880|NCT04515147|101710065|FG004|COMPLETED|Overall Study||28||
48562881|NCT04515147|101710066|FG005|COMPLETED|Overall Study||20||
48562882|NCT04515147|101710061|FG000|NOT COMPLETED|Overall Study||1||
48562883|NCT04515147|101710062|FG001|NOT COMPLETED|Overall Study||1||
48562884|NCT04515147|101710063|FG002|NOT COMPLETED|Overall Study||15||
48562885|NCT04515147|101710064|FG003|NOT COMPLETED|Overall Study||27||
48562886|NCT04515147|101710065|FG004|NOT COMPLETED|Overall Study||3||
48562887|NCT04515147|101710066|FG005|NOT COMPLETED|Overall Study||10||
48562888|NCT01515423|101710067|FG000|STARTED|Open Label Phase||1429||
48562889|NCT01515423|101710068|FG001|STARTED|Open Label Phase||0||
48562890|NCT01515423|101710069|FG002|STARTED|Open Label Phase||0||
48562891|NCT01515423|101710067|FG000|COMPLETED|Open Label Phase||1016||
48562892|NCT01515423|101710068|FG001|COMPLETED|Open Label Phase||0||
48562893|NCT01515423|101710069|FG002|COMPLETED|Open Label Phase||0||
48562894|NCT01515423|101710067|FG000|NOT COMPLETED|Open Label Phase||413||
48562895|NCT01515423|101710068|FG001|NOT COMPLETED|Open Label Phase||0||
48562896|NCT01515423|101710069|FG002|NOT COMPLETED|Open Label Phase||0||
48562897|NCT01515423|101710067|FG000|STARTED|DOUBLE BLIND||0||
48562898|NCT01515423|101710068|FG001|STARTED|DOUBLE BLIND||504||
48562899|NCT01515423|101710069|FG002|STARTED|DOUBLE BLIND||512||
48562900|NCT01515423|101710067|FG000|COMPLETED|DOUBLE BLIND||0||
48562901|NCT01515423|101710068|FG001|COMPLETED|DOUBLE BLIND||422||
48562902|NCT01515423|101710069|FG002|COMPLETED|DOUBLE BLIND||420||
48562903|NCT01515423|101710067|FG000|NOT COMPLETED|DOUBLE BLIND||0||
48562904|NCT01515423|101710068|FG001|NOT COMPLETED|DOUBLE BLIND||82||
48113514|NCT04399161|100604966|FG000|STARTED|Overall Study||20||
48113515|NCT04399161|100604967|FG001|STARTED|Overall Study||20||
48113516|NCT04399161|100604968|FG002|STARTED|Overall Study||20||
48113517|NCT04399161|100604966|FG000|COMPLETED|Overall Study||18||
48113518|NCT04399161|100604967|FG001|COMPLETED|Overall Study||18||
48113519|NCT04399161|100604968|FG002|COMPLETED|Overall Study||18||
48393792|NCT01179347|101291639|FG001|STARTED|Open-label Period (12 Weeks)||294||
48562905|NCT01515423|101710069|FG002|NOT COMPLETED|DOUBLE BLIND||92||
48562906|NCT01778855|101710070|FG000|STARTED|Overall Study||2||
48562907|NCT01778855|101710071|FG001|STARTED|Overall Study||4||
48562908|NCT01778855|101710070|FG000|COMPLETED|Overall Study||2||
48562909|NCT01778855|101710071|FG001|COMPLETED|Overall Study||3||
48562910|NCT01778855|101710070|FG000|NOT COMPLETED|Overall Study||0||
48562911|NCT01778855|101710071|FG001|NOT COMPLETED|Overall Study||1||
48562912|NCT03885661|101710072|FG000|STARTED|Overall Study||12||
48562913|NCT03885661|101710073|FG001|STARTED|Overall Study||8||
48113520|NCT04399161|100604966|FG000|NOT COMPLETED|Overall Study||2||
48113521|NCT04399161|100604967|FG001|NOT COMPLETED|Overall Study||2||
48113522|NCT04399161|100604968|FG002|NOT COMPLETED|Overall Study||2||
48113523|NCT02075320|100604969|FG000|STARTED|Overall Study||50||
48113524|NCT02075320|100604969|FG000|COMPLETED|Overall Study||48||
48562914|NCT03885661|101710072|FG000|Baseline|Overall Study||12||
48562915|NCT03885661|101710073|FG001|Baseline|Overall Study||8||
48562916|NCT03885661|101710072|FG000|Treatment Visit (12 Week)|Overall Study||11||
48562917|NCT03885661|101710073|FG001|Treatment Visit (12 Week)|Overall Study||7||
48562918|NCT03885661|101710072|FG000|COMPLETED|Overall Study||11||
48276798|NCT03596762|101002991|FG003|NOT COMPLETED|Overall Study||1||
48276799|NCT03596762|101002992|FG004|NOT COMPLETED|Overall Study||7||
48276800|NCT00814177|101002993|FG000|STARTED|Overall Study||80||
48276801|NCT00814177|101002994|FG001|STARTED|Overall Study||80||
48276802|NCT00814177|101002993|FG000|COMPLETED|Overall Study||80||
48276803|NCT00814177|101002994|FG001|COMPLETED|Overall Study||80||
48276804|NCT00814177|101002993|FG000|NOT COMPLETED|Overall Study||0||
48276805|NCT00814177|101002994|FG001|NOT COMPLETED|Overall Study||0||
48276806|NCT05017103|101002995|FG000|STARTED|Overall Study||6||
48276807|NCT05017103|101002995|FG000|COMPLETED|Overall Study||4||
48276808|NCT05017103|101002995|FG000|NOT COMPLETED|Overall Study||2||
48276809|NCT00616902|101002996|FG000|STARTED|Overall Study||6||
48276810|NCT00616902|101002997|FG001|STARTED|Overall Study||6||
48276811|NCT00616902|101002996|FG000|COMPLETED|Overall Study||0||
48276812|NCT00616902|101002997|FG001|COMPLETED|Overall Study||0||
48276813|NCT00616902|101002996|FG000|NOT COMPLETED|Overall Study||6||
48276814|NCT00616902|101002997|FG001|NOT COMPLETED|Overall Study||6||
48276815|NCT02636725|101002998|FG000|STARTED|Overall Study||33||
48276816|NCT02636725|101002998|FG000|COMPLETED|Overall Study||32||
48276817|NCT02636725|101002998|FG000|NOT COMPLETED|Overall Study||1||
48276818|NCT06390839|101002999|FG000|STARTED|Overall Study||43||
48276819|NCT06390839|101002999|FG000|Started Protocol Therapy|Overall Study||40||
48276820|NCT06390839|101002999|FG000|Eligible and Treated|Overall Study||38||
48276821|NCT06390839|101002999|FG000|Eligible, Treated and Mutation Status Confirmed|Overall Study||25|Primary efficacy analysis set|
48276822|NCT06390839|101002999|FG000|COMPLETED|Overall Study||0||
48276823|NCT06390839|101002999|FG000|NOT COMPLETED|Overall Study||43||
48276824|NCT00859222|101003000|FG000|STARTED|Overall Study||3||
48276825|NCT00859222|101003001|FG001|STARTED|Overall Study||3||
48276826|NCT00859222|101003002|FG002|STARTED|Overall Study||6||
48696457|NCT02851797|102041754|FG000|STARTED|Overall Study||118||
48696458|NCT02851797|102041755|FG001|STARTED|Overall Study||61||
48696459|NCT02851797|102041754|FG000|All Enrolled Subjects|Overall Study||118||
48696460|NCT02851797|102041755|FG001|All Enrolled Subjects|Overall Study||61||
48696461|NCT02851797|102041754|FG000|ITT Population|Overall Study||118||
48696462|NCT02851797|102041755|FG001|ITT Population|Overall Study||61||
48696463|NCT02851797|102041754|FG000|Safety Set|Overall Study||118||
48696464|NCT02851797|102041755|FG001|Safety Set|Overall Study||61||
48696465|NCT02851797|102041754|FG000|PK Analysis Set|Overall Study||117||
48696466|NCT02851797|102041755|FG001|PK Analysis Set|Overall Study||0||
48696467|NCT02851797|102041754|FG000|Target Population|Overall Study||81||
48696468|NCT02851797|102041755|FG001|Target Population|Overall Study||39||
48696469|NCT02851797|102041754|FG000|MR Cohort|Overall Study||77||
48696470|NCT02851797|102041755|FG001|MR Cohort|Overall Study||37||
48696471|NCT02851797|102041754|FG000|COMPLETED|Overall Study||111||
48696472|NCT02851797|102041755|FG001|COMPLETED|Overall Study||59||
48696473|NCT02851797|102041754|FG000|NOT COMPLETED|Overall Study||7||
48696474|NCT02851797|102041755|FG001|NOT COMPLETED|Overall Study||2||
48696475|NCT02029755|102041756|FG000|STARTED|Overall Study||36||
48696476|NCT02029755|102041757|FG001|STARTED|Overall Study||36||
48696477|NCT02029755|102041758|FG002|STARTED|Overall Study||36||
48696478|NCT02029755|102041756|FG000|COMPLETED|Overall Study||36||
48696479|NCT02029755|102041757|FG001|COMPLETED|Overall Study||36||
48696480|NCT02029755|102041758|FG002|COMPLETED|Overall Study||36||
48696481|NCT02029755|102041756|FG000|NOT COMPLETED|Overall Study||0||
48696482|NCT02029755|102041757|FG001|NOT COMPLETED|Overall Study||0||
48696483|NCT02029755|102041758|FG002|NOT COMPLETED|Overall Study||0||
48696484|NCT03332017|102041759|FG000|STARTED|Overall Study||72||
48276827|NCT00859222|101003003|FG003|STARTED|Overall Study||24||
48276828|NCT00859222|101003004|FG004|STARTED|Overall Study||15||
48276829|NCT00859222|101003000|FG000|COMPLETED|Overall Study||0||
48393793|NCT01179347|101291638|FG000|COMPLETED|Open-label Period (12 Weeks)||132||
48696485|NCT03332017|102041760|FG001|STARTED|Overall Study||145||
48276830|NCT00859222|101003001|FG001|COMPLETED|Overall Study||0||
48696486|NCT03332017|102041759|FG000|COMPLETED|Overall Study||0||
48276831|NCT00859222|101003002|FG002|COMPLETED|Overall Study||0||
48276832|NCT00859222|101003003|FG003|COMPLETED|Overall Study||0||
48696487|NCT03332017|102041760|FG001|COMPLETED|Overall Study||0||
48696488|NCT03332017|102041759|FG000|NOT COMPLETED|Overall Study||72||
48696489|NCT03332017|102041760|FG001|NOT COMPLETED|Overall Study||145||
48696490|NCT02494518|102041761|FG000|STARTED|Overall Study||11||
48696491|NCT02494518|102041762|FG001|STARTED|Overall Study||12||
48696492|NCT02494518|102041763|FG002|STARTED|Overall Study||11||
48696493|NCT02494518|102041761|FG000|COMPLETED|Overall Study||10||
48696494|NCT02494518|102041762|FG001|COMPLETED|Overall Study||10||
48276833|NCT00859222|101003004|FG004|COMPLETED|Overall Study||0||
48696495|NCT02494518|102041763|FG002|COMPLETED|Overall Study||8||
48696496|NCT02494518|102041761|FG000|NOT COMPLETED|Overall Study||1||
48696497|NCT02494518|102041762|FG001|NOT COMPLETED|Overall Study||2||
48276834|NCT00859222|101003000|FG000|NOT COMPLETED|Overall Study||3||
48276835|NCT00859222|101003001|FG001|NOT COMPLETED|Overall Study||3||
48276836|NCT00859222|101003002|FG002|NOT COMPLETED|Overall Study||6||
48276837|NCT00859222|101003003|FG003|NOT COMPLETED|Overall Study||24||
48276838|NCT00859222|101003004|FG004|NOT COMPLETED|Overall Study||15||
48696498|NCT02494518|102041763|FG002|NOT COMPLETED|Overall Study||3||
48276839|NCT00565851|101003005|FG000|STARTED|Surgical Assignment||316||
48276840|NCT00565851|101003006|FG001|STARTED|Surgical Assignment||456||
48276841|NCT00565851|101003007|FG002|STARTED|Surgical Assignment||33||
48276842|NCT00565851|101003008|FG003|STARTED|Surgical Assignment||165||
48276843|NCT00565851|101003009|FG004|STARTED|Surgical Assignment||6||
48276844|NCT00565851|101003010|FG005|STARTED|Surgical Assignment||34||
48276845|NCT00565851|101003011|FG006|STARTED|Surgical Assignment||5||
48393794|NCT01179347|101291639|FG001|COMPLETED|Open-label Period (12 Weeks)||278||
48393795|NCT01179347|101291638|FG000|NOT COMPLETED|Open-label Period (12 Weeks)||15||
48393796|NCT01179347|101291639|FG001|NOT COMPLETED|Open-label Period (12 Weeks)||16||
48393797|NCT04154943|101291640|FG000|STARTED|Overall Study||79||
48393798|NCT04154943|101291640|FG000|COMPLETED|Overall Study||0||
48393799|NCT04154943|101291640|FG000|NOT COMPLETED|Overall Study||79||
48393800|NCT01235728|101291641|FG000|STARTED|Overall Study||3||
48393801|NCT01235728|101291642|FG001|STARTED|Overall Study||3||
48393802|NCT01235728|101291643|FG002|STARTED|Overall Study||3||
48393803|NCT01235728|101291644|FG003|STARTED|Overall Study||3||
48393804|NCT01235728|101291645|FG004|STARTED|Overall Study||3||
48393805|NCT01235728|101291646|FG005|STARTED|Overall Study||3||
48393806|NCT01235728|101291647|FG006|STARTED|Overall Study||3||
48393807|NCT01235728|101291648|FG007|STARTED|Overall Study||3||
48276846|NCT00565851|101003012|FG007|STARTED|Surgical Assignment||37||
48276847|NCT00565851|101003005|FG000|Randomized - Yes Surgery|Surgical Assignment||0||
48276848|NCT00565851|101003006|FG001|Randomized - Yes Surgery|Surgical Assignment||0||
48276849|NCT00565851|101003007|FG002|Randomized - Yes Surgery|Surgical Assignment||33||
48276850|NCT00565851|101003008|FG003|Randomized - Yes Surgery|Surgical Assignment||165||
48276851|NCT00565851|101003009|FG004|Randomized - Yes Surgery|Surgical Assignment||0||
48276852|NCT00565851|101003010|FG005|Randomized - Yes Surgery|Surgical Assignment||0||
48276853|NCT00565851|101003011|FG006|Randomized - Yes Surgery|Surgical Assignment||5||
48276854|NCT00565851|101003012|FG007|Randomized - Yes Surgery|Surgical Assignment||37||
48276855|NCT00565851|101003005|FG000|Randomized - no Surgery|Surgical Assignment||33||
48276856|NCT00565851|101003006|FG001|Randomized - no Surgery|Surgical Assignment||172||
48276857|NCT00565851|101003007|FG002|Randomized - no Surgery|Surgical Assignment||0||
48276858|NCT00565851|101003008|FG003|Randomized - no Surgery|Surgical Assignment||0||
48276859|NCT00565851|101003009|FG004|Randomized - no Surgery|Surgical Assignment||6||
48276860|NCT00565851|101003010|FG005|Randomized - no Surgery|Surgical Assignment||34||
48276861|NCT00565851|101003011|FG006|Randomized - no Surgery|Surgical Assignment||0||
48276862|NCT00565851|101003012|FG007|Randomized - no Surgery|Surgical Assignment||0||
48276863|NCT00565851|101003005|FG000|Not Surgical Candidate|Surgical Assignment||283||
48276864|NCT00565851|101003006|FG001|Not Surgical Candidate|Surgical Assignment||284||
48276865|NCT00565851|101003007|FG002|Not Surgical Candidate|Surgical Assignment||0||
48276866|NCT00565851|101003008|FG003|Not Surgical Candidate|Surgical Assignment||0||
48276867|NCT00565851|101003009|FG004|Not Surgical Candidate|Surgical Assignment||0||
48276868|NCT00565851|101003010|FG005|Not Surgical Candidate|Surgical Assignment||0||
48276869|NCT00565851|101003011|FG006|Not Surgical Candidate|Surgical Assignment||0||
48276870|NCT00565851|101003012|FG007|Not Surgical Candidate|Surgical Assignment||0||
48276871|NCT00565851|101003005|FG000|COMPLETED|Surgical Assignment||313|Includes participants who followed through with surgical assignment|
48276872|NCT00565851|101003006|FG001|COMPLETED|Surgical Assignment||454|Includes participants who followed through with surgical assignment|
48276873|NCT00565851|101003007|FG002|COMPLETED|Surgical Assignment||31|Includes participants who followed through with surgical assignment|
48276874|NCT00565851|101003008|FG003|COMPLETED|Surgical Assignment||154|Includes participants who followed through with surgical assignment|
48276875|NCT00565851|101003009|FG004|COMPLETED|Surgical Assignment||6|Includes participants who followed through with surgical assignment|
48276876|NCT00565851|101003010|FG005|COMPLETED|Surgical Assignment||34|Includes participants who followed through with surgical assignment|
48276877|NCT00565851|101003011|FG006|COMPLETED|Surgical Assignment||5|Includes participants who followed through with surgical assignment|
48276878|NCT00565851|101003012|FG007|COMPLETED|Surgical Assignment||35|Includes participants who followed through with surgical assignment|
48276879|NCT00565851|101003005|FG000|NOT COMPLETED|Surgical Assignment||3||
48276880|NCT00565851|101003006|FG001|NOT COMPLETED|Surgical Assignment||2||
48276881|NCT00565851|101003007|FG002|NOT COMPLETED|Surgical Assignment||2||
48276882|NCT00565851|101003008|FG003|NOT COMPLETED|Surgical Assignment||11||
48276883|NCT00565851|101003009|FG004|NOT COMPLETED|Surgical Assignment||0||
48276884|NCT00565851|101003010|FG005|NOT COMPLETED|Surgical Assignment||0||
48276885|NCT00565851|101003011|FG006|NOT COMPLETED|Surgical Assignment||0||
48276886|NCT00565851|101003012|FG007|NOT COMPLETED|Surgical Assignment||2||
48276887|NCT00565851|101003005|FG000|STARTED|Chemotherapy Assignment||316||
48393808|NCT01235728|101291641|FG000|COMPLETED|Overall Study||3||
48393809|NCT01235728|101291642|FG001|COMPLETED|Overall Study||3||
48393810|NCT01235728|101291643|FG002|COMPLETED|Overall Study||3||
48393811|NCT01235728|101291644|FG003|COMPLETED|Overall Study||2||
48393812|NCT01235728|101291645|FG004|COMPLETED|Overall Study||3||
48393813|NCT01235728|101291646|FG005|COMPLETED|Overall Study||3||
48393814|NCT01235728|101291647|FG006|COMPLETED|Overall Study||3||
48393815|NCT01235728|101291648|FG007|COMPLETED|Overall Study||3||
48393816|NCT01235728|101291641|FG000|NOT COMPLETED|Overall Study||0||
48393817|NCT01235728|101291642|FG001|NOT COMPLETED|Overall Study||0||
48276888|NCT00565851|101003006|FG001|STARTED|Chemotherapy Assignment||456||
48276889|NCT00565851|101003007|FG002|STARTED|Chemotherapy Assignment||33||
48276890|NCT00565851|101003008|FG003|STARTED|Chemotherapy Assignment||165||
48276891|NCT00565851|101003009|FG004|STARTED|Chemotherapy Assignment||6||
48393818|NCT01235728|101291643|FG002|NOT COMPLETED|Overall Study||0||
48393819|NCT01235728|101291644|FG003|NOT COMPLETED|Overall Study||1||
48393820|NCT01235728|101291645|FG004|NOT COMPLETED|Overall Study||0||
48393821|NCT01235728|101291646|FG005|NOT COMPLETED|Overall Study||0||
48393822|NCT01235728|101291647|FG006|NOT COMPLETED|Overall Study||0||
48696499|NCT00395486|102041764|FG000|STARTED|Overall Study||132||
48696500|NCT00395486|102041765|FG001|STARTED|Overall Study||126||
48696501|NCT00395486|102041764|FG000|COMPLETED|Overall Study||126||
48113525|NCT02075320|100604969|FG000|NOT COMPLETED|Overall Study||2||
48113526|NCT01485861|100604970|FG000|STARTED|Phase Ib||14|Intent-To-Treat (ITT) population based on randomization|
48113527|NCT01485861|100604971|FG001|STARTED|Phase Ib||6|Intent-To-Treat (ITT) population based on randomization|
48113528|NCT01485861|100604972|FG002|STARTED|Phase Ib||0|Intent-To-Treat (ITT) population based on randomization|
48276892|NCT00565851|101003010|FG005|STARTED|Chemotherapy Assignment||34||
48276893|NCT00565851|101003011|FG006|STARTED|Chemotherapy Assignment||5||
48276894|NCT00565851|101003012|FG007|STARTED|Chemotherapy Assignment||37||
48276895|NCT00565851|101003005|FG000|Randomized to Chemo|Chemotherapy Assignment||310||
48276896|NCT00565851|101003006|FG001|Randomized to Chemo|Chemotherapy Assignment||311||
48276897|NCT00565851|101003007|FG002|Randomized to Chemo|Chemotherapy Assignment||27||
48276898|NCT00565851|101003008|FG003|Randomized to Chemo|Chemotherapy Assignment||26||
48276899|NCT00565851|101003009|FG004|Randomized to Chemo|Chemotherapy Assignment||0||
48696502|NCT00395486|102041765|FG001|COMPLETED|Overall Study||121||
48696503|NCT00395486|102041764|FG000|NOT COMPLETED|Overall Study||6||
48696504|NCT00395486|102041765|FG001|NOT COMPLETED|Overall Study||5||
48696505|NCT03315793|102041766|FG000|STARTED|Overall Study||75||
48696506|NCT03315793|102041767|FG001|STARTED|Overall Study||74||
48696507|NCT03315793|102041766|FG000|Received at Least 1 Dose of Study Drug|Overall Study||75||
48696508|NCT03315793|102041767|FG001|Received at Least 1 Dose of Study Drug|Overall Study||74||
48696509|NCT03315793|102041766|FG000|COMPLETED|Overall Study||70||
48696510|NCT03315793|102041767|FG001|COMPLETED|Overall Study||71||
48696511|NCT03315793|102041766|FG000|NOT COMPLETED|Overall Study||5||
48696512|NCT03315793|102041767|FG001|NOT COMPLETED|Overall Study||3||
48696513|NCT00249808|102041768|FG000|STARTED|Overall Study||1266||
48696514|NCT00249808|102041768|FG000|COMPLETED|Overall Study||1084||
48696515|NCT00249808|102041768|FG000|NOT COMPLETED|Overall Study||182||
48696516|NCT02835313|102041769|FG000|STARTED|Overall Study||80||
48696517|NCT02835313|102041770|FG001|STARTED|Overall Study||89||
48696518|NCT02835313|102041771|FG002|STARTED|Overall Study||81||
48696519|NCT02835313|102041769|FG000|Completed POST (3-month)|Overall Study||63||
48696520|NCT02835313|102041770|FG001|Completed POST (3-month)|Overall Study||69||
48696521|NCT02835313|102041771|FG002|Completed POST (3-month)|Overall Study||68||
48696522|NCT02835313|102041769|FG000|Completed 6-month|Overall Study||62||
48696523|NCT02835313|102041770|FG001|Completed 6-month|Overall Study||68||
48276900|NCT00565851|101003010|FG005|Randomized to Chemo|Chemotherapy Assignment||0||
48276901|NCT00565851|101003011|FG006|Randomized to Chemo|Chemotherapy Assignment||0||
48276902|NCT00565851|101003012|FG007|Randomized to Chemo|Chemotherapy Assignment||0||
48276903|NCT00565851|101003005|FG000|Pre-specified Chemo|Chemotherapy Assignment||6||
48276904|NCT00565851|101003006|FG001|Pre-specified Chemo|Chemotherapy Assignment||145||
48113529|NCT01485861|100604973|FG003|STARTED|Phase Ib||0|Intent-To-Treat (ITT) population based on randomization|
48113530|NCT01485861|100604974|FG004|STARTED|Phase Ib||0|Intent-To-Treat (ITT) population based on randomization|
48276905|NCT00565851|101003007|FG002|Pre-specified Chemo|Chemotherapy Assignment||6||
48276906|NCT00565851|101003008|FG003|Pre-specified Chemo|Chemotherapy Assignment||139||
48276907|NCT00565851|101003009|FG004|Pre-specified Chemo|Chemotherapy Assignment||6||
48276908|NCT00565851|101003010|FG005|Pre-specified Chemo|Chemotherapy Assignment||34||
48393823|NCT01235728|101291648|FG007|NOT COMPLETED|Overall Study||0||
48393824|NCT03644108|101291649|FG000|STARTED|Overall Study||30||
48696524|NCT02835313|102041771|FG002|Completed 6-month|Overall Study||58||
48696525|NCT02835313|102041769|FG000|Completed 12-month|Overall Study||48||
48696526|NCT02835313|102041770|FG001|Completed 12-month|Overall Study||64||
48696527|NCT02835313|102041771|FG002|Completed 12-month|Overall Study||49||
48696528|NCT02835313|102041769|FG000|COMPLETED|Overall Study||48||
48696529|NCT02835313|102041770|FG001|COMPLETED|Overall Study||64||
48696530|NCT02835313|102041771|FG002|COMPLETED|Overall Study||49||
48113531|NCT01485861|100604975|FG005|STARTED|Phase Ib||0|Intent-To-Treat (ITT) population based on randomization|
48113532|NCT01485861|100604970|FG000|Safety Population|Phase Ib||14|Based on treatment received|
48276909|NCT00565851|101003011|FG006|Pre-specified Chemo|Chemotherapy Assignment||5||
48276910|NCT00565851|101003012|FG007|Pre-specified Chemo|Chemotherapy Assignment||37||
48276911|NCT00565851|101003005|FG000|COMPLETED|Chemotherapy Assignment||307||
48276912|NCT00565851|101003006|FG001|COMPLETED|Chemotherapy Assignment||433||
48276913|NCT00565851|101003007|FG002|COMPLETED|Chemotherapy Assignment||30||
48276914|NCT00565851|101003008|FG003|COMPLETED|Chemotherapy Assignment||129||
48276915|NCT00565851|101003009|FG004|COMPLETED|Chemotherapy Assignment||6||
48393825|NCT03644108|101291649|FG000|COMPLETED|Overall Study||30||
48393826|NCT03644108|101291649|FG000|NOT COMPLETED|Overall Study||0||
48393827|NCT01827319|101291650|FG000|STARTED|Overall Study||203||
48393828|NCT01827319|101291650|FG000|COMPLETED|Overall Study||200||
48393829|NCT01827319|101291650|FG000|NOT COMPLETED|Overall Study||3||
48393830|NCT04295356|101295800|FG000|STARTED|Overall Study||93||
48393831|NCT04295356|101295801|FG001|STARTED|Overall Study||87||
48393832|NCT04295356|101295800|FG000|COMPLETED|Overall Study||92||
48393833|NCT04295356|101295801|FG001|COMPLETED|Overall Study||83||
48393834|NCT04295356|101295800|FG000|NOT COMPLETED|Overall Study||1||
48393835|NCT04295356|101295801|FG001|NOT COMPLETED|Overall Study||4||
48393836|NCT01998880|101295802|FG000|STARTED|Overall Study||233||
48393837|NCT01998880|101295803|FG001|STARTED|Overall Study||118||
48393838|NCT01998880|101295802|FG000|Received Study Drug|Overall Study||230||
48393839|NCT01998880|101295803|FG001|Received Study Drug|Overall Study||116||
48393840|NCT01998880|101295802|FG000|COMPLETED|Overall Study||205||
48562919|NCT03885661|101710073|FG001|COMPLETED|Overall Study||7||
48562920|NCT03885661|101710072|FG000|NOT COMPLETED|Overall Study||1||
48562921|NCT03885661|101710073|FG001|NOT COMPLETED|Overall Study||1||
48562922|NCT00571324|101710074|FG000|STARTED|Intervention 1 (7 Hours)||5||
48562923|NCT00571324|101710075|FG001|STARTED|Intervention 1 (7 Hours)||4||
48562924|NCT00571324|101710074|FG000|COMPLETED|Intervention 1 (7 Hours)||5||
48562925|NCT00571324|101710075|FG001|COMPLETED|Intervention 1 (7 Hours)||4||
48562926|NCT00571324|101710074|FG000|NOT COMPLETED|Intervention 1 (7 Hours)||0||
48562927|NCT00571324|101710075|FG001|NOT COMPLETED|Intervention 1 (7 Hours)||0||
48562928|NCT00571324|101710074|FG000|STARTED|Intervention 2 (7 Hours)||5||
48696531|NCT02835313|102041769|FG000|NOT COMPLETED|Overall Study||32||
48696532|NCT02835313|102041770|FG001|NOT COMPLETED|Overall Study||25||
48696533|NCT02835313|102041771|FG002|NOT COMPLETED|Overall Study||32||
48696534|NCT00616018|102041772|FG000|STARTED|Overall Study||27||
48696535|NCT00616018|102041772|FG000|COMPLETED|Overall Study||24||
48696536|NCT00616018|102041772|FG000|NOT COMPLETED|Overall Study||3||
48696537|NCT02920528|102041773|FG000|STARTED|Overall Study||35||
48696538|NCT02920528|102041774|FG001|STARTED|Overall Study||36||
48696539|NCT02920528|102041775|FG002|STARTED|Overall Study||35||
48696540|NCT02920528|102041773|FG000|COMPLETED|Overall Study||32||
48696541|NCT02920528|102041774|FG001|COMPLETED|Overall Study||35||
48696542|NCT02920528|102041775|FG002|COMPLETED|Overall Study||30||
48696543|NCT02920528|102041773|FG000|NOT COMPLETED|Overall Study||3||
48696544|NCT02920528|102041774|FG001|NOT COMPLETED|Overall Study||1||
48696545|NCT02920528|102041775|FG002|NOT COMPLETED|Overall Study||5||
48696546|NCT00748618|102041776|FG000|STARTED|Overall Study||46||
48696547|NCT00748618|102041777|FG001|STARTED|Overall Study||44||
48696548|NCT00748618|102041776|FG000|COMPLETED|Overall Study||45||
48696549|NCT00748618|102041777|FG001|COMPLETED|Overall Study||44||
48696550|NCT00748618|102041776|FG000|NOT COMPLETED|Overall Study||1||
48696551|NCT00748618|102041777|FG001|NOT COMPLETED|Overall Study||0||
48696552|NCT05398159|102041778|FG000|STARTED|Overall Study||75||
48696553|NCT05398159|102041778|FG000|COMPLETED|Overall Study||44||
48696554|NCT05398159|102041778|FG000|NOT COMPLETED|Overall Study||31||
48696555|NCT04551963|102041779|FG000|STARTED|Overall Study||13||
48696556|NCT04551963|102041780|FG001|STARTED|Overall Study||13||
48696557|NCT04551963|102041779|FG000|COMPLETED|Overall Study||11||
48696558|NCT04551963|102041780|FG001|COMPLETED|Overall Study||12||
48696559|NCT04551963|102041779|FG000|NOT COMPLETED|Overall Study||2||
48696560|NCT04551963|102041780|FG001|NOT COMPLETED|Overall Study||1||
48696561|NCT04472650|102041781|FG000|STARTED|Period 1 (Up to 15 Days)||13||
48696562|NCT04472650|102041782|FG001|STARTED|Period 1 (Up to 15 Days)||13||
48696563|NCT04472650|102041781|FG000|COMPLETED|Period 1 (Up to 15 Days)||13||
48696564|NCT04472650|102041782|FG001|COMPLETED|Period 1 (Up to 15 Days)||13||
48276916|NCT00565851|101003010|FG005|COMPLETED|Chemotherapy Assignment||31||
48276917|NCT00565851|101003011|FG006|COMPLETED|Chemotherapy Assignment||5||
48276918|NCT00565851|101003012|FG007|COMPLETED|Chemotherapy Assignment||34||
48393841|NCT01998880|101295803|FG001|COMPLETED|Overall Study||78||
48393842|NCT01998880|101295802|FG000|NOT COMPLETED|Overall Study||28||
48393843|NCT01998880|101295803|FG001|NOT COMPLETED|Overall Study||40||
48393844|NCT03332303|101295804|FG000|STARTED|Overall Study||215||
48393845|NCT03332303|101295805|FG001|STARTED|Overall Study||216||
48393846|NCT03332303|101295806|FG002|STARTED|Overall Study||109||
48393847|NCT03332303|101295804|FG000|Safety Population|Overall Study||215|All participants who were randomized and received study product.|
48393848|NCT03332303|101295805|FG001|Safety Population|Overall Study||216|All participants who were randomized and received study product.|
48393849|NCT03332303|101295806|FG002|Safety Population|Overall Study||109|All participants who were randomized and received study product.|
48393850|NCT03332303|101295804|FG000|Modified Intention to Treat (mITT) Population|Overall Study||214|mITT = All participants administered at least one dose of randomized study product and had a post-randomization evaluation.|
48393851|NCT03332303|101295805|FG001|Modified Intention to Treat (mITT) Population|Overall Study||213|mITT = All participants administered at least one dose of randomized study product and had a post-randomization evaluation.|
48393852|NCT03332303|101295806|FG002|Modified Intention to Treat (mITT) Population|Overall Study||109|mITT = All participants administered at least one dose of randomized study product and had a post-randomization evaluation.|
48393853|NCT03332303|101295804|FG000|Per Protocol (PP) Population|Overall Study||196|PP = All participants who met all I/E criteria, had no significant protocol deviations, did not develop concurrent vaginal infection, completed Day 8 or Day 9 visit, and administered 75% - 125% of required doses.|
48393854|NCT03332303|101295805|FG001|Per Protocol (PP) Population|Overall Study||196|PP = All participants who met all I/E criteria, had no significant protocol deviations, did not develop concurrent vaginal infection, completed Day 8 or Day 9 visit, and administered 75% - 125% of required doses.|
48393855|NCT03332303|101295806|FG002|Per Protocol (PP) Population|Overall Study||104|PP = All participants who met all I/E criteria, had no significant protocol deviations, did not develop concurrent vaginal infection, completed Day 8 or Day 9 visit, and administered 75% - 125% of required doses.|
48393856|NCT03332303|101295804|FG000|COMPLETED|Overall Study||196||
48393857|NCT03332303|101295805|FG001|COMPLETED|Overall Study||196||
48393858|NCT03332303|101295806|FG002|COMPLETED|Overall Study||104||
48393859|NCT03332303|101295804|FG000|NOT COMPLETED|Overall Study||19||
48393860|NCT03332303|101295805|FG001|NOT COMPLETED|Overall Study||20||
48393861|NCT03332303|101295806|FG002|NOT COMPLETED|Overall Study||5||
48393862|NCT01453998|101295807|FG000|STARTED|Before Protocol Amendment 2||85||
48393863|NCT01453998|101295808|FG001|STARTED|Before Protocol Amendment 2||88||
48393864|NCT01453998|101295809|FG002|STARTED|Before Protocol Amendment 2||99||
48393865|NCT01453998|101295807|FG000|COMPLETED|Before Protocol Amendment 2||85||
48393866|NCT01453998|101295808|FG001|COMPLETED|Before Protocol Amendment 2||88||
48393867|NCT01453998|101295809|FG002|COMPLETED|Before Protocol Amendment 2||99||
48393868|NCT01453998|101295807|FG000|NOT COMPLETED|Before Protocol Amendment 2||0||
48393869|NCT01453998|101295808|FG001|NOT COMPLETED|Before Protocol Amendment 2||0||
48393870|NCT01453998|101295809|FG002|NOT COMPLETED|Before Protocol Amendment 2||0||
48393871|NCT01453998|101295807|FG000|STARTED|After Protocol Amendment 2.||131||
48393872|NCT01453998|101295808|FG001|STARTED|After Protocol Amendment 2.||130||
48393873|NCT01453998|101295809|FG002|STARTED|After Protocol Amendment 2.||124||
48393874|NCT01453998|101295807|FG000|COMPLETED|After Protocol Amendment 2.||130||
48393875|NCT01453998|101295808|FG001|COMPLETED|After Protocol Amendment 2.||130||
48393876|NCT01453998|101295809|FG002|COMPLETED|After Protocol Amendment 2.||124||
48393877|NCT01453998|101295807|FG000|NOT COMPLETED|After Protocol Amendment 2.||1||
48393878|NCT01453998|101295808|FG001|NOT COMPLETED|After Protocol Amendment 2.||0||
48393879|NCT01453998|101295809|FG002|NOT COMPLETED|After Protocol Amendment 2.||0||
48562929|NCT00571324|101710075|FG001|STARTED|Intervention 2 (7 Hours)||4||
48562930|NCT00571324|101710074|FG000|COMPLETED|Intervention 2 (7 Hours)||5||
48562931|NCT00571324|101710075|FG001|COMPLETED|Intervention 2 (7 Hours)||4||
48562932|NCT00571324|101710074|FG000|NOT COMPLETED|Intervention 2 (7 Hours)||0||
48562933|NCT00571324|101710075|FG001|NOT COMPLETED|Intervention 2 (7 Hours)||0||
48562934|NCT03518008|101710076|FG000|STARTED|Period 1, First Week of Wear||11||
48562935|NCT03518008|101710077|FG001|STARTED|Period 1, First Week of Wear||11||
48393880|NCT04681729|101295810|FG000|STARTED|Overall Study||40||
48393881|NCT04681729|101295811|FG001|STARTED|Overall Study||42||
48393882|NCT04681729|101295810|FG000|COMPLETED|Overall Study||30||
48393883|NCT04681729|101295811|FG001|COMPLETED|Overall Study||31||
48393884|NCT04681729|101295810|FG000|NOT COMPLETED|Overall Study||10||
48393885|NCT04681729|101295811|FG001|NOT COMPLETED|Overall Study||11||
48393886|NCT00753688|101295812|FG000|STARTED|Overall Study||123||
48393887|NCT00753688|101295813|FG001|STARTED|Overall Study||246||
48393888|NCT00753688|101295812|FG000|Ongoing - in Follow-up|Overall Study||15||
48393889|NCT00753688|101295813|FG001|Ongoing - in Follow-up|Overall Study||31||
48393890|NCT00753688|101295812|FG000|COMPLETED|Overall Study||0||
48393891|NCT00753688|101295813|FG001|COMPLETED|Overall Study||0||
48393892|NCT00753688|101295812|FG000|NOT COMPLETED|Overall Study||123||
48393893|NCT00753688|101295813|FG001|NOT COMPLETED|Overall Study||246||
48393894|NCT00879437|101295814|FG000|STARTED|Overall Study||20||
48393895|NCT00879437|101295815|FG001|STARTED|Overall Study||18||
48393896|NCT00879437|101295814|FG000|COMPLETED|Overall Study||19||
48393897|NCT00879437|101295815|FG001|COMPLETED|Overall Study||17||
48393898|NCT00879437|101295814|FG000|NOT COMPLETED|Overall Study||1||
48393899|NCT00879437|101295815|FG001|NOT COMPLETED|Overall Study||1||
48393900|NCT01225172|101295816|FG000|STARTED|Overall Study||52||
48393901|NCT01225172|101295817|FG001|STARTED|Overall Study||7||
48393902|NCT01225172|101295816|FG000|COMPLETED|Overall Study||46||
48393903|NCT01225172|101295817|FG001|COMPLETED|Overall Study||6||
48393904|NCT01225172|101295816|FG000|NOT COMPLETED|Overall Study||6||
48393905|NCT01225172|101295817|FG001|NOT COMPLETED|Overall Study||1||
48393906|NCT01677507|101295818|FG000|STARTED|Initial Assignment||63||
48393907|NCT01677507|101295819|FG001|STARTED|Initial Assignment||58||
48393908|NCT01677507|101295818|FG000|COMPLETED|Initial Assignment||63||
48393909|NCT01677507|101295819|FG001|COMPLETED|Initial Assignment||56||
48393910|NCT01677507|101295818|FG000|NOT COMPLETED|Initial Assignment||0||
48393911|NCT01677507|101295819|FG001|NOT COMPLETED|Initial Assignment||2||
48393912|NCT01677507|101295818|FG000|STARTED|Second Assigment||63||
48393913|NCT01677507|101295819|FG001|STARTED|Second Assigment||56||
48393914|NCT01677507|101295818|FG000|COMPLETED|Second Assigment||60||
48393915|NCT01677507|101295819|FG001|COMPLETED|Second Assigment||51||
48393916|NCT01677507|101295818|FG000|NOT COMPLETED|Second Assigment||3||
48393917|NCT01677507|101295819|FG001|NOT COMPLETED|Second Assigment||5||
48393918|NCT01978509|101295820|FG000|STARTED|Overall Study||10||
48562936|NCT03518008|101710076|FG000|COMPLETED|Period 1, First Week of Wear||11||
48562937|NCT03518008|101710077|FG001|COMPLETED|Period 1, First Week of Wear||11||
48562938|NCT03518008|101710076|FG000|NOT COMPLETED|Period 1, First Week of Wear||0||
48562939|NCT03518008|101710077|FG001|NOT COMPLETED|Period 1, First Week of Wear||0||
48562940|NCT03518008|101710076|FG000|STARTED|Period 2, Second Week of Wear||11||
48562941|NCT03518008|101710077|FG001|STARTED|Period 2, Second Week of Wear||11||
48562942|NCT03518008|101710076|FG000|COMPLETED|Period 2, Second Week of Wear||11||
48562943|NCT03518008|101710077|FG001|COMPLETED|Period 2, Second Week of Wear||10||
48562944|NCT03518008|101710076|FG000|NOT COMPLETED|Period 2, Second Week of Wear||0||
48562945|NCT03518008|101710077|FG001|NOT COMPLETED|Period 2, Second Week of Wear||1||
48562946|NCT02088177|101710078|FG000|STARTED|Overall Study||12||
48562947|NCT02088177|101710078|FG000|COMPLETED|Overall Study||9||
48562948|NCT02088177|101710078|FG000|NOT COMPLETED|Overall Study||3||
48562949|NCT05064397|101710079|FG000|STARTED|Overall Study||131||
48562950|NCT05064397|101710079|FG000|Received at Least 1 Dose of Study Drug|Overall Study||131||
48562951|NCT05064397|101710079|FG000|COMPLETED|Overall Study||108||
48562952|NCT05064397|101710079|FG000|NOT COMPLETED|Overall Study||23||
48562953|NCT02503540|101710080|FG000|STARTED|Overall Study||31||
48393919|NCT01978509|101295821|FG001|STARTED|Overall Study||13||
48393920|NCT01978509|101295822|FG002|STARTED|Overall Study||9||
48393921|NCT01978509|101295820|FG000|COMPLETED|Overall Study||8||
48393922|NCT01978509|101295821|FG001|COMPLETED|Overall Study||8||
48393923|NCT01978509|101295822|FG002|COMPLETED|Overall Study||9||
48393924|NCT01978509|101295820|FG000|NOT COMPLETED|Overall Study||2||
48393925|NCT01978509|101295821|FG001|NOT COMPLETED|Overall Study||5||
48393926|NCT01978509|101295822|FG002|NOT COMPLETED|Overall Study||0||
48562954|NCT02503540|101710080|FG000|COMPLETED|Overall Study||28||
48696565|NCT04472650|102041781|FG000|NOT COMPLETED|Period 1 (Up to 15 Days)||0||
48696566|NCT04472650|102041782|FG001|NOT COMPLETED|Period 1 (Up to 15 Days)||0||
48696567|NCT04472650|102041781|FG000|STARTED|Washout Period (Minimum 14 Days)||13||
48696568|NCT04472650|102041782|FG001|STARTED|Washout Period (Minimum 14 Days)||13||
48696569|NCT04472650|102041781|FG000|COMPLETED|Washout Period (Minimum 14 Days)||12||
48696570|NCT04472650|102041782|FG001|COMPLETED|Washout Period (Minimum 14 Days)||13||
48696571|NCT04472650|102041781|FG000|NOT COMPLETED|Washout Period (Minimum 14 Days)||1||
48696572|NCT04472650|102041782|FG001|NOT COMPLETED|Washout Period (Minimum 14 Days)||0||
48696573|NCT04472650|102041781|FG000|STARTED|Period 2 (Up to 15 Days)||12||
48696574|NCT04472650|102041782|FG001|STARTED|Period 2 (Up to 15 Days)||13||
48696575|NCT04472650|102041781|FG000|COMPLETED|Period 2 (Up to 15 Days)||12||
48696576|NCT04472650|102041782|FG001|COMPLETED|Period 2 (Up to 15 Days)||13||
48696577|NCT04472650|102041781|FG000|NOT COMPLETED|Period 2 (Up to 15 Days)||0||
48696578|NCT04472650|102041782|FG001|NOT COMPLETED|Period 2 (Up to 15 Days)||0||
48696579|NCT03077438|102041783|FG000|STARTED|Overall Study||499||
48696580|NCT03077438|102041784|FG001|STARTED|Overall Study||501||
48696581|NCT03077438|102041783|FG000|Safety Analysis Set (SafAS)|Overall Study||498|SafAS:participants who received at least 1 dose of study vaccine(s) \& had any safety data available.|
48696582|NCT03077438|102041784|FG001|Safety Analysis Set (SafAS)|Overall Study||494|SafAS:participants who received at least 1 dose of study vaccine(s) \& had any safety data available.|
48696583|NCT03077438|102041783|FG000|COMPLETED|Overall Study||487||
48696584|NCT03077438|102041784|FG001|COMPLETED|Overall Study||487||
48696585|NCT03077438|102041783|FG000|NOT COMPLETED|Overall Study||12||
48696586|NCT03077438|102041784|FG001|NOT COMPLETED|Overall Study||14||
48696587|NCT02701283|102041785|FG000|STARTED|Overall Study||737||
48696588|NCT02701283|102041786|FG001|STARTED|Overall Study||741||
48696589|NCT02701283|102041787|FG002|STARTED|Overall Study||745||
48696590|NCT02701283|102041785|FG000|As Treated (Attempted Implant)|Overall Study||730|"Randomized Controlled Trial - The As Treated set includes 4 subjects that crossed over from the Medtronic TAVR Systems arm to the SAVR arm, which accounts for 727 subjects in the Implanted set for the Medtronic TAVR Systems arm.~The As Treated set includes 1 subject that crossed over from the SAVR arm to the Medtronic TAVR Systems arm, and 1 subject that was not implanted, which accounts for 686 subjects in the Implanted set for the SAVR arm."|
48696591|NCT02701283|102041786|FG001|As Treated (Attempted Implant)|Overall Study||684|"Randomized Controlled Trial - The As Treated set includes 4 subjects that crossed over from the Medtronic TAVR Systems arm to the SAVR arm, which accounts for 727 subjects in the Implanted set for the Medtronic TAVR Systems arm.~The As Treated set includes 1 subject that crossed over from the SAVR arm to the Medtronic TAVR Systems arm, and 1 subject that was not implanted, which accounts for 686 subjects in the Implanted set for the SAVR arm."|
48696592|NCT02701283|102041787|FG002|As Treated (Attempted Implant)|Overall Study||745|"Randomized Controlled Trial - The As Treated set includes 4 subjects that crossed over from the Medtronic TAVR Systems arm to the SAVR arm, which accounts for 727 subjects in the Implanted set for the Medtronic TAVR Systems arm.~The As Treated set includes 1 subject that crossed over from the SAVR arm to the Medtronic TAVR Systems arm, and 1 subject that was not implanted, which accounts for 686 subjects in the Implanted set for the SAVR arm."|
48113533|NCT01485861|100604971|FG001|Safety Population|Phase Ib||6|Based on treatment received|
48113534|NCT01485861|100604972|FG002|Safety Population|Phase Ib||0|Based on treatment received|
48113535|NCT01485861|100604973|FG003|Safety Population|Phase Ib||0|Based on treatment received|
48113536|NCT01485861|100604974|FG004|Safety Population|Phase Ib||0|Based on treatment received|
48113537|NCT01485861|100604975|FG005|Safety Population|Phase Ib||0|Based on treatment received|
48113538|NCT01485861|100604970|FG000|COMPLETED|Phase Ib||0||
48113539|NCT01485861|100604971|FG001|COMPLETED|Phase Ib||0||
48113540|NCT01485861|100604972|FG002|COMPLETED|Phase Ib||0||
48113541|NCT01485861|100604973|FG003|COMPLETED|Phase Ib||0||
48113542|NCT01485861|100604974|FG004|COMPLETED|Phase Ib||0||
48276919|NCT00565851|101003005|FG000|NOT COMPLETED|Chemotherapy Assignment||9||
48276920|NCT00565851|101003006|FG001|NOT COMPLETED|Chemotherapy Assignment||23||
48276921|NCT00565851|101003007|FG002|NOT COMPLETED|Chemotherapy Assignment||3||
48276922|NCT00565851|101003008|FG003|NOT COMPLETED|Chemotherapy Assignment||36||
48276923|NCT00565851|101003009|FG004|NOT COMPLETED|Chemotherapy Assignment||0||
48276924|NCT00565851|101003010|FG005|NOT COMPLETED|Chemotherapy Assignment||3||
48393927|NCT01677624|101295823|FG000|STARTED|Overall Study||28||
48113543|NCT01485861|100604975|FG005|COMPLETED|Phase Ib||0||
48113544|NCT01485861|100604970|FG000|NOT COMPLETED|Phase Ib||14||
48113545|NCT01485861|100604971|FG001|NOT COMPLETED|Phase Ib||6||
48113546|NCT01485861|100604972|FG002|NOT COMPLETED|Phase Ib||0||
48113547|NCT01485861|100604973|FG003|NOT COMPLETED|Phase Ib||0||
48113548|NCT01485861|100604974|FG004|NOT COMPLETED|Phase Ib||0||
48113549|NCT01485861|100604975|FG005|NOT COMPLETED|Phase Ib||0||
48113550|NCT01485861|100604970|FG000|STARTED|Phase II||0||
48113551|NCT01485861|100604971|FG001|STARTED|Phase II||0||
48113552|NCT01485861|100604972|FG002|STARTED|Phase II||84||
48113553|NCT01485861|100604973|FG003|STARTED|Phase II||86||
48113554|NCT01485861|100604974|FG004|STARTED|Phase II||83||
48113555|NCT01485861|100604975|FG005|STARTED|Phase II||0||
48113556|NCT01485861|100604970|FG000|Safety Population|Phase II||0||
48276925|NCT00565851|101003011|FG006|NOT COMPLETED|Chemotherapy Assignment||0||
48276926|NCT00565851|101003012|FG007|NOT COMPLETED|Chemotherapy Assignment||3||
48276927|NCT00037830|101003013|FG000|STARTED|Overall Study||39||
48276928|NCT00037830|101003014|FG001|STARTED|Overall Study||38||
48276929|NCT00037830|101003015|FG002|STARTED|Overall Study||17||
48562955|NCT02503540|101710080|FG000|NOT COMPLETED|Overall Study||3||
48562956|NCT00354913|101710081|FG000|STARTED|Overall Study||21||
48562957|NCT00354913|101710081|FG000|COMPLETED|Overall Study||21||
48562958|NCT00354913|101710081|FG000|NOT COMPLETED|Overall Study||0||
48562959|NCT04011722|101710082|FG000|STARTED|Baseline||260||
48696593|NCT02701283|102041785|FG000|Implanted|Overall Study||727||
48696594|NCT02701283|102041786|FG001|Implanted|Overall Study||686||
48696595|NCT02701283|102041787|FG002|Implanted|Overall Study||745||
48696596|NCT02701283|102041785|FG000|COMPLETED|Overall Study||668|"The number of completed participants in the Randomized Controlled Trial arms account for the subjects in the As Treated set who completed the 2-year visit.~The number of completed participants in the Continued Access Study arm account for the subjects in the Attempted Implant set who completed the 1-year visit."|
48696597|NCT02701283|102041786|FG001|COMPLETED|Overall Study||579|"The number of completed participants in the Randomized Controlled Trial arms account for the subjects in the As Treated set who completed the 2-year visit.~The number of completed participants in the Continued Access Study arm account for the subjects in the Attempted Implant set who completed the 1-year visit."|
48696598|NCT02701283|102041787|FG002|COMPLETED|Overall Study||724|"The number of completed participants in the Randomized Controlled Trial arms account for the subjects in the As Treated set who completed the 2-year visit.~The number of completed participants in the Continued Access Study arm account for the subjects in the Attempted Implant set who completed the 1-year visit."|
48696599|NCT02701283|102041785|FG000|NOT COMPLETED|Overall Study||69||
48696600|NCT02701283|102041786|FG001|NOT COMPLETED|Overall Study||162||
48696601|NCT02701283|102041787|FG002|NOT COMPLETED|Overall Study||21||
48696602|NCT00583752|102041788|FG000|STARTED|Overall Study||25||
48696603|NCT00583752|102041789|FG001|STARTED|Overall Study||25||
48696604|NCT00583752|102041788|FG000|COMPLETED|Overall Study||20||
48696605|NCT00583752|102041789|FG001|COMPLETED|Overall Study||20||
48696606|NCT00583752|102041788|FG000|NOT COMPLETED|Overall Study||5||
48696607|NCT00583752|102041789|FG001|NOT COMPLETED|Overall Study||5||
48696608|NCT03350035|102041790|FG000|STARTED|Overall Study||5||
48696609|NCT03350035|102041791|FG001|STARTED|Overall Study||4||
48696610|NCT03350035|102041792|FG002|STARTED|Overall Study||8||
48696611|NCT03350035|102041790|FG000|COMPLETED|Overall Study||3||
48696612|NCT03350035|102041791|FG001|COMPLETED|Overall Study||4||
48696613|NCT03350035|102041792|FG002|COMPLETED|Overall Study||7||
48696614|NCT03350035|102041790|FG000|NOT COMPLETED|Overall Study||2||
48696615|NCT03350035|102041791|FG001|NOT COMPLETED|Overall Study||0||
48696616|NCT03350035|102041792|FG002|NOT COMPLETED|Overall Study||1||
48696617|NCT01659996|102041793|FG000|STARTED|Overall Study||421||
48276930|NCT00037830|101003013|FG000|COMPLETED|Overall Study||29||
48276931|NCT00037830|101003014|FG001|COMPLETED|Overall Study||31||
48276932|NCT00037830|101003015|FG002|COMPLETED|Overall Study||16||
48276933|NCT00037830|101003013|FG000|NOT COMPLETED|Overall Study||10||
48276934|NCT00037830|101003014|FG001|NOT COMPLETED|Overall Study||7||
48276935|NCT00037830|101003015|FG002|NOT COMPLETED|Overall Study||1||
48276936|NCT01162863|101003016|FG000|STARTED|Overall Study||18||
48276937|NCT01162863|101003017|FG001|STARTED|Overall Study||17||
48276938|NCT01162863|101003018|FG002|STARTED|Overall Study||17||
48276939|NCT01162863|101003016|FG000|COMPLETED|Overall Study||17||
48276940|NCT01162863|101003017|FG001|COMPLETED|Overall Study||16||
48276941|NCT01162863|101003018|FG002|COMPLETED|Overall Study||17||
48276942|NCT01162863|101003016|FG000|NOT COMPLETED|Overall Study||1||
48276943|NCT01162863|101003017|FG001|NOT COMPLETED|Overall Study||1||
48562960|NCT04011722|101710083|FG001|STARTED|Baseline||73||
48562961|NCT04011722|101710082|FG000|COMPLETED|Baseline||260||
48562962|NCT04011722|101710083|FG001|COMPLETED|Baseline||73||
48562963|NCT04011722|101710082|FG000|NOT COMPLETED|Baseline||0||
48562964|NCT04011722|101710083|FG001|NOT COMPLETED|Baseline||0||
48696618|NCT01659996|102041794|FG001|STARTED|Overall Study||395||
48696619|NCT01659996|102041795|FG002|STARTED|Overall Study||472||
48562965|NCT04011722|101710082|FG000|STARTED|Procedure||260||
48562966|NCT04011722|101710083|FG001|STARTED|Procedure||73||
48562967|NCT04011722|101710082|FG000|COMPLETED|Procedure||260||
48562968|NCT04011722|101710083|FG001|COMPLETED|Procedure||73||
48562969|NCT04011722|101710082|FG000|NOT COMPLETED|Procedure||0||
48562970|NCT04011722|101710083|FG001|NOT COMPLETED|Procedure||0||
48562971|NCT04011722|101710082|FG000|STARTED|Discharge||260||
48562972|NCT04011722|101710083|FG001|STARTED|Discharge||73||
48276944|NCT01162863|101003018|FG002|NOT COMPLETED|Overall Study||0||
48276945|NCT02787044|101003019|FG000|STARTED|Overall Study||2630|Total Randomized patients|
48276946|NCT02787044|101003020|FG001|STARTED|Overall Study||2630|Total Randomized patients|
48276947|NCT02787044|101003019|FG000|COMPLETED|Overall Study||2615||
48276948|NCT02787044|101003020|FG001|COMPLETED|Overall Study||2611||
48562973|NCT04011722|101710082|FG000|COMPLETED|Discharge||260||
48562974|NCT04011722|101710083|FG001|COMPLETED|Discharge||73||
48562975|NCT04011722|101710082|FG000|NOT COMPLETED|Discharge||0||
48562976|NCT04011722|101710083|FG001|NOT COMPLETED|Discharge||0||
48562977|NCT04011722|101710082|FG000|STARTED|30 Days||260||
48562978|NCT04011722|101710083|FG001|STARTED|30 Days||73||
48276949|NCT02787044|101003019|FG000|NOT COMPLETED|Overall Study||15||
48276950|NCT02787044|101003020|FG001|NOT COMPLETED|Overall Study||19||
48562979|NCT04011722|101710082|FG000|COMPLETED|30 Days||255||
48562980|NCT04011722|101710083|FG001|COMPLETED|30 Days||72||
48562981|NCT04011722|101710082|FG000|NOT COMPLETED|30 Days||5||
48562982|NCT04011722|101710083|FG001|NOT COMPLETED|30 Days||1||
48562983|NCT04011722|101710082|FG000|STARTED|1 Year||255||
48562984|NCT04011722|101710083|FG001|STARTED|1 Year||72||
48562985|NCT04011722|101710082|FG000|COMPLETED|1 Year||228||
48562986|NCT04011722|101710083|FG001|COMPLETED|1 Year||44||
48562987|NCT04011722|101710082|FG000|NOT COMPLETED|1 Year||27||
48562988|NCT04011722|101710083|FG001|NOT COMPLETED|1 Year||28||
48562989|NCT04011722|101710082|FG000|STARTED|2 Year||234||
48562990|NCT04011722|101710083|FG001|STARTED|2 Year||64||
48113557|NCT01485861|100604971|FG001|Safety Population|Phase II||0||
48113558|NCT01485861|100604972|FG002|Safety Population|Phase II||84||
48113559|NCT01485861|100604973|FG003|Safety Population|Phase II||88||
48113560|NCT01485861|100604974|FG004|Safety Population|Phase II||81||
48113561|NCT01485861|100604975|FG005|Safety Population|Phase II||0||
48113562|NCT01485861|100604970|FG000|COMPLETED|Phase II||0||
48113563|NCT01485861|100604971|FG001|COMPLETED|Phase II||0||
48113564|NCT01485861|100604972|FG002|COMPLETED|Phase II||1||
48562991|NCT04011722|101710082|FG000|COMPLETED|2 Year||155||
48562992|NCT04011722|101710083|FG001|COMPLETED|2 Year||5||
48562993|NCT04011722|101710082|FG000|NOT COMPLETED|2 Year||79||
48562994|NCT04011722|101710083|FG001|NOT COMPLETED|2 Year||59||
48562995|NCT04011722|101710082|FG000|STARTED|3 Year||208||
48562996|NCT04011722|101710083|FG001|STARTED|3 Year||0||
48562997|NCT04011722|101710082|FG000|COMPLETED|3 Year||61||
48562998|NCT04011722|101710083|FG001|COMPLETED|3 Year||0||
48562999|NCT04011722|101710082|FG000|NOT COMPLETED|3 Year||147||
48563000|NCT04011722|101710083|FG001|NOT COMPLETED|3 Year||0||
48563001|NCT01293695|101710084|FG000|STARTED|Overall Study||93||
48113565|NCT01485861|100604973|FG003|COMPLETED|Phase II||0||
48113566|NCT01485861|100604974|FG004|COMPLETED|Phase II||0||
48113567|NCT01485861|100604975|FG005|COMPLETED|Phase II||0||
48113568|NCT01485861|100604970|FG000|NOT COMPLETED|Phase II||0||
48113569|NCT01485861|100604971|FG001|NOT COMPLETED|Phase II||0||
48113570|NCT01485861|100604972|FG002|NOT COMPLETED|Phase II||83||
48113571|NCT01485861|100604973|FG003|NOT COMPLETED|Phase II||86||
48113572|NCT01485861|100604974|FG004|NOT COMPLETED|Phase II||83||
48113573|NCT01485861|100604975|FG005|NOT COMPLETED|Phase II||0||
48113574|NCT01485861|100604970|FG000|STARTED|Safety Phase||0||
48113575|NCT01485861|100604971|FG001|STARTED|Safety Phase||0||
48113576|NCT01485861|100604972|FG002|STARTED|Safety Phase||0||
48113577|NCT01485861|100604973|FG003|STARTED|Safety Phase||0||
48113578|NCT01485861|100604974|FG004|STARTED|Safety Phase||0||
48113579|NCT01485861|100604975|FG005|STARTED|Safety Phase||25||
48113580|NCT01485861|100604970|FG000|COMPLETED|Safety Phase||0||
48113581|NCT01485861|100604971|FG001|COMPLETED|Safety Phase||0||
48113582|NCT01485861|100604972|FG002|COMPLETED|Safety Phase||0||
48113583|NCT01485861|100604973|FG003|COMPLETED|Safety Phase||0||
48113584|NCT01485861|100604974|FG004|COMPLETED|Safety Phase||0||
48276951|NCT00468143|101003021|FG000|STARTED|First Intervention (3 Weeks)||31||
48563002|NCT01293695|101710085|FG001|STARTED|Overall Study||94||
48113585|NCT01485861|100604975|FG005|COMPLETED|Safety Phase||0||
48113586|NCT01485861|100604970|FG000|NOT COMPLETED|Safety Phase||0||
48113587|NCT01485861|100604971|FG001|NOT COMPLETED|Safety Phase||0||
48113588|NCT01485861|100604972|FG002|NOT COMPLETED|Safety Phase||0||
48113589|NCT01485861|100604973|FG003|NOT COMPLETED|Safety Phase||0||
48113590|NCT01485861|100604974|FG004|NOT COMPLETED|Safety Phase||0||
48113591|NCT01485861|100604975|FG005|NOT COMPLETED|Safety Phase||25||
48113592|NCT03018392|100604976|FG000|STARTED|Overall Study||20||
48113593|NCT03018392|100604976|FG000|COMPLETED|Overall Study||20||
48113594|NCT03018392|100604976|FG000|NOT COMPLETED|Overall Study||0||
48113595|NCT04688164|100604977|FG000|STARTED|Overall Study||113||
48113596|NCT04688164|100604978|FG001|STARTED|Overall Study||114||
48113597|NCT04688164|100604977|FG000|COMPLETED|Overall Study||106||
48113598|NCT04688164|100604978|FG001|COMPLETED|Overall Study||99||
48113599|NCT04688164|100604977|FG000|NOT COMPLETED|Overall Study||7||
48113600|NCT04688164|100604978|FG001|NOT COMPLETED|Overall Study||15||
48113601|NCT02159547|100604979|FG000|STARTED|Overall Study||112||
48563003|NCT01293695|101710084|FG000|COMPLETED|Overall Study||78||
48113602|NCT02159547|100604980|FG001|STARTED|Overall Study||112||
48276952|NCT00468143|101003022|FG001|STARTED|First Intervention (3 Weeks)||31||
48113603|NCT02159547|100604979|FG000|COMPLETED|Overall Study||112||
48113604|NCT02159547|100604980|FG001|COMPLETED|Overall Study||112||
48113605|NCT02159547|100604979|FG000|NOT COMPLETED|Overall Study||0||
48113606|NCT02159547|100604980|FG001|NOT COMPLETED|Overall Study||0||
48113607|NCT02832674|100604981|FG000|STARTED|Overall Study||72||
48113608|NCT02832674|100604981|FG000|COMPLETED|Overall Study||67||
48563004|NCT01293695|101710085|FG001|COMPLETED|Overall Study||87||
48563005|NCT01293695|101710084|FG000|NOT COMPLETED|Overall Study||15||
48563006|NCT01293695|101710085|FG001|NOT COMPLETED|Overall Study||7||
48113609|NCT02832674|100604981|FG000|NOT COMPLETED|Overall Study||5||
48113610|NCT00931307|100604982|FG000|STARTED|Overall Study||22||
48113611|NCT00931307|100604982|FG000|COMPLETED|Overall Study||9||
48113612|NCT00931307|100604982|FG000|NOT COMPLETED|Overall Study||13||
48113613|NCT01922024|100604983|FG000|STARTED|Overall Study||1653||
48113614|NCT01922024|100604984|FG001|STARTED|Overall Study||471||
48113615|NCT01922024|100604983|FG000|COMPLETED|Overall Study||1653||
48113616|NCT01922024|100604984|FG001|COMPLETED|Overall Study||471||
48563007|NCT01205269|101710086|FG000|STARTED|Period 1 - First Intervention||4||
48563008|NCT01205269|101710087|FG001|STARTED|Period 1 - First Intervention||4||
48276953|NCT00468143|101003021|FG000|COMPLETED|First Intervention (3 Weeks)||28||
48276954|NCT00468143|101003022|FG001|COMPLETED|First Intervention (3 Weeks)||27||
48276955|NCT00468143|101003021|FG000|NOT COMPLETED|First Intervention (3 Weeks)||3||
48276956|NCT00468143|101003022|FG001|NOT COMPLETED|First Intervention (3 Weeks)||4||
48276957|NCT00468143|101003021|FG000|STARTED|Second Intervention (3 Weeks)||28||
48276958|NCT00468143|101003022|FG001|STARTED|Second Intervention (3 Weeks)||27||
48276959|NCT00468143|101003021|FG000|COMPLETED|Second Intervention (3 Weeks)||25||
48276960|NCT00468143|101003022|FG001|COMPLETED|Second Intervention (3 Weeks)||24||
48276961|NCT00468143|101003021|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||3||
48276962|NCT00468143|101003022|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||3||
48276963|NCT00316602|101003023|FG000|STARTED|Overall Study||282||
48276964|NCT00316602|101003024|FG001|STARTED|Overall Study||350||
48276965|NCT00316602|101003023|FG000|COMPLETED|Overall Study||272||
48276966|NCT00316602|101003024|FG001|COMPLETED|Overall Study||325||
48276967|NCT00316602|101003023|FG000|NOT COMPLETED|Overall Study||10||
48276968|NCT00316602|101003024|FG001|NOT COMPLETED|Overall Study||25||
48276969|NCT00867308|101003025|FG000|STARTED|Overall Study||9||
48276970|NCT00867308|101003026|FG001|STARTED|Overall Study||18||
48276971|NCT00867308|101003025|FG000|COMPLETED|Overall Study||0||
48276972|NCT00867308|101003026|FG001|COMPLETED|Overall Study||0||
48276973|NCT00867308|101003025|FG000|NOT COMPLETED|Overall Study||9||
48276974|NCT00867308|101003026|FG001|NOT COMPLETED|Overall Study||18||
48276975|NCT00474526|101003027|FG000|STARTED|Overall Study||154||
48276976|NCT00474526|101003028|FG001|STARTED|Overall Study||166||
48276977|NCT00474526|101003029|FG002|STARTED|Overall Study||159||
48276978|NCT00474526|101003030|FG003|STARTED|Overall Study||680||
48276979|NCT00474526|101003031|FG004|STARTED|Overall Study||76||
48276980|NCT00474526|101003032|FG005|STARTED|Overall Study||70||
48276981|NCT00474526|101003033|FG006|STARTED|Overall Study||203||
48276982|NCT00474526|101003034|FG007|STARTED|Overall Study||151||
48276983|NCT00474526|101003035|FG008|STARTED|Overall Study||150||
48276984|NCT00474526|101003036|FG009|STARTED|Overall Study||148||
48276985|NCT00474526|101003037|FG010|STARTED|Overall Study||151||
48276986|NCT00474526|101003038|FG011|STARTED|Overall Study||150||
48276987|NCT00474526|101003039|FG012|STARTED|Overall Study||150||
48276988|NCT00474526|101003040|FG013|STARTED|Overall Study||1426||
48276989|NCT00474526|101003041|FG014|STARTED|Overall Study||358||
48276990|NCT00474526|101003042|FG015|STARTED|Overall Study||170||
48276991|NCT00474526|101003043|FG016|STARTED|Overall Study||183||
48276992|NCT00474526|101003027|FG000|COMPLETED|Overall Study||121||
48276993|NCT00474526|101003028|FG001|COMPLETED|Overall Study||120||
48276994|NCT00474526|101003029|FG002|COMPLETED|Overall Study||110||
48276995|NCT00474526|101003030|FG003|COMPLETED|Overall Study||561||
48276996|NCT00474526|101003031|FG004|COMPLETED|Overall Study||8||
48276997|NCT00474526|101003032|FG005|COMPLETED|Overall Study||54||
48276998|NCT00474526|101003033|FG006|COMPLETED|Overall Study||178||
48276999|NCT00474526|101003034|FG007|COMPLETED|Overall Study||145||
48277000|NCT00474526|101003035|FG008|COMPLETED|Overall Study||144||
48277001|NCT00474526|101003036|FG009|COMPLETED|Overall Study||121||
48277002|NCT00474526|101003037|FG010|COMPLETED|Overall Study||141||
48277003|NCT00474526|101003038|FG011|COMPLETED|Overall Study||139||
48277004|NCT00474526|101003039|FG012|COMPLETED|Overall Study||135||
48277005|NCT00474526|101003040|FG013|COMPLETED|Overall Study||1270||
48277006|NCT00474526|101003041|FG014|COMPLETED|Overall Study||281||
48277007|NCT00474526|101003042|FG015|COMPLETED|Overall Study||152||
48277008|NCT00474526|101003043|FG016|COMPLETED|Overall Study||174||
48277009|NCT00474526|101003027|FG000|NOT COMPLETED|Overall Study||33||
48277010|NCT00474526|101003028|FG001|NOT COMPLETED|Overall Study||46||
48277011|NCT00474526|101003029|FG002|NOT COMPLETED|Overall Study||49||
48277012|NCT00474526|101003030|FG003|NOT COMPLETED|Overall Study||119||
48277013|NCT00474526|101003031|FG004|NOT COMPLETED|Overall Study||68||
48277014|NCT00474526|101003032|FG005|NOT COMPLETED|Overall Study||16||
48393928|NCT01677624|101295823|FG000|COMPLETED|Overall Study||27||
48393929|NCT01677624|101295823|FG000|NOT COMPLETED|Overall Study||1||
48393930|NCT00400439|101295824|FG000|STARTED|Overall Study||52||
48393931|NCT00400439|101295825|FG001|STARTED|Overall Study||25||
48393932|NCT00400439|101295824|FG000|COMPLETED|Overall Study||47||
48277015|NCT00474526|101003033|FG006|NOT COMPLETED|Overall Study||25||
48277016|NCT00474526|101003034|FG007|NOT COMPLETED|Overall Study||6||
48277017|NCT00474526|101003035|FG008|NOT COMPLETED|Overall Study||6||
48277018|NCT00474526|101003036|FG009|NOT COMPLETED|Overall Study||27||
48277019|NCT00474526|101003037|FG010|NOT COMPLETED|Overall Study||10||
48277020|NCT00474526|101003038|FG011|NOT COMPLETED|Overall Study||11||
48277021|NCT00474526|101003039|FG012|NOT COMPLETED|Overall Study||15||
48277022|NCT00474526|101003040|FG013|NOT COMPLETED|Overall Study||156||
48277023|NCT00474526|101003041|FG014|NOT COMPLETED|Overall Study||77||
48277024|NCT00474526|101003042|FG015|NOT COMPLETED|Overall Study||18||
48277025|NCT00474526|101003043|FG016|NOT COMPLETED|Overall Study||9||
48277026|NCT00608868|101003044|FG000|STARTED|Overall Study||156||
48277027|NCT00608868|101003044|FG000|Enrolled|Overall Study||156||
48277028|NCT00608868|101003044|FG000|Safety Population|Overall Study||154||
48277029|NCT00608868|101003044|FG000|Treatment Completed|Overall Study||141||
48277030|NCT00608868|101003044|FG000|Intention to Treat (ITT) Population|Overall Study||138||
48277031|NCT00608868|101003044|FG000|Per Protocol (PP) Population|Overall Study||121||
48277032|NCT00608868|101003044|FG000|COMPLETED|Overall Study||141||
48277033|NCT00608868|101003044|FG000|NOT COMPLETED|Overall Study||15||
48277034|NCT02412371|101003045|FG000|STARTED|Overall Study||7||
48277035|NCT02412371|101003046|FG001|STARTED|Overall Study||9||
48277036|NCT02412371|101003047|FG002|STARTED|Overall Study||7||
48277037|NCT02412371|101003048|FG003|STARTED|Overall Study||8||
48277038|NCT02412371|101003049|FG004|STARTED|Overall Study||12||
48277039|NCT02412371|101003050|FG005|STARTED|Overall Study||5||
48277040|NCT02412371|101003045|FG000|COMPLETED|Overall Study||0|Completed indicates participants remaining on study.|
48277041|NCT02412371|101003046|FG001|COMPLETED|Overall Study||0|Completed indicates participants remaining on study.|
48277042|NCT02412371|101003047|FG002|COMPLETED|Overall Study||0|Completed indicates participants remaining on study.|
48277043|NCT02412371|101003048|FG003|COMPLETED|Overall Study||0|Completed indicates participants remaining on study.|
48277044|NCT02412371|101003049|FG004|COMPLETED|Overall Study||0|Completed indicates participants remaining on study.|
48277045|NCT02412371|101003050|FG005|COMPLETED|Overall Study||0|Completed indicates participants remaining on study.|
48277046|NCT02412371|101003045|FG000|NOT COMPLETED|Overall Study||7||
48277047|NCT02412371|101003046|FG001|NOT COMPLETED|Overall Study||9||
48277048|NCT02412371|101003047|FG002|NOT COMPLETED|Overall Study||7||
48277049|NCT02412371|101003048|FG003|NOT COMPLETED|Overall Study||8||
48277050|NCT02412371|101003049|FG004|NOT COMPLETED|Overall Study||12||
48277051|NCT02412371|101003050|FG005|NOT COMPLETED|Overall Study||5||
48277052|NCT01528345|101003051|FG000|STARTED|Overall Study||47||
48277053|NCT01528345|101003052|FG001|STARTED|Overall Study||50||
48277054|NCT01528345|101003051|FG000|COMPLETED|Overall Study||0||
48277055|NCT01528345|101003052|FG001|COMPLETED|Overall Study||0||
48277056|NCT01528345|101003051|FG000|NOT COMPLETED|Overall Study||47||
48277057|NCT01528345|101003052|FG001|NOT COMPLETED|Overall Study||50||
48277058|NCT00700778|101003053|FG000|STARTED|Overall Study||2||
48277059|NCT00700778|101003053|FG000|COMPLETED|Overall Study||0||
48277060|NCT00700778|101003053|FG000|NOT COMPLETED|Overall Study||2||
48696620|NCT01659996|102041793|FG000|COMPLETED|Overall Study||413||
48696621|NCT01659996|102041794|FG001|COMPLETED|Overall Study||388||
48696622|NCT01659996|102041795|FG002|COMPLETED|Overall Study||461||
48696623|NCT01659996|102041793|FG000|NOT COMPLETED|Overall Study||8||
48696624|NCT01659996|102041794|FG001|NOT COMPLETED|Overall Study||7||
48696625|NCT01659996|102041795|FG002|NOT COMPLETED|Overall Study||11||
48696626|NCT01092780|102041796|FG000|STARTED|Treatment Period 1||14||
48696627|NCT01092780|102041797|FG001|STARTED|Treatment Period 1||15||
48696628|NCT01092780|102041798|FG002|STARTED|Treatment Period 1||14||
48696629|NCT01092780|102041799|FG003|STARTED|Treatment Period 1||13||
48696630|NCT01092780|102041796|FG000|COMPLETED|Treatment Period 1||14||
48696631|NCT01092780|102041797|FG001|COMPLETED|Treatment Period 1||15||
48696632|NCT01092780|102041798|FG002|COMPLETED|Treatment Period 1||14||
48696633|NCT01092780|102041799|FG003|COMPLETED|Treatment Period 1||13||
48696634|NCT01092780|102041796|FG000|NOT COMPLETED|Treatment Period 1||0||
48696635|NCT01092780|102041797|FG001|NOT COMPLETED|Treatment Period 1||0||
48696636|NCT01092780|102041798|FG002|NOT COMPLETED|Treatment Period 1||0||
48696637|NCT01092780|102041799|FG003|NOT COMPLETED|Treatment Period 1||0||
48696638|NCT01092780|102041796|FG000|STARTED|Washout Period 1||14||
48696639|NCT01092780|102041797|FG001|STARTED|Washout Period 1||15||
48696640|NCT01092780|102041798|FG002|STARTED|Washout Period 1||14||
48696641|NCT01092780|102041799|FG003|STARTED|Washout Period 1||13||
48696642|NCT01092780|102041796|FG000|COMPLETED|Washout Period 1||13||
48696643|NCT01092780|102041797|FG001|COMPLETED|Washout Period 1||14||
48696644|NCT01092780|102041798|FG002|COMPLETED|Washout Period 1||14||
48696645|NCT01092780|102041799|FG003|COMPLETED|Washout Period 1||13||
48277061|NCT03775486|101003054|FG000|STARTED|Initial Therapy Phase||0||
48277062|NCT03775486|101003055|FG001|STARTED|Initial Therapy Phase||401||
48277063|NCT03775486|101003054|FG000|COMPLETED|Initial Therapy Phase||0||
48277064|NCT03775486|101003055|FG001|COMPLETED|Initial Therapy Phase||269||
48277065|NCT03775486|101003054|FG000|NOT COMPLETED|Initial Therapy Phase||0||
48277066|NCT03775486|101003055|FG001|NOT COMPLETED|Initial Therapy Phase||132||
48696646|NCT01092780|102041796|FG000|NOT COMPLETED|Washout Period 1||1||
48696647|NCT01092780|102041797|FG001|NOT COMPLETED|Washout Period 1||1||
48696648|NCT01092780|102041798|FG002|NOT COMPLETED|Washout Period 1||0||
48696649|NCT01092780|102041799|FG003|NOT COMPLETED|Washout Period 1||0||
48696650|NCT01092780|102041796|FG000|STARTED|Treatment Period 2||13||
48696651|NCT01092780|102041797|FG001|STARTED|Treatment Period 2||14||
48696652|NCT01092780|102041798|FG002|STARTED|Treatment Period 2||14||
48696653|NCT01092780|102041799|FG003|STARTED|Treatment Period 2||13||
48696654|NCT01092780|102041796|FG000|COMPLETED|Treatment Period 2||13||
48277067|NCT03775486|101003054|FG000|STARTED|Maintenance Phase||134||
48277068|NCT03775486|101003055|FG001|STARTED|Maintenance Phase||135||
48277069|NCT03775486|101003054|FG000|Participants Who Received Durvalumab|Maintenance Phase||134||
48696655|NCT01092780|102041797|FG001|COMPLETED|Treatment Period 2||14||
48696656|NCT01092780|102041798|FG002|COMPLETED|Treatment Period 2||14||
48696657|NCT01092780|102041799|FG003|COMPLETED|Treatment Period 2||13||
48696658|NCT01092780|102041796|FG000|NOT COMPLETED|Treatment Period 2||0||
48696659|NCT01092780|102041797|FG001|NOT COMPLETED|Treatment Period 2||0||
48696660|NCT01092780|102041798|FG002|NOT COMPLETED|Treatment Period 2||0||
48696661|NCT01092780|102041799|FG003|NOT COMPLETED|Treatment Period 2||0||
48696662|NCT01092780|102041796|FG000|STARTED|Washout Period 2||13||
48696663|NCT01092780|102041797|FG001|STARTED|Washout Period 2||14||
48696664|NCT01092780|102041798|FG002|STARTED|Washout Period 2||14||
48696665|NCT01092780|102041799|FG003|STARTED|Washout Period 2||13||
48277070|NCT03775486|101003055|FG001|Participants Who Received Durvalumab|Maintenance Phase||134||
48277071|NCT03775486|101003054|FG000|Participants Who Received Olaparib/Placebo|Maintenance Phase||128||
48277072|NCT03775486|101003055|FG001|Participants Who Received Olaparib/Placebo|Maintenance Phase||128||
48277073|NCT03775486|101003054|FG000|Participants Who Terminated the Study|Maintenance Phase||57||
48277074|NCT03775486|101003055|FG001|Participants Who Terminated the Study|Maintenance Phase||57||
48277075|NCT03775486|101003054|FG000|COMPLETED|Maintenance Phase||77|Participants ongoing study at data cut-off|
48277076|NCT03775486|101003055|FG001|COMPLETED|Maintenance Phase||78|Participants ongoing study at data cut-off|
48277077|NCT03775486|101003054|FG000|NOT COMPLETED|Maintenance Phase||57||
48696666|NCT01092780|102041796|FG000|COMPLETED|Washout Period 2||13||
48696667|NCT01092780|102041797|FG001|COMPLETED|Washout Period 2||13||
48696668|NCT01092780|102041798|FG002|COMPLETED|Washout Period 2||13||
48696669|NCT01092780|102041799|FG003|COMPLETED|Washout Period 2||13||
48696670|NCT01092780|102041796|FG000|NOT COMPLETED|Washout Period 2||0||
48696671|NCT01092780|102041797|FG001|NOT COMPLETED|Washout Period 2||1||
48696672|NCT01092780|102041798|FG002|NOT COMPLETED|Washout Period 2||1||
48696673|NCT01092780|102041799|FG003|NOT COMPLETED|Washout Period 2||0||
48696674|NCT01092780|102041796|FG000|STARTED|Treatment Period 3||13||
48696675|NCT01092780|102041797|FG001|STARTED|Treatment Period 3||13||
48393933|NCT00400439|101295825|FG001|COMPLETED|Overall Study||23||
48393934|NCT00400439|101295824|FG000|NOT COMPLETED|Overall Study||5||
48393935|NCT00400439|101295825|FG001|NOT COMPLETED|Overall Study||2||
48393936|NCT01459068|101295826|FG000|STARTED|Overall Study||165||
48277078|NCT03775486|101003055|FG001|NOT COMPLETED|Maintenance Phase||57||
48277079|NCT05597787|101003056|FG000|STARTED|Overall Study||26||
48277080|NCT05597787|101003057|FG001|STARTED|Overall Study||26||
48277081|NCT05597787|101003058|FG002|STARTED|Overall Study||26||
48277082|NCT05597787|101003056|FG000|COMPLETED|Overall Study||26||
48696676|NCT01092780|102041798|FG002|STARTED|Treatment Period 3||13||
48696677|NCT01092780|102041799|FG003|STARTED|Treatment Period 3||13||
48696678|NCT01092780|102041796|FG000|COMPLETED|Treatment Period 3||13||
48696679|NCT01092780|102041797|FG001|COMPLETED|Treatment Period 3||13||
48696680|NCT01092780|102041798|FG002|COMPLETED|Treatment Period 3||13||
48696681|NCT01092780|102041799|FG003|COMPLETED|Treatment Period 3||13||
48696682|NCT01092780|102041796|FG000|NOT COMPLETED|Treatment Period 3||0||
48696683|NCT01092780|102041797|FG001|NOT COMPLETED|Treatment Period 3||0||
48696684|NCT01092780|102041798|FG002|NOT COMPLETED|Treatment Period 3||0||
48696685|NCT01092780|102041799|FG003|NOT COMPLETED|Treatment Period 3||0||
48696686|NCT01092780|102041796|FG000|STARTED|Washout Period 3||13||
48696687|NCT01092780|102041797|FG001|STARTED|Washout Period 3||13||
48696688|NCT01092780|102041798|FG002|STARTED|Washout Period 3||13||
48277083|NCT05597787|101003057|FG001|COMPLETED|Overall Study||26||
48277084|NCT05597787|101003058|FG002|COMPLETED|Overall Study||25||
48277085|NCT05597787|101003056|FG000|NOT COMPLETED|Overall Study||0||
48277086|NCT05597787|101003057|FG001|NOT COMPLETED|Overall Study||0||
48277087|NCT05597787|101003058|FG002|NOT COMPLETED|Overall Study||1||
48277088|NCT00588692|101003059|FG000|STARTED|Overall Study||30||
48277089|NCT00588692|101003060|FG001|STARTED|Overall Study||30||
48277090|NCT00588692|101003059|FG000|COMPLETED|Overall Study||23||
48277091|NCT00588692|101003060|FG001|COMPLETED|Overall Study||27||
48393937|NCT01459068|101295827|FG001|STARTED|Overall Study||182||
48393938|NCT01459068|101295826|FG000|COMPLETED|Overall Study||126||
48696689|NCT01092780|102041799|FG003|STARTED|Washout Period 3||13||
48696690|NCT01092780|102041796|FG000|COMPLETED|Washout Period 3||13||
48696691|NCT01092780|102041797|FG001|COMPLETED|Washout Period 3||13||
48696692|NCT01092780|102041798|FG002|COMPLETED|Washout Period 3||13||
48696693|NCT01092780|102041799|FG003|COMPLETED|Washout Period 3||13||
48696694|NCT01092780|102041796|FG000|NOT COMPLETED|Washout Period 3||0||
48696695|NCT01092780|102041797|FG001|NOT COMPLETED|Washout Period 3||0||
48696696|NCT01092780|102041798|FG002|NOT COMPLETED|Washout Period 3||0||
48696697|NCT01092780|102041799|FG003|NOT COMPLETED|Washout Period 3||0||
48393939|NCT01459068|101295827|FG001|COMPLETED|Overall Study||148||
48393940|NCT01459068|101295826|FG000|NOT COMPLETED|Overall Study||39||
48696698|NCT01092780|102041796|FG000|STARTED|Treatment Period 4||13||
48696699|NCT01092780|102041797|FG001|STARTED|Treatment Period 4||13||
48696700|NCT01092780|102041798|FG002|STARTED|Treatment Period 4||13||
48696701|NCT01092780|102041799|FG003|STARTED|Treatment Period 4||13||
48696702|NCT01092780|102041796|FG000|COMPLETED|Treatment Period 4||13||
48277092|NCT00588692|101003059|FG000|NOT COMPLETED|Overall Study||7||
48277093|NCT00588692|101003060|FG001|NOT COMPLETED|Overall Study||3||
48277094|NCT04514510|101003061|FG000|STARTED|Overall Study||23||
48277095|NCT04514510|101003062|FG001|STARTED|Overall Study||23||
48696703|NCT01092780|102041797|FG001|COMPLETED|Treatment Period 4||13||
48696704|NCT01092780|102041798|FG002|COMPLETED|Treatment Period 4||13||
48696705|NCT01092780|102041799|FG003|COMPLETED|Treatment Period 4||13||
48696706|NCT01092780|102041796|FG000|NOT COMPLETED|Treatment Period 4||0||
48696707|NCT01092780|102041797|FG001|NOT COMPLETED|Treatment Period 4||0||
48696708|NCT01092780|102041798|FG002|NOT COMPLETED|Treatment Period 4||0||
48696709|NCT01092780|102041799|FG003|NOT COMPLETED|Treatment Period 4||0||
48696710|NCT03145064|102041800|FG000|STARTED|Overall Study||41||
48696711|NCT03145064|102041800|FG000|Received At Least 1 Dose of Study Drug|Overall Study||41||
48696712|NCT03145064|102041800|FG000|COMPLETED|Overall Study||0||
48696713|NCT03145064|102041800|FG000|NOT COMPLETED|Overall Study||41||
48696714|NCT04559022|102041801|FG000|STARTED|Overall Study||10||
48696715|NCT04559022|102041801|FG000|COMPLETED|Overall Study||10||
48696716|NCT04559022|102041801|FG000|NOT COMPLETED|Overall Study||0||
48696717|NCT02712983|102041802|FG000|STARTED|Treatment Phase||14|All randomized patients (Full Analysis Set and Safety Set)|
48696718|NCT02712983|102041803|FG001|STARTED|Treatment Phase||13|All randomized patients (Full Analysis Set and Safety Set)|
48696719|NCT02712983|102041804|FG002|STARTED|Treatment Phase||7|All randomized patients (Full Analysis Set and Safety Set)|
48696720|NCT02712983|102041805|FG003|STARTED|Treatment Phase||15|All randomized patients (Full Analysis Set and Safety Set)|
48696721|NCT02712983|102041806|FG004|STARTED|Treatment Phase||14|All randomized patients (Full Analysis Set and Safety Set)|
48696722|NCT02712983|102041807|FG005|STARTED|Treatment Phase||7|All randomized patients (Full Analysis Set and Safety Set)|
48696723|NCT02712983|102041808|FG006|STARTED|Treatment Phase||15|All randomized patients (Full Analysis Set and Safety Set)|
48696724|NCT02712983|102041809|FG007|STARTED|Treatment Phase||15|All randomized patients (Full Analysis Set and Safety Set)|
48696725|NCT02712983|102041810|FG008|STARTED|Treatment Phase||7|All randomized patients (Full Analysis Set and Safety Set)|
48696726|NCT02712983|102041802|FG000|Pharmacokinetic Analysis Set|Treatment Phase||14||
48696727|NCT02712983|102041803|FG001|Pharmacokinetic Analysis Set|Treatment Phase||13||
48696728|NCT02712983|102041804|FG002|Pharmacokinetic Analysis Set|Treatment Phase||0||
48696729|NCT02712983|102041805|FG003|Pharmacokinetic Analysis Set|Treatment Phase||15||
48696730|NCT02712983|102041806|FG004|Pharmacokinetic Analysis Set|Treatment Phase||14||
48696731|NCT02712983|102041807|FG005|Pharmacokinetic Analysis Set|Treatment Phase||0||
48696732|NCT02712983|102041808|FG006|Pharmacokinetic Analysis Set|Treatment Phase||15||
48696733|NCT02712983|102041809|FG007|Pharmacokinetic Analysis Set|Treatment Phase||14||
48696734|NCT02712983|102041810|FG008|Pharmacokinetic Analysis Set|Treatment Phase||0||
48696735|NCT02712983|102041802|FG000|COMPLETED|Treatment Phase||9||
48696736|NCT02712983|102041803|FG001|COMPLETED|Treatment Phase||12||
48696737|NCT02712983|102041804|FG002|COMPLETED|Treatment Phase||6||
48696738|NCT02712983|102041805|FG003|COMPLETED|Treatment Phase||7||
48696739|NCT02712983|102041806|FG004|COMPLETED|Treatment Phase||10||
48696740|NCT02712983|102041807|FG005|COMPLETED|Treatment Phase||7||
48696741|NCT02712983|102041808|FG006|COMPLETED|Treatment Phase||6||
48277096|NCT04514510|101003061|FG000|COMPLETED|Overall Study||22||
48277097|NCT04514510|101003062|FG001|COMPLETED|Overall Study||22||
48277098|NCT04514510|101003061|FG000|NOT COMPLETED|Overall Study||1||
48277099|NCT04514510|101003062|FG001|NOT COMPLETED|Overall Study||1||
48277100|NCT04476251|101003063|FG000|STARTED|Overall Study||1||
48277101|NCT04476251|101003063|FG000|COMPLETED|Overall Study||0||
48277102|NCT04476251|101003063|FG000|NOT COMPLETED|Overall Study||1||
48277103|NCT03165747|101003064|FG000|STARTED|Overall Study||0||
48393941|NCT01459068|101295827|FG001|NOT COMPLETED|Overall Study||34||
48393942|NCT02177175|101295828|FG000|STARTED|Overall Study||5||
48393943|NCT02177175|101295829|FG001|STARTED|Overall Study||6||
48277104|NCT03165747|101003065|FG001|STARTED|Overall Study||0||
48277105|NCT03165747|101003064|FG000|COMPLETED|Overall Study||0||
48277106|NCT03165747|101003065|FG001|COMPLETED|Overall Study||0||
48277107|NCT03165747|101003064|FG000|NOT COMPLETED|Overall Study||0||
48277108|NCT03165747|101003065|FG001|NOT COMPLETED|Overall Study||0||
48277109|NCT03563157|101003066|FG000|STARTED|Overall Study||2||
48277110|NCT03563157|101003066|FG000|COMPLETED|Overall Study||0||
48393944|NCT02177175|101295828|FG000|COMPLETED|Overall Study||4||
48393945|NCT02177175|101295829|FG001|COMPLETED|Overall Study||6||
48696742|NCT02712983|102041809|FG007|COMPLETED|Treatment Phase||6||
48696743|NCT02712983|102041810|FG008|COMPLETED|Treatment Phase||5||
48696744|NCT02712983|102041802|FG000|NOT COMPLETED|Treatment Phase||5||
48696745|NCT02712983|102041803|FG001|NOT COMPLETED|Treatment Phase||1||
48696746|NCT02712983|102041804|FG002|NOT COMPLETED|Treatment Phase||1||
48696747|NCT02712983|102041805|FG003|NOT COMPLETED|Treatment Phase||8||
48696748|NCT02712983|102041806|FG004|NOT COMPLETED|Treatment Phase||4||
48277111|NCT03563157|101003066|FG000|NOT COMPLETED|Overall Study||2||
48277112|NCT03896152|101003067|FG000|STARTED|Overall Study||7||
48393946|NCT02177175|101295828|FG000|NOT COMPLETED|Overall Study||1||
48393947|NCT02177175|101295829|FG001|NOT COMPLETED|Overall Study||0||
48696749|NCT02712983|102041807|FG005|NOT COMPLETED|Treatment Phase||0||
48696750|NCT02712983|102041808|FG006|NOT COMPLETED|Treatment Phase||9||
48277113|NCT03896152|101003068|FG001|STARTED|Overall Study||6||
48277114|NCT03896152|101003067|FG000|COMPLETED|Overall Study||4||
48277115|NCT03896152|101003068|FG001|COMPLETED|Overall Study||4||
48277116|NCT03896152|101003067|FG000|NOT COMPLETED|Overall Study||3||
48277117|NCT03896152|101003068|FG001|NOT COMPLETED|Overall Study||2||
48277118|NCT00827099|101003069|FG000|STARTED|Overall Study||5||
48277119|NCT00827099|101003069|FG000|COMPLETED|Overall Study||5||
48277120|NCT00827099|101003069|FG000|NOT COMPLETED|Overall Study||0||
48393948|NCT02137837|101295830|FG000|STARTED|Overall Study||13||
48393949|NCT02137837|101295831|FG001|STARTED|Overall Study||12||
48393950|NCT02137837|101295832|FG002|STARTED|Overall Study||12||
48393951|NCT02137837|101295830|FG000|Received Protocol Therapy|Overall Study||13||
48393952|NCT02137837|101295831|FG001|Received Protocol Therapy|Overall Study||11||
48393953|NCT02137837|101295832|FG002|Received Protocol Therapy|Overall Study||12||
48393954|NCT02137837|101295830|FG000|COMPLETED|Overall Study||0||
48393955|NCT02137837|101295831|FG001|COMPLETED|Overall Study||0||
48393956|NCT02137837|101295832|FG002|COMPLETED|Overall Study||0||
48393957|NCT02137837|101295830|FG000|NOT COMPLETED|Overall Study||13||
48393958|NCT02137837|101295831|FG001|NOT COMPLETED|Overall Study||12||
48393959|NCT02137837|101295832|FG002|NOT COMPLETED|Overall Study||12||
48393960|NCT03750240|101295833|FG000|STARTED|Overall Study||2||
48393961|NCT03750240|101295833|FG000|COMPLETED|Overall Study||0||
48393962|NCT03750240|101295833|FG000|NOT COMPLETED|Overall Study||2||
48393963|NCT04449276|101295834|FG000|STARTED|Overall Study||47||
48393964|NCT04449276|101295835|FG001|STARTED|Overall Study||48||
48393965|NCT04449276|101295836|FG002|STARTED|Overall Study||48||
48696751|NCT02712983|102041809|FG007|NOT COMPLETED|Treatment Phase||9||
48696752|NCT02712983|102041810|FG008|NOT COMPLETED|Treatment Phase||2||
48696753|NCT02712983|102041802|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase||0|All patients who discontinued treatment and entered Post-Treatment Efficacy Follow-Up Phase|
48696754|NCT02712983|102041803|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase||1|All patients who discontinued treatment and entered Post-Treatment Efficacy Follow-Up Phase|
48696755|NCT02712983|102041804|FG002|STARTED|Post-Treatment Efficacy Follow-Up Phase||0|All patients who discontinued treatment and entered Post-Treatment Efficacy Follow-Up Phase|
48696756|NCT02712983|102041805|FG003|STARTED|Post-Treatment Efficacy Follow-Up Phase||1|All patients who discontinued treatment and entered Post-Treatment Efficacy Follow-Up Phase|
48696757|NCT02712983|102041806|FG004|STARTED|Post-Treatment Efficacy Follow-Up Phase||2|All patients who discontinued treatment and entered Post-Treatment Efficacy Follow-Up Phase|
48696758|NCT02712983|102041807|FG005|STARTED|Post-Treatment Efficacy Follow-Up Phase||1|All patients who discontinued treatment and entered Post-Treatment Efficacy Follow-Up Phase|
48696759|NCT02712983|102041808|FG006|STARTED|Post-Treatment Efficacy Follow-Up Phase||2|All patients who discontinued treatment and entered Post-Treatment Efficacy Follow-Up Phase|
48696760|NCT02712983|102041809|FG007|STARTED|Post-Treatment Efficacy Follow-Up Phase||3|All patients who discontinued treatment and entered Post-Treatment Efficacy Follow-Up Phase|
48113617|NCT01922024|100604983|FG000|NOT COMPLETED|Overall Study||0||
48113618|NCT01922024|100604984|FG001|NOT COMPLETED|Overall Study||0||
48113619|NCT00261716|100604985|FG000|STARTED|Overall Study||17||
48113620|NCT00261716|100604986|FG001|STARTED|Overall Study||21||
48113621|NCT00261716|100604985|FG000|COMPLETED|Overall Study||11||
48113622|NCT00261716|100604986|FG001|COMPLETED|Overall Study||11||
48113623|NCT00261716|100604985|FG000|NOT COMPLETED|Overall Study||6||
48113624|NCT00261716|100604986|FG001|NOT COMPLETED|Overall Study||10||
48113625|NCT02096458|100604987|FG000|STARTED|Overall Study||8||
48113626|NCT02096458|100604987|FG000|COMPLETED|Overall Study||8||
48113627|NCT02096458|100604987|FG000|NOT COMPLETED|Overall Study||0||
48113628|NCT01604343|100604988|FG000|STARTED|Prior to W52 Administration(Through W52)||556||
48113629|NCT01604343|100604989|FG001|STARTED|Prior to W52 Administration(Through W52)||0||
48113630|NCT01604343|100604990|FG002|STARTED|Prior to W52 Administration(Through W52)||557||
48113631|NCT01604343|100604991|FG003|STARTED|Prior to W52 Administration(Through W52)||0||
48277121|NCT03668223|101003070|FG000|STARTED|Overall Study||99||
48277122|NCT03668223|101003071|FG001|STARTED|Overall Study||96||
48393966|NCT04449276|101295837|FG003|STARTED|Overall Study||49||
48393967|NCT04449276|101295838|FG004|STARTED|Overall Study||28||
48393968|NCT04449276|101295839|FG005|STARTED|Overall Study||16||
48393969|NCT04449276|101295840|FG006|STARTED|Overall Study||12||
48393970|NCT04449276|101295841|FG007|STARTED|Overall Study||32||
48393971|NCT04449276|101295834|FG000|COMPLETED|Overall Study||44||
48393972|NCT04449276|101295835|FG001|COMPLETED|Overall Study||44||
48393973|NCT04449276|101295836|FG002|COMPLETED|Overall Study||45||
48563009|NCT01205269|101710088|FG002|STARTED|Period 1 - First Intervention||4||
48563010|NCT01205269|101710089|FG003|STARTED|Period 1 - First Intervention||6||
48563011|NCT01205269|101710090|FG004|STARTED|Period 1 - First Intervention||5||
48563012|NCT01205269|101710091|FG005|STARTED|Period 1 - First Intervention||5||
48563013|NCT01205269|101710086|FG000|COMPLETED|Period 1 - First Intervention||4||
48563014|NCT01205269|101710087|FG001|COMPLETED|Period 1 - First Intervention||4||
48563015|NCT01205269|101710088|FG002|COMPLETED|Period 1 - First Intervention||4||
48563016|NCT01205269|101710089|FG003|COMPLETED|Period 1 - First Intervention||6||
48563017|NCT01205269|101710090|FG004|COMPLETED|Period 1 - First Intervention||5||
48277123|NCT03668223|101003070|FG000|COMPLETED|Overall Study||69||
48277124|NCT03668223|101003071|FG001|COMPLETED|Overall Study||76||
48277125|NCT03668223|101003070|FG000|NOT COMPLETED|Overall Study||30||
48277126|NCT03668223|101003071|FG001|NOT COMPLETED|Overall Study||20||
48277127|NCT02236988|101003072|FG000|STARTED|Overall Study||16||
48277128|NCT02236988|101003073|FG001|STARTED|Overall Study||16||
48277129|NCT02236988|101003074|FG002|STARTED|Overall Study||18||
48277130|NCT02236988|101003075|FG003|STARTED|Overall Study||30||
48277131|NCT02236988|101003072|FG000|COMPLETED|Overall Study||16||
48277132|NCT02236988|101003073|FG001|COMPLETED|Overall Study||16||
48277133|NCT02236988|101003074|FG002|COMPLETED|Overall Study||18||
48277134|NCT02236988|101003075|FG003|COMPLETED|Overall Study||27||
48277135|NCT02236988|101003072|FG000|NOT COMPLETED|Overall Study||0||
48277136|NCT02236988|101003073|FG001|NOT COMPLETED|Overall Study||0||
48277137|NCT02236988|101003074|FG002|NOT COMPLETED|Overall Study||0||
48277138|NCT02236988|101003075|FG003|NOT COMPLETED|Overall Study||3||
48277139|NCT05269966|101003076|FG000|STARTED|Overall Study||105||
48277140|NCT05269966|101003076|FG000|COMPLETED|Overall Study||95||
48277141|NCT05269966|101003076|FG000|NOT COMPLETED|Overall Study||10||
48277142|NCT00684723|101003077|FG000|STARTED|First Intervention||27||
48277143|NCT00684723|101003078|FG001|STARTED|First Intervention||27||
48277144|NCT00684723|101003077|FG000|COMPLETED|First Intervention||27||
48277145|NCT00684723|101003078|FG001|COMPLETED|First Intervention||27||
48277146|NCT00684723|101003077|FG000|NOT COMPLETED|First Intervention||0||
48277147|NCT00684723|101003078|FG001|NOT COMPLETED|First Intervention||0||
48277148|NCT00684723|101003077|FG000|STARTED|Washout Period of 7 Days||27||
48277149|NCT00684723|101003078|FG001|STARTED|Washout Period of 7 Days||27||
48277150|NCT00684723|101003077|FG000|COMPLETED|Washout Period of 7 Days||27||
48277151|NCT00684723|101003078|FG001|COMPLETED|Washout Period of 7 Days||27||
48277152|NCT00684723|101003077|FG000|NOT COMPLETED|Washout Period of 7 Days||0||
48277153|NCT00684723|101003078|FG001|NOT COMPLETED|Washout Period of 7 Days||0||
48277154|NCT00684723|101003077|FG000|STARTED|Second Intervention||27||
48563018|NCT01205269|101710091|FG005|COMPLETED|Period 1 - First Intervention||5||
48563019|NCT01205269|101710086|FG000|NOT COMPLETED|Period 1 - First Intervention||0||
48563020|NCT01205269|101710087|FG001|NOT COMPLETED|Period 1 - First Intervention||0||
48277155|NCT00684723|101003078|FG001|STARTED|Second Intervention||27||
48277156|NCT00684723|101003077|FG000|COMPLETED|Second Intervention||27||
48277157|NCT00684723|101003078|FG001|COMPLETED|Second Intervention||27||
48563021|NCT01205269|101710088|FG002|NOT COMPLETED|Period 1 - First Intervention||0||
48563022|NCT01205269|101710089|FG003|NOT COMPLETED|Period 1 - First Intervention||0||
48563023|NCT01205269|101710090|FG004|NOT COMPLETED|Period 1 - First Intervention||0||
48113632|NCT01604343|100604992|FG004|STARTED|Prior to W52 Administration(Through W52)||557||
48277158|NCT00684723|101003077|FG000|NOT COMPLETED|Second Intervention||0||
48277159|NCT00684723|101003078|FG001|NOT COMPLETED|Second Intervention||0||
48113633|NCT01604343|100604988|FG000|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||187||
48113634|NCT01604343|100604989|FG001|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0||
48277160|NCT00848588|101003079|FG000|STARTED|Overall Study||404||
48277161|NCT00848588|101003079|FG000|COMPLETED|Overall Study||404||
48277162|NCT00848588|101003079|FG000|NOT COMPLETED|Overall Study||0||
48277163|NCT03231800|101003080|FG000|STARTED|Overall Study||48||
48563024|NCT01205269|101710091|FG005|NOT COMPLETED|Period 1 - First Intervention||0||
48563025|NCT01205269|101710086|FG000|STARTED|Period 2 - Washout||4||
48563026|NCT01205269|101710087|FG001|STARTED|Period 2 - Washout||4||
48563027|NCT01205269|101710088|FG002|STARTED|Period 2 - Washout||4||
48563028|NCT01205269|101710089|FG003|STARTED|Period 2 - Washout||6||
48563029|NCT01205269|101710090|FG004|STARTED|Period 2 - Washout||5||
48563030|NCT01205269|101710091|FG005|STARTED|Period 2 - Washout||5||
48563031|NCT01205269|101710086|FG000|COMPLETED|Period 2 - Washout||4||
48563032|NCT01205269|101710087|FG001|COMPLETED|Period 2 - Washout||4||
48563033|NCT01205269|101710088|FG002|COMPLETED|Period 2 - Washout||4||
48563034|NCT01205269|101710089|FG003|COMPLETED|Period 2 - Washout||6||
48563035|NCT01205269|101710090|FG004|COMPLETED|Period 2 - Washout||5||
48563036|NCT01205269|101710091|FG005|COMPLETED|Period 2 - Washout||5||
48563037|NCT01205269|101710086|FG000|NOT COMPLETED|Period 2 - Washout||0||
48563038|NCT01205269|101710087|FG001|NOT COMPLETED|Period 2 - Washout||0||
48563039|NCT01205269|101710088|FG002|NOT COMPLETED|Period 2 - Washout||0||
48563040|NCT01205269|101710089|FG003|NOT COMPLETED|Period 2 - Washout||0||
48563041|NCT01205269|101710090|FG004|NOT COMPLETED|Period 2 - Washout||0||
48563042|NCT01205269|101710091|FG005|NOT COMPLETED|Period 2 - Washout||0||
48563043|NCT01205269|101710086|FG000|STARTED|Period 3 - Second Intervention||4||
48563044|NCT01205269|101710087|FG001|STARTED|Period 3 - Second Intervention||4||
48563045|NCT01205269|101710088|FG002|STARTED|Period 3 - Second Intervention||4||
48563046|NCT01205269|101710089|FG003|STARTED|Period 3 - Second Intervention||6||
48563047|NCT01205269|101710090|FG004|STARTED|Period 3 - Second Intervention||5||
48563048|NCT01205269|101710091|FG005|STARTED|Period 3 - Second Intervention||5||
48563049|NCT01205269|101710086|FG000|COMPLETED|Period 3 - Second Intervention||4||
48563050|NCT01205269|101710087|FG001|COMPLETED|Period 3 - Second Intervention||4||
48563051|NCT01205269|101710088|FG002|COMPLETED|Period 3 - Second Intervention||4||
48563052|NCT01205269|101710089|FG003|COMPLETED|Period 3 - Second Intervention||6||
48563053|NCT01205269|101710090|FG004|COMPLETED|Period 3 - Second Intervention||5||
48277164|NCT03231800|101003081|FG001|STARTED|Overall Study||47||
48277165|NCT03231800|101003080|FG000|Safety Population|Overall Study||47||
48277166|NCT03231800|101003081|FG001|Safety Population|Overall Study||47||
48277167|NCT03231800|101003080|FG000|COMPLETED|Overall Study||45||
48277168|NCT03231800|101003081|FG001|COMPLETED|Overall Study||44||
48277169|NCT03231800|101003080|FG000|NOT COMPLETED|Overall Study||3||
48563054|NCT01205269|101710091|FG005|COMPLETED|Period 3 - Second Intervention||5||
48563055|NCT01205269|101710086|FG000|NOT COMPLETED|Period 3 - Second Intervention||0||
48563056|NCT01205269|101710087|FG001|NOT COMPLETED|Period 3 - Second Intervention||0||
48563057|NCT01205269|101710088|FG002|NOT COMPLETED|Period 3 - Second Intervention||0||
48563058|NCT01205269|101710089|FG003|NOT COMPLETED|Period 3 - Second Intervention||0||
48563059|NCT01205269|101710090|FG004|NOT COMPLETED|Period 3 - Second Intervention||0||
48563060|NCT01205269|101710091|FG005|NOT COMPLETED|Period 3 - Second Intervention||0||
48113635|NCT01604343|100604990|FG002|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0||
48277170|NCT03231800|101003081|FG001|NOT COMPLETED|Overall Study||3||
48277171|NCT05618912|101003082|FG000|STARTED|Overall Study||72||
48563061|NCT01205269|101710086|FG000|STARTED|Period 4 - Washout||4||
48563062|NCT01205269|101710087|FG001|STARTED|Period 4 - Washout||4||
48563063|NCT01205269|101710088|FG002|STARTED|Period 4 - Washout||4||
48563064|NCT01205269|101710089|FG003|STARTED|Period 4 - Washout||6||
48563065|NCT01205269|101710090|FG004|STARTED|Period 4 - Washout||5||
48563066|NCT01205269|101710091|FG005|STARTED|Period 4 - Washout||5||
48563067|NCT01205269|101710086|FG000|COMPLETED|Period 4 - Washout||4||
48563068|NCT01205269|101710087|FG001|COMPLETED|Period 4 - Washout||4||
48563069|NCT01205269|101710088|FG002|COMPLETED|Period 4 - Washout||4||
48563070|NCT01205269|101710089|FG003|COMPLETED|Period 4 - Washout||5||
48563071|NCT01205269|101710090|FG004|COMPLETED|Period 4 - Washout||5||
48563072|NCT01205269|101710091|FG005|COMPLETED|Period 4 - Washout||5||
48563073|NCT01205269|101710086|FG000|NOT COMPLETED|Period 4 - Washout||0||
48141420|NCT01454583|100670421|FG002|NOT COMPLETED|3rd Year||297||
48277172|NCT05618912|101003083|FG001|STARTED|Overall Study||74||
48563074|NCT01205269|101710087|FG001|NOT COMPLETED|Period 4 - Washout||0||
48563075|NCT01205269|101710088|FG002|NOT COMPLETED|Period 4 - Washout||0||
48563076|NCT01205269|101710089|FG003|NOT COMPLETED|Period 4 - Washout||1||
48563077|NCT01205269|101710090|FG004|NOT COMPLETED|Period 4 - Washout||0||
48563078|NCT01205269|101710091|FG005|NOT COMPLETED|Period 4 - Washout||0||
48563079|NCT01205269|101710086|FG000|STARTED|Period 5 - Third Intervention||4||
48563080|NCT01205269|101710087|FG001|STARTED|Period 5 - Third Intervention||4||
48563081|NCT01205269|101710088|FG002|STARTED|Period 5 - Third Intervention||4||
48563082|NCT01205269|101710089|FG003|STARTED|Period 5 - Third Intervention||5||
48563083|NCT01205269|101710090|FG004|STARTED|Period 5 - Third Intervention||5||
48563084|NCT01205269|101710091|FG005|STARTED|Period 5 - Third Intervention||5||
48563085|NCT01205269|101710086|FG000|COMPLETED|Period 5 - Third Intervention||4||
48563086|NCT01205269|101710087|FG001|COMPLETED|Period 5 - Third Intervention||4||
48563087|NCT01205269|101710088|FG002|COMPLETED|Period 5 - Third Intervention||4||
48563088|NCT01205269|101710089|FG003|COMPLETED|Period 5 - Third Intervention||5||
48277173|NCT05618912|101003082|FG000|COMPLETED|Overall Study||58||
48277174|NCT05618912|101003083|FG001|COMPLETED|Overall Study||55||
48277175|NCT05618912|101003082|FG000|NOT COMPLETED|Overall Study||14||
48277176|NCT05618912|101003083|FG001|NOT COMPLETED|Overall Study||19||
48277177|NCT04500769|101003084|FG000|STARTED|Overall Study||38||
48277178|NCT04500769|101003084|FG000|COMPLETED|Overall Study||33||
48277179|NCT04500769|101003084|FG000|NOT COMPLETED|Overall Study||5||
48277180|NCT02304705|101003085|FG000|STARTED|Overall Study||16||
48277181|NCT02304705|101003086|FG001|STARTED|Overall Study||17||
48277182|NCT02304705|101003085|FG000|COMPLETED|Overall Study||12||
48277183|NCT02304705|101003086|FG001|COMPLETED|Overall Study||10||
48277184|NCT02304705|101003085|FG000|NOT COMPLETED|Overall Study||4||
48277185|NCT02304705|101003086|FG001|NOT COMPLETED|Overall Study||7||
48277186|NCT00488475|101003087|FG000|STARTED|Overall Study||4945||
48277187|NCT00488475|101003087|FG000|COMPLETED|Overall Study||3191||
48277188|NCT00488475|101003087|FG000|NOT COMPLETED|Overall Study||1754||
48277189|NCT02065687|101003088|FG000|STARTED|Overall Study||234||
48277190|NCT02065687|101003089|FG001|STARTED|Overall Study||235||
48277191|NCT02065687|101003088|FG000|COMPLETED|Overall Study||234||
48277192|NCT02065687|101003089|FG001|COMPLETED|Overall Study||235||
48277193|NCT02065687|101003088|FG000|NOT COMPLETED|Overall Study||0||
48277194|NCT02065687|101003089|FG001|NOT COMPLETED|Overall Study||0||
48277195|NCT03363854|101003090|FG000|STARTED|Initial Treatment Period||253||
48277196|NCT03363854|101003091|FG001|STARTED|Initial Treatment Period||127||
48277197|NCT03363854|101003092|FG002|STARTED|Initial Treatment Period||0||
48277198|NCT03363854|101003093|FG003|STARTED|Initial Treatment Period||0||
48563089|NCT01205269|101710090|FG004|COMPLETED|Period 5 - Third Intervention||5||
48563090|NCT01205269|101710091|FG005|COMPLETED|Period 5 - Third Intervention||5||
48563091|NCT01205269|101710086|FG000|NOT COMPLETED|Period 5 - Third Intervention||0||
48563092|NCT01205269|101710087|FG001|NOT COMPLETED|Period 5 - Third Intervention||0||
48563093|NCT01205269|101710088|FG002|NOT COMPLETED|Period 5 - Third Intervention||0||
48563094|NCT01205269|101710089|FG003|NOT COMPLETED|Period 5 - Third Intervention||0||
48277199|NCT03363854|101003094|FG004|STARTED|Initial Treatment Period||0||
48277200|NCT03363854|101003095|FG005|STARTED|Initial Treatment Period||0||
48277201|NCT03363854|101003096|FG006|STARTED|Initial Treatment Period||0||
48277202|NCT03363854|101003097|FG007|STARTED|Initial Treatment Period||0||
48277203|NCT03363854|101003090|FG000|COMPLETED|Initial Treatment Period||235||
48277204|NCT03363854|101003091|FG001|COMPLETED|Initial Treatment Period||120||
48277205|NCT03363854|101003092|FG002|COMPLETED|Initial Treatment Period||0||
48277206|NCT03363854|101003093|FG003|COMPLETED|Initial Treatment Period||0||
48277207|NCT03363854|101003094|FG004|COMPLETED|Initial Treatment Period||0||
48277208|NCT03363854|101003095|FG005|COMPLETED|Initial Treatment Period||0||
48277209|NCT03363854|101003096|FG006|COMPLETED|Initial Treatment Period||0||
48277210|NCT03363854|101003097|FG007|COMPLETED|Initial Treatment Period||0||
48277211|NCT03363854|101003090|FG000|NOT COMPLETED|Initial Treatment Period||18||
48277212|NCT03363854|101003091|FG001|NOT COMPLETED|Initial Treatment Period||7||
48277213|NCT03363854|101003092|FG002|NOT COMPLETED|Initial Treatment Period||0||
48277214|NCT03363854|101003093|FG003|NOT COMPLETED|Initial Treatment Period||0||
48277215|NCT03363854|101003094|FG004|NOT COMPLETED|Initial Treatment Period||0||
48277216|NCT03363854|101003095|FG005|NOT COMPLETED|Initial Treatment Period||0||
48277217|NCT03363854|101003096|FG006|NOT COMPLETED|Initial Treatment Period||0||
48277218|NCT03363854|101003097|FG007|NOT COMPLETED|Initial Treatment Period||0||
48277219|NCT03363854|101003090|FG000|STARTED|Continuation Treatment Period||0|Between the inital and continuation treatment periods, 2 participants discontinued treatment.|
48277220|NCT03363854|101003091|FG001|STARTED|Continuation Treatment Period||0|Between the inital and continuation treatment periods, 2 participants discontinued treatment.|
48277221|NCT03363854|101003092|FG002|STARTED|Continuation Treatment Period||69|Between the inital and continuation treatment periods, 2 participants discontinued treatment.|
48277222|NCT03363854|101003093|FG003|STARTED|Continuation Treatment Period||69|Between the inital and continuation treatment periods, 2 participants discontinued treatment.|
48277223|NCT03363854|101003094|FG004|STARTED|Continuation Treatment Period||95|Between the inital and continuation treatment periods, 2 participants discontinued treatment.|
48277224|NCT03363854|101003095|FG005|STARTED|Continuation Treatment Period||79|Between the inital and continuation treatment periods, 2 participants discontinued treatment.|
48277225|NCT03363854|101003096|FG006|STARTED|Continuation Treatment Period||41|Between the inital and continuation treatment periods, 2 participants discontinued treatment.|
48277226|NCT03363854|101003097|FG007|STARTED|Continuation Treatment Period||0|Between the inital and continuation treatment periods, 2 participants discontinued treatment.|
48277227|NCT03363854|101003090|FG000|COMPLETED|Continuation Treatment Period||0||
48277228|NCT03363854|101003091|FG001|COMPLETED|Continuation Treatment Period||0||
48277229|NCT03363854|101003092|FG002|COMPLETED|Continuation Treatment Period||68||
48277230|NCT03363854|101003093|FG003|COMPLETED|Continuation Treatment Period||65||
48277231|NCT03363854|101003094|FG004|COMPLETED|Continuation Treatment Period||87||
48113636|NCT01604343|100604991|FG003|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0||
48113637|NCT01604343|100604992|FG004|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0||
48277232|NCT03363854|101003095|FG005|COMPLETED|Continuation Treatment Period||72||
48277233|NCT03363854|101003096|FG006|COMPLETED|Continuation Treatment Period||38||
48563095|NCT01205269|101710090|FG004|NOT COMPLETED|Period 5 - Third Intervention||0||
48563096|NCT01205269|101710091|FG005|NOT COMPLETED|Period 5 - Third Intervention||0||
48563097|NCT00848718|101710092|FG000|STARTED|Overall Study||7||
48563098|NCT00848718|101710093|FG001|STARTED|Overall Study||9||
48563099|NCT00848718|101710094|FG002|STARTED|Overall Study||6||
48563100|NCT00848718|101710095|FG003|STARTED|Overall Study||5||
48563101|NCT00848718|101710096|FG004|STARTED|Overall Study||6||
48563102|NCT00848718|101710097|FG005|STARTED|Overall Study||5||
48563103|NCT00848718|101710098|FG006|STARTED|Overall Study||3||
48563104|NCT00848718|101710099|FG007|STARTED|Overall Study||5||
48563105|NCT00848718|101710100|FG008|STARTED|Overall Study||4||
48563106|NCT00848718|101710101|FG009|STARTED|Overall Study||9||
48563107|NCT00848718|101710102|FG010|STARTED|Overall Study||4||
48563108|NCT00848718|101710103|FG011|STARTED|Overall Study||6||
48563109|NCT00848718|101710104|FG012|STARTED|Overall Study||8||
48563110|NCT00848718|101710092|FG000|Treated|Overall Study||6||
48563111|NCT00848718|101710093|FG001|Treated|Overall Study||9||
48563112|NCT00848718|101710094|FG002|Treated|Overall Study||5||
48113638|NCT01604343|100604988|FG000|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||24||
48113639|NCT01604343|100604989|FG001|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0||
48113640|NCT01604343|100604990|FG002|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0||
48113641|NCT01604343|100604991|FG003|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0||
48113642|NCT01604343|100604992|FG004|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0||
48113643|NCT01604343|100604988|FG000|COMPLETED|Prior to W52 Administration(Through W52)||458||
48113644|NCT01604343|100604989|FG001|COMPLETED|Prior to W52 Administration(Through W52)||0||
48113645|NCT01604343|100604990|FG002|COMPLETED|Prior to W52 Administration(Through W52)||481||
48113646|NCT01604343|100604991|FG003|COMPLETED|Prior to W52 Administration(Through W52)||0||
48113647|NCT01604343|100604992|FG004|COMPLETED|Prior to W52 Administration(Through W52)||470||
48113648|NCT01604343|100604988|FG000|NOT COMPLETED|Prior to W52 Administration(Through W52)||98||
48113649|NCT01604343|100604989|FG001|NOT COMPLETED|Prior to W52 Administration(Through W52)||0||
48113650|NCT01604343|100604990|FG002|NOT COMPLETED|Prior to W52 Administration(Through W52)||76||
48113651|NCT01604343|100604991|FG003|NOT COMPLETED|Prior to W52 Administration(Through W52)||0||
48113652|NCT01604343|100604992|FG004|NOT COMPLETED|Prior to W52 Administration(Through W52)||87||
48113653|NCT01604343|100604988|FG000|STARTED|Week 52 to Week 104||0||
48113654|NCT01604343|100604989|FG001|STARTED|Week 52 to Week 104||243||
48113655|NCT01604343|100604990|FG002|STARTED|Week 52 to Week 104||481||
48113656|NCT01604343|100604991|FG003|STARTED|Week 52 to Week 104||241||
48563113|NCT00848718|101710095|FG003|Treated|Overall Study||5||
48563114|NCT00848718|101710096|FG004|Treated|Overall Study||6||
48563115|NCT00848718|101710097|FG005|Treated|Overall Study||5||
48113657|NCT01604343|100604992|FG004|STARTED|Week 52 to Week 104||470||
48113658|NCT01604343|100604988|FG000|Treated|Week 52 to Week 104||0||
48113659|NCT01604343|100604989|FG001|Treated|Week 52 to Week 104||242||
48113660|NCT01604343|100604990|FG002|Treated|Week 52 to Week 104||481||
48113661|NCT01604343|100604991|FG003|Treated|Week 52 to Week 104||241||
48113662|NCT01604343|100604992|FG004|Treated|Week 52 to Week 104||470||
48113663|NCT01604343|100604988|FG000|COMPLETED|Week 52 to Week 104||0||
48113664|NCT01604343|100604989|FG001|COMPLETED|Week 52 to Week 104||200||
48113665|NCT01604343|100604990|FG002|COMPLETED|Week 52 to Week 104||414||
48113666|NCT01604343|100604991|FG003|COMPLETED|Week 52 to Week 104||195||
48113667|NCT01604343|100604992|FG004|COMPLETED|Week 52 to Week 104||429||
48113668|NCT01604343|100604988|FG000|NOT COMPLETED|Week 52 to Week 104||0||
48113669|NCT01604343|100604989|FG001|NOT COMPLETED|Week 52 to Week 104||43||
48113670|NCT01604343|100604990|FG002|NOT COMPLETED|Week 52 to Week 104||67||
48113671|NCT01604343|100604991|FG003|NOT COMPLETED|Week 52 to Week 104||46||
48113672|NCT01604343|100604992|FG004|NOT COMPLETED|Week 52 to Week 104||41||
48113673|NCT01604343|100604988|FG000|STARTED|Safety Follow-up Period (Week 104-120)||109||
48113674|NCT01604343|100604989|FG001|STARTED|Safety Follow-up Period (Week 104-120)||27||
48113675|NCT01604343|100604990|FG002|STARTED|Safety Follow-up Period (Week 104-120)||105||
48113676|NCT01604343|100604991|FG003|STARTED|Safety Follow-up Period (Week 104-120)||36||
48563116|NCT00848718|101710098|FG006|Treated|Overall Study||3||
48563117|NCT00848718|101710099|FG007|Treated|Overall Study||4||
48113677|NCT01604343|100604992|FG004|STARTED|Safety Follow-up Period (Week 104-120)||114||
48113678|NCT01604343|100604988|FG000|Safety Population|Safety Follow-up Period (Week 104-120)||109||
48113679|NCT01604343|100604989|FG001|Safety Population|Safety Follow-up Period (Week 104-120)||26||
48113680|NCT01604343|100604990|FG002|Safety Population|Safety Follow-up Period (Week 104-120)||105||
48113681|NCT01604343|100604991|FG003|Safety Population|Safety Follow-up Period (Week 104-120)||36||
48113682|NCT01604343|100604992|FG004|Safety Population|Safety Follow-up Period (Week 104-120)||114||
48113683|NCT01604343|100604988|FG000|COMPLETED|Safety Follow-up Period (Week 104-120)||79||
48113684|NCT01604343|100604989|FG001|COMPLETED|Safety Follow-up Period (Week 104-120)||20||
48113685|NCT01604343|100604990|FG002|COMPLETED|Safety Follow-up Period (Week 104-120)||72||
48563118|NCT00848718|101710100|FG008|Treated|Overall Study||4||
48113686|NCT01604343|100604991|FG003|COMPLETED|Safety Follow-up Period (Week 104-120)||26||
48113687|NCT01604343|100604992|FG004|COMPLETED|Safety Follow-up Period (Week 104-120)||85||
48113688|NCT01604343|100604988|FG000|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||30||
48113689|NCT01604343|100604989|FG001|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||7||
48113690|NCT01604343|100604990|FG002|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||33||
48113691|NCT01604343|100604991|FG003|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||10||
48113692|NCT01604343|100604992|FG004|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||29||
48113693|NCT00075829|100604993|FG000|STARTED|Overall Study||436||
48113694|NCT00075829|100604994|FG001|STARTED|Overall Study||189||
48113695|NCT00075829|100604995|FG002|STARTED|Overall Study||48||
48113696|NCT00075829|100604996|FG003|STARTED|Overall Study||37||
48113697|NCT00075829|100604993|FG000|COMPLETED|Overall Study||178||
48113698|NCT00075829|100604994|FG001|COMPLETED|Overall Study||71||
48113699|NCT00075829|100604995|FG002|COMPLETED|Overall Study||14||
48113700|NCT00075829|100604996|FG003|COMPLETED|Overall Study||13||
48113701|NCT00075829|100604993|FG000|NOT COMPLETED|Overall Study||258||
48113702|NCT00075829|100604994|FG001|NOT COMPLETED|Overall Study||118||
48113703|NCT00075829|100604995|FG002|NOT COMPLETED|Overall Study||34||
48113704|NCT00075829|100604996|FG003|NOT COMPLETED|Overall Study||24||
48113705|NCT00749463|100604997|FG000|STARTED|Overall Study||86||
48113706|NCT00749463|100604998|FG001|STARTED|Overall Study||64||
48113707|NCT00749463|100604999|FG002|STARTED|Overall Study||150||
48113708|NCT00749463|100604997|FG000|COMPLETED|Overall Study||85||
48113709|NCT00749463|100604998|FG001|COMPLETED|Overall Study||60||
48563119|NCT00848718|101710101|FG009|Treated|Overall Study||9||
48563120|NCT00848718|101710102|FG010|Treated|Overall Study||4||
48563121|NCT00848718|101710103|FG011|Treated|Overall Study||6||
48113710|NCT00749463|100604999|FG002|COMPLETED|Overall Study||149||
48113711|NCT00749463|100604997|FG000|NOT COMPLETED|Overall Study||1||
48113712|NCT00749463|100604998|FG001|NOT COMPLETED|Overall Study||4||
48113713|NCT00749463|100604999|FG002|NOT COMPLETED|Overall Study||1||
48113714|NCT04733157|100605000|FG000|STARTED|Overall Study||613||
48113715|NCT04733157|100605001|FG001|STARTED|Overall Study||613||
48113716|NCT04733157|100605000|FG000|COMPLETED|Overall Study||611||
48113717|NCT04733157|100605001|FG001|COMPLETED|Overall Study||613||
48113718|NCT04733157|100605000|FG000|NOT COMPLETED|Overall Study||2||
48113719|NCT04733157|100605001|FG001|NOT COMPLETED|Overall Study||0||
48113720|NCT02800148|100605002|FG000|STARTED|Overall Study||224||
48113721|NCT02800148|100605003|FG001|STARTED|Overall Study||224||
48113722|NCT02800148|100605004|FG002|STARTED|Overall Study||219||
48113723|NCT02800148|100605002|FG000|COMPLETED|Overall Study||199||
48113724|NCT02800148|100605003|FG001|COMPLETED|Overall Study||204||
48113725|NCT02800148|100605004|FG002|COMPLETED|Overall Study||194||
48113726|NCT02800148|100605002|FG000|NOT COMPLETED|Overall Study||25||
48113727|NCT02800148|100605003|FG001|NOT COMPLETED|Overall Study||20||
48113728|NCT02800148|100605004|FG002|NOT COMPLETED|Overall Study||25||
48113729|NCT01495481|100605005|FG000|STARTED|Adenosine||22||
48113730|NCT01495481|100605005|FG000|COMPLETED|Adenosine||22||
48113731|NCT01495481|100605005|FG000|NOT COMPLETED|Adenosine||0||
48113732|NCT01495481|100605005|FG000|STARTED|Washout||22||
48113733|NCT01495481|100605005|FG000|COMPLETED|Washout||22||
48113734|NCT01495481|100605005|FG000|NOT COMPLETED|Washout||0||
48113735|NCT01495481|100605005|FG000|STARTED|Dexmedetomidine||22||
48113736|NCT01495481|100605005|FG000|COMPLETED|Dexmedetomidine||22||
48113737|NCT01495481|100605005|FG000|NOT COMPLETED|Dexmedetomidine||0||
48113738|NCT02719158|100605006|FG000|STARTED|Overall Study||38||
48113739|NCT02719158|100605007|FG001|STARTED|Overall Study||38||
48113740|NCT02719158|100605008|FG002|STARTED|Overall Study||19||
48113741|NCT02719158|100605006|FG000|COMPLETED|Overall Study||38||
48113742|NCT02719158|100605007|FG001|COMPLETED|Overall Study||38||
48113743|NCT02719158|100605008|FG002|COMPLETED|Overall Study||18||
48113744|NCT02719158|100605006|FG000|NOT COMPLETED|Overall Study||0||
48113745|NCT02719158|100605007|FG001|NOT COMPLETED|Overall Study||0||
48113746|NCT02719158|100605008|FG002|NOT COMPLETED|Overall Study||1||
48113747|NCT01533246|100605009|FG000|STARTED|Overall Study||17||
48113748|NCT01533246|100605009|FG000|COMPLETED|Overall Study||15||
48563122|NCT00848718|101710104|FG012|Treated|Overall Study||6||
48113749|NCT01533246|100605009|FG000|NOT COMPLETED|Overall Study||2||
48113750|NCT00134381|100605010|FG000|STARTED|Overall Study||1||
48277234|NCT03363854|101003097|FG007|COMPLETED|Continuation Treatment Period||0||
48563123|NCT00848718|101710092|FG000|COMPLETED|Overall Study||0||
48563124|NCT00848718|101710093|FG001|COMPLETED|Overall Study||0||
48563125|NCT00848718|101710094|FG002|COMPLETED|Overall Study||0||
48563126|NCT00848718|101710095|FG003|COMPLETED|Overall Study||0||
48563127|NCT00848718|101710096|FG004|COMPLETED|Overall Study||0||
48563128|NCT00848718|101710097|FG005|COMPLETED|Overall Study||0||
48563129|NCT00848718|101710098|FG006|COMPLETED|Overall Study||0||
48113751|NCT00134381|100605011|FG001|STARTED|Overall Study||2||
48113752|NCT00134381|100605012|FG002|STARTED|Overall Study||1||
48113753|NCT00134381|100605013|FG003|STARTED|Overall Study||2||
48113754|NCT00134381|100605014|FG004|STARTED|Overall Study||31||
48113755|NCT00134381|100605015|FG005|STARTED|Overall Study||31||
48113756|NCT00134381|100605010|FG000|COMPLETED|Overall Study||1||
48113757|NCT00134381|100605011|FG001|COMPLETED|Overall Study||2||
48113758|NCT00134381|100605012|FG002|COMPLETED|Overall Study||1||
48113759|NCT00134381|100605013|FG003|COMPLETED|Overall Study||2||
48113760|NCT00134381|100605014|FG004|COMPLETED|Overall Study||31||
48113761|NCT00134381|100605015|FG005|COMPLETED|Overall Study||29||
48113762|NCT00134381|100605010|FG000|NOT COMPLETED|Overall Study||0||
48113763|NCT00134381|100605011|FG001|NOT COMPLETED|Overall Study||0||
48113764|NCT00134381|100605012|FG002|NOT COMPLETED|Overall Study||0||
48563130|NCT00848718|101710099|FG007|COMPLETED|Overall Study||0||
48563131|NCT00848718|101710100|FG008|COMPLETED|Overall Study||0||
48113765|NCT00134381|100605013|FG003|NOT COMPLETED|Overall Study||0||
48113766|NCT00134381|100605014|FG004|NOT COMPLETED|Overall Study||0||
48113767|NCT00134381|100605015|FG005|NOT COMPLETED|Overall Study||2||
48277235|NCT03363854|101003090|FG000|NOT COMPLETED|Continuation Treatment Period||0||
48563132|NCT00848718|101710101|FG009|COMPLETED|Overall Study||0||
48563133|NCT00848718|101710102|FG010|COMPLETED|Overall Study||0||
48563134|NCT00848718|101710103|FG011|COMPLETED|Overall Study||0||
48113768|NCT01010282|100605016|FG000|STARTED|Overall Study||97||
48113769|NCT01010282|100605017|FG001|STARTED|Overall Study||95||
48113770|NCT01010282|100605018|FG002|STARTED|Overall Study||96||
48113771|NCT01010282|100605016|FG000|COMPLETED|Overall Study||91||
48113772|NCT01010282|100605017|FG001|COMPLETED|Overall Study||88||
48113773|NCT01010282|100605018|FG002|COMPLETED|Overall Study||77||
48113774|NCT01010282|100605016|FG000|NOT COMPLETED|Overall Study||6||
48113775|NCT01010282|100605017|FG001|NOT COMPLETED|Overall Study||7||
48113776|NCT01010282|100605018|FG002|NOT COMPLETED|Overall Study||19||
48113777|NCT02378844|100605019|FG000|STARTED|Run-in Period||169||
48113778|NCT02378844|100605020|FG001|STARTED|Run-in Period||172||
48113779|NCT02378844|100605021|FG002|STARTED|Run-in Period||136||
48113780|NCT02378844|100605019|FG000|COMPLETED|Run-in Period||165||
48113781|NCT02378844|100605020|FG001|COMPLETED|Run-in Period||167||
48113782|NCT02378844|100605021|FG002|COMPLETED|Run-in Period||0||
48113783|NCT02378844|100605019|FG000|NOT COMPLETED|Run-in Period||4||
48563135|NCT00848718|101710104|FG012|COMPLETED|Overall Study||0||
48563136|NCT00848718|101710092|FG000|NOT COMPLETED|Overall Study||7||
48563137|NCT00848718|101710093|FG001|NOT COMPLETED|Overall Study||9||
48113784|NCT02378844|100605020|FG001|NOT COMPLETED|Run-in Period||5||
48113785|NCT02378844|100605021|FG002|NOT COMPLETED|Run-in Period||136||
48113786|NCT02378844|100605019|FG000|STARTED|Randomized Period (Double Blind)||165||
48113787|NCT02378844|100605020|FG001|STARTED|Randomized Period (Double Blind)||167||
48113788|NCT02378844|100605021|FG002|STARTED|Randomized Period (Double Blind)||0||
48113789|NCT02378844|100605019|FG000|COMPLETED|Randomized Period (Double Blind)||142||
48113790|NCT02378844|100605020|FG001|COMPLETED|Randomized Period (Double Blind)||135||
48113791|NCT02378844|100605021|FG002|COMPLETED|Randomized Period (Double Blind)||0||
48113792|NCT02378844|100605019|FG000|NOT COMPLETED|Randomized Period (Double Blind)||23||
48113793|NCT02378844|100605020|FG001|NOT COMPLETED|Randomized Period (Double Blind)||32||
48113794|NCT02378844|100605021|FG002|NOT COMPLETED|Randomized Period (Double Blind)||0||
48113795|NCT02378844|100605019|FG000|STARTED|Open Label Period||142||
48113796|NCT02378844|100605020|FG001|STARTED|Open Label Period||135||
48113797|NCT02378844|100605021|FG002|STARTED|Open Label Period||0||
48113798|NCT02378844|100605019|FG000|COMPLETED|Open Label Period||99||
48113799|NCT02378844|100605020|FG001|COMPLETED|Open Label Period||87||
48113800|NCT02378844|100605021|FG002|COMPLETED|Open Label Period||0||
48113801|NCT02378844|100605019|FG000|NOT COMPLETED|Open Label Period||43||
48113802|NCT02378844|100605020|FG001|NOT COMPLETED|Open Label Period||48||
48113803|NCT02378844|100605021|FG002|NOT COMPLETED|Open Label Period||0||
48113804|NCT01020019|100605022|FG000|STARTED|Overall Study||61||
48113805|NCT01020019|100605023|FG001|STARTED|Overall Study||61||
48113806|NCT01020019|100605022|FG000|COMPLETED|Overall Study||35||
48113807|NCT01020019|100605023|FG001|COMPLETED|Overall Study||32||
48113808|NCT01020019|100605022|FG000|NOT COMPLETED|Overall Study||26||
48113809|NCT01020019|100605023|FG001|NOT COMPLETED|Overall Study||29||
48113810|NCT00953329|100605024|FG000|STARTED|Overall Study||1||
48113811|NCT00953329|100605024|FG000|COMPLETED|Overall Study||0||
48113812|NCT00953329|100605024|FG000|NOT COMPLETED|Overall Study||1||
48113813|NCT02178475|100605025|FG000|STARTED|Overall Study||943||
48113814|NCT02178475|100605025|FG000|Primary Analysis Set|Overall Study||844||
48277236|NCT03363854|101003091|FG001|NOT COMPLETED|Continuation Treatment Period||0||
48277237|NCT03363854|101003092|FG002|NOT COMPLETED|Continuation Treatment Period||1||
48277238|NCT03363854|101003093|FG003|NOT COMPLETED|Continuation Treatment Period||4||
48563138|NCT00848718|101710094|FG002|NOT COMPLETED|Overall Study||6||
48113815|NCT02178475|100605025|FG000|COMPLETED|Overall Study||814||
48113816|NCT02178475|100605025|FG000|NOT COMPLETED|Overall Study||129||
48113817|NCT04587193|100605026|FG000|STARTED|Overall Study||6||
48277239|NCT03363854|101003094|FG004|NOT COMPLETED|Continuation Treatment Period||8||
48277240|NCT03363854|101003095|FG005|NOT COMPLETED|Continuation Treatment Period||7||
48563139|NCT00848718|101710095|FG003|NOT COMPLETED|Overall Study||5||
48563140|NCT00848718|101710096|FG004|NOT COMPLETED|Overall Study||6||
48563141|NCT00848718|101710097|FG005|NOT COMPLETED|Overall Study||5||
48563142|NCT00848718|101710098|FG006|NOT COMPLETED|Overall Study||3||
48563143|NCT00848718|101710099|FG007|NOT COMPLETED|Overall Study||5||
48563144|NCT00848718|101710100|FG008|NOT COMPLETED|Overall Study||4||
48563145|NCT00848718|101710101|FG009|NOT COMPLETED|Overall Study||9||
48563146|NCT00848718|101710102|FG010|NOT COMPLETED|Overall Study||4||
48563147|NCT00848718|101710103|FG011|NOT COMPLETED|Overall Study||6||
48563148|NCT00848718|101710104|FG012|NOT COMPLETED|Overall Study||8||
48563149|NCT02170220|101710105|FG000|STARTED|Overall Study||6||
48696761|NCT02712983|102041810|FG008|STARTED|Post-Treatment Efficacy Follow-Up Phase||0|All patients who discontinued treatment and entered Post-Treatment Efficacy Follow-Up Phase|
48563150|NCT02170220|101710106|FG001|STARTED|Overall Study||6||
48696762|NCT02712983|102041802|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
48696763|NCT02712983|102041803|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
48696764|NCT02712983|102041804|FG002|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
48696765|NCT02712983|102041805|FG003|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
48696766|NCT02712983|102041806|FG004|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
48277241|NCT03363854|101003096|FG006|NOT COMPLETED|Continuation Treatment Period||3||
48277242|NCT03363854|101003097|FG007|NOT COMPLETED|Continuation Treatment Period||0||
48277243|NCT03363854|101003090|FG000|STARTED|Safety Follow-up Period||0||
48277244|NCT03363854|101003091|FG001|STARTED|Safety Follow-up Period||0||
48277245|NCT03363854|101003092|FG002|STARTED|Safety Follow-up Period||0||
48393974|NCT04449276|101295837|FG003|COMPLETED|Overall Study||46||
48393975|NCT04449276|101295838|FG004|COMPLETED|Overall Study||26||
48393976|NCT04449276|101295839|FG005|COMPLETED|Overall Study||16||
48113818|NCT04587193|100605027|FG001|STARTED|Overall Study||2||
48113819|NCT04587193|100605026|FG000|COMPLETED|Overall Study||0||
48113820|NCT04587193|100605027|FG001|COMPLETED|Overall Study||0||
48393977|NCT04449276|101295840|FG006|COMPLETED|Overall Study||12||
48393978|NCT04449276|101295841|FG007|COMPLETED|Overall Study||30||
48393979|NCT04449276|101295834|FG000|NOT COMPLETED|Overall Study||3||
48393980|NCT04449276|101295835|FG001|NOT COMPLETED|Overall Study||4||
48393981|NCT04449276|101295836|FG002|NOT COMPLETED|Overall Study||3||
48393982|NCT04449276|101295837|FG003|NOT COMPLETED|Overall Study||3||
48563151|NCT02170220|101710105|FG000|COMPLETED|Overall Study||6||
48113821|NCT04587193|100605026|FG000|NOT COMPLETED|Overall Study||6||
48113822|NCT04587193|100605027|FG001|NOT COMPLETED|Overall Study||2||
48113823|NCT02967367|100605028|FG000|STARTED|Overall Study||36||
48113824|NCT02967367|100605028|FG000|COMPLETED|Overall Study||22||
48113825|NCT02967367|100605028|FG000|NOT COMPLETED|Overall Study||14||
48113826|NCT01193907|100605029|FG000|STARTED|Overall Study||22||
48113827|NCT01193907|100605030|FG001|STARTED|Overall Study||22||
48113828|NCT01193907|100605031|FG002|STARTED|Overall Study||22||
48113829|NCT01193907|100605032|FG003|STARTED|Overall Study||22||
48113830|NCT01193907|100605029|FG000|COMPLETED|Overall Study||21||
48113831|NCT01193907|100605030|FG001|COMPLETED|Overall Study||22||
48113832|NCT01193907|100605031|FG002|COMPLETED|Overall Study||22||
48113833|NCT01193907|100605032|FG003|COMPLETED|Overall Study||21||
48113834|NCT01193907|100605029|FG000|NOT COMPLETED|Overall Study||1||
48113835|NCT01193907|100605030|FG001|NOT COMPLETED|Overall Study||0||
48563152|NCT02170220|101710106|FG001|COMPLETED|Overall Study||6||
48563153|NCT02170220|101710105|FG000|NOT COMPLETED|Overall Study||0||
48563154|NCT02170220|101710106|FG001|NOT COMPLETED|Overall Study||0||
48563155|NCT01567462|101710107|FG000|STARTED|Overall Study||45||
48563156|NCT01567462|101710108|FG001|STARTED|Overall Study||45||
48563157|NCT01567462|101710107|FG000|COMPLETED|Overall Study||41||
48563158|NCT01567462|101710108|FG001|COMPLETED|Overall Study||38||
48563159|NCT01567462|101710107|FG000|NOT COMPLETED|Overall Study||4||
48563160|NCT01567462|101710108|FG001|NOT COMPLETED|Overall Study||7||
48563161|NCT02837731|101710109|FG000|STARTED|Allocation||102||
48563162|NCT02837731|101710110|FG001|STARTED|Allocation||48||
48563163|NCT02837731|101710109|FG000|COMPLETED|Allocation||83||
48563164|NCT02837731|101710110|FG001|COMPLETED|Allocation||41||
48563165|NCT02837731|101710109|FG000|NOT COMPLETED|Allocation||19||
48563166|NCT02837731|101710110|FG001|NOT COMPLETED|Allocation||7||
48710817|NCT00884910|102078028|FG000|COMPLETED|Overall Study||32||
48113836|NCT01193907|100605031|FG002|NOT COMPLETED|Overall Study||0||
48113837|NCT01193907|100605032|FG003|NOT COMPLETED|Overall Study||1||
48113838|NCT01454934|100605033|FG000|STARTED|Overall Study||270||
48113839|NCT01454934|100605034|FG001|STARTED|Overall Study||270||
48113840|NCT01454934|100605033|FG000|COMPLETED|Overall Study||0||
48113841|NCT01454934|100605034|FG001|COMPLETED|Overall Study||0||
48113842|NCT01454934|100605033|FG000|NOT COMPLETED|Overall Study||270||
48113843|NCT01454934|100605034|FG001|NOT COMPLETED|Overall Study||270||
48113844|NCT00754247|100605035|FG000|STARTED|Overall Study||10||
48113845|NCT00754247|100605036|FG001|STARTED|Overall Study||10||
48113846|NCT00754247|100605037|FG002|STARTED|Overall Study||10||
48113847|NCT00754247|100605035|FG000|COMPLETED|Overall Study||5||
48113848|NCT00754247|100605036|FG001|COMPLETED|Overall Study||5||
48113849|NCT00754247|100605037|FG002|COMPLETED|Overall Study||5||
48113850|NCT00754247|100605035|FG000|NOT COMPLETED|Overall Study||5||
48113851|NCT00754247|100605036|FG001|NOT COMPLETED|Overall Study||5||
48113852|NCT00754247|100605037|FG002|NOT COMPLETED|Overall Study||5||
48113853|NCT01252290|100605038|FG000|STARTED|Overall Study||35||
48113854|NCT01252290|100605038|FG000|COMPLETED|Overall Study||34||
48113855|NCT01252290|100605038|FG000|NOT COMPLETED|Overall Study||1||
48113856|NCT01632891|100605039|FG000|STARTED|Overall Study||26||
48113857|NCT01632891|100605040|FG001|STARTED|Overall Study||26||
48113858|NCT01632891|100605039|FG000|COMPLETED|Overall Study||25||
48277246|NCT03363854|101003093|FG003|STARTED|Safety Follow-up Period||0||
48277247|NCT03363854|101003094|FG004|STARTED|Safety Follow-up Period||0||
48277248|NCT03363854|101003095|FG005|STARTED|Safety Follow-up Period||0||
48277249|NCT03363854|101003096|FG006|STARTED|Safety Follow-up Period||0||
48277250|NCT03363854|101003097|FG007|STARTED|Safety Follow-up Period||278||
48277251|NCT03363854|101003090|FG000|COMPLETED|Safety Follow-up Period||0|Of the 278 participants who started safety follow-up, 180 transferred to the extension trial.|
48294165|NCT02527343|101047539|FG003|COMPLETED|OLE Period-Year 2: Week 105 to 156||0||
48393983|NCT04449276|101295838|FG004|NOT COMPLETED|Overall Study||2||
48393984|NCT04449276|101295839|FG005|NOT COMPLETED|Overall Study||0||
48393985|NCT04449276|101295840|FG006|NOT COMPLETED|Overall Study||0||
48563167|NCT02837731|101710109|FG000|STARTED|Follow-up||83||
48113859|NCT01632891|100605040|FG001|COMPLETED|Overall Study||25||
48277252|NCT03363854|101003091|FG001|COMPLETED|Safety Follow-up Period||0|Of the 278 participants who started safety follow-up, 180 transferred to the extension trial.|
48277253|NCT03363854|101003092|FG002|COMPLETED|Safety Follow-up Period||0|Of the 278 participants who started safety follow-up, 180 transferred to the extension trial.|
48277254|NCT03363854|101003093|FG003|COMPLETED|Safety Follow-up Period||0|Of the 278 participants who started safety follow-up, 180 transferred to the extension trial.|
48277255|NCT03363854|101003094|FG004|COMPLETED|Safety Follow-up Period||0|Of the 278 participants who started safety follow-up, 180 transferred to the extension trial.|
48277256|NCT03363854|101003095|FG005|COMPLETED|Safety Follow-up Period||0|Of the 278 participants who started safety follow-up, 180 transferred to the extension trial.|
48277257|NCT03363854|101003096|FG006|COMPLETED|Safety Follow-up Period||0|Of the 278 participants who started safety follow-up, 180 transferred to the extension trial.|
48277258|NCT03363854|101003097|FG007|COMPLETED|Safety Follow-up Period||62|Of the 278 participants who started safety follow-up, 180 transferred to the extension trial.|
48277259|NCT03363854|101003090|FG000|NOT COMPLETED|Safety Follow-up Period||0||
48277260|NCT03363854|101003091|FG001|NOT COMPLETED|Safety Follow-up Period||0||
48277261|NCT03363854|101003092|FG002|NOT COMPLETED|Safety Follow-up Period||0||
48277262|NCT03363854|101003093|FG003|NOT COMPLETED|Safety Follow-up Period||0||
48277263|NCT03363854|101003094|FG004|NOT COMPLETED|Safety Follow-up Period||0||
48277264|NCT03363854|101003095|FG005|NOT COMPLETED|Safety Follow-up Period||0||
48277265|NCT03363854|101003096|FG006|NOT COMPLETED|Safety Follow-up Period||0||
48277266|NCT03363854|101003097|FG007|NOT COMPLETED|Safety Follow-up Period||216||
48277267|NCT00704405|101003098|FG000|STARTED|Overall Study (NC Population)||42||
48277268|NCT00704405|101003099|FG001|STARTED|Overall Study (NC Population)||44||
48277269|NCT00704405|101003100|FG002|STARTED|Overall Study (NC Population)||41||
48277270|NCT00704405|101003101|FG003|STARTED|Overall Study (NC Population)||42||
48277271|NCT00704405|101003102|FG004|STARTED|Overall Study (NC Population)||42||
48277272|NCT00704405|101003098|FG000|COMPLETED|Overall Study (NC Population)||37||
48277273|NCT00704405|101003099|FG001|COMPLETED|Overall Study (NC Population)||40||
48277274|NCT00704405|101003100|FG002|COMPLETED|Overall Study (NC Population)||38||
48277275|NCT00704405|101003101|FG003|COMPLETED|Overall Study (NC Population)||38||
48277276|NCT00704405|101003102|FG004|COMPLETED|Overall Study (NC Population)||37||
48277277|NCT00704405|101003098|FG000|NOT COMPLETED|Overall Study (NC Population)||5||
48277278|NCT00704405|101003099|FG001|NOT COMPLETED|Overall Study (NC Population)||4||
48277279|NCT00704405|101003100|FG002|NOT COMPLETED|Overall Study (NC Population)||3||
48277280|NCT00704405|101003101|FG003|NOT COMPLETED|Overall Study (NC Population)||4||
48277281|NCT00704405|101003102|FG004|NOT COMPLETED|Overall Study (NC Population)||5||
48277282|NCT00704405|101003098|FG000|STARTED|Overall Study (C Population)||16||
48277283|NCT00704405|101003099|FG001|STARTED|Overall Study (C Population)||14||
48277284|NCT00704405|101003100|FG002|STARTED|Overall Study (C Population)||15||
48277285|NCT00704405|101003101|FG003|STARTED|Overall Study (C Population)||15||
48277286|NCT00704405|101003102|FG004|STARTED|Overall Study (C Population)||14||
48277287|NCT00704405|101003098|FG000|COMPLETED|Overall Study (C Population)||15||
48277288|NCT00704405|101003099|FG001|COMPLETED|Overall Study (C Population)||11||
48277289|NCT00704405|101003100|FG002|COMPLETED|Overall Study (C Population)||14||
48277290|NCT00704405|101003101|FG003|COMPLETED|Overall Study (C Population)||14||
48277291|NCT00704405|101003102|FG004|COMPLETED|Overall Study (C Population)||14||
48277292|NCT00704405|101003098|FG000|NOT COMPLETED|Overall Study (C Population)||1||
48277293|NCT00704405|101003099|FG001|NOT COMPLETED|Overall Study (C Population)||3||
48277294|NCT00704405|101003100|FG002|NOT COMPLETED|Overall Study (C Population)||1||
48277295|NCT00704405|101003101|FG003|NOT COMPLETED|Overall Study (C Population)||1||
48277296|NCT00704405|101003102|FG004|NOT COMPLETED|Overall Study (C Population)||0||
48277297|NCT00979576|101003103|FG000|STARTED|Combination Treatment Phase||3||
48277298|NCT00979576|101003104|FG001|STARTED|Combination Treatment Phase||6||
48277299|NCT00979576|101003105|FG002|STARTED|Combination Treatment Phase||9||
48277300|NCT00979576|101003103|FG000|COMPLETED|Combination Treatment Phase||0||
48277301|NCT00979576|101003104|FG001|COMPLETED|Combination Treatment Phase||0||
48277302|NCT00979576|101003105|FG002|COMPLETED|Combination Treatment Phase||0||
48277303|NCT00979576|101003103|FG000|NOT COMPLETED|Combination Treatment Phase||3||
48277304|NCT00979576|101003104|FG001|NOT COMPLETED|Combination Treatment Phase||6||
48277305|NCT00979576|101003105|FG002|NOT COMPLETED|Combination Treatment Phase||9||
48277306|NCT00979576|101003103|FG000|STARTED|Combination Followed by Monotherapy||0||
48277307|NCT00979576|101003104|FG001|STARTED|Combination Followed by Monotherapy||2||
48277308|NCT00979576|101003105|FG002|STARTED|Combination Followed by Monotherapy||1||
48277309|NCT00979576|101003103|FG000|COMPLETED|Combination Followed by Monotherapy||0||
48277310|NCT00979576|101003104|FG001|COMPLETED|Combination Followed by Monotherapy||0||
48277311|NCT00979576|101003105|FG002|COMPLETED|Combination Followed by Monotherapy||0||
48277312|NCT00979576|101003103|FG000|NOT COMPLETED|Combination Followed by Monotherapy||0||
48277313|NCT00979576|101003104|FG001|NOT COMPLETED|Combination Followed by Monotherapy||2||
48277314|NCT00979576|101003105|FG002|NOT COMPLETED|Combination Followed by Monotherapy||1||
48277315|NCT02081443|101003106|FG000|STARTED|Overall Study||30||
48277316|NCT02081443|101003107|FG001|STARTED|Overall Study||30||
48277317|NCT02081443|101003106|FG000|COMPLETED|Overall Study||30||
48277318|NCT02081443|101003107|FG001|COMPLETED|Overall Study||30||
48277319|NCT02081443|101003106|FG000|NOT COMPLETED|Overall Study||0||
48277320|NCT02081443|101003107|FG001|NOT COMPLETED|Overall Study||0||
48393986|NCT04449276|101295841|FG007|NOT COMPLETED|Overall Study||2||
48393987|NCT02228564|101295842|FG000|STARTED|Overall Study||155||
48393988|NCT02228564|101295842|FG000|COMPLETED|Overall Study||106||
48393989|NCT02228564|101295842|FG000|NOT COMPLETED|Overall Study||49||
48393990|NCT01383109|101295843|FG000|STARTED|Overall Study||6||
48393991|NCT01383109|101295843|FG000|COMPLETED|Overall Study||6||
48393992|NCT01383109|101295843|FG000|NOT COMPLETED|Overall Study||0||
48393993|NCT04507776|101295844|FG000|STARTED|Overall Study||763||
48393994|NCT04507776|101295844|FG000|COMPLETED|Overall Study||562||
48393995|NCT04507776|101295844|FG000|NOT COMPLETED|Overall Study||201||
48393996|NCT02573233|101295845|FG000|STARTED|Overall Study||22||
48393997|NCT02573233|101295846|FG001|STARTED|Overall Study||20||
48113860|NCT01632891|100605039|FG000|NOT COMPLETED|Overall Study||1||
48113861|NCT01632891|100605040|FG001|NOT COMPLETED|Overall Study||1||
48113862|NCT04296396|100605041|FG000|STARTED|Overall Study||2748||
48113863|NCT04296396|100605042|FG001|STARTED|Overall Study||2773||
48113864|NCT04296396|100605041|FG000|COMPLETED|Overall Study||2386|Participants who completed the 90 day visit.|
48113865|NCT04296396|100605042|FG001|COMPLETED|Overall Study||2426|Participants who completed the 90 day visit.|
48113866|NCT04296396|100605041|FG000|NOT COMPLETED|Overall Study||362||
48113867|NCT04296396|100605042|FG001|NOT COMPLETED|Overall Study||347||
48113868|NCT04144166|100605043|FG000|STARTED|Overall Study||60||
48113869|NCT04144166|100605043|FG000|COMPLETED|Overall Study||57||
48113870|NCT04144166|100605043|FG000|NOT COMPLETED|Overall Study||3||
48113871|NCT01183975|100605044|FG000|STARTED|Overall Study||517||
48113872|NCT01183975|100605044|FG000|COMPLETED|Overall Study||444||
48113873|NCT01183975|100605044|FG000|NOT COMPLETED|Overall Study||73||
48113874|NCT01660711|100605045|FG000|STARTED|Overall Study||22||
48113875|NCT01660711|100605045|FG000|COMPLETED|Overall Study||14||
48113876|NCT01660711|100605045|FG000|NOT COMPLETED|Overall Study||8||
48113877|NCT01639040|100605046|FG000|STARTED|Overall Study||10||
48113878|NCT01639040|100605047|FG001|STARTED|Overall Study||21||
48113879|NCT01639040|100605046|FG000|COMPLETED|Overall Study||9||
48113880|NCT01639040|100605047|FG001|COMPLETED|Overall Study||21||
48113881|NCT01639040|100605046|FG000|NOT COMPLETED|Overall Study||1||
48113882|NCT01639040|100605047|FG001|NOT COMPLETED|Overall Study||0||
48113883|NCT01228929|100605048|FG000|STARTED|Nominal Condition||6||
48113884|NCT01228929|100605049|FG001|STARTED|Nominal Condition||6||
48113885|NCT01228929|100605050|FG002|STARTED|Nominal Condition||6||
48113886|NCT01228929|100605048|FG000|COMPLETED|Nominal Condition||6||
48113887|NCT01228929|100605049|FG001|COMPLETED|Nominal Condition||6||
48113888|NCT01228929|100605050|FG002|COMPLETED|Nominal Condition||6||
48113889|NCT01228929|100605048|FG000|NOT COMPLETED|Nominal Condition||0||
48113890|NCT01228929|100605049|FG001|NOT COMPLETED|Nominal Condition||0||
48113891|NCT01228929|100605050|FG002|NOT COMPLETED|Nominal Condition||0||
48113892|NCT01228929|100605048|FG000|STARTED|Low Humidity Condition||6||
48113893|NCT01228929|100605049|FG001|STARTED|Low Humidity Condition||6||
48113894|NCT01228929|100605050|FG002|STARTED|Low Humidity Condition||6||
48113895|NCT01228929|100605048|FG000|COMPLETED|Low Humidity Condition||6||
48113896|NCT01228929|100605049|FG001|COMPLETED|Low Humidity Condition||6||
48113897|NCT01228929|100605050|FG002|COMPLETED|Low Humidity Condition||6||
48113898|NCT01228929|100605048|FG000|NOT COMPLETED|Low Humidity Condition||0||
48113899|NCT01228929|100605049|FG001|NOT COMPLETED|Low Humidity Condition||0||
48113900|NCT01228929|100605050|FG002|NOT COMPLETED|Low Humidity Condition||0||
48113901|NCT01228929|100605048|FG000|STARTED|High Temperature Condition||6||
48113902|NCT01228929|100605049|FG001|STARTED|High Temperature Condition||6||
48113903|NCT01228929|100605050|FG002|STARTED|High Temperature Condition||6||
48113904|NCT01228929|100605048|FG000|COMPLETED|High Temperature Condition||6||
48113905|NCT01228929|100605049|FG001|COMPLETED|High Temperature Condition||6||
48113906|NCT01228929|100605050|FG002|COMPLETED|High Temperature Condition||6||
48113907|NCT01228929|100605048|FG000|NOT COMPLETED|High Temperature Condition||0||
48113908|NCT01228929|100605049|FG001|NOT COMPLETED|High Temperature Condition||0||
48113909|NCT01228929|100605050|FG002|NOT COMPLETED|High Temperature Condition||0||
48113910|NCT00577083|100605051|FG000|STARTED|First Intervention (14 Days)||48||
48113911|NCT00577083|100605052|FG001|STARTED|First Intervention (14 Days)||52||
48113912|NCT00577083|100605051|FG000|COMPLETED|First Intervention (14 Days)||48||
48113913|NCT00577083|100605052|FG001|COMPLETED|First Intervention (14 Days)||52||
48113914|NCT00577083|100605051|FG000|NOT COMPLETED|First Intervention (14 Days)||0||
48113915|NCT00577083|100605052|FG001|NOT COMPLETED|First Intervention (14 Days)||0||
48113916|NCT00577083|100605051|FG000|STARTED|Washout (14 Days)||48||
48113917|NCT00577083|100605052|FG001|STARTED|Washout (14 Days)||52||
48113918|NCT00577083|100605051|FG000|COMPLETED|Washout (14 Days)||48||
48113919|NCT00577083|100605052|FG001|COMPLETED|Washout (14 Days)||52||
48113920|NCT00577083|100605051|FG000|NOT COMPLETED|Washout (14 Days)||0||
48393998|NCT02573233|101295845|FG000|COMPLETED|Overall Study||22||
48393999|NCT02573233|101295846|FG001|COMPLETED|Overall Study||20||
48394000|NCT02573233|101295845|FG000|NOT COMPLETED|Overall Study||0||
48113921|NCT00577083|100605052|FG001|NOT COMPLETED|Washout (14 Days)||0||
48113922|NCT00577083|100605051|FG000|STARTED|Second Intervention (14days)||48||
48113923|NCT00577083|100605052|FG001|STARTED|Second Intervention (14days)||52||
48113924|NCT00577083|100605051|FG000|COMPLETED|Second Intervention (14days)||48||
48394001|NCT02573233|101295846|FG001|NOT COMPLETED|Overall Study||0||
48696767|NCT02712983|102041807|FG005|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
48113925|NCT00577083|100605052|FG001|COMPLETED|Second Intervention (14days)||52||
48113926|NCT00577083|100605051|FG000|NOT COMPLETED|Second Intervention (14days)||0||
48113927|NCT00577083|100605052|FG001|NOT COMPLETED|Second Intervention (14days)||0||
48113928|NCT01764607|100605053|FG000|STARTED|Overall Study||1||
48113929|NCT01764607|100605053|FG000|COMPLETED|Overall Study||1||
48113930|NCT01764607|100605053|FG000|NOT COMPLETED|Overall Study||0||
48113931|NCT00376168|100605054|FG000|STARTED|Overall Study||16||
48113932|NCT00376168|100605055|FG001|STARTED|Overall Study||16||
48113933|NCT00376168|100605054|FG000|COMPLETED|Overall Study||14||
48113934|NCT00376168|100605055|FG001|COMPLETED|Overall Study||15||
48113935|NCT00376168|100605054|FG000|NOT COMPLETED|Overall Study||2||
48113936|NCT00376168|100605055|FG001|NOT COMPLETED|Overall Study||1||
48113937|NCT02822508|100605056|FG000|STARTED|Overall Study||114||
48113938|NCT02822508|100605057|FG001|STARTED|Overall Study||105||
48113939|NCT02822508|100605058|FG002|STARTED|Overall Study||115||
48113940|NCT02822508|100605059|FG003|STARTED|Overall Study||100||
48113941|NCT02822508|100605056|FG000|COMPLETED|Overall Study||101||
48113942|NCT02822508|100605057|FG001|COMPLETED|Overall Study||90||
48113943|NCT02822508|100605058|FG002|COMPLETED|Overall Study||100||
48113944|NCT02822508|100605059|FG003|COMPLETED|Overall Study||90||
48113945|NCT02822508|100605056|FG000|NOT COMPLETED|Overall Study||13||
48113946|NCT02822508|100605057|FG001|NOT COMPLETED|Overall Study||15||
48113947|NCT02822508|100605058|FG002|NOT COMPLETED|Overall Study||15||
48113948|NCT02822508|100605059|FG003|NOT COMPLETED|Overall Study||10||
48113949|NCT01394926|100605060|FG000|STARTED|Overall Study||21||
48113950|NCT01394926|100605060|FG000|COMPLETED|Overall Study||21||
48113951|NCT01394926|100605060|FG000|NOT COMPLETED|Overall Study||0||
48113952|NCT01369875|100605061|FG000|STARTED|Overall Study||1||
48113953|NCT01369875|100605062|FG001|STARTED|Overall Study||1||
48113954|NCT01369875|100605061|FG000|COMPLETED|Overall Study||1||
48113955|NCT01369875|100605062|FG001|COMPLETED|Overall Study||1||
48113956|NCT01369875|100605061|FG000|NOT COMPLETED|Overall Study||0||
48113957|NCT01369875|100605062|FG001|NOT COMPLETED|Overall Study||0||
48113958|NCT01140477|100605063|FG000|STARTED|Overall Study||153||
48113959|NCT01140477|100605064|FG001|STARTED|Overall Study||76||
48113960|NCT01140477|100605063|FG000|COMPLETED|Overall Study||145||
48113961|NCT01140477|100605064|FG001|COMPLETED|Overall Study||70||
48113962|NCT01140477|100605063|FG000|NOT COMPLETED|Overall Study||8||
48113963|NCT01140477|100605064|FG001|NOT COMPLETED|Overall Study||6||
48113964|NCT01641367|100605065|FG000|STARTED|Cohorts||287|Participants were followed on step 1/2 until 48 weeks after the last participant enrolled to Step 1.|
48113965|NCT01641367|100605066|FG001|STARTED|Cohorts||74|Participants were followed on step 1/2 until 48 weeks after the last participant enrolled to Step 1.|
48113966|NCT01641367|100605067|FG002|STARTED|Cohorts||72|Participants were followed on step 1/2 until 48 weeks after the last participant enrolled to Step 1.|
48113967|NCT01641367|100605068|FG003|STARTED|Cohorts||8|Participants were followed on step 1/2 until 48 weeks after the last participant enrolled to Step 1.|
48113968|NCT01641367|100605069|FG004|STARTED|Cohorts||70|Participants were followed on step 1/2 until 48 weeks after the last participant enrolled to Step 1.|
48113969|NCT01641367|100605070|FG005|STARTED|Cohorts||34|Participants were followed on step 1/2 until 48 weeks after the last participant enrolled to Step 1.|
48113970|NCT01641367|100605071|FG006|STARTED|Cohorts||0|Participants were followed on step 1/2 until 48 weeks after the last participant enrolled to Step 1.|
48113971|NCT01641367|100605072|FG007|STARTED|Cohorts||0|Participants were followed on step 1/2 until 48 weeks after the last participant enrolled to Step 1.|
48113972|NCT01641367|100605065|FG000|Followed 72 Weeks on Step 1/2|Cohorts||211||
48113973|NCT01641367|100605066|FG001|Followed 72 Weeks on Step 1/2|Cohorts||60||
48113974|NCT01641367|100605067|FG002|Followed 72 Weeks on Step 1/2|Cohorts||60||
48113975|NCT01641367|100605068|FG003|Followed 72 Weeks on Step 1/2|Cohorts||6||
48113976|NCT01641367|100605069|FG004|Followed 72 Weeks on Step 1/2|Cohorts||52||
48113977|NCT01641367|100605070|FG005|Followed 72 Weeks on Step 1/2|Cohorts||30||
48113978|NCT01641367|100605071|FG006|Followed 72 Weeks on Step 1/2|Cohorts||0||
48113979|NCT01641367|100605072|FG007|Followed 72 Weeks on Step 1/2|Cohorts||0||
48113980|NCT01641367|100605065|FG000|COMPLETED|Cohorts||253|Completed the study = participant must have had the last step 1/2 visit between 22NOV2016-13FEB2017|
48113981|NCT01641367|100605066|FG001|COMPLETED|Cohorts||73|Completed the study = participant must have had the last step 1/2 visit between 22NOV2016-13FEB2017|
48113982|NCT01641367|100605067|FG002|COMPLETED|Cohorts||68|Completed the study = participant must have had the last step 1/2 visit between 22NOV2016-13FEB2017|
48113983|NCT01641367|100605068|FG003|COMPLETED|Cohorts||8|Completed the study = participant must have had the last step 1/2 visit between 22NOV2016-13FEB2017|
48113984|NCT01641367|100605069|FG004|COMPLETED|Cohorts||67|Completed the study = participant must have had the last step 1/2 visit between 22NOV2016-13FEB2017|
48113985|NCT01641367|100605070|FG005|COMPLETED|Cohorts||33|Completed the study = participant must have had the last step 1/2 visit between 22NOV2016-13FEB2017|
48113986|NCT01641367|100605071|FG006|COMPLETED|Cohorts||0|Completed the study = participant must have had the last step 1/2 visit between 22NOV2016-13FEB2017|
48141421|NCT01319396|100670422|FG000|STARTED|Overall Study||24||
48277321|NCT03307005|101003108|FG000|STARTED|Overall Study||3||
48696768|NCT02712983|102041808|FG006|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
48696769|NCT02712983|102041809|FG007|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
48696770|NCT02712983|102041810|FG008|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
48277322|NCT03307005|101003109|FG001|STARTED|Overall Study||2||
48277323|NCT03307005|101003108|FG000|COMPLETED|Overall Study||3||
48277324|NCT03307005|101003109|FG001|COMPLETED|Overall Study||2||
48277325|NCT03307005|101003108|FG000|NOT COMPLETED|Overall Study||0||
48277326|NCT03307005|101003109|FG001|NOT COMPLETED|Overall Study||0||
48277327|NCT01879553|101003110|FG000|STARTED|Overall Study||63||
48277328|NCT01879553|101003111|FG001|STARTED|Overall Study||63||
48277329|NCT01879553|101003110|FG000|COMPLETED|Overall Study||62||
48563168|NCT02837731|101710110|FG001|STARTED|Follow-up||41||
48563169|NCT02837731|101710109|FG000|COMPLETED|Follow-up||83||
48563170|NCT02837731|101710110|FG001|COMPLETED|Follow-up||41||
48563171|NCT02837731|101710109|FG000|NOT COMPLETED|Follow-up||0||
48563172|NCT02837731|101710110|FG001|NOT COMPLETED|Follow-up||0||
48563173|NCT02837731|101710109|FG000|STARTED|Analysis||83||
48563174|NCT02837731|101710110|FG001|STARTED|Analysis||41||
48563175|NCT02837731|101710109|FG000|COMPLETED|Analysis||83||
48563176|NCT02837731|101710110|FG001|COMPLETED|Analysis||41||
48563177|NCT02837731|101710109|FG000|NOT COMPLETED|Analysis||0||
48563178|NCT02837731|101710110|FG001|NOT COMPLETED|Analysis||0||
48563179|NCT00395629|101710111|FG000|STARTED|Core Study||11||
48563180|NCT00395629|101710112|FG001|STARTED|Core Study||15||
48696771|NCT02712983|102041802|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
48696772|NCT02712983|102041803|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1||
48696773|NCT02712983|102041804|FG002|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
48113987|NCT01641367|100605072|FG007|COMPLETED|Cohorts||0|Completed the study = participant must have had the last step 1/2 visit between 22NOV2016-13FEB2017|
48113988|NCT01641367|100605065|FG000|NOT COMPLETED|Cohorts||34||
48113989|NCT01641367|100605066|FG001|NOT COMPLETED|Cohorts||1||
48113990|NCT01641367|100605067|FG002|NOT COMPLETED|Cohorts||4||
48113991|NCT01641367|100605068|FG003|NOT COMPLETED|Cohorts||0||
48113992|NCT01641367|100605069|FG004|NOT COMPLETED|Cohorts||3||
48113993|NCT01641367|100605070|FG005|NOT COMPLETED|Cohorts||1||
48113994|NCT01641367|100605071|FG006|NOT COMPLETED|Cohorts||0||
48113995|NCT01641367|100605072|FG007|NOT COMPLETED|Cohorts||0||
48113996|NCT01641367|100605065|FG000|STARTED|Randomized Adherence Intervention||0|Participants were followed on step 1/2 until 48 weeks after the last participant enrolled to Step 1.|
48113997|NCT01641367|100605066|FG001|STARTED|Randomized Adherence Intervention||0|Participants were followed on step 1/2 until 48 weeks after the last participant enrolled to Step 1.|
48113998|NCT01641367|100605067|FG002|STARTED|Randomized Adherence Intervention||0|Participants were followed on step 1/2 until 48 weeks after the last participant enrolled to Step 1.|
48113999|NCT01641367|100605068|FG003|STARTED|Randomized Adherence Intervention||0|Participants were followed on step 1/2 until 48 weeks after the last participant enrolled to Step 1.|
48114000|NCT01641367|100605069|FG004|STARTED|Randomized Adherence Intervention||0|Participants were followed on step 1/2 until 48 weeks after the last participant enrolled to Step 1.|
48114001|NCT01641367|100605070|FG005|STARTED|Randomized Adherence Intervention||0|Participants were followed on step 1/2 until 48 weeks after the last participant enrolled to Step 1.|
48114002|NCT01641367|100605071|FG006|STARTED|Randomized Adherence Intervention||257|Participants were followed on step 1/2 until 48 weeks after the last participant enrolled to Step 1.|
48114003|NCT01641367|100605072|FG007|STARTED|Randomized Adherence Intervention||264|Participants were followed on step 1/2 until 48 weeks after the last participant enrolled to Step 1.|
48114004|NCT01641367|100605065|FG000|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0||
48114005|NCT01641367|100605066|FG001|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0||
48114006|NCT01641367|100605067|FG002|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0||
48114007|NCT01641367|100605068|FG003|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0||
48277330|NCT01879553|101003111|FG001|COMPLETED|Overall Study||63||
48277331|NCT01879553|101003110|FG000|NOT COMPLETED|Overall Study||1||
48277332|NCT01879553|101003111|FG001|NOT COMPLETED|Overall Study||0||
48277333|NCT04020185|101003112|FG000|STARTED|Overall Study||4||
48277334|NCT04020185|101003113|FG001|STARTED|Overall Study||3||
48277335|NCT04020185|101003114|FG002|STARTED|Overall Study||4||
48277336|NCT04020185|101003115|FG003|STARTED|Overall Study||4||
48277337|NCT04020185|101003116|FG004|STARTED|Overall Study||7||
48277338|NCT04020185|101003117|FG005|STARTED|Overall Study||4||
48277339|NCT04020185|101003118|FG006|STARTED|Overall Study||7||
48277340|NCT04020185|101003119|FG007|STARTED|Overall Study||7||
48277341|NCT04020185|101003112|FG000|COMPLETED|Overall Study||3||
48394002|NCT00936299|101295847|FG000|STARTED|Overall Study||53||
48394003|NCT00936299|101295848|FG001|STARTED|Overall Study||52||
48696774|NCT02712983|102041805|FG003|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1||
48696775|NCT02712983|102041806|FG004|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2||
48277342|NCT04020185|101003113|FG001|COMPLETED|Overall Study||2||
48277343|NCT04020185|101003114|FG002|COMPLETED|Overall Study||3||
48277344|NCT04020185|101003115|FG003|COMPLETED|Overall Study||2||
48277345|NCT04020185|101003116|FG004|COMPLETED|Overall Study||4||
48277346|NCT04020185|101003117|FG005|COMPLETED|Overall Study||4||
48277347|NCT04020185|101003118|FG006|COMPLETED|Overall Study||4||
48277348|NCT04020185|101003119|FG007|COMPLETED|Overall Study||5||
48394004|NCT00936299|101295847|FG000|COMPLETED|Overall Study||40||
48394005|NCT00936299|101295848|FG001|COMPLETED|Overall Study||40||
48563181|NCT00395629|101710113|FG002|STARTED|Core Study||23||
48563182|NCT00395629|101710111|FG000|COMPLETED|Core Study||10||
48563183|NCT00395629|101710112|FG001|COMPLETED|Core Study||11||
48696776|NCT02712983|102041807|FG005|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1||
48696777|NCT02712983|102041808|FG006|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2||
48114008|NCT01641367|100605069|FG004|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0||
48114009|NCT01641367|100605070|FG005|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0||
48114010|NCT01641367|100605071|FG006|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||196||
48114011|NCT01641367|100605072|FG007|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||202||
48114012|NCT01641367|100605065|FG000|COMPLETED|Randomized Adherence Intervention||0|Completed the study = participant must have had the last step 1/2 visit between 22NOV2016-13FEB2017|
48114013|NCT01641367|100605066|FG001|COMPLETED|Randomized Adherence Intervention||0|Completed the study = participant must have had the last step 1/2 visit between 22NOV2016-13FEB2017|
48114014|NCT01641367|100605067|FG002|COMPLETED|Randomized Adherence Intervention||0|Completed the study = participant must have had the last step 1/2 visit between 22NOV2016-13FEB2017|
48114015|NCT01641367|100605068|FG003|COMPLETED|Randomized Adherence Intervention||0|Completed the study = participant must have had the last step 1/2 visit between 22NOV2016-13FEB2017|
48114016|NCT01641367|100605069|FG004|COMPLETED|Randomized Adherence Intervention||0|Completed the study = participant must have had the last step 1/2 visit between 22NOV2016-13FEB2017|
48114017|NCT01641367|100605070|FG005|COMPLETED|Randomized Adherence Intervention||0|Completed the study = participant must have had the last step 1/2 visit between 22NOV2016-13FEB2017|
48114018|NCT01641367|100605071|FG006|COMPLETED|Randomized Adherence Intervention||238|Completed the study = participant must have had the last step 1/2 visit between 22NOV2016-13FEB2017|
48114019|NCT01641367|100605072|FG007|COMPLETED|Randomized Adherence Intervention||240|Completed the study = participant must have had the last step 1/2 visit between 22NOV2016-13FEB2017|
48277349|NCT04020185|101003112|FG000|NOT COMPLETED|Overall Study||1||
48277350|NCT04020185|101003113|FG001|NOT COMPLETED|Overall Study||1||
48277351|NCT04020185|101003114|FG002|NOT COMPLETED|Overall Study||1||
48277352|NCT04020185|101003115|FG003|NOT COMPLETED|Overall Study||2||
48277353|NCT04020185|101003116|FG004|NOT COMPLETED|Overall Study||3||
48277354|NCT04020185|101003117|FG005|NOT COMPLETED|Overall Study||0||
48277355|NCT04020185|101003118|FG006|NOT COMPLETED|Overall Study||3||
48277356|NCT04020185|101003119|FG007|NOT COMPLETED|Overall Study||2||
48114020|NCT01641367|100605065|FG000|NOT COMPLETED|Randomized Adherence Intervention||0||
48114021|NCT01641367|100605066|FG001|NOT COMPLETED|Randomized Adherence Intervention||0||
48114022|NCT01641367|100605067|FG002|NOT COMPLETED|Randomized Adherence Intervention||0||
48114023|NCT01641367|100605068|FG003|NOT COMPLETED|Randomized Adherence Intervention||0||
48114024|NCT01641367|100605069|FG004|NOT COMPLETED|Randomized Adherence Intervention||0||
48114025|NCT01641367|100605070|FG005|NOT COMPLETED|Randomized Adherence Intervention||0||
48114026|NCT01641367|100605071|FG006|NOT COMPLETED|Randomized Adherence Intervention||19||
48114027|NCT01641367|100605072|FG007|NOT COMPLETED|Randomized Adherence Intervention||24||
48114028|NCT04545515|100605073|FG000|STARTED|Overall Study||120||
48114029|NCT04545515|100605073|FG000|Placebo-ELX/TEZ/IVA|Overall Study||61|Participants from the Placebo group of the parent study VX19-445-116, who received ELX/TEZ/IVA during the current study VX20-445-119.|
48114030|NCT04545515|100605073|FG000|ELX/TEZ/IVA-ELX/TEZ/IVA|Overall Study||59|Participants from the ELX/TEZ/IVA group of the parent study VX19-445-116, who continued to receive ELX/TEZ/IVA during the current study VX20-445-119.|
48114031|NCT04545515|100605073|FG000|COMPLETED|Overall Study||110||
48114032|NCT04545515|100605073|FG000|NOT COMPLETED|Overall Study||10||
48114033|NCT00895180|100605074|FG000|STARTED|Overall Study||40||
48114034|NCT00895180|100605075|FG001|STARTED|Overall Study||40||
48114035|NCT00895180|100605074|FG000|Received at Least 1 Dose of Study Drug|Overall Study||40||
48114036|NCT00895180|100605075|FG001|Received at Least 1 Dose of Study Drug|Overall Study||40||
48114037|NCT00895180|100605074|FG000|COMPLETED|Overall Study||40||
48114038|NCT00895180|100605075|FG001|COMPLETED|Overall Study||40||
48114039|NCT00895180|100605074|FG000|NOT COMPLETED|Overall Study||0||
48114040|NCT00895180|100605075|FG001|NOT COMPLETED|Overall Study||0||
48114041|NCT03863210|100605076|FG000|STARTED|Overall Study||104||
48114042|NCT03863210|100605076|FG000|COMPLETED|Overall Study||102||
48114043|NCT03863210|100605076|FG000|NOT COMPLETED|Overall Study||2||
48114044|NCT00519649|100605077|FG000|STARTED|Overall Study||300||
48277357|NCT00979550|101003120|FG000|STARTED|Overall Study||4||
48277358|NCT00979550|101003121|FG001|STARTED|Overall Study||3||
48277359|NCT00979550|101003120|FG000|COMPLETED|Overall Study||4||
48277360|NCT00979550|101003121|FG001|COMPLETED|Overall Study||3||
48277361|NCT00979550|101003120|FG000|NOT COMPLETED|Overall Study||0||
48277362|NCT00979550|101003121|FG001|NOT COMPLETED|Overall Study||0||
48277363|NCT01036438|101003122|FG000|STARTED|Overall Study||101||
48394006|NCT00936299|101295847|FG000|NOT COMPLETED|Overall Study||13||
48394007|NCT00936299|101295848|FG001|NOT COMPLETED|Overall Study||12||
48394008|NCT02685995|101295849|FG000|STARTED|Overall Study||50||
48394009|NCT02685995|101295850|FG001|STARTED|Overall Study||50||
48394010|NCT02685995|101295849|FG000|COMPLETED|Overall Study||49||
48394011|NCT02685995|101295850|FG001|COMPLETED|Overall Study||49||
48696778|NCT02712983|102041809|FG007|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||3||
48696779|NCT02712983|102041810|FG008|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
48696780|NCT04091581|102041811|FG000|STARTED|Overall Study||10||
48277364|NCT01036438|101003123|FG001|STARTED|Overall Study||100||
48394012|NCT02685995|101295849|FG000|NOT COMPLETED|Overall Study||1||
48277365|NCT01036438|101003122|FG000|COMPLETED|Overall Study||91||
48277366|NCT01036438|101003123|FG001|COMPLETED|Overall Study||90||
48277367|NCT01036438|101003122|FG000|NOT COMPLETED|Overall Study||10||
48277368|NCT01036438|101003123|FG001|NOT COMPLETED|Overall Study||10||
48277369|NCT00384189|101003124|FG000|STARTED|Overall Study||305||
48277370|NCT00384189|101003125|FG001|STARTED|Overall Study||312||
48277371|NCT00384189|101003126|FG002|STARTED|Overall Study||313||
48277372|NCT00384189|101003127|FG003|STARTED|Overall Study||150||
48277373|NCT00384189|101003124|FG000|Randomized, Not Treated|Overall Study||1||
48277374|NCT00384189|101003125|FG001|Randomized, Not Treated|Overall Study||0||
48277375|NCT00384189|101003126|FG002|Randomized, Not Treated|Overall Study||2||
48277376|NCT00384189|101003127|FG003|Randomized, Not Treated|Overall Study||4||
48277377|NCT00384189|101003124|FG000|Actual Treatment Received|Overall Study||305||
48277378|NCT00384189|101003125|FG001|Actual Treatment Received|Overall Study||312||
48277379|NCT00384189|101003126|FG002|Actual Treatment Received|Overall Study||310||
48277380|NCT00384189|101003127|FG003|Actual Treatment Received|Overall Study||146||
48277381|NCT00384189|101003124|FG000|COMPLETED|Overall Study||255||
48277382|NCT00384189|101003125|FG001|COMPLETED|Overall Study||255||
48277383|NCT00384189|101003126|FG002|COMPLETED|Overall Study||255||
48277384|NCT00384189|101003127|FG003|COMPLETED|Overall Study||110||
48277385|NCT00384189|101003124|FG000|NOT COMPLETED|Overall Study||50||
48277386|NCT00384189|101003125|FG001|NOT COMPLETED|Overall Study||57||
48277387|NCT00384189|101003126|FG002|NOT COMPLETED|Overall Study||58||
48277388|NCT00384189|101003127|FG003|NOT COMPLETED|Overall Study||40||
48277389|NCT01253135|101003128|FG000|STARTED|Original Protocol||15||
48277390|NCT01253135|101003128|FG000|COMPLETED|Original Protocol||0||
48277391|NCT01253135|101003128|FG000|NOT COMPLETED|Original Protocol||15||
48277392|NCT01253135|101003128|FG000|STARTED|Amended Protocol||25||
48277393|NCT01253135|101003128|FG000|COMPLETED|Amended Protocol||24||
48277394|NCT01253135|101003128|FG000|NOT COMPLETED|Amended Protocol||1||
48277395|NCT04996004|101003129|FG000|STARTED|Phase I||3||
48277396|NCT04996004|101003130|FG001|STARTED|Phase I||3||
48277397|NCT04996004|101003131|FG002|STARTED|Phase I||3||
48277398|NCT04996004|101003132|FG003|STARTED|Phase I||0||
48277399|NCT04996004|101003133|FG004|STARTED|Phase I||0||
48114045|NCT00519649|100605077|FG000|COMPLETED|Overall Study||299||
48114046|NCT00519649|100605077|FG000|NOT COMPLETED|Overall Study||1||
48114047|NCT00974571|100605078|FG000|STARTED|Overall Study||630||
48114048|NCT00974571|100605079|FG001|STARTED|Overall Study||122||
48114049|NCT00974571|100605080|FG002|STARTED|Overall Study||613||
48114050|NCT00974571|100605078|FG000|COMPLETED|Overall Study||562||
48277400|NCT04996004|101003134|FG005|STARTED|Phase I||0||
48277401|NCT04996004|101003129|FG000|COMPLETED|Phase I||0||
48277402|NCT04996004|101003130|FG001|COMPLETED|Phase I||0||
48277403|NCT04996004|101003131|FG002|COMPLETED|Phase I||0||
48277404|NCT04996004|101003132|FG003|COMPLETED|Phase I||0||
48277405|NCT04996004|101003133|FG004|COMPLETED|Phase I||0||
48277406|NCT04996004|101003134|FG005|COMPLETED|Phase I||0||
48277407|NCT04996004|101003129|FG000|NOT COMPLETED|Phase I||3||
48277408|NCT04996004|101003130|FG001|NOT COMPLETED|Phase I||3||
48277409|NCT04996004|101003131|FG002|NOT COMPLETED|Phase I||3||
48277410|NCT04996004|101003132|FG003|NOT COMPLETED|Phase I||0||
48277411|NCT04996004|101003133|FG004|NOT COMPLETED|Phase I||0||
48277412|NCT04996004|101003134|FG005|NOT COMPLETED|Phase I||0||
48277413|NCT04996004|101003129|FG000|STARTED|Phase II||0||
48277414|NCT04996004|101003130|FG001|STARTED|Phase II||0||
48277415|NCT04996004|101003131|FG002|STARTED|Phase II||0||
48277416|NCT04996004|101003132|FG003|STARTED|Phase II||32||
48277417|NCT04996004|101003133|FG004|STARTED|Phase II||13||
48277418|NCT04996004|101003134|FG005|STARTED|Phase II||22||
48277419|NCT04996004|101003129|FG000|COMPLETED|Phase II||0||
48277420|NCT04996004|101003130|FG001|COMPLETED|Phase II||0||
48277421|NCT04996004|101003131|FG002|COMPLETED|Phase II||0||
48277422|NCT04996004|101003132|FG003|COMPLETED|Phase II||0||
48277423|NCT04996004|101003133|FG004|COMPLETED|Phase II||0||
48277424|NCT04996004|101003134|FG005|COMPLETED|Phase II||0||
48277425|NCT04996004|101003129|FG000|NOT COMPLETED|Phase II||0||
48277426|NCT04996004|101003130|FG001|NOT COMPLETED|Phase II||0||
48277427|NCT04996004|101003131|FG002|NOT COMPLETED|Phase II||0||
48277428|NCT04996004|101003132|FG003|NOT COMPLETED|Phase II||32||
48277429|NCT04996004|101003133|FG004|NOT COMPLETED|Phase II||13||
48277430|NCT04996004|101003134|FG005|NOT COMPLETED|Phase II||22||
48277431|NCT03031470|101003135|FG000|STARTED|Overall Study||22||
48277432|NCT03031470|101003136|FG001|STARTED|Overall Study||18||
48277433|NCT03031470|101003135|FG000|Modified Intention to Treat Population (mITT)|Overall Study||22||
48277434|NCT03031470|101003136|FG001|Modified Intention to Treat Population (mITT)|Overall Study||16||
48277435|NCT03031470|101003135|FG000|Per-Protocol Population (PP)|Overall Study||17||
48277436|NCT03031470|101003136|FG001|Per-Protocol Population (PP)|Overall Study||16||
48277437|NCT03031470|101003135|FG000|Safety Population (SAF)|Overall Study||22||
48277438|NCT03031470|101003136|FG001|Safety Population (SAF)|Overall Study||16||
48114051|NCT00974571|100605079|FG001|COMPLETED|Overall Study||106||
48114052|NCT00974571|100605080|FG002|COMPLETED|Overall Study||530||
48277439|NCT03031470|101003135|FG000|COMPLETED|Overall Study||14||
48277440|NCT03031470|101003136|FG001|COMPLETED|Overall Study||14||
48277441|NCT03031470|101003135|FG000|NOT COMPLETED|Overall Study||8||
48277442|NCT03031470|101003136|FG001|NOT COMPLETED|Overall Study||4||
48277443|NCT05833100|101003137|FG000|STARTED|Day 1(August 15th)||2||
48277444|NCT05833100|101003138|FG001|STARTED|Day 1(August 15th)||3||
48277445|NCT05833100|101003139|FG002|STARTED|Day 1(August 15th)||0||
48277446|NCT05833100|101003137|FG000|COMPLETED|Day 1(August 15th)||2||
48277447|NCT05833100|101003138|FG001|COMPLETED|Day 1(August 15th)||3||
48277448|NCT05833100|101003139|FG002|COMPLETED|Day 1(August 15th)||0||
48277449|NCT05833100|101003137|FG000|NOT COMPLETED|Day 1(August 15th)||0||
48277450|NCT05833100|101003138|FG001|NOT COMPLETED|Day 1(August 15th)||0||
48277451|NCT05833100|101003139|FG002|NOT COMPLETED|Day 1(August 15th)||0||
48277452|NCT05833100|101003137|FG000|STARTED|Day 2(August 16th)||5||
48277453|NCT05833100|101003138|FG001|STARTED|Day 2(August 16th)||0||
48277454|NCT05833100|101003139|FG002|STARTED|Day 2(August 16th)||0||
48277455|NCT05833100|101003137|FG000|COMPLETED|Day 2(August 16th)||4||
48277456|NCT05833100|101003138|FG001|COMPLETED|Day 2(August 16th)||0||
48277457|NCT05833100|101003139|FG002|COMPLETED|Day 2(August 16th)||0||
48277458|NCT05833100|101003137|FG000|NOT COMPLETED|Day 2(August 16th)||1||
48277459|NCT05833100|101003138|FG001|NOT COMPLETED|Day 2(August 16th)||0||
48277460|NCT05833100|101003139|FG002|NOT COMPLETED|Day 2(August 16th)||0||
48277461|NCT05833100|101003137|FG000|STARTED|Day 3(August 23rd)||5||
48277462|NCT05833100|101003138|FG001|STARTED|Day 3(August 23rd)||3||
48277463|NCT05833100|101003139|FG002|STARTED|Day 3(August 23rd)||0||
48696781|NCT04091581|102041812|FG001|STARTED|Overall Study||11||
48696782|NCT04091581|102041811|FG000|COMPLETED|Overall Study||10||
48696783|NCT04091581|102041812|FG001|COMPLETED|Overall Study||10||
48696784|NCT04091581|102041811|FG000|NOT COMPLETED|Overall Study||0||
48696785|NCT04091581|102041812|FG001|NOT COMPLETED|Overall Study||1||
48696786|NCT03501992|102041813|FG000|STARTED|Step 1 - Months 1-12||848||
48696787|NCT03501992|102041814|FG001|STARTED|Step 1 - Months 1-12||228||
48696788|NCT03501992|102041815|FG002|STARTED|Step 1 - Months 1-12||479||
48696789|NCT03501992|102041816|FG003|STARTED|Step 1 - Months 1-12||320||
48696790|NCT03501992|102041817|FG004|STARTED|Step 1 - Months 1-12||414||
48696791|NCT03501992|102041818|FG005|STARTED|Step 1 - Months 1-12||265||
48696792|NCT03501992|102041813|FG000|COMPLETED|Step 1 - Months 1-12||848||
48696793|NCT03501992|102041814|FG001|COMPLETED|Step 1 - Months 1-12||228||
48696794|NCT03501992|102041815|FG002|COMPLETED|Step 1 - Months 1-12||479||
48696795|NCT03501992|102041816|FG003|COMPLETED|Step 1 - Months 1-12||320||
48696796|NCT03501992|102041817|FG004|COMPLETED|Step 1 - Months 1-12||414||
48696797|NCT03501992|102041818|FG005|COMPLETED|Step 1 - Months 1-12||265||
48696798|NCT03501992|102041813|FG000|NOT COMPLETED|Step 1 - Months 1-12||0||
48696799|NCT03501992|102041814|FG001|NOT COMPLETED|Step 1 - Months 1-12||0||
48696800|NCT03501992|102041815|FG002|NOT COMPLETED|Step 1 - Months 1-12||0||
48696801|NCT03501992|102041816|FG003|NOT COMPLETED|Step 1 - Months 1-12||0||
48696802|NCT03501992|102041817|FG004|NOT COMPLETED|Step 1 - Months 1-12||0||
48696803|NCT03501992|102041818|FG005|NOT COMPLETED|Step 1 - Months 1-12||0||
48696804|NCT03501992|102041813|FG000|STARTED|Step 2 - Months 13-24||726||
48696805|NCT03501992|102041814|FG001|STARTED|Step 2 - Months 13-24||218||
48696806|NCT03501992|102041815|FG002|STARTED|Step 2 - Months 13-24||434||
48696807|NCT03501992|102041816|FG003|STARTED|Step 2 - Months 13-24||292||
48696808|NCT03501992|102041817|FG004|STARTED|Step 2 - Months 13-24||386||
48696809|NCT03501992|102041818|FG005|STARTED|Step 2 - Months 13-24||264||
48696810|NCT03501992|102041813|FG000|COMPLETED|Step 2 - Months 13-24||726||
48696811|NCT03501992|102041814|FG001|COMPLETED|Step 2 - Months 13-24||218||
48696812|NCT03501992|102041815|FG002|COMPLETED|Step 2 - Months 13-24||434||
48696813|NCT03501992|102041816|FG003|COMPLETED|Step 2 - Months 13-24||292||
48277464|NCT05833100|101003137|FG000|COMPLETED|Day 3(August 23rd)||5||
48277465|NCT05833100|101003138|FG001|COMPLETED|Day 3(August 23rd)||3||
48277466|NCT05833100|101003139|FG002|COMPLETED|Day 3(August 23rd)||0||
48277467|NCT05833100|101003137|FG000|NOT COMPLETED|Day 3(August 23rd)||0||
48277468|NCT05833100|101003138|FG001|NOT COMPLETED|Day 3(August 23rd)||0||
48277469|NCT05833100|101003139|FG002|NOT COMPLETED|Day 3(August 23rd)||0||
48277470|NCT05833100|101003137|FG000|STARTED|Day 4(August 24th)||0||
48277471|NCT05833100|101003138|FG001|STARTED|Day 4(August 24th)||2||
48277472|NCT05833100|101003139|FG002|STARTED|Day 4(August 24th)||0||
48277473|NCT05833100|101003137|FG000|COMPLETED|Day 4(August 24th)||0||
48277474|NCT05833100|101003138|FG001|COMPLETED|Day 4(August 24th)||2||
48277475|NCT05833100|101003139|FG002|COMPLETED|Day 4(August 24th)||0||
48277476|NCT05833100|101003137|FG000|NOT COMPLETED|Day 4(August 24th)||0||
48277477|NCT05833100|101003138|FG001|NOT COMPLETED|Day 4(August 24th)||0||
48277478|NCT05833100|101003139|FG002|NOT COMPLETED|Day 4(August 24th)||0||
48277479|NCT05833100|101003137|FG000|STARTED|Day 5(August 29th)||0||
48277480|NCT05833100|101003138|FG001|STARTED|Day 5(August 29th)||5||
48277481|NCT05833100|101003139|FG002|STARTED|Day 5(August 29th)||1||
48277482|NCT05833100|101003137|FG000|COMPLETED|Day 5(August 29th)||0||
48696814|NCT03501992|102041817|FG004|COMPLETED|Step 2 - Months 13-24||386||
48696815|NCT03501992|102041818|FG005|COMPLETED|Step 2 - Months 13-24||264||
48696816|NCT03501992|102041813|FG000|NOT COMPLETED|Step 2 - Months 13-24||0||
48696817|NCT03501992|102041814|FG001|NOT COMPLETED|Step 2 - Months 13-24||0||
48696818|NCT03501992|102041815|FG002|NOT COMPLETED|Step 2 - Months 13-24||0||
48696819|NCT03501992|102041816|FG003|NOT COMPLETED|Step 2 - Months 13-24||0||
48696820|NCT03501992|102041817|FG004|NOT COMPLETED|Step 2 - Months 13-24||0||
48696821|NCT03501992|102041818|FG005|NOT COMPLETED|Step 2 - Months 13-24||0||
48696822|NCT03501992|102041813|FG000|STARTED|Step 3 - Months 25-36||702||
48696823|NCT03501992|102041814|FG001|STARTED|Step 3 - Months 25-36||188||
48696824|NCT03501992|102041815|FG002|STARTED|Step 3 - Months 25-36||401||
48696825|NCT03501992|102041816|FG003|STARTED|Step 3 - Months 25-36||241||
48277483|NCT05833100|101003138|FG001|COMPLETED|Day 5(August 29th)||5||
48277484|NCT05833100|101003139|FG002|COMPLETED|Day 5(August 29th)||1||
48277485|NCT05833100|101003137|FG000|NOT COMPLETED|Day 5(August 29th)||0||
48277486|NCT05833100|101003138|FG001|NOT COMPLETED|Day 5(August 29th)||0||
48277487|NCT05833100|101003139|FG002|NOT COMPLETED|Day 5(August 29th)||0||
48277488|NCT05833100|101003137|FG000|STARTED|Day 6(August 31st)||0||
48277489|NCT05833100|101003138|FG001|STARTED|Day 6(August 31st)||6||
48277490|NCT05833100|101003139|FG002|STARTED|Day 6(August 31st)||0||
48277491|NCT05833100|101003137|FG000|COMPLETED|Day 6(August 31st)||0||
48277492|NCT05833100|101003138|FG001|COMPLETED|Day 6(August 31st)||6||
48277493|NCT05833100|101003139|FG002|COMPLETED|Day 6(August 31st)||0||
48277494|NCT05833100|101003137|FG000|NOT COMPLETED|Day 6(August 31st)||0||
48277495|NCT05833100|101003138|FG001|NOT COMPLETED|Day 6(August 31st)||0||
48277496|NCT05833100|101003139|FG002|NOT COMPLETED|Day 6(August 31st)||0||
48277497|NCT05833100|101003137|FG000|STARTED|Day 7(September 6th)||0||
48277498|NCT05833100|101003138|FG001|STARTED|Day 7(September 6th)||7||
48277499|NCT05833100|101003139|FG002|STARTED|Day 7(September 6th)||1||
48277500|NCT05833100|101003137|FG000|COMPLETED|Day 7(September 6th)||0||
48277501|NCT05833100|101003138|FG001|COMPLETED|Day 7(September 6th)||7||
48277502|NCT05833100|101003139|FG002|COMPLETED|Day 7(September 6th)||1||
48277503|NCT05833100|101003137|FG000|NOT COMPLETED|Day 7(September 6th)||0||
48277504|NCT05833100|101003138|FG001|NOT COMPLETED|Day 7(September 6th)||0||
48277505|NCT05833100|101003139|FG002|NOT COMPLETED|Day 7(September 6th)||0||
48277506|NCT05833100|101003137|FG000|STARTED|Day 8(September 9th)||0||
48277507|NCT05833100|101003138|FG001|STARTED|Day 8(September 9th)||8||
48277508|NCT05833100|101003139|FG002|STARTED|Day 8(September 9th)||0||
48277509|NCT05833100|101003137|FG000|COMPLETED|Day 8(September 9th)||0||
48277510|NCT05833100|101003138|FG001|COMPLETED|Day 8(September 9th)||8||
48277511|NCT05833100|101003139|FG002|COMPLETED|Day 8(September 9th)||0||
48277512|NCT05833100|101003137|FG000|NOT COMPLETED|Day 8(September 9th)||0||
48277513|NCT05833100|101003138|FG001|NOT COMPLETED|Day 8(September 9th)||0||
48277514|NCT05833100|101003139|FG002|NOT COMPLETED|Day 8(September 9th)||0||
48277515|NCT05833100|101003137|FG000|STARTED|Day 9(September 13th)||0||
48277516|NCT05833100|101003138|FG001|STARTED|Day 9(September 13th)||10||
48277517|NCT05833100|101003139|FG002|STARTED|Day 9(September 13th)||0||
48277518|NCT05833100|101003137|FG000|COMPLETED|Day 9(September 13th)||0||
48277519|NCT05833100|101003138|FG001|COMPLETED|Day 9(September 13th)||10||
48394013|NCT02685995|101295850|FG001|NOT COMPLETED|Overall Study||1||
48394014|NCT01510834|101295851|FG000|STARTED|Overall Study||90||
48394015|NCT01510834|101295851|FG000|COMPLETED|Overall Study||57||
48394016|NCT01510834|101295851|FG000|NOT COMPLETED|Overall Study||33||
48277520|NCT05833100|101003139|FG002|COMPLETED|Day 9(September 13th)||0||
48277521|NCT05833100|101003137|FG000|NOT COMPLETED|Day 9(September 13th)||0||
48277522|NCT05833100|101003138|FG001|NOT COMPLETED|Day 9(September 13th)||0||
48277523|NCT05833100|101003139|FG002|NOT COMPLETED|Day 9(September 13th)||0||
48277524|NCT05833100|101003137|FG000|STARTED|Day 10(September 19th)||0||
48277525|NCT05833100|101003138|FG001|STARTED|Day 10(September 19th)||8||
48277526|NCT05833100|101003139|FG002|STARTED|Day 10(September 19th)||0||
48277527|NCT05833100|101003137|FG000|COMPLETED|Day 10(September 19th)||0||
48277528|NCT05833100|101003138|FG001|COMPLETED|Day 10(September 19th)||8||
48277529|NCT05833100|101003139|FG002|COMPLETED|Day 10(September 19th)||0||
48277530|NCT05833100|101003137|FG000|NOT COMPLETED|Day 10(September 19th)||0||
48277531|NCT05833100|101003138|FG001|NOT COMPLETED|Day 10(September 19th)||0||
48277532|NCT05833100|101003139|FG002|NOT COMPLETED|Day 10(September 19th)||0||
48277533|NCT05833100|101003137|FG000|STARTED|Day 11(September 21st)||0||
48277534|NCT05833100|101003138|FG001|STARTED|Day 11(September 21st)||8||
48394017|NCT03628599|101295852|FG000|STARTED|Overall Study||18||
48394018|NCT03628599|101295853|FG001|STARTED|Overall Study||19||
48696826|NCT03501992|102041817|FG004|STARTED|Step 3 - Months 25-36||364||
48696827|NCT03501992|102041818|FG005|STARTED|Step 3 - Months 25-36||309||
48696828|NCT03501992|102041813|FG000|COMPLETED|Step 3 - Months 25-36||702||
48696829|NCT03501992|102041814|FG001|COMPLETED|Step 3 - Months 25-36||188||
48696830|NCT03501992|102041815|FG002|COMPLETED|Step 3 - Months 25-36||401||
48696831|NCT03501992|102041816|FG003|COMPLETED|Step 3 - Months 25-36||241||
48696832|NCT03501992|102041817|FG004|COMPLETED|Step 3 - Months 25-36||364||
48394019|NCT03628599|101295852|FG000|COMPLETED|Overall Study||18||
48277535|NCT05833100|101003139|FG002|STARTED|Day 11(September 21st)||0||
48277536|NCT05833100|101003137|FG000|COMPLETED|Day 11(September 21st)||0||
48277537|NCT05833100|101003138|FG001|COMPLETED|Day 11(September 21st)||8||
48277538|NCT05833100|101003139|FG002|COMPLETED|Day 11(September 21st)||0||
48277539|NCT05833100|101003137|FG000|NOT COMPLETED|Day 11(September 21st)||0||
48277540|NCT05833100|101003138|FG001|NOT COMPLETED|Day 11(September 21st)||0||
48277541|NCT05833100|101003139|FG002|NOT COMPLETED|Day 11(September 21st)||0||
48277542|NCT01652495|101003140|FG000|STARTED|Overall Study||22||
48277543|NCT01652495|101003141|FG001|STARTED|Overall Study||22||
48277544|NCT01652495|101003140|FG000|COMPLETED|Overall Study||20||
48277545|NCT01652495|101003141|FG001|COMPLETED|Overall Study||20||
48277546|NCT01652495|101003140|FG000|NOT COMPLETED|Overall Study||2||
48277547|NCT01652495|101003141|FG001|NOT COMPLETED|Overall Study||2||
48277548|NCT00699153|101003142|FG000|STARTED|Overall Study||203||
48277549|NCT00699153|101003143|FG001|STARTED|Overall Study||202||
48277550|NCT00699153|101003142|FG000|COMPLETED|Overall Study||200||
48277551|NCT00699153|101003143|FG001|COMPLETED|Overall Study||200||
48277552|NCT00699153|101003142|FG000|NOT COMPLETED|Overall Study||3||
48277553|NCT00699153|101003143|FG001|NOT COMPLETED|Overall Study||2||
48277554|NCT02387970|101003144|FG000|STARTED|Overall Study||27||
48277555|NCT02387970|101003145|FG001|STARTED|Overall Study||25||
48277556|NCT02387970|101003144|FG000|COMPLETED|Overall Study||26||
48277557|NCT02387970|101003145|FG001|COMPLETED|Overall Study||23||
48277558|NCT02387970|101003144|FG000|NOT COMPLETED|Overall Study||1||
48277559|NCT02387970|101003145|FG001|NOT COMPLETED|Overall Study||2||
48277560|NCT00452023|101003146|FG000|STARTED|Overall Study||3||
48277561|NCT00452023|101003147|FG001|STARTED|Overall Study||3||
48277562|NCT00452023|101003148|FG002|STARTED|Overall Study||19||
48277563|NCT00452023|101003149|FG003|STARTED|Overall Study||26||
48277564|NCT00452023|101003150|FG004|STARTED|Overall Study||32||
48277565|NCT00452023|101003146|FG000|COMPLETED|Overall Study||3||
48277566|NCT00452023|101003147|FG001|COMPLETED|Overall Study||3||
48277567|NCT00452023|101003148|FG002|COMPLETED|Overall Study||19||
48277568|NCT00452023|101003149|FG003|COMPLETED|Overall Study||26||
48277569|NCT00452023|101003150|FG004|COMPLETED|Overall Study||32||
48277570|NCT00452023|101003146|FG000|NOT COMPLETED|Overall Study||0||
48277571|NCT00452023|101003147|FG001|NOT COMPLETED|Overall Study||0||
48277572|NCT00452023|101003148|FG002|NOT COMPLETED|Overall Study||0||
48277573|NCT00452023|101003149|FG003|NOT COMPLETED|Overall Study||0||
48277574|NCT00452023|101003150|FG004|NOT COMPLETED|Overall Study||0||
48277575|NCT04368364|101003151|FG000|STARTED|Overall Study||1||
48277576|NCT04368364|101003152|FG001|STARTED|Overall Study||1||
48277577|NCT04368364|101003153|FG002|STARTED|Overall Study||1||
48277578|NCT04368364|101003151|FG000|COMPLETED|Overall Study||1||
48277579|NCT04368364|101003152|FG001|COMPLETED|Overall Study||1||
48277580|NCT04368364|101003153|FG002|COMPLETED|Overall Study||1||
48277581|NCT04368364|101003151|FG000|NOT COMPLETED|Overall Study||0||
48277582|NCT04368364|101003152|FG001|NOT COMPLETED|Overall Study||0||
48277583|NCT04368364|101003153|FG002|NOT COMPLETED|Overall Study||0||
48277584|NCT05038163|101003154|FG000|STARTED|Stage 1||4033||
48277585|NCT05038163|101003155|FG001|STARTED|Stage 1||0||
48277586|NCT05038163|101003156|FG002|STARTED|Stage 1||0||
48277587|NCT05038163|101003157|FG003|STARTED|Stage 1||0||
48277588|NCT05038163|101003158|FG004|STARTED|Stage 1||0||
48277589|NCT05038163|101003159|FG005|STARTED|Stage 1||0||
48563184|NCT00395629|101710113|FG002|COMPLETED|Core Study||16||
48563185|NCT00395629|101710111|FG000|NOT COMPLETED|Core Study||1||
48277590|NCT05038163|101003154|FG000|COMPLETED|Stage 1||3659||
48277591|NCT05038163|101003155|FG001|COMPLETED|Stage 1||0||
48563186|NCT00395629|101710112|FG001|NOT COMPLETED|Core Study||4||
48563187|NCT00395629|101710113|FG002|NOT COMPLETED|Core Study||7||
48563188|NCT00395629|101710111|FG000|STARTED|Extension Study||9||
48563189|NCT00395629|101710112|FG001|STARTED|Extension Study||6||
48563190|NCT00395629|101710113|FG002|STARTED|Extension Study||11||
48563191|NCT00395629|101710111|FG000|COMPLETED|Extension Study||9||
48563192|NCT00395629|101710112|FG001|COMPLETED|Extension Study||6||
48563193|NCT00395629|101710113|FG002|COMPLETED|Extension Study||8||
48563194|NCT00395629|101710111|FG000|NOT COMPLETED|Extension Study||0||
48563195|NCT00395629|101710112|FG001|NOT COMPLETED|Extension Study||0||
48563196|NCT00395629|101710113|FG002|NOT COMPLETED|Extension Study||3||
48563197|NCT02757053|101710114|FG000|STARTED|Overall Study||3||
48563198|NCT02757053|101710115|FG001|STARTED|Overall Study||5||
48277592|NCT05038163|101003156|FG002|COMPLETED|Stage 1||0||
48277593|NCT05038163|101003157|FG003|COMPLETED|Stage 1||0||
48277594|NCT05038163|101003158|FG004|COMPLETED|Stage 1||0||
48277595|NCT05038163|101003159|FG005|COMPLETED|Stage 1||0||
48277596|NCT05038163|101003154|FG000|NOT COMPLETED|Stage 1||374||
48277597|NCT05038163|101003155|FG001|NOT COMPLETED|Stage 1||0||
48277598|NCT05038163|101003156|FG002|NOT COMPLETED|Stage 1||0||
48277599|NCT05038163|101003157|FG003|NOT COMPLETED|Stage 1||0||
48277600|NCT05038163|101003158|FG004|NOT COMPLETED|Stage 1||0||
48277601|NCT05038163|101003159|FG005|NOT COMPLETED|Stage 1||0||
48277602|NCT05038163|101003154|FG000|STARTED|Stage 2||0||
48277603|NCT05038163|101003155|FG001|STARTED|Stage 2||696||
48277604|NCT05038163|101003156|FG002|STARTED|Stage 2||683||
48277605|NCT05038163|101003157|FG003|STARTED|Stage 2||668||
48563199|NCT02757053|101710114|FG000|COMPLETED|Overall Study||0||
48563200|NCT02757053|101710115|FG001|COMPLETED|Overall Study||0||
48563201|NCT02757053|101710114|FG000|NOT COMPLETED|Overall Study||3||
48563202|NCT02757053|101710115|FG001|NOT COMPLETED|Overall Study||5||
48277606|NCT05038163|101003158|FG004|STARTED|Stage 2||683||
48277607|NCT05038163|101003159|FG005|STARTED|Stage 2||100||
48277608|NCT05038163|101003154|FG000|COMPLETED|Stage 2||0||
48277609|NCT05038163|101003155|FG001|COMPLETED|Stage 2||667||
48277610|NCT05038163|101003156|FG002|COMPLETED|Stage 2||653||
48277611|NCT05038163|101003157|FG003|COMPLETED|Stage 2||644||
48277612|NCT05038163|101003158|FG004|COMPLETED|Stage 2||662||
48277613|NCT05038163|101003159|FG005|COMPLETED|Stage 2||0||
48277614|NCT05038163|101003154|FG000|NOT COMPLETED|Stage 2||0||
48277615|NCT05038163|101003155|FG001|NOT COMPLETED|Stage 2||29||
48394020|NCT03628599|101295853|FG001|COMPLETED|Overall Study||18||
48394021|NCT03628599|101295852|FG000|NOT COMPLETED|Overall Study||0||
48394022|NCT03628599|101295853|FG001|NOT COMPLETED|Overall Study||1||
48394023|NCT01297309|101295854|FG000|STARTED|Overall Study||51||
48394024|NCT01297309|101295854|FG000|Treated|Overall Study||49||
48394025|NCT01297309|101295854|FG000|Started Extension Period|Overall Study||46||
48394026|NCT01297309|101295854|FG000|COMPLETED|Overall Study||37||
48277616|NCT05038163|101003156|FG002|NOT COMPLETED|Stage 2||30||
48277617|NCT05038163|101003157|FG003|NOT COMPLETED|Stage 2||24||
48277618|NCT05038163|101003158|FG004|NOT COMPLETED|Stage 2||21||
48394027|NCT01297309|101295854|FG000|NOT COMPLETED|Overall Study||14||
48394028|NCT01797445|101295855|FG000|STARTED|Double-Blind Phase||435||
48394029|NCT01797445|101295856|FG001|STARTED|Double-Blind Phase||437||
48394030|NCT01797445|101295855|FG000|COMPLETED|Double-Blind Phase||348||
48394031|NCT01797445|101295856|FG001|COMPLETED|Double-Blind Phase||348||
48394032|NCT01797445|101295855|FG000|NOT COMPLETED|Double-Blind Phase||87||
48394033|NCT01797445|101295856|FG001|NOT COMPLETED|Double-Blind Phase||89||
48394034|NCT01797445|101295855|FG000|STARTED|Open-Label Extension Phase||141||
48394035|NCT01797445|101295856|FG001|STARTED|Open-Label Extension Phase||119||
48394036|NCT01797445|101295855|FG000|COMPLETED|Open-Label Extension Phase||140||
48394037|NCT01797445|101295856|FG001|COMPLETED|Open-Label Extension Phase||119||
48394038|NCT01797445|101295855|FG000|NOT COMPLETED|Open-Label Extension Phase||1||
48394039|NCT01797445|101295856|FG001|NOT COMPLETED|Open-Label Extension Phase||0||
48394040|NCT01624506|101295857|FG000|STARTED|Overall Study||530||
48394041|NCT01624506|101295858|FG001|STARTED|Overall Study||230||
48277619|NCT05038163|101003159|FG005|NOT COMPLETED|Stage 2||100||
48277620|NCT00400725|101003160|FG000|STARTED|Initial Phase (up to 4 Weeks)||288||
48277621|NCT00400725|101003161|FG001|STARTED|Initial Phase (up to 4 Weeks)||0||
48277622|NCT00400725|101003162|FG002|STARTED|Initial Phase (up to 4 Weeks)||0||
48277623|NCT00400725|101003160|FG000|COMPLETED|Initial Phase (up to 4 Weeks)||271||
48277624|NCT00400725|101003161|FG001|COMPLETED|Initial Phase (up to 4 Weeks)||0||
48277625|NCT00400725|101003162|FG002|COMPLETED|Initial Phase (up to 4 Weeks)||0||
48277626|NCT00400725|101003160|FG000|NOT COMPLETED|Initial Phase (up to 4 Weeks)||17||
48277627|NCT00400725|101003161|FG001|NOT COMPLETED|Initial Phase (up to 4 Weeks)||0||
48394042|NCT01624506|101295857|FG000|COMPLETED|Overall Study||465||
48394043|NCT01624506|101295858|FG001|COMPLETED|Overall Study||213||
48394044|NCT01624506|101295857|FG000|NOT COMPLETED|Overall Study||65||
48394045|NCT01624506|101295858|FG001|NOT COMPLETED|Overall Study||17||
48394046|NCT00851253|101295859|FG000|STARTED|Overall Study||2||
48394047|NCT00851253|101295860|FG001|STARTED|Overall Study||10||
48394048|NCT00851253|101295859|FG000|COMPLETED|Overall Study||1||
48394049|NCT00851253|101295860|FG001|COMPLETED|Overall Study||10||
48394050|NCT00851253|101295859|FG000|NOT COMPLETED|Overall Study||1||
48394051|NCT00851253|101295860|FG001|NOT COMPLETED|Overall Study||0||
48394052|NCT02758613|101295861|FG000|STARTED|Treatment||8||
48394053|NCT02758613|101295862|FG001|STARTED|Treatment||8||
48394054|NCT02758613|101295863|FG002|STARTED|Treatment||9||
48394055|NCT02758613|101295864|FG003|STARTED|Treatment||8||
48394056|NCT02758613|101295861|FG000|Received at Least One Dose of Study Drug|Treatment||8||
48394057|NCT02758613|101295862|FG001|Received at Least One Dose of Study Drug|Treatment||8||
48394058|NCT02758613|101295863|FG002|Received at Least One Dose of Study Drug|Treatment||9||
48394059|NCT02758613|101295864|FG003|Received at Least One Dose of Study Drug|Treatment||8||
48394060|NCT02758613|101295861|FG000|COMPLETED|Treatment||6||
48394061|NCT02758613|101295862|FG001|COMPLETED|Treatment||8||
48394062|NCT02758613|101295863|FG002|COMPLETED|Treatment||8||
48394063|NCT02758613|101295864|FG003|COMPLETED|Treatment||8||
48394064|NCT02758613|101295861|FG000|NOT COMPLETED|Treatment||2||
48394065|NCT02758613|101295862|FG001|NOT COMPLETED|Treatment||0||
48394066|NCT02758613|101295863|FG002|NOT COMPLETED|Treatment||1||
48394067|NCT02758613|101295864|FG003|NOT COMPLETED|Treatment||0||
48394068|NCT02758613|101295861|FG000|STARTED|Follow-up||6||
48394069|NCT02758613|101295862|FG001|STARTED|Follow-up||8||
48394070|NCT02758613|101295863|FG002|STARTED|Follow-up||8||
48394071|NCT02758613|101295864|FG003|STARTED|Follow-up||8||
48394072|NCT02758613|101295861|FG000|COMPLETED|Follow-up||6||
48394073|NCT02758613|101295862|FG001|COMPLETED|Follow-up||8||
48394074|NCT02758613|101295863|FG002|COMPLETED|Follow-up||8||
48394075|NCT02758613|101295864|FG003|COMPLETED|Follow-up||8||
48394076|NCT02758613|101295861|FG000|NOT COMPLETED|Follow-up||0||
48394077|NCT02758613|101295862|FG001|NOT COMPLETED|Follow-up||0||
48394078|NCT02758613|101295863|FG002|NOT COMPLETED|Follow-up||0||
48394079|NCT02758613|101295864|FG003|NOT COMPLETED|Follow-up||0||
48394080|NCT02678312|101295865|FG000|STARTED|Part 1 Open Label Epoch- Period 1||17|Out of 26 participants enrolled in the Part 1 of the study, 17 were dosed based on their age to receive LCZ696 0.8 mg or 0.4 mg in Period 1.|
48394081|NCT02678312|101295866|FG001|STARTED|Part 1 Open Label Epoch- Period 1||0|Out of 26 participants enrolled in the Part 1 of the study, 17 were dosed based on their age to receive LCZ696 0.8 mg or 0.4 mg in Period 1.|
48394082|NCT02678312|101295867|FG002|STARTED|Part 1 Open Label Epoch- Period 1||0|Out of 26 participants enrolled in the Part 1 of the study, 17 were dosed based on their age to receive LCZ696 0.8 mg or 0.4 mg in Period 1.|
48394083|NCT02678312|101295868|FG003|STARTED|Part 1 Open Label Epoch- Period 1||0|Out of 26 participants enrolled in the Part 1 of the study, 17 were dosed based on their age to receive LCZ696 0.8 mg or 0.4 mg in Period 1.|
48277628|NCT00400725|101003162|FG002|NOT COMPLETED|Initial Phase (up to 4 Weeks)||0||
48277629|NCT00400725|101003160|FG000|STARTED|Maintenance Phase (up to 6 Months)||0||
48277630|NCT00400725|101003161|FG001|STARTED|Maintenance Phase (up to 6 Months)||106||
48277631|NCT00400725|101003162|FG002|STARTED|Maintenance Phase (up to 6 Months)||111||
48394084|NCT02678312|101295869|FG004|STARTED|Part 1 Open Label Epoch- Period 1||0|Out of 26 participants enrolled in the Part 1 of the study, 17 were dosed based on their age to receive LCZ696 0.8 mg or 0.4 mg in Period 1.|
48696833|NCT03501992|102041818|FG005|COMPLETED|Step 3 - Months 25-36||309||
48696834|NCT03501992|102041813|FG000|NOT COMPLETED|Step 3 - Months 25-36||0||
48696835|NCT03501992|102041814|FG001|NOT COMPLETED|Step 3 - Months 25-36||0||
48696836|NCT03501992|102041815|FG002|NOT COMPLETED|Step 3 - Months 25-36||0||
48696837|NCT03501992|102041816|FG003|NOT COMPLETED|Step 3 - Months 25-36||0||
48696838|NCT03501992|102041817|FG004|NOT COMPLETED|Step 3 - Months 25-36||0||
48696839|NCT03501992|102041818|FG005|NOT COMPLETED|Step 3 - Months 25-36||0||
48696840|NCT03501992|102041813|FG000|STARTED|Step 4 - Months 37-48||682||
48696841|NCT03501992|102041814|FG001|STARTED|Step 4 - Months 37-48||161||
48696842|NCT03501992|102041815|FG002|STARTED|Step 4 - Months 37-48||421||
48696843|NCT03501992|102041816|FG003|STARTED|Step 4 - Months 37-48||254||
48696844|NCT03501992|102041817|FG004|STARTED|Step 4 - Months 37-48||342||
48696845|NCT03501992|102041818|FG005|STARTED|Step 4 - Months 37-48||303||
48277632|NCT00400725|101003160|FG000|COMPLETED|Maintenance Phase (up to 6 Months)||0||
48277633|NCT00400725|101003161|FG001|COMPLETED|Maintenance Phase (up to 6 Months)||90||
48277634|NCT00400725|101003162|FG002|COMPLETED|Maintenance Phase (up to 6 Months)||82||
48277635|NCT00400725|101003160|FG000|NOT COMPLETED|Maintenance Phase (up to 6 Months)||0||
48277636|NCT00400725|101003161|FG001|NOT COMPLETED|Maintenance Phase (up to 6 Months)||16||
48277637|NCT00400725|101003162|FG002|NOT COMPLETED|Maintenance Phase (up to 6 Months)||29||
48696846|NCT03501992|102041813|FG000|COMPLETED|Step 4 - Months 37-48||682||
48696847|NCT03501992|102041814|FG001|COMPLETED|Step 4 - Months 37-48||161||
48696848|NCT03501992|102041815|FG002|COMPLETED|Step 4 - Months 37-48||421||
48696849|NCT03501992|102041816|FG003|COMPLETED|Step 4 - Months 37-48||254||
48696850|NCT03501992|102041817|FG004|COMPLETED|Step 4 - Months 37-48||342||
48696851|NCT03501992|102041818|FG005|COMPLETED|Step 4 - Months 37-48||303||
48696852|NCT03501992|102041813|FG000|NOT COMPLETED|Step 4 - Months 37-48||0||
48696853|NCT03501992|102041814|FG001|NOT COMPLETED|Step 4 - Months 37-48||0||
48696854|NCT03501992|102041815|FG002|NOT COMPLETED|Step 4 - Months 37-48||0||
48696855|NCT03501992|102041816|FG003|NOT COMPLETED|Step 4 - Months 37-48||0||
48696856|NCT03501992|102041817|FG004|NOT COMPLETED|Step 4 - Months 37-48||0||
48696857|NCT03501992|102041818|FG005|NOT COMPLETED|Step 4 - Months 37-48||0||
48277638|NCT02818244|101003163|FG000|STARTED|Overall Study||25||25
48277639|NCT02818244|101003164|FG001|STARTED|Overall Study||25||25
48114053|NCT00974571|100605078|FG000|NOT COMPLETED|Overall Study||68||
48114054|NCT00974571|100605079|FG001|NOT COMPLETED|Overall Study||16||
48114055|NCT00974571|100605080|FG002|NOT COMPLETED|Overall Study||83||
48114056|NCT00006184|100605081|FG000|STARTED|Overall Study||10||
48114057|NCT00006184|100605082|FG001|STARTED|Overall Study||10||
48114058|NCT00006184|100605081|FG000|COMPLETED|Overall Study||9||
48114059|NCT00006184|100605082|FG001|COMPLETED|Overall Study||10||
48277640|NCT02818244|101003165|FG002|STARTED|Overall Study||25||25
48277641|NCT02818244|101003166|FG003|STARTED|Overall Study||25||25
48277642|NCT02818244|101003163|FG000|COMPLETED|Overall Study||25||25
48277643|NCT02818244|101003164|FG001|COMPLETED|Overall Study||25||25
48277644|NCT02818244|101003165|FG002|COMPLETED|Overall Study||25||25
48114060|NCT00006184|100605081|FG000|NOT COMPLETED|Overall Study||1||
48114061|NCT00006184|100605082|FG001|NOT COMPLETED|Overall Study||0||
48114062|NCT00355238|100605083|FG000|STARTED|Overall Study||55||
48114063|NCT00355238|100605084|FG001|STARTED|Overall Study||46||
48114064|NCT00355238|100605085|FG002|STARTED|Overall Study||22||
48277645|NCT02818244|101003166|FG003|COMPLETED|Overall Study||25||25
48277646|NCT02818244|101003163|FG000|NOT COMPLETED|Overall Study||0||0
48277647|NCT02818244|101003164|FG001|NOT COMPLETED|Overall Study||0||0
48277648|NCT02818244|101003165|FG002|NOT COMPLETED|Overall Study||0||0
48277649|NCT02818244|101003166|FG003|NOT COMPLETED|Overall Study||0||0
48696858|NCT03763656|102041819|FG000|STARTED|Overall Study||33|Overall (Screened)|
48696859|NCT03763656|102041819|FG000|Pre-treatment Discontinuation|Overall Study||1||
48696860|NCT03763656|102041819|FG000|Safety Population|Overall Study||32||
48696861|NCT03763656|102041819|FG000|Age Group (6 Months - 1.99 Years)|Overall Study||6||
48696862|NCT03763656|102041819|FG000|Discontinuations From Age Group (6 Months - 1.99 Years)|Overall Study||3||
48696863|NCT03763656|102041819|FG000|Completed From Age Group (6 Months - 1.99 Years)|Overall Study||3||
48696864|NCT03763656|102041819|FG000|Age Group (2 - 5.99 Years)|Overall Study||16||
48696865|NCT03763656|102041819|FG000|Discontinuations From Age Group (2 - 5.99 Years)|Overall Study||2||
48696866|NCT03763656|102041819|FG000|Completions From Age Group (2 - 5.99 Years)|Overall Study||14||
48696867|NCT03763656|102041819|FG000|Age Group (6 - 17.99 Years)|Overall Study||10||
48696868|NCT03763656|102041819|FG000|Discontinuations From Age Group (6 - 17.99 Years)|Overall Study||3||
48696869|NCT03763656|102041819|FG000|Completions From Age Group (6 - 17.99 Years)|Overall Study||7||
48696870|NCT03763656|102041819|FG000|COMPLETED|Overall Study||24|Overall from all age groups|
48696871|NCT03763656|102041819|FG000|NOT COMPLETED|Overall Study||9||
48696872|NCT00123162|102041820|FG000|STARTED|Overall Study||13||
48696873|NCT00123162|102041821|FG001|STARTED|Overall Study||12||
48696874|NCT00123162|102041820|FG000|COMPLETED|Overall Study||13||
48696875|NCT00123162|102041821|FG001|COMPLETED|Overall Study||12||
48114065|NCT00355238|100605086|FG003|STARTED|Overall Study||14||
48114066|NCT00355238|100605083|FG000|Crossed Over From Doxorubicin to Recieve Brivanib Alaninate|Overall Study||0||
48277650|NCT01283152|101003167|FG000|STARTED|Overall Study||25||
48277651|NCT01283152|101003168|FG001|STARTED|Overall Study||25||
48277652|NCT01283152|101003167|FG000|ITT Population|Overall Study||25||
48696876|NCT00123162|102041820|FG000|NOT COMPLETED|Overall Study||0||
48696877|NCT00123162|102041821|FG001|NOT COMPLETED|Overall Study||0||
48696878|NCT00218634|102041822|FG000|STARTED|Overall Study||44||
48277653|NCT01283152|101003168|FG001|ITT Population|Overall Study||25||
48394085|NCT02678312|101295865|FG000|COMPLETED|Part 1 Open Label Epoch- Period 1||14||
48394086|NCT02678312|101295866|FG001|COMPLETED|Part 1 Open Label Epoch- Period 1||0||
48394087|NCT02678312|101295867|FG002|COMPLETED|Part 1 Open Label Epoch- Period 1||0||
48277654|NCT01283152|101003167|FG000|Study Treatment Received|Overall Study||25||
48277655|NCT01283152|101003168|FG001|Study Treatment Received|Overall Study||25||
48277656|NCT01283152|101003167|FG000|24-hr HESA Attempted|Overall Study||25||
48277657|NCT01283152|101003168|FG001|24-hr HESA Attempted|Overall Study||25||
48277658|NCT01283152|101003167|FG000|COMPLETED|Overall Study||23||
48277659|NCT01283152|101003168|FG001|COMPLETED|Overall Study||25||
48277660|NCT01283152|101003167|FG000|NOT COMPLETED|Overall Study||2||
48277661|NCT01283152|101003168|FG001|NOT COMPLETED|Overall Study||0||
48277662|NCT05327816|101003169|FG000|STARTED|Overall Study||12||
48277663|NCT05327816|101003170|FG001|STARTED|Overall Study||12||
48277664|NCT05327816|101003171|FG002|STARTED|Overall Study||12||
48277665|NCT05327816|101003172|FG003|STARTED|Overall Study||12||
48277666|NCT05327816|101003173|FG004|STARTED|Overall Study||12||
48277667|NCT05327816|101003174|FG005|STARTED|Overall Study||12||
48277668|NCT05327816|101003175|FG006|STARTED|Overall Study||12||
48277669|NCT05327816|101003176|FG007|STARTED|Overall Study||12||
48277670|NCT05327816|101003177|FG008|STARTED|Overall Study||12||
48277671|NCT05327816|101003178|FG009|STARTED|Overall Study||12||
48277672|NCT05327816|101003179|FG010|STARTED|Overall Study||12||
48277673|NCT05327816|101003169|FG000|Treated (Full Analysis Set)|Overall Study||12||
48277674|NCT05327816|101003170|FG001|Treated (Full Analysis Set)|Overall Study||12||
48277675|NCT05327816|101003171|FG002|Treated (Full Analysis Set)|Overall Study||12||
48277676|NCT05327816|101003172|FG003|Treated (Full Analysis Set)|Overall Study||12||
48277677|NCT05327816|101003173|FG004|Treated (Full Analysis Set)|Overall Study||12||
48277678|NCT05327816|101003174|FG005|Treated (Full Analysis Set)|Overall Study||12||
48277679|NCT05327816|101003175|FG006|Treated (Full Analysis Set)|Overall Study||11||
48394088|NCT02678312|101295868|FG003|COMPLETED|Part 1 Open Label Epoch- Period 1||0||
48394089|NCT02678312|101295869|FG004|COMPLETED|Part 1 Open Label Epoch- Period 1||0||
48563203|NCT03743051|101710116|FG000|STARTED|Overall Study||159|Randomized patients|
48563204|NCT03743051|101710117|FG001|STARTED|Overall Study||159|Randomized patients|
48563205|NCT03743051|101710116|FG000|Treated Patients|Overall Study||159||
48563206|NCT03743051|101710117|FG001|Treated Patients|Overall Study||159||
48563207|NCT03743051|101710116|FG000|COMPLETED|Overall Study||78||
48563208|NCT03743051|101710117|FG001|COMPLETED|Overall Study||76||
48563209|NCT03743051|101710116|FG000|NOT COMPLETED|Overall Study||81||
48563210|NCT03743051|101710117|FG001|NOT COMPLETED|Overall Study||83||
48563211|NCT02452944|101710118|FG000|STARTED|Overall Study||31||
48563212|NCT02452944|101710119|FG001|STARTED|Overall Study||31||
48563213|NCT02452944|101710118|FG000|COMPLETED|Overall Study||31||
48563214|NCT02452944|101710119|FG001|COMPLETED|Overall Study||31||
48563215|NCT02452944|101710118|FG000|NOT COMPLETED|Overall Study||0||
48563216|NCT02452944|101710119|FG001|NOT COMPLETED|Overall Study||0||
48563217|NCT01890122|101710120|FG000|STARTED|Overall Study||162||
48563218|NCT01890122|101710121|FG001|STARTED|Overall Study||163||
48563219|NCT01890122|101710122|FG002|STARTED|Overall Study||159||
48563220|NCT01890122|101710123|FG003|STARTED|Overall Study||163||
48563221|NCT01890122|101710120|FG000|Treated|Overall Study||161||
48563222|NCT01890122|101710121|FG001|Treated|Overall Study||162||
48563223|NCT01890122|101710122|FG002|Treated|Overall Study||159||
48563224|NCT01890122|101710123|FG003|Treated|Overall Study||163||
48563225|NCT01890122|101710120|FG000|COMPLETED|Overall Study||135||
48563226|NCT01890122|101710121|FG001|COMPLETED|Overall Study||126||
48563227|NCT01890122|101710122|FG002|COMPLETED|Overall Study||146||
48563228|NCT01890122|101710123|FG003|COMPLETED|Overall Study||104||
48563229|NCT01890122|101710120|FG000|NOT COMPLETED|Overall Study||27||
48563230|NCT01890122|101710121|FG001|NOT COMPLETED|Overall Study||37||
48563231|NCT01890122|101710122|FG002|NOT COMPLETED|Overall Study||13||
48563232|NCT01890122|101710123|FG003|NOT COMPLETED|Overall Study||59||
48277680|NCT05327816|101003176|FG007|Treated (Full Analysis Set)|Overall Study||11||
48277681|NCT05327816|101003177|FG008|Treated (Full Analysis Set)|Overall Study||11||
48277682|NCT05327816|101003178|FG009|Treated (Full Analysis Set)|Overall Study||12||
48277683|NCT05327816|101003179|FG010|Treated (Full Analysis Set)|Overall Study||12||
48277684|NCT05327816|101003169|FG000|COMPLETED|Overall Study||0||
48277685|NCT05327816|101003170|FG001|COMPLETED|Overall Study||0||
48277686|NCT05327816|101003171|FG002|COMPLETED|Overall Study||0||
48277687|NCT05327816|101003172|FG003|COMPLETED|Overall Study||0||
48696879|NCT00218634|102041823|FG001|STARTED|Overall Study||45||
48696880|NCT00218634|102041822|FG000|COMPLETED|Overall Study||36||
48277688|NCT05327816|101003173|FG004|COMPLETED|Overall Study||0||
48277689|NCT05327816|101003174|FG005|COMPLETED|Overall Study||0||
48277690|NCT05327816|101003175|FG006|COMPLETED|Overall Study||0||
48563233|NCT02394600|101710124|FG000|STARTED|Overall Study||47||
48563234|NCT02394600|101710125|FG001|STARTED|Overall Study||46||
48563235|NCT02394600|101710124|FG000|COMPLETED|Overall Study||43||
48563236|NCT02394600|101710125|FG001|COMPLETED|Overall Study||44||
48696881|NCT00218634|102041823|FG001|COMPLETED|Overall Study||30||
48277691|NCT05327816|101003176|FG007|COMPLETED|Overall Study||0||
48277692|NCT05327816|101003177|FG008|COMPLETED|Overall Study||0||
48277693|NCT05327816|101003178|FG009|COMPLETED|Overall Study||0||
48277694|NCT05327816|101003179|FG010|COMPLETED|Overall Study||0||
48277695|NCT05327816|101003169|FG000|NOT COMPLETED|Overall Study||12||
48277696|NCT05327816|101003170|FG001|NOT COMPLETED|Overall Study||12||
48277697|NCT05327816|101003171|FG002|NOT COMPLETED|Overall Study||12||
48277698|NCT05327816|101003172|FG003|NOT COMPLETED|Overall Study||12||
48277699|NCT05327816|101003173|FG004|NOT COMPLETED|Overall Study||12||
48277700|NCT05327816|101003174|FG005|NOT COMPLETED|Overall Study||12||
48394090|NCT02678312|101295865|FG000|NOT COMPLETED|Part 1 Open Label Epoch- Period 1||3||
48394091|NCT02678312|101295866|FG001|NOT COMPLETED|Part 1 Open Label Epoch- Period 1||0||
48394092|NCT02678312|101295867|FG002|NOT COMPLETED|Part 1 Open Label Epoch- Period 1||0||
48394093|NCT02678312|101295868|FG003|NOT COMPLETED|Part 1 Open Label Epoch- Period 1||0||
48394094|NCT02678312|101295869|FG004|NOT COMPLETED|Part 1 Open Label Epoch- Period 1||0||
48563237|NCT02394600|101710124|FG000|NOT COMPLETED|Overall Study||4||
48394095|NCT02678312|101295865|FG000|STARTED|Part 1 Open Label Epoch- Period 2||0||
48394096|NCT02678312|101295866|FG001|STARTED|Part 1 Open Label Epoch- Period 2||18||
48394097|NCT02678312|101295867|FG002|STARTED|Part 1 Open Label Epoch- Period 2||2||
48394098|NCT02678312|101295868|FG003|STARTED|Part 1 Open Label Epoch- Period 2||0||
48394099|NCT02678312|101295869|FG004|STARTED|Part 1 Open Label Epoch- Period 2||0||
48563238|NCT02394600|101710125|FG001|NOT COMPLETED|Overall Study||2||
48563239|NCT00350207|101710126|FG000|STARTED|Overall Study||128||
48563240|NCT00350207|101710127|FG001|STARTED|Overall Study||134||
48563241|NCT00350207|101710128|FG002|STARTED|Overall Study||126||
48563242|NCT00350207|101710126|FG000|COMPLETED|Overall Study||120||
48563243|NCT00350207|101710127|FG001|COMPLETED|Overall Study||128||
48563244|NCT00350207|101710128|FG002|COMPLETED|Overall Study||119||
48563245|NCT00350207|101710126|FG000|NOT COMPLETED|Overall Study||8||
48563246|NCT00350207|101710127|FG001|NOT COMPLETED|Overall Study||6||
48563247|NCT00350207|101710128|FG002|NOT COMPLETED|Overall Study||7||
48563248|NCT02045264|101710129|FG000|STARTED|Overall Study||12||
48563249|NCT02045264|101710129|FG000|COMPLETED|Overall Study||12||
48563250|NCT02045264|101710129|FG000|NOT COMPLETED|Overall Study||0||
48563251|NCT02137252|101710130|FG000|STARTED|Overall Study||2|Represents intervention phase|
48563252|NCT02137252|101710131|FG001|STARTED|Overall Study||1|Represents intervention phase|
48563253|NCT02137252|101710130|FG000|COMPLETED|Overall Study||0||
48563254|NCT02137252|101710131|FG001|COMPLETED|Overall Study||0||
48563255|NCT02137252|101710130|FG000|NOT COMPLETED|Overall Study||2||
48563256|NCT02137252|101710131|FG001|NOT COMPLETED|Overall Study||1||
48563257|NCT01922037|101710132|FG000|STARTED|Overall Study||69||
48563258|NCT01922037|101710133|FG001|STARTED|Overall Study||737||
48563259|NCT01922037|101710132|FG000|Treated|Overall Study||69||
48696882|NCT00218634|102041822|FG000|NOT COMPLETED|Overall Study||8||
48696883|NCT00218634|102041823|FG001|NOT COMPLETED|Overall Study||15||
48696884|NCT03955250|102041824|FG000|STARTED|Overall Study||19||
48696885|NCT03955250|102041825|FG001|STARTED|Overall Study||23||
48696886|NCT03955250|102041824|FG000|COMPLETED|Overall Study||17||
48696887|NCT03955250|102041825|FG001|COMPLETED|Overall Study||16||
48696888|NCT03955250|102041824|FG000|NOT COMPLETED|Overall Study||2||
48696889|NCT03955250|102041825|FG001|NOT COMPLETED|Overall Study||7||
48696890|NCT04022226|102041826|FG000|STARTED|Overall Study||11||
48696891|NCT04022226|102041826|FG000|COMPLETED|Overall Study||11|Funding was delayed secondary to COVID, impacting study design and recruitment.|
48563260|NCT01922037|101710133|FG001|Treated|Overall Study||732||
48563261|NCT01922037|101710132|FG000|COMPLETED|Overall Study||59||
48563262|NCT01922037|101710133|FG001|COMPLETED|Overall Study||563||
48563263|NCT01922037|101710132|FG000|NOT COMPLETED|Overall Study||10||
48563264|NCT01922037|101710133|FG001|NOT COMPLETED|Overall Study||174||
48563265|NCT02418949|101710134|FG000|STARTED|Overall Study||23||
48696892|NCT04022226|102041826|FG000|NOT COMPLETED|Overall Study||0||
48696893|NCT02993822|102041827|FG000|STARTED|Overall Study||79||
48696894|NCT02993822|102041828|FG001|STARTED|Overall Study||78||
48696895|NCT02993822|102041829|FG002|STARTED|Overall Study||79||
48696896|NCT02993822|102041830|FG003|STARTED|Overall Study||79||
48696897|NCT02993822|102041827|FG000|COMPLETED|Overall Study||69||
48696898|NCT02993822|102041828|FG001|COMPLETED|Overall Study||74||
48696899|NCT02993822|102041829|FG002|COMPLETED|Overall Study||69||
48277701|NCT05327816|101003175|FG006|NOT COMPLETED|Overall Study||12||
48277702|NCT05327816|101003176|FG007|NOT COMPLETED|Overall Study||12||
48277703|NCT05327816|101003177|FG008|NOT COMPLETED|Overall Study||12||
48563266|NCT02418949|101710135|FG001|STARTED|Overall Study||22||
48563267|NCT02418949|101710136|FG002|STARTED|Overall Study||26||
48563268|NCT02418949|101710137|FG003|STARTED|Overall Study||25||
48563269|NCT02418949|101710134|FG000|COMPLETED|Overall Study||20||
48563270|NCT02418949|101710135|FG001|COMPLETED|Overall Study||21||
48696900|NCT02993822|102041830|FG003|COMPLETED|Overall Study||75||
48696901|NCT02993822|102041827|FG000|NOT COMPLETED|Overall Study||10||
48696902|NCT02993822|102041828|FG001|NOT COMPLETED|Overall Study||4||
48696903|NCT02993822|102041829|FG002|NOT COMPLETED|Overall Study||10||
48696904|NCT02993822|102041830|FG003|NOT COMPLETED|Overall Study||4||
48696905|NCT03844672|102041831|FG000|STARTED|Overall Study||23||
48563271|NCT02418949|101710136|FG002|COMPLETED|Overall Study||23||
48563272|NCT02418949|101710137|FG003|COMPLETED|Overall Study||24||
48563273|NCT02418949|101710134|FG000|NOT COMPLETED|Overall Study||3||
48277704|NCT05327816|101003178|FG009|NOT COMPLETED|Overall Study||12||
48277705|NCT05327816|101003179|FG010|NOT COMPLETED|Overall Study||12||
48277706|NCT05775991|101003180|FG000|STARTED|Overall Study||5||
48563274|NCT02418949|101710135|FG001|NOT COMPLETED|Overall Study||1||
48563275|NCT02418949|101710136|FG002|NOT COMPLETED|Overall Study||3||
48563276|NCT02418949|101710137|FG003|NOT COMPLETED|Overall Study||1||
48563277|NCT01217112|101710138|FG000|STARTED|Overall Study||11||
48563278|NCT01217112|101710139|FG001|STARTED|Overall Study||12||
48563279|NCT01217112|101710140|FG002|STARTED|Overall Study||13||
48563280|NCT01217112|101710141|FG003|STARTED|Overall Study||12||
48563281|NCT01217112|101710142|FG004|STARTED|Overall Study||14||
48563282|NCT01217112|101710138|FG000|COMPLETED|Overall Study||11||
48696906|NCT03844672|102041832|FG001|STARTED|Overall Study||24||
48696907|NCT03844672|102041833|FG002|STARTED|Overall Study||23||
48696908|NCT03844672|102041834|FG003|STARTED|Overall Study||23||
48696909|NCT03844672|102041831|FG000|COMPLETED|Overall Study||17||
48696910|NCT03844672|102041832|FG001|COMPLETED|Overall Study||18||
48696911|NCT03844672|102041833|FG002|COMPLETED|Overall Study||17||
48696912|NCT03844672|102041834|FG003|COMPLETED|Overall Study||15||
48696913|NCT03844672|102041831|FG000|NOT COMPLETED|Overall Study||6||
48696914|NCT03844672|102041832|FG001|NOT COMPLETED|Overall Study||6||
48696915|NCT03844672|102041833|FG002|NOT COMPLETED|Overall Study||6||
48696916|NCT03844672|102041834|FG003|NOT COMPLETED|Overall Study||8||
48696917|NCT02888691|102041835|FG000|STARTED|First Intervention Period||7||
48696918|NCT02888691|102041836|FG001|STARTED|First Intervention Period||7||
48696919|NCT02888691|102041835|FG000|COMPLETED|First Intervention Period||6||
48696920|NCT02888691|102041836|FG001|COMPLETED|First Intervention Period||7||
48696921|NCT02888691|102041835|FG000|NOT COMPLETED|First Intervention Period||1||
48696922|NCT02888691|102041836|FG001|NOT COMPLETED|First Intervention Period||0||
48696923|NCT02888691|102041835|FG000|STARTED|Second Intervention Period||7||
48696924|NCT02888691|102041836|FG001|STARTED|Second Intervention Period||5||
48696925|NCT02888691|102041835|FG000|COMPLETED|Second Intervention Period||7||
48696926|NCT02888691|102041836|FG001|COMPLETED|Second Intervention Period||3||
48696927|NCT02888691|102041835|FG000|NOT COMPLETED|Second Intervention Period||0||
48696928|NCT02888691|102041836|FG001|NOT COMPLETED|Second Intervention Period||2||
48114067|NCT00355238|100605084|FG001|Crossed Over From Doxorubicin to Recieve Brivanib Alaninate|Overall Study||0||
48114068|NCT00355238|100605085|FG002|Crossed Over From Doxorubicin to Recieve Brivanib Alaninate|Overall Study||0||
48114069|NCT00355238|100605086|FG003|Crossed Over From Doxorubicin to Recieve Brivanib Alaninate|Overall Study||6||
48114070|NCT00355238|100605083|FG000|COMPLETED|Overall Study||0||
48114071|NCT00355238|100605084|FG001|COMPLETED|Overall Study||0||
48114072|NCT00355238|100605085|FG002|COMPLETED|Overall Study||0||
48114073|NCT00355238|100605086|FG003|COMPLETED|Overall Study||0||
48114074|NCT00355238|100605083|FG000|NOT COMPLETED|Overall Study||55||
48114075|NCT00355238|100605084|FG001|NOT COMPLETED|Overall Study||46||
48114076|NCT00355238|100605085|FG002|NOT COMPLETED|Overall Study||22||
48114077|NCT00355238|100605086|FG003|NOT COMPLETED|Overall Study||14||
48114078|NCT01420302|100605087|FG000|STARTED|Overall Study||149||
48114079|NCT01420302|100605088|FG001|STARTED|Overall Study||151||
48114080|NCT01420302|100605087|FG000|COMPLETED|Overall Study||149||
48114081|NCT01420302|100605088|FG001|COMPLETED|Overall Study||151||
48114082|NCT01420302|100605087|FG000|NOT COMPLETED|Overall Study||0||
48114083|NCT01420302|100605088|FG001|NOT COMPLETED|Overall Study||0||
48114084|NCT00670800|100605089|FG000|STARTED|Overall Study||7||
48114085|NCT00670800|100605090|FG001|STARTED|Overall Study||7||
48114086|NCT00670800|100605089|FG000|COMPLETED|Overall Study||7||
48114087|NCT00670800|100605090|FG001|COMPLETED|Overall Study||5||
48114088|NCT00670800|100605089|FG000|NOT COMPLETED|Overall Study||0||
48114089|NCT00670800|100605090|FG001|NOT COMPLETED|Overall Study||2||
48114090|NCT02375672|100605091|FG000|STARTED|Overall Study||30||
48114091|NCT02375672|100605091|FG000|COMPLETED|Overall Study||10||
48114092|NCT02375672|100605091|FG000|NOT COMPLETED|Overall Study||20||
48114093|NCT01403090|100605092|FG000|STARTED|Overall Study||8||
48114094|NCT01403090|100605092|FG000|COMPLETED|Overall Study||8||
48114095|NCT01403090|100605092|FG000|NOT COMPLETED|Overall Study||0||
48114096|NCT03852316|100605093|FG000|STARTED|Overall Study||1585||
48114097|NCT03852316|100605093|FG000|COMPLETED|Overall Study||1581||
48563283|NCT01217112|101710139|FG001|COMPLETED|Overall Study||10||
48696929|NCT02461290|102041837|FG000|STARTED|Overall Study||99||
48696930|NCT02461290|102041837|FG000|COMPLETED|Overall Study||89||
48563284|NCT01217112|101710140|FG002|COMPLETED|Overall Study||12||
48563285|NCT01217112|101710141|FG003|COMPLETED|Overall Study||10||
48563286|NCT01217112|101710142|FG004|COMPLETED|Overall Study||13||
48563287|NCT01217112|101710138|FG000|NOT COMPLETED|Overall Study||0||
48563288|NCT01217112|101710139|FG001|NOT COMPLETED|Overall Study||2||
48563289|NCT01217112|101710140|FG002|NOT COMPLETED|Overall Study||1||
48563290|NCT01217112|101710141|FG003|NOT COMPLETED|Overall Study||2||
48563291|NCT01217112|101710142|FG004|NOT COMPLETED|Overall Study||1||
48563292|NCT00615550|101710143|FG000|STARTED|Overall Study||229||
48563293|NCT00615550|101710144|FG001|STARTED|Overall Study||236||
48563294|NCT00615550|101710143|FG000|COMPLETED|Overall Study||223||
48563295|NCT00615550|101710144|FG001|COMPLETED|Overall Study||235||
48563296|NCT00615550|101710143|FG000|NOT COMPLETED|Overall Study||6||
48563297|NCT00615550|101710144|FG001|NOT COMPLETED|Overall Study||1||
48563298|NCT03655405|101710145|FG000|STARTED|Overall Study||32||
48696931|NCT02461290|102041837|FG000|NOT COMPLETED|Overall Study||10||
48696932|NCT04776720|102041838|FG000|STARTED|Overall Study||121||
48114098|NCT03852316|100605093|FG000|NOT COMPLETED|Overall Study||4||
48114099|NCT01987427|100605094|FG000|STARTED|Overall Study||78||
48114100|NCT01987427|100605095|FG001|STARTED|Overall Study||78||
48114101|NCT01987427|100605096|FG002|STARTED|Overall Study||79||
48563299|NCT03655405|101710146|FG001|STARTED|Overall Study||30||
48563300|NCT03655405|101710145|FG000|COMPLETED|Overall Study||27||
48563301|NCT03655405|101710146|FG001|COMPLETED|Overall Study||25||
48563302|NCT03655405|101710145|FG000|NOT COMPLETED|Overall Study||5||
48563303|NCT03655405|101710146|FG001|NOT COMPLETED|Overall Study||5||
48114102|NCT01987427|100605094|FG000|COMPLETED|Overall Study||64||
48114103|NCT01987427|100605095|FG001|COMPLETED|Overall Study||68||
48114104|NCT01987427|100605096|FG002|COMPLETED|Overall Study||59||
48114105|NCT01987427|100605094|FG000|NOT COMPLETED|Overall Study||14||
48114106|NCT01987427|100605095|FG001|NOT COMPLETED|Overall Study||10||
48114107|NCT01987427|100605096|FG002|NOT COMPLETED|Overall Study||20||
48114108|NCT01962558|100605097|FG000|STARTED|Overall Study||16||
48114109|NCT01962558|100605098|FG001|STARTED|Overall Study||14||
48114110|NCT01962558|100605097|FG000|Acute Study|Overall Study||16||
48114111|NCT01962558|100605098|FG001|Acute Study|Overall Study||14||
48114112|NCT01962558|100605097|FG000|12-Weeks|Overall Study||16||
48114113|NCT01962558|100605098|FG001|12-Weeks|Overall Study||14||
48563304|NCT02505217|101710147|FG000|STARTED|Overall Study||105||
48563305|NCT02505217|101710148|FG001|STARTED|Overall Study||95||
48563306|NCT02505217|101710147|FG000|COMPLETED|Overall Study||104||
48114114|NCT01962558|100605097|FG000|COMPLETED|Overall Study||16||
48114115|NCT01962558|100605098|FG001|COMPLETED|Overall Study||14||
48114116|NCT01962558|100605097|FG000|NOT COMPLETED|Overall Study||0||
48114117|NCT01962558|100605098|FG001|NOT COMPLETED|Overall Study||0||
48114118|NCT02624284|100605099|FG000|STARTED|Overall Study||49|Only participants who attended their first session of tDCS are included in this number.|
48114119|NCT02624284|100605100|FG001|STARTED|Overall Study||53|Only participants who attended their first session of tDCS are included in this number.|
48114120|NCT02624284|100605101|FG002|STARTED|Overall Study||47|Only participants who attended their first session of tDCS are included in this number.|
48114121|NCT02624284|100605099|FG000|COMPLETED|Overall Study||35||
48114122|NCT02624284|100605100|FG001|COMPLETED|Overall Study||35||
48114123|NCT02624284|100605101|FG002|COMPLETED|Overall Study||36||
48114124|NCT02624284|100605099|FG000|NOT COMPLETED|Overall Study||14||
48114125|NCT02624284|100605100|FG001|NOT COMPLETED|Overall Study||18||
48114126|NCT02624284|100605101|FG002|NOT COMPLETED|Overall Study||11||
48114127|NCT03181828|100605102|FG000|STARTED|Overall Study||2||
48114128|NCT03181828|100605103|FG001|STARTED|Overall Study||2||
48114129|NCT03181828|100605102|FG000|COMPLETED|Overall Study||2||
48114130|NCT03181828|100605103|FG001|COMPLETED|Overall Study||2||
48114131|NCT03181828|100605102|FG000|NOT COMPLETED|Overall Study||0||
48114132|NCT03181828|100605103|FG001|NOT COMPLETED|Overall Study||0||
48277707|NCT05775991|101003181|FG001|STARTED|Overall Study||4||
48277708|NCT05775991|101003182|FG002|STARTED|Overall Study||9||
48277709|NCT05775991|101003180|FG000|COMPLETED|Overall Study||5||
48563307|NCT02505217|101710148|FG001|COMPLETED|Overall Study||93||
48563308|NCT02505217|101710147|FG000|NOT COMPLETED|Overall Study||1||
48563309|NCT02505217|101710148|FG001|NOT COMPLETED|Overall Study||2||
48563310|NCT03620708|101710149|FG000|STARTED|Overall Study||19||
48563311|NCT03620708|101710150|FG001|STARTED|Overall Study||19||
48563312|NCT03620708|101710151|FG002|STARTED|Overall Study||20||
48563313|NCT03620708|101710149|FG000|COMPLETED|Overall Study||18||
48114133|NCT02388997|100605104|FG000|STARTED|Overall Study||15||
48277710|NCT05775991|101003181|FG001|COMPLETED|Overall Study||4||
48277711|NCT05775991|101003182|FG002|COMPLETED|Overall Study||7||
48563314|NCT03620708|101710150|FG001|COMPLETED|Overall Study||18||
48563315|NCT03620708|101710151|FG002|COMPLETED|Overall Study||17||
48563316|NCT03620708|101710149|FG000|NOT COMPLETED|Overall Study||1||
48696933|NCT04776720|102041839|FG001|STARTED|Overall Study||119||
48696934|NCT04776720|102041838|FG000|COMPLETED|Overall Study||101||
48114134|NCT02388997|100605105|FG001|STARTED|Overall Study||16||
48114135|NCT02388997|100605104|FG000|COMPLETED|Overall Study||12||
48563317|NCT03620708|101710150|FG001|NOT COMPLETED|Overall Study||1||
48563318|NCT03620708|101710151|FG002|NOT COMPLETED|Overall Study||3||
48563319|NCT03877068|101710152|FG000|STARTED|Overall Study||94|Started inpatient portion of the study|
48114136|NCT02388997|100605105|FG001|COMPLETED|Overall Study||10||
48114137|NCT02388997|100605104|FG000|NOT COMPLETED|Overall Study||3||
48114138|NCT02388997|100605105|FG001|NOT COMPLETED|Overall Study||6||
48114139|NCT01818804|100605106|FG000|STARTED|Overall Study||73||
48114140|NCT01818804|100605107|FG001|STARTED|Overall Study||72||
48696935|NCT04776720|102041839|FG001|COMPLETED|Overall Study||109||
48696936|NCT04776720|102041838|FG000|NOT COMPLETED|Overall Study||20||
48696937|NCT04776720|102041839|FG001|NOT COMPLETED|Overall Study||10||
48696938|NCT03419897|102041840|FG000|STARTED|Overall Study||249||
48696939|NCT03419897|102041840|FG000|COMPLETED|Overall Study||0||
48696940|NCT03419897|102041840|FG000|NOT COMPLETED|Overall Study||249||
48696941|NCT03709277|102041841|FG000|STARTED|Overall Study||218||
48696942|NCT03709277|102041842|FG001|STARTED|Overall Study||220||
48696943|NCT03709277|102041841|FG000|COMPLETED|Overall Study||218||
48696944|NCT03709277|102041842|FG001|COMPLETED|Overall Study||220||
48696945|NCT03709277|102041841|FG000|NOT COMPLETED|Overall Study||0||
48114141|NCT01818804|100605106|FG000|COMPLETED|Overall Study||68||
48114142|NCT01818804|100605107|FG001|COMPLETED|Overall Study||65||
48114143|NCT01818804|100605106|FG000|NOT COMPLETED|Overall Study||5||
48114144|NCT01818804|100605107|FG001|NOT COMPLETED|Overall Study||7||
48114145|NCT01613339|100605108|FG000|STARTED|Overall Study||24||
48114146|NCT01613339|100605109|FG001|STARTED|Overall Study||22||
48114147|NCT01613339|100605108|FG000|COMPLETED|Overall Study||21||
48114148|NCT01613339|100605109|FG001|COMPLETED|Overall Study||21||
48114149|NCT01613339|100605108|FG000|NOT COMPLETED|Overall Study||3||
48114150|NCT01613339|100605109|FG001|NOT COMPLETED|Overall Study||1||
48114151|NCT01469065|100605110|FG000|STARTED|Overall Study||16||
48114152|NCT01469065|100605111|FG001|STARTED|Overall Study||17||
48114153|NCT01469065|100605112|FG002|STARTED|Overall Study||16||
48114154|NCT01469065|100605113|FG003|STARTED|Overall Study||16||
48114155|NCT01469065|100605114|FG004|STARTED|Overall Study||17||
48114156|NCT01469065|100605110|FG000|COMPLETED|Overall Study||16||
48114157|NCT01469065|100605111|FG001|COMPLETED|Overall Study||16||
48114158|NCT01469065|100605112|FG002|COMPLETED|Overall Study||16||
48114159|NCT01469065|100605113|FG003|COMPLETED|Overall Study||16||
48114160|NCT01469065|100605114|FG004|COMPLETED|Overall Study||16||
48114161|NCT01469065|100605110|FG000|NOT COMPLETED|Overall Study||0||
48114162|NCT01469065|100605111|FG001|NOT COMPLETED|Overall Study||1||
48114163|NCT01469065|100605112|FG002|NOT COMPLETED|Overall Study||0||
48114164|NCT01469065|100605113|FG003|NOT COMPLETED|Overall Study||0||
48114165|NCT01469065|100605114|FG004|NOT COMPLETED|Overall Study||1||
48114166|NCT00409292|100605115|FG000|STARTED|Overall Study||33||
48114167|NCT00409292|100605115|FG000|COMPLETED|Overall Study||33||
48114168|NCT00409292|100605115|FG000|NOT COMPLETED|Overall Study||0||
48114169|NCT02412631|100605116|FG000|STARTED|Overall Study||44||
48114170|NCT02412631|100605117|FG001|STARTED|Overall Study||40||
48114171|NCT02412631|100605116|FG000|COMPLETED|Overall Study||18||
48114172|NCT02412631|100605117|FG001|COMPLETED|Overall Study||16||
48114173|NCT02412631|100605116|FG000|NOT COMPLETED|Overall Study||26||
48114174|NCT02412631|100605117|FG001|NOT COMPLETED|Overall Study||24||
48114175|NCT02474199|100605118|FG000|STARTED|Overall Study||5||
48114176|NCT02474199|100605119|FG001|STARTED|Overall Study||5||
48114177|NCT02474199|100605120|FG002|STARTED|Overall Study||2||
48114178|NCT02474199|100605121|FG003|STARTED|Overall Study||3||
48114179|NCT02474199|100605118|FG000|COMPLETED|Overall Study||3||
48114180|NCT02474199|100605119|FG001|COMPLETED|Overall Study||2||
48114181|NCT02474199|100605120|FG002|COMPLETED|Overall Study||0||
48114182|NCT02474199|100605121|FG003|COMPLETED|Overall Study||0||
48114183|NCT02474199|100605118|FG000|NOT COMPLETED|Overall Study||2||
48114184|NCT02474199|100605119|FG001|NOT COMPLETED|Overall Study||3||
48114185|NCT02474199|100605120|FG002|NOT COMPLETED|Overall Study||2||
48114186|NCT02474199|100605121|FG003|NOT COMPLETED|Overall Study||3||
48114187|NCT00678561|100605122|FG000|STARTED|Overall Study||6||
48114188|NCT00678561|100605123|FG001|STARTED|Overall Study||6||
48696946|NCT03709277|102041842|FG001|NOT COMPLETED|Overall Study||0||
48696947|NCT02777203|102041843|FG000|STARTED|Overall Study||60||
48696948|NCT02777203|102041843|FG000|COMPLETED|Overall Study||60||
48696949|NCT02777203|102041843|FG000|NOT COMPLETED|Overall Study||0||
48696950|NCT01709110|102041844|FG000|STARTED|Overall Study||683||
48696951|NCT01709110|102041845|FG001|STARTED|Overall Study||683||
48696952|NCT01709110|102041844|FG000|Received at Least One Dose of Study Drug|Overall Study||680||
48696953|NCT01709110|102041845|FG001|Received at Least One Dose of Study Drug|Overall Study||680||
48696954|NCT01709110|102041844|FG000|COMPLETED|Overall Study||498||
48114189|NCT00678561|100605124|FG002|STARTED|Overall Study||8||
48114190|NCT00678561|100605125|FG003|STARTED|Overall Study||4||
48114191|NCT00678561|100605126|FG004|STARTED|Overall Study||17||
48114192|NCT00678561|100605127|FG005|STARTED|Overall Study||17||
48114193|NCT00678561|100605128|FG006|STARTED|Overall Study||15||
48114194|NCT00678561|100605129|FG007|STARTED|Overall Study||8||
48114195|NCT00678561|100605122|FG000|COMPLETED|Overall Study||6||
48114196|NCT00678561|100605123|FG001|COMPLETED|Overall Study||5||
48114197|NCT00678561|100605124|FG002|COMPLETED|Overall Study||7||
48114198|NCT00678561|100605125|FG003|COMPLETED|Overall Study||4||
48114199|NCT00678561|100605126|FG004|COMPLETED|Overall Study||15||
48696955|NCT01709110|102041845|FG001|COMPLETED|Overall Study||515||
48277712|NCT05775991|101003180|FG000|NOT COMPLETED|Overall Study||0||
48277713|NCT05775991|101003181|FG001|NOT COMPLETED|Overall Study||0||
48277714|NCT05775991|101003182|FG002|NOT COMPLETED|Overall Study||2||
48277715|NCT02683772|101003183|FG000|STARTED|Overall Study||15||
48277716|NCT02683772|101003184|FG001|STARTED|Overall Study||23||
48277717|NCT02683772|101003183|FG000|COMPLETED|Overall Study||15||
48696956|NCT01709110|102041844|FG000|NOT COMPLETED|Overall Study||185||
48696957|NCT01709110|102041845|FG001|NOT COMPLETED|Overall Study||168||
48696958|NCT02331589|102041846|FG000|STARTED|Overall Study||39||
48696959|NCT02331589|102041847|FG001|STARTED|Overall Study||36||
48696960|NCT02331589|102041846|FG000|COMPLETED|Overall Study||34||
48696961|NCT02331589|102041847|FG001|COMPLETED|Overall Study||31||
48696962|NCT02331589|102041846|FG000|NOT COMPLETED|Overall Study||5||
48696963|NCT02331589|102041847|FG001|NOT COMPLETED|Overall Study||5||
48696964|NCT02379988|102041848|FG000|STARTED|Overall Study||15||
48696965|NCT02379988|102041848|FG000|COMPLETED|Overall Study||14||
48696966|NCT02379988|102041848|FG000|NOT COMPLETED|Overall Study||1||
48696967|NCT01986231|102041849|FG000|STARTED|Overall Study||12||
48696968|NCT01986231|102041849|FG000|COMPLETED|Overall Study||11||
48696969|NCT01986231|102041849|FG000|NOT COMPLETED|Overall Study||1||
48696970|NCT02330653|102041850|FG000|STARTED|Overall Study||10||
48696971|NCT02330653|102041851|FG001|STARTED|Overall Study||5||
48277718|NCT02683772|101003184|FG001|COMPLETED|Overall Study||23||
48277719|NCT02683772|101003183|FG000|NOT COMPLETED|Overall Study||0||
48277720|NCT02683772|101003184|FG001|NOT COMPLETED|Overall Study||0||
48277721|NCT02770612|101003185|FG000|STARTED|Overall Study||51||
48696972|NCT02330653|102041850|FG000|COMPLETED|Overall Study||7||
48696973|NCT02330653|102041851|FG001|COMPLETED|Overall Study||4||
48696974|NCT02330653|102041850|FG000|NOT COMPLETED|Overall Study||3||
48696975|NCT02330653|102041851|FG001|NOT COMPLETED|Overall Study||1||
48696976|NCT03037476|102041852|FG000|STARTED|Overall Study||414||
48696977|NCT03037476|102041853|FG001|STARTED|Overall Study||429||
48696978|NCT03037476|102041852|FG000|COMPLETED|Overall Study||351||
48696979|NCT03037476|102041853|FG001|COMPLETED|Overall Study||383||
48114200|NCT00678561|100605127|FG005|COMPLETED|Overall Study||16||
48114201|NCT00678561|100605128|FG006|COMPLETED|Overall Study||15||
48114202|NCT00678561|100605129|FG007|COMPLETED|Overall Study||7||
48114203|NCT00678561|100605122|FG000|NOT COMPLETED|Overall Study||0||
48114204|NCT00678561|100605123|FG001|NOT COMPLETED|Overall Study||1||
48114205|NCT00678561|100605124|FG002|NOT COMPLETED|Overall Study||1||
48114206|NCT00678561|100605125|FG003|NOT COMPLETED|Overall Study||0||
48114207|NCT00678561|100605126|FG004|NOT COMPLETED|Overall Study||2||
48114208|NCT00678561|100605127|FG005|NOT COMPLETED|Overall Study||1||
48114209|NCT00678561|100605128|FG006|NOT COMPLETED|Overall Study||0||
48114210|NCT00678561|100605129|FG007|NOT COMPLETED|Overall Study||1||
48114211|NCT00610532|100605130|FG000|STARTED|Intravenous Phenytoin Alone||8||
48114212|NCT00610532|100605130|FG000|COMPLETED|Intravenous Phenytoin Alone||8||
48114213|NCT00610532|100605130|FG000|NOT COMPLETED|Intravenous Phenytoin Alone||0||
48114214|NCT00610532|100605130|FG000|STARTED|Intravenous Phenytoin Plus Probenecid||7||
48114215|NCT00610532|100605130|FG000|COMPLETED|Intravenous Phenytoin Plus Probenecid||7||
48114216|NCT00610532|100605130|FG000|NOT COMPLETED|Intravenous Phenytoin Plus Probenecid||0||
48114217|NCT00638885|100605131|FG000|STARTED|Overall Study||142||
48114218|NCT00638885|100605131|FG000|COMPLETED|Overall Study||142||
48114219|NCT00638885|100605131|FG000|NOT COMPLETED|Overall Study||0||
48277722|NCT02770612|101003185|FG000|COMPLETED|Overall Study||50||
48277723|NCT02770612|101003185|FG000|NOT COMPLETED|Overall Study||1||
48277724|NCT01743989|101003186|FG000|STARTED|Treatment Phase||120||
48277725|NCT01743989|101003187|FG001|STARTED|Treatment Phase||119||
48277726|NCT01743989|101003188|FG002|STARTED|Treatment Phase||381||
48277727|NCT01743989|101003186|FG000|Participants Who Signed Informed Consent|Treatment Phase||120|Participants for whom informed consent was obtained prior to any study specific procedure|
48277728|NCT01743989|101003187|FG001|Participants Who Signed Informed Consent|Treatment Phase||118|Participants for whom informed consent was obtained prior to any study specific procedure|
48696980|NCT03037476|102041852|FG000|NOT COMPLETED|Overall Study||63||
48696981|NCT03037476|102041853|FG001|NOT COMPLETED|Overall Study||46||
48696982|NCT00564902|102041854|FG000|STARTED|Overall Study||10||
48696983|NCT00564902|102041855|FG001|STARTED|Overall Study||25||
48696984|NCT00564902|102041856|FG002|STARTED|Overall Study||25||
48696985|NCT00564902|102041854|FG000|4 Months|Overall Study||9||
48696986|NCT00564902|102041855|FG001|4 Months|Overall Study||24||
48696987|NCT00564902|102041856|FG002|4 Months|Overall Study||23||
48696988|NCT00564902|102041854|FG000|8 Months|Overall Study||9||
48696989|NCT00564902|102041855|FG001|8 Months|Overall Study||22||
48696990|NCT00564902|102041856|FG002|8 Months|Overall Study||21||
48696991|NCT00564902|102041854|FG000|12 Months|Overall Study||9||
48114220|NCT00298831|100605132|FG000|STARTED|Overall Study||224||
48114221|NCT00298831|100605132|FG000|Treated|Overall Study||197||
48114222|NCT00298831|100605132|FG000|COMPLETED|Overall Study||192||
48114223|NCT00298831|100605132|FG000|NOT COMPLETED|Overall Study||32||
48277729|NCT01743989|101003188|FG002|Participants Who Signed Informed Consent|Treatment Phase||381|Participants for whom informed consent was obtained prior to any study specific procedure|
48277730|NCT01743989|101003186|FG000|COMPLETED|Treatment Phase||119||
48277731|NCT01743989|101003187|FG001|COMPLETED|Treatment Phase||104||
48277732|NCT01743989|101003188|FG002|COMPLETED|Treatment Phase||0||
48277733|NCT01743989|101003186|FG000|NOT COMPLETED|Treatment Phase||1||
48277734|NCT01743989|101003187|FG001|NOT COMPLETED|Treatment Phase||15||
48277735|NCT01743989|101003188|FG002|NOT COMPLETED|Treatment Phase||381||
48277736|NCT01743989|101003186|FG000|STARTED|TFR Phase||119||
48277737|NCT01743989|101003187|FG001|STARTED|TFR Phase||104||
48277738|NCT01743989|101003188|FG002|STARTED|TFR Phase||0||
48277739|NCT01743989|101003186|FG000|COMPLETED|TFR Phase||37||
48277740|NCT01743989|101003187|FG001|COMPLETED|TFR Phase||36||
48277741|NCT01743989|101003188|FG002|COMPLETED|TFR Phase||0||
48277742|NCT01743989|101003186|FG000|NOT COMPLETED|TFR Phase||82||
48277743|NCT01743989|101003187|FG001|NOT COMPLETED|TFR Phase||68||
48277744|NCT01743989|101003188|FG002|NOT COMPLETED|TFR Phase||0||
48277745|NCT01743989|101003186|FG000|STARTED|Re-treatment Phase||74||
48277746|NCT01743989|101003187|FG001|STARTED|Re-treatment Phase||55||
48277747|NCT01743989|101003188|FG002|STARTED|Re-treatment Phase||0||
48277748|NCT01743989|101003186|FG000|COMPLETED|Re-treatment Phase||58||
48277749|NCT01743989|101003187|FG001|COMPLETED|Re-treatment Phase||46||
48563320|NCT03877068|101710153|FG001|STARTED|Overall Study||91|Started inpatient portion of the study|
48563321|NCT03877068|101710152|FG000|Began Optional Outpatient Portion of Study|Overall Study||52||
48563322|NCT03877068|101710153|FG001|Began Optional Outpatient Portion of Study|Overall Study||53||
48563323|NCT03877068|101710152|FG000|Completed Optional Outpatient Portion of Study|Overall Study||41||
48563324|NCT03877068|101710153|FG001|Completed Optional Outpatient Portion of Study|Overall Study||44||
48563325|NCT03877068|101710152|FG000|COMPLETED|Overall Study||85|Completed inpatient portion of the study|
48696992|NCT00564902|102041855|FG001|12 Months|Overall Study||21||
48114224|NCT01631474|100605133|FG000|STARTED|Overall Study||72||
48277750|NCT01743989|101003188|FG002|COMPLETED|Re-treatment Phase||0||
48277751|NCT01743989|101003186|FG000|NOT COMPLETED|Re-treatment Phase||16||
48394100|NCT02678312|101295865|FG000|COMPLETED|Part 1 Open Label Epoch- Period 2||0||
48114225|NCT01631474|100605134|FG001|STARTED|Overall Study||76||
48114226|NCT01631474|100605135|FG002|STARTED|Overall Study||70||
48277752|NCT01743989|101003187|FG001|NOT COMPLETED|Re-treatment Phase||9||
48277753|NCT01743989|101003188|FG002|NOT COMPLETED|Re-treatment Phase||0||
48563326|NCT03877068|101710153|FG001|COMPLETED|Overall Study||88|Completed inpatient portion of the study|
48563327|NCT03877068|101710152|FG000|NOT COMPLETED|Overall Study||9||
48563328|NCT03877068|101710153|FG001|NOT COMPLETED|Overall Study||3||
48114227|NCT01631474|100605136|FG003|STARTED|Overall Study||70||
48114228|NCT01631474|100605137|FG004|STARTED|Overall Study||75||
48114229|NCT01631474|100605133|FG000|COMPLETED|Overall Study||58||
48114230|NCT01631474|100605134|FG001|COMPLETED|Overall Study||64||
48114231|NCT01631474|100605135|FG002|COMPLETED|Overall Study||61||
48114232|NCT01631474|100605136|FG003|COMPLETED|Overall Study||59||
48114233|NCT01631474|100605137|FG004|COMPLETED|Overall Study||62||
48114234|NCT01631474|100605133|FG000|NOT COMPLETED|Overall Study||14||
48114235|NCT01631474|100605134|FG001|NOT COMPLETED|Overall Study||12||
48114236|NCT01631474|100605135|FG002|NOT COMPLETED|Overall Study||9||
48114237|NCT01631474|100605136|FG003|NOT COMPLETED|Overall Study||11||
48114238|NCT01631474|100605137|FG004|NOT COMPLETED|Overall Study||13||
48114239|NCT01340976|100605138|FG000|STARTED|Overall Study||4||
48114240|NCT01340976|100605139|FG001|STARTED|Overall Study||3||
48114241|NCT01340976|100605140|FG002|STARTED|Overall Study||7||
48114242|NCT01340976|100605141|FG003|STARTED|Overall Study||5||
48114243|NCT01340976|100605142|FG004|STARTED|Overall Study||7||
48114244|NCT01340976|100605143|FG005|STARTED|Overall Study||7||
48114245|NCT01340976|100605138|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4||
48114246|NCT01340976|100605139|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3||
48114247|NCT01340976|100605140|FG002|Received at Least 1 Dose of Study Drug|Overall Study||7||
48114248|NCT01340976|100605141|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5||
48114249|NCT01340976|100605142|FG004|Received at Least 1 Dose of Study Drug|Overall Study||7||
48114250|NCT01340976|100605143|FG005|Received at Least 1 Dose of Study Drug|Overall Study||7||
48114251|NCT01340976|100605138|FG000|COMPLETED|Overall Study||0||
48114252|NCT01340976|100605139|FG001|COMPLETED|Overall Study||1||
48114253|NCT01340976|100605140|FG002|COMPLETED|Overall Study||4||
48277754|NCT01853475|101003189|FG000|STARTED|Overall Study||8||
48394101|NCT02678312|101295866|FG001|COMPLETED|Part 1 Open Label Epoch- Period 2||18||
48563329|NCT00654095|101710154|FG000|STARTED|Overall Study||146||
48696993|NCT00564902|102041856|FG002|12 Months|Overall Study||21||
48114254|NCT01340976|100605141|FG003|COMPLETED|Overall Study||2||
48114255|NCT01340976|100605142|FG004|COMPLETED|Overall Study||5||
48114256|NCT01340976|100605143|FG005|COMPLETED|Overall Study||6||
48114257|NCT01340976|100605138|FG000|NOT COMPLETED|Overall Study||4||
48114258|NCT01340976|100605139|FG001|NOT COMPLETED|Overall Study||2||
48114259|NCT01340976|100605140|FG002|NOT COMPLETED|Overall Study||3||
48114260|NCT01340976|100605141|FG003|NOT COMPLETED|Overall Study||3||
48277755|NCT01853475|101003190|FG001|STARTED|Overall Study||8||
48277756|NCT01853475|101003191|FG002|STARTED|Overall Study||8||
48696994|NCT00564902|102041854|FG000|COMPLETED|Overall Study||9||
48696995|NCT00564902|102041855|FG001|COMPLETED|Overall Study||21||
48696996|NCT00564902|102041856|FG002|COMPLETED|Overall Study||21||
48114261|NCT01340976|100605142|FG004|NOT COMPLETED|Overall Study||2||
48114262|NCT01340976|100605143|FG005|NOT COMPLETED|Overall Study||1||
48114263|NCT01723228|100605144|FG000|STARTED|Overall Study||86||
48114264|NCT01723228|100605145|FG001|STARTED|Overall Study||84||
48114265|NCT01723228|100605144|FG000|COMPLETED|Overall Study||78||
48114266|NCT01723228|100605145|FG001|COMPLETED|Overall Study||73||
48114267|NCT01723228|100605144|FG000|NOT COMPLETED|Overall Study||8||
48114268|NCT01723228|100605145|FG001|NOT COMPLETED|Overall Study||11||
48114269|NCT00480636|100605146|FG000|STARTED|Overall Study||102||
48114270|NCT00480636|100605146|FG000|COMPLETED|Overall Study||83||
48114271|NCT00480636|100605146|FG000|NOT COMPLETED|Overall Study||19||
48114272|NCT00463060|100605147|FG000|STARTED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||3||
48114273|NCT00463060|100605147|FG000|COMPLETED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||3||
48114274|NCT00463060|100605147|FG000|NOT COMPLETED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||0||
48114275|NCT00463060|100605147|FG000|STARTED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||3||
48114276|NCT00463060|100605147|FG000|COMPLETED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||3||
48114277|NCT00463060|100605147|FG000|NOT COMPLETED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||0||
48114278|NCT00463060|100605147|FG000|STARTED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||10||
48114279|NCT00463060|100605147|FG000|COMPLETED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||10||
48114280|NCT00463060|100605147|FG000|NOT COMPLETED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||0||
48114281|NCT00463060|100605147|FG000|STARTED|Phase 1-Radiation 50Gy +Sunitinib 50mg||5||
48114282|NCT00463060|100605147|FG000|COMPLETED|Phase 1-Radiation 50Gy +Sunitinib 50mg||0||
48114283|NCT00463060|100605147|FG000|NOT COMPLETED|Phase 1-Radiation 50Gy +Sunitinib 50mg||5||
48114284|NCT00463060|100605147|FG000|STARTED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||26||
48114285|NCT00463060|100605147|FG000|COMPLETED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||25||
48114286|NCT00463060|100605147|FG000|NOT COMPLETED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||1||
48114287|NCT01921829|100605148|FG000|STARTED|Overall Study||10||
48114288|NCT01921829|100605149|FG001|STARTED|Overall Study||9||
48114289|NCT01921829|100605148|FG000|COMPLETED|Overall Study||10||
48114290|NCT01921829|100605149|FG001|COMPLETED|Overall Study||8||
48114291|NCT01921829|100605148|FG000|NOT COMPLETED|Overall Study||0||
48114292|NCT01921829|100605149|FG001|NOT COMPLETED|Overall Study||1||
48114293|NCT01825408|100605150|FG000|STARTED|Overall Study||7||
48114294|NCT01825408|100605151|FG001|STARTED|Overall Study||7||
48114295|NCT01825408|100605152|FG002|STARTED|Overall Study||14||
48114296|NCT01825408|100605153|FG003|STARTED|Overall Study||12||
48114297|NCT01825408|100605150|FG000|COMPLETED|Overall Study||7||
48114298|NCT01825408|100605151|FG001|COMPLETED|Overall Study||7||
48114299|NCT01825408|100605152|FG002|COMPLETED|Overall Study||14||
48114300|NCT01825408|100605153|FG003|COMPLETED|Overall Study||12||
48114301|NCT01825408|100605150|FG000|NOT COMPLETED|Overall Study||0||
48114302|NCT01825408|100605151|FG001|NOT COMPLETED|Overall Study||0||
48114303|NCT01825408|100605152|FG002|NOT COMPLETED|Overall Study||0||
48114304|NCT01825408|100605153|FG003|NOT COMPLETED|Overall Study||0||
48114305|NCT03400033|100605154|FG000|STARTED|Overall Study||270||
48114306|NCT03400033|100605155|FG001|STARTED|Overall Study||137||
48114307|NCT03400033|100605154|FG000|COMPLETED|Overall Study||269||
48114308|NCT03400033|100605155|FG001|COMPLETED|Overall Study||135||
48114309|NCT03400033|100605154|FG000|NOT COMPLETED|Overall Study||1||
48114310|NCT03400033|100605155|FG001|NOT COMPLETED|Overall Study||2||
48114311|NCT04497987|100605156|FG000|STARTED|Overall Study||592||
48114312|NCT04497987|100605157|FG001|STARTED|Overall Study||588||
48114313|NCT04497987|100605156|FG000|Received at Least One Dose of Study Drug|Overall Study||587||
48114314|NCT04497987|100605157|FG001|Received at Least One Dose of Study Drug|Overall Study||588||
48114315|NCT04497987|100605156|FG000|Prevention Population|Overall Study||485||
48114316|NCT04497987|100605157|FG001|Prevention Population|Overall Study||487||
48114317|NCT04497987|100605156|FG000|Treatment Population|Overall Study||68||
48114318|NCT04497987|100605157|FG001|Treatment Population|Overall Study||66||
48114319|NCT04497987|100605156|FG000|Serology Positive|Overall Study||36||
48114320|NCT04497987|100605157|FG001|Serology Positive|Overall Study||35||
48114321|NCT04497987|100605156|FG000|COMPLETED|Overall Study||493||
48114322|NCT04497987|100605157|FG001|COMPLETED|Overall Study||521||
48114323|NCT04497987|100605156|FG000|NOT COMPLETED|Overall Study||99||
48114324|NCT04497987|100605157|FG001|NOT COMPLETED|Overall Study||67||
48114325|NCT00333606|100605158|FG000|STARTED|Overall Study||30||
48114326|NCT00333606|100605159|FG001|STARTED|Overall Study||30||
48114327|NCT00333606|100605158|FG000|COMPLETED|Overall Study||30||
48696997|NCT00564902|102041854|FG000|NOT COMPLETED|Overall Study||1||
48696998|NCT00564902|102041855|FG001|NOT COMPLETED|Overall Study||4||
48114328|NCT00333606|100605159|FG001|COMPLETED|Overall Study||30||
48114329|NCT00333606|100605158|FG000|NOT COMPLETED|Overall Study||0||
48114330|NCT00333606|100605159|FG001|NOT COMPLETED|Overall Study||0||
48114331|NCT04041869|100605160|FG000|STARTED|Overall Study||68||
48114332|NCT04041869|100605160|FG000|COMPLETED|Overall Study||54||
48114333|NCT04041869|100605160|FG000|NOT COMPLETED|Overall Study||14||
48114334|NCT02711800|100605161|FG000|STARTED|Overall Study||9||
48114335|NCT02711800|100605161|FG000|COMPLETED|Overall Study||7||
48277757|NCT01853475|101003189|FG000|COMPLETED|Overall Study||8||
48277758|NCT01853475|101003190|FG001|COMPLETED|Overall Study||7||
48277759|NCT01853475|101003191|FG002|COMPLETED|Overall Study||8||
48277760|NCT01853475|101003189|FG000|NOT COMPLETED|Overall Study||0||
48277761|NCT01853475|101003190|FG001|NOT COMPLETED|Overall Study||1||
48277762|NCT01853475|101003191|FG002|NOT COMPLETED|Overall Study||0||
48277763|NCT01531673|101003192|FG000|STARTED|Overall Study||33||
48277764|NCT01531673|101003193|FG001|STARTED|Overall Study||8||
48277765|NCT01531673|101003194|FG002|STARTED|Overall Study||8||
48277766|NCT01531673|101003195|FG003|STARTED|Overall Study||18||
48277767|NCT01531673|101003196|FG004|STARTED|Overall Study||8||
48277768|NCT01531673|101003197|FG005|STARTED|Overall Study||19||
48277769|NCT01531673|101003198|FG006|STARTED|Overall Study||17||
48394102|NCT02678312|101295867|FG002|COMPLETED|Part 1 Open Label Epoch- Period 2||2||
48394103|NCT02678312|101295868|FG003|COMPLETED|Part 1 Open Label Epoch- Period 2||0||
48394104|NCT02678312|101295869|FG004|COMPLETED|Part 1 Open Label Epoch- Period 2||0||
48394105|NCT02678312|101295865|FG000|NOT COMPLETED|Part 1 Open Label Epoch- Period 2||0||
48394106|NCT02678312|101295866|FG001|NOT COMPLETED|Part 1 Open Label Epoch- Period 2||0||
48394107|NCT02678312|101295867|FG002|NOT COMPLETED|Part 1 Open Label Epoch- Period 2||0||
48394108|NCT02678312|101295868|FG003|NOT COMPLETED|Part 1 Open Label Epoch- Period 2||0||
48277770|NCT01531673|101003199|FG007|STARTED|Overall Study||9||
48277771|NCT01531673|101003200|FG008|STARTED|Overall Study||17||
48277772|NCT01531673|101003201|FG009|STARTED|Overall Study||19||
48696999|NCT00564902|102041856|FG002|NOT COMPLETED|Overall Study||4||
48697000|NCT03983382|102041857|FG000|STARTED|Overall Study||190||
48697001|NCT03983382|102041857|FG000|COMPLETED|Overall Study||172||
48394109|NCT02678312|101295869|FG004|NOT COMPLETED|Part 1 Open Label Epoch- Period 2||0||
48394110|NCT02678312|101295865|FG000|STARTED|Part 2 Double Blind Epoch||0|Out of 377 participants enrolled in Part 2 of the study, 2 participants in the enalapril arm were randomized in error and did not receive the study medication. Therefore, 375 of 377 randomized participants received study medication.|
48394111|NCT02678312|101295866|FG001|STARTED|Part 2 Double Blind Epoch||0|Out of 377 participants enrolled in Part 2 of the study, 2 participants in the enalapril arm were randomized in error and did not receive the study medication. Therefore, 375 of 377 randomized participants received study medication.|
48394112|NCT02678312|101295867|FG002|STARTED|Part 2 Double Blind Epoch||0|Out of 377 participants enrolled in Part 2 of the study, 2 participants in the enalapril arm were randomized in error and did not receive the study medication. Therefore, 375 of 377 randomized participants received study medication.|
48394113|NCT02678312|101295868|FG003|STARTED|Part 2 Double Blind Epoch||187|Out of 377 participants enrolled in Part 2 of the study, 2 participants in the enalapril arm were randomized in error and did not receive the study medication. Therefore, 375 of 377 randomized participants received study medication.|
48394114|NCT02678312|101295869|FG004|STARTED|Part 2 Double Blind Epoch||188|Out of 377 participants enrolled in Part 2 of the study, 2 participants in the enalapril arm were randomized in error and did not receive the study medication. Therefore, 375 of 377 randomized participants received study medication.|
48394115|NCT02678312|101295865|FG000|COMPLETED|Part 2 Double Blind Epoch||0||
48394116|NCT02678312|101295866|FG001|COMPLETED|Part 2 Double Blind Epoch||0||
48394117|NCT02678312|101295867|FG002|COMPLETED|Part 2 Double Blind Epoch||0||
48394118|NCT02678312|101295868|FG003|COMPLETED|Part 2 Double Blind Epoch||169||
48394119|NCT02678312|101295869|FG004|COMPLETED|Part 2 Double Blind Epoch||164||
48394120|NCT02678312|101295865|FG000|NOT COMPLETED|Part 2 Double Blind Epoch||0||
48697002|NCT03983382|102041857|FG000|NOT COMPLETED|Overall Study||18||
48697003|NCT01606176|102041858|FG000|STARTED|Overall Study||36||
48697004|NCT01606176|102041859|FG001|STARTED|Overall Study||34||
48697005|NCT01606176|102041858|FG000|COMPLETED|Overall Study||32||
48697006|NCT01606176|102041859|FG001|COMPLETED|Overall Study||31||
48697007|NCT01606176|102041858|FG000|NOT COMPLETED|Overall Study||4||
48697008|NCT01606176|102041859|FG001|NOT COMPLETED|Overall Study||3||
48697009|NCT05007899|102041860|FG000|STARTED|Overall Study||7||
48697010|NCT05007899|102041861|FG001|STARTED|Overall Study||6||
48697011|NCT05007899|102041860|FG000|COMPLETED|Overall Study||5||
48697012|NCT05007899|102041861|FG001|COMPLETED|Overall Study||2||
48697013|NCT05007899|102041860|FG000|NOT COMPLETED|Overall Study||2||
48697014|NCT05007899|102041861|FG001|NOT COMPLETED|Overall Study||4||
48697015|NCT00772915|102041862|FG000|STARTED|Overall Study||38||
48697016|NCT00772915|102041862|FG000|COMPLETED|Overall Study||23||
48697017|NCT00772915|102041862|FG000|NOT COMPLETED|Overall Study||15||
48697018|NCT02619591|102041863|FG000|STARTED|Overall Study||139||
48697019|NCT02619591|102041864|FG001|STARTED|Overall Study||121||
48697020|NCT02619591|102041863|FG000|COMPLETED|Overall Study||0||
48697021|NCT02619591|102041864|FG001|COMPLETED|Overall Study||0||
48697022|NCT02619591|102041863|FG000|NOT COMPLETED|Overall Study||139||
48697023|NCT02619591|102041864|FG001|NOT COMPLETED|Overall Study||121||
48697024|NCT00668382|102041865|FG000|STARTED|Overall Study||11||
48697025|NCT00668382|102041865|FG000|COMPLETED|Overall Study||11||
48697026|NCT00668382|102041865|FG000|NOT COMPLETED|Overall Study||0||
48697027|NCT00722722|102041866|FG000|STARTED|Overall Study||3||
48697028|NCT00722722|102041867|FG001|STARTED|Overall Study||5||
48697029|NCT00722722|102041868|FG002|STARTED|Overall Study||10||
48697030|NCT00722722|102041866|FG000|COMPLETED|Overall Study||3||
48277773|NCT01531673|101003202|FG010|STARTED|Overall Study||16||
48277774|NCT01531673|101003203|FG011|STARTED|Overall Study||4||
48277775|NCT01531673|101003204|FG012|STARTED|Overall Study||14||
48277776|NCT01531673|101003192|FG000|COMPLETED|Overall Study||33||
48277777|NCT01531673|101003193|FG001|COMPLETED|Overall Study||7||
48277778|NCT01531673|101003194|FG002|COMPLETED|Overall Study||8||
48277779|NCT01531673|101003195|FG003|COMPLETED|Overall Study||17||
48277780|NCT01531673|101003196|FG004|COMPLETED|Overall Study||7||
48277781|NCT01531673|101003197|FG005|COMPLETED|Overall Study||18||
48277782|NCT01531673|101003198|FG006|COMPLETED|Overall Study||17||
48277783|NCT01531673|101003199|FG007|COMPLETED|Overall Study||9||
48277784|NCT01531673|101003200|FG008|COMPLETED|Overall Study||17||
48277785|NCT01531673|101003201|FG009|COMPLETED|Overall Study||18||
48277786|NCT01531673|101003202|FG010|COMPLETED|Overall Study||16||
48277787|NCT01531673|101003203|FG011|COMPLETED|Overall Study||4||
48277788|NCT01531673|101003204|FG012|COMPLETED|Overall Study||14||
48277789|NCT01531673|101003192|FG000|NOT COMPLETED|Overall Study||0||
48277790|NCT01531673|101003193|FG001|NOT COMPLETED|Overall Study||1||
48277791|NCT01531673|101003194|FG002|NOT COMPLETED|Overall Study||0||
48277792|NCT01531673|101003195|FG003|NOT COMPLETED|Overall Study||1||
48277793|NCT01531673|101003196|FG004|NOT COMPLETED|Overall Study||1||
48277794|NCT01531673|101003197|FG005|NOT COMPLETED|Overall Study||1||
48277795|NCT01531673|101003198|FG006|NOT COMPLETED|Overall Study||0||
48277796|NCT01531673|101003199|FG007|NOT COMPLETED|Overall Study||0||
48277797|NCT01531673|101003200|FG008|NOT COMPLETED|Overall Study||0||
48277798|NCT01531673|101003201|FG009|NOT COMPLETED|Overall Study||1||
48277799|NCT01531673|101003202|FG010|NOT COMPLETED|Overall Study||0||
48277800|NCT01531673|101003203|FG011|NOT COMPLETED|Overall Study||0||
48277801|NCT01531673|101003204|FG012|NOT COMPLETED|Overall Study||0||
48277802|NCT03241927|101003205|FG000|STARTED|Overall Study||1||
48394121|NCT02678312|101295866|FG001|NOT COMPLETED|Part 2 Double Blind Epoch||0||
48394122|NCT02678312|101295867|FG002|NOT COMPLETED|Part 2 Double Blind Epoch||0||
48563330|NCT00654095|101710154|FG000|COMPLETED|Overall Study||114||
48563331|NCT00654095|101710154|FG000|NOT COMPLETED|Overall Study||32||
48563332|NCT01593670|101710155|FG000|STARTED|Overall Study||9||
48563333|NCT01593670|101710155|FG000|COMPLETED|Overall Study||9||
48563334|NCT01593670|101710155|FG000|NOT COMPLETED|Overall Study||0||
48563335|NCT01051310|101710156|FG000|STARTED|Overall Study||18||
48563336|NCT01051310|101710156|FG000|COMPLETED|Overall Study||13||
48563337|NCT01051310|101710156|FG000|NOT COMPLETED|Overall Study||5||
48563338|NCT01418378|101710157|FG000|STARTED|Overall Study||90||
48563339|NCT01418378|101710158|FG001|STARTED|Overall Study||88||
48563340|NCT01418378|101710157|FG000|Subjects Who Received Study Implant|Overall Study||90||
48563341|NCT01418378|101710158|FG001|Subjects Who Received Study Implant|Overall Study||88||
48563342|NCT01418378|101710157|FG000|COMPLETED|Overall Study||89||
48277803|NCT03241927|101003206|FG001|STARTED|Overall Study||0||
48394123|NCT02678312|101295868|FG003|NOT COMPLETED|Part 2 Double Blind Epoch||18||
48394124|NCT02678312|101295869|FG004|NOT COMPLETED|Part 2 Double Blind Epoch||24||
48394125|NCT01349972|101295870|FG000|STARTED|Overall Study||114||
48394126|NCT01349972|101295871|FG001|STARTED|Overall Study||58||
48563343|NCT01418378|101710158|FG001|COMPLETED|Overall Study||83||
48277804|NCT03241927|101003205|FG000|COMPLETED|Overall Study||0||
48277805|NCT03241927|101003206|FG001|COMPLETED|Overall Study||0||
48277806|NCT03241927|101003205|FG000|NOT COMPLETED|Overall Study||1||
48277807|NCT03241927|101003206|FG001|NOT COMPLETED|Overall Study||0||
48277808|NCT05560243|101003207|FG000|STARTED|Overall Study||56||
48277809|NCT05560243|101003207|FG000|COMPLETED|Overall Study||31||
48277810|NCT05560243|101003207|FG000|NOT COMPLETED|Overall Study||25||
48277811|NCT03784001|101003208|FG000|STARTED|Overall Study||46|The number of participants who completed their baseline questionnaire and first list.|
48277812|NCT03784001|101003209|FG001|STARTED|Overall Study||38|The number of participants who completed their baseline questionnaire and first list.|
48277813|NCT03784001|101003210|FG002|STARTED|Overall Study||41|The number of participants who completed their baseline questionnaire and first list.|
48394127|NCT01349972|101295870|FG000|COMPLETED|Overall Study||109||
48563344|NCT01418378|101710157|FG000|NOT COMPLETED|Overall Study||1||
48394128|NCT01349972|101295871|FG001|COMPLETED|Overall Study||56||
48563345|NCT01418378|101710158|FG001|NOT COMPLETED|Overall Study||5||
48563346|NCT03711188|101710159|FG000|STARTED|Overall Study||16||
48563347|NCT03711188|101710159|FG000|COMPLETED|Overall Study||4||
48563348|NCT03711188|101710159|FG000|NOT COMPLETED|Overall Study||12||
48563349|NCT02094352|101710160|FG000|STARTED|Overall Study||2||
48563350|NCT02094352|101710161|FG001|STARTED|Overall Study||1||
48563351|NCT02094352|101710160|FG000|COMPLETED|Overall Study||2||
48563352|NCT02094352|101710161|FG001|COMPLETED|Overall Study||1||
48563353|NCT02094352|101710160|FG000|NOT COMPLETED|Overall Study||0||
48697031|NCT00722722|102041867|FG001|COMPLETED|Overall Study||5||
48697032|NCT00722722|102041868|FG002|COMPLETED|Overall Study||10||
48697033|NCT00722722|102041866|FG000|NOT COMPLETED|Overall Study||0||
48697034|NCT00722722|102041867|FG001|NOT COMPLETED|Overall Study||0||
48697035|NCT00722722|102041868|FG002|NOT COMPLETED|Overall Study||0||
48697036|NCT01164891|102041869|FG000|STARTED|Overall Study||7||
48697037|NCT01164891|102041869|FG000|COMPLETED|Overall Study||1||
48697038|NCT01164891|102041869|FG000|NOT COMPLETED|Overall Study||6||
48697039|NCT00526656|102041870|FG000|STARTED|Overall Study||9||
48697040|NCT00526656|102041870|FG000|COMPLETED|Overall Study||7||
48697041|NCT00526656|102041870|FG000|NOT COMPLETED|Overall Study||2||
48697042|NCT01252186|102041871|FG000|STARTED|Overall Study||87||
48697043|NCT01252186|102041872|FG001|STARTED|Overall Study||91||
48697044|NCT01252186|102041873|FG002|STARTED|Overall Study||87||
48697045|NCT01252186|102041871|FG000|Received Study Drug|Overall Study||83||
48697046|NCT01252186|102041872|FG001|Received Study Drug|Overall Study||89||
48697047|NCT01252186|102041873|FG002|Received Study Drug|Overall Study||80||
48697048|NCT01252186|102041871|FG000|COMPLETED|Overall Study||57||
48697049|NCT01252186|102041872|FG001|COMPLETED|Overall Study||59||
48697050|NCT01252186|102041873|FG002|COMPLETED|Overall Study||53||
48697051|NCT01252186|102041871|FG000|NOT COMPLETED|Overall Study||30||
48697052|NCT01252186|102041872|FG001|NOT COMPLETED|Overall Study||32||
48697053|NCT01252186|102041873|FG002|NOT COMPLETED|Overall Study||34||
48697054|NCT00623233|102041874|FG000|STARTED|Overall Study||52||
48697055|NCT00623233|102041874|FG000|COMPLETED|Overall Study||28||
48697056|NCT00623233|102041874|FG000|NOT COMPLETED|Overall Study||24||
48697057|NCT01813058|102041875|FG000|STARTED|Overall Study||60||
48697058|NCT01813058|102041876|FG001|STARTED|Overall Study||60||
48697059|NCT01813058|102041875|FG000|COMPLETED|Overall Study||55||
48697060|NCT01813058|102041876|FG001|COMPLETED|Overall Study||56||
48697061|NCT01813058|102041875|FG000|NOT COMPLETED|Overall Study||5||
48697062|NCT01813058|102041876|FG001|NOT COMPLETED|Overall Study||4||
48697063|NCT00705250|102041877|FG000|STARTED|Overall Study||36||
48697064|NCT00705250|102041877|FG000|COMPLETED|Overall Study||34||
48697065|NCT00705250|102041877|FG000|NOT COMPLETED|Overall Study||2||
48697066|NCT00967694|102041878|FG000|STARTED|Overall Study||26||
48697067|NCT00967694|102041878|FG000|COMPLETED|Overall Study||20||
48697068|NCT00967694|102041878|FG000|NOT COMPLETED|Overall Study||6||
48697069|NCT03430843|102041879|FG000|STARTED|Overall Study||256||
48697070|NCT03430843|102041880|FG001|STARTED|Overall Study||256||
48697071|NCT03430843|102041879|FG000|Treated|Overall Study||255||
48697072|NCT03430843|102041880|FG001|Treated|Overall Study||240||
48697073|NCT03430843|102041879|FG000|COMPLETED|Overall Study||0||
48697074|NCT03430843|102041880|FG001|COMPLETED|Overall Study||0||
48697075|NCT03430843|102041879|FG000|NOT COMPLETED|Overall Study||256||
48697076|NCT03430843|102041880|FG001|NOT COMPLETED|Overall Study||256||
48697077|NCT02377752|102041881|FG000|STARTED|Overall Study||7||
48697078|NCT02377752|102041882|FG001|STARTED|Overall Study||6||
48697079|NCT02377752|102041883|FG002|STARTED|Overall Study||6||
48697080|NCT02377752|102041884|FG003|STARTED|Overall Study||6||
48563354|NCT02094352|101710161|FG001|NOT COMPLETED|Overall Study||0||
48697081|NCT02377752|102041881|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7||
48563355|NCT01017536|101710162|FG000|STARTED|Overall Study||13||
48563356|NCT01017536|101710163|FG001|STARTED|Overall Study||13||
48563357|NCT01017536|101710162|FG000|COMPLETED|Overall Study||13||
48563358|NCT01017536|101710163|FG001|COMPLETED|Overall Study||13||
48563359|NCT01017536|101710162|FG000|NOT COMPLETED|Overall Study||0||
48563360|NCT01017536|101710163|FG001|NOT COMPLETED|Overall Study||0||
48563361|NCT03490110|101710164|FG000|STARTED|Overall Study||9||
48563362|NCT03490110|101710165|FG001|STARTED|Overall Study||9||
48563363|NCT03490110|101710164|FG000|COMPLETED|Overall Study||6||
48563364|NCT03490110|101710165|FG001|COMPLETED|Overall Study||6||
48563365|NCT03490110|101710164|FG000|NOT COMPLETED|Overall Study||3||
48697082|NCT02377752|102041882|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
48697083|NCT02377752|102041883|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
48697084|NCT02377752|102041884|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6||
48697085|NCT02377752|102041881|FG000|COMPLETED|Overall Study||7||
48697086|NCT02377752|102041882|FG001|COMPLETED|Overall Study||6||
48697087|NCT02377752|102041883|FG002|COMPLETED|Overall Study||6||
48697088|NCT02377752|102041884|FG003|COMPLETED|Overall Study||6||
48277814|NCT03784001|101003208|FG000|COMPLETED|Overall Study||44||
48277815|NCT03784001|101003209|FG001|COMPLETED|Overall Study||38||
48277816|NCT03784001|101003210|FG002|COMPLETED|Overall Study||40||
48277817|NCT03784001|101003208|FG000|NOT COMPLETED|Overall Study||2||
48277818|NCT03784001|101003209|FG001|NOT COMPLETED|Overall Study||0||
48277819|NCT03784001|101003210|FG002|NOT COMPLETED|Overall Study||1||
48277820|NCT00545753|101003211|FG000|STARTED|Overall Study||243||
48277821|NCT00545753|101003212|FG001|STARTED|Overall Study||59||
48277822|NCT00545753|101003213|FG002|STARTED|Overall Study||256||
48277823|NCT00545753|101003211|FG000|COMPLETED|Overall Study||227||
48277824|NCT00545753|101003212|FG001|COMPLETED|Overall Study||54||
48277825|NCT00545753|101003213|FG002|COMPLETED|Overall Study||230||
48277826|NCT00545753|101003211|FG000|NOT COMPLETED|Overall Study||16||
48277827|NCT00545753|101003212|FG001|NOT COMPLETED|Overall Study||5||
48277828|NCT00545753|101003213|FG002|NOT COMPLETED|Overall Study||26||
48277829|NCT01758900|101003214|FG000|STARTED|Overall Study||106||
48563366|NCT03490110|101710165|FG001|NOT COMPLETED|Overall Study||3||
48563367|NCT01402570|101710166|FG000|STARTED|Overall Study||20||
48563368|NCT01402570|101710166|FG000|COMPLETED|Overall Study||19||
48277830|NCT01758900|101003215|FG001|STARTED|Overall Study||108||
48277831|NCT01758900|101003214|FG000|COMPLETED|Overall Study||99||
48563369|NCT01402570|101710166|FG000|NOT COMPLETED|Overall Study||1||
48277832|NCT01758900|101003215|FG001|COMPLETED|Overall Study||100||
48697089|NCT02377752|102041881|FG000|NOT COMPLETED|Overall Study||0||
48697090|NCT02377752|102041882|FG001|NOT COMPLETED|Overall Study||0||
48697091|NCT02377752|102041883|FG002|NOT COMPLETED|Overall Study||0||
48697092|NCT02377752|102041884|FG003|NOT COMPLETED|Overall Study||0||
48697093|NCT03249909|102041885|FG000|STARTED|Overall Study||78||
48563370|NCT01465412|101710167|FG000|STARTED|Overall Study||12||
48563371|NCT01465412|101710168|FG001|STARTED|Overall Study||12||
48697094|NCT03249909|102041886|FG001|STARTED|Overall Study||15||
48697095|NCT03249909|102041887|FG002|STARTED|Overall Study||16||
48697096|NCT03249909|102041885|FG000|COMPLETED|Overall Study||72||
48697097|NCT03249909|102041886|FG001|COMPLETED|Overall Study||14||
48697098|NCT03249909|102041887|FG002|COMPLETED|Overall Study||16||
48697099|NCT03249909|102041885|FG000|NOT COMPLETED|Overall Study||6||
48697100|NCT03249909|102041886|FG001|NOT COMPLETED|Overall Study||1||
48697101|NCT03249909|102041887|FG002|NOT COMPLETED|Overall Study||0||
48697102|NCT05111002|102041888|FG000|STARTED|Primary Outcome||6||
48394129|NCT01349972|101295870|FG000|NOT COMPLETED|Overall Study||5||
48394130|NCT01349972|101295871|FG001|NOT COMPLETED|Overall Study||2||
48394131|NCT01250756|101295872|FG000|STARTED|Infant Series||161||
48394132|NCT01250756|101295873|FG001|STARTED|Infant Series||160||
48394133|NCT01250756|101295872|FG000|Vaccinated Dose 1|Infant Series||159||
48394134|NCT01250756|101295873|FG001|Vaccinated Dose 1|Infant Series||158||
48394135|NCT01250756|101295872|FG000|Vaccinated Dose 2|Infant Series||147||
48394136|NCT01250756|101295873|FG001|Vaccinated Dose 2|Infant Series||157||
48394137|NCT01250756|101295872|FG000|Vaccinated Dose 3|Infant Series||133||
48394138|NCT01250756|101295873|FG001|Vaccinated Dose 3|Infant Series||155||
48563372|NCT01465412|101710169|FG002|STARTED|Overall Study||9||
48563373|NCT01465412|101710170|FG003|STARTED|Overall Study||9||
48563374|NCT01465412|101710167|FG000|COMPLETED|Overall Study||12||
48563375|NCT01465412|101710168|FG001|COMPLETED|Overall Study||12||
48563376|NCT01465412|101710169|FG002|COMPLETED|Overall Study||9||
48563377|NCT01465412|101710170|FG003|COMPLETED|Overall Study||9||
48563378|NCT01465412|101710167|FG000|NOT COMPLETED|Overall Study||0||
48563379|NCT01465412|101710168|FG001|NOT COMPLETED|Overall Study||0||
48563380|NCT01465412|101710169|FG002|NOT COMPLETED|Overall Study||0||
48563381|NCT01465412|101710170|FG003|NOT COMPLETED|Overall Study||0||
48563382|NCT02223546|101710171|FG000|STARTED|Overall Study||15||
48563383|NCT02223546|101710171|FG000|COMPLETED|Overall Study||15||
48563384|NCT02223546|101710171|FG000|NOT COMPLETED|Overall Study||0||
48563385|NCT01962103|101710172|FG000|STARTED|Phase 1||16||
48563386|NCT01962103|101710173|FG001|STARTED|Phase 1||8||
48563387|NCT01962103|101710174|FG002|STARTED|Phase 1||14||
48563388|NCT01962103|101710175|FG003|STARTED|Phase 1||11||
48563389|NCT01962103|101710176|FG004|STARTED|Phase 1||8||
48563390|NCT01962103|101710177|FG005|STARTED|Phase 1||7||
48563391|NCT01962103|101710178|FG006|STARTED|Phase 1||0||
48563392|NCT01962103|101710179|FG007|STARTED|Phase 1||0||
48563393|NCT01962103|101710180|FG008|STARTED|Phase 1||0||
48563394|NCT01962103|101710172|FG000|COMPLETED|Phase 1||0||
48563395|NCT01962103|101710173|FG001|COMPLETED|Phase 1||0||
48563396|NCT01962103|101710174|FG002|COMPLETED|Phase 1||0||
48697103|NCT05111002|102041889|FG001|STARTED|Primary Outcome||6||
48697104|NCT05111002|102041888|FG000|COMPLETED|Primary Outcome||5||
48697105|NCT05111002|102041889|FG001|COMPLETED|Primary Outcome||6||
48697106|NCT05111002|102041888|FG000|NOT COMPLETED|Primary Outcome||1||
48697107|NCT05111002|102041889|FG001|NOT COMPLETED|Primary Outcome||0||
48697108|NCT05111002|102041888|FG000|STARTED|Secondary Outcome||5||
48697109|NCT05111002|102041889|FG001|STARTED|Secondary Outcome||6||
48697110|NCT05111002|102041888|FG000|COMPLETED|Secondary Outcome||4||
48697111|NCT05111002|102041889|FG001|COMPLETED|Secondary Outcome||6||
48697112|NCT05111002|102041888|FG000|NOT COMPLETED|Secondary Outcome||1||
48697113|NCT05111002|102041889|FG001|NOT COMPLETED|Secondary Outcome||0||
48697114|NCT01524224|102041890|FG000|STARTED|Overall Study||4||
48697115|NCT01524224|102041891|FG001|STARTED|Overall Study||3||
48394139|NCT01250756|101295872|FG000|COMPLETED|Infant Series||133||
48697116|NCT01524224|102041892|FG002|STARTED|Overall Study||3||
48697117|NCT01524224|102041893|FG003|STARTED|Overall Study||3||
48697118|NCT01524224|102041894|FG004|STARTED|Overall Study||4||
48697119|NCT01524224|102041895|FG005|STARTED|Overall Study||3||
48697120|NCT01524224|102041896|FG006|STARTED|Overall Study||3||
48394140|NCT01250756|101295873|FG001|COMPLETED|Infant Series||153||
48394141|NCT01250756|101295872|FG000|NOT COMPLETED|Infant Series||28||
48394142|NCT01250756|101295873|FG001|NOT COMPLETED|Infant Series||7||
48563397|NCT01962103|101710175|FG003|COMPLETED|Phase 1||0||
48563398|NCT01962103|101710176|FG004|COMPLETED|Phase 1||0||
48563399|NCT01962103|101710177|FG005|COMPLETED|Phase 1||0||
48563400|NCT01962103|101710178|FG006|COMPLETED|Phase 1||0||
48563401|NCT01962103|101710179|FG007|COMPLETED|Phase 1||0||
48563402|NCT01962103|101710180|FG008|COMPLETED|Phase 1||0||
48563403|NCT01962103|101710172|FG000|NOT COMPLETED|Phase 1||16||
48563404|NCT01962103|101710173|FG001|NOT COMPLETED|Phase 1||8||
48563405|NCT01962103|101710174|FG002|NOT COMPLETED|Phase 1||14||
48563406|NCT01962103|101710175|FG003|NOT COMPLETED|Phase 1||11||
48563407|NCT01962103|101710176|FG004|NOT COMPLETED|Phase 1||8||
48697121|NCT01524224|102041897|FG007|STARTED|Overall Study||6||
48697122|NCT01524224|102041890|FG000|Received at Least One Dose of Study Drug|Overall Study||4||
48697123|NCT01524224|102041891|FG001|Received at Least One Dose of Study Drug|Overall Study||3||
48697124|NCT01524224|102041892|FG002|Received at Least One Dose of Study Drug|Overall Study||3||
48697125|NCT01524224|102041893|FG003|Received at Least One Dose of Study Drug|Overall Study||3||
48277833|NCT01758900|101003214|FG000|NOT COMPLETED|Overall Study||7||
48277834|NCT01758900|101003215|FG001|NOT COMPLETED|Overall Study||8||
48277835|NCT02656706|101003216|FG000|STARTED|Overall Study||22||
48277836|NCT02656706|101003216|FG000|COMPLETED|Overall Study||21||
48277837|NCT02656706|101003216|FG000|NOT COMPLETED|Overall Study||1||
48277838|NCT00159263|101003217|FG000|STARTED|First Intervention||1||
48697126|NCT01524224|102041894|FG004|Received at Least One Dose of Study Drug|Overall Study||4||
48697127|NCT01524224|102041895|FG005|Received at Least One Dose of Study Drug|Overall Study||3||
48697128|NCT01524224|102041896|FG006|Received at Least One Dose of Study Drug|Overall Study||3||
48697129|NCT01524224|102041897|FG007|Received at Least One Dose of Study Drug|Overall Study||6||
48697130|NCT01524224|102041890|FG000|COMPLETED|Overall Study||1||
48697131|NCT01524224|102041891|FG001|COMPLETED|Overall Study||2||
48697132|NCT01524224|102041892|FG002|COMPLETED|Overall Study||1||
48697133|NCT01524224|102041893|FG003|COMPLETED|Overall Study||1||
48697134|NCT01524224|102041894|FG004|COMPLETED|Overall Study||0||
48697135|NCT01524224|102041895|FG005|COMPLETED|Overall Study||1||
48697136|NCT01524224|102041896|FG006|COMPLETED|Overall Study||0||
48697137|NCT01524224|102041897|FG007|COMPLETED|Overall Study||0||
48697138|NCT01524224|102041890|FG000|NOT COMPLETED|Overall Study||3||
48697139|NCT01524224|102041891|FG001|NOT COMPLETED|Overall Study||1||
48697140|NCT01524224|102041892|FG002|NOT COMPLETED|Overall Study||2||
48697141|NCT01524224|102041893|FG003|NOT COMPLETED|Overall Study||2||
48697142|NCT01524224|102041894|FG004|NOT COMPLETED|Overall Study||4||
48697143|NCT01524224|102041895|FG005|NOT COMPLETED|Overall Study||2||
48697144|NCT01524224|102041896|FG006|NOT COMPLETED|Overall Study||3||
48697145|NCT01524224|102041897|FG007|NOT COMPLETED|Overall Study||6||
48697146|NCT01562314|102041898|FG000|STARTED|Overall Study||29||
48697147|NCT01562314|102041899|FG001|STARTED|Overall Study||31||
48277839|NCT00159263|101003218|FG001|STARTED|First Intervention||1||
48277840|NCT00159263|101003219|FG002|STARTED|First Intervention||2||
48277841|NCT00159263|101003220|FG003|STARTED|First Intervention||2||
48277842|NCT00159263|101003221|FG004|STARTED|First Intervention||2||
48277843|NCT00159263|101003222|FG005|STARTED|First Intervention||2||
48277844|NCT00159263|101003217|FG000|COMPLETED|First Intervention||1||
48277845|NCT00159263|101003218|FG001|COMPLETED|First Intervention||1||
48277846|NCT00159263|101003219|FG002|COMPLETED|First Intervention||2||
48277847|NCT00159263|101003220|FG003|COMPLETED|First Intervention||2||
48277848|NCT00159263|101003221|FG004|COMPLETED|First Intervention||2||
48277849|NCT00159263|101003222|FG005|COMPLETED|First Intervention||2||
48277850|NCT00159263|101003217|FG000|NOT COMPLETED|First Intervention||0||
48277851|NCT00159263|101003218|FG001|NOT COMPLETED|First Intervention||0||
48277852|NCT00159263|101003219|FG002|NOT COMPLETED|First Intervention||0||
48277853|NCT00159263|101003220|FG003|NOT COMPLETED|First Intervention||0||
48277854|NCT00159263|101003221|FG004|NOT COMPLETED|First Intervention||0||
48277855|NCT00159263|101003222|FG005|NOT COMPLETED|First Intervention||0||
48277856|NCT00159263|101003217|FG000|STARTED|Washout||1||
48277857|NCT00159263|101003218|FG001|STARTED|Washout||1||
48277858|NCT00159263|101003219|FG002|STARTED|Washout||2||
48277859|NCT00159263|101003220|FG003|STARTED|Washout||2||
48277860|NCT00159263|101003221|FG004|STARTED|Washout||2||
48277861|NCT00159263|101003222|FG005|STARTED|Washout||2||
48277862|NCT00159263|101003217|FG000|COMPLETED|Washout||1||
48277863|NCT00159263|101003218|FG001|COMPLETED|Washout||1||
48277864|NCT00159263|101003219|FG002|COMPLETED|Washout||2||
48277865|NCT00159263|101003220|FG003|COMPLETED|Washout||2||
48277866|NCT00159263|101003221|FG004|COMPLETED|Washout||2||
48277867|NCT00159263|101003222|FG005|COMPLETED|Washout||2||
48277868|NCT00159263|101003217|FG000|NOT COMPLETED|Washout||0||
48277869|NCT00159263|101003218|FG001|NOT COMPLETED|Washout||0||
48697148|NCT01562314|102041898|FG000|Received at Least 1 Dose of Study Drug|Overall Study||29|Safety analysis set; participants analyzed according to treatment received.|
48697149|NCT01562314|102041899|FG001|Received at Least 1 Dose of Study Drug|Overall Study||31|Safety analysis set; participants analyzed according to treatment received.|
48697150|NCT01562314|102041898|FG000|Intent-to-Treat (ITT) Analysis Set|Overall Study||29|All randomized participants who received ≥1 dose of study drug; analyzed by randomization group.|
48697151|NCT01562314|102041899|FG001|Intent-to-Treat (ITT) Analysis Set|Overall Study||31|All randomized participants who received ≥1 dose of study drug; analyzed by randomization group.|
48697152|NCT01562314|102041898|FG000|Per Protocol (PP) Analysis Set|Overall Study||17|All participants without protocol violations that compromised the assessments of efficacy.|
48697153|NCT01562314|102041899|FG001|Per Protocol (PP) Analysis Set|Overall Study||27|All participants without protocol violations that compromised the assessments of efficacy.|
48277870|NCT00159263|101003219|FG002|NOT COMPLETED|Washout||0||
48277871|NCT00159263|101003220|FG003|NOT COMPLETED|Washout||0||
48277872|NCT00159263|101003221|FG004|NOT COMPLETED|Washout||0||
48277873|NCT00159263|101003222|FG005|NOT COMPLETED|Washout||0||
48277874|NCT00159263|101003217|FG000|STARTED|Second Intervention||1||
48277875|NCT00159263|101003218|FG001|STARTED|Second Intervention||1||
48114336|NCT02711800|100605161|FG000|NOT COMPLETED|Overall Study||2||
48114337|NCT02584309|100605162|FG000|STARTED|Overall Study||62||
48114338|NCT02584309|100605163|FG001|STARTED|Overall Study||10||
48114339|NCT02584309|100605164|FG002|STARTED|Overall Study||1||
48114340|NCT02584309|100605162|FG000|COMPLETED|Overall Study||62||
48563408|NCT01962103|101710177|FG005|NOT COMPLETED|Phase 1||7||
48563409|NCT01962103|101710178|FG006|NOT COMPLETED|Phase 1||0||
48114341|NCT02584309|100605163|FG001|COMPLETED|Overall Study||10||
48114342|NCT02584309|100605164|FG002|COMPLETED|Overall Study||0||
48114343|NCT02584309|100605162|FG000|NOT COMPLETED|Overall Study||0||
48114344|NCT02584309|100605163|FG001|NOT COMPLETED|Overall Study||0||
48114345|NCT02584309|100605164|FG002|NOT COMPLETED|Overall Study||1||
48114346|NCT00699972|100605165|FG000|STARTED|Overall Study||122||
48114347|NCT00699972|100605166|FG001|STARTED|Overall Study||133||
48114348|NCT00699972|100605167|FG002|STARTED|Overall Study||135||
48114349|NCT00699972|100605165|FG000|COMPLETED|Overall Study||106||
48114350|NCT00699972|100605166|FG001|COMPLETED|Overall Study||114||
48114351|NCT00699972|100605167|FG002|COMPLETED|Overall Study||100||
48114352|NCT00699972|100605165|FG000|NOT COMPLETED|Overall Study||16||
48114353|NCT00699972|100605166|FG001|NOT COMPLETED|Overall Study||19||
48114354|NCT00699972|100605167|FG002|NOT COMPLETED|Overall Study||35||
48114355|NCT03491150|100605168|FG000|STARTED|Overall Study||76||
48114356|NCT03491150|100605169|FG001|STARTED|Overall Study||73||
48114357|NCT03491150|100605168|FG000|COMPLETED|Overall Study||0||
48114358|NCT03491150|100605169|FG001|COMPLETED|Overall Study||0||
48114359|NCT03491150|100605168|FG000|NOT COMPLETED|Overall Study||76||
48114360|NCT03491150|100605169|FG001|NOT COMPLETED|Overall Study||73||
48114361|NCT01337297|100605170|FG000|STARTED|Overall Study||11||
48114362|NCT01337297|100605171|FG001|STARTED|Overall Study||9||
48114363|NCT01337297|100605170|FG000|COMPLETED|Overall Study||6||
48114364|NCT01337297|100605171|FG001|COMPLETED|Overall Study||3||
48114365|NCT01337297|100605170|FG000|NOT COMPLETED|Overall Study||5||
48114366|NCT01337297|100605171|FG001|NOT COMPLETED|Overall Study||6||
48114367|NCT00094653|100605172|FG000|STARTED|Overall Study||403||
48114368|NCT00094653|100605173|FG001|STARTED|Overall Study||137||
48114369|NCT00094653|100605174|FG002|STARTED|Overall Study||136||
48277876|NCT00159263|101003219|FG002|STARTED|Second Intervention||2||
48277877|NCT00159263|101003220|FG003|STARTED|Second Intervention||2||
48277878|NCT00159263|101003221|FG004|STARTED|Second Intervention||2||
48277879|NCT00159263|101003222|FG005|STARTED|Second Intervention||2||
48277880|NCT00159263|101003217|FG000|COMPLETED|Second Intervention||1||
48277881|NCT00159263|101003218|FG001|COMPLETED|Second Intervention||1||
48277882|NCT00159263|101003219|FG002|COMPLETED|Second Intervention||2||
48277883|NCT00159263|101003220|FG003|COMPLETED|Second Intervention||2||
48563410|NCT01962103|101710179|FG007|NOT COMPLETED|Phase 1||0||
48563411|NCT01962103|101710180|FG008|NOT COMPLETED|Phase 1||0||
48563412|NCT01962103|101710172|FG000|STARTED|Phase 2||0||
48114370|NCT00094653|100605172|FG000|Treated|Overall Study||381||
48114371|NCT00094653|100605173|FG001|Treated|Overall Study||131||
48114372|NCT00094653|100605174|FG002|Treated|Overall Study||131||
48114373|NCT00094653|100605172|FG000|COMPLETED|Overall Study||82||
48114374|NCT00094653|100605173|FG001|COMPLETED|Overall Study||31||
48114375|NCT00094653|100605174|FG002|COMPLETED|Overall Study||10||
48277884|NCT00159263|101003221|FG004|COMPLETED|Second Intervention||2||
48277885|NCT00159263|101003222|FG005|COMPLETED|Second Intervention||2||
48563413|NCT01962103|101710173|FG001|STARTED|Phase 2||0||
48563414|NCT01962103|101710174|FG002|STARTED|Phase 2||0||
48563415|NCT01962103|101710175|FG003|STARTED|Phase 2||0||
48563416|NCT01962103|101710176|FG004|STARTED|Phase 2||0||
48563417|NCT01962103|101710177|FG005|STARTED|Phase 2||0||
48563418|NCT01962103|101710178|FG006|STARTED|Phase 2||14||
48563419|NCT01962103|101710179|FG007|STARTED|Phase 2||14||
48563420|NCT01962103|101710180|FG008|STARTED|Phase 2||14||
48563421|NCT01962103|101710172|FG000|COMPLETED|Phase 2||0||
48563422|NCT01962103|101710173|FG001|COMPLETED|Phase 2||0||
48563423|NCT01962103|101710174|FG002|COMPLETED|Phase 2||0||
48563424|NCT01962103|101710175|FG003|COMPLETED|Phase 2||0||
48563425|NCT01962103|101710176|FG004|COMPLETED|Phase 2||0||
48563426|NCT01962103|101710177|FG005|COMPLETED|Phase 2||0||
48563427|NCT01962103|101710178|FG006|COMPLETED|Phase 2||0||
48563428|NCT01962103|101710179|FG007|COMPLETED|Phase 2||0||
48563429|NCT01962103|101710180|FG008|COMPLETED|Phase 2||0||
48277886|NCT00159263|101003217|FG000|NOT COMPLETED|Second Intervention||0||
48114376|NCT00094653|100605172|FG000|NOT COMPLETED|Overall Study||321||
48114377|NCT00094653|100605173|FG001|NOT COMPLETED|Overall Study||106||
48114378|NCT00094653|100605174|FG002|NOT COMPLETED|Overall Study||126||
48114379|NCT00528528|100605175|FG000|STARTED|Overall Study||40||
48114380|NCT00528528|100605176|FG001|STARTED|Overall Study||42||
48114381|NCT00528528|100605177|FG002|STARTED|Overall Study||40||
48114382|NCT00528528|100605178|FG003|STARTED|Overall Study||39||
48141422|NCT01319396|100670422|FG000|COMPLETED|Overall Study||24||
48277887|NCT00159263|101003218|FG001|NOT COMPLETED|Second Intervention||0||
48563430|NCT01962103|101710172|FG000|NOT COMPLETED|Phase 2||0||
48563431|NCT01962103|101710173|FG001|NOT COMPLETED|Phase 2||0||
48563432|NCT01962103|101710174|FG002|NOT COMPLETED|Phase 2||0||
48563433|NCT01962103|101710175|FG003|NOT COMPLETED|Phase 2||0||
48563434|NCT01962103|101710176|FG004|NOT COMPLETED|Phase 2||0||
48563435|NCT01962103|101710177|FG005|NOT COMPLETED|Phase 2||0||
48394143|NCT01250756|101295872|FG000|STARTED|After Infant Series||133||
48394144|NCT01250756|101295873|FG001|STARTED|After Infant Series||153||
48394145|NCT01250756|101295872|FG000|COMPLETED|After Infant Series||122||
48394146|NCT01250756|101295873|FG001|COMPLETED|After Infant Series||149||
48394147|NCT01250756|101295872|FG000|NOT COMPLETED|After Infant Series||11||
48394148|NCT01250756|101295873|FG001|NOT COMPLETED|After Infant Series||4||
48394149|NCT01250756|101295872|FG000|STARTED|Toddler Dose||122||
48394150|NCT01250756|101295873|FG001|STARTED|Toddler Dose||149||
48394151|NCT01250756|101295872|FG000|COMPLETED|Toddler Dose||122||
48394152|NCT01250756|101295873|FG001|COMPLETED|Toddler Dose||148||
48563436|NCT01962103|101710178|FG006|NOT COMPLETED|Phase 2||14||
48563437|NCT01962103|101710179|FG007|NOT COMPLETED|Phase 2||14||
48563438|NCT01962103|101710180|FG008|NOT COMPLETED|Phase 2||14||
48563439|NCT01134939|101710181|FG000|STARTED|Overall Study||59||
48563440|NCT01134939|101710182|FG001|STARTED|Overall Study||42||
48563441|NCT01134939|101710183|FG002|STARTED|Overall Study||51||
48563442|NCT01134939|101710184|FG003|STARTED|Overall Study||46||
48563443|NCT01134939|101710185|FG004|STARTED|Overall Study||33||
48563444|NCT01134939|101710186|FG005|STARTED|Overall Study||14||
48563445|NCT01134939|101710187|FG006|STARTED|Overall Study||19||
48114383|NCT00528528|100605175|FG000|Ongoing at Time of Cut-off|Overall Study||0||
48114384|NCT00528528|100605176|FG001|Ongoing at Time of Cut-off|Overall Study||0||
48114385|NCT00528528|100605177|FG002|Ongoing at Time of Cut-off|Overall Study||1||
48114386|NCT00528528|100605178|FG003|Ongoing at Time of Cut-off|Overall Study||0||
48114387|NCT00528528|100605175|FG000|COMPLETED|Overall Study||37||
48114388|NCT00528528|100605176|FG001|COMPLETED|Overall Study||39||
48114389|NCT00528528|100605177|FG002|COMPLETED|Overall Study||37||
48114390|NCT00528528|100605178|FG003|COMPLETED|Overall Study||36||
48114391|NCT00528528|100605175|FG000|NOT COMPLETED|Overall Study||3||
48114392|NCT00528528|100605176|FG001|NOT COMPLETED|Overall Study||3||
48114393|NCT00528528|100605177|FG002|NOT COMPLETED|Overall Study||3||
48114394|NCT00528528|100605178|FG003|NOT COMPLETED|Overall Study||3||
48114395|NCT02059148|100605179|FG000|STARTED|Treatment 1||4||
48114396|NCT02059148|100605180|FG001|STARTED|Treatment 1||4||
48114397|NCT02059148|100605181|FG002|STARTED|Treatment 1||4||
48114398|NCT02059148|100605182|FG003|STARTED|Treatment 1||4||
48114399|NCT02059148|100605183|FG004|STARTED|Treatment 1||4||
48114400|NCT02059148|100605184|FG005|STARTED|Treatment 1||4||
48114401|NCT02059148|100605179|FG000|COMPLETED|Treatment 1||4||
48114402|NCT02059148|100605180|FG001|COMPLETED|Treatment 1||4||
48114403|NCT02059148|100605181|FG002|COMPLETED|Treatment 1||4||
48114404|NCT02059148|100605182|FG003|COMPLETED|Treatment 1||4||
48114405|NCT02059148|100605183|FG004|COMPLETED|Treatment 1||4||
48114406|NCT02059148|100605184|FG005|COMPLETED|Treatment 1||3||
48114407|NCT02059148|100605179|FG000|NOT COMPLETED|Treatment 1||0||
48114408|NCT02059148|100605180|FG001|NOT COMPLETED|Treatment 1||0||
48114409|NCT02059148|100605181|FG002|NOT COMPLETED|Treatment 1||0||
48114410|NCT02059148|100605182|FG003|NOT COMPLETED|Treatment 1||0||
48114411|NCT02059148|100605183|FG004|NOT COMPLETED|Treatment 1||0||
48114412|NCT02059148|100605184|FG005|NOT COMPLETED|Treatment 1||1||
48114413|NCT02059148|100605179|FG000|STARTED|Treatment 2||4||
48114414|NCT02059148|100605180|FG001|STARTED|Treatment 2||4||
48114415|NCT02059148|100605181|FG002|STARTED|Treatment 2||4||
48114416|NCT02059148|100605182|FG003|STARTED|Treatment 2||4||
48114417|NCT02059148|100605183|FG004|STARTED|Treatment 2||4||
48114418|NCT02059148|100605184|FG005|STARTED|Treatment 2||3||
48563446|NCT01134939|101710188|FG007|STARTED|Overall Study||1||
48114419|NCT02059148|100605179|FG000|COMPLETED|Treatment 2||4||
48114420|NCT02059148|100605180|FG001|COMPLETED|Treatment 2||4||
48114421|NCT02059148|100605181|FG002|COMPLETED|Treatment 2||4||
48114422|NCT02059148|100605182|FG003|COMPLETED|Treatment 2||4||
48114423|NCT02059148|100605183|FG004|COMPLETED|Treatment 2||4||
48114424|NCT02059148|100605184|FG005|COMPLETED|Treatment 2||3||
48114425|NCT02059148|100605179|FG000|NOT COMPLETED|Treatment 2||0||
48114426|NCT02059148|100605180|FG001|NOT COMPLETED|Treatment 2||0||
48114427|NCT02059148|100605181|FG002|NOT COMPLETED|Treatment 2||0||
48394153|NCT01250756|101295872|FG000|NOT COMPLETED|Toddler Dose||0||
48394154|NCT01250756|101295873|FG001|NOT COMPLETED|Toddler Dose||1||
48394155|NCT01250756|101295872|FG000|STARTED|After Toddler Dose||0||
48394156|NCT01250756|101295873|FG001|STARTED|After Toddler Dose||148||
48394157|NCT01250756|101295872|FG000|COMPLETED|After Toddler Dose||0||
48394158|NCT01250756|101295873|FG001|COMPLETED|After Toddler Dose||147||
48394159|NCT01250756|101295872|FG000|NOT COMPLETED|After Toddler Dose||0||
48394160|NCT01250756|101295873|FG001|NOT COMPLETED|After Toddler Dose||1||
48394161|NCT03097614|101295874|FG000|STARTED|Overall Study||57||
48394162|NCT03097614|101295874|FG000|COMPLETED|Overall Study||54||
48394163|NCT03097614|101295874|FG000|NOT COMPLETED|Overall Study||3||
48394164|NCT03342937|101295875|FG000|STARTED|Overall Study||36||
48563447|NCT01134939|101710181|FG000|COMPLETED|Overall Study||42||
48114428|NCT02059148|100605182|FG003|NOT COMPLETED|Treatment 2||0||
48114429|NCT02059148|100605183|FG004|NOT COMPLETED|Treatment 2||0||
48563448|NCT01134939|101710182|FG001|COMPLETED|Overall Study||24||
48114430|NCT02059148|100605184|FG005|NOT COMPLETED|Treatment 2||0||
48114431|NCT02059148|100605179|FG000|STARTED|Treatment 3||4||
48114432|NCT02059148|100605180|FG001|STARTED|Treatment 3||4||
48394165|NCT03342937|101295875|FG000|COMPLETED|Overall Study||36||
48563449|NCT01134939|101710183|FG002|COMPLETED|Overall Study||41||
48563450|NCT01134939|101710184|FG003|COMPLETED|Overall Study||32||
48563451|NCT01134939|101710185|FG004|COMPLETED|Overall Study||23||
48563452|NCT01134939|101710186|FG005|COMPLETED|Overall Study||5||
48563453|NCT01134939|101710187|FG006|COMPLETED|Overall Study||10||
48563454|NCT01134939|101710188|FG007|COMPLETED|Overall Study||1||
48563455|NCT01134939|101710181|FG000|NOT COMPLETED|Overall Study||17||
48563456|NCT01134939|101710182|FG001|NOT COMPLETED|Overall Study||18||
48563457|NCT01134939|101710183|FG002|NOT COMPLETED|Overall Study||10||
48563458|NCT01134939|101710184|FG003|NOT COMPLETED|Overall Study||14||
48563459|NCT01134939|101710185|FG004|NOT COMPLETED|Overall Study||10||
48563460|NCT01134939|101710186|FG005|NOT COMPLETED|Overall Study||9||
48563461|NCT01134939|101710187|FG006|NOT COMPLETED|Overall Study||9||
48563462|NCT01134939|101710188|FG007|NOT COMPLETED|Overall Study||0||
48563463|NCT04537078|101710189|FG000|STARTED|Overall Study||45||
48394166|NCT03342937|101295875|FG000|NOT COMPLETED|Overall Study||0||
48394167|NCT00345540|101295876|FG000|STARTED|Overall Study||16||
48563464|NCT04537078|101710190|FG001|STARTED|Overall Study||45||
48563465|NCT04537078|101710189|FG000|COMPLETED|Overall Study||41||
48563466|NCT04537078|101710190|FG001|COMPLETED|Overall Study||42||
48394168|NCT00345540|101295876|FG000|COMPLETED|Overall Study||15||
48394169|NCT00345540|101295876|FG000|NOT COMPLETED|Overall Study||1||
48394170|NCT02022033|101295877|FG000|STARTED|Overall Study||25||
48394171|NCT02022033|101295877|FG000|COMPLETED|Overall Study||24||
48394172|NCT02022033|101295877|FG000|NOT COMPLETED|Overall Study||1||
48394173|NCT02621619|101295878|FG000|STARTED|Overall Study||80||
48394174|NCT02621619|101295879|FG001|STARTED|Overall Study||79||
48394175|NCT02621619|101295878|FG000|COMPLETED|Overall Study||80||
48394176|NCT02621619|101295879|FG001|COMPLETED|Overall Study||79||
48563467|NCT04537078|101710189|FG000|NOT COMPLETED|Overall Study||4||
48563468|NCT04537078|101710190|FG001|NOT COMPLETED|Overall Study||3||
48563469|NCT01115244|101710191|FG000|STARTED|Overall Study||0||
48563470|NCT01115244|101710192|FG001|STARTED|Overall Study||0||
48394177|NCT02621619|101295878|FG000|NOT COMPLETED|Overall Study||0||
48394178|NCT02621619|101295879|FG001|NOT COMPLETED|Overall Study||0||
48394179|NCT00425113|101295880|FG000|STARTED|Overall Study||17||
48563471|NCT01115244|101710191|FG000|COMPLETED|Overall Study||0||
48563472|NCT01115244|101710192|FG001|COMPLETED|Overall Study||0||
48563473|NCT01115244|101710191|FG000|NOT COMPLETED|Overall Study||0||
48563474|NCT01115244|101710192|FG001|NOT COMPLETED|Overall Study||0||
48563475|NCT01329380|101710193|FG000|STARTED|Overall Study||403|Participants who were registered|
48563476|NCT01329380|101710193|FG000|Safety Population|Overall Study||396|Excludes duplicate participants and participants starting treatment prior to study registration|
48563477|NCT01329380|101710193|FG000|COMPLETED|Overall Study||374|Participants with available efficacy data at 12 weeks or 24 weeks after the start of treatment|
48563478|NCT01329380|101710193|FG000|NOT COMPLETED|Overall Study||29||
48563479|NCT02905240|101710194|FG000|STARTED|Overall Study||172||
48563480|NCT02905240|101710195|FG001|STARTED|Overall Study||160||
48563481|NCT02905240|101710194|FG000|COMPLETED|Overall Study||154||
48563482|NCT02905240|101710195|FG001|COMPLETED|Overall Study||137||
48563483|NCT02905240|101710194|FG000|NOT COMPLETED|Overall Study||18||
48563484|NCT02905240|101710195|FG001|NOT COMPLETED|Overall Study||23||
48563485|NCT02017210|101710196|FG000|STARTED|Overall Study||17|Individuals who participated in 2 previous studies performed at the Garvan Institute|
48563486|NCT02017210|101710197|FG001|STARTED|Overall Study||20|Individuals who participated in 2 previous studies performed at the Garvan Institute|
48563487|NCT02017210|101710198|FG002|STARTED|Overall Study||20|Individuals who participated in 2 previous studies performed at the Garvan Institute|
48563488|NCT02017210|101710196|FG000|COMPLETED|Overall Study||17||
48563489|NCT02017210|101710197|FG001|COMPLETED|Overall Study||20||
48563490|NCT02017210|101710198|FG002|COMPLETED|Overall Study||20||
48563491|NCT02017210|101710196|FG000|NOT COMPLETED|Overall Study||0||
48563492|NCT02017210|101710197|FG001|NOT COMPLETED|Overall Study||0||
48563493|NCT02017210|101710198|FG002|NOT COMPLETED|Overall Study||0||
48563494|NCT00793871|101710199|FG000|STARTED|Overall Study||60||
48563495|NCT00793871|101710199|FG000|Received Treatment|Overall Study||59||
48563496|NCT00793871|101710199|FG000|COMPLETED|Overall Study||0||
48563497|NCT00793871|101710199|FG000|NOT COMPLETED|Overall Study||60||
48563498|NCT03313180|101710200|FG000|STARTED|Overall Study||444||
48563499|NCT03313180|101710200|FG000|COMPLETED|Overall Study||265||
48563500|NCT03313180|101710200|FG000|NOT COMPLETED|Overall Study||179||
48563501|NCT03767153|101710201|FG000|STARTED|Overall Study||14||
48563502|NCT03767153|101710202|FG001|STARTED|Overall Study||11||
48563503|NCT03767153|101710201|FG000|COMPLETED|Overall Study||14||
48394180|NCT00425113|101295881|FG001|STARTED|Overall Study||18||
48394181|NCT00425113|101295880|FG000|Exposed to Study Drug|Overall Study||16||
48394182|NCT00425113|101295881|FG001|Exposed to Study Drug|Overall Study||17||
48394183|NCT00425113|101295880|FG000|COMPLETED|Overall Study||15||
48563504|NCT03767153|101710202|FG001|COMPLETED|Overall Study||11||
48563505|NCT03767153|101710201|FG000|NOT COMPLETED|Overall Study||0||
48563506|NCT03767153|101710202|FG001|NOT COMPLETED|Overall Study||0||
48563507|NCT00722137|101710203|FG000|STARTED|Overall Study||244||
48563508|NCT00722137|101710204|FG001|STARTED|Overall Study||243||
48563509|NCT00722137|101710203|FG000|COMPLETED|Overall Study||199|Completed participants are the participants who completed the treatment.|
48394184|NCT00425113|101295881|FG001|COMPLETED|Overall Study||16||
48394185|NCT00425113|101295880|FG000|NOT COMPLETED|Overall Study||2||
48394186|NCT00425113|101295881|FG001|NOT COMPLETED|Overall Study||2||
48394187|NCT04397796|101295882|FG000|STARTED|Overall Study||3||
48394188|NCT04397796|101295883|FG001|STARTED|Overall Study||1||
48394189|NCT04397796|101295882|FG000|COMPLETED|Overall Study||0||
48563510|NCT00722137|101710204|FG001|COMPLETED|Overall Study||195|Completed participants are the participants who completed the treatment.|
48563511|NCT00722137|101710203|FG000|NOT COMPLETED|Overall Study||45||
48563512|NCT00722137|101710204|FG001|NOT COMPLETED|Overall Study||48||
48563513|NCT03351608|101710205|FG000|STARTED|Overall Study||19||
48563514|NCT03351608|101710206|FG001|STARTED|Overall Study||23||
48563515|NCT03351608|101710207|FG002|STARTED|Overall Study||35||
48563516|NCT03351608|101710208|FG003|STARTED|Overall Study||176||
48563517|NCT03351608|101710209|FG004|STARTED|Overall Study||35||
48563518|NCT03351608|101710205|FG000|Treated|Overall Study||18||
48563519|NCT03351608|101710206|FG001|Treated|Overall Study||22||
48563520|NCT03351608|101710207|FG002|Treated|Overall Study||33||
48563521|NCT03351608|101710208|FG003|Treated|Overall Study||169||
48563522|NCT03351608|101710209|FG004|Treated|Overall Study||34||
48563523|NCT03351608|101710205|FG000|COMPLETED|Overall Study||18||
48563524|NCT03351608|101710206|FG001|COMPLETED|Overall Study||21||
48563525|NCT03351608|101710207|FG002|COMPLETED|Overall Study||32||
48563526|NCT03351608|101710208|FG003|COMPLETED|Overall Study||168||
48563527|NCT03351608|101710209|FG004|COMPLETED|Overall Study||33||
48563528|NCT03351608|101710205|FG000|NOT COMPLETED|Overall Study||1||
48563529|NCT03351608|101710206|FG001|NOT COMPLETED|Overall Study||2||
48563530|NCT03351608|101710207|FG002|NOT COMPLETED|Overall Study||3||
48563531|NCT03351608|101710208|FG003|NOT COMPLETED|Overall Study||8||
48563532|NCT03351608|101710209|FG004|NOT COMPLETED|Overall Study||2||
48563533|NCT03870880|101710210|FG000|STARTED|Overall Study||27||
48563534|NCT03870880|101710211|FG001|STARTED|Overall Study||58||
48563535|NCT03870880|101710212|FG002|STARTED|Overall Study||31||
48563536|NCT03870880|101710213|FG003|STARTED|Overall Study||28||
48563537|NCT03870880|101710214|FG004|STARTED|Overall Study||61||
48563538|NCT03870880|101710215|FG005|STARTED|Overall Study||10||
48563539|NCT03870880|101710210|FG000|COMPLETED|Overall Study||21||
48563540|NCT03870880|101710211|FG001|COMPLETED|Overall Study||43||
48563541|NCT03870880|101710212|FG002|COMPLETED|Overall Study||26||
48563542|NCT03870880|101710213|FG003|COMPLETED|Overall Study||20||
48563543|NCT03870880|101710214|FG004|COMPLETED|Overall Study||44||
48563544|NCT03870880|101710215|FG005|COMPLETED|Overall Study||7||
48563545|NCT03870880|101710210|FG000|NOT COMPLETED|Overall Study||6||
48563546|NCT03870880|101710211|FG001|NOT COMPLETED|Overall Study||15||
48563547|NCT03870880|101710212|FG002|NOT COMPLETED|Overall Study||5||
48563548|NCT03870880|101710213|FG003|NOT COMPLETED|Overall Study||8||
48563549|NCT03870880|101710214|FG004|NOT COMPLETED|Overall Study||17||
48563550|NCT03870880|101710215|FG005|NOT COMPLETED|Overall Study||3||
48563551|NCT02996227|101710216|FG000|STARTED|Overall Study||260||
48563552|NCT02996227|101710217|FG001|STARTED|Overall Study||254||
48563553|NCT02996227|101710216|FG000|COMPLETED|Overall Study||255||
48563554|NCT02996227|101710217|FG001|COMPLETED|Overall Study||243||
48563555|NCT02996227|101710216|FG000|NOT COMPLETED|Overall Study||5||
48563556|NCT02996227|101710217|FG001|NOT COMPLETED|Overall Study||11||
48563557|NCT02857816|101710218|FG000|STARTED|Overall Study||154||
48563558|NCT02857816|101710218|FG000|Subjects Qualified and Treated With PTNM|Overall Study||120|This includes those subjects that met eligibility criteria and received PTNM therapy in the study.|
48563559|NCT02857816|101710218|FG000|COMPLETED|Overall Study||116||
48277888|NCT00159263|101003219|FG002|NOT COMPLETED|Second Intervention||0||
48277889|NCT00159263|101003220|FG003|NOT COMPLETED|Second Intervention||0||
48277890|NCT00159263|101003221|FG004|NOT COMPLETED|Second Intervention||0||
48277891|NCT00159263|101003222|FG005|NOT COMPLETED|Second Intervention||0||
48277892|NCT00159263|101003217|FG000|STARTED|Washout||1||
48563560|NCT02857816|101710218|FG000|NOT COMPLETED|Overall Study||38||
48563561|NCT00391768|101710219|FG000|STARTED|Overall Study||12||
48563562|NCT00391768|101710220|FG001|STARTED|Overall Study||3||
48563563|NCT00391768|101710221|FG002|STARTED|Overall Study||7||
48277893|NCT00159263|101003218|FG001|STARTED|Washout||1||
48277894|NCT00159263|101003219|FG002|STARTED|Washout||2||
48277895|NCT00159263|101003220|FG003|STARTED|Washout||2||
48563564|NCT00391768|101710222|FG003|STARTED|Overall Study||8||
48563565|NCT00391768|101710223|FG004|STARTED|Overall Study||24||
48563566|NCT00391768|101710224|FG005|STARTED|Overall Study||10||
48563567|NCT00391768|101710225|FG006|STARTED|Overall Study||23||
48563568|NCT00391768|101710219|FG000|COMPLETED|Overall Study||12||
48394190|NCT04397796|101295883|FG001|COMPLETED|Overall Study||0||
48394191|NCT04397796|101295882|FG000|NOT COMPLETED|Overall Study||3||
48563569|NCT00391768|101710220|FG001|COMPLETED|Overall Study||3||
48563570|NCT00391768|101710221|FG002|COMPLETED|Overall Study||6||
48563571|NCT00391768|101710222|FG003|COMPLETED|Overall Study||7||
48563572|NCT00391768|101710223|FG004|COMPLETED|Overall Study||22||
48563573|NCT00391768|101710224|FG005|COMPLETED|Overall Study||7||
48277896|NCT00159263|101003221|FG004|STARTED|Washout||2||
48277897|NCT00159263|101003222|FG005|STARTED|Washout||2||
48277898|NCT00159263|101003217|FG000|COMPLETED|Washout||1||
48394192|NCT04397796|101295883|FG001|NOT COMPLETED|Overall Study||1||
48563574|NCT00391768|101710225|FG006|COMPLETED|Overall Study||19||
48563575|NCT00391768|101710219|FG000|NOT COMPLETED|Overall Study||0||
48563576|NCT00391768|101710220|FG001|NOT COMPLETED|Overall Study||0||
48563577|NCT00391768|101710221|FG002|NOT COMPLETED|Overall Study||1||
48563578|NCT00391768|101710222|FG003|NOT COMPLETED|Overall Study||1||
48563579|NCT00391768|101710223|FG004|NOT COMPLETED|Overall Study||2||
48563580|NCT00391768|101710224|FG005|NOT COMPLETED|Overall Study||3||
48563581|NCT00391768|101710225|FG006|NOT COMPLETED|Overall Study||4||
48563582|NCT03751098|101710226|FG000|STARTED|Overall Study||37||74
48563583|NCT03751098|101710227|FG001|STARTED|Overall Study||33||66
48563584|NCT03751098|101710226|FG000|COMPLETED|Overall Study||37||74
48563585|NCT03751098|101710227|FG001|COMPLETED|Overall Study||32||64
48563586|NCT03751098|101710226|FG000|NOT COMPLETED|Overall Study||0||0
48563587|NCT03751098|101710227|FG001|NOT COMPLETED|Overall Study||1||2
48563588|NCT01011816|101710228|FG000|STARTED|26-Week Primary Endpoint||164||
48563589|NCT01011816|101710229|FG001|STARTED|26-Week Primary Endpoint||56||
48563590|NCT01011816|101710228|FG000|COMPLETED|26-Week Primary Endpoint||157||
48563591|NCT01011816|101710229|FG001|COMPLETED|26-Week Primary Endpoint||54||
48277899|NCT00159263|101003218|FG001|COMPLETED|Washout||1||
48277900|NCT00159263|101003219|FG002|COMPLETED|Washout||2||
48277901|NCT00159263|101003220|FG003|COMPLETED|Washout||2||
48277902|NCT00159263|101003221|FG004|COMPLETED|Washout||2||
48277903|NCT00159263|101003222|FG005|COMPLETED|Washout||2||
48277904|NCT00159263|101003217|FG000|NOT COMPLETED|Washout||0||
48563592|NCT01011816|101710228|FG000|NOT COMPLETED|26-Week Primary Endpoint||7||
48563593|NCT01011816|101710229|FG001|NOT COMPLETED|26-Week Primary Endpoint||2||
48563594|NCT01011816|101710228|FG000|STARTED|78-Week Extended Follow-up||157||
48563595|NCT01011816|101710229|FG001|STARTED|78-Week Extended Follow-up||54||
48563596|NCT01011816|101710228|FG000|COMPLETED|78-Week Extended Follow-up||85||
48563597|NCT01011816|101710229|FG001|COMPLETED|78-Week Extended Follow-up||26||
48563598|NCT01011816|101710228|FG000|NOT COMPLETED|78-Week Extended Follow-up||72||
48563599|NCT01011816|101710229|FG001|NOT COMPLETED|78-Week Extended Follow-up||28||
48563600|NCT01699373|101710230|FG000|STARTED|Overall Study||85||
48697154|NCT01562314|102041898|FG000|COMPLETED|Overall Study||16||
48697155|NCT01562314|102041899|FG001|COMPLETED|Overall Study||23||
48697156|NCT01562314|102041898|FG000|NOT COMPLETED|Overall Study||13||
48563601|NCT01699373|101710231|FG001|STARTED|Overall Study||85||
48563602|NCT01699373|101710230|FG000|COMPLETED|Overall Study||85||
48563603|NCT01699373|101710231|FG001|COMPLETED|Overall Study||85||
48563604|NCT01699373|101710230|FG000|NOT COMPLETED|Overall Study||0||
48563605|NCT01699373|101710231|FG001|NOT COMPLETED|Overall Study||0||
48563606|NCT02359955|101710232|FG000|STARTED|Overall Study||10||
48697157|NCT01562314|102041899|FG001|NOT COMPLETED|Overall Study||8||
48697158|NCT01716039|102041900|FG000|STARTED|Overall Study||4||
48697159|NCT01716039|102041901|FG001|STARTED|Overall Study||8||
48114433|NCT02059148|100605181|FG002|STARTED|Treatment 3||4||
48114434|NCT02059148|100605182|FG003|STARTED|Treatment 3||4||
48114435|NCT02059148|100605183|FG004|STARTED|Treatment 3||4||
48114436|NCT02059148|100605184|FG005|STARTED|Treatment 3||3||
48114437|NCT02059148|100605179|FG000|COMPLETED|Treatment 3||4||
48114438|NCT02059148|100605180|FG001|COMPLETED|Treatment 3||4||
48114439|NCT02059148|100605181|FG002|COMPLETED|Treatment 3||4||
48563607|NCT02359955|101710233|FG001|STARTED|Overall Study||10||
48563608|NCT02359955|101710232|FG000|COMPLETED|Overall Study||10||
48114440|NCT02059148|100605182|FG003|COMPLETED|Treatment 3||4||
48114441|NCT02059148|100605183|FG004|COMPLETED|Treatment 3||4||
48114442|NCT02059148|100605184|FG005|COMPLETED|Treatment 3||3||
48114443|NCT02059148|100605179|FG000|NOT COMPLETED|Treatment 3||0||
48114444|NCT02059148|100605180|FG001|NOT COMPLETED|Treatment 3||0||
48114445|NCT02059148|100605181|FG002|NOT COMPLETED|Treatment 3||0||
48114446|NCT02059148|100605182|FG003|NOT COMPLETED|Treatment 3||0||
48114447|NCT02059148|100605183|FG004|NOT COMPLETED|Treatment 3||0||
48114448|NCT02059148|100605184|FG005|NOT COMPLETED|Treatment 3||0||
48114449|NCT00826267|100605185|FG000|STARTED|Overall Study||10||
48114450|NCT00826267|100605186|FG001|STARTED|Overall Study||8||
48277905|NCT00159263|101003218|FG001|NOT COMPLETED|Washout||0||
48697160|NCT01716039|102041902|FG002|STARTED|Overall Study||10||
48697161|NCT01716039|102041900|FG000|COMPLETED|Overall Study||3||
48697162|NCT01716039|102041901|FG001|COMPLETED|Overall Study||6||
48114451|NCT00826267|100605187|FG002|STARTED|Overall Study||11||
48277906|NCT00159263|101003219|FG002|NOT COMPLETED|Washout||0||
48277907|NCT00159263|101003220|FG003|NOT COMPLETED|Washout||0||
48563609|NCT02359955|101710233|FG001|COMPLETED|Overall Study||10||
48563610|NCT02359955|101710232|FG000|NOT COMPLETED|Overall Study||0||
48563611|NCT02359955|101710233|FG001|NOT COMPLETED|Overall Study||0||
48563612|NCT02188147|101710234|FG000|STARTED|Overall Study||39||
48563613|NCT02188147|101710234|FG000|COMPLETED|Overall Study||39||
48563614|NCT02188147|101710234|FG000|NOT COMPLETED|Overall Study||0||
48563615|NCT01045187|101710235|FG000|STARTED|Overall Study||15||
48114452|NCT00826267|100605185|FG000|COMPLETED|Overall Study||9||
48114453|NCT00826267|100605186|FG001|COMPLETED|Overall Study||8||
48114454|NCT00826267|100605187|FG002|COMPLETED|Overall Study||11||
48697163|NCT01716039|102041902|FG002|COMPLETED|Overall Study||8||
48277908|NCT00159263|101003221|FG004|NOT COMPLETED|Washout||0||
48277909|NCT00159263|101003222|FG005|NOT COMPLETED|Washout||0||
48697164|NCT01716039|102041900|FG000|NOT COMPLETED|Overall Study||1||
48697165|NCT01716039|102041901|FG001|NOT COMPLETED|Overall Study||2||
48697166|NCT01716039|102041902|FG002|NOT COMPLETED|Overall Study||2||
48697167|NCT02512874|102041903|FG000|STARTED|Overall Study||65||
48697168|NCT02512874|102041903|FG000|COMPLETED|Overall Study||63||
48697169|NCT02512874|102041903|FG000|NOT COMPLETED|Overall Study||2||
48114455|NCT00826267|100605185|FG000|NOT COMPLETED|Overall Study||1||
48697170|NCT01066104|102041904|FG000|STARTED|Overall Study||14||
48697171|NCT01066104|102041905|FG001|STARTED|Overall Study||13||
48697172|NCT01066104|102041904|FG000|COMPLETED|Overall Study||12||
48697173|NCT01066104|102041905|FG001|COMPLETED|Overall Study||12||
48697174|NCT01066104|102041904|FG000|NOT COMPLETED|Overall Study||2||
48114456|NCT00826267|100605186|FG001|NOT COMPLETED|Overall Study||0||
48697175|NCT01066104|102041905|FG001|NOT COMPLETED|Overall Study||1||
48697176|NCT01222117|102041906|FG000|STARTED|Overall Study||20||
48697177|NCT01222117|102041907|FG001|STARTED|Overall Study||20||
48697178|NCT01222117|102041908|FG002|STARTED|Overall Study||22||
48697179|NCT01222117|102041909|FG003|STARTED|Overall Study||20||
48697180|NCT01222117|102041910|FG004|STARTED|Overall Study||9||
48114457|NCT00826267|100605187|FG002|NOT COMPLETED|Overall Study||0||
48114458|NCT04519658|100605188|FG000|STARTED|Overall Study||69||
48114459|NCT04519658|100605189|FG001|STARTED|Overall Study||70||
48277910|NCT00159263|101003217|FG000|STARTED|Third Intervention||1||
48277911|NCT00159263|101003218|FG001|STARTED|Third Intervention||1||
48277912|NCT00159263|101003219|FG002|STARTED|Third Intervention||2||
48277913|NCT00159263|101003220|FG003|STARTED|Third Intervention||2||
48277914|NCT00159263|101003221|FG004|STARTED|Third Intervention||2||
48277915|NCT00159263|101003222|FG005|STARTED|Third Intervention||2||
48277916|NCT00159263|101003217|FG000|COMPLETED|Third Intervention||1||
48277917|NCT00159263|101003218|FG001|COMPLETED|Third Intervention||1||
48277918|NCT00159263|101003219|FG002|COMPLETED|Third Intervention||2||
48277919|NCT00159263|101003220|FG003|COMPLETED|Third Intervention||2||
48277920|NCT00159263|101003221|FG004|COMPLETED|Third Intervention||2||
48277921|NCT00159263|101003222|FG005|COMPLETED|Third Intervention||2||
48277922|NCT00159263|101003217|FG000|NOT COMPLETED|Third Intervention||0||
48277923|NCT00159263|101003218|FG001|NOT COMPLETED|Third Intervention||0||
48697181|NCT01222117|102041911|FG005|STARTED|Overall Study||10||
48114460|NCT04519658|100605190|FG002|STARTED|Overall Study||67||
48114461|NCT04519658|100605191|FG003|STARTED|Overall Study||69||
48114462|NCT04519658|100605188|FG000|COMPLETED|Overall Study||65||
48114463|NCT04519658|100605189|FG001|COMPLETED|Overall Study||60||
48114464|NCT04519658|100605190|FG002|COMPLETED|Overall Study||56||
48114465|NCT04519658|100605191|FG003|COMPLETED|Overall Study||67||
48114466|NCT04519658|100605188|FG000|NOT COMPLETED|Overall Study||4||
48114467|NCT04519658|100605189|FG001|NOT COMPLETED|Overall Study||10||
48114468|NCT04519658|100605190|FG002|NOT COMPLETED|Overall Study||11||
48114469|NCT04519658|100605191|FG003|NOT COMPLETED|Overall Study||2||
48114470|NCT01700179|100605192|FG000|STARTED|Overall Study||8||
48114471|NCT01700179|100605192|FG000|COMPLETED|Overall Study||6||
48114472|NCT01700179|100605192|FG000|NOT COMPLETED|Overall Study||2||
48114473|NCT00502697|100605193|FG000|STARTED|Overall Study||122||
48114474|NCT00502697|100605194|FG001|STARTED|Overall Study||114||
48114475|NCT00502697|100605193|FG000|COMPLETED|Overall Study||109||
48114476|NCT00502697|100605194|FG001|COMPLETED|Overall Study||102||
48114477|NCT00502697|100605193|FG000|NOT COMPLETED|Overall Study||13||
48114478|NCT00502697|100605194|FG001|NOT COMPLETED|Overall Study||12||
48114479|NCT00352612|100605195|FG000|STARTED|Overall Study||100||
48114480|NCT00352612|100605196|FG001|STARTED|Overall Study||100||
48114481|NCT00352612|100605195|FG000|COMPLETED|Overall Study||100||
48114482|NCT00352612|100605196|FG001|COMPLETED|Overall Study||100||
48114483|NCT00352612|100605195|FG000|NOT COMPLETED|Overall Study||0||
48114484|NCT00352612|100605196|FG001|NOT COMPLETED|Overall Study||0||
48114485|NCT00983281|100605197|FG000|STARTED|Overall Study||805||
48114486|NCT00983281|100605198|FG001|STARTED|Overall Study||909||
48114487|NCT00983281|100605197|FG000|COMPLETED|Overall Study||805||
48114488|NCT00983281|100605198|FG001|COMPLETED|Overall Study||909||
48114489|NCT00983281|100605197|FG000|NOT COMPLETED|Overall Study||0||
48114490|NCT00983281|100605198|FG001|NOT COMPLETED|Overall Study||0||
48114491|NCT03341052|100605199|FG000|STARTED|Overall Study||8||
48114492|NCT03341052|100605200|FG001|STARTED|Overall Study||8||
48114493|NCT03341052|100605199|FG000|COMPLETED|Overall Study||8||
48114494|NCT03341052|100605200|FG001|COMPLETED|Overall Study||8||
48114495|NCT03341052|100605199|FG000|NOT COMPLETED|Overall Study||0||
48114496|NCT03341052|100605200|FG001|NOT COMPLETED|Overall Study||0||
48114497|NCT01387607|100605201|FG000|STARTED|Overall Study||173||
48114498|NCT01387607|100605202|FG001|STARTED|Overall Study||170||
48114499|NCT01387607|100605201|FG000|Received Treatment|Overall Study||170||
48114500|NCT01387607|100605202|FG001|Received Treatment|Overall Study||164||
48114501|NCT01387607|100605201|FG000|COMPLETED|Overall Study||122||
48114502|NCT01387607|100605202|FG001|COMPLETED|Overall Study||125||
48114503|NCT01387607|100605201|FG000|NOT COMPLETED|Overall Study||51||
48114504|NCT01387607|100605202|FG001|NOT COMPLETED|Overall Study||45||
48114505|NCT01852292|100605203|FG000|STARTED|Overall Study||79||
48114506|NCT01852292|100605204|FG001|STARTED|Overall Study||79||
48114507|NCT01852292|100605203|FG000|COMPLETED|Overall Study||0||
48114508|NCT01852292|100605204|FG001|COMPLETED|Overall Study||0||
48277924|NCT00159263|101003219|FG002|NOT COMPLETED|Third Intervention||0||
48277925|NCT00159263|101003220|FG003|NOT COMPLETED|Third Intervention||0||
48277926|NCT00159263|101003221|FG004|NOT COMPLETED|Third Intervention||0||
48277927|NCT00159263|101003222|FG005|NOT COMPLETED|Third Intervention||0||
48277928|NCT00159263|101003217|FG000|STARTED|Washout||1||
48277929|NCT00159263|101003218|FG001|STARTED|Washout||1||
48114509|NCT01852292|100605203|FG000|NOT COMPLETED|Overall Study||79||
48114510|NCT01852292|100605204|FG001|NOT COMPLETED|Overall Study||79||
48114511|NCT00004031|100605205|FG000|STARTED|Overall Study||128||
48114512|NCT00004031|100605206|FG001|STARTED|Overall Study||125||
48114513|NCT00004031|100605205|FG000|Assessed for Adverse Events|Overall Study||123||
48277930|NCT00159263|101003219|FG002|STARTED|Washout||2||
48277931|NCT00159263|101003220|FG003|STARTED|Washout||2||
48277932|NCT00159263|101003221|FG004|STARTED|Washout||2||
48277933|NCT00159263|101003222|FG005|STARTED|Washout||2||
48277934|NCT00159263|101003217|FG000|COMPLETED|Washout||1||
48277935|NCT00159263|101003218|FG001|COMPLETED|Washout||1||
48394193|NCT00554463|101295884|FG000|STARTED|Overall Study||5||
48697182|NCT01222117|102041912|FG006|STARTED|Overall Study||13||
48114514|NCT00004031|100605206|FG001|Assessed for Adverse Events|Overall Study||113||
48114515|NCT00004031|100605205|FG000|COMPLETED|Overall Study||103||
48114516|NCT00004031|100605206|FG001|COMPLETED|Overall Study||104||
48114517|NCT00004031|100605205|FG000|NOT COMPLETED|Overall Study||25||
48114518|NCT00004031|100605206|FG001|NOT COMPLETED|Overall Study||21||
48114519|NCT01782313|100605207|FG000|STARTED|Reached First Response/Completed 2 Cycle||58||
48114520|NCT01782313|100605207|FG000|COMPLETED|Reached First Response/Completed 2 Cycle||52||
48114521|NCT01782313|100605207|FG000|NOT COMPLETED|Reached First Response/Completed 2 Cycle||6||
48114522|NCT01782313|100605207|FG000|STARTED|Treated Cycle 3||52||
48114523|NCT01782313|100605207|FG000|COMPLETED|Treated Cycle 3||31||
48114524|NCT01782313|100605207|FG000|NOT COMPLETED|Treated Cycle 3||21||
48114525|NCT01782313|100605207|FG000|STARTED|Treated Cycle 4/Reached 16 Week Response||31||
48114526|NCT01782313|100605207|FG000|COMPLETED|Treated Cycle 4/Reached 16 Week Response||25||
48114527|NCT01782313|100605207|FG000|NOT COMPLETED|Treated Cycle 4/Reached 16 Week Response||6||
48114528|NCT01782313|100605207|FG000|STARTED|Continued Treatment After 16 Weeks||25||
48114529|NCT01782313|100605207|FG000|COMPLETED|Continued Treatment After 16 Weeks||18||
48114530|NCT01782313|100605207|FG000|NOT COMPLETED|Continued Treatment After 16 Weeks||7||
48114531|NCT01782313|100605207|FG000|STARTED|Survival Follow up||58||
48114532|NCT01782313|100605207|FG000|COMPLETED|Survival Follow up||57||
48114533|NCT01782313|100605207|FG000|NOT COMPLETED|Survival Follow up||1||
48114534|NCT03568942|100605208|FG000|STARTED|Overall Study||22||
48114535|NCT03568942|100605208|FG000|COMPLETED|Overall Study||20||
48114536|NCT03568942|100605208|FG000|NOT COMPLETED|Overall Study||2||
48114537|NCT02287896|100605209|FG000|STARTED|Screening Visit V1||36||
48114538|NCT02287896|100605210|FG001|STARTED|Screening Visit V1||26||
48114539|NCT02287896|100605209|FG000|COMPLETED|Screening Visit V1||36||
48114540|NCT02287896|100605210|FG001|COMPLETED|Screening Visit V1||26||
48114541|NCT02287896|100605209|FG000|NOT COMPLETED|Screening Visit V1||0||
48114542|NCT02287896|100605210|FG001|NOT COMPLETED|Screening Visit V1||0||
48114543|NCT02287896|100605209|FG000|STARTED|First Injection Visit||36||
48114544|NCT02287896|100605210|FG001|STARTED|First Injection Visit||26||
48114545|NCT02287896|100605209|FG000|COMPLETED|First Injection Visit||36||
48114546|NCT02287896|100605210|FG001|COMPLETED|First Injection Visit||26||
48114547|NCT02287896|100605209|FG000|NOT COMPLETED|First Injection Visit||0||
48114548|NCT02287896|100605210|FG001|NOT COMPLETED|First Injection Visit||0||
48114549|NCT02287896|100605209|FG000|STARTED|Second Injection Visit||36||
48114550|NCT02287896|100605210|FG001|STARTED|Second Injection Visit||26||
48114551|NCT02287896|100605209|FG000|COMPLETED|Second Injection Visit||36||
48114552|NCT02287896|100605210|FG001|COMPLETED|Second Injection Visit||25||
48114553|NCT02287896|100605209|FG000|NOT COMPLETED|Second Injection Visit||0||
48114554|NCT02287896|100605210|FG001|NOT COMPLETED|Second Injection Visit||1||
48114555|NCT00658112|100605211|FG000|STARTED|Overall Study||20||
48114556|NCT00658112|100605211|FG000|COMPLETED|Overall Study||11||
48114557|NCT00658112|100605211|FG000|NOT COMPLETED|Overall Study||9||
48114558|NCT02434770|100605212|FG000|STARTED|Week 1 to Week 18||250||
48114559|NCT02434770|100605213|FG001|STARTED|Week 1 to Week 18||250||
48114560|NCT02434770|100605214|FG002|STARTED|Week 1 to Week 18||250||
48114561|NCT02434770|100605212|FG000|Received at Least One Vaccination|Week 1 to Week 18||249||
48114562|NCT02434770|100605213|FG001|Received at Least One Vaccination|Week 1 to Week 18||250||
48141423|NCT01319396|100670422|FG000|NOT COMPLETED|Overall Study||0||
48114563|NCT02434770|100605214|FG002|Received at Least One Vaccination|Week 1 to Week 18||250||
48114564|NCT02434770|100605212|FG000|COMPLETED|Week 1 to Week 18||235||
48114565|NCT02434770|100605213|FG001|COMPLETED|Week 1 to Week 18||228||
48114566|NCT02434770|100605214|FG002|COMPLETED|Week 1 to Week 18||233||
48114567|NCT02434770|100605212|FG000|NOT COMPLETED|Week 1 to Week 18||15||
48114568|NCT02434770|100605213|FG001|NOT COMPLETED|Week 1 to Week 18||22||
48114569|NCT02434770|100605214|FG002|NOT COMPLETED|Week 1 to Week 18||17||
48114570|NCT02434770|100605212|FG000|STARTED|Week 18 to Week||235||
48114571|NCT02434770|100605213|FG001|STARTED|Week 18 to Week||228||
48114572|NCT02434770|100605214|FG002|STARTED|Week 18 to Week||233||
48114573|NCT02434770|100605212|FG000|COMPLETED|Week 18 to Week||227||
48114574|NCT02434770|100605213|FG001|COMPLETED|Week 18 to Week||220||
48114575|NCT02434770|100605214|FG002|COMPLETED|Week 18 to Week||227||
48114576|NCT02434770|100605212|FG000|NOT COMPLETED|Week 18 to Week||8||
48114577|NCT02434770|100605213|FG001|NOT COMPLETED|Week 18 to Week||8||
48114578|NCT02434770|100605214|FG002|NOT COMPLETED|Week 18 to Week||6||
48114579|NCT02388737|100605215|FG000|STARTED|Overall Study||235||
48114580|NCT02388737|100605216|FG001|STARTED|Overall Study||226||
48114581|NCT02388737|100605217|FG002|STARTED|Overall Study||242||
48114582|NCT02388737|100605215|FG000|COMPLETED|Overall Study||181||
48114583|NCT02388737|100605216|FG001|COMPLETED|Overall Study||166||
48114584|NCT02388737|100605217|FG002|COMPLETED|Overall Study||180||
48114585|NCT02388737|100605215|FG000|NOT COMPLETED|Overall Study||54||
48114586|NCT02388737|100605216|FG001|NOT COMPLETED|Overall Study||60||
48114587|NCT02388737|100605217|FG002|NOT COMPLETED|Overall Study||62||
48114588|NCT00240071|100605218|FG000|STARTED|Overall Study||30||
48114589|NCT00240071|100605218|FG000|COMPLETED|Overall Study||27||
48394194|NCT00554463|101295884|FG000|COMPLETED|Overall Study||5|Subjects contributing any data to results are considered to have completed the study|
48394195|NCT00554463|101295884|FG000|NOT COMPLETED|Overall Study||0||
48394196|NCT03057951|101295885|FG000|STARTED|Overall Study||2991|Randomised|
48394197|NCT03057951|101295886|FG001|STARTED|Overall Study||2997|Randomised|
48394198|NCT03057951|101295885|FG000|Treated|Overall Study||2989||
48394199|NCT03057951|101295886|FG001|Treated|Overall Study||2996||
48394200|NCT03057951|101295885|FG000|COMPLETED|Overall Study||2046|Patients who did not prematurely discontinue from trial medication|
48697183|NCT01222117|102041913|FG007|STARTED|Overall Study||12||
48697184|NCT01222117|102041914|FG008|STARTED|Overall Study||23||
48697185|NCT01222117|102041915|FG009|STARTED|Overall Study||19||
48697186|NCT01222117|102041916|FG010|STARTED|Overall Study||6||
48697187|NCT01222117|102041906|FG000|COMPLETED|Overall Study||17||
48697188|NCT01222117|102041907|FG001|COMPLETED|Overall Study||19||
48697189|NCT01222117|102041908|FG002|COMPLETED|Overall Study||22||
48697190|NCT01222117|102041909|FG003|COMPLETED|Overall Study||19||
48697191|NCT01222117|102041910|FG004|COMPLETED|Overall Study||8||
48697192|NCT01222117|102041911|FG005|COMPLETED|Overall Study||9||
48697193|NCT01222117|102041912|FG006|COMPLETED|Overall Study||13||
48697194|NCT01222117|102041913|FG007|COMPLETED|Overall Study||12||
48697195|NCT01222117|102041914|FG008|COMPLETED|Overall Study||20||
48697196|NCT01222117|102041915|FG009|COMPLETED|Overall Study||17||
48114590|NCT00240071|100605218|FG000|NOT COMPLETED|Overall Study||3||
48114591|NCT01454726|100605219|FG000|STARTED|Overall Study||16||
48114592|NCT01454726|100605220|FG001|STARTED|Overall Study||11||
48114593|NCT01454726|100605219|FG000|COMPLETED|Overall Study||16||
48114594|NCT01454726|100605220|FG001|COMPLETED|Overall Study||10||
48114595|NCT01454726|100605219|FG000|NOT COMPLETED|Overall Study||0||
48114596|NCT01454726|100605220|FG001|NOT COMPLETED|Overall Study||1||
48114597|NCT02410811|100605221|FG000|STARTED|Overall Study||5||
48114598|NCT02410811|100605222|FG001|STARTED|Overall Study||10||
48114599|NCT02410811|100605223|FG002|STARTED|Overall Study||11||
48114600|NCT02410811|100605224|FG003|STARTED|Overall Study||7||
48114601|NCT02410811|100605221|FG000|COMPLETED|Overall Study||5||
48114602|NCT02410811|100605222|FG001|COMPLETED|Overall Study||10||
48114603|NCT02410811|100605223|FG002|COMPLETED|Overall Study||10||
48114604|NCT02410811|100605224|FG003|COMPLETED|Overall Study||7||
48114605|NCT02410811|100605221|FG000|NOT COMPLETED|Overall Study||0||
48114606|NCT02410811|100605222|FG001|NOT COMPLETED|Overall Study||0||
48114607|NCT02410811|100605223|FG002|NOT COMPLETED|Overall Study||1||
48114608|NCT02410811|100605224|FG003|NOT COMPLETED|Overall Study||0||
48114609|NCT02896400|100605225|FG000|STARTED|Baseline||66||
48114610|NCT02896400|100605226|FG001|STARTED|Baseline||66||
48114611|NCT02896400|100605227|FG002|STARTED|Baseline||66||
48114612|NCT02896400|100605228|FG003|STARTED|Baseline||66||
48394201|NCT03057951|101295886|FG001|COMPLETED|Overall Study||2051|Patients who did not prematurely discontinue from trial medication|
48697197|NCT01222117|102041916|FG010|COMPLETED|Overall Study||6||
48114613|NCT02896400|100605229|FG004|STARTED|Baseline||66||
48394202|NCT03057951|101295885|FG000|NOT COMPLETED|Overall Study||945||
48697198|NCT01222117|102041906|FG000|NOT COMPLETED|Overall Study||3||
48697199|NCT01222117|102041907|FG001|NOT COMPLETED|Overall Study||1||
48114614|NCT02896400|100605230|FG005|STARTED|Baseline||66||
48114615|NCT02896400|100605231|FG006|STARTED|Baseline||66||
48114616|NCT02896400|100605232|FG007|STARTED|Baseline||66||
48114617|NCT02896400|100605233|FG008|STARTED|Baseline||66||
48114618|NCT02896400|100605234|FG009|STARTED|Baseline||66||
48114619|NCT02896400|100605235|FG010|STARTED|Baseline||66||
48114620|NCT02896400|100605236|FG011|STARTED|Baseline||66||
48114621|NCT02896400|100605237|FG012|STARTED|Baseline||66||
48114622|NCT02896400|100605238|FG013|STARTED|Baseline||66||
48114623|NCT02896400|100605239|FG014|STARTED|Baseline||66||
48114624|NCT02896400|100605240|FG015|STARTED|Baseline||66||
48114625|NCT02896400|100605225|FG000|COMPLETED|Baseline||66||
48114626|NCT02896400|100605226|FG001|COMPLETED|Baseline||66||
48114627|NCT02896400|100605227|FG002|COMPLETED|Baseline||66||
48114628|NCT02896400|100605228|FG003|COMPLETED|Baseline||66||
48114629|NCT02896400|100605229|FG004|COMPLETED|Baseline||66||
48114630|NCT02896400|100605230|FG005|COMPLETED|Baseline||66||
48114631|NCT02896400|100605231|FG006|COMPLETED|Baseline||66||
48114632|NCT02896400|100605232|FG007|COMPLETED|Baseline||66||
48114633|NCT02896400|100605233|FG008|COMPLETED|Baseline||66||
48114634|NCT02896400|100605234|FG009|COMPLETED|Baseline||66||
48114635|NCT02896400|100605235|FG010|COMPLETED|Baseline||66||
48114636|NCT02896400|100605236|FG011|COMPLETED|Baseline||66||
48114637|NCT02896400|100605237|FG012|COMPLETED|Baseline||66||
48114638|NCT02896400|100605238|FG013|COMPLETED|Baseline||66||
48114639|NCT02896400|100605239|FG014|COMPLETED|Baseline||66||
48114640|NCT02896400|100605240|FG015|COMPLETED|Baseline||66||
48114641|NCT02896400|100605225|FG000|NOT COMPLETED|Baseline||0||
48114642|NCT02896400|100605226|FG001|NOT COMPLETED|Baseline||0||
48563616|NCT01045187|101710235|FG000|COMPLETED|Overall Study||15||
48563617|NCT01045187|101710235|FG000|NOT COMPLETED|Overall Study||0||
48563618|NCT01787292|101710236|FG000|STARTED|Crossover Exercise Interventions||17||
48563619|NCT01787292|101710237|FG001|STARTED|Crossover Exercise Interventions||16||
48563620|NCT01787292|101710236|FG000|COMPLETED|Crossover Exercise Interventions||15||
48563621|NCT01787292|101710237|FG001|COMPLETED|Crossover Exercise Interventions||14||
48563622|NCT01787292|101710236|FG000|NOT COMPLETED|Crossover Exercise Interventions||2||
48563623|NCT01787292|101710237|FG001|NOT COMPLETED|Crossover Exercise Interventions||2||
48563624|NCT01787292|101710236|FG000|STARTED|Home Based Exercise Program||15||
48563625|NCT01787292|101710237|FG001|STARTED|Home Based Exercise Program||14||
48563626|NCT01787292|101710236|FG000|COMPLETED|Home Based Exercise Program||12||
48563627|NCT01787292|101710237|FG001|COMPLETED|Home Based Exercise Program||13||
48563628|NCT01787292|101710236|FG000|NOT COMPLETED|Home Based Exercise Program||3||
48563629|NCT01787292|101710237|FG001|NOT COMPLETED|Home Based Exercise Program||1||
48563630|NCT04871776|101710238|FG000|STARTED|Overall Study||1200||
48563631|NCT04871776|101710239|FG001|STARTED|Overall Study||1252||
48563632|NCT04871776|101710240|FG002|STARTED|Overall Study||1219||
48563633|NCT04871776|101710238|FG000|COMPLETED|Overall Study||1199||
48563634|NCT04871776|101710239|FG001|COMPLETED|Overall Study||1249||
48563635|NCT04871776|101710240|FG002|COMPLETED|Overall Study||1217||
48563636|NCT04871776|101710238|FG000|NOT COMPLETED|Overall Study||1||
48114643|NCT02896400|100605227|FG002|NOT COMPLETED|Baseline||0||
48114644|NCT02896400|100605228|FG003|NOT COMPLETED|Baseline||0||
48114645|NCT02896400|100605229|FG004|NOT COMPLETED|Baseline||0||
48114646|NCT02896400|100605230|FG005|NOT COMPLETED|Baseline||0||
48114647|NCT02896400|100605231|FG006|NOT COMPLETED|Baseline||0||
48114648|NCT02896400|100605232|FG007|NOT COMPLETED|Baseline||0||
48114649|NCT02896400|100605233|FG008|NOT COMPLETED|Baseline||0||
48114650|NCT02896400|100605234|FG009|NOT COMPLETED|Baseline||0||
48114651|NCT02896400|100605235|FG010|NOT COMPLETED|Baseline||0||
48563637|NCT04871776|101710239|FG001|NOT COMPLETED|Overall Study||3||
48563638|NCT04871776|101710240|FG002|NOT COMPLETED|Overall Study||2||
48563639|NCT01198470|101713760|FG000|STARTED|Overall Study||20||
48114652|NCT02896400|100605236|FG011|NOT COMPLETED|Baseline||0||
48114653|NCT02896400|100605237|FG012|NOT COMPLETED|Baseline||0||
48114654|NCT02896400|100605238|FG013|NOT COMPLETED|Baseline||0||
48114655|NCT02896400|100605239|FG014|NOT COMPLETED|Baseline||0||
48114656|NCT02896400|100605240|FG015|NOT COMPLETED|Baseline||0||
48114657|NCT02896400|100605225|FG000|STARTED|1 Month Follow-up||66||
48114658|NCT02896400|100605226|FG001|STARTED|1 Month Follow-up||66||
48114659|NCT02896400|100605227|FG002|STARTED|1 Month Follow-up||66||
48114660|NCT02896400|100605228|FG003|STARTED|1 Month Follow-up||66||
48114661|NCT02896400|100605229|FG004|STARTED|1 Month Follow-up||66||
48114662|NCT02896400|100605230|FG005|STARTED|1 Month Follow-up||66||
48114663|NCT02896400|100605231|FG006|STARTED|1 Month Follow-up||66||
48563640|NCT01198470|101713760|FG000|COMPLETED|Overall Study||18||
48563641|NCT01198470|101713760|FG000|NOT COMPLETED|Overall Study||2||
48563642|NCT01791894|101713761|FG000|STARTED|Overall Study||5||
48563643|NCT01791894|101713761|FG000|COMPLETED|Overall Study||4||
48563644|NCT01791894|101713761|FG000|NOT COMPLETED|Overall Study||1||
48563645|NCT04149821|101713762|FG000|STARTED|Overall Study||0||
48563646|NCT04149821|101713763|FG001|STARTED|Overall Study||1||
48563647|NCT04149821|101713762|FG000|COMPLETED|Overall Study||0||
48563648|NCT04149821|101713763|FG001|COMPLETED|Overall Study||1||
48563649|NCT04149821|101713762|FG000|NOT COMPLETED|Overall Study||0||
48114664|NCT02896400|100605232|FG007|STARTED|1 Month Follow-up||66||
48114665|NCT02896400|100605233|FG008|STARTED|1 Month Follow-up||66||
48114666|NCT02896400|100605234|FG009|STARTED|1 Month Follow-up||66||
48114667|NCT02896400|100605235|FG010|STARTED|1 Month Follow-up||66||
48114668|NCT02896400|100605236|FG011|STARTED|1 Month Follow-up||66||
48114669|NCT02896400|100605237|FG012|STARTED|1 Month Follow-up||66||
48114670|NCT02896400|100605238|FG013|STARTED|1 Month Follow-up||66||
48114671|NCT02896400|100605239|FG014|STARTED|1 Month Follow-up||66||
48114672|NCT02896400|100605240|FG015|STARTED|1 Month Follow-up||66||
48563650|NCT04149821|101713763|FG001|NOT COMPLETED|Overall Study||0||
48563651|NCT00620945|101713764|FG000|STARTED|Overall Study||87||
48563652|NCT00620945|101713764|FG000|COMPLETED|Overall Study||87||
48563653|NCT00620945|101713764|FG000|NOT COMPLETED|Overall Study||0||
48563654|NCT01786161|101713765|FG000|STARTED|Overall Study||22||
48563655|NCT01786161|101713766|FG001|STARTED|Overall Study||22||
48563656|NCT01786161|101713765|FG000|COMPLETED|Overall Study||22||
48563657|NCT01786161|101713766|FG001|COMPLETED|Overall Study||22||
48563658|NCT01786161|101713765|FG000|NOT COMPLETED|Overall Study||0||
48114673|NCT02896400|100605225|FG000|COMPLETED|1 Month Follow-up||59||
48114674|NCT02896400|100605226|FG001|COMPLETED|1 Month Follow-up||59||
48114675|NCT02896400|100605227|FG002|COMPLETED|1 Month Follow-up||61||
48114676|NCT02896400|100605228|FG003|COMPLETED|1 Month Follow-up||58||
48114677|NCT02896400|100605229|FG004|COMPLETED|1 Month Follow-up||57||
48114678|NCT02896400|100605230|FG005|COMPLETED|1 Month Follow-up||60||
48114679|NCT02896400|100605231|FG006|COMPLETED|1 Month Follow-up||61||
48114680|NCT02896400|100605232|FG007|COMPLETED|1 Month Follow-up||60||
48114681|NCT02896400|100605233|FG008|COMPLETED|1 Month Follow-up||62||
48114682|NCT02896400|100605234|FG009|COMPLETED|1 Month Follow-up||59||
48114683|NCT02896400|100605235|FG010|COMPLETED|1 Month Follow-up||61||
48114684|NCT02896400|100605236|FG011|COMPLETED|1 Month Follow-up||61||
48114685|NCT02896400|100605237|FG012|COMPLETED|1 Month Follow-up||63||
48114686|NCT02896400|100605238|FG013|COMPLETED|1 Month Follow-up||62||
48114687|NCT02896400|100605239|FG014|COMPLETED|1 Month Follow-up||65||
48114688|NCT02896400|100605240|FG015|COMPLETED|1 Month Follow-up||63||
48114689|NCT02896400|100605225|FG000|NOT COMPLETED|1 Month Follow-up||7||
48114690|NCT02896400|100605226|FG001|NOT COMPLETED|1 Month Follow-up||7||
48114691|NCT02896400|100605227|FG002|NOT COMPLETED|1 Month Follow-up||5||
48114692|NCT02896400|100605228|FG003|NOT COMPLETED|1 Month Follow-up||8||
48114693|NCT02896400|100605229|FG004|NOT COMPLETED|1 Month Follow-up||9||
48114694|NCT02896400|100605230|FG005|NOT COMPLETED|1 Month Follow-up||6||
48114695|NCT02896400|100605231|FG006|NOT COMPLETED|1 Month Follow-up||5||
48114696|NCT02896400|100605232|FG007|NOT COMPLETED|1 Month Follow-up||6||
48114697|NCT02896400|100605233|FG008|NOT COMPLETED|1 Month Follow-up||4||
48114698|NCT02896400|100605234|FG009|NOT COMPLETED|1 Month Follow-up||7||
48114699|NCT02896400|100605235|FG010|NOT COMPLETED|1 Month Follow-up||5||
48114700|NCT02896400|100605236|FG011|NOT COMPLETED|1 Month Follow-up||5||
48563659|NCT01786161|101713766|FG001|NOT COMPLETED|Overall Study||0||
48563660|NCT02946463|101713767|FG000|STARTED|Primary Evaluation Period||125||
48563661|NCT02946463|101713768|FG001|STARTED|Primary Evaluation Period||121||
48563662|NCT02946463|101713769|FG002|STARTED|Primary Evaluation Period||0||
48563663|NCT02946463|101713770|FG003|STARTED|Primary Evaluation Period||0||
48563664|NCT02946463|101713767|FG000|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||125||
48563665|NCT02946463|101713768|FG001|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||121||
48563666|NCT02946463|101713769|FG002|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||0||
48563667|NCT02946463|101713770|FG003|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||0||
48563668|NCT02946463|101713767|FG000|COMPLETED|Primary Evaluation Period||125||
48114701|NCT02896400|100605237|FG012|NOT COMPLETED|1 Month Follow-up||3||
48114702|NCT02896400|100605238|FG013|NOT COMPLETED|1 Month Follow-up||4||
48114703|NCT02896400|100605239|FG014|NOT COMPLETED|1 Month Follow-up||1||
48114704|NCT02896400|100605240|FG015|NOT COMPLETED|1 Month Follow-up||3||
48114705|NCT02896400|100605225|FG000|STARTED|3 Month Follow-up||66|We call all participants at the 3m follow-up time point even if the 1m follow-up was not completed.|
48114706|NCT02896400|100605226|FG001|STARTED|3 Month Follow-up||66|We call all participants at the 3m follow-up time point even if the 1m follow-up was not completed.|
48114707|NCT02896400|100605227|FG002|STARTED|3 Month Follow-up||66|We call all participants at the 3m follow-up time point even if the 1m follow-up was not completed.|
48114708|NCT02896400|100605228|FG003|STARTED|3 Month Follow-up||66|We call all participants at the 3m follow-up time point even if the 1m follow-up was not completed.|
48114709|NCT02896400|100605229|FG004|STARTED|3 Month Follow-up||66|We call all participants at the 3m follow-up time point even if the 1m follow-up was not completed.|
48114710|NCT02896400|100605230|FG005|STARTED|3 Month Follow-up||66|We call all participants at the 3m follow-up time point even if the 1m follow-up was not completed.|
48114711|NCT02896400|100605231|FG006|STARTED|3 Month Follow-up||66|We call all participants at the 3m follow-up time point even if the 1m follow-up was not completed.|
48114712|NCT02896400|100605232|FG007|STARTED|3 Month Follow-up||66|We call all participants at the 3m follow-up time point even if the 1m follow-up was not completed.|
48114713|NCT02896400|100605233|FG008|STARTED|3 Month Follow-up||66|We call all participants at the 3m follow-up time point even if the 1m follow-up was not completed.|
48114714|NCT02896400|100605234|FG009|STARTED|3 Month Follow-up||66|We call all participants at the 3m follow-up time point even if the 1m follow-up was not completed.|
48114715|NCT02896400|100605235|FG010|STARTED|3 Month Follow-up||66|We call all participants at the 3m follow-up time point even if the 1m follow-up was not completed.|
48114716|NCT02896400|100605236|FG011|STARTED|3 Month Follow-up||66|We call all participants at the 3m follow-up time point even if the 1m follow-up was not completed.|
48563669|NCT02946463|101713768|FG001|COMPLETED|Primary Evaluation Period||119||
48563670|NCT02946463|101713769|FG002|COMPLETED|Primary Evaluation Period||0||
48563671|NCT02946463|101713770|FG003|COMPLETED|Primary Evaluation Period||0||
48563672|NCT02946463|101713767|FG000|NOT COMPLETED|Primary Evaluation Period||0||
48697200|NCT01222117|102041908|FG002|NOT COMPLETED|Overall Study||0||
48114717|NCT02896400|100605237|FG012|STARTED|3 Month Follow-up||66|We call all participants at the 3m follow-up time point even if the 1m follow-up was not completed.|
48114718|NCT02896400|100605238|FG013|STARTED|3 Month Follow-up||66|We call all participants at the 3m follow-up time point even if the 1m follow-up was not completed.|
48114719|NCT02896400|100605239|FG014|STARTED|3 Month Follow-up||66|We call all participants at the 3m follow-up time point even if the 1m follow-up was not completed.|
48114720|NCT02896400|100605240|FG015|STARTED|3 Month Follow-up||65|We call all participants at the 3m follow-up time point even if the 1m follow-up was not completed.|
48114721|NCT02896400|100605225|FG000|COMPLETED|3 Month Follow-up||60||
48114722|NCT02896400|100605226|FG001|COMPLETED|3 Month Follow-up||63||
48114723|NCT02896400|100605227|FG002|COMPLETED|3 Month Follow-up||60||
48114724|NCT02896400|100605228|FG003|COMPLETED|3 Month Follow-up||55||
48114725|NCT02896400|100605229|FG004|COMPLETED|3 Month Follow-up||54||
48114726|NCT02896400|100605230|FG005|COMPLETED|3 Month Follow-up||60||
48114727|NCT02896400|100605231|FG006|COMPLETED|3 Month Follow-up||62||
48114728|NCT02896400|100605232|FG007|COMPLETED|3 Month Follow-up||63||
48114729|NCT02896400|100605233|FG008|COMPLETED|3 Month Follow-up||60||
48114730|NCT02896400|100605234|FG009|COMPLETED|3 Month Follow-up||61||
48114731|NCT02896400|100605235|FG010|COMPLETED|3 Month Follow-up||60||
48114732|NCT02896400|100605236|FG011|COMPLETED|3 Month Follow-up||60||
48114733|NCT02896400|100605237|FG012|COMPLETED|3 Month Follow-up||63||
48114734|NCT02896400|100605238|FG013|COMPLETED|3 Month Follow-up||60||
48114735|NCT02896400|100605239|FG014|COMPLETED|3 Month Follow-up||62||
48114736|NCT02896400|100605240|FG015|COMPLETED|3 Month Follow-up||63||
48114737|NCT02896400|100605225|FG000|NOT COMPLETED|3 Month Follow-up||6||
48114738|NCT02896400|100605226|FG001|NOT COMPLETED|3 Month Follow-up||3||
48114739|NCT02896400|100605227|FG002|NOT COMPLETED|3 Month Follow-up||6||
48114740|NCT02896400|100605228|FG003|NOT COMPLETED|3 Month Follow-up||11||
48114741|NCT02896400|100605229|FG004|NOT COMPLETED|3 Month Follow-up||12||
48114742|NCT02896400|100605230|FG005|NOT COMPLETED|3 Month Follow-up||6||
48114743|NCT02896400|100605231|FG006|NOT COMPLETED|3 Month Follow-up||4||
48114744|NCT02896400|100605232|FG007|NOT COMPLETED|3 Month Follow-up||3||
48563673|NCT02946463|101713768|FG001|NOT COMPLETED|Primary Evaluation Period||2||
48114745|NCT02896400|100605233|FG008|NOT COMPLETED|3 Month Follow-up||6||
48114746|NCT02896400|100605234|FG009|NOT COMPLETED|3 Month Follow-up||5||
48114747|NCT02896400|100605235|FG010|NOT COMPLETED|3 Month Follow-up||6||
48114748|NCT02896400|100605236|FG011|NOT COMPLETED|3 Month Follow-up||6||
48114749|NCT02896400|100605237|FG012|NOT COMPLETED|3 Month Follow-up||3||
48114750|NCT02896400|100605238|FG013|NOT COMPLETED|3 Month Follow-up||6||
48114751|NCT02896400|100605239|FG014|NOT COMPLETED|3 Month Follow-up||4||
48114752|NCT02896400|100605240|FG015|NOT COMPLETED|3 Month Follow-up||2||
48114753|NCT02896400|100605225|FG000|STARTED|Biochemical Verification at 3 Months||60||
48114754|NCT02896400|100605226|FG001|STARTED|Biochemical Verification at 3 Months||63||
48114755|NCT02896400|100605227|FG002|STARTED|Biochemical Verification at 3 Months||60||
48114756|NCT02896400|100605228|FG003|STARTED|Biochemical Verification at 3 Months||55||
48114757|NCT02896400|100605229|FG004|STARTED|Biochemical Verification at 3 Months||54||
48114758|NCT02896400|100605230|FG005|STARTED|Biochemical Verification at 3 Months||60||
48114759|NCT02896400|100605231|FG006|STARTED|Biochemical Verification at 3 Months||62||
48114760|NCT02896400|100605232|FG007|STARTED|Biochemical Verification at 3 Months||63||
48114761|NCT02896400|100605233|FG008|STARTED|Biochemical Verification at 3 Months||60||
48114762|NCT02896400|100605234|FG009|STARTED|Biochemical Verification at 3 Months||61||
48114763|NCT02896400|100605235|FG010|STARTED|Biochemical Verification at 3 Months||60||
48114764|NCT02896400|100605236|FG011|STARTED|Biochemical Verification at 3 Months||60||
48114765|NCT02896400|100605237|FG012|STARTED|Biochemical Verification at 3 Months||63||
48114766|NCT02896400|100605238|FG013|STARTED|Biochemical Verification at 3 Months||60||
48114767|NCT02896400|100605239|FG014|STARTED|Biochemical Verification at 3 Months||62||
48114768|NCT02896400|100605240|FG015|STARTED|Biochemical Verification at 3 Months||63||
48114769|NCT02896400|100605225|FG000|COMPLETED|Biochemical Verification at 3 Months||14|Only participants reporting abstinence at the 3m follow-up complete the biochem.|
48114770|NCT02896400|100605226|FG001|COMPLETED|Biochemical Verification at 3 Months||15|Only participants reporting abstinence at the 3m follow-up complete the biochem.|
48114771|NCT02896400|100605227|FG002|COMPLETED|Biochemical Verification at 3 Months||13|Only participants reporting abstinence at the 3m follow-up complete the biochem.|
48141424|NCT01780922|100670423|FG000|STARTED|First Intervention (1 Day)||2||
48563674|NCT02946463|101713769|FG002|NOT COMPLETED|Primary Evaluation Period||0||
48563675|NCT02946463|101713770|FG003|NOT COMPLETED|Primary Evaluation Period||0||
48563676|NCT02946463|101713767|FG000|STARTED|Extension Period||124|1 participant did not enter the Extension Period.|
48592782|NCT02847182|101783180|FG000|First Intervention (6 Months)|Overall Study||119||
48114772|NCT02896400|100605228|FG003|COMPLETED|Biochemical Verification at 3 Months||14|Only participants reporting abstinence at the 3m follow-up complete the biochem.|
48114773|NCT02896400|100605229|FG004|COMPLETED|Biochemical Verification at 3 Months||9|Only participants reporting abstinence at the 3m follow-up complete the biochem.|
48114774|NCT02896400|100605230|FG005|COMPLETED|Biochemical Verification at 3 Months||11|Only participants reporting abstinence at the 3m follow-up complete the biochem.|
48114775|NCT02896400|100605231|FG006|COMPLETED|Biochemical Verification at 3 Months||11|Only participants reporting abstinence at the 3m follow-up complete the biochem.|
48114776|NCT02896400|100605232|FG007|COMPLETED|Biochemical Verification at 3 Months||14|Only participants reporting abstinence at the 3m follow-up complete the biochem.|
48114777|NCT02896400|100605233|FG008|COMPLETED|Biochemical Verification at 3 Months||15|Only participants reporting abstinence at the 3m follow-up complete the biochem.|
48114778|NCT02896400|100605234|FG009|COMPLETED|Biochemical Verification at 3 Months||8|Only participants reporting abstinence at the 3m follow-up complete the biochem.|
48114779|NCT02896400|100605235|FG010|COMPLETED|Biochemical Verification at 3 Months||5|Only participants reporting abstinence at the 3m follow-up complete the biochem.|
48114780|NCT02896400|100605236|FG011|COMPLETED|Biochemical Verification at 3 Months||19|Only participants reporting abstinence at the 3m follow-up complete the biochem.|
48114781|NCT02896400|100605237|FG012|COMPLETED|Biochemical Verification at 3 Months||10|Only participants reporting abstinence at the 3m follow-up complete the biochem.|
48114782|NCT02896400|100605238|FG013|COMPLETED|Biochemical Verification at 3 Months||12|Only participants reporting abstinence at the 3m follow-up complete the biochem.|
48114783|NCT02896400|100605239|FG014|COMPLETED|Biochemical Verification at 3 Months||7|Only participants reporting abstinence at the 3m follow-up complete the biochem.|
48114784|NCT02896400|100605240|FG015|COMPLETED|Biochemical Verification at 3 Months||6|Only participants reporting abstinence at the 3m follow-up complete the biochem.|
48114785|NCT02896400|100605225|FG000|NOT COMPLETED|Biochemical Verification at 3 Months||46||
48114786|NCT02896400|100605226|FG001|NOT COMPLETED|Biochemical Verification at 3 Months||48||
48114787|NCT02896400|100605227|FG002|NOT COMPLETED|Biochemical Verification at 3 Months||47||
48114788|NCT02896400|100605228|FG003|NOT COMPLETED|Biochemical Verification at 3 Months||41||
48114789|NCT02896400|100605229|FG004|NOT COMPLETED|Biochemical Verification at 3 Months||45||
48114790|NCT02896400|100605230|FG005|NOT COMPLETED|Biochemical Verification at 3 Months||49||
48114791|NCT02896400|100605231|FG006|NOT COMPLETED|Biochemical Verification at 3 Months||51||
48114792|NCT02896400|100605232|FG007|NOT COMPLETED|Biochemical Verification at 3 Months||49||
48114793|NCT02896400|100605233|FG008|NOT COMPLETED|Biochemical Verification at 3 Months||45||
48114794|NCT02896400|100605234|FG009|NOT COMPLETED|Biochemical Verification at 3 Months||53||
48114795|NCT02896400|100605235|FG010|NOT COMPLETED|Biochemical Verification at 3 Months||55||
48114796|NCT02896400|100605236|FG011|NOT COMPLETED|Biochemical Verification at 3 Months||41||
48114797|NCT02896400|100605237|FG012|NOT COMPLETED|Biochemical Verification at 3 Months||53||
48114798|NCT02896400|100605238|FG013|NOT COMPLETED|Biochemical Verification at 3 Months||48||
48114799|NCT02896400|100605239|FG014|NOT COMPLETED|Biochemical Verification at 3 Months||55||
48114800|NCT02896400|100605240|FG015|NOT COMPLETED|Biochemical Verification at 3 Months||57||
48114801|NCT01610791|100605241|FG000|STARTED|Overall Study||121||
48114802|NCT01610791|100605241|FG000|COMPLETED|Overall Study||100||
48114803|NCT01610791|100605241|FG000|NOT COMPLETED|Overall Study||21||
48114804|NCT00235989|100605242|FG000|STARTED|Core Treatment Period (CT)||0||
48114805|NCT00235989|100605243|FG001|STARTED|Core Treatment Period (CT)||0||
48114806|NCT00235989|100605244|FG002|STARTED|Core Treatment Period (CT)||0||
48114807|NCT00235989|100605245|FG003|STARTED|Core Treatment Period (CT)||0||
48114808|NCT00235989|100605246|FG004|STARTED|Core Treatment Period (CT)||36||
48114809|NCT00235989|100605247|FG005|STARTED|Core Treatment Period (CT)||27||
48114810|NCT00235989|100605242|FG000|COMPLETED|Core Treatment Period (CT)||0||
48114811|NCT00235989|100605243|FG001|COMPLETED|Core Treatment Period (CT)||0||
48114812|NCT00235989|100605244|FG002|COMPLETED|Core Treatment Period (CT)||0||
48114813|NCT00235989|100605245|FG003|COMPLETED|Core Treatment Period (CT)||0||
48277936|NCT00159263|101003219|FG002|COMPLETED|Washout||2||
48277937|NCT00159263|101003220|FG003|COMPLETED|Washout||2||
48277938|NCT00159263|101003221|FG004|COMPLETED|Washout||2||
48277939|NCT00159263|101003222|FG005|COMPLETED|Washout||2||
48277940|NCT00159263|101003217|FG000|NOT COMPLETED|Washout||0||
48277941|NCT00159263|101003218|FG001|NOT COMPLETED|Washout||0||
48277942|NCT00159263|101003219|FG002|NOT COMPLETED|Washout||0||
48277943|NCT00159263|101003220|FG003|NOT COMPLETED|Washout||0||
48277944|NCT00159263|101003221|FG004|NOT COMPLETED|Washout||0||
48277945|NCT00159263|101003222|FG005|NOT COMPLETED|Washout||0||
48277946|NCT00159263|101003217|FG000|STARTED|Fourth Intervention||1||
48277947|NCT00159263|101003218|FG001|STARTED|Fourth Intervention||1||
48114814|NCT00235989|100605246|FG004|COMPLETED|Core Treatment Period (CT)||36||
48114815|NCT00235989|100605247|FG005|COMPLETED|Core Treatment Period (CT)||25||
48114816|NCT00235989|100605242|FG000|NOT COMPLETED|Core Treatment Period (CT)||0||
48114817|NCT00235989|100605243|FG001|NOT COMPLETED|Core Treatment Period (CT)||0||
48114818|NCT00235989|100605244|FG002|NOT COMPLETED|Core Treatment Period (CT)||0||
48114819|NCT00235989|100605245|FG003|NOT COMPLETED|Core Treatment Period (CT)||0||
48114820|NCT00235989|100605246|FG004|NOT COMPLETED|Core Treatment Period (CT)||0||
48277948|NCT00159263|101003219|FG002|STARTED|Fourth Intervention||2||
48277949|NCT00159263|101003220|FG003|STARTED|Fourth Intervention||2||
48277950|NCT00159263|101003221|FG004|STARTED|Fourth Intervention||2||
48114821|NCT00235989|100605247|FG005|NOT COMPLETED|Core Treatment Period (CT)||2||
48114822|NCT00235989|100605242|FG000|STARTED|Extension Treatment Period (ET)||16||
48114823|NCT00235989|100605243|FG001|STARTED|Extension Treatment Period (ET)||6||
48114824|NCT00235989|100605244|FG002|STARTED|Extension Treatment Period (ET)||19||
48114825|NCT00235989|100605245|FG003|STARTED|Extension Treatment Period (ET)||20||
48114826|NCT00235989|100605246|FG004|STARTED|Extension Treatment Period (ET)||0||
48114827|NCT00235989|100605247|FG005|STARTED|Extension Treatment Period (ET)||0||
48114828|NCT00235989|100605242|FG000|COMPLETED|Extension Treatment Period (ET)||8||
48114829|NCT00235989|100605243|FG001|COMPLETED|Extension Treatment Period (ET)||2||
48114830|NCT00235989|100605244|FG002|COMPLETED|Extension Treatment Period (ET)||14||
48114831|NCT00235989|100605245|FG003|COMPLETED|Extension Treatment Period (ET)||14||
48114832|NCT00235989|100605246|FG004|COMPLETED|Extension Treatment Period (ET)||0||
48114833|NCT00235989|100605247|FG005|COMPLETED|Extension Treatment Period (ET)||0||
48114834|NCT00235989|100605242|FG000|NOT COMPLETED|Extension Treatment Period (ET)||8||
48394203|NCT03057951|101295886|FG001|NOT COMPLETED|Overall Study||946||
48394204|NCT02899377|101295887|FG000|STARTED|Overall Study||13||
48394205|NCT02899377|101295888|FG001|STARTED|Overall Study||12||
48394206|NCT02899377|101295887|FG000|COMPLETED|Overall Study||12||
48394207|NCT02899377|101295888|FG001|COMPLETED|Overall Study||12||
48394208|NCT02899377|101295887|FG000|NOT COMPLETED|Overall Study||1||
48563677|NCT02946463|101713768|FG001|STARTED|Extension Period||119|1 participant did not enter the Extension Period.|
48563678|NCT02946463|101713769|FG002|STARTED|Extension Period||24|1 participant did not enter the Extension Period.|
48563679|NCT02946463|101713770|FG003|STARTED|Extension Period||2|1 participant did not enter the Extension Period.|
48114835|NCT00235989|100605243|FG001|NOT COMPLETED|Extension Treatment Period (ET)||4||
48114836|NCT00235989|100605244|FG002|NOT COMPLETED|Extension Treatment Period (ET)||5||
48114837|NCT00235989|100605245|FG003|NOT COMPLETED|Extension Treatment Period (ET)||6||
48394209|NCT02899377|101295888|FG001|NOT COMPLETED|Overall Study||0||
48394210|NCT00810459|101295889|FG000|STARTED|Overall Study||4||
48394211|NCT00810459|101295890|FG001|STARTED|Overall Study||2||
48394212|NCT00810459|101295889|FG000|COMPLETED|Overall Study||4||
48394213|NCT00810459|101295890|FG001|COMPLETED|Overall Study||2||
48394214|NCT00810459|101295889|FG000|NOT COMPLETED|Overall Study||0||
48394215|NCT00810459|101295890|FG001|NOT COMPLETED|Overall Study||0||
48394216|NCT01245764|101295891|FG000|STARTED|Study Phase A||80||
48114838|NCT00235989|100605246|FG004|NOT COMPLETED|Extension Treatment Period (ET)||0||
48114839|NCT00235989|100605247|FG005|NOT COMPLETED|Extension Treatment Period (ET)||0||
48114840|NCT00167934|100605248|FG000|STARTED|Overall Study||82||
48114841|NCT00167934|100605249|FG001|STARTED|Overall Study||82||
48114842|NCT00167934|100605248|FG000|COMPLETED|Overall Study||82||
48114843|NCT00167934|100605249|FG001|COMPLETED|Overall Study||82||
48114844|NCT00167934|100605248|FG000|NOT COMPLETED|Overall Study||0||
48114845|NCT00167934|100605249|FG001|NOT COMPLETED|Overall Study||0||
48114846|NCT04380857|100605250|FG000|STARTED|Overall Study||20||20
48114847|NCT04380857|100605251|FG001|STARTED|Overall Study||20||20
48114848|NCT04380857|100605250|FG000|COMPLETED|Overall Study||17||17
48114849|NCT04380857|100605251|FG001|COMPLETED|Overall Study||17||17
48114850|NCT04380857|100605250|FG000|NOT COMPLETED|Overall Study||3||3
48114851|NCT04380857|100605251|FG001|NOT COMPLETED|Overall Study||3||3
48114852|NCT01398566|100605252|FG000|STARTED|Overall Study||20|Enroll up to 20 participants|
48114853|NCT01398566|100605252|FG000|COMPLETED|Overall Study||20||
48114854|NCT01398566|100605252|FG000|NOT COMPLETED|Overall Study||0||
48114855|NCT01448850|100605253|FG000|STARTED|Overall Study||164||
48114856|NCT01448850|100605254|FG001|STARTED|Overall Study||160||
48114857|NCT01448850|100605253|FG000|COMPLETED|Overall Study||130||
48114858|NCT01448850|100605254|FG001|COMPLETED|Overall Study||120||
48114859|NCT01448850|100605253|FG000|NOT COMPLETED|Overall Study||34||
48394217|NCT01245764|101295892|FG001|STARTED|Study Phase A||30||
48394218|NCT01245764|101295893|FG002|STARTED|Study Phase A||120||
48563680|NCT02946463|101713767|FG000|Received at Least 1 Dose of Ravulizumab|Extension Period||124||
48563681|NCT02946463|101713768|FG001|Received at Least 1 Dose of Ravulizumab|Extension Period||119||
48563682|NCT02946463|101713769|FG002|Received at Least 1 Dose of Ravulizumab|Extension Period||24||
48563683|NCT02946463|101713770|FG003|Received at Least 1 Dose of Ravulizumab|Extension Period||2||
48114860|NCT01448850|100605254|FG001|NOT COMPLETED|Overall Study||40||
48114861|NCT04587934|100605255|FG000|STARTED|Overall Study||19||
48114862|NCT04587934|100605256|FG001|STARTED|Overall Study||23||
48114863|NCT04587934|100605255|FG000|COMPLETED|Overall Study||19||
48114864|NCT04587934|100605256|FG001|COMPLETED|Overall Study||23||
48114865|NCT04587934|100605255|FG000|NOT COMPLETED|Overall Study||0||
48114866|NCT04587934|100605256|FG001|NOT COMPLETED|Overall Study||0||
48394219|NCT01245764|101295894|FG003|STARTED|Study Phase A||20||
48394220|NCT01245764|101295891|FG000|Completed Vaccinations in Study Phase A|Study Phase A||77||
48394221|NCT01245764|101295892|FG001|Completed Vaccinations in Study Phase A|Study Phase A||28||
48394222|NCT01245764|101295893|FG002|Completed Vaccinations in Study Phase A|Study Phase A||117||
48277951|NCT00159263|101003222|FG005|STARTED|Fourth Intervention||2||
48277952|NCT00159263|101003217|FG000|COMPLETED|Fourth Intervention||1||
48277953|NCT00159263|101003218|FG001|COMPLETED|Fourth Intervention||1||
48277954|NCT00159263|101003219|FG002|COMPLETED|Fourth Intervention||2||
48394223|NCT01245764|101295894|FG003|Completed Vaccinations in Study Phase A|Study Phase A||19||
48394224|NCT01245764|101295891|FG000|COMPLETED|Study Phase A||71||
48394225|NCT01245764|101295892|FG001|COMPLETED|Study Phase A||25||
48394226|NCT01245764|101295893|FG002|COMPLETED|Study Phase A||110||
48114867|NCT04320940|100605257|FG000|STARTED|Overall Study||3||
48114868|NCT04320940|100605258|FG001|STARTED|Overall Study||1||
48114869|NCT04320940|100605257|FG000|COMPLETED|Overall Study||3||
48114870|NCT04320940|100605258|FG001|COMPLETED|Overall Study||1||
48114871|NCT04320940|100605257|FG000|NOT COMPLETED|Overall Study||0||
48114872|NCT04320940|100605258|FG001|NOT COMPLETED|Overall Study||0||
48114873|NCT03571516|100605259|FG000|STARTED|Overall Study||5||
48114874|NCT03571516|100605260|FG001|STARTED|Overall Study||5||
48114875|NCT03571516|100605259|FG000|COMPLETED|Overall Study||4||
48114876|NCT03571516|100605260|FG001|COMPLETED|Overall Study||4||
48114877|NCT03571516|100605259|FG000|NOT COMPLETED|Overall Study||1||
48114878|NCT03571516|100605260|FG001|NOT COMPLETED|Overall Study||1||
48114879|NCT00117143|100605261|FG000|STARTED|Overall Study||4||
48114880|NCT00117143|100605262|FG001|STARTED|Overall Study||4||
48114881|NCT00117143|100605263|FG002|STARTED|Overall Study||7||
48114882|NCT00117143|100605264|FG003|STARTED|Overall Study||1||
48114883|NCT00117143|100605261|FG000|Received First Dose|Overall Study||4||
48114884|NCT00117143|100605262|FG001|Received First Dose|Overall Study||4||
48114885|NCT00117143|100605263|FG002|Received First Dose|Overall Study||7||
48114886|NCT00117143|100605264|FG003|Received First Dose|Overall Study||1||
48114887|NCT00117143|100605261|FG000|Received Second Dose|Overall Study||4||
48114888|NCT00117143|100605262|FG001|Received Second Dose|Overall Study||4||
48114889|NCT00117143|100605263|FG002|Received Second Dose|Overall Study||6||
48114890|NCT00117143|100605264|FG003|Received Second Dose|Overall Study||0||
48114891|NCT00117143|100605261|FG000|COMPLETED|Overall Study||4||
48114892|NCT00117143|100605262|FG001|COMPLETED|Overall Study||4||
48114893|NCT00117143|100605263|FG002|COMPLETED|Overall Study||7||
48114894|NCT00117143|100605264|FG003|COMPLETED|Overall Study||1||
48114895|NCT00117143|100605261|FG000|NOT COMPLETED|Overall Study||0||
48114896|NCT00117143|100605262|FG001|NOT COMPLETED|Overall Study||0||
48114897|NCT00117143|100605263|FG002|NOT COMPLETED|Overall Study||0||
48114898|NCT00117143|100605264|FG003|NOT COMPLETED|Overall Study||0||
48114899|NCT02098161|100608398|FG000|STARTED|Overall Study||50||
48114900|NCT02098161|100608398|FG000|COMPLETED|Overall Study||50||
48114901|NCT02098161|100608398|FG000|NOT COMPLETED|Overall Study||0||
48114902|NCT00782210|100608399|FG000|STARTED|Overall Study||209||
48114903|NCT00782210|100608400|FG001|STARTED|Overall Study||208||
48114904|NCT00782210|100608401|FG002|STARTED|Overall Study||207||
48114905|NCT00782210|100608399|FG000|COMPLETED|Overall Study||159||
48114906|NCT00782210|100608400|FG001|COMPLETED|Overall Study||173||
48114907|NCT00782210|100608401|FG002|COMPLETED|Overall Study||172||
48114908|NCT00782210|100608399|FG000|NOT COMPLETED|Overall Study||50||
48114909|NCT00782210|100608400|FG001|NOT COMPLETED|Overall Study||35||
48114910|NCT00782210|100608401|FG002|NOT COMPLETED|Overall Study||35||
48114911|NCT03022617|100608402|FG000|STARTED|Overall Study||12||
48114912|NCT03022617|100608402|FG000|COMPLETED|Overall Study||6||
48114913|NCT03022617|100608402|FG000|NOT COMPLETED|Overall Study||6||
48114914|NCT00325234|100608403|FG000|STARTED|Overall Study||69||
48114915|NCT00325234|100608404|FG001|STARTED|Overall Study||66||
48114916|NCT00325234|100608403|FG000|Received At Least 1 Dose of Study Drug|Overall Study||65||
48114917|NCT00325234|100608404|FG001|Received At Least 1 Dose of Study Drug|Overall Study||66||
48114918|NCT00325234|100608403|FG000|COMPLETED|Overall Study||0||
48277955|NCT00159263|101003220|FG003|COMPLETED|Fourth Intervention||2||
48277956|NCT00159263|101003221|FG004|COMPLETED|Fourth Intervention||2||
48277957|NCT00159263|101003222|FG005|COMPLETED|Fourth Intervention||2||
48394227|NCT01245764|101295894|FG003|COMPLETED|Study Phase A||17||
48277958|NCT00159263|101003217|FG000|NOT COMPLETED|Fourth Intervention||0||
48114919|NCT00325234|100608404|FG001|COMPLETED|Overall Study||0||
48277959|NCT00159263|101003218|FG001|NOT COMPLETED|Fourth Intervention||0||
48277960|NCT00159263|101003219|FG002|NOT COMPLETED|Fourth Intervention||0||
48277961|NCT00159263|101003220|FG003|NOT COMPLETED|Fourth Intervention||0||
48277962|NCT00159263|101003221|FG004|NOT COMPLETED|Fourth Intervention||0||
48277963|NCT00159263|101003222|FG005|NOT COMPLETED|Fourth Intervention||0||
48277964|NCT00159263|101003217|FG000|STARTED|Washout||1||
48114920|NCT00325234|100608403|FG000|NOT COMPLETED|Overall Study||69||
48114921|NCT00325234|100608404|FG001|NOT COMPLETED|Overall Study||66||
48114922|NCT02665975|100608405|FG000|STARTED|Overall Study||46||
48114923|NCT02665975|100608406|FG001|STARTED|Overall Study||46||
48114924|NCT02665975|100608405|FG000|COMPLETED|Overall Study||37||
48114925|NCT02665975|100608406|FG001|COMPLETED|Overall Study||37||
48114926|NCT02665975|100608405|FG000|NOT COMPLETED|Overall Study||9||
48114927|NCT02665975|100608406|FG001|NOT COMPLETED|Overall Study||9||
48114928|NCT02307552|100608407|FG000|STARTED|Overall Study||1||
48114929|NCT02307552|100608407|FG000|COMPLETED|Overall Study||1||
48114930|NCT02307552|100608407|FG000|NOT COMPLETED|Overall Study||0||
48394228|NCT01245764|101295891|FG000|NOT COMPLETED|Study Phase A||9||
48277965|NCT00159263|101003218|FG001|STARTED|Washout||1||
48277966|NCT00159263|101003219|FG002|STARTED|Washout||2||
48277967|NCT00159263|101003220|FG003|STARTED|Washout||2||
48277968|NCT00159263|101003221|FG004|STARTED|Washout||2||
48277969|NCT00159263|101003222|FG005|STARTED|Washout||2||
48277970|NCT00159263|101003217|FG000|COMPLETED|Washout||1||
48277971|NCT00159263|101003218|FG001|COMPLETED|Washout||1||
48277972|NCT00159263|101003219|FG002|COMPLETED|Washout||2||
48277973|NCT00159263|101003220|FG003|COMPLETED|Washout||2||
48277974|NCT00159263|101003221|FG004|COMPLETED|Washout||2||
48277975|NCT00159263|101003222|FG005|COMPLETED|Washout||2||
48277976|NCT00159263|101003217|FG000|NOT COMPLETED|Washout||0||
48277977|NCT00159263|101003218|FG001|NOT COMPLETED|Washout||0||
48277978|NCT00159263|101003219|FG002|NOT COMPLETED|Washout||0||
48277979|NCT00159263|101003220|FG003|NOT COMPLETED|Washout||0||
48277980|NCT00159263|101003221|FG004|NOT COMPLETED|Washout||0||
48277981|NCT00159263|101003222|FG005|NOT COMPLETED|Washout||0||
48277982|NCT00159263|101003217|FG000|STARTED|Fifth Intervention||1||
48277983|NCT00159263|101003218|FG001|STARTED|Fifth Intervention||1||
48277984|NCT00159263|101003219|FG002|STARTED|Fifth Intervention||2||
48277985|NCT00159263|101003220|FG003|STARTED|Fifth Intervention||2||
48277986|NCT00159263|101003221|FG004|STARTED|Fifth Intervention||2||
48277987|NCT00159263|101003222|FG005|STARTED|Fifth Intervention||2||
48277988|NCT00159263|101003217|FG000|COMPLETED|Fifth Intervention||1||
48277989|NCT00159263|101003218|FG001|COMPLETED|Fifth Intervention||1||
48563684|NCT02946463|101713767|FG000|COMPLETED|Extension Period||108||
48563685|NCT02946463|101713768|FG001|COMPLETED|Extension Period||102||
48563686|NCT02946463|101713769|FG002|COMPLETED|Extension Period||22||
48563687|NCT02946463|101713770|FG003|COMPLETED|Extension Period||2||
48563688|NCT02946463|101713767|FG000|NOT COMPLETED|Extension Period||16||
48563689|NCT02946463|101713768|FG001|NOT COMPLETED|Extension Period||17||
48563690|NCT02946463|101713769|FG002|NOT COMPLETED|Extension Period||2||
48563691|NCT02946463|101713770|FG003|NOT COMPLETED|Extension Period||0||
48563692|NCT00656656|101713771|FG000|STARTED|Overall Study||23||
48563693|NCT00656656|101713771|FG000|COMPLETED|Overall Study||23||
48563694|NCT00656656|101713771|FG000|NOT COMPLETED|Overall Study||0||
48563695|NCT01445730|101713772|FG000|STARTED|Overall Study||82||
48563696|NCT01445730|101713772|FG000|COMPLETED|Overall Study||71||
48277990|NCT00159263|101003219|FG002|COMPLETED|Fifth Intervention||2||
48277991|NCT00159263|101003220|FG003|COMPLETED|Fifth Intervention||2||
48277992|NCT00159263|101003221|FG004|COMPLETED|Fifth Intervention||2||
48277993|NCT00159263|101003222|FG005|COMPLETED|Fifth Intervention||2||
48277994|NCT00159263|101003217|FG000|NOT COMPLETED|Fifth Intervention||0||
48277995|NCT00159263|101003218|FG001|NOT COMPLETED|Fifth Intervention||0||
48277996|NCT00159263|101003219|FG002|NOT COMPLETED|Fifth Intervention||0||
48277997|NCT00159263|101003220|FG003|NOT COMPLETED|Fifth Intervention||0||
48277998|NCT00159263|101003221|FG004|NOT COMPLETED|Fifth Intervention||0||
48277999|NCT00159263|101003222|FG005|NOT COMPLETED|Fifth Intervention||0||
48278000|NCT00159263|101003217|FG000|STARTED|Washout||1||
48278001|NCT00159263|101003218|FG001|STARTED|Washout||1||
48278002|NCT00159263|101003219|FG002|STARTED|Washout||2||
48278003|NCT00159263|101003220|FG003|STARTED|Washout||2||
48278004|NCT00159263|101003221|FG004|STARTED|Washout||2||
48278005|NCT00159263|101003222|FG005|STARTED|Washout||2||
48278006|NCT00159263|101003217|FG000|COMPLETED|Washout||1||
48278007|NCT00159263|101003218|FG001|COMPLETED|Washout||1||
48563697|NCT01445730|101713772|FG000|NOT COMPLETED|Overall Study||11||
48563698|NCT00360282|101713773|FG000|STARTED|First Intervention||6||
48278008|NCT00159263|101003219|FG002|COMPLETED|Washout||2||
48278009|NCT00159263|101003220|FG003|COMPLETED|Washout||2||
48278010|NCT00159263|101003221|FG004|COMPLETED|Washout||2||
48278011|NCT00159263|101003222|FG005|COMPLETED|Washout||2||
48278012|NCT00159263|101003217|FG000|NOT COMPLETED|Washout||0||
48278013|NCT00159263|101003218|FG001|NOT COMPLETED|Washout||0||
48278014|NCT00159263|101003219|FG002|NOT COMPLETED|Washout||0||
48278015|NCT00159263|101003220|FG003|NOT COMPLETED|Washout||0||
48278016|NCT00159263|101003221|FG004|NOT COMPLETED|Washout||0||
48278017|NCT00159263|101003222|FG005|NOT COMPLETED|Washout||0||
48278018|NCT00159263|101003217|FG000|STARTED|Sixth Intervention||1||
48563699|NCT00360282|101713774|FG001|STARTED|First Intervention||8||
48114931|NCT00792610|100608408|FG000|STARTED|Overall Study||127||
48114932|NCT00792610|100608408|FG000|Youths|Overall Study||127||
48114933|NCT00792610|100608408|FG000|COMPLETED|Overall Study||127||
48114934|NCT00792610|100608408|FG000|NOT COMPLETED|Overall Study||0||
48114935|NCT00348205|100608409|FG000|STARTED|Overall Study||80||
48114936|NCT00348205|100608409|FG000|COMPLETED|Overall Study||78||
48114937|NCT00348205|100608409|FG000|NOT COMPLETED|Overall Study||2||
48114938|NCT05028374|100608410|FG000|STARTED|Overall Study||52||
48114939|NCT05028374|100608411|FG001|STARTED|Overall Study||51||
48114940|NCT05028374|100608412|FG002|STARTED|Overall Study||16||
48114941|NCT05028374|100608410|FG000|COMPLETED|Overall Study||52||
48114942|NCT05028374|100608411|FG001|COMPLETED|Overall Study||50||
48114943|NCT05028374|100608412|FG002|COMPLETED|Overall Study||16||
48114944|NCT05028374|100608410|FG000|NOT COMPLETED|Overall Study||0||
48114945|NCT05028374|100608411|FG001|NOT COMPLETED|Overall Study||1||
48114946|NCT05028374|100608412|FG002|NOT COMPLETED|Overall Study||0||
48114947|NCT04707534|100608413|FG000|STARTED|Overall Study||55||
48114948|NCT04707534|100608414|FG001|STARTED|Overall Study||55||
48114949|NCT04707534|100608413|FG000|Dexamethasone 20mg|Overall Study||52||
48114950|NCT04707534|100608414|FG001|Dexamethasone 20mg|Overall Study||0||
48114951|NCT04707534|100608413|FG000|Dexamethasone 6mg|Overall Study||0||
48114952|NCT04707534|100608414|FG001|Dexamethasone 6mg|Overall Study||55||
48563700|NCT00360282|101713775|FG002|STARTED|First Intervention||7||
48563701|NCT00360282|101713776|FG003|STARTED|First Intervention||6||
48563702|NCT00360282|101713773|FG000|COMPLETED|First Intervention||6||
48563703|NCT00360282|101713774|FG001|COMPLETED|First Intervention||8||
48563704|NCT00360282|101713775|FG002|COMPLETED|First Intervention||7||
48563705|NCT00360282|101713776|FG003|COMPLETED|First Intervention||6||
48563706|NCT00360282|101713773|FG000|NOT COMPLETED|First Intervention||0||
48563707|NCT00360282|101713774|FG001|NOT COMPLETED|First Intervention||0||
48563708|NCT00360282|101713775|FG002|NOT COMPLETED|First Intervention||0||
48114953|NCT04707534|100608413|FG000|COMPLETED|Overall Study||52||
48114954|NCT04707534|100608414|FG001|COMPLETED|Overall Study||55||
48114955|NCT04707534|100608413|FG000|NOT COMPLETED|Overall Study||3||
48563709|NCT00360282|101713776|FG003|NOT COMPLETED|First Intervention||0||
48563710|NCT00360282|101713773|FG000|STARTED|Washout 1-3 Weeks||6||
48563711|NCT00360282|101713774|FG001|STARTED|Washout 1-3 Weeks||8||
48563712|NCT00360282|101713775|FG002|STARTED|Washout 1-3 Weeks||7||
48563713|NCT00360282|101713776|FG003|STARTED|Washout 1-3 Weeks||6||
48563714|NCT00360282|101713773|FG000|COMPLETED|Washout 1-3 Weeks||6||
48563715|NCT00360282|101713774|FG001|COMPLETED|Washout 1-3 Weeks||8||
48563716|NCT00360282|101713775|FG002|COMPLETED|Washout 1-3 Weeks||6||
48563717|NCT00360282|101713776|FG003|COMPLETED|Washout 1-3 Weeks||6||
48563718|NCT00360282|101713773|FG000|NOT COMPLETED|Washout 1-3 Weeks||0||
48114956|NCT04707534|100608414|FG001|NOT COMPLETED|Overall Study||0||
48114957|NCT01228968|100608415|FG000|STARTED|Overall Study||9||
48114958|NCT01228968|100608415|FG000|COMPLETED|Overall Study||9||
48114959|NCT01228968|100608415|FG000|NOT COMPLETED|Overall Study||0||
48114960|NCT04476030|100608416|FG000|STARTED|Overall Study||220||
48114961|NCT04476030|100608417|FG001|STARTED|Overall Study||220||
48114962|NCT04476030|100608416|FG000|Safety Population|Overall Study||218|Safety Set included all participants who administered blinded IP.|
48114963|NCT04476030|100608417|FG001|Safety Population|Overall Study||212|Safety Set included all participants who administered blinded IP.|
48114964|NCT04476030|100608416|FG000|COMPLETED|Overall Study||177||
48114965|NCT04476030|100608417|FG001|COMPLETED|Overall Study||180||
48114966|NCT04476030|100608416|FG000|NOT COMPLETED|Overall Study||43||
48114967|NCT04476030|100608417|FG001|NOT COMPLETED|Overall Study||40||
48563719|NCT00360282|101713774|FG001|NOT COMPLETED|Washout 1-3 Weeks||0||
48563720|NCT00360282|101713775|FG002|NOT COMPLETED|Washout 1-3 Weeks||1||
48563721|NCT00360282|101713776|FG003|NOT COMPLETED|Washout 1-3 Weeks||0||
48563722|NCT00360282|101713773|FG000|STARTED|Second Intervention||6||
48114968|NCT05320029|100608418|FG000|STARTED|Overall Study||82||
48114969|NCT05320029|100608419|FG001|STARTED|Overall Study||82||
48114970|NCT05320029|100608418|FG000|COMPLETED|Overall Study||80||
48114971|NCT05320029|100608419|FG001|COMPLETED|Overall Study||80||
48114972|NCT05320029|100608418|FG000|NOT COMPLETED|Overall Study||2||
48114973|NCT05320029|100608419|FG001|NOT COMPLETED|Overall Study||2||
48394229|NCT01245764|101295892|FG001|NOT COMPLETED|Study Phase A||5||
48394230|NCT01245764|101295893|FG002|NOT COMPLETED|Study Phase A||10||
48563723|NCT00360282|101713774|FG001|STARTED|Second Intervention||8||
48563724|NCT00360282|101713775|FG002|STARTED|Second Intervention||6||
48114974|NCT00700011|100608420|FG000|STARTED|Overall Study||8||
48114975|NCT00700011|100608421|FG001|STARTED|Overall Study||2||
48114976|NCT00700011|100608420|FG000|COMPLETED|Overall Study||8||
48114977|NCT00700011|100608421|FG001|COMPLETED|Overall Study||1||
48114978|NCT00700011|100608420|FG000|NOT COMPLETED|Overall Study||0||
48114979|NCT00700011|100608421|FG001|NOT COMPLETED|Overall Study||1||
48114980|NCT03304379|100608422|FG000|STARTED|Overall Study||308||
48114981|NCT03304379|100608423|FG001|STARTED|Overall Study||612||
48114982|NCT03304379|100608424|FG002|STARTED|Overall Study||612||
48114983|NCT03304379|100608425|FG003|STARTED|Overall Study||59||
48114984|NCT03304379|100608426|FG004|STARTED|Overall Study||59||
48114985|NCT03304379|100608422|FG000|Full Analysis Set (FAS)|Overall Study||308|FAS included all randomized participants excluding participants affected by the urgent safety measure and was based on the treatment allocated (as randomized)|
48114986|NCT03304379|100608423|FG001|Full Analysis Set (FAS)|Overall Study||612|FAS included all randomized participants excluding participants affected by the urgent safety measure and was based on the treatment allocated (as randomized)|
48114987|NCT03304379|100608424|FG002|Full Analysis Set (FAS)|Overall Study||612|FAS included all randomized participants excluding participants affected by the urgent safety measure and was based on the treatment allocated (as randomized)|
48114988|NCT03304379|100608425|FG003|Full Analysis Set (FAS)|Overall Study||0|FAS included all randomized participants excluding participants affected by the urgent safety measure and was based on the treatment allocated (as randomized)|
48114989|NCT03304379|100608426|FG004|Full Analysis Set (FAS)|Overall Study||0|FAS included all randomized participants excluding participants affected by the urgent safety measure and was based on the treatment allocated (as randomized)|
48114990|NCT03304379|100608422|FG000|Safety Analysis Set (SAF)|Overall Study||309|SAF included all randomized participants from the FAS who received any study drug. It is based on the actual treatment received.|
48114991|NCT03304379|100608423|FG001|Safety Analysis Set (SAF)|Overall Study||609|SAF included all randomized participants from the FAS who received any study drug. It is based on the actual treatment received.|
48141425|NCT01780922|100670424|FG001|STARTED|First Intervention (1 Day)||2||
48278019|NCT00159263|101003218|FG001|STARTED|Sixth Intervention||1||
48563725|NCT00360282|101713776|FG003|STARTED|Second Intervention||6||
48563726|NCT00360282|101713773|FG000|COMPLETED|Second Intervention||6||
48563727|NCT00360282|101713774|FG001|COMPLETED|Second Intervention||7||
48563728|NCT00360282|101713775|FG002|COMPLETED|Second Intervention||6||
48563729|NCT00360282|101713776|FG003|COMPLETED|Second Intervention||6||
48278020|NCT00159263|101003219|FG002|STARTED|Sixth Intervention||2||
48278021|NCT00159263|101003220|FG003|STARTED|Sixth Intervention||2||
48278022|NCT00159263|101003221|FG004|STARTED|Sixth Intervention||2||
48278023|NCT00159263|101003222|FG005|STARTED|Sixth Intervention||2||
48394231|NCT01245764|101295894|FG003|NOT COMPLETED|Study Phase A||3||
48394232|NCT01245764|101295891|FG000|STARTED|Study Phase B||0||
48394233|NCT01245764|101295892|FG001|STARTED|Study Phase B||0||
48394234|NCT01245764|101295893|FG002|STARTED|Study Phase B||0||
48394235|NCT01245764|101295894|FG003|STARTED|Study Phase B||17||
48394236|NCT01245764|101295891|FG000|Completed Vaccinations in Study Phase B|Study Phase B||0||
48394237|NCT01245764|101295892|FG001|Completed Vaccinations in Study Phase B|Study Phase B||0||
48394238|NCT01245764|101295893|FG002|Completed Vaccinations in Study Phase B|Study Phase B||0||
48278024|NCT00159263|101003217|FG000|COMPLETED|Sixth Intervention||1||
48278025|NCT00159263|101003218|FG001|COMPLETED|Sixth Intervention||1||
48278026|NCT00159263|101003219|FG002|COMPLETED|Sixth Intervention||2||
48278027|NCT00159263|101003220|FG003|COMPLETED|Sixth Intervention||2||
48394239|NCT01245764|101295894|FG003|Completed Vaccinations in Study Phase B|Study Phase B||17||
48563730|NCT00360282|101713773|FG000|NOT COMPLETED|Second Intervention||0||
48563731|NCT00360282|101713774|FG001|NOT COMPLETED|Second Intervention||1||
48563732|NCT00360282|101713775|FG002|NOT COMPLETED|Second Intervention||0||
48563733|NCT00360282|101713776|FG003|NOT COMPLETED|Second Intervention||0||
48563734|NCT02021929|101713777|FG000|STARTED|Overall Study||16||
48563735|NCT02021929|101713778|FG001|STARTED|Overall Study||12||
48563736|NCT02021929|101713777|FG000|COMPLETED|Overall Study||14||
48563737|NCT02021929|101713778|FG001|COMPLETED|Overall Study||11||
48563738|NCT02021929|101713777|FG000|NOT COMPLETED|Overall Study||2||
48278028|NCT00159263|101003221|FG004|COMPLETED|Sixth Intervention||2||
48278029|NCT00159263|101003222|FG005|COMPLETED|Sixth Intervention||2||
48278030|NCT00159263|101003217|FG000|NOT COMPLETED|Sixth Intervention||0||
48278031|NCT00159263|101003218|FG001|NOT COMPLETED|Sixth Intervention||0||
48278032|NCT00159263|101003219|FG002|NOT COMPLETED|Sixth Intervention||0||
48278033|NCT00159263|101003220|FG003|NOT COMPLETED|Sixth Intervention||0||
48563739|NCT02021929|101713778|FG001|NOT COMPLETED|Overall Study||1||
48563740|NCT02570308|101713779|FG000|STARTED|Overall Study||3||
48563741|NCT02570308|101713780|FG001|STARTED|Overall Study||6||
48563742|NCT02570308|101713781|FG002|STARTED|Overall Study||4||
48563743|NCT02570308|101713782|FG003|STARTED|Overall Study||6||
48563744|NCT02570308|101713783|FG004|STARTED|Overall Study||127||
48563745|NCT02570308|101713779|FG000|COMPLETED|Overall Study||2||
48563746|NCT02570308|101713780|FG001|COMPLETED|Overall Study||1||
48563747|NCT02570308|101713781|FG002|COMPLETED|Overall Study||0||
48563748|NCT02570308|101713782|FG003|COMPLETED|Overall Study||2||
48563749|NCT02570308|101713783|FG004|COMPLETED|Overall Study||53||
48563750|NCT02570308|101713779|FG000|NOT COMPLETED|Overall Study||1||
48697201|NCT01222117|102041909|FG003|NOT COMPLETED|Overall Study||1||
48114992|NCT03304379|100608424|FG002|Safety Analysis Set (SAF)|Overall Study||609|SAF included all randomized participants from the FAS who received any study drug. It is based on the actual treatment received.|
48114993|NCT03304379|100608425|FG003|Safety Analysis Set (SAF)|Overall Study||0|SAF included all randomized participants from the FAS who received any study drug. It is based on the actual treatment received.|
48114994|NCT03304379|100608426|FG004|Safety Analysis Set (SAF)|Overall Study||0|SAF included all randomized participants from the FAS who received any study drug. It is based on the actual treatment received.|
48114995|NCT03304379|100608422|FG000|Urgent Safety Measure Set (USMS)|Overall Study||0|USMS included all participants randomized to Fasinumab 3 mg Q4W or 6 mg Q8W and was based on the treatment allocated (as randomized)|
48278034|NCT00159263|101003221|FG004|NOT COMPLETED|Sixth Intervention||0||
48278035|NCT00159263|101003222|FG005|NOT COMPLETED|Sixth Intervention||0||
48278036|NCT04032613|101003223|FG000|STARTED|Overall Study||21||
48278037|NCT04032613|101003224|FG001|STARTED|Overall Study||25||
48278038|NCT04032613|101003223|FG000|COMPLETED|Overall Study||16||
48278039|NCT04032613|101003224|FG001|COMPLETED|Overall Study||23||
48278040|NCT04032613|101003223|FG000|NOT COMPLETED|Overall Study||5||
48278041|NCT04032613|101003224|FG001|NOT COMPLETED|Overall Study||2||
48278042|NCT01012362|101003225|FG000|STARTED|Overall Study||9||
48278043|NCT01012362|101003226|FG001|STARTED|Overall Study||6||
48278044|NCT01012362|101003227|FG002|STARTED|Overall Study||3||
48278045|NCT01012362|101003228|FG003|STARTED|Overall Study||4||
48278046|NCT01012362|101003229|FG004|STARTED|Overall Study||9||
48394240|NCT01245764|101295891|FG000|COMPLETED|Study Phase B||0||
48394241|NCT01245764|101295892|FG001|COMPLETED|Study Phase B||0||
48563751|NCT02570308|101713780|FG001|NOT COMPLETED|Overall Study||5||
48563752|NCT02570308|101713781|FG002|NOT COMPLETED|Overall Study||4||
48563753|NCT02570308|101713782|FG003|NOT COMPLETED|Overall Study||4||
48563754|NCT02570308|101713783|FG004|NOT COMPLETED|Overall Study||74||
48563755|NCT00365794|101713784|FG000|STARTED|Overall Study||22|All milestones were met 1) target number enrolled and 2) all finished study therapy and measurements|
48563756|NCT00365794|101713784|FG000|COMPLETED|Overall Study||20||
48563757|NCT00365794|101713784|FG000|NOT COMPLETED|Overall Study||2||
48563758|NCT02712320|101713785|FG000|STARTED|Overall Study||30||
48563759|NCT02712320|101713785|FG000|COMPLETED|Overall Study||25||
48563760|NCT02712320|101713785|FG000|NOT COMPLETED|Overall Study||5||
48563761|NCT00523848|101713786|FG000|STARTED|Overall Study||46||
48563762|NCT00523848|101713786|FG000|Treated With Study Therapy|Overall Study||44||
48697202|NCT01222117|102041910|FG004|NOT COMPLETED|Overall Study||1||
48697203|NCT01222117|102041911|FG005|NOT COMPLETED|Overall Study||1||
48278047|NCT01012362|101003225|FG000|COMPLETED|Overall Study||9||
48278048|NCT01012362|101003226|FG001|COMPLETED|Overall Study||6||
48278049|NCT01012362|101003227|FG002|COMPLETED|Overall Study||3||
48278050|NCT01012362|101003228|FG003|COMPLETED|Overall Study||4||
48278051|NCT01012362|101003229|FG004|COMPLETED|Overall Study||9||
48278052|NCT01012362|101003225|FG000|NOT COMPLETED|Overall Study||0||
48278053|NCT01012362|101003226|FG001|NOT COMPLETED|Overall Study||0||
48278054|NCT01012362|101003227|FG002|NOT COMPLETED|Overall Study||0||
48278055|NCT01012362|101003228|FG003|NOT COMPLETED|Overall Study||0||
48278056|NCT01012362|101003229|FG004|NOT COMPLETED|Overall Study||0||
48278057|NCT01656200|101003230|FG000|STARTED|Overall Study||17||
48278058|NCT01656200|101003230|FG000|COMPLETED|Overall Study||16||
48278059|NCT01656200|101003230|FG000|NOT COMPLETED|Overall Study||1||
48278060|NCT05096221|101003231|FG000|STARTED|Part 1||63||
48278061|NCT05096221|101003232|FG001|STARTED|Part 1||62||
48278062|NCT05096221|101003231|FG000|Received at Least 1 Dose of Study Drug in Part 1|Part 1||63||
48278063|NCT05096221|101003232|FG001|Received at Least 1 Dose of Study Drug in Part 1|Part 1||62||
48394242|NCT01245764|101295893|FG002|COMPLETED|Study Phase B||0||
48563763|NCT00523848|101713786|FG000|COMPLETED|Overall Study||22||
48563764|NCT00523848|101713786|FG000|NOT COMPLETED|Overall Study||24||
48563765|NCT01038336|101713787|FG000|STARTED|Overall Study||43||
48563766|NCT01038336|101713788|FG001|STARTED|Overall Study||42||
48563767|NCT01038336|101713789|FG002|STARTED|Overall Study||44||
48563768|NCT01038336|101713787|FG000|COMPLETED|Overall Study||43||
48278064|NCT05096221|101003231|FG000|COMPLETED|Part 1||63||
48278065|NCT05096221|101003232|FG001|COMPLETED|Part 1||62||
48278066|NCT05096221|101003231|FG000|NOT COMPLETED|Part 1||0||
48278067|NCT05096221|101003232|FG001|NOT COMPLETED|Part 1||0||
48278068|NCT05096221|101003231|FG000|STARTED|Part 2||63||
48278069|NCT05096221|101003232|FG001|STARTED|Part 2||62||
48278070|NCT05096221|101003231|FG000|COMPLETED|Part 2||0||
48278071|NCT05096221|101003232|FG001|COMPLETED|Part 2||0||
48278072|NCT05096221|101003231|FG000|NOT COMPLETED|Part 2||63||
48278073|NCT05096221|101003232|FG001|NOT COMPLETED|Part 2||62||
48278074|NCT03592745|101003233|FG000|STARTED|Overall Study||18||
48278075|NCT03592745|101003234|FG001|STARTED|Overall Study||18||
48278076|NCT03592745|101003233|FG000|COMPLETED|Overall Study||15||
48278077|NCT03592745|101003234|FG001|COMPLETED|Overall Study||15||
48563769|NCT01038336|101713788|FG001|COMPLETED|Overall Study||42||
48563770|NCT01038336|101713789|FG002|COMPLETED|Overall Study||44||
48563771|NCT01038336|101713787|FG000|NOT COMPLETED|Overall Study||0||
48394243|NCT01245764|101295894|FG003|COMPLETED|Study Phase B||17||
48394244|NCT01245764|101295891|FG000|NOT COMPLETED|Study Phase B||0||
48394245|NCT01245764|101295892|FG001|NOT COMPLETED|Study Phase B||0||
48394246|NCT01245764|101295893|FG002|NOT COMPLETED|Study Phase B||0||
48394247|NCT01245764|101295894|FG003|NOT COMPLETED|Study Phase B||0||
48394248|NCT01838590|101295895|FG000|STARTED|Overall Study||52||
48394249|NCT01838590|101295896|FG001|STARTED|Overall Study||51||
48563772|NCT01038336|101713788|FG001|NOT COMPLETED|Overall Study||0||
48563773|NCT01038336|101713789|FG002|NOT COMPLETED|Overall Study||0||
48563774|NCT03817853|101713790|FG000|STARTED|Induction Phase||113||
48563775|NCT03817853|101713791|FG001|STARTED|Induction Phase||0||
48563776|NCT03817853|101713792|FG002|STARTED|Induction Phase||0||
48563777|NCT03817853|101713790|FG000|COMPLETED|Induction Phase||93||
48563778|NCT03817853|101713791|FG001|COMPLETED|Induction Phase||0||
48563779|NCT03817853|101713792|FG002|COMPLETED|Induction Phase||0||
48563780|NCT03817853|101713790|FG000|NOT COMPLETED|Induction Phase||20||
48563781|NCT03817853|101713791|FG001|NOT COMPLETED|Induction Phase||0||
48697204|NCT01222117|102041912|FG006|NOT COMPLETED|Overall Study||0||
48697205|NCT01222117|102041913|FG007|NOT COMPLETED|Overall Study||0||
48697206|NCT01222117|102041914|FG008|NOT COMPLETED|Overall Study||3||
48697207|NCT01222117|102041915|FG009|NOT COMPLETED|Overall Study||2||
48697208|NCT01222117|102041916|FG010|NOT COMPLETED|Overall Study||0||
48697209|NCT00613327|102041917|FG000|STARTED|Overall Study||345||
48697210|NCT00613327|102041917|FG000|COMPLETED|Overall Study||244||
48697211|NCT00613327|102041917|FG000|NOT COMPLETED|Overall Study||101||
48278078|NCT03592745|101003233|FG000|NOT COMPLETED|Overall Study||3||
48278079|NCT03592745|101003234|FG001|NOT COMPLETED|Overall Study||3||
48278080|NCT03465904|101003235|FG000|STARTED|Overall Study||299||
48278081|NCT03465904|101003236|FG001|STARTED|Overall Study||308||
48278082|NCT03465904|101003235|FG000|COMPLETED|Overall Study||259||
48278083|NCT03465904|101003236|FG001|COMPLETED|Overall Study||279||
48394250|NCT01838590|101295895|FG000|COMPLETED|Overall Study||40||
48394251|NCT01838590|101295896|FG001|COMPLETED|Overall Study||46||
48394252|NCT01838590|101295895|FG000|NOT COMPLETED|Overall Study||12||
48394253|NCT01838590|101295896|FG001|NOT COMPLETED|Overall Study||5||
48394254|NCT00397878|101295897|FG000|STARTED|Overall Study||10||
48394255|NCT00397878|101295897|FG000|COMPLETED|Overall Study||10||
48563782|NCT03817853|101713792|FG002|NOT COMPLETED|Induction Phase||0||
48563783|NCT03817853|101713790|FG000|STARTED|Maintenance Phase||0||
48563784|NCT03817853|101713791|FG001|STARTED|Maintenance Phase||95||
48563785|NCT03817853|101713792|FG002|STARTED|Maintenance Phase||0||
48563786|NCT03817853|101713790|FG000|COMPLETED|Maintenance Phase||0||
48563787|NCT03817853|101713791|FG001|COMPLETED|Maintenance Phase||67||
48697212|NCT06053541|102041918|FG000|STARTED|Overall Study||3015000||
48697213|NCT06053541|102041918|FG000|COMPLETED|Overall Study||3015000||
48697214|NCT06053541|102041918|FG000|NOT COMPLETED|Overall Study||0||
48394256|NCT00397878|101295897|FG000|NOT COMPLETED|Overall Study||0||
48563788|NCT03817853|101713792|FG002|COMPLETED|Maintenance Phase||0||
48697215|NCT03268954|102041919|FG000|STARTED|Overall Study||227||
48278084|NCT03465904|101003235|FG000|NOT COMPLETED|Overall Study||40||
48278085|NCT03465904|101003236|FG001|NOT COMPLETED|Overall Study||29||
48697216|NCT03268954|102041920|FG001|STARTED|Overall Study||227||
48278086|NCT02296502|101003237|FG000|STARTED|Overall Study||248||
48278087|NCT02296502|101003238|FG001|STARTED|Overall Study||1||
48278088|NCT02296502|101003239|FG002|STARTED|Overall Study||30||
48278089|NCT02296502|101003240|FG003|STARTED|Overall Study||160||
48278090|NCT02296502|101003237|FG000|COMPLETED|Overall Study||248||
48278091|NCT02296502|101003238|FG001|COMPLETED|Overall Study||1||
48710723|NCT02699450|102077999|FG000|STARTED|Overall Study||90|Intent-to-Treat (ITT) Population|
48278092|NCT02296502|101003239|FG002|COMPLETED|Overall Study||30||
48278093|NCT02296502|101003240|FG003|COMPLETED|Overall Study||160||
48278094|NCT02296502|101003237|FG000|NOT COMPLETED|Overall Study||0||
48278095|NCT02296502|101003238|FG001|NOT COMPLETED|Overall Study||0||
48278096|NCT02296502|101003239|FG002|NOT COMPLETED|Overall Study||0||
48278097|NCT02296502|101003240|FG003|NOT COMPLETED|Overall Study||0||
48394257|NCT03805971|101295898|FG000|STARTED|Overall Study||65||
48394258|NCT03805971|101295898|FG000|COMPLETED|Overall Study||62||
48394259|NCT03805971|101295898|FG000|NOT COMPLETED|Overall Study||3||
48394260|NCT00617591|101295899|FG000|STARTED|Overall Study||57||
48114996|NCT03304379|100608423|FG001|Urgent Safety Measure Set (USMS)|Overall Study||0|USMS included all participants randomized to Fasinumab 3 mg Q4W or 6 mg Q8W and was based on the treatment allocated (as randomized)|
48114997|NCT03304379|100608424|FG002|Urgent Safety Measure Set (USMS)|Overall Study||0|USMS included all participants randomized to Fasinumab 3 mg Q4W or 6 mg Q8W and was based on the treatment allocated (as randomized)|
48114998|NCT03304379|100608425|FG003|Urgent Safety Measure Set (USMS)|Overall Study||59|USMS included all participants randomized to Fasinumab 3 mg Q4W or 6 mg Q8W and was based on the treatment allocated (as randomized)|
48114999|NCT03304379|100608426|FG004|Urgent Safety Measure Set (USMS)|Overall Study||59|USMS included all participants randomized to Fasinumab 3 mg Q4W or 6 mg Q8W and was based on the treatment allocated (as randomized)|
48115000|NCT03304379|100608422|FG000|Completed Treatment|Overall Study||218||
48115001|NCT03304379|100608423|FG001|Completed Treatment|Overall Study||436||
48115002|NCT03304379|100608424|FG002|Completed Treatment|Overall Study||454||
48278098|NCT02615002|101003241|FG000|STARTED|Run-In Phase (2 Weeks)||89||
48278099|NCT02615002|101003242|FG001|STARTED|Run-In Phase (2 Weeks)||88||
48278100|NCT02615002|101003243|FG002|STARTED|Run-In Phase (2 Weeks)||88||
48278101|NCT02615002|101003244|FG003|STARTED|Run-In Phase (2 Weeks)||106||
48278102|NCT02615002|101003241|FG000|COMPLETED|Run-In Phase (2 Weeks)||89||
48115003|NCT03304379|100608425|FG003|Completed Treatment|Overall Study||0||
48115004|NCT03304379|100608426|FG004|Completed Treatment|Overall Study||0||
48115005|NCT03304379|100608422|FG000|COMPLETED|Overall Study||238||
48115006|NCT03304379|100608423|FG001|COMPLETED|Overall Study||471||
48115007|NCT03304379|100608424|FG002|COMPLETED|Overall Study||463||
48115008|NCT03304379|100608425|FG003|COMPLETED|Overall Study||42||
48115009|NCT03304379|100608426|FG004|COMPLETED|Overall Study||42||
48115010|NCT03304379|100608422|FG000|NOT COMPLETED|Overall Study||70||
48115011|NCT03304379|100608423|FG001|NOT COMPLETED|Overall Study||141||
48115012|NCT03304379|100608424|FG002|NOT COMPLETED|Overall Study||149||
48115013|NCT03304379|100608425|FG003|NOT COMPLETED|Overall Study||17||
48115014|NCT03304379|100608426|FG004|NOT COMPLETED|Overall Study||17||
48115015|NCT01306617|100608427|FG000|STARTED|Overall Study||19||
48115016|NCT01306617|100608428|FG001|STARTED|Overall Study||14||
48115017|NCT01306617|100608429|FG002|STARTED|Overall Study||17||
48278103|NCT02615002|101003242|FG001|COMPLETED|Run-In Phase (2 Weeks)||88||
48278104|NCT02615002|101003243|FG002|COMPLETED|Run-In Phase (2 Weeks)||88||
48278105|NCT02615002|101003244|FG003|COMPLETED|Run-In Phase (2 Weeks)||106||
48563789|NCT03817853|101713790|FG000|NOT COMPLETED|Maintenance Phase||0||
48563790|NCT03817853|101713791|FG001|NOT COMPLETED|Maintenance Phase||28||
48563791|NCT03817853|101713792|FG002|NOT COMPLETED|Maintenance Phase||0||
48563792|NCT03817853|101713790|FG000|STARTED|Follow-up Phase||0||
48563793|NCT03817853|101713791|FG001|STARTED|Follow-up Phase||0||
48563794|NCT03817853|101713792|FG002|STARTED|Follow-up Phase||99||
48563795|NCT03817853|101713790|FG000|COMPLETED|Follow-up Phase||0||
48563796|NCT03817853|101713791|FG001|COMPLETED|Follow-up Phase||0||
48563797|NCT03817853|101713792|FG002|COMPLETED|Follow-up Phase||92||
48115018|NCT01306617|100608427|FG000|COMPLETED|Overall Study||18||
48115019|NCT01306617|100608428|FG001|COMPLETED|Overall Study||13||
48115020|NCT01306617|100608429|FG002|COMPLETED|Overall Study||12||
48115021|NCT01306617|100608427|FG000|NOT COMPLETED|Overall Study||1||
48115022|NCT01306617|100608428|FG001|NOT COMPLETED|Overall Study||1||
48115023|NCT01306617|100608429|FG002|NOT COMPLETED|Overall Study||5||
48115024|NCT00437034|100608430|FG000|STARTED|Overall Study||6||
48115025|NCT00437034|100608430|FG000|COMPLETED|Overall Study||0||
48115026|NCT00437034|100608430|FG000|NOT COMPLETED|Overall Study||6||
48115027|NCT03256552|100608431|FG000|STARTED|Overall Study||66||66
48115028|NCT03256552|100608431|FG000|GP MDI 28.8 µg|Overall Study||61|Glycopyrronium Metered Dose Inhaler (MDI) 28.8 µg BID|61
48115029|NCT03256552|100608431|FG000|GP MDI 14.4 µg|Overall Study||63|Glycopyrronium Metered Dose Inhaler (MDI) 14.4 µg BID|63
48115030|NCT03256552|100608431|FG000|GP MDI 7.2 µg|Overall Study||62|Glycopyrronium Metered Dose Inhaler (MDI) 7.2 µg BID|62
48278106|NCT02615002|101003241|FG000|NOT COMPLETED|Run-In Phase (2 Weeks)||0||
48278107|NCT02615002|101003242|FG001|NOT COMPLETED|Run-In Phase (2 Weeks)||0||
48278108|NCT02615002|101003243|FG002|NOT COMPLETED|Run-In Phase (2 Weeks)||0||
48278109|NCT02615002|101003244|FG003|NOT COMPLETED|Run-In Phase (2 Weeks)||0||
48563798|NCT03817853|101713790|FG000|NOT COMPLETED|Follow-up Phase||0||
48563799|NCT03817853|101713791|FG001|NOT COMPLETED|Follow-up Phase||0||
48563800|NCT03817853|101713792|FG002|NOT COMPLETED|Follow-up Phase||7||
48563801|NCT02389829|101713793|FG000|STARTED|Overall Study||64||
48563802|NCT02389829|101713794|FG001|STARTED|Overall Study||63||
48563803|NCT02389829|101713793|FG000|COMPLETED|Overall Study||64||
48563804|NCT02389829|101713794|FG001|COMPLETED|Overall Study||62||
48563805|NCT02389829|101713793|FG000|NOT COMPLETED|Overall Study||0||
48115031|NCT03256552|100608431|FG000|Placebo MDI|Overall Study||65|Placebo Metered Dose Inhaler BID|65
48115032|NCT03256552|100608431|FG000|COMPLETED|Overall Study||61||61
48115033|NCT03256552|100608431|FG000|NOT COMPLETED|Overall Study||5||5
48115034|NCT01886833|100608432|FG000|STARTED|Overall Study||420||
48115035|NCT01886833|100608432|FG000|COMPLETED|Overall Study||216||
48115036|NCT01886833|100608432|FG000|NOT COMPLETED|Overall Study||204||
48115037|NCT01833403|100608433|FG000|STARTED|Overall Study||4||
48115038|NCT01833403|100608433|FG000|COMPLETED|Overall Study||4||
48115039|NCT01833403|100608433|FG000|NOT COMPLETED|Overall Study||0||
48115040|NCT05074433|100608434|FG000|STARTED|Overall Study||16||
48115041|NCT05074433|100608435|FG001|STARTED|Overall Study||17||
48115042|NCT05074433|100608436|FG002|STARTED|Overall Study||16||
48115043|NCT05074433|100608437|FG003|STARTED|Overall Study||17||
48115044|NCT05074433|100608434|FG000|COMPLETED|Overall Study||7||
48563806|NCT02389829|101713794|FG001|NOT COMPLETED|Overall Study||1||
48563807|NCT03170362|101713795|FG000|STARTED|Overall Study||966||
48563808|NCT03170362|101713796|FG001|STARTED|Overall Study||978||
48563809|NCT03170362|101713795|FG000|COMPLETED|Overall Study||754||
48563810|NCT03170362|101713796|FG001|COMPLETED|Overall Study||787||
48563811|NCT03170362|101713795|FG000|NOT COMPLETED|Overall Study||212||
48563812|NCT03170362|101713796|FG001|NOT COMPLETED|Overall Study||191||
48115045|NCT05074433|100608435|FG001|COMPLETED|Overall Study||8||
48115046|NCT05074433|100608436|FG002|COMPLETED|Overall Study||9||
48115047|NCT05074433|100608437|FG003|COMPLETED|Overall Study||11||
48115048|NCT05074433|100608434|FG000|NOT COMPLETED|Overall Study||9||
48115049|NCT05074433|100608435|FG001|NOT COMPLETED|Overall Study||9||
48115050|NCT05074433|100608436|FG002|NOT COMPLETED|Overall Study||7||
48115051|NCT05074433|100608437|FG003|NOT COMPLETED|Overall Study||6||
48115052|NCT00071812|100608438|FG000|STARTED|24-Week Double-Blind Period||69||
48115053|NCT00071812|100608439|FG001|STARTED|24-Week Double-Blind Period||72||
48115054|NCT00071812|100608440|FG002|STARTED|24-Week Double-Blind Period||71||
48115055|NCT00071812|100608441|FG003|STARTED|24-Week Double-Blind Period||71||
48115056|NCT00071812|100608438|FG000|COMPLETED|24-Week Double-Blind Period||59||
48115057|NCT00071812|100608439|FG001|COMPLETED|24-Week Double-Blind Period||66||
48115058|NCT00071812|100608440|FG002|COMPLETED|24-Week Double-Blind Period||63||
48115059|NCT00071812|100608441|FG003|COMPLETED|24-Week Double-Blind Period||60||
48115060|NCT00071812|100608438|FG000|NOT COMPLETED|24-Week Double-Blind Period||10||
48115061|NCT00071812|100608439|FG001|NOT COMPLETED|24-Week Double-Blind Period||6||
48115062|NCT00071812|100608440|FG002|NOT COMPLETED|24-Week Double-Blind Period||8||
48115063|NCT00071812|100608441|FG003|NOT COMPLETED|24-Week Double-Blind Period||11||
48115064|NCT00071812|100608438|FG000|STARTED|24-Week Open-Label Extension Period||0||
48563813|NCT04620746|101713797|FG000|STARTED|Overall Study||139||
48563814|NCT04620746|101713798|FG001|STARTED|Overall Study||145||
48563815|NCT04620746|101713797|FG000|COMPLETED|Overall Study||136||
48115065|NCT00071812|100608439|FG001|STARTED|24-Week Open-Label Extension Period||11||
48115066|NCT00071812|100608440|FG002|STARTED|24-Week Open-Label Extension Period||8||
48115067|NCT00071812|100608441|FG003|STARTED|24-Week Open-Label Extension Period||218||
48115068|NCT00071812|100608438|FG000|COMPLETED|24-Week Open-Label Extension Period||0||
48115069|NCT00071812|100608439|FG001|COMPLETED|24-Week Open-Label Extension Period||11||
48115070|NCT00071812|100608440|FG002|COMPLETED|24-Week Open-Label Extension Period||7||
48115071|NCT00071812|100608441|FG003|COMPLETED|24-Week Open-Label Extension Period||178||
48115072|NCT00071812|100608438|FG000|NOT COMPLETED|24-Week Open-Label Extension Period||0||
48115073|NCT00071812|100608439|FG001|NOT COMPLETED|24-Week Open-Label Extension Period||0||
48115074|NCT00071812|100608440|FG002|NOT COMPLETED|24-Week Open-Label Extension Period||1||
48115075|NCT00071812|100608441|FG003|NOT COMPLETED|24-Week Open-Label Extension Period||40||
48115076|NCT01712984|100608442|FG000|STARTED|Overall Study||1672||
48115077|NCT01712984|100608443|FG001|STARTED|Overall Study||837||
48115078|NCT01712984|100608444|FG002|STARTED|Overall Study||846||
48115079|NCT01712984|100608442|FG000|COMPLETED|Overall Study||1656||
48115080|NCT01712984|100608443|FG001|COMPLETED|Overall Study||821||
48115081|NCT01712984|100608444|FG002|COMPLETED|Overall Study||836||
48115082|NCT01712984|100608442|FG000|NOT COMPLETED|Overall Study||16||
48563816|NCT04620746|101713798|FG001|COMPLETED|Overall Study||144||
48563817|NCT04620746|101713797|FG000|NOT COMPLETED|Overall Study||3||
48563818|NCT04620746|101713798|FG001|NOT COMPLETED|Overall Study||1||
48563819|NCT00063934|101713799|FG000|STARTED|Overall Study||31||
48563820|NCT00063934|101713799|FG000|COMPLETED|Overall Study||30||
48563821|NCT00063934|101713799|FG000|NOT COMPLETED|Overall Study||1||
48563822|NCT02571673|101713800|FG000|STARTED|Overall Study||65||
48563823|NCT02571673|101713800|FG000|COMPLETED|Overall Study||65||
48115083|NCT01712984|100608443|FG001|NOT COMPLETED|Overall Study||16||
48115084|NCT01712984|100608444|FG002|NOT COMPLETED|Overall Study||10||
48115085|NCT00378014|100608445|FG000|STARTED|Core (Randomization to Month 11)||101||
48115086|NCT00378014|100608446|FG001|STARTED|Core (Randomization to Month 11)||102||
48115087|NCT00378014|100608445|FG000|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)||96||
48115088|NCT00378014|100608446|FG001|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)||98||
48115089|NCT00378014|100608445|FG000|COMPLETED|Core (Randomization to Month 11)||87||
48563824|NCT02571673|101713800|FG000|NOT COMPLETED|Overall Study||0||
48563825|NCT02375971|101713801|FG000|STARTED|Treatment (Day 1 - Baseline)||74|All randomized patients to whom treatment had been assigned (FAS)|
48697217|NCT03268954|102041919|FG000|Safety Population|Overall Study||220|Safety Population included all enrolled participants who received at least 1 dose of azacitidine alone or pevonedistat + azacitidine.|
48697218|NCT03268954|102041920|FG001|Safety Population|Overall Study||223|Safety Population included all enrolled participants who received at least 1 dose of azacitidine alone or pevonedistat + azacitidine.|
48697219|NCT03268954|102041919|FG000|COMPLETED|Overall Study||0||
48697220|NCT03268954|102041920|FG001|COMPLETED|Overall Study||0||
48697221|NCT03268954|102041919|FG000|NOT COMPLETED|Overall Study||227||
48697222|NCT03268954|102041920|FG001|NOT COMPLETED|Overall Study||227||
48697223|NCT03062280|102041921|FG000|STARTED|Overall Study||91||
48278110|NCT02615002|101003241|FG000|STARTED|Double Blind Dose Escalation (26 Weeks)||89||
48278111|NCT02615002|101003242|FG001|STARTED|Double Blind Dose Escalation (26 Weeks)||88||
48278112|NCT02615002|101003243|FG002|STARTED|Double Blind Dose Escalation (26 Weeks)||88||
48278113|NCT02615002|101003244|FG003|STARTED|Double Blind Dose Escalation (26 Weeks)||106||
48278114|NCT02615002|101003241|FG000|Number of Baseline Participants|Double Blind Dose Escalation (26 Weeks)||83||
48278115|NCT02615002|101003242|FG001|Number of Baseline Participants|Double Blind Dose Escalation (26 Weeks)||87||
48115090|NCT00378014|100608446|FG001|COMPLETED|Core (Randomization to Month 11)||90||
48115091|NCT00378014|100608445|FG000|NOT COMPLETED|Core (Randomization to Month 11)||14||
48115092|NCT00378014|100608446|FG001|NOT COMPLETED|Core (Randomization to Month 11)||12||
48115093|NCT00378014|100608445|FG000|STARTED|Extension (Month 12 to Month 59)||41||
48115094|NCT00378014|100608446|FG001|STARTED|Extension (Month 12 to Month 59)||40||
48115095|NCT00378014|100608445|FG000|COMPLETED|Extension (Month 12 to Month 59)||27||
48115096|NCT00378014|100608446|FG001|COMPLETED|Extension (Month 12 to Month 59)||26||
48115097|NCT00378014|100608445|FG000|NOT COMPLETED|Extension (Month 12 to Month 59)||14||
48115098|NCT00378014|100608446|FG001|NOT COMPLETED|Extension (Month 12 to Month 59)||14||
48115099|NCT01633944|100608447|FG000|STARTED|Open-label Titration Phase||752||
48115100|NCT01633944|100608448|FG001|STARTED|Open-label Titration Phase||0||
48115101|NCT01633944|100608449|FG002|STARTED|Open-label Titration Phase||0||
48115102|NCT01633944|100608447|FG000|COMPLETED|Open-label Titration Phase||462||
48115103|NCT01633944|100608448|FG001|COMPLETED|Open-label Titration Phase||0||
48115104|NCT01633944|100608449|FG002|COMPLETED|Open-label Titration Phase||0||
48115105|NCT01633944|100608447|FG000|NOT COMPLETED|Open-label Titration Phase||290||
48115106|NCT01633944|100608448|FG001|NOT COMPLETED|Open-label Titration Phase||0||
48115107|NCT01633944|100608449|FG002|NOT COMPLETED|Open-label Titration Phase||0||
48115108|NCT01633944|100608447|FG000|STARTED|Double-blind Treatment Phase||0||
48115109|NCT01633944|100608448|FG001|STARTED|Double-blind Treatment Phase||230||
48115110|NCT01633944|100608449|FG002|STARTED|Double-blind Treatment Phase||232||
48115111|NCT01633944|100608447|FG000|COMPLETED|Double-blind Treatment Phase||0||
48115112|NCT01633944|100608448|FG001|COMPLETED|Double-blind Treatment Phase||176||
48115113|NCT01633944|100608449|FG002|COMPLETED|Double-blind Treatment Phase||174||
48115114|NCT01633944|100608447|FG000|NOT COMPLETED|Double-blind Treatment Phase||0||
48115115|NCT01633944|100608448|FG001|NOT COMPLETED|Double-blind Treatment Phase||54||
48115116|NCT01633944|100608449|FG002|NOT COMPLETED|Double-blind Treatment Phase||58||
48115117|NCT02165111|100608450|FG000|STARTED|Overall Study||40||40
48115118|NCT02165111|100608451|FG001|STARTED|Overall Study||40||40
48115119|NCT02165111|100608450|FG000|COMPLETED|Overall Study||40||40
48115120|NCT02165111|100608451|FG001|COMPLETED|Overall Study||40||40
48115121|NCT02165111|100608450|FG000|NOT COMPLETED|Overall Study||0||0
48115122|NCT02165111|100608451|FG001|NOT COMPLETED|Overall Study||0||0
48115123|NCT00779766|100608452|FG000|STARTED|Month 24||3026||
48115124|NCT00779766|100608453|FG001|STARTED|Month 24||3025||
48115125|NCT00779766|100608452|FG000|COMPLETED|Month 24||2694||
48115126|NCT00779766|100608453|FG001|COMPLETED|Month 24||2693||
48115127|NCT00779766|100608452|FG000|NOT COMPLETED|Month 24||332||
48115128|NCT00779766|100608453|FG001|NOT COMPLETED|Month 24||332||
48115129|NCT00779766|100608452|FG000|STARTED|Month 48||2703||
48115130|NCT00779766|100608453|FG001|STARTED|Month 48||2727||
48278116|NCT02615002|101003243|FG002|Number of Baseline Participants|Double Blind Dose Escalation (26 Weeks)||80||
48394261|NCT00617591|101295899|FG000|COMPLETED|Overall Study||47||
48115131|NCT00779766|100608452|FG000|COMPLETED|Month 48||2529||
48115132|NCT00779766|100608453|FG001|COMPLETED|Month 48||2559||
48115133|NCT00779766|100608452|FG000|NOT COMPLETED|Month 48||174||
48115134|NCT00779766|100608453|FG001|NOT COMPLETED|Month 48||168||
48115135|NCT00779766|100608452|FG000|STARTED|Month 72||2319||
48115136|NCT00779766|100608453|FG001|STARTED|Month 72||2347||
48115137|NCT00779766|100608452|FG000|COMPLETED|Month 72||2134||
48115138|NCT00779766|100608453|FG001|COMPLETED|Month 72||2158||
48115139|NCT00779766|100608452|FG000|NOT COMPLETED|Month 72||185||
48115140|NCT00779766|100608453|FG001|NOT COMPLETED|Month 72||189||
48115141|NCT00280566|100608454|FG000|STARTED|Period 1 Open Label Ziprasidone||584||
48115142|NCT00280566|100608455|FG001|STARTED|Period 1 Open Label Ziprasidone||0||
48115143|NCT00280566|100608456|FG002|STARTED|Period 1 Open Label Ziprasidone||0||
48115144|NCT00280566|100608454|FG000|COMPLETED|Period 1 Open Label Ziprasidone||241||
48115145|NCT00280566|100608455|FG001|COMPLETED|Period 1 Open Label Ziprasidone||0||
48115146|NCT00280566|100608456|FG002|COMPLETED|Period 1 Open Label Ziprasidone||0||
48115147|NCT00280566|100608454|FG000|NOT COMPLETED|Period 1 Open Label Ziprasidone||343||
48115148|NCT00280566|100608455|FG001|NOT COMPLETED|Period 1 Open Label Ziprasidone||0||
48115149|NCT00280566|100608456|FG002|NOT COMPLETED|Period 1 Open Label Ziprasidone||0||
48115150|NCT00280566|100608454|FG000|STARTED|Period 2 Double Blind||0||
48115151|NCT00280566|100608455|FG001|STARTED|Period 2 Double Blind||127||
48115152|NCT00280566|100608456|FG002|STARTED|Period 2 Double Blind||111||
48115153|NCT00280566|100608454|FG000|COMPLETED|Period 2 Double Blind||0||
48115154|NCT00280566|100608455|FG001|COMPLETED|Period 2 Double Blind||84||
48115155|NCT00280566|100608456|FG002|COMPLETED|Period 2 Double Blind||54||
48115156|NCT00280566|100608454|FG000|NOT COMPLETED|Period 2 Double Blind||0||
48115157|NCT00280566|100608455|FG001|NOT COMPLETED|Period 2 Double Blind||43||
48115158|NCT00280566|100608456|FG002|NOT COMPLETED|Period 2 Double Blind||57||
48115159|NCT02533921|100608457|FG000|STARTED|Overall Study||104||
48115160|NCT02533921|100608458|FG001|STARTED|Overall Study||106||
48115161|NCT02533921|100608457|FG000|COMPLETED|Overall Study||88||
48115162|NCT02533921|100608458|FG001|COMPLETED|Overall Study||95||
48115163|NCT02533921|100608457|FG000|NOT COMPLETED|Overall Study||16||
48115164|NCT02533921|100608458|FG001|NOT COMPLETED|Overall Study||11||
48115165|NCT01114516|100608459|FG000|STARTED|Overall Study||26||
48115166|NCT01114516|100608460|FG001|STARTED|Overall Study||27||
48278117|NCT02615002|101003244|FG003|Number of Baseline Participants|Double Blind Dose Escalation (26 Weeks)||102||
48278118|NCT02615002|101003241|FG000|COMPLETED|Double Blind Dose Escalation (26 Weeks)||71||
48278119|NCT02615002|101003242|FG001|COMPLETED|Double Blind Dose Escalation (26 Weeks)||88||
48278120|NCT02615002|101003243|FG002|COMPLETED|Double Blind Dose Escalation (26 Weeks)||88||
48278121|NCT02615002|101003244|FG003|COMPLETED|Double Blind Dose Escalation (26 Weeks)||85||
48278122|NCT02615002|101003241|FG000|NOT COMPLETED|Double Blind Dose Escalation (26 Weeks)||18||
48278123|NCT02615002|101003242|FG001|NOT COMPLETED|Double Blind Dose Escalation (26 Weeks)||0||
48278124|NCT02615002|101003243|FG002|NOT COMPLETED|Double Blind Dose Escalation (26 Weeks)||0||
48278125|NCT02615002|101003244|FG003|NOT COMPLETED|Double Blind Dose Escalation (26 Weeks)||21||
48278126|NCT04546217|101003245|FG000|STARTED|Overall Study||12|Training sessions.|
48697224|NCT03062280|102041921|FG000|COMPLETED|Overall Study||69||
48697225|NCT03062280|102041921|FG000|NOT COMPLETED|Overall Study||22||
48697226|NCT03938103|102041922|FG000|STARTED|Technical Assistant (TA) Coaches||14|"TA coaches were part of intervention delivery and randomized to a study arm. Periods were used in this flow to represent units of people serving a childcare center."|55
48697227|NCT03938103|102041923|FG001|STARTED|Technical Assistant (TA) Coaches||13|"TA coaches were part of intervention delivery and randomized to a study arm. Periods were used in this flow to represent units of people serving a childcare center."|42
48697228|NCT03938103|102041922|FG000|COMPLETED|Technical Assistant (TA) Coaches||14||48
48697229|NCT03938103|102041923|FG001|COMPLETED|Technical Assistant (TA) Coaches||13||39
48697230|NCT03938103|102041922|FG000|NOT COMPLETED|Technical Assistant (TA) Coaches||0||7
48697231|NCT03938103|102041923|FG001|NOT COMPLETED|Technical Assistant (TA) Coaches||0||3
48697232|NCT03938103|102041922|FG000|STARTED|Center Directors||65|Periods in this flow represent groups of child care directors recruited within centers.|55
48115167|NCT01114516|100608459|FG000|COMPLETED|Overall Study||24||
48115168|NCT01114516|100608460|FG001|COMPLETED|Overall Study||26||
48115169|NCT01114516|100608459|FG000|NOT COMPLETED|Overall Study||2||
48115170|NCT01114516|100608460|FG001|NOT COMPLETED|Overall Study||1||
48115171|NCT01207778|100608461|FG000|STARTED|Overall Study||39||
48115172|NCT01207778|100608462|FG001|STARTED|Overall Study||24||
48115173|NCT01207778|100608463|FG002|STARTED|Overall Study||14||
48115174|NCT01207778|100608461|FG000|COMPLETED|Overall Study||39||
48115175|NCT01207778|100608462|FG001|COMPLETED|Overall Study||21||
48115176|NCT01207778|100608463|FG002|COMPLETED|Overall Study||11||
48115177|NCT01207778|100608461|FG000|NOT COMPLETED|Overall Study||0||
48115178|NCT01207778|100608462|FG001|NOT COMPLETED|Overall Study||3||
48115179|NCT01207778|100608463|FG002|NOT COMPLETED|Overall Study||3||
48278127|NCT04546217|101003246|FG001|STARTED|Overall Study||7|Training sessions.|
48278128|NCT04546217|101003245|FG000|COMPLETED|Overall Study||9||
48278129|NCT04546217|101003246|FG001|COMPLETED|Overall Study||7||
48278130|NCT04546217|101003245|FG000|NOT COMPLETED|Overall Study||3||
48278131|NCT04546217|101003246|FG001|NOT COMPLETED|Overall Study||0||
48278132|NCT05384938|101003247|FG000|STARTED|Overall Study||139||
48115180|NCT03117387|100608464|FG000|STARTED|Overall Study||126||
48115181|NCT03117387|100608465|FG001|STARTED|Overall Study||74||
48115182|NCT03117387|100608466|FG002|STARTED|Overall Study||43||
48115183|NCT03117387|100608467|FG003|STARTED|Overall Study||7||
48115184|NCT03117387|100608464|FG000|COMPLETED|Overall Study||126||
48115185|NCT03117387|100608465|FG001|COMPLETED|Overall Study||74||
48115186|NCT03117387|100608466|FG002|COMPLETED|Overall Study||43||
48115187|NCT03117387|100608467|FG003|COMPLETED|Overall Study||7||
48115188|NCT03117387|100608464|FG000|NOT COMPLETED|Overall Study||0||
48115189|NCT03117387|100608465|FG001|NOT COMPLETED|Overall Study||0||
48115190|NCT03117387|100608466|FG002|NOT COMPLETED|Overall Study||0||
48115191|NCT03117387|100608467|FG003|NOT COMPLETED|Overall Study||0||
48115192|NCT02684006|100608468|FG000|STARTED|Overall Study||442||
48115193|NCT02684006|100608469|FG001|STARTED|Overall Study||444||
48115194|NCT02684006|100608468|FG000|COMPLETED|Overall Study||0||
48115195|NCT02684006|100608469|FG001|COMPLETED|Overall Study||0||
48115196|NCT02684006|100608468|FG000|NOT COMPLETED|Overall Study||442||
48115197|NCT02684006|100608469|FG001|NOT COMPLETED|Overall Study||444||
48115198|NCT01516879|100608470|FG000|STARTED|Overall Study||303||
48115199|NCT01516879|100608471|FG001|STARTED|Overall Study||602||
48115200|NCT01516879|100608470|FG000|Received Treatment|Overall Study||302||
48115201|NCT01516879|100608471|FG001|Received Treatment|Overall Study||599||
48115202|NCT01516879|100608470|FG000|COMPLETED|Overall Study||287||
48115203|NCT01516879|100608471|FG001|COMPLETED|Overall Study||568||
48115204|NCT01516879|100608470|FG000|NOT COMPLETED|Overall Study||16||
48115205|NCT01516879|100608471|FG001|NOT COMPLETED|Overall Study||34||
48115206|NCT01868633|100608472|FG000|STARTED|Overall Study||26||
48115207|NCT01868633|100608473|FG001|STARTED|Overall Study||26||
48115208|NCT01868633|100608472|FG000|COMPLETED|Overall Study||26||
48115209|NCT01868633|100608473|FG001|COMPLETED|Overall Study||26||
48115210|NCT01868633|100608472|FG000|NOT COMPLETED|Overall Study||0||
48115211|NCT01868633|100608473|FG001|NOT COMPLETED|Overall Study||0||
48115212|NCT04070833|100608474|FG000|STARTED|Overall Study||66||
48115213|NCT04070833|100608475|FG001|STARTED|Overall Study||75||
48115214|NCT04070833|100608476|FG002|STARTED|Overall Study||82||
48115215|NCT04070833|100608477|FG003|STARTED|Overall Study||67||
48115216|NCT04070833|100608474|FG000|COMPLETED|Overall Study||58||
48115217|NCT04070833|100608475|FG001|COMPLETED|Overall Study||69||
48115218|NCT04070833|100608476|FG002|COMPLETED|Overall Study||71||
48115219|NCT04070833|100608477|FG003|COMPLETED|Overall Study||60||
48115220|NCT04070833|100608474|FG000|NOT COMPLETED|Overall Study||8||
48115221|NCT04070833|100608475|FG001|NOT COMPLETED|Overall Study||6||
48115222|NCT04070833|100608476|FG002|NOT COMPLETED|Overall Study||11||
48115223|NCT04070833|100608477|FG003|NOT COMPLETED|Overall Study||7||
48115224|NCT01558700|100608478|FG000|STARTED|Overall Study||19||
48115225|NCT01558700|100608479|FG001|STARTED|Overall Study||21||
48115226|NCT01558700|100608478|FG000|COMPLETED|Overall Study||19||
48115227|NCT01558700|100608479|FG001|COMPLETED|Overall Study||21||
48115228|NCT01558700|100608478|FG000|NOT COMPLETED|Overall Study||0||
48115229|NCT01558700|100608479|FG001|NOT COMPLETED|Overall Study||0||
48115230|NCT00589108|100608480|FG000|STARTED|Overall Study||80||
48115231|NCT00589108|100608481|FG001|STARTED|Overall Study||80||
48115232|NCT00589108|100608482|FG002|STARTED|Overall Study||80||
48115233|NCT00589108|100608480|FG000|COMPLETED|Overall Study||76||
48115234|NCT00589108|100608481|FG001|COMPLETED|Overall Study||76||
48115235|NCT00589108|100608482|FG002|COMPLETED|Overall Study||75||
48115236|NCT00589108|100608480|FG000|NOT COMPLETED|Overall Study||4||
48115237|NCT00589108|100608481|FG001|NOT COMPLETED|Overall Study||4||
48115238|NCT00589108|100608482|FG002|NOT COMPLETED|Overall Study||5||
48115239|NCT02141516|100608483|FG000|STARTED|Overall Study||40||
48115240|NCT02141516|100608484|FG001|STARTED|Overall Study||112||
48115241|NCT02141516|100608485|FG002|STARTED|Overall Study||87||
48115242|NCT02141516|100608483|FG000|COMPLETED|Overall Study||40||
48115243|NCT02141516|100608484|FG001|COMPLETED|Overall Study||107||
48115244|NCT02141516|100608485|FG002|COMPLETED|Overall Study||87||
48115245|NCT02141516|100608483|FG000|NOT COMPLETED|Overall Study||0||
48115246|NCT02141516|100608484|FG001|NOT COMPLETED|Overall Study||5||
48115247|NCT02141516|100608485|FG002|NOT COMPLETED|Overall Study||0||
48115248|NCT02219815|100608486|FG000|STARTED|Overall Study||44||
48115249|NCT02219815|100608487|FG001|STARTED|Overall Study||45||
48115250|NCT02219815|100608486|FG000|Post Hospital Discharge Analysis|Overall Study||42|The study analysis for the primary outcome was based on this milestone. Post discharge is defined as completed surgery and discharged from hospital. This would complete the requirement for our analysis.|
48115251|NCT02219815|100608487|FG001|Post Hospital Discharge Analysis|Overall Study||39|The study analysis for the primary outcome was based on this milestone. Post discharge is defined as completed surgery and discharged from hospital. This would complete the requirement for our analysis.|
48115252|NCT02219815|100608486|FG000|3 Month Post Surgery|Overall Study||34||
48115253|NCT02219815|100608487|FG001|3 Month Post Surgery|Overall Study||31||
48115254|NCT02219815|100608486|FG000|COMPLETED|Overall Study||22||
48115255|NCT02219815|100608487|FG001|COMPLETED|Overall Study||21||
48115256|NCT02219815|100608486|FG000|NOT COMPLETED|Overall Study||22||
48115257|NCT02219815|100608487|FG001|NOT COMPLETED|Overall Study||24||
48115258|NCT00322335|100608488|FG000|STARTED|Subjects 18 Months After Booster Dose||58||
48115259|NCT00322335|100608489|FG001|STARTED|Subjects 18 Months After Booster Dose||123||
48115260|NCT00322335|100608490|FG002|STARTED|Subjects 18 Months After Booster Dose||3||
48115261|NCT00322335|100608488|FG000|COMPLETED|Subjects 18 Months After Booster Dose||58||
48115262|NCT00322335|100608489|FG001|COMPLETED|Subjects 18 Months After Booster Dose||123||
48115263|NCT00322335|100608490|FG002|COMPLETED|Subjects 18 Months After Booster Dose||3||
48115264|NCT00322335|100608488|FG000|NOT COMPLETED|Subjects 18 Months After Booster Dose||0||
48115265|NCT00322335|100608489|FG001|NOT COMPLETED|Subjects 18 Months After Booster Dose||0||
48115266|NCT00322335|100608490|FG002|NOT COMPLETED|Subjects 18 Months After Booster Dose||0||
48115267|NCT00322335|100608488|FG000|STARTED|Subjects 30 Months After Booster Dose||54||
48115268|NCT00322335|100608489|FG001|STARTED|Subjects 30 Months After Booster Dose||119||
48115269|NCT00322335|100608490|FG002|STARTED|Subjects 30 Months After Booster Dose||57||
48115270|NCT00322335|100608488|FG000|COMPLETED|Subjects 30 Months After Booster Dose||54||
48115271|NCT00322335|100608489|FG001|COMPLETED|Subjects 30 Months After Booster Dose||119||
48115272|NCT00322335|100608490|FG002|COMPLETED|Subjects 30 Months After Booster Dose||57||
48115273|NCT00322335|100608488|FG000|NOT COMPLETED|Subjects 30 Months After Booster Dose||0||
48115274|NCT00322335|100608489|FG001|NOT COMPLETED|Subjects 30 Months After Booster Dose||0||
48115275|NCT00322335|100608490|FG002|NOT COMPLETED|Subjects 30 Months After Booster Dose||0||
48115276|NCT00322335|100608488|FG000|STARTED|Subjects 42 Months After Booster Dose||51||
48115277|NCT00322335|100608489|FG001|STARTED|Subjects 42 Months After Booster Dose||113||
48115278|NCT00322335|100608490|FG002|STARTED|Subjects 42 Months After Booster Dose||56||
48115279|NCT00322335|100608488|FG000|COMPLETED|Subjects 42 Months After Booster Dose||51||
48115280|NCT00322335|100608489|FG001|COMPLETED|Subjects 42 Months After Booster Dose||113||
48115281|NCT00322335|100608490|FG002|COMPLETED|Subjects 42 Months After Booster Dose||56||
48115282|NCT00322335|100608488|FG000|NOT COMPLETED|Subjects 42 Months After Booster Dose||0||
48115283|NCT00322335|100608489|FG001|NOT COMPLETED|Subjects 42 Months After Booster Dose||0||
48115284|NCT00322335|100608490|FG002|NOT COMPLETED|Subjects 42 Months After Booster Dose||0||
48115285|NCT00322335|100608488|FG000|STARTED|Subjects 54 Months After Booster Dose||50||
48115286|NCT00322335|100608489|FG001|STARTED|Subjects 54 Months After Booster Dose||108||
48115287|NCT00322335|100608490|FG002|STARTED|Subjects 54 Months After Booster Dose||56||
48115288|NCT00322335|100608488|FG000|COMPLETED|Subjects 54 Months After Booster Dose||50||
48115289|NCT00322335|100608489|FG001|COMPLETED|Subjects 54 Months After Booster Dose||108||
48115290|NCT00322335|100608490|FG002|COMPLETED|Subjects 54 Months After Booster Dose||56||
48115291|NCT00322335|100608488|FG000|NOT COMPLETED|Subjects 54 Months After Booster Dose||0||
48115292|NCT00322335|100608489|FG001|NOT COMPLETED|Subjects 54 Months After Booster Dose||0||
48115293|NCT00322335|100608490|FG002|NOT COMPLETED|Subjects 54 Months After Booster Dose||0||
48115294|NCT00322335|100608488|FG000|STARTED|Subjects 66 Months After Booster Dose||48||
48115295|NCT00322335|100608489|FG001|STARTED|Subjects 66 Months After Booster Dose||104||
48115296|NCT00322335|100608490|FG002|STARTED|Subjects 66 Months After Booster Dose||53||
48115297|NCT00322335|100608488|FG000|COMPLETED|Subjects 66 Months After Booster Dose||48||
48115298|NCT00322335|100608489|FG001|COMPLETED|Subjects 66 Months After Booster Dose||104||
48115299|NCT00322335|100608490|FG002|COMPLETED|Subjects 66 Months After Booster Dose||53||
48115300|NCT00322335|100608488|FG000|NOT COMPLETED|Subjects 66 Months After Booster Dose||0||
48115301|NCT00322335|100608489|FG001|NOT COMPLETED|Subjects 66 Months After Booster Dose||0||
48115302|NCT00322335|100608490|FG002|NOT COMPLETED|Subjects 66 Months After Booster Dose||0||
48115303|NCT01205165|100608491|FG000|STARTED|Overall Study||104||
48115304|NCT01205165|100608491|FG000|COMPLETED|Overall Study||102||
48115305|NCT01205165|100608491|FG000|NOT COMPLETED|Overall Study||2||
48115306|NCT00720876|100608492|FG000|STARTED|Overall Study||30||
48115307|NCT00720876|100608492|FG000|COMPLETED|Overall Study||28||
48115308|NCT00720876|100608492|FG000|NOT COMPLETED|Overall Study||2||
48115309|NCT01910064|100608493|FG000|STARTED|Overall Study||436||
48115310|NCT01910064|100608493|FG000|COMPLETED|Overall Study||391||
48115311|NCT01910064|100608493|FG000|NOT COMPLETED|Overall Study||45||
48115312|NCT01234467|100608494|FG000|STARTED|Overall Study||23||
48115313|NCT01234467|100608494|FG000|COMPLETED|Overall Study||11||
48115314|NCT01234467|100608494|FG000|NOT COMPLETED|Overall Study||12||
48115315|NCT04300296|100608495|FG000|STARTED|Treatment Period 1: Baseline to 16 Weeks||25||
48115316|NCT04300296|100608496|FG001|STARTED|Treatment Period 1: Baseline to 16 Weeks||12||
48115317|NCT04300296|100608497|FG002|STARTED|Treatment Period 1: Baseline to 16 Weeks||24||
48115318|NCT04300296|100608498|FG003|STARTED|Treatment Period 1: Baseline to 16 Weeks||13||
48115319|NCT04300296|100608499|FG004|STARTED|Treatment Period 1: Baseline to 16 Weeks||24||
48115320|NCT04300296|100608500|FG005|STARTED|Treatment Period 1: Baseline to 16 Weeks||13||
48115321|NCT04300296|100608495|FG000|Placebo Responder|Treatment Period 1: Baseline to 16 Weeks||0||
48115322|NCT04300296|100608496|FG001|Placebo Responder|Treatment Period 1: Baseline to 16 Weeks||1||
48115323|NCT04300296|100608497|FG002|Placebo Responder|Treatment Period 1: Baseline to 16 Weeks||0||
48115324|NCT04300296|100608498|FG003|Placebo Responder|Treatment Period 1: Baseline to 16 Weeks||1||
48115325|NCT04300296|100608499|FG004|Placebo Responder|Treatment Period 1: Baseline to 16 Weeks||0||
48115326|NCT04300296|100608500|FG005|Placebo Responder|Treatment Period 1: Baseline to 16 Weeks||0||
48115327|NCT04300296|100608495|FG000|COMPLETED|Treatment Period 1: Baseline to 16 Weeks||23||
48115328|NCT04300296|100608496|FG001|COMPLETED|Treatment Period 1: Baseline to 16 Weeks||10||
48115329|NCT04300296|100608497|FG002|COMPLETED|Treatment Period 1: Baseline to 16 Weeks||24||
48115330|NCT04300296|100608498|FG003|COMPLETED|Treatment Period 1: Baseline to 16 Weeks||13||
48115331|NCT04300296|100608499|FG004|COMPLETED|Treatment Period 1: Baseline to 16 Weeks||23||
48115332|NCT04300296|100608500|FG005|COMPLETED|Treatment Period 1: Baseline to 16 Weeks||12||
48115333|NCT04300296|100608495|FG000|NOT COMPLETED|Treatment Period 1: Baseline to 16 Weeks||2||
48115334|NCT04300296|100608496|FG001|NOT COMPLETED|Treatment Period 1: Baseline to 16 Weeks||2||
48115335|NCT04300296|100608497|FG002|NOT COMPLETED|Treatment Period 1: Baseline to 16 Weeks||0||
48115336|NCT04300296|100608498|FG003|NOT COMPLETED|Treatment Period 1: Baseline to 16 Weeks||0||
48115337|NCT04300296|100608499|FG004|NOT COMPLETED|Treatment Period 1: Baseline to 16 Weeks||1||
48115338|NCT04300296|100608500|FG005|NOT COMPLETED|Treatment Period 1: Baseline to 16 Weeks||1||
48115339|NCT04300296|100608495|FG000|STARTED|Treatment Period 2: 16 to 32 Weeks||22||
48115340|NCT04300296|100608496|FG001|STARTED|Treatment Period 2: 16 to 32 Weeks||8||
48115341|NCT04300296|100608497|FG002|STARTED|Treatment Period 2: 16 to 32 Weeks||23||
48115342|NCT04300296|100608498|FG003|STARTED|Treatment Period 2: 16 to 32 Weeks||11||
48115343|NCT04300296|100608499|FG004|STARTED|Treatment Period 2: 16 to 32 Weeks||23||
48115344|NCT04300296|100608500|FG005|STARTED|Treatment Period 2: 16 to 32 Weeks||12||
48115345|NCT04300296|100608495|FG000|COMPLETED|Treatment Period 2: 16 to 32 Weeks||17||
48115346|NCT04300296|100608496|FG001|COMPLETED|Treatment Period 2: 16 to 32 Weeks||7||
48115347|NCT04300296|100608497|FG002|COMPLETED|Treatment Period 2: 16 to 32 Weeks||19||
48115348|NCT04300296|100608498|FG003|COMPLETED|Treatment Period 2: 16 to 32 Weeks||10||
48115349|NCT04300296|100608499|FG004|COMPLETED|Treatment Period 2: 16 to 32 Weeks||17||
48278133|NCT05384938|101003247|FG000|COMPLETED|Overall Study||124||
48278134|NCT05384938|101003247|FG000|NOT COMPLETED|Overall Study||15||
48278135|NCT01911390|101003248|FG000|STARTED|Overall Study||10||
48278136|NCT01911390|101003249|FG001|STARTED|Overall Study||10||
48278137|NCT01911390|101003250|FG002|STARTED|Overall Study||10||
48115350|NCT04300296|100608500|FG005|COMPLETED|Treatment Period 2: 16 to 32 Weeks||12||
48115351|NCT04300296|100608495|FG000|NOT COMPLETED|Treatment Period 2: 16 to 32 Weeks||5||
48115352|NCT04300296|100608496|FG001|NOT COMPLETED|Treatment Period 2: 16 to 32 Weeks||1||
48115353|NCT04300296|100608497|FG002|NOT COMPLETED|Treatment Period 2: 16 to 32 Weeks||4||
48115354|NCT04300296|100608498|FG003|NOT COMPLETED|Treatment Period 2: 16 to 32 Weeks||1||
48115355|NCT04300296|100608499|FG004|NOT COMPLETED|Treatment Period 2: 16 to 32 Weeks||6||
48115356|NCT04300296|100608500|FG005|NOT COMPLETED|Treatment Period 2: 16 to 32 Weeks||0||
48115357|NCT03075644|100608501|FG000|STARTED|Overall Study||16||
48115358|NCT03075644|100608502|FG001|STARTED|Overall Study||46||
48115359|NCT03075644|100608501|FG000|Full Analysis Set (FAS)|Overall Study||16||
48115360|NCT03075644|100608502|FG001|Full Analysis Set (FAS)|Overall Study||46||
48115361|NCT03075644|100608501|FG000|Safety Analysis Set (SAS)|Overall Study||16||
48115362|NCT03075644|100608502|FG001|Safety Analysis Set (SAS)|Overall Study||46||
48115363|NCT03075644|100608501|FG000|COMPLETED|Overall Study||15||
48115364|NCT03075644|100608502|FG001|COMPLETED|Overall Study||45||
48115365|NCT03075644|100608501|FG000|NOT COMPLETED|Overall Study||1||
48115366|NCT03075644|100608502|FG001|NOT COMPLETED|Overall Study||1||
48115367|NCT01054703|100608503|FG000|STARTED|Overall Study||14||
48115368|NCT01054703|100608503|FG000|COMPLETED|Overall Study||14||
48115369|NCT01054703|100608503|FG000|NOT COMPLETED|Overall Study||0||
48115370|NCT01705288|100608504|FG000|STARTED|Overall Study||52||
48278138|NCT01911390|101003251|FG003|STARTED|Overall Study||11||
48278139|NCT01911390|101003248|FG000|COMPLETED|Overall Study||9||
48278140|NCT01911390|101003249|FG001|COMPLETED|Overall Study||10||
48278141|NCT01911390|101003250|FG002|COMPLETED|Overall Study||9||
48278142|NCT01911390|101003251|FG003|COMPLETED|Overall Study||10||
48278143|NCT01911390|101003248|FG000|NOT COMPLETED|Overall Study||1||
48278144|NCT01911390|101003249|FG001|NOT COMPLETED|Overall Study||0||
48278145|NCT01911390|101003250|FG002|NOT COMPLETED|Overall Study||1||
48278146|NCT01911390|101003251|FG003|NOT COMPLETED|Overall Study||1||
48278147|NCT02559895|101003252|FG000|STARTED|Overall Study||224||
48278148|NCT02559895|101003253|FG001|STARTED|Overall Study||225||
48278149|NCT02559895|101003254|FG002|STARTED|Overall Study||224||
48278150|NCT02559895|101003255|FG003|STARTED|Overall Study||225||
48278151|NCT02559895|101003252|FG000|Participants Treated|Overall Study||222|2 participants received duplicate randomization, participants are summarized in first group assigned|
48278152|NCT02559895|101003253|FG001|Participants Treated|Overall Study||221|2 participants received duplicate randomization, participants are summarized in first group assigned|
48115371|NCT01705288|100608505|FG001|STARTED|Overall Study||51||
48697233|NCT03938103|102041923|FG001|STARTED|Center Directors||49|Periods in this flow represent groups of child care directors recruited within centers.|42
48697234|NCT03938103|102041922|FG000|COMPLETED|Center Directors||48||48
48697235|NCT03938103|102041923|FG001|COMPLETED|Center Directors||36||39
48697236|NCT03938103|102041922|FG000|NOT COMPLETED|Center Directors||17||7
48697237|NCT03938103|102041923|FG001|NOT COMPLETED|Center Directors||13||3
48697238|NCT03938103|102041922|FG000|STARTED|Center Staff||128|Periods in this flow represent groups of child care staff recruited within centers.|55
48697239|NCT03938103|102041923|FG001|STARTED|Center Staff||95|Periods in this flow represent groups of child care staff recruited within centers.|42
48697240|NCT03938103|102041922|FG000|COMPLETED|Center Staff||73||48
48697241|NCT03938103|102041923|FG001|COMPLETED|Center Staff||60||39
48697242|NCT03938103|102041922|FG000|NOT COMPLETED|Center Staff||55||7
48697243|NCT03938103|102041923|FG001|NOT COMPLETED|Center Staff||35||3
48115372|NCT01705288|100608504|FG000|COMPLETED|Overall Study||52||
48115373|NCT01705288|100608505|FG001|COMPLETED|Overall Study||51||
48115374|NCT01705288|100608504|FG000|NOT COMPLETED|Overall Study||0||
48278153|NCT02559895|101003254|FG002|Participants Treated|Overall Study||223|2 participants received duplicate randomization, participants are summarized in first group assigned|
48278154|NCT02559895|101003255|FG003|Participants Treated|Overall Study||222|2 participants received duplicate randomization, participants are summarized in first group assigned|
48115375|NCT01705288|100608505|FG001|NOT COMPLETED|Overall Study||0||
48115376|NCT03567850|100608506|FG000|STARTED|Overall Study||25||
48115377|NCT03567850|100608507|FG001|STARTED|Overall Study||25||
48115378|NCT03567850|100608506|FG000|COMPLETED|Overall Study||25||
48115379|NCT03567850|100608507|FG001|COMPLETED|Overall Study||25||
48115380|NCT03567850|100608506|FG000|NOT COMPLETED|Overall Study||0||
48115381|NCT03567850|100608507|FG001|NOT COMPLETED|Overall Study||0||
48115382|NCT03364049|100608508|FG000|STARTED|Overall Study||6||
48115383|NCT03364049|100608509|FG001|STARTED|Overall Study||6||
48115384|NCT03364049|100608510|FG002|STARTED|Overall Study||6||
48115385|NCT03364049|100608511|FG003|STARTED|Overall Study||15||
48115386|NCT03364049|100608508|FG000|COMPLETED|Overall Study||0||
48115387|NCT03364049|100608509|FG001|COMPLETED|Overall Study||0||
48115388|NCT03364049|100608510|FG002|COMPLETED|Overall Study||0||
48115389|NCT03364049|100608511|FG003|COMPLETED|Overall Study||0||
48115390|NCT03364049|100608508|FG000|NOT COMPLETED|Overall Study||6||
48115391|NCT03364049|100608509|FG001|NOT COMPLETED|Overall Study||6||
48115392|NCT03364049|100608510|FG002|NOT COMPLETED|Overall Study||6||
48115393|NCT03364049|100608511|FG003|NOT COMPLETED|Overall Study||15||
48115394|NCT01706250|100608512|FG000|STARTED|Overall Study||20||
48115395|NCT01706250|100608512|FG000|COMPLETED|Overall Study||18||
48115396|NCT01706250|100608512|FG000|NOT COMPLETED|Overall Study||2||
48115397|NCT00577122|100608513|FG000|STARTED|Overall Study||14||
48115398|NCT00577122|100608514|FG001|STARTED|Overall Study||16||
48115399|NCT00577122|100608513|FG000|COMPLETED|Overall Study||0||
48115400|NCT00577122|100608514|FG001|COMPLETED|Overall Study||0||
48115401|NCT00577122|100608513|FG000|NOT COMPLETED|Overall Study||14||
48115402|NCT00577122|100608514|FG001|NOT COMPLETED|Overall Study||16||
48115403|NCT00494494|100608515|FG000|STARTED|Overall Study||40||
48115404|NCT00494494|100608516|FG001|STARTED|Overall Study||39||
48115405|NCT00494494|100608515|FG000|COMPLETED|Overall Study||40||
48115406|NCT00494494|100608516|FG001|COMPLETED|Overall Study||39||
48115407|NCT00494494|100608515|FG000|NOT COMPLETED|Overall Study||0||
48115408|NCT00494494|100608516|FG001|NOT COMPLETED|Overall Study||0||
48115409|NCT00458484|100608517|FG000|STARTED|Overall Study||4||
48115410|NCT00458484|100608518|FG001|STARTED|Overall Study||6||
48115411|NCT00458484|100608519|FG002|STARTED|Overall Study||3||
48115412|NCT00458484|100608520|FG003|STARTED|Overall Study||6||
48115413|NCT00458484|100608521|FG004|STARTED|Overall Study||4||
48115414|NCT00458484|100608522|FG005|STARTED|Overall Study||5||
48115415|NCT00458484|100608523|FG006|STARTED|Overall Study||3||
48115416|NCT00458484|100608517|FG000|COMPLETED|Overall Study||4||
48115417|NCT00458484|100608518|FG001|COMPLETED|Overall Study||6||
48115418|NCT00458484|100608519|FG002|COMPLETED|Overall Study||3||
48115419|NCT00458484|100608520|FG003|COMPLETED|Overall Study||6||
48115420|NCT00458484|100608521|FG004|COMPLETED|Overall Study||4||
48115421|NCT00458484|100608522|FG005|COMPLETED|Overall Study||4||
48115422|NCT00458484|100608523|FG006|COMPLETED|Overall Study||3||
48115423|NCT00458484|100608517|FG000|NOT COMPLETED|Overall Study||0||
48115424|NCT00458484|100608518|FG001|NOT COMPLETED|Overall Study||0||
48278155|NCT02559895|101003252|FG000|COMPLETED|Overall Study||169||
48278156|NCT02559895|101003253|FG001|COMPLETED|Overall Study||172||
48278157|NCT02559895|101003254|FG002|COMPLETED|Overall Study||170||
48697244|NCT02684058|102041924|FG000|STARTED|Treatment Period||73||
48697245|NCT02684058|102041925|FG001|STARTED|Treatment Period||37||
48697246|NCT02684058|102041926|FG002|STARTED|Treatment Period||41||
48697247|NCT02684058|102041924|FG000|Treated|Treatment Period||73||
48278158|NCT02559895|101003255|FG003|COMPLETED|Overall Study||165||
48278159|NCT02559895|101003252|FG000|NOT COMPLETED|Overall Study||55||
48278160|NCT02559895|101003253|FG001|NOT COMPLETED|Overall Study||53||
48278161|NCT02559895|101003254|FG002|NOT COMPLETED|Overall Study||54||
48278162|NCT02559895|101003255|FG003|NOT COMPLETED|Overall Study||60||
48278163|NCT04958200|101003256|FG000|STARTED|Overall Study||24||
48278164|NCT04958200|101003257|FG001|STARTED|Overall Study||24||
48278165|NCT04958200|101003256|FG000|COMPLETED|Overall Study||21||
48278166|NCT04958200|101003257|FG001|COMPLETED|Overall Study||20||
48278167|NCT04958200|101003256|FG000|NOT COMPLETED|Overall Study||3||
48278168|NCT04958200|101003257|FG001|NOT COMPLETED|Overall Study||4||
48278169|NCT04548544|101003258|FG000|STARTED|Overall Study||12||
48697248|NCT02684058|102041925|FG001|Treated|Treatment Period||33||
48115425|NCT00458484|100608519|FG002|NOT COMPLETED|Overall Study||0||
48115426|NCT00458484|100608520|FG003|NOT COMPLETED|Overall Study||0||
48115427|NCT00458484|100608521|FG004|NOT COMPLETED|Overall Study||0||
48115428|NCT00458484|100608522|FG005|NOT COMPLETED|Overall Study||1||
48115429|NCT00458484|100608523|FG006|NOT COMPLETED|Overall Study||0||
48115430|NCT02402452|100608524|FG000|STARTED|Overall Study||10||
48115431|NCT02402452|100608525|FG001|STARTED|Overall Study||10||
48115432|NCT02402452|100608524|FG000|COMPLETED|Overall Study||10||
48115433|NCT02402452|100608525|FG001|COMPLETED|Overall Study||10||
48115434|NCT02402452|100608524|FG000|NOT COMPLETED|Overall Study||0||
48115435|NCT02402452|100608525|FG001|NOT COMPLETED|Overall Study||0||
48278170|NCT04548544|101003259|FG001|STARTED|Overall Study||9||
48278171|NCT04548544|101003258|FG000|COMPLETED|Overall Study||12||
48278172|NCT04548544|101003259|FG001|COMPLETED|Overall Study||9||
48278173|NCT04548544|101003258|FG000|NOT COMPLETED|Overall Study||0||
48697249|NCT02684058|102041926|FG002|Treated|Treatment Period||41||
48115436|NCT02043015|100608526|FG000|STARTED|Overall Study||115||
48115437|NCT02043015|100608526|FG000|COMPLETED|Overall Study||87||
48115438|NCT02043015|100608526|FG000|NOT COMPLETED|Overall Study||28||
48115439|NCT01430585|100608527|FG000|STARTED|Overall Study||14||
48115440|NCT01430585|100608527|FG000|COMPLETED|Overall Study||0||
48115441|NCT01430585|100608527|FG000|NOT COMPLETED|Overall Study||14||
48115442|NCT00353366|100608528|FG000|STARTED|Overall Study||1439||
48115443|NCT00353366|100608528|FG000|COMPLETED|Overall Study||1296||
48115444|NCT00353366|100608528|FG000|NOT COMPLETED|Overall Study||143||
48115445|NCT03265119|100608529|FG000|STARTED|Overall Study||34||
48115446|NCT03265119|100608530|FG001|STARTED|Overall Study||35||
48115447|NCT03265119|100608529|FG000|COMPLETED|Overall Study||24||
48115448|NCT03265119|100608530|FG001|COMPLETED|Overall Study||28||
48115449|NCT03265119|100608529|FG000|NOT COMPLETED|Overall Study||10||
48115450|NCT03265119|100608530|FG001|NOT COMPLETED|Overall Study||7||
48115451|NCT00571259|100608531|FG000|STARTED|Overall Study||148||
48115452|NCT00571259|100608532|FG001|STARTED|Overall Study||155||
48115453|NCT00571259|100608531|FG000|COMPLETED|Overall Study||4||
48115454|NCT00571259|100608532|FG001|COMPLETED|Overall Study||14||
48115455|NCT00571259|100608531|FG000|NOT COMPLETED|Overall Study||144||
48115456|NCT00571259|100608532|FG001|NOT COMPLETED|Overall Study||141||
48115457|NCT01037790|100608533|FG000|STARTED|Overall Study||63||
48115458|NCT01037790|100608534|FG001|STARTED|Overall Study||18||
48115459|NCT01037790|100608535|FG002|STARTED|Overall Study||19||
48115460|NCT01037790|100608536|FG003|STARTED|Overall Study||30||
48115461|NCT01037790|100608537|FG004|STARTED|Overall Study||11||
48115462|NCT01037790|100608533|FG000|COMPLETED|Overall Study||63||
48115463|NCT01037790|100608534|FG001|COMPLETED|Overall Study||18||
48115464|NCT01037790|100608535|FG002|COMPLETED|Overall Study||19||
48115465|NCT01037790|100608536|FG003|COMPLETED|Overall Study||30||
48115466|NCT01037790|100608537|FG004|COMPLETED|Overall Study||11||
48115467|NCT01037790|100608533|FG000|NOT COMPLETED|Overall Study||0||
48115468|NCT01037790|100608534|FG001|NOT COMPLETED|Overall Study||0||
48115469|NCT01037790|100608535|FG002|NOT COMPLETED|Overall Study||0||
48115470|NCT01037790|100608536|FG003|NOT COMPLETED|Overall Study||0||
48115471|NCT01037790|100608537|FG004|NOT COMPLETED|Overall Study||0||
48115472|NCT00433992|100608538|FG000|STARTED|Overall Study||28||
48115473|NCT00433992|100608539|FG001|STARTED|Overall Study||28||
48115474|NCT00433992|100608538|FG000|COMPLETED|Overall Study||19||
48115475|NCT00433992|100608539|FG001|COMPLETED|Overall Study||20||
48115476|NCT00433992|100608538|FG000|NOT COMPLETED|Overall Study||9||
48115477|NCT00433992|100608539|FG001|NOT COMPLETED|Overall Study||8||
48115478|NCT00578565|100608540|FG000|STARTED|Overall Study||10||
48115479|NCT00578565|100608540|FG000|COMPLETED|Overall Study||7||
48115480|NCT00578565|100608540|FG000|NOT COMPLETED|Overall Study||3||
48115481|NCT01451424|100608541|FG000|STARTED|Overall Study||9||
48115482|NCT01451424|100608542|FG001|STARTED|Overall Study||9||
48115483|NCT01451424|100608543|FG002|STARTED|Overall Study||12||
48115484|NCT01451424|100608544|FG003|STARTED|Overall Study||10||
48115485|NCT01451424|100608541|FG000|COMPLETED|Overall Study||8||
48115486|NCT01451424|100608542|FG001|COMPLETED|Overall Study||7||
48115487|NCT01451424|100608543|FG002|COMPLETED|Overall Study||11||
48115488|NCT01451424|100608544|FG003|COMPLETED|Overall Study||5||
48697250|NCT02684058|102041924|FG000|COMPLETED|Treatment Period||56||
48697251|NCT02684058|102041925|FG001|COMPLETED|Treatment Period||14||
48697252|NCT02684058|102041926|FG002|COMPLETED|Treatment Period||17||
48697253|NCT02684058|102041924|FG000|NOT COMPLETED|Treatment Period||17||
48115489|NCT01451424|100608541|FG000|NOT COMPLETED|Overall Study||1||
48115490|NCT01451424|100608542|FG001|NOT COMPLETED|Overall Study||2||
48697254|NCT02684058|102041925|FG001|NOT COMPLETED|Treatment Period||23||
48115491|NCT01451424|100608543|FG002|NOT COMPLETED|Overall Study||1||
48115492|NCT01451424|100608544|FG003|NOT COMPLETED|Overall Study||5||
48115493|NCT02907359|100608545|FG000|STARTED|Overall Study||277|The Efficacy Analysis Set included all participants randomly assigned to the study treatment.|
48115494|NCT02907359|100608546|FG001|STARTED|Overall Study||140|The Efficacy Analysis Set included all participants randomly assigned to the study treatment.|
48115495|NCT02907359|100608545|FG000|Safety Analysis Set|Overall Study||270|The Safety Analysis Set included all participants randomly assigned to study treatment who received any amount of study treatment or any component of a multi-dose study treatment regimen.|
48115496|NCT02907359|100608546|FG001|Safety Analysis Set|Overall Study||122|The Safety Analysis Set included all participants randomly assigned to study treatment who received any amount of study treatment or any component of a multi-dose study treatment regimen.|
48115497|NCT02907359|100608545|FG000|COMPLETED|Overall Study||36||
48115498|NCT02907359|100608546|FG001|COMPLETED|Overall Study||12||
48115499|NCT02907359|100608545|FG000|NOT COMPLETED|Overall Study||241||
48115500|NCT02907359|100608546|FG001|NOT COMPLETED|Overall Study||128||
48115501|NCT01864291|100608547|FG000|STARTED|Overall Study||9||
48115502|NCT01864291|100608547|FG000|COMPLETED|Overall Study||7||
48115503|NCT01864291|100608547|FG000|NOT COMPLETED|Overall Study||2||
48115504|NCT01121211|100608548|FG000|STARTED|Overall Study||43||
48115505|NCT01121211|100608549|FG001|STARTED|Overall Study||47||
48115506|NCT01121211|100608548|FG000|COMPLETED|Overall Study||32||
48697255|NCT02684058|102041926|FG002|NOT COMPLETED|Treatment Period||24||
48115507|NCT01121211|100608549|FG001|COMPLETED|Overall Study||35||
48115508|NCT01121211|100608548|FG000|NOT COMPLETED|Overall Study||11||
48115509|NCT01121211|100608549|FG001|NOT COMPLETED|Overall Study||12||
48115510|NCT02553421|100608550|FG000|STARTED|Overall Study||185||
48115511|NCT02553421|100608551|FG001|STARTED|Overall Study||58||
48115512|NCT02553421|100608550|FG000|COMPLETED|Overall Study||156||
48115513|NCT02553421|100608551|FG001|COMPLETED|Overall Study||57||
48115514|NCT02553421|100608550|FG000|NOT COMPLETED|Overall Study||29||
48115515|NCT02553421|100608551|FG001|NOT COMPLETED|Overall Study||1||
48115516|NCT00646204|100608552|FG000|STARTED|Overall Study||20||
48115517|NCT00646204|100608553|FG001|STARTED|Overall Study||20||
48115518|NCT00646204|100608552|FG000|COMPLETED|Overall Study||16||
48115519|NCT00646204|100608553|FG001|COMPLETED|Overall Study||20||
48115520|NCT00646204|100608552|FG000|NOT COMPLETED|Overall Study||4||
48115521|NCT00646204|100608553|FG001|NOT COMPLETED|Overall Study||0||
48115522|NCT01018420|100608554|FG000|STARTED|Overall Study||15||
48115523|NCT01018420|100608555|FG001|STARTED|Overall Study||3||
48115524|NCT01018420|100608554|FG000|COMPLETED|Overall Study||15||
48115525|NCT01018420|100608555|FG001|COMPLETED|Overall Study||3||
48115526|NCT01018420|100608554|FG000|NOT COMPLETED|Overall Study||0||
48115527|NCT01018420|100608555|FG001|NOT COMPLETED|Overall Study||0||
48115528|NCT04171414|100608556|FG000|STARTED|Overall Study||62||
48115529|NCT04171414|100608556|FG000|COMPLETED|Overall Study||60||
48115530|NCT04171414|100608556|FG000|NOT COMPLETED|Overall Study||2||
48115531|NCT04409041|100608557|FG000|STARTED|Overall Study||43||
48115532|NCT04409041|100608557|FG000|COMPLETED|Overall Study||26||
48278174|NCT04548544|101003259|FG001|NOT COMPLETED|Overall Study||0||
48278175|NCT05038800|101003260|FG000|STARTED|Overall Study||1||
48278176|NCT05038800|101003261|FG001|STARTED|Overall Study||1||
48278177|NCT05038800|101003262|FG002|STARTED|Overall Study||5||
48278178|NCT05038800|101003263|FG003|STARTED|Overall Study||3||
48278179|NCT05038800|101003264|FG004|STARTED|Overall Study||3||
48278180|NCT05038800|101003260|FG000|Treated|Overall Study||1||
48278181|NCT05038800|101003261|FG001|Treated|Overall Study||1||
48278182|NCT05038800|101003262|FG002|Treated|Overall Study||5||
48394262|NCT00617591|101295899|FG000|NOT COMPLETED|Overall Study||10||
48563826|NCT02375971|101713802|FG001|STARTED|Treatment (Day 1 - Baseline)||77|All randomized patients to whom treatment had been assigned (FAS)|
48563827|NCT02375971|101713803|FG002|STARTED|Treatment (Day 1 - Baseline)||74|All randomized patients to whom treatment had been assigned (FAS)|
48563828|NCT02375971|101713801|FG000|Safety Set|Treatment (Day 1 - Baseline)||73|At least 1 application of investigational treatment and a 1 post baseline safety assessment|
48563829|NCT02375971|101713802|FG001|Safety Set|Treatment (Day 1 - Baseline)||76|At least 1 application of investigational treatment and a 1 post baseline safety assessment|
48563830|NCT02375971|101713803|FG002|Safety Set|Treatment (Day 1 - Baseline)||69|At least 1 application of investigational treatment and a 1 post baseline safety assessment|
48563831|NCT02375971|101713801|FG000|VEGF Set|Treatment (Day 1 - Baseline)||19|All patients who provided valid Vascular endothelial growth factor (VEGF) plasma samples|
48563832|NCT02375971|101713802|FG001|VEGF Set|Treatment (Day 1 - Baseline)||26|All patients who provided valid Vascular endothelial growth factor (VEGF) plasma samples|
48563833|NCT02375971|101713803|FG002|VEGF Set|Treatment (Day 1 - Baseline)||51|All patients who provided valid Vascular endothelial growth factor (VEGF) plasma samples|
48563834|NCT02375971|101713801|FG000|PK Set|Treatment (Day 1 - Baseline)||49|All patients who provided Pharmacokinetics (PK) serum samples|
48115533|NCT04409041|100608557|FG000|NOT COMPLETED|Overall Study||17||
48115534|NCT01420081|100608558|FG000|STARTED|Overall Study||3||
48115535|NCT01420081|100608559|FG001|STARTED|Overall Study||1||
48115536|NCT01420081|100608560|FG002|STARTED|Overall Study||11||
48115537|NCT01420081|100608561|FG003|STARTED|Overall Study||3||
48115538|NCT01420081|100608562|FG004|STARTED|Overall Study||20||
48115539|NCT01420081|100608563|FG005|STARTED|Overall Study||20||
48115540|NCT01420081|100608564|FG006|STARTED|Overall Study||3||
48115541|NCT01420081|100608565|FG007|STARTED|Overall Study||3||
48115542|NCT01420081|100608566|FG008|STARTED|Overall Study||3||
48115543|NCT01420081|100608558|FG000|COMPLETED|Overall Study||0||
48115544|NCT01420081|100608559|FG001|COMPLETED|Overall Study||0||
48115545|NCT01420081|100608560|FG002|COMPLETED|Overall Study||0||
48115546|NCT01420081|100608561|FG003|COMPLETED|Overall Study||0||
48115547|NCT01420081|100608562|FG004|COMPLETED|Overall Study||0||
48115548|NCT01420081|100608563|FG005|COMPLETED|Overall Study||0||
48115549|NCT01420081|100608564|FG006|COMPLETED|Overall Study||0||
48115550|NCT01420081|100608565|FG007|COMPLETED|Overall Study||0||
48115551|NCT01420081|100608566|FG008|COMPLETED|Overall Study||0||
48278183|NCT05038800|101003263|FG003|Treated|Overall Study||3||
48278184|NCT05038800|101003264|FG004|Treated|Overall Study||2||
48278185|NCT05038800|101003260|FG000|COMPLETED|Overall Study||0||
48278186|NCT05038800|101003261|FG001|COMPLETED|Overall Study||0||
48278187|NCT05038800|101003262|FG002|COMPLETED|Overall Study||0||
48278188|NCT05038800|101003263|FG003|COMPLETED|Overall Study||0||
48394263|NCT02700919|101295900|FG000|STARTED|Overall Study||94||
48115552|NCT01420081|100608558|FG000|NOT COMPLETED|Overall Study||3||
48115553|NCT01420081|100608559|FG001|NOT COMPLETED|Overall Study||1||
48115554|NCT01420081|100608560|FG002|NOT COMPLETED|Overall Study||11||
48115555|NCT01420081|100608561|FG003|NOT COMPLETED|Overall Study||3||
48278189|NCT05038800|101003264|FG004|COMPLETED|Overall Study||0||
48278190|NCT05038800|101003260|FG000|NOT COMPLETED|Overall Study||1||
48115556|NCT01420081|100608562|FG004|NOT COMPLETED|Overall Study||20||
48278191|NCT05038800|101003261|FG001|NOT COMPLETED|Overall Study||1||
48115557|NCT01420081|100608563|FG005|NOT COMPLETED|Overall Study||20||
48115558|NCT01420081|100608564|FG006|NOT COMPLETED|Overall Study||3||
48394264|NCT02700919|101295901|FG001|STARTED|Overall Study||97||
48394265|NCT02700919|101295902|FG002|STARTED|Overall Study||91||
48394266|NCT02700919|101295900|FG000|COMPLETED|Overall Study||82||
48394267|NCT02700919|101295901|FG001|COMPLETED|Overall Study||85||
48563835|NCT02375971|101713802|FG001|PK Set|Treatment (Day 1 - Baseline)||46|All patients who provided Pharmacokinetics (PK) serum samples|
48563836|NCT02375971|101713803|FG002|PK Set|Treatment (Day 1 - Baseline)||0|All patients who provided Pharmacokinetics (PK) serum samples|
48115559|NCT01420081|100608565|FG007|NOT COMPLETED|Overall Study||3||
48115560|NCT01420081|100608566|FG008|NOT COMPLETED|Overall Study||3||
48115561|NCT02310672|100608567|FG000|STARTED|Overall Study||87||
48115562|NCT02310672|100608567|FG000|COMPLETED|Overall Study||72||
48115563|NCT02310672|100608567|FG000|NOT COMPLETED|Overall Study||15||
48115564|NCT01860417|100608568|FG000|STARTED|Overall Study||12||
48115565|NCT01860417|100608569|FG001|STARTED|Overall Study||12||
48115566|NCT01860417|100608568|FG000|COMPLETED|Overall Study||12||
48115567|NCT01860417|100608569|FG001|COMPLETED|Overall Study||12||
48115568|NCT01860417|100608568|FG000|NOT COMPLETED|Overall Study||0||
48115569|NCT01860417|100608569|FG001|NOT COMPLETED|Overall Study||0||
48115570|NCT00858390|100608570|FG000|STARTED|Overall Study||18||
48115571|NCT00858390|100608571|FG001|STARTED|Overall Study||18||
48115572|NCT00858390|100608570|FG000|COMPLETED|Overall Study||18||
48115573|NCT00858390|100608571|FG001|COMPLETED|Overall Study||18||
48563837|NCT02375971|101713801|FG000|COMPLETED|Treatment (Day 1 - Baseline)||73|All patients who completed the treatment phase|
48563838|NCT02375971|101713802|FG001|COMPLETED|Treatment (Day 1 - Baseline)||76|All patients who completed the treatment phase|
48563839|NCT02375971|101713803|FG002|COMPLETED|Treatment (Day 1 - Baseline)||69|All patients who completed the treatment phase|
48563840|NCT02375971|101713801|FG000|NOT COMPLETED|Treatment (Day 1 - Baseline)||1||
48115574|NCT00858390|100608570|FG000|NOT COMPLETED|Overall Study||0||
48115575|NCT00858390|100608571|FG001|NOT COMPLETED|Overall Study||0||
48115576|NCT00101101|100608572|FG000|STARTED|Overall Study||43||
48115577|NCT00101101|100608572|FG000|COMPLETED|Overall Study||23||
48115578|NCT00101101|100608572|FG000|NOT COMPLETED|Overall Study||20||
48115579|NCT00689481|100608573|FG000|STARTED|Overall Study||214||
48115580|NCT00689481|100608574|FG001|STARTED|Overall Study||109||
48115581|NCT00689481|100608573|FG000|COMPLETED|Overall Study||190||
48115582|NCT00689481|100608574|FG001|COMPLETED|Overall Study||95||
48115583|NCT00689481|100608573|FG000|NOT COMPLETED|Overall Study||24||
48115584|NCT00689481|100608574|FG001|NOT COMPLETED|Overall Study||14||
48115585|NCT01333488|100608575|FG000|STARTED|Overall Study||2||
48115586|NCT01333488|100608576|FG001|STARTED|Overall Study||1||
48115587|NCT01333488|100608577|FG002|STARTED|Overall Study||3||
48115588|NCT01333488|100608575|FG000|COMPLETED|Overall Study||2||
48115589|NCT01333488|100608576|FG001|COMPLETED|Overall Study||1||
48115590|NCT01333488|100608577|FG002|COMPLETED|Overall Study||3||
48115591|NCT01333488|100608575|FG000|NOT COMPLETED|Overall Study||0||
48115592|NCT01333488|100608576|FG001|NOT COMPLETED|Overall Study||0||
48115593|NCT01333488|100608577|FG002|NOT COMPLETED|Overall Study||0||
48115594|NCT03417141|100608578|FG000|STARTED|Overall Study||12||
48115595|NCT03417141|100608578|FG000|COMPLETED|Overall Study||8||
48115596|NCT03417141|100608578|FG000|NOT COMPLETED|Overall Study||4||
48115597|NCT03097653|100608579|FG000|STARTED|Overall Study||472||
48115598|NCT03097653|100608580|FG001|STARTED|Overall Study||529||
48115599|NCT03097653|100608579|FG000|COMPLETED|Overall Study||472||
48115600|NCT03097653|100608580|FG001|COMPLETED|Overall Study||529||
48115601|NCT03097653|100608579|FG000|NOT COMPLETED|Overall Study||0||
48115602|NCT03097653|100608580|FG001|NOT COMPLETED|Overall Study||0||
48115603|NCT03027466|100608581|FG000|STARTED|Overall Study||2027||
48115604|NCT03027466|100608582|FG001|STARTED|Overall Study||1984||
48115605|NCT03027466|100608583|FG002|STARTED|Overall Study||1903||
48115606|NCT03027466|100608584|FG003|STARTED|Overall Study||1985||
48115607|NCT03027466|100608581|FG000|COMPLETED|Overall Study||158||
48115608|NCT03027466|100608582|FG001|COMPLETED|Overall Study||165||
48115609|NCT03027466|100608583|FG002|COMPLETED|Overall Study||160||
48115610|NCT03027466|100608584|FG003|COMPLETED|Overall Study||164||
48394268|NCT02700919|101295902|FG002|COMPLETED|Overall Study||87||
48394269|NCT02700919|101295900|FG000|NOT COMPLETED|Overall Study||12||
48394270|NCT02700919|101295901|FG001|NOT COMPLETED|Overall Study||12||
48115611|NCT03027466|100608581|FG000|NOT COMPLETED|Overall Study||1869||
48115612|NCT03027466|100608582|FG001|NOT COMPLETED|Overall Study||1819||
48115613|NCT03027466|100608583|FG002|NOT COMPLETED|Overall Study||1743||
48115614|NCT03027466|100608584|FG003|NOT COMPLETED|Overall Study||1821||
48115615|NCT01109316|100608585|FG000|STARTED|Study Period 1||22||
48115616|NCT01109316|100608586|FG001|STARTED|Study Period 1||22||
48115617|NCT01109316|100608587|FG002|STARTED|Study Period 1||22||
48115618|NCT01109316|100608588|FG003|STARTED|Study Period 1||22||
48115619|NCT01109316|100608589|FG004|STARTED|Study Period 1||22||
48115620|NCT01109316|100608590|FG005|STARTED|Study Period 1||22||
48115621|NCT01109316|100608585|FG000|Received at Least One Dose of Study Drug|Study Period 1||22||
48115622|NCT01109316|100608586|FG001|Received at Least One Dose of Study Drug|Study Period 1||22||
48394271|NCT02700919|101295902|FG002|NOT COMPLETED|Overall Study||4||
48394272|NCT00089999|101295903|FG000|STARTED|Overall Study||69||
48115623|NCT01109316|100608587|FG002|Received at Least One Dose of Study Drug|Study Period 1||22||
48115624|NCT01109316|100608588|FG003|Received at Least One Dose of Study Drug|Study Period 1||22||
48115625|NCT01109316|100608589|FG004|Received at Least One Dose of Study Drug|Study Period 1||22||
48115626|NCT01109316|100608590|FG005|Received at Least One Dose of Study Drug|Study Period 1||20||
48115627|NCT01109316|100608585|FG000|COMPLETED|Study Period 1||22||
48115628|NCT01109316|100608586|FG001|COMPLETED|Study Period 1||22||
48115629|NCT01109316|100608587|FG002|COMPLETED|Study Period 1||19||
48115630|NCT01109316|100608588|FG003|COMPLETED|Study Period 1||21||
48115631|NCT01109316|100608589|FG004|COMPLETED|Study Period 1||20||
48115632|NCT01109316|100608590|FG005|COMPLETED|Study Period 1||20||
48115633|NCT01109316|100608585|FG000|NOT COMPLETED|Study Period 1||0||
48115634|NCT01109316|100608586|FG001|NOT COMPLETED|Study Period 1||0||
48115635|NCT01109316|100608587|FG002|NOT COMPLETED|Study Period 1||3||
48115636|NCT01109316|100608588|FG003|NOT COMPLETED|Study Period 1||1||
48115637|NCT01109316|100608589|FG004|NOT COMPLETED|Study Period 1||2||
48115638|NCT01109316|100608590|FG005|NOT COMPLETED|Study Period 1||2||
48115639|NCT01109316|100608585|FG000|STARTED|Study Period 2||22||
48115640|NCT01109316|100608586|FG001|STARTED|Study Period 2||22||
48115641|NCT01109316|100608587|FG002|STARTED|Study Period 2||19||
48115642|NCT01109316|100608588|FG003|STARTED|Study Period 2||21||
48115643|NCT01109316|100608589|FG004|STARTED|Study Period 2||20||
48115644|NCT01109316|100608590|FG005|STARTED|Study Period 2||20||
48115645|NCT01109316|100608585|FG000|COMPLETED|Study Period 2||21||
48115646|NCT01109316|100608586|FG001|COMPLETED|Study Period 2||21||
48115647|NCT01109316|100608587|FG002|COMPLETED|Study Period 2||18||
48394273|NCT00089999|101295904|FG001|STARTED|Overall Study||69||
48563841|NCT02375971|101713802|FG001|NOT COMPLETED|Treatment (Day 1 - Baseline)||1||
48563842|NCT02375971|101713803|FG002|NOT COMPLETED|Treatment (Day 1 - Baseline)||5||
48115648|NCT01109316|100608588|FG003|COMPLETED|Study Period 2||20||
48115649|NCT01109316|100608589|FG004|COMPLETED|Study Period 2||20||
48563843|NCT02375971|101713801|FG000|STARTED|Follow-Up Phase (up to Day 169)||73|All patients who started the follow-up phase|
48115650|NCT01109316|100608590|FG005|COMPLETED|Study Period 2||19||
48115651|NCT01109316|100608585|FG000|NOT COMPLETED|Study Period 2||1||
48115652|NCT01109316|100608586|FG001|NOT COMPLETED|Study Period 2||1||
48115653|NCT01109316|100608587|FG002|NOT COMPLETED|Study Period 2||1||
48115654|NCT01109316|100608588|FG003|NOT COMPLETED|Study Period 2||1||
48115655|NCT01109316|100608589|FG004|NOT COMPLETED|Study Period 2||0||
48115656|NCT01109316|100608590|FG005|NOT COMPLETED|Study Period 2||1||
48115657|NCT01109316|100608585|FG000|STARTED|Study Period 3||21||
48115658|NCT01109316|100608586|FG001|STARTED|Study Period 3||21||
48115659|NCT01109316|100608587|FG002|STARTED|Study Period 3||18||
48115660|NCT01109316|100608588|FG003|STARTED|Study Period 3||20||
48115661|NCT01109316|100608589|FG004|STARTED|Study Period 3||20||
48115662|NCT01109316|100608590|FG005|STARTED|Study Period 3||19||
48115663|NCT01109316|100608585|FG000|COMPLETED|Study Period 3||20||
48115664|NCT01109316|100608586|FG001|COMPLETED|Study Period 3||21||
48115665|NCT01109316|100608587|FG002|COMPLETED|Study Period 3||18||
48115666|NCT01109316|100608588|FG003|COMPLETED|Study Period 3||20||
48115667|NCT01109316|100608589|FG004|COMPLETED|Study Period 3||18||
48115668|NCT01109316|100608590|FG005|COMPLETED|Study Period 3||19||
48115669|NCT01109316|100608585|FG000|NOT COMPLETED|Study Period 3||1||
48115670|NCT01109316|100608586|FG001|NOT COMPLETED|Study Period 3||0||
48115671|NCT01109316|100608587|FG002|NOT COMPLETED|Study Period 3||0||
48115672|NCT01109316|100608588|FG003|NOT COMPLETED|Study Period 3||0||
48115673|NCT01109316|100608589|FG004|NOT COMPLETED|Study Period 3||2||
48115674|NCT01109316|100608590|FG005|NOT COMPLETED|Study Period 3||0||
48115675|NCT01502644|100608591|FG000|STARTED|Enrolled at Visit 1 After Pre-screening||81||
48115676|NCT01502644|100608592|FG001|STARTED|Enrolled at Visit 1 After Pre-screening||0||
48115677|NCT01502644|100608593|FG002|STARTED|Enrolled at Visit 1 After Pre-screening||0||
48115678|NCT01502644|100608594|FG003|STARTED|Enrolled at Visit 1 After Pre-screening||0||
48115679|NCT01502644|100608591|FG000|COMPLETED|Enrolled at Visit 1 After Pre-screening||72||
48115680|NCT01502644|100608592|FG001|COMPLETED|Enrolled at Visit 1 After Pre-screening||0||
48115681|NCT01502644|100608593|FG002|COMPLETED|Enrolled at Visit 1 After Pre-screening||0||
48394274|NCT00089999|101295903|FG000|COMPLETED|Overall Study||0||
48563844|NCT02375971|101713802|FG001|STARTED|Follow-Up Phase (up to Day 169)||76|All patients who started the follow-up phase|
48563845|NCT02375971|101713803|FG002|STARTED|Follow-Up Phase (up to Day 169)||69|All patients who started the follow-up phase|
48563846|NCT02375971|101713801|FG000|COMPLETED|Follow-Up Phase (up to Day 169)||66|All patients who completed the follow-up phase|
48563847|NCT02375971|101713802|FG001|COMPLETED|Follow-Up Phase (up to Day 169)||71|All patients who completed the follow-up phase|
48563848|NCT02375971|101713803|FG002|COMPLETED|Follow-Up Phase (up to Day 169)||64|All patients who completed the follow-up phase|
48563849|NCT02375971|101713801|FG000|NOT COMPLETED|Follow-Up Phase (up to Day 169)||7||
48563850|NCT02375971|101713802|FG001|NOT COMPLETED|Follow-Up Phase (up to Day 169)||5||
48563851|NCT02375971|101713803|FG002|NOT COMPLETED|Follow-Up Phase (up to Day 169)||5||
48115682|NCT01502644|100608594|FG003|COMPLETED|Enrolled at Visit 1 After Pre-screening||0||
48115683|NCT01502644|100608591|FG000|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||9||
48115684|NCT01502644|100608592|FG001|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0||
48115685|NCT01502644|100608593|FG002|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0||
48278192|NCT05038800|101003262|FG002|NOT COMPLETED|Overall Study||5||
48278193|NCT05038800|101003263|FG003|NOT COMPLETED|Overall Study||3||
48278194|NCT05038800|101003264|FG004|NOT COMPLETED|Overall Study||3||
48278195|NCT03901482|101003265|FG000|STARTED|Overall Study||399||
48563852|NCT03242408|101713804|FG000|STARTED|Overall Study||100||
48563853|NCT03242408|101713804|FG000|COMPLETED|Overall Study||98||
48563854|NCT03242408|101713804|FG000|NOT COMPLETED|Overall Study||2||
48563855|NCT01882985|101713805|FG000|STARTED|Overall Study||14||
48563856|NCT01882985|101713805|FG000|COMPLETED|Overall Study||12||
48563857|NCT01882985|101713805|FG000|NOT COMPLETED|Overall Study||2||
48563858|NCT01167140|101713806|FG000|STARTED|Overall Study||42||
48563859|NCT01167140|101713806|FG000|COMPLETED|Overall Study||41||
48563860|NCT01167140|101713806|FG000|NOT COMPLETED|Overall Study||1||
48563861|NCT02179892|101713807|FG000|STARTED|Overall Study||5||
48563862|NCT02179892|101713808|FG001|STARTED|Overall Study||4||
48563863|NCT02179892|101713807|FG000|COMPLETED|Overall Study||5||
48115686|NCT01502644|100608594|FG003|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0||
48697256|NCT02684058|102041924|FG000|STARTED|Post-treatment Efficacy Follow-up||9|Participants who discontinued study treatment for reasons other than disease progression, death, loss to follow up, or withdrawal of consent|
48697257|NCT02684058|102041925|FG001|STARTED|Post-treatment Efficacy Follow-up||22|Participants who discontinued study treatment for reasons other than disease progression, death, loss to follow up, or withdrawal of consent|
48697258|NCT02684058|102041926|FG002|STARTED|Post-treatment Efficacy Follow-up||5|Participants who discontinued study treatment for reasons other than disease progression, death, loss to follow up, or withdrawal of consent|
48697259|NCT02684058|102041924|FG000|COMPLETED|Post-treatment Efficacy Follow-up||2||
48697260|NCT02684058|102041925|FG001|COMPLETED|Post-treatment Efficacy Follow-up||14||
48697261|NCT02684058|102041926|FG002|COMPLETED|Post-treatment Efficacy Follow-up||2||
48697262|NCT02684058|102041924|FG000|NOT COMPLETED|Post-treatment Efficacy Follow-up||7||
48697263|NCT02684058|102041925|FG001|NOT COMPLETED|Post-treatment Efficacy Follow-up||8||
48697264|NCT02684058|102041926|FG002|NOT COMPLETED|Post-treatment Efficacy Follow-up||3||
48697265|NCT02684058|102041924|FG000|STARTED|Post-treatment Survival Follow-up||11||
48697266|NCT02684058|102041925|FG001|STARTED|Post-treatment Survival Follow-up||1||
48697267|NCT02684058|102041926|FG002|STARTED|Post-treatment Survival Follow-up||9||
48697268|NCT02684058|102041924|FG000|COMPLETED|Post-treatment Survival Follow-up||10|Alive at the end of the study|
48697269|NCT02684058|102041925|FG001|COMPLETED|Post-treatment Survival Follow-up||1|Alive at the end of the study|
48697270|NCT02684058|102041926|FG002|COMPLETED|Post-treatment Survival Follow-up||2|Alive at the end of the study|
48697271|NCT02684058|102041924|FG000|NOT COMPLETED|Post-treatment Survival Follow-up||1||
48697272|NCT02684058|102041925|FG001|NOT COMPLETED|Post-treatment Survival Follow-up||0||
48697273|NCT02684058|102041926|FG002|NOT COMPLETED|Post-treatment Survival Follow-up||7||
48697274|NCT02684058|102041924|FG000|STARTED|Crossover Treatment Period||0|Participants randomized to the carboplatin with vincristine treatment arm were allowed to cross-over to receive dabrafenib in combination with trametinib treatment after centrally confirmed and RANO-defined disease progression|
48697275|NCT02684058|102041925|FG001|STARTED|Crossover Treatment Period||12|Participants randomized to the carboplatin with vincristine treatment arm were allowed to cross-over to receive dabrafenib in combination with trametinib treatment after centrally confirmed and RANO-defined disease progression|
48710724|NCT02699450|102078000|FG001|STARTED|Overall Study||55|Intent-to-Treat (ITT) Population|
48710725|NCT02699450|102078001|FG002|STARTED|Overall Study||82|Intent-to-Treat (ITT) Population|
48115687|NCT01502644|100608591|FG000|STARTED|Assigned to NA Groups||0||
48115688|NCT01502644|100608592|FG001|STARTED|Assigned to NA Groups||30||
48115689|NCT01502644|100608593|FG002|STARTED|Assigned to NA Groups||10||
48563864|NCT02179892|101713808|FG001|COMPLETED|Overall Study||4||
48563865|NCT02179892|101713807|FG000|NOT COMPLETED|Overall Study||0||
48563866|NCT02179892|101713808|FG001|NOT COMPLETED|Overall Study||0||
48115690|NCT01502644|100608594|FG003|STARTED|Assigned to NA Groups||32||
48115691|NCT01502644|100608591|FG000|COMPLETED|Assigned to NA Groups||0||
48115692|NCT01502644|100608592|FG001|COMPLETED|Assigned to NA Groups||24||
48115693|NCT01502644|100608593|FG002|COMPLETED|Assigned to NA Groups||7||
48115694|NCT01502644|100608594|FG003|COMPLETED|Assigned to NA Groups||24||
48115695|NCT01502644|100608591|FG000|NOT COMPLETED|Assigned to NA Groups||0||
48115696|NCT01502644|100608592|FG001|NOT COMPLETED|Assigned to NA Groups||6||
48115697|NCT01502644|100608593|FG002|NOT COMPLETED|Assigned to NA Groups||3||
48115698|NCT01502644|100608594|FG003|NOT COMPLETED|Assigned to NA Groups||8||
48115699|NCT00080223|100608595|FG000|STARTED|Overall Study||83||
48278196|NCT03901482|101003266|FG001|STARTED|Overall Study||400||
48278197|NCT03901482|101003267|FG002|STARTED|Overall Study||402||
48278198|NCT03901482|101003265|FG000|COMPLETED|Overall Study||363||
48278199|NCT03901482|101003266|FG001|COMPLETED|Overall Study||368||
48278200|NCT03901482|101003267|FG002|COMPLETED|Overall Study||364||
48278201|NCT03901482|101003265|FG000|NOT COMPLETED|Overall Study||36||
48278202|NCT03901482|101003266|FG001|NOT COMPLETED|Overall Study||32||
48278203|NCT03901482|101003267|FG002|NOT COMPLETED|Overall Study||38||
48115700|NCT00080223|100608595|FG000|COMPLETED|Overall Study||7||
48278204|NCT03214640|101003268|FG000|STARTED|Overall Study||31||
48563867|NCT00502242|101713809|FG000|STARTED|Overall Study||155||
48563868|NCT00502242|101713810|FG001|STARTED|Overall Study||140||
48115701|NCT00080223|100608595|FG000|NOT COMPLETED|Overall Study||76||
48563869|NCT00502242|101713809|FG000|COMPLETED|Overall Study||104||
48563870|NCT00502242|101713810|FG001|COMPLETED|Overall Study||84||
48697276|NCT02684058|102041926|FG002|STARTED|Crossover Treatment Period||0|Participants randomized to the carboplatin with vincristine treatment arm were allowed to cross-over to receive dabrafenib in combination with trametinib treatment after centrally confirmed and RANO-defined disease progression|
48697277|NCT02684058|102041924|FG000|COMPLETED|Crossover Treatment Period||0||
48697278|NCT02684058|102041925|FG001|COMPLETED|Crossover Treatment Period||11||
48115702|NCT00749931|100608596|FG000|STARTED|Overall Study||298||
48115703|NCT00749931|100608597|FG001|STARTED|Overall Study||298||
48115704|NCT00749931|100608598|FG002|STARTED|Overall Study||68||
48115705|NCT00749931|100608596|FG000|COMPLETED|Overall Study||298||
48115706|NCT00749931|100608597|FG001|COMPLETED|Overall Study||298||
48115707|NCT00749931|100608598|FG002|COMPLETED|Overall Study||68||
48115708|NCT00749931|100608596|FG000|NOT COMPLETED|Overall Study||0||
48115709|NCT00749931|100608597|FG001|NOT COMPLETED|Overall Study||0||
48115710|NCT00749931|100608598|FG002|NOT COMPLETED|Overall Study||0||
48115711|NCT04152447|100608599|FG000|STARTED|Overall Study||16||
48115712|NCT04152447|100608600|FG001|STARTED|Overall Study||19||
48115713|NCT04152447|100608599|FG000|COMPLETED|Overall Study||13||
48115714|NCT04152447|100608600|FG001|COMPLETED|Overall Study||14||
48115715|NCT04152447|100608599|FG000|NOT COMPLETED|Overall Study||3||
48115716|NCT04152447|100608600|FG001|NOT COMPLETED|Overall Study||5||
48115717|NCT01713868|100608601|FG000|STARTED|Overall Study||400||
48115718|NCT01713868|100608602|FG001|STARTED|Overall Study||400||
48115719|NCT01713868|100608603|FG002|STARTED|Overall Study||400||
48115720|NCT01713868|100608604|FG003|STARTED|Overall Study||400||
48115721|NCT01713868|100608601|FG000|COMPLETED|Overall Study||303||
48115722|NCT01713868|100608602|FG001|COMPLETED|Overall Study||335||
48115723|NCT01713868|100608603|FG002|COMPLETED|Overall Study||320||
48115724|NCT01713868|100608604|FG003|COMPLETED|Overall Study||305||
48115725|NCT01713868|100608601|FG000|NOT COMPLETED|Overall Study||97||
48115726|NCT01713868|100608602|FG001|NOT COMPLETED|Overall Study||65||
48115727|NCT01713868|100608603|FG002|NOT COMPLETED|Overall Study||80||
48394275|NCT00089999|101295904|FG001|COMPLETED|Overall Study||0||
48394276|NCT00089999|101295903|FG000|NOT COMPLETED|Overall Study||69||
48394277|NCT00089999|101295904|FG001|NOT COMPLETED|Overall Study||69||
48394278|NCT01595438|101295905|FG000|STARTED|Overall Study||516||
48394279|NCT01595438|101295906|FG001|STARTED|Overall Study||517||
48394280|NCT01595438|101295905|FG000|COMPLETED|Overall Study||473||
48394281|NCT01595438|101295906|FG001|COMPLETED|Overall Study||476||
48394282|NCT01595438|101295905|FG000|NOT COMPLETED|Overall Study||43||
48563871|NCT00502242|101713809|FG000|NOT COMPLETED|Overall Study||51||
48563872|NCT00502242|101713810|FG001|NOT COMPLETED|Overall Study||56||
48563873|NCT03063437|101713811|FG000|STARTED|Overall Study||4||
48563874|NCT03063437|101713812|FG001|STARTED|Overall Study||5||
48563875|NCT03063437|101713811|FG000|COMPLETED|Overall Study||4||
48563876|NCT03063437|101713812|FG001|COMPLETED|Overall Study||5||
48115728|NCT01713868|100608604|FG003|NOT COMPLETED|Overall Study||95||
48115729|NCT01209624|100608605|FG000|STARTED|Overall Study||902||
48115730|NCT01209624|100608605|FG000|Per Protocol Population|Overall Study||469||
48115731|NCT01209624|100608605|FG000|COMPLETED|Overall Study||576||
48115732|NCT01209624|100608605|FG000|NOT COMPLETED|Overall Study||326||
48115733|NCT02177266|100608606|FG000|STARTED|Overall Study||1||
48115734|NCT02177266|100608607|FG001|STARTED|Overall Study||1||
48115735|NCT02177266|100608606|FG000|COMPLETED|Overall Study||0||
48115736|NCT02177266|100608607|FG001|COMPLETED|Overall Study||0||
48115737|NCT02177266|100608606|FG000|NOT COMPLETED|Overall Study||1||
48115738|NCT02177266|100608607|FG001|NOT COMPLETED|Overall Study||1||
48115739|NCT00183872|100608608|FG000|STARTED|Overall Study||40||
48115740|NCT00183872|100608608|FG000|COMPLETED|Overall Study||24||
48115741|NCT00183872|100608608|FG000|NOT COMPLETED|Overall Study||16||
48394283|NCT01595438|101295906|FG001|NOT COMPLETED|Overall Study||41||
48394284|NCT02372097|101295907|FG000|STARTED|First Intervention Period (8 Days)||12||
48394285|NCT02372097|101295908|FG001|STARTED|First Intervention Period (8 Days)||12||
48394286|NCT02372097|101295907|FG000|COMPLETED|First Intervention Period (8 Days)||12||
48394287|NCT02372097|101295908|FG001|COMPLETED|First Intervention Period (8 Days)||12||
48563877|NCT03063437|101713811|FG000|NOT COMPLETED|Overall Study||0||
48563878|NCT03063437|101713812|FG001|NOT COMPLETED|Overall Study||0||
48563879|NCT00712712|101713813|FG000|STARTED|Overall Study||78||
48563880|NCT00712712|101713813|FG000|COMPLETED|Overall Study||55||
48563881|NCT00712712|101713813|FG000|NOT COMPLETED|Overall Study||23||
48563882|NCT01082328|101713814|FG000|STARTED|Overall Study||59||
48563883|NCT01082328|101713814|FG000|COMPLETED|Overall Study||58||
48697279|NCT02684058|102041926|FG002|COMPLETED|Crossover Treatment Period||0||
48697280|NCT02684058|102041924|FG000|NOT COMPLETED|Crossover Treatment Period||0||
48115742|NCT03641378|100608609|FG000|STARTED|Overall Study||180||
48115743|NCT03641378|100608610|FG001|STARTED|Overall Study||180||
48115744|NCT03641378|100608611|FG002|STARTED|Overall Study||101||
48115745|NCT03641378|100608612|FG003|STARTED|Overall Study||85||
48115746|NCT03641378|100608609|FG000|COMPLETED|Overall Study||173||
48563884|NCT01082328|101713814|FG000|NOT COMPLETED|Overall Study||1||
48115747|NCT03641378|100608610|FG001|COMPLETED|Overall Study||160||
48115748|NCT03641378|100608611|FG002|COMPLETED|Overall Study||87||
48115749|NCT03641378|100608612|FG003|COMPLETED|Overall Study||79||
48563885|NCT01532934|101713815|FG000|STARTED|Overall Study||53||
48115750|NCT03641378|100608609|FG000|NOT COMPLETED|Overall Study||7||
48115751|NCT03641378|100608610|FG001|NOT COMPLETED|Overall Study||20||
48115752|NCT03641378|100608611|FG002|NOT COMPLETED|Overall Study||14||
48115753|NCT03641378|100608612|FG003|NOT COMPLETED|Overall Study||6||
48115754|NCT00495716|100608613|FG000|STARTED|Overall Study||35||
48115755|NCT00495716|100608614|FG001|STARTED|Overall Study||37||
48115756|NCT00495716|100608613|FG000|COMPLETED|Overall Study||20||
48115757|NCT00495716|100608614|FG001|COMPLETED|Overall Study||24||
48115758|NCT00495716|100608613|FG000|NOT COMPLETED|Overall Study||15||
48115759|NCT00495716|100608614|FG001|NOT COMPLETED|Overall Study||13||
48115760|NCT00354224|100608615|FG000|STARTED|Overall Study||10||
48115761|NCT00354224|100608615|FG000|COMPLETED|Overall Study||10||
48115762|NCT00354224|100608615|FG000|NOT COMPLETED|Overall Study||0||
48115763|NCT02379585|100608616|FG000|STARTED|Overall Study||3||
48115764|NCT02379585|100608617|FG001|STARTED|Overall Study||5||
48115765|NCT02379585|100608616|FG000|COMPLETED|Overall Study||0||
48115766|NCT02379585|100608617|FG001|COMPLETED|Overall Study||0||
48115767|NCT02379585|100608616|FG000|NOT COMPLETED|Overall Study||3||
48697281|NCT02684058|102041925|FG001|NOT COMPLETED|Crossover Treatment Period||1||
48697282|NCT02684058|102041926|FG002|NOT COMPLETED|Crossover Treatment Period||0||
48115768|NCT02379585|100608617|FG001|NOT COMPLETED|Overall Study||5||
48115769|NCT02376166|100608618|FG000|STARTED|Overall Study||15||
48115770|NCT02376166|100608618|FG000|COMPLETED|Overall Study||12||
48697283|NCT00316225|102041927|FG000|STARTED|Overall Study||31||
48697284|NCT00316225|102041927|FG000|COMPLETED|Overall Study||6||
48697285|NCT00316225|102041927|FG000|NOT COMPLETED|Overall Study||25||
48697286|NCT01096368|102041928|FG000|STARTED|Overall Study||37||
48697287|NCT01096368|102041929|FG001|STARTED|Overall Study||167||
48697288|NCT01096368|102041930|FG002|STARTED|Overall Study||163||
48697289|NCT01096368|102041931|FG003|STARTED|Overall Study||63||
48697290|NCT01096368|102041932|FG004|STARTED|Overall Study||49||
48697291|NCT01096368|102041928|FG000|COMPLETED|Overall Study||37||
48115771|NCT02376166|100608618|FG000|NOT COMPLETED|Overall Study||3||
48115772|NCT02488785|100608619|FG000|STARTED|Overall Study||47||
48115773|NCT02488785|100608620|FG001|STARTED|Overall Study||49||
48115774|NCT02488785|100608619|FG000|COMPLETED|Overall Study||41||
48115775|NCT02488785|100608620|FG001|COMPLETED|Overall Study||38||
48115776|NCT02488785|100608619|FG000|NOT COMPLETED|Overall Study||6||
48115777|NCT02488785|100608620|FG001|NOT COMPLETED|Overall Study||11||
48115778|NCT03192150|100608621|FG000|STARTED|Overall Study||163||
48115779|NCT03192150|100608622|FG001|STARTED|Overall Study||83||
48115780|NCT03192150|100608621|FG000|COMPLETED|Overall Study||108||
48115781|NCT03192150|100608622|FG001|COMPLETED|Overall Study||29||
48115782|NCT03192150|100608621|FG000|NOT COMPLETED|Overall Study||55||
48115783|NCT03192150|100608622|FG001|NOT COMPLETED|Overall Study||54||
48115784|NCT01589822|100608623|FG000|STARTED|Overall Study||84||
48115785|NCT01589822|100608624|FG001|STARTED|Overall Study||89||
48115786|NCT01589822|100608625|FG002|STARTED|Overall Study||41||
48115787|NCT01589822|100608623|FG000|COMPLETED|Overall Study||80||
48697292|NCT01096368|102041929|FG001|COMPLETED|Overall Study||88||
48115788|NCT01589822|100608624|FG001|COMPLETED|Overall Study||86||
48115789|NCT01589822|100608625|FG002|COMPLETED|Overall Study||40||
48115790|NCT01589822|100608623|FG000|NOT COMPLETED|Overall Study||4||
48115791|NCT01589822|100608624|FG001|NOT COMPLETED|Overall Study||3||
48115792|NCT01589822|100608625|FG002|NOT COMPLETED|Overall Study||1||
48115793|NCT02932891|100608626|FG000|STARTED|Overall Study||28||
48115794|NCT02932891|100608626|FG000|COMPLETED|Overall Study||24||
48115795|NCT02932891|100608626|FG000|NOT COMPLETED|Overall Study||4||
48115796|NCT03662100|100608627|FG000|STARTED|Overall Study||11||
48697293|NCT01096368|102041930|FG002|COMPLETED|Overall Study||154||
48697294|NCT01096368|102041931|FG003|COMPLETED|Overall Study||39||
48115797|NCT03662100|100608628|FG001|STARTED|Overall Study||11||
48115798|NCT03662100|100608629|FG002|STARTED|Overall Study||11||
48115799|NCT03662100|100608630|FG003|STARTED|Overall Study||11||
48115800|NCT03662100|100608631|FG004|STARTED|Overall Study||11||
48115801|NCT03662100|100608632|FG005|STARTED|Overall Study||11||
48115802|NCT03662100|100608627|FG000|Received at Least One Dose of Drug|Overall Study||11||
48115803|NCT03662100|100608628|FG001|Received at Least One Dose of Drug|Overall Study||11||
48697295|NCT01096368|102041932|FG004|COMPLETED|Overall Study||0||
48697296|NCT01096368|102041928|FG000|NOT COMPLETED|Overall Study||0||
48697297|NCT01096368|102041929|FG001|NOT COMPLETED|Overall Study||79||
48697298|NCT01096368|102041930|FG002|NOT COMPLETED|Overall Study||9||
48697299|NCT01096368|102041931|FG003|NOT COMPLETED|Overall Study||24||
48697300|NCT01096368|102041932|FG004|NOT COMPLETED|Overall Study||49||
48697301|NCT04324541|102045350|FG000|STARTED|Overall Study||12||
48697302|NCT04324541|102045350|FG000|COMPLETED|Overall Study||12||
48115804|NCT03662100|100608629|FG002|Received at Least One Dose of Drug|Overall Study||11||
48115805|NCT03662100|100608630|FG003|Received at Least One Dose of Drug|Overall Study||11||
48115806|NCT03662100|100608631|FG004|Received at Least One Dose of Drug|Overall Study||11||
48697303|NCT04324541|102045350|FG000|NOT COMPLETED|Overall Study||0||
48697304|NCT03654404|102045351|FG000|STARTED|Overall Study||20||
48697305|NCT03654404|102045351|FG000|COMPLETED|Overall Study||12||
48697306|NCT03654404|102045351|FG000|NOT COMPLETED|Overall Study||8||
48697307|NCT03539211|102045352|FG000|STARTED|Overall Study||16||
48697308|NCT03539211|102045353|FG001|STARTED|Overall Study||15||
48697309|NCT03539211|102045352|FG000|COMPLETED|Overall Study||16||
48115807|NCT03662100|100608632|FG005|Received at Least One Dose of Drug|Overall Study||11||
48115808|NCT03662100|100608627|FG000|COMPLETED|Overall Study||11||
48115809|NCT03662100|100608628|FG001|COMPLETED|Overall Study||11||
48115810|NCT03662100|100608629|FG002|COMPLETED|Overall Study||11||
48115811|NCT03662100|100608630|FG003|COMPLETED|Overall Study||11||
48115812|NCT03662100|100608631|FG004|COMPLETED|Overall Study||11||
48115813|NCT03662100|100608632|FG005|COMPLETED|Overall Study||11||
48115814|NCT03662100|100608627|FG000|NOT COMPLETED|Overall Study||0||
48115815|NCT03662100|100608628|FG001|NOT COMPLETED|Overall Study||0||
48115816|NCT03662100|100608629|FG002|NOT COMPLETED|Overall Study||0||
48115817|NCT03662100|100608630|FG003|NOT COMPLETED|Overall Study||0||
48115818|NCT03662100|100608631|FG004|NOT COMPLETED|Overall Study||0||
48115819|NCT03662100|100608632|FG005|NOT COMPLETED|Overall Study||0||
48115820|NCT03746522|100608633|FG000|STARTED|Period 1: Double-Blind (14 Weeks)||27||
48115821|NCT03746522|100608634|FG001|STARTED|Period 1: Double-Blind (14 Weeks)||25||
48115822|NCT03746522|100608635|FG002|STARTED|Period 1: Double-Blind (14 Weeks)||0||
48115823|NCT03746522|100608633|FG000|COMPLETED|Period 1: Double-Blind (14 Weeks)||27||
48115824|NCT03746522|100608634|FG001|COMPLETED|Period 1: Double-Blind (14 Weeks)||23||
48115825|NCT03746522|100608635|FG002|COMPLETED|Period 1: Double-Blind (14 Weeks)||0||
48115826|NCT03746522|100608633|FG000|NOT COMPLETED|Period 1: Double-Blind (14 Weeks)||0||
48115827|NCT03746522|100608634|FG001|NOT COMPLETED|Period 1: Double-Blind (14 Weeks)||2||
48115828|NCT03746522|100608635|FG002|NOT COMPLETED|Period 1: Double-Blind (14 Weeks)||0||
48115829|NCT03746522|100608633|FG000|STARTED|Period 2: Open-Label (38 Weeks)||0||
48115830|NCT03746522|100608634|FG001|STARTED|Period 2: Open-Label (38 Weeks)||0||
48115831|NCT03746522|100608635|FG002|STARTED|Period 2: Open-Label (38 Weeks)||50||
48115832|NCT03746522|100608633|FG000|COMPLETED|Period 2: Open-Label (38 Weeks)||0||
48115833|NCT03746522|100608634|FG001|COMPLETED|Period 2: Open-Label (38 Weeks)||0||
48115834|NCT03746522|100608635|FG002|COMPLETED|Period 2: Open-Label (38 Weeks)||41||
48115835|NCT03746522|100608633|FG000|NOT COMPLETED|Period 2: Open-Label (38 Weeks)||0||
48115836|NCT03746522|100608634|FG001|NOT COMPLETED|Period 2: Open-Label (38 Weeks)||0||
48115837|NCT03746522|100608635|FG002|NOT COMPLETED|Period 2: Open-Label (38 Weeks)||9||
48115838|NCT03746522|100608633|FG000|STARTED|Period 3: Open-Label (14 Weeks)||0||
48115839|NCT03746522|100608634|FG001|STARTED|Period 3: Open-Label (14 Weeks)||0||
48115840|NCT03746522|100608635|FG002|STARTED|Period 3: Open-Label (14 Weeks)||41||
48278205|NCT03214640|101003269|FG001|STARTED|Overall Study||32||
48697310|NCT03539211|102045353|FG001|COMPLETED|Overall Study||15||
48697311|NCT03539211|102045352|FG000|NOT COMPLETED|Overall Study||0||
48697312|NCT03539211|102045353|FG001|NOT COMPLETED|Overall Study||0||
48697313|NCT03219034|102045354|FG000|STARTED|Overall Study||31||
48697314|NCT03219034|102045355|FG001|STARTED|Overall Study||31||
48697315|NCT03219034|102045354|FG000|COMPLETED|Overall Study||20||
48697316|NCT03219034|102045355|FG001|COMPLETED|Overall Study||16||
48697317|NCT03219034|102045354|FG000|NOT COMPLETED|Overall Study||11||
48697318|NCT03219034|102045355|FG001|NOT COMPLETED|Overall Study||15||
48697319|NCT02139878|102045356|FG000|STARTED|First Intervention (7 Days)||10||
48697320|NCT02139878|102045357|FG001|STARTED|First Intervention (7 Days)||10||
48115841|NCT03746522|100608633|FG000|COMPLETED|Period 3: Open-Label (14 Weeks)||0||
48697321|NCT02139878|102045356|FG000|COMPLETED|First Intervention (7 Days)||9||
48697322|NCT02139878|102045357|FG001|COMPLETED|First Intervention (7 Days)||10||
48697323|NCT02139878|102045356|FG000|NOT COMPLETED|First Intervention (7 Days)||1||
48710818|NCT00884910|102078028|FG000|NOT COMPLETED|Overall Study||1||
48115842|NCT03746522|100608634|FG001|COMPLETED|Period 3: Open-Label (14 Weeks)||0||
48115843|NCT03746522|100608635|FG002|COMPLETED|Period 3: Open-Label (14 Weeks)||41||
48115844|NCT03746522|100608633|FG000|NOT COMPLETED|Period 3: Open-Label (14 Weeks)||0||
48115845|NCT03746522|100608634|FG001|NOT COMPLETED|Period 3: Open-Label (14 Weeks)||0||
48115846|NCT03746522|100608635|FG002|NOT COMPLETED|Period 3: Open-Label (14 Weeks)||0||
48115847|NCT01916304|100608636|FG000|STARTED|Overall Study||101||
48115848|NCT01916304|100608636|FG000|Safety Set|Overall Study||101||
48115849|NCT01916304|100608636|FG000|Intent-to-Treat Set|Overall Study||84||
48115850|NCT01916304|100608636|FG000|COMPLETED|Overall Study||84||
48115851|NCT01916304|100608636|FG000|NOT COMPLETED|Overall Study||17||
48115852|NCT00850200|100608637|FG000|STARTED|Overall Study||20||
48115853|NCT00850200|100608637|FG000|COMPLETED|Overall Study||15||
48115854|NCT00850200|100608637|FG000|NOT COMPLETED|Overall Study||5||
48115855|NCT05035017|100608638|FG000|STARTED|Period 1 (2 Days)||18||
48697324|NCT02139878|102045357|FG001|NOT COMPLETED|First Intervention (7 Days)||0||
48697325|NCT02139878|102045356|FG000|STARTED|Washout Period (8 Days)||9||
48697326|NCT02139878|102045357|FG001|STARTED|Washout Period (8 Days)||10||
48697327|NCT02139878|102045356|FG000|COMPLETED|Washout Period (8 Days)||9||
48697328|NCT02139878|102045357|FG001|COMPLETED|Washout Period (8 Days)||10||
48697329|NCT02139878|102045356|FG000|NOT COMPLETED|Washout Period (8 Days)||0||
48697330|NCT02139878|102045357|FG001|NOT COMPLETED|Washout Period (8 Days)||0||
48697331|NCT02139878|102045356|FG000|STARTED|Second Intervention (7 Days)||9||
48697332|NCT02139878|102045357|FG001|STARTED|Second Intervention (7 Days)||10||
48697333|NCT02139878|102045356|FG000|COMPLETED|Second Intervention (7 Days)||9||
48697334|NCT02139878|102045357|FG001|COMPLETED|Second Intervention (7 Days)||10||
48697335|NCT02139878|102045356|FG000|NOT COMPLETED|Second Intervention (7 Days)||0||
48697336|NCT02139878|102045357|FG001|NOT COMPLETED|Second Intervention (7 Days)||0||
48697337|NCT03379259|102045358|FG000|STARTED|Overall Study||3||
48697338|NCT03379259|102045359|FG001|STARTED|Overall Study||3||
48697339|NCT03379259|102045360|FG002|STARTED|Overall Study||6||
48697340|NCT03379259|102045361|FG003|STARTED|Overall Study||3||
48697341|NCT03379259|102045362|FG004|STARTED|Overall Study||12||
48697342|NCT03379259|102045363|FG005|STARTED|Overall Study||12||
48697343|NCT03379259|102045358|FG000|COMPLETED|Overall Study||2||
48115856|NCT05035017|100608639|FG001|STARTED|Period 1 (2 Days)||17||
48115857|NCT05035017|100608638|FG000|COMPLETED|Period 1 (2 Days)||18||
48115858|NCT05035017|100608639|FG001|COMPLETED|Period 1 (2 Days)||17||
48115859|NCT05035017|100608638|FG000|NOT COMPLETED|Period 1 (2 Days)||0||
48115860|NCT05035017|100608639|FG001|NOT COMPLETED|Period 1 (2 Days)||0||
48115861|NCT05035017|100608638|FG000|STARTED|Period 2 (2 Days)||18||
48115862|NCT05035017|100608639|FG001|STARTED|Period 2 (2 Days)||17||
48697344|NCT03379259|102045359|FG001|COMPLETED|Overall Study||2||
48697345|NCT03379259|102045360|FG002|COMPLETED|Overall Study||3||
48697346|NCT03379259|102045361|FG003|COMPLETED|Overall Study||0||
48697347|NCT03379259|102045362|FG004|COMPLETED|Overall Study||3||
48697348|NCT03379259|102045363|FG005|COMPLETED|Overall Study||5||
48697349|NCT03379259|102045358|FG000|NOT COMPLETED|Overall Study||1||
48697350|NCT03379259|102045359|FG001|NOT COMPLETED|Overall Study||1||
48697351|NCT03379259|102045360|FG002|NOT COMPLETED|Overall Study||3||
48697352|NCT03379259|102045361|FG003|NOT COMPLETED|Overall Study||3||
48697353|NCT03379259|102045362|FG004|NOT COMPLETED|Overall Study||9||
48697354|NCT03379259|102045363|FG005|NOT COMPLETED|Overall Study||7||
48278206|NCT03214640|101003270|FG002|STARTED|Overall Study||31||
48278207|NCT03214640|101003271|FG003|STARTED|Overall Study||34||
48278208|NCT03214640|101003268|FG000|COMPLETED|Overall Study||30||
48278209|NCT03214640|101003269|FG001|COMPLETED|Overall Study||30||
48278210|NCT03214640|101003270|FG002|COMPLETED|Overall Study||30||
48278211|NCT03214640|101003271|FG003|COMPLETED|Overall Study||30||
48278212|NCT03214640|101003268|FG000|NOT COMPLETED|Overall Study||1||
48278213|NCT03214640|101003269|FG001|NOT COMPLETED|Overall Study||2||
48278214|NCT03214640|101003270|FG002|NOT COMPLETED|Overall Study||1||
48278215|NCT03214640|101003271|FG003|NOT COMPLETED|Overall Study||4||
48278216|NCT03208036|101003272|FG000|STARTED|Baseline Assessment||11||
48278217|NCT03208036|101003273|FG001|STARTED|Baseline Assessment||11||
48278218|NCT03208036|101003272|FG000|COMPLETED|Baseline Assessment||10||
48278219|NCT03208036|101003273|FG001|COMPLETED|Baseline Assessment||10||
48278220|NCT03208036|101003272|FG000|NOT COMPLETED|Baseline Assessment||1||
48278221|NCT03208036|101003273|FG001|NOT COMPLETED|Baseline Assessment||1||
48278222|NCT03208036|101003272|FG000|STARTED|2nd Baseline Assessment||10||
48278223|NCT03208036|101003273|FG001|STARTED|2nd Baseline Assessment||10||
48697355|NCT00295009|102045364|FG000|STARTED|Overall Study||93||
48697356|NCT00295009|102045365|FG001|STARTED|Overall Study||183||
48697357|NCT00295009|102045366|FG002|STARTED|Overall Study||51||
48697358|NCT00295009|102045367|FG003|STARTED|Overall Study||82||
48697359|NCT00295009|102045368|FG004|STARTED|Overall Study||174||
48697360|NCT00295009|102045369|FG005|STARTED|Overall Study||269||
48697361|NCT00295009|102045364|FG000|Treated|Overall Study||80||
48697362|NCT00295009|102045365|FG001|Treated|Overall Study||162||
48697363|NCT00295009|102045366|FG002|Treated|Overall Study||50||
48697364|NCT00295009|102045367|FG003|Treated|Overall Study||72||
48697365|NCT00295009|102045368|FG004|Treated|Overall Study||165||
48697366|NCT00295009|102045369|FG005|Treated|Overall Study||259||
48697367|NCT00295009|102045364|FG000|Completed 24 Month Analysis|Overall Study||71||
48697368|NCT00295009|102045365|FG001|Completed 24 Month Analysis|Overall Study||148||
48697369|NCT00295009|102045366|FG002|Completed 24 Month Analysis|Overall Study||45||
48278224|NCT03208036|101003272|FG000|COMPLETED|2nd Baseline Assessment||9||
48278225|NCT03208036|101003273|FG001|COMPLETED|2nd Baseline Assessment||8||
48278226|NCT03208036|101003272|FG000|NOT COMPLETED|2nd Baseline Assessment||1||
48278227|NCT03208036|101003273|FG001|NOT COMPLETED|2nd Baseline Assessment||2||
48278228|NCT03208036|101003272|FG000|STARTED|Intervention||9||
48278229|NCT03208036|101003273|FG001|STARTED|Intervention||8||
48278230|NCT03208036|101003272|FG000|COMPLETED|Intervention||6||
48278231|NCT03208036|101003273|FG001|COMPLETED|Intervention||6||
48697370|NCT00295009|102045367|FG003|Completed 24 Month Analysis|Overall Study||60||
48278232|NCT03208036|101003272|FG000|NOT COMPLETED|Intervention||3||
48697371|NCT00295009|102045368|FG004|Completed 24 Month Analysis|Overall Study||133||
48697372|NCT00295009|102045369|FG005|Completed 24 Month Analysis|Overall Study||198||
48697373|NCT00295009|102045364|FG000|COMPLETED|Overall Study||52||
48697374|NCT00295009|102045365|FG001|COMPLETED|Overall Study||134||
48697375|NCT00295009|102045366|FG002|COMPLETED|Overall Study||39||
48697376|NCT00295009|102045367|FG003|COMPLETED|Overall Study||57||
48697377|NCT00295009|102045368|FG004|COMPLETED|Overall Study||116||
48697378|NCT00295009|102045369|FG005|COMPLETED|Overall Study||0||
48697379|NCT00295009|102045364|FG000|NOT COMPLETED|Overall Study||41||
48697380|NCT00295009|102045365|FG001|NOT COMPLETED|Overall Study||49||
48697381|NCT00295009|102045366|FG002|NOT COMPLETED|Overall Study||12||
48697382|NCT00295009|102045367|FG003|NOT COMPLETED|Overall Study||25||
48697383|NCT00295009|102045368|FG004|NOT COMPLETED|Overall Study||58||
48697384|NCT00295009|102045369|FG005|NOT COMPLETED|Overall Study||269||
48697385|NCT05875727|102045370|FG000|STARTED|Overall Study||200||
48697386|NCT05875727|102045371|FG001|STARTED|Overall Study||200||
48697387|NCT05875727|102045370|FG000|COMPLETED|Overall Study||200||
48697388|NCT05875727|102045371|FG001|COMPLETED|Overall Study||200||
48697389|NCT05875727|102045370|FG000|NOT COMPLETED|Overall Study||0||
48697390|NCT05875727|102045371|FG001|NOT COMPLETED|Overall Study||0||
48697391|NCT03070223|102045372|FG000|STARTED|Overall Study||316||
48697392|NCT03070223|102045373|FG001|STARTED|Overall Study||286||
48697393|NCT03070223|102045372|FG000|COMPLETED|Overall Study||270||
48697394|NCT03070223|102045373|FG001|COMPLETED|Overall Study||236||
48697395|NCT03070223|102045372|FG000|NOT COMPLETED|Overall Study||46||
48697396|NCT03070223|102045373|FG001|NOT COMPLETED|Overall Study||50||
48697397|NCT00210353|102045374|FG000|STARTED|Overall Study||151||
48697398|NCT00210353|102045375|FG001|STARTED|Overall Study||152||
48697399|NCT00210353|102045376|FG002|STARTED|Overall Study||151||
48697400|NCT00210353|102045374|FG000|COMPLETED|Overall Study||113||
48697401|NCT00210353|102045375|FG001|COMPLETED|Overall Study||107||
48697402|NCT00210353|102045376|FG002|COMPLETED|Overall Study||125||
48697403|NCT00210353|102045374|FG000|NOT COMPLETED|Overall Study||38||
48697404|NCT00210353|102045375|FG001|NOT COMPLETED|Overall Study||45||
48697405|NCT00210353|102045376|FG002|NOT COMPLETED|Overall Study||26||
48697406|NCT00157196|102045377|FG000|STARTED|Overall Study||22||
48697407|NCT00157196|102045377|FG000|COMPLETED|Overall Study||13||
48697408|NCT00157196|102045377|FG000|NOT COMPLETED|Overall Study||9||
48697409|NCT03296137|102045378|FG000|STARTED|Overall Study||25||
48697410|NCT03296137|102045378|FG000|COMPLETED|Overall Study||25||
48697411|NCT03296137|102045378|FG000|NOT COMPLETED|Overall Study||0||
48697412|NCT00654745|102045379|FG000|STARTED|Overall Study||207||
48697413|NCT00654745|102045379|FG000|COMPLETED|Overall Study||164||
48697414|NCT00654745|102045379|FG000|NOT COMPLETED|Overall Study||43||
48697415|NCT00413894|102045380|FG000|STARTED|Overall Study||424||
48697416|NCT00413894|102045380|FG000|COMPLETED|Overall Study||344||
48697417|NCT00413894|102045380|FG000|NOT COMPLETED|Overall Study||80||
48697418|NCT00104416|102045381|FG000|STARTED|Double-Blind Phase||77||
48697419|NCT00104416|102045382|FG001|STARTED|Double-Blind Phase||76||
48697420|NCT00104416|102045383|FG002|STARTED|Double-Blind Phase||0||
48697421|NCT00104416|102045384|FG003|STARTED|Double-Blind Phase||0||
48697422|NCT00104416|102045385|FG004|STARTED|Double-Blind Phase||0||
48697423|NCT00104416|102045381|FG000|COMPLETED|Double-Blind Phase||69||
48697424|NCT00104416|102045382|FG001|COMPLETED|Double-Blind Phase||66||
48697425|NCT00104416|102045383|FG002|COMPLETED|Double-Blind Phase||0||
48697426|NCT00104416|102045384|FG003|COMPLETED|Double-Blind Phase||0||
48697427|NCT00104416|102045385|FG004|COMPLETED|Double-Blind Phase||0||
48697428|NCT00104416|102045381|FG000|NOT COMPLETED|Double-Blind Phase||8||
48115863|NCT05035017|100608638|FG000|COMPLETED|Period 2 (2 Days)||18||
48115864|NCT05035017|100608639|FG001|COMPLETED|Period 2 (2 Days)||17||
48115865|NCT05035017|100608638|FG000|NOT COMPLETED|Period 2 (2 Days)||0||
48115866|NCT05035017|100608639|FG001|NOT COMPLETED|Period 2 (2 Days)||0||
48115867|NCT01888497|100608640|FG000|STARTED|First Intervention Period||13||
48115868|NCT01888497|100608641|FG001|STARTED|First Intervention Period||14||
48697429|NCT00104416|102045382|FG001|NOT COMPLETED|Double-Blind Phase||10||
48697430|NCT00104416|102045383|FG002|NOT COMPLETED|Double-Blind Phase||0||
48697431|NCT00104416|102045384|FG003|NOT COMPLETED|Double-Blind Phase||0||
48697432|NCT00104416|102045385|FG004|NOT COMPLETED|Double-Blind Phase||0||
48697433|NCT00104416|102045381|FG000|STARTED|Continuation Phase||0||
48697434|NCT00104416|102045382|FG001|STARTED|Continuation Phase||0||
48697435|NCT00104416|102045383|FG002|STARTED|Continuation Phase||69||
48697436|NCT00104416|102045384|FG003|STARTED|Continuation Phase||67||
48697437|NCT00104416|102045385|FG004|STARTED|Continuation Phase||32||
48697438|NCT00104416|102045381|FG000|COMPLETED|Continuation Phase||0||
48697439|NCT00104416|102045382|FG001|COMPLETED|Continuation Phase||0||
48697440|NCT00104416|102045383|FG002|COMPLETED|Continuation Phase||63||
48697441|NCT00104416|102045384|FG003|COMPLETED|Continuation Phase||65||
48697442|NCT00104416|102045385|FG004|COMPLETED|Continuation Phase||27||
48697443|NCT00104416|102045381|FG000|NOT COMPLETED|Continuation Phase||0||
48697444|NCT00104416|102045382|FG001|NOT COMPLETED|Continuation Phase||0||
48697445|NCT00104416|102045383|FG002|NOT COMPLETED|Continuation Phase||6||
48697446|NCT00104416|102045384|FG003|NOT COMPLETED|Continuation Phase||2||
48697447|NCT00104416|102045385|FG004|NOT COMPLETED|Continuation Phase||5||
48697448|NCT01129765|102045386|FG000|STARTED|Overall Study||30||
48697449|NCT01129765|102045386|FG000|COMPLETED|Overall Study||30||
48697450|NCT01129765|102045386|FG000|NOT COMPLETED|Overall Study||0||
48115869|NCT01888497|100608642|FG002|STARTED|First Intervention Period||15||
48115870|NCT01888497|100608643|FG003|STARTED|First Intervention Period||17||
48115871|NCT01888497|100608640|FG000|COMPLETED|First Intervention Period||13||
48115872|NCT01888497|100608641|FG001|COMPLETED|First Intervention Period||14||
48115873|NCT01888497|100608642|FG002|COMPLETED|First Intervention Period||15||
48115874|NCT01888497|100608643|FG003|COMPLETED|First Intervention Period||17||
48115875|NCT01888497|100608640|FG000|NOT COMPLETED|First Intervention Period||0||
48115876|NCT01888497|100608641|FG001|NOT COMPLETED|First Intervention Period||0||
48115877|NCT01888497|100608642|FG002|NOT COMPLETED|First Intervention Period||0||
48115878|NCT01888497|100608643|FG003|NOT COMPLETED|First Intervention Period||0||
48115879|NCT01888497|100608640|FG000|STARTED|Washout Period 1||13||
48115880|NCT01888497|100608641|FG001|STARTED|Washout Period 1||14||
48115881|NCT01888497|100608642|FG002|STARTED|Washout Period 1||15||
48115882|NCT01888497|100608643|FG003|STARTED|Washout Period 1||17||
48115883|NCT01888497|100608640|FG000|COMPLETED|Washout Period 1||13||
48115884|NCT01888497|100608641|FG001|COMPLETED|Washout Period 1||14||
48115885|NCT01888497|100608642|FG002|COMPLETED|Washout Period 1||14||
48115886|NCT01888497|100608643|FG003|COMPLETED|Washout Period 1||16||
48115887|NCT01888497|100608640|FG000|NOT COMPLETED|Washout Period 1||0||
48115888|NCT01888497|100608641|FG001|NOT COMPLETED|Washout Period 1||0||
48115889|NCT01888497|100608642|FG002|NOT COMPLETED|Washout Period 1||1||
48115890|NCT01888497|100608643|FG003|NOT COMPLETED|Washout Period 1||1||
48115891|NCT01888497|100608640|FG000|STARTED|Second Intervention Period||13||
48115892|NCT01888497|100608641|FG001|STARTED|Second Intervention Period||14||
48115893|NCT01888497|100608642|FG002|STARTED|Second Intervention Period||14||
48115894|NCT01888497|100608643|FG003|STARTED|Second Intervention Period||16||
48115895|NCT01888497|100608640|FG000|COMPLETED|Second Intervention Period||13||
48115896|NCT01888497|100608641|FG001|COMPLETED|Second Intervention Period||14||
48115897|NCT01888497|100608642|FG002|COMPLETED|Second Intervention Period||14||
48115898|NCT01888497|100608643|FG003|COMPLETED|Second Intervention Period||16||
48115899|NCT01888497|100608640|FG000|NOT COMPLETED|Second Intervention Period||0||
48115900|NCT01888497|100608641|FG001|NOT COMPLETED|Second Intervention Period||0||
48115901|NCT01888497|100608642|FG002|NOT COMPLETED|Second Intervention Period||0||
48115902|NCT01888497|100608643|FG003|NOT COMPLETED|Second Intervention Period||0||
48115903|NCT01888497|100608640|FG000|STARTED|Washout Period 2||13||
48115904|NCT01888497|100608641|FG001|STARTED|Washout Period 2||14||
48115905|NCT01888497|100608642|FG002|STARTED|Washout Period 2||14||
48115906|NCT01888497|100608643|FG003|STARTED|Washout Period 2||16||
48115907|NCT01888497|100608640|FG000|COMPLETED|Washout Period 2||13||
48115908|NCT01888497|100608641|FG001|COMPLETED|Washout Period 2||14||
48115909|NCT01888497|100608642|FG002|COMPLETED|Washout Period 2||14||
48115910|NCT01888497|100608643|FG003|COMPLETED|Washout Period 2||14||
48115911|NCT01888497|100608640|FG000|NOT COMPLETED|Washout Period 2||0||
48115912|NCT01888497|100608641|FG001|NOT COMPLETED|Washout Period 2||0||
48115913|NCT01888497|100608642|FG002|NOT COMPLETED|Washout Period 2||0||
48115914|NCT01888497|100608643|FG003|NOT COMPLETED|Washout Period 2||2||
48115915|NCT01888497|100608640|FG000|STARTED|Third Intervention Period||13||
48115916|NCT01888497|100608641|FG001|STARTED|Third Intervention Period||14||
48115917|NCT01888497|100608642|FG002|STARTED|Third Intervention Period||14||
48115918|NCT01888497|100608643|FG003|STARTED|Third Intervention Period||14||
48115919|NCT01888497|100608640|FG000|COMPLETED|Third Intervention Period||13||
48115920|NCT01888497|100608641|FG001|COMPLETED|Third Intervention Period||14||
48115921|NCT01888497|100608642|FG002|COMPLETED|Third Intervention Period||14||
48115922|NCT01888497|100608643|FG003|COMPLETED|Third Intervention Period||14||
48115923|NCT01888497|100608640|FG000|NOT COMPLETED|Third Intervention Period||0||
48115924|NCT01888497|100608641|FG001|NOT COMPLETED|Third Intervention Period||0||
48115925|NCT01888497|100608642|FG002|NOT COMPLETED|Third Intervention Period||0||
48115926|NCT01888497|100608643|FG003|NOT COMPLETED|Third Intervention Period||0||
48115927|NCT01888497|100608640|FG000|STARTED|Washout Period 3||13||
48115928|NCT01888497|100608641|FG001|STARTED|Washout Period 3||14||
48115929|NCT01888497|100608642|FG002|STARTED|Washout Period 3||14||
48115930|NCT01888497|100608643|FG003|STARTED|Washout Period 3||14||
48115931|NCT01888497|100608640|FG000|COMPLETED|Washout Period 3||13||
48115932|NCT01888497|100608641|FG001|COMPLETED|Washout Period 3||14||
48115933|NCT01888497|100608642|FG002|COMPLETED|Washout Period 3||14||
48115934|NCT01888497|100608643|FG003|COMPLETED|Washout Period 3||14||
48115935|NCT01888497|100608640|FG000|NOT COMPLETED|Washout Period 3||0||
48278233|NCT03208036|101003273|FG001|NOT COMPLETED|Intervention||2||
48278234|NCT03208036|101003272|FG000|STARTED|4-month Assessment||6||
48115936|NCT01888497|100608641|FG001|NOT COMPLETED|Washout Period 3||0||
48115937|NCT01888497|100608642|FG002|NOT COMPLETED|Washout Period 3||0||
48115938|NCT01888497|100608643|FG003|NOT COMPLETED|Washout Period 3||0||
48115939|NCT01888497|100608640|FG000|STARTED|Fourth Intervention Period||13||
48115940|NCT01888497|100608641|FG001|STARTED|Fourth Intervention Period||14||
48115941|NCT01888497|100608642|FG002|STARTED|Fourth Intervention Period||14||
48115942|NCT01888497|100608643|FG003|STARTED|Fourth Intervention Period||14||
48115943|NCT01888497|100608640|FG000|COMPLETED|Fourth Intervention Period||13||
48115944|NCT01888497|100608641|FG001|COMPLETED|Fourth Intervention Period||14||
48115945|NCT01888497|100608642|FG002|COMPLETED|Fourth Intervention Period||14||
48115946|NCT01888497|100608643|FG003|COMPLETED|Fourth Intervention Period||14||
48697451|NCT03493451|102045387|FG000|STARTED|Overall Study||22||
48697452|NCT03493451|102045388|FG001|STARTED|Overall Study||44||
48697453|NCT03493451|102045389|FG002|STARTED|Overall Study||11||
48697454|NCT03493451|102045387|FG000|COMPLETED|Overall Study||0||
48697455|NCT03493451|102045388|FG001|COMPLETED|Overall Study||0||
48697456|NCT03493451|102045389|FG002|COMPLETED|Overall Study||0||
48697457|NCT03493451|102045387|FG000|NOT COMPLETED|Overall Study||22||
48697458|NCT03493451|102045388|FG001|NOT COMPLETED|Overall Study||44||
48697459|NCT03493451|102045389|FG002|NOT COMPLETED|Overall Study||11||
48697460|NCT00113399|102045390|FG000|STARTED|Overall Study||7||
48697461|NCT00113399|102045391|FG001|STARTED|Overall Study||8||
48697462|NCT00113399|102045390|FG000|COMPLETED|Overall Study||5||
48697463|NCT00113399|102045391|FG001|COMPLETED|Overall Study||3||
48697464|NCT00113399|102045390|FG000|NOT COMPLETED|Overall Study||2||
48697465|NCT00113399|102045391|FG001|NOT COMPLETED|Overall Study||5||
48697466|NCT02723916|102045392|FG000|STARTED|Overall Study||144||
48697467|NCT02723916|102045393|FG001|STARTED|Overall Study||143||
48697468|NCT02723916|102045392|FG000|COMPLETED|Overall Study||135||
48697469|NCT02723916|102045393|FG001|COMPLETED|Overall Study||137||
48697470|NCT02723916|102045392|FG000|NOT COMPLETED|Overall Study||9||
48115947|NCT01888497|100608640|FG000|NOT COMPLETED|Fourth Intervention Period||0||
48115948|NCT01888497|100608641|FG001|NOT COMPLETED|Fourth Intervention Period||0||
48115949|NCT01888497|100608642|FG002|NOT COMPLETED|Fourth Intervention Period||0||
48697471|NCT02723916|102045393|FG001|NOT COMPLETED|Overall Study||6||
48697472|NCT04838054|102045394|FG000|STARTED|Overall Study||29||
48697473|NCT04838054|102045395|FG001|STARTED|Overall Study||28||
48697474|NCT04838054|102045394|FG000|COMPLETED|Overall Study||27||
48697475|NCT04838054|102045395|FG001|COMPLETED|Overall Study||28||
48697476|NCT04838054|102045394|FG000|NOT COMPLETED|Overall Study||2||
48697477|NCT04838054|102045395|FG001|NOT COMPLETED|Overall Study||0||
48697478|NCT03286829|102045396|FG000|STARTED|Overall Study||15||
48697479|NCT03286829|102045397|FG001|STARTED|Overall Study||15||
48697480|NCT03286829|102045398|FG002|STARTED|Overall Study||15||
48697481|NCT03286829|102045399|FG003|STARTED|Overall Study||15||
48697482|NCT03286829|102045396|FG000|COMPLETED|Overall Study||15||
48697483|NCT03286829|102045397|FG001|COMPLETED|Overall Study||15||
48115950|NCT01888497|100608643|FG003|NOT COMPLETED|Fourth Intervention Period||0||
48278235|NCT03208036|101003273|FG001|STARTED|4-month Assessment||6||
48278236|NCT03208036|101003272|FG000|COMPLETED|4-month Assessment||6||
48278237|NCT03208036|101003273|FG001|COMPLETED|4-month Assessment||6||
48278238|NCT03208036|101003272|FG000|NOT COMPLETED|4-month Assessment||0||
48278239|NCT03208036|101003273|FG001|NOT COMPLETED|4-month Assessment||0||
48278240|NCT03208036|101003272|FG000|STARTED|5.5 Month Assessment||6||
48115951|NCT02214147|100608644|FG000|STARTED|Overall Study||16||
48115952|NCT02214147|100608645|FG001|STARTED|Overall Study||12||
48278241|NCT03208036|101003273|FG001|STARTED|5.5 Month Assessment||6||
48278242|NCT03208036|101003272|FG000|COMPLETED|5.5 Month Assessment||5||
48278243|NCT03208036|101003273|FG001|COMPLETED|5.5 Month Assessment||4||
48278244|NCT03208036|101003272|FG000|NOT COMPLETED|5.5 Month Assessment||1||
48278245|NCT03208036|101003273|FG001|NOT COMPLETED|5.5 Month Assessment||2||
48278246|NCT03632941|101003274|FG000|STARTED|Overall Study||1||
48278247|NCT03632941|101003275|FG001|STARTED|Overall Study||2||
48278248|NCT03632941|101003276|FG002|STARTED|Overall Study||5||
48278249|NCT03632941|101003274|FG000|COMPLETED|Overall Study||1||
48278250|NCT03632941|101003275|FG001|COMPLETED|Overall Study||2||
48278251|NCT03632941|101003276|FG002|COMPLETED|Overall Study||5||
48278252|NCT03632941|101003274|FG000|NOT COMPLETED|Overall Study||0||
48278253|NCT03632941|101003275|FG001|NOT COMPLETED|Overall Study||0||
48278254|NCT03632941|101003276|FG002|NOT COMPLETED|Overall Study||0||
48278255|NCT04958642|101003277|FG000|STARTED|Overall Study||18||
48278256|NCT04958642|101003278|FG001|STARTED|Overall Study||13||
48278257|NCT04958642|101003279|FG002|STARTED|Overall Study||35||
48278258|NCT04958642|101003277|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18||
48278259|NCT04958642|101003278|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13||
48278260|NCT04958642|101003279|FG002|Received at Least 1 Dose of Study Drug|Overall Study||35||
48278261|NCT04958642|101003277|FG000|COMPLETED|Overall Study||0||
48278262|NCT04958642|101003278|FG001|COMPLETED|Overall Study||0||
48278263|NCT04958642|101003279|FG002|COMPLETED|Overall Study||0||
48278264|NCT04958642|101003277|FG000|NOT COMPLETED|Overall Study||18||
48278265|NCT04958642|101003278|FG001|NOT COMPLETED|Overall Study||13||
48278266|NCT04958642|101003279|FG002|NOT COMPLETED|Overall Study||35||
48278267|NCT01202903|101003280|FG000|STARTED|Overall Study||308||
48278268|NCT01202903|101003281|FG001|STARTED|Overall Study||308||
48278269|NCT01202903|101003280|FG000|Full Analysis Set|Overall Study||306||
48278270|NCT01202903|101003281|FG001|Full Analysis Set|Overall Study||302||
48278271|NCT01202903|101003280|FG000|Safety Set*|Overall Study||310||
48115953|NCT02214147|100608646|FG002|STARTED|Overall Study||8||
48394288|NCT02372097|101295907|FG000|NOT COMPLETED|First Intervention Period (8 Days)||0||
48394289|NCT02372097|101295908|FG001|NOT COMPLETED|First Intervention Period (8 Days)||0||
48394290|NCT02372097|101295907|FG000|STARTED|Wash Out Period (13 Days)||12||
48394291|NCT02372097|101295908|FG001|STARTED|Wash Out Period (13 Days)||12||
48394292|NCT02372097|101295907|FG000|COMPLETED|Wash Out Period (13 Days)||12||
48394293|NCT02372097|101295908|FG001|COMPLETED|Wash Out Period (13 Days)||12||
48394294|NCT02372097|101295907|FG000|NOT COMPLETED|Wash Out Period (13 Days)||0||
48394295|NCT02372097|101295908|FG001|NOT COMPLETED|Wash Out Period (13 Days)||0||
48394296|NCT02372097|101295907|FG000|STARTED|Second Intervention Period (8 Days)||12||
48394297|NCT02372097|101295908|FG001|STARTED|Second Intervention Period (8 Days)||12||
48394298|NCT02372097|101295907|FG000|COMPLETED|Second Intervention Period (8 Days)||12||
48394299|NCT02372097|101295908|FG001|COMPLETED|Second Intervention Period (8 Days)||12||
48563886|NCT01532934|101713816|FG001|STARTED|Overall Study||52||
48563887|NCT01532934|101713815|FG000|COMPLETED|Overall Study||39||
48563888|NCT01532934|101713816|FG001|COMPLETED|Overall Study||39||
48563889|NCT01532934|101713815|FG000|NOT COMPLETED|Overall Study||14||
48394300|NCT02372097|101295907|FG000|NOT COMPLETED|Second Intervention Period (8 Days)||0||
48563890|NCT01532934|101713816|FG001|NOT COMPLETED|Overall Study||13||
48563891|NCT00253435|101713817|FG000|STARTED|Overall Study||42||
48563892|NCT00253435|101713818|FG001|STARTED|Overall Study||8||
48563893|NCT00253435|101713817|FG000|1st Interim Analysis|Overall Study||15||
48563894|NCT00253435|101713818|FG001|1st Interim Analysis|Overall Study||8||
48563895|NCT00253435|101713817|FG000|2nd Interim Analysis|Overall Study||10||
48563896|NCT00253435|101713818|FG001|2nd Interim Analysis|Overall Study||0||
48563897|NCT00253435|101713817|FG000|3rd Interim Analysis|Overall Study||10||
48563898|NCT00253435|101713818|FG001|3rd Interim Analysis|Overall Study||0||
48563899|NCT00253435|101713817|FG000|COMPLETED|Overall Study||42||
48697484|NCT03286829|102045398|FG002|COMPLETED|Overall Study||15||
48697485|NCT03286829|102045399|FG003|COMPLETED|Overall Study||15||
48697486|NCT03286829|102045396|FG000|NOT COMPLETED|Overall Study||0||
48697487|NCT03286829|102045397|FG001|NOT COMPLETED|Overall Study||0||
48697488|NCT03286829|102045398|FG002|NOT COMPLETED|Overall Study||0||
48697489|NCT03286829|102045399|FG003|NOT COMPLETED|Overall Study||0||
48697490|NCT00802997|102045400|FG000|STARTED|Baseline to 3 Months||34||
48697491|NCT00802997|102045401|FG001|STARTED|Baseline to 3 Months||17||
48697492|NCT00802997|102045400|FG000|COMPLETED|Baseline to 3 Months||34||
48697493|NCT00802997|102045401|FG001|COMPLETED|Baseline to 3 Months||17||
48697494|NCT00802997|102045400|FG000|NOT COMPLETED|Baseline to 3 Months||0||
48697495|NCT00802997|102045401|FG001|NOT COMPLETED|Baseline to 3 Months||0||
48697496|NCT00802997|102045400|FG000|STARTED|3 Months to 6 Months||34||
48697497|NCT00802997|102045401|FG001|STARTED|3 Months to 6 Months||0||
48697498|NCT00802997|102045400|FG000|COMPLETED|3 Months to 6 Months||27||
48697499|NCT00802997|102045401|FG001|COMPLETED|3 Months to 6 Months||0||
48697500|NCT00802997|102045400|FG000|NOT COMPLETED|3 Months to 6 Months||7||
48697501|NCT00802997|102045401|FG001|NOT COMPLETED|3 Months to 6 Months||0||
48697502|NCT00802997|102045400|FG000|STARTED|6 Month to 9 Months||27||
48697503|NCT00802997|102045401|FG001|STARTED|6 Month to 9 Months||0||
48563900|NCT00253435|101713818|FG001|COMPLETED|Overall Study||8||
48563901|NCT00253435|101713817|FG000|NOT COMPLETED|Overall Study||0||
48563902|NCT00253435|101713818|FG001|NOT COMPLETED|Overall Study||0||
48563903|NCT00778817|101713819|FG000|STARTED|Overall Study||20||
48563904|NCT00778817|101713819|FG000|COMPLETED|Overall Study||16||
48563905|NCT00778817|101713819|FG000|NOT COMPLETED|Overall Study||4||
48563906|NCT01169064|101713820|FG000|STARTED|Overall Study||239||
48563907|NCT01169064|101713821|FG001|STARTED|Overall Study||236||
48697504|NCT00802997|102045400|FG000|COMPLETED|6 Month to 9 Months||25||
48697505|NCT00802997|102045401|FG001|COMPLETED|6 Month to 9 Months||0||
48697506|NCT00802997|102045400|FG000|NOT COMPLETED|6 Month to 9 Months||2||
48278272|NCT01202903|101003281|FG001|Safety Set*|Overall Study||299||
48278273|NCT01202903|101003280|FG000|COMPLETED|Overall Study||297||
48697507|NCT00802997|102045401|FG001|NOT COMPLETED|6 Month to 9 Months||0||
48697508|NCT02150551|102045402|FG000|STARTED|Overall Study||1||
48697509|NCT02150551|102045402|FG000|COMPLETED|Overall Study||1||
48697510|NCT02150551|102045402|FG000|NOT COMPLETED|Overall Study||0||
48697511|NCT01436656|102045403|FG000|STARTED|Dose Escalation||4||
48697512|NCT01436656|102045404|FG001|STARTED|Dose Escalation||10||
48697513|NCT01436656|102045405|FG002|STARTED|Dose Escalation||6||
48697514|NCT01436656|102045406|FG003|STARTED|Dose Escalation||3||
48697515|NCT01436656|102045407|FG004|STARTED|Dose Escalation||5||
48115954|NCT02214147|100608644|FG000|COMPLETED|Overall Study||16|Completed=Completed protocol-specified dosing and PK assessment.|
48115955|NCT02214147|100608645|FG001|COMPLETED|Overall Study||12|Completed=Completed protocol-specified dosing and PK assessment.|
48115956|NCT02214147|100608646|FG002|COMPLETED|Overall Study||8|Completed=Completed protocol-specified dosing and PK assessment.|
48697516|NCT01436656|102045408|FG005|STARTED|Dose Escalation||4||
48697517|NCT01436656|102045409|FG006|STARTED|Dose Escalation||4||
48115957|NCT02214147|100608644|FG000|NOT COMPLETED|Overall Study||0||
48115958|NCT02214147|100608645|FG001|NOT COMPLETED|Overall Study||0||
48115959|NCT02214147|100608646|FG002|NOT COMPLETED|Overall Study||0||
48115960|NCT00723606|100608647|FG000|STARTED|Overall Study||189||
48115961|NCT00723606|100608648|FG001|STARTED|Overall Study||187||
48115962|NCT00723606|100608647|FG000|COMPLETED|Overall Study||185||
48115963|NCT00723606|100608648|FG001|COMPLETED|Overall Study||180||
48115964|NCT00723606|100608647|FG000|NOT COMPLETED|Overall Study||4||
48115965|NCT00723606|100608648|FG001|NOT COMPLETED|Overall Study||7||
48115966|NCT03240575|100608649|FG000|STARTED|Overall Study||146||
48115967|NCT03240575|100608650|FG001|STARTED|Overall Study||145||
48115968|NCT03240575|100608651|FG002|STARTED|Overall Study||6||
48115969|NCT03240575|100608652|FG003|STARTED|Overall Study||5||
48115970|NCT03240575|100608649|FG000|COMPLETED|Overall Study||144||
48115971|NCT03240575|100608650|FG001|COMPLETED|Overall Study||131||
48115972|NCT03240575|100608651|FG002|COMPLETED|Overall Study||6||
48115973|NCT03240575|100608652|FG003|COMPLETED|Overall Study||3||
48115974|NCT03240575|100608649|FG000|NOT COMPLETED|Overall Study||2||
48697518|NCT01436656|102045410|FG007|STARTED|Dose Escalation||5||
48697519|NCT01436656|102045411|FG008|STARTED|Dose Escalation||6||
48697520|NCT01436656|102045412|FG009|STARTED|Dose Escalation||5||
48697521|NCT01436656|102045413|FG010|STARTED|Dose Escalation||2||
48697522|NCT01436656|102045414|FG011|STARTED|Dose Escalation||0||
48115975|NCT03240575|100608650|FG001|NOT COMPLETED|Overall Study||14||
48115976|NCT03240575|100608651|FG002|NOT COMPLETED|Overall Study||0||
48115977|NCT03240575|100608652|FG003|NOT COMPLETED|Overall Study||2||
48115978|NCT02517905|100608653|FG000|STARTED|Overall Study||107||
48115979|NCT02517905|100608654|FG001|STARTED|Overall Study||59||
48115980|NCT02517905|100608653|FG000|COMPLETED|Overall Study||97||
48115981|NCT02517905|100608654|FG001|COMPLETED|Overall Study||57||
48115982|NCT02517905|100608653|FG000|NOT COMPLETED|Overall Study||10||
48115983|NCT02517905|100608654|FG001|NOT COMPLETED|Overall Study||2||
48115984|NCT02111252|100608655|FG000|STARTED|Overall Study||55||
48115985|NCT02111252|100608655|FG000|COMPLETED|Overall Study||55||
48115986|NCT02111252|100608655|FG000|NOT COMPLETED|Overall Study||0||
48115987|NCT01856543|100608656|FG000|STARTED|Overall Study||73||
48115988|NCT01856543|100608657|FG001|STARTED|Overall Study||70||
48115989|NCT01856543|100608656|FG000|COMPLETED|Overall Study||60||
48115990|NCT01856543|100608657|FG001|COMPLETED|Overall Study||64||
48115991|NCT01856543|100608656|FG000|NOT COMPLETED|Overall Study||13||
48115992|NCT01856543|100608657|FG001|NOT COMPLETED|Overall Study||6||
48115993|NCT04015219|100608658|FG000|STARTED|Overall Study||2||
48115994|NCT04015219|100608659|FG001|STARTED|Overall Study||1||
48115995|NCT04015219|100608658|FG000|COMPLETED|Overall Study||2||
48115996|NCT04015219|100608659|FG001|COMPLETED|Overall Study||1||
48115997|NCT04015219|100608658|FG000|NOT COMPLETED|Overall Study||0||
48115998|NCT04015219|100608659|FG001|NOT COMPLETED|Overall Study||0||
48115999|NCT00179647|100608660|FG000|STARTED|Overall Study||1913||
48116000|NCT00179647|100608660|FG000|COMPLETED|Overall Study||0||
48116001|NCT00179647|100608660|FG000|NOT COMPLETED|Overall Study||1913||
48116002|NCT04055116|100608661|FG000|STARTED|First Intervention||30||
48116003|NCT04055116|100608662|FG001|STARTED|First Intervention||34||
48116004|NCT04055116|100608661|FG000|Recieved Intervention|First Intervention||28||
48116005|NCT04055116|100608662|FG001|Recieved Intervention|First Intervention||27||
48116006|NCT04055116|100608661|FG000|COMPLETED|First Intervention||28||
48116007|NCT04055116|100608662|FG001|COMPLETED|First Intervention||27||
48116008|NCT04055116|100608661|FG000|NOT COMPLETED|First Intervention||2||
48116009|NCT04055116|100608662|FG001|NOT COMPLETED|First Intervention||7||
48116010|NCT04055116|100608661|FG000|STARTED|Washout (14 Days)||28||
48116011|NCT04055116|100608662|FG001|STARTED|Washout (14 Days)||27||
48116012|NCT04055116|100608661|FG000|COMPLETED|Washout (14 Days)||28||
48278274|NCT01202903|101003281|FG001|COMPLETED|Overall Study||292||
48278275|NCT01202903|101003280|FG000|NOT COMPLETED|Overall Study||11||
48697523|NCT01436656|102045415|FG012|STARTED|Dose Escalation||0||
48697524|NCT01436656|102045416|FG013|STARTED|Dose Escalation||0||
48697525|NCT01436656|102045417|FG014|STARTED|Dose Escalation||0||
48697526|NCT01436656|102045418|FG015|STARTED|Dose Escalation||0||
48394301|NCT02372097|101295908|FG001|NOT COMPLETED|Second Intervention Period (8 Days)||0||
48394302|NCT02494440|101295909|FG000|STARTED|Overall Study||90||
48394303|NCT02494440|101295909|FG000|COMPLETED|Overall Study||90||
48116013|NCT04055116|100608662|FG001|COMPLETED|Washout (14 Days)||27||
48116014|NCT04055116|100608661|FG000|NOT COMPLETED|Washout (14 Days)||0||
48116015|NCT04055116|100608662|FG001|NOT COMPLETED|Washout (14 Days)||0||
48116016|NCT04055116|100608661|FG000|STARTED|Second Intervention (After 14 Days)||28||
48116017|NCT04055116|100608662|FG001|STARTED|Second Intervention (After 14 Days)||27||
48116018|NCT04055116|100608661|FG000|COMPLETED|Second Intervention (After 14 Days)||28||
48116019|NCT04055116|100608662|FG001|COMPLETED|Second Intervention (After 14 Days)||27||
48116020|NCT04055116|100608661|FG000|NOT COMPLETED|Second Intervention (After 14 Days)||0||
48116021|NCT04055116|100608662|FG001|NOT COMPLETED|Second Intervention (After 14 Days)||0||
48116022|NCT04542070|100608663|FG000|STARTED|Maintenance Period (Day 1 - Month 12)||175|Intent-to-Treat-Exposed (ITT-E)|
48116023|NCT04542070|100608664|FG001|STARTED|Maintenance Period (Day 1 - Month 12)||279|Intent-to-Treat-Exposed (ITT-E)|
48116024|NCT04542070|100608665|FG002|STARTED|Maintenance Period (Day 1 - Month 12)||227|Intent-to-Treat-Exposed (ITT-E)|
48116025|NCT04542070|100608666|FG003|STARTED|Maintenance Period (Day 1 - Month 12)||0|Intent-to-Treat-Exposed (ITT-E)|
48116026|NCT04542070|100608663|FG000|COMPLETED|Maintenance Period (Day 1 - Month 12)||152||
48116027|NCT04542070|100608664|FG001|COMPLETED|Maintenance Period (Day 1 - Month 12)||255||
48116028|NCT04542070|100608665|FG002|COMPLETED|Maintenance Period (Day 1 - Month 12)||213||
48116029|NCT04542070|100608666|FG003|COMPLETED|Maintenance Period (Day 1 - Month 12)||0||
48116030|NCT04542070|100608663|FG000|NOT COMPLETED|Maintenance Period (Day 1 - Month 12)||23||
48116031|NCT04542070|100608664|FG001|NOT COMPLETED|Maintenance Period (Day 1 - Month 12)||24||
48116032|NCT04542070|100608665|FG002|NOT COMPLETED|Maintenance Period (Day 1 - Month 12)||14||
48116033|NCT04542070|100608666|FG003|NOT COMPLETED|Maintenance Period (Day 1 - Month 12)||0||
48116034|NCT04542070|100608663|FG000|STARTED|Maintenance + Extension Period||173||
48116035|NCT04542070|100608664|FG001|STARTED|Maintenance + Extension Period||274||
48116036|NCT04542070|100608665|FG002|STARTED|Maintenance + Extension Period||0||
48116037|NCT04542070|100608666|FG003|STARTED|Maintenance + Extension Period||0||
48116038|NCT04542070|100608663|FG000|COMPLETED|Maintenance + Extension Period||150||
48116039|NCT04542070|100608664|FG001|COMPLETED|Maintenance + Extension Period||247||
48116040|NCT04542070|100608665|FG002|COMPLETED|Maintenance + Extension Period||0||
48116041|NCT04542070|100608666|FG003|COMPLETED|Maintenance + Extension Period||0||
48116042|NCT04542070|100608663|FG000|NOT COMPLETED|Maintenance + Extension Period||23||
48116043|NCT04542070|100608664|FG001|NOT COMPLETED|Maintenance + Extension Period||27||
48116044|NCT04542070|100608665|FG002|NOT COMPLETED|Maintenance + Extension Period||0||
48116045|NCT04542070|100608666|FG003|NOT COMPLETED|Maintenance + Extension Period||0||
48116046|NCT04542070|100608663|FG000|STARTED|Extension Period (Month 13 - Month 27)||0||
48697527|NCT01436656|102045419|FG016|STARTED|Dose Escalation||0||
48278276|NCT01202903|101003281|FG001|NOT COMPLETED|Overall Study||16||
48278277|NCT04927884|101003282|FG000|STARTED|Overall Study||3||
48278278|NCT04927884|101003282|FG000|COMPLETED|Overall Study||1||
48394304|NCT02494440|101295909|FG000|NOT COMPLETED|Overall Study||0||
48394305|NCT01532570|101295910|FG000|STARTED|Overall Study||11||
48394306|NCT01532570|101295911|FG001|STARTED|Overall Study||2||
48697528|NCT01436656|102045420|FG017|STARTED|Dose Escalation||0||
48697529|NCT01436656|102045403|FG000|COMPLETED|Dose Escalation||1||
48697530|NCT01436656|102045404|FG001|COMPLETED|Dose Escalation||6||
48116047|NCT04542070|100608664|FG001|STARTED|Extension Period (Month 13 - Month 27)||0||
48116048|NCT04542070|100608665|FG002|STARTED|Extension Period (Month 13 - Month 27)||0||
48116049|NCT04542070|100608666|FG003|STARTED|Extension Period (Month 13 - Month 27)||143||
48116050|NCT04542070|100608663|FG000|COMPLETED|Extension Period (Month 13 - Month 27)||0||
48116051|NCT04542070|100608664|FG001|COMPLETED|Extension Period (Month 13 - Month 27)||0||
48278279|NCT04927884|101003282|FG000|NOT COMPLETED|Overall Study||2||
48278280|NCT04142359|101003283|FG000|STARTED|Overall Study||1||
48278281|NCT04142359|101003284|FG001|STARTED|Overall Study||0||
48278282|NCT04142359|101003285|FG002|STARTED|Overall Study||0||
48278283|NCT04142359|101003283|FG000|COMPLETED|Overall Study||1||
48278284|NCT04142359|101003284|FG001|COMPLETED|Overall Study||0||
48278285|NCT04142359|101003285|FG002|COMPLETED|Overall Study||0||
48278286|NCT04142359|101003283|FG000|NOT COMPLETED|Overall Study||0||
48278287|NCT04142359|101003284|FG001|NOT COMPLETED|Overall Study||0||
48278288|NCT04142359|101003285|FG002|NOT COMPLETED|Overall Study||0||
48278289|NCT00529958|101003286|FG000|STARTED|2-Year Follow-up||110||
48278290|NCT00529958|101003287|FG001|STARTED|2-Year Follow-up||110||
48278291|NCT00529958|101003288|FG002|STARTED|2-Year Follow-up||110||
48278292|NCT00529958|101003286|FG000|COMPLETED|2-Year Follow-up||106||
48278293|NCT00529958|101003287|FG001|COMPLETED|2-Year Follow-up||108||
48278294|NCT00529958|101003288|FG002|COMPLETED|2-Year Follow-up||108||
48394307|NCT01532570|101295912|FG002|STARTED|Overall Study||1||
48394308|NCT01532570|101295913|FG003|STARTED|Overall Study||4||
48394309|NCT01532570|101295910|FG000|COMPLETED|Overall Study||10||
48394310|NCT01532570|101295911|FG001|COMPLETED|Overall Study||1||
48394311|NCT01532570|101295912|FG002|COMPLETED|Overall Study||1||
48394312|NCT01532570|101295913|FG003|COMPLETED|Overall Study||4||
48394313|NCT01532570|101295910|FG000|NOT COMPLETED|Overall Study||1||
48394314|NCT01532570|101295911|FG001|NOT COMPLETED|Overall Study||1||
48278295|NCT00529958|101003286|FG000|NOT COMPLETED|2-Year Follow-up||4||
48278296|NCT00529958|101003287|FG001|NOT COMPLETED|2-Year Follow-up||2||
48278297|NCT00529958|101003288|FG002|NOT COMPLETED|2-Year Follow-up||2||
48278298|NCT00529958|101003286|FG000|STARTED|5-Year Follow-up||106||
48278299|NCT00529958|101003287|FG001|STARTED|5-Year Follow-up||108||
48278300|NCT00529958|101003288|FG002|STARTED|5-Year Follow-up||108||
48278301|NCT00529958|101003286|FG000|COMPLETED|5-Year Follow-up||103||
48278302|NCT00529958|101003287|FG001|COMPLETED|5-Year Follow-up||105||
48278303|NCT00529958|101003288|FG002|COMPLETED|5-Year Follow-up||107||
48394315|NCT01532570|101295912|FG002|NOT COMPLETED|Overall Study||0||
48278304|NCT00529958|101003286|FG000|NOT COMPLETED|5-Year Follow-up||3||
48278305|NCT00529958|101003287|FG001|NOT COMPLETED|5-Year Follow-up||3||
48278306|NCT00529958|101003288|FG002|NOT COMPLETED|5-Year Follow-up||1||
48278307|NCT01012414|101003289|FG000|STARTED|Overall Study||10||
48278308|NCT01012414|101003289|FG000|COMPLETED|Overall Study||0||
48278309|NCT01012414|101003289|FG000|NOT COMPLETED|Overall Study||10||
48278310|NCT00835900|101003290|FG000|STARTED|Overall Study||32||
48278311|NCT00835900|101003291|FG001|STARTED|Overall Study||28||
48278312|NCT00835900|101003290|FG000|COMPLETED|Overall Study||27||
48278313|NCT00835900|101003291|FG001|COMPLETED|Overall Study||22||
48278314|NCT00835900|101003290|FG000|NOT COMPLETED|Overall Study||5||
48278315|NCT00835900|101003291|FG001|NOT COMPLETED|Overall Study||6||
48278316|NCT01807000|101003292|FG000|STARTED|Overall Study||6||
48278317|NCT01807000|101003292|FG000|COMPLETED|Overall Study||6||
48278318|NCT01807000|101003292|FG000|NOT COMPLETED|Overall Study||0||
48278319|NCT01332630|101003293|FG000|STARTED|Overall Study||24||
48278320|NCT01332630|101003293|FG000|COMPLETED|Overall Study||21||
48278321|NCT01332630|101003293|FG000|NOT COMPLETED|Overall Study||3||
48278322|NCT02015455|101007041|FG000|STARTED|Step 0 - Oct 2013 to Mar 2014||48233|By pretrial design, for 1 site (21 clinics), step 0 extended through May 2014, and step 1 began June 2014.|98
48278323|NCT02015455|101007042|FG001|STARTED|Step 0 - Oct 2013 to Mar 2014||0|By pretrial design, for 1 site (21 clinics), step 0 extended through May 2014, and step 1 began June 2014.|0
48278324|NCT02015455|101007041|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 0 - Oct 2013 to Mar 2014||135||98
48278325|NCT02015455|101007042|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 0 - Oct 2013 to Mar 2014||0||0
48278326|NCT02015455|101007041|FG000|COMPLETED|Step 0 - Oct 2013 to Mar 2014||48233||98
48278327|NCT02015455|101007042|FG001|COMPLETED|Step 0 - Oct 2013 to Mar 2014||0||0
48278328|NCT02015455|101007041|FG000|NOT COMPLETED|Step 0 - Oct 2013 to Mar 2014||0||0
48278329|NCT02015455|101007042|FG001|NOT COMPLETED|Step 0 - Oct 2013 to Mar 2014||0||0
48278330|NCT02015455|101007041|FG000|STARTED|Step 1 - Apr 2014 to Sep 2014||24074|By pretrial design, for 1 site (21 clinics), step 0 extended through May 2014, and step 1 began June 2014.|79
48278331|NCT02015455|101007042|FG001|STARTED|Step 1 - Apr 2014 to Sep 2014||6455|By pretrial design, for 1 site (21 clinics), step 0 extended through May 2014, and step 1 began June 2014.|19
48278332|NCT02015455|101007041|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 1 - Apr 2014 to Sep 2014||390||79
48278333|NCT02015455|101007042|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 1 - Apr 2014 to Sep 2014||2208||19
48278334|NCT02015455|101007041|FG000|COMPLETED|Step 1 - Apr 2014 to Sep 2014||24074||79
48278335|NCT02015455|101007042|FG001|COMPLETED|Step 1 - Apr 2014 to Sep 2014||6455||19
48116052|NCT04542070|100608665|FG002|COMPLETED|Extension Period (Month 13 - Month 27)||0||
48116053|NCT04542070|100608666|FG003|COMPLETED|Extension Period (Month 13 - Month 27)||130||
48116054|NCT04542070|100608663|FG000|NOT COMPLETED|Extension Period (Month 13 - Month 27)||0||
48116055|NCT04542070|100608664|FG001|NOT COMPLETED|Extension Period (Month 13 - Month 27)||0||
48116056|NCT04542070|100608665|FG002|NOT COMPLETED|Extension Period (Month 13 - Month 27)||0||
48116057|NCT04542070|100608666|FG003|NOT COMPLETED|Extension Period (Month 13 - Month 27)||13||
48116058|NCT00773097|100608667|FG000|STARTED|Overall Study||46||
48116059|NCT00773097|100608667|FG000|COMPLETED|Overall Study||39||
48116060|NCT00773097|100608667|FG000|NOT COMPLETED|Overall Study||7||
48116061|NCT02107703|100608668|FG000|STARTED|Overall Study||446||
48116062|NCT02107703|100608669|FG001|STARTED|Overall Study||223||
48116063|NCT02107703|100608668|FG000|Received at Least 1 Dose of Study Drug|Overall Study||441||
48116064|NCT02107703|100608669|FG001|Received at Least 1 Dose of Study Drug|Overall Study||223||
48116065|NCT02107703|100608668|FG000|COMPLETED|Overall Study||332||
48116066|NCT02107703|100608669|FG001|COMPLETED|Overall Study||188||
48116067|NCT02107703|100608668|FG000|NOT COMPLETED|Overall Study||114||
48116068|NCT02107703|100608669|FG001|NOT COMPLETED|Overall Study||35||
48116069|NCT03568422|100608670|FG000|STARTED|Overall Study||4||
48116070|NCT03568422|100608671|FG001|STARTED|Overall Study||3||
48116071|NCT03568422|100608672|FG002|STARTED|Overall Study||6||
48116072|NCT03568422|100608673|FG003|STARTED|Overall Study||7||
48116073|NCT03568422|100608674|FG004|STARTED|Overall Study||6||
48116074|NCT03568422|100608675|FG005|STARTED|Overall Study||11||
48116075|NCT03568422|100608670|FG000|COMPLETED|Overall Study||4||
48116076|NCT03568422|100608671|FG001|COMPLETED|Overall Study||3||
48116077|NCT03568422|100608672|FG002|COMPLETED|Overall Study||6||
48116078|NCT03568422|100608673|FG003|COMPLETED|Overall Study||7||
48116079|NCT03568422|100608674|FG004|COMPLETED|Overall Study||6||
48116080|NCT03568422|100608675|FG005|COMPLETED|Overall Study||11||
48116081|NCT03568422|100608670|FG000|NOT COMPLETED|Overall Study||0||
48116082|NCT03568422|100608671|FG001|NOT COMPLETED|Overall Study||0||
48116083|NCT03568422|100608672|FG002|NOT COMPLETED|Overall Study||0||
48116084|NCT03568422|100608673|FG003|NOT COMPLETED|Overall Study||0||
48116085|NCT03568422|100608674|FG004|NOT COMPLETED|Overall Study||0||
48116086|NCT03568422|100608675|FG005|NOT COMPLETED|Overall Study||0||
48116087|NCT00556842|100608676|FG000|STARTED|Overall Study||749||
48116088|NCT00556842|100608677|FG001|STARTED|Overall Study||746||
48116089|NCT00556842|100608676|FG000|COMPLETED|Overall Study||718||
48116090|NCT00556842|100608677|FG001|COMPLETED|Overall Study||723||
48116091|NCT00556842|100608676|FG000|NOT COMPLETED|Overall Study||31||
48116092|NCT00556842|100608677|FG001|NOT COMPLETED|Overall Study||23||
48116093|NCT00179413|100608678|FG000|STARTED|Overall Study||282||
48116094|NCT00179413|100608679|FG001|STARTED|Overall Study||267||
48116095|NCT00179413|100608678|FG000|COMPLETED|Overall Study||157||
48278336|NCT02015455|101007041|FG000|NOT COMPLETED|Step 1 - Apr 2014 to Sep 2014||0||0
48278337|NCT02015455|101007042|FG001|NOT COMPLETED|Step 1 - Apr 2014 to Sep 2014||0||0
48278338|NCT02015455|101007041|FG000|STARTED|Step 2 - Oct 2014 to Mar 2015||23139||59
48278339|NCT02015455|101007042|FG001|STARTED|Step 2 - Oct 2014 to Mar 2015||16285||39
48278340|NCT02015455|101007041|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 2 - Oct 2014 to Mar 2015||98||59
48394316|NCT01532570|101295913|FG003|NOT COMPLETED|Overall Study||0||
48116096|NCT00179413|100608679|FG001|COMPLETED|Overall Study||152||
48116097|NCT00179413|100608678|FG000|NOT COMPLETED|Overall Study||125||
48116098|NCT00179413|100608679|FG001|NOT COMPLETED|Overall Study||115||
48116099|NCT03252522|100608680|FG000|STARTED|Phase 1: Intervention & Placebo||78||
48116100|NCT03252522|100608681|FG001|STARTED|Phase 1: Intervention & Placebo||57||
48116101|NCT03252522|100608682|FG002|STARTED|Phase 1: Intervention & Placebo||0||
48116102|NCT03252522|100608680|FG000|COMPLETED|Phase 1: Intervention & Placebo||69||
48116103|NCT03252522|100608681|FG001|COMPLETED|Phase 1: Intervention & Placebo||54||
48116104|NCT03252522|100608682|FG002|COMPLETED|Phase 1: Intervention & Placebo||0||
48116105|NCT03252522|100608680|FG000|NOT COMPLETED|Phase 1: Intervention & Placebo||9||
48116106|NCT03252522|100608681|FG001|NOT COMPLETED|Phase 1: Intervention & Placebo||3||
48116107|NCT03252522|100608682|FG002|NOT COMPLETED|Phase 1: Intervention & Placebo||0||
48116108|NCT03252522|100608680|FG000|STARTED|Phase 2: Open Label||0||
48116109|NCT03252522|100608681|FG001|STARTED|Phase 2: Open Label||0||
48116110|NCT03252522|100608682|FG002|STARTED|Phase 2: Open Label||123||
48116111|NCT03252522|100608680|FG000|COMPLETED|Phase 2: Open Label||0||
48116112|NCT03252522|100608681|FG001|COMPLETED|Phase 2: Open Label||0||
48116113|NCT03252522|100608682|FG002|COMPLETED|Phase 2: Open Label||99||
48278341|NCT02015455|101007042|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 2 - Oct 2014 to Mar 2015||1511||39
48278342|NCT02015455|101007041|FG000|COMPLETED|Step 2 - Oct 2014 to Mar 2015||23139||59
48278343|NCT02015455|101007042|FG001|COMPLETED|Step 2 - Oct 2014 to Mar 2015||16285||39
48278344|NCT02015455|101007041|FG000|NOT COMPLETED|Step 2 - Oct 2014 to Mar 2015||0||0
48278345|NCT02015455|101007042|FG001|NOT COMPLETED|Step 2 - Oct 2014 to Mar 2015||0||0
48278346|NCT02015455|101007041|FG000|STARTED|Step 3 - Apr 2015 to Sep 2015||14135||39
48278347|NCT02015455|101007042|FG001|STARTED|Step 3 - Apr 2015 to Sep 2015||27661||59
48278348|NCT02015455|101007041|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 3 - Apr 2015 to Sep 2015||72||39
48278349|NCT02015455|101007042|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 3 - Apr 2015 to Sep 2015||4915||59
48278350|NCT02015455|101007041|FG000|COMPLETED|Step 3 - Apr 2015 to Sep 2015||14135||39
48278351|NCT02015455|101007042|FG001|COMPLETED|Step 3 - Apr 2015 to Sep 2015||27661||59
48278352|NCT02015455|101007041|FG000|NOT COMPLETED|Step 3 - Apr 2015 to Sep 2015||0||0
48278353|NCT02015455|101007042|FG001|NOT COMPLETED|Step 3 - Apr 2015 to Sep 2015||0||0
48394317|NCT03007719|101295914|FG000|STARTED|Overall Study||0||
48278354|NCT02015455|101007041|FG000|STARTED|Step 4 - Oct 2015 to Mar 2016||7874||21
48278355|NCT02015455|101007042|FG001|STARTED|Step 4 - Oct 2015 to Mar 2016||31316||77
48278356|NCT02015455|101007041|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 4 - Oct 2015 to Mar 2016||76||21
48394318|NCT03007719|101295915|FG001|STARTED|Overall Study||4||
48278357|NCT02015455|101007042|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 4 - Oct 2015 to Mar 2016||3742||77
48278358|NCT02015455|101007041|FG000|COMPLETED|Step 4 - Oct 2015 to Mar 2016||7874||21
48278359|NCT02015455|101007042|FG001|COMPLETED|Step 4 - Oct 2015 to Mar 2016||31316||77
48278360|NCT02015455|101007041|FG000|NOT COMPLETED|Step 4 - Oct 2015 to Mar 2016||0||0
48278361|NCT02015455|101007042|FG001|NOT COMPLETED|Step 4 - Oct 2015 to Mar 2016||0||0
48278362|NCT02015455|101007041|FG000|STARTED|Step 5 - Apr 2016 to Sep 2016||0||0
48278363|NCT02015455|101007042|FG001|STARTED|Step 5 - Apr 2016 to Sep 2016||39714||98
48278364|NCT02015455|101007041|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 5 - Apr 2016 to Sep 2016||0||0
48278365|NCT02015455|101007042|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 5 - Apr 2016 to Sep 2016||3512||98
48278366|NCT02015455|101007041|FG000|COMPLETED|Step 5 - Apr 2016 to Sep 2016||0||0
48278367|NCT02015455|101007042|FG001|COMPLETED|Step 5 - Apr 2016 to Sep 2016||39714||98
48278368|NCT02015455|101007041|FG000|NOT COMPLETED|Step 5 - Apr 2016 to Sep 2016||0||0
48278369|NCT02015455|101007042|FG001|NOT COMPLETED|Step 5 - Apr 2016 to Sep 2016||0||0
48278370|NCT02113124|101007043|FG000|STARTED|Overall Study||18||
48278371|NCT02113124|101007044|FG001|STARTED|Overall Study||25||
48278372|NCT02113124|101007043|FG000|COMPLETED|Overall Study||17||
48278373|NCT02113124|101007044|FG001|COMPLETED|Overall Study||24||
48278374|NCT02113124|101007043|FG000|NOT COMPLETED|Overall Study||1||
48278375|NCT02113124|101007044|FG001|NOT COMPLETED|Overall Study||1||
48278376|NCT01305200|101007045|FG000|STARTED|Overall Study||111||
48278377|NCT01305200|101007046|FG001|STARTED|Overall Study||112||
48278378|NCT01305200|101007047|FG002|STARTED|Overall Study||3||
48278379|NCT01305200|101007045|FG000|COMPLETED|Overall Study||82||
48278380|NCT01305200|101007046|FG001|COMPLETED|Overall Study||81||
48116114|NCT03252522|100608680|FG000|NOT COMPLETED|Phase 2: Open Label||0||
48278381|NCT01305200|101007047|FG002|COMPLETED|Overall Study||0||
48278382|NCT01305200|101007045|FG000|NOT COMPLETED|Overall Study||29||
48278383|NCT01305200|101007046|FG001|NOT COMPLETED|Overall Study||31||
48278384|NCT01305200|101007047|FG002|NOT COMPLETED|Overall Study||3||
48278385|NCT02389452|101007048|FG000|STARTED|Overall Study||394||
48278386|NCT02389452|101007048|FG000|Participants Received Repeat Injection|Overall Study||11||
48278387|NCT02389452|101007048|FG000|COMPLETED|Overall Study||369||
48278388|NCT02389452|101007048|FG000|NOT COMPLETED|Overall Study||25||
48116115|NCT03252522|100608681|FG001|NOT COMPLETED|Phase 2: Open Label||0||
48116116|NCT03252522|100608682|FG002|NOT COMPLETED|Phase 2: Open Label||24||
48116117|NCT02327429|100608683|FG000|STARTED|Overall Study||19||
48116118|NCT02327429|100608683|FG000|COMPLETED|Overall Study||17||
48116119|NCT02327429|100608683|FG000|NOT COMPLETED|Overall Study||2||
48116120|NCT00110812|100608684|FG000|STARTED|Main Study||91||
48116121|NCT00110812|100608685|FG001|STARTED|Main Study||89||
48116122|NCT00110812|100608686|FG002|STARTED|Main Study||87||
48116123|NCT00110812|100608684|FG000|COMPLETED|Main Study||83||
48116124|NCT00110812|100608685|FG001|COMPLETED|Main Study||78||
48116125|NCT00110812|100608686|FG002|COMPLETED|Main Study||74||
48116126|NCT00110812|100608684|FG000|NOT COMPLETED|Main Study||8||
48116127|NCT00110812|100608685|FG001|NOT COMPLETED|Main Study||11||
48116128|NCT00110812|100608686|FG002|NOT COMPLETED|Main Study||13||
48116129|NCT00110812|100608684|FG000|STARTED|Extended Follow-up||80||
48116130|NCT00110812|100608685|FG001|STARTED|Extended Follow-up||69||
48116131|NCT00110812|100608686|FG002|STARTED|Extended Follow-up||73||
48116132|NCT00110812|100608684|FG000|COMPLETED|Extended Follow-up||78||
48278389|NCT00635427|101007049|FG000|STARTED|Overall Study||13||
48116133|NCT00110812|100608685|FG001|COMPLETED|Extended Follow-up||65||
48116134|NCT00110812|100608686|FG002|COMPLETED|Extended Follow-up||69||
48116135|NCT00110812|100608684|FG000|NOT COMPLETED|Extended Follow-up||2||
48116136|NCT00110812|100608685|FG001|NOT COMPLETED|Extended Follow-up||4||
48116137|NCT00110812|100608686|FG002|NOT COMPLETED|Extended Follow-up||4||
48278390|NCT00635427|101007050|FG001|STARTED|Overall Study||12||
48278391|NCT00635427|101007051|FG002|STARTED|Overall Study||16||
48278392|NCT00635427|101007052|FG003|STARTED|Overall Study||16||
48278393|NCT00635427|101007053|FG004|STARTED|Overall Study||38||
48278394|NCT00635427|101007049|FG000|COMPLETED|Overall Study||1||
48278395|NCT00635427|101007050|FG001|COMPLETED|Overall Study||6||
48278396|NCT00635427|101007051|FG002|COMPLETED|Overall Study||5||
48116138|NCT01714310|100608687|FG000|STARTED|Open Lisdexamfetamine Titration||0||
48116139|NCT01714310|100608688|FG001|STARTED|Open Lisdexamfetamine Titration||0||
48278397|NCT00635427|101007052|FG003|COMPLETED|Overall Study||7||
48278398|NCT00635427|101007053|FG004|COMPLETED|Overall Study||30||
48116140|NCT01714310|100608689|FG002|STARTED|Open Lisdexamfetamine Titration||34||
48116141|NCT01714310|100608687|FG000|COMPLETED|Open Lisdexamfetamine Titration||0||
48116142|NCT01714310|100608688|FG001|COMPLETED|Open Lisdexamfetamine Titration||0||
48116143|NCT01714310|100608689|FG002|COMPLETED|Open Lisdexamfetamine Titration||30||
48278399|NCT00635427|101007049|FG000|NOT COMPLETED|Overall Study||12||
48278400|NCT00635427|101007050|FG001|NOT COMPLETED|Overall Study||6||
48278401|NCT00635427|101007051|FG002|NOT COMPLETED|Overall Study||11||
48697531|NCT01436656|102045405|FG002|COMPLETED|Dose Escalation||5||
48697532|NCT01436656|102045406|FG003|COMPLETED|Dose Escalation||3||
48697533|NCT01436656|102045407|FG004|COMPLETED|Dose Escalation||1||
48697534|NCT01436656|102045408|FG005|COMPLETED|Dose Escalation||2||
48278402|NCT00635427|101007052|FG003|NOT COMPLETED|Overall Study||9||
48278403|NCT00635427|101007053|FG004|NOT COMPLETED|Overall Study||8||
48278404|NCT01472549|101007054|FG000|STARTED|Overall Study||572||
48278405|NCT01472549|101007055|FG001|STARTED|Overall Study||575||
48278406|NCT01472549|101007054|FG000|COMPLETED|Overall Study||572||
48278407|NCT01472549|101007055|FG001|COMPLETED|Overall Study||575||
48278408|NCT01472549|101007054|FG000|NOT COMPLETED|Overall Study||0||
48278409|NCT01472549|101007055|FG001|NOT COMPLETED|Overall Study||0||
48278410|NCT00939159|101007056|FG000|STARTED|Overall Study||13||
48394319|NCT03007719|101295914|FG000|COMPLETED|Overall Study||0||
48394320|NCT03007719|101295915|FG001|COMPLETED|Overall Study||4||
48394321|NCT03007719|101295914|FG000|NOT COMPLETED|Overall Study||0||
48116144|NCT01714310|100608687|FG000|NOT COMPLETED|Open Lisdexamfetamine Titration||0||
48116145|NCT01714310|100608688|FG001|NOT COMPLETED|Open Lisdexamfetamine Titration||0||
48116146|NCT01714310|100608689|FG002|NOT COMPLETED|Open Lisdexamfetamine Titration||4||
48116147|NCT01714310|100608687|FG000|STARTED|Double Blind Adjunctive Treatment||12||
48697535|NCT01436656|102045409|FG006|COMPLETED|Dose Escalation||3||
48697536|NCT01436656|102045410|FG007|COMPLETED|Dose Escalation||2||
48394322|NCT03007719|101295915|FG001|NOT COMPLETED|Overall Study||0||
48394323|NCT01280266|101295916|FG000|STARTED|First Intervention (Week 1-4)||15||
48394324|NCT01280266|101295917|FG001|STARTED|First Intervention (Week 1-4)||14||
48394325|NCT01280266|101295916|FG000|COMPLETED|First Intervention (Week 1-4)||14||
48394326|NCT01280266|101295917|FG001|COMPLETED|First Intervention (Week 1-4)||12||
48394327|NCT01280266|101295916|FG000|NOT COMPLETED|First Intervention (Week 1-4)||1||
48394328|NCT01280266|101295917|FG001|NOT COMPLETED|First Intervention (Week 1-4)||2||
48697537|NCT01436656|102045411|FG008|COMPLETED|Dose Escalation||4||
48116148|NCT01714310|100608688|FG001|STARTED|Double Blind Adjunctive Treatment||14||
48116149|NCT01714310|100608689|FG002|STARTED|Double Blind Adjunctive Treatment||0||
48116150|NCT01714310|100608687|FG000|COMPLETED|Double Blind Adjunctive Treatment||10||
48116151|NCT01714310|100608688|FG001|COMPLETED|Double Blind Adjunctive Treatment||11||
48116152|NCT01714310|100608689|FG002|COMPLETED|Double Blind Adjunctive Treatment||0||
48116153|NCT01714310|100608687|FG000|NOT COMPLETED|Double Blind Adjunctive Treatment||2||
48116154|NCT01714310|100608688|FG001|NOT COMPLETED|Double Blind Adjunctive Treatment||3||
48116155|NCT01714310|100608689|FG002|NOT COMPLETED|Double Blind Adjunctive Treatment||0||
48116156|NCT04960228|100608690|FG000|STARTED|Overall Study||1098|Randomized to intervention|
48116157|NCT04960228|100608691|FG001|STARTED|Overall Study||999|Randomized to intervention|
48116158|NCT04960228|100608690|FG000|COMPLETED|Overall Study||810|Completed full survey including post-intervention outcome measure|
48116159|NCT04960228|100608691|FG001|COMPLETED|Overall Study||813|Completed full survey including post-intervention outcome measure|
48278411|NCT00939159|101007056|FG000|COMPLETED|Overall Study||13||
48278412|NCT00939159|101007056|FG000|NOT COMPLETED|Overall Study||0||
48394329|NCT01280266|101295916|FG000|STARTED|Washout Period (Week 4-5)||14||
48394330|NCT01280266|101295917|FG001|STARTED|Washout Period (Week 4-5)||12||
48394331|NCT01280266|101295916|FG000|COMPLETED|Washout Period (Week 4-5)||14||
48394332|NCT01280266|101295917|FG001|COMPLETED|Washout Period (Week 4-5)||12||
48697538|NCT01436656|102045412|FG009|COMPLETED|Dose Escalation||3||
48697539|NCT01436656|102045413|FG010|COMPLETED|Dose Escalation||1||
48697540|NCT01436656|102045414|FG011|COMPLETED|Dose Escalation||0||
48697541|NCT01436656|102045415|FG012|COMPLETED|Dose Escalation||0||
48697542|NCT01436656|102045416|FG013|COMPLETED|Dose Escalation||0||
48697543|NCT01436656|102045417|FG014|COMPLETED|Dose Escalation||0||
48697544|NCT01436656|102045418|FG015|COMPLETED|Dose Escalation||0||
48697545|NCT01436656|102045419|FG016|COMPLETED|Dose Escalation||0||
48697546|NCT01436656|102045420|FG017|COMPLETED|Dose Escalation||0||
48697547|NCT01436656|102045403|FG000|NOT COMPLETED|Dose Escalation||3||
48697548|NCT01436656|102045404|FG001|NOT COMPLETED|Dose Escalation||4||
48697549|NCT01436656|102045405|FG002|NOT COMPLETED|Dose Escalation||1||
48697550|NCT01436656|102045406|FG003|NOT COMPLETED|Dose Escalation||0||
48116160|NCT04960228|100608690|FG000|NOT COMPLETED|Overall Study||288||
48278413|NCT05602727|101007057|FG000|STARTED|Overall Study||35||
48278414|NCT05602727|101007058|FG001|STARTED|Overall Study||31||
48278415|NCT05602727|101007059|FG002|STARTED|Overall Study||33||
48278416|NCT05602727|101007057|FG000|COMPLETED|Overall Study||13||
48278417|NCT05602727|101007058|FG001|COMPLETED|Overall Study||8||
48278418|NCT05602727|101007059|FG002|COMPLETED|Overall Study||12||
48278419|NCT05602727|101007057|FG000|NOT COMPLETED|Overall Study||22||
48278420|NCT05602727|101007058|FG001|NOT COMPLETED|Overall Study||23||
48278421|NCT05602727|101007059|FG002|NOT COMPLETED|Overall Study||21||
48278422|NCT06298669|101007060|FG000|STARTED|First Intervention (Three Months)||1||
48278423|NCT06298669|101007061|FG001|STARTED|First Intervention (Three Months)||0||
48278424|NCT06298669|101007060|FG000|COMPLETED|First Intervention (Three Months)||0||
48278425|NCT06298669|101007061|FG001|COMPLETED|First Intervention (Three Months)||0||
48278426|NCT06298669|101007060|FG000|NOT COMPLETED|First Intervention (Three Months)||1||
48278427|NCT06298669|101007061|FG001|NOT COMPLETED|First Intervention (Three Months)||0||
48278428|NCT06298669|101007060|FG000|STARTED|Second Intervention (Three Months)||0||
48278429|NCT06298669|101007061|FG001|STARTED|Second Intervention (Three Months)||0||
48394333|NCT01280266|101295916|FG000|NOT COMPLETED|Washout Period (Week 4-5)||0||
48394334|NCT01280266|101295917|FG001|NOT COMPLETED|Washout Period (Week 4-5)||0||
48394335|NCT01280266|101295916|FG000|STARTED|Second Intervention (Week 5-9)||14||
48394336|NCT01280266|101295917|FG001|STARTED|Second Intervention (Week 5-9)||12||
48394337|NCT01280266|101295916|FG000|COMPLETED|Second Intervention (Week 5-9)||14||
48394338|NCT01280266|101295917|FG001|COMPLETED|Second Intervention (Week 5-9)||12||
48394339|NCT01280266|101295916|FG000|NOT COMPLETED|Second Intervention (Week 5-9)||0||
48394340|NCT01280266|101295917|FG001|NOT COMPLETED|Second Intervention (Week 5-9)||0||
48394341|NCT01293006|101295918|FG000|STARTED|Period 1||11||
48563908|NCT01169064|101713820|FG000|COMPLETED|Overall Study||239||
48563909|NCT01169064|101713821|FG001|COMPLETED|Overall Study||236||
48563910|NCT01169064|101713820|FG000|NOT COMPLETED|Overall Study||0||
48563911|NCT01169064|101713821|FG001|NOT COMPLETED|Overall Study||0||
48563912|NCT02714218|101713822|FG000|STARTED|Pre-Treatment Period||180||
48563913|NCT02714218|101713823|FG001|STARTED|Pre-Treatment Period||180||
48563914|NCT02714218|101713824|FG002|STARTED|Pre-Treatment Period||27||
48563915|NCT02714218|101713822|FG000|COMPLETED|Pre-Treatment Period||180|Moved to treatment period|
48563916|NCT02714218|101713823|FG001|COMPLETED|Pre-Treatment Period||178|Moved to treatment period|
48563917|NCT02714218|101713824|FG002|COMPLETED|Pre-Treatment Period||27|Moved to treatment period|
48563918|NCT02714218|101713822|FG000|NOT COMPLETED|Pre-Treatment Period||0||
48563919|NCT02714218|101713823|FG001|NOT COMPLETED|Pre-Treatment Period||2||
48563920|NCT02714218|101713824|FG002|NOT COMPLETED|Pre-Treatment Period||0||
48563921|NCT02714218|101713822|FG000|STARTED|Treatment Period||180||
48563922|NCT02714218|101713823|FG001|STARTED|Treatment Period||178||
48563923|NCT02714218|101713824|FG002|STARTED|Treatment Period||27||
48563924|NCT02714218|101713822|FG000|COMPLETED|Treatment Period||6||
48563925|NCT02714218|101713823|FG001|COMPLETED|Treatment Period||2||
48563926|NCT02714218|101713824|FG002|COMPLETED|Treatment Period||2||
48563927|NCT02714218|101713822|FG000|NOT COMPLETED|Treatment Period||174||
48563928|NCT02714218|101713823|FG001|NOT COMPLETED|Treatment Period||176||
48563929|NCT02714218|101713824|FG002|NOT COMPLETED|Treatment Period||25||
48563930|NCT02157376|101713825|FG000|STARTED|Overall Study||155||
48697551|NCT01436656|102045407|FG004|NOT COMPLETED|Dose Escalation||4||
48697552|NCT01436656|102045408|FG005|NOT COMPLETED|Dose Escalation||2||
48697553|NCT01436656|102045409|FG006|NOT COMPLETED|Dose Escalation||1||
48697554|NCT01436656|102045410|FG007|NOT COMPLETED|Dose Escalation||3||
48697555|NCT01436656|102045411|FG008|NOT COMPLETED|Dose Escalation||2||
48697556|NCT01436656|102045412|FG009|NOT COMPLETED|Dose Escalation||2||
48697557|NCT01436656|102045413|FG010|NOT COMPLETED|Dose Escalation||1||
48697558|NCT01436656|102045414|FG011|NOT COMPLETED|Dose Escalation||0||
48697559|NCT01436656|102045415|FG012|NOT COMPLETED|Dose Escalation||0||
48697560|NCT01436656|102045416|FG013|NOT COMPLETED|Dose Escalation||0||
48697561|NCT01436656|102045417|FG014|NOT COMPLETED|Dose Escalation||0||
48697562|NCT01436656|102045418|FG015|NOT COMPLETED|Dose Escalation||0||
48697563|NCT01436656|102045419|FG016|NOT COMPLETED|Dose Escalation||0||
48697564|NCT01436656|102045420|FG017|NOT COMPLETED|Dose Escalation||0||
48697565|NCT01436656|102045403|FG000|STARTED|Dose Expansion||0||
48697566|NCT01436656|102045404|FG001|STARTED|Dose Expansion||0||
48697567|NCT01436656|102045405|FG002|STARTED|Dose Expansion||0||
48697568|NCT01436656|102045406|FG003|STARTED|Dose Expansion||0||
48697569|NCT01436656|102045407|FG004|STARTED|Dose Expansion||0||
48697570|NCT01436656|102045408|FG005|STARTED|Dose Expansion||0||
48697571|NCT01436656|102045409|FG006|STARTED|Dose Expansion||0||
48697572|NCT01436656|102045410|FG007|STARTED|Dose Expansion||0||
48697573|NCT01436656|102045411|FG008|STARTED|Dose Expansion||0||
48116161|NCT04960228|100608691|FG001|NOT COMPLETED|Overall Study||186||
48278430|NCT06298669|101007060|FG000|COMPLETED|Second Intervention (Three Months)||0||
48697574|NCT01436656|102045412|FG009|STARTED|Dose Expansion||0||
48697575|NCT01436656|102045413|FG010|STARTED|Dose Expansion||0||
48697576|NCT01436656|102045414|FG011|STARTED|Dose Expansion||9||
48278431|NCT06298669|101007061|FG001|COMPLETED|Second Intervention (Three Months)||0||
48563931|NCT02157376|101713826|FG001|STARTED|Overall Study||156||
48563932|NCT02157376|101713825|FG000|COMPLETED|Overall Study||133||
48563933|NCT02157376|101713826|FG001|COMPLETED|Overall Study||138||
48116162|NCT02469610|100608692|FG000|STARTED|Overall Study||34||
48116163|NCT02469610|100608693|FG001|STARTED|Overall Study||31||
48116164|NCT02469610|100608692|FG000|COMPLETED|Overall Study||30||
48116165|NCT02469610|100608693|FG001|COMPLETED|Overall Study||30||
48116166|NCT02469610|100608692|FG000|NOT COMPLETED|Overall Study||4||
48116167|NCT02469610|100608693|FG001|NOT COMPLETED|Overall Study||1||
48116168|NCT01956110|100608694|FG000|STARTED|Overall Study||665||
48116169|NCT01956110|100608695|FG001|STARTED|Overall Study||661||
48116170|NCT01956110|100608694|FG000|COMPLETED|Overall Study||630||
48116171|NCT01956110|100608695|FG001|COMPLETED|Overall Study||639||
48116172|NCT01956110|100608694|FG000|NOT COMPLETED|Overall Study||35||
48116173|NCT01956110|100608695|FG001|NOT COMPLETED|Overall Study||22||
48116174|NCT01479621|100608696|FG000|STARTED|Pre-Assignment Period (Run-In Placebo)||909||
48116175|NCT01479621|100608697|FG001|STARTED|Pre-Assignment Period (Run-In Placebo)||0||
48116176|NCT01479621|100608698|FG002|STARTED|Pre-Assignment Period (Run-In Placebo)||0||
48116177|NCT01479621|100608699|FG003|STARTED|Pre-Assignment Period (Run-In Placebo)||0||
48116178|NCT01479621|100608700|FG004|STARTED|Pre-Assignment Period (Run-In Placebo)||0||
48116179|NCT01479621|100608701|FG005|STARTED|Pre-Assignment Period (Run-In Placebo)||0||
48116180|NCT01479621|100608702|FG006|STARTED|Pre-Assignment Period (Run-In Placebo)||0||
48116181|NCT01479621|100608696|FG000|COMPLETED|Pre-Assignment Period (Run-In Placebo)||622||
48116182|NCT01479621|100608697|FG001|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
48116183|NCT01479621|100608698|FG002|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
48563934|NCT02157376|101713825|FG000|NOT COMPLETED|Overall Study||22||
48278432|NCT06298669|101007060|FG000|NOT COMPLETED|Second Intervention (Three Months)||0||
48278433|NCT06298669|101007061|FG001|NOT COMPLETED|Second Intervention (Three Months)||0||
48278434|NCT06024278|101007062|FG000|STARTED|Overall Study||10||
48278435|NCT06024278|101007063|FG001|STARTED|Overall Study||10||
48278436|NCT06024278|101007062|FG000|COMPLETED|Overall Study||10||
48278437|NCT06024278|101007063|FG001|COMPLETED|Overall Study||10||
48278438|NCT06024278|101007062|FG000|NOT COMPLETED|Overall Study||0||
48278439|NCT06024278|101007063|FG001|NOT COMPLETED|Overall Study||0||
48116184|NCT01479621|100608699|FG003|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
48116185|NCT01479621|100608700|FG004|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
48116186|NCT01479621|100608701|FG005|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
48116187|NCT01479621|100608702|FG006|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
48116188|NCT01479621|100608696|FG000|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||287||
48116189|NCT01479621|100608697|FG001|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
48116190|NCT01479621|100608698|FG002|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
48116191|NCT01479621|100608699|FG003|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
48116192|NCT01479621|100608700|FG004|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
48116193|NCT01479621|100608701|FG005|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
48697577|NCT01436656|102045415|FG012|STARTED|Dose Expansion||6||
48697578|NCT01436656|102045416|FG013|STARTED|Dose Expansion||2||
48697579|NCT01436656|102045417|FG014|STARTED|Dose Expansion||16||
48697580|NCT01436656|102045418|FG015|STARTED|Dose Expansion||2||
48697581|NCT01436656|102045419|FG016|STARTED|Dose Expansion||6||
48697582|NCT01436656|102045420|FG017|STARTED|Dose Expansion||12||
48697583|NCT01436656|102045403|FG000|COMPLETED|Dose Expansion||0||
48697584|NCT01436656|102045404|FG001|COMPLETED|Dose Expansion||0||
48697585|NCT01436656|102045405|FG002|COMPLETED|Dose Expansion||0||
48697586|NCT01436656|102045406|FG003|COMPLETED|Dose Expansion||0||
48697587|NCT01436656|102045407|FG004|COMPLETED|Dose Expansion||0||
48697588|NCT01436656|102045408|FG005|COMPLETED|Dose Expansion||0||
48697589|NCT01436656|102045409|FG006|COMPLETED|Dose Expansion||0||
48697590|NCT01436656|102045410|FG007|COMPLETED|Dose Expansion||0||
48697591|NCT01436656|102045411|FG008|COMPLETED|Dose Expansion||0||
48697592|NCT01436656|102045412|FG009|COMPLETED|Dose Expansion||0||
48697593|NCT01436656|102045413|FG010|COMPLETED|Dose Expansion||0||
48697594|NCT01436656|102045414|FG011|COMPLETED|Dose Expansion||3||
48116194|NCT01479621|100608702|FG006|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
48116195|NCT01479621|100608696|FG000|STARTED|Treatment Period||0||
48116196|NCT01479621|100608697|FG001|STARTED|Treatment Period||103||
48278440|NCT01552603|101007064|FG000|STARTED|Overall Study||14||
48278441|NCT01552603|101007064|FG000|COMPLETED|Overall Study||13||
48278442|NCT01552603|101007064|FG000|NOT COMPLETED|Overall Study||1||
48278443|NCT05653427|101007065|FG000|STARTED|Overall Study||18||
48278444|NCT05653427|101007065|FG000|COMPLETED|Overall Study||5||
48278445|NCT05653427|101007065|FG000|NOT COMPLETED|Overall Study||13||
48278446|NCT00503139|101007066|FG000|STARTED|Overall Study||684||
48278447|NCT00503139|101007066|FG000|COMPLETED|Overall Study||676||
48697595|NCT01436656|102045415|FG012|COMPLETED|Dose Expansion||0||
48697596|NCT01436656|102045416|FG013|COMPLETED|Dose Expansion||1||
48116197|NCT01479621|100608698|FG002|STARTED|Treatment Period||104||
48116198|NCT01479621|100608699|FG003|STARTED|Treatment Period||104||
48116199|NCT01479621|100608700|FG004|STARTED|Treatment Period||103||
48278448|NCT00503139|101007066|FG000|NOT COMPLETED|Overall Study||8||
48278449|NCT01253018|101007067|FG000|STARTED|Overall Study||22||
48116200|NCT01479621|100608701|FG005|STARTED|Treatment Period||104||
48278450|NCT01253018|101007068|FG001|STARTED|Overall Study||23||
48697597|NCT01436656|102045417|FG014|COMPLETED|Dose Expansion||8||
48697598|NCT01436656|102045418|FG015|COMPLETED|Dose Expansion||2||
48697599|NCT01436656|102045419|FG016|COMPLETED|Dose Expansion||2||
48697600|NCT01436656|102045420|FG017|COMPLETED|Dose Expansion||4||
48116201|NCT01479621|100608702|FG006|STARTED|Treatment Period||104||
48116202|NCT01479621|100608696|FG000|Safety Population|Treatment Period||0||
48116203|NCT01479621|100608697|FG001|Safety Population|Treatment Period||103||
48116204|NCT01479621|100608698|FG002|Safety Population|Treatment Period||104||
48116205|NCT01479621|100608699|FG003|Safety Population|Treatment Period||104||
48116206|NCT01479621|100608700|FG004|Safety Population|Treatment Period||103||
48116207|NCT01479621|100608701|FG005|Safety Population|Treatment Period||104||
48116208|NCT01479621|100608702|FG006|Safety Population|Treatment Period||104||
48116209|NCT01479621|100608696|FG000|Full Analysis Set|Treatment Period||0||
48116210|NCT01479621|100608697|FG001|Full Analysis Set|Treatment Period||102||
48116211|NCT01479621|100608698|FG002|Full Analysis Set|Treatment Period||101||
48116212|NCT01479621|100608699|FG003|Full Analysis Set|Treatment Period||102||
48116213|NCT01479621|100608700|FG004|Full Analysis Set|Treatment Period||102||
48116214|NCT01479621|100608701|FG005|Full Analysis Set|Treatment Period||102||
48116215|NCT01479621|100608702|FG006|Full Analysis Set|Treatment Period||102||
48116216|NCT01479621|100608696|FG000|COMPLETED|Treatment Period||0||
48116217|NCT01479621|100608697|FG001|COMPLETED|Treatment Period||79||
48116218|NCT01479621|100608698|FG002|COMPLETED|Treatment Period||83||
48116219|NCT01479621|100608699|FG003|COMPLETED|Treatment Period||92||
48116220|NCT01479621|100608700|FG004|COMPLETED|Treatment Period||82||
48116221|NCT01479621|100608701|FG005|COMPLETED|Treatment Period||63||
48116222|NCT01479621|100608702|FG006|COMPLETED|Treatment Period||84||
48116223|NCT01479621|100608696|FG000|NOT COMPLETED|Treatment Period||0||
48116224|NCT01479621|100608697|FG001|NOT COMPLETED|Treatment Period||24||
48116225|NCT01479621|100608698|FG002|NOT COMPLETED|Treatment Period||21||
48116226|NCT01479621|100608699|FG003|NOT COMPLETED|Treatment Period||12||
48116227|NCT01479621|100608700|FG004|NOT COMPLETED|Treatment Period||21||
48116228|NCT01479621|100608701|FG005|NOT COMPLETED|Treatment Period||41||
48116229|NCT01479621|100608702|FG006|NOT COMPLETED|Treatment Period||20||
48116230|NCT00427635|100608703|FG000|STARTED|Treatment Phase||26||
48116231|NCT00427635|100608704|FG001|STARTED|Treatment Phase||26||
48116232|NCT00427635|100608703|FG000|COMPLETED|Treatment Phase||25||
48116233|NCT00427635|100608704|FG001|COMPLETED|Treatment Phase||26||
48116234|NCT00427635|100608703|FG000|NOT COMPLETED|Treatment Phase||1||
48116235|NCT00427635|100608704|FG001|NOT COMPLETED|Treatment Phase||0||
48116236|NCT00427635|100608703|FG000|STARTED|Study Completion to Safety Follow-up||25||
48278451|NCT01253018|101007067|FG000|COMPLETED|Overall Study||18||
48697601|NCT01436656|102045403|FG000|NOT COMPLETED|Dose Expansion||0||
48697602|NCT01436656|102045404|FG001|NOT COMPLETED|Dose Expansion||0||
48697603|NCT01436656|102045405|FG002|NOT COMPLETED|Dose Expansion||0||
48697604|NCT01436656|102045406|FG003|NOT COMPLETED|Dose Expansion||0||
48697605|NCT01436656|102045407|FG004|NOT COMPLETED|Dose Expansion||0||
48697606|NCT01436656|102045408|FG005|NOT COMPLETED|Dose Expansion||0||
48697607|NCT01436656|102045409|FG006|NOT COMPLETED|Dose Expansion||0||
48697608|NCT01436656|102045410|FG007|NOT COMPLETED|Dose Expansion||0||
48697609|NCT01436656|102045411|FG008|NOT COMPLETED|Dose Expansion||0||
48697610|NCT01436656|102045412|FG009|NOT COMPLETED|Dose Expansion||0||
48697611|NCT01436656|102045413|FG010|NOT COMPLETED|Dose Expansion||0||
48697612|NCT01436656|102045414|FG011|NOT COMPLETED|Dose Expansion||6||
48697613|NCT01436656|102045415|FG012|NOT COMPLETED|Dose Expansion||6||
48116237|NCT00427635|100608704|FG001|STARTED|Study Completion to Safety Follow-up||26||
48278452|NCT01253018|101007068|FG001|COMPLETED|Overall Study||21||
48697614|NCT01436656|102045416|FG013|NOT COMPLETED|Dose Expansion||1||
48697615|NCT01436656|102045417|FG014|NOT COMPLETED|Dose Expansion||8||
48278453|NCT01253018|101007067|FG000|NOT COMPLETED|Overall Study||4||
48278454|NCT01253018|101007068|FG001|NOT COMPLETED|Overall Study||2||
48278455|NCT02180243|101007069|FG000|STARTED|Overall Study||75||
48116238|NCT00427635|100608703|FG000|COMPLETED|Study Completion to Safety Follow-up||25||
48116239|NCT00427635|100608704|FG001|COMPLETED|Study Completion to Safety Follow-up||25||
48116240|NCT00427635|100608703|FG000|NOT COMPLETED|Study Completion to Safety Follow-up||0||
48116241|NCT00427635|100608704|FG001|NOT COMPLETED|Study Completion to Safety Follow-up||1||
48116242|NCT00357370|100608705|FG000|STARTED|Cohort 1||4||
48116243|NCT00357370|100608706|FG001|STARTED|Cohort 1||0||
48116244|NCT00357370|100608707|FG002|STARTED|Cohort 1||0||
48116245|NCT00357370|100608705|FG000|COMPLETED|Cohort 1||4||
48116246|NCT00357370|100608706|FG001|COMPLETED|Cohort 1||0||
48278456|NCT02180243|101007070|FG001|STARTED|Overall Study||74||
48278457|NCT02180243|101007069|FG000|COMPLETED|Overall Study||51||
48278458|NCT02180243|101007070|FG001|COMPLETED|Overall Study||60||
48278459|NCT02180243|101007069|FG000|NOT COMPLETED|Overall Study||24||
48278460|NCT02180243|101007070|FG001|NOT COMPLETED|Overall Study||14||
48278461|NCT02738853|101007071|FG000|STARTED|Enrollment||93||
48278462|NCT02738853|101007071|FG000|COMPLETED|Enrollment||60||
48278463|NCT02738853|101007071|FG000|NOT COMPLETED|Enrollment||33||
48278464|NCT02738853|101007071|FG000|STARTED|Procedure||60||
48278465|NCT02738853|101007071|FG000|COMPLETED|Procedure||59||
48278466|NCT02738853|101007071|FG000|NOT COMPLETED|Procedure||1||
48697616|NCT01436656|102045418|FG015|NOT COMPLETED|Dose Expansion||0||
48697617|NCT01436656|102045419|FG016|NOT COMPLETED|Dose Expansion||4||
48278467|NCT02738853|101007071|FG000|STARTED|1 Month||59||
48278468|NCT02738853|101007071|FG000|COMPLETED|1 Month||57||
48278469|NCT02738853|101007071|FG000|NOT COMPLETED|1 Month||2||
48278470|NCT02738853|101007071|FG000|STARTED|6 Month||57||
48278471|NCT02738853|101007071|FG000|COMPLETED|6 Month||51||
48278472|NCT02738853|101007071|FG000|NOT COMPLETED|6 Month||6||
48563935|NCT02157376|101713826|FG001|NOT COMPLETED|Overall Study||18||
48563936|NCT01343043|101713827|FG000|STARTED|Overall Study||15||
48563937|NCT01343043|101713828|FG001|STARTED|Overall Study||14||
48563938|NCT01343043|101713829|FG002|STARTED|Overall Study||5||
48563939|NCT01343043|101713830|FG003|STARTED|Overall Study||16||
48563940|NCT01343043|101713827|FG000|Received T-cell Infusion|Overall Study||12||
48563941|NCT01343043|101713828|FG001|Received T-cell Infusion|Overall Study||13||
48563942|NCT01343043|101713829|FG002|Received T-cell Infusion|Overall Study||5||
48563943|NCT01343043|101713830|FG003|Received T-cell Infusion|Overall Study||15||
48697618|NCT01436656|102045420|FG017|NOT COMPLETED|Dose Expansion||8||
48697619|NCT01289275|102045421|FG000|STARTED|Overall Study||317||
48697620|NCT01289275|102045422|FG001|STARTED|Overall Study||320||
48697621|NCT01289275|102045423|FG002|STARTED|Overall Study||317||
48697622|NCT01289275|102045424|FG003|STARTED|Overall Study||316||
48697623|NCT01289275|102045421|FG000|COMPLETED|Overall Study||317||
48697624|NCT01289275|102045422|FG001|COMPLETED|Overall Study||320||
48697625|NCT01289275|102045423|FG002|COMPLETED|Overall Study||317||
48697626|NCT01289275|102045424|FG003|COMPLETED|Overall Study||316||
48697627|NCT01289275|102045421|FG000|NOT COMPLETED|Overall Study||0||
48697628|NCT01289275|102045422|FG001|NOT COMPLETED|Overall Study||0||
48697629|NCT01289275|102045423|FG002|NOT COMPLETED|Overall Study||0||
48697630|NCT01289275|102045424|FG003|NOT COMPLETED|Overall Study||0||
48697631|NCT00443872|102045425|FG000|STARTED|Overall Study||77||
48697632|NCT00443872|102045425|FG000|COMPLETED|Overall Study||60||
48116247|NCT00357370|100608707|FG002|COMPLETED|Cohort 1||0||
48116248|NCT00357370|100608705|FG000|NOT COMPLETED|Cohort 1||0||
48116249|NCT00357370|100608706|FG001|NOT COMPLETED|Cohort 1||0||
48116250|NCT00357370|100608707|FG002|NOT COMPLETED|Cohort 1||0||
48116251|NCT00357370|100608705|FG000|STARTED|Cohort 2||24||
48116252|NCT00357370|100608706|FG001|STARTED|Cohort 2||23||
48116253|NCT00357370|100608707|FG002|STARTED|Cohort 2||24||
48116254|NCT00357370|100608705|FG000|COMPLETED|Cohort 2||22||
48116255|NCT00357370|100608706|FG001|COMPLETED|Cohort 2||16||
48116256|NCT00357370|100608707|FG002|COMPLETED|Cohort 2||22||
48116257|NCT00357370|100608705|FG000|NOT COMPLETED|Cohort 2||2||
48116258|NCT00357370|100608706|FG001|NOT COMPLETED|Cohort 2||7||
48116259|NCT00357370|100608707|FG002|NOT COMPLETED|Cohort 2||2||
48278473|NCT02738853|101007071|FG000|STARTED|1 Year||51||
48278474|NCT02738853|101007071|FG000|COMPLETED|1 Year||44||
48278475|NCT02738853|101007071|FG000|NOT COMPLETED|1 Year||7||
48563944|NCT01343043|101713827|FG000|COMPLETED|Overall Study||12||
48563945|NCT01343043|101713828|FG001|COMPLETED|Overall Study||13||
48278476|NCT02738853|101007071|FG000|STARTED|2 Year||44||
48278477|NCT02738853|101007071|FG000|COMPLETED|2 Year||41||
48278478|NCT02738853|101007071|FG000|NOT COMPLETED|2 Year||3||
48278479|NCT02738853|101007071|FG000|STARTED|3 Year||41||
48278480|NCT02738853|101007071|FG000|COMPLETED|3 Year||38||
48563946|NCT01343043|101713829|FG002|COMPLETED|Overall Study||5||
48697633|NCT00443872|102045425|FG000|NOT COMPLETED|Overall Study||17||
48116260|NCT03228680|100608708|FG000|STARTED|Overall Study||170||
48278481|NCT02738853|101007071|FG000|NOT COMPLETED|3 Year||3||
48563947|NCT01343043|101713830|FG003|COMPLETED|Overall Study||15||
48697634|NCT02591472|102045426|FG000|STARTED|Overall Study||50||
48697635|NCT02591472|102045427|FG001|STARTED|Overall Study||38||
48697636|NCT02591472|102045426|FG000|COMPLETED|Overall Study||50||
48697637|NCT02591472|102045427|FG001|COMPLETED|Overall Study||38||
48563948|NCT01343043|101713827|FG000|NOT COMPLETED|Overall Study||3||
48563949|NCT01343043|101713828|FG001|NOT COMPLETED|Overall Study||1||
48563950|NCT01343043|101713829|FG002|NOT COMPLETED|Overall Study||0||
48563951|NCT01343043|101713830|FG003|NOT COMPLETED|Overall Study||1||
48563952|NCT01611883|101713831|FG000|STARTED|Overall Study||75||
48563953|NCT01611883|101713832|FG001|STARTED|Overall Study||77||
48563954|NCT01611883|101713831|FG000|COMPLETED|Overall Study||74||
48563955|NCT01611883|101713832|FG001|COMPLETED|Overall Study||76||
48563956|NCT01611883|101713831|FG000|NOT COMPLETED|Overall Study||1||
48563957|NCT01611883|101713832|FG001|NOT COMPLETED|Overall Study||1||
48563958|NCT02182843|101713833|FG000|STARTED|Overall Study||81||
48563959|NCT02182843|101713833|FG000|COMPLETED|Overall Study||71||
48563960|NCT02182843|101713833|FG000|NOT COMPLETED|Overall Study||10||
48278482|NCT02738853|101007071|FG000|STARTED|4 Year||38||
48563961|NCT04205643|101713834|FG000|STARTED|Induction Phase||548||
48563962|NCT04205643|101713835|FG001|STARTED|Induction Phase||0||
48563963|NCT04205643|101713836|FG002|STARTED|Induction Phase||0||
48563964|NCT04205643|101713834|FG000|COMPLETED|Induction Phase||438||
48563965|NCT04205643|101713835|FG001|COMPLETED|Induction Phase||0||
48563966|NCT04205643|101713836|FG002|COMPLETED|Induction Phase||0||
48563967|NCT04205643|101713834|FG000|NOT COMPLETED|Induction Phase||110||
48563968|NCT04205643|101713835|FG001|NOT COMPLETED|Induction Phase||0||
48563969|NCT04205643|101713836|FG002|NOT COMPLETED|Induction Phase||0||
48563970|NCT04205643|101713834|FG000|STARTED|Maintenance Phase||0||
48563971|NCT04205643|101713835|FG001|STARTED|Maintenance Phase||294||
48563972|NCT04205643|101713836|FG002|STARTED|Maintenance Phase||144||
48563973|NCT04205643|101713834|FG000|COMPLETED|Maintenance Phase||0||
48563974|NCT04205643|101713835|FG001|COMPLETED|Maintenance Phase||240||
48563975|NCT04205643|101713836|FG002|COMPLETED|Maintenance Phase||113||
48563976|NCT04205643|101713834|FG000|NOT COMPLETED|Maintenance Phase||0||
48563977|NCT04205643|101713835|FG001|NOT COMPLETED|Maintenance Phase||54||
48563978|NCT04205643|101713836|FG002|NOT COMPLETED|Maintenance Phase||31||
48563979|NCT00014495|101713837|FG000|STARTED|Overall Study||3||
48563980|NCT00014495|101713838|FG001|STARTED|Overall Study||3||
48563981|NCT00014495|101713839|FG002|STARTED|Overall Study||20||
48563982|NCT00014495|101713840|FG003|STARTED|Overall Study||6||
48563983|NCT00014495|101713837|FG000|COMPLETED|Overall Study||3||
48563984|NCT00014495|101713838|FG001|COMPLETED|Overall Study||3||
48563985|NCT00014495|101713839|FG002|COMPLETED|Overall Study||19||
48563986|NCT00014495|101713840|FG003|COMPLETED|Overall Study||5||
48563987|NCT00014495|101713837|FG000|NOT COMPLETED|Overall Study||0||
48563988|NCT00014495|101713838|FG001|NOT COMPLETED|Overall Study||0||
48563989|NCT00014495|101713839|FG002|NOT COMPLETED|Overall Study||1||
48563990|NCT00014495|101713840|FG003|NOT COMPLETED|Overall Study||1||
48563991|NCT00455403|101713841|FG000|STARTED|Overall Study||59||
48563992|NCT00455403|101713842|FG001|STARTED|Overall Study||57||
48563993|NCT00455403|101713841|FG000|COMPLETED|Overall Study||56||
48563994|NCT00455403|101713842|FG001|COMPLETED|Overall Study||51||
48563995|NCT00455403|101713841|FG000|NOT COMPLETED|Overall Study||3||
48563996|NCT00455403|101713842|FG001|NOT COMPLETED|Overall Study||6||
48563997|NCT00856193|101713843|FG000|STARTED|Period 1||16||
48563998|NCT00856193|101713844|FG001|STARTED|Period 1||17||
48563999|NCT00856193|101713843|FG000|COMPLETED|Period 1||16||
48564000|NCT00856193|101713844|FG001|COMPLETED|Period 1||17||
48564001|NCT00856193|101713843|FG000|NOT COMPLETED|Period 1||0||
48564002|NCT00856193|101713844|FG001|NOT COMPLETED|Period 1||0||
48564003|NCT00856193|101713843|FG000|STARTED|Period 2||16||
48564004|NCT00856193|101713844|FG001|STARTED|Period 2||17||
48278483|NCT02738853|101007071|FG000|COMPLETED|4 Year||29||
48564005|NCT00856193|101713843|FG000|COMPLETED|Period 2||16||
48278484|NCT02738853|101007071|FG000|NOT COMPLETED|4 Year||9||
48278485|NCT02738853|101007071|FG000|STARTED|5 Year||29||
48564006|NCT00856193|101713844|FG001|COMPLETED|Period 2||15||
48564007|NCT00856193|101713843|FG000|NOT COMPLETED|Period 2||0||
48564008|NCT00856193|101713844|FG001|NOT COMPLETED|Period 2||2||
48564009|NCT02716714|101713845|FG000|STARTED|Overall Study||67||
48564010|NCT02716714|101713846|FG001|STARTED|Overall Study||10||
48564011|NCT02716714|101713845|FG000|COMPLETED|Overall Study||55||
48564012|NCT02716714|101713846|FG001|COMPLETED|Overall Study||8||
48564013|NCT02716714|101713845|FG000|NOT COMPLETED|Overall Study||12||
48564014|NCT02716714|101713846|FG001|NOT COMPLETED|Overall Study||2||
48564015|NCT00958828|101713847|FG000|STARTED|Period 1, 1 Week of Wear||89||
48564016|NCT00958828|101713848|FG001|STARTED|Period 1, 1 Week of Wear||89||
48564017|NCT00958828|101713847|FG000|COMPLETED|Period 1, 1 Week of Wear||89||
48564018|NCT00958828|101713848|FG001|COMPLETED|Period 1, 1 Week of Wear||88||
48564019|NCT00958828|101713847|FG000|NOT COMPLETED|Period 1, 1 Week of Wear||0||
48564020|NCT00958828|101713848|FG001|NOT COMPLETED|Period 1, 1 Week of Wear||1||
48564021|NCT00958828|101713847|FG000|STARTED|Period 2, 1 Week of Wear||89||
48564022|NCT00958828|101713848|FG001|STARTED|Period 2, 1 Week of Wear||88||
48564023|NCT00958828|101713847|FG000|COMPLETED|Period 2, 1 Week of Wear||89||
48564024|NCT00958828|101713848|FG001|COMPLETED|Period 2, 1 Week of Wear||87||
48564025|NCT00958828|101713847|FG000|NOT COMPLETED|Period 2, 1 Week of Wear||0||
48564026|NCT00958828|101713848|FG001|NOT COMPLETED|Period 2, 1 Week of Wear||1||
48564027|NCT00574704|101713849|FG000|STARTED|Overall Study||10||
48564028|NCT00574704|101713850|FG001|STARTED|Overall Study||10||
48697638|NCT02591472|102045426|FG000|NOT COMPLETED|Overall Study||0||
48697639|NCT02591472|102045427|FG001|NOT COMPLETED|Overall Study||0||
48697640|NCT04669262|102045428|FG000|STARTED|Overall Study||6||
48697641|NCT04669262|102045429|FG001|STARTED|Overall Study||7||
48697642|NCT04669262|102045430|FG002|STARTED|Overall Study||6||
48278486|NCT02738853|101007071|FG000|COMPLETED|5 Year||25||
48564029|NCT00574704|101713851|FG002|STARTED|Overall Study||10||
48564030|NCT00574704|101713852|FG003|STARTED|Overall Study||10||
48278487|NCT02738853|101007071|FG000|NOT COMPLETED|5 Year||4||
48278488|NCT03333876|101007072|FG000|STARTED|Screening Period||58||29
48278489|NCT03333876|101007072|FG000|COMPLETED|Screening Period||54||27
48278490|NCT03333876|101007072|FG000|NOT COMPLETED|Screening Period||4||2
48278491|NCT03333876|101007072|FG000|STARTED|Nasal Dilator||54||27
48278492|NCT03333876|101007072|FG000|COMPLETED|Nasal Dilator||48||24
48278493|NCT03333876|101007072|FG000|NOT COMPLETED|Nasal Dilator||6||3
48564031|NCT00574704|101713849|FG000|COMPLETED|Overall Study||10||
48564032|NCT00574704|101713850|FG001|COMPLETED|Overall Study||10||
48564033|NCT00574704|101713851|FG002|COMPLETED|Overall Study||9||
48564034|NCT00574704|101713852|FG003|COMPLETED|Overall Study||10||
48564035|NCT00574704|101713849|FG000|NOT COMPLETED|Overall Study||0||
48564036|NCT00574704|101713850|FG001|NOT COMPLETED|Overall Study||0||
48564037|NCT00574704|101713851|FG002|NOT COMPLETED|Overall Study||1||
48564038|NCT00574704|101713852|FG003|NOT COMPLETED|Overall Study||0||
48564039|NCT00669669|101713853|FG000|STARTED|Overall Study||12||
48564040|NCT00669669|101713853|FG000|COMPLETED|Overall Study||11||
48564041|NCT00669669|101713853|FG000|NOT COMPLETED|Overall Study||1||
48564042|NCT01342523|101713854|FG000|STARTED|Overall Study||35||
48564043|NCT01342523|101713855|FG001|STARTED|Overall Study||32||
48564044|NCT01342523|101713856|FG002|STARTED|Overall Study||36||
48564045|NCT01342523|101713857|FG003|STARTED|Overall Study||33||
48564046|NCT01342523|101713858|FG004|STARTED|Overall Study||36||
48564047|NCT01342523|101713859|FG005|STARTED|Overall Study||36||
48564048|NCT01342523|101713860|FG006|STARTED|Overall Study||22||
48564049|NCT01342523|101713861|FG007|STARTED|Overall Study||27||
48564050|NCT01342523|101713862|FG008|STARTED|Overall Study||28||
48564051|NCT01342523|101713863|FG009|STARTED|Overall Study||28||
48564052|NCT01342523|101713864|FG010|STARTED|Overall Study||38||
48564053|NCT01342523|101713865|FG011|STARTED|Overall Study||38||
48564054|NCT01342523|101713866|FG012|STARTED|Overall Study||39||
48564055|NCT01342523|101713867|FG013|STARTED|Overall Study||38||
48564056|NCT01342523|101713868|FG014|STARTED|Overall Study||38||
48564057|NCT01342523|101713869|FG015|STARTED|Overall Study||32||
48564058|NCT01342523|101713870|FG016|STARTED|Overall Study||29||
48564059|NCT01342523|101713871|FG017|STARTED|Overall Study||27||
48564060|NCT01342523|101713872|FG018|STARTED|Overall Study||21||
48564061|NCT01342523|101713873|FG019|STARTED|Overall Study||27||
48564062|NCT01342523|101713874|FG020|STARTED|Overall Study||29||
48564063|NCT01342523|101713875|FG021|STARTED|Overall Study||30||
48564064|NCT01342523|101713876|FG022|STARTED|Overall Study||36||
48697643|NCT04669262|102045431|FG003|STARTED|Overall Study||6||
48697644|NCT04669262|102045428|FG000|COMPLETED|Overall Study||6||
48697645|NCT04669262|102045429|FG001|COMPLETED|Overall Study||6||
48697646|NCT04669262|102045430|FG002|COMPLETED|Overall Study||6||
48697647|NCT04669262|102045431|FG003|COMPLETED|Overall Study||5||
48697648|NCT04669262|102045428|FG000|NOT COMPLETED|Overall Study||0||
48697649|NCT04669262|102045429|FG001|NOT COMPLETED|Overall Study||1||
48697650|NCT04669262|102045430|FG002|NOT COMPLETED|Overall Study||0||
48697651|NCT04669262|102045431|FG003|NOT COMPLETED|Overall Study||1||
48697652|NCT02550288|102045432|FG000|STARTED|Overall Study||35||
48697653|NCT02550288|102045433|FG001|STARTED|Overall Study||68||
48697654|NCT02550288|102045434|FG002|STARTED|Overall Study||69||
48697655|NCT02550288|102045435|FG003|STARTED|Overall Study||68||
48278494|NCT03333876|101007072|FG000|STARTED|Mandibular Advancement||54||27
48278495|NCT03333876|101007072|FG000|COMPLETED|Mandibular Advancement||50||25
48278496|NCT03333876|101007072|FG000|NOT COMPLETED|Mandibular Advancement||4||2
48278497|NCT03333876|101007072|FG000|STARTED|Positional Therapy||54||27
48278498|NCT03333876|101007072|FG000|COMPLETED|Positional Therapy||54||27
48278499|NCT03333876|101007072|FG000|NOT COMPLETED|Positional Therapy||0||0
48278500|NCT04165031|101007073|FG000|STARTED|Overall Study||2||
48278501|NCT04165031|101007074|FG001|STARTED|Overall Study||1||
48278502|NCT04165031|101007075|FG002|STARTED|Overall Study||2||
48278503|NCT04165031|101007076|FG003|STARTED|Overall Study||0||
48564065|NCT01342523|101713877|FG023|STARTED|Overall Study||36||
48564066|NCT01342523|101713878|FG024|STARTED|Overall Study||37||
48564067|NCT01342523|101713879|FG025|STARTED|Overall Study||38||
48564068|NCT01342523|101713880|FG026|STARTED|Overall Study||34||
48564069|NCT01342523|101713881|FG027|STARTED|Overall Study||31||
48564070|NCT01342523|101713882|FG028|STARTED|Overall Study||35||
48564071|NCT01342523|101713883|FG029|STARTED|Overall Study||29||
48564072|NCT01342523|101713884|FG030|STARTED|Overall Study||31||
48564073|NCT01342523|101713885|FG031|STARTED|Overall Study||28||
48564074|NCT01342523|101713854|FG000|COMPLETED|Overall Study||34||
48564075|NCT01342523|101713855|FG001|COMPLETED|Overall Study||32||
48697656|NCT02550288|102045436|FG004|STARTED|Overall Study||69||
48697657|NCT02550288|102045432|FG000|COMPLETED|Overall Study||33||
48697658|NCT02550288|102045433|FG001|COMPLETED|Overall Study||65||
48697659|NCT02550288|102045434|FG002|COMPLETED|Overall Study||68||
48697660|NCT02550288|102045435|FG003|COMPLETED|Overall Study||65||
48697661|NCT02550288|102045436|FG004|COMPLETED|Overall Study||66||
48697662|NCT02550288|102045432|FG000|NOT COMPLETED|Overall Study||2||
48697663|NCT02550288|102045433|FG001|NOT COMPLETED|Overall Study||3||
48697664|NCT02550288|102045434|FG002|NOT COMPLETED|Overall Study||1||
48697665|NCT02550288|102045435|FG003|NOT COMPLETED|Overall Study||3||
48697666|NCT02550288|102045436|FG004|NOT COMPLETED|Overall Study||3||
48697667|NCT02301546|102045437|FG000|STARTED|Short-term Effectiveness (~13 Weeks)||73||
48697668|NCT02301546|102045438|FG001|STARTED|Short-term Effectiveness (~13 Weeks)||73||
48697669|NCT02301546|102045437|FG000|COMPLETED|Short-term Effectiveness (~13 Weeks)||55||
48697670|NCT02301546|102045438|FG001|COMPLETED|Short-term Effectiveness (~13 Weeks)||58||
48697671|NCT02301546|102045437|FG000|NOT COMPLETED|Short-term Effectiveness (~13 Weeks)||18||
48697672|NCT02301546|102045438|FG001|NOT COMPLETED|Short-term Effectiveness (~13 Weeks)||15||
48697673|NCT02301546|102045437|FG000|STARTED|Long Term Effectiveness (~1 Year)||55||
48697674|NCT02301546|102045438|FG001|STARTED|Long Term Effectiveness (~1 Year)||58||
48697675|NCT02301546|102045437|FG000|COMPLETED|Long Term Effectiveness (~1 Year)||43||
48697676|NCT02301546|102045438|FG001|COMPLETED|Long Term Effectiveness (~1 Year)||51||
48697677|NCT02301546|102045437|FG000|NOT COMPLETED|Long Term Effectiveness (~1 Year)||12||
48564076|NCT01342523|101713856|FG002|COMPLETED|Overall Study||36||
48564077|NCT01342523|101713857|FG003|COMPLETED|Overall Study||32||
48697678|NCT02301546|102045438|FG001|NOT COMPLETED|Long Term Effectiveness (~1 Year)||7||
48697679|NCT00487942|102045439|FG000|STARTED|Overall Study||15||
48697680|NCT00487942|102045440|FG001|STARTED|Overall Study||15||
48697681|NCT00487942|102045441|FG002|STARTED|Overall Study||15||
48697682|NCT00487942|102045442|FG003|STARTED|Overall Study||15||
48564078|NCT01342523|101713858|FG004|COMPLETED|Overall Study||36||
48564079|NCT01342523|101713859|FG005|COMPLETED|Overall Study||36||
48564080|NCT01342523|101713860|FG006|COMPLETED|Overall Study||22||
48564081|NCT01342523|101713861|FG007|COMPLETED|Overall Study||27||
48564082|NCT01342523|101713862|FG008|COMPLETED|Overall Study||28||
48564083|NCT01342523|101713863|FG009|COMPLETED|Overall Study||28||
48116261|NCT03228680|100608709|FG001|STARTED|Overall Study||178||
48116262|NCT03228680|100608708|FG000|COMPLETED|Overall Study||147||
48116263|NCT03228680|100608709|FG001|COMPLETED|Overall Study||143||
48116264|NCT03228680|100608708|FG000|NOT COMPLETED|Overall Study||23||
48116265|NCT03228680|100608709|FG001|NOT COMPLETED|Overall Study||35||
48116266|NCT00087633|100608710|FG000|STARTED|Overall Study||55||
48116267|NCT00087633|100608711|FG001|STARTED|Overall Study||60||
48116268|NCT00087633|100608710|FG000|COMPLETED|Overall Study||31||
48116269|NCT00087633|100608711|FG001|COMPLETED|Overall Study||43||
48116270|NCT00087633|100608710|FG000|NOT COMPLETED|Overall Study||24||
48116271|NCT00087633|100608711|FG001|NOT COMPLETED|Overall Study||17||
48116272|NCT00770120|100608712|FG000|STARTED|Overall Study||61||
48116273|NCT00770120|100608712|FG000|Eligible|Overall Study||60||
48116274|NCT00770120|100608712|FG000|Not Analyzable|Overall Study||1||
48116275|NCT00770120|100608712|FG000|COMPLETED|Overall Study||0||
48116276|NCT00770120|100608712|FG000|NOT COMPLETED|Overall Study||61||
48116277|NCT03144180|100608713|FG000|STARTED|Overall Study||16||
48116278|NCT03144180|100608714|FG001|STARTED|Overall Study||16||
48116279|NCT03144180|100608713|FG000|COMPLETED|Overall Study||14||
48116280|NCT03144180|100608714|FG001|COMPLETED|Overall Study||10||
48564084|NCT01342523|101713864|FG010|COMPLETED|Overall Study||38||
48697683|NCT00487942|102045439|FG000|COMPLETED|Overall Study||12||
48116281|NCT03144180|100608713|FG000|NOT COMPLETED|Overall Study||2||
48116282|NCT03144180|100608714|FG001|NOT COMPLETED|Overall Study||6||
48116283|NCT01288534|100608715|FG000|STARTED|Overall Study||68||
48116284|NCT01288534|100608715|FG000|COMPLETED|Overall Study||68||
48116285|NCT01288534|100608715|FG000|NOT COMPLETED|Overall Study||0||
48116286|NCT00259857|100612499|FG000|STARTED|12 Months Treatment||11||
48116287|NCT00259857|100612500|FG001|STARTED|12 Months Treatment||11||
48116288|NCT00259857|100612499|FG000|COMPLETED|12 Months Treatment||10||
48116289|NCT00259857|100612500|FG001|COMPLETED|12 Months Treatment||9||
48116290|NCT00259857|100612499|FG000|NOT COMPLETED|12 Months Treatment||1||
48116291|NCT00259857|100612500|FG001|NOT COMPLETED|12 Months Treatment||2||
48116292|NCT00259857|100612499|FG000|STARTED|24 Months Treatment||10||
48116293|NCT00259857|100612500|FG001|STARTED|24 Months Treatment||9||
48116294|NCT00259857|100612499|FG000|COMPLETED|24 Months Treatment||10||
48564085|NCT01342523|101713865|FG011|COMPLETED|Overall Study||36||
48564086|NCT01342523|101713866|FG012|COMPLETED|Overall Study||39||
48564087|NCT01342523|101713867|FG013|COMPLETED|Overall Study||36||
48564088|NCT01342523|101713868|FG014|COMPLETED|Overall Study||37||
48564089|NCT01342523|101713869|FG015|COMPLETED|Overall Study||32||
48564090|NCT01342523|101713870|FG016|COMPLETED|Overall Study||28||
48564091|NCT01342523|101713871|FG017|COMPLETED|Overall Study||27||
48564092|NCT01342523|101713872|FG018|COMPLETED|Overall Study||21||
48564093|NCT01342523|101713873|FG019|COMPLETED|Overall Study||27||
48564094|NCT01342523|101713874|FG020|COMPLETED|Overall Study||29||
48564095|NCT01342523|101713875|FG021|COMPLETED|Overall Study||30||
48564096|NCT01342523|101713876|FG022|COMPLETED|Overall Study||36||
48697684|NCT00487942|102045440|FG001|COMPLETED|Overall Study||12||
48697685|NCT00487942|102045441|FG002|COMPLETED|Overall Study||12||
48697686|NCT00487942|102045442|FG003|COMPLETED|Overall Study||13||
48116295|NCT00259857|100612500|FG001|COMPLETED|24 Months Treatment||6||
48116296|NCT00259857|100612499|FG000|NOT COMPLETED|24 Months Treatment||0||
48278504|NCT04165031|101007077|FG004|STARTED|Overall Study||0||
48278505|NCT04165031|101007078|FG005|STARTED|Overall Study||0||
48278506|NCT04165031|101007073|FG000|Received at Least One Dose of Study Drug|Overall Study||2||
48278507|NCT04165031|101007074|FG001|Received at Least One Dose of Study Drug|Overall Study||1||
48278508|NCT04165031|101007075|FG002|Received at Least One Dose of Study Drug|Overall Study||2||
48278509|NCT04165031|101007076|FG003|Received at Least One Dose of Study Drug|Overall Study||0||
48278510|NCT04165031|101007077|FG004|Received at Least One Dose of Study Drug|Overall Study||0||
48278511|NCT04165031|101007078|FG005|Received at Least One Dose of Study Drug|Overall Study||0||
48278512|NCT04165031|101007073|FG000|COMPLETED|Overall Study||1||
48278513|NCT04165031|101007074|FG001|COMPLETED|Overall Study||0||
48278514|NCT04165031|101007075|FG002|COMPLETED|Overall Study||1||
48278515|NCT04165031|101007076|FG003|COMPLETED|Overall Study||0||
48278516|NCT04165031|101007077|FG004|COMPLETED|Overall Study||0||
48278517|NCT04165031|101007078|FG005|COMPLETED|Overall Study||0||
48278518|NCT04165031|101007073|FG000|NOT COMPLETED|Overall Study||1||
48278519|NCT04165031|101007074|FG001|NOT COMPLETED|Overall Study||1||
48278520|NCT04165031|101007075|FG002|NOT COMPLETED|Overall Study||1||
48278521|NCT04165031|101007076|FG003|NOT COMPLETED|Overall Study||0||
48278522|NCT04165031|101007077|FG004|NOT COMPLETED|Overall Study||0||
48278523|NCT04165031|101007078|FG005|NOT COMPLETED|Overall Study||0||
48278524|NCT01373151|101007079|FG000|STARTED|Period 1||61||
48278525|NCT01373151|101007080|FG001|STARTED|Period 1||59||
48278526|NCT01373151|101007081|FG002|STARTED|Period 1||60||
48278527|NCT01373151|101007082|FG003|STARTED|Period 1||60||
48278528|NCT01373151|101007083|FG004|STARTED|Period 1||59||
48278529|NCT01373151|101007084|FG005|STARTED|Period 1||60||
48278530|NCT01373151|101007085|FG006|STARTED|Period 1||59||
48278531|NCT01373151|101007079|FG000|COMPLETED|Period 1||56||
48278532|NCT01373151|101007080|FG001|COMPLETED|Period 1||59||
48278533|NCT01373151|101007081|FG002|COMPLETED|Period 1||56||
48278534|NCT01373151|101007082|FG003|COMPLETED|Period 1||59||
48278535|NCT01373151|101007083|FG004|COMPLETED|Period 1||54||
48278536|NCT01373151|101007084|FG005|COMPLETED|Period 1||56||
48278537|NCT01373151|101007085|FG006|COMPLETED|Period 1||59||
48278538|NCT01373151|101007079|FG000|NOT COMPLETED|Period 1||5||
48278539|NCT01373151|101007080|FG001|NOT COMPLETED|Period 1||0||
48278540|NCT01373151|101007081|FG002|NOT COMPLETED|Period 1||4||
48278541|NCT01373151|101007082|FG003|NOT COMPLETED|Period 1||1||
48278542|NCT01373151|101007083|FG004|NOT COMPLETED|Period 1||5||
48278543|NCT01373151|101007084|FG005|NOT COMPLETED|Period 1||4||
48278544|NCT01373151|101007085|FG006|NOT COMPLETED|Period 1||0||
48278545|NCT01373151|101007079|FG000|STARTED|Period 2||56||
48278546|NCT01373151|101007080|FG001|STARTED|Period 2||58||
48278547|NCT01373151|101007081|FG002|STARTED|Period 2||56||
48278548|NCT01373151|101007082|FG003|STARTED|Period 2||59||
48278549|NCT01373151|101007083|FG004|STARTED|Period 2||54||
48278550|NCT01373151|101007084|FG005|STARTED|Period 2||55||
48278551|NCT01373151|101007085|FG006|STARTED|Period 2||59||
48278552|NCT01373151|101007079|FG000|COMPLETED|Period 2||47||
48278553|NCT01373151|101007080|FG001|COMPLETED|Period 2||57||
48278554|NCT01373151|101007081|FG002|COMPLETED|Period 2||52||
48278555|NCT01373151|101007082|FG003|COMPLETED|Period 2||54||
48278556|NCT01373151|101007083|FG004|COMPLETED|Period 2||52||
48278557|NCT01373151|101007084|FG005|COMPLETED|Period 2||55||
48278558|NCT01373151|101007085|FG006|COMPLETED|Period 2||54||
48278559|NCT01373151|101007079|FG000|NOT COMPLETED|Period 2||9||
48564097|NCT01342523|101713877|FG023|COMPLETED|Overall Study||35||
48564098|NCT01342523|101713878|FG024|COMPLETED|Overall Study||36||
48564099|NCT01342523|101713879|FG025|COMPLETED|Overall Study||36||
48564100|NCT01342523|101713880|FG026|COMPLETED|Overall Study||33||
48564101|NCT01342523|101713881|FG027|COMPLETED|Overall Study||30||
48564102|NCT01342523|101713882|FG028|COMPLETED|Overall Study||34||
48116297|NCT00259857|100612500|FG001|NOT COMPLETED|24 Months Treatment||3||
48116298|NCT01859715|100612501|FG000|STARTED|Overall Study||141||
48116299|NCT01859715|100612502|FG001|STARTED|Overall Study||91||
48116300|NCT01859715|100612503|FG002|STARTED|Overall Study||116||
48564103|NCT01342523|101713883|FG029|COMPLETED|Overall Study||28||
48564104|NCT01342523|101713884|FG030|COMPLETED|Overall Study||30||
48564105|NCT01342523|101713885|FG031|COMPLETED|Overall Study||27||
48278560|NCT01373151|101007080|FG001|NOT COMPLETED|Period 2||1||
48278561|NCT01373151|101007081|FG002|NOT COMPLETED|Period 2||4||
48278562|NCT01373151|101007082|FG003|NOT COMPLETED|Period 2||5||
48278563|NCT01373151|101007083|FG004|NOT COMPLETED|Period 2||2||
48278564|NCT01373151|101007084|FG005|NOT COMPLETED|Period 2||0||
48278565|NCT01373151|101007085|FG006|NOT COMPLETED|Period 2||5||
48278566|NCT04860297|101007086|FG000|STARTED|Part A (Primary Series)||3||
48278567|NCT04860297|101007087|FG001|STARTED|Part A (Primary Series)||58||
48278568|NCT04860297|101007088|FG002|STARTED|Part A (Primary Series)||71||
48278569|NCT04860297|101007089|FG003|STARTED|Part A (Primary Series)||20||
48564106|NCT01342523|101713854|FG000|NOT COMPLETED|Overall Study||1||
48564107|NCT01342523|101713855|FG001|NOT COMPLETED|Overall Study||0||
48564108|NCT01342523|101713856|FG002|NOT COMPLETED|Overall Study||0||
48564109|NCT01342523|101713857|FG003|NOT COMPLETED|Overall Study||1||
48564110|NCT01342523|101713858|FG004|NOT COMPLETED|Overall Study||0||
48278570|NCT04860297|101007090|FG004|STARTED|Part A (Primary Series)||0||
48278571|NCT04860297|101007091|FG005|STARTED|Part A (Primary Series)||0||
48278572|NCT04860297|101007092|FG006|STARTED|Part A (Primary Series)||0||
48278573|NCT04860297|101007093|FG007|STARTED|Part A (Primary Series)||0||
48278574|NCT04860297|101007086|FG000|Received First Study Injection|Part A (Primary Series)||3||
48278575|NCT04860297|101007087|FG001|Received First Study Injection|Part A (Primary Series)||58||
48278576|NCT04860297|101007088|FG002|Received First Study Injection|Part A (Primary Series)||0||
48278577|NCT04860297|101007089|FG003|Received First Study Injection|Part A (Primary Series)||20||
48278578|NCT04860297|101007090|FG004|Received First Study Injection|Part A (Primary Series)||0||
48278579|NCT04860297|101007091|FG005|Received First Study Injection|Part A (Primary Series)||0||
48278580|NCT04860297|101007092|FG006|Received First Study Injection|Part A (Primary Series)||0||
48278581|NCT04860297|101007093|FG007|Received First Study Injection|Part A (Primary Series)||0||
48278582|NCT04860297|101007086|FG000|Received Second Study Injection|Part A (Primary Series)||3||
48564111|NCT01342523|101713859|FG005|NOT COMPLETED|Overall Study||0||
48564112|NCT01342523|101713860|FG006|NOT COMPLETED|Overall Study||0||
48564113|NCT01342523|101713861|FG007|NOT COMPLETED|Overall Study||0||
48564114|NCT01342523|101713862|FG008|NOT COMPLETED|Overall Study||0||
48564115|NCT01342523|101713863|FG009|NOT COMPLETED|Overall Study||0||
48564116|NCT01342523|101713864|FG010|NOT COMPLETED|Overall Study||0||
48564117|NCT01342523|101713865|FG011|NOT COMPLETED|Overall Study||2||
48564118|NCT01342523|101713866|FG012|NOT COMPLETED|Overall Study||0||
48564119|NCT01342523|101713867|FG013|NOT COMPLETED|Overall Study||2||
48564120|NCT01342523|101713868|FG014|NOT COMPLETED|Overall Study||1||
48564121|NCT01342523|101713869|FG015|NOT COMPLETED|Overall Study||0||
48564122|NCT01342523|101713870|FG016|NOT COMPLETED|Overall Study||1||
48116301|NCT01859715|100612501|FG000|COMPLETED|Overall Study||125||
48116302|NCT01859715|100612502|FG001|COMPLETED|Overall Study||83||
48116303|NCT01859715|100612503|FG002|COMPLETED|Overall Study||93||
48116304|NCT01859715|100612501|FG000|NOT COMPLETED|Overall Study||16||
48116305|NCT01859715|100612502|FG001|NOT COMPLETED|Overall Study||8||
48116306|NCT01859715|100612503|FG002|NOT COMPLETED|Overall Study||23||
48116307|NCT01271543|100612504|FG000|STARTED|Overall Study||30||
48116308|NCT01271543|100612505|FG001|STARTED|Overall Study||30||
48116309|NCT01271543|100612504|FG000|COMPLETED|Overall Study||29||
48116310|NCT01271543|100612505|FG001|COMPLETED|Overall Study||29||
48116311|NCT01271543|100612504|FG000|NOT COMPLETED|Overall Study||1||
48116312|NCT01271543|100612505|FG001|NOT COMPLETED|Overall Study||1||
48116313|NCT00774995|100612506|FG000|STARTED|Overall Study||9||
48116314|NCT00774995|100612507|FG001|STARTED|Overall Study||16||
48116315|NCT00774995|100612508|FG002|STARTED|Overall Study||8||
48116316|NCT00774995|100612509|FG003|STARTED|Overall Study||16||
48116317|NCT00774995|100612506|FG000|COMPLETED|Overall Study||9||
48116318|NCT00774995|100612507|FG001|COMPLETED|Overall Study||16||
48116319|NCT00774995|100612508|FG002|COMPLETED|Overall Study||7||
48116320|NCT00774995|100612509|FG003|COMPLETED|Overall Study||16||
48116321|NCT00774995|100612506|FG000|NOT COMPLETED|Overall Study||0||
48116322|NCT00774995|100612507|FG001|NOT COMPLETED|Overall Study||0||
48116323|NCT00774995|100612508|FG002|NOT COMPLETED|Overall Study||1||
48116324|NCT00774995|100612509|FG003|NOT COMPLETED|Overall Study||0||
48116325|NCT02047110|100612510|FG000|STARTED|DB Treatment Period up to Week 24||40||
48564123|NCT01342523|101713871|FG017|NOT COMPLETED|Overall Study||0||
48564124|NCT01342523|101713872|FG018|NOT COMPLETED|Overall Study||0||
48564125|NCT01342523|101713873|FG019|NOT COMPLETED|Overall Study||0||
48564126|NCT01342523|101713874|FG020|NOT COMPLETED|Overall Study||0||
48564127|NCT01342523|101713875|FG021|NOT COMPLETED|Overall Study||0||
48564128|NCT01342523|101713876|FG022|NOT COMPLETED|Overall Study||0||
48564129|NCT01342523|101713877|FG023|NOT COMPLETED|Overall Study||1||
48564130|NCT01342523|101713878|FG024|NOT COMPLETED|Overall Study||1||
48564131|NCT01342523|101713879|FG025|NOT COMPLETED|Overall Study||2||
48564132|NCT01342523|101713880|FG026|NOT COMPLETED|Overall Study||1||
48564133|NCT01342523|101713881|FG027|NOT COMPLETED|Overall Study||1||
48564134|NCT01342523|101713882|FG028|NOT COMPLETED|Overall Study||1||
48564135|NCT01342523|101713883|FG029|NOT COMPLETED|Overall Study||1||
48564136|NCT01342523|101713884|FG030|NOT COMPLETED|Overall Study||1||
48564137|NCT01342523|101713885|FG031|NOT COMPLETED|Overall Study||1||
48564138|NCT00594165|101713886|FG000|STARTED|Overall Study||217||
48564139|NCT00594165|101713886|FG000|COMPLETED|Overall Study||0||
48564140|NCT00594165|101713886|FG000|NOT COMPLETED|Overall Study||217||
48564141|NCT04200651|101713887|FG000|STARTED|Overall Study||14||14
48116326|NCT02047110|100612511|FG001|STARTED|DB Treatment Period up to Week 24||40||
48116327|NCT02047110|100612512|FG002|STARTED|DB Treatment Period up to Week 24||39||
48116328|NCT02047110|100612513|FG003|STARTED|DB Treatment Period up to Week 24||40||
48116329|NCT02047110|100612510|FG000|COMPLETED|DB Treatment Period up to Week 24||35||
48116330|NCT02047110|100612511|FG001|COMPLETED|DB Treatment Period up to Week 24||38||
48116331|NCT02047110|100612512|FG002|COMPLETED|DB Treatment Period up to Week 24||36||
48116332|NCT02047110|100612513|FG003|COMPLETED|DB Treatment Period up to Week 24||38||
48116333|NCT02047110|100612510|FG000|NOT COMPLETED|DB Treatment Period up to Week 24||5||
48116334|NCT02047110|100612511|FG001|NOT COMPLETED|DB Treatment Period up to Week 24||2||
48394342|NCT01293006|101295919|FG001|STARTED|Period 1||2||
48564142|NCT04200651|101713888|FG001|STARTED|Overall Study||10||10
48564143|NCT04200651|101713887|FG000|COMPLETED|Overall Study||11||11
48564144|NCT04200651|101713888|FG001|COMPLETED|Overall Study||5||5
48564145|NCT04200651|101713887|FG000|NOT COMPLETED|Overall Study||3||3
48564146|NCT04200651|101713888|FG001|NOT COMPLETED|Overall Study||5||5
48564147|NCT03077737|101713889|FG000|STARTED|Week 6 (10 Weeks After Enrollment)||97||
48564148|NCT03077737|101713890|FG001|STARTED|Week 6 (10 Weeks After Enrollment)||93||
48564149|NCT03077737|101713889|FG000|COMPLETED|Week 6 (10 Weeks After Enrollment)||89||
48564150|NCT03077737|101713890|FG001|COMPLETED|Week 6 (10 Weeks After Enrollment)||79||
48564151|NCT03077737|101713889|FG000|NOT COMPLETED|Week 6 (10 Weeks After Enrollment)||8||
48564152|NCT03077737|101713890|FG001|NOT COMPLETED|Week 6 (10 Weeks After Enrollment)||14||
48564153|NCT03077737|101713889|FG000|STARTED|Week 14 (18 Weeks After Enrollment)||97||
48564154|NCT03077737|101713890|FG001|STARTED|Week 14 (18 Weeks After Enrollment)||93||
48564155|NCT03077737|101713889|FG000|COMPLETED|Week 14 (18 Weeks After Enrollment)||83||
48564156|NCT03077737|101713890|FG001|COMPLETED|Week 14 (18 Weeks After Enrollment)||76||
48564157|NCT03077737|101713889|FG000|NOT COMPLETED|Week 14 (18 Weeks After Enrollment)||14||
48564158|NCT03077737|101713890|FG001|NOT COMPLETED|Week 14 (18 Weeks After Enrollment)||17||
48564159|NCT03077737|101713889|FG000|STARTED|Week 28 (32 Weeks After Enrollment)||49|Due to project timeline constraints, only the first 96 participants enrolled in the study were followed for 32 weeks.|
48564160|NCT03077737|101713890|FG001|STARTED|Week 28 (32 Weeks After Enrollment)||47|Due to project timeline constraints, only the first 96 participants enrolled in the study were followed for 32 weeks.|
48116335|NCT02047110|100612512|FG002|NOT COMPLETED|DB Treatment Period up to Week 24||3||
48116336|NCT02047110|100612513|FG003|NOT COMPLETED|DB Treatment Period up to Week 24||2||
48116337|NCT02047110|100612510|FG000|STARTED|DB (Week 12 up to Week 24)||9||
48116338|NCT02047110|100612511|FG001|STARTED|DB (Week 12 up to Week 24)||17||
48394343|NCT01293006|101295920|FG002|STARTED|Period 1||9||
48564161|NCT03077737|101713889|FG000|COMPLETED|Week 28 (32 Weeks After Enrollment)||39||
48564162|NCT03077737|101713890|FG001|COMPLETED|Week 28 (32 Weeks After Enrollment)||40||
48564163|NCT03077737|101713889|FG000|NOT COMPLETED|Week 28 (32 Weeks After Enrollment)||10||
48564164|NCT03077737|101713890|FG001|NOT COMPLETED|Week 28 (32 Weeks After Enrollment)||7||
48564165|NCT04909853|101713891|FG000|STARTED|Part 1||10||
48564166|NCT04909853|101713892|FG001|STARTED|Part 1||8||
48564167|NCT04909853|101713893|FG002|STARTED|Part 1||9||
48564168|NCT04909853|101713894|FG003|STARTED|Part 1||0||
48564169|NCT04909853|101713891|FG000|Treated|Part 1||10||
48564170|NCT04909853|101713892|FG001|Treated|Part 1||8||
48564171|NCT04909853|101713893|FG002|Treated|Part 1||8||
48564172|NCT04909853|101713894|FG003|Treated|Part 1||0||
48564173|NCT04909853|101713891|FG000|COMPLETED|Part 1||10||
48564174|NCT04909853|101713892|FG001|COMPLETED|Part 1||8||
48564175|NCT04909853|101713893|FG002|COMPLETED|Part 1||8||
48564176|NCT04909853|101713894|FG003|COMPLETED|Part 1||0||
48564177|NCT04909853|101713891|FG000|NOT COMPLETED|Part 1||0||
48564178|NCT04909853|101713892|FG001|NOT COMPLETED|Part 1||0||
48564179|NCT04909853|101713893|FG002|NOT COMPLETED|Part 1||1||
48564180|NCT04909853|101713894|FG003|NOT COMPLETED|Part 1||0||
48564181|NCT04909853|101713891|FG000|STARTED|Part 2||0||
48116339|NCT02047110|100612512|FG002|STARTED|DB (Week 12 up to Week 24)||13||
48116340|NCT02047110|100612513|FG003|STARTED|DB (Week 12 up to Week 24)||12||
48116341|NCT02047110|100612510|FG000|COMPLETED|DB (Week 12 up to Week 24)||9||
48116342|NCT02047110|100612511|FG001|COMPLETED|DB (Week 12 up to Week 24)||15||
48116343|NCT02047110|100612512|FG002|COMPLETED|DB (Week 12 up to Week 24)||12||
48116344|NCT02047110|100612513|FG003|COMPLETED|DB (Week 12 up to Week 24)||12||
48116345|NCT02047110|100612510|FG000|NOT COMPLETED|DB (Week 12 up to Week 24)||0||
48116346|NCT02047110|100612511|FG001|NOT COMPLETED|DB (Week 12 up to Week 24)||2||
48116347|NCT02047110|100612512|FG002|NOT COMPLETED|DB (Week 12 up to Week 24)||1||
48116348|NCT02047110|100612513|FG003|NOT COMPLETED|DB (Week 12 up to Week 24)||0||
48116349|NCT02047110|100612510|FG000|STARTED|Escape Treatment Period||26||
48116350|NCT02047110|100612511|FG001|STARTED|Escape Treatment Period||21||
48116351|NCT02047110|100612512|FG002|STARTED|Escape Treatment Period||23||
48116352|NCT02047110|100612513|FG003|STARTED|Escape Treatment Period||26||
48116353|NCT02047110|100612510|FG000|COMPLETED|Escape Treatment Period||23||
48116354|NCT02047110|100612511|FG001|COMPLETED|Escape Treatment Period||15||
48116355|NCT02047110|100612512|FG002|COMPLETED|Escape Treatment Period||20||
48116356|NCT02047110|100612513|FG003|COMPLETED|Escape Treatment Period||24||
48116357|NCT02047110|100612510|FG000|NOT COMPLETED|Escape Treatment Period||3||
48116358|NCT02047110|100612511|FG001|NOT COMPLETED|Escape Treatment Period||6||
48564182|NCT04909853|101713892|FG001|STARTED|Part 2||0||
48564183|NCT04909853|101713893|FG002|STARTED|Part 2||0||
48564184|NCT04909853|101713894|FG003|STARTED|Part 2||8||
48116359|NCT02047110|100612512|FG002|NOT COMPLETED|Escape Treatment Period||3||
48116360|NCT02047110|100612513|FG003|NOT COMPLETED|Escape Treatment Period||2||
48116361|NCT02047110|100612510|FG000|STARTED|OLE Treatment Period||4||
48116362|NCT02047110|100612511|FG001|STARTED|OLE Treatment Period||8||
48116363|NCT02047110|100612512|FG002|STARTED|OLE Treatment Period||5||
48116364|NCT02047110|100612513|FG003|STARTED|OLE Treatment Period||9||
48116365|NCT02047110|100612510|FG000|COMPLETED|OLE Treatment Period||4||
48116366|NCT02047110|100612511|FG001|COMPLETED|OLE Treatment Period||8||
48116367|NCT02047110|100612512|FG002|COMPLETED|OLE Treatment Period||4||
48116368|NCT02047110|100612513|FG003|COMPLETED|OLE Treatment Period||9||
48116369|NCT02047110|100612510|FG000|NOT COMPLETED|OLE Treatment Period||0||
48116370|NCT02047110|100612511|FG001|NOT COMPLETED|OLE Treatment Period||0||
48116371|NCT02047110|100612512|FG002|NOT COMPLETED|OLE Treatment Period||1||
48116372|NCT02047110|100612513|FG003|NOT COMPLETED|OLE Treatment Period||0||
48116373|NCT01800903|100612514|FG000|STARTED|First Test Period||7||
48116374|NCT01800903|100612515|FG001|STARTED|First Test Period||6||
48116375|NCT01800903|100612516|FG002|STARTED|First Test Period||4||
48116376|NCT01800903|100612517|FG003|STARTED|First Test Period||7||
48116377|NCT01800903|100612518|FG004|STARTED|First Test Period||6||
48564185|NCT04909853|101713891|FG000|COMPLETED|Part 2||0||
48564186|NCT04909853|101713892|FG001|COMPLETED|Part 2||0||
48116378|NCT01800903|100612519|FG005|STARTED|First Test Period||6||
48116379|NCT01800903|100612514|FG000|COMPLETED|First Test Period||7||
48564187|NCT04909853|101713893|FG002|COMPLETED|Part 2||0||
48564188|NCT04909853|101713894|FG003|COMPLETED|Part 2||7||
48564189|NCT04909853|101713891|FG000|NOT COMPLETED|Part 2||0||
48564190|NCT04909853|101713892|FG001|NOT COMPLETED|Part 2||0||
48394344|NCT01293006|101295921|FG003|STARTED|Period 1||3||
48394345|NCT01293006|101295918|FG000|COMPLETED|Period 1||11||
48394346|NCT01293006|101295919|FG001|COMPLETED|Period 1||2||
48394347|NCT01293006|101295920|FG002|COMPLETED|Period 1||9||
48394348|NCT01293006|101295921|FG003|COMPLETED|Period 1||3||
48394349|NCT01293006|101295918|FG000|NOT COMPLETED|Period 1||0||
48394350|NCT01293006|101295919|FG001|NOT COMPLETED|Period 1||0||
48394351|NCT01293006|101295920|FG002|NOT COMPLETED|Period 1||0||
48564191|NCT04909853|101713893|FG002|NOT COMPLETED|Part 2||0||
48564192|NCT04909853|101713894|FG003|NOT COMPLETED|Part 2||1||
48564193|NCT04421131|101713895|FG000|STARTED|Overall Study||110||
48394352|NCT01293006|101295921|FG003|NOT COMPLETED|Period 1||0||
48564194|NCT04421131|101713895|FG000|Referred to a Follow up Screening|Overall Study||17||
48564195|NCT04421131|101713895|FG000|COMPLETED|Overall Study||102||
48564196|NCT04421131|101713895|FG000|NOT COMPLETED|Overall Study||8||
48564197|NCT05370040|101713896|FG000|STARTED|Overall Study||10||
48564198|NCT05370040|101713897|FG001|STARTED|Overall Study||10||
48564199|NCT05370040|101713898|FG002|STARTED|Overall Study||10||
48564200|NCT05370040|101713899|FG003|STARTED|Overall Study||10||
48564201|NCT05370040|101713900|FG004|STARTED|Overall Study||10||
48564202|NCT05370040|101713901|FG005|STARTED|Overall Study||10||
48564203|NCT05370040|101713896|FG000|COMPLETED|Overall Study||10||
48564204|NCT05370040|101713897|FG001|COMPLETED|Overall Study||10||
48116380|NCT01800903|100612515|FG001|COMPLETED|First Test Period||6||
48116381|NCT01800903|100612516|FG002|COMPLETED|First Test Period||4||
48116382|NCT01800903|100612517|FG003|COMPLETED|First Test Period||7||
48116383|NCT01800903|100612518|FG004|COMPLETED|First Test Period||6||
48116384|NCT01800903|100612519|FG005|COMPLETED|First Test Period||6||
48116385|NCT01800903|100612514|FG000|NOT COMPLETED|First Test Period||0||
48116386|NCT01800903|100612515|FG001|NOT COMPLETED|First Test Period||0||
48116387|NCT01800903|100612516|FG002|NOT COMPLETED|First Test Period||0||
48116388|NCT01800903|100612517|FG003|NOT COMPLETED|First Test Period||0||
48116389|NCT01800903|100612518|FG004|NOT COMPLETED|First Test Period||0||
48116390|NCT01800903|100612519|FG005|NOT COMPLETED|First Test Period||0||
48116391|NCT01800903|100612514|FG000|STARTED|Second Test Period||7||
48116392|NCT01800903|100612515|FG001|STARTED|Second Test Period||6||
48116393|NCT01800903|100612516|FG002|STARTED|Second Test Period||4||
48116394|NCT01800903|100612517|FG003|STARTED|Second Test Period||7||
48116395|NCT01800903|100612518|FG004|STARTED|Second Test Period||6||
48116396|NCT01800903|100612519|FG005|STARTED|Second Test Period||6||
48116397|NCT01800903|100612514|FG000|COMPLETED|Second Test Period||6||
48116398|NCT01800903|100612515|FG001|COMPLETED|Second Test Period||6||
48116399|NCT01800903|100612516|FG002|COMPLETED|Second Test Period||4||
48116400|NCT01800903|100612517|FG003|COMPLETED|Second Test Period||7||
48116401|NCT01800903|100612518|FG004|COMPLETED|Second Test Period||6||
48116402|NCT01800903|100612519|FG005|COMPLETED|Second Test Period||6||
48116403|NCT01800903|100612514|FG000|NOT COMPLETED|Second Test Period||1||
48116404|NCT01800903|100612515|FG001|NOT COMPLETED|Second Test Period||0||
48116405|NCT01800903|100612516|FG002|NOT COMPLETED|Second Test Period||0||
48116406|NCT01800903|100612517|FG003|NOT COMPLETED|Second Test Period||0||
48116407|NCT01800903|100612518|FG004|NOT COMPLETED|Second Test Period||0||
48116408|NCT01800903|100612519|FG005|NOT COMPLETED|Second Test Period||0||
48116409|NCT01800903|100612514|FG000|STARTED|Third Test Period||6||
48116410|NCT01800903|100612515|FG001|STARTED|Third Test Period||6||
48116411|NCT01800903|100612516|FG002|STARTED|Third Test Period||4||
48116412|NCT01800903|100612517|FG003|STARTED|Third Test Period||7||
48116413|NCT01800903|100612518|FG004|STARTED|Third Test Period||6||
48116414|NCT01800903|100612519|FG005|STARTED|Third Test Period||6||
48116415|NCT01800903|100612514|FG000|COMPLETED|Third Test Period||6||
48116416|NCT01800903|100612515|FG001|COMPLETED|Third Test Period||6||
48116417|NCT01800903|100612516|FG002|COMPLETED|Third Test Period||4||
48116418|NCT01800903|100612517|FG003|COMPLETED|Third Test Period||7||
48116419|NCT01800903|100612518|FG004|COMPLETED|Third Test Period||6||
48116420|NCT01800903|100612519|FG005|COMPLETED|Third Test Period||6||
48116421|NCT01800903|100612514|FG000|NOT COMPLETED|Third Test Period||0||
48116422|NCT01800903|100612515|FG001|NOT COMPLETED|Third Test Period||0||
48116423|NCT01800903|100612516|FG002|NOT COMPLETED|Third Test Period||0||
48116424|NCT01800903|100612517|FG003|NOT COMPLETED|Third Test Period||0||
48116425|NCT01800903|100612518|FG004|NOT COMPLETED|Third Test Period||0||
48116426|NCT01800903|100612519|FG005|NOT COMPLETED|Third Test Period||0||
48116427|NCT03362515|100612520|FG000|STARTED|Overall Study||9||
48116428|NCT03362515|100612521|FG001|STARTED|Overall Study||9||
48116429|NCT03362515|100612520|FG000|COMPLETED|Overall Study||6||
48116430|NCT03362515|100612521|FG001|COMPLETED|Overall Study||6||
48116431|NCT03362515|100612520|FG000|NOT COMPLETED|Overall Study||3||
48116432|NCT03362515|100612521|FG001|NOT COMPLETED|Overall Study||3||
48116433|NCT02514252|100612522|FG000|STARTED|Overall Study||6||
48116434|NCT02514252|100612522|FG000|COMPLETED|Overall Study||6||
48116435|NCT02514252|100612522|FG000|NOT COMPLETED|Overall Study||0||
48116436|NCT00203203|100612523|FG000|STARTED|Overall Study||10||
48394353|NCT01293006|101295918|FG000|STARTED|Washout||11||
48116437|NCT00203203|100612524|FG001|STARTED|Overall Study||20||
48116438|NCT00203203|100612523|FG000|COMPLETED|Overall Study||9||
48116439|NCT00203203|100612524|FG001|COMPLETED|Overall Study||20||
48116440|NCT00203203|100612523|FG000|NOT COMPLETED|Overall Study||1||
48116441|NCT00203203|100612524|FG001|NOT COMPLETED|Overall Study||0||
48116442|NCT01898793|100612525|FG000|STARTED|Overall Study||5||
48116443|NCT01898793|100612526|FG001|STARTED|Overall Study||5||
48116444|NCT01898793|100612527|FG002|STARTED|Overall Study||9||
48116445|NCT01898793|100612528|FG003|STARTED|Overall Study||8||
48116446|NCT01898793|100612529|FG004|STARTED|Overall Study||9||
48116447|NCT01898793|100612530|FG005|STARTED|Overall Study||8||
48116448|NCT01898793|100612531|FG006|STARTED|Overall Study||45||
48116449|NCT01898793|100612525|FG000|COMPLETED|Overall Study||3||
48116450|NCT01898793|100612526|FG001|COMPLETED|Overall Study||4||
48116451|NCT01898793|100612527|FG002|COMPLETED|Overall Study||5||
48116452|NCT01898793|100612528|FG003|COMPLETED|Overall Study||8||
48116453|NCT01898793|100612529|FG004|COMPLETED|Overall Study||9||
48116454|NCT01898793|100612530|FG005|COMPLETED|Overall Study||8||
48116455|NCT01898793|100612531|FG006|COMPLETED|Overall Study||45||
48116456|NCT01898793|100612525|FG000|NOT COMPLETED|Overall Study||2||
48116457|NCT01898793|100612526|FG001|NOT COMPLETED|Overall Study||1||
48116458|NCT01898793|100612527|FG002|NOT COMPLETED|Overall Study||4||
48116459|NCT01898793|100612528|FG003|NOT COMPLETED|Overall Study||0||
48116460|NCT01898793|100612529|FG004|NOT COMPLETED|Overall Study||0||
48116461|NCT01898793|100612530|FG005|NOT COMPLETED|Overall Study||0||
48116462|NCT01898793|100612531|FG006|NOT COMPLETED|Overall Study||0||
48116463|NCT01993108|100612532|FG000|STARTED|Overall Study||11||
48116464|NCT01993108|100612533|FG001|STARTED|Overall Study||12||
48116465|NCT01993108|100612532|FG000|COMPLETED|Overall Study||11||
48116466|NCT01993108|100612533|FG001|COMPLETED|Overall Study||12||
48116467|NCT01993108|100612532|FG000|NOT COMPLETED|Overall Study||0||
48116468|NCT01993108|100612533|FG001|NOT COMPLETED|Overall Study||0||
48116469|NCT01797328|100612534|FG000|STARTED|Overall Study||16||
48116470|NCT01797328|100612535|FG001|STARTED|Overall Study||12||
48116471|NCT01797328|100612534|FG000|COMPLETED|Overall Study||14||
48116472|NCT01797328|100612535|FG001|COMPLETED|Overall Study||12||
48116473|NCT01797328|100612534|FG000|NOT COMPLETED|Overall Study||2||
48116474|NCT01797328|100612535|FG001|NOT COMPLETED|Overall Study||0||
48116475|NCT01257204|100612536|FG000|STARTED|Treatment Period (up to Week 24)||50||
48116476|NCT01257204|100612537|FG001|STARTED|Treatment Period (up to Week 24)||50||
48116477|NCT01257204|100612538|FG002|STARTED|Treatment Period (up to Week 24)||51||
48116478|NCT01257204|100612536|FG000|COMPLETED|Treatment Period (up to Week 24)||45||
48116479|NCT01257204|100612537|FG001|COMPLETED|Treatment Period (up to Week 24)||44||
48116480|NCT01257204|100612538|FG002|COMPLETED|Treatment Period (up to Week 24)||42||
48116481|NCT01257204|100612536|FG000|NOT COMPLETED|Treatment Period (up to Week 24)||5||
48116482|NCT01257204|100612537|FG001|NOT COMPLETED|Treatment Period (up to Week 24)||6||
48116483|NCT01257204|100612538|FG002|NOT COMPLETED|Treatment Period (up to Week 24)||9||
48116484|NCT01257204|100612536|FG000|STARTED|Follow-up Period (up to Week 48)||49||
48116485|NCT01257204|100612537|FG001|STARTED|Follow-up Period (up to Week 48)||47||
48116486|NCT01257204|100612538|FG002|STARTED|Follow-up Period (up to Week 48)||49||
48116487|NCT01257204|100612536|FG000|COMPLETED|Follow-up Period (up to Week 48)||48||
48116488|NCT01257204|100612537|FG001|COMPLETED|Follow-up Period (up to Week 48)||41||
48116489|NCT01257204|100612538|FG002|COMPLETED|Follow-up Period (up to Week 48)||39||
48116490|NCT01257204|100612536|FG000|NOT COMPLETED|Follow-up Period (up to Week 48)||1||
48116491|NCT01257204|100612537|FG001|NOT COMPLETED|Follow-up Period (up to Week 48)||6||
48116492|NCT01257204|100612538|FG002|NOT COMPLETED|Follow-up Period (up to Week 48)||10||
48116493|NCT00685932|100612539|FG000|STARTED|Overall Study||76||
48116494|NCT00685932|100612540|FG001|STARTED|Overall Study||78||
48116495|NCT00685932|100612539|FG000|COMPLETED|Overall Study||55||
48116496|NCT00685932|100612540|FG001|COMPLETED|Overall Study||58||
48116497|NCT00685932|100612539|FG000|NOT COMPLETED|Overall Study||21||
48116498|NCT00685932|100612540|FG001|NOT COMPLETED|Overall Study||20||
48116499|NCT00279708|100612541|FG000|STARTED|Overall Study||27||
48116500|NCT00279708|100612542|FG001|STARTED|Overall Study||28||
48116501|NCT00279708|100612541|FG000|COMPLETED|Overall Study||24||
48116502|NCT00279708|100612542|FG001|COMPLETED|Overall Study||24||
48116503|NCT00279708|100612541|FG000|NOT COMPLETED|Overall Study||3||
48116504|NCT00279708|100612542|FG001|NOT COMPLETED|Overall Study||4||
48116505|NCT04118010|100612543|FG000|STARTED|Overall Study||10||
48116506|NCT04118010|100612544|FG001|STARTED|Overall Study||10||
48116507|NCT04118010|100612545|FG002|STARTED|Overall Study||10||
48116508|NCT04118010|100612546|FG003|STARTED|Overall Study||10||
48116509|NCT04118010|100612543|FG000|COMPLETED|Overall Study||7||
48116510|NCT04118010|100612544|FG001|COMPLETED|Overall Study||8||
48116511|NCT04118010|100612545|FG002|COMPLETED|Overall Study||7||
48116512|NCT04118010|100612546|FG003|COMPLETED|Overall Study||9||
48116513|NCT04118010|100612543|FG000|NOT COMPLETED|Overall Study||3||
48116514|NCT04118010|100612544|FG001|NOT COMPLETED|Overall Study||2||
48116515|NCT04118010|100612545|FG002|NOT COMPLETED|Overall Study||3||
48116516|NCT04118010|100612546|FG003|NOT COMPLETED|Overall Study||1||
48116517|NCT03337724|100612547|FG000|STARTED|Overall Study||87||
48116518|NCT03337724|100612548|FG001|STARTED|Overall Study||168||
48116519|NCT03337724|100612549|FG002|STARTED|Overall Study||76||
48116520|NCT03337724|100612550|FG003|STARTED|Overall Study||146||
48116521|NCT03337724|100612551|FG004|STARTED|Overall Study||102||
48116522|NCT03337724|100612547|FG000|Safety Evaluable Population|Overall Study||87|Safety Evaluable Population included all participants who received any amount of study treatment. Participants who were randomized (Cohorts A and B) or enrolled (Cohort C) into the study but who did not receive any study drug were not included in the Safety Evaluable Population.|
48116523|NCT03337724|100612548|FG001|Safety Evaluable Population|Overall Study||166|Safety Evaluable Population included all participants who received any amount of study treatment. Participants who were randomized (Cohorts A and B) or enrolled (Cohort C) into the study but who did not receive any study drug were not included in the Safety Evaluable Population.|
48116524|NCT03337724|100612549|FG002|Safety Evaluable Population|Overall Study||75|Safety Evaluable Population included all participants who received any amount of study treatment. Participants who were randomized (Cohorts A and B) or enrolled (Cohort C) into the study but who did not receive any study drug were not included in the Safety Evaluable Population.|
48116525|NCT03337724|100612550|FG003|Safety Evaluable Population|Overall Study||145|Safety Evaluable Population included all participants who received any amount of study treatment. Participants who were randomized (Cohorts A and B) or enrolled (Cohort C) into the study but who did not receive any study drug were not included in the Safety Evaluable Population.|
48116526|NCT03337724|100612551|FG004|Safety Evaluable Population|Overall Study||102|Safety Evaluable Population included all participants who received any amount of study treatment. Participants who were randomized (Cohorts A and B) or enrolled (Cohort C) into the study but who did not receive any study drug were not included in the Safety Evaluable Population.|
48116527|NCT03337724|100612547|FG000|COMPLETED|Overall Study||0||
48116528|NCT03337724|100612548|FG001|COMPLETED|Overall Study||0||
48116529|NCT03337724|100612549|FG002|COMPLETED|Overall Study||0||
48116530|NCT03337724|100612550|FG003|COMPLETED|Overall Study||0||
48116531|NCT03337724|100612551|FG004|COMPLETED|Overall Study||0||
48116532|NCT03337724|100612547|FG000|NOT COMPLETED|Overall Study||87||
48116533|NCT03337724|100612548|FG001|NOT COMPLETED|Overall Study||168||
48116534|NCT03337724|100612549|FG002|NOT COMPLETED|Overall Study||76||
48116535|NCT03337724|100612550|FG003|NOT COMPLETED|Overall Study||146||
48116536|NCT03337724|100612551|FG004|NOT COMPLETED|Overall Study||102||
48116537|NCT05009251|100612552|FG000|STARTED|Overall Study||9017||
48116538|NCT05009251|100612553|FG001|STARTED|Overall Study||9013||
48116539|NCT05009251|100612554|FG002|STARTED|Overall Study||9011||
48116540|NCT05009251|100612555|FG003|STARTED|Overall Study||9003||
48116541|NCT05009251|100612556|FG004|STARTED|Overall Study||9017||
48116542|NCT05009251|100612552|FG000|COMPLETED|Overall Study||8892||
48116543|NCT05009251|100612553|FG001|COMPLETED|Overall Study||8886||
48116544|NCT05009251|100612554|FG002|COMPLETED|Overall Study||8868||
48116545|NCT05009251|100612555|FG003|COMPLETED|Overall Study||8864||
48564205|NCT05370040|101713898|FG002|COMPLETED|Overall Study||9||
48564206|NCT05370040|101713899|FG003|COMPLETED|Overall Study||10||
48564207|NCT05370040|101713900|FG004|COMPLETED|Overall Study||9||
48564208|NCT05370040|101713901|FG005|COMPLETED|Overall Study||10||
48564209|NCT05370040|101713896|FG000|NOT COMPLETED|Overall Study||0||
48564210|NCT05370040|101713897|FG001|NOT COMPLETED|Overall Study||0||
48116546|NCT05009251|100612556|FG004|COMPLETED|Overall Study||8883||
48116547|NCT05009251|100612552|FG000|NOT COMPLETED|Overall Study||125||
48116548|NCT05009251|100612553|FG001|NOT COMPLETED|Overall Study||127||
48116549|NCT05009251|100612554|FG002|NOT COMPLETED|Overall Study||143||
48116550|NCT05009251|100612555|FG003|NOT COMPLETED|Overall Study||139||
48116551|NCT05009251|100612556|FG004|NOT COMPLETED|Overall Study||134||
48116552|NCT01800916|100612557|FG000|STARTED|Test Period 1 (1 Week)||7||
48116553|NCT01800916|100612558|FG001|STARTED|Test Period 1 (1 Week)||7||
48116554|NCT01800916|100612559|FG002|STARTED|Test Period 1 (1 Week)||7||
48116555|NCT01800916|100612560|FG003|STARTED|Test Period 1 (1 Week)||7||
48116556|NCT01800916|100612561|FG004|STARTED|Test Period 1 (1 Week)||8||
48116557|NCT01800916|100612562|FG005|STARTED|Test Period 1 (1 Week)||7||
48116558|NCT01800916|100612563|FG006|STARTED|Test Period 1 (1 Week)||7||
48116559|NCT01800916|100612564|FG007|STARTED|Test Period 1 (1 Week)||7||
48116560|NCT01800916|100612565|FG008|STARTED|Test Period 1 (1 Week)||7||
48564211|NCT05370040|101713898|FG002|NOT COMPLETED|Overall Study||1||
48564212|NCT05370040|101713899|FG003|NOT COMPLETED|Overall Study||0||
48564213|NCT05370040|101713900|FG004|NOT COMPLETED|Overall Study||1||
48564214|NCT05370040|101713901|FG005|NOT COMPLETED|Overall Study||0||
48564215|NCT01960413|101713902|FG000|STARTED|Overall Study||24||
48564216|NCT01960413|101713903|FG001|STARTED|Overall Study||22||
48564217|NCT01960413|101713902|FG000|COMPLETED|Overall Study||20||
48564218|NCT01960413|101713903|FG001|COMPLETED|Overall Study||21||
48116561|NCT01800916|100612557|FG000|COMPLETED|Test Period 1 (1 Week)||7||
48116562|NCT01800916|100612558|FG001|COMPLETED|Test Period 1 (1 Week)||7||
48116563|NCT01800916|100612559|FG002|COMPLETED|Test Period 1 (1 Week)||7||
48116564|NCT01800916|100612560|FG003|COMPLETED|Test Period 1 (1 Week)||6||
48564219|NCT01960413|101713902|FG000|NOT COMPLETED|Overall Study||4||
48564220|NCT01960413|101713903|FG001|NOT COMPLETED|Overall Study||1||
48116565|NCT01800916|100612561|FG004|COMPLETED|Test Period 1 (1 Week)||7||
48116566|NCT01800916|100612562|FG005|COMPLETED|Test Period 1 (1 Week)||7||
48116567|NCT01800916|100612563|FG006|COMPLETED|Test Period 1 (1 Week)||7||
48116568|NCT01800916|100612564|FG007|COMPLETED|Test Period 1 (1 Week)||7||
48116569|NCT01800916|100612565|FG008|COMPLETED|Test Period 1 (1 Week)||7||
48116570|NCT01800916|100612557|FG000|NOT COMPLETED|Test Period 1 (1 Week)||0||
48116571|NCT01800916|100612558|FG001|NOT COMPLETED|Test Period 1 (1 Week)||0||
48116572|NCT01800916|100612559|FG002|NOT COMPLETED|Test Period 1 (1 Week)||0||
48116573|NCT01800916|100612560|FG003|NOT COMPLETED|Test Period 1 (1 Week)||1||
48116574|NCT01800916|100612561|FG004|NOT COMPLETED|Test Period 1 (1 Week)||1||
48116575|NCT01800916|100612562|FG005|NOT COMPLETED|Test Period 1 (1 Week)||0||
48116576|NCT01800916|100612563|FG006|NOT COMPLETED|Test Period 1 (1 Week)||0||
48116577|NCT01800916|100612564|FG007|NOT COMPLETED|Test Period 1 (1 Week)||0||
48116578|NCT01800916|100612565|FG008|NOT COMPLETED|Test Period 1 (1 Week)||0||
48116579|NCT01800916|100612557|FG000|STARTED|Test Period 2 (1 Week)||7||
48116580|NCT01800916|100612558|FG001|STARTED|Test Period 2 (1 Week)||7||
48116581|NCT01800916|100612559|FG002|STARTED|Test Period 2 (1 Week)||7||
48116582|NCT01800916|100612560|FG003|STARTED|Test Period 2 (1 Week)||6||
48116583|NCT01800916|100612561|FG004|STARTED|Test Period 2 (1 Week)||7||
48116584|NCT01800916|100612562|FG005|STARTED|Test Period 2 (1 Week)||7||
48116585|NCT01800916|100612563|FG006|STARTED|Test Period 2 (1 Week)||7||
48116586|NCT01800916|100612564|FG007|STARTED|Test Period 2 (1 Week)||7||
48116587|NCT01800916|100612565|FG008|STARTED|Test Period 2 (1 Week)||7||
48116588|NCT01800916|100612557|FG000|COMPLETED|Test Period 2 (1 Week)||7||
48116589|NCT01800916|100612558|FG001|COMPLETED|Test Period 2 (1 Week)||7||
48116590|NCT01800916|100612559|FG002|COMPLETED|Test Period 2 (1 Week)||7||
48116591|NCT01800916|100612560|FG003|COMPLETED|Test Period 2 (1 Week)||6||
48116592|NCT01800916|100612561|FG004|COMPLETED|Test Period 2 (1 Week)||7||
48116593|NCT01800916|100612562|FG005|COMPLETED|Test Period 2 (1 Week)||7||
48116594|NCT01800916|100612563|FG006|COMPLETED|Test Period 2 (1 Week)||7||
48116595|NCT01800916|100612564|FG007|COMPLETED|Test Period 2 (1 Week)||7||
48116596|NCT01800916|100612565|FG008|COMPLETED|Test Period 2 (1 Week)||7||
48116597|NCT01800916|100612557|FG000|NOT COMPLETED|Test Period 2 (1 Week)||0||
48116598|NCT01800916|100612558|FG001|NOT COMPLETED|Test Period 2 (1 Week)||0||
48116599|NCT01800916|100612559|FG002|NOT COMPLETED|Test Period 2 (1 Week)||0||
48116600|NCT01800916|100612560|FG003|NOT COMPLETED|Test Period 2 (1 Week)||0||
48116601|NCT01800916|100612561|FG004|NOT COMPLETED|Test Period 2 (1 Week)||0||
48116602|NCT01800916|100612562|FG005|NOT COMPLETED|Test Period 2 (1 Week)||0||
48116603|NCT01800916|100612563|FG006|NOT COMPLETED|Test Period 2 (1 Week)||0||
48116604|NCT01800916|100612564|FG007|NOT COMPLETED|Test Period 2 (1 Week)||0||
48116605|NCT01800916|100612565|FG008|NOT COMPLETED|Test Period 2 (1 Week)||0||
48116606|NCT01800916|100612557|FG000|STARTED|Test Period 3 (1 Week)||7||
48116607|NCT01800916|100612558|FG001|STARTED|Test Period 3 (1 Week)||7||
48116608|NCT01800916|100612559|FG002|STARTED|Test Period 3 (1 Week)||7||
48116609|NCT01800916|100612560|FG003|STARTED|Test Period 3 (1 Week)||6||
48116610|NCT01800916|100612561|FG004|STARTED|Test Period 3 (1 Week)||7||
48116611|NCT01800916|100612562|FG005|STARTED|Test Period 3 (1 Week)||7||
48116612|NCT01800916|100612563|FG006|STARTED|Test Period 3 (1 Week)||7||
48116613|NCT01800916|100612564|FG007|STARTED|Test Period 3 (1 Week)||7||
48116614|NCT01800916|100612565|FG008|STARTED|Test Period 3 (1 Week)||7||
48116615|NCT01800916|100612557|FG000|COMPLETED|Test Period 3 (1 Week)||7||
48116616|NCT01800916|100612558|FG001|COMPLETED|Test Period 3 (1 Week)||7||
48116617|NCT01800916|100612559|FG002|COMPLETED|Test Period 3 (1 Week)||7||
48116618|NCT01800916|100612560|FG003|COMPLETED|Test Period 3 (1 Week)||6||
48116619|NCT01800916|100612561|FG004|COMPLETED|Test Period 3 (1 Week)||7||
48116620|NCT01800916|100612562|FG005|COMPLETED|Test Period 3 (1 Week)||7||
48116621|NCT01800916|100612563|FG006|COMPLETED|Test Period 3 (1 Week)||7||
48116622|NCT01800916|100612564|FG007|COMPLETED|Test Period 3 (1 Week)||7||
48116623|NCT01800916|100612565|FG008|COMPLETED|Test Period 3 (1 Week)||7||
48116624|NCT01800916|100612557|FG000|NOT COMPLETED|Test Period 3 (1 Week)||0||
48116625|NCT01800916|100612558|FG001|NOT COMPLETED|Test Period 3 (1 Week)||0||
48116626|NCT01800916|100612559|FG002|NOT COMPLETED|Test Period 3 (1 Week)||0||
48116627|NCT01800916|100612560|FG003|NOT COMPLETED|Test Period 3 (1 Week)||0||
48116628|NCT01800916|100612561|FG004|NOT COMPLETED|Test Period 3 (1 Week)||0||
48116629|NCT01800916|100612562|FG005|NOT COMPLETED|Test Period 3 (1 Week)||0||
48116630|NCT01800916|100612563|FG006|NOT COMPLETED|Test Period 3 (1 Week)||0||
48116631|NCT01800916|100612564|FG007|NOT COMPLETED|Test Period 3 (1 Week)||0||
48116632|NCT01800916|100612565|FG008|NOT COMPLETED|Test Period 3 (1 Week)||0||
48116633|NCT02223767|100612566|FG000|STARTED|Overall Study||24||
48116634|NCT02223767|100612567|FG001|STARTED|Overall Study||23||
48116635|NCT02223767|100612566|FG000|COMPLETED|Overall Study||20||
48116636|NCT02223767|100612567|FG001|COMPLETED|Overall Study||19||
48116637|NCT02223767|100612566|FG000|NOT COMPLETED|Overall Study||4||
48116638|NCT02223767|100612567|FG001|NOT COMPLETED|Overall Study||4||
48116639|NCT00678691|100612568|FG000|STARTED|Overall Study||27||
48116640|NCT00678691|100612569|FG001|STARTED|Overall Study||28||
48116641|NCT00678691|100612568|FG000|COMPLETED|Overall Study||21||
48116642|NCT00678691|100612569|FG001|COMPLETED|Overall Study||24||
48116643|NCT00678691|100612568|FG000|NOT COMPLETED|Overall Study||6||
48116644|NCT00678691|100612569|FG001|NOT COMPLETED|Overall Study||4||
48697687|NCT00487942|102045439|FG000|NOT COMPLETED|Overall Study||3||
48564221|NCT03397589|101713904|FG000|STARTED|Overall Study||211||
48564222|NCT03397589|101713905|FG001|STARTED|Overall Study||209||
48564223|NCT03397589|101713904|FG000|COMPLETED|Overall Study||175||
48564224|NCT03397589|101713905|FG001|COMPLETED|Overall Study||187||
48564225|NCT03397589|101713904|FG000|NOT COMPLETED|Overall Study||36||
48564226|NCT03397589|101713905|FG001|NOT COMPLETED|Overall Study||22||
48697688|NCT00487942|102045440|FG001|NOT COMPLETED|Overall Study||3||
48697689|NCT00487942|102045441|FG002|NOT COMPLETED|Overall Study||3||
48697690|NCT00487942|102045442|FG003|NOT COMPLETED|Overall Study||2||
48697691|NCT00435227|102045443|FG000|STARTED|Overall Study||5||
48697692|NCT00435227|102045444|FG001|STARTED|Overall Study||7||
48697693|NCT00435227|102045443|FG000|COMPLETED|Overall Study||5||
48278583|NCT04860297|101007087|FG001|Received Second Study Injection|Part A (Primary Series)||58||
48278584|NCT04860297|101007088|FG002|Received Second Study Injection|Part A (Primary Series)||0||
48278585|NCT04860297|101007089|FG003|Received Second Study Injection|Part A (Primary Series)||0||
48278586|NCT04860297|101007090|FG004|Received Second Study Injection|Part A (Primary Series)||0||
48278587|NCT04860297|101007091|FG005|Received Second Study Injection|Part A (Primary Series)||0||
48278588|NCT04860297|101007092|FG006|Received Second Study Injection|Part A (Primary Series)||0||
48278589|NCT04860297|101007093|FG007|Received Second Study Injection|Part A (Primary Series)||0||
48278590|NCT04860297|101007086|FG000|Received Third Study Injection|Part A (Primary Series)||0||
48278591|NCT04860297|101007087|FG001|Received Third Study Injection|Part A (Primary Series)||57||
48278592|NCT04860297|101007088|FG002|Received Third Study Injection|Part A (Primary Series)||71||
48278593|NCT04860297|101007089|FG003|Received Third Study Injection|Part A (Primary Series)||0||
48278594|NCT04860297|101007090|FG004|Received Third Study Injection|Part A (Primary Series)||0||
48697694|NCT00435227|102045444|FG001|COMPLETED|Overall Study||7||
48697695|NCT00435227|102045443|FG000|NOT COMPLETED|Overall Study||0||
48697696|NCT00435227|102045444|FG001|NOT COMPLETED|Overall Study||0||
48278595|NCT04860297|101007091|FG005|Received Third Study Injection|Part A (Primary Series)||0||
48697697|NCT01660672|102045445|FG000|STARTED|Overall Study||7||
48697698|NCT01660672|102045445|FG000|COMPLETED|Overall Study||7||
48697699|NCT01660672|102045445|FG000|NOT COMPLETED|Overall Study||0||
48697700|NCT02910401|102045446|FG000|STARTED|Overall Study||6||
48697701|NCT02910401|102045447|FG001|STARTED|Overall Study||17||
48697702|NCT02910401|102045448|FG002|STARTED|Overall Study||15||
48697703|NCT02910401|102045446|FG000|COMPLETED|Overall Study||5||
48697704|NCT02910401|102045447|FG001|COMPLETED|Overall Study||17||
48116645|NCT00145509|100612570|FG000|STARTED|Overall Study||41||
48116646|NCT00145509|100612571|FG001|STARTED|Overall Study||36||
48116647|NCT00145509|100612570|FG000|COMPLETED|Overall Study||19||
48116648|NCT00145509|100612571|FG001|COMPLETED|Overall Study||15||
48697705|NCT02910401|102045448|FG002|COMPLETED|Overall Study||13||
48697706|NCT02910401|102045446|FG000|NOT COMPLETED|Overall Study||1||
48697707|NCT02910401|102045447|FG001|NOT COMPLETED|Overall Study||0||
48697708|NCT02910401|102045448|FG002|NOT COMPLETED|Overall Study||2||
48116649|NCT00145509|100612570|FG000|NOT COMPLETED|Overall Study||22||
48278596|NCT04860297|101007092|FG006|Received Third Study Injection|Part A (Primary Series)||0||
48278597|NCT04860297|101007093|FG007|Received Third Study Injection|Part A (Primary Series)||0||
48278598|NCT04860297|101007086|FG000|COMPLETED|Part A (Primary Series)||2||
48278599|NCT04860297|101007087|FG001|COMPLETED|Part A (Primary Series)||57||
48278600|NCT04860297|101007088|FG002|COMPLETED|Part A (Primary Series)||71||
48278601|NCT04860297|101007089|FG003|COMPLETED|Part A (Primary Series)||17||
48564227|NCT01842438|101713906|FG000|STARTED|T1: Immediately After the Intervention||42||
48564228|NCT01842438|101713907|FG001|STARTED|T1: Immediately After the Intervention||44||
48564229|NCT01842438|101713906|FG000|COMPLETED|T1: Immediately After the Intervention||36||
48697709|NCT00344318|102045449|FG000|STARTED|Overall Study||300||
48697710|NCT00344318|102045450|FG001|STARTED|Overall Study||303||
48697711|NCT00344318|102045451|FG002|STARTED|Overall Study||100||
48697712|NCT00344318|102045452|FG003|STARTED|Overall Study||103||
48116650|NCT00145509|100612571|FG001|NOT COMPLETED|Overall Study||21||
48116651|NCT04046471|100612572|FG000|STARTED|6-month||63||
48116652|NCT04046471|100612573|FG001|STARTED|6-month||66||
48116653|NCT04046471|100612572|FG000|COMPLETED|6-month||54||
48116654|NCT04046471|100612573|FG001|COMPLETED|6-month||62||
48564230|NCT01842438|101713907|FG001|COMPLETED|T1: Immediately After the Intervention||36||
48564231|NCT01842438|101713906|FG000|NOT COMPLETED|T1: Immediately After the Intervention||6||
48564232|NCT01842438|101713907|FG001|NOT COMPLETED|T1: Immediately After the Intervention||8||
48564233|NCT01842438|101713906|FG000|STARTED|T2: 6month Follow-up||36||
48564234|NCT01842438|101713907|FG001|STARTED|T2: 6month Follow-up||36||
48564235|NCT01842438|101713906|FG000|COMPLETED|T2: 6month Follow-up||32||
48564236|NCT01842438|101713907|FG001|COMPLETED|T2: 6month Follow-up||32||
48564237|NCT01842438|101713906|FG000|NOT COMPLETED|T2: 6month Follow-up||4||
48564238|NCT01842438|101713907|FG001|NOT COMPLETED|T2: 6month Follow-up||4||
48697713|NCT00344318|102045449|FG000|COMPLETED|Overall Study||296||
48697714|NCT00344318|102045450|FG001|COMPLETED|Overall Study||298||
48697715|NCT00344318|102045451|FG002|COMPLETED|Overall Study||99||
48116655|NCT04046471|100612572|FG000|NOT COMPLETED|6-month||9||
48116656|NCT04046471|100612573|FG001|NOT COMPLETED|6-month||4||
48116657|NCT04046471|100612572|FG000|STARTED|12-month||54||
48116658|NCT04046471|100612573|FG001|STARTED|12-month||62||
48278602|NCT04860297|101007090|FG004|COMPLETED|Part A (Primary Series)||0||
48278603|NCT04860297|101007091|FG005|COMPLETED|Part A (Primary Series)||0||
48278604|NCT04860297|101007092|FG006|COMPLETED|Part A (Primary Series)||0||
48278605|NCT04860297|101007093|FG007|COMPLETED|Part A (Primary Series)||0||
48278606|NCT04860297|101007086|FG000|NOT COMPLETED|Part A (Primary Series)||1||
48278607|NCT04860297|101007087|FG001|NOT COMPLETED|Part A (Primary Series)||1||
48278608|NCT04860297|101007088|FG002|NOT COMPLETED|Part A (Primary Series)||0||
48278609|NCT04860297|101007089|FG003|NOT COMPLETED|Part A (Primary Series)||3||
48278610|NCT04860297|101007090|FG004|NOT COMPLETED|Part A (Primary Series)||0||
48278611|NCT04860297|101007091|FG005|NOT COMPLETED|Part A (Primary Series)||0||
48278612|NCT04860297|101007092|FG006|NOT COMPLETED|Part A (Primary Series)||0||
48278613|NCT04860297|101007093|FG007|NOT COMPLETED|Part A (Primary Series)||0||
48278614|NCT04860297|101007086|FG000|STARTED|Part B (Booster Dose)||0||
48278615|NCT04860297|101007087|FG001|STARTED|Part B (Booster Dose)||0||
48278616|NCT04860297|101007088|FG002|STARTED|Part B (Booster Dose)||0||
48278617|NCT04860297|101007089|FG003|STARTED|Part B (Booster Dose)||0||
48278618|NCT04860297|101007090|FG004|STARTED|Part B (Booster Dose)||33||
48278619|NCT04860297|101007091|FG005|STARTED|Part B (Booster Dose)||44||
48278620|NCT04860297|101007092|FG006|STARTED|Part B (Booster Dose)||82||
48278621|NCT04860297|101007093|FG007|STARTED|Part B (Booster Dose)||10||
48278622|NCT04860297|101007086|FG000|Received Booster Injection|Part B (Booster Dose)||0||
48278623|NCT04860297|101007087|FG001|Received Booster Injection|Part B (Booster Dose)||0||
48278624|NCT04860297|101007088|FG002|Received Booster Injection|Part B (Booster Dose)||0||
48278625|NCT04860297|101007089|FG003|Received Booster Injection|Part B (Booster Dose)||0||
48278626|NCT04860297|101007090|FG004|Received Booster Injection|Part B (Booster Dose)||33||
48278627|NCT04860297|101007091|FG005|Received Booster Injection|Part B (Booster Dose)||44||
48278628|NCT04860297|101007092|FG006|Received Booster Injection|Part B (Booster Dose)||81||
48278629|NCT04860297|101007093|FG007|Received Booster Injection|Part B (Booster Dose)||10||
48278630|NCT04860297|101007086|FG000|COMPLETED|Part B (Booster Dose)||0||
48278631|NCT04860297|101007087|FG001|COMPLETED|Part B (Booster Dose)||0||
48278632|NCT04860297|101007088|FG002|COMPLETED|Part B (Booster Dose)||0||
48278633|NCT04860297|101007089|FG003|COMPLETED|Part B (Booster Dose)||0||
48278634|NCT04860297|101007090|FG004|COMPLETED|Part B (Booster Dose)||29||
48564239|NCT00660517|101713908|FG000|STARTED|Overall Study||153||
48564240|NCT00660517|101713909|FG001|STARTED|Overall Study||152||
48564241|NCT00660517|101713910|FG002|STARTED|Overall Study||151||
48564242|NCT00660517|101713911|FG003|STARTED|Overall Study||151||
48564243|NCT00660517|101713908|FG000|COMPLETED|Overall Study||145||
48564244|NCT00660517|101713909|FG001|COMPLETED|Overall Study||144||
48564245|NCT00660517|101713910|FG002|COMPLETED|Overall Study||144||
48564246|NCT00660517|101713911|FG003|COMPLETED|Overall Study||144||
48564247|NCT00660517|101713908|FG000|NOT COMPLETED|Overall Study||8||
48564248|NCT00660517|101713909|FG001|NOT COMPLETED|Overall Study||8||
48564249|NCT00660517|101713910|FG002|NOT COMPLETED|Overall Study||7||
48564250|NCT00660517|101713911|FG003|NOT COMPLETED|Overall Study||7||
48116659|NCT04046471|100612572|FG000|COMPLETED|12-month||49||
48116660|NCT04046471|100612573|FG001|COMPLETED|12-month||58||
48116661|NCT04046471|100612572|FG000|NOT COMPLETED|12-month||5||
48116662|NCT04046471|100612573|FG001|NOT COMPLETED|12-month||4||
48278635|NCT04860297|101007091|FG005|COMPLETED|Part B (Booster Dose)||34||
48278636|NCT04860297|101007092|FG006|COMPLETED|Part B (Booster Dose)||78||
48394354|NCT01293006|101295919|FG001|STARTED|Washout||2||
48394355|NCT01293006|101295920|FG002|STARTED|Washout||9||
48394356|NCT01293006|101295921|FG003|STARTED|Washout||3||
48394357|NCT01293006|101295918|FG000|COMPLETED|Washout||11||
48394358|NCT01293006|101295919|FG001|COMPLETED|Washout||2||
48394359|NCT01293006|101295920|FG002|COMPLETED|Washout||9||
48394360|NCT01293006|101295921|FG003|COMPLETED|Washout||3||
48394361|NCT01293006|101295918|FG000|NOT COMPLETED|Washout||0||
48564251|NCT03850483|101713912|FG000|STARTED|Treatment for Stage 1||37||
48564252|NCT03850483|101713913|FG001|STARTED|Treatment for Stage 1||37||
48116663|NCT02052739|100612574|FG000|STARTED|Overall Study||19||
48116664|NCT02052739|100612575|FG001|STARTED|Overall Study||6||
48116665|NCT02052739|100612574|FG000|COMPLETED|Overall Study||14||
48116666|NCT02052739|100612575|FG001|COMPLETED|Overall Study||5||
48116667|NCT02052739|100612574|FG000|NOT COMPLETED|Overall Study||5||
48116668|NCT02052739|100612575|FG001|NOT COMPLETED|Overall Study||1||
48116669|NCT01866709|100612576|FG000|STARTED|Overall Study||15||
48116670|NCT01866709|100612577|FG001|STARTED|Overall Study||17||
48116671|NCT01866709|100612576|FG000|COMPLETED|Overall Study||14||
48116672|NCT01866709|100612577|FG001|COMPLETED|Overall Study||17||
48278637|NCT04860297|101007093|FG007|COMPLETED|Part B (Booster Dose)||7||
48278638|NCT04860297|101007086|FG000|NOT COMPLETED|Part B (Booster Dose)||0||
48278639|NCT04860297|101007087|FG001|NOT COMPLETED|Part B (Booster Dose)||0||
48278640|NCT04860297|101007088|FG002|NOT COMPLETED|Part B (Booster Dose)||0||
48278641|NCT04860297|101007089|FG003|NOT COMPLETED|Part B (Booster Dose)||0||
48394362|NCT01293006|101295919|FG001|NOT COMPLETED|Washout||0||
48394363|NCT01293006|101295920|FG002|NOT COMPLETED|Washout||0||
48394364|NCT01293006|101295921|FG003|NOT COMPLETED|Washout||0||
48564253|NCT03850483|101713914|FG002|STARTED|Treatment for Stage 1||37||
48564254|NCT03850483|101713915|FG003|STARTED|Treatment for Stage 1||36||
48564255|NCT03850483|101713916|FG004|STARTED|Treatment for Stage 1||37||
48394365|NCT01293006|101295918|FG000|STARTED|Period 2||11||
48394366|NCT01293006|101295919|FG001|STARTED|Period 2||2||
48394367|NCT01293006|101295920|FG002|STARTED|Period 2||9||
48394368|NCT01293006|101295921|FG003|STARTED|Period 2||3||
48116673|NCT01866709|100612576|FG000|NOT COMPLETED|Overall Study||1||
48116674|NCT01866709|100612577|FG001|NOT COMPLETED|Overall Study||0||
48116675|NCT01409291|100612578|FG000|STARTED|Overall Study||36||
48116676|NCT01409291|100612579|FG001|STARTED|Overall Study||28||
48116677|NCT01409291|100612578|FG000|COMPLETED|Overall Study||29||
48116678|NCT01409291|100612579|FG001|COMPLETED|Overall Study||19||
48116679|NCT01409291|100612578|FG000|NOT COMPLETED|Overall Study||7||
48116680|NCT01409291|100612579|FG001|NOT COMPLETED|Overall Study||9||
48116681|NCT01976845|100612580|FG000|STARTED|Overall Study||48||
48116682|NCT01976845|100612581|FG001|STARTED|Overall Study||48||
48116683|NCT01976845|100612582|FG002|STARTED|Overall Study||43||
48116684|NCT01976845|100612580|FG000|COMPLETED|Overall Study||40||
48116685|NCT01976845|100612581|FG001|COMPLETED|Overall Study||40||
48116686|NCT01976845|100612582|FG002|COMPLETED|Overall Study||40||
48116687|NCT01976845|100612580|FG000|NOT COMPLETED|Overall Study||8||
48116688|NCT01976845|100612581|FG001|NOT COMPLETED|Overall Study||8||
48116689|NCT01976845|100612582|FG002|NOT COMPLETED|Overall Study||3||
48116690|NCT02118428|100612583|FG000|STARTED|Overall Study||113||
48116691|NCT02118428|100612584|FG001|STARTED|Overall Study||113||
48116692|NCT02118428|100612585|FG002|STARTED|Overall Study||1||
48116693|NCT02118428|100612583|FG000|Received Study Transfusion|Overall Study||111||
48116694|NCT02118428|100612584|FG001|Received Study Transfusion|Overall Study||112||
48116695|NCT02118428|100612585|FG002|Received Study Transfusion|Overall Study||0||
48116696|NCT02118428|100612583|FG000|COMPLETED|Overall Study||100||
48116697|NCT02118428|100612584|FG001|COMPLETED|Overall Study||104||
48116698|NCT02118428|100612585|FG002|COMPLETED|Overall Study||0||
48116699|NCT02118428|100612583|FG000|NOT COMPLETED|Overall Study||13||
48116700|NCT02118428|100612584|FG001|NOT COMPLETED|Overall Study||9||
48116701|NCT02118428|100612585|FG002|NOT COMPLETED|Overall Study||1||
48116702|NCT01443442|100612586|FG000|STARTED|Overall Study||12||
48116703|NCT01443442|100612587|FG001|STARTED|Overall Study||11||
48116704|NCT01443442|100612586|FG000|COMPLETED|Overall Study||12||
48116705|NCT01443442|100612587|FG001|COMPLETED|Overall Study||11||
48116706|NCT01443442|100612586|FG000|NOT COMPLETED|Overall Study||0||
48116707|NCT01443442|100612587|FG001|NOT COMPLETED|Overall Study||0||
48116708|NCT00856024|100612588|FG000|STARTED|Overall Study||902||
48116709|NCT00856024|100612588|FG000|COMPLETED|Overall Study||902||
48116710|NCT00856024|100612588|FG000|NOT COMPLETED|Overall Study||0||
48116711|NCT00779675|100612589|FG000|STARTED|Treatment Period||660||
48116712|NCT00779675|100612589|FG000|COMPLETED|Treatment Period||328||
48116713|NCT00779675|100612589|FG000|NOT COMPLETED|Treatment Period||332||
48116714|NCT00779675|100612589|FG000|STARTED|Extended Treatment Period||193||
48116715|NCT00779675|100612589|FG000|COMPLETED|Extended Treatment Period||147||
48116716|NCT00779675|100612589|FG000|NOT COMPLETED|Extended Treatment Period||46||
48116717|NCT01988571|100612590|FG000|STARTED|Overall Study||139||
48116718|NCT01988571|100612591|FG001|STARTED|Overall Study||140||
48116719|NCT01988571|100612590|FG000|Completed Baseline|Overall Study||136|Defined as having labs done at that time point.|
48116720|NCT01988571|100612591|FG001|Completed Baseline|Overall Study||139|Defined as having labs done at that time point.|
48116721|NCT01988571|100612590|FG000|Completed 6 Month Visit|Overall Study||122|Defined as having labs done at that time point.|
48116722|NCT01988571|100612591|FG001|Completed 6 Month Visit|Overall Study||126|Defined as having labs done at that time point.|
48116723|NCT01988571|100612590|FG000|COMPLETED|Overall Study||100|Defined as having labs done at that time point.|
48116724|NCT01988571|100612591|FG001|COMPLETED|Overall Study||105|Defined as having labs done at that time point.|
48116725|NCT01988571|100612590|FG000|NOT COMPLETED|Overall Study||39||
48116726|NCT01988571|100612591|FG001|NOT COMPLETED|Overall Study||35||
48116727|NCT03459196|100612592|FG000|STARTED|Overall Study||54|Subjects who signed the informed consent form are considered as enrolled and started the study.|
48116728|NCT03459196|100612592|FG000|COMPLETED|Overall Study||52||
48116729|NCT03459196|100612592|FG000|NOT COMPLETED|Overall Study||2||
48116730|NCT01545817|100612593|FG000|STARTED|Pazopanib||74||
48116731|NCT01545817|100612594|FG001|STARTED|Pazopanib||0||
48116732|NCT01545817|100612593|FG000|COMPLETED|Pazopanib||0||
48116733|NCT01545817|100612594|FG001|COMPLETED|Pazopanib||0||
48116734|NCT01545817|100612593|FG000|NOT COMPLETED|Pazopanib||74||
48116735|NCT01545817|100612594|FG001|NOT COMPLETED|Pazopanib||0||
48116736|NCT01545817|100612593|FG000|STARTED|Everolimus||0||
48116737|NCT01545817|100612594|FG001|STARTED|Everolimus||38||
48116738|NCT01545817|100612593|FG000|COMPLETED|Everolimus||0||
48394369|NCT01293006|101295918|FG000|COMPLETED|Period 2||10||
48116739|NCT01545817|100612594|FG001|COMPLETED|Everolimus||0||
48116740|NCT01545817|100612593|FG000|NOT COMPLETED|Everolimus||0||
48116741|NCT01545817|100612594|FG001|NOT COMPLETED|Everolimus||38||
48394370|NCT01293006|101295919|FG001|COMPLETED|Period 2||2||
48394371|NCT01293006|101295920|FG002|COMPLETED|Period 2||9||
48394372|NCT01293006|101295921|FG003|COMPLETED|Period 2||3||
48116742|NCT01573624|100612595|FG000|STARTED|Period 1 : Treatment Period 1 (14 Days)||64||
48116743|NCT01573624|100612596|FG001|STARTED|Period 1 : Treatment Period 1 (14 Days)||62||
48116744|NCT01573624|100612597|FG002|STARTED|Period 1 : Treatment Period 1 (14 Days)||60||
48394373|NCT01293006|101295918|FG000|NOT COMPLETED|Period 2||1||
48564256|NCT03850483|101713917|FG005|STARTED|Treatment for Stage 1||38||
48564257|NCT03850483|101713918|FG006|STARTED|Treatment for Stage 1||36||
48564258|NCT03850483|101713919|FG007|STARTED|Treatment for Stage 1||36||
48564259|NCT03850483|101713920|FG008|STARTED|Treatment for Stage 1||0||
48564260|NCT03850483|101713921|FG009|STARTED|Treatment for Stage 1||0||
48394374|NCT01293006|101295919|FG001|NOT COMPLETED|Period 2||0||
48394375|NCT01293006|101295920|FG002|NOT COMPLETED|Period 2||0||
48394376|NCT01293006|101295921|FG003|NOT COMPLETED|Period 2||0||
48394377|NCT00583661|101295922|FG000|STARTED|Overall Study||48||
48394378|NCT00583661|101295922|FG000|COMPLETED|Overall Study||48||
48394379|NCT00583661|101295922|FG000|NOT COMPLETED|Overall Study||0||
48564261|NCT03850483|101713912|FG000|Treated|Treatment for Stage 1||37||
48564262|NCT03850483|101713913|FG001|Treated|Treatment for Stage 1||37||
48564263|NCT03850483|101713914|FG002|Treated|Treatment for Stage 1||37||
48564264|NCT03850483|101713915|FG003|Treated|Treatment for Stage 1||36||
48564265|NCT03850483|101713916|FG004|Treated|Treatment for Stage 1||37||
48564266|NCT03850483|101713917|FG005|Treated|Treatment for Stage 1||37||
48564267|NCT03850483|101713918|FG006|Treated|Treatment for Stage 1||36||
48564268|NCT03850483|101713919|FG007|Treated|Treatment for Stage 1||36||
48564269|NCT03850483|101713920|FG008|Treated|Treatment for Stage 1||0||
48564270|NCT03850483|101713921|FG009|Treated|Treatment for Stage 1||0||
48564271|NCT03850483|101713912|FG000|COMPLETED|Treatment for Stage 1||29||
48564272|NCT03850483|101713913|FG001|COMPLETED|Treatment for Stage 1||29||
48564273|NCT03850483|101713914|FG002|COMPLETED|Treatment for Stage 1||26||
48564274|NCT03850483|101713915|FG003|COMPLETED|Treatment for Stage 1||30||
48564275|NCT03850483|101713916|FG004|COMPLETED|Treatment for Stage 1||28||
48564276|NCT03850483|101713917|FG005|COMPLETED|Treatment for Stage 1||27||
48564277|NCT03850483|101713918|FG006|COMPLETED|Treatment for Stage 1||25||
48564278|NCT03850483|101713919|FG007|COMPLETED|Treatment for Stage 1||30||
48564279|NCT03850483|101713920|FG008|COMPLETED|Treatment for Stage 1||0||
48564280|NCT03850483|101713921|FG009|COMPLETED|Treatment for Stage 1||0||
48564281|NCT03850483|101713912|FG000|NOT COMPLETED|Treatment for Stage 1||8||
48564282|NCT03850483|101713913|FG001|NOT COMPLETED|Treatment for Stage 1||8||
48564283|NCT03850483|101713914|FG002|NOT COMPLETED|Treatment for Stage 1||11||
48564284|NCT03850483|101713915|FG003|NOT COMPLETED|Treatment for Stage 1||6||
48564285|NCT03850483|101713916|FG004|NOT COMPLETED|Treatment for Stage 1||9||
48564286|NCT03850483|101713917|FG005|NOT COMPLETED|Treatment for Stage 1||11||
48564287|NCT03850483|101713918|FG006|NOT COMPLETED|Treatment for Stage 1||11||
48564288|NCT03850483|101713919|FG007|NOT COMPLETED|Treatment for Stage 1||6||
48564289|NCT03850483|101713920|FG008|NOT COMPLETED|Treatment for Stage 1||0||
48564290|NCT03850483|101713921|FG009|NOT COMPLETED|Treatment for Stage 1||0||
48564291|NCT03850483|101713912|FG000|STARTED|Follow-up for Stage 1||37||
48564292|NCT03850483|101713913|FG001|STARTED|Follow-up for Stage 1||37||
48564293|NCT03850483|101713914|FG002|STARTED|Follow-up for Stage 1||37||
48394380|NCT02156804|101295923|FG000|STARTED|Overall Study||1009||
48564294|NCT03850483|101713915|FG003|STARTED|Follow-up for Stage 1||36||
48564295|NCT03850483|101713916|FG004|STARTED|Follow-up for Stage 1||37||
48564296|NCT03850483|101713917|FG005|STARTED|Follow-up for Stage 1||37||
48564297|NCT03850483|101713918|FG006|STARTED|Follow-up for Stage 1||36||
48564298|NCT03850483|101713919|FG007|STARTED|Follow-up for Stage 1||36||
48116745|NCT01573624|100612598|FG003|STARTED|Period 1 : Treatment Period 1 (14 Days)||63||
48116746|NCT01573624|100612599|FG004|STARTED|Period 1 : Treatment Period 1 (14 Days)||58||
48116747|NCT01573624|100612600|FG005|STARTED|Period 1 : Treatment Period 1 (14 Days)||55||
48116748|NCT01573624|100612601|FG006|STARTED|Period 1 : Treatment Period 1 (14 Days)||59||
48394381|NCT02156804|101295923|FG000|COMPLETED|Overall Study||1008||
48394382|NCT02156804|101295923|FG000|NOT COMPLETED|Overall Study||1||
48394383|NCT00249795|101295924|FG000|STARTED|Overall Study||4518||
48394384|NCT00249795|101295925|FG001|STARTED|Overall Study||4498||
48394385|NCT00249795|101295924|FG000|COMPLETED|Overall Study||3124||
48394386|NCT00249795|101295925|FG001|COMPLETED|Overall Study||3108||
48394387|NCT00249795|101295924|FG000|NOT COMPLETED|Overall Study||1394||
48394388|NCT00249795|101295925|FG001|NOT COMPLETED|Overall Study||1390||
48394389|NCT03437044|101295926|FG000|STARTED|Overall Study||20||
48394390|NCT03437044|101295927|FG001|STARTED|Overall Study||20||
48394391|NCT03437044|101295926|FG000|COMPLETED|Overall Study||17||
48394392|NCT03437044|101295927|FG001|COMPLETED|Overall Study||18||
48116749|NCT01573624|100612595|FG000|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||58||
48116750|NCT01573624|100612596|FG001|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||59||
48116751|NCT01573624|100612597|FG002|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51||
48116752|NCT01573624|100612598|FG003|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||61||
48116753|NCT01573624|100612599|FG004|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||56||
48116754|NCT01573624|100612600|FG005|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51||
48116755|NCT01573624|100612601|FG006|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||57||
48116756|NCT01573624|100612595|FG000|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||6||
48116757|NCT01573624|100612596|FG001|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||3||
48116758|NCT01573624|100612597|FG002|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||9||
48116759|NCT01573624|100612598|FG003|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2||
48116760|NCT01573624|100612599|FG004|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2||
48116761|NCT01573624|100612600|FG005|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||4||
48116762|NCT01573624|100612601|FG006|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2||
48116763|NCT01573624|100612595|FG000|STARTED|Period 2 : Washout Period 1 (12-14 Days)||58||
48116764|NCT01573624|100612596|FG001|STARTED|Period 2 : Washout Period 1 (12-14 Days)||59||
48116765|NCT01573624|100612597|FG002|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51||
48116766|NCT01573624|100612598|FG003|STARTED|Period 2 : Washout Period 1 (12-14 Days)||61||
48116767|NCT01573624|100612599|FG004|STARTED|Period 2 : Washout Period 1 (12-14 Days)||56||
48116768|NCT01573624|100612600|FG005|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51||
48116769|NCT01573624|100612601|FG006|STARTED|Period 2 : Washout Period 1 (12-14 Days)||57||
48116770|NCT01573624|100612595|FG000|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||57||
48116771|NCT01573624|100612596|FG001|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||58||
48116772|NCT01573624|100612597|FG002|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48||
48116773|NCT01573624|100612598|FG003|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56||
48116774|NCT01573624|100612599|FG004|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56||
48116775|NCT01573624|100612600|FG005|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48||
48116776|NCT01573624|100612601|FG006|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||55||
48116777|NCT01573624|100612595|FG000|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1||
48116778|NCT01573624|100612596|FG001|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1||
48116779|NCT01573624|100612597|FG002|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3||
48116780|NCT01573624|100612598|FG003|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||5||
48116781|NCT01573624|100612599|FG004|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||0||
48116782|NCT01573624|100612600|FG005|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3||
48116783|NCT01573624|100612601|FG006|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||2||
48116784|NCT01573624|100612595|FG000|STARTED|Period 3 : Treatment Period 2 (14 Days)||57||
48116785|NCT01573624|100612596|FG001|STARTED|Period 3 : Treatment Period 2 (14 Days)||58||
48116786|NCT01573624|100612597|FG002|STARTED|Period 3 : Treatment Period 2 (14 Days)||48||
48116787|NCT01573624|100612598|FG003|STARTED|Period 3 : Treatment Period 2 (14 Days)||56||
48116788|NCT01573624|100612599|FG004|STARTED|Period 3 : Treatment Period 2 (14 Days)||56||
48116789|NCT01573624|100612600|FG005|STARTED|Period 3 : Treatment Period 2 (14 Days)||48||
48116790|NCT01573624|100612601|FG006|STARTED|Period 3 : Treatment Period 2 (14 Days)||55||
48394393|NCT03437044|101295926|FG000|NOT COMPLETED|Overall Study||3||
48394394|NCT03437044|101295927|FG001|NOT COMPLETED|Overall Study||2||
48394395|NCT03124901|101295928|FG000|STARTED|Overall Study||147||
48394396|NCT03124901|101295928|FG000|COMPLETED|Overall Study||147||
48394397|NCT03124901|101295928|FG000|NOT COMPLETED|Overall Study||0||
48394398|NCT04172701|101295929|FG000|STARTED|Overall Study||6352||
48394399|NCT04172701|101295930|FG001|STARTED|Overall Study||2932||
48394400|NCT04172701|101295929|FG000|Propensity Score (PS) Matched Population|Overall Study||2444||
48394401|NCT04172701|101295930|FG001|Propensity Score (PS) Matched Population|Overall Study||2444||
48394402|NCT04172701|101295929|FG000|COMPLETED|Overall Study||6352||
48394403|NCT04172701|101295930|FG001|COMPLETED|Overall Study||2932||
48394404|NCT04172701|101295929|FG000|NOT COMPLETED|Overall Study||0||
48394405|NCT04172701|101295930|FG001|NOT COMPLETED|Overall Study||0||
48394406|NCT01664858|101295931|FG000|STARTED|Overall Study||481||
48394407|NCT01664858|101295932|FG001|STARTED|Overall Study||481||
48278642|NCT04860297|101007090|FG004|NOT COMPLETED|Part B (Booster Dose)||4||
48278643|NCT04860297|101007091|FG005|NOT COMPLETED|Part B (Booster Dose)||10||
48278644|NCT04860297|101007092|FG006|NOT COMPLETED|Part B (Booster Dose)||4||
48278645|NCT04860297|101007093|FG007|NOT COMPLETED|Part B (Booster Dose)||3||
48278646|NCT01008410|101007094|FG000|STARTED|Overall Study||133||
48278647|NCT01008410|101007095|FG001|STARTED|Overall Study||132||
48278648|NCT01008410|101007094|FG000|Received at Least 1 Dose of Study Drug|Overall Study||133||
48278649|NCT01008410|101007095|FG001|Received at Least 1 Dose of Study Drug|Overall Study||132||
48278650|NCT01008410|101007094|FG000|COMPLETED|Overall Study||108||
48116791|NCT01573624|100612595|FG000|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||50||
48116792|NCT01573624|100612596|FG001|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||52||
48116793|NCT01573624|100612597|FG002|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||45||
48116794|NCT01573624|100612598|FG003|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55||
48116795|NCT01573624|100612599|FG004|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||53||
48116796|NCT01573624|100612600|FG005|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||43||
48116797|NCT01573624|100612601|FG006|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55||
48116798|NCT01573624|100612595|FG000|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||7||
48116799|NCT01573624|100612596|FG001|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||6||
48116800|NCT01573624|100612597|FG002|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3||
48116801|NCT01573624|100612598|FG003|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||1||
48116802|NCT01573624|100612599|FG004|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3||
48116803|NCT01573624|100612600|FG005|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||5||
48116804|NCT01573624|100612601|FG006|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||0||
48116805|NCT01573624|100612595|FG000|STARTED|Period 4 : Washout Period 2 (12-14 Days)||50||
48116806|NCT01573624|100612596|FG001|STARTED|Period 4 : Washout Period 2 (12-14 Days)||52||
48116807|NCT01573624|100612597|FG002|STARTED|Period 4 : Washout Period 2 (12-14 Days)||45||
48116808|NCT01573624|100612598|FG003|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55||
48116809|NCT01573624|100612599|FG004|STARTED|Period 4 : Washout Period 2 (12-14 Days)||53||
48116810|NCT01573624|100612600|FG005|STARTED|Period 4 : Washout Period 2 (12-14 Days)||43||
48116811|NCT01573624|100612601|FG006|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55||
48116812|NCT01573624|100612595|FG000|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||49||
48116813|NCT01573624|100612596|FG001|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||48||
48116814|NCT01573624|100612597|FG002|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||43||
48116815|NCT01573624|100612598|FG003|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||53||
48116816|NCT01573624|100612599|FG004|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52||
48116817|NCT01573624|100612600|FG005|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||41||
48278651|NCT01008410|101007095|FG001|COMPLETED|Overall Study||116||
48278652|NCT01008410|101007094|FG000|NOT COMPLETED|Overall Study||25||
48278653|NCT01008410|101007095|FG001|NOT COMPLETED|Overall Study||16||
48278654|NCT00886795|101007096|FG000|STARTED|Overall Study||4||
48394408|NCT01664858|101295933|FG002|STARTED|Overall Study||240||
48394409|NCT01664858|101295931|FG000|COMPLETED|Overall Study||467||
48394410|NCT01664858|101295932|FG001|COMPLETED|Overall Study||468||
48394411|NCT01664858|101295933|FG002|COMPLETED|Overall Study||234||
48394412|NCT01664858|101295931|FG000|NOT COMPLETED|Overall Study||14||
48394413|NCT01664858|101295932|FG001|NOT COMPLETED|Overall Study||13||
48564299|NCT03850483|101713920|FG008|STARTED|Follow-up for Stage 1||0||
48116818|NCT01573624|100612601|FG006|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52||
48116819|NCT01573624|100612595|FG000|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1||
48116820|NCT01573624|100612596|FG001|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||4||
48116821|NCT01573624|100612597|FG002|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2||
48116822|NCT01573624|100612598|FG003|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2||
48116823|NCT01573624|100612599|FG004|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1||
48116824|NCT01573624|100612600|FG005|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2||
48116825|NCT01573624|100612601|FG006|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||3||
48116826|NCT01573624|100612595|FG000|STARTED|Period 5 : Treatment Period 3 (14 Days)||49||
48116827|NCT01573624|100612596|FG001|STARTED|Period 5 : Treatment Period 3 (14 Days)||48||
48116828|NCT01573624|100612597|FG002|STARTED|Period 5 : Treatment Period 3 (14 Days)||43||
48116829|NCT01573624|100612598|FG003|STARTED|Period 5 : Treatment Period 3 (14 Days)||53||
48278655|NCT00886795|101007096|FG000|COMPLETED|Overall Study||3||
48278656|NCT00886795|101007096|FG000|NOT COMPLETED|Overall Study||1||
48278657|NCT03181789|101007097|FG000|STARTED|Overall Study||25||
48278658|NCT03181789|101007098|FG001|STARTED|Overall Study||25||
48278659|NCT03181789|101007099|FG002|STARTED|Overall Study||3||
48278660|NCT03181789|101007100|FG003|STARTED|Overall Study||3||
48278661|NCT03181789|101007097|FG000|Safety Population|Overall Study||25||
48278662|NCT03181789|101007098|FG001|Safety Population|Overall Study||25||
48278663|NCT03181789|101007099|FG002|Safety Population|Overall Study||3||
48278664|NCT03181789|101007100|FG003|Safety Population|Overall Study||3||
48278665|NCT03181789|101007097|FG000|COMPLETED|Overall Study||18||
48278666|NCT03181789|101007098|FG001|COMPLETED|Overall Study||22||
48278667|NCT03181789|101007099|FG002|COMPLETED|Overall Study||2||
48278668|NCT03181789|101007100|FG003|COMPLETED|Overall Study||3||
48278669|NCT03181789|101007097|FG000|NOT COMPLETED|Overall Study||7||
48278670|NCT03181789|101007098|FG001|NOT COMPLETED|Overall Study||3||
48278671|NCT03181789|101007099|FG002|NOT COMPLETED|Overall Study||1||
48278672|NCT03181789|101007100|FG003|NOT COMPLETED|Overall Study||0||
48278673|NCT02019667|101007101|FG000|STARTED|First Intervention (6 Months)||10||
48278674|NCT02019667|101007102|FG001|STARTED|First Intervention (6 Months)||9||
48278675|NCT02019667|101007101|FG000|COMPLETED|First Intervention (6 Months)||10||
48278676|NCT02019667|101007102|FG001|COMPLETED|First Intervention (6 Months)||8||
48278677|NCT02019667|101007101|FG000|NOT COMPLETED|First Intervention (6 Months)||0||
48278678|NCT02019667|101007102|FG001|NOT COMPLETED|First Intervention (6 Months)||1||
48278679|NCT02019667|101007101|FG000|STARTED|Washout Period (9 Weeks)||10||
48278680|NCT02019667|101007102|FG001|STARTED|Washout Period (9 Weeks)||8||
48278681|NCT02019667|101007101|FG000|COMPLETED|Washout Period (9 Weeks)||10||
48278682|NCT02019667|101007102|FG001|COMPLETED|Washout Period (9 Weeks)||8||
48278683|NCT02019667|101007101|FG000|NOT COMPLETED|Washout Period (9 Weeks)||0||
48278684|NCT02019667|101007102|FG001|NOT COMPLETED|Washout Period (9 Weeks)||0||
48394414|NCT01664858|101295933|FG002|NOT COMPLETED|Overall Study||6||
48394415|NCT00655057|101295934|FG000|STARTED|Overall Study||0||
48394416|NCT00655057|101295935|FG001|STARTED|Overall Study||0||
48394417|NCT00655057|101295936|FG002|STARTED|Overall Study||0||
48394418|NCT00655057|101295934|FG000|COMPLETED|Overall Study||0||
48394419|NCT00655057|101295935|FG001|COMPLETED|Overall Study||0||
48394420|NCT00655057|101295936|FG002|COMPLETED|Overall Study||0||
48394421|NCT00655057|101295934|FG000|NOT COMPLETED|Overall Study||0||
48278685|NCT02019667|101007101|FG000|STARTED|2nd Intervention (6 Months)||10||
48278686|NCT02019667|101007102|FG001|STARTED|2nd Intervention (6 Months)||8||
48278687|NCT02019667|101007101|FG000|COMPLETED|2nd Intervention (6 Months)||10||
48278688|NCT02019667|101007102|FG001|COMPLETED|2nd Intervention (6 Months)||6||
48278689|NCT02019667|101007101|FG000|NOT COMPLETED|2nd Intervention (6 Months)||0||
48278690|NCT02019667|101007102|FG001|NOT COMPLETED|2nd Intervention (6 Months)||2||
48278691|NCT02019667|101007101|FG000|STARTED|Washout Period (9 Weeks)||10||
48394422|NCT00655057|101295935|FG001|NOT COMPLETED|Overall Study||0||
48116830|NCT01573624|100612599|FG004|STARTED|Period 5 : Treatment Period 3 (14 Days)||52||
48116831|NCT01573624|100612600|FG005|STARTED|Period 5 : Treatment Period 3 (14 Days)||41||
48116832|NCT01573624|100612601|FG006|STARTED|Period 5 : Treatment Period 3 (14 Days)||52||
48116833|NCT01573624|100612595|FG000|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||46||
48116834|NCT01573624|100612596|FG001|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||47||
48116835|NCT01573624|100612597|FG002|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||43||
48116836|NCT01573624|100612598|FG003|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||53||
48116837|NCT01573624|100612599|FG004|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||51||
48116838|NCT01573624|100612600|FG005|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||39||
48116839|NCT01573624|100612601|FG006|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||48||
48116840|NCT01573624|100612595|FG000|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||3||
48116841|NCT01573624|100612596|FG001|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1||
48116842|NCT01573624|100612597|FG002|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0||
48116843|NCT01573624|100612598|FG003|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0||
48116844|NCT01573624|100612599|FG004|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1||
48116845|NCT01573624|100612600|FG005|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||2||
48116846|NCT01573624|100612601|FG006|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||4||
48116847|NCT01573624|100612595|FG000|STARTED|Period 6 : Follow-up Period (7 Days)||46||
48116848|NCT01573624|100612596|FG001|STARTED|Period 6 : Follow-up Period (7 Days)||47||
48116849|NCT01573624|100612597|FG002|STARTED|Period 6 : Follow-up Period (7 Days)||43||
48116850|NCT01573624|100612598|FG003|STARTED|Period 6 : Follow-up Period (7 Days)||53||
48116851|NCT01573624|100612599|FG004|STARTED|Period 6 : Follow-up Period (7 Days)||51||
48116852|NCT01573624|100612600|FG005|STARTED|Period 6 : Follow-up Period (7 Days)||39||
48116853|NCT01573624|100612601|FG006|STARTED|Period 6 : Follow-up Period (7 Days)||48||
48116854|NCT01573624|100612595|FG000|COMPLETED|Period 6 : Follow-up Period (7 Days)||45||
48116855|NCT01573624|100612596|FG001|COMPLETED|Period 6 : Follow-up Period (7 Days)||47||
48116856|NCT01573624|100612597|FG002|COMPLETED|Period 6 : Follow-up Period (7 Days)||43||
48394423|NCT00655057|101295936|FG002|NOT COMPLETED|Overall Study||0||
48394424|NCT01924299|101295937|FG000|STARTED|Period 1||18||
48564300|NCT03850483|101713921|FG009|STARTED|Follow-up for Stage 1||0||
48564301|NCT03850483|101713912|FG000|COMPLETED|Follow-up for Stage 1||37||
48564302|NCT03850483|101713913|FG001|COMPLETED|Follow-up for Stage 1||34||
48564303|NCT03850483|101713914|FG002|COMPLETED|Follow-up for Stage 1||35||
48564304|NCT03850483|101713915|FG003|COMPLETED|Follow-up for Stage 1||34||
48564305|NCT03850483|101713916|FG004|COMPLETED|Follow-up for Stage 1||34||
48564306|NCT03850483|101713917|FG005|COMPLETED|Follow-up for Stage 1||33||
48564307|NCT03850483|101713918|FG006|COMPLETED|Follow-up for Stage 1||34||
48564308|NCT03850483|101713919|FG007|COMPLETED|Follow-up for Stage 1||33||
48564309|NCT03850483|101713920|FG008|COMPLETED|Follow-up for Stage 1||0||
48564310|NCT03850483|101713921|FG009|COMPLETED|Follow-up for Stage 1||0||
48564311|NCT03850483|101713912|FG000|NOT COMPLETED|Follow-up for Stage 1||0||
48564312|NCT03850483|101713913|FG001|NOT COMPLETED|Follow-up for Stage 1||3||
48564313|NCT03850483|101713914|FG002|NOT COMPLETED|Follow-up for Stage 1||2||
48564314|NCT03850483|101713915|FG003|NOT COMPLETED|Follow-up for Stage 1||2||
48564315|NCT03850483|101713916|FG004|NOT COMPLETED|Follow-up for Stage 1||3||
48564316|NCT03850483|101713917|FG005|NOT COMPLETED|Follow-up for Stage 1||4||
48564317|NCT03850483|101713918|FG006|NOT COMPLETED|Follow-up for Stage 1||2||
48564318|NCT03850483|101713919|FG007|NOT COMPLETED|Follow-up for Stage 1||3||
48564319|NCT03850483|101713920|FG008|NOT COMPLETED|Follow-up for Stage 1||0||
48564320|NCT03850483|101713921|FG009|NOT COMPLETED|Follow-up for Stage 1||0||
48564321|NCT03850483|101713912|FG000|STARTED|Treatment for Stage 2||0||
48564322|NCT03850483|101713913|FG001|STARTED|Treatment for Stage 2||0||
48564323|NCT03850483|101713914|FG002|STARTED|Treatment for Stage 2||0||
48564324|NCT03850483|101713915|FG003|STARTED|Treatment for Stage 2||0||
48564325|NCT03850483|101713916|FG004|STARTED|Treatment for Stage 2||0||
48564326|NCT03850483|101713917|FG005|STARTED|Treatment for Stage 2||0||
48564327|NCT03850483|101713918|FG006|STARTED|Treatment for Stage 2||0||
48564328|NCT03850483|101713919|FG007|STARTED|Treatment for Stage 2||0||
48564329|NCT03850483|101713920|FG008|STARTED|Treatment for Stage 2||12||
48564330|NCT03850483|101713921|FG009|STARTED|Treatment for Stage 2||38||
48697716|NCT00344318|102045452|FG003|COMPLETED|Overall Study||100||
48697717|NCT00344318|102045449|FG000|NOT COMPLETED|Overall Study||4||
48116857|NCT01573624|100612598|FG003|COMPLETED|Period 6 : Follow-up Period (7 Days)||53||
48116858|NCT01573624|100612599|FG004|COMPLETED|Period 6 : Follow-up Period (7 Days)||49||
48394425|NCT01924299|101295938|FG001|STARTED|Period 1||18||
48116859|NCT01573624|100612600|FG005|COMPLETED|Period 6 : Follow-up Period (7 Days)||38||
48116860|NCT01573624|100612601|FG006|COMPLETED|Period 6 : Follow-up Period (7 Days)||48||
48116861|NCT01573624|100612595|FG000|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1||
48116862|NCT01573624|100612596|FG001|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0||
48116863|NCT01573624|100612597|FG002|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0||
48564331|NCT03850483|101713912|FG000|COMPLETED|Treatment for Stage 2||0||
48564332|NCT03850483|101713913|FG001|COMPLETED|Treatment for Stage 2||0||
48564333|NCT03850483|101713914|FG002|COMPLETED|Treatment for Stage 2||0||
48564334|NCT03850483|101713915|FG003|COMPLETED|Treatment for Stage 2||0||
48697718|NCT00344318|102045450|FG001|NOT COMPLETED|Overall Study||5||
48394426|NCT01924299|101295937|FG000|Received Baricitinib|Period 1||18||
48116864|NCT01573624|100612598|FG003|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0||
48116865|NCT01573624|100612599|FG004|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||2||
48116866|NCT01573624|100612600|FG005|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1||
48116867|NCT01573624|100612601|FG006|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0||
48116868|NCT00384813|100612602|FG000|STARTED|Overall Study||23||
48116869|NCT00384813|100612603|FG001|STARTED|Overall Study||20||
48394427|NCT01924299|101295938|FG001|Received Baricitinib|Period 1||18||
48394428|NCT01924299|101295937|FG000|COMPLETED|Period 1||18||
48394429|NCT01924299|101295938|FG001|COMPLETED|Period 1||18||
48394430|NCT01924299|101295937|FG000|NOT COMPLETED|Period 1||0||
48394431|NCT01924299|101295938|FG001|NOT COMPLETED|Period 1||0||
48394432|NCT01924299|101295937|FG000|STARTED|Period 2||18||
48394433|NCT01924299|101295938|FG001|STARTED|Period 2||18||
48394434|NCT01924299|101295937|FG000|Received at Least 1 Dose of Study Drug|Period 2||18||
48394435|NCT01924299|101295938|FG001|Received at Least 1 Dose of Study Drug|Period 2||18||
48394436|NCT01924299|101295937|FG000|Received Baricitinib|Period 2||17||
48394437|NCT01924299|101295938|FG001|Received Baricitinib|Period 2||17||
48564335|NCT03850483|101713916|FG004|COMPLETED|Treatment for Stage 2||0||
48564336|NCT03850483|101713917|FG005|COMPLETED|Treatment for Stage 2||0||
48564337|NCT03850483|101713918|FG006|COMPLETED|Treatment for Stage 2||0||
48564338|NCT03850483|101713919|FG007|COMPLETED|Treatment for Stage 2||0||
48116870|NCT00384813|100612602|FG000|COMPLETED|Overall Study||21||
48116871|NCT00384813|100612603|FG001|COMPLETED|Overall Study||20||
48116872|NCT00384813|100612602|FG000|NOT COMPLETED|Overall Study||2||
48116873|NCT00384813|100612603|FG001|NOT COMPLETED|Overall Study||0||
48116874|NCT02357576|100612604|FG000|STARTED|Treatment Period||12||
48116875|NCT02357576|100612605|FG001|STARTED|Treatment Period||9||
48116876|NCT02357576|100612604|FG000|COMPLETED|Treatment Period||12||
48116877|NCT02357576|100612605|FG001|COMPLETED|Treatment Period||7||
48116878|NCT02357576|100612604|FG000|NOT COMPLETED|Treatment Period||0||
48116879|NCT02357576|100612605|FG001|NOT COMPLETED|Treatment Period||2||
48116880|NCT02357576|100612604|FG000|STARTED|Neurodevelopmental Outcome Follow Up||11||
48116881|NCT02357576|100612605|FG001|STARTED|Neurodevelopmental Outcome Follow Up||7||
48116882|NCT02357576|100612604|FG000|COMPLETED|Neurodevelopmental Outcome Follow Up||6|Completed 24 Month Follow Up|
48116883|NCT02357576|100612605|FG001|COMPLETED|Neurodevelopmental Outcome Follow Up||2|Completed 24 Month Follow Up|
48116884|NCT02357576|100612604|FG000|NOT COMPLETED|Neurodevelopmental Outcome Follow Up||5||
48116885|NCT02357576|100612605|FG001|NOT COMPLETED|Neurodevelopmental Outcome Follow Up||5||
48116886|NCT02143843|100612606|FG000|STARTED|Overall Study||75||
48116887|NCT02143843|100612606|FG000|COMPLETED|Overall Study||63||
48116888|NCT02143843|100612606|FG000|NOT COMPLETED|Overall Study||12||
48116889|NCT02489227|100612607|FG000|STARTED|Overall Study||274||
48116890|NCT02489227|100612608|FG001|STARTED|Overall Study||135||
48116891|NCT02489227|100612609|FG002|STARTED|Overall Study||136||
48116892|NCT02489227|100612607|FG000|COMPLETED|Overall Study||220||
48116893|NCT02489227|100612608|FG001|COMPLETED|Overall Study||101||
48116894|NCT02489227|100612609|FG002|COMPLETED|Overall Study||117||
48116895|NCT02489227|100612607|FG000|NOT COMPLETED|Overall Study||54||
48116896|NCT02489227|100612608|FG001|NOT COMPLETED|Overall Study||34||
48116897|NCT02489227|100612609|FG002|NOT COMPLETED|Overall Study||19||
48116898|NCT04514991|100612610|FG000|STARTED|Overall Study||41||41
48116899|NCT04514991|100612611|FG001|STARTED|Overall Study||45||45
48116900|NCT04514991|100612610|FG000|COMPLETED|Overall Study||30||30
48116901|NCT04514991|100612611|FG001|COMPLETED|Overall Study||36||36
48116902|NCT04514991|100612610|FG000|NOT COMPLETED|Overall Study||11||11
48116903|NCT04514991|100612611|FG001|NOT COMPLETED|Overall Study||9||9
48116904|NCT01282216|100612612|FG000|STARTED|Overall Study||18||
48116905|NCT01282216|100612613|FG001|STARTED|Overall Study||26||
48116906|NCT01282216|100612614|FG002|STARTED|Overall Study||52||
48116907|NCT01282216|100612615|FG003|STARTED|Overall Study||8||
48116908|NCT01282216|100612612|FG000|COMPLETED|Overall Study||18||
48394438|NCT01924299|101295937|FG000|COMPLETED|Period 2||17||
48394439|NCT01924299|101295938|FG001|COMPLETED|Period 2||17||
48394440|NCT01924299|101295937|FG000|NOT COMPLETED|Period 2||1||
48394441|NCT01924299|101295938|FG001|NOT COMPLETED|Period 2||1||
48394442|NCT02148211|101295939|FG000|STARTED|Overall Study||507||
48116909|NCT01282216|100612613|FG001|COMPLETED|Overall Study||26||
48116910|NCT01282216|100612614|FG002|COMPLETED|Overall Study||19||
48116911|NCT01282216|100612615|FG003|COMPLETED|Overall Study||0||
48116912|NCT01282216|100612612|FG000|NOT COMPLETED|Overall Study||0||
48116913|NCT01282216|100612613|FG001|NOT COMPLETED|Overall Study||0||
48394443|NCT02148211|101295939|FG000|COMPLETED|Overall Study||155||
48394444|NCT02148211|101295939|FG000|NOT COMPLETED|Overall Study||352||
48116914|NCT01282216|100612614|FG002|NOT COMPLETED|Overall Study||33||
48116915|NCT01282216|100612615|FG003|NOT COMPLETED|Overall Study||8||
48116916|NCT03592641|100612616|FG000|STARTED|Overall Study||5||
48116917|NCT03592641|100612616|FG000|COMPLETED|Overall Study||4||
48116918|NCT03592641|100612616|FG000|NOT COMPLETED|Overall Study||1||
48116919|NCT05478174|100612617|FG000|STARTED|Overall Study||267||
48394445|NCT01410799|101295940|FG000|STARTED|Overall Study||13||
48564339|NCT03850483|101713920|FG008|COMPLETED|Treatment for Stage 2||7||
48116920|NCT05478174|100612618|FG001|STARTED|Overall Study||133||
48116921|NCT05478174|100612617|FG000|Dosed|Overall Study||255||
48116922|NCT05478174|100612618|FG001|Dosed|Overall Study||129||
48116923|NCT05478174|100612617|FG000|Full Analysis Set|Overall Study||255||
48116924|NCT05478174|100612618|FG001|Full Analysis Set|Overall Study||128||
48116925|NCT05478174|100612617|FG000|Safety Set|Overall Study||255||
48116926|NCT05478174|100612618|FG001|Safety Set|Overall Study||129||
48116927|NCT05478174|100612617|FG000|COMPLETED|Overall Study||254||
48116928|NCT05478174|100612618|FG001|COMPLETED|Overall Study||129||
48116929|NCT05478174|100612617|FG000|NOT COMPLETED|Overall Study||13||
48116930|NCT05478174|100612618|FG001|NOT COMPLETED|Overall Study||4||
48116931|NCT00333229|100612619|FG000|STARTED|Overall Study||6||
48116932|NCT00333229|100612620|FG001|STARTED|Overall Study||5||
48116933|NCT00333229|100612619|FG000|COMPLETED|Overall Study||6||
48116934|NCT00333229|100612620|FG001|COMPLETED|Overall Study||4||
48116935|NCT00333229|100612619|FG000|NOT COMPLETED|Overall Study||0||
48116936|NCT00333229|100612620|FG001|NOT COMPLETED|Overall Study||1||
48116937|NCT00466960|100612621|FG000|STARTED|Overall Study||21||
48116938|NCT00466960|100612621|FG000|COMPLETED|Overall Study||21||
48116939|NCT00466960|100612621|FG000|NOT COMPLETED|Overall Study||0||
48697719|NCT00344318|102045451|FG002|NOT COMPLETED|Overall Study||1||
48697720|NCT00344318|102045452|FG003|NOT COMPLETED|Overall Study||3||
48697721|NCT02078180|102045453|FG000|STARTED|Overall Study||34||
48116940|NCT00554749|100612622|FG000|STARTED|Overall Study||7||
48116941|NCT00554749|100612622|FG000|COMPLETED|Overall Study||7||
48116942|NCT00554749|100612622|FG000|NOT COMPLETED|Overall Study||0||
48116943|NCT00705575|100612623|FG000|STARTED|Overall Study||349||
48116944|NCT00705575|100612624|FG001|STARTED|Overall Study||339||
48116945|NCT00705575|100612623|FG000|COMPLETED|Overall Study||326||
48116946|NCT00705575|100612624|FG001|COMPLETED|Overall Study||293||
48116947|NCT00705575|100612623|FG000|NOT COMPLETED|Overall Study||23||
48116948|NCT00705575|100612624|FG001|NOT COMPLETED|Overall Study||46||
48116949|NCT00414661|100612625|FG000|STARTED|Overall Study||48||
48116950|NCT00414661|100612626|FG001|STARTED|Overall Study||89||
48116951|NCT00414661|100612627|FG002|STARTED|Overall Study||22||
48116952|NCT00414661|100612628|FG003|STARTED|Overall Study||3||
48116953|NCT00414661|100612625|FG000|COMPLETED|Overall Study||34||
48116954|NCT00414661|100612626|FG001|COMPLETED|Overall Study||75||
48116955|NCT00414661|100612627|FG002|COMPLETED|Overall Study||20||
48564340|NCT03850483|101713921|FG009|COMPLETED|Treatment for Stage 2||27||
48564341|NCT03850483|101713912|FG000|NOT COMPLETED|Treatment for Stage 2||0||
48564342|NCT03850483|101713913|FG001|NOT COMPLETED|Treatment for Stage 2||0||
48564343|NCT03850483|101713914|FG002|NOT COMPLETED|Treatment for Stage 2||0||
48564344|NCT03850483|101713915|FG003|NOT COMPLETED|Treatment for Stage 2||0||
48564345|NCT03850483|101713916|FG004|NOT COMPLETED|Treatment for Stage 2||0||
48564346|NCT03850483|101713917|FG005|NOT COMPLETED|Treatment for Stage 2||0||
48564347|NCT03850483|101713918|FG006|NOT COMPLETED|Treatment for Stage 2||0||
48564348|NCT03850483|101713919|FG007|NOT COMPLETED|Treatment for Stage 2||0||
48564349|NCT03850483|101713920|FG008|NOT COMPLETED|Treatment for Stage 2||5||
48564350|NCT03850483|101713921|FG009|NOT COMPLETED|Treatment for Stage 2||11||
48564351|NCT03850483|101713912|FG000|STARTED|Follow-up For Stage 2||0||
48564352|NCT03850483|101713913|FG001|STARTED|Follow-up For Stage 2||0||
48564353|NCT03850483|101713914|FG002|STARTED|Follow-up For Stage 2||0||
48697722|NCT02078180|102045453|FG000|IR75|Overall Study||30||
48697723|NCT02078180|102045453|FG000|IR100|Overall Study||31||
48116956|NCT00414661|100612628|FG003|COMPLETED|Overall Study||0||
48116957|NCT00414661|100612625|FG000|NOT COMPLETED|Overall Study||14||
48116958|NCT00414661|100612626|FG001|NOT COMPLETED|Overall Study||14||
48116959|NCT00414661|100612627|FG002|NOT COMPLETED|Overall Study||2||
48697724|NCT02078180|102045453|FG000|SR100|Overall Study||31||
48697725|NCT02078180|102045453|FG000|SR150|Overall Study||32||
48697726|NCT02078180|102045453|FG000|XL 150|Overall Study||31||
48697727|NCT02078180|102045453|FG000|XL 300|Overall Study||32||
48116960|NCT00414661|100612628|FG003|NOT COMPLETED|Overall Study||3||
48116961|NCT00548860|100612629|FG000|STARTED|Overall Study||996||
48116962|NCT00548860|100612630|FG001|STARTED|Overall Study||1022||
48116963|NCT00548860|100612629|FG000|COMPLETED|Overall Study||860||
48116964|NCT00548860|100612630|FG001|COMPLETED|Overall Study||847||
48116965|NCT00548860|100612629|FG000|NOT COMPLETED|Overall Study||136||
48116966|NCT00548860|100612630|FG001|NOT COMPLETED|Overall Study||175||
48116967|NCT01122511|100612631|FG000|STARTED|Overall Study||2||
48116968|NCT01122511|100612632|FG001|STARTED|Overall Study||2||
48116969|NCT01122511|100612631|FG000|COMPLETED|Overall Study||0||
48116970|NCT01122511|100612632|FG001|COMPLETED|Overall Study||0||
48116971|NCT01122511|100612631|FG000|NOT COMPLETED|Overall Study||2||
48116972|NCT01122511|100612632|FG001|NOT COMPLETED|Overall Study||2||
48116973|NCT04689737|100612633|FG000|STARTED|Overall Study||8||
48116974|NCT04689737|100612633|FG000|COMPLETED|Overall Study||8||
48564354|NCT03850483|101713915|FG003|STARTED|Follow-up For Stage 2||0||
48564355|NCT03850483|101713916|FG004|STARTED|Follow-up For Stage 2||0||
48564356|NCT03850483|101713917|FG005|STARTED|Follow-up For Stage 2||0||
48564357|NCT03850483|101713918|FG006|STARTED|Follow-up For Stage 2||0||
48564358|NCT03850483|101713919|FG007|STARTED|Follow-up For Stage 2||0||
48278692|NCT02019667|101007102|FG001|STARTED|Washout Period (9 Weeks)||6||
48278693|NCT02019667|101007101|FG000|COMPLETED|Washout Period (9 Weeks)||10||
48278694|NCT02019667|101007102|FG001|COMPLETED|Washout Period (9 Weeks)||6||
48278695|NCT02019667|101007101|FG000|NOT COMPLETED|Washout Period (9 Weeks)||0||
48278696|NCT02019667|101007102|FG001|NOT COMPLETED|Washout Period (9 Weeks)||0||
48278697|NCT03525392|101007103|FG000|STARTED|Overall Study||2||
48278698|NCT03525392|101007104|FG001|STARTED|Overall Study||3||
48278699|NCT03525392|101007105|FG002|STARTED|Overall Study||5||
48278700|NCT03525392|101007106|FG003|STARTED|Overall Study||3||
48278701|NCT03525392|101007107|FG004|STARTED|Overall Study||1||
48278702|NCT03525392|101007103|FG000|COMPLETED|Overall Study||1|Completed the EOCT.|
48278703|NCT03525392|101007104|FG001|COMPLETED|Overall Study||2|Completed the EOCT.|
48278704|NCT03525392|101007105|FG002|COMPLETED|Overall Study||2|Completed the EOCT.|
48278705|NCT03525392|101007106|FG003|COMPLETED|Overall Study||0|Completed the EOCT.|
48278706|NCT03525392|101007107|FG004|COMPLETED|Overall Study||0|Completed the EOCT.|
48278707|NCT03525392|101007103|FG000|NOT COMPLETED|Overall Study||1||
48278708|NCT03525392|101007104|FG001|NOT COMPLETED|Overall Study||1||
48278709|NCT03525392|101007105|FG002|NOT COMPLETED|Overall Study||3||
48278710|NCT03525392|101007106|FG003|NOT COMPLETED|Overall Study||3||
48278711|NCT03525392|101007107|FG004|NOT COMPLETED|Overall Study||1||
48278712|NCT00591851|101007108|FG000|STARTED|Overall Study||70||
48278713|NCT00591851|101007108|FG000|COMPLETED|Overall Study||64||
48278714|NCT00591851|101007108|FG000|NOT COMPLETED|Overall Study||6||
48278715|NCT00548262|101007109|FG000|STARTED|Overall Study||54||
48278716|NCT00548262|101007109|FG000|COMPLETED|Overall Study||22||
48278717|NCT00548262|101007109|FG000|NOT COMPLETED|Overall Study||32||
48278718|NCT02124811|101007110|FG000|STARTED|Overall Study||5||
48278719|NCT02124811|101007111|FG001|STARTED|Overall Study||5||
48278720|NCT02124811|101007110|FG000|COMPLETED|Overall Study||2||
48278721|NCT02124811|101007111|FG001|COMPLETED|Overall Study||3||
48278722|NCT02124811|101007110|FG000|NOT COMPLETED|Overall Study||3||
48278723|NCT02124811|101007111|FG001|NOT COMPLETED|Overall Study||2||
48564359|NCT03850483|101713920|FG008|STARTED|Follow-up For Stage 2||12||
48564360|NCT03850483|101713921|FG009|STARTED|Follow-up For Stage 2||38||
48564361|NCT03850483|101713912|FG000|COMPLETED|Follow-up For Stage 2||0||
48564362|NCT03850483|101713913|FG001|COMPLETED|Follow-up For Stage 2||0||
48564363|NCT03850483|101713914|FG002|COMPLETED|Follow-up For Stage 2||0||
48564364|NCT03850483|101713915|FG003|COMPLETED|Follow-up For Stage 2||0||
48564365|NCT03850483|101713916|FG004|COMPLETED|Follow-up For Stage 2||0||
48564366|NCT03850483|101713917|FG005|COMPLETED|Follow-up For Stage 2||0||
48564367|NCT03850483|101713918|FG006|COMPLETED|Follow-up For Stage 2||0||
48564368|NCT03850483|101713919|FG007|COMPLETED|Follow-up For Stage 2||0||
48564369|NCT03850483|101713920|FG008|COMPLETED|Follow-up For Stage 2||12||
48564370|NCT03850483|101713921|FG009|COMPLETED|Follow-up For Stage 2||36||
48564371|NCT03850483|101713912|FG000|NOT COMPLETED|Follow-up For Stage 2||0||
48564372|NCT03850483|101713913|FG001|NOT COMPLETED|Follow-up For Stage 2||0||
48564373|NCT03850483|101713914|FG002|NOT COMPLETED|Follow-up For Stage 2||0||
48564374|NCT03850483|101713915|FG003|NOT COMPLETED|Follow-up For Stage 2||0||
48564375|NCT03850483|101713916|FG004|NOT COMPLETED|Follow-up For Stage 2||0||
48564376|NCT03850483|101713917|FG005|NOT COMPLETED|Follow-up For Stage 2||0||
48564377|NCT03850483|101713918|FG006|NOT COMPLETED|Follow-up For Stage 2||0||
48564378|NCT03850483|101713919|FG007|NOT COMPLETED|Follow-up For Stage 2||0||
48564379|NCT03850483|101713920|FG008|NOT COMPLETED|Follow-up For Stage 2||0||
48564380|NCT03850483|101713921|FG009|NOT COMPLETED|Follow-up For Stage 2||2||
48564381|NCT01731119|101713922|FG000|STARTED|Overall Study||9||
48564382|NCT01731119|101713922|FG000|COMPLETED|Overall Study||7||
48564383|NCT01731119|101713922|FG000|NOT COMPLETED|Overall Study||2||
48564384|NCT03926117|101713923|FG000|STARTED|Overall Study||66||
48564385|NCT03926117|101713924|FG001|STARTED|Overall Study||66||
48278724|NCT01327495|101007112|FG000|STARTED|Overall Study||10||
48278725|NCT01327495|101007113|FG001|STARTED|Overall Study||11||
48278726|NCT01327495|101007114|FG002|STARTED|Overall Study||10||
48564386|NCT03926117|101713925|FG002|STARTED|Overall Study||66||
48278727|NCT01327495|101007115|FG003|STARTED|Overall Study||9||
48278728|NCT01327495|101007116|FG004|STARTED|Overall Study||11||
48278729|NCT01327495|101007117|FG005|STARTED|Overall Study||11||
48278730|NCT01327495|101007112|FG000|COMPLETED|Overall Study||8||
48564387|NCT03926117|101713926|FG003|STARTED|Overall Study||66||
48564388|NCT03926117|101713923|FG000|Intent-to-treat Analysis Population|Overall Study||66||
48564389|NCT03926117|101713924|FG001|Intent-to-treat Analysis Population|Overall Study||66||
48564390|NCT03926117|101713925|FG002|Intent-to-treat Analysis Population|Overall Study||66||
48564391|NCT03926117|101713926|FG003|Intent-to-treat Analysis Population|Overall Study||66||
48564392|NCT03926117|101713923|FG000|Safety Analysis Population|Overall Study||65||
48564393|NCT03926117|101713924|FG001|Safety Analysis Population|Overall Study||65||
48564394|NCT03926117|101713925|FG002|Safety Analysis Population|Overall Study||66||
48564395|NCT03926117|101713926|FG003|Safety Analysis Population|Overall Study||65||
48564396|NCT03926117|101713923|FG000|Treated|Overall Study||65||
48564397|NCT03926117|101713924|FG001|Treated|Overall Study||65||
48564398|NCT03926117|101713925|FG002|Treated|Overall Study||66||
48564399|NCT03926117|101713926|FG003|Treated|Overall Study||65||
48564400|NCT03926117|101713923|FG000|COMPLETED|Overall Study||60||
48564401|NCT03926117|101713924|FG001|COMPLETED|Overall Study||57||
48564402|NCT03926117|101713925|FG002|COMPLETED|Overall Study||60||
48564403|NCT03926117|101713926|FG003|COMPLETED|Overall Study||59||
48564404|NCT03926117|101713923|FG000|NOT COMPLETED|Overall Study||6||
48564405|NCT03926117|101713924|FG001|NOT COMPLETED|Overall Study||9||
48564406|NCT03926117|101713925|FG002|NOT COMPLETED|Overall Study||6||
48564407|NCT03926117|101713926|FG003|NOT COMPLETED|Overall Study||7||
48564408|NCT01277601|101713927|FG000|STARTED|Overall Study||188||
48278731|NCT01327495|101007113|FG001|COMPLETED|Overall Study||9||
48278732|NCT01327495|101007114|FG002|COMPLETED|Overall Study||8||
48278733|NCT01327495|101007115|FG003|COMPLETED|Overall Study||9||
48278734|NCT01327495|101007116|FG004|COMPLETED|Overall Study||8||
48278735|NCT01327495|101007117|FG005|COMPLETED|Overall Study||9||
48394446|NCT01410799|101295940|FG000|COMPLETED|Overall Study||0||
48564409|NCT01277601|101713928|FG001|STARTED|Overall Study||187||
48564410|NCT01277601|101713929|FG002|STARTED|Overall Study||190||
48564411|NCT01277601|101713930|FG003|STARTED|Overall Study||186||
48564412|NCT01277601|101713927|FG000|COMPLETED|Overall Study||151||
48564413|NCT01277601|101713928|FG001|COMPLETED|Overall Study||139||
48564414|NCT01277601|101713929|FG002|COMPLETED|Overall Study||163||
48564415|NCT01277601|101713930|FG003|COMPLETED|Overall Study||150||
48564416|NCT01277601|101713927|FG000|NOT COMPLETED|Overall Study||37||
48564417|NCT01277601|101713928|FG001|NOT COMPLETED|Overall Study||48||
48564418|NCT01277601|101713929|FG002|NOT COMPLETED|Overall Study||27||
48564419|NCT01277601|101713930|FG003|NOT COMPLETED|Overall Study||36||
48564420|NCT01804946|101713931|FG000|STARTED|Overall Study||81||
48564421|NCT01804946|101713932|FG001|STARTED|Overall Study||80||
48564422|NCT01804946|101713931|FG000|COMPLETED|Overall Study||79||
48564423|NCT01804946|101713932|FG001|COMPLETED|Overall Study||76||
48564424|NCT01804946|101713931|FG000|NOT COMPLETED|Overall Study||2||
48564425|NCT01804946|101713932|FG001|NOT COMPLETED|Overall Study||4||
48564426|NCT01837901|101713933|FG000|STARTED|Overall Study||22||
48564427|NCT01837901|101713934|FG001|STARTED|Overall Study||21||
48564428|NCT01837901|101713935|FG002|STARTED|Overall Study||20||
48564429|NCT01837901|101713933|FG000|COMPLETED|Overall Study||20||
48564430|NCT01837901|101713934|FG001|COMPLETED|Overall Study||15||
48564431|NCT01837901|101713935|FG002|COMPLETED|Overall Study||17||
48564432|NCT01837901|101713933|FG000|NOT COMPLETED|Overall Study||2||
48564433|NCT01837901|101713934|FG001|NOT COMPLETED|Overall Study||6||
48564434|NCT01837901|101713935|FG002|NOT COMPLETED|Overall Study||3||
48564435|NCT01205776|101713936|FG000|STARTED|Overall Study||948||
48564436|NCT01205776|101713937|FG001|STARTED|Overall Study||957||
48564437|NCT01205776|101713936|FG000|COMPLETED|Overall Study||884||
48564438|NCT01205776|101713937|FG001|COMPLETED|Overall Study||862||
48564439|NCT01205776|101713936|FG000|NOT COMPLETED|Overall Study||64||
48564440|NCT01205776|101713937|FG001|NOT COMPLETED|Overall Study||95||
48564441|NCT05000164|101713938|FG000|STARTED|Overall Study||72||
48564442|NCT05000164|101713938|FG000|COMPLETED|Overall Study||62||
48564443|NCT05000164|101713938|FG000|NOT COMPLETED|Overall Study||10||
48278736|NCT01327495|101007112|FG000|NOT COMPLETED|Overall Study||2||
48564444|NCT01268553|101713939|FG000|STARTED|Overall Study||6||
48564445|NCT01268553|101713939|FG000|COMPLETED|Overall Study||6||
48564446|NCT01268553|101713939|FG000|NOT COMPLETED|Overall Study||0||
48564447|NCT01686373|101713940|FG000|STARTED|Overall Study||34||
48564448|NCT01686373|101713941|FG001|STARTED|Overall Study||40||
48564449|NCT01686373|101713940|FG000|Received 15 Treatment Sessions|Overall Study||33||
48564450|NCT01686373|101713941|FG001|Received 15 Treatment Sessions|Overall Study||39||
48564451|NCT01686373|101713940|FG000|COMPLETED|Overall Study||31||
48564452|NCT01686373|101713941|FG001|COMPLETED|Overall Study||38||
48564453|NCT01686373|101713940|FG000|NOT COMPLETED|Overall Study||3||
48278737|NCT01327495|101007113|FG001|NOT COMPLETED|Overall Study||2||
48394447|NCT01410799|101295940|FG000|NOT COMPLETED|Overall Study||13||
48394448|NCT01270958|101295941|FG000|STARTED|Overall Study||60||
48394449|NCT01270958|101295941|FG000|COMPLETED|Overall Study||56||
48564454|NCT01686373|101713941|FG001|NOT COMPLETED|Overall Study||2||
48564455|NCT00126750|101713942|FG000|STARTED|Overall Study||385||
48564456|NCT00126750|101713943|FG001|STARTED|Overall Study||462||
48564457|NCT00126750|101713942|FG000|COMPLETED|Overall Study||205||
48564458|NCT00126750|101713943|FG001|COMPLETED|Overall Study||196||
48564459|NCT00126750|101713942|FG000|NOT COMPLETED|Overall Study||180||
48564460|NCT00126750|101713943|FG001|NOT COMPLETED|Overall Study||266||
48564461|NCT01973439|101713944|FG000|STARTED|Overall Study||23||
48564462|NCT01973439|101713944|FG000|Two Evaluable PK Days|Overall Study||18||
48564463|NCT01973439|101713944|FG000|One Evaluable PK Day Only|Overall Study||5||
48564464|NCT01973439|101713944|FG000|COMPLETED|Overall Study||18||
48564465|NCT01973439|101713944|FG000|NOT COMPLETED|Overall Study||5||
48564466|NCT00808210|101713945|FG000|STARTED|Study Period + 48 Weeks of Follow-up||15||
48564467|NCT00808210|101713946|FG001|STARTED|Study Period + 48 Weeks of Follow-up||13||
48564468|NCT00808210|101713945|FG000|COMPLETED|Study Period + 48 Weeks of Follow-up||6||
48564469|NCT00808210|101713946|FG001|COMPLETED|Study Period + 48 Weeks of Follow-up||4||
48564470|NCT00808210|101713945|FG000|NOT COMPLETED|Study Period + 48 Weeks of Follow-up||9||
48564471|NCT00808210|101713946|FG001|NOT COMPLETED|Study Period + 48 Weeks of Follow-up||9||
48564472|NCT00808210|101713945|FG000|STARTED|Double-Blind TX Period||15||
48564473|NCT00808210|101713946|FG001|STARTED|Double-Blind TX Period||13||
48564474|NCT00808210|101713945|FG000|COMPLETED|Double-Blind TX Period||13||
48697728|NCT02078180|102045453|FG000|COMPLETED|Overall Study||29||
48697729|NCT02078180|102045453|FG000|NOT COMPLETED|Overall Study||5||
48697730|NCT02713386|102045454|FG000|STARTED|Phase 1 - Dose Level 1||0||
48697731|NCT02713386|102045455|FG001|STARTED|Phase 1 - Dose Level 1||0||
48697732|NCT02713386|102045456|FG002|STARTED|Phase 1 - Dose Level 1||7||
48697733|NCT02713386|102045457|FG003|STARTED|Phase 1 - Dose Level 1||0||
48697734|NCT02713386|102045454|FG000|COMPLETED|Phase 1 - Dose Level 1||0||
48697735|NCT02713386|102045455|FG001|COMPLETED|Phase 1 - Dose Level 1||0||
48697736|NCT02713386|102045456|FG002|COMPLETED|Phase 1 - Dose Level 1||7||
48697737|NCT02713386|102045457|FG003|COMPLETED|Phase 1 - Dose Level 1||0||
48697738|NCT02713386|102045454|FG000|NOT COMPLETED|Phase 1 - Dose Level 1||0||
48697739|NCT02713386|102045455|FG001|NOT COMPLETED|Phase 1 - Dose Level 1||0||
48697740|NCT02713386|102045456|FG002|NOT COMPLETED|Phase 1 - Dose Level 1||0||
48697741|NCT02713386|102045457|FG003|NOT COMPLETED|Phase 1 - Dose Level 1||0||
48697742|NCT02713386|102045454|FG000|STARTED|Phase 1 - Dose Level 2||0||
48697743|NCT02713386|102045455|FG001|STARTED|Phase 1 - Dose Level 2||0||
48564475|NCT00808210|101713946|FG001|COMPLETED|Double-Blind TX Period||10||
48564476|NCT00808210|101713945|FG000|NOT COMPLETED|Double-Blind TX Period||2||
48564477|NCT00808210|101713946|FG001|NOT COMPLETED|Double-Blind TX Period||3||
48697744|NCT02713386|102045456|FG002|STARTED|Phase 1 - Dose Level 2||0||
48697745|NCT02713386|102045457|FG003|STARTED|Phase 1 - Dose Level 2||10||
48697746|NCT02713386|102045454|FG000|COMPLETED|Phase 1 - Dose Level 2||0||
48697747|NCT02713386|102045455|FG001|COMPLETED|Phase 1 - Dose Level 2||0||
48697748|NCT02713386|102045456|FG002|COMPLETED|Phase 1 - Dose Level 2||0||
48697749|NCT02713386|102045457|FG003|COMPLETED|Phase 1 - Dose Level 2||10||
48697750|NCT02713386|102045454|FG000|NOT COMPLETED|Phase 1 - Dose Level 2||0||
48278738|NCT01327495|101007114|FG002|NOT COMPLETED|Overall Study||2||
48278739|NCT01327495|101007115|FG003|NOT COMPLETED|Overall Study||0||
48564478|NCT00808210|101713945|FG000|STARTED|Open Label Ocrelizumab Treatment Period||9||
48564479|NCT00808210|101713946|FG001|STARTED|Open Label Ocrelizumab Treatment Period||4||
48564480|NCT00808210|101713945|FG000|COMPLETED|Open Label Ocrelizumab Treatment Period||0||
48564481|NCT00808210|101713946|FG001|COMPLETED|Open Label Ocrelizumab Treatment Period||0||
48564482|NCT00808210|101713945|FG000|NOT COMPLETED|Open Label Ocrelizumab Treatment Period||9||
48564483|NCT00808210|101713946|FG001|NOT COMPLETED|Open Label Ocrelizumab Treatment Period||4||
48564484|NCT01967862|101713947|FG000|STARTED|Overall Study||54||
48564485|NCT01967862|101713947|FG000|COMPLETED|Overall Study||54||
48564486|NCT01967862|101713947|FG000|NOT COMPLETED|Overall Study||0||
48564487|NCT03442751|101713948|FG000|STARTED|Overall Study||156||189
48564488|NCT03442751|101713949|FG001|STARTED|Overall Study||83||90
48564489|NCT03442751|101713948|FG000|Month 6|Overall Study||153||186
48564490|NCT03442751|101713949|FG001|Month 6|Overall Study||82||89
48564491|NCT03442751|101713948|FG000|Month 12|Overall Study||150||183
48564492|NCT03442751|101713949|FG001|Month 12|Overall Study||0||0
48564493|NCT03442751|101713948|FG000|COMPLETED|Overall Study||150||183
48564494|NCT03442751|101713949|FG001|COMPLETED|Overall Study||82||89
48564495|NCT03442751|101713948|FG000|NOT COMPLETED|Overall Study||6||6
48564496|NCT03442751|101713949|FG001|NOT COMPLETED|Overall Study||1||1
48564497|NCT01283464|101713950|FG000|STARTED|Overall Study||12||
48564498|NCT01283464|101713951|FG001|STARTED|Overall Study||12||
48564499|NCT01283464|101713950|FG000|COMPLETED|Overall Study||10||
48564500|NCT01283464|101713951|FG001|COMPLETED|Overall Study||11||
48564501|NCT01283464|101713950|FG000|NOT COMPLETED|Overall Study||2||
48564502|NCT01283464|101713951|FG001|NOT COMPLETED|Overall Study||1||
48564503|NCT02182492|101713952|FG000|STARTED|Overall Study||93||
48564504|NCT02182492|101713953|FG001|STARTED|Overall Study||94||
48564505|NCT02182492|101713952|FG000|COMPLETED|Overall Study||86||
48564506|NCT02182492|101713953|FG001|COMPLETED|Overall Study||86||
48564507|NCT02182492|101713952|FG000|NOT COMPLETED|Overall Study||7||
48564508|NCT02182492|101713953|FG001|NOT COMPLETED|Overall Study||8||
48564509|NCT01410097|101713954|FG000|STARTED|Overall Study||556||
48564510|NCT01410097|101713955|FG001|STARTED|Overall Study||533||
48564511|NCT01410097|101713954|FG000|COMPLETED|Overall Study||551||
48564512|NCT01410097|101713955|FG001|COMPLETED|Overall Study||530||
48564513|NCT01410097|101713954|FG000|NOT COMPLETED|Overall Study||5||
48564514|NCT01410097|101713955|FG001|NOT COMPLETED|Overall Study||3||
48564515|NCT01928472|101713956|FG000|STARTED|Overall Study||98||
48564516|NCT01928472|101713957|FG001|STARTED|Overall Study||104||
48564517|NCT01928472|101713958|FG002|STARTED|Overall Study||98||
48564518|NCT01928472|101713959|FG003|STARTED|Overall Study||102||
48564519|NCT01928472|101713956|FG000|COMPLETED|Overall Study||90||
48564520|NCT01928472|101713957|FG001|COMPLETED|Overall Study||96||
48564521|NCT01928472|101713958|FG002|COMPLETED|Overall Study||91||
48564522|NCT01928472|101713959|FG003|COMPLETED|Overall Study||100||
48564523|NCT01928472|101713956|FG000|NOT COMPLETED|Overall Study||8||
48564524|NCT01928472|101713957|FG001|NOT COMPLETED|Overall Study||8||
48564525|NCT01928472|101713958|FG002|NOT COMPLETED|Overall Study||7||
48697751|NCT02713386|102045455|FG001|NOT COMPLETED|Phase 1 - Dose Level 2||0||
48697752|NCT02713386|102045456|FG002|NOT COMPLETED|Phase 1 - Dose Level 2||0||
48697753|NCT02713386|102045457|FG003|NOT COMPLETED|Phase 1 - Dose Level 2||0||
48697754|NCT02713386|102045454|FG000|STARTED|Phase 2||42||
48697755|NCT02713386|102045455|FG001|STARTED|Phase 2||88||
48697756|NCT02713386|102045456|FG002|STARTED|Phase 2||0||
48697757|NCT02713386|102045457|FG003|STARTED|Phase 2||0||
48697758|NCT02713386|102045454|FG000|COMPLETED|Phase 2||42||
48564526|NCT01928472|101713959|FG003|NOT COMPLETED|Overall Study||2||
48564527|NCT00444535|101713960|FG000|STARTED|Overall Study||52||
48564528|NCT00444535|101713960|FG000|COMPLETED|Overall Study||39||
48564529|NCT00444535|101713960|FG000|NOT COMPLETED|Overall Study||13||
48564530|NCT02259010|101713961|FG000|STARTED|Overall Study||24||
48564531|NCT02259010|101713961|FG000|COMPLETED|Overall Study||19||
48564532|NCT02259010|101713961|FG000|NOT COMPLETED|Overall Study||5||
48564533|NCT01730053|101713962|FG000|STARTED|Overall Study||48||
48564534|NCT01730053|101713963|FG001|STARTED|Overall Study||48||
48697759|NCT02713386|102045455|FG001|COMPLETED|Phase 2||88||
48697760|NCT02713386|102045456|FG002|COMPLETED|Phase 2||0||
48564535|NCT01730053|101713964|FG002|STARTED|Overall Study||49||
48564536|NCT01730053|101713965|FG003|STARTED|Overall Study||53||
48564537|NCT01730053|101713966|FG004|STARTED|Overall Study||53||
48564538|NCT01730053|101713967|FG005|STARTED|Overall Study||54||
48116975|NCT04689737|100612633|FG000|NOT COMPLETED|Overall Study||0||
48116976|NCT02579616|100612634|FG000|STARTED|Overall Study||29||
48116977|NCT02579616|100612634|FG000|Treated|Overall Study||26||
48116978|NCT02579616|100612634|FG000|COMPLETED|Overall Study||26||
48116979|NCT02579616|100612634|FG000|NOT COMPLETED|Overall Study||3||
48116980|NCT00548808|100612635|FG000|STARTED|Overall Study||214||
48564539|NCT01730053|101713962|FG000|Treated|Overall Study||48||
48564540|NCT01730053|101713963|FG001|Treated|Overall Study||48||
48564541|NCT01730053|101713964|FG002|Treated|Overall Study||49||
48564542|NCT01730053|101713965|FG003|Treated|Overall Study||53||
48564543|NCT01730053|101713966|FG004|Treated|Overall Study||53||
48564544|NCT01730053|101713967|FG005|Treated|Overall Study||54||
48564545|NCT01730053|101713962|FG000|COMPLETED|Overall Study||43||
48564546|NCT01730053|101713963|FG001|COMPLETED|Overall Study||34||
48564547|NCT01730053|101713964|FG002|COMPLETED|Overall Study||38||
48564548|NCT01730053|101713965|FG003|COMPLETED|Overall Study||45||
48564549|NCT01730053|101713966|FG004|COMPLETED|Overall Study||44||
48564550|NCT01730053|101713967|FG005|COMPLETED|Overall Study||41||
48564551|NCT01730053|101713962|FG000|NOT COMPLETED|Overall Study||5||
48564552|NCT01730053|101713963|FG001|NOT COMPLETED|Overall Study||14||
48564553|NCT01730053|101713964|FG002|NOT COMPLETED|Overall Study||11||
48564554|NCT01730053|101713965|FG003|NOT COMPLETED|Overall Study||8||
48116981|NCT00548808|100612636|FG001|STARTED|Overall Study||212||
48116982|NCT00548808|100612635|FG000|Full Analysis Set|Overall Study||211||
48116983|NCT00548808|100612636|FG001|Full Analysis Set|Overall Study||212||
48116984|NCT00548808|100612635|FG000|Per-Protocol Set|Overall Study||177||
48116985|NCT00548808|100612636|FG001|Per-Protocol Set|Overall Study||184||
48116986|NCT00548808|100612635|FG000|COMPLETED|Overall Study||172||
48116987|NCT00548808|100612636|FG001|COMPLETED|Overall Study||186||
48116988|NCT00548808|100612635|FG000|NOT COMPLETED|Overall Study||42||
48116989|NCT00548808|100612636|FG001|NOT COMPLETED|Overall Study||26||
48116990|NCT03296163|100612637|FG000|STARTED|Combination Therapy||315||
48116991|NCT03296163|100612638|FG001|STARTED|Combination Therapy||312||
48564555|NCT01730053|101713966|FG004|NOT COMPLETED|Overall Study||9||
48564556|NCT01730053|101713967|FG005|NOT COMPLETED|Overall Study||13||
48564557|NCT01068860|101713968|FG000|STARTED|Overall Study||33||
48564558|NCT01068860|101713969|FG001|STARTED|Overall Study||17||
48564559|NCT01068860|101713970|FG002|STARTED|Overall Study||33||
48564560|NCT01068860|101713971|FG003|STARTED|Overall Study||17||
48564561|NCT01068860|101713972|FG004|STARTED|Overall Study||32||
48564562|NCT01068860|101713973|FG005|STARTED|Overall Study||16||
48564563|NCT01068860|101713974|FG006|STARTED|Overall Study||28||
48564564|NCT01068860|101713975|FG007|STARTED|Overall Study||15||
48564565|NCT01068860|101713976|FG008|STARTED|Overall Study||28||
48564566|NCT01068860|101713977|FG009|STARTED|Overall Study||27||
48564567|NCT01068860|101713968|FG000|COMPLETED|Overall Study||33||
48564568|NCT01068860|101713969|FG001|COMPLETED|Overall Study||16||
48564569|NCT01068860|101713970|FG002|COMPLETED|Overall Study||33||
48564570|NCT01068860|101713971|FG003|COMPLETED|Overall Study||16||
48116992|NCT03296163|100612637|FG000|COMPLETED|Combination Therapy||207||
48116993|NCT03296163|100612638|FG001|COMPLETED|Combination Therapy||220||
48564571|NCT01068860|101713972|FG004|COMPLETED|Overall Study||32||
48564572|NCT01068860|101713973|FG005|COMPLETED|Overall Study||14||
48116994|NCT03296163|100612637|FG000|NOT COMPLETED|Combination Therapy||108||
48116995|NCT03296163|100612638|FG001|NOT COMPLETED|Combination Therapy||92||
48564573|NCT01068860|101713974|FG006|COMPLETED|Overall Study||28||
48564574|NCT01068860|101713975|FG007|COMPLETED|Overall Study||15||
48564575|NCT01068860|101713976|FG008|COMPLETED|Overall Study||28||
48564576|NCT01068860|101713977|FG009|COMPLETED|Overall Study||23||
48564577|NCT01068860|101713968|FG000|NOT COMPLETED|Overall Study||0||
48564578|NCT01068860|101713969|FG001|NOT COMPLETED|Overall Study||1||
48564579|NCT01068860|101713970|FG002|NOT COMPLETED|Overall Study||0||
48564580|NCT01068860|101713971|FG003|NOT COMPLETED|Overall Study||1||
48564581|NCT01068860|101713972|FG004|NOT COMPLETED|Overall Study||0||
48116996|NCT03296163|100612637|FG000|STARTED|Monotherapy||207||
48116997|NCT03296163|100612638|FG001|STARTED|Monotherapy||220||
48116998|NCT03296163|100612637|FG000|COMPLETED|Monotherapy||68||
48116999|NCT03296163|100612638|FG001|COMPLETED|Monotherapy||74||
48117000|NCT03296163|100612637|FG000|NOT COMPLETED|Monotherapy||139||
48117001|NCT03296163|100612638|FG001|NOT COMPLETED|Monotherapy||146||
48117002|NCT01434823|100612639|FG000|STARTED|Overall Study||824||
48117003|NCT01434823|100612640|FG001|STARTED|Overall Study||785||
48117004|NCT01434823|100612639|FG000|COMPLETED|Overall Study||820||
48117005|NCT01434823|100612640|FG001|COMPLETED|Overall Study||778||
48117006|NCT01434823|100612639|FG000|NOT COMPLETED|Overall Study||4||
48117007|NCT01434823|100612640|FG001|NOT COMPLETED|Overall Study||7||
48117008|NCT03837899|100612641|FG000|STARTED|Overall Study||7||
48117009|NCT03837899|100612642|FG001|STARTED|Overall Study||11||
48117010|NCT03837899|100612643|FG002|STARTED|Overall Study||3||
48117011|NCT03837899|100612644|FG003|STARTED|Overall Study||8||
48117012|NCT03837899|100612645|FG004|STARTED|Overall Study||11||
48117013|NCT03837899|100612646|FG005|STARTED|Overall Study||10||
48117014|NCT03837899|100612641|FG000|COMPLETED|Overall Study||1||
48117015|NCT03837899|100612642|FG001|COMPLETED|Overall Study||0||
48117016|NCT03837899|100612643|FG002|COMPLETED|Overall Study||0||
48117017|NCT03837899|100612644|FG003|COMPLETED|Overall Study||0||
48117018|NCT03837899|100612645|FG004|COMPLETED|Overall Study||0||
48117019|NCT03837899|100612646|FG005|COMPLETED|Overall Study||0||
48117020|NCT03837899|100612641|FG000|NOT COMPLETED|Overall Study||6||
48117021|NCT03837899|100612642|FG001|NOT COMPLETED|Overall Study||11||
48117022|NCT03837899|100612643|FG002|NOT COMPLETED|Overall Study||3||
48117023|NCT03837899|100612644|FG003|NOT COMPLETED|Overall Study||8||
48117024|NCT03837899|100612645|FG004|NOT COMPLETED|Overall Study||11||
48117025|NCT03837899|100612646|FG005|NOT COMPLETED|Overall Study||10||
48117026|NCT01440946|100612647|FG000|STARTED|Overall Study||15||
48117027|NCT01440946|100612648|FG001|STARTED|Overall Study||15||
48117028|NCT01440946|100612647|FG000|COMPLETED|Overall Study||13||
48117029|NCT01440946|100612648|FG001|COMPLETED|Overall Study||14||
48117030|NCT01440946|100612647|FG000|NOT COMPLETED|Overall Study||2||
48117031|NCT01440946|100612648|FG001|NOT COMPLETED|Overall Study||1||
48117032|NCT02130765|100612649|FG000|STARTED|Overall Study||11||
48117033|NCT02130765|100612650|FG001|STARTED|Overall Study||8||
48117034|NCT02130765|100612651|FG002|STARTED|Overall Study||26||
48117035|NCT02130765|100612652|FG003|STARTED|Overall Study||19||
48117036|NCT02130765|100612649|FG000|COMPLETED|Overall Study||7||
48117037|NCT02130765|100612650|FG001|COMPLETED|Overall Study||8||
48117038|NCT02130765|100612651|FG002|COMPLETED|Overall Study||26||
48117039|NCT02130765|100612652|FG003|COMPLETED|Overall Study||19||
48117040|NCT02130765|100612649|FG000|NOT COMPLETED|Overall Study||4||
48117041|NCT02130765|100612650|FG001|NOT COMPLETED|Overall Study||0||
48117042|NCT02130765|100612651|FG002|NOT COMPLETED|Overall Study||0||
48117043|NCT02130765|100612652|FG003|NOT COMPLETED|Overall Study||0||
48117044|NCT00079274|100612653|FG000|STARTED|Overall Study||1402||
48117045|NCT00079274|100612654|FG001|STARTED|Overall Study||111||
48117046|NCT00079274|100612655|FG002|STARTED|Overall Study||111||
48117047|NCT00079274|100612656|FG003|STARTED|Overall Study||1350||
48117048|NCT00079274|100612657|FG004|STARTED|Overall Study||45||
48117049|NCT00079274|100612658|FG005|STARTED|Overall Study||46||
48117050|NCT00079274|100612659|FG006|STARTED|Overall Study||332||
48117051|NCT00079274|100612653|FG000|COMPLETED|Overall Study||1081||
48117052|NCT00079274|100612654|FG001|COMPLETED|Overall Study||84||
48117053|NCT00079274|100612655|FG002|COMPLETED|Overall Study||84||
48117054|NCT00079274|100612656|FG003|COMPLETED|Overall Study||906||
48117055|NCT00079274|100612657|FG004|COMPLETED|Overall Study||30||
48117056|NCT00079274|100612658|FG005|COMPLETED|Overall Study||26||
48117057|NCT00079274|100612659|FG006|COMPLETED|Overall Study||332||
48117058|NCT00079274|100612653|FG000|NOT COMPLETED|Overall Study||321||
48117059|NCT00079274|100612654|FG001|NOT COMPLETED|Overall Study||27||
48117060|NCT00079274|100612655|FG002|NOT COMPLETED|Overall Study||27||
48117061|NCT00079274|100612656|FG003|NOT COMPLETED|Overall Study||444||
48117062|NCT00079274|100612657|FG004|NOT COMPLETED|Overall Study||15||
48117063|NCT00079274|100612658|FG005|NOT COMPLETED|Overall Study||20||
48117064|NCT00079274|100612659|FG006|NOT COMPLETED|Overall Study||0||
48117065|NCT01743092|100612660|FG000|STARTED|Overall Study||33||
48117066|NCT01743092|100612661|FG001|STARTED|Overall Study||26||
48117067|NCT01743092|100612660|FG000|COMPLETED|Overall Study||19||
48117068|NCT01743092|100612661|FG001|COMPLETED|Overall Study||11||
48117069|NCT01743092|100612660|FG000|NOT COMPLETED|Overall Study||14||
48117070|NCT01743092|100612661|FG001|NOT COMPLETED|Overall Study||15||
48117071|NCT02316717|100612662|FG000|STARTED|Overall Study||43||
48117072|NCT02316717|100612663|FG001|STARTED|Overall Study||46||
48117073|NCT02316717|100612664|FG002|STARTED|Overall Study||44||
48117074|NCT02316717|100612662|FG000|COMPLETED|Overall Study||32||
48117075|NCT02316717|100612663|FG001|COMPLETED|Overall Study||39||
48117076|NCT02316717|100612664|FG002|COMPLETED|Overall Study||41||
48117077|NCT02316717|100612662|FG000|NOT COMPLETED|Overall Study||11||
48117078|NCT02316717|100612663|FG001|NOT COMPLETED|Overall Study||7||
48117079|NCT02316717|100612664|FG002|NOT COMPLETED|Overall Study||3||
48117080|NCT01218997|100612665|FG000|STARTED|Overall Study||371||
48117081|NCT01218997|100612666|FG001|STARTED|Overall Study||65||
48117082|NCT01218997|100612665|FG000|COMPLETED|Overall Study||126||
48117083|NCT01218997|100612666|FG001|COMPLETED|Overall Study||24||
48117084|NCT01218997|100612665|FG000|NOT COMPLETED|Overall Study||245||
48117085|NCT01218997|100612666|FG001|NOT COMPLETED|Overall Study||41||
48117086|NCT00424372|100612667|FG000|STARTED|Overall Study||126||
48117087|NCT00424372|100612667|FG000|COMPLETED|Overall Study||95||
48117088|NCT00424372|100612667|FG000|NOT COMPLETED|Overall Study||31||
48117089|NCT03912233|100612668|FG000|STARTED|Overall Study||10||
48117090|NCT03912233|100612669|FG001|STARTED|Overall Study||9||
48117091|NCT03912233|100612670|FG002|STARTED|Overall Study||19||
48117092|NCT03912233|100612671|FG003|STARTED|Overall Study||20||
48117093|NCT03912233|100612672|FG004|STARTED|Overall Study||10||
48117094|NCT03912233|100612673|FG005|STARTED|Overall Study||18||
48117095|NCT03912233|100612668|FG000|COMPLETED|Overall Study||8||
48117096|NCT03912233|100612669|FG001|COMPLETED|Overall Study||9||
48117097|NCT03912233|100612670|FG002|COMPLETED|Overall Study||19||
48117098|NCT03912233|100612671|FG003|COMPLETED|Overall Study||20||
48117099|NCT03912233|100612672|FG004|COMPLETED|Overall Study||3||
48117100|NCT03912233|100612673|FG005|COMPLETED|Overall Study||6||
48117101|NCT03912233|100612668|FG000|NOT COMPLETED|Overall Study||2||
48117102|NCT03912233|100612669|FG001|NOT COMPLETED|Overall Study||0||
48117103|NCT03912233|100612670|FG002|NOT COMPLETED|Overall Study||0||
48117104|NCT03912233|100612671|FG003|NOT COMPLETED|Overall Study||0||
48117105|NCT03912233|100612672|FG004|NOT COMPLETED|Overall Study||7||
48117106|NCT03912233|100612673|FG005|NOT COMPLETED|Overall Study||12||
48117107|NCT02908529|100612674|FG000|STARTED|Overall Study||10||
48117108|NCT02908529|100612675|FG001|STARTED|Overall Study||12||
48117109|NCT02908529|100612674|FG000|COMPLETED|Overall Study||10||
48117110|NCT02908529|100612675|FG001|COMPLETED|Overall Study||10||
48117111|NCT02908529|100612674|FG000|NOT COMPLETED|Overall Study||0||
48117112|NCT02908529|100612675|FG001|NOT COMPLETED|Overall Study||2||
48564582|NCT01068860|101713973|FG005|NOT COMPLETED|Overall Study||2||
48564583|NCT01068860|101713974|FG006|NOT COMPLETED|Overall Study||0||
48564584|NCT01068860|101713975|FG007|NOT COMPLETED|Overall Study||0||
48564585|NCT01068860|101713976|FG008|NOT COMPLETED|Overall Study||0||
48564586|NCT01068860|101713977|FG009|NOT COMPLETED|Overall Study||4||
48564587|NCT00739882|101713978|FG000|STARTED|Double-blind Period||51||
48564588|NCT00739882|101713979|FG001|STARTED|Double-blind Period||25||
48564589|NCT00739882|101713978|FG000|COMPLETED|Double-blind Period||32||
48564590|NCT00739882|101713979|FG001|COMPLETED|Double-blind Period||14||
48564591|NCT00739882|101713978|FG000|NOT COMPLETED|Double-blind Period||19||
48697761|NCT02713386|102045457|FG003|COMPLETED|Phase 2||0||
48117113|NCT02678039|100612676|FG000|STARTED|Overall Study||53||
48117114|NCT02678039|100612677|FG001|STARTED|Overall Study||47||
48117115|NCT02678039|100612676|FG000|COMPLETED|Overall Study||53||
48117116|NCT02678039|100612677|FG001|COMPLETED|Overall Study||47||
48117117|NCT02678039|100612676|FG000|NOT COMPLETED|Overall Study||0||
48117118|NCT02678039|100612677|FG001|NOT COMPLETED|Overall Study||0||
48117119|NCT00441337|100612678|FG000|STARTED|Overall Study||6||
48117120|NCT00441337|100612679|FG001|STARTED|Overall Study||6||
48117121|NCT00441337|100612680|FG002|STARTED|Overall Study||6||
48117122|NCT00441337|100612681|FG003|STARTED|Overall Study||21||
48117123|NCT00441337|100612678|FG000|COMPLETED|Overall Study||0||
48117124|NCT00441337|100612679|FG001|COMPLETED|Overall Study||0||
48117125|NCT00441337|100612680|FG002|COMPLETED|Overall Study||0||
48117126|NCT00441337|100612681|FG003|COMPLETED|Overall Study||0||
48117127|NCT00441337|100612678|FG000|NOT COMPLETED|Overall Study||6||
48117128|NCT00441337|100612679|FG001|NOT COMPLETED|Overall Study||6||
48117129|NCT00441337|100612680|FG002|NOT COMPLETED|Overall Study||6||
48117130|NCT00441337|100612681|FG003|NOT COMPLETED|Overall Study||21||
48117131|NCT03779997|100612682|FG000|STARTED|Overall Study||39||
48117132|NCT03779997|100612683|FG001|STARTED|Overall Study||39||
48117133|NCT03779997|100612682|FG000|Completed at Least One Visit|Overall Study||39||
48117134|NCT03779997|100612683|FG001|Completed at Least One Visit|Overall Study||39||
48117135|NCT03779997|100612682|FG000|COMPLETED|Overall Study||39||
48117136|NCT03779997|100612683|FG001|COMPLETED|Overall Study||39||
48117137|NCT03779997|100612682|FG000|NOT COMPLETED|Overall Study||0||
48117138|NCT03779997|100612683|FG001|NOT COMPLETED|Overall Study||0||
48564592|NCT00739882|101713979|FG001|NOT COMPLETED|Double-blind Period||11||
48697762|NCT02713386|102045454|FG000|NOT COMPLETED|Phase 2||0||
48117139|NCT03306264|100612684|FG000|STARTED|Overall Study||69||
48117140|NCT03306264|100612685|FG001|STARTED|Overall Study||69||
48117141|NCT03306264|100612686|FG002|STARTED|Overall Study||44||
48117142|NCT03306264|100612687|FG003|STARTED|Overall Study||45||
48117143|NCT03306264|100612684|FG000|Safety Analysis Set|Overall Study||66|The Safety Analysis Set included all participants who received any amount of study treatment.|
48117144|NCT03306264|100612685|FG001|Safety Analysis Set|Overall Study||67|The Safety Analysis Set included all participants who received any amount of study treatment.|
48117145|NCT03306264|100612686|FG002|Safety Analysis Set|Overall Study||43|The Safety Analysis Set included all participants who received any amount of study treatment.|
48117146|NCT03306264|100612687|FG003|Safety Analysis Set|Overall Study||44|The Safety Analysis Set included all participants who received any amount of study treatment.|
48117147|NCT03306264|100612684|FG000|COMPLETED|Overall Study||0||
48117148|NCT03306264|100612685|FG001|COMPLETED|Overall Study||0||
48117149|NCT03306264|100612686|FG002|COMPLETED|Overall Study||0||
48117150|NCT03306264|100612687|FG003|COMPLETED|Overall Study||0||
48117151|NCT03306264|100612684|FG000|NOT COMPLETED|Overall Study||69||
48117152|NCT03306264|100612685|FG001|NOT COMPLETED|Overall Study||69||
48117153|NCT03306264|100612686|FG002|NOT COMPLETED|Overall Study||44||
48117154|NCT03306264|100612687|FG003|NOT COMPLETED|Overall Study||45||
48117155|NCT01797536|100612688|FG000|STARTED|Overall Study||8||
48117156|NCT01797536|100612689|FG001|STARTED|Overall Study||11||
48117157|NCT01797536|100612690|FG002|STARTED|Overall Study||7||
48117158|NCT01797536|100612691|FG003|STARTED|Overall Study||8||
48117159|NCT01797536|100612688|FG000|COMPLETED|Overall Study||8||
48117160|NCT01797536|100612689|FG001|COMPLETED|Overall Study||10||
48117161|NCT01797536|100612690|FG002|COMPLETED|Overall Study||7||
48117162|NCT01797536|100612691|FG003|COMPLETED|Overall Study||8||
48117163|NCT01797536|100612688|FG000|NOT COMPLETED|Overall Study||0||
48117164|NCT01797536|100612689|FG001|NOT COMPLETED|Overall Study||1||
48117165|NCT01797536|100612690|FG002|NOT COMPLETED|Overall Study||0||
48117166|NCT01797536|100612691|FG003|NOT COMPLETED|Overall Study||0||
48117167|NCT00622635|100612692|FG000|STARTED|Treatment Period 1||13||
48117168|NCT00622635|100612693|FG001|STARTED|Treatment Period 1||11||
48117169|NCT00622635|100612694|FG002|STARTED|Treatment Period 1||11||
48117170|NCT00622635|100612695|FG003|STARTED|Treatment Period 1||13||
48117171|NCT00622635|100612696|FG004|STARTED|Treatment Period 1||10||
48117172|NCT00622635|100612697|FG005|STARTED|Treatment Period 1||10||
48117173|NCT00622635|100612692|FG000|COMPLETED|Treatment Period 1||13||
48117174|NCT00622635|100612693|FG001|COMPLETED|Treatment Period 1||10||
48117175|NCT00622635|100612694|FG002|COMPLETED|Treatment Period 1||10||
48117176|NCT00622635|100612695|FG003|COMPLETED|Treatment Period 1||13||
48117177|NCT00622635|100612696|FG004|COMPLETED|Treatment Period 1||9||
48117178|NCT00622635|100612697|FG005|COMPLETED|Treatment Period 1||10||
48117179|NCT00622635|100612692|FG000|NOT COMPLETED|Treatment Period 1||0||
48117180|NCT00622635|100612693|FG001|NOT COMPLETED|Treatment Period 1||1||
48117181|NCT00622635|100612694|FG002|NOT COMPLETED|Treatment Period 1||1||
48117182|NCT00622635|100612695|FG003|NOT COMPLETED|Treatment Period 1||0||
48117183|NCT00622635|100612696|FG004|NOT COMPLETED|Treatment Period 1||1||
48117184|NCT00622635|100612697|FG005|NOT COMPLETED|Treatment Period 1||0||
48117185|NCT00622635|100612692|FG000|STARTED|Treatment Period 2||13||
48117186|NCT00622635|100612693|FG001|STARTED|Treatment Period 2||10||
48117187|NCT00622635|100612694|FG002|STARTED|Treatment Period 2||10||
48117188|NCT00622635|100612695|FG003|STARTED|Treatment Period 2||13||
48117189|NCT00622635|100612696|FG004|STARTED|Treatment Period 2||9||
48117190|NCT00622635|100612697|FG005|STARTED|Treatment Period 2||10||
48117191|NCT00622635|100612692|FG000|COMPLETED|Treatment Period 2||12||
48117192|NCT00622635|100612693|FG001|COMPLETED|Treatment Period 2||10||
48117193|NCT00622635|100612694|FG002|COMPLETED|Treatment Period 2||10||
48117194|NCT00622635|100612695|FG003|COMPLETED|Treatment Period 2||13||
48117195|NCT00622635|100612696|FG004|COMPLETED|Treatment Period 2||9||
48117196|NCT00622635|100612697|FG005|COMPLETED|Treatment Period 2||10||
48117197|NCT00622635|100612692|FG000|NOT COMPLETED|Treatment Period 2||1||
48394450|NCT01270958|101295941|FG000|NOT COMPLETED|Overall Study||4||
48117198|NCT00622635|100612693|FG001|NOT COMPLETED|Treatment Period 2||0||
48117199|NCT00622635|100612694|FG002|NOT COMPLETED|Treatment Period 2||0||
48117200|NCT00622635|100612695|FG003|NOT COMPLETED|Treatment Period 2||0||
48117201|NCT00622635|100612696|FG004|NOT COMPLETED|Treatment Period 2||0||
48117202|NCT00622635|100612697|FG005|NOT COMPLETED|Treatment Period 2||0||
48117203|NCT00622635|100612692|FG000|STARTED|Treatment Period 3||12||
48117204|NCT00622635|100612693|FG001|STARTED|Treatment Period 3||10||
48117205|NCT00622635|100612694|FG002|STARTED|Treatment Period 3||10||
48117206|NCT00622635|100612695|FG003|STARTED|Treatment Period 3||13||
48117207|NCT00622635|100612696|FG004|STARTED|Treatment Period 3||9||
48117208|NCT00622635|100612697|FG005|STARTED|Treatment Period 3||10||
48117209|NCT00622635|100612692|FG000|COMPLETED|Treatment Period 3||12||
48117210|NCT00622635|100612693|FG001|COMPLETED|Treatment Period 3||10||
48117211|NCT00622635|100612694|FG002|COMPLETED|Treatment Period 3||10||
48117212|NCT00622635|100612695|FG003|COMPLETED|Treatment Period 3||10||
48117213|NCT00622635|100612696|FG004|COMPLETED|Treatment Period 3||9||
48117214|NCT00622635|100612697|FG005|COMPLETED|Treatment Period 3||10||
48117215|NCT00622635|100612692|FG000|NOT COMPLETED|Treatment Period 3||0||
48117216|NCT00622635|100612693|FG001|NOT COMPLETED|Treatment Period 3||0||
48117217|NCT00622635|100612694|FG002|NOT COMPLETED|Treatment Period 3||0||
48117218|NCT00622635|100612695|FG003|NOT COMPLETED|Treatment Period 3||3||
48117219|NCT00622635|100612696|FG004|NOT COMPLETED|Treatment Period 3||0||
48117220|NCT00622635|100612697|FG005|NOT COMPLETED|Treatment Period 3||0||
48117221|NCT00627679|100612698|FG000|STARTED|Overall Study||4||
48117222|NCT00627679|100612699|FG001|STARTED|Overall Study||4||
48117223|NCT00627679|100612700|FG002|STARTED|Overall Study||4||
48117224|NCT00627679|100612701|FG003|STARTED|Overall Study||4||
48117225|NCT00627679|100612698|FG000|COMPLETED|Overall Study||4||
48117226|NCT00627679|100612699|FG001|COMPLETED|Overall Study||4||
48117227|NCT00627679|100612700|FG002|COMPLETED|Overall Study||4||
48117228|NCT00627679|100612701|FG003|COMPLETED|Overall Study||4||
48117229|NCT00627679|100612698|FG000|NOT COMPLETED|Overall Study||0||
48117230|NCT00627679|100612699|FG001|NOT COMPLETED|Overall Study||0||
48117231|NCT00627679|100612700|FG002|NOT COMPLETED|Overall Study||0||
48117232|NCT00627679|100612701|FG003|NOT COMPLETED|Overall Study||0||
48117233|NCT02755831|100612702|FG000|STARTED|Overall Study||100||
48117234|NCT02755831|100612703|FG001|STARTED|Overall Study||93||
48117235|NCT02755831|100612702|FG000|COMPLETED|Overall Study||97||
48117236|NCT02755831|100612703|FG001|COMPLETED|Overall Study||90||
48117237|NCT02755831|100612702|FG000|NOT COMPLETED|Overall Study||3||
48117238|NCT02755831|100612703|FG001|NOT COMPLETED|Overall Study||3||
48117239|NCT02472756|100612704|FG000|STARTED|Induction (Approximately 6 Months)||41||
48117240|NCT02472756|100612704|FG000|Treated|Induction (Approximately 6 Months)||40||
48117241|NCT02472756|100612704|FG000|COMPLETED|Induction (Approximately 6 Months)||39||
48117242|NCT02472756|100612704|FG000|NOT COMPLETED|Induction (Approximately 6 Months)||2||
48117243|NCT02472756|100612704|FG000|STARTED|Maintenance (Approximately 2 Years)||20||
48117244|NCT02472756|100612704|FG000|COMPLETED|Maintenance (Approximately 2 Years)||10||
48117245|NCT02472756|100612704|FG000|NOT COMPLETED|Maintenance (Approximately 2 Years)||10||
48117246|NCT00192075|100612705|FG000|STARTED|Overall Study||42||
48117247|NCT00192075|100612706|FG001|STARTED|Overall Study||42||
48117248|NCT00192075|100612705|FG000|COMPLETED|Overall Study||3||
48117249|NCT00192075|100612706|FG001|COMPLETED|Overall Study||23||
48117250|NCT00192075|100612705|FG000|NOT COMPLETED|Overall Study||39||
48117251|NCT00192075|100612706|FG001|NOT COMPLETED|Overall Study||19||
48117252|NCT01777997|100612707|FG000|STARTED|12 Week lead-in of no ART||38||
48117253|NCT01777997|100612707|FG000|COMPLETED|12 Week lead-in of no ART||36||
48117254|NCT01777997|100612707|FG000|NOT COMPLETED|12 Week lead-in of no ART||2||
48117255|NCT01777997|100612707|FG000|STARTED|Weeks 0 to 24/48 on ART||36||
48117256|NCT01777997|100612707|FG000|COMPLETED|Weeks 0 to 24/48 on ART||35||
48117257|NCT01777997|100612707|FG000|NOT COMPLETED|Weeks 0 to 24/48 on ART||1||
48117258|NCT01777997|100612707|FG000|STARTED|Weeks 48 to 72/96 on ART||28||
48117259|NCT01777997|100612707|FG000|COMPLETED|Weeks 48 to 72/96 on ART||26||
48117260|NCT01777997|100612707|FG000|NOT COMPLETED|Weeks 48 to 72/96 on ART||2||
48117261|NCT04524403|100612708|FG000|STARTED|Overall Study||50||
48117262|NCT04524403|100612709|FG001|STARTED|Overall Study||48||
48117263|NCT04524403|100612710|FG002|STARTED|Overall Study||52||
48117264|NCT04524403|100612708|FG000|COMPLETED|Overall Study||33||
48117265|NCT04524403|100612709|FG001|COMPLETED|Overall Study||37||
48117266|NCT04524403|100612710|FG002|COMPLETED|Overall Study||34||
48117267|NCT04524403|100612708|FG000|NOT COMPLETED|Overall Study||17||
48117268|NCT04524403|100612709|FG001|NOT COMPLETED|Overall Study||11||
48117269|NCT04524403|100612710|FG002|NOT COMPLETED|Overall Study||18||
48117270|NCT03795922|100612711|FG000|STARTED|Overall Study||80||
48117271|NCT03795922|100612712|FG001|STARTED|Overall Study||154||
48117272|NCT03795922|100612711|FG000|COMPLETED|Overall Study||67||
48117273|NCT03795922|100612712|FG001|COMPLETED|Overall Study||129||
48117274|NCT03795922|100612711|FG000|NOT COMPLETED|Overall Study||13||
48117275|NCT03795922|100612712|FG001|NOT COMPLETED|Overall Study||25||
48117276|NCT02399085|100612713|FG000|STARTED|Overall Study||81||
48117277|NCT02399085|100612713|FG000|Received MOR00208 + LEN|Overall Study||80||
48117278|NCT02399085|100612713|FG000|Received MOR00208 Only|Overall Study||1||
48278740|NCT01327495|101007116|FG004|NOT COMPLETED|Overall Study||3||
48278741|NCT01327495|101007117|FG005|NOT COMPLETED|Overall Study||2||
48564593|NCT00739882|101713978|FG000|STARTED|Open-label Period||17||
48564594|NCT00739882|101713979|FG001|STARTED|Open-label Period||14||
48564595|NCT00739882|101713978|FG000|COMPLETED|Open-label Period||7||
48564596|NCT00739882|101713979|FG001|COMPLETED|Open-label Period||9||
48278742|NCT02525718|101007118|FG000|STARTED|Overall Study||23||
48394451|NCT03657810|101295942|FG000|STARTED|Overall Study||87||
48278743|NCT02525718|101007119|FG001|STARTED|Overall Study||24||
48278744|NCT02525718|101007118|FG000|COMPLETED|Overall Study||22||
48278745|NCT02525718|101007119|FG001|COMPLETED|Overall Study||23||
48278746|NCT02525718|101007118|FG000|NOT COMPLETED|Overall Study||1||
48278747|NCT02525718|101007119|FG001|NOT COMPLETED|Overall Study||1||
48278748|NCT02755818|101007120|FG000|STARTED|Overall Study||30||
48278749|NCT02755818|101007121|FG001|STARTED|Overall Study||2||
48278750|NCT02755818|101007122|FG002|STARTED|Overall Study||2||
48278751|NCT02755818|101007123|FG003|STARTED|Overall Study||17||
48278752|NCT02755818|101007120|FG000|COMPLETED|Overall Study||30||
48278753|NCT02755818|101007121|FG001|COMPLETED|Overall Study||2||
48278754|NCT02755818|101007122|FG002|COMPLETED|Overall Study||1||
48278755|NCT02755818|101007123|FG003|COMPLETED|Overall Study||14||
48278756|NCT02755818|101007120|FG000|NOT COMPLETED|Overall Study||0||
48278757|NCT02755818|101007121|FG001|NOT COMPLETED|Overall Study||0||
48278758|NCT02755818|101007122|FG002|NOT COMPLETED|Overall Study||1||
48278759|NCT02755818|101007123|FG003|NOT COMPLETED|Overall Study||3||
48278760|NCT02654691|101007124|FG000|STARTED|Overall Study||63||
48278761|NCT02654691|101007124|FG000|COMPLETED|Overall Study||63||
48278762|NCT02654691|101007124|FG000|NOT COMPLETED|Overall Study||0||
48278763|NCT02544451|101007125|FG000|STARTED|Treatment Period 1 (96 Weeks)||143||
48278764|NCT02544451|101007126|FG001|STARTED|Treatment Period 1 (96 Weeks)||96||
48278765|NCT02544451|101007127|FG002|STARTED|Treatment Period 1 (96 Weeks)||6||
48278766|NCT02544451|101007128|FG003|STARTED|Treatment Period 1 (96 Weeks)||0||
48278767|NCT02544451|101007125|FG000|COMPLETED|Treatment Period 1 (96 Weeks)||129||
48278768|NCT02544451|101007126|FG001|COMPLETED|Treatment Period 1 (96 Weeks)||84||
48278769|NCT02544451|101007127|FG002|COMPLETED|Treatment Period 1 (96 Weeks)||5||
48278770|NCT02544451|101007128|FG003|COMPLETED|Treatment Period 1 (96 Weeks)||0||
48278771|NCT02544451|101007125|FG000|NOT COMPLETED|Treatment Period 1 (96 Weeks)||14||
48278772|NCT02544451|101007126|FG001|NOT COMPLETED|Treatment Period 1 (96 Weeks)||12||
48278773|NCT02544451|101007127|FG002|NOT COMPLETED|Treatment Period 1 (96 Weeks)||1||
48278774|NCT02544451|101007128|FG003|NOT COMPLETED|Treatment Period 1 (96 Weeks)||0||
48278775|NCT02544451|101007125|FG000|STARTED|Treatment Period 2 (168 Weeks)||0||
48278776|NCT02544451|101007126|FG001|STARTED|Treatment Period 2 (168 Weeks)||0||
48278777|NCT02544451|101007127|FG002|STARTED|Treatment Period 2 (168 Weeks)||0||
48278778|NCT02544451|101007128|FG003|STARTED|Treatment Period 2 (168 Weeks)||10||
48278779|NCT02544451|101007125|FG000|COMPLETED|Treatment Period 2 (168 Weeks)||0||
48278780|NCT02544451|101007126|FG001|COMPLETED|Treatment Period 2 (168 Weeks)||0||
48278781|NCT02544451|101007127|FG002|COMPLETED|Treatment Period 2 (168 Weeks)||0||
48278782|NCT02544451|101007128|FG003|COMPLETED|Treatment Period 2 (168 Weeks)||0||
48278783|NCT02544451|101007125|FG000|NOT COMPLETED|Treatment Period 2 (168 Weeks)||0||
48278784|NCT02544451|101007126|FG001|NOT COMPLETED|Treatment Period 2 (168 Weeks)||0||
48278785|NCT02544451|101007127|FG002|NOT COMPLETED|Treatment Period 2 (168 Weeks)||0||
48278786|NCT02544451|101007128|FG003|NOT COMPLETED|Treatment Period 2 (168 Weeks)||10||
48278787|NCT01854138|101007129|FG000|STARTED|Overall Study||400||
48278788|NCT01854138|101007130|FG001|STARTED|Overall Study||248||
48278789|NCT01854138|101007129|FG000|COMPLETED|Overall Study||400||
48278790|NCT01854138|101007130|FG001|COMPLETED|Overall Study||196||
48278791|NCT01854138|101007129|FG000|NOT COMPLETED|Overall Study||0||
48278792|NCT01854138|101007130|FG001|NOT COMPLETED|Overall Study||52||
48278793|NCT00396019|101007131|FG000|STARTED|Overall Study||27||
48278794|NCT00396019|101007132|FG001|STARTED|Overall Study||29||
48278795|NCT00396019|101007133|FG002|STARTED|Overall Study||30||
48564597|NCT00739882|101713978|FG000|NOT COMPLETED|Open-label Period||10||
48564598|NCT00739882|101713979|FG001|NOT COMPLETED|Open-label Period||5||
48564599|NCT00110396|101713980|FG000|STARTED|Overall Study||260||
48564600|NCT00110396|101713980|FG000|COMPLETED|Overall Study||224||
48564601|NCT00110396|101713980|FG000|NOT COMPLETED|Overall Study||36||
48278796|NCT00396019|101007131|FG000|COMPLETED|Overall Study||27||
48278797|NCT00396019|101007132|FG001|COMPLETED|Overall Study||26||
48278798|NCT00396019|101007133|FG002|COMPLETED|Overall Study||29||
48278799|NCT00396019|101007131|FG000|NOT COMPLETED|Overall Study||0||
48564602|NCT03207815|101713981|FG000|STARTED|Overall Study||38||
48564603|NCT03207815|101713982|FG001|STARTED|Overall Study||36||
48278800|NCT00396019|101007132|FG001|NOT COMPLETED|Overall Study||3||
48278801|NCT00396019|101007133|FG002|NOT COMPLETED|Overall Study||1||
48278802|NCT01631227|101007134|FG000|STARTED|Overall Study||333||
48278803|NCT01631227|101007135|FG001|STARTED|Overall Study||332||
48278804|NCT01631227|101007134|FG000|Safety Subject Sample|Overall Study||332||
48278805|NCT01631227|101007135|FG001|Safety Subject Sample|Overall Study||332||
48278806|NCT01631227|101007134|FG000|Full Analysis Set Population|Overall Study||330||
48278807|NCT01631227|101007135|FG001|Full Analysis Set Population|Overall Study||331||
48564604|NCT03207815|101713981|FG000|COMPLETED|Overall Study||30||
48394452|NCT03657810|101295943|FG001|STARTED|Overall Study||90||
48394453|NCT03657810|101295944|FG002|STARTED|Overall Study||44||
48394454|NCT03657810|101295942|FG000|COMPLETED|Overall Study||82||
48394455|NCT03657810|101295943|FG001|COMPLETED|Overall Study||86||
48394456|NCT03657810|101295944|FG002|COMPLETED|Overall Study||41||
48394457|NCT03657810|101295942|FG000|NOT COMPLETED|Overall Study||5||
48394458|NCT03657810|101295943|FG001|NOT COMPLETED|Overall Study||4||
48117279|NCT02399085|100612713|FG000|Completed: Participants Who Were Still on Treatment at EOS|Overall Study||8||
48117280|NCT02399085|100612713|FG000|Not Completed: Participants Who Were no Longer Receiving Treatment at EOS|Overall Study||73||
48117281|NCT02399085|100612713|FG000|COMPLETED|Overall Study||8||
48117282|NCT02399085|100612713|FG000|NOT COMPLETED|Overall Study||73||
48117283|NCT02488629|100612714|FG000|STARTED|Overall Study||3||
48117284|NCT02488629|100612715|FG001|STARTED|Overall Study||2||
48117285|NCT02488629|100612716|FG002|STARTED|Overall Study||0||
48117286|NCT02488629|100612717|FG003|STARTED|Overall Study||0||
48117287|NCT02488629|100612714|FG000|COMPLETED|Overall Study||0||
48117288|NCT02488629|100612715|FG001|COMPLETED|Overall Study||0||
48117289|NCT02488629|100612716|FG002|COMPLETED|Overall Study||0||
48117290|NCT02488629|100612717|FG003|COMPLETED|Overall Study||0||
48394459|NCT03657810|101295944|FG002|NOT COMPLETED|Overall Study||3||
48117291|NCT02488629|100612714|FG000|NOT COMPLETED|Overall Study||3||
48117292|NCT02488629|100612715|FG001|NOT COMPLETED|Overall Study||2||
48117293|NCT02488629|100612716|FG002|NOT COMPLETED|Overall Study||0||
48117294|NCT02488629|100612717|FG003|NOT COMPLETED|Overall Study||0||
48117295|NCT02460224|100612718|FG000|STARTED|Overall Study||17||
48117296|NCT02460224|100612719|FG001|STARTED|Overall Study||12||
48117297|NCT02460224|100612720|FG002|STARTED|Overall Study||6||
48117298|NCT02460224|100612721|FG003|STARTED|Overall Study||6||
48117299|NCT02460224|100612722|FG004|STARTED|Overall Study||6||
48117300|NCT02460224|100612723|FG005|STARTED|Overall Study||30||
48117301|NCT02460224|100612724|FG006|STARTED|Overall Study||30||
48117302|NCT02460224|100612725|FG007|STARTED|Overall Study||5||
48117303|NCT02460224|100612726|FG008|STARTED|Overall Study||6||
48117304|NCT02460224|100612727|FG009|STARTED|Overall Study||11||
48117305|NCT02460224|100612728|FG010|STARTED|Overall Study||5||
48117306|NCT02460224|100612729|FG011|STARTED|Overall Study||6||
48117307|NCT02460224|100612730|FG012|STARTED|Overall Study||6||
48117308|NCT02460224|100612731|FG013|STARTED|Overall Study||6||
48117309|NCT02460224|100612732|FG014|STARTED|Overall Study||5||
48117310|NCT02460224|100612733|FG015|STARTED|Overall Study||6||
48117311|NCT02460224|100612734|FG016|STARTED|Overall Study||20||
48117312|NCT02460224|100612735|FG017|STARTED|Overall Study||6||
48117313|NCT02460224|100612736|FG018|STARTED|Overall Study||12||
48117314|NCT02460224|100612737|FG019|STARTED|Overall Study||7||
48117315|NCT02460224|100612738|FG020|STARTED|Overall Study||6||
48117316|NCT02460224|100612739|FG021|STARTED|Overall Study||12||
48117317|NCT02460224|100612740|FG022|STARTED|Overall Study||6||
48117318|NCT02460224|100612741|FG023|STARTED|Overall Study||11||
48117319|NCT02460224|100612742|FG024|STARTED|Overall Study||6||
48117320|NCT02460224|100612743|FG025|STARTED|Overall Study||6||
48117321|NCT02460224|100612744|FG026|STARTED|Overall Study||121||
48117322|NCT02460224|100612745|FG027|STARTED|Overall Study||21||
48117323|NCT02460224|100612746|FG028|STARTED|Overall Study||93||
48117324|NCT02460224|100612718|FG000|Rest of the World Patients in the Dose Escalation Part|Overall Study||13||
48117325|NCT02460224|100612719|FG001|Rest of the World Patients in the Dose Escalation Part|Overall Study||12||
48117326|NCT02460224|100612720|FG002|Rest of the World Patients in the Dose Escalation Part|Overall Study||6||
48117327|NCT02460224|100612721|FG003|Rest of the World Patients in the Dose Escalation Part|Overall Study||6||
48394460|NCT00728936|101295945|FG000|STARTED|Overall Study||10||
48394461|NCT00728936|101295946|FG001|STARTED|Overall Study||8||
48394462|NCT00728936|101295947|FG002|STARTED|Overall Study||9||
48394463|NCT00728936|101295948|FG003|STARTED|Overall Study||8||
48394464|NCT00728936|101295949|FG004|STARTED|Overall Study||8||
48394465|NCT00728936|101295950|FG005|STARTED|Overall Study||8||
48394466|NCT00728936|101295951|FG006|STARTED|Overall Study||7||
48394467|NCT00728936|101295945|FG000|COMPLETED|Overall Study||10||
48394468|NCT00728936|101295946|FG001|COMPLETED|Overall Study||8||
48394469|NCT00728936|101295947|FG002|COMPLETED|Overall Study||9||
48394470|NCT00728936|101295948|FG003|COMPLETED|Overall Study||8||
48394471|NCT00728936|101295949|FG004|COMPLETED|Overall Study||8||
48564605|NCT03207815|101713982|FG001|COMPLETED|Overall Study||29||
48564606|NCT03207815|101713981|FG000|NOT COMPLETED|Overall Study||8||
48117328|NCT02460224|100612722|FG004|Rest of the World Patients in the Dose Escalation Part|Overall Study||6||
48117329|NCT02460224|100612723|FG005|Rest of the World Patients in the Dose Escalation Part|Overall Study||25||
48117330|NCT02460224|100612724|FG006|Rest of the World Patients in the Dose Escalation Part|Overall Study||24||
48117331|NCT02460224|100612725|FG007|Rest of the World Patients in the Dose Escalation Part|Overall Study||5||
48564607|NCT03207815|101713982|FG001|NOT COMPLETED|Overall Study||7||
48117332|NCT02460224|100612726|FG008|Rest of the World Patients in the Dose Escalation Part|Overall Study||6||
48117333|NCT02460224|100612727|FG009|Rest of the World Patients in the Dose Escalation Part|Overall Study||11||
48394472|NCT00728936|101295950|FG005|COMPLETED|Overall Study||7||
48394473|NCT00728936|101295951|FG006|COMPLETED|Overall Study||7||
48394474|NCT00728936|101295945|FG000|NOT COMPLETED|Overall Study||0||
48117334|NCT02460224|100612728|FG010|Rest of the World Patients in the Dose Escalation Part|Overall Study||5||
48117335|NCT02460224|100612729|FG011|Rest of the World Patients in the Dose Escalation Part|Overall Study||6||
48564608|NCT01662635|101713983|FG000|STARTED|Overall Study||230||
48117336|NCT02460224|100612730|FG012|Rest of the World Patients in the Dose Escalation Part|Overall Study||6||
48117337|NCT02460224|100612731|FG013|Rest of the World Patients in the Dose Escalation Part|Overall Study||6||
48117338|NCT02460224|100612732|FG014|Rest of the World Patients in the Dose Escalation Part|Overall Study||5||
48117339|NCT02460224|100612733|FG015|Rest of the World Patients in the Dose Escalation Part|Overall Study||6||
48117340|NCT02460224|100612734|FG016|Rest of the World Patients in the Dose Escalation Part|Overall Study||20||
48117341|NCT02460224|100612735|FG017|Rest of the World Patients in the Dose Escalation Part|Overall Study||6||
48117342|NCT02460224|100612736|FG018|Rest of the World Patients in the Dose Escalation Part|Overall Study||12||
48117343|NCT02460224|100612737|FG019|Rest of the World Patients in the Dose Escalation Part|Overall Study||7||
48117344|NCT02460224|100612738|FG020|Rest of the World Patients in the Dose Escalation Part|Overall Study||6||
48117345|NCT02460224|100612739|FG021|Rest of the World Patients in the Dose Escalation Part|Overall Study||12||
48117346|NCT02460224|100612740|FG022|Rest of the World Patients in the Dose Escalation Part|Overall Study||6||
48117347|NCT02460224|100612741|FG023|Rest of the World Patients in the Dose Escalation Part|Overall Study||11||
48117348|NCT02460224|100612742|FG024|Rest of the World Patients in the Dose Escalation Part|Overall Study||6||
48117349|NCT02460224|100612743|FG025|Rest of the World Patients in the Dose Escalation Part|Overall Study||6||
48117350|NCT02460224|100612744|FG026|Rest of the World Patients in the Dose Escalation Part|Overall Study||0||
48117351|NCT02460224|100612745|FG027|Rest of the World Patients in the Dose Escalation Part|Overall Study||0||
48117352|NCT02460224|100612746|FG028|Rest of the World Patients in the Dose Escalation Part|Overall Study||0||
48117353|NCT02460224|100612718|FG000|Japanese Patients in the Dose Escalation Part|Overall Study||4||
48117354|NCT02460224|100612719|FG001|Japanese Patients in the Dose Escalation Part|Overall Study||0||
48117355|NCT02460224|100612720|FG002|Japanese Patients in the Dose Escalation Part|Overall Study||0||
48117356|NCT02460224|100612721|FG003|Japanese Patients in the Dose Escalation Part|Overall Study||0||
48117357|NCT02460224|100612722|FG004|Japanese Patients in the Dose Escalation Part|Overall Study||0||
48117358|NCT02460224|100612723|FG005|Japanese Patients in the Dose Escalation Part|Overall Study||5||
48117359|NCT02460224|100612724|FG006|Japanese Patients in the Dose Escalation Part|Overall Study||6||
48117360|NCT02460224|100612725|FG007|Japanese Patients in the Dose Escalation Part|Overall Study||0||
48117361|NCT02460224|100612726|FG008|Japanese Patients in the Dose Escalation Part|Overall Study||0||
48117362|NCT02460224|100612727|FG009|Japanese Patients in the Dose Escalation Part|Overall Study||0||
48117363|NCT02460224|100612728|FG010|Japanese Patients in the Dose Escalation Part|Overall Study||0||
48117364|NCT02460224|100612729|FG011|Japanese Patients in the Dose Escalation Part|Overall Study||0||
48117365|NCT02460224|100612730|FG012|Japanese Patients in the Dose Escalation Part|Overall Study||0||
48117366|NCT02460224|100612731|FG013|Japanese Patients in the Dose Escalation Part|Overall Study||0||
48117367|NCT02460224|100612732|FG014|Japanese Patients in the Dose Escalation Part|Overall Study||0||
48117368|NCT02460224|100612733|FG015|Japanese Patients in the Dose Escalation Part|Overall Study||0||
48117369|NCT02460224|100612734|FG016|Japanese Patients in the Dose Escalation Part|Overall Study||0||
48117370|NCT02460224|100612735|FG017|Japanese Patients in the Dose Escalation Part|Overall Study||0||
48117371|NCT02460224|100612736|FG018|Japanese Patients in the Dose Escalation Part|Overall Study||0||
48117372|NCT02460224|100612737|FG019|Japanese Patients in the Dose Escalation Part|Overall Study||0||
48117373|NCT02460224|100612738|FG020|Japanese Patients in the Dose Escalation Part|Overall Study||0||
48117374|NCT02460224|100612739|FG021|Japanese Patients in the Dose Escalation Part|Overall Study||0||
48117375|NCT02460224|100612740|FG022|Japanese Patients in the Dose Escalation Part|Overall Study||0||
48117376|NCT02460224|100612741|FG023|Japanese Patients in the Dose Escalation Part|Overall Study||0||
48117377|NCT02460224|100612742|FG024|Japanese Patients in the Dose Escalation Part|Overall Study||0||
48117378|NCT02460224|100612743|FG025|Japanese Patients in the Dose Escalation Part|Overall Study||0||
48117379|NCT02460224|100612744|FG026|Japanese Patients in the Dose Escalation Part|Overall Study||0||
48117380|NCT02460224|100612745|FG027|Japanese Patients in the Dose Escalation Part|Overall Study||0||
48117381|NCT02460224|100612746|FG028|Japanese Patients in the Dose Escalation Part|Overall Study||0||
48278808|NCT01631227|101007134|FG000|COMPLETED|Overall Study||303||
48278809|NCT01631227|101007135|FG001|COMPLETED|Overall Study||310||
48278810|NCT01631227|101007134|FG000|NOT COMPLETED|Overall Study||30||
48278811|NCT01631227|101007135|FG001|NOT COMPLETED|Overall Study||22||
48278812|NCT00453193|101007136|FG000|STARTED|Overall Study||24||
48278813|NCT00453193|101007136|FG000|COMPLETED|Overall Study||24||
48278814|NCT00453193|101007136|FG000|NOT COMPLETED|Overall Study||0||
48278815|NCT02285153|101007137|FG000|STARTED|Overall Study||7||
48278816|NCT02285153|101007138|FG001|STARTED|Overall Study||8||
48278817|NCT02285153|101007137|FG000|COMPLETED|Overall Study||6||
48278818|NCT02285153|101007138|FG001|COMPLETED|Overall Study||8||
48278819|NCT02285153|101007137|FG000|NOT COMPLETED|Overall Study||1||
48278820|NCT02285153|101007138|FG001|NOT COMPLETED|Overall Study||0||
48278821|NCT01283516|101007139|FG000|STARTED|Overall Study||2||
48278822|NCT01283516|101007140|FG001|STARTED|Overall Study||2||
48564609|NCT01662635|101713983|FG000|COMPLETED|Overall Study||200||
48278823|NCT01283516|101007141|FG002|STARTED|Overall Study||3||
48278824|NCT01283516|101007142|FG003|STARTED|Overall Study||3||
48278825|NCT01283516|101007143|FG004|STARTED|Overall Study||14||
48278826|NCT01283516|101007144|FG005|STARTED|Overall Study||10||
48278827|NCT01283516|101007145|FG006|STARTED|Overall Study||10||
48278828|NCT01283516|101007146|FG007|STARTED|Overall Study||5||
48278829|NCT01283516|101007147|FG008|STARTED|Overall Study||255||
48278830|NCT01283516|101007139|FG000|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2||
48278831|NCT01283516|101007140|FG001|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||1||
48278832|NCT01283516|101007141|FG002|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2||
48278833|NCT01283516|101007142|FG003|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||3||
48278834|NCT01283516|101007143|FG004|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||12||
48278835|NCT01283516|101007144|FG005|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||10||
48278836|NCT01283516|101007145|FG006|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||9||
48278837|NCT01283516|101007146|FG007|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||5||
48278838|NCT01283516|101007147|FG008|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||246||
48278839|NCT01283516|101007139|FG000|Dose-Determining Set (DDS)|Overall Study||2||
48278840|NCT01283516|101007140|FG001|Dose-Determining Set (DDS)|Overall Study||1||
48278841|NCT01283516|101007141|FG002|Dose-Determining Set (DDS)|Overall Study||3||
48278842|NCT01283516|101007142|FG003|Dose-Determining Set (DDS)|Overall Study||3||
48278843|NCT01283516|101007143|FG004|Dose-Determining Set (DDS)|Overall Study||14||
48278844|NCT01283516|101007144|FG005|Dose-Determining Set (DDS)|Overall Study||8||
48278845|NCT01283516|101007145|FG006|Dose-Determining Set (DDS)|Overall Study||10||
48278846|NCT01283516|101007146|FG007|Dose-Determining Set (DDS)|Overall Study||5||
48278847|NCT01283516|101007147|FG008|Dose-Determining Set (DDS)|Overall Study||8||
48278848|NCT01283516|101007139|FG000|Non-NSCLC|Overall Study||0||
48278849|NCT01283516|101007140|FG001|Non-NSCLC|Overall Study||1||
48278850|NCT01283516|101007141|FG002|Non-NSCLC|Overall Study||1||
48278851|NCT01283516|101007142|FG003|Non-NSCLC|Overall Study||0||
48278852|NCT01283516|101007143|FG004|Non-NSCLC|Overall Study||2||
48278853|NCT01283516|101007144|FG005|Non-NSCLC|Overall Study||0||
48278854|NCT01283516|101007145|FG006|Non-NSCLC|Overall Study||1||
48278855|NCT01283516|101007146|FG007|Non-NSCLC|Overall Study||0||
48278856|NCT01283516|101007147|FG008|Non-NSCLC|Overall Study||9||
48394475|NCT00728936|101295946|FG001|NOT COMPLETED|Overall Study||0||
48394476|NCT00728936|101295947|FG002|NOT COMPLETED|Overall Study||0||
48394477|NCT00728936|101295948|FG003|NOT COMPLETED|Overall Study||0||
48394478|NCT00728936|101295949|FG004|NOT COMPLETED|Overall Study||0||
48394479|NCT00728936|101295950|FG005|NOT COMPLETED|Overall Study||1||
48394480|NCT00728936|101295951|FG006|NOT COMPLETED|Overall Study||0||
48394481|NCT02267226|101295952|FG000|STARTED|Overall Study||25||
48394482|NCT02267226|101295952|FG000|SAFETY Population|Overall Study||25|25 patients received at least one administration of Octafibrin.|
48394483|NCT02267226|101295952|FG000|FAS-Bleeding Population|Overall Study||24|Patients received Octafibrin for treatment of bleeding.|
48394484|NCT02267226|101295952|FG000|Surgical Prophylaxis Population|Overall Study||9|Patients received Octafibrin for surgical procedures.|
48394485|NCT02267226|101295952|FG000|COMPLETED|Overall Study||18||
48394486|NCT02267226|101295952|FG000|NOT COMPLETED|Overall Study||7||
48394487|NCT03024255|101295953|FG000|STARTED|Overall Study||57||
48394488|NCT03024255|101295954|FG001|STARTED|Overall Study||57||
48394489|NCT03024255|101295955|FG002|STARTED|Overall Study||56||
48564610|NCT01662635|101713983|FG000|NOT COMPLETED|Overall Study||30||
48564611|NCT01801865|101713984|FG000|STARTED|Overall Study||657||
48564612|NCT01801865|101713984|FG000|COMPLETED|Overall Study||615||
48564613|NCT01801865|101713984|FG000|NOT COMPLETED|Overall Study||42||
48278857|NCT01283516|101007139|FG000|COMPLETED|Overall Study||0||
48278858|NCT01283516|101007140|FG001|COMPLETED|Overall Study||0||
48278859|NCT01283516|101007141|FG002|COMPLETED|Overall Study||0||
48278860|NCT01283516|101007142|FG003|COMPLETED|Overall Study||0||
48278861|NCT01283516|101007143|FG004|COMPLETED|Overall Study||0||
48278862|NCT01283516|101007144|FG005|COMPLETED|Overall Study||0||
48278863|NCT01283516|101007145|FG006|COMPLETED|Overall Study||0||
48278864|NCT01283516|101007146|FG007|COMPLETED|Overall Study||0||
48278865|NCT01283516|101007147|FG008|COMPLETED|Overall Study||0||
48278866|NCT01283516|101007139|FG000|NOT COMPLETED|Overall Study||2||
48278867|NCT01283516|101007140|FG001|NOT COMPLETED|Overall Study||2||
48278868|NCT01283516|101007141|FG002|NOT COMPLETED|Overall Study||3||
48278869|NCT01283516|101007142|FG003|NOT COMPLETED|Overall Study||3||
48278870|NCT01283516|101007143|FG004|NOT COMPLETED|Overall Study||14||
48278871|NCT01283516|101007144|FG005|NOT COMPLETED|Overall Study||10||
48278872|NCT01283516|101007145|FG006|NOT COMPLETED|Overall Study||10||
48278873|NCT01283516|101007146|FG007|NOT COMPLETED|Overall Study||5||
48278874|NCT01283516|101007147|FG008|NOT COMPLETED|Overall Study||255||
48278875|NCT01901419|101007148|FG000|STARTED|Overall Study||40||
48278876|NCT01901419|101007149|FG001|STARTED|Overall Study||40||
48278877|NCT01901419|101007148|FG000|COMPLETED|Overall Study||32||
48394490|NCT03024255|101295956|FG003|STARTED|Overall Study||57||
48394491|NCT03024255|101295953|FG000|COMPLETED|Overall Study||50||
48394492|NCT03024255|101295954|FG001|COMPLETED|Overall Study||49||
48394493|NCT03024255|101295955|FG002|COMPLETED|Overall Study||45||
48564614|NCT00460811|101713985|FG000|STARTED|Overall Study||79||
48278878|NCT01901419|101007149|FG001|COMPLETED|Overall Study||31||
48394494|NCT03024255|101295956|FG003|COMPLETED|Overall Study||52||
48394495|NCT03024255|101295953|FG000|NOT COMPLETED|Overall Study||7||
48394496|NCT03024255|101295954|FG001|NOT COMPLETED|Overall Study||8||
48394497|NCT03024255|101295955|FG002|NOT COMPLETED|Overall Study||11||
48394498|NCT03024255|101295956|FG003|NOT COMPLETED|Overall Study||5||
48394499|NCT03814005|101295957|FG000|STARTED|Part A: Day 1 to Day 4||10||
48564615|NCT00460811|101713986|FG001|STARTED|Overall Study||82||
48564616|NCT00460811|101713987|FG002|STARTED|Overall Study||85||
48564617|NCT00460811|101713988|FG003|STARTED|Overall Study||89||
48564618|NCT00460811|101713989|FG004|STARTED|Overall Study||85||
48564619|NCT00460811|101713985|FG000|COMPLETED|Overall Study||63||
48564620|NCT00460811|101713986|FG001|COMPLETED|Overall Study||67||
48117382|NCT02460224|100612718|FG000|COMPLETED|Overall Study||0||
48117383|NCT02460224|100612719|FG001|COMPLETED|Overall Study||0||
48117384|NCT02460224|100612720|FG002|COMPLETED|Overall Study||0||
48117385|NCT02460224|100612721|FG003|COMPLETED|Overall Study||0||
48117386|NCT02460224|100612722|FG004|COMPLETED|Overall Study||0||
48117387|NCT02460224|100612723|FG005|COMPLETED|Overall Study||0||
48117388|NCT02460224|100612724|FG006|COMPLETED|Overall Study||0||
48117389|NCT02460224|100612725|FG007|COMPLETED|Overall Study||0||
48117390|NCT02460224|100612726|FG008|COMPLETED|Overall Study||0||
48117391|NCT02460224|100612727|FG009|COMPLETED|Overall Study||0||
48117392|NCT02460224|100612728|FG010|COMPLETED|Overall Study||0||
48117393|NCT02460224|100612729|FG011|COMPLETED|Overall Study||0||
48117394|NCT02460224|100612730|FG012|COMPLETED|Overall Study||0||
48117395|NCT02460224|100612731|FG013|COMPLETED|Overall Study||0||
48117396|NCT02460224|100612732|FG014|COMPLETED|Overall Study||0||
48117397|NCT02460224|100612733|FG015|COMPLETED|Overall Study||0||
48117398|NCT02460224|100612734|FG016|COMPLETED|Overall Study||0||
48117399|NCT02460224|100612735|FG017|COMPLETED|Overall Study||0||
48117400|NCT02460224|100612736|FG018|COMPLETED|Overall Study||0||
48117401|NCT02460224|100612737|FG019|COMPLETED|Overall Study||0||
48117402|NCT02460224|100612738|FG020|COMPLETED|Overall Study||0||
48117403|NCT02460224|100612739|FG021|COMPLETED|Overall Study||0||
48117404|NCT02460224|100612740|FG022|COMPLETED|Overall Study||0||
48117405|NCT02460224|100612741|FG023|COMPLETED|Overall Study||0||
48117406|NCT02460224|100612742|FG024|COMPLETED|Overall Study||0||
48117407|NCT02460224|100612743|FG025|COMPLETED|Overall Study||0||
48117408|NCT02460224|100612744|FG026|COMPLETED|Overall Study||0||
48117409|NCT02460224|100612745|FG027|COMPLETED|Overall Study||0||
48117410|NCT02460224|100612746|FG028|COMPLETED|Overall Study||0||
48117411|NCT02460224|100612718|FG000|NOT COMPLETED|Overall Study||17||
48117412|NCT02460224|100612719|FG001|NOT COMPLETED|Overall Study||12||
48117413|NCT02460224|100612720|FG002|NOT COMPLETED|Overall Study||6||
48117414|NCT02460224|100612721|FG003|NOT COMPLETED|Overall Study||6||
48117415|NCT02460224|100612722|FG004|NOT COMPLETED|Overall Study||6||
48117416|NCT02460224|100612723|FG005|NOT COMPLETED|Overall Study||30||
48117417|NCT02460224|100612724|FG006|NOT COMPLETED|Overall Study||30||
48117418|NCT02460224|100612725|FG007|NOT COMPLETED|Overall Study||5||
48117419|NCT02460224|100612726|FG008|NOT COMPLETED|Overall Study||6||
48117420|NCT02460224|100612727|FG009|NOT COMPLETED|Overall Study||11||
48117421|NCT02460224|100612728|FG010|NOT COMPLETED|Overall Study||5||
48117422|NCT02460224|100612729|FG011|NOT COMPLETED|Overall Study||6||
48117423|NCT02460224|100612730|FG012|NOT COMPLETED|Overall Study||6||
48117424|NCT02460224|100612731|FG013|NOT COMPLETED|Overall Study||6||
48117425|NCT02460224|100612732|FG014|NOT COMPLETED|Overall Study||5||
48117426|NCT02460224|100612733|FG015|NOT COMPLETED|Overall Study||6||
48117427|NCT02460224|100612734|FG016|NOT COMPLETED|Overall Study||20||
48117428|NCT02460224|100612735|FG017|NOT COMPLETED|Overall Study||6||
48117429|NCT02460224|100612736|FG018|NOT COMPLETED|Overall Study||12||
48117430|NCT02460224|100612737|FG019|NOT COMPLETED|Overall Study||7||
48117431|NCT02460224|100612738|FG020|NOT COMPLETED|Overall Study||6||
48117432|NCT02460224|100612739|FG021|NOT COMPLETED|Overall Study||12||
48117433|NCT02460224|100612740|FG022|NOT COMPLETED|Overall Study||6||
48117434|NCT02460224|100612741|FG023|NOT COMPLETED|Overall Study||11||
48117435|NCT02460224|100612742|FG024|NOT COMPLETED|Overall Study||6||
48117436|NCT02460224|100612743|FG025|NOT COMPLETED|Overall Study||6||
48117437|NCT02460224|100612744|FG026|NOT COMPLETED|Overall Study||121||
48117438|NCT02460224|100612745|FG027|NOT COMPLETED|Overall Study||21||
48117439|NCT02460224|100612746|FG028|NOT COMPLETED|Overall Study||93||
48117440|NCT02439775|100612747|FG000|STARTED|Overall Study||206||
48117441|NCT02439775|100612748|FG001|STARTED|Overall Study||131||
48564621|NCT00460811|101713987|FG002|COMPLETED|Overall Study||71||
48117442|NCT02439775|100612747|FG000|COMPLETED|Overall Study||115||
48117443|NCT02439775|100612748|FG001|COMPLETED|Overall Study||73||
48117444|NCT02439775|100612747|FG000|NOT COMPLETED|Overall Study||91||
48117445|NCT02439775|100612748|FG001|NOT COMPLETED|Overall Study||58||
48117446|NCT02942979|100612749|FG000|STARTED|Step 0||108||
48117447|NCT02942979|100612750|FG001|STARTED|Step 0||0||
48117448|NCT02942979|100612749|FG000|COMPLETED|Step 0||108||
48117449|NCT02942979|100612750|FG001|COMPLETED|Step 0||0||
48117450|NCT02942979|100612749|FG000|NOT COMPLETED|Step 0||0||
48117451|NCT02942979|100612750|FG001|NOT COMPLETED|Step 0||0||
48117452|NCT02942979|100612749|FG000|STARTED|Step 1||15||
48117453|NCT02942979|100612750|FG001|STARTED|Step 1||93||
48564622|NCT00460811|101713988|FG003|COMPLETED|Overall Study||71||
48697763|NCT02713386|102045455|FG001|NOT COMPLETED|Phase 2||0||
48278879|NCT01901419|101007148|FG000|NOT COMPLETED|Overall Study||8||
48278880|NCT01901419|101007149|FG001|NOT COMPLETED|Overall Study||9||
48278881|NCT01663922|101007150|FG000|STARTED|First Intervention (14 Days or 5 Days)||8||
48278882|NCT01663922|101007151|FG001|STARTED|First Intervention (14 Days or 5 Days)||9||
48278883|NCT01663922|101007150|FG000|COMPLETED|First Intervention (14 Days or 5 Days)||8||
48278884|NCT01663922|101007151|FG001|COMPLETED|First Intervention (14 Days or 5 Days)||9||
48278885|NCT01663922|101007150|FG000|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0||
48278886|NCT01663922|101007151|FG001|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0||
48278887|NCT01663922|101007150|FG000|STARTED|Washout (7 Days)||8||
48278888|NCT01663922|101007151|FG001|STARTED|Washout (7 Days)||9||
48278889|NCT01663922|101007150|FG000|COMPLETED|Washout (7 Days)||8||
48278890|NCT01663922|101007151|FG001|COMPLETED|Washout (7 Days)||9||
48278891|NCT01663922|101007150|FG000|NOT COMPLETED|Washout (7 Days)||0||
48394500|NCT03814005|101295958|FG001|STARTED|Part A: Day 1 to Day 4||4||
48394501|NCT03814005|101295959|FG002|STARTED|Part A: Day 1 to Day 4||3||
48564623|NCT00460811|101713989|FG004|COMPLETED|Overall Study||65||
48117454|NCT02942979|100612749|FG000|COMPLETED|Step 1||15||
48117455|NCT02942979|100612750|FG001|COMPLETED|Step 1||93||
48117456|NCT02942979|100612749|FG000|NOT COMPLETED|Step 1||0||
48117457|NCT02942979|100612750|FG001|NOT COMPLETED|Step 1||0||
48117458|NCT02942979|100612749|FG000|STARTED|Step 2||0||
48117459|NCT02942979|100612750|FG001|STARTED|Step 2||108||
48117460|NCT02942979|100612749|FG000|COMPLETED|Step 2||0||
48117461|NCT02942979|100612750|FG001|COMPLETED|Step 2||108||
48117462|NCT02942979|100612749|FG000|NOT COMPLETED|Step 2||0||
48117463|NCT02942979|100612750|FG001|NOT COMPLETED|Step 2||0||
48117464|NCT02203591|100612751|FG000|STARTED|Overall Study||343||343
48117465|NCT02203591|100612752|FG001|STARTED|Overall Study||344||344
48117466|NCT02203591|100612753|FG002|STARTED|Overall Study||347||347
48117467|NCT02203591|100612754|FG003|STARTED|Overall Study||104||104
48117468|NCT02203591|100612755|FG004|STARTED|Overall Study||242||242
48117469|NCT02203591|100612756|FG005|STARTED|Overall Study||244||244
48117470|NCT02203591|100612757|FG006|STARTED|Overall Study||248||248
48117471|NCT02203591|100612758|FG007|STARTED|Overall Study||74||74
48117472|NCT02203591|100612751|FG000|COMPLETED|Overall Study||196||196
48117473|NCT02203591|100612752|FG001|COMPLETED|Overall Study||202||202
48117474|NCT02203591|100612753|FG002|COMPLETED|Overall Study||196||196
48117475|NCT02203591|100612754|FG003|COMPLETED|Overall Study||59||59
48117476|NCT02203591|100612755|FG004|COMPLETED|Overall Study||208||208
48117477|NCT02203591|100612756|FG005|COMPLETED|Overall Study||209||209
48117478|NCT02203591|100612757|FG006|COMPLETED|Overall Study||219||219
48117479|NCT02203591|100612758|FG007|COMPLETED|Overall Study||61||61
48117480|NCT02203591|100612751|FG000|NOT COMPLETED|Overall Study||147||147
48117481|NCT02203591|100612752|FG001|NOT COMPLETED|Overall Study||142||142
48117482|NCT02203591|100612753|FG002|NOT COMPLETED|Overall Study||151||151
48117483|NCT02203591|100612754|FG003|NOT COMPLETED|Overall Study||45||45
48117484|NCT02203591|100612755|FG004|NOT COMPLETED|Overall Study||34||34
48117485|NCT02203591|100612756|FG005|NOT COMPLETED|Overall Study||35||35
48117486|NCT02203591|100612757|FG006|NOT COMPLETED|Overall Study||29||29
48117487|NCT02203591|100612758|FG007|NOT COMPLETED|Overall Study||13||13
48117488|NCT04160260|100612759|FG000|STARTED|Overall Study||18||
48117489|NCT04160260|100612759|FG000|COMPLETED|Overall Study||18||
48117490|NCT04160260|100612759|FG000|NOT COMPLETED|Overall Study||0||
48117491|NCT00574405|100612760|FG000|STARTED|Overall Study||12||
48117492|NCT00574405|100612761|FG001|STARTED|Overall Study||12||
48117493|NCT00574405|100612760|FG000|COMPLETED|Overall Study||9||
48117494|NCT00574405|100612761|FG001|COMPLETED|Overall Study||10||
48117495|NCT00574405|100612760|FG000|NOT COMPLETED|Overall Study||3||
48117496|NCT00574405|100612761|FG001|NOT COMPLETED|Overall Study||2||
48117497|NCT00937547|100612762|FG000|STARTED|Overall Study||96||
48117498|NCT00937547|100612763|FG001|STARTED|Overall Study||84||
48117499|NCT00937547|100612764|FG002|STARTED|Overall Study||149||
48117500|NCT00937547|100612762|FG000|Histological Samples|Overall Study||95||
48117501|NCT00937547|100612763|FG001|Histological Samples|Overall Study||78||
48117502|NCT00937547|100612764|FG002|Histological Samples|Overall Study||142||
48117503|NCT00937547|100612762|FG000|COMPLETED|Overall Study||95||
48117504|NCT00937547|100612763|FG001|COMPLETED|Overall Study||78||
48117505|NCT00937547|100612764|FG002|COMPLETED|Overall Study||142||
48564624|NCT00460811|101713985|FG000|NOT COMPLETED|Overall Study||16||
48564625|NCT00460811|101713986|FG001|NOT COMPLETED|Overall Study||15||
48564626|NCT00460811|101713987|FG002|NOT COMPLETED|Overall Study||14||
48564627|NCT00460811|101713988|FG003|NOT COMPLETED|Overall Study||18||
48564628|NCT00460811|101713989|FG004|NOT COMPLETED|Overall Study||20||
48564629|NCT02630251|101713990|FG000|STARTED|Overall Study||2||
48564630|NCT02630251|101713991|FG001|STARTED|Overall Study||1||
48697764|NCT02713386|102045456|FG002|NOT COMPLETED|Phase 2||0||
48697765|NCT02713386|102045457|FG003|NOT COMPLETED|Phase 2||0||
48697766|NCT02719691|102045458|FG000|STARTED|Overall Study||3||
48117506|NCT00937547|100612762|FG000|NOT COMPLETED|Overall Study||1||
48278892|NCT01663922|101007151|FG001|NOT COMPLETED|Washout (7 Days)||0||
48117507|NCT00937547|100612763|FG001|NOT COMPLETED|Overall Study||6||
48117508|NCT00937547|100612764|FG002|NOT COMPLETED|Overall Study||7||
48278893|NCT01663922|101007150|FG000|STARTED|Second Intervention (14 Days)||8||
48278894|NCT01663922|101007151|FG001|STARTED|Second Intervention (14 Days)||9||
48564631|NCT02630251|101713992|FG002|STARTED|Overall Study||1||
48564632|NCT02630251|101713993|FG003|STARTED|Overall Study||1||
48564633|NCT02630251|101713990|FG000|COMPLETED|Overall Study||2||
48564634|NCT02630251|101713991|FG001|COMPLETED|Overall Study||1||
48564635|NCT02630251|101713992|FG002|COMPLETED|Overall Study||0||
48564636|NCT02630251|101713993|FG003|COMPLETED|Overall Study||1||
48564637|NCT02630251|101713990|FG000|NOT COMPLETED|Overall Study||0||
48564638|NCT02630251|101713991|FG001|NOT COMPLETED|Overall Study||0||
48564639|NCT02630251|101713992|FG002|NOT COMPLETED|Overall Study||1||
48564640|NCT02630251|101713993|FG003|NOT COMPLETED|Overall Study||0||
48564641|NCT00489918|101713994|FG000|STARTED|Overall Study||33||
48564642|NCT00489918|101713995|FG001|STARTED|Overall Study||34||
48564643|NCT00489918|101713996|FG002|STARTED|Overall Study||32||
48564644|NCT00489918|101713997|FG003|STARTED|Overall Study||33||
48278895|NCT01663922|101007150|FG000|COMPLETED|Second Intervention (14 Days)||8||
48278896|NCT01663922|101007151|FG001|COMPLETED|Second Intervention (14 Days)||9||
48278897|NCT01663922|101007150|FG000|NOT COMPLETED|Second Intervention (14 Days)||0||
48278898|NCT01663922|101007151|FG001|NOT COMPLETED|Second Intervention (14 Days)||0||
48278899|NCT01663922|101007150|FG000|STARTED|Washout (7 Days)||8||
48278900|NCT01663922|101007151|FG001|STARTED|Washout (7 Days)||9||
48278901|NCT01663922|101007150|FG000|COMPLETED|Washout (7 Days)||8||
48278902|NCT01663922|101007151|FG001|COMPLETED|Washout (7 Days)||9||
48278903|NCT01663922|101007150|FG000|NOT COMPLETED|Washout (7 Days)||0||
48278904|NCT01663922|101007151|FG001|NOT COMPLETED|Washout (7 Days)||0||
48278905|NCT01663922|101007150|FG000|STARTED|Third Intervention (14 Days or 5 Days)||8||
48278906|NCT01663922|101007151|FG001|STARTED|Third Intervention (14 Days or 5 Days)||9||
48278907|NCT01663922|101007150|FG000|COMPLETED|Third Intervention (14 Days or 5 Days)||8||
48278908|NCT01663922|101007151|FG001|COMPLETED|Third Intervention (14 Days or 5 Days)||9||
48278909|NCT01663922|101007150|FG000|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0||
48278910|NCT01663922|101007151|FG001|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0||
48278911|NCT00626626|101007152|FG000|STARTED|Overall Study||5||
48278912|NCT00626626|101007153|FG001|STARTED|Overall Study||3||
48278913|NCT00626626|101007152|FG000|COMPLETED|Overall Study||5||
48278914|NCT00626626|101007153|FG001|COMPLETED|Overall Study||3||
48278915|NCT00626626|101007152|FG000|NOT COMPLETED|Overall Study||0||
48278916|NCT00626626|101007153|FG001|NOT COMPLETED|Overall Study||0||
48278917|NCT03900416|101007154|FG000|STARTED|Baseline||72||
48278918|NCT03900416|101007155|FG001|STARTED|Baseline||80||
48278919|NCT03900416|101007154|FG000|COMPLETED|Baseline||72||
48278920|NCT03900416|101007155|FG001|COMPLETED|Baseline||80||
48117509|NCT04646616|100612765|FG000|STARTED|Overall Study||178||
48117510|NCT04646616|100612765|FG000|COMPLETED|Overall Study||139||
48117511|NCT04646616|100612765|FG000|NOT COMPLETED|Overall Study||39||
48117512|NCT03100825|100612766|FG000|STARTED|Overall Study||94||
48117513|NCT03100825|100612766|FG000|COMPLETED|Overall Study||86||
48117514|NCT03100825|100612766|FG000|NOT COMPLETED|Overall Study||8||
48117515|NCT02059928|100612767|FG000|STARTED|Overall Study||20||
48117516|NCT02059928|100612767|FG000|COMPLETED|Overall Study||20||
48117517|NCT02059928|100612767|FG000|NOT COMPLETED|Overall Study||0||
48278921|NCT03900416|101007154|FG000|NOT COMPLETED|Baseline||0||
48278922|NCT03900416|101007155|FG001|NOT COMPLETED|Baseline||0||
48278923|NCT03900416|101007154|FG000|STARTED|Post||72||
48278924|NCT03900416|101007155|FG001|STARTED|Post||80||
48404091|NCT03689972|101321768|FG002|NOT COMPLETED|Part 2:Run-in Period (Week73uptoWeek107)||5||
48564645|NCT00489918|101713998|FG004|STARTED|Overall Study||33||
48564646|NCT00489918|101713994|FG000|COMPLETED|Overall Study||31||
48564647|NCT00489918|101713995|FG001|COMPLETED|Overall Study||32||
48564648|NCT00489918|101713996|FG002|COMPLETED|Overall Study||28||
48564649|NCT00489918|101713997|FG003|COMPLETED|Overall Study||32||
48564650|NCT00489918|101713998|FG004|COMPLETED|Overall Study||32||
48117518|NCT01930058|100612768|FG000|STARTED|Overall Study||3||
48117519|NCT01930058|100612769|FG001|STARTED|Overall Study||3||
48278925|NCT03900416|101007154|FG000|COMPLETED|Post||72||
48278926|NCT03900416|101007155|FG001|COMPLETED|Post||80||
48278927|NCT03900416|101007154|FG000|NOT COMPLETED|Post||0||
48278928|NCT03900416|101007155|FG001|NOT COMPLETED|Post||0||
48278929|NCT03900416|101007154|FG000|STARTED|Six Week Follow-up||72||
48278930|NCT03900416|101007155|FG001|STARTED|Six Week Follow-up||80||
48564651|NCT00489918|101713994|FG000|NOT COMPLETED|Overall Study||2||
48564652|NCT00489918|101713995|FG001|NOT COMPLETED|Overall Study||2||
48564653|NCT00489918|101713996|FG002|NOT COMPLETED|Overall Study||4||
48564654|NCT00489918|101713997|FG003|NOT COMPLETED|Overall Study||1||
48564655|NCT00489918|101713998|FG004|NOT COMPLETED|Overall Study||1||
48278931|NCT03900416|101007154|FG000|COMPLETED|Six Week Follow-up||70||
48278932|NCT03900416|101007155|FG001|COMPLETED|Six Week Follow-up||80||
48278933|NCT03900416|101007154|FG000|NOT COMPLETED|Six Week Follow-up||2||
48278934|NCT03900416|101007155|FG001|NOT COMPLETED|Six Week Follow-up||0||
48278935|NCT03900416|101007154|FG000|STARTED|Twelve Week Follow-up||70||
48278936|NCT03900416|101007155|FG001|STARTED|Twelve Week Follow-up||80||
48278937|NCT03900416|101007154|FG000|COMPLETED|Twelve Week Follow-up||69||
48278938|NCT03900416|101007155|FG001|COMPLETED|Twelve Week Follow-up||76||
48278939|NCT03900416|101007154|FG000|NOT COMPLETED|Twelve Week Follow-up||1||
48278940|NCT03900416|101007155|FG001|NOT COMPLETED|Twelve Week Follow-up||4||
48278941|NCT03900416|101007154|FG000|STARTED|Six Month Follow-up||69||
48278942|NCT03900416|101007155|FG001|STARTED|Six Month Follow-up||76||
48278943|NCT03900416|101007154|FG000|COMPLETED|Six Month Follow-up||64||
48278944|NCT03900416|101007155|FG001|COMPLETED|Six Month Follow-up||72||
48278945|NCT03900416|101007154|FG000|NOT COMPLETED|Six Month Follow-up||5||
48278946|NCT03900416|101007155|FG001|NOT COMPLETED|Six Month Follow-up||4||
48278947|NCT01143181|101007156|FG000|STARTED|Overall Study||30||
48278948|NCT01143181|101007157|FG001|STARTED|Overall Study||38||
48278949|NCT01143181|101007158|FG002|STARTED|Overall Study||102||
48278950|NCT01143181|101007159|FG003|STARTED|Overall Study||40||
48278951|NCT01143181|101007156|FG000|COMPLETED|Overall Study||14||
48278952|NCT01143181|101007157|FG001|COMPLETED|Overall Study||22||
48278953|NCT01143181|101007158|FG002|COMPLETED|Overall Study||58||
48278954|NCT01143181|101007159|FG003|COMPLETED|Overall Study||17||
48278955|NCT01143181|101007156|FG000|NOT COMPLETED|Overall Study||16||
48278956|NCT01143181|101007157|FG001|NOT COMPLETED|Overall Study||16||
48278957|NCT01143181|101007158|FG002|NOT COMPLETED|Overall Study||44||
48278958|NCT01143181|101007159|FG003|NOT COMPLETED|Overall Study||23||
48278959|NCT01205152|101007160|FG000|STARTED|Overall Study||10||
48278960|NCT01205152|101007160|FG000|COMPLETED|Overall Study||9||
48278961|NCT01205152|101007160|FG000|NOT COMPLETED|Overall Study||1||
48278962|NCT01493427|101007161|FG000|STARTED|Overall Study||199||
48278963|NCT01493427|101007161|FG000|COMPLETED|Overall Study||179||
48278964|NCT01493427|101007161|FG000|NOT COMPLETED|Overall Study||20||
48278965|NCT04343287|101007162|FG000|STARTED|Overall Study||108||
48278966|NCT04343287|101007163|FG001|STARTED|Overall Study||112||
48278967|NCT04343287|101007162|FG000|COMPLETED|Overall Study||108||
48278968|NCT04343287|101007163|FG001|COMPLETED|Overall Study||111||
48278969|NCT04343287|101007162|FG000|NOT COMPLETED|Overall Study||0||
48278970|NCT04343287|101007163|FG001|NOT COMPLETED|Overall Study||1||
48278971|NCT03538301|101007164|FG000|STARTED|Overall Study||42||
48278972|NCT03538301|101007165|FG001|STARTED|Overall Study||41||
48278973|NCT03538301|101007166|FG002|STARTED|Overall Study||40||
48278974|NCT03538301|101007164|FG000|COMPLETED|Overall Study||31||
48278975|NCT03538301|101007165|FG001|COMPLETED|Overall Study||29||
48278976|NCT03538301|101007166|FG002|COMPLETED|Overall Study||28||
48278977|NCT03538301|101007164|FG000|NOT COMPLETED|Overall Study||11||
48278978|NCT03538301|101007165|FG001|NOT COMPLETED|Overall Study||12||
48278979|NCT03538301|101007166|FG002|NOT COMPLETED|Overall Study||12||
48278980|NCT01732822|101007167|FG000|STARTED|Overall Study||6930||
48278981|NCT01732822|101007168|FG001|STARTED|Overall Study||6955||
48278982|NCT01732822|101007167|FG000|COMPLETED|Overall Study||6807||
48278983|NCT01732822|101007168|FG001|COMPLETED|Overall Study||6842||
48278984|NCT01732822|101007167|FG000|NOT COMPLETED|Overall Study||123||
48278985|NCT01732822|101007168|FG001|NOT COMPLETED|Overall Study||113||
48278986|NCT01302080|101007169|FG000|STARTED|Overall Study||696||
48278987|NCT01302080|101007170|FG001|STARTED|Overall Study||245||
48278988|NCT01302080|101007169|FG000|COMPLETED|Overall Study||330||
48394502|NCT03814005|101295957|FG000|Response-evaluable Population|Part A: Day 1 to Day 4||8|Response-evaluable population included participants who received at least 1 dose of study drug, had a baseline disease assessment, and had at least 1 postbaseline disease assessment to analyze response.|
48394503|NCT03814005|101295958|FG001|Response-evaluable Population|Part A: Day 1 to Day 4||1|Response-evaluable population included participants who received at least 1 dose of study drug, had a baseline disease assessment, and had at least 1 postbaseline disease assessment to analyze response.|
48394504|NCT03814005|101295959|FG002|Response-evaluable Population|Part A: Day 1 to Day 4||2|Response-evaluable population included participants who received at least 1 dose of study drug, had a baseline disease assessment, and had at least 1 postbaseline disease assessment to analyze response.|
48394505|NCT03814005|101295957|FG000|COMPLETED|Part A: Day 1 to Day 4||10||
48394506|NCT03814005|101295958|FG001|COMPLETED|Part A: Day 1 to Day 4||4||
48394507|NCT03814005|101295959|FG002|COMPLETED|Part A: Day 1 to Day 4||3||
48394508|NCT03814005|101295957|FG000|NOT COMPLETED|Part A: Day 1 to Day 4||0||
48394509|NCT03814005|101295958|FG001|NOT COMPLETED|Part A: Day 1 to Day 4||0||
48394510|NCT03814005|101295959|FG002|NOT COMPLETED|Part A: Day 1 to Day 4||0||
48394511|NCT03814005|101295957|FG000|STARTED|Washout Period : Day 4 to Day 7||10||
48278989|NCT01302080|101007170|FG001|COMPLETED|Overall Study||102||
48278990|NCT01302080|101007169|FG000|NOT COMPLETED|Overall Study||366||
48278991|NCT01302080|101007170|FG001|NOT COMPLETED|Overall Study||143||
48278992|NCT01012817|101007171|FG000|STARTED|Overall Study||3||
48278993|NCT01012817|101007172|FG001|STARTED|Overall Study||3||
48278994|NCT01012817|101007173|FG002|STARTED|Overall Study||3||
48278995|NCT01012817|101007174|FG003|STARTED|Overall Study||4||
48278996|NCT01012817|101007175|FG004|STARTED|Overall Study||6||
48278997|NCT01012817|101007176|FG005|STARTED|Overall Study||7||
48278998|NCT01012817|101007177|FG006|STARTED|Overall Study||3||
48278999|NCT01012817|101007178|FG007|STARTED|Overall Study||4||
48279000|NCT01012817|101007179|FG008|STARTED|Overall Study||3||
48279001|NCT01012817|101007180|FG009|STARTED|Overall Study||6||
48279002|NCT01012817|101007181|FG010|STARTED|Overall Study||5||
48279003|NCT01012817|101007182|FG011|STARTED|Overall Study||7||
48279004|NCT01012817|101007183|FG012|STARTED|Overall Study||3||
48279005|NCT01012817|101007184|FG013|STARTED|Overall Study||31||
48279006|NCT01012817|101007171|FG000|COMPLETED|Overall Study||3||
48279007|NCT01012817|101007172|FG001|COMPLETED|Overall Study||3||
48279008|NCT01012817|101007173|FG002|COMPLETED|Overall Study||3||
48279009|NCT01012817|101007174|FG003|COMPLETED|Overall Study||3||
48279010|NCT01012817|101007175|FG004|COMPLETED|Overall Study||6||
48279011|NCT01012817|101007176|FG005|COMPLETED|Overall Study||6||
48279012|NCT01012817|101007177|FG006|COMPLETED|Overall Study||3||
48564656|NCT01210560|101713999|FG000|STARTED|Intervention 1 (7 Days)||2||
48564657|NCT01210560|101714000|FG001|STARTED|Intervention 1 (7 Days)||2||
48564658|NCT01210560|101714001|FG002|STARTED|Intervention 1 (7 Days)||2||
48564659|NCT01210560|101714002|FG003|STARTED|Intervention 1 (7 Days)||2||
48564660|NCT01210560|101714003|FG004|STARTED|Intervention 1 (7 Days)||2||
48564661|NCT01210560|101714004|FG005|STARTED|Intervention 1 (7 Days)||2||
48564662|NCT01210560|101714005|FG006|STARTED|Intervention 1 (7 Days)||4||
48564663|NCT01210560|101714006|FG007|STARTED|Intervention 1 (7 Days)||4||
48564664|NCT01210560|101714007|FG008|STARTED|Intervention 1 (7 Days)||5||
48564665|NCT01210560|101713999|FG000|COMPLETED|Intervention 1 (7 Days)||2||
48394512|NCT03814005|101295958|FG001|STARTED|Washout Period : Day 4 to Day 7||4||
48394513|NCT03814005|101295959|FG002|STARTED|Washout Period : Day 4 to Day 7||3||
48394514|NCT03814005|101295957|FG000|COMPLETED|Washout Period : Day 4 to Day 7||10||
48394515|NCT03814005|101295958|FG001|COMPLETED|Washout Period : Day 4 to Day 7||4||
48394516|NCT03814005|101295959|FG002|COMPLETED|Washout Period : Day 4 to Day 7||3||
48564666|NCT01210560|101714000|FG001|COMPLETED|Intervention 1 (7 Days)||2||
48564667|NCT01210560|101714001|FG002|COMPLETED|Intervention 1 (7 Days)||2||
48564668|NCT01210560|101714002|FG003|COMPLETED|Intervention 1 (7 Days)||2||
48564669|NCT01210560|101714003|FG004|COMPLETED|Intervention 1 (7 Days)||2||
48564670|NCT01210560|101714004|FG005|COMPLETED|Intervention 1 (7 Days)||2||
48564671|NCT01210560|101714005|FG006|COMPLETED|Intervention 1 (7 Days)||4||
48564672|NCT01210560|101714006|FG007|COMPLETED|Intervention 1 (7 Days)||4||
48564673|NCT01210560|101714007|FG008|COMPLETED|Intervention 1 (7 Days)||5||
48564674|NCT01210560|101713999|FG000|NOT COMPLETED|Intervention 1 (7 Days)||0||
48564675|NCT01210560|101714000|FG001|NOT COMPLETED|Intervention 1 (7 Days)||0||
48564676|NCT01210560|101714001|FG002|NOT COMPLETED|Intervention 1 (7 Days)||0||
48564677|NCT01210560|101714002|FG003|NOT COMPLETED|Intervention 1 (7 Days)||0||
48564678|NCT01210560|101714003|FG004|NOT COMPLETED|Intervention 1 (7 Days)||0||
48564679|NCT01210560|101714004|FG005|NOT COMPLETED|Intervention 1 (7 Days)||0||
48564680|NCT01210560|101714005|FG006|NOT COMPLETED|Intervention 1 (7 Days)||0||
48564681|NCT01210560|101714006|FG007|NOT COMPLETED|Intervention 1 (7 Days)||0||
48564682|NCT01210560|101714007|FG008|NOT COMPLETED|Intervention 1 (7 Days)||0||
48564683|NCT01210560|101713999|FG000|STARTED|Intervention 2 (7 Days)||2||
48564684|NCT01210560|101714000|FG001|STARTED|Intervention 2 (7 Days)||2||
48564685|NCT01210560|101714001|FG002|STARTED|Intervention 2 (7 Days)||2||
48564686|NCT01210560|101714002|FG003|STARTED|Intervention 2 (7 Days)||2||
48564687|NCT01210560|101714003|FG004|STARTED|Intervention 2 (7 Days)||2||
48564688|NCT01210560|101714004|FG005|STARTED|Intervention 2 (7 Days)||2||
48279013|NCT01012817|101007178|FG007|COMPLETED|Overall Study||3||
48279014|NCT01012817|101007179|FG008|COMPLETED|Overall Study||3||
48279015|NCT01012817|101007180|FG009|COMPLETED|Overall Study||6||
48279016|NCT01012817|101007181|FG010|COMPLETED|Overall Study||3||
48279017|NCT01012817|101007182|FG011|COMPLETED|Overall Study||6||
48279018|NCT01012817|101007183|FG012|COMPLETED|Overall Study||3||
48279019|NCT01012817|101007184|FG013|COMPLETED|Overall Study||29||
48279020|NCT01012817|101007171|FG000|NOT COMPLETED|Overall Study||0||
48279021|NCT01012817|101007172|FG001|NOT COMPLETED|Overall Study||0||
48279022|NCT01012817|101007173|FG002|NOT COMPLETED|Overall Study||0||
48279023|NCT01012817|101007174|FG003|NOT COMPLETED|Overall Study||1||
48279024|NCT01012817|101007175|FG004|NOT COMPLETED|Overall Study||0||
48279025|NCT01012817|101007176|FG005|NOT COMPLETED|Overall Study||1||
48279026|NCT01012817|101007177|FG006|NOT COMPLETED|Overall Study||0||
48279027|NCT01012817|101007178|FG007|NOT COMPLETED|Overall Study||1||
48394517|NCT03814005|101295957|FG000|NOT COMPLETED|Washout Period : Day 4 to Day 7||0||
48564689|NCT01210560|101714005|FG006|STARTED|Intervention 2 (7 Days)||4||
48564690|NCT01210560|101714006|FG007|STARTED|Intervention 2 (7 Days)||4||
48564691|NCT01210560|101714007|FG008|STARTED|Intervention 2 (7 Days)||5||
48697767|NCT02719691|102045459|FG001|STARTED|Overall Study||4||
48279028|NCT01012817|101007179|FG008|NOT COMPLETED|Overall Study||0||
48279029|NCT01012817|101007180|FG009|NOT COMPLETED|Overall Study||0||
48279030|NCT01012817|101007181|FG010|NOT COMPLETED|Overall Study||2||
48279031|NCT01012817|101007182|FG011|NOT COMPLETED|Overall Study||1||
48279032|NCT01012817|101007183|FG012|NOT COMPLETED|Overall Study||0||
48279033|NCT01012817|101007184|FG013|NOT COMPLETED|Overall Study||2||
48564692|NCT01210560|101713999|FG000|COMPLETED|Intervention 2 (7 Days)||2||
48564693|NCT01210560|101714000|FG001|COMPLETED|Intervention 2 (7 Days)||2||
48564694|NCT01210560|101714001|FG002|COMPLETED|Intervention 2 (7 Days)||2||
48564695|NCT01210560|101714002|FG003|COMPLETED|Intervention 2 (7 Days)||2||
48279034|NCT03122223|101007185|FG000|STARTED|Overall Study||50||
48279035|NCT03122223|101007186|FG001|STARTED|Overall Study||50||
48279036|NCT03122223|101007187|FG002|STARTED|Overall Study||50||
48564696|NCT01210560|101714003|FG004|COMPLETED|Intervention 2 (7 Days)||2||
48564697|NCT01210560|101714004|FG005|COMPLETED|Intervention 2 (7 Days)||2||
48279037|NCT03122223|101007188|FG003|STARTED|Overall Study||10||
48279038|NCT03122223|101007185|FG000|Month 6.5 Immunogenicity Cohort|Overall Study||49||
48279039|NCT03122223|101007186|FG001|Month 6.5 Immunogenicity Cohort|Overall Study||48||
48279040|NCT03122223|101007187|FG002|Month 6.5 Immunogenicity Cohort|Overall Study||47||
48279041|NCT03122223|101007188|FG003|Month 6.5 Immunogenicity Cohort|Overall Study||8||
48279042|NCT03122223|101007185|FG000|Month 12 Immunogenicity Cohort|Overall Study||47||
48279043|NCT03122223|101007186|FG001|Month 12 Immunogenicity Cohort|Overall Study||45||
48279044|NCT03122223|101007187|FG002|Month 12 Immunogenicity Cohort|Overall Study||46||
48564698|NCT01210560|101714005|FG006|COMPLETED|Intervention 2 (7 Days)||4||
48564699|NCT01210560|101714006|FG007|COMPLETED|Intervention 2 (7 Days)||4||
48564700|NCT01210560|101714007|FG008|COMPLETED|Intervention 2 (7 Days)||5||
48564701|NCT01210560|101713999|FG000|NOT COMPLETED|Intervention 2 (7 Days)||0||
48564702|NCT01210560|101714000|FG001|NOT COMPLETED|Intervention 2 (7 Days)||0||
48564703|NCT01210560|101714001|FG002|NOT COMPLETED|Intervention 2 (7 Days)||0||
48564704|NCT01210560|101714002|FG003|NOT COMPLETED|Intervention 2 (7 Days)||0||
48564705|NCT01210560|101714003|FG004|NOT COMPLETED|Intervention 2 (7 Days)||0||
48279045|NCT03122223|101007188|FG003|Month 12 Immunogenicity Cohort|Overall Study||10||
48279046|NCT03122223|101007185|FG000|COMPLETED|Overall Study||47||
48279047|NCT03122223|101007186|FG001|COMPLETED|Overall Study||45||
48279048|NCT03122223|101007187|FG002|COMPLETED|Overall Study||46||
48279049|NCT03122223|101007188|FG003|COMPLETED|Overall Study||10||
48279050|NCT03122223|101007185|FG000|NOT COMPLETED|Overall Study||3||
48279051|NCT03122223|101007186|FG001|NOT COMPLETED|Overall Study||5||
48279052|NCT03122223|101007187|FG002|NOT COMPLETED|Overall Study||4||
48564706|NCT01210560|101714004|FG005|NOT COMPLETED|Intervention 2 (7 Days)||0||
48564707|NCT01210560|101714005|FG006|NOT COMPLETED|Intervention 2 (7 Days)||0||
48564708|NCT01210560|101714006|FG007|NOT COMPLETED|Intervention 2 (7 Days)||0||
48564709|NCT01210560|101714007|FG008|NOT COMPLETED|Intervention 2 (7 Days)||0||
48564710|NCT01210560|101713999|FG000|STARTED|Intervention 3 (7 Days)||2||
48564711|NCT01210560|101714000|FG001|STARTED|Intervention 3 (7 Days)||2||
48564712|NCT01210560|101714001|FG002|STARTED|Intervention 3 (7 Days)||2||
48564713|NCT01210560|101714002|FG003|STARTED|Intervention 3 (7 Days)||2||
48564714|NCT01210560|101714003|FG004|STARTED|Intervention 3 (7 Days)||2||
48564715|NCT01210560|101714004|FG005|STARTED|Intervention 3 (7 Days)||2||
48564716|NCT01210560|101714005|FG006|STARTED|Intervention 3 (7 Days)||4||
48564717|NCT01210560|101714006|FG007|STARTED|Intervention 3 (7 Days)||4||
48564718|NCT01210560|101714007|FG008|STARTED|Intervention 3 (7 Days)||5||
48564719|NCT01210560|101713999|FG000|COMPLETED|Intervention 3 (7 Days)||2||
48564720|NCT01210560|101714000|FG001|COMPLETED|Intervention 3 (7 Days)||2||
48564721|NCT01210560|101714001|FG002|COMPLETED|Intervention 3 (7 Days)||2||
48564722|NCT01210560|101714002|FG003|COMPLETED|Intervention 3 (7 Days)||2||
48564723|NCT01210560|101714003|FG004|COMPLETED|Intervention 3 (7 Days)||2||
48564724|NCT01210560|101714004|FG005|COMPLETED|Intervention 3 (7 Days)||2||
48394518|NCT03814005|101295958|FG001|NOT COMPLETED|Washout Period : Day 4 to Day 7||0||
48394519|NCT03814005|101295959|FG002|NOT COMPLETED|Washout Period : Day 4 to Day 7||0||
48394520|NCT03814005|101295957|FG000|STARTED|Part B: Day 8 to Day 343||10||
48394521|NCT03814005|101295958|FG001|STARTED|Part B: Day 8 to Day 343||4||
48394522|NCT03814005|101295959|FG002|STARTED|Part B: Day 8 to Day 343||3||
48394523|NCT03814005|101295957|FG000|COMPLETED|Part B: Day 8 to Day 343||0||
48564725|NCT01210560|101714005|FG006|COMPLETED|Intervention 3 (7 Days)||4||
48697768|NCT02719691|102045460|FG002|STARTED|Overall Study||7||
48697769|NCT02719691|102045461|FG003|STARTED|Overall Study||2||
48279053|NCT03122223|101007188|FG003|NOT COMPLETED|Overall Study||0||
48279054|NCT01395888|101007189|FG000|STARTED|2-week Run-in Period||279||
48279055|NCT01395888|101007190|FG001|STARTED|2-week Run-in Period||0||
48279056|NCT01395888|101007191|FG002|STARTED|2-week Run-in Period||0||
48394524|NCT03814005|101295958|FG001|COMPLETED|Part B: Day 8 to Day 343||0||
48394525|NCT03814005|101295959|FG002|COMPLETED|Part B: Day 8 to Day 343||0||
48394526|NCT03814005|101295957|FG000|NOT COMPLETED|Part B: Day 8 to Day 343||10||
48394527|NCT03814005|101295958|FG001|NOT COMPLETED|Part B: Day 8 to Day 343||4||
48394528|NCT03814005|101295959|FG002|NOT COMPLETED|Part B: Day 8 to Day 343||3||
48394529|NCT01142193|101295960|FG000|STARTED|Overall Study||124||
48394530|NCT01142193|101295961|FG001|STARTED|Overall Study||125||
48394531|NCT01142193|101295960|FG000|COMPLETED|Overall Study||103||
48394532|NCT01142193|101295961|FG001|COMPLETED|Overall Study||114||
48697770|NCT02719691|102045462|FG004|STARTED|Overall Study||10||
48279057|NCT01395888|101007189|FG000|COMPLETED|2-week Run-in Period||257||
48279058|NCT01395888|101007190|FG001|COMPLETED|2-week Run-in Period||0||
48394533|NCT01142193|101295960|FG000|NOT COMPLETED|Overall Study||21||
48564726|NCT01210560|101714006|FG007|COMPLETED|Intervention 3 (7 Days)||4||
48697771|NCT02719691|102045463|FG005|STARTED|Overall Study||10||
48697772|NCT02719691|102045464|FG006|STARTED|Overall Study||11||
48697773|NCT02719691|102045458|FG000|COMPLETED|Overall Study||3||
48394534|NCT01142193|101295961|FG001|NOT COMPLETED|Overall Study||11||
48394535|NCT00696436|101295962|FG000|STARTED|Overall Study||280||
48564727|NCT01210560|101714007|FG008|COMPLETED|Intervention 3 (7 Days)||5||
48564728|NCT01210560|101713999|FG000|NOT COMPLETED|Intervention 3 (7 Days)||0||
48564729|NCT01210560|101714000|FG001|NOT COMPLETED|Intervention 3 (7 Days)||0||
48697774|NCT02719691|102045459|FG001|COMPLETED|Overall Study||4||
48697775|NCT02719691|102045460|FG002|COMPLETED|Overall Study||6||
48279059|NCT01395888|101007191|FG002|COMPLETED|2-week Run-in Period||0||
48117520|NCT01930058|100612770|FG002|STARTED|Overall Study||3||
48117521|NCT01930058|100612768|FG000|COMPLETED|Overall Study||3||
48117522|NCT01930058|100612769|FG001|COMPLETED|Overall Study||3||
48117523|NCT01930058|100612770|FG002|COMPLETED|Overall Study||3||
48117524|NCT01930058|100612768|FG000|NOT COMPLETED|Overall Study||0||
48117525|NCT01930058|100612769|FG001|NOT COMPLETED|Overall Study||0||
48117526|NCT01930058|100612770|FG002|NOT COMPLETED|Overall Study||0||
48279060|NCT01395888|101007189|FG000|NOT COMPLETED|2-week Run-in Period||22||
48279061|NCT01395888|101007190|FG001|NOT COMPLETED|2-week Run-in Period||0||
48564730|NCT01210560|101714001|FG002|NOT COMPLETED|Intervention 3 (7 Days)||0||
48564731|NCT01210560|101714002|FG003|NOT COMPLETED|Intervention 3 (7 Days)||0||
48564732|NCT01210560|101714003|FG004|NOT COMPLETED|Intervention 3 (7 Days)||0||
48564733|NCT01210560|101714004|FG005|NOT COMPLETED|Intervention 3 (7 Days)||0||
48564734|NCT01210560|101714005|FG006|NOT COMPLETED|Intervention 3 (7 Days)||0||
48564735|NCT01210560|101714006|FG007|NOT COMPLETED|Intervention 3 (7 Days)||0||
48564736|NCT01210560|101714007|FG008|NOT COMPLETED|Intervention 3 (7 Days)||0||
48564737|NCT01812109|101714008|FG000|STARTED|Overall Study||154||
48117527|NCT01514318|100612771|FG000|STARTED|Overall Study||8||
48117528|NCT01514318|100612771|FG000|COMPLETED|Overall Study||8||
48117529|NCT01514318|100612771|FG000|NOT COMPLETED|Overall Study||0||
48117530|NCT02751983|100612772|FG000|STARTED|Baseline and Randomization||35||
48117531|NCT02751983|100612773|FG001|STARTED|Baseline and Randomization||35||
48117532|NCT02751983|100612772|FG000|COMPLETED|Baseline and Randomization||35||
48279062|NCT01395888|101007191|FG002|NOT COMPLETED|2-week Run-in Period||0||
48279063|NCT01395888|101007189|FG000|STARTED|Treatment Period (TP)||0||
48279064|NCT01395888|101007190|FG001|STARTED|Treatment Period (TP)||127||
48279065|NCT01395888|101007191|FG002|STARTED|Treatment Period (TP)||130||
48117533|NCT02751983|100612773|FG001|COMPLETED|Baseline and Randomization||35||
48117534|NCT02751983|100612772|FG000|NOT COMPLETED|Baseline and Randomization||0||
48117535|NCT02751983|100612773|FG001|NOT COMPLETED|Baseline and Randomization||0||
48117536|NCT02751983|100612772|FG000|STARTED|Treatment||35||
48117537|NCT02751983|100612773|FG001|STARTED|Treatment||35||
48117538|NCT02751983|100612772|FG000|COMPLETED|Treatment||31||
48117539|NCT02751983|100612773|FG001|COMPLETED|Treatment||35||
48117540|NCT02751983|100612772|FG000|NOT COMPLETED|Treatment||4||
48394536|NCT00696436|101295963|FG001|STARTED|Overall Study||285||
48394537|NCT00696436|101295964|FG002|STARTED|Overall Study||282||
48394538|NCT00696436|101295965|FG003|STARTED|Overall Study||290||
48394539|NCT00696436|101295966|FG004|STARTED|Overall Study||154||
48394540|NCT00696436|101295962|FG000|COMPLETED|Overall Study||257||
48394541|NCT00696436|101295963|FG001|COMPLETED|Overall Study||255||
48394542|NCT00696436|101295964|FG002|COMPLETED|Overall Study||254||
48394543|NCT00696436|101295965|FG003|COMPLETED|Overall Study||268||
48394544|NCT00696436|101295966|FG004|COMPLETED|Overall Study||141||
48117541|NCT02751983|100612773|FG001|NOT COMPLETED|Treatment||0||
48117542|NCT02751983|100612772|FG000|STARTED|Post-Treatment Assessment||35||
48117543|NCT02751983|100612773|FG001|STARTED|Post-Treatment Assessment||0||
48279066|NCT01395888|101007189|FG000|Completed the Treatment Period|Treatment Period (TP)||0||
48279067|NCT01395888|101007190|FG001|Completed the Treatment Period|Treatment Period (TP)||112||
48394545|NCT00696436|101295962|FG000|NOT COMPLETED|Overall Study||23||
48394546|NCT00696436|101295963|FG001|NOT COMPLETED|Overall Study||30||
48564738|NCT01812109|101714008|FG000|With Torsion|Overall Study||36||
48564739|NCT01812109|101714008|FG000|Without Torsion|Overall Study||85||
48564740|NCT01812109|101714008|FG000|COMPLETED|Overall Study||121||
48564741|NCT01812109|101714008|FG000|NOT COMPLETED|Overall Study||33||
48564742|NCT03652051|101714009|FG000|STARTED|Stage 1||9||
48564743|NCT03652051|101714010|FG001|STARTED|Stage 1||27||
48117544|NCT02751983|100612772|FG000|COMPLETED|Post-Treatment Assessment||30||
48117545|NCT02751983|100612773|FG001|COMPLETED|Post-Treatment Assessment||0||
48279068|NCT01395888|101007191|FG002|Completed the Treatment Period|Treatment Period (TP)||113||
48279069|NCT01395888|101007189|FG000|COMPLETED|Treatment Period (TP)||0||
48279070|NCT01395888|101007190|FG001|COMPLETED|Treatment Period (TP)||112||
48279071|NCT01395888|101007191|FG002|COMPLETED|Treatment Period (TP)||113||
48279072|NCT01395888|101007189|FG000|NOT COMPLETED|Treatment Period (TP)||0||
48279073|NCT01395888|101007190|FG001|NOT COMPLETED|Treatment Period (TP)||15||
48279074|NCT01395888|101007191|FG002|NOT COMPLETED|Treatment Period (TP)||17||
48279075|NCT00958841|101007192|FG000|STARTED|Overall Study||118||
48279076|NCT00958841|101007192|FG000|Completed Month 6 (M6)|Overall Study||90||
48279077|NCT00958841|101007192|FG000|Entered in Extension|Overall Study||63||
48279078|NCT00958841|101007192|FG000|COMPLETED|Overall Study||22||
48394547|NCT00696436|101295964|FG002|NOT COMPLETED|Overall Study||28||
48394548|NCT00696436|101295965|FG003|NOT COMPLETED|Overall Study||22||
48564744|NCT03652051|101714011|FG002|STARTED|Stage 1||24||
48564745|NCT03652051|101714012|FG003|STARTED|Stage 1||16||
48117546|NCT02751983|100612772|FG000|NOT COMPLETED|Post-Treatment Assessment||5||
48279079|NCT00958841|101007192|FG000|NOT COMPLETED|Overall Study||96||
48279080|NCT02580305|101007193|FG000|STARTED|Overall Study||190||
48279081|NCT02580305|101007194|FG001|STARTED|Overall Study||185||
48279082|NCT02580305|101007195|FG002|STARTED|Overall Study||189||
48279083|NCT02580305|101007193|FG000|Safety Population|Overall Study||187||
48394549|NCT00696436|101295966|FG004|NOT COMPLETED|Overall Study||13||
48394550|NCT01814826|101295967|FG000|STARTED|Overall Study||32||
48394551|NCT01814826|101295968|FG001|STARTED|Overall Study||29||
48394552|NCT01814826|101295969|FG002|STARTED|Overall Study||3||
48394553|NCT01814826|101295967|FG000|COMPLETED|Overall Study||0||
48394554|NCT01814826|101295968|FG001|COMPLETED|Overall Study||0||
48394555|NCT01814826|101295969|FG002|COMPLETED|Overall Study||0||
48394556|NCT01814826|101295967|FG000|NOT COMPLETED|Overall Study||32||
48394557|NCT01814826|101295968|FG001|NOT COMPLETED|Overall Study||29||
48394558|NCT01814826|101295969|FG002|NOT COMPLETED|Overall Study||3||
48394559|NCT00924729|101295970|FG000|STARTED|Overall Study||25||
48394560|NCT00924729|101295971|FG001|STARTED|Overall Study||25||
48394561|NCT00924729|101295970|FG000|COMPLETED|Overall Study||23||
48394562|NCT00924729|101295971|FG001|COMPLETED|Overall Study||25||
48394563|NCT00924729|101295970|FG000|NOT COMPLETED|Overall Study||2||
48394564|NCT00924729|101295971|FG001|NOT COMPLETED|Overall Study||0||
48394565|NCT00709124|101295972|FG000|STARTED|Overall Study||16||
48564746|NCT03652051|101714009|FG000|COMPLETED|Stage 1||9||
48564747|NCT03652051|101714010|FG001|COMPLETED|Stage 1||22||
48564748|NCT03652051|101714011|FG002|COMPLETED|Stage 1||16||
48394566|NCT00709124|101295973|FG001|STARTED|Overall Study||18||
48394567|NCT00709124|101295972|FG000|COMPLETED|Overall Study||12||
48394568|NCT00709124|101295973|FG001|COMPLETED|Overall Study||17||
48394569|NCT00709124|101295972|FG000|NOT COMPLETED|Overall Study||4||
48394570|NCT00709124|101295973|FG001|NOT COMPLETED|Overall Study||1||
48394571|NCT02674685|101295974|FG000|STARTED|Overall Study||241||
48394572|NCT02674685|101295974|FG000|COMPLETED|Overall Study||237||
48394573|NCT02674685|101295974|FG000|NOT COMPLETED|Overall Study||4||
48394574|NCT04152642|101295975|FG000|STARTED|Overall Study||22||
48394575|NCT04152642|101295975|FG000|C (Water/Negative) Control|Overall Study||20|This was a 3-treatment, 3-period, cross-over design. Each subject was assigned to receive each treatment. Each period lasted 4 days.|
48394576|NCT04152642|101295975|FG000|A (Marketed Rinse)|Overall Study||19|This was a 3-treatment, 3-period, cross-over design. Each subject was assigned to receive each treatment. Each period lasted 4 days.|
48394577|NCT04152642|101295975|FG000|B (Experimental Rinse)|Overall Study||19|This was a 3-treatment, 3-period, cross-over design. Each subject was assigned to receive each treatment. Each period lasted 4 days.|
48564749|NCT03652051|101714012|FG003|COMPLETED|Stage 1||15||
48564750|NCT03652051|101714009|FG000|NOT COMPLETED|Stage 1||0||
48564751|NCT03652051|101714010|FG001|NOT COMPLETED|Stage 1||5||
48564752|NCT03652051|101714011|FG002|NOT COMPLETED|Stage 1||8||
48697776|NCT02719691|102045461|FG003|COMPLETED|Overall Study||2||
48697777|NCT02719691|102045462|FG004|COMPLETED|Overall Study||10||
48697778|NCT02719691|102045463|FG005|COMPLETED|Overall Study||9||
48697779|NCT02719691|102045464|FG006|COMPLETED|Overall Study||11||
48697780|NCT02719691|102045458|FG000|NOT COMPLETED|Overall Study||0||
48697781|NCT02719691|102045459|FG001|NOT COMPLETED|Overall Study||0||
48697782|NCT02719691|102045460|FG002|NOT COMPLETED|Overall Study||1||
48697783|NCT02719691|102045461|FG003|NOT COMPLETED|Overall Study||0||
48697784|NCT02719691|102045462|FG004|NOT COMPLETED|Overall Study||0||
48697785|NCT02719691|102045463|FG005|NOT COMPLETED|Overall Study||1||
48697786|NCT02719691|102045464|FG006|NOT COMPLETED|Overall Study||0||
48697787|NCT03588806|102045465|FG000|STARTED|Overall Study||11||
48697788|NCT03588806|102045465|FG000|COMPLETED|Overall Study||11||
48697789|NCT03588806|102045465|FG000|NOT COMPLETED|Overall Study||0||
48697790|NCT03635424|102045466|FG000|STARTED|Overall Study||150||
48697791|NCT03635424|102045466|FG000|COMPLETED|Overall Study||147||
48697792|NCT03635424|102045466|FG000|NOT COMPLETED|Overall Study||3||
48697793|NCT01780337|102045467|FG000|STARTED|Overall Study||6||
48697794|NCT01780337|102045468|FG001|STARTED|Overall Study||6||
48394578|NCT04152642|101295975|FG000|COMPLETED|Overall Study||15|15 subjects received all 3 treatment products|
48394579|NCT04152642|101295975|FG000|NOT COMPLETED|Overall Study||7||
48394580|NCT02983799|101295976|FG000|STARTED|Overall Study||75||
48394581|NCT02983799|101295977|FG001|STARTED|Overall Study||26||
48564753|NCT03652051|101714012|FG003|NOT COMPLETED|Stage 1||1||
48697795|NCT01780337|102045467|FG000|COMPLETED|Overall Study||6||
48564754|NCT03652051|101714009|FG000|STARTED|Stage 2||0|Stage 2 was conducted without including any subjects from Stage 1 to enable Stage 2 to qualify as a confirmatory efficacy study based upon feedback from the FDA at a pre-IND meeting.|
48564755|NCT03652051|101714010|FG001|STARTED|Stage 2||82|Stage 2 was conducted without including any subjects from Stage 1 to enable Stage 2 to qualify as a confirmatory efficacy study based upon feedback from the FDA at a pre-IND meeting.|
48564756|NCT03652051|101714011|FG002|STARTED|Stage 2||83|Stage 2 was conducted without including any subjects from Stage 1 to enable Stage 2 to qualify as a confirmatory efficacy study based upon feedback from the FDA at a pre-IND meeting.|
48564757|NCT03652051|101714012|FG003|STARTED|Stage 2||80|Stage 2 was conducted without including any subjects from Stage 1 to enable Stage 2 to qualify as a confirmatory efficacy study based upon feedback from the FDA at a pre-IND meeting.|
48564758|NCT03652051|101714009|FG000|COMPLETED|Stage 2||0||
48564759|NCT03652051|101714010|FG001|COMPLETED|Stage 2||66||
48564760|NCT03652051|101714011|FG002|COMPLETED|Stage 2||67||
48564761|NCT03652051|101714012|FG003|COMPLETED|Stage 2||74||
48564762|NCT03652051|101714009|FG000|NOT COMPLETED|Stage 2||0||
48697796|NCT01780337|102045468|FG001|COMPLETED|Overall Study||6||
48697797|NCT01780337|102045467|FG000|NOT COMPLETED|Overall Study||0||
48697798|NCT01780337|102045468|FG001|NOT COMPLETED|Overall Study||0||
48697799|NCT01511614|102045469|FG000|STARTED|Overall Study||14||
48697800|NCT01511614|102045470|FG001|STARTED|Overall Study||28||
48394582|NCT02983799|101295978|FG002|STARTED|Overall Study||68||
48564763|NCT03652051|101714010|FG001|NOT COMPLETED|Stage 2||16||
48564764|NCT03652051|101714011|FG002|NOT COMPLETED|Stage 2||16||
48564765|NCT03652051|101714012|FG003|NOT COMPLETED|Stage 2||6||
48564766|NCT01131455|101714013|FG000|STARTED|Overall Study||6||
48564767|NCT01131455|101714014|FG001|STARTED|Overall Study||4||
48564768|NCT01131455|101714015|FG002|STARTED|Overall Study||0||
48564769|NCT01131455|101714013|FG000|COMPLETED|Overall Study||0||
48564770|NCT01131455|101714014|FG001|COMPLETED|Overall Study||0||
48564771|NCT01131455|101714015|FG002|COMPLETED|Overall Study||0||
48564772|NCT01131455|101714013|FG000|NOT COMPLETED|Overall Study||6||
48564773|NCT01131455|101714014|FG001|NOT COMPLETED|Overall Study||4||
48564774|NCT01131455|101714015|FG002|NOT COMPLETED|Overall Study||0||
48564775|NCT01253902|101714016|FG000|STARTED|Overall Study||56||
48564776|NCT01253902|101714017|FG001|STARTED|Overall Study||53||
48564777|NCT01253902|101714018|FG002|STARTED|Overall Study||55||
48564778|NCT01253902|101714016|FG000|COMPLETED|Overall Study||51||
48564779|NCT01253902|101714017|FG001|COMPLETED|Overall Study||51||
48564780|NCT01253902|101714018|FG002|COMPLETED|Overall Study||51||
48564781|NCT01253902|101714016|FG000|NOT COMPLETED|Overall Study||5||
48564782|NCT01253902|101714017|FG001|NOT COMPLETED|Overall Study||2||
48564783|NCT01253902|101714018|FG002|NOT COMPLETED|Overall Study||4||
48564784|NCT05005507|101714019|FG000|STARTED|Overall Study||1||
48564785|NCT05005507|101714019|FG000|COMPLETED|Overall Study||0||
48564786|NCT05005507|101714019|FG000|NOT COMPLETED|Overall Study||1||
48564787|NCT04742400|101714020|FG000|STARTED|Overall Study||7||
48564788|NCT04742400|101714021|FG001|STARTED|Overall Study||5||
48564789|NCT04742400|101714020|FG000|COMPLETED|Overall Study||7||
48564790|NCT04742400|101714021|FG001|COMPLETED|Overall Study||5||
48564791|NCT04742400|101714020|FG000|NOT COMPLETED|Overall Study||0||
48564792|NCT04742400|101714021|FG001|NOT COMPLETED|Overall Study||0||
48564793|NCT02064816|101714022|FG000|STARTED|Overall Study||104||
48564794|NCT02064816|101714023|FG001|STARTED|Overall Study||96||
48564795|NCT02064816|101714022|FG000|COMPLETED|Overall Study||96||
48564796|NCT02064816|101714023|FG001|COMPLETED|Overall Study||88||
48564797|NCT02064816|101714022|FG000|NOT COMPLETED|Overall Study||8||
48564798|NCT02064816|101714023|FG001|NOT COMPLETED|Overall Study||8||
48564799|NCT00608777|101714024|FG000|STARTED|Overall Study||6||
48564800|NCT00608777|101714024|FG000|COMPLETED|Overall Study||6||
48564801|NCT00608777|101714024|FG000|NOT COMPLETED|Overall Study||0||
48564802|NCT02314026|101714025|FG000|STARTED|Overall Study||135||
48564803|NCT02314026|101714025|FG000|COMPLETED|Overall Study||107||
48564804|NCT02314026|101714025|FG000|NOT COMPLETED|Overall Study||28||
48564805|NCT00867529|101714026|FG000|STARTED|Overall Study||63||
48564806|NCT00867529|101714026|FG000|COMPLETED|Overall Study||63||
48564807|NCT00867529|101714026|FG000|NOT COMPLETED|Overall Study||0||
48564808|NCT01422889|101714027|FG000|STARTED|Overall Study||1120||
48564809|NCT01422889|101714027|FG000|COMPLETED|Overall Study||1111||
48564810|NCT01422889|101714027|FG000|NOT COMPLETED|Overall Study||9||
48564811|NCT01819233|101714028|FG000|STARTED|Overall Study||38||
48564812|NCT01819233|101714028|FG000|COMPLETED|Overall Study||32||
48564813|NCT01819233|101714028|FG000|NOT COMPLETED|Overall Study||6||
48564814|NCT00113763|101714029|FG000|STARTED|Overall Study||231||
48564815|NCT00113763|101714030|FG001|STARTED|Overall Study||232||
48564816|NCT00113763|101714029|FG000|Received Study Drug|Overall Study||229||
48564817|NCT00113763|101714030|FG001|Received Study Drug|Overall Study||0||
48564818|NCT00113763|101714029|FG000|COMPLETED|Overall Study||158||
48564819|NCT00113763|101714030|FG001|COMPLETED|Overall Study||206||
48564820|NCT00113763|101714029|FG000|NOT COMPLETED|Overall Study||73||
48564821|NCT00113763|101714030|FG001|NOT COMPLETED|Overall Study||26||
48564822|NCT01564693|101714031|FG000|STARTED|Overall Study||9||
48564823|NCT01564693|101714032|FG001|STARTED|Overall Study||4||
48564824|NCT01564693|101714033|FG002|STARTED|Overall Study||2||
48564825|NCT01564693|101714031|FG000|COMPLETED|Overall Study||9||
48564826|NCT01564693|101714032|FG001|COMPLETED|Overall Study||4||
48564827|NCT01564693|101714033|FG002|COMPLETED|Overall Study||2||
48564828|NCT01564693|101714031|FG000|NOT COMPLETED|Overall Study||0||
48564829|NCT01564693|101714032|FG001|NOT COMPLETED|Overall Study||0||
48564830|NCT01564693|101714033|FG002|NOT COMPLETED|Overall Study||0||
48564831|NCT01956773|101714034|FG000|STARTED|Overall Study||2520||
48564832|NCT01956773|101714035|FG001|STARTED|Overall Study||100||
48564833|NCT01956773|101714034|FG000|COMPLETED|Overall Study||1892||
48564834|NCT01956773|101714035|FG001|COMPLETED|Overall Study||99||
48564835|NCT01956773|101714034|FG000|NOT COMPLETED|Overall Study||628||
48564836|NCT01956773|101714035|FG001|NOT COMPLETED|Overall Study||1||
48564837|NCT01094574|101714036|FG000|STARTED|Overall Study||1||
48564838|NCT01094574|101714037|FG001|STARTED|Overall Study||1||
48564839|NCT01094574|101714038|FG002|STARTED|Overall Study||2||
48564840|NCT01094574|101714039|FG003|STARTED|Overall Study||2||
48564841|NCT01094574|101714040|FG004|STARTED|Overall Study||2||
48564842|NCT01094574|101714041|FG005|STARTED|Overall Study||2||
48564843|NCT01094574|101714036|FG000|COMPLETED|Overall Study||1||
48564844|NCT01094574|101714037|FG001|COMPLETED|Overall Study||1||
48564845|NCT01094574|101714038|FG002|COMPLETED|Overall Study||2||
48564846|NCT01094574|101714039|FG003|COMPLETED|Overall Study||2||
48564847|NCT01094574|101714040|FG004|COMPLETED|Overall Study||2||
48564848|NCT01094574|101714041|FG005|COMPLETED|Overall Study||2||
48564849|NCT01094574|101714036|FG000|NOT COMPLETED|Overall Study||0||
48564850|NCT01094574|101714037|FG001|NOT COMPLETED|Overall Study||0||
48564851|NCT01094574|101714038|FG002|NOT COMPLETED|Overall Study||0||
48564852|NCT01094574|101714039|FG003|NOT COMPLETED|Overall Study||0||
48564853|NCT01094574|101714040|FG004|NOT COMPLETED|Overall Study||0||
48564854|NCT01094574|101714041|FG005|NOT COMPLETED|Overall Study||0||
48117547|NCT02751983|100612773|FG001|NOT COMPLETED|Post-Treatment Assessment||0||
48279084|NCT02580305|101007194|FG001|Safety Population|Overall Study||181||
48279085|NCT02580305|101007195|FG002|Safety Population|Overall Study||188||
48564855|NCT01431716|101714042|FG000|STARTED|Overall Study||42||
48564856|NCT01431716|101714042|FG000|COMPLETED|Overall Study||41||
48564857|NCT01431716|101714042|FG000|NOT COMPLETED|Overall Study||1||
48564858|NCT04526288|101714043|FG000|STARTED|Overall Study||1||
48564859|NCT04526288|101714044|FG001|STARTED|Overall Study||0||
48564860|NCT04526288|101714043|FG000|COMPLETED|Overall Study||0||
48564861|NCT04526288|101714044|FG001|COMPLETED|Overall Study||0||
48564862|NCT04526288|101714043|FG000|NOT COMPLETED|Overall Study||1||
48564863|NCT04526288|101714044|FG001|NOT COMPLETED|Overall Study||0||
48564864|NCT05344560|101714045|FG000|STARTED|Period 1||63||
48564865|NCT05344560|101714046|FG001|STARTED|Period 1||63||
48564866|NCT05344560|101714045|FG000|COMPLETED|Period 1||62||
48564867|NCT05344560|101714046|FG001|COMPLETED|Period 1||62||
48564868|NCT05344560|101714045|FG000|NOT COMPLETED|Period 1||1||
48564869|NCT05344560|101714046|FG001|NOT COMPLETED|Period 1||1||
48564870|NCT05344560|101714045|FG000|STARTED|Period 2||62||
48564871|NCT05344560|101714046|FG001|STARTED|Period 2||62||
48564872|NCT05344560|101714045|FG000|COMPLETED|Period 2||59||
48564873|NCT05344560|101714046|FG001|COMPLETED|Period 2||61||
48564874|NCT05344560|101714045|FG000|NOT COMPLETED|Period 2||3||
48564875|NCT05344560|101714046|FG001|NOT COMPLETED|Period 2||1||
48564876|NCT05344560|101714045|FG000|STARTED|Period 3||59||
48564877|NCT05344560|101714046|FG001|STARTED|Period 3||61||
48564878|NCT05344560|101714045|FG000|COMPLETED|Period 3||58||
48564879|NCT05344560|101714046|FG001|COMPLETED|Period 3||61||
48279086|NCT02580305|101007193|FG000|Modified Intent-to-treat (mITT) Population|Overall Study||184||
48279087|NCT02580305|101007194|FG001|Modified Intent-to-treat (mITT) Population|Overall Study||176||
48279088|NCT02580305|101007195|FG002|Modified Intent-to-treat (mITT) Population|Overall Study||183||
48279089|NCT02580305|101007193|FG000|COMPLETED|Overall Study||147||
48279090|NCT02580305|101007194|FG001|COMPLETED|Overall Study||136||
48279091|NCT02580305|101007195|FG002|COMPLETED|Overall Study||157||
48279092|NCT02580305|101007193|FG000|NOT COMPLETED|Overall Study||43||
48279093|NCT02580305|101007194|FG001|NOT COMPLETED|Overall Study||49||
48279094|NCT02580305|101007195|FG002|NOT COMPLETED|Overall Study||32||
48279095|NCT01262027|101007196|FG000|STARTED|Overall Study||22||
48564880|NCT05344560|101714045|FG000|NOT COMPLETED|Period 3||1||
48564881|NCT05344560|101714046|FG001|NOT COMPLETED|Period 3||0||
48564882|NCT03749330|101714047|FG000|STARTED|Overall Study||60||
48564883|NCT03749330|101714048|FG001|STARTED|Overall Study||24||
48564884|NCT03749330|101714049|FG002|STARTED|Overall Study||202||
48564885|NCT03749330|101714050|FG003|STARTED|Overall Study||45||
48564886|NCT03749330|101714051|FG004|STARTED|Overall Study||21||
48564887|NCT03749330|101714052|FG005|STARTED|Overall Study||99||
48564888|NCT03749330|101714047|FG000|COMPLETED|Overall Study||60||
48564889|NCT03749330|101714048|FG001|COMPLETED|Overall Study||22||
48564890|NCT03749330|101714049|FG002|COMPLETED|Overall Study||202||
48564891|NCT03749330|101714050|FG003|COMPLETED|Overall Study||45||
48564892|NCT03749330|101714051|FG004|COMPLETED|Overall Study||21||
48564893|NCT03749330|101714052|FG005|COMPLETED|Overall Study||99||
48564894|NCT03749330|101714047|FG000|NOT COMPLETED|Overall Study||0||
48564895|NCT03749330|101714048|FG001|NOT COMPLETED|Overall Study||2||
48564896|NCT03749330|101714049|FG002|NOT COMPLETED|Overall Study||0||
48564897|NCT03749330|101714050|FG003|NOT COMPLETED|Overall Study||0||
48564898|NCT03749330|101714051|FG004|NOT COMPLETED|Overall Study||0||
48564899|NCT03749330|101714052|FG005|NOT COMPLETED|Overall Study||0||
48564900|NCT03711786|101714053|FG000|STARTED|Period 1: Recruited in Study Months 1-5||168||5
48279096|NCT01262027|101007196|FG000|COMPLETED|Overall Study||17||
48279097|NCT01262027|101007196|FG000|NOT COMPLETED|Overall Study||5||
48279098|NCT00727311|101007197|FG000|STARTED|Overall Study||2302||
48279099|NCT00727311|101007197|FG000|COMPLETED|Overall Study||1195||
48279100|NCT00727311|101007197|FG000|NOT COMPLETED|Overall Study||1107||
48279101|NCT02909764|101007198|FG000|STARTED|Overall Study||19||
48564901|NCT03711786|101714054|FG001|STARTED|Period 1: Recruited in Study Months 1-5||189||5
48564902|NCT03711786|101714053|FG000|3-month Assessment|Period 1: Recruited in Study Months 1-5||162||5
48564903|NCT03711786|101714054|FG001|3-month Assessment|Period 1: Recruited in Study Months 1-5||186||5
48564904|NCT03711786|101714053|FG000|6-month Assessment|Period 1: Recruited in Study Months 1-5||156||5
48564905|NCT03711786|101714054|FG001|6-month Assessment|Period 1: Recruited in Study Months 1-5||179||5
48564906|NCT03711786|101714053|FG000|12-month Assessment|Period 1: Recruited in Study Months 1-5||148||5
48564907|NCT03711786|101714054|FG001|12-month Assessment|Period 1: Recruited in Study Months 1-5||183||5
48564908|NCT03711786|101714053|FG000|COMPLETED|Period 1: Recruited in Study Months 1-5||148||5
48117548|NCT02751983|100612772|FG000|STARTED|One-Month Follow-Up Assessments||35||
48697801|NCT01511614|102045471|FG002|STARTED|Overall Study||2||
48279102|NCT02909764|101007199|FG001|STARTED|Overall Study||20||
48564909|NCT03711786|101714054|FG001|COMPLETED|Period 1: Recruited in Study Months 1-5||183||5
48564910|NCT03711786|101714053|FG000|NOT COMPLETED|Period 1: Recruited in Study Months 1-5||20||0
48564911|NCT03711786|101714054|FG001|NOT COMPLETED|Period 1: Recruited in Study Months 1-5||6||0
48564912|NCT03711786|101714053|FG000|STARTED|Period 1: Recruited in Study Months 6-32||301||5
48564913|NCT03711786|101714054|FG001|STARTED|Period 1: Recruited in Study Months 6-32||288||5
48564914|NCT03711786|101714053|FG000|3-month Assessment|Period 1: Recruited in Study Months 6-32||275||5
48564915|NCT03711786|101714054|FG001|3-month Assessment|Period 1: Recruited in Study Months 6-32||264||5
48564916|NCT03711786|101714053|FG000|6-month Assessment|Period 1: Recruited in Study Months 6-32||277||5
48564917|NCT03711786|101714054|FG001|6-month Assessment|Period 1: Recruited in Study Months 6-32||267||5
48564918|NCT03711786|101714053|FG000|12-month Assessment|Period 1: Recruited in Study Months 6-32||237||5
48564919|NCT03711786|101714054|FG001|12-month Assessment|Period 1: Recruited in Study Months 6-32||220||5
48564920|NCT03711786|101714053|FG000|COMPLETED|Period 1: Recruited in Study Months 6-32||279||5
48564921|NCT03711786|101714054|FG001|COMPLETED|Period 1: Recruited in Study Months 6-32||258||5
48564922|NCT03711786|101714053|FG000|NOT COMPLETED|Period 1: Recruited in Study Months 6-32||22||0
48564923|NCT03711786|101714054|FG001|NOT COMPLETED|Period 1: Recruited in Study Months 6-32||30||0
48564924|NCT03428152|101714055|FG000|STARTED|Overall Study||37||
48564925|NCT03428152|101714056|FG001|STARTED|Overall Study||41||
48564926|NCT03428152|101714055|FG000|COMPLETED|Overall Study||30||
48564927|NCT03428152|101714056|FG001|COMPLETED|Overall Study||30||
48564928|NCT03428152|101714055|FG000|NOT COMPLETED|Overall Study||7||
48564929|NCT03428152|101714056|FG001|NOT COMPLETED|Overall Study||11||
48564930|NCT01537042|101714057|FG000|STARTED|Overall Study||10||
48564931|NCT01537042|101714058|FG001|STARTED|Overall Study||20||
48564932|NCT01537042|101714057|FG000|COMPLETED|Overall Study||10||
48564933|NCT01537042|101714058|FG001|COMPLETED|Overall Study||15||
48564934|NCT01537042|101714057|FG000|NOT COMPLETED|Overall Study||0||
48564935|NCT01537042|101714058|FG001|NOT COMPLETED|Overall Study||5||
48564936|NCT00762710|101714059|FG000|STARTED|Overall Study||48||
48564937|NCT00762710|101714060|FG001|STARTED|Overall Study||44||
48564938|NCT00762710|101714059|FG000|COMPLETED|Overall Study||27||
48564939|NCT00762710|101714060|FG001|COMPLETED|Overall Study||29||
48564940|NCT00762710|101714059|FG000|NOT COMPLETED|Overall Study||21||
48564941|NCT00762710|101714060|FG001|NOT COMPLETED|Overall Study||15||
48564942|NCT03328507|101714061|FG000|STARTED|Overall Study||21||
48564943|NCT03328507|101714062|FG001|STARTED|Overall Study||40||
48564944|NCT03328507|101714063|FG002|STARTED|Overall Study||41||
48564945|NCT03328507|101714064|FG003|STARTED|Overall Study||19||
48564946|NCT03328507|101714061|FG000|COMPLETED|Overall Study||21||
48564947|NCT03328507|101714062|FG001|COMPLETED|Overall Study||40||
48564948|NCT03328507|101714063|FG002|COMPLETED|Overall Study||40||
48564949|NCT03328507|101714064|FG003|COMPLETED|Overall Study||19||
48564950|NCT03328507|101714061|FG000|NOT COMPLETED|Overall Study||0||
48564951|NCT03328507|101714062|FG001|NOT COMPLETED|Overall Study||0||
48564952|NCT03328507|101714063|FG002|NOT COMPLETED|Overall Study||1||
48564953|NCT03328507|101714064|FG003|NOT COMPLETED|Overall Study||0||
48564954|NCT02502149|101714065|FG000|STARTED|PK1 Assessment Period||24||
48564955|NCT02502149|101714066|FG001|STARTED|PK1 Assessment Period||0||
48117549|NCT02751983|100612773|FG001|STARTED|One-Month Follow-Up Assessments||35||
48117550|NCT02751983|100612772|FG000|COMPLETED|One-Month Follow-Up Assessments||21||
48564956|NCT02502149|101714067|FG002|STARTED|PK1 Assessment Period||0||
48564957|NCT02502149|101714068|FG003|STARTED|PK1 Assessment Period||0||
48564958|NCT02502149|101714069|FG004|STARTED|PK1 Assessment Period||0||
48564959|NCT02502149|101714065|FG000|COMPLETED|PK1 Assessment Period||24||
48564960|NCT02502149|101714066|FG001|COMPLETED|PK1 Assessment Period||0||
48564961|NCT02502149|101714067|FG002|COMPLETED|PK1 Assessment Period||0||
48564962|NCT02502149|101714068|FG003|COMPLETED|PK1 Assessment Period||0||
48564963|NCT02502149|101714069|FG004|COMPLETED|PK1 Assessment Period||0||
48564964|NCT02502149|101714065|FG000|NOT COMPLETED|PK1 Assessment Period||0||
48564965|NCT02502149|101714066|FG001|NOT COMPLETED|PK1 Assessment Period||0||
48564966|NCT02502149|101714067|FG002|NOT COMPLETED|PK1 Assessment Period||0||
48564967|NCT02502149|101714068|FG003|NOT COMPLETED|PK1 Assessment Period||0||
48564968|NCT02502149|101714069|FG004|NOT COMPLETED|PK1 Assessment Period||0||
48564969|NCT02502149|101714065|FG000|STARTED|Intermediate||24||
48564970|NCT02502149|101714066|FG001|STARTED|Intermediate||0||
48564971|NCT02502149|101714067|FG002|STARTED|Intermediate||0||
48564972|NCT02502149|101714068|FG003|STARTED|Intermediate||0||
48564973|NCT02502149|101714069|FG004|STARTED|Intermediate||0||
48564974|NCT02502149|101714065|FG000|COMPLETED|Intermediate||23||
48117551|NCT02751983|100612773|FG001|COMPLETED|One-Month Follow-Up Assessments||23||
48117552|NCT02751983|100612772|FG000|NOT COMPLETED|One-Month Follow-Up Assessments||14||
48117553|NCT02751983|100612773|FG001|NOT COMPLETED|One-Month Follow-Up Assessments||12||
48117554|NCT02751983|100612772|FG000|STARTED|Three-Month Follow-Up Assessments||35||
48117555|NCT02751983|100612773|FG001|STARTED|Three-Month Follow-Up Assessments||35||
48117556|NCT02751983|100612772|FG000|COMPLETED|Three-Month Follow-Up Assessments||23||
48564975|NCT02502149|101714066|FG001|COMPLETED|Intermediate||0||
48564976|NCT02502149|101714067|FG002|COMPLETED|Intermediate||0||
48564977|NCT02502149|101714068|FG003|COMPLETED|Intermediate||0||
48564978|NCT02502149|101714069|FG004|COMPLETED|Intermediate||0||
48564979|NCT02502149|101714065|FG000|NOT COMPLETED|Intermediate||1||
48564980|NCT02502149|101714066|FG001|NOT COMPLETED|Intermediate||0||
48564981|NCT02502149|101714067|FG002|NOT COMPLETED|Intermediate||0||
48564982|NCT02502149|101714068|FG003|NOT COMPLETED|Intermediate||0||
48564983|NCT02502149|101714069|FG004|NOT COMPLETED|Intermediate||0||
48564984|NCT02502149|101714065|FG000|STARTED|PK2 Assessment Period||0||
48564985|NCT02502149|101714066|FG001|STARTED|PK2 Assessment Period||11||
48564986|NCT02502149|101714067|FG002|STARTED|PK2 Assessment Period||12||
48564987|NCT02502149|101714068|FG003|STARTED|PK2 Assessment Period||0||
48564988|NCT02502149|101714069|FG004|STARTED|PK2 Assessment Period||0||
48564989|NCT02502149|101714065|FG000|COMPLETED|PK2 Assessment Period||0||
48564990|NCT02502149|101714066|FG001|COMPLETED|PK2 Assessment Period||11||
48564991|NCT02502149|101714067|FG002|COMPLETED|PK2 Assessment Period||12||
48564992|NCT02502149|101714068|FG003|COMPLETED|PK2 Assessment Period||0||
48564993|NCT02502149|101714069|FG004|COMPLETED|PK2 Assessment Period||0||
48564994|NCT02502149|101714065|FG000|NOT COMPLETED|PK2 Assessment Period||0||
48564995|NCT02502149|101714066|FG001|NOT COMPLETED|PK2 Assessment Period||0||
48564996|NCT02502149|101714067|FG002|NOT COMPLETED|PK2 Assessment Period||0||
48564997|NCT02502149|101714068|FG003|NOT COMPLETED|PK2 Assessment Period||0||
48564998|NCT02502149|101714069|FG004|NOT COMPLETED|PK2 Assessment Period||0||
48564999|NCT02502149|101714065|FG000|STARTED|Treatment Period||0||
48565000|NCT02502149|101714066|FG001|STARTED|Treatment Period||0||
48565001|NCT02502149|101714067|FG002|STARTED|Treatment Period||0||
48565002|NCT02502149|101714068|FG003|STARTED|Treatment Period||11||
48565003|NCT02502149|101714069|FG004|STARTED|Treatment Period||12||
48565004|NCT02502149|101714065|FG000|COMPLETED|Treatment Period||0||
48565005|NCT02502149|101714066|FG001|COMPLETED|Treatment Period||0||
48565006|NCT02502149|101714067|FG002|COMPLETED|Treatment Period||0||
48565007|NCT02502149|101714068|FG003|COMPLETED|Treatment Period||11||
48117557|NCT02751983|100612773|FG001|COMPLETED|Three-Month Follow-Up Assessments||19||
48117558|NCT02751983|100612772|FG000|NOT COMPLETED|Three-Month Follow-Up Assessments||12||
48117559|NCT02751983|100612773|FG001|NOT COMPLETED|Three-Month Follow-Up Assessments||16||
48117560|NCT01585766|100612774|FG000|STARTED|Overall Study||7||
48117561|NCT01585766|100612775|FG001|STARTED|Overall Study||5||
48117562|NCT01585766|100612776|FG002|STARTED|Overall Study||3||
48117563|NCT01585766|100612777|FG003|STARTED|Overall Study||4||
48117564|NCT01585766|100612778|FG004|STARTED|Overall Study||3||
48117565|NCT01585766|100612779|FG005|STARTED|Overall Study||6||
48117566|NCT01585766|100612774|FG000|COMPLETED|Overall Study||7||
48117567|NCT01585766|100612775|FG001|COMPLETED|Overall Study||3||
48117568|NCT01585766|100612776|FG002|COMPLETED|Overall Study||1||
48117569|NCT01585766|100612777|FG003|COMPLETED|Overall Study||4||
48117570|NCT01585766|100612778|FG004|COMPLETED|Overall Study||3||
48565008|NCT02502149|101714069|FG004|COMPLETED|Treatment Period||12||
48565009|NCT02502149|101714065|FG000|NOT COMPLETED|Treatment Period||0||
48565010|NCT02502149|101714066|FG001|NOT COMPLETED|Treatment Period||0||
48565011|NCT02502149|101714067|FG002|NOT COMPLETED|Treatment Period||0||
48565012|NCT02502149|101714068|FG003|NOT COMPLETED|Treatment Period||0||
48565013|NCT02502149|101714069|FG004|NOT COMPLETED|Treatment Period||0||
48565014|NCT00661557|101714070|FG000|STARTED|Overall Study||192||
48565015|NCT00661557|101714071|FG001|STARTED|Overall Study||79||
48565016|NCT00661557|101714070|FG000|COMPLETED|Overall Study||183||
48565017|NCT00661557|101714071|FG001|COMPLETED|Overall Study||79||
48565018|NCT00661557|101714070|FG000|NOT COMPLETED|Overall Study||9||
48565019|NCT00661557|101714071|FG001|NOT COMPLETED|Overall Study||0||
48565020|NCT00513695|101714072|FG000|STARTED|Overall Study||68||
48565021|NCT00513695|101714072|FG000|COMPLETED|Overall Study||63||
48565022|NCT00513695|101714072|FG000|NOT COMPLETED|Overall Study||5||
48565023|NCT04910100|101714073|FG000|STARTED|Overall Study||54||
48565024|NCT04910100|101714074|FG001|STARTED|Overall Study||58||
48565025|NCT04910100|101714075|FG002|STARTED|Overall Study||56||
48565026|NCT04910100|101714076|FG003|STARTED|Overall Study||58||
48697802|NCT01511614|102045472|FG003|STARTED|Overall Study||32||
48117571|NCT01585766|100612779|FG005|COMPLETED|Overall Study||6||
48117572|NCT01585766|100612774|FG000|NOT COMPLETED|Overall Study||0||
48117573|NCT01585766|100612775|FG001|NOT COMPLETED|Overall Study||2||
48117574|NCT01585766|100612776|FG002|NOT COMPLETED|Overall Study||2||
48117575|NCT01585766|100612777|FG003|NOT COMPLETED|Overall Study||0||
48117576|NCT01585766|100612778|FG004|NOT COMPLETED|Overall Study||0||
48117577|NCT01585766|100612779|FG005|NOT COMPLETED|Overall Study||0||
48117578|NCT05022810|100612780|FG000|STARTED|Period 1 (2 Days)||18||
48117579|NCT05022810|100612781|FG001|STARTED|Period 1 (2 Days)||17||
48565027|NCT04910100|101714073|FG000|COMPLETED|Overall Study||49||
48565028|NCT04910100|101714074|FG001|COMPLETED|Overall Study||51||
48565029|NCT04910100|101714075|FG002|COMPLETED|Overall Study||55||
48565030|NCT04910100|101714076|FG003|COMPLETED|Overall Study||54||
48565031|NCT04910100|101714073|FG000|NOT COMPLETED|Overall Study||5||
48565032|NCT04910100|101714074|FG001|NOT COMPLETED|Overall Study||7||
48565033|NCT04910100|101714075|FG002|NOT COMPLETED|Overall Study||1||
48565034|NCT04910100|101714076|FG003|NOT COMPLETED|Overall Study||4||
48565035|NCT00127231|101714077|FG000|STARTED|Overall Study||74||
48565036|NCT00127231|101714078|FG001|STARTED|Overall Study||74||
48565037|NCT00127231|101714077|FG000|COMPLETED|Overall Study||68||
48279103|NCT02909764|101007198|FG000|COMPLETED|Overall Study||19||
48279104|NCT02909764|101007199|FG001|COMPLETED|Overall Study||20||
48279105|NCT02909764|101007198|FG000|NOT COMPLETED|Overall Study||0||
48279106|NCT02909764|101007199|FG001|NOT COMPLETED|Overall Study||0||
48279107|NCT02712905|101007200|FG000|STARTED|Monotherapy||3||
48279108|NCT02712905|101007201|FG001|STARTED|Monotherapy||6||
48279109|NCT02712905|101007202|FG002|STARTED|Monotherapy||1||
48279110|NCT02712905|101007203|FG003|STARTED|Monotherapy||5||
48279111|NCT02712905|101007204|FG004|STARTED|Monotherapy||18||
48279112|NCT02712905|101007205|FG005|STARTED|Monotherapy||2||
48565038|NCT00127231|101714078|FG001|COMPLETED|Overall Study||68||
48565039|NCT00127231|101714077|FG000|NOT COMPLETED|Overall Study||6||
48565040|NCT00127231|101714078|FG001|NOT COMPLETED|Overall Study||6||
48565041|NCT00080912|101714079|FG000|STARTED|Overall Study||425||
48565042|NCT00080912|101714080|FG001|STARTED|Overall Study||425||
48565043|NCT00080912|101714079|FG000|COMPLETED|Overall Study||425||
48565044|NCT00080912|101714080|FG001|COMPLETED|Overall Study||425||
48565045|NCT00080912|101714079|FG000|NOT COMPLETED|Overall Study||0||
48565046|NCT00080912|101714080|FG001|NOT COMPLETED|Overall Study||0||
48565047|NCT02586974|101714081|FG000|STARTED|Overall Study||32||
48565048|NCT02586974|101714082|FG001|STARTED|Overall Study||32||
48565049|NCT02586974|101714081|FG000|COMPLETED|Overall Study||32||
48565050|NCT02586974|101714082|FG001|COMPLETED|Overall Study||32||
48565051|NCT02586974|101714081|FG000|NOT COMPLETED|Overall Study||0||
48565052|NCT02586974|101714082|FG001|NOT COMPLETED|Overall Study||0||
48565053|NCT02418182|101714083|FG000|STARTED|Overall Study||49||
48565054|NCT02418182|101714084|FG001|STARTED|Overall Study||50||
48565055|NCT02418182|101714083|FG000|COMPLETED|Overall Study||31||
48565056|NCT02418182|101714084|FG001|COMPLETED|Overall Study||33||
48565057|NCT02418182|101714083|FG000|NOT COMPLETED|Overall Study||18||
48565058|NCT02418182|101714084|FG001|NOT COMPLETED|Overall Study||17||
48565059|NCT00315458|101714085|FG000|STARTED|Overall Study||51||
48565060|NCT00315458|101714086|FG001|STARTED|Overall Study||56||
48565061|NCT00315458|101714087|FG002|STARTED|Overall Study||159||
48565062|NCT00315458|101714088|FG003|STARTED|Overall Study||39||
48394583|NCT02983799|101295979|FG003|STARTED|Overall Study||90||
48394584|NCT02983799|101295980|FG004|STARTED|Overall Study||13||
48394585|NCT02983799|101295976|FG000|COMPLETED|Overall Study||25|Patients continuing study at data cut-off|
48394586|NCT02983799|101295977|FG001|COMPLETED|Overall Study||8|Patients continuing study at data cut-off|
48394587|NCT02983799|101295978|FG002|COMPLETED|Overall Study||18|Patients continuing study at data cut-off|
48279113|NCT02712905|101007206|FG006|STARTED|Monotherapy||3||
48279114|NCT02712905|101007207|FG007|STARTED|Monotherapy||3||
48279115|NCT02712905|101007208|FG008|STARTED|Monotherapy||1||
48394588|NCT02983799|101295979|FG003|COMPLETED|Overall Study||14|Patients continuing study at data cut-off|
48565063|NCT00315458|101714085|FG000|COMPLETED|Overall Study||48||
48117580|NCT05022810|100612780|FG000|COMPLETED|Period 1 (2 Days)||18||
48279116|NCT02712905|101007209|FG009|STARTED|Monotherapy||36||
48279117|NCT02712905|101007210|FG010|STARTED|Monotherapy||3||
48279118|NCT02712905|101007211|FG011|STARTED|Monotherapy||7||
48279119|NCT02712905|101007212|FG012|STARTED|Monotherapy||0||
48279120|NCT02712905|101007213|FG013|STARTED|Monotherapy||0||
48279121|NCT02712905|101007214|FG014|STARTED|Monotherapy||0||
48279122|NCT02712905|101007215|FG015|STARTED|Monotherapy||0||
48279123|NCT02712905|101007216|FG016|STARTED|Monotherapy||0||
48279124|NCT02712905|101007217|FG017|STARTED|Monotherapy||0||
48279125|NCT02712905|101007200|FG000|COMPLETED|Monotherapy||0||
48279126|NCT02712905|101007201|FG001|COMPLETED|Monotherapy||0||
48565064|NCT00315458|101714086|FG001|COMPLETED|Overall Study||44||
48565065|NCT00315458|101714087|FG002|COMPLETED|Overall Study||107||
48565066|NCT00315458|101714088|FG003|COMPLETED|Overall Study||10||
48565067|NCT00315458|101714085|FG000|NOT COMPLETED|Overall Study||3||
48565068|NCT00315458|101714086|FG001|NOT COMPLETED|Overall Study||12||
48565069|NCT00315458|101714087|FG002|NOT COMPLETED|Overall Study||52||
48565070|NCT00315458|101714088|FG003|NOT COMPLETED|Overall Study||29||
48565071|NCT03922321|101714089|FG000|STARTED|Overall Study||7||
48565072|NCT03922321|101714089|FG000|COMPLETED|Overall Study||5||
48565073|NCT03922321|101714089|FG000|NOT COMPLETED|Overall Study||2||
48565074|NCT01415518|101714090|FG000|STARTED|Overall Study||292||
48279127|NCT02712905|101007202|FG002|COMPLETED|Monotherapy||0||
48279128|NCT02712905|101007203|FG003|COMPLETED|Monotherapy||0||
48565075|NCT01415518|101714091|FG001|STARTED|Overall Study||292||
48565076|NCT01415518|101714090|FG000|Patients Who Received Study Treatment|Overall Study||290||
48565077|NCT01415518|101714091|FG001|Patients Who Received Study Treatment|Overall Study||292||
48565078|NCT01415518|101714090|FG000|Pts With Correct Randomized Treatment|Overall Study||290||
48565079|NCT01415518|101714091|FG001|Pts With Correct Randomized Treatment|Overall Study||289||
48565080|NCT01415518|101714090|FG000|COMPLETED|Overall Study||276||
48565081|NCT01415518|101714091|FG001|COMPLETED|Overall Study||261||
48565082|NCT01415518|101714090|FG000|NOT COMPLETED|Overall Study||16||
48565083|NCT01415518|101714091|FG001|NOT COMPLETED|Overall Study||31||
48565084|NCT03218995|101714092|FG000|STARTED|Overall Study||15||
48279129|NCT02712905|101007204|FG004|COMPLETED|Monotherapy||0||
48279130|NCT02712905|101007205|FG005|COMPLETED|Monotherapy||0||
48279131|NCT02712905|101007206|FG006|COMPLETED|Monotherapy||0||
48279132|NCT02712905|101007207|FG007|COMPLETED|Monotherapy||0||
48279133|NCT02712905|101007208|FG008|COMPLETED|Monotherapy||0||
48279134|NCT02712905|101007209|FG009|COMPLETED|Monotherapy||0||
48279135|NCT02712905|101007210|FG010|COMPLETED|Monotherapy||0||
48279136|NCT02712905|101007211|FG011|COMPLETED|Monotherapy||0||
48279137|NCT02712905|101007212|FG012|COMPLETED|Monotherapy||0||
48279138|NCT02712905|101007213|FG013|COMPLETED|Monotherapy||0||
48279139|NCT02712905|101007214|FG014|COMPLETED|Monotherapy||0||
48279140|NCT02712905|101007215|FG015|COMPLETED|Monotherapy||0||
48279141|NCT02712905|101007216|FG016|COMPLETED|Monotherapy||0||
48279142|NCT02712905|101007217|FG017|COMPLETED|Monotherapy||0||
48279143|NCT02712905|101007200|FG000|NOT COMPLETED|Monotherapy||3||
48279144|NCT02712905|101007201|FG001|NOT COMPLETED|Monotherapy||6||
48279145|NCT02712905|101007202|FG002|NOT COMPLETED|Monotherapy||1||
48279146|NCT02712905|101007203|FG003|NOT COMPLETED|Monotherapy||5||
48279147|NCT02712905|101007204|FG004|NOT COMPLETED|Monotherapy||18||
48279148|NCT02712905|101007205|FG005|NOT COMPLETED|Monotherapy||2||
48279149|NCT02712905|101007206|FG006|NOT COMPLETED|Monotherapy||3||
48279150|NCT02712905|101007207|FG007|NOT COMPLETED|Monotherapy||3||
48279151|NCT02712905|101007208|FG008|NOT COMPLETED|Monotherapy||1||
48279152|NCT02712905|101007209|FG009|NOT COMPLETED|Monotherapy||36||
48565085|NCT03218995|101714092|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15||
48565086|NCT03218995|101714092|FG000|COMPLETED|Overall Study||15||
48565087|NCT03218995|101714092|FG000|NOT COMPLETED|Overall Study||0||
48565088|NCT00114140|101714093|FG000|STARTED|Overall Study||136||
48565089|NCT00114140|101714093|FG000|COMPLETED|Overall Study||129||
48117581|NCT05022810|100612781|FG001|COMPLETED|Period 1 (2 Days)||17||
48117582|NCT05022810|100612780|FG000|NOT COMPLETED|Period 1 (2 Days)||0||
48117583|NCT05022810|100612781|FG001|NOT COMPLETED|Period 1 (2 Days)||0||
48117584|NCT05022810|100612780|FG000|STARTED|Washout Period (3 Days)||18||
48117585|NCT05022810|100612781|FG001|STARTED|Washout Period (3 Days)||17||
48117586|NCT05022810|100612780|FG000|COMPLETED|Washout Period (3 Days)||18||
48117587|NCT05022810|100612781|FG001|COMPLETED|Washout Period (3 Days)||17||
48117588|NCT05022810|100612780|FG000|NOT COMPLETED|Washout Period (3 Days)||0||
48117589|NCT05022810|100612781|FG001|NOT COMPLETED|Washout Period (3 Days)||0||
48279153|NCT02712905|101007210|FG010|NOT COMPLETED|Monotherapy||3||
48279154|NCT02712905|101007211|FG011|NOT COMPLETED|Monotherapy||7||
48279155|NCT02712905|101007212|FG012|NOT COMPLETED|Monotherapy||0||
48279156|NCT02712905|101007213|FG013|NOT COMPLETED|Monotherapy||0||
48279157|NCT02712905|101007214|FG014|NOT COMPLETED|Monotherapy||0||
48279158|NCT02712905|101007215|FG015|NOT COMPLETED|Monotherapy||0||
48279159|NCT02712905|101007216|FG016|NOT COMPLETED|Monotherapy||0||
48279160|NCT02712905|101007217|FG017|NOT COMPLETED|Monotherapy||0||
48279161|NCT02712905|101007200|FG000|STARTED|Combination Therapy||0||
48279162|NCT02712905|101007201|FG001|STARTED|Combination Therapy||0||
48279163|NCT02712905|101007202|FG002|STARTED|Combination Therapy||0||
48279164|NCT02712905|101007203|FG003|STARTED|Combination Therapy||0||
48279165|NCT02712905|101007204|FG004|STARTED|Combination Therapy||0||
48279166|NCT02712905|101007205|FG005|STARTED|Combination Therapy||0||
48279167|NCT02712905|101007206|FG006|STARTED|Combination Therapy||0||
48279168|NCT02712905|101007207|FG007|STARTED|Combination Therapy||0||
48279169|NCT02712905|101007208|FG008|STARTED|Combination Therapy||0||
48279170|NCT02712905|101007209|FG009|STARTED|Combination Therapy||0||
48279171|NCT02712905|101007210|FG010|STARTED|Combination Therapy||0||
48279172|NCT02712905|101007211|FG011|STARTED|Combination Therapy||0||
48279173|NCT02712905|101007212|FG012|STARTED|Combination Therapy||5||
48279174|NCT02712905|101007213|FG013|STARTED|Combination Therapy||7||
48565090|NCT00114140|101714093|FG000|NOT COMPLETED|Overall Study||7||
48565091|NCT00226499|101714094|FG000|STARTED|Overall Study||2489||
48565092|NCT00226499|101714095|FG001|STARTED|Overall Study||2487||
48117590|NCT05022810|100612780|FG000|STARTED|Period 2 (2 Days)||18||
48279175|NCT02712905|101007214|FG014|STARTED|Combination Therapy||1||
48279176|NCT02712905|101007215|FG015|STARTED|Combination Therapy||7||
48279177|NCT02712905|101007216|FG016|STARTED|Combination Therapy||1||
48279178|NCT02712905|101007217|FG017|STARTED|Combination Therapy||6||
48279179|NCT02712905|101007200|FG000|COMPLETED|Combination Therapy||0||
48565093|NCT00226499|101714096|FG002|STARTED|Overall Study||827||
48565094|NCT00226499|101714094|FG000|COMPLETED|Overall Study||1415||
48565095|NCT00226499|101714095|FG001|COMPLETED|Overall Study||1415||
48565096|NCT00226499|101714096|FG002|COMPLETED|Overall Study||468||
48117591|NCT05022810|100612781|FG001|STARTED|Period 2 (2 Days)||17||
48117592|NCT05022810|100612780|FG000|COMPLETED|Period 2 (2 Days)||18||
48117593|NCT05022810|100612781|FG001|COMPLETED|Period 2 (2 Days)||17||
48117594|NCT05022810|100612780|FG000|NOT COMPLETED|Period 2 (2 Days)||0||
48117595|NCT05022810|100612781|FG001|NOT COMPLETED|Period 2 (2 Days)||0||
48117596|NCT00679341|100612782|FG000|STARTED|Overall Study||67||
48117597|NCT00679341|100612783|FG001|STARTED|Overall Study||70||
48117598|NCT00679341|100612782|FG000|COMPLETED|Overall Study||14||
48117599|NCT00679341|100612783|FG001|COMPLETED|Overall Study||19||
48117600|NCT00679341|100612782|FG000|NOT COMPLETED|Overall Study||53||
48117601|NCT00679341|100612783|FG001|NOT COMPLETED|Overall Study||51||
48117602|NCT04099524|100612784|FG000|STARTED|Overall Study||20||
48117603|NCT04099524|100612785|FG001|STARTED|Overall Study||20||
48117604|NCT04099524|100612784|FG000|COMPLETED|Overall Study||20||
48117605|NCT04099524|100612785|FG001|COMPLETED|Overall Study||19||
48117606|NCT04099524|100612784|FG000|NOT COMPLETED|Overall Study||0||
48117607|NCT04099524|100612785|FG001|NOT COMPLETED|Overall Study||1||
48117608|NCT02224872|100612786|FG000|STARTED|Overall Study||18||
48117609|NCT02224872|100612786|FG000|COMPLETED|Overall Study||16||
48117610|NCT02224872|100612786|FG000|NOT COMPLETED|Overall Study||2||
48117611|NCT05955560|100612787|FG000|STARTED|Void 1||30||
48117612|NCT05955560|100612788|FG001|STARTED|Void 1||29||
48117613|NCT05955560|100612787|FG000|COMPLETED|Void 1||30||
48117614|NCT05955560|100612788|FG001|COMPLETED|Void 1||29||
48117615|NCT05955560|100612787|FG000|NOT COMPLETED|Void 1||0||
48117616|NCT05955560|100612788|FG001|NOT COMPLETED|Void 1||0||
48117617|NCT05955560|100612787|FG000|STARTED|Void 2||30||
48117618|NCT05955560|100612788|FG001|STARTED|Void 2||29||
48117619|NCT05955560|100612787|FG000|COMPLETED|Void 2||30||
48117620|NCT05955560|100612788|FG001|COMPLETED|Void 2||29||
48117621|NCT05955560|100612787|FG000|NOT COMPLETED|Void 2||0||
48117622|NCT05955560|100612788|FG001|NOT COMPLETED|Void 2||0||
48117623|NCT00767676|100612789|FG000|STARTED|Overall Study||259||
48117624|NCT00767676|100612789|FG000|COMPLETED|Overall Study||205||
48117625|NCT00767676|100612789|FG000|NOT COMPLETED|Overall Study||54||
48117626|NCT01117727|100612790|FG000|STARTED|Overall Study||1||
48117627|NCT01117727|100612790|FG000|COMPLETED|Overall Study||1||
48117628|NCT01117727|100612790|FG000|NOT COMPLETED|Overall Study||0||
48117629|NCT02127307|100612791|FG000|STARTED|Overall Study||964||
48565097|NCT00226499|101714094|FG000|NOT COMPLETED|Overall Study||1074||
48565098|NCT00226499|101714095|FG001|NOT COMPLETED|Overall Study||1072||
48565099|NCT00226499|101714096|FG002|NOT COMPLETED|Overall Study||359||
48565100|NCT01554527|101714097|FG000|STARTED|Overall Study||34||
48565101|NCT01554527|101714098|FG001|STARTED|Overall Study||38||
48565102|NCT01554527|101714099|FG002|STARTED|Overall Study||33||
48117630|NCT02127307|100612791|FG000|COMPLETED|Overall Study||656||
48117631|NCT02127307|100612791|FG000|NOT COMPLETED|Overall Study||308||
48117632|NCT02471521|100612792|FG000|STARTED|Overall Study||60||
48117633|NCT02471521|100612793|FG001|STARTED|Overall Study||60||
48117634|NCT02471521|100612792|FG000|COMPLETED|Overall Study||60||
48117635|NCT02471521|100612793|FG001|COMPLETED|Overall Study||52||
48117636|NCT02471521|100612792|FG000|NOT COMPLETED|Overall Study||0||
48117637|NCT02471521|100612793|FG001|NOT COMPLETED|Overall Study||8||
48117638|NCT01427296|100612794|FG000|STARTED|Overall Study||1041||
48117639|NCT01427296|100612795|FG001|STARTED|Overall Study||1051||
48117640|NCT01427296|100612794|FG000|COMPLETED|Overall Study||1041||
48117641|NCT01427296|100612795|FG001|COMPLETED|Overall Study||1051||
48117642|NCT01427296|100612794|FG000|NOT COMPLETED|Overall Study||0||
48117643|NCT01427296|100612795|FG001|NOT COMPLETED|Overall Study||0||
48565103|NCT01554527|101714097|FG000|Crossed Over to Control|Overall Study||0||
48565104|NCT01554527|101714098|FG001|Crossed Over to Control|Overall Study||0||
48565105|NCT01554527|101714099|FG002|Crossed Over to Control|Overall Study||2||
48117644|NCT00799617|100612796|FG000|STARTED|Main Testosterone Trial||395||
48117645|NCT00799617|100612797|FG001|STARTED|Main Testosterone Trial||395||
48117646|NCT00799617|100612796|FG000|COMPLETED|Main Testosterone Trial||376|The Testosterone Trials are a coordinated set of 7 trials.|
48117647|NCT00799617|100612797|FG001|COMPLETED|Main Testosterone Trial||374|The Testosterone Trials are a coordinated set of 7 trials.|
48565106|NCT01554527|101714097|FG000|Had CPAP Titration|Overall Study||0||
48565107|NCT01554527|101714098|FG001|Had CPAP Titration|Overall Study||38||
48565108|NCT01554527|101714099|FG002|Had CPAP Titration|Overall Study||30||
48565109|NCT01554527|101714097|FG000|Initiated CPAP Treatment at Home|Overall Study||0||
48565110|NCT01554527|101714098|FG001|Initiated CPAP Treatment at Home|Overall Study||38||
48117648|NCT00799617|100612796|FG000|NOT COMPLETED|Main Testosterone Trial||19||
48117649|NCT00799617|100612797|FG001|NOT COMPLETED|Main Testosterone Trial||21||
48117650|NCT00799617|100612796|FG000|STARTED|Sexual Funtion Trial||234||
48117651|NCT00799617|100612797|FG001|STARTED|Sexual Funtion Trial||236||
48117652|NCT00799617|100612796|FG000|COMPLETED|Sexual Funtion Trial||218||
48117653|NCT00799617|100612797|FG001|COMPLETED|Sexual Funtion Trial||215||
48117654|NCT00799617|100612796|FG000|NOT COMPLETED|Sexual Funtion Trial||16||
48117655|NCT00799617|100612797|FG001|NOT COMPLETED|Sexual Funtion Trial||21||
48117656|NCT00799617|100612796|FG000|STARTED|Physical Function Trial||191||
48117657|NCT00799617|100612797|FG001|STARTED|Physical Function Trial||196||
48117658|NCT00799617|100612796|FG000|COMPLETED|Physical Function Trial||185||
48117659|NCT00799617|100612797|FG001|COMPLETED|Physical Function Trial||185||
48117660|NCT00799617|100612796|FG000|NOT COMPLETED|Physical Function Trial||6||
48117661|NCT00799617|100612797|FG001|NOT COMPLETED|Physical Function Trial||11||
48117662|NCT00799617|100612796|FG000|STARTED|Vitality Trial||236||
48117663|NCT00799617|100612797|FG001|STARTED|Vitality Trial||238||
48117664|NCT00799617|100612796|FG000|COMPLETED|Vitality Trial||229||
48117665|NCT00799617|100612797|FG001|COMPLETED|Vitality Trial||216||
48117666|NCT00799617|100612796|FG000|NOT COMPLETED|Vitality Trial||7||
48117667|NCT00799617|100612797|FG001|NOT COMPLETED|Vitality Trial||22||
48117668|NCT00799617|100612796|FG000|STARTED|Cardiovascular Trial||88||
48117669|NCT00799617|100612797|FG001|STARTED|Cardiovascular Trial||82||
48117670|NCT00799617|100612796|FG000|COMPLETED|Cardiovascular Trial||73||
48117671|NCT00799617|100612797|FG001|COMPLETED|Cardiovascular Trial||65||
48565111|NCT01554527|101714099|FG002|Initiated CPAP Treatment at Home|Overall Study||28||
48565112|NCT01554527|101714097|FG000|Completed as a Control|Overall Study||33||
48565113|NCT01554527|101714098|FG001|Completed as a Control|Overall Study||0||
48565114|NCT01554527|101714099|FG002|Completed as a Control|Overall Study||1||
48117672|NCT00799617|100612796|FG000|NOT COMPLETED|Cardiovascular Trial||15||
48117673|NCT00799617|100612797|FG001|NOT COMPLETED|Cardiovascular Trial||17||
48117674|NCT00799617|100612796|FG000|STARTED|Bone Trial||110||
48117675|NCT00799617|100612797|FG001|STARTED|Bone Trial||101||
48117676|NCT00799617|100612796|FG000|COMPLETED|Bone Trial||104||
48117677|NCT00799617|100612797|FG001|COMPLETED|Bone Trial||85||
48117678|NCT00799617|100612796|FG000|NOT COMPLETED|Bone Trial||6||
48117679|NCT00799617|100612797|FG001|NOT COMPLETED|Bone Trial||16||
48117680|NCT00799617|100612796|FG000|STARTED|Cognitive Function Trial||247||
48117681|NCT00799617|100612797|FG001|STARTED|Cognitive Function Trial||246||
48117682|NCT00799617|100612796|FG000|COMPLETED|Cognitive Function Trial||247||
48117683|NCT00799617|100612797|FG001|COMPLETED|Cognitive Function Trial||245||
48117684|NCT00799617|100612796|FG000|NOT COMPLETED|Cognitive Function Trial||0||
48117685|NCT00799617|100612797|FG001|NOT COMPLETED|Cognitive Function Trial||1||
48117686|NCT00799617|100612796|FG000|STARTED|Anemia Trial||27||
48117687|NCT00799617|100612797|FG001|STARTED|Anemia Trial||35||
48117688|NCT00799617|100612796|FG000|COMPLETED|Anemia Trial||24||
48117689|NCT00799617|100612797|FG001|COMPLETED|Anemia Trial||32||
48117690|NCT00799617|100612796|FG000|NOT COMPLETED|Anemia Trial||3||
48117691|NCT00799617|100612797|FG001|NOT COMPLETED|Anemia Trial||3||
48117692|NCT00098839|100612798|FG000|STARTED|Overall Study||56||
48117693|NCT00098839|100612799|FG001|STARTED|Overall Study||60||
48117694|NCT00098839|100612798|FG000|COMPLETED|Overall Study||24||
48117695|NCT00098839|100612799|FG001|COMPLETED|Overall Study||27||
48697803|NCT01511614|102045473|FG004|STARTED|Overall Study||33||
48117696|NCT00098839|100612798|FG000|NOT COMPLETED|Overall Study||32||
48117697|NCT00098839|100612799|FG001|NOT COMPLETED|Overall Study||33||
48117698|NCT01767792|100612800|FG000|STARTED|Overall Study||22||
48117699|NCT01767792|100612800|FG000|COMPLETED|Overall Study||20||
48117700|NCT01767792|100612800|FG000|NOT COMPLETED|Overall Study||2||
48117701|NCT02432716|100612801|FG000|STARTED|Overall Study||6||
48117702|NCT02432716|100612802|FG001|STARTED|Overall Study||6||
48117703|NCT02432716|100612801|FG000|COMPLETED|Overall Study||6||
48117704|NCT02432716|100612802|FG001|COMPLETED|Overall Study||6||
48117705|NCT02432716|100612801|FG000|NOT COMPLETED|Overall Study||0||
48117706|NCT02432716|100612802|FG001|NOT COMPLETED|Overall Study||0||
48117707|NCT04537806|100612803|FG000|STARTED|Overall Study||15||
48117708|NCT04537806|100612804|FG001|STARTED|Overall Study||14||
48117709|NCT04537806|100612803|FG000|Safety Analysis Set|Overall Study||14|Safety analysis set included all participants who initiated Investigational product (IP) (brexanolone or placebo).|
48117710|NCT04537806|100612804|FG001|Safety Analysis Set|Overall Study||14|Safety analysis set included all participants who initiated Investigational product (IP) (brexanolone or placebo).|
48117711|NCT04537806|100612803|FG000|Full Analysis Set|Overall Study||14|Full analysis set (FAS) included all randomized participants who initiated IP (brexanolone or placebo).|
48117712|NCT04537806|100612804|FG001|Full Analysis Set|Overall Study||14|Full analysis set (FAS) included all randomized participants who initiated IP (brexanolone or placebo).|
48117713|NCT04537806|100612803|FG000|COMPLETED|Overall Study||13||
48117714|NCT04537806|100612804|FG001|COMPLETED|Overall Study||13||
48117715|NCT04537806|100612803|FG000|NOT COMPLETED|Overall Study||2||
48117716|NCT04537806|100612804|FG001|NOT COMPLETED|Overall Study||1||
48117717|NCT00537446|100612805|FG000|STARTED|Overall Study||8||
48565115|NCT01554527|101714097|FG000|COMPLETED|Overall Study||33||
48565116|NCT01554527|101714098|FG001|COMPLETED|Overall Study||38||
48697804|NCT01511614|102045474|FG005|STARTED|Overall Study||3||
48565117|NCT01554527|101714099|FG002|COMPLETED|Overall Study||25||
48565118|NCT01554527|101714097|FG000|NOT COMPLETED|Overall Study||1||
48565119|NCT01554527|101714098|FG001|NOT COMPLETED|Overall Study||0||
48565120|NCT01554527|101714099|FG002|NOT COMPLETED|Overall Study||8||
48117718|NCT00537446|100612805|FG000|COMPLETED|Overall Study||8||
48117719|NCT00537446|100612805|FG000|NOT COMPLETED|Overall Study||0||
48117720|NCT04452188|100612806|FG000|STARTED|Overall Study||15||
48117721|NCT04452188|100612807|FG001|STARTED|Overall Study||14||
48117722|NCT04452188|100612806|FG000|COMPLETED|Overall Study||15||
48117723|NCT04452188|100612807|FG001|COMPLETED|Overall Study||14||
48117724|NCT04452188|100612806|FG000|NOT COMPLETED|Overall Study||0||
48117725|NCT04452188|100612807|FG001|NOT COMPLETED|Overall Study||0||
48117726|NCT00775437|100612808|FG000|STARTED|Overall Study||32||
48117727|NCT00775437|100612808|FG000|COMPLETED|Overall Study||26||
48117728|NCT00775437|100612808|FG000|NOT COMPLETED|Overall Study||6||
48117729|NCT02797262|100612809|FG000|STARTED|Overall Study||65||
48117730|NCT02797262|100612810|FG001|STARTED|Overall Study||65||
48117731|NCT02797262|100612809|FG000|Baseline|Overall Study||54||
48117732|NCT02797262|100612810|FG001|Baseline|Overall Study||58||
48117733|NCT02797262|100612809|FG000|COMPLETED|Overall Study||45||
48117734|NCT02797262|100612810|FG001|COMPLETED|Overall Study||54||
48117735|NCT02797262|100612809|FG000|NOT COMPLETED|Overall Study||20||
48117736|NCT02797262|100612810|FG001|NOT COMPLETED|Overall Study||11||
48117737|NCT01163604|100612811|FG000|STARTED|Overall Study||58||
48117738|NCT01163604|100612812|FG001|STARTED|Overall Study||56||
48117739|NCT01163604|100612811|FG000|COMPLETED|Overall Study||58||
48117740|NCT01163604|100612812|FG001|COMPLETED|Overall Study||56||
48117741|NCT01163604|100612811|FG000|NOT COMPLETED|Overall Study||0||
48117742|NCT01163604|100612812|FG001|NOT COMPLETED|Overall Study||0||
48117743|NCT01362907|100612813|FG000|STARTED|Period 1, One Week||20||
48117744|NCT01362907|100612814|FG001|STARTED|Period 1, One Week||20||
48565121|NCT02568189|101717193|FG000|STARTED|Overall Study||0||
48565122|NCT02568189|101717194|FG001|STARTED|Overall Study||0||
48565123|NCT02568189|101717195|FG002|STARTED|Overall Study||52||
48565124|NCT02568189|101717196|FG003|STARTED|Overall Study||54||
48565125|NCT02568189|101717193|FG000|COMPLETED|Overall Study||0||
48565126|NCT02568189|101717194|FG001|COMPLETED|Overall Study||0||
48117745|NCT01362907|100612813|FG000|COMPLETED|Period 1, One Week||20||
48117746|NCT01362907|100612814|FG001|COMPLETED|Period 1, One Week||20||
48117747|NCT01362907|100612813|FG000|NOT COMPLETED|Period 1, One Week||0||
48117748|NCT01362907|100612814|FG001|NOT COMPLETED|Period 1, One Week||0||
48117749|NCT01362907|100612813|FG000|STARTED|Period 2, One Week||20||
48117750|NCT01362907|100612814|FG001|STARTED|Period 2, One Week||20||
48117751|NCT01362907|100612813|FG000|COMPLETED|Period 2, One Week||20||
48117752|NCT01362907|100612814|FG001|COMPLETED|Period 2, One Week||20||
48117753|NCT01362907|100612813|FG000|NOT COMPLETED|Period 2, One Week||0||
48117754|NCT01362907|100612814|FG001|NOT COMPLETED|Period 2, One Week||0||
48117755|NCT00128180|100612815|FG000|STARTED|Overall Study||32||
48117756|NCT00128180|100612816|FG001|STARTED|Overall Study||34||
48117757|NCT00128180|100612815|FG000|COMPLETED|Overall Study||32||
48117758|NCT00128180|100612816|FG001|COMPLETED|Overall Study||34||
48117759|NCT00128180|100612815|FG000|NOT COMPLETED|Overall Study||0||
48117760|NCT00128180|100612816|FG001|NOT COMPLETED|Overall Study||0||
48117761|NCT02373124|100612817|FG000|STARTED|Overall Study||4||
48117762|NCT02373124|100612817|FG000|COMPLETED|Overall Study||3||
48117763|NCT02373124|100612817|FG000|NOT COMPLETED|Overall Study||1||
48117764|NCT02148003|100612818|FG000|STARTED|Overall Study||60||
48117765|NCT02148003|100612819|FG001|STARTED|Overall Study||60||
48117766|NCT02148003|100612818|FG000|COMPLETED|Overall Study||59||
48117767|NCT02148003|100612819|FG001|COMPLETED|Overall Study||58||
48117768|NCT02148003|100612818|FG000|NOT COMPLETED|Overall Study||1||
48117769|NCT02148003|100612819|FG001|NOT COMPLETED|Overall Study||2||
48117770|NCT01611571|100612820|FG000|STARTED|Overall Study||11||
48117771|NCT01611571|100612821|FG001|STARTED|Overall Study||10||
48117772|NCT01611571|100612822|FG002|STARTED|Overall Study||10||
48117773|NCT01611571|100612820|FG000|COMPLETED|Overall Study||10||
48117774|NCT01611571|100612821|FG001|COMPLETED|Overall Study||10||
48117775|NCT01611571|100612822|FG002|COMPLETED|Overall Study||9||
48117776|NCT01611571|100612820|FG000|NOT COMPLETED|Overall Study||1||
48117777|NCT01611571|100612821|FG001|NOT COMPLETED|Overall Study||0||
48117778|NCT01611571|100612822|FG002|NOT COMPLETED|Overall Study||1||
48117779|NCT03697811|100612823|FG000|STARTED|Overall Study||107||
48117780|NCT03697811|100612823|FG000|COMPLETED|Overall Study||104||
48565127|NCT02568189|101717195|FG002|COMPLETED|Overall Study||33||
48565128|NCT02568189|101717196|FG003|COMPLETED|Overall Study||36||
48565129|NCT02568189|101717193|FG000|NOT COMPLETED|Overall Study||0||
48565130|NCT02568189|101717194|FG001|NOT COMPLETED|Overall Study||0||
48697805|NCT01511614|102045469|FG000|COMPLETED|Overall Study||3||
48279180|NCT02712905|101007201|FG001|COMPLETED|Combination Therapy||0||
48279181|NCT02712905|101007202|FG002|COMPLETED|Combination Therapy||0||
48565131|NCT02568189|101717195|FG002|NOT COMPLETED|Overall Study||19||
48565132|NCT02568189|101717196|FG003|NOT COMPLETED|Overall Study||18||
48565133|NCT02157935|101717197|FG000|STARTED|Overall Study||606||
48117781|NCT03697811|100612823|FG000|NOT COMPLETED|Overall Study||3||
48117782|NCT00835497|100612824|FG000|STARTED|First Intervention||20||
48117783|NCT00835497|100612825|FG001|STARTED|First Intervention||20||
48117784|NCT00835497|100612824|FG000|COMPLETED|First Intervention||20||
48117785|NCT00835497|100612825|FG001|COMPLETED|First Intervention||20||
48117786|NCT00835497|100612824|FG000|NOT COMPLETED|First Intervention||0||
48279182|NCT02712905|101007203|FG003|COMPLETED|Combination Therapy||0||
48117787|NCT00835497|100612825|FG001|NOT COMPLETED|First Intervention||0||
48117788|NCT00835497|100612824|FG000|STARTED|Washout: 7 Days||20||
48117789|NCT00835497|100612825|FG001|STARTED|Washout: 7 Days||20||
48117790|NCT00835497|100612824|FG000|COMPLETED|Washout: 7 Days||20||
48117791|NCT00835497|100612825|FG001|COMPLETED|Washout: 7 Days||20||
48117792|NCT00835497|100612824|FG000|NOT COMPLETED|Washout: 7 Days||0||
48117793|NCT00835497|100612825|FG001|NOT COMPLETED|Washout: 7 Days||0||
48117794|NCT00835497|100612824|FG000|STARTED|Second Intervention||20||
48117795|NCT00835497|100612825|FG001|STARTED|Second Intervention||20||
48117796|NCT00835497|100612824|FG000|COMPLETED|Second Intervention||20||
48117797|NCT00835497|100612825|FG001|COMPLETED|Second Intervention||20||
48117798|NCT00835497|100612824|FG000|NOT COMPLETED|Second Intervention||0||
48117799|NCT00835497|100612825|FG001|NOT COMPLETED|Second Intervention||0||
48117800|NCT03427658|100612826|FG000|STARTED|Overall Study||21||
48117801|NCT03427658|100612827|FG001|STARTED|Overall Study||15||
48117802|NCT03427658|100612826|FG000|COMPLETED|Overall Study||21||
48117803|NCT03427658|100612827|FG001|COMPLETED|Overall Study||15||
48117804|NCT03427658|100612826|FG000|NOT COMPLETED|Overall Study||0||
48117805|NCT03427658|100612827|FG001|NOT COMPLETED|Overall Study||0||
48117806|NCT03913078|100612828|FG000|STARTED|Overall Study||200||
48117807|NCT03913078|100612829|FG001|STARTED|Overall Study||205||
48117808|NCT03913078|100612828|FG000|COMPLETED|Overall Study||200||
48117809|NCT03913078|100612829|FG001|COMPLETED|Overall Study||205||
48117810|NCT03913078|100612828|FG000|NOT COMPLETED|Overall Study||0||
48117811|NCT03913078|100612829|FG001|NOT COMPLETED|Overall Study||0||
48117812|NCT00293384|100612830|FG000|STARTED|Overall Study||40||
48117813|NCT00293384|100612830|FG000|COMPLETED|Overall Study||35||
48117814|NCT00293384|100612830|FG000|NOT COMPLETED|Overall Study||5||
48117815|NCT02145039|100612831|FG000|STARTED|Overall Study||2||
48117816|NCT02145039|100612831|FG000|COMPLETED|Overall Study||2||
48117817|NCT02145039|100612831|FG000|NOT COMPLETED|Overall Study||0||
48117818|NCT01470469|100612832|FG000|STARTED|Overall Study||21||
48117819|NCT01470469|100612833|FG001|STARTED|Overall Study||62||
48117820|NCT01470469|100612832|FG000|COMPLETED|Overall Study||11||
48117821|NCT01470469|100612833|FG001|COMPLETED|Overall Study||38||
48117822|NCT01470469|100612832|FG000|NOT COMPLETED|Overall Study||10||
48117823|NCT01470469|100612833|FG001|NOT COMPLETED|Overall Study||24||
48117824|NCT02530294|100612834|FG000|STARTED|Overall Study||234||
48117825|NCT02530294|100612835|FG001|STARTED|Overall Study||119||
48117826|NCT02530294|100612834|FG000|COMPLETED|Overall Study||218||
48117827|NCT02530294|100612835|FG001|COMPLETED|Overall Study||113||
48117828|NCT02530294|100612834|FG000|NOT COMPLETED|Overall Study||16||
48117829|NCT02530294|100612835|FG001|NOT COMPLETED|Overall Study||6||
48117830|NCT00512096|100612836|FG000|STARTED|Overall Study||30||
48117831|NCT00512096|100612836|FG000|COMPLETED|Overall Study||23||
48697806|NCT01511614|102045470|FG001|COMPLETED|Overall Study||19||
48697807|NCT01511614|102045471|FG002|COMPLETED|Overall Study||2||
48697808|NCT01511614|102045472|FG003|COMPLETED|Overall Study||19||
48697809|NCT01511614|102045473|FG004|COMPLETED|Overall Study||30||
48697810|NCT01511614|102045474|FG005|COMPLETED|Overall Study||3||
48697811|NCT01511614|102045469|FG000|NOT COMPLETED|Overall Study||11||
48697812|NCT01511614|102045470|FG001|NOT COMPLETED|Overall Study||9||
48697813|NCT01511614|102045471|FG002|NOT COMPLETED|Overall Study||0||
48697814|NCT01511614|102045472|FG003|NOT COMPLETED|Overall Study||13||
48697815|NCT01511614|102045473|FG004|NOT COMPLETED|Overall Study||3||
48697816|NCT01511614|102045474|FG005|NOT COMPLETED|Overall Study||0||
48117832|NCT00512096|100612836|FG000|NOT COMPLETED|Overall Study||7||
48117833|NCT00785486|100612837|FG000|STARTED|Midazolam Alone||24||
48117834|NCT00785486|100612837|FG000|COMPLETED|Midazolam Alone||23||
48117835|NCT00785486|100612837|FG000|NOT COMPLETED|Midazolam Alone||1||
48117836|NCT00785486|100612837|FG000|STARTED|3 Day Washout||23||
48117837|NCT00785486|100612837|FG000|COMPLETED|3 Day Washout||23||
48117838|NCT00785486|100612837|FG000|NOT COMPLETED|3 Day Washout||0||
48117839|NCT00785486|100612837|FG000|STARTED|Qualaquin Alone at Steady State||23||
48117840|NCT00785486|100612837|FG000|COMPLETED|Qualaquin Alone at Steady State||23||
48117841|NCT00785486|100612837|FG000|NOT COMPLETED|Qualaquin Alone at Steady State||0||
48117842|NCT00785486|100612837|FG000|STARTED|Midazolam With Qualaquin at Steady State||23||
48117843|NCT00785486|100612837|FG000|COMPLETED|Midazolam With Qualaquin at Steady State||23||
48117844|NCT00785486|100612837|FG000|NOT COMPLETED|Midazolam With Qualaquin at Steady State||0||
48279183|NCT02712905|101007204|FG004|COMPLETED|Combination Therapy||0||
48697817|NCT03990415|102045475|FG000|STARTED|Overall Study||19||
48697818|NCT03990415|102045476|FG001|STARTED|Overall Study||19||
48697819|NCT03990415|102045477|FG002|STARTED|Overall Study||14||
48117845|NCT00596011|100612838|FG000|STARTED|Overall Study||49||
48117846|NCT00596011|100612839|FG001|STARTED|Overall Study||48||
48117847|NCT00596011|100612838|FG000|COMPLETED|Overall Study||36||
48117848|NCT00596011|100612839|FG001|COMPLETED|Overall Study||38||
48117849|NCT00596011|100612838|FG000|NOT COMPLETED|Overall Study||13||
48697820|NCT03990415|102045475|FG000|COMPLETED|Overall Study||15||
48117850|NCT00596011|100612839|FG001|NOT COMPLETED|Overall Study||10||
48117851|NCT00326911|100612840|FG000|STARTED|Overall Study||30||
48117852|NCT00326911|100612841|FG001|STARTED|Overall Study||31||
48117853|NCT00326911|100612840|FG000|COMPLETED|Overall Study||29||
48117854|NCT00326911|100612841|FG001|COMPLETED|Overall Study||29||
48117855|NCT00326911|100612840|FG000|NOT COMPLETED|Overall Study||1||
48117856|NCT00326911|100612841|FG001|NOT COMPLETED|Overall Study||2||
48117857|NCT00864474|100612842|FG000|STARTED|Overall Study||68||
48117858|NCT00864474|100612842|FG000|COMPLETED|Overall Study||68||
48117859|NCT00864474|100612842|FG000|NOT COMPLETED|Overall Study||0||
48117860|NCT01785602|100612843|FG000|STARTED|Overall Study||76||
48117861|NCT01785602|100612844|FG001|STARTED|Overall Study||27||
48117862|NCT01785602|100612843|FG000|COMPLETED|Overall Study||63||
48117863|NCT01785602|100612844|FG001|COMPLETED|Overall Study||18||
48117864|NCT01785602|100612843|FG000|NOT COMPLETED|Overall Study||13||
48117865|NCT01785602|100612844|FG001|NOT COMPLETED|Overall Study||9||
48565134|NCT02157935|101717198|FG001|STARTED|Overall Study||613||
48565135|NCT02157935|101717197|FG000|COMPLETED|Overall Study||567||
48565136|NCT02157935|101717198|FG001|COMPLETED|Overall Study||548||
48565137|NCT02157935|101717197|FG000|NOT COMPLETED|Overall Study||39||
48117866|NCT02871375|100612845|FG000|STARTED|Period 1, First 14 Days of Wear||89||
48279184|NCT02712905|101007205|FG005|COMPLETED|Combination Therapy||0||
48279185|NCT02712905|101007206|FG006|COMPLETED|Combination Therapy||0||
48279186|NCT02712905|101007207|FG007|COMPLETED|Combination Therapy||0||
48279187|NCT02712905|101007208|FG008|COMPLETED|Combination Therapy||0||
48279188|NCT02712905|101007209|FG009|COMPLETED|Combination Therapy||0||
48279189|NCT02712905|101007210|FG010|COMPLETED|Combination Therapy||0||
48279190|NCT02712905|101007211|FG011|COMPLETED|Combination Therapy||0||
48279191|NCT02712905|101007212|FG012|COMPLETED|Combination Therapy||0||
48279192|NCT02712905|101007213|FG013|COMPLETED|Combination Therapy||0||
48279193|NCT02712905|101007214|FG014|COMPLETED|Combination Therapy||0||
48394589|NCT02983799|101295980|FG004|COMPLETED|Overall Study||3|Patients continuing study at data cut-off|
48394590|NCT02983799|101295976|FG000|NOT COMPLETED|Overall Study||50||
48565138|NCT02157935|101717198|FG001|NOT COMPLETED|Overall Study||65||
48697821|NCT03990415|102045476|FG001|COMPLETED|Overall Study||17||
48697822|NCT03990415|102045477|FG002|COMPLETED|Overall Study||14||
48697823|NCT03990415|102045475|FG000|NOT COMPLETED|Overall Study||4||
48697824|NCT03990415|102045476|FG001|NOT COMPLETED|Overall Study||2||
48697825|NCT03990415|102045477|FG002|NOT COMPLETED|Overall Study||0||
48697826|NCT01597908|102045478|FG000|STARTED|Randomized Phase||352|All randomized patients included into Intent-to-Treat (ITT) population.|
48697827|NCT01597908|102045479|FG001|STARTED|Randomized Phase||352|All randomized patients included into Intent-to-Treat (ITT) population.|
48697828|NCT01597908|102045480|FG002|STARTED|Randomized Phase||0|All randomized patients included into Intent-to-Treat (ITT) population.|
48697829|NCT01597908|102045478|FG000|Safety Set|Randomized Phase||350|All patients who received at least one dose of study treatment|
48697830|NCT01597908|102045479|FG001|Safety Set|Randomized Phase||349|All patients who received at least one dose of study treatment|
48710819|NCT02590562|102078029|FG000|STARTED|Overall Study||808||
48394591|NCT02983799|101295977|FG001|NOT COMPLETED|Overall Study||18||
48394592|NCT02983799|101295978|FG002|NOT COMPLETED|Overall Study||50||
48394593|NCT02983799|101295979|FG003|NOT COMPLETED|Overall Study||76||
48394594|NCT02983799|101295980|FG004|NOT COMPLETED|Overall Study||10||
48394595|NCT01517412|101295981|FG000|STARTED|Overall Study||225||
48117867|NCT02871375|100612846|FG001|STARTED|Period 1, First 14 Days of Wear||77||
48394596|NCT01517412|101295982|FG001|STARTED|Overall Study||226||
48394597|NCT01517412|101295981|FG000|COMPLETED|Overall Study||189||
48394598|NCT01517412|101295982|FG001|COMPLETED|Overall Study||202||
48394599|NCT01517412|101295981|FG000|NOT COMPLETED|Overall Study||36||
48565139|NCT02461433|101717199|FG000|STARTED|Overall Study||1||
48565140|NCT02461433|101717200|FG001|STARTED|Overall Study||1||
48117868|NCT02871375|100612845|FG000|COMPLETED|Period 1, First 14 Days of Wear||89||
48117869|NCT02871375|100612846|FG001|COMPLETED|Period 1, First 14 Days of Wear||76||
48117870|NCT02871375|100612845|FG000|NOT COMPLETED|Period 1, First 14 Days of Wear||0||
48117871|NCT02871375|100612846|FG001|NOT COMPLETED|Period 1, First 14 Days of Wear||1||
48117872|NCT02871375|100612845|FG000|STARTED|Period 2, Second 14 Days of Wear||89||
48117873|NCT02871375|100612846|FG001|STARTED|Period 2, Second 14 Days of Wear||76||
48117874|NCT02871375|100612845|FG000|COMPLETED|Period 2, Second 14 Days of Wear||89||
48117875|NCT02871375|100612846|FG001|COMPLETED|Period 2, Second 14 Days of Wear||76||
48117876|NCT02871375|100612845|FG000|NOT COMPLETED|Period 2, Second 14 Days of Wear||0||
48117877|NCT02871375|100612846|FG001|NOT COMPLETED|Period 2, Second 14 Days of Wear||0||
48117878|NCT02867605|100612847|FG000|STARTED|Overall Study||20||
48279194|NCT02712905|101007215|FG015|COMPLETED|Combination Therapy||0||
48279195|NCT02712905|101007216|FG016|COMPLETED|Combination Therapy||0||
48279196|NCT02712905|101007217|FG017|COMPLETED|Combination Therapy||0||
48279197|NCT02712905|101007200|FG000|NOT COMPLETED|Combination Therapy||0||
48279198|NCT02712905|101007201|FG001|NOT COMPLETED|Combination Therapy||0||
48279199|NCT02712905|101007202|FG002|NOT COMPLETED|Combination Therapy||0||
48394600|NCT01517412|101295982|FG001|NOT COMPLETED|Overall Study||24||
48394601|NCT00091962|101295983|FG000|STARTED|Overall Study||150||
48565141|NCT02461433|101717199|FG000|COMPLETED|Overall Study||1||
48565142|NCT02461433|101717200|FG001|COMPLETED|Overall Study||1||
48565143|NCT02461433|101717199|FG000|NOT COMPLETED|Overall Study||0||
48117879|NCT02867605|100612847|FG000|COMPLETED|Overall Study||20||
48117880|NCT02867605|100612847|FG000|NOT COMPLETED|Overall Study||0||
48117881|NCT04879745|100612848|FG000|STARTED|Overall Study||35||
48117882|NCT04879745|100612849|FG001|STARTED|Overall Study||10||
48697831|NCT01597908|102045480|FG002|Safety Set|Randomized Phase||0|All patients who received at least one dose of study treatment|
48697832|NCT01597908|102045478|FG000|COMPLETED|Randomized Phase||1|ongoing status (incomplete end-of-study data and never received study treatment)|
48697833|NCT01597908|102045479|FG001|COMPLETED|Randomized Phase||0|ongoing status (incomplete end-of-study data and never received study treatment)|
48697834|NCT01597908|102045480|FG002|COMPLETED|Randomized Phase||0|ongoing status (incomplete end-of-study data and never received study treatment)|
48697835|NCT01597908|102045478|FG000|NOT COMPLETED|Randomized Phase||351||
48697836|NCT01597908|102045479|FG001|NOT COMPLETED|Randomized Phase||352||
48697837|NCT01597908|102045480|FG002|NOT COMPLETED|Randomized Phase||0||
48697838|NCT01597908|102045478|FG000|STARTED|Crossover Phase||0|All crossover randomized patients included into ITT \& Safety Sets|
48697839|NCT01597908|102045479|FG001|STARTED|Crossover Phase||0|All crossover randomized patients included into ITT \& Safety Sets|
48697840|NCT01597908|102045480|FG002|STARTED|Crossover Phase||34|All crossover randomized patients included into ITT \& Safety Sets|
48697841|NCT01597908|102045478|FG000|COMPLETED|Crossover Phase||0||
48697842|NCT01597908|102045479|FG001|COMPLETED|Crossover Phase||0||
48697843|NCT01597908|102045480|FG002|COMPLETED|Crossover Phase||0||
48697844|NCT01597908|102045478|FG000|NOT COMPLETED|Crossover Phase||0||
48697845|NCT01597908|102045479|FG001|NOT COMPLETED|Crossover Phase||0||
48697846|NCT01597908|102045480|FG002|NOT COMPLETED|Crossover Phase||34||
48697847|NCT04731298|102045481|FG000|STARTED|Allogeneic HSCT (Day 0)||0||
48697848|NCT04731298|102045482|FG001|STARTED|Allogeneic HSCT (Day 0)||2||
48697849|NCT04731298|102045481|FG000|COMPLETED|Allogeneic HSCT (Day 0)||0||
48697850|NCT04731298|102045482|FG001|COMPLETED|Allogeneic HSCT (Day 0)||2||
48117883|NCT04879745|100612848|FG000|Post-intervention Assessment|Overall Study||31|After participants were enrolled in the study and randomized to each arm, they completed a post-intervention assessment after their visit with their rheumatologist.|
48117884|NCT04879745|100612849|FG001|Post-intervention Assessment|Overall Study||9|After participants were enrolled in the study and randomized to each arm, they completed a post-intervention assessment after their visit with their rheumatologist.|
48117885|NCT04879745|100612848|FG000|COMPLETED|Overall Study||31||
48117886|NCT04879745|100612849|FG001|COMPLETED|Overall Study||9||
48697851|NCT04731298|102045481|FG000|NOT COMPLETED|Allogeneic HSCT (Day 0)||0||
48697852|NCT04731298|102045482|FG001|NOT COMPLETED|Allogeneic HSCT (Day 0)||0||
48697853|NCT04731298|102045481|FG000|STARTED|Monitoring - Primary GF (Day 1 to 42)||0||
48117887|NCT04879745|100612848|FG000|NOT COMPLETED|Overall Study||4||
48117888|NCT04879745|100612849|FG001|NOT COMPLETED|Overall Study||1||
48117889|NCT00095784|100612850|FG000|STARTED|Overall Study||21||
48117890|NCT00095784|100612850|FG000|COMPLETED|Overall Study||21||
48279200|NCT02712905|101007203|FG003|NOT COMPLETED|Combination Therapy||0||
48279201|NCT02712905|101007204|FG004|NOT COMPLETED|Combination Therapy||0||
48279202|NCT02712905|101007205|FG005|NOT COMPLETED|Combination Therapy||0||
48279203|NCT02712905|101007206|FG006|NOT COMPLETED|Combination Therapy||0||
48279204|NCT02712905|101007207|FG007|NOT COMPLETED|Combination Therapy||0||
48279205|NCT02712905|101007208|FG008|NOT COMPLETED|Combination Therapy||0||
48279206|NCT02712905|101007209|FG009|NOT COMPLETED|Combination Therapy||0||
48697854|NCT04731298|102045482|FG001|STARTED|Monitoring - Primary GF (Day 1 to 42)||2||
48697855|NCT04731298|102045481|FG000|COMPLETED|Monitoring - Primary GF (Day 1 to 42)||0||
48697856|NCT04731298|102045482|FG001|COMPLETED|Monitoring - Primary GF (Day 1 to 42)||2||
48279207|NCT02712905|101007210|FG010|NOT COMPLETED|Combination Therapy||0||
48279208|NCT02712905|101007211|FG011|NOT COMPLETED|Combination Therapy||0||
48697857|NCT04731298|102045481|FG000|NOT COMPLETED|Monitoring - Primary GF (Day 1 to 42)||0||
48697858|NCT04731298|102045482|FG001|NOT COMPLETED|Monitoring - Primary GF (Day 1 to 42)||0||
48697859|NCT04731298|102045481|FG000|STARTED|Monitoring - Secondary GF (Up to Day 98)||0||
48697860|NCT04731298|102045482|FG001|STARTED|Monitoring - Secondary GF (Up to Day 98)||2||
48697861|NCT04731298|102045481|FG000|COMPLETED|Monitoring - Secondary GF (Up to Day 98)||0||
48697862|NCT04731298|102045482|FG001|COMPLETED|Monitoring - Secondary GF (Up to Day 98)||2||
48697863|NCT04731298|102045481|FG000|NOT COMPLETED|Monitoring - Secondary GF (Up to Day 98)||0||
48697864|NCT04731298|102045482|FG001|NOT COMPLETED|Monitoring - Secondary GF (Up to Day 98)||0||
48279209|NCT02712905|101007212|FG012|NOT COMPLETED|Combination Therapy||5||
48279210|NCT02712905|101007213|FG013|NOT COMPLETED|Combination Therapy||7||
48279211|NCT02712905|101007214|FG014|NOT COMPLETED|Combination Therapy||1||
48279212|NCT02712905|101007215|FG015|NOT COMPLETED|Combination Therapy||7||
48279213|NCT02712905|101007216|FG016|NOT COMPLETED|Combination Therapy||1||
48279214|NCT02712905|101007217|FG017|NOT COMPLETED|Combination Therapy||6||
48279215|NCT03262662|101007218|FG000|STARTED|Overall Study||163||
48279216|NCT03262662|101007219|FG001|STARTED|Overall Study||157||
48279217|NCT03262662|101007218|FG000|Retained at Wk 15 (EOT)|Overall Study||127||
48697865|NCT04731298|102045481|FG000|STARTED|Follow-up (3 Years From HSCT)||0||
48697866|NCT04731298|102045482|FG001|STARTED|Follow-up (3 Years From HSCT)||2||
48697867|NCT04731298|102045481|FG000|COMPLETED|Follow-up (3 Years From HSCT)||0||
48697868|NCT04731298|102045482|FG001|COMPLETED|Follow-up (3 Years From HSCT)||0||
48697869|NCT04731298|102045481|FG000|NOT COMPLETED|Follow-up (3 Years From HSCT)||0||
48697870|NCT04731298|102045482|FG001|NOT COMPLETED|Follow-up (3 Years From HSCT)||2||
48279218|NCT03262662|101007219|FG001|Retained at Wk 15 (EOT)|Overall Study||126||
48279219|NCT03262662|101007218|FG000|Retained at Wk 28 (6-month Follow-up)|Overall Study||124||
48279220|NCT03262662|101007219|FG001|Retained at Wk 28 (6-month Follow-up)|Overall Study||121||
48279221|NCT03262662|101007218|FG000|COMPLETED|Overall Study||163||
48279222|NCT03262662|101007219|FG001|COMPLETED|Overall Study||157||
48697871|NCT03655054|102045483|FG000|STARTED|Overall Study||23||
48697872|NCT03655054|102045483|FG000|COMPLETED|Overall Study||22||
48697873|NCT03655054|102045483|FG000|NOT COMPLETED|Overall Study||1||
48697874|NCT01357161|102045484|FG000|STARTED|Part 1 (Open Label Run-in)||15||
48697875|NCT01357161|102045485|FG001|STARTED|Part 1 (Open Label Run-in)||0||
48697876|NCT01357161|102045486|FG002|STARTED|Part 1 (Open Label Run-in)||0||
48697877|NCT01357161|102045484|FG000|COMPLETED|Part 1 (Open Label Run-in)||0||
48697878|NCT01357161|102045485|FG001|COMPLETED|Part 1 (Open Label Run-in)||0||
48697879|NCT01357161|102045486|FG002|COMPLETED|Part 1 (Open Label Run-in)||0||
48697880|NCT01357161|102045484|FG000|NOT COMPLETED|Part 1 (Open Label Run-in)||15||
48697881|NCT01357161|102045485|FG001|NOT COMPLETED|Part 1 (Open Label Run-in)||0||
48697882|NCT01357161|102045486|FG002|NOT COMPLETED|Part 1 (Open Label Run-in)||0||
48697883|NCT01357161|102045484|FG000|STARTED|Part 2 (Double-Blind Comparison)||0||
48697884|NCT01357161|102045485|FG001|STARTED|Part 2 (Double-Blind Comparison)||59||
48697885|NCT01357161|102045486|FG002|STARTED|Part 2 (Double-Blind Comparison)||62||
48697886|NCT01357161|102045484|FG000|Treated|Part 2 (Double-Blind Comparison)||0||
48697887|NCT01357161|102045485|FG001|Treated|Part 2 (Double-Blind Comparison)||59||
48697888|NCT01357161|102045486|FG002|Treated|Part 2 (Double-Blind Comparison)||60||
48697889|NCT01357161|102045484|FG000|COMPLETED|Part 2 (Double-Blind Comparison)||0||
48697890|NCT01357161|102045485|FG001|COMPLETED|Part 2 (Double-Blind Comparison)||0||
48697891|NCT01357161|102045486|FG002|COMPLETED|Part 2 (Double-Blind Comparison)||0||
48697892|NCT01357161|102045484|FG000|NOT COMPLETED|Part 2 (Double-Blind Comparison)||0||
48697893|NCT01357161|102045485|FG001|NOT COMPLETED|Part 2 (Double-Blind Comparison)||59||
48697894|NCT01357161|102045486|FG002|NOT COMPLETED|Part 2 (Double-Blind Comparison)||62||
48697895|NCT00578877|102045487|FG000|STARTED|Overall Study||150||
48697896|NCT00578877|102045488|FG001|STARTED|Overall Study||300||
48697897|NCT00578877|102045487|FG000|COMPLETED|Overall Study||69||
48697898|NCT00578877|102045488|FG001|COMPLETED|Overall Study||172||
48697899|NCT00578877|102045487|FG000|NOT COMPLETED|Overall Study||81||
48697900|NCT00578877|102045488|FG001|NOT COMPLETED|Overall Study||128||
48697901|NCT00842153|102045489|FG000|STARTED|Overall Study||28||
48697902|NCT00842153|102045490|FG001|STARTED|Overall Study||30||
48279223|NCT03262662|101007218|FG000|NOT COMPLETED|Overall Study||0||
48279224|NCT03262662|101007219|FG001|NOT COMPLETED|Overall Study||0||
48279225|NCT05148962|101007220|FG000|STARTED|Overall Study||11||
48279226|NCT05148962|101007221|FG001|STARTED|Overall Study||8||
48279227|NCT05148962|101007222|FG002|STARTED|Overall Study||10||
48279228|NCT05148962|101007223|FG003|STARTED|Overall Study||12||
48279229|NCT05148962|101007224|FG004|STARTED|Overall Study||3||
48279230|NCT05148962|101007220|FG000|Vaccinated|Overall Study||10||
48279231|NCT05148962|101007221|FG001|Vaccinated|Overall Study||7||
48279232|NCT05148962|101007222|FG002|Vaccinated|Overall Study||10||
48279233|NCT05148962|101007223|FG003|Vaccinated|Overall Study||10||
48279234|NCT05148962|101007224|FG004|Vaccinated|Overall Study||3||
48279235|NCT05148962|101007220|FG000|COMPLETED|Overall Study||10||
48279236|NCT05148962|101007221|FG001|COMPLETED|Overall Study||7||
48279237|NCT05148962|101007222|FG002|COMPLETED|Overall Study||7||
48279238|NCT05148962|101007223|FG003|COMPLETED|Overall Study||5||
48279239|NCT05148962|101007224|FG004|COMPLETED|Overall Study||1||
48279240|NCT05148962|101007220|FG000|NOT COMPLETED|Overall Study||1||
48279241|NCT05148962|101007221|FG001|NOT COMPLETED|Overall Study||1||
48279242|NCT05148962|101007222|FG002|NOT COMPLETED|Overall Study||3||
48279243|NCT05148962|101007223|FG003|NOT COMPLETED|Overall Study||7||
48697903|NCT00842153|102045489|FG000|COMPLETED|Overall Study||27||
48697904|NCT00842153|102045490|FG001|COMPLETED|Overall Study||27||
48279244|NCT05148962|101007224|FG004|NOT COMPLETED|Overall Study||2||
48279245|NCT03582943|101007225|FG000|STARTED|Allocated to Groups||42||
48279246|NCT03582943|101007226|FG001|STARTED|Allocated to Groups||40||
48279247|NCT03582943|101007225|FG000|COMPLETED|Allocated to Groups||41||
48279248|NCT03582943|101007226|FG001|COMPLETED|Allocated to Groups||39||
48279249|NCT03582943|101007225|FG000|NOT COMPLETED|Allocated to Groups||1||
48279250|NCT03582943|101007226|FG001|NOT COMPLETED|Allocated to Groups||1||
48394602|NCT00091962|101295984|FG001|STARTED|Overall Study||152||
48279251|NCT03582943|101007225|FG000|STARTED|Intervention and Follow up||41||
48279252|NCT03582943|101007226|FG001|STARTED|Intervention and Follow up||39||
48279253|NCT03582943|101007225|FG000|COMPLETED|Intervention and Follow up||37||
48279254|NCT03582943|101007226|FG001|COMPLETED|Intervention and Follow up||37||
48279255|NCT03582943|101007225|FG000|NOT COMPLETED|Intervention and Follow up||4||
48279256|NCT03582943|101007226|FG001|NOT COMPLETED|Intervention and Follow up||2||
48697905|NCT00842153|102045489|FG000|NOT COMPLETED|Overall Study||1||
48697906|NCT00842153|102045490|FG001|NOT COMPLETED|Overall Study||3||
48697907|NCT00313313|102045491|FG000|STARTED|Overall Study||248||
48697908|NCT00313313|102045492|FG001|STARTED|Overall Study||253||
48697909|NCT00313313|102045493|FG002|STARTED|Overall Study||267||
48697910|NCT00313313|102045491|FG000|COMPLETED|Overall Study||185||
48697911|NCT00313313|102045492|FG001|COMPLETED|Overall Study||187||
48279257|NCT03582943|101007225|FG000|STARTED|Analyzed||37||
48279258|NCT03582943|101007226|FG001|STARTED|Analyzed||37||
48279259|NCT03582943|101007225|FG000|COMPLETED|Analyzed||33||
48279260|NCT03582943|101007226|FG001|COMPLETED|Analyzed||36||
48279261|NCT03582943|101007225|FG000|NOT COMPLETED|Analyzed||4||
48279262|NCT03582943|101007226|FG001|NOT COMPLETED|Analyzed||1||
48279263|NCT03339245|101007227|FG000|STARTED|Overall Study||6||
48565144|NCT02461433|101717200|FG001|NOT COMPLETED|Overall Study||0||
48565145|NCT02546375|101717201|FG000|STARTED|Overall Study||87||
48565146|NCT02546375|101717201|FG000|COMPLETED|Overall Study||87||
48565147|NCT02546375|101717201|FG000|NOT COMPLETED|Overall Study||0||
48565148|NCT01958437|101717202|FG000|STARTED|Overall Study||11||
48565149|NCT01958437|101717203|FG001|STARTED|Overall Study||11||
48565150|NCT01958437|101717204|FG002|STARTED|Overall Study||11||
48565151|NCT01958437|101717205|FG003|STARTED|Overall Study||11||
48565152|NCT01958437|101717202|FG000|COMPLETED|Overall Study||11||
48565153|NCT01958437|101717203|FG001|COMPLETED|Overall Study||11||
48565154|NCT01958437|101717204|FG002|COMPLETED|Overall Study||10||
48565155|NCT01958437|101717205|FG003|COMPLETED|Overall Study||10||
48565156|NCT01958437|101717202|FG000|NOT COMPLETED|Overall Study||0||
48394603|NCT00091962|101295985|FG002|STARTED|Overall Study||151||
48394604|NCT00091962|101295983|FG000|COMPLETED|Overall Study||150||
48394605|NCT00091962|101295984|FG001|COMPLETED|Overall Study||152||
48394606|NCT00091962|101295985|FG002|COMPLETED|Overall Study||151||
48394607|NCT00091962|101295983|FG000|NOT COMPLETED|Overall Study||0||
48394608|NCT00091962|101295984|FG001|NOT COMPLETED|Overall Study||0||
48279264|NCT03339245|101007228|FG001|STARTED|Overall Study||7||
48279265|NCT03339245|101007227|FG000|COMPLETED|Overall Study||4||
48279266|NCT03339245|101007228|FG001|COMPLETED|Overall Study||6||
48279267|NCT03339245|101007227|FG000|NOT COMPLETED|Overall Study||2||
48279268|NCT03339245|101007228|FG001|NOT COMPLETED|Overall Study||1||
48279269|NCT03828747|101007229|FG000|STARTED|Double-Blind Treatment Period||136||
48394609|NCT00091962|101295985|FG002|NOT COMPLETED|Overall Study||0||
48565157|NCT01958437|101717203|FG001|NOT COMPLETED|Overall Study||0||
48565158|NCT01958437|101717204|FG002|NOT COMPLETED|Overall Study||1||
48279270|NCT03828747|101007230|FG001|STARTED|Double-Blind Treatment Period||136||
48394610|NCT02248857|101295986|FG000|STARTED|Baseline||157||
48394611|NCT02248857|101295987|FG001|STARTED|Baseline||168||
48565159|NCT01958437|101717205|FG003|NOT COMPLETED|Overall Study||1||
48565160|NCT02965573|101717206|FG000|STARTED|Overall Study||12||
48565161|NCT02965573|101717207|FG001|STARTED|Overall Study||12||
48565162|NCT02965573|101717206|FG000|COMPLETED|Overall Study||11||
48565163|NCT02965573|101717207|FG001|COMPLETED|Overall Study||12||
48565164|NCT02965573|101717206|FG000|NOT COMPLETED|Overall Study||1||
48279271|NCT03828747|101007229|FG000|Cohort 1|Double-Blind Treatment Period||92|Participants who completed the double-blind treatment period (before implementation of Protocol Version 3), or participants who completed the double-blind study drug treatment through Week 45 without any missed doses of study drug (after implementation of Protocol Version 4), were assigned to Cohort 1. In Cohort 1, the double-blind treatment period has a duration of 48 weeks.|
48279272|NCT03828747|101007230|FG001|Cohort 1|Double-Blind Treatment Period||99|Participants who completed the double-blind treatment period (before implementation of Protocol Version 3), or participants who completed the double-blind study drug treatment through Week 45 without any missed doses of study drug (after implementation of Protocol Version 4), were assigned to Cohort 1. In Cohort 1, the double-blind treatment period has a duration of 48 weeks.|
48279273|NCT03828747|101007229|FG000|Cohort 2|Double-Blind Treatment Period||43|Participants who were active in the double-blind treatment period (after implementation of Protocol Version 3) or participants who missed one or more study drug dose (after implementation of Protocol version 4) were assigned to Cohort 2. In Cohort 2, the double-blind treatment period has a duration of 60 weeks.|
48394612|NCT02248857|101295988|FG002|STARTED|Baseline||127||
48394613|NCT02248857|101295986|FG000|COMPLETED|Baseline||157||
48394614|NCT02248857|101295987|FG001|COMPLETED|Baseline||168||
48697912|NCT00313313|102045493|FG002|COMPLETED|Overall Study||185||
48697913|NCT00313313|102045491|FG000|NOT COMPLETED|Overall Study||63||
48697914|NCT00313313|102045492|FG001|NOT COMPLETED|Overall Study||66||
48394615|NCT02248857|101295988|FG002|COMPLETED|Baseline||127||
48394616|NCT02248857|101295986|FG000|NOT COMPLETED|Baseline||0||
48394617|NCT02248857|101295987|FG001|NOT COMPLETED|Baseline||0||
48394618|NCT02248857|101295988|FG002|NOT COMPLETED|Baseline||0||
48394619|NCT02248857|101295986|FG000|STARTED|3 Month||157||
48394620|NCT02248857|101295987|FG001|STARTED|3 Month||168||
48394621|NCT02248857|101295988|FG002|STARTED|3 Month||127||
48394622|NCT02248857|101295986|FG000|COMPLETED|3 Month||111||
48394623|NCT02248857|101295987|FG001|COMPLETED|3 Month||134||
48394624|NCT02248857|101295988|FG002|COMPLETED|3 Month||96||
48394625|NCT02248857|101295986|FG000|NOT COMPLETED|3 Month||46||
48394626|NCT02248857|101295987|FG001|NOT COMPLETED|3 Month||34||
48394627|NCT02248857|101295988|FG002|NOT COMPLETED|3 Month||31||
48394628|NCT02248857|101295986|FG000|STARTED|6 Month||148|Participants were still eligible for the 6 month if they did not complete the 3 month.|
48394629|NCT02248857|101295987|FG001|STARTED|6 Month||165|Participants were still eligible for the 6 month if they did not complete the 3 month.|
48394630|NCT02248857|101295988|FG002|STARTED|6 Month||123|Participants were still eligible for the 6 month if they did not complete the 3 month.|
48394631|NCT02248857|101295986|FG000|COMPLETED|6 Month||120||
48394632|NCT02248857|101295987|FG001|COMPLETED|6 Month||136||
48394633|NCT02248857|101295988|FG002|COMPLETED|6 Month||106||
48394634|NCT02248857|101295986|FG000|NOT COMPLETED|6 Month||28||
48394635|NCT02248857|101295987|FG001|NOT COMPLETED|6 Month||29||
48394636|NCT02248857|101295988|FG002|NOT COMPLETED|6 Month||17||
48394637|NCT01185704|101295989|FG000|STARTED|Overall Study||68||
48394638|NCT01185704|101295990|FG001|STARTED|Overall Study||68||
48394639|NCT01185704|101295989|FG000|Treated|Overall Study||65||
48394640|NCT01185704|101295990|FG001|Treated|Overall Study||65||
48394641|NCT01185704|101295989|FG000|COMPLETED|Overall Study||55||
48394642|NCT01185704|101295990|FG001|COMPLETED|Overall Study||60||
48394643|NCT01185704|101295989|FG000|NOT COMPLETED|Overall Study||13||
48394644|NCT01185704|101295990|FG001|NOT COMPLETED|Overall Study||8||
48394645|NCT01874119|101295991|FG000|STARTED|First Intervention (6 Days)||8||
48394646|NCT01874119|101295992|FG001|STARTED|First Intervention (6 Days)||5||
48394647|NCT01874119|101295991|FG000|COMPLETED|First Intervention (6 Days)||7||
48394648|NCT01874119|101295992|FG001|COMPLETED|First Intervention (6 Days)||5||
48394649|NCT01874119|101295991|FG000|NOT COMPLETED|First Intervention (6 Days)||1||
48394650|NCT01874119|101295992|FG001|NOT COMPLETED|First Intervention (6 Days)||0||
48394651|NCT01874119|101295991|FG000|STARTED|Washout (7 Days)||7||
48394652|NCT01874119|101295992|FG001|STARTED|Washout (7 Days)||5||
48394653|NCT01874119|101295991|FG000|COMPLETED|Washout (7 Days)||4||
48394654|NCT01874119|101295992|FG001|COMPLETED|Washout (7 Days)||3||
48394655|NCT01874119|101295991|FG000|NOT COMPLETED|Washout (7 Days)||3||
48394656|NCT01874119|101295992|FG001|NOT COMPLETED|Washout (7 Days)||2||
48394657|NCT01874119|101295991|FG000|STARTED|Second Intervention (6 Days)||4||
48394658|NCT01874119|101295992|FG001|STARTED|Second Intervention (6 Days)||3||
48394659|NCT01874119|101295991|FG000|COMPLETED|Second Intervention (6 Days)||4||
48394660|NCT01874119|101295992|FG001|COMPLETED|Second Intervention (6 Days)||3||
48394661|NCT01874119|101295991|FG000|NOT COMPLETED|Second Intervention (6 Days)||0||
48394662|NCT01874119|101295992|FG001|NOT COMPLETED|Second Intervention (6 Days)||0||
48394663|NCT02911818|101295993|FG000|STARTED|52 Week Study||50||
48394664|NCT02911818|101295994|FG001|STARTED|52 Week Study||50||
48394665|NCT02911818|101295995|FG002|STARTED|52 Week Study||50||
48394666|NCT02911818|101295996|FG003|STARTED|52 Week Study||0||
48394667|NCT02911818|101295997|FG004|STARTED|52 Week Study||0||
48394668|NCT02911818|101295993|FG000|COMPLETED|52 Week Study||46||
48394669|NCT02911818|101295994|FG001|COMPLETED|52 Week Study||45||
48394670|NCT02911818|101295995|FG002|COMPLETED|52 Week Study||46||
48394671|NCT02911818|101295996|FG003|COMPLETED|52 Week Study||0||
48394672|NCT02911818|101295997|FG004|COMPLETED|52 Week Study||0||
48394673|NCT02911818|101295993|FG000|NOT COMPLETED|52 Week Study||4||
48394674|NCT02911818|101295994|FG001|NOT COMPLETED|52 Week Study||5||
48394675|NCT02911818|101295995|FG002|NOT COMPLETED|52 Week Study||4||
48697915|NCT00313313|102045493|FG002|NOT COMPLETED|Overall Study||82||
48279274|NCT03828747|101007230|FG001|Cohort 2|Double-Blind Treatment Period||33|Participants who were active in the double-blind treatment period (after implementation of Protocol Version 3) or participants who missed one or more study drug dose (after implementation of Protocol version 4) were assigned to Cohort 2. In Cohort 2, the double-blind treatment period has a duration of 60 weeks.|
48279275|NCT03828747|101007229|FG000|COMPLETED|Double-Blind Treatment Period||106||
48565165|NCT02965573|101717207|FG001|NOT COMPLETED|Overall Study||0||
48565166|NCT01930162|101717208|FG000|STARTED|Overall Study||9||
48565167|NCT01930162|101717208|FG000|COMPLETED|Overall Study||4||
48565168|NCT01930162|101717208|FG000|NOT COMPLETED|Overall Study||5||
48565169|NCT03187301|101717209|FG000|STARTED|Titration Period||7||
48565170|NCT03187301|101717210|FG001|STARTED|Titration Period||7||
48565171|NCT03187301|101717211|FG002|STARTED|Titration Period||7||
48565172|NCT03187301|101717212|FG003|STARTED|Titration Period||6||
48565173|NCT03187301|101717213|FG004|STARTED|Titration Period||7||
48565174|NCT03187301|101717214|FG005|STARTED|Titration Period||7||
48565175|NCT03187301|101717215|FG006|STARTED|Titration Period||7||
48565176|NCT03187301|101717209|FG000|COMPLETED|Titration Period||7||
48565177|NCT03187301|101717210|FG001|COMPLETED|Titration Period||7||
48565178|NCT03187301|101717211|FG002|COMPLETED|Titration Period||7||
48565179|NCT03187301|101717212|FG003|COMPLETED|Titration Period||6||
48565180|NCT03187301|101717213|FG004|COMPLETED|Titration Period||7||
48697916|NCT03549572|102045494|FG000|STARTED|Overall Study||56||
48697917|NCT03549572|102045494|FG000|COMPLETED|Overall Study||45||
48697918|NCT03549572|102045494|FG000|NOT COMPLETED|Overall Study||11||
48697919|NCT01794312|102045495|FG000|STARTED|Overall Study||74||
48697920|NCT01794312|102045496|FG001|STARTED|Overall Study||78||
48697921|NCT01794312|102045495|FG000|COMPLETED|Overall Study||68||
48697922|NCT01794312|102045496|FG001|COMPLETED|Overall Study||67||
48279276|NCT03828747|101007230|FG001|COMPLETED|Double-Blind Treatment Period||102||
48697923|NCT01794312|102045495|FG000|NOT COMPLETED|Overall Study||6||
48697924|NCT01794312|102045496|FG001|NOT COMPLETED|Overall Study||11||
48697925|NCT04123093|102045497|FG000|STARTED|Phase 1||11||
48697926|NCT04123093|102045498|FG001|STARTED|Phase 1||0||
48697927|NCT04123093|102045497|FG000|Baseline Visit|Phase 1||10||
48697928|NCT04123093|102045498|FG001|Baseline Visit|Phase 1||0||
48697929|NCT04123093|102045497|FG000|COMPLETED|Phase 1||10||
48279277|NCT03828747|101007229|FG000|NOT COMPLETED|Double-Blind Treatment Period||30||
48394676|NCT02911818|101295996|FG003|NOT COMPLETED|52 Week Study||0||
48394677|NCT02911818|101295997|FG004|NOT COMPLETED|52 Week Study||0||
48697930|NCT04123093|102045498|FG001|COMPLETED|Phase 1||0||
48697931|NCT04123093|102045497|FG000|NOT COMPLETED|Phase 1||1||
48697932|NCT04123093|102045498|FG001|NOT COMPLETED|Phase 1||0||
48697933|NCT04123093|102045497|FG000|STARTED|Phase 2||0||
48697934|NCT04123093|102045498|FG001|STARTED|Phase 2||2||
48697935|NCT04123093|102045497|FG000|Baseline Visit|Phase 2||0||
48697936|NCT04123093|102045498|FG001|Baseline Visit|Phase 2||2||
48697937|NCT04123093|102045497|FG000|COMPLETED|Phase 2||0||
48697938|NCT04123093|102045498|FG001|COMPLETED|Phase 2||0||
48697939|NCT04123093|102045497|FG000|NOT COMPLETED|Phase 2||0||
48697940|NCT04123093|102045498|FG001|NOT COMPLETED|Phase 2||2||
48697941|NCT00614445|102045499|FG000|STARTED|Overall Study||140||
48394678|NCT02911818|101295993|FG000|STARTED|12 Week Extension Study||0||
48565181|NCT03187301|101717214|FG005|COMPLETED|Titration Period||7||
48565182|NCT03187301|101717215|FG006|COMPLETED|Titration Period||0||
48565183|NCT03187301|101717209|FG000|NOT COMPLETED|Titration Period||0||
48565184|NCT03187301|101717210|FG001|NOT COMPLETED|Titration Period||0||
48565185|NCT03187301|101717211|FG002|NOT COMPLETED|Titration Period||0||
48565186|NCT03187301|101717212|FG003|NOT COMPLETED|Titration Period||0||
48565187|NCT03187301|101717213|FG004|NOT COMPLETED|Titration Period||0||
48565188|NCT03187301|101717214|FG005|NOT COMPLETED|Titration Period||0||
48565189|NCT03187301|101717215|FG006|NOT COMPLETED|Titration Period||7||
48565190|NCT03187301|101717209|FG000|STARTED|Pre-Intervention||7||
48697942|NCT00614445|102045500|FG001|STARTED|Overall Study||140||
48697943|NCT00614445|102045499|FG000|COMPLETED|Overall Study||112||
48697944|NCT00614445|102045500|FG001|COMPLETED|Overall Study||91||
48697945|NCT00614445|102045499|FG000|NOT COMPLETED|Overall Study||28||
48697946|NCT00614445|102045500|FG001|NOT COMPLETED|Overall Study||49||
48697947|NCT02414607|102045501|FG000|STARTED|Overall Study||11||
48697948|NCT02414607|102045502|FG001|STARTED|Overall Study||13||
48697949|NCT02414607|102045501|FG000|COMPLETED|Overall Study||9||
48697950|NCT02414607|102045502|FG001|COMPLETED|Overall Study||11||
48697951|NCT02414607|102045501|FG000|NOT COMPLETED|Overall Study||2||
48697952|NCT02414607|102045502|FG001|NOT COMPLETED|Overall Study||2||
48697953|NCT01296711|102045503|FG000|STARTED|Overall Study||20||
48697954|NCT01296711|102045504|FG001|STARTED|Overall Study||20||
48279278|NCT03828747|101007230|FG001|NOT COMPLETED|Double-Blind Treatment Period||34||
48279279|NCT03828747|101007229|FG000|STARTED|Open-Label Extension||102||
48697955|NCT01296711|102045505|FG002|STARTED|Overall Study||21||
48697956|NCT01296711|102045506|FG003|STARTED|Overall Study||20||
48697957|NCT01296711|102045507|FG004|STARTED|Overall Study||17||
48697958|NCT01296711|102045508|FG005|STARTED|Overall Study||16||
48697959|NCT01296711|102045509|FG006|STARTED|Overall Study||40||
48697960|NCT01296711|102045510|FG007|STARTED|Overall Study||36||
48697961|NCT01296711|102045503|FG000|COMPLETED|Overall Study||4||
48279280|NCT03828747|101007230|FG001|STARTED|Open-Label Extension||97||
48279281|NCT03828747|101007229|FG000|COMPLETED|Open-Label Extension||48||
48279282|NCT03828747|101007230|FG001|COMPLETED|Open-Label Extension||52||
48279283|NCT03828747|101007229|FG000|NOT COMPLETED|Open-Label Extension||54||
48279284|NCT03828747|101007230|FG001|NOT COMPLETED|Open-Label Extension||45||
48279285|NCT02942277|101007231|FG000|STARTED|Year 1||5||
48279286|NCT02942277|101007232|FG001|STARTED|Year 1||10||
48279287|NCT02942277|101007233|FG002|STARTED|Year 1||5||
48279288|NCT02942277|101007234|FG003|STARTED|Year 1||10||
48279289|NCT02942277|101007235|FG004|STARTED|Year 1||56||
48279290|NCT02942277|101007236|FG005|STARTED|Year 1||61||
48279291|NCT02942277|101007237|FG006|STARTED|Year 1||5||
48279292|NCT02942277|101007238|FG007|STARTED|Year 1||10||
48279293|NCT02942277|101007239|FG008|STARTED|Year 1||10||
48279294|NCT02942277|101007240|FG009|STARTED|Year 1||10||
48279295|NCT02942277|101007241|FG010|STARTED|Year 1||119||
48279296|NCT02942277|101007231|FG000|COMPLETED|Year 1||5||
48279297|NCT02942277|101007232|FG001|COMPLETED|Year 1||8||
48279298|NCT02942277|101007233|FG002|COMPLETED|Year 1||5||
48279299|NCT02942277|101007234|FG003|COMPLETED|Year 1||9||
48279300|NCT02942277|101007235|FG004|COMPLETED|Year 1||49||
48279301|NCT02942277|101007236|FG005|COMPLETED|Year 1||51||
48279302|NCT02942277|101007237|FG006|COMPLETED|Year 1||5||
48279303|NCT02942277|101007238|FG007|COMPLETED|Year 1||9||
48279304|NCT02942277|101007239|FG008|COMPLETED|Year 1||10||
48279305|NCT02942277|101007240|FG009|COMPLETED|Year 1||10||
48279306|NCT02942277|101007241|FG010|COMPLETED|Year 1||104||
48279307|NCT02942277|101007231|FG000|NOT COMPLETED|Year 1||0||
48279308|NCT02942277|101007232|FG001|NOT COMPLETED|Year 1||2||
48279309|NCT02942277|101007233|FG002|NOT COMPLETED|Year 1||0||
48279310|NCT02942277|101007234|FG003|NOT COMPLETED|Year 1||1||
48279311|NCT02942277|101007235|FG004|NOT COMPLETED|Year 1||7||
48279312|NCT02942277|101007236|FG005|NOT COMPLETED|Year 1||10||
48279313|NCT02942277|101007237|FG006|NOT COMPLETED|Year 1||0||
48279314|NCT02942277|101007238|FG007|NOT COMPLETED|Year 1||1||
48279315|NCT02942277|101007239|FG008|NOT COMPLETED|Year 1||0||
48279316|NCT02942277|101007240|FG009|NOT COMPLETED|Year 1||0||
48279317|NCT02942277|101007241|FG010|NOT COMPLETED|Year 1||15||
48279318|NCT02942277|101007231|FG000|STARTED|Year 2||5||
48279319|NCT02942277|101007232|FG001|STARTED|Year 2||8||
48279320|NCT02942277|101007233|FG002|STARTED|Year 2||5||
48279321|NCT02942277|101007234|FG003|STARTED|Year 2||9||
48279322|NCT02942277|101007235|FG004|STARTED|Year 2||49||
48279323|NCT02942277|101007236|FG005|STARTED|Year 2||51||
48279324|NCT02942277|101007237|FG006|STARTED|Year 2||5||
48279325|NCT02942277|101007238|FG007|STARTED|Year 2||9||
48697962|NCT01296711|102045504|FG001|COMPLETED|Overall Study||12||
48697963|NCT01296711|102045505|FG002|COMPLETED|Overall Study||8||
48697964|NCT01296711|102045506|FG003|COMPLETED|Overall Study||7||
48697965|NCT01296711|102045507|FG004|COMPLETED|Overall Study||7||
48697966|NCT01296711|102045508|FG005|COMPLETED|Overall Study||5||
48697967|NCT01296711|102045509|FG006|COMPLETED|Overall Study||9||
48697968|NCT01296711|102045510|FG007|COMPLETED|Overall Study||15||
48697969|NCT01296711|102045503|FG000|NOT COMPLETED|Overall Study||16||
48697970|NCT01296711|102045504|FG001|NOT COMPLETED|Overall Study||8||
48697971|NCT01296711|102045505|FG002|NOT COMPLETED|Overall Study||13||
48697972|NCT01296711|102045506|FG003|NOT COMPLETED|Overall Study||13||
48279326|NCT02942277|101007239|FG008|STARTED|Year 2||10||
48279327|NCT02942277|101007240|FG009|STARTED|Year 2||10||
48279328|NCT02942277|101007241|FG010|STARTED|Year 2||104||
48279329|NCT02942277|101007231|FG000|COMPLETED|Year 2||5||
48279330|NCT02942277|101007232|FG001|COMPLETED|Year 2||7||
48279331|NCT02942277|101007233|FG002|COMPLETED|Year 2||4||
48279332|NCT02942277|101007234|FG003|COMPLETED|Year 2||8||
48279333|NCT02942277|101007235|FG004|COMPLETED|Year 2||36||
48279334|NCT02942277|101007236|FG005|COMPLETED|Year 2||40||
48279335|NCT02942277|101007237|FG006|COMPLETED|Year 2||4||
48279336|NCT02942277|101007238|FG007|COMPLETED|Year 2||8||
48279337|NCT02942277|101007239|FG008|COMPLETED|Year 2||10||
48279338|NCT02942277|101007240|FG009|COMPLETED|Year 2||9||
48279339|NCT02942277|101007241|FG010|COMPLETED|Year 2||79||
48279340|NCT02942277|101007231|FG000|NOT COMPLETED|Year 2||0||
48279341|NCT02942277|101007232|FG001|NOT COMPLETED|Year 2||1||
48279342|NCT02942277|101007233|FG002|NOT COMPLETED|Year 2||1||
48279343|NCT02942277|101007234|FG003|NOT COMPLETED|Year 2||1||
48279344|NCT02942277|101007235|FG004|NOT COMPLETED|Year 2||13||
48279345|NCT02942277|101007236|FG005|NOT COMPLETED|Year 2||11||
48279346|NCT02942277|101007237|FG006|NOT COMPLETED|Year 2||1||
48697973|NCT01296711|102045507|FG004|NOT COMPLETED|Overall Study||10||
48697974|NCT01296711|102045508|FG005|NOT COMPLETED|Overall Study||11||
48697975|NCT01296711|102045509|FG006|NOT COMPLETED|Overall Study||31||
48697976|NCT01296711|102045510|FG007|NOT COMPLETED|Overall Study||21||
48697977|NCT02305017|102045511|FG000|STARTED|Overall Study||14||
48697978|NCT02305017|102045512|FG001|STARTED|Overall Study||14||
48697979|NCT02305017|102045511|FG000|COMPLETED|Overall Study||14||
48697980|NCT02305017|102045512|FG001|COMPLETED|Overall Study||14||
48697981|NCT02305017|102045511|FG000|NOT COMPLETED|Overall Study||0||
48697982|NCT02305017|102045512|FG001|NOT COMPLETED|Overall Study||0||
48697983|NCT02265536|102045513|FG000|STARTED|Overall Study||6||
48697984|NCT02265536|102045514|FG001|STARTED|Overall Study||5||
48697985|NCT02265536|102045515|FG002|STARTED|Overall Study||5||
48697986|NCT02265536|102045516|FG003|STARTED|Overall Study||6||
48697987|NCT02265536|102045517|FG004|STARTED|Overall Study||8||
48697988|NCT02265536|102045518|FG005|STARTED|Overall Study||4||
48697989|NCT02265536|102045513|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
48697990|NCT02265536|102045514|FG001|Received at Least 1 Dose of Study Drug|Overall Study||5||
48697991|NCT02265536|102045515|FG002|Received at Least 1 Dose of Study Drug|Overall Study||5||
48697992|NCT02265536|102045516|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6||
48697993|NCT02265536|102045517|FG004|Received at Least 1 Dose of Study Drug|Overall Study||8||
48697994|NCT02265536|102045518|FG005|Received at Least 1 Dose of Study Drug|Overall Study||4||
48697995|NCT02265536|102045513|FG000|COMPLETED|Overall Study||5||
48697996|NCT02265536|102045514|FG001|COMPLETED|Overall Study||2||
48697997|NCT02265536|102045515|FG002|COMPLETED|Overall Study||5||
48697998|NCT02265536|102045516|FG003|COMPLETED|Overall Study||6||
48697999|NCT02265536|102045517|FG004|COMPLETED|Overall Study||5||
48698000|NCT02265536|102045518|FG005|COMPLETED|Overall Study||4||
48698001|NCT02265536|102045513|FG000|NOT COMPLETED|Overall Study||1||
48698002|NCT02265536|102045514|FG001|NOT COMPLETED|Overall Study||3||
48698003|NCT02265536|102045515|FG002|NOT COMPLETED|Overall Study||0||
48698004|NCT02265536|102045516|FG003|NOT COMPLETED|Overall Study||0||
48279347|NCT02942277|101007238|FG007|NOT COMPLETED|Year 2||1||
48279348|NCT02942277|101007239|FG008|NOT COMPLETED|Year 2||0||
48279349|NCT02942277|101007240|FG009|NOT COMPLETED|Year 2||1||
48279350|NCT02942277|101007241|FG010|NOT COMPLETED|Year 2||25||
48279351|NCT01325311|101007242|FG000|STARTED|Overall Study||8||
48279352|NCT01325311|101007243|FG001|STARTED|Overall Study||7||
48698005|NCT02265536|102045517|FG004|NOT COMPLETED|Overall Study||3||
48698006|NCT02265536|102045518|FG005|NOT COMPLETED|Overall Study||0||
48698007|NCT02234713|102045519|FG000|STARTED|Overall Study||31||
48698008|NCT02234713|102045520|FG001|STARTED|Overall Study||32||
48698009|NCT02234713|102045519|FG000|COMPLETED|Overall Study||25||
48698010|NCT02234713|102045520|FG001|COMPLETED|Overall Study||27||
48698011|NCT02234713|102045519|FG000|NOT COMPLETED|Overall Study||6||
48698012|NCT02234713|102045520|FG001|NOT COMPLETED|Overall Study||5||
48698013|NCT00716482|102045521|FG000|STARTED|Overall Study||1681||
48698014|NCT00716482|102045521|FG000|COMPLETED|Overall Study||1562||
48698015|NCT00716482|102045521|FG000|NOT COMPLETED|Overall Study||119||
48698016|NCT04730635|102045522|FG000|STARTED|Overall Study||29||
48698017|NCT04730635|102045523|FG001|STARTED|Overall Study||15||
48698018|NCT04730635|102045522|FG000|COMPLETED|Overall Study||28||
48698019|NCT04730635|102045523|FG001|COMPLETED|Overall Study||14||
48698020|NCT04730635|102045522|FG000|NOT COMPLETED|Overall Study||1||
48698021|NCT04730635|102045523|FG001|NOT COMPLETED|Overall Study||1||
48698022|NCT02926027|102045524|FG000|STARTED|Overall Study||40||
48698023|NCT02926027|102045525|FG001|STARTED|Overall Study||40||
48698024|NCT02926027|102045524|FG000|COMPLETED|Overall Study||31||
48279353|NCT01325311|101007242|FG000|COMPLETED|Overall Study||8||
48279354|NCT01325311|101007243|FG001|COMPLETED|Overall Study||7||
48279355|NCT01325311|101007242|FG000|NOT COMPLETED|Overall Study||0||
48279356|NCT01325311|101007243|FG001|NOT COMPLETED|Overall Study||0||
48279357|NCT01081132|101007244|FG000|STARTED|Overall Study||157||
48279358|NCT01081132|101007245|FG001|STARTED|Overall Study||157||
48279359|NCT01081132|101007244|FG000|COMPLETED|Overall Study||102||
48279360|NCT01081132|101007245|FG001|COMPLETED|Overall Study||105||
48279361|NCT01081132|101007244|FG000|NOT COMPLETED|Overall Study||55||
48279362|NCT01081132|101007245|FG001|NOT COMPLETED|Overall Study||52||
48698025|NCT02926027|102045525|FG001|COMPLETED|Overall Study||37||
48698026|NCT02926027|102045524|FG000|NOT COMPLETED|Overall Study||9||
48698027|NCT02926027|102045525|FG001|NOT COMPLETED|Overall Study||3||
48698028|NCT01253148|102045526|FG000|STARTED|Overall Study||25||
48698029|NCT01253148|102045526|FG000|COMPLETED|Overall Study||25||
48698030|NCT01253148|102045526|FG000|NOT COMPLETED|Overall Study||0||
48698031|NCT01200407|102045527|FG000|STARTED|Overall Study||615||
48698032|NCT01200407|102045527|FG000|COMPLETED|Overall Study||533||
48698033|NCT01200407|102045527|FG000|NOT COMPLETED|Overall Study||82||
48698034|NCT01566149|102045528|FG000|STARTED|Overall Study||24||
48698035|NCT01566149|102045529|FG001|STARTED|Overall Study||25||
48698036|NCT01566149|102045528|FG000|COMPLETED|Overall Study||21||
48698037|NCT01566149|102045529|FG001|COMPLETED|Overall Study||23||
48698038|NCT01566149|102045528|FG000|NOT COMPLETED|Overall Study||3||
48279363|NCT00528931|101007246|FG000|STARTED|Overall Study||16||
48279364|NCT00528931|101007246|FG000|COMPLETED|Overall Study||15||
48279365|NCT00528931|101007246|FG000|NOT COMPLETED|Overall Study||1||
48279366|NCT01258595|101007247|FG000|STARTED|Overall Study||148||
48279367|NCT01258595|101007248|FG001|STARTED|Overall Study||152||
48117891|NCT00095784|100612850|FG000|NOT COMPLETED|Overall Study||0||
48117892|NCT00947297|100612851|FG000|STARTED|Overall Study||60||
48117893|NCT00947297|100612851|FG000|COMPLETED|Overall Study||53||
48117894|NCT00947297|100612851|FG000|NOT COMPLETED|Overall Study||7||
48117895|NCT05044234|100616182|FG000|STARTED|Overall Study||39||
48117896|NCT05044234|100616183|FG001|STARTED|Overall Study||39||
48117897|NCT05044234|100616184|FG002|STARTED|Overall Study||39||
48117898|NCT05044234|100616185|FG003|STARTED|Overall Study||39||
48117899|NCT05044234|100616182|FG000|COMPLETED|Overall Study||10||
48117900|NCT05044234|100616183|FG001|COMPLETED|Overall Study||13||
48117901|NCT05044234|100616184|FG002|COMPLETED|Overall Study||12||
48117902|NCT05044234|100616185|FG003|COMPLETED|Overall Study||12||
48117903|NCT05044234|100616182|FG000|NOT COMPLETED|Overall Study||29||
48117904|NCT05044234|100616183|FG001|NOT COMPLETED|Overall Study||26||
48117905|NCT05044234|100616184|FG002|NOT COMPLETED|Overall Study||27||
48117906|NCT05044234|100616185|FG003|NOT COMPLETED|Overall Study||27||
48117907|NCT01166594|100616186|FG000|STARTED|Overall Study||30||
48117908|NCT01166594|100616187|FG001|STARTED|Overall Study||29||
48117909|NCT01166594|100616186|FG000|COMPLETED|Overall Study||23||
48117910|NCT01166594|100616187|FG001|COMPLETED|Overall Study||24||
48117911|NCT01166594|100616186|FG000|NOT COMPLETED|Overall Study||7||
48117912|NCT01166594|100616187|FG001|NOT COMPLETED|Overall Study||5||
48117913|NCT01848990|100616188|FG000|STARTED|Overall Study||227||
48117914|NCT01848990|100616189|FG001|STARTED|Overall Study||115||
48117915|NCT01848990|100616190|FG002|STARTED|Overall Study||114||
48117916|NCT01848990|100616188|FG000|Received at Least 1 Dose of Study Drug|Overall Study||227||
48117917|NCT01848990|100616189|FG001|Received at Least 1 Dose of Study Drug|Overall Study||115||
48117918|NCT01848990|100616190|FG002|Received at Least 1 Dose of Study Drug|Overall Study||113||
48117919|NCT01848990|100616188|FG000|Completed Month 6|Overall Study||194||
48117920|NCT01848990|100616189|FG001|Completed Month 6|Overall Study||106||
48117921|NCT01848990|100616190|FG002|Completed Month 6|Overall Study||103||
48117922|NCT01848990|100616188|FG000|COMPLETED|Overall Study||181||
48117923|NCT01848990|100616189|FG001|COMPLETED|Overall Study||95||
48117924|NCT01848990|100616190|FG002|COMPLETED|Overall Study||98||
48117925|NCT01848990|100616188|FG000|NOT COMPLETED|Overall Study||46||
48117926|NCT01848990|100616189|FG001|NOT COMPLETED|Overall Study||20||
48117927|NCT01848990|100616190|FG002|NOT COMPLETED|Overall Study||16||
48117928|NCT02492451|100616191|FG000|STARTED|Overall Study||40||
48394679|NCT02911818|101295994|FG001|STARTED|12 Week Extension Study||0||
48565191|NCT03187301|101717210|FG001|STARTED|Pre-Intervention||7||
48117929|NCT02492451|100616192|FG001|STARTED|Overall Study||39||
48117930|NCT02492451|100616193|FG002|STARTED|Overall Study||39||
48117931|NCT02492451|100616191|FG000|COMPLETED|Overall Study||40||
48117932|NCT02492451|100616192|FG001|COMPLETED|Overall Study||39||
48117933|NCT02492451|100616193|FG002|COMPLETED|Overall Study||39||
48117934|NCT02492451|100616191|FG000|NOT COMPLETED|Overall Study||0||
48117935|NCT02492451|100616192|FG001|NOT COMPLETED|Overall Study||0||
48117936|NCT02492451|100616193|FG002|NOT COMPLETED|Overall Study||0||
48117937|NCT02919670|100616194|FG000|STARTED|Overall Study||49||
48117938|NCT02919670|100616195|FG001|STARTED|Overall Study||50||
48117939|NCT02919670|100616194|FG000|COMPLETED|Overall Study||6||
48117940|NCT02919670|100616195|FG001|COMPLETED|Overall Study||11||
48117941|NCT02919670|100616194|FG000|NOT COMPLETED|Overall Study||43||
48117942|NCT02919670|100616195|FG001|NOT COMPLETED|Overall Study||39||
48117943|NCT01857258|100616196|FG000|STARTED|First Intervention (3 h Postprandially)||8||
48117944|NCT01857258|100616197|FG001|STARTED|First Intervention (3 h Postprandially)||7||
48117945|NCT01857258|100616196|FG000|COMPLETED|First Intervention (3 h Postprandially)||8||
48117946|NCT01857258|100616197|FG001|COMPLETED|First Intervention (3 h Postprandially)||7||
48117947|NCT01857258|100616196|FG000|NOT COMPLETED|First Intervention (3 h Postprandially)||0||
48117948|NCT01857258|100616197|FG001|NOT COMPLETED|First Intervention (3 h Postprandially)||0||
48117949|NCT01857258|100616196|FG000|STARTED|Wash-out Period (7 Days)||8||
48117950|NCT01857258|100616197|FG001|STARTED|Wash-out Period (7 Days)||7||
48394680|NCT02911818|101295995|FG002|STARTED|12 Week Extension Study||0||
48394681|NCT02911818|101295996|FG003|STARTED|12 Week Extension Study||22||
48394682|NCT02911818|101295997|FG004|STARTED|12 Week Extension Study||23||
48394683|NCT02911818|101295993|FG000|COMPLETED|12 Week Extension Study||0||
48394684|NCT02911818|101295994|FG001|COMPLETED|12 Week Extension Study||0||
48394685|NCT02911818|101295995|FG002|COMPLETED|12 Week Extension Study||0||
48394686|NCT02911818|101295996|FG003|COMPLETED|12 Week Extension Study||22||
48394687|NCT02911818|101295997|FG004|COMPLETED|12 Week Extension Study||22||
48394688|NCT02911818|101295993|FG000|NOT COMPLETED|12 Week Extension Study||0||
48394689|NCT02911818|101295994|FG001|NOT COMPLETED|12 Week Extension Study||0||
48394690|NCT02911818|101295995|FG002|NOT COMPLETED|12 Week Extension Study||0||
48394691|NCT02911818|101295996|FG003|NOT COMPLETED|12 Week Extension Study||0||
48394692|NCT02911818|101295997|FG004|NOT COMPLETED|12 Week Extension Study||1||
48394693|NCT01194869|101295998|FG000|STARTED|Overall Study||25||
48394694|NCT01194869|101295998|FG000|COMPLETED|Overall Study||21||
48394695|NCT01194869|101295998|FG000|NOT COMPLETED|Overall Study||4||
48394696|NCT03859960|101295999|FG000|STARTED|Overall Study||14||
48394697|NCT03859960|101296000|FG001|STARTED|Overall Study||19||
48394698|NCT03859960|101295999|FG000|COMPLETED|Overall Study||14||
48394699|NCT03859960|101296000|FG001|COMPLETED|Overall Study||19||
48279368|NCT01258595|101007247|FG000|COMPLETED|Overall Study||147||
48279369|NCT01258595|101007248|FG001|COMPLETED|Overall Study||151||
48279370|NCT01258595|101007247|FG000|NOT COMPLETED|Overall Study||1||
48279371|NCT01258595|101007248|FG001|NOT COMPLETED|Overall Study||1||
48279372|NCT02503852|101007249|FG000|STARTED|Overall Study||16||
48279373|NCT02503852|101007250|FG001|STARTED|Overall Study||22||
48279374|NCT02503852|101007251|FG002|STARTED|Overall Study||24||
48279375|NCT02503852|101007252|FG003|STARTED|Overall Study||9||
48279376|NCT02503852|101007249|FG000|COMPLETED|Overall Study||12||
48279377|NCT02503852|101007250|FG001|COMPLETED|Overall Study||19||
48279378|NCT02503852|101007251|FG002|COMPLETED|Overall Study||21||
48279379|NCT02503852|101007252|FG003|COMPLETED|Overall Study||8||
48279380|NCT02503852|101007249|FG000|NOT COMPLETED|Overall Study||4||
48279381|NCT02503852|101007250|FG001|NOT COMPLETED|Overall Study||3||
48279382|NCT02503852|101007251|FG002|NOT COMPLETED|Overall Study||3||
48279383|NCT02503852|101007252|FG003|NOT COMPLETED|Overall Study||1||
48279384|NCT01174576|101007253|FG000|STARTED|Overall Study||16||
48279385|NCT01174576|101007253|FG000|COMPLETED|Overall Study||16||
48279386|NCT01174576|101007253|FG000|NOT COMPLETED|Overall Study||0||
48279387|NCT03199118|101007254|FG000|STARTED|Overall Study||14||
48279388|NCT03199118|101007255|FG001|STARTED|Overall Study||14||
48279389|NCT03199118|101007254|FG000|COMPLETED|Overall Study||14||
48279390|NCT03199118|101007255|FG001|COMPLETED|Overall Study||14||
48279391|NCT03199118|101007254|FG000|NOT COMPLETED|Overall Study||0||
48279392|NCT03199118|101007255|FG001|NOT COMPLETED|Overall Study||0||
48279393|NCT04772898|101007256|FG000|STARTED|Overall Study||15||
48279394|NCT04772898|101007257|FG001|STARTED|Overall Study||15||
48279395|NCT04772898|101007256|FG000|COMPLETED|Overall Study||15||
48279396|NCT04772898|101007257|FG001|COMPLETED|Overall Study||14||
48279397|NCT04772898|101007256|FG000|NOT COMPLETED|Overall Study||0||
48279398|NCT04772898|101007257|FG001|NOT COMPLETED|Overall Study||1||
48279399|NCT01076647|101007258|FG000|STARTED|Overall Study||233||
48279400|NCT01076647|101007259|FG001|STARTED|Overall Study||234||
48279401|NCT01076647|101007258|FG000|COMPLETED|Overall Study||208||
48279402|NCT01076647|101007259|FG001|COMPLETED|Overall Study||209||
48279403|NCT01076647|101007258|FG000|NOT COMPLETED|Overall Study||25||
48279404|NCT01076647|101007259|FG001|NOT COMPLETED|Overall Study||25||
48279405|NCT02182947|101007260|FG000|STARTED|Overall Study||45||
48279406|NCT02182947|101007260|FG000|COMPLETED|Overall Study||27||
48279407|NCT02182947|101007260|FG000|NOT COMPLETED|Overall Study||18||
48279408|NCT02060539|101007261|FG000|STARTED|Overall Study||19||
48279409|NCT02060539|101007261|FG000|COMPLETED|Overall Study||19||
48279410|NCT02060539|101007261|FG000|NOT COMPLETED|Overall Study||0||
48279411|NCT00506441|101007262|FG000|STARTED|Period 1; Open-label Period||245||
48279412|NCT00506441|101007263|FG001|STARTED|Period 1; Open-label Period||0||
48279413|NCT00506441|101007262|FG000|COMPLETED|Period 1; Open-label Period||169||
48279414|NCT00506441|101007263|FG001|COMPLETED|Period 1; Open-label Period||0||
48279415|NCT00506441|101007262|FG000|NOT COMPLETED|Period 1; Open-label Period||76||
48279416|NCT00506441|101007263|FG001|NOT COMPLETED|Period 1; Open-label Period||0||
48279417|NCT00506441|101007262|FG000|STARTED|Period 2; Double-blind Period||85||
48279418|NCT00506441|101007263|FG001|STARTED|Period 2; Double-blind Period||84||
48279419|NCT00506441|101007262|FG000|COMPLETED|Period 2; Double-blind Period||82||
48279420|NCT00506441|101007263|FG001|COMPLETED|Period 2; Double-blind Period||79||
48279421|NCT00506441|101007262|FG000|NOT COMPLETED|Period 2; Double-blind Period||3||
48279422|NCT00506441|101007263|FG001|NOT COMPLETED|Period 2; Double-blind Period||5||
48279423|NCT04101318|101007264|FG000|STARTED|First Intervention (42 +/- 3 Days)||34||
48279424|NCT04101318|101007265|FG001|STARTED|First Intervention (42 +/- 3 Days)||38||
48279425|NCT04101318|101007264|FG000|Received Allocated Intervention|First Intervention (42 +/- 3 Days)||34||
48279426|NCT04101318|101007265|FG001|Received Allocated Intervention|First Intervention (42 +/- 3 Days)||36||
48279427|NCT04101318|101007264|FG000|COMPLETED|First Intervention (42 +/- 3 Days)||34||
48279428|NCT04101318|101007265|FG001|COMPLETED|First Intervention (42 +/- 3 Days)||36||
48279429|NCT04101318|101007264|FG000|NOT COMPLETED|First Intervention (42 +/- 3 Days)||0||
48279430|NCT04101318|101007265|FG001|NOT COMPLETED|First Intervention (42 +/- 3 Days)||2||
48279431|NCT04101318|101007264|FG000|STARTED|Second Intervention (42 +/- 3 Days)||34||
48279432|NCT04101318|101007265|FG001|STARTED|Second Intervention (42 +/- 3 Days)||36||
48279433|NCT04101318|101007264|FG000|Received Allocated Intervention|Second Intervention (42 +/- 3 Days)||33||
48279434|NCT04101318|101007265|FG001|Received Allocated Intervention|Second Intervention (42 +/- 3 Days)||35||
48279435|NCT04101318|101007264|FG000|COMPLETED|Second Intervention (42 +/- 3 Days)||33||
48279436|NCT04101318|101007265|FG001|COMPLETED|Second Intervention (42 +/- 3 Days)||35||
48279437|NCT04101318|101007264|FG000|NOT COMPLETED|Second Intervention (42 +/- 3 Days)||1||
48279438|NCT04101318|101007265|FG001|NOT COMPLETED|Second Intervention (42 +/- 3 Days)||1||
48279439|NCT00910039|101007266|FG000|STARTED|Overall Study||14||
48279440|NCT00910039|101007266|FG000|COMPLETED|Overall Study||13||
48279441|NCT00910039|101007266|FG000|NOT COMPLETED|Overall Study||1||
48279442|NCT01781078|101007267|FG000|STARTED|Overall Study||229||
48279443|NCT01781078|101007268|FG001|STARTED|Overall Study||118||
48279444|NCT01781078|101007269|FG002|STARTED|Overall Study||16||
48279445|NCT01781078|101007267|FG000|COMPLETED|Overall Study||217||
48279446|NCT01781078|101007268|FG001|COMPLETED|Overall Study||113||
48279447|NCT01781078|101007269|FG002|COMPLETED|Overall Study||0||
48279448|NCT01781078|101007267|FG000|NOT COMPLETED|Overall Study||12||
48279449|NCT01781078|101007268|FG001|NOT COMPLETED|Overall Study||5||
48279450|NCT01781078|101007269|FG002|NOT COMPLETED|Overall Study||16||
48279451|NCT01129102|101007270|FG000|STARTED|Overall Study||110||
48279452|NCT01129102|101007271|FG001|STARTED|Overall Study||50||
48279453|NCT01129102|101007272|FG002|STARTED|Overall Study||55||
48279454|NCT01129102|101007270|FG000|COMPLETED|Overall Study||102||
48279455|NCT01129102|101007271|FG001|COMPLETED|Overall Study||44||
48279456|NCT01129102|101007272|FG002|COMPLETED|Overall Study||48||
48279457|NCT01129102|101007270|FG000|NOT COMPLETED|Overall Study||8||
48279458|NCT01129102|101007271|FG001|NOT COMPLETED|Overall Study||6||
48279459|NCT01129102|101007272|FG002|NOT COMPLETED|Overall Study||7||
48279460|NCT04738292|101007273|FG000|STARTED|Overall Study||11||
48279461|NCT04738292|101007273|FG000|COMPLETED|Overall Study||10||
48565192|NCT03187301|101717211|FG002|STARTED|Pre-Intervention||7||
48565193|NCT03187301|101717212|FG003|STARTED|Pre-Intervention||6||
48565194|NCT03187301|101717213|FG004|STARTED|Pre-Intervention||7||
48565195|NCT03187301|101717214|FG005|STARTED|Pre-Intervention||7||
48565196|NCT03187301|101717215|FG006|STARTED|Pre-Intervention||0||
48565197|NCT03187301|101717209|FG000|COMPLETED|Pre-Intervention||6||
48565198|NCT03187301|101717210|FG001|COMPLETED|Pre-Intervention||7||
48565199|NCT03187301|101717211|FG002|COMPLETED|Pre-Intervention||7||
48565200|NCT03187301|101717212|FG003|COMPLETED|Pre-Intervention||6||
48565201|NCT03187301|101717213|FG004|COMPLETED|Pre-Intervention||7||
48565202|NCT03187301|101717214|FG005|COMPLETED|Pre-Intervention||7||
48565203|NCT03187301|101717215|FG006|COMPLETED|Pre-Intervention||0||
48565204|NCT03187301|101717209|FG000|NOT COMPLETED|Pre-Intervention||1||
48565205|NCT03187301|101717210|FG001|NOT COMPLETED|Pre-Intervention||0||
48565206|NCT03187301|101717211|FG002|NOT COMPLETED|Pre-Intervention||0||
48565207|NCT03187301|101717212|FG003|NOT COMPLETED|Pre-Intervention||0||
48565208|NCT03187301|101717213|FG004|NOT COMPLETED|Pre-Intervention||0||
48565209|NCT03187301|101717214|FG005|NOT COMPLETED|Pre-Intervention||0||
48565210|NCT03187301|101717215|FG006|NOT COMPLETED|Pre-Intervention||0||
48565211|NCT03187301|101717209|FG000|STARTED|First Intervention||6||
48565212|NCT03187301|101717210|FG001|STARTED|First Intervention||7||
48565213|NCT03187301|101717211|FG002|STARTED|First Intervention||7||
48565214|NCT03187301|101717212|FG003|STARTED|First Intervention||6||
48698039|NCT01566149|102045529|FG001|NOT COMPLETED|Overall Study||2||
48698040|NCT00313144|102045530|FG000|STARTED|Overall Study||127||
48698041|NCT00313144|102045530|FG000|COMPLETED|Overall Study||17||
48698042|NCT00313144|102045530|FG000|NOT COMPLETED|Overall Study||110||
48698043|NCT01331837|102045531|FG000|STARTED|Overall Study||1538||
48698044|NCT01331837|102045532|FG001|STARTED|Overall Study||1542||
48698045|NCT01331837|102045531|FG000|COMPLETED|Overall Study||1482||
48698046|NCT01331837|102045532|FG001|COMPLETED|Overall Study||1475||
48279462|NCT04738292|101007273|FG000|NOT COMPLETED|Overall Study||1||
48279463|NCT00266227|101007274|FG000|STARTED|Initial Treatment||0||
48279464|NCT00266227|101007275|FG001|STARTED|Initial Treatment||0||
48279465|NCT00266227|101007276|FG002|STARTED|Initial Treatment||559||
48279466|NCT00266227|101007274|FG000|COMPLETED|Initial Treatment||0||
48565215|NCT03187301|101717213|FG004|STARTED|First Intervention||7||
48565216|NCT03187301|101717214|FG005|STARTED|First Intervention||7||
48565217|NCT03187301|101717215|FG006|STARTED|First Intervention||0||
48565218|NCT03187301|101717209|FG000|COMPLETED|First Intervention||6||
48565219|NCT03187301|101717210|FG001|COMPLETED|First Intervention||7||
48565220|NCT03187301|101717211|FG002|COMPLETED|First Intervention||7||
48565221|NCT03187301|101717212|FG003|COMPLETED|First Intervention||6||
48565222|NCT03187301|101717213|FG004|COMPLETED|First Intervention||7||
48565223|NCT03187301|101717214|FG005|COMPLETED|First Intervention||7||
48565224|NCT03187301|101717215|FG006|COMPLETED|First Intervention||0||
48565225|NCT03187301|101717209|FG000|NOT COMPLETED|First Intervention||0||
48565226|NCT03187301|101717210|FG001|NOT COMPLETED|First Intervention||0||
48565227|NCT03187301|101717211|FG002|NOT COMPLETED|First Intervention||0||
48565228|NCT03187301|101717212|FG003|NOT COMPLETED|First Intervention||0||
48565229|NCT03187301|101717213|FG004|NOT COMPLETED|First Intervention||0||
48698047|NCT01331837|102045531|FG000|NOT COMPLETED|Overall Study||56||
48565230|NCT03187301|101717214|FG005|NOT COMPLETED|First Intervention||0||
48565231|NCT03187301|101717215|FG006|NOT COMPLETED|First Intervention||0||
48698048|NCT01331837|102045532|FG001|NOT COMPLETED|Overall Study||67||
48279467|NCT00266227|101007275|FG001|COMPLETED|Initial Treatment||0||
48279468|NCT00266227|101007276|FG002|COMPLETED|Initial Treatment||482||
48279469|NCT00266227|101007274|FG000|NOT COMPLETED|Initial Treatment||0||
48698049|NCT01355679|102045533|FG000|STARTED|Overall Study||16||
48565232|NCT03187301|101717209|FG000|STARTED|First Washout||6||
48565233|NCT03187301|101717210|FG001|STARTED|First Washout||7||
48565234|NCT03187301|101717211|FG002|STARTED|First Washout||7||
48565235|NCT03187301|101717212|FG003|STARTED|First Washout||6||
48565236|NCT03187301|101717213|FG004|STARTED|First Washout||7||
48565237|NCT03187301|101717214|FG005|STARTED|First Washout||7||
48565238|NCT03187301|101717215|FG006|STARTED|First Washout||0||
48565239|NCT03187301|101717209|FG000|COMPLETED|First Washout||6||
48565240|NCT03187301|101717210|FG001|COMPLETED|First Washout||7||
48565241|NCT03187301|101717211|FG002|COMPLETED|First Washout||7||
48565242|NCT03187301|101717212|FG003|COMPLETED|First Washout||6||
48565243|NCT03187301|101717213|FG004|COMPLETED|First Washout||7||
48565244|NCT03187301|101717214|FG005|COMPLETED|First Washout||7||
48565245|NCT03187301|101717215|FG006|COMPLETED|First Washout||0||
48565246|NCT03187301|101717209|FG000|NOT COMPLETED|First Washout||0||
48565247|NCT03187301|101717210|FG001|NOT COMPLETED|First Washout||0||
48117951|NCT01857258|100616196|FG000|COMPLETED|Wash-out Period (7 Days)||8||
48117952|NCT01857258|100616197|FG001|COMPLETED|Wash-out Period (7 Days)||7||
48117953|NCT01857258|100616196|FG000|NOT COMPLETED|Wash-out Period (7 Days)||0||
48565248|NCT03187301|101717211|FG002|NOT COMPLETED|First Washout||0||
48565249|NCT03187301|101717212|FG003|NOT COMPLETED|First Washout||0||
48565250|NCT03187301|101717213|FG004|NOT COMPLETED|First Washout||0||
48565251|NCT03187301|101717214|FG005|NOT COMPLETED|First Washout||0||
48565252|NCT03187301|101717215|FG006|NOT COMPLETED|First Washout||0||
48565253|NCT03187301|101717209|FG000|STARTED|Second Intervention||6||
48565254|NCT03187301|101717210|FG001|STARTED|Second Intervention||7||
48565255|NCT03187301|101717211|FG002|STARTED|Second Intervention||7||
48565256|NCT03187301|101717212|FG003|STARTED|Second Intervention||6||
48565257|NCT03187301|101717213|FG004|STARTED|Second Intervention||7||
48565258|NCT03187301|101717214|FG005|STARTED|Second Intervention||7||
48565259|NCT03187301|101717215|FG006|STARTED|Second Intervention||0||
48565260|NCT03187301|101717209|FG000|COMPLETED|Second Intervention||6||
48565261|NCT03187301|101717210|FG001|COMPLETED|Second Intervention||7||
48565262|NCT03187301|101717211|FG002|COMPLETED|Second Intervention||7||
48565263|NCT03187301|101717212|FG003|COMPLETED|Second Intervention||6||
48565264|NCT03187301|101717213|FG004|COMPLETED|Second Intervention||7||
48117954|NCT01857258|100616197|FG001|NOT COMPLETED|Wash-out Period (7 Days)||0||
48117955|NCT01857258|100616196|FG000|STARTED|Second Intervention (3 h Postprandially)||8||
48117956|NCT01857258|100616197|FG001|STARTED|Second Intervention (3 h Postprandially)||7||
48117957|NCT01857258|100616196|FG000|COMPLETED|Second Intervention (3 h Postprandially)||8||
48117958|NCT01857258|100616197|FG001|COMPLETED|Second Intervention (3 h Postprandially)||7||
48565265|NCT03187301|101717214|FG005|COMPLETED|Second Intervention||7||
48565266|NCT03187301|101717215|FG006|COMPLETED|Second Intervention||0||
48565267|NCT03187301|101717209|FG000|NOT COMPLETED|Second Intervention||0||
48565268|NCT03187301|101717210|FG001|NOT COMPLETED|Second Intervention||0||
48565269|NCT03187301|101717211|FG002|NOT COMPLETED|Second Intervention||0||
48565270|NCT03187301|101717212|FG003|NOT COMPLETED|Second Intervention||0||
48565271|NCT03187301|101717213|FG004|NOT COMPLETED|Second Intervention||0||
48565272|NCT03187301|101717214|FG005|NOT COMPLETED|Second Intervention||0||
48698050|NCT01355679|102045533|FG000|COMPLETED|Overall Study||14||
48698051|NCT01355679|102045533|FG000|NOT COMPLETED|Overall Study||2||
48117959|NCT01857258|100616196|FG000|NOT COMPLETED|Second Intervention (3 h Postprandially)||0||
48117960|NCT01857258|100616197|FG001|NOT COMPLETED|Second Intervention (3 h Postprandially)||0||
48117961|NCT02215070|100616198|FG000|STARTED|Overall Study||26||
48117962|NCT02215070|100616199|FG001|STARTED|Overall Study||52||
48279470|NCT00266227|101007275|FG001|NOT COMPLETED|Initial Treatment||0||
48565273|NCT03187301|101717215|FG006|NOT COMPLETED|Second Intervention||0||
48565274|NCT03187301|101717209|FG000|STARTED|Second Washout||6||
48565275|NCT03187301|101717210|FG001|STARTED|Second Washout||7||
48565276|NCT03187301|101717211|FG002|STARTED|Second Washout||7||
48565277|NCT03187301|101717212|FG003|STARTED|Second Washout||6||
48565278|NCT03187301|101717213|FG004|STARTED|Second Washout||7||
48565279|NCT03187301|101717214|FG005|STARTED|Second Washout||7||
48565280|NCT03187301|101717215|FG006|STARTED|Second Washout||0||
48565281|NCT03187301|101717209|FG000|COMPLETED|Second Washout||6||
48698052|NCT02978157|102045534|FG000|STARTED|Overall Study||52||
48698053|NCT02978157|102045535|FG001|STARTED|Overall Study||50||
48698054|NCT02978157|102045534|FG000|COMPLETED|Overall Study||52||
48565282|NCT03187301|101717210|FG001|COMPLETED|Second Washout||7||
48565283|NCT03187301|101717211|FG002|COMPLETED|Second Washout||7||
48565284|NCT03187301|101717212|FG003|COMPLETED|Second Washout||6||
48565285|NCT03187301|101717213|FG004|COMPLETED|Second Washout||7||
48565286|NCT03187301|101717214|FG005|COMPLETED|Second Washout||7||
48565287|NCT03187301|101717215|FG006|COMPLETED|Second Washout||0||
48565288|NCT03187301|101717209|FG000|NOT COMPLETED|Second Washout||0||
48565289|NCT03187301|101717210|FG001|NOT COMPLETED|Second Washout||0||
48565290|NCT03187301|101717211|FG002|NOT COMPLETED|Second Washout||0||
48565291|NCT03187301|101717212|FG003|NOT COMPLETED|Second Washout||0||
48565292|NCT03187301|101717213|FG004|NOT COMPLETED|Second Washout||0||
48698055|NCT02978157|102045535|FG001|COMPLETED|Overall Study||50||
48698056|NCT02978157|102045534|FG000|NOT COMPLETED|Overall Study||0||
48117963|NCT02215070|100616198|FG000|COMPLETED|Overall Study||20||
48117964|NCT02215070|100616199|FG001|COMPLETED|Overall Study||52||
48117965|NCT02215070|100616198|FG000|NOT COMPLETED|Overall Study||6||
48117966|NCT02215070|100616199|FG001|NOT COMPLETED|Overall Study||0||
48117967|NCT02433834|100616200|FG000|STARTED|Overall Study||248||
48117968|NCT02433834|100616200|FG000|GP MDI 28.8 µg|Overall Study||112||
48117969|NCT02433834|100616200|FG000|GP MDI 14.4 µg|Overall Study||230||
48117970|NCT02433834|100616200|FG000|GP MDI 7.2 µg|Overall Study||228||
48117971|NCT02433834|100616200|FG000|GP MDI 3.6 µg|Overall Study||118||
48117972|NCT02433834|100616200|FG000|GP MDI 1.9 µg|Overall Study||107||
48117973|NCT02433834|100616200|FG000|Placebo MDI|Overall Study||174||
48117974|NCT02433834|100616200|FG000|SAL 50 µg|Overall Study||167||
48117975|NCT02433834|100616200|FG000|COMPLETED|Overall Study||211||
48117976|NCT02433834|100616200|FG000|NOT COMPLETED|Overall Study||37||
48117977|NCT02948842|100616201|FG000|STARTED|Overall Study||5||
48117978|NCT02948842|100616201|FG000|COMPLETED|Overall Study||1||
48117979|NCT02948842|100616201|FG000|NOT COMPLETED|Overall Study||4||
48117980|NCT04971031|100616202|FG000|STARTED|Overall Study||80||
48117981|NCT04971031|100616203|FG001|STARTED|Overall Study||78||
48117982|NCT04971031|100616202|FG000|COMPLETED|Overall Study||79||
48117983|NCT04971031|100616203|FG001|COMPLETED|Overall Study||75||
48117984|NCT04971031|100616202|FG000|NOT COMPLETED|Overall Study||1||
48117985|NCT04971031|100616203|FG001|NOT COMPLETED|Overall Study||3||
48117986|NCT00594256|100616204|FG000|STARTED|Overall Study||8||
48117987|NCT00594256|100616204|FG000|COMPLETED|Overall Study||8||
48117988|NCT00594256|100616204|FG000|NOT COMPLETED|Overall Study||0||
48117989|NCT01507493|100616205|FG000|STARTED|Overall Study||22||
48117990|NCT01507493|100616206|FG001|STARTED|Overall Study||178||
48117991|NCT01507493|100616205|FG000|COMPLETED|Overall Study||22||
48117992|NCT01507493|100616206|FG001|COMPLETED|Overall Study||178||
48117993|NCT01507493|100616205|FG000|NOT COMPLETED|Overall Study||0||
48117994|NCT01507493|100616206|FG001|NOT COMPLETED|Overall Study||0||
48117995|NCT00501540|100616207|FG000|STARTED|Overall Study||15||
48117996|NCT00501540|100616207|FG000|COMPLETED|Overall Study||10||
48117997|NCT00501540|100616207|FG000|NOT COMPLETED|Overall Study||5||
48117998|NCT00827372|100616208|FG000|STARTED|Overall Study||10||
48117999|NCT00827372|100616208|FG000|COMPLETED|Overall Study||2||
48118000|NCT00827372|100616208|FG000|NOT COMPLETED|Overall Study||8||
48118001|NCT02610868|100616209|FG000|STARTED|MYOBLOC: Treatment Session 1||187||
48118002|NCT02610868|100616209|FG000|COMPLETED|MYOBLOC: Treatment Session 1||180||
48118003|NCT02610868|100616209|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 1||7||
48118004|NCT02610868|100616209|FG000|STARTED|MYOBLOC: Treatment Session 2||177||
48118005|NCT02610868|100616209|FG000|COMPLETED|MYOBLOC: Treatment Session 2||165||
48118006|NCT02610868|100616209|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 2||12||
48118007|NCT02610868|100616209|FG000|STARTED|MYOBLOC: Treatment Session 3||50||
48118008|NCT02610868|100616209|FG000|COMPLETED|MYOBLOC: Treatment Session 3||43||
48565293|NCT03187301|101717214|FG005|NOT COMPLETED|Second Washout||0||
48565294|NCT03187301|101717215|FG006|NOT COMPLETED|Second Washout||0||
48565295|NCT03187301|101717209|FG000|STARTED|Third Intervention||6||
48118009|NCT02610868|100616209|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 3||7||
48118010|NCT02610868|100616209|FG000|STARTED|MYOBLOC: Treatment Session 4||24||
48118011|NCT02610868|100616209|FG000|COMPLETED|MYOBLOC: Treatment Session 4||22||
48118012|NCT02610868|100616209|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 4||2||
48118013|NCT01433263|100616210|FG000|STARTED|Overall Study||29||
48118014|NCT01433263|100616211|FG001|STARTED|Overall Study||28||
48118015|NCT01433263|100616210|FG000|COMPLETED|Overall Study||10||
48118016|NCT01433263|100616211|FG001|COMPLETED|Overall Study||16||
48118017|NCT01433263|100616210|FG000|NOT COMPLETED|Overall Study||19||
48118018|NCT01433263|100616211|FG001|NOT COMPLETED|Overall Study||12||
48118019|NCT00281840|100616212|FG000|STARTED|Overall Study||30||
48118020|NCT00281840|100616212|FG000|COMPLETED|Overall Study||5||
48565296|NCT03187301|101717210|FG001|STARTED|Third Intervention||7||
48565297|NCT03187301|101717211|FG002|STARTED|Third Intervention||7||
48565298|NCT03187301|101717212|FG003|STARTED|Third Intervention||6||
48565299|NCT03187301|101717213|FG004|STARTED|Third Intervention||7||
48118021|NCT00281840|100616212|FG000|NOT COMPLETED|Overall Study||25||
48565300|NCT03187301|101717214|FG005|STARTED|Third Intervention||7||
48565301|NCT03187301|101717215|FG006|STARTED|Third Intervention||0||
48565302|NCT03187301|101717209|FG000|COMPLETED|Third Intervention||6||
48118022|NCT03722017|100616213|FG000|STARTED|Overall Study||130||
48118023|NCT03722017|100616214|FG001|STARTED|Overall Study||130||
48118024|NCT03722017|100616213|FG000|Hospital Discharge|Overall Study||123||
48118025|NCT03722017|100616214|FG001|Hospital Discharge|Overall Study||122||
48118026|NCT03722017|100616213|FG000|SNF Discharge|Overall Study||70||
48118027|NCT03722017|100616214|FG001|SNF Discharge|Overall Study||84||
48118028|NCT03722017|100616213|FG000|7-Day Follow-Up|Overall Study||99||
48118029|NCT03722017|100616214|FG001|7-Day Follow-Up|Overall Study||104||
48118030|NCT03722017|100616213|FG000|COMPLETED|Overall Study||89||
48118031|NCT03722017|100616214|FG001|COMPLETED|Overall Study||94||
48118032|NCT03722017|100616213|FG000|NOT COMPLETED|Overall Study||41||
48118033|NCT03722017|100616214|FG001|NOT COMPLETED|Overall Study||36||
48118034|NCT02652624|100616215|FG000|STARTED|Randomized Phase||234||
48118035|NCT02652624|100616216|FG001|STARTED|Randomized Phase||236||
48118036|NCT02652624|100616215|FG000|COMPLETED|Randomized Phase||231||
48118037|NCT02652624|100616216|FG001|COMPLETED|Randomized Phase||231||
48118038|NCT02652624|100616215|FG000|NOT COMPLETED|Randomized Phase||3||
48118039|NCT02652624|100616216|FG001|NOT COMPLETED|Randomized Phase||5||
48118040|NCT02652624|100616215|FG000|STARTED|Extension Phase||231||
48118041|NCT02652624|100616216|FG001|STARTED|Extension Phase||228||
48118042|NCT02652624|100616215|FG000|COMPLETED|Extension Phase||227||
48118043|NCT02652624|100616216|FG001|COMPLETED|Extension Phase||224||
48118044|NCT02652624|100616215|FG000|NOT COMPLETED|Extension Phase||4||
48118045|NCT02652624|100616216|FG001|NOT COMPLETED|Extension Phase||4||
48118046|NCT00414050|100616217|FG000|STARTED|Overall Study||431||
48118047|NCT00414050|100616218|FG001|STARTED|Overall Study||427||
48118048|NCT00414050|100616219|FG002|STARTED|Overall Study||429||
48118049|NCT00414050|100616220|FG003|STARTED|Overall Study||431||
48118050|NCT00414050|100616217|FG000|Received Vaccination 1|Overall Study||431||
48118051|NCT00414050|100616218|FG001|Received Vaccination 1|Overall Study||426||
48565303|NCT03187301|101717210|FG001|COMPLETED|Third Intervention||7||
48565304|NCT03187301|101717211|FG002|COMPLETED|Third Intervention||7||
48565305|NCT03187301|101717212|FG003|COMPLETED|Third Intervention||6||
48565306|NCT03187301|101717213|FG004|COMPLETED|Third Intervention||7||
48565307|NCT03187301|101717214|FG005|COMPLETED|Third Intervention||7||
48565308|NCT03187301|101717215|FG006|COMPLETED|Third Intervention||0||
48565309|NCT03187301|101717209|FG000|NOT COMPLETED|Third Intervention||0||
48565310|NCT03187301|101717210|FG001|NOT COMPLETED|Third Intervention||0||
48565311|NCT03187301|101717211|FG002|NOT COMPLETED|Third Intervention||0||
48565312|NCT03187301|101717212|FG003|NOT COMPLETED|Third Intervention||0||
48565313|NCT03187301|101717213|FG004|NOT COMPLETED|Third Intervention||0||
48565314|NCT03187301|101717214|FG005|NOT COMPLETED|Third Intervention||0||
48565315|NCT03187301|101717215|FG006|NOT COMPLETED|Third Intervention||0||
48565316|NCT02829320|101717216|FG000|STARTED|Overall Study||28||
48565317|NCT02829320|101717216|FG000|COMPLETED|Overall Study||28||
48565318|NCT02829320|101717216|FG000|NOT COMPLETED|Overall Study||0||
48565319|NCT01703260|101717217|FG000|STARTED|Overall Study||7||
48565320|NCT01703260|101717218|FG001|STARTED|Overall Study||7||
48565321|NCT01703260|101717219|FG002|STARTED|Overall Study||6||
48565322|NCT01703260|101717217|FG000|COMPLETED|Overall Study||4||
48565323|NCT01703260|101717218|FG001|COMPLETED|Overall Study||3||
48565324|NCT01703260|101717219|FG002|COMPLETED|Overall Study||3||
48565325|NCT01703260|101717217|FG000|NOT COMPLETED|Overall Study||3||
48565326|NCT01703260|101717218|FG001|NOT COMPLETED|Overall Study||4||
48565327|NCT01703260|101717219|FG002|NOT COMPLETED|Overall Study||3||
48565328|NCT05393037|101717220|FG000|STARTED|Overall Study||156||
48565329|NCT05393037|101717221|FG001|STARTED|Overall Study||157||
48565330|NCT05393037|101717220|FG000|Vaccination 1- V116|Overall Study||155||
48565331|NCT05393037|101717221|FG001|Vaccination 1- V116|Overall Study||0||
48565332|NCT05393037|101717220|FG000|Vaccination 1- PCV15|Overall Study||1||
48565333|NCT05393037|101717221|FG001|Vaccination 1- PCV15|Overall Study||156||
48118052|NCT00414050|100616219|FG002|Received Vaccination 1|Overall Study||429||
48118053|NCT00414050|100616220|FG003|Received Vaccination 1|Overall Study||431||
48118054|NCT00414050|100616217|FG000|Received Vaccination 2|Overall Study||425||
48565334|NCT05393037|101717220|FG000|Vaccination 2- Placebo|Overall Study||154||
48565335|NCT05393037|101717221|FG001|Vaccination 2- Placebo|Overall Study||0||
48565336|NCT05393037|101717220|FG000|Vaccination 2-PCV15|Overall Study||0||
48565337|NCT05393037|101717221|FG001|Vaccination 2-PCV15|Overall Study||1||
48565338|NCT05393037|101717220|FG000|Vaccination 2-PPSV23|Overall Study||0||
48565339|NCT05393037|101717221|FG001|Vaccination 2-PPSV23|Overall Study||151||
48565340|NCT05393037|101717220|FG000|COMPLETED|Overall Study||0||
48565341|NCT05393037|101717221|FG001|COMPLETED|Overall Study||152||
48118055|NCT00414050|100616218|FG001|Received Vaccination 2|Overall Study||421||
48118056|NCT00414050|100616219|FG002|Received Vaccination 2|Overall Study||425||
48565342|NCT05393037|101717220|FG000|NOT COMPLETED|Overall Study||156||
48565343|NCT05393037|101717221|FG001|NOT COMPLETED|Overall Study||5||
48565344|NCT02182115|101717222|FG000|STARTED|Overall Study||53||
48565345|NCT02182115|101717223|FG001|STARTED|Overall Study||57||
48565346|NCT02182115|101717222|FG000|COMPLETED|Overall Study||53||
48118057|NCT00414050|100616220|FG003|Received Vaccination 2|Overall Study||425||
48565347|NCT02182115|101717223|FG001|COMPLETED|Overall Study||57||
48565348|NCT02182115|101717222|FG000|NOT COMPLETED|Overall Study||0||
48565349|NCT02182115|101717223|FG001|NOT COMPLETED|Overall Study||0||
48565350|NCT01966120|101717224|FG000|STARTED|Overall Study||55||
48565351|NCT01966120|101717225|FG001|STARTED|Overall Study||32||
48565352|NCT01966120|101717224|FG000|COMPLETED|Overall Study||54||
48565353|NCT01966120|101717225|FG001|COMPLETED|Overall Study||26||
48565354|NCT01966120|101717224|FG000|NOT COMPLETED|Overall Study||1||
48565355|NCT01966120|101717225|FG001|NOT COMPLETED|Overall Study||6||
48698057|NCT02978157|102045535|FG001|NOT COMPLETED|Overall Study||0||
48698058|NCT02095873|102045536|FG000|STARTED|First Intervention (8 Weeks)||16||
48698059|NCT02095873|102045537|FG001|STARTED|First Intervention (8 Weeks)||16||
48698060|NCT02095873|102045536|FG000|COMPLETED|First Intervention (8 Weeks)||15||
48698061|NCT02095873|102045537|FG001|COMPLETED|First Intervention (8 Weeks)||16||
48698062|NCT02095873|102045536|FG000|NOT COMPLETED|First Intervention (8 Weeks)||1||
48698063|NCT02095873|102045537|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0||
48698064|NCT02095873|102045536|FG000|STARTED|Second Intervention (8 Weeks)||15||
48698065|NCT02095873|102045537|FG001|STARTED|Second Intervention (8 Weeks)||16||
48698066|NCT02095873|102045536|FG000|COMPLETED|Second Intervention (8 Weeks)||13||
48698067|NCT02095873|102045537|FG001|COMPLETED|Second Intervention (8 Weeks)||16||
48698068|NCT02095873|102045536|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||2||
48698069|NCT02095873|102045537|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0||
48698070|NCT00271856|102045538|FG000|STARTED|Overall Study||89||
48698071|NCT00271856|102045539|FG001|STARTED|Overall Study||88||
48698072|NCT00271856|102045538|FG000|COMPLETED|Overall Study||78||
48698073|NCT00271856|102045539|FG001|COMPLETED|Overall Study||70||
48698074|NCT00271856|102045538|FG000|NOT COMPLETED|Overall Study||11||
48698075|NCT00271856|102045539|FG001|NOT COMPLETED|Overall Study||18||
48698076|NCT00868140|102045540|FG000|STARTED|Overall Study||26||
48698077|NCT00868140|102045541|FG001|STARTED|Overall Study||25||
48698078|NCT00868140|102045540|FG000|COMPLETED|Overall Study||26||
48698079|NCT00868140|102045541|FG001|COMPLETED|Overall Study||25||
48698080|NCT00868140|102045540|FG000|NOT COMPLETED|Overall Study||0||
48698081|NCT00868140|102045541|FG001|NOT COMPLETED|Overall Study||0||
48565356|NCT00717912|101717226|FG000|STARTED|Overall Study||1||
48698082|NCT02664311|102045542|FG000|STARTED|Overall Study||6||
48698083|NCT02664311|102045543|FG001|STARTED|Overall Study||3||
48698084|NCT02664311|102045542|FG000|COMPLETED|Overall Study||6|Insufficient faculty interest to recruit patients|
48698085|NCT02664311|102045543|FG001|COMPLETED|Overall Study||3|Insufficient faculty interest to recruit patients|
48698086|NCT02664311|102045542|FG000|NOT COMPLETED|Overall Study||0||
48698087|NCT02664311|102045543|FG001|NOT COMPLETED|Overall Study||0||
48698088|NCT04621240|102045544|FG000|STARTED|Overall Study||180||
48698089|NCT04621240|102045544|FG000|BrainHealth Index #1|Overall Study||180||
48698090|NCT04621240|102045544|FG000|Online Training|Overall Study||174||
48698091|NCT04621240|102045544|FG000|BrainHealth Index #2|Overall Study||144||
48698092|NCT04621240|102045544|FG000|COMPLETED|Overall Study||144||
48698093|NCT04621240|102045544|FG000|NOT COMPLETED|Overall Study||36||
48698094|NCT02582814|102045545|FG000|STARTED|Overall Study||76||
48698095|NCT02582814|102045546|FG001|STARTED|Overall Study||75||
48698096|NCT02582814|102045545|FG000|COMPLETED|Overall Study||67||
48698097|NCT02582814|102045546|FG001|COMPLETED|Overall Study||68||
48698098|NCT02582814|102045545|FG000|NOT COMPLETED|Overall Study||9||
48698099|NCT02582814|102045546|FG001|NOT COMPLETED|Overall Study||7||
48698100|NCT02346643|102045547|FG000|STARTED|Overall Study||41||
48698101|NCT02346643|102045547|FG000|Received Trial System|Overall Study||29||
48698102|NCT02346643|102045547|FG000|Received Permanent System|Overall Study||31|Two cases were trials on the table (all-in-one procedures)|
48698103|NCT02346643|102045547|FG000|COMPLETED|Overall Study||6||
48698104|NCT02346643|102045547|FG000|NOT COMPLETED|Overall Study||35||
48698105|NCT01179217|102045548|FG000|STARTED|Overall Study||152||
48698106|NCT01179217|102045549|FG001|STARTED|Overall Study||78||
48698107|NCT01179217|102045548|FG000|COMPLETED|Overall Study||97||
48698108|NCT01179217|102045549|FG001|COMPLETED|Overall Study||59||
48698109|NCT01179217|102045548|FG000|NOT COMPLETED|Overall Study||55||
48565357|NCT00717912|101717227|FG001|STARTED|Overall Study||1||
48565358|NCT00717912|101717228|FG002|STARTED|Overall Study||1||
48698110|NCT01179217|102045549|FG001|NOT COMPLETED|Overall Study||19||
48698111|NCT00566982|102045550|FG000|STARTED|Overall Study||63||
48698112|NCT00566982|102045551|FG001|STARTED|Overall Study||363||
48698113|NCT00566982|102045550|FG000|COMPLETED|Overall Study||55||
48698114|NCT00566982|102045551|FG001|COMPLETED|Overall Study||294||
48698115|NCT00566982|102045550|FG000|NOT COMPLETED|Overall Study||8||
48698116|NCT00566982|102045551|FG001|NOT COMPLETED|Overall Study||69||
48698117|NCT01955369|102045552|FG000|STARTED|Overall Study||200||
48698118|NCT01955369|102045552|FG000|COMPLETED|Overall Study||200||
48698119|NCT01955369|102045552|FG000|NOT COMPLETED|Overall Study||0||
48698120|NCT03201965|102045553|FG000|STARTED|Overall Study||28||
48118058|NCT00414050|100616217|FG000|Received Vaccination 3|Overall Study||424||
48118059|NCT00414050|100616218|FG001|Received Vaccination 3|Overall Study||419||
48118060|NCT00414050|100616219|FG002|Received Vaccination 3|Overall Study||425||
48118061|NCT00414050|100616220|FG003|Received Vaccination 3|Overall Study||424||
48118062|NCT00414050|100616217|FG000|COMPLETED|Overall Study||422||
48118063|NCT00414050|100616218|FG001|COMPLETED|Overall Study||419||
48118064|NCT00414050|100616219|FG002|COMPLETED|Overall Study||423||
48118065|NCT00414050|100616220|FG003|COMPLETED|Overall Study||423||
48118066|NCT00414050|100616217|FG000|NOT COMPLETED|Overall Study||9||
48118067|NCT00414050|100616218|FG001|NOT COMPLETED|Overall Study||8||
48118068|NCT00414050|100616219|FG002|NOT COMPLETED|Overall Study||6||
48118069|NCT00414050|100616220|FG003|NOT COMPLETED|Overall Study||8||
48118070|NCT04251533|100616221|FG000|STARTED|Overall Study||52||
48118071|NCT04251533|100616222|FG001|STARTED|Overall Study||50||
48279471|NCT00266227|101007276|FG002|NOT COMPLETED|Initial Treatment||77||
48279472|NCT00266227|101007274|FG000|STARTED|Retreatment: Up to Week 48||318||
48279473|NCT00266227|101007275|FG001|STARTED|Retreatment: Up to Week 48||157||
48279474|NCT00266227|101007276|FG002|STARTED|Retreatment: Up to Week 48||0||
48279475|NCT00266227|101007274|FG000|COMPLETED|Retreatment: Up to Week 48||291||
48118072|NCT04251533|100616223|FG002|STARTED|Overall Study||35||
48118073|NCT04251533|100616221|FG000|COMPLETED|Overall Study||8||
48118074|NCT04251533|100616222|FG001|COMPLETED|Overall Study||14||
48118075|NCT04251533|100616223|FG002|COMPLETED|Overall Study||4||
48118076|NCT04251533|100616221|FG000|NOT COMPLETED|Overall Study||44||
48118077|NCT04251533|100616222|FG001|NOT COMPLETED|Overall Study||36||
48118078|NCT04251533|100616223|FG002|NOT COMPLETED|Overall Study||31||
48118079|NCT00983814|100616224|FG000|STARTED|Open-Label (6 Weeks)||20||
48118080|NCT00983814|100616225|FG001|STARTED|Open-Label (6 Weeks)||0||
48118081|NCT00983814|100616226|FG002|STARTED|Open-Label (6 Weeks)||0||
48118082|NCT00983814|100616224|FG000|Received at Least 1 Dose of Study Drug|Open-Label (6 Weeks)||2||
48118083|NCT00983814|100616225|FG001|Received at Least 1 Dose of Study Drug|Open-Label (6 Weeks)||0||
48118084|NCT00983814|100616226|FG002|Received at Least 1 Dose of Study Drug|Open-Label (6 Weeks)||0||
48118085|NCT00983814|100616224|FG000|COMPLETED|Open-Label (6 Weeks)||13||
48118086|NCT00983814|100616225|FG001|COMPLETED|Open-Label (6 Weeks)||0||
48118087|NCT00983814|100616226|FG002|COMPLETED|Open-Label (6 Weeks)||0||
48118088|NCT00983814|100616224|FG000|NOT COMPLETED|Open-Label (6 Weeks)||7||
48118089|NCT00983814|100616225|FG001|NOT COMPLETED|Open-Label (6 Weeks)||0||
48118090|NCT00983814|100616226|FG002|NOT COMPLETED|Open-Label (6 Weeks)||0||
48279476|NCT00266227|101007275|FG001|COMPLETED|Retreatment: Up to Week 48||134||
48279477|NCT00266227|101007276|FG002|COMPLETED|Retreatment: Up to Week 48||0||
48279478|NCT00266227|101007274|FG000|NOT COMPLETED|Retreatment: Up to Week 48||27||
48279479|NCT00266227|101007275|FG001|NOT COMPLETED|Retreatment: Up to Week 48||23||
48279480|NCT00266227|101007276|FG002|NOT COMPLETED|Retreatment: Up to Week 48||0||
48279481|NCT00266227|101007274|FG000|STARTED|Retreatment: Week 48 to Week 72||291||
48279482|NCT00266227|101007275|FG001|STARTED|Retreatment: Week 48 to Week 72||134||
48279483|NCT00266227|101007276|FG002|STARTED|Retreatment: Week 48 to Week 72||0||
48698121|NCT03201965|102045554|FG001|STARTED|Overall Study||193||
48698122|NCT03201965|102045555|FG002|STARTED|Overall Study||195||
48698123|NCT03201965|102045553|FG000|Treated|Overall Study||28||
48279484|NCT00266227|101007274|FG000|COMPLETED|Retreatment: Week 48 to Week 72||227||
48279485|NCT00266227|101007275|FG001|COMPLETED|Retreatment: Week 48 to Week 72||92||
48279486|NCT00266227|101007276|FG002|COMPLETED|Retreatment: Week 48 to Week 72||0||
48279487|NCT00266227|101007274|FG000|NOT COMPLETED|Retreatment: Week 48 to Week 72||64||
48279488|NCT00266227|101007275|FG001|NOT COMPLETED|Retreatment: Week 48 to Week 72||42||
48279489|NCT00266227|101007276|FG002|NOT COMPLETED|Retreatment: Week 48 to Week 72||0||
48279490|NCT00060424|101007277|FG000|STARTED|Overall Study||21||
48279491|NCT00060424|101007277|FG000|COMPLETED|Overall Study||21||
48279492|NCT00060424|101007277|FG000|NOT COMPLETED|Overall Study||0||
48279493|NCT00129480|101007278|FG000|STARTED|Overall Study||187||
48279494|NCT00129480|101007279|FG001|STARTED|Overall Study||214||
48279495|NCT00129480|101007278|FG000|COMPLETED|Overall Study||187||
48279496|NCT00129480|101007279|FG001|COMPLETED|Overall Study||214||
48698124|NCT03201965|102045554|FG001|Treated|Overall Study||188||
48118091|NCT00983814|100616224|FG000|STARTED|Double-Blind (2 Weeks)||0||
48118092|NCT00983814|100616225|FG001|STARTED|Double-Blind (2 Weeks)||6||
48118093|NCT00983814|100616226|FG002|STARTED|Double-Blind (2 Weeks)||5||
48118094|NCT00983814|100616224|FG000|Received at Least 1 Dose of Study Drug|Double-Blind (2 Weeks)||0||
48118095|NCT00983814|100616225|FG001|Received at Least 1 Dose of Study Drug|Double-Blind (2 Weeks)||6||
48118096|NCT00983814|100616226|FG002|Received at Least 1 Dose of Study Drug|Double-Blind (2 Weeks)||5||
48118097|NCT00983814|100616224|FG000|COMPLETED|Double-Blind (2 Weeks)||0||
48279497|NCT00129480|101007278|FG000|NOT COMPLETED|Overall Study||0||
48279498|NCT00129480|101007279|FG001|NOT COMPLETED|Overall Study||0||
48279499|NCT03056300|101007280|FG000|STARTED|Overall Study||50||
48279500|NCT03056300|101007280|FG000|COMPLETED|Overall Study||47||
48279501|NCT03056300|101007280|FG000|NOT COMPLETED|Overall Study||3||
48279502|NCT02735577|101007281|FG000|STARTED|Disulfiram Treatment||7||
48394700|NCT03859960|101295999|FG000|NOT COMPLETED|Overall Study||0||
48118098|NCT00983814|100616225|FG001|COMPLETED|Double-Blind (2 Weeks)||6||
48698125|NCT03201965|102045555|FG002|Treated|Overall Study||193||
48279503|NCT02735577|101007281|FG000|COMPLETED|Disulfiram Treatment||6||
48279504|NCT02735577|101007281|FG000|NOT COMPLETED|Disulfiram Treatment||1||
48279505|NCT02735577|101007281|FG000|STARTED|Optional 28 Days of Disulfiram Treatment||6||
48279506|NCT02735577|101007281|FG000|COMPLETED|Optional 28 Days of Disulfiram Treatment||4||
48279507|NCT02735577|101007281|FG000|NOT COMPLETED|Optional 28 Days of Disulfiram Treatment||2||
48279508|NCT05652647|101007282|FG000|STARTED|Overall Study||6||
48279509|NCT05652647|101007282|FG000|COMPLETED|Overall Study||6||
48279510|NCT05652647|101007282|FG000|NOT COMPLETED|Overall Study||0||
48279511|NCT03651622|101007283|FG000|STARTED|Diet Period 1 (Randomization 1)||23||
48279512|NCT03651622|101007284|FG001|STARTED|Diet Period 1 (Randomization 1)||24||
48279513|NCT03651622|101007285|FG002|STARTED|Diet Period 1 (Randomization 1)||21||
48279514|NCT03651622|101007283|FG000|COMPLETED|Diet Period 1 (Randomization 1)||19||
48279515|NCT03651622|101007284|FG001|COMPLETED|Diet Period 1 (Randomization 1)||17||
48279516|NCT03651622|101007285|FG002|COMPLETED|Diet Period 1 (Randomization 1)||12||
48279517|NCT03651622|101007283|FG000|NOT COMPLETED|Diet Period 1 (Randomization 1)||4||
48118099|NCT00983814|100616226|FG002|COMPLETED|Double-Blind (2 Weeks)||4||
48118100|NCT00983814|100616224|FG000|NOT COMPLETED|Double-Blind (2 Weeks)||0||
48118101|NCT00983814|100616225|FG001|NOT COMPLETED|Double-Blind (2 Weeks)||0||
48565359|NCT00717912|101717229|FG003|STARTED|Overall Study||1||
48698126|NCT03201965|102045553|FG000|COMPLETED|Overall Study||0||
48698127|NCT03201965|102045554|FG001|COMPLETED|Overall Study||0||
48698128|NCT03201965|102045555|FG002|COMPLETED|Overall Study||0||
48118102|NCT00983814|100616226|FG002|NOT COMPLETED|Double-Blind (2 Weeks)||1||
48118103|NCT01632800|100616227|FG000|STARTED|Overall Study||26||
48118104|NCT01632800|100616227|FG000|COMPLETED|Overall Study||25||
48279518|NCT03651622|101007284|FG001|NOT COMPLETED|Diet Period 1 (Randomization 1)||7||
48565360|NCT00717912|101717230|FG004|STARTED|Overall Study||1||
48565361|NCT00717912|101717231|FG005|STARTED|Overall Study||1||
48565362|NCT00717912|101717226|FG000|COMPLETED|Overall Study||1||
48565363|NCT00717912|101717227|FG001|COMPLETED|Overall Study||1||
48565364|NCT00717912|101717228|FG002|COMPLETED|Overall Study||1||
48565365|NCT00717912|101717229|FG003|COMPLETED|Overall Study||1||
48565366|NCT00717912|101717230|FG004|COMPLETED|Overall Study||1||
48565367|NCT00717912|101717231|FG005|COMPLETED|Overall Study||1||
48565368|NCT00717912|101717226|FG000|NOT COMPLETED|Overall Study||0||
48565369|NCT00717912|101717227|FG001|NOT COMPLETED|Overall Study||0||
48565370|NCT00717912|101717228|FG002|NOT COMPLETED|Overall Study||0||
48565371|NCT00717912|101717229|FG003|NOT COMPLETED|Overall Study||0||
48565372|NCT00717912|101717230|FG004|NOT COMPLETED|Overall Study||0||
48698129|NCT03201965|102045553|FG000|NOT COMPLETED|Overall Study||28||
48698130|NCT03201965|102045554|FG001|NOT COMPLETED|Overall Study||193||
48698131|NCT03201965|102045555|FG002|NOT COMPLETED|Overall Study||195||
48698132|NCT00177294|102045556|FG000|STARTED|Overall Study||60||
48698133|NCT00177294|102045557|FG001|STARTED|Overall Study||64||
48698134|NCT00177294|102045556|FG000|COMPLETED|Overall Study||53||
48698135|NCT00177294|102045557|FG001|COMPLETED|Overall Study||59||
48698136|NCT00177294|102045556|FG000|NOT COMPLETED|Overall Study||7||
48698137|NCT00177294|102045557|FG001|NOT COMPLETED|Overall Study||5||
48698138|NCT02789345|102045558|FG000|STARTED|Overall Study||3||
48698139|NCT02789345|102045559|FG001|STARTED|Overall Study||4||
48698140|NCT02789345|102045560|FG002|STARTED|Overall Study||22||
48698141|NCT02789345|102045558|FG000|Received at Least One Dose of Study Drug|Overall Study||3||
48698142|NCT02789345|102045559|FG001|Received at Least One Dose of Study Drug|Overall Study||4||
48698143|NCT02789345|102045560|FG002|Received at Least One Dose of Study Drug|Overall Study||22||
48698144|NCT02789345|102045558|FG000|COMPLETED|Overall Study||0||
48698145|NCT02789345|102045559|FG001|COMPLETED|Overall Study||1||
48698146|NCT02789345|102045560|FG002|COMPLETED|Overall Study||5||
48698147|NCT02789345|102045558|FG000|NOT COMPLETED|Overall Study||3||
48698148|NCT02789345|102045559|FG001|NOT COMPLETED|Overall Study||3||
48698149|NCT02789345|102045560|FG002|NOT COMPLETED|Overall Study||17||
48698150|NCT02487654|102045561|FG000|STARTED|Overall Study||53||
48698151|NCT02487654|102045562|FG001|STARTED|Overall Study||63||
48118105|NCT01632800|100616227|FG000|NOT COMPLETED|Overall Study||1||
48118106|NCT04115358|100616228|FG000|STARTED|Overall Study||34||51
48118107|NCT04115358|100616229|FG001|STARTED|Overall Study||33||40
48118108|NCT04115358|100616230|FG002|STARTED|Overall Study||34||39
48118109|NCT04115358|100616228|FG000|COMPLETED|Overall Study||34|In the 12th month follow-up, the dropouts increased due to the Covid-19 pandemic and periapical radiographs could not be taken in a total of eight children.|48
48279519|NCT03651622|101007285|FG002|NOT COMPLETED|Diet Period 1 (Randomization 1)||9||
48279520|NCT03651622|101007283|FG000|STARTED|Diet Period 2 (Randomization 2)||19||
48565373|NCT00717912|101717231|FG005|NOT COMPLETED|Overall Study||0||
48565374|NCT02767011|101717232|FG000|STARTED|Overall Study||16||
48565375|NCT02767011|101717233|FG001|STARTED|Overall Study||14||
48698152|NCT02487654|102045561|FG000|COMPLETED|Overall Study||50||
48698153|NCT02487654|102045562|FG001|COMPLETED|Overall Study||52||
48698154|NCT02487654|102045561|FG000|NOT COMPLETED|Overall Study||3||
48698155|NCT02487654|102045562|FG001|NOT COMPLETED|Overall Study||11||
48279521|NCT03651622|101007284|FG001|STARTED|Diet Period 2 (Randomization 2)||15||
48279522|NCT03651622|101007285|FG002|STARTED|Diet Period 2 (Randomization 2)||14||
48279523|NCT03651622|101007283|FG000|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 2 (Randomization 2)||0||
48279524|NCT03651622|101007284|FG001|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 2 (Randomization 2)||5||
48279525|NCT03651622|101007285|FG002|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 2 (Randomization 2)||5||
48279526|NCT03651622|101007283|FG000|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 2 (Randomization 2)||5||
48279527|NCT03651622|101007284|FG001|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 2 (Randomization 2)||0||
48279528|NCT03651622|101007285|FG002|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 2 (Randomization 2)||6||
48279529|NCT03651622|101007283|FG000|Number of Participants Rerandomized From Mediterranean, no Caloric Restriction Diet|Diet Period 2 (Randomization 2)||5||
48279530|NCT03651622|101007284|FG001|Number of Participants Rerandomized From Mediterranean, no Caloric Restriction Diet|Diet Period 2 (Randomization 2)||4||
48279531|NCT03651622|101007285|FG002|Number of Participants Rerandomized From Mediterranean, no Caloric Restriction Diet|Diet Period 2 (Randomization 2)||0||
48279532|NCT03651622|101007283|FG000|Number of Participants Not Rerandomized|Diet Period 2 (Randomization 2)||9||
48279533|NCT03651622|101007284|FG001|Number of Participants Not Rerandomized|Diet Period 2 (Randomization 2)||6||
48279534|NCT03651622|101007285|FG002|Number of Participants Not Rerandomized|Diet Period 2 (Randomization 2)||3||
48279535|NCT03651622|101007283|FG000|COMPLETED|Diet Period 2 (Randomization 2)||17||
48279536|NCT03651622|101007284|FG001|COMPLETED|Diet Period 2 (Randomization 2)||13||
48279537|NCT03651622|101007285|FG002|COMPLETED|Diet Period 2 (Randomization 2)||11||
48279538|NCT03651622|101007283|FG000|NOT COMPLETED|Diet Period 2 (Randomization 2)||2||
48279539|NCT03651622|101007284|FG001|NOT COMPLETED|Diet Period 2 (Randomization 2)||2||
48279540|NCT03651622|101007285|FG002|NOT COMPLETED|Diet Period 2 (Randomization 2)||3||
48279541|NCT03651622|101007283|FG000|STARTED|Diet Period 3 (Randomization 3)||14||
48279542|NCT03651622|101007284|FG001|STARTED|Diet Period 3 (Randomization 3)||9||
48279543|NCT03651622|101007285|FG002|STARTED|Diet Period 3 (Randomization 3)||18||
48279544|NCT03651622|101007283|FG000|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 3 (Randomization 3)||0||
48279545|NCT03651622|101007284|FG001|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 3 (Randomization 3)||2||
48279546|NCT03651622|101007285|FG002|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 3 (Randomization 3)||10||
48279547|NCT03651622|101007283|FG000|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 3 (Randomization 3)||4||
48279548|NCT03651622|101007284|FG001|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 3 (Randomization 3)||0||
48279549|NCT03651622|101007285|FG002|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 3 (Randomization 3)||6||
48279550|NCT03651622|101007283|FG000|Number of Participants Rerandomized From Mediterranean|Diet Period 3 (Randomization 3)||6||
48279551|NCT03651622|101007284|FG001|Number of Participants Rerandomized From Mediterranean|Diet Period 3 (Randomization 3)||4||
48279552|NCT03651622|101007285|FG002|Number of Participants Rerandomized From Mediterranean|Diet Period 3 (Randomization 3)||0||
48565376|NCT02767011|101717232|FG000|COMPLETED|Overall Study||16||
48565377|NCT02767011|101717233|FG001|COMPLETED|Overall Study||14||
48565378|NCT02767011|101717232|FG000|NOT COMPLETED|Overall Study||0||
48565379|NCT02767011|101717233|FG001|NOT COMPLETED|Overall Study||0||
48565380|NCT05340764|101717234|FG000|STARTED|Overall Study||45||
48565381|NCT05340764|101717235|FG001|STARTED|Overall Study||51||
48279553|NCT03651622|101007283|FG000|Number of Participants Not Rerandomized|Diet Period 3 (Randomization 3)||4||
48279554|NCT03651622|101007284|FG001|Number of Participants Not Rerandomized|Diet Period 3 (Randomization 3)||3||
48279555|NCT03651622|101007285|FG002|Number of Participants Not Rerandomized|Diet Period 3 (Randomization 3)||2||
48279556|NCT03651622|101007283|FG000|COMPLETED|Diet Period 3 (Randomization 3)||14||
48279557|NCT03651622|101007284|FG001|COMPLETED|Diet Period 3 (Randomization 3)||9||
48279558|NCT03651622|101007285|FG002|COMPLETED|Diet Period 3 (Randomization 3)||17||
48279559|NCT03651622|101007283|FG000|NOT COMPLETED|Diet Period 3 (Randomization 3)||0||
48279560|NCT03651622|101007284|FG001|NOT COMPLETED|Diet Period 3 (Randomization 3)||0||
48279561|NCT03651622|101007285|FG002|NOT COMPLETED|Diet Period 3 (Randomization 3)||1||
48279562|NCT02217475|101007286|FG000|STARTED|Treatment Period 1 (Year 1)||72||
48565382|NCT05340764|101717234|FG000|COMPLETED|Overall Study||45||
48565383|NCT05340764|101717235|FG001|COMPLETED|Overall Study||50||
48565384|NCT05340764|101717234|FG000|NOT COMPLETED|Overall Study||0||
48565385|NCT05340764|101717235|FG001|NOT COMPLETED|Overall Study||1||
48565386|NCT01557504|101717236|FG000|STARTED|Overall Study||13||
48565387|NCT01557504|101717237|FG001|STARTED|Overall Study||12||
48565388|NCT01557504|101717236|FG000|COMPLETED|Overall Study||12||
48565389|NCT01557504|101717237|FG001|COMPLETED|Overall Study||12||
48565390|NCT01557504|101717236|FG000|NOT COMPLETED|Overall Study||1||
48565391|NCT01557504|101717237|FG001|NOT COMPLETED|Overall Study||0||
48565392|NCT00571727|101717238|FG000|STARTED|Overall Study||92||
48279563|NCT02217475|101007287|FG001|STARTED|Treatment Period 1 (Year 1)||72||
48565393|NCT00571727|101717238|FG000|COMPLETED|Overall Study||26||
48565394|NCT00571727|101717238|FG000|NOT COMPLETED|Overall Study||66||
48565395|NCT02872714|101717239|FG000|STARTED|Overall Study||103||
48565396|NCT02872714|101717240|FG001|STARTED|Overall Study||44||
48279564|NCT02217475|101007288|FG002|STARTED|Treatment Period 1 (Year 1)||145||
48279565|NCT02217475|101007286|FG000|Safety Analysis Set|Treatment Period 1 (Year 1)||72|Received at least one dose of study drug.|
48279566|NCT02217475|101007287|FG001|Safety Analysis Set|Treatment Period 1 (Year 1)||72|Received at least one dose of study drug.|
48279567|NCT02217475|101007288|FG002|Safety Analysis Set|Treatment Period 1 (Year 1)||144|Received at least one dose of study drug.|
48279568|NCT02217475|101007286|FG000|COMPLETED|Treatment Period 1 (Year 1)||62||
48279569|NCT02217475|101007287|FG001|COMPLETED|Treatment Period 1 (Year 1)||64||
48279570|NCT02217475|101007288|FG002|COMPLETED|Treatment Period 1 (Year 1)||124||
48279571|NCT02217475|101007286|FG000|NOT COMPLETED|Treatment Period 1 (Year 1)||10||
48279572|NCT02217475|101007287|FG001|NOT COMPLETED|Treatment Period 1 (Year 1)||8||
48279573|NCT02217475|101007288|FG002|NOT COMPLETED|Treatment Period 1 (Year 1)||21||
48279574|NCT02217475|101007286|FG000|STARTED|Discontinued After Period 1||62||
48279575|NCT02217475|101007287|FG001|STARTED|Discontinued After Period 1||64||
48279576|NCT02217475|101007288|FG002|STARTED|Discontinued After Period 1||124||
48279577|NCT02217475|101007286|FG000|COMPLETED|Discontinued After Period 1||60||
48279578|NCT02217475|101007287|FG001|COMPLETED|Discontinued After Period 1||61||
48565397|NCT02872714|101717241|FG002|STARTED|Overall Study||9||
48565398|NCT02872714|101717242|FG003|STARTED|Overall Study||101||
48565399|NCT02872714|101717243|FG004|STARTED|Overall Study||3||
48565400|NCT02872714|101717239|FG000|COMPLETED|Overall Study||10||
48565401|NCT02872714|101717240|FG001|COMPLETED|Overall Study||2||
48565402|NCT02872714|101717241|FG002|COMPLETED|Overall Study||1||
48565403|NCT02872714|101717242|FG003|COMPLETED|Overall Study||13||
48565404|NCT02872714|101717243|FG004|COMPLETED|Overall Study||1||
48565405|NCT02872714|101717239|FG000|NOT COMPLETED|Overall Study||93||
48565406|NCT02872714|101717240|FG001|NOT COMPLETED|Overall Study||42||
48565407|NCT02872714|101717241|FG002|NOT COMPLETED|Overall Study||8||
48565408|NCT02872714|101717242|FG003|NOT COMPLETED|Overall Study||88||
48565409|NCT02872714|101717243|FG004|NOT COMPLETED|Overall Study||2||
48565410|NCT01592786|101717244|FG000|STARTED|Overall Study||903||
48565411|NCT01592786|101717244|FG000|COMPLETED|Overall Study||765||
48565412|NCT01592786|101717244|FG000|NOT COMPLETED|Overall Study||138||
48565413|NCT02268916|101717245|FG000|STARTED|Overall Study||52||
48565414|NCT02268916|101717246|FG001|STARTED|Overall Study||52||
48565415|NCT02268916|101717245|FG000|COMPLETED|Overall Study||35||
48565416|NCT02268916|101717246|FG001|COMPLETED|Overall Study||42||
48565417|NCT02268916|101717245|FG000|NOT COMPLETED|Overall Study||17||
48565418|NCT02268916|101717246|FG001|NOT COMPLETED|Overall Study||10||
48565419|NCT01333592|101717247|FG000|STARTED|Overall Study||67||
48565420|NCT01333592|101717248|FG001|STARTED|Overall Study||69||
48565421|NCT01333592|101717247|FG000|COMPLETED|Overall Study||58||
48565422|NCT01333592|101717248|FG001|COMPLETED|Overall Study||52||
48565423|NCT01333592|101717247|FG000|NOT COMPLETED|Overall Study||9||
48565424|NCT01333592|101717248|FG001|NOT COMPLETED|Overall Study||17||
48565425|NCT00323453|101717249|FG000|STARTED|Overall Study||61||
48565426|NCT00323453|101717250|FG001|STARTED|Overall Study||48||
48565427|NCT00323453|101717249|FG000|COMPLETED|Overall Study||61||
48565428|NCT00323453|101717250|FG001|COMPLETED|Overall Study||48||
48565429|NCT00323453|101717249|FG000|NOT COMPLETED|Overall Study||0||
48565430|NCT00323453|101717250|FG001|NOT COMPLETED|Overall Study||0||
48279579|NCT02217475|101007288|FG002|COMPLETED|Discontinued After Period 1||121||
48279580|NCT02217475|101007286|FG000|NOT COMPLETED|Discontinued After Period 1||2||
48279581|NCT02217475|101007287|FG001|NOT COMPLETED|Discontinued After Period 1||3||
48279582|NCT02217475|101007288|FG002|NOT COMPLETED|Discontinued After Period 1||3||
48279583|NCT02217475|101007286|FG000|STARTED|Treatment Period 2 (Year 2)||60||
48279584|NCT02217475|101007287|FG001|STARTED|Treatment Period 2 (Year 2)||61||
48279585|NCT02217475|101007288|FG002|STARTED|Treatment Period 2 (Year 2)||121||
48279586|NCT02217475|101007286|FG000|COMPLETED|Treatment Period 2 (Year 2)||58||
48279587|NCT02217475|101007287|FG001|COMPLETED|Treatment Period 2 (Year 2)||59||
48279588|NCT02217475|101007288|FG002|COMPLETED|Treatment Period 2 (Year 2)||109||
48279589|NCT02217475|101007286|FG000|NOT COMPLETED|Treatment Period 2 (Year 2)||2||
48279590|NCT02217475|101007287|FG001|NOT COMPLETED|Treatment Period 2 (Year 2)||2||
48279591|NCT02217475|101007288|FG002|NOT COMPLETED|Treatment Period 2 (Year 2)||12||
48279592|NCT01209234|101007289|FG000|STARTED|Overall Study||1070||
48279593|NCT01209234|101007290|FG001|STARTED|Overall Study||1070||
48279594|NCT01209234|101007289|FG000|COMPLETED|Overall Study||1058||
48279595|NCT01209234|101007290|FG001|COMPLETED|Overall Study||1063||
48279596|NCT01209234|101007289|FG000|NOT COMPLETED|Overall Study||12||
48279597|NCT01209234|101007290|FG001|NOT COMPLETED|Overall Study||7||
48565431|NCT01790984|101717251|FG000|STARTED|First Dietary Intervention (12 Weeks)||6||
48565432|NCT01790984|101717252|FG001|STARTED|First Dietary Intervention (12 Weeks)||8||
48565433|NCT01790984|101717253|FG002|STARTED|First Dietary Intervention (12 Weeks)||6||
48565434|NCT01790984|101717254|FG003|STARTED|First Dietary Intervention (12 Weeks)||7||
48565435|NCT01790984|101717251|FG000|COMPLETED|First Dietary Intervention (12 Weeks)||5||
48565436|NCT01790984|101717252|FG001|COMPLETED|First Dietary Intervention (12 Weeks)||7||
48279598|NCT01517295|101007291|FG000|STARTED|Overall Study||16||
48279599|NCT01517295|101007292|FG001|STARTED|Overall Study||14||
48565437|NCT01790984|101717253|FG002|COMPLETED|First Dietary Intervention (12 Weeks)||6||
48565438|NCT01790984|101717254|FG003|COMPLETED|First Dietary Intervention (12 Weeks)||7||
48118110|NCT04115358|100616229|FG001|COMPLETED|Overall Study||33|In the 12th month follow-up, the dropouts increased due to the Covid-19 pandemic and periapical radiographs could not be taken in a total of eight children.|40
48118111|NCT04115358|100616230|FG002|COMPLETED|Overall Study||33|In the 12th month follow-up, the dropouts increased due to the Covid-19 pandemic and periapical radiographs could not be taken in a total of eight children.|38
48118112|NCT04115358|100616228|FG000|NOT COMPLETED|Overall Study||0||3
48118113|NCT04115358|100616229|FG001|NOT COMPLETED|Overall Study||0||0
48118114|NCT04115358|100616230|FG002|NOT COMPLETED|Overall Study||1||1
48118115|NCT01830140|100616231|FG000|STARTED|Overall Study||233||
48394701|NCT03859960|101296000|FG001|NOT COMPLETED|Overall Study||0||
48565439|NCT01790984|101717251|FG000|NOT COMPLETED|First Dietary Intervention (12 Weeks)||1||
48118116|NCT01830140|100616232|FG001|STARTED|Overall Study||233||
48118117|NCT01830140|100616231|FG000|COMPLETED|Overall Study||226||
48118118|NCT01830140|100616232|FG001|COMPLETED|Overall Study||229||
48118119|NCT01830140|100616231|FG000|NOT COMPLETED|Overall Study||7||
48118120|NCT01830140|100616232|FG001|NOT COMPLETED|Overall Study||4||
48118121|NCT03226067|100616233|FG000|STARTED|Overall Study||36||
48118122|NCT03226067|100616234|FG001|STARTED|Overall Study||38||
48118123|NCT03226067|100616235|FG002|STARTED|Overall Study||37||
48118124|NCT03226067|100616233|FG000|COMPLETED|Overall Study||36||
48118125|NCT03226067|100616234|FG001|COMPLETED|Overall Study||38||
48118126|NCT03226067|100616235|FG002|COMPLETED|Overall Study||37||
48118127|NCT03226067|100616233|FG000|NOT COMPLETED|Overall Study||0||
48118128|NCT03226067|100616234|FG001|NOT COMPLETED|Overall Study||0||
48118129|NCT03226067|100616235|FG002|NOT COMPLETED|Overall Study||0||
48118130|NCT02582840|100616236|FG000|STARTED|Overall Study||14||
48118131|NCT02582840|100616237|FG001|STARTED|Overall Study||14||
48118132|NCT02582840|100616238|FG002|STARTED|Overall Study||14||
48118133|NCT02582840|100616236|FG000|COMPLETED|Overall Study||14||
48118134|NCT02582840|100616237|FG001|COMPLETED|Overall Study||14||
48118135|NCT02582840|100616238|FG002|COMPLETED|Overall Study||14||
48118136|NCT02582840|100616236|FG000|NOT COMPLETED|Overall Study||0||
48118137|NCT02582840|100616237|FG001|NOT COMPLETED|Overall Study||0||
48118138|NCT02582840|100616238|FG002|NOT COMPLETED|Overall Study||0||
48118139|NCT00427804|100616239|FG000|STARTED|Overall Study||4||
48118140|NCT00427804|100616240|FG001|STARTED|Overall Study||5||
48118141|NCT00427804|100616239|FG000|COMPLETED|Overall Study||4||
48118142|NCT00427804|100616240|FG001|COMPLETED|Overall Study||5||
48118143|NCT00427804|100616239|FG000|NOT COMPLETED|Overall Study||0||
48118144|NCT00427804|100616240|FG001|NOT COMPLETED|Overall Study||0||
48118145|NCT00651482|100616241|FG000|STARTED|Overall Study||10||
48118146|NCT00651482|100616241|FG000|COMPLETED|Overall Study||10||
48118147|NCT00651482|100616241|FG000|NOT COMPLETED|Overall Study||0||
48118148|NCT02709395|100616242|FG000|STARTED|Overall Study||28||
48118149|NCT02709395|100616242|FG000|COMPLETED|Overall Study||19||
48118150|NCT02709395|100616242|FG000|NOT COMPLETED|Overall Study||9||
48118151|NCT01461096|100616243|FG000|STARTED|Overall Study||288||
48118152|NCT01461096|100616244|FG001|STARTED|Overall Study||287||
48118153|NCT01461096|100616243|FG000|Did Not Start Treatment|Overall Study||0||
48118154|NCT01461096|100616244|FG001|Did Not Start Treatment|Overall Study||1||
48118155|NCT01461096|100616243|FG000|COMPLETED|Overall Study||226|Unexpected closure of study. Completed study requirements up to the time of unexpected closure.|
48118156|NCT01461096|100616244|FG001|COMPLETED|Overall Study||226|Unexpected closure of study. Completed study requirements up to the time of unexpected closure.|
48118157|NCT01461096|100616243|FG000|NOT COMPLETED|Overall Study||62||
48118158|NCT01461096|100616244|FG001|NOT COMPLETED|Overall Study||61||
48118159|NCT03390907|100616245|FG000|STARTED|Overall Study||40||
48118160|NCT03390907|100616245|FG000|COMPLETED|Overall Study||40||
48118161|NCT03390907|100616245|FG000|NOT COMPLETED|Overall Study||0||
48118162|NCT02212730|100616246|FG000|STARTED|Overall Study||6||
48118163|NCT02212730|100616247|FG001|STARTED|Overall Study||4||
48118164|NCT02212730|100616246|FG000|Received Neoadjuvant Pembrolizumab|Overall Study||4||
48118165|NCT02212730|100616247|FG001|Received Neoadjuvant Pembrolizumab|Overall Study||0||
48118166|NCT02212730|100616246|FG000|Underwent RCC|Overall Study||4||
48118167|NCT02212730|100616247|FG001|Underwent RCC|Overall Study||3||
48118168|NCT02212730|100616246|FG000|Received Post-RCC Pembrolizumab|Overall Study||1||
48118169|NCT02212730|100616247|FG001|Received Post-RCC Pembrolizumab|Overall Study||1||
48118170|NCT02212730|100616246|FG000|COMPLETED|Overall Study||4||
48118171|NCT02212730|100616247|FG001|COMPLETED|Overall Study||3||
48118172|NCT02212730|100616246|FG000|NOT COMPLETED|Overall Study||2||
48118173|NCT02212730|100616247|FG001|NOT COMPLETED|Overall Study||1||
48279600|NCT01517295|101007291|FG000|COMPLETED|Overall Study||15||
48279601|NCT01517295|101007292|FG001|COMPLETED|Overall Study||14||
48279602|NCT01517295|101007291|FG000|NOT COMPLETED|Overall Study||1||
48279603|NCT01517295|101007292|FG001|NOT COMPLETED|Overall Study||0||
48279604|NCT02308787|101007293|FG000|STARTED|Overall Study||12||
48279605|NCT02308787|101007293|FG000|COMPLETED|Overall Study||12||
48279606|NCT02308787|101007293|FG000|NOT COMPLETED|Overall Study||0||
48279607|NCT02495792|101007294|FG000|STARTED|Overall Study||96||
48279608|NCT02495792|101007295|FG001|STARTED|Overall Study||95||
48279609|NCT02495792|101007294|FG000|COMPLETED|Overall Study||59||
48279610|NCT02495792|101007295|FG001|COMPLETED|Overall Study||55||
48279611|NCT02495792|101007294|FG000|NOT COMPLETED|Overall Study||37||
48565440|NCT01790984|101717252|FG001|NOT COMPLETED|First Dietary Intervention (12 Weeks)||1||
48565441|NCT01790984|101717253|FG002|NOT COMPLETED|First Dietary Intervention (12 Weeks)||0||
48565442|NCT01790984|101717254|FG003|NOT COMPLETED|First Dietary Intervention (12 Weeks)||0||
48565443|NCT01790984|101717251|FG000|STARTED|Wash-out (4 Weeks)||5||
48565444|NCT01790984|101717252|FG001|STARTED|Wash-out (4 Weeks)||7||
48698156|NCT04308239|102045563|FG000|STARTED|Pre-intervention Evaluation (1 Week)||20||
48698157|NCT04308239|102045564|FG001|STARTED|Pre-intervention Evaluation (1 Week)||14||
48698158|NCT04308239|102045563|FG000|COMPLETED|Pre-intervention Evaluation (1 Week)||17||
48698159|NCT04308239|102045564|FG001|COMPLETED|Pre-intervention Evaluation (1 Week)||11||
48698160|NCT04308239|102045563|FG000|NOT COMPLETED|Pre-intervention Evaluation (1 Week)||3||
48698161|NCT04308239|102045564|FG001|NOT COMPLETED|Pre-intervention Evaluation (1 Week)||3||
48698162|NCT04308239|102045563|FG000|STARTED|Intervention (2 Weeks)||20||
48698163|NCT04308239|102045564|FG001|STARTED|Intervention (2 Weeks)||14||
48698164|NCT04308239|102045563|FG000|COMPLETED|Intervention (2 Weeks)||20||
48698165|NCT04308239|102045564|FG001|COMPLETED|Intervention (2 Weeks)||14||
48118174|NCT01282424|100616248|FG000|STARTED|Treatment Period (TP) (81 Months)||125||
48118175|NCT01282424|100616248|FG000|Completed: Disease Progression|Treatment Period (TP) (81 Months)||70||
48118176|NCT01282424|100616248|FG000|Completed: Death|Treatment Period (TP) (81 Months)||9||
48118177|NCT01282424|100616248|FG000|COMPLETED|Treatment Period (TP) (81 Months)||79||
48118178|NCT01282424|100616248|FG000|NOT COMPLETED|Treatment Period (TP) (81 Months)||46||
48118179|NCT01282424|100616248|FG000|STARTED|Long-term Follow-up Period (5 Years)||84||
48118180|NCT01282424|100616248|FG000|COMPLETED|Long-term Follow-up Period (5 Years)||20||
48118181|NCT01282424|100616248|FG000|NOT COMPLETED|Long-term Follow-up Period (5 Years)||64||
48118182|NCT01878604|100616249|FG000|STARTED|Overall Study||5||
48118183|NCT01878604|100616249|FG000|COMPLETED|Overall Study||5||
48118184|NCT01878604|100616249|FG000|NOT COMPLETED|Overall Study||0||
48118185|NCT03235024|100616250|FG000|STARTED|Overall Study||61||
48118186|NCT03235024|100616251|FG001|STARTED|Overall Study||61||
48118187|NCT03235024|100616250|FG000|COMPLETED|Overall Study||55||
48118188|NCT03235024|100616251|FG001|COMPLETED|Overall Study||51||
48118189|NCT03235024|100616250|FG000|NOT COMPLETED|Overall Study||6||
48118190|NCT03235024|100616251|FG001|NOT COMPLETED|Overall Study||10||
48118191|NCT00451282|100616252|FG000|STARTED|Overall Study||46||
48118192|NCT00451282|100616253|FG001|STARTED|Overall Study||39||
48118193|NCT00451282|100616252|FG000|COMPLETED|Overall Study||40||
48118194|NCT00451282|100616253|FG001|COMPLETED|Overall Study||34||
48118195|NCT00451282|100616252|FG000|NOT COMPLETED|Overall Study||6||
48118196|NCT00451282|100616253|FG001|NOT COMPLETED|Overall Study||5||
48118197|NCT02978690|100616254|FG000|STARTED|Overall Study||7||
48118198|NCT02978690|100616254|FG000|COMPLETED|Overall Study||7||
48118199|NCT02978690|100616254|FG000|NOT COMPLETED|Overall Study||0||
48118200|NCT01222494|100616255|FG000|STARTED|Overall Study||7||
48118201|NCT01222494|100616256|FG001|STARTED|Overall Study||19||
48118202|NCT01222494|100616257|FG002|STARTED|Overall Study||21||
48118203|NCT01222494|100616255|FG000|COMPLETED|Overall Study||6||
48118204|NCT01222494|100616256|FG001|COMPLETED|Overall Study||15||
48118205|NCT01222494|100616257|FG002|COMPLETED|Overall Study||17||
48118206|NCT01222494|100616255|FG000|NOT COMPLETED|Overall Study||1||
48118207|NCT01222494|100616256|FG001|NOT COMPLETED|Overall Study||4||
48118208|NCT01222494|100616257|FG002|NOT COMPLETED|Overall Study||4||
48118209|NCT00436280|100616258|FG000|STARTED|Period 1: Induction||68||
48118210|NCT00436280|100616258|FG000|Received at Least 1 Dose of Study Drug|Period 1: Induction||68||
48118211|NCT00436280|100616258|FG000|COMPLETED|Period 1: Induction||40||
48118212|NCT00436280|100616258|FG000|NOT COMPLETED|Period 1: Induction||28||
48118213|NCT00436280|100616258|FG000|STARTED|Period 2: Consolidation||40||
48118214|NCT00436280|100616258|FG000|COMPLETED|Period 2: Consolidation||23||
48118215|NCT00436280|100616258|FG000|NOT COMPLETED|Period 2: Consolidation||17||
48118216|NCT00436280|100616258|FG000|STARTED|Period 3: Maintenance||23||
48565445|NCT01790984|101717253|FG002|STARTED|Wash-out (4 Weeks)||6||
48565446|NCT01790984|101717254|FG003|STARTED|Wash-out (4 Weeks)||7||
48565447|NCT01790984|101717251|FG000|COMPLETED|Wash-out (4 Weeks)||5||
48565448|NCT01790984|101717252|FG001|COMPLETED|Wash-out (4 Weeks)||7||
48565449|NCT01790984|101717253|FG002|COMPLETED|Wash-out (4 Weeks)||6||
48565450|NCT01790984|101717254|FG003|COMPLETED|Wash-out (4 Weeks)||7||
48118217|NCT00436280|100616258|FG000|COMPLETED|Period 3: Maintenance||5||
48118218|NCT00436280|100616258|FG000|NOT COMPLETED|Period 3: Maintenance||18||
48118219|NCT01948375|100616259|FG000|STARTED|Overall Study||30||
48118220|NCT01948375|100616260|FG001|STARTED|Overall Study||30||
48118221|NCT01948375|100616259|FG000|COMPLETED|Overall Study||30||
48118222|NCT01948375|100616260|FG001|COMPLETED|Overall Study||30||
48118223|NCT01948375|100616259|FG000|NOT COMPLETED|Overall Study||0||
48118224|NCT01948375|100616260|FG001|NOT COMPLETED|Overall Study||0||
48118225|NCT01038778|100616261|FG000|STARTED|Overall Study||3||
48118226|NCT01038778|100616262|FG001|STARTED|Overall Study||8||
48118227|NCT01038778|100616263|FG002|STARTED|Overall Study||36||
48118228|NCT01038778|100616261|FG000|COMPLETED|Overall Study||3||
48118229|NCT01038778|100616262|FG001|COMPLETED|Overall Study||6||
48118230|NCT01038778|100616263|FG002|COMPLETED|Overall Study||33||
48118231|NCT01038778|100616261|FG000|NOT COMPLETED|Overall Study||0||
48118232|NCT01038778|100616262|FG001|NOT COMPLETED|Overall Study||2||
48279612|NCT02495792|101007295|FG001|NOT COMPLETED|Overall Study||40||
48279613|NCT01416389|101007296|FG000|STARTED|Overall Study||26||
48279614|NCT01416389|101007297|FG001|STARTED|Overall Study||13||
48279615|NCT01416389|101007296|FG000|Received at Least 1 Dose of Study Drug|Overall Study||26||
48279616|NCT01416389|101007297|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13||
48279617|NCT01416389|101007296|FG000|COMPLETED|Overall Study||23||
48279618|NCT01416389|101007297|FG001|COMPLETED|Overall Study||13||
48279619|NCT01416389|101007296|FG000|NOT COMPLETED|Overall Study||3||
48279620|NCT01416389|101007297|FG001|NOT COMPLETED|Overall Study||0||
48279621|NCT02955147|101007298|FG000|STARTED|Overall Study||13||
48279622|NCT02955147|101007298|FG000|COMPLETED|Overall Study||13||
48279623|NCT02955147|101007298|FG000|NOT COMPLETED|Overall Study||0||
48279624|NCT02093949|101007299|FG000|STARTED|Overall Study||105||
48279625|NCT02093949|101007300|FG001|STARTED|Overall Study||47||
48565451|NCT01790984|101717251|FG000|NOT COMPLETED|Wash-out (4 Weeks)||0||
48565452|NCT01790984|101717252|FG001|NOT COMPLETED|Wash-out (4 Weeks)||0||
48565453|NCT01790984|101717253|FG002|NOT COMPLETED|Wash-out (4 Weeks)||0||
48565454|NCT01790984|101717254|FG003|NOT COMPLETED|Wash-out (4 Weeks)||0||
48565455|NCT01790984|101717251|FG000|STARTED|Second Dietary Intervention (12 Weeks)||5||
48565456|NCT01790984|101717252|FG001|STARTED|Second Dietary Intervention (12 Weeks)||7||
48565457|NCT01790984|101717253|FG002|STARTED|Second Dietary Intervention (12 Weeks)||6||
48565458|NCT01790984|101717254|FG003|STARTED|Second Dietary Intervention (12 Weeks)||7||
48565459|NCT01790984|101717251|FG000|COMPLETED|Second Dietary Intervention (12 Weeks)||5||
48565460|NCT01790984|101717252|FG001|COMPLETED|Second Dietary Intervention (12 Weeks)||7||
48279626|NCT02093949|101007299|FG000|COMPLETED|Overall Study||105||
48279627|NCT02093949|101007300|FG001|COMPLETED|Overall Study||47||
48565461|NCT01790984|101717253|FG002|COMPLETED|Second Dietary Intervention (12 Weeks)||6||
48565462|NCT01790984|101717254|FG003|COMPLETED|Second Dietary Intervention (12 Weeks)||7||
48565463|NCT01790984|101717251|FG000|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0||
48565464|NCT01790984|101717252|FG001|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0||
48565465|NCT01790984|101717253|FG002|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0||
48565466|NCT01790984|101717254|FG003|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0||
48565467|NCT00869622|101717255|FG000|STARTED|Overall Study||40||
48565468|NCT00869622|101717256|FG001|STARTED|Overall Study||40||
48565469|NCT00869622|101717255|FG000|COMPLETED|Overall Study||27||
48565470|NCT00869622|101717256|FG001|COMPLETED|Overall Study||26||
48565471|NCT00869622|101717255|FG000|NOT COMPLETED|Overall Study||13||
48565472|NCT00869622|101717256|FG001|NOT COMPLETED|Overall Study||14||
48565473|NCT02859337|101717257|FG000|STARTED|Overall Study||25||
48565474|NCT02859337|101717258|FG001|STARTED|Overall Study||27||
48279628|NCT02093949|101007299|FG000|NOT COMPLETED|Overall Study||0||
48279629|NCT02093949|101007300|FG001|NOT COMPLETED|Overall Study||0||
48279630|NCT00350103|101007301|FG000|STARTED|Overall Study||179||
48279631|NCT00350103|101007302|FG001|STARTED|Overall Study||190||
48279632|NCT00350103|101007303|FG002|STARTED|Overall Study||182||
48279633|NCT00350103|101007301|FG000|Entered Titration Phase|Overall Study||179|Received at least 1 dose of study medication (Safety Set)|
48279634|NCT00350103|101007302|FG001|Entered Titration Phase|Overall Study||189|Received at least 1 dose of study medication (Safety Set)|
48279635|NCT00350103|101007303|FG002|Entered Titration Phase|Overall Study||181|Received at least 1 dose of study medication (Safety Set)|
48279636|NCT00350103|101007301|FG000|Completed Titration Phase|Overall Study||162||
48279637|NCT00350103|101007302|FG001|Completed Titration Phase|Overall Study||164||
48279638|NCT00350103|101007303|FG002|Completed Titration Phase|Overall Study||165||
48279639|NCT00350103|101007301|FG000|Entered Maintenance Phase|Overall Study||162||
48279640|NCT00350103|101007302|FG001|Entered Maintenance Phase|Overall Study||163||
48279641|NCT00350103|101007303|FG002|Entered Maintenance Phase|Overall Study||164||
48279642|NCT00350103|101007301|FG000|Completed Maintenance Phase|Overall Study||150||
48279643|NCT00350103|101007302|FG001|Completed Maintenance Phase|Overall Study||149||
48279644|NCT00350103|101007303|FG002|Completed Maintenance Phase|Overall Study||148||
48565475|NCT02859337|101717259|FG002|STARTED|Overall Study||12||
48565476|NCT02859337|101717257|FG000|COMPLETED|Overall Study||19||
48565477|NCT02859337|101717258|FG001|COMPLETED|Overall Study||24||
48565478|NCT02859337|101717259|FG002|COMPLETED|Overall Study||12||
48565479|NCT02859337|101717257|FG000|NOT COMPLETED|Overall Study||6||
48565480|NCT02859337|101717258|FG001|NOT COMPLETED|Overall Study||3||
48565481|NCT02859337|101717259|FG002|NOT COMPLETED|Overall Study||0||
48565482|NCT03861390|101717260|FG000|STARTED|First Intervention||6||
48565483|NCT03861390|101717261|FG001|STARTED|First Intervention||6||
48565484|NCT03861390|101717260|FG000|COMPLETED|First Intervention||6||
48565485|NCT03861390|101717261|FG001|COMPLETED|First Intervention||6||
48565486|NCT03861390|101717260|FG000|NOT COMPLETED|First Intervention||0||
48565487|NCT03861390|101717261|FG001|NOT COMPLETED|First Intervention||0||
48565488|NCT03861390|101717260|FG000|STARTED|Washout (4 Weeks)||6||
48565489|NCT03861390|101717261|FG001|STARTED|Washout (4 Weeks)||6||
48279645|NCT00350103|101007301|FG000|COMPLETED|Overall Study||149||
48279646|NCT00350103|101007302|FG001|COMPLETED|Overall Study||148||
48279647|NCT00350103|101007303|FG002|COMPLETED|Overall Study||146||
48279648|NCT00350103|101007301|FG000|NOT COMPLETED|Overall Study||30||
48279649|NCT00350103|101007302|FG001|NOT COMPLETED|Overall Study||42||
48118233|NCT01038778|100616263|FG002|NOT COMPLETED|Overall Study||3||
48118234|NCT05932290|100616264|FG000|STARTED|Overall Study||123||
48118235|NCT05932290|100616265|FG001|STARTED|Overall Study||239||
48118236|NCT05932290|100616266|FG002|STARTED|Overall Study||152||
48118237|NCT05932290|100616264|FG000|COMPLETED|Overall Study||123||
48279650|NCT00350103|101007303|FG002|NOT COMPLETED|Overall Study||36||
48279651|NCT00467350|101007304|FG000|STARTED|Overall Study||41||
48279652|NCT00467350|101007305|FG001|STARTED|Overall Study||39||
48279653|NCT00467350|101007304|FG000|COMPLETED|Overall Study||40||
48279654|NCT00467350|101007305|FG001|COMPLETED|Overall Study||39||
48279655|NCT00467350|101007304|FG000|NOT COMPLETED|Overall Study||1||
48279656|NCT00467350|101007305|FG001|NOT COMPLETED|Overall Study||0||
48279657|NCT00132873|101007306|FG000|STARTED|Overall Study||59||
48279658|NCT00132873|101007306|FG000|COMPLETED|Overall Study||50||
48279659|NCT00132873|101007306|FG000|NOT COMPLETED|Overall Study||9||
48279660|NCT02053792|101007307|FG000|STARTED|Overall Study||83||
48279661|NCT02053792|101007308|FG001|STARTED|Overall Study||14||
48279662|NCT02053792|101007307|FG000|COMPLETED|Overall Study||77||
48279663|NCT02053792|101007308|FG001|COMPLETED|Overall Study||10||
48279664|NCT02053792|101007307|FG000|NOT COMPLETED|Overall Study||6||
48565490|NCT03861390|101717260|FG000|COMPLETED|Washout (4 Weeks)||6||
48565491|NCT03861390|101717261|FG001|COMPLETED|Washout (4 Weeks)||6||
48565492|NCT03861390|101717260|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
48565493|NCT03861390|101717261|FG001|NOT COMPLETED|Washout (4 Weeks)||0||
48565494|NCT03861390|101717260|FG000|STARTED|Period Title: Second Intervention||6||
48565495|NCT03861390|101717261|FG001|STARTED|Period Title: Second Intervention||6||
48565496|NCT03861390|101717260|FG000|COMPLETED|Period Title: Second Intervention||6||
48565497|NCT03861390|101717261|FG001|COMPLETED|Period Title: Second Intervention||6||
48565498|NCT03861390|101717260|FG000|NOT COMPLETED|Period Title: Second Intervention||0||
48565499|NCT03861390|101717261|FG001|NOT COMPLETED|Period Title: Second Intervention||0||
48565500|NCT01074268|101717262|FG000|STARTED|Main: Week 0 to 26 (NN1250-3585)||303||
48565501|NCT01074268|101717263|FG001|STARTED|Main: Week 0 to 26 (NN1250-3585)||153||
48565502|NCT01074268|101717262|FG000|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)||302||
48565503|NCT01074268|101717263|FG001|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)||153||
48565504|NCT01074268|101717262|FG000|Exposed|Main: Week 0 to 26 (NN1250-3585)||301||
48118238|NCT05932290|100616265|FG001|COMPLETED|Overall Study||239||
48118239|NCT05932290|100616266|FG002|COMPLETED|Overall Study||152||
48118240|NCT05932290|100616264|FG000|NOT COMPLETED|Overall Study||0||
48118241|NCT05932290|100616265|FG001|NOT COMPLETED|Overall Study||0||
48279665|NCT02053792|101007308|FG001|NOT COMPLETED|Overall Study||4||
48279666|NCT00022659|101007309|FG000|STARTED|Overall Study||64||
48279667|NCT00022659|101007309|FG000|COMPLETED|Overall Study||62||
48565505|NCT01074268|101717263|FG001|Exposed|Main: Week 0 to 26 (NN1250-3585)||152||
48565506|NCT01074268|101717262|FG000|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||283||
48565507|NCT01074268|101717263|FG001|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||138||
48565508|NCT01074268|101717262|FG000|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||20||
48565509|NCT01074268|101717263|FG001|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||15||
48565510|NCT01074268|101717262|FG000|STARTED|Extension: Week 27 to 52 (NN1250-3725)||248||
48565511|NCT01074268|101717263|FG001|STARTED|Extension: Week 27 to 52 (NN1250-3725)||122||
48565512|NCT01074268|101717262|FG000|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||242||
48118242|NCT05932290|100616266|FG002|NOT COMPLETED|Overall Study||0||
48279668|NCT00022659|101007309|FG000|NOT COMPLETED|Overall Study||2||
48279669|NCT05032872|101007310|FG000|STARTED|Overall Study||38|enrolled in the study|
48279670|NCT05032872|101007311|FG001|STARTED|Overall Study||42|enrolled in the study|
48279671|NCT05032872|101007310|FG000|Completed Pretest|Overall Study||38||
48279672|NCT05032872|101007311|FG001|Completed Pretest|Overall Study||38||
48279673|NCT05032872|101007310|FG000|COMPLETED|Overall Study||31|completed posttest|
48279674|NCT05032872|101007311|FG001|COMPLETED|Overall Study||35|completed posttest|
48279675|NCT05032872|101007310|FG000|NOT COMPLETED|Overall Study||7||
48279676|NCT05032872|101007311|FG001|NOT COMPLETED|Overall Study||7||
48118243|NCT00727194|100616267|FG000|STARTED|Screening Period||7||
48118244|NCT00727194|100616268|FG001|STARTED|Screening Period||7||
48118245|NCT00727194|100616269|FG002|STARTED|Screening Period||16||
48565513|NCT01074268|101717263|FG001|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||115||
48565514|NCT01074268|101717262|FG000|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||6||
48565515|NCT01074268|101717263|FG001|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||7||
48565516|NCT00387335|101717264|FG000|STARTED|Overall Study||15||
48565517|NCT00387335|101717265|FG001|STARTED|Overall Study||7||
48565518|NCT00387335|101717264|FG000|COMPLETED|Overall Study||15||
48565519|NCT00387335|101717265|FG001|COMPLETED|Overall Study||7||
48565520|NCT00387335|101717264|FG000|NOT COMPLETED|Overall Study||0||
48565521|NCT00387335|101717265|FG001|NOT COMPLETED|Overall Study||0||
48565522|NCT00915018|101717266|FG000|STARTED|Overall Study||242||
48565523|NCT00915018|101717267|FG001|STARTED|Overall Study||237||
48565524|NCT00915018|101717266|FG000|Received Treatment|Overall Study||240||
48565525|NCT00915018|101717267|FG001|Received Treatment|Overall Study||234||
48118246|NCT00727194|100616267|FG000|COMPLETED|Screening Period||7||
48118247|NCT00727194|100616268|FG001|COMPLETED|Screening Period||7||
48118248|NCT00727194|100616269|FG002|COMPLETED|Screening Period||0||
48118249|NCT00727194|100616267|FG000|NOT COMPLETED|Screening Period||0||
48118250|NCT00727194|100616268|FG001|NOT COMPLETED|Screening Period||0||
48118251|NCT00727194|100616269|FG002|NOT COMPLETED|Screening Period||16||
48118252|NCT00727194|100616267|FG000|STARTED|Treatment Period 1||7||
48118253|NCT00727194|100616268|FG001|STARTED|Treatment Period 1||7||
48118254|NCT00727194|100616269|FG002|STARTED|Treatment Period 1||0||
48118255|NCT00727194|100616267|FG000|COMPLETED|Treatment Period 1||7||
48118256|NCT00727194|100616268|FG001|COMPLETED|Treatment Period 1||7||
48118257|NCT00727194|100616269|FG002|COMPLETED|Treatment Period 1||0||
48118258|NCT00727194|100616267|FG000|NOT COMPLETED|Treatment Period 1||0||
48118259|NCT00727194|100616268|FG001|NOT COMPLETED|Treatment Period 1||0||
48118260|NCT00727194|100616269|FG002|NOT COMPLETED|Treatment Period 1||0||
48118261|NCT00727194|100616267|FG000|STARTED|Washout Period||7||
48118262|NCT00727194|100616268|FG001|STARTED|Washout Period||7||
48118263|NCT00727194|100616269|FG002|STARTED|Washout Period||0||
48118264|NCT00727194|100616267|FG000|COMPLETED|Washout Period||7||
48118265|NCT00727194|100616268|FG001|COMPLETED|Washout Period||7||
48118266|NCT00727194|100616269|FG002|COMPLETED|Washout Period||0||
48118267|NCT00727194|100616267|FG000|NOT COMPLETED|Washout Period||0||
48118268|NCT00727194|100616268|FG001|NOT COMPLETED|Washout Period||0||
48118269|NCT00727194|100616269|FG002|NOT COMPLETED|Washout Period||0||
48565526|NCT00915018|101717266|FG000|COMPLETED|Overall Study||27||
48565527|NCT00915018|101717267|FG001|COMPLETED|Overall Study||30||
48565528|NCT00915018|101717266|FG000|NOT COMPLETED|Overall Study||215||
48565529|NCT00915018|101717267|FG001|NOT COMPLETED|Overall Study||207||
48565530|NCT05209867|101717268|FG000|STARTED|Overall Study||4||
48565531|NCT05209867|101717268|FG000|Completed 1 Month of Intervention|Overall Study||4|The individual completed one month of intervention and attended the second visit|
48565532|NCT05209867|101717268|FG000|Completed 2 Months of Intervention|Overall Study||3|The individual completed two months of intervention and attended the third visit|
48565533|NCT05209867|101717268|FG000|COMPLETED|Overall Study||4||
48565534|NCT05209867|101717268|FG000|NOT COMPLETED|Overall Study||0||
48565535|NCT01468337|101717269|FG000|STARTED|Overall Study||5||
48565536|NCT01468337|101717269|FG000|Week 2|Overall Study||5||
48565537|NCT01468337|101717269|FG000|Received Interferon Gamma-1b at Week 4|Overall Study||2||
48565538|NCT01468337|101717269|FG000|Received Interferon Gamma-1b After Wk 8|Overall Study||4||
48565539|NCT01468337|101717269|FG000|Week 48|Overall Study||3||
48565540|NCT01468337|101717269|FG000|COMPLETED|Overall Study||5||
48565541|NCT01468337|101717269|FG000|NOT COMPLETED|Overall Study||0||
48565542|NCT02531308|101717270|FG000|STARTED|Overall Study||5||
48565543|NCT02531308|101717270|FG000|COMPLETED|Overall Study||2||
48565544|NCT02531308|101717270|FG000|NOT COMPLETED|Overall Study||3||
48565545|NCT02835625|101717271|FG000|STARTED|Overall Study||14734||
48565546|NCT02835625|101717272|FG001|STARTED|Overall Study||14719||
48118270|NCT00727194|100616267|FG000|STARTED|Treatment Period 2||6||
48279677|NCT03345576|101007312|FG000|STARTED|Overall Study||6||
48279678|NCT03345576|101007313|FG001|STARTED|Overall Study||6||
48279679|NCT03345576|101007312|FG000|COMPLETED|Overall Study||3||
48279680|NCT03345576|101007313|FG001|COMPLETED|Overall Study||4||
48279681|NCT03345576|101007312|FG000|NOT COMPLETED|Overall Study||3||
48279682|NCT03345576|101007313|FG001|NOT COMPLETED|Overall Study||2||
48279683|NCT01720277|101007314|FG000|STARTED|Overall Study||1461||20
48279684|NCT01720277|101007315|FG001|STARTED|Overall Study||1496||19
48279685|NCT01720277|101007314|FG000|COMPLETED|Overall Study||958||20
48279686|NCT01720277|101007315|FG001|COMPLETED|Overall Study||938||19
48279687|NCT01720277|101007314|FG000|NOT COMPLETED|Overall Study||503||0
48279688|NCT01720277|101007315|FG001|NOT COMPLETED|Overall Study||558||0
48279689|NCT04833127|101007316|FG000|STARTED|Overall Study||50||8
48279690|NCT04833127|101007317|FG001|STARTED|Overall Study||50||8
48279691|NCT04833127|101007316|FG000|COMPLETED|Overall Study||49||8
48279692|NCT04833127|101007317|FG001|COMPLETED|Overall Study||49||8
48279693|NCT04833127|101007316|FG000|NOT COMPLETED|Overall Study||1||0
48279694|NCT04833127|101007317|FG001|NOT COMPLETED|Overall Study||1||0
48279695|NCT03330405|101007318|FG000|STARTED|Overall Study||12||
48279696|NCT03330405|101007319|FG001|STARTED|Overall Study||42||
48279697|NCT03330405|101007320|FG002|STARTED|Overall Study||5||
48279698|NCT03330405|101007321|FG003|STARTED|Overall Study||22||
48279699|NCT03330405|101007322|FG004|STARTED|Overall Study||23||
48279700|NCT03330405|101007323|FG005|STARTED|Overall Study||20||
48565547|NCT02835625|101717271|FG000|COMPLETED|Overall Study||14734||
48279701|NCT03330405|101007324|FG006|STARTED|Overall Study||11||
48279702|NCT03330405|101007325|FG007|STARTED|Overall Study||40||
48279703|NCT03330405|101007326|FG008|STARTED|Overall Study||21||
48279704|NCT03330405|101007327|FG009|STARTED|Overall Study||18||
48279705|NCT03330405|101007328|FG010|STARTED|Overall Study||9||
48279706|NCT03330405|101007318|FG000|COMPLETED|Overall Study||0||
48279707|NCT03330405|101007319|FG001|COMPLETED|Overall Study||0||
48279708|NCT03330405|101007320|FG002|COMPLETED|Overall Study||0||
48279709|NCT03330405|101007321|FG003|COMPLETED|Overall Study||0||
48279710|NCT03330405|101007322|FG004|COMPLETED|Overall Study||0||
48565548|NCT02835625|101717272|FG001|COMPLETED|Overall Study||14719||
48565549|NCT02835625|101717271|FG000|NOT COMPLETED|Overall Study||0||
48565550|NCT02835625|101717272|FG001|NOT COMPLETED|Overall Study||0||
48565551|NCT00942578|101717273|FG000|STARTED|Dose Escalation Phase||3||
48565552|NCT00942578|101717274|FG001|STARTED|Dose Escalation Phase||3||
48565553|NCT00942578|101717275|FG002|STARTED|Dose Escalation Phase||3||
48565554|NCT00942578|101717273|FG000|COMPLETED|Dose Escalation Phase||3||
48565555|NCT00942578|101717274|FG001|COMPLETED|Dose Escalation Phase||3||
48565556|NCT00942578|101717275|FG002|COMPLETED|Dose Escalation Phase||3||
48279711|NCT03330405|101007323|FG005|COMPLETED|Overall Study||0||
48279712|NCT03330405|101007324|FG006|COMPLETED|Overall Study||0||
48279713|NCT03330405|101007325|FG007|COMPLETED|Overall Study||0||
48279714|NCT03330405|101007326|FG008|COMPLETED|Overall Study||0||
48279715|NCT03330405|101007327|FG009|COMPLETED|Overall Study||0||
48279716|NCT03330405|101007328|FG010|COMPLETED|Overall Study||0||
48279717|NCT03330405|101007318|FG000|NOT COMPLETED|Overall Study||12||
48279718|NCT03330405|101007319|FG001|NOT COMPLETED|Overall Study||42||
48279719|NCT03330405|101007320|FG002|NOT COMPLETED|Overall Study||5||
48279720|NCT03330405|101007321|FG003|NOT COMPLETED|Overall Study||22||
48279721|NCT03330405|101007322|FG004|NOT COMPLETED|Overall Study||23||
48279722|NCT03330405|101007323|FG005|NOT COMPLETED|Overall Study||20||
48279723|NCT03330405|101007324|FG006|NOT COMPLETED|Overall Study||11||
48565557|NCT00942578|101717273|FG000|NOT COMPLETED|Dose Escalation Phase||0||
48565558|NCT00942578|101717274|FG001|NOT COMPLETED|Dose Escalation Phase||0||
48565559|NCT00942578|101717275|FG002|NOT COMPLETED|Dose Escalation Phase||0||
48565560|NCT00942578|101717273|FG000|STARTED|Expansion Phase||11||
48565561|NCT00942578|101717274|FG001|STARTED|Expansion Phase||0||
48565562|NCT00942578|101717275|FG002|STARTED|Expansion Phase||43||
48279724|NCT03330405|101007325|FG007|NOT COMPLETED|Overall Study||40||
48279725|NCT03330405|101007326|FG008|NOT COMPLETED|Overall Study||21||
48279726|NCT03330405|101007327|FG009|NOT COMPLETED|Overall Study||18||
48279727|NCT03330405|101007328|FG010|NOT COMPLETED|Overall Study||9||
48279728|NCT04535310|101007329|FG000|STARTED|Overall Study||35||
48279729|NCT04535310|101007329|FG000|COMPLETED|Overall Study||35||
48279730|NCT04535310|101007329|FG000|NOT COMPLETED|Overall Study||0||
48279731|NCT02576587|101007330|FG000|STARTED|Baseline||161||
48279732|NCT02576587|101007331|FG001|STARTED|Baseline||156||
48279733|NCT02576587|101007330|FG000|COMPLETED|Baseline||161||
48279734|NCT02576587|101007331|FG001|COMPLETED|Baseline||155||
48279735|NCT02576587|101007330|FG000|NOT COMPLETED|Baseline||0||
48279736|NCT02576587|101007331|FG001|NOT COMPLETED|Baseline||1||
48279737|NCT02576587|101007330|FG000|STARTED|Follow up Period (Case Only)||161||
48279738|NCT02576587|101007331|FG001|STARTED|Follow up Period (Case Only)||155||
48279739|NCT02576587|101007330|FG000|Selected for Follow up|Follow up Period (Case Only)||61|Cases with apnea hypopnea index greater or equal to 15 were selected for follow up.|
48279740|NCT02576587|101007331|FG001|Selected for Follow up|Follow up Period (Case Only)||0|Cases with apnea hypopnea index greater or equal to 15 were selected for follow up.|
48279741|NCT02576587|101007330|FG000|COMPLETED|Follow up Period (Case Only)||44||
48279742|NCT02576587|101007331|FG001|COMPLETED|Follow up Period (Case Only)||0||
48565563|NCT00942578|101717273|FG000|COMPLETED|Expansion Phase||11||
48565564|NCT00942578|101717274|FG001|COMPLETED|Expansion Phase||0||
48565565|NCT00942578|101717275|FG002|COMPLETED|Expansion Phase||43||
48565566|NCT00942578|101717273|FG000|NOT COMPLETED|Expansion Phase||0||
48565567|NCT00942578|101717274|FG001|NOT COMPLETED|Expansion Phase||0||
48565568|NCT00942578|101717275|FG002|NOT COMPLETED|Expansion Phase||0||
48565569|NCT00733421|101717276|FG000|STARTED|Overall Study||50||
48565570|NCT00733421|101717277|FG001|STARTED|Overall Study||50||
48565571|NCT00733421|101717276|FG000|COMPLETED|Overall Study||49||
48118271|NCT00727194|100616268|FG001|STARTED|Treatment Period 2||6||
48279743|NCT02576587|101007330|FG000|NOT COMPLETED|Follow up Period (Case Only)||117||
48279744|NCT02576587|101007331|FG001|NOT COMPLETED|Follow up Period (Case Only)||155||
48279745|NCT01081665|101007332|FG000|STARTED|Overall Study||237||
48279746|NCT01081665|101007332|FG000|Full Analysis Set|Overall Study||237||
48279747|NCT01081665|101007332|FG000|Evaluable Population|Overall Study||212||
48565572|NCT00733421|101717277|FG001|COMPLETED|Overall Study||49||
48565573|NCT00733421|101717276|FG000|NOT COMPLETED|Overall Study||1||
48565574|NCT00733421|101717277|FG001|NOT COMPLETED|Overall Study||1||
48565575|NCT01671007|101717278|FG000|STARTED|Overall Study||2089||
48565576|NCT01671007|101717279|FG001|STARTED|Overall Study||2834||
48565577|NCT01671007|101717280|FG002|STARTED|Overall Study||2033||
48565578|NCT01671007|101717281|FG003|STARTED|Overall Study||2214||
48279748|NCT01081665|101007332|FG000|COMPLETED|Overall Study||142||
48565579|NCT01671007|101717282|FG004|STARTED|Overall Study||180||
48279749|NCT01081665|101007332|FG000|NOT COMPLETED|Overall Study||95||
48565580|NCT01671007|101717283|FG005|STARTED|Overall Study||513||
48565581|NCT01671007|101717284|FG006|STARTED|Overall Study||80||
48565582|NCT01671007|101717285|FG007|STARTED|Overall Study||526||
48565583|NCT01671007|101717286|FG008|STARTED|Overall Study||2||
48565584|NCT01671007|101717278|FG000|All Eligible|Overall Study||2066||
48279750|NCT00659880|101007333|FG000|STARTED|Overall Study||9||
48279751|NCT00659880|101007333|FG000|6 Weeks|Overall Study||9||
48279752|NCT00659880|101007333|FG000|6 Months|Overall Study||9||
48279753|NCT00659880|101007333|FG000|12 Months|Overall Study||7||
48279754|NCT00659880|101007333|FG000|24 Months|Overall Study||6||
48279755|NCT00659880|101007333|FG000|COMPLETED|Overall Study||4||
48565585|NCT01671007|101717279|FG001|All Eligible|Overall Study||2758||
48565586|NCT01671007|101717280|FG002|All Eligible|Overall Study||2008||
48565587|NCT01671007|101717281|FG003|All Eligible|Overall Study||2197||
48565588|NCT01671007|101717282|FG004|All Eligible|Overall Study||180||
48565589|NCT01671007|101717283|FG005|All Eligible|Overall Study||507||
48565590|NCT01671007|101717284|FG006|All Eligible|Overall Study||79||
48565591|NCT01671007|101717285|FG007|All Eligible|Overall Study||507||
48565592|NCT01671007|101717286|FG008|All Eligible|Overall Study||2||
48565593|NCT01671007|101717278|FG000|COMPLETED|Overall Study||1768||
48565594|NCT01671007|101717279|FG001|COMPLETED|Overall Study||2183||
48565595|NCT01671007|101717280|FG002|COMPLETED|Overall Study||1667||
48565596|NCT01671007|101717281|FG003|COMPLETED|Overall Study||1846||
48565597|NCT01671007|101717282|FG004|COMPLETED|Overall Study||155||
48565598|NCT01671007|101717283|FG005|COMPLETED|Overall Study||401||
48565599|NCT01671007|101717284|FG006|COMPLETED|Overall Study||59||
48565600|NCT01671007|101717285|FG007|COMPLETED|Overall Study||394||
48565601|NCT01671007|101717286|FG008|COMPLETED|Overall Study||2||
48565602|NCT01671007|101717278|FG000|NOT COMPLETED|Overall Study||321||
48394702|NCT01779648|101296001|FG000|STARTED|Overall Study||28||
48394703|NCT01779648|101296002|FG001|STARTED|Overall Study||27||
48394704|NCT01779648|101296001|FG000|COMPLETED|Overall Study||27||
48394705|NCT01779648|101296002|FG001|COMPLETED|Overall Study||27||
48565603|NCT01671007|101717279|FG001|NOT COMPLETED|Overall Study||651||
48565604|NCT01671007|101717280|FG002|NOT COMPLETED|Overall Study||366||
48565605|NCT01671007|101717281|FG003|NOT COMPLETED|Overall Study||368||
48565606|NCT01671007|101717282|FG004|NOT COMPLETED|Overall Study||25||
48565607|NCT01671007|101717283|FG005|NOT COMPLETED|Overall Study||112||
48565608|NCT01671007|101717284|FG006|NOT COMPLETED|Overall Study||21||
48565609|NCT01671007|101717285|FG007|NOT COMPLETED|Overall Study||132||
48565610|NCT01671007|101717286|FG008|NOT COMPLETED|Overall Study||0||
48279756|NCT00659880|101007333|FG000|NOT COMPLETED|Overall Study||5||
48279757|NCT00287690|101007334|FG000|STARTED|Overall Study||33||
48279758|NCT00287690|101007335|FG001|STARTED|Overall Study||38||
48279759|NCT00287690|101007334|FG000|COMPLETED|Overall Study||13||
48279760|NCT00287690|101007335|FG001|COMPLETED|Overall Study||12||
48279761|NCT00287690|101007334|FG000|NOT COMPLETED|Overall Study||20||
48279762|NCT00287690|101007335|FG001|NOT COMPLETED|Overall Study||26||
48279763|NCT03435692|101007336|FG000|STARTED|Overall Study||17||
48279764|NCT03435692|101007337|FG001|STARTED|Overall Study||18||
48279765|NCT03435692|101007338|FG002|STARTED|Overall Study||7||
48279766|NCT03435692|101007336|FG000|COMPLETED|Overall Study||15||
48279767|NCT03435692|101007337|FG001|COMPLETED|Overall Study||16||
48279768|NCT03435692|101007338|FG002|COMPLETED|Overall Study||7||
48279769|NCT03435692|101007336|FG000|NOT COMPLETED|Overall Study||2||
48279770|NCT03435692|101007337|FG001|NOT COMPLETED|Overall Study||2||
48279771|NCT03435692|101007338|FG002|NOT COMPLETED|Overall Study||0||
48279772|NCT02081417|101007339|FG000|STARTED|Overall Study||163|These individuals were determined eligible, randomized to study arms and attended 1 treatment group.|
48394706|NCT01779648|101296001|FG000|NOT COMPLETED|Overall Study||1||
48394707|NCT01779648|101296002|FG001|NOT COMPLETED|Overall Study||0||
48394708|NCT03549117|101296003|FG000|STARTED|Overall Study||70||
48394709|NCT03549117|101296004|FG001|STARTED|Overall Study||70||
48394710|NCT03549117|101296003|FG000|COMPLETED|Overall Study||69||
48394711|NCT03549117|101296004|FG001|COMPLETED|Overall Study||70||
48394712|NCT03549117|101296003|FG000|NOT COMPLETED|Overall Study||1||
48394713|NCT03549117|101296004|FG001|NOT COMPLETED|Overall Study||0||
48394714|NCT00971633|101296005|FG000|STARTED|Period 1||2||
48394715|NCT00971633|101296006|FG001|STARTED|Period 1||2||
48394716|NCT00971633|101296007|FG002|STARTED|Period 1||2||
48394717|NCT00971633|101296008|FG003|STARTED|Period 1||2||
48394718|NCT00971633|101296009|FG004|STARTED|Period 1||2||
48394719|NCT00971633|101296010|FG005|STARTED|Period 1||2||
48394720|NCT00971633|101296005|FG000|COMPLETED|Period 1||2||
48394721|NCT00971633|101296006|FG001|COMPLETED|Period 1||2||
48394722|NCT00971633|101296007|FG002|COMPLETED|Period 1||2||
48394723|NCT00971633|101296008|FG003|COMPLETED|Period 1||2||
48565611|NCT00739661|101717287|FG000|STARTED|Overall Study||52||
48279773|NCT02081417|101007340|FG001|STARTED|Overall Study||166|These individuals were determined eligible, randomized to study arms and attended 1 treatment group.|
48279774|NCT02081417|101007339|FG000|1st Interview Completed|Overall Study||146|These individuals attended one treatment session, were consented and completed a first interview.|
48294166|NCT02527343|101047540|FG004|COMPLETED|OLE Period-Year 2: Week 105 to 156||0||
48394724|NCT00971633|101296009|FG004|COMPLETED|Period 1||2||
48394725|NCT00971633|101296010|FG005|COMPLETED|Period 1||2||
48394726|NCT00971633|101296005|FG000|NOT COMPLETED|Period 1||0||
48565612|NCT00739661|101717288|FG001|STARTED|Overall Study||52||
48565613|NCT00739661|101717287|FG000|COMPLETED|Overall Study||6||
48565614|NCT00739661|101717288|FG001|COMPLETED|Overall Study||10||
48565615|NCT00739661|101717287|FG000|NOT COMPLETED|Overall Study||46||
48565616|NCT00739661|101717288|FG001|NOT COMPLETED|Overall Study||42||
48565617|NCT02445248|101717289|FG000|STARTED|Overall Study||99|Started = Infused|
48279775|NCT02081417|101007340|FG001|1st Interview Completed|Overall Study||145|These individuals attended one treatment session, were consented and completed a first interview.|
48279776|NCT02081417|101007339|FG000|3-Month Follow-Up|Overall Study||94||
48279777|NCT02081417|101007340|FG001|3-Month Follow-Up|Overall Study||95||
48279778|NCT02081417|101007339|FG000|6-Month Follow-Up|Overall Study||82||
48279779|NCT02081417|101007340|FG001|6-Month Follow-Up|Overall Study||92||
48279780|NCT02081417|101007339|FG000|COMPLETED|Overall Study||107|Defined as completing at least one follow-up interview (3 or 6 months)|
48279781|NCT02081417|101007340|FG001|COMPLETED|Overall Study||115|Defined as completing at least one follow-up interview (3 or 6 months)|
48279782|NCT02081417|101007339|FG000|NOT COMPLETED|Overall Study||56||
48279783|NCT02081417|101007340|FG001|NOT COMPLETED|Overall Study||51||
48279784|NCT04560010|101007341|FG000|STARTED|Overall Study||8||
48279785|NCT04560010|101007342|FG001|STARTED|Overall Study||9||
48279786|NCT04560010|101007341|FG000|COMPLETED|Overall Study||8||
48279787|NCT04560010|101007342|FG001|COMPLETED|Overall Study||9||
48279788|NCT04560010|101007341|FG000|NOT COMPLETED|Overall Study||0||
48279789|NCT04560010|101007342|FG001|NOT COMPLETED|Overall Study||0||
48279790|NCT01144052|101007343|FG000|STARTED|Overall Study||10||
48279791|NCT01144052|101007344|FG001|STARTED|Overall Study||9||
48279792|NCT01144052|101007343|FG000|COMPLETED|Overall Study||9||
48565618|NCT02445248|101717290|FG001|STARTED|Overall Study||16|Started = Infused|
48565619|NCT02445248|101717289|FG000|COMPLETED|Overall Study||26|Completed = Study follow-up completed|
48565620|NCT02445248|101717290|FG001|COMPLETED|Overall Study||3|Completed = Study follow-up completed|
48565621|NCT02445248|101717289|FG000|NOT COMPLETED|Overall Study||73||
48565622|NCT02445248|101717290|FG001|NOT COMPLETED|Overall Study||13||
48565623|NCT00776035|101717291|FG000|STARTED|Overall Study||9||
48565624|NCT00776035|101717292|FG001|STARTED|Overall Study||10||
48565625|NCT00776035|101717291|FG000|COMPLETED|Overall Study||9||
48565626|NCT00776035|101717292|FG001|COMPLETED|Overall Study||10||
48565627|NCT00776035|101717291|FG000|NOT COMPLETED|Overall Study||0||
48565628|NCT00776035|101717292|FG001|NOT COMPLETED|Overall Study||0||
48565629|NCT04855760|101717293|FG000|STARTED|Overall Study||627||
48565630|NCT04855760|101717293|FG000|Dosed|Overall Study||618||
48565631|NCT04855760|101717293|FG000|COMPLETED|Overall Study||182||
48565632|NCT04855760|101717293|FG000|NOT COMPLETED|Overall Study||445||
48565633|NCT01058642|101717294|FG000|STARTED|Treatment Period 1||9||
48565634|NCT01058642|101717295|FG001|STARTED|Treatment Period 1||12||
48565635|NCT01058642|101717296|FG002|STARTED|Treatment Period 1||11||
48118272|NCT00727194|100616269|FG002|STARTED|Treatment Period 2||0||
48565636|NCT01058642|101717297|FG003|STARTED|Treatment Period 1||9||
48565637|NCT01058642|101717294|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||9||
48565638|NCT01058642|101717295|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||12||
48118273|NCT00727194|100616267|FG000|COMPLETED|Treatment Period 2||6||
48565639|NCT01058642|101717296|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1||11||
48565640|NCT01058642|101717297|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 1||9||
48565641|NCT01058642|101717294|FG000|COMPLETED|Treatment Period 1||7||
48565642|NCT01058642|101717295|FG001|COMPLETED|Treatment Period 1||11||
48565643|NCT01058642|101717296|FG002|COMPLETED|Treatment Period 1||9||
48565644|NCT01058642|101717297|FG003|COMPLETED|Treatment Period 1||7||
48565645|NCT01058642|101717294|FG000|NOT COMPLETED|Treatment Period 1||2||
48565646|NCT01058642|101717295|FG001|NOT COMPLETED|Treatment Period 1||1||
48565647|NCT01058642|101717296|FG002|NOT COMPLETED|Treatment Period 1||2||
48565648|NCT01058642|101717297|FG003|NOT COMPLETED|Treatment Period 1||2||
48565649|NCT01058642|101717294|FG000|STARTED|Washout Period||7||
48565650|NCT01058642|101717295|FG001|STARTED|Washout Period||11||
48565651|NCT01058642|101717296|FG002|STARTED|Washout Period||9||
48565652|NCT01058642|101717297|FG003|STARTED|Washout Period||7||
48565653|NCT01058642|101717294|FG000|COMPLETED|Washout Period||7||
48565654|NCT01058642|101717295|FG001|COMPLETED|Washout Period||11||
48565655|NCT01058642|101717296|FG002|COMPLETED|Washout Period||9||
48565656|NCT01058642|101717297|FG003|COMPLETED|Washout Period||7||
48565657|NCT01058642|101717294|FG000|NOT COMPLETED|Washout Period||0||
48565658|NCT01058642|101717295|FG001|NOT COMPLETED|Washout Period||0||
48565659|NCT01058642|101717296|FG002|NOT COMPLETED|Washout Period||0||
48279793|NCT01144052|101007344|FG001|COMPLETED|Overall Study||8||
48279794|NCT01144052|101007343|FG000|NOT COMPLETED|Overall Study||1||
48279795|NCT01144052|101007344|FG001|NOT COMPLETED|Overall Study||1||
48279796|NCT03835351|101007345|FG000|STARTED|Overall Study||241||
48565660|NCT01058642|101717297|FG003|NOT COMPLETED|Washout Period||0||
48565661|NCT01058642|101717294|FG000|STARTED|Treatment Period 2||7||
48565662|NCT01058642|101717295|FG001|STARTED|Treatment Period 2||11||
48565663|NCT01058642|101717296|FG002|STARTED|Treatment Period 2||9||
48565664|NCT01058642|101717297|FG003|STARTED|Treatment Period 2||7||
48565665|NCT01058642|101717294|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||7||
48565666|NCT01058642|101717295|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2||11||
48710820|NCT02590562|102078029|FG000|COMPLETED|Overall Study||802||
48279797|NCT03835351|101007346|FG001|STARTED|Overall Study||250||
48565667|NCT01058642|101717296|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 2||9||
48565668|NCT01058642|101717297|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 2||7||
48565669|NCT01058642|101717294|FG000|COMPLETED|Treatment Period 2||7||
48565670|NCT01058642|101717295|FG001|COMPLETED|Treatment Period 2||11||
48565671|NCT01058642|101717296|FG002|COMPLETED|Treatment Period 2||9||
48565672|NCT01058642|101717297|FG003|COMPLETED|Treatment Period 2||7||
48565673|NCT01058642|101717294|FG000|NOT COMPLETED|Treatment Period 2||0||
48565674|NCT01058642|101717295|FG001|NOT COMPLETED|Treatment Period 2||0||
48565675|NCT01058642|101717296|FG002|NOT COMPLETED|Treatment Period 2||0||
48565676|NCT01058642|101717297|FG003|NOT COMPLETED|Treatment Period 2||0||
48565677|NCT03270657|101717298|FG000|STARTED|Overall Study||5||
48565678|NCT03270657|101717298|FG000|COMPLETED|Overall Study||4||
48565679|NCT03270657|101717298|FG000|NOT COMPLETED|Overall Study||1||
48565680|NCT00083382|101717299|FG000|STARTED|Overall Study||83||
48565681|NCT00083382|101717299|FG000|COMPLETED|Overall Study||83||
48565682|NCT00083382|101717299|FG000|NOT COMPLETED|Overall Study||0||
48565683|NCT05286450|101717300|FG000|STARTED|Overall Study||153||
48565684|NCT05286450|101717300|FG000|COMPLETED|Overall Study||153||
48565685|NCT05286450|101717300|FG000|NOT COMPLETED|Overall Study||0||
48565686|NCT03283566|101717301|FG000|STARTED|Overall Study||4||
48565687|NCT03283566|101717302|FG001|STARTED|Overall Study||5||
48565688|NCT03283566|101717301|FG000|COMPLETED|Overall Study||3||
48565689|NCT03283566|101717302|FG001|COMPLETED|Overall Study||3||
48565690|NCT03283566|101717301|FG000|NOT COMPLETED|Overall Study||1||
48565691|NCT03283566|101717302|FG001|NOT COMPLETED|Overall Study||2||
48565692|NCT03762265|101717303|FG000|STARTED|BT Period: Weeks 1 to 37||66||
48118274|NCT00727194|100616268|FG001|COMPLETED|Treatment Period 2||5||
48118275|NCT00727194|100616269|FG002|COMPLETED|Treatment Period 2||0||
48118276|NCT00727194|100616267|FG000|NOT COMPLETED|Treatment Period 2||0||
48118277|NCT00727194|100616268|FG001|NOT COMPLETED|Treatment Period 2||1||
48118278|NCT00727194|100616269|FG002|NOT COMPLETED|Treatment Period 2||0||
48118279|NCT02995915|100616270|FG000|STARTED|Overall Study||30||
48118280|NCT02995915|100616271|FG001|STARTED|Overall Study||15||
48118281|NCT02995915|100616270|FG000|COMPLETED|Overall Study||30||
48118282|NCT02995915|100616271|FG001|COMPLETED|Overall Study||15||
48118283|NCT02995915|100616270|FG000|NOT COMPLETED|Overall Study||0||
48118284|NCT02995915|100616271|FG001|NOT COMPLETED|Overall Study||0||
48118285|NCT02056171|100616272|FG000|STARTED|Overall Study||3||
48118286|NCT02056171|100616273|FG001|STARTED|Overall Study||3||
48118287|NCT02056171|100616272|FG000|COMPLETED|Overall Study||3||
48118288|NCT02056171|100616273|FG001|COMPLETED|Overall Study||3||
48118289|NCT02056171|100616272|FG000|NOT COMPLETED|Overall Study||0||
48118290|NCT02056171|100616273|FG001|NOT COMPLETED|Overall Study||0||
48118291|NCT00393939|100616274|FG000|STARTED|Overall Study||296||
48118292|NCT00393939|100616275|FG001|STARTED|Overall Study||297||
48565693|NCT03762265|101717304|FG001|STARTED|BT Period: Weeks 1 to 37||65||
48118293|NCT00393939|100616274|FG000|Treated|Overall Study||295||
48118294|NCT00393939|100616275|FG001|Treated|Overall Study||293||
48565694|NCT03762265|101717303|FG000|COMPLETED|BT Period: Weeks 1 to 37||51||
48565695|NCT03762265|101717304|FG001|COMPLETED|BT Period: Weeks 1 to 37||62||
48565696|NCT03762265|101717303|FG000|NOT COMPLETED|BT Period: Weeks 1 to 37||15||
48565697|NCT03762265|101717304|FG001|NOT COMPLETED|BT Period: Weeks 1 to 37||3||
48565698|NCT03762265|101717303|FG000|STARTED|OLE Period: Weeks 37 to 61||51||
48565699|NCT03762265|101717304|FG001|STARTED|OLE Period: Weeks 37 to 61||61||
48565700|NCT03762265|101717303|FG000|COMPLETED|OLE Period: Weeks 37 to 61||35||
48565701|NCT03762265|101717304|FG001|COMPLETED|OLE Period: Weeks 37 to 61||45||
48565702|NCT03762265|101717303|FG000|NOT COMPLETED|OLE Period: Weeks 37 to 61||16||
48565703|NCT03762265|101717304|FG001|NOT COMPLETED|OLE Period: Weeks 37 to 61||16||
48565704|NCT03762265|101717303|FG000|STARTED|LTE Period: Weeks 61 to 109||35||
48565705|NCT03762265|101717304|FG001|STARTED|LTE Period: Weeks 61 to 109||34||
48565706|NCT03762265|101717303|FG000|COMPLETED|LTE Period: Weeks 61 to 109||6||
48565707|NCT03762265|101717304|FG001|COMPLETED|LTE Period: Weeks 61 to 109||6||
48565708|NCT03762265|101717303|FG000|NOT COMPLETED|LTE Period: Weeks 61 to 109||29||
48565709|NCT03762265|101717304|FG001|NOT COMPLETED|LTE Period: Weeks 61 to 109||28||
48565710|NCT02712554|101717305|FG000|STARTED|Part A: Dose Selection Phase||12||
48118295|NCT00393939|100616274|FG000|COMPLETED|Overall Study||0||
48118296|NCT00393939|100616275|FG001|COMPLETED|Overall Study||0||
48118297|NCT00393939|100616274|FG000|NOT COMPLETED|Overall Study||296||
48118298|NCT00393939|100616275|FG001|NOT COMPLETED|Overall Study||297||
48118299|NCT01101841|100616276|FG000|STARTED|Overall Study||285||
48565711|NCT02712554|101717306|FG001|STARTED|Part A: Dose Selection Phase||0||
48565712|NCT02712554|101717305|FG000|COMPLETED|Part A: Dose Selection Phase||12||
48565713|NCT02712554|101717306|FG001|COMPLETED|Part A: Dose Selection Phase||0||
48565714|NCT02712554|101717305|FG000|NOT COMPLETED|Part A: Dose Selection Phase||0||
48565715|NCT02712554|101717306|FG001|NOT COMPLETED|Part A: Dose Selection Phase||0||
48565716|NCT02712554|101717305|FG000|STARTED|Part B: Qualification Phase||0||
48565717|NCT02712554|101717306|FG001|STARTED|Part B: Qualification Phase||61||
48565718|NCT02712554|101717305|FG000|COMPLETED|Part B: Qualification Phase||0||
48565719|NCT02712554|101717306|FG001|COMPLETED|Part B: Qualification Phase||40||
48565720|NCT02712554|101717305|FG000|NOT COMPLETED|Part B: Qualification Phase||0||
48565721|NCT02712554|101717306|FG001|NOT COMPLETED|Part B: Qualification Phase||21||
48565722|NCT02712554|101717305|FG000|STARTED|Part B: Treatment Phase||0||
48565723|NCT02712554|101717306|FG001|STARTED|Part B: Treatment Phase||40||
48565724|NCT02712554|101717305|FG000|COMPLETED|Part B: Treatment Phase||0||
48565725|NCT02712554|101717306|FG001|COMPLETED|Part B: Treatment Phase||37||
48565726|NCT02712554|101717305|FG000|NOT COMPLETED|Part B: Treatment Phase||0||
48565727|NCT02712554|101717306|FG001|NOT COMPLETED|Part B: Treatment Phase||3||
48565728|NCT03004638|101717307|FG000|STARTED|Overall Study||6||
48565729|NCT03004638|101717308|FG001|STARTED|Overall Study||6||
48118300|NCT01101841|100616277|FG001|STARTED|Overall Study||285||
48118301|NCT01101841|100616276|FG000|COMPLETED|Overall Study||235||
48118302|NCT01101841|100616277|FG001|COMPLETED|Overall Study||218||
48118303|NCT01101841|100616276|FG000|NOT COMPLETED|Overall Study||50||
48118304|NCT01101841|100616277|FG001|NOT COMPLETED|Overall Study||67||
48118305|NCT01422434|100616278|FG000|STARTED|Overall Study||227||
48118306|NCT01422434|100616279|FG001|STARTED|Overall Study||226||
48118307|NCT01422434|100616280|FG002|STARTED|Overall Study||223||
48118308|NCT01422434|100616278|FG000|COMPLETED|Overall Study||216||
48565730|NCT03004638|101717309|FG002|STARTED|Overall Study||6||
48565731|NCT03004638|101717310|FG003|STARTED|Overall Study||6||
48565732|NCT03004638|101717311|FG004|STARTED|Overall Study||1||
48698166|NCT04308239|102045563|FG000|NOT COMPLETED|Intervention (2 Weeks)||0||
48698167|NCT04308239|102045564|FG001|NOT COMPLETED|Intervention (2 Weeks)||0||
48698168|NCT04308239|102045563|FG000|STARTED|Post-intervention Evaluation (1 Week)||20||
48118309|NCT01422434|100616279|FG001|COMPLETED|Overall Study||221||
48118310|NCT01422434|100616280|FG002|COMPLETED|Overall Study||217||
48118311|NCT01422434|100616278|FG000|NOT COMPLETED|Overall Study||11||
48118312|NCT01422434|100616279|FG001|NOT COMPLETED|Overall Study||5||
48118313|NCT01422434|100616280|FG002|NOT COMPLETED|Overall Study||6||
48118314|NCT00853658|100616281|FG000|STARTED|Overall Study||2354||
48118315|NCT00853658|100616282|FG001|STARTED|Overall Study||2356||
48118316|NCT00853658|100616283|FG002|STARTED|Overall Study||2354||
48118317|NCT00853658|100616281|FG000|Full Analysis Set (FAS)|Overall Study||2340||
48118318|NCT00853658|100616282|FG001|Full Analysis Set (FAS)|Overall Study||2340||
48118319|NCT00853658|100616283|FG002|Full Analysis Set (FAS)|Overall Study||2336||
48118320|NCT00853658|100616281|FG000|Safety Set|Overall Study||2347||
48118321|NCT00853658|100616282|FG001|Safety Set|Overall Study||2348||
48118322|NCT00853658|100616283|FG002|Safety Set|Overall Study||2345||
48118323|NCT00853658|100616281|FG000|COMPLETED|Overall Study||1567||
48118324|NCT00853658|100616282|FG001|COMPLETED|Overall Study||1524||
48118325|NCT00853658|100616283|FG002|COMPLETED|Overall Study||1539||
48698169|NCT04308239|102045564|FG001|STARTED|Post-intervention Evaluation (1 Week)||14||
48118326|NCT00853658|100616281|FG000|NOT COMPLETED|Overall Study||787||
48118327|NCT00853658|100616282|FG001|NOT COMPLETED|Overall Study||832||
48118328|NCT00853658|100616283|FG002|NOT COMPLETED|Overall Study||815||
48118329|NCT02616250|100616284|FG000|STARTED|Overall Study||95||
48118330|NCT02616250|100616285|FG001|STARTED|Overall Study||95||
48118331|NCT02616250|100616284|FG000|COMPLETED|Overall Study||85||
48118332|NCT02616250|100616285|FG001|COMPLETED|Overall Study||86||
48118333|NCT02616250|100616284|FG000|NOT COMPLETED|Overall Study||10||
48118334|NCT02616250|100616285|FG001|NOT COMPLETED|Overall Study||9||
48118335|NCT02099721|100616286|FG000|STARTED|Overall Study||1066||
48118336|NCT02099721|100616287|FG001|STARTED|Overall Study||127||
48118337|NCT02099721|100616288|FG002|STARTED|Overall Study||1068||
48118338|NCT02099721|100616289|FG003|STARTED|Overall Study||845||
48565733|NCT03004638|101717312|FG005|STARTED|Overall Study||7||
48565734|NCT03004638|101717307|FG000|COMPLETED|Overall Study||6||
48565735|NCT03004638|101717308|FG001|COMPLETED|Overall Study||6||
48565736|NCT03004638|101717309|FG002|COMPLETED|Overall Study||6||
48565737|NCT03004638|101717310|FG003|COMPLETED|Overall Study||6||
48565738|NCT03004638|101717311|FG004|COMPLETED|Overall Study||1||
48565739|NCT03004638|101717312|FG005|COMPLETED|Overall Study||7||
48565740|NCT03004638|101717307|FG000|NOT COMPLETED|Overall Study||0||
48565741|NCT03004638|101717308|FG001|NOT COMPLETED|Overall Study||0||
48565742|NCT03004638|101717309|FG002|NOT COMPLETED|Overall Study||0||
48565743|NCT03004638|101717310|FG003|NOT COMPLETED|Overall Study||0||
48565744|NCT03004638|101717311|FG004|NOT COMPLETED|Overall Study||0||
48118339|NCT02099721|100616290|FG004|STARTED|Overall Study||331||
48118340|NCT02099721|100616291|FG005|STARTED|Overall Study||452||
48118341|NCT02099721|100616286|FG000|COMPLETED|Overall Study||990|Non-exited patients. Patients from China were considered completers if they had a 24 month visit.|
48118342|NCT02099721|100616287|FG001|COMPLETED|Overall Study||0|Non-exited patients. Patients from China were considered completers if they had a 24 month visit.|
48118343|NCT02099721|100616288|FG002|COMPLETED|Overall Study||983|Non-exited patients. Patients from China were considered completers if they had a 24 month visit.|
48118344|NCT02099721|100616289|FG003|COMPLETED|Overall Study||774|Non-exited patients. Patients from China were considered completers if they had a 24 month visit.|
48279798|NCT03835351|101007345|FG000|COMPLETED|Overall Study||241||
48565745|NCT03004638|101717312|FG005|NOT COMPLETED|Overall Study||0||
48565746|NCT00568451|101717313|FG000|STARTED|Overall Study||0||
48565747|NCT00568451|101717314|FG001|STARTED|Overall Study||0||
48565748|NCT00568451|101717315|FG002|STARTED|Overall Study||2||
48565749|NCT00568451|101717316|FG003|STARTED|Overall Study||9||
48565750|NCT00568451|101717313|FG000|COMPLETED|Overall Study||0||
48118345|NCT02099721|100616290|FG004|COMPLETED|Overall Study||304|Non-exited patients. Patients from China were considered completers if they had a 24 month visit.|
48118346|NCT02099721|100616291|FG005|COMPLETED|Overall Study||432|Non-exited patients. Patients from China were considered completers if they had a 24 month visit.|
48118347|NCT02099721|100616286|FG000|NOT COMPLETED|Overall Study||76||
48118348|NCT02099721|100616287|FG001|NOT COMPLETED|Overall Study||127||
48118349|NCT02099721|100616288|FG002|NOT COMPLETED|Overall Study||85||
48118350|NCT02099721|100616289|FG003|NOT COMPLETED|Overall Study||71||
48118351|NCT02099721|100616290|FG004|NOT COMPLETED|Overall Study||27||
48118352|NCT02099721|100616291|FG005|NOT COMPLETED|Overall Study||20||
48118353|NCT04176796|100616292|FG000|STARTED|Overall Study||56||
48118354|NCT04176796|100616293|FG001|STARTED|Overall Study||49||
48118355|NCT04176796|100616292|FG000|COMPLETED|Overall Study||56||
48698170|NCT04308239|102045563|FG000|COMPLETED|Post-intervention Evaluation (1 Week)||19||
48698171|NCT04308239|102045564|FG001|COMPLETED|Post-intervention Evaluation (1 Week)||10||
48118356|NCT04176796|100616293|FG001|COMPLETED|Overall Study||49||
48118357|NCT04176796|100616292|FG000|NOT COMPLETED|Overall Study||0||
48118358|NCT04176796|100616293|FG001|NOT COMPLETED|Overall Study||0||
48118359|NCT01400841|100616294|FG000|STARTED|Initial Study Phase (6 Months)||16||
48118360|NCT01400841|100616294|FG000|COMPLETED|Initial Study Phase (6 Months)||15||
48118361|NCT01400841|100616294|FG000|NOT COMPLETED|Initial Study Phase (6 Months)||1||
48118362|NCT01400841|100616294|FG000|STARTED|Extended Study Phase (2 Years)||13||
48118363|NCT01400841|100616294|FG000|COMPLETED|Extended Study Phase (2 Years)||11||
48118364|NCT01400841|100616294|FG000|NOT COMPLETED|Extended Study Phase (2 Years)||2||
48118365|NCT02442830|100616295|FG000|STARTED|Overall Study||42||
48118366|NCT02442830|100616296|FG001|STARTED|Overall Study||45||
48118367|NCT02442830|100616295|FG000|COMPLETED|Overall Study||42||
48118368|NCT02442830|100616296|FG001|COMPLETED|Overall Study||44||
48118369|NCT02442830|100616295|FG000|NOT COMPLETED|Overall Study||0||
48118370|NCT02442830|100616296|FG001|NOT COMPLETED|Overall Study||1||
48118371|NCT05421078|100616297|FG000|STARTED|Overall Study||26||
48118372|NCT05421078|100616298|FG001|STARTED|Overall Study||25||
48118373|NCT05421078|100616299|FG002|STARTED|Overall Study||25||
48118374|NCT05421078|100616300|FG003|STARTED|Overall Study||26||
48118375|NCT05421078|100616297|FG000|COMPLETED|Overall Study||26||
48118376|NCT05421078|100616298|FG001|COMPLETED|Overall Study||25||
48118377|NCT05421078|100616299|FG002|COMPLETED|Overall Study||25||
48118378|NCT05421078|100616300|FG003|COMPLETED|Overall Study||26||
48118379|NCT05421078|100616297|FG000|NOT COMPLETED|Overall Study||0||
48118380|NCT05421078|100616298|FG001|NOT COMPLETED|Overall Study||0||
48118381|NCT05421078|100616299|FG002|NOT COMPLETED|Overall Study||0||
48118382|NCT05421078|100616300|FG003|NOT COMPLETED|Overall Study||0||
48118383|NCT01698463|100616301|FG000|STARTED|Overall Study||11||
48118384|NCT01698463|100616301|FG000|COMPLETED|Overall Study||11||
48118385|NCT01698463|100616301|FG000|NOT COMPLETED|Overall Study||0||
48118386|NCT03191903|100616302|FG000|STARTED|Overall Study||251|Safety Population|
48118387|NCT03191903|100616303|FG001|STARTED|Overall Study||251|Safety Population|
48118388|NCT03191903|100616304|FG002|STARTED|Overall Study||74|Safety Population|
48118389|NCT03191903|100616302|FG000|Intent to Treat Population|Overall Study||251||
48118390|NCT03191903|100616303|FG001|Intent to Treat Population|Overall Study||251||
48118391|NCT03191903|100616304|FG002|Intent to Treat Population|Overall Study||74||
48118392|NCT03191903|100616302|FG000|COMPLETED|Overall Study||244||
48698172|NCT04308239|102045563|FG000|NOT COMPLETED|Post-intervention Evaluation (1 Week)||1||
48698173|NCT04308239|102045564|FG001|NOT COMPLETED|Post-intervention Evaluation (1 Week)||4||
48698174|NCT04181593|102045565|FG000|STARTED|Overall Study||157||
48698175|NCT04181593|102045566|FG001|STARTED|Overall Study||165||
48698176|NCT04181593|102045565|FG000|COMPLETED|Overall Study||157||
48698177|NCT04181593|102045566|FG001|COMPLETED|Overall Study||165||
48698178|NCT04181593|102045565|FG000|NOT COMPLETED|Overall Study||0||
48118393|NCT03191903|100616303|FG001|COMPLETED|Overall Study||246||
48118394|NCT03191903|100616304|FG002|COMPLETED|Overall Study||70||
48118395|NCT03191903|100616302|FG000|NOT COMPLETED|Overall Study||7||
48118396|NCT03191903|100616303|FG001|NOT COMPLETED|Overall Study||5||
48118397|NCT03191903|100616304|FG002|NOT COMPLETED|Overall Study||4||
48118398|NCT00061048|100616305|FG000|STARTED|Overall Study||29||
48118399|NCT00061048|100616305|FG000|COMPLETED|Overall Study||7||
48118400|NCT00061048|100616305|FG000|NOT COMPLETED|Overall Study||22||
48118401|NCT04068181|100616306|FG000|STARTED|Overall Study||27||
48118402|NCT04068181|100616307|FG001|STARTED|Overall Study||15||
48118403|NCT04068181|100616308|FG002|STARTED|Overall Study||15||
48118404|NCT04068181|100616309|FG003|STARTED|Overall Study||15||
48118405|NCT04068181|100616306|FG000|Received Talimogene Laherparepvec|Overall Study||26||
48118406|NCT04068181|100616307|FG001|Received Talimogene Laherparepvec|Overall Study||15||
48118407|NCT04068181|100616308|FG002|Received Talimogene Laherparepvec|Overall Study||15||
48118408|NCT04068181|100616309|FG003|Received Talimogene Laherparepvec|Overall Study||15||
48698179|NCT04181593|102045566|FG001|NOT COMPLETED|Overall Study||0||
48118409|NCT04068181|100616306|FG000|Received Pembrolizumab|Overall Study||26||
48118410|NCT04068181|100616307|FG001|Received Pembrolizumab|Overall Study||15||
48118411|NCT04068181|100616308|FG002|Received Pembrolizumab|Overall Study||15||
48118412|NCT04068181|100616309|FG003|Received Pembrolizumab|Overall Study||15||
48698180|NCT01675297|102045567|FG000|STARTED|Overall Study||806||
48118413|NCT04068181|100616306|FG000|COMPLETED|Overall Study||0||
48118414|NCT04068181|100616307|FG001|COMPLETED|Overall Study||0||
48118415|NCT04068181|100616308|FG002|COMPLETED|Overall Study||0||
48118416|NCT04068181|100616309|FG003|COMPLETED|Overall Study||0||
48118417|NCT04068181|100616306|FG000|NOT COMPLETED|Overall Study||27||
48118418|NCT04068181|100616307|FG001|NOT COMPLETED|Overall Study||15||
48118419|NCT04068181|100616308|FG002|NOT COMPLETED|Overall Study||15||
48118420|NCT04068181|100616309|FG003|NOT COMPLETED|Overall Study||15||
48118421|NCT03779841|100616310|FG000|STARTED|Randomized Population||108||
48118422|NCT03779841|100616311|FG001|STARTED|Randomized Population||106||
48118423|NCT03779841|100616312|FG002|STARTED|Randomized Population||109||
48118424|NCT03779841|100616310|FG000|COMPLETED|Randomized Population||105||
48118425|NCT03779841|100616311|FG001|COMPLETED|Randomized Population||105||
48118426|NCT03779841|100616312|FG002|COMPLETED|Randomized Population||109||
48118427|NCT03779841|100616310|FG000|NOT COMPLETED|Randomized Population||3||
48118428|NCT03779841|100616311|FG001|NOT COMPLETED|Randomized Population||1||
48118429|NCT03779841|100616312|FG002|NOT COMPLETED|Randomized Population||0||
48118430|NCT03779841|100616310|FG000|STARTED|Treated (Safety) Population||105||
48118431|NCT03779841|100616311|FG001|STARTED|Treated (Safety) Population||105||
48118432|NCT03779841|100616312|FG002|STARTED|Treated (Safety) Population||109||
48118433|NCT03779841|100616310|FG000|COMPLETED|Treated (Safety) Population||94||
48118434|NCT03779841|100616311|FG001|COMPLETED|Treated (Safety) Population||87||
48118435|NCT03779841|100616312|FG002|COMPLETED|Treated (Safety) Population||93||
48118436|NCT03779841|100616310|FG000|NOT COMPLETED|Treated (Safety) Population||11||
48118437|NCT03779841|100616311|FG001|NOT COMPLETED|Treated (Safety) Population||18||
48118438|NCT03779841|100616312|FG002|NOT COMPLETED|Treated (Safety) Population||16||
48118439|NCT01663259|100616313|FG000|STARTED|Overall Study||42||
48118440|NCT01663259|100616313|FG000|COMPLETED|Overall Study||42||
48118441|NCT01663259|100616313|FG000|NOT COMPLETED|Overall Study||0||
48118442|NCT03329352|100616314|FG000|STARTED|F&P Toffee Full Face Mask Validation||44||
48118443|NCT03329352|100616314|FG000|COMPLETED|F&P Toffee Full Face Mask Validation||42||
48118444|NCT03329352|100616314|FG000|NOT COMPLETED|F&P Toffee Full Face Mask Validation||2||
48118445|NCT03329352|100616314|FG000|STARTED|Extension||29||
48118446|NCT03329352|100616314|FG000|COMPLETED|Extension||22||
48118447|NCT03329352|100616314|FG000|NOT COMPLETED|Extension||7||
48118448|NCT00595582|100616315|FG000|STARTED|Overall Study||10||
48118449|NCT00595582|100616315|FG000|COMPLETED|Overall Study||0||
48118450|NCT00595582|100616315|FG000|NOT COMPLETED|Overall Study||10||
48118451|NCT01707004|100616316|FG000|STARTED|Overall Study||20||
48118452|NCT01707004|100616316|FG000|COMPLETED|Overall Study||17||
48118453|NCT01707004|100616316|FG000|NOT COMPLETED|Overall Study||3||
48118454|NCT01850004|100616317|FG000|STARTED|Overall Study||84||
48118455|NCT01850004|100616317|FG000|Restart Treatment|Overall Study||47|Restarted treatment due to failure to maintain MMR levels of BCL-ABL|
48118456|NCT01850004|100616317|FG000|Discontinued Study Treatment After Restart|Overall Study||47||
48118457|NCT01850004|100616317|FG000|COMPLETED|Overall Study||60|Completed study|
48118458|NCT01850004|100616317|FG000|NOT COMPLETED|Overall Study||24||
48565751|NCT00568451|101717314|FG001|COMPLETED|Overall Study||0||
48565752|NCT00568451|101717315|FG002|COMPLETED|Overall Study||0||
48565753|NCT00568451|101717316|FG003|COMPLETED|Overall Study||2||
48565754|NCT00568451|101717313|FG000|NOT COMPLETED|Overall Study||0||
48565755|NCT00568451|101717314|FG001|NOT COMPLETED|Overall Study||0||
48565756|NCT00568451|101717315|FG002|NOT COMPLETED|Overall Study||2||
48565757|NCT00568451|101717316|FG003|NOT COMPLETED|Overall Study||7||
48565758|NCT00086619|101717317|FG000|STARTED|Overall Study||40||
48565759|NCT00086619|101717318|FG001|STARTED|Overall Study||40||
48565760|NCT00086619|101717317|FG000|Completed Baseline Visit|Overall Study||34||
48118459|NCT01701258|100616318|FG000|STARTED|Assessment and Scheduling||153|153 individuals were enrolled in the study. 96 were eligible after the screening visit.|
48118460|NCT01701258|100616319|FG001|STARTED|Assessment and Scheduling||0|153 individuals were enrolled in the study. 96 were eligible after the screening visit.|
48118461|NCT01701258|100616320|FG002|STARTED|Assessment and Scheduling||0|153 individuals were enrolled in the study. 96 were eligible after the screening visit.|
48118462|NCT01701258|100616321|FG003|STARTED|Assessment and Scheduling||0|153 individuals were enrolled in the study. 96 were eligible after the screening visit.|
48118463|NCT01701258|100616322|FG004|STARTED|Assessment and Scheduling||0|153 individuals were enrolled in the study. 96 were eligible after the screening visit.|
48118464|NCT01701258|100616323|FG005|STARTED|Assessment and Scheduling||0|153 individuals were enrolled in the study. 96 were eligible after the screening visit.|
48118465|NCT01701258|100616324|FG006|STARTED|Assessment and Scheduling||0|153 individuals were enrolled in the study. 96 were eligible after the screening visit.|
48118466|NCT01701258|100616325|FG007|STARTED|Assessment and Scheduling||0|153 individuals were enrolled in the study. 96 were eligible after the screening visit.|
48118467|NCT01701258|100616326|FG008|STARTED|Assessment and Scheduling||0|153 individuals were enrolled in the study. 96 were eligible after the screening visit.|
48118468|NCT01701258|100616327|FG009|STARTED|Assessment and Scheduling||0|153 individuals were enrolled in the study. 96 were eligible after the screening visit.|
48279799|NCT03835351|101007346|FG001|COMPLETED|Overall Study||250||
48394727|NCT00971633|101296006|FG001|NOT COMPLETED|Period 1||0||
48565761|NCT00086619|101717318|FG001|Completed Baseline Visit|Overall Study||36||
48565762|NCT00086619|101717317|FG000|Completed 12 Month Visit|Overall Study||26||
48565763|NCT00086619|101717318|FG001|Completed 12 Month Visit|Overall Study||26||
48118469|NCT01701258|100616328|FG010|STARTED|Assessment and Scheduling||0|153 individuals were enrolled in the study. 96 were eligible after the screening visit.|
48118470|NCT01701258|100616329|FG011|STARTED|Assessment and Scheduling||0|153 individuals were enrolled in the study. 96 were eligible after the screening visit.|
48118471|NCT01701258|100616330|FG012|STARTED|Assessment and Scheduling||0|153 individuals were enrolled in the study. 96 were eligible after the screening visit.|
48118472|NCT01701258|100616318|FG000|Eligible After Screening Visit|Assessment and Scheduling||96|96 participants were eligible after the screening visit. These were our baseline participants.|
48118473|NCT01701258|100616319|FG001|Eligible After Screening Visit|Assessment and Scheduling||0|96 participants were eligible after the screening visit. These were our baseline participants.|
48118474|NCT01701258|100616320|FG002|Eligible After Screening Visit|Assessment and Scheduling||0|96 participants were eligible after the screening visit. These were our baseline participants.|
48118475|NCT01701258|100616321|FG003|Eligible After Screening Visit|Assessment and Scheduling||0|96 participants were eligible after the screening visit. These were our baseline participants.|
48118476|NCT01701258|100616322|FG004|Eligible After Screening Visit|Assessment and Scheduling||0|96 participants were eligible after the screening visit. These were our baseline participants.|
48118477|NCT01701258|100616323|FG005|Eligible After Screening Visit|Assessment and Scheduling||0|96 participants were eligible after the screening visit. These were our baseline participants.|
48118478|NCT01701258|100616324|FG006|Eligible After Screening Visit|Assessment and Scheduling||0|96 participants were eligible after the screening visit. These were our baseline participants.|
48118479|NCT01701258|100616325|FG007|Eligible After Screening Visit|Assessment and Scheduling||0|96 participants were eligible after the screening visit. These were our baseline participants.|
48118480|NCT01701258|100616326|FG008|Eligible After Screening Visit|Assessment and Scheduling||0|96 participants were eligible after the screening visit. These were our baseline participants.|
48118481|NCT01701258|100616327|FG009|Eligible After Screening Visit|Assessment and Scheduling||0|96 participants were eligible after the screening visit. These were our baseline participants.|
48118482|NCT01701258|100616328|FG010|Eligible After Screening Visit|Assessment and Scheduling||0|96 participants were eligible after the screening visit. These were our baseline participants.|
48118483|NCT01701258|100616329|FG011|Eligible After Screening Visit|Assessment and Scheduling||0|96 participants were eligible after the screening visit. These were our baseline participants.|
48394728|NCT00971633|101296007|FG002|NOT COMPLETED|Period 1||0||
48118484|NCT01701258|100616330|FG012|Eligible After Screening Visit|Assessment and Scheduling||0|96 participants were eligible after the screening visit. These were our baseline participants.|
48118485|NCT01701258|100616318|FG000|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||68|68 out of the 96 eligible participants completed the MRI.|
48118486|NCT01701258|100616319|FG001|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0|68 out of the 96 eligible participants completed the MRI.|
48118487|NCT01701258|100616320|FG002|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0|68 out of the 96 eligible participants completed the MRI.|
48118488|NCT01701258|100616321|FG003|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0|68 out of the 96 eligible participants completed the MRI.|
48118489|NCT01701258|100616322|FG004|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0|68 out of the 96 eligible participants completed the MRI.|
48118490|NCT01701258|100616323|FG005|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0|68 out of the 96 eligible participants completed the MRI.|
48118491|NCT01701258|100616324|FG006|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0|68 out of the 96 eligible participants completed the MRI.|
48118492|NCT01701258|100616325|FG007|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0|68 out of the 96 eligible participants completed the MRI.|
48118493|NCT01701258|100616326|FG008|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0|68 out of the 96 eligible participants completed the MRI.|
48118494|NCT01701258|100616327|FG009|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0|68 out of the 96 eligible participants completed the MRI.|
48118495|NCT01701258|100616328|FG010|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0|68 out of the 96 eligible participants completed the MRI.|
48394729|NCT00971633|101296008|FG003|NOT COMPLETED|Period 1||0||
48394730|NCT00971633|101296009|FG004|NOT COMPLETED|Period 1||0||
48394731|NCT00971633|101296010|FG005|NOT COMPLETED|Period 1||0||
48394732|NCT00971633|101296005|FG000|STARTED|Period 2||2||
48394733|NCT00971633|101296006|FG001|STARTED|Period 2||2||
48394734|NCT00971633|101296007|FG002|STARTED|Period 2||2||
48394735|NCT00971633|101296008|FG003|STARTED|Period 2||2||
48394736|NCT00971633|101296009|FG004|STARTED|Period 2||2||
48394737|NCT00971633|101296010|FG005|STARTED|Period 2||2||
48394738|NCT00971633|101296005|FG000|COMPLETED|Period 2||2||
48394739|NCT00971633|101296006|FG001|COMPLETED|Period 2||2||
48394740|NCT00971633|101296007|FG002|COMPLETED|Period 2||2||
48394741|NCT00971633|101296008|FG003|COMPLETED|Period 2||2||
48394742|NCT00971633|101296009|FG004|COMPLETED|Period 2||2||
48394743|NCT00971633|101296010|FG005|COMPLETED|Period 2||2||
48118496|NCT01701258|100616329|FG011|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0|68 out of the 96 eligible participants completed the MRI.|
48118497|NCT01701258|100616330|FG012|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0|68 out of the 96 eligible participants completed the MRI.|
48118498|NCT01701258|100616318|FG000|Returned for PET (Session 3)|Assessment and Scheduling||73|73 /96 eligible completed the PET. They didn't need to complete the the MRI to complete the PET.|
48118499|NCT01701258|100616319|FG001|Returned for PET (Session 3)|Assessment and Scheduling||0|73 /96 eligible completed the PET. They didn't need to complete the the MRI to complete the PET.|
48118500|NCT01701258|100616320|FG002|Returned for PET (Session 3)|Assessment and Scheduling||0|73 /96 eligible completed the PET. They didn't need to complete the the MRI to complete the PET.|
48118501|NCT01701258|100616321|FG003|Returned for PET (Session 3)|Assessment and Scheduling||0|73 /96 eligible completed the PET. They didn't need to complete the the MRI to complete the PET.|
48118502|NCT01701258|100616322|FG004|Returned for PET (Session 3)|Assessment and Scheduling||0|73 /96 eligible completed the PET. They didn't need to complete the the MRI to complete the PET.|
48118503|NCT01701258|100616323|FG005|Returned for PET (Session 3)|Assessment and Scheduling||0|73 /96 eligible completed the PET. They didn't need to complete the the MRI to complete the PET.|
48118504|NCT01701258|100616324|FG006|Returned for PET (Session 3)|Assessment and Scheduling||0|73 /96 eligible completed the PET. They didn't need to complete the the MRI to complete the PET.|
48118505|NCT01701258|100616325|FG007|Returned for PET (Session 3)|Assessment and Scheduling||0|73 /96 eligible completed the PET. They didn't need to complete the the MRI to complete the PET.|
48118506|NCT01701258|100616326|FG008|Returned for PET (Session 3)|Assessment and Scheduling||0|73 /96 eligible completed the PET. They didn't need to complete the the MRI to complete the PET.|
48118507|NCT01701258|100616327|FG009|Returned for PET (Session 3)|Assessment and Scheduling||0|73 /96 eligible completed the PET. They didn't need to complete the the MRI to complete the PET.|
48118508|NCT01701258|100616328|FG010|Returned for PET (Session 3)|Assessment and Scheduling||0|73 /96 eligible completed the PET. They didn't need to complete the the MRI to complete the PET.|
48279800|NCT03835351|101007345|FG000|NOT COMPLETED|Overall Study||0||
48279801|NCT03835351|101007346|FG001|NOT COMPLETED|Overall Study||0||
48279802|NCT01534143|101007347|FG000|STARTED|Overall Study||1||
48279803|NCT01534143|101007347|FG000|COMPLETED|Overall Study||1||
48279804|NCT01534143|101007347|FG000|NOT COMPLETED|Overall Study||0||
48279805|NCT03053518|101007348|FG000|STARTED|Overall Study||22||
48118509|NCT01701258|100616329|FG011|Returned for PET (Session 3)|Assessment and Scheduling||0|73 /96 eligible completed the PET. They didn't need to complete the the MRI to complete the PET.|
48118510|NCT01701258|100616330|FG012|Returned for PET (Session 3)|Assessment and Scheduling||0|73 /96 eligible completed the PET. They didn't need to complete the the MRI to complete the PET.|
48118511|NCT01701258|100616318|FG000|Returned for EEG (Session 4)|Assessment and Scheduling||66|66/96 completed the EEG. Participants did at least two sessions after the screening visit.|
48118512|NCT01701258|100616319|FG001|Returned for EEG (Session 4)|Assessment and Scheduling||0|66/96 completed the EEG. Participants did at least two sessions after the screening visit.|
48118513|NCT01701258|100616320|FG002|Returned for EEG (Session 4)|Assessment and Scheduling||0|66/96 completed the EEG. Participants did at least two sessions after the screening visit.|
48118514|NCT01701258|100616321|FG003|Returned for EEG (Session 4)|Assessment and Scheduling||0|66/96 completed the EEG. Participants did at least two sessions after the screening visit.|
48118515|NCT01701258|100616322|FG004|Returned for EEG (Session 4)|Assessment and Scheduling||0|66/96 completed the EEG. Participants did at least two sessions after the screening visit.|
48118516|NCT01701258|100616323|FG005|Returned for EEG (Session 4)|Assessment and Scheduling||0|66/96 completed the EEG. Participants did at least two sessions after the screening visit.|
48118517|NCT01701258|100616324|FG006|Returned for EEG (Session 4)|Assessment and Scheduling||0|66/96 completed the EEG. Participants did at least two sessions after the screening visit.|
48118518|NCT01701258|100616325|FG007|Returned for EEG (Session 4)|Assessment and Scheduling||0|66/96 completed the EEG. Participants did at least two sessions after the screening visit.|
48279806|NCT03053518|101007348|FG000|COMPLETED|Overall Study||12||
48279807|NCT03053518|101007348|FG000|NOT COMPLETED|Overall Study||10||
48279808|NCT00862719|101010350|FG000|STARTED|Overall Study||17||
48279809|NCT00862719|101010351|FG001|STARTED|Overall Study||7||
48279810|NCT00862719|101010352|FG002|STARTED|Overall Study||4||
48279811|NCT00862719|101010353|FG003|STARTED|Overall Study||1||
48279812|NCT00862719|101010350|FG000|COMPLETED|Overall Study||7||
48279813|NCT00862719|101010351|FG001|COMPLETED|Overall Study||1||
48279814|NCT00862719|101010352|FG002|COMPLETED|Overall Study||0||
48279815|NCT00862719|101010353|FG003|COMPLETED|Overall Study||0||
48279816|NCT00862719|101010350|FG000|NOT COMPLETED|Overall Study||10||
48279817|NCT00862719|101010351|FG001|NOT COMPLETED|Overall Study||6||
48279818|NCT00862719|101010352|FG002|NOT COMPLETED|Overall Study||4||
48279819|NCT00862719|101010353|FG003|NOT COMPLETED|Overall Study||1||
48279820|NCT02688218|101010354|FG000|STARTED|First Exercise Intervention (2 Hours)||24||
48279821|NCT02688218|101010355|FG001|STARTED|First Exercise Intervention (2 Hours)||6||
48279822|NCT02688218|101010354|FG000|COMPLETED|First Exercise Intervention (2 Hours)||24||
48279823|NCT02688218|101010355|FG001|COMPLETED|First Exercise Intervention (2 Hours)||6||
48279824|NCT02688218|101010354|FG000|NOT COMPLETED|First Exercise Intervention (2 Hours)||0||
48279825|NCT02688218|101010355|FG001|NOT COMPLETED|First Exercise Intervention (2 Hours)||0||
48279826|NCT02688218|101010354|FG000|STARTED|Washout (30 Minutes)||24||
48279827|NCT02688218|101010355|FG001|STARTED|Washout (30 Minutes)||6||
48279828|NCT02688218|101010354|FG000|COMPLETED|Washout (30 Minutes)||24||
48279829|NCT02688218|101010355|FG001|COMPLETED|Washout (30 Minutes)||6||
48279830|NCT02688218|101010354|FG000|NOT COMPLETED|Washout (30 Minutes)||0||
48279831|NCT02688218|101010355|FG001|NOT COMPLETED|Washout (30 Minutes)||0||
48279832|NCT02688218|101010354|FG000|STARTED|Second Exercise Intervention (2 Hours)||24||
48279833|NCT02688218|101010355|FG001|STARTED|Second Exercise Intervention (2 Hours)||6||
48279834|NCT02688218|101010354|FG000|COMPLETED|Second Exercise Intervention (2 Hours)||24||
48279835|NCT02688218|101010355|FG001|COMPLETED|Second Exercise Intervention (2 Hours)||6||
48118519|NCT01701258|100616326|FG008|Returned for EEG (Session 4)|Assessment and Scheduling||0|66/96 completed the EEG. Participants did at least two sessions after the screening visit.|
48118520|NCT01701258|100616327|FG009|Returned for EEG (Session 4)|Assessment and Scheduling||0|66/96 completed the EEG. Participants did at least two sessions after the screening visit.|
48118521|NCT01701258|100616328|FG010|Returned for EEG (Session 4)|Assessment and Scheduling||0|66/96 completed the EEG. Participants did at least two sessions after the screening visit.|
48118522|NCT01701258|100616329|FG011|Returned for EEG (Session 4)|Assessment and Scheduling||0|66/96 completed the EEG. Participants did at least two sessions after the screening visit.|
48118523|NCT01701258|100616330|FG012|Returned for EEG (Session 4)|Assessment and Scheduling||0|66/96 completed the EEG. Participants did at least two sessions after the screening visit.|
48118524|NCT01701258|100616318|FG000|COMPLETED|Assessment and Scheduling||70|Participants completed the study if they completed the screening session and two imaging sessions.|
48118525|NCT01701258|100616319|FG001|COMPLETED|Assessment and Scheduling||0|Participants completed the study if they completed the screening session and two imaging sessions.|
48118526|NCT01701258|100616320|FG002|COMPLETED|Assessment and Scheduling||0|Participants completed the study if they completed the screening session and two imaging sessions.|
48118527|NCT01701258|100616321|FG003|COMPLETED|Assessment and Scheduling||0|Participants completed the study if they completed the screening session and two imaging sessions.|
48118528|NCT01701258|100616322|FG004|COMPLETED|Assessment and Scheduling||0|Participants completed the study if they completed the screening session and two imaging sessions.|
48118529|NCT01701258|100616323|FG005|COMPLETED|Assessment and Scheduling||0|Participants completed the study if they completed the screening session and two imaging sessions.|
48118530|NCT01701258|100616324|FG006|COMPLETED|Assessment and Scheduling||0|Participants completed the study if they completed the screening session and two imaging sessions.|
48118531|NCT01701258|100616325|FG007|COMPLETED|Assessment and Scheduling||0|Participants completed the study if they completed the screening session and two imaging sessions.|
48118532|NCT01701258|100616326|FG008|COMPLETED|Assessment and Scheduling||0|Participants completed the study if they completed the screening session and two imaging sessions.|
48118533|NCT01701258|100616327|FG009|COMPLETED|Assessment and Scheduling||0|Participants completed the study if they completed the screening session and two imaging sessions.|
48118534|NCT01701258|100616328|FG010|COMPLETED|Assessment and Scheduling||0|Participants completed the study if they completed the screening session and two imaging sessions.|
48118535|NCT01701258|100616329|FG011|COMPLETED|Assessment and Scheduling||0|Participants completed the study if they completed the screening session and two imaging sessions.|
48118536|NCT01701258|100616330|FG012|COMPLETED|Assessment and Scheduling||0|Participants completed the study if they completed the screening session and two imaging sessions.|
48118537|NCT01701258|100616318|FG000|NOT COMPLETED|Assessment and Scheduling||83||
48118538|NCT01701258|100616319|FG001|NOT COMPLETED|Assessment and Scheduling||0||
48118539|NCT01701258|100616320|FG002|NOT COMPLETED|Assessment and Scheduling||0||
48118540|NCT01701258|100616321|FG003|NOT COMPLETED|Assessment and Scheduling||0||
48118541|NCT01701258|100616322|FG004|NOT COMPLETED|Assessment and Scheduling||0||
48118542|NCT01701258|100616323|FG005|NOT COMPLETED|Assessment and Scheduling||0||
48118543|NCT01701258|100616324|FG006|NOT COMPLETED|Assessment and Scheduling||0||
48118544|NCT01701258|100616325|FG007|NOT COMPLETED|Assessment and Scheduling||0||
48118545|NCT01701258|100616326|FG008|NOT COMPLETED|Assessment and Scheduling||0||
48118546|NCT01701258|100616327|FG009|NOT COMPLETED|Assessment and Scheduling||0||
48118547|NCT01701258|100616328|FG010|NOT COMPLETED|Assessment and Scheduling||0||
48279836|NCT02688218|101010354|FG000|NOT COMPLETED|Second Exercise Intervention (2 Hours)||0||
48279837|NCT02688218|101010355|FG001|NOT COMPLETED|Second Exercise Intervention (2 Hours)||0||
48279838|NCT01656252|101010356|FG000|STARTED|Phase I||14||
48279839|NCT01656252|101010356|FG000|COMPLETED|Phase I||14||
48279840|NCT01656252|101010356|FG000|NOT COMPLETED|Phase I||0||
48279841|NCT01656252|101010356|FG000|STARTED|Phase II||0||
48394744|NCT00971633|101296005|FG000|NOT COMPLETED|Period 2||0||
48394745|NCT00971633|101296006|FG001|NOT COMPLETED|Period 2||0||
48394746|NCT00971633|101296007|FG002|NOT COMPLETED|Period 2||0||
48394747|NCT00971633|101296008|FG003|NOT COMPLETED|Period 2||0||
48394748|NCT00971633|101296009|FG004|NOT COMPLETED|Period 2||0||
48394749|NCT00971633|101296010|FG005|NOT COMPLETED|Period 2||0||
48394750|NCT00971633|101296005|FG000|STARTED|Period 3||2||
48394751|NCT00971633|101296006|FG001|STARTED|Period 3||2||
48394752|NCT00971633|101296007|FG002|STARTED|Period 3||2||
48394753|NCT00971633|101296008|FG003|STARTED|Period 3||2||
48394754|NCT00971633|101296009|FG004|STARTED|Period 3||2||
48394755|NCT00971633|101296010|FG005|STARTED|Period 3||2||
48394756|NCT00971633|101296005|FG000|COMPLETED|Period 3||2||
48394757|NCT00971633|101296006|FG001|COMPLETED|Period 3||2||
48394758|NCT00971633|101296007|FG002|COMPLETED|Period 3||2||
48394759|NCT00971633|101296008|FG003|COMPLETED|Period 3||2||
48394760|NCT00971633|101296009|FG004|COMPLETED|Period 3||2||
48394761|NCT00971633|101296010|FG005|COMPLETED|Period 3||2||
48394762|NCT00971633|101296005|FG000|NOT COMPLETED|Period 3||0||
48394763|NCT00971633|101296006|FG001|NOT COMPLETED|Period 3||0||
48394764|NCT00971633|101296007|FG002|NOT COMPLETED|Period 3||0||
48565764|NCT00086619|101717317|FG000|COMPLETED|Overall Study||25||
48565765|NCT00086619|101717318|FG001|COMPLETED|Overall Study||23||
48565766|NCT00086619|101717317|FG000|NOT COMPLETED|Overall Study||15||
48565767|NCT00086619|101717318|FG001|NOT COMPLETED|Overall Study||17||
48565768|NCT02871011|101717319|FG000|STARTED|Overall Study||7||
48565769|NCT02871011|101717320|FG001|STARTED|Overall Study||13||
48565770|NCT02871011|101717319|FG000|COMPLETED|Overall Study||7||
48565771|NCT02871011|101717320|FG001|COMPLETED|Overall Study||13||
48565772|NCT02871011|101717319|FG000|NOT COMPLETED|Overall Study||0||
48565773|NCT02871011|101717320|FG001|NOT COMPLETED|Overall Study||0||
48565774|NCT00603473|101717321|FG000|STARTED|Overall Study||89||
48565775|NCT00603473|101717321|FG000|COMPLETED|Overall Study||80||
48565776|NCT00603473|101717321|FG000|NOT COMPLETED|Overall Study||9||
48565777|NCT02422446|101717322|FG000|STARTED|Overall Study||1||
48565778|NCT02422446|101717323|FG001|STARTED|Overall Study||1||
48565779|NCT02422446|101717322|FG000|COMPLETED|Overall Study||1||
48565780|NCT02422446|101717323|FG001|COMPLETED|Overall Study||1||
48565781|NCT02422446|101717322|FG000|NOT COMPLETED|Overall Study||0||
48565782|NCT02422446|101717323|FG001|NOT COMPLETED|Overall Study||0||
48565783|NCT01823328|101717324|FG000|STARTED|Overall Study||70||
48565784|NCT01823328|101717325|FG001|STARTED|Overall Study||73||
48565785|NCT01823328|101717324|FG000|COMPLETED|Overall Study||62|The number of completions is lower than the number started because of withdrawal by patients.|
48565786|NCT01823328|101717325|FG001|COMPLETED|Overall Study||67|The number of completions is lower than the number started because of withdrawal by patients.|
48565787|NCT01823328|101717324|FG000|NOT COMPLETED|Overall Study||8||
48279842|NCT01656252|101010356|FG000|COMPLETED|Phase II||0||
48279843|NCT01656252|101010356|FG000|NOT COMPLETED|Phase II||0||
48279844|NCT03419832|101010357|FG000|STARTED|Overall Study||52||
48279845|NCT03419832|101010358|FG001|STARTED|Overall Study||49||
48279846|NCT03419832|101010357|FG000|COMPLETED|Overall Study||52||
48279847|NCT03419832|101010358|FG001|COMPLETED|Overall Study||49||
48279848|NCT03419832|101010357|FG000|NOT COMPLETED|Overall Study||0||
48279849|NCT03419832|101010358|FG001|NOT COMPLETED|Overall Study||0||
48279850|NCT03141905|101010359|FG000|STARTED|Overall Study||176||
48279851|NCT03141905|101010360|FG001|STARTED|Overall Study||166||
48279852|NCT03141905|101010359|FG000|COMPLETED|Overall Study||152||
48279853|NCT03141905|101010360|FG001|COMPLETED|Overall Study||147||
48279854|NCT03141905|101010359|FG000|NOT COMPLETED|Overall Study||24||
48279855|NCT03141905|101010360|FG001|NOT COMPLETED|Overall Study||19||
48279856|NCT03980808|101010361|FG000|STARTED|Overall Study||24||
48279857|NCT03980808|101010362|FG001|STARTED|Overall Study||17||
48279858|NCT03980808|101010361|FG000|Phase 2 - 30-day Follow-up|Overall Study||24||
48279859|NCT03980808|101010362|FG001|Phase 2 - 30-day Follow-up|Overall Study||17||
48279860|NCT03980808|101010361|FG000|COMPLETED|Overall Study||22||
48279861|NCT03980808|101010362|FG001|COMPLETED|Overall Study||15||
48279862|NCT03980808|101010361|FG000|NOT COMPLETED|Overall Study||2||
48279863|NCT03980808|101010362|FG001|NOT COMPLETED|Overall Study||2||
48279864|NCT02952534|101010363|FG000|STARTED|Overall Study||172||
48279865|NCT02952534|101010364|FG001|STARTED|Overall Study||59||
48279866|NCT02952534|101010365|FG002|STARTED|Overall Study||14||
48279867|NCT02952534|101010366|FG003|STARTED|Overall Study||7||
48279868|NCT02952534|101010367|FG004|STARTED|Overall Study||25||
48565788|NCT01823328|101717325|FG001|NOT COMPLETED|Overall Study||6||
48565789|NCT02996968|101717326|FG000|STARTED|Overall Study||79||
48565790|NCT02996968|101717327|FG001|STARTED|Overall Study||79||
48565791|NCT02996968|101717326|FG000|COMPLETED|Overall Study||78||
48565792|NCT02996968|101717327|FG001|COMPLETED|Overall Study||79||
48565793|NCT02996968|101717326|FG000|NOT COMPLETED|Overall Study||1||
48698181|NCT01675297|102045568|FG001|STARTED|Overall Study||247||
48279869|NCT02952534|101010363|FG000|COMPLETED|Overall Study||172||
48279870|NCT02952534|101010364|FG001|COMPLETED|Overall Study||59||
48279871|NCT02952534|101010365|FG002|COMPLETED|Overall Study||14||
48279872|NCT02952534|101010366|FG003|COMPLETED|Overall Study||7||
48279873|NCT02952534|101010367|FG004|COMPLETED|Overall Study||25||
48279874|NCT02952534|101010363|FG000|NOT COMPLETED|Overall Study||0||
48279875|NCT02952534|101010364|FG001|NOT COMPLETED|Overall Study||0||
48279876|NCT02952534|101010365|FG002|NOT COMPLETED|Overall Study||0||
48279877|NCT02952534|101010366|FG003|NOT COMPLETED|Overall Study||0||
48279878|NCT02952534|101010367|FG004|NOT COMPLETED|Overall Study||0||
48279879|NCT03775434|101010368|FG000|STARTED|Overall Study||28||
48279880|NCT03775434|101010368|FG000|COMPLETED|Overall Study||25||
48279881|NCT03775434|101010368|FG000|NOT COMPLETED|Overall Study||3||
48279882|NCT02112708|101010369|FG000|STARTED|Baseline||79||
48279883|NCT02112708|101010370|FG001|STARTED|Baseline||50||
48279884|NCT02112708|101010369|FG000|COMPLETED|Baseline||51||
48279885|NCT02112708|101010370|FG001|COMPLETED|Baseline||39||
48279886|NCT02112708|101010369|FG000|NOT COMPLETED|Baseline||28||
48279887|NCT02112708|101010370|FG001|NOT COMPLETED|Baseline||11||
48279888|NCT02112708|101010369|FG000|STARTED|4 Month||51||
48279889|NCT02112708|101010370|FG001|STARTED|4 Month||39||
48565794|NCT02996968|101717327|FG001|NOT COMPLETED|Overall Study||0||
48565795|NCT01796392|101717328|FG000|STARTED|Overall Study||128||
48565796|NCT01796392|101717329|FG001|STARTED|Overall Study||62||
48565797|NCT01796392|101717328|FG000|COMPLETED|Overall Study||119||
48565798|NCT01796392|101717329|FG001|COMPLETED|Overall Study||59||
48394765|NCT00971633|101296008|FG003|NOT COMPLETED|Period 3||0||
48394766|NCT00971633|101296009|FG004|NOT COMPLETED|Period 3||0||
48698182|NCT01675297|102045567|FG000|COMPLETED|Overall Study||642||
48698183|NCT01675297|102045568|FG001|COMPLETED|Overall Study||199||
48698184|NCT01675297|102045567|FG000|NOT COMPLETED|Overall Study||164||
48698185|NCT01675297|102045568|FG001|NOT COMPLETED|Overall Study||48||
48698186|NCT01453205|102045569|FG000|STARTED|Overall Study||80||
48698187|NCT01453205|102045570|FG001|STARTED|Overall Study||52||
48698188|NCT01453205|102045571|FG002|STARTED|Overall Study||55||
48698189|NCT01453205|102045569|FG000|COMPLETED|Overall Study||0||
48698190|NCT01453205|102045570|FG001|COMPLETED|Overall Study||0||
48698191|NCT01453205|102045571|FG002|COMPLETED|Overall Study||1||
48698192|NCT01453205|102045569|FG000|NOT COMPLETED|Overall Study||80||
48279890|NCT02112708|101010369|FG000|COMPLETED|4 Month||39||
48394767|NCT00971633|101296010|FG005|NOT COMPLETED|Period 3||0||
48394768|NCT00525785|101296011|FG000|STARTED|Overall Study||58||
48394769|NCT00525785|101296011|FG000|COMPLETED|Overall Study||55||
48394770|NCT00525785|101296011|FG000|NOT COMPLETED|Overall Study||3||
48394771|NCT02501902|101296012|FG000|STARTED|Overall Study||3||
48394772|NCT02501902|101296013|FG001|STARTED|Overall Study||7||
48394773|NCT02501902|101296014|FG002|STARTED|Overall Study||4||
48394774|NCT02501902|101296015|FG003|STARTED|Overall Study||11||
48394775|NCT02501902|101296016|FG004|STARTED|Overall Study||11||
48394776|NCT02501902|101296017|FG005|STARTED|Overall Study||11||
48394777|NCT02501902|101296018|FG006|STARTED|Overall Study||9||
48394778|NCT02501902|101296019|FG007|STARTED|Overall Study||20||
48698193|NCT01453205|102045570|FG001|NOT COMPLETED|Overall Study||52||
48698194|NCT01453205|102045571|FG002|NOT COMPLETED|Overall Study||54||
48698195|NCT01521871|102045572|FG000|STARTED|Overall Study||32||
48118548|NCT01701258|100616329|FG011|NOT COMPLETED|Assessment and Scheduling||0||
48118549|NCT01701258|100616330|FG012|NOT COMPLETED|Assessment and Scheduling||0||
48118550|NCT01701258|100616318|FG000|STARTED|Drug+fMRI (Session 2)||0|Eligible participants after the screening session were invited to participate in this session.|
48118551|NCT01701258|100616319|FG001|STARTED|Drug+fMRI (Session 2)||0|Eligible participants after the screening session were invited to participate in this session.|
48118552|NCT01701258|100616320|FG002|STARTED|Drug+fMRI (Session 2)||11|Eligible participants after the screening session were invited to participate in this session.|
48118553|NCT01701258|100616321|FG003|STARTED|Drug+fMRI (Session 2)||11|Eligible participants after the screening session were invited to participate in this session.|
48118554|NCT01701258|100616322|FG004|STARTED|Drug+fMRI (Session 2)||0|Eligible participants after the screening session were invited to participate in this session.|
48118555|NCT01701258|100616323|FG005|STARTED|Drug+fMRI (Session 2)||9|Eligible participants after the screening session were invited to participate in this session.|
48118556|NCT01701258|100616324|FG006|STARTED|Drug+fMRI (Session 2)||8|Eligible participants after the screening session were invited to participate in this session.|
48118557|NCT01701258|100616325|FG007|STARTED|Drug+fMRI (Session 2)||0|Eligible participants after the screening session were invited to participate in this session.|
48118558|NCT01701258|100616326|FG008|STARTED|Drug+fMRI (Session 2)||6|Eligible participants after the screening session were invited to participate in this session.|
48118559|NCT01701258|100616327|FG009|STARTED|Drug+fMRI (Session 2)||6|Eligible participants after the screening session were invited to participate in this session.|
48118560|NCT01701258|100616328|FG010|STARTED|Drug+fMRI (Session 2)||0|Eligible participants after the screening session were invited to participate in this session.|
48118561|NCT01701258|100616329|FG011|STARTED|Drug+fMRI (Session 2)||10|Eligible participants after the screening session were invited to participate in this session.|
48141426|NCT01780922|100670425|FG002|STARTED|First Intervention (1 Day)||2||
48565799|NCT01796392|101717328|FG000|NOT COMPLETED|Overall Study||9||
48565800|NCT01796392|101717329|FG001|NOT COMPLETED|Overall Study||3||
48565801|NCT03566199|101717330|FG000|STARTED|Overall Study||1||
48565802|NCT03566199|101717331|FG001|STARTED|Overall Study||0||
48565803|NCT03566199|101717332|FG002|STARTED|Overall Study||1||
48565804|NCT03566199|101717333|FG003|STARTED|Overall Study||0||
48565805|NCT03566199|101717334|FG004|STARTED|Overall Study||1||
48565806|NCT03566199|101717335|FG005|STARTED|Overall Study||0||
48565807|NCT03566199|101717336|FG006|STARTED|Overall Study||4||
48565808|NCT03566199|101717337|FG007|STARTED|Overall Study||0||
48565809|NCT03566199|101717330|FG000|COMPLETED|Overall Study||1||
48565810|NCT03566199|101717331|FG001|COMPLETED|Overall Study||0||
48565811|NCT03566199|101717332|FG002|COMPLETED|Overall Study||1||
48118562|NCT01701258|100616330|FG012|STARTED|Drug+fMRI (Session 2)||7|Eligible participants after the screening session were invited to participate in this session.|
48565812|NCT03566199|101717333|FG003|COMPLETED|Overall Study||0||
48565813|NCT03566199|101717334|FG004|COMPLETED|Overall Study||1||
48565814|NCT03566199|101717335|FG005|COMPLETED|Overall Study||0||
48565815|NCT03566199|101717336|FG006|COMPLETED|Overall Study||4||
48565816|NCT03566199|101717337|FG007|COMPLETED|Overall Study||0||
48565817|NCT03566199|101717330|FG000|NOT COMPLETED|Overall Study||0||
48565818|NCT03566199|101717331|FG001|NOT COMPLETED|Overall Study||0||
48565819|NCT03566199|101717332|FG002|NOT COMPLETED|Overall Study||0||
48565820|NCT03566199|101717333|FG003|NOT COMPLETED|Overall Study||0||
48565821|NCT03566199|101717334|FG004|NOT COMPLETED|Overall Study||0||
48565822|NCT03566199|101717335|FG005|NOT COMPLETED|Overall Study||0||
48565823|NCT03566199|101717336|FG006|NOT COMPLETED|Overall Study||0||
48565824|NCT03566199|101717337|FG007|NOT COMPLETED|Overall Study||0||
48565825|NCT02640664|101717338|FG000|STARTED|Epoch 1||61||
48565826|NCT02640664|101717339|FG001|STARTED|Epoch 1||65||
48565827|NCT02640664|101717340|FG002|STARTED|Epoch 1||54||
48565828|NCT02640664|101717338|FG000|COMPLETED|Epoch 1||60|Number of subjects who completed post-treatment follow-up 1 (Epoch 1)|
48565829|NCT02640664|101717339|FG001|COMPLETED|Epoch 1||65|Number of subjects who completed post-treatment follow-up 1 (Epoch 1)|
48565830|NCT02640664|101717340|FG002|COMPLETED|Epoch 1||53|Number of subjects who completed post-treatment follow-up 1 (Epoch 1)|
48565831|NCT02640664|101717338|FG000|NOT COMPLETED|Epoch 1||1||
48565832|NCT02640664|101717339|FG001|NOT COMPLETED|Epoch 1||0||
48565833|NCT02640664|101717340|FG002|NOT COMPLETED|Epoch 1||1||
48565834|NCT02640664|101717338|FG000|STARTED|Epoch 2||60||
48565835|NCT02640664|101717339|FG001|STARTED|Epoch 2||65||
48565836|NCT02640664|101717340|FG002|STARTED|Epoch 2||53||
48565837|NCT02640664|101717338|FG000|COMPLETED|Epoch 2||54|Number of subjects who completed post-treatment follow-up 2|
48565838|NCT02640664|101717339|FG001|COMPLETED|Epoch 2||55|Number of subjects who completed post-treatment follow-up 2|
48565839|NCT02640664|101717340|FG002|COMPLETED|Epoch 2||47|Number of subjects who completed post-treatment follow-up 2|
48565840|NCT02640664|101717338|FG000|NOT COMPLETED|Epoch 2||6||
48698196|NCT01521871|102045573|FG001|STARTED|Overall Study||32||
48698197|NCT01521871|102045572|FG000|COMPLETED|Overall Study||32||
48698198|NCT01521871|102045573|FG001|COMPLETED|Overall Study||32||
48698199|NCT01521871|102045572|FG000|NOT COMPLETED|Overall Study||0||
48698200|NCT01521871|102045573|FG001|NOT COMPLETED|Overall Study||0||
48698201|NCT04295681|102045574|FG000|STARTED|Overall Study||123||
48118563|NCT01701258|100616318|FG000|Received Drug Challenge|Drug+fMRI (Session 2)||0|Not all participants that were eligible completed the MRI.|
48565841|NCT02640664|101717339|FG001|NOT COMPLETED|Epoch 2||10||
48565842|NCT02640664|101717340|FG002|NOT COMPLETED|Epoch 2||6||
48565843|NCT01120808|101717341|FG000|STARTED|Overall Study||136||
48565844|NCT01120808|101717341|FG000|COMPLETED|Overall Study||90||
48565845|NCT01120808|101717341|FG000|NOT COMPLETED|Overall Study||46||
48565846|NCT02092298|101717342|FG000|STARTED|Overall Study||19||
48565847|NCT02092298|101717342|FG000|COMPLETED|Overall Study||19||
48565848|NCT02092298|101717342|FG000|NOT COMPLETED|Overall Study||0||
48118564|NCT01701258|100616319|FG001|Received Drug Challenge|Drug+fMRI (Session 2)||0|Not all participants that were eligible completed the MRI.|
48118565|NCT01701258|100616320|FG002|Received Drug Challenge|Drug+fMRI (Session 2)||11|Not all participants that were eligible completed the MRI.|
48118566|NCT01701258|100616321|FG003|Received Drug Challenge|Drug+fMRI (Session 2)||11|Not all participants that were eligible completed the MRI.|
48118567|NCT01701258|100616322|FG004|Received Drug Challenge|Drug+fMRI (Session 2)||0|Not all participants that were eligible completed the MRI.|
48118568|NCT01701258|100616323|FG005|Received Drug Challenge|Drug+fMRI (Session 2)||9|Not all participants that were eligible completed the MRI.|
48118569|NCT01701258|100616324|FG006|Received Drug Challenge|Drug+fMRI (Session 2)||8|Not all participants that were eligible completed the MRI.|
48118570|NCT01701258|100616325|FG007|Received Drug Challenge|Drug+fMRI (Session 2)||0|Not all participants that were eligible completed the MRI.|
48118571|NCT01701258|100616326|FG008|Received Drug Challenge|Drug+fMRI (Session 2)||6|Not all participants that were eligible completed the MRI.|
48279891|NCT02112708|101010370|FG001|COMPLETED|4 Month||38||
48565849|NCT03102606|101717343|FG000|STARTED|Overall Study||53||
48565850|NCT03102606|101717344|FG001|STARTED|Overall Study||52||
48565851|NCT03102606|101717343|FG000|COMPLETED|Overall Study||39||
48565852|NCT03102606|101717344|FG001|COMPLETED|Overall Study||45||
48565853|NCT03102606|101717343|FG000|NOT COMPLETED|Overall Study||14||
48565854|NCT03102606|101717344|FG001|NOT COMPLETED|Overall Study||7||
48698202|NCT04295681|102045575|FG001|STARTED|Overall Study||122||
48698203|NCT04295681|102045574|FG000|COMPLETED|Overall Study||122||
48698204|NCT04295681|102045575|FG001|COMPLETED|Overall Study||119||
48279892|NCT02112708|101010369|FG000|NOT COMPLETED|4 Month||12||
48279893|NCT02112708|101010370|FG001|NOT COMPLETED|4 Month||1||
48279894|NCT02112708|101010369|FG000|STARTED|12 Month||39||
48279895|NCT02112708|101010370|FG001|STARTED|12 Month||38||
48279896|NCT02112708|101010369|FG000|COMPLETED|12 Month||39||
48565855|NCT05541003|101717345|FG000|STARTED|Overall Study||12||
48565856|NCT05541003|101717345|FG000|COMPLETED|Overall Study||10||
48565857|NCT05541003|101717345|FG000|NOT COMPLETED|Overall Study||2||
48565858|NCT01833481|101717346|FG000|STARTED|Overall Study||10||
48698205|NCT04295681|102045574|FG000|NOT COMPLETED|Overall Study||1||
48698206|NCT04295681|102045575|FG001|NOT COMPLETED|Overall Study||3||
48698207|NCT01477710|102045576|FG000|STARTED|Overall Study||30||
48698208|NCT01477710|102045576|FG000|COMPLETED|Overall Study||30||
48698209|NCT01477710|102045576|FG000|NOT COMPLETED|Overall Study||0||
48698210|NCT00323960|102045577|FG000|STARTED|Overall Study||47||
48698211|NCT00323960|102045578|FG001|STARTED|Overall Study||46||
48698212|NCT00323960|102045579|FG002|STARTED|Overall Study||46||
48698213|NCT00323960|102045577|FG000|COMPLETED|Overall Study||47||
48698214|NCT00323960|102045578|FG001|COMPLETED|Overall Study||46||
48698215|NCT00323960|102045579|FG002|COMPLETED|Overall Study||46||
48698216|NCT00323960|102045577|FG000|NOT COMPLETED|Overall Study||0||
48698217|NCT00323960|102045578|FG001|NOT COMPLETED|Overall Study||0||
48698218|NCT00323960|102045579|FG002|NOT COMPLETED|Overall Study||0||
48698219|NCT00338286|102045580|FG000|STARTED|Overall Study||1048||
48698220|NCT00338286|102045581|FG001|STARTED|Overall Study||1050||
48698221|NCT00338286|102045580|FG000|COMPLETED|Overall Study||815||
48698222|NCT00338286|102045581|FG001|COMPLETED|Overall Study||837||
48698223|NCT00338286|102045580|FG000|NOT COMPLETED|Overall Study||233||
48698224|NCT00338286|102045581|FG001|NOT COMPLETED|Overall Study||213||
48698225|NCT04238481|102045582|FG000|STARTED|Overall Study||3||
48698226|NCT04238481|102045583|FG001|STARTED|Overall Study||4||
48698227|NCT04238481|102045584|FG002|STARTED|Overall Study||3||
48698228|NCT04238481|102045585|FG003|STARTED|Overall Study||3||
48698229|NCT04238481|102045582|FG000|Treated|Overall Study||3||
48698230|NCT04238481|102045583|FG001|Treated|Overall Study||3||
48698231|NCT04238481|102045584|FG002|Treated|Overall Study||3||
48698232|NCT04238481|102045585|FG003|Treated|Overall Study||3||
48698233|NCT04238481|102045582|FG000|COMPLETED|Overall Study||3||
48698234|NCT04238481|102045583|FG001|COMPLETED|Overall Study||3||
48698235|NCT04238481|102045584|FG002|COMPLETED|Overall Study||3||
48698236|NCT04238481|102045585|FG003|COMPLETED|Overall Study||3||
48698237|NCT04238481|102045582|FG000|NOT COMPLETED|Overall Study||0||
48698238|NCT04238481|102045583|FG001|NOT COMPLETED|Overall Study||1||
48698239|NCT04238481|102045584|FG002|NOT COMPLETED|Overall Study||0||
48698240|NCT04238481|102045585|FG003|NOT COMPLETED|Overall Study||0||
48698241|NCT02839720|102045586|FG000|STARTED|Overall Study||11||
48698242|NCT02839720|102045586|FG000|COMPLETED|Overall Study||4||
48698243|NCT02839720|102045586|FG000|NOT COMPLETED|Overall Study||7||
48565859|NCT01833481|101717347|FG001|STARTED|Overall Study||10||
48565860|NCT01833481|101717348|FG002|STARTED|Overall Study||10||
48565861|NCT01833481|101717346|FG000|COMPLETED|Overall Study||10||
48565862|NCT01833481|101717347|FG001|COMPLETED|Overall Study||10||
48565863|NCT01833481|101717348|FG002|COMPLETED|Overall Study||10||
48565864|NCT01833481|101717346|FG000|NOT COMPLETED|Overall Study||0||
48565865|NCT01833481|101717347|FG001|NOT COMPLETED|Overall Study||0||
48565866|NCT01833481|101717348|FG002|NOT COMPLETED|Overall Study||0||
48565867|NCT01099618|101717349|FG000|STARTED|Overall Study||17||
48565868|NCT01099618|101717350|FG001|STARTED|Overall Study||16||
48565869|NCT01099618|101717351|FG002|STARTED|Overall Study||15||
48698244|NCT00522418|102045587|FG000|STARTED|Overall Study||59||
48698245|NCT00522418|102045588|FG001|STARTED|Overall Study||63||
48565870|NCT01099618|101717349|FG000|COMPLETED|Overall Study||17||
48565871|NCT01099618|101717350|FG001|COMPLETED|Overall Study||16||
48565872|NCT01099618|101717351|FG002|COMPLETED|Overall Study||15||
48565873|NCT01099618|101717349|FG000|NOT COMPLETED|Overall Study||0||
48565874|NCT01099618|101717350|FG001|NOT COMPLETED|Overall Study||0||
48565875|NCT01099618|101717351|FG002|NOT COMPLETED|Overall Study||0||
48565876|NCT01290068|101717352|FG000|STARTED|Overall Study||108||
48565877|NCT01290068|101717353|FG001|STARTED|Overall Study||100||
48565878|NCT01290068|101717352|FG000|Implanted|Overall Study||108||
48279897|NCT02112708|101010370|FG001|COMPLETED|12 Month||38||
48279898|NCT02112708|101010369|FG000|NOT COMPLETED|12 Month||0||
48279899|NCT02112708|101010370|FG001|NOT COMPLETED|12 Month||0||
48565879|NCT01290068|101717353|FG001|Implanted|Overall Study||98||
48565880|NCT01290068|101717352|FG000|COMPLETED|Overall Study||101||
48565881|NCT01290068|101717353|FG001|COMPLETED|Overall Study||94||
48565882|NCT01290068|101717352|FG000|NOT COMPLETED|Overall Study||7||
48698246|NCT00522418|102045587|FG000|Safety Set|Overall Study||54||
48698247|NCT00522418|102045588|FG001|Safety Set|Overall Study||58||
48698248|NCT00522418|102045587|FG000|Efficacy Set|Overall Study||48||
48698249|NCT00522418|102045588|FG001|Efficacy Set|Overall Study||48||
48698250|NCT00522418|102045587|FG000|Baseline and Month 3|Overall Study||47||
48698251|NCT00522418|102045588|FG001|Baseline and Month 3|Overall Study||47||
48698252|NCT00522418|102045587|FG000|Baseline and Month 6|Overall Study||38||
48698253|NCT00522418|102045588|FG001|Baseline and Month 6|Overall Study||45||
48565883|NCT01290068|101717353|FG001|NOT COMPLETED|Overall Study||6||
48565884|NCT00216125|101717354|FG000|STARTED|Pre-Randomization Phase||243||
48565885|NCT00216125|101717355|FG001|STARTED|Pre-Randomization Phase||0||
48565886|NCT00216125|101717356|FG002|STARTED|Pre-Randomization Phase||0||
48565887|NCT00216125|101717354|FG000|DSMB Cohort for Futility|Pre-Randomization Phase||203||
48565888|NCT00216125|101717355|FG001|DSMB Cohort for Futility|Pre-Randomization Phase||0||
48565889|NCT00216125|101717356|FG002|DSMB Cohort for Futility|Pre-Randomization Phase||0||
48565890|NCT00216125|101717354|FG000|COMPLETED|Pre-Randomization Phase||166||
48565891|NCT00216125|101717355|FG001|COMPLETED|Pre-Randomization Phase||0||
48565892|NCT00216125|101717356|FG002|COMPLETED|Pre-Randomization Phase||0||
48565893|NCT00216125|101717354|FG000|NOT COMPLETED|Pre-Randomization Phase||77||
48565894|NCT00216125|101717355|FG001|NOT COMPLETED|Pre-Randomization Phase||0||
48565895|NCT00216125|101717356|FG002|NOT COMPLETED|Pre-Randomization Phase||0||
48565896|NCT00216125|101717354|FG000|STARTED|Randomization Phase||0||
48565897|NCT00216125|101717355|FG001|STARTED|Randomization Phase||84||
48565898|NCT00216125|101717356|FG002|STARTED|Randomization Phase||82||
48565899|NCT00216125|101717354|FG000|DSMB Cohort for Futility|Randomization Phase||0||
48565900|NCT00216125|101717355|FG001|DSMB Cohort for Futility|Randomization Phase||73||
48565901|NCT00216125|101717356|FG002|DSMB Cohort for Futility|Randomization Phase||74||
48565902|NCT00216125|101717354|FG000|COMPLETED|Randomization Phase||0||
48565903|NCT00216125|101717355|FG001|COMPLETED|Randomization Phase||73||
48565904|NCT00216125|101717356|FG002|COMPLETED|Randomization Phase||74||
48565905|NCT00216125|101717354|FG000|NOT COMPLETED|Randomization Phase||0||
48565906|NCT00216125|101717355|FG001|NOT COMPLETED|Randomization Phase||11||
48565907|NCT00216125|101717356|FG002|NOT COMPLETED|Randomization Phase||8||
48565908|NCT02147834|101717357|FG000|STARTED|Overall Study||3||
48565909|NCT02147834|101717358|FG001|STARTED|Overall Study||2||
48565910|NCT02147834|101717357|FG000|COMPLETED|Overall Study||3||
48565911|NCT02147834|101717358|FG001|COMPLETED|Overall Study||2||
48565912|NCT02147834|101717357|FG000|NOT COMPLETED|Overall Study||0||
48565913|NCT02147834|101717358|FG001|NOT COMPLETED|Overall Study||0||
48565914|NCT02356588|101717359|FG000|STARTED|Overall Study||107||
48565915|NCT02356588|101717360|FG001|STARTED|Overall Study||54||
48565916|NCT02356588|101717359|FG000|COMPLETED|Overall Study||102||
48565917|NCT02356588|101717360|FG001|COMPLETED|Overall Study||41||
48565918|NCT02356588|101717359|FG000|NOT COMPLETED|Overall Study||5||
48565919|NCT02356588|101717360|FG001|NOT COMPLETED|Overall Study||13||
48565920|NCT01006122|101717361|FG000|STARTED|First Double-blind Intervention Period||47||
48565921|NCT01006122|101717362|FG001|STARTED|First Double-blind Intervention Period||48||
48565922|NCT01006122|101717361|FG000|COMPLETED|First Double-blind Intervention Period||31||
48565923|NCT01006122|101717362|FG001|COMPLETED|First Double-blind Intervention Period||31||
48565924|NCT01006122|101717361|FG000|NOT COMPLETED|First Double-blind Intervention Period||16||
48565925|NCT01006122|101717362|FG001|NOT COMPLETED|First Double-blind Intervention Period||17||
48565926|NCT01006122|101717361|FG000|STARTED|Wash-out Period (at Least 7 Days)||31||
48565927|NCT01006122|101717362|FG001|STARTED|Wash-out Period (at Least 7 Days)||31||
48565928|NCT01006122|101717361|FG000|COMPLETED|Wash-out Period (at Least 7 Days)||31||
48565929|NCT01006122|101717362|FG001|COMPLETED|Wash-out Period (at Least 7 Days)||31||
48565930|NCT01006122|101717361|FG000|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0||
48565931|NCT01006122|101717362|FG001|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0||
48565932|NCT01006122|101717361|FG000|STARTED|Second Double-blind Intervention Period||31||
48698254|NCT00522418|102045587|FG000|Baseline and Month 9|Overall Study||33||
48565933|NCT01006122|101717362|FG001|STARTED|Second Double-blind Intervention Period||31||
48565934|NCT01006122|101717361|FG000|COMPLETED|Second Double-blind Intervention Period||29||
48565935|NCT01006122|101717362|FG001|COMPLETED|Second Double-blind Intervention Period||24||
48565936|NCT01006122|101717361|FG000|NOT COMPLETED|Second Double-blind Intervention Period||2||
48565937|NCT01006122|101717362|FG001|NOT COMPLETED|Second Double-blind Intervention Period||7||
48565938|NCT01568892|101717363|FG000|STARTED|Double-blind Phase||14||
48565939|NCT01568892|101717364|FG001|STARTED|Double-blind Phase||16||
48565940|NCT01568892|101717363|FG000|COMPLETED|Double-blind Phase||14||
48565941|NCT01568892|101717364|FG001|COMPLETED|Double-blind Phase||16||
48565942|NCT01568892|101717363|FG000|NOT COMPLETED|Double-blind Phase||0||
48698255|NCT00522418|102045588|FG001|Baseline and Month 9|Overall Study||35||
48698256|NCT00522418|102045587|FG000|Baseline and Month 12|Overall Study||31||
48698257|NCT00522418|102045588|FG001|Baseline and Month 12|Overall Study||29||
48698258|NCT00522418|102045587|FG000|COMPLETED|Overall Study||2||
48698259|NCT00522418|102045588|FG001|COMPLETED|Overall Study||5||
48698260|NCT00522418|102045587|FG000|NOT COMPLETED|Overall Study||57||
48698261|NCT00522418|102045588|FG001|NOT COMPLETED|Overall Study||58||
48698262|NCT00957944|102045589|FG000|STARTED|First Intervention- 24 Hours||20||
48698263|NCT00957944|102045590|FG001|STARTED|First Intervention- 24 Hours||20||
48698264|NCT00957944|102045589|FG000|COMPLETED|First Intervention- 24 Hours||20||
48118572|NCT01701258|100616327|FG009|Received Drug Challenge|Drug+fMRI (Session 2)||6|Not all participants that were eligible completed the MRI.|
48118573|NCT01701258|100616328|FG010|Received Drug Challenge|Drug+fMRI (Session 2)||0|Not all participants that were eligible completed the MRI.|
48118574|NCT01701258|100616329|FG011|Received Drug Challenge|Drug+fMRI (Session 2)||10|Not all participants that were eligible completed the MRI.|
48118575|NCT01701258|100616330|FG012|Received Drug Challenge|Drug+fMRI (Session 2)||7|Not all participants that were eligible completed the MRI.|
48118576|NCT01701258|100616318|FG000|COMPLETED|Drug+fMRI (Session 2)||0||
48118577|NCT01701258|100616319|FG001|COMPLETED|Drug+fMRI (Session 2)||0||
48118578|NCT01701258|100616320|FG002|COMPLETED|Drug+fMRI (Session 2)||11||
48118579|NCT01701258|100616321|FG003|COMPLETED|Drug+fMRI (Session 2)||11||
48118580|NCT01701258|100616322|FG004|COMPLETED|Drug+fMRI (Session 2)||0||
48118581|NCT01701258|100616323|FG005|COMPLETED|Drug+fMRI (Session 2)||9||
48118582|NCT01701258|100616324|FG006|COMPLETED|Drug+fMRI (Session 2)||8||
48118583|NCT01701258|100616325|FG007|COMPLETED|Drug+fMRI (Session 2)||0||
48118584|NCT01701258|100616326|FG008|COMPLETED|Drug+fMRI (Session 2)||6||
48118585|NCT01701258|100616327|FG009|COMPLETED|Drug+fMRI (Session 2)||6||
48118586|NCT01701258|100616328|FG010|COMPLETED|Drug+fMRI (Session 2)||0||
48118587|NCT01701258|100616329|FG011|COMPLETED|Drug+fMRI (Session 2)||10||
48118588|NCT01701258|100616330|FG012|COMPLETED|Drug+fMRI (Session 2)||7||
48118589|NCT01701258|100616318|FG000|NOT COMPLETED|Drug+fMRI (Session 2)||0||
48118590|NCT01701258|100616319|FG001|NOT COMPLETED|Drug+fMRI (Session 2)||0||
48118591|NCT01701258|100616320|FG002|NOT COMPLETED|Drug+fMRI (Session 2)||0||
48118592|NCT01701258|100616321|FG003|NOT COMPLETED|Drug+fMRI (Session 2)||0||
48118593|NCT01701258|100616322|FG004|NOT COMPLETED|Drug+fMRI (Session 2)||0||
48118594|NCT01701258|100616323|FG005|NOT COMPLETED|Drug+fMRI (Session 2)||0||
48118595|NCT01701258|100616324|FG006|NOT COMPLETED|Drug+fMRI (Session 2)||0||
48565943|NCT01568892|101717364|FG001|NOT COMPLETED|Double-blind Phase||0||
48565944|NCT01568892|101717363|FG000|STARTED|Open-label Phase||13||
48565945|NCT01568892|101717364|FG001|STARTED|Open-label Phase||16||
48565946|NCT01568892|101717363|FG000|COMPLETED|Open-label Phase||7||
48118596|NCT01701258|100616325|FG007|NOT COMPLETED|Drug+fMRI (Session 2)||0||
48118597|NCT01701258|100616326|FG008|NOT COMPLETED|Drug+fMRI (Session 2)||0||
48118598|NCT01701258|100616327|FG009|NOT COMPLETED|Drug+fMRI (Session 2)||0||
48118599|NCT01701258|100616328|FG010|NOT COMPLETED|Drug+fMRI (Session 2)||0||
48118600|NCT01701258|100616329|FG011|NOT COMPLETED|Drug+fMRI (Session 2)||0||
48118601|NCT01701258|100616330|FG012|NOT COMPLETED|Drug+fMRI (Session 2)||0||
48118602|NCT01701258|100616318|FG000|STARTED|PET (Session 3)||0|Not all participants that were eligible or completed the MRI completed the PET.|
48118603|NCT01701258|100616319|FG001|STARTED|PET (Session 3)||20|Not all participants that were eligible or completed the MRI completed the PET.|
48118604|NCT01701258|100616320|FG002|STARTED|PET (Session 3)||0|Not all participants that were eligible or completed the MRI completed the PET.|
48118605|NCT01701258|100616321|FG003|STARTED|PET (Session 3)||0|Not all participants that were eligible or completed the MRI completed the PET.|
48118606|NCT01701258|100616322|FG004|STARTED|PET (Session 3)||16|Not all participants that were eligible or completed the MRI completed the PET.|
48118607|NCT01701258|100616323|FG005|STARTED|PET (Session 3)||0|Not all participants that were eligible or completed the MRI completed the PET.|
48118608|NCT01701258|100616324|FG006|STARTED|PET (Session 3)||0|Not all participants that were eligible or completed the MRI completed the PET.|
48118609|NCT01701258|100616325|FG007|STARTED|PET (Session 3)||19|Not all participants that were eligible or completed the MRI completed the PET.|
48118610|NCT01701258|100616326|FG008|STARTED|PET (Session 3)||0|Not all participants that were eligible or completed the MRI completed the PET.|
48118611|NCT01701258|100616327|FG009|STARTED|PET (Session 3)||0|Not all participants that were eligible or completed the MRI completed the PET.|
48118612|NCT01701258|100616328|FG010|STARTED|PET (Session 3)||18|Not all participants that were eligible or completed the MRI completed the PET.|
48118613|NCT01701258|100616329|FG011|STARTED|PET (Session 3)||0|Not all participants that were eligible or completed the MRI completed the PET.|
48118614|NCT01701258|100616330|FG012|STARTED|PET (Session 3)||0|Not all participants that were eligible or completed the MRI completed the PET.|
48118615|NCT01701258|100616318|FG000|COMPLETED|PET (Session 3)||0||
48118616|NCT01701258|100616319|FG001|COMPLETED|PET (Session 3)||20||
48118617|NCT01701258|100616320|FG002|COMPLETED|PET (Session 3)||0||
48118618|NCT01701258|100616321|FG003|COMPLETED|PET (Session 3)||0||
48118619|NCT01701258|100616322|FG004|COMPLETED|PET (Session 3)||16||
48118620|NCT01701258|100616323|FG005|COMPLETED|PET (Session 3)||0||
48118621|NCT01701258|100616324|FG006|COMPLETED|PET (Session 3)||0||
48118622|NCT01701258|100616325|FG007|COMPLETED|PET (Session 3)||19||
48118623|NCT01701258|100616326|FG008|COMPLETED|PET (Session 3)||0||
48118624|NCT01701258|100616327|FG009|COMPLETED|PET (Session 3)||0||
48118625|NCT01701258|100616328|FG010|COMPLETED|PET (Session 3)||18||
48279900|NCT00942305|101010371|FG000|STARTED|Overall Study||30||
48565947|NCT01568892|101717364|FG001|COMPLETED|Open-label Phase||13||
48565948|NCT01568892|101717363|FG000|NOT COMPLETED|Open-label Phase||6||
48565949|NCT01568892|101717364|FG001|NOT COMPLETED|Open-label Phase||3||
48565950|NCT02285361|101717365|FG000|STARTED|Overall Study||1272||
48565951|NCT02285361|101717365|FG000|COMPLETED|Overall Study||1221|All Participants whose case report forms (CRFs) were retrieved during the re-examination period and who did not violate the inclusion/exclusion criteria.|
48565952|NCT02285361|101717365|FG000|NOT COMPLETED|Overall Study||51||
48565953|NCT00420420|101717366|FG000|STARTED|Overall Study||73||
48565954|NCT00420420|101717367|FG001|STARTED|Overall Study||71||
48565955|NCT00420420|101717366|FG000|COMPLETED|Overall Study||65||
48565956|NCT00420420|101717367|FG001|COMPLETED|Overall Study||67||
48565957|NCT00420420|101717366|FG000|NOT COMPLETED|Overall Study||8||
48565958|NCT00420420|101717367|FG001|NOT COMPLETED|Overall Study||4||
48565959|NCT00488644|101717368|FG000|STARTED|Overall Study||12||
48565960|NCT00488644|101717368|FG000|COMPLETED|Overall Study||10||
48565961|NCT00488644|101717368|FG000|NOT COMPLETED|Overall Study||2||
48565962|NCT01591096|101717369|FG000|STARTED|Overall Study||1||
48565963|NCT01591096|101717369|FG000|COMPLETED|Overall Study||0||
48565964|NCT01591096|101717369|FG000|NOT COMPLETED|Overall Study||1||
48565965|NCT00553839|101717370|FG000|STARTED|Overall Study||21||
48565966|NCT00553839|101717370|FG000|COMPLETED|Overall Study||21||
48565967|NCT00553839|101717370|FG000|NOT COMPLETED|Overall Study||0||
48565968|NCT00191477|101717371|FG000|STARTED|Overall Study||179||
48565969|NCT00191477|101717372|FG001|STARTED|Overall Study||176||
48565970|NCT00191477|101717371|FG000|Received Study Drug|Overall Study||166||
48565971|NCT00191477|101717372|FG001|Received Study Drug|Overall Study||162||
48565972|NCT00191477|101717371|FG000|COMPLETED|Overall Study||41||
48565973|NCT00191477|101717372|FG001|COMPLETED|Overall Study||47||
48565974|NCT00191477|101717371|FG000|NOT COMPLETED|Overall Study||138||
48565975|NCT00191477|101717372|FG001|NOT COMPLETED|Overall Study||129||
48565976|NCT01067105|101717373|FG000|STARTED|Overall Study||824||
48565977|NCT01067105|101717373|FG000|COMPLETED|Overall Study||683||
48565978|NCT01067105|101717373|FG000|NOT COMPLETED|Overall Study||141||
48698265|NCT00957944|102045590|FG001|COMPLETED|First Intervention- 24 Hours||19||
48698266|NCT00957944|102045589|FG000|NOT COMPLETED|First Intervention- 24 Hours||0||
48698267|NCT00957944|102045590|FG001|NOT COMPLETED|First Intervention- 24 Hours||1||
48698268|NCT00957944|102045589|FG000|STARTED|Washout Period of at Least 5 Days||20||
48698269|NCT00957944|102045590|FG001|STARTED|Washout Period of at Least 5 Days||19||
48698270|NCT00957944|102045589|FG000|COMPLETED|Washout Period of at Least 5 Days||20||
48698271|NCT00957944|102045590|FG001|COMPLETED|Washout Period of at Least 5 Days||19||
48698272|NCT00957944|102045589|FG000|NOT COMPLETED|Washout Period of at Least 5 Days||0||
48698273|NCT00957944|102045590|FG001|NOT COMPLETED|Washout Period of at Least 5 Days||0||
48698274|NCT00957944|102045589|FG000|STARTED|Second Intervention- 24 Hours||20||
48698275|NCT00957944|102045590|FG001|STARTED|Second Intervention- 24 Hours||19||
48698276|NCT00957944|102045589|FG000|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours||20||
48698277|NCT00957944|102045590|FG001|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours||18||
48698278|NCT00957944|102045589|FG000|COMPLETED|Second Intervention- 24 Hours||20||
48698279|NCT00957944|102045590|FG001|COMPLETED|Second Intervention- 24 Hours||19||
48698280|NCT00957944|102045589|FG000|NOT COMPLETED|Second Intervention- 24 Hours||0||
48698281|NCT00957944|102045590|FG001|NOT COMPLETED|Second Intervention- 24 Hours||0||
48118626|NCT01701258|100616329|FG011|COMPLETED|PET (Session 3)||0||
48118627|NCT01701258|100616330|FG012|COMPLETED|PET (Session 3)||0||
48118628|NCT01701258|100616318|FG000|NOT COMPLETED|PET (Session 3)||0||
48698282|NCT02003638|102045591|FG000|STARTED|Overall Study||6||
48698283|NCT02003638|102045592|FG001|STARTED|Overall Study||3||
48118629|NCT01701258|100616319|FG001|NOT COMPLETED|PET (Session 3)||0||
48118630|NCT01701258|100616320|FG002|NOT COMPLETED|PET (Session 3)||0||
48118631|NCT01701258|100616321|FG003|NOT COMPLETED|PET (Session 3)||0||
48118632|NCT01701258|100616322|FG004|NOT COMPLETED|PET (Session 3)||0||
48118633|NCT01701258|100616323|FG005|NOT COMPLETED|PET (Session 3)||0||
48565979|NCT00298272|101717374|FG000|STARTED|Double-blind Phase||36||
48565980|NCT00298272|101717375|FG001|STARTED|Double-blind Phase||18||
48565981|NCT00298272|101717374|FG000|Safety Population|Double-blind Phase||33||
48565982|NCT00298272|101717375|FG001|Safety Population|Double-blind Phase||18||
48565983|NCT00298272|101717374|FG000|Completed to Week 24|Double-blind Phase||31||
48565984|NCT00298272|101717375|FG001|Completed to Week 24|Double-blind Phase||18||
48565985|NCT00298272|101717374|FG000|Completed to Week 56|Double-blind Phase||8||
48565986|NCT00298272|101717375|FG001|Completed to Week 56|Double-blind Phase||3||
48565987|NCT00298272|101717374|FG000|COMPLETED|Double-blind Phase||28||
48565988|NCT00298272|101717375|FG001|COMPLETED|Double-blind Phase||18||
48565989|NCT00298272|101717374|FG000|NOT COMPLETED|Double-blind Phase||8||
48565990|NCT00298272|101717375|FG001|NOT COMPLETED|Double-blind Phase||0||
48565991|NCT00298272|101717374|FG000|STARTED|Open Label Retreatment Phase||22||
48565992|NCT00298272|101717375|FG001|STARTED|Open Label Retreatment Phase||16||
48118634|NCT01701258|100616324|FG006|NOT COMPLETED|PET (Session 3)||0||
48118635|NCT01701258|100616325|FG007|NOT COMPLETED|PET (Session 3)||0||
48565993|NCT00298272|101717374|FG000|Completed to Week 24|Open Label Retreatment Phase||22||
48565994|NCT00298272|101717375|FG001|Completed to Week 24|Open Label Retreatment Phase||15||
48565995|NCT00298272|101717374|FG000|Completed to Week 56|Open Label Retreatment Phase||13||
48565996|NCT00298272|101717375|FG001|Completed to Week 56|Open Label Retreatment Phase||12||
48565997|NCT00298272|101717374|FG000|COMPLETED|Open Label Retreatment Phase||13||
48118636|NCT01701258|100616326|FG008|NOT COMPLETED|PET (Session 3)||0||
48118637|NCT01701258|100616327|FG009|NOT COMPLETED|PET (Session 3)||0||
48565998|NCT00298272|101717375|FG001|COMPLETED|Open Label Retreatment Phase||12||
48565999|NCT00298272|101717374|FG000|NOT COMPLETED|Open Label Retreatment Phase||9||
48698284|NCT02003638|102045591|FG000|COMPLETED|Overall Study||5||
48698285|NCT02003638|102045592|FG001|COMPLETED|Overall Study||3||
48118638|NCT01701258|100616328|FG010|NOT COMPLETED|PET (Session 3)||0||
48118639|NCT01701258|100616329|FG011|NOT COMPLETED|PET (Session 3)||0||
48279901|NCT00942305|101010372|FG001|STARTED|Overall Study||10||
48279902|NCT00942305|101010373|FG002|STARTED|Overall Study||29||
48279903|NCT00942305|101010374|FG003|STARTED|Overall Study||10||
48279904|NCT00942305|101010375|FG004|STARTED|Overall Study||39||
48279905|NCT00942305|101010376|FG005|STARTED|Overall Study||14||
48566000|NCT00298272|101717375|FG001|NOT COMPLETED|Open Label Retreatment Phase||4||
48566001|NCT00298272|101717374|FG000|STARTED|Safety Follow-up Phase||22||
48566002|NCT00298272|101717375|FG001|STARTED|Safety Follow-up Phase||17||
48698286|NCT02003638|102045591|FG000|NOT COMPLETED|Overall Study||1||
48698287|NCT02003638|102045592|FG001|NOT COMPLETED|Overall Study||0||
48698288|NCT03276026|102045593|FG000|STARTED|Overall Study||35||
48698289|NCT03276026|102045594|FG001|STARTED|Overall Study||33||
48279906|NCT00942305|101010377|FG006|STARTED|Overall Study||30||
48566003|NCT00298272|101717374|FG000|COMPLETED|Safety Follow-up Phase||18||
48566004|NCT00298272|101717375|FG001|COMPLETED|Safety Follow-up Phase||13||
48566005|NCT00298272|101717374|FG000|NOT COMPLETED|Safety Follow-up Phase||4||
48566006|NCT00298272|101717375|FG001|NOT COMPLETED|Safety Follow-up Phase||4||
48566007|NCT04335123|101717376|FG000|STARTED|Overall Study||34||
48566008|NCT04335123|101717377|FG001|STARTED|Overall Study||46||
48566009|NCT04335123|101717376|FG000|COMPLETED|Overall Study||30||
48566010|NCT04335123|101717377|FG001|COMPLETED|Overall Study||46||
48566011|NCT04335123|101717376|FG000|NOT COMPLETED|Overall Study||4||
48566012|NCT04335123|101717377|FG001|NOT COMPLETED|Overall Study||0||
48566013|NCT00806403|101717378|FG000|STARTED|Overall Study||104||
48566014|NCT00806403|101717379|FG001|STARTED|Overall Study||101||
48566015|NCT00806403|101717378|FG000|COMPLETED|Overall Study||100||
48566016|NCT00806403|101717379|FG001|COMPLETED|Overall Study||98||
48566017|NCT00806403|101717378|FG000|NOT COMPLETED|Overall Study||4||
48566018|NCT00806403|101717379|FG001|NOT COMPLETED|Overall Study||3||
48566019|NCT02454608|101717380|FG000|STARTED|Double-Blind Period||15||
48566020|NCT02454608|101717381|FG001|STARTED|Double-Blind Period||14||
48566021|NCT02454608|101717382|FG002|STARTED|Double-Blind Period||0||
48566022|NCT02454608|101717380|FG000|COMPLETED|Double-Blind Period||15||
48566023|NCT02454608|101717381|FG001|COMPLETED|Double-Blind Period||12||
48566024|NCT02454608|101717382|FG002|COMPLETED|Double-Blind Period||0||
48566025|NCT02454608|101717380|FG000|NOT COMPLETED|Double-Blind Period||0||
48566026|NCT02454608|101717381|FG001|NOT COMPLETED|Double-Blind Period||2||
48566027|NCT02454608|101717382|FG002|NOT COMPLETED|Double-Blind Period||0||
48566028|NCT02454608|101717380|FG000|STARTED|Open Label Period||0||
48566029|NCT02454608|101717381|FG001|STARTED|Open Label Period||0||
48566030|NCT02454608|101717382|FG002|STARTED|Open Label Period||29||
48566031|NCT02454608|101717380|FG000|COMPLETED|Open Label Period||0||
48566032|NCT02454608|101717381|FG001|COMPLETED|Open Label Period||0||
48566033|NCT02454608|101717382|FG002|COMPLETED|Open Label Period||10||
48566034|NCT02454608|101717380|FG000|NOT COMPLETED|Open Label Period||0||
48566035|NCT02454608|101717381|FG001|NOT COMPLETED|Open Label Period||0||
48698290|NCT03276026|102045593|FG000|COMPLETED|Overall Study||34||
48698291|NCT03276026|102045594|FG001|COMPLETED|Overall Study||33||
48279907|NCT00942305|101010378|FG007|STARTED|Overall Study||10||
48279908|NCT00942305|101010379|FG008|STARTED|Overall Study||50||
48279909|NCT00942305|101010380|FG009|STARTED|Overall Study||17||
48566036|NCT02454608|101717382|FG002|NOT COMPLETED|Open Label Period||19||
48566037|NCT01279317|101717383|FG000|STARTED|Period 1||6||
48566038|NCT01279317|101717384|FG001|STARTED|Period 1||6||
48566039|NCT01279317|101717383|FG000|COMPLETED|Period 1||6||
48566040|NCT01279317|101717384|FG001|COMPLETED|Period 1||6||
48566041|NCT01279317|101717383|FG000|NOT COMPLETED|Period 1||0||
48566042|NCT01279317|101717384|FG001|NOT COMPLETED|Period 1||0||
48566043|NCT01279317|101717383|FG000|STARTED|Washout||6||
48566044|NCT01279317|101717384|FG001|STARTED|Washout||6||
48566045|NCT01279317|101717383|FG000|COMPLETED|Washout||6||
48566046|NCT01279317|101717384|FG001|COMPLETED|Washout||6||
48566047|NCT01279317|101717383|FG000|NOT COMPLETED|Washout||0||
48566048|NCT01279317|101717384|FG001|NOT COMPLETED|Washout||0||
48566049|NCT01279317|101717383|FG000|STARTED|Period 2||6||
48566050|NCT01279317|101717384|FG001|STARTED|Period 2||6||
48566051|NCT01279317|101717383|FG000|COMPLETED|Period 2||6||
48566052|NCT01279317|101717384|FG001|COMPLETED|Period 2||6||
48566053|NCT01279317|101717383|FG000|NOT COMPLETED|Period 2||0||
48566054|NCT01279317|101717384|FG001|NOT COMPLETED|Period 2||0||
48566055|NCT01408303|101717385|FG000|STARTED|Overall Study||215||
48566056|NCT01408303|101717386|FG001|STARTED|Overall Study||216||
48566057|NCT01408303|101717387|FG002|STARTED|Overall Study||216||
48566058|NCT01408303|101717385|FG000|COMPLETED|Overall Study||209||
48566059|NCT01408303|101717386|FG001|COMPLETED|Overall Study||204||
48698292|NCT03276026|102045593|FG000|NOT COMPLETED|Overall Study||1||
48279910|NCT00942305|101010371|FG000|COMPLETED|Overall Study||7||
48279911|NCT00942305|101010372|FG001|COMPLETED|Overall Study||5||
48566060|NCT01408303|101717387|FG002|COMPLETED|Overall Study||210||
48566061|NCT01408303|101717385|FG000|NOT COMPLETED|Overall Study||6||
48566062|NCT01408303|101717386|FG001|NOT COMPLETED|Overall Study||12||
48566063|NCT01408303|101717387|FG002|NOT COMPLETED|Overall Study||6||
48566064|NCT04630002|101717388|FG000|STARTED|Cohort 1:Treatment Period 1(Days 1 to 7)||19||
48566065|NCT04630002|101717389|FG001|STARTED|Cohort 1:Treatment Period 1(Days 1 to 7)||0||
48566066|NCT04630002|101717390|FG002|STARTED|Cohort 1:Treatment Period 1(Days 1 to 7)||0||
48566067|NCT04630002|101717388|FG000|COMPLETED|Cohort 1:Treatment Period 1(Days 1 to 7)||19||
48566068|NCT04630002|101717389|FG001|COMPLETED|Cohort 1:Treatment Period 1(Days 1 to 7)||0||
48566069|NCT04630002|101717390|FG002|COMPLETED|Cohort 1:Treatment Period 1(Days 1 to 7)||0||
48698293|NCT03276026|102045594|FG001|NOT COMPLETED|Overall Study||0||
48698294|NCT03136497|102045595|FG000|STARTED|Overall Study||5||
48698295|NCT03136497|102045596|FG001|STARTED|Overall Study||3||
48698296|NCT03136497|102045597|FG002|STARTED|Overall Study||2||
48698297|NCT03136497|102045595|FG000|COMPLETED|Overall Study||4||
48698298|NCT03136497|102045596|FG001|COMPLETED|Overall Study||3||
48698299|NCT03136497|102045597|FG002|COMPLETED|Overall Study||2||
48279912|NCT00942305|101010373|FG002|COMPLETED|Overall Study||14||
48279913|NCT00942305|101010374|FG003|COMPLETED|Overall Study||4||
48279914|NCT00942305|101010375|FG004|COMPLETED|Overall Study||14||
48698300|NCT03136497|102045595|FG000|NOT COMPLETED|Overall Study||1||
48698301|NCT03136497|102045596|FG001|NOT COMPLETED|Overall Study||0||
48698302|NCT03136497|102045597|FG002|NOT COMPLETED|Overall Study||0||
48698303|NCT01126437|102045598|FG000|STARTED|Overall Study||5741||
48698304|NCT01126437|102045599|FG001|STARTED|Overall Study||5729||
48698305|NCT01126437|102045600|FG002|STARTED|Overall Study||5713||
48698306|NCT01126437|102045598|FG000|COMPLETED|Overall Study||4400||
48698307|NCT01126437|102045599|FG001|COMPLETED|Overall Study||4399||
48698308|NCT01126437|102045600|FG002|COMPLETED|Overall Study||4400||
48698309|NCT01126437|102045598|FG000|NOT COMPLETED|Overall Study||1341||
48279915|NCT00942305|101010376|FG005|COMPLETED|Overall Study||9||
48279916|NCT00942305|101010377|FG006|COMPLETED|Overall Study||6||
48279917|NCT00942305|101010378|FG007|COMPLETED|Overall Study||5||
48279918|NCT00942305|101010379|FG008|COMPLETED|Overall Study||25||
48279919|NCT00942305|101010380|FG009|COMPLETED|Overall Study||7||
48279920|NCT00942305|101010371|FG000|NOT COMPLETED|Overall Study||23||
48279921|NCT00942305|101010372|FG001|NOT COMPLETED|Overall Study||5||
48279922|NCT00942305|101010373|FG002|NOT COMPLETED|Overall Study||15||
48279923|NCT00942305|101010374|FG003|NOT COMPLETED|Overall Study||6||
48279924|NCT00942305|101010375|FG004|NOT COMPLETED|Overall Study||25||
48279925|NCT00942305|101010376|FG005|NOT COMPLETED|Overall Study||5||
48279926|NCT00942305|101010377|FG006|NOT COMPLETED|Overall Study||24||
48279927|NCT00942305|101010378|FG007|NOT COMPLETED|Overall Study||5||
48279928|NCT00942305|101010379|FG008|NOT COMPLETED|Overall Study||25||
48279929|NCT00942305|101010380|FG009|NOT COMPLETED|Overall Study||10||
48279930|NCT00929110|101010381|FG000|STARTED|Overall Study||529||
48279931|NCT00929110|101010382|FG001|STARTED|Overall Study||269||
48279932|NCT00929110|101010383|FG002|STARTED|Overall Study||268||
48279933|NCT00929110|101010381|FG000|COMPLETED|Overall Study||411||
48279934|NCT00929110|101010382|FG001|COMPLETED|Overall Study||193||
48279935|NCT00929110|101010383|FG002|COMPLETED|Overall Study||206||
48279936|NCT00929110|101010381|FG000|NOT COMPLETED|Overall Study||118||
48279937|NCT00929110|101010382|FG001|NOT COMPLETED|Overall Study||76||
48279938|NCT00929110|101010383|FG002|NOT COMPLETED|Overall Study||62||
48698310|NCT01126437|102045599|FG001|NOT COMPLETED|Overall Study||1330||
48698311|NCT01126437|102045600|FG002|NOT COMPLETED|Overall Study||1313||
48698312|NCT01848977|102045601|FG000|STARTED|Overall Study||20||
48698313|NCT01848977|102045601|FG000|COMPLETED|Overall Study||20||
48698314|NCT01848977|102045601|FG000|NOT COMPLETED|Overall Study||0||
48698315|NCT03230890|102045602|FG000|STARTED|Overall Study||32||
48698316|NCT03230890|102045602|FG000|COMPLETED|Overall Study||32||
48698317|NCT03230890|102045602|FG000|NOT COMPLETED|Overall Study||0||
48698318|NCT02321319|102045603|FG000|STARTED|Overall Study||5||
48698319|NCT02321319|102045603|FG000|COMPLETED|Overall Study||0||
48698320|NCT02321319|102045603|FG000|NOT COMPLETED|Overall Study||5||
48698321|NCT00855933|102045604|FG000|STARTED|Overall Study||30||
48698322|NCT00855933|102045605|FG001|STARTED|Overall Study||30||
48698323|NCT00855933|102045604|FG000|COMPLETED|Overall Study||30||
48698324|NCT00855933|102045605|FG001|COMPLETED|Overall Study||29||
48698325|NCT00855933|102045604|FG000|NOT COMPLETED|Overall Study||0||
48698326|NCT00855933|102045605|FG001|NOT COMPLETED|Overall Study||1||
48279939|NCT01806623|101010384|FG000|STARTED|Overall Study||157||
48279940|NCT01806623|101010384|FG000|COMPLETED|Overall Study||99||
48279941|NCT01806623|101010384|FG000|NOT COMPLETED|Overall Study||58||
48279942|NCT01253070|101010385|FG000|STARTED|Overall Study||54||
48279943|NCT01253070|101010385|FG000|COMPLETED|Overall Study||54||
48279944|NCT01253070|101010385|FG000|NOT COMPLETED|Overall Study||0||
48279945|NCT02124603|101010386|FG000|STARTED|Overall Study||120||
48566070|NCT04630002|101717388|FG000|NOT COMPLETED|Cohort 1:Treatment Period 1(Days 1 to 7)||0||
48566071|NCT04630002|101717389|FG001|NOT COMPLETED|Cohort 1:Treatment Period 1(Days 1 to 7)||0||
48566072|NCT04630002|101717390|FG002|NOT COMPLETED|Cohort 1:Treatment Period 1(Days 1 to 7)||0||
48698327|NCT01529515|102045606|FG000|STARTED|TRANSITION PHASE||506||
48698328|NCT01529515|102045607|FG001|STARTED|TRANSITION PHASE||0||
48698329|NCT01529515|102045608|FG002|STARTED|TRANSITION PHASE||0||
48279946|NCT02124603|101010386|FG000|COMPLETED|Overall Study||120||
48279947|NCT02124603|101010386|FG000|NOT COMPLETED|Overall Study||0||
48279948|NCT01014208|101010387|FG000|STARTED|Overall Study||225||
48279949|NCT01014208|101010388|FG001|STARTED|Overall Study||222||
48118640|NCT01701258|100616330|FG012|NOT COMPLETED|PET (Session 3)||0||
48118641|NCT01701258|100616318|FG000|STARTED|EEG (Session 4)||0|Not all participants that were eligible or completed the MRI/PET completed the EEG.|
48118642|NCT01701258|100616319|FG001|STARTED|EEG (Session 4)||19|Not all participants that were eligible or completed the MRI/PET completed the EEG.|
48118643|NCT01701258|100616320|FG002|STARTED|EEG (Session 4)||0|Not all participants that were eligible or completed the MRI/PET completed the EEG.|
48118644|NCT01701258|100616321|FG003|STARTED|EEG (Session 4)||0|Not all participants that were eligible or completed the MRI/PET completed the EEG.|
48118645|NCT01701258|100616322|FG004|STARTED|EEG (Session 4)||14|Not all participants that were eligible or completed the MRI/PET completed the EEG.|
48118646|NCT01701258|100616323|FG005|STARTED|EEG (Session 4)||0|Not all participants that were eligible or completed the MRI/PET completed the EEG.|
48118647|NCT01701258|100616324|FG006|STARTED|EEG (Session 4)||0|Not all participants that were eligible or completed the MRI/PET completed the EEG.|
48279950|NCT01014208|101010387|FG000|Intent-to-Treat Population|Overall Study||223||
48279951|NCT01014208|101010388|FG001|Intent-to-Treat Population|Overall Study||222||
48279952|NCT01014208|101010387|FG000|COMPLETED|Overall Study||131||
48279953|NCT01014208|101010388|FG001|COMPLETED|Overall Study||122||
48279954|NCT01014208|101010387|FG000|NOT COMPLETED|Overall Study||94||
48279955|NCT01014208|101010388|FG001|NOT COMPLETED|Overall Study||100||
48279956|NCT00939822|101010389|FG000|STARTED|Overall Study||44||
48279957|NCT00939822|101010390|FG001|STARTED|Overall Study||44||
48279958|NCT00939822|101010389|FG000|COMPLETED|Overall Study||42||
48279959|NCT00939822|101010390|FG001|COMPLETED|Overall Study||41||
48279960|NCT00939822|101010389|FG000|NOT COMPLETED|Overall Study||2||
48279961|NCT00939822|101010390|FG001|NOT COMPLETED|Overall Study||3||
48279962|NCT01145209|101010391|FG000|STARTED|Overall Study||13||
48279963|NCT01145209|101010392|FG001|STARTED|Overall Study||19||
48279964|NCT01145209|101010391|FG000|COMPLETED|Overall Study||10||
48279965|NCT01145209|101010392|FG001|COMPLETED|Overall Study||18||
48566073|NCT04630002|101717388|FG000|STARTED|Cohort 1:Washout Period (Days 8 to 11)||19||
48566074|NCT04630002|101717389|FG001|STARTED|Cohort 1:Washout Period (Days 8 to 11)||0||
48566075|NCT04630002|101717390|FG002|STARTED|Cohort 1:Washout Period (Days 8 to 11)||0||
48566076|NCT04630002|101717388|FG000|COMPLETED|Cohort 1:Washout Period (Days 8 to 11)||19||
48279966|NCT01145209|101010391|FG000|NOT COMPLETED|Overall Study||3||
48279967|NCT01145209|101010392|FG001|NOT COMPLETED|Overall Study||1||
48279968|NCT00920075|101010393|FG000|STARTED|Last Study, 25 Pts Invited,11 Responded||11||
48279969|NCT00920075|101010393|FG000|COMPLETED|Last Study, 25 Pts Invited,11 Responded||11||
48279970|NCT00920075|101010393|FG000|NOT COMPLETED|Last Study, 25 Pts Invited,11 Responded||0||
48279971|NCT00920075|101010393|FG000|STARTED|Post Study, 11 Pts Responded||11||
48566077|NCT04630002|101717389|FG001|COMPLETED|Cohort 1:Washout Period (Days 8 to 11)||0||
48566078|NCT04630002|101717390|FG002|COMPLETED|Cohort 1:Washout Period (Days 8 to 11)||0||
48566079|NCT04630002|101717388|FG000|NOT COMPLETED|Cohort 1:Washout Period (Days 8 to 11)||0||
48566080|NCT04630002|101717389|FG001|NOT COMPLETED|Cohort 1:Washout Period (Days 8 to 11)||0||
48566081|NCT04630002|101717390|FG002|NOT COMPLETED|Cohort 1:Washout Period (Days 8 to 11)||0||
48566082|NCT04630002|101717388|FG000|STARTED|Cohort1:Treatment Period2(Days 12 to 21)||19||
48698330|NCT01529515|102045609|FG003|STARTED|TRANSITION PHASE||0||
48698331|NCT01529515|102045606|FG000|COMPLETED|TRANSITION PHASE||379||
48279972|NCT00920075|101010393|FG000|COMPLETED|Post Study, 11 Pts Responded||11||
48279973|NCT00920075|101010393|FG000|NOT COMPLETED|Post Study, 11 Pts Responded||0||
48279974|NCT00710021|101010394|FG000|STARTED|Overall Study||19||
48279975|NCT00710021|101010395|FG001|STARTED|Overall Study||19||
48279976|NCT00710021|101010396|FG002|STARTED|Overall Study||19||
48279977|NCT00710021|101010394|FG000|Modified Intent-to-Treat (mITT)|Overall Study||19||
48279978|NCT00710021|101010395|FG001|Modified Intent-to-Treat (mITT)|Overall Study||17||
48279979|NCT00710021|101010396|FG002|Modified Intent-to-Treat (mITT)|Overall Study||18||
48279980|NCT00710021|101010394|FG000|COMPLETED|Overall Study||18||
48279981|NCT00710021|101010395|FG001|COMPLETED|Overall Study||16||
48279982|NCT00710021|101010396|FG002|COMPLETED|Overall Study||18||
48279983|NCT00710021|101010394|FG000|NOT COMPLETED|Overall Study||1||
48279984|NCT00710021|101010395|FG001|NOT COMPLETED|Overall Study||3||
48279985|NCT00710021|101010396|FG002|NOT COMPLETED|Overall Study||1||
48279986|NCT01244529|101010397|FG000|STARTED|Overall Study||41||
48279987|NCT01244529|101010397|FG000|COMPLETED|Overall Study||41||
48279988|NCT01244529|101010397|FG000|NOT COMPLETED|Overall Study||0||
48279989|NCT00490724|101010398|FG000|STARTED|Period I||21||
48279990|NCT00490724|101010399|FG001|STARTED|Period I||20||
48279991|NCT00490724|101010400|FG002|STARTED|Period I||20||
48279992|NCT00490724|101010398|FG000|COMPLETED|Period I||21||
48279993|NCT00490724|101010399|FG001|COMPLETED|Period I||20||
48279994|NCT00490724|101010400|FG002|COMPLETED|Period I||19||
48279995|NCT00490724|101010398|FG000|NOT COMPLETED|Period I||0||
48566083|NCT04630002|101717389|FG001|STARTED|Cohort1:Treatment Period2(Days 12 to 21)||0||
48566084|NCT04630002|101717390|FG002|STARTED|Cohort1:Treatment Period2(Days 12 to 21)||0||
48566085|NCT04630002|101717388|FG000|COMPLETED|Cohort1:Treatment Period2(Days 12 to 21)||17||
48566086|NCT04630002|101717389|FG001|COMPLETED|Cohort1:Treatment Period2(Days 12 to 21)||0||
48566087|NCT04630002|101717390|FG002|COMPLETED|Cohort1:Treatment Period2(Days 12 to 21)||0||
48698332|NCT01529515|102045607|FG001|COMPLETED|TRANSITION PHASE||0||
48698333|NCT01529515|102045608|FG002|COMPLETED|TRANSITION PHASE||0||
48698334|NCT01529515|102045609|FG003|COMPLETED|TRANSITION PHASE||0||
48118648|NCT01701258|100616325|FG007|STARTED|EEG (Session 4)||16|Not all participants that were eligible or completed the MRI/PET completed the EEG.|
48118649|NCT01701258|100616326|FG008|STARTED|EEG (Session 4)||0|Not all participants that were eligible or completed the MRI/PET completed the EEG.|
48118650|NCT01701258|100616327|FG009|STARTED|EEG (Session 4)||0|Not all participants that were eligible or completed the MRI/PET completed the EEG.|
48118651|NCT01701258|100616328|FG010|STARTED|EEG (Session 4)||17|Not all participants that were eligible or completed the MRI/PET completed the EEG.|
48118652|NCT01701258|100616329|FG011|STARTED|EEG (Session 4)||0|Not all participants that were eligible or completed the MRI/PET completed the EEG.|
48118653|NCT01701258|100616330|FG012|STARTED|EEG (Session 4)||0|Not all participants that were eligible or completed the MRI/PET completed the EEG.|
48118654|NCT01701258|100616318|FG000|COMPLETED|EEG (Session 4)||0||
48118655|NCT01701258|100616319|FG001|COMPLETED|EEG (Session 4)||19||
48118656|NCT01701258|100616320|FG002|COMPLETED|EEG (Session 4)||0||
48118657|NCT01701258|100616321|FG003|COMPLETED|EEG (Session 4)||0||
48118658|NCT01701258|100616322|FG004|COMPLETED|EEG (Session 4)||14||
48698335|NCT01529515|102045606|FG000|NOT COMPLETED|TRANSITION PHASE||127||
48698336|NCT01529515|102045607|FG001|NOT COMPLETED|TRANSITION PHASE||0||
48698337|NCT01529515|102045608|FG002|NOT COMPLETED|TRANSITION PHASE||0||
48698338|NCT01529515|102045609|FG003|NOT COMPLETED|TRANSITION PHASE||0||
48698339|NCT01529515|102045606|FG000|STARTED|MAINTENANCE PHASE||0||
48698340|NCT01529515|102045607|FG001|STARTED|MAINTENANCE PHASE||379||
48698341|NCT01529515|102045608|FG002|STARTED|MAINTENANCE PHASE||0||
48698342|NCT01529515|102045609|FG003|STARTED|MAINTENANCE PHASE||0||
48698343|NCT01529515|102045606|FG000|COMPLETED|MAINTENANCE PHASE||0||
48118659|NCT01701258|100616323|FG005|COMPLETED|EEG (Session 4)||0||
48118660|NCT01701258|100616324|FG006|COMPLETED|EEG (Session 4)||0||
48118661|NCT01701258|100616325|FG007|COMPLETED|EEG (Session 4)||16||
48118662|NCT01701258|100616326|FG008|COMPLETED|EEG (Session 4)||0||
48118663|NCT01701258|100616327|FG009|COMPLETED|EEG (Session 4)||0||
48118664|NCT01701258|100616328|FG010|COMPLETED|EEG (Session 4)||17||
48118665|NCT01701258|100616329|FG011|COMPLETED|EEG (Session 4)||0||
48118666|NCT01701258|100616330|FG012|COMPLETED|EEG (Session 4)||0||
48118667|NCT01701258|100616318|FG000|NOT COMPLETED|EEG (Session 4)||0||
48118668|NCT01701258|100616319|FG001|NOT COMPLETED|EEG (Session 4)||0||
48118669|NCT01701258|100616320|FG002|NOT COMPLETED|EEG (Session 4)||0||
48118670|NCT01701258|100616321|FG003|NOT COMPLETED|EEG (Session 4)||0||
48118671|NCT01701258|100616322|FG004|NOT COMPLETED|EEG (Session 4)||0||
48118672|NCT01701258|100616323|FG005|NOT COMPLETED|EEG (Session 4)||0||
48118673|NCT01701258|100616324|FG006|NOT COMPLETED|EEG (Session 4)||0||
48118674|NCT01701258|100616325|FG007|NOT COMPLETED|EEG (Session 4)||0||
48118675|NCT01701258|100616326|FG008|NOT COMPLETED|EEG (Session 4)||0||
48118676|NCT01701258|100616327|FG009|NOT COMPLETED|EEG (Session 4)||0||
48118677|NCT01701258|100616328|FG010|NOT COMPLETED|EEG (Session 4)||0||
48118678|NCT01701258|100616329|FG011|NOT COMPLETED|EEG (Session 4)||0||
48118679|NCT01701258|100616330|FG012|NOT COMPLETED|EEG (Session 4)||0||
48118680|NCT02649972|100616331|FG000|STARTED|Overall Study||35||
48118681|NCT02649972|100616331|FG000|COMPLETED|Overall Study||34||
48118682|NCT02649972|100616331|FG000|NOT COMPLETED|Overall Study||1||
48118683|NCT00813124|100616332|FG000|STARTED|Overall Study||24||
48118684|NCT00813124|100616332|FG000|COMPLETED|Overall Study||12||
48118685|NCT00813124|100616332|FG000|NOT COMPLETED|Overall Study||12||
48118686|NCT04085523|100616333|FG000|STARTED|Double-Blind Period (Weeks 0 to 52)||10||
48118687|NCT04085523|100616334|FG001|STARTED|Double-Blind Period (Weeks 0 to 52)||11||
48118688|NCT04085523|100616335|FG002|STARTED|Double-Blind Period (Weeks 0 to 52)||10||
48118689|NCT04085523|100616336|FG003|STARTED|Double-Blind Period (Weeks 0 to 52)||11||
48118690|NCT04085523|100616337|FG004|STARTED|Double-Blind Period (Weeks 0 to 52)||15||
48118691|NCT04085523|100616338|FG005|STARTED|Double-Blind Period (Weeks 0 to 52)||0||
48118692|NCT04085523|100616333|FG000|COMPLETED|Double-Blind Period (Weeks 0 to 52)||10||
48118693|NCT04085523|100616334|FG001|COMPLETED|Double-Blind Period (Weeks 0 to 52)||11||
48118694|NCT04085523|100616335|FG002|COMPLETED|Double-Blind Period (Weeks 0 to 52)||10||
48118695|NCT04085523|100616336|FG003|COMPLETED|Double-Blind Period (Weeks 0 to 52)||11||
48118696|NCT04085523|100616337|FG004|COMPLETED|Double-Blind Period (Weeks 0 to 52)||15||
48118697|NCT04085523|100616338|FG005|COMPLETED|Double-Blind Period (Weeks 0 to 52)||0||
48118698|NCT04085523|100616333|FG000|NOT COMPLETED|Double-Blind Period (Weeks 0 to 52)||0||
48118699|NCT04085523|100616334|FG001|NOT COMPLETED|Double-Blind Period (Weeks 0 to 52)||0||
48118700|NCT04085523|100616335|FG002|NOT COMPLETED|Double-Blind Period (Weeks 0 to 52)||0||
48118701|NCT04085523|100616336|FG003|NOT COMPLETED|Double-Blind Period (Weeks 0 to 52)||0||
48118702|NCT04085523|100616337|FG004|NOT COMPLETED|Double-Blind Period (Weeks 0 to 52)||0||
48698344|NCT01529515|102045607|FG001|COMPLETED|MAINTENANCE PHASE||305||
48698345|NCT01529515|102045608|FG002|COMPLETED|MAINTENANCE PHASE||0||
48698346|NCT01529515|102045609|FG003|COMPLETED|MAINTENANCE PHASE||0||
48698347|NCT01529515|102045606|FG000|NOT COMPLETED|MAINTENANCE PHASE||0||
48698348|NCT01529515|102045607|FG001|NOT COMPLETED|MAINTENANCE PHASE||74||
48698349|NCT01529515|102045608|FG002|NOT COMPLETED|MAINTENANCE PHASE||0||
48118703|NCT04085523|100616338|FG005|NOT COMPLETED|Double-Blind Period (Weeks 0 to 52)||0||
48118704|NCT04085523|100616333|FG000|STARTED|Open-Label Period (Weeks 52 to 156)||0||
48118705|NCT04085523|100616334|FG001|STARTED|Open-Label Period (Weeks 52 to 156)||0||
48279996|NCT00490724|101010399|FG001|NOT COMPLETED|Period I||0||
48118706|NCT04085523|100616335|FG002|STARTED|Open-Label Period (Weeks 52 to 156)||0||
48118707|NCT04085523|100616336|FG003|STARTED|Open-Label Period (Weeks 52 to 156)||0||
48118708|NCT04085523|100616337|FG004|STARTED|Open-Label Period (Weeks 52 to 156)||0||
48118709|NCT04085523|100616338|FG005|STARTED|Open-Label Period (Weeks 52 to 156)||57||
48118710|NCT04085523|100616333|FG000|COMPLETED|Open-Label Period (Weeks 52 to 156)||0||
48118711|NCT04085523|100616334|FG001|COMPLETED|Open-Label Period (Weeks 52 to 156)||0||
48118712|NCT04085523|100616335|FG002|COMPLETED|Open-Label Period (Weeks 52 to 156)||0||
48118713|NCT04085523|100616336|FG003|COMPLETED|Open-Label Period (Weeks 52 to 156)||0||
48118714|NCT04085523|100616337|FG004|COMPLETED|Open-Label Period (Weeks 52 to 156)||0||
48118715|NCT04085523|100616338|FG005|COMPLETED|Open-Label Period (Weeks 52 to 156)||0||
48118716|NCT04085523|100616333|FG000|NOT COMPLETED|Open-Label Period (Weeks 52 to 156)||0||
48118717|NCT04085523|100616334|FG001|NOT COMPLETED|Open-Label Period (Weeks 52 to 156)||0||
48118718|NCT04085523|100616335|FG002|NOT COMPLETED|Open-Label Period (Weeks 52 to 156)||0||
48118719|NCT04085523|100616336|FG003|NOT COMPLETED|Open-Label Period (Weeks 52 to 156)||0||
48118720|NCT04085523|100616337|FG004|NOT COMPLETED|Open-Label Period (Weeks 52 to 156)||0||
48118721|NCT04085523|100616338|FG005|NOT COMPLETED|Open-Label Period (Weeks 52 to 156)||57||
48118722|NCT00428610|100616339|FG000|STARTED|Overall Study||53||
48118723|NCT00428610|100616340|FG001|STARTED|Overall Study||18||
48118724|NCT00428610|100616341|FG002|STARTED|Overall Study||32||
48118725|NCT00428610|100616339|FG000|Received at Least One Dose of Study Drug|Overall Study||53||
48118726|NCT00428610|100616340|FG001|Received at Least One Dose of Study Drug|Overall Study||18||
48118727|NCT00428610|100616341|FG002|Received at Least One Dose of Study Drug|Overall Study||32||
48118728|NCT00428610|100616339|FG000|COMPLETED|Overall Study||0||
48118729|NCT00428610|100616340|FG001|COMPLETED|Overall Study||0||
48118730|NCT00428610|100616341|FG002|COMPLETED|Overall Study||0||
48118731|NCT00428610|100616339|FG000|NOT COMPLETED|Overall Study||53||
48118732|NCT00428610|100616340|FG001|NOT COMPLETED|Overall Study||18||
48118733|NCT00428610|100616341|FG002|NOT COMPLETED|Overall Study||32||
48118734|NCT02100072|100616342|FG000|STARTED|Overall Study||5||
48118735|NCT02100072|100616342|FG000|COMPLETED|Overall Study||5||
48118736|NCT02100072|100616342|FG000|NOT COMPLETED|Overall Study||0||
48118737|NCT01891734|100616343|FG000|STARTED|Overall Study||17||
48118738|NCT01891734|100616344|FG001|STARTED|Overall Study||16||
48118739|NCT01891734|100616343|FG000|COMPLETED|Overall Study||14||
48118740|NCT01891734|100616344|FG001|COMPLETED|Overall Study||13||
48118741|NCT01891734|100616343|FG000|NOT COMPLETED|Overall Study||3||
48118742|NCT01891734|100616344|FG001|NOT COMPLETED|Overall Study||3||
48118743|NCT02082717|100616345|FG000|STARTED|Overall Study||8||
48118744|NCT02082717|100616346|FG001|STARTED|Overall Study||9||
48118745|NCT02082717|100616345|FG000|COMPLETED|Overall Study||8||
48118746|NCT02082717|100616346|FG001|COMPLETED|Overall Study||9||
48118747|NCT02082717|100616345|FG000|NOT COMPLETED|Overall Study||0||
48566088|NCT04630002|101717388|FG000|NOT COMPLETED|Cohort1:Treatment Period2(Days 12 to 21)||2||
48118748|NCT02082717|100616346|FG001|NOT COMPLETED|Overall Study||0||
48118749|NCT01438541|100616347|FG000|STARTED|Overall Study||29||
48118750|NCT01438541|100616347|FG000|COMPLETED|Overall Study||22||
48118751|NCT01438541|100616347|FG000|NOT COMPLETED|Overall Study||7||
48118752|NCT01158924|100616348|FG000|STARTED|Overall Study||14||
48118753|NCT01158924|100616349|FG001|STARTED|Overall Study||26||
48118754|NCT01158924|100616348|FG000|COMPLETED|Overall Study||13||
48118755|NCT01158924|100616349|FG001|COMPLETED|Overall Study||23||
48118756|NCT01158924|100616348|FG000|NOT COMPLETED|Overall Study||1||
48118757|NCT01158924|100616349|FG001|NOT COMPLETED|Overall Study||3||
48118758|NCT03358576|100616350|FG000|STARTED|Overall Study||338||
48118759|NCT03358576|100616351|FG001|STARTED|Overall Study||336||
48118760|NCT03358576|100616350|FG000|COMPLETED|Overall Study||312||
48118761|NCT03358576|100616351|FG001|COMPLETED|Overall Study||311||
48118762|NCT03358576|100616350|FG000|NOT COMPLETED|Overall Study||26||
48118763|NCT03358576|100616351|FG001|NOT COMPLETED|Overall Study||25||
48118764|NCT02583256|100616352|FG000|STARTED|Overall Study||403||
48118765|NCT02583256|100616353|FG001|STARTED|Overall Study||403||
48118766|NCT02583256|100616354|FG002|STARTED|Overall Study||402||
48118767|NCT02583256|100616355|FG003|STARTED|Overall Study||393||
48118768|NCT02583256|100616352|FG000|Exposed|Overall Study||403||
48118769|NCT02583256|100616353|FG001|Exposed|Overall Study||403||
48118770|NCT02583256|100616354|FG002|Exposed|Overall Study||402||
48118771|NCT02583256|100616355|FG003|Exposed|Overall Study||393||
48118772|NCT02583256|100616352|FG000|COMPLETED|Overall Study||400||
48118773|NCT02583256|100616353|FG001|COMPLETED|Overall Study||401||
48118774|NCT02583256|100616354|FG002|COMPLETED|Overall Study||400||
48118775|NCT02583256|100616355|FG003|COMPLETED|Overall Study||390||
48118776|NCT02583256|100616352|FG000|NOT COMPLETED|Overall Study||3||
48118777|NCT02583256|100616353|FG001|NOT COMPLETED|Overall Study||2||
48118778|NCT02583256|100616354|FG002|NOT COMPLETED|Overall Study||2||
48118779|NCT02583256|100616355|FG003|NOT COMPLETED|Overall Study||3||
48118780|NCT02805647|100616356|FG000|STARTED|Overall Study||100||
48118781|NCT02805647|100616357|FG001|STARTED|Overall Study||122||
48118782|NCT02805647|100616356|FG000|COMPLETED|Overall Study||100||
48118783|NCT02805647|100616357|FG001|COMPLETED|Overall Study||122||
48118784|NCT02805647|100616356|FG000|NOT COMPLETED|Overall Study||0||
48118785|NCT02805647|100616357|FG001|NOT COMPLETED|Overall Study||0||
48118786|NCT01000051|100616358|FG000|STARTED|Overall Study||42||
48118787|NCT01000051|100616359|FG001|STARTED|Overall Study||18||
48118788|NCT01000051|100616358|FG000|COMPLETED|Overall Study||39||
48118789|NCT01000051|100616359|FG001|COMPLETED|Overall Study||17||
48118790|NCT01000051|100616358|FG000|NOT COMPLETED|Overall Study||3||
48118791|NCT01000051|100616359|FG001|NOT COMPLETED|Overall Study||1||
48118792|NCT00546715|100616360|FG000|STARTED|Overall Study||6||
48118793|NCT00546715|100616361|FG001|STARTED|Overall Study||5||
48566089|NCT04630002|101717389|FG001|NOT COMPLETED|Cohort1:Treatment Period2(Days 12 to 21)||0||
48566090|NCT04630002|101717390|FG002|NOT COMPLETED|Cohort1:Treatment Period2(Days 12 to 21)||0||
48566091|NCT04630002|101717388|FG000|STARTED|Cohort1:Treatment Period3(Days 22 to 31)||17||
48118794|NCT00546715|100616362|FG002|STARTED|Overall Study||5||
48118795|NCT00546715|100616363|FG003|STARTED|Overall Study||2||
48118796|NCT00546715|100616360|FG000|COMPLETED|Overall Study||6||
48118797|NCT00546715|100616361|FG001|COMPLETED|Overall Study||4||
48118798|NCT00546715|100616362|FG002|COMPLETED|Overall Study||5||
48118799|NCT00546715|100616363|FG003|COMPLETED|Overall Study||2||
48118800|NCT00546715|100616360|FG000|NOT COMPLETED|Overall Study||0||
48118801|NCT00546715|100616361|FG001|NOT COMPLETED|Overall Study||1||
48118802|NCT00546715|100616362|FG002|NOT COMPLETED|Overall Study||0||
48118803|NCT00546715|100616363|FG003|NOT COMPLETED|Overall Study||0||
48118804|NCT03237234|100616364|FG000|STARTED|Overall Study||14||
48118805|NCT03237234|100616365|FG001|STARTED|Overall Study||11||
48118806|NCT03237234|100616364|FG000|COMPLETED|Overall Study||14||
48118807|NCT03237234|100616365|FG001|COMPLETED|Overall Study||11||
48118808|NCT03237234|100616364|FG000|NOT COMPLETED|Overall Study||0||
48118809|NCT03237234|100616365|FG001|NOT COMPLETED|Overall Study||0||
48118810|NCT01687166|100616366|FG000|STARTED|Overall Study||167||
48118811|NCT01687166|100616367|FG001|STARTED|Overall Study||172||
48118812|NCT01687166|100616368|FG002|STARTED|Overall Study||56||
48118813|NCT01687166|100616369|FG003|STARTED|Overall Study||3||
48118814|NCT01687166|100616366|FG000|COMPLETED|Overall Study||139||
48118815|NCT01687166|100616367|FG001|COMPLETED|Overall Study||145||
48118816|NCT01687166|100616368|FG002|COMPLETED|Overall Study||42||
48118817|NCT01687166|100616369|FG003|COMPLETED|Overall Study||1||
48118818|NCT01687166|100616366|FG000|NOT COMPLETED|Overall Study||28||
48118819|NCT01687166|100616367|FG001|NOT COMPLETED|Overall Study||27||
48118820|NCT01687166|100616368|FG002|NOT COMPLETED|Overall Study||14||
48118821|NCT01687166|100616369|FG003|NOT COMPLETED|Overall Study||2||
48118822|NCT00057746|100616370|FG000|STARTED|Overall Study||131||
48118823|NCT00057746|100616371|FG001|STARTED|Overall Study||67||
48118824|NCT00057746|100616372|FG002|STARTED|Overall Study||67||
48118825|NCT00057746|100616370|FG000|COMPLETED|Overall Study||131||
48118826|NCT00057746|100616371|FG001|COMPLETED|Overall Study||67||
48118827|NCT00057746|100616372|FG002|COMPLETED|Overall Study||66||
48118828|NCT00057746|100616370|FG000|NOT COMPLETED|Overall Study||0||
48279997|NCT00490724|101010400|FG002|NOT COMPLETED|Period I||1||
48279998|NCT00490724|101010398|FG000|STARTED|Period II||21||
48279999|NCT00490724|101010399|FG001|STARTED|Period II||20||
48280000|NCT00490724|101010400|FG002|STARTED|Period II||19||
48280001|NCT00490724|101010398|FG000|COMPLETED|Period II||18||
48566092|NCT04630002|101717389|FG001|STARTED|Cohort1:Treatment Period3(Days 22 to 31)||0||
48566093|NCT04630002|101717390|FG002|STARTED|Cohort1:Treatment Period3(Days 22 to 31)||0||
48566094|NCT04630002|101717388|FG000|COMPLETED|Cohort1:Treatment Period3(Days 22 to 31)||15||
48566095|NCT04630002|101717389|FG001|COMPLETED|Cohort1:Treatment Period3(Days 22 to 31)||0||
48566096|NCT04630002|101717390|FG002|COMPLETED|Cohort1:Treatment Period3(Days 22 to 31)||0||
48566097|NCT04630002|101717388|FG000|NOT COMPLETED|Cohort1:Treatment Period3(Days 22 to 31)||2||
48118829|NCT00057746|100616371|FG001|NOT COMPLETED|Overall Study||0||
48118830|NCT00057746|100616372|FG002|NOT COMPLETED|Overall Study||1||
48118831|NCT01560624|100616373|FG000|STARTED|Overall Study||346||
48118832|NCT01560624|100616374|FG001|STARTED|Overall Study||344||
48280002|NCT00490724|101010399|FG001|COMPLETED|Period II||19||
48280003|NCT00490724|101010400|FG002|COMPLETED|Period II||16||
48566098|NCT04630002|101717389|FG001|NOT COMPLETED|Cohort1:Treatment Period3(Days 22 to 31)||0||
48566099|NCT04630002|101717390|FG002|NOT COMPLETED|Cohort1:Treatment Period3(Days 22 to 31)||0||
48566100|NCT04630002|101717388|FG000|STARTED|Cohort 2:Treatment Period 1(Days 1 to 7)||0||
48566101|NCT04630002|101717389|FG001|STARTED|Cohort 2:Treatment Period 1(Days 1 to 7)||19||
48566102|NCT04630002|101717390|FG002|STARTED|Cohort 2:Treatment Period 1(Days 1 to 7)||0||
48566103|NCT04630002|101717388|FG000|COMPLETED|Cohort 2:Treatment Period 1(Days 1 to 7)||0||
48566104|NCT04630002|101717389|FG001|COMPLETED|Cohort 2:Treatment Period 1(Days 1 to 7)||19||
48118833|NCT01560624|100616373|FG000|Clinical Worsening Event|Overall Study||91|Including death|
48118834|NCT01560624|100616374|FG001|Clinical Worsening Event|Overall Study||133|Including death|
48141427|NCT01780922|100670426|FG003|STARTED|First Intervention (1 Day)||2||
48118835|NCT01560624|100616373|FG000|Early Discontinuation From Treatment|Overall Study||107|Due to progressive disease, AE, withdrawal by subject, protocol violation, lost to follow-up|
48118836|NCT01560624|100616374|FG001|Early Discontinuation From Treatment|Overall Study||56|Due to progressive disease, AE, withdrawal by subject, protocol violation, lost to follow-up|
48118837|NCT01560624|100616373|FG000|COMPLETED|Overall Study||148|Completed the study without clinical worsening or early discontinuation|
48118838|NCT01560624|100616374|FG001|COMPLETED|Overall Study||155|Completed the study without clinical worsening or early discontinuation|
48118839|NCT01560624|100616373|FG000|NOT COMPLETED|Overall Study||198||
48118840|NCT01560624|100616374|FG001|NOT COMPLETED|Overall Study||189||
48118841|NCT01736566|100616375|FG000|STARTED|Main Study||51||
48118842|NCT01736566|100616376|FG001|STARTED|Main Study||50||
48280004|NCT00490724|101010398|FG000|NOT COMPLETED|Period II||3||
48280005|NCT00490724|101010399|FG001|NOT COMPLETED|Period II||1||
48280006|NCT00490724|101010400|FG002|NOT COMPLETED|Period II||3||
48280007|NCT00955253|101010401|FG000|STARTED|First Intervention (Day 2)||7||
48280008|NCT00955253|101010402|FG001|STARTED|First Intervention (Day 2)||6||
48280009|NCT00955253|101010401|FG000|COMPLETED|First Intervention (Day 2)||7||
48118843|NCT01736566|100616377|FG002|STARTED|Main Study||50||
48118844|NCT01736566|100616378|FG003|STARTED|Main Study||52||
48118845|NCT01736566|100616379|FG004|STARTED|Main Study||10||
48118846|NCT01736566|100616375|FG000|COMPLETED|Main Study||50||
48118847|NCT01736566|100616376|FG001|COMPLETED|Main Study||50||
48118848|NCT01736566|100616377|FG002|COMPLETED|Main Study||49||
48118849|NCT01736566|100616378|FG003|COMPLETED|Main Study||51||
48118850|NCT01736566|100616379|FG004|COMPLETED|Main Study||6||
48118851|NCT01736566|100616375|FG000|NOT COMPLETED|Main Study||1||
48118852|NCT01736566|100616376|FG001|NOT COMPLETED|Main Study||0||
48118853|NCT01736566|100616377|FG002|NOT COMPLETED|Main Study||1||
48118854|NCT01736566|100616378|FG003|NOT COMPLETED|Main Study||1||
48118855|NCT01736566|100616379|FG004|NOT COMPLETED|Main Study||4||
48118856|NCT01736566|100616375|FG000|STARTED|Long Term Follow-up||26||
48118857|NCT01736566|100616376|FG001|STARTED|Long Term Follow-up||16||
48118858|NCT01736566|100616377|FG002|STARTED|Long Term Follow-up||25||
48280010|NCT00955253|101010402|FG001|COMPLETED|First Intervention (Day 2)||6||
48280011|NCT00955253|101010401|FG000|NOT COMPLETED|First Intervention (Day 2)||0||
48280012|NCT00955253|101010402|FG001|NOT COMPLETED|First Intervention (Day 2)||0||
48280013|NCT00955253|101010401|FG000|STARTED|Second Intervention (Day 4)||7||
48280014|NCT00955253|101010402|FG001|STARTED|Second Intervention (Day 4)||6||
48280015|NCT00955253|101010401|FG000|COMPLETED|Second Intervention (Day 4)||7||
48280016|NCT00955253|101010402|FG001|COMPLETED|Second Intervention (Day 4)||6||
48280017|NCT00955253|101010401|FG000|NOT COMPLETED|Second Intervention (Day 4)||0||
48280018|NCT00955253|101010402|FG001|NOT COMPLETED|Second Intervention (Day 4)||0||
48280019|NCT00831129|101010403|FG000|STARTED|Overall Study||20||
48280020|NCT00831129|101010404|FG001|STARTED|Overall Study||33||
48280021|NCT00831129|101010403|FG000|COMPLETED|Overall Study||20||
48280022|NCT00831129|101010404|FG001|COMPLETED|Overall Study||23||
48280023|NCT00831129|101010403|FG000|NOT COMPLETED|Overall Study||0||
48280024|NCT00831129|101010404|FG001|NOT COMPLETED|Overall Study||10||
48280025|NCT05187364|101010405|FG000|STARTED|Overall Study||4||
48280026|NCT05187364|101010405|FG000|COMPLETED|Overall Study||1||
48280027|NCT05187364|101010405|FG000|NOT COMPLETED|Overall Study||3||
48280028|NCT02595073|101010406|FG000|STARTED|Overall Study||61||
48280029|NCT02595073|101010407|FG001|STARTED|Overall Study||63||
48280030|NCT02595073|101010406|FG000|COMPLETED|Overall Study||59||
48280031|NCT02595073|101010407|FG001|COMPLETED|Overall Study||62||
48280032|NCT02595073|101010406|FG000|NOT COMPLETED|Overall Study||2||
48280033|NCT02595073|101010407|FG001|NOT COMPLETED|Overall Study||1||
48280034|NCT04587752|101010408|FG000|STARTED|Overall Study||28||
48280035|NCT04587752|101010408|FG000|COMPLETED|Overall Study||21||
48280036|NCT04587752|101010408|FG000|NOT COMPLETED|Overall Study||7||
48566105|NCT04630002|101717390|FG002|COMPLETED|Cohort 2:Treatment Period 1(Days 1 to 7)||0||
48566106|NCT04630002|101717388|FG000|NOT COMPLETED|Cohort 2:Treatment Period 1(Days 1 to 7)||0||
48566107|NCT04630002|101717389|FG001|NOT COMPLETED|Cohort 2:Treatment Period 1(Days 1 to 7)||0||
48566108|NCT04630002|101717390|FG002|NOT COMPLETED|Cohort 2:Treatment Period 1(Days 1 to 7)||0||
48118859|NCT01736566|100616378|FG003|STARTED|Long Term Follow-up||25||
48280037|NCT00924118|101010409|FG000|STARTED|Overall Study||15||
48280038|NCT00924118|101010410|FG001|STARTED|Overall Study||15||
48280039|NCT00924118|101010409|FG000|COMPLETED|Overall Study||15||
48280040|NCT00924118|101010410|FG001|COMPLETED|Overall Study||15||
48280041|NCT00924118|101010409|FG000|NOT COMPLETED|Overall Study||0||
48280042|NCT00924118|101010410|FG001|NOT COMPLETED|Overall Study||0||
48280043|NCT02233543|101010411|FG000|STARTED|Period 1||22||
48280044|NCT02233543|101010412|FG001|STARTED|Period 1||16||
48280045|NCT02233543|101010411|FG000|COMPLETED|Period 1||19||
48280046|NCT02233543|101010412|FG001|COMPLETED|Period 1||13||
48566109|NCT04630002|101717388|FG000|STARTED|Cohort 2: Washout Period (Days 8 to 11)||0||
48566110|NCT04630002|101717389|FG001|STARTED|Cohort 2: Washout Period (Days 8 to 11)||19||
48566111|NCT04630002|101717390|FG002|STARTED|Cohort 2: Washout Period (Days 8 to 11)||0||
48280047|NCT02233543|101010411|FG000|NOT COMPLETED|Period 1||3||
48280048|NCT02233543|101010412|FG001|NOT COMPLETED|Period 1||3||
48280049|NCT02233543|101010411|FG000|STARTED|Period 2||19||
48280050|NCT02233543|101010412|FG001|STARTED|Period 2||13||
48118860|NCT01736566|100616379|FG004|STARTED|Long Term Follow-up||4||
48118861|NCT01736566|100616375|FG000|COMPLETED|Long Term Follow-up||26||
48118862|NCT01736566|100616376|FG001|COMPLETED|Long Term Follow-up||16||
48280051|NCT02233543|101010411|FG000|COMPLETED|Period 2||17||
48280052|NCT02233543|101010412|FG001|COMPLETED|Period 2||12||
48118863|NCT01736566|100616377|FG002|COMPLETED|Long Term Follow-up||25||
48118864|NCT01736566|100616378|FG003|COMPLETED|Long Term Follow-up||25||
48118865|NCT01736566|100616379|FG004|COMPLETED|Long Term Follow-up||4||
48118866|NCT01736566|100616375|FG000|NOT COMPLETED|Long Term Follow-up||0||
48118867|NCT01736566|100616376|FG001|NOT COMPLETED|Long Term Follow-up||0||
48118868|NCT01736566|100616377|FG002|NOT COMPLETED|Long Term Follow-up||0||
48118869|NCT01736566|100616378|FG003|NOT COMPLETED|Long Term Follow-up||0||
48118870|NCT01736566|100616379|FG004|NOT COMPLETED|Long Term Follow-up||0||
48118871|NCT02821104|100616380|FG000|STARTED|Overall Study||77||
48118872|NCT02821104|100616380|FG000|COMPLETED|Overall Study||77||
48118873|NCT02821104|100616380|FG000|NOT COMPLETED|Overall Study||0||
48118874|NCT00933491|100616381|FG000|STARTED|Overall Study||14||
48118875|NCT00933491|100616382|FG001|STARTED|Overall Study||18||
48118876|NCT00933491|100616381|FG000|COMPLETED|Overall Study||14||
48118877|NCT00933491|100616382|FG001|COMPLETED|Overall Study||18||
48118878|NCT00933491|100616381|FG000|NOT COMPLETED|Overall Study||0||
48118879|NCT00933491|100616382|FG001|NOT COMPLETED|Overall Study||0||
48118880|NCT03759223|100616383|FG000|STARTED|Overall Study||19||
48118881|NCT03759223|100616384|FG001|STARTED|Overall Study||19||
48118882|NCT03759223|100616385|FG002|STARTED|Overall Study||12||
48118883|NCT03759223|100616383|FG000|COMPLETED|Overall Study||16||
48118884|NCT03759223|100616384|FG001|COMPLETED|Overall Study||14||
48118885|NCT03759223|100616385|FG002|COMPLETED|Overall Study||7||
48118886|NCT03759223|100616383|FG000|NOT COMPLETED|Overall Study||3||
48118887|NCT03759223|100616384|FG001|NOT COMPLETED|Overall Study||5||
48118888|NCT03759223|100616385|FG002|NOT COMPLETED|Overall Study||5||
48118889|NCT01174030|100616386|FG000|STARTED|Overall Study||53||
48118890|NCT01174030|100616387|FG001|STARTED|Overall Study||54||
48118891|NCT01174030|100616388|FG002|STARTED|Overall Study||54||
48118892|NCT01174030|100616389|FG003|STARTED|Overall Study||55||
48118893|NCT01174030|100616390|FG004|STARTED|Overall Study||53||
48118894|NCT01174030|100616386|FG000|COMPLETED|Overall Study||51||
48118895|NCT01174030|100616387|FG001|COMPLETED|Overall Study||52||
48118896|NCT01174030|100616388|FG002|COMPLETED|Overall Study||52||
48118897|NCT01174030|100616389|FG003|COMPLETED|Overall Study||53||
48118898|NCT01174030|100616390|FG004|COMPLETED|Overall Study||52||
48118899|NCT01174030|100616386|FG000|NOT COMPLETED|Overall Study||2||
48118900|NCT01174030|100616387|FG001|NOT COMPLETED|Overall Study||2||
48118901|NCT01174030|100616388|FG002|NOT COMPLETED|Overall Study||2||
48118902|NCT01174030|100616389|FG003|NOT COMPLETED|Overall Study||2||
48118903|NCT01174030|100616390|FG004|NOT COMPLETED|Overall Study||1||
48118904|NCT00958880|100616391|FG000|STARTED|Overall Study||20||
48118905|NCT00958880|100616392|FG001|STARTED|Overall Study||20||
48118906|NCT00958880|100616391|FG000|COMPLETED|Overall Study||18||
48118907|NCT00958880|100616392|FG001|COMPLETED|Overall Study||18||
48118908|NCT00958880|100616391|FG000|NOT COMPLETED|Overall Study||2||
48118909|NCT00958880|100616392|FG001|NOT COMPLETED|Overall Study||2||
48118910|NCT02262728|100616393|FG000|STARTED|Treatment Period (12 Weeks)||19||
48280053|NCT02233543|101010411|FG000|NOT COMPLETED|Period 2||2||
48280054|NCT02233543|101010412|FG001|NOT COMPLETED|Period 2||1||
48118911|NCT02262728|100616394|FG001|STARTED|Treatment Period (12 Weeks)||21||
48118912|NCT02262728|100616393|FG000|COMPLETED|Treatment Period (12 Weeks)||19||
48118913|NCT02262728|100616394|FG001|COMPLETED|Treatment Period (12 Weeks)||21||
48118914|NCT02262728|100616393|FG000|NOT COMPLETED|Treatment Period (12 Weeks)||0||
48118915|NCT02262728|100616394|FG001|NOT COMPLETED|Treatment Period (12 Weeks)||0||
48118916|NCT02262728|100616393|FG000|STARTED|Follow-up Phase (3 Years)||19||
48118917|NCT02262728|100616394|FG001|STARTED|Follow-up Phase (3 Years)||21||
48280055|NCT03339583|101010413|FG000|STARTED|First Intervention (14 Days)||19||
48280056|NCT03339583|101010414|FG001|STARTED|First Intervention (14 Days)||23||
48280057|NCT03339583|101010413|FG000|COMPLETED|First Intervention (14 Days)||18||
48280058|NCT03339583|101010414|FG001|COMPLETED|First Intervention (14 Days)||23||
48280059|NCT03339583|101010413|FG000|NOT COMPLETED|First Intervention (14 Days)||1||
48280060|NCT03339583|101010414|FG001|NOT COMPLETED|First Intervention (14 Days)||0||
48566112|NCT04630002|101717388|FG000|COMPLETED|Cohort 2: Washout Period (Days 8 to 11)||0||
48566113|NCT04630002|101717389|FG001|COMPLETED|Cohort 2: Washout Period (Days 8 to 11)||19||
48566114|NCT04630002|101717390|FG002|COMPLETED|Cohort 2: Washout Period (Days 8 to 11)||0||
48566115|NCT04630002|101717388|FG000|NOT COMPLETED|Cohort 2: Washout Period (Days 8 to 11)||0||
48698350|NCT01529515|102045609|FG003|NOT COMPLETED|MAINTENANCE PHASE||0||
48698351|NCT01529515|102045606|FG000|STARTED|DOUBLE BLIND PHASE||0||
48698352|NCT01529515|102045607|FG001|STARTED|DOUBLE BLIND PHASE||0||
48698353|NCT01529515|102045608|FG002|STARTED|DOUBLE BLIND PHASE||145||
48698354|NCT01529515|102045609|FG003|STARTED|DOUBLE BLIND PHASE||160||
48698355|NCT01529515|102045606|FG000|COMPLETED|DOUBLE BLIND PHASE||0||
48698356|NCT01529515|102045607|FG001|COMPLETED|DOUBLE BLIND PHASE||0||
48698357|NCT01529515|102045608|FG002|COMPLETED|DOUBLE BLIND PHASE||122||
48698358|NCT01529515|102045609|FG003|COMPLETED|DOUBLE BLIND PHASE||148||
48698359|NCT01529515|102045606|FG000|NOT COMPLETED|DOUBLE BLIND PHASE||0||
48698360|NCT01529515|102045607|FG001|NOT COMPLETED|DOUBLE BLIND PHASE||0||
48698361|NCT01529515|102045608|FG002|NOT COMPLETED|DOUBLE BLIND PHASE||23||
48698362|NCT01529515|102045609|FG003|NOT COMPLETED|DOUBLE BLIND PHASE||12||
48698363|NCT00327015|102045610|FG000|STARTED|Overall Study||320||
48698364|NCT00327015|102045611|FG001|STARTED|Overall Study||323||
48280061|NCT03339583|101010413|FG000|STARTED|Washout (14 Days)||18||
48280062|NCT03339583|101010414|FG001|STARTED|Washout (14 Days)||23||
48280063|NCT03339583|101010413|FG000|COMPLETED|Washout (14 Days)||18||
48280064|NCT03339583|101010414|FG001|COMPLETED|Washout (14 Days)||23||
48280065|NCT03339583|101010413|FG000|NOT COMPLETED|Washout (14 Days)||0||
48280066|NCT03339583|101010414|FG001|NOT COMPLETED|Washout (14 Days)||0||
48280067|NCT03339583|101010413|FG000|STARTED|Second Intervention (14 Days)||18||
48280068|NCT03339583|101010414|FG001|STARTED|Second Intervention (14 Days)||23||
48280069|NCT03339583|101010413|FG000|COMPLETED|Second Intervention (14 Days)||18||
48280070|NCT03339583|101010414|FG001|COMPLETED|Second Intervention (14 Days)||21||
48280071|NCT03339583|101010413|FG000|NOT COMPLETED|Second Intervention (14 Days)||0||
48280072|NCT03339583|101010414|FG001|NOT COMPLETED|Second Intervention (14 Days)||2||
48280073|NCT03339583|101010413|FG000|STARTED|Follow-up (14 Days)||18||
48280074|NCT03339583|101010414|FG001|STARTED|Follow-up (14 Days)||21||
48280075|NCT03339583|101010413|FG000|COMPLETED|Follow-up (14 Days)||12||
48280076|NCT03339583|101010414|FG001|COMPLETED|Follow-up (14 Days)||18||
48280077|NCT03339583|101010413|FG000|NOT COMPLETED|Follow-up (14 Days)||6||
48280078|NCT03339583|101010414|FG001|NOT COMPLETED|Follow-up (14 Days)||3||
48280079|NCT02399254|101010415|FG000|STARTED|Overall Study||21||
48280080|NCT02399254|101010415|FG000|COMPLETED|Overall Study||19|Transferring activity data was an issue at all sites despite good support from the manufacturer.|
48280081|NCT02399254|101010415|FG000|NOT COMPLETED|Overall Study||2||
48280082|NCT01253304|101010416|FG000|STARTED|Overall Study||11||
48280083|NCT01253304|101010417|FG001|STARTED|Overall Study||6||
48280084|NCT01253304|101010418|FG002|STARTED|Overall Study||6||
48280085|NCT01253304|101010419|FG003|STARTED|Overall Study||3||
48280086|NCT01253304|101010416|FG000|Received at Least 1 Dose of Study Drug|Overall Study||11||
48280087|NCT01253304|101010417|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
48280088|NCT01253304|101010418|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
48280089|NCT01253304|101010419|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3||
48280090|NCT01253304|101010416|FG000|COMPLETED|Overall Study||11||
48280091|NCT01253304|101010417|FG001|COMPLETED|Overall Study||6||
48566116|NCT04630002|101717389|FG001|NOT COMPLETED|Cohort 2: Washout Period (Days 8 to 11)||0||
48698365|NCT00327015|102045612|FG002|STARTED|Overall Study||335||
48698366|NCT00327015|102045613|FG003|STARTED|Overall Study||328||
48698367|NCT00327015|102045610|FG000|Completed Study Without Being Rescued|Overall Study||179||
48280092|NCT01253304|101010418|FG002|COMPLETED|Overall Study||6||
48280093|NCT01253304|101010419|FG003|COMPLETED|Overall Study||2||
48280094|NCT01253304|101010416|FG000|NOT COMPLETED|Overall Study||0||
48280095|NCT01253304|101010417|FG001|NOT COMPLETED|Overall Study||0||
48280096|NCT01253304|101010418|FG002|NOT COMPLETED|Overall Study||0||
48280097|NCT01253304|101010419|FG003|NOT COMPLETED|Overall Study||1||
48280098|NCT02297139|101010420|FG000|STARTED|Overall Study||1||
48280099|NCT02297139|101010421|FG001|STARTED|Overall Study||16||
48280100|NCT02297139|101010420|FG000|COMPLETED|Overall Study||0||
48280101|NCT02297139|101010421|FG001|COMPLETED|Overall Study||0||
48280102|NCT02297139|101010420|FG000|NOT COMPLETED|Overall Study||1||
48280103|NCT02297139|101010421|FG001|NOT COMPLETED|Overall Study||16||
48280104|NCT02964325|101010422|FG000|STARTED|Overall Study||164||
48280105|NCT02964325|101010423|FG001|STARTED|Overall Study||166||
48280106|NCT02964325|101010422|FG000|Full Analysis Set|Overall Study||164|The Full Analysis Set (FAS) included all randomized subjects. Subjects were analyzed according to the treatment group to which they were assigned at randomization.|
48280107|NCT02964325|101010423|FG001|Full Analysis Set|Overall Study||166|The Full Analysis Set (FAS) included all randomized subjects. Subjects were analyzed according to the treatment group to which they were assigned at randomization.|
48566117|NCT04630002|101717390|FG002|NOT COMPLETED|Cohort 2: Washout Period (Days 8 to 11)||0||
48566118|NCT04630002|101717388|FG000|STARTED|Cohort2:Treatment Period2(Days 12 to 21)||0||
48566119|NCT04630002|101717389|FG001|STARTED|Cohort2:Treatment Period2(Days 12 to 21)||19||
48566120|NCT04630002|101717390|FG002|STARTED|Cohort2:Treatment Period2(Days 12 to 21)||0||
48698368|NCT00327015|102045611|FG001|Completed Study Without Being Rescued|Overall Study||177||
48280108|NCT02964325|101010422|FG000|Modified Intent-to-Treat|Overall Study||145|The Modified Intent-to-Treat (mITT) Set included all randomized subjects who underwent at least 1 study transfusion post randomization according to the treatment group (MIRASOL or CONTROL) to which they were randomized.|
48280109|NCT02964325|101010423|FG001|Modified Intent-to-Treat|Overall Study||152|The Modified Intent-to-Treat (mITT) Set included all randomized subjects who underwent at least 1 study transfusion post randomization according to the treatment group (MIRASOL or CONTROL) to which they were randomized.|
48280110|NCT02964325|101010422|FG000|Safety Set|Overall Study||141|The Safety Set (SS) included all randomized subjects who underwent at least 1 PLT transfusion post randomization, independent of the outcome or successful completion of the procedure. Subjects were analyzed according to the majority treatment (MIR PLTs or REF PLTs) received.|
48280111|NCT02964325|101010423|FG001|Safety Set|Overall Study||161|The Safety Set (SS) included all randomized subjects who underwent at least 1 PLT transfusion post randomization, independent of the outcome or successful completion of the procedure. Subjects were analyzed according to the majority treatment (MIR PLTs or REF PLTs) received.|
48280112|NCT02964325|101010422|FG000|COMPLETED|Overall Study||143||
48280113|NCT02964325|101010423|FG001|COMPLETED|Overall Study||143||
48280114|NCT02964325|101010422|FG000|NOT COMPLETED|Overall Study||21||
48280115|NCT02964325|101010423|FG001|NOT COMPLETED|Overall Study||23||
48280116|NCT01821352|101010424|FG000|STARTED|Overall Study||28||
48280117|NCT01821352|101010425|FG001|STARTED|Overall Study||25||
48280118|NCT01821352|101010424|FG000|COMPLETED|Overall Study||28||
48280119|NCT01821352|101010425|FG001|COMPLETED|Overall Study||25||
48280120|NCT01821352|101010424|FG000|NOT COMPLETED|Overall Study||0||
48280121|NCT01821352|101010425|FG001|NOT COMPLETED|Overall Study||0||
48280122|NCT00465998|101010426|FG000|STARTED|Overall Study||275||
48280123|NCT00465998|101010426|FG000|COMPLETED|Overall Study||275||
48280124|NCT00465998|101010426|FG000|NOT COMPLETED|Overall Study||0||
48280125|NCT00446043|101010427|FG000|STARTED|Overall Study||452||
48280126|NCT00446043|101010427|FG000|COMPLETED|Overall Study||327||
48280127|NCT00446043|101010427|FG000|NOT COMPLETED|Overall Study||125||
48280128|NCT02880540|101010428|FG000|STARTED|Overall Study||13||
48280129|NCT02880540|101010429|FG001|STARTED|Overall Study||13||
48280130|NCT02880540|101010428|FG000|COMPLETED|Overall Study||13||
48280131|NCT02880540|101010429|FG001|COMPLETED|Overall Study||13||
48280132|NCT02880540|101010428|FG000|NOT COMPLETED|Overall Study||0||
48280133|NCT02880540|101010429|FG001|NOT COMPLETED|Overall Study||0||
48280134|NCT02781090|101010430|FG000|STARTED|3-Month Follow-Up||255||
48280135|NCT02781090|101010431|FG001|STARTED|3-Month Follow-Up||251||
48280136|NCT02781090|101010430|FG000|COMPLETED|3-Month Follow-Up||190||
48280137|NCT02781090|101010431|FG001|COMPLETED|3-Month Follow-Up||194||
48280138|NCT02781090|101010430|FG000|NOT COMPLETED|3-Month Follow-Up||65||
48280139|NCT02781090|101010431|FG001|NOT COMPLETED|3-Month Follow-Up||57||
48280140|NCT02781090|101010430|FG000|STARTED|6-Month Follow-Up||190||
48280141|NCT02781090|101010431|FG001|STARTED|6-Month Follow-Up||194||
48280142|NCT02781090|101010430|FG000|COMPLETED|6-Month Follow-Up||169||
48280143|NCT02781090|101010431|FG001|COMPLETED|6-Month Follow-Up||169||
48280144|NCT02781090|101010430|FG000|NOT COMPLETED|6-Month Follow-Up||21||
48280145|NCT02781090|101010431|FG001|NOT COMPLETED|6-Month Follow-Up||25||
48280146|NCT01215188|101010432|FG000|STARTED|Overall Study||378||
48280147|NCT01215188|101010433|FG001|STARTED|Overall Study||386||
48280148|NCT01215188|101010434|FG002|STARTED|Overall Study||378||
48280149|NCT01215188|101010432|FG000|COMPLETED|Overall Study||320||
48280150|NCT01215188|101010433|FG001|COMPLETED|Overall Study||327||
48280151|NCT01215188|101010434|FG002|COMPLETED|Overall Study||326||
48280152|NCT01215188|101010432|FG000|NOT COMPLETED|Overall Study||58||
48280153|NCT01215188|101010433|FG001|NOT COMPLETED|Overall Study||59||
48280154|NCT01215188|101010434|FG002|NOT COMPLETED|Overall Study||52||
48280155|NCT00998790|101010435|FG000|STARTED|Overall Study||114||
48280156|NCT00998790|101010435|FG000|Participants Who Were Treated|Overall Study||113||
48280157|NCT00998790|101010435|FG000|COMPLETED|Overall Study||93||
48280158|NCT00998790|101010435|FG000|NOT COMPLETED|Overall Study||21||
48280159|NCT02766465|101010436|FG000|STARTED|Overall Study||28||
48280160|NCT02766465|101010437|FG001|STARTED|Overall Study||95||
48280161|NCT02766465|101010436|FG000|COMPLETED|Overall Study||28||
48280162|NCT02766465|101010437|FG001|COMPLETED|Overall Study||85||
48280163|NCT02766465|101010436|FG000|NOT COMPLETED|Overall Study||0||
48280164|NCT02766465|101010437|FG001|NOT COMPLETED|Overall Study||10||
48280165|NCT00151281|101010438|FG000|STARTED|Overall Study||25||
48280166|NCT00151281|101010438|FG000|COMPLETED|Overall Study||22||
48280167|NCT00151281|101010438|FG000|NOT COMPLETED|Overall Study||3||
48280168|NCT05203068|101010439|FG000|STARTED|RTA Result Assessment, 72 Hours||150||
48280169|NCT05203068|101010439|FG000|COMPLETED|RTA Result Assessment, 72 Hours||150||
48280170|NCT05203068|101010439|FG000|NOT COMPLETED|RTA Result Assessment, 72 Hours||0||
48280171|NCT05203068|101010439|FG000|STARTED|RTA Safety Assessment, 28 Days||150||
48280172|NCT05203068|101010439|FG000|COMPLETED|RTA Safety Assessment, 28 Days||150||
48280173|NCT05203068|101010439|FG000|NOT COMPLETED|RTA Safety Assessment, 28 Days||0||
48280174|NCT00673400|101010440|FG000|STARTED|Overall Study||52||
48280175|NCT00673400|101010440|FG000|COMPLETED|Overall Study||52||
48280176|NCT00673400|101010440|FG000|NOT COMPLETED|Overall Study||0||
48280177|NCT00564889|101010441|FG000|STARTED|Overall Study||35||
48280178|NCT00564889|101010441|FG000|COMPLETED|Overall Study||6||
48280179|NCT00564889|101010441|FG000|NOT COMPLETED|Overall Study||29||
48280180|NCT00715754|101010442|FG000|STARTED|Overall Study||47||
48280181|NCT00715754|101010442|FG000|COMPLETED|Overall Study||47||
48280182|NCT00715754|101010442|FG000|NOT COMPLETED|Overall Study||0||
48280183|NCT00201643|101010443|FG000|STARTED|Overall Study||223||
48280184|NCT00201643|101010444|FG001|STARTED|Overall Study||214||
48280185|NCT00201643|101010443|FG000|COMPLETED|Overall Study||218||
48280186|NCT00201643|101010444|FG001|COMPLETED|Overall Study||210||
48280187|NCT00201643|101010443|FG000|NOT COMPLETED|Overall Study||5||
48280188|NCT00201643|101010444|FG001|NOT COMPLETED|Overall Study||4||
48280189|NCT00626990|101010445|FG000|STARTED|Overall Study||189||
48280190|NCT00626990|101010446|FG001|STARTED|Overall Study||188||
48280191|NCT00626990|101010447|FG002|STARTED|Overall Study||186||
48280192|NCT00626990|101010448|FG003|STARTED|Overall Study||188||
48280193|NCT00626990|101010445|FG000|COMPLETED|Overall Study||175||
48280194|NCT00626990|101010446|FG001|COMPLETED|Overall Study||163||
48280195|NCT00626990|101010447|FG002|COMPLETED|Overall Study||109||
48280196|NCT00626990|101010448|FG003|COMPLETED|Overall Study||93||
48280197|NCT00626990|101010445|FG000|NOT COMPLETED|Overall Study||14||
48280198|NCT00626990|101010446|FG001|NOT COMPLETED|Overall Study||25||
48280199|NCT00626990|101010447|FG002|NOT COMPLETED|Overall Study||77||
48280200|NCT00626990|101010448|FG003|NOT COMPLETED|Overall Study||95||
48280201|NCT00707759|101010449|FG000|STARTED|Overall Study||14||
48280202|NCT00707759|101010450|FG001|STARTED|Overall Study||14||
48280203|NCT00707759|101010449|FG000|COMPLETED|Overall Study||12||
48280204|NCT00707759|101010450|FG001|COMPLETED|Overall Study||12||
48280205|NCT00707759|101010449|FG000|NOT COMPLETED|Overall Study||2||
48280206|NCT00707759|101010450|FG001|NOT COMPLETED|Overall Study||2||
48280207|NCT02317432|101010451|FG000|STARTED|Overall Study||153||
48280208|NCT02317432|101010452|FG001|STARTED|Overall Study||154||
48280209|NCT02317432|101010451|FG000|Completed CBT|Overall Study||118|Completed 50% or more (5 or more) Positive Minds CBT sessions, which is considered the appropriate threshold for populations not recognizing the need for services and not actively seeking treatment.|
48280210|NCT02317432|101010452|FG001|Completed CBT|Overall Study||0|Completed 50% or more (5 or more) Positive Minds CBT sessions, which is considered the appropriate threshold for populations not recognizing the need for services and not actively seeking treatment.|
48280211|NCT02317432|101010451|FG000|Completed InVEST|Overall Study||63|Completed 50% or more (18 or more) Strong Minds InVEST sessions, which is considered the appropriate threshold for populations not recognizing the need for services and not actively seeking treatment.|
48280212|NCT02317432|101010452|FG001|Completed InVEST|Overall Study||0|Completed 50% or more (18 or more) Strong Minds InVEST sessions, which is considered the appropriate threshold for populations not recognizing the need for services and not actively seeking treatment.|
48280213|NCT02317432|101010451|FG000|Completed CBT + InVEST Exercise|Overall Study||122|Completed either 50% or more Positive Minds CBT sessions or 50% or more Strong Minds InVEST sessions.|
48280214|NCT02317432|101010452|FG001|Completed CBT + InVEST Exercise|Overall Study||0|Completed either 50% or more Positive Minds CBT sessions or 50% or more Strong Minds InVEST sessions.|
48280215|NCT02317432|101010451|FG000|Completed Enhanced Usual Care|Overall Study||0||
48280216|NCT02317432|101010452|FG001|Completed Enhanced Usual Care|Overall Study||148||
48280217|NCT02317432|101010451|FG000|COMPLETED|Overall Study||122||
48280218|NCT02317432|101010452|FG001|COMPLETED|Overall Study||148||
48280219|NCT02317432|101010451|FG000|NOT COMPLETED|Overall Study||31||
48280220|NCT02317432|101010452|FG001|NOT COMPLETED|Overall Study||6||
48280221|NCT00721149|101010453|FG000|STARTED|Overall Study||10||
48280222|NCT00721149|101010453|FG000|COMPLETED|Overall Study||9||
48280223|NCT00721149|101010453|FG000|NOT COMPLETED|Overall Study||1||
48280224|NCT03284229|101010454|FG000|STARTED|Overall Study||28||
48280225|NCT03284229|101010454|FG000|COMPLETED|Overall Study||25||
48280226|NCT03284229|101010454|FG000|NOT COMPLETED|Overall Study||3||
48280227|NCT01011153|101010455|FG000|STARTED|Overall Study||54||
48280228|NCT01011153|101010456|FG001|STARTED|Overall Study||75||
48280229|NCT01011153|101010457|FG002|STARTED|Overall Study||54||
48280230|NCT01011153|101010455|FG000|COMPLETED|Overall Study||46||
48280231|NCT01011153|101010456|FG001|COMPLETED|Overall Study||64||
48280232|NCT01011153|101010457|FG002|COMPLETED|Overall Study||45||
48280233|NCT01011153|101010455|FG000|NOT COMPLETED|Overall Study||8||
48280234|NCT01011153|101010456|FG001|NOT COMPLETED|Overall Study||11||
48280235|NCT01011153|101010457|FG002|NOT COMPLETED|Overall Study||9||
48280236|NCT02008877|101010458|FG000|STARTED|Overall Study||3||
48280237|NCT02008877|101010459|FG001|STARTED|Overall Study||7||
48118918|NCT02262728|100616393|FG000|COMPLETED|Follow-up Phase (3 Years)||15||
48118919|NCT02262728|100616394|FG001|COMPLETED|Follow-up Phase (3 Years)||18||
48280238|NCT02008877|101010460|FG002|STARTED|Overall Study||10||
48280239|NCT02008877|101010458|FG000|COMPLETED|Overall Study||3||
48280240|NCT02008877|101010459|FG001|COMPLETED|Overall Study||6||
48280241|NCT02008877|101010460|FG002|COMPLETED|Overall Study||10||
48280242|NCT02008877|101010458|FG000|NOT COMPLETED|Overall Study||0||
48280243|NCT02008877|101010459|FG001|NOT COMPLETED|Overall Study||1||
48280244|NCT02008877|101010460|FG002|NOT COMPLETED|Overall Study||0||
48280245|NCT01361594|101010461|FG000|STARTED|Overall Study||152||
48280246|NCT01361594|101010462|FG001|STARTED|Overall Study||153||
48280247|NCT01361594|101010461|FG000|COMPLETED|Overall Study||151||
48280248|NCT01361594|101010462|FG001|COMPLETED|Overall Study||151||
48280249|NCT01361594|101010461|FG000|NOT COMPLETED|Overall Study||1||
48280250|NCT01361594|101010462|FG001|NOT COMPLETED|Overall Study||2||
48280251|NCT03845140|101010463|FG000|STARTED|Overall Study||100||
48280252|NCT03845140|101010464|FG001|STARTED|Overall Study||50||
48280253|NCT03845140|101010465|FG002|STARTED|Overall Study||30||
48280254|NCT03845140|101010466|FG003|STARTED|Overall Study||18||
48280255|NCT03845140|101010467|FG004|STARTED|Overall Study||30||
48280256|NCT03845140|101010468|FG005|STARTED|Overall Study||60||
48280257|NCT03845140|101010463|FG000|COMPLETED|Overall Study||100||
48280258|NCT03845140|101010464|FG001|COMPLETED|Overall Study||49||
48280259|NCT03845140|101010465|FG002|COMPLETED|Overall Study||30||
48280260|NCT03845140|101010466|FG003|COMPLETED|Overall Study||18||
48280261|NCT03845140|101010467|FG004|COMPLETED|Overall Study||30||
48280262|NCT03845140|101010468|FG005|COMPLETED|Overall Study||60||
48280263|NCT03845140|101010463|FG000|NOT COMPLETED|Overall Study||0||
48280264|NCT03845140|101010464|FG001|NOT COMPLETED|Overall Study||1||
48280265|NCT03845140|101010465|FG002|NOT COMPLETED|Overall Study||0||
48280266|NCT03845140|101010466|FG003|NOT COMPLETED|Overall Study||0||
48280267|NCT03845140|101010467|FG004|NOT COMPLETED|Overall Study||0||
48280268|NCT03845140|101010468|FG005|NOT COMPLETED|Overall Study||0||
48280269|NCT05114473|101010469|FG000|STARTED|Overall Study||18||
48280270|NCT05114473|101010470|FG001|STARTED|Overall Study||29||
48280271|NCT05114473|101010471|FG002|STARTED|Overall Study||22||
48280272|NCT05114473|101010469|FG000|COMPLETED|Overall Study||16||
48280273|NCT05114473|101010470|FG001|COMPLETED|Overall Study||27||
48280274|NCT05114473|101010471|FG002|COMPLETED|Overall Study||22||
48280275|NCT05114473|101010469|FG000|NOT COMPLETED|Overall Study||2||
48280276|NCT05114473|101010470|FG001|NOT COMPLETED|Overall Study||2||
48280277|NCT05114473|101010471|FG002|NOT COMPLETED|Overall Study||0||
48280278|NCT02677428|101010472|FG000|STARTED|Overall Study||63||
48280279|NCT02677428|101010473|FG001|STARTED|Overall Study||55||
48280280|NCT02677428|101010472|FG000|COMPLETED|Overall Study||63||
48280281|NCT02677428|101010473|FG001|COMPLETED|Overall Study||55||
48280282|NCT02677428|101010472|FG000|NOT COMPLETED|Overall Study||0||
48280283|NCT02677428|101010473|FG001|NOT COMPLETED|Overall Study||0||
48280284|NCT03140280|101010474|FG000|STARTED|Overall Study||23||
48280285|NCT03140280|101010474|FG000|COMPLETED|Overall Study||18||
48280286|NCT03140280|101010474|FG000|NOT COMPLETED|Overall Study||5||
48280287|NCT00738894|101010475|FG000|STARTED|Overall Study||441||
48280288|NCT00738894|101010476|FG001|STARTED|Overall Study||223||
48280289|NCT00738894|101010475|FG000|COMPLETED|Overall Study||402||
48280290|NCT00738894|101010476|FG001|COMPLETED|Overall Study||190||
48280291|NCT00738894|101010475|FG000|NOT COMPLETED|Overall Study||39||
48280292|NCT00738894|101010476|FG001|NOT COMPLETED|Overall Study||33||
48280293|NCT01964924|101010477|FG000|STARTED|Trametinib Monotherapy||37||
48280294|NCT01964924|101010478|FG001|STARTED|Trametinib Monotherapy||0||
48280295|NCT01964924|101010477|FG000|COMPLETED|Trametinib Monotherapy||18||
48280296|NCT01964924|101010478|FG001|COMPLETED|Trametinib Monotherapy||0||
48280297|NCT01964924|101010477|FG000|NOT COMPLETED|Trametinib Monotherapy||19||
48280298|NCT01964924|101010478|FG001|NOT COMPLETED|Trametinib Monotherapy||0||
48280299|NCT01964924|101010477|FG000|STARTED|Trametinib + GSK2141||0|Participants who completed Part 1 were not eligible for Part 2|
48280300|NCT01964924|101010478|FG001|STARTED|Trametinib + GSK2141||19|Participants who completed Part 1 were not eligible for Part 2|
48280301|NCT01964924|101010477|FG000|COMPLETED|Trametinib + GSK2141||0||
48280302|NCT01964924|101010478|FG001|COMPLETED|Trametinib + GSK2141||19||
48280303|NCT01964924|101010477|FG000|NOT COMPLETED|Trametinib + GSK2141||0||
48280304|NCT01964924|101010478|FG001|NOT COMPLETED|Trametinib + GSK2141||0||
48280305|NCT05180500|101010479|FG000|STARTED|Overall Study||33||
48280306|NCT05180500|101010480|FG001|STARTED|Overall Study||17||
48280307|NCT05180500|101010479|FG000|COMPLETED|Overall Study||30||
48280308|NCT05180500|101010480|FG001|COMPLETED|Overall Study||17||
48280309|NCT05180500|101010479|FG000|NOT COMPLETED|Overall Study||3||
48280310|NCT05180500|101010480|FG001|NOT COMPLETED|Overall Study||0||
48280311|NCT01170390|101010481|FG000|STARTED|Oral Contraceptives||32||
48280312|NCT01170390|101010482|FG001|STARTED|Oral Contraceptives||0||
48280313|NCT01170390|101010483|FG002|STARTED|Oral Contraceptives||0||
48280314|NCT01170390|101010481|FG000|COMPLETED|Oral Contraceptives||31||
48280315|NCT01170390|101010482|FG001|COMPLETED|Oral Contraceptives||0||
48280316|NCT01170390|101010483|FG002|COMPLETED|Oral Contraceptives||0||
48280317|NCT01170390|101010481|FG000|NOT COMPLETED|Oral Contraceptives||1||
48280318|NCT01170390|101010482|FG001|NOT COMPLETED|Oral Contraceptives||0||
48280319|NCT01170390|101010483|FG002|NOT COMPLETED|Oral Contraceptives||0||
48280320|NCT01170390|101010481|FG000|STARTED|Randomized Treatment||0||
48394779|NCT02501902|101296012|FG000|COMPLETED|Overall Study||0|0|
48280321|NCT01170390|101010482|FG001|STARTED|Randomized Treatment||17||
48280322|NCT01170390|101010483|FG002|STARTED|Randomized Treatment||15||
48280323|NCT01170390|101010481|FG000|COMPLETED|Randomized Treatment||0||
48280324|NCT01170390|101010482|FG001|COMPLETED|Randomized Treatment||16||
48280325|NCT01170390|101010483|FG002|COMPLETED|Randomized Treatment||15||
48280326|NCT01170390|101010481|FG000|NOT COMPLETED|Randomized Treatment||0||
48280327|NCT01170390|101010482|FG001|NOT COMPLETED|Randomized Treatment||1||
48280328|NCT01170390|101010483|FG002|NOT COMPLETED|Randomized Treatment||0||
48280329|NCT01153321|101010484|FG000|STARTED|Overall Study||22||
48280330|NCT01153321|101010485|FG001|STARTED|Overall Study||22||
48280331|NCT01153321|101010484|FG000|COMPLETED|Overall Study||21||
48280332|NCT01153321|101010485|FG001|COMPLETED|Overall Study||19||
48280333|NCT01153321|101010484|FG000|NOT COMPLETED|Overall Study||1||
48118920|NCT02262728|100616393|FG000|NOT COMPLETED|Follow-up Phase (3 Years)||4||
48118921|NCT02262728|100616394|FG001|NOT COMPLETED|Follow-up Phase (3 Years)||3||
48118922|NCT03354429|100616395|FG000|STARTED|Overall Study||5523||
48118923|NCT03354429|100616396|FG001|STARTED|Overall Study||5493||
48118924|NCT03354429|100616395|FG000|COMPLETED|Overall Study||5514||
48280334|NCT01153321|101010485|FG001|NOT COMPLETED|Overall Study||3||
48280335|NCT00225017|101010486|FG000|STARTED|Overall Study||26||
48280336|NCT00225017|101010487|FG001|STARTED|Overall Study||24||
48280337|NCT00225017|101010486|FG000|COMPLETED|Overall Study||26||
48280338|NCT00225017|101010487|FG001|COMPLETED|Overall Study||23||
48280339|NCT00225017|101010486|FG000|NOT COMPLETED|Overall Study||0||
48280340|NCT00225017|101010487|FG001|NOT COMPLETED|Overall Study||1||
48280341|NCT02665338|101010488|FG000|STARTED|Overall Study||5||
48280342|NCT02665338|101010489|FG001|STARTED|Overall Study||6||
48280343|NCT02665338|101010488|FG000|COMPLETED|Overall Study||5||
48280344|NCT02665338|101010489|FG001|COMPLETED|Overall Study||5||
48280345|NCT02665338|101010488|FG000|NOT COMPLETED|Overall Study||0||
48280346|NCT02665338|101010489|FG001|NOT COMPLETED|Overall Study||1||
48280347|NCT04143945|101010490|FG000|STARTED|Treatment Period 1 (Day 1)||26||
48280348|NCT04143945|101010491|FG001|STARTED|Treatment Period 1 (Day 1)||26||
48280349|NCT04143945|101010492|FG002|STARTED|Treatment Period 1 (Day 1)||26||
48280350|NCT04143945|101010493|FG003|STARTED|Treatment Period 1 (Day 1)||26||
48280351|NCT04143945|101010490|FG000|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26||
48280352|NCT04143945|101010491|FG001|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26||
48280353|NCT04143945|101010492|FG002|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26||
48280354|NCT04143945|101010493|FG003|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26||
48118925|NCT03354429|100616396|FG001|COMPLETED|Overall Study||5486||
48118926|NCT03354429|100616395|FG000|NOT COMPLETED|Overall Study||9||
48118927|NCT03354429|100616396|FG001|NOT COMPLETED|Overall Study||7||
48118928|NCT03120013|100616397|FG000|STARTED|First Intervention (2 Weeks)||10||
48118929|NCT03120013|100616398|FG001|STARTED|First Intervention (2 Weeks)||11||
48118930|NCT03120013|100616397|FG000|Received Intervention|First Intervention (2 Weeks)||10||
48118931|NCT03120013|100616398|FG001|Received Intervention|First Intervention (2 Weeks)||11||
48118932|NCT03120013|100616397|FG000|COMPLETED|First Intervention (2 Weeks)||10||
48118933|NCT03120013|100616398|FG001|COMPLETED|First Intervention (2 Weeks)||10||
48118934|NCT03120013|100616397|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0||
48118935|NCT03120013|100616398|FG001|NOT COMPLETED|First Intervention (2 Weeks)||1||
48118936|NCT03120013|100616397|FG000|STARTED|Washout (6 Months)||10||
48118937|NCT03120013|100616398|FG001|STARTED|Washout (6 Months)||10||
48566121|NCT04630002|101717388|FG000|COMPLETED|Cohort2:Treatment Period2(Days 12 to 21)||0||
48566122|NCT04630002|101717389|FG001|COMPLETED|Cohort2:Treatment Period2(Days 12 to 21)||17||
48566123|NCT04630002|101717390|FG002|COMPLETED|Cohort2:Treatment Period2(Days 12 to 21)||0||
48566124|NCT04630002|101717388|FG000|NOT COMPLETED|Cohort2:Treatment Period2(Days 12 to 21)||0||
48566125|NCT04630002|101717389|FG001|NOT COMPLETED|Cohort2:Treatment Period2(Days 12 to 21)||2||
48566126|NCT04630002|101717390|FG002|NOT COMPLETED|Cohort2:Treatment Period2(Days 12 to 21)||0||
48566127|NCT04630002|101717388|FG000|STARTED|Cohort2:Treatment Period3(Days 22 to 31)||0||
48566128|NCT04630002|101717389|FG001|STARTED|Cohort2:Treatment Period3(Days 22 to 31)||17||
48566129|NCT04630002|101717390|FG002|STARTED|Cohort2:Treatment Period3(Days 22 to 31)||0||
48566130|NCT04630002|101717388|FG000|COMPLETED|Cohort2:Treatment Period3(Days 22 to 31)||0||
48566131|NCT04630002|101717389|FG001|COMPLETED|Cohort2:Treatment Period3(Days 22 to 31)||14||
48566132|NCT04630002|101717390|FG002|COMPLETED|Cohort2:Treatment Period3(Days 22 to 31)||0||
48566133|NCT04630002|101717388|FG000|NOT COMPLETED|Cohort2:Treatment Period3(Days 22 to 31)||0||
48566134|NCT04630002|101717389|FG001|NOT COMPLETED|Cohort2:Treatment Period3(Days 22 to 31)||3||
48118938|NCT03120013|100616397|FG000|COMPLETED|Washout (6 Months)||10||
48118939|NCT03120013|100616398|FG001|COMPLETED|Washout (6 Months)||10||
48118940|NCT03120013|100616397|FG000|NOT COMPLETED|Washout (6 Months)||0||
48280355|NCT04143945|101010490|FG000|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26||
48280356|NCT04143945|101010491|FG001|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26||
48566135|NCT04630002|101717390|FG002|NOT COMPLETED|Cohort2:Treatment Period3(Days 22 to 31)||0||
48566136|NCT04630002|101717388|FG000|STARTED|Cohort 3:Treatment Period 1(Days 1 to 7)||0||
48566137|NCT04630002|101717389|FG001|STARTED|Cohort 3:Treatment Period 1(Days 1 to 7)||0||
48566138|NCT04630002|101717390|FG002|STARTED|Cohort 3:Treatment Period 1(Days 1 to 7)||16||
48566139|NCT04630002|101717388|FG000|COMPLETED|Cohort 3:Treatment Period 1(Days 1 to 7)||0||
48566140|NCT04630002|101717389|FG001|COMPLETED|Cohort 3:Treatment Period 1(Days 1 to 7)||0||
48566141|NCT04630002|101717390|FG002|COMPLETED|Cohort 3:Treatment Period 1(Days 1 to 7)||16||
48566142|NCT04630002|101717388|FG000|NOT COMPLETED|Cohort 3:Treatment Period 1(Days 1 to 7)||0||
48566143|NCT04630002|101717389|FG001|NOT COMPLETED|Cohort 3:Treatment Period 1(Days 1 to 7)||0||
48566144|NCT04630002|101717390|FG002|NOT COMPLETED|Cohort 3:Treatment Period 1(Days 1 to 7)||0||
48118941|NCT03120013|100616398|FG001|NOT COMPLETED|Washout (6 Months)||0||
48118942|NCT03120013|100616397|FG000|STARTED|Second Intervention (2 Weeks)||10||
48118943|NCT03120013|100616398|FG001|STARTED|Second Intervention (2 Weeks)||10||
48118944|NCT03120013|100616397|FG000|COMPLETED|Second Intervention (2 Weeks)||10||
48118945|NCT03120013|100616398|FG001|COMPLETED|Second Intervention (2 Weeks)||10||
48118946|NCT03120013|100616397|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48118947|NCT03120013|100616398|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48118948|NCT01873989|100616399|FG000|STARTED|Overall Study||8||
48118949|NCT01873989|100616400|FG001|STARTED|Overall Study||7||
48118950|NCT01873989|100616399|FG000|COMPLETED|Overall Study||7||
48118951|NCT01873989|100616400|FG001|COMPLETED|Overall Study||6||
48118952|NCT01873989|100616399|FG000|NOT COMPLETED|Overall Study||1||
48118953|NCT01873989|100616400|FG001|NOT COMPLETED|Overall Study||1||
48118954|NCT00211081|100616401|FG000|STARTED|Overall Study||12||
48118955|NCT00211081|100616401|FG000|COMPLETED|Overall Study||10||
48118956|NCT00211081|100616401|FG000|NOT COMPLETED|Overall Study||2||
48118957|NCT04640311|100616402|FG000|STARTED|Part A:Treatment Period 1 (Up to 2 Days)||16||
48118958|NCT04640311|100616403|FG001|STARTED|Part A:Treatment Period 1 (Up to 2 Days)||18||
48118959|NCT04640311|100616404|FG002|STARTED|Part A:Treatment Period 1 (Up to 2 Days)||18||
48118960|NCT04640311|100616405|FG003|STARTED|Part A:Treatment Period 1 (Up to 2 Days)||0||
48118961|NCT04640311|100616406|FG004|STARTED|Part A:Treatment Period 1 (Up to 2 Days)||0||
48118962|NCT04640311|100616407|FG005|STARTED|Part A:Treatment Period 1 (Up to 2 Days)||0||
48118963|NCT04640311|100616408|FG006|STARTED|Part A:Treatment Period 1 (Up to 2 Days)||0||
48118964|NCT04640311|100616409|FG007|STARTED|Part A:Treatment Period 1 (Up to 2 Days)||0||
48118965|NCT04640311|100616410|FG008|STARTED|Part A:Treatment Period 1 (Up to 2 Days)||0||
48118966|NCT04640311|100616411|FG009|STARTED|Part A:Treatment Period 1 (Up to 2 Days)||0||
48118967|NCT04640311|100616412|FG010|STARTED|Part A:Treatment Period 1 (Up to 2 Days)||0||
48118968|NCT04640311|100616413|FG011|STARTED|Part A:Treatment Period 1 (Up to 2 Days)||0||
48118969|NCT04640311|100616414|FG012|STARTED|Part A:Treatment Period 1 (Up to 2 Days)||0||
48118970|NCT04640311|100616402|FG000|COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||15||
48118971|NCT04640311|100616403|FG001|COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||16||
48118972|NCT04640311|100616404|FG002|COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||18||
48118973|NCT04640311|100616405|FG003|COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
48118974|NCT04640311|100616406|FG004|COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
48118975|NCT04640311|100616407|FG005|COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
48118976|NCT04640311|100616408|FG006|COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
48118977|NCT04640311|100616409|FG007|COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
48118978|NCT04640311|100616410|FG008|COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
48118979|NCT04640311|100616411|FG009|COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
48118980|NCT04640311|100616412|FG010|COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
48118981|NCT04640311|100616413|FG011|COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
48118982|NCT04640311|100616414|FG012|COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
48118983|NCT04640311|100616402|FG000|NOT COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||1||
48118984|NCT04640311|100616403|FG001|NOT COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||2||
48118985|NCT04640311|100616404|FG002|NOT COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
48118986|NCT04640311|100616405|FG003|NOT COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
48118987|NCT04640311|100616406|FG004|NOT COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
48118988|NCT04640311|100616407|FG005|NOT COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
48118989|NCT04640311|100616408|FG006|NOT COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
48118990|NCT04640311|100616409|FG007|NOT COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
48118991|NCT04640311|100616410|FG008|NOT COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
48118992|NCT04640311|100616411|FG009|NOT COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
48118993|NCT04640311|100616412|FG010|NOT COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
48118994|NCT04640311|100616413|FG011|NOT COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
48118995|NCT04640311|100616414|FG012|NOT COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
48118996|NCT04640311|100616402|FG000|STARTED|Part A: Washout 1 (Up to 7 Days)||15||
48118997|NCT04640311|100616403|FG001|STARTED|Part A: Washout 1 (Up to 7 Days)||16||
48118998|NCT04640311|100616404|FG002|STARTED|Part A: Washout 1 (Up to 7 Days)||18||
48118999|NCT04640311|100616405|FG003|STARTED|Part A: Washout 1 (Up to 7 Days)||0||
48119000|NCT04640311|100616406|FG004|STARTED|Part A: Washout 1 (Up to 7 Days)||0||
48119001|NCT04640311|100616407|FG005|STARTED|Part A: Washout 1 (Up to 7 Days)||0||
48119002|NCT04640311|100616408|FG006|STARTED|Part A: Washout 1 (Up to 7 Days)||0||
48119003|NCT04640311|100616409|FG007|STARTED|Part A: Washout 1 (Up to 7 Days)||0||
48119004|NCT04640311|100616410|FG008|STARTED|Part A: Washout 1 (Up to 7 Days)||0||
48119005|NCT04640311|100616411|FG009|STARTED|Part A: Washout 1 (Up to 7 Days)||0||
48119006|NCT04640311|100616412|FG010|STARTED|Part A: Washout 1 (Up to 7 Days)||0||
48119007|NCT04640311|100616413|FG011|STARTED|Part A: Washout 1 (Up to 7 Days)||0||
48119008|NCT04640311|100616414|FG012|STARTED|Part A: Washout 1 (Up to 7 Days)||0||
48119009|NCT04640311|100616402|FG000|COMPLETED|Part A: Washout 1 (Up to 7 Days)||15||
48119010|NCT04640311|100616403|FG001|COMPLETED|Part A: Washout 1 (Up to 7 Days)||16||
48119011|NCT04640311|100616404|FG002|COMPLETED|Part A: Washout 1 (Up to 7 Days)||18||
48119012|NCT04640311|100616405|FG003|COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
48119013|NCT04640311|100616406|FG004|COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
48119014|NCT04640311|100616407|FG005|COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
48119015|NCT04640311|100616408|FG006|COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
48119016|NCT04640311|100616409|FG007|COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
48119017|NCT04640311|100616410|FG008|COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
48119018|NCT04640311|100616411|FG009|COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
48119019|NCT04640311|100616412|FG010|COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
48119020|NCT04640311|100616413|FG011|COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
48119021|NCT04640311|100616414|FG012|COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
48119022|NCT04640311|100616402|FG000|NOT COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
48119023|NCT04640311|100616403|FG001|NOT COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
48119024|NCT04640311|100616404|FG002|NOT COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
48119025|NCT04640311|100616405|FG003|NOT COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
48119026|NCT04640311|100616406|FG004|NOT COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
48119027|NCT04640311|100616407|FG005|NOT COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
48119028|NCT04640311|100616408|FG006|NOT COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
48119029|NCT04640311|100616409|FG007|NOT COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
48119030|NCT04640311|100616410|FG008|NOT COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
48119031|NCT04640311|100616411|FG009|NOT COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
48119032|NCT04640311|100616412|FG010|NOT COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
48119033|NCT04640311|100616413|FG011|NOT COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
48119034|NCT04640311|100616414|FG012|NOT COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
48119035|NCT04640311|100616402|FG000|STARTED|Part A:Treatment Period 2 (Up to 2 Days)||15||
48280357|NCT04143945|101010492|FG002|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26||
48280358|NCT04143945|101010493|FG003|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26||
48280359|NCT04143945|101010490|FG000|Per Protocol Set|Treatment Period 1 (Day 1)||26||
48280360|NCT04143945|101010491|FG001|Per Protocol Set|Treatment Period 1 (Day 1)||26||
48280361|NCT04143945|101010492|FG002|Per Protocol Set|Treatment Period 1 (Day 1)||26||
48280362|NCT04143945|101010493|FG003|Per Protocol Set|Treatment Period 1 (Day 1)||26||
48280363|NCT04143945|101010490|FG000|COMPLETED|Treatment Period 1 (Day 1)||26||
48280364|NCT04143945|101010491|FG001|COMPLETED|Treatment Period 1 (Day 1)||26||
48280365|NCT04143945|101010492|FG002|COMPLETED|Treatment Period 1 (Day 1)||26||
48280366|NCT04143945|101010493|FG003|COMPLETED|Treatment Period 1 (Day 1)||26||
48280367|NCT04143945|101010490|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48280368|NCT04143945|101010491|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48280369|NCT04143945|101010492|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48280370|NCT04143945|101010493|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48280371|NCT04143945|101010490|FG000|STARTED|Treatment Period 2 (Day 1)||26||
48280372|NCT04143945|101010491|FG001|STARTED|Treatment Period 2 (Day 1)||26||
48280373|NCT04143945|101010492|FG002|STARTED|Treatment Period 2 (Day 1)||26||
48119036|NCT04640311|100616403|FG001|STARTED|Part A:Treatment Period 2 (Up to 2 Days)||16||
48119037|NCT04640311|100616404|FG002|STARTED|Part A:Treatment Period 2 (Up to 2 Days)||18||
48119038|NCT04640311|100616405|FG003|STARTED|Part A:Treatment Period 2 (Up to 2 Days)||0||
48119039|NCT04640311|100616406|FG004|STARTED|Part A:Treatment Period 2 (Up to 2 Days)||0||
48119040|NCT04640311|100616407|FG005|STARTED|Part A:Treatment Period 2 (Up to 2 Days)||0||
48119041|NCT04640311|100616408|FG006|STARTED|Part A:Treatment Period 2 (Up to 2 Days)||0||
48119042|NCT04640311|100616409|FG007|STARTED|Part A:Treatment Period 2 (Up to 2 Days)||0||
48119043|NCT04640311|100616410|FG008|STARTED|Part A:Treatment Period 2 (Up to 2 Days)||0||
48119044|NCT04640311|100616411|FG009|STARTED|Part A:Treatment Period 2 (Up to 2 Days)||0||
48119045|NCT04640311|100616412|FG010|STARTED|Part A:Treatment Period 2 (Up to 2 Days)||0||
48119046|NCT04640311|100616413|FG011|STARTED|Part A:Treatment Period 2 (Up to 2 Days)||0||
48119047|NCT04640311|100616414|FG012|STARTED|Part A:Treatment Period 2 (Up to 2 Days)||0||
48119048|NCT04640311|100616402|FG000|COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||12||
48119049|NCT04640311|100616403|FG001|COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||11||
48119050|NCT04640311|100616404|FG002|COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||10||
48119051|NCT04640311|100616405|FG003|COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
48119052|NCT04640311|100616406|FG004|COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
48119053|NCT04640311|100616407|FG005|COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
48119054|NCT04640311|100616408|FG006|COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
48119055|NCT04640311|100616409|FG007|COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
48119056|NCT04640311|100616410|FG008|COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
48119057|NCT04640311|100616411|FG009|COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
48394780|NCT02501902|101296013|FG001|COMPLETED|Overall Study||0|0|
48394781|NCT02501902|101296014|FG002|COMPLETED|Overall Study||0|0|
48394782|NCT02501902|101296015|FG003|COMPLETED|Overall Study||0|0|
48119058|NCT04640311|100616412|FG010|COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
48119059|NCT04640311|100616413|FG011|COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
48119060|NCT04640311|100616414|FG012|COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
48119061|NCT04640311|100616402|FG000|NOT COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||3||
48119062|NCT04640311|100616403|FG001|NOT COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||5||
48119063|NCT04640311|100616404|FG002|NOT COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||8||
48119064|NCT04640311|100616405|FG003|NOT COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
48119065|NCT04640311|100616406|FG004|NOT COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
48119066|NCT04640311|100616407|FG005|NOT COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
48119067|NCT04640311|100616408|FG006|NOT COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
48119068|NCT04640311|100616409|FG007|NOT COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
48119069|NCT04640311|100616410|FG008|NOT COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
48119070|NCT04640311|100616411|FG009|NOT COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
48119071|NCT04640311|100616412|FG010|NOT COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
48119072|NCT04640311|100616413|FG011|NOT COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
48394783|NCT02501902|101296016|FG004|COMPLETED|Overall Study||0|0|
48394784|NCT02501902|101296017|FG005|COMPLETED|Overall Study||0|0|
48394785|NCT02501902|101296018|FG006|COMPLETED|Overall Study||0|0|
48394786|NCT02501902|101296019|FG007|COMPLETED|Overall Study||0|0|
48394787|NCT02501902|101296012|FG000|NOT COMPLETED|Overall Study||3||
48394788|NCT02501902|101296013|FG001|NOT COMPLETED|Overall Study||7||
48394789|NCT02501902|101296014|FG002|NOT COMPLETED|Overall Study||4||
48394790|NCT02501902|101296015|FG003|NOT COMPLETED|Overall Study||11||
48394791|NCT02501902|101296016|FG004|NOT COMPLETED|Overall Study||11||
48119073|NCT04640311|100616414|FG012|NOT COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
48394792|NCT02501902|101296017|FG005|NOT COMPLETED|Overall Study||11||
48394793|NCT02501902|101296018|FG006|NOT COMPLETED|Overall Study||9||
48698369|NCT00327015|102045612|FG002|Completed Study Without Being Rescued|Overall Study||113||
48698370|NCT00327015|102045613|FG003|Completed Study Without Being Rescued|Overall Study||144||
48698371|NCT00327015|102045610|FG000|COMPLETED|Overall Study||229||
48698372|NCT00327015|102045611|FG001|COMPLETED|Overall Study||231||
48698373|NCT00327015|102045612|FG002|COMPLETED|Overall Study||209||
48698374|NCT00327015|102045613|FG003|COMPLETED|Overall Study||219||
48698375|NCT00327015|102045610|FG000|NOT COMPLETED|Overall Study||91||
48698376|NCT00327015|102045611|FG001|NOT COMPLETED|Overall Study||92||
48698377|NCT00327015|102045612|FG002|NOT COMPLETED|Overall Study||126||
48698378|NCT00327015|102045613|FG003|NOT COMPLETED|Overall Study||109||
48394794|NCT02501902|101296019|FG007|NOT COMPLETED|Overall Study||20||
48698379|NCT00580034|102045614|FG000|STARTED|Overall Study||88||
48698380|NCT00580034|102045615|FG001|STARTED|Overall Study||88||
48698381|NCT00580034|102045614|FG000|COMPLETED|Overall Study||78||
48698382|NCT00580034|102045615|FG001|COMPLETED|Overall Study||88||
48698383|NCT00580034|102045614|FG000|NOT COMPLETED|Overall Study||10||
48698384|NCT00580034|102045615|FG001|NOT COMPLETED|Overall Study||0||
48698385|NCT00322452|102045616|FG000|STARTED|Overall Study||609||
48698386|NCT00322452|102045617|FG001|STARTED|Overall Study||608||
48698387|NCT00322452|102045616|FG000|COMPLETED|Overall Study||362||
48119074|NCT04640311|100616402|FG000|STARTED|Part A: Washout 2 (Up to 7 Days)||12||
48394795|NCT00865189|101296020|FG000|STARTED|Overall Study||46||
48394796|NCT00865189|101296021|FG001|STARTED|Overall Study||45||
48394797|NCT00865189|101296020|FG000|COMPLETED|Overall Study||34||
48698388|NCT00322452|102045617|FG001|COMPLETED|Overall Study||332||
48698389|NCT00322452|102045616|FG000|NOT COMPLETED|Overall Study||247||
48698390|NCT00322452|102045617|FG001|NOT COMPLETED|Overall Study||276||
48698391|NCT04026009|102045618|FG000|STARTED|Overall Study||10||
48698392|NCT04026009|102045619|FG001|STARTED|Overall Study||10||
48698393|NCT04026009|102045620|FG002|STARTED|Overall Study||45||
48698394|NCT04026009|102045621|FG003|STARTED|Overall Study||45||
48698395|NCT04026009|102045622|FG004|STARTED|Overall Study||30||
48698396|NCT04026009|102045618|FG000|COMPLETED|Overall Study||10||
48698397|NCT04026009|102045619|FG001|COMPLETED|Overall Study||10||
48698398|NCT04026009|102045620|FG002|COMPLETED|Overall Study||45||
48698399|NCT04026009|102045621|FG003|COMPLETED|Overall Study||44||
48394798|NCT00865189|101296021|FG001|COMPLETED|Overall Study||26||
48394799|NCT00865189|101296020|FG000|NOT COMPLETED|Overall Study||12||
48394800|NCT00865189|101296021|FG001|NOT COMPLETED|Overall Study||19||
48394801|NCT02629614|101296022|FG000|STARTED|Overall Study||48||
48394802|NCT02629614|101296023|FG001|STARTED|Overall Study||45||
48394803|NCT02629614|101296022|FG000|COMPLETED|Overall Study||48||
48394804|NCT02629614|101296023|FG001|COMPLETED|Overall Study||44||
48394805|NCT02629614|101296022|FG000|NOT COMPLETED|Overall Study||0||
48394806|NCT02629614|101296023|FG001|NOT COMPLETED|Overall Study||1||
48394807|NCT03559192|101296024|FG000|STARTED|Lead-in Period (3 Weeks)||181||
48394808|NCT03559192|101296025|FG001|STARTED|Lead-in Period (3 Weeks)||0||
48394809|NCT03559192|101296026|FG002|STARTED|Lead-in Period (3 Weeks)||0||
48394810|NCT03559192|101296024|FG000|COMPLETED|Lead-in Period (3 Weeks)||169||
48394811|NCT03559192|101296025|FG001|COMPLETED|Lead-in Period (3 Weeks)||0||
48394812|NCT03559192|101296026|FG002|COMPLETED|Lead-in Period (3 Weeks)||0||
48394813|NCT03559192|101296024|FG000|NOT COMPLETED|Lead-in Period (3 Weeks)||12||
48566145|NCT04630002|101717388|FG000|STARTED|Cohort 3:Treatment Period2(Days 8 to 21)||0||
48394814|NCT03559192|101296025|FG001|NOT COMPLETED|Lead-in Period (3 Weeks)||0||
48394815|NCT03559192|101296026|FG002|NOT COMPLETED|Lead-in Period (3 Weeks)||0||
48394816|NCT03559192|101296024|FG000|STARTED|DB Treatment(6 Wks) + Withdrawal(2 Wks)||0||
48394817|NCT03559192|101296025|FG001|STARTED|DB Treatment(6 Wks) + Withdrawal(2 Wks)||84||
48394818|NCT03559192|101296026|FG002|STARTED|DB Treatment(6 Wks) + Withdrawal(2 Wks)||85||
48394819|NCT03559192|101296024|FG000|Placebo Lead-in Responders|DB Treatment(6 Wks) + Withdrawal(2 Wks)||0||
48394820|NCT03559192|101296025|FG001|Placebo Lead-in Responders|DB Treatment(6 Wks) + Withdrawal(2 Wks)||22||
48394821|NCT03559192|101296026|FG002|Placebo Lead-in Responders|DB Treatment(6 Wks) + Withdrawal(2 Wks)||23||
48566146|NCT04630002|101717389|FG001|STARTED|Cohort 3:Treatment Period2(Days 8 to 21)||0||
48566147|NCT04630002|101717390|FG002|STARTED|Cohort 3:Treatment Period2(Days 8 to 21)||16||
48566148|NCT04630002|101717388|FG000|COMPLETED|Cohort 3:Treatment Period2(Days 8 to 21)||0||
48566149|NCT04630002|101717389|FG001|COMPLETED|Cohort 3:Treatment Period2(Days 8 to 21)||0||
48566150|NCT04630002|101717390|FG002|COMPLETED|Cohort 3:Treatment Period2(Days 8 to 21)||14||
48566151|NCT04630002|101717388|FG000|NOT COMPLETED|Cohort 3:Treatment Period2(Days 8 to 21)||0||
48566152|NCT04630002|101717389|FG001|NOT COMPLETED|Cohort 3:Treatment Period2(Days 8 to 21)||0||
48566153|NCT04630002|101717390|FG002|NOT COMPLETED|Cohort 3:Treatment Period2(Days 8 to 21)||2||
48566154|NCT01313897|101717391|FG000|STARTED|Overall Study||10||
48566155|NCT01313897|101717391|FG000|COMPLETED|Overall Study||8||
48566156|NCT01313897|101717391|FG000|NOT COMPLETED|Overall Study||2||
48698400|NCT04026009|102045622|FG004|COMPLETED|Overall Study||29||
48394822|NCT03559192|101296024|FG000|Placebo Lead-In Non-Responders|DB Treatment(6 Wks) + Withdrawal(2 Wks)||0||
48394823|NCT03559192|101296025|FG001|Placebo Lead-In Non-Responders|DB Treatment(6 Wks) + Withdrawal(2 Wks)||62||
48566157|NCT00529087|101717392|FG000|STARTED|Overall Study||150||
48566158|NCT00529087|101717393|FG001|STARTED|Overall Study||148||
48566159|NCT00529087|101717394|FG002|STARTED|Overall Study||162||
48566160|NCT00529087|101717392|FG000|COMPLETED|Overall Study||122||
48566161|NCT00529087|101717393|FG001|COMPLETED|Overall Study||120||
48566162|NCT00529087|101717394|FG002|COMPLETED|Overall Study||146||
48566163|NCT00529087|101717392|FG000|NOT COMPLETED|Overall Study||28||
48566164|NCT00529087|101717393|FG001|NOT COMPLETED|Overall Study||28||
48566165|NCT00529087|101717394|FG002|NOT COMPLETED|Overall Study||16||
48566166|NCT02774941|101717395|FG000|STARTED|Overall Study||110||
48566167|NCT02774941|101717396|FG001|STARTED|Overall Study||110||
48698401|NCT04026009|102045618|FG000|NOT COMPLETED|Overall Study||0||
48698402|NCT04026009|102045619|FG001|NOT COMPLETED|Overall Study||0||
48698403|NCT04026009|102045620|FG002|NOT COMPLETED|Overall Study||0||
48119075|NCT04640311|100616403|FG001|STARTED|Part A: Washout 2 (Up to 7 Days)||11||
48119076|NCT04640311|100616404|FG002|STARTED|Part A: Washout 2 (Up to 7 Days)||10||
48566168|NCT02774941|101717395|FG000|Subjects Excluded|Overall Study||1||
48566169|NCT02774941|101717396|FG001|Subjects Excluded|Overall Study||2||
48566170|NCT02774941|101717395|FG000|COMPLETED|Overall Study||109||
48566171|NCT02774941|101717396|FG001|COMPLETED|Overall Study||108||
48566172|NCT02774941|101717395|FG000|NOT COMPLETED|Overall Study||1||
48566173|NCT02774941|101717396|FG001|NOT COMPLETED|Overall Study||2||
48566174|NCT00449865|101717397|FG000|STARTED|Overall Study||867||
48566175|NCT00449865|101717398|FG001|STARTED|Overall Study||874||
48566176|NCT00449865|101717397|FG000|Completed Year 1|Overall Study||802||
48566177|NCT00449865|101717398|FG001|Completed Year 1|Overall Study||822||
48566178|NCT00449865|101717397|FG000|Completed Year 2|Overall Study||768||
48566179|NCT00449865|101717398|FG001|Completed Year 2|Overall Study||766||
48566180|NCT00449865|101717397|FG000|Completed Year 3|Overall Study||719||
48566181|NCT00449865|101717398|FG001|Completed Year 3|Overall Study||715||
48566182|NCT00449865|101717397|FG000|Completed Year 4|Overall Study||521||
48566183|NCT00449865|101717398|FG001|Completed Year 4|Overall Study||523||
48566184|NCT00449865|101717397|FG000|COMPLETED|Overall Study||345||
48566185|NCT00449865|101717398|FG001|COMPLETED|Overall Study||340||
48566186|NCT00449865|101717397|FG000|NOT COMPLETED|Overall Study||522||
48566187|NCT00449865|101717398|FG001|NOT COMPLETED|Overall Study||534||
48566188|NCT03892642|101717399|FG000|STARTED|Overall Study||18||
48566189|NCT03892642|101717399|FG000|COMPLETED|Overall Study||18||
48566190|NCT03892642|101717399|FG000|NOT COMPLETED|Overall Study||0||
48566191|NCT01113892|101717400|FG000|STARTED|Overall Study||101||
48566192|NCT01113892|101717401|FG001|STARTED|Overall Study||106||
48566193|NCT01113892|101717400|FG000|COMPLETED|Overall Study||87||
48566194|NCT01113892|101717401|FG001|COMPLETED|Overall Study||90||
48566195|NCT01113892|101717400|FG000|NOT COMPLETED|Overall Study||14||
48280374|NCT04143945|101010493|FG003|STARTED|Treatment Period 2 (Day 1)||26||
48280375|NCT04143945|101010490|FG000|COMPLETED|Treatment Period 2 (Day 1)||26||
48280376|NCT04143945|101010491|FG001|COMPLETED|Treatment Period 2 (Day 1)||26||
48280377|NCT04143945|101010492|FG002|COMPLETED|Treatment Period 2 (Day 1)||26||
48280378|NCT04143945|101010493|FG003|COMPLETED|Treatment Period 2 (Day 1)||26||
48280379|NCT04143945|101010490|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
48280380|NCT04143945|101010491|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
48280381|NCT04143945|101010492|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
48280382|NCT04143945|101010493|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
48280383|NCT01195948|101010494|FG000|STARTED|Overall Study||10||
48280384|NCT01195948|101010495|FG001|STARTED|Overall Study||10||
48566196|NCT01113892|101717401|FG001|NOT COMPLETED|Overall Study||16||
48566197|NCT02059512|101717402|FG000|STARTED|Overall Study||46||
48566198|NCT02059512|101717403|FG001|STARTED|Overall Study||34||
48566199|NCT02059512|101717404|FG002|STARTED|Overall Study||37||
48566200|NCT02059512|101717402|FG000|COMPLETED|Overall Study||37||
48566201|NCT02059512|101717403|FG001|COMPLETED|Overall Study||25||
48566202|NCT02059512|101717404|FG002|COMPLETED|Overall Study||23||
48566203|NCT02059512|101717402|FG000|NOT COMPLETED|Overall Study||9||
48566204|NCT02059512|101717403|FG001|NOT COMPLETED|Overall Study||9||
48566205|NCT02059512|101717404|FG002|NOT COMPLETED|Overall Study||14||
48566206|NCT01598064|101717405|FG000|STARTED|Overall Study||25||
48566207|NCT01598064|101717406|FG001|STARTED|Overall Study||24||
48566208|NCT01598064|101717405|FG000|COMPLETED|Overall Study||25||
48566209|NCT01598064|101717406|FG001|COMPLETED|Overall Study||24||
48566210|NCT01598064|101717405|FG000|NOT COMPLETED|Overall Study||0||
48566211|NCT01598064|101717406|FG001|NOT COMPLETED|Overall Study||0||
48566212|NCT00580151|101717407|FG000|STARTED|Overall Study||9||
48280385|NCT01195948|101010496|FG002|STARTED|Overall Study||11||
48280386|NCT01195948|101010494|FG000|Week 24|Overall Study||10||
48280387|NCT01195948|101010495|FG001|Week 24|Overall Study||10||
48280388|NCT01195948|101010496|FG002|Week 24|Overall Study||10||
48280389|NCT01195948|101010494|FG000|COMPLETED|Overall Study||10||
48280390|NCT01195948|101010495|FG001|COMPLETED|Overall Study||9||
48280391|NCT01195948|101010496|FG002|COMPLETED|Overall Study||9||
48280392|NCT01195948|101010494|FG000|NOT COMPLETED|Overall Study||0||
48566213|NCT00580151|101717408|FG001|STARTED|Overall Study||0||
48566214|NCT00580151|101717407|FG000|COMPLETED|Overall Study||9||
48566215|NCT00580151|101717408|FG001|COMPLETED|Overall Study||0||
48566216|NCT00580151|101717407|FG000|NOT COMPLETED|Overall Study||0||
48566217|NCT00580151|101717408|FG001|NOT COMPLETED|Overall Study||0||
48566218|NCT02044302|101717409|FG000|STARTED|Overall Study||2||
48566219|NCT02044302|101717410|FG001|STARTED|Overall Study||0||
48566220|NCT02044302|101717409|FG000|COMPLETED|Overall Study||0||
48566221|NCT02044302|101717410|FG001|COMPLETED|Overall Study||0||
48566222|NCT02044302|101717409|FG000|NOT COMPLETED|Overall Study||2||
48566223|NCT02044302|101717410|FG001|NOT COMPLETED|Overall Study||0||
48566224|NCT01788631|101717411|FG000|STARTED|Overall Study||52||
48280393|NCT01195948|101010495|FG001|NOT COMPLETED|Overall Study||1||
48280394|NCT01195948|101010496|FG002|NOT COMPLETED|Overall Study||2||
48280395|NCT03245151|101010497|FG000|STARTED|Overall Study||5||
48280396|NCT03245151|101010498|FG001|STARTED|Overall Study||18||
48566225|NCT01788631|101717412|FG001|STARTED|Overall Study||44||
48566226|NCT01788631|101717411|FG000|Randomized|Overall Study||53||
48566227|NCT01788631|101717412|FG001|Randomized|Overall Study||47||
48566228|NCT01788631|101717411|FG000|COMPLETED|Overall Study||49||
48566229|NCT01788631|101717412|FG001|COMPLETED|Overall Study||43||
48566230|NCT01788631|101717411|FG000|NOT COMPLETED|Overall Study||3||
48566231|NCT01788631|101717412|FG001|NOT COMPLETED|Overall Study||1||
48566232|NCT05021133|101717413|FG000|STARTED|Overall Study||20||
48566233|NCT05021133|101717413|FG000|COMPLETED|Overall Study||20||
48566234|NCT05021133|101717413|FG000|NOT COMPLETED|Overall Study||0||
48566235|NCT00320710|101717414|FG000|STARTED|Overall Study||200||
48566236|NCT00320710|101717415|FG001|STARTED|Overall Study||203||
48566237|NCT00320710|101717416|FG002|STARTED|Overall Study||13||
48566238|NCT00320710|101717414|FG000|Treated (Safety Set)|Overall Study||198||
48566239|NCT00320710|101717415|FG001|Treated (Safety Set)|Overall Study||202||
48280397|NCT03245151|101010499|FG002|STARTED|Overall Study||10||
48566240|NCT00320710|101717416|FG002|Treated (Safety Set)|Overall Study||13||
48566241|NCT00320710|101717414|FG000|COMPLETED|Overall Study||106||
48280398|NCT03245151|101010500|FG003|STARTED|Overall Study||20||
48280399|NCT03245151|101010501|FG004|STARTED|Overall Study||11||
48280400|NCT03245151|101010497|FG000|COMPLETED|Overall Study||0||
48280401|NCT03245151|101010498|FG001|COMPLETED|Overall Study||3||
48280402|NCT03245151|101010499|FG002|COMPLETED|Overall Study||1||
48280403|NCT03245151|101010500|FG003|COMPLETED|Overall Study||2||
48566242|NCT00320710|101717415|FG001|COMPLETED|Overall Study||127||
48566243|NCT00320710|101717416|FG002|COMPLETED|Overall Study||8||
48566244|NCT00320710|101717414|FG000|NOT COMPLETED|Overall Study||94||
48566245|NCT00320710|101717415|FG001|NOT COMPLETED|Overall Study||76||
48566246|NCT00320710|101717416|FG002|NOT COMPLETED|Overall Study||5||
48280404|NCT03245151|101010501|FG004|COMPLETED|Overall Study||3||
48280405|NCT03245151|101010497|FG000|NOT COMPLETED|Overall Study||5||
48280406|NCT03245151|101010498|FG001|NOT COMPLETED|Overall Study||15||
48280407|NCT03245151|101010499|FG002|NOT COMPLETED|Overall Study||9||
48280408|NCT03245151|101010500|FG003|NOT COMPLETED|Overall Study||18||
48280409|NCT03245151|101010501|FG004|NOT COMPLETED|Overall Study||8||
48280410|NCT00864253|101010502|FG000|STARTED|Overall Study||264||
48280411|NCT00864253|101010503|FG001|STARTED|Overall Study||265||
48280412|NCT00864253|101010502|FG000|Treated|Overall Study||257||
48280413|NCT00864253|101010503|FG001|Treated|Overall Study||258||
48280414|NCT00864253|101010502|FG000|COMPLETED|Overall Study||165||
48280415|NCT00864253|101010503|FG001|COMPLETED|Overall Study||207||
48280416|NCT00864253|101010502|FG000|NOT COMPLETED|Overall Study||99||
48280417|NCT00864253|101010503|FG001|NOT COMPLETED|Overall Study||58||
48280418|NCT00357331|101010504|FG000|STARTED|Overall Study||42||
48280419|NCT00357331|101010505|FG001|STARTED|Overall Study||41||
48280420|NCT00357331|101010504|FG000|COMPLETED|Overall Study||42||
48280421|NCT00357331|101010505|FG001|COMPLETED|Overall Study||41||
48280422|NCT00357331|101010504|FG000|NOT COMPLETED|Overall Study||0||
48280423|NCT00357331|101010505|FG001|NOT COMPLETED|Overall Study||0||
48280424|NCT04041453|101010506|FG000|STARTED|Overall Study||38||
48280425|NCT04041453|101010507|FG001|STARTED|Overall Study||57||
48280426|NCT04041453|101010508|FG002|STARTED|Overall Study||23||
48280427|NCT04041453|101010509|FG003|STARTED|Overall Study||58||
48280428|NCT04041453|101010506|FG000|Safety Population|Overall Study||38||
48566247|NCT02060838|101717417|FG000|STARTED|Overall Study||28||
48566248|NCT02060838|101717418|FG001|STARTED|Overall Study||22||
48566249|NCT02060838|101717417|FG000|COMPLETED|Overall Study||28||
48566250|NCT02060838|101717418|FG001|COMPLETED|Overall Study||22||
48566251|NCT02060838|101717417|FG000|NOT COMPLETED|Overall Study||0||
48566252|NCT02060838|101717418|FG001|NOT COMPLETED|Overall Study||0||
48566253|NCT04687137|101717419|FG000|STARTED|Overall Study||11||
48566254|NCT04687137|101717420|FG001|STARTED|Overall Study||1||
48566255|NCT04687137|101717419|FG000|COMPLETED|Overall Study||11||
48566256|NCT04687137|101717420|FG001|COMPLETED|Overall Study||1||
48566257|NCT04687137|101717419|FG000|NOT COMPLETED|Overall Study||0||
48566258|NCT04687137|101717420|FG001|NOT COMPLETED|Overall Study||0||
48566259|NCT02062450|101717421|FG000|STARTED|Overall Study||379||
48566260|NCT02062450|101717421|FG000|Per Protocol Cohort|Overall Study||255||
48566261|NCT02062450|101717421|FG000|COMPLETED|Overall Study||255||
48566262|NCT02062450|101717421|FG000|NOT COMPLETED|Overall Study||124||
48119077|NCT04640311|100616405|FG003|STARTED|Part A: Washout 2 (Up to 7 Days)||0||
48566263|NCT00634803|101717422|FG000|STARTED|Overall Study||30||
48566264|NCT00634803|101717423|FG001|STARTED|Overall Study||30||
48566265|NCT00634803|101717424|FG002|STARTED|Overall Study||30||
48566266|NCT00634803|101717422|FG000|Month 1|Overall Study||29||
48566267|NCT00634803|101717423|FG001|Month 1|Overall Study||29||
48566268|NCT00634803|101717424|FG002|Month 1|Overall Study||29||
48566269|NCT00634803|101717422|FG000|Month 2|Overall Study||26||
48566270|NCT00634803|101717423|FG001|Month 2|Overall Study||26||
48566271|NCT00634803|101717424|FG002|Month 2|Overall Study||28||
48566272|NCT00634803|101717422|FG000|Month 3|Overall Study||25||
48566273|NCT00634803|101717423|FG001|Month 3|Overall Study||23||
48566274|NCT00634803|101717424|FG002|Month 3|Overall Study||26||
48119078|NCT04640311|100616406|FG004|STARTED|Part A: Washout 2 (Up to 7 Days)||0||
48119079|NCT04640311|100616407|FG005|STARTED|Part A: Washout 2 (Up to 7 Days)||0||
48280429|NCT04041453|101010507|FG001|Safety Population|Overall Study||56||
48566275|NCT00634803|101717422|FG000|COMPLETED|Overall Study||24||
48566276|NCT00634803|101717423|FG001|COMPLETED|Overall Study||23||
48566277|NCT00634803|101717424|FG002|COMPLETED|Overall Study||23||
48566278|NCT00634803|101717422|FG000|NOT COMPLETED|Overall Study||6||
48566279|NCT00634803|101717423|FG001|NOT COMPLETED|Overall Study||7||
48566280|NCT00634803|101717424|FG002|NOT COMPLETED|Overall Study||7||
48280430|NCT04041453|101010508|FG002|Safety Population|Overall Study||23||
48280431|NCT04041453|101010509|FG003|Safety Population|Overall Study||58||
48280432|NCT04041453|101010506|FG000|COMPLETED|Overall Study||24||
48280433|NCT04041453|101010507|FG001|COMPLETED|Overall Study||35||
48280434|NCT04041453|101010508|FG002|COMPLETED|Overall Study||18||
48566281|NCT02509507|101717425|FG000|STARTED|Overall Study||23||
48566282|NCT02509507|101717426|FG001|STARTED|Overall Study||5||
48566283|NCT02509507|101717427|FG002|STARTED|Overall Study||24||
48566284|NCT02509507|101717428|FG003|STARTED|Overall Study||22||
48566285|NCT02509507|101717429|FG004|STARTED|Overall Study||10||
48566286|NCT02509507|101717430|FG005|STARTED|Overall Study||18||
48566287|NCT02509507|101717431|FG006|STARTED|Overall Study||10||
48566288|NCT02509507|101717432|FG007|STARTED|Overall Study||5||
48566289|NCT02509507|101717433|FG008|STARTED|Overall Study||10||
48566290|NCT02509507|101717425|FG000|Received Talimogene Laherparepvec|Overall Study||23||
48566291|NCT02509507|101717426|FG001|Received Talimogene Laherparepvec|Overall Study||5||
48566292|NCT02509507|101717427|FG002|Received Talimogene Laherparepvec|Overall Study||24||
48566293|NCT02509507|101717428|FG003|Received Talimogene Laherparepvec|Overall Study||22||
48566294|NCT02509507|101717429|FG004|Received Talimogene Laherparepvec|Overall Study||10||
48566295|NCT02509507|101717430|FG005|Received Talimogene Laherparepvec|Overall Study||18||
48566296|NCT02509507|101717431|FG006|Received Talimogene Laherparepvec|Overall Study||10||
48566297|NCT02509507|101717432|FG007|Received Talimogene Laherparepvec|Overall Study||5||
48566298|NCT02509507|101717433|FG008|Received Talimogene Laherparepvec|Overall Study||10||
48566299|NCT02509507|101717425|FG000|Received Pembrolizumab|Overall Study||0||
48566300|NCT02509507|101717426|FG001|Received Pembrolizumab|Overall Study||0||
48566301|NCT02509507|101717427|FG002|Received Pembrolizumab|Overall Study||24||
48119080|NCT04640311|100616408|FG006|STARTED|Part A: Washout 2 (Up to 7 Days)||0||
48119081|NCT04640311|100616409|FG007|STARTED|Part A: Washout 2 (Up to 7 Days)||0||
48119082|NCT04640311|100616410|FG008|STARTED|Part A: Washout 2 (Up to 7 Days)||0||
48119083|NCT04640311|100616411|FG009|STARTED|Part A: Washout 2 (Up to 7 Days)||0||
48119084|NCT04640311|100616412|FG010|STARTED|Part A: Washout 2 (Up to 7 Days)||0||
48119085|NCT04640311|100616413|FG011|STARTED|Part A: Washout 2 (Up to 7 Days)||0||
48119086|NCT04640311|100616414|FG012|STARTED|Part A: Washout 2 (Up to 7 Days)||0||
48119087|NCT04640311|100616402|FG000|COMPLETED|Part A: Washout 2 (Up to 7 Days)||12||
48119088|NCT04640311|100616403|FG001|COMPLETED|Part A: Washout 2 (Up to 7 Days)||11||
48119089|NCT04640311|100616404|FG002|COMPLETED|Part A: Washout 2 (Up to 7 Days)||10||
48119090|NCT04640311|100616405|FG003|COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
48119091|NCT04640311|100616406|FG004|COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
48119092|NCT04640311|100616407|FG005|COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
48119093|NCT04640311|100616408|FG006|COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
48119094|NCT04640311|100616409|FG007|COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
48119095|NCT04640311|100616410|FG008|COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
48119096|NCT04640311|100616411|FG009|COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
48119097|NCT04640311|100616412|FG010|COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
48119098|NCT04640311|100616413|FG011|COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
48119099|NCT04640311|100616414|FG012|COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
48119100|NCT04640311|100616402|FG000|NOT COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
48119101|NCT04640311|100616403|FG001|NOT COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
48119102|NCT04640311|100616404|FG002|NOT COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
48119103|NCT04640311|100616405|FG003|NOT COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
48119104|NCT04640311|100616406|FG004|NOT COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
48119105|NCT04640311|100616407|FG005|NOT COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
48119106|NCT04640311|100616408|FG006|NOT COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
48119107|NCT04640311|100616409|FG007|NOT COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
48119108|NCT04640311|100616410|FG008|NOT COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
48119109|NCT04640311|100616411|FG009|NOT COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
48566302|NCT02509507|101717428|FG003|Received Pembrolizumab|Overall Study||22||
48566303|NCT02509507|101717429|FG004|Received Pembrolizumab|Overall Study||10||
48119110|NCT04640311|100616412|FG010|NOT COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
48119111|NCT04640311|100616413|FG011|NOT COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
48119112|NCT04640311|100616414|FG012|NOT COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
48119113|NCT04640311|100616402|FG000|STARTED|Part A:Treatment Period 3 (Up to 2 Days)||12||
48119114|NCT04640311|100616403|FG001|STARTED|Part A:Treatment Period 3 (Up to 2 Days)||11||
48119115|NCT04640311|100616404|FG002|STARTED|Part A:Treatment Period 3 (Up to 2 Days)||10||
48119116|NCT04640311|100616405|FG003|STARTED|Part A:Treatment Period 3 (Up to 2 Days)||0||
48566304|NCT02509507|101717430|FG005|Received Pembrolizumab|Overall Study||18||
48566305|NCT02509507|101717431|FG006|Received Pembrolizumab|Overall Study||10||
48566306|NCT02509507|101717432|FG007|Received Pembrolizumab|Overall Study||5||
48566307|NCT02509507|101717433|FG008|Received Pembrolizumab|Overall Study||10||
48566308|NCT02509507|101717425|FG000|COMPLETED|Overall Study||0||
48566309|NCT02509507|101717426|FG001|COMPLETED|Overall Study||1||
48566310|NCT02509507|101717427|FG002|COMPLETED|Overall Study||1||
48119117|NCT04640311|100616406|FG004|STARTED|Part A:Treatment Period 3 (Up to 2 Days)||0||
48119118|NCT04640311|100616407|FG005|STARTED|Part A:Treatment Period 3 (Up to 2 Days)||0||
48119119|NCT04640311|100616408|FG006|STARTED|Part A:Treatment Period 3 (Up to 2 Days)||0||
48119120|NCT04640311|100616409|FG007|STARTED|Part A:Treatment Period 3 (Up to 2 Days)||0||
48119121|NCT04640311|100616410|FG008|STARTED|Part A:Treatment Period 3 (Up to 2 Days)||0||
48119122|NCT04640311|100616411|FG009|STARTED|Part A:Treatment Period 3 (Up to 2 Days)||0||
48119123|NCT04640311|100616412|FG010|STARTED|Part A:Treatment Period 3 (Up to 2 Days)||0||
48119124|NCT04640311|100616413|FG011|STARTED|Part A:Treatment Period 3 (Up to 2 Days)||0||
48119125|NCT04640311|100616414|FG012|STARTED|Part A:Treatment Period 3 (Up to 2 Days)||0||
48119126|NCT04640311|100616402|FG000|COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||12||
48119127|NCT04640311|100616403|FG001|COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||11||
48119128|NCT04640311|100616404|FG002|COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||10||
48119129|NCT04640311|100616405|FG003|COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
48119130|NCT04640311|100616406|FG004|COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
48119131|NCT04640311|100616407|FG005|COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
48119132|NCT04640311|100616408|FG006|COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
48119133|NCT04640311|100616409|FG007|COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
48119134|NCT04640311|100616410|FG008|COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
48119135|NCT04640311|100616411|FG009|COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
48119136|NCT04640311|100616412|FG010|COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
48119137|NCT04640311|100616413|FG011|COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
48119138|NCT04640311|100616414|FG012|COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
48280435|NCT04041453|101010509|FG003|COMPLETED|Overall Study||40||
48119139|NCT04640311|100616402|FG000|NOT COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
48119140|NCT04640311|100616403|FG001|NOT COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
48119141|NCT04640311|100616404|FG002|NOT COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
48119142|NCT04640311|100616405|FG003|NOT COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
48119143|NCT04640311|100616406|FG004|NOT COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
48119144|NCT04640311|100616407|FG005|NOT COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
48119145|NCT04640311|100616408|FG006|NOT COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
48119146|NCT04640311|100616409|FG007|NOT COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
48119147|NCT04640311|100616410|FG008|NOT COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
48119148|NCT04640311|100616411|FG009|NOT COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
48119149|NCT04640311|100616412|FG010|NOT COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
48119150|NCT04640311|100616413|FG011|NOT COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
48119151|NCT04640311|100616414|FG012|NOT COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
48119152|NCT04640311|100616402|FG000|STARTED|Part B:Treatment Period 1 (Up to 2 Days)||0||
48119153|NCT04640311|100616403|FG001|STARTED|Part B:Treatment Period 1 (Up to 2 Days)||0||
48119154|NCT04640311|100616404|FG002|STARTED|Part B:Treatment Period 1 (Up to 2 Days)||0||
48119155|NCT04640311|100616405|FG003|STARTED|Part B:Treatment Period 1 (Up to 2 Days)||21||
48119156|NCT04640311|100616406|FG004|STARTED|Part B:Treatment Period 1 (Up to 2 Days)||19||
48119157|NCT04640311|100616407|FG005|STARTED|Part B:Treatment Period 1 (Up to 2 Days)||21||
48119158|NCT04640311|100616408|FG006|STARTED|Part B:Treatment Period 1 (Up to 2 Days)||22||
48119159|NCT04640311|100616409|FG007|STARTED|Part B:Treatment Period 1 (Up to 2 Days)||21||
48119160|NCT04640311|100616410|FG008|STARTED|Part B:Treatment Period 1 (Up to 2 Days)||21||
48119161|NCT04640311|100616411|FG009|STARTED|Part B:Treatment Period 1 (Up to 2 Days)||21||
48119162|NCT04640311|100616412|FG010|STARTED|Part B:Treatment Period 1 (Up to 2 Days)||21||
48119163|NCT04640311|100616413|FG011|STARTED|Part B:Treatment Period 1 (Up to 2 Days)||20||
48119164|NCT04640311|100616414|FG012|STARTED|Part B:Treatment Period 1 (Up to 2 Days)||20||
48119165|NCT04640311|100616402|FG000|COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||0||
48119166|NCT04640311|100616403|FG001|COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||0||
48119167|NCT04640311|100616404|FG002|COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||0||
48119168|NCT04640311|100616405|FG003|COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||20||
48119169|NCT04640311|100616406|FG004|COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||19||
48119170|NCT04640311|100616407|FG005|COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||20||
48119171|NCT04640311|100616408|FG006|COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||20||
48119172|NCT04640311|100616409|FG007|COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||21||
48119173|NCT04640311|100616410|FG008|COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||19||
48119174|NCT04640311|100616411|FG009|COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||21||
48119175|NCT04640311|100616412|FG010|COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||20||
48119176|NCT04640311|100616413|FG011|COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||20||
48119177|NCT04640311|100616414|FG012|COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||20||
48119178|NCT04640311|100616402|FG000|NOT COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||0||
48119179|NCT04640311|100616403|FG001|NOT COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||0||
48119180|NCT04640311|100616404|FG002|NOT COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||0||
48119181|NCT04640311|100616405|FG003|NOT COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||1||
48119182|NCT04640311|100616406|FG004|NOT COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||0||
48119183|NCT04640311|100616407|FG005|NOT COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||1||
48119184|NCT04640311|100616408|FG006|NOT COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||2||
48119185|NCT04640311|100616409|FG007|NOT COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||0||
48119186|NCT04640311|100616410|FG008|NOT COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||2||
48119187|NCT04640311|100616411|FG009|NOT COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||0||
48119188|NCT04640311|100616412|FG010|NOT COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||1||
48119189|NCT04640311|100616413|FG011|NOT COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||0||
48119190|NCT04640311|100616414|FG012|NOT COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||0||
48119191|NCT04640311|100616402|FG000|STARTED|Part B: Washout 1 (Up to 7 Days)||0||
48119192|NCT04640311|100616403|FG001|STARTED|Part B: Washout 1 (Up to 7 Days)||0||
48698404|NCT04026009|102045621|FG003|NOT COMPLETED|Overall Study||1||
48698405|NCT04026009|102045622|FG004|NOT COMPLETED|Overall Study||1||
48698406|NCT02374814|102045623|FG000|STARTED|Overall Study||12||
48119193|NCT04640311|100616404|FG002|STARTED|Part B: Washout 1 (Up to 7 Days)||0||
48119194|NCT04640311|100616405|FG003|STARTED|Part B: Washout 1 (Up to 7 Days)||20||
48394824|NCT03559192|101296026|FG002|Placebo Lead-In Non-Responders|DB Treatment(6 Wks) + Withdrawal(2 Wks)||62||
48394825|NCT03559192|101296024|FG000|Completed DB Period and Entered Withdrawal|DB Treatment(6 Wks) + Withdrawal(2 Wks)||0||
48119195|NCT04640311|100616406|FG004|STARTED|Part B: Washout 1 (Up to 7 Days)||19||
48119196|NCT04640311|100616407|FG005|STARTED|Part B: Washout 1 (Up to 7 Days)||20||
48119197|NCT04640311|100616408|FG006|STARTED|Part B: Washout 1 (Up to 7 Days)||20||
48119198|NCT04640311|100616409|FG007|STARTED|Part B: Washout 1 (Up to 7 Days)||21||
48119199|NCT04640311|100616410|FG008|STARTED|Part B: Washout 1 (Up to 7 Days)||19||
48119200|NCT04640311|100616411|FG009|STARTED|Part B: Washout 1 (Up to 7 Days)||21||
48119201|NCT04640311|100616412|FG010|STARTED|Part B: Washout 1 (Up to 7 Days)||20||
48119202|NCT04640311|100616413|FG011|STARTED|Part B: Washout 1 (Up to 7 Days)||20||
48119203|NCT04640311|100616414|FG012|STARTED|Part B: Washout 1 (Up to 7 Days)||20||
48119204|NCT04640311|100616402|FG000|COMPLETED|Part B: Washout 1 (Up to 7 Days)||0||
48119205|NCT04640311|100616403|FG001|COMPLETED|Part B: Washout 1 (Up to 7 Days)||0||
48119206|NCT04640311|100616404|FG002|COMPLETED|Part B: Washout 1 (Up to 7 Days)||0||
48119207|NCT04640311|100616405|FG003|COMPLETED|Part B: Washout 1 (Up to 7 Days)||20||
48119208|NCT04640311|100616406|FG004|COMPLETED|Part B: Washout 1 (Up to 7 Days)||19||
48119209|NCT04640311|100616407|FG005|COMPLETED|Part B: Washout 1 (Up to 7 Days)||20||
48119210|NCT04640311|100616408|FG006|COMPLETED|Part B: Washout 1 (Up to 7 Days)||20||
48119211|NCT04640311|100616409|FG007|COMPLETED|Part B: Washout 1 (Up to 7 Days)||21||
48119212|NCT04640311|100616410|FG008|COMPLETED|Part B: Washout 1 (Up to 7 Days)||19||
48119213|NCT04640311|100616411|FG009|COMPLETED|Part B: Washout 1 (Up to 7 Days)||21||
48119214|NCT04640311|100616412|FG010|COMPLETED|Part B: Washout 1 (Up to 7 Days)||20||
48119215|NCT04640311|100616413|FG011|COMPLETED|Part B: Washout 1 (Up to 7 Days)||20||
48394826|NCT03559192|101296025|FG001|Completed DB Period and Entered Withdrawal|DB Treatment(6 Wks) + Withdrawal(2 Wks)||81||
48394827|NCT03559192|101296026|FG002|Completed DB Period and Entered Withdrawal|DB Treatment(6 Wks) + Withdrawal(2 Wks)||80||
48394828|NCT03559192|101296024|FG000|COMPLETED|DB Treatment(6 Wks) + Withdrawal(2 Wks)||0||
48394829|NCT03559192|101296025|FG001|COMPLETED|DB Treatment(6 Wks) + Withdrawal(2 Wks)||81||
48394830|NCT03559192|101296026|FG002|COMPLETED|DB Treatment(6 Wks) + Withdrawal(2 Wks)||79||
48394831|NCT03559192|101296024|FG000|NOT COMPLETED|DB Treatment(6 Wks) + Withdrawal(2 Wks)||0||
48394832|NCT03559192|101296025|FG001|NOT COMPLETED|DB Treatment(6 Wks) + Withdrawal(2 Wks)||3||
48394833|NCT03559192|101296026|FG002|NOT COMPLETED|DB Treatment(6 Wks) + Withdrawal(2 Wks)||6||
48394834|NCT04491240|101296027|FG000|STARTED|Overall Study||10||
48394835|NCT04491240|101296028|FG001|STARTED|Overall Study||10||
48394836|NCT04491240|101296029|FG002|STARTED|Overall Study||10||
48698407|NCT02374814|102045624|FG001|STARTED|Overall Study||12||
48698408|NCT02374814|102045625|FG002|STARTED|Overall Study||12||
48119216|NCT04640311|100616414|FG012|COMPLETED|Part B: Washout 1 (Up to 7 Days)||20||
48119217|NCT04640311|100616402|FG000|NOT COMPLETED|Part B: Washout 1 (Up to 7 Days)||0||
48119218|NCT04640311|100616403|FG001|NOT COMPLETED|Part B: Washout 1 (Up to 7 Days)||0||
48119219|NCT04640311|100616404|FG002|NOT COMPLETED|Part B: Washout 1 (Up to 7 Days)||0||
48119220|NCT04640311|100616405|FG003|NOT COMPLETED|Part B: Washout 1 (Up to 7 Days)||0||
48119221|NCT04640311|100616406|FG004|NOT COMPLETED|Part B: Washout 1 (Up to 7 Days)||0||
48119222|NCT04640311|100616407|FG005|NOT COMPLETED|Part B: Washout 1 (Up to 7 Days)||0||
48119223|NCT04640311|100616408|FG006|NOT COMPLETED|Part B: Washout 1 (Up to 7 Days)||0||
48119224|NCT04640311|100616409|FG007|NOT COMPLETED|Part B: Washout 1 (Up to 7 Days)||0||
48119225|NCT04640311|100616410|FG008|NOT COMPLETED|Part B: Washout 1 (Up to 7 Days)||0||
48119226|NCT04640311|100616411|FG009|NOT COMPLETED|Part B: Washout 1 (Up to 7 Days)||0||
48119227|NCT04640311|100616412|FG010|NOT COMPLETED|Part B: Washout 1 (Up to 7 Days)||0||
48119228|NCT04640311|100616413|FG011|NOT COMPLETED|Part B: Washout 1 (Up to 7 Days)||0||
48119229|NCT04640311|100616414|FG012|NOT COMPLETED|Part B: Washout 1 (Up to 7 Days)||0||
48119230|NCT04640311|100616402|FG000|STARTED|Part B: Treatment Period 2(Up to 2 Days)||0||
48119231|NCT04640311|100616403|FG001|STARTED|Part B: Treatment Period 2(Up to 2 Days)||0||
48119232|NCT04640311|100616404|FG002|STARTED|Part B: Treatment Period 2(Up to 2 Days)||0||
48119233|NCT04640311|100616405|FG003|STARTED|Part B: Treatment Period 2(Up to 2 Days)||20||
48119234|NCT04640311|100616406|FG004|STARTED|Part B: Treatment Period 2(Up to 2 Days)||19||
48119235|NCT04640311|100616407|FG005|STARTED|Part B: Treatment Period 2(Up to 2 Days)||20||
48119236|NCT04640311|100616408|FG006|STARTED|Part B: Treatment Period 2(Up to 2 Days)||20||
48119237|NCT04640311|100616409|FG007|STARTED|Part B: Treatment Period 2(Up to 2 Days)||21||
48119238|NCT04640311|100616410|FG008|STARTED|Part B: Treatment Period 2(Up to 2 Days)||19||
48119239|NCT04640311|100616411|FG009|STARTED|Part B: Treatment Period 2(Up to 2 Days)||21||
48119240|NCT04640311|100616412|FG010|STARTED|Part B: Treatment Period 2(Up to 2 Days)||20||
48119241|NCT04640311|100616413|FG011|STARTED|Part B: Treatment Period 2(Up to 2 Days)||20||
48119242|NCT04640311|100616414|FG012|STARTED|Part B: Treatment Period 2(Up to 2 Days)||20||
48119243|NCT04640311|100616402|FG000|COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||0||
48119244|NCT04640311|100616403|FG001|COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||0||
48119245|NCT04640311|100616404|FG002|COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||0||
48119246|NCT04640311|100616405|FG003|COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||20||
48119247|NCT04640311|100616406|FG004|COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||19||
48119248|NCT04640311|100616407|FG005|COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||20||
48119249|NCT04640311|100616408|FG006|COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||20||
48119250|NCT04640311|100616409|FG007|COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||21||
48119251|NCT04640311|100616410|FG008|COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||19||
48119252|NCT04640311|100616411|FG009|COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||21||
48119253|NCT04640311|100616412|FG010|COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||20||
48119254|NCT04640311|100616413|FG011|COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||19||
48119255|NCT04640311|100616414|FG012|COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||20||
48119256|NCT04640311|100616402|FG000|NOT COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||0||
48119257|NCT04640311|100616403|FG001|NOT COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||0||
48119258|NCT04640311|100616404|FG002|NOT COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||0||
48119259|NCT04640311|100616405|FG003|NOT COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||0||
48119260|NCT04640311|100616406|FG004|NOT COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||0||
48119261|NCT04640311|100616407|FG005|NOT COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||0||
48119262|NCT04640311|100616408|FG006|NOT COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||0||
48119263|NCT04640311|100616409|FG007|NOT COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||0||
48119264|NCT04640311|100616410|FG008|NOT COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||0||
48119265|NCT04640311|100616411|FG009|NOT COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||0||
48119266|NCT04640311|100616412|FG010|NOT COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||0||
48119267|NCT04640311|100616413|FG011|NOT COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||1||
48119268|NCT04640311|100616414|FG012|NOT COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||0||
48119269|NCT01222585|100616415|FG000|STARTED|Overall Study||24||
48119270|NCT01222585|100616415|FG000|COMPLETED|Overall Study||24||
48119271|NCT01222585|100616415|FG000|NOT COMPLETED|Overall Study||0||
48119272|NCT01302964|100616416|FG000|STARTED|Overall Study||20||
48119273|NCT01302964|100616417|FG001|STARTED|Overall Study||10||
48119274|NCT01302964|100616416|FG000|COMPLETED|Overall Study||19||
48119275|NCT01302964|100616417|FG001|COMPLETED|Overall Study||10||
48119276|NCT01302964|100616416|FG000|NOT COMPLETED|Overall Study||1||
48119277|NCT01302964|100616417|FG001|NOT COMPLETED|Overall Study||0||
48119278|NCT01649856|100616418|FG000|STARTED|Overall Study||369||
48119279|NCT01649856|100616419|FG001|STARTED|Overall Study||203||
48119280|NCT01649856|100616418|FG000|COMPLETED|Overall Study||230||
48119281|NCT01649856|100616419|FG001|COMPLETED|Overall Study||125||
48119282|NCT01649856|100616418|FG000|NOT COMPLETED|Overall Study||139||
48119283|NCT01649856|100616419|FG001|NOT COMPLETED|Overall Study||78||
48119284|NCT04904510|100616420|FG000|STARTED|Overall Study||297||
48119285|NCT04904510|100616420|FG000|COMPLETED|Overall Study||297||
48119286|NCT04904510|100616420|FG000|NOT COMPLETED|Overall Study||0||
48119287|NCT00559962|100616421|FG000|STARTED|Overall Study||33||
48119288|NCT00559962|100616422|FG001|STARTED|Overall Study||34||
48119289|NCT00559962|100616423|FG002|STARTED|Overall Study||34||
48119290|NCT00559962|100616424|FG003|STARTED|Overall Study||34||
48119291|NCT00559962|100616425|FG004|STARTED|Overall Study||35||
48119292|NCT00559962|100616426|FG005|STARTED|Overall Study||28||
48119293|NCT00559962|100616427|FG006|STARTED|Overall Study||33||
48119294|NCT00559962|100616428|FG007|STARTED|Overall Study||29||
48119295|NCT00559962|100616421|FG000|COMPLETED|Overall Study||31||
48119296|NCT00559962|100616422|FG001|COMPLETED|Overall Study||25||
48119297|NCT00559962|100616423|FG002|COMPLETED|Overall Study||24||
48119298|NCT00559962|100616424|FG003|COMPLETED|Overall Study||29||
48119299|NCT00559962|100616425|FG004|COMPLETED|Overall Study||21||
48119300|NCT00559962|100616426|FG005|COMPLETED|Overall Study||23||
48119301|NCT00559962|100616427|FG006|COMPLETED|Overall Study||28||
48119302|NCT00559962|100616428|FG007|COMPLETED|Overall Study||25||
48119303|NCT00559962|100616421|FG000|NOT COMPLETED|Overall Study||2||
48119304|NCT00559962|100616422|FG001|NOT COMPLETED|Overall Study||9||
48119305|NCT00559962|100616423|FG002|NOT COMPLETED|Overall Study||10||
48119306|NCT00559962|100616424|FG003|NOT COMPLETED|Overall Study||5||
48119307|NCT00559962|100616425|FG004|NOT COMPLETED|Overall Study||14||
48119308|NCT00559962|100616426|FG005|NOT COMPLETED|Overall Study||5||
48119309|NCT00559962|100616427|FG006|NOT COMPLETED|Overall Study||5||
48119310|NCT00559962|100616428|FG007|NOT COMPLETED|Overall Study||4||
48119311|NCT01195467|100616429|FG000|STARTED|Overall Study||40||
48119312|NCT01195467|100616429|FG000|COMPLETED|Overall Study||30||
48119313|NCT01195467|100616429|FG000|NOT COMPLETED|Overall Study||10||
48119314|NCT01110915|100616430|FG000|STARTED|Overall Study||177||
48119315|NCT01110915|100616431|FG001|STARTED|Overall Study||86||
48566311|NCT02509507|101717428|FG003|COMPLETED|Overall Study||4||
48566312|NCT02509507|101717429|FG004|COMPLETED|Overall Study||1||
48119316|NCT01110915|100616430|FG000|COMPLETED|Overall Study||167||
48119317|NCT01110915|100616431|FG001|COMPLETED|Overall Study||84||
48119318|NCT01110915|100616430|FG000|NOT COMPLETED|Overall Study||10||
48119319|NCT01110915|100616431|FG001|NOT COMPLETED|Overall Study||2||
48119320|NCT00667342|100616432|FG000|STARTED|Overall Study||31||
48119321|NCT00667342|100616433|FG001|STARTED|Overall Study||0||
48119322|NCT00667342|100616434|FG002|STARTED|Overall Study||12||
48119323|NCT00667342|100616432|FG000|COMPLETED|Overall Study||17||
48119324|NCT00667342|100616433|FG001|COMPLETED|Overall Study||0||
48119325|NCT00667342|100616434|FG002|COMPLETED|Overall Study||3||
48119326|NCT00667342|100616432|FG000|NOT COMPLETED|Overall Study||14||
48119327|NCT00667342|100616433|FG001|NOT COMPLETED|Overall Study||0||
48119328|NCT00667342|100616434|FG002|NOT COMPLETED|Overall Study||9||
48119329|NCT00796861|100616435|FG000|STARTED|Overall Study||4||
48119330|NCT00796861|100616435|FG000|COMPLETED|Overall Study||0||
48119331|NCT00796861|100616435|FG000|NOT COMPLETED|Overall Study||4||
48119332|NCT01663272|100616436|FG000|STARTED|Overall Study||5||
48119333|NCT01663272|100616437|FG001|STARTED|Overall Study||6||
48119334|NCT01663272|100616438|FG002|STARTED|Overall Study||1||
48119335|NCT01663272|100616436|FG000|COMPLETED|Overall Study||5||
48119336|NCT01663272|100616437|FG001|COMPLETED|Overall Study||6||
48119337|NCT01663272|100616438|FG002|COMPLETED|Overall Study||1||
48119338|NCT01663272|100616436|FG000|NOT COMPLETED|Overall Study||0||
48119339|NCT01663272|100616437|FG001|NOT COMPLETED|Overall Study||0||
48119340|NCT01663272|100616438|FG002|NOT COMPLETED|Overall Study||0||
48119341|NCT01416194|100616439|FG000|STARTED|Overall Study||1111||
48119342|NCT01416194|100616440|FG001|STARTED|Overall Study||2720||
48119343|NCT01416194|100616441|FG002|STARTED|Overall Study||6666||
48119344|NCT01416194|100616439|FG000|COMPLETED|Overall Study||1111||
48119345|NCT01416194|100616440|FG001|COMPLETED|Overall Study||2720||
48119346|NCT01416194|100616441|FG002|COMPLETED|Overall Study||6666||
48119347|NCT01416194|100616439|FG000|NOT COMPLETED|Overall Study||0||
48119348|NCT01416194|100616440|FG001|NOT COMPLETED|Overall Study||0||
48119349|NCT01416194|100616441|FG002|NOT COMPLETED|Overall Study||0||
48119350|NCT00691210|100616442|FG000|STARTED|Overall Study||3||
48119351|NCT00691210|100616443|FG001|STARTED|Overall Study||5||
48119352|NCT00691210|100616444|FG002|STARTED|Overall Study||3||
48119353|NCT00691210|100616445|FG003|STARTED|Overall Study||9||
48119354|NCT00691210|100616446|FG004|STARTED|Overall Study||5||
48119355|NCT00691210|100616447|FG005|STARTED|Overall Study||7||
48119356|NCT00691210|100616448|FG006|STARTED|Overall Study||6||
48119357|NCT00691210|100616449|FG007|STARTED|Overall Study||0||
48566313|NCT02509507|101717430|FG005|COMPLETED|Overall Study||1||
48119358|NCT00691210|100616442|FG000|COMPLETED|Overall Study||3||
48119359|NCT00691210|100616443|FG001|COMPLETED|Overall Study||5||
48566314|NCT02509507|101717431|FG006|COMPLETED|Overall Study||1||
48566315|NCT02509507|101717432|FG007|COMPLETED|Overall Study||1||
48566316|NCT02509507|101717433|FG008|COMPLETED|Overall Study||1||
48566317|NCT02509507|101717425|FG000|NOT COMPLETED|Overall Study||23||
48566318|NCT02509507|101717426|FG001|NOT COMPLETED|Overall Study||4||
48566319|NCT02509507|101717427|FG002|NOT COMPLETED|Overall Study||23||
48119360|NCT00691210|100616444|FG002|COMPLETED|Overall Study||3||
48119361|NCT00691210|100616445|FG003|COMPLETED|Overall Study||6||
48119362|NCT00691210|100616446|FG004|COMPLETED|Overall Study||5||
48119363|NCT00691210|100616447|FG005|COMPLETED|Overall Study||6||
48119364|NCT00691210|100616448|FG006|COMPLETED|Overall Study||6||
48119365|NCT00691210|100616449|FG007|COMPLETED|Overall Study||0||
48119366|NCT00691210|100616442|FG000|NOT COMPLETED|Overall Study||0||
48119367|NCT00691210|100616443|FG001|NOT COMPLETED|Overall Study||0||
48119368|NCT00691210|100616444|FG002|NOT COMPLETED|Overall Study||0||
48119369|NCT00691210|100616445|FG003|NOT COMPLETED|Overall Study||3||
48119370|NCT00691210|100616446|FG004|NOT COMPLETED|Overall Study||0||
48119371|NCT00691210|100616447|FG005|NOT COMPLETED|Overall Study||1||
48119372|NCT00691210|100616448|FG006|NOT COMPLETED|Overall Study||0||
48119373|NCT00691210|100616449|FG007|NOT COMPLETED|Overall Study||0||
48119374|NCT03135522|100616450|FG000|STARTED|Overall Study||17||
48119375|NCT03135522|100616451|FG001|STARTED|Overall Study||17||
48119376|NCT03135522|100616450|FG000|COMPLETED|Overall Study||16||
48119377|NCT03135522|100616451|FG001|COMPLETED|Overall Study||17||
48119378|NCT03135522|100616450|FG000|NOT COMPLETED|Overall Study||1||
48119379|NCT03135522|100616451|FG001|NOT COMPLETED|Overall Study||0||
48119380|NCT02247349|100616452|FG000|STARTED|Overall Study||7||
48119381|NCT02247349|100616453|FG001|STARTED|Overall Study||6||
48119382|NCT02247349|100616454|FG002|STARTED|Overall Study||29||
48119383|NCT02247349|100616455|FG003|STARTED|Overall Study||35||
48119384|NCT02247349|100616456|FG004|STARTED|Overall Study||21||
48119385|NCT02247349|100616457|FG005|STARTED|Overall Study||8||
48119386|NCT02247349|100616452|FG000|COMPLETED|Overall Study||0||
48119387|NCT02247349|100616453|FG001|COMPLETED|Overall Study||0||
48119388|NCT02247349|100616454|FG002|COMPLETED|Overall Study||0||
48566320|NCT02509507|101717428|FG003|NOT COMPLETED|Overall Study||18||
48566321|NCT02509507|101717429|FG004|NOT COMPLETED|Overall Study||9||
48566322|NCT02509507|101717430|FG005|NOT COMPLETED|Overall Study||17||
48566323|NCT02509507|101717431|FG006|NOT COMPLETED|Overall Study||9||
48566324|NCT02509507|101717432|FG007|NOT COMPLETED|Overall Study||4||
48566325|NCT02509507|101717433|FG008|NOT COMPLETED|Overall Study||9||
48566326|NCT01286467|101717434|FG000|STARTED|Overall Study||4||
48566327|NCT01286467|101717435|FG001|STARTED|Overall Study||4||
48566328|NCT01286467|101717436|FG002|STARTED|Overall Study||7||
48566329|NCT01286467|101717437|FG003|STARTED|Overall Study||8||
48566330|NCT01286467|101717434|FG000|COMPLETED|Overall Study||0||
48566331|NCT01286467|101717435|FG001|COMPLETED|Overall Study||0||
48566332|NCT01286467|101717436|FG002|COMPLETED|Overall Study||0||
48119389|NCT02247349|100616455|FG003|COMPLETED|Overall Study||0||
48119390|NCT02247349|100616456|FG004|COMPLETED|Overall Study||0||
48119391|NCT02247349|100616457|FG005|COMPLETED|Overall Study||0||
48119392|NCT02247349|100616452|FG000|NOT COMPLETED|Overall Study||7||
48119393|NCT02247349|100616453|FG001|NOT COMPLETED|Overall Study||6||
48119394|NCT02247349|100616454|FG002|NOT COMPLETED|Overall Study||29||
48119395|NCT02247349|100616455|FG003|NOT COMPLETED|Overall Study||35||
48119396|NCT02247349|100616456|FG004|NOT COMPLETED|Overall Study||21||
48119397|NCT02247349|100616457|FG005|NOT COMPLETED|Overall Study||8||
48119398|NCT00654628|100616458|FG000|STARTED|6-week Active Treatment Period||173||
48119399|NCT00654628|100616458|FG000|COMPLETED|6-week Active Treatment Period||152||
48119400|NCT00654628|100616458|FG000|NOT COMPLETED|6-week Active Treatment Period||21||
48119401|NCT00654628|100616458|FG000|STARTED|6 -Week Extension Period (Single Site)||60||
48119402|NCT00654628|100616458|FG000|COMPLETED|6 -Week Extension Period (Single Site)||55||
48119403|NCT00654628|100616458|FG000|NOT COMPLETED|6 -Week Extension Period (Single Site)||5||
48119404|NCT02164396|100616459|FG000|STARTED|Overall Study||10||
48119405|NCT02164396|100616460|FG001|STARTED|Overall Study||10||
48119406|NCT02164396|100616461|FG002|STARTED|Overall Study||10||
48119407|NCT02164396|100616459|FG000|COMPLETED|Overall Study||10||
48119408|NCT02164396|100616460|FG001|COMPLETED|Overall Study||10||
48119409|NCT02164396|100616461|FG002|COMPLETED|Overall Study||10||
48119410|NCT02164396|100616459|FG000|NOT COMPLETED|Overall Study||0||
48119411|NCT02164396|100616460|FG001|NOT COMPLETED|Overall Study||0||
48119412|NCT02164396|100616461|FG002|NOT COMPLETED|Overall Study||0||
48119413|NCT03194646|100616462|FG000|STARTED|Overall Study||363|Randomized|
48119414|NCT03194646|100616463|FG001|STARTED|Overall Study||361|Randomized|
48119415|NCT03194646|100616464|FG002|STARTED|Overall Study||183|Randomized|
48119416|NCT03194646|100616465|FG003|STARTED|Overall Study||365|Randomized|
48566333|NCT01286467|101717437|FG003|COMPLETED|Overall Study||0||
48566334|NCT01286467|101717434|FG000|NOT COMPLETED|Overall Study||4||
48566335|NCT01286467|101717435|FG001|NOT COMPLETED|Overall Study||4||
48566336|NCT01286467|101717436|FG002|NOT COMPLETED|Overall Study||7||
48566337|NCT01286467|101717437|FG003|NOT COMPLETED|Overall Study||8||
48566338|NCT03379727|101717438|FG000|STARTED|Overall Study||301||
48566339|NCT03379727|101717438|FG000|Entered Induction Phase|Overall Study||301||
48566340|NCT03379727|101717438|FG000|Entered Consolidation Phase|Overall Study||210||
48119417|NCT03194646|100616462|FG000|Treated|Overall Study||349|Treated (with study drug or study drug administration status unknown or randomized to Standard of Care)|
48119418|NCT03194646|100616463|FG001|Treated|Overall Study||347|Treated (with study drug or study drug administration status unknown or randomized to Standard of Care)|
48119419|NCT03194646|100616464|FG002|Treated|Overall Study||177|Treated (with study drug or study drug administration status unknown or randomized to Standard of Care)|
48119420|NCT03194646|100616465|FG003|Treated|Overall Study||365|Treated (with study drug or study drug administration status unknown or randomized to Standard of Care)|
48119421|NCT03194646|100616462|FG000|COMPLETED|Overall Study||59||
48119422|NCT03194646|100616463|FG001|COMPLETED|Overall Study||93||
48119423|NCT03194646|100616464|FG002|COMPLETED|Overall Study||44||
48119424|NCT03194646|100616465|FG003|COMPLETED|Overall Study||85||
48119425|NCT03194646|100616462|FG000|NOT COMPLETED|Overall Study||304||
48119426|NCT03194646|100616463|FG001|NOT COMPLETED|Overall Study||268||
48119427|NCT03194646|100616464|FG002|NOT COMPLETED|Overall Study||139||
48119428|NCT03194646|100616465|FG003|NOT COMPLETED|Overall Study||280||
48119429|NCT03921411|100616466|FG000|STARTED|Overall Study||20||
48119430|NCT03921411|100616466|FG000|Treated|Overall Study||18||
48119431|NCT03921411|100616466|FG000|COMPLETED|Overall Study||15||
48119432|NCT03921411|100616466|FG000|NOT COMPLETED|Overall Study||5||
48119433|NCT01540370|100616467|FG000|STARTED|Overall Study||102||
48119434|NCT01540370|100616467|FG000|COMPLETED|Overall Study||100||
48119435|NCT01540370|100616467|FG000|NOT COMPLETED|Overall Study||2||
48119436|NCT00807092|100616468|FG000|STARTED|Overall Study||72||
48119437|NCT00807092|100616469|FG001|STARTED|Overall Study||73||
48119438|NCT00807092|100616468|FG000|Exposed to Drug|Overall Study||71||
48119439|NCT00807092|100616469|FG001|Exposed to Drug|Overall Study||73||
48119440|NCT00807092|100616468|FG000|COMPLETED|Overall Study||71||
48119441|NCT00807092|100616469|FG001|COMPLETED|Overall Study||69||
48119442|NCT00807092|100616468|FG000|NOT COMPLETED|Overall Study||1||
48119443|NCT00807092|100616469|FG001|NOT COMPLETED|Overall Study||4||
48119444|NCT00910715|100616470|FG000|STARTED|Overall Study||108||
48566341|NCT03379727|101717438|FG000|Entered Maintenance Phase|Overall Study||93||
48566342|NCT03379727|101717438|FG000|COMPLETED|Overall Study||52|Completed = Patients who completed all 3 phases (Induction, Consolidation \& Maintenance)|
48566343|NCT03379727|101717438|FG000|NOT COMPLETED|Overall Study||249||
48566344|NCT03190993|101717439|FG000|STARTED|Overall Study||10||
48566345|NCT03190993|101717440|FG001|STARTED|Overall Study||10||
48566346|NCT03190993|101717439|FG000|COMPLETED|Overall Study||10||
48566347|NCT03190993|101717440|FG001|COMPLETED|Overall Study||10||
48566348|NCT03190993|101717439|FG000|NOT COMPLETED|Overall Study||0||
48566349|NCT03190993|101717440|FG001|NOT COMPLETED|Overall Study||0||
48566350|NCT03526861|101717441|FG000|STARTED|Initial Treatment Period||101||
48566351|NCT03526861|101717442|FG001|STARTED|Initial Treatment Period||100||
48566352|NCT03526861|101717443|FG002|STARTED|Initial Treatment Period||100||
48566353|NCT03526861|101717444|FG003|STARTED|Initial Treatment Period||0||
48566354|NCT03526861|101717445|FG004|STARTED|Initial Treatment Period||0||
48119445|NCT00910715|100616471|FG001|STARTED|Overall Study||117||
48119446|NCT00910715|100616472|FG002|STARTED|Overall Study||81||
48566355|NCT03526861|101717446|FG005|STARTED|Initial Treatment Period||0||
48566356|NCT03526861|101717447|FG006|STARTED|Initial Treatment Period||0||
48566357|NCT03526861|101717448|FG007|STARTED|Initial Treatment Period||0||
48394837|NCT04491240|101296027|FG000|COMPLETED|Overall Study||10||
48394838|NCT04491240|101296028|FG001|COMPLETED|Overall Study||10||
48394839|NCT04491240|101296029|FG002|COMPLETED|Overall Study||10||
48394840|NCT04491240|101296027|FG000|NOT COMPLETED|Overall Study||0||
48394841|NCT04491240|101296028|FG001|NOT COMPLETED|Overall Study||0||
48394842|NCT04491240|101296029|FG002|NOT COMPLETED|Overall Study||0||
48394843|NCT01998399|101296030|FG000|STARTED|Overall Study||12||
48394844|NCT01998399|101296031|FG001|STARTED|Overall Study||13||
48394845|NCT01998399|101296030|FG000|COMPLETED|Overall Study||4||
48394846|NCT01998399|101296031|FG001|COMPLETED|Overall Study||4||
48394847|NCT01998399|101296030|FG000|NOT COMPLETED|Overall Study||8||
48394848|NCT01998399|101296031|FG001|NOT COMPLETED|Overall Study||9||
48394849|NCT01332019|101296032|FG000|STARTED|Overall Study||530||
48394850|NCT01332019|101296033|FG001|STARTED|Overall Study||547||
48394851|NCT01332019|101296032|FG000|COMPLETED|Overall Study||417||
48394852|NCT01332019|101296033|FG001|COMPLETED|Overall Study||425||
48394853|NCT01332019|101296032|FG000|NOT COMPLETED|Overall Study||113||
48394854|NCT01332019|101296033|FG001|NOT COMPLETED|Overall Study||122||
48394855|NCT02062398|101296034|FG000|STARTED|Overall Study||13||
48394856|NCT02062398|101296034|FG000|COMPLETED|Overall Study||12||
48394857|NCT02062398|101296034|FG000|NOT COMPLETED|Overall Study||1||
48394858|NCT04179786|101296035|FG000|STARTED|Overall Study||91||
48394859|NCT04179786|101296035|FG000|COMPLETED|Overall Study||83||
48394860|NCT04179786|101296035|FG000|NOT COMPLETED|Overall Study||8||
48394861|NCT03434418|101296036|FG000|STARTED|Overall Study||17||
48394862|NCT03434418|101296036|FG000|COMPLETED|Overall Study||2||
48566358|NCT03526861|101717449|FG008|STARTED|Initial Treatment Period||0||
48566359|NCT03526861|101717441|FG000|COMPLETED|Initial Treatment Period||94||
48566360|NCT03526861|101717442|FG001|COMPLETED|Initial Treatment Period||93||
48280436|NCT04041453|101010506|FG000|NOT COMPLETED|Overall Study||14||
48280437|NCT04041453|101010507|FG001|NOT COMPLETED|Overall Study||22||
48280438|NCT04041453|101010508|FG002|NOT COMPLETED|Overall Study||5||
48566361|NCT03526861|101717443|FG002|COMPLETED|Initial Treatment Period||86||
48566362|NCT03526861|101717444|FG003|COMPLETED|Initial Treatment Period||0||
48566363|NCT03526861|101717445|FG004|COMPLETED|Initial Treatment Period||0||
48566364|NCT03526861|101717446|FG005|COMPLETED|Initial Treatment Period||0||
48280439|NCT04041453|101010509|FG003|NOT COMPLETED|Overall Study||18||
48566365|NCT03526861|101717447|FG006|COMPLETED|Initial Treatment Period||0||
48698409|NCT02374814|102045626|FG003|STARTED|Overall Study||11||
48698410|NCT02374814|102045627|FG004|STARTED|Overall Study||6||
48280440|NCT04193826|101010510|FG000|STARTED|Overall Study||20||
48280441|NCT04193826|101010510|FG000|Screen Failed|Overall Study||1||
48280442|NCT04193826|101010510|FG000|Implanted|Overall Study||19||
48280443|NCT04193826|101010510|FG000|Subject Death|Overall Study||2||
48280444|NCT04193826|101010510|FG000|COMPLETED|Overall Study||17||
48280445|NCT04193826|101010510|FG000|NOT COMPLETED|Overall Study||3||
48280446|NCT02349425|101010511|FG000|STARTED|Period 1||15||
48280447|NCT02349425|101010512|FG001|STARTED|Period 1||14||
48280448|NCT02349425|101010513|FG002|STARTED|Period 1||15||
48280449|NCT02349425|101010514|FG003|STARTED|Period 1||15||
48280450|NCT02349425|101010511|FG000|COMPLETED|Period 1||14||
48280451|NCT02349425|101010512|FG001|COMPLETED|Period 1||13||
48280452|NCT02349425|101010513|FG002|COMPLETED|Period 1||15||
48280453|NCT02349425|101010514|FG003|COMPLETED|Period 1||15||
48280454|NCT02349425|101010511|FG000|NOT COMPLETED|Period 1||1||
48280455|NCT02349425|101010512|FG001|NOT COMPLETED|Period 1||1||
48280456|NCT02349425|101010513|FG002|NOT COMPLETED|Period 1||0||
48566366|NCT03526861|101717448|FG007|COMPLETED|Initial Treatment Period||0||
48566367|NCT03526861|101717449|FG008|COMPLETED|Initial Treatment Period||0||
48566368|NCT03526861|101717441|FG000|NOT COMPLETED|Initial Treatment Period||7||
48566369|NCT03526861|101717442|FG001|NOT COMPLETED|Initial Treatment Period||7||
48566370|NCT03526861|101717443|FG002|NOT COMPLETED|Initial Treatment Period||14||
48698411|NCT02374814|102045628|FG005|STARTED|Overall Study||6||
48698412|NCT02374814|102045623|FG000|COMPLETED|Overall Study||11||
48698413|NCT02374814|102045624|FG001|COMPLETED|Overall Study||11||
48698414|NCT02374814|102045625|FG002|COMPLETED|Overall Study||11||
48698415|NCT02374814|102045626|FG003|COMPLETED|Overall Study||9||
48698416|NCT02374814|102045627|FG004|COMPLETED|Overall Study||6||
48698417|NCT02374814|102045628|FG005|COMPLETED|Overall Study||6||
48698418|NCT02374814|102045623|FG000|NOT COMPLETED|Overall Study||1||
48698419|NCT02374814|102045624|FG001|NOT COMPLETED|Overall Study||1||
48698420|NCT02374814|102045625|FG002|NOT COMPLETED|Overall Study||1||
48698421|NCT02374814|102045626|FG003|NOT COMPLETED|Overall Study||2||
48698422|NCT02374814|102045627|FG004|NOT COMPLETED|Overall Study||0||
48698423|NCT02374814|102045628|FG005|NOT COMPLETED|Overall Study||0||
48698424|NCT03006458|102045629|FG000|STARTED|First Intervention||14||
48698425|NCT03006458|102045630|FG001|STARTED|First Intervention||10||
48698426|NCT03006458|102045629|FG000|COMPLETED|First Intervention||14||
48698427|NCT03006458|102045630|FG001|COMPLETED|First Intervention||7||
48698428|NCT03006458|102045629|FG000|NOT COMPLETED|First Intervention||0||
48698429|NCT03006458|102045630|FG001|NOT COMPLETED|First Intervention||3||
48698430|NCT03006458|102045629|FG000|STARTED|Second Intervention||14||
48698431|NCT03006458|102045630|FG001|STARTED|Second Intervention||10||
48698432|NCT03006458|102045629|FG000|COMPLETED|Second Intervention||14||
48698433|NCT03006458|102045630|FG001|COMPLETED|Second Intervention||10||
48280457|NCT02349425|101010514|FG003|NOT COMPLETED|Period 1||0||
48566371|NCT03526861|101717444|FG003|NOT COMPLETED|Initial Treatment Period||0||
48566372|NCT03526861|101717445|FG004|NOT COMPLETED|Initial Treatment Period||0||
48566373|NCT03526861|101717446|FG005|NOT COMPLETED|Initial Treatment Period||0||
48566374|NCT03526861|101717447|FG006|NOT COMPLETED|Initial Treatment Period||0||
48566375|NCT03526861|101717448|FG007|NOT COMPLETED|Initial Treatment Period||0||
48566376|NCT03526861|101717449|FG008|NOT COMPLETED|Initial Treatment Period||0||
48566377|NCT03526861|101717441|FG000|STARTED|Maintenance Treatment Period||0|Maintenance treatment period was in parallel to the open-label treatment period.|
48566378|NCT03526861|101717442|FG001|STARTED|Maintenance Treatment Period||0|Maintenance treatment period was in parallel to the open-label treatment period.|
48566379|NCT03526861|101717443|FG002|STARTED|Maintenance Treatment Period||0|Maintenance treatment period was in parallel to the open-label treatment period.|
48566380|NCT03526861|101717444|FG003|STARTED|Maintenance Treatment Period||13|Maintenance treatment period was in parallel to the open-label treatment period.|
48698434|NCT03006458|102045629|FG000|NOT COMPLETED|Second Intervention||0||
48698435|NCT03006458|102045630|FG001|NOT COMPLETED|Second Intervention||0||
48280458|NCT02349425|101010511|FG000|STARTED|Period 2||14||
48280459|NCT02349425|101010512|FG001|STARTED|Period 2||13||
48280460|NCT02349425|101010513|FG002|STARTED|Period 2||15||
48119447|NCT00910715|100616470|FG000|COMPLETED|Overall Study||86||
48566381|NCT03526861|101717445|FG004|STARTED|Maintenance Treatment Period||14|Maintenance treatment period was in parallel to the open-label treatment period.|
48566382|NCT03526861|101717446|FG005|STARTED|Maintenance Treatment Period||12|Maintenance treatment period was in parallel to the open-label treatment period.|
48566383|NCT03526861|101717447|FG006|STARTED|Maintenance Treatment Period||14|Maintenance treatment period was in parallel to the open-label treatment period.|
48566384|NCT03526861|101717448|FG007|STARTED|Maintenance Treatment Period||6|Maintenance treatment period was in parallel to the open-label treatment period.|
48566385|NCT03526861|101717449|FG008|STARTED|Maintenance Treatment Period||0|Maintenance treatment period was in parallel to the open-label treatment period.|
48566386|NCT03526861|101717441|FG000|COMPLETED|Maintenance Treatment Period||0||
48698436|NCT04627675|102050313|FG000|STARTED|Overall Study||3||
48698437|NCT04627675|102050314|FG001|STARTED|Overall Study||3||
48280461|NCT02349425|101010514|FG003|STARTED|Period 2||15||
48119448|NCT00910715|100616471|FG001|COMPLETED|Overall Study||91||
48119449|NCT00910715|100616472|FG002|COMPLETED|Overall Study||81||
48119450|NCT00910715|100616470|FG000|NOT COMPLETED|Overall Study||22||
48280462|NCT02349425|101010511|FG000|COMPLETED|Period 2||14||
48280463|NCT02349425|101010512|FG001|COMPLETED|Period 2||12||
48280464|NCT02349425|101010513|FG002|COMPLETED|Period 2||14||
48280465|NCT02349425|101010514|FG003|COMPLETED|Period 2||15||
48280466|NCT02349425|101010511|FG000|NOT COMPLETED|Period 2||0||
48280467|NCT02349425|101010512|FG001|NOT COMPLETED|Period 2||1||
48698438|NCT04627675|102050315|FG002|STARTED|Overall Study||2||
48698439|NCT04627675|102050316|FG003|STARTED|Overall Study||3||
48698440|NCT04627675|102050313|FG000|COMPLETED|Overall Study||3||
48698441|NCT04627675|102050314|FG001|COMPLETED|Overall Study||3||
48698442|NCT04627675|102050315|FG002|COMPLETED|Overall Study||2||
48698443|NCT04627675|102050316|FG003|COMPLETED|Overall Study||3||
48698444|NCT04627675|102050313|FG000|NOT COMPLETED|Overall Study||0||
48698445|NCT04627675|102050314|FG001|NOT COMPLETED|Overall Study||0||
48698446|NCT04627675|102050315|FG002|NOT COMPLETED|Overall Study||0||
48698447|NCT04627675|102050316|FG003|NOT COMPLETED|Overall Study||0||
48698448|NCT02141867|102050317|FG000|STARTED|Overall Study||4021||
48698449|NCT02141867|102050317|FG000|COMPLETED|Overall Study||3927||
48698450|NCT02141867|102050317|FG000|NOT COMPLETED|Overall Study||94||
48698451|NCT00542490|102050318|FG000|STARTED|Overall Study||23||
48698452|NCT00542490|102050318|FG000|COMPLETED|Overall Study||21||
48698453|NCT00542490|102050318|FG000|NOT COMPLETED|Overall Study||2||
48698454|NCT01335724|102050319|FG000|STARTED|Overall Study||36||
48698455|NCT01335724|102050320|FG001|STARTED|Overall Study||36||
48698456|NCT01335724|102050319|FG000|COMPLETED|Overall Study||36||
48698457|NCT01335724|102050320|FG001|COMPLETED|Overall Study||36||
48698458|NCT01335724|102050319|FG000|NOT COMPLETED|Overall Study||0||
48698459|NCT01335724|102050320|FG001|NOT COMPLETED|Overall Study||0||
48698460|NCT01218958|102050321|FG000|STARTED|Overall Study||210||
48698461|NCT01218958|102050322|FG001|STARTED|Overall Study||205||
48698462|NCT01218958|102050323|FG002|STARTED|Overall Study||209||
48119451|NCT00910715|100616471|FG001|NOT COMPLETED|Overall Study||26||
48280468|NCT02349425|101010513|FG002|NOT COMPLETED|Period 2||1||
48280469|NCT02349425|101010514|FG003|NOT COMPLETED|Period 2||0||
48280470|NCT03385343|101010515|FG000|STARTED|Overall Study||30||
48280471|NCT03385343|101010515|FG000|COMPLETED|Overall Study||22||
48280472|NCT03385343|101010515|FG000|NOT COMPLETED|Overall Study||8||
48698463|NCT01218958|102050321|FG000|COMPLETED|Overall Study||126||
48698464|NCT01218958|102050322|FG001|COMPLETED|Overall Study||124||
48698465|NCT01218958|102050323|FG002|COMPLETED|Overall Study||128||
48698466|NCT01218958|102050321|FG000|NOT COMPLETED|Overall Study||84||
48698467|NCT01218958|102050322|FG001|NOT COMPLETED|Overall Study||81||
48698468|NCT01218958|102050323|FG002|NOT COMPLETED|Overall Study||81||
48698469|NCT00178919|102050324|FG000|STARTED|Overall Study||19||
48698470|NCT00178919|102050325|FG001|STARTED|Overall Study||93||
48698471|NCT00178919|102050324|FG000|COMPLETED|Overall Study||19||
48698472|NCT00178919|102050325|FG001|COMPLETED|Overall Study||68||
48698473|NCT00178919|102050324|FG000|NOT COMPLETED|Overall Study||0||
48698474|NCT00178919|102050325|FG001|NOT COMPLETED|Overall Study||25||
48698475|NCT00624585|102050326|FG000|STARTED|Overall Study||18||
48280473|NCT04512703|101010516|FG000|STARTED|Within 7 Days From Start of Device Wear||6||
48280474|NCT04512703|101010517|FG001|STARTED|Within 7 Days From Start of Device Wear||45||
48566387|NCT03526861|101717442|FG001|COMPLETED|Maintenance Treatment Period||0||
48566388|NCT03526861|101717443|FG002|COMPLETED|Maintenance Treatment Period||0||
48566389|NCT03526861|101717444|FG003|COMPLETED|Maintenance Treatment Period||5||
48566390|NCT03526861|101717445|FG004|COMPLETED|Maintenance Treatment Period||8||
48566391|NCT03526861|101717446|FG005|COMPLETED|Maintenance Treatment Period||8||
48566392|NCT03526861|101717447|FG006|COMPLETED|Maintenance Treatment Period||8||
48566393|NCT03526861|101717448|FG007|COMPLETED|Maintenance Treatment Period||4||
48566394|NCT03526861|101717449|FG008|COMPLETED|Maintenance Treatment Period||0||
48566395|NCT03526861|101717441|FG000|NOT COMPLETED|Maintenance Treatment Period||0||
48566396|NCT03526861|101717442|FG001|NOT COMPLETED|Maintenance Treatment Period||0||
48566397|NCT03526861|101717443|FG002|NOT COMPLETED|Maintenance Treatment Period||0||
48566398|NCT03526861|101717444|FG003|NOT COMPLETED|Maintenance Treatment Period||8||
48566399|NCT03526861|101717445|FG004|NOT COMPLETED|Maintenance Treatment Period||6||
48566400|NCT03526861|101717446|FG005|NOT COMPLETED|Maintenance Treatment Period||4||
48566401|NCT03526861|101717447|FG006|NOT COMPLETED|Maintenance Treatment Period||6||
48280475|NCT04512703|101010516|FG000|Wore Front Position|Within 7 Days From Start of Device Wear||6||
48280476|NCT04512703|101010517|FG001|Wore Front Position|Within 7 Days From Start of Device Wear||45||
48280477|NCT04512703|101010516|FG000|Wore Side Position|Within 7 Days From Start of Device Wear||6||
48280478|NCT04512703|101010517|FG001|Wore Side Position|Within 7 Days From Start of Device Wear||45||
48280479|NCT04512703|101010516|FG000|COMPLETED|Within 7 Days From Start of Device Wear||6||
48280480|NCT04512703|101010517|FG001|COMPLETED|Within 7 Days From Start of Device Wear||45||
48566402|NCT03526861|101717448|FG007|NOT COMPLETED|Maintenance Treatment Period||2||
48566403|NCT03526861|101717449|FG008|NOT COMPLETED|Maintenance Treatment Period||0||
48566404|NCT03526861|101717441|FG000|STARTED|Open-label Treatment Period||0|Open-label treatment period was in parallel to the maintenance treatment period.|
48566405|NCT03526861|101717442|FG001|STARTED|Open-label Treatment Period||0|Open-label treatment period was in parallel to the maintenance treatment period.|
48566406|NCT03526861|101717443|FG002|STARTED|Open-label Treatment Period||0|Open-label treatment period was in parallel to the maintenance treatment period.|
48566407|NCT03526861|101717444|FG003|STARTED|Open-label Treatment Period||0|Open-label treatment period was in parallel to the maintenance treatment period.|
48566408|NCT03526861|101717445|FG004|STARTED|Open-label Treatment Period||0|Open-label treatment period was in parallel to the maintenance treatment period.|
48566409|NCT03526861|101717446|FG005|STARTED|Open-label Treatment Period||0|Open-label treatment period was in parallel to the maintenance treatment period.|
48566410|NCT03526861|101717447|FG006|STARTED|Open-label Treatment Period||0|Open-label treatment period was in parallel to the maintenance treatment period.|
48566411|NCT03526861|101717448|FG007|STARTED|Open-label Treatment Period||0|Open-label treatment period was in parallel to the maintenance treatment period.|
48566412|NCT03526861|101717449|FG008|STARTED|Open-label Treatment Period||242|Open-label treatment period was in parallel to the maintenance treatment period.|
48566413|NCT03526861|101717441|FG000|COMPLETED|Open-label Treatment Period||0||
48566414|NCT03526861|101717442|FG001|COMPLETED|Open-label Treatment Period||0||
48566415|NCT03526861|101717443|FG002|COMPLETED|Open-label Treatment Period||0||
48566416|NCT03526861|101717444|FG003|COMPLETED|Open-label Treatment Period||0||
48566417|NCT03526861|101717445|FG004|COMPLETED|Open-label Treatment Period||0||
48566418|NCT03526861|101717446|FG005|COMPLETED|Open-label Treatment Period||0||
48566419|NCT03526861|101717447|FG006|COMPLETED|Open-label Treatment Period||0||
48566420|NCT03526861|101717448|FG007|COMPLETED|Open-label Treatment Period||0||
48566421|NCT03526861|101717449|FG008|COMPLETED|Open-label Treatment Period||214||
48566422|NCT03526861|101717441|FG000|NOT COMPLETED|Open-label Treatment Period||0||
48566423|NCT03526861|101717442|FG001|NOT COMPLETED|Open-label Treatment Period||0||
48566424|NCT03526861|101717443|FG002|NOT COMPLETED|Open-label Treatment Period||0||
48566425|NCT03526861|101717444|FG003|NOT COMPLETED|Open-label Treatment Period||0||
48566426|NCT03526861|101717445|FG004|NOT COMPLETED|Open-label Treatment Period||0||
48566427|NCT03526861|101717446|FG005|NOT COMPLETED|Open-label Treatment Period||0||
48566428|NCT03526861|101717447|FG006|NOT COMPLETED|Open-label Treatment Period||0||
48566429|NCT03526861|101717448|FG007|NOT COMPLETED|Open-label Treatment Period||0||
48566430|NCT03526861|101717449|FG008|NOT COMPLETED|Open-label Treatment Period||28||
48566431|NCT00696423|101717450|FG000|STARTED|Overall Study||244||
48566432|NCT00696423|101717451|FG001|STARTED|Overall Study||223||
48566433|NCT00696423|101717450|FG000|COMPLETED|Overall Study||244||
48566434|NCT00696423|101717451|FG001|COMPLETED|Overall Study||218||
48566435|NCT00696423|101717450|FG000|NOT COMPLETED|Overall Study||0||
48566436|NCT00696423|101717451|FG001|NOT COMPLETED|Overall Study||5||
48566437|NCT01582490|101717452|FG000|STARTED|Overall Study||9||
48280481|NCT04512703|101010516|FG000|NOT COMPLETED|Within 7 Days From Start of Device Wear||0||
48280482|NCT04512703|101010517|FG001|NOT COMPLETED|Within 7 Days From Start of Device Wear||0||
48280483|NCT04512703|101010516|FG000|STARTED|Between 7th and 90th Day of Device Wear||6||
48280484|NCT04512703|101010517|FG001|STARTED|Between 7th and 90th Day of Device Wear||45||
48280485|NCT04512703|101010516|FG000|Wore Side Position Device|Between 7th and 90th Day of Device Wear||3||
48394863|NCT03434418|101296036|FG000|NOT COMPLETED|Overall Study||15||
48394864|NCT00179517|101296037|FG000|STARTED|Overall Study||20||
48394865|NCT00179517|101296038|FG001|STARTED|Overall Study||20||
48394866|NCT00179517|101296037|FG000|COMPLETED|Overall Study||18||
48394867|NCT00179517|101296038|FG001|COMPLETED|Overall Study||19||
48394868|NCT00179517|101296037|FG000|NOT COMPLETED|Overall Study||2||
48566438|NCT01582490|101717453|FG001|STARTED|Overall Study||10||
48566439|NCT01582490|101717452|FG000|COMPLETED|Overall Study||8||
48566440|NCT01582490|101717453|FG001|COMPLETED|Overall Study||9||
48566441|NCT01582490|101717452|FG000|NOT COMPLETED|Overall Study||1||
48566442|NCT01582490|101717453|FG001|NOT COMPLETED|Overall Study||1||
48566443|NCT02512302|101717454|FG000|STARTED|Period 1||3||
48280486|NCT04512703|101010517|FG001|Wore Side Position Device|Between 7th and 90th Day of Device Wear||23||
48280487|NCT04512703|101010516|FG000|Wore Front Position Device|Between 7th and 90th Day of Device Wear||3||
48280488|NCT04512703|101010517|FG001|Wore Front Position Device|Between 7th and 90th Day of Device Wear||22||
48280489|NCT04512703|101010516|FG000|COMPLETED|Between 7th and 90th Day of Device Wear||6||
48280490|NCT04512703|101010517|FG001|COMPLETED|Between 7th and 90th Day of Device Wear||45||
48280491|NCT04512703|101010516|FG000|NOT COMPLETED|Between 7th and 90th Day of Device Wear||0||
48280492|NCT04512703|101010517|FG001|NOT COMPLETED|Between 7th and 90th Day of Device Wear||0||
48394869|NCT00179517|101296038|FG001|NOT COMPLETED|Overall Study||1||
48394870|NCT02980692|101296039|FG000|STARTED|Double Blind Placebo Controlled Period||78||
48394871|NCT02980692|101296040|FG001|STARTED|Double Blind Placebo Controlled Period||79||
48119452|NCT00910715|100616472|FG002|NOT COMPLETED|Overall Study||0||
48119453|NCT01440322|100616473|FG000|STARTED|Overall Study||97||
48119454|NCT01440322|100616474|FG001|STARTED|Overall Study||50||
48280493|NCT00112827|101010518|FG000|STARTED|Overall Study||3||
48394872|NCT02980692|101296041|FG002|STARTED|Double Blind Placebo Controlled Period||77||
48394873|NCT02980692|101296042|FG003|STARTED|Double Blind Placebo Controlled Period||78||
48394874|NCT02980692|101296043|FG004|STARTED|Double Blind Placebo Controlled Period||79||
48394875|NCT02980692|101296039|FG000|COMPLETED|Double Blind Placebo Controlled Period||62||
48394876|NCT02980692|101296040|FG001|COMPLETED|Double Blind Placebo Controlled Period||64||
48394877|NCT02980692|101296041|FG002|COMPLETED|Double Blind Placebo Controlled Period||60||
48394878|NCT02980692|101296042|FG003|COMPLETED|Double Blind Placebo Controlled Period||71||
48394879|NCT02980692|101296043|FG004|COMPLETED|Double Blind Placebo Controlled Period||74||
48394880|NCT02980692|101296039|FG000|NOT COMPLETED|Double Blind Placebo Controlled Period||16||
48394881|NCT02980692|101296040|FG001|NOT COMPLETED|Double Blind Placebo Controlled Period||15||
48394882|NCT02980692|101296041|FG002|NOT COMPLETED|Double Blind Placebo Controlled Period||17||
48394883|NCT02980692|101296042|FG003|NOT COMPLETED|Double Blind Placebo Controlled Period||7||
48394884|NCT02980692|101296043|FG004|NOT COMPLETED|Double Blind Placebo Controlled Period||5||
48394885|NCT02980692|101296039|FG000|STARTED|Double-blind Follow-up Period||62||
48394886|NCT02980692|101296040|FG001|STARTED|Double-blind Follow-up Period||64||
48394887|NCT02980692|101296041|FG002|STARTED|Double-blind Follow-up Period||60||
48394888|NCT02980692|101296042|FG003|STARTED|Double-blind Follow-up Period||71||
48394889|NCT02980692|101296043|FG004|STARTED|Double-blind Follow-up Period||74||
48394890|NCT02980692|101296039|FG000|COMPLETED|Double-blind Follow-up Period||62||
48394891|NCT02980692|101296040|FG001|COMPLETED|Double-blind Follow-up Period||61||
48394892|NCT02980692|101296041|FG002|COMPLETED|Double-blind Follow-up Period||56||
48394893|NCT02980692|101296042|FG003|COMPLETED|Double-blind Follow-up Period||67||
48566444|NCT02512302|101717455|FG001|STARTED|Period 1||3||
48280494|NCT00112827|101010519|FG001|STARTED|Overall Study||4||
48280495|NCT00112827|101010520|FG002|STARTED|Overall Study||4||
48280496|NCT00112827|101010521|FG003|STARTED|Overall Study||36||
48698476|NCT00624585|102050326|FG000|COMPLETED|Overall Study||6||
48698477|NCT00624585|102050326|FG000|NOT COMPLETED|Overall Study||12||
48698478|NCT02752685|102050327|FG000|STARTED|Overall Study||20||
48698479|NCT02752685|102050328|FG001|STARTED|Overall Study||30||
48698480|NCT02752685|102050329|FG002|STARTED|Overall Study||20||
48394894|NCT02980692|101296043|FG004|COMPLETED|Double-blind Follow-up Period||69||
48394895|NCT02980692|101296039|FG000|NOT COMPLETED|Double-blind Follow-up Period||0||
48394896|NCT02980692|101296040|FG001|NOT COMPLETED|Double-blind Follow-up Period||3||
48394897|NCT02980692|101296041|FG002|NOT COMPLETED|Double-blind Follow-up Period||4||
48394898|NCT02980692|101296042|FG003|NOT COMPLETED|Double-blind Follow-up Period||4||
48394899|NCT02980692|101296043|FG004|NOT COMPLETED|Double-blind Follow-up Period||5||
48394900|NCT00232505|101296044|FG000|STARTED|Overall Study||31||
48394901|NCT00232505|101296045|FG001|STARTED|Overall Study||71||
48394902|NCT00232505|101296044|FG000|Not Evaluable|Overall Study||0||
48394903|NCT00232505|101296045|FG001|Not Evaluable|Overall Study||6||
48394904|NCT00232505|101296044|FG000|Early Progressors|Overall Study||2||
48394905|NCT00232505|101296045|FG001|Early Progressors|Overall Study||5||
48394906|NCT00232505|101296044|FG000|Off Protocol|Overall Study||5||
48394907|NCT00232505|101296045|FG001|Off Protocol|Overall Study||0||
48394908|NCT00232505|101296044|FG000|COMPLETED|Overall Study||26||
48394909|NCT00232505|101296045|FG001|COMPLETED|Overall Study||60||
48394910|NCT00232505|101296044|FG000|NOT COMPLETED|Overall Study||5||
48394911|NCT00232505|101296045|FG001|NOT COMPLETED|Overall Study||11||
48394912|NCT02823080|101296046|FG000|STARTED|Overall Study||24||
48394913|NCT02823080|101296047|FG001|STARTED|Overall Study||24||
48394914|NCT02823080|101296046|FG000|COMPLETED|Overall Study||24||
48394915|NCT02823080|101296047|FG001|COMPLETED|Overall Study||24||
48394916|NCT02823080|101296046|FG000|NOT COMPLETED|Overall Study||0||
48394917|NCT02823080|101296047|FG001|NOT COMPLETED|Overall Study||0||
48394918|NCT03148756|101296048|FG000|STARTED|Overall Study||0||
48394919|NCT03148756|101296049|FG001|STARTED|Overall Study||2||
48394920|NCT03148756|101296048|FG000|COMPLETED|Overall Study||0||
48394921|NCT03148756|101296049|FG001|COMPLETED|Overall Study||1||
48394922|NCT03148756|101296048|FG000|NOT COMPLETED|Overall Study||0||
48394923|NCT03148756|101296049|FG001|NOT COMPLETED|Overall Study||1||
48394924|NCT04114539|101296050|FG000|STARTED|Overall Study||124||
48394925|NCT04114539|101296050|FG000|Safety Set (Treated)|Overall Study||121|The Safety Set included all participants who received at least one dose of study drug from the open labelled study.|
48394926|NCT04114539|101296050|FG000|Modified Intention-to-Treat Set|Overall Study||121|The Modified Intention-to-Treat (mITT) set included all participants who received at least one dose of study drug and had at least one post Baseline scoring of Yale Global Tic Severity Scale (YGTSS).|
48394927|NCT04114539|101296050|FG000|COMPLETED|Overall Study||80||
48394928|NCT04114539|101296050|FG000|NOT COMPLETED|Overall Study||44||
48698481|NCT02752685|102050327|FG000|COMPLETED|Overall Study||19||
48698482|NCT02752685|102050328|FG001|COMPLETED|Overall Study||29||
48698483|NCT02752685|102050329|FG002|COMPLETED|Overall Study||19||
48698484|NCT02752685|102050327|FG000|NOT COMPLETED|Overall Study||1||
48698485|NCT02752685|102050328|FG001|NOT COMPLETED|Overall Study||1||
48698486|NCT02752685|102050329|FG002|NOT COMPLETED|Overall Study||1||
48394929|NCT03154307|101296051|FG000|STARTED|Overall Study||2||
48394930|NCT03154307|101296052|FG001|STARTED|Overall Study||0||
48698487|NCT01707654|102050330|FG000|STARTED|Overall Study||9||
48698488|NCT01707654|102050330|FG000|COMPLETED|Overall Study||9||
48698489|NCT01707654|102050330|FG000|NOT COMPLETED|Overall Study||0||
48394931|NCT03154307|101296053|FG002|STARTED|Overall Study||0||
48394932|NCT03154307|101296054|FG003|STARTED|Overall Study||0||
48394933|NCT03154307|101296051|FG000|COMPLETED|Overall Study||1||
48394934|NCT03154307|101296052|FG001|COMPLETED|Overall Study||0||
48394935|NCT03154307|101296053|FG002|COMPLETED|Overall Study||0||
48394936|NCT03154307|101296054|FG003|COMPLETED|Overall Study||0||
48394937|NCT03154307|101296051|FG000|NOT COMPLETED|Overall Study||1||
48698490|NCT04537208|102050331|FG000|STARTED|Overall Study||34||
48280497|NCT00112827|101010522|FG004|STARTED|Overall Study||7||
48280498|NCT00112827|101010518|FG000|COMPLETED|Overall Study||3||
48280499|NCT00112827|101010519|FG001|COMPLETED|Overall Study||4||
48280500|NCT00112827|101010520|FG002|COMPLETED|Overall Study||4||
48280501|NCT00112827|101010521|FG003|COMPLETED|Overall Study||36||
48280502|NCT00112827|101010522|FG004|COMPLETED|Overall Study||7||
48280503|NCT00112827|101010518|FG000|NOT COMPLETED|Overall Study||0||
48280504|NCT00112827|101010519|FG001|NOT COMPLETED|Overall Study||0||
48280505|NCT00112827|101010520|FG002|NOT COMPLETED|Overall Study||0||
48280506|NCT00112827|101010521|FG003|NOT COMPLETED|Overall Study||0||
48280507|NCT00112827|101010522|FG004|NOT COMPLETED|Overall Study||0||
48280508|NCT00953745|101010523|FG000|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||37||
48280509|NCT00953745|101010524|FG001|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||6||
48280510|NCT00953745|101010523|FG000|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||24||
48280511|NCT00953745|101010524|FG001|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||6||
48280512|NCT00953745|101010523|FG000|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||13||
48280513|NCT00953745|101010524|FG001|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||0||
48280514|NCT00953745|101010523|FG000|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||18||
48280515|NCT00953745|101010524|FG001|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||0||
48280516|NCT00953745|101010523|FG000|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||17||
48280517|NCT00953745|101010524|FG001|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0||
48280518|NCT00953745|101010523|FG000|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||1||
48280519|NCT00953745|101010524|FG001|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0||
48280520|NCT00953745|101010523|FG000|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||17||
48280521|NCT00953745|101010524|FG001|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||0||
48280522|NCT00953745|101010523|FG000|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||17||
48280523|NCT00953745|101010524|FG001|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0||
48280524|NCT00953745|101010523|FG000|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0||
48394938|NCT03154307|101296052|FG001|NOT COMPLETED|Overall Study||0||
48566445|NCT02512302|101717456|FG002|STARTED|Period 1||4||
48566446|NCT02512302|101717457|FG003|STARTED|Period 1||3||
48566447|NCT02512302|101717458|FG004|STARTED|Period 1||3||
48566448|NCT02512302|101717459|FG005|STARTED|Period 1||3||
48566449|NCT02512302|101717460|FG006|STARTED|Period 1||2||
48566450|NCT02512302|101717461|FG007|STARTED|Period 1||3||
48566451|NCT02512302|101717462|FG008|STARTED|Period 1||3||
48566452|NCT02512302|101717463|FG009|STARTED|Period 1||3||
48566453|NCT02512302|101717454|FG000|COMPLETED|Period 1||3||
48566454|NCT02512302|101717455|FG001|COMPLETED|Period 1||2||
48566455|NCT02512302|101717456|FG002|COMPLETED|Period 1||4||
48566456|NCT02512302|101717457|FG003|COMPLETED|Period 1||3||
48566457|NCT02512302|101717458|FG004|COMPLETED|Period 1||3||
48566458|NCT02512302|101717459|FG005|COMPLETED|Period 1||3||
48566459|NCT02512302|101717460|FG006|COMPLETED|Period 1||2||
48566460|NCT02512302|101717461|FG007|COMPLETED|Period 1||3||
48566461|NCT02512302|101717462|FG008|COMPLETED|Period 1||3||
48566462|NCT02512302|101717463|FG009|COMPLETED|Period 1||3||
48566463|NCT02512302|101717454|FG000|NOT COMPLETED|Period 1||0||
48566464|NCT02512302|101717455|FG001|NOT COMPLETED|Period 1||1||
48566465|NCT02512302|101717456|FG002|NOT COMPLETED|Period 1||0||
48566466|NCT02512302|101717457|FG003|NOT COMPLETED|Period 1||0||
48566467|NCT02512302|101717458|FG004|NOT COMPLETED|Period 1||0||
48566468|NCT02512302|101717459|FG005|NOT COMPLETED|Period 1||0||
48566469|NCT02512302|101717460|FG006|NOT COMPLETED|Period 1||0||
48566470|NCT02512302|101717461|FG007|NOT COMPLETED|Period 1||0||
48566471|NCT02512302|101717462|FG008|NOT COMPLETED|Period 1||0||
48566472|NCT02512302|101717463|FG009|NOT COMPLETED|Period 1||0||
48566473|NCT02512302|101717454|FG000|STARTED|Period 2||3||
48566474|NCT02512302|101717455|FG001|STARTED|Period 2||2||
48566475|NCT02512302|101717456|FG002|STARTED|Period 2||4||
48566476|NCT02512302|101717457|FG003|STARTED|Period 2||3||
48566477|NCT02512302|101717458|FG004|STARTED|Period 2||3||
48566478|NCT02512302|101717459|FG005|STARTED|Period 2||3||
48566479|NCT02512302|101717460|FG006|STARTED|Period 2||2||
48280525|NCT00953745|101010524|FG001|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0||
48280526|NCT01871805|101010525|FG000|STARTED|Phase I||7||
48280527|NCT01871805|101010526|FG001|STARTED|Phase I||7||
48280528|NCT01871805|101010527|FG002|STARTED|Phase I||13||
48280529|NCT01871805|101010528|FG003|STARTED|Phase I||7||
48280530|NCT01871805|101010529|FG004|STARTED|Phase I||13||
48280531|NCT01871805|101010530|FG005|STARTED|Phase I||0||
48280532|NCT01871805|101010525|FG000|COMPLETED|Phase I||0||
48280533|NCT01871805|101010526|FG001|COMPLETED|Phase I||0||
48280534|NCT01871805|101010527|FG002|COMPLETED|Phase I||0||
48566480|NCT02512302|101717461|FG007|STARTED|Period 2||3||
48566481|NCT02512302|101717462|FG008|STARTED|Period 2||3||
48566482|NCT02512302|101717463|FG009|STARTED|Period 2||3||
48566483|NCT02512302|101717454|FG000|COMPLETED|Period 2||3||
48566484|NCT02512302|101717455|FG001|COMPLETED|Period 2||2||
48566485|NCT02512302|101717456|FG002|COMPLETED|Period 2||4||
48566486|NCT02512302|101717457|FG003|COMPLETED|Period 2||3||
48566487|NCT02512302|101717458|FG004|COMPLETED|Period 2||3||
48566488|NCT02512302|101717459|FG005|COMPLETED|Period 2||3||
48566489|NCT02512302|101717460|FG006|COMPLETED|Period 2||2||
48566490|NCT02512302|101717461|FG007|COMPLETED|Period 2||3||
48566491|NCT02512302|101717462|FG008|COMPLETED|Period 2||3||
48566492|NCT02512302|101717463|FG009|COMPLETED|Period 2||2||
48566493|NCT02512302|101717454|FG000|NOT COMPLETED|Period 2||0||
48566494|NCT02512302|101717455|FG001|NOT COMPLETED|Period 2||0||
48280535|NCT01871805|101010528|FG003|COMPLETED|Phase I||0||
48280536|NCT01871805|101010529|FG004|COMPLETED|Phase I||0||
48280537|NCT01871805|101010530|FG005|COMPLETED|Phase I||0||
48566495|NCT02512302|101717456|FG002|NOT COMPLETED|Period 2||0||
48566496|NCT02512302|101717457|FG003|NOT COMPLETED|Period 2||0||
48566497|NCT02512302|101717458|FG004|NOT COMPLETED|Period 2||0||
48566498|NCT02512302|101717459|FG005|NOT COMPLETED|Period 2||0||
48566499|NCT02512302|101717460|FG006|NOT COMPLETED|Period 2||0||
48566500|NCT02512302|101717461|FG007|NOT COMPLETED|Period 2||0||
48566501|NCT02512302|101717462|FG008|NOT COMPLETED|Period 2||0||
48566502|NCT02512302|101717463|FG009|NOT COMPLETED|Period 2||1||
48566503|NCT02512302|101717454|FG000|STARTED|Period 3||3||
48566504|NCT02512302|101717455|FG001|STARTED|Period 3||2||
48566505|NCT02512302|101717456|FG002|STARTED|Period 3||4||
48566506|NCT02512302|101717457|FG003|STARTED|Period 3||3||
48566507|NCT02512302|101717458|FG004|STARTED|Period 3||3||
48566508|NCT02512302|101717459|FG005|STARTED|Period 3||3||
48566509|NCT02512302|101717460|FG006|STARTED|Period 3||2||
48119455|NCT01440322|100616473|FG000|COMPLETED|Overall Study||90||
48280538|NCT01871805|101010525|FG000|NOT COMPLETED|Phase I||7||
48566510|NCT02512302|101717461|FG007|STARTED|Period 3||3||
48566511|NCT02512302|101717462|FG008|STARTED|Period 3||3||
48280539|NCT01871805|101010526|FG001|NOT COMPLETED|Phase I||7||
48280540|NCT01871805|101010527|FG002|NOT COMPLETED|Phase I||13||
48280541|NCT01871805|101010528|FG003|NOT COMPLETED|Phase I||7||
48280542|NCT01871805|101010529|FG004|NOT COMPLETED|Phase I||13||
48280543|NCT01871805|101010530|FG005|NOT COMPLETED|Phase I||0||
48280544|NCT01871805|101010525|FG000|STARTED|Phase II||0||
48280545|NCT01871805|101010526|FG001|STARTED|Phase II||0||
48280546|NCT01871805|101010527|FG002|STARTED|Phase II||0||
48566512|NCT02512302|101717463|FG009|STARTED|Period 3||2||
48566513|NCT02512302|101717454|FG000|COMPLETED|Period 3||3||
48566514|NCT02512302|101717455|FG001|COMPLETED|Period 3||2||
48566515|NCT02512302|101717456|FG002|COMPLETED|Period 3||3||
48566516|NCT02512302|101717457|FG003|COMPLETED|Period 3||3||
48566517|NCT02512302|101717458|FG004|COMPLETED|Period 3||3||
48566518|NCT02512302|101717459|FG005|COMPLETED|Period 3||3||
48566519|NCT02512302|101717460|FG006|COMPLETED|Period 3||2||
48566520|NCT02512302|101717461|FG007|COMPLETED|Period 3||3||
48566521|NCT02512302|101717462|FG008|COMPLETED|Period 3||3||
48566522|NCT02512302|101717463|FG009|COMPLETED|Period 3||2||
48566523|NCT02512302|101717454|FG000|NOT COMPLETED|Period 3||0||
48566524|NCT02512302|101717455|FG001|NOT COMPLETED|Period 3||0||
48566525|NCT02512302|101717456|FG002|NOT COMPLETED|Period 3||1||
48566526|NCT02512302|101717457|FG003|NOT COMPLETED|Period 3||0||
48566527|NCT02512302|101717458|FG004|NOT COMPLETED|Period 3||0||
48566528|NCT02512302|101717459|FG005|NOT COMPLETED|Period 3||0||
48280547|NCT01871805|101010528|FG003|STARTED|Phase II||0||
48280548|NCT01871805|101010529|FG004|STARTED|Phase II||0||
48280549|NCT01871805|101010530|FG005|STARTED|Phase II||87||
48280550|NCT01871805|101010525|FG000|COMPLETED|Phase II||0||
48280551|NCT01871805|101010526|FG001|COMPLETED|Phase II||0||
48280552|NCT01871805|101010527|FG002|COMPLETED|Phase II||0||
48280553|NCT01871805|101010528|FG003|COMPLETED|Phase II||0||
48280554|NCT01871805|101010529|FG004|COMPLETED|Phase II||0||
48280555|NCT01871805|101010530|FG005|COMPLETED|Phase II||0||
48280556|NCT01871805|101010525|FG000|NOT COMPLETED|Phase II||0||
48280557|NCT01871805|101010526|FG001|NOT COMPLETED|Phase II||0||
48280558|NCT01871805|101010527|FG002|NOT COMPLETED|Phase II||0||
48280559|NCT01871805|101010528|FG003|NOT COMPLETED|Phase II||0||
48280560|NCT01871805|101010529|FG004|NOT COMPLETED|Phase II||0||
48280561|NCT01871805|101010530|FG005|NOT COMPLETED|Phase II||87||
48280562|NCT04737187|101010531|FG000|STARTED|Overall Study||246||
48280563|NCT04737187|101010532|FG001|STARTED|Overall Study||246||
48280564|NCT04737187|101010531|FG000|COMPLETED|Overall Study||0||
48280565|NCT04737187|101010532|FG001|COMPLETED|Overall Study||0||
48280566|NCT04737187|101010531|FG000|NOT COMPLETED|Overall Study||246||
48280567|NCT04737187|101010532|FG001|NOT COMPLETED|Overall Study||246||
48394939|NCT03154307|101296053|FG002|NOT COMPLETED|Overall Study||0||
48394940|NCT03154307|101296054|FG003|NOT COMPLETED|Overall Study||0||
48394941|NCT01255306|101296055|FG000|STARTED|Overall Study||26||
48394942|NCT01255306|101296056|FG001|STARTED|Overall Study||33||
48394943|NCT01255306|101296055|FG000|COMPLETED|Overall Study||25||
48394944|NCT01255306|101296056|FG001|COMPLETED|Overall Study||32||
48394945|NCT01255306|101296055|FG000|NOT COMPLETED|Overall Study||1||
48394946|NCT01255306|101296056|FG001|NOT COMPLETED|Overall Study||1||
48394947|NCT00156910|101296057|FG000|STARTED|Double-Blind Phase (DB)||341||
48394948|NCT00156910|101296058|FG001|STARTED|Double-Blind Phase (DB)||338||
48394949|NCT00156910|101296057|FG000|COMPLETED|Double-Blind Phase (DB)||296||
48394950|NCT00156910|101296058|FG001|COMPLETED|Double-Blind Phase (DB)||295||
48394951|NCT00156910|101296057|FG000|NOT COMPLETED|Double-Blind Phase (DB)||45||
48394952|NCT00156910|101296058|FG001|NOT COMPLETED|Double-Blind Phase (DB)||43||
48394953|NCT00156910|101296057|FG000|STARTED|Open-Label Phase (OL)||285||
48394954|NCT00156910|101296058|FG001|STARTED|Open-Label Phase (OL)||286||
48394955|NCT00156910|101296057|FG000|COMPLETED|Open-Label Phase (OL)||252||
48394956|NCT00156910|101296058|FG001|COMPLETED|Open-Label Phase (OL)||231||
48394957|NCT00156910|101296057|FG000|NOT COMPLETED|Open-Label Phase (OL)||33||
48394958|NCT00156910|101296058|FG001|NOT COMPLETED|Open-Label Phase (OL)||55||
48394959|NCT01342952|101296059|FG000|STARTED|Overall Study||9||
48394960|NCT01342952|101296060|FG001|STARTED|Overall Study||19||
48394961|NCT01342952|101296061|FG002|STARTED|Overall Study||5||
48394962|NCT01342952|101296062|FG003|STARTED|Overall Study||5||
48394963|NCT01342952|101296059|FG000|Intent-to-Treat Population|Overall Study||9|The Intention-to-Treat (ITT) Population consisted of all participants who received at least 1 dose of study drug. Participants were considered as belonging to ITT population at the start of study AMB114588|
48394964|NCT01342952|101296060|FG001|Intent-to-Treat Population|Overall Study||19|The Intention-to-Treat (ITT) Population consisted of all participants who received at least 1 dose of study drug. Participants were considered as belonging to ITT population at the start of study AMB114588|
48394965|NCT01342952|101296061|FG002|Intent-to-Treat Population|Overall Study||5|The Intention-to-Treat (ITT) Population consisted of all participants who received at least 1 dose of study drug. Participants were considered as belonging to ITT population at the start of study AMB114588|
48394966|NCT01342952|101296062|FG003|Intent-to-Treat Population|Overall Study||5|The Intention-to-Treat (ITT) Population consisted of all participants who received at least 1 dose of study drug. Participants were considered as belonging to ITT population at the start of study AMB114588|
48566529|NCT02512302|101717460|FG006|NOT COMPLETED|Period 3||0||
48566530|NCT02512302|101717461|FG007|NOT COMPLETED|Period 3||0||
48566531|NCT02512302|101717462|FG008|NOT COMPLETED|Period 3||0||
48698491|NCT04537208|102050332|FG001|STARTED|Overall Study||34||
48566532|NCT02512302|101717463|FG009|NOT COMPLETED|Period 3||0||
48566533|NCT02512302|101717454|FG000|STARTED|Period 4||3||
48566534|NCT02512302|101717455|FG001|STARTED|Period 4||2||
48698492|NCT04537208|102050333|FG002|STARTED|Overall Study||34||
48698493|NCT04537208|102050334|FG003|STARTED|Overall Study||34||
48280568|NCT00992225|101010533|FG000|STARTED|Overall Study||43||
48280569|NCT00992225|101010533|FG000|Received at Least One Dose of Study Drug|Overall Study||33||
48280570|NCT00992225|101010533|FG000|COMPLETED|Overall Study||33||
48280571|NCT00992225|101010533|FG000|NOT COMPLETED|Overall Study||10||
48280572|NCT01534689|101010534|FG000|STARTED|Overall Study||105||
48280573|NCT01534689|101010534|FG000|COMPLETED|Overall Study||105||
48280574|NCT01534689|101010534|FG000|NOT COMPLETED|Overall Study||0||
48280575|NCT00626197|101010535|FG000|STARTED|Overall Study||127||
48280576|NCT00626197|101010536|FG001|STARTED|Overall Study||128||
48280577|NCT00626197|101010537|FG002|STARTED|Overall Study||126||
48280578|NCT00626197|101010535|FG000|COMPLETED|Overall Study||83||
48280579|NCT00626197|101010536|FG001|COMPLETED|Overall Study||74||
48280580|NCT00626197|101010537|FG002|COMPLETED|Overall Study||49||
48394967|NCT01342952|101296059|FG000|Safety Population|Overall Study||4|The Safety Population is defined as all participants who received at least 1 dose of study drug. Participants were considered as belonging to the treatment group according to the highest dose received|
48394968|NCT01342952|101296060|FG001|Safety Population|Overall Study||16|The Safety Population is defined as all participants who received at least 1 dose of study drug. Participants were considered as belonging to the treatment group according to the highest dose received|
48394969|NCT01342952|101296061|FG002|Safety Population|Overall Study||6|The Safety Population is defined as all participants who received at least 1 dose of study drug. Participants were considered as belonging to the treatment group according to the highest dose received|
48280581|NCT00626197|101010535|FG000|NOT COMPLETED|Overall Study||44||
48280582|NCT00626197|101010536|FG001|NOT COMPLETED|Overall Study||54||
48280583|NCT00626197|101010537|FG002|NOT COMPLETED|Overall Study||77||
48280584|NCT01994837|101010538|FG000|STARTED|Overall Study||32||
48280585|NCT01994837|101010538|FG000|Treated|Overall Study||32||
48280586|NCT01994837|101010538|FG000|COMPLETED|Overall Study||0||
48280587|NCT01994837|101010538|FG000|NOT COMPLETED|Overall Study||32||
48280588|NCT01276379|101010539|FG000|STARTED|Overall Study||221||
48280589|NCT01276379|101010539|FG000|COMPLETED|Overall Study||181||
48280590|NCT01276379|101010539|FG000|NOT COMPLETED|Overall Study||40||
48280591|NCT01140295|101010540|FG000|STARTED|Overall Study||17||
48280592|NCT01140295|101010541|FG001|STARTED|Overall Study||16||
48280593|NCT01140295|101010540|FG000|COMPLETED|Overall Study||16||
48280594|NCT01140295|101010541|FG001|COMPLETED|Overall Study||14||
48280595|NCT01140295|101010540|FG000|NOT COMPLETED|Overall Study||1||
48280596|NCT01140295|101010541|FG001|NOT COMPLETED|Overall Study||2||
48280597|NCT00652327|101010542|FG000|STARTED|Overall Study||42||
48280598|NCT00652327|101010543|FG001|STARTED|Overall Study||41||
48280599|NCT00652327|101010542|FG000|COMPLETED|Overall Study||42||
48280600|NCT00652327|101010543|FG001|COMPLETED|Overall Study||36||
48280601|NCT00652327|101010542|FG000|NOT COMPLETED|Overall Study||0||
48280602|NCT00652327|101010543|FG001|NOT COMPLETED|Overall Study||5||
48280603|NCT01342341|101010544|FG000|STARTED|Overall Study||24||
48280604|NCT01342341|101010545|FG001|STARTED|Overall Study||24||
48280605|NCT01342341|101010544|FG000|COMPLETED|Overall Study||20||
48280606|NCT01342341|101010545|FG001|COMPLETED|Overall Study||20||
48280607|NCT01342341|101010544|FG000|NOT COMPLETED|Overall Study||4||
48280608|NCT01342341|101010545|FG001|NOT COMPLETED|Overall Study||4||
48280609|NCT02153073|101010546|FG000|STARTED|Overall Study||3084||
48280610|NCT02153073|101010546|FG000|COMPLETED|Overall Study||2786||
48280611|NCT02153073|101010546|FG000|NOT COMPLETED|Overall Study||298||
48280612|NCT02217501|101010547|FG000|STARTED|Overall Study||77||
48280613|NCT02217501|101010548|FG001|STARTED|Overall Study||82||
48280614|NCT02217501|101010547|FG000|COMPLETED|Overall Study||74||
48280615|NCT02217501|101010548|FG001|COMPLETED|Overall Study||78||
48280616|NCT02217501|101010547|FG000|NOT COMPLETED|Overall Study||3||
48280617|NCT02217501|101010548|FG001|NOT COMPLETED|Overall Study||4||
48280618|NCT00888927|101010549|FG000|STARTED|Overall Study||3||
48280619|NCT00888927|101010550|FG001|STARTED|Overall Study||3||
48280620|NCT00888927|101010551|FG002|STARTED|Overall Study||3||
48280621|NCT00888927|101010552|FG003|STARTED|Overall Study||33||
48280622|NCT00888927|101010549|FG000|COMPLETED|Overall Study||3||
48280623|NCT00888927|101010550|FG001|COMPLETED|Overall Study||3||
48280624|NCT00888927|101010551|FG002|COMPLETED|Overall Study||3||
48280625|NCT00888927|101010552|FG003|COMPLETED|Overall Study||31||
48280626|NCT00888927|101010549|FG000|NOT COMPLETED|Overall Study||0||
48280627|NCT00888927|101010550|FG001|NOT COMPLETED|Overall Study||0||
48280628|NCT00888927|101010551|FG002|NOT COMPLETED|Overall Study||0||
48280629|NCT00888927|101010552|FG003|NOT COMPLETED|Overall Study||2||
48280630|NCT03889704|101010553|FG000|STARTED|Overall Study||2||
48280631|NCT03889704|101010553|FG000|COMPLETED|Overall Study||1||
48280632|NCT03889704|101010553|FG000|NOT COMPLETED|Overall Study||1||
48280633|NCT00673959|101010554|FG000|STARTED|Overall Study||10||
48280634|NCT00673959|101010555|FG001|STARTED|Overall Study||10||
48280635|NCT00673959|101010554|FG000|COMPLETED|Overall Study||10||
48280636|NCT00673959|101010555|FG001|COMPLETED|Overall Study||10||
48280637|NCT00673959|101010554|FG000|NOT COMPLETED|Overall Study||0||
48280638|NCT00673959|101010555|FG001|NOT COMPLETED|Overall Study||0||
48280639|NCT03507777|101010556|FG000|STARTED|Overall Study||1233||
48280640|NCT03507777|101010557|FG001|STARTED|Overall Study||1254||
48280641|NCT03507777|101010556|FG000|COMPLETED|Overall Study||1189||
48280642|NCT03507777|101010557|FG001|COMPLETED|Overall Study||1184||
48280643|NCT03507777|101010556|FG000|NOT COMPLETED|Overall Study||44||
48280644|NCT03507777|101010557|FG001|NOT COMPLETED|Overall Study||70||
48280645|NCT01307579|101010558|FG000|STARTED|Overall Study||257||
48280646|NCT01307579|101010559|FG001|STARTED|Overall Study||260||
48280647|NCT01307579|101010558|FG000|COMPLETED|Overall Study||117||
48280648|NCT01307579|101010559|FG001|COMPLETED|Overall Study||115||
48280649|NCT01307579|101010558|FG000|NOT COMPLETED|Overall Study||140||
48566535|NCT02512302|101717456|FG002|STARTED|Period 4||3||
48566536|NCT02512302|101717457|FG003|STARTED|Period 4||3||
48280650|NCT01307579|101010559|FG001|NOT COMPLETED|Overall Study||145||
48280651|NCT01204710|101010560|FG000|STARTED|Randomization Treatment||63||
48280652|NCT01204710|101010561|FG001|STARTED|Randomization Treatment||60||
48280653|NCT01204710|101010560|FG000|Received ≥1 Dose of Study Drug|Randomization Treatment||62||
48394970|NCT01342952|101296062|FG003|Safety Population|Overall Study||12|The Safety Population is defined as all participants who received at least 1 dose of study drug. Participants were considered as belonging to the treatment group according to the highest dose received|
48394971|NCT01342952|101296059|FG000|COMPLETED|Overall Study||5||
48394972|NCT01342952|101296060|FG001|COMPLETED|Overall Study||8||
48394973|NCT01342952|101296061|FG002|COMPLETED|Overall Study||3||
48394974|NCT01342952|101296062|FG003|COMPLETED|Overall Study||5||
48394975|NCT01342952|101296059|FG000|NOT COMPLETED|Overall Study||4||
48394976|NCT01342952|101296060|FG001|NOT COMPLETED|Overall Study||11||
48394977|NCT01342952|101296061|FG002|NOT COMPLETED|Overall Study||2||
48394978|NCT01342952|101296062|FG003|NOT COMPLETED|Overall Study||0||
48394979|NCT01188538|101296063|FG000|STARTED|Overall Study||20||
48394980|NCT01188538|101296064|FG001|STARTED|Overall Study||20||
48394981|NCT01188538|101296063|FG000|COMPLETED|Overall Study||20||
48394982|NCT01188538|101296064|FG001|COMPLETED|Overall Study||19||
48394983|NCT01188538|101296063|FG000|NOT COMPLETED|Overall Study||0||
48394984|NCT01188538|101296064|FG001|NOT COMPLETED|Overall Study||1||
48394985|NCT02142504|101296065|FG000|STARTED|Overall Study||153||
48394986|NCT02142504|101296066|FG001|STARTED|Overall Study||147||
48394987|NCT02142504|101296067|FG002|STARTED|Overall Study||154||
48394988|NCT02142504|101296065|FG000|Randomized and Received Treatment|Overall Study||153||
48394989|NCT02142504|101296066|FG001|Randomized and Received Treatment|Overall Study||145||
48394990|NCT02142504|101296067|FG002|Randomized and Received Treatment|Overall Study||154||
48394991|NCT02142504|101296065|FG000|Received Booster (Second Vaccination)|Overall Study||126||
48394992|NCT02142504|101296066|FG001|Received Booster (Second Vaccination)|Overall Study||109||
48394993|NCT02142504|101296067|FG002|Received Booster (Second Vaccination)|Overall Study||116||
48394994|NCT02142504|101296065|FG000|COMPLETED|Overall Study||122||
48566537|NCT02512302|101717458|FG004|STARTED|Period 4||3||
48566538|NCT02512302|101717459|FG005|STARTED|Period 4||3||
48566539|NCT02512302|101717460|FG006|STARTED|Period 4||2||
48566540|NCT02512302|101717461|FG007|STARTED|Period 4||3||
48566541|NCT02512302|101717462|FG008|STARTED|Period 4||3||
48566542|NCT02512302|101717463|FG009|STARTED|Period 4||2||
48566543|NCT02512302|101717454|FG000|COMPLETED|Period 4||3||
48566544|NCT02512302|101717455|FG001|COMPLETED|Period 4||2||
48566545|NCT02512302|101717456|FG002|COMPLETED|Period 4||3||
48566546|NCT02512302|101717457|FG003|COMPLETED|Period 4||3||
48566547|NCT02512302|101717458|FG004|COMPLETED|Period 4||3||
48566548|NCT02512302|101717459|FG005|COMPLETED|Period 4||3||
48566549|NCT02512302|101717460|FG006|COMPLETED|Period 4||1||
48566550|NCT02512302|101717461|FG007|COMPLETED|Period 4||3||
48566551|NCT02512302|101717462|FG008|COMPLETED|Period 4||3||
48566552|NCT02512302|101717463|FG009|COMPLETED|Period 4||2||
48566553|NCT02512302|101717454|FG000|NOT COMPLETED|Period 4||0||
48698494|NCT04537208|102050335|FG004|STARTED|Overall Study||34||
48698495|NCT04537208|102050336|FG005|STARTED|Overall Study||28||
48280654|NCT01204710|101010561|FG001|Received ≥1 Dose of Study Drug|Randomization Treatment||59||
48280655|NCT01204710|101010560|FG000|COMPLETED|Randomization Treatment||49||
48280656|NCT01204710|101010561|FG001|COMPLETED|Randomization Treatment||47||
48280657|NCT01204710|101010560|FG000|NOT COMPLETED|Randomization Treatment||14||
48280658|NCT01204710|101010561|FG001|NOT COMPLETED|Randomization Treatment||13||
48280659|NCT01204710|101010560|FG000|STARTED|Optional Olaratumab Monotherapy||0||
48280660|NCT01204710|101010561|FG001|STARTED|Optional Olaratumab Monotherapy||19||
48280661|NCT01204710|101010560|FG000|COMPLETED|Optional Olaratumab Monotherapy||0||
48394995|NCT02142504|101296066|FG001|COMPLETED|Overall Study||105||
48394996|NCT02142504|101296067|FG002|COMPLETED|Overall Study||111||
48698496|NCT04537208|102050337|FG006|STARTED|Overall Study||84||
48698497|NCT04537208|102050338|FG007|STARTED|Overall Study||27||
48698498|NCT04537208|102050339|FG008|STARTED|Overall Study||85||
48698499|NCT04537208|102050340|FG009|STARTED|Overall Study||18||
48698500|NCT04537208|102050341|FG010|STARTED|Overall Study||29||
48698501|NCT04537208|102050331|FG000|Vaccinated on Day 1|Overall Study||34||
48698502|NCT04537208|102050332|FG001|Vaccinated on Day 1|Overall Study||34||
48698503|NCT04537208|102050333|FG002|Vaccinated on Day 1|Overall Study||34||
48280662|NCT01204710|101010561|FG001|COMPLETED|Optional Olaratumab Monotherapy||16||
48280663|NCT01204710|101010560|FG000|NOT COMPLETED|Optional Olaratumab Monotherapy||0||
48394997|NCT02142504|101296065|FG000|NOT COMPLETED|Overall Study||31||
48394998|NCT02142504|101296066|FG001|NOT COMPLETED|Overall Study||42||
48394999|NCT02142504|101296067|FG002|NOT COMPLETED|Overall Study||43||
48566554|NCT02512302|101717455|FG001|NOT COMPLETED|Period 4||0||
48566555|NCT02512302|101717456|FG002|NOT COMPLETED|Period 4||0||
48566556|NCT02512302|101717457|FG003|NOT COMPLETED|Period 4||0||
48566557|NCT02512302|101717458|FG004|NOT COMPLETED|Period 4||0||
48566558|NCT02512302|101717459|FG005|NOT COMPLETED|Period 4||0||
48698504|NCT04537208|102050334|FG003|Vaccinated on Day 1|Overall Study||34||
48698505|NCT04537208|102050335|FG004|Vaccinated on Day 1|Overall Study||34||
48395000|NCT01149343|101296068|FG000|STARTED|Overall Study||20|107 patients were treated, 106 patients have 1 dose of vaccine assigned in the randomization system|
48395001|NCT01149343|101296069|FG001|STARTED|Overall Study||24|107 patients were treated, 106 patients have 1 dose of vaccine assigned in the randomization system|
48395002|NCT01149343|101296070|FG002|STARTED|Overall Study||22|107 patients were treated, 106 patients have 1 dose of vaccine assigned in the randomization system|
48395003|NCT01149343|101296071|FG003|STARTED|Overall Study||40|107 patients were treated, 106 patients have 1 dose of vaccine assigned in the randomization system|
48395004|NCT01149343|101296068|FG000|COMPLETED|Overall Study||0||
48395005|NCT01149343|101296069|FG001|COMPLETED|Overall Study||0||
48395006|NCT01149343|101296070|FG002|COMPLETED|Overall Study||0||
48395007|NCT01149343|101296071|FG003|COMPLETED|Overall Study||0||
48395008|NCT01149343|101296068|FG000|NOT COMPLETED|Overall Study||20||
48395009|NCT01149343|101296069|FG001|NOT COMPLETED|Overall Study||24||
48395010|NCT01149343|101296070|FG002|NOT COMPLETED|Overall Study||22||
48395011|NCT01149343|101296071|FG003|NOT COMPLETED|Overall Study||40||
48395012|NCT04569799|101296072|FG000|STARTED|Overall Study||26||33
48395013|NCT04569799|101296072|FG000|COMPLETED|Overall Study||26||30
48395014|NCT04569799|101296072|FG000|NOT COMPLETED|Overall Study||0||3
48395015|NCT01854593|101296073|FG000|STARTED|Overall Study||34||
48395016|NCT01854593|101296074|FG001|STARTED|Overall Study||35||
48395017|NCT01854593|101296073|FG000|COMPLETED|Overall Study||32||
48395018|NCT01854593|101296074|FG001|COMPLETED|Overall Study||34||
48395019|NCT01854593|101296073|FG000|NOT COMPLETED|Overall Study||2||
48395020|NCT01854593|101296074|FG001|NOT COMPLETED|Overall Study||1||
48395021|NCT00082329|101296075|FG000|STARTED|Overall Study||9||
48395022|NCT00082329|101296075|FG000|COMPLETED|Overall Study||9||
48395023|NCT00082329|101296075|FG000|NOT COMPLETED|Overall Study||0||
48566559|NCT02512302|101717460|FG006|NOT COMPLETED|Period 4||1||
48566560|NCT02512302|101717461|FG007|NOT COMPLETED|Period 4||0||
48566561|NCT02512302|101717462|FG008|NOT COMPLETED|Period 4||0||
48566562|NCT02512302|101717463|FG009|NOT COMPLETED|Period 4||0||
48566563|NCT02512302|101717454|FG000|STARTED|Period 5||3||
48566564|NCT02512302|101717455|FG001|STARTED|Period 5||2||
48395024|NCT04294095|101296076|FG000|STARTED|Overall Study||26||
48395025|NCT04294095|101296077|FG001|STARTED|Overall Study||24||
48395026|NCT04294095|101296076|FG000|COMPLETED|Overall Study||25||
48395027|NCT04294095|101296077|FG001|COMPLETED|Overall Study||24||
48395028|NCT04294095|101296076|FG000|NOT COMPLETED|Overall Study||1||
48395029|NCT04294095|101296077|FG001|NOT COMPLETED|Overall Study||0||
48395030|NCT05441540|101296078|FG000|STARTED|Overall Study||20||
48395031|NCT05441540|101296078|FG000|COMPLETED|Overall Study||18||
48395032|NCT05441540|101296078|FG000|NOT COMPLETED|Overall Study||2||
48395033|NCT01299610|101296079|FG000|STARTED|Overall Study||10||
48395034|NCT01299610|101296080|FG001|STARTED|Overall Study||5||
48395035|NCT01299610|101296081|FG002|STARTED|Overall Study||10||
48395036|NCT01299610|101296079|FG000|COMPLETED|Overall Study||10||
48395037|NCT01299610|101296080|FG001|COMPLETED|Overall Study||5||
48395038|NCT01299610|101296081|FG002|COMPLETED|Overall Study||10||
48395039|NCT01299610|101296079|FG000|NOT COMPLETED|Overall Study||0||
48395040|NCT01299610|101296080|FG001|NOT COMPLETED|Overall Study||0||
48395041|NCT01299610|101296081|FG002|NOT COMPLETED|Overall Study||0||
48395042|NCT00990249|101296082|FG000|STARTED|Overall Study||120||
48395043|NCT00990249|101296082|FG000|COMPLETED|Overall Study||107||
48395044|NCT00990249|101296082|FG000|NOT COMPLETED|Overall Study||13||
48395045|NCT03587584|101296083|FG000|STARTED|Overall Study||37||
48395046|NCT03587584|101296084|FG001|STARTED|Overall Study||42||
48395047|NCT03587584|101296083|FG000|COMPLETED|Overall Study||33||
48395048|NCT03587584|101296084|FG001|COMPLETED|Overall Study||33||
48395049|NCT03587584|101296083|FG000|NOT COMPLETED|Overall Study||4||
48395050|NCT03587584|101296084|FG001|NOT COMPLETED|Overall Study||9||
48395051|NCT00092677|101296085|FG000|STARTED|Overall Study||944||
48395052|NCT00092677|101296086|FG001|STARTED|Overall Study||929||
48566565|NCT02512302|101717456|FG002|STARTED|Period 5||3||
48566566|NCT02512302|101717457|FG003|STARTED|Period 5||3||
48395053|NCT00092677|101296085|FG000|COMPLETED|Overall Study||939||
48395054|NCT00092677|101296086|FG001|COMPLETED|Overall Study||918||
48395055|NCT00092677|101296085|FG000|NOT COMPLETED|Overall Study||5||
48566567|NCT02512302|101717458|FG004|STARTED|Period 5||3||
48566568|NCT02512302|101717459|FG005|STARTED|Period 5||3||
48566569|NCT02512302|101717460|FG006|STARTED|Period 5||1||
48566570|NCT02512302|101717461|FG007|STARTED|Period 5||3||
48566571|NCT02512302|101717462|FG008|STARTED|Period 5||3||
48566572|NCT02512302|101717463|FG009|STARTED|Period 5||2||
48566573|NCT02512302|101717454|FG000|COMPLETED|Period 5||3||
48395056|NCT00092677|101296086|FG001|NOT COMPLETED|Overall Study||11||
48395057|NCT01229891|101296087|FG000|STARTED|Overall Study||30||
48566574|NCT02512302|101717455|FG001|COMPLETED|Period 5||2||
48566575|NCT02512302|101717456|FG002|COMPLETED|Period 5||3||
48698506|NCT04537208|102050336|FG005|Vaccinated on Day 1|Overall Study||28||
48698507|NCT04537208|102050337|FG006|Vaccinated on Day 1|Overall Study||82||
48698508|NCT04537208|102050338|FG007|Vaccinated on Day 1|Overall Study||27||
48698509|NCT04537208|102050339|FG008|Vaccinated on Day 1|Overall Study||85||
48698510|NCT04537208|102050340|FG009|Vaccinated on Day 1|Overall Study||18||
48698511|NCT04537208|102050341|FG010|Vaccinated on Day 1|Overall Study||29||
48698512|NCT04537208|102050331|FG000|Vaccinated on Day 22|Overall Study||0|Only Cohort 2 participants received second dose of vaccine at Day 22.|
48566576|NCT02512302|101717457|FG003|COMPLETED|Period 5||3||
48566577|NCT02512302|101717458|FG004|COMPLETED|Period 5||3||
48566578|NCT02512302|101717459|FG005|COMPLETED|Period 5||3||
48698513|NCT04537208|102050332|FG001|Vaccinated on Day 22|Overall Study||0|Only Cohort 2 participants received second dose of vaccine at Day 22.|
48698514|NCT04537208|102050333|FG002|Vaccinated on Day 22|Overall Study||0|Only Cohort 2 participants received second dose of vaccine at Day 22.|
48698515|NCT04537208|102050334|FG003|Vaccinated on Day 22|Overall Study||0|Only Cohort 2 participants received second dose of vaccine at Day 22.|
48698516|NCT04537208|102050335|FG004|Vaccinated on Day 22|Overall Study||0|Only Cohort 2 participants received second dose of vaccine at Day 22.|
48395058|NCT01229891|101296088|FG001|STARTED|Overall Study||30||
48698517|NCT04537208|102050336|FG005|Vaccinated on Day 22|Overall Study||26|Only Cohort 2 participants received second dose of vaccine at Day 22.|
48698518|NCT04537208|102050337|FG006|Vaccinated on Day 22|Overall Study||80|Only Cohort 2 participants received second dose of vaccine at Day 22.|
48698519|NCT04537208|102050338|FG007|Vaccinated on Day 22|Overall Study||26|Only Cohort 2 participants received second dose of vaccine at Day 22.|
48710821|NCT02590562|102078029|FG000|NOT COMPLETED|Overall Study||6||
48395059|NCT01229891|101296089|FG002|STARTED|Overall Study||30||
48395060|NCT01229891|101296087|FG000|COMPLETED|Overall Study||30||
48566579|NCT02512302|101717460|FG006|COMPLETED|Period 5||1||
48566580|NCT02512302|101717461|FG007|COMPLETED|Period 5||3||
48566581|NCT02512302|101717462|FG008|COMPLETED|Period 5||3||
48566582|NCT02512302|101717463|FG009|COMPLETED|Period 5||2||
48566583|NCT02512302|101717454|FG000|NOT COMPLETED|Period 5||0||
48566584|NCT02512302|101717455|FG001|NOT COMPLETED|Period 5||0||
48566585|NCT02512302|101717456|FG002|NOT COMPLETED|Period 5||0||
48566586|NCT02512302|101717457|FG003|NOT COMPLETED|Period 5||0||
48566587|NCT02512302|101717458|FG004|NOT COMPLETED|Period 5||0||
48566588|NCT02512302|101717459|FG005|NOT COMPLETED|Period 5||0||
48566589|NCT02512302|101717460|FG006|NOT COMPLETED|Period 5||0||
48566590|NCT02512302|101717461|FG007|NOT COMPLETED|Period 5||0||
48566591|NCT02512302|101717462|FG008|NOT COMPLETED|Period 5||0||
48566592|NCT02512302|101717463|FG009|NOT COMPLETED|Period 5||0||
48395061|NCT01229891|101296088|FG001|COMPLETED|Overall Study||30||
48566593|NCT00966992|101717464|FG000|STARTED|Overall Study||3||
48566594|NCT00966992|101717465|FG001|STARTED|Overall Study||0||
48566595|NCT00966992|101717464|FG000|COMPLETED|Overall Study||3||
48566596|NCT00966992|101717465|FG001|COMPLETED|Overall Study||0||
48566597|NCT00966992|101717464|FG000|NOT COMPLETED|Overall Study||0||
48566598|NCT00966992|101717465|FG001|NOT COMPLETED|Overall Study||0||
48566599|NCT01391858|101717466|FG000|STARTED|Overall Study||25||
48566600|NCT01391858|101717467|FG001|STARTED|Overall Study||24||
48566601|NCT01391858|101717466|FG000|COMPLETED|Overall Study||23||
48566602|NCT01391858|101717467|FG001|COMPLETED|Overall Study||24||
48566603|NCT01391858|101717466|FG000|NOT COMPLETED|Overall Study||2||
48566604|NCT01391858|101717467|FG001|NOT COMPLETED|Overall Study||0||
48698520|NCT04537208|102050339|FG008|Vaccinated on Day 22|Overall Study||85|Only Cohort 2 participants received second dose of vaccine at Day 22.|
48698521|NCT04537208|102050340|FG009|Vaccinated on Day 22|Overall Study||17|Only Cohort 2 participants received second dose of vaccine at Day 22.|
48698522|NCT04537208|102050341|FG010|Vaccinated on Day 22|Overall Study||29|Only Cohort 2 participants received second dose of vaccine at Day 22.|
48698523|NCT04537208|102050331|FG000|Safety Analysis Set (SafAS)|Overall Study||36|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
48698524|NCT04537208|102050332|FG001|Safety Analysis Set (SafAS)|Overall Study||36|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
48698525|NCT04537208|102050333|FG002|Safety Analysis Set (SafAS)|Overall Study||35|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
48119456|NCT01440322|100616474|FG001|COMPLETED|Overall Study||49||
48280664|NCT01204710|101010561|FG001|NOT COMPLETED|Optional Olaratumab Monotherapy||3||
48280665|NCT03456427|101010562|FG000|STARTED|Overall Study||36||
48280666|NCT03456427|101010562|FG000|COMPLETED|Overall Study||33||
48280667|NCT03456427|101010562|FG000|NOT COMPLETED|Overall Study||3||
48280668|NCT01699503|101010563|FG000|STARTED|Overall Study||2008||
48566605|NCT03776357|101717468|FG000|STARTED|Overall Study||9||
48566606|NCT03776357|101717468|FG000|COMPLETED|Overall Study||6||
48566607|NCT03776357|101717468|FG000|NOT COMPLETED|Overall Study||3||
48566608|NCT00840749|101717469|FG000|STARTED|Overall Study||31||
48566609|NCT00840749|101717470|FG001|STARTED|Overall Study||27||
48566610|NCT00840749|101717469|FG000|Treatment|Overall Study||20||
48566611|NCT00840749|101717470|FG001|Treatment|Overall Study||16||
48566612|NCT00840749|101717469|FG000|1 Month Post tx|Overall Study||19||
48566613|NCT00840749|101717470|FG001|1 Month Post tx|Overall Study||15||
48566614|NCT00840749|101717469|FG000|6 Months Post tx|Overall Study||16||
48566615|NCT00840749|101717470|FG001|6 Months Post tx|Overall Study||10||
48566616|NCT00840749|101717469|FG000|12 Months Post tx|Overall Study||14||
48566617|NCT00840749|101717470|FG001|12 Months Post tx|Overall Study||7||
48566618|NCT00840749|101717469|FG000|18 Months Post tx|Overall Study||12||
48566619|NCT00840749|101717470|FG001|18 Months Post tx|Overall Study||6||
48566620|NCT00840749|101717469|FG000|24 Months Post tx|Overall Study||9||
48566621|NCT00840749|101717470|FG001|24 Months Post tx|Overall Study||3||
48566622|NCT00840749|101717469|FG000|36 Months Post tx|Overall Study||1||
48566623|NCT00840749|101717470|FG001|36 Months Post tx|Overall Study||0||
48566624|NCT00840749|101717469|FG000|COMPLETED|Overall Study||0||
48566625|NCT00840749|101717470|FG001|COMPLETED|Overall Study||0||
48566626|NCT00840749|101717469|FG000|NOT COMPLETED|Overall Study||31||
48566627|NCT00840749|101717470|FG001|NOT COMPLETED|Overall Study||27||
48566628|NCT02755103|101717471|FG000|STARTED|Overall Study||45||
48698526|NCT04537208|102050334|FG003|Safety Analysis Set (SafAS)|Overall Study||34|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
48566629|NCT02755103|101717472|FG001|STARTED|Overall Study||45||
48566630|NCT02755103|101717471|FG000|8 Week Follow-up Completed|Overall Study||32||
48566631|NCT02755103|101717472|FG001|8 Week Follow-up Completed|Overall Study||28||
48566632|NCT02755103|101717471|FG000|3 Month Follow-up Completed|Overall Study||26||
48566633|NCT02755103|101717472|FG001|3 Month Follow-up Completed|Overall Study||27||
48566634|NCT02755103|101717471|FG000|COMPLETED|Overall Study||25|6 Month Follow-up Completed|
48566635|NCT02755103|101717472|FG001|COMPLETED|Overall Study||27|6 Month Follow-up Completed|
48566636|NCT02755103|101717471|FG000|NOT COMPLETED|Overall Study||20||
48566637|NCT02755103|101717472|FG001|NOT COMPLETED|Overall Study||18||
48566638|NCT01999920|101717473|FG000|STARTED|Overall Study||13||
48566639|NCT01999920|101717474|FG001|STARTED|Overall Study||11||
48566640|NCT01999920|101717473|FG000|COMPLETED|Overall Study||7||
48566641|NCT01999920|101717474|FG001|COMPLETED|Overall Study||9||
48566642|NCT01999920|101717473|FG000|NOT COMPLETED|Overall Study||6||
48566643|NCT01999920|101717474|FG001|NOT COMPLETED|Overall Study||2||
48566644|NCT00730483|101717475|FG000|STARTED|Overall Study||13||
48566645|NCT00730483|101717475|FG000|1 Month After First DEB-TACE|Overall Study||13||
48566646|NCT00730483|101717475|FG000|6 Months After First DEB-TACE|Overall Study||10||
48566647|NCT00730483|101717475|FG000|COMPLETED|Overall Study||6|12 months after first DEB-TACE|
48119457|NCT01440322|100616473|FG000|NOT COMPLETED|Overall Study||7||
48566648|NCT00730483|101717475|FG000|NOT COMPLETED|Overall Study||7||
48566649|NCT01321749|101717476|FG000|STARTED|Overall Study||51||
48566650|NCT01321749|101717477|FG001|STARTED|Overall Study||52||
48566651|NCT01321749|101717476|FG000|COMPLETED|Overall Study||38||
48566652|NCT01321749|101717477|FG001|COMPLETED|Overall Study||30||
48566653|NCT01321749|101717476|FG000|NOT COMPLETED|Overall Study||13||
48566654|NCT01321749|101717477|FG001|NOT COMPLETED|Overall Study||22||
48566655|NCT00514215|101717478|FG000|STARTED|Overall Study||8||
48566656|NCT00514215|101717478|FG000|COMPLETED|Overall Study||8||
48566657|NCT00514215|101717478|FG000|NOT COMPLETED|Overall Study||0||
48566658|NCT01620138|101717479|FG000|STARTED|Overall Study||12||
48566659|NCT01620138|101717480|FG001|STARTED|Overall Study||9||
48566660|NCT01620138|101717479|FG000|COMPLETED|Overall Study||6||
48566661|NCT01620138|101717480|FG001|COMPLETED|Overall Study||9||
48566662|NCT01620138|101717479|FG000|NOT COMPLETED|Overall Study||6||
48566663|NCT01620138|101717480|FG001|NOT COMPLETED|Overall Study||0||
48280669|NCT01699503|101010564|FG001|STARTED|Overall Study||1997||
48280670|NCT01699503|101010563|FG000|Baseline|Overall Study||1723||
48280671|NCT01699503|101010564|FG001|Baseline|Overall Study||1693||
48280672|NCT01699503|101010563|FG000|1 Month Follow-up|Overall Study||998||
48698527|NCT04537208|102050335|FG004|Safety Analysis Set (SafAS)|Overall Study||34|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
48698528|NCT04537208|102050336|FG005|Safety Analysis Set (SafAS)|Overall Study||26|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
48698529|NCT04537208|102050337|FG006|Safety Analysis Set (SafAS)|Overall Study||80|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
48698530|NCT04537208|102050338|FG007|Safety Analysis Set (SafAS)|Overall Study||26|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
48710726|NCT02699450|102077999|FG000|Received at Least One Dose of Study Drug|Overall Study||89|Safety Population|
48280673|NCT01699503|101010564|FG001|1 Month Follow-up|Overall Study||1022||
48280674|NCT01699503|101010563|FG000|6 Month Follow-up|Overall Study||903||
48280675|NCT01699503|101010564|FG001|6 Month Follow-up|Overall Study||893||
48280676|NCT01699503|101010563|FG000|COMPLETED|Overall Study||1008||
48280677|NCT01699503|101010564|FG001|COMPLETED|Overall Study||992||
48566664|NCT01669863|101717481|FG000|STARTED|Overall Study||6||
48280678|NCT01699503|101010563|FG000|NOT COMPLETED|Overall Study||1000||
48280679|NCT01699503|101010564|FG001|NOT COMPLETED|Overall Study||1005||
48280680|NCT01163292|101010565|FG000|STARTED|Overall Study||106||
48566665|NCT01669863|101717481|FG000|COMPLETED|Overall Study||6||
48698531|NCT04537208|102050339|FG008|Safety Analysis Set (SafAS)|Overall Study||85|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
48698532|NCT04537208|102050340|FG009|Safety Analysis Set (SafAS)|Overall Study||18|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
48698533|NCT04537208|102050341|FG010|Safety Analysis Set (SafAS)|Overall Study||29|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
48698534|NCT04537208|102050331|FG000|COMPLETED|Overall Study||26||
48698535|NCT04537208|102050332|FG001|COMPLETED|Overall Study||31||
48698536|NCT04537208|102050333|FG002|COMPLETED|Overall Study||28||
48280681|NCT01163292|101010566|FG001|STARTED|Overall Study||114||
48280682|NCT01163292|101010565|FG000|COMPLETED|Overall Study||65||
48280683|NCT01163292|101010566|FG001|COMPLETED|Overall Study||92||
48280684|NCT01163292|101010565|FG000|NOT COMPLETED|Overall Study||41||
48280685|NCT01163292|101010566|FG001|NOT COMPLETED|Overall Study||22||
48280686|NCT02075476|101010567|FG000|STARTED|Overall Study||20||
48280687|NCT02075476|101010568|FG001|STARTED|Overall Study||20||
48280688|NCT02075476|101010567|FG000|COMPLETED|Overall Study||17||
48280689|NCT02075476|101010568|FG001|COMPLETED|Overall Study||15||
48280690|NCT02075476|101010567|FG000|NOT COMPLETED|Overall Study||3||
48280691|NCT02075476|101010568|FG001|NOT COMPLETED|Overall Study||5||
48280692|NCT04664400|101010569|FG000|STARTED|Overall Study||10||
48280693|NCT04664400|101010569|FG000|COMPLETED|Overall Study||8||
48280694|NCT04664400|101010569|FG000|NOT COMPLETED|Overall Study||2||
48280695|NCT00515853|101010570|FG000|STARTED|Overall Study||61||
48280696|NCT00515853|101010571|FG001|STARTED|Overall Study||60||
48280697|NCT00515853|101010570|FG000|COMPLETED|Overall Study||46||
48280698|NCT00515853|101010571|FG001|COMPLETED|Overall Study||43||
48280699|NCT00515853|101010570|FG000|NOT COMPLETED|Overall Study||15||
48280700|NCT00515853|101010571|FG001|NOT COMPLETED|Overall Study||17||
48280701|NCT00185965|101010572|FG000|STARTED|Overall Study||15||
48698537|NCT04537208|102050334|FG003|COMPLETED|Overall Study||27||
48698538|NCT04537208|102050335|FG004|COMPLETED|Overall Study||26||
48698539|NCT04537208|102050336|FG005|COMPLETED|Overall Study||23||
48698540|NCT04537208|102050337|FG006|COMPLETED|Overall Study||71||
48280702|NCT00185965|101010573|FG001|STARTED|Overall Study||15||
48280703|NCT00185965|101010572|FG000|COMPLETED|Overall Study||15||
48280704|NCT00185965|101010573|FG001|COMPLETED|Overall Study||14||
48280705|NCT00185965|101010572|FG000|NOT COMPLETED|Overall Study||0||
48566666|NCT01669863|101717481|FG000|NOT COMPLETED|Overall Study||0||
48566667|NCT04305327|101717482|FG000|STARTED|Overall Study||2||
48566668|NCT04305327|101717483|FG001|STARTED|Overall Study||6||
48566669|NCT04305327|101717484|FG002|STARTED|Overall Study||2||
48566670|NCT04305327|101717485|FG003|STARTED|Overall Study||2||
48566671|NCT04305327|101717482|FG000|COMPLETED|Overall Study||0||
48566672|NCT04305327|101717483|FG001|COMPLETED|Overall Study||0||
48566673|NCT04305327|101717484|FG002|COMPLETED|Overall Study||0||
48566674|NCT04305327|101717485|FG003|COMPLETED|Overall Study||0||
48566675|NCT04305327|101717482|FG000|NOT COMPLETED|Overall Study||2||
48566676|NCT04305327|101717483|FG001|NOT COMPLETED|Overall Study||6||
48566677|NCT04305327|101717484|FG002|NOT COMPLETED|Overall Study||2||
48566678|NCT04305327|101717485|FG003|NOT COMPLETED|Overall Study||2||
48566679|NCT02461966|101720200|FG000|STARTED|Overall Study||160||
48566680|NCT02461966|101720201|FG001|STARTED|Overall Study||80||
48566681|NCT02461966|101720202|FG002|STARTED|Overall Study||60||
48566682|NCT02461966|101720200|FG000|COMPLETED|Overall Study||160||
48566683|NCT02461966|101720201|FG001|COMPLETED|Overall Study||80||
48566684|NCT02461966|101720202|FG002|COMPLETED|Overall Study||60||
48566685|NCT02461966|101720200|FG000|NOT COMPLETED|Overall Study||0||
48566686|NCT02461966|101720201|FG001|NOT COMPLETED|Overall Study||0||
48566687|NCT02461966|101720202|FG002|NOT COMPLETED|Overall Study||0||
48566688|NCT02059135|101720203|FG000|STARTED|Maternal Follow-up (ITT Population)||62||
48566689|NCT02059135|101720204|FG001|STARTED|Maternal Follow-up (ITT Population)||58||
48566690|NCT02059135|101720203|FG000|COMPLETED|Maternal Follow-up (ITT Population)||59||
48566691|NCT02059135|101720204|FG001|COMPLETED|Maternal Follow-up (ITT Population)||51||
48395062|NCT01229891|101296089|FG002|COMPLETED|Overall Study||30||
48395063|NCT01229891|101296087|FG000|NOT COMPLETED|Overall Study||0||
48395064|NCT01229891|101296088|FG001|NOT COMPLETED|Overall Study||0||
48566692|NCT02059135|101720203|FG000|NOT COMPLETED|Maternal Follow-up (ITT Population)||3||
48566693|NCT02059135|101720204|FG001|NOT COMPLETED|Maternal Follow-up (ITT Population)||7||
48395065|NCT01229891|101296089|FG002|NOT COMPLETED|Overall Study||0||
48395066|NCT02064205|101296090|FG000|STARTED|Overall Study||32||
48395067|NCT02064205|101296090|FG000|Condition A|Overall Study||32||
48395068|NCT02064205|101296090|FG000|Condition B|Overall Study||32||
48566694|NCT02059135|101720203|FG000|STARTED|Neonatal Follow-up (Safety Population)||60||
48566695|NCT02059135|101720204|FG001|STARTED|Neonatal Follow-up (Safety Population)||54||
48395069|NCT02064205|101296090|FG000|Condition C|Overall Study||31||
48566696|NCT02059135|101720203|FG000|COMPLETED|Neonatal Follow-up (Safety Population)||56||
48566697|NCT02059135|101720204|FG001|COMPLETED|Neonatal Follow-up (Safety Population)||50||
48566698|NCT02059135|101720203|FG000|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4||
48280706|NCT00185965|101010573|FG001|NOT COMPLETED|Overall Study||1||
48280707|NCT02207569|101010574|FG000|STARTED|Implant||241||
48280708|NCT02207569|101010574|FG000|COMPLETED|Implant||241||
48280709|NCT02207569|101010574|FG000|NOT COMPLETED|Implant||0||
48395070|NCT02064205|101296090|FG000|Condition D|Overall Study||32||
48280710|NCT02207569|101010574|FG000|STARTED|1-Month||241||
48280711|NCT02207569|101010574|FG000|COMPLETED|1-Month||232||
48566699|NCT02059135|101720204|FG001|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4||
48566700|NCT01783990|101720205|FG000|STARTED|Overall Study||130||
48566701|NCT01783990|101720206|FG001|STARTED|Overall Study||20||
48566702|NCT01783990|101720205|FG000|COMPLETED|Overall Study||125||
48566703|NCT01783990|101720206|FG001|COMPLETED|Overall Study||18||
48566704|NCT01783990|101720205|FG000|NOT COMPLETED|Overall Study||5||
48566705|NCT01783990|101720206|FG001|NOT COMPLETED|Overall Study||2||
48566706|NCT00984542|101720207|FG000|STARTED|Overall Study||50||
48566707|NCT00984542|101720207|FG000|COMPLETED|Overall Study||9||
48566708|NCT00984542|101720207|FG000|NOT COMPLETED|Overall Study||41||
48566709|NCT00828568|101720208|FG000|STARTED|Randomized||184||
48566710|NCT00828568|101720209|FG001|STARTED|Randomized||179||
48395071|NCT02064205|101296090|FG000|COMPLETED|Overall Study||31||
48395072|NCT02064205|101296090|FG000|NOT COMPLETED|Overall Study||1||
48395073|NCT05552859|101296091|FG000|STARTED|Overall Study||31||
48395074|NCT05552859|101296092|FG001|STARTED|Overall Study||31||
48280712|NCT02207569|101010574|FG000|NOT COMPLETED|1-Month||9||
48280713|NCT02207569|101010574|FG000|STARTED|6-Month||232||
48280714|NCT02207569|101010574|FG000|COMPLETED|6-Month||222||
48280715|NCT02207569|101010574|FG000|NOT COMPLETED|6-Month||10||
48280716|NCT02207569|101010574|FG000|STARTED|12-Month||213||
48280717|NCT02207569|101010574|FG000|COMPLETED|12-Month||197||
48280718|NCT02207569|101010574|FG000|NOT COMPLETED|12-Month||16||
48280719|NCT02207569|101010574|FG000|STARTED|24-Month||197||
48280720|NCT02207569|101010574|FG000|COMPLETED|24-Month||171||
48280721|NCT02207569|101010574|FG000|NOT COMPLETED|24-Month||26||
48280722|NCT02207569|101010574|FG000|STARTED|36-Month||171||
48280723|NCT02207569|101010574|FG000|COMPLETED|36-Month||144||
48280724|NCT02207569|101010574|FG000|NOT COMPLETED|36-Month||27||
48280725|NCT02207569|101010574|FG000|STARTED|48-Month||144||
48280726|NCT02207569|101010574|FG000|COMPLETED|48-Month||113||
48280727|NCT02207569|101010574|FG000|NOT COMPLETED|48-Month||31||
48395075|NCT05552859|101296091|FG000|COMPLETED|Overall Study||1|Sanofi LPS17007 study was terminated by the Sponsor due to poor recruitment/severe recruitment delay and was not related to safety concern.|
48280728|NCT02207569|101010574|FG000|STARTED|60-Month||113||
48280729|NCT02207569|101010574|FG000|COMPLETED|60-Month||109||
48566711|NCT00828568|101720210|FG002|STARTED|Randomized||62||
48566712|NCT00828568|101720208|FG000|COMPLETED|Randomized||183||
48280730|NCT02207569|101010574|FG000|NOT COMPLETED|60-Month||4||
48280731|NCT03932812|101010575|FG000|STARTED|Overall Study||42||
48280732|NCT03932812|101010576|FG001|STARTED|Overall Study||40||
48280733|NCT03932812|101010575|FG000|Baseline Interview|Overall Study||42||
48280734|NCT03932812|101010576|FG001|Baseline Interview|Overall Study||40||
48280735|NCT03932812|101010575|FG000|3 Month Survey|Overall Study||29||
48280736|NCT03932812|101010576|FG001|3 Month Survey|Overall Study||26||
48280737|NCT03932812|101010575|FG000|6 Month Survey|Overall Study||25||
48280738|NCT03932812|101010576|FG001|6 Month Survey|Overall Study||25||
48280739|NCT03932812|101010575|FG000|COMPLETED|Overall Study||25||
48280740|NCT03932812|101010576|FG001|COMPLETED|Overall Study||25||
48566713|NCT00828568|101720209|FG001|COMPLETED|Randomized||179||
48566714|NCT00828568|101720210|FG002|COMPLETED|Randomized||60||
48566715|NCT00828568|101720208|FG000|NOT COMPLETED|Randomized||1||
48566716|NCT00828568|101720209|FG001|NOT COMPLETED|Randomized||0||
48566717|NCT00828568|101720210|FG002|NOT COMPLETED|Randomized||2||
48566718|NCT00828568|101720208|FG000|STARTED|Treated - Received at Least One Dose||183||
48566719|NCT00828568|101720209|FG001|STARTED|Treated - Received at Least One Dose||179||
48566720|NCT00828568|101720210|FG002|STARTED|Treated - Received at Least One Dose||60||
48566721|NCT00828568|101720208|FG000|COMPLETED|Treated - Received at Least One Dose||153||
48566722|NCT00828568|101720209|FG001|COMPLETED|Treated - Received at Least One Dose||150||
48566723|NCT00828568|101720210|FG002|COMPLETED|Treated - Received at Least One Dose||55||
48566724|NCT00828568|101720208|FG000|NOT COMPLETED|Treated - Received at Least One Dose||30||
48566725|NCT00828568|101720209|FG001|NOT COMPLETED|Treated - Received at Least One Dose||29||
48566726|NCT00828568|101720210|FG002|NOT COMPLETED|Treated - Received at Least One Dose||5||
48566727|NCT02481206|101720211|FG000|STARTED|Overall Study||34||
48566728|NCT02481206|101720212|FG001|STARTED|Overall Study||32||
48566729|NCT02481206|101720211|FG000|COMPLETED|Overall Study||29||
48566730|NCT02481206|101720212|FG001|COMPLETED|Overall Study||31||
48566731|NCT02481206|101720211|FG000|NOT COMPLETED|Overall Study||5||
48566732|NCT02481206|101720212|FG001|NOT COMPLETED|Overall Study||1||
48566733|NCT03070236|101720213|FG000|STARTED|Overall Study||912||
48566734|NCT03070236|101720213|FG000|Guideline Concordant Care (GCC) Arm|Overall Study||538||
48566735|NCT03070236|101720213|FG000|Active Surveillance (AS) Arm|Overall Study||374||
48566736|NCT03070236|101720213|FG000|COMPLETED|Overall Study||912||
48566737|NCT03070236|101720213|FG000|NOT COMPLETED|Overall Study||0||
48698541|NCT04537208|102050338|FG007|COMPLETED|Overall Study||24||
48698542|NCT04537208|102050339|FG008|COMPLETED|Overall Study||69||
48698543|NCT04537208|102050340|FG009|COMPLETED|Overall Study||14||
48698544|NCT04537208|102050341|FG010|COMPLETED|Overall Study||21||
48698545|NCT04537208|102050331|FG000|NOT COMPLETED|Overall Study||8||
48698546|NCT04537208|102050332|FG001|NOT COMPLETED|Overall Study||3||
48280741|NCT03932812|101010575|FG000|NOT COMPLETED|Overall Study||17||
48280742|NCT03932812|101010576|FG001|NOT COMPLETED|Overall Study||15||
48280743|NCT04606771|101010577|FG000|STARTED|Overall Study||14||
48280744|NCT04606771|101010578|FG001|STARTED|Overall Study||16||
48280745|NCT04606771|101010577|FG000|COMPLETED|Overall Study||0||
48280746|NCT04606771|101010578|FG001|COMPLETED|Overall Study||0||
48280747|NCT04606771|101010577|FG000|NOT COMPLETED|Overall Study||14||
48280748|NCT04606771|101010578|FG001|NOT COMPLETED|Overall Study||16||
48280749|NCT03590366|101010579|FG000|STARTED|Overall Study||73||
48280750|NCT03590366|101010580|FG001|STARTED|Overall Study||67||
48280751|NCT03590366|101010579|FG000|COMPLETED|Overall Study||70||
48280752|NCT03590366|101010580|FG001|COMPLETED|Overall Study||59||
48280753|NCT03590366|101010579|FG000|NOT COMPLETED|Overall Study||3||
48395076|NCT05552859|101296092|FG001|COMPLETED|Overall Study||1|Sanofi LPS17007 study was terminated by the Sponsor due to poor recruitment/severe recruitment delay and was not related to safety concern.|
48395077|NCT05552859|101296091|FG000|NOT COMPLETED|Overall Study||30||
48395078|NCT05552859|101296092|FG001|NOT COMPLETED|Overall Study||30||
48566738|NCT02060058|101720214|FG000|STARTED|Overall Study||4||
48566739|NCT02060058|101720215|FG001|STARTED|Overall Study||0||
48566740|NCT02060058|101720216|FG002|STARTED|Overall Study||8||
48566741|NCT02060058|101720214|FG000|COMPLETED|Overall Study||4||
48698547|NCT04537208|102050333|FG002|NOT COMPLETED|Overall Study||6||
48698548|NCT04537208|102050334|FG003|NOT COMPLETED|Overall Study||7||
48698549|NCT04537208|102050335|FG004|NOT COMPLETED|Overall Study||8||
48698550|NCT04537208|102050336|FG005|NOT COMPLETED|Overall Study||5||
48698551|NCT04537208|102050337|FG006|NOT COMPLETED|Overall Study||13||
48698552|NCT04537208|102050338|FG007|NOT COMPLETED|Overall Study||3||
48698553|NCT04537208|102050339|FG008|NOT COMPLETED|Overall Study||16||
48698554|NCT04537208|102050340|FG009|NOT COMPLETED|Overall Study||4||
48698555|NCT04537208|102050341|FG010|NOT COMPLETED|Overall Study||8||
48698556|NCT04115748|102050342|FG000|STARTED|Main Study (Up to 16 Weeks)||19||
48119458|NCT01440322|100616474|FG001|NOT COMPLETED|Overall Study||1||
48280754|NCT03590366|101010580|FG001|NOT COMPLETED|Overall Study||8||
48280755|NCT01127763|101010581|FG000|STARTED|Overall Study||25||
48395079|NCT01011218|101296093|FG000|STARTED|Overall Study||9||
48395080|NCT01011218|101296094|FG001|STARTED|Overall Study||9||
48280756|NCT01127763|101010581|FG000|COMPLETED|Overall Study||20||
48566742|NCT02060058|101720215|FG001|COMPLETED|Overall Study||0||
48566743|NCT02060058|101720216|FG002|COMPLETED|Overall Study||8||
48566744|NCT02060058|101720214|FG000|NOT COMPLETED|Overall Study||0||
48566745|NCT02060058|101720215|FG001|NOT COMPLETED|Overall Study||0||
48280757|NCT01127763|101010581|FG000|NOT COMPLETED|Overall Study||5||
48280758|NCT01587027|101010582|FG000|STARTED|First Intervention (1 Day)||8||
48280759|NCT01587027|101010583|FG001|STARTED|First Intervention (1 Day)||8||
48566746|NCT02060058|101720216|FG002|NOT COMPLETED|Overall Study||0||
48698557|NCT04115748|102050343|FG001|STARTED|Main Study (Up to 16 Weeks)||19||
48698558|NCT04115748|102050344|FG002|STARTED|Main Study (Up to 16 Weeks)||9||
48698559|NCT04115748|102050345|FG003|STARTED|Main Study (Up to 16 Weeks)||20||
48698560|NCT04115748|102050346|FG004|STARTED|Main Study (Up to 16 Weeks)||0||
48698561|NCT04115748|102050347|FG005|STARTED|Main Study (Up to 16 Weeks)||0||
48698562|NCT04115748|102050348|FG006|STARTED|Main Study (Up to 16 Weeks)||0||
48698563|NCT04115748|102050349|FG007|STARTED|Main Study (Up to 16 Weeks)||0||
48698564|NCT04115748|102050350|FG008|STARTED|Main Study (Up to 16 Weeks)||0||
48698565|NCT04115748|102050351|FG009|STARTED|Main Study (Up to 16 Weeks)||0||
48280760|NCT01587027|101010582|FG000|COMPLETED|First Intervention (1 Day)||8||
48280761|NCT01587027|101010583|FG001|COMPLETED|First Intervention (1 Day)||8||
48280762|NCT01587027|101010582|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48280763|NCT01587027|101010583|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48280764|NCT01587027|101010582|FG000|STARTED|Washout (1 Day)||8||
48280765|NCT01587027|101010583|FG001|STARTED|Washout (1 Day)||8||
48280766|NCT01587027|101010582|FG000|COMPLETED|Washout (1 Day)||8||
48280767|NCT01587027|101010583|FG001|COMPLETED|Washout (1 Day)||8||
48280768|NCT01587027|101010582|FG000|NOT COMPLETED|Washout (1 Day)||0||
48280769|NCT01587027|101010583|FG001|NOT COMPLETED|Washout (1 Day)||0||
48280770|NCT01587027|101010582|FG000|STARTED|Second Intervention (1 Day)||8||
48280771|NCT01587027|101010583|FG001|STARTED|Second Intervention (1 Day)||8||
48280772|NCT01587027|101010582|FG000|COMPLETED|Second Intervention (1 Day)||8||
48280773|NCT01587027|101010583|FG001|COMPLETED|Second Intervention (1 Day)||8||
48280774|NCT01587027|101010582|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48395081|NCT01011218|101296095|FG002|STARTED|Overall Study||26||
48395082|NCT01011218|101296096|FG003|STARTED|Overall Study||26||
48395083|NCT01011218|101296093|FG000|COMPLETED|Overall Study||9||
48395084|NCT01011218|101296094|FG001|COMPLETED|Overall Study||9||
48395085|NCT01011218|101296095|FG002|COMPLETED|Overall Study||26||
48280775|NCT01587027|101010583|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48280776|NCT01587027|101010582|FG000|STARTED|Washout (1 Day)||8||
48280777|NCT01587027|101010583|FG001|STARTED|Washout (1 Day)||8||
48280778|NCT01587027|101010582|FG000|COMPLETED|Washout (1 Day)||8||
48280779|NCT01587027|101010583|FG001|COMPLETED|Washout (1 Day)||8||
48280780|NCT01587027|101010582|FG000|NOT COMPLETED|Washout (1 Day)||0||
48280781|NCT01587027|101010583|FG001|NOT COMPLETED|Washout (1 Day)||0||
48280782|NCT01587027|101010582|FG000|STARTED|Third Intervention (1 Day)||8||
48280783|NCT01587027|101010583|FG001|STARTED|Third Intervention (1 Day)||8||
48280784|NCT01587027|101010582|FG000|COMPLETED|Third Intervention (1 Day)||8||
48280785|NCT01587027|101010583|FG001|COMPLETED|Third Intervention (1 Day)||8||
48280786|NCT01587027|101010582|FG000|NOT COMPLETED|Third Intervention (1 Day)||0||
48280787|NCT01587027|101010583|FG001|NOT COMPLETED|Third Intervention (1 Day)||0||
48280788|NCT01587027|101010582|FG000|STARTED|Discharge (1 Day)||8||
48280789|NCT01587027|101010583|FG001|STARTED|Discharge (1 Day)||8||
48280790|NCT01587027|101010582|FG000|COMPLETED|Discharge (1 Day)||8||
48280791|NCT01587027|101010583|FG001|COMPLETED|Discharge (1 Day)||8||
48395086|NCT01011218|101296096|FG003|COMPLETED|Overall Study||26||
48395087|NCT01011218|101296093|FG000|NOT COMPLETED|Overall Study||0||
48395088|NCT01011218|101296094|FG001|NOT COMPLETED|Overall Study||0||
48395089|NCT01011218|101296095|FG002|NOT COMPLETED|Overall Study||0||
48698566|NCT04115748|102050342|FG000|COMPLETED|Main Study (Up to 16 Weeks)||4||
48698567|NCT04115748|102050343|FG001|COMPLETED|Main Study (Up to 16 Weeks)||3||
48698568|NCT04115748|102050344|FG002|COMPLETED|Main Study (Up to 16 Weeks)||2||
48280792|NCT01587027|101010582|FG000|NOT COMPLETED|Discharge (1 Day)||0||
48280793|NCT01587027|101010583|FG001|NOT COMPLETED|Discharge (1 Day)||0||
48280794|NCT01143870|101010584|FG000|STARTED|Overall Study||58||
48280795|NCT01143870|101010585|FG001|STARTED|Overall Study||58||
48280796|NCT01143870|101010586|FG002|STARTED|Overall Study||61||
48280797|NCT01143870|101010584|FG000|Post-intervention Survey|Overall Study||53||
48280798|NCT01143870|101010585|FG001|Post-intervention Survey|Overall Study||50||
48280799|NCT01143870|101010586|FG002|Post-intervention Survey|Overall Study||61||
48280800|NCT01143870|101010584|FG000|Had Available 6-month A1C|Overall Study||27||
48280801|NCT01143870|101010585|FG001|Had Available 6-month A1C|Overall Study||29||
48280802|NCT01143870|101010586|FG002|Had Available 6-month A1C|Overall Study||31||
48280803|NCT01143870|101010584|FG000|A1C Imputed|Overall Study||31||
48280804|NCT01143870|101010585|FG001|A1C Imputed|Overall Study||29||
48280805|NCT01143870|101010586|FG002|A1C Imputed|Overall Study||30||
48698569|NCT04115748|102050345|FG003|COMPLETED|Main Study (Up to 16 Weeks)||4||
48698570|NCT04115748|102050346|FG004|COMPLETED|Main Study (Up to 16 Weeks)||0||
48698571|NCT04115748|102050347|FG005|COMPLETED|Main Study (Up to 16 Weeks)||0||
48698572|NCT04115748|102050348|FG006|COMPLETED|Main Study (Up to 16 Weeks)||0||
48698573|NCT04115748|102050349|FG007|COMPLETED|Main Study (Up to 16 Weeks)||0||
48698574|NCT04115748|102050350|FG008|COMPLETED|Main Study (Up to 16 Weeks)||0||
48698575|NCT04115748|102050351|FG009|COMPLETED|Main Study (Up to 16 Weeks)||0||
48698576|NCT04115748|102050342|FG000|NOT COMPLETED|Main Study (Up to 16 Weeks)||15||
48280806|NCT01143870|101010584|FG000|COMPLETED|Overall Study||58||
48280807|NCT01143870|101010585|FG001|COMPLETED|Overall Study||58||
48280808|NCT01143870|101010586|FG002|COMPLETED|Overall Study||61||
48280809|NCT01143870|101010584|FG000|NOT COMPLETED|Overall Study||0||
48280810|NCT01143870|101010585|FG001|NOT COMPLETED|Overall Study||0||
48280811|NCT01143870|101010586|FG002|NOT COMPLETED|Overall Study||0||
48280812|NCT02045875|101010587|FG000|STARTED|Overall Study||27||
48280813|NCT02045875|101010588|FG001|STARTED|Overall Study||23||
48280814|NCT02045875|101010587|FG000|COMPLETED|Overall Study||20||
48280815|NCT02045875|101010588|FG001|COMPLETED|Overall Study||20||
48280816|NCT02045875|101010587|FG000|NOT COMPLETED|Overall Study||7||
48280817|NCT02045875|101010588|FG001|NOT COMPLETED|Overall Study||3||
48395090|NCT01011218|101296096|FG003|NOT COMPLETED|Overall Study||0||
48395091|NCT00196196|101296097|FG000|STARTED|Overall Study||274||
48395092|NCT00196196|101296097|FG000|COMPLETED|Overall Study||267||
48395093|NCT00196196|101296097|FG000|NOT COMPLETED|Overall Study||7||
48395094|NCT03943446|101296098|FG000|STARTED|Overall Study||12||
48395095|NCT03943446|101296099|FG001|STARTED|Overall Study||11||
48395096|NCT03943446|101296100|FG002|STARTED|Overall Study||11||
48395097|NCT03943446|101296098|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||12|PK analysis set included participants from the safety analysis set with at least 1 reported PK concentration.|
48395098|NCT03943446|101296099|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||11|PK analysis set included participants from the safety analysis set with at least 1 reported PK concentration.|
48698577|NCT04115748|102050343|FG001|NOT COMPLETED|Main Study (Up to 16 Weeks)||16||
48698578|NCT04115748|102050344|FG002|NOT COMPLETED|Main Study (Up to 16 Weeks)||7||
48698579|NCT04115748|102050345|FG003|NOT COMPLETED|Main Study (Up to 16 Weeks)||16||
48698580|NCT04115748|102050346|FG004|NOT COMPLETED|Main Study (Up to 16 Weeks)||0||
48698581|NCT04115748|102050347|FG005|NOT COMPLETED|Main Study (Up to 16 Weeks)||0||
48280818|NCT05745701|101010589|FG000|STARTED|Period 1: PF-07081532||16||
48280819|NCT05745701|101010589|FG000|COMPLETED|Period 1: PF-07081532||16||
48280820|NCT05745701|101010589|FG000|NOT COMPLETED|Period 1: PF-07081532||0||
48280821|NCT05745701|101010589|FG000|STARTED|Period 2: Cyclosporine + PF-07081532||16||
48395099|NCT03943446|101296100|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||11|PK analysis set included participants from the safety analysis set with at least 1 reported PK concentration.|
48395100|NCT03943446|101296098|FG000|COMPLETED|Overall Study||5||
48395101|NCT03943446|101296099|FG001|COMPLETED|Overall Study||7||
48395102|NCT03943446|101296100|FG002|COMPLETED|Overall Study||4||
48395103|NCT03943446|101296098|FG000|NOT COMPLETED|Overall Study||7||
48395104|NCT03943446|101296099|FG001|NOT COMPLETED|Overall Study||4||
48280822|NCT05745701|101010589|FG000|COMPLETED|Period 2: Cyclosporine + PF-07081532||16||
48395105|NCT03943446|101296100|FG002|NOT COMPLETED|Overall Study||7||
48395106|NCT03407170|101296101|FG000|STARTED|Overall Study||1||
48395107|NCT03407170|101296101|FG000|COMPLETED|Overall Study||0||
48395108|NCT03407170|101296101|FG000|NOT COMPLETED|Overall Study||1||
48395109|NCT01877941|101296102|FG000|STARTED|Overall Study||39||
48395110|NCT01877941|101296102|FG000|COMPLETED|Overall Study||39||
48280823|NCT05745701|101010589|FG000|NOT COMPLETED|Period 2: Cyclosporine + PF-07081532||0||
48280824|NCT05745701|101010589|FG000|STARTED|Period 3: Itraconazole + PF-07081532||16||
48280825|NCT05745701|101010589|FG000|COMPLETED|Period 3: Itraconazole + PF-07081532||16||
48280826|NCT05745701|101010589|FG000|NOT COMPLETED|Period 3: Itraconazole + PF-07081532||0||
48395111|NCT01877941|101296102|FG000|NOT COMPLETED|Overall Study||0||
48395112|NCT03097029|101296103|FG000|STARTED|Overall Study||15||
48395113|NCT03097029|101296103|FG000|COMPLETED|Overall Study||14||
48395114|NCT03097029|101296103|FG000|NOT COMPLETED|Overall Study||1||
48395115|NCT00065442|101296104|FG000|STARTED|Overall Study||171||
48395116|NCT00065442|101296105|FG001|STARTED|Overall Study||341||
48395117|NCT00065442|101296104|FG000|COMPLETED|Overall Study||46||
48395118|NCT00065442|101296105|FG001|COMPLETED|Overall Study||121||
48395119|NCT00065442|101296104|FG000|NOT COMPLETED|Overall Study||125||
48395120|NCT00065442|101296105|FG001|NOT COMPLETED|Overall Study||220||
48395121|NCT00888615|101296106|FG000|STARTED|Overall Study||58||
48395122|NCT00888615|101296106|FG000|COMPLETED|Overall Study||56||
48395123|NCT00888615|101296106|FG000|NOT COMPLETED|Overall Study||2||
48395124|NCT01504971|101296107|FG000|STARTED|Overall Study||95||
48395125|NCT01504971|101296107|FG000|COMPLETED|Overall Study||82||
48395126|NCT01504971|101296107|FG000|NOT COMPLETED|Overall Study||13||
48395127|NCT00456885|101299079|FG000|STARTED|First Treatment Period, 16 Weeks||24||
48395128|NCT00456885|101299080|FG001|STARTED|First Treatment Period, 16 Weeks||17||
48395129|NCT00456885|101299079|FG000|COMPLETED|First Treatment Period, 16 Weeks||24||
48395130|NCT00456885|101299080|FG001|COMPLETED|First Treatment Period, 16 Weeks||17||
48395131|NCT00456885|101299079|FG000|NOT COMPLETED|First Treatment Period, 16 Weeks||0||
48395132|NCT00456885|101299080|FG001|NOT COMPLETED|First Treatment Period, 16 Weeks||0||
48395133|NCT00456885|101299079|FG000|STARTED|Washout, 3 Weeks||24||
48395134|NCT00456885|101299080|FG001|STARTED|Washout, 3 Weeks||17||
48395135|NCT00456885|101299079|FG000|COMPLETED|Washout, 3 Weeks||24||
48395136|NCT00456885|101299080|FG001|COMPLETED|Washout, 3 Weeks||17||
48395137|NCT00456885|101299079|FG000|NOT COMPLETED|Washout, 3 Weeks||0||
48698582|NCT04115748|102050348|FG006|NOT COMPLETED|Main Study (Up to 16 Weeks)||0||
48698583|NCT04115748|102050349|FG007|NOT COMPLETED|Main Study (Up to 16 Weeks)||0||
48280827|NCT01470001|101010590|FG000|STARTED|Overall Study||58||
48280828|NCT01470001|101010591|FG001|STARTED|Overall Study||60||
48280829|NCT01470001|101010590|FG000|COMPLETED|Overall Study||53||
48395138|NCT00456885|101299080|FG001|NOT COMPLETED|Washout, 3 Weeks||0||
48395139|NCT00456885|101299079|FG000|STARTED|Second Treatment Period, 16 Weeks||24||
48395140|NCT00456885|101299080|FG001|STARTED|Second Treatment Period, 16 Weeks||17||
48566747|NCT01870973|101720217|FG000|STARTED|Overall Study||56||
48566748|NCT01870973|101720218|FG001|STARTED|Overall Study||52||
48566749|NCT01870973|101720217|FG000|COMPLETED|Overall Study||46||
48566750|NCT01870973|101720218|FG001|COMPLETED|Overall Study||49||
48566751|NCT01870973|101720217|FG000|NOT COMPLETED|Overall Study||10||
48566752|NCT01870973|101720218|FG001|NOT COMPLETED|Overall Study||3||
48566753|NCT04762160|101720219|FG000|STARTED|Overall Study||5||
48566754|NCT04762160|101720219|FG000|COMPLETED|Overall Study||0||
48566755|NCT04762160|101720219|FG000|NOT COMPLETED|Overall Study||5||
48566756|NCT00314340|101720220|FG000|STARTED|Overall Study||12||
48566757|NCT00314340|101720220|FG000|ER Morphine|Overall Study||11||
48566758|NCT00314340|101720220|FG000|Hydrocodone Plus APAP|Overall Study||12||
48566759|NCT00314340|101720220|FG000|Placebo|Overall Study||12||
48566760|NCT00314340|101720220|FG000|COMPLETED|Overall Study||11||
48566761|NCT00314340|101720220|FG000|NOT COMPLETED|Overall Study||1||
48566762|NCT03588910|101720221|FG000|STARTED|Overall Study||60||
48566763|NCT03588910|101720222|FG001|STARTED|Overall Study||60||
48566764|NCT03588910|101720221|FG000|Post Op Day 1 Survey|Overall Study||52||
48566765|NCT03588910|101720222|FG001|Post Op Day 1 Survey|Overall Study||47||
48566766|NCT03588910|101720221|FG000|COMPLETED|Overall Study||47|Post Op Day 7 Survey|
48566767|NCT03588910|101720222|FG001|COMPLETED|Overall Study||45|Post Op Day 7 Survey|
48566768|NCT03588910|101720221|FG000|NOT COMPLETED|Overall Study||13||
48566769|NCT03588910|101720222|FG001|NOT COMPLETED|Overall Study||15||
48566770|NCT01420068|101720223|FG000|STARTED|Overall Study||51||
48566771|NCT01420068|101720224|FG001|STARTED|Overall Study||55||
48566772|NCT01420068|101720223|FG000|COMPLETED|Overall Study||49||
48566773|NCT01420068|101720224|FG001|COMPLETED|Overall Study||50||
48566774|NCT01420068|101720223|FG000|NOT COMPLETED|Overall Study||2||
48566775|NCT01420068|101720224|FG001|NOT COMPLETED|Overall Study||5||
48566776|NCT02560922|101720225|FG000|STARTED|Overall Study||124||
48566777|NCT02560922|101720226|FG001|STARTED|Overall Study||124||
48566778|NCT02560922|101720225|FG000|COMPLETED|Overall Study||98||
48566779|NCT02560922|101720226|FG001|COMPLETED|Overall Study||112||
48566780|NCT02560922|101720225|FG000|NOT COMPLETED|Overall Study||26||
48566781|NCT02560922|101720226|FG001|NOT COMPLETED|Overall Study||12||
48566782|NCT04185220|101720227|FG000|STARTED|Dose Escalation||3||
48566783|NCT04185220|101720228|FG001|STARTED|Dose Escalation||3||
48566784|NCT04185220|101720227|FG000|COMPLETED|Dose Escalation||3||
48566785|NCT04185220|101720228|FG001|COMPLETED|Dose Escalation||1||
48566786|NCT04185220|101720227|FG000|NOT COMPLETED|Dose Escalation||0||
48566787|NCT04185220|101720228|FG001|NOT COMPLETED|Dose Escalation||2||
48566788|NCT04185220|101720227|FG000|STARTED|Dose Expansion||0||
48566789|NCT04185220|101720228|FG001|STARTED|Dose Expansion||0||
48566790|NCT04185220|101720227|FG000|COMPLETED|Dose Expansion||0||
48566791|NCT04185220|101720228|FG001|COMPLETED|Dose Expansion||0||
48566792|NCT04185220|101720227|FG000|NOT COMPLETED|Dose Expansion||0||
48566793|NCT04185220|101720228|FG001|NOT COMPLETED|Dose Expansion||0||
48566794|NCT02721277|101720229|FG000|STARTED|Overall Study||2||
48566795|NCT02721277|101720229|FG000|COMPLETED|Overall Study||2||
48566796|NCT02721277|101720229|FG000|NOT COMPLETED|Overall Study||0||
48566797|NCT00428246|101720230|FG000|STARTED|Overall Study||8||
48566798|NCT00428246|101720231|FG001|STARTED|Overall Study||8||
48566799|NCT00428246|101720232|FG002|STARTED|Overall Study||8||
48566800|NCT00428246|101720230|FG000|COMPLETED|Overall Study||7||
48566801|NCT00428246|101720231|FG001|COMPLETED|Overall Study||8||
48566802|NCT00428246|101720232|FG002|COMPLETED|Overall Study||7||
48566803|NCT00428246|101720230|FG000|NOT COMPLETED|Overall Study||1||
48566804|NCT00428246|101720231|FG001|NOT COMPLETED|Overall Study||0||
48566805|NCT00428246|101720232|FG002|NOT COMPLETED|Overall Study||1||
48566806|NCT00359424|101720233|FG000|STARTED|Overall Study||434||
48566807|NCT00359424|101720234|FG001|STARTED|Overall Study||222||
48566808|NCT00359424|101720233|FG000|90 Day Follow up|Overall Study||343||
48566809|NCT00359424|101720234|FG001|90 Day Follow up|Overall Study||172||
48566810|NCT00359424|101720233|FG000|180 Day Follow up|Overall Study||325||
48566811|NCT00359424|101720234|FG001|180 Day Follow up|Overall Study||167||
48566812|NCT00359424|101720233|FG000|270 Day Follow up|Overall Study||313||
48566813|NCT00359424|101720234|FG001|270 Day Follow up|Overall Study||159||
48566814|NCT00359424|101720233|FG000|COMPLETED|Overall Study||304||
48566815|NCT00359424|101720234|FG001|COMPLETED|Overall Study||155||
48566816|NCT00359424|101720233|FG000|NOT COMPLETED|Overall Study||130||
48566817|NCT00359424|101720234|FG001|NOT COMPLETED|Overall Study||67||
48566818|NCT01472692|101720235|FG000|STARTED|Overall Study||0||
48566819|NCT01472692|101720236|FG001|STARTED|Overall Study||0||
48566820|NCT01472692|101720235|FG000|COMPLETED|Overall Study||0||
48566821|NCT01472692|101720236|FG001|COMPLETED|Overall Study||0||
48566822|NCT01472692|101720235|FG000|NOT COMPLETED|Overall Study||0||
48566823|NCT01472692|101720236|FG001|NOT COMPLETED|Overall Study||0||
48566824|NCT01697748|101720237|FG000|STARTED|Overall Study||329||
48566825|NCT01697748|101720238|FG001|STARTED|Overall Study||328||
48566826|NCT01697748|101720237|FG000|COMPLETED|Overall Study||271||
48566827|NCT01697748|101720238|FG001|COMPLETED|Overall Study||260||
48566828|NCT01697748|101720237|FG000|NOT COMPLETED|Overall Study||58||
48280830|NCT01470001|101010591|FG001|COMPLETED|Overall Study||58||
48280831|NCT01470001|101010590|FG000|NOT COMPLETED|Overall Study||5||
48280832|NCT01470001|101010591|FG001|NOT COMPLETED|Overall Study||2||
48280833|NCT02566044|101010592|FG000|STARTED|Overall Study||6||
48280834|NCT02566044|101010593|FG001|STARTED|Overall Study||6||
48280835|NCT02566044|101010594|FG002|STARTED|Overall Study||4||
48280836|NCT02566044|101010592|FG000|COMPLETED|Overall Study||6||
48698584|NCT04115748|102050350|FG008|NOT COMPLETED|Main Study (Up to 16 Weeks)||0||
48698585|NCT04115748|102050351|FG009|NOT COMPLETED|Main Study (Up to 16 Weeks)||0||
48698586|NCT04115748|102050342|FG000|STARTED|LTE (After 16 Weeks to Week 50)||0||
48698587|NCT04115748|102050343|FG001|STARTED|LTE (After 16 Weeks to Week 50)||0||
48698588|NCT04115748|102050344|FG002|STARTED|LTE (After 16 Weeks to Week 50)||0||
48698589|NCT04115748|102050345|FG003|STARTED|LTE (After 16 Weeks to Week 50)||0||
48698590|NCT04115748|102050346|FG004|STARTED|LTE (After 16 Weeks to Week 50)||4||
48395141|NCT00456885|101299079|FG000|COMPLETED|Second Treatment Period, 16 Weeks||23||
48395142|NCT00456885|101299080|FG001|COMPLETED|Second Treatment Period, 16 Weeks||17||
48395143|NCT00456885|101299079|FG000|NOT COMPLETED|Second Treatment Period, 16 Weeks||1||
48395144|NCT00456885|101299080|FG001|NOT COMPLETED|Second Treatment Period, 16 Weeks||0||
48395145|NCT02966353|101299081|FG000|STARTED|Overall Study||51||
48395146|NCT02966353|101299081|FG000|Completed After Data Cutoff|Overall Study||1|One patient completed one week after 30 days follow up for safety|
48698591|NCT04115748|102050347|FG005|STARTED|LTE (After 16 Weeks to Week 50)||3||
48698592|NCT04115748|102050348|FG006|STARTED|LTE (After 16 Weeks to Week 50)||1||
48698593|NCT04115748|102050349|FG007|STARTED|LTE (After 16 Weeks to Week 50)||1||
48698594|NCT04115748|102050350|FG008|STARTED|LTE (After 16 Weeks to Week 50)||2||
48698595|NCT04115748|102050351|FG009|STARTED|LTE (After 16 Weeks to Week 50)||2||
48698596|NCT04115748|102050342|FG000|COMPLETED|LTE (After 16 Weeks to Week 50)||0||
48698597|NCT04115748|102050343|FG001|COMPLETED|LTE (After 16 Weeks to Week 50)||0||
48698598|NCT04115748|102050344|FG002|COMPLETED|LTE (After 16 Weeks to Week 50)||0||
48698599|NCT04115748|102050345|FG003|COMPLETED|LTE (After 16 Weeks to Week 50)||0||
48698600|NCT04115748|102050346|FG004|COMPLETED|LTE (After 16 Weeks to Week 50)||0||
48280837|NCT02566044|101010593|FG001|COMPLETED|Overall Study||6||
48280838|NCT02566044|101010594|FG002|COMPLETED|Overall Study||4||
48280839|NCT02566044|101010592|FG000|NOT COMPLETED|Overall Study||0||
48280840|NCT02566044|101010593|FG001|NOT COMPLETED|Overall Study||0||
48395147|NCT02966353|101299081|FG000|COMPLETED|Overall Study||29|Primary reason for discontinuation is presented for reason not completed.|
48698601|NCT04115748|102050347|FG005|COMPLETED|LTE (After 16 Weeks to Week 50)||0||
48698602|NCT04115748|102050348|FG006|COMPLETED|LTE (After 16 Weeks to Week 50)||0||
48280841|NCT02566044|101010594|FG002|NOT COMPLETED|Overall Study||0||
48280842|NCT03518567|101010595|FG000|STARTED|Overall Study||133||
48280843|NCT03518567|101010595|FG000|Completed Baseline|Overall Study||114||
48280844|NCT03518567|101010595|FG000|Completed Session 1|Overall Study||101||
48280845|NCT03518567|101010595|FG000|Completed Session 2|Overall Study||72||
48280846|NCT03518567|101010595|FG000|COMPLETED|Overall Study||72|This is the number of participants who completed Baseline, Session 1, and Session 2.|
48698603|NCT04115748|102050349|FG007|COMPLETED|LTE (After 16 Weeks to Week 50)||0||
48698604|NCT04115748|102050350|FG008|COMPLETED|LTE (After 16 Weeks to Week 50)||0||
48698605|NCT04115748|102050351|FG009|COMPLETED|LTE (After 16 Weeks to Week 50)||0||
48698606|NCT04115748|102050342|FG000|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||0||
48698607|NCT04115748|102050343|FG001|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||0||
48698608|NCT04115748|102050344|FG002|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||0||
48698609|NCT04115748|102050345|FG003|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||0||
48698610|NCT04115748|102050346|FG004|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||4||
48698611|NCT04115748|102050347|FG005|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||3||
48280847|NCT03518567|101010595|FG000|NOT COMPLETED|Overall Study||61||
48698612|NCT04115748|102050348|FG006|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||1||
48698613|NCT04115748|102050349|FG007|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||1||
48698614|NCT04115748|102050350|FG008|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||2||
48698615|NCT04115748|102050351|FG009|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||2||
48698616|NCT05096247|102050352|FG000|STARTED|Overall Study||13||
48698617|NCT05096247|102050353|FG001|STARTED|Overall Study||35||
48698618|NCT05096247|102050352|FG000|COMPLETED|Overall Study||13||
48280848|NCT00858364|101010596|FG000|STARTED|Overall Study||846||
48280849|NCT00858364|101010597|FG001|STARTED|Overall Study||1703||
48395148|NCT02966353|101299081|FG000|NOT COMPLETED|Overall Study||22||
48395149|NCT04702984|101299082|FG000|STARTED|Overall Study||39||78
48395150|NCT04702984|101299082|FG000|COMPLETED|Overall Study||38||76
48395151|NCT04702984|101299082|FG000|NOT COMPLETED|Overall Study||1||2
48395152|NCT00367432|101299083|FG000|STARTED|First Period (16 Weeks)||313||
48395153|NCT00367432|101299084|FG001|STARTED|First Period (16 Weeks)||0||
48395154|NCT00367432|101299083|FG000|COMPLETED|First Period (16 Weeks)||275||
48395155|NCT00367432|101299084|FG001|COMPLETED|First Period (16 Weeks)||0||
48395156|NCT00367432|101299083|FG000|NOT COMPLETED|First Period (16 Weeks)||38||
48395157|NCT00367432|101299084|FG001|NOT COMPLETED|First Period (16 Weeks)||0||
48395158|NCT00367432|101299083|FG000|STARTED|Second Period (up to 54 Months)||275||
48395159|NCT00367432|101299084|FG001|STARTED|Second Period (up to 54 Months)||85||
48280850|NCT00858364|101010596|FG000|Received Study Drug|Overall Study||837||
48280851|NCT00858364|101010597|FG001|Received Study Drug|Overall Study||1681||
48280852|NCT00858364|101010596|FG000|COMPLETED|Overall Study||642|Participants who died|
48280853|NCT00858364|101010597|FG001|COMPLETED|Overall Study||1246|Participants who died|
48280854|NCT00858364|101010596|FG000|NOT COMPLETED|Overall Study||204||
48280855|NCT00858364|101010597|FG001|NOT COMPLETED|Overall Study||457||
48280856|NCT04155047|101010598|FG000|STARTED|Overall Study||11||
48280857|NCT04155047|101010599|FG001|STARTED|Overall Study||11||
48280858|NCT04155047|101010598|FG000|COMPLETED|Overall Study||9||
48280859|NCT04155047|101010599|FG001|COMPLETED|Overall Study||11||
48280860|NCT04155047|101010598|FG000|NOT COMPLETED|Overall Study||2||
48280861|NCT04155047|101010599|FG001|NOT COMPLETED|Overall Study||0||
48280862|NCT02141620|101010600|FG000|STARTED|Treatment Condition 1 (7 Days)||8||
48280863|NCT02141620|101010601|FG001|STARTED|Treatment Condition 1 (7 Days)||7||
48280864|NCT02141620|101010600|FG000|COMPLETED|Treatment Condition 1 (7 Days)||7||
48280865|NCT02141620|101010601|FG001|COMPLETED|Treatment Condition 1 (7 Days)||7||
48280866|NCT02141620|101010600|FG000|NOT COMPLETED|Treatment Condition 1 (7 Days)||1||
48280867|NCT02141620|101010601|FG001|NOT COMPLETED|Treatment Condition 1 (7 Days)||0||
48698619|NCT05096247|102050353|FG001|COMPLETED|Overall Study||35||
48698620|NCT05096247|102050352|FG000|NOT COMPLETED|Overall Study||0||
48698621|NCT05096247|102050353|FG001|NOT COMPLETED|Overall Study||0||
48698622|NCT01468233|102050354|FG000|STARTED|Treatment Period 1||163||
48698623|NCT01468233|102050355|FG001|STARTED|Treatment Period 1||163||
48698624|NCT01468233|102050356|FG002|STARTED|Treatment Period 1||0||
48698625|NCT01468233|102050357|FG003|STARTED|Treatment Period 1||0||
48698626|NCT01468233|102050358|FG004|STARTED|Treatment Period 1||0||
48698627|NCT01468233|102050359|FG005|STARTED|Treatment Period 1||0||
48698628|NCT01468233|102050354|FG000|COMPLETED|Treatment Period 1||151||
48698629|NCT01468233|102050355|FG001|COMPLETED|Treatment Period 1||155||
48698630|NCT01468233|102050356|FG002|COMPLETED|Treatment Period 1||0||
48698631|NCT01468233|102050357|FG003|COMPLETED|Treatment Period 1||0||
48698632|NCT01468233|102050358|FG004|COMPLETED|Treatment Period 1||0||
48698633|NCT01468233|102050359|FG005|COMPLETED|Treatment Period 1||0||
48698634|NCT01468233|102050354|FG000|NOT COMPLETED|Treatment Period 1||12||
48698635|NCT01468233|102050355|FG001|NOT COMPLETED|Treatment Period 1||8||
48698636|NCT01468233|102050356|FG002|NOT COMPLETED|Treatment Period 1||0||
48698637|NCT01468233|102050357|FG003|NOT COMPLETED|Treatment Period 1||0||
48698638|NCT01468233|102050358|FG004|NOT COMPLETED|Treatment Period 1||0||
48698639|NCT01468233|102050359|FG005|NOT COMPLETED|Treatment Period 1||0||
48698640|NCT01468233|102050354|FG000|STARTED|Treatment Period 2||0||
48698641|NCT01468233|102050355|FG001|STARTED|Treatment Period 2||0||
48698642|NCT01468233|102050356|FG002|STARTED|Treatment Period 2||151||
48698643|NCT01468233|102050357|FG003|STARTED|Treatment Period 2||51||
48119459|NCT04096560|100616475|FG000|STARTED|Overall Study||7||
48280868|NCT02141620|101010600|FG000|STARTED|Treatment Condition 2 (7 Days)||7||
48698644|NCT01468233|102050358|FG004|STARTED|Treatment Period 2||53||
48698645|NCT01468233|102050359|FG005|STARTED|Treatment Period 2||51||
48698646|NCT01468233|102050354|FG000|COMPLETED|Treatment Period 2||0||
48698647|NCT01468233|102050355|FG001|COMPLETED|Treatment Period 2||0||
48698648|NCT01468233|102050356|FG002|COMPLETED|Treatment Period 2||40||
48698649|NCT01468233|102050357|FG003|COMPLETED|Treatment Period 2||23||
48698650|NCT01468233|102050358|FG004|COMPLETED|Treatment Period 2||25||
48698651|NCT01468233|102050359|FG005|COMPLETED|Treatment Period 2||28||
48698652|NCT01468233|102050354|FG000|NOT COMPLETED|Treatment Period 2||0||
48698653|NCT01468233|102050355|FG001|NOT COMPLETED|Treatment Period 2||0||
48698654|NCT01468233|102050356|FG002|NOT COMPLETED|Treatment Period 2||111||
48698655|NCT01468233|102050357|FG003|NOT COMPLETED|Treatment Period 2||28||
48280869|NCT02141620|101010601|FG001|STARTED|Treatment Condition 2 (7 Days)||7||
48280870|NCT02141620|101010600|FG000|COMPLETED|Treatment Condition 2 (7 Days)||7||
48280871|NCT02141620|101010601|FG001|COMPLETED|Treatment Condition 2 (7 Days)||7||
48698656|NCT01468233|102050358|FG004|NOT COMPLETED|Treatment Period 2||28||
48698657|NCT01468233|102050359|FG005|NOT COMPLETED|Treatment Period 2||23||
48698658|NCT00735826|102050360|FG000|STARTED|Overall Study||10||
48698659|NCT00735826|102050360|FG000|COMPLETED|Overall Study||10||
48698660|NCT00735826|102050360|FG000|NOT COMPLETED|Overall Study||0||
48698661|NCT04550832|102050361|FG000|STARTED|Overall Study||15|Randomized|
48698662|NCT04550832|102050362|FG001|STARTED|Overall Study||15|Randomized|
48698663|NCT04550832|102050363|FG002|STARTED|Overall Study||15|Randomized|
48280872|NCT02141620|101010600|FG000|NOT COMPLETED|Treatment Condition 2 (7 Days)||0||
48280873|NCT02141620|101010601|FG001|NOT COMPLETED|Treatment Condition 2 (7 Days)||0||
48280874|NCT03207451|101010602|FG000|STARTED|Overall Study||21||
48280875|NCT03207451|101010603|FG001|STARTED|Overall Study||8||
48566829|NCT01697748|101720238|FG001|NOT COMPLETED|Overall Study||68||
48566830|NCT04577404|101720239|FG000|STARTED|Overall Study||124||
48698664|NCT04550832|102050364|FG003|STARTED|Overall Study||16|Randomized|
48698665|NCT04550832|102050365|FG004|STARTED|Overall Study||15|Randomized|
48698666|NCT04550832|102050361|FG000|Received ≥ 1 Dose of Study Drug|Overall Study||15||
48698667|NCT04550832|102050362|FG001|Received ≥ 1 Dose of Study Drug|Overall Study||15||
48698668|NCT04550832|102050363|FG002|Received ≥ 1 Dose of Study Drug|Overall Study||15||
48698669|NCT04550832|102050364|FG003|Received ≥ 1 Dose of Study Drug|Overall Study||16||
48566831|NCT04577404|101720239|FG000|COMPLETED|Overall Study||49||
48566832|NCT04577404|101720239|FG000|NOT COMPLETED|Overall Study||75||
48566833|NCT02729025|101720240|FG000|STARTED|Overall Study||64||
48566834|NCT02729025|101720241|FG001|STARTED|Overall Study||65||
48566835|NCT02729025|101720240|FG000|COMPLETED|Overall Study||64||
48566836|NCT02729025|101720241|FG001|COMPLETED|Overall Study||64||
48566837|NCT02729025|101720240|FG000|NOT COMPLETED|Overall Study||0||
48566838|NCT02729025|101720241|FG001|NOT COMPLETED|Overall Study||1||
48566839|NCT00105079|101720242|FG000|STARTED|Overall Study||167||
48566840|NCT00105079|101720243|FG001|STARTED|Overall Study||170||
48566841|NCT00105079|101720242|FG000|Safety Population|Overall Study||163||
48566842|NCT00105079|101720243|FG001|Safety Population|Overall Study||168||
48566843|NCT00105079|101720242|FG000|COMPLETED|Overall Study||128||
48566844|NCT00105079|101720243|FG001|COMPLETED|Overall Study||135||
48566845|NCT00105079|101720242|FG000|NOT COMPLETED|Overall Study||39||
48566846|NCT00105079|101720243|FG001|NOT COMPLETED|Overall Study||35||
48566847|NCT01285362|101720244|FG000|STARTED|Overall Study||4||
48566848|NCT01285362|101720245|FG001|STARTED|Overall Study||4||
48566849|NCT01285362|101720244|FG000|COMPLETED|Overall Study||4||
48566850|NCT01285362|101720245|FG001|COMPLETED|Overall Study||4||
48566851|NCT01285362|101720244|FG000|NOT COMPLETED|Overall Study||0||
48566852|NCT01285362|101720245|FG001|NOT COMPLETED|Overall Study||0||
48566853|NCT05506046|101720246|FG000|STARTED|Overall Study||468|Number of participants who started session 1|
48698670|NCT04550832|102050365|FG004|Received ≥ 1 Dose of Study Drug|Overall Study||15||
48698671|NCT04550832|102050361|FG000|COMPLETED|Overall Study||15||
48698672|NCT04550832|102050362|FG001|COMPLETED|Overall Study||15||
48698673|NCT04550832|102050363|FG002|COMPLETED|Overall Study||13||
48698674|NCT04550832|102050364|FG003|COMPLETED|Overall Study||16||
48698675|NCT04550832|102050365|FG004|COMPLETED|Overall Study||14||
48280876|NCT03207451|101010604|FG002|STARTED|Overall Study||29||
48280877|NCT03207451|101010605|FG003|STARTED|Overall Study||23||
48566854|NCT05506046|101720247|FG001|STARTED|Overall Study||484|Number of participants who started session 1|
48566855|NCT05506046|101720248|FG002|STARTED|Overall Study||476|Number of participants who started session 1|
48566856|NCT05506046|101720249|FG003|STARTED|Overall Study||473|Number of participants who started session 1|
48566857|NCT05506046|101720246|FG000|Compete Session 1|Overall Study||468|Number of participants who completed session 1|
48566858|NCT05506046|101720247|FG001|Compete Session 1|Overall Study||484|Number of participants who completed session 1|
48698676|NCT04550832|102050361|FG000|NOT COMPLETED|Overall Study||0||
48698677|NCT04550832|102050362|FG001|NOT COMPLETED|Overall Study||0||
48698678|NCT04550832|102050363|FG002|NOT COMPLETED|Overall Study||2||
48566859|NCT05506046|101720248|FG002|Compete Session 1|Overall Study||476|Number of participants who completed session 1|
48566860|NCT05506046|101720249|FG003|Compete Session 1|Overall Study||473|Number of participants who completed session 1|
48566861|NCT05506046|101720246|FG000|Started Session 2|Overall Study||379|Number of participants who started session 2|
48566862|NCT05506046|101720247|FG001|Started Session 2|Overall Study||383|Number of participants who started session 2|
48566863|NCT05506046|101720248|FG002|Started Session 2|Overall Study||374|Number of participants who started session 2|
48566864|NCT05506046|101720249|FG003|Started Session 2|Overall Study||374|Number of participants who started session 2|
48566865|NCT05506046|101720246|FG000|COMPLETED|Overall Study||379|number of participants who completed session 2|
48566866|NCT05506046|101720247|FG001|COMPLETED|Overall Study||383|number of participants who completed session 2|
48566867|NCT05506046|101720248|FG002|COMPLETED|Overall Study||374|number of participants who completed session 2|
48566868|NCT05506046|101720249|FG003|COMPLETED|Overall Study||374|number of participants who completed session 2|
48566869|NCT05506046|101720246|FG000|NOT COMPLETED|Overall Study||89||
48566870|NCT05506046|101720247|FG001|NOT COMPLETED|Overall Study||101||
48566871|NCT05506046|101720248|FG002|NOT COMPLETED|Overall Study||102||
48566872|NCT05506046|101720249|FG003|NOT COMPLETED|Overall Study||99||
48566873|NCT00031590|101720250|FG000|STARTED|Overall Study||28||
48566874|NCT00031590|101720250|FG000|COMPLETED|Overall Study||25||
48566875|NCT00031590|101720250|FG000|NOT COMPLETED|Overall Study||3||
48566876|NCT00506415|101720251|FG000|STARTED|Initial Open Label (Maximum 48 Weeks)||1584||
48566877|NCT00506415|101720252|FG001|STARTED|Initial Open Label (Maximum 48 Weeks)||0||
48566878|NCT00506415|101720253|FG002|STARTED|Initial Open Label (Maximum 48 Weeks)||0||
48566879|NCT00506415|101720254|FG003|STARTED|Initial Open Label (Maximum 48 Weeks)||0||
48566880|NCT00506415|101720251|FG000|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||1582||
48566881|NCT00506415|101720252|FG001|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0||
48566882|NCT00506415|101720253|FG002|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0||
48566883|NCT00506415|101720254|FG003|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0||
48566884|NCT00506415|101720251|FG000|COMPLETED|Initial Open Label (Maximum 48 Weeks)||1085||
48566885|NCT00506415|101720252|FG001|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0||
48566886|NCT00506415|101720253|FG002|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0||
48566887|NCT00506415|101720254|FG003|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0||
48566888|NCT00506415|101720251|FG000|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||499||
48566889|NCT00506415|101720252|FG001|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0||
48566890|NCT00506415|101720253|FG002|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0||
48566891|NCT00506415|101720254|FG003|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0||
48566892|NCT00506415|101720251|FG000|STARTED|Double Blind (Maximum 48 Weeks )||0||
48566893|NCT00506415|101720252|FG001|STARTED|Double Blind (Maximum 48 Weeks )||286||
48566894|NCT00506415|101720253|FG002|STARTED|Double Blind (Maximum 48 Weeks )||280||
48566895|NCT00506415|101720254|FG003|STARTED|Double Blind (Maximum 48 Weeks )||0||
48566896|NCT00506415|101720251|FG000|COMPLETED|Double Blind (Maximum 48 Weeks )||0||
48566897|NCT00506415|101720252|FG001|COMPLETED|Double Blind (Maximum 48 Weeks )||203||
48566898|NCT00506415|101720253|FG002|COMPLETED|Double Blind (Maximum 48 Weeks )||207||
48566899|NCT00506415|101720254|FG003|COMPLETED|Double Blind (Maximum 48 Weeks )||0||
48566900|NCT00506415|101720251|FG000|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0||
48566901|NCT00506415|101720252|FG001|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||83||
48566902|NCT00506415|101720253|FG002|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||73||
48566903|NCT00506415|101720254|FG003|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0||
48566904|NCT00506415|101720251|FG000|STARTED|Extended Open Label (Maximum 48 Weeks)||0||
48566905|NCT00506415|101720252|FG001|STARTED|Extended Open Label (Maximum 48 Weeks)||0||
48566906|NCT00506415|101720253|FG002|STARTED|Extended Open Label (Maximum 48 Weeks)||0||
48566907|NCT00506415|101720254|FG003|STARTED|Extended Open Label (Maximum 48 Weeks)||457||
48566908|NCT00506415|101720251|FG000|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0||
48566909|NCT00506415|101720252|FG001|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0||
48566910|NCT00506415|101720253|FG002|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0||
48566911|NCT00506415|101720254|FG003|COMPLETED|Extended Open Label (Maximum 48 Weeks)||395||
48566912|NCT00506415|101720251|FG000|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0||
48566913|NCT00506415|101720252|FG001|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0||
48566914|NCT00506415|101720253|FG002|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0||
48566915|NCT00506415|101720254|FG003|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||62||
48566916|NCT03437863|101720255|FG000|STARTED|Overall Study||12||
48566917|NCT03437863|101720255|FG000|COMPLETED|Overall Study||12||
48566918|NCT03437863|101720255|FG000|NOT COMPLETED|Overall Study||0||
48566919|NCT00838903|101720256|FG000|STARTED|Treatment Period (156 Weeks)||101||
48566920|NCT00838903|101720257|FG001|STARTED|Treatment Period (156 Weeks)||302||
48566921|NCT00838903|101720258|FG002|STARTED|Treatment Period (156 Weeks)||307||
48566922|NCT00838903|101720259|FG003|STARTED|Treatment Period (156 Weeks)||302||
48566923|NCT00838903|101720256|FG000|Missing Active Treatment Status|Treatment Period (156 Weeks)||1||
48566924|NCT00838903|101720257|FG001|Missing Active Treatment Status|Treatment Period (156 Weeks)||0||
48566925|NCT00838903|101720258|FG002|Missing Active Treatment Status|Treatment Period (156 Weeks)||0||
48566926|NCT00838903|101720259|FG003|Missing Active Treatment Status|Treatment Period (156 Weeks)||0||
48566927|NCT00838903|101720256|FG000|COMPLETED|Treatment Period (156 Weeks)||55||
48566928|NCT00838903|101720257|FG001|COMPLETED|Treatment Period (156 Weeks)||190||
48566929|NCT00838903|101720258|FG002|COMPLETED|Treatment Period (156 Weeks)||191||
48566930|NCT00838903|101720259|FG003|COMPLETED|Treatment Period (156 Weeks)||192||
48566931|NCT00838903|101720256|FG000|NOT COMPLETED|Treatment Period (156 Weeks)||46||
48566932|NCT00838903|101720257|FG001|NOT COMPLETED|Treatment Period (156 Weeks)||112||
48566933|NCT00838903|101720258|FG002|NOT COMPLETED|Treatment Period (156 Weeks)||116||
48566934|NCT00838903|101720259|FG003|NOT COMPLETED|Treatment Period (156 Weeks)||110||
48566935|NCT00838903|101720256|FG000|STARTED|Follow-up Period (8 Weeks)||101||
48566936|NCT00838903|101720257|FG001|STARTED|Follow-up Period (8 Weeks)||302||
48566937|NCT00838903|101720258|FG002|STARTED|Follow-up Period (8 Weeks)||307||
48566938|NCT00838903|101720259|FG003|STARTED|Follow-up Period (8 Weeks)||302||
48566939|NCT00838903|101720256|FG000|COMPLETED|Follow-up Period (8 Weeks)||75||
48566940|NCT00838903|101720257|FG001|COMPLETED|Follow-up Period (8 Weeks)||237||
48566941|NCT00838903|101720258|FG002|COMPLETED|Follow-up Period (8 Weeks)||243||
48566942|NCT00838903|101720259|FG003|COMPLETED|Follow-up Period (8 Weeks)||244||
48566943|NCT00838903|101720256|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||26||
48566944|NCT00838903|101720257|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||65||
48566945|NCT00838903|101720258|FG002|NOT COMPLETED|Follow-up Period (8 Weeks)||64||
48566946|NCT00838903|101720259|FG003|NOT COMPLETED|Follow-up Period (8 Weeks)||58||
48566947|NCT00288626|101720260|FG000|STARTED|Overall Study||24||
48566948|NCT00288626|101720260|FG000|COMPLETED|Overall Study||17||
48566949|NCT00288626|101720260|FG000|NOT COMPLETED|Overall Study||7||
48566950|NCT01775813|101720261|FG000|STARTED|Overall Study||47|Patients that had data collected at Study Visit 1 (1st IVGTT)|
48566951|NCT01775813|101720262|FG001|STARTED|Overall Study||13|Patients that had data collected at Study Visit 1 (1st IVGTT)|
48566952|NCT01775813|101720263|FG002|STARTED|Overall Study||24|Patients that had data collected at Study Visit 1 (1st IVGTT)|
48566953|NCT01775813|101720264|FG003|STARTED|Overall Study||20|Patients that had data collected at Study Visit 1 (1st IVGTT)|
48566954|NCT01775813|101720261|FG000|Study Visit 2 (Tanner 4)|Overall Study||36||
48566955|NCT01775813|101720262|FG001|Study Visit 2 (Tanner 4)|Overall Study||4||
48566956|NCT01775813|101720263|FG002|Study Visit 2 (Tanner 4)|Overall Study||11||
48566957|NCT01775813|101720264|FG003|Study Visit 2 (Tanner 4)|Overall Study||11||
48566958|NCT01775813|101720261|FG000|Study Visit 3 (Tanner 5)|Overall Study||34||
48566959|NCT01775813|101720262|FG001|Study Visit 3 (Tanner 5)|Overall Study||8||
48566960|NCT01775813|101720263|FG002|Study Visit 3 (Tanner 5)|Overall Study||12||
48566961|NCT01775813|101720264|FG003|Study Visit 3 (Tanner 5)|Overall Study||11||
48566962|NCT01775813|101720261|FG000|Study Visit 4 (Post-Puberty)|Overall Study||10||
48566963|NCT01775813|101720262|FG001|Study Visit 4 (Post-Puberty)|Overall Study||0||
48566964|NCT01775813|101720263|FG002|Study Visit 4 (Post-Puberty)|Overall Study||13||
48566965|NCT01775813|101720264|FG003|Study Visit 4 (Post-Puberty)|Overall Study||11||
48566966|NCT01775813|101720261|FG000|COMPLETED|Overall Study||34|Patients that completed Study Visit 3 (Primary Outcome)|
48566967|NCT01775813|101720262|FG001|COMPLETED|Overall Study||8|Patients that completed Study Visit 3 (Primary Outcome)|
48566968|NCT01775813|101720263|FG002|COMPLETED|Overall Study||12|Patients that completed Study Visit 3 (Primary Outcome)|
48566969|NCT01775813|101720264|FG003|COMPLETED|Overall Study||11|Patients that completed Study Visit 3 (Primary Outcome)|
48566970|NCT01775813|101720261|FG000|NOT COMPLETED|Overall Study||13||
48566971|NCT01775813|101720262|FG001|NOT COMPLETED|Overall Study||5||
48566972|NCT01775813|101720263|FG002|NOT COMPLETED|Overall Study||12||
48566973|NCT01775813|101720264|FG003|NOT COMPLETED|Overall Study||9||
48566974|NCT00364923|101720265|FG000|STARTED|Treatment With Pralatrexate||111||
48566975|NCT00364923|101720265|FG000|COMPLETED|Treatment With Pralatrexate||107||
48566976|NCT00364923|101720265|FG000|NOT COMPLETED|Treatment With Pralatrexate||4||
48566977|NCT00364923|101720265|FG000|STARTED|Survival Follow-up, After Pralatrexate||107||
48566978|NCT00364923|101720265|FG000|COMPLETED|Survival Follow-up, After Pralatrexate||83||
48566979|NCT00364923|101720265|FG000|NOT COMPLETED|Survival Follow-up, After Pralatrexate||24||
48566980|NCT03181633|101720266|FG000|STARTED|Overall Study||8||
48566981|NCT03181633|101720266|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8||
48566982|NCT03181633|101720266|FG000|COMPLETED|Overall Study||6||
48698679|NCT04550832|102050364|FG003|NOT COMPLETED|Overall Study||0||
48698680|NCT04550832|102050365|FG004|NOT COMPLETED|Overall Study||1||
48698681|NCT03574610|102050366|FG000|STARTED|Overall Study||11||
48698682|NCT03574610|102050366|FG000|COMPLETED|Overall Study||10||
48698683|NCT03574610|102050366|FG000|NOT COMPLETED|Overall Study||1||
48698684|NCT00211757|102050367|FG000|STARTED|Overall Study||11||
48566983|NCT03181633|101720266|FG000|NOT COMPLETED|Overall Study||2||
48566984|NCT04152837|101720267|FG000|STARTED|Baseline Period (No Treatment)||7||
48566985|NCT04152837|101720267|FG000|COMPLETED|Baseline Period (No Treatment)||6||
48566986|NCT04152837|101720267|FG000|NOT COMPLETED|Baseline Period (No Treatment)||1||
48698685|NCT00211757|102050368|FG001|STARTED|Overall Study||16||
48698686|NCT00211757|102050367|FG000|COMPLETED|Overall Study||10||
48566987|NCT04152837|101720267|FG000|STARTED|Titration Period||6||
48566988|NCT04152837|101720267|FG000|COMPLETED|Titration Period||6||
48566989|NCT04152837|101720267|FG000|NOT COMPLETED|Titration Period||0||
48698687|NCT00211757|102050368|FG001|COMPLETED|Overall Study||14||
48698688|NCT00211757|102050367|FG000|NOT COMPLETED|Overall Study||1||
48698689|NCT00211757|102050368|FG001|NOT COMPLETED|Overall Study||2||
48566990|NCT04152837|101720267|FG000|STARTED|Maintenance Period||6||
48566991|NCT04152837|101720267|FG000|COMPLETED|Maintenance Period||2||
48566992|NCT04152837|101720267|FG000|NOT COMPLETED|Maintenance Period||4||
48566993|NCT04152837|101720267|FG000|STARTED|Follow-up Period||6||
48566994|NCT04152837|101720267|FG000|COMPLETED|Follow-up Period||6||
48566995|NCT04152837|101720267|FG000|NOT COMPLETED|Follow-up Period||0||
48698690|NCT03632993|102050369|FG000|STARTED|Overall Study||7||14
48698691|NCT03632993|102050370|FG001|STARTED|Overall Study||6||12
48698692|NCT03632993|102050371|FG002|STARTED|Overall Study||6||12
48566996|NCT02104219|101720268|FG000|STARTED|Overall Study||32||
48566997|NCT02104219|101720268|FG000|COMPLETED|Overall Study||32||
48566998|NCT02104219|101720268|FG000|NOT COMPLETED|Overall Study||0||
48566999|NCT02348918|101720269|FG000|STARTED|Overall Study||39||
48567000|NCT02348918|101720270|FG001|STARTED|Overall Study||33||
48567001|NCT02348918|101720271|FG002|STARTED|Overall Study||42||
48567002|NCT02348918|101720272|FG003|STARTED|Overall Study||24||
48567003|NCT02348918|101720273|FG004|STARTED|Overall Study||19||
48567004|NCT02348918|101720274|FG005|STARTED|Overall Study||17||
48698693|NCT03632993|102050372|FG003|STARTED|Overall Study||7||14
48698694|NCT03632993|102050373|FG004|STARTED|Overall Study||6||12
48698695|NCT03632993|102050374|FG005|STARTED|Overall Study||6||12
48698696|NCT03632993|102050375|FG006|STARTED|Overall Study||6||12
48567005|NCT02348918|101720275|FG006|STARTED|Overall Study||13||
48567006|NCT02348918|101720276|FG007|STARTED|Overall Study||16||
48567007|NCT02348918|101720277|FG008|STARTED|Overall Study||15||
48567008|NCT02348918|101720269|FG000|COMPLETED|Overall Study||39||
48567009|NCT02348918|101720270|FG001|COMPLETED|Overall Study||33||
48567010|NCT02348918|101720271|FG002|COMPLETED|Overall Study||42||
48567011|NCT02348918|101720272|FG003|COMPLETED|Overall Study||24||
48698697|NCT03632993|102050376|FG007|STARTED|Overall Study||7||14
48698698|NCT03632993|102050377|FG008|STARTED|Overall Study||7||14
48698699|NCT03632993|102050378|FG009|STARTED|Overall Study||6||12
48698700|NCT03632993|102050369|FG000|COMPLETED|Overall Study||6||12
48567012|NCT02348918|101720273|FG004|COMPLETED|Overall Study||19||
48567013|NCT02348918|101720274|FG005|COMPLETED|Overall Study||17||
48567014|NCT02348918|101720275|FG006|COMPLETED|Overall Study||13||
48567015|NCT02348918|101720276|FG007|COMPLETED|Overall Study||16||
48567016|NCT02348918|101720277|FG008|COMPLETED|Overall Study||15||
48567017|NCT02348918|101720269|FG000|NOT COMPLETED|Overall Study||0||
48567018|NCT02348918|101720270|FG001|NOT COMPLETED|Overall Study||0||
48567019|NCT02348918|101720271|FG002|NOT COMPLETED|Overall Study||0||
48567020|NCT02348918|101720272|FG003|NOT COMPLETED|Overall Study||0||
48567021|NCT02348918|101720273|FG004|NOT COMPLETED|Overall Study||0||
48567022|NCT02348918|101720274|FG005|NOT COMPLETED|Overall Study||0||
48567023|NCT02348918|101720275|FG006|NOT COMPLETED|Overall Study||0||
48567024|NCT02348918|101720276|FG007|NOT COMPLETED|Overall Study||0||
48567025|NCT02348918|101720277|FG008|NOT COMPLETED|Overall Study||0||
48567026|NCT00403481|101720278|FG000|STARTED|Olmesartan Medoxomil (Olm) 20 mg||192||
48567027|NCT00403481|101720278|FG000|COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||186||
48567028|NCT00403481|101720278|FG000|NOT COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||6||
48567029|NCT00403481|101720278|FG000|STARTED|Olm 40 mg||182||
48567030|NCT00403481|101720278|FG000|COMPLETED|Olm 40 mg||177||
48567031|NCT00403481|101720278|FG000|NOT COMPLETED|Olm 40 mg||5||
48567032|NCT00403481|101720278|FG000|STARTED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||173||
48567033|NCT00403481|101720278|FG000|COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||168||
48567034|NCT00403481|101720278|FG000|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||5||
48567035|NCT00403481|101720278|FG000|STARTED|Olm 40 mg + Hydrochlorothiazide 25 mg||144||
48567036|NCT00403481|101720278|FG000|COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||142||
48567037|NCT00403481|101720278|FG000|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||2||
48567038|NCT01051960|101720279|FG000|STARTED|Overall Study||12||
48567039|NCT01051960|101720279|FG000|COMPLETED|Overall Study||11||
48567040|NCT01051960|101720279|FG000|NOT COMPLETED|Overall Study||1||
48567041|NCT03493854|101720280|FG000|STARTED|Neoadjuvant Treatment Phase (24 Weeks)||252|Intent-to-Treat (ITT) Population|
48567042|NCT03493854|101720281|FG001|STARTED|Neoadjuvant Treatment Phase (24 Weeks)||248|Intent-to-Treat (ITT) Population|
48567043|NCT03493854|101720280|FG000|Received at Least One Dose of Study Drug|Neoadjuvant Treatment Phase (24 Weeks)||252|Safety Population|
48698701|NCT03632993|102050370|FG001|COMPLETED|Overall Study||5||10
48698702|NCT03632993|102050371|FG002|COMPLETED|Overall Study||6||12
48698703|NCT03632993|102050372|FG003|COMPLETED|Overall Study||7||14
48698704|NCT03632993|102050373|FG004|COMPLETED|Overall Study||6||12
48698705|NCT03632993|102050374|FG005|COMPLETED|Overall Study||4||8
48698706|NCT03632993|102050375|FG006|COMPLETED|Overall Study||6||12
48698707|NCT03632993|102050376|FG007|COMPLETED|Overall Study||5||10
48698708|NCT03632993|102050377|FG008|COMPLETED|Overall Study||7||14
48698709|NCT03632993|102050378|FG009|COMPLETED|Overall Study||5||10
48698710|NCT03632993|102050369|FG000|NOT COMPLETED|Overall Study||1||2
48698711|NCT03632993|102050370|FG001|NOT COMPLETED|Overall Study||1||2
48698712|NCT03632993|102050371|FG002|NOT COMPLETED|Overall Study||0||0
48698713|NCT03632993|102050372|FG003|NOT COMPLETED|Overall Study||0||0
48698714|NCT03632993|102050373|FG004|NOT COMPLETED|Overall Study||0||0
48698715|NCT03632993|102050374|FG005|NOT COMPLETED|Overall Study||2||4
48698716|NCT03632993|102050375|FG006|NOT COMPLETED|Overall Study||0||0
48698717|NCT03632993|102050376|FG007|NOT COMPLETED|Overall Study||2||4
48698718|NCT03632993|102050377|FG008|NOT COMPLETED|Overall Study||0||0
48698719|NCT03632993|102050378|FG009|NOT COMPLETED|Overall Study||1||2
48567044|NCT03493854|101720281|FG001|Received at Least One Dose of Study Drug|Neoadjuvant Treatment Phase (24 Weeks)||248|Safety Population|
48567045|NCT03493854|101720280|FG000|COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||242||
48567046|NCT03493854|101720281|FG001|COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||234||
48567047|NCT03493854|101720280|FG000|NOT COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||10||
48567048|NCT03493854|101720281|FG001|NOT COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||14||
48567049|NCT03493854|101720280|FG000|STARTED|Surgery & Adjuvant Treatment (42 Weeks)||242|Completed Neoadjuvant Treatment Phase|
48567050|NCT03493854|101720281|FG001|STARTED|Surgery & Adjuvant Treatment (42 Weeks)||234|Completed Neoadjuvant Treatment Phase|
48567051|NCT03493854|101720280|FG000|Completed Surgery|Surgery & Adjuvant Treatment (42 Weeks)||239||
48567052|NCT03493854|101720281|FG001|Completed Surgery|Surgery & Adjuvant Treatment (42 Weeks)||234||
48567053|NCT03493854|101720280|FG000|COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||209||
48567054|NCT03493854|101720281|FG001|COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||217||
48567055|NCT03493854|101720280|FG000|NOT COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||33||
48567056|NCT03493854|101720281|FG001|NOT COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||17||
48567057|NCT03493854|101720280|FG000|STARTED|Treatment-Free Follow-Up (up to 3 Years)||247||
48567058|NCT03493854|101720281|FG001|STARTED|Treatment-Free Follow-Up (up to 3 Years)||241||
48567059|NCT03493854|101720280|FG000|COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||223||
48567060|NCT03493854|101720281|FG001|COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||219||
48567061|NCT03493854|101720280|FG000|NOT COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||24||
48567062|NCT03493854|101720281|FG001|NOT COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||22||
48567063|NCT02547428|101720282|FG000|STARTED|Period 1- Treatment Sequence 1 (3 Weeks)||42||
48567064|NCT02547428|101720283|FG001|STARTED|Period 1- Treatment Sequence 1 (3 Weeks)||43||
48567065|NCT02547428|101720282|FG000|Received at Least 1 Dose of Study Drug|Period 1- Treatment Sequence 1 (3 Weeks)||42||
48567066|NCT02547428|101720283|FG001|Received at Least 1 Dose of Study Drug|Period 1- Treatment Sequence 1 (3 Weeks)||43||
48567067|NCT02547428|101720282|FG000|COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||31||
48567068|NCT02547428|101720283|FG001|COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||37||
48567069|NCT02547428|101720282|FG000|NOT COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||11||
48567070|NCT02547428|101720283|FG001|NOT COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||6||
48567071|NCT02547428|101720282|FG000|STARTED|Period 2- Treatment Sequence 2 (3 Weeks)||31||
48567072|NCT02547428|101720283|FG001|STARTED|Period 2- Treatment Sequence 2 (3 Weeks)||37||
48567073|NCT02547428|101720282|FG000|COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||30||
48567074|NCT02547428|101720283|FG001|COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||30||
48567075|NCT02547428|101720282|FG000|NOT COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||1||
48567076|NCT02547428|101720283|FG001|NOT COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||7||
48567077|NCT01753310|101720284|FG000|STARTED|Overall Study||89||
48567078|NCT01753310|101720285|FG001|STARTED|Overall Study||45||
48567079|NCT01753310|101720284|FG000|COMPLETED|Overall Study||57||
48567080|NCT01753310|101720285|FG001|COMPLETED|Overall Study||21||
48567081|NCT01753310|101720284|FG000|NOT COMPLETED|Overall Study||32||
48567082|NCT01753310|101720285|FG001|NOT COMPLETED|Overall Study||24||
48567083|NCT02641093|101720286|FG000|STARTED|Overall Study||96||
48567084|NCT02641093|101720286|FG000|COMPLETED|Overall Study||67||
48567085|NCT02641093|101720286|FG000|NOT COMPLETED|Overall Study||29||
48567086|NCT01017874|101720287|FG000|STARTED|Overall Study||118||
48567087|NCT01017874|101720288|FG001|STARTED|Overall Study||118||
48567088|NCT01017874|101720287|FG000|Received at Least 1 Dose of Study Drug|Overall Study||114||
48567089|NCT01017874|101720288|FG001|Received at Least 1 Dose of Study Drug|Overall Study||118||
48567090|NCT01017874|101720287|FG000|COMPLETED|Overall Study||88||
48567091|NCT01017874|101720288|FG001|COMPLETED|Overall Study||92||
48567092|NCT01017874|101720287|FG000|NOT COMPLETED|Overall Study||30||
48567093|NCT01017874|101720288|FG001|NOT COMPLETED|Overall Study||26||
48567094|NCT04408729|101720289|FG000|STARTED|Overall Study||75||
48567095|NCT04408729|101720290|FG001|STARTED|Overall Study||75||
48567096|NCT04408729|101720289|FG000|COMPLETED|Overall Study||71||
48567097|NCT04408729|101720290|FG001|COMPLETED|Overall Study||71||
48567098|NCT04408729|101720289|FG000|NOT COMPLETED|Overall Study||4||
48567099|NCT04408729|101720290|FG001|NOT COMPLETED|Overall Study||4||
48567100|NCT04471194|101720291|FG000|STARTED|Overall Study||24||
48698720|NCT02566785|102050379|FG000|STARTED|Overall Study||15||
48698721|NCT02566785|102050380|FG001|STARTED|Overall Study||18||
48698722|NCT02566785|102050379|FG000|COMPLETED|Overall Study||14||
48698723|NCT02566785|102050380|FG001|COMPLETED|Overall Study||15||
48698724|NCT02566785|102050379|FG000|NOT COMPLETED|Overall Study||1||
48698725|NCT02566785|102050380|FG001|NOT COMPLETED|Overall Study||3||
48698726|NCT02957747|102050381|FG000|STARTED|Overall Study||76||
48698727|NCT02957747|102050382|FG001|STARTED|Overall Study||77||
48698728|NCT02957747|102050381|FG000|COMPLETED|Overall Study||66||
48698729|NCT02957747|102050382|FG001|COMPLETED|Overall Study||69||
48698730|NCT02957747|102050381|FG000|NOT COMPLETED|Overall Study||10||
48698731|NCT02957747|102050382|FG001|NOT COMPLETED|Overall Study||8||
48698732|NCT04790279|102050383|FG000|STARTED|Overall Study||87||
48698733|NCT04790279|102050384|FG001|STARTED|Overall Study||88||
48698734|NCT04790279|102050383|FG000|COMPLETED|Overall Study||51||
48567101|NCT04471194|101720292|FG001|STARTED|Overall Study||24||
48567102|NCT04471194|101720291|FG000|COMPLETED|Overall Study||21||
48567103|NCT04471194|101720292|FG001|COMPLETED|Overall Study||21||
48567104|NCT04471194|101720291|FG000|NOT COMPLETED|Overall Study||3||
48567105|NCT04471194|101720292|FG001|NOT COMPLETED|Overall Study||3||
48567106|NCT01120184|101720293|FG000|STARTED|Overall Study||365||
48567107|NCT01120184|101720294|FG001|STARTED|Overall Study||367||
48567108|NCT01120184|101720295|FG002|STARTED|Overall Study||363||
48567109|NCT01120184|101720293|FG000|Treated|Overall Study||355||
48567110|NCT01120184|101720294|FG001|Treated|Overall Study||365||
48567111|NCT01120184|101720295|FG002|Treated|Overall Study||360||
48698735|NCT04790279|102050384|FG001|COMPLETED|Overall Study||69||
48698736|NCT04790279|102050383|FG000|NOT COMPLETED|Overall Study||36||
48119460|NCT04096560|100616476|FG001|STARTED|Overall Study||7||
48698737|NCT04790279|102050384|FG001|NOT COMPLETED|Overall Study||19||
48698738|NCT02710981|102050385|FG000|STARTED|6th Ovulation Induction Cycle (5 Days)||42||
48280878|NCT03207451|101010602|FG000|COMPLETED|Overall Study||20||
48698739|NCT02710981|102050386|FG001|STARTED|6th Ovulation Induction Cycle (5 Days)||0||
48698740|NCT02710981|102050385|FG000|COMPLETED|6th Ovulation Induction Cycle (5 Days)||41||
48698741|NCT02710981|102050386|FG001|COMPLETED|6th Ovulation Induction Cycle (5 Days)||0||
48698742|NCT02710981|102050385|FG000|NOT COMPLETED|6th Ovulation Induction Cycle (5 Days)||1||
48698743|NCT02710981|102050386|FG001|NOT COMPLETED|6th Ovulation Induction Cycle (5 Days)||0||
48698744|NCT02710981|102050385|FG000|STARTED|7th Ovulation Induction Cycle (5 Days)||0||
48698745|NCT02710981|102050386|FG001|STARTED|7th Ovulation Induction Cycle (5 Days)||41||
48698746|NCT02710981|102050385|FG000|COMPLETED|7th Ovulation Induction Cycle (5 Days)||0||
48698747|NCT02710981|102050386|FG001|COMPLETED|7th Ovulation Induction Cycle (5 Days)||36||
48698748|NCT02710981|102050385|FG000|NOT COMPLETED|7th Ovulation Induction Cycle (5 Days)||0||
48698749|NCT02710981|102050386|FG001|NOT COMPLETED|7th Ovulation Induction Cycle (5 Days)||5||
48280879|NCT03207451|101010603|FG001|COMPLETED|Overall Study||8||
48280880|NCT03207451|101010604|FG002|COMPLETED|Overall Study||27||
48280881|NCT03207451|101010605|FG003|COMPLETED|Overall Study||20||
48280882|NCT03207451|101010602|FG000|NOT COMPLETED|Overall Study||1||
48567112|NCT01120184|101720293|FG000|COMPLETED|Overall Study||0||
48567113|NCT01120184|101720294|FG001|COMPLETED|Overall Study||0||
48698750|NCT04812028|102050387|FG000|STARTED|Overall Study||2||
48698751|NCT04812028|102050388|FG001|STARTED|Overall Study||9||
48698752|NCT04812028|102050389|FG002|STARTED|Overall Study||21||
48119461|NCT04096560|100616477|FG002|STARTED|Overall Study||8||
48119462|NCT04096560|100616478|FG003|STARTED|Overall Study||17||
48119463|NCT04096560|100616479|FG004|STARTED|Overall Study||17||
48119464|NCT04096560|100616480|FG005|STARTED|Overall Study||20||
48119465|NCT04096560|100616481|FG006|STARTED|Overall Study||19||
48119466|NCT04096560|100616482|FG007|STARTED|Overall Study||2||
48280883|NCT03207451|101010603|FG001|NOT COMPLETED|Overall Study||0||
48567114|NCT01120184|101720295|FG002|COMPLETED|Overall Study||0||
48567115|NCT01120184|101720293|FG000|NOT COMPLETED|Overall Study||365||
48395160|NCT00367432|101299083|FG000|COMPLETED|Second Period (up to 54 Months)||188||
48395161|NCT00367432|101299084|FG001|COMPLETED|Second Period (up to 54 Months)||69||
48395162|NCT00367432|101299083|FG000|NOT COMPLETED|Second Period (up to 54 Months)||87||
48395163|NCT00367432|101299084|FG001|NOT COMPLETED|Second Period (up to 54 Months)||16||
48395164|NCT00510484|101299085|FG000|STARTED|Period 1||16||
48395165|NCT00510484|101299086|FG001|STARTED|Period 1||16||
48395166|NCT00510484|101299085|FG000|COMPLETED|Period 1||16||
48395167|NCT00510484|101299086|FG001|COMPLETED|Period 1||16||
48395168|NCT00510484|101299085|FG000|NOT COMPLETED|Period 1||0||
48395169|NCT00510484|101299086|FG001|NOT COMPLETED|Period 1||0||
48395170|NCT00510484|101299085|FG000|STARTED|Wash-out Period||16||
48395171|NCT00510484|101299086|FG001|STARTED|Wash-out Period||16||
48395172|NCT00510484|101299085|FG000|COMPLETED|Wash-out Period||16||
48567116|NCT01120184|101720294|FG001|NOT COMPLETED|Overall Study||367||
48567117|NCT01120184|101720295|FG002|NOT COMPLETED|Overall Study||363||
48119467|NCT04096560|100616475|FG000|COMPLETED|Overall Study||6||
48395173|NCT00510484|101299086|FG001|COMPLETED|Wash-out Period||15||
48395174|NCT00510484|101299085|FG000|NOT COMPLETED|Wash-out Period||0||
48395175|NCT00510484|101299086|FG001|NOT COMPLETED|Wash-out Period||1||
48395176|NCT00510484|101299085|FG000|STARTED|Period 2||16||
48395177|NCT00510484|101299086|FG001|STARTED|Period 2||15||
48395178|NCT00510484|101299085|FG000|COMPLETED|Period 2||16||
48395179|NCT00510484|101299086|FG001|COMPLETED|Period 2||15||
48395180|NCT00510484|101299085|FG000|NOT COMPLETED|Period 2||0||
48395181|NCT00510484|101299086|FG001|NOT COMPLETED|Period 2||0||
48395182|NCT01610206|101299087|FG000|STARTED|Overall Study||73||
48395183|NCT01610206|101299088|FG001|STARTED|Overall Study||75||
48395184|NCT01610206|101299087|FG000|COMPLETED|Overall Study||63||
48395185|NCT01610206|101299088|FG001|COMPLETED|Overall Study||45||
48395186|NCT01610206|101299087|FG000|NOT COMPLETED|Overall Study||10||
48395187|NCT01610206|101299088|FG001|NOT COMPLETED|Overall Study||30||
48395188|NCT00646113|101299089|FG000|STARTED|Overall Study||69|Completed surgery|97
48395189|NCT00646113|101299089|FG000|COMPLETED|Overall Study||61||86
48395190|NCT00646113|101299089|FG000|NOT COMPLETED|Overall Study||8||11
48395191|NCT03485222|101299090|FG000|STARTED|Overall Study||42||
48395192|NCT03485222|101299091|FG001|STARTED|Overall Study||42||
48395193|NCT03485222|101299090|FG000|COMPLETED|Overall Study||40||
48395194|NCT03485222|101299091|FG001|COMPLETED|Overall Study||40||
48395195|NCT03485222|101299090|FG000|NOT COMPLETED|Overall Study||2||
48395196|NCT03485222|101299091|FG001|NOT COMPLETED|Overall Study||2||
48395197|NCT00089102|101299092|FG000|STARTED|Overall Study||9||
48395198|NCT00089102|101299092|FG000|COMPLETED|Overall Study||9||
48567118|NCT01954056|101720296|FG000|STARTED|Birth to 60 Days of Life||6||
48567119|NCT01954056|101720297|FG001|STARTED|Birth to 60 Days of Life||6||
48567120|NCT01954056|101720296|FG000|COMPLETED|Birth to 60 Days of Life||6||
48567121|NCT01954056|101720297|FG001|COMPLETED|Birth to 60 Days of Life||6||
48567122|NCT01954056|101720296|FG000|NOT COMPLETED|Birth to 60 Days of Life||0||
48698753|NCT04812028|102050390|FG003|STARTED|Overall Study||34||
48698754|NCT04812028|102050387|FG000|COMPLETED|Overall Study||2||
48698755|NCT04812028|102050388|FG001|COMPLETED|Overall Study||9||
48698756|NCT04812028|102050389|FG002|COMPLETED|Overall Study||21||
48698757|NCT04812028|102050390|FG003|COMPLETED|Overall Study||34||
48698758|NCT04812028|102050387|FG000|NOT COMPLETED|Overall Study||0||
48698759|NCT04812028|102050388|FG001|NOT COMPLETED|Overall Study||0||
48698760|NCT04812028|102050389|FG002|NOT COMPLETED|Overall Study||0||
48698761|NCT04812028|102050390|FG003|NOT COMPLETED|Overall Study||0||
48567123|NCT01954056|101720297|FG001|NOT COMPLETED|Birth to 60 Days of Life||0||
48567124|NCT01954056|101720296|FG000|STARTED|Birth to 22-26 Mos. Corrected GA||6||
48567125|NCT01954056|101720297|FG001|STARTED|Birth to 22-26 Mos. Corrected GA||6||
48567126|NCT01954056|101720296|FG000|COMPLETED|Birth to 22-26 Mos. Corrected GA||5||
48567127|NCT01954056|101720297|FG001|COMPLETED|Birth to 22-26 Mos. Corrected GA||6||
48567128|NCT01954056|101720296|FG000|NOT COMPLETED|Birth to 22-26 Mos. Corrected GA||1||
48567129|NCT01954056|101720297|FG001|NOT COMPLETED|Birth to 22-26 Mos. Corrected GA||0||
48567130|NCT00749073|101720298|FG000|STARTED|Overall Study||10||
48567131|NCT00749073|101720298|FG000|COMPLETED|Overall Study||10||
48698762|NCT01747343|102050391|FG000|STARTED|Baseline||4||
48698763|NCT01747343|102050391|FG000|COMPLETED|Baseline||4||
48698764|NCT01747343|102050391|FG000|NOT COMPLETED|Baseline||0||
48698765|NCT01747343|102050391|FG000|STARTED|Underwear||4||
48698766|NCT01747343|102050391|FG000|COMPLETED|Underwear||4||
48698767|NCT01747343|102050391|FG000|NOT COMPLETED|Underwear||0||
48698768|NCT01747343|102050391|FG000|STARTED|Underwear/Differential Reinforcement||4||
48698769|NCT01747343|102050391|FG000|COMPLETED|Underwear/Differential Reinforcement||4||
48698770|NCT01747343|102050391|FG000|NOT COMPLETED|Underwear/Differential Reinforcement||0||
48698771|NCT03640325|102050392|FG000|STARTED|Overall Study||50||
48698772|NCT03640325|102050393|FG001|STARTED|Overall Study||44||
48698773|NCT03640325|102050394|FG002|STARTED|Overall Study||49||
48395199|NCT00089102|101299092|FG000|NOT COMPLETED|Overall Study||0||
48395200|NCT00637377|101299093|FG000|STARTED|Overall Study||303||
48395201|NCT00637377|101299094|FG001|STARTED|Overall Study||313||
48395202|NCT00637377|101299095|FG002|STARTED|Overall Study||311||
48395203|NCT00637377|101299096|FG003|STARTED|Overall Study||313||
48395204|NCT00637377|101299093|FG000|Participants Received Treatment|Overall Study||291||
48395205|NCT00637377|101299094|FG001|Participants Received Treatment|Overall Study||309||
48395206|NCT00637377|101299095|FG002|Participants Received Treatment|Overall Study||297||
48698774|NCT03640325|102050392|FG000|COMPLETED|Overall Study||37||
48698775|NCT03640325|102050393|FG001|COMPLETED|Overall Study||33||
48395207|NCT00637377|101299096|FG003|Participants Received Treatment|Overall Study||307||
48567132|NCT00749073|101720298|FG000|NOT COMPLETED|Overall Study||0||
48567133|NCT01297517|101720299|FG000|STARTED|Overall Study||214||
48567134|NCT01297517|101720300|FG001|STARTED|Overall Study||226||
48567135|NCT01297517|101720301|FG002|STARTED|Overall Study||220||
48567136|NCT01297517|101720299|FG000|COMPLETED|Overall Study||187||
48567137|NCT01297517|101720300|FG001|COMPLETED|Overall Study||214||
48567138|NCT01297517|101720301|FG002|COMPLETED|Overall Study||193||
48567139|NCT01297517|101720299|FG000|NOT COMPLETED|Overall Study||27||
48567140|NCT01297517|101720300|FG001|NOT COMPLETED|Overall Study||12||
48567141|NCT01297517|101720301|FG002|NOT COMPLETED|Overall Study||27||
48567142|NCT00396656|101720302|FG000|STARTED|First Treatment Period||15||
48567143|NCT00396656|101720303|FG001|STARTED|First Treatment Period||15||
48567144|NCT00396656|101720302|FG000|COMPLETED|First Treatment Period||15||
48567145|NCT00396656|101720303|FG001|COMPLETED|First Treatment Period||13||
48567146|NCT00396656|101720302|FG000|NOT COMPLETED|First Treatment Period||0||
48567147|NCT00396656|101720303|FG001|NOT COMPLETED|First Treatment Period||2||
48567148|NCT00396656|101720302|FG000|STARTED|Second Treatment Period||15||
48567149|NCT00396656|101720303|FG001|STARTED|Second Treatment Period||13||
48567150|NCT00396656|101720302|FG000|COMPLETED|Second Treatment Period||15||
48567151|NCT00396656|101720303|FG001|COMPLETED|Second Treatment Period||12||
48567152|NCT00396656|101720302|FG000|NOT COMPLETED|Second Treatment Period||0||
48567153|NCT00396656|101720303|FG001|NOT COMPLETED|Second Treatment Period||1||
48395208|NCT00637377|101299093|FG000|Participants Treated (FAS)|Overall Study||291||
48395209|NCT00637377|101299094|FG001|Participants Treated (FAS)|Overall Study||309||
48395210|NCT00637377|101299095|FG002|Participants Treated (FAS)|Overall Study||296||
48395211|NCT00637377|101299096|FG003|Participants Treated (FAS)|Overall Study||306||
48395212|NCT00637377|101299093|FG000|COMPLETED|Overall Study||276||
48395213|NCT00637377|101299094|FG001|COMPLETED|Overall Study||281||
48395214|NCT00637377|101299095|FG002|COMPLETED|Overall Study||274||
48395215|NCT00637377|101299096|FG003|COMPLETED|Overall Study||284||
48395216|NCT00637377|101299093|FG000|NOT COMPLETED|Overall Study||27||
48395217|NCT00637377|101299094|FG001|NOT COMPLETED|Overall Study||32||
48395218|NCT00637377|101299095|FG002|NOT COMPLETED|Overall Study||37||
48395219|NCT00637377|101299096|FG003|NOT COMPLETED|Overall Study||29||
48395220|NCT00214487|101299097|FG000|STARTED|Overall Study||43||
48395221|NCT00214487|101299098|FG001|STARTED|Overall Study||43||
48395222|NCT00214487|101299097|FG000|COMPLETED|Overall Study||38||
48395223|NCT00214487|101299098|FG001|COMPLETED|Overall Study||40||
48395224|NCT00214487|101299097|FG000|NOT COMPLETED|Overall Study||5||
48395225|NCT00214487|101299098|FG001|NOT COMPLETED|Overall Study||3||
48395226|NCT01705587|101299099|FG000|STARTED|Overall Study||7||
48395227|NCT01705587|101299100|FG001|STARTED|Overall Study||6||
48395228|NCT01705587|101299099|FG000|COMPLETED|Overall Study||7||
48395229|NCT01705587|101299100|FG001|COMPLETED|Overall Study||5||
48395230|NCT01705587|101299099|FG000|NOT COMPLETED|Overall Study||0||
48395231|NCT01705587|101299100|FG001|NOT COMPLETED|Overall Study||1||
48395232|NCT02917629|101299101|FG000|STARTED|Overall Study||4||
48395233|NCT02917629|101299102|FG001|STARTED|Overall Study||2||
48395234|NCT02917629|101299101|FG000|Considered Study Compliant|Overall Study||4||
48395235|NCT02917629|101299102|FG001|Considered Study Compliant|Overall Study||1||
48395236|NCT02917629|101299101|FG000|Experienced Study Drug Interruption|Overall Study||2||
48395237|NCT02917629|101299102|FG001|Experienced Study Drug Interruption|Overall Study||1||
48395238|NCT02917629|101299101|FG000|COMPLETED|Overall Study||4||
48395239|NCT02917629|101299102|FG001|COMPLETED|Overall Study||1||
48395240|NCT02917629|101299101|FG000|NOT COMPLETED|Overall Study||0||
48395241|NCT02917629|101299102|FG001|NOT COMPLETED|Overall Study||1||
48395242|NCT03722472|101299103|FG000|STARTED|Overall Study||23||
48395243|NCT03722472|101299104|FG001|STARTED|Overall Study||25||
48395244|NCT03722472|101299103|FG000|COMPLETED|Overall Study||23||
48567154|NCT03448419|101720304|FG000|STARTED|Overall Study||156||
48395245|NCT03722472|101299104|FG001|COMPLETED|Overall Study||22||
48395246|NCT03722472|101299103|FG000|NOT COMPLETED|Overall Study||0||
48698776|NCT03640325|102050394|FG002|COMPLETED|Overall Study||28||
48698777|NCT03640325|102050392|FG000|NOT COMPLETED|Overall Study||13||
48698778|NCT03640325|102050393|FG001|NOT COMPLETED|Overall Study||11||
48698779|NCT03640325|102050394|FG002|NOT COMPLETED|Overall Study||21||
48698780|NCT00675441|102050395|FG000|STARTED|Overall Study||5||
48698781|NCT00675441|102050395|FG000|COMPLETED|Overall Study||2||
48698782|NCT00675441|102050395|FG000|NOT COMPLETED|Overall Study||3||
48567155|NCT03448419|101720305|FG001|STARTED|Overall Study||156||
48567156|NCT03448419|101720304|FG000|Treated|Overall Study||156||
48567157|NCT03448419|101720305|FG001|Treated|Overall Study||155||
48567158|NCT03448419|101720304|FG000|COMPLETED|Overall Study||143||
48567159|NCT03448419|101720305|FG001|COMPLETED|Overall Study||140||
48567160|NCT03448419|101720304|FG000|NOT COMPLETED|Overall Study||13||
48567161|NCT03448419|101720305|FG001|NOT COMPLETED|Overall Study||16||
48567162|NCT02169271|101720306|FG000|STARTED|Overall Study||49||
48567163|NCT02169271|101720307|FG001|STARTED|Overall Study||49||
48567164|NCT02169271|101720306|FG000|COMPLETED|Overall Study||48||
48567165|NCT02169271|101720307|FG001|COMPLETED|Overall Study||47||
48567166|NCT02169271|101720306|FG000|NOT COMPLETED|Overall Study||1||
48567167|NCT02169271|101720307|FG001|NOT COMPLETED|Overall Study||2||
48698783|NCT04644237|102050396|FG000|STARTED|Overall Study||102|Completed = Participants ongoing treatment as of 23 Dec 2022, Not Completed = Participants who discontinued treatment|
48698784|NCT04644237|102050397|FG001|STARTED|Overall Study||50|Completed = Participants ongoing treatment as of 23 Dec 2022, Not Completed = Participants who discontinued treatment|
48698785|NCT04644237|102050396|FG000|COMPLETED|Overall Study||27||
48698786|NCT04644237|102050397|FG001|COMPLETED|Overall Study||14||
48698787|NCT04644237|102050396|FG000|NOT COMPLETED|Overall Study||75||
48567168|NCT03208166|101720308|FG000|STARTED|Overall Study||1||
48567169|NCT03208166|101720309|FG001|STARTED|Overall Study||1||
48567170|NCT03208166|101720308|FG000|COMPLETED|Overall Study||1||
48567171|NCT03208166|101720309|FG001|COMPLETED|Overall Study||1||
48567172|NCT03208166|101720308|FG000|NOT COMPLETED|Overall Study||0||
48567173|NCT03208166|101720309|FG001|NOT COMPLETED|Overall Study||0||
48567174|NCT00318474|101720310|FG000|STARTED|Overall Study||25||
48395247|NCT03722472|101299104|FG001|NOT COMPLETED|Overall Study||3||
48395248|NCT02119468|101299105|FG000|STARTED|Overall Study||7||
48395249|NCT02119468|101299106|FG001|STARTED|Overall Study||25||
48395250|NCT02119468|101299105|FG000|COMPLETED|Overall Study||7||
48698788|NCT04644237|102050397|FG001|NOT COMPLETED|Overall Study||36||
48698789|NCT00433966|102050398|FG000|STARTED|Pharmacology Intervention/Randomization||1800||
48698790|NCT00433966|102050399|FG001|STARTED|Pharmacology Intervention/Randomization||1802||
48698791|NCT00433966|102050400|FG002|STARTED|Pharmacology Intervention/Randomization||0||
48698792|NCT00433966|102050401|FG003|STARTED|Pharmacology Intervention/Randomization||0||
48698793|NCT00433966|102050398|FG000|30-Day Follow-up|Pharmacology Intervention/Randomization||1787||
48698794|NCT00433966|102050399|FG001|30-Day Follow-up|Pharmacology Intervention/Randomization||1791||
48698795|NCT00433966|102050400|FG002|30-Day Follow-up|Pharmacology Intervention/Randomization||0||
48698796|NCT00433966|102050401|FG003|30-Day Follow-up|Pharmacology Intervention/Randomization||0||
48698797|NCT00433966|102050398|FG000|1-Year Follow-up|Pharmacology Intervention/Randomization||1696||
48698798|NCT00433966|102050399|FG001|1-Year Follow-up|Pharmacology Intervention/Randomization||1702||
48698799|NCT00433966|102050400|FG002|1-Year Follow-up|Pharmacology Intervention/Randomization||0||
48698800|NCT00433966|102050401|FG003|1-Year Follow-up|Pharmacology Intervention/Randomization||0||
48698801|NCT00433966|102050398|FG000|3-Year Follow-up|Pharmacology Intervention/Randomization||1634||
48698802|NCT00433966|102050399|FG001|3-Year Follow-up|Pharmacology Intervention/Randomization||1628||
48698803|NCT00433966|102050400|FG002|3-Year Follow-up|Pharmacology Intervention/Randomization||0||
48698804|NCT00433966|102050401|FG003|3-Year Follow-up|Pharmacology Intervention/Randomization||0||
48698805|NCT00433966|102050398|FG000|COMPLETED|Pharmacology Intervention/Randomization||1634||
48698806|NCT00433966|102050399|FG001|COMPLETED|Pharmacology Intervention/Randomization||1628||
48395251|NCT02119468|101299106|FG001|COMPLETED|Overall Study||25||
48395252|NCT02119468|101299105|FG000|NOT COMPLETED|Overall Study||0||
48395253|NCT02119468|101299106|FG001|NOT COMPLETED|Overall Study||0||
48395254|NCT04581863|101299107|FG000|STARTED|Overall Study||1041||
48395255|NCT04581863|101299108|FG001|STARTED|Overall Study||1056||
48395256|NCT04581863|101299107|FG000|COMPLETED|Overall Study||1024||
48395257|NCT04581863|101299108|FG001|COMPLETED|Overall Study||1025||
48395258|NCT04581863|101299107|FG000|NOT COMPLETED|Overall Study||17||
48395259|NCT04581863|101299108|FG001|NOT COMPLETED|Overall Study||31||
48395260|NCT00260429|101299109|FG000|STARTED|Overall Study||23||
48395261|NCT00260429|101299110|FG001|STARTED|Overall Study||12||
48395262|NCT00260429|101299109|FG000|COMPLETED|Overall Study||21||
48395263|NCT00260429|101299110|FG001|COMPLETED|Overall Study||12||
48395264|NCT00260429|101299109|FG000|NOT COMPLETED|Overall Study||2||
48395265|NCT00260429|101299110|FG001|NOT COMPLETED|Overall Study||0||
48395266|NCT02141217|101299111|FG000|STARTED|Overall Study||234||
48395267|NCT02141217|101299112|FG001|STARTED|Overall Study||237||
48567175|NCT00318474|101720311|FG001|STARTED|Overall Study||27||
48567176|NCT00318474|101720310|FG000|COMPLETED|Overall Study||7||
48567177|NCT00318474|101720311|FG001|COMPLETED|Overall Study||10||
48567178|NCT00318474|101720310|FG000|NOT COMPLETED|Overall Study||18||
48567179|NCT00318474|101720311|FG001|NOT COMPLETED|Overall Study||17||
48567180|NCT00824772|101720312|FG000|STARTED|Overall Study||204||
48567181|NCT00824772|101720312|FG000|COMPLETED|Overall Study||196||
48567182|NCT00824772|101720312|FG000|NOT COMPLETED|Overall Study||8||
48395268|NCT02141217|101299111|FG000|ITT Population-Randomized Treatment Arm|Overall Study||234||
48395269|NCT02141217|101299112|FG001|ITT Population-Randomized Treatment Arm|Overall Study||237||
48395270|NCT02141217|101299111|FG000|ITT Population-Actual Treatment Received|Overall Study||236||
48395271|NCT02141217|101299112|FG001|ITT Population-Actual Treatment Received|Overall Study||235||
48395272|NCT02141217|101299111|FG000|COMPLETED|Overall Study||223||
48395273|NCT02141217|101299112|FG001|COMPLETED|Overall Study||229||
48395274|NCT02141217|101299111|FG000|NOT COMPLETED|Overall Study||11||
48395275|NCT02141217|101299112|FG001|NOT COMPLETED|Overall Study||8||
48395276|NCT02150213|101299113|FG000|STARTED|Overall Study||59||
48395277|NCT02150213|101299113|FG000|COMPLETED|Overall Study||57||
48395278|NCT02150213|101299113|FG000|NOT COMPLETED|Overall Study||2||
48395279|NCT00751179|101299114|FG000|STARTED|Overall Study||76||
48395280|NCT00751179|101299115|FG001|STARTED|Overall Study||85||
48395281|NCT00751179|101299114|FG000|COMPLETED|Overall Study||62||
48395282|NCT00751179|101299115|FG001|COMPLETED|Overall Study||70||
48395283|NCT00751179|101299114|FG000|NOT COMPLETED|Overall Study||14||
48395284|NCT00751179|101299115|FG001|NOT COMPLETED|Overall Study||15||
48395285|NCT00801138|101299116|FG000|STARTED|Overall Study||54||
48395286|NCT00801138|101299117|FG001|STARTED|Overall Study||56||
48395287|NCT00801138|101299118|FG002|STARTED|Overall Study||54||
48395288|NCT00801138|101299119|FG003|STARTED|Overall Study||54||
48395289|NCT00801138|101299116|FG000|COMPLETED|Overall Study||54||
48395290|NCT00801138|101299117|FG001|COMPLETED|Overall Study||56||
48395291|NCT00801138|101299118|FG002|COMPLETED|Overall Study||54||
48395292|NCT00801138|101299119|FG003|COMPLETED|Overall Study||54||
48395293|NCT00801138|101299116|FG000|NOT COMPLETED|Overall Study||0||
48395294|NCT00801138|101299117|FG001|NOT COMPLETED|Overall Study||0||
48395295|NCT00801138|101299118|FG002|NOT COMPLETED|Overall Study||0||
48395296|NCT00801138|101299119|FG003|NOT COMPLETED|Overall Study||0||
48395297|NCT01803711|101299120|FG000|STARTED|Overall Study||2||
48395298|NCT01803711|101299121|FG001|STARTED|Overall Study||3||
48395299|NCT01803711|101299120|FG000|COMPLETED|Overall Study||1||
48395300|NCT01803711|101299121|FG001|COMPLETED|Overall Study||2||
48395301|NCT01803711|101299120|FG000|NOT COMPLETED|Overall Study||1||
48395302|NCT01803711|101299121|FG001|NOT COMPLETED|Overall Study||1||
48395303|NCT01184456|101299122|FG000|STARTED|Overall Study||0||
48395304|NCT01184456|101299123|FG001|STARTED|Overall Study||0||
48395305|NCT01184456|101299122|FG000|COMPLETED|Overall Study||0||
48395306|NCT01184456|101299123|FG001|COMPLETED|Overall Study||0||
48395307|NCT01184456|101299122|FG000|NOT COMPLETED|Overall Study||0||
48395308|NCT01184456|101299123|FG001|NOT COMPLETED|Overall Study||0||
48395309|NCT01357889|101299124|FG000|STARTED|Single-dose Phase (BE Phase: 28 Days)||86||
48395310|NCT01357889|101299125|FG001|STARTED|Single-dose Phase (BE Phase: 28 Days)||81||
48395311|NCT01357889|101299124|FG000|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||82||
48395312|NCT01357889|101299125|FG001|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||79||
48395313|NCT01357889|101299124|FG000|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||4||
48395314|NCT01357889|101299125|FG001|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||2||
48395315|NCT01357889|101299124|FG000|STARTED|Multiple-dose Phase (MDP) (Overall)||141||
48395316|NCT01357889|101299125|FG001|STARTED|Multiple-dose Phase (MDP) (Overall)||142||
48395317|NCT01357889|101299124|FG000|COMPLETED|Multiple-dose Phase (MDP) (Overall)||125||
48395318|NCT01357889|101299125|FG001|COMPLETED|Multiple-dose Phase (MDP) (Overall)||126||
48395319|NCT01357889|101299124|FG000|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16||
48395320|NCT01357889|101299125|FG001|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16||
48395321|NCT01357889|101299124|FG000|STARTED|Follow-up Phase (FUP) (8 Weeks)||141||
48395322|NCT01357889|101299125|FG001|STARTED|Follow-up Phase (FUP) (8 Weeks)||142||
48395323|NCT01357889|101299124|FG000|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138||
48395324|NCT01357889|101299125|FG001|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138||
48395325|NCT01357889|101299124|FG000|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||3||
48395326|NCT01357889|101299125|FG001|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||4||
48395327|NCT02666508|101299126|FG000|STARTED|Overall Study||31||
48395328|NCT02666508|101299127|FG001|STARTED|Overall Study||30||
48395329|NCT02666508|101299126|FG000|COMPLETED|Overall Study||31||
48395330|NCT02666508|101299127|FG001|COMPLETED|Overall Study||30||
48395331|NCT02666508|101299126|FG000|NOT COMPLETED|Overall Study||0||
48395332|NCT02666508|101299127|FG001|NOT COMPLETED|Overall Study||0||
48395333|NCT01082367|101299128|FG000|STARTED|Double-blind Period||26||
48395334|NCT01082367|101299129|FG001|STARTED|Double-blind Period||25||
48395335|NCT01082367|101299128|FG000|Stage 1:1st Treatment (tx) Cycle|Double-blind Period||26||
48395336|NCT01082367|101299129|FG001|Stage 1:1st Treatment (tx) Cycle|Double-blind Period||25||
48395337|NCT01082367|101299128|FG000|Stage 2:no tx|Double-blind Period||0||
48395338|NCT01082367|101299129|FG001|Stage 2:no tx|Double-blind Period||0||
48395339|NCT01082367|101299128|FG000|Entered OL TOBI|Double-blind Period||4||
48395340|NCT01082367|101299129|FG001|Entered OL TOBI|Double-blind Period||18||
48395341|NCT01082367|101299128|FG000|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||9||
48395342|NCT01082367|101299129|FG001|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||0||
48395343|NCT01082367|101299128|FG000|Stage 3: Cross-over (co) tx|Double-blind Period||13||
48395344|NCT01082367|101299129|FG001|Stage 3: Cross-over (co) tx|Double-blind Period||6||
48395345|NCT01082367|101299128|FG000|Stage 4:no tx for Patients Not in co|Double-blind Period||0||
48395346|NCT01082367|101299129|FG001|Stage 4:no tx for Patients Not in co|Double-blind Period||0||
48395347|NCT01082367|101299128|FG000|COMPLETED|Double-blind Period||21||
48395348|NCT01082367|101299129|FG001|COMPLETED|Double-blind Period||12||
48698807|NCT00433966|102050400|FG002|COMPLETED|Pharmacology Intervention/Randomization||0||
48698808|NCT00433966|102050401|FG003|COMPLETED|Pharmacology Intervention/Randomization||0||
48698809|NCT00433966|102050398|FG000|NOT COMPLETED|Pharmacology Intervention/Randomization||166||
48698810|NCT00433966|102050399|FG001|NOT COMPLETED|Pharmacology Intervention/Randomization||174||
48698811|NCT00433966|102050400|FG002|NOT COMPLETED|Pharmacology Intervention/Randomization||0||
48698812|NCT00433966|102050401|FG003|NOT COMPLETED|Pharmacology Intervention/Randomization||0||
48698813|NCT00433966|102050398|FG000|STARTED|Stent Intervention/Randomization||0||
48698814|NCT00433966|102050399|FG001|STARTED|Stent Intervention/Randomization||0||
48698815|NCT00433966|102050400|FG002|STARTED|Stent Intervention/Randomization||2257||
48698816|NCT00433966|102050401|FG003|STARTED|Stent Intervention/Randomization||749||
48698817|NCT00433966|102050398|FG000|1-Year Follow-up|Stent Intervention/Randomization||0||
48698818|NCT00433966|102050399|FG001|1-Year Follow-up|Stent Intervention/Randomization||0||
48698819|NCT00433966|102050400|FG002|1-Year Follow-up|Stent Intervention/Randomization||2186||
48698820|NCT00433966|102050401|FG003|1-Year Follow-up|Stent Intervention/Randomization||715||
48698821|NCT00433966|102050398|FG000|3-Year Follow-up|Stent Intervention/Randomization||0||
48698822|NCT00433966|102050399|FG001|3-Year Follow-up|Stent Intervention/Randomization||0||
48698823|NCT00433966|102050400|FG002|3-Year Follow-up|Stent Intervention/Randomization||2103||
48698824|NCT00433966|102050401|FG003|3-Year Follow-up|Stent Intervention/Randomization||687||
48698825|NCT00433966|102050398|FG000|COMPLETED|Stent Intervention/Randomization||0||
48698826|NCT00433966|102050399|FG001|COMPLETED|Stent Intervention/Randomization||0||
48698827|NCT00433966|102050400|FG002|COMPLETED|Stent Intervention/Randomization||2103||
48698828|NCT00433966|102050401|FG003|COMPLETED|Stent Intervention/Randomization||687||
48698829|NCT00433966|102050398|FG000|NOT COMPLETED|Stent Intervention/Randomization||0||
48698830|NCT00433966|102050399|FG001|NOT COMPLETED|Stent Intervention/Randomization||0||
48698831|NCT00433966|102050400|FG002|NOT COMPLETED|Stent Intervention/Randomization||154||
48698832|NCT00433966|102050401|FG003|NOT COMPLETED|Stent Intervention/Randomization||62||
48698833|NCT05425732|102050402|FG000|STARTED|Overall Study||1181|Randomized participants|
48698834|NCT05425732|102050403|FG001|STARTED|Overall Study||1181|Randomized participants|
48698835|NCT05425732|102050404|FG002|STARTED|Overall Study||201|Randomized participants|
48698836|NCT05425732|102050405|FG003|STARTED|Overall Study||100|Randomized participants|
48698837|NCT05425732|102050402|FG000|Vaccinated|Overall Study||1179|Randomized participants who were vaccinated|
48698838|NCT05425732|102050403|FG001|Vaccinated|Overall Study||1177|Randomized participants who were vaccinated|
48698839|NCT05425732|102050404|FG002|Vaccinated|Overall Study||200|Randomized participants who were vaccinated|
48395349|NCT01082367|101299128|FG000|NOT COMPLETED|Double-blind Period||5||
48395350|NCT01082367|101299129|FG001|NOT COMPLETED|Double-blind Period||13||
48395351|NCT01082367|101299128|FG000|STARTED|Follow-up (F-U) Period||19||
48395352|NCT01082367|101299129|FG001|STARTED|Follow-up (F-U) Period||10||
48395353|NCT01082367|101299128|FG000|Treated in F-U|Follow-up (F-U) Period||5||
48698840|NCT05425732|102050405|FG003|Vaccinated|Overall Study||100|Randomized participants who were vaccinated|
48698841|NCT05425732|102050402|FG000|Safety All Cause Mortality (ACM) Population|Overall Study||1179||
48698842|NCT05425732|102050403|FG001|Safety All Cause Mortality (ACM) Population|Overall Study||1179||
48698843|NCT05425732|102050404|FG002|Safety All Cause Mortality (ACM) Population|Overall Study||201||
48698844|NCT05425732|102050405|FG003|Safety All Cause Mortality (ACM) Population|Overall Study||100||
48698845|NCT05425732|102050402|FG000|All Participants As Treated (APaT)|Overall Study||1177|Randomized participants who were included in the group corresponding to the vaccine they actually received|
48698846|NCT05425732|102050403|FG001|All Participants As Treated (APaT)|Overall Study||1175|Randomized participants who were included in the group corresponding to the vaccine they actually received|
48698847|NCT05425732|102050404|FG002|All Participants As Treated (APaT)|Overall Study||200|Randomized participants who were included in the group corresponding to the vaccine they actually received|
48698848|NCT05425732|102050405|FG003|All Participants As Treated (APaT)|Overall Study||100|Randomized participants who were included in the group corresponding to the vaccine they actually received|
48698849|NCT05425732|102050402|FG000|Safety Adverse Event (AE) Population|Overall Study||1177|All Participants As Treated (APaT)|
48698850|NCT05425732|102050403|FG001|Safety Adverse Event (AE) Population|Overall Study||1175|All Participants As Treated (APaT)|
48710822|NCT03446053|102078030|FG000|STARTED|Overall Study||2||
48395354|NCT01082367|101299129|FG001|Treated in F-U|Follow-up (F-U) Period||5||
48395355|NCT01082367|101299128|FG000|COMPLETED|Follow-up (F-U) Period||17||
48395356|NCT01082367|101299129|FG001|COMPLETED|Follow-up (F-U) Period||9||
48395357|NCT01082367|101299128|FG000|NOT COMPLETED|Follow-up (F-U) Period||2||
48395358|NCT01082367|101299129|FG001|NOT COMPLETED|Follow-up (F-U) Period||1||
48395359|NCT00961662|101299130|FG000|STARTED|Overall Study||57||
48395360|NCT00961662|101299131|FG001|STARTED|Overall Study||51||
48395361|NCT00961662|101299132|FG002|STARTED|Overall Study||53||
48395362|NCT00961662|101299130|FG000|COMPLETED|Overall Study||35||
48395363|NCT00961662|101299131|FG001|COMPLETED|Overall Study||32||
48395364|NCT00961662|101299132|FG002|COMPLETED|Overall Study||34||
48395365|NCT00961662|101299130|FG000|NOT COMPLETED|Overall Study||22||
48395366|NCT00961662|101299131|FG001|NOT COMPLETED|Overall Study||19||
48395367|NCT00961662|101299132|FG002|NOT COMPLETED|Overall Study||19||
48395368|NCT04406389|101299133|FG000|STARTED|Overall Study||4||
48395369|NCT04406389|101299134|FG001|STARTED|Overall Study||10||
48395370|NCT04406389|101299133|FG000|COMPLETED|Overall Study||4||
48395371|NCT04406389|101299134|FG001|COMPLETED|Overall Study||10||
48395372|NCT04406389|101299133|FG000|NOT COMPLETED|Overall Study||0||
48395373|NCT04406389|101299134|FG001|NOT COMPLETED|Overall Study||0||
48395374|NCT00973622|101299135|FG000|STARTED|Overall Study||47||
48395375|NCT00973622|101299136|FG001|STARTED|Overall Study||19||
48395376|NCT00973622|101299135|FG000|COMPLETED|Overall Study||16||
48395377|NCT00973622|101299136|FG001|COMPLETED|Overall Study||14||
48395378|NCT00973622|101299135|FG000|NOT COMPLETED|Overall Study||31||
48395379|NCT00973622|101299136|FG001|NOT COMPLETED|Overall Study||5||
48395380|NCT03841526|101299137|FG000|STARTED|CRC Phase: First Treatment||8||
48395381|NCT03841526|101299138|FG001|STARTED|CRC Phase: First Treatment||10||
48698851|NCT05425732|102050404|FG002|Safety Adverse Event (AE) Population|Overall Study||200|All Participants As Treated (APaT)|
48698852|NCT05425732|102050405|FG003|Safety Adverse Event (AE) Population|Overall Study||100|All Participants As Treated (APaT)|
48698853|NCT05425732|102050402|FG000|COMPLETED|Overall Study||1160||
48280884|NCT03207451|101010604|FG002|NOT COMPLETED|Overall Study||2||
48280885|NCT03207451|101010605|FG003|NOT COMPLETED|Overall Study||3||
48280886|NCT01318018|101010606|FG000|STARTED|Overall Study||10||
48280887|NCT01318018|101010607|FG001|STARTED|Overall Study||10||
48280888|NCT01318018|101010606|FG000|COMPLETED|Overall Study||10||
48280889|NCT01318018|101010607|FG001|COMPLETED|Overall Study||10||
48280890|NCT01318018|101010606|FG000|NOT COMPLETED|Overall Study||0||
48280891|NCT01318018|101010607|FG001|NOT COMPLETED|Overall Study||0||
48280892|NCT04073446|101010608|FG000|STARTED|Overall Study||2||
48280893|NCT04073446|101010608|FG000|DC Perception|Overall Study||2||
48698854|NCT05425732|102050403|FG001|COMPLETED|Overall Study||1152||
48698855|NCT05425732|102050404|FG002|COMPLETED|Overall Study||195||
48698856|NCT05425732|102050405|FG003|COMPLETED|Overall Study||96||
48280894|NCT04073446|101010608|FG000|DR Perception|Overall Study||2||
48698857|NCT05425732|102050402|FG000|NOT COMPLETED|Overall Study||21||
48698858|NCT05425732|102050403|FG001|NOT COMPLETED|Overall Study||29||
48698859|NCT05425732|102050404|FG002|NOT COMPLETED|Overall Study||6||
48280895|NCT04073446|101010608|FG000|DR Subperception|Overall Study||2||
48280896|NCT04073446|101010608|FG000|DC Subperception|Overall Study||1||
48280897|NCT04073446|101010608|FG000|COMPLETED|Overall Study||1||
48280898|NCT04073446|101010608|FG000|NOT COMPLETED|Overall Study||1||
48280899|NCT01134952|101010609|FG000|STARTED|Overall Study||11||
48698860|NCT05425732|102050405|FG003|NOT COMPLETED|Overall Study||4||
48698861|NCT03086707|102050406|FG000|STARTED|Overall Study||7||
48698862|NCT03086707|102050407|FG001|STARTED|Overall Study||7||
48280900|NCT01134952|101010609|FG000|COMPLETED|Overall Study||11||
48280901|NCT01134952|101010609|FG000|NOT COMPLETED|Overall Study||0||
48395382|NCT03841526|101299139|FG002|STARTED|CRC Phase: First Treatment||6||
48395383|NCT03841526|101299140|FG003|STARTED|CRC Phase: First Treatment||11||
48395384|NCT03841526|101299141|FG004|STARTED|CRC Phase: First Treatment||5||
48395385|NCT03841526|101299142|FG005|STARTED|CRC Phase: First Treatment||8||
48395386|NCT03841526|101299137|FG000|Received 1st CRC Dose|CRC Phase: First Treatment||8||
48395387|NCT03841526|101299138|FG001|Received 1st CRC Dose|CRC Phase: First Treatment||10||
48698863|NCT03086707|102050406|FG000|COMPLETED|Overall Study||7||
48698864|NCT03086707|102050407|FG001|COMPLETED|Overall Study||7||
48280902|NCT00837694|101010610|FG000|STARTED|Overall Study||10||
48280903|NCT00837694|101010611|FG001|STARTED|Overall Study||11||
48280904|NCT00837694|101010612|FG002|STARTED|Overall Study||10||
48280905|NCT00837694|101010613|FG003|STARTED|Overall Study||11||
48280906|NCT00837694|101010614|FG004|STARTED|Overall Study||12||
48280907|NCT00837694|101010615|FG005|STARTED|Overall Study||11||
48280908|NCT00837694|101010610|FG000|COMPLETED|Overall Study||8||
48280909|NCT00837694|101010611|FG001|COMPLETED|Overall Study||11||
48280910|NCT00837694|101010612|FG002|COMPLETED|Overall Study||8||
48280911|NCT00837694|101010613|FG003|COMPLETED|Overall Study||10||
48280912|NCT00837694|101010614|FG004|COMPLETED|Overall Study||11||
48280913|NCT00837694|101010615|FG005|COMPLETED|Overall Study||10||
48280914|NCT00837694|101010610|FG000|NOT COMPLETED|Overall Study||2||
48280915|NCT00837694|101010611|FG001|NOT COMPLETED|Overall Study||0||
48280916|NCT00837694|101010612|FG002|NOT COMPLETED|Overall Study||2||
48280917|NCT00837694|101010613|FG003|NOT COMPLETED|Overall Study||1||
48280918|NCT00837694|101010614|FG004|NOT COMPLETED|Overall Study||1||
48280919|NCT00837694|101010615|FG005|NOT COMPLETED|Overall Study||1||
48280920|NCT04819776|101010616|FG000|STARTED|Overall Study||206||
48280921|NCT04819776|101010617|FG001|STARTED|Overall Study||208||
48280922|NCT04819776|101010616|FG000|COMPLETED|Overall Study||139||
48280923|NCT04819776|101010617|FG001|COMPLETED|Overall Study||153||
48280924|NCT04819776|101010616|FG000|NOT COMPLETED|Overall Study||67||
48280925|NCT04819776|101010617|FG001|NOT COMPLETED|Overall Study||55||
48280926|NCT02601300|101010618|FG000|STARTED|Induction Phase||41||
48567183|NCT04005404|101720313|FG000|STARTED|Overall Study||43||
48280927|NCT02601300|101010618|FG000|COMPLETED|Induction Phase||38||
48280928|NCT02601300|101010618|FG000|NOT COMPLETED|Induction Phase||3||
48280929|NCT02601300|101010618|FG000|STARTED|Extension Phase||35||
48280930|NCT02601300|101010618|FG000|Treated With IP|Extension Phase||34||
48280931|NCT02601300|101010618|FG000|COMPLETED|Extension Phase||18||
48280932|NCT02601300|101010618|FG000|NOT COMPLETED|Extension Phase||17||
48280933|NCT04718779|101010619|FG000|STARTED|Overall Study||2||
48280934|NCT04718779|101010620|FG001|STARTED|Overall Study||2||
48280935|NCT04718779|101010619|FG000|COMPLETED|Overall Study||2||
48280936|NCT04718779|101010620|FG001|COMPLETED|Overall Study||2||
48280937|NCT04718779|101010619|FG000|NOT COMPLETED|Overall Study||0||
48280938|NCT04718779|101010620|FG001|NOT COMPLETED|Overall Study||0||
48280939|NCT00774930|101010621|FG000|STARTED|DB Phase||59||
48280940|NCT00774930|101010622|FG001|STARTED|DB Phase||56||
48280941|NCT00774930|101010621|FG000|COMPLETED|DB Phase||45||
48280942|NCT00774930|101010622|FG001|COMPLETED|DB Phase||34||
48280943|NCT00774930|101010621|FG000|NOT COMPLETED|DB Phase||14||
48280944|NCT00774930|101010622|FG001|NOT COMPLETED|DB Phase||22||
48280945|NCT00774930|101010621|FG000|STARTED|IOL Phase||56||
48280946|NCT00774930|101010622|FG001|STARTED|IOL Phase||46||
48280947|NCT00774930|101010621|FG000|COMPLETED|IOL Phase||43||
48280948|NCT00774930|101010622|FG001|COMPLETED|IOL Phase||37||
48280949|NCT00774930|101010621|FG000|NOT COMPLETED|IOL Phase||13||
48280950|NCT00774930|101010622|FG001|NOT COMPLETED|IOL Phase||9||
48280951|NCT00774930|101010621|FG000|STARTED|LTOLE Phase||32||
48280952|NCT00774930|101010622|FG001|STARTED|LTOLE Phase||25||
48280953|NCT00774930|101010621|FG000|COMPLETED|LTOLE Phase||17||
48280954|NCT00774930|101010622|FG001|COMPLETED|LTOLE Phase||8||
48280955|NCT00774930|101010621|FG000|NOT COMPLETED|LTOLE Phase||15||
48280956|NCT00774930|101010622|FG001|NOT COMPLETED|LTOLE Phase||17||
48280957|NCT00291642|101010623|FG000|STARTED|Overall Study||78||
48280958|NCT00291642|101010624|FG001|STARTED|Overall Study||116||
48280959|NCT00291642|101010625|FG002|STARTED|Overall Study||119||
48280960|NCT00291642|101010626|FG003|STARTED|Overall Study||119||
48280961|NCT00291642|101010627|FG004|STARTED|Overall Study||119||
48280962|NCT00291642|101010623|FG000|COMPLETED|Overall Study||76||
48280963|NCT00291642|101010624|FG001|COMPLETED|Overall Study||116||
48280964|NCT00291642|101010625|FG002|COMPLETED|Overall Study||117||
48280965|NCT00291642|101010626|FG003|COMPLETED|Overall Study||119||
48280966|NCT00291642|101010627|FG004|COMPLETED|Overall Study||118||
48280967|NCT00291642|101010623|FG000|NOT COMPLETED|Overall Study||2||
48280968|NCT00291642|101010624|FG001|NOT COMPLETED|Overall Study||0||
48280969|NCT00291642|101010625|FG002|NOT COMPLETED|Overall Study||2||
48280970|NCT00291642|101010626|FG003|NOT COMPLETED|Overall Study||0||
48280971|NCT00291642|101010627|FG004|NOT COMPLETED|Overall Study||1||
48280972|NCT01123070|101010628|FG000|STARTED|Part A Cohort 1 Open Label Period||3||
48280973|NCT01123070|101010629|FG001|STARTED|Part A Cohort 1 Open Label Period||0||
48280974|NCT01123070|101010630|FG002|STARTED|Part A Cohort 1 Open Label Period||0||
48280975|NCT01123070|101010631|FG003|STARTED|Part A Cohort 1 Open Label Period||0||
48280976|NCT01123070|101010628|FG000|COMPLETED|Part A Cohort 1 Open Label Period||3||
48280977|NCT01123070|101010629|FG001|COMPLETED|Part A Cohort 1 Open Label Period||0||
48280978|NCT01123070|101010630|FG002|COMPLETED|Part A Cohort 1 Open Label Period||0||
48280979|NCT01123070|101010631|FG003|COMPLETED|Part A Cohort 1 Open Label Period||0||
48280980|NCT01123070|101010628|FG000|NOT COMPLETED|Part A Cohort 1 Open Label Period||0||
48280981|NCT01123070|101010629|FG001|NOT COMPLETED|Part A Cohort 1 Open Label Period||0||
48280982|NCT01123070|101010630|FG002|NOT COMPLETED|Part A Cohort 1 Open Label Period||0||
48280983|NCT01123070|101010631|FG003|NOT COMPLETED|Part A Cohort 1 Open Label Period||0||
48280984|NCT01123070|101010628|FG000|STARTED|Part A Cohort 2 Open Label Period||0||
48395388|NCT03841526|101299139|FG002|Received 1st CRC Dose|CRC Phase: First Treatment||6||
48395389|NCT03841526|101299140|FG003|Received 1st CRC Dose|CRC Phase: First Treatment||11||
48395390|NCT03841526|101299141|FG004|Received 1st CRC Dose|CRC Phase: First Treatment||5||
48395391|NCT03841526|101299142|FG005|Received 1st CRC Dose|CRC Phase: First Treatment||8||
48395392|NCT03841526|101299137|FG000|COMPLETED|CRC Phase: First Treatment||8||
48395393|NCT03841526|101299138|FG001|COMPLETED|CRC Phase: First Treatment||10||
48395394|NCT03841526|101299139|FG002|COMPLETED|CRC Phase: First Treatment||6||
48395395|NCT03841526|101299140|FG003|COMPLETED|CRC Phase: First Treatment||11||
48395396|NCT03841526|101299141|FG004|COMPLETED|CRC Phase: First Treatment||5||
48395397|NCT03841526|101299142|FG005|COMPLETED|CRC Phase: First Treatment||8||
48395398|NCT03841526|101299137|FG000|NOT COMPLETED|CRC Phase: First Treatment||0||
48395399|NCT03841526|101299138|FG001|NOT COMPLETED|CRC Phase: First Treatment||0||
48395400|NCT03841526|101299139|FG002|NOT COMPLETED|CRC Phase: First Treatment||0||
48395401|NCT03841526|101299140|FG003|NOT COMPLETED|CRC Phase: First Treatment||0||
48395402|NCT03841526|101299141|FG004|NOT COMPLETED|CRC Phase: First Treatment||0||
48395403|NCT03841526|101299142|FG005|NOT COMPLETED|CRC Phase: First Treatment||0||
48395404|NCT03841526|101299137|FG000|STARTED|CRC Phase: Second Treatment||8||
48395405|NCT03841526|101299138|FG001|STARTED|CRC Phase: Second Treatment||10||
48567184|NCT04005404|101720314|FG001|STARTED|Overall Study||34||
48567185|NCT04005404|101720315|FG002|STARTED|Overall Study||3||
48567186|NCT04005404|101720313|FG000|COMPLETED|Overall Study||42||
48567187|NCT04005404|101720314|FG001|COMPLETED|Overall Study||33||
48567188|NCT04005404|101720315|FG002|COMPLETED|Overall Study||3||
48567189|NCT04005404|101720313|FG000|NOT COMPLETED|Overall Study||1||
48567190|NCT04005404|101720314|FG001|NOT COMPLETED|Overall Study||1||
48567191|NCT04005404|101720315|FG002|NOT COMPLETED|Overall Study||0||
48567192|NCT02572570|101720316|FG000|STARTED|Overall Study||27||64
48567193|NCT02572570|101720316|FG000|Filtek Bulk Fill Posterior|Overall Study||27||32
48567194|NCT02572570|101720316|FG000|Filtek Supreme Ultra|Overall Study||27||32
48567195|NCT02572570|101720316|FG000|1 Year Follow-Up|Overall Study||20||46
48698865|NCT03086707|102050406|FG000|NOT COMPLETED|Overall Study||0||
48698866|NCT03086707|102050407|FG001|NOT COMPLETED|Overall Study||0||
48698867|NCT02808052|102050408|FG000|STARTED|Overall Study||4||
48698868|NCT02808052|102050409|FG001|STARTED|Overall Study||3||
48698869|NCT02808052|102050410|FG002|STARTED|Overall Study||2||
48698870|NCT02808052|102050408|FG000|COMPLETED|Overall Study||4||
48698871|NCT02808052|102050409|FG001|COMPLETED|Overall Study||3||
48698872|NCT02808052|102050410|FG002|COMPLETED|Overall Study||2||
48698873|NCT02808052|102050408|FG000|NOT COMPLETED|Overall Study||0||
48698874|NCT02808052|102050409|FG001|NOT COMPLETED|Overall Study||0||
48698875|NCT02808052|102050410|FG002|NOT COMPLETED|Overall Study||0||
48698876|NCT03582553|102050411|FG000|STARTED|Intervention 1/Visit 1||3||
48698877|NCT03582553|102050412|FG001|STARTED|Intervention 1/Visit 1||3||
48698878|NCT03582553|102050413|FG002|STARTED|Intervention 1/Visit 1||3||
48698879|NCT03582553|102050414|FG003|STARTED|Intervention 1/Visit 1||3||
48698880|NCT03582553|102050415|FG004|STARTED|Intervention 1/Visit 1||3||
48698881|NCT03582553|102050416|FG005|STARTED|Intervention 1/Visit 1||3||
48698882|NCT03582553|102050411|FG000|COMPLETED|Intervention 1/Visit 1||3||
48698883|NCT03582553|102050412|FG001|COMPLETED|Intervention 1/Visit 1||3||
48698884|NCT03582553|102050413|FG002|COMPLETED|Intervention 1/Visit 1||3||
48698885|NCT03582553|102050414|FG003|COMPLETED|Intervention 1/Visit 1||3||
48698886|NCT03582553|102050415|FG004|COMPLETED|Intervention 1/Visit 1||3||
48698887|NCT03582553|102050416|FG005|COMPLETED|Intervention 1/Visit 1||3||
48698888|NCT03582553|102050411|FG000|NOT COMPLETED|Intervention 1/Visit 1||0||
48567196|NCT02572570|101720316|FG000|2 Year Follow-Up|Overall Study||13||34
48567197|NCT02572570|101720316|FG000|3 Year Follow-Up|Overall Study||5||12
48567198|NCT02572570|101720316|FG000|5 Year Follow-Up|Overall Study||0||0
48567199|NCT02572570|101720316|FG000|COMPLETED|Overall Study||0||0
48567200|NCT02572570|101720316|FG000|NOT COMPLETED|Overall Study||27||64
48567201|NCT03126968|101720317|FG000|STARTED|Overall Study||33||46
48567202|NCT03126968|101720318|FG001|STARTED|Overall Study||33||54
48567203|NCT03126968|101720317|FG000|COMPLETED|Overall Study||33||46
48567204|NCT03126968|101720318|FG001|COMPLETED|Overall Study||33||54
48698889|NCT03582553|102050412|FG001|NOT COMPLETED|Intervention 1/Visit 1||0||
48698890|NCT03582553|102050413|FG002|NOT COMPLETED|Intervention 1/Visit 1||0||
48698891|NCT03582553|102050414|FG003|NOT COMPLETED|Intervention 1/Visit 1||0||
48698892|NCT03582553|102050415|FG004|NOT COMPLETED|Intervention 1/Visit 1||0||
48698893|NCT03582553|102050416|FG005|NOT COMPLETED|Intervention 1/Visit 1||0||
48698894|NCT03582553|102050411|FG000|STARTED|Washout Period ( At Least 1 Week)||3||
48698895|NCT03582553|102050412|FG001|STARTED|Washout Period ( At Least 1 Week)||3||
48698896|NCT03582553|102050413|FG002|STARTED|Washout Period ( At Least 1 Week)||3||
48698897|NCT03582553|102050414|FG003|STARTED|Washout Period ( At Least 1 Week)||3||
48698898|NCT03582553|102050415|FG004|STARTED|Washout Period ( At Least 1 Week)||3||
48698899|NCT03582553|102050416|FG005|STARTED|Washout Period ( At Least 1 Week)||3||
48698900|NCT03582553|102050411|FG000|COMPLETED|Washout Period ( At Least 1 Week)||3||
48698901|NCT03582553|102050412|FG001|COMPLETED|Washout Period ( At Least 1 Week)||3||
48698902|NCT03582553|102050413|FG002|COMPLETED|Washout Period ( At Least 1 Week)||3||
48698903|NCT03582553|102050414|FG003|COMPLETED|Washout Period ( At Least 1 Week)||3||
48698904|NCT03582553|102050415|FG004|COMPLETED|Washout Period ( At Least 1 Week)||3||
48567205|NCT03126968|101720317|FG000|NOT COMPLETED|Overall Study||0||0
48567206|NCT03126968|101720318|FG001|NOT COMPLETED|Overall Study||0||0
48567207|NCT03070600|101720319|FG000|STARTED|Overall Study||2250||
48567208|NCT03070600|101720320|FG001|STARTED|Overall Study||2197||
48567209|NCT03070600|101720319|FG000|COMPLETED|Overall Study||2156||
48567210|NCT03070600|101720320|FG001|COMPLETED|Overall Study||2032||
48567211|NCT03070600|101720319|FG000|NOT COMPLETED|Overall Study||94||
48567212|NCT03070600|101720320|FG001|NOT COMPLETED|Overall Study||165||
48567213|NCT02755467|101720321|FG000|STARTED|Overall Study||22||
48567214|NCT02755467|101720321|FG000|COMPLETED|Overall Study||21||
48567215|NCT02755467|101720321|FG000|NOT COMPLETED|Overall Study||1||
48567216|NCT04565145|101720322|FG000|STARTED|Overall Study||10||
48567217|NCT04565145|101720323|FG001|STARTED|Overall Study||10||
48567218|NCT04565145|101720322|FG000|COMPLETED|Overall Study||9||
48567219|NCT04565145|101720323|FG001|COMPLETED|Overall Study||9||
48698905|NCT03582553|102050416|FG005|COMPLETED|Washout Period ( At Least 1 Week)||3||
48698906|NCT03582553|102050411|FG000|NOT COMPLETED|Washout Period ( At Least 1 Week)||0||
48698907|NCT03582553|102050412|FG001|NOT COMPLETED|Washout Period ( At Least 1 Week)||0||
48698908|NCT03582553|102050413|FG002|NOT COMPLETED|Washout Period ( At Least 1 Week)||0||
48698909|NCT03582553|102050414|FG003|NOT COMPLETED|Washout Period ( At Least 1 Week)||0||
48698910|NCT03582553|102050415|FG004|NOT COMPLETED|Washout Period ( At Least 1 Week)||0||
48698911|NCT03582553|102050416|FG005|NOT COMPLETED|Washout Period ( At Least 1 Week)||0||
48698912|NCT03582553|102050411|FG000|STARTED|Intervention 2/Visit 2||3||
48698913|NCT03582553|102050412|FG001|STARTED|Intervention 2/Visit 2||3||
48698914|NCT03582553|102050413|FG002|STARTED|Intervention 2/Visit 2||3||
48698915|NCT03582553|102050414|FG003|STARTED|Intervention 2/Visit 2||3||
48698916|NCT03582553|102050415|FG004|STARTED|Intervention 2/Visit 2||3||
48698917|NCT03582553|102050416|FG005|STARTED|Intervention 2/Visit 2||3||
48698918|NCT03582553|102050411|FG000|COMPLETED|Intervention 2/Visit 2||3||
48698919|NCT03582553|102050412|FG001|COMPLETED|Intervention 2/Visit 2||3||
48698920|NCT03582553|102050413|FG002|COMPLETED|Intervention 2/Visit 2||3||
48698921|NCT03582553|102050414|FG003|COMPLETED|Intervention 2/Visit 2||3||
48698922|NCT03582553|102050415|FG004|COMPLETED|Intervention 2/Visit 2||3||
48698923|NCT03582553|102050416|FG005|COMPLETED|Intervention 2/Visit 2||3||
48698924|NCT03582553|102050411|FG000|NOT COMPLETED|Intervention 2/Visit 2||0||
48698925|NCT03582553|102050412|FG001|NOT COMPLETED|Intervention 2/Visit 2||0||
48698926|NCT03582553|102050413|FG002|NOT COMPLETED|Intervention 2/Visit 2||0||
48698927|NCT03582553|102050414|FG003|NOT COMPLETED|Intervention 2/Visit 2||0||
48698928|NCT03582553|102050415|FG004|NOT COMPLETED|Intervention 2/Visit 2||0||
48698929|NCT03582553|102050416|FG005|NOT COMPLETED|Intervention 2/Visit 2||0||
48698930|NCT03582553|102050411|FG000|STARTED|Washout Period (At Least 1 Week)||3||
48698931|NCT03582553|102050412|FG001|STARTED|Washout Period (At Least 1 Week)||3||
48698932|NCT03582553|102050413|FG002|STARTED|Washout Period (At Least 1 Week)||3||
48567220|NCT04565145|101720322|FG000|NOT COMPLETED|Overall Study||1||
48567221|NCT04565145|101720323|FG001|NOT COMPLETED|Overall Study||1||
48567222|NCT01873846|101720324|FG000|STARTED|Overall Study||400||
48698933|NCT03582553|102050414|FG003|STARTED|Washout Period (At Least 1 Week)||3||
48698934|NCT03582553|102050415|FG004|STARTED|Washout Period (At Least 1 Week)||3||
48698935|NCT03582553|102050416|FG005|STARTED|Washout Period (At Least 1 Week)||3||
48698936|NCT03582553|102050411|FG000|COMPLETED|Washout Period (At Least 1 Week)||3||
48567223|NCT01873846|101720324|FG000|Eligble Participants Dispensed Lenses|Overall Study||396||
48567224|NCT01873846|101720324|FG000|COMPLETED|Overall Study||388||
48567225|NCT01873846|101720324|FG000|NOT COMPLETED|Overall Study||12||
48567226|NCT02801617|101720325|FG000|STARTED|Overall Study||51||
48567227|NCT02801617|101720326|FG001|STARTED|Overall Study||56||
48567228|NCT02801617|101720325|FG000|COMPLETED|Overall Study||49||
48280985|NCT01123070|101010629|FG001|STARTED|Part A Cohort 2 Open Label Period||3||
48395406|NCT03841526|101299139|FG002|STARTED|CRC Phase: Second Treatment||6||
48395407|NCT03841526|101299140|FG003|STARTED|CRC Phase: Second Treatment||11||
48395408|NCT03841526|101299141|FG004|STARTED|CRC Phase: Second Treatment||5||
48395409|NCT03841526|101299142|FG005|STARTED|CRC Phase: Second Treatment||8||
48395410|NCT03841526|101299137|FG000|Received 2nd CRC Dose|CRC Phase: Second Treatment||7||
48395411|NCT03841526|101299138|FG001|Received 2nd CRC Dose|CRC Phase: Second Treatment||10||
48280986|NCT01123070|101010630|FG002|STARTED|Part A Cohort 2 Open Label Period||0||
48280987|NCT01123070|101010631|FG003|STARTED|Part A Cohort 2 Open Label Period||0||
48280988|NCT01123070|101010628|FG000|COMPLETED|Part A Cohort 2 Open Label Period||0||
48280989|NCT01123070|101010629|FG001|COMPLETED|Part A Cohort 2 Open Label Period||3||
48280990|NCT01123070|101010630|FG002|COMPLETED|Part A Cohort 2 Open Label Period||0||
48280991|NCT01123070|101010631|FG003|COMPLETED|Part A Cohort 2 Open Label Period||0||
48395412|NCT03841526|101299139|FG002|Received 2nd CRC Dose|CRC Phase: Second Treatment||6||
48395413|NCT03841526|101299140|FG003|Received 2nd CRC Dose|CRC Phase: Second Treatment||9||
48395414|NCT03841526|101299141|FG004|Received 2nd CRC Dose|CRC Phase: Second Treatment||5||
48395415|NCT03841526|101299142|FG005|Received 2nd CRC Dose|CRC Phase: Second Treatment||8||
48395416|NCT03841526|101299137|FG000|COMPLETED|CRC Phase: Second Treatment||7||
48395417|NCT03841526|101299138|FG001|COMPLETED|CRC Phase: Second Treatment||10||
48280992|NCT01123070|101010628|FG000|NOT COMPLETED|Part A Cohort 2 Open Label Period||0||
48280993|NCT01123070|101010629|FG001|NOT COMPLETED|Part A Cohort 2 Open Label Period||0||
48280994|NCT01123070|101010630|FG002|NOT COMPLETED|Part A Cohort 2 Open Label Period||0||
48395418|NCT03841526|101299139|FG002|COMPLETED|CRC Phase: Second Treatment||6||
48395419|NCT03841526|101299140|FG003|COMPLETED|CRC Phase: Second Treatment||9||
48395420|NCT03841526|101299141|FG004|COMPLETED|CRC Phase: Second Treatment||5||
48395421|NCT03841526|101299142|FG005|COMPLETED|CRC Phase: Second Treatment||8||
48395422|NCT03841526|101299137|FG000|NOT COMPLETED|CRC Phase: Second Treatment||1||
48280995|NCT01123070|101010631|FG003|NOT COMPLETED|Part A Cohort 2 Open Label Period||0||
48280996|NCT01123070|101010628|FG000|STARTED|Part B Double Blind Period||0||
48280997|NCT01123070|101010629|FG001|STARTED|Part B Double Blind Period||0||
48280998|NCT01123070|101010630|FG002|STARTED|Part B Double Blind Period||25||
48280999|NCT01123070|101010631|FG003|STARTED|Part B Double Blind Period||23||
48395423|NCT03841526|101299138|FG001|NOT COMPLETED|CRC Phase: Second Treatment||0||
48567229|NCT02801617|101720326|FG001|COMPLETED|Overall Study||50||
48567230|NCT02801617|101720325|FG000|NOT COMPLETED|Overall Study||2||
48567231|NCT02801617|101720326|FG001|NOT COMPLETED|Overall Study||6||
48567232|NCT04021914|101720327|FG000|STARTED|Overall Study||6||
48567233|NCT04021914|101720327|FG000|COMPLETED|Overall Study||5||
48567234|NCT04021914|101720327|FG000|NOT COMPLETED|Overall Study||1||
48567235|NCT00813150|101720328|FG000|STARTED|Treatment Period||46||
48567236|NCT00813150|101720329|FG001|STARTED|Treatment Period||47||
48567237|NCT00813150|101720328|FG000|Intent-to-treat Participants|Treatment Period||43||
48567238|NCT00813150|101720329|FG001|Intent-to-treat Participants|Treatment Period||47||
48567239|NCT00813150|101720328|FG000|COMPLETED|Treatment Period||14||
48567240|NCT00813150|101720329|FG001|COMPLETED|Treatment Period||15||
48567241|NCT00813150|101720328|FG000|NOT COMPLETED|Treatment Period||32||
48567242|NCT00813150|101720329|FG001|NOT COMPLETED|Treatment Period||32||
48698937|NCT03582553|102050412|FG001|COMPLETED|Washout Period (At Least 1 Week)||3||
48698938|NCT03582553|102050413|FG002|COMPLETED|Washout Period (At Least 1 Week)||3||
48698939|NCT03582553|102050414|FG003|COMPLETED|Washout Period (At Least 1 Week)||3||
48281000|NCT01123070|101010628|FG000|COMPLETED|Part B Double Blind Period||0||
48395424|NCT03841526|101299139|FG002|NOT COMPLETED|CRC Phase: Second Treatment||0||
48567243|NCT00813150|101720328|FG000|STARTED|Long Term Follow-up||26||
48567244|NCT00813150|101720329|FG001|STARTED|Long Term Follow-up||31||
48567245|NCT00813150|101720328|FG000|COMPLETED|Long Term Follow-up||2||
48567246|NCT00813150|101720329|FG001|COMPLETED|Long Term Follow-up||0||
48567247|NCT00813150|101720328|FG000|NOT COMPLETED|Long Term Follow-up||24||
48567248|NCT00813150|101720329|FG001|NOT COMPLETED|Long Term Follow-up||31||
48567249|NCT01537926|101720330|FG000|STARTED|Overall Study||29||
48567250|NCT01537926|101720331|FG001|STARTED|Overall Study||13||
48698940|NCT03582553|102050415|FG004|COMPLETED|Washout Period (At Least 1 Week)||3||
48698941|NCT03582553|102050416|FG005|COMPLETED|Washout Period (At Least 1 Week)||3||
48698942|NCT03582553|102050411|FG000|NOT COMPLETED|Washout Period (At Least 1 Week)||0||
48281001|NCT01123070|101010629|FG001|COMPLETED|Part B Double Blind Period||0||
48281002|NCT01123070|101010630|FG002|COMPLETED|Part B Double Blind Period||21||
48281003|NCT01123070|101010631|FG003|COMPLETED|Part B Double Blind Period||20||
48281004|NCT01123070|101010628|FG000|NOT COMPLETED|Part B Double Blind Period||0||
48281005|NCT01123070|101010629|FG001|NOT COMPLETED|Part B Double Blind Period||0||
48567251|NCT01537926|101720330|FG000|COMPLETED|Overall Study||24||
48281006|NCT01123070|101010630|FG002|NOT COMPLETED|Part B Double Blind Period||4||
48281007|NCT01123070|101010631|FG003|NOT COMPLETED|Part B Double Blind Period||3||
48567252|NCT01537926|101720331|FG001|COMPLETED|Overall Study||11||
48567253|NCT01537926|101720330|FG000|NOT COMPLETED|Overall Study||5||
48567254|NCT01537926|101720331|FG001|NOT COMPLETED|Overall Study||2||
48567255|NCT00765336|101720332|FG000|STARTED|Overall Study||91||
48567256|NCT00765336|101720333|FG001|STARTED|Overall Study||89||
48567257|NCT00765336|101720332|FG000|COMPLETED|Overall Study||72||
48567258|NCT00765336|101720333|FG001|COMPLETED|Overall Study||73||
48567259|NCT00765336|101720332|FG000|NOT COMPLETED|Overall Study||19||
48567260|NCT00765336|101720333|FG001|NOT COMPLETED|Overall Study||16||
48567261|NCT02703467|101720334|FG000|STARTED|Overall Study||20||
48567262|NCT02703467|101720335|FG001|STARTED|Overall Study||5||
48567263|NCT02703467|101720336|FG002|STARTED|Overall Study||45||
48567264|NCT02703467|101720334|FG000|COMPLETED|Overall Study||20||
48395425|NCT03841526|101299140|FG003|NOT COMPLETED|CRC Phase: Second Treatment||2||
48395426|NCT03841526|101299141|FG004|NOT COMPLETED|CRC Phase: Second Treatment||0||
48395427|NCT03841526|101299142|FG005|NOT COMPLETED|CRC Phase: Second Treatment||0||
48567265|NCT02703467|101720335|FG001|COMPLETED|Overall Study||5||
48567266|NCT02703467|101720336|FG002|COMPLETED|Overall Study||45||
48567267|NCT02703467|101720334|FG000|NOT COMPLETED|Overall Study||0||
48567268|NCT02703467|101720335|FG001|NOT COMPLETED|Overall Study||0||
48567269|NCT02703467|101720336|FG002|NOT COMPLETED|Overall Study||0||
48567270|NCT02513160|101720337|FG000|STARTED|Run-In Period (Days -14 to Day -1)||713||
48567271|NCT02513160|101720338|FG001|STARTED|Run-In Period (Days -14 to Day -1)||0||
48567272|NCT02513160|101720339|FG002|STARTED|Run-In Period (Days -14 to Day -1)||0||
48567273|NCT02513160|101720340|FG003|STARTED|Run-In Period (Days -14 to Day -1)||0||
48567274|NCT02513160|101720337|FG000|COMPLETED|Run-In Period (Days -14 to Day -1)||425||
48567275|NCT02513160|101720338|FG001|COMPLETED|Run-In Period (Days -14 to Day -1)||0||
48567276|NCT02513160|101720339|FG002|COMPLETED|Run-In Period (Days -14 to Day -1)||0||
48567277|NCT02513160|101720340|FG003|COMPLETED|Run-In Period (Days -14 to Day -1)||0||
48567278|NCT02513160|101720337|FG000|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||288||
48567279|NCT02513160|101720338|FG001|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0||
48567280|NCT02513160|101720339|FG002|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0||
48567281|NCT02513160|101720340|FG003|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0||
48567282|NCT02513160|101720337|FG000|STARTED|Treatment Period (Day 0 to Week 6)||107||
48567283|NCT02513160|101720338|FG001|STARTED|Treatment Period (Day 0 to Week 6)||108||
48567284|NCT02513160|101720339|FG002|STARTED|Treatment Period (Day 0 to Week 6)||105||
48567285|NCT02513160|101720340|FG003|STARTED|Treatment Period (Day 0 to Week 6)||105||
48567286|NCT02513160|101720337|FG000|COMPLETED|Treatment Period (Day 0 to Week 6)||101||
48567287|NCT02513160|101720338|FG001|COMPLETED|Treatment Period (Day 0 to Week 6)||104||
48567288|NCT02513160|101720339|FG002|COMPLETED|Treatment Period (Day 0 to Week 6)||104||
48567289|NCT02513160|101720340|FG003|COMPLETED|Treatment Period (Day 0 to Week 6)||103||
48567290|NCT02513160|101720337|FG000|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||6||
48567291|NCT02513160|101720338|FG001|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||4||
48567292|NCT02513160|101720339|FG002|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||1||
48567293|NCT02513160|101720340|FG003|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||2||
48567294|NCT01173523|101720341|FG000|STARTED|Overall Study||13||
48567295|NCT01173523|101720342|FG001|STARTED|Overall Study||12||
48567296|NCT01173523|101720341|FG000|COMPLETED|Overall Study||0||
48119468|NCT04096560|100616476|FG001|COMPLETED|Overall Study||7||
48119469|NCT04096560|100616477|FG002|COMPLETED|Overall Study||8||
48119470|NCT04096560|100616478|FG003|COMPLETED|Overall Study||12||
48119471|NCT04096560|100616479|FG004|COMPLETED|Overall Study||10||
48281008|NCT01323972|101010632|FG000|STARTED|Overall Study||81||
48281009|NCT01323972|101010633|FG001|STARTED|Overall Study||79||
48119472|NCT04096560|100616480|FG005|COMPLETED|Overall Study||12||
48119473|NCT04096560|100616481|FG006|COMPLETED|Overall Study||9||
48119474|NCT04096560|100616482|FG007|COMPLETED|Overall Study||0||
48281010|NCT01323972|101010634|FG002|STARTED|Overall Study||80||
48281011|NCT01323972|101010635|FG003|STARTED|Overall Study||80||
48281012|NCT01323972|101010632|FG000|COMPLETED|Overall Study||79||
48281013|NCT01323972|101010633|FG001|COMPLETED|Overall Study||76||
48281014|NCT01323972|101010634|FG002|COMPLETED|Overall Study||78||
48281015|NCT01323972|101010635|FG003|COMPLETED|Overall Study||79||
48281016|NCT01323972|101010632|FG000|NOT COMPLETED|Overall Study||2||
48281017|NCT01323972|101010633|FG001|NOT COMPLETED|Overall Study||3||
48281018|NCT01323972|101010634|FG002|NOT COMPLETED|Overall Study||2||
48281019|NCT01323972|101010635|FG003|NOT COMPLETED|Overall Study||1||
48281020|NCT02514239|101010636|FG000|STARTED|Overall Study||5||
48281021|NCT02514239|101010637|FG001|STARTED|Overall Study||4||
48281022|NCT02514239|101010638|FG002|STARTED|Overall Study||3||
48281023|NCT02514239|101010639|FG003|STARTED|Overall Study||3||
48281024|NCT02514239|101010640|FG004|STARTED|Overall Study||3||
48395428|NCT03841526|101299137|FG000|STARTED|Outpatient Phase Treatment||7||
48567297|NCT01173523|101720342|FG001|COMPLETED|Overall Study||0||
48281025|NCT02514239|101010641|FG005|STARTED|Overall Study||5||
48567298|NCT01173523|101720341|FG000|NOT COMPLETED|Overall Study||13||
48567299|NCT01173523|101720342|FG001|NOT COMPLETED|Overall Study||12||
48567300|NCT03376789|101720343|FG000|STARTED|Overall Study||108||
48567301|NCT03376789|101720344|FG001|STARTED|Overall Study||111||
48567302|NCT03376789|101720343|FG000|COMPLETED|Overall Study||103||
48567303|NCT03376789|101720344|FG001|COMPLETED|Overall Study||102||
48119475|NCT04096560|100616475|FG000|NOT COMPLETED|Overall Study||1||
48119476|NCT04096560|100616476|FG001|NOT COMPLETED|Overall Study||0||
48119477|NCT04096560|100616477|FG002|NOT COMPLETED|Overall Study||0||
48119478|NCT04096560|100616478|FG003|NOT COMPLETED|Overall Study||5||
48119479|NCT04096560|100616479|FG004|NOT COMPLETED|Overall Study||7||
48119480|NCT04096560|100616480|FG005|NOT COMPLETED|Overall Study||8||
48119481|NCT04096560|100616481|FG006|NOT COMPLETED|Overall Study||10||
48119482|NCT04096560|100616482|FG007|NOT COMPLETED|Overall Study||2||
48119483|NCT02566759|100616483|FG000|STARTED|All Parts||12||
48119484|NCT02566759|100616484|FG001|STARTED|All Parts||6||
48395429|NCT03841526|101299138|FG001|STARTED|Outpatient Phase Treatment||10||
48395430|NCT03841526|101299139|FG002|STARTED|Outpatient Phase Treatment||6||
48395431|NCT03841526|101299140|FG003|STARTED|Outpatient Phase Treatment||9||
48395432|NCT03841526|101299141|FG004|STARTED|Outpatient Phase Treatment||5||
48395433|NCT03841526|101299142|FG005|STARTED|Outpatient Phase Treatment||8||
48395434|NCT03841526|101299137|FG000|Received at Least 1 Outpatient Dose|Outpatient Phase Treatment||7||
48395435|NCT03841526|101299138|FG001|Received at Least 1 Outpatient Dose|Outpatient Phase Treatment||9||
48395436|NCT03841526|101299139|FG002|Received at Least 1 Outpatient Dose|Outpatient Phase Treatment||6||
48395437|NCT03841526|101299140|FG003|Received at Least 1 Outpatient Dose|Outpatient Phase Treatment||9||
48395438|NCT03841526|101299141|FG004|Received at Least 1 Outpatient Dose|Outpatient Phase Treatment||5||
48395439|NCT03841526|101299142|FG005|Received at Least 1 Outpatient Dose|Outpatient Phase Treatment||8||
48395440|NCT03841526|101299137|FG000|COMPLETED|Outpatient Phase Treatment||7||
48395441|NCT03841526|101299138|FG001|COMPLETED|Outpatient Phase Treatment||9||
48395442|NCT03841526|101299139|FG002|COMPLETED|Outpatient Phase Treatment||5||
48395443|NCT03841526|101299140|FG003|COMPLETED|Outpatient Phase Treatment||9||
48395444|NCT03841526|101299141|FG004|COMPLETED|Outpatient Phase Treatment||5||
48395445|NCT03841526|101299142|FG005|COMPLETED|Outpatient Phase Treatment||7||
48395446|NCT03841526|101299137|FG000|NOT COMPLETED|Outpatient Phase Treatment||0||
48395447|NCT03841526|101299138|FG001|NOT COMPLETED|Outpatient Phase Treatment||1||
48395448|NCT03841526|101299139|FG002|NOT COMPLETED|Outpatient Phase Treatment||1||
48395449|NCT03841526|101299140|FG003|NOT COMPLETED|Outpatient Phase Treatment||0||
48395450|NCT03841526|101299141|FG004|NOT COMPLETED|Outpatient Phase Treatment||0||
48395451|NCT03841526|101299142|FG005|NOT COMPLETED|Outpatient Phase Treatment||1||
48395452|NCT03094611|101299143|FG000|STARTED|Overall Study||4||
48395453|NCT03094611|101299143|FG000|COMPLETED|Overall Study||2||
48395454|NCT03094611|101299143|FG000|NOT COMPLETED|Overall Study||2||
48395455|NCT00661570|101299144|FG000|STARTED|Overall Study||26||
48395456|NCT00661570|101299144|FG000|COMPLETED|Overall Study||26||
48395457|NCT00661570|101299144|FG000|NOT COMPLETED|Overall Study||0||
48395458|NCT04992546|101299145|FG000|STARTED|Double-Blinded Treatment Period||39||78
48395459|NCT04992546|101299145|FG000|COMPLETED|Double-Blinded Treatment Period||37||74
48395460|NCT04992546|101299145|FG000|NOT COMPLETED|Double-Blinded Treatment Period||2||4
48395461|NCT04992546|101299145|FG000|STARTED|Open-Label Treatment Period||38||76
48395462|NCT04992546|101299145|FG000|COMPLETED|Open-Label Treatment Period||34||68
48395463|NCT04992546|101299145|FG000|NOT COMPLETED|Open-Label Treatment Period||4||8
48395464|NCT03447821|101299146|FG000|STARTED|Overall Study||14||
48395465|NCT03447821|101299147|FG001|STARTED|Overall Study||13||
48395466|NCT03447821|101299148|FG002|STARTED|Overall Study||13||
48395467|NCT03447821|101299146|FG000|COMPLETED|Overall Study||13||
48395468|NCT03447821|101299147|FG001|COMPLETED|Overall Study||12||
48395469|NCT03447821|101299148|FG002|COMPLETED|Overall Study||12||
48119485|NCT02566759|100616485|FG002|STARTED|All Parts||6||
48119486|NCT02566759|100616486|FG003|STARTED|All Parts||6||
48119487|NCT02566759|100616487|FG004|STARTED|All Parts||6||
48119488|NCT02566759|100616488|FG005|STARTED|All Parts||6||
48119489|NCT02566759|100616489|FG006|STARTED|All Parts||6||
48119490|NCT02566759|100616490|FG007|STARTED|All Parts||8||
48119491|NCT02566759|100616491|FG008|STARTED|All Parts||6||
48395470|NCT03447821|101299146|FG000|NOT COMPLETED|Overall Study||1||
48395471|NCT03447821|101299147|FG001|NOT COMPLETED|Overall Study||1||
48395472|NCT03447821|101299148|FG002|NOT COMPLETED|Overall Study||1||
48395473|NCT00724815|101299149|FG000|STARTED|Overall Study||265||
48395474|NCT00724815|101299150|FG001|STARTED|Overall Study||265||
48395475|NCT00724815|101299149|FG000|COMPLETED|Overall Study||222||
48395476|NCT00724815|101299150|FG001|COMPLETED|Overall Study||226||
48395477|NCT00724815|101299149|FG000|NOT COMPLETED|Overall Study||43||
48395478|NCT00724815|101299150|FG001|NOT COMPLETED|Overall Study||39||
48395479|NCT01601704|101299151|FG000|STARTED|Overall Study||4456|Represents number of participants randomized|
48567304|NCT03376789|101720343|FG000|NOT COMPLETED|Overall Study||5||
48567305|NCT03376789|101720344|FG001|NOT COMPLETED|Overall Study||9||
48119492|NCT02566759|100616492|FG009|STARTED|All Parts||6||
48119493|NCT02566759|100616493|FG010|STARTED|All Parts||6||
48119494|NCT02566759|100616494|FG011|STARTED|All Parts||6||
48119495|NCT02566759|100616495|FG012|STARTED|All Parts||1||
48119496|NCT02566759|100616496|FG013|STARTED|All Parts||5||
48119497|NCT02566759|100616497|FG014|STARTED|All Parts||8||
48119498|NCT02566759|100616498|FG015|STARTED|All Parts||8||
48119499|NCT02566759|100616499|FG016|STARTED|All Parts||8||
48119500|NCT02566759|100616483|FG000|COMPLETED|All Parts||12||
48119501|NCT02566759|100616484|FG001|COMPLETED|All Parts||5||
48119502|NCT02566759|100616485|FG002|COMPLETED|All Parts||6||
48119503|NCT02566759|100616486|FG003|COMPLETED|All Parts||6||
48119504|NCT02566759|100616487|FG004|COMPLETED|All Parts||6||
48119505|NCT02566759|100616488|FG005|COMPLETED|All Parts||6||
48119506|NCT02566759|100616489|FG006|COMPLETED|All Parts||6||
48119507|NCT02566759|100616490|FG007|COMPLETED|All Parts||8||
48119508|NCT02566759|100616491|FG008|COMPLETED|All Parts||6||
48119509|NCT02566759|100616492|FG009|COMPLETED|All Parts||6||
48119510|NCT02566759|100616493|FG010|COMPLETED|All Parts||6||
48119511|NCT02566759|100616494|FG011|COMPLETED|All Parts||6||
48119512|NCT02566759|100616495|FG012|COMPLETED|All Parts||0||
48119513|NCT02566759|100616496|FG013|COMPLETED|All Parts||0||
48119514|NCT02566759|100616497|FG014|COMPLETED|All Parts||8||
48119515|NCT02566759|100616498|FG015|COMPLETED|All Parts||8||
48119516|NCT02566759|100616499|FG016|COMPLETED|All Parts||8||
48119517|NCT02566759|100616483|FG000|NOT COMPLETED|All Parts||0||
48119518|NCT02566759|100616484|FG001|NOT COMPLETED|All Parts||1||
48119519|NCT02566759|100616485|FG002|NOT COMPLETED|All Parts||0||
48119520|NCT02566759|100616486|FG003|NOT COMPLETED|All Parts||0||
48119521|NCT02566759|100616487|FG004|NOT COMPLETED|All Parts||0||
48119522|NCT02566759|100616488|FG005|NOT COMPLETED|All Parts||0||
48119523|NCT02566759|100616489|FG006|NOT COMPLETED|All Parts||0||
48119524|NCT02566759|100616490|FG007|NOT COMPLETED|All Parts||0||
48119525|NCT02566759|100616491|FG008|NOT COMPLETED|All Parts||0||
48119526|NCT02566759|100616492|FG009|NOT COMPLETED|All Parts||0||
48119527|NCT02566759|100616493|FG010|NOT COMPLETED|All Parts||0||
48119528|NCT02566759|100616494|FG011|NOT COMPLETED|All Parts||0||
48119529|NCT02566759|100616495|FG012|NOT COMPLETED|All Parts||1||
48119530|NCT02566759|100616496|FG013|NOT COMPLETED|All Parts||5||
48119531|NCT02566759|100616497|FG014|NOT COMPLETED|All Parts||0||
48119532|NCT02566759|100616498|FG015|NOT COMPLETED|All Parts||0||
48119533|NCT02566759|100616499|FG016|NOT COMPLETED|All Parts||0||
48119534|NCT02566759|100616483|FG000|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
48119535|NCT02566759|100616484|FG001|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
48119536|NCT02566759|100616485|FG002|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
48119537|NCT02566759|100616486|FG003|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
48119538|NCT02566759|100616487|FG004|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
48119539|NCT02566759|100616488|FG005|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
48119540|NCT02566759|100616489|FG006|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
48119541|NCT02566759|100616490|FG007|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
48119542|NCT02566759|100616491|FG008|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
48567306|NCT02172664|101720345|FG000|STARTED|Overall Study||33||40
48567307|NCT02172664|101720346|FG001|STARTED|Overall Study||33||41
48567308|NCT02172664|101720345|FG000|COMPLETED|Overall Study||27||35
48119543|NCT02566759|100616492|FG009|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
48119544|NCT02566759|100616493|FG010|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
48567309|NCT02172664|101720346|FG001|COMPLETED|Overall Study||27||31
48567310|NCT02172664|101720345|FG000|NOT COMPLETED|Overall Study||6||5
48567311|NCT02172664|101720346|FG001|NOT COMPLETED|Overall Study||6||10
48567312|NCT02907177|101720347|FG000|STARTED|Overall Study||68||
48119545|NCT02566759|100616494|FG011|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
48119546|NCT02566759|100616495|FG012|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
48119547|NCT02566759|100616496|FG013|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
48119548|NCT02566759|100616497|FG014|STARTED|Washout Crossover Period (Part 4:5 Days)||8||
48119549|NCT02566759|100616498|FG015|STARTED|Washout Crossover Period (Part 4:5 Days)||8||
48119550|NCT02566759|100616499|FG016|STARTED|Washout Crossover Period (Part 4:5 Days)||8||
48404092|NCT03689972|101321769|FG003|NOT COMPLETED|Part 2:Run-in Period (Week73uptoWeek107)||0||
48567313|NCT02907177|101720348|FG001|STARTED|Overall Study||68||
48567314|NCT02907177|101720347|FG000|Treated|Overall Study||67||
48567315|NCT02907177|101720348|FG001|Treated|Overall Study||68||
48567316|NCT02907177|101720347|FG000|Randomized Analysis Set|Overall Study||68||
48119551|NCT02566759|100616483|FG000|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119552|NCT02566759|100616484|FG001|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119553|NCT02566759|100616485|FG002|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119554|NCT02566759|100616486|FG003|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119555|NCT02566759|100616487|FG004|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119556|NCT02566759|100616488|FG005|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119557|NCT02566759|100616489|FG006|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119558|NCT02566759|100616490|FG007|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119559|NCT02566759|100616491|FG008|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119560|NCT02566759|100616492|FG009|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48567317|NCT02907177|101720348|FG001|Randomized Analysis Set|Overall Study||68||
48567318|NCT02907177|101720347|FG000|COMPLETED|Overall Study||0||
48119561|NCT02566759|100616493|FG010|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119562|NCT02566759|100616494|FG011|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119563|NCT02566759|100616495|FG012|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119564|NCT02566759|100616496|FG013|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119565|NCT02566759|100616497|FG014|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8||
48119566|NCT02566759|100616498|FG015|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8||
48119567|NCT02566759|100616499|FG016|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8||
48119568|NCT02566759|100616483|FG000|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119569|NCT02566759|100616484|FG001|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119570|NCT02566759|100616485|FG002|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119571|NCT02566759|100616486|FG003|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119572|NCT02566759|100616487|FG004|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119573|NCT02566759|100616488|FG005|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119574|NCT02566759|100616489|FG006|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119575|NCT02566759|100616490|FG007|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119576|NCT02566759|100616491|FG008|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119577|NCT02566759|100616492|FG009|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119578|NCT02566759|100616493|FG010|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119579|NCT02566759|100616494|FG011|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119580|NCT02566759|100616495|FG012|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119581|NCT02566759|100616496|FG013|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119582|NCT02566759|100616497|FG014|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119583|NCT02566759|100616498|FG015|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119584|NCT02566759|100616499|FG016|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119585|NCT02566759|100616483|FG000|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
48119586|NCT02566759|100616484|FG001|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
48395480|NCT01601704|101299152|FG001|STARTED|Overall Study||4454|Represents number of participants randomized|
48395481|NCT01601704|101299151|FG000|Treated|Overall Study||4455|Represents number of participants included in the ITT analysis|
48395482|NCT01601704|101299152|FG001|Treated|Overall Study||4450|Represents number of participants included in the ITT analysis|
48395483|NCT01601704|101299151|FG000|COMPLETED|Overall Study||4455|Completed indicates treated participants. Represents number of participants in the ITT analysis.|
48395484|NCT01601704|101299152|FG001|COMPLETED|Overall Study||4450|Completed indicates treated participants. Represents number of participants in the ITT analysis.|
48395485|NCT01601704|101299151|FG000|NOT COMPLETED|Overall Study||1||
48119587|NCT02566759|100616485|FG002|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
48119588|NCT02566759|100616486|FG003|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
48119589|NCT02566759|100616487|FG004|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
48119590|NCT02566759|100616488|FG005|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
48119591|NCT02566759|100616489|FG006|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
48119592|NCT02566759|100616490|FG007|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
48119593|NCT02566759|100616491|FG008|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
48119594|NCT02566759|100616492|FG009|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
48119595|NCT02566759|100616493|FG010|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
48119596|NCT02566759|100616494|FG011|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
48119597|NCT02566759|100616495|FG012|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
48119598|NCT02566759|100616496|FG013|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
48119599|NCT02566759|100616497|FG014|STARTED|Crossover Treatment (Part 4: 1 Day)||8||
48567319|NCT02907177|101720348|FG001|COMPLETED|Overall Study||0||
48567320|NCT02907177|101720347|FG000|NOT COMPLETED|Overall Study||68||
48567321|NCT02907177|101720348|FG001|NOT COMPLETED|Overall Study||68||
48567322|NCT05061693|101720349|FG000|STARTED|Overall Study||37||
48567323|NCT05061693|101720350|FG001|STARTED|Overall Study||36||
48567324|NCT05061693|101720351|FG002|STARTED|Overall Study||36||
48567325|NCT05061693|101720352|FG003|STARTED|Overall Study||37||
48567326|NCT05061693|101720349|FG000|COMPLETED|Overall Study||32||
48567327|NCT05061693|101720350|FG001|COMPLETED|Overall Study||29||
48119600|NCT02566759|100616498|FG015|STARTED|Crossover Treatment (Part 4: 1 Day)||8||
48119601|NCT02566759|100616499|FG016|STARTED|Crossover Treatment (Part 4: 1 Day)||8||
48119602|NCT02566759|100616483|FG000|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119603|NCT02566759|100616484|FG001|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48395486|NCT01601704|101299152|FG001|NOT COMPLETED|Overall Study||4||
48395487|NCT03371251|101299153|FG000|STARTED|Overall Study||7||
48395488|NCT03371251|101299154|FG001|STARTED|Overall Study||5||
48395489|NCT03371251|101299155|FG002|STARTED|Overall Study||9||
48395490|NCT03371251|101299156|FG003|STARTED|Overall Study||9||
48567328|NCT05061693|101720351|FG002|COMPLETED|Overall Study||31||
48567329|NCT05061693|101720352|FG003|COMPLETED|Overall Study||33||
48567330|NCT05061693|101720349|FG000|NOT COMPLETED|Overall Study||5||
48567331|NCT05061693|101720350|FG001|NOT COMPLETED|Overall Study||7||
48567332|NCT05061693|101720351|FG002|NOT COMPLETED|Overall Study||5||
48567333|NCT05061693|101720352|FG003|NOT COMPLETED|Overall Study||4||
48567334|NCT00302848|101720353|FG000|STARTED|Overall Study||16534||
48567335|NCT00302848|101720354|FG001|STARTED|Overall Study||15428||
48567336|NCT00302848|101720355|FG002|STARTED|Overall Study||26341||
48567337|NCT00302848|101720353|FG000|COMPLETED|Overall Study||16133||
48567338|NCT00302848|101720354|FG001|COMPLETED|Overall Study||15009||
48567339|NCT00302848|101720355|FG002|COMPLETED|Overall Study||25762||
48567340|NCT00302848|101720353|FG000|NOT COMPLETED|Overall Study||401||
48567341|NCT00302848|101720354|FG001|NOT COMPLETED|Overall Study||419||
48119604|NCT02566759|100616485|FG002|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119605|NCT02566759|100616486|FG003|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119606|NCT02566759|100616487|FG004|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119607|NCT02566759|100616488|FG005|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119608|NCT02566759|100616489|FG006|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119609|NCT02566759|100616490|FG007|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119610|NCT02566759|100616491|FG008|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119611|NCT02566759|100616492|FG009|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119612|NCT02566759|100616493|FG010|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119613|NCT02566759|100616494|FG011|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119614|NCT02566759|100616495|FG012|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119615|NCT02566759|100616496|FG013|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119616|NCT02566759|100616497|FG014|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8||
48119617|NCT02566759|100616498|FG015|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8||
48119618|NCT02566759|100616499|FG016|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7||
48119619|NCT02566759|100616483|FG000|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119620|NCT02566759|100616484|FG001|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119621|NCT02566759|100616485|FG002|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119622|NCT02566759|100616486|FG003|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119623|NCT02566759|100616487|FG004|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119624|NCT02566759|100616488|FG005|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119625|NCT02566759|100616489|FG006|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119626|NCT02566759|100616490|FG007|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119627|NCT02566759|100616491|FG008|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119628|NCT02566759|100616492|FG009|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119629|NCT02566759|100616493|FG010|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48281026|NCT02514239|101010642|FG006|STARTED|Overall Study||4||
48281027|NCT02514239|101010643|FG007|STARTED|Overall Study||3||
48281028|NCT02514239|101010644|FG008|STARTED|Overall Study||10||
48281029|NCT02514239|101010645|FG009|STARTED|Overall Study||3||
48281030|NCT02514239|101010636|FG000|Treated|Overall Study||5||
48281031|NCT02514239|101010637|FG001|Treated|Overall Study||3||
48281032|NCT02514239|101010638|FG002|Treated|Overall Study||3||
48281033|NCT02514239|101010639|FG003|Treated|Overall Study||3||
48281034|NCT02514239|101010640|FG004|Treated|Overall Study||3||
48281035|NCT02514239|101010641|FG005|Treated|Overall Study||5||
48281036|NCT02514239|101010642|FG006|Treated|Overall Study||4||
48281037|NCT02514239|101010643|FG007|Treated|Overall Study||3||
48281038|NCT02514239|101010644|FG008|Treated|Overall Study||10||
48281039|NCT02514239|101010645|FG009|Treated|Overall Study||3||
48281040|NCT02514239|101010636|FG000|COMPLETED|Overall Study||0|10 cycles completed|
48281041|NCT02514239|101010637|FG001|COMPLETED|Overall Study||0|10 cycles completed|
48281042|NCT02514239|101010638|FG002|COMPLETED|Overall Study||1|10 cycles completed|
48281043|NCT02514239|101010639|FG003|COMPLETED|Overall Study||0|10 cycles completed|
48281044|NCT02514239|101010640|FG004|COMPLETED|Overall Study||0|10 cycles completed|
48281045|NCT02514239|101010641|FG005|COMPLETED|Overall Study||1|10 cycles completed|
48281046|NCT02514239|101010642|FG006|COMPLETED|Overall Study||0|10 cycles completed|
48281047|NCT02514239|101010643|FG007|COMPLETED|Overall Study||0|10 cycles completed|
48281048|NCT02514239|101010644|FG008|COMPLETED|Overall Study||2|10 cycles completed|
48281049|NCT02514239|101010645|FG009|COMPLETED|Overall Study||0|10 cycles completed|
48281050|NCT02514239|101010636|FG000|NOT COMPLETED|Overall Study||5||
48281051|NCT02514239|101010637|FG001|NOT COMPLETED|Overall Study||4||
48281052|NCT02514239|101010638|FG002|NOT COMPLETED|Overall Study||2||
48281053|NCT02514239|101010639|FG003|NOT COMPLETED|Overall Study||3||
48281054|NCT02514239|101010640|FG004|NOT COMPLETED|Overall Study||3||
48281055|NCT02514239|101010641|FG005|NOT COMPLETED|Overall Study||4||
48281056|NCT02514239|101010642|FG006|NOT COMPLETED|Overall Study||4||
48281057|NCT02514239|101010643|FG007|NOT COMPLETED|Overall Study||3||
48281058|NCT02514239|101010644|FG008|NOT COMPLETED|Overall Study||8||
48281059|NCT02514239|101010645|FG009|NOT COMPLETED|Overall Study||3||
48281060|NCT02935660|101014065|FG000|STARTED|Overall Study||27||
48567342|NCT00302848|101720355|FG002|NOT COMPLETED|Overall Study||579||
48567343|NCT02644668|101720356|FG000|STARTED|Overall Study||26||
48281061|NCT02935660|101014065|FG000|COMPLETED|Overall Study||25||
48281062|NCT02935660|101014065|FG000|NOT COMPLETED|Overall Study||2||
48281063|NCT02643303|101014066|FG000|STARTED|Overall Study||4|Subjects who started treatment.|
48567344|NCT02644668|101720357|FG001|STARTED|Overall Study||24||
48567345|NCT02644668|101720358|FG002|STARTED|Overall Study||20||
48119630|NCT02566759|100616494|FG011|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119631|NCT02566759|100616495|FG012|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119632|NCT02566759|100616496|FG013|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119633|NCT02566759|100616497|FG014|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119634|NCT02566759|100616498|FG015|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119635|NCT02566759|100616499|FG016|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||1||
48119636|NCT02566759|100616483|FG000|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
48119637|NCT02566759|100616484|FG001|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
48119638|NCT02566759|100616485|FG002|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
48119639|NCT02566759|100616486|FG003|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
48119640|NCT02566759|100616487|FG004|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
48119641|NCT02566759|100616488|FG005|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
48119642|NCT02566759|100616489|FG006|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
48119643|NCT02566759|100616490|FG007|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
48119644|NCT02566759|100616491|FG008|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
48119645|NCT02566759|100616492|FG009|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
48119646|NCT02566759|100616493|FG010|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
48119647|NCT02566759|100616494|FG011|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
48395491|NCT03371251|101299157|FG004|STARTED|Overall Study||37||
48395492|NCT03371251|101299158|FG005|STARTED|Overall Study||76||
48395493|NCT03371251|101299153|FG000|COMPLETED|Overall Study||5||
48119648|NCT02566759|100616495|FG012|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
48119649|NCT02566759|100616496|FG013|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
48119650|NCT02566759|100616497|FG014|STARTED|Washout Crossover Period (Part 4:5 Days)||8||
48119651|NCT02566759|100616498|FG015|STARTED|Washout Crossover Period (Part 4:5 Days)||8||
48119652|NCT02566759|100616499|FG016|STARTED|Washout Crossover Period (Part 4:5 Days)||7||
48119653|NCT02566759|100616483|FG000|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119654|NCT02566759|100616484|FG001|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119655|NCT02566759|100616485|FG002|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119656|NCT02566759|100616486|FG003|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119657|NCT02566759|100616487|FG004|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119658|NCT02566759|100616488|FG005|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119659|NCT02566759|100616489|FG006|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119660|NCT02566759|100616490|FG007|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119661|NCT02566759|100616491|FG008|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119662|NCT02566759|100616492|FG009|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119663|NCT02566759|100616493|FG010|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119664|NCT02566759|100616494|FG011|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119665|NCT02566759|100616495|FG012|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119666|NCT02566759|100616496|FG013|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119667|NCT02566759|100616497|FG014|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8||
48119668|NCT02566759|100616498|FG015|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8||
48119669|NCT02566759|100616499|FG016|COMPLETED|Washout Crossover Period (Part 4:5 Days)||7||
48281064|NCT02643303|101014067|FG001|STARTED|Overall Study||5|Subjects who started treatment.|
48281065|NCT02643303|101014068|FG002|STARTED|Overall Study||1|Subjects who started treatment.|
48281066|NCT02643303|101014069|FG003|STARTED|Overall Study||15|Subjects who started treatment.|
48281067|NCT02643303|101014070|FG004|STARTED|Overall Study||7|Subjects who started treatment.|
48281068|NCT02643303|101014071|FG005|STARTED|Overall Study||4|Subjects who started treatment.|
48281069|NCT02643303|101014072|FG006|STARTED|Overall Study||10|Subjects who started treatment.|
48281070|NCT02643303|101014073|FG007|STARTED|Overall Study||3|Subjects who started treatment.|
48281071|NCT02643303|101014074|FG008|STARTED|Overall Study||7|Subjects who started treatment.|
48281072|NCT02643303|101014066|FG000|COMPLETED|Overall Study||0|Subjects who completed 12 cycles of treatment.|
48294167|NCT02527343|101047541|FG005|COMPLETED|OLE Period-Year 2: Week 105 to 156||0||
48395494|NCT03371251|101299154|FG001|COMPLETED|Overall Study||5||
48119670|NCT02566759|100616483|FG000|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119671|NCT02566759|100616484|FG001|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119672|NCT02566759|100616485|FG002|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119673|NCT02566759|100616486|FG003|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119674|NCT02566759|100616487|FG004|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119675|NCT02566759|100616488|FG005|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119676|NCT02566759|100616489|FG006|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119677|NCT02566759|100616490|FG007|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48395495|NCT03371251|101299155|FG002|COMPLETED|Overall Study||8||
48119678|NCT02566759|100616491|FG008|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119679|NCT02566759|100616492|FG009|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119680|NCT02566759|100616493|FG010|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119681|NCT02566759|100616494|FG011|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119682|NCT02566759|100616495|FG012|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119683|NCT02566759|100616496|FG013|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119684|NCT02566759|100616497|FG014|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119685|NCT02566759|100616498|FG015|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119686|NCT02566759|100616499|FG016|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
48119687|NCT02566759|100616483|FG000|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
48119688|NCT02566759|100616484|FG001|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
48119689|NCT02566759|100616485|FG002|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
48119690|NCT02566759|100616486|FG003|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
48119691|NCT02566759|100616487|FG004|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
48395496|NCT03371251|101299156|FG003|COMPLETED|Overall Study||9||
48395497|NCT03371251|101299157|FG004|COMPLETED|Overall Study||30||
48395498|NCT03371251|101299158|FG005|COMPLETED|Overall Study||71||
48395499|NCT03371251|101299153|FG000|NOT COMPLETED|Overall Study||2||
48395500|NCT03371251|101299154|FG001|NOT COMPLETED|Overall Study||0||
48395501|NCT03371251|101299155|FG002|NOT COMPLETED|Overall Study||1||
48395502|NCT03371251|101299156|FG003|NOT COMPLETED|Overall Study||0||
48395503|NCT03371251|101299157|FG004|NOT COMPLETED|Overall Study||7||
48395504|NCT03371251|101299158|FG005|NOT COMPLETED|Overall Study||5||
48395505|NCT00962754|101299159|FG000|STARTED|Overall Study||86||
48395506|NCT00962754|101299160|FG001|STARTED|Overall Study||84||
48395507|NCT00962754|101299159|FG000|COMPLETED|Overall Study||86||
48567346|NCT02644668|101720356|FG000|COMPLETED|Overall Study||24||
48567347|NCT02644668|101720357|FG001|COMPLETED|Overall Study||24||
48567348|NCT02644668|101720358|FG002|COMPLETED|Overall Study||17||
48567349|NCT02644668|101720356|FG000|NOT COMPLETED|Overall Study||2||
48567350|NCT02644668|101720357|FG001|NOT COMPLETED|Overall Study||0||
48567351|NCT02644668|101720358|FG002|NOT COMPLETED|Overall Study||3||
48567352|NCT03335475|101720359|FG000|STARTED|Overall Study||29||
48567353|NCT03335475|101720360|FG001|STARTED|Overall Study||31||
48119692|NCT02566759|100616488|FG005|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
48119693|NCT02566759|100616489|FG006|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
48119694|NCT02566759|100616490|FG007|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
48119695|NCT02566759|100616491|FG008|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
48119696|NCT02566759|100616492|FG009|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
48119697|NCT02566759|100616493|FG010|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
48119698|NCT02566759|100616494|FG011|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
48119699|NCT02566759|100616495|FG012|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
48119700|NCT02566759|100616496|FG013|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
48119701|NCT02566759|100616497|FG014|STARTED|Crossover Treatment (Part 4: 1 Day)||8||
48119702|NCT02566759|100616498|FG015|STARTED|Crossover Treatment (Part 4: 1 Day)||8||
48119703|NCT02566759|100616499|FG016|STARTED|Crossover Treatment (Part 4: 1 Day)||7||
48119704|NCT02566759|100616483|FG000|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48395508|NCT00962754|101299160|FG001|COMPLETED|Overall Study||84||
48395509|NCT00962754|101299159|FG000|NOT COMPLETED|Overall Study||0||
48395510|NCT00962754|101299160|FG001|NOT COMPLETED|Overall Study||0||
48395511|NCT04401904|101299161|FG000|STARTED|Overall Study||10||
48395512|NCT04401904|101299162|FG001|STARTED|Overall Study||10||
48395513|NCT04401904|101299161|FG000|COMPLETED|Overall Study||10||
48395514|NCT04401904|101299162|FG001|COMPLETED|Overall Study||10||
48395515|NCT04401904|101299161|FG000|NOT COMPLETED|Overall Study||0||
48395516|NCT04401904|101299162|FG001|NOT COMPLETED|Overall Study||0||
48395517|NCT03406715|101299163|FG000|STARTED|Overall Study||14||
48395518|NCT03406715|101299163|FG000|COMPLETED|Overall Study||14||
48395519|NCT03406715|101299163|FG000|NOT COMPLETED|Overall Study||0||
48395520|NCT00807014|101299164|FG000|STARTED|Overall Study||83||
48395521|NCT00807014|101299165|FG001|STARTED|Overall Study||85||
48567354|NCT03335475|101720359|FG000|COMPLETED|Overall Study||25||
48567355|NCT03335475|101720360|FG001|COMPLETED|Overall Study||30||
48567356|NCT03335475|101720359|FG000|NOT COMPLETED|Overall Study||4||
48119705|NCT02566759|100616484|FG001|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119706|NCT02566759|100616485|FG002|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119707|NCT02566759|100616486|FG003|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119708|NCT02566759|100616487|FG004|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119709|NCT02566759|100616488|FG005|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119710|NCT02566759|100616489|FG006|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119711|NCT02566759|100616490|FG007|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119712|NCT02566759|100616491|FG008|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119713|NCT02566759|100616492|FG009|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48395522|NCT00807014|101299164|FG000|COMPLETED|Overall Study||56||
48567357|NCT03335475|101720360|FG001|NOT COMPLETED|Overall Study||1||
48567358|NCT03187730|101720361|FG000|STARTED|Overall Study||208||
48567359|NCT03187730|101720362|FG001|STARTED|Overall Study||202||
48119714|NCT02566759|100616493|FG010|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119715|NCT02566759|100616494|FG011|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119716|NCT02566759|100616495|FG012|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119717|NCT02566759|100616496|FG013|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119718|NCT02566759|100616497|FG014|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8||
48119719|NCT02566759|100616498|FG015|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8||
48119720|NCT02566759|100616499|FG016|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7||
48119721|NCT02566759|100616483|FG000|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119722|NCT02566759|100616484|FG001|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119723|NCT02566759|100616485|FG002|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119724|NCT02566759|100616486|FG003|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119725|NCT02566759|100616487|FG004|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119726|NCT02566759|100616488|FG005|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119727|NCT02566759|100616489|FG006|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119728|NCT02566759|100616490|FG007|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119729|NCT02566759|100616491|FG008|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119730|NCT02566759|100616492|FG009|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119731|NCT02566759|100616493|FG010|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119732|NCT02566759|100616494|FG011|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119733|NCT02566759|100616495|FG012|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119734|NCT02566759|100616496|FG013|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119735|NCT02566759|100616497|FG014|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119736|NCT02566759|100616498|FG015|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119737|NCT02566759|100616499|FG016|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
48119738|NCT00978731|100616500|FG000|STARTED|Overall Study||22||
48119739|NCT00978731|100616501|FG001|STARTED|Overall Study||15||
48119740|NCT00978731|100616502|FG002|STARTED|Overall Study||5||
48119741|NCT00978731|100616503|FG003|STARTED|Overall Study||4||
48119742|NCT00978731|100616500|FG000|COMPLETED|Overall Study||0||
48119743|NCT00978731|100616501|FG001|COMPLETED|Overall Study||0||
48119744|NCT00978731|100616502|FG002|COMPLETED|Overall Study||0||
48119745|NCT00978731|100616503|FG003|COMPLETED|Overall Study||0||
48119746|NCT00978731|100616500|FG000|NOT COMPLETED|Overall Study||22||
48119747|NCT00978731|100616501|FG001|NOT COMPLETED|Overall Study||15||
48119748|NCT00978731|100616502|FG002|NOT COMPLETED|Overall Study||5||
48119749|NCT00978731|100616503|FG003|NOT COMPLETED|Overall Study||4||
48119750|NCT00236938|100616504|FG000|STARTED|Overall Study||75||
48119751|NCT00236938|100616505|FG001|STARTED|Overall Study||46||
48119752|NCT00236938|100616504|FG000|COMPLETED|Overall Study||62||
48119753|NCT00236938|100616505|FG001|COMPLETED|Overall Study||26||
48395523|NCT00807014|101299165|FG001|COMPLETED|Overall Study||58||
48395524|NCT00807014|101299164|FG000|NOT COMPLETED|Overall Study||27||
48395525|NCT00807014|101299165|FG001|NOT COMPLETED|Overall Study||27||
48395526|NCT01263093|101299166|FG000|STARTED|Period 1||24||
48395527|NCT01263093|101299167|FG001|STARTED|Period 1||23||
48395528|NCT01263093|101299166|FG000|COMPLETED|Period 1||24||
48395529|NCT01263093|101299167|FG001|COMPLETED|Period 1||23||
48395530|NCT01263093|101299166|FG000|NOT COMPLETED|Period 1||0||
48395531|NCT01263093|101299167|FG001|NOT COMPLETED|Period 1||0||
48395532|NCT01263093|101299166|FG000|STARTED|Washout||24||
48395533|NCT01263093|101299167|FG001|STARTED|Washout||23||
48395534|NCT01263093|101299166|FG000|COMPLETED|Washout||23||
48395535|NCT01263093|101299167|FG001|COMPLETED|Washout||23||
48395536|NCT01263093|101299166|FG000|NOT COMPLETED|Washout||1||
48395537|NCT01263093|101299167|FG001|NOT COMPLETED|Washout||0||
48395538|NCT01263093|101299166|FG000|STARTED|Period 2||23||
48395539|NCT01263093|101299167|FG001|STARTED|Period 2||23||
48395540|NCT01263093|101299166|FG000|COMPLETED|Period 2||22||
48395541|NCT01263093|101299167|FG001|COMPLETED|Period 2||23||
48395542|NCT01263093|101299166|FG000|NOT COMPLETED|Period 2||1||
48395543|NCT01263093|101299167|FG001|NOT COMPLETED|Period 2||0||
48395544|NCT00994162|101299168|FG000|STARTED|Overall Study||153||
48395545|NCT00994162|101299168|FG000|Participants Receiving Treatment|Overall Study||152||
48395546|NCT00994162|101299168|FG000|COMPLETED|Overall Study||125||
48395547|NCT00994162|101299168|FG000|NOT COMPLETED|Overall Study||28||
48395548|NCT02174861|101299169|FG000|STARTED|Overall Study||609||
48119754|NCT00236938|100616504|FG000|NOT COMPLETED|Overall Study||13||
48119755|NCT00236938|100616505|FG001|NOT COMPLETED|Overall Study||20||
48119756|NCT01485601|100616506|FG000|STARTED|Overall Study||31||
48119757|NCT01485601|100616507|FG001|STARTED|Overall Study||31||
48119758|NCT01485601|100616508|FG002|STARTED|Overall Study||27||
48119759|NCT01485601|100616509|FG003|STARTED|Overall Study||32||
48119760|NCT01485601|100616506|FG000|COMPLETED|Overall Study||28||
48119761|NCT01485601|100616507|FG001|COMPLETED|Overall Study||23||
48119762|NCT01485601|100616508|FG002|COMPLETED|Overall Study||25||
48119763|NCT01485601|100616509|FG003|COMPLETED|Overall Study||26||
48119764|NCT01485601|100616506|FG000|NOT COMPLETED|Overall Study||3||
48119765|NCT01485601|100616507|FG001|NOT COMPLETED|Overall Study||8||
48395549|NCT02174861|101299169|FG000|Enrolled in CHU Substudy|Overall Study||53||
48395550|NCT02174861|101299169|FG000|COMPLETED|Overall Study||451||
48395551|NCT02174861|101299169|FG000|NOT COMPLETED|Overall Study||158||
48119766|NCT01485601|100616508|FG002|NOT COMPLETED|Overall Study||2||
48119767|NCT01485601|100616509|FG003|NOT COMPLETED|Overall Study||6||
48119768|NCT00529386|100616510|FG000|STARTED|Overall Study||7||
48119769|NCT00529386|100616510|FG000|COMPLETED|Overall Study||6||
48119770|NCT00529386|100616510|FG000|NOT COMPLETED|Overall Study||1||
48119771|NCT02665728|100616511|FG000|STARTED|Overall Study||33||
48119772|NCT02665728|100616511|FG000|COMPLETED|Overall Study||33||
48119773|NCT02665728|100616511|FG000|NOT COMPLETED|Overall Study||0||
48119774|NCT04805983|100616512|FG000|STARTED|Overall Study||6||
48119775|NCT04805983|100616513|FG001|STARTED|Overall Study||6||
48119776|NCT04805983|100616514|FG002|STARTED|Overall Study||6||
48119777|NCT04805983|100616515|FG003|STARTED|Overall Study||6||
48119778|NCT04805983|100616516|FG004|STARTED|Overall Study||6||
48119779|NCT04805983|100616517|FG005|STARTED|Overall Study||6||
48567360|NCT03187730|101720361|FG000|COMPLETED|Overall Study||129||
48567361|NCT03187730|101720362|FG001|COMPLETED|Overall Study||154||
48567362|NCT03187730|101720361|FG000|NOT COMPLETED|Overall Study||79||
48567363|NCT03187730|101720362|FG001|NOT COMPLETED|Overall Study||48||
48567364|NCT03308097|101720363|FG000|STARTED|Overall Study||33||
48567365|NCT03308097|101720364|FG001|STARTED|Overall Study||32||
48567366|NCT03308097|101720363|FG000|COMPLETED|Overall Study||31||
48567367|NCT03308097|101720364|FG001|COMPLETED|Overall Study||31||
48567368|NCT03308097|101720363|FG000|NOT COMPLETED|Overall Study||2||
48567369|NCT03308097|101720364|FG001|NOT COMPLETED|Overall Study||1||
48567370|NCT00782626|101720365|FG000|STARTED|Overall Study||23||
48567371|NCT00782626|101720365|FG000|COMPLETED|Overall Study||16||
48567372|NCT00782626|101720365|FG000|NOT COMPLETED|Overall Study||7||
48567373|NCT03889418|101720366|FG000|STARTED|April-June 2019 (Months 0-3)||48|\[EMR-CDS with CCM\] participants started enrollment in region 1 in period 1. In Region 2, 3, 4 \& 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48567374|NCT03889418|101720367|FG001|STARTED|April-June 2019 (Months 0-3)||10|\[EMR-CDS with CCM\] participants started enrollment in region 1 in period 1. In Region 2, 3, 4 \& 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48567375|NCT03889418|101720368|FG002|STARTED|April-June 2019 (Months 0-3)||21|\[EMR-CDS with CCM\] participants started enrollment in region 1 in period 1. In Region 2, 3, 4 \& 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48567376|NCT03889418|101720369|FG003|STARTED|April-June 2019 (Months 0-3)||0|\[EMR-CDS with CCM\] participants started enrollment in region 1 in period 1. In Region 2, 3, 4 \& 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|0
48567377|NCT03889418|101720370|FG004|STARTED|April-June 2019 (Months 0-3)||14|\[EMR-CDS with CCM\] participants started enrollment in region 1 in period 1. In Region 2, 3, 4 \& 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48567378|NCT03889418|101720371|FG005|STARTED|April-June 2019 (Months 0-3)||0|\[EMR-CDS with CCM\] participants started enrollment in region 1 in period 1. In Region 2, 3, 4 \& 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|0
48567379|NCT03889418|101720372|FG006|STARTED|April-June 2019 (Months 0-3)||10|\[EMR-CDS with CCM\] participants started enrollment in region 1 in period 1. In Region 2, 3, 4 \& 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48567380|NCT03889418|101720373|FG007|STARTED|April-June 2019 (Months 0-3)||0|\[EMR-CDS with CCM\] participants started enrollment in region 1 in period 1. In Region 2, 3, 4 \& 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|0
48567381|NCT03889418|101720374|FG008|STARTED|April-June 2019 (Months 0-3)||12|\[EMR-CDS with CCM\] participants started enrollment in region 1 in period 1. In Region 2, 3, 4 \& 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48567382|NCT03889418|101720375|FG009|STARTED|April-June 2019 (Months 0-3)||0|\[EMR-CDS with CCM\] participants started enrollment in region 1 in period 1. In Region 2, 3, 4 \& 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|0
48567383|NCT03889418|101720366|FG000|COMPLETED|April-June 2019 (Months 0-3)||47||1
48567384|NCT03889418|101720367|FG001|COMPLETED|April-June 2019 (Months 0-3)||10||1
48567385|NCT03889418|101720368|FG002|COMPLETED|April-June 2019 (Months 0-3)||21||1
48567386|NCT03889418|101720369|FG003|COMPLETED|April-June 2019 (Months 0-3)||0||0
48567387|NCT03889418|101720370|FG004|COMPLETED|April-June 2019 (Months 0-3)||14||1
48567388|NCT03889418|101720371|FG005|COMPLETED|April-June 2019 (Months 0-3)||0||0
48119780|NCT04805983|100616512|FG000|Completed Baseline (Study Day 1)|Overall Study||6||
48119781|NCT04805983|100616513|FG001|Completed Baseline (Study Day 1)|Overall Study||6||
48119782|NCT04805983|100616514|FG002|Completed Baseline (Study Day 1)|Overall Study||6||
48119783|NCT04805983|100616515|FG003|Completed Baseline (Study Day 1)|Overall Study||6||
48119784|NCT04805983|100616516|FG004|Completed Baseline (Study Day 1)|Overall Study||6||
48395552|NCT00158223|101299170|FG000|STARTED|Overall Study||28||
48395553|NCT00158223|101299171|FG001|STARTED|Overall Study||25||
48567389|NCT03889418|101720372|FG006|COMPLETED|April-June 2019 (Months 0-3)||10||1
48567390|NCT03889418|101720373|FG007|COMPLETED|April-June 2019 (Months 0-3)||0||0
48567391|NCT03889418|101720374|FG008|COMPLETED|April-June 2019 (Months 0-3)||12||1
48567392|NCT03889418|101720375|FG009|COMPLETED|April-June 2019 (Months 0-3)||0||0
48567393|NCT03889418|101720366|FG000|NOT COMPLETED|April-June 2019 (Months 0-3)||1||0
48281073|NCT02643303|101014067|FG001|COMPLETED|Overall Study||0|Subjects who completed 12 cycles of treatment.|
48281074|NCT02643303|101014068|FG002|COMPLETED|Overall Study||0|Subjects who completed 12 cycles of treatment.|
48281075|NCT02643303|101014069|FG003|COMPLETED|Overall Study||2|Subjects who completed 12 cycles of treatment.|
48395554|NCT00158223|101299170|FG000|COMPLETED|Overall Study||23||
48395555|NCT00158223|101299171|FG001|COMPLETED|Overall Study||22||
48395556|NCT00158223|101299170|FG000|NOT COMPLETED|Overall Study||5||
48395557|NCT00158223|101299171|FG001|NOT COMPLETED|Overall Study||3||
48395558|NCT00415519|101299172|FG000|STARTED|Overall Study||13||
48395559|NCT00415519|101299173|FG001|STARTED|Overall Study||12||
48395560|NCT00415519|101299172|FG000|COMPLETED|Overall Study||9||
48395561|NCT00415519|101299173|FG001|COMPLETED|Overall Study||12||
48395562|NCT00415519|101299172|FG000|NOT COMPLETED|Overall Study||4||
48395563|NCT00415519|101299173|FG001|NOT COMPLETED|Overall Study||0||
48395564|NCT02375984|101299174|FG000|STARTED|Overall Study||1||
48395565|NCT02375984|101299174|FG000|COMPLETED|Overall Study||1||
48395566|NCT02375984|101299174|FG000|NOT COMPLETED|Overall Study||0||
48567394|NCT03889418|101720367|FG001|NOT COMPLETED|April-June 2019 (Months 0-3)||0||0
48567395|NCT03889418|101720368|FG002|NOT COMPLETED|April-June 2019 (Months 0-3)||0||0
48567396|NCT03889418|101720369|FG003|NOT COMPLETED|April-June 2019 (Months 0-3)||0||0
48567397|NCT03889418|101720370|FG004|NOT COMPLETED|April-June 2019 (Months 0-3)||0||0
48567398|NCT03889418|101720371|FG005|NOT COMPLETED|April-June 2019 (Months 0-3)||0||0
48567399|NCT03889418|101720372|FG006|NOT COMPLETED|April-June 2019 (Months 0-3)||0||0
48567400|NCT03889418|101720373|FG007|NOT COMPLETED|April-June 2019 (Months 0-3)||0||0
48567401|NCT03889418|101720374|FG008|NOT COMPLETED|April-June 2019 (Months 0-3)||0||0
48567402|NCT03889418|101720375|FG009|NOT COMPLETED|April-June 2019 (Months 0-3)||0||0
48567403|NCT03889418|101720366|FG000|STARTED|July-September 2019 (Months 4-6)||54|\[EMR-CDS with CCM\] participants started enrollment in region 2 in period 2. In Region 3, 4 \& 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48567404|NCT03889418|101720367|FG001|STARTED|July-September 2019 (Months 4-6)||20|\[EMR-CDS with CCM\] participants started enrollment in region 2 in period 2. In Region 3, 4 \& 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48567405|NCT03889418|101720368|FG002|STARTED|July-September 2019 (Months 4-6)||23|\[EMR-CDS with CCM\] participants started enrollment in region 2 in period 2. In Region 3, 4 \& 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48567406|NCT03889418|101720369|FG003|STARTED|July-September 2019 (Months 4-6)||2|\[EMR-CDS with CCM\] participants started enrollment in region 2 in period 2. In Region 3, 4 \& 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48281076|NCT02643303|101014070|FG004|COMPLETED|Overall Study||0|Subjects who completed 12 cycles of treatment.|
48281077|NCT02643303|101014071|FG005|COMPLETED|Overall Study||0|Subjects who completed 12 cycles of treatment.|
48281078|NCT02643303|101014072|FG006|COMPLETED|Overall Study||1|Subjects who completed 12 cycles of treatment.|
48281079|NCT02643303|101014073|FG007|COMPLETED|Overall Study||0|Subjects who completed 12 cycles of treatment.|
48281080|NCT02643303|101014074|FG008|COMPLETED|Overall Study||0|Subjects who completed 12 cycles of treatment.|
48281081|NCT02643303|101014066|FG000|NOT COMPLETED|Overall Study||4||
48281082|NCT02643303|101014067|FG001|NOT COMPLETED|Overall Study||5||
48281083|NCT02643303|101014068|FG002|NOT COMPLETED|Overall Study||1||
48395567|NCT01147406|101299175|FG000|STARTED|Overall Study||6||
48395568|NCT01147406|101299176|FG001|STARTED|Overall Study||12||
48395569|NCT01147406|101299177|FG002|STARTED|Overall Study||1||
48395570|NCT01147406|101299178|FG003|STARTED|Overall Study||6||
48395571|NCT01147406|101299179|FG004|STARTED|Overall Study||6||
48395572|NCT01147406|101299180|FG005|STARTED|Overall Study||10||
48395573|NCT01147406|101299175|FG000|COMPLETED|Overall Study||6||
48395574|NCT01147406|101299176|FG001|COMPLETED|Overall Study||12||
48395575|NCT01147406|101299177|FG002|COMPLETED|Overall Study||1||
48395576|NCT01147406|101299178|FG003|COMPLETED|Overall Study||6||
48395577|NCT01147406|101299179|FG004|COMPLETED|Overall Study||6||
48395578|NCT01147406|101299180|FG005|COMPLETED|Overall Study||10||
48395579|NCT01147406|101299175|FG000|NOT COMPLETED|Overall Study||0||
48395580|NCT01147406|101299176|FG001|NOT COMPLETED|Overall Study||0||
48395581|NCT01147406|101299177|FG002|NOT COMPLETED|Overall Study||0||
48395582|NCT01147406|101299178|FG003|NOT COMPLETED|Overall Study||0||
48395583|NCT01147406|101299179|FG004|NOT COMPLETED|Overall Study||0||
48395584|NCT01147406|101299180|FG005|NOT COMPLETED|Overall Study||0||
48395585|NCT01269047|101299181|FG000|STARTED|Overall Study||13||
48395586|NCT01269047|101299182|FG001|STARTED|Overall Study||13||
48395587|NCT01269047|101299183|FG002|STARTED|Overall Study||11||
48395588|NCT01269047|101299181|FG000|COMPLETED|Overall Study||12||
48395589|NCT01269047|101299182|FG001|COMPLETED|Overall Study||11||
48395590|NCT01269047|101299183|FG002|COMPLETED|Overall Study||10||
48395591|NCT01269047|101299181|FG000|NOT COMPLETED|Overall Study||1||
48395592|NCT01269047|101299182|FG001|NOT COMPLETED|Overall Study||2||
48395593|NCT01269047|101299183|FG002|NOT COMPLETED|Overall Study||1||
48395594|NCT00436982|101299184|FG000|STARTED|Overall Study||30||
48395595|NCT00436982|101299185|FG001|STARTED|Overall Study||30||
48395596|NCT00436982|101299184|FG000|COMPLETED|Overall Study||26|Completed/Not completed counts based on participants status at the 2 year primary outcome interval|
48281084|NCT02643303|101014069|FG003|NOT COMPLETED|Overall Study||13||
48281085|NCT02643303|101014070|FG004|NOT COMPLETED|Overall Study||7||
48281086|NCT02643303|101014071|FG005|NOT COMPLETED|Overall Study||4||
48281087|NCT02643303|101014072|FG006|NOT COMPLETED|Overall Study||9||
48281088|NCT02643303|101014073|FG007|NOT COMPLETED|Overall Study||3||
48281089|NCT02643303|101014074|FG008|NOT COMPLETED|Overall Study||7||
48395597|NCT00436982|101299185|FG001|COMPLETED|Overall Study||26|Completed/Not completed counts based on participants status at the 2 year primary outcome interval|
48395598|NCT00436982|101299184|FG000|NOT COMPLETED|Overall Study||4||
48567407|NCT03889418|101720370|FG004|STARTED|July-September 2019 (Months 4-6)||16|\[EMR-CDS with CCM\] participants started enrollment in region 2 in period 2. In Region 3, 4 \& 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48567408|NCT03889418|101720371|FG005|STARTED|July-September 2019 (Months 4-6)||1|\[EMR-CDS with CCM\] participants started enrollment in region 2 in period 2. In Region 3, 4 \& 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|0
48281090|NCT04540887|101014075|FG000|STARTED|Overall Study||10||
48281091|NCT04540887|101014075|FG000|COMPLETED|Overall Study||8||
48281092|NCT04540887|101014075|FG000|NOT COMPLETED|Overall Study||2||
48281093|NCT03014011|101014076|FG000|STARTED|First Intervention||14|Participants randomized and started intervention visit|
48281094|NCT03014011|101014077|FG001|STARTED|First Intervention||13|Participants randomized and started intervention visit|
48281095|NCT03014011|101014076|FG000|COMPLETED|First Intervention||13|Participants who completed the intervention visit|
48281096|NCT03014011|101014077|FG001|COMPLETED|First Intervention||13|Participants who completed the intervention visit|
48281097|NCT03014011|101014076|FG000|NOT COMPLETED|First Intervention||1||
48281098|NCT03014011|101014077|FG001|NOT COMPLETED|First Intervention||0||
48281099|NCT03014011|101014076|FG000|STARTED|Washout||13|started intervention visit|
48281100|NCT03014011|101014077|FG001|STARTED|Washout||13|started intervention visit|
48281101|NCT03014011|101014076|FG000|COMPLETED|Washout||12||
48281102|NCT03014011|101014077|FG001|COMPLETED|Washout||13||
48281103|NCT03014011|101014076|FG000|NOT COMPLETED|Washout||1||
48281104|NCT03014011|101014077|FG001|NOT COMPLETED|Washout||0||
48281105|NCT03014011|101014076|FG000|STARTED|Second Intervention||12||
48281106|NCT03014011|101014077|FG001|STARTED|Second Intervention||13||
48281107|NCT03014011|101014076|FG000|COMPLETED|Second Intervention||12|completed intervention visit|
48567409|NCT03889418|101720372|FG006|STARTED|July-September 2019 (Months 4-6)||10|\[EMR-CDS with CCM\] participants started enrollment in region 2 in period 2. In Region 3, 4 \& 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48698943|NCT03582553|102050412|FG001|NOT COMPLETED|Washout Period (At Least 1 Week)||0||
48698944|NCT03582553|102050413|FG002|NOT COMPLETED|Washout Period (At Least 1 Week)||0||
48698945|NCT03582553|102050414|FG003|NOT COMPLETED|Washout Period (At Least 1 Week)||0||
48698946|NCT03582553|102050415|FG004|NOT COMPLETED|Washout Period (At Least 1 Week)||0||
48281108|NCT03014011|101014077|FG001|COMPLETED|Second Intervention||13|completed intervention visit|
48698947|NCT03582553|102050416|FG005|NOT COMPLETED|Washout Period (At Least 1 Week)||0||
48698948|NCT03582553|102050411|FG000|STARTED|Intervention 3/Visit 3||3||
48698949|NCT03582553|102050412|FG001|STARTED|Intervention 3/Visit 3||3||
48698950|NCT03582553|102050413|FG002|STARTED|Intervention 3/Visit 3||3||
48698951|NCT03582553|102050414|FG003|STARTED|Intervention 3/Visit 3||3||
48698952|NCT03582553|102050415|FG004|STARTED|Intervention 3/Visit 3||3||
48698953|NCT03582553|102050416|FG005|STARTED|Intervention 3/Visit 3||3||
48698954|NCT03582553|102050411|FG000|COMPLETED|Intervention 3/Visit 3||3||
48281109|NCT03014011|101014076|FG000|NOT COMPLETED|Second Intervention||0||
48395599|NCT00436982|101299185|FG001|NOT COMPLETED|Overall Study||4||
48395600|NCT01937624|101299186|FG000|STARTED|Overall Study||51||
48395601|NCT01937624|101299186|FG000|COMPLETED|Overall Study||51||
48395602|NCT01937624|101299186|FG000|NOT COMPLETED|Overall Study||0||
48395603|NCT01495923|101299187|FG000|STARTED|Overall Study||73||
48395604|NCT01495923|101299188|FG001|STARTED|Overall Study||72||
48395605|NCT01495923|101299187|FG000|COMPLETED|Overall Study||73||
48395606|NCT01495923|101299188|FG001|COMPLETED|Overall Study||72||
48698955|NCT03582553|102050412|FG001|COMPLETED|Intervention 3/Visit 3||3||
48698956|NCT03582553|102050413|FG002|COMPLETED|Intervention 3/Visit 3||3||
48698957|NCT03582553|102050414|FG003|COMPLETED|Intervention 3/Visit 3||3||
48698958|NCT03582553|102050415|FG004|COMPLETED|Intervention 3/Visit 3||3||
48698959|NCT03582553|102050416|FG005|COMPLETED|Intervention 3/Visit 3||3||
48698960|NCT03582553|102050411|FG000|NOT COMPLETED|Intervention 3/Visit 3||0||
48281110|NCT03014011|101014077|FG001|NOT COMPLETED|Second Intervention||0||
48395607|NCT01495923|101299187|FG000|NOT COMPLETED|Overall Study||0||
48395608|NCT01495923|101299188|FG001|NOT COMPLETED|Overall Study||0||
48567410|NCT03889418|101720373|FG007|STARTED|July-September 2019 (Months 4-6)||0|\[EMR-CDS with CCM\] participants started enrollment in region 2 in period 2. In Region 3, 4 \& 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|0
48567411|NCT03889418|101720374|FG008|STARTED|July-September 2019 (Months 4-6)||13|\[EMR-CDS with CCM\] participants started enrollment in region 2 in period 2. In Region 3, 4 \& 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48698961|NCT03582553|102050412|FG001|NOT COMPLETED|Intervention 3/Visit 3||0||
48698962|NCT03582553|102050413|FG002|NOT COMPLETED|Intervention 3/Visit 3||0||
48698963|NCT03582553|102050414|FG003|NOT COMPLETED|Intervention 3/Visit 3||0||
48698964|NCT03582553|102050415|FG004|NOT COMPLETED|Intervention 3/Visit 3||0||
48567412|NCT03889418|101720375|FG009|STARTED|July-September 2019 (Months 4-6)||0|\[EMR-CDS with CCM\] participants started enrollment in region 2 in period 2. In Region 3, 4 \& 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|0
48567413|NCT03889418|101720366|FG000|COMPLETED|July-September 2019 (Months 4-6)||54||1
48567414|NCT03889418|101720367|FG001|COMPLETED|July-September 2019 (Months 4-6)||19||1
48567415|NCT03889418|101720368|FG002|COMPLETED|July-September 2019 (Months 4-6)||22||1
48567416|NCT03889418|101720369|FG003|COMPLETED|July-September 2019 (Months 4-6)||2||1
48567417|NCT03889418|101720370|FG004|COMPLETED|July-September 2019 (Months 4-6)||16||1
48567418|NCT03889418|101720371|FG005|COMPLETED|July-September 2019 (Months 4-6)||1||0
48567419|NCT03889418|101720372|FG006|COMPLETED|July-September 2019 (Months 4-6)||10||1
48567420|NCT03889418|101720373|FG007|COMPLETED|July-September 2019 (Months 4-6)||0||0
48698965|NCT03582553|102050416|FG005|NOT COMPLETED|Intervention 3/Visit 3||0||
48698966|NCT03061721|102050417|FG000|STARTED|Overall Study||26||
48698967|NCT03061721|102050418|FG001|STARTED|Overall Study||25||
48698968|NCT03061721|102050419|FG002|STARTED|Overall Study||27||
48698969|NCT03061721|102050420|FG003|STARTED|Overall Study||28||
48698970|NCT03061721|102050417|FG000|COMPLETED|Overall Study||26||
48698971|NCT03061721|102050418|FG001|COMPLETED|Overall Study||20||
48698972|NCT03061721|102050419|FG002|COMPLETED|Overall Study||27||
48567421|NCT03889418|101720374|FG008|COMPLETED|July-September 2019 (Months 4-6)||13||1
48567422|NCT03889418|101720375|FG009|COMPLETED|July-September 2019 (Months 4-6)||0||0
48567423|NCT03889418|101720366|FG000|NOT COMPLETED|July-September 2019 (Months 4-6)||0||0
48567424|NCT03889418|101720367|FG001|NOT COMPLETED|July-September 2019 (Months 4-6)||1||0
48567425|NCT03889418|101720368|FG002|NOT COMPLETED|July-September 2019 (Months 4-6)||1||0
48567426|NCT03889418|101720369|FG003|NOT COMPLETED|July-September 2019 (Months 4-6)||0||0
48567427|NCT03889418|101720370|FG004|NOT COMPLETED|July-September 2019 (Months 4-6)||0||0
48567428|NCT03889418|101720371|FG005|NOT COMPLETED|July-September 2019 (Months 4-6)||0||0
48567429|NCT03889418|101720372|FG006|NOT COMPLETED|July-September 2019 (Months 4-6)||0||0
48567430|NCT03889418|101720373|FG007|NOT COMPLETED|July-September 2019 (Months 4-6)||0||0
48567431|NCT03889418|101720374|FG008|NOT COMPLETED|July-September 2019 (Months 4-6)||0||0
48567432|NCT03889418|101720375|FG009|NOT COMPLETED|July-September 2019 (Months 4-6)||0||0
48567433|NCT03889418|101720366|FG000|STARTED|October-December 2019 (Month 7-9)||60|\[EMR-CDS with CCM\] participants started enrollment in region 3 in period 3. In Regions 4 \& 5, EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48567434|NCT03889418|101720367|FG001|STARTED|October-December 2019 (Month 7-9)||36|\[EMR-CDS with CCM\] participants started enrollment in region 3 in period 3. In Regions 4 \& 5, EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48567435|NCT03889418|101720368|FG002|STARTED|October-December 2019 (Month 7-9)||28|\[EMR-CDS with CCM\] participants started enrollment in region 3 in period 3. In Regions 4 \& 5, EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48592783|NCT02847182|101783181|FG001|First Intervention (6 Months)|Overall Study||61||
48592784|NCT02847182|101783180|FG000|Second Intervention (6 Months)|Overall Study||61||
48698973|NCT03061721|102050420|FG003|COMPLETED|Overall Study||25||
48698974|NCT03061721|102050417|FG000|NOT COMPLETED|Overall Study||0||
48698975|NCT03061721|102050418|FG001|NOT COMPLETED|Overall Study||5||
48698976|NCT03061721|102050419|FG002|NOT COMPLETED|Overall Study||0||
48698977|NCT03061721|102050420|FG003|NOT COMPLETED|Overall Study||3||
48698978|NCT00066222|102050421|FG000|STARTED|Overall Study||72||
48698979|NCT00066222|102050421|FG000|COMPLETED|Overall Study||71||
48698980|NCT00066222|102050421|FG000|NOT COMPLETED|Overall Study||1||
48698981|NCT01180036|102050422|FG000|STARTED|Overall Study||65||
48698982|NCT01180036|102050423|FG001|STARTED|Overall Study||65||
48698983|NCT01180036|102050422|FG000|COMPLETED|Overall Study||65||
48698984|NCT01180036|102050423|FG001|COMPLETED|Overall Study||65||
48698985|NCT01180036|102050422|FG000|NOT COMPLETED|Overall Study||0||
48698986|NCT01180036|102050423|FG001|NOT COMPLETED|Overall Study||0||
48698987|NCT02141399|102050424|FG000|STARTED|Overall Study||1485||
48698988|NCT02141399|102050424|FG000|COMPLETED|Overall Study||741||
48698989|NCT02141399|102050424|FG000|NOT COMPLETED|Overall Study||744||
48698990|NCT04600505|102050425|FG000|STARTED|Overall Study||8||
48698991|NCT04600505|102050426|FG001|STARTED|Overall Study||8||
48698992|NCT04600505|102050427|FG002|STARTED|Overall Study||8||
48567436|NCT03889418|101720369|FG003|STARTED|October-December 2019 (Month 7-9)||11|\[EMR-CDS with CCM\] participants started enrollment in region 3 in period 3. In Regions 4 \& 5, EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48567437|NCT03889418|101720370|FG004|STARTED|October-December 2019 (Month 7-9)||16|\[EMR-CDS with CCM\] participants started enrollment in region 3 in period 3. In Regions 4 \& 5, EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48567438|NCT03889418|101720371|FG005|STARTED|October-December 2019 (Month 7-9)||1|\[EMR-CDS with CCM\] participants started enrollment in region 3 in period 3. In Regions 4 \& 5, EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48567439|NCT03889418|101720372|FG006|STARTED|October-December 2019 (Month 7-9)||12|\[EMR-CDS with CCM\] participants started enrollment in region 3 in period 3. In Regions 4 \& 5, EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48592785|NCT02847182|101783181|FG001|Second Intervention (6 Months)|Overall Study||119||
48592786|NCT02847182|101783180|FG000|COMPLETED|Overall Study||119||
48592787|NCT02847182|101783181|FG001|COMPLETED|Overall Study||60||
48395609|NCT04169113|101299189|FG000|STARTED|Overall Study||52||
48395610|NCT04169113|101299190|FG001|STARTED|Overall Study||59||
48395611|NCT04169113|101299189|FG000|COMPLETED|Overall Study||47||
48395612|NCT04169113|101299190|FG001|COMPLETED|Overall Study||53||
48395613|NCT04169113|101299189|FG000|NOT COMPLETED|Overall Study||5||
48395614|NCT04169113|101299190|FG001|NOT COMPLETED|Overall Study||6||
48395615|NCT02513771|101299191|FG000|STARTED|Overall Study||45||
48395616|NCT02513771|101299192|FG001|STARTED|Overall Study||45||
48395617|NCT02513771|101299191|FG000|COMPLETED|Overall Study||43||
48395618|NCT02513771|101299192|FG001|COMPLETED|Overall Study||44||
48395619|NCT02513771|101299191|FG000|NOT COMPLETED|Overall Study||2||
48395620|NCT02513771|101299192|FG001|NOT COMPLETED|Overall Study||1||
48395621|NCT00830115|101299193|FG000|STARTED|Overall Study||1045||
48395622|NCT00830115|101299193|FG000|COMPLETED|Overall Study||1042||
48395623|NCT00830115|101299193|FG000|NOT COMPLETED|Overall Study||3||
48395624|NCT00444964|101299194|FG000|STARTED|Overall Study||11||
48395625|NCT00444964|101299194|FG000|COMPLETED|Overall Study||11||
48395626|NCT00444964|101299194|FG000|NOT COMPLETED|Overall Study||0||
48395627|NCT01938001|101299195|FG000|STARTED|Pre-Treatment||178|Started=randomized|
48395628|NCT01938001|101299196|FG001|STARTED|Pre-Treatment||180|Started=randomized|
48395629|NCT01938001|101299195|FG000|COMPLETED|Pre-Treatment||176|Completed=treated|
48395630|NCT01938001|101299196|FG001|COMPLETED|Pre-Treatment||180|Completed=treated|
48395631|NCT01938001|101299195|FG000|NOT COMPLETED|Pre-Treatment||2||
48395632|NCT01938001|101299196|FG001|NOT COMPLETED|Pre-Treatment||0||
48395633|NCT01938001|101299195|FG000|STARTED|Treatment||176|Started=treated|
48395634|NCT01938001|101299196|FG001|STARTED|Treatment||180|Started=treated|
48395635|NCT01938001|101299195|FG000|COMPLETED|Treatment||124|Completed=completed 12 cycles of treatment|
48395636|NCT01938001|101299196|FG001|COMPLETED|Treatment||110|Completed=completed 12 cycles of treatment|
48395637|NCT01938001|101299195|FG000|NOT COMPLETED|Treatment||52||
48395638|NCT01938001|101299196|FG001|NOT COMPLETED|Treatment||70||
48395639|NCT00989612|101299197|FG000|STARTED|Overall Study||100||
48395640|NCT00989612|101299197|FG000|COMPLETED|Overall Study||100||
48395641|NCT00989612|101299197|FG000|NOT COMPLETED|Overall Study||0||
48395642|NCT01659268|101299198|FG000|STARTED|Overall Study||9||
48395643|NCT01659268|101299199|FG001|STARTED|Overall Study||8||
48395644|NCT01659268|101299198|FG000|COMPLETED|Overall Study||9||
48395645|NCT01659268|101299199|FG001|COMPLETED|Overall Study||8||
48395646|NCT01659268|101299198|FG000|NOT COMPLETED|Overall Study||0||
48395647|NCT01659268|101299199|FG001|NOT COMPLETED|Overall Study||0||
48395648|NCT01118715|101299200|FG000|STARTED|Overall Study||68||
48395649|NCT01118715|101299201|FG001|STARTED|Overall Study||60||
48395650|NCT01118715|101299200|FG000|COMPLETED|Overall Study||68||
48395651|NCT01118715|101299201|FG001|COMPLETED|Overall Study||60||
48395652|NCT01118715|101299200|FG000|NOT COMPLETED|Overall Study||0||
48395653|NCT01118715|101299201|FG001|NOT COMPLETED|Overall Study||0||
48395654|NCT04241146|101299202|FG000|STARTED|Overall Study||24||
48395655|NCT04241146|101299203|FG001|STARTED|Overall Study||28||
48395656|NCT04241146|101299202|FG000|COMPLETED|Overall Study||24||
48395657|NCT04241146|101299203|FG001|COMPLETED|Overall Study||28||
48395658|NCT04241146|101299202|FG000|NOT COMPLETED|Overall Study||0||
48395659|NCT04241146|101299203|FG001|NOT COMPLETED|Overall Study||0||
48395660|NCT00801892|101299204|FG000|STARTED|Main Study Period||12||
48395661|NCT00801892|101299205|FG001|STARTED|Main Study Period||11||
48395662|NCT00801892|101299204|FG000|COMPLETED|Main Study Period||12||
48395663|NCT00801892|101299205|FG001|COMPLETED|Main Study Period||10||
48395664|NCT00801892|101299204|FG000|NOT COMPLETED|Main Study Period||0||
48395665|NCT00801892|101299205|FG001|NOT COMPLETED|Main Study Period||1||
48395666|NCT00801892|101299204|FG000|STARTED|Sham Crossover Period||0||
48395667|NCT00801892|101299205|FG001|STARTED|Sham Crossover Period||7||
48395668|NCT00801892|101299204|FG000|COMPLETED|Sham Crossover Period||0||
48395669|NCT00801892|101299205|FG001|COMPLETED|Sham Crossover Period||5||
48395670|NCT00801892|101299204|FG000|NOT COMPLETED|Sham Crossover Period||0||
48395671|NCT00801892|101299205|FG001|NOT COMPLETED|Sham Crossover Period||2||
48567440|NCT03889418|101720373|FG007|STARTED|October-December 2019 (Month 7-9)||0|\[EMR-CDS with CCM\] participants started enrollment in region 3 in period 3. In Regions 4 \& 5, EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|0
48567441|NCT03889418|101720374|FG008|STARTED|October-December 2019 (Month 7-9)||16|\[EMR-CDS with CCM\] participants started enrollment in region 3 in period 3. In Regions 4 \& 5, EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48567442|NCT03889418|101720375|FG009|STARTED|October-December 2019 (Month 7-9)||1|\[EMR-CDS with CCM\] participants started enrollment in region 3 in period 3. In Regions 4 \& 5, EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|0
48567443|NCT03889418|101720366|FG000|COMPLETED|October-December 2019 (Month 7-9)||60||1
48567444|NCT03889418|101720367|FG001|COMPLETED|October-December 2019 (Month 7-9)||36||1
48567445|NCT03889418|101720368|FG002|COMPLETED|October-December 2019 (Month 7-9)||28||1
48567446|NCT03889418|101720369|FG003|COMPLETED|October-December 2019 (Month 7-9)||11||1
48567447|NCT03889418|101720370|FG004|COMPLETED|October-December 2019 (Month 7-9)||16||1
48567448|NCT03889418|101720371|FG005|COMPLETED|October-December 2019 (Month 7-9)||1||1
48567449|NCT03889418|101720372|FG006|COMPLETED|October-December 2019 (Month 7-9)||12||1
48567450|NCT03889418|101720373|FG007|COMPLETED|October-December 2019 (Month 7-9)||0||0
48567451|NCT03889418|101720374|FG008|COMPLETED|October-December 2019 (Month 7-9)||15||1
48567452|NCT03889418|101720375|FG009|COMPLETED|October-December 2019 (Month 7-9)||1||0
48567453|NCT03889418|101720366|FG000|NOT COMPLETED|October-December 2019 (Month 7-9)||0||0
48567454|NCT03889418|101720367|FG001|NOT COMPLETED|October-December 2019 (Month 7-9)||0||0
48567455|NCT03889418|101720368|FG002|NOT COMPLETED|October-December 2019 (Month 7-9)||0||0
48281111|NCT01877239|101014078|FG000|STARTED|Overall Study||111||
48281112|NCT01877239|101014078|FG000|Treated|Overall Study||76||
48281113|NCT01877239|101014078|FG000|COMPLETED|Overall Study||61||
48281114|NCT01877239|101014078|FG000|NOT COMPLETED|Overall Study||50||
48281115|NCT00477659|101014079|FG000|STARTED|Overall Study||14||
48395672|NCT00571688|101299206|FG000|STARTED|Overall Study||25||
48395673|NCT00571688|101299207|FG001|STARTED|Overall Study||25||
48395674|NCT00571688|101299206|FG000|COMPLETED|Overall Study||20||
48395675|NCT00571688|101299207|FG001|COMPLETED|Overall Study||19||
48395676|NCT00571688|101299206|FG000|NOT COMPLETED|Overall Study||5||
48395677|NCT00571688|101299207|FG001|NOT COMPLETED|Overall Study||6||
48395678|NCT01467661|101299208|FG000|STARTED|Overall Study||53||
48281116|NCT00477659|101014079|FG000|COMPLETED|Overall Study||14||
48281117|NCT00477659|101014079|FG000|NOT COMPLETED|Overall Study||0||
48281118|NCT03482466|101014080|FG000|STARTED|Overall Study||14||
48281119|NCT03482466|101014080|FG000|COMPLETED|Overall Study||12|2 of the 14 study participants did not complete the study protocol. These 2 study participants were removed from the study for inappropriate/ uncooperative behavior.|
48281120|NCT03482466|101014080|FG000|NOT COMPLETED|Overall Study||2||
48281121|NCT04420949|101014081|FG000|STARTED|Overall Study||5||
48281122|NCT04420949|101014082|FG001|STARTED|Overall Study||5||
48281123|NCT04420949|101014081|FG000|COMPLETED|Overall Study||5||
48281124|NCT04420949|101014082|FG001|COMPLETED|Overall Study||5||
48281125|NCT04420949|101014081|FG000|NOT COMPLETED|Overall Study||0||
48281126|NCT04420949|101014082|FG001|NOT COMPLETED|Overall Study||0||
48281127|NCT01151852|101014083|FG000|STARTED|Overall Study||41||
48281128|NCT01151852|101014084|FG001|STARTED|Overall Study||40||
48281129|NCT01151852|101014083|FG000|COMPLETED|Overall Study||41||
48281130|NCT01151852|101014084|FG001|COMPLETED|Overall Study||40||
48281131|NCT01151852|101014083|FG000|NOT COMPLETED|Overall Study||0||
48281132|NCT01151852|101014084|FG001|NOT COMPLETED|Overall Study||0||
48395679|NCT01467661|101299208|FG000|Completed SPD422-308 (NCT01214915)|Overall Study||42||
48395680|NCT01467661|101299208|FG000|Started SPD422-309 (NCT01467661)|Overall Study||41||
48395681|NCT01467661|101299208|FG000|Started Post Marketing Trial|Overall Study||33||
48395682|NCT01467661|101299208|FG000|COMPLETED|Overall Study||32||
48395683|NCT01467661|101299208|FG000|NOT COMPLETED|Overall Study||21||
48395684|NCT01451398|101299209|FG000|STARTED|Overall Study||177||
48395685|NCT01451398|101299210|FG001|STARTED|Overall Study||176||
48395686|NCT01451398|101299209|FG000|COMPLETED|Overall Study||150||
48395687|NCT01451398|101299210|FG001|COMPLETED|Overall Study||139||
48395688|NCT01451398|101299209|FG000|NOT COMPLETED|Overall Study||27||
48395689|NCT01451398|101299210|FG001|NOT COMPLETED|Overall Study||37||
48395690|NCT00268463|101299211|FG000|STARTED|Overall Study||10||
48395691|NCT00268463|101299212|FG001|STARTED|Overall Study||12||
48395692|NCT00268463|101299211|FG000|COMPLETED|Overall Study||0||
48395693|NCT00268463|101299212|FG001|COMPLETED|Overall Study||0||
48281133|NCT03909529|101014085|FG000|STARTED|Open Label, Balanced, Randomized DDI||14||
48281134|NCT03909529|101014086|FG001|STARTED|Open Label, Balanced, Randomized DDI||14||
48281135|NCT03909529|101014085|FG000|COMPLETED|Open Label, Balanced, Randomized DDI||14||
48281136|NCT03909529|101014086|FG001|COMPLETED|Open Label, Balanced, Randomized DDI||14||
48395694|NCT00268463|101299211|FG000|NOT COMPLETED|Overall Study||10||
48395695|NCT00268463|101299212|FG001|NOT COMPLETED|Overall Study||12||
48395696|NCT04521920|101299213|FG000|STARTED|Overall Study||17||
48395697|NCT04521920|101299213|FG000|Month 3|Overall Study||13||
48395698|NCT04521920|101299213|FG000|COMPLETED|Overall Study||12||
48395699|NCT04521920|101299213|FG000|NOT COMPLETED|Overall Study||5||
48395700|NCT03039738|101299214|FG000|STARTED|Overall Study||206||
48395701|NCT03039738|101299215|FG001|STARTED|Overall Study||0||
48395702|NCT03039738|101299214|FG000|COMPLETED|Overall Study||152||
48395703|NCT03039738|101299215|FG001|COMPLETED|Overall Study||0||
48395704|NCT03039738|101299214|FG000|NOT COMPLETED|Overall Study||54||
48395705|NCT03039738|101299215|FG001|NOT COMPLETED|Overall Study||0||
48395706|NCT04377672|101299216|FG000|STARTED|Overall Study||14||
48395707|NCT04377672|101299216|FG000|COMPLETED|Overall Study||13||
48395708|NCT04377672|101299216|FG000|NOT COMPLETED|Overall Study||1||
48395709|NCT02667457|101299217|FG000|STARTED|Overall Study||27|All screened/enrolled participants|
48395710|NCT02667457|101299218|FG001|STARTED|Overall Study||12|All screened/enrolled participants|
48395711|NCT02667457|101299217|FG000|Dosed Participants|Overall Study||26|All infused enrolled participants were included in Safety Population Set|
48395712|NCT02667457|101299218|FG001|Dosed Participants|Overall Study||10|All infused enrolled participants were included in Safety Population Set|
48395713|NCT02667457|101299217|FG000|Full Analysis Set Population (FAS)|Overall Study||25|Dosed participants who completed 99mTc-rhAnnexin V-128 imaging procedure.|
48395714|NCT02667457|101299218|FG001|Full Analysis Set Population (FAS)|Overall Study||10|Dosed participants who completed 99mTc-rhAnnexin V-128 imaging procedure.|
48395715|NCT02667457|101299217|FG000|COMPLETED|Overall Study||26||
48395716|NCT02667457|101299218|FG001|COMPLETED|Overall Study||10||
48395717|NCT02667457|101299217|FG000|NOT COMPLETED|Overall Study||1||
48395718|NCT02667457|101299218|FG001|NOT COMPLETED|Overall Study||2||
48395719|NCT00562640|101299219|FG000|STARTED|Overall Study||3||
48395720|NCT00562640|101299220|FG001|STARTED|Overall Study||3||
48395721|NCT00562640|101299221|FG002|STARTED|Overall Study||4||
48395722|NCT00562640|101299222|FG003|STARTED|Overall Study||2||
48567456|NCT03889418|101720369|FG003|NOT COMPLETED|October-December 2019 (Month 7-9)||0||0
48567457|NCT03889418|101720370|FG004|NOT COMPLETED|October-December 2019 (Month 7-9)||0||0
48567458|NCT03889418|101720371|FG005|NOT COMPLETED|October-December 2019 (Month 7-9)||0||0
48567459|NCT03889418|101720372|FG006|NOT COMPLETED|October-December 2019 (Month 7-9)||0||0
48567460|NCT03889418|101720373|FG007|NOT COMPLETED|October-December 2019 (Month 7-9)||0||0
48567461|NCT03889418|101720374|FG008|NOT COMPLETED|October-December 2019 (Month 7-9)||1||0
48281137|NCT03909529|101014085|FG000|NOT COMPLETED|Open Label, Balanced, Randomized DDI||0||
48281138|NCT03909529|101014086|FG001|NOT COMPLETED|Open Label, Balanced, Randomized DDI||0||
48281139|NCT03909529|101014085|FG000|STARTED|Open Label, Balanced, Randomized DDI||14||
48281140|NCT03909529|101014086|FG001|STARTED|Open Label, Balanced, Randomized DDI||14||
48281141|NCT03909529|101014085|FG000|COMPLETED|Open Label, Balanced, Randomized DDI||14||
48281142|NCT03909529|101014086|FG001|COMPLETED|Open Label, Balanced, Randomized DDI||14||
48395723|NCT00562640|101299219|FG000|COMPLETED|Overall Study||3||
48395724|NCT00562640|101299220|FG001|COMPLETED|Overall Study||2||
48395725|NCT00562640|101299221|FG002|COMPLETED|Overall Study||3||
48395726|NCT00562640|101299222|FG003|COMPLETED|Overall Study||2||
48395727|NCT00562640|101299219|FG000|NOT COMPLETED|Overall Study||0||
48567462|NCT03889418|101720375|FG009|NOT COMPLETED|October-December 2019 (Month 7-9)||0||0
48567463|NCT03889418|101720366|FG000|STARTED|January - March 2020 (Month 10-12)||67|\[EMR-CDS with CCM\] participants started enrollment in region 4 in period 4. In Region 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48281143|NCT03909529|101014085|FG000|NOT COMPLETED|Open Label, Balanced, Randomized DDI||0||
48281144|NCT03909529|101014086|FG001|NOT COMPLETED|Open Label, Balanced, Randomized DDI||0||
48281145|NCT00658788|101014087|FG000|STARTED|Overall Study||305||
48281146|NCT00658788|101014087|FG000|COMPLETED|Overall Study||231||
48281147|NCT00658788|101014087|FG000|NOT COMPLETED|Overall Study||74||
48281148|NCT00436852|101014088|FG000|STARTED|Overall Study||45||
48281149|NCT00436852|101014089|FG001|STARTED|Overall Study||47||
48281150|NCT00436852|101014088|FG000|COMPLETED|Overall Study||10||
48281151|NCT00436852|101014089|FG001|COMPLETED|Overall Study||2||
48281152|NCT00436852|101014088|FG000|NOT COMPLETED|Overall Study||35||
48281153|NCT00436852|101014089|FG001|NOT COMPLETED|Overall Study||45||
48567464|NCT03889418|101720367|FG001|STARTED|January - March 2020 (Month 10-12)||48|\[EMR-CDS with CCM\] participants started enrollment in region 4 in period 4. In Region 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48592788|NCT02847182|101783180|FG000|NOT COMPLETED|Overall Study||0||
48592789|NCT02847182|101783181|FG001|NOT COMPLETED|Overall Study||1||
48281154|NCT03992131|101014090|FG000|STARTED|Overall Study||6||
48281155|NCT03992131|101014091|FG001|STARTED|Overall Study||4||
48281156|NCT03992131|101014092|FG002|STARTED|Overall Study||3||
48281157|NCT03992131|101014093|FG003|STARTED|Overall Study||6||
48281158|NCT03992131|101014094|FG004|STARTED|Overall Study||3||
48281159|NCT03992131|101014095|FG005|STARTED|Overall Study||3||
48395728|NCT00562640|101299220|FG001|NOT COMPLETED|Overall Study||1||
48281160|NCT03992131|101014090|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
48395729|NCT00562640|101299221|FG002|NOT COMPLETED|Overall Study||1||
48395730|NCT00562640|101299222|FG003|NOT COMPLETED|Overall Study||0||
48395731|NCT01231607|101299223|FG000|STARTED|Overall Study||185||
48395732|NCT01231607|101299224|FG001|STARTED|Overall Study||188||
48395733|NCT01231607|101299225|FG002|STARTED|Overall Study||184||
48567465|NCT03889418|101720368|FG002|STARTED|January - March 2020 (Month 10-12)||34|\[EMR-CDS with CCM\] participants started enrollment in region 4 in period 4. In Region 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48567466|NCT03889418|101720369|FG003|STARTED|January - March 2020 (Month 10-12)||24|\[EMR-CDS with CCM\] participants started enrollment in region 4 in period 4. In Region 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48567467|NCT03889418|101720370|FG004|STARTED|January - March 2020 (Month 10-12)||16|\[EMR-CDS with CCM\] participants started enrollment in region 4 in period 4. In Region 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48567468|NCT03889418|101720371|FG005|STARTED|January - March 2020 (Month 10-12)||2|\[EMR-CDS with CCM\] participants started enrollment in region 4 in period 4. In Region 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48567469|NCT03889418|101720372|FG006|STARTED|January - March 2020 (Month 10-12)||13|\[EMR-CDS with CCM\] participants started enrollment in region 4 in period 4. In Region 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48567470|NCT03889418|101720373|FG007|STARTED|January - March 2020 (Month 10-12)||5|\[EMR-CDS with CCM\] participants started enrollment in region 4 in period 4. In Region 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48567471|NCT03889418|101720374|FG008|STARTED|January - March 2020 (Month 10-12)||16|\[EMR-CDS with CCM\] participants started enrollment in region 4 in period 4. In Region 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48567472|NCT03889418|101720375|FG009|STARTED|January - March 2020 (Month 10-12)||1|\[EMR-CDS with CCM\] participants started enrollment in region 4 in period 4. In Region 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|0
48567473|NCT03889418|101720366|FG000|COMPLETED|January - March 2020 (Month 10-12)||67||1
48567474|NCT03889418|101720367|FG001|COMPLETED|January - March 2020 (Month 10-12)||48||1
48567475|NCT03889418|101720368|FG002|COMPLETED|January - March 2020 (Month 10-12)||34||1
48567476|NCT03889418|101720369|FG003|COMPLETED|January - March 2020 (Month 10-12)||23||1
48567477|NCT03889418|101720370|FG004|COMPLETED|January - March 2020 (Month 10-12)||16||1
48567478|NCT03889418|101720371|FG005|COMPLETED|January - March 2020 (Month 10-12)||2||1
48567479|NCT03889418|101720372|FG006|COMPLETED|January - March 2020 (Month 10-12)||13||1
48567480|NCT03889418|101720373|FG007|COMPLETED|January - March 2020 (Month 10-12)||3||1
48567481|NCT03889418|101720374|FG008|COMPLETED|January - March 2020 (Month 10-12)||16||1
48567482|NCT03889418|101720375|FG009|COMPLETED|January - March 2020 (Month 10-12)||1||0
48567483|NCT03889418|101720366|FG000|NOT COMPLETED|January - March 2020 (Month 10-12)||0||0
48567484|NCT03889418|101720367|FG001|NOT COMPLETED|January - March 2020 (Month 10-12)||0||0
48567485|NCT03889418|101720368|FG002|NOT COMPLETED|January - March 2020 (Month 10-12)||0||0
48567486|NCT03889418|101720369|FG003|NOT COMPLETED|January - March 2020 (Month 10-12)||1||0
48567487|NCT03889418|101720370|FG004|NOT COMPLETED|January - March 2020 (Month 10-12)||0||0
48567488|NCT03889418|101720371|FG005|NOT COMPLETED|January - March 2020 (Month 10-12)||0||0
48567489|NCT03889418|101720372|FG006|NOT COMPLETED|January - March 2020 (Month 10-12)||0||0
48567490|NCT03889418|101720373|FG007|NOT COMPLETED|January - March 2020 (Month 10-12)||2||0
48567491|NCT03889418|101720374|FG008|NOT COMPLETED|January - March 2020 (Month 10-12)||0||0
48567492|NCT03889418|101720375|FG009|NOT COMPLETED|January - March 2020 (Month 10-12)||0||0
48567493|NCT03889418|101720366|FG000|STARTED|April - June 2020 (Month 13-15)||75|\[EMR-CDS with CCM\] participants started enrollment in region 5 in period 5. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48567494|NCT03889418|101720367|FG001|STARTED|April - June 2020 (Month 13-15)||60|\[EMR-CDS with CCM\] participants started enrollment in region 5 in period 5. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48567495|NCT03889418|101720368|FG002|STARTED|April - June 2020 (Month 13-15)||38|\[EMR-CDS with CCM\] participants started enrollment in region 5 in period 5. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48567496|NCT03889418|101720369|FG003|STARTED|April - June 2020 (Month 13-15)||27|\[EMR-CDS with CCM\] participants started enrollment in region 5 in period 5. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48567497|NCT03889418|101720370|FG004|STARTED|April - June 2020 (Month 13-15)||19|\[EMR-CDS with CCM\] participants started enrollment in region 5 in period 5. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48567498|NCT03889418|101720371|FG005|STARTED|April - June 2020 (Month 13-15)||2|\[EMR-CDS with CCM\] participants started enrollment in region 5 in period 5. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48567499|NCT03889418|101720372|FG006|STARTED|April - June 2020 (Month 13-15)||16|\[EMR-CDS with CCM\] participants started enrollment in region 5 in period 5. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48698993|NCT04600505|102050428|FG003|STARTED|Overall Study||8||
48698994|NCT04600505|102050429|FG004|STARTED|Overall Study||7||
48567500|NCT03889418|101720373|FG007|STARTED|April - June 2020 (Month 13-15)||3|\[EMR-CDS with CCM\] participants started enrollment in region 5 in period 5. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48567501|NCT03889418|101720374|FG008|STARTED|April - June 2020 (Month 13-15)||19|\[EMR-CDS with CCM\] participants started enrollment in region 5 in period 5. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48567502|NCT03889418|101720375|FG009|STARTED|April - June 2020 (Month 13-15)||4|\[EMR-CDS with CCM\] participants started enrollment in region 5 in period 5. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
48567503|NCT03889418|101720366|FG000|COMPLETED|April - June 2020 (Month 13-15)||75||1
48567504|NCT03889418|101720367|FG001|COMPLETED|April - June 2020 (Month 13-15)||59||1
48567505|NCT03889418|101720368|FG002|COMPLETED|April - June 2020 (Month 13-15)||38||1
48567506|NCT03889418|101720369|FG003|COMPLETED|April - June 2020 (Month 13-15)||26||1
48567507|NCT03889418|101720370|FG004|COMPLETED|April - June 2020 (Month 13-15)||19||1
48567508|NCT03889418|101720371|FG005|COMPLETED|April - June 2020 (Month 13-15)||2||1
48567509|NCT03889418|101720372|FG006|COMPLETED|April - June 2020 (Month 13-15)||16||1
48567510|NCT03889418|101720373|FG007|COMPLETED|April - June 2020 (Month 13-15)||3||1
48567511|NCT03889418|101720374|FG008|COMPLETED|April - June 2020 (Month 13-15)||19||1
48567512|NCT03889418|101720375|FG009|COMPLETED|April - June 2020 (Month 13-15)||4||1
48567513|NCT03889418|101720366|FG000|NOT COMPLETED|April - June 2020 (Month 13-15)||0||0
48567514|NCT03889418|101720367|FG001|NOT COMPLETED|April - June 2020 (Month 13-15)||1||0
48567515|NCT03889418|101720368|FG002|NOT COMPLETED|April - June 2020 (Month 13-15)||0||0
48567516|NCT03889418|101720369|FG003|NOT COMPLETED|April - June 2020 (Month 13-15)||1||0
48567517|NCT03889418|101720370|FG004|NOT COMPLETED|April - June 2020 (Month 13-15)||0||0
48567518|NCT03889418|101720371|FG005|NOT COMPLETED|April - June 2020 (Month 13-15)||0||0
48567519|NCT03889418|101720372|FG006|NOT COMPLETED|April - June 2020 (Month 13-15)||0||0
48567520|NCT03889418|101720373|FG007|NOT COMPLETED|April - June 2020 (Month 13-15)||0||0
48567521|NCT03889418|101720374|FG008|NOT COMPLETED|April - June 2020 (Month 13-15)||0||0
48567522|NCT03889418|101720375|FG009|NOT COMPLETED|April - June 2020 (Month 13-15)||0||0
48567523|NCT03889418|101720366|FG000|STARTED|July 2020 - January 2022 (Month 16-28)||101||1
48567524|NCT03889418|101720367|FG001|STARTED|July 2020 - January 2022 (Month 16-28)||112||1
48567525|NCT03889418|101720368|FG002|STARTED|July 2020 - January 2022 (Month 16-28)||67||1
48567526|NCT03889418|101720369|FG003|STARTED|July 2020 - January 2022 (Month 16-28)||52||1
48567527|NCT03889418|101720370|FG004|STARTED|July 2020 - January 2022 (Month 16-28)||21||1
48567528|NCT03889418|101720371|FG005|STARTED|July 2020 - January 2022 (Month 16-28)||6||1
48567529|NCT03889418|101720372|FG006|STARTED|July 2020 - January 2022 (Month 16-28)||24||1
48567530|NCT03889418|101720373|FG007|STARTED|July 2020 - January 2022 (Month 16-28)||21||1
48567531|NCT03889418|101720374|FG008|STARTED|July 2020 - January 2022 (Month 16-28)||23||1
48567532|NCT03889418|101720375|FG009|STARTED|July 2020 - January 2022 (Month 16-28)||42||1
48567533|NCT03889418|101720366|FG000|COMPLETED|July 2020 - January 2022 (Month 16-28)||100||1
48567534|NCT03889418|101720367|FG001|COMPLETED|July 2020 - January 2022 (Month 16-28)||108||1
48567535|NCT03889418|101720368|FG002|COMPLETED|July 2020 - January 2022 (Month 16-28)||63||1
48567536|NCT03889418|101720369|FG003|COMPLETED|July 2020 - January 2022 (Month 16-28)||50||1
48567537|NCT03889418|101720370|FG004|COMPLETED|July 2020 - January 2022 (Month 16-28)||21||1
48567538|NCT03889418|101720371|FG005|COMPLETED|July 2020 - January 2022 (Month 16-28)||6||1
48567539|NCT03889418|101720372|FG006|COMPLETED|July 2020 - January 2022 (Month 16-28)||24||1
48567540|NCT03889418|101720373|FG007|COMPLETED|July 2020 - January 2022 (Month 16-28)||19||1
48567541|NCT03889418|101720374|FG008|COMPLETED|July 2020 - January 2022 (Month 16-28)||23||1
48567542|NCT03889418|101720375|FG009|COMPLETED|July 2020 - January 2022 (Month 16-28)||38||1
48567543|NCT03889418|101720366|FG000|NOT COMPLETED|July 2020 - January 2022 (Month 16-28)||1||0
48567544|NCT03889418|101720367|FG001|NOT COMPLETED|July 2020 - January 2022 (Month 16-28)||4||0
48567545|NCT03889418|101720368|FG002|NOT COMPLETED|July 2020 - January 2022 (Month 16-28)||4||0
48567546|NCT03889418|101720369|FG003|NOT COMPLETED|July 2020 - January 2022 (Month 16-28)||2||0
48567547|NCT03889418|101720370|FG004|NOT COMPLETED|July 2020 - January 2022 (Month 16-28)||0||0
48567548|NCT03889418|101720371|FG005|NOT COMPLETED|July 2020 - January 2022 (Month 16-28)||0||0
48567549|NCT03889418|101720372|FG006|NOT COMPLETED|July 2020 - January 2022 (Month 16-28)||0||0
48567550|NCT03889418|101720373|FG007|NOT COMPLETED|July 2020 - January 2022 (Month 16-28)||2||0
48567551|NCT03889418|101720374|FG008|NOT COMPLETED|July 2020 - January 2022 (Month 16-28)||0||0
48567552|NCT03889418|101720375|FG009|NOT COMPLETED|July 2020 - January 2022 (Month 16-28)||4||0
48567553|NCT03411031|101720376|FG000|STARTED|Overall Study||9||
48567554|NCT03411031|101720377|FG001|STARTED|Overall Study||9||
48567555|NCT03411031|101720376|FG000|COMPLETED|Overall Study||9||
48567556|NCT03411031|101720377|FG001|COMPLETED|Overall Study||9||
48567557|NCT03411031|101720376|FG000|NOT COMPLETED|Overall Study||0||
48698995|NCT04600505|102050430|FG005|STARTED|Overall Study||8||
48281161|NCT03992131|101014091|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4||
48281162|NCT03992131|101014092|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
48281163|NCT03992131|101014093|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6||
48395734|NCT01231607|101299226|FG003|STARTED|Overall Study||179||
48567558|NCT03411031|101720377|FG001|NOT COMPLETED|Overall Study||0||
48567559|NCT00347958|101720378|FG000|STARTED|Overall Study||544||
48567560|NCT00347958|101720378|FG000|COMPLETED|Overall Study||540||
48567561|NCT00347958|101720378|FG000|NOT COMPLETED|Overall Study||4||
48567562|NCT04029584|101720379|FG000|STARTED|Uninduced Study 1st Intervention (1 Day)||4||
48567563|NCT04029584|101720380|FG001|STARTED|Uninduced Study 1st Intervention (1 Day)||6||
48567564|NCT04029584|101720379|FG000|COMPLETED|Uninduced Study 1st Intervention (1 Day)||4||
48567565|NCT04029584|101720380|FG001|COMPLETED|Uninduced Study 1st Intervention (1 Day)||6||
48567566|NCT04029584|101720379|FG000|NOT COMPLETED|Uninduced Study 1st Intervention (1 Day)||0||
48567567|NCT04029584|101720380|FG001|NOT COMPLETED|Uninduced Study 1st Intervention (1 Day)||0||
48567568|NCT04029584|101720379|FG000|STARTED|Uninduced Washout (1 Day)||4||
48567569|NCT04029584|101720380|FG001|STARTED|Uninduced Washout (1 Day)||6||
48567570|NCT04029584|101720379|FG000|COMPLETED|Uninduced Washout (1 Day)||4||
48567571|NCT04029584|101720380|FG001|COMPLETED|Uninduced Washout (1 Day)||6||
48567572|NCT04029584|101720379|FG000|NOT COMPLETED|Uninduced Washout (1 Day)||0||
48567573|NCT04029584|101720380|FG001|NOT COMPLETED|Uninduced Washout (1 Day)||0||
48567574|NCT04029584|101720379|FG000|STARTED|Uninduced Study 2nd Intervention (1 Day)||4||
48567575|NCT04029584|101720380|FG001|STARTED|Uninduced Study 2nd Intervention (1 Day)||6||
48567576|NCT04029584|101720379|FG000|COMPLETED|Uninduced Study 2nd Intervention (1 Day)||4||
48567577|NCT04029584|101720380|FG001|COMPLETED|Uninduced Study 2nd Intervention (1 Day)||6||
48567578|NCT04029584|101720379|FG000|NOT COMPLETED|Uninduced Study 2nd Intervention (1 Day)||0||
48567579|NCT04029584|101720380|FG001|NOT COMPLETED|Uninduced Study 2nd Intervention (1 Day)||0||
48567580|NCT04029584|101720379|FG000|STARTED|Washout Between (>1 Week)||4||
48567581|NCT04029584|101720380|FG001|STARTED|Washout Between (>1 Week)||6||
48567582|NCT04029584|101720379|FG000|COMPLETED|Washout Between (>1 Week)||4||
48567583|NCT04029584|101720380|FG001|COMPLETED|Washout Between (>1 Week)||6||
48567584|NCT04029584|101720379|FG000|NOT COMPLETED|Washout Between (>1 Week)||0||
48567585|NCT04029584|101720380|FG001|NOT COMPLETED|Washout Between (>1 Week)||0||
48567586|NCT04029584|101720379|FG000|STARTED|Induced Study 1st Intervention (1 Day)||2||
48567587|NCT04029584|101720380|FG001|STARTED|Induced Study 1st Intervention (1 Day)||8||
48567588|NCT04029584|101720379|FG000|COMPLETED|Induced Study 1st Intervention (1 Day)||2||
48567589|NCT04029584|101720380|FG001|COMPLETED|Induced Study 1st Intervention (1 Day)||8||
48567590|NCT04029584|101720379|FG000|NOT COMPLETED|Induced Study 1st Intervention (1 Day)||0||
48567591|NCT04029584|101720380|FG001|NOT COMPLETED|Induced Study 1st Intervention (1 Day)||0||
48567592|NCT04029584|101720379|FG000|STARTED|Induced Washout (1 Day)||2||
48567593|NCT04029584|101720380|FG001|STARTED|Induced Washout (1 Day)||8||
48567594|NCT04029584|101720379|FG000|COMPLETED|Induced Washout (1 Day)||2||
48567595|NCT04029584|101720380|FG001|COMPLETED|Induced Washout (1 Day)||8||
48567596|NCT04029584|101720379|FG000|NOT COMPLETED|Induced Washout (1 Day)||0||
48567597|NCT04029584|101720380|FG001|NOT COMPLETED|Induced Washout (1 Day)||0||
48567598|NCT04029584|101720379|FG000|STARTED|Induced Study 2nd Intervention (1 Day)||2||
48567599|NCT04029584|101720380|FG001|STARTED|Induced Study 2nd Intervention (1 Day)||8||
48567600|NCT04029584|101720379|FG000|COMPLETED|Induced Study 2nd Intervention (1 Day)||2||
48567601|NCT04029584|101720380|FG001|COMPLETED|Induced Study 2nd Intervention (1 Day)||8||
48567602|NCT04029584|101720379|FG000|NOT COMPLETED|Induced Study 2nd Intervention (1 Day)||0||
48567603|NCT04029584|101720380|FG001|NOT COMPLETED|Induced Study 2nd Intervention (1 Day)||0||
48567604|NCT03278223|101720381|FG000|STARTED|Overall Study||125||
48567605|NCT03278223|101720382|FG001|STARTED|Overall Study||69||
48567606|NCT03278223|101720381|FG000|COMPLETED|Overall Study||122||
48567607|NCT03278223|101720382|FG001|COMPLETED|Overall Study||65||
48567608|NCT03278223|101720381|FG000|NOT COMPLETED|Overall Study||3||
48567609|NCT03278223|101720382|FG001|NOT COMPLETED|Overall Study||4||
48567610|NCT00507455|101720383|FG000|STARTED|Overall Study||74||
48567611|NCT00507455|101720384|FG001|STARTED|Overall Study||74||
48567612|NCT00507455|101720385|FG002|STARTED|Overall Study||74||
48567613|NCT00507455|101720383|FG000|COMPLETED|Overall Study||62||
48567614|NCT00507455|101720384|FG001|COMPLETED|Overall Study||68||
48567615|NCT00507455|101720385|FG002|COMPLETED|Overall Study||62||
48567616|NCT00507455|101720383|FG000|NOT COMPLETED|Overall Study||12||
48567617|NCT00507455|101720384|FG001|NOT COMPLETED|Overall Study||6||
48567618|NCT00507455|101720385|FG002|NOT COMPLETED|Overall Study||12||
48567619|NCT01778530|101720386|FG000|STARTED|Overall Study||2||
48567620|NCT01778530|101720386|FG000|COMPLETED|Overall Study||0||
48567621|NCT01778530|101720386|FG000|NOT COMPLETED|Overall Study||2||
48567622|NCT02892955|101720387|FG000|STARTED|Overall Study||1685||
48567623|NCT02892955|101720387|FG000|COMPLETED|Overall Study||1685||
48567624|NCT02892955|101720387|FG000|NOT COMPLETED|Overall Study||0||
48567625|NCT00855894|101720388|FG000|STARTED|Overall Study||41||
48567626|NCT00855894|101720388|FG000|COMPLETED|Overall Study||8||
48567627|NCT00855894|101720388|FG000|NOT COMPLETED|Overall Study||33||
48567628|NCT00030901|101720389|FG000|STARTED|Initial Registration||619||
48567629|NCT00030901|101720390|FG001|STARTED|Initial Registration||0||
48567630|NCT00030901|101720391|FG002|STARTED|Initial Registration||0||
48567631|NCT00030901|101720389|FG000|COMPLETED|Initial Registration||452||
48567632|NCT00030901|101720390|FG001|COMPLETED|Initial Registration||0||
48567633|NCT00030901|101720391|FG002|COMPLETED|Initial Registration||0||
48567634|NCT00030901|101720389|FG000|NOT COMPLETED|Initial Registration||167||
48567635|NCT00030901|101720390|FG001|NOT COMPLETED|Initial Registration||0||
48567636|NCT00030901|101720391|FG002|NOT COMPLETED|Initial Registration||0||
48567637|NCT00030901|101720389|FG000|STARTED|Randomization||0||
48567638|NCT00030901|101720390|FG001|STARTED|Randomization||227||
48567639|NCT00030901|101720391|FG002|STARTED|Randomization||225||
48567640|NCT00030901|101720389|FG000|Eligible|Randomization||0||
48567641|NCT00030901|101720390|FG001|Eligible|Randomization||212||
48567642|NCT00030901|101720391|FG002|Eligible|Randomization||211||
48567643|NCT00030901|101720389|FG000|COMPLETED|Randomization||0||
48567644|NCT00030901|101720390|FG001|COMPLETED|Randomization||126||
48567645|NCT00030901|101720391|FG002|COMPLETED|Randomization||137||
48567646|NCT00030901|101720389|FG000|NOT COMPLETED|Randomization||0||
48567647|NCT00030901|101720390|FG001|NOT COMPLETED|Randomization||101||
48567648|NCT00030901|101720391|FG002|NOT COMPLETED|Randomization||88||
48567649|NCT01164579|101720392|FG000|STARTED|Overall Study||36||
48567650|NCT01164579|101720393|FG001|STARTED|Overall Study||36||
48567651|NCT01164579|101720394|FG002|STARTED|Overall Study||37||
48567652|NCT01164579|101720392|FG000|COMPLETED|Overall Study||28||
48567653|NCT01164579|101720393|FG001|COMPLETED|Overall Study||27||
48567654|NCT01164579|101720394|FG002|COMPLETED|Overall Study||21||
48567655|NCT01164579|101720392|FG000|NOT COMPLETED|Overall Study||8||
48567656|NCT01164579|101720393|FG001|NOT COMPLETED|Overall Study||9||
48567657|NCT01164579|101720394|FG002|NOT COMPLETED|Overall Study||16||
48567658|NCT00789854|101720395|FG000|STARTED|Overall Study||228||
48567659|NCT00789854|101720396|FG001|STARTED|Overall Study||231||
48567660|NCT00789854|101720397|FG002|STARTED|Overall Study||229||
48567661|NCT00789854|101720395|FG000|COMPLETED|Overall Study||179||
48567662|NCT00789854|101720396|FG001|COMPLETED|Overall Study||196||
48567663|NCT00789854|101720397|FG002|COMPLETED|Overall Study||182||
48567664|NCT00789854|101720395|FG000|NOT COMPLETED|Overall Study||49||
48567665|NCT00789854|101720396|FG001|NOT COMPLETED|Overall Study||35||
48567666|NCT00789854|101720397|FG002|NOT COMPLETED|Overall Study||47||
48567667|NCT02344238|101720398|FG000|STARTED|Overall Study||20||
48567668|NCT02344238|101720399|FG001|STARTED|Overall Study||20||
48567669|NCT02344238|101720400|FG002|STARTED|Overall Study||20||
48567670|NCT02344238|101720398|FG000|COMPLETED|Overall Study||20||
48567671|NCT02344238|101720399|FG001|COMPLETED|Overall Study||20||
48567672|NCT02344238|101720400|FG002|COMPLETED|Overall Study||20||
48567673|NCT02344238|101720398|FG000|NOT COMPLETED|Overall Study||0||
48567674|NCT02344238|101720399|FG001|NOT COMPLETED|Overall Study||0||
48567675|NCT02344238|101720400|FG002|NOT COMPLETED|Overall Study||0||
48567676|NCT02588612|101720401|FG000|STARTED|Overall Study||10||
48567677|NCT02588612|101720401|FG000|Received T-cell Infusion|Overall Study||5||
48567678|NCT02588612|101720401|FG000|COMPLETED|Overall Study||5||
48567679|NCT02588612|101720401|FG000|NOT COMPLETED|Overall Study||5||
48567680|NCT00351468|101720402|FG000|STARTED|Overall Study||302||
48567681|NCT00351468|101720402|FG000|Subjects From TRA100773A|Overall Study||51||
48567682|NCT00351468|101720402|FG000|Subjects From TRA100773B|Overall Study||61||
48567683|NCT00351468|101720402|FG000|Subjects From TRA102537 Raise|Overall Study||146||
48567684|NCT00351468|101720402|FG000|Subjects From TRA108057 Repeat|Overall Study||43||
48567685|NCT00351468|101720402|FG000|Unknown - Not From Previous Trial|Overall Study||1||
48567686|NCT00351468|101720402|FG000|COMPLETED|Overall Study||135||
48567687|NCT00351468|101720402|FG000|NOT COMPLETED|Overall Study||167||
48567688|NCT00832455|101720403|FG000|STARTED|Overall Study||445||
48567689|NCT00832455|101720403|FG000|Baseline|Overall Study||420||
48567690|NCT00832455|101720403|FG000|Week 4|Overall Study||411||
48567691|NCT00832455|101720403|FG000|Week 8 (Optional)|Overall Study||247||
48567692|NCT00832455|101720403|FG000|Week 12|Overall Study||373||
48567693|NCT00832455|101720403|FG000|COMPLETED|Overall Study||373||
48567694|NCT00832455|101720403|FG000|NOT COMPLETED|Overall Study||72||
48567695|NCT00077207|101720404|FG000|STARTED|Overall Study||66||
48567696|NCT00077207|101720404|FG000|COMPLETED|Overall Study||36||
48567697|NCT00077207|101720404|FG000|NOT COMPLETED|Overall Study||30||
48567698|NCT01294241|101720405|FG000|STARTED|Overall Study||10||12
48567699|NCT01294241|101720405|FG000|COMPLETED|Overall Study||10||12
48567700|NCT01294241|101720405|FG000|NOT COMPLETED|Overall Study||0||0
48567701|NCT04830969|101720406|FG000|STARTED|Overall Study||58||
48567702|NCT04830969|101720407|FG001|STARTED|Overall Study||56||
48567703|NCT04830969|101720406|FG000|COMPLETED|Overall Study||45||
48567704|NCT04830969|101720407|FG001|COMPLETED|Overall Study||41||
48567705|NCT04830969|101720406|FG000|NOT COMPLETED|Overall Study||13||
48567706|NCT04830969|101720407|FG001|NOT COMPLETED|Overall Study||15||
48567707|NCT03922308|101720408|FG000|STARTED|Overall Study||10||
48567708|NCT03922308|101720409|FG001|STARTED|Overall Study||9||
48567709|NCT03922308|101720410|FG002|STARTED|Overall Study||9||
48592790|NCT01764997|101783182|FG000|STARTED|Run-in Period||776||
48592791|NCT01764997|101783183|FG001|STARTED|Run-in Period||0||
48567710|NCT03922308|101720408|FG000|Pharmacokinetic Population|Overall Study||10|Pharmacokinetic (PK) set included all enrolled participants with confirmed aTTP diagnosis who have received at least 1 dose of investigational product and who have at least 1 evaluable post-dose PK value.|
48567711|NCT03922308|101720409|FG001|Pharmacokinetic Population|Overall Study||8|Pharmacokinetic (PK) set included all enrolled participants with confirmed aTTP diagnosis who have received at least 1 dose of investigational product and who have at least 1 evaluable post-dose PK value.|
48567712|NCT03922308|101720410|FG002|Pharmacokinetic Population|Overall Study||9|Pharmacokinetic (PK) set included all enrolled participants with confirmed aTTP diagnosis who have received at least 1 dose of investigational product and who have at least 1 evaluable post-dose PK value.|
48567713|NCT03922308|101720408|FG000|COMPLETED|Overall Study||9||
48567714|NCT03922308|101720409|FG001|COMPLETED|Overall Study||6||
48567715|NCT03922308|101720410|FG002|COMPLETED|Overall Study||8||
48567716|NCT03922308|101720408|FG000|NOT COMPLETED|Overall Study||1||
48567717|NCT03922308|101720409|FG001|NOT COMPLETED|Overall Study||3||
48567718|NCT03922308|101720410|FG002|NOT COMPLETED|Overall Study||1||
48567719|NCT00734994|101720411|FG000|STARTED|Overall Study||15||
48281164|NCT03992131|101014094|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3||
48281165|NCT03992131|101014095|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3||
48281166|NCT03992131|101014090|FG000|COMPLETED|Overall Study||6||
48281167|NCT03992131|101014091|FG001|COMPLETED|Overall Study||4||
48281168|NCT03992131|101014092|FG002|COMPLETED|Overall Study||3||
48281169|NCT03992131|101014093|FG003|COMPLETED|Overall Study||6||
48281170|NCT03992131|101014094|FG004|COMPLETED|Overall Study||3||
48281171|NCT03992131|101014095|FG005|COMPLETED|Overall Study||3||
48281172|NCT03992131|101014090|FG000|NOT COMPLETED|Overall Study||0||
48281173|NCT03992131|101014091|FG001|NOT COMPLETED|Overall Study||0||
48281174|NCT03992131|101014092|FG002|NOT COMPLETED|Overall Study||0||
48281175|NCT03992131|101014093|FG003|NOT COMPLETED|Overall Study||0||
48281176|NCT03992131|101014094|FG004|NOT COMPLETED|Overall Study||0||
48281177|NCT03992131|101014095|FG005|NOT COMPLETED|Overall Study||0||
48281178|NCT00282672|101014096|FG000|STARTED|1 Year||22||
48567720|NCT00734994|101720411|FG000|COMPLETED|Overall Study||14||
48567721|NCT00734994|101720411|FG000|NOT COMPLETED|Overall Study||1||
48567722|NCT00637312|101720412|FG000|STARTED|Overall Study||72||
48567723|NCT00637312|101720413|FG001|STARTED|Overall Study||36||
48567724|NCT00637312|101720412|FG000|COMPLETED|Overall Study||30||
48567725|NCT00637312|101720413|FG001|COMPLETED|Overall Study||19||
48395735|NCT01231607|101299227|FG004|STARTED|Overall Study||181||
48395736|NCT01231607|101299223|FG000|COMPLETED|Overall Study||156||
48395737|NCT01231607|101299224|FG001|COMPLETED|Overall Study||154||
48395738|NCT01231607|101299225|FG002|COMPLETED|Overall Study||153||
48395739|NCT01231607|101299226|FG003|COMPLETED|Overall Study||141||
48395740|NCT01231607|101299227|FG004|COMPLETED|Overall Study||157||
48395741|NCT01231607|101299223|FG000|NOT COMPLETED|Overall Study||29||
48395742|NCT01231607|101299224|FG001|NOT COMPLETED|Overall Study||34||
48395743|NCT01231607|101299225|FG002|NOT COMPLETED|Overall Study||31||
48395744|NCT01231607|101299226|FG003|NOT COMPLETED|Overall Study||38||
48395745|NCT01231607|101299227|FG004|NOT COMPLETED|Overall Study||24||
48395746|NCT02285504|101299228|FG000|STARTED|Overall Study||4||
48567726|NCT00637312|101720412|FG000|NOT COMPLETED|Overall Study||42||
48698996|NCT04600505|102050425|FG000|COMPLETED|Overall Study||8||
48281179|NCT00282672|101014097|FG001|STARTED|1 Year||42||
48281180|NCT00282672|101014098|FG002|STARTED|1 Year||21||
48281181|NCT00282672|101014099|FG003|STARTED|1 Year||42||
48281182|NCT00282672|101014096|FG000|COMPLETED|1 Year||19||
48281183|NCT00282672|101014097|FG001|COMPLETED|1 Year||40||
48281184|NCT00282672|101014098|FG002|COMPLETED|1 Year||20||
48281185|NCT00282672|101014099|FG003|COMPLETED|1 Year||38||
48281186|NCT00282672|101014096|FG000|NOT COMPLETED|1 Year||3||
48698997|NCT04600505|102050426|FG001|COMPLETED|Overall Study||8||
48698998|NCT04600505|102050427|FG002|COMPLETED|Overall Study||8||
48698999|NCT04600505|102050428|FG003|COMPLETED|Overall Study||8||
48281187|NCT00282672|101014097|FG001|NOT COMPLETED|1 Year||2||
48281188|NCT00282672|101014098|FG002|NOT COMPLETED|1 Year||1||
48395747|NCT02285504|101299228|FG000|COMPLETED|Overall Study||4||
48281189|NCT00282672|101014099|FG003|NOT COMPLETED|1 Year||4||
48281190|NCT00282672|101014096|FG000|STARTED|2 Year: Sham Crossed Over to RFA||19||
48281191|NCT00282672|101014097|FG001|STARTED|2 Year: Sham Crossed Over to RFA||40||
48281192|NCT00282672|101014098|FG002|STARTED|2 Year: Sham Crossed Over to RFA||16||
48281193|NCT00282672|101014099|FG003|STARTED|2 Year: Sham Crossed Over to RFA||38||
48281194|NCT00282672|101014096|FG000|COMPLETED|2 Year: Sham Crossed Over to RFA||16||
48395748|NCT02285504|101299228|FG000|NOT COMPLETED|Overall Study||0||
48395749|NCT01563107|101299229|FG000|STARTED|Overall Study||12||
48281195|NCT00282672|101014097|FG001|COMPLETED|2 Year: Sham Crossed Over to RFA||39||
48281196|NCT00282672|101014098|FG002|COMPLETED|2 Year: Sham Crossed Over to RFA||15||
48281197|NCT00282672|101014099|FG003|COMPLETED|2 Year: Sham Crossed Over to RFA||36||
48281198|NCT00282672|101014096|FG000|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||3||
48281199|NCT00282672|101014097|FG001|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1||
48395750|NCT01563107|101299230|FG001|STARTED|Overall Study||5||
48395751|NCT01563107|101299231|FG002|STARTED|Overall Study||10||
48395752|NCT01563107|101299232|FG003|STARTED|Overall Study||11||
48395753|NCT01563107|101299229|FG000|Phase 1 Baseline Labs|Overall Study||12||
48395754|NCT01563107|101299230|FG001|Phase 1 Baseline Labs|Overall Study||4||
48567727|NCT00637312|101720413|FG001|NOT COMPLETED|Overall Study||17||
48567728|NCT02431676|101720414|FG000|STARTED|Overall Study||40||
48567729|NCT02431676|101720415|FG001|STARTED|Overall Study||39||
48567730|NCT02431676|101720416|FG002|STARTED|Overall Study||42||
48567731|NCT02431676|101720414|FG000|COMPLETED|Overall Study||40||
48567732|NCT02431676|101720415|FG001|COMPLETED|Overall Study||38||
48567733|NCT02431676|101720416|FG002|COMPLETED|Overall Study||40||
48567734|NCT02431676|101720414|FG000|NOT COMPLETED|Overall Study||0||
48567735|NCT02431676|101720415|FG001|NOT COMPLETED|Overall Study||1||
48567736|NCT02431676|101720416|FG002|NOT COMPLETED|Overall Study||2||
48567737|NCT01987089|101720417|FG000|STARTED|Overall Study||31||
48567738|NCT01987089|101720418|FG001|STARTED|Overall Study||32||
48567739|NCT01987089|101720417|FG000|COMPLETED|Overall Study||30||
48567740|NCT01987089|101720418|FG001|COMPLETED|Overall Study||28||
48567741|NCT01987089|101720417|FG000|NOT COMPLETED|Overall Study||1||
48567742|NCT01987089|101720418|FG001|NOT COMPLETED|Overall Study||4||
48567743|NCT00764660|101720419|FG000|STARTED|Overall Study||75||
48567744|NCT00764660|101720420|FG001|STARTED|Overall Study||66||
48567745|NCT00764660|101720419|FG000|COMPLETED|Overall Study||53||
48567746|NCT00764660|101720420|FG001|COMPLETED|Overall Study||55||
48567747|NCT00764660|101720419|FG000|NOT COMPLETED|Overall Study||22||
48567748|NCT00764660|101720420|FG001|NOT COMPLETED|Overall Study||11||
48567749|NCT01965756|101720421|FG000|STARTED|Overall Study||10||
48567750|NCT01965756|101720422|FG001|STARTED|Overall Study||10||
48567751|NCT01965756|101720421|FG000|COMPLETED|Overall Study||10||
48567752|NCT01965756|101720422|FG001|COMPLETED|Overall Study||10||
48281200|NCT00282672|101014098|FG002|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1||
48281201|NCT00282672|101014099|FG003|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||2||
48281202|NCT00282672|101014096|FG000|STARTED|5 Year: Follow up||15||
48281203|NCT00282672|101014097|FG001|STARTED|5 Year: Follow up||32||
48281204|NCT00282672|101014098|FG002|STARTED|5 Year: Follow up||12||
48281205|NCT00282672|101014099|FG003|STARTED|5 Year: Follow up||25||
48281206|NCT00282672|101014096|FG000|COMPLETED|5 Year: Follow up||14||
48395755|NCT01563107|101299231|FG002|Phase 1 Baseline Labs|Overall Study||8||
48395756|NCT01563107|101299232|FG003|Phase 1 Baseline Labs|Overall Study||7||
48395757|NCT01563107|101299229|FG000|Phase 1-150 mEq Sodium/Day|Overall Study||12||
48395758|NCT01563107|101299230|FG001|Phase 1-150 mEq Sodium/Day|Overall Study||4||
48395759|NCT01563107|101299231|FG002|Phase 1-150 mEq Sodium/Day|Overall Study||8||
48395760|NCT01563107|101299232|FG003|Phase 1-150 mEq Sodium/Day|Overall Study||7||
48395761|NCT01563107|101299229|FG000|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||12||
48567753|NCT01965756|101720421|FG000|NOT COMPLETED|Overall Study||0||
48567754|NCT01965756|101720422|FG001|NOT COMPLETED|Overall Study||0||
48567755|NCT00595920|101720423|FG000|STARTED|Overall Study||116||
48567756|NCT00595920|101720423|FG000|Patients Dosed|Overall Study||38||
48281207|NCT00282672|101014097|FG001|COMPLETED|5 Year: Follow up||27||
48281208|NCT00282672|101014098|FG002|COMPLETED|5 Year: Follow up||12||
48281209|NCT00282672|101014099|FG003|COMPLETED|5 Year: Follow up||20||
48281210|NCT00282672|101014096|FG000|NOT COMPLETED|5 Year: Follow up||1||
48395762|NCT01563107|101299230|FG001|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||4||
48395763|NCT01563107|101299231|FG002|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||8||
48395764|NCT01563107|101299232|FG003|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||7||
48395765|NCT01563107|101299229|FG000|Phase 1-finish|Overall Study||11||
48395766|NCT01563107|101299230|FG001|Phase 1-finish|Overall Study||2||
48395767|NCT01563107|101299231|FG002|Phase 1-finish|Overall Study||8||
48395768|NCT01563107|101299232|FG003|Phase 1-finish|Overall Study||6||
48395769|NCT01563107|101299229|FG000|Phase 2-150 mEq Sodium/Day|Overall Study||11||
48395770|NCT01563107|101299230|FG001|Phase 2-150 mEq Sodium/Day|Overall Study||2||
48395771|NCT01563107|101299231|FG002|Phase 2-150 mEq Sodium/Day|Overall Study||8||
48395772|NCT01563107|101299232|FG003|Phase 2-150 mEq Sodium/Day|Overall Study||6||
48395773|NCT01563107|101299229|FG000|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||11||
48395774|NCT01563107|101299230|FG001|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||2||
48395775|NCT01563107|101299231|FG002|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||8||
48395776|NCT01563107|101299232|FG003|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||6||
48395777|NCT01563107|101299229|FG000|Phase 2-finish|Overall Study||11||
48395778|NCT01563107|101299230|FG001|Phase 2-finish|Overall Study||2||
48395779|NCT01563107|101299231|FG002|Phase 2-finish|Overall Study||8||
48567757|NCT00595920|101720423|FG000|COMPLETED|Overall Study||0||
48567758|NCT00595920|101720423|FG000|NOT COMPLETED|Overall Study||116||
48567759|NCT03570619|101720424|FG000|STARTED|Overall Study||33||
48567760|NCT03570619|101720425|FG001|STARTED|Overall Study||8||
48567761|NCT03570619|101720426|FG002|STARTED|Overall Study||15||
48567762|NCT03570619|101720424|FG000|COMPLETED|Overall Study||29||
48567763|NCT03570619|101720425|FG001|COMPLETED|Overall Study||5||
48567764|NCT03570619|101720426|FG002|COMPLETED|Overall Study||14||
48567765|NCT03570619|101720424|FG000|NOT COMPLETED|Overall Study||4||
48567766|NCT03570619|101720425|FG001|NOT COMPLETED|Overall Study||3||
48567767|NCT03570619|101720426|FG002|NOT COMPLETED|Overall Study||1||
48567768|NCT01303172|101720427|FG000|STARTED|Overall Study||75||
48567769|NCT01303172|101720428|FG001|STARTED|Overall Study||35||
48567770|NCT01303172|101720427|FG000|COMPLETED|Overall Study||12||
48567771|NCT01303172|101720428|FG001|COMPLETED|Overall Study||1||
48567772|NCT01303172|101720427|FG000|NOT COMPLETED|Overall Study||63||
48567773|NCT01303172|101720428|FG001|NOT COMPLETED|Overall Study||34||
48567774|NCT03103152|101720429|FG000|STARTED|Overall Study||17||
48567775|NCT03103152|101720430|FG001|STARTED|Overall Study||16||
48567776|NCT03103152|101720431|FG002|STARTED|Overall Study||19||
48567777|NCT03103152|101720432|FG003|STARTED|Overall Study||18||
48567778|NCT03103152|101720433|FG004|STARTED|Overall Study||16||
48567779|NCT03103152|101720434|FG005|STARTED|Overall Study||18||
48699000|NCT04600505|102050429|FG004|COMPLETED|Overall Study||7||
48699001|NCT04600505|102050430|FG005|COMPLETED|Overall Study||8||
48699002|NCT04600505|102050425|FG000|NOT COMPLETED|Overall Study||0||
48699003|NCT04600505|102050426|FG001|NOT COMPLETED|Overall Study||0||
48699004|NCT04600505|102050427|FG002|NOT COMPLETED|Overall Study||0||
48699005|NCT04600505|102050428|FG003|NOT COMPLETED|Overall Study||0||
48699006|NCT04600505|102050429|FG004|NOT COMPLETED|Overall Study||0||
48699007|NCT04600505|102050430|FG005|NOT COMPLETED|Overall Study||0||
48567780|NCT03103152|101720429|FG000|COMPLETED|Overall Study||7||
48567781|NCT03103152|101720430|FG001|COMPLETED|Overall Study||10||
48567782|NCT03103152|101720431|FG002|COMPLETED|Overall Study||8||
48567783|NCT03103152|101720432|FG003|COMPLETED|Overall Study||9||
48567784|NCT03103152|101720433|FG004|COMPLETED|Overall Study||10||
48567785|NCT03103152|101720434|FG005|COMPLETED|Overall Study||9||
48567786|NCT03103152|101720429|FG000|NOT COMPLETED|Overall Study||10||
48567787|NCT03103152|101720430|FG001|NOT COMPLETED|Overall Study||6||
48567788|NCT03103152|101720431|FG002|NOT COMPLETED|Overall Study||11||
48567789|NCT03103152|101720432|FG003|NOT COMPLETED|Overall Study||9||
48567790|NCT03103152|101720433|FG004|NOT COMPLETED|Overall Study||6||
48567791|NCT03103152|101720434|FG005|NOT COMPLETED|Overall Study||9||
48567792|NCT02861807|101720435|FG000|STARTED|Overall Study||47||
48567793|NCT02861807|101720436|FG001|STARTED|Overall Study||37||
48567794|NCT02861807|101720435|FG000|Attended Post-treatment Assessment|Overall Study||34||
48567795|NCT02861807|101720436|FG001|Attended Post-treatment Assessment|Overall Study||18||
48567796|NCT02861807|101720435|FG000|Attended 2-month Follow-up|Overall Study||32||
48567797|NCT02861807|101720436|FG001|Attended 2-month Follow-up|Overall Study||20||
48567798|NCT02861807|101720435|FG000|COMPLETED|Overall Study||35||
48567799|NCT02861807|101720436|FG001|COMPLETED|Overall Study||23||
48567800|NCT02861807|101720435|FG000|NOT COMPLETED|Overall Study||12||
48567801|NCT02861807|101720436|FG001|NOT COMPLETED|Overall Study||14||
48567802|NCT03197389|101720437|FG000|STARTED|Overall Study||16||
48567803|NCT03197389|101720438|FG001|STARTED|Overall Study||5||
48567804|NCT03197389|101720439|FG002|STARTED|Overall Study||18||
48567805|NCT03197389|101720440|FG003|STARTED|Overall Study||9||
48567806|NCT03197389|101720441|FG004|STARTED|Overall Study||1||
48567807|NCT03197389|101720442|FG005|STARTED|Overall Study||5||
48567808|NCT03197389|101720437|FG000|COMPLETED|Overall Study||16||
48567809|NCT03197389|101720438|FG001|COMPLETED|Overall Study||5||
48567810|NCT03197389|101720439|FG002|COMPLETED|Overall Study||18||
48567811|NCT03197389|101720440|FG003|COMPLETED|Overall Study||9||
48567812|NCT03197389|101720441|FG004|COMPLETED|Overall Study||1||
48567813|NCT03197389|101720442|FG005|COMPLETED|Overall Study||5||
48567814|NCT03197389|101720437|FG000|NOT COMPLETED|Overall Study||0||
48567815|NCT03197389|101720438|FG001|NOT COMPLETED|Overall Study||0||
48567816|NCT03197389|101720439|FG002|NOT COMPLETED|Overall Study||0||
48699008|NCT01250184|102050431|FG000|STARTED|Overall Study||43||
48699009|NCT01250184|102050432|FG001|STARTED|Overall Study||41||
48699010|NCT01250184|102050433|FG002|STARTED|Overall Study||43||
48699011|NCT01250184|102050431|FG000|COMPLETED|Overall Study||43||
48699012|NCT01250184|102050432|FG001|COMPLETED|Overall Study||41||
48699013|NCT01250184|102050433|FG002|COMPLETED|Overall Study||43||
48699014|NCT01250184|102050431|FG000|NOT COMPLETED|Overall Study||0||
48699015|NCT01250184|102050432|FG001|NOT COMPLETED|Overall Study||0||
48699016|NCT01250184|102050433|FG002|NOT COMPLETED|Overall Study||0||
48699017|NCT02218697|102050434|FG000|STARTED|Overall Study||179||
48699018|NCT02218697|102050435|FG001|STARTED|Overall Study||177||
48699019|NCT02218697|102050434|FG000|COMPLETED|Overall Study||177||
48699020|NCT02218697|102050435|FG001|COMPLETED|Overall Study||171||
48699021|NCT02218697|102050434|FG000|NOT COMPLETED|Overall Study||2||
48699022|NCT02218697|102050435|FG001|NOT COMPLETED|Overall Study||6||
48567817|NCT03197389|101720440|FG003|NOT COMPLETED|Overall Study||0||
48567818|NCT03197389|101720441|FG004|NOT COMPLETED|Overall Study||0||
48567819|NCT03197389|101720442|FG005|NOT COMPLETED|Overall Study||0||
48567820|NCT03137160|101720443|FG000|STARTED|Overall Study||4|One screen failed due to infection and never enrolled or received drug|
48567821|NCT03137160|101720443|FG000|COMPLETED|Overall Study||2||
48567822|NCT03137160|101720443|FG000|NOT COMPLETED|Overall Study||2||
48567823|NCT02841995|101720444|FG000|STARTED|Overall Study||17||
48567824|NCT02841995|101720445|FG001|STARTED|Overall Study||16||
48567825|NCT02841995|101720446|FG002|STARTED|Overall Study||21||
48567826|NCT02841995|101720444|FG000|COMPLETED|Overall Study||0||
48567827|NCT02841995|101720445|FG001|COMPLETED|Overall Study||0||
48567828|NCT02841995|101720446|FG002|COMPLETED|Overall Study||0||
48567829|NCT02841995|101720444|FG000|NOT COMPLETED|Overall Study||17||
48699023|NCT02309645|102050436|FG000|STARTED|Overall Study||26||
48699024|NCT02309645|102050437|FG001|STARTED|Overall Study||14||
48567830|NCT02841995|101720445|FG001|NOT COMPLETED|Overall Study||16||
48567831|NCT02841995|101720446|FG002|NOT COMPLETED|Overall Study||21||
48567832|NCT03134144|101720447|FG000|STARTED|Overall Study||15||
48567833|NCT03134144|101720448|FG001|STARTED|Overall Study||30||
48567834|NCT03134144|101720447|FG000|COMPLETED|Overall Study||15||
48567835|NCT03134144|101720448|FG001|COMPLETED|Overall Study||30||
48567836|NCT03134144|101720447|FG000|NOT COMPLETED|Overall Study||0||
48567837|NCT03134144|101720448|FG001|NOT COMPLETED|Overall Study||0||
48395780|NCT01563107|101299232|FG003|Phase 2-finish|Overall Study||6||
48395781|NCT01563107|101299229|FG000|COMPLETED|Overall Study||11||
48395782|NCT01563107|101299230|FG001|COMPLETED|Overall Study||2||
48395783|NCT01563107|101299231|FG002|COMPLETED|Overall Study||8||
48395784|NCT01563107|101299232|FG003|COMPLETED|Overall Study||6||
48567838|NCT02522884|101720449|FG000|STARTED|Overall Study||213||
48567839|NCT02522884|101720449|FG000|COMPLETED|Overall Study||195||
48567840|NCT02522884|101720449|FG000|NOT COMPLETED|Overall Study||18||
48567841|NCT02555228|101720450|FG000|STARTED|Overall Study||27||
48567842|NCT02555228|101720451|FG001|STARTED|Overall Study||27||
48567843|NCT02555228|101720450|FG000|COMPLETED|Overall Study||27||
48567844|NCT02555228|101720451|FG001|COMPLETED|Overall Study||27||
48567845|NCT02555228|101720450|FG000|NOT COMPLETED|Overall Study||0||
48567846|NCT02555228|101720451|FG001|NOT COMPLETED|Overall Study||0||
48395785|NCT01563107|101299229|FG000|NOT COMPLETED|Overall Study||1||
48395786|NCT01563107|101299230|FG001|NOT COMPLETED|Overall Study||3||
48395787|NCT01563107|101299231|FG002|NOT COMPLETED|Overall Study||2||
48395788|NCT01563107|101299232|FG003|NOT COMPLETED|Overall Study||5||
48395789|NCT03043807|101299233|FG000|STARTED|Overall Study||26||
48395790|NCT03043807|101299233|FG000|COMPLETED|Overall Study||25||
48395791|NCT03043807|101299233|FG000|NOT COMPLETED|Overall Study||1||
48395792|NCT01135017|101299234|FG000|STARTED|Overall Study||55||
48395793|NCT01135017|101299235|FG001|STARTED|Overall Study||57||
48395794|NCT01135017|101299234|FG000|Treated|Overall Study||55||
48395795|NCT01135017|101299235|FG001|Treated|Overall Study||57||
48395796|NCT01135017|101299234|FG000|Evaluable for Efficacy|Overall Study||55||
48395797|NCT01135017|101299235|FG001|Evaluable for Efficacy|Overall Study||55||
48395798|NCT01135017|101299234|FG000|COMPLETED|Overall Study||49||
48395799|NCT01135017|101299235|FG001|COMPLETED|Overall Study||45||
48395800|NCT01135017|101299234|FG000|NOT COMPLETED|Overall Study||6||
48395801|NCT01135017|101299235|FG001|NOT COMPLETED|Overall Study||12||
48395802|NCT01425229|101299236|FG000|STARTED|Bosentan Single Dose||16||
48395803|NCT01425229|101299236|FG000|COMPLETED|Bosentan Single Dose||16||
48395804|NCT01425229|101299236|FG000|NOT COMPLETED|Bosentan Single Dose||0||
48395805|NCT01425229|101299236|FG000|STARTED|Bosentan Steady-state||16||
48395806|NCT01425229|101299236|FG000|COMPLETED|Bosentan Steady-state||16||
48395807|NCT01425229|101299236|FG000|NOT COMPLETED|Bosentan Steady-state||0||
48395808|NCT01425229|101299236|FG000|STARTED|Bosentan During Clarithromycin||16||
48395809|NCT01425229|101299236|FG000|COMPLETED|Bosentan During Clarithromycin||16||
48395810|NCT01425229|101299236|FG000|NOT COMPLETED|Bosentan During Clarithromycin||0||
48395811|NCT03310580|101299237|FG000|STARTED|Overall Study||15||
48395812|NCT03310580|101299238|FG001|STARTED|Overall Study||15||
48395813|NCT03310580|101299239|FG002|STARTED|Overall Study||12||
48395814|NCT03310580|101299237|FG000|COMPLETED|Overall Study||15||
48395815|NCT03310580|101299238|FG001|COMPLETED|Overall Study||14||
48395816|NCT03310580|101299239|FG002|COMPLETED|Overall Study||12||
48395817|NCT03310580|101299237|FG000|NOT COMPLETED|Overall Study||0||
48395818|NCT03310580|101299238|FG001|NOT COMPLETED|Overall Study||1||
48395819|NCT03310580|101299239|FG002|NOT COMPLETED|Overall Study||0||
48395820|NCT05159362|101299240|FG000|STARTED|Usability Testing (1 Day)||0||
48395821|NCT05159362|101299241|FG001|STARTED|Usability Testing (1 Day)||12||
48395822|NCT05159362|101299242|FG002|STARTED|Usability Testing (1 Day)||4||
48395823|NCT05159362|101299240|FG000|COMPLETED|Usability Testing (1 Day)||0||
48395824|NCT05159362|101299241|FG001|COMPLETED|Usability Testing (1 Day)||12||
48395825|NCT05159362|101299242|FG002|COMPLETED|Usability Testing (1 Day)||4||
48395826|NCT05159362|101299240|FG000|NOT COMPLETED|Usability Testing (1 Day)||0||
48395827|NCT05159362|101299241|FG001|NOT COMPLETED|Usability Testing (1 Day)||0||
48395828|NCT05159362|101299242|FG002|NOT COMPLETED|Usability Testing (1 Day)||0||
48395829|NCT05159362|101299240|FG000|STARTED|Field Testing (4 Weeks)||11||
48395830|NCT05159362|101299241|FG001|STARTED|Field Testing (4 Weeks)||0||
48395831|NCT05159362|101299242|FG002|STARTED|Field Testing (4 Weeks)||0||
48395832|NCT05159362|101299240|FG000|COMPLETED|Field Testing (4 Weeks)||10||
48395833|NCT05159362|101299241|FG001|COMPLETED|Field Testing (4 Weeks)||0||
48395834|NCT05159362|101299242|FG002|COMPLETED|Field Testing (4 Weeks)||0||
48395835|NCT05159362|101299240|FG000|NOT COMPLETED|Field Testing (4 Weeks)||1||
48567847|NCT02479451|101720452|FG000|STARTED|Overall Study||7||
48567848|NCT02479451|101720452|FG000|COMPLETED|Overall Study||7||
48567849|NCT02479451|101720452|FG000|NOT COMPLETED|Overall Study||0||
48567850|NCT02015611|101720453|FG000|STARTED|Overall Study||70||
48567851|NCT02015611|101720454|FG001|STARTED|Overall Study||66||
48567852|NCT02015611|101720453|FG000|COMPLETED|Overall Study||65||
48567853|NCT02015611|101720454|FG001|COMPLETED|Overall Study||64||
48567854|NCT02015611|101720453|FG000|NOT COMPLETED|Overall Study||5||
48567855|NCT02015611|101720454|FG001|NOT COMPLETED|Overall Study||2||
48567856|NCT03187418|101720455|FG000|STARTED|Overall Study||52||
48567857|NCT03187418|101720455|FG000|COMPLETED|Overall Study||52||
48567858|NCT03187418|101720455|FG000|NOT COMPLETED|Overall Study||0||
48567859|NCT00954941|101720456|FG000|STARTED|Overall Study||50||
48567860|NCT00954941|101720457|FG001|STARTED|Overall Study||48||
48567861|NCT00954941|101720456|FG000|COMPLETED|Overall Study||42||
48567862|NCT00954941|101720457|FG001|COMPLETED|Overall Study||41||
48567863|NCT00954941|101720456|FG000|NOT COMPLETED|Overall Study||8||
48567864|NCT00954941|101720457|FG001|NOT COMPLETED|Overall Study||7||
48567865|NCT01511978|101720458|FG000|STARTED|Overall Study||14||
48567866|NCT01511978|101720459|FG001|STARTED|Overall Study||18||
48567867|NCT01511978|101720458|FG000|COMPLETED|Overall Study||14||
48567868|NCT01511978|101720459|FG001|COMPLETED|Overall Study||18||
48567869|NCT01511978|101720458|FG000|NOT COMPLETED|Overall Study||0||
48567870|NCT01511978|101720459|FG001|NOT COMPLETED|Overall Study||0||
48567871|NCT01198769|101720460|FG000|STARTED|Overall Study||15||
48567872|NCT01198769|101720460|FG000|COMPLETED|Overall Study||15||
48567873|NCT01198769|101720460|FG000|NOT COMPLETED|Overall Study||0||
48567874|NCT03097757|101720461|FG000|STARTED|Overall Study||2||
48567875|NCT03097757|101720462|FG001|STARTED|Overall Study||2||
48567876|NCT03097757|101720461|FG000|COMPLETED|Overall Study||2||
48567877|NCT03097757|101720462|FG001|COMPLETED|Overall Study||2||
48567878|NCT03097757|101720461|FG000|NOT COMPLETED|Overall Study||0||
48567879|NCT03097757|101720462|FG001|NOT COMPLETED|Overall Study||0||
48567880|NCT02019472|101720463|FG000|STARTED|Overall Study||186||
48567881|NCT02019472|101720464|FG001|STARTED|Overall Study||186||
48567882|NCT02019472|101720465|FG002|STARTED|Overall Study||187||
48567883|NCT02019472|101720463|FG000|COMPLETED|Overall Study||149||
48567884|NCT02019472|101720464|FG001|COMPLETED|Overall Study||134||
48567885|NCT02019472|101720465|FG002|COMPLETED|Overall Study||145||
48567886|NCT02019472|101720463|FG000|NOT COMPLETED|Overall Study||37||
48567887|NCT02019472|101720464|FG001|NOT COMPLETED|Overall Study||52||
48567888|NCT02019472|101720465|FG002|NOT COMPLETED|Overall Study||42||
48567889|NCT01383707|101720466|FG000|STARTED|Overall Study||77||
48567890|NCT01383707|101720466|FG000|COMPLETED|Overall Study||5||
48567891|NCT01383707|101720466|FG000|NOT COMPLETED|Overall Study||72||
48567892|NCT03511105|101720467|FG000|STARTED|Overall Study||25||
48567893|NCT03511105|101720468|FG001|STARTED|Overall Study||22||
48567894|NCT03511105|101720467|FG000|COMPLETED|Overall Study||23||
48567895|NCT03511105|101720468|FG001|COMPLETED|Overall Study||22||
48567896|NCT03511105|101720467|FG000|NOT COMPLETED|Overall Study||2||
48567897|NCT03511105|101720468|FG001|NOT COMPLETED|Overall Study||0||
48567898|NCT00304096|101720469|FG000|STARTED|Overall Study||6||
48567899|NCT00304096|101720470|FG001|STARTED|Overall Study||5||
48567900|NCT00304096|101720469|FG000|COMPLETED|Overall Study||6||
48567901|NCT00304096|101720470|FG001|COMPLETED|Overall Study||5||
48567902|NCT00304096|101720469|FG000|NOT COMPLETED|Overall Study||0||
48567903|NCT00304096|101720470|FG001|NOT COMPLETED|Overall Study||0||
48567904|NCT00218023|101720471|FG000|STARTED|Overall Study||22|Number that started phase 2, the phase in which subjects were assigned to the 4 arms.|
48567905|NCT00218023|101720472|FG001|STARTED|Overall Study||25|Number that started phase 2, the phase in which subjects were assigned to the 4 arms.|
48567906|NCT00218023|101720473|FG002|STARTED|Overall Study||16|Number that started phase 2, the phase in which subjects were assigned to the 4 arms.|
48567907|NCT00218023|101720474|FG003|STARTED|Overall Study||18|Number that started phase 2, the phase in which subjects were assigned to the 4 arms.|
48567908|NCT00218023|101720471|FG000|Received Drug or Placebo in Phase II|Overall Study||18||
48567909|NCT00218023|101720472|FG001|Received Drug or Placebo in Phase II|Overall Study||24||
48567910|NCT00218023|101720473|FG002|Received Drug or Placebo in Phase II|Overall Study||15||
48567911|NCT00218023|101720474|FG003|Received Drug or Placebo in Phase II|Overall Study||18||
48567912|NCT00218023|101720471|FG000|COMPLETED|Overall Study||9||
48395836|NCT05159362|101299241|FG001|NOT COMPLETED|Field Testing (4 Weeks)||0||
48395837|NCT05159362|101299242|FG002|NOT COMPLETED|Field Testing (4 Weeks)||0||
48395838|NCT01929707|101299243|FG000|STARTED|Intervention Period 1||6||
48567913|NCT00218023|101720472|FG001|COMPLETED|Overall Study||10||
48395839|NCT01929707|101299244|FG001|STARTED|Intervention Period 1||8||
48395840|NCT01929707|101299245|FG002|STARTED|Intervention Period 1||12||
48395841|NCT01929707|101299246|FG003|STARTED|Intervention Period 1||10||
48395842|NCT01929707|101299247|FG004|STARTED|Intervention Period 1||0||
48395843|NCT01929707|101299248|FG005|STARTED|Intervention Period 1||0||
48395844|NCT01929707|101299249|FG006|STARTED|Intervention Period 1||0||
48395845|NCT01929707|101299250|FG007|STARTED|Intervention Period 1||0||
48567914|NCT00218023|101720473|FG002|COMPLETED|Overall Study||6||
48567915|NCT00218023|101720474|FG003|COMPLETED|Overall Study||11||
48567916|NCT00218023|101720471|FG000|NOT COMPLETED|Overall Study||13||
48567917|NCT00218023|101720472|FG001|NOT COMPLETED|Overall Study||15||
48567918|NCT00218023|101720473|FG002|NOT COMPLETED|Overall Study||10||
48567919|NCT00218023|101720474|FG003|NOT COMPLETED|Overall Study||7||
48567920|NCT02074358|101720475|FG000|STARTED|Overall Study||3||
48567921|NCT02074358|101720476|FG001|STARTED|Overall Study||3||
48567922|NCT02074358|101720477|FG002|STARTED|Overall Study||2||
48567923|NCT02074358|101720478|FG003|STARTED|Overall Study||2||
48567924|NCT02074358|101720479|FG004|STARTED|Overall Study||3||
48567925|NCT02074358|101720480|FG005|STARTED|Overall Study||2||
48567926|NCT02074358|101720475|FG000|COMPLETED|Overall Study||3||
48567927|NCT02074358|101720476|FG001|COMPLETED|Overall Study||3||
48567928|NCT02074358|101720477|FG002|COMPLETED|Overall Study||2||
48567929|NCT02074358|101720478|FG003|COMPLETED|Overall Study||2||
48567930|NCT02074358|101720479|FG004|COMPLETED|Overall Study||3||
48567931|NCT02074358|101720480|FG005|COMPLETED|Overall Study||2||
48567932|NCT02074358|101720475|FG000|NOT COMPLETED|Overall Study||0||
48567933|NCT02074358|101720476|FG001|NOT COMPLETED|Overall Study||0||
48567934|NCT02074358|101720477|FG002|NOT COMPLETED|Overall Study||0||
48567935|NCT02074358|101720478|FG003|NOT COMPLETED|Overall Study||0||
48567936|NCT02074358|101720479|FG004|NOT COMPLETED|Overall Study||0||
48567937|NCT02074358|101720480|FG005|NOT COMPLETED|Overall Study||0||
48567938|NCT01256450|101720481|FG000|STARTED|Open-label Titration||334||
48567939|NCT01256450|101720482|FG001|STARTED|Open-label Titration||0||
48567940|NCT01256450|101720483|FG002|STARTED|Open-label Titration||0||
48567941|NCT01256450|101720481|FG000|COMPLETED|Open-label Titration||235||
48567942|NCT01256450|101720482|FG001|COMPLETED|Open-label Titration||0||
48567943|NCT01256450|101720483|FG002|COMPLETED|Open-label Titration||0||
48567944|NCT01256450|101720481|FG000|NOT COMPLETED|Open-label Titration||99||
48567945|NCT01256450|101720482|FG001|NOT COMPLETED|Open-label Titration||0||
48567946|NCT01256450|101720483|FG002|NOT COMPLETED|Open-label Titration||0||
48567947|NCT01256450|101720481|FG000|STARTED|Double-blind Treatment||0||
48567948|NCT01256450|101720482|FG001|STARTED|Double-blind Treatment||117||
48567949|NCT01256450|101720483|FG002|STARTED|Double-blind Treatment||118||
48567950|NCT01256450|101720481|FG000|COMPLETED|Double-blind Treatment||0||
48567951|NCT01256450|101720482|FG001|COMPLETED|Double-blind Treatment||89||
48567952|NCT01256450|101720483|FG002|COMPLETED|Double-blind Treatment||81||
48567953|NCT01256450|101720481|FG000|NOT COMPLETED|Double-blind Treatment||0||
48567954|NCT01256450|101720482|FG001|NOT COMPLETED|Double-blind Treatment||28||
48567955|NCT01256450|101720483|FG002|NOT COMPLETED|Double-blind Treatment||37||
48567956|NCT04387435|101720484|FG000|STARTED|Overall Study||1||
48567957|NCT04387435|101720484|FG000|COMPLETED|Overall Study||0||
48567958|NCT04387435|101720484|FG000|NOT COMPLETED|Overall Study||1||
48567959|NCT01216241|101720485|FG000|STARTED|Overall Study||18||
48567960|NCT01216241|101720486|FG001|STARTED|Overall Study||18||
48567961|NCT01216241|101720485|FG000|COMPLETED|Overall Study||18||
48567962|NCT01216241|101720486|FG001|COMPLETED|Overall Study||18||
48567963|NCT01216241|101720485|FG000|NOT COMPLETED|Overall Study||0||
48567964|NCT01216241|101720486|FG001|NOT COMPLETED|Overall Study||0||
48567965|NCT04615403|101720487|FG000|STARTED|Overall Study||33||
48567966|NCT04615403|101720487|FG000|COMPLETED|Overall Study||32||
48567967|NCT04615403|101720487|FG000|NOT COMPLETED|Overall Study||1||
48567968|NCT03096314|101720488|FG000|STARTED|Screened Vitamin D Deficient||690||
48395846|NCT01929707|101299243|FG000|Received at Least 1 Dose of Study Drug|Intervention Period 1||6||
48395847|NCT01929707|101299244|FG001|Received at Least 1 Dose of Study Drug|Intervention Period 1||8||
48395848|NCT01929707|101299245|FG002|Received at Least 1 Dose of Study Drug|Intervention Period 1||12||
48395849|NCT01929707|101299246|FG003|Received at Least 1 Dose of Study Drug|Intervention Period 1||10||
48395850|NCT01929707|101299247|FG004|Received at Least 1 Dose of Study Drug|Intervention Period 1||0||
48395851|NCT01929707|101299248|FG005|Received at Least 1 Dose of Study Drug|Intervention Period 1||0||
48395852|NCT01929707|101299249|FG006|Received at Least 1 Dose of Study Drug|Intervention Period 1||0||
48395853|NCT01929707|101299250|FG007|Received at Least 1 Dose of Study Drug|Intervention Period 1||0||
48395854|NCT01929707|101299243|FG000|COMPLETED|Intervention Period 1||6||
48395855|NCT01929707|101299244|FG001|COMPLETED|Intervention Period 1||8||
48395856|NCT01929707|101299245|FG002|COMPLETED|Intervention Period 1||12||
48395857|NCT01929707|101299246|FG003|COMPLETED|Intervention Period 1||7||
48395858|NCT01929707|101299247|FG004|COMPLETED|Intervention Period 1||0||
48395859|NCT01929707|101299248|FG005|COMPLETED|Intervention Period 1||0||
48395860|NCT01929707|101299249|FG006|COMPLETED|Intervention Period 1||0||
48395861|NCT01929707|101299250|FG007|COMPLETED|Intervention Period 1||0||
48395862|NCT01929707|101299243|FG000|NOT COMPLETED|Intervention Period 1||0||
48395863|NCT01929707|101299244|FG001|NOT COMPLETED|Intervention Period 1||0||
48395864|NCT01929707|101299245|FG002|NOT COMPLETED|Intervention Period 1||0||
48395865|NCT01929707|101299246|FG003|NOT COMPLETED|Intervention Period 1||3||
48395866|NCT01929707|101299247|FG004|NOT COMPLETED|Intervention Period 1||0||
48567969|NCT03096314|101720489|FG001|STARTED|Screened Vitamin D Deficient||668||
48567970|NCT03096314|101720488|FG000|COMPLETED|Screened Vitamin D Deficient||681||
48395867|NCT01929707|101299248|FG005|NOT COMPLETED|Intervention Period 1||0||
48395868|NCT01929707|101299249|FG006|NOT COMPLETED|Intervention Period 1||0||
48395869|NCT01929707|101299250|FG007|NOT COMPLETED|Intervention Period 1||0||
48567971|NCT03096314|101720489|FG001|COMPLETED|Screened Vitamin D Deficient||656||
48567972|NCT03096314|101720488|FG000|NOT COMPLETED|Screened Vitamin D Deficient||9||
48567973|NCT03096314|101720489|FG001|NOT COMPLETED|Screened Vitamin D Deficient||12||
48395870|NCT01929707|101299243|FG000|STARTED|Washout Period ≥7 Days||6||
48567974|NCT03096314|101720488|FG000|STARTED|Confirmed Vitamin D Deficient||538||
48567975|NCT03096314|101720489|FG001|STARTED|Confirmed Vitamin D Deficient||540||
48567976|NCT03096314|101720488|FG000|COMPLETED|Confirmed Vitamin D Deficient||531||
48567977|NCT03096314|101720489|FG001|COMPLETED|Confirmed Vitamin D Deficient||528||
48567978|NCT03096314|101720488|FG000|NOT COMPLETED|Confirmed Vitamin D Deficient||7||
48567979|NCT03096314|101720489|FG001|NOT COMPLETED|Confirmed Vitamin D Deficient||12||
48567980|NCT00591565|101724456|FG000|STARTED|Overall Study||13||
48567981|NCT00591565|101724456|FG000|COMPLETED|Overall Study||8||
48567982|NCT00591565|101724456|FG000|NOT COMPLETED|Overall Study||5||
48567983|NCT02547220|101724457|FG000|STARTED|Overall Study||19||
48567984|NCT02547220|101724458|FG001|STARTED|Overall Study||20||
48567985|NCT02547220|101724457|FG000|COMPLETED|Overall Study||0||
48567986|NCT02547220|101724458|FG001|COMPLETED|Overall Study||0||
48567987|NCT02547220|101724457|FG000|NOT COMPLETED|Overall Study||19||
48567988|NCT02547220|101724458|FG001|NOT COMPLETED|Overall Study||20||
48567989|NCT02053766|101724459|FG000|STARTED|Overall Study||6||
48567990|NCT02053766|101724460|FG001|STARTED|Overall Study||7||
48281211|NCT00282672|101014097|FG001|NOT COMPLETED|5 Year: Follow up||5||
48281212|NCT00282672|101014098|FG002|NOT COMPLETED|5 Year: Follow up||0||
48281213|NCT00282672|101014099|FG003|NOT COMPLETED|5 Year: Follow up||5||
48567991|NCT02053766|101724461|FG002|STARTED|Overall Study||6||
48567992|NCT02053766|101724459|FG000|COMPLETED|Overall Study||6||
48567993|NCT02053766|101724460|FG001|COMPLETED|Overall Study||6||
48567994|NCT02053766|101724461|FG002|COMPLETED|Overall Study||6||
48567995|NCT02053766|101724459|FG000|NOT COMPLETED|Overall Study||0||
48567996|NCT02053766|101724460|FG001|NOT COMPLETED|Overall Study||1||
48567997|NCT02053766|101724461|FG002|NOT COMPLETED|Overall Study||0||
48567998|NCT02025725|101724462|FG000|STARTED|Overall Study||102||
48567999|NCT02025725|101724463|FG001|STARTED|Overall Study||103||
48568000|NCT02025725|101724462|FG000|COMPLETED|Overall Study||91||
48568001|NCT02025725|101724463|FG001|COMPLETED|Overall Study||99||
48568002|NCT02025725|101724462|FG000|NOT COMPLETED|Overall Study||11||
48568003|NCT02025725|101724463|FG001|NOT COMPLETED|Overall Study||4||
48568004|NCT01276756|101724464|FG000|STARTED|Overall Study||50||
48568005|NCT01276756|101724465|FG001|STARTED|Overall Study||50||
48568006|NCT01276756|101724464|FG000|COMPLETED|Overall Study||45||
48568007|NCT01276756|101724465|FG001|COMPLETED|Overall Study||48||
48568008|NCT01276756|101724464|FG000|NOT COMPLETED|Overall Study||5||
48568009|NCT01276756|101724465|FG001|NOT COMPLETED|Overall Study||2||
48568010|NCT01808963|101724466|FG000|STARTED|Overall Study||13||
48568011|NCT01808963|101724466|FG000|COMPLETED|Overall Study||13||
48568012|NCT01808963|101724466|FG000|NOT COMPLETED|Overall Study||0||
48568013|NCT01030289|101724467|FG000|STARTED|Overall Study||9||
48568014|NCT01030289|101724468|FG001|STARTED|Overall Study||10||
48568015|NCT01030289|101724467|FG000|COMPLETED|Overall Study||9||
48568016|NCT01030289|101724468|FG001|COMPLETED|Overall Study||10||
48568017|NCT01030289|101724467|FG000|NOT COMPLETED|Overall Study||0||
48281214|NCT02440659|101014100|FG000|STARTED|Overall Study||1997||
48281215|NCT02440659|101014101|FG001|STARTED|Overall Study||949||
48281216|NCT02440659|101014100|FG000|COMPLETED|Overall Study||1346||
48281217|NCT02440659|101014101|FG001|COMPLETED|Overall Study||614||
48281218|NCT02440659|101014100|FG000|NOT COMPLETED|Overall Study||651||
48281219|NCT02440659|101014101|FG001|NOT COMPLETED|Overall Study||335||
48281220|NCT04887064|101014102|FG000|STARTED|Overall Study||7||
48281221|NCT04887064|101014103|FG001|STARTED|Overall Study||8||
48281222|NCT04887064|101014104|FG002|STARTED|Overall Study||5||
48281223|NCT04887064|101014102|FG000|COMPLETED|Overall Study||7||
48281224|NCT04887064|101014103|FG001|COMPLETED|Overall Study||8||
48281225|NCT04887064|101014104|FG002|COMPLETED|Overall Study||5||
48281226|NCT04887064|101014102|FG000|NOT COMPLETED|Overall Study||0||
48281227|NCT04887064|101014103|FG001|NOT COMPLETED|Overall Study||0||
48281228|NCT04887064|101014104|FG002|NOT COMPLETED|Overall Study||0||
48281229|NCT01451827|101014105|FG000|STARTED|Overall Study||45||
48281230|NCT01451827|101014106|FG001|STARTED|Overall Study||45||
48568018|NCT01030289|101724468|FG001|NOT COMPLETED|Overall Study||0||
48568019|NCT01464593|101724469|FG000|STARTED|Overall Study||1||
48568020|NCT01464593|101724469|FG000|COMPLETED|Overall Study||0||
48568021|NCT01464593|101724469|FG000|NOT COMPLETED|Overall Study||1||
48568022|NCT03192488|101724470|FG000|STARTED|First Intervention (d1)||1||
48568023|NCT03192488|101724471|FG001|STARTED|First Intervention (d1)||5||
48568024|NCT03192488|101724472|FG002|STARTED|First Intervention (d1)||2||
48568025|NCT03192488|101724473|FG003|STARTED|First Intervention (d1)||1||
48568026|NCT03192488|101724474|FG004|STARTED|First Intervention (d1)||1||
48568027|NCT03192488|101724475|FG005|STARTED|First Intervention (d1)||1||
48568028|NCT03192488|101724470|FG000|COMPLETED|First Intervention (d1)||1||
48568029|NCT03192488|101724471|FG001|COMPLETED|First Intervention (d1)||5||
48568030|NCT03192488|101724472|FG002|COMPLETED|First Intervention (d1)||2||
48568031|NCT03192488|101724473|FG003|COMPLETED|First Intervention (d1)||1||
48568032|NCT03192488|101724474|FG004|COMPLETED|First Intervention (d1)||1||
48568033|NCT03192488|101724475|FG005|COMPLETED|First Intervention (d1)||1||
48568034|NCT03192488|101724470|FG000|NOT COMPLETED|First Intervention (d1)||0||
48568035|NCT03192488|101724471|FG001|NOT COMPLETED|First Intervention (d1)||0||
48568036|NCT03192488|101724472|FG002|NOT COMPLETED|First Intervention (d1)||0||
48568037|NCT03192488|101724473|FG003|NOT COMPLETED|First Intervention (d1)||0||
48281231|NCT01451827|101014107|FG002|STARTED|Overall Study||44||
48281232|NCT01451827|101014108|FG003|STARTED|Overall Study||43||
48281233|NCT01451827|101014105|FG000|COMPLETED|Overall Study||42||
48568038|NCT03192488|101724474|FG004|NOT COMPLETED|First Intervention (d1)||0||
48568039|NCT03192488|101724475|FG005|NOT COMPLETED|First Intervention (d1)||0||
48568040|NCT03192488|101724470|FG000|STARTED|First Washout (>6d)||1||
48568041|NCT03192488|101724471|FG001|STARTED|First Washout (>6d)||5||
48395871|NCT01929707|101299244|FG001|STARTED|Washout Period ≥7 Days||8||
48395872|NCT01929707|101299245|FG002|STARTED|Washout Period ≥7 Days||12||
48395873|NCT01929707|101299246|FG003|STARTED|Washout Period ≥7 Days||7||
48395874|NCT01929707|101299247|FG004|STARTED|Washout Period ≥7 Days||0||
48395875|NCT01929707|101299248|FG005|STARTED|Washout Period ≥7 Days||0||
48395876|NCT01929707|101299249|FG006|STARTED|Washout Period ≥7 Days||0||
48395877|NCT01929707|101299250|FG007|STARTED|Washout Period ≥7 Days||0||
48395878|NCT01929707|101299243|FG000|COMPLETED|Washout Period ≥7 Days||6||
48395879|NCT01929707|101299244|FG001|COMPLETED|Washout Period ≥7 Days||8||
48395880|NCT01929707|101299245|FG002|COMPLETED|Washout Period ≥7 Days||12||
48395881|NCT01929707|101299246|FG003|COMPLETED|Washout Period ≥7 Days||7||
48395882|NCT01929707|101299247|FG004|COMPLETED|Washout Period ≥7 Days||0||
48395883|NCT01929707|101299248|FG005|COMPLETED|Washout Period ≥7 Days||0||
48395884|NCT01929707|101299249|FG006|COMPLETED|Washout Period ≥7 Days||0||
48395885|NCT01929707|101299250|FG007|COMPLETED|Washout Period ≥7 Days||0||
48395886|NCT01929707|101299243|FG000|NOT COMPLETED|Washout Period ≥7 Days||0||
48395887|NCT01929707|101299244|FG001|NOT COMPLETED|Washout Period ≥7 Days||0||
48395888|NCT01929707|101299245|FG002|NOT COMPLETED|Washout Period ≥7 Days||0||
48395889|NCT01929707|101299246|FG003|NOT COMPLETED|Washout Period ≥7 Days||0||
48395890|NCT01929707|101299247|FG004|NOT COMPLETED|Washout Period ≥7 Days||0||
48395891|NCT01929707|101299248|FG005|NOT COMPLETED|Washout Period ≥7 Days||0||
48395892|NCT01929707|101299249|FG006|NOT COMPLETED|Washout Period ≥7 Days||0||
48395893|NCT01929707|101299250|FG007|NOT COMPLETED|Washout Period ≥7 Days||0||
48395894|NCT01929707|101299243|FG000|STARTED|Intervention Period 2||0||
48395895|NCT01929707|101299244|FG001|STARTED|Intervention Period 2||0||
48395896|NCT01929707|101299245|FG002|STARTED|Intervention Period 2||0||
48395897|NCT01929707|101299246|FG003|STARTED|Intervention Period 2||5||
48395898|NCT01929707|101299247|FG004|STARTED|Intervention Period 2||6||
48395899|NCT01929707|101299248|FG005|STARTED|Intervention Period 2||8||
48395900|NCT01929707|101299249|FG006|STARTED|Intervention Period 2||12||
48395901|NCT01929707|101299250|FG007|STARTED|Intervention Period 2||4||
48395902|NCT01929707|101299243|FG000|COMPLETED|Intervention Period 2||0||
48395903|NCT01929707|101299244|FG001|COMPLETED|Intervention Period 2||0||
48395904|NCT01929707|101299245|FG002|COMPLETED|Intervention Period 2||0||
48395905|NCT01929707|101299246|FG003|COMPLETED|Intervention Period 2||5||
48395906|NCT01929707|101299247|FG004|COMPLETED|Intervention Period 2||6||
48395907|NCT01929707|101299248|FG005|COMPLETED|Intervention Period 2||6||
48395908|NCT01929707|101299249|FG006|COMPLETED|Intervention Period 2||12||
48395909|NCT01929707|101299250|FG007|COMPLETED|Intervention Period 2||4||
48395910|NCT01929707|101299243|FG000|NOT COMPLETED|Intervention Period 2||0||
48395911|NCT01929707|101299244|FG001|NOT COMPLETED|Intervention Period 2||0||
48395912|NCT01929707|101299245|FG002|NOT COMPLETED|Intervention Period 2||0||
48395913|NCT01929707|101299246|FG003|NOT COMPLETED|Intervention Period 2||0||
48395914|NCT01929707|101299247|FG004|NOT COMPLETED|Intervention Period 2||0||
48395915|NCT01929707|101299248|FG005|NOT COMPLETED|Intervention Period 2||2||
48395916|NCT01929707|101299249|FG006|NOT COMPLETED|Intervention Period 2||0||
48395917|NCT01929707|101299250|FG007|NOT COMPLETED|Intervention Period 2||0||
48395918|NCT04095442|101299251|FG000|STARTED|Overall Study||16||
48395919|NCT04095442|101299252|FG001|STARTED|Overall Study||16||
48395920|NCT04095442|101299251|FG000|COMPLETED|Overall Study||15||
48395921|NCT04095442|101299252|FG001|COMPLETED|Overall Study||15||
48395922|NCT04095442|101299251|FG000|NOT COMPLETED|Overall Study||1||
48395923|NCT04095442|101299252|FG001|NOT COMPLETED|Overall Study||1||
48395924|NCT03205982|101299253|FG000|STARTED|Overall Study||101||
48395925|NCT03205982|101299254|FG001|STARTED|Overall Study||99||
48395926|NCT03205982|101299253|FG000|COMPLETED|Overall Study||77||
48395927|NCT03205982|101299254|FG001|COMPLETED|Overall Study||76||
48395928|NCT03205982|101299253|FG000|NOT COMPLETED|Overall Study||24||
48395929|NCT03205982|101299254|FG001|NOT COMPLETED|Overall Study||23||
48395930|NCT00435994|101299255|FG000|STARTED|Overall Study||22||
48395931|NCT00435994|101299256|FG001|STARTED|Overall Study||25||
48395932|NCT00435994|101299257|FG002|STARTED|Overall Study||12||
48395933|NCT00435994|101299255|FG000|COMPLETED|Overall Study||15||
48395934|NCT00435994|101299256|FG001|COMPLETED|Overall Study||25||
48395935|NCT00435994|101299257|FG002|COMPLETED|Overall Study||12||
48568042|NCT03192488|101724472|FG002|STARTED|First Washout (>6d)||2||
48568043|NCT03192488|101724473|FG003|STARTED|First Washout (>6d)||1||
48395936|NCT00435994|101299255|FG000|NOT COMPLETED|Overall Study||7||
48395937|NCT00435994|101299256|FG001|NOT COMPLETED|Overall Study||0||
48395938|NCT00435994|101299257|FG002|NOT COMPLETED|Overall Study||0||
48395939|NCT02759562|101299258|FG000|STARTED|Double-Blind Treatment Period (8 Weeks)||3||
48395940|NCT02759562|101299259|FG001|STARTED|Double-Blind Treatment Period (8 Weeks)||3||
48395941|NCT02759562|101299258|FG000|COMPLETED|Double-Blind Treatment Period (8 Weeks)||3||
48395942|NCT02759562|101299259|FG001|COMPLETED|Double-Blind Treatment Period (8 Weeks)||3||
48395943|NCT02759562|101299258|FG000|NOT COMPLETED|Double-Blind Treatment Period (8 Weeks)||0||
48395944|NCT02759562|101299259|FG001|NOT COMPLETED|Double-Blind Treatment Period (8 Weeks)||0||
48404093|NCT03689972|101321770|FG004|NOT COMPLETED|Part 2:Run-in Period (Week73uptoWeek107)||0||
48568044|NCT03192488|101724474|FG004|STARTED|First Washout (>6d)||1||
48568045|NCT03192488|101724475|FG005|STARTED|First Washout (>6d)||1||
48568046|NCT03192488|101724470|FG000|COMPLETED|First Washout (>6d)||1||
48568047|NCT03192488|101724471|FG001|COMPLETED|First Washout (>6d)||5||
48568048|NCT03192488|101724472|FG002|COMPLETED|First Washout (>6d)||1||
48568049|NCT03192488|101724473|FG003|COMPLETED|First Washout (>6d)||1||
48568050|NCT03192488|101724474|FG004|COMPLETED|First Washout (>6d)||1||
48568051|NCT03192488|101724475|FG005|COMPLETED|First Washout (>6d)||0||
48568052|NCT03192488|101724470|FG000|NOT COMPLETED|First Washout (>6d)||0||
48568053|NCT03192488|101724471|FG001|NOT COMPLETED|First Washout (>6d)||0||
48568054|NCT03192488|101724472|FG002|NOT COMPLETED|First Washout (>6d)||1||
48568055|NCT03192488|101724473|FG003|NOT COMPLETED|First Washout (>6d)||0||
48568056|NCT03192488|101724474|FG004|NOT COMPLETED|First Washout (>6d)||0||
48568057|NCT03192488|101724475|FG005|NOT COMPLETED|First Washout (>6d)||1||
48568058|NCT03192488|101724470|FG000|STARTED|Second Intervention (d1)||1||
48568059|NCT03192488|101724471|FG001|STARTED|Second Intervention (d1)||5||
48568060|NCT03192488|101724472|FG002|STARTED|Second Intervention (d1)||1||
48568061|NCT03192488|101724473|FG003|STARTED|Second Intervention (d1)||1||
48568062|NCT03192488|101724474|FG004|STARTED|Second Intervention (d1)||1||
48568063|NCT03192488|101724475|FG005|STARTED|Second Intervention (d1)||0||
48568064|NCT03192488|101724470|FG000|COMPLETED|Second Intervention (d1)||1||
48568065|NCT03192488|101724471|FG001|COMPLETED|Second Intervention (d1)||5||
48568066|NCT03192488|101724472|FG002|COMPLETED|Second Intervention (d1)||1||
48568067|NCT03192488|101724473|FG003|COMPLETED|Second Intervention (d1)||1||
48568068|NCT03192488|101724474|FG004|COMPLETED|Second Intervention (d1)||1||
48568069|NCT03192488|101724475|FG005|COMPLETED|Second Intervention (d1)||0||
48568070|NCT03192488|101724470|FG000|NOT COMPLETED|Second Intervention (d1)||0||
48568071|NCT03192488|101724471|FG001|NOT COMPLETED|Second Intervention (d1)||0||
48568072|NCT03192488|101724472|FG002|NOT COMPLETED|Second Intervention (d1)||0||
48568073|NCT03192488|101724473|FG003|NOT COMPLETED|Second Intervention (d1)||0||
48568074|NCT03192488|101724474|FG004|NOT COMPLETED|Second Intervention (d1)||0||
48568075|NCT03192488|101724475|FG005|NOT COMPLETED|Second Intervention (d1)||0||
48568076|NCT03192488|101724470|FG000|STARTED|Second Washout (>6d)||1||
48568077|NCT03192488|101724471|FG001|STARTED|Second Washout (>6d)||5||
48568078|NCT03192488|101724472|FG002|STARTED|Second Washout (>6d)||1||
48568079|NCT03192488|101724473|FG003|STARTED|Second Washout (>6d)||1||
48568080|NCT03192488|101724474|FG004|STARTED|Second Washout (>6d)||1||
48568081|NCT03192488|101724475|FG005|STARTED|Second Washout (>6d)||0||
48568082|NCT03192488|101724470|FG000|COMPLETED|Second Washout (>6d)||1||
48568083|NCT03192488|101724471|FG001|COMPLETED|Second Washout (>6d)||5||
48568084|NCT03192488|101724472|FG002|COMPLETED|Second Washout (>6d)||1||
48568085|NCT03192488|101724473|FG003|COMPLETED|Second Washout (>6d)||1||
48568086|NCT03192488|101724474|FG004|COMPLETED|Second Washout (>6d)||1||
48568087|NCT03192488|101724475|FG005|COMPLETED|Second Washout (>6d)||0||
48568088|NCT03192488|101724470|FG000|NOT COMPLETED|Second Washout (>6d)||0||
48568089|NCT03192488|101724471|FG001|NOT COMPLETED|Second Washout (>6d)||0||
48568090|NCT03192488|101724472|FG002|NOT COMPLETED|Second Washout (>6d)||0||
48568091|NCT03192488|101724473|FG003|NOT COMPLETED|Second Washout (>6d)||0||
48568092|NCT03192488|101724474|FG004|NOT COMPLETED|Second Washout (>6d)||0||
48568093|NCT03192488|101724475|FG005|NOT COMPLETED|Second Washout (>6d)||0||
48568094|NCT03192488|101724470|FG000|STARTED|Third Intervention (d1)||1||
48568095|NCT03192488|101724471|FG001|STARTED|Third Intervention (d1)||5||
48281234|NCT01451827|101014106|FG001|COMPLETED|Overall Study||40||
48281235|NCT01451827|101014107|FG002|COMPLETED|Overall Study||42||
48281236|NCT01451827|101014108|FG003|COMPLETED|Overall Study||39||
48281237|NCT01451827|101014105|FG000|NOT COMPLETED|Overall Study||3||
48281238|NCT01451827|101014106|FG001|NOT COMPLETED|Overall Study||5||
48281239|NCT01451827|101014107|FG002|NOT COMPLETED|Overall Study||2||
48281240|NCT01451827|101014108|FG003|NOT COMPLETED|Overall Study||4||
48281241|NCT02571153|101014109|FG000|STARTED|Overall Study||45||
48281242|NCT02571153|101014110|FG001|STARTED|Overall Study||45||
48281243|NCT02571153|101014111|FG002|STARTED|Overall Study||45||
48281244|NCT02571153|101014109|FG000|COMPLETED|Overall Study||39||
48281245|NCT02571153|101014110|FG001|COMPLETED|Overall Study||37||
48281246|NCT02571153|101014111|FG002|COMPLETED|Overall Study||43||
48281247|NCT02571153|101014109|FG000|NOT COMPLETED|Overall Study||6||
48281248|NCT02571153|101014110|FG001|NOT COMPLETED|Overall Study||8||
48281249|NCT02571153|101014111|FG002|NOT COMPLETED|Overall Study||2||
48568096|NCT03192488|101724472|FG002|STARTED|Third Intervention (d1)||1||
48568097|NCT03192488|101724473|FG003|STARTED|Third Intervention (d1)||1||
48568098|NCT03192488|101724474|FG004|STARTED|Third Intervention (d1)||1||
48568099|NCT03192488|101724475|FG005|STARTED|Third Intervention (d1)||0||
48568100|NCT03192488|101724470|FG000|COMPLETED|Third Intervention (d1)||1||
48568101|NCT03192488|101724471|FG001|COMPLETED|Third Intervention (d1)||5||
48568102|NCT03192488|101724472|FG002|COMPLETED|Third Intervention (d1)||1||
48281250|NCT00490490|101014112|FG000|STARTED|Completed Assessment for CR||8||
48568103|NCT03192488|101724473|FG003|COMPLETED|Third Intervention (d1)||1||
48568104|NCT03192488|101724474|FG004|COMPLETED|Third Intervention (d1)||0||
48568105|NCT03192488|101724475|FG005|COMPLETED|Third Intervention (d1)||0||
48281251|NCT00490490|101014112|FG000|COMPLETED|Completed Assessment for CR||8||
48568106|NCT03192488|101724470|FG000|NOT COMPLETED|Third Intervention (d1)||0||
48568107|NCT03192488|101724471|FG001|NOT COMPLETED|Third Intervention (d1)||0||
48568108|NCT03192488|101724472|FG002|NOT COMPLETED|Third Intervention (d1)||0||
48568109|NCT03192488|101724473|FG003|NOT COMPLETED|Third Intervention (d1)||0||
48281252|NCT00490490|101014112|FG000|NOT COMPLETED|Completed Assessment for CR||0||
48281253|NCT00490490|101014112|FG000|STARTED|Completed Assessment for TTP||8||
48281254|NCT00490490|101014112|FG000|COMPLETED|Completed Assessment for TTP||5||
48568110|NCT03192488|101724474|FG004|NOT COMPLETED|Third Intervention (d1)||1||
48568111|NCT03192488|101724475|FG005|NOT COMPLETED|Third Intervention (d1)||0||
48568112|NCT00558467|101724476|FG000|STARTED|Overall Study||20||
48568113|NCT00558467|101724477|FG001|STARTED|Overall Study||43||
48568114|NCT00558467|101724476|FG000|COMPLETED|Overall Study||19||
48568115|NCT00558467|101724477|FG001|COMPLETED|Overall Study||39||
48568116|NCT00558467|101724476|FG000|NOT COMPLETED|Overall Study||1||
48568117|NCT00558467|101724477|FG001|NOT COMPLETED|Overall Study||4||
48568118|NCT02962648|101724478|FG000|STARTED|Overall Study||103||
48568119|NCT02962648|101724478|FG000|COMPLETED|Overall Study||94||
48568120|NCT02962648|101724478|FG000|NOT COMPLETED|Overall Study||9||
48568121|NCT02151851|101724479|FG000|STARTED|Overall Study||114||
48568122|NCT02151851|101724480|FG001|STARTED|Overall Study||316||
48568123|NCT02151851|101724479|FG000|Included in the Safety Set|Overall Study||113||
48568124|NCT02151851|101724480|FG001|Included in the Safety Set|Overall Study||316||
48281255|NCT00490490|101014112|FG000|NOT COMPLETED|Completed Assessment for TTP||3||
48281256|NCT04619251|101014113|FG000|STARTED|Period 1||6||
48281257|NCT04619251|101014114|FG001|STARTED|Period 1||6||
48281258|NCT04619251|101014115|FG002|STARTED|Period 1||6||
48281259|NCT04619251|101014116|FG003|STARTED|Period 1||3||
48281260|NCT04619251|101014117|FG004|STARTED|Period 1||3||
48281261|NCT04619251|101014118|FG005|STARTED|Period 1||3||
48281262|NCT04619251|101014119|FG006|STARTED|Period 1||9||
48281263|NCT04619251|101014120|FG007|STARTED|Period 1||9||
48568125|NCT02151851|101724479|FG000|COMPLETED|Overall Study||38||
48568126|NCT02151851|101724480|FG001|COMPLETED|Overall Study||186||
48568127|NCT02151851|101724479|FG000|NOT COMPLETED|Overall Study||76||
48568128|NCT02151851|101724480|FG001|NOT COMPLETED|Overall Study||130||
48568129|NCT00462709|101724481|FG000|STARTED|Overall Study||146||
48568130|NCT00462709|101724481|FG000|COMPLETED|Overall Study||79||
48568131|NCT00462709|101724481|FG000|NOT COMPLETED|Overall Study||67||
48568132|NCT02525783|101724482|FG000|STARTED|Overall Study||157||
48568133|NCT02525783|101724482|FG000|COMPLETED|Overall Study||147||
48568134|NCT02525783|101724482|FG000|NOT COMPLETED|Overall Study||10||
48281264|NCT04619251|101014121|FG008|STARTED|Period 1||9||
48281265|NCT04619251|101014122|FG009|STARTED|Period 1||6||
48281266|NCT04619251|101014123|FG010|STARTED|Period 1||14||
48281267|NCT04619251|101014113|FG000|COMPLETED|Period 1||6||
48281268|NCT04619251|101014114|FG001|COMPLETED|Period 1||6||
48281269|NCT04619251|101014115|FG002|COMPLETED|Period 1||6||
48281270|NCT04619251|101014116|FG003|COMPLETED|Period 1||3||
48281271|NCT04619251|101014117|FG004|COMPLETED|Period 1||3||
48281272|NCT04619251|101014118|FG005|COMPLETED|Period 1||3||
48281273|NCT04619251|101014119|FG006|COMPLETED|Period 1||9||
48281274|NCT04619251|101014120|FG007|COMPLETED|Period 1||9||
48281275|NCT04619251|101014121|FG008|COMPLETED|Period 1||9||
48281276|NCT04619251|101014122|FG009|COMPLETED|Period 1||6||
48281277|NCT04619251|101014123|FG010|COMPLETED|Period 1||14||
48281278|NCT04619251|101014113|FG000|NOT COMPLETED|Period 1||0||
48281279|NCT04619251|101014114|FG001|NOT COMPLETED|Period 1||0||
48281280|NCT04619251|101014115|FG002|NOT COMPLETED|Period 1||0||
48281281|NCT04619251|101014116|FG003|NOT COMPLETED|Period 1||0||
48281282|NCT04619251|101014117|FG004|NOT COMPLETED|Period 1||0||
48281283|NCT04619251|101014118|FG005|NOT COMPLETED|Period 1||0||
48281284|NCT04619251|101014119|FG006|NOT COMPLETED|Period 1||0||
48281285|NCT04619251|101014120|FG007|NOT COMPLETED|Period 1||0||
48568135|NCT03123393|101724483|FG000|STARTED|Overall Study||24||
48568136|NCT03123393|101724484|FG001|STARTED|Overall Study||25||
48281286|NCT04619251|101014121|FG008|NOT COMPLETED|Period 1||0||
48281287|NCT04619251|101014122|FG009|NOT COMPLETED|Period 1||0||
48281288|NCT04619251|101014123|FG010|NOT COMPLETED|Period 1||0||
48281289|NCT04619251|101014113|FG000|STARTED|Period 2||0||
48281290|NCT04619251|101014114|FG001|STARTED|Period 2||0||
48281291|NCT04619251|101014115|FG002|STARTED|Period 2||0||
48281292|NCT04619251|101014116|FG003|STARTED|Period 2||0||
48281293|NCT04619251|101014117|FG004|STARTED|Period 2||0||
48281294|NCT04619251|101014118|FG005|STARTED|Period 2||0||
48281295|NCT04619251|101014119|FG006|STARTED|Period 2||0||
48568137|NCT03123393|101724483|FG000|COMPLETED|Overall Study||3||
48568138|NCT03123393|101724484|FG001|COMPLETED|Overall Study||2||
48568139|NCT03123393|101724483|FG000|NOT COMPLETED|Overall Study||21||
48568140|NCT03123393|101724484|FG001|NOT COMPLETED|Overall Study||23||
48568141|NCT01051791|101724485|FG000|STARTED|Overall Study||13||
48568142|NCT01051791|101724485|FG000|COMPLETED|Overall Study||9||
48568143|NCT01051791|101724485|FG000|NOT COMPLETED|Overall Study||4||
48568144|NCT03944668|101724486|FG000|STARTED|Overall Study||17||
48281296|NCT04619251|101014120|FG007|STARTED|Period 2||0||
48281297|NCT04619251|101014121|FG008|STARTED|Period 2||0||
48281298|NCT04619251|101014122|FG009|STARTED|Period 2||0||
48281299|NCT04619251|101014123|FG010|STARTED|Period 2||14||
48281300|NCT04619251|101014113|FG000|COMPLETED|Period 2||0||
48281301|NCT04619251|101014114|FG001|COMPLETED|Period 2||0||
48281302|NCT04619251|101014115|FG002|COMPLETED|Period 2||0||
48568145|NCT03944668|101724486|FG000|Able to Use Patient Data|Overall Study||14||
48568146|NCT03944668|101724486|FG000|Participated in Intervention|Overall Study||10||
48568147|NCT03944668|101724486|FG000|COMPLETED|Overall Study||8||
48568148|NCT03944668|101724486|FG000|NOT COMPLETED|Overall Study||9||
48568149|NCT02506868|101724487|FG000|STARTED|Main Period of Study (24 Weeks)||98||
48568150|NCT02506868|101724488|FG001|STARTED|Main Period of Study (24 Weeks)||98||
48568151|NCT02506868|101724487|FG000|mITT Population|Main Period of Study (24 Weeks)||98|The analysis included all patients who received at least one injection of BCD-066 or Aranesp.|
48568152|NCT02506868|101724488|FG001|mITT Population|Main Period of Study (24 Weeks)||97|The analysis included all patients who received at least one injection of BCD-066 or Aranesp.|
48568153|NCT02506868|101724487|FG000|Per Protocol Population|Main Period of Study (24 Weeks)||86|The analysis included all patients who completed 24 weeks of study|
48568154|NCT02506868|101724488|FG001|Per Protocol Population|Main Period of Study (24 Weeks)||90|The analysis included all patients who completed 24 weeks of study|
48568155|NCT02506868|101724487|FG000|COMPLETED|Main Period of Study (24 Weeks)||86||
48568156|NCT02506868|101724488|FG001|COMPLETED|Main Period of Study (24 Weeks)||90||
48568157|NCT02506868|101724487|FG000|NOT COMPLETED|Main Period of Study (24 Weeks)||12||
48568158|NCT02506868|101724488|FG001|NOT COMPLETED|Main Period of Study (24 Weeks)||8||
48568159|NCT02506868|101724487|FG000|STARTED|Additional Period of Study (Until 52W)||86||
48568160|NCT02506868|101724488|FG001|STARTED|Additional Period of Study (Until 52W)||90||
48568161|NCT02506868|101724487|FG000|COMPLETED|Additional Period of Study (Until 52W)||83||
48568162|NCT02506868|101724488|FG001|COMPLETED|Additional Period of Study (Until 52W)||85||
48568163|NCT02506868|101724487|FG000|NOT COMPLETED|Additional Period of Study (Until 52W)||3||
48568164|NCT02506868|101724488|FG001|NOT COMPLETED|Additional Period of Study (Until 52W)||5||
48568165|NCT02887183|101724489|FG000|STARTED|Overall Study||795||
48568166|NCT02887183|101724489|FG000|Full Analysis Set|Overall Study||794||
48568167|NCT02887183|101724489|FG000|COMPLETED|Overall Study||654||
48568168|NCT02887183|101724489|FG000|NOT COMPLETED|Overall Study||141||
48568169|NCT03340454|101724490|FG000|STARTED|Overall Study||67||
48568170|NCT03340454|101724491|FG001|STARTED|Overall Study||68||
48568171|NCT03340454|101724490|FG000|COMPLETED|Overall Study||67||
48568172|NCT03340454|101724491|FG001|COMPLETED|Overall Study||64||
48568173|NCT03340454|101724490|FG000|NOT COMPLETED|Overall Study||0||
48281303|NCT04619251|101014116|FG003|COMPLETED|Period 2||0||
48281304|NCT04619251|101014117|FG004|COMPLETED|Period 2||0||
48281305|NCT04619251|101014118|FG005|COMPLETED|Period 2||0||
48568174|NCT03340454|101724491|FG001|NOT COMPLETED|Overall Study||4||
48568175|NCT01719367|101724492|FG000|STARTED|Overall Study||19||
48568176|NCT01719367|101724493|FG001|STARTED|Overall Study||19||
48568177|NCT01719367|101724492|FG000|COMPLETED|Overall Study||19||
48568178|NCT01719367|101724493|FG001|COMPLETED|Overall Study||19||
48568179|NCT01719367|101724492|FG000|NOT COMPLETED|Overall Study||0||
48568180|NCT01719367|101724493|FG001|NOT COMPLETED|Overall Study||0||
48568181|NCT00536939|101724494|FG000|STARTED|Overall Study||2||
48568182|NCT00536939|101724495|FG001|STARTED|Overall Study||0||
48568183|NCT00536939|101724494|FG000|Entered Safety lead-in|Overall Study||2||
48568184|NCT00536939|101724495|FG001|Entered Safety lead-in|Overall Study||0||
48568185|NCT00536939|101724494|FG000|Randomized|Overall Study||0||
48568186|NCT00536939|101724495|FG001|Randomized|Overall Study||0||
48568187|NCT00536939|101724494|FG000|COMPLETED|Overall Study||0||
48568188|NCT00536939|101724495|FG001|COMPLETED|Overall Study||0||
48568189|NCT00536939|101724494|FG000|NOT COMPLETED|Overall Study||2||
48568190|NCT00536939|101724495|FG001|NOT COMPLETED|Overall Study||0||
48568191|NCT00386360|101724496|FG000|STARTED|Overall Study||49||
48568192|NCT00386360|101724497|FG001|STARTED|Overall Study||112||
48568193|NCT00386360|101724496|FG000|Intent to Treat Population (ITT)|Overall Study||49||
48568194|NCT00386360|101724497|FG001|Intent to Treat Population (ITT)|Overall Study||110||
48568195|NCT00386360|101724496|FG000|Primary Efficacy|Overall Study||36||
48568196|NCT00386360|101724497|FG001|Primary Efficacy|Overall Study||77||
48568197|NCT00386360|101724496|FG000|COMPLETED|Overall Study||40||
48281306|NCT04619251|101014119|FG006|COMPLETED|Period 2||0||
48281307|NCT04619251|101014120|FG007|COMPLETED|Period 2||0||
48281308|NCT04619251|101014121|FG008|COMPLETED|Period 2||0||
48281309|NCT04619251|101014122|FG009|COMPLETED|Period 2||0||
48568198|NCT00386360|101724497|FG001|COMPLETED|Overall Study||95||
48568199|NCT00386360|101724496|FG000|NOT COMPLETED|Overall Study||9||
48568200|NCT00386360|101724497|FG001|NOT COMPLETED|Overall Study||17||
48568201|NCT01002989|101724498|FG000|STARTED|Overall Study||98||
48568202|NCT01002989|101724498|FG000|COMPLETED|Overall Study||93||
48568203|NCT01002989|101724498|FG000|NOT COMPLETED|Overall Study||5||
48568204|NCT02898597|101724499|FG000|STARTED|Overall Study||25||
48281310|NCT04619251|101014123|FG010|COMPLETED|Period 2||14||
48281311|NCT04619251|101014113|FG000|NOT COMPLETED|Period 2||0||
48568205|NCT02898597|101724500|FG001|STARTED|Overall Study||24||
48568206|NCT02898597|101724499|FG000|COMPLETED|Overall Study||21||
48568207|NCT02898597|101724500|FG001|COMPLETED|Overall Study||12||
48568208|NCT02898597|101724499|FG000|NOT COMPLETED|Overall Study||4||
48568209|NCT02898597|101724500|FG001|NOT COMPLETED|Overall Study||12||
48281312|NCT04619251|101014114|FG001|NOT COMPLETED|Period 2||0||
48568210|NCT01051596|101724501|FG000|STARTED|Overall Study||75||
48568211|NCT01051596|101724501|FG000|COMPLETED|Overall Study||75||
48568212|NCT01051596|101724501|FG000|NOT COMPLETED|Overall Study||0||
48568213|NCT00245466|101724502|FG000|STARTED|Overall Study||43||
48568214|NCT00245466|101724503|FG001|STARTED|Overall Study||46||
48568215|NCT00245466|101724504|FG002|STARTED|Overall Study||40||
48568216|NCT00245466|101724502|FG000|Started FE200486 CS02A|Overall Study||32||
48568217|NCT00245466|101724503|FG001|Started FE200486 CS02A|Overall Study||30||
48568218|NCT00245466|101724504|FG002|Started FE200486 CS02A|Overall Study||26||
48568219|NCT00245466|101724502|FG000|COMPLETED|Overall Study||7||
48568220|NCT00245466|101724503|FG001|COMPLETED|Overall Study||2||
48568221|NCT00245466|101724504|FG002|COMPLETED|Overall Study||3||
48568222|NCT00245466|101724502|FG000|NOT COMPLETED|Overall Study||36||
48568223|NCT00245466|101724503|FG001|NOT COMPLETED|Overall Study||44||
48568224|NCT00245466|101724504|FG002|NOT COMPLETED|Overall Study||37||
48568225|NCT01609296|101724505|FG000|STARTED|Overall Study||1406||
48568226|NCT01609296|101724505|FG000|COMPLETED|Overall Study||918||
48568227|NCT01609296|101724505|FG000|NOT COMPLETED|Overall Study||488||
48568228|NCT02198664|101724506|FG000|STARTED|Overall Study||26||
48568229|NCT02198664|101724507|FG001|STARTED|Overall Study||21||
48568230|NCT02198664|101724506|FG000|COMPLETED|Overall Study||10||
48568231|NCT02198664|101724507|FG001|COMPLETED|Overall Study||13||
48568232|NCT02198664|101724506|FG000|NOT COMPLETED|Overall Study||16||
48568233|NCT02198664|101724507|FG001|NOT COMPLETED|Overall Study||8||
48568234|NCT01464333|101724508|FG000|STARTED|Overall Study||389||
48568235|NCT01464333|101724508|FG000|COMPLETED|Overall Study||226||
48568236|NCT01464333|101724508|FG000|NOT COMPLETED|Overall Study||163||
48568237|NCT04544241|101724509|FG000|STARTED|Overall Study||37||
48568238|NCT04544241|101724509|FG000|COMPLETED|Overall Study||37||
48568239|NCT04544241|101724509|FG000|NOT COMPLETED|Overall Study||0||
48568240|NCT02569801|101724510|FG000|STARTED|Overall Study||36|Started=Randomized|
48568241|NCT02569801|101724511|FG001|STARTED|Overall Study||35|Started=Randomized|
48568242|NCT02569801|101724510|FG000|Received Treatment|Overall Study||35||
48568243|NCT02569801|101724511|FG001|Received Treatment|Overall Study||35||
48568244|NCT02569801|101724510|FG000|COMPLETED|Overall Study||0||
48568245|NCT02569801|101724511|FG001|COMPLETED|Overall Study||0||
48568246|NCT02569801|101724510|FG000|NOT COMPLETED|Overall Study||36||
48568247|NCT02569801|101724511|FG001|NOT COMPLETED|Overall Study||35||
48568248|NCT02176655|101724512|FG000|STARTED|Overall Study||31||
48568249|NCT02176655|101724512|FG000|COMPLETED|Overall Study||25||
48568250|NCT02176655|101724512|FG000|NOT COMPLETED|Overall Study||6||
48568251|NCT00774163|101724513|FG000|STARTED|Overall Study||30||
48568252|NCT00774163|101724514|FG001|STARTED|Overall Study||15||
48568253|NCT00774163|101724513|FG000|COMPLETED|Overall Study||30||
48568254|NCT00774163|101724514|FG001|COMPLETED|Overall Study||15||
48568255|NCT00774163|101724513|FG000|NOT COMPLETED|Overall Study||0||
48568256|NCT00774163|101724514|FG001|NOT COMPLETED|Overall Study||0||
48568257|NCT00818766|101724515|FG000|STARTED|Overall Study||125||
48568258|NCT00818766|101724516|FG001|STARTED|Overall Study||126||
48568259|NCT00818766|101724515|FG000|Received Allocated Intervention|Overall Study||122||
48568260|NCT00818766|101724516|FG001|Received Allocated Intervention|Overall Study||126||
48281313|NCT04619251|101014115|FG002|NOT COMPLETED|Period 2||0||
48281314|NCT04619251|101014116|FG003|NOT COMPLETED|Period 2||0||
48568261|NCT00818766|101724515|FG000|Intent-to-Treat Population|Overall Study||121||
48568262|NCT00818766|101724516|FG001|Intent-to-Treat Population|Overall Study||124||
48568263|NCT00818766|101724515|FG000|COMPLETED|Overall Study||110|Completed = completed through 28-day follow-up phone call|
48568264|NCT00818766|101724516|FG001|COMPLETED|Overall Study||116|Completed = completed through 28-day follow-up phone call|
48568265|NCT00818766|101724515|FG000|NOT COMPLETED|Overall Study||15||
48568266|NCT00818766|101724516|FG001|NOT COMPLETED|Overall Study||10||
48568267|NCT04548193|101724517|FG000|STARTED|Overall Study||25||
48568268|NCT04548193|101724518|FG001|STARTED|Overall Study||24||
48568269|NCT04548193|101724517|FG000|COMPLETED|Overall Study||22||
48568270|NCT04548193|101724518|FG001|COMPLETED|Overall Study||20||
48568271|NCT04548193|101724517|FG000|NOT COMPLETED|Overall Study||3||
48568272|NCT04548193|101724518|FG001|NOT COMPLETED|Overall Study||4||
48568273|NCT04031846|101724519|FG000|STARTED|Overall Study||591||
48568274|NCT04031846|101724520|FG001|STARTED|Overall Study||593||
48568275|NCT04031846|101724519|FG000|Vaccinated|Overall Study||588||
48281315|NCT04619251|101014117|FG004|NOT COMPLETED|Period 2||0||
48568276|NCT04031846|101724520|FG001|Vaccinated|Overall Study||591||
48281316|NCT04619251|101014118|FG005|NOT COMPLETED|Period 2||0||
48568277|NCT04031846|101724519|FG000|All Participants As Treated|Overall Study||587||
48568278|NCT04031846|101724520|FG001|All Participants As Treated|Overall Study||591||
48568279|NCT04031846|101724519|FG000|PCV Dose at Age 2 Months|Overall Study||588||
48568280|NCT04031846|101724520|FG001|PCV Dose at Age 2 Months|Overall Study||591||
48568281|NCT04031846|101724519|FG000|PCV Dose at Age 3 Months|Overall Study||32||
48568282|NCT04031846|101724520|FG001|PCV Dose at Age 3 Months|Overall Study||35||
48568283|NCT04031846|101724519|FG000|PCV Dose at Age 4 Months|Overall Study||582||
48568284|NCT04031846|101724520|FG001|PCV Dose at Age 4 Months|Overall Study||584||
48568285|NCT04031846|101724519|FG000|PCV Dose at Age 11-15 Months|Overall Study||571||
48592792|NCT01764997|101783184|FG002|STARTED|Run-in Period||0||
48281317|NCT04619251|101014119|FG006|NOT COMPLETED|Period 2||0||
48568286|NCT04031846|101724520|FG001|PCV Dose at Age 11-15 Months|Overall Study||574||
48568287|NCT04031846|101724519|FG000|COMPLETED|Overall Study||569||
48568288|NCT04031846|101724520|FG001|COMPLETED|Overall Study||570||
48568289|NCT04031846|101724519|FG000|NOT COMPLETED|Overall Study||22||
48568290|NCT04031846|101724520|FG001|NOT COMPLETED|Overall Study||23||
48568291|NCT03051100|101724521|FG000|STARTED|Overall Study||20||
48568292|NCT03051100|101724522|FG001|STARTED|Overall Study||43||
48568293|NCT03051100|101724521|FG000|COMPLETED|Overall Study||19||
48568294|NCT03051100|101724522|FG001|COMPLETED|Overall Study||43||
48568295|NCT03051100|101724521|FG000|NOT COMPLETED|Overall Study||1||
48568296|NCT03051100|101724522|FG001|NOT COMPLETED|Overall Study||0||
48568297|NCT00684411|101724523|FG000|STARTED|Overall Study||12||
48568298|NCT00684411|101724523|FG000|Disease Evaluable|Overall Study||11||
48568299|NCT00684411|101724523|FG000|COMPLETED|Overall Study||0||
48568300|NCT00684411|101724523|FG000|NOT COMPLETED|Overall Study||12||
48568301|NCT04370873|101724524|FG000|STARTED|Part 1: 7-day Dosing||6||
48568302|NCT04370873|101724525|FG001|STARTED|Part 1: 7-day Dosing||3||
48568303|NCT04370873|101724526|FG002|STARTED|Part 1: 7-day Dosing||0||
48568304|NCT04370873|101724527|FG003|STARTED|Part 1: 7-day Dosing||0||
48568305|NCT04370873|101724524|FG000|COMPLETED|Part 1: 7-day Dosing||6||
48568306|NCT04370873|101724525|FG001|COMPLETED|Part 1: 7-day Dosing||3||
48568307|NCT04370873|101724526|FG002|COMPLETED|Part 1: 7-day Dosing||0||
48568308|NCT04370873|101724527|FG003|COMPLETED|Part 1: 7-day Dosing||0||
48568309|NCT04370873|101724524|FG000|NOT COMPLETED|Part 1: 7-day Dosing||0||
48568310|NCT04370873|101724525|FG001|NOT COMPLETED|Part 1: 7-day Dosing||0||
48568311|NCT04370873|101724526|FG002|NOT COMPLETED|Part 1: 7-day Dosing||0||
48568312|NCT04370873|101724527|FG003|NOT COMPLETED|Part 1: 7-day Dosing||0||
48568313|NCT04370873|101724524|FG000|STARTED|Part 2: 28-day Dosing||0||
48568314|NCT04370873|101724525|FG001|STARTED|Part 2: 28-day Dosing||0||
48568315|NCT04370873|101724526|FG002|STARTED|Part 2: 28-day Dosing||8||
48568316|NCT04370873|101724527|FG003|STARTED|Part 2: 28-day Dosing||5||
48568317|NCT04370873|101724524|FG000|COMPLETED|Part 2: 28-day Dosing||0||
48568318|NCT04370873|101724525|FG001|COMPLETED|Part 2: 28-day Dosing||0||
48568319|NCT04370873|101724526|FG002|COMPLETED|Part 2: 28-day Dosing||8||
48568320|NCT04370873|101724527|FG003|COMPLETED|Part 2: 28-day Dosing||5||
48568321|NCT04370873|101724524|FG000|NOT COMPLETED|Part 2: 28-day Dosing||0||
48568322|NCT04370873|101724525|FG001|NOT COMPLETED|Part 2: 28-day Dosing||0||
48568323|NCT04370873|101724526|FG002|NOT COMPLETED|Part 2: 28-day Dosing||0||
48568324|NCT04370873|101724527|FG003|NOT COMPLETED|Part 2: 28-day Dosing||0||
48568325|NCT01996241|101724528|FG000|STARTED|Overall Study||1164||40
48568326|NCT01996241|101724529|FG001|STARTED|Overall Study||1111||40
48568327|NCT01996241|101724528|FG000|COMPLETED|Overall Study||912||40
48568328|NCT01996241|101724529|FG001|COMPLETED|Overall Study||876||40
48568329|NCT01996241|101724528|FG000|NOT COMPLETED|Overall Study||252||0
48568330|NCT01996241|101724529|FG001|NOT COMPLETED|Overall Study||235||0
48568331|NCT01100086|101724530|FG000|STARTED|Period 1||43||
48568332|NCT01100086|101724531|FG001|STARTED|Period 1||41||
48568333|NCT01100086|101724530|FG000|COMPLETED|Period 1||42||
48568334|NCT01100086|101724531|FG001|COMPLETED|Period 1||41||
48568335|NCT01100086|101724530|FG000|NOT COMPLETED|Period 1||1||
48568336|NCT01100086|101724531|FG001|NOT COMPLETED|Period 1||0||
48568337|NCT01100086|101724530|FG000|STARTED|Period 2||42||
48568338|NCT01100086|101724531|FG001|STARTED|Period 2||41||
48568339|NCT01100086|101724530|FG000|COMPLETED|Period 2||42||
48568340|NCT01100086|101724531|FG001|COMPLETED|Period 2||41||
48568341|NCT01100086|101724530|FG000|NOT COMPLETED|Period 2||0||
48568342|NCT01100086|101724531|FG001|NOT COMPLETED|Period 2||0||
48568343|NCT01479465|101724532|FG000|STARTED|Overall Study||11||
48568344|NCT01479465|101724533|FG001|STARTED|Overall Study||84||
48568345|NCT01479465|101724534|FG002|STARTED|Overall Study||86||
48568346|NCT01479465|101724535|FG003|STARTED|Overall Study||85||
48568347|NCT01479465|101724532|FG000|COMPLETED|Overall Study||0||
48568348|NCT01479465|101724533|FG001|COMPLETED|Overall Study||0||
48568349|NCT01479465|101724534|FG002|COMPLETED|Overall Study||0||
48568350|NCT01479465|101724535|FG003|COMPLETED|Overall Study||0||
48568351|NCT01479465|101724532|FG000|NOT COMPLETED|Overall Study||11||
48568352|NCT01479465|101724533|FG001|NOT COMPLETED|Overall Study||84||
48568353|NCT01479465|101724534|FG002|NOT COMPLETED|Overall Study||86||
48568354|NCT01479465|101724535|FG003|NOT COMPLETED|Overall Study||85||
48568355|NCT03150719|101724536|FG000|STARTED|Overall Study||47||
48568356|NCT03150719|101724537|FG001|STARTED|Overall Study||50||
48568357|NCT03150719|101724536|FG000|COMPLETED|Overall Study||46||
48568358|NCT03150719|101724537|FG001|COMPLETED|Overall Study||48||
48568359|NCT03150719|101724536|FG000|NOT COMPLETED|Overall Study||1||
48568360|NCT03150719|101724537|FG001|NOT COMPLETED|Overall Study||2||
48568361|NCT03682848|101724538|FG000|STARTED|Overall Study||32||
48568362|NCT03682848|101724538|FG000|COMPLETED|Overall Study||23||
48568363|NCT03682848|101724538|FG000|NOT COMPLETED|Overall Study||9||
48568364|NCT02593097|101724539|FG000|STARTED|First Intervention (12 Weeks)||14||
48568365|NCT02593097|101724540|FG001|STARTED|First Intervention (12 Weeks)||20||
48568366|NCT02593097|101724539|FG000|Received Intervention|First Intervention (12 Weeks)||14||
48568367|NCT02593097|101724540|FG001|Received Intervention|First Intervention (12 Weeks)||20||
48568368|NCT02593097|101724539|FG000|COMPLETED|First Intervention (12 Weeks)||12||
48568369|NCT02593097|101724540|FG001|COMPLETED|First Intervention (12 Weeks)||16||
48568370|NCT02593097|101724539|FG000|NOT COMPLETED|First Intervention (12 Weeks)||2||
48568371|NCT02593097|101724540|FG001|NOT COMPLETED|First Intervention (12 Weeks)||4||
48568372|NCT02593097|101724539|FG000|STARTED|Washout (4 Weeks)||12||
48568373|NCT02593097|101724540|FG001|STARTED|Washout (4 Weeks)||16||
48568374|NCT02593097|101724539|FG000|COMPLETED|Washout (4 Weeks)||12||
48568375|NCT02593097|101724540|FG001|COMPLETED|Washout (4 Weeks)||16||
48568376|NCT02593097|101724539|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
48568377|NCT02593097|101724540|FG001|NOT COMPLETED|Washout (4 Weeks)||0||
48568378|NCT02593097|101724539|FG000|STARTED|Second Intervention (12 Weeks)||12||
48568379|NCT02593097|101724540|FG001|STARTED|Second Intervention (12 Weeks)||16||
48568380|NCT02593097|101724539|FG000|COMPLETED|Second Intervention (12 Weeks)||9||
48568381|NCT02593097|101724540|FG001|COMPLETED|Second Intervention (12 Weeks)||15||
48568382|NCT02593097|101724539|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||3||
48568383|NCT02593097|101724540|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||1||
48568384|NCT00917852|101724541|FG000|STARTED|Overall Study||51||
48568385|NCT00917852|101724541|FG000|COMPLETED|Overall Study||45||
48568386|NCT00917852|101724541|FG000|NOT COMPLETED|Overall Study||6||
48568387|NCT01464424|101724542|FG000|STARTED|Period 1, First 6 Weeks||42||
48568388|NCT01464424|101724543|FG001|STARTED|Period 1, First 6 Weeks||42||
48568389|NCT01464424|101724542|FG000|COMPLETED|Period 1, First 6 Weeks||42||
48568390|NCT01464424|101724543|FG001|COMPLETED|Period 1, First 6 Weeks||41||
48568391|NCT01464424|101724542|FG000|NOT COMPLETED|Period 1, First 6 Weeks||0||
48568392|NCT01464424|101724543|FG001|NOT COMPLETED|Period 1, First 6 Weeks||1||
48568393|NCT01464424|101724542|FG000|STARTED|Period 2, Second 6 Weeks||42||
48568394|NCT01464424|101724543|FG001|STARTED|Period 2, Second 6 Weeks||41||
48568395|NCT01464424|101724542|FG000|COMPLETED|Period 2, Second 6 Weeks||42||
48568396|NCT01464424|101724543|FG001|COMPLETED|Period 2, Second 6 Weeks||41||
48568397|NCT01464424|101724542|FG000|NOT COMPLETED|Period 2, Second 6 Weeks||0||
48568398|NCT01464424|101724543|FG001|NOT COMPLETED|Period 2, Second 6 Weeks||0||
48568399|NCT02518048|101724544|FG000|STARTED|Overall Study||35||
48568400|NCT02518048|101724544|FG000|COMPLETED|Overall Study||34||
48568401|NCT02518048|101724544|FG000|NOT COMPLETED|Overall Study||1||
48568402|NCT00611923|101724545|FG000|STARTED|Overall Study||12||
48568403|NCT00611923|101724546|FG001|STARTED|Overall Study||13||
48568404|NCT00611923|101724545|FG000|COMPLETED|Overall Study||10||
48568405|NCT00611923|101724546|FG001|COMPLETED|Overall Study||11||
48568406|NCT00611923|101724545|FG000|NOT COMPLETED|Overall Study||2||
48568407|NCT00611923|101724546|FG001|NOT COMPLETED|Overall Study||2||
48568408|NCT00746889|101724547|FG000|STARTED|Overall Study||40||
48568409|NCT00746889|101724548|FG001|STARTED|Overall Study||39||
48568410|NCT00746889|101724547|FG000|COMPLETED|Overall Study||36||
48568411|NCT00746889|101724548|FG001|COMPLETED|Overall Study||35||
48568412|NCT00746889|101724547|FG000|NOT COMPLETED|Overall Study||4||
48568413|NCT00746889|101724548|FG001|NOT COMPLETED|Overall Study||4||
48568414|NCT00757042|101724549|FG000|STARTED|Overall Study||6||
48568415|NCT00757042|101724550|FG001|STARTED|Overall Study||6||
48568416|NCT00757042|101724551|FG002|STARTED|Overall Study||6||
48281318|NCT04619251|101014120|FG007|NOT COMPLETED|Period 2||0||
48281319|NCT04619251|101014121|FG008|NOT COMPLETED|Period 2||0||
48281320|NCT04619251|101014122|FG009|NOT COMPLETED|Period 2||0||
48281321|NCT04619251|101014123|FG010|NOT COMPLETED|Period 2||0||
48281322|NCT02624791|101014124|FG000|STARTED|Overall Study||2||
48281323|NCT02624791|101014125|FG001|STARTED|Overall Study||1||
48281324|NCT02624791|101014126|FG002|STARTED|Overall Study||2||
48395945|NCT02759562|101299258|FG000|STARTED|Open-Label Treatment Period||2|2 participants completed the Double-Blind Phase, but did not enter in the Open-Label Phase.|
48395946|NCT02759562|101299259|FG001|STARTED|Open-Label Treatment Period||2|2 participants completed the Double-Blind Phase, but did not enter in the Open-Label Phase.|
48395947|NCT02759562|101299258|FG000|COMPLETED|Open-Label Treatment Period||0||
48395948|NCT02759562|101299259|FG001|COMPLETED|Open-Label Treatment Period||0||
48395949|NCT02759562|101299258|FG000|NOT COMPLETED|Open-Label Treatment Period||2||
48395950|NCT02759562|101299259|FG001|NOT COMPLETED|Open-Label Treatment Period||2||
48395951|NCT00364819|101299260|FG000|STARTED|Overall Study||6||
48568417|NCT00757042|101724552|FG003|STARTED|Overall Study||6||
48568418|NCT00757042|101724553|FG004|STARTED|Overall Study||6||
48568419|NCT00757042|101724554|FG005|STARTED|Overall Study||6||
48281325|NCT02624791|101014127|FG003|STARTED|Overall Study||2||
48281326|NCT02624791|101014128|FG004|STARTED|Overall Study||2||
48281327|NCT02624791|101014129|FG005|STARTED|Overall Study||2||
48281328|NCT02624791|101014124|FG000|COMPLETED|Overall Study||0||
48281329|NCT02624791|101014125|FG001|COMPLETED|Overall Study||1||
48568420|NCT00757042|101724555|FG006|STARTED|Overall Study||6||
48568421|NCT00757042|101724556|FG007|STARTED|Overall Study||6||
48568422|NCT00757042|101724557|FG008|STARTED|Overall Study||16||
48568423|NCT00757042|101724558|FG009|STARTED|Overall Study||10||
48568424|NCT00757042|101724559|FG010|STARTED|Overall Study||4||
48568425|NCT00757042|101724549|FG000|Received Study Drug|Overall Study||6||
48568426|NCT00757042|101724550|FG001|Received Study Drug|Overall Study||6||
48568427|NCT00757042|101724551|FG002|Received Study Drug|Overall Study||6||
48568428|NCT00757042|101724552|FG003|Received Study Drug|Overall Study||6||
48568429|NCT00757042|101724553|FG004|Received Study Drug|Overall Study||6||
48395952|NCT00364819|101299260|FG000|COMPLETED|Overall Study||6||
48395953|NCT00364819|101299260|FG000|NOT COMPLETED|Overall Study||0||
48395954|NCT02500368|101299261|FG000|STARTED|First Intervention (1 Week)||20||
48395955|NCT02500368|101299262|FG001|STARTED|First Intervention (1 Week)||20||
48568430|NCT00757042|101724554|FG005|Received Study Drug|Overall Study||6||
48568431|NCT00757042|101724555|FG006|Received Study Drug|Overall Study||6||
48568432|NCT00757042|101724556|FG007|Received Study Drug|Overall Study||6||
48568433|NCT00757042|101724557|FG008|Received Study Drug|Overall Study||16||
48568434|NCT00757042|101724558|FG009|Received Study Drug|Overall Study||9||
48568435|NCT00757042|101724559|FG010|Received Study Drug|Overall Study||3||
48568436|NCT00757042|101724549|FG000|COMPLETED|Overall Study||6||
48568437|NCT00757042|101724550|FG001|COMPLETED|Overall Study||6||
48568438|NCT00757042|101724551|FG002|COMPLETED|Overall Study||6||
48568439|NCT00757042|101724552|FG003|COMPLETED|Overall Study||6||
48568440|NCT00757042|101724553|FG004|COMPLETED|Overall Study||6||
48568441|NCT00757042|101724554|FG005|COMPLETED|Overall Study||6||
48568442|NCT00757042|101724555|FG006|COMPLETED|Overall Study||6||
48568443|NCT00757042|101724556|FG007|COMPLETED|Overall Study||6||
48568444|NCT00757042|101724557|FG008|COMPLETED|Overall Study||15||
48568445|NCT00757042|101724558|FG009|COMPLETED|Overall Study||9||
48568446|NCT00757042|101724559|FG010|COMPLETED|Overall Study||3||
48568447|NCT00757042|101724549|FG000|NOT COMPLETED|Overall Study||0||
48568448|NCT00757042|101724550|FG001|NOT COMPLETED|Overall Study||0||
48568449|NCT00757042|101724551|FG002|NOT COMPLETED|Overall Study||0||
48568450|NCT00757042|101724552|FG003|NOT COMPLETED|Overall Study||0||
48568451|NCT00757042|101724553|FG004|NOT COMPLETED|Overall Study||0||
48568452|NCT00757042|101724554|FG005|NOT COMPLETED|Overall Study||0||
48568453|NCT00757042|101724555|FG006|NOT COMPLETED|Overall Study||0||
48568454|NCT00757042|101724556|FG007|NOT COMPLETED|Overall Study||0||
48568455|NCT00757042|101724557|FG008|NOT COMPLETED|Overall Study||1||
48568456|NCT00757042|101724558|FG009|NOT COMPLETED|Overall Study||1||
48568457|NCT00757042|101724559|FG010|NOT COMPLETED|Overall Study||1||
48568458|NCT00251238|101724560|FG000|STARTED|Overall Study||21||
48568459|NCT00251238|101724561|FG001|STARTED|Overall Study||20||
48568460|NCT00251238|101724560|FG000|COMPLETED|Overall Study||21||
48568461|NCT00251238|101724561|FG001|COMPLETED|Overall Study||20||
48568462|NCT00251238|101724560|FG000|NOT COMPLETED|Overall Study||0||
48568463|NCT00251238|101724561|FG001|NOT COMPLETED|Overall Study||0||
48568464|NCT01295827|101724562|FG000|STARTED|Overall Study||4||
48568465|NCT01295827|101724563|FG001|STARTED|Overall Study||3||
48568466|NCT01295827|101724564|FG002|STARTED|Overall Study||12||
48568467|NCT01295827|101724565|FG003|STARTED|Overall Study||4||
48568468|NCT01295827|101724566|FG004|STARTED|Overall Study||3||
48568469|NCT01295827|101724567|FG005|STARTED|Overall Study||6||
48568470|NCT01295827|101724568|FG006|STARTED|Overall Study||164||
48568471|NCT01295827|101724569|FG007|STARTED|Overall Study||321||
48568472|NCT01295827|101724570|FG008|STARTED|Overall Study||183||
48568473|NCT01295827|101724571|FG009|STARTED|Overall Study||61||
48568474|NCT01295827|101724572|FG010|STARTED|Overall Study||296||
48281330|NCT02624791|101014126|FG002|COMPLETED|Overall Study||2||
48281331|NCT02624791|101014127|FG003|COMPLETED|Overall Study||2||
48281332|NCT02624791|101014128|FG004|COMPLETED|Overall Study||2||
48281333|NCT02624791|101014129|FG005|COMPLETED|Overall Study||2||
48281334|NCT02624791|101014124|FG000|NOT COMPLETED|Overall Study||2||
48281335|NCT02624791|101014125|FG001|NOT COMPLETED|Overall Study||0||
48281336|NCT02624791|101014126|FG002|NOT COMPLETED|Overall Study||0||
48281337|NCT02624791|101014127|FG003|NOT COMPLETED|Overall Study||0||
48281338|NCT02624791|101014128|FG004|NOT COMPLETED|Overall Study||0||
48281339|NCT02624791|101014129|FG005|NOT COMPLETED|Overall Study||0||
48281340|NCT04488770|101014130|FG000|STARTED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||2||
48395956|NCT02500368|101299261|FG000|COMPLETED|First Intervention (1 Week)||20||
48281341|NCT04488770|101014131|FG001|STARTED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||2||
48395957|NCT02500368|101299262|FG001|COMPLETED|First Intervention (1 Week)||20||
48395958|NCT02500368|101299261|FG000|NOT COMPLETED|First Intervention (1 Week)||0||
48568475|NCT01295827|101724573|FG011|STARTED|Overall Study||203||
48568476|NCT01295827|101724574|FG012|STARTED|Overall Study||0||
48568477|NCT01295827|101724575|FG013|STARTED|Overall Study||0||
48568478|NCT01295827|101724576|FG014|STARTED|Overall Study||0||
48568479|NCT01295827|101724562|FG000|Treated (All Treated Population)|Overall Study||4||
48568480|NCT01295827|101724563|FG001|Treated (All Treated Population)|Overall Study||3||
48568481|NCT01295827|101724564|FG002|Treated (All Treated Population)|Overall Study||10||
48568482|NCT01295827|101724565|FG003|Treated (All Treated Population)|Overall Study||4||
48568483|NCT01295827|101724566|FG004|Treated (All Treated Population)|Overall Study||3||
48568484|NCT01295827|101724567|FG005|Treated (All Treated Population)|Overall Study||6||
48568485|NCT01295827|101724568|FG006|Treated (All Treated Population)|Overall Study||162||
48395959|NCT02500368|101299262|FG001|NOT COMPLETED|First Intervention (1 Week)||0||
48568486|NCT01295827|101724569|FG007|Treated (All Treated Population)|Overall Study||313||
48568487|NCT01295827|101724570|FG008|Treated (All Treated Population)|Overall Study||180||
48568488|NCT01295827|101724571|FG009|Treated (All Treated Population)|Overall Study||61||
48395960|NCT02500368|101299261|FG000|STARTED|Second Intervention (1 Week)||20||
48568489|NCT01295827|101724572|FG010|Treated (All Treated Population)|Overall Study||287||
48568490|NCT01295827|101724573|FG011|Treated (All Treated Population)|Overall Study||202||
48568491|NCT01295827|101724574|FG012|Treated (All Treated Population)|Overall Study||0||
48568492|NCT01295827|101724575|FG013|Treated (All Treated Population)|Overall Study||0||
48568493|NCT01295827|101724576|FG014|Treated (All Treated Population)|Overall Study||0||
48568494|NCT01295827|101724562|FG000|COMPLETED|Overall Study||0||
48568495|NCT01295827|101724563|FG001|COMPLETED|Overall Study||0||
48568496|NCT01295827|101724564|FG002|COMPLETED|Overall Study||0||
48568497|NCT01295827|101724565|FG003|COMPLETED|Overall Study||0||
48568498|NCT01295827|101724566|FG004|COMPLETED|Overall Study||1||
48699025|NCT02309645|102050436|FG000|Full Analysis Set (FAS)|Overall Study||25||
48699026|NCT02309645|102050437|FG001|Full Analysis Set (FAS)|Overall Study||15||
48699027|NCT02309645|102050436|FG000|COMPLETED|Overall Study||26||
48699028|NCT02309645|102050437|FG001|COMPLETED|Overall Study||14||
48699029|NCT02309645|102050436|FG000|NOT COMPLETED|Overall Study||0||
48699030|NCT02309645|102050437|FG001|NOT COMPLETED|Overall Study||0||
48395961|NCT02500368|101299262|FG001|STARTED|Second Intervention (1 Week)||20||
48395962|NCT02500368|101299261|FG000|COMPLETED|Second Intervention (1 Week)||20||
48395963|NCT02500368|101299262|FG001|COMPLETED|Second Intervention (1 Week)||20||
48395964|NCT02500368|101299261|FG000|NOT COMPLETED|Second Intervention (1 Week)||0||
48395965|NCT02500368|101299262|FG001|NOT COMPLETED|Second Intervention (1 Week)||0||
48395966|NCT01753830|101299263|FG000|STARTED|Overall Study||37||
48395967|NCT01753830|101299264|FG001|STARTED|Overall Study||38||
48395968|NCT01753830|101299263|FG000|COMPLETED|Overall Study||30||
48119785|NCT04805983|100616517|FG005|Completed Baseline (Study Day 1)|Overall Study||6||
48395969|NCT01753830|101299264|FG001|COMPLETED|Overall Study||35||
48568499|NCT01295827|101724567|FG005|COMPLETED|Overall Study||0||
48568500|NCT01295827|101724568|FG006|COMPLETED|Overall Study||18||
48568501|NCT01295827|101724569|FG007|COMPLETED|Overall Study||24||
48568502|NCT01295827|101724570|FG008|COMPLETED|Overall Study||14||
48568503|NCT01295827|101724571|FG009|COMPLETED|Overall Study||6||
48568504|NCT01295827|101724572|FG010|COMPLETED|Overall Study||20||
48568505|NCT01295827|101724573|FG011|COMPLETED|Overall Study||17||
48395970|NCT01753830|101299263|FG000|NOT COMPLETED|Overall Study||7||
48395971|NCT01753830|101299264|FG001|NOT COMPLETED|Overall Study||3||
48568506|NCT01295827|101724574|FG012|COMPLETED|Overall Study||0||
48568507|NCT01295827|101724575|FG013|COMPLETED|Overall Study||0||
48568508|NCT01295827|101724576|FG014|COMPLETED|Overall Study||0||
48568509|NCT01295827|101724562|FG000|NOT COMPLETED|Overall Study||4||
48568510|NCT01295827|101724563|FG001|NOT COMPLETED|Overall Study||3||
48568511|NCT01295827|101724564|FG002|NOT COMPLETED|Overall Study||12||
48568512|NCT01295827|101724565|FG003|NOT COMPLETED|Overall Study||4||
48568513|NCT01295827|101724566|FG004|NOT COMPLETED|Overall Study||2||
48568514|NCT01295827|101724567|FG005|NOT COMPLETED|Overall Study||6||
48568515|NCT01295827|101724568|FG006|NOT COMPLETED|Overall Study||146||
48568516|NCT01295827|101724569|FG007|NOT COMPLETED|Overall Study||297||
48568517|NCT01295827|101724570|FG008|NOT COMPLETED|Overall Study||169||
48568518|NCT01295827|101724571|FG009|NOT COMPLETED|Overall Study||55||
48568519|NCT01295827|101724572|FG010|NOT COMPLETED|Overall Study||276||
48568520|NCT01295827|101724573|FG011|NOT COMPLETED|Overall Study||186||
48568521|NCT01295827|101724574|FG012|NOT COMPLETED|Overall Study||0||
48568522|NCT01295827|101724575|FG013|NOT COMPLETED|Overall Study||0||
48568523|NCT01295827|101724576|FG014|NOT COMPLETED|Overall Study||0||
48568524|NCT02877004|101724577|FG000|STARTED|Overall Study||20||
48568525|NCT02877004|101724578|FG001|STARTED|Overall Study||20||
48568526|NCT02877004|101724579|FG002|STARTED|Overall Study||20||
48568527|NCT02877004|101724577|FG000|COMPLETED|Overall Study||20||
48568528|NCT02877004|101724578|FG001|COMPLETED|Overall Study||20||
48568529|NCT02877004|101724579|FG002|COMPLETED|Overall Study||19||
48568530|NCT02877004|101724577|FG000|NOT COMPLETED|Overall Study||0||
48568531|NCT02877004|101724578|FG001|NOT COMPLETED|Overall Study||0||
48568532|NCT02877004|101724579|FG002|NOT COMPLETED|Overall Study||1||
48699031|NCT05623475|102050438|FG000|STARTED|Overall Study||61||
48699032|NCT05623475|102050439|FG001|STARTED|Overall Study||39||
48699033|NCT05623475|102050438|FG000|COMPLETED|Overall Study||59||
48699034|NCT05623475|102050439|FG001|COMPLETED|Overall Study||38||
48699035|NCT05623475|102050438|FG000|NOT COMPLETED|Overall Study||2||
48699036|NCT05623475|102050439|FG001|NOT COMPLETED|Overall Study||1||
48699037|NCT01320553|102050440|FG000|STARTED|Overall Study||31||
48699038|NCT01320553|102050441|FG001|STARTED|Overall Study||30||
48699039|NCT01320553|102050442|FG002|STARTED|Overall Study||31||
48699040|NCT01320553|102050443|FG003|STARTED|Overall Study||30||
48568533|NCT02019264|101724580|FG000|STARTED|Overall Study||6000||
48568534|NCT02019264|101724581|FG001|STARTED|Overall Study||6000||
48568535|NCT02019264|101724580|FG000|Safety Analysis Set|Overall Study||5992||
48568536|NCT02019264|101724581|FG001|Safety Analysis Set|Overall Study||5995||
48699041|NCT01320553|102050440|FG000|COMPLETED|Overall Study||30||
48699042|NCT01320553|102050441|FG001|COMPLETED|Overall Study||26||
48699043|NCT01320553|102050442|FG002|COMPLETED|Overall Study||29||
48699044|NCT01320553|102050443|FG003|COMPLETED|Overall Study||29||
48395972|NCT02527187|101299265|FG000|STARTED|Overall Study||75||
48395973|NCT02527187|101299266|FG001|STARTED|Overall Study||126||
48395974|NCT02527187|101299265|FG000|COMPLETED|Overall Study||75||
48395975|NCT02527187|101299266|FG001|COMPLETED|Overall Study||126||
48568537|NCT02019264|101724580|FG000|COMPLETED|Overall Study||5752|Participants who died on trial were considered completed.|
48568538|NCT02019264|101724581|FG001|COMPLETED|Overall Study||5793|Participants who died on trial were considered completed.|
48568539|NCT02019264|101724580|FG000|NOT COMPLETED|Overall Study||248||
48568540|NCT02019264|101724581|FG001|NOT COMPLETED|Overall Study||207||
48568541|NCT02293512|101724582|FG000|STARTED|Overall Study||10||
48568542|NCT02293512|101724583|FG001|STARTED|Overall Study||10||
48568543|NCT02293512|101724584|FG002|STARTED|Overall Study||10||
48568544|NCT02293512|101724585|FG003|STARTED|Overall Study||10||
48568545|NCT02293512|101724582|FG000|COMPLETED|Overall Study||6||
48119786|NCT04805983|100616512|FG000|Completed Inpatient Treatment (Study Day 3)|Overall Study||6||
48119787|NCT04805983|100616513|FG001|Completed Inpatient Treatment (Study Day 3)|Overall Study||6||
48119788|NCT04805983|100616514|FG002|Completed Inpatient Treatment (Study Day 3)|Overall Study||6||
48395976|NCT02527187|101299265|FG000|NOT COMPLETED|Overall Study||0||
48395977|NCT02527187|101299266|FG001|NOT COMPLETED|Overall Study||0||
48395978|NCT03104985|101299267|FG000|STARTED|Overall Study||34||
48395979|NCT03104985|101299268|FG001|STARTED|Overall Study||34||
48395980|NCT03104985|101299267|FG000|COMPLETED|Overall Study||34||
48395981|NCT03104985|101299268|FG001|COMPLETED|Overall Study||34||
48395982|NCT03104985|101299267|FG000|NOT COMPLETED|Overall Study||0||
48395983|NCT03104985|101299268|FG001|NOT COMPLETED|Overall Study||0||
48395984|NCT00438464|101299269|FG000|STARTED|Overall Study||103||
48395985|NCT00438464|101299270|FG001|STARTED|Overall Study||101||
48395986|NCT00438464|101299269|FG000|Received Assigned Intervention|Overall Study||89||
48395987|NCT00438464|101299270|FG001|Received Assigned Intervention|Overall Study||94||
48395988|NCT00438464|101299269|FG000|COMPLETED|Overall Study||89||
48395989|NCT00438464|101299270|FG001|COMPLETED|Overall Study||94||
48119789|NCT04805983|100616515|FG003|Completed Inpatient Treatment (Study Day 3)|Overall Study||6||
48119790|NCT04805983|100616516|FG004|Completed Inpatient Treatment (Study Day 3)|Overall Study||6||
48119791|NCT04805983|100616517|FG005|Completed Inpatient Treatment (Study Day 3)|Overall Study||6||
48119792|NCT04805983|100616512|FG000|Completed In-Clinic Follow-Up (Study Day 4)|Overall Study||6||
48119793|NCT04805983|100616513|FG001|Completed In-Clinic Follow-Up (Study Day 4)|Overall Study||6||
48119794|NCT04805983|100616514|FG002|Completed In-Clinic Follow-Up (Study Day 4)|Overall Study||6||
48119795|NCT04805983|100616515|FG003|Completed In-Clinic Follow-Up (Study Day 4)|Overall Study||6||
48119796|NCT04805983|100616516|FG004|Completed In-Clinic Follow-Up (Study Day 4)|Overall Study||6||
48119797|NCT04805983|100616517|FG005|Completed In-Clinic Follow-Up (Study Day 4)|Overall Study||6||
48119798|NCT04805983|100616512|FG000|Completed Phone Visit Follow-Up (Study Day 5)|Overall Study||6||
48119799|NCT04805983|100616513|FG001|Completed Phone Visit Follow-Up (Study Day 5)|Overall Study||6||
48119800|NCT04805983|100616514|FG002|Completed Phone Visit Follow-Up (Study Day 5)|Overall Study||6||
48119801|NCT04805983|100616515|FG003|Completed Phone Visit Follow-Up (Study Day 5)|Overall Study||6||
48119802|NCT04805983|100616516|FG004|Completed Phone Visit Follow-Up (Study Day 5)|Overall Study||6||
48119803|NCT04805983|100616517|FG005|Completed Phone Visit Follow-Up (Study Day 5)|Overall Study||6||
48119804|NCT04805983|100616512|FG000|Completed In-Clinic Final Follow- Up/Completed Protocol (Study Day 7)|Overall Study||6||
48119805|NCT04805983|100616513|FG001|Completed In-Clinic Final Follow- Up/Completed Protocol (Study Day 7)|Overall Study||6||
48119806|NCT04805983|100616514|FG002|Completed In-Clinic Final Follow- Up/Completed Protocol (Study Day 7)|Overall Study||6||
48119807|NCT04805983|100616515|FG003|Completed In-Clinic Final Follow- Up/Completed Protocol (Study Day 7)|Overall Study||6||
48119808|NCT04805983|100616516|FG004|Completed In-Clinic Final Follow- Up/Completed Protocol (Study Day 7)|Overall Study||6||
48119809|NCT04805983|100616517|FG005|Completed In-Clinic Final Follow- Up/Completed Protocol (Study Day 7)|Overall Study||6||
48119810|NCT04805983|100616512|FG000|COMPLETED|Overall Study||6||
48119811|NCT04805983|100616513|FG001|COMPLETED|Overall Study||6||
48119812|NCT04805983|100616514|FG002|COMPLETED|Overall Study||6||
48119813|NCT04805983|100616515|FG003|COMPLETED|Overall Study||6||
48119814|NCT04805983|100616516|FG004|COMPLETED|Overall Study||6||
48395990|NCT00438464|101299269|FG000|NOT COMPLETED|Overall Study||14||
48395991|NCT00438464|101299270|FG001|NOT COMPLETED|Overall Study||7||
48395992|NCT01167153|101299271|FG000|STARTED|Overall Study||282||
48395993|NCT01167153|101299272|FG001|STARTED|Overall Study||282||
48395994|NCT01167153|101299271|FG000|Intention to Treat (ITT)|Overall Study||272||
48568546|NCT02293512|101724583|FG001|COMPLETED|Overall Study||4||
48568547|NCT02293512|101724584|FG002|COMPLETED|Overall Study||7||
48568548|NCT02293512|101724585|FG003|COMPLETED|Overall Study||8||
48568549|NCT02293512|101724582|FG000|NOT COMPLETED|Overall Study||4||
48568550|NCT02293512|101724583|FG001|NOT COMPLETED|Overall Study||6||
48568551|NCT02293512|101724584|FG002|NOT COMPLETED|Overall Study||3||
48568552|NCT02293512|101724585|FG003|NOT COMPLETED|Overall Study||2||
48568553|NCT01691560|101724586|FG000|STARTED|Overall Study||34||
48568554|NCT01691560|101724587|FG001|STARTED|Overall Study||33||
48568555|NCT01691560|101724588|FG002|STARTED|Overall Study||34||
48568556|NCT01691560|101724589|FG003|STARTED|Overall Study||33||
48568557|NCT01691560|101724586|FG000|COMPLETED|Overall Study||34||
48568558|NCT01691560|101724587|FG001|COMPLETED|Overall Study||33||
48568559|NCT01691560|101724588|FG002|COMPLETED|Overall Study||34||
48568560|NCT01691560|101724589|FG003|COMPLETED|Overall Study||33||
48568561|NCT01691560|101724586|FG000|NOT COMPLETED|Overall Study||0||
48568562|NCT01691560|101724587|FG001|NOT COMPLETED|Overall Study||0||
48568563|NCT01691560|101724588|FG002|NOT COMPLETED|Overall Study||0||
48568564|NCT01691560|101724589|FG003|NOT COMPLETED|Overall Study||0||
48568565|NCT00791778|101724590|FG000|STARTED|Double-blind Treatment||123||
48568566|NCT00791778|101724591|FG001|STARTED|Double-blind Treatment||123||
48568567|NCT00791778|101724590|FG000|COMPLETED|Double-blind Treatment||46||
48568568|NCT00791778|101724591|FG001|COMPLETED|Double-blind Treatment||75||
48568569|NCT00791778|101724590|FG000|NOT COMPLETED|Double-blind Treatment||77||
48568570|NCT00791778|101724591|FG001|NOT COMPLETED|Double-blind Treatment||48||
48568571|NCT00791778|101724590|FG000|STARTED|Follow-up||100||
48568572|NCT00791778|101724591|FG001|STARTED|Follow-up||91||
48568573|NCT00791778|101724590|FG000|COMPLETED|Follow-up||95||
48568574|NCT00791778|101724591|FG001|COMPLETED|Follow-up||90||
48568575|NCT00791778|101724590|FG000|NOT COMPLETED|Follow-up||5||
48568576|NCT00791778|101724591|FG001|NOT COMPLETED|Follow-up||1||
48568577|NCT00461630|101724592|FG000|STARTED|Overall Study||12838||
48568578|NCT00461630|101724593|FG001|STARTED|Overall Study||12835||
48568579|NCT00461630|101724592|FG000|COMPLETED|Overall Study||11932||
48568580|NCT00461630|101724593|FG001|COMPLETED|Overall Study||12008||
48568581|NCT00461630|101724592|FG000|NOT COMPLETED|Overall Study||906||
48568582|NCT00461630|101724593|FG001|NOT COMPLETED|Overall Study||827||
48568583|NCT00504712|101724594|FG000|STARTED|Overall Study||11||
48568584|NCT00504712|101724595|FG001|STARTED|Overall Study||13||
48568585|NCT00504712|101724594|FG000|COMPLETED|Overall Study||11||
48568586|NCT00504712|101724595|FG001|COMPLETED|Overall Study||13||
48568587|NCT00504712|101724594|FG000|NOT COMPLETED|Overall Study||0||
48568588|NCT00504712|101724595|FG001|NOT COMPLETED|Overall Study||0||
48568589|NCT05002790|101724596|FG000|STARTED|Overall Study||20||
48568590|NCT05002790|101724596|FG000|COMPLETED|Overall Study||20||
48568591|NCT05002790|101724596|FG000|NOT COMPLETED|Overall Study||0||
48568592|NCT01467713|101724597|FG000|STARTED|Overall Study||164||
48568593|NCT01467713|101724598|FG001|STARTED|Overall Study||164||
48568594|NCT01467713|101724599|FG002|STARTED|Overall Study||160||
48568595|NCT01467713|101724600|FG003|STARTED|Overall Study||154||
48568596|NCT01467713|101724597|FG000|Safety Analysis Set: Received Treatment|Overall Study||163||
48568597|NCT01467713|101724598|FG001|Safety Analysis Set: Received Treatment|Overall Study||164||
48568598|NCT01467713|101724599|FG002|Safety Analysis Set: Received Treatment|Overall Study||159||
48568599|NCT01467713|101724600|FG003|Safety Analysis Set: Received Treatment|Overall Study||154||
48568600|NCT01467713|101724597|FG000|COMPLETED|Overall Study||62||
48568601|NCT01467713|101724598|FG001|COMPLETED|Overall Study||60||
48568602|NCT01467713|101724599|FG002|COMPLETED|Overall Study||58||
48568603|NCT01467713|101724600|FG003|COMPLETED|Overall Study||45||
48568604|NCT01467713|101724597|FG000|NOT COMPLETED|Overall Study||102||
48568605|NCT01467713|101724598|FG001|NOT COMPLETED|Overall Study||104||
48568606|NCT01467713|101724599|FG002|NOT COMPLETED|Overall Study||102||
48568607|NCT01467713|101724600|FG003|NOT COMPLETED|Overall Study||109||
48568608|NCT01965366|101724601|FG000|STARTED|Overall Study||13||
48568609|NCT01965366|101724602|FG001|STARTED|Overall Study||14||
48568610|NCT01965366|101724601|FG000|COMPLETED|Overall Study||3||
48568611|NCT01965366|101724602|FG001|COMPLETED|Overall Study||9||
48568612|NCT01965366|101724601|FG000|NOT COMPLETED|Overall Study||10||
48568613|NCT01965366|101724602|FG001|NOT COMPLETED|Overall Study||5||
48568614|NCT01627574|101724603|FG000|STARTED|Overall Study||142||
48568615|NCT01627574|101724604|FG001|STARTED|Overall Study||130||
48568616|NCT01627574|101724603|FG000|COMPLETED|Overall Study||121||
48568617|NCT01627574|101724604|FG001|COMPLETED|Overall Study||112||
48568618|NCT01627574|101724603|FG000|NOT COMPLETED|Overall Study||21||
48568619|NCT01627574|101724604|FG001|NOT COMPLETED|Overall Study||18||
48568620|NCT00961350|101724605|FG000|STARTED|Overall Study||265||
48568621|NCT00961350|101724606|FG001|STARTED|Overall Study||265||
48568622|NCT00961350|101724605|FG000|Intent-to-Treat Population (ITT)|Overall Study||265||
48568623|NCT00961350|101724606|FG001|Intent-to-Treat Population (ITT)|Overall Study||265||
48568624|NCT00961350|101724605|FG000|Safety Population|Overall Study||264||
48568625|NCT00961350|101724606|FG001|Safety Population|Overall Study||265||
48568626|NCT00961350|101724605|FG000|COMPLETED|Overall Study||218||
48568627|NCT00961350|101724606|FG001|COMPLETED|Overall Study||198||
48568628|NCT00961350|101724605|FG000|NOT COMPLETED|Overall Study||47||
48568629|NCT00961350|101724606|FG001|NOT COMPLETED|Overall Study||67||
48568630|NCT01314872|101724607|FG000|STARTED|Treatment Period 1||141||
48568631|NCT01314872|101724608|FG001|STARTED|Treatment Period 1||144||
48568632|NCT01314872|101724609|FG002|STARTED|Treatment Period 1||134||
48568633|NCT01314872|101724610|FG003|STARTED|Treatment Period 1||150||
48568634|NCT01314872|101724611|FG004|STARTED|Treatment Period 1||149||
48568635|NCT01314872|101724612|FG005|STARTED|Treatment Period 1||135||
48568636|NCT01314872|101724613|FG006|STARTED|Treatment Period 1||134||
48568637|NCT01314872|101724614|FG007|STARTED|Treatment Period 1||64||
48568638|NCT01314872|101724615|FG008|STARTED|Treatment Period 1||112||
48568639|NCT01314872|101724616|FG009|STARTED|Treatment Period 1||122||
48568640|NCT01314872|101724617|FG010|STARTED|Treatment Period 1||110||
48568641|NCT01314872|101724618|FG011|STARTED|Treatment Period 1||0||
48568642|NCT01314872|101724619|FG012|STARTED|Treatment Period 1||0||
48568643|NCT01314872|101724620|FG013|STARTED|Treatment Period 1||0||
48568644|NCT01314872|101724621|FG014|STARTED|Treatment Period 1||0||
48281342|NCT04488770|101014132|FG002|STARTED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||2||
48281343|NCT04488770|101014133|FG003|STARTED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||2||
48281344|NCT04488770|101014134|FG004|STARTED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
48568645|NCT01314872|101724607|FG000|COMPLETED|Treatment Period 1||131||
48568646|NCT01314872|101724608|FG001|COMPLETED|Treatment Period 1||138||
48568647|NCT01314872|101724609|FG002|COMPLETED|Treatment Period 1||128||
48568648|NCT01314872|101724610|FG003|COMPLETED|Treatment Period 1||143||
48568649|NCT01314872|101724611|FG004|COMPLETED|Treatment Period 1||142||
48568650|NCT01314872|101724612|FG005|COMPLETED|Treatment Period 1||128||
48568651|NCT01314872|101724613|FG006|COMPLETED|Treatment Period 1||126||
48568652|NCT01314872|101724614|FG007|COMPLETED|Treatment Period 1||57||
48568653|NCT01314872|101724615|FG008|COMPLETED|Treatment Period 1||106||
48568654|NCT01314872|101724616|FG009|COMPLETED|Treatment Period 1||118||
48568655|NCT01314872|101724617|FG010|COMPLETED|Treatment Period 1||107||
48568656|NCT01314872|101724618|FG011|COMPLETED|Treatment Period 1||0||
48568657|NCT01314872|101724619|FG012|COMPLETED|Treatment Period 1||0||
48568658|NCT01314872|101724620|FG013|COMPLETED|Treatment Period 1||0||
48568659|NCT01314872|101724621|FG014|COMPLETED|Treatment Period 1||0||
48568660|NCT01314872|101724607|FG000|NOT COMPLETED|Treatment Period 1||10||
48568661|NCT01314872|101724608|FG001|NOT COMPLETED|Treatment Period 1||6||
48568662|NCT01314872|101724609|FG002|NOT COMPLETED|Treatment Period 1||6||
48568663|NCT01314872|101724610|FG003|NOT COMPLETED|Treatment Period 1||7||
48568664|NCT01314872|101724611|FG004|NOT COMPLETED|Treatment Period 1||7||
48568665|NCT01314872|101724612|FG005|NOT COMPLETED|Treatment Period 1||7||
48568666|NCT01314872|101724613|FG006|NOT COMPLETED|Treatment Period 1||8||
48568667|NCT01314872|101724614|FG007|NOT COMPLETED|Treatment Period 1||7||
48568668|NCT01314872|101724615|FG008|NOT COMPLETED|Treatment Period 1||6||
48568669|NCT01314872|101724616|FG009|NOT COMPLETED|Treatment Period 1||4||
48568670|NCT01314872|101724617|FG010|NOT COMPLETED|Treatment Period 1||3||
48568671|NCT01314872|101724618|FG011|NOT COMPLETED|Treatment Period 1||0||
48568672|NCT01314872|101724619|FG012|NOT COMPLETED|Treatment Period 1||0||
48568673|NCT01314872|101724620|FG013|NOT COMPLETED|Treatment Period 1||0||
48568674|NCT01314872|101724621|FG014|NOT COMPLETED|Treatment Period 1||0||
48568675|NCT01314872|101724607|FG000|STARTED|Period 2||0||
48568676|NCT01314872|101724608|FG001|STARTED|Period 2||0||
48568677|NCT01314872|101724609|FG002|STARTED|Period 2||0||
48568678|NCT01314872|101724610|FG003|STARTED|Period 2||0||
48568679|NCT01314872|101724611|FG004|STARTED|Period 2||0||
48568680|NCT01314872|101724612|FG005|STARTED|Period 2||0||
48568681|NCT01314872|101724613|FG006|STARTED|Period 2||0||
48568682|NCT01314872|101724614|FG007|STARTED|Period 2||0||
48568683|NCT01314872|101724615|FG008|STARTED|Period 2||0||
48281345|NCT04488770|101014135|FG005|STARTED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
48281346|NCT04488770|101014136|FG006|STARTED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
48281347|NCT04488770|101014137|FG007|STARTED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
48281348|NCT04488770|101014138|FG008|STARTED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
48568684|NCT01314872|101724616|FG009|STARTED|Period 2||0||
48568685|NCT01314872|101724617|FG010|STARTED|Period 2||0||
48568686|NCT01314872|101724618|FG011|STARTED|Period 2||223||
48568687|NCT01314872|101724619|FG012|STARTED|Period 2||248||
48568688|NCT01314872|101724620|FG013|STARTED|Period 2||240||
48568689|NCT01314872|101724621|FG014|STARTED|Period 2||134||
48568690|NCT01314872|101724607|FG000|COMPLETED|Period 2||0||
48568691|NCT01314872|101724608|FG001|COMPLETED|Period 2||0||
48568692|NCT01314872|101724609|FG002|COMPLETED|Period 2||0||
48568693|NCT01314872|101724610|FG003|COMPLETED|Period 2||0||
48568694|NCT01314872|101724611|FG004|COMPLETED|Period 2||0||
48568695|NCT01314872|101724612|FG005|COMPLETED|Period 2||0||
48119815|NCT04805983|100616517|FG005|COMPLETED|Overall Study||6||
48119816|NCT04805983|100616512|FG000|NOT COMPLETED|Overall Study||0||
48119817|NCT04805983|100616513|FG001|NOT COMPLETED|Overall Study||0||
48119818|NCT04805983|100616514|FG002|NOT COMPLETED|Overall Study||0||
48119819|NCT04805983|100616515|FG003|NOT COMPLETED|Overall Study||0||
48119820|NCT04805983|100616516|FG004|NOT COMPLETED|Overall Study||0||
48119821|NCT04805983|100616517|FG005|NOT COMPLETED|Overall Study||0||
48119822|NCT03056690|100616518|FG000|STARTED|Overall Study||95||
48119823|NCT03056690|100616519|FG001|STARTED|Overall Study||91||
48119824|NCT03056690|100616518|FG000|Treated|Overall Study||94||
48119825|NCT03056690|100616519|FG001|Treated|Overall Study||90||
48119826|NCT03056690|100616518|FG000|COMPLETED|Overall Study||81||
48119827|NCT03056690|100616519|FG001|COMPLETED|Overall Study||75||
48119828|NCT03056690|100616518|FG000|NOT COMPLETED|Overall Study||14||
48119829|NCT03056690|100616519|FG001|NOT COMPLETED|Overall Study||16||
48119830|NCT01343160|100616520|FG000|STARTED|Overall Study||36||
48119831|NCT01343160|100616520|FG000|COMPLETED|Overall Study||31||
48395995|NCT01167153|101299272|FG001|Intention to Treat (ITT)|Overall Study||268||
48395996|NCT01167153|101299271|FG000|COMPLETED|Overall Study||264||
48395997|NCT01167153|101299272|FG001|COMPLETED|Overall Study||249||
48395998|NCT01167153|101299271|FG000|NOT COMPLETED|Overall Study||18||
48395999|NCT01167153|101299272|FG001|NOT COMPLETED|Overall Study||33||
48396000|NCT01001234|101299273|FG000|STARTED|Overall Study||492||
48396001|NCT01001234|101299274|FG001|STARTED|Overall Study||31||
48396002|NCT01001234|101299275|FG002|STARTED|Overall Study||409||
48396003|NCT01001234|101299276|FG003|STARTED|Overall Study||410||
48396004|NCT01001234|101299277|FG004|STARTED|Overall Study||40||
48396005|NCT01001234|101299273|FG000|Particpants Treated|Overall Study||124||
48396006|NCT01001234|101299274|FG001|Particpants Treated|Overall Study||8||
48396007|NCT01001234|101299275|FG002|Particpants Treated|Overall Study||400||
48396008|NCT01001234|101299276|FG003|Particpants Treated|Overall Study||405||
48396009|NCT01001234|101299277|FG004|Particpants Treated|Overall Study||40||
48396010|NCT01001234|101299273|FG000|Participants Not Treated|Overall Study||368||
48396011|NCT01001234|101299274|FG001|Participants Not Treated|Overall Study||23||
48396012|NCT01001234|101299275|FG002|Participants Not Treated|Overall Study||9||
48396013|NCT01001234|101299276|FG003|Participants Not Treated|Overall Study||5||
48396014|NCT01001234|101299277|FG004|Participants Not Treated|Overall Study||0||
48119832|NCT01343160|100616520|FG000|NOT COMPLETED|Overall Study||5||
48119833|NCT00218062|100616521|FG000|STARTED|Overall Study||22||
48119834|NCT00218062|100616522|FG001|STARTED|Overall Study||20||
48119835|NCT00218062|100616523|FG002|STARTED|Overall Study||15||
48119836|NCT00218062|100616524|FG003|STARTED|Overall Study||16||
48119837|NCT00218062|100616521|FG000|Received First Dose of Study Medication|Overall Study||16||
48119838|NCT00218062|100616522|FG001|Received First Dose of Study Medication|Overall Study||11||
48119839|NCT00218062|100616523|FG002|Received First Dose of Study Medication|Overall Study||10||
48119840|NCT00218062|100616524|FG003|Received First Dose of Study Medication|Overall Study||12||
48119841|NCT00218062|100616521|FG000|COMPLETED|Overall Study||7||
48119842|NCT00218062|100616522|FG001|COMPLETED|Overall Study||4||
48119843|NCT00218062|100616523|FG002|COMPLETED|Overall Study||3||
48119844|NCT00218062|100616524|FG003|COMPLETED|Overall Study||3||
48119845|NCT00218062|100616521|FG000|NOT COMPLETED|Overall Study||15||
48119846|NCT00218062|100616522|FG001|NOT COMPLETED|Overall Study||16||
48119847|NCT00218062|100616523|FG002|NOT COMPLETED|Overall Study||12||
48119848|NCT00218062|100616524|FG003|NOT COMPLETED|Overall Study||13||
48119849|NCT04122443|100616525|FG000|STARTED|Stage 1 - Open Label||0||
48119850|NCT04122443|100616526|FG001|STARTED|Stage 1 - Open Label||0||
48119851|NCT04122443|100616527|FG002|STARTED|Stage 1 - Open Label||393||
48119852|NCT04122443|100616525|FG000|COMPLETED|Stage 1 - Open Label||0||
48119853|NCT04122443|100616526|FG001|COMPLETED|Stage 1 - Open Label||0||
48119854|NCT04122443|100616527|FG002|COMPLETED|Stage 1 - Open Label||154||
48119855|NCT04122443|100616525|FG000|NOT COMPLETED|Stage 1 - Open Label||0||
48119856|NCT04122443|100616526|FG001|NOT COMPLETED|Stage 1 - Open Label||0||
48396015|NCT01001234|101299273|FG000|COMPLETED|Overall Study||87||
48396016|NCT01001234|101299274|FG001|COMPLETED|Overall Study||5||
48396017|NCT01001234|101299275|FG002|COMPLETED|Overall Study||377||
48396018|NCT01001234|101299276|FG003|COMPLETED|Overall Study||385||
48396019|NCT01001234|101299277|FG004|COMPLETED|Overall Study||40||
48396020|NCT01001234|101299273|FG000|NOT COMPLETED|Overall Study||405||
48396021|NCT01001234|101299274|FG001|NOT COMPLETED|Overall Study||26||
48396022|NCT01001234|101299275|FG002|NOT COMPLETED|Overall Study||32||
48396023|NCT01001234|101299276|FG003|NOT COMPLETED|Overall Study||25||
48396024|NCT01001234|101299277|FG004|NOT COMPLETED|Overall Study||0||
48119857|NCT04122443|100616527|FG002|NOT COMPLETED|Stage 1 - Open Label||239||
48119858|NCT04122443|100616525|FG000|STARTED|Stage 2 - Double Blinded||77||
48119859|NCT04122443|100616526|FG001|STARTED|Stage 2 - Double Blinded||77||
48119860|NCT04122443|100616527|FG002|STARTED|Stage 2 - Double Blinded||0||
48119861|NCT04122443|100616525|FG000|COMPLETED|Stage 2 - Double Blinded||77||
48119862|NCT04122443|100616526|FG001|COMPLETED|Stage 2 - Double Blinded||77||
48396025|NCT03617913|101299278|FG000|STARTED|Overall Study||2||
48396026|NCT03617913|101299278|FG000|COMPLETED|Overall Study||2||
48396027|NCT03617913|101299278|FG000|NOT COMPLETED|Overall Study||0||
48396028|NCT01010854|101299279|FG000|STARTED|Overall Study||6||
48568696|NCT01314872|101724613|FG006|COMPLETED|Period 2||0||
48568697|NCT01314872|101724614|FG007|COMPLETED|Period 2||0||
48568698|NCT01314872|101724615|FG008|COMPLETED|Period 2||0||
48568699|NCT01314872|101724616|FG009|COMPLETED|Period 2||0||
48568700|NCT01314872|101724617|FG010|COMPLETED|Period 2||0||
48568701|NCT01314872|101724618|FG011|COMPLETED|Period 2||175||
48568702|NCT01314872|101724619|FG012|COMPLETED|Period 2||188||
48568703|NCT01314872|101724620|FG013|COMPLETED|Period 2||187||
48568704|NCT01314872|101724621|FG014|COMPLETED|Period 2||110||
48568705|NCT01314872|101724607|FG000|NOT COMPLETED|Period 2||0||
48568706|NCT01314872|101724608|FG001|NOT COMPLETED|Period 2||0||
48568707|NCT01314872|101724609|FG002|NOT COMPLETED|Period 2||0||
48568708|NCT01314872|101724610|FG003|NOT COMPLETED|Period 2||0||
48568709|NCT01314872|101724611|FG004|NOT COMPLETED|Period 2||0||
48568710|NCT01314872|101724612|FG005|NOT COMPLETED|Period 2||0||
48568711|NCT01314872|101724613|FG006|NOT COMPLETED|Period 2||0||
48568712|NCT01314872|101724614|FG007|NOT COMPLETED|Period 2||0||
48568713|NCT01314872|101724615|FG008|NOT COMPLETED|Period 2||0||
48568714|NCT01314872|101724616|FG009|NOT COMPLETED|Period 2||0||
48568715|NCT01314872|101724617|FG010|NOT COMPLETED|Period 2||0||
48568716|NCT01314872|101724618|FG011|NOT COMPLETED|Period 2||48||
48568717|NCT01314872|101724619|FG012|NOT COMPLETED|Period 2||60||
48568718|NCT01314872|101724620|FG013|NOT COMPLETED|Period 2||53||
48568719|NCT01314872|101724621|FG014|NOT COMPLETED|Period 2||24||
48568720|NCT00630825|101724622|FG000|STARTED|Overall Study||65||
48568721|NCT00630825|101724623|FG001|STARTED|Overall Study||65||
48568722|NCT00630825|101724624|FG002|STARTED|Overall Study||66||
48568723|NCT00630825|101724625|FG003|STARTED|Overall Study||66||
48568724|NCT00630825|101724622|FG000|Received at Least One Dose of Study Drug|Overall Study||65||
48568725|NCT00630825|101724623|FG001|Received at Least One Dose of Study Drug|Overall Study||65||
48568726|NCT00630825|101724624|FG002|Received at Least One Dose of Study Drug|Overall Study||66||
48568727|NCT00630825|101724625|FG003|Received at Least One Dose of Study Drug|Overall Study||66||
48568728|NCT00630825|101724622|FG000|COMPLETED|Overall Study||56||
48568729|NCT00630825|101724623|FG001|COMPLETED|Overall Study||58||
48568730|NCT00630825|101724624|FG002|COMPLETED|Overall Study||58||
48568731|NCT00630825|101724625|FG003|COMPLETED|Overall Study||60||
48568732|NCT00630825|101724622|FG000|NOT COMPLETED|Overall Study||9||
48568733|NCT00630825|101724623|FG001|NOT COMPLETED|Overall Study||7||
48568734|NCT00630825|101724624|FG002|NOT COMPLETED|Overall Study||8||
48568735|NCT00630825|101724625|FG003|NOT COMPLETED|Overall Study||6||
48568736|NCT04090060|101724626|FG000|STARTED|Overall Study||359||
48568737|NCT04090060|101724627|FG001|STARTED|Overall Study||359||
48568738|NCT04090060|101724626|FG000|COMPLETED|Overall Study||283||
48568739|NCT04090060|101724627|FG001|COMPLETED|Overall Study||282||
48568740|NCT04090060|101724626|FG000|NOT COMPLETED|Overall Study||76||
48568741|NCT04090060|101724627|FG001|NOT COMPLETED|Overall Study||77||
48568742|NCT00866281|101724628|FG000|STARTED|Overall Study||7||
48568743|NCT00866281|101724629|FG001|STARTED|Overall Study||15||
48568744|NCT00866281|101724628|FG000|COMPLETED|Overall Study||0||
48568745|NCT00866281|101724629|FG001|COMPLETED|Overall Study||0||
48568746|NCT00866281|101724628|FG000|NOT COMPLETED|Overall Study||7||
48568747|NCT00866281|101724629|FG001|NOT COMPLETED|Overall Study||15||
48568748|NCT02362360|101724630|FG000|STARTED|Period 1||26||
48568749|NCT02362360|101724631|FG001|STARTED|Period 1||26||
48568750|NCT02362360|101724630|FG000|COMPLETED|Period 1||23||
48568751|NCT02362360|101724631|FG001|COMPLETED|Period 1||25||
48568752|NCT02362360|101724630|FG000|NOT COMPLETED|Period 1||3||
48568753|NCT02362360|101724631|FG001|NOT COMPLETED|Period 1||1||
48568754|NCT02362360|101724630|FG000|STARTED|Period 2||23||
48568755|NCT02362360|101724631|FG001|STARTED|Period 2||25||
48568756|NCT02362360|101724630|FG000|COMPLETED|Period 2||23||
48568757|NCT02362360|101724631|FG001|COMPLETED|Period 2||25||
48568758|NCT02362360|101724630|FG000|NOT COMPLETED|Period 2||0||
48568759|NCT02362360|101724631|FG001|NOT COMPLETED|Period 2||0||
48568760|NCT02386319|101724632|FG000|STARTED|Overall Study||18||
48568761|NCT02386319|101724633|FG001|STARTED|Overall Study||18||
48568762|NCT02386319|101724632|FG000|COMPLETED|Overall Study||16||
48568763|NCT02386319|101724633|FG001|COMPLETED|Overall Study||17||
48568764|NCT02386319|101724632|FG000|NOT COMPLETED|Overall Study||2||
48568765|NCT02386319|101724633|FG001|NOT COMPLETED|Overall Study||1||
48568766|NCT01354652|101724634|FG000|STARTED|Overall Study||3||
48568767|NCT01354652|101724635|FG001|STARTED|Overall Study||2||
48568768|NCT01354652|101724636|FG002|STARTED|Overall Study||0||
48568769|NCT01354652|101724634|FG000|COMPLETED|Overall Study||0||
48568770|NCT01354652|101724635|FG001|COMPLETED|Overall Study||0||
48568771|NCT01354652|101724636|FG002|COMPLETED|Overall Study||0||
48568772|NCT01354652|101724634|FG000|NOT COMPLETED|Overall Study||3||
48568773|NCT01354652|101724635|FG001|NOT COMPLETED|Overall Study||2||
48568774|NCT01354652|101724636|FG002|NOT COMPLETED|Overall Study||0||
48568775|NCT01907490|101724637|FG000|STARTED|Overall Study||38||
48568776|NCT01907490|101724637|FG000|COMPLETED|Overall Study||38||
48568777|NCT01907490|101724637|FG000|NOT COMPLETED|Overall Study||0||
48568778|NCT00607620|101724638|FG000|STARTED|Overall Study||409||
48568779|NCT00607620|101724639|FG001|STARTED|Overall Study||469||
48119863|NCT04122443|100616527|FG002|COMPLETED|Stage 2 - Double Blinded||0||
48396029|NCT01010854|101299279|FG000|COMPLETED|Overall Study||6||
48396030|NCT01010854|101299279|FG000|NOT COMPLETED|Overall Study||0||
48396031|NCT05294341|101299280|FG000|STARTED|Overall Study||3||
48396032|NCT05294341|101299281|FG001|STARTED|Overall Study||3||
48396033|NCT05294341|101299280|FG000|COMPLETED|Overall Study||3||
48396034|NCT05294341|101299281|FG001|COMPLETED|Overall Study||3||
48396035|NCT05294341|101299280|FG000|NOT COMPLETED|Overall Study||0||
48396036|NCT05294341|101299281|FG001|NOT COMPLETED|Overall Study||0||
48119864|NCT04122443|100616525|FG000|NOT COMPLETED|Stage 2 - Double Blinded||0||
48119865|NCT04122443|100616526|FG001|NOT COMPLETED|Stage 2 - Double Blinded||0||
48119866|NCT04122443|100616527|FG002|NOT COMPLETED|Stage 2 - Double Blinded||0||
48119867|NCT01632579|100619498|FG000|STARTED|Period 1 (First Intervention)||2||
48119868|NCT01632579|100619499|FG001|STARTED|Period 1 (First Intervention)||6||
48119869|NCT01632579|100619500|FG002|STARTED|Period 1 (First Intervention)||2||
48119870|NCT01632579|100619501|FG003|STARTED|Period 1 (First Intervention)||2||
48119871|NCT01632579|100619502|FG004|STARTED|Period 1 (First Intervention)||6||
48119872|NCT01632579|100619503|FG005|STARTED|Period 1 (First Intervention)||2||
48119873|NCT01632579|100619504|FG006|STARTED|Period 1 (First Intervention)||2||
48119874|NCT01632579|100619505|FG007|STARTED|Period 1 (First Intervention)||6||
48119875|NCT01632579|100619506|FG008|STARTED|Period 1 (First Intervention)||2||
48396037|NCT02633046|101299282|FG000|STARTED|Overall Study||63||
48699045|NCT01320553|102050440|FG000|NOT COMPLETED|Overall Study||1||
48699046|NCT01320553|102050441|FG001|NOT COMPLETED|Overall Study||4||
48699047|NCT01320553|102050442|FG002|NOT COMPLETED|Overall Study||2||
48699048|NCT01320553|102050443|FG003|NOT COMPLETED|Overall Study||1||
48699049|NCT02543281|102050444|FG000|STARTED|Overall Study||15||
48699050|NCT02543281|102050445|FG001|STARTED|Overall Study||12||
48699051|NCT02543281|102050446|FG002|STARTED|Overall Study||5||
48699052|NCT02543281|102050444|FG000|COMPLETED|Overall Study||15||
48699053|NCT02543281|102050445|FG001|COMPLETED|Overall Study||12||
48699054|NCT02543281|102050446|FG002|COMPLETED|Overall Study||4||
48699055|NCT02543281|102050444|FG000|NOT COMPLETED|Overall Study||0||
48119876|NCT01632579|100619498|FG000|Received at Least 1 Dose|Period 1 (First Intervention)||2||
48119877|NCT01632579|100619499|FG001|Received at Least 1 Dose|Period 1 (First Intervention)||6||
48119878|NCT01632579|100619500|FG002|Received at Least 1 Dose|Period 1 (First Intervention)||2||
48119879|NCT01632579|100619501|FG003|Received at Least 1 Dose|Period 1 (First Intervention)||2||
48119880|NCT01632579|100619502|FG004|Received at Least 1 Dose|Period 1 (First Intervention)||6||
48119881|NCT01632579|100619503|FG005|Received at Least 1 Dose|Period 1 (First Intervention)||2||
48119882|NCT01632579|100619504|FG006|Received at Least 1 Dose|Period 1 (First Intervention)||2||
48119883|NCT01632579|100619505|FG007|Received at Least 1 Dose|Period 1 (First Intervention)||6||
48119884|NCT01632579|100619506|FG008|Received at Least 1 Dose|Period 1 (First Intervention)||2||
48119885|NCT01632579|100619498|FG000|COMPLETED|Period 1 (First Intervention)||2||
48119886|NCT01632579|100619499|FG001|COMPLETED|Period 1 (First Intervention)||6||
48119887|NCT01632579|100619500|FG002|COMPLETED|Period 1 (First Intervention)||2||
48119888|NCT01632579|100619501|FG003|COMPLETED|Period 1 (First Intervention)||2||
48119889|NCT01632579|100619502|FG004|COMPLETED|Period 1 (First Intervention)||6||
48119890|NCT01632579|100619503|FG005|COMPLETED|Period 1 (First Intervention)||2||
48119891|NCT01632579|100619504|FG006|COMPLETED|Period 1 (First Intervention)||2||
48119892|NCT01632579|100619505|FG007|COMPLETED|Period 1 (First Intervention)||6||
48119893|NCT01632579|100619506|FG008|COMPLETED|Period 1 (First Intervention)||2||
48119894|NCT01632579|100619498|FG000|NOT COMPLETED|Period 1 (First Intervention)||0||
48281349|NCT04488770|101014139|FG009|STARTED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
48281350|NCT04488770|101014140|FG010|STARTED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
48281351|NCT04488770|101014141|FG011|STARTED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
48281352|NCT04488770|101014142|FG012|STARTED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
48281353|NCT04488770|101014130|FG000|COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||2||
48281354|NCT04488770|101014131|FG001|COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||2||
48281355|NCT04488770|101014132|FG002|COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||2||
48396038|NCT02633046|101299282|FG000|Safety Population|Overall Study||63||
48699056|NCT02543281|102050445|FG001|NOT COMPLETED|Overall Study||0||
48699057|NCT02543281|102050446|FG002|NOT COMPLETED|Overall Study||1||
48699058|NCT02351063|102050447|FG000|STARTED|Overall Study||1||
48699059|NCT02351063|102050447|FG000|COMPLETED|Overall Study||1||
48699060|NCT02351063|102050447|FG000|NOT COMPLETED|Overall Study||0||
48119895|NCT01632579|100619499|FG001|NOT COMPLETED|Period 1 (First Intervention)||0||
48119896|NCT01632579|100619500|FG002|NOT COMPLETED|Period 1 (First Intervention)||0||
48119897|NCT01632579|100619501|FG003|NOT COMPLETED|Period 1 (First Intervention)||0||
48119898|NCT01632579|100619502|FG004|NOT COMPLETED|Period 1 (First Intervention)||0||
48119899|NCT01632579|100619503|FG005|NOT COMPLETED|Period 1 (First Intervention)||0||
48119900|NCT01632579|100619504|FG006|NOT COMPLETED|Period 1 (First Intervention)||0||
48119901|NCT01632579|100619505|FG007|NOT COMPLETED|Period 1 (First Intervention)||0||
48119902|NCT01632579|100619506|FG008|NOT COMPLETED|Period 1 (First Intervention)||0||
48119903|NCT01632579|100619498|FG000|STARTED|Washout Period||2||
48119904|NCT01632579|100619499|FG001|STARTED|Washout Period||6||
48119905|NCT01632579|100619500|FG002|STARTED|Washout Period||2||
48119906|NCT01632579|100619501|FG003|STARTED|Washout Period||2||
48119907|NCT01632579|100619502|FG004|STARTED|Washout Period||6||
48119908|NCT01632579|100619503|FG005|STARTED|Washout Period||2||
48119909|NCT01632579|100619504|FG006|STARTED|Washout Period||2||
48119910|NCT01632579|100619505|FG007|STARTED|Washout Period||6||
48119911|NCT01632579|100619506|FG008|STARTED|Washout Period||2||
48119912|NCT01632579|100619498|FG000|COMPLETED|Washout Period||1||
48119913|NCT01632579|100619499|FG001|COMPLETED|Washout Period||6||
48119914|NCT01632579|100619500|FG002|COMPLETED|Washout Period||2||
48119915|NCT01632579|100619501|FG003|COMPLETED|Washout Period||2||
48281356|NCT04488770|101014133|FG003|COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||1||
48281357|NCT04488770|101014134|FG004|COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
48699061|NCT03913013|102050448|FG000|STARTED|Overall Study||32||
48699062|NCT03913013|102050449|FG001|STARTED|Overall Study||33||
48699063|NCT03913013|102050448|FG000|COMPLETED|Overall Study||29||
48699064|NCT03913013|102050449|FG001|COMPLETED|Overall Study||30||
48699065|NCT03913013|102050448|FG000|NOT COMPLETED|Overall Study||3||
48699066|NCT03913013|102050449|FG001|NOT COMPLETED|Overall Study||3||
48699067|NCT01558492|102050450|FG000|STARTED|Overall Study||3||
48699068|NCT01558492|102050450|FG000|COMPLETED|Overall Study||3||
48699069|NCT01558492|102050450|FG000|NOT COMPLETED|Overall Study||0||
48699070|NCT02889289|102050451|FG000|STARTED|Overall Study||1||
48568780|NCT00607620|101724638|FG000|COMPLETED|Overall Study||409||
48568781|NCT00607620|101724639|FG001|COMPLETED|Overall Study||469||
48568782|NCT00607620|101724638|FG000|NOT COMPLETED|Overall Study||0||
48568783|NCT00607620|101724639|FG001|NOT COMPLETED|Overall Study||0||
48568784|NCT01877642|101724640|FG000|STARTED|Overall Study||4||
48568785|NCT01877642|101724641|FG001|STARTED|Overall Study||3||
48568786|NCT01877642|101724642|FG002|STARTED|Overall Study||3||
48119916|NCT01632579|100619502|FG004|COMPLETED|Washout Period||6||
48119917|NCT01632579|100619503|FG005|COMPLETED|Washout Period||2||
48119918|NCT01632579|100619504|FG006|COMPLETED|Washout Period||2||
48119919|NCT01632579|100619505|FG007|COMPLETED|Washout Period||6||
48119920|NCT01632579|100619506|FG008|COMPLETED|Washout Period||2||
48281358|NCT04488770|101014135|FG005|COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
48119921|NCT01632579|100619498|FG000|NOT COMPLETED|Washout Period||1||
48119922|NCT01632579|100619499|FG001|NOT COMPLETED|Washout Period||0||
48119923|NCT01632579|100619500|FG002|NOT COMPLETED|Washout Period||0||
48119924|NCT01632579|100619501|FG003|NOT COMPLETED|Washout Period||0||
48119925|NCT01632579|100619502|FG004|NOT COMPLETED|Washout Period||0||
48119926|NCT01632579|100619503|FG005|NOT COMPLETED|Washout Period||0||
48119927|NCT01632579|100619504|FG006|NOT COMPLETED|Washout Period||0||
48119928|NCT01632579|100619505|FG007|NOT COMPLETED|Washout Period||0||
48119929|NCT01632579|100619506|FG008|NOT COMPLETED|Washout Period||0||
48119930|NCT01632579|100619498|FG000|STARTED|Period 2 (Second Intervention)||1||
48119931|NCT01632579|100619499|FG001|STARTED|Period 2 (Second Intervention)||6||
48119932|NCT01632579|100619500|FG002|STARTED|Period 2 (Second Intervention)||2||
48119933|NCT01632579|100619501|FG003|STARTED|Period 2 (Second Intervention)||2||
48119934|NCT01632579|100619502|FG004|STARTED|Period 2 (Second Intervention)||6||
48119935|NCT01632579|100619503|FG005|STARTED|Period 2 (Second Intervention)||2||
48119936|NCT01632579|100619504|FG006|STARTED|Period 2 (Second Intervention)||2||
48281359|NCT04488770|101014136|FG006|COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
48568787|NCT01877642|101724643|FG003|STARTED|Overall Study||3||
48568788|NCT01877642|101724644|FG004|STARTED|Overall Study||3||
48568789|NCT01877642|101724645|FG005|STARTED|Overall Study||3||
48568790|NCT01877642|101724646|FG006|STARTED|Overall Study||3||
48568791|NCT01877642|101724640|FG000|COMPLETED|Overall Study||4||
48568792|NCT01877642|101724641|FG001|COMPLETED|Overall Study||3||
48568793|NCT01877642|101724642|FG002|COMPLETED|Overall Study||3||
48699071|NCT02889289|102050451|FG000|COMPLETED|Overall Study||1||
48699072|NCT02889289|102050451|FG000|NOT COMPLETED|Overall Study||0||
48699073|NCT04065074|102050452|FG000|STARTED|Overall Study||16||
48568794|NCT01877642|101724643|FG003|COMPLETED|Overall Study||3||
48568795|NCT01877642|101724644|FG004|COMPLETED|Overall Study||3||
48568796|NCT01877642|101724645|FG005|COMPLETED|Overall Study||3||
48699074|NCT04065074|102050452|FG000|COMPLETED|Overall Study||14||
48699075|NCT04065074|102050452|FG000|NOT COMPLETED|Overall Study||2||
48699076|NCT01956097|102050453|FG000|STARTED|Overall Study||30||
48119937|NCT01632579|100619505|FG007|STARTED|Period 2 (Second Intervention)||6||
48119938|NCT01632579|100619506|FG008|STARTED|Period 2 (Second Intervention)||2||
48119939|NCT01632579|100619498|FG000|Received at Least 1 Dose|Period 2 (Second Intervention)||1||
48119940|NCT01632579|100619499|FG001|Received at Least 1 Dose|Period 2 (Second Intervention)||6||
48119941|NCT01632579|100619500|FG002|Received at Least 1 Dose|Period 2 (Second Intervention)||2||
48119942|NCT01632579|100619501|FG003|Received at Least 1 Dose|Period 2 (Second Intervention)||2||
48119943|NCT01632579|100619502|FG004|Received at Least 1 Dose|Period 2 (Second Intervention)||6||
48119944|NCT01632579|100619503|FG005|Received at Least 1 Dose|Period 2 (Second Intervention)||2||
48119945|NCT01632579|100619504|FG006|Received at Least 1 Dose|Period 2 (Second Intervention)||2||
48119946|NCT01632579|100619505|FG007|Received at Least 1 Dose|Period 2 (Second Intervention)||6||
48119947|NCT01632579|100619506|FG008|Received at Least 1 Dose|Period 2 (Second Intervention)||2||
48119948|NCT01632579|100619498|FG000|COMPLETED|Period 2 (Second Intervention)||0||
48119949|NCT01632579|100619499|FG001|COMPLETED|Period 2 (Second Intervention)||6||
48119950|NCT01632579|100619500|FG002|COMPLETED|Period 2 (Second Intervention)||2||
48119951|NCT01632579|100619501|FG003|COMPLETED|Period 2 (Second Intervention)||2||
48119952|NCT01632579|100619502|FG004|COMPLETED|Period 2 (Second Intervention)||6||
48119953|NCT01632579|100619503|FG005|COMPLETED|Period 2 (Second Intervention)||2||
48119954|NCT01632579|100619504|FG006|COMPLETED|Period 2 (Second Intervention)||2||
48119955|NCT01632579|100619505|FG007|COMPLETED|Period 2 (Second Intervention)||6||
48119956|NCT01632579|100619506|FG008|COMPLETED|Period 2 (Second Intervention)||2||
48119957|NCT01632579|100619498|FG000|NOT COMPLETED|Period 2 (Second Intervention)||1||
48119958|NCT01632579|100619499|FG001|NOT COMPLETED|Period 2 (Second Intervention)||0||
48119959|NCT01632579|100619500|FG002|NOT COMPLETED|Period 2 (Second Intervention)||0||
48119960|NCT01632579|100619501|FG003|NOT COMPLETED|Period 2 (Second Intervention)||0||
48119961|NCT01632579|100619502|FG004|NOT COMPLETED|Period 2 (Second Intervention)||0||
48119962|NCT01632579|100619503|FG005|NOT COMPLETED|Period 2 (Second Intervention)||0||
48119963|NCT01632579|100619504|FG006|NOT COMPLETED|Period 2 (Second Intervention)||0||
48119964|NCT01632579|100619505|FG007|NOT COMPLETED|Period 2 (Second Intervention)||0||
48119965|NCT01632579|100619506|FG008|NOT COMPLETED|Period 2 (Second Intervention)||0||
48119966|NCT01632579|100619498|FG000|STARTED|Washout Period||0||
48119967|NCT01632579|100619499|FG001|STARTED|Washout Period||6||
48119968|NCT01632579|100619500|FG002|STARTED|Washout Period||2||
48281360|NCT04488770|101014137|FG007|COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
48281361|NCT04488770|101014138|FG008|COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
48281362|NCT04488770|101014139|FG009|COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
48281363|NCT04488770|101014140|FG010|COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
48281364|NCT04488770|101014141|FG011|COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
48281365|NCT04488770|101014142|FG012|COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
48281366|NCT04488770|101014130|FG000|NOT COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
48281367|NCT04488770|101014131|FG001|NOT COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
48281368|NCT04488770|101014132|FG002|NOT COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
48281369|NCT04488770|101014133|FG003|NOT COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||1||
48281370|NCT04488770|101014134|FG004|NOT COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
48396039|NCT02633046|101299282|FG000|COMPLETED|Overall Study||36||
48396040|NCT02633046|101299282|FG000|NOT COMPLETED|Overall Study||27||
48396041|NCT01438307|101299283|FG000|STARTED|Overall Study||14||
48396042|NCT01438307|101299284|FG001|STARTED|Overall Study||14||
48396043|NCT01438307|101299283|FG000|COMPLETED|Overall Study||13||
48396044|NCT01438307|101299284|FG001|COMPLETED|Overall Study||13||
48396045|NCT01438307|101299283|FG000|NOT COMPLETED|Overall Study||1||
48396046|NCT01438307|101299284|FG001|NOT COMPLETED|Overall Study||1||
48396047|NCT03096444|101299285|FG000|STARTED|Overall Study||13||65
48396048|NCT03096444|101299285|FG000|COMPLETED|Overall Study||13||65
48396049|NCT03096444|101299285|FG000|NOT COMPLETED|Overall Study||0||0
48568797|NCT01877642|101724646|FG006|COMPLETED|Overall Study||3||
48119969|NCT01632579|100619501|FG003|STARTED|Washout Period||2||
48119970|NCT01632579|100619502|FG004|STARTED|Washout Period||6||
48119971|NCT01632579|100619503|FG005|STARTED|Washout Period||2||
48119972|NCT01632579|100619504|FG006|STARTED|Washout Period||2||
48119973|NCT01632579|100619505|FG007|STARTED|Washout Period||6||
48119974|NCT01632579|100619506|FG008|STARTED|Washout Period||2||
48119975|NCT01632579|100619498|FG000|COMPLETED|Washout Period||0||
48119976|NCT01632579|100619499|FG001|COMPLETED|Washout Period||6||
48119977|NCT01632579|100619500|FG002|COMPLETED|Washout Period||2||
48119978|NCT01632579|100619501|FG003|COMPLETED|Washout Period||2||
48119979|NCT01632579|100619502|FG004|COMPLETED|Washout Period||6||
48119980|NCT01632579|100619503|FG005|COMPLETED|Washout Period||2||
48119981|NCT01632579|100619504|FG006|COMPLETED|Washout Period||2||
48119982|NCT01632579|100619505|FG007|COMPLETED|Washout Period||6||
48119983|NCT01632579|100619506|FG008|COMPLETED|Washout Period||2||
48119984|NCT01632579|100619498|FG000|NOT COMPLETED|Washout Period||0||
48119985|NCT01632579|100619499|FG001|NOT COMPLETED|Washout Period||0||
48119986|NCT01632579|100619500|FG002|NOT COMPLETED|Washout Period||0||
48119987|NCT01632579|100619501|FG003|NOT COMPLETED|Washout Period||0||
48119988|NCT01632579|100619502|FG004|NOT COMPLETED|Washout Period||0||
48281371|NCT04488770|101014135|FG005|NOT COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
48396050|NCT02061748|101299286|FG000|STARTED|Overall Study||7646||
48119989|NCT01632579|100619503|FG005|NOT COMPLETED|Washout Period||0||
48396051|NCT02061748|101299287|FG001|STARTED|Overall Study||30853||
48396052|NCT02061748|101299286|FG000|COMPLETED|Overall Study||7646||
48396053|NCT02061748|101299287|FG001|COMPLETED|Overall Study||30853||
48396054|NCT02061748|101299286|FG000|NOT COMPLETED|Overall Study||0||
48396055|NCT02061748|101299287|FG001|NOT COMPLETED|Overall Study||0||
48396056|NCT00091026|101299288|FG000|STARTED|Overall Study||72||
48396057|NCT00091026|101299289|FG001|STARTED|Overall Study||71||
48396058|NCT00091026|101299288|FG000|COMPLETED|Overall Study||71||
48396059|NCT00091026|101299289|FG001|COMPLETED|Overall Study||68||
48396060|NCT00091026|101299288|FG000|NOT COMPLETED|Overall Study||1||
48396061|NCT00091026|101299289|FG001|NOT COMPLETED|Overall Study||3||
48396062|NCT01367860|101299290|FG000|STARTED|Overall Study||20||
48396063|NCT01367860|101299291|FG001|STARTED|Overall Study||20||
48396064|NCT01367860|101299290|FG000|COMPLETED|Overall Study||20||
48396065|NCT01367860|101299291|FG001|COMPLETED|Overall Study||20||
48396066|NCT01367860|101299290|FG000|NOT COMPLETED|Overall Study||0||
48396067|NCT01367860|101299291|FG001|NOT COMPLETED|Overall Study||0||
48396068|NCT00563368|101299292|FG000|STARTED|Overall Study||109||
48396069|NCT00563368|101299293|FG001|STARTED|Overall Study||109||
48396070|NCT00563368|101299294|FG002|STARTED|Overall Study||108||
48396071|NCT00563368|101299295|FG003|STARTED|Overall Study||107||
48396072|NCT00563368|101299296|FG004|STARTED|Overall Study||108||
48396073|NCT00563368|101299297|FG005|STARTED|Overall Study||107||
48396074|NCT00563368|101299298|FG006|STARTED|Overall Study||108||
48396075|NCT00563368|101299292|FG000|COMPLETED|Overall Study||74||
48396076|NCT00563368|101299293|FG001|COMPLETED|Overall Study||79||
48396077|NCT00563368|101299294|FG002|COMPLETED|Overall Study||78||
48396078|NCT00563368|101299295|FG003|COMPLETED|Overall Study||78||
48396079|NCT00563368|101299296|FG004|COMPLETED|Overall Study||80||
48396080|NCT00563368|101299297|FG005|COMPLETED|Overall Study||77||
48396081|NCT00563368|101299298|FG006|COMPLETED|Overall Study||75||
48396082|NCT00563368|101299292|FG000|NOT COMPLETED|Overall Study||35||
48396083|NCT00563368|101299293|FG001|NOT COMPLETED|Overall Study||30||
48119990|NCT01632579|100619504|FG006|NOT COMPLETED|Washout Period||0||
48119991|NCT01632579|100619505|FG007|NOT COMPLETED|Washout Period||0||
48119992|NCT01632579|100619506|FG008|NOT COMPLETED|Washout Period||0||
48119993|NCT01632579|100619498|FG000|STARTED|Period 3 (Third Intervention)||0||
48119994|NCT01632579|100619499|FG001|STARTED|Period 3 (Third Intervention)||6||
48119995|NCT01632579|100619500|FG002|STARTED|Period 3 (Third Intervention)||2||
48119996|NCT01632579|100619501|FG003|STARTED|Period 3 (Third Intervention)||2||
48119997|NCT01632579|100619502|FG004|STARTED|Period 3 (Third Intervention)||6||
48119998|NCT01632579|100619503|FG005|STARTED|Period 3 (Third Intervention)||2||
48119999|NCT01632579|100619504|FG006|STARTED|Period 3 (Third Intervention)||2||
48699077|NCT01956097|102050454|FG001|STARTED|Overall Study||30||
48699078|NCT01956097|102050455|FG002|STARTED|Overall Study||15||
48120000|NCT01632579|100619505|FG007|STARTED|Period 3 (Third Intervention)||6||
48120001|NCT01632579|100619506|FG008|STARTED|Period 3 (Third Intervention)||2||
48120002|NCT01632579|100619498|FG000|Received at Least 1 Dose|Period 3 (Third Intervention)||0||
48120003|NCT01632579|100619499|FG001|Received at Least 1 Dose|Period 3 (Third Intervention)||6||
48120004|NCT01632579|100619500|FG002|Received at Least 1 Dose|Period 3 (Third Intervention)||2||
48120005|NCT01632579|100619501|FG003|Received at Least 1 Dose|Period 3 (Third Intervention)||2||
48120006|NCT01632579|100619502|FG004|Received at Least 1 Dose|Period 3 (Third Intervention)||6||
48120007|NCT01632579|100619503|FG005|Received at Least 1 Dose|Period 3 (Third Intervention)||2||
48120008|NCT01632579|100619504|FG006|Received at Least 1 Dose|Period 3 (Third Intervention)||2||
48120009|NCT01632579|100619505|FG007|Received at Least 1 Dose|Period 3 (Third Intervention)||6||
48120010|NCT01632579|100619506|FG008|Received at Least 1 Dose|Period 3 (Third Intervention)||2||
48120011|NCT01632579|100619498|FG000|COMPLETED|Period 3 (Third Intervention)||0||
48120012|NCT01632579|100619499|FG001|COMPLETED|Period 3 (Third Intervention)||6||
48120013|NCT01632579|100619500|FG002|COMPLETED|Period 3 (Third Intervention)||2||
48120014|NCT01632579|100619501|FG003|COMPLETED|Period 3 (Third Intervention)||2||
48120015|NCT01632579|100619502|FG004|COMPLETED|Period 3 (Third Intervention)||6||
48120016|NCT01632579|100619503|FG005|COMPLETED|Period 3 (Third Intervention)||2||
48699079|NCT01956097|102050453|FG000|COMPLETED|Overall Study||24||
48699080|NCT01956097|102050454|FG001|COMPLETED|Overall Study||28||
48699081|NCT01956097|102050455|FG002|COMPLETED|Overall Study||15||
48699082|NCT01956097|102050453|FG000|NOT COMPLETED|Overall Study||6||
48120017|NCT01632579|100619504|FG006|COMPLETED|Period 3 (Third Intervention)||2||
48699083|NCT01956097|102050454|FG001|NOT COMPLETED|Overall Study||2||
48699084|NCT01956097|102050455|FG002|NOT COMPLETED|Overall Study||0||
48120018|NCT01632579|100619505|FG007|COMPLETED|Period 3 (Third Intervention)||6||
48396084|NCT00563368|101299294|FG002|NOT COMPLETED|Overall Study||30||
48396085|NCT00563368|101299295|FG003|NOT COMPLETED|Overall Study||29||
48396086|NCT00563368|101299296|FG004|NOT COMPLETED|Overall Study||28||
48396087|NCT00563368|101299297|FG005|NOT COMPLETED|Overall Study||30||
48396088|NCT00563368|101299298|FG006|NOT COMPLETED|Overall Study||33||
48396089|NCT01162304|101299299|FG000|STARTED|Overall Study||18||
48396090|NCT01162304|101299299|FG000|COMPLETED|Overall Study||7||
48396091|NCT01162304|101299299|FG000|NOT COMPLETED|Overall Study||11||
48699085|NCT02285023|102050456|FG000|STARTED|Overall Study||166||
48120019|NCT01632579|100619506|FG008|COMPLETED|Period 3 (Third Intervention)||2||
48120020|NCT01632579|100619498|FG000|NOT COMPLETED|Period 3 (Third Intervention)||0||
48120021|NCT01632579|100619499|FG001|NOT COMPLETED|Period 3 (Third Intervention)||0||
48120022|NCT01632579|100619500|FG002|NOT COMPLETED|Period 3 (Third Intervention)||0||
48120023|NCT01632579|100619501|FG003|NOT COMPLETED|Period 3 (Third Intervention)||0||
48120024|NCT01632579|100619502|FG004|NOT COMPLETED|Period 3 (Third Intervention)||0||
48120025|NCT01632579|100619503|FG005|NOT COMPLETED|Period 3 (Third Intervention)||0||
48120026|NCT01632579|100619504|FG006|NOT COMPLETED|Period 3 (Third Intervention)||0||
48120027|NCT01632579|100619505|FG007|NOT COMPLETED|Period 3 (Third Intervention)||0||
48120028|NCT01632579|100619506|FG008|NOT COMPLETED|Period 3 (Third Intervention)||0||
48120029|NCT02465528|100619507|FG000|STARTED|Overall Study||1||
48120030|NCT02465528|100619508|FG001|STARTED|Overall Study||4||
48120031|NCT02465528|100619509|FG002|STARTED|Overall Study||12||
48120032|NCT02465528|100619510|FG003|STARTED|Overall Study||5||
48120033|NCT02465528|100619507|FG000|COMPLETED|Overall Study||0||
48120034|NCT02465528|100619508|FG001|COMPLETED|Overall Study||0||
48120035|NCT02465528|100619509|FG002|COMPLETED|Overall Study||0||
48120036|NCT02465528|100619510|FG003|COMPLETED|Overall Study||0||
48120037|NCT02465528|100619507|FG000|NOT COMPLETED|Overall Study||1||
48120038|NCT02465528|100619508|FG001|NOT COMPLETED|Overall Study||4||
48120039|NCT02465528|100619509|FG002|NOT COMPLETED|Overall Study||12||
48120040|NCT02465528|100619510|FG003|NOT COMPLETED|Overall Study||5||
48120041|NCT03895853|100619511|FG000|STARTED|Overall Study||0||
48120042|NCT03895853|100619512|FG001|STARTED|Overall Study||2||
48120043|NCT03895853|100619511|FG000|COMPLETED|Overall Study||0||
48120044|NCT03895853|100619512|FG001|COMPLETED|Overall Study||2||
48120045|NCT03895853|100619511|FG000|NOT COMPLETED|Overall Study||0||
48120046|NCT03895853|100619512|FG001|NOT COMPLETED|Overall Study||0||
48120047|NCT01688336|100619513|FG000|STARTED|Overall Study||9||
48120048|NCT01688336|100619513|FG000|COMPLETED|Overall Study||9||
48120049|NCT01688336|100619513|FG000|NOT COMPLETED|Overall Study||0||
48120050|NCT00797667|100619514|FG000|STARTED|Overall Study||265||
48120051|NCT00797667|100619515|FG001|STARTED|Overall Study||264||
48120052|NCT00797667|100619516|FG002|STARTED|Overall Study||131||
48120053|NCT00797667|100619514|FG000|Treated|Overall Study||263||
48120054|NCT00797667|100619515|FG001|Treated|Overall Study||263||
48120055|NCT00797667|100619516|FG002|Treated|Overall Study||130||
48120056|NCT00797667|100619514|FG000|COMPLETED|Overall Study||5||
48120057|NCT00797667|100619515|FG001|COMPLETED|Overall Study||5||
48120058|NCT00797667|100619516|FG002|COMPLETED|Overall Study||4||
48120059|NCT00797667|100619514|FG000|NOT COMPLETED|Overall Study||260||
48120060|NCT00797667|100619515|FG001|NOT COMPLETED|Overall Study||259||
48120061|NCT00797667|100619516|FG002|NOT COMPLETED|Overall Study||127||
48120062|NCT05446909|100619517|FG000|STARTED|Overall Study||20||
48120063|NCT05446909|100619518|FG001|STARTED|Overall Study||20||
48120064|NCT05446909|100619517|FG000|COMPLETED|Overall Study||20||
48120065|NCT05446909|100619518|FG001|COMPLETED|Overall Study||20||
48120066|NCT05446909|100619517|FG000|NOT COMPLETED|Overall Study||0||
48120067|NCT05446909|100619518|FG001|NOT COMPLETED|Overall Study||0||
48120068|NCT02545907|100619519|FG000|STARTED|Overall Study||3||
48120069|NCT02545907|100619520|FG001|STARTED|Overall Study||3||
48120070|NCT02545907|100619521|FG002|STARTED|Overall Study||4||
48120071|NCT02545907|100619519|FG000|COMPLETED|Overall Study||3||
48120072|NCT02545907|100619520|FG001|COMPLETED|Overall Study||3||
48120073|NCT02545907|100619521|FG002|COMPLETED|Overall Study||4||
48120074|NCT02545907|100619519|FG000|NOT COMPLETED|Overall Study||0||
48120075|NCT02545907|100619520|FG001|NOT COMPLETED|Overall Study||0||
48120076|NCT02545907|100619521|FG002|NOT COMPLETED|Overall Study||0||
48120077|NCT02880371|100619522|FG000|STARTED|Phase 1b||6||
48120078|NCT02880371|100619523|FG001|STARTED|Phase 1b||7||
48120079|NCT02880371|100619524|FG002|STARTED|Phase 1b||7||
48120080|NCT02880371|100619525|FG003|STARTED|Phase 1b||1||
48120081|NCT02880371|100619526|FG004|STARTED|Phase 1b||0||
48120082|NCT02880371|100619527|FG005|STARTED|Phase 1b||0||
48120083|NCT02880371|100619528|FG006|STARTED|Phase 1b||0||
48120084|NCT02880371|100619529|FG007|STARTED|Phase 1b||0||
48281372|NCT04488770|101014136|FG006|NOT COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
48281373|NCT04488770|101014137|FG007|NOT COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
48120085|NCT02880371|100619522|FG000|Treated|Phase 1b||6||
48120086|NCT02880371|100619523|FG001|Treated|Phase 1b||6||
48120087|NCT02880371|100619524|FG002|Treated|Phase 1b||7||
48120088|NCT02880371|100619525|FG003|Treated|Phase 1b||1||
48120089|NCT02880371|100619526|FG004|Treated|Phase 1b||0||
48120090|NCT02880371|100619527|FG005|Treated|Phase 1b||0||
48120091|NCT02880371|100619528|FG006|Treated|Phase 1b||0||
48120092|NCT02880371|100619529|FG007|Treated|Phase 1b||0||
48120093|NCT02880371|100619522|FG000|COMPLETED|Phase 1b||0||
48120094|NCT02880371|100619523|FG001|COMPLETED|Phase 1b||0||
48396092|NCT02126670|101299300|FG000|STARTED|Overall Study||26||
48396093|NCT02126670|101299301|FG001|STARTED|Overall Study||24||
48396094|NCT02126670|101299302|FG002|STARTED|Overall Study||25||
48396095|NCT02126670|101299303|FG003|STARTED|Overall Study||25||
48396096|NCT02126670|101299300|FG000|COMPLETED|Overall Study||25||
48396097|NCT02126670|101299301|FG001|COMPLETED|Overall Study||24||
48396098|NCT02126670|101299302|FG002|COMPLETED|Overall Study||25||
48396099|NCT02126670|101299303|FG003|COMPLETED|Overall Study||24||
48120095|NCT02880371|100619524|FG002|COMPLETED|Phase 1b||1||
48120096|NCT02880371|100619525|FG003|COMPLETED|Phase 1b||0||
48120097|NCT02880371|100619526|FG004|COMPLETED|Phase 1b||0||
48120098|NCT02880371|100619527|FG005|COMPLETED|Phase 1b||0||
48120099|NCT02880371|100619528|FG006|COMPLETED|Phase 1b||0||
48120100|NCT02880371|100619529|FG007|COMPLETED|Phase 1b||0||
48120101|NCT02880371|100619522|FG000|NOT COMPLETED|Phase 1b||6||
48120102|NCT02880371|100619523|FG001|NOT COMPLETED|Phase 1b||7||
48120103|NCT02880371|100619524|FG002|NOT COMPLETED|Phase 1b||6||
48120104|NCT02880371|100619525|FG003|NOT COMPLETED|Phase 1b||1||
48120105|NCT02880371|100619526|FG004|NOT COMPLETED|Phase 1b||0||
48120106|NCT02880371|100619527|FG005|NOT COMPLETED|Phase 1b||0||
48120107|NCT02880371|100619528|FG006|NOT COMPLETED|Phase 1b||0||
48120108|NCT02880371|100619529|FG007|NOT COMPLETED|Phase 1b||0||
48120109|NCT02880371|100619522|FG000|STARTED|Phase 2||0||
48396100|NCT02126670|101299300|FG000|NOT COMPLETED|Overall Study||1||
48396101|NCT02126670|101299301|FG001|NOT COMPLETED|Overall Study||0||
48396102|NCT02126670|101299302|FG002|NOT COMPLETED|Overall Study||0||
48396103|NCT02126670|101299303|FG003|NOT COMPLETED|Overall Study||1||
48396104|NCT01148693|101299304|FG000|STARTED|Overall Study||70||
48396105|NCT01148693|101299305|FG001|STARTED|Overall Study||67||
48396106|NCT01148693|101299304|FG000|COMPLETED|Overall Study||57||
48396107|NCT01148693|101299305|FG001|COMPLETED|Overall Study||57||
48396108|NCT01148693|101299304|FG000|NOT COMPLETED|Overall Study||13||
48396109|NCT01148693|101299305|FG001|NOT COMPLETED|Overall Study||10||
48396110|NCT02661464|101299306|FG000|STARTED|Overall Study||617||
48396111|NCT02661464|101299307|FG001|STARTED|Overall Study||57||
48396112|NCT02661464|101299308|FG002|STARTED|Overall Study||2||
48396113|NCT02661464|101299309|FG003|STARTED|Overall Study||1||
48396114|NCT02661464|101299306|FG000|Full Analysis Set|Overall Study||614||
48396115|NCT02661464|101299307|FG001|Full Analysis Set|Overall Study||53||
48396116|NCT02661464|101299308|FG002|Full Analysis Set|Overall Study||2||
48396117|NCT02661464|101299309|FG003|Full Analysis Set|Overall Study||1||
48396118|NCT02661464|101299306|FG000|COMPLETED|Overall Study||295||
48396119|NCT02661464|101299307|FG001|COMPLETED|Overall Study||0||
48396120|NCT02661464|101299308|FG002|COMPLETED|Overall Study||1||
48396121|NCT02661464|101299309|FG003|COMPLETED|Overall Study||0||
48396122|NCT02661464|101299306|FG000|NOT COMPLETED|Overall Study||322||
48396123|NCT02661464|101299307|FG001|NOT COMPLETED|Overall Study||57||
48396124|NCT02661464|101299308|FG002|NOT COMPLETED|Overall Study||1||
48396125|NCT02661464|101299309|FG003|NOT COMPLETED|Overall Study||1||
48396126|NCT00045630|101299310|FG000|STARTED|Overall Study||77||
48396127|NCT00045630|101299310|FG000|Eligible|Overall Study||75||
48396128|NCT00045630|101299310|FG000|Eligible and Began Protocol Therapy|Overall Study||74||
48396129|NCT00045630|101299310|FG000|COMPLETED|Overall Study||71||
48396130|NCT00045630|101299310|FG000|NOT COMPLETED|Overall Study||6||
48396131|NCT02023112|101299311|FG000|STARTED|Overall Study||85||
48396132|NCT02023112|101299312|FG001|STARTED|Overall Study||86||
48396133|NCT02023112|101299311|FG000|COMPLETED|Overall Study||83||
48396134|NCT02023112|101299312|FG001|COMPLETED|Overall Study||85||
48396135|NCT02023112|101299311|FG000|NOT COMPLETED|Overall Study||2||
48396136|NCT02023112|101299312|FG001|NOT COMPLETED|Overall Study||1||
48396137|NCT02867163|101299313|FG000|STARTED|Overall Study||25||
48396138|NCT02867163|101299313|FG000|COMPLETED|Overall Study||25||
48396139|NCT02867163|101299313|FG000|NOT COMPLETED|Overall Study||0||
48396140|NCT02564029|101299314|FG000|STARTED|Overall Study||7||
48120110|NCT02880371|100619523|FG001|STARTED|Phase 2||0||
48120111|NCT02880371|100619524|FG002|STARTED|Phase 2||0||
48120112|NCT02880371|100619525|FG003|STARTED|Phase 2||0||
48396141|NCT02564029|101299314|FG000|COMPLETED|Overall Study||7||
48396142|NCT02564029|101299314|FG000|NOT COMPLETED|Overall Study||0||
48396143|NCT00779311|101299315|FG000|STARTED|Overall Study||8||
48396144|NCT00779311|101299316|FG001|STARTED|Overall Study||0||
48396145|NCT00779311|101299317|FG002|STARTED|Overall Study||0||
48396146|NCT00779311|101299318|FG003|STARTED|Overall Study||0||
48120113|NCT02880371|100619526|FG004|STARTED|Phase 2||2||
48396147|NCT00779311|101299319|FG004|STARTED|Overall Study||0||
48396148|NCT00779311|101299315|FG000|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||6||
48120114|NCT02880371|100619527|FG005|STARTED|Phase 2||20||
48120115|NCT02880371|100619528|FG006|STARTED|Phase 2||28||
48120116|NCT02880371|100619529|FG007|STARTED|Phase 2||11||
48120117|NCT02880371|100619522|FG000|Treated|Phase 2||0||
48396149|NCT00779311|101299316|FG001|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0||
48396150|NCT00779311|101299317|FG002|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0||
48396151|NCT00779311|101299318|FG003|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0||
48396152|NCT00779311|101299319|FG004|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0||
48396153|NCT00779311|101299315|FG000|COMPLETED|Overall Study||8||
48120118|NCT02880371|100619523|FG001|Treated|Phase 2||0||
48120119|NCT02880371|100619524|FG002|Treated|Phase 2||0||
48120120|NCT02880371|100619525|FG003|Treated|Phase 2||0||
48120121|NCT02880371|100619526|FG004|Treated|Phase 2||2||
48120122|NCT02880371|100619527|FG005|Treated|Phase 2||19||
48120123|NCT02880371|100619528|FG006|Treated|Phase 2||27||
48120124|NCT02880371|100619529|FG007|Treated|Phase 2||11||
48120125|NCT02880371|100619522|FG000|COMPLETED|Phase 2||0||
48120126|NCT02880371|100619523|FG001|COMPLETED|Phase 2||0||
48120127|NCT02880371|100619524|FG002|COMPLETED|Phase 2||0||
48120128|NCT02880371|100619525|FG003|COMPLETED|Phase 2||0||
48120129|NCT02880371|100619526|FG004|COMPLETED|Phase 2||0||
48120130|NCT02880371|100619527|FG005|COMPLETED|Phase 2||0||
48120131|NCT02880371|100619528|FG006|COMPLETED|Phase 2||0||
48120132|NCT02880371|100619529|FG007|COMPLETED|Phase 2||0||
48120133|NCT02880371|100619522|FG000|NOT COMPLETED|Phase 2||0||
48120134|NCT02880371|100619523|FG001|NOT COMPLETED|Phase 2||0||
48120135|NCT02880371|100619524|FG002|NOT COMPLETED|Phase 2||0||
48120136|NCT02880371|100619525|FG003|NOT COMPLETED|Phase 2||0||
48120137|NCT02880371|100619526|FG004|NOT COMPLETED|Phase 2||2||
48120138|NCT02880371|100619527|FG005|NOT COMPLETED|Phase 2||20||
48120139|NCT02880371|100619528|FG006|NOT COMPLETED|Phase 2||28||
48120140|NCT02880371|100619529|FG007|NOT COMPLETED|Phase 2||11||
48120141|NCT02066857|100619530|FG000|STARTED|Overall Study||1||
48120142|NCT02066857|100619531|FG001|STARTED|Overall Study||4||
48120143|NCT02066857|100619530|FG000|COMPLETED|Overall Study||0||
48120144|NCT02066857|100619531|FG001|COMPLETED|Overall Study||3||
48120145|NCT02066857|100619530|FG000|NOT COMPLETED|Overall Study||1||
48120146|NCT02066857|100619531|FG001|NOT COMPLETED|Overall Study||1||
48120147|NCT03698773|100619532|FG000|STARTED|Overall Study||50||
48120148|NCT03698773|100619533|FG001|STARTED|Overall Study||56||
48568798|NCT01877642|101724640|FG000|NOT COMPLETED|Overall Study||0||
48120149|NCT03698773|100619532|FG000|COMPLETED|Overall Study||48||
48120150|NCT03698773|100619533|FG001|COMPLETED|Overall Study||55||
48120151|NCT03698773|100619532|FG000|NOT COMPLETED|Overall Study||2||
48120152|NCT03698773|100619533|FG001|NOT COMPLETED|Overall Study||1||
48568799|NCT01877642|101724641|FG001|NOT COMPLETED|Overall Study||0||
48568800|NCT01877642|101724642|FG002|NOT COMPLETED|Overall Study||0||
48568801|NCT01877642|101724643|FG003|NOT COMPLETED|Overall Study||0||
48568802|NCT01877642|101724644|FG004|NOT COMPLETED|Overall Study||0||
48568803|NCT01877642|101724645|FG005|NOT COMPLETED|Overall Study||0||
48120153|NCT01974050|100619534|FG000|STARTED|Overall Study||166||
48120154|NCT01974050|100619534|FG000|COMPLETED|Overall Study||141||
48281374|NCT04488770|101014138|FG008|NOT COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
48281375|NCT04488770|101014139|FG009|NOT COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
48281376|NCT04488770|101014140|FG010|NOT COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
48120155|NCT01974050|100619534|FG000|NOT COMPLETED|Overall Study||25||
48120156|NCT01236196|100619535|FG000|STARTED|Overall Study||18||
48120157|NCT01236196|100619536|FG001|STARTED|Overall Study||21||
48120158|NCT01236196|100619535|FG000|COMPLETED|Overall Study||17||
48120159|NCT01236196|100619536|FG001|COMPLETED|Overall Study||13||
48120160|NCT01236196|100619535|FG000|NOT COMPLETED|Overall Study||1||
48120161|NCT01236196|100619536|FG001|NOT COMPLETED|Overall Study||8||
48120162|NCT00622427|100619537|FG000|STARTED|Overall Study||16||
48120163|NCT00622427|100619538|FG001|STARTED|Overall Study||16||
48120164|NCT00622427|100619537|FG000|COMPLETED|Overall Study||16||
48120165|NCT00622427|100619538|FG001|COMPLETED|Overall Study||16||
48120166|NCT00622427|100619537|FG000|NOT COMPLETED|Overall Study||0||
48281377|NCT04488770|101014141|FG011|NOT COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
48281378|NCT04488770|101014142|FG012|NOT COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
48281379|NCT04488770|101014130|FG000|STARTED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||2||
48281380|NCT04488770|101014131|FG001|STARTED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||2||
48120167|NCT00622427|100619538|FG001|NOT COMPLETED|Overall Study||0||
48120168|NCT05165121|100619539|FG000|STARTED|Overall Study||20||
48120169|NCT05165121|100619540|FG001|STARTED|Overall Study||36||
48120170|NCT05165121|100619541|FG002|STARTED|Overall Study||35||
48568804|NCT01877642|101724646|FG006|NOT COMPLETED|Overall Study||0||
48120171|NCT05165121|100619539|FG000|COMPLETED|Overall Study||20||
48120172|NCT05165121|100619540|FG001|COMPLETED|Overall Study||32||
48568805|NCT01749826|101724647|FG000|STARTED|Overall Study||20||
48568806|NCT01749826|101724648|FG001|STARTED|Overall Study||0||
48568807|NCT01749826|101724647|FG000|COMPLETED|Overall Study||0||
48568808|NCT01749826|101724648|FG001|COMPLETED|Overall Study||0||
48568809|NCT01749826|101724647|FG000|NOT COMPLETED|Overall Study||20||
48568810|NCT01749826|101724648|FG001|NOT COMPLETED|Overall Study||0||
48120173|NCT05165121|100619541|FG002|COMPLETED|Overall Study||32||
48120174|NCT05165121|100619539|FG000|NOT COMPLETED|Overall Study||0||
48120175|NCT05165121|100619540|FG001|NOT COMPLETED|Overall Study||4||
48120176|NCT05165121|100619541|FG002|NOT COMPLETED|Overall Study||3||
48120177|NCT03146650|100619542|FG000|STARTED|Registered for Study||25||
48396154|NCT00779311|101299316|FG001|COMPLETED|Overall Study||0||
48396155|NCT00779311|101299317|FG002|COMPLETED|Overall Study||0||
48396156|NCT00779311|101299318|FG003|COMPLETED|Overall Study||0||
48396157|NCT00779311|101299319|FG004|COMPLETED|Overall Study||0||
48120178|NCT03146650|100619542|FG000|Received First Dose of Study Drug|Registered for Study||24||
48120179|NCT03146650|100619542|FG000|COMPLETED|Registered for Study||24||
48120180|NCT03146650|100619542|FG000|NOT COMPLETED|Registered for Study||1||
48120181|NCT03146650|100619542|FG000|STARTED|Completed Cycle 1 of Treatment(Nivo+Ipi)||24||
48120182|NCT03146650|100619542|FG000|COMPLETED|Completed Cycle 1 of Treatment(Nivo+Ipi)||23||
48120183|NCT03146650|100619542|FG000|NOT COMPLETED|Completed Cycle 1 of Treatment(Nivo+Ipi)||1||
48120184|NCT03146650|100619542|FG000|STARTED|Continued to Cycle 2 and Beyond||23|Nivolumab and ipilimumab administered intravenously until disease progression/intolerable toxicity.|
48120185|NCT03146650|100619542|FG000|Reached First Response Assessment|Continued to Cycle 2 and Beyond||23||
48120186|NCT03146650|100619542|FG000|Received Cycle 2 Dose of Study Drugs|Continued to Cycle 2 and Beyond||21||
48281381|NCT04488770|101014132|FG002|STARTED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||2||
48281382|NCT04488770|101014133|FG003|STARTED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||2||
48281383|NCT04488770|101014134|FG004|STARTED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
48281384|NCT04488770|101014135|FG005|STARTED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
48281385|NCT04488770|101014136|FG006|STARTED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
48281386|NCT04488770|101014137|FG007|STARTED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
48281387|NCT04488770|101014138|FG008|STARTED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
48281388|NCT04488770|101014139|FG009|STARTED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
48281389|NCT04488770|101014140|FG010|STARTED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
48281390|NCT04488770|101014141|FG011|STARTED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
48281391|NCT04488770|101014142|FG012|STARTED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
48281392|NCT04488770|101014130|FG000|COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||2||
48396158|NCT00779311|101299315|FG000|NOT COMPLETED|Overall Study||0||
48396159|NCT00779311|101299316|FG001|NOT COMPLETED|Overall Study||0||
48396160|NCT00779311|101299317|FG002|NOT COMPLETED|Overall Study||0||
48396161|NCT00779311|101299318|FG003|NOT COMPLETED|Overall Study||0||
48396162|NCT00779311|101299319|FG004|NOT COMPLETED|Overall Study||0||
48396163|NCT03488238|101299320|FG000|STARTED|Overall Study||31||
48281393|NCT04488770|101014131|FG001|COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||2||
48281394|NCT04488770|101014132|FG002|COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||2||
48281395|NCT04488770|101014133|FG003|COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||2||
48396164|NCT03488238|101299320|FG000|COMPLETED|Overall Study||29||
48396165|NCT03488238|101299320|FG000|NOT COMPLETED|Overall Study||2||
48396166|NCT00422903|101299321|FG000|STARTED|Overall Study||49||
48396167|NCT00422903|101299322|FG001|STARTED|Overall Study||43||
48396168|NCT00422903|101299321|FG000|COMPLETED|Overall Study||45||
48396169|NCT00422903|101299322|FG001|COMPLETED|Overall Study||38||
48396170|NCT00422903|101299321|FG000|NOT COMPLETED|Overall Study||4||
48396171|NCT00422903|101299322|FG001|NOT COMPLETED|Overall Study||5||
48396172|NCT03326869|101299323|FG000|STARTED|Overall Study||1||
48396173|NCT03326869|101299324|FG001|STARTED|Overall Study||1||
48396174|NCT03326869|101299323|FG000|COMPLETED|Overall Study||0||
48396175|NCT03326869|101299324|FG001|COMPLETED|Overall Study||0||
48396176|NCT03326869|101299323|FG000|NOT COMPLETED|Overall Study||1||
48396177|NCT03326869|101299324|FG001|NOT COMPLETED|Overall Study||1||
48396178|NCT00605072|101299325|FG000|STARTED|Overall Study||18||
48396179|NCT00605072|101299326|FG001|STARTED|Overall Study||20||
48396180|NCT00605072|101299327|FG002|STARTED|Overall Study||15||
48396181|NCT00605072|101299325|FG000|COMPLETED|Overall Study||11||
48396182|NCT00605072|101299326|FG001|COMPLETED|Overall Study||9||
48281396|NCT04488770|101014134|FG004|COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
48396183|NCT00605072|101299327|FG002|COMPLETED|Overall Study||11||
48396184|NCT00605072|101299325|FG000|NOT COMPLETED|Overall Study||7||
48396185|NCT00605072|101299326|FG001|NOT COMPLETED|Overall Study||11||
48396186|NCT00605072|101299327|FG002|NOT COMPLETED|Overall Study||4||
48396187|NCT01618422|101299328|FG000|STARTED|Overall Study||114||
48396188|NCT01618422|101299329|FG001|STARTED|Overall Study||111||
48396189|NCT01618422|101299328|FG000|COMPLETED|Overall Study||114||
48396190|NCT01618422|101299329|FG001|COMPLETED|Overall Study||111||
48396191|NCT01618422|101299328|FG000|NOT COMPLETED|Overall Study||0||
48396192|NCT01618422|101299329|FG001|NOT COMPLETED|Overall Study||0||
48396193|NCT00810810|101299330|FG000|STARTED|Overall Study||124||
48396194|NCT00810810|101299331|FG001|STARTED|Overall Study||49||
48396195|NCT00810810|101299332|FG002|STARTED|Overall Study||56||
48396196|NCT00810810|101299333|FG003|STARTED|Overall Study||51||
48396197|NCT00810810|101299330|FG000|COMPLETED|Overall Study||124||
48396198|NCT00810810|101299331|FG001|COMPLETED|Overall Study||38||
48396199|NCT00810810|101299332|FG002|COMPLETED|Overall Study||45||
48396200|NCT00810810|101299333|FG003|COMPLETED|Overall Study||38||
48396201|NCT00810810|101299330|FG000|NOT COMPLETED|Overall Study||0||
48396202|NCT00810810|101299331|FG001|NOT COMPLETED|Overall Study||11||
48396203|NCT00810810|101299332|FG002|NOT COMPLETED|Overall Study||11||
48396204|NCT00810810|101299333|FG003|NOT COMPLETED|Overall Study||13||
48396205|NCT02757092|101299334|FG000|STARTED|Overall Study||18||
48396206|NCT02757092|101299335|FG001|STARTED|Overall Study||18||
48396207|NCT02757092|101299334|FG000|COMPLETED|Overall Study||18||
48396208|NCT02757092|101299335|FG001|COMPLETED|Overall Study||18||
48396209|NCT02757092|101299334|FG000|NOT COMPLETED|Overall Study||0||
48396210|NCT02757092|101299335|FG001|NOT COMPLETED|Overall Study||0||
48396211|NCT01804114|101299336|FG000|STARTED|Overall Study||17||
48396212|NCT01804114|101299337|FG001|STARTED|Overall Study||12||
48396213|NCT01804114|101299336|FG000|COMPLETED|Overall Study||17||
48396214|NCT01804114|101299337|FG001|COMPLETED|Overall Study||12||
48396215|NCT01804114|101299336|FG000|NOT COMPLETED|Overall Study||0||
48396216|NCT01804114|101299337|FG001|NOT COMPLETED|Overall Study||0||
48396217|NCT01009918|101299338|FG000|STARTED|Overall Study||158||
48396218|NCT01009918|101299339|FG001|STARTED|Overall Study||156||
48396219|NCT01009918|101299340|FG002|STARTED|Overall Study||154||
48699086|NCT02285023|102050456|FG000|COMPLETED|Overall Study||166||
48699087|NCT02285023|102050456|FG000|NOT COMPLETED|Overall Study||0||
48699088|NCT03362502|102050457|FG000|STARTED|Overall Study||3||
48699089|NCT03362502|102050458|FG001|STARTED|Overall Study||16||
48699090|NCT03362502|102050459|FG002|STARTED|Overall Study||3||
48699091|NCT03362502|102050457|FG000|COMPLETED|Overall Study||3|Completed indicates participants completed the 1-year follow-up as of data cutoff on 30 Sep 2022.|
48281397|NCT04488770|101014135|FG005|COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
48281398|NCT04488770|101014136|FG006|COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
48281399|NCT04488770|101014137|FG007|COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
48281400|NCT04488770|101014138|FG008|COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
48281401|NCT04488770|101014139|FG009|COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
48281402|NCT04488770|101014140|FG010|COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
48281403|NCT04488770|101014141|FG011|COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
48281404|NCT04488770|101014142|FG012|COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
48281405|NCT04488770|101014130|FG000|NOT COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
48281406|NCT04488770|101014131|FG001|NOT COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
48281407|NCT04488770|101014132|FG002|NOT COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
48281408|NCT04488770|101014133|FG003|NOT COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
48281409|NCT04488770|101014134|FG004|NOT COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
48699092|NCT03362502|102050458|FG001|COMPLETED|Overall Study||16|Completed indicates participants completed the 1-year follow-up as of data cutoff on 30 Sep 2022.|
48281410|NCT04488770|101014135|FG005|NOT COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
48281411|NCT04488770|101014136|FG006|NOT COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
48281412|NCT04488770|101014137|FG007|NOT COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
48281413|NCT04488770|101014138|FG008|NOT COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
48281414|NCT04488770|101014139|FG009|NOT COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
48281415|NCT04488770|101014140|FG010|NOT COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
48281416|NCT04488770|101014141|FG011|NOT COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
48281417|NCT04488770|101014142|FG012|NOT COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
48281418|NCT04488770|101014130|FG000|STARTED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||2||
48281419|NCT04488770|101014131|FG001|STARTED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||2||
48396220|NCT01009918|101299338|FG000|COMPLETED|Overall Study||134||
48396221|NCT01009918|101299339|FG001|COMPLETED|Overall Study||132||
48396222|NCT01009918|101299340|FG002|COMPLETED|Overall Study||124||
48396223|NCT01009918|101299338|FG000|NOT COMPLETED|Overall Study||24||
48699093|NCT03362502|102050459|FG002|COMPLETED|Overall Study||2|Completed indicates participants completed the 1-year follow-up as of data cutoff on 30 Sep 2022.|
48699094|NCT03362502|102050457|FG000|NOT COMPLETED|Overall Study||0||
48699095|NCT03362502|102050458|FG001|NOT COMPLETED|Overall Study||0||
48699096|NCT03362502|102050459|FG002|NOT COMPLETED|Overall Study||1||
48281420|NCT04488770|101014132|FG002|STARTED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||2||
48281421|NCT04488770|101014133|FG003|STARTED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||2||
48281422|NCT04488770|101014134|FG004|STARTED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
48281423|NCT04488770|101014135|FG005|STARTED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
48281424|NCT04488770|101014136|FG006|STARTED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
48396224|NCT01009918|101299339|FG001|NOT COMPLETED|Overall Study||24||
48396225|NCT01009918|101299340|FG002|NOT COMPLETED|Overall Study||30||
48396226|NCT02427100|101299341|FG000|STARTED|Overall Study||15||
48396227|NCT02427100|101299342|FG001|STARTED|Overall Study||17||
48396228|NCT02427100|101299341|FG000|COMPLETED|Overall Study||15||
48396229|NCT02427100|101299342|FG001|COMPLETED|Overall Study||15||
48396230|NCT02427100|101299341|FG000|NOT COMPLETED|Overall Study||0||
48396231|NCT02427100|101299342|FG001|NOT COMPLETED|Overall Study||2||
48396232|NCT01040845|101299343|FG000|STARTED|Overall Study||15||
48396233|NCT01040845|101299344|FG001|STARTED|Overall Study||15||
48396234|NCT01040845|101299343|FG000|COMPLETED|Overall Study||13||
48396235|NCT01040845|101299344|FG001|COMPLETED|Overall Study||14||
48396236|NCT01040845|101299343|FG000|NOT COMPLETED|Overall Study||2||
48396237|NCT01040845|101299344|FG001|NOT COMPLETED|Overall Study||1||
48396238|NCT03287869|101299345|FG000|STARTED|Overall Study||188||
48396239|NCT03287869|101299346|FG001|STARTED|Overall Study||193||
48404073|NCT03689972|101321770|FG004|COMPLETED|Part 1 (Day 1 up to Week 72)||0|Completed denotes the participants that completed the study treatment.|
48699097|NCT02589665|102050460|FG000|STARTED|Induction Period||63||
48699098|NCT02589665|102050461|FG001|STARTED|Induction Period||63||
48281425|NCT04488770|101014137|FG007|STARTED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
48281426|NCT04488770|101014138|FG008|STARTED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
48281427|NCT04488770|101014139|FG009|STARTED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
48396240|NCT03287869|101299345|FG000|Analyzed For Safety (Safety Sample)|Overall Study||184|Participants who received at least 1 dose of investigational medicinal product (IMP-brexpiprazole).|
48396241|NCT03287869|101299346|FG001|Analyzed For Safety (Safety Sample)|Overall Study||184|Participants who received at least 1 dose of investigational medicinal product (IMP-brexpiprazole).|
48396242|NCT03287869|101299345|FG000|COMPLETED|Overall Study||105||
48396243|NCT03287869|101299346|FG001|COMPLETED|Overall Study||100||
48281428|NCT04488770|101014140|FG010|STARTED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
48281429|NCT04488770|101014141|FG011|STARTED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
48281430|NCT04488770|101014142|FG012|STARTED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
48281431|NCT04488770|101014130|FG000|COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||1||
48281432|NCT04488770|101014131|FG001|COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||2||
48281433|NCT04488770|101014132|FG002|COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||2||
48281434|NCT04488770|101014133|FG003|COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||2||
48281435|NCT04488770|101014134|FG004|COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
48281436|NCT04488770|101014135|FG005|COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
48281437|NCT04488770|101014136|FG006|COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
48281438|NCT04488770|101014137|FG007|COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
48281439|NCT04488770|101014138|FG008|COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
48281440|NCT04488770|101014139|FG009|COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
48281441|NCT04488770|101014140|FG010|COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
48281442|NCT04488770|101014141|FG011|COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
48281443|NCT04488770|101014142|FG012|COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
48281444|NCT04488770|101014130|FG000|NOT COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||1||
48281445|NCT04488770|101014131|FG001|NOT COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
48281446|NCT04488770|101014132|FG002|NOT COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
48281447|NCT04488770|101014133|FG003|NOT COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
48281448|NCT04488770|101014134|FG004|NOT COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
48281449|NCT04488770|101014135|FG005|NOT COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
48281450|NCT04488770|101014136|FG006|NOT COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
48281451|NCT04488770|101014137|FG007|NOT COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
48281452|NCT04488770|101014138|FG008|NOT COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
48281453|NCT04488770|101014139|FG009|NOT COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
48281454|NCT04488770|101014140|FG010|NOT COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
48281455|NCT04488770|101014141|FG011|NOT COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
48281456|NCT04488770|101014142|FG012|NOT COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
48281457|NCT04488770|101014130|FG000|STARTED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||2||
48281458|NCT04488770|101014131|FG001|STARTED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||2||
48281459|NCT04488770|101014132|FG002|STARTED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||2||
48281460|NCT04488770|101014133|FG003|STARTED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||2||
48699099|NCT02589665|102050462|FG002|STARTED|Induction Period||62||
48699100|NCT02589665|102050463|FG003|STARTED|Induction Period||61||
48699101|NCT02589665|102050464|FG004|STARTED|Induction Period||0||
48699102|NCT02589665|102050465|FG005|STARTED|Induction Period||0||
48699103|NCT02589665|102050466|FG006|STARTED|Induction Period||0||
48699104|NCT02589665|102050467|FG007|STARTED|Induction Period||0||
48699105|NCT02589665|102050468|FG008|STARTED|Induction Period||0||
48699106|NCT02589665|102050469|FG009|STARTED|Induction Period||0||
48699107|NCT02589665|102050460|FG000|Received at Least One Dose of Study Drug|Induction Period||63||
48699108|NCT02589665|102050461|FG001|Received at Least One Dose of Study Drug|Induction Period||63||
48699109|NCT02589665|102050462|FG002|Received at Least One Dose of Study Drug|Induction Period||62||
48699110|NCT02589665|102050463|FG003|Received at Least One Dose of Study Drug|Induction Period||60||
48699111|NCT02589665|102050464|FG004|Received at Least One Dose of Study Drug|Induction Period||0||
48699112|NCT02589665|102050465|FG005|Received at Least One Dose of Study Drug|Induction Period||0||
48281461|NCT04488770|101014134|FG004|STARTED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
48281462|NCT04488770|101014135|FG005|STARTED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
48281463|NCT04488770|101014136|FG006|STARTED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
48281464|NCT04488770|101014137|FG007|STARTED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
48396244|NCT03287869|101299345|FG000|NOT COMPLETED|Overall Study||83||
48396245|NCT03287869|101299346|FG001|NOT COMPLETED|Overall Study||93||
48396246|NCT01522443|101299347|FG000|STARTED|Overall Study||61|Randomized|
48699113|NCT02589665|102050466|FG006|Received at Least One Dose of Study Drug|Induction Period||0||
48699114|NCT02589665|102050467|FG007|Received at Least One Dose of Study Drug|Induction Period||0||
48699115|NCT02589665|102050468|FG008|Received at Least One Dose of Study Drug|Induction Period||0||
48699116|NCT02589665|102050469|FG009|Received at Least One Dose of Study Drug|Induction Period||0||
48699117|NCT02589665|102050460|FG000|COMPLETED|Induction Period||60||
48699118|NCT02589665|102050461|FG001|COMPLETED|Induction Period||61||
48568811|NCT03048747|101724649|FG000|STARTED|Overall Study||16||
48568812|NCT03048747|101724649|FG000|COMPLETED|Overall Study||11||
48568813|NCT03048747|101724649|FG000|NOT COMPLETED|Overall Study||5||
48568814|NCT01806051|101724650|FG000|STARTED|Overall Study||6||
48568815|NCT01806051|101724650|FG000|COMPLETED|Overall Study||0||
48568816|NCT01806051|101724650|FG000|NOT COMPLETED|Overall Study||6||
48568817|NCT03852472|101724651|FG000|STARTED|Period 1 - 12 Weeks||130|The Intent-to-Treat Population in period 1 (ITT1) was defined as all subjects who were randomized at baseline and received at least 1 dose of investigational product during period 1 and excluded Site 138 subjects (please see additional milestone below for exact figures)|
48568818|NCT03852472|101724652|FG001|STARTED|Period 1 - 12 Weeks||134|The Intent-to-Treat Population in period 1 (ITT1) was defined as all subjects who were randomized at baseline and received at least 1 dose of investigational product during period 1 and excluded Site 138 subjects (please see additional milestone below for exact figures)|
48568819|NCT03852472|101724653|FG002|STARTED|Period 1 - 12 Weeks||134|The Intent-to-Treat Population in period 1 (ITT1) was defined as all subjects who were randomized at baseline and received at least 1 dose of investigational product during period 1 and excluded Site 138 subjects (please see additional milestone below for exact figures)|
48568820|NCT03852472|101724654|FG003|STARTED|Period 1 - 12 Weeks||0|The Intent-to-Treat Population in period 1 (ITT1) was defined as all subjects who were randomized at baseline and received at least 1 dose of investigational product during period 1 and excluded Site 138 subjects (please see additional milestone below for exact figures)|
48568821|NCT03852472|101724655|FG004|STARTED|Period 1 - 12 Weeks||0|The Intent-to-Treat Population in period 1 (ITT1) was defined as all subjects who were randomized at baseline and received at least 1 dose of investigational product during period 1 and excluded Site 138 subjects (please see additional milestone below for exact figures)|
48568822|NCT03852472|101724651|FG000|Excluded Site 138 Subjects From ITT1|Period 1 - 12 Weeks||13|Subjects from Site 138 were excluded from the analysis due to potential misconduct and noncompliance at this site.|
48568823|NCT03852472|101724652|FG001|Excluded Site 138 Subjects From ITT1|Period 1 - 12 Weeks||11|Subjects from Site 138 were excluded from the analysis due to potential misconduct and noncompliance at this site.|
48568824|NCT03852472|101724653|FG002|Excluded Site 138 Subjects From ITT1|Period 1 - 12 Weeks||13|Subjects from Site 138 were excluded from the analysis due to potential misconduct and noncompliance at this site.|
48568825|NCT03852472|101724654|FG003|Excluded Site 138 Subjects From ITT1|Period 1 - 12 Weeks||0|Subjects from Site 138 were excluded from the analysis due to potential misconduct and noncompliance at this site.|
48568826|NCT03852472|101724655|FG004|Excluded Site 138 Subjects From ITT1|Period 1 - 12 Weeks||0|Subjects from Site 138 were excluded from the analysis due to potential misconduct and noncompliance at this site.|
48568827|NCT03852472|101724651|FG000|COMPLETED|Period 1 - 12 Weeks||109||
48568828|NCT03852472|101724652|FG001|COMPLETED|Period 1 - 12 Weeks||108||
48568829|NCT03852472|101724653|FG002|COMPLETED|Period 1 - 12 Weeks||109||
48568830|NCT03852472|101724654|FG003|COMPLETED|Period 1 - 12 Weeks||0||
48568831|NCT03852472|101724655|FG004|COMPLETED|Period 1 - 12 Weeks||0||
48568832|NCT03852472|101724651|FG000|NOT COMPLETED|Period 1 - 12 Weeks||21||
48568833|NCT03852472|101724652|FG001|NOT COMPLETED|Period 1 - 12 Weeks||26||
48568834|NCT03852472|101724653|FG002|NOT COMPLETED|Period 1 - 12 Weeks||25||
48568835|NCT03852472|101724654|FG003|NOT COMPLETED|Period 1 - 12 Weeks||0||
48568836|NCT03852472|101724655|FG004|NOT COMPLETED|Period 1 - 12 Weeks||0||
48568837|NCT03852472|101724651|FG000|STARTED|Period 2 - Week 44||0|The Intent-to-Treat Population in period 2 (ITT2) was defined as all subjects who received at least 1 dose of investigational product during period 2 and excluded Site 138 subjects (please see additional milestone below for exact figures)|
48568838|NCT03852472|101724652|FG001|STARTED|Period 2 - Week 44||108|The Intent-to-Treat Population in period 2 (ITT2) was defined as all subjects who received at least 1 dose of investigational product during period 2 and excluded Site 138 subjects (please see additional milestone below for exact figures)|
48568839|NCT03852472|101724653|FG002|STARTED|Period 2 - Week 44||108|The Intent-to-Treat Population in period 2 (ITT2) was defined as all subjects who received at least 1 dose of investigational product during period 2 and excluded Site 138 subjects (please see additional milestone below for exact figures)|
48568840|NCT03852472|101724654|FG003|STARTED|Period 2 - Week 44||56|The Intent-to-Treat Population in period 2 (ITT2) was defined as all subjects who received at least 1 dose of investigational product during period 2 and excluded Site 138 subjects (please see additional milestone below for exact figures)|
48568841|NCT03852472|101724655|FG004|STARTED|Period 2 - Week 44||53|The Intent-to-Treat Population in period 2 (ITT2) was defined as all subjects who received at least 1 dose of investigational product during period 2 and excluded Site 138 subjects (please see additional milestone below for exact figures)|
48568842|NCT03852472|101724651|FG000|Excluded Site 138 Subjects From ITT2|Period 2 - Week 44||0|Subjects from Site 138 were excluded from the analysis due to potential misconduct and noncompliance at this site.|
48568843|NCT03852472|101724652|FG001|Excluded Site 138 Subjects From ITT2|Period 2 - Week 44||7|Subjects from Site 138 were excluded from the analysis due to potential misconduct and noncompliance at this site.|
48568844|NCT03852472|101724653|FG002|Excluded Site 138 Subjects From ITT2|Period 2 - Week 44||9|Subjects from Site 138 were excluded from the analysis due to potential misconduct and noncompliance at this site.|
48568845|NCT03852472|101724654|FG003|Excluded Site 138 Subjects From ITT2|Period 2 - Week 44||3|Subjects from Site 138 were excluded from the analysis due to potential misconduct and noncompliance at this site.|
48568846|NCT03852472|101724655|FG004|Excluded Site 138 Subjects From ITT2|Period 2 - Week 44||6|Subjects from Site 138 were excluded from the analysis due to potential misconduct and noncompliance at this site.|
48568847|NCT03852472|101724651|FG000|Completed Week 36|Period 2 - Week 44||0||
48568848|NCT03852472|101724652|FG001|Completed Week 36|Period 2 - Week 44||71||
48568849|NCT03852472|101724653|FG002|Completed Week 36|Period 2 - Week 44||79||
48568850|NCT03852472|101724654|FG003|Completed Week 36|Period 2 - Week 44||41||
48568851|NCT03852472|101724655|FG004|Completed Week 36|Period 2 - Week 44||36||
48568852|NCT03852472|101724651|FG000|Completed Week 44|Period 2 - Week 44||0||
48568853|NCT03852472|101724652|FG001|Completed Week 44|Period 2 - Week 44||70||
48568854|NCT03852472|101724653|FG002|Completed Week 44|Period 2 - Week 44||75||
48568855|NCT03852472|101724654|FG003|Completed Week 44|Period 2 - Week 44||39||
48568856|NCT03852472|101724655|FG004|Completed Week 44|Period 2 - Week 44||35||
48568857|NCT03852472|101724651|FG000|COMPLETED|Period 2 - Week 44||0||
48568858|NCT03852472|101724652|FG001|COMPLETED|Period 2 - Week 44||70||
48568859|NCT03852472|101724653|FG002|COMPLETED|Period 2 - Week 44||75||
48568860|NCT03852472|101724654|FG003|COMPLETED|Period 2 - Week 44||39||
48568861|NCT03852472|101724655|FG004|COMPLETED|Period 2 - Week 44||35||
48568862|NCT03852472|101724651|FG000|NOT COMPLETED|Period 2 - Week 44||0||
48568863|NCT03852472|101724652|FG001|NOT COMPLETED|Period 2 - Week 44||38||
48568864|NCT03852472|101724653|FG002|NOT COMPLETED|Period 2 - Week 44||33||
48568865|NCT03852472|101724654|FG003|NOT COMPLETED|Period 2 - Week 44||17||
48568866|NCT03852472|101724655|FG004|NOT COMPLETED|Period 2 - Week 44||18||
48568867|NCT03809663|101724656|FG000|STARTED|Overall Study||63||
48568868|NCT03809663|101724657|FG001|STARTED|Overall Study||62||
48568869|NCT03809663|101724658|FG002|STARTED|Overall Study||63||
48568870|NCT03809663|101724659|FG003|STARTED|Overall Study||63||
48568871|NCT03809663|101724660|FG004|STARTED|Overall Study||0||
48568872|NCT03809663|101724661|FG005|STARTED|Overall Study||0||
48568873|NCT03809663|101724656|FG000|Participants Who Received Investigational Product|Overall Study||63||
48568874|NCT03809663|101724657|FG001|Participants Who Received Investigational Product|Overall Study||61||
48568875|NCT03809663|101724658|FG002|Participants Who Received Investigational Product|Overall Study||63||
48396247|NCT01522443|101299348|FG001|STARTED|Overall Study||58|Randomized|
48396248|NCT01522443|101299347|FG000|COMPLETED|Overall Study||8|Subjects still on study treatment at data cut-off date|
48281465|NCT04488770|101014138|FG008|STARTED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
48281466|NCT04488770|101014139|FG009|STARTED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
48281467|NCT04488770|101014140|FG010|STARTED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
48281468|NCT04488770|101014141|FG011|STARTED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
48404074|NCT03689972|101321766|FG000|NOT COMPLETED|Part 1 (Day 1 up to Week 72)||54||
48141428|NCT01780922|100670427|FG004|STARTED|First Intervention (1 Day)||2||
48141429|NCT01780922|100670428|FG005|STARTED|First Intervention (1 Day)||2||
48141430|NCT01780922|100670423|FG000|COMPLETED|First Intervention (1 Day)||2||
48141431|NCT01780922|100670424|FG001|COMPLETED|First Intervention (1 Day)||2||
48141432|NCT01780922|100670425|FG002|COMPLETED|First Intervention (1 Day)||2||
48141433|NCT01780922|100670426|FG003|COMPLETED|First Intervention (1 Day)||2||
48568876|NCT03809663|101724659|FG003|Participants Who Received Investigational Product|Overall Study||63||
48568877|NCT03809663|101724660|FG004|Participants Who Received Investigational Product|Overall Study||0||
48568878|NCT03809663|101724661|FG005|Participants Who Received Investigational Product|Overall Study||0||
48568879|NCT03809663|101724656|FG000|EASI 50 Non-responder at Week 16|Overall Study||40||
48568880|NCT03809663|101724657|FG001|EASI 50 Non-responder at Week 16|Overall Study||26||
48568881|NCT03809663|101724658|FG002|EASI 50 Non-responder at Week 16|Overall Study||30||
48568882|NCT03809663|101724659|FG003|EASI 50 Non-responder at Week 16|Overall Study||38||
48568883|NCT03809663|101724660|FG004|EASI 50 Non-responder at Week 16|Overall Study||0||
48568884|NCT03809663|101724661|FG005|EASI 50 Non-responder at Week 16|Overall Study||0||
48568885|NCT03809663|101724656|FG000|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||39||
48568886|NCT03809663|101724657|FG001|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||24||
48568887|NCT03809663|101724658|FG002|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||30||
48568888|NCT03809663|101724659|FG003|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||38||
48568889|NCT03809663|101724660|FG004|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||0||
48568890|NCT03809663|101724661|FG005|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||0||
48281469|NCT04488770|101014142|FG012|STARTED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
48281470|NCT04488770|101014130|FG000|COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||2||
48281471|NCT04488770|101014131|FG001|COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||2||
48281472|NCT04488770|101014132|FG002|COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||2||
48281473|NCT04488770|101014133|FG003|COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||2||
48281474|NCT04488770|101014134|FG004|COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
48281475|NCT04488770|101014135|FG005|COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
48281476|NCT04488770|101014136|FG006|COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
48281477|NCT04488770|101014137|FG007|COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
48568891|NCT03809663|101724656|FG000|COMPLETED|Overall Study||12||
48568892|NCT03809663|101724657|FG001|COMPLETED|Overall Study||18||
48568893|NCT03809663|101724658|FG002|COMPLETED|Overall Study||15||
48568894|NCT03809663|101724659|FG003|COMPLETED|Overall Study||16||
48568895|NCT03809663|101724660|FG004|COMPLETED|Overall Study||0||
48568896|NCT03809663|101724661|FG005|COMPLETED|Overall Study||0||
48568897|NCT03809663|101724656|FG000|NOT COMPLETED|Overall Study||51||
48568898|NCT03809663|101724657|FG001|NOT COMPLETED|Overall Study||44||
48568899|NCT03809663|101724658|FG002|NOT COMPLETED|Overall Study||48||
48568900|NCT03809663|101724659|FG003|NOT COMPLETED|Overall Study||47||
48568901|NCT03809663|101724660|FG004|NOT COMPLETED|Overall Study||0||
48568902|NCT03809663|101724661|FG005|NOT COMPLETED|Overall Study||0||
48568903|NCT00602459|101724662|FG000|STARTED|Initial Registration/Randomization||138||
48568904|NCT00602459|101724663|FG001|STARTED|Initial Registration/Randomization||140||
48568905|NCT00602459|101724664|FG002|STARTED|Initial Registration/Randomization||140||
48568906|NCT00602459|101724665|FG003|STARTED|Initial Registration/Randomization||0||
48568907|NCT00602459|101724662|FG000|COMPLETED|Initial Registration/Randomization||133||
48281478|NCT04488770|101014138|FG008|COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
48568908|NCT00602459|101724663|FG001|COMPLETED|Initial Registration/Randomization||130||
48568909|NCT00602459|101724664|FG002|COMPLETED|Initial Registration/Randomization||137||
48568910|NCT00602459|101724665|FG003|COMPLETED|Initial Registration/Randomization||0||
48568911|NCT00602459|101724662|FG000|NOT COMPLETED|Initial Registration/Randomization||5||
48568912|NCT00602459|101724663|FG001|NOT COMPLETED|Initial Registration/Randomization||10||
48568913|NCT00602459|101724664|FG002|NOT COMPLETED|Initial Registration/Randomization||3||
48568914|NCT00602459|101724665|FG003|NOT COMPLETED|Initial Registration/Randomization||0||
48568915|NCT00602459|101724662|FG000|STARTED|Re-assignment After Del(11q22.3) Testing||123||
48568916|NCT00602459|101724663|FG001|STARTED|Re-assignment After Del(11q22.3) Testing||109||
48568917|NCT00602459|101724664|FG002|STARTED|Re-assignment After Del(11q22.3) Testing||137||
48568918|NCT00602459|101724665|FG003|STARTED|Re-assignment After Del(11q22.3) Testing||31||
48568919|NCT00602459|101724662|FG000|COMPLETED|Re-assignment After Del(11q22.3) Testing||123||
48568920|NCT00602459|101724663|FG001|COMPLETED|Re-assignment After Del(11q22.3) Testing||109||
48568921|NCT00602459|101724664|FG002|COMPLETED|Re-assignment After Del(11q22.3) Testing||137||
48568922|NCT00602459|101724665|FG003|COMPLETED|Re-assignment After Del(11q22.3) Testing||31||
48568923|NCT00602459|101724662|FG000|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0||
48568924|NCT00602459|101724663|FG001|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0||
48592793|NCT01764997|101783185|FG003|STARTED|Run-in Period||0||
48120187|NCT03146650|100619542|FG000|COMPLETED|Continued to Cycle 2 and Beyond||19|2 patients discontinued after completing Cycle 1 due to disease progression.|
48281479|NCT04488770|101014139|FG009|COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
48281480|NCT04488770|101014140|FG010|COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
48281481|NCT04488770|101014141|FG011|COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
48281482|NCT04488770|101014142|FG012|COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
48281483|NCT04488770|101014130|FG000|NOT COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
48281484|NCT04488770|101014131|FG001|NOT COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
48281485|NCT04488770|101014132|FG002|NOT COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
48281486|NCT04488770|101014133|FG003|NOT COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
48281487|NCT04488770|101014134|FG004|NOT COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
48396249|NCT01522443|101299348|FG001|COMPLETED|Overall Study||3|Subjects still on study treatment at data cut-off date|
48396250|NCT01522443|101299347|FG000|NOT COMPLETED|Overall Study||53||
48396251|NCT01522443|101299348|FG001|NOT COMPLETED|Overall Study||55||
48396252|NCT01878097|101299349|FG000|STARTED|Baseline||10725||13
48396253|NCT01878097|101299350|FG001|STARTED|Baseline||10081||13
48396254|NCT01878097|101299349|FG000|COMPLETED|Baseline||8228|Anonymous surveys; sum of all completed surveys.|13
48396255|NCT01878097|101299350|FG001|COMPLETED|Baseline||8281|Anonymous surveys; sum of all completed surveys.|13
48396256|NCT01878097|101299349|FG000|NOT COMPLETED|Baseline||2497||0
48396257|NCT01878097|101299350|FG001|NOT COMPLETED|Baseline||1800||0
48396258|NCT01878097|101299349|FG000|STARTED|Implementation Year 1||11742||13
48396259|NCT01878097|101299350|FG001|STARTED|Implementation Year 1||9866||12
48396260|NCT01878097|101299349|FG000|COMPLETED|Implementation Year 1||8540||13
48396261|NCT01878097|101299350|FG001|COMPLETED|Implementation Year 1||7317||12
48396262|NCT01878097|101299349|FG000|NOT COMPLETED|Implementation Year 1||3202||0
48396263|NCT01878097|101299350|FG001|NOT COMPLETED|Implementation Year 1||2549||0
48396264|NCT01878097|101299349|FG000|STARTED|Implementation Year 2||11567||13
48396265|NCT01878097|101299350|FG001|STARTED|Implementation Year 2||9611||12
48396266|NCT01878097|101299349|FG000|COMPLETED|Implementation Year 2||8286||13
48396267|NCT01878097|101299350|FG001|COMPLETED|Implementation Year 2||6770||12
48396268|NCT01878097|101299349|FG000|NOT COMPLETED|Implementation Year 2||3281||0
48120188|NCT03146650|100619542|FG000|NOT COMPLETED|Continued to Cycle 2 and Beyond||4||
48120189|NCT03146650|100619542|FG000|STARTED|2 Year Follow-up||22|Patients who received one dose of study drug and have discontinued treatment go into follow-up.|
48120190|NCT03146650|100619542|FG000|COMPLETED|2 Year Follow-up||3||
48120191|NCT03146650|100619542|FG000|NOT COMPLETED|2 Year Follow-up||19||
48120192|NCT04439240|100619543|FG000|STARTED|Overall Study||52||
48120193|NCT04439240|100619543|FG000|Started Protocol Therapy|Overall Study||50||
48120194|NCT04439240|100619543|FG000|Eligible|Overall Study||49||
48120195|NCT04439240|100619543|FG000|Eligible and Started Protocol Therapy|Overall Study||48|2 patients ineligible, 1 patient never started treatment, 1 patient both ineligible and never started treatment. This is the primary analysis population.|
48120196|NCT04439240|100619543|FG000|Reported Adverse Events Data|Overall Study||49|1 of the 50 treated patients had no adverse events reported|
48120197|NCT04439240|100619543|FG000|COMPLETED|Overall Study||0|Treatment continued until disease progression or intolerability.|
48120198|NCT04439240|100619543|FG000|NOT COMPLETED|Overall Study||52||
48120199|NCT00724451|100619544|FG000|STARTED|Overall Study||1128||
48120200|NCT00724451|100619544|FG000|Received Antiviral Treatment|Overall Study||500||
48120201|NCT00724451|100619544|FG000|COMPLETED|Overall Study||326||
48120202|NCT00724451|100619544|FG000|NOT COMPLETED|Overall Study||802||
48120203|NCT02662387|100619545|FG000|STARTED|Overall Study||27||
48120204|NCT02662387|100619546|FG001|STARTED|Overall Study||28||
48120205|NCT02662387|100619545|FG000|COMPLETED|Overall Study||27||
48120206|NCT02662387|100619546|FG001|COMPLETED|Overall Study||28||
48120207|NCT02662387|100619545|FG000|NOT COMPLETED|Overall Study||0||
48120208|NCT02662387|100619546|FG001|NOT COMPLETED|Overall Study||0||
48120209|NCT00286949|100619547|FG000|STARTED|Overall Study||12||
48120210|NCT00286949|100619547|FG000|COMPLETED|Overall Study||12||
48120211|NCT00286949|100619547|FG000|NOT COMPLETED|Overall Study||0||
48120212|NCT00912405|100619548|FG000|STARTED|Overall Study||50||
48120213|NCT00912405|100619548|FG000|COMPLETED|Overall Study||45||
48396269|NCT01878097|101299350|FG001|NOT COMPLETED|Implementation Year 2||2841||0
48396270|NCT01878097|101299349|FG000|STARTED|Implementation Year 3||10540||13
48396271|NCT01878097|101299350|FG001|STARTED|Implementation Year 3||9750||12
48396272|NCT01878097|101299349|FG000|COMPLETED|Implementation Year 3||7046||13
48396273|NCT01878097|101299350|FG001|COMPLETED|Implementation Year 3||6770||12
48396274|NCT01878097|101299349|FG000|NOT COMPLETED|Implementation Year 3||3494||0
48396275|NCT01878097|101299350|FG001|NOT COMPLETED|Implementation Year 3||2980||0
48396276|NCT01878097|101299349|FG000|STARTED|Implementation Year 4||10585||12
48396277|NCT01878097|101299350|FG001|STARTED|Implementation Year 4||9614||12
48396278|NCT01878097|101299349|FG000|COMPLETED|Implementation Year 4||6981||12
48396279|NCT01878097|101299350|FG001|COMPLETED|Implementation Year 4||6607||12
48396280|NCT01878097|101299349|FG000|NOT COMPLETED|Implementation Year 4||3604||0
48396281|NCT01878097|101299350|FG001|NOT COMPLETED|Implementation Year 4||3007||0
48396282|NCT01271413|101299351|FG000|STARTED|Overall Study||37||
48396283|NCT01271413|101299352|FG001|STARTED|Overall Study||36||
48396284|NCT01271413|101299351|FG000|COMPLETED|Overall Study||28||
48396285|NCT01271413|101299352|FG001|COMPLETED|Overall Study||28||
48396286|NCT01271413|101299351|FG000|NOT COMPLETED|Overall Study||9||
48396287|NCT01271413|101299352|FG001|NOT COMPLETED|Overall Study||8||
48396288|NCT01170221|101299353|FG000|STARTED|Overall Study||332||
48396289|NCT01170221|101299354|FG001|STARTED|Overall Study||335||
48120214|NCT00912405|100619548|FG000|NOT COMPLETED|Overall Study||5||
48120215|NCT02992899|100619549|FG000|STARTED|Overall Study||27||
48120216|NCT02992899|100619550|FG001|STARTED|Overall Study||29||
48120217|NCT02992899|100619549|FG000|COMPLETED|Overall Study||25||
48120218|NCT02992899|100619550|FG001|COMPLETED|Overall Study||26||
48120219|NCT02992899|100619549|FG000|NOT COMPLETED|Overall Study||2||
48120220|NCT02992899|100619550|FG001|NOT COMPLETED|Overall Study||3||
48120221|NCT01824303|100619551|FG000|STARTED|Randomized Study||16||
48120222|NCT01824303|100619552|FG001|STARTED|Randomized Study||14||
48120223|NCT01824303|100619551|FG000|COMPLETED|Randomized Study||14||
48120224|NCT01824303|100619552|FG001|COMPLETED|Randomized Study||13||
48120225|NCT01824303|100619551|FG000|NOT COMPLETED|Randomized Study||2||
48120226|NCT01824303|100619552|FG001|NOT COMPLETED|Randomized Study||1||
48120227|NCT01824303|100619551|FG000|STARTED|Open Label Extension||12||
48120228|NCT01824303|100619552|FG001|STARTED|Open Label Extension||11||
48120229|NCT01824303|100619551|FG000|COMPLETED|Open Label Extension||12||
48120230|NCT01824303|100619552|FG001|COMPLETED|Open Label Extension||11||
48120231|NCT01824303|100619551|FG000|NOT COMPLETED|Open Label Extension||0||
48120232|NCT01824303|100619552|FG001|NOT COMPLETED|Open Label Extension||0||
48120233|NCT02944877|100619553|FG000|STARTED|Overall Study||450||
48120234|NCT02944877|100619554|FG001|STARTED|Overall Study||450||
48120235|NCT02944877|100619553|FG000|COMPLETED|Overall Study||421||
48120236|NCT02944877|100619554|FG001|COMPLETED|Overall Study||418||
48120237|NCT02944877|100619553|FG000|NOT COMPLETED|Overall Study||29||
48120238|NCT02944877|100619554|FG001|NOT COMPLETED|Overall Study||32||
48281488|NCT04488770|101014135|FG005|NOT COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
48281489|NCT04488770|101014136|FG006|NOT COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
48281490|NCT04488770|101014137|FG007|NOT COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
48281491|NCT04488770|101014138|FG008|NOT COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
48281492|NCT04488770|101014139|FG009|NOT COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
48281493|NCT04488770|101014140|FG010|NOT COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
48281494|NCT04488770|101014141|FG011|NOT COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
48281495|NCT04488770|101014142|FG012|NOT COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
48281496|NCT04488770|101014130|FG000|STARTED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
48281497|NCT04488770|101014131|FG001|STARTED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
48281498|NCT04488770|101014132|FG002|STARTED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
48281499|NCT04488770|101014133|FG003|STARTED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
48120239|NCT00306592|100619555|FG000|STARTED|Overall Study||404||
48281500|NCT04488770|101014134|FG004|STARTED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||2||
48281501|NCT04488770|101014135|FG005|STARTED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||2||
48281502|NCT04488770|101014136|FG006|STARTED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||2||
48281503|NCT04488770|101014137|FG007|STARTED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||2||
48281504|NCT04488770|101014138|FG008|STARTED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
48281505|NCT04488770|101014139|FG009|STARTED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
48281506|NCT04488770|101014140|FG010|STARTED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
48281507|NCT04488770|101014141|FG011|STARTED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
48281508|NCT04488770|101014142|FG012|STARTED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
48281509|NCT04488770|101014130|FG000|COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
48281510|NCT04488770|101014131|FG001|COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
48281511|NCT04488770|101014132|FG002|COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
48281512|NCT04488770|101014133|FG003|COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
48120240|NCT00306592|100619556|FG001|STARTED|Overall Study||690||
48120241|NCT00306592|100619555|FG000|Completed at 24 Weeks|Overall Study||207||
48120242|NCT00306592|100619556|FG001|Completed at 24 Weeks|Overall Study||0||
48120243|NCT00306592|100619555|FG000|Completed Between 24 and 48 Weeks|Overall Study||85||
48120244|NCT00306592|100619556|FG001|Completed Between 24 and 48 Weeks|Overall Study||0||
48120245|NCT00306592|100619555|FG000|Completed at 48 Weeks|Overall Study||81||
48120246|NCT00306592|100619556|FG001|Completed at 48 Weeks|Overall Study||632||
48120247|NCT00306592|100619555|FG000|Entered 101-MS-321 Extension Study|Overall Study||22||
48120248|NCT00306592|100619556|FG001|Entered 101-MS-321 Extension Study|Overall Study||0||
48120249|NCT00306592|100619555|FG000|COMPLETED|Overall Study||373||
48120250|NCT00306592|100619556|FG001|COMPLETED|Overall Study||632||
48120251|NCT00306592|100619555|FG000|NOT COMPLETED|Overall Study||31||
48120252|NCT00306592|100619556|FG001|NOT COMPLETED|Overall Study||58||
48120253|NCT00555438|100619557|FG000|STARTED|10 Days Post-operative||442||
48120254|NCT00555438|100619557|FG000|COMPLETED|10 Days Post-operative||438||
48281513|NCT04488770|101014134|FG004|COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||2||
48281514|NCT04488770|101014135|FG005|COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||1||
48396290|NCT01170221|101299353|FG000|COMPLETED|Overall Study||299||
48396291|NCT01170221|101299354|FG001|COMPLETED|Overall Study||307||
48120255|NCT00555438|100619557|FG000|NOT COMPLETED|10 Days Post-operative||4||
48281515|NCT04488770|101014136|FG006|COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||1||
48281516|NCT04488770|101014137|FG007|COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||2||
48699119|NCT02589665|102050462|FG002|COMPLETED|Induction Period||60||
48120256|NCT00555438|100619557|FG000|STARTED|Between 10 Days and 30 Days Postoperativ||438||
48120257|NCT00555438|100619557|FG000|COMPLETED|Between 10 Days and 30 Days Postoperativ||433||
48120258|NCT00555438|100619557|FG000|NOT COMPLETED|Between 10 Days and 30 Days Postoperativ||5||
48120259|NCT02097134|100619558|FG000|STARTED|Overall Study||14||
48120260|NCT02097134|100619558|FG000|COMPLETED|Overall Study||5||
48120261|NCT02097134|100619558|FG000|NOT COMPLETED|Overall Study||9||
48120262|NCT02565381|100619559|FG000|STARTED|Overall Study||25||
48120263|NCT02565381|100619560|FG001|STARTED|Overall Study||25||
48120264|NCT02565381|100619561|FG002|STARTED|Overall Study||25||
48120265|NCT02565381|100619559|FG000|COMPLETED|Overall Study||24||
48120266|NCT02565381|100619560|FG001|COMPLETED|Overall Study||25||
48120267|NCT02565381|100619561|FG002|COMPLETED|Overall Study||24||
48120268|NCT02565381|100619559|FG000|NOT COMPLETED|Overall Study||1||
48120269|NCT02565381|100619560|FG001|NOT COMPLETED|Overall Study||0||
48120270|NCT02565381|100619561|FG002|NOT COMPLETED|Overall Study||1||
48120271|NCT02181231|100619562|FG000|STARTED|Overall Study||12||
48120272|NCT02181231|100619563|FG001|STARTED|Overall Study||6||
48120273|NCT02181231|100619562|FG000|COMPLETED|Overall Study||10||
48120274|NCT02181231|100619563|FG001|COMPLETED|Overall Study||6||
48120275|NCT02181231|100619562|FG000|NOT COMPLETED|Overall Study||2||
48120276|NCT02181231|100619563|FG001|NOT COMPLETED|Overall Study||0||
48120277|NCT01422070|100619564|FG000|STARTED|Overall Study||5031||
48120278|NCT01422070|100619565|FG001|STARTED|Overall Study||803||
48120279|NCT01422070|100619564|FG000|COMPLETED|Overall Study||5031||
48120280|NCT01422070|100619565|FG001|COMPLETED|Overall Study||803||
48120281|NCT01422070|100619564|FG000|NOT COMPLETED|Overall Study||0||
48120282|NCT01422070|100619565|FG001|NOT COMPLETED|Overall Study||0||
48120283|NCT01208233|100619566|FG000|STARTED|Overall Study||11||
48120284|NCT01208233|100619567|FG001|STARTED|Overall Study||9||
48120285|NCT01208233|100619568|FG002|STARTED|Overall Study||11||
48120286|NCT01208233|100619569|FG003|STARTED|Overall Study||10||
48120287|NCT01208233|100619570|FG004|STARTED|Overall Study||70||
48120288|NCT01208233|100619571|FG005|STARTED|Overall Study||67||
48120289|NCT01208233|100619566|FG000|COMPLETED|Overall Study||6||
48120290|NCT01208233|100619567|FG001|COMPLETED|Overall Study||6||
48120291|NCT01208233|100619568|FG002|COMPLETED|Overall Study||7||
48120292|NCT01208233|100619569|FG003|COMPLETED|Overall Study||9||
48120293|NCT01208233|100619570|FG004|COMPLETED|Overall Study||46||
48120294|NCT01208233|100619571|FG005|COMPLETED|Overall Study||46||
48120295|NCT01208233|100619566|FG000|NOT COMPLETED|Overall Study||5||
48120296|NCT01208233|100619567|FG001|NOT COMPLETED|Overall Study||3||
48120297|NCT01208233|100619568|FG002|NOT COMPLETED|Overall Study||4||
48120298|NCT01208233|100619569|FG003|NOT COMPLETED|Overall Study||1||
48120299|NCT01208233|100619570|FG004|NOT COMPLETED|Overall Study||24||
48120300|NCT01208233|100619571|FG005|NOT COMPLETED|Overall Study||21||
48120301|NCT04496258|100619572|FG000|STARTED|Overall Study||49||
48120302|NCT04496258|100619573|FG001|STARTED|Overall Study||50||
48120303|NCT04496258|100619572|FG000|COMPLETED|Overall Study||47||
48120304|NCT04496258|100619573|FG001|COMPLETED|Overall Study||49||
48120305|NCT04496258|100619572|FG000|NOT COMPLETED|Overall Study||2||
48120306|NCT04496258|100619573|FG001|NOT COMPLETED|Overall Study||1||
48120307|NCT00550836|100619574|FG000|STARTED|Overall Study||49||
48120308|NCT00550836|100619575|FG001|STARTED|Overall Study||55||
48120309|NCT00550836|100619574|FG000|COMPLETED|Overall Study||46||
48120310|NCT00550836|100619575|FG001|COMPLETED|Overall Study||46||
48120311|NCT00550836|100619574|FG000|NOT COMPLETED|Overall Study||3||
48120312|NCT00550836|100619575|FG001|NOT COMPLETED|Overall Study||9||
48120313|NCT00110266|100619576|FG000|STARTED|Overall Study||173||
48281517|NCT04488770|101014138|FG008|COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
48281518|NCT04488770|101014139|FG009|COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
48281519|NCT04488770|101014140|FG010|COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
48281520|NCT04488770|101014141|FG011|COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
48281521|NCT04488770|101014142|FG012|COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
48281522|NCT04488770|101014130|FG000|NOT COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
48281523|NCT04488770|101014131|FG001|NOT COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
48281524|NCT04488770|101014132|FG002|NOT COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
48281525|NCT04488770|101014133|FG003|NOT COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
48281526|NCT04488770|101014134|FG004|NOT COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
48120314|NCT00110266|100619576|FG000|COMPLETED|Overall Study||95||
48120315|NCT00110266|100619576|FG000|NOT COMPLETED|Overall Study||78||
48120316|NCT02447991|100619577|FG000|STARTED|Overall Study||45||
48120317|NCT02447991|100619578|FG001|STARTED|Overall Study||89||
48120318|NCT02447991|100619577|FG000|COMPLETED|Overall Study||35||
48120319|NCT02447991|100619578|FG001|COMPLETED|Overall Study||59||
48120320|NCT02447991|100619577|FG000|NOT COMPLETED|Overall Study||10||
48120321|NCT02447991|100619578|FG001|NOT COMPLETED|Overall Study||30||
48120322|NCT04455893|100619579|FG000|STARTED|Overall Study||38||
48120323|NCT04455893|100619580|FG001|STARTED|Overall Study||34||
48120324|NCT04455893|100619579|FG000|COMPLETED|Overall Study||38||
48568925|NCT00602459|101724664|FG002|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0||
48568926|NCT00602459|101724665|FG003|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0||
48568927|NCT00171210|101724666|FG000|STARTED|Overall Study||259||
48568928|NCT00171210|101724667|FG001|STARTED|Overall Study||296||
48568929|NCT00171210|101724666|FG000|STARTED EXTENSION STUDY|Overall Study||259||
48568930|NCT00171210|101724667|FG001|STARTED EXTENSION STUDY|Overall Study||247||
48568931|NCT00171210|101724666|FG000|COMPLETED|Overall Study||190||
48568932|NCT00171210|101724667|FG001|COMPLETED|Overall Study||181||
48568933|NCT00171210|101724666|FG000|NOT COMPLETED|Overall Study||69||
48568934|NCT00171210|101724667|FG001|NOT COMPLETED|Overall Study||115||
48568935|NCT02626026|101724668|FG000|STARTED|Overall Study||8||
48568936|NCT02626026|101724669|FG001|STARTED|Overall Study||2||
48568937|NCT02626026|101724670|FG002|STARTED|Overall Study||8||
48568938|NCT02626026|101724671|FG003|STARTED|Overall Study||2||
48568939|NCT02626026|101724672|FG004|STARTED|Overall Study||17||
48568940|NCT02626026|101724673|FG005|STARTED|Overall Study||5||
48568941|NCT02626026|101724668|FG000|COMPLETED|Overall Study||8||
48568942|NCT02626026|101724669|FG001|COMPLETED|Overall Study||2||
48568943|NCT02626026|101724670|FG002|COMPLETED|Overall Study||8||
48568944|NCT02626026|101724671|FG003|COMPLETED|Overall Study||2||
48568945|NCT02626026|101724672|FG004|COMPLETED|Overall Study||16||
48568946|NCT02626026|101724673|FG005|COMPLETED|Overall Study||5||
48568947|NCT02626026|101724668|FG000|NOT COMPLETED|Overall Study||0||
48568948|NCT02626026|101724669|FG001|NOT COMPLETED|Overall Study||0||
48568949|NCT02626026|101724670|FG002|NOT COMPLETED|Overall Study||0||
48568950|NCT02626026|101724671|FG003|NOT COMPLETED|Overall Study||0||
48568951|NCT02626026|101724672|FG004|NOT COMPLETED|Overall Study||1||
48568952|NCT02626026|101724673|FG005|NOT COMPLETED|Overall Study||0||
48568953|NCT03349060|101724674|FG000|STARTED|Overall Study||156||
48568954|NCT03349060|101724675|FG001|STARTED|Overall Study||154||
48568955|NCT03349060|101724676|FG002|STARTED|Overall Study||77||
48568956|NCT03349060|101724674|FG000|COMPLETED|Overall Study||135||
48568957|NCT03349060|101724675|FG001|COMPLETED|Overall Study||137||
48568958|NCT03349060|101724676|FG002|COMPLETED|Overall Study||61||
48568959|NCT03349060|101724674|FG000|NOT COMPLETED|Overall Study||21||
48568960|NCT03349060|101724675|FG001|NOT COMPLETED|Overall Study||17||
48568961|NCT03349060|101724676|FG002|NOT COMPLETED|Overall Study||16||
48568962|NCT03649932|101724677|FG000|STARTED|Overall Study||14||
48568963|NCT03649932|101724678|FG001|STARTED|Overall Study||14||
48568964|NCT03649932|101724679|FG002|STARTED|Overall Study||14||
48568965|NCT03649932|101724677|FG000|COMPLETED|Overall Study||14||
48568966|NCT03649932|101724678|FG001|COMPLETED|Overall Study||13||
48568967|NCT03649932|101724679|FG002|COMPLETED|Overall Study||13||
48568968|NCT03649932|101724677|FG000|NOT COMPLETED|Overall Study||0||
48120325|NCT04455893|100619580|FG001|COMPLETED|Overall Study||34||
48396292|NCT01170221|101299353|FG000|NOT COMPLETED|Overall Study||33||
48396293|NCT01170221|101299354|FG001|NOT COMPLETED|Overall Study||28||
48396294|NCT03864536|101299355|FG000|STARTED|Overall Study||14||
48396295|NCT03864536|101299356|FG001|STARTED|Overall Study||12||
48568969|NCT03649932|101724678|FG001|NOT COMPLETED|Overall Study||1||
48568970|NCT03649932|101724679|FG002|NOT COMPLETED|Overall Study||1||
48568971|NCT00628212|101724680|FG000|STARTED|Overall Study||80||
48568972|NCT00628212|101724681|FG001|STARTED|Overall Study||84||
48568973|NCT00628212|101724682|FG002|STARTED|Overall Study||79||
48568974|NCT00628212|101724683|FG003|STARTED|Overall Study||81||
48568975|NCT00628212|101724680|FG000|COMPLETED|Overall Study||77||
48568976|NCT00628212|101724681|FG001|COMPLETED|Overall Study||83||
48120326|NCT04455893|100619579|FG000|NOT COMPLETED|Overall Study||0||
48120327|NCT04455893|100619580|FG001|NOT COMPLETED|Overall Study||0||
48396296|NCT03864536|101299357|FG002|STARTED|Overall Study||13||
48396297|NCT03864536|101299355|FG000|COMPLETED|Overall Study||14||
48396298|NCT03864536|101299356|FG001|COMPLETED|Overall Study||12||
48396299|NCT03864536|101299357|FG002|COMPLETED|Overall Study||12||
48396300|NCT03864536|101299355|FG000|NOT COMPLETED|Overall Study||0||
48568977|NCT00628212|101724682|FG002|COMPLETED|Overall Study||76||
48568978|NCT00628212|101724683|FG003|COMPLETED|Overall Study||76||
48568979|NCT00628212|101724680|FG000|NOT COMPLETED|Overall Study||3||
48568980|NCT00628212|101724681|FG001|NOT COMPLETED|Overall Study||1||
48568981|NCT00628212|101724682|FG002|NOT COMPLETED|Overall Study||3||
48568982|NCT00628212|101724683|FG003|NOT COMPLETED|Overall Study||5||
48568983|NCT02806908|101724684|FG000|STARTED|Overall Study||11||
48568984|NCT02806908|101724685|FG001|STARTED|Overall Study||13||
48568985|NCT02806908|101724684|FG000|COMPLETED|Overall Study||10||
48568986|NCT02806908|101724685|FG001|COMPLETED|Overall Study||12||
48568987|NCT02806908|101724684|FG000|NOT COMPLETED|Overall Study||1||
48568988|NCT02806908|101724685|FG001|NOT COMPLETED|Overall Study||1||
48568989|NCT03480542|101724686|FG000|STARTED|Overall Study||12||
48568990|NCT03480542|101724687|FG001|STARTED|Overall Study||53||
48568991|NCT03480542|101724688|FG002|STARTED|Overall Study||152||
48568992|NCT03480542|101724686|FG000|COMPLETED|Overall Study||12||
48568993|NCT03480542|101724687|FG001|COMPLETED|Overall Study||53||
48568994|NCT03480542|101724688|FG002|COMPLETED|Overall Study||152||
48568995|NCT03480542|101724686|FG000|NOT COMPLETED|Overall Study||0||
48568996|NCT03480542|101724687|FG001|NOT COMPLETED|Overall Study||0||
48396301|NCT03864536|101299356|FG001|NOT COMPLETED|Overall Study||0||
48396302|NCT03864536|101299357|FG002|NOT COMPLETED|Overall Study||1||
48396303|NCT03235726|101299358|FG000|STARTED|Part 1 (Cohort A 60 mg - Day 1)||6||
48396304|NCT03235726|101299359|FG001|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0||
48396305|NCT03235726|101299360|FG002|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0||
48120328|NCT01332149|100619581|FG000|STARTED|Overall Study||314||
48120329|NCT01332149|100619582|FG001|STARTED|Overall Study||309||
48120330|NCT01332149|100619581|FG000|Treated|Overall Study||313||
48120331|NCT01332149|100619582|FG001|Treated|Overall Study||307||
48120332|NCT01332149|100619581|FG000|COMPLETED|Overall Study||284||
48120333|NCT01332149|100619582|FG001|COMPLETED|Overall Study||271||
48120334|NCT01332149|100619581|FG000|NOT COMPLETED|Overall Study||30||
48120335|NCT01332149|100619582|FG001|NOT COMPLETED|Overall Study||38||
48120336|NCT02897141|100619583|FG000|STARTED|Overall Study||40||
48120337|NCT02897141|100619584|FG001|STARTED|Overall Study||40||
48120338|NCT02897141|100619583|FG000|COMPLETED|Overall Study||38||
48120339|NCT02897141|100619584|FG001|COMPLETED|Overall Study||39||
48120340|NCT02897141|100619583|FG000|NOT COMPLETED|Overall Study||2||
48120341|NCT02897141|100619584|FG001|NOT COMPLETED|Overall Study||1||
48120342|NCT03773757|100619585|FG000|STARTED|Overall Study||198||
48120343|NCT03773757|100619586|FG001|STARTED|Overall Study||204||
48120344|NCT03773757|100619585|FG000|COMPLETED|Overall Study||196||
48120345|NCT03773757|100619586|FG001|COMPLETED|Overall Study||200||
48120346|NCT03773757|100619585|FG000|NOT COMPLETED|Overall Study||2||
48120347|NCT03773757|100619586|FG001|NOT COMPLETED|Overall Study||4||
48120348|NCT00087568|100619587|FG000|STARTED|Overall Study||32||
48396306|NCT03235726|101299361|FG003|STARTED|Part 1 (Cohort A 60 mg - Day 1)||2||
48396307|NCT03235726|101299362|FG004|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0||
48396308|NCT03235726|101299363|FG005|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0||
48396309|NCT03235726|101299364|FG006|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0||
48396310|NCT03235726|101299365|FG007|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0||
48396311|NCT03235726|101299366|FG008|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0||
48699120|NCT02589665|102050463|FG003|COMPLETED|Induction Period||57||
48699121|NCT02589665|102050464|FG004|COMPLETED|Induction Period||0||
48699122|NCT02589665|102050465|FG005|COMPLETED|Induction Period||0||
48699123|NCT02589665|102050466|FG006|COMPLETED|Induction Period||0||
48699124|NCT02589665|102050467|FG007|COMPLETED|Induction Period||0||
48699125|NCT02589665|102050468|FG008|COMPLETED|Induction Period||0||
48699126|NCT02589665|102050469|FG009|COMPLETED|Induction Period||0||
48699127|NCT02589665|102050460|FG000|NOT COMPLETED|Induction Period||3||
48699128|NCT02589665|102050461|FG001|NOT COMPLETED|Induction Period||2||
48699129|NCT02589665|102050462|FG002|NOT COMPLETED|Induction Period||2||
48699130|NCT02589665|102050463|FG003|NOT COMPLETED|Induction Period||4||
48699131|NCT02589665|102050464|FG004|NOT COMPLETED|Induction Period||0||
48699132|NCT02589665|102050465|FG005|NOT COMPLETED|Induction Period||0||
48699133|NCT02589665|102050466|FG006|NOT COMPLETED|Induction Period||0||
48699134|NCT02589665|102050467|FG007|NOT COMPLETED|Induction Period||0||
48699135|NCT02589665|102050468|FG008|NOT COMPLETED|Induction Period||0||
48699136|NCT02589665|102050469|FG009|NOT COMPLETED|Induction Period||0||
48699137|NCT02589665|102050460|FG000|STARTED|Maintenance Period||0||
48699138|NCT02589665|102050461|FG001|STARTED|Maintenance Period||0||
48120349|NCT00087568|100619588|FG001|STARTED|Overall Study||25||
48120350|NCT00087568|100619587|FG000|COMPLETED|Overall Study||2||
48120351|NCT00087568|100619588|FG001|COMPLETED|Overall Study||23||
48120352|NCT00087568|100619587|FG000|NOT COMPLETED|Overall Study||30||
48120353|NCT00087568|100619588|FG001|NOT COMPLETED|Overall Study||2||
48120354|NCT05061446|100619589|FG000|STARTED|Overall Study||18||
48120355|NCT05061446|100619590|FG001|STARTED|Overall Study||17||
48120356|NCT05061446|100619591|FG002|STARTED|Overall Study||19||
48120357|NCT05061446|100619589|FG000|COMPLETED|Overall Study||16||
48120358|NCT05061446|100619590|FG001|COMPLETED|Overall Study||16||
48120359|NCT05061446|100619591|FG002|COMPLETED|Overall Study||19||
48120360|NCT05061446|100619589|FG000|NOT COMPLETED|Overall Study||2||
48120361|NCT05061446|100619590|FG001|NOT COMPLETED|Overall Study||1||
48120362|NCT05061446|100619591|FG002|NOT COMPLETED|Overall Study||0||
48120363|NCT01978184|100619592|FG000|STARTED|Overall Study||43||
48120364|NCT01978184|100619593|FG001|STARTED|Overall Study||61||
48120365|NCT01978184|100619592|FG000|COMPLETED|Overall Study||30||
48396312|NCT03235726|101299367|FG009|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0||
48699139|NCT02589665|102050462|FG002|STARTED|Maintenance Period||0||
48699140|NCT02589665|102050463|FG003|STARTED|Maintenance Period||0||
48699141|NCT02589665|102050464|FG004|STARTED|Maintenance Period||13||
48699142|NCT02589665|102050465|FG005|STARTED|Maintenance Period||47||
48699143|NCT02589665|102050466|FG006|STARTED|Maintenance Period||46||
48699144|NCT02589665|102050467|FG007|STARTED|Maintenance Period||0||
48120366|NCT01978184|100619593|FG001|COMPLETED|Overall Study||41||
48120367|NCT01978184|100619592|FG000|NOT COMPLETED|Overall Study||13||
48120368|NCT01978184|100619593|FG001|NOT COMPLETED|Overall Study||20||
48120369|NCT02312310|100619594|FG000|STARTED|Overall Study||53||
48396313|NCT03235726|101299358|FG000|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||6||
48396314|NCT03235726|101299359|FG001|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
48396315|NCT03235726|101299360|FG002|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
48699145|NCT02589665|102050468|FG008|STARTED|Maintenance Period||0||
48699146|NCT02589665|102050469|FG009|STARTED|Maintenance Period||0||
48699147|NCT02589665|102050460|FG000|COMPLETED|Maintenance Period||0||
48699148|NCT02589665|102050461|FG001|COMPLETED|Maintenance Period||0||
48699149|NCT02589665|102050462|FG002|COMPLETED|Maintenance Period||0||
48699150|NCT02589665|102050463|FG003|COMPLETED|Maintenance Period||0||
48699151|NCT02589665|102050464|FG004|COMPLETED|Maintenance Period||0||
48699152|NCT02589665|102050465|FG005|COMPLETED|Maintenance Period||0||
48699153|NCT02589665|102050466|FG006|COMPLETED|Maintenance Period||0||
48699154|NCT02589665|102050467|FG007|COMPLETED|Maintenance Period||0||
48699155|NCT02589665|102050468|FG008|COMPLETED|Maintenance Period||0||
48699156|NCT02589665|102050469|FG009|COMPLETED|Maintenance Period||0||
48699157|NCT02589665|102050460|FG000|NOT COMPLETED|Maintenance Period||0||
48699158|NCT02589665|102050461|FG001|NOT COMPLETED|Maintenance Period||0||
48699159|NCT02589665|102050462|FG002|NOT COMPLETED|Maintenance Period||0||
48699160|NCT02589665|102050463|FG003|NOT COMPLETED|Maintenance Period||0||
48699161|NCT02589665|102050464|FG004|NOT COMPLETED|Maintenance Period||13||
48699162|NCT02589665|102050465|FG005|NOT COMPLETED|Maintenance Period||47||
48699163|NCT02589665|102050466|FG006|NOT COMPLETED|Maintenance Period||46||
48699164|NCT02589665|102050467|FG007|NOT COMPLETED|Maintenance Period||0||
48699165|NCT02589665|102050468|FG008|NOT COMPLETED|Maintenance Period||0||
48699166|NCT02589665|102050469|FG009|NOT COMPLETED|Maintenance Period||0||
48699167|NCT02589665|102050460|FG000|STARTED|Induction Extension Period||0||
48699168|NCT02589665|102050461|FG001|STARTED|Induction Extension Period||0||
48699169|NCT02589665|102050462|FG002|STARTED|Induction Extension Period||0||
48699170|NCT02589665|102050463|FG003|STARTED|Induction Extension Period||0||
48699171|NCT02589665|102050464|FG004|STARTED|Induction Extension Period||0||
48699172|NCT02589665|102050465|FG005|STARTED|Induction Extension Period||0||
48699173|NCT02589665|102050466|FG006|STARTED|Induction Extension Period||0||
48699174|NCT02589665|102050467|FG007|STARTED|Induction Extension Period||32||
48699175|NCT02589665|102050468|FG008|STARTED|Induction Extension Period||96||
48699176|NCT02589665|102050469|FG009|STARTED|Induction Extension Period||0||
48699177|NCT02589665|102050460|FG000|COMPLETED|Induction Extension Period||0||
48699178|NCT02589665|102050461|FG001|COMPLETED|Induction Extension Period||0||
48699179|NCT02589665|102050462|FG002|COMPLETED|Induction Extension Period||0||
48699180|NCT02589665|102050463|FG003|COMPLETED|Induction Extension Period||0||
48699181|NCT02589665|102050464|FG004|COMPLETED|Induction Extension Period||0||
48699182|NCT02589665|102050465|FG005|COMPLETED|Induction Extension Period||0||
48699183|NCT02589665|102050466|FG006|COMPLETED|Induction Extension Period||0||
48699184|NCT02589665|102050467|FG007|COMPLETED|Induction Extension Period||30||
48699185|NCT02589665|102050468|FG008|COMPLETED|Induction Extension Period||84||
48699186|NCT02589665|102050469|FG009|COMPLETED|Induction Extension Period||0||
48699187|NCT02589665|102050460|FG000|NOT COMPLETED|Induction Extension Period||0||
48699188|NCT02589665|102050461|FG001|NOT COMPLETED|Induction Extension Period||0||
48699189|NCT02589665|102050462|FG002|NOT COMPLETED|Induction Extension Period||0||
48699190|NCT02589665|102050463|FG003|NOT COMPLETED|Induction Extension Period||0||
48699191|NCT02589665|102050464|FG004|NOT COMPLETED|Induction Extension Period||0||
48699192|NCT02589665|102050465|FG005|NOT COMPLETED|Induction Extension Period||0||
48699193|NCT02589665|102050466|FG006|NOT COMPLETED|Induction Extension Period||0||
48699194|NCT02589665|102050467|FG007|NOT COMPLETED|Induction Extension Period||2||
48699195|NCT02589665|102050468|FG008|NOT COMPLETED|Induction Extension Period||12||
48699196|NCT02589665|102050469|FG009|NOT COMPLETED|Induction Extension Period||0||
48699197|NCT02589665|102050460|FG000|STARTED|Maintenance Extension Period||0||
48699198|NCT02589665|102050461|FG001|STARTED|Maintenance Extension Period||0||
48699199|NCT02589665|102050462|FG002|STARTED|Maintenance Extension Period||0||
48699200|NCT02589665|102050463|FG003|STARTED|Maintenance Extension Period||0||
48699201|NCT02589665|102050464|FG004|STARTED|Maintenance Extension Period||0||
48699202|NCT02589665|102050465|FG005|STARTED|Maintenance Extension Period||0||
48699203|NCT02589665|102050466|FG006|STARTED|Maintenance Extension Period||0||
48699204|NCT02589665|102050467|FG007|STARTED|Maintenance Extension Period||0||
48699205|NCT02589665|102050468|FG008|STARTED|Maintenance Extension Period||0||
48699206|NCT02589665|102050469|FG009|STARTED|Maintenance Extension Period||68||
48699207|NCT02589665|102050460|FG000|COMPLETED|Maintenance Extension Period||0||
48699208|NCT02589665|102050461|FG001|COMPLETED|Maintenance Extension Period||0||
48699209|NCT02589665|102050462|FG002|COMPLETED|Maintenance Extension Period||0||
48699210|NCT02589665|102050463|FG003|COMPLETED|Maintenance Extension Period||0||
48699211|NCT02589665|102050464|FG004|COMPLETED|Maintenance Extension Period||0||
48699212|NCT02589665|102050465|FG005|COMPLETED|Maintenance Extension Period||0||
48699213|NCT02589665|102050466|FG006|COMPLETED|Maintenance Extension Period||0||
48699214|NCT02589665|102050467|FG007|COMPLETED|Maintenance Extension Period||0||
48699215|NCT02589665|102050468|FG008|COMPLETED|Maintenance Extension Period||0||
48699216|NCT02589665|102050469|FG009|COMPLETED|Maintenance Extension Period||0||
48699217|NCT02589665|102050460|FG000|NOT COMPLETED|Maintenance Extension Period||0||
48699218|NCT02589665|102050461|FG001|NOT COMPLETED|Maintenance Extension Period||0||
48699219|NCT02589665|102050462|FG002|NOT COMPLETED|Maintenance Extension Period||0||
48699220|NCT02589665|102050463|FG003|NOT COMPLETED|Maintenance Extension Period||0||
48710823|NCT03446053|102078031|FG001|STARTED|Overall Study||6||
48120370|NCT02312310|100619595|FG001|STARTED|Overall Study||53||
48120371|NCT02312310|100619596|FG002|STARTED|Overall Study||53||
48699221|NCT02589665|102050464|FG004|NOT COMPLETED|Maintenance Extension Period||0||
48699222|NCT02589665|102050465|FG005|NOT COMPLETED|Maintenance Extension Period||0||
48699223|NCT02589665|102050466|FG006|NOT COMPLETED|Maintenance Extension Period||0||
48699224|NCT02589665|102050467|FG007|NOT COMPLETED|Maintenance Extension Period||0||
48699225|NCT02589665|102050468|FG008|NOT COMPLETED|Maintenance Extension Period||0||
48699226|NCT02589665|102050469|FG009|NOT COMPLETED|Maintenance Extension Period||68||
48699227|NCT04470908|102050470|FG000|STARTED|Zanubrutinib on Day 1||13||
48699228|NCT04470908|102050470|FG000|COMPLETED|Zanubrutinib on Day 1||13||
48699229|NCT04470908|102050470|FG000|NOT COMPLETED|Zanubrutinib on Day 1||0||
48699230|NCT04470908|102050470|FG000|STARTED|Rifabutin on Days 3 to 10||13||
48699231|NCT04470908|102050470|FG000|COMPLETED|Rifabutin on Days 3 to 10||13||
48699232|NCT04470908|102050470|FG000|NOT COMPLETED|Rifabutin on Days 3 to 10||0||
48699233|NCT04470908|102050470|FG000|STARTED|Zanubrutinib + Rifabutin on Day 11||13||
48699234|NCT04470908|102050470|FG000|COMPLETED|Zanubrutinib + Rifabutin on Day 11||12||
48699235|NCT04470908|102050470|FG000|NOT COMPLETED|Zanubrutinib + Rifabutin on Day 11||1||
48699236|NCT02551094|102050471|FG000|STARTED|Overall Study||2366||
48699237|NCT02551094|102050472|FG001|STARTED|Overall Study||2379||
48699238|NCT02551094|102050471|FG000|COMPLETED|Overall Study||2226||
48699239|NCT02551094|102050472|FG001|COMPLETED|Overall Study||2232||
48699240|NCT02551094|102050471|FG000|NOT COMPLETED|Overall Study||140||
48699241|NCT02551094|102050472|FG001|NOT COMPLETED|Overall Study||147||
48699242|NCT02130687|102050473|FG000|STARTED|Washout||36||
48699243|NCT02130687|102050474|FG001|STARTED|Washout||35||
48699244|NCT02130687|102050475|FG002|STARTED|Washout||35||
48699245|NCT02130687|102050473|FG000|COMPLETED|Washout||36||
48699246|NCT02130687|102050474|FG001|COMPLETED|Washout||33||
48699247|NCT02130687|102050475|FG002|COMPLETED|Washout||31||
48699248|NCT02130687|102050473|FG000|NOT COMPLETED|Washout||0||
48699249|NCT02130687|102050474|FG001|NOT COMPLETED|Washout||2||
48699250|NCT02130687|102050475|FG002|NOT COMPLETED|Washout||4||
48699251|NCT02130687|102050473|FG000|STARTED|Drug 1 Only||36||
48699252|NCT02130687|102050474|FG001|STARTED|Drug 1 Only||33||
48699253|NCT02130687|102050475|FG002|STARTED|Drug 1 Only||31||
48699254|NCT02130687|102050473|FG000|COMPLETED|Drug 1 Only||33||
48699255|NCT02130687|102050474|FG001|COMPLETED|Drug 1 Only||30||
48699256|NCT02130687|102050475|FG002|COMPLETED|Drug 1 Only||30||
48699257|NCT02130687|102050473|FG000|NOT COMPLETED|Drug 1 Only||3||
48120372|NCT02312310|100619597|FG003|STARTED|Overall Study||52||
48120373|NCT02312310|100619594|FG000|COMPLETED|Overall Study||51||
48120374|NCT02312310|100619595|FG001|COMPLETED|Overall Study||51||
48120375|NCT02312310|100619596|FG002|COMPLETED|Overall Study||50||
48699258|NCT02130687|102050474|FG001|NOT COMPLETED|Drug 1 Only||3||
48699259|NCT02130687|102050475|FG002|NOT COMPLETED|Drug 1 Only||1||
48699260|NCT02130687|102050473|FG000|STARTED|Crossover Period 1||33||
48699261|NCT02130687|102050474|FG001|STARTED|Crossover Period 1||30||
48699262|NCT02130687|102050475|FG002|STARTED|Crossover Period 1||30||
48699263|NCT02130687|102050473|FG000|COMPLETED|Crossover Period 1||33||
48699264|NCT02130687|102050474|FG001|COMPLETED|Crossover Period 1||30||
48699265|NCT02130687|102050475|FG002|COMPLETED|Crossover Period 1||30||
48699266|NCT02130687|102050473|FG000|NOT COMPLETED|Crossover Period 1||0||
48699267|NCT02130687|102050474|FG001|NOT COMPLETED|Crossover Period 1||0||
48699268|NCT02130687|102050475|FG002|NOT COMPLETED|Crossover Period 1||0||
48699269|NCT02130687|102050473|FG000|STARTED|Drug 1 Only Between Periods 1 and 2||33||
48699270|NCT02130687|102050474|FG001|STARTED|Drug 1 Only Between Periods 1 and 2||30||
48699271|NCT02130687|102050475|FG002|STARTED|Drug 1 Only Between Periods 1 and 2||30||
48699272|NCT02130687|102050473|FG000|COMPLETED|Drug 1 Only Between Periods 1 and 2||33||
48699273|NCT02130687|102050474|FG001|COMPLETED|Drug 1 Only Between Periods 1 and 2||26||
48699274|NCT02130687|102050475|FG002|COMPLETED|Drug 1 Only Between Periods 1 and 2||29||
48699275|NCT02130687|102050473|FG000|NOT COMPLETED|Drug 1 Only Between Periods 1 and 2||0||
48699276|NCT02130687|102050474|FG001|NOT COMPLETED|Drug 1 Only Between Periods 1 and 2||4||
48699277|NCT02130687|102050475|FG002|NOT COMPLETED|Drug 1 Only Between Periods 1 and 2||1||
48699278|NCT02130687|102050473|FG000|STARTED|Crossover Period 2||33||
48699279|NCT02130687|102050474|FG001|STARTED|Crossover Period 2||26||
48699280|NCT02130687|102050475|FG002|STARTED|Crossover Period 2||29||
48699281|NCT02130687|102050473|FG000|COMPLETED|Crossover Period 2||33||
48699282|NCT02130687|102050474|FG001|COMPLETED|Crossover Period 2||26||
48699283|NCT02130687|102050475|FG002|COMPLETED|Crossover Period 2||29||
48699284|NCT02130687|102050473|FG000|NOT COMPLETED|Crossover Period 2||0||
48699285|NCT02130687|102050474|FG001|NOT COMPLETED|Crossover Period 2||0||
48699286|NCT02130687|102050475|FG002|NOT COMPLETED|Crossover Period 2||0||
48699287|NCT02130687|102050473|FG000|STARTED|Drug 1 Only Between Periods 2 and 3||33||
48699288|NCT02130687|102050474|FG001|STARTED|Drug 1 Only Between Periods 2 and 3||26||
48710824|NCT03446053|102078032|FG002|STARTED|Overall Study||6||
48568997|NCT03480542|101724688|FG002|NOT COMPLETED|Overall Study||0||
48568998|NCT00703157|101724689|FG000|STARTED|Overall Study||26||
48568999|NCT00703157|101724690|FG001|STARTED|Overall Study||26||
48569000|NCT00703157|101724689|FG000|6 Months FU|Overall Study||25||
48569001|NCT00703157|101724690|FG001|6 Months FU|Overall Study||25||
48396316|NCT03235726|101299361|FG003|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||2||
48396317|NCT03235726|101299362|FG004|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
48396318|NCT03235726|101299363|FG005|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
48120376|NCT02312310|100619597|FG003|COMPLETED|Overall Study||52||
48120377|NCT02312310|100619594|FG000|NOT COMPLETED|Overall Study||2||
48120378|NCT02312310|100619595|FG001|NOT COMPLETED|Overall Study||2||
48120379|NCT02312310|100619596|FG002|NOT COMPLETED|Overall Study||3||
48120380|NCT02312310|100619597|FG003|NOT COMPLETED|Overall Study||0||
48120381|NCT03837496|100619598|FG000|STARTED|Overall Study||50||
48396319|NCT03235726|101299364|FG006|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
48120382|NCT03837496|100619599|FG001|STARTED|Overall Study||50||
48120383|NCT03837496|100619598|FG000|COMPLETED|Overall Study||45||
48120384|NCT03837496|100619599|FG001|COMPLETED|Overall Study||47||
48120385|NCT03837496|100619598|FG000|NOT COMPLETED|Overall Study||5||
48120386|NCT03837496|100619599|FG001|NOT COMPLETED|Overall Study||3||
48120387|NCT04286594|100619600|FG000|STARTED|Overall Study||12|Completed Baseline Visit|
48120388|NCT04286594|100619600|FG000|COMPLETED|Overall Study||12|Completed 6-Week Visit|
48120389|NCT04286594|100619600|FG000|NOT COMPLETED|Overall Study||0||
48120390|NCT02661828|100619601|FG000|STARTED|Overall Study||1||
48120391|NCT02661828|100619602|FG001|STARTED|Overall Study||0||
48120392|NCT02661828|100619601|FG000|COMPLETED|Overall Study||1||
48120393|NCT02661828|100619602|FG001|COMPLETED|Overall Study||0||
48120394|NCT02661828|100619601|FG000|NOT COMPLETED|Overall Study||0||
48120395|NCT02661828|100619602|FG001|NOT COMPLETED|Overall Study||0||
48120396|NCT04027686|100619603|FG000|STARTED|Overall Study||17||
48120397|NCT04027686|100619604|FG001|STARTED|Overall Study||6||
48120398|NCT04027686|100619603|FG000|COMPLETED|Overall Study||15||
48120399|NCT04027686|100619604|FG001|COMPLETED|Overall Study||5||
48396320|NCT03235726|101299365|FG007|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
48396321|NCT03235726|101299366|FG008|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
48569002|NCT00703157|101724689|FG000|24 Months FU|Overall Study||22||
48569003|NCT00703157|101724690|FG001|24 Months FU|Overall Study||24||
48569004|NCT00703157|101724689|FG000|COMPLETED|Overall Study||22||
48569005|NCT00703157|101724690|FG001|COMPLETED|Overall Study||24||
48120400|NCT04027686|100619603|FG000|NOT COMPLETED|Overall Study||2||
48569006|NCT00703157|101724689|FG000|NOT COMPLETED|Overall Study||4||
48569007|NCT00703157|101724690|FG001|NOT COMPLETED|Overall Study||2||
48569008|NCT01339260|101724691|FG000|STARTED|Cycle 1||726||
48569009|NCT01339260|101724692|FG001|STARTED|Cycle 1||729||
48569010|NCT01339260|101724691|FG000|Safety Population|Cycle 1||725||
48569011|NCT01339260|101724692|FG001|Safety Population|Cycle 1||725||
48569012|NCT01339260|101724691|FG000|Full Analysis Set|Cycle 1||724||
48569013|NCT01339260|101724692|FG001|Full Analysis Set|Cycle 1||725||
48569014|NCT01339260|101724691|FG000|COMPLETED|Cycle 1||719||
48569015|NCT01339260|101724692|FG001|COMPLETED|Cycle 1||719||
48569016|NCT01339260|101724691|FG000|NOT COMPLETED|Cycle 1||7||
48569017|NCT01339260|101724692|FG001|NOT COMPLETED|Cycle 1||10||
48569018|NCT01339260|101724691|FG000|STARTED|Multi-cycle Extension||635||
48569019|NCT01339260|101724692|FG001|STARTED|Multi-cycle Extension||651||
48569020|NCT01339260|101724691|FG000|Safety Population|Multi-cycle Extension||635||
48569021|NCT01339260|101724692|FG001|Safety Population|Multi-cycle Extension||651||
48569022|NCT01339260|101724691|FG000|COMPLETED|Multi-cycle Extension||449||
48569023|NCT01339260|101724692|FG001|COMPLETED|Multi-cycle Extension||458||
48699289|NCT02130687|102050475|FG002|STARTED|Drug 1 Only Between Periods 2 and 3||29||
48699290|NCT02130687|102050473|FG000|COMPLETED|Drug 1 Only Between Periods 2 and 3||33||
48699291|NCT02130687|102050474|FG001|COMPLETED|Drug 1 Only Between Periods 2 and 3||25||
48699292|NCT02130687|102050475|FG002|COMPLETED|Drug 1 Only Between Periods 2 and 3||27||
48699293|NCT02130687|102050473|FG000|NOT COMPLETED|Drug 1 Only Between Periods 2 and 3||0||
48699294|NCT02130687|102050474|FG001|NOT COMPLETED|Drug 1 Only Between Periods 2 and 3||1||
48699295|NCT02130687|102050475|FG002|NOT COMPLETED|Drug 1 Only Between Periods 2 and 3||2||
48699296|NCT02130687|102050473|FG000|STARTED|Crossover Period 3||33||
48699297|NCT02130687|102050474|FG001|STARTED|Crossover Period 3||25||
48699298|NCT02130687|102050475|FG002|STARTED|Crossover Period 3||27||
48699299|NCT02130687|102050473|FG000|COMPLETED|Crossover Period 3||33||
48699300|NCT02130687|102050474|FG001|COMPLETED|Crossover Period 3||25||
48699301|NCT02130687|102050475|FG002|COMPLETED|Crossover Period 3||27||
48699302|NCT02130687|102050473|FG000|NOT COMPLETED|Crossover Period 3||0||
48699303|NCT02130687|102050474|FG001|NOT COMPLETED|Crossover Period 3||0||
48699304|NCT02130687|102050475|FG002|NOT COMPLETED|Crossover Period 3||0||
48699305|NCT03255967|102050476|FG000|STARTED|Overall Study||238||
48120401|NCT04027686|100619604|FG001|NOT COMPLETED|Overall Study||1||
48120402|NCT04016324|100619605|FG000|STARTED|Overall Study||110||
48120403|NCT04016324|100619605|FG000|COMPLETED|Overall Study||107||
48120404|NCT04016324|100619605|FG000|NOT COMPLETED|Overall Study||3||
48569024|NCT01339260|101724691|FG000|NOT COMPLETED|Multi-cycle Extension||186||
48569025|NCT01339260|101724692|FG001|NOT COMPLETED|Multi-cycle Extension||193||
48569026|NCT00758290|101724693|FG000|STARTED|Overall Study||11||
48569027|NCT00758290|101724694|FG001|STARTED|Overall Study||12||
48569028|NCT00758290|101724693|FG000|COMPLETED|Overall Study||11||
48569029|NCT00758290|101724694|FG001|COMPLETED|Overall Study||12||
48569030|NCT00758290|101724693|FG000|NOT COMPLETED|Overall Study||0||
48569031|NCT00758290|101724694|FG001|NOT COMPLETED|Overall Study||0||
48569032|NCT03396653|101724695|FG000|STARTED|Phase I (Weight Loss): 16 Weeks||153||
48569033|NCT03396653|101724696|FG001|STARTED|Phase I (Weight Loss): 16 Weeks||134||
48569034|NCT03396653|101724697|FG002|STARTED|Phase I (Weight Loss): 16 Weeks||562||
48569035|NCT03396653|101724695|FG000|COMPLETED|Phase I (Weight Loss): 16 Weeks||153||
48569036|NCT03396653|101724696|FG001|COMPLETED|Phase I (Weight Loss): 16 Weeks||134||
48569037|NCT03396653|101724697|FG002|COMPLETED|Phase I (Weight Loss): 16 Weeks||0||
48569038|NCT03396653|101724695|FG000|NOT COMPLETED|Phase I (Weight Loss): 16 Weeks||0||
48569039|NCT03396653|101724696|FG001|NOT COMPLETED|Phase I (Weight Loss): 16 Weeks||0||
48120405|NCT01049919|100619606|FG000|STARTED|Overall Study||117||119
48120406|NCT01049919|100619607|FG001|STARTED|Overall Study||36||36
48120407|NCT01049919|100619606|FG000|COMPLETED|Overall Study||65||67
48120408|NCT01049919|100619607|FG001|COMPLETED|Overall Study||19||19
48120409|NCT01049919|100619606|FG000|NOT COMPLETED|Overall Study||52||52
48396322|NCT03235726|101299367|FG009|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
48120410|NCT01049919|100619607|FG001|NOT COMPLETED|Overall Study||17||17
48120411|NCT01276327|100619608|FG000|STARTED|Overall Study||32||
48396323|NCT03235726|101299358|FG000|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
48396324|NCT03235726|101299359|FG001|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
48396325|NCT03235726|101299360|FG002|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
48569040|NCT03396653|101724697|FG002|NOT COMPLETED|Phase I (Weight Loss): 16 Weeks||562||
48569041|NCT03396653|101724695|FG000|STARTED|Phase II (Weight Maintenance): 18 Months||153||
48569042|NCT03396653|101724696|FG001|STARTED|Phase II (Weight Maintenance): 18 Months||134||
48120412|NCT01276327|100619609|FG001|STARTED|Overall Study||32||
48120413|NCT01276327|100619608|FG000|COMPLETED|Overall Study||30||
48120414|NCT01276327|100619609|FG001|COMPLETED|Overall Study||29||
48120415|NCT01276327|100619608|FG000|NOT COMPLETED|Overall Study||2||
48120416|NCT01276327|100619609|FG001|NOT COMPLETED|Overall Study||3||
48120417|NCT00563797|100619610|FG000|STARTED|Overall Study||11||
48120418|NCT00563797|100619611|FG001|STARTED|Overall Study||10||
48120419|NCT00563797|100619610|FG000|Received Allocated Intervention|Overall Study||11||
48120420|NCT00563797|100619611|FG001|Received Allocated Intervention|Overall Study||10||
48120421|NCT00563797|100619610|FG000|Follow-Up|Overall Study||11||
48569043|NCT03396653|101724697|FG002|STARTED|Phase II (Weight Maintenance): 18 Months||0||
48569044|NCT03396653|101724695|FG000|6 Month Assessment|Phase II (Weight Maintenance): 18 Months||145||
48569045|NCT03396653|101724696|FG001|6 Month Assessment|Phase II (Weight Maintenance): 18 Months||131||
48569046|NCT03396653|101724697|FG002|6 Month Assessment|Phase II (Weight Maintenance): 18 Months||0||
48569047|NCT03396653|101724695|FG000|12 Month Assessment|Phase II (Weight Maintenance): 18 Months||139||
48592794|NCT01764997|101783186|FG004|STARTED|Run-in Period||0||
48120422|NCT00563797|100619611|FG001|Follow-Up|Overall Study||10||
48120423|NCT00563797|100619610|FG000|COMPLETED|Overall Study||4||
48120424|NCT00563797|100619611|FG001|COMPLETED|Overall Study||8||
48120425|NCT00563797|100619610|FG000|NOT COMPLETED|Overall Study||7||
48120426|NCT00563797|100619611|FG001|NOT COMPLETED|Overall Study||2||
48120427|NCT00368940|100619612|FG000|STARTED|Intention-to-Treat||37||
48120428|NCT00368940|100619613|FG001|STARTED|Intention-to-Treat||37||
48120429|NCT00368940|100619612|FG000|COMPLETED|Intention-to-Treat||37||
48120430|NCT00368940|100619613|FG001|COMPLETED|Intention-to-Treat||37||
48396326|NCT03235726|101299361|FG003|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
48396327|NCT03235726|101299362|FG004|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
48396328|NCT03235726|101299363|FG005|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
48396329|NCT03235726|101299364|FG006|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
48396330|NCT03235726|101299365|FG007|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
48699306|NCT03255967|102050477|FG001|STARTED|Overall Study||192||
48699307|NCT03255967|102050476|FG000|Number of Patients Started|Overall Study||119||
48699308|NCT03255967|102050477|FG001|Number of Patients Started|Overall Study||96||
48699309|NCT03255967|102050476|FG000|Number of Patients Completed|Overall Study||99||
48699310|NCT03255967|102050477|FG001|Number of Patients Completed|Overall Study||76||
48699311|NCT03255967|102050476|FG000|Number of Caregivers Started|Overall Study||119||
48699312|NCT03255967|102050477|FG001|Number of Caregivers Started|Overall Study||96||
48699313|NCT03255967|102050476|FG000|Number of Caregivers Completed|Overall Study||99||
48396331|NCT03235726|101299366|FG008|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
48396332|NCT03235726|101299367|FG009|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
48396333|NCT03235726|101299358|FG000|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0||
48396334|NCT03235726|101299359|FG001|STARTED|Part 1 (Cohort A 120 mg - Day 3)||6||
48396335|NCT03235726|101299360|FG002|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0||
48396336|NCT03235726|101299361|FG003|STARTED|Part 1 (Cohort A 120 mg - Day 3)||2||
48396337|NCT03235726|101299362|FG004|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0||
48396338|NCT03235726|101299363|FG005|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0||
48396339|NCT03235726|101299364|FG006|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0||
48699314|NCT03255967|102050477|FG001|Number of Caregivers Completed|Overall Study||76||
48699315|NCT03255967|102050476|FG000|COMPLETED|Overall Study||198||
48699316|NCT03255967|102050477|FG001|COMPLETED|Overall Study||152||
48699317|NCT03255967|102050476|FG000|NOT COMPLETED|Overall Study||40||
48699318|NCT03255967|102050477|FG001|NOT COMPLETED|Overall Study||40||
48699319|NCT02890303|102050478|FG000|STARTED|Overall Study||100||
48699320|NCT02890303|102050478|FG000|COMPLETED|Overall Study||100||
48699321|NCT02890303|102050478|FG000|NOT COMPLETED|Overall Study||0||
48699322|NCT00776594|102050479|FG000|STARTED|Overall Study||66||
48699323|NCT00776594|102050480|FG001|STARTED|Overall Study||36||
48699324|NCT00776594|102050479|FG000|COMPLETED|Overall Study||62||
48699325|NCT00776594|102050480|FG001|COMPLETED|Overall Study||34||
48699326|NCT00776594|102050479|FG000|NOT COMPLETED|Overall Study||4||
48699327|NCT00776594|102050480|FG001|NOT COMPLETED|Overall Study||2||
48699328|NCT02126553|102050481|FG000|STARTED|Overall Study||29||
48699329|NCT02126553|102050481|FG000|COMPLETED|Overall Study||29||
48699330|NCT02126553|102050481|FG000|NOT COMPLETED|Overall Study||0||
48699331|NCT02256384|102050482|FG000|STARTED|Overall Study||76||
48699332|NCT02256384|102050482|FG000|COMPLETED|Overall Study||62||
48396340|NCT03235726|101299365|FG007|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0||
48396341|NCT03235726|101299366|FG008|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0||
48396342|NCT03235726|101299367|FG009|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0||
48396343|NCT03235726|101299358|FG000|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
48396344|NCT03235726|101299359|FG001|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||6||
48396345|NCT03235726|101299360|FG002|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
48396346|NCT03235726|101299361|FG003|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||2||
48396347|NCT03235726|101299362|FG004|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
48396348|NCT03235726|101299363|FG005|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
48396349|NCT03235726|101299364|FG006|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
48396350|NCT03235726|101299365|FG007|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
48396351|NCT03235726|101299366|FG008|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
48396352|NCT03235726|101299367|FG009|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
48396353|NCT03235726|101299358|FG000|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
48396354|NCT03235726|101299359|FG001|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
48396355|NCT03235726|101299360|FG002|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
48396356|NCT03235726|101299361|FG003|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
48592795|NCT01764997|101783182|FG000|COMPLETED|Run-in Period||738||
48396357|NCT03235726|101299362|FG004|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
48396358|NCT03235726|101299363|FG005|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
48699333|NCT02256384|102050482|FG000|NOT COMPLETED|Overall Study||14||
48120431|NCT00368940|100619612|FG000|NOT COMPLETED|Intention-to-Treat||0||
48120432|NCT00368940|100619613|FG001|NOT COMPLETED|Intention-to-Treat||0||
48120433|NCT00368940|100619612|FG000|STARTED|Completed 12-wk Treatment||37||
48120434|NCT00368940|100619613|FG001|STARTED|Completed 12-wk Treatment||37||
48120435|NCT00368940|100619612|FG000|COMPLETED|Completed 12-wk Treatment||31||
48120436|NCT00368940|100619613|FG001|COMPLETED|Completed 12-wk Treatment||32||
48120437|NCT00368940|100619612|FG000|NOT COMPLETED|Completed 12-wk Treatment||6||
48120438|NCT00368940|100619613|FG001|NOT COMPLETED|Completed 12-wk Treatment||5||
48120439|NCT01532362|100619614|FG000|STARTED|Overall Study||1||
48699334|NCT06239441|102050483|FG000|STARTED|Overall Study||22||
48699335|NCT06239441|102050484|FG001|STARTED|Overall Study||86||
48699336|NCT06239441|102050483|FG000|COMPLETED|Overall Study||22||
48699337|NCT06239441|102050484|FG001|COMPLETED|Overall Study||86||
48120440|NCT01532362|100619615|FG001|STARTED|Overall Study||0||
48120441|NCT01532362|100619614|FG000|COMPLETED|Overall Study||1||
48699338|NCT06239441|102050483|FG000|NOT COMPLETED|Overall Study||0||
48699339|NCT06239441|102050484|FG001|NOT COMPLETED|Overall Study||0||
48699340|NCT00227344|102050485|FG000|STARTED|Overall Study||87||
48699341|NCT00227344|102050486|FG001|STARTED|Overall Study||42||
48699342|NCT00227344|102050485|FG000|COMPLETED|Overall Study||75||
48699343|NCT00227344|102050486|FG001|COMPLETED|Overall Study||37||
48699344|NCT00227344|102050485|FG000|NOT COMPLETED|Overall Study||12||
48699345|NCT00227344|102050486|FG001|NOT COMPLETED|Overall Study||5||
48699346|NCT03172884|102050487|FG000|STARTED|Overall Study||8||
48699347|NCT03172884|102050488|FG001|STARTED|Overall Study||6||
48699348|NCT03172884|102050489|FG002|STARTED|Overall Study||8||
48699349|NCT03172884|102050490|FG003|STARTED|Overall Study||8||
48699350|NCT03172884|102050487|FG000|COMPLETED|Overall Study||8||
48699351|NCT03172884|102050488|FG001|COMPLETED|Overall Study||6||
48699352|NCT03172884|102050489|FG002|COMPLETED|Overall Study||8||
48699353|NCT03172884|102050490|FG003|COMPLETED|Overall Study||8||
48699354|NCT03172884|102050487|FG000|NOT COMPLETED|Overall Study||0||
48699355|NCT03172884|102050488|FG001|NOT COMPLETED|Overall Study||0||
48699356|NCT03172884|102050489|FG002|NOT COMPLETED|Overall Study||0||
48699357|NCT03172884|102050490|FG003|NOT COMPLETED|Overall Study||0||
48699358|NCT00391430|102050491|FG000|STARTED|Overall Study||8||
48699359|NCT00391430|102050492|FG001|STARTED|Overall Study||0||
48699360|NCT00391430|102050493|FG002|STARTED|Overall Study||31||
48699361|NCT00391430|102050491|FG000|COMPLETED|Overall Study||5||
48699362|NCT00391430|102050492|FG001|COMPLETED|Overall Study||0||
48699363|NCT00391430|102050493|FG002|COMPLETED|Overall Study||19||
48699364|NCT00391430|102050491|FG000|NOT COMPLETED|Overall Study||3||
48699365|NCT00391430|102050492|FG001|NOT COMPLETED|Overall Study||0||
48699366|NCT00391430|102050493|FG002|NOT COMPLETED|Overall Study||12||
48699367|NCT00615589|102050494|FG000|STARTED|Overall Study||22||
48699368|NCT00615589|102050494|FG000|COMPLETED|Overall Study||22||
48699369|NCT00615589|102050494|FG000|NOT COMPLETED|Overall Study||0||
48699370|NCT00765037|102050495|FG000|STARTED|Overall Study||19||
48699371|NCT00765037|102050495|FG000|COMPLETED|Overall Study||13||
48699372|NCT00765037|102050495|FG000|NOT COMPLETED|Overall Study||6||
48699373|NCT02179424|102050496|FG000|STARTED|Overall Study||76||
48699374|NCT02179424|102050497|FG001|STARTED|Overall Study||11||
48699375|NCT02179424|102050498|FG002|STARTED|Overall Study||516||
48699376|NCT02179424|102050499|FG003|STARTED|Overall Study||39||
48699377|NCT02179424|102050496|FG000|COMPLETED|Overall Study||76||
48120442|NCT01532362|100619615|FG001|COMPLETED|Overall Study||0||
48120443|NCT01532362|100619614|FG000|NOT COMPLETED|Overall Study||0||
48120444|NCT01532362|100619615|FG001|NOT COMPLETED|Overall Study||0||
48120445|NCT01138124|100619616|FG000|STARTED|Overall Study||3149||
48396359|NCT03235726|101299364|FG006|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
48699378|NCT02179424|102050497|FG001|COMPLETED|Overall Study||11||
48699379|NCT02179424|102050498|FG002|COMPLETED|Overall Study||516||
48699380|NCT02179424|102050499|FG003|COMPLETED|Overall Study||39||
48699381|NCT02179424|102050496|FG000|NOT COMPLETED|Overall Study||0||
48699382|NCT02179424|102050497|FG001|NOT COMPLETED|Overall Study||0||
48699383|NCT02179424|102050498|FG002|NOT COMPLETED|Overall Study||0||
48699384|NCT02179424|102050499|FG003|NOT COMPLETED|Overall Study||0||
48699385|NCT00142168|102050500|FG000|STARTED|Overall Study||16||
48699386|NCT00142168|102050500|FG000|COMPLETED|Overall Study||16||
48699387|NCT00142168|102050500|FG000|NOT COMPLETED|Overall Study||0||
48699388|NCT00118846|102050501|FG000|STARTED|Overall Study||175||
48699389|NCT00118846|102050502|FG001|STARTED|Overall Study||175||
48699390|NCT00118846|102050501|FG000|COMPLETED|Overall Study||162||
48699391|NCT00118846|102050502|FG001|COMPLETED|Overall Study||163||
48699392|NCT00118846|102050501|FG000|NOT COMPLETED|Overall Study||13||
48699393|NCT00118846|102050502|FG001|NOT COMPLETED|Overall Study||12||
48699394|NCT05538312|102050503|FG000|STARTED|Period 1 (6 Days)||12||
48699395|NCT05538312|102050503|FG000|COMPLETED|Period 1 (6 Days)||12||
48120446|NCT01138124|100619617|FG001|STARTED|Overall Study||30026||
48120447|NCT01138124|100619618|FG002|STARTED|Overall Study||1981||
48396360|NCT03235726|101299365|FG007|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
48396361|NCT03235726|101299366|FG008|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
48396362|NCT03235726|101299367|FG009|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
48396363|NCT03235726|101299358|FG000|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
48396364|NCT03235726|101299359|FG001|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
48396365|NCT03235726|101299360|FG002|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||6||
48396366|NCT03235726|101299361|FG003|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||2||
48396367|NCT03235726|101299362|FG004|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
48396368|NCT03235726|101299363|FG005|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
48120448|NCT01138124|100619619|FG003|STARTED|Overall Study||19046||
48120449|NCT01138124|100619616|FG000|COMPLETED|Overall Study||3149||
48396369|NCT03235726|101299364|FG006|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
48396370|NCT03235726|101299365|FG007|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
48396371|NCT03235726|101299366|FG008|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
48396372|NCT03235726|101299367|FG009|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
48396373|NCT03235726|101299358|FG000|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
48120450|NCT01138124|100619617|FG001|COMPLETED|Overall Study||30026||
48120451|NCT01138124|100619618|FG002|COMPLETED|Overall Study||1981||
48120452|NCT01138124|100619619|FG003|COMPLETED|Overall Study||19046||
48120453|NCT01138124|100619616|FG000|NOT COMPLETED|Overall Study||0||
48120454|NCT01138124|100619617|FG001|NOT COMPLETED|Overall Study||0||
48120455|NCT01138124|100619618|FG002|NOT COMPLETED|Overall Study||0||
48120456|NCT01138124|100619619|FG003|NOT COMPLETED|Overall Study||0||
48120457|NCT01410110|100619620|FG000|STARTED|Overall Study||24||
48120458|NCT01410110|100619621|FG001|STARTED|Overall Study||24||
48120459|NCT01410110|100619620|FG000|Randomization|Overall Study||24||
48120460|NCT01410110|100619621|FG001|Randomization|Overall Study||24||
48120461|NCT01410110|100619620|FG000|3 Months (End of Intervention)|Overall Study||20||
48120462|NCT01410110|100619621|FG001|3 Months (End of Intervention)|Overall Study||22||
48120463|NCT01410110|100619620|FG000|6 Month Follow-up|Overall Study||20||
48120464|NCT01410110|100619621|FG001|6 Month Follow-up|Overall Study||22||
48120465|NCT01410110|100619620|FG000|COMPLETED|Overall Study||20||
48120466|NCT01410110|100619621|FG001|COMPLETED|Overall Study||22||
48120467|NCT01410110|100619620|FG000|NOT COMPLETED|Overall Study||4||
48120468|NCT01410110|100619621|FG001|NOT COMPLETED|Overall Study||2||
48120469|NCT02851108|100619622|FG000|STARTED|Overall Study||50||
48120470|NCT02851108|100619623|FG001|STARTED|Overall Study||50||
48120471|NCT02851108|100619622|FG000|COMPLETED|Overall Study||42||
48120472|NCT02851108|100619623|FG001|COMPLETED|Overall Study||49||
48120473|NCT02851108|100619622|FG000|NOT COMPLETED|Overall Study||8||
48120474|NCT02851108|100619623|FG001|NOT COMPLETED|Overall Study||1||
48120475|NCT03246958|100619624|FG000|STARTED|Overall Study||17||
48120476|NCT03246958|100619625|FG001|STARTED|Overall Study||18||
48120477|NCT03246958|100619626|FG002|STARTED|Overall Study||3||
48120478|NCT03246958|100619627|FG003|STARTED|Overall Study||4||
48120479|NCT03246958|100619628|FG004|STARTED|Overall Study||2||
48120480|NCT03246958|100619629|FG005|STARTED|Overall Study||4||
48120481|NCT03246958|100619630|FG006|STARTED|Overall Study||4||
48120482|NCT03246958|100619624|FG000|Analyzable|Overall Study||16||
48120483|NCT03246958|100619625|FG001|Analyzable|Overall Study||16||
48120484|NCT03246958|100619626|FG002|Analyzable|Overall Study||3||
48120485|NCT03246958|100619627|FG003|Analyzable|Overall Study||4||
48120486|NCT03246958|100619628|FG004|Analyzable|Overall Study||2||
48120487|NCT03246958|100619629|FG005|Analyzable|Overall Study||4||
48120488|NCT03246958|100619630|FG006|Analyzable|Overall Study||4||
48120489|NCT03246958|100619624|FG000|COMPLETED|Overall Study||1||
48120490|NCT03246958|100619625|FG001|COMPLETED|Overall Study||3||
48120491|NCT03246958|100619626|FG002|COMPLETED|Overall Study||0||
48120492|NCT03246958|100619627|FG003|COMPLETED|Overall Study||0||
48120493|NCT03246958|100619628|FG004|COMPLETED|Overall Study||0||
48120494|NCT03246958|100619629|FG005|COMPLETED|Overall Study||1||
48120495|NCT03246958|100619630|FG006|COMPLETED|Overall Study||1||
48120496|NCT03246958|100619624|FG000|NOT COMPLETED|Overall Study||16||
48120497|NCT03246958|100619625|FG001|NOT COMPLETED|Overall Study||15||
48120498|NCT03246958|100619626|FG002|NOT COMPLETED|Overall Study||3||
48120499|NCT03246958|100619627|FG003|NOT COMPLETED|Overall Study||4||
48120500|NCT03246958|100619628|FG004|NOT COMPLETED|Overall Study||2||
48120501|NCT03246958|100619629|FG005|NOT COMPLETED|Overall Study||3||
48120502|NCT03246958|100619630|FG006|NOT COMPLETED|Overall Study||3||
48120503|NCT02258152|100619631|FG000|STARTED|Overall Study||44||
48120504|NCT02258152|100619632|FG001|STARTED|Overall Study||38||
48120505|NCT02258152|100619631|FG000|COMPLETED|Overall Study||38||
48120506|NCT02258152|100619632|FG001|COMPLETED|Overall Study||34||
48120507|NCT02258152|100619631|FG000|NOT COMPLETED|Overall Study||6||
48120508|NCT02258152|100619632|FG001|NOT COMPLETED|Overall Study||4||
48120509|NCT01132144|100619633|FG000|STARTED|Overall Study||79||
48120510|NCT01132144|100619634|FG001|STARTED|Overall Study||79||
48120511|NCT01132144|100619633|FG000|COMPLETED|Overall Study||79||
48120512|NCT01132144|100619634|FG001|COMPLETED|Overall Study||79||
48120513|NCT01132144|100619633|FG000|NOT COMPLETED|Overall Study||0||
48120514|NCT01132144|100619634|FG001|NOT COMPLETED|Overall Study||0||
48120515|NCT04258839|100619635|FG000|STARTED|Overall Study||49||
48120516|NCT04258839|100619636|FG001|STARTED|Overall Study||46||
48120517|NCT04258839|100619635|FG000|Safety Sample|Overall Study||49|Safety Sample included all enrolled participants who received at least one dose of investigational medicinal product (IMP).|
48120518|NCT04258839|100619636|FG001|Safety Sample|Overall Study||46|Safety Sample included all enrolled participants who received at least one dose of investigational medicinal product (IMP).|
48120519|NCT04258839|100619635|FG000|Efficacy Sample|Overall Study||48|Efficacy Sample included all participants in the Safety Sample who had a baseline assessment and at least one post-baseline assessment of the Aberrant Behavior Checklist - Irritability (ABC-I) subscale score.|
48120520|NCT04258839|100619636|FG001|Efficacy Sample|Overall Study||46|Efficacy Sample included all participants in the Safety Sample who had a baseline assessment and at least one post-baseline assessment of the Aberrant Behavior Checklist - Irritability (ABC-I) subscale score.|
48120521|NCT04258839|100619635|FG000|COMPLETED|Overall Study||39||
48120522|NCT04258839|100619636|FG001|COMPLETED|Overall Study||31||
48120523|NCT04258839|100619635|FG000|NOT COMPLETED|Overall Study||10||
48120524|NCT04258839|100619636|FG001|NOT COMPLETED|Overall Study||15||
48120525|NCT01915563|100619637|FG000|STARTED|Overall Study||243||
48120526|NCT01915563|100619638|FG001|STARTED|Overall Study||227||
48120527|NCT01915563|100619637|FG000|COMPLETED|Overall Study||243||
48120528|NCT01915563|100619638|FG001|COMPLETED|Overall Study||227||
48120529|NCT01915563|100619637|FG000|NOT COMPLETED|Overall Study||0||
48120530|NCT01915563|100619638|FG001|NOT COMPLETED|Overall Study||0||
48120531|NCT01079234|100619639|FG000|STARTED|Main: Week 0 to 26||164||
48120532|NCT01079234|100619640|FG001|STARTED|Main: Week 0 to 26||165||
48120533|NCT01079234|100619641|FG002|STARTED|Main: Week 0 to 26||164||
48120534|NCT01079234|100619642|FG003|STARTED|Main: Week 0 to 26||0||
48120535|NCT01079234|100619639|FG000|Exposed|Main: Week 0 to 26||164||
48120536|NCT01079234|100619640|FG001|Exposed|Main: Week 0 to 26||165||
48120537|NCT01079234|100619641|FG002|Exposed|Main: Week 0 to 26||161||
48396374|NCT03235726|101299359|FG001|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
48699396|NCT05538312|102050503|FG000|NOT COMPLETED|Period 1 (6 Days)||0||
48699397|NCT05538312|102050503|FG000|STARTED|Period 2 (12 Days)||12||
48699398|NCT05538312|102050503|FG000|COMPLETED|Period 2 (12 Days)||12||
48699399|NCT05538312|102050503|FG000|NOT COMPLETED|Period 2 (12 Days)||0||
48699400|NCT01345513|102050504|FG000|STARTED|Overall Study||50||
48699401|NCT01345513|102050504|FG000|COMPLETED|Overall Study||50||
48569048|NCT03396653|101724696|FG001|12 Month Assessment|Phase II (Weight Maintenance): 18 Months||122||
48569049|NCT03396653|101724697|FG002|12 Month Assessment|Phase II (Weight Maintenance): 18 Months||0||
48569050|NCT03396653|101724695|FG000|COMPLETED|Phase II (Weight Maintenance): 18 Months||144||
48569051|NCT03396653|101724696|FG001|COMPLETED|Phase II (Weight Maintenance): 18 Months||123||
48569052|NCT03396653|101724697|FG002|COMPLETED|Phase II (Weight Maintenance): 18 Months||0||
48699402|NCT01345513|102050504|FG000|NOT COMPLETED|Overall Study||0||
48699403|NCT01106859|102050505|FG000|STARTED|Overall Study||40||
48699404|NCT01106859|102050505|FG000|COMPLETED|Overall Study||40||
48396375|NCT03235726|101299360|FG002|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||6||
48396376|NCT03235726|101299361|FG003|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||2||
48396377|NCT03235726|101299362|FG004|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
48396378|NCT03235726|101299363|FG005|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
48396379|NCT03235726|101299364|FG006|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
48396380|NCT03235726|101299365|FG007|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
48699405|NCT01106859|102050505|FG000|NOT COMPLETED|Overall Study||0||
48699406|NCT01811485|102050506|FG000|STARTED|Overall Study||56||
48120538|NCT01079234|100619642|FG003|Exposed|Main: Week 0 to 26||0||
48120539|NCT01079234|100619639|FG000|COMPLETED|Main: Week 0 to 26||138||
48396381|NCT03235726|101299366|FG008|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
48396382|NCT03235726|101299367|FG009|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
48396383|NCT03235726|101299358|FG000|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
48569053|NCT03396653|101724695|FG000|NOT COMPLETED|Phase II (Weight Maintenance): 18 Months||9||
48699407|NCT01811485|102050507|FG001|STARTED|Overall Study||59||
48699408|NCT01811485|102050508|FG002|STARTED|Overall Study||56||
48120540|NCT01079234|100619640|FG001|COMPLETED|Main: Week 0 to 26||139||
48120541|NCT01079234|100619641|FG002|COMPLETED|Main: Week 0 to 26||152||
48120542|NCT01079234|100619642|FG003|COMPLETED|Main: Week 0 to 26||0||
48569054|NCT03396653|101724696|FG001|NOT COMPLETED|Phase II (Weight Maintenance): 18 Months||11||
48699409|NCT01811485|102050506|FG000|COMPLETED|Overall Study||54||
48699410|NCT01811485|102050507|FG001|COMPLETED|Overall Study||55||
48699411|NCT01811485|102050508|FG002|COMPLETED|Overall Study||51||
48699412|NCT01811485|102050506|FG000|NOT COMPLETED|Overall Study||2||
48699413|NCT01811485|102050507|FG001|NOT COMPLETED|Overall Study||4||
48699414|NCT01811485|102050508|FG002|NOT COMPLETED|Overall Study||5||
48699415|NCT00501592|102050509|FG000|STARTED|Overall Study||20||
48699416|NCT00501592|102050510|FG001|STARTED|Overall Study||21||
48699417|NCT00501592|102050511|FG002|STARTED|Overall Study||23||
48569055|NCT03396653|101724697|FG002|NOT COMPLETED|Phase II (Weight Maintenance): 18 Months||0||
48569056|NCT01581437|101724698|FG000|STARTED|Overall Study||78||
48569057|NCT01581437|101724698|FG000|COMPLETED|Overall Study||78||
48569058|NCT01581437|101724698|FG000|NOT COMPLETED|Overall Study||0||
48569059|NCT01532518|101724699|FG000|STARTED|Overall Study||6||
48569060|NCT01532518|101724700|FG001|STARTED|Overall Study||15||
48569061|NCT01532518|101724701|FG002|STARTED|Overall Study||6||
48569062|NCT01532518|101724699|FG000|COMPLETED|Overall Study||6||
48569063|NCT01532518|101724700|FG001|COMPLETED|Overall Study||15||
48569064|NCT01532518|101724701|FG002|COMPLETED|Overall Study||5||
48569065|NCT01532518|101724699|FG000|NOT COMPLETED|Overall Study||0||
48569066|NCT01532518|101724700|FG001|NOT COMPLETED|Overall Study||0||
48569067|NCT01532518|101724701|FG002|NOT COMPLETED|Overall Study||1||
48569068|NCT01611935|101724702|FG000|STARTED|Overall Study||50||
48569069|NCT01611935|101724703|FG001|STARTED|Overall Study||51||
48569070|NCT01611935|101724702|FG000|COMPLETED|Overall Study||49||
48569071|NCT01611935|101724703|FG001|COMPLETED|Overall Study||51||
48569072|NCT01611935|101724702|FG000|NOT COMPLETED|Overall Study||1||
48569073|NCT01611935|101724703|FG001|NOT COMPLETED|Overall Study||0||
48569074|NCT05028790|101724704|FG000|STARTED|First Intervention (40 Mins)||9||
48569075|NCT05028790|101724705|FG001|STARTED|First Intervention (40 Mins)||7||
48569076|NCT05028790|101724704|FG000|COMPLETED|First Intervention (40 Mins)||9||
48569077|NCT05028790|101724705|FG001|COMPLETED|First Intervention (40 Mins)||7||
48569078|NCT05028790|101724704|FG000|NOT COMPLETED|First Intervention (40 Mins)||0||
48569079|NCT05028790|101724705|FG001|NOT COMPLETED|First Intervention (40 Mins)||0||
48569080|NCT05028790|101724704|FG000|STARTED|Washout (5 Mins)||9||
48569081|NCT05028790|101724705|FG001|STARTED|Washout (5 Mins)||7||
48569082|NCT05028790|101724704|FG000|COMPLETED|Washout (5 Mins)||9||
48120543|NCT01079234|100619639|FG000|NOT COMPLETED|Main: Week 0 to 26||26||
48396384|NCT03235726|101299359|FG001|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
48396385|NCT03235726|101299360|FG002|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
48396386|NCT03235726|101299361|FG003|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
48396387|NCT03235726|101299362|FG004|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
48396388|NCT03235726|101299363|FG005|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
48120544|NCT01079234|100619640|FG001|NOT COMPLETED|Main: Week 0 to 26||26||
48120545|NCT01079234|100619641|FG002|NOT COMPLETED|Main: Week 0 to 26||12||
48120546|NCT01079234|100619642|FG003|NOT COMPLETED|Main: Week 0 to 26||0||
48120547|NCT01079234|100619639|FG000|STARTED|Extension: Week 27 to 52||0||
48120548|NCT01079234|100619640|FG001|STARTED|Extension: Week 27 to 52||0||
48120549|NCT01079234|100619641|FG002|STARTED|Extension: Week 27 to 52||133||
48120550|NCT01079234|100619642|FG003|STARTED|Extension: Week 27 to 52||239||
48120551|NCT01079234|100619639|FG000|COMPLETED|Extension: Week 27 to 52||0||
48120552|NCT01079234|100619640|FG001|COMPLETED|Extension: Week 27 to 52||0||
48396389|NCT03235726|101299364|FG006|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
48396390|NCT03235726|101299365|FG007|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
48396391|NCT03235726|101299366|FG008|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
48396392|NCT03235726|101299367|FG009|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
48396393|NCT03235726|101299358|FG000|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0||
48396394|NCT03235726|101299359|FG001|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0||
48396395|NCT03235726|101299360|FG002|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0||
48396396|NCT03235726|101299361|FG003|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0||
48396397|NCT03235726|101299362|FG004|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||12||
48396398|NCT03235726|101299363|FG005|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||2||
48396399|NCT03235726|101299364|FG006|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||14||
48396400|NCT03235726|101299365|FG007|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0||
48569083|NCT05028790|101724705|FG001|COMPLETED|Washout (5 Mins)||7||
48569084|NCT05028790|101724704|FG000|NOT COMPLETED|Washout (5 Mins)||0||
48569085|NCT05028790|101724705|FG001|NOT COMPLETED|Washout (5 Mins)||0||
48569086|NCT05028790|101724704|FG000|STARTED|Second Intervention (40 Mins)||9||
48569087|NCT05028790|101724705|FG001|STARTED|Second Intervention (40 Mins)||7||
48569088|NCT05028790|101724704|FG000|COMPLETED|Second Intervention (40 Mins)||9||
48396401|NCT03235726|101299366|FG008|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0||
48569089|NCT05028790|101724705|FG001|COMPLETED|Second Intervention (40 Mins)||7||
48569090|NCT05028790|101724704|FG000|NOT COMPLETED|Second Intervention (40 Mins)||0||
48569091|NCT05028790|101724705|FG001|NOT COMPLETED|Second Intervention (40 Mins)||0||
48569092|NCT03010800|101724706|FG000|STARTED|Initial Assignment||4||
48569093|NCT03010800|101724707|FG001|STARTED|Initial Assignment||4||
48120553|NCT01079234|100619641|FG002|COMPLETED|Extension: Week 27 to 52||122||
48120554|NCT01079234|100619642|FG003|COMPLETED|Extension: Week 27 to 52||223||
48569094|NCT03010800|101724706|FG000|COMPLETED|Initial Assignment||4||
48569095|NCT03010800|101724707|FG001|COMPLETED|Initial Assignment||4||
48120555|NCT01079234|100619639|FG000|NOT COMPLETED|Extension: Week 27 to 52||0||
48120556|NCT01079234|100619640|FG001|NOT COMPLETED|Extension: Week 27 to 52||0||
48120557|NCT01079234|100619641|FG002|NOT COMPLETED|Extension: Week 27 to 52||11||
48120558|NCT01079234|100619642|FG003|NOT COMPLETED|Extension: Week 27 to 52||16||
48120559|NCT03835260|100619643|FG000|STARTED|Overall Study||15||
48120560|NCT03835260|100619643|FG000|COMPLETED|Overall Study||15||
48120561|NCT03835260|100619643|FG000|NOT COMPLETED|Overall Study||0||
48120562|NCT02707640|100619644|FG000|STARTED|Overall Study||61||
48120563|NCT02707640|100619645|FG001|STARTED|Overall Study||62||
48120564|NCT02707640|100619644|FG000|COMPLETED|Overall Study||52||
48120565|NCT02707640|100619645|FG001|COMPLETED|Overall Study||55||
48120566|NCT02707640|100619644|FG000|NOT COMPLETED|Overall Study||9||
48120567|NCT02707640|100619645|FG001|NOT COMPLETED|Overall Study||7||
48120568|NCT02409615|100619646|FG000|STARTED|Overall Study||10||
48120569|NCT02409615|100619647|FG001|STARTED|Overall Study||10||
48120570|NCT02409615|100619648|FG002|STARTED|Overall Study||10||
48120571|NCT02409615|100619646|FG000|COMPLETED|Overall Study||10||
48120572|NCT02409615|100619647|FG001|COMPLETED|Overall Study||9||
48120573|NCT02409615|100619648|FG002|COMPLETED|Overall Study||10||
48120574|NCT02409615|100619646|FG000|NOT COMPLETED|Overall Study||0||
48120575|NCT02409615|100619647|FG001|NOT COMPLETED|Overall Study||1||
48120576|NCT02409615|100619648|FG002|NOT COMPLETED|Overall Study||0||
48120577|NCT01465802|100619649|FG000|STARTED|Overall Study||66||
48396402|NCT03235726|101299367|FG009|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0||
48396403|NCT03235726|101299358|FG000|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0||
48396404|NCT03235726|101299359|FG001|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0||
48396405|NCT03235726|101299360|FG002|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0||
48396406|NCT03235726|101299361|FG003|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0||
48396407|NCT03235726|101299362|FG004|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||10||
48396408|NCT03235726|101299363|FG005|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||2||
48396409|NCT03235726|101299364|FG006|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||14||
48569096|NCT03010800|101724706|FG000|NOT COMPLETED|Initial Assignment||0||
48569097|NCT03010800|101724707|FG001|NOT COMPLETED|Initial Assignment||0||
48569098|NCT03010800|101724706|FG000|STARTED|Cross Over||4||
48569099|NCT03010800|101724707|FG001|STARTED|Cross Over||4||
48120578|NCT01465802|100619650|FG001|STARTED|Overall Study||66||
48120579|NCT01465802|100619651|FG002|STARTED|Overall Study||7||
48120580|NCT01465802|100619652|FG003|STARTED|Overall Study||67||
48120581|NCT01465802|100619653|FG004|STARTED|Overall Study||25||
48120582|NCT01465802|100619649|FG000|COMPLETED|Overall Study||33||
48120583|NCT01465802|100619650|FG001|COMPLETED|Overall Study||42||
48120584|NCT01465802|100619651|FG002|COMPLETED|Overall Study||7||
48120585|NCT01465802|100619652|FG003|COMPLETED|Overall Study||38||
48120586|NCT01465802|100619653|FG004|COMPLETED|Overall Study||13||
48120587|NCT01465802|100619649|FG000|NOT COMPLETED|Overall Study||33||
48120588|NCT01465802|100619650|FG001|NOT COMPLETED|Overall Study||24||
48120589|NCT01465802|100619651|FG002|NOT COMPLETED|Overall Study||0||
48120590|NCT01465802|100619652|FG003|NOT COMPLETED|Overall Study||29||
48120591|NCT01465802|100619653|FG004|NOT COMPLETED|Overall Study||12||
48281527|NCT04488770|101014135|FG005|NOT COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||1||
48281528|NCT04488770|101014136|FG006|NOT COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||1||
48281529|NCT04488770|101014137|FG007|NOT COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
48281530|NCT04488770|101014138|FG008|NOT COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
48281531|NCT04488770|101014139|FG009|NOT COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
48120592|NCT03154710|100619654|FG000|STARTED|Overall Study||27||
48120593|NCT03154710|100619655|FG001|STARTED|Overall Study||25||
48120594|NCT03154710|100619654|FG000|COMPLETED|Overall Study||20||
48120595|NCT03154710|100619655|FG001|COMPLETED|Overall Study||20||
48120596|NCT03154710|100619654|FG000|NOT COMPLETED|Overall Study||7||
48120597|NCT03154710|100619655|FG001|NOT COMPLETED|Overall Study||5||
48120598|NCT03149328|100619656|FG000|STARTED|Overall Study||284||
48120599|NCT03149328|100619657|FG001|STARTED|Overall Study||259||
48281532|NCT04488770|101014140|FG010|NOT COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
48396410|NCT03235726|101299365|FG007|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0||
48396411|NCT03235726|101299366|FG008|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0||
48569100|NCT03010800|101724706|FG000|COMPLETED|Cross Over||4||
48569101|NCT03010800|101724707|FG001|COMPLETED|Cross Over||4||
48569102|NCT03010800|101724706|FG000|NOT COMPLETED|Cross Over||0||
48120600|NCT03149328|100619656|FG000|COMPLETED|Overall Study||200||
48120601|NCT03149328|100619657|FG001|COMPLETED|Overall Study||213||
48120602|NCT03149328|100619656|FG000|NOT COMPLETED|Overall Study||84||
48120603|NCT03149328|100619657|FG001|NOT COMPLETED|Overall Study||46||
48120604|NCT04847050|100619658|FG000|STARTED|Initial Phase||2||
48120605|NCT04847050|100619659|FG001|STARTED|Initial Phase||3||
48120606|NCT04847050|100619660|FG002|STARTED|Initial Phase||7||
48120607|NCT04847050|100619661|FG003|STARTED|Initial Phase||3||
48120608|NCT04847050|100619662|FG004|STARTED|Initial Phase||0||
48120609|NCT04847050|100619663|FG005|STARTED|Initial Phase||0||
48120610|NCT04847050|100619664|FG006|STARTED|Initial Phase||0||
48120611|NCT04847050|100619665|FG007|STARTED|Initial Phase||0||
48120612|NCT04847050|100619666|FG008|STARTED|Initial Phase||0||
48120613|NCT04847050|100619667|FG009|STARTED|Initial Phase||0||
48120614|NCT04847050|100619668|FG010|STARTED|Initial Phase||0||
48120615|NCT04847050|100619658|FG000|Participants Eligible for the Booster Phase|Initial Phase||1|All participants will be eligible to receive up to (3) booster doses of vaccine on study.|
48120616|NCT04847050|100619659|FG001|Participants Eligible for the Booster Phase|Initial Phase||3|All participants will be eligible to receive up to (3) booster doses of vaccine on study.|
48120617|NCT04847050|100619660|FG002|Participants Eligible for the Booster Phase|Initial Phase||3|All participants will be eligible to receive up to (3) booster doses of vaccine on study.|
48120618|NCT04847050|100619661|FG003|Participants Eligible for the Booster Phase|Initial Phase||2|All participants will be eligible to receive up to (3) booster doses of vaccine on study.|
48120619|NCT04847050|100619662|FG004|Participants Eligible for the Booster Phase|Initial Phase||0|All participants will be eligible to receive up to (3) booster doses of vaccine on study.|
48120620|NCT04847050|100619663|FG005|Participants Eligible for the Booster Phase|Initial Phase||0|All participants will be eligible to receive up to (3) booster doses of vaccine on study.|
48120621|NCT04847050|100619664|FG006|Participants Eligible for the Booster Phase|Initial Phase||0|All participants will be eligible to receive up to (3) booster doses of vaccine on study.|
48120622|NCT04847050|100619665|FG007|Participants Eligible for the Booster Phase|Initial Phase||0|All participants will be eligible to receive up to (3) booster doses of vaccine on study.|
48120623|NCT04847050|100619666|FG008|Participants Eligible for the Booster Phase|Initial Phase||0|All participants will be eligible to receive up to (3) booster doses of vaccine on study.|
48120624|NCT04847050|100619667|FG009|Participants Eligible for the Booster Phase|Initial Phase||0|All participants will be eligible to receive up to (3) booster doses of vaccine on study.|
48120625|NCT04847050|100619668|FG010|Participants Eligible for the Booster Phase|Initial Phase||0|All participants will be eligible to receive up to (3) booster doses of vaccine on study.|
48120626|NCT04847050|100619658|FG000|COMPLETED|Initial Phase||2||
48120627|NCT04847050|100619659|FG001|COMPLETED|Initial Phase||3||
48120628|NCT04847050|100619660|FG002|COMPLETED|Initial Phase||7||
48120629|NCT04847050|100619661|FG003|COMPLETED|Initial Phase||3||
48120630|NCT04847050|100619662|FG004|COMPLETED|Initial Phase||0||
48120631|NCT04847050|100619663|FG005|COMPLETED|Initial Phase||0||
48120632|NCT04847050|100619664|FG006|COMPLETED|Initial Phase||0||
48120633|NCT04847050|100619665|FG007|COMPLETED|Initial Phase||0||
48120634|NCT04847050|100619666|FG008|COMPLETED|Initial Phase||0||
48569103|NCT03010800|101724707|FG001|NOT COMPLETED|Cross Over||0||
48569104|NCT03337113|101724708|FG000|STARTED|Overall Study||13||
48569105|NCT03337113|101724709|FG001|STARTED|Overall Study||12||
48569106|NCT03337113|101724710|FG002|STARTED|Overall Study||12||
48569107|NCT03337113|101724711|FG003|STARTED|Overall Study||13||
48569108|NCT03337113|101724708|FG000|COMPLETED|Overall Study||12||
48569109|NCT03337113|101724709|FG001|COMPLETED|Overall Study||9||
48569110|NCT03337113|101724710|FG002|COMPLETED|Overall Study||11||
48569111|NCT03337113|101724711|FG003|COMPLETED|Overall Study||11||
48569112|NCT03337113|101724708|FG000|NOT COMPLETED|Overall Study||1||
48569113|NCT03337113|101724709|FG001|NOT COMPLETED|Overall Study||3||
48569114|NCT03337113|101724710|FG002|NOT COMPLETED|Overall Study||1||
48569115|NCT03337113|101724711|FG003|NOT COMPLETED|Overall Study||2||
48569116|NCT03825939|101724712|FG000|STARTED|Overall Study||18||
48569117|NCT03825939|101724713|FG001|STARTED|Overall Study||20||
48569118|NCT03825939|101724714|FG002|STARTED|Overall Study||14||
48569119|NCT03825939|101724712|FG000|COMPLETED|Overall Study||18||
48569120|NCT03825939|101724713|FG001|COMPLETED|Overall Study||20||
48569121|NCT03825939|101724714|FG002|COMPLETED|Overall Study||14||
48569122|NCT03825939|101724712|FG000|NOT COMPLETED|Overall Study||0||
48569123|NCT03825939|101724713|FG001|NOT COMPLETED|Overall Study||0||
48569124|NCT03825939|101724714|FG002|NOT COMPLETED|Overall Study||0||
48569125|NCT02764762|101724715|FG000|STARTED|Overall Study||55||
48569126|NCT02764762|101724715|FG000|Triple Combination Therapy|Overall Study||55|Participants who received triple combination therapy of vedolizumab 300 mg, IV infusion, adalimumab 160-80-40 mg SC and Methotrexate 15 mg tablets orally.|
48569127|NCT02764762|101724715|FG000|Monotherapy|Overall Study||45|Participants who received vedolizumab 300 mg IV infusion as monotherapy or have any visit data after Week 26 and before the safety follow up.|
48120635|NCT04847050|100619667|FG009|COMPLETED|Initial Phase||0||
48120636|NCT04847050|100619668|FG010|COMPLETED|Initial Phase||0||
48120637|NCT04847050|100619658|FG000|NOT COMPLETED|Initial Phase||0||
48120638|NCT04847050|100619659|FG001|NOT COMPLETED|Initial Phase||0||
48120639|NCT04847050|100619660|FG002|NOT COMPLETED|Initial Phase||0||
48120640|NCT04847050|100619661|FG003|NOT COMPLETED|Initial Phase||0||
48120641|NCT04847050|100619662|FG004|NOT COMPLETED|Initial Phase||0||
48569128|NCT02764762|101724715|FG000|Safety Follow-up|Overall Study||53|Participants who completed the study treatment or were terminated early from the study were followed-up for safety up to 18 weeks after receiving the last dose of study drug.|
48569129|NCT02764762|101724715|FG000|COMPLETED|Overall Study||16||
48569130|NCT02764762|101724715|FG000|NOT COMPLETED|Overall Study||39||
48569131|NCT02962492|101724716|FG000|STARTED|Overall Study||17||
48120642|NCT04847050|100619663|FG005|NOT COMPLETED|Initial Phase||0||
48120643|NCT04847050|100619664|FG006|NOT COMPLETED|Initial Phase||0||
48120644|NCT04847050|100619665|FG007|NOT COMPLETED|Initial Phase||0||
48120645|NCT04847050|100619666|FG008|NOT COMPLETED|Initial Phase||0||
48120646|NCT04847050|100619667|FG009|NOT COMPLETED|Initial Phase||0||
48120647|NCT04847050|100619668|FG010|NOT COMPLETED|Initial Phase||0||
48120648|NCT04847050|100619658|FG000|STARTED|Booster Phase||0||
48120649|NCT04847050|100619659|FG001|STARTED|Booster Phase||0||
48120650|NCT04847050|100619660|FG002|STARTED|Booster Phase||0||
48120651|NCT04847050|100619661|FG003|STARTED|Booster Phase||0||
48569132|NCT02962492|101724717|FG001|STARTED|Overall Study||17||
48569133|NCT02962492|101724718|FG002|STARTED|Overall Study||13||
48569134|NCT02962492|101724719|FG003|STARTED|Overall Study||23||
48569135|NCT02962492|101724716|FG000|COMPLETED|Overall Study||15||
48281533|NCT04488770|101014141|FG011|NOT COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
48281534|NCT04488770|101014142|FG012|NOT COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
48281535|NCT04488770|101014130|FG000|STARTED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
48281536|NCT04488770|101014131|FG001|STARTED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
48281537|NCT04488770|101014132|FG002|STARTED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
48281538|NCT04488770|101014133|FG003|STARTED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
48281539|NCT04488770|101014134|FG004|STARTED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||2||
48281540|NCT04488770|101014135|FG005|STARTED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||2||
48281541|NCT04488770|101014136|FG006|STARTED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||2||
48281542|NCT04488770|101014137|FG007|STARTED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||2||
48281543|NCT04488770|101014138|FG008|STARTED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
48281544|NCT04488770|101014139|FG009|STARTED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
48281545|NCT04488770|101014140|FG010|STARTED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
48281546|NCT04488770|101014141|FG011|STARTED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
48281547|NCT04488770|101014142|FG012|STARTED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
48281548|NCT04488770|101014130|FG000|COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
48281549|NCT04488770|101014131|FG001|COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
48281550|NCT04488770|101014132|FG002|COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
48281551|NCT04488770|101014133|FG003|COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
48281552|NCT04488770|101014134|FG004|COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||1||
48281553|NCT04488770|101014135|FG005|COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||2||
48281554|NCT04488770|101014136|FG006|COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||2||
48281555|NCT04488770|101014137|FG007|COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||2||
48281556|NCT04488770|101014138|FG008|COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
48281557|NCT04488770|101014139|FG009|COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
48281558|NCT04488770|101014140|FG010|COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
48281559|NCT04488770|101014141|FG011|COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
48281560|NCT04488770|101014142|FG012|COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
48281561|NCT04488770|101014130|FG000|NOT COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
48281562|NCT04488770|101014131|FG001|NOT COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
48281563|NCT04488770|101014132|FG002|NOT COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
48281564|NCT04488770|101014133|FG003|NOT COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
48281565|NCT04488770|101014134|FG004|NOT COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||1||
48281566|NCT04488770|101014135|FG005|NOT COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
48281567|NCT04488770|101014136|FG006|NOT COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
48281568|NCT04488770|101014137|FG007|NOT COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
48281569|NCT04488770|101014138|FG008|NOT COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
48281570|NCT04488770|101014139|FG009|NOT COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
48281571|NCT04488770|101014140|FG010|NOT COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
48281572|NCT04488770|101014141|FG011|NOT COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
48281573|NCT04488770|101014142|FG012|NOT COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
48281574|NCT04488770|101014130|FG000|STARTED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
48281575|NCT04488770|101014131|FG001|STARTED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
48281576|NCT04488770|101014132|FG002|STARTED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
48281577|NCT04488770|101014133|FG003|STARTED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
48281578|NCT04488770|101014134|FG004|STARTED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||2||
48281579|NCT04488770|101014135|FG005|STARTED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||2||
48281580|NCT04488770|101014136|FG006|STARTED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||2||
48281581|NCT04488770|101014137|FG007|STARTED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||2||
48281582|NCT04488770|101014138|FG008|STARTED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
48281583|NCT04488770|101014139|FG009|STARTED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
48281584|NCT04488770|101014140|FG010|STARTED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
48281585|NCT04488770|101014141|FG011|STARTED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
48281586|NCT04488770|101014142|FG012|STARTED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
48281587|NCT04488770|101014130|FG000|COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
48281588|NCT04488770|101014131|FG001|COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
48281589|NCT04488770|101014132|FG002|COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
48281590|NCT04488770|101014133|FG003|COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
48281591|NCT04488770|101014134|FG004|COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||2||
48281592|NCT04488770|101014135|FG005|COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||2||
48281593|NCT04488770|101014136|FG006|COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||2||
48396412|NCT03235726|101299367|FG009|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0||
48396413|NCT03235726|101299358|FG000|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0||
48396414|NCT03235726|101299359|FG001|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0||
48396415|NCT03235726|101299360|FG002|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0||
48396416|NCT03235726|101299361|FG003|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0||
48396417|NCT03235726|101299362|FG004|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||2||
48396418|NCT03235726|101299363|FG005|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0||
48396419|NCT03235726|101299364|FG006|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0||
48281594|NCT04488770|101014137|FG007|COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||2||
48281595|NCT04488770|101014138|FG008|COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
48281596|NCT04488770|101014139|FG009|COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
48281597|NCT04488770|101014140|FG010|COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
48281598|NCT04488770|101014141|FG011|COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
48281599|NCT04488770|101014142|FG012|COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
48281600|NCT04488770|101014130|FG000|NOT COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
48281601|NCT04488770|101014131|FG001|NOT COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
48281602|NCT04488770|101014132|FG002|NOT COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
48281603|NCT04488770|101014133|FG003|NOT COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
48281604|NCT04488770|101014134|FG004|NOT COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
48281605|NCT04488770|101014135|FG005|NOT COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
48120652|NCT04847050|100619662|FG004|STARTED|Booster Phase||0||
48120653|NCT04847050|100619663|FG005|STARTED|Booster Phase||0||
48120654|NCT04847050|100619664|FG006|STARTED|Booster Phase||0||
48120655|NCT04847050|100619665|FG007|STARTED|Booster Phase||2||
48120656|NCT04847050|100619666|FG008|STARTED|Booster Phase||1||
48281606|NCT04488770|101014136|FG006|NOT COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
48281607|NCT04488770|101014137|FG007|NOT COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
48281608|NCT04488770|101014138|FG008|NOT COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
48281609|NCT04488770|101014139|FG009|NOT COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
48281610|NCT04488770|101014140|FG010|NOT COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
48281611|NCT04488770|101014141|FG011|NOT COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
48281612|NCT04488770|101014142|FG012|NOT COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
48281613|NCT04488770|101014130|FG000|STARTED|Part 2 (Up to 26 Days)||0||
48281614|NCT04488770|101014131|FG001|STARTED|Part 2 (Up to 26 Days)||0||
48281615|NCT04488770|101014132|FG002|STARTED|Part 2 (Up to 26 Days)||0||
48281616|NCT04488770|101014133|FG003|STARTED|Part 2 (Up to 26 Days)||0||
48281617|NCT04488770|101014134|FG004|STARTED|Part 2 (Up to 26 Days)||0||
48281618|NCT04488770|101014135|FG005|STARTED|Part 2 (Up to 26 Days)||0||
48281619|NCT04488770|101014136|FG006|STARTED|Part 2 (Up to 26 Days)||0||
48281620|NCT04488770|101014137|FG007|STARTED|Part 2 (Up to 26 Days)||0||
48281621|NCT04488770|101014138|FG008|STARTED|Part 2 (Up to 26 Days)||8||
48281622|NCT04488770|101014139|FG009|STARTED|Part 2 (Up to 26 Days)||8||
48396420|NCT03235726|101299365|FG007|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0||
48396421|NCT03235726|101299366|FG008|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0||
48396422|NCT03235726|101299367|FG009|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0||
48396423|NCT03235726|101299358|FG000|STARTED|Part 2 (Cohort A - Day 1)||0||
48396424|NCT03235726|101299359|FG001|STARTED|Part 2 (Cohort A - Day 1)||0||
48396425|NCT03235726|101299360|FG002|STARTED|Part 2 (Cohort A - Day 1)||0||
48396426|NCT03235726|101299361|FG003|STARTED|Part 2 (Cohort A - Day 1)||0||
48699418|NCT00501592|102050509|FG000|COMPLETED|Overall Study||20||
48120657|NCT04847050|100619667|FG009|STARTED|Booster Phase||10||
48120658|NCT04847050|100619668|FG010|STARTED|Booster Phase||0||
48120659|NCT04847050|100619658|FG000|Number of Participants Who Crossed Over From Hematologic Low Immunosuppression -Initial Phase (Ph)|Booster Phase||0||
48120660|NCT04847050|100619659|FG001|Number of Participants Who Crossed Over From Hematologic Low Immunosuppression -Initial Phase (Ph)|Booster Phase||0||
48120661|NCT04847050|100619660|FG002|Number of Participants Who Crossed Over From Hematologic Low Immunosuppression -Initial Phase (Ph)|Booster Phase||0||
48120662|NCT04847050|100619661|FG003|Number of Participants Who Crossed Over From Hematologic Low Immunosuppression -Initial Phase (Ph)|Booster Phase||0||
48120663|NCT04847050|100619662|FG004|Number of Participants Who Crossed Over From Hematologic Low Immunosuppression -Initial Phase (Ph)|Booster Phase||0||
48120664|NCT04847050|100619663|FG005|Number of Participants Who Crossed Over From Hematologic Low Immunosuppression -Initial Phase (Ph)|Booster Phase||0||
48281623|NCT04488770|101014140|FG010|STARTED|Part 2 (Up to 26 Days)||8||
48396427|NCT03235726|101299362|FG004|STARTED|Part 2 (Cohort A - Day 1)||0||
48396428|NCT03235726|101299363|FG005|STARTED|Part 2 (Cohort A - Day 1)||0||
48396429|NCT03235726|101299364|FG006|STARTED|Part 2 (Cohort A - Day 1)||0||
48396430|NCT03235726|101299365|FG007|STARTED|Part 2 (Cohort A - Day 1)||6||
48396431|NCT03235726|101299366|FG008|STARTED|Part 2 (Cohort A - Day 1)||2||
48396432|NCT03235726|101299367|FG009|STARTED|Part 2 (Cohort A - Day 1)||0||
48396433|NCT03235726|101299358|FG000|COMPLETED|Part 2 (Cohort A - Day 1)||0||
48396434|NCT03235726|101299359|FG001|COMPLETED|Part 2 (Cohort A - Day 1)||0||
48396435|NCT03235726|101299360|FG002|COMPLETED|Part 2 (Cohort A - Day 1)||0||
48120665|NCT04847050|100619664|FG006|Number of Participants Who Crossed Over From Hematologic Low Immunosuppression -Initial Phase (Ph)|Booster Phase||0||
48120666|NCT04847050|100619665|FG007|Number of Participants Who Crossed Over From Hematologic Low Immunosuppression -Initial Phase (Ph)|Booster Phase||0||
48120667|NCT04847050|100619666|FG008|Number of Participants Who Crossed Over From Hematologic Low Immunosuppression -Initial Phase (Ph)|Booster Phase||0||
48141434|NCT01780922|100670427|FG004|COMPLETED|First Intervention (1 Day)||2||
48281624|NCT04488770|101014141|FG011|STARTED|Part 2 (Up to 26 Days)||8||
48396436|NCT03235726|101299361|FG003|COMPLETED|Part 2 (Cohort A - Day 1)||0||
48699419|NCT00501592|102050510|FG001|COMPLETED|Overall Study||16||
48396437|NCT03235726|101299362|FG004|COMPLETED|Part 2 (Cohort A - Day 1)||0||
48396438|NCT03235726|101299363|FG005|COMPLETED|Part 2 (Cohort A - Day 1)||0||
48396439|NCT03235726|101299364|FG006|COMPLETED|Part 2 (Cohort A - Day 1)||0||
48396440|NCT03235726|101299365|FG007|COMPLETED|Part 2 (Cohort A - Day 1)||6||
48396441|NCT03235726|101299366|FG008|COMPLETED|Part 2 (Cohort A - Day 1)||2||
48396442|NCT03235726|101299367|FG009|COMPLETED|Part 2 (Cohort A - Day 1)||0||
48396443|NCT03235726|101299358|FG000|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0||
48396444|NCT03235726|101299359|FG001|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0||
48396445|NCT03235726|101299360|FG002|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0||
48396446|NCT03235726|101299361|FG003|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0||
48396447|NCT03235726|101299362|FG004|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0||
48396448|NCT03235726|101299363|FG005|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0||
48396449|NCT03235726|101299364|FG006|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0||
48396450|NCT03235726|101299365|FG007|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0||
48396451|NCT03235726|101299366|FG008|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0||
48396452|NCT03235726|101299367|FG009|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0||
48396453|NCT03235726|101299358|FG000|STARTED|Part 2 (Cohort B - Days 1 to 14)||0||
48396454|NCT03235726|101299359|FG001|STARTED|Part 2 (Cohort B - Days 1 to 14)||0||
48396455|NCT03235726|101299360|FG002|STARTED|Part 2 (Cohort B - Days 1 to 14)||0||
48396456|NCT03235726|101299361|FG003|STARTED|Part 2 (Cohort B - Days 1 to 14)||0||
48396457|NCT03235726|101299362|FG004|STARTED|Part 2 (Cohort B - Days 1 to 14)||0||
48396458|NCT03235726|101299363|FG005|STARTED|Part 2 (Cohort B - Days 1 to 14)||0||
48396459|NCT03235726|101299364|FG006|STARTED|Part 2 (Cohort B - Days 1 to 14)||0||
48396460|NCT03235726|101299365|FG007|STARTED|Part 2 (Cohort B - Days 1 to 14)||0||
48396461|NCT03235726|101299366|FG008|STARTED|Part 2 (Cohort B - Days 1 to 14)||0||
48396462|NCT03235726|101299367|FG009|STARTED|Part 2 (Cohort B - Days 1 to 14)||8||
48396463|NCT03235726|101299358|FG000|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
48396464|NCT03235726|101299359|FG001|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
48396465|NCT03235726|101299360|FG002|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
48396466|NCT03235726|101299361|FG003|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
48396467|NCT03235726|101299362|FG004|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
48569136|NCT02962492|101724717|FG001|COMPLETED|Overall Study||15||
48569137|NCT02962492|101724718|FG002|COMPLETED|Overall Study||11||
48569138|NCT02962492|101724719|FG003|COMPLETED|Overall Study||21||
48569139|NCT02962492|101724716|FG000|NOT COMPLETED|Overall Study||2||
48569140|NCT02962492|101724717|FG001|NOT COMPLETED|Overall Study||2||
48569141|NCT02962492|101724718|FG002|NOT COMPLETED|Overall Study||2||
48569142|NCT02962492|101724719|FG003|NOT COMPLETED|Overall Study||2||
48569143|NCT02954601|101724720|FG000|STARTED|First Intervention (Five Days)||11||
48569144|NCT02954601|101724721|FG001|STARTED|First Intervention (Five Days)||6||
48396468|NCT03235726|101299363|FG005|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
48396469|NCT03235726|101299364|FG006|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
48396470|NCT03235726|101299365|FG007|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
48396471|NCT03235726|101299366|FG008|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
48569145|NCT02954601|101724722|FG002|STARTED|First Intervention (Five Days)||8||
48569146|NCT02954601|101724723|FG003|STARTED|First Intervention (Five Days)||7||
48569147|NCT02954601|101724720|FG000|COMPLETED|First Intervention (Five Days)||11||
48569148|NCT02954601|101724721|FG001|COMPLETED|First Intervention (Five Days)||6||
48569149|NCT02954601|101724722|FG002|COMPLETED|First Intervention (Five Days)||7||
48569150|NCT02954601|101724723|FG003|COMPLETED|First Intervention (Five Days)||7||
48569151|NCT02954601|101724720|FG000|NOT COMPLETED|First Intervention (Five Days)||0||
48569152|NCT02954601|101724721|FG001|NOT COMPLETED|First Intervention (Five Days)||0||
48569153|NCT02954601|101724722|FG002|NOT COMPLETED|First Intervention (Five Days)||1||
48569154|NCT02954601|101724723|FG003|NOT COMPLETED|First Intervention (Five Days)||0||
48569155|NCT02954601|101724720|FG000|STARTED|Second Intervention (Five Days)||11||
48396472|NCT03235726|101299367|FG009|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||8||
48396473|NCT03235726|101299358|FG000|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
48396474|NCT03235726|101299359|FG001|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
48396475|NCT03235726|101299360|FG002|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
48396476|NCT03235726|101299361|FG003|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
48396477|NCT03235726|101299362|FG004|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
48396478|NCT03235726|101299363|FG005|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
48396479|NCT03235726|101299364|FG006|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
48396480|NCT03235726|101299365|FG007|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
48396481|NCT03235726|101299366|FG008|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
48569156|NCT02954601|101724721|FG001|STARTED|Second Intervention (Five Days)||6||
48569157|NCT02954601|101724722|FG002|STARTED|Second Intervention (Five Days)||8||
48569158|NCT02954601|101724723|FG003|STARTED|Second Intervention (Five Days)||6||
48281625|NCT04488770|101014142|FG012|STARTED|Part 2 (Up to 26 Days)||8||
48396482|NCT03235726|101299367|FG009|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
48396483|NCT01455415|101299368|FG000|STARTED|Period 1||154||
48396484|NCT01455415|101299369|FG001|STARTED|Period 1||147||
48396485|NCT01455415|101299368|FG000|COMPLETED|Period 1||135||
48396486|NCT01455415|101299369|FG001|COMPLETED|Period 1||123||
48396487|NCT01455415|101299368|FG000|NOT COMPLETED|Period 1||19||
48396488|NCT01455415|101299369|FG001|NOT COMPLETED|Period 1||24||
48396489|NCT01455415|101299368|FG000|STARTED|Washout||135||
48699420|NCT00501592|102050511|FG002|COMPLETED|Overall Study||20||
48699421|NCT00501592|102050509|FG000|NOT COMPLETED|Overall Study||0||
48699422|NCT00501592|102050510|FG001|NOT COMPLETED|Overall Study||5||
48699423|NCT00501592|102050511|FG002|NOT COMPLETED|Overall Study||3||
48699424|NCT00801723|102050512|FG000|STARTED|Overall Study||61||
48699425|NCT00801723|102050513|FG001|STARTED|Overall Study||62||
48699426|NCT00801723|102050512|FG000|COMPLETED|Overall Study||25||
48699427|NCT00801723|102050513|FG001|COMPLETED|Overall Study||27||
48699428|NCT00801723|102050512|FG000|NOT COMPLETED|Overall Study||36||
48699429|NCT00801723|102050513|FG001|NOT COMPLETED|Overall Study||35||
48281626|NCT04488770|101014130|FG000|COMPLETED|Part 2 (Up to 26 Days)||0||
48281627|NCT04488770|101014131|FG001|COMPLETED|Part 2 (Up to 26 Days)||0||
48281628|NCT04488770|101014132|FG002|COMPLETED|Part 2 (Up to 26 Days)||0||
48281629|NCT04488770|101014133|FG003|COMPLETED|Part 2 (Up to 26 Days)||0||
48281630|NCT04488770|101014134|FG004|COMPLETED|Part 2 (Up to 26 Days)||0||
48281631|NCT04488770|101014135|FG005|COMPLETED|Part 2 (Up to 26 Days)||0||
48281632|NCT04488770|101014136|FG006|COMPLETED|Part 2 (Up to 26 Days)||0||
48281633|NCT04488770|101014137|FG007|COMPLETED|Part 2 (Up to 26 Days)||0||
48281634|NCT04488770|101014138|FG008|COMPLETED|Part 2 (Up to 26 Days)||8||
48281635|NCT04488770|101014139|FG009|COMPLETED|Part 2 (Up to 26 Days)||8||
48281636|NCT04488770|101014140|FG010|COMPLETED|Part 2 (Up to 26 Days)||8||
48281637|NCT04488770|101014141|FG011|COMPLETED|Part 2 (Up to 26 Days)||8||
48281638|NCT04488770|101014142|FG012|COMPLETED|Part 2 (Up to 26 Days)||8||
48281639|NCT04488770|101014130|FG000|NOT COMPLETED|Part 2 (Up to 26 Days)||0||
48281640|NCT04488770|101014131|FG001|NOT COMPLETED|Part 2 (Up to 26 Days)||0||
48281641|NCT04488770|101014132|FG002|NOT COMPLETED|Part 2 (Up to 26 Days)||0||
48281642|NCT04488770|101014133|FG003|NOT COMPLETED|Part 2 (Up to 26 Days)||0||
48281643|NCT04488770|101014134|FG004|NOT COMPLETED|Part 2 (Up to 26 Days)||0||
48281644|NCT04488770|101014135|FG005|NOT COMPLETED|Part 2 (Up to 26 Days)||0||
48281645|NCT04488770|101014136|FG006|NOT COMPLETED|Part 2 (Up to 26 Days)||0||
48281646|NCT04488770|101014137|FG007|NOT COMPLETED|Part 2 (Up to 26 Days)||0||
48699430|NCT03172325|102050514|FG000|STARTED|Overall Study||68||
48699431|NCT03172325|102050515|FG001|STARTED|Overall Study||68||
48699432|NCT03172325|102050514|FG000|COMPLETED|Overall Study||64||
48699433|NCT03172325|102050515|FG001|COMPLETED|Overall Study||64||
48699434|NCT03172325|102050514|FG000|NOT COMPLETED|Overall Study||4||
48281647|NCT04488770|101014138|FG008|NOT COMPLETED|Part 2 (Up to 26 Days)||0||
48281648|NCT04488770|101014139|FG009|NOT COMPLETED|Part 2 (Up to 26 Days)||0||
48281649|NCT04488770|101014140|FG010|NOT COMPLETED|Part 2 (Up to 26 Days)||0||
48396490|NCT01455415|101299369|FG001|STARTED|Washout||123||
48396491|NCT01455415|101299368|FG000|COMPLETED|Washout||127||
48396492|NCT01455415|101299369|FG001|COMPLETED|Washout||116||
48396493|NCT01455415|101299368|FG000|NOT COMPLETED|Washout||8||
48396494|NCT01455415|101299369|FG001|NOT COMPLETED|Washout||7||
48396495|NCT01455415|101299368|FG000|STARTED|Period 2||127||
48396496|NCT01455415|101299369|FG001|STARTED|Period 2||116||
48396497|NCT01455415|101299368|FG000|COMPLETED|Period 2||114||
48396498|NCT01455415|101299369|FG001|COMPLETED|Period 2||106||
48396499|NCT01455415|101299368|FG000|NOT COMPLETED|Period 2||13||
48396500|NCT01455415|101299369|FG001|NOT COMPLETED|Period 2||10||
48396501|NCT01455415|101299368|FG000|STARTED|Follow-up||114||
48396502|NCT01455415|101299369|FG001|STARTED|Follow-up||106||
48396503|NCT01455415|101299368|FG000|COMPLETED|Follow-up||111||
48396504|NCT01455415|101299369|FG001|COMPLETED|Follow-up||104||
48281650|NCT04488770|101014141|FG011|NOT COMPLETED|Part 2 (Up to 26 Days)||0||
48396505|NCT01455415|101299368|FG000|NOT COMPLETED|Follow-up||3||
48396506|NCT01455415|101299369|FG001|NOT COMPLETED|Follow-up||2||
48396507|NCT03532776|101299370|FG000|STARTED|Overall Study||201||
48396508|NCT03532776|101299371|FG001|STARTED|Overall Study||198||
48396509|NCT03532776|101299372|FG002|STARTED|Overall Study||67||
48396510|NCT03532776|101299370|FG000|COMPLETED|Overall Study||196||
48396511|NCT03532776|101299371|FG001|COMPLETED|Overall Study||194||
48396512|NCT03532776|101299372|FG002|COMPLETED|Overall Study||63||
48396513|NCT03532776|101299370|FG000|NOT COMPLETED|Overall Study||5||
48396514|NCT03532776|101299371|FG001|NOT COMPLETED|Overall Study||4||
48396515|NCT03532776|101299372|FG002|NOT COMPLETED|Overall Study||4||
48396516|NCT02354092|101299373|FG000|STARTED|Overall Study||7||
48396517|NCT02354092|101299374|FG001|STARTED|Overall Study||7||
48699435|NCT03172325|102050515|FG001|NOT COMPLETED|Overall Study||4||
48699436|NCT01311115|102050516|FG000|STARTED|Overall Study||132||
48699437|NCT01311115|102050517|FG001|STARTED|Overall Study||69||
48699438|NCT01311115|102050516|FG000|COMPLETED|Overall Study||132||
48699439|NCT01311115|102050517|FG001|COMPLETED|Overall Study||69||
48699440|NCT01311115|102050516|FG000|NOT COMPLETED|Overall Study||0||
48699441|NCT01311115|102050517|FG001|NOT COMPLETED|Overall Study||0||
48699442|NCT02058511|102050518|FG000|STARTED|Overall Study||24||
48699443|NCT02058511|102050518|FG000|COMPLETED|Overall Study||24||
48699444|NCT02058511|102050518|FG000|NOT COMPLETED|Overall Study||0||
48699445|NCT00835198|102050519|FG000|STARTED|Overall Study||82||
48699446|NCT00835198|102050520|FG001|STARTED|Overall Study||81||
48699447|NCT00835198|102050519|FG000|COMPLETED|Overall Study||74||
48699448|NCT00835198|102050520|FG001|COMPLETED|Overall Study||74||
48699449|NCT00835198|102050519|FG000|NOT COMPLETED|Overall Study||8||
48699450|NCT00835198|102050520|FG001|NOT COMPLETED|Overall Study||7||
48699451|NCT00152477|102050521|FG000|STARTED|Chemotherapy Period||50||
48699452|NCT00152477|102050522|FG001|STARTED|Chemotherapy Period||56||
48699453|NCT00152477|102050523|FG002|STARTED|Chemotherapy Period||59||
48699454|NCT00152477|102050521|FG000|Part II|Chemotherapy Period||50||
48699455|NCT00152477|102050522|FG001|Part II|Chemotherapy Period||53||
48699456|NCT00152477|102050523|FG002|Part II|Chemotherapy Period||53||
48699457|NCT00152477|102050521|FG000|COMPLETED|Chemotherapy Period||22||
48699458|NCT00152477|102050522|FG001|COMPLETED|Chemotherapy Period||34||
48699459|NCT00152477|102050523|FG002|COMPLETED|Chemotherapy Period||39||
48699460|NCT00152477|102050521|FG000|NOT COMPLETED|Chemotherapy Period||28||
48699461|NCT00152477|102050522|FG001|NOT COMPLETED|Chemotherapy Period||22||
48699462|NCT00152477|102050523|FG002|NOT COMPLETED|Chemotherapy Period||20||
48699463|NCT00152477|102050521|FG000|STARTED|Monotherapy Period||15||
48699464|NCT00152477|102050522|FG001|STARTED|Monotherapy Period||29||
48699465|NCT00152477|102050523|FG002|STARTED|Monotherapy Period||34||
48699466|NCT00152477|102050521|FG000|Part II|Monotherapy Period||13||
48699467|NCT00152477|102050522|FG001|Part II|Monotherapy Period||26||
48699468|NCT00152477|102050523|FG002|Part II|Monotherapy Period||29||
48699469|NCT00152477|102050521|FG000|COMPLETED|Monotherapy Period||0||
48699470|NCT00152477|102050522|FG001|COMPLETED|Monotherapy Period||0||
48699471|NCT00152477|102050523|FG002|COMPLETED|Monotherapy Period||0||
48699472|NCT00152477|102050521|FG000|NOT COMPLETED|Monotherapy Period||15||
48699473|NCT00152477|102050522|FG001|NOT COMPLETED|Monotherapy Period||29||
48699474|NCT00152477|102050523|FG002|NOT COMPLETED|Monotherapy Period||34||
48699475|NCT03397394|102050524|FG000|STARTED|Overall Study||47||
48699476|NCT03397394|102050525|FG001|STARTED|Overall Study||30||
48699477|NCT03397394|102050526|FG002|STARTED|Overall Study||20||
48699478|NCT03397394|102050524|FG000|COMPLETED|Overall Study||47||
48699479|NCT03397394|102050525|FG001|COMPLETED|Overall Study||30||
48699480|NCT03397394|102050526|FG002|COMPLETED|Overall Study||20||
48699481|NCT03397394|102050524|FG000|NOT COMPLETED|Overall Study||0||
48699482|NCT03397394|102050525|FG001|NOT COMPLETED|Overall Study||0||
48699483|NCT03397394|102050526|FG002|NOT COMPLETED|Overall Study||0||
48699484|NCT01271712|102050527|FG000|STARTED|Double Blind Treatment||133||
48699485|NCT01271712|102050528|FG001|STARTED|Double Blind Treatment||66||
48699486|NCT01271712|102050527|FG000|Participants Received Treatment|Double Blind Treatment||132||
48699487|NCT01271712|102050528|FG001|Participants Received Treatment|Double Blind Treatment||66||
48699488|NCT01271712|102050527|FG000|COMPLETED|Double Blind Treatment||91||
48699489|NCT01271712|102050528|FG001|COMPLETED|Double Blind Treatment||58||
48699490|NCT01271712|102050527|FG000|NOT COMPLETED|Double Blind Treatment||42||
48699491|NCT01271712|102050528|FG001|NOT COMPLETED|Double Blind Treatment||8||
48120668|NCT04847050|100619667|FG009|Number of Participants Who Crossed Over From Hematologic Low Immunosuppression -Initial Phase (Ph)|Booster Phase||1||
48120669|NCT04847050|100619668|FG010|Number of Participants Who Crossed Over From Hematologic Low Immunosuppression -Initial Phase (Ph)|Booster Phase||0||
48120670|NCT04847050|100619658|FG000|Number of Participants Who Crossed Over From Hematologic Intermediate Immunosuppression Initial Ph.|Booster Phase||0||
48120671|NCT04847050|100619659|FG001|Number of Participants Who Crossed Over From Hematologic Intermediate Immunosuppression Initial Ph.|Booster Phase||0||
48120672|NCT04847050|100619660|FG002|Number of Participants Who Crossed Over From Hematologic Intermediate Immunosuppression Initial Ph.|Booster Phase||0||
48120673|NCT04847050|100619661|FG003|Number of Participants Who Crossed Over From Hematologic Intermediate Immunosuppression Initial Ph.|Booster Phase||0||
48281651|NCT04488770|101014142|FG012|NOT COMPLETED|Part 2 (Up to 26 Days)||0||
48699492|NCT01271712|102050527|FG000|STARTED|Open Label Treatment||91||
48699493|NCT01271712|102050528|FG001|STARTED|Open Label Treatment||58||
48699494|NCT01271712|102050527|FG000|COMPLETED|Open Label Treatment||0||
48699495|NCT01271712|102050528|FG001|COMPLETED|Open Label Treatment||0||
48699496|NCT01271712|102050527|FG000|NOT COMPLETED|Open Label Treatment||91||
48699497|NCT01271712|102050528|FG001|NOT COMPLETED|Open Label Treatment||58||
48699498|NCT01271712|102050527|FG000|STARTED|Safety Follow-up||118||
48699499|NCT01271712|102050528|FG001|STARTED|Safety Follow-up||52||
48699500|NCT01271712|102050527|FG000|COMPLETED|Safety Follow-up||97||
48699501|NCT01271712|102050528|FG001|COMPLETED|Safety Follow-up||37||
48699502|NCT01271712|102050527|FG000|NOT COMPLETED|Safety Follow-up||21||
48699503|NCT01271712|102050528|FG001|NOT COMPLETED|Safety Follow-up||15||
48699504|NCT01271712|102050527|FG000|STARTED|Survival Follow-up||100||
48699505|NCT01271712|102050528|FG001|STARTED|Survival Follow-up||39||
48699506|NCT01271712|102050527|FG000|COMPLETED|Survival Follow-up||85||
48699507|NCT01271712|102050528|FG001|COMPLETED|Survival Follow-up||33||
48699508|NCT01271712|102050527|FG000|NOT COMPLETED|Survival Follow-up||15||
48699509|NCT01271712|102050528|FG001|NOT COMPLETED|Survival Follow-up||6||
48699510|NCT01114971|102050529|FG000|STARTED|Overall Study||25||
48699511|NCT01114971|102050530|FG001|STARTED|Overall Study||25||
48699512|NCT01114971|102050531|FG002|STARTED|Overall Study||25||
48699513|NCT01114971|102050529|FG000|COMPLETED|Overall Study||25||
48699514|NCT01114971|102050530|FG001|COMPLETED|Overall Study||25||
48699515|NCT01114971|102050531|FG002|COMPLETED|Overall Study||25||
48699516|NCT01114971|102050529|FG000|NOT COMPLETED|Overall Study||0||
48699517|NCT01114971|102050530|FG001|NOT COMPLETED|Overall Study||0||
48699518|NCT01114971|102050531|FG002|NOT COMPLETED|Overall Study||0||
48699519|NCT03374683|102050532|FG000|STARTED|Overall Study||148||
48699520|NCT03374683|102050533|FG001|STARTED|Overall Study||150||
48699521|NCT03374683|102050534|FG002|STARTED|Overall Study||153||
48699522|NCT03374683|102050532|FG000|1-week Post-intervention|Overall Study||135||
48699523|NCT03374683|102050533|FG001|1-week Post-intervention|Overall Study||113||
48699524|NCT03374683|102050534|FG002|1-week Post-intervention|Overall Study||85||
48699525|NCT03374683|102050532|FG000|COMPLETED|Overall Study||123||
48281652|NCT00128102|101014143|FG000|STARTED|Overall Study||329||
48281653|NCT00128102|101014144|FG001|STARTED|Overall Study||332||
48699526|NCT03374683|102050533|FG001|COMPLETED|Overall Study||105||
48699527|NCT03374683|102050534|FG002|COMPLETED|Overall Study||84||
48699528|NCT03374683|102050532|FG000|NOT COMPLETED|Overall Study||25||
48699529|NCT03374683|102050533|FG001|NOT COMPLETED|Overall Study||45||
48396518|NCT02354092|101299373|FG000|COMPLETED|Overall Study||7||
48396519|NCT02354092|101299374|FG001|COMPLETED|Overall Study||7||
48396520|NCT02354092|101299373|FG000|NOT COMPLETED|Overall Study||0||
48396521|NCT02354092|101299374|FG001|NOT COMPLETED|Overall Study||0||
48396522|NCT00358501|101299375|FG000|STARTED|Overall Study||102||
48569159|NCT02954601|101724720|FG000|COMPLETED|Second Intervention (Five Days)||11||
48569160|NCT02954601|101724721|FG001|COMPLETED|Second Intervention (Five Days)||6||
48569161|NCT02954601|101724722|FG002|COMPLETED|Second Intervention (Five Days)||8||
48569162|NCT02954601|101724723|FG003|COMPLETED|Second Intervention (Five Days)||6||
48569163|NCT02954601|101724720|FG000|NOT COMPLETED|Second Intervention (Five Days)||0||
48569164|NCT02954601|101724721|FG001|NOT COMPLETED|Second Intervention (Five Days)||0||
48569165|NCT02954601|101724722|FG002|NOT COMPLETED|Second Intervention (Five Days)||0||
48569166|NCT02954601|101724723|FG003|NOT COMPLETED|Second Intervention (Five Days)||0||
48569167|NCT02954601|101724720|FG000|STARTED|Third Intervention (Five Days)||9||
48569168|NCT02954601|101724721|FG001|STARTED|Third Intervention (Five Days)||8||
48569169|NCT02954601|101724722|FG002|STARTED|Third Intervention (Five Days)||6||
48569170|NCT02954601|101724723|FG003|STARTED|Third Intervention (Five Days)||8||
48569171|NCT02954601|101724720|FG000|COMPLETED|Third Intervention (Five Days)||9||
48569172|NCT02954601|101724721|FG001|COMPLETED|Third Intervention (Five Days)||8||
48569173|NCT02954601|101724722|FG002|COMPLETED|Third Intervention (Five Days)||6||
48569174|NCT02954601|101724723|FG003|COMPLETED|Third Intervention (Five Days)||8||
48569175|NCT02954601|101724720|FG000|NOT COMPLETED|Third Intervention (Five Days)||0||
48569176|NCT02954601|101724721|FG001|NOT COMPLETED|Third Intervention (Five Days)||0||
48569177|NCT02954601|101724722|FG002|NOT COMPLETED|Third Intervention (Five Days)||0||
48569178|NCT02954601|101724723|FG003|NOT COMPLETED|Third Intervention (Five Days)||0||
48569179|NCT01209520|101724724|FG000|STARTED|Overall Study||6||
48569180|NCT01209520|101724724|FG000|COMPLETED|Overall Study||3||
48569181|NCT01209520|101724724|FG000|NOT COMPLETED|Overall Study||3||
48569182|NCT04227197|101724725|FG000|STARTED|Randomization||117||
48569183|NCT04227197|101724726|FG001|STARTED|Randomization||113||
48569184|NCT04227197|101724725|FG000|COMPLETED|Randomization||115||
48396523|NCT00358501|101299376|FG001|STARTED|Overall Study||32||
48396524|NCT00358501|101299375|FG000|COMPLETED|Overall Study||102||
48396525|NCT00358501|101299376|FG001|COMPLETED|Overall Study||32||
48396526|NCT00358501|101299375|FG000|NOT COMPLETED|Overall Study||0||
48396527|NCT00358501|101299376|FG001|NOT COMPLETED|Overall Study||0||
48396528|NCT02097485|101299377|FG000|STARTED|Overall Study||25||
48396529|NCT02097485|101299378|FG001|STARTED|Overall Study||25||
48396530|NCT02097485|101299377|FG000|COMPLETED|Overall Study||25||
48396531|NCT02097485|101299378|FG001|COMPLETED|Overall Study||25||
48396532|NCT02097485|101299377|FG000|NOT COMPLETED|Overall Study||0||
48396533|NCT02097485|101299378|FG001|NOT COMPLETED|Overall Study||0||
48396534|NCT00132314|101299379|FG000|STARTED|Overall Study||190||
48396535|NCT00132314|101299380|FG001|STARTED|Overall Study||192||
48396536|NCT00132314|101299379|FG000|Received Treatment|Overall Study||188||
48396537|NCT00132314|101299380|FG001|Received Treatment|Overall Study||185||
48396538|NCT00132314|101299379|FG000|Completed Baseline Visit, Provided SSN|Overall Study||187||
48396539|NCT00132314|101299380|FG001|Completed Baseline Visit, Provided SSN|Overall Study||182||
48396540|NCT00132314|101299379|FG000|COMPLETED|Overall Study||117||
48396541|NCT00132314|101299380|FG001|COMPLETED|Overall Study||120||
48396542|NCT00132314|101299379|FG000|NOT COMPLETED|Overall Study||73||
48396543|NCT00132314|101299380|FG001|NOT COMPLETED|Overall Study||72||
48396544|NCT00961441|101299381|FG000|STARTED|Overall Study||12||
48396545|NCT00961441|101299382|FG001|STARTED|Overall Study||13||
48396546|NCT00961441|101299381|FG000|Pharmacokinetic (PK-PP) Population|Overall Study||12||
48396547|NCT00961441|101299382|FG001|Pharmacokinetic (PK-PP) Population|Overall Study||10||
48396548|NCT00961441|101299381|FG000|COMPLETED|Overall Study||12||
48396549|NCT00961441|101299382|FG001|COMPLETED|Overall Study||13||
48396550|NCT00961441|101299381|FG000|NOT COMPLETED|Overall Study||0||
48396551|NCT00961441|101299382|FG001|NOT COMPLETED|Overall Study||0||
48396552|NCT00861380|101299383|FG000|STARTED|Overall Study||8427||
48396553|NCT00861380|101299384|FG001|STARTED|Overall Study||9112||
48396554|NCT00861380|101299385|FG002|STARTED|Overall Study||8872||
48396555|NCT00861380|101299386|FG003|STARTED|Overall Study||3689||
48396556|NCT00861380|101299387|FG004|STARTED|Overall Study||1812||
48396557|NCT00861380|101299388|FG005|STARTED|Overall Study||6249||
48396558|NCT00861380|101299389|FG006|STARTED|Overall Study||3020||
48396559|NCT00861380|101299383|FG000|COMPLETED|Overall Study||0||
48396560|NCT00861380|101299384|FG001|COMPLETED|Overall Study||0||
48569185|NCT04227197|101724726|FG001|COMPLETED|Randomization||113||
48569186|NCT04227197|101724725|FG000|NOT COMPLETED|Randomization||2||
48569187|NCT04227197|101724726|FG001|NOT COMPLETED|Randomization||0||
48569188|NCT04227197|101724725|FG000|STARTED|Primary Care Provider (PCP) Visit||115||
48396561|NCT00861380|101299385|FG002|COMPLETED|Overall Study||0||
48396562|NCT00861380|101299386|FG003|COMPLETED|Overall Study||0||
48396563|NCT00861380|101299387|FG004|COMPLETED|Overall Study||0||
48569189|NCT04227197|101724726|FG001|STARTED|Primary Care Provider (PCP) Visit||113||
48569190|NCT04227197|101724725|FG000|COMPLETED|Primary Care Provider (PCP) Visit||113||
48569191|NCT04227197|101724726|FG001|COMPLETED|Primary Care Provider (PCP) Visit||113||
48396564|NCT00861380|101299388|FG005|COMPLETED|Overall Study||0||
48396565|NCT00861380|101299389|FG006|COMPLETED|Overall Study||0||
48569192|NCT04227197|101724725|FG000|NOT COMPLETED|Primary Care Provider (PCP) Visit||2||
48569193|NCT04227197|101724726|FG001|NOT COMPLETED|Primary Care Provider (PCP) Visit||0||
48569194|NCT04227197|101724725|FG000|STARTED|2-week Follow-up Survey for Caregivers||113||
48569195|NCT04227197|101724726|FG001|STARTED|2-week Follow-up Survey for Caregivers||113||
48569196|NCT04227197|101724725|FG000|COMPLETED|2-week Follow-up Survey for Caregivers||101||
48569197|NCT04227197|101724726|FG001|COMPLETED|2-week Follow-up Survey for Caregivers||108||
48569198|NCT04227197|101724725|FG000|NOT COMPLETED|2-week Follow-up Survey for Caregivers||12||
48396566|NCT00861380|101299383|FG000|NOT COMPLETED|Overall Study||8427||
48396567|NCT00861380|101299384|FG001|NOT COMPLETED|Overall Study||9112||
48396568|NCT00861380|101299385|FG002|NOT COMPLETED|Overall Study||8872||
48569199|NCT04227197|101724726|FG001|NOT COMPLETED|2-week Follow-up Survey for Caregivers||5||
48569200|NCT04227197|101724725|FG000|STARTED|2-week Follow-up Survey for PCP's||114||
48569201|NCT04227197|101724726|FG001|STARTED|2-week Follow-up Survey for PCP's||113||
48569202|NCT04227197|101724725|FG000|COMPLETED|2-week Follow-up Survey for PCP's||94||
48569203|NCT04227197|101724726|FG001|COMPLETED|2-week Follow-up Survey for PCP's||88||
48569204|NCT04227197|101724725|FG000|NOT COMPLETED|2-week Follow-up Survey for PCP's||20||
48569205|NCT04227197|101724726|FG001|NOT COMPLETED|2-week Follow-up Survey for PCP's||25||
48569206|NCT04227197|101724725|FG000|STARTED|7-month Follow-up Survey for Caregivers||114||
48569207|NCT04227197|101724726|FG001|STARTED|7-month Follow-up Survey for Caregivers||113||
48569208|NCT04227197|101724725|FG000|COMPLETED|7-month Follow-up Survey for Caregivers||103||
48569209|NCT04227197|101724726|FG001|COMPLETED|7-month Follow-up Survey for Caregivers||110||
48569210|NCT04227197|101724725|FG000|NOT COMPLETED|7-month Follow-up Survey for Caregivers||11||
48569211|NCT04227197|101724726|FG001|NOT COMPLETED|7-month Follow-up Survey for Caregivers||3||
48569212|NCT00470717|101724727|FG000|STARTED|Overall Study||38|Milestone is beginning enrollment|1976
48569213|NCT00470717|101724727|FG000|COMPLETED|Overall Study||38|End of calling attempts|813
48569214|NCT00470717|101724727|FG000|NOT COMPLETED|Overall Study||0||1163
48569215|NCT01073605|101724728|FG000|STARTED|Overall Study||68||
48569216|NCT01073605|101724729|FG001|STARTED|Overall Study||71||
48569217|NCT01073605|101724730|FG002|STARTED|Overall Study||69||
48569218|NCT01073605|101724728|FG000|Received Treatment|Overall Study||68||
48569219|NCT01073605|101724729|FG001|Received Treatment|Overall Study||70||
48569220|NCT01073605|101724730|FG002|Received Treatment|Overall Study||68||
48569221|NCT01073605|101724728|FG000|COMPLETED|Overall Study||6||
48569222|NCT01073605|101724729|FG001|COMPLETED|Overall Study||4||
48569223|NCT01073605|101724730|FG002|COMPLETED|Overall Study||8||
48569224|NCT01073605|101724728|FG000|NOT COMPLETED|Overall Study||62||
48569225|NCT01073605|101724729|FG001|NOT COMPLETED|Overall Study||67||
48569226|NCT01073605|101724730|FG002|NOT COMPLETED|Overall Study||61||
48569227|NCT01323387|101724731|FG000|STARTED|Overall Study||178||
48569228|NCT01323387|101724731|FG000|COMPLETED|Overall Study||94||
48569229|NCT01323387|101724731|FG000|NOT COMPLETED|Overall Study||84||
48569230|NCT00092118|101724732|FG000|STARTED|Overall Study||990||
48569231|NCT00092118|101724733|FG001|STARTED|Overall Study||1002||
48569232|NCT00092118|101724732|FG000|COMPLETED|Overall Study||906||
48569233|NCT00092118|101724733|FG001|COMPLETED|Overall Study||913||
48569234|NCT00092118|101724732|FG000|NOT COMPLETED|Overall Study||84||
48569235|NCT00092118|101724733|FG001|NOT COMPLETED|Overall Study||89||
48569236|NCT00321698|101724734|FG000|STARTED|Phase I, Rad Only & Dose 1-3||3||
48569237|NCT00321698|101724735|FG001|STARTED|Phase I, Rad Only & Dose 1-3||3||
48569238|NCT00321698|101724736|FG002|STARTED|Phase I, Rad Only & Dose 1-3||3||
48569239|NCT00321698|101724737|FG003|STARTED|Phase I, Rad Only & Dose 1-3||3||
48569240|NCT00321698|101724738|FG004|STARTED|Phase I, Rad Only & Dose 1-3||0||
48569241|NCT00321698|101724734|FG000|COMPLETED|Phase I, Rad Only & Dose 1-3||3||
48569242|NCT00321698|101724735|FG001|COMPLETED|Phase I, Rad Only & Dose 1-3||3||
48569243|NCT00321698|101724736|FG002|COMPLETED|Phase I, Rad Only & Dose 1-3||3||
48569244|NCT00321698|101724737|FG003|COMPLETED|Phase I, Rad Only & Dose 1-3||3||
48569245|NCT00321698|101724738|FG004|COMPLETED|Phase I, Rad Only & Dose 1-3||0||
48569246|NCT00321698|101724734|FG000|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0||
48699530|NCT03374683|102050534|FG002|NOT COMPLETED|Overall Study||69||
48120674|NCT04847050|100619662|FG004|Number of Participants Who Crossed Over From Hematologic Intermediate Immunosuppression Initial Ph.|Booster Phase||0||
48120675|NCT04847050|100619663|FG005|Number of Participants Who Crossed Over From Hematologic Intermediate Immunosuppression Initial Ph.|Booster Phase||0||
48120676|NCT04847050|100619664|FG006|Number of Participants Who Crossed Over From Hematologic Intermediate Immunosuppression Initial Ph.|Booster Phase||0||
48396569|NCT00861380|101299386|FG003|NOT COMPLETED|Overall Study||3689||
48569247|NCT00321698|101724735|FG001|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0||
48569248|NCT00321698|101724736|FG002|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0||
48569249|NCT00321698|101724737|FG003|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0||
48569250|NCT00321698|101724738|FG004|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0||
48569251|NCT00321698|101724734|FG000|STARTED|Phase II, MTD Dose||0||
48569252|NCT00321698|101724735|FG001|STARTED|Phase II, MTD Dose||0||
48569253|NCT00321698|101724736|FG002|STARTED|Phase II, MTD Dose||0||
48569254|NCT00321698|101724737|FG003|STARTED|Phase II, MTD Dose||0||
48569255|NCT00321698|101724738|FG004|STARTED|Phase II, MTD Dose||13||
48569256|NCT00321698|101724734|FG000|COMPLETED|Phase II, MTD Dose||0||
48699531|NCT04570605|102050535|FG000|STARTED|Overall Study||15||
48569257|NCT00321698|101724735|FG001|COMPLETED|Phase II, MTD Dose||0||
48569258|NCT00321698|101724736|FG002|COMPLETED|Phase II, MTD Dose||0||
48569259|NCT00321698|101724737|FG003|COMPLETED|Phase II, MTD Dose||0||
48569260|NCT00321698|101724738|FG004|COMPLETED|Phase II, MTD Dose||13||
48569261|NCT00321698|101724734|FG000|NOT COMPLETED|Phase II, MTD Dose||0||
48569262|NCT00321698|101724735|FG001|NOT COMPLETED|Phase II, MTD Dose||0||
48569263|NCT00321698|101724736|FG002|NOT COMPLETED|Phase II, MTD Dose||0||
48569264|NCT00321698|101724737|FG003|NOT COMPLETED|Phase II, MTD Dose||0||
48569265|NCT00321698|101724738|FG004|NOT COMPLETED|Phase II, MTD Dose||0||
48569266|NCT00683618|101724739|FG000|STARTED|Randomised Treatment Period||145||
48569267|NCT00683618|101724740|FG001|STARTED|Randomised Treatment Period||145||
48569268|NCT00683618|101724741|FG002|STARTED|Randomised Treatment Period||146||
48569269|NCT00683618|101724739|FG000|COMPLETED|Randomised Treatment Period||139||
48569270|NCT00683618|101724740|FG001|COMPLETED|Randomised Treatment Period||143||
48569271|NCT00683618|101724741|FG002|COMPLETED|Randomised Treatment Period||140||
48569272|NCT00683618|101724739|FG000|NOT COMPLETED|Randomised Treatment Period||6||
48569273|NCT00683618|101724740|FG001|NOT COMPLETED|Randomised Treatment Period||2||
48569274|NCT00683618|101724741|FG002|NOT COMPLETED|Randomised Treatment Period||6||
48569275|NCT00683618|101724739|FG000|STARTED|Extension Treatment Period||36||
48569276|NCT00683618|101724740|FG001|STARTED|Extension Treatment Period||23||
48569277|NCT00683618|101724741|FG002|STARTED|Extension Treatment Period||0||
48569278|NCT00683618|101724739|FG000|COMPLETED|Extension Treatment Period||33||
48569279|NCT00683618|101724740|FG001|COMPLETED|Extension Treatment Period||23||
48569280|NCT00683618|101724741|FG002|COMPLETED|Extension Treatment Period||0||
48569281|NCT00683618|101724739|FG000|NOT COMPLETED|Extension Treatment Period||3||
48569282|NCT00683618|101724740|FG001|NOT COMPLETED|Extension Treatment Period||0||
48569283|NCT00683618|101724741|FG002|NOT COMPLETED|Extension Treatment Period||0||
48569284|NCT00425750|101724742|FG000|STARTED|Overall Study||25||
48569285|NCT00425750|101724742|FG000|COMPLETED|Overall Study||0||
48569286|NCT00425750|101724742|FG000|NOT COMPLETED|Overall Study||25||
48569287|NCT00961571|101724743|FG000|STARTED|Overall Study||50||
48569288|NCT00961571|101724743|FG000|COMPLETED|Overall Study||11||
48569289|NCT00961571|101724743|FG000|NOT COMPLETED|Overall Study||39||
48569290|NCT00670358|101724744|FG000|STARTED|Overall Study||3||
48569291|NCT00670358|101724745|FG001|STARTED|Overall Study||3||
48569292|NCT00670358|101724746|FG002|STARTED|Overall Study||6||
48569293|NCT00670358|101724747|FG003|STARTED|Overall Study||77||
48569294|NCT00670358|101724748|FG004|STARTED|Overall Study||39||
48569295|NCT00670358|101724749|FG005|STARTED|Overall Study||10||
48569296|NCT00670358|101724744|FG000|COMPLETED|Overall Study||3||
48569297|NCT00670358|101724745|FG001|COMPLETED|Overall Study||3||
48569298|NCT00670358|101724746|FG002|COMPLETED|Overall Study||5||
48281654|NCT00128102|101014143|FG000|Treated|Overall Study||329||
48281655|NCT00128102|101014144|FG001|Treated|Overall Study||329||
48281656|NCT00128102|101014143|FG000|COMPLETED|Overall Study||1||
48281657|NCT00128102|101014144|FG001|COMPLETED|Overall Study||0||
48281658|NCT00128102|101014143|FG000|NOT COMPLETED|Overall Study||328||
48281659|NCT00128102|101014144|FG001|NOT COMPLETED|Overall Study||332||
48281660|NCT01808326|101014145|FG000|STARTED|Overall Study||5||
48569299|NCT00670358|101724747|FG003|COMPLETED|Overall Study||59||
48569300|NCT00670358|101724748|FG004|COMPLETED|Overall Study||33||
48569301|NCT00670358|101724749|FG005|COMPLETED|Overall Study||0||
48569302|NCT00670358|101724744|FG000|NOT COMPLETED|Overall Study||0||
48569303|NCT00670358|101724745|FG001|NOT COMPLETED|Overall Study||0||
48569304|NCT00670358|101724746|FG002|NOT COMPLETED|Overall Study||1||
48569305|NCT00670358|101724747|FG003|NOT COMPLETED|Overall Study||18||
48569306|NCT00670358|101724748|FG004|NOT COMPLETED|Overall Study||6||
48569307|NCT00670358|101724749|FG005|NOT COMPLETED|Overall Study||10||
48569308|NCT03225105|101724750|FG000|STARTED|Overall Study||3||
48569309|NCT03225105|101724751|FG001|STARTED|Overall Study||4||
48569310|NCT03225105|101724752|FG002|STARTED|Overall Study||5||
48569311|NCT03225105|101724753|FG003|STARTED|Overall Study||3||
48569312|NCT03225105|101724750|FG000|COMPLETED|Overall Study||0||
48569313|NCT03225105|101724751|FG001|COMPLETED|Overall Study||0||
48569314|NCT03225105|101724752|FG002|COMPLETED|Overall Study||0||
48569315|NCT03225105|101724753|FG003|COMPLETED|Overall Study||0||
48569316|NCT03225105|101724750|FG000|NOT COMPLETED|Overall Study||3||
48569317|NCT03225105|101724751|FG001|NOT COMPLETED|Overall Study||4||
48569318|NCT03225105|101724752|FG002|NOT COMPLETED|Overall Study||5||
48569319|NCT03225105|101724753|FG003|NOT COMPLETED|Overall Study||3||
48281661|NCT01808326|101014145|FG000|COMPLETED|Overall Study||5||
48281662|NCT01808326|101014145|FG000|NOT COMPLETED|Overall Study||0||
48569320|NCT01735916|101724754|FG000|STARTED|Overall Study||18||
48569321|NCT01735916|101724755|FG001|STARTED|Overall Study||19||
48569322|NCT01735916|101724756|FG002|STARTED|Overall Study||7||
48569323|NCT01735916|101724754|FG000|COMPLETED|Overall Study||0||
48569324|NCT01735916|101724755|FG001|COMPLETED|Overall Study||0||
48569325|NCT01735916|101724756|FG002|COMPLETED|Overall Study||0||
48569326|NCT01735916|101724754|FG000|NOT COMPLETED|Overall Study||18||
48569327|NCT01735916|101724755|FG001|NOT COMPLETED|Overall Study||19||
48569328|NCT01735916|101724756|FG002|NOT COMPLETED|Overall Study||7||
48569329|NCT00957801|101724757|FG000|STARTED|Overall Study||7||
48569330|NCT00957801|101724758|FG001|STARTED|Overall Study||7||
48569331|NCT00957801|101724759|FG002|STARTED|Overall Study||7||
48569332|NCT00957801|101724760|FG003|STARTED|Overall Study||8||
48569333|NCT00957801|101724757|FG000|COMPLETED|Overall Study||7||
48569334|NCT00957801|101724758|FG001|COMPLETED|Overall Study||7||
48569335|NCT00957801|101724759|FG002|COMPLETED|Overall Study||7||
48569336|NCT00957801|101724760|FG003|COMPLETED|Overall Study||7||
48569337|NCT00957801|101724757|FG000|NOT COMPLETED|Overall Study||0||
48569338|NCT00957801|101724758|FG001|NOT COMPLETED|Overall Study||0||
48569339|NCT00957801|101724759|FG002|NOT COMPLETED|Overall Study||0||
48569340|NCT00957801|101724760|FG003|NOT COMPLETED|Overall Study||1||
48569341|NCT03980145|101724761|FG000|STARTED|Overall Study||7||
48569342|NCT03980145|101724762|FG001|STARTED|Overall Study||8||
48569343|NCT03980145|101724761|FG000|COMPLETED|Overall Study||7||
48569344|NCT03980145|101724762|FG001|COMPLETED|Overall Study||8||
48569345|NCT03980145|101724761|FG000|NOT COMPLETED|Overall Study||0||
48569346|NCT03980145|101724762|FG001|NOT COMPLETED|Overall Study||0||
48569347|NCT03325816|101724763|FG000|STARTED|Overall Study||3||
48569348|NCT03325816|101724764|FG001|STARTED|Overall Study||6||
48569349|NCT03325816|101724763|FG000|COMPLETED|Overall Study||3||
48569350|NCT03325816|101724764|FG001|COMPLETED|Overall Study||6||
48569351|NCT03325816|101724763|FG000|NOT COMPLETED|Overall Study||0||
48569352|NCT03325816|101724764|FG001|NOT COMPLETED|Overall Study||0||
48569353|NCT01367886|101724765|FG000|STARTED|Overall Study||21||
48569354|NCT01367886|101724765|FG000|COMPLETED|Overall Study||14||
48569355|NCT01367886|101724765|FG000|NOT COMPLETED|Overall Study||7||
48569356|NCT03960008|101724766|FG000|STARTED|Overall Study||4||
48569357|NCT03960008|101724767|FG001|STARTED|Overall Study||5||
48120677|NCT04847050|100619665|FG007|Number of Participants Who Crossed Over From Hematologic Intermediate Immunosuppression Initial Ph.|Booster Phase||0||
48120678|NCT04847050|100619666|FG008|Number of Participants Who Crossed Over From Hematologic Intermediate Immunosuppression Initial Ph.|Booster Phase||0||
48120679|NCT04847050|100619667|FG009|Number of Participants Who Crossed Over From Hematologic Intermediate Immunosuppression Initial Ph.|Booster Phase||3||
48120680|NCT04847050|100619668|FG010|Number of Participants Who Crossed Over From Hematologic Intermediate Immunosuppression Initial Ph.|Booster Phase||0||
48120681|NCT04847050|100619658|FG000|Number of Participants Who Crossed Over From Hematologic High Immunosuppression -Initial Phase|Booster Phase||0||
48120682|NCT04847050|100619659|FG001|Number of Participants Who Crossed Over From Hematologic High Immunosuppression -Initial Phase|Booster Phase||0||
48120683|NCT04847050|100619660|FG002|Number of Participants Who Crossed Over From Hematologic High Immunosuppression -Initial Phase|Booster Phase||0||
48120684|NCT04847050|100619661|FG003|Number of Participants Who Crossed Over From Hematologic High Immunosuppression -Initial Phase|Booster Phase||0||
48120685|NCT04847050|100619662|FG004|Number of Participants Who Crossed Over From Hematologic High Immunosuppression -Initial Phase|Booster Phase||0||
48120686|NCT04847050|100619663|FG005|Number of Participants Who Crossed Over From Hematologic High Immunosuppression -Initial Phase|Booster Phase||0||
48120687|NCT04847050|100619664|FG006|Number of Participants Who Crossed Over From Hematologic High Immunosuppression -Initial Phase|Booster Phase||0||
48281663|NCT01056718|101014146|FG000|STARTED|Overall Study||53||
48569358|NCT03960008|101724766|FG000|COMPLETED|Overall Study||0||
48569359|NCT03960008|101724767|FG001|COMPLETED|Overall Study||0||
48569360|NCT03960008|101724766|FG000|NOT COMPLETED|Overall Study||4||
48120688|NCT04847050|100619665|FG007|Number of Participants Who Crossed Over From Hematologic High Immunosuppression -Initial Phase|Booster Phase||0||
48120689|NCT04847050|100619666|FG008|Number of Participants Who Crossed Over From Hematologic High Immunosuppression -Initial Phase|Booster Phase||0||
48120690|NCT04847050|100619667|FG009|Number of Participants Who Crossed Over From Hematologic High Immunosuppression -Initial Phase|Booster Phase||3||
48120691|NCT04847050|100619668|FG010|Number of Participants Who Crossed Over From Hematologic High Immunosuppression -Initial Phase|Booster Phase||0||
48120692|NCT04847050|100619658|FG000|Number of Participants Who Crossed Over From Solid Tumor on PD1/PDL-1 -Initial Phase|Booster Phase||0||
48120693|NCT04847050|100619659|FG001|Number of Participants Who Crossed Over From Solid Tumor on PD1/PDL-1 -Initial Phase|Booster Phase||0||
48120694|NCT04847050|100619660|FG002|Number of Participants Who Crossed Over From Solid Tumor on PD1/PDL-1 -Initial Phase|Booster Phase||0||
48281664|NCT01056718|101014146|FG000|COMPLETED|Overall Study||50||
48396570|NCT00861380|101299387|FG004|NOT COMPLETED|Overall Study||1812||
48569361|NCT03960008|101724767|FG001|NOT COMPLETED|Overall Study||5||
48569362|NCT02158585|101724768|FG000|STARTED|Overall Study||8||
48569363|NCT02158585|101724769|FG001|STARTED|Overall Study||7||
48569364|NCT02158585|101724768|FG000|COMPLETED|Overall Study||7||
48569365|NCT02158585|101724769|FG001|COMPLETED|Overall Study||6||
48569366|NCT02158585|101724768|FG000|NOT COMPLETED|Overall Study||1||
48569367|NCT02158585|101724769|FG001|NOT COMPLETED|Overall Study||1||
48569368|NCT01739231|101724770|FG000|STARTED|Part A||24||
48569369|NCT01739231|101724771|FG001|STARTED|Part A||24||
48569370|NCT01739231|101724772|FG002|STARTED|Part A||12||
48569371|NCT01739231|101724773|FG003|STARTED|Part A||0||
48569372|NCT01739231|101724770|FG000|Received All 3 Vaccinations|Part A||21||
48569373|NCT01739231|101724771|FG001|Received All 3 Vaccinations|Part A||20||
48569374|NCT01739231|101724772|FG002|Received All 3 Vaccinations|Part A||12||
48569375|NCT01739231|101724773|FG003|Received All 3 Vaccinations|Part A||0||
48569376|NCT01739231|101724770|FG000|COMPLETED|Part A||20||
48569377|NCT01739231|101724771|FG001|COMPLETED|Part A||17||
48569378|NCT01739231|101724772|FG002|COMPLETED|Part A||12||
48569379|NCT01739231|101724773|FG003|COMPLETED|Part A||0||
48120695|NCT04847050|100619661|FG003|Number of Participants Who Crossed Over From Solid Tumor on PD1/PDL-1 -Initial Phase|Booster Phase||0||
48120696|NCT04847050|100619662|FG004|Number of Participants Who Crossed Over From Solid Tumor on PD1/PDL-1 -Initial Phase|Booster Phase||0||
48120697|NCT04847050|100619663|FG005|Number of Participants Who Crossed Over From Solid Tumor on PD1/PDL-1 -Initial Phase|Booster Phase||0||
48120698|NCT04847050|100619664|FG006|Number of Participants Who Crossed Over From Solid Tumor on PD1/PDL-1 -Initial Phase|Booster Phase||0||
48120699|NCT04847050|100619665|FG007|Number of Participants Who Crossed Over From Solid Tumor on PD1/PDL-1 -Initial Phase|Booster Phase||2||
48120700|NCT04847050|100619666|FG008|Number of Participants Who Crossed Over From Solid Tumor on PD1/PDL-1 -Initial Phase|Booster Phase||0||
48120701|NCT04847050|100619667|FG009|Number of Participants Who Crossed Over From Solid Tumor on PD1/PDL-1 -Initial Phase|Booster Phase||0||
48120702|NCT04847050|100619668|FG010|Number of Participants Who Crossed Over From Solid Tumor on PD1/PDL-1 -Initial Phase|Booster Phase||0||
48120703|NCT04847050|100619658|FG000|COMPLETED|Booster Phase||0||
48120704|NCT04847050|100619659|FG001|COMPLETED|Booster Phase||0||
48120705|NCT04847050|100619660|FG002|COMPLETED|Booster Phase||0||
48120706|NCT04847050|100619661|FG003|COMPLETED|Booster Phase||0||
48120707|NCT04847050|100619662|FG004|COMPLETED|Booster Phase||0||
48120708|NCT04847050|100619663|FG005|COMPLETED|Booster Phase||0||
48120709|NCT04847050|100619664|FG006|COMPLETED|Booster Phase||0||
48120710|NCT04847050|100619665|FG007|COMPLETED|Booster Phase||2||
48120711|NCT04847050|100619666|FG008|COMPLETED|Booster Phase||1||
48120712|NCT04847050|100619667|FG009|COMPLETED|Booster Phase||10||
48120713|NCT04847050|100619668|FG010|COMPLETED|Booster Phase||0||
48120714|NCT04847050|100619658|FG000|NOT COMPLETED|Booster Phase||0||
48120715|NCT04847050|100619659|FG001|NOT COMPLETED|Booster Phase||0||
48396571|NCT00861380|101299388|FG005|NOT COMPLETED|Overall Study||6249||
48396572|NCT00861380|101299389|FG006|NOT COMPLETED|Overall Study||3020||
48396573|NCT01213264|101299390|FG000|STARTED|Overall Study||155||
48396574|NCT01213264|101299391|FG001|STARTED|Overall Study||177||
48396575|NCT01213264|101299392|FG002|STARTED|Overall Study||327||
48396576|NCT01213264|101299390|FG000|COMPLETED|Overall Study||153||
48396577|NCT01213264|101299391|FG001|COMPLETED|Overall Study||175||
48569380|NCT01739231|101724770|FG000|NOT COMPLETED|Part A||4||
48569381|NCT01739231|101724771|FG001|NOT COMPLETED|Part A||7||
48569382|NCT01739231|101724772|FG002|NOT COMPLETED|Part A||0||
48569383|NCT01739231|101724773|FG003|NOT COMPLETED|Part A||0||
48569384|NCT01739231|101724770|FG000|STARTED|Part B||20||
48569385|NCT01739231|101724771|FG001|STARTED|Part B||17||
48569386|NCT01739231|101724772|FG002|STARTED|Part B||12||
48120716|NCT04847050|100619660|FG002|NOT COMPLETED|Booster Phase||0||
48120717|NCT04847050|100619661|FG003|NOT COMPLETED|Booster Phase||0||
48120718|NCT04847050|100619662|FG004|NOT COMPLETED|Booster Phase||0||
48120719|NCT04847050|100619663|FG005|NOT COMPLETED|Booster Phase||0||
48120720|NCT04847050|100619664|FG006|NOT COMPLETED|Booster Phase||0||
48120721|NCT04847050|100619665|FG007|NOT COMPLETED|Booster Phase||0||
48120722|NCT04847050|100619666|FG008|NOT COMPLETED|Booster Phase||0||
48120723|NCT04847050|100619667|FG009|NOT COMPLETED|Booster Phase||0||
48120724|NCT04847050|100619668|FG010|NOT COMPLETED|Booster Phase||0||
48120725|NCT00320281|100619669|FG000|STARTED|Overall Study||10||
48120726|NCT00320281|100619670|FG001|STARTED|Overall Study||9||
48120727|NCT00320281|100619669|FG000|COMPLETED|Overall Study||10||
48120728|NCT00320281|100619670|FG001|COMPLETED|Overall Study||9||
48120729|NCT00320281|100619669|FG000|NOT COMPLETED|Overall Study||0||
48120730|NCT00320281|100619670|FG001|NOT COMPLETED|Overall Study||0||
48120731|NCT01790750|100619671|FG000|STARTED|Overall Study||50||
48120732|NCT01790750|100619671|FG000|COMPLETED|Overall Study||50||
48120733|NCT01790750|100619671|FG000|NOT COMPLETED|Overall Study||0||
48120734|NCT01863446|100619672|FG000|STARTED|Overall Study||5||
48120735|NCT01863446|100619673|FG001|STARTED|Overall Study||4||
48120736|NCT01863446|100619674|FG002|STARTED|Overall Study||12||
48120737|NCT01863446|100619675|FG003|STARTED|Overall Study||12||
48120738|NCT01863446|100619672|FG000|COMPLETED|Overall Study||4||
48120739|NCT01863446|100619673|FG001|COMPLETED|Overall Study||4||
48120740|NCT01863446|100619674|FG002|COMPLETED|Overall Study||10||
48120741|NCT01863446|100619675|FG003|COMPLETED|Overall Study||10||
48120742|NCT01863446|100619672|FG000|NOT COMPLETED|Overall Study||1||
48120743|NCT01863446|100619673|FG001|NOT COMPLETED|Overall Study||0||
48120744|NCT01863446|100619674|FG002|NOT COMPLETED|Overall Study||2||
48120745|NCT01863446|100619675|FG003|NOT COMPLETED|Overall Study||2||
48120746|NCT01175382|100619676|FG000|STARTED|Overall Study||71||
48120747|NCT01175382|100619677|FG001|STARTED|Overall Study||68||
48120748|NCT01175382|100619678|FG002|STARTED|Overall Study||65||
48120749|NCT01175382|100619676|FG000|COMPLETED|Overall Study||63||
48120750|NCT01175382|100619677|FG001|COMPLETED|Overall Study||61||
48396578|NCT01213264|101299392|FG002|COMPLETED|Overall Study||321||
48396579|NCT01213264|101299390|FG000|NOT COMPLETED|Overall Study||2||
48396580|NCT01213264|101299391|FG001|NOT COMPLETED|Overall Study||2||
48569387|NCT01739231|101724773|FG003|STARTED|Part B||21||
48569388|NCT01739231|101724770|FG000|Challenged|Part B||13||
48569389|NCT01739231|101724771|FG001|Challenged|Part B||13||
48120751|NCT01175382|100619678|FG002|COMPLETED|Overall Study||59||
48120752|NCT01175382|100619676|FG000|NOT COMPLETED|Overall Study||8||
48120753|NCT01175382|100619677|FG001|NOT COMPLETED|Overall Study||7||
48120754|NCT01175382|100619678|FG002|NOT COMPLETED|Overall Study||6||
48120755|NCT02896127|100619679|FG000|STARTED|COMPLETED WEEK 52||305|Started the Week 52 period|
48120756|NCT02896127|100619680|FG001|STARTED|COMPLETED WEEK 52||153|Started the Week 52 period|
48120757|NCT02896127|100619679|FG000|COMPLETED|COMPLETED WEEK 52||278|Discontinued before or at Week 52|
48120758|NCT02896127|100619680|FG001|COMPLETED|COMPLETED WEEK 52||142|Discontinued before or at Week 52|
48120759|NCT02896127|100619679|FG000|NOT COMPLETED|COMPLETED WEEK 52||27||
48120760|NCT02896127|100619680|FG001|NOT COMPLETED|COMPLETED WEEK 52||11||
48120761|NCT02896127|100619679|FG000|STARTED|COMPLETED POST-TREATMENT FOLLOW UP||280|All patients independent of completer status were asked to enter follow up whenever they exited the study no matter at what time in their participation. Moreover, not all participants who completed Week 52 entered the follow up period and some did not complete follow-up. Therefore, the number of participants who started the follow-up period is not equal to the number of participants who completed the previous period.|
48120762|NCT02896127|100619680|FG001|STARTED|COMPLETED POST-TREATMENT FOLLOW UP||139|All patients independent of completer status were asked to enter follow up whenever they exited the study no matter at what time in their participation. Moreover, not all participants who completed Week 52 entered the follow up period and some did not complete follow-up. Therefore, the number of participants who started the follow-up period is not equal to the number of participants who completed the previous period.|
48120763|NCT02896127|100619679|FG000|COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP||276||
48120764|NCT02896127|100619680|FG001|COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP||134||
48120765|NCT02896127|100619679|FG000|NOT COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP||4||
48120766|NCT02896127|100619680|FG001|NOT COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP||5||
48120767|NCT03738904|100619681|FG000|STARTED|Overall Study||54||
48120768|NCT03738904|100619682|FG001|STARTED|Overall Study||55||
48120769|NCT03738904|100619681|FG000|COMPLETED|Overall Study||45||
48120770|NCT03738904|100619682|FG001|COMPLETED|Overall Study||44||
48120771|NCT03738904|100619681|FG000|NOT COMPLETED|Overall Study||9||
48120772|NCT03738904|100619682|FG001|NOT COMPLETED|Overall Study||11||
48120773|NCT01936259|100619683|FG000|STARTED|Overall Study||130||133
48120774|NCT01936259|100619684|FG001|STARTED|Overall Study||131||132
48120775|NCT01936259|100619683|FG000|COMPLETED|Overall Study||118||121
48120776|NCT01936259|100619684|FG001|COMPLETED|Overall Study||111||112
48120777|NCT01936259|100619683|FG000|NOT COMPLETED|Overall Study||12||12
48120778|NCT01936259|100619684|FG001|NOT COMPLETED|Overall Study||20||20
48120779|NCT00739336|100619685|FG000|STARTED|Overall Study||21||
48120780|NCT00739336|100619686|FG001|STARTED|Overall Study||24||
48120781|NCT00739336|100619685|FG000|COMPLETED|Overall Study||17||
48120782|NCT00739336|100619686|FG001|COMPLETED|Overall Study||24||
48120783|NCT00739336|100619685|FG000|NOT COMPLETED|Overall Study||4||
48120784|NCT00739336|100619686|FG001|NOT COMPLETED|Overall Study||0||
48120785|NCT00612313|100619687|FG000|STARTED|Overall Study||69||
48120786|NCT00612313|100619688|FG001|STARTED|Overall Study||75||
48120787|NCT00612313|100619687|FG000|COMPLETED|Overall Study||52||
48120788|NCT00612313|100619688|FG001|COMPLETED|Overall Study||62||
48120789|NCT00612313|100619687|FG000|NOT COMPLETED|Overall Study||17||
48120790|NCT00612313|100619688|FG001|NOT COMPLETED|Overall Study||13||
48120791|NCT03064126|100619689|FG000|STARTED|Overall Study||278||
48120792|NCT03064126|100619690|FG001|STARTED|Overall Study||98||
48120793|NCT03064126|100619691|FG002|STARTED|Overall Study||52||
48120794|NCT03064126|100619692|FG003|STARTED|Overall Study||12||
48569390|NCT01739231|101724772|FG002|Challenged|Part B||10||
48569391|NCT01739231|101724773|FG003|Challenged|Part B||21||
48569392|NCT01739231|101724770|FG000|COMPLETED|Part B||13||
48120795|NCT03064126|100619689|FG000|COMPLETED|Overall Study||203||
48120796|NCT03064126|100619690|FG001|COMPLETED|Overall Study||67||
48120797|NCT03064126|100619691|FG002|COMPLETED|Overall Study||48||
48569393|NCT01739231|101724771|FG001|COMPLETED|Part B||12||
48569394|NCT01739231|101724772|FG002|COMPLETED|Part B||10||
48569395|NCT01739231|101724773|FG003|COMPLETED|Part B||19||
48120798|NCT03064126|100619692|FG003|COMPLETED|Overall Study||8||
48120799|NCT03064126|100619689|FG000|NOT COMPLETED|Overall Study||75||
48120800|NCT03064126|100619690|FG001|NOT COMPLETED|Overall Study||31||
48120801|NCT03064126|100619691|FG002|NOT COMPLETED|Overall Study||4||
48120802|NCT03064126|100619692|FG003|NOT COMPLETED|Overall Study||4||
48120803|NCT03285477|100619693|FG000|STARTED|Treatment and Response Assessment Period||176||
48120804|NCT03285477|100619694|FG001|STARTED|Treatment and Response Assessment Period||175||
48120805|NCT03285477|100619693|FG000|COMPLETED|Treatment and Response Assessment Period||174||
48120806|NCT03285477|100619694|FG001|COMPLETED|Treatment and Response Assessment Period||175||
48120807|NCT03285477|100619693|FG000|NOT COMPLETED|Treatment and Response Assessment Period||2||
48120808|NCT03285477|100619694|FG001|NOT COMPLETED|Treatment and Response Assessment Period||0||
48120809|NCT03285477|100619693|FG000|STARTED|Recurrence Follow-up Period||8|Number of participants who achieved 100% AK clearance at Day 57 visit and entered the recurrence follow-up period.|
48120810|NCT03285477|100619694|FG001|STARTED|Recurrence Follow-up Period||77|Number of participants who achieved 100% AK clearance at Day 57 visit and entered the recurrence follow-up period.|
48120811|NCT03285477|100619693|FG000|COMPLETED|Recurrence Follow-up Period||2||
48569396|NCT01739231|101724770|FG000|NOT COMPLETED|Part B||7||
48569397|NCT01739231|101724771|FG001|NOT COMPLETED|Part B||5||
48569398|NCT01739231|101724772|FG002|NOT COMPLETED|Part B||2||
48569399|NCT01739231|101724773|FG003|NOT COMPLETED|Part B||2||
48569400|NCT00725153|101724774|FG000|STARTED|Period One, 10 Hours of Wear||27||
48120812|NCT03285477|100619694|FG001|COMPLETED|Recurrence Follow-up Period||22||
48120813|NCT03285477|100619693|FG000|NOT COMPLETED|Recurrence Follow-up Period||6||
48120814|NCT03285477|100619694|FG001|NOT COMPLETED|Recurrence Follow-up Period||55||
48120815|NCT01516268|100619695|FG000|STARTED|Overall Study||25||
48120816|NCT01516268|100619696|FG001|STARTED|Overall Study||25||
48120817|NCT01516268|100619695|FG000|COMPLETED|Overall Study||25||
48120818|NCT01516268|100619696|FG001|COMPLETED|Overall Study||25||
48120819|NCT01516268|100619695|FG000|NOT COMPLETED|Overall Study||0||
48120820|NCT01516268|100619696|FG001|NOT COMPLETED|Overall Study||0||
48120821|NCT02927691|100619697|FG000|STARTED|Overall Study||34||
48120822|NCT02927691|100619698|FG001|STARTED|Overall Study||31||
48120823|NCT02927691|100619697|FG000|COMPLETED|Overall Study||30||
48120824|NCT02927691|100619698|FG001|COMPLETED|Overall Study||28||
48120825|NCT02927691|100619697|FG000|NOT COMPLETED|Overall Study||4||
48120826|NCT02927691|100619698|FG001|NOT COMPLETED|Overall Study||3||
48120827|NCT02962895|100619699|FG000|STARTED|Period 2 (Randomized Set: Up to Week 24)||49|All randomized patients were included in the Full Analysis Set (FAS) and Safety Set (SAF)|
48120828|NCT02962895|100619700|FG001|STARTED|Period 2 (Randomized Set: Up to Week 24)||47|All randomized patients were included in the Full Analysis Set (FAS) and Safety Set (SAF)|
48120829|NCT02962895|100619701|FG002|STARTED|Period 2 (Randomized Set: Up to Week 24)||47|All randomized patients were included in the Full Analysis Set (FAS) and Safety Set (SAF)|
48120830|NCT02962895|100619702|FG003|STARTED|Period 2 (Randomized Set: Up to Week 24)||47|All randomized patients were included in the Full Analysis Set (FAS) and Safety Set (SAF)|
48120831|NCT02962895|100619703|FG004|STARTED|Period 2 (Randomized Set: Up to Week 24)||0|All randomized patients were included in the Full Analysis Set (FAS) and Safety Set (SAF)|
48120832|NCT02962895|100619704|FG005|STARTED|Period 2 (Randomized Set: Up to Week 24)||0|All randomized patients were included in the Full Analysis Set (FAS) and Safety Set (SAF)|
48120833|NCT02962895|100619705|FG006|STARTED|Period 2 (Randomized Set: Up to Week 24)||0|All randomized patients were included in the Full Analysis Set (FAS) and Safety Set (SAF)|
48120834|NCT02962895|100619699|FG000|COMPLETED|Period 2 (Randomized Set: Up to Week 24)||47||
48120835|NCT02962895|100619700|FG001|COMPLETED|Period 2 (Randomized Set: Up to Week 24)||42||
48120836|NCT02962895|100619701|FG002|COMPLETED|Period 2 (Randomized Set: Up to Week 24)||43||
48396581|NCT01213264|101299392|FG002|NOT COMPLETED|Overall Study||6||
48120837|NCT02962895|100619702|FG003|COMPLETED|Period 2 (Randomized Set: Up to Week 24)||46||
48120838|NCT02962895|100619703|FG004|COMPLETED|Period 2 (Randomized Set: Up to Week 24)||0||
48120839|NCT02962895|100619704|FG005|COMPLETED|Period 2 (Randomized Set: Up to Week 24)||0||
48120840|NCT02962895|100619705|FG006|COMPLETED|Period 2 (Randomized Set: Up to Week 24)||0||
48120841|NCT02962895|100619699|FG000|NOT COMPLETED|Period 2 (Randomized Set: Up to Week 24)||2||
48120842|NCT02962895|100619700|FG001|NOT COMPLETED|Period 2 (Randomized Set: Up to Week 24)||5||
48120843|NCT02962895|100619701|FG002|NOT COMPLETED|Period 2 (Randomized Set: Up to Week 24)||4||
48120844|NCT02962895|100619702|FG003|NOT COMPLETED|Period 2 (Randomized Set: Up to Week 24)||1||
48120845|NCT02962895|100619703|FG004|NOT COMPLETED|Period 2 (Randomized Set: Up to Week 24)||0||
48120846|NCT02962895|100619704|FG005|NOT COMPLETED|Period 2 (Randomized Set: Up to Week 24)||0||
48120847|NCT02962895|100619705|FG006|NOT COMPLETED|Period 2 (Randomized Set: Up to Week 24)||0||
48120848|NCT02962895|100619699|FG000|STARTED|Period 3 (Randomized Set / Weeks: 24-52)||0||
48120849|NCT02962895|100619700|FG001|STARTED|Period 3 (Randomized Set / Weeks: 24-52)||0||
48120850|NCT02962895|100619701|FG002|STARTED|Period 3 (Randomized Set / Weeks: 24-52)||0||
48120851|NCT02962895|100619702|FG003|STARTED|Period 3 (Randomized Set / Weeks: 24-52)||0||
48120852|NCT02962895|100619703|FG004|STARTED|Period 3 (Randomized Set / Weeks: 24-52)||47||
48120853|NCT02962895|100619704|FG005|STARTED|Period 3 (Randomized Set / Weeks: 24-52)||22||
48120854|NCT02962895|100619705|FG006|STARTED|Period 3 (Randomized Set / Weeks: 24-52)||21||
48120855|NCT02962895|100619699|FG000|COMPLETED|Period 3 (Randomized Set / Weeks: 24-52)||0||
48120856|NCT02962895|100619700|FG001|COMPLETED|Period 3 (Randomized Set / Weeks: 24-52)||0||
48120857|NCT02962895|100619701|FG002|COMPLETED|Period 3 (Randomized Set / Weeks: 24-52)||0||
48120858|NCT02962895|100619702|FG003|COMPLETED|Period 3 (Randomized Set / Weeks: 24-52)||0||
48120859|NCT02962895|100619703|FG004|COMPLETED|Period 3 (Randomized Set / Weeks: 24-52)||42||
48120860|NCT02962895|100619704|FG005|COMPLETED|Period 3 (Randomized Set / Weeks: 24-52)||22||
48281665|NCT01056718|101014146|FG000|NOT COMPLETED|Overall Study||3||
48281666|NCT01859988|101014147|FG000|STARTED|Overall Study||63||
48281667|NCT01859988|101014148|FG001|STARTED|Overall Study||64||
48281668|NCT01859988|101014149|FG002|STARTED|Overall Study||62||
48281669|NCT01859988|101014150|FG003|STARTED|Overall Study||65||
48281670|NCT01859988|101014151|FG004|STARTED|Overall Study||65||
48281671|NCT01859988|101014152|FG005|STARTED|Overall Study||61||
48281672|NCT01859988|101014147|FG000|Treated|Overall Study||63||
48281673|NCT01859988|101014148|FG001|Treated|Overall Study||64||
48281674|NCT01859988|101014149|FG002|Treated|Overall Study||61||
48281675|NCT01859988|101014150|FG003|Treated|Overall Study||65||
48281676|NCT01859988|101014151|FG004|Treated|Overall Study||65||
48396582|NCT00884221|101299393|FG000|STARTED|Overall Study||374||
48569401|NCT00725153|101724775|FG001|STARTED|Period One, 10 Hours of Wear||28||
48569402|NCT00725153|101724774|FG000|COMPLETED|Period One, 10 Hours of Wear||27||
48569403|NCT00725153|101724775|FG001|COMPLETED|Period One, 10 Hours of Wear||28||
48592796|NCT01764997|101783183|FG001|COMPLETED|Run-in Period||0||
48120861|NCT02962895|100619705|FG006|COMPLETED|Period 3 (Randomized Set / Weeks: 24-52)||17||
48120862|NCT02962895|100619699|FG000|NOT COMPLETED|Period 3 (Randomized Set / Weeks: 24-52)||0||
48120863|NCT02962895|100619700|FG001|NOT COMPLETED|Period 3 (Randomized Set / Weeks: 24-52)||0||
48120864|NCT02962895|100619701|FG002|NOT COMPLETED|Period 3 (Randomized Set / Weeks: 24-52)||0||
48120865|NCT02962895|100619702|FG003|NOT COMPLETED|Period 3 (Randomized Set / Weeks: 24-52)||0||
48120866|NCT02962895|100619703|FG004|NOT COMPLETED|Period 3 (Randomized Set / Weeks: 24-52)||5||
48120867|NCT02962895|100619704|FG005|NOT COMPLETED|Period 3 (Randomized Set / Weeks: 24-52)||0||
48120868|NCT02962895|100619705|FG006|NOT COMPLETED|Period 3 (Randomized Set / Weeks: 24-52)||4||
48120869|NCT02962895|100619699|FG000|STARTED|Period 4 (Safety Follow-Up)||2||
48120870|NCT02962895|100619700|FG001|STARTED|Period 4 (Safety Follow-Up)||47||
48120871|NCT02962895|100619701|FG002|STARTED|Period 4 (Safety Follow-Up)||47||
48120872|NCT02962895|100619702|FG003|STARTED|Period 4 (Safety Follow-Up)||4||
48120873|NCT02962895|100619703|FG004|STARTED|Period 4 (Safety Follow-Up)||46||
48120874|NCT02962895|100619704|FG005|STARTED|Period 4 (Safety Follow-Up)||22||
48120875|NCT02962895|100619705|FG006|STARTED|Period 4 (Safety Follow-Up)||20||
48120876|NCT02962895|100619699|FG000|COMPLETED|Period 4 (Safety Follow-Up)||2||
48120877|NCT02962895|100619700|FG001|COMPLETED|Period 4 (Safety Follow-Up)||41||
48120878|NCT02962895|100619701|FG002|COMPLETED|Period 4 (Safety Follow-Up)||43||
48120879|NCT02962895|100619702|FG003|COMPLETED|Period 4 (Safety Follow-Up)||1||
48120880|NCT02962895|100619703|FG004|COMPLETED|Period 4 (Safety Follow-Up)||42||
48120881|NCT02962895|100619704|FG005|COMPLETED|Period 4 (Safety Follow-Up)||20||
48120882|NCT02962895|100619705|FG006|COMPLETED|Period 4 (Safety Follow-Up)||20||
48120883|NCT02962895|100619699|FG000|NOT COMPLETED|Period 4 (Safety Follow-Up)||0||
48120884|NCT02962895|100619700|FG001|NOT COMPLETED|Period 4 (Safety Follow-Up)||6||
48120885|NCT02962895|100619701|FG002|NOT COMPLETED|Period 4 (Safety Follow-Up)||4||
48120886|NCT02962895|100619702|FG003|NOT COMPLETED|Period 4 (Safety Follow-Up)||3||
48120887|NCT02962895|100619703|FG004|NOT COMPLETED|Period 4 (Safety Follow-Up)||4||
48120888|NCT02962895|100619704|FG005|NOT COMPLETED|Period 4 (Safety Follow-Up)||2||
48120889|NCT02962895|100619705|FG006|NOT COMPLETED|Period 4 (Safety Follow-Up)||0||
48120890|NCT00501891|100619706|FG000|STARTED|Overall Study||32||
48120891|NCT00501891|100619706|FG000|COMPLETED|Overall Study||32||
48120892|NCT00501891|100619706|FG000|NOT COMPLETED|Overall Study||0||
48120893|NCT03049813|100619707|FG000|STARTED|Randomized Control Trial Phase||38|Signed a consent form|
48120894|NCT03049813|100619708|FG001|STARTED|Randomized Control Trial Phase||61|Signed a consent form|
48120895|NCT03049813|100619709|FG002|STARTED|Randomized Control Trial Phase||44|Signed a consent form|
48120896|NCT03049813|100619710|FG003|STARTED|Randomized Control Trial Phase||0|Signed a consent form|
48120897|NCT03049813|100619707|FG000|COMPLETED|Randomized Control Trial Phase||36|Employment Outcomes Obtained by 9-Month Follow-Up|
48120898|NCT03049813|100619708|FG001|COMPLETED|Randomized Control Trial Phase||54|Employment Outcomes Obtained by 9-Month Follow-Up|
48120899|NCT03049813|100619709|FG002|COMPLETED|Randomized Control Trial Phase||41|Employment Outcomes Obtained by 9-Month Follow-Up|
48120900|NCT03049813|100619710|FG003|COMPLETED|Randomized Control Trial Phase||0|Employment Outcomes Obtained by 9-Month Follow-Up|
48120901|NCT03049813|100619707|FG000|NOT COMPLETED|Randomized Control Trial Phase||2||
48120902|NCT03049813|100619708|FG001|NOT COMPLETED|Randomized Control Trial Phase||7||
48120903|NCT03049813|100619709|FG002|NOT COMPLETED|Randomized Control Trial Phase||3||
48120904|NCT03049813|100619710|FG003|NOT COMPLETED|Randomized Control Trial Phase||0||
48120905|NCT03049813|100619707|FG000|STARTED|Focus Group Phase||0||
48120906|NCT03049813|100619708|FG001|STARTED|Focus Group Phase||0||
48120907|NCT03049813|100619709|FG002|STARTED|Focus Group Phase||0||
48120908|NCT03049813|100619710|FG003|STARTED|Focus Group Phase||25||
48120909|NCT03049813|100619707|FG000|COMPLETED|Focus Group Phase||0||
48120910|NCT03049813|100619708|FG001|COMPLETED|Focus Group Phase||0||
48120911|NCT03049813|100619709|FG002|COMPLETED|Focus Group Phase||0||
48120912|NCT03049813|100619710|FG003|COMPLETED|Focus Group Phase||25||
48120913|NCT03049813|100619707|FG000|NOT COMPLETED|Focus Group Phase||0||
48120914|NCT03049813|100619708|FG001|NOT COMPLETED|Focus Group Phase||0||
48120915|NCT03049813|100619709|FG002|NOT COMPLETED|Focus Group Phase||0||
48120916|NCT03049813|100619710|FG003|NOT COMPLETED|Focus Group Phase||0||
48120917|NCT04114058|100619711|FG000|STARTED|Overall Study||20||
48120918|NCT04114058|100619712|FG001|STARTED|Overall Study||17||
48120919|NCT04114058|100619711|FG000|COMPLETED|Overall Study||20||
48120920|NCT04114058|100619712|FG001|COMPLETED|Overall Study||17||
48120921|NCT04114058|100619711|FG000|NOT COMPLETED|Overall Study||0||
48120922|NCT04114058|100619712|FG001|NOT COMPLETED|Overall Study||0||
48120923|NCT03351049|100619713|FG000|STARTED|Overall Study||323||
48120924|NCT03351049|100619714|FG001|STARTED|Overall Study||128||
48120925|NCT03351049|100619713|FG000|COMPLETED|Overall Study||297||
48120926|NCT03351049|100619714|FG001|COMPLETED|Overall Study||106||
48120927|NCT03351049|100619713|FG000|NOT COMPLETED|Overall Study||26||
48120928|NCT03351049|100619714|FG001|NOT COMPLETED|Overall Study||22||
48120929|NCT01599650|100619715|FG000|STARTED|Overall Study||183||
48120930|NCT01599650|100619716|FG001|STARTED|Overall Study||180||
48120931|NCT01599650|100619717|FG002|STARTED|Overall Study||92||
48120932|NCT01599650|100619715|FG000|Completed 6 Mos|Overall Study||174||
48120933|NCT01599650|100619716|FG001|Completed 6 Mos|Overall Study||170||
48120934|NCT01599650|100619717|FG002|Completed 6 Mos|Overall Study||80||
48120935|NCT01599650|100619715|FG000|COMPLETED|Overall Study||161||
48120936|NCT01599650|100619716|FG001|COMPLETED|Overall Study||154||
48120937|NCT01599650|100619717|FG002|COMPLETED|Overall Study||65||
48120938|NCT01599650|100619715|FG000|NOT COMPLETED|Overall Study||22||
48120939|NCT01599650|100619716|FG001|NOT COMPLETED|Overall Study||26||
48120940|NCT01599650|100619717|FG002|NOT COMPLETED|Overall Study||27||
48120941|NCT04622254|100619718|FG000|STARTED|Main Period (Up to 22 Weeks)||94||
48120942|NCT04622254|100619719|FG001|STARTED|Main Period (Up to 22 Weeks)||184||
48120943|NCT04622254|100619720|FG002|STARTED|Main Period (Up to 22 Weeks)||90||
48120944|NCT04622254|100619721|FG003|STARTED|Main Period (Up to 22 Weeks)||0||
48120945|NCT04622254|100619722|FG004|STARTED|Main Period (Up to 22 Weeks)||0||
48120946|NCT04622254|100619723|FG005|STARTED|Main Period (Up to 22 Weeks)||0||
48120947|NCT04622254|100619718|FG000|COMPLETED|Main Period (Up to 22 Weeks)||91||
48120948|NCT04622254|100619719|FG001|COMPLETED|Main Period (Up to 22 Weeks)||180||
48120949|NCT04622254|100619720|FG002|COMPLETED|Main Period (Up to 22 Weeks)||87||
48120950|NCT04622254|100619721|FG003|COMPLETED|Main Period (Up to 22 Weeks)||0||
48120951|NCT04622254|100619722|FG004|COMPLETED|Main Period (Up to 22 Weeks)||0||
48120952|NCT04622254|100619723|FG005|COMPLETED|Main Period (Up to 22 Weeks)||0||
48120953|NCT04622254|100619718|FG000|NOT COMPLETED|Main Period (Up to 22 Weeks)||3||
48120954|NCT04622254|100619719|FG001|NOT COMPLETED|Main Period (Up to 22 Weeks)||4||
48120955|NCT04622254|100619720|FG002|NOT COMPLETED|Main Period (Up to 22 Weeks)||3||
48120956|NCT04622254|100619721|FG003|NOT COMPLETED|Main Period (Up to 22 Weeks)||0||
48120957|NCT04622254|100619722|FG004|NOT COMPLETED|Main Period (Up to 22 Weeks)||0||
48120958|NCT04622254|100619723|FG005|NOT COMPLETED|Main Period (Up to 22 Weeks)||0||
48120959|NCT04622254|100619718|FG000|STARTED|OLEX Period (Up to 39 Weeks)||0||
48120960|NCT04622254|100619719|FG001|STARTED|OLEX Period (Up to 39 Weeks)||0||
48120961|NCT04622254|100619720|FG002|STARTED|OLEX Period (Up to 39 Weeks)||0||
48120962|NCT04622254|100619721|FG003|STARTED|OLEX Period (Up to 39 Weeks)||89||
48120963|NCT04622254|100619722|FG004|STARTED|OLEX Period (Up to 39 Weeks)||170||
48120964|NCT04622254|100619723|FG005|STARTED|OLEX Period (Up to 39 Weeks)||87||
48120965|NCT04622254|100619718|FG000|COMPLETED|OLEX Period (Up to 39 Weeks)||0||
48120966|NCT04622254|100619719|FG001|COMPLETED|OLEX Period (Up to 39 Weeks)||0||
48120967|NCT04622254|100619720|FG002|COMPLETED|OLEX Period (Up to 39 Weeks)||0||
48120968|NCT04622254|100619721|FG003|COMPLETED|OLEX Period (Up to 39 Weeks)||81||
48120969|NCT04622254|100619722|FG004|COMPLETED|OLEX Period (Up to 39 Weeks)||156||
48120970|NCT04622254|100619723|FG005|COMPLETED|OLEX Period (Up to 39 Weeks)||76||
48120971|NCT04622254|100619718|FG000|NOT COMPLETED|OLEX Period (Up to 39 Weeks)||0||
48120972|NCT04622254|100619719|FG001|NOT COMPLETED|OLEX Period (Up to 39 Weeks)||0||
48120973|NCT04622254|100619720|FG002|NOT COMPLETED|OLEX Period (Up to 39 Weeks)||0||
48120974|NCT04622254|100619721|FG003|NOT COMPLETED|OLEX Period (Up to 39 Weeks)||8||
48120975|NCT04622254|100619722|FG004|NOT COMPLETED|OLEX Period (Up to 39 Weeks)||14||
48120976|NCT04622254|100619723|FG005|NOT COMPLETED|OLEX Period (Up to 39 Weeks)||11||
48120977|NCT02984995|100619724|FG000|STARTED|Overall Study||34||
48120978|NCT02984995|100619725|FG001|STARTED|Overall Study||3||
48120979|NCT02984995|100619724|FG000|COMPLETED|Overall Study||9||
48120980|NCT02984995|100619725|FG001|COMPLETED|Overall Study||0||
48120981|NCT02984995|100619724|FG000|NOT COMPLETED|Overall Study||25||
48120982|NCT02984995|100619725|FG001|NOT COMPLETED|Overall Study||3||
48120983|NCT04360824|100619726|FG000|STARTED|Overall Study||88||
48120984|NCT04360824|100619727|FG001|STARTED|Overall Study||88||
48120985|NCT04360824|100619726|FG000|COMPLETED|Overall Study||85||
48120986|NCT04360824|100619727|FG001|COMPLETED|Overall Study||84||
48120987|NCT04360824|100619726|FG000|NOT COMPLETED|Overall Study||3||
48120988|NCT04360824|100619727|FG001|NOT COMPLETED|Overall Study||4||
48120989|NCT02449356|100619728|FG000|STARTED|Overall Study||30||
48120990|NCT02449356|100619729|FG001|STARTED|Overall Study||30||
48120991|NCT02449356|100619728|FG000|COMPLETED|Overall Study||30||
48120992|NCT02449356|100619729|FG001|COMPLETED|Overall Study||30||
48120993|NCT02449356|100619728|FG000|NOT COMPLETED|Overall Study||0||
48120994|NCT02449356|100619729|FG001|NOT COMPLETED|Overall Study||0||
48120995|NCT05872035|100619730|FG000|STARTED|Overall Study||59||
48120996|NCT05872035|100619731|FG001|STARTED|Overall Study||59||
48120997|NCT05872035|100619730|FG000|COMPLETED|Overall Study||59||
48120998|NCT05872035|100619731|FG001|COMPLETED|Overall Study||59||
48120999|NCT05872035|100619730|FG000|NOT COMPLETED|Overall Study||0||
48121000|NCT05872035|100619731|FG001|NOT COMPLETED|Overall Study||0||
48121001|NCT01331148|100619732|FG000|STARTED|Overall Study||23||
48121002|NCT01331148|100619733|FG001|STARTED|Overall Study||23||
48121003|NCT01331148|100619732|FG000|COMPLETED|Overall Study||20||
48121004|NCT01331148|100619733|FG001|COMPLETED|Overall Study||19||
48121005|NCT01331148|100619732|FG000|NOT COMPLETED|Overall Study||3||
48121006|NCT01331148|100619733|FG001|NOT COMPLETED|Overall Study||4||
48121007|NCT00456092|100619734|FG000|STARTED|Extension Phase||46||
48121008|NCT00456092|100619735|FG001|STARTED|Extension Phase||40||
48121009|NCT00456092|100619736|FG002|STARTED|Extension Phase||0||
48121010|NCT00456092|100619737|FG003|STARTED|Extension Phase||20||
48121011|NCT00456092|100619738|FG004|STARTED|Extension Phase||20||
48121012|NCT00456092|100619734|FG000|COMPLETED|Extension Phase||35||
48121013|NCT00456092|100619735|FG001|COMPLETED|Extension Phase||36||
48121014|NCT00456092|100619736|FG002|COMPLETED|Extension Phase||0||
48281677|NCT01859988|101014152|FG005|Treated|Overall Study||61||
48121015|NCT00456092|100619737|FG003|COMPLETED|Extension Phase||19||
48121016|NCT00456092|100619738|FG004|COMPLETED|Extension Phase||13||
48121017|NCT00456092|100619734|FG000|NOT COMPLETED|Extension Phase||11||
48121018|NCT00456092|100619735|FG001|NOT COMPLETED|Extension Phase||4||
48121019|NCT00456092|100619736|FG002|NOT COMPLETED|Extension Phase||0||
48121020|NCT00456092|100619737|FG003|NOT COMPLETED|Extension Phase||1||
48121021|NCT00456092|100619738|FG004|NOT COMPLETED|Extension Phase||7||
48121022|NCT00456092|100619734|FG000|STARTED|Treatment Phase (12 Weeks)||67||
48121023|NCT00456092|100619735|FG001|STARTED|Treatment Phase (12 Weeks)||69||
48121024|NCT00456092|100619736|FG002|STARTED|Treatment Phase (12 Weeks)||68||
48121025|NCT00456092|100619737|FG003|STARTED|Treatment Phase (12 Weeks)||0||
48121026|NCT00456092|100619738|FG004|STARTED|Treatment Phase (12 Weeks)||0||
48121027|NCT00456092|100619734|FG000|COMPLETED|Treatment Phase (12 Weeks)||60||
48121028|NCT00456092|100619735|FG001|COMPLETED|Treatment Phase (12 Weeks)||55||
48121029|NCT00456092|100619736|FG002|COMPLETED|Treatment Phase (12 Weeks)||50||
48121030|NCT00456092|100619737|FG003|COMPLETED|Treatment Phase (12 Weeks)||0||
48121031|NCT00456092|100619738|FG004|COMPLETED|Treatment Phase (12 Weeks)||0||
48121032|NCT00456092|100619734|FG000|NOT COMPLETED|Treatment Phase (12 Weeks)||7||
48121033|NCT00456092|100619735|FG001|NOT COMPLETED|Treatment Phase (12 Weeks)||14||
48121034|NCT00456092|100619736|FG002|NOT COMPLETED|Treatment Phase (12 Weeks)||18||
48121035|NCT00456092|100619737|FG003|NOT COMPLETED|Treatment Phase (12 Weeks)||0||
48121036|NCT00456092|100619738|FG004|NOT COMPLETED|Treatment Phase (12 Weeks)||0||
48121037|NCT03511560|100619739|FG000|STARTED|Overall Study||25||
48121038|NCT03511560|100619740|FG001|STARTED|Overall Study||25||
48121039|NCT03511560|100619739|FG000|COMPLETED|Overall Study||24||
48121040|NCT03511560|100619740|FG001|COMPLETED|Overall Study||21||
48121041|NCT03511560|100619739|FG000|NOT COMPLETED|Overall Study||1||
48121042|NCT03511560|100619740|FG001|NOT COMPLETED|Overall Study||4||
48121043|NCT02383758|100619741|FG000|STARTED|Overall Study||10||
48121044|NCT02383758|100619742|FG001|STARTED|Overall Study||10||
48121045|NCT02383758|100619741|FG000|COMPLETED|Overall Study||10||
48121046|NCT02383758|100619742|FG001|COMPLETED|Overall Study||8||
48121047|NCT02383758|100619741|FG000|NOT COMPLETED|Overall Study||0||
48121048|NCT02383758|100619742|FG001|NOT COMPLETED|Overall Study||2||
48121049|NCT03614793|100619743|FG000|STARTED|Overall Study||20||
48121050|NCT03614793|100619744|FG001|STARTED|Overall Study||19||
48121051|NCT03614793|100619743|FG000|COMPLETED|Overall Study||19||
48121052|NCT03614793|100619744|FG001|COMPLETED|Overall Study||6||
48121053|NCT03614793|100619743|FG000|NOT COMPLETED|Overall Study||1||
48121054|NCT03614793|100619744|FG001|NOT COMPLETED|Overall Study||13||
48121055|NCT01343706|100619745|FG000|STARTED|Overall Study||18|Entered subjects|
48121056|NCT01343706|100619746|FG001|STARTED|Overall Study||6|Entered subjects|
48121057|NCT01343706|100619747|FG002|STARTED|Overall Study||6|Entered subjects|
48121058|NCT01343706|100619748|FG003|STARTED|Overall Study||6|Entered subjects|
48121059|NCT01343706|100619749|FG004|STARTED|Overall Study||6|Entered subjects|
48121060|NCT01343706|100619750|FG005|STARTED|Overall Study||6|Entered subjects|
48121061|NCT01343706|100619751|FG006|STARTED|Overall Study||6|Entered subjects|
48121062|NCT01343706|100619752|FG007|STARTED|Overall Study||2|Entered subjects|
48121063|NCT01343706|100619753|FG008|STARTED|Overall Study||6|Entered subjects|
48121064|NCT01343706|100619754|FG009|STARTED|Overall Study||6|Entered subjects|
48121065|NCT01343706|100619755|FG010|STARTED|Overall Study||6|Entered subjects|
48121066|NCT01343706|100619756|FG011|STARTED|Overall Study||6|Entered subjects|
48121067|NCT01343706|100619745|FG000|Not Treated|Overall Study||0|Subject withdrew before the first drug administration|
48121068|NCT01343706|100619746|FG001|Not Treated|Overall Study||0|Subject withdrew before the first drug administration|
48121069|NCT01343706|100619747|FG002|Not Treated|Overall Study||0|Subject withdrew before the first drug administration|
48121070|NCT01343706|100619748|FG003|Not Treated|Overall Study||0|Subject withdrew before the first drug administration|
48121071|NCT01343706|100619749|FG004|Not Treated|Overall Study||0|Subject withdrew before the first drug administration|
48121072|NCT01343706|100619750|FG005|Not Treated|Overall Study||0|Subject withdrew before the first drug administration|
48121073|NCT01343706|100619751|FG006|Not Treated|Overall Study||0|Subject withdrew before the first drug administration|
48121074|NCT01343706|100619752|FG007|Not Treated|Overall Study||0|Subject withdrew before the first drug administration|
48121075|NCT01343706|100619753|FG008|Not Treated|Overall Study||1|Subject withdrew before the first drug administration|
48121076|NCT01343706|100619754|FG009|Not Treated|Overall Study||0|Subject withdrew before the first drug administration|
48121077|NCT01343706|100619755|FG010|Not Treated|Overall Study||0|Subject withdrew before the first drug administration|
48121078|NCT01343706|100619756|FG011|Not Treated|Overall Study||0|Subject withdrew before the first drug administration|
48121079|NCT01343706|100619745|FG000|COMPLETED|Overall Study||18|Completed planned observation time|
48121080|NCT01343706|100619746|FG001|COMPLETED|Overall Study||6|Completed planned observation time|
48121081|NCT01343706|100619747|FG002|COMPLETED|Overall Study||6|Completed planned observation time|
48121082|NCT01343706|100619748|FG003|COMPLETED|Overall Study||6|Completed planned observation time|
48121083|NCT01343706|100619749|FG004|COMPLETED|Overall Study||6|Completed planned observation time|
48121084|NCT01343706|100619750|FG005|COMPLETED|Overall Study||6|Completed planned observation time|
48121085|NCT01343706|100619751|FG006|COMPLETED|Overall Study||6|Completed planned observation time|
48121086|NCT01343706|100619752|FG007|COMPLETED|Overall Study||2|Completed planned observation time|
48121087|NCT01343706|100619753|FG008|COMPLETED|Overall Study||5|Completed planned observation time|
48121088|NCT01343706|100619754|FG009|COMPLETED|Overall Study||6|Completed planned observation time|
48121089|NCT01343706|100619755|FG010|COMPLETED|Overall Study||6|Completed planned observation time|
48121090|NCT01343706|100619756|FG011|COMPLETED|Overall Study||6|Completed planned observation time|
48121091|NCT01343706|100619745|FG000|NOT COMPLETED|Overall Study||0||
48121092|NCT01343706|100619746|FG001|NOT COMPLETED|Overall Study||0||
48121093|NCT01343706|100619747|FG002|NOT COMPLETED|Overall Study||0||
48121094|NCT01343706|100619748|FG003|NOT COMPLETED|Overall Study||0||
48121095|NCT01343706|100619749|FG004|NOT COMPLETED|Overall Study||0||
48121096|NCT01343706|100619750|FG005|NOT COMPLETED|Overall Study||0||
48121097|NCT01343706|100619751|FG006|NOT COMPLETED|Overall Study||0||
48121098|NCT01343706|100619752|FG007|NOT COMPLETED|Overall Study||0||
48121099|NCT01343706|100619753|FG008|NOT COMPLETED|Overall Study||1||
48121100|NCT01343706|100619754|FG009|NOT COMPLETED|Overall Study||0||
48121101|NCT01343706|100619755|FG010|NOT COMPLETED|Overall Study||0||
48121102|NCT01343706|100619756|FG011|NOT COMPLETED|Overall Study||0||
48121103|NCT05267171|100619757|FG000|STARTED|Overall Study||207||
48121104|NCT05267171|100619758|FG001|STARTED|Overall Study||244||
48121105|NCT05267171|100619757|FG000|COMPLETED|Overall Study||101||
48121106|NCT05267171|100619758|FG001|COMPLETED|Overall Study||188||
48121107|NCT05267171|100619757|FG000|NOT COMPLETED|Overall Study||106||
48121108|NCT05267171|100619758|FG001|NOT COMPLETED|Overall Study||56||
48121109|NCT04111497|100619759|FG000|STARTED|Overall Study||15||
48121110|NCT04111497|100619759|FG000|COMPLETED|Overall Study||1|Completed means a participant finished study drug per protocol.|
48121111|NCT04111497|100619759|FG000|NOT COMPLETED|Overall Study||14||
48121112|NCT02506114|100619760|FG000|STARTED|Overall Study||5||
48121113|NCT02506114|100619761|FG001|STARTED|Overall Study||4||
48121114|NCT02506114|100619762|FG002|STARTED|Overall Study||6||
48121115|NCT02506114|100619760|FG000|COMPLETED|Overall Study||5||
48121116|NCT02506114|100619761|FG001|COMPLETED|Overall Study||4||
48121117|NCT02506114|100619762|FG002|COMPLETED|Overall Study||6||
48121118|NCT02506114|100619760|FG000|NOT COMPLETED|Overall Study||0||
48121119|NCT02506114|100619761|FG001|NOT COMPLETED|Overall Study||0||
48121120|NCT02506114|100619762|FG002|NOT COMPLETED|Overall Study||0||
48121121|NCT01328002|100619763|FG000|STARTED|Open-Label Period||116||
48121122|NCT01328002|100619764|FG001|STARTED|Open-Label Period||0||
48121123|NCT01328002|100619763|FG000|COMPLETED|Open-Label Period||20||
48121124|NCT01328002|100619764|FG001|COMPLETED|Open-Label Period||0||
48121125|NCT01328002|100619763|FG000|NOT COMPLETED|Open-Label Period||96||
48121126|NCT01328002|100619764|FG001|NOT COMPLETED|Open-Label Period||0||
48121127|NCT01328002|100619763|FG000|STARTED|Double-Blind Period||14||
48121128|NCT01328002|100619764|FG001|STARTED|Double-Blind Period||6||
48121129|NCT01328002|100619763|FG000|COMPLETED|Double-Blind Period||12||
48121130|NCT01328002|100619764|FG001|COMPLETED|Double-Blind Period||6||
48121131|NCT01328002|100619763|FG000|NOT COMPLETED|Double-Blind Period||2||
48121132|NCT01328002|100619764|FG001|NOT COMPLETED|Double-Blind Period||0||
48121133|NCT02103478|100619765|FG000|STARTED|Overall Study||7||
48121134|NCT02103478|100619766|FG001|STARTED|Overall Study||6||
48121135|NCT02103478|100619767|FG002|STARTED|Overall Study||6||
48121136|NCT02103478|100619768|FG003|STARTED|Overall Study||6||
48121137|NCT02103478|100619769|FG004|STARTED|Overall Study||19||
48121138|NCT02103478|100619770|FG005|STARTED|Overall Study||25||
48121139|NCT02103478|100619771|FG006|STARTED|Overall Study||25||
48121140|NCT02103478|100619772|FG007|STARTED|Overall Study||16||
48121141|NCT02103478|100619773|FG008|STARTED|Overall Study||14||
48121142|NCT02103478|100619765|FG000|COMPLETED|Overall Study||0||
48121143|NCT02103478|100619766|FG001|COMPLETED|Overall Study||0||
48121144|NCT02103478|100619767|FG002|COMPLETED|Overall Study||0||
48121145|NCT02103478|100619768|FG003|COMPLETED|Overall Study||0||
48121146|NCT02103478|100619769|FG004|COMPLETED|Overall Study||0||
48121147|NCT02103478|100619770|FG005|COMPLETED|Overall Study||0||
48121148|NCT02103478|100619771|FG006|COMPLETED|Overall Study||0||
48121149|NCT02103478|100619772|FG007|COMPLETED|Overall Study||0||
48121150|NCT02103478|100619773|FG008|COMPLETED|Overall Study||0||
48121151|NCT02103478|100619765|FG000|NOT COMPLETED|Overall Study||7||
48121152|NCT02103478|100619766|FG001|NOT COMPLETED|Overall Study||6||
48121153|NCT02103478|100619767|FG002|NOT COMPLETED|Overall Study||6||
48121154|NCT02103478|100619768|FG003|NOT COMPLETED|Overall Study||6||
48121155|NCT02103478|100619769|FG004|NOT COMPLETED|Overall Study||19||
48121156|NCT02103478|100619770|FG005|NOT COMPLETED|Overall Study||25||
48121157|NCT02103478|100619771|FG006|NOT COMPLETED|Overall Study||25||
48121158|NCT02103478|100619772|FG007|NOT COMPLETED|Overall Study||16||
48121159|NCT02103478|100619773|FG008|NOT COMPLETED|Overall Study||14||
48121160|NCT02944578|100619774|FG000|STARTED|Overall Study||4||
48121161|NCT02944578|100619775|FG001|STARTED|Overall Study||3||
48121162|NCT02944578|100619774|FG000|COMPLETED|Overall Study||3||
48121163|NCT02944578|100619775|FG001|COMPLETED|Overall Study||3||
48121164|NCT02944578|100619774|FG000|NOT COMPLETED|Overall Study||1||
48121165|NCT02944578|100619775|FG001|NOT COMPLETED|Overall Study||0||
48121166|NCT01312766|100619776|FG000|STARTED|Overall Study||135||
48121167|NCT01312766|100619777|FG001|STARTED|Overall Study||135||
48121168|NCT01312766|100619776|FG000|COMPLETED|Overall Study||129||
48121169|NCT01312766|100619777|FG001|COMPLETED|Overall Study||130||
48121170|NCT01312766|100619776|FG000|NOT COMPLETED|Overall Study||6||
48121171|NCT01312766|100619777|FG001|NOT COMPLETED|Overall Study||5||
48121172|NCT02644967|100619778|FG000|STARTED|Overall Study||53||
48121173|NCT02644967|100619778|FG000|COMPLETED|Overall Study||18||
48121174|NCT02644967|100619778|FG000|NOT COMPLETED|Overall Study||35||
48121175|NCT00323739|100619779|FG000|STARTED|Overall Study||80||
48121176|NCT00323739|100619779|FG000|COMPLETED|Overall Study||80||
48121177|NCT00323739|100619779|FG000|NOT COMPLETED|Overall Study||0||
48121178|NCT03127228|100619780|FG000|STARTED|Overall Study||12||
48121179|NCT03127228|100619781|FG001|STARTED|Overall Study||12||
48121180|NCT03127228|100619780|FG000|COMPLETED|Overall Study||12||
48121181|NCT03127228|100619781|FG001|COMPLETED|Overall Study||12||
48121182|NCT03127228|100619780|FG000|NOT COMPLETED|Overall Study||0||
48121183|NCT03127228|100619781|FG001|NOT COMPLETED|Overall Study||0||
48121184|NCT02187016|100619782|FG000|STARTED|Overall Study||80||
48121185|NCT02187016|100619783|FG001|STARTED|Overall Study||80||
48121186|NCT02187016|100619784|FG002|STARTED|Overall Study||79||
48121187|NCT02187016|100619785|FG003|STARTED|Overall Study||51||
48121188|NCT02187016|100619782|FG000|COMPLETED|Overall Study||79||
48121189|NCT02187016|100619783|FG001|COMPLETED|Overall Study||78||
48121190|NCT02187016|100619784|FG002|COMPLETED|Overall Study||78||
48121191|NCT02187016|100619785|FG003|COMPLETED|Overall Study||51||
48121192|NCT02187016|100619782|FG000|NOT COMPLETED|Overall Study||1||
48121193|NCT02187016|100619783|FG001|NOT COMPLETED|Overall Study||2||
48121194|NCT02187016|100619784|FG002|NOT COMPLETED|Overall Study||1||
48121195|NCT02187016|100619785|FG003|NOT COMPLETED|Overall Study||0||
48121196|NCT01565993|100619786|FG000|STARTED|Overall Study||66||
48121197|NCT01565993|100619787|FG001|STARTED|Overall Study||42||
48121198|NCT01565993|100619786|FG000|COMPLETED|Overall Study||66||
48121199|NCT01565993|100619787|FG001|COMPLETED|Overall Study||39||
48121200|NCT01565993|100619786|FG000|NOT COMPLETED|Overall Study||0||
48121201|NCT01565993|100619787|FG001|NOT COMPLETED|Overall Study||3||
48121202|NCT04327934|100619788|FG000|STARTED|Overall Study||14||
48121203|NCT04327934|100619789|FG001|STARTED|Overall Study||14||
48121204|NCT04327934|100619788|FG000|COMPLETED|Overall Study||7||
48121205|NCT04327934|100619789|FG001|COMPLETED|Overall Study||9||
48121206|NCT04327934|100619788|FG000|NOT COMPLETED|Overall Study||7||
48121207|NCT04327934|100619789|FG001|NOT COMPLETED|Overall Study||5||
48121208|NCT02970968|100619790|FG000|STARTED|Overall Study||77||
48121209|NCT02970968|100619791|FG001|STARTED|Overall Study||75||
48121210|NCT02970968|100619790|FG000|COMPLETED|Overall Study||72||
48121211|NCT02970968|100619791|FG001|COMPLETED|Overall Study||68||
48121212|NCT02970968|100619790|FG000|NOT COMPLETED|Overall Study||5||
48121213|NCT02970968|100619791|FG001|NOT COMPLETED|Overall Study||7||
48121214|NCT01175824|100619792|FG000|STARTED|Overall Study||236||
48121215|NCT01175824|100619793|FG001|STARTED|Overall Study||242||
48121216|NCT01175824|100619792|FG000|Received at Least 1 Dose of Study Drug|Overall Study||236||
48121217|NCT01175824|100619793|FG001|Received at Least 1 Dose of Study Drug|Overall Study||240||
48121218|NCT01175824|100619792|FG000|COMPLETED|Overall Study||220||
48121219|NCT01175824|100619793|FG001|COMPLETED|Overall Study||220||
48121220|NCT01175824|100619792|FG000|NOT COMPLETED|Overall Study||16||
48121221|NCT01175824|100619793|FG001|NOT COMPLETED|Overall Study||22||
48121222|NCT01976416|100619794|FG000|STARTED|Overall Study||104||
48121223|NCT01976416|100619795|FG001|STARTED|Overall Study||104||
48121224|NCT01976416|100619794|FG000|COMPLETED|Overall Study||102||
48121225|NCT01976416|100619795|FG001|COMPLETED|Overall Study||102||
48121226|NCT01976416|100619794|FG000|NOT COMPLETED|Overall Study||2||
48121227|NCT01976416|100619795|FG001|NOT COMPLETED|Overall Study||2||
48121228|NCT00058240|100619796|FG000|STARTED|First Dose Level||20||
48121229|NCT00058240|100619797|FG001|STARTED|First Dose Level||3||
48121230|NCT00058240|100619798|FG002|STARTED|First Dose Level||17||
48121231|NCT00058240|100619799|FG003|STARTED|First Dose Level||12||
48121232|NCT00058240|100619796|FG000|Treated|First Dose Level||20||
48121233|NCT00058240|100619797|FG001|Treated|First Dose Level||3||
48121234|NCT00058240|100619798|FG002|Treated|First Dose Level||17||
48121235|NCT00058240|100619799|FG003|Treated|First Dose Level||12||
48121236|NCT00058240|100619796|FG000|COMPLETED|First Dose Level||20||
48121237|NCT00058240|100619797|FG001|COMPLETED|First Dose Level||3||
48121238|NCT00058240|100619798|FG002|COMPLETED|First Dose Level||17||
48121239|NCT00058240|100619799|FG003|COMPLETED|First Dose Level||12||
48121240|NCT00058240|100619796|FG000|NOT COMPLETED|First Dose Level||0||
48121241|NCT00058240|100619797|FG001|NOT COMPLETED|First Dose Level||0||
48121242|NCT00058240|100619798|FG002|NOT COMPLETED|First Dose Level||0||
48121243|NCT00058240|100619799|FG003|NOT COMPLETED|First Dose Level||0||
48121244|NCT00058240|100619796|FG000|STARTED|Second Dose Level||0||
48121245|NCT00058240|100619797|FG001|STARTED|Second Dose Level||0||
48281678|NCT01859988|101014147|FG000|COMPLETED|Overall Study||52||
48121246|NCT00058240|100619798|FG002|STARTED|Second Dose Level||2||
48121247|NCT00058240|100619799|FG003|STARTED|Second Dose Level||4||
48121248|NCT00058240|100619796|FG000|COMPLETED|Second Dose Level||0||
48121249|NCT00058240|100619797|FG001|COMPLETED|Second Dose Level||0||
48121250|NCT00058240|100619798|FG002|COMPLETED|Second Dose Level||2||
48121251|NCT00058240|100619799|FG003|COMPLETED|Second Dose Level||4||
48121252|NCT00058240|100619796|FG000|NOT COMPLETED|Second Dose Level||0||
48121253|NCT00058240|100619797|FG001|NOT COMPLETED|Second Dose Level||0||
48121254|NCT00058240|100619798|FG002|NOT COMPLETED|Second Dose Level||0||
48121255|NCT00058240|100619799|FG003|NOT COMPLETED|Second Dose Level||0||
48121256|NCT05204134|100619800|FG000|STARTED|Overall Study||33||
48121257|NCT05204134|100619800|FG000|Completed Run-In|Overall Study||33||
48121258|NCT05204134|100619800|FG000|COMPLETED|Overall Study||29||
48121259|NCT05204134|100619800|FG000|NOT COMPLETED|Overall Study||4||
48121260|NCT02442700|100622843|FG000|STARTED|First 12 Weeks||12||
48121261|NCT02442700|100622844|FG001|STARTED|First 12 Weeks||12||
48121262|NCT02442700|100622843|FG000|COMPLETED|First 12 Weeks||12||
48121263|NCT02442700|100622844|FG001|COMPLETED|First 12 Weeks||12||
48121264|NCT02442700|100622843|FG000|NOT COMPLETED|First 12 Weeks||0||
48121265|NCT02442700|100622844|FG001|NOT COMPLETED|First 12 Weeks||0||
48121266|NCT02442700|100622843|FG000|STARTED|Later 12 Weeks||12||
48121267|NCT02442700|100622844|FG001|STARTED|Later 12 Weeks||12||
48121268|NCT02442700|100622843|FG000|COMPLETED|Later 12 Weeks||12||
48121269|NCT02442700|100622844|FG001|COMPLETED|Later 12 Weeks||12||
48121270|NCT02442700|100622843|FG000|NOT COMPLETED|Later 12 Weeks||0||
48121271|NCT02442700|100622844|FG001|NOT COMPLETED|Later 12 Weeks||0||
48121272|NCT03586999|100622845|FG000|STARTED|Overall Study||18||
48121273|NCT03586999|100622845|FG000|COMPLETED|Overall Study||16||
48121274|NCT03586999|100622845|FG000|NOT COMPLETED|Overall Study||2||
48121275|NCT01581593|100622846|FG000|STARTED|Overall Study||45||
48121276|NCT01581593|100622846|FG000|COMPLETED|Overall Study||44||
48121277|NCT01581593|100622846|FG000|NOT COMPLETED|Overall Study||1||
48121278|NCT02082522|100622847|FG000|STARTED|Overall Study||15||
48121279|NCT02082522|100622848|FG001|STARTED|Overall Study||13||
48121280|NCT02082522|100622847|FG000|COMPLETED|Overall Study||0||
48121281|NCT02082522|100622848|FG001|COMPLETED|Overall Study||0||
48121282|NCT02082522|100622847|FG000|NOT COMPLETED|Overall Study||15||
48121283|NCT02082522|100622848|FG001|NOT COMPLETED|Overall Study||13||
48121284|NCT04208412|100622849|FG000|STARTED|Overall Study||34||
48121285|NCT04208412|100622850|FG001|STARTED|Overall Study||34||
48121286|NCT04208412|100622849|FG000|COMPLETED|Overall Study||25||
48121287|NCT04208412|100622850|FG001|COMPLETED|Overall Study||28||
48121288|NCT04208412|100622849|FG000|NOT COMPLETED|Overall Study||9||
48121289|NCT04208412|100622850|FG001|NOT COMPLETED|Overall Study||6||
48121290|NCT01336738|100622851|FG000|STARTED|Overall Study||52||
48121291|NCT01336738|100622852|FG001|STARTED|Overall Study||54||
48121292|NCT01336738|100622853|FG002|STARTED|Overall Study||53||
48121293|NCT01336738|100622854|FG003|STARTED|Overall Study||54||
48121294|NCT01336738|100622855|FG004|STARTED|Overall Study||53||
48121295|NCT01336738|100622851|FG000|COMPLETED|Overall Study||45||
48121296|NCT01336738|100622852|FG001|COMPLETED|Overall Study||45||
48121297|NCT01336738|100622853|FG002|COMPLETED|Overall Study||45||
48121298|NCT01336738|100622854|FG003|COMPLETED|Overall Study||47||
48121299|NCT01336738|100622855|FG004|COMPLETED|Overall Study||43||
48121300|NCT01336738|100622851|FG000|NOT COMPLETED|Overall Study||7||
48121301|NCT01336738|100622852|FG001|NOT COMPLETED|Overall Study||9||
48121302|NCT01336738|100622853|FG002|NOT COMPLETED|Overall Study||8||
48121303|NCT01336738|100622854|FG003|NOT COMPLETED|Overall Study||7||
48121304|NCT01336738|100622855|FG004|NOT COMPLETED|Overall Study||10||
48121305|NCT04031885|100622856|FG000|STARTED|Overall Study||1||
48121306|NCT04031885|100622857|FG001|STARTED|Overall Study||3||
48121307|NCT04031885|100622856|FG000|Received Any Quantity of Study Treatment|Overall Study||1||
48121308|NCT04031885|100622857|FG001|Received Any Quantity of Study Treatment|Overall Study||1||
48121309|NCT04031885|100622856|FG000|COMPLETED|Overall Study||1||
48121310|NCT04031885|100622857|FG001|COMPLETED|Overall Study||3||
48121311|NCT04031885|100622856|FG000|NOT COMPLETED|Overall Study||0||
48121312|NCT04031885|100622857|FG001|NOT COMPLETED|Overall Study||0||
48121313|NCT01548690|100622858|FG000|STARTED|Overall Study||9||
48121314|NCT01548690|100622859|FG001|STARTED|Overall Study||10||
48121315|NCT01548690|100622860|FG002|STARTED|Overall Study||13||
48121316|NCT01548690|100622861|FG003|STARTED|Overall Study||15||
48121317|NCT01548690|100622858|FG000|Evaluable (72 Hours on Infusion)|Overall Study||6||
48121318|NCT01548690|100622859|FG001|Evaluable (72 Hours on Infusion)|Overall Study||6||
48121319|NCT01548690|100622860|FG002|Evaluable (72 Hours on Infusion)|Overall Study||12||
48121320|NCT01548690|100622861|FG003|Evaluable (72 Hours on Infusion)|Overall Study||12||
48121321|NCT01548690|100622858|FG000|COMPLETED|Overall Study||9||
48121322|NCT01548690|100622859|FG001|COMPLETED|Overall Study||7||
48121323|NCT01548690|100622860|FG002|COMPLETED|Overall Study||8||
48121324|NCT01548690|100622861|FG003|COMPLETED|Overall Study||10||
48121325|NCT01548690|100622858|FG000|NOT COMPLETED|Overall Study||0||
48121326|NCT01548690|100622859|FG001|NOT COMPLETED|Overall Study||3||
48121327|NCT01548690|100622860|FG002|NOT COMPLETED|Overall Study||5||
48121328|NCT01548690|100622861|FG003|NOT COMPLETED|Overall Study||5||
48121329|NCT00941733|100622862|FG000|STARTED|Overall Study||239||
48121330|NCT00941733|100622863|FG001|STARTED|Overall Study||119||
48121331|NCT00941733|100622862|FG000|COMPLETED|Overall Study||165||
48121332|NCT00941733|100622863|FG001|COMPLETED|Overall Study||91||
48121333|NCT00941733|100622862|FG000|NOT COMPLETED|Overall Study||74||
48121334|NCT00941733|100622863|FG001|NOT COMPLETED|Overall Study||28||
48121335|NCT01752933|100622864|FG000|STARTED|Treatment||4|"Reason Not Completed shown below are reasons for treatment discontinuation"|
48121336|NCT01752933|100622865|FG001|STARTED|Treatment||46|"Reason Not Completed shown below are reasons for treatment discontinuation"|
48121337|NCT01752933|100622864|FG000|COMPLETED|Treatment||0|Treatment continued as long as patient was benefitting from treatment with manageable side effects|
48121338|NCT01752933|100622865|FG001|COMPLETED|Treatment||0|Treatment continued as long as patient was benefitting from treatment with manageable side effects|
48121339|NCT01752933|100622864|FG000|NOT COMPLETED|Treatment||4||
48121340|NCT01752933|100622865|FG001|NOT COMPLETED|Treatment||46||
48121341|NCT01752933|100622864|FG000|STARTED|Overall Study and Follow-up||4|"Reason Not Completed shown below are reasons for study discontinuation"|
48121342|NCT01752933|100622865|FG001|STARTED|Overall Study and Follow-up||46|"Reason Not Completed shown below are reasons for study discontinuation"|
48121343|NCT01752933|100622864|FG000|COMPLETED|Overall Study and Follow-up||0||
48121344|NCT01752933|100622865|FG001|COMPLETED|Overall Study and Follow-up||0||
48121345|NCT01752933|100622864|FG000|NOT COMPLETED|Overall Study and Follow-up||4||
48121346|NCT01752933|100622865|FG001|NOT COMPLETED|Overall Study and Follow-up||46||
48121347|NCT02550652|100622866|FG000|STARTED|Overall Study||63||
48121348|NCT02550652|100622867|FG001|STARTED|Overall Study||62||
48121349|NCT02550652|100622866|FG000|COMPLETED|Overall Study||55||
48121350|NCT02550652|100622867|FG001|COMPLETED|Overall Study||44||
48121351|NCT02550652|100622866|FG000|NOT COMPLETED|Overall Study||8||
48121352|NCT02550652|100622867|FG001|NOT COMPLETED|Overall Study||18||
48121353|NCT02496884|100622868|FG000|STARTED|Overall Study||17||
48121354|NCT02496884|100622869|FG001|STARTED|Overall Study||34||
48121355|NCT02496884|100622870|FG002|STARTED|Overall Study||1||
48121356|NCT02496884|100622871|FG003|STARTED|Overall Study||4||
48121357|NCT02496884|100622868|FG000|Safety Analysis Set|Overall Study||17||
48121358|NCT02496884|100622869|FG001|Safety Analysis Set|Overall Study||34||
48121359|NCT02496884|100622870|FG002|Safety Analysis Set|Overall Study||1||
48121360|NCT02496884|100622871|FG003|Safety Analysis Set|Overall Study||4||
48121361|NCT02496884|100622868|FG000|Modified Intent to Treat Set (mITT)|Overall Study||17||
48121362|NCT02496884|100622869|FG001|Modified Intent to Treat Set (mITT)|Overall Study||34||
48121363|NCT02496884|100622870|FG002|Modified Intent to Treat Set (mITT)|Overall Study||1||
48121364|NCT02496884|100622871|FG003|Modified Intent to Treat Set (mITT)|Overall Study||4||
48121365|NCT02496884|100622868|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||0||
48121366|NCT02496884|100622869|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||33||
48121367|NCT02496884|100622870|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||0||
48121368|NCT02496884|100622871|FG003|Pharmacokinetic (PK) Analysis Set|Overall Study||4||
48121369|NCT02496884|100622868|FG000|Completed Treatment Per Protocol|Overall Study||16||
48121370|NCT02496884|100622869|FG001|Completed Treatment Per Protocol|Overall Study||27||
48121371|NCT02496884|100622870|FG002|Completed Treatment Per Protocol|Overall Study||1||
48121372|NCT02496884|100622871|FG003|Completed Treatment Per Protocol|Overall Study||3||
48121373|NCT02496884|100622868|FG000|COMPLETED|Overall Study||15||
48121374|NCT02496884|100622869|FG001|COMPLETED|Overall Study||31||
48121375|NCT02496884|100622870|FG002|COMPLETED|Overall Study||1||
48121376|NCT02496884|100622871|FG003|COMPLETED|Overall Study||4||
48121377|NCT02496884|100622868|FG000|NOT COMPLETED|Overall Study||2||
48121378|NCT02496884|100622869|FG001|NOT COMPLETED|Overall Study||3||
48121379|NCT02496884|100622870|FG002|NOT COMPLETED|Overall Study||0||
48121380|NCT02496884|100622871|FG003|NOT COMPLETED|Overall Study||0||
48121381|NCT02287415|100622872|FG000|STARTED|Overall Study||13||
48121382|NCT02287415|100622872|FG000|COMPLETED|Overall Study||13||
48121383|NCT02287415|100622872|FG000|NOT COMPLETED|Overall Study||0||
48121384|NCT01531959|100622873|FG000|STARTED|Overall Study||68||
48121385|NCT01531959|100622874|FG001|STARTED|Overall Study||68||
48121386|NCT01531959|100622873|FG000|COMPLETED|Overall Study||66||
48121387|NCT01531959|100622874|FG001|COMPLETED|Overall Study||66||
48121388|NCT01531959|100622873|FG000|NOT COMPLETED|Overall Study||2||
48121389|NCT01531959|100622874|FG001|NOT COMPLETED|Overall Study||2||
48121390|NCT02337829|100622875|FG000|STARTED|Overall Study||18||
48121391|NCT02337829|100622876|FG001|STARTED|Overall Study||14||
48121392|NCT02337829|100622877|FG002|STARTED|Overall Study||6||
48121393|NCT02337829|100622878|FG003|STARTED|Overall Study||10||
48121394|NCT02337829|100622875|FG000|COMPLETED|Overall Study||0||
48121395|NCT02337829|100622876|FG001|COMPLETED|Overall Study||0||
48121396|NCT02337829|100622877|FG002|COMPLETED|Overall Study||0||
48121397|NCT02337829|100622878|FG003|COMPLETED|Overall Study||0||
48121398|NCT02337829|100622875|FG000|NOT COMPLETED|Overall Study||18||
48121399|NCT02337829|100622876|FG001|NOT COMPLETED|Overall Study||14||
48121400|NCT02337829|100622877|FG002|NOT COMPLETED|Overall Study||6||
48121401|NCT02337829|100622878|FG003|NOT COMPLETED|Overall Study||10||
48121402|NCT02057757|100622879|FG000|STARTED|Overall Study||131||
48121403|NCT02057757|100622880|FG001|STARTED|Overall Study||129||
48121404|NCT02057757|100622879|FG000|Intent to Treat|Overall Study||130||
48121405|NCT02057757|100622880|FG001|Intent to Treat|Overall Study||127||
48121406|NCT02057757|100622879|FG000|COMPLETED|Overall Study||117||
48121407|NCT02057757|100622880|FG001|COMPLETED|Overall Study||121||
48121408|NCT02057757|100622879|FG000|NOT COMPLETED|Overall Study||14||
48121409|NCT02057757|100622880|FG001|NOT COMPLETED|Overall Study||8||
48121410|NCT04524962|100622881|FG000|STARTED|Overall Study||3||
48121411|NCT04524962|100622882|FG001|STARTED|Overall Study||3||
48121412|NCT04524962|100622883|FG002|STARTED|Overall Study||5||
48121413|NCT04524962|100622884|FG003|STARTED|Overall Study||1||
48121414|NCT04524962|100622881|FG000|COMPLETED|Overall Study||3||
48121415|NCT04524962|100622882|FG001|COMPLETED|Overall Study||3||
48121416|NCT04524962|100622883|FG002|COMPLETED|Overall Study||5||
48121417|NCT04524962|100622884|FG003|COMPLETED|Overall Study||1||
48121418|NCT04524962|100622881|FG000|NOT COMPLETED|Overall Study||0||
48121419|NCT04524962|100622882|FG001|NOT COMPLETED|Overall Study||0||
48121420|NCT04524962|100622883|FG002|NOT COMPLETED|Overall Study||0||
48121421|NCT04524962|100622884|FG003|NOT COMPLETED|Overall Study||0||
48121422|NCT00587587|100622885|FG000|STARTED|Overall Study||17||
48121423|NCT00587587|100622886|FG001|STARTED|Overall Study||13||
48121424|NCT00587587|100622885|FG000|COMPLETED|Overall Study||11||
48121425|NCT00587587|100622886|FG001|COMPLETED|Overall Study||12||
48121426|NCT00587587|100622885|FG000|NOT COMPLETED|Overall Study||6||
48121427|NCT00587587|100622886|FG001|NOT COMPLETED|Overall Study||1||
48121428|NCT03970109|100622887|FG000|STARTED|Overall Study||15||
48121429|NCT03970109|100622888|FG001|STARTED|Overall Study||13||
48121430|NCT03970109|100622889|FG002|STARTED|Overall Study||15||
48121431|NCT03970109|100622887|FG000|COMPLETED|Overall Study||14||
48121432|NCT03970109|100622888|FG001|COMPLETED|Overall Study||10||
48121433|NCT03970109|100622889|FG002|COMPLETED|Overall Study||15||
48121434|NCT03970109|100622887|FG000|NOT COMPLETED|Overall Study||1||
48121435|NCT03970109|100622888|FG001|NOT COMPLETED|Overall Study||3||
48121436|NCT03970109|100622889|FG002|NOT COMPLETED|Overall Study||0||
48121437|NCT03509948|100622890|FG000|STARTED|Overall Study||6||
48121438|NCT03509948|100622891|FG001|STARTED|Overall Study||7||
48121439|NCT03509948|100622890|FG000|COMPLETED|Overall Study||6||
48121440|NCT03509948|100622891|FG001|COMPLETED|Overall Study||6||
48121441|NCT03509948|100622890|FG000|NOT COMPLETED|Overall Study||0||
48121442|NCT03509948|100622891|FG001|NOT COMPLETED|Overall Study||1||
48121443|NCT02809976|100622892|FG000|STARTED|Overall Study||11||
48121444|NCT02809976|100622892|FG000|COMPLETED|Overall Study||9||
48121445|NCT02809976|100622892|FG000|NOT COMPLETED|Overall Study||2||
48121446|NCT02489981|100622893|FG000|STARTED|Overall Study||340|Started patients in the safety set|
48121447|NCT02489981|100622893|FG000|COMPLETED|Overall Study||213||
48121448|NCT02489981|100622893|FG000|NOT COMPLETED|Overall Study||127||
48121449|NCT03285646|100622894|FG000|STARTED|Overall Study||32||
48121450|NCT03285646|100622895|FG001|STARTED|Overall Study||31||
48121451|NCT03285646|100622894|FG000|COMPLETED|Overall Study||19||
48121452|NCT03285646|100622895|FG001|COMPLETED|Overall Study||27||
48121453|NCT03285646|100622894|FG000|NOT COMPLETED|Overall Study||13||
48121454|NCT03285646|100622895|FG001|NOT COMPLETED|Overall Study||4||
48121455|NCT04709237|100622896|FG000|STARTED|Overall Study||7||
48121456|NCT04709237|100622897|FG001|STARTED|Overall Study||7||
48121457|NCT04709237|100622898|FG002|STARTED|Overall Study||7||
48121458|NCT04709237|100622896|FG000|COMPLETED|Overall Study||6||
48121459|NCT04709237|100622897|FG001|COMPLETED|Overall Study||7||
48121460|NCT04709237|100622898|FG002|COMPLETED|Overall Study||7||
48121461|NCT04709237|100622896|FG000|NOT COMPLETED|Overall Study||1||
48121462|NCT04709237|100622897|FG001|NOT COMPLETED|Overall Study||0||
48121463|NCT04709237|100622898|FG002|NOT COMPLETED|Overall Study||0||
48121464|NCT01940705|100622899|FG000|STARTED|Overall Study||66||
48121465|NCT01940705|100622900|FG001|STARTED|Overall Study||67||
48121466|NCT01940705|100622901|FG002|STARTED|Overall Study||69||
48121467|NCT01940705|100622902|FG003|STARTED|Overall Study||67||
48121468|NCT01940705|100622899|FG000|COMPLETED|Overall Study||62||
48121469|NCT01940705|100622900|FG001|COMPLETED|Overall Study||59||
48121470|NCT01940705|100622901|FG002|COMPLETED|Overall Study||61||
48121471|NCT01940705|100622902|FG003|COMPLETED|Overall Study||63||
48121472|NCT01940705|100622899|FG000|NOT COMPLETED|Overall Study||4||
48121473|NCT01940705|100622900|FG001|NOT COMPLETED|Overall Study||8||
48121474|NCT01940705|100622901|FG002|NOT COMPLETED|Overall Study||8||
48121475|NCT01940705|100622902|FG003|NOT COMPLETED|Overall Study||4||
48121476|NCT01181895|100622903|FG000|STARTED|Overall Study||116||
48121477|NCT01181895|100622904|FG001|STARTED|Overall Study||115||
48121478|NCT01181895|100622905|FG002|STARTED|Overall Study||116||
48121479|NCT01181895|100622903|FG000|COMPLETED|Overall Study||99||
48121480|NCT01181895|100622904|FG001|COMPLETED|Overall Study||101||
48121481|NCT01181895|100622905|FG002|COMPLETED|Overall Study||98||
48121482|NCT01181895|100622903|FG000|NOT COMPLETED|Overall Study||17||
48121483|NCT01181895|100622904|FG001|NOT COMPLETED|Overall Study||14||
48121484|NCT01181895|100622905|FG002|NOT COMPLETED|Overall Study||18||
48121485|NCT01383681|100622906|FG000|STARTED|Overall Study||235||
48121486|NCT01383681|100622906|FG000|COMPLETED|Overall Study||189||
48121487|NCT01383681|100622906|FG000|NOT COMPLETED|Overall Study||46||
48121488|NCT03383588|100622907|FG000|STARTED|Overall Study||8||
48121489|NCT03383588|100622908|FG001|STARTED|Overall Study||9||
48121490|NCT03383588|100622909|FG002|STARTED|Overall Study||9||
48121491|NCT03383588|100622907|FG000|COMPLETED|Overall Study||8||
48121492|NCT03383588|100622908|FG001|COMPLETED|Overall Study||9||
48121493|NCT03383588|100622909|FG002|COMPLETED|Overall Study||9||
48121494|NCT03383588|100622907|FG000|NOT COMPLETED|Overall Study||0||
48121495|NCT03383588|100622908|FG001|NOT COMPLETED|Overall Study||0||
48121496|NCT03383588|100622909|FG002|NOT COMPLETED|Overall Study||0||
48121497|NCT04048460|100622910|FG000|STARTED|Overall Study||10||
48121498|NCT04048460|100622910|FG000|COMPLETED|Overall Study||10||
48569404|NCT00725153|101724774|FG000|NOT COMPLETED|Period One, 10 Hours of Wear||0||
48569405|NCT00725153|101724775|FG001|NOT COMPLETED|Period One, 10 Hours of Wear||0||
48569406|NCT00725153|101724774|FG000|STARTED|Period Two, 10 Hours of Wear||27||
48569407|NCT00725153|101724775|FG001|STARTED|Period Two, 10 Hours of Wear||28||
48569408|NCT00725153|101724774|FG000|COMPLETED|Period Two, 10 Hours of Wear||27||
48396583|NCT00884221|101299394|FG001|STARTED|Overall Study||375||
48396584|NCT00884221|101299393|FG000|COMPLETED|Overall Study||340||
48396585|NCT00884221|101299394|FG001|COMPLETED|Overall Study||343||
48396586|NCT00884221|101299393|FG000|NOT COMPLETED|Overall Study||34||
48396587|NCT00884221|101299394|FG001|NOT COMPLETED|Overall Study||32||
48569409|NCT00725153|101724775|FG001|COMPLETED|Period Two, 10 Hours of Wear||28||
48569410|NCT00725153|101724774|FG000|NOT COMPLETED|Period Two, 10 Hours of Wear||0||
48569411|NCT00725153|101724775|FG001|NOT COMPLETED|Period Two, 10 Hours of Wear||0||
48569412|NCT04578457|101724776|FG000|STARTED|Hearing Aid Without NR Enabled (0)||19||
48121499|NCT04048460|100622910|FG000|NOT COMPLETED|Overall Study||0||
48121500|NCT01105247|100622911|FG000|STARTED|Overall Study||116||
48121501|NCT01105247|100622912|FG001|STARTED|Overall Study||16||
48121502|NCT01105247|100622911|FG000|COMPLETED|Overall Study||79||
48396588|NCT02186457|101299395|FG000|STARTED|Overall Study||95||
48396589|NCT02186457|101299396|FG001|STARTED|Overall Study||95||
48569413|NCT04578457|101724776|FG000|COMPLETED|Hearing Aid Without NR Enabled (0)||17||
48121503|NCT01105247|100622912|FG001|COMPLETED|Overall Study||16||
48396590|NCT02186457|101299395|FG000|COMPLETED|Overall Study||95||
48396591|NCT02186457|101299396|FG001|COMPLETED|Overall Study||95||
48396592|NCT02186457|101299395|FG000|NOT COMPLETED|Overall Study||0||
48121504|NCT01105247|100622911|FG000|NOT COMPLETED|Overall Study||37||
48121505|NCT01105247|100622912|FG001|NOT COMPLETED|Overall Study||0||
48121506|NCT00843791|100622913|FG000|STARTED|Overall Study||3||
48121507|NCT00843791|100622914|FG001|STARTED|Overall Study||3||
48121508|NCT00843791|100622913|FG000|COMPLETED|Overall Study||3||
48121509|NCT00843791|100622914|FG001|COMPLETED|Overall Study||3||
48121510|NCT00843791|100622913|FG000|NOT COMPLETED|Overall Study||0||
48121511|NCT00843791|100622914|FG001|NOT COMPLETED|Overall Study||0||
48121512|NCT04116229|100622915|FG000|STARTED|Overall Study||10||
48121513|NCT04116229|100622916|FG001|STARTED|Overall Study||10||
48121514|NCT04116229|100622915|FG000|COMPLETED|Overall Study||8||
48121515|NCT04116229|100622916|FG001|COMPLETED|Overall Study||6||
48121516|NCT04116229|100622915|FG000|NOT COMPLETED|Overall Study||2||
48121517|NCT04116229|100622916|FG001|NOT COMPLETED|Overall Study||4||
48396593|NCT02186457|101299396|FG001|NOT COMPLETED|Overall Study||0||
48396594|NCT01378299|101299397|FG000|STARTED|Overall Study||105||
48396595|NCT01378299|101299397|FG000|BMI group1|Overall Study||38|BMI of \<30 kg/m\^2|
48121518|NCT03915548|100622917|FG000|STARTED|Overall Study||144||
48121519|NCT03915548|100622918|FG001|STARTED|Overall Study||140||
48121520|NCT03915548|100622917|FG000|Session 1|Overall Study||139||
48121521|NCT03915548|100622918|FG001|Session 1|Overall Study||136||
48121522|NCT03915548|100622917|FG000|Session 2|Overall Study||138||
48121523|NCT03915548|100622918|FG001|Session 2|Overall Study||135||
48121524|NCT03915548|100622917|FG000|Session 3|Overall Study||134||
48121525|NCT03915548|100622918|FG001|Session 3|Overall Study||132||
48121526|NCT03915548|100622917|FG000|Session 4|Overall Study||131||
48121527|NCT03915548|100622918|FG001|Session 4|Overall Study||130||
48121528|NCT03915548|100622917|FG000|Session 5|Overall Study||128||
48121529|NCT03915548|100622918|FG001|Session 5|Overall Study||128||
48121530|NCT03915548|100622917|FG000|Session 6|Overall Study||127||
48121531|NCT03915548|100622918|FG001|Session 6|Overall Study||126||
48121532|NCT03915548|100622917|FG000|Follow-up Data Collection 1 (Week 8)|Overall Study||124||
48121533|NCT03915548|100622918|FG001|Follow-up Data Collection 1 (Week 8)|Overall Study||128||
48569414|NCT04578457|101724776|FG000|NOT COMPLETED|Hearing Aid Without NR Enabled (0)||2||
48569415|NCT04578457|101724776|FG000|STARTED|Hearing Aid With NR (1)||19|"The discrepancy between the number of participants starting this period and finishing the previous period is simply due to the fact that the study 'periods' as reported are not chronological.~See 'Arm/Group Description' for details."|
48569416|NCT04578457|101724776|FG000|COMPLETED|Hearing Aid With NR (1)||17||
48121534|NCT03915548|100622917|FG000|Session 7|Overall Study||126||
48121535|NCT03915548|100622918|FG001|Session 7|Overall Study||124||
48121536|NCT03915548|100622917|FG000|Session 8|Overall Study||126||
48121537|NCT03915548|100622918|FG001|Session 8|Overall Study||119||
48121538|NCT03915548|100622917|FG000|Session 9|Overall Study||120||
48121539|NCT03915548|100622918|FG001|Session 9|Overall Study||119||
48121540|NCT03915548|100622917|FG000|Follow-up Data Collection 2 (Week 20)|Overall Study||123||
48121541|NCT03915548|100622918|FG001|Follow-up Data Collection 2 (Week 20)|Overall Study||124||
48121542|NCT03915548|100622917|FG000|Follow-up Data Collection 3 (Week 44)|Overall Study||118||
48121543|NCT03915548|100622918|FG001|Follow-up Data Collection 3 (Week 44)|Overall Study||113||
48121544|NCT03915548|100622917|FG000|COMPLETED|Overall Study||118|All 144 intervention participants and all 140 control participants were included in the final analyses|
48121545|NCT03915548|100622918|FG001|COMPLETED|Overall Study||113|All 144 intervention participants and all 140 control participants were included in the final analyses|
48121546|NCT03915548|100622917|FG000|NOT COMPLETED|Overall Study||26||
48121547|NCT03915548|100622918|FG001|NOT COMPLETED|Overall Study||27||
48121548|NCT01706952|100622919|FG000|STARTED|Overall Study||45||
48121549|NCT01706952|100622919|FG000|COMPLETED|Overall Study||37||
48121550|NCT01706952|100622919|FG000|NOT COMPLETED|Overall Study||8||
48121551|NCT03003520|100622920|FG000|STARTED|Overall Study||43||
48121552|NCT03003520|100622921|FG001|STARTED|Overall Study||3||
48121553|NCT03003520|100622920|FG000|Completed Induction Treatment|Overall Study||31||
48121554|NCT03003520|100622921|FG001|Completed Induction Treatment|Overall Study||3||
48121555|NCT03003520|100622920|FG000|Completed Consolidation Treatment|Overall Study||14||
48121556|NCT03003520|100622921|FG001|Completed Consolidation Treatment|Overall Study||2||
48121557|NCT03003520|100622920|FG000|COMPLETED|Overall Study||14||
48121558|NCT03003520|100622921|FG001|COMPLETED|Overall Study||2||
48121559|NCT03003520|100622920|FG000|NOT COMPLETED|Overall Study||29||
48121560|NCT03003520|100622921|FG001|NOT COMPLETED|Overall Study||1||
48121561|NCT02209324|100622922|FG000|STARTED|Overall Study||275||
48121562|NCT02209324|100622922|FG000|COMPLETED|Overall Study||230||
48121563|NCT02209324|100622922|FG000|NOT COMPLETED|Overall Study||45||
48121564|NCT04776148|100622923|FG000|STARTED|Overall Study||241||
48121565|NCT04776148|100622924|FG001|STARTED|Overall Study||239||
48121566|NCT04776148|100622923|FG000|Treated|Overall Study||240||
48121567|NCT04776148|100622924|FG001|Treated|Overall Study||233||
48121568|NCT04776148|100622923|FG000|COMPLETED|Overall Study||0||
48121569|NCT04776148|100622924|FG001|COMPLETED|Overall Study||0||
48121570|NCT04776148|100622923|FG000|NOT COMPLETED|Overall Study||241||
48121571|NCT04776148|100622924|FG001|NOT COMPLETED|Overall Study||239||
48569417|NCT04578457|101724776|FG000|NOT COMPLETED|Hearing Aid With NR (1)||2||
48592797|NCT01764997|101783184|FG002|COMPLETED|Run-in Period||0||
48592798|NCT01764997|101783185|FG003|COMPLETED|Run-in Period||0||
48592799|NCT01764997|101783186|FG004|COMPLETED|Run-in Period||0||
48121572|NCT03251924|100622925|FG000|STARTED|Overall Study||6||
48121573|NCT03251924|100622926|FG001|STARTED|Overall Study||7||
48121574|NCT03251924|100622927|FG002|STARTED|Overall Study||7||
48121575|NCT03251924|100622928|FG003|STARTED|Overall Study||11||
48121576|NCT03251924|100622929|FG004|STARTED|Overall Study||9||
48121577|NCT03251924|100622930|FG005|STARTED|Overall Study||9||
48121578|NCT03251924|100622931|FG006|STARTED|Overall Study||10||
48121579|NCT03251924|100622932|FG007|STARTED|Overall Study||12||
48121580|NCT03251924|100622933|FG008|STARTED|Overall Study||9||
48121581|NCT03251924|100622925|FG000|COMPLETED|Overall Study||0||
48121582|NCT03251924|100622926|FG001|COMPLETED|Overall Study||0||
48121583|NCT03251924|100622927|FG002|COMPLETED|Overall Study||0||
48121584|NCT03251924|100622928|FG003|COMPLETED|Overall Study||0||
48121585|NCT03251924|100622929|FG004|COMPLETED|Overall Study||0||
48121586|NCT03251924|100622930|FG005|COMPLETED|Overall Study||0||
48121587|NCT03251924|100622931|FG006|COMPLETED|Overall Study||3||
48121588|NCT03251924|100622932|FG007|COMPLETED|Overall Study||1||
48121589|NCT03251924|100622933|FG008|COMPLETED|Overall Study||1||
48121590|NCT03251924|100622925|FG000|NOT COMPLETED|Overall Study||6||
48121591|NCT03251924|100622926|FG001|NOT COMPLETED|Overall Study||7||
48121592|NCT03251924|100622927|FG002|NOT COMPLETED|Overall Study||7||
48121593|NCT03251924|100622928|FG003|NOT COMPLETED|Overall Study||11||
48121594|NCT03251924|100622929|FG004|NOT COMPLETED|Overall Study||9||
48121595|NCT03251924|100622930|FG005|NOT COMPLETED|Overall Study||9||
48121596|NCT03251924|100622931|FG006|NOT COMPLETED|Overall Study||7||
48121597|NCT03251924|100622932|FG007|NOT COMPLETED|Overall Study||11||
48121598|NCT03251924|100622933|FG008|NOT COMPLETED|Overall Study||8||
48121599|NCT02744846|100622934|FG000|STARTED|5 Year Outcome Assessment||681739||
48121600|NCT02744846|100622934|FG000|Excluded Ineligible Patients|5 Year Outcome Assessment||319189||
48121601|NCT02744846|100622934|FG000|COMPLETED|5 Year Outcome Assessment||362550||
48121602|NCT02744846|100622934|FG000|NOT COMPLETED|5 Year Outcome Assessment||319189||
48121603|NCT02744846|100622934|FG000|STARTED|10 Year Outcome Assessment||362550||
48121604|NCT02744846|100622934|FG000|Exclude Ineligible Patients|10 Year Outcome Assessment||305820||
48121605|NCT02744846|100622934|FG000|COMPLETED|10 Year Outcome Assessment||56730||
48121606|NCT02744846|100622934|FG000|NOT COMPLETED|10 Year Outcome Assessment||305820||
48121607|NCT04086472|100622935|FG000|STARTED|Overall Study||16||
48121608|NCT04086472|100622936|FG001|STARTED|Overall Study||16||
48121609|NCT04086472|100622937|FG002|STARTED|Overall Study||16||
48121610|NCT04086472|100622938|FG003|STARTED|Overall Study||16||
48121611|NCT04086472|100622939|FG004|STARTED|Overall Study||16||
48121612|NCT04086472|100622935|FG000|Received MK-1654 or Placebo|Overall Study||16||
48121613|NCT04086472|100622936|FG001|Received MK-1654 or Placebo|Overall Study||16||
48121614|NCT04086472|100622937|FG002|Received MK-1654 or Placebo|Overall Study||16||
48121615|NCT04086472|100622938|FG003|Received MK-1654 or Placebo|Overall Study||16||
48121616|NCT04086472|100622939|FG004|Received MK-1654 or Placebo|Overall Study||16||
48121617|NCT04086472|100622935|FG000|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||14||
48121618|NCT04086472|100622936|FG001|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||14||
48121619|NCT04086472|100622937|FG002|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||14||
48121620|NCT04086472|100622938|FG003|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||13||
48121621|NCT04086472|100622939|FG004|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||15||
48121622|NCT04086472|100622935|FG000|Not Inoculated|Overall Study||2||
48121623|NCT04086472|100622936|FG001|Not Inoculated|Overall Study||2||
48121624|NCT04086472|100622937|FG002|Not Inoculated|Overall Study||2||
48121625|NCT04086472|100622938|FG003|Not Inoculated|Overall Study||3||
48121626|NCT04086472|100622939|FG004|Not Inoculated|Overall Study||1||
48121627|NCT04086472|100622935|FG000|COMPLETED|Overall Study||12||
48121628|NCT04086472|100622936|FG001|COMPLETED|Overall Study||14||
48121629|NCT04086472|100622937|FG002|COMPLETED|Overall Study||14||
48121630|NCT04086472|100622938|FG003|COMPLETED|Overall Study||13||
48121631|NCT04086472|100622939|FG004|COMPLETED|Overall Study||14||
48121632|NCT04086472|100622935|FG000|NOT COMPLETED|Overall Study||4||
48121633|NCT04086472|100622936|FG001|NOT COMPLETED|Overall Study||2||
48121634|NCT04086472|100622937|FG002|NOT COMPLETED|Overall Study||2||
48121635|NCT04086472|100622938|FG003|NOT COMPLETED|Overall Study||3||
48121636|NCT04086472|100622939|FG004|NOT COMPLETED|Overall Study||2||
48121637|NCT02602288|100622940|FG000|STARTED|End of Treatment/3 Month Follow-up||199||
48121638|NCT02602288|100622941|FG001|STARTED|End of Treatment/3 Month Follow-up||197||
48121639|NCT02602288|100622940|FG000|COMPLETED|End of Treatment/3 Month Follow-up||174||
48121640|NCT02602288|100622941|FG001|COMPLETED|End of Treatment/3 Month Follow-up||179||
48121641|NCT02602288|100622940|FG000|NOT COMPLETED|End of Treatment/3 Month Follow-up||25||
48121642|NCT02602288|100622941|FG001|NOT COMPLETED|End of Treatment/3 Month Follow-up||18||
48121643|NCT02602288|100622940|FG000|STARTED|12 Month Follow-up||174||
48569418|NCT04578457|101724776|FG000|STARTED|Hearing Aid With NR (2)||19|"The discrepancy between the number of participants starting this period and finishing the previous period is simply due to the fact that the study 'periods' as reported are not chronological.~See 'Arm/Group Description' for details."|
48569419|NCT04578457|101724776|FG000|COMPLETED|Hearing Aid With NR (2)||17||
48569420|NCT04578457|101724776|FG000|NOT COMPLETED|Hearing Aid With NR (2)||2||
48121644|NCT02602288|100622941|FG001|STARTED|12 Month Follow-up||179||
48121645|NCT02602288|100622940|FG000|COMPLETED|12 Month Follow-up||172||
48121646|NCT02602288|100622941|FG001|COMPLETED|12 Month Follow-up||175||
48121647|NCT02602288|100622940|FG000|NOT COMPLETED|12 Month Follow-up||2||
48121648|NCT02602288|100622941|FG001|NOT COMPLETED|12 Month Follow-up||4||
48121649|NCT01845155|100622942|FG000|STARTED|Overall Study||146||
48121650|NCT01845155|100622943|FG001|STARTED|Overall Study||144||
48121651|NCT01845155|100622942|FG000|COMPLETED|Overall Study||145||
48121652|NCT01845155|100622943|FG001|COMPLETED|Overall Study||144||
48121653|NCT01845155|100622942|FG000|NOT COMPLETED|Overall Study||1||
48121654|NCT01845155|100622943|FG001|NOT COMPLETED|Overall Study||0||
48569421|NCT04578457|101724776|FG000|STARTED|Hearing Aid With NR (4)||19|"The discrepancy between the number of participants starting this period and finishing the previous period is simply due to the fact that the study 'periods' as reported are not chronological.~See 'Arm/Group Description' for details."|
48569422|NCT04578457|101724776|FG000|COMPLETED|Hearing Aid With NR (4)||17||
48121655|NCT00627406|100622944|FG000|STARTED|Overall Study||60||
48121656|NCT00627406|100622945|FG001|STARTED|Overall Study||58||
48121657|NCT00627406|100622946|FG002|STARTED|Overall Study||125||
48121658|NCT00627406|100622947|FG003|STARTED|Overall Study||141||
48121659|NCT00627406|100622944|FG000|COMPLETED|Overall Study||60||
48121660|NCT00627406|100622945|FG001|COMPLETED|Overall Study||58||
48121661|NCT00627406|100622946|FG002|COMPLETED|Overall Study||125||
48121662|NCT00627406|100622947|FG003|COMPLETED|Overall Study||141||
48121663|NCT00627406|100622944|FG000|NOT COMPLETED|Overall Study||0||
48121664|NCT00627406|100622945|FG001|NOT COMPLETED|Overall Study||0||
48121665|NCT00627406|100622946|FG002|NOT COMPLETED|Overall Study||0||
48121666|NCT00627406|100622947|FG003|NOT COMPLETED|Overall Study||0||
48121667|NCT03732638|100622948|FG000|STARTED|DBT Phase (Weeks 1 to 12)||370||
48121668|NCT03732638|100622949|FG001|STARTED|DBT Phase (Weeks 1 to 12)||371||
48121669|NCT03732638|100622948|FG000|COMPLETED|DBT Phase (Weeks 1 to 12)||316||
48121670|NCT03732638|100622949|FG001|COMPLETED|DBT Phase (Weeks 1 to 12)||310||
48121671|NCT03732638|100622948|FG000|NOT COMPLETED|DBT Phase (Weeks 1 to 12)||54||
48121672|NCT03732638|100622949|FG001|NOT COMPLETED|DBT Phase (Weeks 1 to 12)||61||
48121673|NCT03732638|100622948|FG000|STARTED|OLE Phase (Weeks 13 to 64)||302||
48121674|NCT03732638|100622949|FG001|STARTED|OLE Phase (Weeks 13 to 64)||301||
48121675|NCT03732638|100622948|FG000|COMPLETED|OLE Phase (Weeks 13 to 64)||209||
48121676|NCT03732638|100622949|FG001|COMPLETED|OLE Phase (Weeks 13 to 64)||219||
48121677|NCT03732638|100622948|FG000|NOT COMPLETED|OLE Phase (Weeks 13 to 64)||93||
48121678|NCT03732638|100622949|FG001|NOT COMPLETED|OLE Phase (Weeks 13 to 64)||82||
48121679|NCT03732638|100622948|FG000|STARTED|Follow-up Phase (up to 72 Weeks)||332||
48121680|NCT03732638|100622949|FG001|STARTED|Follow-up Phase (up to 72 Weeks)||336||
48121681|NCT03732638|100622948|FG000|COMPLETED|Follow-up Phase (up to 72 Weeks)||267||
48121682|NCT03732638|100622949|FG001|COMPLETED|Follow-up Phase (up to 72 Weeks)||274||
48121683|NCT03732638|100622948|FG000|NOT COMPLETED|Follow-up Phase (up to 72 Weeks)||65||
48121684|NCT03732638|100622949|FG001|NOT COMPLETED|Follow-up Phase (up to 72 Weeks)||62||
48121685|NCT02381392|100622950|FG000|STARTED|Overall Study||11||
48121686|NCT02381392|100622951|FG001|STARTED|Overall Study||12||
48121687|NCT02381392|100622950|FG000|COMPLETED|Overall Study||11||
48121688|NCT02381392|100622951|FG001|COMPLETED|Overall Study||12||
48121689|NCT02381392|100622950|FG000|NOT COMPLETED|Overall Study||0||
48121690|NCT02381392|100622951|FG001|NOT COMPLETED|Overall Study||0||
48121691|NCT00503685|100622952|FG000|STARTED|Overall Study||23||
48121692|NCT00503685|100622953|FG001|STARTED|Overall Study||22||
48121693|NCT00503685|100622954|FG002|STARTED|Overall Study||20||
48121694|NCT00503685|100622952|FG000|Received at Least 1 Dose of Study Drug|Overall Study||23||
48121695|NCT00503685|100622953|FG001|Received at Least 1 Dose of Study Drug|Overall Study||21||
48121696|NCT00503685|100622954|FG002|Received at Least 1 Dose of Study Drug|Overall Study||20||
48121697|NCT00503685|100622952|FG000|COMPLETED|Overall Study||23||
48121698|NCT00503685|100622953|FG001|COMPLETED|Overall Study||19||
48121699|NCT00503685|100622954|FG002|COMPLETED|Overall Study||18||
48121700|NCT00503685|100622952|FG000|NOT COMPLETED|Overall Study||0||
48121701|NCT00503685|100622953|FG001|NOT COMPLETED|Overall Study||3||
48121702|NCT00503685|100622954|FG002|NOT COMPLETED|Overall Study||2||
48121703|NCT04346615|100622955|FG000|STARTED|Overall Study||29||
48121704|NCT04346615|100622956|FG001|STARTED|Overall Study||15||
48121705|NCT04346615|100622955|FG000|COMPLETED|Overall Study||22||
48121706|NCT04346615|100622956|FG001|COMPLETED|Overall Study||10||
48121707|NCT04346615|100622955|FG000|NOT COMPLETED|Overall Study||7||
48121708|NCT04346615|100622956|FG001|NOT COMPLETED|Overall Study||5||
48121709|NCT01168999|100622957|FG000|STARTED|Overall Study||28||
48121710|NCT01168999|100622958|FG001|STARTED|Overall Study||27||
48121711|NCT01168999|100622959|FG002|STARTED|Overall Study||27||
48121712|NCT01168999|100622960|FG003|STARTED|Overall Study||28||
48121713|NCT01168999|100622957|FG000|COMPLETED|Overall Study||26||
48121714|NCT01168999|100622958|FG001|COMPLETED|Overall Study||26||
48121715|NCT01168999|100622959|FG002|COMPLETED|Overall Study||27||
48121716|NCT01168999|100622960|FG003|COMPLETED|Overall Study||28||
48121717|NCT01168999|100622957|FG000|NOT COMPLETED|Overall Study||2||
48121718|NCT01168999|100622958|FG001|NOT COMPLETED|Overall Study||1||
48121719|NCT01168999|100622959|FG002|NOT COMPLETED|Overall Study||0||
48121720|NCT01168999|100622960|FG003|NOT COMPLETED|Overall Study||0||
48121721|NCT01696435|100622961|FG000|STARTED|Overall Study||4573||
48121722|NCT01696435|100622962|FG001|STARTED|Overall Study||4563||
48121723|NCT01696435|100622963|FG002|STARTED|Overall Study||4609||
48281679|NCT01859988|101014148|FG001|COMPLETED|Overall Study||52||
48281680|NCT01859988|101014149|FG002|COMPLETED|Overall Study||34||
48121724|NCT01696435|100622964|FG003|STARTED|Overall Study||4608||
48121725|NCT01696435|100622961|FG000|COMPLETED|Overall Study||4573||
48121726|NCT01696435|100622962|FG001|COMPLETED|Overall Study||4563||
48396596|NCT01378299|101299397|FG000|BMI Group 2|Overall Study||40|BMI between 30 to \<35 kg/m\^2|
48121727|NCT01696435|100622963|FG002|COMPLETED|Overall Study||4609||
48281681|NCT01859988|101014150|FG003|COMPLETED|Overall Study||55||
48281682|NCT01859988|101014151|FG004|COMPLETED|Overall Study||42||
48121728|NCT01696435|100622964|FG003|COMPLETED|Overall Study||4608||
48121729|NCT01696435|100622961|FG000|NOT COMPLETED|Overall Study||0||
48121730|NCT01696435|100622962|FG001|NOT COMPLETED|Overall Study||0||
48121731|NCT01696435|100622963|FG002|NOT COMPLETED|Overall Study||0||
48121732|NCT01696435|100622964|FG003|NOT COMPLETED|Overall Study||0||
48121733|NCT04079933|100622965|FG000|STARTED|Overall Study||92||
48121734|NCT04079933|100622966|FG001|STARTED|Overall Study||62||
48281683|NCT01859988|101014152|FG005|COMPLETED|Overall Study||42||
48281684|NCT01859988|101014147|FG000|NOT COMPLETED|Overall Study||11||
48281685|NCT01859988|101014148|FG001|NOT COMPLETED|Overall Study||12||
48281686|NCT01859988|101014149|FG002|NOT COMPLETED|Overall Study||28||
48281687|NCT01859988|101014150|FG003|NOT COMPLETED|Overall Study||10||
48281688|NCT01859988|101014151|FG004|NOT COMPLETED|Overall Study||23||
48281689|NCT01859988|101014152|FG005|NOT COMPLETED|Overall Study||19||
48281690|NCT03554629|101014153|FG000|STARTED|Overall Study||29||232
48121735|NCT04079933|100622965|FG000|COMPLETED|Overall Study||89||
48121736|NCT04079933|100622966|FG001|COMPLETED|Overall Study||57||
48121737|NCT04079933|100622965|FG000|NOT COMPLETED|Overall Study||3||
48121738|NCT04079933|100622966|FG001|NOT COMPLETED|Overall Study||5||
48121739|NCT02047604|100622967|FG000|STARTED|Overall Study||6||
48121740|NCT02047604|100622968|FG001|STARTED|Overall Study||7||
48121741|NCT02047604|100622969|FG002|STARTED|Overall Study||6||
48121742|NCT02047604|100622970|FG003|STARTED|Overall Study||6||
48121743|NCT02047604|100622971|FG004|STARTED|Overall Study||6||
48121744|NCT02047604|100622972|FG005|STARTED|Overall Study||10||
48121745|NCT02047604|100622967|FG000|COMPLETED|Overall Study||6||
48121746|NCT02047604|100622968|FG001|COMPLETED|Overall Study||7||
48121747|NCT02047604|100622969|FG002|COMPLETED|Overall Study||6||
48121748|NCT02047604|100622970|FG003|COMPLETED|Overall Study||6||
48121749|NCT02047604|100622971|FG004|COMPLETED|Overall Study||5||
48121750|NCT02047604|100622972|FG005|COMPLETED|Overall Study||9||
48121751|NCT02047604|100622967|FG000|NOT COMPLETED|Overall Study||0||
48121752|NCT02047604|100622968|FG001|NOT COMPLETED|Overall Study||0||
48121753|NCT02047604|100622969|FG002|NOT COMPLETED|Overall Study||0||
48121754|NCT02047604|100622970|FG003|NOT COMPLETED|Overall Study||0||
48121755|NCT02047604|100622971|FG004|NOT COMPLETED|Overall Study||1||
48121756|NCT02047604|100622972|FG005|NOT COMPLETED|Overall Study||1||
48121757|NCT03296696|100622973|FG000|STARTED|Overall Study||1||
48121758|NCT03296696|100622974|FG001|STARTED|Overall Study||3||
48121759|NCT03296696|100622975|FG002|STARTED|Overall Study||3||
48121760|NCT03296696|100622976|FG003|STARTED|Overall Study||4||
48121761|NCT03296696|100622977|FG004|STARTED|Overall Study||4||
48121762|NCT03296696|100622978|FG005|STARTED|Overall Study||4||
48121763|NCT03296696|100622979|FG006|STARTED|Overall Study||4||
48121764|NCT03296696|100622980|FG007|STARTED|Overall Study||5||
48121765|NCT03296696|100622981|FG008|STARTED|Overall Study||1||
48121766|NCT03296696|100622982|FG009|STARTED|Overall Study||1||
48121767|NCT03296696|100622973|FG000|Received Investigational Product|Overall Study||1||
48121768|NCT03296696|100622974|FG001|Received Investigational Product|Overall Study||3||
48121769|NCT03296696|100622975|FG002|Received Investigational Product|Overall Study||3||
48121770|NCT03296696|100622976|FG003|Received Investigational Product|Overall Study||4||
48121771|NCT03296696|100622977|FG004|Received Investigational Product|Overall Study||3||
48121772|NCT03296696|100622978|FG005|Received Investigational Product|Overall Study||4||
48121773|NCT03296696|100622979|FG006|Received Investigational Product|Overall Study||4||
48121774|NCT03296696|100622980|FG007|Received Investigational Product|Overall Study||5||
48121775|NCT03296696|100622981|FG008|Received Investigational Product|Overall Study||1||
48121776|NCT03296696|100622982|FG009|Received Investigational Product|Overall Study||1||
48281691|NCT03554629|101014153|FG000|COMPLETED|Overall Study||23||184
48281692|NCT03554629|101014153|FG000|NOT COMPLETED|Overall Study||6||48
48281693|NCT01856868|101014154|FG000|STARTED|Overall Study||7||
48281694|NCT01856868|101014154|FG000|COMPLETED|Overall Study||7||
48281695|NCT01856868|101014154|FG000|NOT COMPLETED|Overall Study||0||
48281696|NCT02601976|101014155|FG000|STARTED|Overall Study||64||
48281697|NCT02601976|101014155|FG000|COMPLETED|Overall Study||64||
48281698|NCT02601976|101014155|FG000|NOT COMPLETED|Overall Study||0||
48281699|NCT03218397|101014156|FG000|STARTED|Overall Study||249||
48281700|NCT03218397|101014157|FG001|STARTED|Overall Study||251||
48281701|NCT03218397|101014156|FG000|COMPLETED|Overall Study||226||
48281702|NCT03218397|101014157|FG001|COMPLETED|Overall Study||222||
48281703|NCT03218397|101014156|FG000|NOT COMPLETED|Overall Study||23||
48281704|NCT03218397|101014157|FG001|NOT COMPLETED|Overall Study||29||
48121777|NCT03296696|100622973|FG000|COMPLETED|Overall Study||0||
48121778|NCT03296696|100622974|FG001|COMPLETED|Overall Study||0||
48121779|NCT03296696|100622975|FG002|COMPLETED|Overall Study||0||
48121780|NCT03296696|100622976|FG003|COMPLETED|Overall Study||0||
48121781|NCT03296696|100622977|FG004|COMPLETED|Overall Study||0||
48281705|NCT03020576|101014158|FG000|STARTED|Overall Study||15||
48121782|NCT03296696|100622978|FG005|COMPLETED|Overall Study||0||
48121783|NCT03296696|100622979|FG006|COMPLETED|Overall Study||1||
48121784|NCT03296696|100622980|FG007|COMPLETED|Overall Study||0||
48121785|NCT03296696|100622981|FG008|COMPLETED|Overall Study||0||
48121786|NCT03296696|100622982|FG009|COMPLETED|Overall Study||0||
48121787|NCT03296696|100622973|FG000|NOT COMPLETED|Overall Study||1||
48121788|NCT03296696|100622974|FG001|NOT COMPLETED|Overall Study||3||
48281706|NCT03020576|101014159|FG001|STARTED|Overall Study||16||
48281707|NCT03020576|101014158|FG000|COMPLETED|Overall Study||14||
48281708|NCT03020576|101014159|FG001|COMPLETED|Overall Study||14||
48281709|NCT03020576|101014158|FG000|NOT COMPLETED|Overall Study||1||
48281710|NCT03020576|101014159|FG001|NOT COMPLETED|Overall Study||2||
48281711|NCT00760474|101014160|FG000|STARTED|Period 1 (P1)||13||
48281712|NCT00760474|101014161|FG001|STARTED|Period 1 (P1)||14||
48699532|NCT04570605|102050536|FG001|STARTED|Overall Study||15||
48699533|NCT04570605|102050535|FG000|COMPLETED|Overall Study||11||
48699534|NCT04570605|102050536|FG001|COMPLETED|Overall Study||13||
48281713|NCT00760474|101014160|FG000|Treated|Period 1 (P1)||13||
48281714|NCT00760474|101014161|FG001|Treated|Period 1 (P1)||14||
48281715|NCT00760474|101014160|FG000|Overall Number of Unique Participants|Period 1 (P1)||12||
48281716|NCT00760474|101014161|FG001|Overall Number of Unique Participants|Period 1 (P1)||13||
48281717|NCT00760474|101014160|FG000|COMPLETED|Period 1 (P1)||12||
48281718|NCT00760474|101014161|FG001|COMPLETED|Period 1 (P1)||13||
48699535|NCT04570605|102050535|FG000|NOT COMPLETED|Overall Study||4||
48699536|NCT04570605|102050536|FG001|NOT COMPLETED|Overall Study||2||
48699537|NCT05898672|102050537|FG000|STARTED|Treatment Period 1 (Day -1 up to Day 5)||12||
48121789|NCT03296696|100622975|FG002|NOT COMPLETED|Overall Study||3||
48121790|NCT03296696|100622976|FG003|NOT COMPLETED|Overall Study||4||
48121791|NCT03296696|100622977|FG004|NOT COMPLETED|Overall Study||4||
48121792|NCT03296696|100622978|FG005|NOT COMPLETED|Overall Study||4||
48121793|NCT03296696|100622979|FG006|NOT COMPLETED|Overall Study||3||
48121794|NCT03296696|100622980|FG007|NOT COMPLETED|Overall Study||5||
48121795|NCT03296696|100622981|FG008|NOT COMPLETED|Overall Study||1||
48121796|NCT03296696|100622982|FG009|NOT COMPLETED|Overall Study||1||
48121797|NCT00459134|100622983|FG000|STARTED|Overall Study||94||
48121798|NCT00459134|100622984|FG001|STARTED|Overall Study||92||
48121799|NCT00459134|100622983|FG000|COMPLETED|Overall Study||71||
48121800|NCT00459134|100622984|FG001|COMPLETED|Overall Study||67||
48121801|NCT00459134|100622983|FG000|NOT COMPLETED|Overall Study||23||
48121802|NCT00459134|100622984|FG001|NOT COMPLETED|Overall Study||25||
48121803|NCT01130740|100622985|FG000|STARTED|Overall Study||149||
48121804|NCT01130740|100622986|FG001|STARTED|Overall Study||151||
48121805|NCT01130740|100622985|FG000|COMPLETED|Overall Study||137||
48121806|NCT01130740|100622986|FG001|COMPLETED|Overall Study||136||
48121807|NCT01130740|100622985|FG000|NOT COMPLETED|Overall Study||12||
48121808|NCT01130740|100622986|FG001|NOT COMPLETED|Overall Study||15||
48121809|NCT00818441|100622987|FG000|STARTED|Overall Study||89||
48121810|NCT00818441|100622988|FG001|STARTED|Overall Study||30||
48121811|NCT00818441|100622987|FG000|COMPLETED|Overall Study||0||
48121812|NCT00818441|100622988|FG001|COMPLETED|Overall Study||0||
48121813|NCT00818441|100622987|FG000|NOT COMPLETED|Overall Study||89||
48121814|NCT00818441|100622988|FG001|NOT COMPLETED|Overall Study||30||
48121815|NCT02097992|100622989|FG000|STARTED|Treatment 1 (1 Day)||2||
48121816|NCT02097992|100622990|FG001|STARTED|Treatment 1 (1 Day)||3||
48121817|NCT02097992|100622991|FG002|STARTED|Treatment 1 (1 Day)||4||
48121818|NCT02097992|100622992|FG003|STARTED|Treatment 1 (1 Day)||2||
48121819|NCT02097992|100622989|FG000|COMPLETED|Treatment 1 (1 Day)||2||
48121820|NCT02097992|100622990|FG001|COMPLETED|Treatment 1 (1 Day)||3||
48121821|NCT02097992|100622991|FG002|COMPLETED|Treatment 1 (1 Day)||4||
48121822|NCT02097992|100622992|FG003|COMPLETED|Treatment 1 (1 Day)||2||
48121823|NCT02097992|100622989|FG000|NOT COMPLETED|Treatment 1 (1 Day)||0||
48121824|NCT02097992|100622990|FG001|NOT COMPLETED|Treatment 1 (1 Day)||0||
48121825|NCT02097992|100622991|FG002|NOT COMPLETED|Treatment 1 (1 Day)||0||
48121826|NCT02097992|100622992|FG003|NOT COMPLETED|Treatment 1 (1 Day)||0||
48121827|NCT02097992|100622989|FG000|STARTED|Treatment 2 (4 Weeks)||2||
48121828|NCT02097992|100622990|FG001|STARTED|Treatment 2 (4 Weeks)||3||
48121829|NCT02097992|100622991|FG002|STARTED|Treatment 2 (4 Weeks)||4||
48121830|NCT02097992|100622992|FG003|STARTED|Treatment 2 (4 Weeks)||2||
48121831|NCT02097992|100622989|FG000|COMPLETED|Treatment 2 (4 Weeks)||2||
48281719|NCT00760474|101014160|FG000|NOT COMPLETED|Period 1 (P1)||1||
48281720|NCT00760474|101014161|FG001|NOT COMPLETED|Period 1 (P1)||1||
48281721|NCT00760474|101014160|FG000|STARTED|Placebo Washout Period||12||
48281722|NCT00760474|101014161|FG001|STARTED|Placebo Washout Period||13||
48121832|NCT02097992|100622990|FG001|COMPLETED|Treatment 2 (4 Weeks)||3||
48121833|NCT02097992|100622991|FG002|COMPLETED|Treatment 2 (4 Weeks)||4||
48121834|NCT02097992|100622992|FG003|COMPLETED|Treatment 2 (4 Weeks)||2||
48121835|NCT02097992|100622989|FG000|NOT COMPLETED|Treatment 2 (4 Weeks)||0||
48121836|NCT02097992|100622990|FG001|NOT COMPLETED|Treatment 2 (4 Weeks)||0||
48121837|NCT02097992|100622991|FG002|NOT COMPLETED|Treatment 2 (4 Weeks)||0||
48121838|NCT02097992|100622992|FG003|NOT COMPLETED|Treatment 2 (4 Weeks)||0||
48121839|NCT02097992|100622989|FG000|STARTED|Washout (4 Weeks)||2||
48121840|NCT02097992|100622990|FG001|STARTED|Washout (4 Weeks)||3||
48121841|NCT02097992|100622991|FG002|STARTED|Washout (4 Weeks)||4||
48121842|NCT02097992|100622992|FG003|STARTED|Washout (4 Weeks)||2||
48699538|NCT05898672|102050537|FG000|COMPLETED|Treatment Period 1 (Day -1 up to Day 5)||12||
48699539|NCT05898672|102050537|FG000|NOT COMPLETED|Treatment Period 1 (Day -1 up to Day 5)||0||
48699540|NCT05898672|102050537|FG000|STARTED|Treatment Period 2 (Day 1 up to Day 5)||12||
48121843|NCT02097992|100622989|FG000|COMPLETED|Washout (4 Weeks)||2||
48121844|NCT02097992|100622990|FG001|COMPLETED|Washout (4 Weeks)||3||
48121845|NCT02097992|100622991|FG002|COMPLETED|Washout (4 Weeks)||4||
48121846|NCT02097992|100622992|FG003|COMPLETED|Washout (4 Weeks)||2||
48281723|NCT00760474|101014160|FG000|COMPLETED|Placebo Washout Period||12||
48281724|NCT00760474|101014161|FG001|COMPLETED|Placebo Washout Period||12||
48121847|NCT02097992|100622989|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
48592800|NCT01764997|101783182|FG000|NOT COMPLETED|Run-in Period||38||
48699541|NCT05898672|102050537|FG000|COMPLETED|Treatment Period 2 (Day 1 up to Day 5)||12||
48699542|NCT05898672|102050537|FG000|NOT COMPLETED|Treatment Period 2 (Day 1 up to Day 5)||0||
48699543|NCT00721578|102050538|FG000|STARTED|Overall Study||12||
48699544|NCT00721578|102050539|FG001|STARTED|Overall Study||11||
48699545|NCT00721578|102050538|FG000|COMPLETED|Overall Study||10||
48699546|NCT00721578|102050539|FG001|COMPLETED|Overall Study||9||
48699547|NCT00721578|102050538|FG000|NOT COMPLETED|Overall Study||2||
48699548|NCT00721578|102050539|FG001|NOT COMPLETED|Overall Study||2||
48699549|NCT01779856|102050540|FG000|STARTED|Overall Study||81||
48699550|NCT01779856|102050540|FG000|COMPLETED|Overall Study||57||
48699551|NCT01779856|102050540|FG000|NOT COMPLETED|Overall Study||24||
48699552|NCT02244840|102050541|FG000|STARTED|Overall Study||40||
48699553|NCT02244840|102050541|FG000|COMPLETED|Overall Study||40||
48699554|NCT02244840|102050541|FG000|NOT COMPLETED|Overall Study||0||
48281725|NCT00760474|101014160|FG000|NOT COMPLETED|Placebo Washout Period||0||
48281726|NCT00760474|101014161|FG001|NOT COMPLETED|Placebo Washout Period||1||
48281727|NCT00760474|101014160|FG000|STARTED|Period 2 (P2)||12||
48699555|NCT04068519|102050542|FG000|STARTED|Dose Verification||20||
48699556|NCT04068519|102050542|FG000|COMPLETED|Dose Verification||4||
48699557|NCT04068519|102050542|FG000|NOT COMPLETED|Dose Verification||16||
48699558|NCT04068519|102050542|FG000|STARTED|Pharmacokinetic Sub-study||57||
48699559|NCT04068519|102050542|FG000|COMPLETED|Pharmacokinetic Sub-study||16||
48699560|NCT04068519|102050542|FG000|NOT COMPLETED|Pharmacokinetic Sub-study||41||
48699561|NCT04068519|102050542|FG000|STARTED|Indication Expansion||223||
48699562|NCT04068519|102050542|FG000|COMPLETED|Indication Expansion||54||
48699563|NCT04068519|102050542|FG000|NOT COMPLETED|Indication Expansion||169||
48699564|NCT00607269|102050543|FG000|STARTED|Overall Study||67||
48281728|NCT00760474|101014161|FG001|STARTED|Period 2 (P2)||12||
48281729|NCT00760474|101014160|FG000|COMPLETED|Period 2 (P2)||11||
48281730|NCT00760474|101014161|FG001|COMPLETED|Period 2 (P2)||11||
48281731|NCT00760474|101014160|FG000|NOT COMPLETED|Period 2 (P2)||1||
48281732|NCT00760474|101014161|FG001|NOT COMPLETED|Period 2 (P2)||1||
48281733|NCT03319849|101014162|FG000|STARTED|Overall Study||60||60
48281734|NCT03319849|101014163|FG001|STARTED|Overall Study||59||59
48281735|NCT03319849|101014162|FG000|Treated (Underwent Surgery)|Overall Study||59|Participants who actually underwent surgery for either NT-501 or sham treatment|59
48281736|NCT03319849|101014163|FG001|Treated (Underwent Surgery)|Overall Study||54|Participants who actually underwent surgery for either NT-501 or sham treatment|54
48281737|NCT03319849|101014162|FG000|COMPLETED|Overall Study||57||57
48281738|NCT03319849|101014163|FG001|COMPLETED|Overall Study||49||49
48281739|NCT03319849|101014162|FG000|NOT COMPLETED|Overall Study||3||3
48281740|NCT03319849|101014163|FG001|NOT COMPLETED|Overall Study||10||10
48281741|NCT04076787|101014164|FG000|STARTED|Overall Study||318||
48281742|NCT04076787|101014165|FG001|STARTED|Overall Study||1031||
48281743|NCT04076787|101014166|FG002|STARTED|Overall Study||420||
48281744|NCT04076787|101014164|FG000|COMPLETED|Overall Study||318||
48281745|NCT04076787|101014165|FG001|COMPLETED|Overall Study||1031||
48281746|NCT04076787|101014166|FG002|COMPLETED|Overall Study||420||
48281747|NCT04076787|101014164|FG000|NOT COMPLETED|Overall Study||0||
48699565|NCT00607269|102050544|FG001|STARTED|Overall Study||64||
48699566|NCT00607269|102050543|FG000|COMPLETED|Overall Study||67||
48699567|NCT00607269|102050544|FG001|COMPLETED|Overall Study||64||
48699568|NCT00607269|102050543|FG000|NOT COMPLETED|Overall Study||0||
48699569|NCT00607269|102050544|FG001|NOT COMPLETED|Overall Study||0||
48699570|NCT01394692|102050545|FG000|STARTED|Overall Study||29||
48699571|NCT01394692|102050546|FG001|STARTED|Overall Study||29||
48699572|NCT01394692|102050545|FG000|COMPLETED|Overall Study||29||
48699573|NCT01394692|102050546|FG001|COMPLETED|Overall Study||29||
48281748|NCT04076787|101014165|FG001|NOT COMPLETED|Overall Study||0||
48281749|NCT04076787|101014166|FG002|NOT COMPLETED|Overall Study||0||
48281750|NCT02741323|101014167|FG000|STARTED|Overall Study||49||
48699574|NCT01394692|102050545|FG000|NOT COMPLETED|Overall Study||0||
48699575|NCT01394692|102050546|FG001|NOT COMPLETED|Overall Study||0||
48699576|NCT01576146|102050547|FG000|STARTED|Extension Period 1||30||
48121848|NCT02097992|100622990|FG001|NOT COMPLETED|Washout (4 Weeks)||0||
48121849|NCT02097992|100622991|FG002|NOT COMPLETED|Washout (4 Weeks)||0||
48121850|NCT02097992|100622992|FG003|NOT COMPLETED|Washout (4 Weeks)||0||
48121851|NCT02097992|100622989|FG000|STARTED|Treatment 3 (4 Weeks)||2||
48121852|NCT02097992|100622990|FG001|STARTED|Treatment 3 (4 Weeks)||3||
48121853|NCT02097992|100622991|FG002|STARTED|Treatment 3 (4 Weeks)||4||
48121854|NCT02097992|100622992|FG003|STARTED|Treatment 3 (4 Weeks)||2||
48121855|NCT02097992|100622989|FG000|COMPLETED|Treatment 3 (4 Weeks)||2||
48121856|NCT02097992|100622990|FG001|COMPLETED|Treatment 3 (4 Weeks)||3||
48121857|NCT02097992|100622991|FG002|COMPLETED|Treatment 3 (4 Weeks)||4||
48121858|NCT02097992|100622992|FG003|COMPLETED|Treatment 3 (4 Weeks)||2||
48121859|NCT02097992|100622989|FG000|NOT COMPLETED|Treatment 3 (4 Weeks)||0||
48121860|NCT02097992|100622990|FG001|NOT COMPLETED|Treatment 3 (4 Weeks)||0||
48121861|NCT02097992|100622991|FG002|NOT COMPLETED|Treatment 3 (4 Weeks)||0||
48121862|NCT02097992|100622992|FG003|NOT COMPLETED|Treatment 3 (4 Weeks)||0||
48121863|NCT01600040|100622993|FG000|STARTED|Overall Study||22||
48121864|NCT01600040|100622993|FG000|COMPLETED|Overall Study||21||
48121865|NCT01600040|100622993|FG000|NOT COMPLETED|Overall Study||1||
48121866|NCT01312467|100622994|FG000|STARTED|Overall Study||45||
48121867|NCT01312467|100622994|FG000|COMPLETED|Overall Study||32||
48121868|NCT01312467|100622994|FG000|NOT COMPLETED|Overall Study||13||
48121869|NCT00127790|100622995|FG000|STARTED|Pre-Treatment||6||
48121870|NCT00127790|100622996|FG001|STARTED|Pre-Treatment||5||
48121871|NCT00127790|100622997|FG002|STARTED|Pre-Treatment||6||
48121872|NCT00127790|100622998|FG003|STARTED|Pre-Treatment||4||
48121873|NCT00127790|100622995|FG000|COMPLETED|Pre-Treatment||6||
48121874|NCT00127790|100622996|FG001|COMPLETED|Pre-Treatment||5||
48121875|NCT00127790|100622997|FG002|COMPLETED|Pre-Treatment||6||
48121876|NCT00127790|100622998|FG003|COMPLETED|Pre-Treatment||4||
48121877|NCT00127790|100622995|FG000|NOT COMPLETED|Pre-Treatment||0||
48121878|NCT00127790|100622996|FG001|NOT COMPLETED|Pre-Treatment||0||
48121879|NCT00127790|100622997|FG002|NOT COMPLETED|Pre-Treatment||0||
48121880|NCT00127790|100622998|FG003|NOT COMPLETED|Pre-Treatment||0||
48121881|NCT00127790|100622995|FG000|STARTED|Post-Treatment||6||
48121882|NCT00127790|100622996|FG001|STARTED|Post-Treatment||5||
48121883|NCT00127790|100622997|FG002|STARTED|Post-Treatment||6||
48121884|NCT00127790|100622998|FG003|STARTED|Post-Treatment||4||
48121885|NCT00127790|100622995|FG000|COMPLETED|Post-Treatment||6||
48121886|NCT00127790|100622996|FG001|COMPLETED|Post-Treatment||5||
48121887|NCT00127790|100622997|FG002|COMPLETED|Post-Treatment||6||
48121888|NCT00127790|100622998|FG003|COMPLETED|Post-Treatment||4||
48121889|NCT00127790|100622995|FG000|NOT COMPLETED|Post-Treatment||0||
48121890|NCT00127790|100622996|FG001|NOT COMPLETED|Post-Treatment||0||
48121891|NCT00127790|100622997|FG002|NOT COMPLETED|Post-Treatment||0||
48121892|NCT00127790|100622998|FG003|NOT COMPLETED|Post-Treatment||0||
48121893|NCT01532687|100622999|FG000|STARTED|Overall Study||29||
48121894|NCT01532687|100623000|FG001|STARTED|Overall Study||25||
48121895|NCT01532687|100622999|FG000|Crossover to Open-label Pazopanib|Overall Study||0|Participants who progress, unblinded, and found treated with gemcitibine+placebo arm are eligible to crossover into pazopanib open-label treatment phase|
48121896|NCT01532687|100623000|FG001|Crossover to Open-label Pazopanib|Overall Study||14|Participants who progress, unblinded, and found treated with gemcitibine+placebo arm are eligible to crossover into pazopanib open-label treatment phase|
48121897|NCT01532687|100622999|FG000|COMPLETED|Overall Study||15||
48121898|NCT01532687|100623000|FG001|COMPLETED|Overall Study||23||
48121899|NCT01532687|100622999|FG000|NOT COMPLETED|Overall Study||14||
48121900|NCT01532687|100623000|FG001|NOT COMPLETED|Overall Study||2||
48121901|NCT01733368|100623001|FG000|STARTED|Overall Study||198||
48121902|NCT01733368|100623001|FG000|COMPLETED|Overall Study||167||
48121903|NCT01733368|100623001|FG000|NOT COMPLETED|Overall Study||31||
48396597|NCT01378299|101299397|FG000|BMI Group 3|Overall Study||27|BMI = or \>35 kg/m\^2|
48121904|NCT04382612|100623002|FG000|STARTED|Overall Study||42||
48121905|NCT04382612|100623002|FG000|COMPLETED|Overall Study||41||
48121906|NCT04382612|100623002|FG000|NOT COMPLETED|Overall Study||1||
48699577|NCT01576146|102050547|FG000|COMPLETED|Extension Period 1||20||
48699578|NCT01576146|102050547|FG000|NOT COMPLETED|Extension Period 1||10||
48699579|NCT01576146|102050547|FG000|STARTED|Extension Period 2||17||
48699580|NCT01576146|102050547|FG000|COMPLETED|Extension Period 2||0||
48699581|NCT01576146|102050547|FG000|NOT COMPLETED|Extension Period 2||17||
48699582|NCT00022763|102050548|FG000|STARTED|Overall Study||24||
48699583|NCT00022763|102050549|FG001|STARTED|Overall Study||28||
48699584|NCT00022763|102050548|FG000|COMPLETED|Overall Study||15||
48699585|NCT00022763|102050549|FG001|COMPLETED|Overall Study||11||
48699586|NCT00022763|102050548|FG000|NOT COMPLETED|Overall Study||9||
48699587|NCT00022763|102050549|FG001|NOT COMPLETED|Overall Study||17||
48699588|NCT02292082|102050550|FG000|STARTED|Overall Study||56||
48699589|NCT02292082|102050551|FG001|STARTED|Overall Study||55||
48699590|NCT02292082|102050550|FG000|COMPLETED|Overall Study||56||
48699591|NCT02292082|102050551|FG001|COMPLETED|Overall Study||55||
48699592|NCT02292082|102050550|FG000|NOT COMPLETED|Overall Study||0||
48699593|NCT02292082|102050551|FG001|NOT COMPLETED|Overall Study||0||
48699594|NCT00306293|102050552|FG000|STARTED|Period 1 (Day 1 to Day 60)||35||
48699595|NCT00306293|102050553|FG001|STARTED|Period 1 (Day 1 to Day 60)||35||
48699596|NCT00306293|102050552|FG000|COMPLETED|Period 1 (Day 1 to Day 60)||27||
48699597|NCT00306293|102050553|FG001|COMPLETED|Period 1 (Day 1 to Day 60)||27||
48699598|NCT00306293|102050552|FG000|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8||
48699599|NCT00306293|102050553|FG001|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8||
48699600|NCT00306293|102050552|FG000|STARTED|Washout (Day 61 to Day 66)||27||
48699601|NCT00306293|102050553|FG001|STARTED|Washout (Day 61 to Day 66)||27||
48699602|NCT00306293|102050552|FG000|COMPLETED|Washout (Day 61 to Day 66)||27||
48396598|NCT01378299|101299397|FG000|COMPLETED|Overall Study||74||
48396599|NCT01378299|101299397|FG000|NOT COMPLETED|Overall Study||31||
48396600|NCT01883804|101299398|FG000|STARTED|Overall Study||25||
48396601|NCT01883804|101299398|FG000|COMPLETED|Overall Study||20||
48396602|NCT01883804|101299398|FG000|NOT COMPLETED|Overall Study||5||
48396603|NCT01488409|101299399|FG000|STARTED|Overall Study||20||
48396604|NCT01488409|101299400|FG001|STARTED|Overall Study||19||
48396605|NCT01488409|101299399|FG000|COMPLETED|Overall Study||16||
48396606|NCT01488409|101299400|FG001|COMPLETED|Overall Study||15||
48396607|NCT01488409|101299399|FG000|NOT COMPLETED|Overall Study||4||
48396608|NCT01488409|101299400|FG001|NOT COMPLETED|Overall Study||4||
48396609|NCT00093756|101299401|FG000|STARTED|Overall Study||27||
48396610|NCT00093756|101299402|FG001|STARTED|Overall Study||21||
48396611|NCT00093756|101299401|FG000|COMPLETED|Overall Study||27||
48396612|NCT00093756|101299402|FG001|COMPLETED|Overall Study||21||
48396613|NCT00093756|101299401|FG000|NOT COMPLETED|Overall Study||0||
48396614|NCT00093756|101299402|FG001|NOT COMPLETED|Overall Study||0||
48396615|NCT00744848|101302417|FG000|STARTED|Overall Study||103||
48396616|NCT00744848|101302418|FG001|STARTED|Overall Study||101||
48699603|NCT00306293|102050553|FG001|COMPLETED|Washout (Day 61 to Day 66)||27||
48121907|NCT04071951|100623003|FG000|STARTED|Overall Study||3239||
48121908|NCT04071951|100623004|FG001|STARTED|Overall Study||3239||
48699604|NCT00306293|102050552|FG000|NOT COMPLETED|Washout (Day 61 to Day 66)||0||
48699605|NCT00306293|102050553|FG001|NOT COMPLETED|Washout (Day 61 to Day 66)||0||
48699606|NCT00306293|102050552|FG000|STARTED|Period 2 (Day 67 to Day 126 )||27||
48699607|NCT00306293|102050553|FG001|STARTED|Period 2 (Day 67 to Day 126 )||27||
48121909|NCT04071951|100623003|FG000|COMPLETED|Overall Study||3213||
48121910|NCT04071951|100623004|FG001|COMPLETED|Overall Study||3215||
48121911|NCT04071951|100623003|FG000|NOT COMPLETED|Overall Study||26||
48396617|NCT00744848|101302417|FG000|COMPLETED|Overall Study||103||
48396618|NCT00744848|101302418|FG001|COMPLETED|Overall Study||101||
48396619|NCT00744848|101302417|FG000|NOT COMPLETED|Overall Study||0||
48396620|NCT00744848|101302418|FG001|NOT COMPLETED|Overall Study||0||
48396621|NCT00510068|101302419|FG000|STARTED|Double-blind Period||207||
48396622|NCT00510068|101302420|FG001|STARTED|Double-blind Period||203||
48396623|NCT00510068|101302419|FG000|Safety Population|Double-blind Period||204||
48699608|NCT00306293|102050552|FG000|COMPLETED|Period 2 (Day 67 to Day 126 )||24||
48699609|NCT00306293|102050553|FG001|COMPLETED|Period 2 (Day 67 to Day 126 )||26||
48396624|NCT00510068|101302420|FG001|Safety Population|Double-blind Period||203||
48569423|NCT04578457|101724776|FG000|NOT COMPLETED|Hearing Aid With NR (4)||2||
48569424|NCT00777296|101724777|FG000|STARTED|Overall Study||21||
48569425|NCT00777296|101724778|FG001|STARTED|Overall Study||11||
48569426|NCT00777296|101724779|FG002|STARTED|Overall Study||23||
48569427|NCT00777296|101724780|FG003|STARTED|Overall Study||11||
48569428|NCT00777296|101724777|FG000|COMPLETED|Overall Study||20||
48569429|NCT00777296|101724778|FG001|COMPLETED|Overall Study||10||
48569430|NCT00777296|101724779|FG002|COMPLETED|Overall Study||21||
48569431|NCT00777296|101724780|FG003|COMPLETED|Overall Study||10||
48569432|NCT00777296|101724777|FG000|NOT COMPLETED|Overall Study||1||
48569433|NCT00777296|101724778|FG001|NOT COMPLETED|Overall Study||1||
48569434|NCT00777296|101724779|FG002|NOT COMPLETED|Overall Study||2||
48569435|NCT00777296|101724780|FG003|NOT COMPLETED|Overall Study||1||
48569436|NCT02091089|101724781|FG000|STARTED|Overall Study||20||
48569437|NCT02091089|101724781|FG000|COMPLETED|Overall Study||18||
48569438|NCT02091089|101724781|FG000|NOT COMPLETED|Overall Study||2||
48569439|NCT02818946|101724782|FG000|STARTED|Overall Study||30||
48569440|NCT02818946|101724782|FG000|COMPLETED|Overall Study||30||
48569441|NCT02818946|101724782|FG000|NOT COMPLETED|Overall Study||0||
48569442|NCT04381728|101724783|FG000|STARTED|Overall Study||23||
48569443|NCT04381728|101724783|FG000|COMPLETED|Overall Study||23||
48569444|NCT04381728|101724783|FG000|NOT COMPLETED|Overall Study||0||
48569445|NCT01757184|101724784|FG000|STARTED|Double-blind Period||36||
48569446|NCT01757184|101724785|FG001|STARTED|Double-blind Period||30||
48569447|NCT01757184|101724786|FG002|STARTED|Double-blind Period||0||
48569448|NCT01757184|101724787|FG003|STARTED|Double-blind Period||0||
48569449|NCT01757184|101724784|FG000|Received at Least 1 Dose of Study Drug|Double-blind Period||36||
48569450|NCT01757184|101724785|FG001|Received at Least 1 Dose of Study Drug|Double-blind Period||30||
48569451|NCT01757184|101724786|FG002|Received at Least 1 Dose of Study Drug|Double-blind Period||0||
48569452|NCT01757184|101724787|FG003|Received at Least 1 Dose of Study Drug|Double-blind Period||0||
48569453|NCT01757184|101724784|FG000|COMPLETED|Double-blind Period||35||
48569454|NCT01757184|101724785|FG001|COMPLETED|Double-blind Period||30||
48569455|NCT01757184|101724786|FG002|COMPLETED|Double-blind Period||0||
48569456|NCT01757184|101724787|FG003|COMPLETED|Double-blind Period||0||
48569457|NCT01757184|101724784|FG000|NOT COMPLETED|Double-blind Period||1||
48569458|NCT01757184|101724785|FG001|NOT COMPLETED|Double-blind Period||0||
48569459|NCT01757184|101724786|FG002|NOT COMPLETED|Double-blind Period||0||
48569460|NCT01757184|101724787|FG003|NOT COMPLETED|Double-blind Period||0||
48569461|NCT01757184|101724784|FG000|STARTED|Open-label Period||0||
48569462|NCT01757184|101724785|FG001|STARTED|Open-label Period||0||
48569463|NCT01757184|101724786|FG002|STARTED|Open-label Period||36||
48569464|NCT01757184|101724787|FG003|STARTED|Open-label Period||30||
48569465|NCT01757184|101724784|FG000|Received at Least 1 Dose of Study Drug|Open-label Period||0||
48569466|NCT01757184|101724785|FG001|Received at Least 1 Dose of Study Drug|Open-label Period||0||
48569467|NCT01757184|101724786|FG002|Received at Least 1 Dose of Study Drug|Open-label Period||36||
48569468|NCT01757184|101724787|FG003|Received at Least 1 Dose of Study Drug|Open-label Period||30||
48569469|NCT01757184|101724784|FG000|COMPLETED|Open-label Period||0||
48569470|NCT01757184|101724785|FG001|COMPLETED|Open-label Period||0||
48569471|NCT01757184|101724786|FG002|COMPLETED|Open-label Period||32||
48281751|NCT02741323|101014168|FG001|STARTED|Overall Study||48||
48281752|NCT02741323|101014167|FG000|COMPLETED|Overall Study||43|Provided at least 1-year survival data, completing the requirement for at least 1-3 years of follow-up in the study|
48281753|NCT02741323|101014168|FG001|COMPLETED|Overall Study||40|Provided at least 1-year survival data, completing the requirement for at least 1-3 years of follow-up in the study|
48121912|NCT04071951|100623004|FG001|NOT COMPLETED|Overall Study||24||
48281754|NCT02741323|101014167|FG000|NOT COMPLETED|Overall Study||6||
48281755|NCT02741323|101014168|FG001|NOT COMPLETED|Overall Study||8||
48396625|NCT00510068|101302419|FG000|COMPLETED|Double-blind Period||0||
48396626|NCT00510068|101302420|FG001|COMPLETED|Double-blind Period||0||
48569472|NCT01757184|101724787|FG003|COMPLETED|Open-label Period||27||
48569473|NCT01757184|101724784|FG000|NOT COMPLETED|Open-label Period||0||
48569474|NCT01757184|101724785|FG001|NOT COMPLETED|Open-label Period||0||
48569475|NCT01757184|101724786|FG002|NOT COMPLETED|Open-label Period||4||
48569476|NCT01757184|101724787|FG003|NOT COMPLETED|Open-label Period||3||
48569477|NCT01050582|101724788|FG000|STARTED|Overall Study||133||
48569478|NCT01050582|101724789|FG001|STARTED|Overall Study||51||
48569479|NCT01050582|101724788|FG000|COMPLETED|Overall Study||133||
48569480|NCT01050582|101724789|FG001|COMPLETED|Overall Study||51||
48569481|NCT01050582|101724788|FG000|NOT COMPLETED|Overall Study||0||
48281756|NCT03534284|101014169|FG000|STARTED|Overall Study||43||
48281757|NCT03534284|101014170|FG001|STARTED|Overall Study||42||
48281758|NCT03534284|101014171|FG002|STARTED|Overall Study||41||
48281759|NCT03534284|101014169|FG000|Week 7 Primary Outcome|Overall Study||39||
48281760|NCT03534284|101014170|FG001|Week 7 Primary Outcome|Overall Study||41||
48281761|NCT03534284|101014171|FG002|Week 7 Primary Outcome|Overall Study||40||
48281762|NCT03534284|101014169|FG000|COMPLETED|Overall Study||36|Week 25 primary outcome|
48281763|NCT03534284|101014170|FG001|COMPLETED|Overall Study||39|Week 25 primary outcome|
48281764|NCT03534284|101014171|FG002|COMPLETED|Overall Study||38|Week 25 primary outcome|
48281765|NCT03534284|101014169|FG000|NOT COMPLETED|Overall Study||7||
48281766|NCT03534284|101014170|FG001|NOT COMPLETED|Overall Study||3||
48396627|NCT00510068|101302419|FG000|NOT COMPLETED|Double-blind Period||207||
48396628|NCT00510068|101302420|FG001|NOT COMPLETED|Double-blind Period||203||
48396629|NCT00510068|101302419|FG000|STARTED|Open-label Period||225||
48396630|NCT00510068|101302420|FG001|STARTED|Open-label Period||0||
48396631|NCT00510068|101302419|FG000|COMPLETED|Open-label Period||0||
48396632|NCT00510068|101302420|FG001|COMPLETED|Open-label Period||0||
48396633|NCT00510068|101302419|FG000|NOT COMPLETED|Open-label Period||225||
48396634|NCT00510068|101302420|FG001|NOT COMPLETED|Open-label Period||0||
48396635|NCT01062009|101302421|FG000|STARTED|Overall Study||7||
48396636|NCT01062009|101302422|FG001|STARTED|Overall Study||6||
48396637|NCT01062009|101302423|FG002|STARTED|Overall Study||6||
48396638|NCT01062009|101302424|FG003|STARTED|Overall Study||6||
48396639|NCT01062009|101302421|FG000|COMPLETED|Overall Study||6||
48396640|NCT01062009|101302422|FG001|COMPLETED|Overall Study||6||
48396641|NCT01062009|101302423|FG002|COMPLETED|Overall Study||6||
48396642|NCT01062009|101302424|FG003|COMPLETED|Overall Study||6||
48396643|NCT01062009|101302421|FG000|NOT COMPLETED|Overall Study||1||
48396644|NCT01062009|101302422|FG001|NOT COMPLETED|Overall Study||0||
48396645|NCT01062009|101302423|FG002|NOT COMPLETED|Overall Study||0||
48396646|NCT01062009|101302424|FG003|NOT COMPLETED|Overall Study||0||
48396647|NCT03418064|101302425|FG000|STARTED|First Intervention (1 Month)||21||
48396648|NCT03418064|101302426|FG001|STARTED|First Intervention (1 Month)||21||
48396649|NCT03418064|101302425|FG000|COMPLETED|First Intervention (1 Month)||21||
48396650|NCT03418064|101302426|FG001|COMPLETED|First Intervention (1 Month)||21||
48396651|NCT03418064|101302425|FG000|NOT COMPLETED|First Intervention (1 Month)||0||
48396652|NCT03418064|101302426|FG001|NOT COMPLETED|First Intervention (1 Month)||0||
48396653|NCT03418064|101302425|FG000|STARTED|Second Intervention (1 Month)||21||
48396654|NCT03418064|101302426|FG001|STARTED|Second Intervention (1 Month)||21||
48396655|NCT03418064|101302425|FG000|COMPLETED|Second Intervention (1 Month)||21||
48396656|NCT03418064|101302426|FG001|COMPLETED|Second Intervention (1 Month)||21||
48396657|NCT03418064|101302425|FG000|NOT COMPLETED|Second Intervention (1 Month)||0||
48396658|NCT03418064|101302426|FG001|NOT COMPLETED|Second Intervention (1 Month)||0||
48396659|NCT03820726|101302427|FG000|STARTED|Overall Study||435||
48396660|NCT03820726|101302427|FG000|Treated|Overall Study||434||
48396661|NCT03820726|101302427|FG000|COMPLETED|Overall Study||224|Completed planned treatment period|
48396662|NCT03820726|101302427|FG000|NOT COMPLETED|Overall Study||211||
48396663|NCT01293084|101302428|FG000|STARTED|Overall Study||17||
48396664|NCT01293084|101302428|FG000|COMPLETED|Overall Study||12||
48396665|NCT01293084|101302428|FG000|NOT COMPLETED|Overall Study||5||
48396666|NCT03673956|101302429|FG000|STARTED|Overall Study||12||
48396667|NCT03673956|101302430|FG001|STARTED|Overall Study||1||
48396668|NCT03673956|101302431|FG002|STARTED|Overall Study||5||
48396669|NCT03673956|101302432|FG003|STARTED|Overall Study||1||
48396670|NCT03673956|101302429|FG000|COMPLETED|Overall Study||10||
48396671|NCT03673956|101302430|FG001|COMPLETED|Overall Study||1||
48396672|NCT03673956|101302431|FG002|COMPLETED|Overall Study||5||
48396673|NCT03673956|101302432|FG003|COMPLETED|Overall Study||1||
48396674|NCT03673956|101302429|FG000|NOT COMPLETED|Overall Study||2||
48396675|NCT03673956|101302430|FG001|NOT COMPLETED|Overall Study||0||
48396676|NCT03673956|101302431|FG002|NOT COMPLETED|Overall Study||0||
48396677|NCT03673956|101302432|FG003|NOT COMPLETED|Overall Study||0||
48396678|NCT01711541|101302433|FG000|STARTED|Overall Study||4||
48396679|NCT01711541|101302434|FG001|STARTED|Overall Study||4||
48396680|NCT01711541|101302435|FG002|STARTED|Overall Study||3||
48396681|NCT01711541|101302436|FG003|STARTED|Overall Study||6||
48569482|NCT01050582|101724789|FG001|NOT COMPLETED|Overall Study||0||
48569483|NCT04179838|101724790|FG000|STARTED|First Intervention (1 Day)||13||
48699610|NCT00306293|102050552|FG000|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||3||
48699611|NCT00306293|102050553|FG001|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||1||
48396682|NCT01711541|101302437|FG004|STARTED|Overall Study||7||
48396683|NCT01711541|101302433|FG000|COMPLETED|Overall Study||4||
48396684|NCT01711541|101302434|FG001|COMPLETED|Overall Study||3||
48396685|NCT01711541|101302435|FG002|COMPLETED|Overall Study||3||
48396686|NCT01711541|101302436|FG003|COMPLETED|Overall Study||5||
48396687|NCT01711541|101302437|FG004|COMPLETED|Overall Study||7||
48396688|NCT01711541|101302433|FG000|NOT COMPLETED|Overall Study||0||
48396689|NCT01711541|101302434|FG001|NOT COMPLETED|Overall Study||1||
48396690|NCT01711541|101302435|FG002|NOT COMPLETED|Overall Study||0||
48396691|NCT01711541|101302436|FG003|NOT COMPLETED|Overall Study||1||
48396692|NCT01711541|101302437|FG004|NOT COMPLETED|Overall Study||0||
48569484|NCT04179838|101724791|FG001|STARTED|First Intervention (1 Day)||16||
48121913|NCT03986944|100623005|FG000|STARTED|Overall Study||28||
48121914|NCT03986944|100623006|FG001|STARTED|Overall Study||29||
48121915|NCT03986944|100623007|FG002|STARTED|Overall Study||27||
48121916|NCT03986944|100623005|FG000|COMPLETED|Overall Study||13||
48569485|NCT04179838|101724790|FG000|COMPLETED|First Intervention (1 Day)||13||
48569486|NCT04179838|101724791|FG001|COMPLETED|First Intervention (1 Day)||13||
48569487|NCT04179838|101724790|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48569488|NCT04179838|101724791|FG001|NOT COMPLETED|First Intervention (1 Day)||3||
48569489|NCT04179838|101724790|FG000|STARTED|Washout (4 Weeks)||13||
48569490|NCT04179838|101724791|FG001|STARTED|Washout (4 Weeks)||13||
48569491|NCT04179838|101724790|FG000|COMPLETED|Washout (4 Weeks)||13||
48569492|NCT04179838|101724791|FG001|COMPLETED|Washout (4 Weeks)||13||
48569493|NCT04179838|101724790|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
48569494|NCT04179838|101724791|FG001|NOT COMPLETED|Washout (4 Weeks)||0||
48569495|NCT04179838|101724790|FG000|STARTED|Second Intervention (1 Day)||13||
48569496|NCT04179838|101724791|FG001|STARTED|Second Intervention (1 Day)||13||
48569497|NCT04179838|101724790|FG000|COMPLETED|Second Intervention (1 Day)||13||
48569498|NCT04179838|101724791|FG001|COMPLETED|Second Intervention (1 Day)||12||
48569499|NCT04179838|101724790|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48569500|NCT04179838|101724791|FG001|NOT COMPLETED|Second Intervention (1 Day)||1||
48569501|NCT01346696|101724792|FG000|STARTED|Overall Study||45||94
48569502|NCT01346696|101724792|FG000|COMPLETED|Overall Study||44||90
48569503|NCT01346696|101724792|FG000|NOT COMPLETED|Overall Study||1||4
48569504|NCT02929589|101724793|FG000|STARTED|Overall Study||11||
48569505|NCT02929589|101724794|FG001|STARTED|Overall Study||0||
48569506|NCT02929589|101724795|FG002|STARTED|Overall Study||7||
48569507|NCT02929589|101724796|FG003|STARTED|Overall Study||0||
48569508|NCT02929589|101724793|FG000|COMPLETED|Overall Study||8||
48569509|NCT02929589|101724794|FG001|COMPLETED|Overall Study||0||
48569510|NCT02929589|101724795|FG002|COMPLETED|Overall Study||7||
48569511|NCT02929589|101724796|FG003|COMPLETED|Overall Study||0||
48569512|NCT02929589|101724793|FG000|NOT COMPLETED|Overall Study||3||
48569513|NCT02929589|101724794|FG001|NOT COMPLETED|Overall Study||0||
48569514|NCT02929589|101724795|FG002|NOT COMPLETED|Overall Study||0||
48569515|NCT02929589|101724796|FG003|NOT COMPLETED|Overall Study||0||
48569516|NCT04021238|101724797|FG000|STARTED|Overall Study||24||
48569517|NCT04021238|101724797|FG000|COMPLETED|Overall Study||24||
48569518|NCT04021238|101724797|FG000|NOT COMPLETED|Overall Study||0||
48569519|NCT00913263|101724798|FG000|STARTED|Overall Study||24||
48569520|NCT00913263|101724798|FG000|COMPLETED|Overall Study||24||
48121917|NCT03986944|100623006|FG001|COMPLETED|Overall Study||10||
48121918|NCT03986944|100623007|FG002|COMPLETED|Overall Study||8||
48121919|NCT03986944|100623005|FG000|NOT COMPLETED|Overall Study||15||
48121920|NCT03986944|100623006|FG001|NOT COMPLETED|Overall Study||19||
48121921|NCT03986944|100623007|FG002|NOT COMPLETED|Overall Study||19||
48121922|NCT04973488|100623008|FG000|STARTED|Overall Study||19||
48569521|NCT00913263|101724798|FG000|NOT COMPLETED|Overall Study||0||
48569522|NCT00427648|101724799|FG000|STARTED|Overall Study||12||
48569523|NCT00427648|101724800|FG001|STARTED|Overall Study||10||
48569524|NCT00427648|101724799|FG000|COMPLETED|Overall Study||11||
48569525|NCT00427648|101724800|FG001|COMPLETED|Overall Study||7||
48569526|NCT00427648|101724799|FG000|NOT COMPLETED|Overall Study||1||
48569527|NCT00427648|101724800|FG001|NOT COMPLETED|Overall Study||3||
48569528|NCT01275365|101724801|FG000|STARTED|Overall Study||24||
48569529|NCT01275365|101724802|FG001|STARTED|Overall Study||24||
48569530|NCT01275365|101724803|FG002|STARTED|Overall Study||22||
48569531|NCT01275365|101724804|FG003|STARTED|Overall Study||22||
48569532|NCT01275365|101724801|FG000|COMPLETED|Overall Study||21||
48569533|NCT01275365|101724802|FG001|COMPLETED|Overall Study||21||
48569534|NCT01275365|101724803|FG002|COMPLETED|Overall Study||17||
48569535|NCT01275365|101724804|FG003|COMPLETED|Overall Study||19||
48569536|NCT01275365|101724801|FG000|NOT COMPLETED|Overall Study||3||
48569537|NCT01275365|101724802|FG001|NOT COMPLETED|Overall Study||3||
48569538|NCT01275365|101724803|FG002|NOT COMPLETED|Overall Study||5||
48569539|NCT01275365|101724804|FG003|NOT COMPLETED|Overall Study||3||
48569540|NCT03503669|101724805|FG000|STARTED|Overall Study||39||
48569541|NCT03503669|101724806|FG001|STARTED|Overall Study||40||
48569542|NCT03503669|101724805|FG000|COMPLETED|Overall Study||37||
48569543|NCT03503669|101724806|FG001|COMPLETED|Overall Study||26||
48569544|NCT03503669|101724805|FG000|NOT COMPLETED|Overall Study||2||
48569545|NCT03503669|101724806|FG001|NOT COMPLETED|Overall Study||14||
48569546|NCT00687544|101724807|FG000|STARTED|Overall Study||11||
48569547|NCT00687544|101724807|FG000|COMPLETED|Overall Study||0||
48569548|NCT00687544|101724807|FG000|NOT COMPLETED|Overall Study||11||
48569549|NCT01441765|101724808|FG000|STARTED|Overall Study||11||
48121923|NCT04973488|100623009|FG001|STARTED|Overall Study||19||
48569550|NCT01441765|101724809|FG001|STARTED|Overall Study||0||
48569551|NCT01441765|101724808|FG000|COMPLETED|Overall Study||10||
48121924|NCT04973488|100623008|FG000|COMPLETED|Overall Study||19||
48281767|NCT03534284|101014171|FG002|NOT COMPLETED|Overall Study||3||
48121925|NCT04973488|100623009|FG001|COMPLETED|Overall Study||19||
48569552|NCT01441765|101724809|FG001|COMPLETED|Overall Study||0||
48569553|NCT01441765|101724808|FG000|NOT COMPLETED|Overall Study||1||
48396693|NCT02290340|101302438|FG000|STARTED|Overall Study||18||
48396694|NCT02290340|101302439|FG001|STARTED|Overall Study||8||
48396695|NCT02290340|101302440|FG002|STARTED|Overall Study||31||
48121926|NCT04973488|100623008|FG000|NOT COMPLETED|Overall Study||0||
48121927|NCT04973488|100623009|FG001|NOT COMPLETED|Overall Study||0||
48121928|NCT00132769|100623010|FG000|STARTED|Overall Study||53||
48121929|NCT00132769|100623011|FG001|STARTED|Overall Study||53||
48121930|NCT00132769|100623010|FG000|COMPLETED|Overall Study||42||
48121931|NCT00132769|100623011|FG001|COMPLETED|Overall Study||42||
48121932|NCT00132769|100623010|FG000|NOT COMPLETED|Overall Study||11||
48121933|NCT00132769|100623011|FG001|NOT COMPLETED|Overall Study||11||
48121934|NCT02738775|100623012|FG000|STARTED|Overall Study||8||
48121935|NCT02738775|100623013|FG001|STARTED|Overall Study||8||
48121936|NCT02738775|100623014|FG002|STARTED|Overall Study||8||
48121937|NCT02738775|100623015|FG003|STARTED|Overall Study||9||
48121938|NCT02738775|100623016|FG004|STARTED|Overall Study||8||
48121939|NCT02738775|100623017|FG005|STARTED|Overall Study||8||
48121940|NCT02738775|100623012|FG000|Initially Treated With Placebo|Overall Study||0||
48121941|NCT02738775|100623013|FG001|Initially Treated With Placebo|Overall Study||0||
48121942|NCT02738775|100623014|FG002|Initially Treated With Placebo|Overall Study||0||
48121943|NCT02738775|100623015|FG003|Initially Treated With Placebo|Overall Study||1||
48121944|NCT02738775|100623016|FG004|Initially Treated With Placebo|Overall Study||0||
48121945|NCT02738775|100623017|FG005|Initially Treated With Placebo|Overall Study||0||
48121946|NCT02738775|100623012|FG000|COMPLETED|Overall Study||8||
48121947|NCT02738775|100623013|FG001|COMPLETED|Overall Study||6||
48121948|NCT02738775|100623014|FG002|COMPLETED|Overall Study||8||
48121949|NCT02738775|100623015|FG003|COMPLETED|Overall Study||8||
48121950|NCT02738775|100623016|FG004|COMPLETED|Overall Study||8||
48396696|NCT02290340|101302441|FG003|STARTED|Overall Study||32||
48396697|NCT02290340|101302438|FG000|COMPLETED|Overall Study||16||
48699612|NCT01944098|102050554|FG000|STARTED|Overall Study||10||
48699613|NCT01944098|102050555|FG001|STARTED|Overall Study||10||
48121951|NCT02738775|100623017|FG005|COMPLETED|Overall Study||7||
48121952|NCT02738775|100623012|FG000|NOT COMPLETED|Overall Study||0||
48121953|NCT02738775|100623013|FG001|NOT COMPLETED|Overall Study||2||
48121954|NCT02738775|100623014|FG002|NOT COMPLETED|Overall Study||0||
48121955|NCT02738775|100623015|FG003|NOT COMPLETED|Overall Study||1||
48121956|NCT02738775|100623016|FG004|NOT COMPLETED|Overall Study||0||
48121957|NCT02738775|100623017|FG005|NOT COMPLETED|Overall Study||1||
48121958|NCT02331446|100623018|FG000|STARTED|Overall Study||9||
48121959|NCT02331446|100623019|FG001|STARTED|Overall Study||11||
48121960|NCT02331446|100623020|FG002|STARTED|Overall Study||11||
48121961|NCT02331446|100623021|FG003|STARTED|Overall Study||11||
48121962|NCT02331446|100623018|FG000|COMPLETED|Overall Study||5||
48121963|NCT02331446|100623019|FG001|COMPLETED|Overall Study||6||
48121964|NCT02331446|100623020|FG002|COMPLETED|Overall Study||8||
48121965|NCT02331446|100623021|FG003|COMPLETED|Overall Study||8||
48121966|NCT02331446|100623018|FG000|NOT COMPLETED|Overall Study||4||
48121967|NCT02331446|100623019|FG001|NOT COMPLETED|Overall Study||5||
48121968|NCT02331446|100623020|FG002|NOT COMPLETED|Overall Study||3||
48121969|NCT02331446|100623021|FG003|NOT COMPLETED|Overall Study||3||
48121970|NCT02358889|100623022|FG000|STARTED|Overall Study||30||
48121971|NCT02358889|100623023|FG001|STARTED|Overall Study||30||
48121972|NCT02358889|100623024|FG002|STARTED|Overall Study||28||
48121973|NCT02358889|100623022|FG000|COMPLETED|Overall Study||30||
48396698|NCT02290340|101302439|FG001|COMPLETED|Overall Study||8||
48121974|NCT02358889|100623023|FG001|COMPLETED|Overall Study||28||
48121975|NCT02358889|100623024|FG002|COMPLETED|Overall Study||27||
48121976|NCT02358889|100623022|FG000|NOT COMPLETED|Overall Study||0||
48396699|NCT02290340|101302440|FG002|COMPLETED|Overall Study||31||
48396700|NCT02290340|101302441|FG003|COMPLETED|Overall Study||30||
48396701|NCT02290340|101302438|FG000|NOT COMPLETED|Overall Study||2||
48396702|NCT02290340|101302439|FG001|NOT COMPLETED|Overall Study||0||
48396703|NCT02290340|101302440|FG002|NOT COMPLETED|Overall Study||0||
48396704|NCT02290340|101302441|FG003|NOT COMPLETED|Overall Study||2||
48396705|NCT03276572|101302442|FG000|STARTED|Overall Study||1||
48396706|NCT03276572|101302443|FG001|STARTED|Overall Study||1||
48396707|NCT03276572|101302444|FG002|STARTED|Overall Study||1||
48396708|NCT03276572|101302445|FG003|STARTED|Overall Study||1||
48396709|NCT03276572|101302446|FG004|STARTED|Overall Study||6||
48699614|NCT01944098|102050554|FG000|COMPLETED|Overall Study||9||
48699615|NCT01944098|102050555|FG001|COMPLETED|Overall Study||10||
48699616|NCT01944098|102050554|FG000|NOT COMPLETED|Overall Study||1||
48121977|NCT02358889|100623023|FG001|NOT COMPLETED|Overall Study||2||
48121978|NCT02358889|100623024|FG002|NOT COMPLETED|Overall Study||1||
48121979|NCT02737566|100623025|FG000|STARTED|Overall Study||159||
48121980|NCT02737566|100623026|FG001|STARTED|Overall Study||161||
48396710|NCT03276572|101302447|FG005|STARTED|Overall Study||6||
48396711|NCT03276572|101302448|FG006|STARTED|Overall Study||16||
48121981|NCT02737566|100623025|FG000|COMPLETED|Overall Study||104||
48121982|NCT02737566|100623026|FG001|COMPLETED|Overall Study||105||
48121983|NCT02737566|100623025|FG000|NOT COMPLETED|Overall Study||55||
48396712|NCT03276572|101302442|FG000|COMPLETED|Overall Study||1||
48396713|NCT03276572|101302443|FG001|COMPLETED|Overall Study||1||
48699617|NCT01944098|102050555|FG001|NOT COMPLETED|Overall Study||0||
48121984|NCT02737566|100623026|FG001|NOT COMPLETED|Overall Study||56||
48121985|NCT02621983|100623027|FG000|STARTED|Overall Study||21||
48121986|NCT02621983|100623028|FG001|STARTED|Overall Study||17||
48121987|NCT02621983|100623027|FG000|COMPLETED|Overall Study||9||
48121988|NCT02621983|100623028|FG001|COMPLETED|Overall Study||6||
48121989|NCT02621983|100623027|FG000|NOT COMPLETED|Overall Study||12||
48121990|NCT02621983|100623028|FG001|NOT COMPLETED|Overall Study||11||
48121991|NCT03285373|100623029|FG000|STARTED|Overall Study||314||
48121992|NCT03285373|100623030|FG001|STARTED|Overall Study||253||
48121993|NCT03285373|100623031|FG002|STARTED|Overall Study||266||
48121994|NCT03285373|100623032|FG003|STARTED|Overall Study||130||
48569554|NCT01441765|101724809|FG001|NOT COMPLETED|Overall Study||0||
48569555|NCT01523782|101724810|FG000|STARTED|Overall Study||3||
48569556|NCT01523782|101724811|FG001|STARTED|Overall Study||13||
48569557|NCT01523782|101724812|FG002|STARTED|Overall Study||14||
48569558|NCT01523782|101724810|FG000|COMPLETED|Overall Study||2||
48121995|NCT03285373|100623029|FG000|COMPLETED|Overall Study||314||
48121996|NCT03285373|100623030|FG001|COMPLETED|Overall Study||253||
48121997|NCT03285373|100623031|FG002|COMPLETED|Overall Study||266||
48121998|NCT03285373|100623032|FG003|COMPLETED|Overall Study||130||
48121999|NCT03285373|100623029|FG000|NOT COMPLETED|Overall Study||0||
48122000|NCT03285373|100623030|FG001|NOT COMPLETED|Overall Study||0||
48122001|NCT03285373|100623031|FG002|NOT COMPLETED|Overall Study||0||
48122002|NCT03285373|100623032|FG003|NOT COMPLETED|Overall Study||0||
48122003|NCT02370888|100623033|FG000|STARTED|Overall Study||9||
48122004|NCT02370888|100623033|FG000|Proceed to Treatment|Overall Study||3||
48122005|NCT02370888|100623033|FG000|COMPLETED|Overall Study||1||
48122006|NCT02370888|100623033|FG000|NOT COMPLETED|Overall Study||8||
48122007|NCT04165291|100623034|FG000|STARTED|Overall Study||30||
48122008|NCT04165291|100623035|FG001|STARTED|Overall Study||30||
48122009|NCT04165291|100623034|FG000|COMPLETED|Overall Study||20||
48122010|NCT04165291|100623035|FG001|COMPLETED|Overall Study||21||
48122011|NCT04165291|100623034|FG000|NOT COMPLETED|Overall Study||10||
48122012|NCT04165291|100623035|FG001|NOT COMPLETED|Overall Study||9||
48122013|NCT00139997|100623036|FG000|STARTED|Overall Study||15||
48122014|NCT00139997|100623037|FG001|STARTED|Overall Study||11||
48122015|NCT00139997|100623036|FG000|COMPLETED|Overall Study||14||
48122016|NCT00139997|100623037|FG001|COMPLETED|Overall Study||9||
48122017|NCT00139997|100623036|FG000|NOT COMPLETED|Overall Study||1||
48569559|NCT01523782|101724811|FG001|COMPLETED|Overall Study||13||
48569560|NCT01523782|101724812|FG002|COMPLETED|Overall Study||9||
48569561|NCT01523782|101724810|FG000|NOT COMPLETED|Overall Study||1||
48569562|NCT01523782|101724811|FG001|NOT COMPLETED|Overall Study||0||
48569563|NCT01523782|101724812|FG002|NOT COMPLETED|Overall Study||5||
48569564|NCT04201574|101724813|FG000|STARTED|Overall Study||46||
48569565|NCT04201574|101724814|FG001|STARTED|Overall Study||46||
48569566|NCT04201574|101724815|FG002|STARTED|Overall Study||46||
48569567|NCT04201574|101724813|FG000|COMPLETED|Overall Study||46||
48569568|NCT04201574|101724814|FG001|COMPLETED|Overall Study||46||
48569569|NCT04201574|101724815|FG002|COMPLETED|Overall Study||46||
48569570|NCT04201574|101724813|FG000|NOT COMPLETED|Overall Study||0||
48569571|NCT04201574|101724814|FG001|NOT COMPLETED|Overall Study||0||
48569572|NCT04201574|101724815|FG002|NOT COMPLETED|Overall Study||0||
48569573|NCT02195869|101724816|FG000|STARTED|Overall Study||42||
48569574|NCT02195869|101724816|FG000|All-Treated Population|Overall Study||42||
48569575|NCT02195869|101724816|FG000|COMPLETED|Overall Study||0||
48569576|NCT02195869|101724816|FG000|NOT COMPLETED|Overall Study||42||
48569577|NCT04793711|101724817|FG000|STARTED|Overall Study||1||
48569578|NCT04793711|101724817|FG000|COMPLETED|Overall Study||1||
48569579|NCT04793711|101724817|FG000|NOT COMPLETED|Overall Study||0||
48569580|NCT00586820|101727627|FG000|STARTED|Overall Study||12||
48569581|NCT00586820|101727628|FG001|STARTED|Overall Study||11||
48569582|NCT00586820|101727627|FG000|COMPLETED|Overall Study||11||
48569583|NCT00586820|101727628|FG001|COMPLETED|Overall Study||11||
48569584|NCT00586820|101727627|FG000|NOT COMPLETED|Overall Study||1||
48569585|NCT00586820|101727628|FG001|NOT COMPLETED|Overall Study||0||
48569586|NCT03291080|101727629|FG000|STARTED|First Cycle (2 Weeks)||11||
48569587|NCT03291080|101727630|FG001|STARTED|First Cycle (2 Weeks)||9||
48569588|NCT03291080|101727629|FG000|COMPLETED|First Cycle (2 Weeks)||11||
48569589|NCT03291080|101727630|FG001|COMPLETED|First Cycle (2 Weeks)||9||
48569590|NCT03291080|101727629|FG000|NOT COMPLETED|First Cycle (2 Weeks)||0||
48569591|NCT03291080|101727630|FG001|NOT COMPLETED|First Cycle (2 Weeks)||0||
48569592|NCT03291080|101727629|FG000|STARTED|Washout (2 Weeks)||11||
48122018|NCT00139997|100623037|FG001|NOT COMPLETED|Overall Study||2||
48122019|NCT01994395|100623038|FG000|STARTED|Overall Study||26||
48122020|NCT01994395|100623039|FG001|STARTED|Overall Study||27||
48122021|NCT01994395|100623038|FG000|COMPLETED|Overall Study||25||
48122022|NCT01994395|100623039|FG001|COMPLETED|Overall Study||25||
48122023|NCT01994395|100623038|FG000|NOT COMPLETED|Overall Study||1||
48122024|NCT01994395|100623039|FG001|NOT COMPLETED|Overall Study||2||
48122025|NCT04537715|100623040|FG000|STARTED|Overall Study||21||
48122026|NCT04537715|100623041|FG001|STARTED|Overall Study||21||
48122027|NCT04537715|100623040|FG000|COMPLETED|Overall Study||10||
48122028|NCT04537715|100623041|FG001|COMPLETED|Overall Study||16||
48122029|NCT04537715|100623040|FG000|NOT COMPLETED|Overall Study||11||
48122030|NCT04537715|100623041|FG001|NOT COMPLETED|Overall Study||5||
48122031|NCT04456699|100623042|FG000|STARTED|Overall Study||111||
48122032|NCT04456699|100623043|FG001|STARTED|Overall Study||115||
48122033|NCT04456699|100623044|FG002|STARTED|Overall Study||109||
48122034|NCT04456699|100623042|FG000|Treated|Overall Study||111||
48122035|NCT04456699|100623043|FG001|Treated|Overall Study||113||
48122036|NCT04456699|100623044|FG002|Treated|Overall Study||108||
48122037|NCT04456699|100623042|FG000|COMPLETED|Overall Study||0||
48122038|NCT04456699|100623043|FG001|COMPLETED|Overall Study||0||
48122039|NCT04456699|100623044|FG002|COMPLETED|Overall Study||0||
48122040|NCT04456699|100623042|FG000|NOT COMPLETED|Overall Study||111||
48122041|NCT04456699|100623043|FG001|NOT COMPLETED|Overall Study||115||
48122042|NCT04456699|100623044|FG002|NOT COMPLETED|Overall Study||109||
48569593|NCT03291080|101727630|FG001|STARTED|Washout (2 Weeks)||9||
48569594|NCT03291080|101727629|FG000|COMPLETED|Washout (2 Weeks)||11||
48569595|NCT03291080|101727630|FG001|COMPLETED|Washout (2 Weeks)||9||
48569596|NCT03291080|101727629|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
48122043|NCT02096055|100623045|FG000|STARTED|Overall Study||13||
48122044|NCT02096055|100623046|FG001|STARTED|Overall Study||9||
48122045|NCT02096055|100623047|FG002|STARTED|Overall Study||13||
48122046|NCT02096055|100623048|FG003|STARTED|Overall Study||9||
48122047|NCT02096055|100623045|FG000|COMPLETED|Overall Study||13||
48122048|NCT02096055|100623046|FG001|COMPLETED|Overall Study||9||
48122049|NCT02096055|100623047|FG002|COMPLETED|Overall Study||13||
48122050|NCT02096055|100623048|FG003|COMPLETED|Overall Study||9||
48122051|NCT02096055|100623045|FG000|NOT COMPLETED|Overall Study||0||
48122052|NCT02096055|100623046|FG001|NOT COMPLETED|Overall Study||0||
48122053|NCT02096055|100623047|FG002|NOT COMPLETED|Overall Study||0||
48122054|NCT02096055|100623048|FG003|NOT COMPLETED|Overall Study||0||
48122055|NCT02788175|100623049|FG000|STARTED|Overall Study||26|Screened|
48122056|NCT02788175|100623049|FG000|Received Study Agent|Overall Study||20||
48122057|NCT02788175|100623049|FG000|COMPLETED|Overall Study||13||
48122058|NCT02788175|100623049|FG000|NOT COMPLETED|Overall Study||13||
48122059|NCT03433456|100623050|FG000|STARTED|Overall Study||158|This is the total number of caregivers and children who started the study.|
48122060|NCT03433456|100623051|FG001|STARTED|Overall Study||138|This is the total number of caregivers and children who started the study.|
48122061|NCT03433456|100623050|FG000|Caregivers Started|Overall Study||79|Number of caregivers only who started the study.|
48122062|NCT03433456|100623051|FG001|Caregivers Started|Overall Study||69|Number of caregivers only who started the study.|
48122063|NCT03433456|100623050|FG000|Children Started|Overall Study||79|Number of children only who started the study.|
48122064|NCT03433456|100623051|FG001|Children Started|Overall Study||69|Number of children only who started the study.|
48122065|NCT03433456|100623050|FG000|Caregivers Completed|Overall Study||71|Number of caregivers only who completed the study.|
48122066|NCT03433456|100623051|FG001|Caregivers Completed|Overall Study||63|Number of caregivers only who completed the study.|
48122067|NCT03433456|100623050|FG000|Children Completed|Overall Study||71|Number of children only who completed the study.|
48122068|NCT03433456|100623051|FG001|Children Completed|Overall Study||63|Number of children only who completed the study.|
48122069|NCT03433456|100623050|FG000|COMPLETED|Overall Study||142|This is the total number of caregivers and children who completed the study.|
48122070|NCT03433456|100623051|FG001|COMPLETED|Overall Study||126|This is the total number of caregivers and children who completed the study.|
48122071|NCT03433456|100623050|FG000|NOT COMPLETED|Overall Study||16||
48122072|NCT03433456|100623051|FG001|NOT COMPLETED|Overall Study||12||
48122073|NCT04796610|100623052|FG000|STARTED|Overall Study||30||
48122074|NCT04796610|100623053|FG001|STARTED|Overall Study||30||
48122075|NCT04796610|100623054|FG002|STARTED|Overall Study||17||
48122076|NCT04796610|100623055|FG003|STARTED|Overall Study||28||
48122077|NCT04796610|100623052|FG000|COMPLETED|Overall Study||27||
48122078|NCT04796610|100623053|FG001|COMPLETED|Overall Study||30||
48122079|NCT04796610|100623054|FG002|COMPLETED|Overall Study||16||
48122080|NCT04796610|100623055|FG003|COMPLETED|Overall Study||27||
48122081|NCT04796610|100623052|FG000|NOT COMPLETED|Overall Study||3||
48122082|NCT04796610|100623053|FG001|NOT COMPLETED|Overall Study||0||
48122083|NCT04796610|100623054|FG002|NOT COMPLETED|Overall Study||1||
48122084|NCT04796610|100623055|FG003|NOT COMPLETED|Overall Study||1||
48122085|NCT03160703|100623056|FG000|STARTED|Overall Study||55||
48122086|NCT03160703|100623057|FG001|STARTED|Overall Study||55||
48569597|NCT03291080|101727630|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
48569598|NCT03291080|101727629|FG000|STARTED|Second Cylcle (2 Weeks)||9||
48569599|NCT03291080|101727630|FG001|STARTED|Second Cylcle (2 Weeks)||11||
48569600|NCT03291080|101727629|FG000|COMPLETED|Second Cylcle (2 Weeks)||8||
48569601|NCT03291080|101727630|FG001|COMPLETED|Second Cylcle (2 Weeks)||11||
48569602|NCT03291080|101727629|FG000|NOT COMPLETED|Second Cylcle (2 Weeks)||1||
48122087|NCT03160703|100623058|FG002|STARTED|Overall Study||55||
48122088|NCT03160703|100623059|FG003|STARTED|Overall Study||55||
48122089|NCT03160703|100623056|FG000|COMPLETED|Overall Study||55||
48122090|NCT03160703|100623057|FG001|COMPLETED|Overall Study||55||
48122091|NCT03160703|100623058|FG002|COMPLETED|Overall Study||55||
48122092|NCT03160703|100623059|FG003|COMPLETED|Overall Study||54||
48122093|NCT03160703|100623056|FG000|NOT COMPLETED|Overall Study||0||
48122094|NCT03160703|100623057|FG001|NOT COMPLETED|Overall Study||0||
48122095|NCT03160703|100623058|FG002|NOT COMPLETED|Overall Study||0||
48122096|NCT03160703|100623059|FG003|NOT COMPLETED|Overall Study||1||
48122097|NCT04713748|100623060|FG000|STARTED|Overall Study||135||
48122098|NCT04713748|100623060|FG000|COMPLETED|Overall Study||100||
48122099|NCT04713748|100623060|FG000|NOT COMPLETED|Overall Study||35||
48122100|NCT00733824|100623061|FG000|STARTED|Phase I||10||
48122101|NCT00733824|100623062|FG001|STARTED|Phase I||3||
48122102|NCT00733824|100623063|FG002|STARTED|Phase I||6||
48122103|NCT00733824|100623064|FG003|STARTED|Phase I||6||
48122104|NCT00733824|100623065|FG004|STARTED|Phase I||0||
48122105|NCT00733824|100623061|FG000|COMPLETED|Phase I||9||
48122106|NCT00733824|100623062|FG001|COMPLETED|Phase I||3||
48122107|NCT00733824|100623063|FG002|COMPLETED|Phase I||6||
48122108|NCT00733824|100623064|FG003|COMPLETED|Phase I||6||
48122109|NCT00733824|100623065|FG004|COMPLETED|Phase I||0||
48122110|NCT00733824|100623061|FG000|NOT COMPLETED|Phase I||1||
48122111|NCT00733824|100623062|FG001|NOT COMPLETED|Phase I||0||
48122112|NCT00733824|100623063|FG002|NOT COMPLETED|Phase I||0||
48122113|NCT00733824|100623064|FG003|NOT COMPLETED|Phase I||0||
48122114|NCT00733824|100623065|FG004|NOT COMPLETED|Phase I||0||
48122115|NCT00733824|100623061|FG000|STARTED|Phase II||0||
48122116|NCT00733824|100623062|FG001|STARTED|Phase II||0||
48122117|NCT00733824|100623063|FG002|STARTED|Phase II||0||
48122118|NCT00733824|100623064|FG003|STARTED|Phase II||0||
48122119|NCT00733824|100623065|FG004|STARTED|Phase II||36||
48122120|NCT00733824|100623061|FG000|COMPLETED|Phase II||0||
48122121|NCT00733824|100623062|FG001|COMPLETED|Phase II||0||
48122122|NCT00733824|100623063|FG002|COMPLETED|Phase II||0||
48569603|NCT03291080|101727630|FG001|NOT COMPLETED|Second Cylcle (2 Weeks)||0||
48569604|NCT01706939|101727631|FG000|STARTED|Pre Randomization||23||
48569605|NCT01706939|101727632|FG001|STARTED|Pre Randomization||0||
48569606|NCT01706939|101727633|FG002|STARTED|Pre Randomization||0||
48569607|NCT01706939|101727631|FG000|COMPLETED|Pre Randomization||20||
48569608|NCT01706939|101727632|FG001|COMPLETED|Pre Randomization||0||
48569609|NCT01706939|101727633|FG002|COMPLETED|Pre Randomization||0||
48569610|NCT01706939|101727631|FG000|NOT COMPLETED|Pre Randomization||3||
48569611|NCT01706939|101727632|FG001|NOT COMPLETED|Pre Randomization||0||
48569612|NCT01706939|101727633|FG002|NOT COMPLETED|Pre Randomization||0||
48569613|NCT01706939|101727631|FG000|STARTED|Randomization||0||
48569614|NCT01706939|101727632|FG001|STARTED|Randomization||12||
48569615|NCT01706939|101727633|FG002|STARTED|Randomization||8||
48569616|NCT01706939|101727631|FG000|COMPLETED|Randomization||0||
48569617|NCT01706939|101727632|FG001|COMPLETED|Randomization||9||
48569618|NCT01706939|101727633|FG002|COMPLETED|Randomization||6||
48569619|NCT01706939|101727631|FG000|NOT COMPLETED|Randomization||0||
48569620|NCT01706939|101727632|FG001|NOT COMPLETED|Randomization||3||
48569621|NCT01706939|101727633|FG002|NOT COMPLETED|Randomization||2||
48569622|NCT04570670|101727634|FG000|STARTED|Overall Study||25||
48569623|NCT04570670|101727635|FG001|STARTED|Overall Study||25||
48569624|NCT04570670|101727634|FG000|COMPLETED|Overall Study||24||
48569625|NCT04570670|101727635|FG001|COMPLETED|Overall Study||25||
48569626|NCT04570670|101727634|FG000|NOT COMPLETED|Overall Study||1||
48569627|NCT04570670|101727635|FG001|NOT COMPLETED|Overall Study||0||
48569628|NCT02510664|101727636|FG000|STARTED|Overall Study||84|of 84 consented, n=20 did not receive any intervention (see description in Pre-assignment details)|
48569629|NCT02510664|101727637|FG001|STARTED|Overall Study||84|of 84 consented, n=20 did not receive any intervention (see description in Pre-assignment details)|
48569630|NCT02510664|101727638|FG002|STARTED|Overall Study||4|of 84 consented, n=20 did not receive any intervention (see description in Pre-assignment details)|
48122123|NCT00733824|100623064|FG003|COMPLETED|Phase II||0||
48122124|NCT00733824|100623065|FG004|COMPLETED|Phase II||36||
48122125|NCT00733824|100623061|FG000|NOT COMPLETED|Phase II||0||
48122126|NCT00733824|100623062|FG001|NOT COMPLETED|Phase II||0||
48122127|NCT00733824|100623063|FG002|NOT COMPLETED|Phase II||0||
48122128|NCT00733824|100623064|FG003|NOT COMPLETED|Phase II||0||
48122129|NCT00733824|100623065|FG004|NOT COMPLETED|Phase II||0||
48122130|NCT04101526|100623066|FG000|STARTED|Overall Study||15||
48122131|NCT04101526|100623067|FG001|STARTED|Overall Study||15||
48122132|NCT04101526|100623066|FG000|COMPLETED|Overall Study||15||
48122133|NCT04101526|100623067|FG001|COMPLETED|Overall Study||14||
48122134|NCT04101526|100623066|FG000|NOT COMPLETED|Overall Study||0||
48122135|NCT04101526|100623067|FG001|NOT COMPLETED|Overall Study||1||
48122136|NCT00718718|100623068|FG000|STARTED|Prior to Week 12||19||
48122137|NCT00718718|100623069|FG001|STARTED|Prior to Week 12||0||
48122138|NCT00718718|100623070|FG002|STARTED|Prior to Week 12||17||
48122139|NCT00718718|100623071|FG003|STARTED|Prior to Week 12||0||
48122140|NCT00718718|100623072|FG004|STARTED|Prior to Week 12||30||
48122141|NCT00718718|100623073|FG005|STARTED|Prior to Week 12||0||
48122142|NCT00718718|100623074|FG006|STARTED|Prior to Week 12||30||
48122143|NCT00718718|100623075|FG007|STARTED|Prior to Week 12||30||
48122144|NCT00718718|100623076|FG008|STARTED|Prior to Week 12||30||
48569631|NCT02510664|101727636|FG000|COMPLETED|Overall Study||64||
48569632|NCT02510664|101727637|FG001|COMPLETED|Overall Study||64||
48569633|NCT02510664|101727638|FG002|COMPLETED|Overall Study||4||
48122145|NCT00718718|100623077|FG009|STARTED|Prior to Week 12||31||
48122146|NCT00718718|100623068|FG000|COMPLETED|Prior to Week 12||18||
48122147|NCT00718718|100623069|FG001|COMPLETED|Prior to Week 12||0||
48122148|NCT00718718|100623070|FG002|COMPLETED|Prior to Week 12||16||
48122149|NCT00718718|100623071|FG003|COMPLETED|Prior to Week 12||0||
48122150|NCT00718718|100623072|FG004|COMPLETED|Prior to Week 12||27||
48122151|NCT00718718|100623073|FG005|COMPLETED|Prior to Week 12||0||
48122152|NCT00718718|100623074|FG006|COMPLETED|Prior to Week 12||29||
48122153|NCT00718718|100623075|FG007|COMPLETED|Prior to Week 12||28||
48122154|NCT00718718|100623076|FG008|COMPLETED|Prior to Week 12||28||
48569634|NCT02510664|101727636|FG000|NOT COMPLETED|Overall Study||20||
48569635|NCT02510664|101727637|FG001|NOT COMPLETED|Overall Study||20||
48569636|NCT02510664|101727638|FG002|NOT COMPLETED|Overall Study||0||
48569637|NCT04177095|101727639|FG000|STARTED|Overall Study||17||
48569638|NCT04177095|101727639|FG000|COMPLETED|Overall Study||10||
48569639|NCT04177095|101727639|FG000|NOT COMPLETED|Overall Study||7||
48569640|NCT00086684|101727640|FG000|STARTED|Overall Study||118||
48569641|NCT00086684|101727641|FG001|STARTED|Overall Study||129||
48569642|NCT00086684|101727642|FG002|STARTED|Overall Study||122||
48569643|NCT00086684|101727640|FG000|COMPLETED|Overall Study||63||
48569644|NCT00086684|101727641|FG001|COMPLETED|Overall Study||74||
48569645|NCT00086684|101727642|FG002|COMPLETED|Overall Study||69||
48122155|NCT00718718|100623077|FG009|COMPLETED|Prior to Week 12||31||
48122156|NCT00718718|100623068|FG000|NOT COMPLETED|Prior to Week 12||1||
48122157|NCT00718718|100623069|FG001|NOT COMPLETED|Prior to Week 12||0||
48122158|NCT00718718|100623070|FG002|NOT COMPLETED|Prior to Week 12||1||
48122159|NCT00718718|100623071|FG003|NOT COMPLETED|Prior to Week 12||0||
48122160|NCT00718718|100623072|FG004|NOT COMPLETED|Prior to Week 12||3||
48122161|NCT00718718|100623073|FG005|NOT COMPLETED|Prior to Week 12||0||
48122162|NCT00718718|100623074|FG006|NOT COMPLETED|Prior to Week 12||1||
48569646|NCT00086684|101727640|FG000|NOT COMPLETED|Overall Study||55||
48569647|NCT00086684|101727641|FG001|NOT COMPLETED|Overall Study||55||
48569648|NCT00086684|101727642|FG002|NOT COMPLETED|Overall Study||53||
48569649|NCT00778869|101727643|FG000|STARTED|Overall Study||10||
48569650|NCT00778869|101727643|FG000|COMPLETED|Overall Study||10||
48569651|NCT00778869|101727643|FG000|NOT COMPLETED|Overall Study||0||
48569652|NCT01155180|101727644|FG000|STARTED|Overall Study||18||
48569653|NCT01155180|101727645|FG001|STARTED|Overall Study||6||
48569654|NCT01155180|101727644|FG000|COMPLETED|Overall Study||18||
48569655|NCT01155180|101727645|FG001|COMPLETED|Overall Study||6||
48569656|NCT01155180|101727644|FG000|NOT COMPLETED|Overall Study||0||
48569657|NCT01155180|101727645|FG001|NOT COMPLETED|Overall Study||0||
48569658|NCT04932655|101727646|FG000|STARTED|Period 1||6||
48569659|NCT04932655|101727647|FG001|STARTED|Period 1||6||
48569660|NCT04932655|101727648|FG002|STARTED|Period 1||6||
48569661|NCT04932655|101727649|FG003|STARTED|Period 1||6||
48569662|NCT04932655|101727646|FG000|COMPLETED|Period 1||6||
48122163|NCT00718718|100623075|FG007|NOT COMPLETED|Prior to Week 12||2||
48122164|NCT00718718|100623076|FG008|NOT COMPLETED|Prior to Week 12||2||
48122165|NCT00718718|100623077|FG009|NOT COMPLETED|Prior to Week 12||0||
48122166|NCT00718718|100623068|FG000|STARTED|Week 12 to End of Study||0||
48122167|NCT00718718|100623069|FG001|STARTED|Week 12 to End of Study||18||
48122168|NCT00718718|100623070|FG002|STARTED|Week 12 to End of Study||0||
48122169|NCT00718718|100623071|FG003|STARTED|Week 12 to End of Study||16||
48122170|NCT00718718|100623072|FG004|STARTED|Week 12 to End of Study||0||
48122171|NCT00718718|100623073|FG005|STARTED|Week 12 to End of Study||27||
48122172|NCT00718718|100623074|FG006|STARTED|Week 12 to End of Study||29||
48122173|NCT00718718|100623075|FG007|STARTED|Week 12 to End of Study||28||
48122174|NCT00718718|100623076|FG008|STARTED|Week 12 to End of Study||28||
48122175|NCT00718718|100623077|FG009|STARTED|Week 12 to End of Study||31||
48122176|NCT00718718|100623068|FG000|Treated|Week 12 to End of Study||0||
48122177|NCT00718718|100623069|FG001|Treated|Week 12 to End of Study||18||
48122178|NCT00718718|100623070|FG002|Treated|Week 12 to End of Study||0||
48122179|NCT00718718|100623071|FG003|Treated|Week 12 to End of Study||16||
48122180|NCT00718718|100623072|FG004|Treated|Week 12 to End of Study||0||
48569663|NCT04932655|101727647|FG001|COMPLETED|Period 1||6||
48569664|NCT04932655|101727648|FG002|COMPLETED|Period 1||6||
48569665|NCT04932655|101727649|FG003|COMPLETED|Period 1||6||
48569666|NCT04932655|101727646|FG000|NOT COMPLETED|Period 1||0||
48569667|NCT04932655|101727647|FG001|NOT COMPLETED|Period 1||0||
48569668|NCT04932655|101727648|FG002|NOT COMPLETED|Period 1||0||
48569669|NCT04932655|101727649|FG003|NOT COMPLETED|Period 1||0||
48569670|NCT04932655|101727646|FG000|STARTED|Period 2||6||
48122181|NCT00718718|100623073|FG005|Treated|Week 12 to End of Study||26||
48122182|NCT00718718|100623074|FG006|Treated|Week 12 to End of Study||29||
48122183|NCT00718718|100623075|FG007|Treated|Week 12 to End of Study||28||
48122184|NCT00718718|100623076|FG008|Treated|Week 12 to End of Study||28||
48569671|NCT04932655|101727647|FG001|STARTED|Period 2||6||
48569672|NCT04932655|101727648|FG002|STARTED|Period 2||6||
48569673|NCT04932655|101727649|FG003|STARTED|Period 2||6||
48569674|NCT04932655|101727646|FG000|COMPLETED|Period 2||6||
48122185|NCT00718718|100623077|FG009|Treated|Week 12 to End of Study||31||
48122186|NCT00718718|100623068|FG000|COMPLETED|Week 12 to End of Study||0||
48122187|NCT00718718|100623069|FG001|COMPLETED|Week 12 to End of Study||17||
48569675|NCT04932655|101727647|FG001|COMPLETED|Period 2||6||
48122188|NCT00718718|100623070|FG002|COMPLETED|Week 12 to End of Study||0||
48122189|NCT00718718|100623071|FG003|COMPLETED|Week 12 to End of Study||15||
48569676|NCT04932655|101727648|FG002|COMPLETED|Period 2||6||
48569677|NCT04932655|101727649|FG003|COMPLETED|Period 2||6||
48569678|NCT04932655|101727646|FG000|NOT COMPLETED|Period 2||0||
48122190|NCT00718718|100623072|FG004|COMPLETED|Week 12 to End of Study||0||
48122191|NCT00718718|100623073|FG005|COMPLETED|Week 12 to End of Study||24||
48122192|NCT00718718|100623074|FG006|COMPLETED|Week 12 to End of Study||27||
48122193|NCT00718718|100623075|FG007|COMPLETED|Week 12 to End of Study||27||
48122194|NCT00718718|100623076|FG008|COMPLETED|Week 12 to End of Study||27||
48122195|NCT00718718|100623077|FG009|COMPLETED|Week 12 to End of Study||31||
48122196|NCT00718718|100623068|FG000|NOT COMPLETED|Week 12 to End of Study||0||
48122197|NCT00718718|100623069|FG001|NOT COMPLETED|Week 12 to End of Study||1||
48122198|NCT00718718|100623070|FG002|NOT COMPLETED|Week 12 to End of Study||0||
48122199|NCT00718718|100623071|FG003|NOT COMPLETED|Week 12 to End of Study||1||
48122200|NCT00718718|100623072|FG004|NOT COMPLETED|Week 12 to End of Study||0||
48122201|NCT00718718|100623073|FG005|NOT COMPLETED|Week 12 to End of Study||3||
48122202|NCT00718718|100623074|FG006|NOT COMPLETED|Week 12 to End of Study||2||
48122203|NCT00718718|100623075|FG007|NOT COMPLETED|Week 12 to End of Study||1||
48122204|NCT00718718|100623076|FG008|NOT COMPLETED|Week 12 to End of Study||1||
48122205|NCT00718718|100623077|FG009|NOT COMPLETED|Week 12 to End of Study||0||
48122206|NCT02985736|100623078|FG000|STARTED|Overall Study||20||
48122207|NCT02985736|100623078|FG000|COMPLETED|Overall Study||17||
48122208|NCT02985736|100623078|FG000|NOT COMPLETED|Overall Study||3||
48122209|NCT01150838|100623079|FG000|STARTED|Overall Study||19||
48122210|NCT01150838|100623080|FG001|STARTED|Overall Study||26||
48122211|NCT01150838|100623081|FG002|STARTED|Overall Study||24||
48122212|NCT01150838|100623082|FG003|STARTED|Overall Study||15||
48122213|NCT01150838|100623083|FG004|STARTED|Overall Study||16||
48281768|NCT03981861|101014172|FG000|STARTED|Overall Study||12||
48281769|NCT03981861|101014172|FG000|COMPLETED|Overall Study||9||
48569679|NCT04932655|101727647|FG001|NOT COMPLETED|Period 2||0||
48569680|NCT04932655|101727648|FG002|NOT COMPLETED|Period 2||0||
48569681|NCT04932655|101727649|FG003|NOT COMPLETED|Period 2||0||
48569682|NCT04932655|101727646|FG000|STARTED|Period 3||6||
48569683|NCT04932655|101727647|FG001|STARTED|Period 3||6||
48569684|NCT04932655|101727648|FG002|STARTED|Period 3||6||
48699618|NCT00245050|102050556|FG000|STARTED|Overall Study||18||
48122214|NCT01150838|100623084|FG005|STARTED|Overall Study||2||
48122215|NCT01150838|100623079|FG000|COMPLETED|Overall Study||19||
48122216|NCT01150838|100623080|FG001|COMPLETED|Overall Study||26||
48122217|NCT01150838|100623081|FG002|COMPLETED|Overall Study||24||
48122218|NCT01150838|100623082|FG003|COMPLETED|Overall Study||15||
48122219|NCT01150838|100623083|FG004|COMPLETED|Overall Study||16||
48122220|NCT01150838|100623084|FG005|COMPLETED|Overall Study||2||
48122221|NCT01150838|100623079|FG000|NOT COMPLETED|Overall Study||0||
48281770|NCT03981861|101014172|FG000|NOT COMPLETED|Overall Study||3||
48281771|NCT04763421|101014173|FG000|STARTED|Overall Study||145||
48281772|NCT04763421|101014173|FG000|COMPLETED|Overall Study||145||
48281773|NCT04763421|101014173|FG000|NOT COMPLETED|Overall Study||0||
48122222|NCT01150838|100623080|FG001|NOT COMPLETED|Overall Study||0||
48122223|NCT01150838|100623081|FG002|NOT COMPLETED|Overall Study||0||
48122224|NCT01150838|100623082|FG003|NOT COMPLETED|Overall Study||0||
48122225|NCT01150838|100623083|FG004|NOT COMPLETED|Overall Study||0||
48281774|NCT01680640|101014174|FG000|STARTED|Overall Study||55||
48281775|NCT01680640|101014175|FG001|STARTED|Overall Study||49||
48281776|NCT01680640|101014174|FG000|COMPLETED|Overall Study||45||
48281777|NCT01680640|101014175|FG001|COMPLETED|Overall Study||44||
48281778|NCT01680640|101014174|FG000|NOT COMPLETED|Overall Study||10||
48281779|NCT01680640|101014175|FG001|NOT COMPLETED|Overall Study||5||
48281780|NCT02147899|101014176|FG000|STARTED|Overall Study||71||
48281781|NCT02147899|101014177|FG001|STARTED|Overall Study||72||
48281782|NCT02147899|101014178|FG002|STARTED|Overall Study||72||
48281783|NCT02147899|101014176|FG000|COMPLETED|Overall Study||71||
48569685|NCT04932655|101727649|FG003|STARTED|Period 3||6||
48569686|NCT04932655|101727646|FG000|COMPLETED|Period 3||6||
48569687|NCT04932655|101727647|FG001|COMPLETED|Period 3||6||
48569688|NCT04932655|101727648|FG002|COMPLETED|Period 3||6||
48122226|NCT01150838|100623084|FG005|NOT COMPLETED|Overall Study||0||
48281784|NCT02147899|101014177|FG001|COMPLETED|Overall Study||72||
48569689|NCT04932655|101727649|FG003|COMPLETED|Period 3||6||
48699619|NCT00245050|102050557|FG001|STARTED|Overall Study||16||
48699620|NCT00245050|102050556|FG000|COMPLETED|Overall Study||15||
48699621|NCT00245050|102050557|FG001|COMPLETED|Overall Study||14||
48122227|NCT00672438|100623085|FG000|STARTED|Infusion 1||119||
48122228|NCT00672438|100623086|FG001|STARTED|Infusion 1||118||
48122229|NCT00672438|100623085|FG000|COMPLETED|Infusion 1||119||
48122230|NCT00672438|100623086|FG001|COMPLETED|Infusion 1||118||
48122231|NCT00672438|100623085|FG000|NOT COMPLETED|Infusion 1||0||
48122232|NCT00672438|100623086|FG001|NOT COMPLETED|Infusion 1||0||
48122233|NCT00672438|100623085|FG000|STARTED|Washout||119||
48122234|NCT00672438|100623086|FG001|STARTED|Washout||118||
48281785|NCT02147899|101014178|FG002|COMPLETED|Overall Study||72||
48281786|NCT02147899|101014176|FG000|NOT COMPLETED|Overall Study||0||
48281787|NCT02147899|101014177|FG001|NOT COMPLETED|Overall Study||0||
48569690|NCT04932655|101727646|FG000|NOT COMPLETED|Period 3||0||
48569691|NCT04932655|101727647|FG001|NOT COMPLETED|Period 3||0||
48569692|NCT04932655|101727648|FG002|NOT COMPLETED|Period 3||0||
48569693|NCT04932655|101727649|FG003|NOT COMPLETED|Period 3||0||
48569694|NCT04932655|101727646|FG000|STARTED|Period 4||6||
48122235|NCT00672438|100623085|FG000|COMPLETED|Washout||119||
48122236|NCT00672438|100623086|FG001|COMPLETED|Washout||118||
48122237|NCT00672438|100623085|FG000|NOT COMPLETED|Washout||0||
48122238|NCT00672438|100623086|FG001|NOT COMPLETED|Washout||0||
48122239|NCT00672438|100623085|FG000|STARTED|Infusion 2||119||
48122240|NCT00672438|100623086|FG001|STARTED|Infusion 2||118||
48122241|NCT00672438|100623085|FG000|COMPLETED|Infusion 2||119||
48122242|NCT00672438|100623086|FG001|COMPLETED|Infusion 2||118||
48122243|NCT00672438|100623085|FG000|NOT COMPLETED|Infusion 2||0||
48122244|NCT00672438|100623086|FG001|NOT COMPLETED|Infusion 2||0||
48122245|NCT00298896|100623087|FG000|STARTED|Overall Study||55||
48569695|NCT04932655|101727647|FG001|STARTED|Period 4||6||
48569696|NCT04932655|101727648|FG002|STARTED|Period 4||6||
48569697|NCT04932655|101727649|FG003|STARTED|Period 4||6||
48699622|NCT00245050|102050556|FG000|NOT COMPLETED|Overall Study||3||
48122246|NCT00298896|100623087|FG000|COMPLETED|Overall Study||5||
48122247|NCT00298896|100623087|FG000|NOT COMPLETED|Overall Study||50||
48122248|NCT01070810|100623088|FG000|STARTED|Overall Study||45||
48122249|NCT01070810|100623089|FG001|STARTED|Overall Study||43||
48122250|NCT01070810|100623088|FG000|COMPLETED|Overall Study||45||
48122251|NCT01070810|100623089|FG001|COMPLETED|Overall Study||43||
48569698|NCT04932655|101727646|FG000|COMPLETED|Period 4||6||
48569699|NCT04932655|101727647|FG001|COMPLETED|Period 4||6||
48122252|NCT01070810|100623088|FG000|NOT COMPLETED|Overall Study||0||
48122253|NCT01070810|100623089|FG001|NOT COMPLETED|Overall Study||0||
48122254|NCT03861000|100623090|FG000|STARTED|Overall Study||2||
48122255|NCT03861000|100623091|FG001|STARTED|Overall Study||1||
48122256|NCT03861000|100623090|FG000|COMPLETED|Overall Study||2||
48122257|NCT03861000|100623091|FG001|COMPLETED|Overall Study||1||
48122258|NCT03861000|100623090|FG000|NOT COMPLETED|Overall Study||0||
48122259|NCT03861000|100623091|FG001|NOT COMPLETED|Overall Study||0||
48122260|NCT00162136|100623092|FG000|STARTED|Overall Study||35||
48122261|NCT00162136|100623092|FG000|COMPLETED|Overall Study||0||
48122262|NCT00162136|100623092|FG000|NOT COMPLETED|Overall Study||35||
48122263|NCT04304001|100623093|FG000|STARTED|Overall Study||58||
48122264|NCT04304001|100623094|FG001|STARTED|Overall Study||57||
48122265|NCT04304001|100623093|FG000|COMPLETED|Overall Study||45||
48122266|NCT04304001|100623094|FG001|COMPLETED|Overall Study||48||
48122267|NCT04304001|100623093|FG000|NOT COMPLETED|Overall Study||13||
48122268|NCT04304001|100623094|FG001|NOT COMPLETED|Overall Study||9||
48122269|NCT02710526|100623095|FG000|STARTED|Treatment Phase||28||
48122270|NCT02710526|100623096|FG001|STARTED|Treatment Phase||20||
48122271|NCT02710526|100623097|FG002|STARTED|Treatment Phase||18||
48122272|NCT02710526|100623095|FG000|COMPLETED|Treatment Phase||22||
48122273|NCT02710526|100623096|FG001|COMPLETED|Treatment Phase||16||
48122274|NCT02710526|100623097|FG002|COMPLETED|Treatment Phase||12||
48122275|NCT02710526|100623095|FG000|NOT COMPLETED|Treatment Phase||6||
48122276|NCT02710526|100623096|FG001|NOT COMPLETED|Treatment Phase||4||
48122277|NCT02710526|100623097|FG002|NOT COMPLETED|Treatment Phase||6||
48122278|NCT02710526|100623095|FG000|STARTED|Safety Extension||15||
48122279|NCT02710526|100623096|FG001|STARTED|Safety Extension||12||
48122280|NCT02710526|100623097|FG002|STARTED|Safety Extension||0||
48122281|NCT02710526|100623095|FG000|COMPLETED|Safety Extension||14||
48122282|NCT02710526|100623096|FG001|COMPLETED|Safety Extension||12||
48122283|NCT02710526|100623097|FG002|COMPLETED|Safety Extension||0||
48122284|NCT02710526|100623095|FG000|NOT COMPLETED|Safety Extension||1||
48122285|NCT02710526|100623096|FG001|NOT COMPLETED|Safety Extension||0||
48122286|NCT02710526|100623097|FG002|NOT COMPLETED|Safety Extension||0||
48122287|NCT00813761|100623098|FG000|STARTED|Phase 1 (Baseline to 4 Weeks)||121||
48122288|NCT00813761|100623099|FG001|STARTED|Phase 1 (Baseline to 4 Weeks)||103||
48122289|NCT00813761|100623100|FG002|STARTED|Phase 1 (Baseline to 4 Weeks)||115||
48122290|NCT00813761|100623101|FG003|STARTED|Phase 1 (Baseline to 4 Weeks)||107||
48122291|NCT00813761|100623098|FG000|COMPLETED|Phase 1 (Baseline to 4 Weeks)||117||
48122292|NCT00813761|100623099|FG001|COMPLETED|Phase 1 (Baseline to 4 Weeks)||100||
48122293|NCT00813761|100623100|FG002|COMPLETED|Phase 1 (Baseline to 4 Weeks)||103||
48122294|NCT00813761|100623101|FG003|COMPLETED|Phase 1 (Baseline to 4 Weeks)||105||
48122295|NCT00813761|100623098|FG000|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||4||
48281788|NCT02147899|101014178|FG002|NOT COMPLETED|Overall Study||0||
48122296|NCT00813761|100623099|FG001|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||3||
48122297|NCT00813761|100623100|FG002|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||12||
48281789|NCT05086276|101014179|FG000|STARTED|Overall Study||70||
48281790|NCT05086276|101014180|FG001|STARTED|Overall Study||72||
48281791|NCT05086276|101014179|FG000|COMPLETED|Overall Study||69||
48569700|NCT04932655|101727648|FG002|COMPLETED|Period 4||6||
48569701|NCT04932655|101727649|FG003|COMPLETED|Period 4||6||
48569702|NCT04932655|101727646|FG000|NOT COMPLETED|Period 4||0||
48569703|NCT04932655|101727647|FG001|NOT COMPLETED|Period 4||0||
48699623|NCT00245050|102050557|FG001|NOT COMPLETED|Overall Study||2||
48699624|NCT01106651|102050558|FG000|STARTED|Overall Study||237||
48699625|NCT01106651|102050559|FG001|STARTED|Overall Study||241||
48122298|NCT00813761|100623101|FG003|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||2||
48569704|NCT04932655|101727648|FG002|NOT COMPLETED|Period 4||0||
48569705|NCT04932655|101727649|FG003|NOT COMPLETED|Period 4||0||
48569706|NCT02215369|101727650|FG000|STARTED|Overall Study||112|Enrolled Population|146
48122299|NCT00813761|100623098|FG000|STARTED|Phase 2 (4 Weeks to 24 Weeks)||117||
48122300|NCT00813761|100623099|FG001|STARTED|Phase 2 (4 Weeks to 24 Weeks)||100||
48122301|NCT00813761|100623100|FG002|STARTED|Phase 2 (4 Weeks to 24 Weeks)||103||
48122302|NCT00813761|100623101|FG003|STARTED|Phase 2 (4 Weeks to 24 Weeks)||105||
48122303|NCT00813761|100623098|FG000|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||101||
48122304|NCT00813761|100623099|FG001|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||91||
48699626|NCT01106651|102050560|FG002|STARTED|Overall Study||236||
48122305|NCT00813761|100623100|FG002|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||94||
48122306|NCT00813761|100623101|FG003|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||100||
48122307|NCT00813761|100623098|FG000|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||16||
48122308|NCT00813761|100623099|FG001|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9||
48122309|NCT00813761|100623100|FG002|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9||
48122310|NCT00813761|100623101|FG003|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||5||
48122311|NCT00673452|100623102|FG000|STARTED|Acute Double-Blind Phase||263||
48122312|NCT00673452|100623103|FG001|STARTED|Acute Double-Blind Phase||267||
48122313|NCT00673452|100623102|FG000|COMPLETED|Acute Double-Blind Phase||176||
48122314|NCT00673452|100623103|FG001|COMPLETED|Acute Double-Blind Phase||187||
48122315|NCT00673452|100623102|FG000|NOT COMPLETED|Acute Double-Blind Phase||87||
48281792|NCT05086276|101014180|FG001|COMPLETED|Overall Study||71||
48281793|NCT05086276|101014179|FG000|NOT COMPLETED|Overall Study||1||
48281794|NCT05086276|101014180|FG001|NOT COMPLETED|Overall Study||1||
48281795|NCT01177800|101014181|FG000|STARTED|Overall Study||84||
48281796|NCT01177800|101014182|FG001|STARTED|Overall Study||45||
48281797|NCT01177800|101014181|FG000|COMPLETED|Overall Study||74||
48281798|NCT01177800|101014182|FG001|COMPLETED|Overall Study||40||
48281799|NCT01177800|101014181|FG000|NOT COMPLETED|Overall Study||10||
48281800|NCT01177800|101014182|FG001|NOT COMPLETED|Overall Study||5||
48281801|NCT03291288|101014183|FG000|STARTED|Drug-drug Interaction Phase||32||
48281802|NCT03291288|101014184|FG001|STARTED|Drug-drug Interaction Phase||0||
48281803|NCT03291288|101014183|FG000|COMPLETED|Drug-drug Interaction Phase||26||
48281804|NCT03291288|101014184|FG001|COMPLETED|Drug-drug Interaction Phase||0||
48281805|NCT03291288|101014183|FG000|NOT COMPLETED|Drug-drug Interaction Phase||6||
48281806|NCT03291288|101014184|FG001|NOT COMPLETED|Drug-drug Interaction Phase||0||
48396714|NCT03276572|101302444|FG002|COMPLETED|Overall Study||1||
48281807|NCT03291288|101014183|FG000|STARTED|Pexidartinib Only||0||
48281808|NCT03291288|101014184|FG001|STARTED|Pexidartinib Only||26||
48396715|NCT03276572|101302445|FG003|COMPLETED|Overall Study||1||
48396716|NCT03276572|101302446|FG004|COMPLETED|Overall Study||6||
48396717|NCT03276572|101302447|FG005|COMPLETED|Overall Study||5||
48396718|NCT03276572|101302448|FG006|COMPLETED|Overall Study||14||
48396719|NCT03276572|101302442|FG000|NOT COMPLETED|Overall Study||0||
48396720|NCT03276572|101302443|FG001|NOT COMPLETED|Overall Study||0||
48396721|NCT03276572|101302444|FG002|NOT COMPLETED|Overall Study||0||
48396722|NCT03276572|101302445|FG003|NOT COMPLETED|Overall Study||0||
48396723|NCT03276572|101302446|FG004|NOT COMPLETED|Overall Study||0||
48396724|NCT03276572|101302447|FG005|NOT COMPLETED|Overall Study||1||
48396725|NCT03276572|101302448|FG006|NOT COMPLETED|Overall Study||2||
48396726|NCT02023268|101302449|FG000|STARTED|Overall Study||52||
48396727|NCT02023268|101302450|FG001|STARTED|Overall Study||53||
48396728|NCT02023268|101302449|FG000|COMPLETED|Overall Study||52||
48396729|NCT02023268|101302450|FG001|COMPLETED|Overall Study||49||
48396730|NCT02023268|101302449|FG000|NOT COMPLETED|Overall Study||0||
48569707|NCT02215369|101727650|FG000|COMPLETED|Overall Study||70||113
48569708|NCT02215369|101727650|FG000|NOT COMPLETED|Overall Study||42||33
48569709|NCT01964222|101727651|FG000|STARTED|Overall Study||101||
48569710|NCT01964222|101727652|FG001|STARTED|Overall Study||100||
48569711|NCT01964222|101727651|FG000|COMPLETED|Overall Study||86||
48569712|NCT01964222|101727652|FG001|COMPLETED|Overall Study||89||
48569713|NCT01964222|101727651|FG000|NOT COMPLETED|Overall Study||15||
48569714|NCT01964222|101727652|FG001|NOT COMPLETED|Overall Study||11||
48569715|NCT03283787|101727653|FG000|STARTED|Overall Study||20||
48569716|NCT03283787|101727654|FG001|STARTED|Overall Study||20||
48569717|NCT03283787|101727655|FG002|STARTED|Overall Study||20||
48569718|NCT03283787|101727653|FG000|COMPLETED|Overall Study||17||
48569719|NCT03283787|101727654|FG001|COMPLETED|Overall Study||13||
48569720|NCT03283787|101727655|FG002|COMPLETED|Overall Study||13||
48569721|NCT03283787|101727653|FG000|NOT COMPLETED|Overall Study||3||
48569722|NCT03283787|101727654|FG001|NOT COMPLETED|Overall Study||7||
48569723|NCT03283787|101727655|FG002|NOT COMPLETED|Overall Study||7||
48569724|NCT01704495|101727656|FG000|STARTED|Subjects Randomized||162||
48569725|NCT01704495|101727657|FG001|STARTED|Subjects Randomized||156||
48122316|NCT00673452|100623103|FG001|NOT COMPLETED|Acute Double-Blind Phase||80||
48281809|NCT03291288|101014183|FG000|COMPLETED|Pexidartinib Only||0||
48396731|NCT02023268|101302450|FG001|NOT COMPLETED|Overall Study||4||
48396732|NCT01256983|101302451|FG000|STARTED|Overall Study||15||
48396733|NCT01256983|101302452|FG001|STARTED|Overall Study||15||
48396734|NCT01256983|101302451|FG000|COMPLETED|Overall Study||14||
48569726|NCT01704495|101727658|FG002|STARTED|Subjects Randomized||160||
48569727|NCT01704495|101727659|FG003|STARTED|Subjects Randomized||162||
48569728|NCT01704495|101727656|FG000|COMPLETED|Subjects Randomized||140||
48569729|NCT01704495|101727657|FG001|COMPLETED|Subjects Randomized||141||
48699627|NCT01106651|102050558|FG000|COMPLETED|Overall Study||158||
48281810|NCT03291288|101014184|FG001|COMPLETED|Pexidartinib Only||24||
48281811|NCT03291288|101014183|FG000|NOT COMPLETED|Pexidartinib Only||0||
48281812|NCT03291288|101014184|FG001|NOT COMPLETED|Pexidartinib Only||2||
48281813|NCT02751320|101014185|FG000|STARTED|Overall Study||45||
48281814|NCT02751320|101014185|FG000|Received Test Product 1|Overall Study||29||
48281815|NCT02751320|101014185|FG000|Received Test Prodcut 2|Overall Study||28||
48281816|NCT02751320|101014185|FG000|Received Test Prodcut 3|Overall Study||28||
48281817|NCT02751320|101014185|FG000|Received Reference Product 1|Overall Study||29||
48281818|NCT02751320|101014185|FG000|Received Reference Product 2|Overall Study||28||
48281819|NCT02751320|101014185|FG000|Received Reference Product 3|Overall Study||28||
48281820|NCT02751320|101014185|FG000|COMPLETED|Overall Study||42||
48281821|NCT02751320|101014185|FG000|NOT COMPLETED|Overall Study||3||
48281822|NCT02432196|101014186|FG000|STARTED|Overall Study||26|Enrolled in Study|
48281823|NCT02432196|101014186|FG000|COMPLETED|Overall Study||20||
48281824|NCT02432196|101014186|FG000|NOT COMPLETED|Overall Study||6||
48281825|NCT02030002|101014187|FG000|STARTED|Enrollment||49||
48281826|NCT02030002|101014187|FG000|COMPLETED|Enrollment||44||
48281827|NCT02030002|101014187|FG000|NOT COMPLETED|Enrollment||5||
48281828|NCT02030002|101014187|FG000|STARTED|APC Flash-Free Adhesive Coated Appliance||44||
48281829|NCT02030002|101014187|FG000|COMPLETED|APC Flash-Free Adhesive Coated Appliance||44||
48281830|NCT02030002|101014187|FG000|NOT COMPLETED|APC Flash-Free Adhesive Coated Appliance||0||
48281831|NCT02030002|101014187|FG000|STARTED|APC II Adhesive Coated Appliance System||44||
48281832|NCT02030002|101014187|FG000|COMPLETED|APC II Adhesive Coated Appliance System||44||
48281833|NCT02030002|101014187|FG000|NOT COMPLETED|APC II Adhesive Coated Appliance System||0||
48281834|NCT02030002|101014187|FG000|STARTED|Follow-up||44||
48281835|NCT02030002|101014187|FG000|COMPLETED|Follow-up||42||
48281836|NCT02030002|101014187|FG000|NOT COMPLETED|Follow-up||2||
48281837|NCT03965351|101014188|FG000|STARTED|First Intervention (4 Weeks)||3||
48281838|NCT03965351|101014189|FG001|STARTED|First Intervention (4 Weeks)||5||
48281839|NCT03965351|101014188|FG000|COMPLETED|First Intervention (4 Weeks)||3||
48281840|NCT03965351|101014189|FG001|COMPLETED|First Intervention (4 Weeks)||4||
48281841|NCT03965351|101014188|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0||
48281842|NCT03965351|101014189|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1||
48281843|NCT03965351|101014188|FG000|STARTED|Wash Out Period (4 Weeks)||3||
48281844|NCT03965351|101014189|FG001|STARTED|Wash Out Period (4 Weeks)||4||
48281845|NCT03965351|101014188|FG000|COMPLETED|Wash Out Period (4 Weeks)||3||
48281846|NCT03965351|101014189|FG001|COMPLETED|Wash Out Period (4 Weeks)||4||
48281847|NCT03965351|101014188|FG000|NOT COMPLETED|Wash Out Period (4 Weeks)||0||
48569730|NCT01704495|101727658|FG002|COMPLETED|Subjects Randomized||144||
48569731|NCT01704495|101727659|FG003|COMPLETED|Subjects Randomized||145||
48569732|NCT01704495|101727656|FG000|NOT COMPLETED|Subjects Randomized||22||
48569733|NCT01704495|101727657|FG001|NOT COMPLETED|Subjects Randomized||15||
48569734|NCT01704495|101727658|FG002|NOT COMPLETED|Subjects Randomized||16||
48569735|NCT01704495|101727659|FG003|NOT COMPLETED|Subjects Randomized||17||
48569736|NCT01704495|101727656|FG000|STARTED|Optional Safety Extension||116||
48569737|NCT01704495|101727657|FG001|STARTED|Optional Safety Extension||121||
48569738|NCT01704495|101727658|FG002|STARTED|Optional Safety Extension||114||
48569739|NCT01704495|101727659|FG003|STARTED|Optional Safety Extension||116||
48569740|NCT01704495|101727656|FG000|COMPLETED|Optional Safety Extension||87||
48569741|NCT01704495|101727657|FG001|COMPLETED|Optional Safety Extension||88||
48569742|NCT01704495|101727658|FG002|COMPLETED|Optional Safety Extension||83||
48569743|NCT01704495|101727659|FG003|COMPLETED|Optional Safety Extension||85||
48569744|NCT01704495|101727656|FG000|NOT COMPLETED|Optional Safety Extension||29||
48569745|NCT01704495|101727657|FG001|NOT COMPLETED|Optional Safety Extension||33||
48569746|NCT01704495|101727658|FG002|NOT COMPLETED|Optional Safety Extension||31||
48569747|NCT01704495|101727659|FG003|NOT COMPLETED|Optional Safety Extension||31||
48569748|NCT00442897|101727660|FG000|STARTED|Base Study (12 Week Follow-up)||118||
48569749|NCT00442897|101727661|FG001|STARTED|Base Study (12 Week Follow-up)||111||
48569750|NCT00442897|101727660|FG000|COMPLETED|Base Study (12 Week Follow-up)||101||
48569751|NCT00442897|101727661|FG001|COMPLETED|Base Study (12 Week Follow-up)||99||
48569752|NCT00442897|101727660|FG000|NOT COMPLETED|Base Study (12 Week Follow-up)||17||
48569753|NCT00442897|101727661|FG001|NOT COMPLETED|Base Study (12 Week Follow-up)||12||
48569754|NCT00442897|101727660|FG000|STARTED|24 Weeks Follow-up (3 Centers)||35||
48569755|NCT00442897|101727661|FG001|STARTED|24 Weeks Follow-up (3 Centers)||34||
48569756|NCT00442897|101727660|FG000|COMPLETED|24 Weeks Follow-up (3 Centers)||29||
48569757|NCT00442897|101727661|FG001|COMPLETED|24 Weeks Follow-up (3 Centers)||28||
48569758|NCT00442897|101727660|FG000|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6||
48281848|NCT03965351|101014189|FG001|NOT COMPLETED|Wash Out Period (4 Weeks)||0||
48281849|NCT03965351|101014188|FG000|STARTED|Second Intervention (4 Weeks)||3||
48281850|NCT03965351|101014189|FG001|STARTED|Second Intervention (4 Weeks)||4||
48281851|NCT03965351|101014188|FG000|COMPLETED|Second Intervention (4 Weeks)||3||
48281852|NCT03965351|101014189|FG001|COMPLETED|Second Intervention (4 Weeks)||3||
48569759|NCT00442897|101727661|FG001|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6||
48569760|NCT01372995|101727662|FG000|STARTED|Overall Study||10||
48569761|NCT01372995|101727663|FG001|STARTED|Overall Study||10||
48569762|NCT01372995|101727664|FG002|STARTED|Overall Study||11||
48569763|NCT01372995|101727662|FG000|COMPLETED|Overall Study||10||
48122317|NCT00673452|100623102|FG000|STARTED|Continuation Double-Blind Phase||176||
48122318|NCT00673452|100623103|FG001|STARTED|Continuation Double-Blind Phase||187||
48122319|NCT00673452|100623102|FG000|COMPLETED|Continuation Double-Blind Phase||151||
48122320|NCT00673452|100623103|FG001|COMPLETED|Continuation Double-Blind Phase||153||
48281853|NCT03965351|101014188|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0||
48281854|NCT03965351|101014189|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1||
48281855|NCT01076153|101014190|FG000|STARTED|Overall Study||760||
48281856|NCT01076153|101014190|FG000|COMPLETED|Overall Study||749||
48281857|NCT01076153|101014190|FG000|NOT COMPLETED|Overall Study||11||
48281858|NCT03924765|101014191|FG000|STARTED|Overall Study||5||
48281859|NCT03924765|101014191|FG000|COMPLETED|Overall Study||5||
48281860|NCT03924765|101014191|FG000|NOT COMPLETED|Overall Study||0||
48281861|NCT01239043|101014192|FG000|STARTED|Overall Study||36||
48281862|NCT01239043|101014193|FG001|STARTED|Overall Study||103||
48281863|NCT01239043|101014192|FG000|COMPLETED|Overall Study||34||
48281864|NCT01239043|101014193|FG001|COMPLETED|Overall Study||102||
48281865|NCT01239043|101014192|FG000|NOT COMPLETED|Overall Study||2||
48281866|NCT01239043|101014193|FG001|NOT COMPLETED|Overall Study||1||
48281867|NCT03527238|101014194|FG000|STARTED|Overall Study||31||
48396735|NCT01256983|101302452|FG001|COMPLETED|Overall Study||12||
48396736|NCT01256983|101302451|FG000|NOT COMPLETED|Overall Study||1||
48396737|NCT01256983|101302452|FG001|NOT COMPLETED|Overall Study||3||
48569764|NCT01372995|101727663|FG001|COMPLETED|Overall Study||9||
48569765|NCT01372995|101727664|FG002|COMPLETED|Overall Study||10||
48569766|NCT01372995|101727662|FG000|NOT COMPLETED|Overall Study||0||
48569767|NCT01372995|101727663|FG001|NOT COMPLETED|Overall Study||1||
48569768|NCT01372995|101727664|FG002|NOT COMPLETED|Overall Study||1||
48122321|NCT00673452|100623102|FG000|NOT COMPLETED|Continuation Double-Blind Phase||25||
48281868|NCT03527238|101014195|FG001|STARTED|Overall Study||31||
48281869|NCT03527238|101014194|FG000|COMPLETED|Overall Study||29||
48281870|NCT03527238|101014195|FG001|COMPLETED|Overall Study||27||
48281871|NCT03527238|101014194|FG000|NOT COMPLETED|Overall Study||2||
48281872|NCT03527238|101014195|FG001|NOT COMPLETED|Overall Study||4||
48281873|NCT02549014|101014196|FG000|STARTED|Overall Study||8||
48396738|NCT00391807|101302453|FG000|STARTED|Overall Study||1683||
48396739|NCT00391807|101302453|FG000|COMPLETED|Overall Study||968||
48396740|NCT00391807|101302453|FG000|NOT COMPLETED|Overall Study||715||
48569769|NCT02576847|101727665|FG000|STARTED|Overall Study||307||
48569770|NCT02576847|101727665|FG000|COMPLETED|Overall Study||170||
48569771|NCT02576847|101727665|FG000|NOT COMPLETED|Overall Study||137||
48569772|NCT05406479|101727666|FG000|STARTED|Overall Study||157||
48569773|NCT05406479|101727667|FG001|STARTED|Overall Study||156||
48569774|NCT05406479|101727666|FG000|COMPLETED|Overall Study||156||
48569775|NCT05406479|101727667|FG001|COMPLETED|Overall Study||154||
48569776|NCT05406479|101727666|FG000|NOT COMPLETED|Overall Study||1||
48569777|NCT05406479|101727667|FG001|NOT COMPLETED|Overall Study||2||
48569778|NCT00651261|101727668|FG000|STARTED|Overall Study||360||
48569779|NCT00651261|101727669|FG001|STARTED|Overall Study||357||
48569780|NCT00651261|101727668|FG000|COMPLETED|Overall Study||69||
48569781|NCT00651261|101727669|FG001|COMPLETED|Overall Study||51||
48569782|NCT00651261|101727668|FG000|NOT COMPLETED|Overall Study||291||
48569783|NCT00651261|101727669|FG001|NOT COMPLETED|Overall Study||306||
48569784|NCT03309943|101727670|FG000|STARTED|Overall Study||22||
48569785|NCT03309943|101727671|FG001|STARTED|Overall Study||22||
48569786|NCT03309943|101727670|FG000|COMPLETED|Overall Study||22||
48569787|NCT03309943|101727671|FG001|COMPLETED|Overall Study||20||
48569788|NCT03309943|101727670|FG000|NOT COMPLETED|Overall Study||0||
48281874|NCT02549014|101014197|FG001|STARTED|Overall Study||8||
48281875|NCT02549014|101014196|FG000|COMPLETED|Overall Study||8||
48281876|NCT02549014|101014197|FG001|COMPLETED|Overall Study||8||
48396741|NCT01192204|101302454|FG000|STARTED|Overall Study||23||
48396742|NCT01192204|101302455|FG001|STARTED|Overall Study||18||
48396743|NCT01192204|101302454|FG000|COMPLETED|Overall Study||22||
48396744|NCT01192204|101302455|FG001|COMPLETED|Overall Study||18||
48569789|NCT03309943|101727671|FG001|NOT COMPLETED|Overall Study||2||
48569790|NCT02159053|101727672|FG000|STARTED|Overall Study||116||
48569791|NCT02159053|101727673|FG001|STARTED|Overall Study||117||
48569792|NCT02159053|101727674|FG002|STARTED|Overall Study||117||
48281877|NCT02549014|101014196|FG000|NOT COMPLETED|Overall Study||0||
48281878|NCT02549014|101014197|FG001|NOT COMPLETED|Overall Study||0||
48281879|NCT02863289|101014198|FG000|STARTED|Overall Study||118||
48281880|NCT02863289|101014198|FG000|COMPLETED|Overall Study||35||
48281881|NCT02863289|101014198|FG000|NOT COMPLETED|Overall Study||83||
48281882|NCT00943111|101014199|FG000|STARTED|52-Weeks Primary Analysis Period||106||
48281883|NCT00943111|101014200|FG001|STARTED|52-Weeks Primary Analysis Period||54||
48281884|NCT00943111|101014201|FG002|STARTED|52-Weeks Primary Analysis Period||0||
48396745|NCT01192204|101302454|FG000|NOT COMPLETED|Overall Study||1||
48569793|NCT02159053|101727672|FG000|Paticipants Week 16 Onwards|Overall Study||116||
48569794|NCT02159053|101727673|FG001|Paticipants Week 16 Onwards|Overall Study||117||
48569795|NCT02159053|101727674|FG002|Paticipants Week 16 Onwards|Overall Study||113||
48569796|NCT02159053|101727672|FG000|COMPLETED|Overall Study||96||
48569797|NCT02159053|101727673|FG001|COMPLETED|Overall Study||96||
48569798|NCT02159053|101727674|FG002|COMPLETED|Overall Study||97||
48569799|NCT02159053|101727672|FG000|NOT COMPLETED|Overall Study||20||
48569800|NCT02159053|101727673|FG001|NOT COMPLETED|Overall Study||21||
48122322|NCT00673452|100623103|FG001|NOT COMPLETED|Continuation Double-Blind Phase||34||
48122323|NCT02749903|100623104|FG000|STARTED|Overall Study||46||
48122324|NCT02749903|100623104|FG000|COMPLETED|Overall Study||46||
48122325|NCT02749903|100623104|FG000|NOT COMPLETED|Overall Study||0||
48122326|NCT02665481|100623105|FG000|STARTED|Overall Study||150||
48122327|NCT02665481|100623106|FG001|STARTED|Overall Study||138||
48122328|NCT02665481|100623107|FG002|STARTED|Overall Study||144||
48122329|NCT02665481|100623108|FG003|STARTED|Overall Study||153||
48122330|NCT02665481|100623105|FG000|COMPLETED|Overall Study||139||
48122331|NCT02665481|100623106|FG001|COMPLETED|Overall Study||119||
48122332|NCT02665481|100623107|FG002|COMPLETED|Overall Study||106||
48122333|NCT02665481|100623108|FG003|COMPLETED|Overall Study||111||
48122334|NCT02665481|100623105|FG000|NOT COMPLETED|Overall Study||11||
48122335|NCT02665481|100623106|FG001|NOT COMPLETED|Overall Study||19||
48122336|NCT02665481|100623107|FG002|NOT COMPLETED|Overall Study||38||
48122337|NCT02665481|100623108|FG003|NOT COMPLETED|Overall Study||42||
48122338|NCT01040871|100623109|FG000|STARTED|Overall Study||84||
48122339|NCT01040871|100623110|FG001|STARTED|Overall Study||80||
48122340|NCT01040871|100623109|FG000|COMPLETED|Overall Study||71||
48122341|NCT01040871|100623110|FG001|COMPLETED|Overall Study||73||
48569801|NCT02159053|101727674|FG002|NOT COMPLETED|Overall Study||20||
48569802|NCT01401361|101727675|FG000|STARTED|Overall Study||150||
48569803|NCT01401361|101727675|FG000|COMPLETED|Overall Study||122||
48569804|NCT01401361|101727675|FG000|NOT COMPLETED|Overall Study||28||
48569805|NCT00566020|101727676|FG000|STARTED|6-week Dosage Adjustment Phase||92||
48569806|NCT00566020|101727677|FG001|STARTED|6-week Dosage Adjustment Phase||0||
48569807|NCT00566020|101727676|FG000|COMPLETED|6-week Dosage Adjustment Phase||85||
48569808|NCT00566020|101727677|FG001|COMPLETED|6-week Dosage Adjustment Phase||0||
48569809|NCT00566020|101727676|FG000|NOT COMPLETED|6-week Dosage Adjustment Phase||7||
48569810|NCT00566020|101727677|FG001|NOT COMPLETED|6-week Dosage Adjustment Phase||0||
48569811|NCT00566020|101727676|FG000|STARTED|46-week Long-term Administration Phase||0||
48569812|NCT00566020|101727677|FG001|STARTED|46-week Long-term Administration Phase||85||
48569813|NCT00566020|101727676|FG000|COMPLETED|46-week Long-term Administration Phase||0||
48569814|NCT00566020|101727677|FG001|COMPLETED|46-week Long-term Administration Phase||68||
48569815|NCT00566020|101727676|FG000|NOT COMPLETED|46-week Long-term Administration Phase||0||
48569816|NCT00566020|101727677|FG001|NOT COMPLETED|46-week Long-term Administration Phase||17||
48569817|NCT04938180|101727678|FG000|STARTED|Overall Study||4||
48569818|NCT04938180|101727678|FG000|COMPLETED|Overall Study||3||
48569819|NCT04938180|101727678|FG000|NOT COMPLETED|Overall Study||1||
48569820|NCT02075203|101727679|FG000|STARTED|Overall Study||330||
48122342|NCT01040871|100623109|FG000|NOT COMPLETED|Overall Study||13||
48122343|NCT01040871|100623110|FG001|NOT COMPLETED|Overall Study||7||
48122344|NCT02556710|100623111|FG000|STARTED|Overall Study||237||
48122345|NCT02556710|100623112|FG001|STARTED|Overall Study||243||
48122346|NCT02556710|100623111|FG000|COMPLETED|Overall Study||226||
48122347|NCT02556710|100623112|FG001|COMPLETED|Overall Study||237||
48122348|NCT02556710|100623111|FG000|NOT COMPLETED|Overall Study||11||
48122349|NCT02556710|100623112|FG001|NOT COMPLETED|Overall Study||6||
48122350|NCT01159067|100623113|FG000|STARTED|Overall Study||1||
48122351|NCT01159067|100623113|FG000|COMPLETED|Overall Study||1||
48122352|NCT01159067|100623113|FG000|NOT COMPLETED|Overall Study||0||
48122353|NCT00773175|100623114|FG000|STARTED|Overall Study||73||
48122354|NCT00773175|100623115|FG001|STARTED|Overall Study||75||
48122355|NCT00773175|100623114|FG000|Initial Fluids Via Randomized Route|Overall Study||73||
48569821|NCT02075203|101727680|FG001|STARTED|Overall Study||330||
48569822|NCT02075203|101727681|FG002|STARTED|Overall Study||329||
48569823|NCT02075203|101727679|FG000|COMPLETED|Overall Study||327||
48569824|NCT02075203|101727680|FG001|COMPLETED|Overall Study||330||
48569825|NCT02075203|101727681|FG002|COMPLETED|Overall Study||328||
48569826|NCT02075203|101727679|FG000|NOT COMPLETED|Overall Study||3||
48569827|NCT02075203|101727680|FG001|NOT COMPLETED|Overall Study||0||
48569828|NCT02075203|101727681|FG002|NOT COMPLETED|Overall Study||1||
48569829|NCT03321968|101727682|FG000|STARTED|Overall Study||401||
48569830|NCT03321968|101727683|FG001|STARTED|Overall Study||399||
48569831|NCT03321968|101727684|FG002|STARTED|Overall Study||402||
48569832|NCT03321968|101727682|FG000|Vaccinated|Overall Study||401||
48699628|NCT01106651|102050559|FG001|COMPLETED|Overall Study||184||
48122356|NCT00773175|100623115|FG001|Initial Fluids Via Randomized Route|Overall Study||59||
48122357|NCT00773175|100623114|FG000|Initial Fluids Via Subcutaneous Rescue|Overall Study||0|Subcutaneous fluid administration by hylenex-facilitated infusion was given as rescue.|
48122358|NCT00773175|100623115|FG001|Initial Fluids Via Subcutaneous Rescue|Overall Study||15|Subcutaneous fluid administration by hylenex-facilitated infusion was given as rescue.|
48122359|NCT00773175|100623114|FG000|No Fluids Received|Overall Study||0||
48122360|NCT00773175|100623115|FG001|No Fluids Received|Overall Study||1||
48569833|NCT03321968|101727683|FG001|Vaccinated|Overall Study||398||
48569834|NCT03321968|101727684|FG002|Vaccinated|Overall Study||401||
48569835|NCT03321968|101727682|FG000|COMPLETED|Overall Study||398||
48569836|NCT03321968|101727683|FG001|COMPLETED|Overall Study||397||
48569837|NCT03321968|101727684|FG002|COMPLETED|Overall Study||399||
48699629|NCT01106651|102050560|FG002|COMPLETED|Overall Study||178||
48699630|NCT01106651|102050558|FG000|NOT COMPLETED|Overall Study||79||
48396746|NCT01192204|101302455|FG001|NOT COMPLETED|Overall Study||0||
48396747|NCT00812604|101302456|FG000|STARTED|Overall Study||28||
48396748|NCT00812604|101302457|FG001|STARTED|Overall Study||27||
48396749|NCT00812604|101302456|FG000|COMPLETED|Overall Study||23||
48396750|NCT00812604|101302457|FG001|COMPLETED|Overall Study||22||
48396751|NCT00812604|101302456|FG000|NOT COMPLETED|Overall Study||5||
48396752|NCT00812604|101302457|FG001|NOT COMPLETED|Overall Study||5||
48396753|NCT02281344|101302458|FG000|STARTED|Overall Study||6||
48396754|NCT02281344|101302458|FG000|COMPLETED|Overall Study||6||
48569838|NCT03321968|101727682|FG000|NOT COMPLETED|Overall Study||3||
48569839|NCT03321968|101727683|FG001|NOT COMPLETED|Overall Study||2||
48122361|NCT00773175|100623114|FG000|COMPLETED|Overall Study||71||
48281885|NCT00943111|101014199|FG000|Treated|52-Weeks Primary Analysis Period||106||
48281886|NCT00943111|101014200|FG001|Treated|52-Weeks Primary Analysis Period||53||
48281887|NCT00943111|101014201|FG002|Treated|52-Weeks Primary Analysis Period||0||
48281888|NCT00943111|101014199|FG000|COMPLETED|52-Weeks Primary Analysis Period||104||
48281889|NCT00943111|101014200|FG001|COMPLETED|52-Weeks Primary Analysis Period||52||
48281890|NCT00943111|101014201|FG002|COMPLETED|52-Weeks Primary Analysis Period||0||
48281891|NCT00943111|101014199|FG000|NOT COMPLETED|52-Weeks Primary Analysis Period||2||
48281892|NCT00943111|101014200|FG001|NOT COMPLETED|52-Weeks Primary Analysis Period||2||
48281893|NCT00943111|101014201|FG002|NOT COMPLETED|52-Weeks Primary Analysis Period||0||
48281894|NCT00943111|101014199|FG000|STARTED|5 Years Long-term Treatment Period||0||
48281895|NCT00943111|101014200|FG001|STARTED|5 Years Long-term Treatment Period||0||
48281896|NCT00943111|101014201|FG002|STARTED|5 Years Long-term Treatment Period||152||
48281897|NCT00943111|101014199|FG000|COMPLETED|5 Years Long-term Treatment Period||0||
48281898|NCT00943111|101014200|FG001|COMPLETED|5 Years Long-term Treatment Period||0||
48281899|NCT00943111|101014201|FG002|COMPLETED|5 Years Long-term Treatment Period||77||
48281900|NCT00943111|101014199|FG000|NOT COMPLETED|5 Years Long-term Treatment Period||0||
48281901|NCT00943111|101014200|FG001|NOT COMPLETED|5 Years Long-term Treatment Period||0||
48281902|NCT00943111|101014201|FG002|NOT COMPLETED|5 Years Long-term Treatment Period||75||
48281903|NCT01141647|101014202|FG000|STARTED|Overall Study||213||
48281904|NCT01141647|101014202|FG000|COMPLETED|Overall Study||167||
48281905|NCT01141647|101014202|FG000|NOT COMPLETED|Overall Study||46||
48281906|NCT01655693|101014203|FG000|STARTED|Overall Study||130||
48281907|NCT01655693|101014204|FG001|STARTED|Overall Study||133||
48281908|NCT01655693|101014205|FG002|STARTED|Overall Study||134||
48281909|NCT01655693|101014203|FG000|COMPLETED|Overall Study||4||
48281910|NCT01655693|101014204|FG001|COMPLETED|Overall Study||7||
48281911|NCT01655693|101014205|FG002|COMPLETED|Overall Study||4||
48396755|NCT02281344|101302458|FG000|NOT COMPLETED|Overall Study||0||
48396756|NCT03688685|101302459|FG000|STARTED|Overall Study||25||
48396757|NCT03688685|101302459|FG000|COMPLETED|Overall Study||21||
48396758|NCT03688685|101302459|FG000|NOT COMPLETED|Overall Study||4||
48396759|NCT02785991|101302460|FG000|STARTED|Overall Study||1742||
48396760|NCT02785991|101302460|FG000|COMPLETED|Overall Study||1741||
48396761|NCT02785991|101302460|FG000|NOT COMPLETED|Overall Study||1||
48396762|NCT03911869|101302461|FG000|STARTED|Safety Lead-in Phase||10||
48396763|NCT03911869|101302462|FG001|STARTED|Safety Lead-in Phase||0||
48396764|NCT03911869|101302463|FG002|STARTED|Safety Lead-in Phase||0||
48396765|NCT03911869|101302461|FG000|COMPLETED|Safety Lead-in Phase||0||
48396766|NCT03911869|101302462|FG001|COMPLETED|Safety Lead-in Phase||0||
48396767|NCT03911869|101302463|FG002|COMPLETED|Safety Lead-in Phase||0||
48396768|NCT03911869|101302461|FG000|NOT COMPLETED|Safety Lead-in Phase||10||
48396769|NCT03911869|101302462|FG001|NOT COMPLETED|Safety Lead-in Phase||0||
48699631|NCT01106651|102050559|FG001|NOT COMPLETED|Overall Study||57||
48569840|NCT03321968|101727684|FG002|NOT COMPLETED|Overall Study||3||
48569841|NCT02155283|101727685|FG000|STARTED|Overall Study||16||
48569842|NCT02155283|101727685|FG000|COMPLETED|Overall Study||9||
48569843|NCT02155283|101727685|FG000|NOT COMPLETED|Overall Study||7||
48569844|NCT02283268|101727686|FG000|STARTED|Overall Study||15||
48569845|NCT02283268|101727686|FG000|COMPLETED|Overall Study||14||
48569846|NCT02283268|101727686|FG000|NOT COMPLETED|Overall Study||1||
48699632|NCT01106651|102050560|FG002|NOT COMPLETED|Overall Study||58||
48699633|NCT00939029|102050561|FG000|STARTED|Overall Study||25||
48699634|NCT00939029|102050562|FG001|STARTED|Overall Study||27||
48699635|NCT00939029|102050561|FG000|COMPLETED|Overall Study||19||
48699636|NCT00939029|102050562|FG001|COMPLETED|Overall Study||15||
48699637|NCT00939029|102050561|FG000|NOT COMPLETED|Overall Study||6||
48699638|NCT00939029|102050562|FG001|NOT COMPLETED|Overall Study||12||
48699639|NCT02524275|102050563|FG000|STARTED|Overall Study||14||
48699640|NCT02524275|102050563|FG000|COMPLETED|Overall Study||9||
48699641|NCT02524275|102050563|FG000|NOT COMPLETED|Overall Study||5||
48699642|NCT03639623|102050564|FG000|STARTED|Overall Study||20||
48699643|NCT03639623|102050564|FG000|COMPLETED|Overall Study||15||
48699644|NCT03639623|102050564|FG000|NOT COMPLETED|Overall Study||5||
48699645|NCT00845039|102050565|FG000|STARTED|Overall Study||2||
48699646|NCT00845039|102050566|FG001|STARTED|Overall Study||2||
48122362|NCT00773175|100623115|FG001|COMPLETED|Overall Study||73||
48122363|NCT00773175|100623114|FG000|NOT COMPLETED|Overall Study||2||
48122364|NCT00773175|100623115|FG001|NOT COMPLETED|Overall Study||2||
48122365|NCT02863354|100623116|FG000|STARTED|Year 1||23||23
48122366|NCT02863354|100623117|FG001|STARTED|Year 1||20||20
48122367|NCT02863354|100623116|FG000|COMPLETED|Year 1||19||19
48122368|NCT02863354|100623117|FG001|COMPLETED|Year 1||18||18
48122369|NCT02863354|100623116|FG000|NOT COMPLETED|Year 1||4||4
48122370|NCT02863354|100623117|FG001|NOT COMPLETED|Year 1||2||2
48122371|NCT02863354|100623116|FG000|STARTED|Year 2||19||19
48122372|NCT02863354|100623117|FG001|STARTED|Year 2||18||18
48122373|NCT02863354|100623116|FG000|COMPLETED|Year 2||17||17
48122374|NCT02863354|100623117|FG001|COMPLETED|Year 2||16||16
48122375|NCT02863354|100623116|FG000|NOT COMPLETED|Year 2||2||2
48122376|NCT02863354|100623117|FG001|NOT COMPLETED|Year 2||2||2
48122377|NCT00273364|100623118|FG000|STARTED|Overall Study||55||
48122378|NCT00273364|100623119|FG001|STARTED|Overall Study||55||
48122379|NCT00273364|100623118|FG000|COMPLETED|Overall Study||55||
48122380|NCT00273364|100623119|FG001|COMPLETED|Overall Study||55||
48122381|NCT00273364|100623118|FG000|NOT COMPLETED|Overall Study||0||
48122382|NCT00273364|100623119|FG001|NOT COMPLETED|Overall Study||0||
48122383|NCT01986829|100623120|FG000|STARTED|Overall Study||9||
48122384|NCT01986829|100623120|FG000|COMPLETED|Overall Study||8||
48122385|NCT01986829|100623120|FG000|NOT COMPLETED|Overall Study||1||
48122386|NCT02116322|100623121|FG000|STARTED|Overall Study||1||
48122387|NCT02116322|100623121|FG000|COMPLETED|Overall Study||1||
48122388|NCT02116322|100623121|FG000|NOT COMPLETED|Overall Study||0||
48122389|NCT01018264|100623122|FG000|STARTED|Overall Study||10||
48122390|NCT01018264|100623123|FG001|STARTED|Overall Study||13||
48122391|NCT01018264|100623122|FG000|COMPLETED|Overall Study||9||
48122392|NCT01018264|100623123|FG001|COMPLETED|Overall Study||12||
48122393|NCT01018264|100623122|FG000|NOT COMPLETED|Overall Study||1||
48122394|NCT01018264|100623123|FG001|NOT COMPLETED|Overall Study||1||
48122395|NCT02276495|100623124|FG000|STARTED|Overall Study||18||
48122396|NCT02276495|100623125|FG001|STARTED|Overall Study||17||
48122397|NCT02276495|100623126|FG002|STARTED|Overall Study||20||
48122398|NCT02276495|100623124|FG000|COMPLETED|Overall Study||18||
48122399|NCT02276495|100623125|FG001|COMPLETED|Overall Study||17||
48122400|NCT02276495|100623126|FG002|COMPLETED|Overall Study||20||
48122401|NCT02276495|100623124|FG000|NOT COMPLETED|Overall Study||0||
48122402|NCT02276495|100623125|FG001|NOT COMPLETED|Overall Study||0||
48122403|NCT02276495|100623126|FG002|NOT COMPLETED|Overall Study||0||
48122404|NCT01827904|100623127|FG000|STARTED|Main Study||56||
48122405|NCT01827904|100623128|FG001|STARTED|Main Study||20||
48281912|NCT01655693|101014203|FG000|NOT COMPLETED|Overall Study||126||
48281913|NCT01655693|101014204|FG001|NOT COMPLETED|Overall Study||126||
48281914|NCT01655693|101014205|FG002|NOT COMPLETED|Overall Study||130||
48281915|NCT01346475|101014206|FG000|STARTED|First Intervention||22||
48281916|NCT01346475|101014207|FG001|STARTED|First Intervention||28||
48281917|NCT01346475|101014206|FG000|COMPLETED|First Intervention||18||
48569847|NCT01831076|101727687|FG000|STARTED|Overall Study||31||
48569848|NCT01831076|101727688|FG001|STARTED|Overall Study||5||
48569849|NCT01831076|101727687|FG000|COMPLETED|Overall Study||30||
48569850|NCT01831076|101727688|FG001|COMPLETED|Overall Study||4||
48569851|NCT01831076|101727687|FG000|NOT COMPLETED|Overall Study||1||
48569852|NCT01831076|101727688|FG001|NOT COMPLETED|Overall Study||1||
48569853|NCT01921101|101727689|FG000|STARTED|Overall Study||40||
48569854|NCT01921101|101727690|FG001|STARTED|Overall Study||38||
48569855|NCT01921101|101727689|FG000|COMPLETED|Overall Study||24||
48569856|NCT01921101|101727690|FG001|COMPLETED|Overall Study||32||
48569857|NCT01921101|101727689|FG000|NOT COMPLETED|Overall Study||16||
48569858|NCT01921101|101727690|FG001|NOT COMPLETED|Overall Study||6||
48569859|NCT00511914|101727691|FG000|STARTED|Overall Study||68||
48569860|NCT00511914|101727692|FG001|STARTED|Overall Study||67||
48569861|NCT00511914|101727691|FG000|COMPLETED|Overall Study||68||
48569862|NCT00511914|101727692|FG001|COMPLETED|Overall Study||67||
48569863|NCT00511914|101727691|FG000|NOT COMPLETED|Overall Study||0||
48569864|NCT00511914|101727692|FG001|NOT COMPLETED|Overall Study||0||
48569865|NCT02099110|101727693|FG000|STARTED|Overall Study||250||
48569866|NCT02099110|101727694|FG001|STARTED|Overall Study||248||
48569867|NCT02099110|101727695|FG002|STARTED|Overall Study||247||
48569868|NCT02099110|101727696|FG003|STARTED|Overall Study||243||
48569869|NCT02099110|101727697|FG004|STARTED|Overall Study||245||
48569870|NCT02099110|101727693|FG000|Treated|Overall Study||250||
48569871|NCT02099110|101727694|FG001|Treated|Overall Study||248||
48569872|NCT02099110|101727695|FG002|Treated|Overall Study||247||
48569873|NCT02099110|101727696|FG003|Treated|Overall Study||243||
48569874|NCT02099110|101727697|FG004|Treated|Overall Study||244||
48569875|NCT02099110|101727693|FG000|COMPLETED|Overall Study||226||
48569876|NCT02099110|101727694|FG001|COMPLETED|Overall Study||217||
48569877|NCT02099110|101727695|FG002|COMPLETED|Overall Study||219||
48569878|NCT02099110|101727696|FG003|COMPLETED|Overall Study||221||
48569879|NCT02099110|101727697|FG004|COMPLETED|Overall Study||218||
48569880|NCT02099110|101727693|FG000|NOT COMPLETED|Overall Study||24||
48569881|NCT02099110|101727694|FG001|NOT COMPLETED|Overall Study||31||
48569882|NCT02099110|101727695|FG002|NOT COMPLETED|Overall Study||28||
48281918|NCT01346475|101014207|FG001|COMPLETED|First Intervention||25||
48281919|NCT01346475|101014206|FG000|NOT COMPLETED|First Intervention||4||
48281920|NCT01346475|101014207|FG001|NOT COMPLETED|First Intervention||3||
48281921|NCT01346475|101014206|FG000|STARTED|Second Intervention||18||
48281922|NCT01346475|101014207|FG001|STARTED|Second Intervention||25||
48569883|NCT02099110|101727696|FG003|NOT COMPLETED|Overall Study||22||
48569884|NCT02099110|101727697|FG004|NOT COMPLETED|Overall Study||27||
48569885|NCT03259425|101727698|FG000|STARTED|Overall Study||7||
48569886|NCT03259425|101727698|FG000|Surgery|Overall Study||6||
48699647|NCT00845039|102050565|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2||
48281923|NCT01346475|101014206|FG000|COMPLETED|Second Intervention||18||
48281924|NCT01346475|101014207|FG001|COMPLETED|Second Intervention||25||
48281925|NCT01346475|101014206|FG000|NOT COMPLETED|Second Intervention||0||
48699648|NCT00845039|102050566|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2||
48699649|NCT00845039|102050565|FG000|COMPLETED|Overall Study||2||
48699650|NCT00845039|102050566|FG001|COMPLETED|Overall Study||2||
48699651|NCT00845039|102050565|FG000|NOT COMPLETED|Overall Study||0||
48699652|NCT00845039|102050566|FG001|NOT COMPLETED|Overall Study||0||
48699653|NCT01450696|102050567|FG000|STARTED|Overall Study||148||
48281926|NCT01346475|101014207|FG001|NOT COMPLETED|Second Intervention||0||
48281927|NCT03309813|101014208|FG000|STARTED|Main Randomized Study||5||
48281928|NCT03309813|101014209|FG001|STARTED|Main Randomized Study||5||
48281929|NCT03309813|101014208|FG000|COMPLETED|Main Randomized Study||4||
48281930|NCT03309813|101014209|FG001|COMPLETED|Main Randomized Study||5||
48281931|NCT03309813|101014208|FG000|NOT COMPLETED|Main Randomized Study||1||
48281932|NCT03309813|101014209|FG001|NOT COMPLETED|Main Randomized Study||0||
48294168|NCT02527343|101047536|FG000|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0||
48294169|NCT02527343|101047537|FG001|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0||
48569887|NCT03259425|101727698|FG000|COMPLETED|Overall Study||6||
48569888|NCT03259425|101727698|FG000|NOT COMPLETED|Overall Study||1||
48569889|NCT00648115|101727699|FG000|STARTED|Overall Study||42||
48569890|NCT00648115|101727700|FG001|STARTED|Overall Study||42||
48569891|NCT00648115|101727701|FG002|STARTED|Overall Study||27||
48569892|NCT00648115|101727699|FG000|COMPLETED|Overall Study||42||
48569893|NCT00648115|101727700|FG001|COMPLETED|Overall Study||42||
48569894|NCT00648115|101727701|FG002|COMPLETED|Overall Study||27||
48569895|NCT00648115|101727699|FG000|NOT COMPLETED|Overall Study||0||
48569896|NCT00648115|101727700|FG001|NOT COMPLETED|Overall Study||0||
48569897|NCT00648115|101727701|FG002|NOT COMPLETED|Overall Study||0||
48569898|NCT00424619|101727702|FG000|STARTED|Baseline||22||
48569899|NCT00424619|101727703|FG001|STARTED|Baseline||22||
48569900|NCT00424619|101727704|FG002|STARTED|Baseline||21||
48569901|NCT00424619|101727702|FG000|COMPLETED|Baseline||22||
48569902|NCT00424619|101727703|FG001|COMPLETED|Baseline||22||
48569903|NCT00424619|101727704|FG002|COMPLETED|Baseline||20||
48569904|NCT00424619|101727702|FG000|NOT COMPLETED|Baseline||0||
48122406|NCT01827904|100623129|FG002|STARTED|Main Study||0||
48122407|NCT01827904|100623127|FG000|COMPLETED|Main Study||54||
48122408|NCT01827904|100623128|FG001|COMPLETED|Main Study||20||
48122409|NCT01827904|100623129|FG002|COMPLETED|Main Study||0||
48122410|NCT01827904|100623127|FG000|NOT COMPLETED|Main Study||2||
48122411|NCT01827904|100623128|FG001|NOT COMPLETED|Main Study||0||
48122412|NCT01827904|100623129|FG002|NOT COMPLETED|Main Study||0||
48122413|NCT01827904|100623127|FG000|STARTED|Main Continuation / Crossover Phase||54||
48122414|NCT01827904|100623128|FG001|STARTED|Main Continuation / Crossover Phase||0||
48122415|NCT01827904|100623129|FG002|STARTED|Main Continuation / Crossover Phase||21||
48122416|NCT01827904|100623127|FG000|COMPLETED|Main Continuation / Crossover Phase||51||
48569905|NCT00424619|101727703|FG001|NOT COMPLETED|Baseline||0||
48569906|NCT00424619|101727704|FG002|NOT COMPLETED|Baseline||1||
48569907|NCT00424619|101727702|FG000|STARTED|4 Week||18||
48569908|NCT00424619|101727703|FG001|STARTED|4 Week||17||
48122417|NCT01827904|100623128|FG001|COMPLETED|Main Continuation / Crossover Phase||0||
48122418|NCT01827904|100623129|FG002|COMPLETED|Main Continuation / Crossover Phase||21||
48122419|NCT01827904|100623127|FG000|NOT COMPLETED|Main Continuation / Crossover Phase||3||
48569909|NCT00424619|101727704|FG002|STARTED|4 Week||17||
48569910|NCT00424619|101727702|FG000|COMPLETED|4 Week||18||
48569911|NCT00424619|101727703|FG001|COMPLETED|4 Week||17||
48569912|NCT00424619|101727704|FG002|COMPLETED|4 Week||17||
48569913|NCT00424619|101727702|FG000|NOT COMPLETED|4 Week||0||
48122420|NCT01827904|100623128|FG001|NOT COMPLETED|Main Continuation / Crossover Phase||0||
48122421|NCT01827904|100623129|FG002|NOT COMPLETED|Main Continuation / Crossover Phase||0||
48122422|NCT01827904|100623127|FG000|STARTED|Long-term Annual Follow-up||51||
48122423|NCT01827904|100623128|FG001|STARTED|Long-term Annual Follow-up||0||
48122424|NCT01827904|100623129|FG002|STARTED|Long-term Annual Follow-up||19||
48122425|NCT01827904|100623127|FG000|COMPLETED|Long-term Annual Follow-up||29||
48122426|NCT01827904|100623128|FG001|COMPLETED|Long-term Annual Follow-up||0||
48122427|NCT01827904|100623129|FG002|COMPLETED|Long-term Annual Follow-up||12||
48122428|NCT01827904|100623127|FG000|NOT COMPLETED|Long-term Annual Follow-up||22||
48122429|NCT01827904|100623128|FG001|NOT COMPLETED|Long-term Annual Follow-up||0||
48122430|NCT01827904|100623129|FG002|NOT COMPLETED|Long-term Annual Follow-up||7||
48122431|NCT03394391|100623130|FG000|STARTED|Overall Study||106||
48122432|NCT03394391|100623131|FG001|STARTED|Overall Study||106||
48122433|NCT03394391|100623130|FG000|COMPLETED|Overall Study||105||
48281933|NCT03309813|101014208|FG000|STARTED|Crossover Transcranial Exablate||0|Subjects randomized to Sham Transcranial Exablate (n=5) were given the option to receive the Exablate treatment and follow up in the Crossover Exablate group. Thus, the number of subjects participating in the Crossover Exablate group may not equal the number of subjects completing the Sham group 3 Month visit.|
48281934|NCT03309813|101014209|FG001|STARTED|Crossover Transcranial Exablate||3|Subjects randomized to Sham Transcranial Exablate (n=5) were given the option to receive the Exablate treatment and follow up in the Crossover Exablate group. Thus, the number of subjects participating in the Crossover Exablate group may not equal the number of subjects completing the Sham group 3 Month visit.|
48122434|NCT03394391|100623131|FG001|COMPLETED|Overall Study||104||
48122435|NCT03394391|100623130|FG000|NOT COMPLETED|Overall Study||1||
48122436|NCT03394391|100623131|FG001|NOT COMPLETED|Overall Study||2||
48122437|NCT01805297|100623132|FG000|STARTED|Overall Study||6||
48122438|NCT01805297|100623133|FG001|STARTED|Overall Study||6||
48122439|NCT01805297|100623132|FG000|COMPLETED|Overall Study||4||
48122440|NCT01805297|100623133|FG001|COMPLETED|Overall Study||3||
48122441|NCT01805297|100623132|FG000|NOT COMPLETED|Overall Study||2||
48122442|NCT01805297|100623133|FG001|NOT COMPLETED|Overall Study||3||
48122443|NCT01221441|100623134|FG000|STARTED|Overall Study||67||
48122444|NCT01221441|100623135|FG001|STARTED|Overall Study||35||
48122445|NCT01221441|100623134|FG000|COMPLETED|Overall Study||45||
48281935|NCT03309813|101014208|FG000|COMPLETED|Crossover Transcranial Exablate||0||
48281936|NCT03309813|101014209|FG001|COMPLETED|Crossover Transcranial Exablate||3||
48281937|NCT03309813|101014208|FG000|NOT COMPLETED|Crossover Transcranial Exablate||0||
48281938|NCT03309813|101014209|FG001|NOT COMPLETED|Crossover Transcranial Exablate||0||
48281939|NCT01901432|101014210|FG000|STARTED|Overall Study||3||
48281940|NCT01901432|101014211|FG001|STARTED|Overall Study||3||
48281941|NCT01901432|101014212|FG002|STARTED|Overall Study||3||
48281942|NCT01901432|101014213|FG003|STARTED|Overall Study||3||
48281943|NCT01901432|101014214|FG004|STARTED|Overall Study||36||
48396770|NCT03911869|101302463|FG002|NOT COMPLETED|Safety Lead-in Phase||0||
48396771|NCT03911869|101302461|FG000|STARTED|Phase 2||0||
48396772|NCT03911869|101302462|FG001|STARTED|Phase 2||3||
48396773|NCT03911869|101302463|FG002|STARTED|Phase 2||0||
48396774|NCT03911869|101302461|FG000|COMPLETED|Phase 2||0||
48122446|NCT01221441|100623135|FG001|COMPLETED|Overall Study||23||
48122447|NCT01221441|100623134|FG000|NOT COMPLETED|Overall Study||22||
48122448|NCT01221441|100623135|FG001|NOT COMPLETED|Overall Study||12||
48122449|NCT02039427|100626300|FG000|STARTED|Overall Study||48||
48122450|NCT02039427|100626301|FG001|STARTED|Overall Study||48||
48122451|NCT02039427|100626302|FG002|STARTED|Overall Study||48||
48122452|NCT02039427|100626303|FG003|STARTED|Overall Study||48||
48122453|NCT02039427|100626300|FG000|COMPLETED|Overall Study||45||
48122454|NCT02039427|100626301|FG001|COMPLETED|Overall Study||47||
48122455|NCT02039427|100626302|FG002|COMPLETED|Overall Study||45||
48122456|NCT02039427|100626303|FG003|COMPLETED|Overall Study||43||
48122457|NCT02039427|100626300|FG000|NOT COMPLETED|Overall Study||3||
48122458|NCT02039427|100626301|FG001|NOT COMPLETED|Overall Study||1||
48122459|NCT02039427|100626302|FG002|NOT COMPLETED|Overall Study||3||
48122460|NCT02039427|100626303|FG003|NOT COMPLETED|Overall Study||5||
48122461|NCT00927927|100626304|FG000|STARTED|Overall Study||3||
48122462|NCT00927927|100626305|FG001|STARTED|Overall Study||3||
48122463|NCT00927927|100626306|FG002|STARTED|Overall Study||3||
48122464|NCT00927927|100626307|FG003|STARTED|Overall Study||3||
48122465|NCT00927927|100626308|FG004|STARTED|Overall Study||3||
48122466|NCT00927927|100626309|FG005|STARTED|Overall Study||3||
48122467|NCT00927927|100626310|FG006|STARTED|Overall Study||3||
48122468|NCT00927927|100626311|FG007|STARTED|Overall Study||3||
48122469|NCT00927927|100626312|FG008|STARTED|Overall Study||8||
48122470|NCT00927927|100626313|FG009|STARTED|Overall Study||3||
48122471|NCT00927927|100626314|FG010|STARTED|Overall Study||5||
48122472|NCT00927927|100626315|FG011|STARTED|Overall Study||6||
48122473|NCT00927927|100626316|FG012|STARTED|Overall Study||5||
48122474|NCT00927927|100626317|FG013|STARTED|Overall Study||5||
48122475|NCT00927927|100626318|FG014|STARTED|Overall Study||9||
48122476|NCT00927927|100626304|FG000|Exposed|Overall Study||3||
48122477|NCT00927927|100626305|FG001|Exposed|Overall Study||3||
48122478|NCT00927927|100626306|FG002|Exposed|Overall Study||3||
48122479|NCT00927927|100626307|FG003|Exposed|Overall Study||3||
48122480|NCT00927927|100626308|FG004|Exposed|Overall Study||3||
48122481|NCT00927927|100626309|FG005|Exposed|Overall Study||3||
48122482|NCT00927927|100626310|FG006|Exposed|Overall Study||3||
48122483|NCT00927927|100626311|FG007|Exposed|Overall Study||3||
48122484|NCT00927927|100626312|FG008|Exposed|Overall Study||8||
48122485|NCT00927927|100626313|FG009|Exposed|Overall Study||3||
48122486|NCT00927927|100626314|FG010|Exposed|Overall Study||5||
48122487|NCT00927927|100626315|FG011|Exposed|Overall Study||5||
48122488|NCT00927927|100626316|FG012|Exposed|Overall Study||5||
48122489|NCT00927927|100626317|FG013|Exposed|Overall Study||5||
48122490|NCT00927927|100626318|FG014|Exposed|Overall Study||9||
48122491|NCT00927927|100626304|FG000|COMPLETED|Overall Study||3||
48122492|NCT00927927|100626305|FG001|COMPLETED|Overall Study||3||
48122493|NCT00927927|100626306|FG002|COMPLETED|Overall Study||3||
48122494|NCT00927927|100626307|FG003|COMPLETED|Overall Study||3||
48122495|NCT00927927|100626308|FG004|COMPLETED|Overall Study||3||
48122496|NCT00927927|100626309|FG005|COMPLETED|Overall Study||3||
48122497|NCT00927927|100626310|FG006|COMPLETED|Overall Study||3||
48122498|NCT00927927|100626311|FG007|COMPLETED|Overall Study||1||
48122499|NCT00927927|100626312|FG008|COMPLETED|Overall Study||8||
48122500|NCT00927927|100626313|FG009|COMPLETED|Overall Study||3||
48122501|NCT00927927|100626314|FG010|COMPLETED|Overall Study||5||
48122502|NCT00927927|100626315|FG011|COMPLETED|Overall Study||4||
48122503|NCT00927927|100626316|FG012|COMPLETED|Overall Study||5||
48122504|NCT00927927|100626317|FG013|COMPLETED|Overall Study||5||
48122505|NCT00927927|100626318|FG014|COMPLETED|Overall Study||9||
48122506|NCT00927927|100626304|FG000|NOT COMPLETED|Overall Study||0||
48122507|NCT00927927|100626305|FG001|NOT COMPLETED|Overall Study||0||
48122508|NCT00927927|100626306|FG002|NOT COMPLETED|Overall Study||0||
48122509|NCT00927927|100626307|FG003|NOT COMPLETED|Overall Study||0||
48122510|NCT00927927|100626308|FG004|NOT COMPLETED|Overall Study||0||
48122511|NCT00927927|100626309|FG005|NOT COMPLETED|Overall Study||0||
48122512|NCT00927927|100626310|FG006|NOT COMPLETED|Overall Study||0||
48122513|NCT00927927|100626311|FG007|NOT COMPLETED|Overall Study||2||
48122514|NCT00927927|100626312|FG008|NOT COMPLETED|Overall Study||0||
48122515|NCT00927927|100626313|FG009|NOT COMPLETED|Overall Study||0||
48122516|NCT00927927|100626314|FG010|NOT COMPLETED|Overall Study||0||
48122517|NCT00927927|100626315|FG011|NOT COMPLETED|Overall Study||2||
48122518|NCT00927927|100626316|FG012|NOT COMPLETED|Overall Study||0||
48122519|NCT00927927|100626317|FG013|NOT COMPLETED|Overall Study||0||
48122520|NCT00927927|100626318|FG014|NOT COMPLETED|Overall Study||0||
48122521|NCT01529645|100626319|FG000|STARTED|Overall Study||42||
48122522|NCT01529645|100626320|FG001|STARTED|Overall Study||42||
48122523|NCT01529645|100626321|FG002|STARTED|Overall Study||42||
48122524|NCT01529645|100626322|FG003|STARTED|Overall Study||42||
48122525|NCT01529645|100626323|FG004|STARTED|Overall Study||42||
48122526|NCT01529645|100626324|FG005|STARTED|Overall Study||42||
48122527|NCT01529645|100626325|FG006|STARTED|Overall Study||42||
48122528|NCT01529645|100626326|FG007|STARTED|Overall Study||42||
48122529|NCT01529645|100626327|FG008|STARTED|Overall Study||42||
48122530|NCT01529645|100626328|FG009|STARTED|Overall Study||42||
48122531|NCT01529645|100626319|FG000|COMPLETED|Overall Study||40||
48122532|NCT01529645|100626320|FG001|COMPLETED|Overall Study||41||
48122533|NCT01529645|100626321|FG002|COMPLETED|Overall Study||40||
48122534|NCT01529645|100626322|FG003|COMPLETED|Overall Study||40||
48122535|NCT01529645|100626323|FG004|COMPLETED|Overall Study||40||
48122536|NCT01529645|100626324|FG005|COMPLETED|Overall Study||41||
48122537|NCT01529645|100626325|FG006|COMPLETED|Overall Study||40||
48122538|NCT01529645|100626326|FG007|COMPLETED|Overall Study||42||
48122539|NCT01529645|100626327|FG008|COMPLETED|Overall Study||41||
48122540|NCT01529645|100626328|FG009|COMPLETED|Overall Study||42||
48122541|NCT01529645|100626319|FG000|NOT COMPLETED|Overall Study||2||
48122542|NCT01529645|100626320|FG001|NOT COMPLETED|Overall Study||1||
48122543|NCT01529645|100626321|FG002|NOT COMPLETED|Overall Study||2||
48122544|NCT01529645|100626322|FG003|NOT COMPLETED|Overall Study||2||
48122545|NCT01529645|100626323|FG004|NOT COMPLETED|Overall Study||2||
48122546|NCT01529645|100626324|FG005|NOT COMPLETED|Overall Study||1||
48122547|NCT01529645|100626325|FG006|NOT COMPLETED|Overall Study||2||
48122548|NCT01529645|100626326|FG007|NOT COMPLETED|Overall Study||0||
48122549|NCT01529645|100626327|FG008|NOT COMPLETED|Overall Study||1||
48122550|NCT01529645|100626328|FG009|NOT COMPLETED|Overall Study||0||
48122551|NCT03120624|100626329|FG000|STARTED|Overall Study||3||
48122552|NCT03120624|100626330|FG001|STARTED|Overall Study||10||
48122553|NCT03120624|100626331|FG002|STARTED|Overall Study||3||
48281944|NCT01901432|101014210|FG000|Received Study Drug|Overall Study||3||
48122554|NCT03120624|100626332|FG003|STARTED|Overall Study||6||
48122555|NCT03120624|100626333|FG004|STARTED|Overall Study||3||
48122556|NCT03120624|100626334|FG005|STARTED|Overall Study||3||
48122557|NCT03120624|100626335|FG006|STARTED|Overall Study||3||
48122558|NCT03120624|100626336|FG007|STARTED|Overall Study||3||
48122559|NCT03120624|100626329|FG000|COMPLETED|Overall Study||3||
48122560|NCT03120624|100626330|FG001|COMPLETED|Overall Study||9||
48122561|NCT03120624|100626331|FG002|COMPLETED|Overall Study||3||
48122562|NCT03120624|100626332|FG003|COMPLETED|Overall Study||6||
48122563|NCT03120624|100626333|FG004|COMPLETED|Overall Study||3||
48122564|NCT03120624|100626334|FG005|COMPLETED|Overall Study||3||
48122565|NCT03120624|100626335|FG006|COMPLETED|Overall Study||3||
48122566|NCT03120624|100626336|FG007|COMPLETED|Overall Study||3||
48122567|NCT03120624|100626329|FG000|NOT COMPLETED|Overall Study||0||
48122568|NCT03120624|100626330|FG001|NOT COMPLETED|Overall Study||1||
48122569|NCT03120624|100626331|FG002|NOT COMPLETED|Overall Study||0||
48122570|NCT03120624|100626332|FG003|NOT COMPLETED|Overall Study||0||
48122571|NCT03120624|100626333|FG004|NOT COMPLETED|Overall Study||0||
48122572|NCT03120624|100626334|FG005|NOT COMPLETED|Overall Study||0||
48122573|NCT03120624|100626335|FG006|NOT COMPLETED|Overall Study||0||
48122574|NCT03120624|100626336|FG007|NOT COMPLETED|Overall Study||0||
48122575|NCT03074734|100626337|FG000|STARTED|Overall Study||60||
48122576|NCT03074734|100626337|FG000|Recruitment|Overall Study||60||
48122577|NCT03074734|100626337|FG000|COMPLETED|Overall Study||60||
48122578|NCT03074734|100626337|FG000|NOT COMPLETED|Overall Study||0||
48569914|NCT00424619|101727703|FG001|NOT COMPLETED|4 Week||0||
48569915|NCT00424619|101727704|FG002|NOT COMPLETED|4 Week||0||
48569916|NCT00424619|101727702|FG000|STARTED|3 Month||12||
48569917|NCT00424619|101727703|FG001|STARTED|3 Month||18||
48569918|NCT00424619|101727704|FG002|STARTED|3 Month||17||
48569919|NCT00424619|101727702|FG000|COMPLETED|3 Month||12||
48569920|NCT00424619|101727703|FG001|COMPLETED|3 Month||18||
48569921|NCT00424619|101727704|FG002|COMPLETED|3 Month||17||
48569922|NCT00424619|101727702|FG000|NOT COMPLETED|3 Month||0||
48569923|NCT00424619|101727703|FG001|NOT COMPLETED|3 Month||0||
48569924|NCT00424619|101727704|FG002|NOT COMPLETED|3 Month||0||
48569925|NCT03241862|101727705|FG000|STARTED|Overall Study||20||
48569926|NCT03241862|101727705|FG000|COMPLETED|Overall Study||20||
48569927|NCT03241862|101727705|FG000|NOT COMPLETED|Overall Study||0||
48569928|NCT02343939|101727706|FG000|STARTED|Overall Study||3||
48569929|NCT02343939|101727707|FG001|STARTED|Overall Study||50||
48569930|NCT02343939|101727708|FG002|STARTED|Overall Study||5||
48569931|NCT02343939|101727709|FG003|STARTED|Overall Study||6||
48569932|NCT02343939|101727710|FG004|STARTED|Overall Study||8||
48569933|NCT02343939|101727711|FG005|STARTED|Overall Study||17||
48569934|NCT02343939|101727712|FG006|STARTED|Overall Study||15||
48569935|NCT02343939|101727713|FG007|STARTED|Overall Study||37||
48569936|NCT02343939|101727714|FG008|STARTED|Overall Study||7||
48569937|NCT02343939|101727706|FG000|COMPLETED|Overall Study||0||
48569938|NCT02343939|101727707|FG001|COMPLETED|Overall Study||2||
48569939|NCT02343939|101727708|FG002|COMPLETED|Overall Study||0||
48569940|NCT02343939|101727709|FG003|COMPLETED|Overall Study||0||
48569941|NCT02343939|101727710|FG004|COMPLETED|Overall Study||0||
48122579|NCT01812044|100626338|FG000|STARTED|Overall Study||17||
48122580|NCT01812044|100626339|FG001|STARTED|Overall Study||17||
48122581|NCT01812044|100626340|FG002|STARTED|Overall Study||16||
48122582|NCT01812044|100626338|FG000|COMPLETED|Overall Study||17||
48122583|NCT01812044|100626339|FG001|COMPLETED|Overall Study||17||
48122584|NCT01812044|100626340|FG002|COMPLETED|Overall Study||16||
48122585|NCT01812044|100626338|FG000|NOT COMPLETED|Overall Study||0||
48122586|NCT01812044|100626339|FG001|NOT COMPLETED|Overall Study||0||
48122587|NCT01812044|100626340|FG002|NOT COMPLETED|Overall Study||0||
48569942|NCT02343939|101727711|FG005|COMPLETED|Overall Study||0||
48569943|NCT02343939|101727712|FG006|COMPLETED|Overall Study||0||
48569944|NCT02343939|101727713|FG007|COMPLETED|Overall Study||0||
48569945|NCT02343939|101727714|FG008|COMPLETED|Overall Study||0||
48569946|NCT02343939|101727706|FG000|NOT COMPLETED|Overall Study||3||
48569947|NCT02343939|101727707|FG001|NOT COMPLETED|Overall Study||48||
48569948|NCT02343939|101727708|FG002|NOT COMPLETED|Overall Study||5||
48569949|NCT02343939|101727709|FG003|NOT COMPLETED|Overall Study||6||
48569950|NCT02343939|101727710|FG004|NOT COMPLETED|Overall Study||8||
48569951|NCT02343939|101727711|FG005|NOT COMPLETED|Overall Study||17||
48569952|NCT02343939|101727712|FG006|NOT COMPLETED|Overall Study||15||
48569953|NCT02343939|101727713|FG007|NOT COMPLETED|Overall Study||37||
48569954|NCT02343939|101727714|FG008|NOT COMPLETED|Overall Study||7||
48569955|NCT01031680|101727715|FG000|STARTED|Overall Study||460||
48569956|NCT01031680|101727716|FG001|STARTED|Overall Study||462||
48569957|NCT01031680|101727715|FG000|COMPLETED|Overall Study||403||
48569958|NCT01031680|101727716|FG001|COMPLETED|Overall Study||404||
48569959|NCT01031680|101727715|FG000|NOT COMPLETED|Overall Study||57||
48122588|NCT02460198|100626341|FG000|STARTED|Overall Study||61||
48122589|NCT02460198|100626342|FG001|STARTED|Overall Study||63||
48122590|NCT02460198|100626341|FG000|COMPLETED|Overall Study||0||
48122591|NCT02460198|100626342|FG001|COMPLETED|Overall Study||0||
48122592|NCT02460198|100626341|FG000|NOT COMPLETED|Overall Study||61||
48122593|NCT02460198|100626342|FG001|NOT COMPLETED|Overall Study||63||
48122594|NCT01612546|100626343|FG000|STARTED|Overall Study||10||
48569960|NCT01031680|101727716|FG001|NOT COMPLETED|Overall Study||58||
48569961|NCT04498182|101727717|FG000|STARTED|Overall Study||122||244
48569962|NCT04498182|101727718|FG001|STARTED|Overall Study||121||242
48569963|NCT04498182|101727719|FG002|STARTED|Overall Study||126||252
48569964|NCT04498182|101727717|FG000|COMPLETED|Overall Study||115||230
48569965|NCT04498182|101727718|FG001|COMPLETED|Overall Study||114||228
48569966|NCT04498182|101727719|FG002|COMPLETED|Overall Study||116||232
48569967|NCT04498182|101727717|FG000|NOT COMPLETED|Overall Study||7||14
48569968|NCT04498182|101727718|FG001|NOT COMPLETED|Overall Study||7||14
48569969|NCT04498182|101727719|FG002|NOT COMPLETED|Overall Study||10||20
48569970|NCT02069041|101727720|FG000|STARTED|Overall Study||8||
48569971|NCT02069041|101727720|FG000|Received at Least One Dose of Study Drug|Overall Study||8||
48122595|NCT01612546|100626343|FG000|COMPLETED|Overall Study||10||
48122596|NCT01612546|100626343|FG000|NOT COMPLETED|Overall Study||0||
48122597|NCT01344057|100626344|FG000|STARTED|Overall Study||63||
48122598|NCT01344057|100626344|FG000|COMPLETED|Overall Study||62||
48122599|NCT01344057|100626344|FG000|NOT COMPLETED|Overall Study||1||
48122600|NCT02279641|100626345|FG000|STARTED|Overall Study||6||
48122601|NCT02279641|100626346|FG001|STARTED|Overall Study||6||
48122602|NCT02279641|100626345|FG000|COMPLETED|Overall Study||6||
48122603|NCT02279641|100626346|FG001|COMPLETED|Overall Study||6||
48122604|NCT02279641|100626345|FG000|NOT COMPLETED|Overall Study||0||
48122605|NCT02279641|100626346|FG001|NOT COMPLETED|Overall Study||0||
48122606|NCT03952039|100626347|FG000|STARTED|Overall Study||134||
48122607|NCT03952039|100626348|FG001|STARTED|Overall Study||67||
48122608|NCT03952039|100626347|FG000|Participants Who Crossed Over|Overall Study||0||
48122609|NCT03952039|100626348|FG001|Participants Who Crossed Over|Overall Study||46||
48122610|NCT03952039|100626347|FG000|COMPLETED|Overall Study||43|Completed = Treatment ongoing|
48122611|NCT03952039|100626348|FG001|COMPLETED|Overall Study||28|Completed = Treatment ongoing|
48122612|NCT03952039|100626347|FG000|NOT COMPLETED|Overall Study||91||
48122613|NCT03952039|100626348|FG001|NOT COMPLETED|Overall Study||39||
48122614|NCT01126541|100626349|FG000|STARTED|Overall Study||70||
48122615|NCT01126541|100626350|FG001|STARTED|Overall Study||73||
48122616|NCT01126541|100626351|FG002|STARTED|Overall Study||81||
48122617|NCT01126541|100626349|FG000|COMPLETED|Overall Study||60||
48122618|NCT01126541|100626350|FG001|COMPLETED|Overall Study||61||
48122619|NCT01126541|100626351|FG002|COMPLETED|Overall Study||55||
48122620|NCT01126541|100626349|FG000|NOT COMPLETED|Overall Study||10||
48122621|NCT01126541|100626350|FG001|NOT COMPLETED|Overall Study||12||
48122622|NCT01126541|100626351|FG002|NOT COMPLETED|Overall Study||26||
48122623|NCT03603964|100626352|FG000|STARTED|Overall Study||35||
48122624|NCT03603964|100626352|FG000|COMPLETED|Overall Study||0||
48122625|NCT03603964|100626352|FG000|NOT COMPLETED|Overall Study||35||
48122626|NCT02334748|100626353|FG000|STARTED|Overall Study||31|31|
48122627|NCT02334748|100626353|FG000|COMPLETED|Overall Study||23|23|
48122628|NCT02334748|100626353|FG000|NOT COMPLETED|Overall Study||8||
48122629|NCT02752048|100626354|FG000|STARTED|Overall Study||11||
48122630|NCT02752048|100626355|FG001|STARTED|Overall Study||12||
48122631|NCT02752048|100626356|FG002|STARTED|Overall Study||13||
48122632|NCT02752048|100626354|FG000|COMPLETED|Overall Study||11||
48281945|NCT01901432|101014211|FG001|Received Study Drug|Overall Study||3||
48569972|NCT02069041|101727720|FG000|COMPLETED|Overall Study||8||
48122633|NCT02752048|100626355|FG001|COMPLETED|Overall Study||12||
48122634|NCT02752048|100626356|FG002|COMPLETED|Overall Study||10||
48122635|NCT02752048|100626354|FG000|NOT COMPLETED|Overall Study||0||
48122636|NCT02752048|100626355|FG001|NOT COMPLETED|Overall Study||0||
48122637|NCT02752048|100626356|FG002|NOT COMPLETED|Overall Study||3||
48122638|NCT00961259|100626357|FG000|STARTED|First Intervention||18||
48122639|NCT00961259|100626358|FG001|STARTED|First Intervention||18||
48122640|NCT00961259|100626359|FG002|STARTED|First Intervention||18||
48122641|NCT00961259|100626357|FG000|COMPLETED|First Intervention||18||
48122642|NCT00961259|100626358|FG001|COMPLETED|First Intervention||18||
48122643|NCT00961259|100626359|FG002|COMPLETED|First Intervention||18||
48122644|NCT00961259|100626357|FG000|NOT COMPLETED|First Intervention||0||
48122645|NCT00961259|100626358|FG001|NOT COMPLETED|First Intervention||0||
48122646|NCT00961259|100626359|FG002|NOT COMPLETED|First Intervention||0||
48122647|NCT00961259|100626357|FG000|STARTED|Washout Period of 7 Days||18||
48122648|NCT00961259|100626358|FG001|STARTED|Washout Period of 7 Days||18||
48122649|NCT00961259|100626359|FG002|STARTED|Washout Period of 7 Days||18||
48122650|NCT00961259|100626357|FG000|COMPLETED|Washout Period of 7 Days||18||
48122651|NCT00961259|100626358|FG001|COMPLETED|Washout Period of 7 Days||17||
48122652|NCT00961259|100626359|FG002|COMPLETED|Washout Period of 7 Days||18||
48122653|NCT00961259|100626357|FG000|NOT COMPLETED|Washout Period of 7 Days||0||
48122654|NCT00961259|100626358|FG001|NOT COMPLETED|Washout Period of 7 Days||1||
48122655|NCT00961259|100626359|FG002|NOT COMPLETED|Washout Period of 7 Days||0||
48122656|NCT00961259|100626357|FG000|STARTED|Second Intervention||18||
48122657|NCT00961259|100626358|FG001|STARTED|Second Intervention||17||
48122658|NCT00961259|100626359|FG002|STARTED|Second Intervention||18||
48122659|NCT00961259|100626357|FG000|COMPLETED|Second Intervention||18||
48122660|NCT00961259|100626358|FG001|COMPLETED|Second Intervention||17||
48122661|NCT00961259|100626359|FG002|COMPLETED|Second Intervention||18||
48122662|NCT00961259|100626357|FG000|NOT COMPLETED|Second Intervention||0||
48122663|NCT00961259|100626358|FG001|NOT COMPLETED|Second Intervention||0||
48122664|NCT00961259|100626359|FG002|NOT COMPLETED|Second Intervention||0||
48122665|NCT00961259|100626357|FG000|STARTED|Washout Period of 7 Days||18||
48122666|NCT00961259|100626358|FG001|STARTED|Washout Period of 7 Days||17||
48122667|NCT00961259|100626359|FG002|STARTED|Washout Period of 7 Days||18||
48122668|NCT00961259|100626357|FG000|COMPLETED|Washout Period of 7 Days||18||
48122669|NCT00961259|100626358|FG001|COMPLETED|Washout Period of 7 Days||17||
48122670|NCT00961259|100626359|FG002|COMPLETED|Washout Period of 7 Days||18||
48122671|NCT00961259|100626357|FG000|NOT COMPLETED|Washout Period of 7 Days||0||
48569973|NCT02069041|101727720|FG000|NOT COMPLETED|Overall Study||0||
48122672|NCT00961259|100626358|FG001|NOT COMPLETED|Washout Period of 7 Days||0||
48122673|NCT00961259|100626359|FG002|NOT COMPLETED|Washout Period of 7 Days||0||
48122674|NCT00961259|100626357|FG000|STARTED|Third Intervention||18||
48122675|NCT00961259|100626358|FG001|STARTED|Third Intervention||17||
48122676|NCT00961259|100626359|FG002|STARTED|Third Intervention||18||
48122677|NCT00961259|100626357|FG000|COMPLETED|Third Intervention||18||
48122678|NCT00961259|100626358|FG001|COMPLETED|Third Intervention||17||
48122679|NCT00961259|100626359|FG002|COMPLETED|Third Intervention||18||
48122680|NCT00961259|100626357|FG000|NOT COMPLETED|Third Intervention||0||
48122681|NCT00961259|100626358|FG001|NOT COMPLETED|Third Intervention||0||
48122682|NCT00961259|100626359|FG002|NOT COMPLETED|Third Intervention||0||
48122683|NCT03762135|100626360|FG000|STARTED|Overall Study||52|Started represents 78 dyads (78 parents of 78 adolescents) who consented, downloaded the apps, and began participation.|
48122684|NCT03762135|100626361|FG001|STARTED|Overall Study||26|Started represents 78 dyads (78 parents of 78 adolescents) who consented, downloaded the apps, and began participation.|
48122685|NCT03762135|100626360|FG000|COMPLETED|Overall Study||52||
48122686|NCT03762135|100626361|FG001|COMPLETED|Overall Study||26||
48122687|NCT03762135|100626360|FG000|NOT COMPLETED|Overall Study||0||
48122688|NCT03762135|100626361|FG001|NOT COMPLETED|Overall Study||0||
48122689|NCT00382733|100626362|FG000|STARTED|Overall Study||3||
48122690|NCT00382733|100626363|FG001|STARTED|Overall Study||4||
48122691|NCT00382733|100626364|FG002|STARTED|Overall Study||3||
48122692|NCT00382733|100626365|FG003|STARTED|Overall Study||14||
48122693|NCT00382733|100626366|FG004|STARTED|Overall Study||2||
48569974|NCT00891020|101727721|FG000|STARTED|24 Week Treatment Period||163||
48569975|NCT00891020|101727722|FG001|STARTED|24 Week Treatment Period||363||
48569976|NCT00891020|101727723|FG002|STARTED|24 Week Treatment Period||360||
48569977|NCT00891020|101727721|FG000|Intent-to-Treat (ITT)|24 Week Treatment Period||163||
48569978|NCT00891020|101727722|FG001|Intent-to-Treat (ITT)|24 Week Treatment Period||362||
48569979|NCT00891020|101727723|FG002|Intent-to-Treat (ITT)|24 Week Treatment Period||358||
48569980|NCT00891020|101727721|FG000|Safety Set|24 Week Treatment Period||138||
48569981|NCT00891020|101727722|FG001|Safety Set|24 Week Treatment Period||364||
48569982|NCT00891020|101727723|FG002|Safety Set|24 Week Treatment Period||381||
48122694|NCT00382733|100626362|FG000|COMPLETED|Overall Study||3||
48122695|NCT00382733|100626363|FG001|COMPLETED|Overall Study||3||
48122696|NCT00382733|100626364|FG002|COMPLETED|Overall Study||3||
48122697|NCT00382733|100626365|FG003|COMPLETED|Overall Study||14||
48122698|NCT00382733|100626366|FG004|COMPLETED|Overall Study||2||
48122699|NCT00382733|100626362|FG000|NOT COMPLETED|Overall Study||0||
48122700|NCT00382733|100626363|FG001|NOT COMPLETED|Overall Study||1||
48122701|NCT00382733|100626364|FG002|NOT COMPLETED|Overall Study||0||
48122702|NCT00382733|100626365|FG003|NOT COMPLETED|Overall Study||0||
48122703|NCT00382733|100626366|FG004|NOT COMPLETED|Overall Study||0||
48592801|NCT01764997|101783183|FG001|NOT COMPLETED|Run-in Period||0||
48122704|NCT03003676|100626367|FG000|STARTED|Overall Study||9||
48122705|NCT03003676|100626368|FG001|STARTED|Overall Study||12||
48122706|NCT03003676|100626367|FG000|COMPLETED|Overall Study||3||
48122707|NCT03003676|100626368|FG001|COMPLETED|Overall Study||4||
48122708|NCT03003676|100626367|FG000|NOT COMPLETED|Overall Study||6||
48122709|NCT03003676|100626368|FG001|NOT COMPLETED|Overall Study||8||
48122710|NCT01177098|100626369|FG000|STARTED|Overall Study||278||
48122711|NCT01177098|100626370|FG001|STARTED|Overall Study||283||
48122712|NCT01177098|100626369|FG000|COMPLETED|Overall Study||269||
48122713|NCT01177098|100626370|FG001|COMPLETED|Overall Study||271||
48122714|NCT01177098|100626369|FG000|NOT COMPLETED|Overall Study||9||
48122715|NCT01177098|100626370|FG001|NOT COMPLETED|Overall Study||12||
48122716|NCT03096782|100626371|FG000|STARTED|Overall Study||6||
48122717|NCT03096782|100626371|FG000|COMPLETED|Overall Study||4||
48122718|NCT03096782|100626371|FG000|NOT COMPLETED|Overall Study||2||
48122719|NCT03097068|100626372|FG000|STARTED|Overall Study||10||
48122720|NCT03097068|100626372|FG000|COMPLETED|Overall Study||10||
48122721|NCT03097068|100626372|FG000|NOT COMPLETED|Overall Study||0||
48122722|NCT02453594|100626373|FG000|STARTED|Overall Study||69|Randomized|
48122723|NCT02453594|100626374|FG001|STARTED|Overall Study||81|Randomized|
48122724|NCT02453594|100626375|FG002|STARTED|Overall Study||61|Randomized|
48122725|NCT02453594|100626373|FG000|Treated|Overall Study||69||
48122726|NCT02453594|100626374|FG001|Treated|Overall Study||81||
48122727|NCT02453594|100626375|FG002|Treated|Overall Study||60||
48122728|NCT02453594|100626373|FG000|Second Course Pembrolizumab|Overall Study||10||
48122729|NCT02453594|100626374|FG001|Second Course Pembrolizumab|Overall Study||7||
48122730|NCT02453594|100626375|FG002|Second Course Pembrolizumab|Overall Study||3||
48122731|NCT02453594|100626373|FG000|COMPLETED|Overall Study||0||
48122732|NCT02453594|100626374|FG001|COMPLETED|Overall Study||0||
48122733|NCT02453594|100626375|FG002|COMPLETED|Overall Study||0||
48122734|NCT02453594|100626373|FG000|NOT COMPLETED|Overall Study||69||
48122735|NCT02453594|100626374|FG001|NOT COMPLETED|Overall Study||81||
48122736|NCT02453594|100626375|FG002|NOT COMPLETED|Overall Study||61||
48122737|NCT00530023|100626376|FG000|STARTED|Overall Study||14||
48122738|NCT00530023|100626377|FG001|STARTED|Overall Study||15||
48122739|NCT00530023|100626376|FG000|COMPLETED|Overall Study||14||
48122740|NCT00530023|100626377|FG001|COMPLETED|Overall Study||14||
48122741|NCT00530023|100626376|FG000|NOT COMPLETED|Overall Study||0||
48122742|NCT00530023|100626377|FG001|NOT COMPLETED|Overall Study||1||
48122743|NCT00633984|100626378|FG000|STARTED|Overall Study||87||
48122744|NCT00633984|100626379|FG001|STARTED|Overall Study||82||
48122745|NCT00633984|100626378|FG000|COMPLETED|Overall Study||78||
48122746|NCT00633984|100626379|FG001|COMPLETED|Overall Study||69||
48122747|NCT00633984|100626378|FG000|NOT COMPLETED|Overall Study||9||
48122748|NCT00633984|100626379|FG001|NOT COMPLETED|Overall Study||13||
48122749|NCT01732835|100626380|FG000|STARTED|6-month Primary Endpoint||68||
48122750|NCT01732835|100626380|FG000|COMPLETED|6-month Primary Endpoint||44||
48122751|NCT01732835|100626380|FG000|NOT COMPLETED|6-month Primary Endpoint||24||
48122752|NCT01732835|100626380|FG000|STARTED|2-year Extended Follow-up||44||
48122753|NCT01732835|100626380|FG000|COMPLETED|2-year Extended Follow-up||39||
48122754|NCT01732835|100626380|FG000|NOT COMPLETED|2-year Extended Follow-up||5||
48122755|NCT01268644|100626381|FG000|STARTED|Baseline Period (Week 0)||8||
48122756|NCT01268644|100626381|FG000|COMPLETED|Baseline Period (Week 0)||8||
48122757|NCT01268644|100626381|FG000|NOT COMPLETED|Baseline Period (Week 0)||0||
48122758|NCT01268644|100626381|FG000|STARTED|Phase A (Weeks 0-12) Leptin Therapy||8||
48122759|NCT01268644|100626381|FG000|COMPLETED|Phase A (Weeks 0-12) Leptin Therapy||8||
48122760|NCT01268644|100626381|FG000|NOT COMPLETED|Phase A (Weeks 0-12) Leptin Therapy||0||
48122761|NCT01268644|100626381|FG000|STARTED|Phase B (Weeks 12-20) Leptin Therapy||7||
48122762|NCT01268644|100626381|FG000|COMPLETED|Phase B (Weeks 12-20) Leptin Therapy||7||
48122763|NCT01268644|100626381|FG000|NOT COMPLETED|Phase B (Weeks 12-20) Leptin Therapy||0||
48122764|NCT01268644|100626381|FG000|STARTED|Phase C (Weeks 20-24) Off Leptin Therapy||7||
48122765|NCT01268644|100626381|FG000|COMPLETED|Phase C (Weeks 20-24) Off Leptin Therapy||7||
48122766|NCT01268644|100626381|FG000|NOT COMPLETED|Phase C (Weeks 20-24) Off Leptin Therapy||0||
48122767|NCT00854087|100626382|FG000|STARTED|Overall Study||59||
48122768|NCT00854087|100626383|FG001|STARTED|Overall Study||59||
48122769|NCT00854087|100626382|FG000|COMPLETED|Overall Study||40||
48122770|NCT00854087|100626383|FG001|COMPLETED|Overall Study||40||
48122771|NCT00854087|100626382|FG000|NOT COMPLETED|Overall Study||19||
48281946|NCT01901432|101014212|FG002|Received Study Drug|Overall Study||3||
48569983|NCT00891020|101727721|FG000|COMPLETED|24 Week Treatment Period||126||
48569984|NCT00891020|101727722|FG001|COMPLETED|24 Week Treatment Period||303||
48569985|NCT00891020|101727723|FG002|COMPLETED|24 Week Treatment Period||302||
48569986|NCT00891020|101727721|FG000|NOT COMPLETED|24 Week Treatment Period||37||
48569987|NCT00891020|101727722|FG001|NOT COMPLETED|24 Week Treatment Period||60||
48569988|NCT00891020|101727723|FG002|NOT COMPLETED|24 Week Treatment Period||58||
48569989|NCT00891020|101727721|FG000|STARTED|Long-term Extension Period||55||
48569990|NCT00891020|101727722|FG001|STARTED|Long-term Extension Period||196||
48569991|NCT00891020|101727723|FG002|STARTED|Long-term Extension Period||193||
48569992|NCT00891020|101727721|FG000|COMPLETED|Long-term Extension Period||49||
48569993|NCT00891020|101727722|FG001|COMPLETED|Long-term Extension Period||172||
48569994|NCT00891020|101727723|FG002|COMPLETED|Long-term Extension Period||170||
48569995|NCT00891020|101727721|FG000|NOT COMPLETED|Long-term Extension Period||6||
48569996|NCT00891020|101727722|FG001|NOT COMPLETED|Long-term Extension Period||24||
48569997|NCT00891020|101727723|FG002|NOT COMPLETED|Long-term Extension Period||23||
48569998|NCT05027451|101727724|FG000|STARTED|Overall Study||7||
48569999|NCT05027451|101727725|FG001|STARTED|Overall Study||2||
48570000|NCT05027451|101727724|FG000|COMPLETED|Overall Study||6||
48570001|NCT05027451|101727725|FG001|COMPLETED|Overall Study||1||
48570002|NCT05027451|101727724|FG000|NOT COMPLETED|Overall Study||1||
48570003|NCT05027451|101727725|FG001|NOT COMPLETED|Overall Study||1||
48570004|NCT03793842|101727726|FG000|STARTED|Randomization-Intervention 1 (~6 Hrs)||8|Randomized|
48122772|NCT00854087|100626383|FG001|NOT COMPLETED|Overall Study||19||
48122773|NCT00142909|100626384|FG000|STARTED|Randomization||42||
48122774|NCT00142909|100626385|FG001|STARTED|Randomization||44||
48122775|NCT00142909|100626384|FG000|COMPLETED|Randomization||35||
48122776|NCT00142909|100626385|FG001|COMPLETED|Randomization||34||
48122777|NCT00142909|100626384|FG000|NOT COMPLETED|Randomization||7||
48122778|NCT00142909|100626385|FG001|NOT COMPLETED|Randomization||10||
48122779|NCT00142909|100626384|FG000|STARTED|Medications Begin||35||
48122780|NCT00142909|100626385|FG001|STARTED|Medications Begin||34||
48122781|NCT00142909|100626384|FG000|COMPLETED|Medications Begin||26||
48122782|NCT00142909|100626385|FG001|COMPLETED|Medications Begin||31||
48122783|NCT00142909|100626384|FG000|NOT COMPLETED|Medications Begin||9||
48122784|NCT00142909|100626385|FG001|NOT COMPLETED|Medications Begin||3||
48122785|NCT02758236|100626386|FG000|STARTED|Overall Study||490||
48122786|NCT02758236|100626386|FG000|COMPLETED|Overall Study||447||
48122787|NCT02758236|100626386|FG000|NOT COMPLETED|Overall Study||43||
48122788|NCT01401530|100626387|FG000|STARTED|Overall Study||3||
48122789|NCT01401530|100626388|FG001|STARTED|Overall Study||7||
48122790|NCT01401530|100626389|FG002|STARTED|Overall Study||3||
48122791|NCT01401530|100626387|FG000|COMPLETED|Overall Study||0||
48122792|NCT01401530|100626388|FG001|COMPLETED|Overall Study||1||
48122793|NCT01401530|100626389|FG002|COMPLETED|Overall Study||0||
48122794|NCT01401530|100626387|FG000|NOT COMPLETED|Overall Study||3||
48122795|NCT01401530|100626388|FG001|NOT COMPLETED|Overall Study||6||
48122796|NCT01401530|100626389|FG002|NOT COMPLETED|Overall Study||3||
48122797|NCT01162005|100626390|FG000|STARTED|Overall Study||44||
48122798|NCT01162005|100626391|FG001|STARTED|Overall Study||33||
48122799|NCT01162005|100626390|FG000|COMPLETED|Overall Study||44||
48122800|NCT01162005|100626391|FG001|COMPLETED|Overall Study||33||
48122801|NCT01162005|100626390|FG000|NOT COMPLETED|Overall Study||0||
48122802|NCT01162005|100626391|FG001|NOT COMPLETED|Overall Study||0||
48122803|NCT01611259|100626392|FG000|STARTED|Overall Study||48||
48122804|NCT01611259|100626392|FG000|COMPLETED|Overall Study||34||
48122805|NCT01611259|100626392|FG000|NOT COMPLETED|Overall Study||14||
48122806|NCT01235910|100626393|FG000|STARTED|Overall Study||1||
48122807|NCT01235910|100626393|FG000|COMPLETED|Overall Study||1||
48122808|NCT01235910|100626393|FG000|NOT COMPLETED|Overall Study||0||
48122809|NCT00991302|100626394|FG000|STARTED|Overall Study||86||
48122810|NCT00991302|100626395|FG001|STARTED|Overall Study||86||
48122811|NCT00991302|100626394|FG000|COMPLETED|Overall Study||72||
48122812|NCT00991302|100626395|FG001|COMPLETED|Overall Study||73||
48122813|NCT00991302|100626394|FG000|NOT COMPLETED|Overall Study||14||
48122814|NCT00991302|100626395|FG001|NOT COMPLETED|Overall Study||13||
48122815|NCT00452335|100626396|FG000|STARTED|Overall Study||27||
48122816|NCT00452335|100626397|FG001|STARTED|Overall Study||65||
48122817|NCT00452335|100626398|FG002|STARTED|Overall Study||32||
48122818|NCT00452335|100626396|FG000|COMPLETED|Overall Study||25||
48122819|NCT00452335|100626397|FG001|COMPLETED|Overall Study||61||
48122820|NCT00452335|100626398|FG002|COMPLETED|Overall Study||23||
48122821|NCT00452335|100626396|FG000|NOT COMPLETED|Overall Study||2||
48122822|NCT00452335|100626397|FG001|NOT COMPLETED|Overall Study||4||
48122823|NCT00452335|100626398|FG002|NOT COMPLETED|Overall Study||9||
48122824|NCT02652780|100626399|FG000|STARTED|Overall Study||37||
48122825|NCT02652780|100626399|FG000|COMPLETED|Overall Study||37||
48122826|NCT02652780|100626399|FG000|NOT COMPLETED|Overall Study||0||
48122827|NCT02477020|100626400|FG000|STARTED|Overall Study||81||
48122828|NCT02477020|100626401|FG001|STARTED|Overall Study||83||
48122829|NCT02477020|100626400|FG000|COMPLETED|Overall Study||51||
48122830|NCT02477020|100626401|FG001|COMPLETED|Overall Study||55||
48122831|NCT02477020|100626400|FG000|NOT COMPLETED|Overall Study||30||
48122832|NCT02477020|100626401|FG001|NOT COMPLETED|Overall Study||28||
48122833|NCT03755765|100626402|FG000|STARTED|Overall Study||20||
48122834|NCT03755765|100626403|FG001|STARTED|Overall Study||42||
48122835|NCT03755765|100626404|FG002|STARTED|Overall Study||4||
48122836|NCT03755765|100626402|FG000|COMPLETED|Overall Study||18||
48122837|NCT03755765|100626403|FG001|COMPLETED|Overall Study||38||
48122838|NCT03755765|100626404|FG002|COMPLETED|Overall Study||0||
48122839|NCT03755765|100626402|FG000|NOT COMPLETED|Overall Study||2||
48122840|NCT03755765|100626403|FG001|NOT COMPLETED|Overall Study||4||
48122841|NCT03755765|100626404|FG002|NOT COMPLETED|Overall Study||4||
48122842|NCT00274716|100626405|FG000|STARTED|Phase A||54||
48122843|NCT00274716|100626406|FG001|STARTED|Phase A||54||
48122844|NCT00274716|100626407|FG002|STARTED|Phase A||52||
48122845|NCT00274716|100626408|FG003|STARTED|Phase A||51||
48122846|NCT00274716|100626409|FG004|STARTED|Phase A||19||
48122847|NCT00274716|100626410|FG005|STARTED|Phase A||19||
48122848|NCT00274716|100626405|FG000|COMPLETED|Phase A||43||
48122849|NCT00274716|100626406|FG001|COMPLETED|Phase A||44||
48122850|NCT00274716|100626407|FG002|COMPLETED|Phase A||44||
48122851|NCT00274716|100626408|FG003|COMPLETED|Phase A||42||
48122852|NCT00274716|100626409|FG004|COMPLETED|Phase A||16||
48122853|NCT00274716|100626410|FG005|COMPLETED|Phase A||15||
48122854|NCT00274716|100626405|FG000|NOT COMPLETED|Phase A||11||
48122855|NCT00274716|100626406|FG001|NOT COMPLETED|Phase A||10||
48122856|NCT00274716|100626407|FG002|NOT COMPLETED|Phase A||8||
48122857|NCT00274716|100626408|FG003|NOT COMPLETED|Phase A||9||
48122858|NCT00274716|100626409|FG004|NOT COMPLETED|Phase A||3||
48122859|NCT00274716|100626410|FG005|NOT COMPLETED|Phase A||4||
48122860|NCT00274716|100626405|FG000|STARTED|Phase B||43||
48122861|NCT00274716|100626406|FG001|STARTED|Phase B||44||
48122862|NCT00274716|100626407|FG002|STARTED|Phase B||44||
48122863|NCT00274716|100626408|FG003|STARTED|Phase B||42||
48122864|NCT00274716|100626409|FG004|STARTED|Phase B||16||
48122865|NCT00274716|100626410|FG005|STARTED|Phase B||15||
48122866|NCT00274716|100626405|FG000|COMPLETED|Phase B||42||
48122867|NCT00274716|100626406|FG001|COMPLETED|Phase B||40||
48122868|NCT00274716|100626407|FG002|COMPLETED|Phase B||41||
48122869|NCT00274716|100626408|FG003|COMPLETED|Phase B||41||
48122870|NCT00274716|100626409|FG004|COMPLETED|Phase B||16||
48122871|NCT00274716|100626410|FG005|COMPLETED|Phase B||14||
48122872|NCT00274716|100626405|FG000|NOT COMPLETED|Phase B||1||
48122873|NCT00274716|100626406|FG001|NOT COMPLETED|Phase B||4||
48122874|NCT00274716|100626407|FG002|NOT COMPLETED|Phase B||3||
48122875|NCT00274716|100626408|FG003|NOT COMPLETED|Phase B||1||
48122876|NCT00274716|100626409|FG004|NOT COMPLETED|Phase B||0||
48122877|NCT00274716|100626410|FG005|NOT COMPLETED|Phase B||1||
48122878|NCT01519518|100626411|FG000|STARTED|Overall Study||914||
48122879|NCT01519518|100626412|FG001|STARTED|Overall Study||915||
48122880|NCT01519518|100626411|FG000|COMPLETED|Overall Study||907||
48122881|NCT01519518|100626412|FG001|COMPLETED|Overall Study||905||
48122882|NCT01519518|100626411|FG000|NOT COMPLETED|Overall Study||7||
48122883|NCT01519518|100626412|FG001|NOT COMPLETED|Overall Study||10||
48122884|NCT04452344|100626413|FG000|STARTED|Overall Study||909||
48122885|NCT04452344|100626414|FG001|STARTED|Overall Study||906||
48122886|NCT04452344|100626413|FG000|COMPLETED|Overall Study||897||
48122887|NCT04452344|100626414|FG001|COMPLETED|Overall Study||889||
48122888|NCT04452344|100626413|FG000|NOT COMPLETED|Overall Study||12||
48122889|NCT04452344|100626414|FG001|NOT COMPLETED|Overall Study||17||
48122890|NCT01416805|100626415|FG000|STARTED|Overall Study||49||
48122891|NCT01416805|100626416|FG001|STARTED|Overall Study||51||
48122892|NCT01416805|100626415|FG000|COMPLETED|Overall Study||45||
48122893|NCT01416805|100626416|FG001|COMPLETED|Overall Study||47||
48122894|NCT01416805|100626415|FG000|NOT COMPLETED|Overall Study||4||
48122895|NCT01416805|100626416|FG001|NOT COMPLETED|Overall Study||4||
48122896|NCT01034397|100626417|FG000|STARTED|Overall Study||35||
48122897|NCT01034397|100626418|FG001|STARTED|Overall Study||19||
48122898|NCT01034397|100626417|FG000|COMPLETED|Overall Study||28||
48122899|NCT01034397|100626418|FG001|COMPLETED|Overall Study||17||
48122900|NCT01034397|100626417|FG000|NOT COMPLETED|Overall Study||7||
48122901|NCT01034397|100626418|FG001|NOT COMPLETED|Overall Study||2||
48122902|NCT04387162|100626419|FG000|STARTED|Overall Study||3||
48122903|NCT04387162|100626420|FG001|STARTED|Overall Study||2||
48122904|NCT04387162|100626419|FG000|COMPLETED|Overall Study||3||
48122905|NCT04387162|100626420|FG001|COMPLETED|Overall Study||2||
48122906|NCT04387162|100626419|FG000|NOT COMPLETED|Overall Study||0||
48122907|NCT04387162|100626420|FG001|NOT COMPLETED|Overall Study||0||
48122908|NCT00466193|100626421|FG000|STARTED|Overall Study||150||
48122909|NCT00466193|100626422|FG001|STARTED|Overall Study||145||
48122910|NCT00466193|100626421|FG000|COMPLETED|Overall Study||138||
48122911|NCT00466193|100626422|FG001|COMPLETED|Overall Study||137||
48122912|NCT00466193|100626421|FG000|NOT COMPLETED|Overall Study||12||
48122913|NCT00466193|100626422|FG001|NOT COMPLETED|Overall Study||8||
48122914|NCT01609556|100626423|FG000|STARTED|Dose Escalation: Maximum 101.3 Weeks||2||
48570005|NCT03793842|101727727|FG001|STARTED|Randomization-Intervention 1 (~6 Hrs)||8|Randomized|
48570006|NCT03793842|101727726|FG000|Intervention 1 Started|Randomization-Intervention 1 (~6 Hrs)||6||
48570007|NCT03793842|101727727|FG001|Intervention 1 Started|Randomization-Intervention 1 (~6 Hrs)||6||
48570008|NCT03793842|101727726|FG000|COMPLETED|Randomization-Intervention 1 (~6 Hrs)||6||
48570009|NCT03793842|101727727|FG001|COMPLETED|Randomization-Intervention 1 (~6 Hrs)||6||
48570010|NCT03793842|101727726|FG000|NOT COMPLETED|Randomization-Intervention 1 (~6 Hrs)||2||
48570011|NCT03793842|101727727|FG001|NOT COMPLETED|Randomization-Intervention 1 (~6 Hrs)||2||
48570012|NCT03793842|101727726|FG000|STARTED|Intervention 2 (14-18 Hours)||6||
48570013|NCT03793842|101727727|FG001|STARTED|Intervention 2 (14-18 Hours)||6||
48570014|NCT03793842|101727726|FG000|COMPLETED|Intervention 2 (14-18 Hours)||6||
48570015|NCT03793842|101727727|FG001|COMPLETED|Intervention 2 (14-18 Hours)||6||
48570016|NCT03793842|101727726|FG000|NOT COMPLETED|Intervention 2 (14-18 Hours)||0||
48570017|NCT03793842|101727727|FG001|NOT COMPLETED|Intervention 2 (14-18 Hours)||0||
48570018|NCT02875613|101727728|FG000|STARTED|Overall Study||6||
48699654|NCT01450696|102050568|FG001|STARTED|Overall Study||148||
48122915|NCT01609556|100626424|FG001|STARTED|Dose Escalation: Maximum 101.3 Weeks||1||
48122916|NCT01609556|100626425|FG002|STARTED|Dose Escalation: Maximum 101.3 Weeks||1||
48122917|NCT01609556|100626426|FG003|STARTED|Dose Escalation: Maximum 101.3 Weeks||1||
48122918|NCT01609556|100626427|FG004|STARTED|Dose Escalation: Maximum 101.3 Weeks||9||
48122919|NCT01609556|100626428|FG005|STARTED|Dose Escalation: Maximum 101.3 Weeks||18||
48122920|NCT01609556|100626429|FG006|STARTED|Dose Escalation: Maximum 101.3 Weeks||7||
48122921|NCT01609556|100626430|FG007|STARTED|Dose Escalation: Maximum 101.3 Weeks||5||
48122922|NCT01609556|100626431|FG008|STARTED|Dose Escalation: Maximum 101.3 Weeks||5||
48122923|NCT01609556|100626432|FG009|STARTED|Dose Escalation: Maximum 101.3 Weeks||4||
48122924|NCT01609556|100626433|FG010|STARTED|Dose Escalation: Maximum 101.3 Weeks||9||
48122925|NCT01609556|100626434|FG011|STARTED|Dose Escalation: Maximum 101.3 Weeks||7||
48122926|NCT01609556|100626435|FG012|STARTED|Dose Escalation: Maximum 101.3 Weeks||0||
48570019|NCT02875613|101727728|FG000|COMPLETED|Overall Study||4||
48699655|NCT01450696|102050567|FG000|Treated (Safety Population)|Overall Study||147||
48699656|NCT01450696|102050568|FG001|Treated (Safety Population)|Overall Study||147||
48122927|NCT01609556|100626436|FG013|STARTED|Dose Escalation: Maximum 101.3 Weeks||0||
48122928|NCT01609556|100626437|FG014|STARTED|Dose Escalation: Maximum 101.3 Weeks||0||
48122929|NCT01609556|100626438|FG015|STARTED|Dose Escalation: Maximum 101.3 Weeks||0||
48122930|NCT01609556|100626423|FG000|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||2||
48122931|NCT01609556|100626424|FG001|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||1||
48122932|NCT01609556|100626425|FG002|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||1||
48122933|NCT01609556|100626426|FG003|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||1||
48281947|NCT01901432|101014213|FG003|Received Study Drug|Overall Study||3||
48122934|NCT01609556|100626427|FG004|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||9||
48122935|NCT01609556|100626428|FG005|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||18||
48122936|NCT01609556|100626429|FG006|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||7||
48122937|NCT01609556|100626430|FG007|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||5||
48122938|NCT01609556|100626431|FG008|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||5||
48122939|NCT01609556|100626432|FG009|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||4||
48122940|NCT01609556|100626433|FG010|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||9||
48122941|NCT01609556|100626434|FG011|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||7||
48122942|NCT01609556|100626435|FG012|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0||
48122943|NCT01609556|100626436|FG013|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0||
48122944|NCT01609556|100626437|FG014|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0||
48122945|NCT01609556|100626438|FG015|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0||
48122946|NCT01609556|100626423|FG000|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
48122947|NCT01609556|100626424|FG001|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
48122948|NCT01609556|100626425|FG002|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
48122949|NCT01609556|100626426|FG003|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
48122950|NCT01609556|100626427|FG004|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
48122951|NCT01609556|100626428|FG005|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
48122952|NCT01609556|100626429|FG006|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
48122953|NCT01609556|100626430|FG007|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
48122954|NCT01609556|100626431|FG008|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
48122955|NCT01609556|100626432|FG009|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
48122956|NCT01609556|100626433|FG010|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
48122957|NCT01609556|100626434|FG011|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
48122958|NCT01609556|100626435|FG012|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
48122959|NCT01609556|100626436|FG013|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
48122960|NCT01609556|100626437|FG014|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
48122961|NCT01609556|100626438|FG015|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
48122962|NCT01609556|100626423|FG000|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||2||
48122963|NCT01609556|100626424|FG001|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||1||
48122964|NCT01609556|100626425|FG002|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||1||
48122965|NCT01609556|100626426|FG003|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||1||
48122966|NCT01609556|100626427|FG004|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||9||
48122967|NCT01609556|100626428|FG005|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||18||
48570020|NCT02875613|101727728|FG000|NOT COMPLETED|Overall Study||2||
48570021|NCT00789373|101727729|FG000|STARTED|Induction||939||
48570022|NCT00789373|101727730|FG001|STARTED|Induction||0||
48570023|NCT00789373|101727731|FG002|STARTED|Induction||0||
48570024|NCT00789373|101727729|FG000|COMPLETED|Induction||540||
48122968|NCT01609556|100626429|FG006|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||7||
48122969|NCT01609556|100626430|FG007|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||5||
48122970|NCT01609556|100626431|FG008|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||5||
48122971|NCT01609556|100626432|FG009|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||4||
48122972|NCT01609556|100626433|FG010|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||9||
48122973|NCT01609556|100626434|FG011|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||7||
48122974|NCT01609556|100626435|FG012|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
48122975|NCT01609556|100626436|FG013|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
48122976|NCT01609556|100626437|FG014|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
48122977|NCT01609556|100626438|FG015|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
48122978|NCT01609556|100626423|FG000|STARTED|Dose Expansion: Maximum 124 Weeks||0||
48122979|NCT01609556|100626424|FG001|STARTED|Dose Expansion: Maximum 124 Weeks||0||
48122980|NCT01609556|100626425|FG002|STARTED|Dose Expansion: Maximum 124 Weeks||0||
48122981|NCT01609556|100626426|FG003|STARTED|Dose Expansion: Maximum 124 Weeks||0||
48122982|NCT01609556|100626427|FG004|STARTED|Dose Expansion: Maximum 124 Weeks||0||
48122983|NCT01609556|100626428|FG005|STARTED|Dose Expansion: Maximum 124 Weeks||0||
48122984|NCT01609556|100626429|FG006|STARTED|Dose Expansion: Maximum 124 Weeks||0||
48122985|NCT01609556|100626430|FG007|STARTED|Dose Expansion: Maximum 124 Weeks||0||
48122986|NCT01609556|100626431|FG008|STARTED|Dose Expansion: Maximum 124 Weeks||0||
48122987|NCT01609556|100626432|FG009|STARTED|Dose Expansion: Maximum 124 Weeks||0||
48122988|NCT01609556|100626433|FG010|STARTED|Dose Expansion: Maximum 124 Weeks||0||
48122989|NCT01609556|100626434|FG011|STARTED|Dose Expansion: Maximum 124 Weeks||0||
48570025|NCT00789373|101727730|FG001|COMPLETED|Induction||0||
48570026|NCT00789373|101727731|FG002|COMPLETED|Induction||0||
48570027|NCT00789373|101727729|FG000|NOT COMPLETED|Induction||399||
48570028|NCT00789373|101727730|FG001|NOT COMPLETED|Induction||0||
48570029|NCT00789373|101727731|FG002|NOT COMPLETED|Induction||0||
48570030|NCT00789373|101727729|FG000|STARTED|Maintenance||0||
48570031|NCT00789373|101727730|FG001|STARTED|Maintenance||359||
48570032|NCT00789373|101727731|FG002|STARTED|Maintenance||180||
48122990|NCT01609556|100626435|FG012|STARTED|Dose Expansion: Maximum 124 Weeks||46||
48122991|NCT01609556|100626436|FG013|STARTED|Dose Expansion: Maximum 124 Weeks||24||
48122992|NCT01609556|100626437|FG014|STARTED|Dose Expansion: Maximum 124 Weeks||27||
48122993|NCT01609556|100626438|FG015|STARTED|Dose Expansion: Maximum 124 Weeks||40||
48122994|NCT01609556|100626423|FG000|COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
48122995|NCT01609556|100626424|FG001|COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
48122996|NCT01609556|100626425|FG002|COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
48122997|NCT01609556|100626426|FG003|COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
48122998|NCT01609556|100626427|FG004|COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
48122999|NCT01609556|100626428|FG005|COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
48123000|NCT01609556|100626429|FG006|COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
48123001|NCT01609556|100626430|FG007|COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
48123002|NCT01609556|100626431|FG008|COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
48123003|NCT01609556|100626432|FG009|COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
48123004|NCT01609556|100626433|FG010|COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
48123005|NCT01609556|100626434|FG011|COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
48123006|NCT01609556|100626435|FG012|COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
48123007|NCT01609556|100626436|FG013|COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
48123008|NCT01609556|100626437|FG014|COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
48123009|NCT01609556|100626438|FG015|COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
48123010|NCT01609556|100626423|FG000|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
48123011|NCT01609556|100626424|FG001|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
48123012|NCT01609556|100626425|FG002|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
48123013|NCT01609556|100626426|FG003|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
48123014|NCT01609556|100626427|FG004|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
48123015|NCT01609556|100626428|FG005|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
48123016|NCT01609556|100626429|FG006|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
48123017|NCT01609556|100626430|FG007|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
48123018|NCT01609556|100626431|FG008|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
48123019|NCT01609556|100626432|FG009|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
48123020|NCT01609556|100626433|FG010|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
48123021|NCT01609556|100626434|FG011|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
48123022|NCT01609556|100626435|FG012|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||46||
48123023|NCT01609556|100626436|FG013|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||24||
48123024|NCT01609556|100626437|FG014|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||27||
48123025|NCT01609556|100626438|FG015|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||40||
48123026|NCT01023659|100626439|FG000|STARTED|Overall Study||258||
48123027|NCT01023659|100626440|FG001|STARTED|Overall Study||365||
48123028|NCT01023659|100626441|FG002|STARTED|Overall Study||264||
48396775|NCT03911869|101302462|FG001|COMPLETED|Phase 2||0||
48396776|NCT03911869|101302463|FG002|COMPLETED|Phase 2||0||
48396777|NCT03911869|101302461|FG000|NOT COMPLETED|Phase 2||0||
48396778|NCT03911869|101302462|FG001|NOT COMPLETED|Phase 2||3||
48396779|NCT03911869|101302463|FG002|NOT COMPLETED|Phase 2||0||
48396780|NCT01002742|101302464|FG000|STARTED|Overall Study||119||
48123029|NCT01023659|100626439|FG000|COMPLETED|Overall Study||185||
48123030|NCT01023659|100626440|FG001|COMPLETED|Overall Study||137||
48123031|NCT01023659|100626441|FG002|COMPLETED|Overall Study||165||
48123032|NCT01023659|100626439|FG000|NOT COMPLETED|Overall Study||73||
48123033|NCT01023659|100626440|FG001|NOT COMPLETED|Overall Study||228||
48123034|NCT01023659|100626441|FG002|NOT COMPLETED|Overall Study||99||
48123035|NCT01696032|100626442|FG000|STARTED|Overall Study||14||
48123036|NCT01696032|100626443|FG001|STARTED|Overall Study||6||
48123037|NCT01696032|100626444|FG002|STARTED|Overall Study||51||
48123038|NCT01696032|100626445|FG003|STARTED|Overall Study||49||
48123039|NCT01696032|100626442|FG000|COMPLETED|Overall Study||0||
48123040|NCT01696032|100626443|FG001|COMPLETED|Overall Study||0||
48123041|NCT01696032|100626444|FG002|COMPLETED|Overall Study||0||
48123042|NCT01696032|100626445|FG003|COMPLETED|Overall Study||27||
48123043|NCT01696032|100626442|FG000|NOT COMPLETED|Overall Study||14||
48123044|NCT01696032|100626443|FG001|NOT COMPLETED|Overall Study||6||
48123045|NCT01696032|100626444|FG002|NOT COMPLETED|Overall Study||51||
48396781|NCT01002742|101302465|FG001|STARTED|Overall Study||117||
48396782|NCT01002742|101302464|FG000|COMPLETED|Overall Study||119||
48396783|NCT01002742|101302465|FG001|COMPLETED|Overall Study||116||
48396784|NCT01002742|101302464|FG000|NOT COMPLETED|Overall Study||0||
48396785|NCT01002742|101302465|FG001|NOT COMPLETED|Overall Study||1||
48396786|NCT00228943|101302466|FG000|STARTED|Week 1||28||
48396787|NCT00228943|101302466|FG000|COMPLETED|Week 1||28||
48396788|NCT00228943|101302466|FG000|NOT COMPLETED|Week 1||0||
48396789|NCT00228943|101302466|FG000|STARTED|Week 2||28||
48396790|NCT00228943|101302466|FG000|COMPLETED|Week 2||27||
48396791|NCT00228943|101302466|FG000|NOT COMPLETED|Week 2||1||
48396792|NCT01281189|101302467|FG000|STARTED|Overall Study||468||
48396793|NCT01281189|101302468|FG001|STARTED|Overall Study||474||
48396794|NCT01281189|101302467|FG000|COMPLETED|Overall Study||321||
48396795|NCT01281189|101302468|FG001|COMPLETED|Overall Study||331||
48396796|NCT01281189|101302467|FG000|NOT COMPLETED|Overall Study||147||
48396797|NCT01281189|101302468|FG001|NOT COMPLETED|Overall Study||143||
48123046|NCT01696032|100626445|FG003|NOT COMPLETED|Overall Study||22||
48123047|NCT00844545|100626446|FG000|STARTED|Screening Period||17||
48123048|NCT00844545|100626446|FG000|COMPLETED|Screening Period||17||
48123049|NCT00844545|100626446|FG000|NOT COMPLETED|Screening Period||0||
48123050|NCT00844545|100626446|FG000|STARTED|Treatment Period (26 Weeks)||17||
48123051|NCT00844545|100626446|FG000|COMPLETED|Treatment Period (26 Weeks)||15||
48123052|NCT00844545|100626446|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||2||
48123053|NCT00844545|100626446|FG000|STARTED|Extension Treatment Period||13||
48123054|NCT00844545|100626446|FG000|COMPLETED|Extension Treatment Period||11||
48396798|NCT00282867|101302469|FG000|STARTED|Overall Study||24||
48396799|NCT00282867|101302470|FG001|STARTED|Overall Study||25||
48396800|NCT00282867|101302471|FG002|STARTED|Overall Study||25||
48396801|NCT00282867|101302469|FG000|COMPLETED|Overall Study||23||
48396802|NCT00282867|101302470|FG001|COMPLETED|Overall Study||24||
48396803|NCT00282867|101302471|FG002|COMPLETED|Overall Study||25||
48396804|NCT00282867|101302469|FG000|NOT COMPLETED|Overall Study||1||
48396805|NCT00282867|101302470|FG001|NOT COMPLETED|Overall Study||1||
48396806|NCT00282867|101302471|FG002|NOT COMPLETED|Overall Study||0||
48396807|NCT01732107|101302472|FG000|STARTED|Overall Study||13||
48396808|NCT01732107|101302472|FG000|COMPLETED|Overall Study||0||
48396809|NCT01732107|101302472|FG000|NOT COMPLETED|Overall Study||13||
48396810|NCT01306032|101302473|FG000|STARTED|First Intervention||22||
48396811|NCT01306032|101302474|FG001|STARTED|First Intervention||20||
48396812|NCT01306032|101302475|FG002|STARTED|First Intervention||37||
48396813|NCT01306032|101302476|FG003|STARTED|First Intervention||38||
48396814|NCT01306032|101302477|FG004|STARTED|First Intervention||2||
48396815|NCT01306032|101302478|FG005|STARTED|First Intervention||2||
48396816|NCT01306032|101302473|FG000|COMPLETED|First Intervention||21||
48396817|NCT01306032|101302474|FG001|COMPLETED|First Intervention||18||
48396818|NCT01306032|101302475|FG002|COMPLETED|First Intervention||35||
48396819|NCT01306032|101302476|FG003|COMPLETED|First Intervention||37||
48396820|NCT01306032|101302477|FG004|COMPLETED|First Intervention||0||
48396821|NCT01306032|101302478|FG005|COMPLETED|First Intervention||0||
48396822|NCT01306032|101302473|FG000|NOT COMPLETED|First Intervention||1||
48396823|NCT01306032|101302474|FG001|NOT COMPLETED|First Intervention||2||
48396824|NCT01306032|101302475|FG002|NOT COMPLETED|First Intervention||2||
48396825|NCT01306032|101302476|FG003|NOT COMPLETED|First Intervention||1||
48396826|NCT01306032|101302477|FG004|NOT COMPLETED|First Intervention||2||
48396827|NCT01306032|101302478|FG005|NOT COMPLETED|First Intervention||2||
48396828|NCT01306032|101302473|FG000|STARTED|Disease Progression/Crossover||0||
48396829|NCT01306032|101302474|FG001|STARTED|Disease Progression/Crossover||16||
48396830|NCT01306032|101302475|FG002|STARTED|Disease Progression/Crossover||0||
48396831|NCT01306032|101302476|FG003|STARTED|Disease Progression/Crossover||29||
48396832|NCT01306032|101302477|FG004|STARTED|Disease Progression/Crossover||0||
48396833|NCT01306032|101302478|FG005|STARTED|Disease Progression/Crossover||0||
48396834|NCT01306032|101302473|FG000|COMPLETED|Disease Progression/Crossover||0||
48396835|NCT01306032|101302474|FG001|COMPLETED|Disease Progression/Crossover||14||
48396836|NCT01306032|101302475|FG002|COMPLETED|Disease Progression/Crossover||0||
48396837|NCT01306032|101302476|FG003|COMPLETED|Disease Progression/Crossover||26||
48396838|NCT01306032|101302477|FG004|COMPLETED|Disease Progression/Crossover||0||
48699657|NCT01450696|102050567|FG000|COMPLETED|Overall Study||0||
48699658|NCT01450696|102050568|FG001|COMPLETED|Overall Study||0||
48699659|NCT01450696|102050567|FG000|NOT COMPLETED|Overall Study||148||
48123055|NCT00844545|100626446|FG000|NOT COMPLETED|Extension Treatment Period||2||
48123056|NCT00844545|100626446|FG000|STARTED|Post Treatment Period||6||
48123057|NCT00844545|100626446|FG000|COMPLETED|Post Treatment Period||5||
48123058|NCT00844545|100626446|FG000|NOT COMPLETED|Post Treatment Period||1||
48123059|NCT03662750|100626447|FG000|STARTED|Overall Study||3||
48123060|NCT03662750|100626447|FG000|COMPLETED|Overall Study||2||
48123061|NCT03662750|100626447|FG000|NOT COMPLETED|Overall Study||1||
48123062|NCT02610192|100626448|FG000|STARTED|Overall Study||50||
48123063|NCT02610192|100626448|FG000|COMPLETED|Overall Study||41||
48123064|NCT02610192|100626448|FG000|NOT COMPLETED|Overall Study||9||
48123065|NCT04808609|100626449|FG000|STARTED|Overall Study||20||
48123066|NCT04808609|100626450|FG001|STARTED|Overall Study||20||
48123067|NCT04808609|100626449|FG000|COMPLETED|Overall Study||20||
48123068|NCT04808609|100626450|FG001|COMPLETED|Overall Study||17||
48396839|NCT01306032|101302478|FG005|COMPLETED|Disease Progression/Crossover||0||
48396840|NCT01306032|101302473|FG000|NOT COMPLETED|Disease Progression/Crossover||0||
48396841|NCT01306032|101302474|FG001|NOT COMPLETED|Disease Progression/Crossover||2||
48123069|NCT04808609|100626449|FG000|NOT COMPLETED|Overall Study||0||
48123070|NCT04808609|100626450|FG001|NOT COMPLETED|Overall Study||3||
48123071|NCT01968434|100626451|FG000|STARTED|Overall Study||78||
48123072|NCT01968434|100626452|FG001|STARTED|Overall Study||72||
48123073|NCT01968434|100626451|FG000|COMPLETED|Overall Study||75||
48396842|NCT01306032|101302475|FG002|NOT COMPLETED|Disease Progression/Crossover||0||
48396843|NCT01306032|101302476|FG003|NOT COMPLETED|Disease Progression/Crossover||3||
48396844|NCT01306032|101302477|FG004|NOT COMPLETED|Disease Progression/Crossover||0||
48396845|NCT01306032|101302478|FG005|NOT COMPLETED|Disease Progression/Crossover||0||
48123074|NCT01968434|100626452|FG001|COMPLETED|Overall Study||66||
48123075|NCT01968434|100626451|FG000|NOT COMPLETED|Overall Study||3||
48123076|NCT01968434|100626452|FG001|NOT COMPLETED|Overall Study||6||
48281948|NCT01901432|101014214|FG004|Received Study Drug|Overall Study||35||
48281949|NCT01901432|101014210|FG000|COMPLETED|Overall Study||3||
48281950|NCT01901432|101014211|FG001|COMPLETED|Overall Study||2||
48281951|NCT01901432|101014212|FG002|COMPLETED|Overall Study||1||
48281952|NCT01901432|101014213|FG003|COMPLETED|Overall Study||3||
48281953|NCT01901432|101014214|FG004|COMPLETED|Overall Study||27||
48281954|NCT01901432|101014210|FG000|NOT COMPLETED|Overall Study||0||
48281955|NCT01901432|101014211|FG001|NOT COMPLETED|Overall Study||1||
48281956|NCT01901432|101014212|FG002|NOT COMPLETED|Overall Study||2||
48281957|NCT01901432|101014213|FG003|NOT COMPLETED|Overall Study||0||
48281958|NCT01901432|101014214|FG004|NOT COMPLETED|Overall Study||9||
48281959|NCT01125514|101014215|FG000|STARTED|Treatment Period 1 (Day 1 - Day 7)||37||
48281960|NCT01125514|101014215|FG000|COMPLETED|Treatment Period 1 (Day 1 - Day 7)||35||
48281961|NCT01125514|101014215|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 - Day 7)||2||
48281962|NCT01125514|101014215|FG000|STARTED|Treatment Period 2 (Day 8 - Day 17)||35||
48281963|NCT01125514|101014215|FG000|Pharmacokinetic (PK) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33||
48281964|NCT01125514|101014215|FG000|Pharmacodynamics (PD) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33||
48281965|NCT01125514|101014215|FG000|COMPLETED|Treatment Period 2 (Day 8 - Day 17)||32||
48281966|NCT01125514|101014215|FG000|NOT COMPLETED|Treatment Period 2 (Day 8 - Day 17)||3||
48281967|NCT01125514|101014215|FG000|STARTED|Treatment Period2(Day9-Day27) and Day 28||32||
48281968|NCT01125514|101014215|FG000|COMPLETED|Treatment Period2(Day9-Day27) and Day 28||28||
48281969|NCT01125514|101014215|FG000|NOT COMPLETED|Treatment Period2(Day9-Day27) and Day 28||4||
48281970|NCT05593445|101014216|FG000|STARTED|12-Week DBVC Period||31||
48281971|NCT05593445|101014217|FG001|STARTED|12-Week DBVC Period||30||
48281972|NCT05593445|101014218|FG002|STARTED|12-Week DBVC Period||0||
48281973|NCT05593445|101014219|FG003|STARTED|12-Week DBVC Period||0||
48281974|NCT05593445|101014216|FG000|COMPLETED|12-Week DBVC Period||29||
48281975|NCT05593445|101014217|FG001|COMPLETED|12-Week DBVC Period||27||
48281976|NCT05593445|101014218|FG002|COMPLETED|12-Week DBVC Period||0||
48281977|NCT05593445|101014219|FG003|COMPLETED|12-Week DBVC Period||0||
48281978|NCT05593445|101014216|FG000|NOT COMPLETED|12-Week DBVC Period||2||
48281979|NCT05593445|101014217|FG001|NOT COMPLETED|12-Week DBVC Period||3||
48281980|NCT05593445|101014218|FG002|NOT COMPLETED|12-Week DBVC Period||0||
48281981|NCT05593445|101014219|FG003|NOT COMPLETED|12-Week DBVC Period||0||
48281982|NCT05593445|101014216|FG000|STARTED|12-Week Open-Label Extension Period||0||
48281983|NCT05593445|101014217|FG001|STARTED|12-Week Open-Label Extension Period||0||
48281984|NCT05593445|101014218|FG002|STARTED|12-Week Open-Label Extension Period||29||
48281985|NCT05593445|101014219|FG003|STARTED|12-Week Open-Label Extension Period||27||
48281986|NCT05593445|101014216|FG000|COMPLETED|12-Week Open-Label Extension Period||0||
48281987|NCT05593445|101014217|FG001|COMPLETED|12-Week Open-Label Extension Period||0||
48281988|NCT05593445|101014218|FG002|COMPLETED|12-Week Open-Label Extension Period||26||
48281989|NCT05593445|101014219|FG003|COMPLETED|12-Week Open-Label Extension Period||25||
48281990|NCT05593445|101014216|FG000|NOT COMPLETED|12-Week Open-Label Extension Period||0||
48281991|NCT05593445|101014217|FG001|NOT COMPLETED|12-Week Open-Label Extension Period||0||
48281992|NCT05593445|101014218|FG002|NOT COMPLETED|12-Week Open-Label Extension Period||3||
48281993|NCT05593445|101014219|FG003|NOT COMPLETED|12-Week Open-Label Extension Period||2||
48123077|NCT00699699|100626453|FG000|STARTED|Overall Study||1280||
48123078|NCT00699699|100626453|FG000|COMPLETED|Overall Study||1223||
48123079|NCT00699699|100626453|FG000|NOT COMPLETED|Overall Study||57||
48123080|NCT01144338|100626454|FG000|STARTED|Overall Study||7396||
48123081|NCT01144338|100626455|FG001|STARTED|Overall Study||7356||
48123082|NCT01144338|100626454|FG000|COMPLETED|Overall Study||7093||
48123083|NCT01144338|100626455|FG001|COMPLETED|Overall Study||7094||
48123084|NCT01144338|100626454|FG000|NOT COMPLETED|Overall Study||303||
48281994|NCT02551718|101014220|FG000|STARTED|Overall Study||34||
48281995|NCT02551718|101014220|FG000|COMPLETED|Overall Study||34||
48281996|NCT02551718|101014220|FG000|NOT COMPLETED|Overall Study||0||
48281997|NCT03230877|101014221|FG000|STARTED|Visit 1||23||
48281998|NCT03230877|101014222|FG001|STARTED|Visit 1||15||
48281999|NCT03230877|101014221|FG000|COMPLETED|Visit 1||23||
48282000|NCT03230877|101014222|FG001|COMPLETED|Visit 1||15||
48282001|NCT03230877|101014221|FG000|NOT COMPLETED|Visit 1||0||
48282002|NCT03230877|101014222|FG001|NOT COMPLETED|Visit 1||0||
48282003|NCT03230877|101014221|FG000|STARTED|Visit 2||23||
48570033|NCT00789373|101727729|FG000|COMPLETED|Maintenance||0||
48570034|NCT00789373|101727730|FG001|COMPLETED|Maintenance||0||
48570035|NCT00789373|101727731|FG002|COMPLETED|Maintenance||0||
48570036|NCT00789373|101727729|FG000|NOT COMPLETED|Maintenance||0||
48570037|NCT00789373|101727730|FG001|NOT COMPLETED|Maintenance||359||
48570038|NCT00789373|101727731|FG002|NOT COMPLETED|Maintenance||180||
48570039|NCT03168711|101727732|FG000|STARTED|Overall Study||14||
48570040|NCT03168711|101727733|FG001|STARTED|Overall Study||9||
48570041|NCT03168711|101727732|FG000|COMPLETED|Overall Study||12||
48570042|NCT03168711|101727733|FG001|COMPLETED|Overall Study||7||
48570043|NCT03168711|101727732|FG000|NOT COMPLETED|Overall Study||2||
48570044|NCT03168711|101727733|FG001|NOT COMPLETED|Overall Study||2||
48282004|NCT03230877|101014222|FG001|STARTED|Visit 2||15||
48282005|NCT03230877|101014221|FG000|COMPLETED|Visit 2||23||
48123085|NCT01144338|100626455|FG001|NOT COMPLETED|Overall Study||262||
48123086|NCT02708745|100626456|FG000|STARTED|Overall Study||91||
48123087|NCT02708745|100626457|FG001|STARTED|Overall Study||69||
48123088|NCT02708745|100626458|FG002|STARTED|Overall Study||204||
48123089|NCT02708745|100626459|FG003|STARTED|Overall Study||198||
48123090|NCT02708745|100626456|FG000|COMPLETED|Overall Study||91||
48123091|NCT02708745|100626457|FG001|COMPLETED|Overall Study||65||
48570045|NCT00550043|101727734|FG000|STARTED|Overall Study||9||
48570046|NCT00550043|101727735|FG001|STARTED|Overall Study||12||
48570047|NCT00550043|101727736|FG002|STARTED|Overall Study||9||
48570048|NCT00550043|101727737|FG003|STARTED|Overall Study||10||
48570049|NCT00550043|101727738|FG004|STARTED|Overall Study||10||
48570050|NCT00550043|101727734|FG000|COMPLETED|Overall Study||9||
48570051|NCT00550043|101727735|FG001|COMPLETED|Overall Study||9||
48123092|NCT02708745|100626458|FG002|COMPLETED|Overall Study||121||
48123093|NCT02708745|100626459|FG003|COMPLETED|Overall Study||116||
48123094|NCT02708745|100626456|FG000|NOT COMPLETED|Overall Study||0||
48123095|NCT02708745|100626457|FG001|NOT COMPLETED|Overall Study||4||
48123096|NCT02708745|100626458|FG002|NOT COMPLETED|Overall Study||83||
48123097|NCT02708745|100626459|FG003|NOT COMPLETED|Overall Study||82||
48123098|NCT02664038|100626460|FG000|STARTED|13 Week||29||
48123099|NCT02664038|100626461|FG001|STARTED|13 Week||30||
48123100|NCT02664038|100626460|FG000|COMPLETED|13 Week||21||
48123101|NCT02664038|100626461|FG001|COMPLETED|13 Week||16||
48123102|NCT02664038|100626460|FG000|NOT COMPLETED|13 Week||8||
48123103|NCT02664038|100626461|FG001|NOT COMPLETED|13 Week||14||
48123104|NCT02664038|100626460|FG000|STARTED|26 Week||21||
48123105|NCT02664038|100626461|FG001|STARTED|26 Week||16||
48123106|NCT02664038|100626460|FG000|COMPLETED|26 Week||16||
48123107|NCT02664038|100626461|FG001|COMPLETED|26 Week||12||
48123108|NCT02664038|100626460|FG000|NOT COMPLETED|26 Week||5||
48123109|NCT02664038|100626461|FG001|NOT COMPLETED|26 Week||4||
48123110|NCT01744730|100626462|FG000|STARTED|Overall Study||4||
48123111|NCT01744730|100626463|FG001|STARTED|Overall Study||3||
48123112|NCT01744730|100626464|FG002|STARTED|Overall Study||4||
48123113|NCT01744730|100626465|FG003|STARTED|Overall Study||11||
48123114|NCT01744730|100626466|FG004|STARTED|Overall Study||178||
48123115|NCT01744730|100626462|FG000|COMPLETED|Overall Study||4||
48123116|NCT01744730|100626463|FG001|COMPLETED|Overall Study||3||
48123117|NCT01744730|100626464|FG002|COMPLETED|Overall Study||4||
48123118|NCT01744730|100626465|FG003|COMPLETED|Overall Study||11||
48123119|NCT01744730|100626466|FG004|COMPLETED|Overall Study||178||
48570052|NCT00550043|101727736|FG002|COMPLETED|Overall Study||8||
48570053|NCT00550043|101727737|FG003|COMPLETED|Overall Study||8||
48570054|NCT00550043|101727738|FG004|COMPLETED|Overall Study||9||
48570055|NCT00550043|101727734|FG000|NOT COMPLETED|Overall Study||0||
48570056|NCT00550043|101727735|FG001|NOT COMPLETED|Overall Study||3||
48570057|NCT00550043|101727736|FG002|NOT COMPLETED|Overall Study||1||
48570058|NCT00550043|101727737|FG003|NOT COMPLETED|Overall Study||2||
48123120|NCT01744730|100626462|FG000|NOT COMPLETED|Overall Study||0||
48570059|NCT00550043|101727738|FG004|NOT COMPLETED|Overall Study||1||
48570060|NCT01168232|101727739|FG000|STARTED|Overall Study||42||
48570061|NCT01168232|101727739|FG000|COMPLETED|Overall Study||34||
48570062|NCT01168232|101727739|FG000|NOT COMPLETED|Overall Study||8||
48123121|NCT01744730|100626463|FG001|NOT COMPLETED|Overall Study||0||
48123122|NCT01744730|100626464|FG002|NOT COMPLETED|Overall Study||0||
48123123|NCT01744730|100626465|FG003|NOT COMPLETED|Overall Study||0||
48123124|NCT01744730|100626466|FG004|NOT COMPLETED|Overall Study||0||
48123125|NCT02778204|100626467|FG000|STARTED|Overall Study||8||
48123126|NCT02778204|100626468|FG001|STARTED|Overall Study||7||
48123127|NCT02778204|100626469|FG002|STARTED|Overall Study||16||
48570063|NCT02556775|101727740|FG000|STARTED|Overall Study||7||
48570064|NCT02556775|101727741|FG001|STARTED|Overall Study||2||
48699660|NCT01450696|102050568|FG001|NOT COMPLETED|Overall Study||148||
48699661|NCT02516098|102050569|FG000|STARTED|Period 1||28||
48699662|NCT02516098|102050570|FG001|STARTED|Period 1||28||
48699663|NCT02516098|102050569|FG000|COMPLETED|Period 1||27||
48699664|NCT02516098|102050570|FG001|COMPLETED|Period 1||28||
48699665|NCT02516098|102050569|FG000|NOT COMPLETED|Period 1||1||
48699666|NCT02516098|102050570|FG001|NOT COMPLETED|Period 1||0||
48699667|NCT02516098|102050569|FG000|STARTED|Washout After Period 1||27||
48699668|NCT02516098|102050570|FG001|STARTED|Washout After Period 1||28||
48699669|NCT02516098|102050569|FG000|COMPLETED|Washout After Period 1||27||
48123128|NCT02778204|100626470|FG003|STARTED|Overall Study||16||
48123129|NCT02778204|100626467|FG000|COMPLETED|Overall Study||6||
48123130|NCT02778204|100626468|FG001|COMPLETED|Overall Study||7||
48570065|NCT02556775|101727742|FG002|STARTED|Overall Study||5||
48570066|NCT02556775|101727743|FG003|STARTED|Overall Study||2||
48699670|NCT02516098|102050570|FG001|COMPLETED|Washout After Period 1||27||
48699671|NCT02516098|102050569|FG000|NOT COMPLETED|Washout After Period 1||0||
48699672|NCT02516098|102050570|FG001|NOT COMPLETED|Washout After Period 1||1||
48699673|NCT02516098|102050569|FG000|STARTED|Period 2||27||
48699674|NCT02516098|102050570|FG001|STARTED|Period 2||27||
48570067|NCT02556775|101727740|FG000|COMPLETED|Overall Study||5||
48570068|NCT02556775|101727741|FG001|COMPLETED|Overall Study||2||
48570069|NCT02556775|101727742|FG002|COMPLETED|Overall Study||4||
48570070|NCT02556775|101727743|FG003|COMPLETED|Overall Study||2||
48570071|NCT02556775|101727740|FG000|NOT COMPLETED|Overall Study||2||
48699675|NCT02516098|102050569|FG000|COMPLETED|Period 2||27||
48699676|NCT02516098|102050570|FG001|COMPLETED|Period 2||26||
48699677|NCT02516098|102050569|FG000|NOT COMPLETED|Period 2||0||
48699678|NCT02516098|102050570|FG001|NOT COMPLETED|Period 2||1||
48699679|NCT02516098|102050569|FG000|STARTED|Washout After Period 2||27||
48699680|NCT02516098|102050570|FG001|STARTED|Washout After Period 2||26||
48699681|NCT02516098|102050569|FG000|COMPLETED|Washout After Period 2||27||
48699682|NCT02516098|102050570|FG001|COMPLETED|Washout After Period 2||26||
48123131|NCT02778204|100626469|FG002|COMPLETED|Overall Study||12||
48570072|NCT02556775|101727741|FG001|NOT COMPLETED|Overall Study||0||
48570073|NCT02556775|101727742|FG002|NOT COMPLETED|Overall Study||1||
48570074|NCT02556775|101727743|FG003|NOT COMPLETED|Overall Study||0||
48570075|NCT00471822|101727744|FG000|STARTED|Overall Study||9707||
48570076|NCT00471822|101727744|FG000|Treated|Overall Study||9705||
48570077|NCT00471822|101727744|FG000|COMPLETED|Overall Study||9705||
48570078|NCT00471822|101727744|FG000|NOT COMPLETED|Overall Study||2||
48570079|NCT01067781|101727745|FG000|STARTED|Up to Day 180||203||
48570080|NCT01067781|101727746|FG001|STARTED|Up to Day 180||199||
48699683|NCT02516098|102050569|FG000|NOT COMPLETED|Washout After Period 2||0||
48699684|NCT02516098|102050570|FG001|NOT COMPLETED|Washout After Period 2||0||
48699685|NCT04187144|102050571|FG000|STARTED|Overall Study||805|Participants randomly assigned to the study treatment were included in Intent-to-Treat (ITT) population|
48699686|NCT04187144|102050572|FG001|STARTED|Overall Study||800|Participants randomly assigned to the study treatment were included in Intent-to-Treat (ITT) population|
48699687|NCT04187144|102050571|FG000|Safety Population|Overall Study||804|Safety population included all randomized participants who receive at least 1 dose of study treatment.|
48699688|NCT04187144|102050572|FG001|Safety Population|Overall Study||798|Safety population included all randomized participants who receive at least 1 dose of study treatment.|
48699689|NCT04187144|102050571|FG000|Microbiological ITT (Micro ITT) Population|Overall Study||331|Microbiological ITT (micro-ITT) population included all participants randomly assigned to study treatment who receive at least 1 dose of study treatment and have a qualifying baseline uropathogen \[10\^5 CFU/mL\] from a quantitative bacteriological culture of a pretreatment clean catch midstream urine specimen.|
48699690|NCT04187144|102050572|FG001|Microbiological ITT (Micro ITT) Population|Overall Study||324|Microbiological ITT (micro-ITT) population included all participants randomly assigned to study treatment who receive at least 1 dose of study treatment and have a qualifying baseline uropathogen \[10\^5 CFU/mL\] from a quantitative bacteriological culture of a pretreatment clean catch midstream urine specimen.|
48699691|NCT04187144|102050571|FG000|Micro-ITT NTF-S Population|Overall Study||292|Micro-ITT NTF-S population is defined as all participants in the micro-ITT population whose baseline qualifying uropathogens \[10\^5 CFU/mL\] are all susceptible to nitrofurantoin (NTF-S).|
48699692|NCT04187144|102050572|FG001|Micro-ITT NTF-S Population|Overall Study||275|Micro-ITT NTF-S population is defined as all participants in the micro-ITT population whose baseline qualifying uropathogens \[10\^5 CFU/mL\] are all susceptible to nitrofurantoin (NTF-S).|
48699693|NCT04187144|102050571|FG000|Micro-ITT NTF-S (IA Set) Population|Overall Study||277|Microbiological intent-to-treat susceptible to nitrofurantoin (micro-ITT NTF-S) (IA Set) population included participants in the micro ITT NTF-S who per the interim analysis data had the opportunity to reach their Test of Cure (TOC) visit, or had not yet reached their TOC visit, but were already known to be failures.|
48699694|NCT04187144|102050572|FG001|Micro-ITT NTF-S (IA Set) Population|Overall Study||264|Microbiological intent-to-treat susceptible to nitrofurantoin (micro-ITT NTF-S) (IA Set) population included participants in the micro ITT NTF-S who per the interim analysis data had the opportunity to reach their Test of Cure (TOC) visit, or had not yet reached their TOC visit, but were already known to be failures.|
48699695|NCT04187144|102050571|FG000|COMPLETED|Overall Study||748||
48699696|NCT04187144|102050572|FG001|COMPLETED|Overall Study||759||
48699697|NCT04187144|102050571|FG000|NOT COMPLETED|Overall Study||57||
48699698|NCT04187144|102050572|FG001|NOT COMPLETED|Overall Study||41||
48123132|NCT02778204|100626470|FG003|COMPLETED|Overall Study||12||
48123133|NCT02778204|100626467|FG000|NOT COMPLETED|Overall Study||2||
48570081|NCT01067781|101727747|FG002|STARTED|Up to Day 180||97||
48570082|NCT01067781|101727748|FG003|STARTED|Up to Day 180||101||
48570083|NCT01067781|101727745|FG000|COMPLETED|Up to Day 180||173||
48123134|NCT02778204|100626468|FG001|NOT COMPLETED|Overall Study||0||
48123135|NCT02778204|100626469|FG002|NOT COMPLETED|Overall Study||4||
48123136|NCT02778204|100626470|FG003|NOT COMPLETED|Overall Study||4||
48123137|NCT01310413|100626471|FG000|STARTED|Day 0 to Day 385||199||
48570084|NCT01067781|101727746|FG001|COMPLETED|Up to Day 180||168||
48570085|NCT01067781|101727747|FG002|COMPLETED|Up to Day 180||89||
48570086|NCT01067781|101727748|FG003|COMPLETED|Up to Day 180||89||
48570087|NCT01067781|101727745|FG000|NOT COMPLETED|Up to Day 180||30||
48570088|NCT01067781|101727746|FG001|NOT COMPLETED|Up to Day 180||31||
48570089|NCT01067781|101727747|FG002|NOT COMPLETED|Up to Day 180||8||
48570090|NCT01067781|101727748|FG003|NOT COMPLETED|Up to Day 180||12||
48570091|NCT01067781|101727745|FG000|STARTED|180 to Day 720||173||
48570092|NCT01067781|101727746|FG001|STARTED|180 to Day 720||168||
48570093|NCT01067781|101727747|FG002|STARTED|180 to Day 720||89||
48570094|NCT01067781|101727748|FG003|STARTED|180 to Day 720||89||
48570095|NCT01067781|101727745|FG000|COMPLETED|180 to Day 720||3||
48570096|NCT01067781|101727746|FG001|COMPLETED|180 to Day 720||4||
48570097|NCT01067781|101727747|FG002|COMPLETED|180 to Day 720||0||
48123138|NCT01310413|100626472|FG001|STARTED|Day 0 to Day 385||198||
48123139|NCT01310413|100626473|FG002|STARTED|Day 0 to Day 385||210||
48123140|NCT01310413|100626474|FG003|STARTED|Day 0 to Day 385||75||
48123141|NCT01310413|100626475|FG004|STARTED|Day 0 to Day 385||76||
48570098|NCT01067781|101727748|FG003|COMPLETED|180 to Day 720||0||
48570099|NCT01067781|101727745|FG000|NOT COMPLETED|180 to Day 720||170||
48570100|NCT01067781|101727746|FG001|NOT COMPLETED|180 to Day 720||164||
48570101|NCT01067781|101727747|FG002|NOT COMPLETED|180 to Day 720||89||
48570102|NCT01067781|101727748|FG003|NOT COMPLETED|180 to Day 720||89||
48570103|NCT01450306|101727749|FG000|STARTED|Overall Study||10||
48570104|NCT01450306|101727750|FG001|STARTED|Overall Study||10||
48570105|NCT01450306|101727749|FG000|COMPLETED|Overall Study||10||
48396846|NCT01296698|101302479|FG000|STARTED|Overall Study||244||
48396847|NCT01296698|101302480|FG001|STARTED|Overall Study||13||
48396848|NCT01296698|101302479|FG000|COMPLETED|Overall Study||0||
48396849|NCT01296698|101302480|FG001|COMPLETED|Overall Study||0||
48396850|NCT01296698|101302479|FG000|NOT COMPLETED|Overall Study||244||
48396851|NCT01296698|101302480|FG001|NOT COMPLETED|Overall Study||13||
48396852|NCT03351478|101302481|FG000|STARTED|Overall Study||307||
48396853|NCT03351478|101302482|FG001|STARTED|Overall Study||309||
48396854|NCT03351478|101302483|FG002|STARTED|Overall Study||154||
48396855|NCT03351478|101302481|FG000|COMPLETED|Overall Study||293||
48396856|NCT03351478|101302482|FG001|COMPLETED|Overall Study||292||
48396857|NCT03351478|101302483|FG002|COMPLETED|Overall Study||147||
48396858|NCT03351478|101302481|FG000|NOT COMPLETED|Overall Study||14||
48396859|NCT03351478|101302482|FG001|NOT COMPLETED|Overall Study||17||
48396860|NCT03351478|101302483|FG002|NOT COMPLETED|Overall Study||7||
48396861|NCT00721617|101302484|FG000|STARTED|0 Hour (Baseline) of Saline Infusion||12||
48396862|NCT00721617|101302484|FG000|COMPLETED|0 Hour (Baseline) of Saline Infusion||12||
48396863|NCT00721617|101302484|FG000|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0||
48396864|NCT00721617|101302484|FG000|STARTED|4 Hours Into Saline Infusion||12||
48396865|NCT00721617|101302484|FG000|COMPLETED|4 Hours Into Saline Infusion||12||
48396866|NCT00721617|101302484|FG000|NOT COMPLETED|4 Hours Into Saline Infusion||0||
48396867|NCT00721617|101302484|FG000|STARTED|8 Hours Into Saline Infusion||12||
48396868|NCT00721617|101302484|FG000|COMPLETED|8 Hours Into Saline Infusion||12||
48396869|NCT00721617|101302484|FG000|NOT COMPLETED|8 Hours Into Saline Infusion||0||
48396870|NCT00721617|101302484|FG000|STARTED|0 Hour (Baseline) of Intralipid Infusion||12||
48396871|NCT00721617|101302484|FG000|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12||
48396872|NCT00721617|101302484|FG000|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0||
48396873|NCT00721617|101302484|FG000|STARTED|4 Hours Into Intralipid Infusion||12||
48396874|NCT00721617|101302484|FG000|COMPLETED|4 Hours Into Intralipid Infusion||12||
48396875|NCT00721617|101302484|FG000|NOT COMPLETED|4 Hours Into Intralipid Infusion||0||
48396876|NCT00721617|101302484|FG000|STARTED|8 Hours Into Intralipid Infusion||12||
48396877|NCT00721617|101302484|FG000|COMPLETED|8 Hours Into Intralipid Infusion||12||
48396878|NCT00721617|101302484|FG000|NOT COMPLETED|8 Hours Into Intralipid Infusion||0||
48396879|NCT00721617|101302484|FG000|STARTED|0 Hour (Baseline) of Dextrose Infusion||12||
48570106|NCT01450306|101727750|FG001|COMPLETED|Overall Study||10||
48570107|NCT01450306|101727749|FG000|NOT COMPLETED|Overall Study||0||
48570108|NCT01450306|101727750|FG001|NOT COMPLETED|Overall Study||0||
48570109|NCT01072773|101727751|FG000|STARTED|Overall Study||2||
48570110|NCT01072773|101727751|FG000|COMPLETED|Overall Study||2||
48396880|NCT00721617|101302484|FG000|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12||
48396881|NCT00721617|101302484|FG000|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0||
48396882|NCT00721617|101302484|FG000|STARTED|4 Hours Into Dextrose Infusion||12||
48396883|NCT00721617|101302484|FG000|COMPLETED|4 Hours Into Dextrose Infusion||12||
48396884|NCT00721617|101302484|FG000|NOT COMPLETED|4 Hours Into Dextrose Infusion||0||
48396885|NCT00721617|101302484|FG000|STARTED|8 Hours Into Dextrose Infusion||12||
48396886|NCT00721617|101302484|FG000|COMPLETED|8 Hours Into Dextrose Infusion||12||
48396887|NCT00721617|101302484|FG000|NOT COMPLETED|8 Hours Into Dextrose Infusion||0||
48396888|NCT00721617|101302484|FG000|STARTED|0 Hour (Baseline) of Intralipid/Dextrose||12||
48396889|NCT00721617|101302484|FG000|COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||12||
48396890|NCT00721617|101302484|FG000|NOT COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||0||
48396891|NCT00721617|101302484|FG000|STARTED|4 Hours Into Intralipid/Dextrose||12||
48396892|NCT00721617|101302484|FG000|COMPLETED|4 Hours Into Intralipid/Dextrose||12||
48396893|NCT00721617|101302484|FG000|NOT COMPLETED|4 Hours Into Intralipid/Dextrose||0||
48396894|NCT00721617|101302484|FG000|STARTED|8 Hours Into Intralipid/Dextrose||12||
48396895|NCT00721617|101302484|FG000|COMPLETED|8 Hours Into Intralipid/Dextrose||12||
48396896|NCT00721617|101302484|FG000|NOT COMPLETED|8 Hours Into Intralipid/Dextrose||0||
48396897|NCT02762799|101302485|FG000|STARTED|Overall Study||18||
48396898|NCT02762799|101302486|FG001|STARTED|Overall Study||18||
48396899|NCT02762799|101302487|FG002|STARTED|Overall Study||12||
48396900|NCT02762799|101302488|FG003|STARTED|Overall Study||12||
48396901|NCT02762799|101302485|FG000|COMPLETED|Overall Study||18||
48396902|NCT02762799|101302486|FG001|COMPLETED|Overall Study||18||
48396903|NCT02762799|101302487|FG002|COMPLETED|Overall Study||11||
48396904|NCT02762799|101302488|FG003|COMPLETED|Overall Study||12||
48396905|NCT02762799|101302485|FG000|NOT COMPLETED|Overall Study||0||
48396906|NCT02762799|101302486|FG001|NOT COMPLETED|Overall Study||0||
48396907|NCT02762799|101302487|FG002|NOT COMPLETED|Overall Study||1||
48396908|NCT02762799|101302488|FG003|NOT COMPLETED|Overall Study||0||
48396909|NCT01376362|101302489|FG000|STARTED|Overall Study||5||
48396910|NCT01376362|101302489|FG000|COMPLETED|Overall Study||5||
48396911|NCT01376362|101302489|FG000|NOT COMPLETED|Overall Study||0||
48396912|NCT02918656|101302490|FG000|STARTED|Overall Study||54||
48396913|NCT02918656|101302491|FG001|STARTED|Overall Study||60||
48396914|NCT02918656|101302492|FG002|STARTED|Overall Study||57||
48396915|NCT02918656|101302490|FG000|COMPLETED|Overall Study||54||
48396916|NCT02918656|101302491|FG001|COMPLETED|Overall Study||60||
48396917|NCT02918656|101302492|FG002|COMPLETED|Overall Study||57||
48396918|NCT02918656|101302490|FG000|NOT COMPLETED|Overall Study||0||
48396919|NCT02918656|101302491|FG001|NOT COMPLETED|Overall Study||0||
48396920|NCT02918656|101302492|FG002|NOT COMPLETED|Overall Study||0||
48570111|NCT01072773|101727751|FG000|NOT COMPLETED|Overall Study||0||
48570112|NCT00554515|101727752|FG000|STARTED|Overall Study||123||
48570113|NCT00554515|101727752|FG000|Treated|Overall Study||120|3 participants withdrew consent before starting treatment.|
48570114|NCT00554515|101727752|FG000|COMPLETED|Overall Study||5||
48570115|NCT00554515|101727752|FG000|NOT COMPLETED|Overall Study||118||
48570116|NCT03038867|101727753|FG000|STARTED|Overall Study||37||
48570117|NCT03038867|101727754|FG001|STARTED|Overall Study||32||
48570118|NCT03038867|101727753|FG000|COMPLETED|Overall Study||37||
48570119|NCT03038867|101727754|FG001|COMPLETED|Overall Study||32||
48396921|NCT03363919|101302493|FG000|STARTED|Overall Study||23||
48396922|NCT03363919|101302494|FG001|STARTED|Overall Study||24||
48396923|NCT03363919|101302493|FG000|COMPLETED|Overall Study||22||
48396924|NCT03363919|101302494|FG001|COMPLETED|Overall Study||19||
48570120|NCT03038867|101727753|FG000|NOT COMPLETED|Overall Study||0||
48570121|NCT03038867|101727754|FG001|NOT COMPLETED|Overall Study||0||
48396925|NCT03363919|101302493|FG000|NOT COMPLETED|Overall Study||1||
48396926|NCT03363919|101302494|FG001|NOT COMPLETED|Overall Study||5||
48396927|NCT02562989|101302495|FG000|STARTED|Overall Study||3||
48396928|NCT02562989|101302496|FG001|STARTED|Overall Study||4||
48396929|NCT02562989|101302497|FG002|STARTED|Overall Study||6||
48396930|NCT02562989|101302495|FG000|COMPLETED|Overall Study||3||
48396931|NCT02562989|101302496|FG001|COMPLETED|Overall Study||4||
48570122|NCT00754130|101727755|FG000|STARTED|Period 1 (5 Days)||2||
48570123|NCT00754130|101727756|FG001|STARTED|Period 1 (5 Days)||2||
48570124|NCT00754130|101727757|FG002|STARTED|Period 1 (5 Days)||4||
48570125|NCT00754130|101727758|FG003|STARTED|Period 1 (5 Days)||2||
48570126|NCT00754130|101727759|FG004|STARTED|Period 1 (5 Days)||2||
48570127|NCT00754130|101727760|FG005|STARTED|Period 1 (5 Days)||4||
48570128|NCT00754130|101727755|FG000|COMPLETED|Period 1 (5 Days)||2||
48396932|NCT02562989|101302497|FG002|COMPLETED|Overall Study||6||
48396933|NCT02562989|101302495|FG000|NOT COMPLETED|Overall Study||0||
48396934|NCT02562989|101302496|FG001|NOT COMPLETED|Overall Study||0||
48396935|NCT02562989|101302497|FG002|NOT COMPLETED|Overall Study||0||
48570129|NCT00754130|101727756|FG001|COMPLETED|Period 1 (5 Days)||2||
48570130|NCT00754130|101727757|FG002|COMPLETED|Period 1 (5 Days)||4||
48396936|NCT00654953|101302498|FG000|STARTED|Overall Study||36||
48396937|NCT00654953|101302499|FG001|STARTED|Overall Study||36||
48396938|NCT00654953|101302500|FG002|STARTED|Overall Study||30||
48396939|NCT00654953|101302498|FG000|COMPLETED|Overall Study||6||
48396940|NCT00654953|101302499|FG001|COMPLETED|Overall Study||8||
48396941|NCT00654953|101302500|FG002|COMPLETED|Overall Study||8||
48396942|NCT00654953|101302498|FG000|NOT COMPLETED|Overall Study||30||
48396943|NCT00654953|101302499|FG001|NOT COMPLETED|Overall Study||28||
48570131|NCT00754130|101727758|FG003|COMPLETED|Period 1 (5 Days)||2||
48570132|NCT00754130|101727759|FG004|COMPLETED|Period 1 (5 Days)||2||
48570133|NCT00754130|101727760|FG005|COMPLETED|Period 1 (5 Days)||4||
48570134|NCT00754130|101727755|FG000|NOT COMPLETED|Period 1 (5 Days)||0||
48570135|NCT00754130|101727756|FG001|NOT COMPLETED|Period 1 (5 Days)||0||
48570136|NCT00754130|101727757|FG002|NOT COMPLETED|Period 1 (5 Days)||0||
48570137|NCT00754130|101727758|FG003|NOT COMPLETED|Period 1 (5 Days)||0||
48570138|NCT00754130|101727759|FG004|NOT COMPLETED|Period 1 (5 Days)||0||
48699699|NCT00734604|102050573|FG000|STARTED|Overall Study||62||
48699700|NCT00734604|102050574|FG001|STARTED|Overall Study||63||
48699701|NCT00734604|102050575|FG002|STARTED|Overall Study||63||
48570139|NCT00754130|101727760|FG005|NOT COMPLETED|Period 1 (5 Days)||0||
48570140|NCT00754130|101727755|FG000|STARTED|Washout Period (>=8 Days)||2||
48570141|NCT00754130|101727756|FG001|STARTED|Washout Period (>=8 Days)||2||
48570142|NCT00754130|101727757|FG002|STARTED|Washout Period (>=8 Days)||4||
48570143|NCT00754130|101727758|FG003|STARTED|Washout Period (>=8 Days)||2||
48570144|NCT00754130|101727759|FG004|STARTED|Washout Period (>=8 Days)||2||
48570145|NCT00754130|101727760|FG005|STARTED|Washout Period (>=8 Days)||4||
48570146|NCT00754130|101727755|FG000|COMPLETED|Washout Period (>=8 Days)||2||
48570147|NCT00754130|101727756|FG001|COMPLETED|Washout Period (>=8 Days)||2||
48570148|NCT00754130|101727757|FG002|COMPLETED|Washout Period (>=8 Days)||4||
48570149|NCT00754130|101727758|FG003|COMPLETED|Washout Period (>=8 Days)||2||
48570150|NCT00754130|101727759|FG004|COMPLETED|Washout Period (>=8 Days)||2||
48570151|NCT00754130|101727760|FG005|COMPLETED|Washout Period (>=8 Days)||4||
48570152|NCT00754130|101727755|FG000|NOT COMPLETED|Washout Period (>=8 Days)||0||
48570153|NCT00754130|101727756|FG001|NOT COMPLETED|Washout Period (>=8 Days)||0||
48570154|NCT00754130|101727757|FG002|NOT COMPLETED|Washout Period (>=8 Days)||0||
48570155|NCT00754130|101727758|FG003|NOT COMPLETED|Washout Period (>=8 Days)||0||
48699702|NCT00734604|102050576|FG003|STARTED|Overall Study||63||
48699703|NCT00734604|102050577|FG004|STARTED|Overall Study||63||
48699704|NCT00734604|102050578|FG005|STARTED|Overall Study||64||
48699705|NCT00734604|102050573|FG000|COMPLETED|Overall Study||59||
48699706|NCT00734604|102050574|FG001|COMPLETED|Overall Study||51||
48699707|NCT00734604|102050575|FG002|COMPLETED|Overall Study||57||
48699708|NCT00734604|102050576|FG003|COMPLETED|Overall Study||54||
48699709|NCT00734604|102050577|FG004|COMPLETED|Overall Study||55||
48570156|NCT00754130|101727759|FG004|NOT COMPLETED|Washout Period (>=8 Days)||0||
48570157|NCT00754130|101727760|FG005|NOT COMPLETED|Washout Period (>=8 Days)||0||
48570158|NCT00754130|101727755|FG000|STARTED|Period 2 (5 Days)||2||
48570159|NCT00754130|101727756|FG001|STARTED|Period 2 (5 Days)||2||
48570160|NCT00754130|101727757|FG002|STARTED|Period 2 (5 Days)||4||
48570161|NCT00754130|101727758|FG003|STARTED|Period 2 (5 Days)||2||
48570162|NCT00754130|101727759|FG004|STARTED|Period 2 (5 Days)||2||
48570163|NCT00754130|101727760|FG005|STARTED|Period 2 (5 Days)||4||
48570164|NCT00754130|101727755|FG000|COMPLETED|Period 2 (5 Days)||2||
48570165|NCT00754130|101727756|FG001|COMPLETED|Period 2 (5 Days)||2||
48570166|NCT00754130|101727757|FG002|COMPLETED|Period 2 (5 Days)||4||
48570167|NCT00754130|101727758|FG003|COMPLETED|Period 2 (5 Days)||2||
48570168|NCT00754130|101727759|FG004|COMPLETED|Period 2 (5 Days)||2||
48570169|NCT00754130|101727760|FG005|COMPLETED|Period 2 (5 Days)||4||
48570170|NCT00754130|101727755|FG000|NOT COMPLETED|Period 2 (5 Days)||0||
48570171|NCT00754130|101727756|FG001|NOT COMPLETED|Period 2 (5 Days)||0||
48570172|NCT00754130|101727757|FG002|NOT COMPLETED|Period 2 (5 Days)||0||
48570173|NCT00754130|101727758|FG003|NOT COMPLETED|Period 2 (5 Days)||0||
48570174|NCT00754130|101727759|FG004|NOT COMPLETED|Period 2 (5 Days)||0||
48570175|NCT00754130|101727760|FG005|NOT COMPLETED|Period 2 (5 Days)||0||
48570176|NCT02968173|101727761|FG000|STARTED|Overall Study||50||
48570177|NCT02968173|101727761|FG000|COMPLETED|Overall Study||49||
48570178|NCT02968173|101727761|FG000|NOT COMPLETED|Overall Study||1||
48570179|NCT02490371|101727762|FG000|STARTED|Overall Study||12||
48570180|NCT02490371|101727763|FG001|STARTED|Overall Study||12||
48570181|NCT02490371|101727762|FG000|COMPLETED|Overall Study||11||
48570182|NCT02490371|101727763|FG001|COMPLETED|Overall Study||11||
48570183|NCT02490371|101727762|FG000|NOT COMPLETED|Overall Study||1||
48570184|NCT02490371|101727763|FG001|NOT COMPLETED|Overall Study||1||
48570185|NCT01317095|101727764|FG000|STARTED|Overall Study||39||
48570186|NCT01317095|101727765|FG001|STARTED|Overall Study||41||
48123142|NCT01310413|100626476|FG005|STARTED|Day 0 to Day 385||80||
48123143|NCT01310413|100626477|FG006|STARTED|Day 0 to Day 385||0||
48123144|NCT01310413|100626471|FG000|COMPLETED|Day 0 to Day 385||172||
48123145|NCT01310413|100626472|FG001|COMPLETED|Day 0 to Day 385||190||
48123146|NCT01310413|100626473|FG002|COMPLETED|Day 0 to Day 385||203||
48123147|NCT01310413|100626474|FG003|COMPLETED|Day 0 to Day 385||67||
48282006|NCT03230877|101014222|FG001|COMPLETED|Visit 2||15||
48282007|NCT03230877|101014221|FG000|NOT COMPLETED|Visit 2||0||
48282008|NCT03230877|101014222|FG001|NOT COMPLETED|Visit 2||0||
48282009|NCT00777088|101014223|FG000|STARTED|Overall Study||108||
48282010|NCT00777088|101014223|FG000|COMPLETED|Overall Study||107||
48282011|NCT00777088|101014223|FG000|NOT COMPLETED|Overall Study||1||
48282012|NCT02796300|101014224|FG000|STARTED|Overall Study||10||
48570187|NCT01317095|101727764|FG000|COMPLETED|Overall Study||39||
48570188|NCT01317095|101727765|FG001|COMPLETED|Overall Study||41||
48570189|NCT01317095|101727764|FG000|NOT COMPLETED|Overall Study||0||
48570190|NCT01317095|101727765|FG001|NOT COMPLETED|Overall Study||0||
48570191|NCT02004366|101727766|FG000|STARTED|In-hospital||128||
48570192|NCT02004366|101727767|FG001|STARTED|In-hospital||122||
48123148|NCT01310413|100626475|FG004|COMPLETED|Day 0 to Day 385||73||
48282013|NCT02796300|101014225|FG001|STARTED|Overall Study||22||
48282014|NCT02796300|101014224|FG000|COMPLETED|Overall Study||10||
48282015|NCT02796300|101014225|FG001|COMPLETED|Overall Study||22||
48570193|NCT02004366|101727768|FG002|STARTED|In-hospital||0||
48570194|NCT02004366|101727769|FG003|STARTED|In-hospital||0||
48570195|NCT02004366|101727770|FG004|STARTED|In-hospital||0||
48570196|NCT02004366|101727766|FG000|COMPLETED|In-hospital||128||
48570197|NCT02004366|101727767|FG001|COMPLETED|In-hospital||122||
48570198|NCT02004366|101727768|FG002|COMPLETED|In-hospital||0||
48570199|NCT02004366|101727769|FG003|COMPLETED|In-hospital||0||
48570200|NCT02004366|101727770|FG004|COMPLETED|In-hospital||0||
48699710|NCT00734604|102050578|FG005|COMPLETED|Overall Study||58||
48699711|NCT00734604|102050573|FG000|NOT COMPLETED|Overall Study||3||
48123149|NCT01310413|100626476|FG005|COMPLETED|Day 0 to Day 385||77||
48123150|NCT01310413|100626477|FG006|COMPLETED|Day 0 to Day 385||0||
48123151|NCT01310413|100626471|FG000|NOT COMPLETED|Day 0 to Day 385||27||
48123152|NCT01310413|100626472|FG001|NOT COMPLETED|Day 0 to Day 385||8||
48570201|NCT02004366|101727766|FG000|NOT COMPLETED|In-hospital||0||
48570202|NCT02004366|101727767|FG001|NOT COMPLETED|In-hospital||0||
48570203|NCT02004366|101727768|FG002|NOT COMPLETED|In-hospital||0||
48570204|NCT02004366|101727769|FG003|NOT COMPLETED|In-hospital||0||
48570205|NCT02004366|101727770|FG004|NOT COMPLETED|In-hospital||0||
48570206|NCT02004366|101727766|FG000|STARTED|On Discharge||0||
48570207|NCT02004366|101727767|FG001|STARTED|On Discharge||0||
48570208|NCT02004366|101727768|FG002|STARTED|On Discharge||92||
48570209|NCT02004366|101727769|FG003|STARTED|On Discharge||93||
48570210|NCT02004366|101727770|FG004|STARTED|On Discharge||39||
48570211|NCT02004366|101727766|FG000|COMPLETED|On Discharge||0||
48123153|NCT01310413|100626473|FG002|NOT COMPLETED|Day 0 to Day 385||7||
48123154|NCT01310413|100626474|FG003|NOT COMPLETED|Day 0 to Day 385||8||
48282016|NCT02796300|101014224|FG000|NOT COMPLETED|Overall Study||0||
48282017|NCT02796300|101014225|FG001|NOT COMPLETED|Overall Study||0||
48570212|NCT02004366|101727767|FG001|COMPLETED|On Discharge||0||
48570213|NCT02004366|101727768|FG002|COMPLETED|On Discharge||92||
48570214|NCT02004366|101727769|FG003|COMPLETED|On Discharge||93||
48570215|NCT02004366|101727770|FG004|COMPLETED|On Discharge||39||
48570216|NCT02004366|101727766|FG000|NOT COMPLETED|On Discharge||0||
48570217|NCT02004366|101727767|FG001|NOT COMPLETED|On Discharge||0||
48570218|NCT02004366|101727768|FG002|NOT COMPLETED|On Discharge||0||
48570219|NCT02004366|101727769|FG003|NOT COMPLETED|On Discharge||0||
48570220|NCT02004366|101727770|FG004|NOT COMPLETED|On Discharge||0||
48570221|NCT03334344|101727771|FG000|STARTED|Overall Study||44||
48570222|NCT03334344|101727772|FG001|STARTED|Overall Study||48||
48123155|NCT01310413|100626475|FG004|NOT COMPLETED|Day 0 to Day 385||3||
48123156|NCT01310413|100626476|FG005|NOT COMPLETED|Day 0 to Day 385||3||
48123157|NCT01310413|100626477|FG006|NOT COMPLETED|Day 0 to Day 385||0||
48123158|NCT01310413|100626471|FG000|STARTED|From Day U0 to Day U385||0||
48123159|NCT01310413|100626472|FG001|STARTED|From Day U0 to Day U385||0||
48123160|NCT01310413|100626473|FG002|STARTED|From Day U0 to Day U385||0||
48123161|NCT01310413|100626474|FG003|STARTED|From Day U0 to Day U385||0||
48123162|NCT01310413|100626475|FG004|STARTED|From Day U0 to Day U385||0||
48123163|NCT01310413|100626476|FG005|STARTED|From Day U0 to Day U385||0||
48123164|NCT01310413|100626477|FG006|STARTED|From Day U0 to Day U385||155||
48123165|NCT01310413|100626471|FG000|COMPLETED|From Day U0 to Day U385||0||
48123166|NCT01310413|100626472|FG001|COMPLETED|From Day U0 to Day U385||0||
48123167|NCT01310413|100626473|FG002|COMPLETED|From Day U0 to Day U385||0||
48123168|NCT01310413|100626474|FG003|COMPLETED|From Day U0 to Day U385||0||
48123169|NCT01310413|100626475|FG004|COMPLETED|From Day U0 to Day U385||0||
48123170|NCT01310413|100626476|FG005|COMPLETED|From Day U0 to Day U385||0||
48123171|NCT01310413|100626477|FG006|COMPLETED|From Day U0 to Day U385||152||
48123172|NCT01310413|100626471|FG000|NOT COMPLETED|From Day U0 to Day U385||0||
48123173|NCT01310413|100626472|FG001|NOT COMPLETED|From Day U0 to Day U385||0||
48123174|NCT01310413|100626473|FG002|NOT COMPLETED|From Day U0 to Day U385||0||
48123175|NCT01310413|100626474|FG003|NOT COMPLETED|From Day U0 to Day U385||0||
48123176|NCT01310413|100626475|FG004|NOT COMPLETED|From Day U0 to Day U385||0||
48123177|NCT01310413|100626476|FG005|NOT COMPLETED|From Day U0 to Day U385||0||
48123178|NCT01310413|100626477|FG006|NOT COMPLETED|From Day U0 to Day U385||3||
48123179|NCT02504866|100626478|FG000|STARTED|3-Month Follow up||4||
48123180|NCT02504866|100626479|FG001|STARTED|3-Month Follow up||3||
48123181|NCT02504866|100626480|FG002|STARTED|3-Month Follow up||4||
48123182|NCT02504866|100626478|FG000|COMPLETED|3-Month Follow up||4||
48123183|NCT02504866|100626479|FG001|COMPLETED|3-Month Follow up||3||
48123184|NCT02504866|100626480|FG002|COMPLETED|3-Month Follow up||4||
48123185|NCT02504866|100626478|FG000|NOT COMPLETED|3-Month Follow up||0||
48123186|NCT02504866|100626479|FG001|NOT COMPLETED|3-Month Follow up||0||
48123187|NCT02504866|100626480|FG002|NOT COMPLETED|3-Month Follow up||0||
48570223|NCT03334344|101727771|FG000|COMPLETED|Overall Study||44||
48570224|NCT03334344|101727772|FG001|COMPLETED|Overall Study||48||
48570225|NCT03334344|101727771|FG000|NOT COMPLETED|Overall Study||0||
48570226|NCT03334344|101727772|FG001|NOT COMPLETED|Overall Study||0||
48570227|NCT01760304|101727773|FG000|STARTED|Overall Study||2|This is a double crossover study design, therefore each patient use intervention and placebo|
48570228|NCT01760304|101727774|FG001|STARTED|Overall Study||3|This is a double crossover study design, therefore each patient use intervention and placebo|
48570229|NCT01760304|101727773|FG000|COMPLETED|Overall Study||2||
48570230|NCT01760304|101727774|FG001|COMPLETED|Overall Study||3||
48570231|NCT01760304|101727773|FG000|NOT COMPLETED|Overall Study||0||
48570232|NCT01760304|101727774|FG001|NOT COMPLETED|Overall Study||0||
48570233|NCT01562782|101727775|FG000|STARTED|Overall Study||19||
48570234|NCT01562782|101727776|FG001|STARTED|Overall Study||20||
48570235|NCT01562782|101727775|FG000|COMPLETED|Overall Study||15||
48570236|NCT01562782|101727776|FG001|COMPLETED|Overall Study||15||
48570237|NCT01562782|101727775|FG000|NOT COMPLETED|Overall Study||4||
48570238|NCT01562782|101727776|FG001|NOT COMPLETED|Overall Study||5||
48570239|NCT03423173|101727777|FG000|STARTED|Overall Study||132||
48570240|NCT03423173|101727778|FG001|STARTED|Overall Study||263||
48570241|NCT03423173|101727779|FG002|STARTED|Overall Study||264||
48570242|NCT03423173|101727780|FG003|STARTED|Overall Study||264||
48570243|NCT03423173|101727777|FG000|Received at Least 1 Dose of the IP|Overall Study||131|Investigational Product (IP) includes TDV and placebo.|
48570244|NCT03423173|101727778|FG001|Received at Least 1 Dose of the IP|Overall Study||263|Investigational Product (IP) includes TDV and placebo.|
48570245|NCT03423173|101727779|FG002|Received at Least 1 Dose of the IP|Overall Study||262|Investigational Product (IP) includes TDV and placebo.|
48592802|NCT01764997|101783184|FG002|NOT COMPLETED|Run-in Period||0||
48123188|NCT02504866|100626478|FG000|STARTED|6-Month Follow up (CON Group Only)||1||
48123189|NCT02504866|100626479|FG001|STARTED|6-Month Follow up (CON Group Only)||2||
48123190|NCT02504866|100626480|FG002|STARTED|6-Month Follow up (CON Group Only)||0||
48123191|NCT02504866|100626478|FG000|COMPLETED|6-Month Follow up (CON Group Only)||0||
48123192|NCT02504866|100626479|FG001|COMPLETED|6-Month Follow up (CON Group Only)||2||
48123193|NCT02504866|100626480|FG002|COMPLETED|6-Month Follow up (CON Group Only)||0||
48123194|NCT02504866|100626478|FG000|NOT COMPLETED|6-Month Follow up (CON Group Only)||1||
48123195|NCT02504866|100626479|FG001|NOT COMPLETED|6-Month Follow up (CON Group Only)||0||
48123196|NCT02504866|100626480|FG002|NOT COMPLETED|6-Month Follow up (CON Group Only)||0||
48123197|NCT00803023|100626481|FG000|STARTED|Overall Study||32||
48123198|NCT00803023|100626482|FG001|STARTED|Overall Study||33||
48123199|NCT00803023|100626483|FG002|STARTED|Overall Study||31||
48123200|NCT00803023|100626484|FG003|STARTED|Overall Study||33||
48123201|NCT00803023|100626481|FG000|COMPLETED|Overall Study||27||
48123202|NCT00803023|100626482|FG001|COMPLETED|Overall Study||25||
48123203|NCT00803023|100626483|FG002|COMPLETED|Overall Study||20||
48123204|NCT00803023|100626484|FG003|COMPLETED|Overall Study||25||
48123205|NCT00803023|100626481|FG000|NOT COMPLETED|Overall Study||5||
48123206|NCT00803023|100626482|FG001|NOT COMPLETED|Overall Study||8||
48123207|NCT00803023|100626483|FG002|NOT COMPLETED|Overall Study||11||
48123208|NCT00803023|100626484|FG003|NOT COMPLETED|Overall Study||8||
48123209|NCT00439140|100626485|FG000|STARTED|Treatment Cycle 1||15||
48123210|NCT00439140|100626486|FG001|STARTED|Treatment Cycle 1||14||
48123211|NCT00439140|100626487|FG002|STARTED|Treatment Cycle 1||12||
48123212|NCT00439140|100626485|FG000|COMPLETED|Treatment Cycle 1||14||
48123213|NCT00439140|100626486|FG001|COMPLETED|Treatment Cycle 1||10||
48123214|NCT00439140|100626487|FG002|COMPLETED|Treatment Cycle 1||11||
48123215|NCT00439140|100626485|FG000|NOT COMPLETED|Treatment Cycle 1||1||
48123216|NCT00439140|100626486|FG001|NOT COMPLETED|Treatment Cycle 1||4||
48123217|NCT00439140|100626487|FG002|NOT COMPLETED|Treatment Cycle 1||1||
48123218|NCT00439140|100626485|FG000|STARTED|Treatment Cycle 2||13||
48123219|NCT00439140|100626486|FG001|STARTED|Treatment Cycle 2||7||
48123220|NCT00439140|100626487|FG002|STARTED|Treatment Cycle 2||0||
48123221|NCT00439140|100626485|FG000|COMPLETED|Treatment Cycle 2||11||
48123222|NCT00439140|100626486|FG001|COMPLETED|Treatment Cycle 2||6||
48123223|NCT00439140|100626487|FG002|COMPLETED|Treatment Cycle 2||0||
48123224|NCT00439140|100626485|FG000|NOT COMPLETED|Treatment Cycle 2||2||
48123225|NCT00439140|100626486|FG001|NOT COMPLETED|Treatment Cycle 2||1||
48123226|NCT00439140|100626487|FG002|NOT COMPLETED|Treatment Cycle 2||0||
48123227|NCT02780349|100626488|FG000|STARTED|Overall Study||103||
48123228|NCT02780349|100626488|FG000|COMPLETED|Overall Study||101||
48123229|NCT02780349|100626488|FG000|NOT COMPLETED|Overall Study||2||
48123230|NCT04532112|100626489|FG000|STARTED|Overall Study||25||
48123231|NCT04532112|100626490|FG001|STARTED|Overall Study||12||
48123232|NCT04532112|100626489|FG000|COMPLETED|Overall Study||22||
48123233|NCT04532112|100626490|FG001|COMPLETED|Overall Study||12||
48123234|NCT04532112|100626489|FG000|NOT COMPLETED|Overall Study||3||
48123235|NCT04532112|100626490|FG001|NOT COMPLETED|Overall Study||0||
48123236|NCT00048724|100626491|FG000|STARTED|Overall Study||311||
48123237|NCT00048724|100626492|FG001|STARTED|Overall Study||315||
48123238|NCT00048724|100626491|FG000|COMPLETED|Overall Study||195||
48123239|NCT00048724|100626492|FG001|COMPLETED|Overall Study||197||
48123240|NCT00048724|100626491|FG000|NOT COMPLETED|Overall Study||116||
48123241|NCT00048724|100626492|FG001|NOT COMPLETED|Overall Study||118||
48123242|NCT02461589|100626493|FG000|STARTED|Overall Study||64||
48123243|NCT02461589|100626494|FG001|STARTED|Overall Study||63||
48123244|NCT02461589|100626495|FG002|STARTED|Overall Study||65||
48123245|NCT02461589|100626496|FG003|STARTED|Overall Study||63||
48123246|NCT02461589|100626497|FG004|STARTED|Overall Study||64||
48123247|NCT02461589|100626498|FG005|STARTED|Overall Study||64||
48123248|NCT02461589|100626499|FG006|STARTED|Overall Study||64||
48123249|NCT02461589|100626500|FG007|STARTED|Overall Study||65||
48123250|NCT02461589|100626501|FG008|STARTED|Overall Study||129||
48123251|NCT02461589|100626502|FG009|STARTED|Overall Study||65||
48123252|NCT02461589|100626493|FG000|Exposed|Overall Study||64||
48123253|NCT02461589|100626494|FG001|Exposed|Overall Study||63||
48123254|NCT02461589|100626495|FG002|Exposed|Overall Study||65||
48123255|NCT02461589|100626496|FG003|Exposed|Overall Study||63||
48123256|NCT02461589|100626497|FG004|Exposed|Overall Study||64||
48123257|NCT02461589|100626498|FG005|Exposed|Overall Study||64||
48123258|NCT02461589|100626499|FG006|Exposed|Overall Study||64||
48123259|NCT02461589|100626500|FG007|Exposed|Overall Study||65||
48123260|NCT02461589|100626501|FG008|Exposed|Overall Study||129||
48123261|NCT02461589|100626502|FG009|Exposed|Overall Study||64||
48123262|NCT02461589|100626493|FG000|COMPLETED|Overall Study||58||
48123263|NCT02461589|100626494|FG001|COMPLETED|Overall Study||61||
48123264|NCT02461589|100626495|FG002|COMPLETED|Overall Study||60||
48123265|NCT02461589|100626496|FG003|COMPLETED|Overall Study||58||
48123266|NCT02461589|100626497|FG004|COMPLETED|Overall Study||62||
48123267|NCT02461589|100626498|FG005|COMPLETED|Overall Study||61||
48123268|NCT02461589|100626499|FG006|COMPLETED|Overall Study||58||
48123269|NCT02461589|100626500|FG007|COMPLETED|Overall Study||60||
48123270|NCT02461589|100626501|FG008|COMPLETED|Overall Study||123||
48123271|NCT02461589|100626502|FG009|COMPLETED|Overall Study||60||
48123272|NCT02461589|100626493|FG000|NOT COMPLETED|Overall Study||6||
48123273|NCT02461589|100626494|FG001|NOT COMPLETED|Overall Study||2||
48123274|NCT02461589|100626495|FG002|NOT COMPLETED|Overall Study||5||
48123275|NCT02461589|100626496|FG003|NOT COMPLETED|Overall Study||5||
48123276|NCT02461589|100626497|FG004|NOT COMPLETED|Overall Study||2||
48123277|NCT02461589|100626498|FG005|NOT COMPLETED|Overall Study||3||
48123278|NCT02461589|100626499|FG006|NOT COMPLETED|Overall Study||6||
48123279|NCT02461589|100626500|FG007|NOT COMPLETED|Overall Study||5||
48123280|NCT02461589|100626501|FG008|NOT COMPLETED|Overall Study||6||
48123281|NCT02461589|100626502|FG009|NOT COMPLETED|Overall Study||5||
48123282|NCT00403455|100626503|FG000|STARTED|Overall Study||38||
48123283|NCT00403455|100626503|FG000|COMPLETED|Overall Study||37||
48123284|NCT00403455|100626503|FG000|NOT COMPLETED|Overall Study||1||
48123285|NCT03042312|100626504|FG000|STARTED|Overall Study||28|All randomized participants were included in Intent-to-treat (ITT) population|
48123286|NCT03042312|100626505|FG001|STARTED|Overall Study||43|All randomized participants were included in Intent-to-treat (ITT) population|
48123287|NCT03042312|100626504|FG000|Safety Population|Overall Study||23|The subset of patients in the ITT population who received at least one dose of randomized therapy.|
48123288|NCT03042312|100626505|FG001|Safety Population|Overall Study||41|The subset of patients in the ITT population who received at least one dose of randomized therapy.|
48123289|NCT03042312|100626504|FG000|COMPLETED|Overall Study||18||
48123290|NCT03042312|100626505|FG001|COMPLETED|Overall Study||31||
48123291|NCT03042312|100626504|FG000|NOT COMPLETED|Overall Study||10||
48123292|NCT03042312|100626505|FG001|NOT COMPLETED|Overall Study||12||
48123293|NCT00600821|100626506|FG000|STARTED|Overall Study||58||
48123294|NCT00600821|100626507|FG001|STARTED|Overall Study||60||
48123295|NCT00600821|100626506|FG000|Treated|Overall Study||58||
48123296|NCT00600821|100626507|FG001|Treated|Overall Study||59||
48123297|NCT00600821|100626506|FG000|COMPLETED|Overall Study||0||
48123298|NCT00600821|100626507|FG001|COMPLETED|Overall Study||0||
48123299|NCT00600821|100626506|FG000|NOT COMPLETED|Overall Study||58||
48123300|NCT00600821|100626507|FG001|NOT COMPLETED|Overall Study||60||
48123301|NCT01351740|100626508|FG000|STARTED|Overall Study||25||
48123302|NCT01351740|100626509|FG001|STARTED|Overall Study||25||
48123303|NCT01351740|100626508|FG000|COMPLETED|Overall Study||23||
48123304|NCT01351740|100626509|FG001|COMPLETED|Overall Study||19||
48123305|NCT01351740|100626508|FG000|NOT COMPLETED|Overall Study||2||
48123306|NCT01351740|100626509|FG001|NOT COMPLETED|Overall Study||6||
48123307|NCT04369469|100626510|FG000|STARTED|Overall Study||135||
48123308|NCT04369469|100626511|FG001|STARTED|Overall Study||67||
48123309|NCT04369469|100626510|FG000|Intent to Treat (ITT) Population|Overall Study||135|The ITT Population consisted of all randomized participants. Participants were analyzed as randomized.|
48123310|NCT04369469|100626511|FG001|Intent to Treat (ITT) Population|Overall Study||66|The ITT Population consisted of all randomized participants. Participants were analyzed as randomized.|
48123311|NCT04369469|100626510|FG000|Pharmacokinetic (PK)|Overall Study||127|The PK Set included participants in the ITT population with at least one postdose PK result.|
48123312|NCT04369469|100626511|FG001|Pharmacokinetic (PK)|Overall Study||52|The PK Set included participants in the ITT population with at least one postdose PK result.|
48123313|NCT04369469|100626510|FG000|Safety Population|Overall Study||127|All randomized participants who received at least 1 dose of study drug. Participants were analyzed as treated.|
48123314|NCT04369469|100626511|FG001|Safety Population|Overall Study||67|All randomized participants who received at least 1 dose of study drug. Participants were analyzed as treated.|
48123315|NCT04369469|100626510|FG000|COMPLETED|Overall Study||125||
48123316|NCT04369469|100626511|FG001|COMPLETED|Overall Study||58||
48123317|NCT04369469|100626510|FG000|NOT COMPLETED|Overall Study||10||
48123318|NCT04369469|100626511|FG001|NOT COMPLETED|Overall Study||9||
48699712|NCT00734604|102050574|FG001|NOT COMPLETED|Overall Study||12||
48699713|NCT00734604|102050575|FG002|NOT COMPLETED|Overall Study||6||
48699714|NCT00734604|102050576|FG003|NOT COMPLETED|Overall Study||9||
48699715|NCT00734604|102050577|FG004|NOT COMPLETED|Overall Study||8||
48699716|NCT00734604|102050578|FG005|NOT COMPLETED|Overall Study||6||
48699717|NCT03213938|102050579|FG000|STARTED|Overall Study||220||
48699718|NCT03213938|102050580|FG001|STARTED|Overall Study||220||
48123319|NCT00780962|100626512|FG000|STARTED|Overall Study||200||
48123320|NCT00780962|100626513|FG001|STARTED|Overall Study||199||
48123321|NCT00780962|100626512|FG000|Second Blood Draw (Outcome Measurement)|Overall Study||185||
48123322|NCT00780962|100626513|FG001|Second Blood Draw (Outcome Measurement)|Overall Study||172||
48123323|NCT00780962|100626512|FG000|COMPLETED|Overall Study||185||
48123324|NCT00780962|100626513|FG001|COMPLETED|Overall Study||172||
48123325|NCT00780962|100626512|FG000|NOT COMPLETED|Overall Study||15||
48123326|NCT00780962|100626513|FG001|NOT COMPLETED|Overall Study||27||
48123327|NCT00812812|100626514|FG000|STARTED|Overall Study||27||
48123328|NCT00812812|100626515|FG001|STARTED|Overall Study||29||
48123329|NCT00812812|100626514|FG000|COMPLETED|Overall Study||24||
48123330|NCT00812812|100626515|FG001|COMPLETED|Overall Study||25||
48123331|NCT00812812|100626514|FG000|NOT COMPLETED|Overall Study||3||
48123332|NCT00812812|100626515|FG001|NOT COMPLETED|Overall Study||4||
48123333|NCT02873104|100626516|FG000|STARTED|Overall Study||47||
48123334|NCT02873104|100626517|FG001|STARTED|Overall Study||23||
48123335|NCT02873104|100626516|FG000|COMPLETED|Overall Study||46||
48123336|NCT02873104|100626517|FG001|COMPLETED|Overall Study||23||
48123337|NCT02873104|100626516|FG000|NOT COMPLETED|Overall Study||1||
48123338|NCT02873104|100626517|FG001|NOT COMPLETED|Overall Study||0||
48123339|NCT01693601|100626518|FG000|STARTED|Cohort 1||3||
48123340|NCT01693601|100626519|FG001|STARTED|Cohort 1||0||
48123341|NCT01693601|100626520|FG002|STARTED|Cohort 1||0||
48123342|NCT01693601|100626521|FG003|STARTED|Cohort 1||0||
48123343|NCT01693601|100626518|FG000|COMPLETED|Cohort 1||3||
48123344|NCT01693601|100626519|FG001|COMPLETED|Cohort 1||0||
48123345|NCT01693601|100626520|FG002|COMPLETED|Cohort 1||0||
48123346|NCT01693601|100626521|FG003|COMPLETED|Cohort 1||0||
48123347|NCT01693601|100626518|FG000|NOT COMPLETED|Cohort 1||0||
48123348|NCT01693601|100626519|FG001|NOT COMPLETED|Cohort 1||0||
48699719|NCT03213938|102050579|FG000|COMPLETED|Overall Study||206||
48123349|NCT01693601|100626520|FG002|NOT COMPLETED|Cohort 1||0||
48123350|NCT01693601|100626521|FG003|NOT COMPLETED|Cohort 1||0||
48123351|NCT01693601|100626518|FG000|STARTED|Cohort 2||0||
48123352|NCT01693601|100626519|FG001|STARTED|Cohort 2||6||
48123353|NCT01693601|100626520|FG002|STARTED|Cohort 2||0||
48123354|NCT01693601|100626521|FG003|STARTED|Cohort 2||0||
48123355|NCT01693601|100626518|FG000|COMPLETED|Cohort 2||0||
48123356|NCT01693601|100626519|FG001|COMPLETED|Cohort 2||6||
48123357|NCT01693601|100626520|FG002|COMPLETED|Cohort 2||0||
48123358|NCT01693601|100626521|FG003|COMPLETED|Cohort 2||0||
48123359|NCT01693601|100626518|FG000|NOT COMPLETED|Cohort 2||0||
48123360|NCT01693601|100626519|FG001|NOT COMPLETED|Cohort 2||0||
48123361|NCT01693601|100626520|FG002|NOT COMPLETED|Cohort 2||0||
48123362|NCT01693601|100626521|FG003|NOT COMPLETED|Cohort 2||0||
48123363|NCT01693601|100626518|FG000|STARTED|Cohort 3||0||
48123364|NCT01693601|100626519|FG001|STARTED|Cohort 3||0||
48123365|NCT01693601|100626520|FG002|STARTED|Cohort 3||3||
48123366|NCT01693601|100626521|FG003|STARTED|Cohort 3||0||
48123367|NCT01693601|100626518|FG000|COMPLETED|Cohort 3||0||
48123368|NCT01693601|100626519|FG001|COMPLETED|Cohort 3||0||
48123369|NCT01693601|100626520|FG002|COMPLETED|Cohort 3||3||
48123370|NCT01693601|100626521|FG003|COMPLETED|Cohort 3||0||
48123371|NCT01693601|100626518|FG000|NOT COMPLETED|Cohort 3||0||
48123372|NCT01693601|100626519|FG001|NOT COMPLETED|Cohort 3||0||
48123373|NCT01693601|100626520|FG002|NOT COMPLETED|Cohort 3||0||
48123374|NCT01693601|100626521|FG003|NOT COMPLETED|Cohort 3||0||
48123375|NCT01693601|100626518|FG000|STARTED|Cohort 4||0||
48570246|NCT03423173|101727780|FG003|Received at Least 1 Dose of the IP|Overall Study||263|Investigational Product (IP) includes TDV and placebo.|
48570247|NCT03423173|101727777|FG000|COMPLETED|Overall Study||113||
48570248|NCT03423173|101727778|FG001|COMPLETED|Overall Study||228||
48570249|NCT03423173|101727779|FG002|COMPLETED|Overall Study||237||
48570250|NCT03423173|101727780|FG003|COMPLETED|Overall Study||234||
48570251|NCT03423173|101727777|FG000|NOT COMPLETED|Overall Study||19||
48570252|NCT03423173|101727778|FG001|NOT COMPLETED|Overall Study||35||
48570253|NCT03423173|101727779|FG002|NOT COMPLETED|Overall Study||27||
48570254|NCT03423173|101727780|FG003|NOT COMPLETED|Overall Study||30||
48570255|NCT03478644|101727781|FG000|STARTED|Phase 1||31||
48570256|NCT03478644|101727782|FG001|STARTED|Phase 1||0||
48570257|NCT03478644|101727781|FG000|COMPLETED|Phase 1||31||
48570258|NCT03478644|101727782|FG001|COMPLETED|Phase 1||0||
48570259|NCT03478644|101727781|FG000|NOT COMPLETED|Phase 1||0||
48570260|NCT03478644|101727782|FG001|NOT COMPLETED|Phase 1||0||
48570261|NCT03478644|101727781|FG000|STARTED|Phase 2||76||
48570262|NCT03478644|101727782|FG001|STARTED|Phase 2||76||
48570263|NCT03478644|101727781|FG000|COMPLETED|Phase 2||73||
48570264|NCT03478644|101727782|FG001|COMPLETED|Phase 2||75||
48570265|NCT03478644|101727781|FG000|NOT COMPLETED|Phase 2||3||
48570266|NCT03478644|101727782|FG001|NOT COMPLETED|Phase 2||1||
48123376|NCT01693601|100626519|FG001|STARTED|Cohort 4||0||
48123377|NCT01693601|100626520|FG002|STARTED|Cohort 4||0||
48123378|NCT01693601|100626521|FG003|STARTED|Cohort 4||3||
48123379|NCT01693601|100626518|FG000|COMPLETED|Cohort 4||0||
48123380|NCT01693601|100626519|FG001|COMPLETED|Cohort 4||0||
48123381|NCT01693601|100626520|FG002|COMPLETED|Cohort 4||0||
48123382|NCT01693601|100626521|FG003|COMPLETED|Cohort 4||3||
48123383|NCT01693601|100626518|FG000|NOT COMPLETED|Cohort 4||0||
48123384|NCT01693601|100626519|FG001|NOT COMPLETED|Cohort 4||0||
48123385|NCT01693601|100626520|FG002|NOT COMPLETED|Cohort 4||0||
48123386|NCT01693601|100626521|FG003|NOT COMPLETED|Cohort 4||0||
48123387|NCT01176591|100626522|FG000|STARTED|Session 1||10||
48123388|NCT01176591|100626523|FG001|STARTED|Session 1||3||
48123389|NCT01176591|100626522|FG000|COMPLETED|Session 1||10||
48123390|NCT01176591|100626523|FG001|COMPLETED|Session 1||3||
48123391|NCT01176591|100626522|FG000|NOT COMPLETED|Session 1||0||
48123392|NCT01176591|100626523|FG001|NOT COMPLETED|Session 1||0||
48123393|NCT01176591|100626522|FG000|STARTED|Session 2||10||
48123394|NCT01176591|100626523|FG001|STARTED|Session 2||3||
48123395|NCT01176591|100626522|FG000|COMPLETED|Session 2||10||
48123396|NCT01176591|100626523|FG001|COMPLETED|Session 2||3||
48123397|NCT01176591|100626522|FG000|NOT COMPLETED|Session 2||0||
48123398|NCT01176591|100626523|FG001|NOT COMPLETED|Session 2||0||
48123399|NCT04028388|100626524|FG000|STARTED|Overall Study||51||
48123400|NCT04028388|100626525|FG001|STARTED|Overall Study||52||
48123401|NCT04028388|100626524|FG000|COMPLETED|Overall Study||46||
48123402|NCT04028388|100626525|FG001|COMPLETED|Overall Study||46||
48123403|NCT04028388|100626524|FG000|NOT COMPLETED|Overall Study||5||
48123404|NCT04028388|100626525|FG001|NOT COMPLETED|Overall Study||6||
48123405|NCT00491244|100626526|FG000|STARTED|Overall Study||189||
48123406|NCT00491244|100626527|FG001|STARTED|Overall Study||188||
48123407|NCT00491244|100626526|FG000|COMPLETED|Overall Study||162||
48123408|NCT00491244|100626527|FG001|COMPLETED|Overall Study||168||
48123409|NCT00491244|100626526|FG000|NOT COMPLETED|Overall Study||27||
48123410|NCT00491244|100626527|FG001|NOT COMPLETED|Overall Study||20||
48123411|NCT01815671|100626528|FG000|STARTED|Overall Study||88||
48123412|NCT01815671|100626529|FG001|STARTED|Overall Study||85||
48123413|NCT01815671|100626528|FG000|COMPLETED|Overall Study||88||
48123414|NCT01815671|100626529|FG001|COMPLETED|Overall Study||85||
48123415|NCT01815671|100626528|FG000|NOT COMPLETED|Overall Study||0||
48123416|NCT01815671|100626529|FG001|NOT COMPLETED|Overall Study||0||
48123417|NCT03930745|100626530|FG000|STARTED|Overall Study||40||
48123418|NCT03930745|100626531|FG001|STARTED|Overall Study||41||
48123419|NCT03930745|100626530|FG000|COMPLETED|Overall Study||24||
48123420|NCT03930745|100626531|FG001|COMPLETED|Overall Study||25||
48123421|NCT03930745|100626530|FG000|NOT COMPLETED|Overall Study||16||
48123422|NCT03930745|100626531|FG001|NOT COMPLETED|Overall Study||16||
48123423|NCT03006328|100626532|FG000|STARTED|Overall Study||220||9
48123424|NCT03006328|100626533|FG001|STARTED|Overall Study||269||10
48123425|NCT03006328|100626532|FG000|COMPLETED|Overall Study||220||9
48123426|NCT03006328|100626533|FG001|COMPLETED|Overall Study||269||10
48123427|NCT03006328|100626532|FG000|NOT COMPLETED|Overall Study||0||0
48123428|NCT03006328|100626533|FG001|NOT COMPLETED|Overall Study||0||0
48123429|NCT00617240|100626534|FG000|STARTED|Overall Study||5||
48123430|NCT00617240|100626535|FG001|STARTED|Overall Study||4||
48123431|NCT00617240|100626534|FG000|COMPLETED|Overall Study||4||
48123432|NCT00617240|100626535|FG001|COMPLETED|Overall Study||4||
48570267|NCT01741688|101727783|FG000|STARTED|Overall Study||16||
48570268|NCT01741688|101727783|FG000|COMPLETED|Overall Study||13||
48570269|NCT01741688|101727783|FG000|NOT COMPLETED|Overall Study||3||
48570270|NCT02821754|101727784|FG000|STARTED|Overall Study||36||
48570271|NCT02821754|101727785|FG001|STARTED|Overall Study||16||
48570272|NCT02821754|101727786|FG002|STARTED|Overall Study||2||
48570273|NCT02821754|101727784|FG000|COMPLETED|Overall Study||20||
48123433|NCT00617240|100626534|FG000|NOT COMPLETED|Overall Study||1||
48123434|NCT00617240|100626535|FG001|NOT COMPLETED|Overall Study||0||
48123435|NCT04632940|100626536|FG000|STARTED|DB Period (52 Weeks)||37||
48123436|NCT04632940|100626537|FG001|STARTED|DB Period (52 Weeks)||36||
48123437|NCT04632940|100626536|FG000|Received at Least 1 Dose of Study Drug|DB Period (52 Weeks)||36||
48123438|NCT04632940|100626537|FG001|Received at Least 1 Dose of Study Drug|DB Period (52 Weeks)||36||
48123439|NCT04632940|100626536|FG000|COMPLETED|DB Period (52 Weeks)||35||
48123440|NCT04632940|100626537|FG001|COMPLETED|DB Period (52 Weeks)||36||
48123441|NCT04632940|100626536|FG000|NOT COMPLETED|DB Period (52 Weeks)||2||
48123442|NCT04632940|100626537|FG001|NOT COMPLETED|DB Period (52 Weeks)||0||
48123443|NCT04632940|100626536|FG000|STARTED|OLE Period (52 Weeks)||34||
48123444|NCT04632940|100626537|FG001|STARTED|OLE Period (52 Weeks)||35||
48123445|NCT04632940|100626536|FG000|Received at Least 1 Dose of Study Drug|OLE Period (52 Weeks)||34||
48123446|NCT04632940|100626537|FG001|Received at Least 1 Dose of Study Drug|OLE Period (52 Weeks)||34||
48123447|NCT04632940|100626536|FG000|COMPLETED|OLE Period (52 Weeks)||0||
48123448|NCT04632940|100626537|FG001|COMPLETED|OLE Period (52 Weeks)||0||
48123449|NCT04632940|100626536|FG000|NOT COMPLETED|OLE Period (52 Weeks)||34||
48123450|NCT04632940|100626537|FG001|NOT COMPLETED|OLE Period (52 Weeks)||35||
48123451|NCT00982189|100626538|FG000|STARTED|Overall Study||10||
48123452|NCT00982189|100626539|FG001|STARTED|Overall Study||9||
48123453|NCT00982189|100626540|FG002|STARTED|Overall Study||9||
48123454|NCT00982189|100626541|FG003|STARTED|Overall Study||9||
48123455|NCT00982189|100626538|FG000|COMPLETED|Overall Study||10||
48123456|NCT00982189|100626539|FG001|COMPLETED|Overall Study||9||
48123457|NCT00982189|100626540|FG002|COMPLETED|Overall Study||9||
48123458|NCT00982189|100626541|FG003|COMPLETED|Overall Study||9||
48570274|NCT02821754|101727785|FG001|COMPLETED|Overall Study||4||
48570275|NCT02821754|101727786|FG002|COMPLETED|Overall Study||0||
48123459|NCT00982189|100626538|FG000|NOT COMPLETED|Overall Study||0||
48123460|NCT00982189|100626539|FG001|NOT COMPLETED|Overall Study||0||
48123461|NCT00982189|100626540|FG002|NOT COMPLETED|Overall Study||0||
48123462|NCT00982189|100626541|FG003|NOT COMPLETED|Overall Study||0||
48123463|NCT02520531|100626542|FG000|STARTED|Overall Study||42||
48123464|NCT02520531|100626543|FG001|STARTED|Overall Study||42||
48123465|NCT02520531|100626542|FG000|COMPLETED|Overall Study||36||
48123466|NCT02520531|100626543|FG001|COMPLETED|Overall Study||36||
48123467|NCT02520531|100626542|FG000|NOT COMPLETED|Overall Study||6||
48123468|NCT02520531|100626543|FG001|NOT COMPLETED|Overall Study||6||
48123469|NCT04175262|100626544|FG000|STARTED|Overall Study||102||
48123470|NCT04175262|100626544|FG000|COMPLETED|Overall Study||102||
48123471|NCT04175262|100626544|FG000|NOT COMPLETED|Overall Study||0||
48123472|NCT02192684|100626545|FG000|STARTED|Overall Study||30||
48123473|NCT02192684|100626546|FG001|STARTED|Overall Study||15||
48123474|NCT02192684|100626545|FG000|COMPLETED|Overall Study||30||
48123475|NCT02192684|100626546|FG001|COMPLETED|Overall Study||15||
48123476|NCT02192684|100626545|FG000|NOT COMPLETED|Overall Study||0||
48123477|NCT02192684|100626546|FG001|NOT COMPLETED|Overall Study||0||
48123478|NCT01243944|100626547|FG000|STARTED|Overall Study||110||
48123479|NCT01243944|100626548|FG001|STARTED|Overall Study||112||
48123480|NCT01243944|100626547|FG000|Treated|Overall Study||110||
48123481|NCT01243944|100626548|FG001|Treated|Overall Study||111||
48123482|NCT01243944|100626547|FG000|Followed for Survival|Overall Study||22||
48123483|NCT01243944|100626548|FG001|Followed for Survival|Overall Study||21||
48123484|NCT01243944|100626547|FG000|COMPLETED|Overall Study||65||
48123485|NCT01243944|100626548|FG001|COMPLETED|Overall Study||61||
48123486|NCT01243944|100626547|FG000|NOT COMPLETED|Overall Study||45||
48123487|NCT01243944|100626548|FG001|NOT COMPLETED|Overall Study||51||
48123488|NCT00801684|100626549|FG000|STARTED|Overall Study||24||
48570276|NCT02821754|101727784|FG000|NOT COMPLETED|Overall Study||16||
48570277|NCT02821754|101727785|FG001|NOT COMPLETED|Overall Study||12||
48123489|NCT00801684|100626549|FG000|COMPLETED|Overall Study||24||
48123490|NCT00801684|100626549|FG000|NOT COMPLETED|Overall Study||0||
48123491|NCT03264157|100626550|FG000|STARTED|Overall Study||81||
48123492|NCT03264157|100626551|FG001|STARTED|Overall Study||81||
48123493|NCT03264157|100626550|FG000|COMPLETED|Overall Study||68||
48123494|NCT03264157|100626551|FG001|COMPLETED|Overall Study||74||
48123495|NCT03264157|100626550|FG000|NOT COMPLETED|Overall Study||13||
48123496|NCT03264157|100626551|FG001|NOT COMPLETED|Overall Study||7||
48123497|NCT04177108|100626552|FG000|STARTED|Overall Study||43||
48123498|NCT04177108|100626553|FG001|STARTED|Overall Study||43||
48123499|NCT04177108|100626554|FG002|STARTED|Overall Study||41||
48123500|NCT04177108|100626555|FG003|STARTED|Overall Study||58||
48123501|NCT04177108|100626556|FG004|STARTED|Overall Study||57||
48123502|NCT04177108|100626552|FG000|COMPLETED|Overall Study||0||
48123503|NCT04177108|100626553|FG001|COMPLETED|Overall Study||0||
48123504|NCT04177108|100626554|FG002|COMPLETED|Overall Study||0||
48123505|NCT04177108|100626555|FG003|COMPLETED|Overall Study||0||
48123506|NCT04177108|100626556|FG004|COMPLETED|Overall Study||0||
48123507|NCT04177108|100626552|FG000|NOT COMPLETED|Overall Study||43||
48123508|NCT04177108|100626553|FG001|NOT COMPLETED|Overall Study||43||
48123509|NCT04177108|100626554|FG002|NOT COMPLETED|Overall Study||41||
48123510|NCT04177108|100626555|FG003|NOT COMPLETED|Overall Study||58||
48123511|NCT04177108|100626556|FG004|NOT COMPLETED|Overall Study||57||
48123512|NCT03985813|100626557|FG000|STARTED|Overall Study||27||
48123513|NCT03985813|100626558|FG001|STARTED|Overall Study||26||
48123514|NCT03985813|100626557|FG000|COMPLETED|Overall Study||27||
48123515|NCT03985813|100626558|FG001|COMPLETED|Overall Study||26||
48123516|NCT03985813|100626557|FG000|NOT COMPLETED|Overall Study||0||
48123517|NCT03985813|100626558|FG001|NOT COMPLETED|Overall Study||0||
48123518|NCT02248922|100626559|FG000|STARTED|Overall Study||5||
48123519|NCT02248922|100626560|FG001|STARTED|Overall Study||12||
48123520|NCT02248922|100626559|FG000|COMPLETED|Overall Study||5||
48123521|NCT02248922|100626560|FG001|COMPLETED|Overall Study||12||
48123522|NCT02248922|100626559|FG000|NOT COMPLETED|Overall Study||0||
48123523|NCT02248922|100626560|FG001|NOT COMPLETED|Overall Study||0||
48123524|NCT00780572|100626561|FG000|STARTED|Overall Study||297||
48123525|NCT00780572|100626562|FG001|STARTED|Overall Study||298||
48123526|NCT00780572|100626561|FG000|COMPLETED|Overall Study||297||
48123527|NCT00780572|100626562|FG001|COMPLETED|Overall Study||298||
48123528|NCT00780572|100626561|FG000|NOT COMPLETED|Overall Study||0||
48123529|NCT00780572|100626562|FG001|NOT COMPLETED|Overall Study||0||
48123530|NCT00413413|100626563|FG000|STARTED|Single-Blind||0||
48123531|NCT00413413|100626564|FG001|STARTED|Single-Blind||1134||
48123532|NCT00413413|100626565|FG002|STARTED|Single-Blind||0||
48123533|NCT00413413|100626563|FG000|COMPLETED|Single-Blind||0||
48123534|NCT00413413|100626564|FG001|COMPLETED|Single-Blind||918||
48123535|NCT00413413|100626565|FG002|COMPLETED|Single-Blind||0||
48123536|NCT00413413|100626563|FG000|NOT COMPLETED|Single-Blind||0||
48123537|NCT00413413|100626564|FG001|NOT COMPLETED|Single-Blind||216||
48123538|NCT00413413|100626565|FG002|NOT COMPLETED|Single-Blind||0||
48123539|NCT00413413|100626563|FG000|STARTED|Double-Blind||308||
48123540|NCT00413413|100626564|FG001|STARTED|Double-Blind||307||
48123541|NCT00413413|100626565|FG002|STARTED|Double-Blind||303||
48123542|NCT00413413|100626563|FG000|COMPLETED|Double-Blind||293||
48123543|NCT00413413|100626564|FG001|COMPLETED|Double-Blind||293||
48123544|NCT00413413|100626565|FG002|COMPLETED|Double-Blind||285||
48123545|NCT00413413|100626563|FG000|NOT COMPLETED|Double-Blind||15||
48123546|NCT00413413|100626564|FG001|NOT COMPLETED|Double-Blind||14||
48123547|NCT00413413|100626565|FG002|NOT COMPLETED|Double-Blind||18||
48123548|NCT03004534|100626566|FG000|STARTED|Overall Study||36||
48123549|NCT03004534|100626566|FG000|COMPLETED|Overall Study||36||
48123550|NCT03004534|100626566|FG000|NOT COMPLETED|Overall Study||0||
48123551|NCT03766009|100626567|FG000|STARTED|Usual Care||26||2
48123552|NCT03766009|100626568|FG001|STARTED|Usual Care||54||2
48123553|NCT03766009|100626569|FG002|STARTED|Usual Care||34||2
48123554|NCT03766009|100626570|FG003|STARTED|Usual Care||74||2
48123555|NCT03766009|100626571|FG004|STARTED|Usual Care||77||2
48123556|NCT03766009|100626572|FG005|STARTED|Usual Care||28||10
48123557|NCT03766009|100626567|FG000|COMPLETED|Usual Care||26||2
48123558|NCT03766009|100626568|FG001|COMPLETED|Usual Care||51||2
48123559|NCT03766009|100626569|FG002|COMPLETED|Usual Care||32||2
48123560|NCT03766009|100626570|FG003|COMPLETED|Usual Care||68||2
48123561|NCT03766009|100626571|FG004|COMPLETED|Usual Care||76||2
48123562|NCT03766009|100626572|FG005|COMPLETED|Usual Care||26||10
48123563|NCT03766009|100626567|FG000|NOT COMPLETED|Usual Care||0||0
48123564|NCT03766009|100626568|FG001|NOT COMPLETED|Usual Care||3||0
48123565|NCT03766009|100626569|FG002|NOT COMPLETED|Usual Care||2||0
48123566|NCT03766009|100626570|FG003|NOT COMPLETED|Usual Care||6||0
48123567|NCT03766009|100626571|FG004|NOT COMPLETED|Usual Care||1||0
48123568|NCT03766009|100626572|FG005|NOT COMPLETED|Usual Care||2||0
48123569|NCT03766009|100626567|FG000|STARTED|Implementation||0||0
48123570|NCT03766009|100626568|FG001|STARTED|Implementation||0||0
48123571|NCT03766009|100626569|FG002|STARTED|Implementation||0||0
48123572|NCT03766009|100626570|FG003|STARTED|Implementation||0||0
48123573|NCT03766009|100626571|FG004|STARTED|Implementation||0||0
48123574|NCT03766009|100626572|FG005|STARTED|Implementation||26||10
48123575|NCT03766009|100626567|FG000|COMPLETED|Implementation||0||0
48123576|NCT03766009|100626568|FG001|COMPLETED|Implementation||0||0
48123577|NCT03766009|100626569|FG002|COMPLETED|Implementation||0||0
48123578|NCT03766009|100626570|FG003|COMPLETED|Implementation||0||0
48123579|NCT03766009|100626571|FG004|COMPLETED|Implementation||0||0
48123580|NCT03766009|100626572|FG005|COMPLETED|Implementation||26||10
48123581|NCT03766009|100626567|FG000|NOT COMPLETED|Implementation||0||0
48123582|NCT03766009|100626568|FG001|NOT COMPLETED|Implementation||0||0
48123583|NCT03766009|100626569|FG002|NOT COMPLETED|Implementation||0||0
48123584|NCT03766009|100626570|FG003|NOT COMPLETED|Implementation||0||0
48123585|NCT03766009|100626571|FG004|NOT COMPLETED|Implementation||0||0
48123586|NCT03766009|100626572|FG005|NOT COMPLETED|Implementation||0||0
48123587|NCT03766009|100626567|FG000|STARTED|Intervention||124||2
48123588|NCT03766009|100626568|FG001|STARTED|Intervention||109||2
48123589|NCT03766009|100626569|FG002|STARTED|Intervention||32||2
48123590|NCT03766009|100626570|FG003|STARTED|Intervention||32||2
48123591|NCT03766009|100626571|FG004|STARTED|Intervention||14||2
48123592|NCT03766009|100626572|FG005|STARTED|Intervention||27||10
48123593|NCT03766009|100626567|FG000|COMPLETED|Intervention||118||2
48123594|NCT03766009|100626568|FG001|COMPLETED|Intervention||101||2
48123595|NCT03766009|100626569|FG002|COMPLETED|Intervention||31||2
48123596|NCT03766009|100626570|FG003|COMPLETED|Intervention||25||2
48123597|NCT03766009|100626571|FG004|COMPLETED|Intervention||14||2
48123598|NCT03766009|100626572|FG005|COMPLETED|Intervention||27||10
48123599|NCT03766009|100626567|FG000|NOT COMPLETED|Intervention||6||0
48123600|NCT03766009|100626568|FG001|NOT COMPLETED|Intervention||8||0
48123601|NCT03766009|100626569|FG002|NOT COMPLETED|Intervention||1||0
48123602|NCT03766009|100626570|FG003|NOT COMPLETED|Intervention||7||0
48123603|NCT03766009|100626571|FG004|NOT COMPLETED|Intervention||0||0
48123604|NCT03766009|100626572|FG005|NOT COMPLETED|Intervention||0||0
48123605|NCT03766009|100626567|FG000|STARTED|Extended Enrollment Beyond Wave 7||0||0
48123606|NCT03766009|100626568|FG001|STARTED|Extended Enrollment Beyond Wave 7||16||2
48123607|NCT03766009|100626569|FG002|STARTED|Extended Enrollment Beyond Wave 7||0||0
48123608|NCT03766009|100626570|FG003|STARTED|Extended Enrollment Beyond Wave 7||0||0
48123609|NCT03766009|100626571|FG004|STARTED|Extended Enrollment Beyond Wave 7||6||2
48123610|NCT03766009|100626572|FG005|STARTED|Extended Enrollment Beyond Wave 7||18||10
48123611|NCT03766009|100626567|FG000|COMPLETED|Extended Enrollment Beyond Wave 7||0||0
48123612|NCT03766009|100626568|FG001|COMPLETED|Extended Enrollment Beyond Wave 7||12||2
48123613|NCT03766009|100626569|FG002|COMPLETED|Extended Enrollment Beyond Wave 7||0||0
48123614|NCT03766009|100626570|FG003|COMPLETED|Extended Enrollment Beyond Wave 7||0||0
48123615|NCT03766009|100626571|FG004|COMPLETED|Extended Enrollment Beyond Wave 7||6||2
48123616|NCT03766009|100626572|FG005|COMPLETED|Extended Enrollment Beyond Wave 7||18||10
48123617|NCT03766009|100626567|FG000|NOT COMPLETED|Extended Enrollment Beyond Wave 7||0||0
48123618|NCT03766009|100626568|FG001|NOT COMPLETED|Extended Enrollment Beyond Wave 7||4||0
48123619|NCT03766009|100626569|FG002|NOT COMPLETED|Extended Enrollment Beyond Wave 7||0||0
48123620|NCT03766009|100626570|FG003|NOT COMPLETED|Extended Enrollment Beyond Wave 7||0||0
48123621|NCT03766009|100626571|FG004|NOT COMPLETED|Extended Enrollment Beyond Wave 7||0||0
48123622|NCT03766009|100626572|FG005|NOT COMPLETED|Extended Enrollment Beyond Wave 7||0||0
48123623|NCT02939105|100626573|FG000|STARTED|Overall Study||15||
48123624|NCT02939105|100626573|FG000|COMPLETED|Overall Study||15||
48123625|NCT02939105|100626573|FG000|NOT COMPLETED|Overall Study||0||
48123626|NCT01513291|100626574|FG000|STARTED|Treatment Period||120||
48123627|NCT01513291|100626575|FG001|STARTED|Treatment Period||117||
48123628|NCT01513291|100626576|FG002|STARTED|Treatment Period||0||
48123629|NCT01513291|100626577|FG003|STARTED|Treatment Period||0||
48123630|NCT01513291|100626578|FG004|STARTED|Treatment Period||0||
48123631|NCT01513291|100626574|FG000|Treated|Treatment Period||120||
48123632|NCT01513291|100626575|FG001|Treated|Treatment Period||115||
48123633|NCT01513291|100626576|FG002|Treated|Treatment Period||0||
48123634|NCT01513291|100626577|FG003|Treated|Treatment Period||0||
48123635|NCT01513291|100626578|FG004|Treated|Treatment Period||0||
48123636|NCT01513291|100626574|FG000|COMPLETED|Treatment Period||97||
48123637|NCT01513291|100626575|FG001|COMPLETED|Treatment Period||101||
48123638|NCT01513291|100626576|FG002|COMPLETED|Treatment Period||0||
48123639|NCT01513291|100626577|FG003|COMPLETED|Treatment Period||0||
48123640|NCT01513291|100626578|FG004|COMPLETED|Treatment Period||0||
48123641|NCT01513291|100626574|FG000|NOT COMPLETED|Treatment Period||23||
48123642|NCT01513291|100626575|FG001|NOT COMPLETED|Treatment Period||16||
48123643|NCT01513291|100626576|FG002|NOT COMPLETED|Treatment Period||0||
48123644|NCT01513291|100626577|FG003|NOT COMPLETED|Treatment Period||0||
48123645|NCT01513291|100626578|FG004|NOT COMPLETED|Treatment Period||0||
48123646|NCT01513291|100626574|FG000|STARTED|Run-out Period||0||
48123647|NCT01513291|100626575|FG001|STARTED|Run-out Period||0||
48123648|NCT01513291|100626576|FG002|STARTED|Run-out Period||50||
48123649|NCT01513291|100626577|FG003|STARTED|Run-out Period||47||
48123650|NCT01513291|100626578|FG004|STARTED|Run-out Period||101||
48123651|NCT01513291|100626574|FG000|COMPLETED|Run-out Period||0||
48123652|NCT01513291|100626575|FG001|COMPLETED|Run-out Period||0||
48123653|NCT01513291|100626576|FG002|COMPLETED|Run-out Period||50||
48123654|NCT01513291|100626577|FG003|COMPLETED|Run-out Period||45||
48123655|NCT01513291|100626578|FG004|COMPLETED|Run-out Period||101||
48123656|NCT01513291|100626574|FG000|NOT COMPLETED|Run-out Period||0||
48123657|NCT01513291|100626575|FG001|NOT COMPLETED|Run-out Period||0||
48123658|NCT01513291|100626576|FG002|NOT COMPLETED|Run-out Period||0||
48123659|NCT01513291|100626577|FG003|NOT COMPLETED|Run-out Period||2||
48123660|NCT01513291|100626578|FG004|NOT COMPLETED|Run-out Period||0||
48123661|NCT02564471|100626579|FG000|STARTED|Overall Study||25||
48123662|NCT02564471|100626580|FG001|STARTED|Overall Study||26||
48123663|NCT02564471|100626581|FG002|STARTED|Overall Study||27||
48123664|NCT02564471|100626582|FG003|STARTED|Overall Study||25||
48123665|NCT02564471|100626579|FG000|COMPLETED|Overall Study||22||
48123666|NCT02564471|100626580|FG001|COMPLETED|Overall Study||23||
48123667|NCT02564471|100626581|FG002|COMPLETED|Overall Study||24||
48123668|NCT02564471|100626582|FG003|COMPLETED|Overall Study||25||
48123669|NCT02564471|100626579|FG000|NOT COMPLETED|Overall Study||3||
48123670|NCT02564471|100626580|FG001|NOT COMPLETED|Overall Study||3||
48123671|NCT02564471|100626581|FG002|NOT COMPLETED|Overall Study||3||
48123672|NCT02564471|100626582|FG003|NOT COMPLETED|Overall Study||0||
48123673|NCT01646671|100626583|FG000|STARTED|Overall Study||3||
48123674|NCT01646671|100626584|FG001|STARTED|Overall Study||11||
48123675|NCT01646671|100626585|FG002|STARTED|Overall Study||21||
48123676|NCT01646671|100626583|FG000|COMPLETED|Overall Study||3||
48123677|NCT01646671|100626584|FG001|COMPLETED|Overall Study||11||
48123678|NCT01646671|100626585|FG002|COMPLETED|Overall Study||21||
48123679|NCT01646671|100626583|FG000|NOT COMPLETED|Overall Study||0||
48123680|NCT01646671|100626584|FG001|NOT COMPLETED|Overall Study||0||
48123681|NCT01646671|100626585|FG002|NOT COMPLETED|Overall Study||0||
48123682|NCT03843788|100626586|FG000|STARTED|Overall Study||5||
48123683|NCT03843788|100626587|FG001|STARTED|Overall Study||3||
48123684|NCT03843788|100626588|FG002|STARTED|Overall Study||5||
48123685|NCT03843788|100626589|FG003|STARTED|Overall Study||2||
48123686|NCT03843788|100626586|FG000|COMPLETED|Overall Study||5||
48123687|NCT03843788|100626587|FG001|COMPLETED|Overall Study||3||
48123688|NCT03843788|100626588|FG002|COMPLETED|Overall Study||5||
48123689|NCT03843788|100626589|FG003|COMPLETED|Overall Study||2||
48123690|NCT03843788|100626586|FG000|NOT COMPLETED|Overall Study||0||
48123691|NCT03843788|100626587|FG001|NOT COMPLETED|Overall Study||0||
48123692|NCT03843788|100626588|FG002|NOT COMPLETED|Overall Study||0||
48123693|NCT03843788|100626589|FG003|NOT COMPLETED|Overall Study||0||
48123694|NCT02838017|100626590|FG000|STARTED|Overall Study||252||
48123695|NCT02838017|100626591|FG001|STARTED|Overall Study||252||
48123696|NCT02838017|100626590|FG000|COMPLETED|Overall Study||238||
48123697|NCT02838017|100626591|FG001|COMPLETED|Overall Study||241||
48123698|NCT02838017|100626590|FG000|NOT COMPLETED|Overall Study||14||
48123699|NCT02838017|100626591|FG001|NOT COMPLETED|Overall Study||11||
48123700|NCT01375049|100626592|FG000|STARTED|Overall Study||105||
48123701|NCT01375049|100626592|FG000|COMPLETED|Overall Study||55||
48123702|NCT01375049|100626592|FG000|NOT COMPLETED|Overall Study||50||
48123703|NCT01709227|100626593|FG000|STARTED|Overall Study||32||
48123704|NCT01709227|100626594|FG001|STARTED|Overall Study||41||
48123705|NCT01709227|100626593|FG000|COMPLETED|Overall Study||31||
48123706|NCT01709227|100626594|FG001|COMPLETED|Overall Study||32||
48123707|NCT01709227|100626593|FG000|NOT COMPLETED|Overall Study||1||
48123708|NCT01709227|100626594|FG001|NOT COMPLETED|Overall Study||9||
48123709|NCT00852397|100626595|FG000|STARTED|Overall Study||52||
48123710|NCT00852397|100626596|FG001|STARTED|Overall Study||49||
48123711|NCT00852397|100626597|FG002|STARTED|Overall Study||50||
48123712|NCT00852397|100626595|FG000|Treated Participants|Overall Study||51||
48282018|NCT02101385|101014226|FG000|STARTED|Study Treatment||71||
48282019|NCT02101385|101014227|FG001|STARTED|Study Treatment||122||
48282020|NCT02101385|101014226|FG000|COMPLETED|Study Treatment||45||
48282021|NCT02101385|101014227|FG001|COMPLETED|Study Treatment||110||
48282022|NCT02101385|101014226|FG000|NOT COMPLETED|Study Treatment||26||
48282023|NCT02101385|101014227|FG001|NOT COMPLETED|Study Treatment||12||
48282024|NCT02101385|101014226|FG000|STARTED|Follow up||70|Treatment and Follow up both are at different time period. Therefore, the number of subjects to start follow up is not equal to the number of subjects who have completed treatment.|
48123713|NCT00852397|100626596|FG001|Treated Participants|Overall Study||49||
48123714|NCT00852397|100626597|FG002|Treated Participants|Overall Study||49||
48123715|NCT00852397|100626595|FG000|COMPLETED|Overall Study||41||
48123716|NCT00852397|100626596|FG001|COMPLETED|Overall Study||41||
48123717|NCT00852397|100626597|FG002|COMPLETED|Overall Study||36||
48123718|NCT00852397|100626595|FG000|NOT COMPLETED|Overall Study||11||
48123719|NCT00852397|100626596|FG001|NOT COMPLETED|Overall Study||8||
48123720|NCT00852397|100626597|FG002|NOT COMPLETED|Overall Study||14||
48123721|NCT01816139|100626598|FG000|STARTED|Overall Study||289||
48123722|NCT01816139|100626599|FG001|STARTED|Overall Study||287||
48123723|NCT01816139|100626598|FG000|Safety Population|Overall Study||287||
48123724|NCT01816139|100626599|FG001|Safety Population|Overall Study||286||
48123725|NCT01816139|100626598|FG000|Modified Intent-to-treat (mITT) Population|Overall Study||240||
48123726|NCT01816139|100626599|FG001|Modified Intent-to-treat (mITT) Population|Overall Study||248||
48396944|NCT00654953|101302500|FG002|NOT COMPLETED|Overall Study||22||
48123727|NCT01816139|100626598|FG000|COMPLETED|Overall Study||261||
48123728|NCT01816139|100626599|FG001|COMPLETED|Overall Study||265||
48123729|NCT01816139|100626598|FG000|NOT COMPLETED|Overall Study||28||
48123730|NCT01816139|100626599|FG001|NOT COMPLETED|Overall Study||22||
48123731|NCT03246529|100626600|FG000|STARTED|Core Study (Until 100 d Post-transplant)||12||
48123732|NCT03246529|100626601|FG001|STARTED|Core Study (Until 100 d Post-transplant)||80||
48123733|NCT03246529|100626602|FG002|STARTED|Core Study (Until 100 d Post-transplant)||42||
48123734|NCT03246529|100626600|FG000|Post Transplantation Analysis Set|Core Study (Until 100 d Post-transplant)||12||
48123735|NCT03246529|100626601|FG001|Post Transplantation Analysis Set|Core Study (Until 100 d Post-transplant)||77||
48123736|NCT03246529|100626602|FG002|Post Transplantation Analysis Set|Core Study (Until 100 d Post-transplant)||37||
48123737|NCT03246529|100626600|FG000|COMPLETED|Core Study (Until 100 d Post-transplant)||12||
48123738|NCT03246529|100626601|FG001|COMPLETED|Core Study (Until 100 d Post-transplant)||74||
48123739|NCT03246529|100626602|FG002|COMPLETED|Core Study (Until 100 d Post-transplant)||34||
48123740|NCT03246529|100626600|FG000|NOT COMPLETED|Core Study (Until 100 d Post-transplant)||0||
48123741|NCT03246529|100626601|FG001|NOT COMPLETED|Core Study (Until 100 d Post-transplant)||6||
48123742|NCT03246529|100626602|FG002|NOT COMPLETED|Core Study (Until 100 d Post-transplant)||8||
48123743|NCT03246529|100626600|FG000|STARTED|Follow-up Period at 1 Year FU Completion||12||
48123744|NCT03246529|100626601|FG001|STARTED|Follow-up Period at 1 Year FU Completion||73||
48123745|NCT03246529|100626602|FG002|STARTED|Follow-up Period at 1 Year FU Completion||34||
48123746|NCT03246529|100626600|FG000|COMPLETED|Follow-up Period at 1 Year FU Completion||9|Long Term FU is ongoing. Numbers are of the subject ongoing in the study.|
48123747|NCT03246529|100626601|FG001|COMPLETED|Follow-up Period at 1 Year FU Completion||66|Long Term FU is ongoing. Numbers are of the subject ongoing in the study.|
48123748|NCT03246529|100626602|FG002|COMPLETED|Follow-up Period at 1 Year FU Completion||32|Long Term FU is ongoing. Numbers are of the subject ongoing in the study.|
48123749|NCT03246529|100626600|FG000|NOT COMPLETED|Follow-up Period at 1 Year FU Completion||3||
48123750|NCT03246529|100626601|FG001|NOT COMPLETED|Follow-up Period at 1 Year FU Completion||7||
48123751|NCT03246529|100626602|FG002|NOT COMPLETED|Follow-up Period at 1 Year FU Completion||2||
48123752|NCT01117311|100626603|FG000|STARTED|Lead-in Mixed Meal 1||3||
48123753|NCT01117311|100626604|FG001|STARTED|Lead-in Mixed Meal 1||4||
48123754|NCT01117311|100626603|FG000|COMPLETED|Lead-in Mixed Meal 1||3||
48123755|NCT01117311|100626604|FG001|COMPLETED|Lead-in Mixed Meal 1||4||
48123756|NCT01117311|100626603|FG000|NOT COMPLETED|Lead-in Mixed Meal 1||0||
48123757|NCT01117311|100626604|FG001|NOT COMPLETED|Lead-in Mixed Meal 1||0||
48123758|NCT01117311|100626603|FG000|STARTED|First Intervention - Mixed Meal 2||3||
48123759|NCT01117311|100626604|FG001|STARTED|First Intervention - Mixed Meal 2||4||
48123760|NCT01117311|100626603|FG000|COMPLETED|First Intervention - Mixed Meal 2||3||
48123761|NCT01117311|100626604|FG001|COMPLETED|First Intervention - Mixed Meal 2||4||
48282025|NCT02101385|101014227|FG001|STARTED|Follow up||122|Treatment and Follow up both are at different time period. Therefore, the number of subjects to start follow up is not equal to the number of subjects who have completed treatment.|
48282026|NCT02101385|101014226|FG000|COMPLETED|Follow up||3||
48282027|NCT02101385|101014227|FG001|COMPLETED|Follow up||9||
48282028|NCT02101385|101014226|FG000|NOT COMPLETED|Follow up||67||
48282029|NCT02101385|101014227|FG001|NOT COMPLETED|Follow up||113||
48570278|NCT02821754|101727786|FG002|NOT COMPLETED|Overall Study||2||
48570279|NCT00457197|101727787|FG000|STARTED|Overall Study||45||
48570280|NCT00457197|101727788|FG001|STARTED|Overall Study||45||
48570281|NCT00457197|101727787|FG000|COMPLETED|Overall Study||44||
48570282|NCT00457197|101727788|FG001|COMPLETED|Overall Study||44||
48123762|NCT01117311|100626603|FG000|NOT COMPLETED|First Intervention - Mixed Meal 2||0||
48123763|NCT01117311|100626604|FG001|NOT COMPLETED|First Intervention - Mixed Meal 2||0||
48123764|NCT01117311|100626603|FG000|STARTED|Second Intervention - Mixed Meal 3||3||
48123765|NCT01117311|100626604|FG001|STARTED|Second Intervention - Mixed Meal 3||4||
48123766|NCT01117311|100626603|FG000|COMPLETED|Second Intervention - Mixed Meal 3||3||
48123767|NCT01117311|100626604|FG001|COMPLETED|Second Intervention - Mixed Meal 3||4||
48123768|NCT01117311|100626603|FG000|NOT COMPLETED|Second Intervention - Mixed Meal 3||0||
48123769|NCT01117311|100626604|FG001|NOT COMPLETED|Second Intervention - Mixed Meal 3||0||
48123770|NCT00559897|100626605|FG000|STARTED|Overall Study||6||
48123771|NCT00559897|100626605|FG000|COMPLETED|Overall Study||6||
48123772|NCT00559897|100626605|FG000|NOT COMPLETED|Overall Study||0||
48282030|NCT03866798|101014228|FG000|STARTED|Overall Study||6||
48282031|NCT03866798|101014228|FG000|COMPLETED|Overall Study||6||
48282032|NCT03866798|101014228|FG000|NOT COMPLETED|Overall Study||0||
48282033|NCT00105001|101014229|FG000|STARTED|Overall Study||70||
48282034|NCT00105001|101014230|FG001|STARTED|Overall Study||71||
48282035|NCT00105001|101014231|FG002|STARTED|Overall Study||69||
48123773|NCT02476565|100626606|FG000|STARTED|Overall Study||20||
48123774|NCT02476565|100626607|FG001|STARTED|Overall Study||19||
48123775|NCT02476565|100626606|FG000|COMPLETED|Overall Study||20||
48123776|NCT02476565|100626607|FG001|COMPLETED|Overall Study||19||
48282036|NCT00105001|101014229|FG000|COMPLETED|Overall Study||70||
48282037|NCT00105001|101014230|FG001|COMPLETED|Overall Study||71||
48282038|NCT00105001|101014231|FG002|COMPLETED|Overall Study||69||
48282039|NCT00105001|101014229|FG000|NOT COMPLETED|Overall Study||0||
48282040|NCT00105001|101014230|FG001|NOT COMPLETED|Overall Study||0||
48570283|NCT00457197|101727787|FG000|NOT COMPLETED|Overall Study||1||
48570284|NCT00457197|101727788|FG001|NOT COMPLETED|Overall Study||1||
48570285|NCT03834688|101727789|FG000|STARTED|Overall Study||33||
48123777|NCT02476565|100626606|FG000|NOT COMPLETED|Overall Study||0||
48123778|NCT02476565|100626607|FG001|NOT COMPLETED|Overall Study||0||
48123779|NCT01299077|100626608|FG000|STARTED|Overall Study||478||
48123780|NCT01299077|100626608|FG000|COMPLETED|Overall Study||478||
48123781|NCT01299077|100626608|FG000|NOT COMPLETED|Overall Study||0||
48123782|NCT01196871|100626609|FG000|STARTED|Stage 1: Period 1||5||
48123783|NCT01196871|100626610|FG001|STARTED|Stage 1: Period 1||3||
48123784|NCT01196871|100626611|FG002|STARTED|Stage 1: Period 1||4||
48123785|NCT01196871|100626612|FG003|STARTED|Stage 1: Period 1||0||
48123786|NCT01196871|100626613|FG004|STARTED|Stage 1: Period 1||0||
48123787|NCT01196871|100626614|FG005|STARTED|Stage 1: Period 1||0||
48123788|NCT01196871|100626609|FG000|PK Population|Stage 1: Period 1||5|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
48123789|NCT01196871|100626610|FG001|PK Population|Stage 1: Period 1||3|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
48123790|NCT01196871|100626611|FG002|PK Population|Stage 1: Period 1||4|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
48123791|NCT01196871|100626612|FG003|PK Population|Stage 1: Period 1||0|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
48123792|NCT01196871|100626613|FG004|PK Population|Stage 1: Period 1||0|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
48123793|NCT01196871|100626614|FG005|PK Population|Stage 1: Period 1||0|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
48123794|NCT01196871|100626609|FG000|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||5|Safety Population|
48123795|NCT01196871|100626610|FG001|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||3|Safety Population|
48123796|NCT01196871|100626611|FG002|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||4|Safety Population|
48123797|NCT01196871|100626612|FG003|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0|Safety Population|
48570286|NCT03834688|101727789|FG000|COMPLETED|Overall Study||33||
48570287|NCT03834688|101727789|FG000|NOT COMPLETED|Overall Study||0||
48570288|NCT03337087|101727790|FG000|STARTED|Overall Study||18||
48570289|NCT03337087|101727790|FG000|COMPLETED|Overall Study||12||
48570290|NCT03337087|101727790|FG000|NOT COMPLETED|Overall Study||6||
48570291|NCT00927862|101727791|FG000|STARTED|Overall Study||504||
48570292|NCT00927862|101727792|FG001|STARTED|Overall Study||1911||
48570293|NCT00927862|101727791|FG000|COMPLETED|Overall Study||477||
48570294|NCT00927862|101727792|FG001|COMPLETED|Overall Study||1866||
48570295|NCT00927862|101727791|FG000|NOT COMPLETED|Overall Study||27||
48570296|NCT00927862|101727792|FG001|NOT COMPLETED|Overall Study||45||
48570297|NCT00931528|101727793|FG000|STARTED|Overall Study||121||
48570298|NCT00931528|101727794|FG001|STARTED|Overall Study||121||
48570299|NCT00931528|101727793|FG000|COMPLETED|Overall Study||80||
48570300|NCT00931528|101727794|FG001|COMPLETED|Overall Study||61||
48570301|NCT00931528|101727793|FG000|NOT COMPLETED|Overall Study||41||
48570302|NCT00931528|101727794|FG001|NOT COMPLETED|Overall Study||60||
48570303|NCT00997373|101727795|FG000|STARTED|Overall Study||28||
48570304|NCT00997373|101727796|FG001|STARTED|Overall Study||15||
48570305|NCT00997373|101727795|FG000|Received Letrozole|Overall Study||23||
48570306|NCT00997373|101727796|FG001|Received Letrozole|Overall Study||0||
48570307|NCT00997373|101727795|FG000|Completed Hysterectomy|Overall Study||17||
48570308|NCT00997373|101727796|FG001|Completed Hysterectomy|Overall Study||15||
48570309|NCT00997373|101727795|FG000|COMPLETED|Overall Study||13||
48570310|NCT00997373|101727796|FG001|COMPLETED|Overall Study||15||
48570311|NCT00997373|101727795|FG000|NOT COMPLETED|Overall Study||15||
48570312|NCT00997373|101727796|FG001|NOT COMPLETED|Overall Study||0||
48570313|NCT00343044|101727797|FG000|STARTED|Overall Study||40||
48570314|NCT00343044|101727797|FG000|COMPLETED|Overall Study||40||
48570315|NCT00343044|101727797|FG000|NOT COMPLETED|Overall Study||0||
48570316|NCT04390503|101727798|FG000|STARTED|Overall Study||150||
48699720|NCT03213938|102050580|FG001|COMPLETED|Overall Study||208||
48699721|NCT03213938|102050579|FG000|NOT COMPLETED|Overall Study||14||
48123798|NCT01196871|100626613|FG004|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0|Safety Population|
48123799|NCT01196871|100626614|FG005|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0|Safety Population|
48570317|NCT04390503|101727799|FG001|STARTED|Overall Study||73||
48570318|NCT04390503|101727798|FG000|COMPLETED|Overall Study||147||
48570319|NCT04390503|101727799|FG001|COMPLETED|Overall Study||72||
48570320|NCT04390503|101727798|FG000|NOT COMPLETED|Overall Study||3||
48570321|NCT04390503|101727799|FG001|NOT COMPLETED|Overall Study||1||
48570322|NCT01623310|101727800|FG000|STARTED|Overall Study||223||
48570323|NCT01623310|101727800|FG000|COMPLETED|Overall Study||144||
48570324|NCT01623310|101727800|FG000|NOT COMPLETED|Overall Study||79||
48570325|NCT03963232|101727801|FG000|STARTED|Double-Blind Treatment Phase||259||
48570326|NCT03963232|101727802|FG001|STARTED|Double-Blind Treatment Phase||261||
48570327|NCT03963232|101727801|FG000|Received at Least One Dose of Study Drug|Double-Blind Treatment Phase||259||
48570328|NCT03963232|101727802|FG001|Received at Least One Dose of Study Drug|Double-Blind Treatment Phase||261||
48570329|NCT03963232|101727801|FG000|COMPLETED|Double-Blind Treatment Phase||242||
48699722|NCT03213938|102050580|FG001|NOT COMPLETED|Overall Study||12||
48699723|NCT00079391|102050581|FG000|STARTED|Overall Study||50||
48699724|NCT00079391|102050581|FG000|COMPLETED|Overall Study||49||
48699725|NCT00079391|102050581|FG000|NOT COMPLETED|Overall Study||1||
48699726|NCT01668628|102050582|FG000|STARTED|Overall Study||349||
48570330|NCT03963232|101727802|FG001|COMPLETED|Double-Blind Treatment Phase||245||
48570331|NCT03963232|101727801|FG000|NOT COMPLETED|Double-Blind Treatment Phase||17||
48570332|NCT03963232|101727802|FG001|NOT COMPLETED|Double-Blind Treatment Phase||16||
48570333|NCT03963232|101727801|FG000|STARTED|Open-Label Treatment Phase||241||
48570334|NCT03963232|101727802|FG001|STARTED|Open-Label Treatment Phase||243||
48570335|NCT03963232|101727801|FG000|COMPLETED|Open-Label Treatment Phase||234||
48570336|NCT03963232|101727802|FG001|COMPLETED|Open-Label Treatment Phase||232||
48570337|NCT03963232|101727801|FG000|NOT COMPLETED|Open-Label Treatment Phase||7||
48570338|NCT03963232|101727802|FG001|NOT COMPLETED|Open-Label Treatment Phase||11||
48570339|NCT03963232|101727801|FG000|STARTED|Follow-up Phase||243||
48570340|NCT03963232|101727802|FG001|STARTED|Follow-up Phase||247||
48570341|NCT03963232|101727801|FG000|Entered From Double-blind Treatment Phase|Follow-up Phase||7||
48570342|NCT03963232|101727802|FG001|Entered From Double-blind Treatment Phase|Follow-up Phase||11||
48570343|NCT03963232|101727801|FG000|Entered From Open-Label Treatment Phase|Follow-up Phase||236||
48570344|NCT03963232|101727802|FG001|Entered From Open-Label Treatment Phase|Follow-up Phase||236||
48570345|NCT03963232|101727801|FG000|COMPLETED|Follow-up Phase||236||
48570346|NCT03963232|101727802|FG001|COMPLETED|Follow-up Phase||238||
48570347|NCT03963232|101727801|FG000|NOT COMPLETED|Follow-up Phase||7||
48570348|NCT03963232|101727802|FG001|NOT COMPLETED|Follow-up Phase||9||
48570349|NCT00735969|101727803|FG000|STARTED|Overall Study||21||
48570350|NCT00735969|101727803|FG000|COMPLETED|Overall Study||21||
48570351|NCT00735969|101727803|FG000|NOT COMPLETED|Overall Study||0||
48699727|NCT01668628|102050583|FG001|STARTED|Overall Study||359||
48699728|NCT01668628|102050584|FG002|STARTED|Overall Study||367||
48699729|NCT01668628|102050582|FG000|COMPLETED|Overall Study||347||
48123800|NCT01196871|100626609|FG000|COMPLETED|Stage 1: Period 1||5||
48123801|NCT01196871|100626610|FG001|COMPLETED|Stage 1: Period 1||3||
48123802|NCT01196871|100626611|FG002|COMPLETED|Stage 1: Period 1||4||
48123803|NCT01196871|100626612|FG003|COMPLETED|Stage 1: Period 1||0||
48123804|NCT01196871|100626613|FG004|COMPLETED|Stage 1: Period 1||0||
48123805|NCT01196871|100626614|FG005|COMPLETED|Stage 1: Period 1||0||
48123806|NCT01196871|100626609|FG000|NOT COMPLETED|Stage 1: Period 1||0||
48123807|NCT01196871|100626610|FG001|NOT COMPLETED|Stage 1: Period 1||0||
48123808|NCT01196871|100626611|FG002|NOT COMPLETED|Stage 1: Period 1||0||
48123809|NCT01196871|100626612|FG003|NOT COMPLETED|Stage 1: Period 1||0||
48123810|NCT01196871|100626613|FG004|NOT COMPLETED|Stage 1: Period 1||0||
48123811|NCT01196871|100626614|FG005|NOT COMPLETED|Stage 1: Period 1||0||
48123812|NCT01196871|100626609|FG000|STARTED|Stage 1: Period 2||5||
48123813|NCT01196871|100626610|FG001|STARTED|Stage 1: Period 2||3||
48123814|NCT01196871|100626611|FG002|STARTED|Stage 1: Period 2||4||
48123815|NCT01196871|100626612|FG003|STARTED|Stage 1: Period 2||0||
48123816|NCT01196871|100626613|FG004|STARTED|Stage 1: Period 2||0||
48123817|NCT01196871|100626614|FG005|STARTED|Stage 1: Period 2||0||
48123818|NCT01196871|100626609|FG000|PK Population|Stage 1: Period 2||5|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
48123819|NCT01196871|100626610|FG001|PK Population|Stage 1: Period 2||3|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
48123820|NCT01196871|100626611|FG002|PK Population|Stage 1: Period 2||4|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
48123821|NCT01196871|100626612|FG003|PK Population|Stage 1: Period 2||0|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
48123822|NCT01196871|100626613|FG004|PK Population|Stage 1: Period 2||0|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
48123823|NCT01196871|100626614|FG005|PK Population|Stage 1: Period 2||0|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
48123824|NCT01196871|100626609|FG000|COMPLETED|Stage 1: Period 2||5||
48123825|NCT01196871|100626610|FG001|COMPLETED|Stage 1: Period 2||3||
48123826|NCT01196871|100626611|FG002|COMPLETED|Stage 1: Period 2||4||
48123827|NCT01196871|100626612|FG003|COMPLETED|Stage 1: Period 2||0||
48123828|NCT01196871|100626613|FG004|COMPLETED|Stage 1: Period 2||0||
48123829|NCT01196871|100626614|FG005|COMPLETED|Stage 1: Period 2||0||
48123830|NCT01196871|100626609|FG000|NOT COMPLETED|Stage 1: Period 2||0||
48123831|NCT01196871|100626610|FG001|NOT COMPLETED|Stage 1: Period 2||0||
48123832|NCT01196871|100626611|FG002|NOT COMPLETED|Stage 1: Period 2||0||
48123833|NCT01196871|100626612|FG003|NOT COMPLETED|Stage 1: Period 2||0||
48123834|NCT01196871|100626613|FG004|NOT COMPLETED|Stage 1: Period 2||0||
48123835|NCT01196871|100626614|FG005|NOT COMPLETED|Stage 1: Period 2||0||
48123836|NCT01196871|100626609|FG000|STARTED|Stage 1: Period 3||5||
48570352|NCT00684320|101727804|FG000|STARTED|Overall Study||26||
48570353|NCT00684320|101727805|FG001|STARTED|Overall Study||22||
48570354|NCT00684320|101727804|FG000|COMPLETED|Overall Study||22||
48570355|NCT00684320|101727805|FG001|COMPLETED|Overall Study||22||
48570356|NCT00684320|101727804|FG000|NOT COMPLETED|Overall Study||4||
48570357|NCT00684320|101727805|FG001|NOT COMPLETED|Overall Study||0||
48570358|NCT01346059|101727806|FG000|STARTED|Overall Study||1||
48570359|NCT01346059|101727807|FG001|STARTED|Overall Study||1||
48699730|NCT01668628|102050583|FG001|COMPLETED|Overall Study||359||
48699731|NCT01668628|102050584|FG002|COMPLETED|Overall Study||367||
48699732|NCT01668628|102050582|FG000|NOT COMPLETED|Overall Study||2||
48699733|NCT01668628|102050583|FG001|NOT COMPLETED|Overall Study||0||
48699734|NCT01668628|102050584|FG002|NOT COMPLETED|Overall Study||0||
48123837|NCT01196871|100626610|FG001|STARTED|Stage 1: Period 3||3||
48123838|NCT01196871|100626611|FG002|STARTED|Stage 1: Period 3||4||
48123839|NCT01196871|100626612|FG003|STARTED|Stage 1: Period 3||0||
48123840|NCT01196871|100626613|FG004|STARTED|Stage 1: Period 3||0||
48123841|NCT01196871|100626614|FG005|STARTED|Stage 1: Period 3||0||
48123842|NCT01196871|100626609|FG000|COMPLETED|Stage 1: Period 3||5||
48123843|NCT01196871|100626610|FG001|COMPLETED|Stage 1: Period 3||3||
48123844|NCT01196871|100626611|FG002|COMPLETED|Stage 1: Period 3||4||
48570360|NCT01346059|101727806|FG000|COMPLETED|Overall Study||0||
48570361|NCT01346059|101727807|FG001|COMPLETED|Overall Study||1||
48570362|NCT01346059|101727806|FG000|NOT COMPLETED|Overall Study||1||
48570363|NCT01346059|101727807|FG001|NOT COMPLETED|Overall Study||0||
48123845|NCT01196871|100626612|FG003|COMPLETED|Stage 1: Period 3||0||
48123846|NCT01196871|100626613|FG004|COMPLETED|Stage 1: Period 3||0||
48123847|NCT01196871|100626614|FG005|COMPLETED|Stage 1: Period 3||0||
48123848|NCT01196871|100626609|FG000|NOT COMPLETED|Stage 1: Period 3||0||
48123849|NCT01196871|100626610|FG001|NOT COMPLETED|Stage 1: Period 3||0||
48123850|NCT01196871|100626611|FG002|NOT COMPLETED|Stage 1: Period 3||0||
48123851|NCT01196871|100626612|FG003|NOT COMPLETED|Stage 1: Period 3||0||
48123852|NCT01196871|100626613|FG004|NOT COMPLETED|Stage 1: Period 3||0||
48123853|NCT01196871|100626614|FG005|NOT COMPLETED|Stage 1: Period 3||0||
48123854|NCT01196871|100626609|FG000|STARTED|Stage 2: Period 1||0||
48123855|NCT01196871|100626610|FG001|STARTED|Stage 2: Period 1||0||
48123856|NCT01196871|100626611|FG002|STARTED|Stage 2: Period 1||0||
48123857|NCT01196871|100626612|FG003|STARTED|Stage 2: Period 1||2||
48123858|NCT01196871|100626613|FG004|STARTED|Stage 2: Period 1||5||
48123859|NCT01196871|100626614|FG005|STARTED|Stage 2: Period 1||4||
48123860|NCT01196871|100626609|FG000|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0|Safety Population|
48123861|NCT01196871|100626610|FG001|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0|Safety Population|
48123862|NCT01196871|100626611|FG002|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0|Safety Population|
48123863|NCT01196871|100626612|FG003|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||2|Safety Population|
48123864|NCT01196871|100626613|FG004|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||5|Safety Population|
48123865|NCT01196871|100626614|FG005|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||4|Safety Population|
48123866|NCT01196871|100626609|FG000|PK Population|Stage 2: Period 1||0|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
48123867|NCT01196871|100626610|FG001|PK Population|Stage 2: Period 1||0|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
48123868|NCT01196871|100626611|FG002|PK Population|Stage 2: Period 1||0|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
48123869|NCT01196871|100626612|FG003|PK Population|Stage 2: Period 1||1|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
48123870|NCT01196871|100626613|FG004|PK Population|Stage 2: Period 1||5|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
48123871|NCT01196871|100626614|FG005|PK Population|Stage 2: Period 1||4|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
48123872|NCT01196871|100626609|FG000|COMPLETED|Stage 2: Period 1||0||
48123873|NCT01196871|100626610|FG001|COMPLETED|Stage 2: Period 1||0||
48123874|NCT01196871|100626611|FG002|COMPLETED|Stage 2: Period 1||0||
48123875|NCT01196871|100626612|FG003|COMPLETED|Stage 2: Period 1||2||
48123876|NCT01196871|100626613|FG004|COMPLETED|Stage 2: Period 1||5||
48123877|NCT01196871|100626614|FG005|COMPLETED|Stage 2: Period 1||4||
48123878|NCT01196871|100626609|FG000|NOT COMPLETED|Stage 2: Period 1||0||
48123879|NCT01196871|100626610|FG001|NOT COMPLETED|Stage 2: Period 1||0||
48123880|NCT01196871|100626611|FG002|NOT COMPLETED|Stage 2: Period 1||0||
48123881|NCT01196871|100626612|FG003|NOT COMPLETED|Stage 2: Period 1||0||
48123882|NCT01196871|100626613|FG004|NOT COMPLETED|Stage 2: Period 1||0||
48123883|NCT01196871|100626614|FG005|NOT COMPLETED|Stage 2: Period 1||0||
48123884|NCT01196871|100626609|FG000|STARTED|Stage 2: Period 2||0||
48123885|NCT01196871|100626610|FG001|STARTED|Stage 2: Period 2||0||
48123886|NCT01196871|100626611|FG002|STARTED|Stage 2: Period 2||0||
48123887|NCT01196871|100626612|FG003|STARTED|Stage 2: Period 2||1||
48123888|NCT01196871|100626613|FG004|STARTED|Stage 2: Period 2||6||
48123889|NCT01196871|100626614|FG005|STARTED|Stage 2: Period 2||4||
48282041|NCT00105001|101014231|FG002|NOT COMPLETED|Overall Study||0||
48282042|NCT01802151|101014232|FG000|STARTED|Overall Study||20||
48282043|NCT01802151|101014233|FG001|STARTED|Overall Study||21||
48282044|NCT01802151|101014234|FG002|STARTED|Overall Study||22||
48282045|NCT01802151|101014235|FG003|STARTED|Overall Study||20||
48282046|NCT01802151|101014232|FG000|COMPLETED|Overall Study||20||
48282047|NCT01802151|101014233|FG001|COMPLETED|Overall Study||21||
48570364|NCT00083759|101727808|FG000|STARTED|Overall Study||150||
48570365|NCT00083759|101727809|FG001|STARTED|Overall Study||149||
48570366|NCT00083759|101727808|FG000|COMPLETED|Overall Study||66||
48282048|NCT01802151|101014234|FG002|COMPLETED|Overall Study||20||
48282049|NCT01802151|101014235|FG003|COMPLETED|Overall Study||20||
48570367|NCT00083759|101727809|FG001|COMPLETED|Overall Study||66||
48570368|NCT00083759|101727808|FG000|NOT COMPLETED|Overall Study||84||
48570369|NCT00083759|101727809|FG001|NOT COMPLETED|Overall Study||83||
48570370|NCT00912743|101727810|FG000|STARTED|Overall Study||13||
48570371|NCT00912743|101727811|FG001|STARTED|Overall Study||20||
48570372|NCT00912743|101727810|FG000|COMPLETED|Overall Study||0||
48123890|NCT01196871|100626609|FG000|PK Population|Stage 2: Period 2||0|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
48123891|NCT01196871|100626610|FG001|PK Population|Stage 2: Period 2||0|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
48123892|NCT01196871|100626611|FG002|PK Population|Stage 2: Period 2||0|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
48123893|NCT01196871|100626612|FG003|PK Population|Stage 2: Period 2||1|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
48123894|NCT01196871|100626613|FG004|PK Population|Stage 2: Period 2||6|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
48123895|NCT01196871|100626614|FG005|PK Population|Stage 2: Period 2||4|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
48123896|NCT01196871|100626609|FG000|COMPLETED|Stage 2: Period 2||0||
48123897|NCT01196871|100626610|FG001|COMPLETED|Stage 2: Period 2||0||
48123898|NCT01196871|100626611|FG002|COMPLETED|Stage 2: Period 2||0||
48123899|NCT01196871|100626612|FG003|COMPLETED|Stage 2: Period 2||1||
48123900|NCT01196871|100626613|FG004|COMPLETED|Stage 2: Period 2||6||
48123901|NCT01196871|100626614|FG005|COMPLETED|Stage 2: Period 2||4||
48123902|NCT01196871|100626609|FG000|NOT COMPLETED|Stage 2: Period 2||0||
48123903|NCT01196871|100626610|FG001|NOT COMPLETED|Stage 2: Period 2||0||
48123904|NCT01196871|100626611|FG002|NOT COMPLETED|Stage 2: Period 2||0||
48123905|NCT01196871|100626612|FG003|NOT COMPLETED|Stage 2: Period 2||0||
48123906|NCT01196871|100626613|FG004|NOT COMPLETED|Stage 2: Period 2||0||
48123907|NCT01196871|100626614|FG005|NOT COMPLETED|Stage 2: Period 2||0||
48123908|NCT00774787|100626615|FG000|STARTED|Overall Study||27||
48123909|NCT00774787|100626615|FG000|COMPLETED|Overall Study||26||
48123910|NCT00774787|100626615|FG000|NOT COMPLETED|Overall Study||1||
48123911|NCT01513317|100626616|FG000|STARTED|Overall Study||50||
48123912|NCT01513317|100626617|FG001|STARTED|Overall Study||26||
48123913|NCT01513317|100626616|FG000|COMPLETED|Overall Study||16||
48123914|NCT01513317|100626617|FG001|COMPLETED|Overall Study||2||
48123915|NCT01513317|100626616|FG000|NOT COMPLETED|Overall Study||34||
48123916|NCT01513317|100626617|FG001|NOT COMPLETED|Overall Study||24||
48123917|NCT02091167|100626618|FG000|STARTED|Overall Study||19||
48123918|NCT02091167|100626619|FG001|STARTED|Overall Study||16||
48123919|NCT02091167|100626618|FG000|COMPLETED|Overall Study||19||
48123920|NCT02091167|100626619|FG001|COMPLETED|Overall Study||14||
48123921|NCT02091167|100626618|FG000|NOT COMPLETED|Overall Study||0||
48123922|NCT02091167|100626619|FG001|NOT COMPLETED|Overall Study||2||
48123923|NCT03058796|100626620|FG000|STARTED|Overall Study||27||
48123924|NCT03058796|100626621|FG001|STARTED|Overall Study||25||
48123925|NCT03058796|100626620|FG000|COMPLETED|Overall Study||18||
48123926|NCT03058796|100626621|FG001|COMPLETED|Overall Study||21||
48123927|NCT03058796|100626620|FG000|NOT COMPLETED|Overall Study||9||
48123928|NCT03058796|100626621|FG001|NOT COMPLETED|Overall Study||4||
48123929|NCT02682420|100626622|FG000|STARTED|Overall Study||100||
48123930|NCT02682420|100626622|FG000|COMPLETED|Overall Study||63||
48123931|NCT02682420|100626622|FG000|NOT COMPLETED|Overall Study||37||
48123932|NCT02670629|100626623|FG000|STARTED|Overall Study||29||
48123933|NCT02670629|100626624|FG001|STARTED|Overall Study||29||
48123934|NCT02670629|100626623|FG000|COMPLETED|Overall Study||29||
48123935|NCT02670629|100626624|FG001|COMPLETED|Overall Study||29||
48123936|NCT02670629|100626623|FG000|NOT COMPLETED|Overall Study||0||
48123937|NCT02670629|100626624|FG001|NOT COMPLETED|Overall Study||0||
48123938|NCT04354831|100626625|FG000|STARTED|Overall Study||41||
48123939|NCT04354831|100626626|FG001|STARTED|Overall Study||90||
48123940|NCT04354831|100626625|FG000|COMPLETED|Overall Study||41||
48699735|NCT05286658|102050585|FG000|STARTED|Overall Study||17||
48699736|NCT05286658|102050585|FG000|Inward Variability Condition|Overall Study||15||
48699737|NCT05286658|102050585|FG000|Outward Variability Condition|Overall Study||15||
48699738|NCT05286658|102050585|FG000|Control Condition|Overall Study||15||
48123941|NCT04354831|100626626|FG001|COMPLETED|Overall Study||89||
48123942|NCT04354831|100626625|FG000|NOT COMPLETED|Overall Study||0||
48123943|NCT04354831|100626626|FG001|NOT COMPLETED|Overall Study||1||
48123944|NCT04982029|100626627|FG000|STARTED|Overall Study||7||
48123945|NCT04982029|100626628|FG001|STARTED|Overall Study||8||
48123946|NCT04982029|100626627|FG000|Baseline|Overall Study||7|This milestone represents the baseline measures and initial study visit.|
48123947|NCT04982029|100626628|FG001|Baseline|Overall Study||8|This milestone represents the baseline measures and initial study visit.|
48123948|NCT04982029|100626627|FG000|First Intervention|Overall Study||5|This is the visit where participants receive their first intervention.|
48123949|NCT04982029|100626628|FG001|First Intervention|Overall Study||5|This is the visit where participants receive their first intervention.|
48123950|NCT04982029|100626627|FG000|Second Intervention|Overall Study||5|This is the study visit where participants receive their second intervention after the 7-day washout period.|
48699739|NCT05286658|102050585|FG000|Analysis Population|Overall Study||15||
48699740|NCT05286658|102050585|FG000|COMPLETED|Overall Study||15||
48699741|NCT05286658|102050585|FG000|NOT COMPLETED|Overall Study||2||
48699742|NCT02241655|102050586|FG000|STARTED|Overall Study||614||
48123951|NCT04982029|100626628|FG001|Second Intervention|Overall Study||5|This is the study visit where participants receive their second intervention after the 7-day washout period.|
48123952|NCT04982029|100626627|FG000|COMPLETED|Overall Study||5||
48123953|NCT04982029|100626628|FG001|COMPLETED|Overall Study||5||
48123954|NCT04982029|100626627|FG000|NOT COMPLETED|Overall Study||2||
48123955|NCT04982029|100626628|FG001|NOT COMPLETED|Overall Study||3||
48123956|NCT02167035|100626629|FG000|STARTED|Overall Study||21||
48123957|NCT02167035|100626630|FG001|STARTED|Overall Study||22||
48123958|NCT02167035|100626629|FG000|COMPLETED|Overall Study||16||
48123959|NCT02167035|100626630|FG001|COMPLETED|Overall Study||16||
48123960|NCT02167035|100626629|FG000|NOT COMPLETED|Overall Study||5||
48123961|NCT02167035|100626630|FG001|NOT COMPLETED|Overall Study||6||
48123962|NCT01896895|100626631|FG000|STARTED|Double-blind MP||20||
48123963|NCT01896895|100626632|FG001|STARTED|Double-blind MP||22||
48123964|NCT01896895|100626633|FG002|STARTED|Double-blind MP||19||
48123965|NCT01896895|100626634|FG003|STARTED|Double-blind MP||0||
48123966|NCT01896895|100626631|FG000|COMPLETED|Double-blind MP||19||
48123967|NCT01896895|100626632|FG001|COMPLETED|Double-blind MP||20||
48123968|NCT01896895|100626633|FG002|COMPLETED|Double-blind MP||16||
48123969|NCT01896895|100626634|FG003|COMPLETED|Double-blind MP||0||
48123970|NCT01896895|100626631|FG000|NOT COMPLETED|Double-blind MP||1||
48123971|NCT01896895|100626632|FG001|NOT COMPLETED|Double-blind MP||2||
48123972|NCT01896895|100626633|FG002|NOT COMPLETED|Double-blind MP||3||
48123973|NCT01896895|100626634|FG003|NOT COMPLETED|Double-blind MP||0||
48123974|NCT01896895|100626631|FG000|STARTED|OLEX Period||0||
48570373|NCT00912743|101727811|FG001|COMPLETED|Overall Study||0||
48570374|NCT00912743|101727810|FG000|NOT COMPLETED|Overall Study||13||
48123975|NCT01896895|100626632|FG001|STARTED|OLEX Period||0||
48123976|NCT01896895|100626633|FG002|STARTED|OLEX Period||0||
48123977|NCT01896895|100626634|FG003|STARTED|OLEX Period||39||
48123978|NCT01896895|100626631|FG000|COMPLETED|OLEX Period||0||
48123979|NCT01896895|100626632|FG001|COMPLETED|OLEX Period||0||
48123980|NCT01896895|100626633|FG002|COMPLETED|OLEX Period||0||
48123981|NCT01896895|100626634|FG003|COMPLETED|OLEX Period||39||
48123982|NCT01896895|100626631|FG000|NOT COMPLETED|OLEX Period||0||
48123983|NCT01896895|100626632|FG001|NOT COMPLETED|OLEX Period||0||
48123984|NCT01896895|100626633|FG002|NOT COMPLETED|OLEX Period||0||
48123985|NCT01896895|100626634|FG003|NOT COMPLETED|OLEX Period||0||
48123986|NCT01110239|100626635|FG000|STARTED|Sham Preconditioning||7||
48123987|NCT01110239|100626636|FG001|STARTED|Sham Preconditioning||14||
48123988|NCT01110239|100626637|FG002|STARTED|Sham Preconditioning||7||
48123989|NCT01110239|100626638|FG003|STARTED|Sham Preconditioning||6||
48123990|NCT01110239|100626635|FG000|COMPLETED|Sham Preconditioning||7||
48123991|NCT01110239|100626636|FG001|COMPLETED|Sham Preconditioning||14||
48123992|NCT01110239|100626637|FG002|COMPLETED|Sham Preconditioning||6||
48123993|NCT01110239|100626638|FG003|COMPLETED|Sham Preconditioning||6||
48123994|NCT01110239|100626635|FG000|NOT COMPLETED|Sham Preconditioning||0||
48123995|NCT01110239|100626636|FG001|NOT COMPLETED|Sham Preconditioning||0||
48123996|NCT01110239|100626637|FG002|NOT COMPLETED|Sham Preconditioning||1||
48123997|NCT01110239|100626638|FG003|NOT COMPLETED|Sham Preconditioning||0||
48123998|NCT01110239|100626635|FG000|STARTED|5 Min Ischemia||0||
48123999|NCT01110239|100626636|FG001|STARTED|5 Min Ischemia||14||
48124000|NCT01110239|100626637|FG002|STARTED|5 Min Ischemia||0||
48124001|NCT01110239|100626638|FG003|STARTED|5 Min Ischemia||0||
48124002|NCT01110239|100626635|FG000|COMPLETED|5 Min Ischemia||0||
48124003|NCT01110239|100626636|FG001|COMPLETED|5 Min Ischemia||0||
48570375|NCT00912743|101727811|FG001|NOT COMPLETED|Overall Study||20||
48124004|NCT01110239|100626637|FG002|COMPLETED|5 Min Ischemia||0||
48124005|NCT01110239|100626638|FG003|COMPLETED|5 Min Ischemia||0||
48124006|NCT01110239|100626635|FG000|NOT COMPLETED|5 Min Ischemia||0||
48124007|NCT01110239|100626636|FG001|NOT COMPLETED|5 Min Ischemia||14||
48124008|NCT01110239|100626637|FG002|NOT COMPLETED|5 Min Ischemia||0||
48124009|NCT01110239|100626638|FG003|NOT COMPLETED|5 Min Ischemia||0||
48124010|NCT01110239|100626635|FG000|STARTED|7.5 Min Ischemia||0||
48124011|NCT01110239|100626636|FG001|STARTED|7.5 Min Ischemia||0||
48124012|NCT01110239|100626637|FG002|STARTED|7.5 Min Ischemia||7||
48124013|NCT01110239|100626638|FG003|STARTED|7.5 Min Ischemia||0||
48124014|NCT01110239|100626635|FG000|COMPLETED|7.5 Min Ischemia||0||
48124015|NCT01110239|100626636|FG001|COMPLETED|7.5 Min Ischemia||0||
48124016|NCT01110239|100626637|FG002|COMPLETED|7.5 Min Ischemia||6||
48124017|NCT01110239|100626638|FG003|COMPLETED|7.5 Min Ischemia||0||
48124018|NCT01110239|100626635|FG000|NOT COMPLETED|7.5 Min Ischemia||0||
48124019|NCT01110239|100626636|FG001|NOT COMPLETED|7.5 Min Ischemia||0||
48124020|NCT01110239|100626637|FG002|NOT COMPLETED|7.5 Min Ischemia||1||
48124021|NCT01110239|100626638|FG003|NOT COMPLETED|7.5 Min Ischemia||0||
48124022|NCT01110239|100626635|FG000|STARTED|10 Min Ischemia||0||
48570376|NCT05245526|101727812|FG000|STARTED|Overall Study||12||
48124023|NCT01110239|100626636|FG001|STARTED|10 Min Ischemia||0||
48124024|NCT01110239|100626637|FG002|STARTED|10 Min Ischemia||0||
48124025|NCT01110239|100626638|FG003|STARTED|10 Min Ischemia||6||
48124026|NCT01110239|100626635|FG000|COMPLETED|10 Min Ischemia||0||
48124027|NCT01110239|100626636|FG001|COMPLETED|10 Min Ischemia||0||
48124028|NCT01110239|100626637|FG002|COMPLETED|10 Min Ischemia||0||
48124029|NCT01110239|100626638|FG003|COMPLETED|10 Min Ischemia||6||
48570377|NCT05245526|101727812|FG000|COMPLETED|Overall Study||12||
48124030|NCT01110239|100626635|FG000|NOT COMPLETED|10 Min Ischemia||0||
48124031|NCT01110239|100626636|FG001|NOT COMPLETED|10 Min Ischemia||0||
48124032|NCT01110239|100626637|FG002|NOT COMPLETED|10 Min Ischemia||0||
48124033|NCT01110239|100626638|FG003|NOT COMPLETED|10 Min Ischemia||0||
48124034|NCT03085927|100626639|FG000|STARTED|Overall Study||69|Numbers listed reflect child/parents in a dyad. Arm 1=138 individuals Arm 2=134|
48124035|NCT03085927|100626640|FG001|STARTED|Overall Study||67|Numbers listed reflect child/parents in a dyad. Arm 1=138 individuals Arm 2=134|
48124036|NCT03085927|100626639|FG000|Study Sessions|Overall Study||65|Arm 1=130 individuals Arm 2=126 individuals|
48124037|NCT03085927|100626640|FG001|Study Sessions|Overall Study||63|Arm 1=130 individuals Arm 2=126 individuals|
48124038|NCT03085927|100626639|FG000|Time 2 Measures|Overall Study||65|Arm 1=130 individuals Arm 2=124 individuals|
48124039|NCT03085927|100626640|FG001|Time 2 Measures|Overall Study||62|Arm 1=130 individuals Arm 2=124 individuals|
48124040|NCT03085927|100626639|FG000|COMPLETED|Overall Study||63|Arm 1=126 individuals Arm 2=122 individuals|
48124041|NCT03085927|100626640|FG001|COMPLETED|Overall Study||61|Arm 1=126 individuals Arm 2=122 individuals|
48124042|NCT03085927|100626639|FG000|NOT COMPLETED|Overall Study||6||
48124043|NCT03085927|100626640|FG001|NOT COMPLETED|Overall Study||6||
48124044|NCT01127438|100626641|FG000|STARTED|Overall Study||25||
48699743|NCT02241655|102050587|FG001|STARTED|Overall Study||618||
48699744|NCT02241655|102050586|FG000|COMPLETED|Overall Study||614||
48699745|NCT02241655|102050587|FG001|COMPLETED|Overall Study||618||
48699746|NCT02241655|102050586|FG000|NOT COMPLETED|Overall Study||0||
48396945|NCT02091921|101302501|FG000|STARTED|Overall Study||53||
48396946|NCT02091921|101302501|FG000|COMPLETED|Overall Study||50||
48396947|NCT02091921|101302501|FG000|NOT COMPLETED|Overall Study||3||
48396948|NCT01186003|101302502|FG000|STARTED|Overall Study||14||
48124045|NCT01127438|100626642|FG001|STARTED|Overall Study||25||
48124046|NCT01127438|100626643|FG002|STARTED|Overall Study||26||
48124047|NCT01127438|100626644|FG003|STARTED|Overall Study||24||
48124048|NCT01127438|100626645|FG004|STARTED|Overall Study||28||
48124049|NCT01127438|100626646|FG005|STARTED|Overall Study||25||
48124050|NCT01127438|100626641|FG000|COMPLETED|Overall Study||25||
48124051|NCT01127438|100626642|FG001|COMPLETED|Overall Study||25||
48124052|NCT01127438|100626643|FG002|COMPLETED|Overall Study||26||
48124053|NCT01127438|100626644|FG003|COMPLETED|Overall Study||24||
48124054|NCT01127438|100626645|FG004|COMPLETED|Overall Study||28||
48124055|NCT01127438|100626646|FG005|COMPLETED|Overall Study||25||
48124056|NCT01127438|100626641|FG000|NOT COMPLETED|Overall Study||0||
48124057|NCT01127438|100626642|FG001|NOT COMPLETED|Overall Study||0||
48124058|NCT01127438|100626643|FG002|NOT COMPLETED|Overall Study||0||
48124059|NCT01127438|100626644|FG003|NOT COMPLETED|Overall Study||0||
48124060|NCT01127438|100626645|FG004|NOT COMPLETED|Overall Study||0||
48570378|NCT05245526|101727812|FG000|NOT COMPLETED|Overall Study||0||
48570379|NCT01028014|101727813|FG000|STARTED|Overall Study||10||
48570380|NCT01028014|101727814|FG001|STARTED|Overall Study||10||
48570381|NCT01028014|101727815|FG002|STARTED|Overall Study||10||
48570382|NCT01028014|101727816|FG003|STARTED|Overall Study||10||
48124061|NCT01127438|100626646|FG005|NOT COMPLETED|Overall Study||0||
48124062|NCT02002767|100626647|FG000|STARTED|Overall Study||9||
48124063|NCT02002767|100626648|FG001|STARTED|Overall Study||10||
48124064|NCT02002767|100626647|FG000|COMPLETED|Overall Study||9||
48124065|NCT02002767|100626648|FG001|COMPLETED|Overall Study||10||
48124066|NCT02002767|100626647|FG000|NOT COMPLETED|Overall Study||0||
48124067|NCT02002767|100626648|FG001|NOT COMPLETED|Overall Study||0||
48124068|NCT01692197|100626649|FG000|STARTED|Overall Study||43||
48124069|NCT01692197|100626649|FG000|COMPLETED|Overall Study||40||
48124070|NCT01692197|100626649|FG000|NOT COMPLETED|Overall Study||3||
48124071|NCT02877485|100626650|FG000|STARTED|Overall Study||22||
48124072|NCT02877485|100626651|FG001|STARTED|Overall Study||20||
48124073|NCT02877485|100626650|FG000|COMPLETED|Overall Study||22||
48124074|NCT02877485|100626651|FG001|COMPLETED|Overall Study||20||
48124075|NCT02877485|100626650|FG000|NOT COMPLETED|Overall Study||0||
48124076|NCT02877485|100626651|FG001|NOT COMPLETED|Overall Study||0||
48124077|NCT02098343|100626652|FG000|STARTED|Overall Study||9||
48124078|NCT02098343|100626653|FG001|STARTED|Overall Study||6||
48396949|NCT01186003|101302503|FG001|STARTED|Overall Study||16||
48396950|NCT01186003|101302502|FG000|COMPLETED|Overall Study||14||
48396951|NCT01186003|101302503|FG001|COMPLETED|Overall Study||16||
48396952|NCT01186003|101302502|FG000|NOT COMPLETED|Overall Study||0||
48396953|NCT01186003|101302503|FG001|NOT COMPLETED|Overall Study||0||
48396954|NCT02773368|101302504|FG000|STARTED|Overall Study||210||
48396955|NCT02773368|101302505|FG001|STARTED|Overall Study||210||
48570383|NCT01028014|101727817|FG004|STARTED|Overall Study||10||
48570384|NCT01028014|101727818|FG005|STARTED|Overall Study||6||
48570385|NCT01028014|101727813|FG000|COMPLETED|Overall Study||9||
48699747|NCT02241655|102050587|FG001|NOT COMPLETED|Overall Study||0||
48124079|NCT02098343|100626654|FG002|STARTED|Overall Study||21||
48124080|NCT02098343|100626655|FG003|STARTED|Overall Study||105||
48570386|NCT01028014|101727814|FG001|COMPLETED|Overall Study||8||
48699748|NCT00984165|102050588|FG000|STARTED|Overall Study||9||
48699749|NCT00984165|102050589|FG001|STARTED|Overall Study||1||
48699750|NCT00984165|102050590|FG002|STARTED|Overall Study||4||
48699751|NCT00984165|102050591|FG003|STARTED|Overall Study||4||
48699752|NCT00984165|102050588|FG000|COMPLETED|Overall Study||2||
48396956|NCT02773368|101302504|FG000|Exposed|Overall Study||209||
48124081|NCT02098343|100626656|FG004|STARTED|Overall Study||106||
48124082|NCT02098343|100626652|FG000|COMPLETED|Overall Study||9||
48124083|NCT02098343|100626653|FG001|COMPLETED|Overall Study||6||
48124084|NCT02098343|100626654|FG002|COMPLETED|Overall Study||20||
48124085|NCT02098343|100626655|FG003|COMPLETED|Overall Study||105||
48124086|NCT02098343|100626656|FG004|COMPLETED|Overall Study||106||
48124087|NCT02098343|100626652|FG000|NOT COMPLETED|Overall Study||0||
48124088|NCT02098343|100626653|FG001|NOT COMPLETED|Overall Study||0||
48124089|NCT02098343|100626654|FG002|NOT COMPLETED|Overall Study||1||
48124090|NCT02098343|100626655|FG003|NOT COMPLETED|Overall Study||0||
48124091|NCT02098343|100626656|FG004|NOT COMPLETED|Overall Study||0||
48124092|NCT02570321|100626657|FG000|STARTED|Overall Study||19||
48124093|NCT02570321|100626658|FG001|STARTED|Overall Study||17||
48124094|NCT02570321|100626659|FG002|STARTED|Overall Study||26||
48124095|NCT02570321|100626660|FG003|STARTED|Overall Study||27||
48124096|NCT02570321|100626661|FG004|STARTED|Overall Study||30||
48124097|NCT02570321|100626662|FG005|STARTED|Overall Study||28||
48124098|NCT02570321|100626657|FG000|COMPLETED|Overall Study||17||
48124099|NCT02570321|100626658|FG001|COMPLETED|Overall Study||16||
48124100|NCT02570321|100626659|FG002|COMPLETED|Overall Study||21||
48124101|NCT02570321|100626660|FG003|COMPLETED|Overall Study||27||
48124102|NCT02570321|100626661|FG004|COMPLETED|Overall Study||27||
48124103|NCT02570321|100626662|FG005|COMPLETED|Overall Study||25||
48124104|NCT02570321|100626657|FG000|NOT COMPLETED|Overall Study||2||
48124105|NCT02570321|100626658|FG001|NOT COMPLETED|Overall Study||1||
48124106|NCT02570321|100626659|FG002|NOT COMPLETED|Overall Study||5||
48124107|NCT02570321|100626660|FG003|NOT COMPLETED|Overall Study||0||
48124108|NCT02570321|100626661|FG004|NOT COMPLETED|Overall Study||3||
48124109|NCT02570321|100626662|FG005|NOT COMPLETED|Overall Study||3||
48124110|NCT00938431|100626663|FG000|STARTED|Overall Study||15||
48124111|NCT00938431|100626664|FG001|STARTED|Overall Study||23||
48124112|NCT00938431|100626665|FG002|STARTED|Overall Study||9||
48124113|NCT00938431|100626663|FG000|COMPLETED|Overall Study||9||
48124114|NCT00938431|100626664|FG001|COMPLETED|Overall Study||14||
48124115|NCT00938431|100626665|FG002|COMPLETED|Overall Study||1||
48124116|NCT00938431|100626663|FG000|NOT COMPLETED|Overall Study||6||
48124117|NCT00938431|100626664|FG001|NOT COMPLETED|Overall Study||9||
48124118|NCT00938431|100626665|FG002|NOT COMPLETED|Overall Study||8||
48124119|NCT03099382|100626666|FG000|STARTED|Overall Study||228||
48124120|NCT03099382|100626667|FG001|STARTED|Overall Study||220||
48124121|NCT03099382|100626666|FG000|COMPLETED|Overall Study||226||
48124122|NCT03099382|100626667|FG001|COMPLETED|Overall Study||217||
48396957|NCT02773368|101302505|FG001|Exposed|Overall Study||210||
48396958|NCT02773368|101302504|FG000|COMPLETED|Overall Study||200||
48699753|NCT00984165|102050589|FG001|COMPLETED|Overall Study||0||
48699754|NCT00984165|102050590|FG002|COMPLETED|Overall Study||4||
48699755|NCT00984165|102050591|FG003|COMPLETED|Overall Study||0||
48699756|NCT00984165|102050588|FG000|NOT COMPLETED|Overall Study||7||
48699757|NCT00984165|102050589|FG001|NOT COMPLETED|Overall Study||1||
48699758|NCT00984165|102050590|FG002|NOT COMPLETED|Overall Study||0||
48699759|NCT00984165|102050591|FG003|NOT COMPLETED|Overall Study||4||
48699760|NCT02643615|102050592|FG000|STARTED|Overall Study||9||
48699761|NCT02643615|102050593|FG001|STARTED|Overall Study||11||
48699762|NCT02643615|102050592|FG000|COMPLETED|Overall Study||9||
48699763|NCT02643615|102050593|FG001|COMPLETED|Overall Study||11||
48699764|NCT02643615|102050592|FG000|NOT COMPLETED|Overall Study||0||
48699765|NCT02643615|102050593|FG001|NOT COMPLETED|Overall Study||0||
48699766|NCT00108303|102050594|FG000|STARTED|Overall Study||179||
48699767|NCT00108303|102050595|FG001|STARTED|Overall Study||179||
48699768|NCT00108303|102050596|FG002|STARTED|Overall Study||180||
48699769|NCT00108303|102050594|FG000|COMPLETED|Overall Study||179||
48699770|NCT00108303|102050595|FG001|COMPLETED|Overall Study||179||
48699771|NCT00108303|102050596|FG002|COMPLETED|Overall Study||180||
48699772|NCT00108303|102050594|FG000|NOT COMPLETED|Overall Study||0||
48699773|NCT00108303|102050595|FG001|NOT COMPLETED|Overall Study||0||
48124123|NCT03099382|100626666|FG000|NOT COMPLETED|Overall Study||2||
48124124|NCT03099382|100626667|FG001|NOT COMPLETED|Overall Study||3||
48124125|NCT01734746|100630325|FG000|STARTED|Overall Study||22||
48124126|NCT01734746|100630325|FG000|COMPLETED|Overall Study||21||
48124127|NCT01734746|100630325|FG000|NOT COMPLETED|Overall Study||1||
48124128|NCT01241734|100630326|FG000|STARTED|Overall Study||3||
48124129|NCT01241734|100630327|FG001|STARTED|Overall Study||4||
48124130|NCT01241734|100630328|FG002|STARTED|Overall Study||3||
48699774|NCT00108303|102050596|FG002|NOT COMPLETED|Overall Study||0||
48124131|NCT01241734|100630329|FG003|STARTED|Overall Study||3||
48396959|NCT02773368|101302505|FG001|COMPLETED|Overall Study||206||
48396960|NCT02773368|101302504|FG000|NOT COMPLETED|Overall Study||10||
48396961|NCT02773368|101302505|FG001|NOT COMPLETED|Overall Study||4||
48396962|NCT00291499|101302506|FG000|STARTED|Overall Study||81||
48396963|NCT00291499|101302507|FG001|STARTED|Overall Study||82||
48396964|NCT00291499|101302506|FG000|Intention to Treat (ITT)|Overall Study||80||
48282050|NCT01802151|101014232|FG000|NOT COMPLETED|Overall Study||0||
48282051|NCT01802151|101014233|FG001|NOT COMPLETED|Overall Study||0||
48282052|NCT01802151|101014234|FG002|NOT COMPLETED|Overall Study||2||
48282053|NCT01802151|101014235|FG003|NOT COMPLETED|Overall Study||0||
48282054|NCT00006011|101014236|FG000|STARTED|Overall Study||288||
48282055|NCT00006011|101014237|FG001|STARTED|Overall Study||298||
48396965|NCT00291499|101302507|FG001|Intention to Treat (ITT)|Overall Study||82||
48396966|NCT00291499|101302506|FG000|Per Protocol (PP)|Overall Study||72||
48396967|NCT00291499|101302507|FG001|Per Protocol (PP)|Overall Study||67||
48396968|NCT00291499|101302506|FG000|Safety Population|Overall Study||81||
48396969|NCT00291499|101302507|FG001|Safety Population|Overall Study||82||
48396970|NCT00291499|101302506|FG000|COMPLETED|Overall Study||72||
48699775|NCT01208961|102050597|FG000|STARTED|Low-Fat Period I||27||
48282056|NCT00006011|101014238|FG002|STARTED|Overall Study||73||
48282057|NCT00006011|101014236|FG000|COMPLETED|Overall Study||223||
48282058|NCT00006011|101014237|FG001|COMPLETED|Overall Study||221||
48282059|NCT00006011|101014238|FG002|COMPLETED|Overall Study||0||
48282060|NCT00006011|101014236|FG000|NOT COMPLETED|Overall Study||65||
48282061|NCT00006011|101014237|FG001|NOT COMPLETED|Overall Study||77||
48396971|NCT00291499|101302507|FG001|COMPLETED|Overall Study||67||
48124132|NCT01241734|100630330|FG004|STARTED|Overall Study||5||
48124133|NCT01241734|100630326|FG000|COMPLETED|Overall Study||1||
48124134|NCT01241734|100630327|FG001|COMPLETED|Overall Study||2||
48282062|NCT00006011|101014238|FG002|NOT COMPLETED|Overall Study||73||
48282063|NCT01097707|101014239|FG000|STARTED|Overall Study||83||
48282064|NCT01097707|101014240|FG001|STARTED|Overall Study||80||
48282065|NCT01097707|101014241|FG002|STARTED|Overall Study||82||
48282066|NCT01097707|101014242|FG003|STARTED|Overall Study||84||
48396972|NCT00291499|101302506|FG000|NOT COMPLETED|Overall Study||9||
48396973|NCT00291499|101302507|FG001|NOT COMPLETED|Overall Study||15||
48396974|NCT00601146|101302508|FG000|STARTED|Overall Study||39||
48396975|NCT00601146|101302508|FG000|COMPLETED|Overall Study||39|Study stopped early due to low accrual. Study is close to enrollment|
48396976|NCT00601146|101302508|FG000|NOT COMPLETED|Overall Study||0||
48396977|NCT01376245|101302509|FG000|STARTED|2-wk Single-blind Placebo Run-in Period||744||
48396978|NCT01376245|101302510|FG001|STARTED|2-wk Single-blind Placebo Run-in Period||0||
48396979|NCT01376245|101302511|FG002|STARTED|2-wk Single-blind Placebo Run-in Period||0||
48124135|NCT01241734|100630328|FG002|COMPLETED|Overall Study||2||
48396980|NCT01376245|101302512|FG003|STARTED|2-wk Single-blind Placebo Run-in Period||0||
48396981|NCT01376245|101302513|FG004|STARTED|2-wk Single-blind Placebo Run-in Period||0||
48396982|NCT01376245|101302509|FG000|COMPLETED|2-wk Single-blind Placebo Run-in Period||643||
48396983|NCT01376245|101302510|FG001|COMPLETED|2-wk Single-blind Placebo Run-in Period||0||
48396984|NCT01376245|101302511|FG002|COMPLETED|2-wk Single-blind Placebo Run-in Period||0||
48396985|NCT01376245|101302512|FG003|COMPLETED|2-wk Single-blind Placebo Run-in Period||0||
48124136|NCT01241734|100630329|FG003|COMPLETED|Overall Study||1||
48124137|NCT01241734|100630330|FG004|COMPLETED|Overall Study||2||
48124138|NCT01241734|100630326|FG000|NOT COMPLETED|Overall Study||2||
48124139|NCT01241734|100630327|FG001|NOT COMPLETED|Overall Study||2||
48124140|NCT01241734|100630328|FG002|NOT COMPLETED|Overall Study||1||
48124141|NCT01241734|100630329|FG003|NOT COMPLETED|Overall Study||2||
48124142|NCT01241734|100630330|FG004|NOT COMPLETED|Overall Study||3||
48124143|NCT00534352|100630331|FG000|STARTED|Treatment A: TMC125 + TDF/FTC||23||
48282067|NCT01097707|101014243|FG004|STARTED|Overall Study||85||
48282068|NCT01097707|101014239|FG000|COMPLETED|Overall Study||39||
48282069|NCT01097707|101014240|FG001|COMPLETED|Overall Study||37||
48396986|NCT01376245|101302513|FG004|COMPLETED|2-wk Single-blind Placebo Run-in Period||0||
48396987|NCT01376245|101302509|FG000|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||101||
48396988|NCT01376245|101302510|FG001|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0||
48396989|NCT01376245|101302511|FG002|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0||
48396990|NCT01376245|101302512|FG003|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0||
48396991|NCT01376245|101302513|FG004|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0||
48396992|NCT01376245|101302509|FG000|STARTED|24-week, Double-blind Treatment Period||0||
48396993|NCT01376245|101302510|FG001|STARTED|24-week, Double-blind Treatment Period||162||
48699776|NCT01208961|102050598|FG001|STARTED|Low-Fat Period I||27||
48699777|NCT01208961|102050597|FG000|COMPLETED|Low-Fat Period I||27||
48124144|NCT00534352|100630331|FG000|COMPLETED|Treatment A: TMC125 + TDF/FTC||21||
48282070|NCT01097707|101014241|FG002|COMPLETED|Overall Study||37||
48282071|NCT01097707|101014242|FG003|COMPLETED|Overall Study||40||
48282072|NCT01097707|101014243|FG004|COMPLETED|Overall Study||35||
48396994|NCT01376245|101302511|FG002|STARTED|24-week, Double-blind Treatment Period||160||
48396995|NCT01376245|101302512|FG003|STARTED|24-week, Double-blind Treatment Period||161||
48396996|NCT01376245|101302513|FG004|STARTED|24-week, Double-blind Treatment Period||160||
48396997|NCT01376245|101302509|FG000|COMPLETED|24-week, Double-blind Treatment Period||0||
48396998|NCT01376245|101302510|FG001|COMPLETED|24-week, Double-blind Treatment Period||130||
48396999|NCT01376245|101302511|FG002|COMPLETED|24-week, Double-blind Treatment Period||135||
48397000|NCT01376245|101302512|FG003|COMPLETED|24-week, Double-blind Treatment Period||138||
48397001|NCT01376245|101302513|FG004|COMPLETED|24-week, Double-blind Treatment Period||134||
48397002|NCT01376245|101302509|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0||
48397003|NCT01376245|101302510|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||32||
48397004|NCT01376245|101302511|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||25||
48397005|NCT01376245|101302512|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||23||
48397006|NCT01376245|101302513|FG004|NOT COMPLETED|24-week, Double-blind Treatment Period||26||
48397007|NCT01347632|101302514|FG000|STARTED|Overall Study||35||
48397008|NCT01347632|101302514|FG000|COMPLETED|Overall Study||33||
48397009|NCT01347632|101302514|FG000|NOT COMPLETED|Overall Study||2||
48397010|NCT01155193|101302515|FG000|STARTED|Overall Study||10924||
48397011|NCT01155193|101302516|FG001|STARTED|Overall Study||3818||
48397012|NCT01155193|101302517|FG002|STARTED|Overall Study||2260||
48397013|NCT01155193|101302518|FG003|STARTED|Overall Study||13802||
48397014|NCT01155193|101302515|FG000|COMPLETED|Overall Study||10686||
48397015|NCT01155193|101302516|FG001|COMPLETED|Overall Study||3805||
48397016|NCT01155193|101302517|FG002|COMPLETED|Overall Study||2248||
48397017|NCT01155193|101302518|FG003|COMPLETED|Overall Study||13711||
48699778|NCT01208961|102050598|FG001|COMPLETED|Low-Fat Period I||27||
48699779|NCT01208961|102050597|FG000|NOT COMPLETED|Low-Fat Period I||0||
48699780|NCT01208961|102050598|FG001|NOT COMPLETED|Low-Fat Period I||0||
48397018|NCT01155193|101302515|FG000|NOT COMPLETED|Overall Study||238||
48397019|NCT01155193|101302516|FG001|NOT COMPLETED|Overall Study||13||
48397020|NCT01155193|101302517|FG002|NOT COMPLETED|Overall Study||12||
48397021|NCT01155193|101302518|FG003|NOT COMPLETED|Overall Study||91||
48397022|NCT00443846|101302519|FG000|STARTED|Overall Study||124||
48397023|NCT00443846|101302520|FG001|STARTED|Overall Study||123||
48397024|NCT00443846|101302519|FG000|Vaccinated|Overall Study||116||
48397025|NCT00443846|101302520|FG001|Vaccinated|Overall Study||123||
48397026|NCT00443846|101302519|FG000|COMPLETED|Overall Study||113||
48699781|NCT01208961|102050597|FG000|STARTED|Low-Fat Period II||26||
48699782|NCT01208961|102050598|FG001|STARTED|Low-Fat Period II||27||
48699783|NCT01208961|102050597|FG000|COMPLETED|Low-Fat Period II||26||
48699784|NCT01208961|102050598|FG001|COMPLETED|Low-Fat Period II||27||
48699785|NCT01208961|102050597|FG000|NOT COMPLETED|Low-Fat Period II||0||
48699786|NCT01208961|102050598|FG001|NOT COMPLETED|Low-Fat Period II||0||
48699787|NCT01208961|102050597|FG000|STARTED|High-Fat Period III||26||
48699788|NCT01208961|102050598|FG001|STARTED|High-Fat Period III||26||
48699789|NCT01208961|102050597|FG000|COMPLETED|High-Fat Period III||25||
48699790|NCT01208961|102050598|FG001|COMPLETED|High-Fat Period III||26||
48699791|NCT01208961|102050597|FG000|NOT COMPLETED|High-Fat Period III||1||
48699792|NCT01208961|102050598|FG001|NOT COMPLETED|High-Fat Period III||0||
48699793|NCT01208961|102050597|FG000|STARTED|High-Fat Period IV||25||
48699794|NCT01208961|102050598|FG001|STARTED|High-Fat Period IV||26||
48699795|NCT01208961|102050597|FG000|COMPLETED|High-Fat Period IV||25||
48699796|NCT01208961|102050598|FG001|COMPLETED|High-Fat Period IV||26||
48699797|NCT01208961|102050597|FG000|NOT COMPLETED|High-Fat Period IV||0||
48699798|NCT01208961|102050598|FG001|NOT COMPLETED|High-Fat Period IV||0||
48699799|NCT00117715|102050599|FG000|STARTED|Overall Study||121||
48699800|NCT00117715|102050599|FG000|1 Year|Overall Study||88||
48699801|NCT00117715|102050599|FG000|1.5 Year|Overall Study||85||
48699802|NCT00117715|102050599|FG000|2 Year|Overall Study||76||
48699803|NCT00117715|102050599|FG000|2.5 Year|Overall Study||70||
48699804|NCT00117715|102050599|FG000|3 Year|Overall Study||61||
48699805|NCT00117715|102050599|FG000|3.5 Year|Overall Study||60||
48699806|NCT00117715|102050599|FG000|4 Year|Overall Study||58||
48699807|NCT00117715|102050599|FG000|4.5 Year|Overall Study||55||
48699808|NCT00117715|102050599|FG000|5 Year|Overall Study||49||
48699809|NCT00117715|102050599|FG000|COMPLETED|Overall Study||49||
48282073|NCT01097707|101014239|FG000|NOT COMPLETED|Overall Study||44||
48397027|NCT00443846|101302520|FG001|COMPLETED|Overall Study||117||
48397028|NCT00443846|101302519|FG000|NOT COMPLETED|Overall Study||11||
48397029|NCT00443846|101302520|FG001|NOT COMPLETED|Overall Study||6||
48397030|NCT03549429|101302521|FG000|STARTED|Overall Study||81||
48397031|NCT03549429|101302522|FG001|STARTED|Overall Study||78||
48397032|NCT03549429|101302521|FG000|COMPLETED|Overall Study||76||
48397033|NCT03549429|101302522|FG001|COMPLETED|Overall Study||75||
48570387|NCT01028014|101727815|FG002|COMPLETED|Overall Study||10||
48699810|NCT00117715|102050599|FG000|NOT COMPLETED|Overall Study||72||
48699811|NCT02305849|102050600|FG000|STARTED|Overall Study||175||
48397034|NCT03549429|101302521|FG000|NOT COMPLETED|Overall Study||5||
48397035|NCT03549429|101302522|FG001|NOT COMPLETED|Overall Study||3||
48570388|NCT01028014|101727816|FG003|COMPLETED|Overall Study||9||
48570389|NCT01028014|101727817|FG004|COMPLETED|Overall Study||9||
48570390|NCT01028014|101727818|FG005|COMPLETED|Overall Study||4||
48570391|NCT01028014|101727813|FG000|NOT COMPLETED|Overall Study||1||
48570392|NCT01028014|101727814|FG001|NOT COMPLETED|Overall Study||2||
48699812|NCT02305849|102050601|FG001|STARTED|Overall Study||174||
48124145|NCT00534352|100630331|FG000|NOT COMPLETED|Treatment A: TMC125 + TDF/FTC||2||
48699813|NCT02305849|102050602|FG002|STARTED|Overall Study||85||
48699814|NCT02305849|102050603|FG003|STARTED|Overall Study||85||
48699815|NCT02305849|102050600|FG000|COMPLETED|Overall Study||148||
48699816|NCT02305849|102050601|FG001|COMPLETED|Overall Study||146||
48699817|NCT02305849|102050602|FG002|COMPLETED|Overall Study||67||
48699818|NCT02305849|102050603|FG003|COMPLETED|Overall Study||66||
48699819|NCT02305849|102050600|FG000|NOT COMPLETED|Overall Study||27||
48699820|NCT02305849|102050601|FG001|NOT COMPLETED|Overall Study||28||
48699821|NCT02305849|102050602|FG002|NOT COMPLETED|Overall Study||18||
48699822|NCT02305849|102050603|FG003|NOT COMPLETED|Overall Study||19||
48699823|NCT03257202|102050604|FG000|STARTED|Overall Study||12||
48699824|NCT03257202|102050604|FG000|COMPLETED|Overall Study||12||
48699825|NCT03257202|102050604|FG000|NOT COMPLETED|Overall Study||0||
48699826|NCT05791565|102050605|FG000|STARTED|Period 1 (Day 1)||14||
48699827|NCT05791565|102050606|FG001|STARTED|Period 1 (Day 1)||14||
48699828|NCT05791565|102050605|FG000|COMPLETED|Period 1 (Day 1)||14||
48699829|NCT05791565|102050606|FG001|COMPLETED|Period 1 (Day 1)||14||
48699830|NCT05791565|102050605|FG000|NOT COMPLETED|Period 1 (Day 1)||0||
48699831|NCT05791565|102050606|FG001|NOT COMPLETED|Period 1 (Day 1)||0||
48699832|NCT05791565|102050605|FG000|STARTED|Washout Period (Minimum 72 Hours)||14||
48699833|NCT05791565|102050606|FG001|STARTED|Washout Period (Minimum 72 Hours)||14||
48699834|NCT05791565|102050605|FG000|COMPLETED|Washout Period (Minimum 72 Hours)||13||
48699835|NCT05791565|102050606|FG001|COMPLETED|Washout Period (Minimum 72 Hours)||14||
48699836|NCT05791565|102050605|FG000|NOT COMPLETED|Washout Period (Minimum 72 Hours)||1||
48699837|NCT05791565|102050606|FG001|NOT COMPLETED|Washout Period (Minimum 72 Hours)||0||
48699838|NCT05791565|102050605|FG000|STARTED|Period 2 (Day 4)||13||
48699839|NCT05791565|102050606|FG001|STARTED|Period 2 (Day 4)||14||
48699840|NCT05791565|102050605|FG000|COMPLETED|Period 2 (Day 4)||13||
48699841|NCT05791565|102050606|FG001|COMPLETED|Period 2 (Day 4)||14||
48699842|NCT05791565|102050605|FG000|NOT COMPLETED|Period 2 (Day 4)||0||
48699843|NCT05791565|102050606|FG001|NOT COMPLETED|Period 2 (Day 4)||0||
48699844|NCT05160168|102050607|FG000|STARTED|Overall Study||3||
48699845|NCT05160168|102050608|FG001|STARTED|Overall Study||7||
48699846|NCT05160168|102050609|FG002|STARTED|Overall Study||3||
48699847|NCT05160168|102050610|FG003|STARTED|Overall Study||3||
48699848|NCT05160168|102050611|FG004|STARTED|Overall Study||3||
48699849|NCT05160168|102050612|FG005|STARTED|Overall Study||7||
48699850|NCT05160168|102050613|FG006|STARTED|Overall Study||6||
48699851|NCT05160168|102050614|FG007|STARTED|Overall Study||0||
48699852|NCT05160168|102050615|FG008|STARTED|Overall Study||0||
48699853|NCT05160168|102050616|FG009|STARTED|Overall Study||0||
48699854|NCT05160168|102050607|FG000|COMPLETED|Overall Study||3||
48699855|NCT05160168|102050608|FG001|COMPLETED|Overall Study||7||
48699856|NCT05160168|102050609|FG002|COMPLETED|Overall Study||3||
48570393|NCT01028014|101727815|FG002|NOT COMPLETED|Overall Study||0||
48570394|NCT01028014|101727816|FG003|NOT COMPLETED|Overall Study||1||
48397036|NCT01599806|101302523|FG000|STARTED|Overall Study||516||
48570395|NCT01028014|101727817|FG004|NOT COMPLETED|Overall Study||1||
48570396|NCT01028014|101727818|FG005|NOT COMPLETED|Overall Study||2||
48570397|NCT02273063|101727819|FG000|STARTED|Overall Study||40||
48699857|NCT05160168|102050610|FG003|COMPLETED|Overall Study||3||
48699858|NCT05160168|102050611|FG004|COMPLETED|Overall Study||3||
48699859|NCT05160168|102050612|FG005|COMPLETED|Overall Study||7||
48699860|NCT05160168|102050613|FG006|COMPLETED|Overall Study||6||
48699861|NCT05160168|102050614|FG007|COMPLETED|Overall Study||0||
48699862|NCT05160168|102050615|FG008|COMPLETED|Overall Study||0||
48397037|NCT01599806|101302524|FG001|STARTED|Overall Study||517||
48282074|NCT01097707|101014240|FG001|NOT COMPLETED|Overall Study||43||
48282075|NCT01097707|101014241|FG002|NOT COMPLETED|Overall Study||45||
48282076|NCT01097707|101014242|FG003|NOT COMPLETED|Overall Study||44||
48282077|NCT01097707|101014243|FG004|NOT COMPLETED|Overall Study||50||
48282078|NCT02324608|101014244|FG000|STARTED|Overall Study||15||
48282079|NCT02324608|101014244|FG000|COMPLETED|Overall Study||15||
48282080|NCT02324608|101014244|FG000|NOT COMPLETED|Overall Study||0||
48282081|NCT02819557|101014245|FG000|STARTED|Overall Study||14||
48397038|NCT01599806|101302523|FG000|COMPLETED|Overall Study||473||
48570398|NCT02273063|101727819|FG000|COMPLETED|Overall Study||35||
48570399|NCT02273063|101727819|FG000|NOT COMPLETED|Overall Study||5||
48570400|NCT02042014|101727820|FG000|STARTED|Overall Study||8||
48570401|NCT02042014|101727820|FG000|COMPLETED|Overall Study||0||
48570402|NCT02042014|101727820|FG000|NOT COMPLETED|Overall Study||8||
48570403|NCT02366689|101727821|FG000|STARTED|Overall Study||60||
48699863|NCT05160168|102050616|FG009|COMPLETED|Overall Study||0||
48699864|NCT05160168|102050607|FG000|NOT COMPLETED|Overall Study||0||
48699865|NCT05160168|102050608|FG001|NOT COMPLETED|Overall Study||0||
48699866|NCT05160168|102050609|FG002|NOT COMPLETED|Overall Study||0||
48699867|NCT05160168|102050610|FG003|NOT COMPLETED|Overall Study||0||
48699868|NCT05160168|102050611|FG004|NOT COMPLETED|Overall Study||0||
48699869|NCT05160168|102050612|FG005|NOT COMPLETED|Overall Study||0||
48699870|NCT05160168|102050613|FG006|NOT COMPLETED|Overall Study||0||
48699871|NCT05160168|102050614|FG007|NOT COMPLETED|Overall Study||0||
48570404|NCT02366689|101727822|FG001|STARTED|Overall Study||58||
48570405|NCT02366689|101727823|FG002|STARTED|Overall Study||61||
48570406|NCT02366689|101727821|FG000|COMPLETED|Overall Study||56||
48570407|NCT02366689|101727822|FG001|COMPLETED|Overall Study||55||
48570408|NCT02366689|101727823|FG002|COMPLETED|Overall Study||59||
48570409|NCT02366689|101727821|FG000|NOT COMPLETED|Overall Study||4||
48699872|NCT05160168|102050615|FG008|NOT COMPLETED|Overall Study||0||
48699873|NCT05160168|102050616|FG009|NOT COMPLETED|Overall Study||0||
48282082|NCT02819557|101014245|FG000|Safety Population|Overall Study||14|All participants who received at least 1 dose of ataluren.|
48294170|NCT02527343|101047538|FG002|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0||
48397039|NCT01599806|101302524|FG001|COMPLETED|Overall Study||476||
48397040|NCT01599806|101302523|FG000|NOT COMPLETED|Overall Study||43||
48570410|NCT02366689|101727822|FG001|NOT COMPLETED|Overall Study||3||
48570411|NCT02366689|101727823|FG002|NOT COMPLETED|Overall Study||2||
48570412|NCT00463047|101727824|FG000|STARTED|Titration Period 1||160||
48570413|NCT00463047|101727825|FG001|STARTED|Titration Period 1||160||
48570414|NCT00463047|101727824|FG000|COMPLETED|Titration Period 1||123||
48570415|NCT00463047|101727825|FG001|COMPLETED|Titration Period 1||121||
48570416|NCT00463047|101727824|FG000|NOT COMPLETED|Titration Period 1||37||
48570417|NCT00463047|101727825|FG001|NOT COMPLETED|Titration Period 1||39||
48570418|NCT00463047|101727824|FG000|STARTED|Titration Period 2||123||
48570419|NCT00463047|101727825|FG001|STARTED|Titration Period 2||121||
48570420|NCT00463047|101727824|FG000|COMPLETED|Titration Period 2||93||
48570421|NCT00463047|101727825|FG001|COMPLETED|Titration Period 2||98||
48570422|NCT00463047|101727824|FG000|NOT COMPLETED|Titration Period 2||30||
48570423|NCT00463047|101727825|FG001|NOT COMPLETED|Titration Period 2||23||
48570424|NCT00463047|101727824|FG000|STARTED|Double-Blind Treatment Period 1||96||
48570425|NCT00463047|101727825|FG001|STARTED|Double-Blind Treatment Period 1||94||
48282083|NCT02819557|101014245|FG000|Pharmacokinetics (PK) Population|Overall Study||14|All participants who received at least 1 dose of ataluren and had at least 1 PK concentration value.|
48282084|NCT02819557|101014245|FG000|Evaluable Population|Overall Study||14|Received ≥1 dose, baseline and a postbaseline TFT, NSAA, or answer to ataluren palatability question|
48282085|NCT02819557|101014245|FG000|COMPLETED|Overall Study||14||
48282086|NCT02819557|101014245|FG000|NOT COMPLETED|Overall Study||0||
48282087|NCT03001076|101014246|FG000|STARTED|Overall Study||88||
48282088|NCT03001076|101014247|FG001|STARTED|Overall Study||181||
48282089|NCT03001076|101014246|FG000|COMPLETED|Overall Study||81||
48282090|NCT03001076|101014247|FG001|COMPLETED|Overall Study||176||
48282091|NCT03001076|101014246|FG000|NOT COMPLETED|Overall Study||7||
48124146|NCT00534352|100630331|FG000|STARTED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21||
48124147|NCT00534352|100630331|FG000|COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21||
48124148|NCT00534352|100630331|FG000|NOT COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||0||
48124149|NCT00534352|100630331|FG000|STARTED|Treatment C: DRV/Rtv + TDF/FTC||21||
48124150|NCT00534352|100630331|FG000|COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||20||
48124151|NCT00534352|100630331|FG000|NOT COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||1||
48570426|NCT00463047|101727824|FG000|COMPLETED|Double-Blind Treatment Period 1||93||
48570427|NCT00463047|101727825|FG001|COMPLETED|Double-Blind Treatment Period 1||90||
48570428|NCT00463047|101727824|FG000|NOT COMPLETED|Double-Blind Treatment Period 1||3||
48570429|NCT00463047|101727825|FG001|NOT COMPLETED|Double-Blind Treatment Period 1||4||
48570430|NCT00463047|101727824|FG000|STARTED|Double-Blind Treatment Period 2||93||
48570431|NCT00463047|101727825|FG001|STARTED|Double-Blind Treatment Period 2||90||
48570432|NCT00463047|101727824|FG000|COMPLETED|Double-Blind Treatment Period 2||92||
48570433|NCT00463047|101727825|FG001|COMPLETED|Double-Blind Treatment Period 2||88||
48570434|NCT00463047|101727824|FG000|NOT COMPLETED|Double-Blind Treatment Period 2||1||
48570435|NCT00463047|101727825|FG001|NOT COMPLETED|Double-Blind Treatment Period 2||2||
48570436|NCT03056638|101727826|FG000|STARTED|Overall Study||27||
48570437|NCT03056638|101727827|FG001|STARTED|Overall Study||29||
48570438|NCT03056638|101727826|FG000|COMPLETED|Overall Study||26||
48124152|NCT00534352|100630331|FG000|STARTED|Optional Extension: DRV/Rtv + TDF/FTC||18||
48124153|NCT00534352|100630331|FG000|COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||14||
48124154|NCT00534352|100630331|FG000|NOT COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||4||
48124155|NCT01194297|100630332|FG000|STARTED|Overall Study||2||
48124156|NCT01194297|100630333|FG001|STARTED|Overall Study||1||
48124157|NCT01194297|100630332|FG000|COMPLETED|Overall Study||2||
48124158|NCT01194297|100630333|FG001|COMPLETED|Overall Study||1||
48124159|NCT01194297|100630332|FG000|NOT COMPLETED|Overall Study||0||
48124160|NCT01194297|100630333|FG001|NOT COMPLETED|Overall Study||0||
48124161|NCT00608829|100630334|FG000|STARTED|Overall Study||23||
48124162|NCT00608829|100630334|FG000|COMPLETED|Overall Study||8||
48282092|NCT03001076|101014247|FG001|NOT COMPLETED|Overall Study||5||
48282093|NCT00847808|101014248|FG000|STARTED|Overall Study||178||
48570439|NCT03056638|101727827|FG001|COMPLETED|Overall Study||29||
48570440|NCT03056638|101727826|FG000|NOT COMPLETED|Overall Study||1||
48570441|NCT03056638|101727827|FG001|NOT COMPLETED|Overall Study||0||
48570442|NCT02028767|101727828|FG000|STARTED|Treatment Period 1||16||
48570443|NCT02028767|101727829|FG001|STARTED|Treatment Period 1||16||
48570444|NCT02028767|101727828|FG000|COMPLETED|Treatment Period 1||16||
48570445|NCT02028767|101727829|FG001|COMPLETED|Treatment Period 1||16||
48570446|NCT02028767|101727828|FG000|NOT COMPLETED|Treatment Period 1||0||
48699874|NCT03006848|102050617|FG000|STARTED|Overall Study||18||
48699875|NCT03006848|102050617|FG000|COMPLETED|Overall Study||0||
48699876|NCT03006848|102050617|FG000|NOT COMPLETED|Overall Study||18||
48699877|NCT01681069|102050618|FG000|STARTED|Overall Study||60||
48699878|NCT01681069|102050619|FG001|STARTED|Overall Study||60||
48124163|NCT00608829|100630334|FG000|NOT COMPLETED|Overall Study||15||
48124164|NCT00965848|100630335|FG000|STARTED|Overall Study||107||
48282094|NCT00847808|101014248|FG000|COMPLETED|Overall Study||163||
48282095|NCT00847808|101014248|FG000|NOT COMPLETED|Overall Study||15||
48570447|NCT02028767|101727829|FG001|NOT COMPLETED|Treatment Period 1||0||
48570448|NCT02028767|101727828|FG000|STARTED|Treatment Period 2||16||
48570449|NCT02028767|101727829|FG001|STARTED|Treatment Period 2||16||
48124165|NCT00965848|100630336|FG001|STARTED|Overall Study||34||
48570450|NCT02028767|101727828|FG000|COMPLETED|Treatment Period 2||14||
48570451|NCT02028767|101727829|FG001|COMPLETED|Treatment Period 2||16||
48570452|NCT02028767|101727828|FG000|NOT COMPLETED|Treatment Period 2||2||
48570453|NCT02028767|101727829|FG001|NOT COMPLETED|Treatment Period 2||0||
48124166|NCT00965848|100630337|FG002|STARTED|Overall Study||127||
48124167|NCT00965848|100630335|FG000|COMPLETED|Overall Study||78||
48124168|NCT00965848|100630336|FG001|COMPLETED|Overall Study||32||
48124169|NCT00965848|100630337|FG002|COMPLETED|Overall Study||117||
48124170|NCT00965848|100630335|FG000|NOT COMPLETED|Overall Study||29||
48124171|NCT00965848|100630336|FG001|NOT COMPLETED|Overall Study||2||
48124172|NCT00965848|100630337|FG002|NOT COMPLETED|Overall Study||10||
48124173|NCT01168934|100630338|FG000|STARTED|First Intervention Period||7||
48124174|NCT01168934|100630339|FG001|STARTED|First Intervention Period||7||
48124175|NCT01168934|100630338|FG000|COMPLETED|First Intervention Period||7||
48124176|NCT01168934|100630339|FG001|COMPLETED|First Intervention Period||7||
48124177|NCT01168934|100630338|FG000|NOT COMPLETED|First Intervention Period||0||
48124178|NCT01168934|100630339|FG001|NOT COMPLETED|First Intervention Period||0||
48124179|NCT01168934|100630338|FG000|STARTED|Washout Period (at Least 14 Days)||7||
48124180|NCT01168934|100630339|FG001|STARTED|Washout Period (at Least 14 Days)||7||
48124181|NCT01168934|100630338|FG000|COMPLETED|Washout Period (at Least 14 Days)||7||
48124182|NCT01168934|100630339|FG001|COMPLETED|Washout Period (at Least 14 Days)||7||
48124183|NCT01168934|100630338|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48124184|NCT01168934|100630339|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48124185|NCT01168934|100630338|FG000|STARTED|Second Intervention Period||7||
48124186|NCT01168934|100630339|FG001|STARTED|Second Intervention Period||7||
48124187|NCT01168934|100630338|FG000|COMPLETED|Second Intervention Period||7||
48124188|NCT01168934|100630339|FG001|COMPLETED|Second Intervention Period||7||
48124189|NCT01168934|100630338|FG000|NOT COMPLETED|Second Intervention Period||0||
48124190|NCT01168934|100630339|FG001|NOT COMPLETED|Second Intervention Period||0||
48124191|NCT00440271|100630340|FG000|STARTED|Overall Study||15||
48124192|NCT00440271|100630341|FG001|STARTED|Overall Study||18||
48124193|NCT00440271|100630340|FG000|COMPLETED|Overall Study||3||
48124194|NCT00440271|100630341|FG001|COMPLETED|Overall Study||3||
48124195|NCT00440271|100630340|FG000|NOT COMPLETED|Overall Study||12||
48124196|NCT00440271|100630341|FG001|NOT COMPLETED|Overall Study||15||
48124197|NCT00887341|100630342|FG000|STARTED|Overall Study||37||
48124198|NCT00887341|100630343|FG001|STARTED|Overall Study||39||
48124199|NCT00887341|100630342|FG000|COMPLETED|Overall Study||35||
48124200|NCT00887341|100630343|FG001|COMPLETED|Overall Study||36||
48124201|NCT00887341|100630342|FG000|NOT COMPLETED|Overall Study||2||
48124202|NCT00887341|100630343|FG001|NOT COMPLETED|Overall Study||3||
48124203|NCT00718042|100630344|FG000|STARTED|ABBOTT PRISM Chagas Testing||16313||
48124204|NCT00718042|100630345|FG001|STARTED|ABBOTT PRISM Chagas Testing||289||
48124205|NCT00718042|100630346|FG002|STARTED|ABBOTT PRISM Chagas Testing||525||
48124206|NCT00718042|100630347|FG003|STARTED|ABBOTT PRISM Chagas Testing||110||
48124207|NCT00718042|100630348|FG004|STARTED|ABBOTT PRISM Chagas Testing||25549||
48124208|NCT00718042|100630349|FG005|STARTED|ABBOTT PRISM Chagas Testing||0||
48124209|NCT00718042|100630344|FG000|COMPLETED|ABBOTT PRISM Chagas Testing||16249||
48124210|NCT00718042|100630345|FG001|COMPLETED|ABBOTT PRISM Chagas Testing||287||
48124211|NCT00718042|100630346|FG002|COMPLETED|ABBOTT PRISM Chagas Testing||524||
48124212|NCT00718042|100630347|FG003|COMPLETED|ABBOTT PRISM Chagas Testing||110||
48124213|NCT00718042|100630348|FG004|COMPLETED|ABBOTT PRISM Chagas Testing||25511||
48124214|NCT00718042|100630349|FG005|COMPLETED|ABBOTT PRISM Chagas Testing||0||
48124215|NCT00718042|100630344|FG000|NOT COMPLETED|ABBOTT PRISM Chagas Testing||64||
48124216|NCT00718042|100630345|FG001|NOT COMPLETED|ABBOTT PRISM Chagas Testing||2||
48124217|NCT00718042|100630346|FG002|NOT COMPLETED|ABBOTT PRISM Chagas Testing||1||
48124218|NCT00718042|100630347|FG003|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0||
48124219|NCT00718042|100630348|FG004|NOT COMPLETED|ABBOTT PRISM Chagas Testing||38||
48124220|NCT00718042|100630349|FG005|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0||
48124221|NCT00718042|100630344|FG000|STARTED|ESA Chagas Testing||36||
48124222|NCT00718042|100630345|FG001|STARTED|ESA Chagas Testing||287||
48124223|NCT00718042|100630346|FG002|STARTED|ESA Chagas Testing||524||
48124224|NCT00718042|100630347|FG003|STARTED|ESA Chagas Testing||110||
48124225|NCT00718042|100630348|FG004|STARTED|ESA Chagas Testing||43||
48124226|NCT00718042|100630349|FG005|STARTED|ESA Chagas Testing||330||
48124227|NCT00718042|100630344|FG000|COMPLETED|ESA Chagas Testing||36||
48124228|NCT00718042|100630345|FG001|COMPLETED|ESA Chagas Testing||287||
48124229|NCT00718042|100630346|FG002|COMPLETED|ESA Chagas Testing||524||
48124230|NCT00718042|100630347|FG003|COMPLETED|ESA Chagas Testing||110||
48124231|NCT00718042|100630348|FG004|COMPLETED|ESA Chagas Testing||43||
48124232|NCT00718042|100630349|FG005|COMPLETED|ESA Chagas Testing||330||
48124233|NCT00718042|100630344|FG000|NOT COMPLETED|ESA Chagas Testing||0||
48124234|NCT00718042|100630345|FG001|NOT COMPLETED|ESA Chagas Testing||0||
48124235|NCT00718042|100630346|FG002|NOT COMPLETED|ESA Chagas Testing||0||
48124236|NCT00718042|100630347|FG003|NOT COMPLETED|ESA Chagas Testing||0||
48124237|NCT00718042|100630348|FG004|NOT COMPLETED|ESA Chagas Testing||0||
48124238|NCT00718042|100630349|FG005|NOT COMPLETED|ESA Chagas Testing||0||
48124239|NCT00718042|100630344|FG000|STARTED|Donor Follow-up||36||
48124240|NCT00718042|100630345|FG001|STARTED|Donor Follow-up||0||
48124241|NCT00718042|100630346|FG002|STARTED|Donor Follow-up||0||
48124242|NCT00718042|100630347|FG003|STARTED|Donor Follow-up||0||
48124243|NCT00718042|100630348|FG004|STARTED|Donor Follow-up||43||
48124244|NCT00718042|100630349|FG005|STARTED|Donor Follow-up||0||
48124245|NCT00718042|100630344|FG000|COMPLETED|Donor Follow-up||23||
48124246|NCT00718042|100630345|FG001|COMPLETED|Donor Follow-up||0||
48124247|NCT00718042|100630346|FG002|COMPLETED|Donor Follow-up||0||
48124248|NCT00718042|100630347|FG003|COMPLETED|Donor Follow-up||0||
48124249|NCT00718042|100630348|FG004|COMPLETED|Donor Follow-up||24||
48124250|NCT00718042|100630349|FG005|COMPLETED|Donor Follow-up||0||
48124251|NCT00718042|100630344|FG000|NOT COMPLETED|Donor Follow-up||13||
48124252|NCT00718042|100630345|FG001|NOT COMPLETED|Donor Follow-up||0||
48124253|NCT00718042|100630346|FG002|NOT COMPLETED|Donor Follow-up||0||
48124254|NCT00718042|100630347|FG003|NOT COMPLETED|Donor Follow-up||0||
48124255|NCT00718042|100630348|FG004|NOT COMPLETED|Donor Follow-up||19||
48124256|NCT00718042|100630349|FG005|NOT COMPLETED|Donor Follow-up||0||
48124257|NCT04442737|100630350|FG000|STARTED|Overall Study||53||
48124258|NCT04442737|100630351|FG001|STARTED|Overall Study||50||
48124259|NCT04442737|100630350|FG000|Treatment Phase IS1: Baseline up to Week 24|Overall Study||53||
48124260|NCT04442737|100630351|FG001|Treatment Phase IS1: Baseline up to Week 24|Overall Study||0||
48124261|NCT04442737|100630350|FG000|Treatment Phase IS2: Week 25 to Week 48|Overall Study||49||
48124262|NCT04442737|100630351|FG001|Treatment Phase IS2: Week 25 to Week 48|Overall Study||0||
48124263|NCT04442737|100630350|FG000|Treatment Phase DS1: Baseline up to Week 24|Overall Study||0||
48124264|NCT04442737|100630351|FG001|Treatment Phase DS1: Baseline up to Week 24|Overall Study||50||
48124265|NCT04442737|100630350|FG000|Treatment Phase DS2: Week 25 to Week 48|Overall Study||0||
48124266|NCT04442737|100630351|FG001|Treatment Phase DS2: Week 25 to Week 48|Overall Study||49||
48124267|NCT04442737|100630350|FG000|COMPLETED|Overall Study||45||
48124268|NCT04442737|100630351|FG001|COMPLETED|Overall Study||39||
48124269|NCT04442737|100630350|FG000|NOT COMPLETED|Overall Study||8||
48124270|NCT04442737|100630351|FG001|NOT COMPLETED|Overall Study||11||
48124271|NCT02720484|100630352|FG000|STARTED|Treatment on Study||10||
48124272|NCT02720484|100630352|FG000|Reached 1st Response/2 Cycles|Treatment on Study||7||
48124273|NCT02720484|100630352|FG000|Treated Cycle 3|Treatment on Study||4||
48124274|NCT02720484|100630352|FG000|COMPLETED|Treatment on Study||4||
48124275|NCT02720484|100630352|FG000|NOT COMPLETED|Treatment on Study||6||
48124276|NCT02720484|100630352|FG000|STARTED|Follow Up for 2 Years||7|2 patients died before entering follow up period and 1 patient withdrew consent.|
48124277|NCT02720484|100630352|FG000|COMPLETED|Follow Up for 2 Years||1||
48124278|NCT02720484|100630352|FG000|NOT COMPLETED|Follow Up for 2 Years||6||
48124279|NCT01010984|100630353|FG000|STARTED|Overall Study||20||
48124280|NCT01010984|100630353|FG000|COMPLETED|Overall Study||20||
48124281|NCT01010984|100630353|FG000|NOT COMPLETED|Overall Study||0||
48124282|NCT00653224|100630354|FG000|STARTED|Overall Study||293||
48124283|NCT00653224|100630355|FG001|STARTED|Overall Study||287||
48124284|NCT00653224|100630354|FG000|COMPLETED|Overall Study||286||
48124285|NCT00653224|100630355|FG001|COMPLETED|Overall Study||280||
48124286|NCT00653224|100630354|FG000|NOT COMPLETED|Overall Study||7||
48124287|NCT00653224|100630355|FG001|NOT COMPLETED|Overall Study||7||
48124288|NCT01229436|100630356|FG000|STARTED|Overall Study||254||
48124289|NCT01229436|100630356|FG000|COMPLETED|Overall Study||249||
48124290|NCT01229436|100630356|FG000|NOT COMPLETED|Overall Study||5||
48124291|NCT00660010|100630357|FG000|STARTED|Overall Study||55||
48124292|NCT00660010|100630357|FG000|COMPLETED|Overall Study||46||
48124293|NCT00660010|100630357|FG000|NOT COMPLETED|Overall Study||9||
48124294|NCT02956629|100630358|FG000|STARTED|Overall Study||78||
48124295|NCT02956629|100630359|FG001|STARTED|Overall Study||47||
48124296|NCT02956629|100630360|FG002|STARTED|Overall Study||61||
48124297|NCT02956629|100630361|FG003|STARTED|Overall Study||56||
48124298|NCT02956629|100630362|FG004|STARTED|Overall Study||18||
48124299|NCT02956629|100630363|FG005|STARTED|Overall Study||22||
48124300|NCT02956629|100630358|FG000|COMPLETED|Overall Study||73||
48124301|NCT02956629|100630359|FG001|COMPLETED|Overall Study||41||
48124302|NCT02956629|100630360|FG002|COMPLETED|Overall Study||57||
48570454|NCT02484456|101727830|FG000|STARTED|First Treatment Period: Week 1||10||
48570455|NCT02484456|101727831|FG001|STARTED|First Treatment Period: Week 1||9||
48570456|NCT02484456|101727830|FG000|COMPLETED|First Treatment Period: Week 1||10||
48570457|NCT02484456|101727831|FG001|COMPLETED|First Treatment Period: Week 1||9||
48570458|NCT02484456|101727830|FG000|NOT COMPLETED|First Treatment Period: Week 1||0||
48570459|NCT02484456|101727831|FG001|NOT COMPLETED|First Treatment Period: Week 1||0||
48570460|NCT02484456|101727830|FG000|STARTED|First Treatment Period: Week 2||10||
48124303|NCT02956629|100630361|FG003|COMPLETED|Overall Study||55||
48124304|NCT02956629|100630362|FG004|COMPLETED|Overall Study||18||
48124305|NCT02956629|100630363|FG005|COMPLETED|Overall Study||21||
48124306|NCT02956629|100630358|FG000|NOT COMPLETED|Overall Study||5||
48124307|NCT02956629|100630359|FG001|NOT COMPLETED|Overall Study||6||
48124308|NCT02956629|100630360|FG002|NOT COMPLETED|Overall Study||4||
48124309|NCT02956629|100630361|FG003|NOT COMPLETED|Overall Study||1||
48124310|NCT02956629|100630362|FG004|NOT COMPLETED|Overall Study||0||
48124311|NCT02956629|100630363|FG005|NOT COMPLETED|Overall Study||1||
48124312|NCT03950492|100630364|FG000|STARTED|Overall Study||4||
48124313|NCT03950492|100630364|FG000|COMPLETED|Overall Study||2||
48124314|NCT03950492|100630364|FG000|NOT COMPLETED|Overall Study||2||
48124315|NCT00533949|100630365|FG000|STARTED|Overall Study||166||
48124316|NCT00533949|100630366|FG001|STARTED|Overall Study||121||
48124317|NCT00533949|100630367|FG002|STARTED|Overall Study||147||
48124318|NCT00533949|100630368|FG003|STARTED|Overall Study||110||
48124319|NCT00533949|100630365|FG000|COMPLETED|Overall Study||151||
48570461|NCT02484456|101727831|FG001|STARTED|First Treatment Period: Week 2||9||
48570462|NCT02484456|101727830|FG000|COMPLETED|First Treatment Period: Week 2||10||
48570463|NCT02484456|101727831|FG001|COMPLETED|First Treatment Period: Week 2||9||
48570464|NCT02484456|101727830|FG000|NOT COMPLETED|First Treatment Period: Week 2||0||
48570465|NCT02484456|101727831|FG001|NOT COMPLETED|First Treatment Period: Week 2||0||
48570466|NCT02484456|101727830|FG000|STARTED|Washout Period||10||
48570467|NCT02484456|101727831|FG001|STARTED|Washout Period||9||
48570468|NCT02484456|101727830|FG000|COMPLETED|Washout Period||10||
48570469|NCT02484456|101727831|FG001|COMPLETED|Washout Period||8||
48570470|NCT02484456|101727830|FG000|NOT COMPLETED|Washout Period||0||
48570471|NCT02484456|101727831|FG001|NOT COMPLETED|Washout Period||1||
48570472|NCT02484456|101727830|FG000|STARTED|Second Treatment Period: Week 1||10||
48570473|NCT02484456|101727831|FG001|STARTED|Second Treatment Period: Week 1||8||
48570474|NCT02484456|101727830|FG000|COMPLETED|Second Treatment Period: Week 1||9||
48570475|NCT02484456|101727831|FG001|COMPLETED|Second Treatment Period: Week 1||7||
48570476|NCT02484456|101727830|FG000|NOT COMPLETED|Second Treatment Period: Week 1||1||
48570477|NCT02484456|101727831|FG001|NOT COMPLETED|Second Treatment Period: Week 1||1||
48570478|NCT02484456|101727830|FG000|STARTED|Second Treatment Period: Week 2||9||
48570479|NCT02484456|101727831|FG001|STARTED|Second Treatment Period: Week 2||7||
48570480|NCT02484456|101727830|FG000|COMPLETED|Second Treatment Period: Week 2||9||
48570481|NCT02484456|101727831|FG001|COMPLETED|Second Treatment Period: Week 2||6||
48570482|NCT02484456|101727830|FG000|NOT COMPLETED|Second Treatment Period: Week 2||0||
48570483|NCT02484456|101727831|FG001|NOT COMPLETED|Second Treatment Period: Week 2||1||
48570484|NCT01022307|101727832|FG000|STARTED|Overall Study||184||
48570485|NCT01022307|101727833|FG001|STARTED|Overall Study||28||
48570486|NCT01022307|101727832|FG000|COMPLETED|Overall Study||184||
48570487|NCT01022307|101727833|FG001|COMPLETED|Overall Study||24||
48124320|NCT00533949|100630366|FG001|COMPLETED|Overall Study||107||
48124321|NCT00533949|100630367|FG002|COMPLETED|Overall Study||137||
48124322|NCT00533949|100630368|FG003|COMPLETED|Overall Study||100||
48124323|NCT00533949|100630365|FG000|NOT COMPLETED|Overall Study||15||
48124324|NCT00533949|100630366|FG001|NOT COMPLETED|Overall Study||14||
48124325|NCT00533949|100630367|FG002|NOT COMPLETED|Overall Study||10||
48124326|NCT00533949|100630368|FG003|NOT COMPLETED|Overall Study||10||
48124327|NCT03617679|100630369|FG000|STARTED|Overall Study||39||
48124328|NCT03617679|100630370|FG001|STARTED|Overall Study||40||
48124329|NCT03617679|100630369|FG000|COMPLETED|Overall Study||39||
48124330|NCT03617679|100630370|FG001|COMPLETED|Overall Study||40||
48124331|NCT03617679|100630369|FG000|NOT COMPLETED|Overall Study||0||
48124332|NCT03617679|100630370|FG001|NOT COMPLETED|Overall Study||0||
48124333|NCT02265705|100630371|FG000|STARTED|Treatment Period Week 0-24||145||
48124334|NCT02265705|100630372|FG001|STARTED|Treatment Period Week 0-24||145||
48124335|NCT02265705|100630373|FG002|STARTED|Treatment Period Week 0-24||0||
48124336|NCT02265705|100630374|FG003|STARTED|Treatment Period Week 0-24||0||
48124337|NCT02265705|100630375|FG004|STARTED|Treatment Period Week 0-24||0||
48124338|NCT02265705|100630376|FG005|STARTED|Treatment Period Week 0-24||0||
48124339|NCT02265705|100630377|FG006|STARTED|Treatment Period Week 0-24||0||
48124340|NCT02265705|100630371|FG000|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||145||
48124341|NCT02265705|100630372|FG001|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||145||
48124342|NCT02265705|100630373|FG002|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0||
48124343|NCT02265705|100630374|FG003|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0||
48124344|NCT02265705|100630375|FG004|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0||
48124345|NCT02265705|100630376|FG005|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0||
48124346|NCT02265705|100630377|FG006|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0||
48124347|NCT02265705|100630371|FG000|Rescued|Treatment Period Week 0-24||59||
48124348|NCT02265705|100630372|FG001|Rescued|Treatment Period Week 0-24||17||
48124349|NCT02265705|100630373|FG002|Rescued|Treatment Period Week 0-24||0||
48124350|NCT02265705|100630374|FG003|Rescued|Treatment Period Week 0-24||0||
48124351|NCT02265705|100630375|FG004|Rescued|Treatment Period Week 0-24||0||
48124352|NCT02265705|100630376|FG005|Rescued|Treatment Period Week 0-24||0||
48124353|NCT02265705|100630377|FG006|Rescued|Treatment Period Week 0-24||0||
48124354|NCT02265705|100630371|FG000|COMPLETED|Treatment Period Week 0-24||133||
48124355|NCT02265705|100630372|FG001|COMPLETED|Treatment Period Week 0-24||136||
48124356|NCT02265705|100630373|FG002|COMPLETED|Treatment Period Week 0-24||0||
48124357|NCT02265705|100630374|FG003|COMPLETED|Treatment Period Week 0-24||0||
48570488|NCT01022307|101727832|FG000|NOT COMPLETED|Overall Study||0||
48699879|NCT01681069|102050618|FG000|Full Analysis Set (FAS)|Overall Study||57||
48124358|NCT02265705|100630375|FG004|COMPLETED|Treatment Period Week 0-24||0||
48124359|NCT02265705|100630376|FG005|COMPLETED|Treatment Period Week 0-24||0||
48124360|NCT02265705|100630377|FG006|COMPLETED|Treatment Period Week 0-24||0||
48570489|NCT01022307|101727833|FG001|NOT COMPLETED|Overall Study||4||
48570490|NCT00558701|101727834|FG000|STARTED|Overall Study||15||
48570491|NCT00558701|101727835|FG001|STARTED|Overall Study||15||
48570492|NCT00558701|101727834|FG000|COMPLETED|Overall Study||14||
48570493|NCT00558701|101727835|FG001|COMPLETED|Overall Study||11||
48124361|NCT02265705|100630371|FG000|NOT COMPLETED|Treatment Period Week 0-24||12||
48124362|NCT02265705|100630372|FG001|NOT COMPLETED|Treatment Period Week 0-24||9||
48124363|NCT02265705|100630373|FG002|NOT COMPLETED|Treatment Period Week 0-24||0||
48124364|NCT02265705|100630374|FG003|NOT COMPLETED|Treatment Period Week 0-24||0||
48124365|NCT02265705|100630375|FG004|NOT COMPLETED|Treatment Period Week 0-24||0||
48124366|NCT02265705|100630376|FG005|NOT COMPLETED|Treatment Period Week 0-24||0||
48124367|NCT02265705|100630377|FG006|NOT COMPLETED|Treatment Period Week 0-24||0||
48124368|NCT02265705|100630371|FG000|STARTED|Rescue Period||0||
48570494|NCT00558701|101727834|FG000|NOT COMPLETED|Overall Study||1||
48570495|NCT00558701|101727835|FG001|NOT COMPLETED|Overall Study||4||
48570496|NCT02589626|101727836|FG000|STARTED|Overall Study||32||
48570497|NCT02589626|101727837|FG001|STARTED|Overall Study||33||
48570498|NCT02589626|101727836|FG000|COMPLETED|Overall Study||29||
48570499|NCT02589626|101727837|FG001|COMPLETED|Overall Study||31||
48570500|NCT02589626|101727836|FG000|NOT COMPLETED|Overall Study||3||
48570501|NCT02589626|101727837|FG001|NOT COMPLETED|Overall Study||2||
48570502|NCT01826513|101727838|FG000|STARTED|Overall Study||5||
48570503|NCT01826513|101727839|FG001|STARTED|Overall Study||10||
48570504|NCT01826513|101727840|FG002|STARTED|Overall Study||10||
48570505|NCT01826513|101727838|FG000|COMPLETED|Overall Study||5||
48570506|NCT01826513|101727839|FG001|COMPLETED|Overall Study||10||
48570507|NCT01826513|101727840|FG002|COMPLETED|Overall Study||10||
48570508|NCT01826513|101727838|FG000|NOT COMPLETED|Overall Study||0||
48570509|NCT01826513|101727839|FG001|NOT COMPLETED|Overall Study||0||
48570510|NCT01826513|101727840|FG002|NOT COMPLETED|Overall Study||0||
48570511|NCT02068508|101727841|FG000|STARTED|Overall Study||1067||
48570512|NCT02068508|101727841|FG000|COMPLETED|Overall Study||1035||
48570513|NCT02068508|101727841|FG000|NOT COMPLETED|Overall Study||32||
48570514|NCT02449798|101727842|FG000|STARTED|Overall Study||120||
48570515|NCT02449798|101727842|FG000|COMPLETED|Overall Study||120||
48570516|NCT02449798|101727842|FG000|NOT COMPLETED|Overall Study||0||
48570517|NCT02073929|101727843|FG000|STARTED|Overall Study||48||
48570518|NCT02073929|101727844|FG001|STARTED|Overall Study||24||
48570519|NCT02073929|101727843|FG000|COMPLETED|Overall Study||44||
48570520|NCT02073929|101727844|FG001|COMPLETED|Overall Study||21||
48570521|NCT02073929|101727843|FG000|NOT COMPLETED|Overall Study||4||
48570522|NCT02073929|101727844|FG001|NOT COMPLETED|Overall Study||3||
48570523|NCT02097745|101727845|FG000|STARTED|Overall Study||335||
48570524|NCT02097745|101727845|FG000|COMPLETED|Overall Study||157||
48699880|NCT01681069|102050619|FG001|Full Analysis Set (FAS)|Overall Study||60||
48699881|NCT01681069|102050618|FG000|COMPLETED|Overall Study||55||
48124369|NCT02265705|100630372|FG001|STARTED|Rescue Period||0||
48124370|NCT02265705|100630373|FG002|STARTED|Rescue Period||77||
48124371|NCT02265705|100630374|FG003|STARTED|Rescue Period||0||
48124372|NCT02265705|100630375|FG004|STARTED|Rescue Period||0||
48124373|NCT02265705|100630376|FG005|STARTED|Rescue Period||0||
48124374|NCT02265705|100630377|FG006|STARTED|Rescue Period||0||
48124375|NCT02265705|100630371|FG000|COMPLETED|Rescue Period||0||
48124376|NCT02265705|100630372|FG001|COMPLETED|Rescue Period||0||
48124377|NCT02265705|100630373|FG002|COMPLETED|Rescue Period||74||
48124378|NCT02265705|100630374|FG003|COMPLETED|Rescue Period||0||
48124379|NCT02265705|100630375|FG004|COMPLETED|Rescue Period||0||
48124380|NCT02265705|100630376|FG005|COMPLETED|Rescue Period||0||
48124381|NCT02265705|100630377|FG006|COMPLETED|Rescue Period||0||
48124382|NCT02265705|100630371|FG000|NOT COMPLETED|Rescue Period||0||
48124383|NCT02265705|100630372|FG001|NOT COMPLETED|Rescue Period||0||
48124384|NCT02265705|100630373|FG002|NOT COMPLETED|Rescue Period||3||
48124385|NCT02265705|100630374|FG003|NOT COMPLETED|Rescue Period||0||
48124386|NCT02265705|100630375|FG004|NOT COMPLETED|Rescue Period||0||
48124387|NCT02265705|100630376|FG005|NOT COMPLETED|Rescue Period||0||
48124388|NCT02265705|100630377|FG006|NOT COMPLETED|Rescue Period||0||
48124389|NCT02265705|100630371|FG000|STARTED|Open Label Period||0||
48124390|NCT02265705|100630372|FG001|STARTED|Open Label Period||0||
48124391|NCT02265705|100630373|FG002|STARTED|Open Label Period||0||
48570525|NCT02097745|101727845|FG000|NOT COMPLETED|Overall Study||178||
48570526|NCT01548040|101727846|FG000|STARTED|Overall Study||56||
48570527|NCT01548040|101727847|FG001|STARTED|Overall Study||55||
48570528|NCT01548040|101727846|FG000|COMPLETED|Overall Study||43||
48570529|NCT01548040|101727847|FG001|COMPLETED|Overall Study||45||
48570530|NCT01548040|101727846|FG000|NOT COMPLETED|Overall Study||13||
48570531|NCT01548040|101727847|FG001|NOT COMPLETED|Overall Study||10||
48570532|NCT00381862|101727848|FG000|STARTED|Overall Study||54||
48570533|NCT00381862|101727848|FG000|COMPLETED|Overall Study||44||
48699882|NCT01681069|102050619|FG001|COMPLETED|Overall Study||53||
48124392|NCT02265705|100630374|FG003|STARTED|Open Label Period||74||
48124393|NCT02265705|100630375|FG004|STARTED|Open Label Period||120||
48124394|NCT02265705|100630376|FG005|STARTED|Open Label Period||0||
48124395|NCT02265705|100630377|FG006|STARTED|Open Label Period||0||
48124396|NCT02265705|100630371|FG000|COMPLETED|Open Label Period||0||
48124397|NCT02265705|100630372|FG001|COMPLETED|Open Label Period||0||
48124398|NCT02265705|100630373|FG002|COMPLETED|Open Label Period||0||
48570534|NCT00381862|101727848|FG000|NOT COMPLETED|Overall Study||10||
48570535|NCT01435460|101727849|FG000|STARTED|Overall Study||151||
48570536|NCT01435460|101727850|FG001|STARTED|Overall Study||149||
48570537|NCT01435460|101727849|FG000|COMPLETED|Overall Study||140||
48699883|NCT01681069|102050618|FG000|NOT COMPLETED|Overall Study||5||
48699884|NCT01681069|102050619|FG001|NOT COMPLETED|Overall Study||7||
48699885|NCT03327220|102050620|FG000|STARTED|Overall Study||62||
48699886|NCT03327220|102050621|FG001|STARTED|Overall Study||62||
48699887|NCT03327220|102050620|FG000|Safety Population: Received Study Treatment|Overall Study||59||
48699888|NCT03327220|102050621|FG001|Safety Population: Received Study Treatment|Overall Study||60||
48124399|NCT02265705|100630374|FG003|COMPLETED|Open Label Period||72||
48124400|NCT02265705|100630375|FG004|COMPLETED|Open Label Period||115||
48124401|NCT02265705|100630376|FG005|COMPLETED|Open Label Period||0||
48124402|NCT02265705|100630377|FG006|COMPLETED|Open Label Period||0||
48124403|NCT02265705|100630371|FG000|NOT COMPLETED|Open Label Period||0||
48124404|NCT02265705|100630372|FG001|NOT COMPLETED|Open Label Period||0||
48124405|NCT02265705|100630373|FG002|NOT COMPLETED|Open Label Period||0||
48124406|NCT02265705|100630374|FG003|NOT COMPLETED|Open Label Period||2||
48124407|NCT02265705|100630375|FG004|NOT COMPLETED|Open Label Period||5||
48124408|NCT02265705|100630376|FG005|NOT COMPLETED|Open Label Period||0||
48124409|NCT02265705|100630377|FG006|NOT COMPLETED|Open Label Period||0||
48124410|NCT02265705|100630371|FG000|STARTED|Follow-up Period||0||
48124411|NCT02265705|100630372|FG001|STARTED|Follow-up Period||0||
48124412|NCT02265705|100630373|FG002|STARTED|Follow-up Period||0||
48124413|NCT02265705|100630374|FG003|STARTED|Follow-up Period||0||
48124414|NCT02265705|100630375|FG004|STARTED|Follow-up Period||0||
48124415|NCT02265705|100630376|FG005|STARTED|Follow-up Period||2||
48124416|NCT02265705|100630377|FG006|STARTED|Follow-up Period||58||
48124417|NCT02265705|100630371|FG000|COMPLETED|Follow-up Period||0||
48124418|NCT02265705|100630372|FG001|COMPLETED|Follow-up Period||0||
48124419|NCT02265705|100630373|FG002|COMPLETED|Follow-up Period||0||
48124420|NCT02265705|100630374|FG003|COMPLETED|Follow-up Period||0||
48124421|NCT02265705|100630375|FG004|COMPLETED|Follow-up Period||0||
48124422|NCT02265705|100630376|FG005|COMPLETED|Follow-up Period||1||
48124423|NCT02265705|100630377|FG006|COMPLETED|Follow-up Period||47||
48699889|NCT03327220|102050620|FG000|COMPLETED|Overall Study||57||
48699890|NCT03327220|102050621|FG001|COMPLETED|Overall Study||58||
48699891|NCT03327220|102050620|FG000|NOT COMPLETED|Overall Study||5||
48699892|NCT03327220|102050621|FG001|NOT COMPLETED|Overall Study||4||
48699893|NCT01127607|102050622|FG000|STARTED|Phase I (Within Subjects)||14||
48124424|NCT02265705|100630371|FG000|NOT COMPLETED|Follow-up Period||0||
48124425|NCT02265705|100630372|FG001|NOT COMPLETED|Follow-up Period||0||
48124426|NCT02265705|100630373|FG002|NOT COMPLETED|Follow-up Period||0||
48124427|NCT02265705|100630374|FG003|NOT COMPLETED|Follow-up Period||0||
48124428|NCT02265705|100630375|FG004|NOT COMPLETED|Follow-up Period||0||
48124429|NCT02265705|100630376|FG005|NOT COMPLETED|Follow-up Period||1||
48124430|NCT02265705|100630377|FG006|NOT COMPLETED|Follow-up Period||11||
48124431|NCT04133831|100630378|FG000|STARTED|Overall Study||183||
48124432|NCT04133831|100630379|FG001|STARTED|Overall Study||194||
48124433|NCT04133831|100630380|FG002|STARTED|Overall Study||192||
48124434|NCT04133831|100630381|FG003|STARTED|Overall Study||209||
48124435|NCT04133831|100630382|FG004|STARTED|Overall Study||241||
48124436|NCT04133831|100630378|FG000|COMPLETED|Overall Study||183||
48570538|NCT01435460|101727850|FG001|COMPLETED|Overall Study||143||
48570539|NCT01435460|101727849|FG000|NOT COMPLETED|Overall Study||11||
48570540|NCT01435460|101727850|FG001|NOT COMPLETED|Overall Study||6||
48570541|NCT01379768|101727851|FG000|STARTED|Overall Study||23||
48570542|NCT01379768|101727852|FG001|STARTED|Overall Study||22||
48570543|NCT01379768|101727853|FG002|STARTED|Overall Study||20||
48570544|NCT01379768|101727851|FG000|COMPLETED|Overall Study||20||
48570545|NCT01379768|101727852|FG001|COMPLETED|Overall Study||21||
48570546|NCT01379768|101727853|FG002|COMPLETED|Overall Study||20||
48570547|NCT01379768|101727851|FG000|NOT COMPLETED|Overall Study||3||
48570548|NCT01379768|101727852|FG001|NOT COMPLETED|Overall Study||1||
48570549|NCT01379768|101727853|FG002|NOT COMPLETED|Overall Study||0||
48570550|NCT01549587|101727854|FG000|STARTED|Overall Study||373||
48570551|NCT01549587|101727855|FG001|STARTED|Overall Study||373||
48570552|NCT01549587|101727854|FG000|COMPLETED|Overall Study||334||
48570553|NCT01549587|101727855|FG001|COMPLETED|Overall Study||336||
48699894|NCT01127607|102050623|FG001|STARTED|Phase I (Within Subjects)||13||
48699895|NCT01127607|102050622|FG000|COMPLETED|Phase I (Within Subjects)||14||
48699896|NCT01127607|102050623|FG001|COMPLETED|Phase I (Within Subjects)||13||
48699897|NCT01127607|102050622|FG000|NOT COMPLETED|Phase I (Within Subjects)||0||
48699898|NCT01127607|102050623|FG001|NOT COMPLETED|Phase I (Within Subjects)||0||
48699899|NCT01127607|102050622|FG000|STARTED|Phase II (Between Subjects)||14||
48570554|NCT01549587|101727854|FG000|NOT COMPLETED|Overall Study||39||
48124437|NCT04133831|100630379|FG001|COMPLETED|Overall Study||194||
48124438|NCT04133831|100630380|FG002|COMPLETED|Overall Study||192||
48124439|NCT04133831|100630381|FG003|COMPLETED|Overall Study||209||
48124440|NCT04133831|100630382|FG004|COMPLETED|Overall Study||241||
48124441|NCT04133831|100630378|FG000|NOT COMPLETED|Overall Study||0||
48124442|NCT04133831|100630379|FG001|NOT COMPLETED|Overall Study||0||
48124443|NCT04133831|100630380|FG002|NOT COMPLETED|Overall Study||0||
48124444|NCT04133831|100630381|FG003|NOT COMPLETED|Overall Study||0||
48124445|NCT04133831|100630382|FG004|NOT COMPLETED|Overall Study||0||
48124446|NCT01677195|100630383|FG000|STARTED|Overall Study||71||
48570555|NCT01549587|101727855|FG001|NOT COMPLETED|Overall Study||37||
48124447|NCT01677195|100630384|FG001|STARTED|Overall Study||83||
48124448|NCT01677195|100630385|FG002|STARTED|Overall Study||80||
48124449|NCT01677195|100630383|FG000|COMPLETED|Overall Study||42||
48282096|NCT02996474|101014249|FG000|STARTED|Overall Study||10||
48282097|NCT02996474|101014249|FG000|COMPLETED|Overall Study||5||
48570556|NCT02134015|101727856|FG000|STARTED|Overall Study||71||
48570557|NCT02134015|101727857|FG001|STARTED|Overall Study||74||
48570558|NCT02134015|101727856|FG000|COMPLETED|Overall Study||0||
48570559|NCT02134015|101727857|FG001|COMPLETED|Overall Study||0||
48570560|NCT02134015|101727856|FG000|NOT COMPLETED|Overall Study||71||
48570561|NCT02134015|101727857|FG001|NOT COMPLETED|Overall Study||74||
48570562|NCT03431831|101727858|FG000|STARTED|Overall Study||8||
48570563|NCT03431831|101727859|FG001|STARTED|Overall Study||10||
48570564|NCT03431831|101727860|FG002|STARTED|Overall Study||10||
48570565|NCT03431831|101727861|FG003|STARTED|Overall Study||10||
48570566|NCT03431831|101727862|FG004|STARTED|Overall Study||13||
48570567|NCT03431831|101727863|FG005|STARTED|Overall Study||14||
48570568|NCT03431831|101727864|FG006|STARTED|Overall Study||11||
48570569|NCT03431831|101727865|FG007|STARTED|Overall Study||10||
48570570|NCT03431831|101727858|FG000|COMPLETED|Overall Study||6||
48570571|NCT03431831|101727859|FG001|COMPLETED|Overall Study||8||
48570572|NCT03431831|101727860|FG002|COMPLETED|Overall Study||8||
48699900|NCT01127607|102050623|FG001|STARTED|Phase II (Between Subjects)||13||
48699901|NCT01127607|102050622|FG000|COMPLETED|Phase II (Between Subjects)||13||
48699902|NCT01127607|102050623|FG001|COMPLETED|Phase II (Between Subjects)||11||
48124450|NCT01677195|100630384|FG001|COMPLETED|Overall Study||51||
48124451|NCT01677195|100630385|FG002|COMPLETED|Overall Study||50||
48124452|NCT01677195|100630383|FG000|NOT COMPLETED|Overall Study||29||
48124453|NCT01677195|100630384|FG001|NOT COMPLETED|Overall Study||32||
48124454|NCT01677195|100630385|FG002|NOT COMPLETED|Overall Study||30||
48124455|NCT05070897|100630386|FG000|STARTED|Overall Study||781||
48124456|NCT05070897|100630387|FG001|STARTED|Overall Study||737||
48124457|NCT05070897|100630386|FG000|COMPLETED|Overall Study||658||
48124458|NCT05070897|100630387|FG001|COMPLETED|Overall Study||669||
48124459|NCT05070897|100630386|FG000|NOT COMPLETED|Overall Study||123||
48124460|NCT05070897|100630387|FG001|NOT COMPLETED|Overall Study||68||
48124461|NCT04317586|100630388|FG000|STARTED|Overall Study||16||17
48124462|NCT04317586|100630388|FG000|COMPLETED|Overall Study||0||0
48124463|NCT04317586|100630388|FG000|NOT COMPLETED|Overall Study||16||17
48124464|NCT04382326|100630389|FG000|STARTED|Overall Study||1001||
48124465|NCT04382326|100630390|FG001|STARTED|Overall Study||987||
48124466|NCT04382326|100630389|FG000|COMPLETED|Overall Study||821||
48124467|NCT04382326|100630390|FG001|COMPLETED|Overall Study||799||
48124468|NCT04382326|100630389|FG000|NOT COMPLETED|Overall Study||180||
48124469|NCT04382326|100630390|FG001|NOT COMPLETED|Overall Study||188||
48124470|NCT04798586|100630391|FG000|STARTED|Overall Study||4||
48124471|NCT04798586|100630391|FG000|COMPLETED|Overall Study||2||
48124472|NCT04798586|100630391|FG000|NOT COMPLETED|Overall Study||2||
48124473|NCT03455855|100630392|FG000|STARTED|Overall Study||60||
48124474|NCT03455855|100630393|FG001|STARTED|Overall Study||12||
48124475|NCT03455855|100630392|FG000|Primary Endpoint(30days)|Overall Study||60||
48124476|NCT03455855|100630393|FG001|Primary Endpoint(30days)|Overall Study||12||
48124477|NCT03455855|100630392|FG000|COMPLETED|Overall Study||56||
48124478|NCT03455855|100630393|FG001|COMPLETED|Overall Study||10||
48124479|NCT03455855|100630392|FG000|NOT COMPLETED|Overall Study||4||
48124480|NCT03455855|100630393|FG001|NOT COMPLETED|Overall Study||2||
48124481|NCT03880578|100630394|FG000|STARTED|Overall Study||0||
48124482|NCT03880578|100630395|FG001|STARTED|Overall Study||51||
48124483|NCT03880578|100630396|FG002|STARTED|Overall Study||50||
48124484|NCT03880578|100630394|FG000|12 Months|Overall Study||0||
48124485|NCT03880578|100630395|FG001|12 Months|Overall Study||14||
48124486|NCT03880578|100630396|FG002|12 Months|Overall Study||19||
48124487|NCT03880578|100630394|FG000|COMPLETED|Overall Study||0||
48124488|NCT03880578|100630395|FG001|COMPLETED|Overall Study||47||
48124489|NCT03880578|100630396|FG002|COMPLETED|Overall Study||49||
48124490|NCT03880578|100630394|FG000|NOT COMPLETED|Overall Study||0||
48124491|NCT03880578|100630395|FG001|NOT COMPLETED|Overall Study||4||
48124492|NCT03880578|100630396|FG002|NOT COMPLETED|Overall Study||1||
48124493|NCT00120042|100630397|FG000|STARTED|Overall Study||85||
48124494|NCT00120042|100630398|FG001|STARTED|Overall Study||83||
48124495|NCT00120042|100630399|FG002|STARTED|Overall Study||83||
48124496|NCT00120042|100630397|FG000|COMPLETED|Overall Study||85||
48124497|NCT00120042|100630398|FG001|COMPLETED|Overall Study||83||
48124498|NCT00120042|100630399|FG002|COMPLETED|Overall Study||83||
48124499|NCT00120042|100630397|FG000|NOT COMPLETED|Overall Study||0||
48124500|NCT00120042|100630398|FG001|NOT COMPLETED|Overall Study||0||
48124501|NCT00120042|100630399|FG002|NOT COMPLETED|Overall Study||0||
48124502|NCT04551105|100630400|FG000|STARTED|The 1st Study Sessions||8||314
48124503|NCT04551105|100630401|FG001|STARTED|The 1st Study Sessions||8||314
48124504|NCT04551105|100630400|FG000|COMPLETED|The 1st Study Sessions||8||314
48570573|NCT03431831|101727861|FG003|COMPLETED|Overall Study||9||
48124505|NCT04551105|100630401|FG001|COMPLETED|The 1st Study Sessions||8||314
48124506|NCT04551105|100630400|FG000|NOT COMPLETED|The 1st Study Sessions||0||0
48570574|NCT03431831|101727862|FG004|COMPLETED|Overall Study||9||
48699903|NCT01127607|102050622|FG000|NOT COMPLETED|Phase II (Between Subjects)||1||
48282098|NCT02996474|101014249|FG000|NOT COMPLETED|Overall Study||5||
48699904|NCT01127607|102050623|FG001|NOT COMPLETED|Phase II (Between Subjects)||2||
48282099|NCT01034163|101014250|FG000|STARTED|Overall Study||27||
48282100|NCT01034163|101014251|FG001|STARTED|Overall Study||14||
48282101|NCT01034163|101014250|FG000|Untreated (Not in Safety Set)|Overall Study||1||
48282102|NCT01034163|101014251|FG001|Untreated (Not in Safety Set)|Overall Study||2||
48282103|NCT01034163|101014250|FG000|Safety Set|Overall Study||26||
48282104|NCT01034163|101014251|FG001|Safety Set|Overall Study||12||
48282105|NCT01034163|101014250|FG000|In Open Label Phase After Unblinding|Overall Study||5||
48282106|NCT01034163|101014251|FG001|In Open Label Phase After Unblinding|Overall Study||0||
48282107|NCT01034163|101014250|FG000|COMPLETED|Overall Study||0||
48282108|NCT01034163|101014251|FG001|COMPLETED|Overall Study||0||
48282109|NCT01034163|101014250|FG000|NOT COMPLETED|Overall Study||27||
48282110|NCT01034163|101014251|FG001|NOT COMPLETED|Overall Study||14||
48282111|NCT00794144|101014252|FG000|STARTED|Overall Study||66||
48282112|NCT00794144|101014253|FG001|STARTED|Overall Study||66||
48282113|NCT00794144|101014252|FG000|COMPLETED|Overall Study||63||
48282114|NCT00794144|101014253|FG001|COMPLETED|Overall Study||63||
48282115|NCT00794144|101014252|FG000|NOT COMPLETED|Overall Study||3||
48282116|NCT00794144|101014253|FG001|NOT COMPLETED|Overall Study||3||
48282117|NCT04510090|101014254|FG000|STARTED|SAD-HS||10||
48282118|NCT04510090|101014255|FG001|STARTED|SAD-HS||0||
48282119|NCT04510090|101014256|FG002|STARTED|SAD-HS||6||
48282120|NCT04510090|101014257|FG003|STARTED|SAD-HS||0||
48282121|NCT04510090|101014258|FG004|STARTED|SAD-HS||6||
48282122|NCT04510090|101014259|FG005|STARTED|SAD-HS||6||
48282123|NCT04510090|101014260|FG006|STARTED|SAD-HS||6||
48282124|NCT04510090|101014261|FG007|STARTED|SAD-HS||6||
48282125|NCT04510090|101014254|FG000|COMPLETED|SAD-HS||10||
48282126|NCT04510090|101014255|FG001|COMPLETED|SAD-HS||0||
48282127|NCT04510090|101014256|FG002|COMPLETED|SAD-HS||6||
48282128|NCT04510090|101014257|FG003|COMPLETED|SAD-HS||0||
48282129|NCT04510090|101014258|FG004|COMPLETED|SAD-HS||6||
48282130|NCT04510090|101014259|FG005|COMPLETED|SAD-HS||6||
48282131|NCT04510090|101014260|FG006|COMPLETED|SAD-HS||6||
48282132|NCT04510090|101014261|FG007|COMPLETED|SAD-HS||6||
48282133|NCT04510090|101014254|FG000|NOT COMPLETED|SAD-HS||0||
48282134|NCT04510090|101014255|FG001|NOT COMPLETED|SAD-HS||0||
48282135|NCT04510090|101014256|FG002|NOT COMPLETED|SAD-HS||0||
48282136|NCT04510090|101014257|FG003|NOT COMPLETED|SAD-HS||0||
48282137|NCT04510090|101014258|FG004|NOT COMPLETED|SAD-HS||0||
48282138|NCT04510090|101014259|FG005|NOT COMPLETED|SAD-HS||0||
48282139|NCT04510090|101014260|FG006|NOT COMPLETED|SAD-HS||0||
48282140|NCT04510090|101014261|FG007|NOT COMPLETED|SAD-HS||0||
48282141|NCT04510090|101014254|FG000|STARTED|MAD-HS||6||
48282142|NCT04510090|101014255|FG001|STARTED|MAD-HS||0||
48282143|NCT04510090|101014256|FG002|STARTED|MAD-HS||6||
48282144|NCT04510090|101014257|FG003|STARTED|MAD-HS||0||
48282145|NCT04510090|101014258|FG004|STARTED|MAD-HS||6||
48282146|NCT04510090|101014259|FG005|STARTED|MAD-HS||6||
48282147|NCT04510090|101014260|FG006|STARTED|MAD-HS||0||
48282148|NCT04510090|101014261|FG007|STARTED|MAD-HS||0||
48282149|NCT04510090|101014254|FG000|COMPLETED|MAD-HS||6||
48282150|NCT04510090|101014255|FG001|COMPLETED|MAD-HS||0||
48282151|NCT04510090|101014256|FG002|COMPLETED|MAD-HS||6||
48282152|NCT04510090|101014257|FG003|COMPLETED|MAD-HS||0||
48282153|NCT04510090|101014258|FG004|COMPLETED|MAD-HS||6||
48282154|NCT04510090|101014259|FG005|COMPLETED|MAD-HS||6||
48282155|NCT04510090|101014260|FG006|COMPLETED|MAD-HS||0||
48282156|NCT04510090|101014261|FG007|COMPLETED|MAD-HS||0||
48397041|NCT01599806|101302524|FG001|NOT COMPLETED|Overall Study||41||
48699905|NCT00075725|102050624|FG000|STARTED|Overall Study||246||
48282157|NCT04510090|101014254|FG000|NOT COMPLETED|MAD-HS||0||
48282158|NCT04510090|101014255|FG001|NOT COMPLETED|MAD-HS||0||
48282159|NCT04510090|101014256|FG002|NOT COMPLETED|MAD-HS||0||
48282160|NCT04510090|101014257|FG003|NOT COMPLETED|MAD-HS||0||
48282161|NCT04510090|101014258|FG004|NOT COMPLETED|MAD-HS||0||
48282162|NCT04510090|101014259|FG005|NOT COMPLETED|MAD-HS||0||
48282163|NCT04510090|101014260|FG006|NOT COMPLETED|MAD-HS||0||
48397042|NCT03228394|101302525|FG000|STARTED|Overall Study||4||
48282164|NCT04510090|101014261|FG007|NOT COMPLETED|MAD-HS||0||
48282165|NCT04510090|101014254|FG000|STARTED|FE-HS||0||
48282166|NCT04510090|101014255|FG001|STARTED|FE-HS||0||
48282167|NCT04510090|101014256|FG002|STARTED|FE-HS||0||
48397043|NCT03228394|101302526|FG001|STARTED|Overall Study||5||
48699906|NCT00075725|102050625|FG001|STARTED|Overall Study||106||
48699907|NCT00075725|102050626|FG002|STARTED|Overall Study||296||
48282168|NCT04510090|101014257|FG003|STARTED|FE-HS||0||
48282169|NCT04510090|101014258|FG004|STARTED|FE-HS||5||
48282170|NCT04510090|101014259|FG005|STARTED|FE-HS||0||
48282171|NCT04510090|101014260|FG006|STARTED|FE-HS||0||
48282172|NCT04510090|101014261|FG007|STARTED|FE-HS||0||
48282173|NCT04510090|101014254|FG000|COMPLETED|FE-HS||0||
48282174|NCT04510090|101014255|FG001|COMPLETED|FE-HS||0||
48282175|NCT04510090|101014256|FG002|COMPLETED|FE-HS||0||
48282176|NCT04510090|101014257|FG003|COMPLETED|FE-HS||0||
48282177|NCT04510090|101014258|FG004|COMPLETED|FE-HS||4||
48282178|NCT04510090|101014259|FG005|COMPLETED|FE-HS||0||
48282179|NCT04510090|101014260|FG006|COMPLETED|FE-HS||0||
48397044|NCT03228394|101302527|FG002|STARTED|Overall Study||14||
48699908|NCT00075725|102050627|FG003|STARTED|Overall Study||246||
48699909|NCT00075725|102050628|FG004|STARTED|Overall Study||232||
48699910|NCT00075725|102050629|FG005|STARTED|Overall Study||710||
48699911|NCT00075725|102050630|FG006|STARTED|Overall Study||246||
48699912|NCT00075725|102050631|FG007|STARTED|Overall Study||696||
48699913|NCT00075725|102050632|FG008|STARTED|Overall Study||302||
48699914|NCT00075725|102050633|FG009|STARTED|Overall Study||34||
48699915|NCT00075725|102050634|FG010|STARTED|Overall Study||12||
48699916|NCT00075725|102050635|FG011|STARTED|Overall Study||28||
48699917|NCT00075725|102050624|FG000|COMPLETED|Overall Study||172||
48699918|NCT00075725|102050625|FG001|COMPLETED|Overall Study||57||
48699919|NCT00075725|102050626|FG002|COMPLETED|Overall Study||175||
48699920|NCT00075725|102050627|FG003|COMPLETED|Overall Study||168||
48699921|NCT00075725|102050628|FG004|COMPLETED|Overall Study||166||
48699922|NCT00075725|102050629|FG005|COMPLETED|Overall Study||397||
48699923|NCT00075725|102050630|FG006|COMPLETED|Overall Study||171||
48699924|NCT00075725|102050631|FG007|COMPLETED|Overall Study||401||
48699925|NCT00075725|102050632|FG008|COMPLETED|Overall Study||185||
48699926|NCT00075725|102050633|FG009|COMPLETED|Overall Study||16||
48699927|NCT00075725|102050634|FG010|COMPLETED|Overall Study||3||
48699928|NCT00075725|102050635|FG011|COMPLETED|Overall Study||10||
48699929|NCT00075725|102050624|FG000|NOT COMPLETED|Overall Study||74||
48699930|NCT00075725|102050625|FG001|NOT COMPLETED|Overall Study||49||
48699931|NCT00075725|102050626|FG002|NOT COMPLETED|Overall Study||121||
48699932|NCT00075725|102050627|FG003|NOT COMPLETED|Overall Study||78||
48699933|NCT00075725|102050628|FG004|NOT COMPLETED|Overall Study||66||
48699934|NCT00075725|102050629|FG005|NOT COMPLETED|Overall Study||313||
48699935|NCT00075725|102050630|FG006|NOT COMPLETED|Overall Study||75||
48699936|NCT00075725|102050631|FG007|NOT COMPLETED|Overall Study||295||
48699937|NCT00075725|102050632|FG008|NOT COMPLETED|Overall Study||117||
48699938|NCT00075725|102050633|FG009|NOT COMPLETED|Overall Study||18||
48699939|NCT00075725|102050634|FG010|NOT COMPLETED|Overall Study||9||
48699940|NCT00075725|102050635|FG011|NOT COMPLETED|Overall Study||18||
48699941|NCT02964559|102050636|FG000|STARTED|Overall Study||11||
48699942|NCT02964559|102050636|FG000|COMPLETED|Overall Study||11||
48699943|NCT02964559|102050636|FG000|NOT COMPLETED|Overall Study||0||
48699944|NCT01942668|102050637|FG000|STARTED|Overall Study||418|Number of subjects started reflects total number of subjects randomized per arm.|
48699945|NCT01942668|102050638|FG001|STARTED|Overall Study||426|Number of subjects started reflects total number of subjects randomized per arm.|
48699946|NCT01942668|102050639|FG002|STARTED|Overall Study||422|Number of subjects started reflects total number of subjects randomized per arm.|
48699947|NCT01942668|102050640|FG003|STARTED|Overall Study||427|Number of subjects started reflects total number of subjects randomized per arm.|
48699948|NCT01942668|102050641|FG004|STARTED|Overall Study||152|Number of subjects started reflects total number of subjects randomized per arm.|
48699949|NCT01942668|102050637|FG000|COMPLETED|Overall Study||284||
48699950|NCT01942668|102050638|FG001|COMPLETED|Overall Study||305||
48699951|NCT01942668|102050639|FG002|COMPLETED|Overall Study||312||
48699952|NCT01942668|102050640|FG003|COMPLETED|Overall Study||281||
48699953|NCT01942668|102050641|FG004|COMPLETED|Overall Study||93||
48699954|NCT01942668|102050637|FG000|NOT COMPLETED|Overall Study||134||
48699955|NCT01942668|102050638|FG001|NOT COMPLETED|Overall Study||121||
48699956|NCT01942668|102050639|FG002|NOT COMPLETED|Overall Study||110||
48699957|NCT01942668|102050640|FG003|NOT COMPLETED|Overall Study||146||
48699958|NCT01942668|102050641|FG004|NOT COMPLETED|Overall Study||59||
48699959|NCT01194089|102050642|FG000|STARTED|Overall Study||42||
48699960|NCT01194089|102050643|FG001|STARTED|Overall Study||47||
48699961|NCT01194089|102050642|FG000|COMPLETED|Overall Study||42||
48699962|NCT01194089|102050643|FG001|COMPLETED|Overall Study||47||
48699963|NCT01194089|102050642|FG000|NOT COMPLETED|Overall Study||0||
48699964|NCT01194089|102050643|FG001|NOT COMPLETED|Overall Study||0||
48699965|NCT03575065|102050644|FG000|STARTED|Overall Study||62||
48699966|NCT03575065|102050645|FG001|STARTED|Overall Study||26||
48699967|NCT03575065|102050644|FG000|COMPLETED|Overall Study||0||
48699968|NCT03575065|102050645|FG001|COMPLETED|Overall Study||0||
48699969|NCT03575065|102050644|FG000|NOT COMPLETED|Overall Study||62||
48699970|NCT03575065|102050645|FG001|NOT COMPLETED|Overall Study||26||
48699971|NCT00557310|102050646|FG000|STARTED|Main Study (0 - 18 Months)||35||
48699972|NCT00557310|102050646|FG000|COMPLETED|Main Study (0 - 18 Months)||30||
48699973|NCT00557310|102050646|FG000|NOT COMPLETED|Main Study (0 - 18 Months)||5||
48699974|NCT00557310|102050646|FG000|STARTED|Extension Phase (18 - 24 Months)||30||
48699975|NCT00557310|102050646|FG000|COMPLETED|Extension Phase (18 - 24 Months)||25||
48699976|NCT00557310|102050646|FG000|NOT COMPLETED|Extension Phase (18 - 24 Months)||5||
48699977|NCT03299881|102050647|FG000|STARTED|Overall Study||39||
48699978|NCT03299881|102050648|FG001|STARTED|Overall Study||38||
48699979|NCT03299881|102050647|FG000|COMPLETED|Overall Study||22||
48699980|NCT03299881|102050648|FG001|COMPLETED|Overall Study||25||
48699981|NCT03299881|102050647|FG000|NOT COMPLETED|Overall Study||17||
48699982|NCT03299881|102050648|FG001|NOT COMPLETED|Overall Study||13||
48699983|NCT04173260|102053907|FG000|STARTED|Overall Study||15||
48699984|NCT04173260|102053907|FG000|COMPLETED|Overall Study||11||
48699985|NCT04173260|102053907|FG000|NOT COMPLETED|Overall Study||4||
48699986|NCT00853242|102053908|FG000|STARTED|Overall Study||50||
48699987|NCT00853242|102053909|FG001|STARTED|Overall Study||50||
48699988|NCT00853242|102053910|FG002|STARTED|Overall Study||49||
48699989|NCT00853242|102053911|FG003|STARTED|Overall Study||50||
48699990|NCT00853242|102053912|FG004|STARTED|Overall Study||50||
48282180|NCT04510090|101014261|FG007|COMPLETED|FE-HS||0||
48282181|NCT04510090|101014254|FG000|NOT COMPLETED|FE-HS||0||
48282182|NCT04510090|101014255|FG001|NOT COMPLETED|FE-HS||0||
48282183|NCT04510090|101014256|FG002|NOT COMPLETED|FE-HS||0||
48282184|NCT04510090|101014257|FG003|NOT COMPLETED|FE-HS||0||
48282185|NCT04510090|101014258|FG004|NOT COMPLETED|FE-HS||1||
48282186|NCT04510090|101014259|FG005|NOT COMPLETED|FE-HS||0||
48282187|NCT04510090|101014260|FG006|NOT COMPLETED|FE-HS||0||
48282188|NCT04510090|101014261|FG007|NOT COMPLETED|FE-HS||0||
48282189|NCT04510090|101014254|FG000|STARTED|SD-CP||0||
48282190|NCT04510090|101014255|FG001|STARTED|SD-CP||0||
48282191|NCT04510090|101014256|FG002|STARTED|SD-CP||0||
48282192|NCT04510090|101014257|FG003|STARTED|SD-CP||0||
48282193|NCT04510090|101014258|FG004|STARTED|SD-CP||5||
48282194|NCT04510090|101014259|FG005|STARTED|SD-CP||0||
48282195|NCT04510090|101014260|FG006|STARTED|SD-CP||0||
48282196|NCT04510090|101014261|FG007|STARTED|SD-CP||0||
48282197|NCT04510090|101014254|FG000|COMPLETED|SD-CP||0||
48282198|NCT04510090|101014255|FG001|COMPLETED|SD-CP||0||
48282199|NCT04510090|101014256|FG002|COMPLETED|SD-CP||0||
48282200|NCT04510090|101014257|FG003|COMPLETED|SD-CP||0||
48282201|NCT04510090|101014258|FG004|COMPLETED|SD-CP||5||
48282202|NCT04510090|101014259|FG005|COMPLETED|SD-CP||0||
48282203|NCT04510090|101014260|FG006|COMPLETED|SD-CP||0||
48282204|NCT04510090|101014261|FG007|COMPLETED|SD-CP||0||
48282205|NCT04510090|101014254|FG000|NOT COMPLETED|SD-CP||0||
48282206|NCT04510090|101014255|FG001|NOT COMPLETED|SD-CP||0||
48282207|NCT04510090|101014256|FG002|NOT COMPLETED|SD-CP||0||
48282208|NCT04510090|101014257|FG003|NOT COMPLETED|SD-CP||0||
48282209|NCT04510090|101014258|FG004|NOT COMPLETED|SD-CP||0||
48282210|NCT04510090|101014259|FG005|NOT COMPLETED|SD-CP||0||
48397045|NCT03228394|101302528|FG003|STARTED|Overall Study||15||
48397046|NCT03228394|101302529|FG004|STARTED|Overall Study||10||
48397047|NCT03228394|101302530|FG005|STARTED|Overall Study||10||
48397048|NCT03228394|101302531|FG006|STARTED|Overall Study||17||
48397049|NCT03228394|101302532|FG007|STARTED|Overall Study||16||
48397050|NCT03228394|101302525|FG000|COMPLETED|Overall Study||4||
48397051|NCT03228394|101302526|FG001|COMPLETED|Overall Study||5||
48397052|NCT03228394|101302527|FG002|COMPLETED|Overall Study||12||
48397053|NCT03228394|101302528|FG003|COMPLETED|Overall Study||13||
48397054|NCT03228394|101302529|FG004|COMPLETED|Overall Study||10||
48397055|NCT03228394|101302530|FG005|COMPLETED|Overall Study||10||
48397056|NCT03228394|101302531|FG006|COMPLETED|Overall Study||12||
48397057|NCT03228394|101302532|FG007|COMPLETED|Overall Study||13||
48397058|NCT03228394|101302525|FG000|NOT COMPLETED|Overall Study||0||
48397059|NCT03228394|101302526|FG001|NOT COMPLETED|Overall Study||0||
48397060|NCT03228394|101302527|FG002|NOT COMPLETED|Overall Study||2||
48397061|NCT03228394|101302528|FG003|NOT COMPLETED|Overall Study||2||
48397062|NCT03228394|101302529|FG004|NOT COMPLETED|Overall Study||0||
48397063|NCT03228394|101302530|FG005|NOT COMPLETED|Overall Study||0||
48397064|NCT03228394|101302531|FG006|NOT COMPLETED|Overall Study||5||
48397065|NCT03228394|101302532|FG007|NOT COMPLETED|Overall Study||3||
48397066|NCT00944216|101302533|FG000|STARTED|Overall Study||1||
48397067|NCT00944216|101302533|FG000|COMPLETED|Overall Study||1||
48397068|NCT00944216|101302533|FG000|NOT COMPLETED|Overall Study||0||
48397069|NCT01985971|101302534|FG000|STARTED|Overall Study||2||
48397070|NCT01985971|101302534|FG000|COMPLETED|Overall Study||1||
48397071|NCT01985971|101302534|FG000|NOT COMPLETED|Overall Study||1||
48397072|NCT00841269|101302535|FG000|STARTED|Overall Study||20||
48397073|NCT00841269|101302536|FG001|STARTED|Overall Study||22||
48397074|NCT00841269|101302535|FG000|COMPLETED|Overall Study||12||
48397075|NCT00841269|101302536|FG001|COMPLETED|Overall Study||13||
48397076|NCT00841269|101302535|FG000|NOT COMPLETED|Overall Study||8||
48397077|NCT00841269|101302536|FG001|NOT COMPLETED|Overall Study||9||
48397078|NCT02481596|101302537|FG000|STARTED|Overall Study||126||
48397079|NCT02481596|101302538|FG001|STARTED|Overall Study||127||
48397080|NCT02481596|101302539|FG002|STARTED|Overall Study||253||
48397081|NCT02481596|101302537|FG000|COMPLETED|Overall Study||123||
48397082|NCT02481596|101302538|FG001|COMPLETED|Overall Study||126||
48397083|NCT02481596|101302539|FG002|COMPLETED|Overall Study||245||
48397084|NCT02481596|101302537|FG000|NOT COMPLETED|Overall Study||3||
48397085|NCT02481596|101302538|FG001|NOT COMPLETED|Overall Study||1||
48397086|NCT02481596|101302539|FG002|NOT COMPLETED|Overall Study||8||
48397087|NCT02460978|101302540|FG000|STARTED|Overall Study||271||
48397088|NCT02460978|101302541|FG001|STARTED|Overall Study||270||
48397089|NCT02460978|101302542|FG002|STARTED|Overall Study||272||
48397090|NCT02460978|101302540|FG000|COMPLETED|Overall Study||244||
48397091|NCT02460978|101302541|FG001|COMPLETED|Overall Study||245||
48282211|NCT04510090|101014260|FG006|NOT COMPLETED|SD-CP||0||
48282212|NCT04510090|101014261|FG007|NOT COMPLETED|SD-CP||0||
48397092|NCT02460978|101302542|FG002|COMPLETED|Overall Study||239||
48282213|NCT04510090|101014254|FG000|STARTED|SD-UP||0||
48397093|NCT02460978|101302540|FG000|NOT COMPLETED|Overall Study||27||
48282214|NCT04510090|101014255|FG001|STARTED|SD-UP||0||
48282215|NCT04510090|101014256|FG002|STARTED|SD-UP||0||
48699991|NCT00853242|102053913|FG005|STARTED|Overall Study||51||
48699992|NCT00853242|102053914|FG006|STARTED|Overall Study||49||
48570575|NCT03431831|101727863|FG005|COMPLETED|Overall Study||10||
48282216|NCT04510090|101014257|FG003|STARTED|SD-UP||0||
48282217|NCT04510090|101014258|FG004|STARTED|SD-UP||6||
48282218|NCT04510090|101014259|FG005|STARTED|SD-UP||0||
48282219|NCT04510090|101014260|FG006|STARTED|SD-UP||0||
48282220|NCT04510090|101014261|FG007|STARTED|SD-UP||0||
48282221|NCT04510090|101014254|FG000|COMPLETED|SD-UP||0||
48282222|NCT04510090|101014255|FG001|COMPLETED|SD-UP||0||
48282223|NCT04510090|101014256|FG002|COMPLETED|SD-UP||0||
48282224|NCT04510090|101014257|FG003|COMPLETED|SD-UP||0||
48282225|NCT04510090|101014258|FG004|COMPLETED|SD-UP||6||
48282226|NCT04510090|101014259|FG005|COMPLETED|SD-UP||0||
48282227|NCT04510090|101014260|FG006|COMPLETED|SD-UP||0||
48282228|NCT04510090|101014261|FG007|COMPLETED|SD-UP||0||
48282229|NCT04510090|101014254|FG000|NOT COMPLETED|SD-UP||0||
48282230|NCT04510090|101014255|FG001|NOT COMPLETED|SD-UP||0||
48282231|NCT04510090|101014256|FG002|NOT COMPLETED|SD-UP||0||
48282232|NCT04510090|101014257|FG003|NOT COMPLETED|SD-UP||0||
48282233|NCT04510090|101014258|FG004|NOT COMPLETED|SD-UP||0||
48282234|NCT04510090|101014259|FG005|NOT COMPLETED|SD-UP||0||
48282235|NCT04510090|101014260|FG006|NOT COMPLETED|SD-UP||0||
48282236|NCT04510090|101014261|FG007|NOT COMPLETED|SD-UP||0||
48282237|NCT04510090|101014254|FG000|STARTED|MD-CP||1||
48282238|NCT04510090|101014255|FG001|STARTED|MD-CP||0||
48282239|NCT04510090|101014256|FG002|STARTED|MD-CP||0||
48282240|NCT04510090|101014257|FG003|STARTED|MD-CP||2||
48282241|NCT04510090|101014258|FG004|STARTED|MD-CP||0||
48282242|NCT04510090|101014259|FG005|STARTED|MD-CP||0||
48282243|NCT04510090|101014260|FG006|STARTED|MD-CP||0||
48282244|NCT04510090|101014261|FG007|STARTED|MD-CP||0||
48282245|NCT04510090|101014254|FG000|COMPLETED|MD-CP||1||
48282246|NCT04510090|101014255|FG001|COMPLETED|MD-CP||0||
48282247|NCT04510090|101014256|FG002|COMPLETED|MD-CP||0||
48282248|NCT04510090|101014257|FG003|COMPLETED|MD-CP||2||
48282249|NCT04510090|101014258|FG004|COMPLETED|MD-CP||0||
48282250|NCT04510090|101014259|FG005|COMPLETED|MD-CP||0||
48282251|NCT04510090|101014260|FG006|COMPLETED|MD-CP||0||
48282252|NCT04510090|101014261|FG007|COMPLETED|MD-CP||0||
48282253|NCT04510090|101014254|FG000|NOT COMPLETED|MD-CP||0||
48282254|NCT04510090|101014255|FG001|NOT COMPLETED|MD-CP||0||
48282255|NCT04510090|101014256|FG002|NOT COMPLETED|MD-CP||0||
48282256|NCT04510090|101014257|FG003|NOT COMPLETED|MD-CP||0||
48282257|NCT04510090|101014258|FG004|NOT COMPLETED|MD-CP||0||
48282258|NCT04510090|101014259|FG005|NOT COMPLETED|MD-CP||0||
48282259|NCT04510090|101014260|FG006|NOT COMPLETED|MD-CP||0||
48282260|NCT04510090|101014261|FG007|NOT COMPLETED|MD-CP||0||
48282261|NCT04510090|101014254|FG000|STARTED|MD-UP||2||
48282262|NCT04510090|101014255|FG001|STARTED|MD-UP||4||
48282263|NCT04510090|101014256|FG002|STARTED|MD-UP||0||
48282264|NCT04510090|101014257|FG003|STARTED|MD-UP||0||
48282265|NCT04510090|101014258|FG004|STARTED|MD-UP||0||
48282266|NCT04510090|101014259|FG005|STARTED|MD-UP||0||
48699993|NCT00853242|102053908|FG000|Treated|Overall Study||50||
48570576|NCT03431831|101727864|FG006|COMPLETED|Overall Study||10||
48570577|NCT03431831|101727865|FG007|COMPLETED|Overall Study||9||
48570578|NCT03431831|101727858|FG000|NOT COMPLETED|Overall Study||2||
48570579|NCT03431831|101727859|FG001|NOT COMPLETED|Overall Study||2||
48570580|NCT03431831|101727860|FG002|NOT COMPLETED|Overall Study||2||
48282267|NCT04510090|101014260|FG006|STARTED|MD-UP||0||
48282268|NCT04510090|101014261|FG007|STARTED|MD-UP||0||
48282269|NCT04510090|101014254|FG000|COMPLETED|MD-UP||2||
48282270|NCT04510090|101014255|FG001|COMPLETED|MD-UP||4||
48282271|NCT04510090|101014256|FG002|COMPLETED|MD-UP||0||
48282272|NCT04510090|101014257|FG003|COMPLETED|MD-UP||0||
48282273|NCT04510090|101014258|FG004|COMPLETED|MD-UP||0||
48282274|NCT04510090|101014259|FG005|COMPLETED|MD-UP||0||
48282275|NCT04510090|101014260|FG006|COMPLETED|MD-UP||0||
48282276|NCT04510090|101014261|FG007|COMPLETED|MD-UP||0||
48282277|NCT04510090|101014254|FG000|NOT COMPLETED|MD-UP||0||
48282278|NCT04510090|101014255|FG001|NOT COMPLETED|MD-UP||0||
48282279|NCT04510090|101014256|FG002|NOT COMPLETED|MD-UP||0||
48282280|NCT04510090|101014257|FG003|NOT COMPLETED|MD-UP||0||
48282281|NCT04510090|101014258|FG004|NOT COMPLETED|MD-UP||0||
48282282|NCT04510090|101014259|FG005|NOT COMPLETED|MD-UP||0||
48282283|NCT04510090|101014260|FG006|NOT COMPLETED|MD-UP||0||
48282284|NCT04510090|101014261|FG007|NOT COMPLETED|MD-UP||0||
48282285|NCT03954392|101014262|FG000|STARTED|Overall Study||23||
48282286|NCT03954392|101014263|FG001|STARTED|Overall Study||22||
48570581|NCT03431831|101727861|FG003|NOT COMPLETED|Overall Study||1||
48570582|NCT03431831|101727862|FG004|NOT COMPLETED|Overall Study||4||
48282287|NCT03954392|101014262|FG000|COMPLETED|Overall Study||23||
48282288|NCT03954392|101014263|FG001|COMPLETED|Overall Study||22||
48282289|NCT03954392|101014262|FG000|NOT COMPLETED|Overall Study||0||
48282290|NCT03954392|101014263|FG001|NOT COMPLETED|Overall Study||0||
48570583|NCT03431831|101727863|FG005|NOT COMPLETED|Overall Study||4||
48570584|NCT03431831|101727864|FG006|NOT COMPLETED|Overall Study||1||
48570585|NCT03431831|101727865|FG007|NOT COMPLETED|Overall Study||1||
48570586|NCT03957200|101727866|FG000|STARTED|Overall Study||57||
48570587|NCT03957200|101727866|FG000|COMPLETED|Overall Study||57||
48570588|NCT03957200|101727866|FG000|NOT COMPLETED|Overall Study||0||
48570589|NCT03297645|101727867|FG000|STARTED|Overall Study||118||
48282291|NCT02885324|101014264|FG000|STARTED|Overall Study||4||
48282292|NCT02885324|101014264|FG000|COMPLETED|Overall Study||4||
48282293|NCT02885324|101014264|FG000|NOT COMPLETED|Overall Study||0||
48282294|NCT02040259|101014265|FG000|STARTED|Overall Study||2008||
48282295|NCT02040259|101014265|FG000|COMPLETED|Overall Study||1645||
48282296|NCT02040259|101014265|FG000|NOT COMPLETED|Overall Study||363||
48282297|NCT02929329|101014266|FG000|STARTED|Overall Study||4112||
48282298|NCT02929329|101014267|FG001|STARTED|Overall Study||4120||
48570590|NCT03297645|101727868|FG001|STARTED|Overall Study||69||
48570591|NCT03297645|101727869|FG002|STARTED|Overall Study||63||
48570592|NCT03297645|101727867|FG000|COMPLETED|Overall Study||81||
48570593|NCT03297645|101727868|FG001|COMPLETED|Overall Study||51||
48570594|NCT03297645|101727869|FG002|COMPLETED|Overall Study||54||
48570595|NCT03297645|101727867|FG000|NOT COMPLETED|Overall Study||37||
48570596|NCT03297645|101727868|FG001|NOT COMPLETED|Overall Study||18||
48570597|NCT03297645|101727869|FG002|NOT COMPLETED|Overall Study||9||
48570598|NCT02589639|101727870|FG000|STARTED|Overall Study||90||
48570599|NCT02589639|101727871|FG001|STARTED|Overall Study||89||
48570600|NCT02589639|101727872|FG002|STARTED|Overall Study||90||
48570601|NCT02589639|101727870|FG000|Treated|Overall Study||90||
48570602|NCT02589639|101727871|FG001|Treated|Overall Study||86||
48570603|NCT02589639|101727872|FG002|Treated|Overall Study||90||
48282299|NCT02929329|101014266|FG000|Received Treatment|Overall Study||4101||
48282300|NCT02929329|101014267|FG001|Received Treatment|Overall Study||4110||
48282301|NCT02929329|101014266|FG000|COMPLETED|Overall Study||3008||
48282302|NCT02929329|101014267|FG001|COMPLETED|Overall Study||3028||
48282303|NCT02929329|101014266|FG000|NOT COMPLETED|Overall Study||1104||
48282304|NCT02929329|101014267|FG001|NOT COMPLETED|Overall Study||1092||
48282305|NCT00770029|101014268|FG000|STARTED|Overall Study||184||
48282306|NCT00770029|101014269|FG001|STARTED|Overall Study||92||
48282307|NCT00770029|101014268|FG000|COMPLETED|Overall Study||178||
48282308|NCT00770029|101014269|FG001|COMPLETED|Overall Study||89||
48282309|NCT00770029|101014268|FG000|NOT COMPLETED|Overall Study||6||
48282310|NCT00770029|101014269|FG001|NOT COMPLETED|Overall Study||3||
48282311|NCT00603304|101014270|FG000|STARTED|Overall Study||183||
48282312|NCT00603304|101014271|FG001|STARTED|Overall Study||186||
48282313|NCT00603304|101014270|FG000|COMPLETED|Overall Study||151||
48282314|NCT00603304|101014271|FG001|COMPLETED|Overall Study||155||
48282315|NCT00603304|101014270|FG000|NOT COMPLETED|Overall Study||32||
48282316|NCT00603304|101014271|FG001|NOT COMPLETED|Overall Study||31||
48282317|NCT00356408|101014272|FG000|STARTED|Overall Study||103||
48282318|NCT00356408|101014272|FG000|COMPLETED|Overall Study||43||
48282319|NCT00356408|101014272|FG000|NOT COMPLETED|Overall Study||60||
48282320|NCT00818168|101014273|FG000|STARTED|Overall Study||320||
48282321|NCT00818168|101014273|FG000|COMPLETED|Overall Study||250||
48282322|NCT00818168|101014273|FG000|NOT COMPLETED|Overall Study||70||
48282323|NCT03167359|101014274|FG000|STARTED|Overall Study||74||
48282324|NCT03167359|101014274|FG000|COMPLETED|Overall Study||72||
48282325|NCT03167359|101014274|FG000|NOT COMPLETED|Overall Study||2||
48282326|NCT04313608|101014275|FG000|STARTED|Overall Study||17||
48282327|NCT04313608|101014276|FG001|STARTED|Overall Study||6||
48282328|NCT04313608|101014275|FG000|COMPLETED|Overall Study||5||
48282329|NCT04313608|101014276|FG001|COMPLETED|Overall Study||3||
48282330|NCT04313608|101014275|FG000|NOT COMPLETED|Overall Study||12||
48282331|NCT04313608|101014276|FG001|NOT COMPLETED|Overall Study||3||
48282332|NCT00921687|101014277|FG000|STARTED|Overall Study||418||
48282333|NCT00921687|101014278|FG001|STARTED|Overall Study||363||
48282334|NCT00921687|101014277|FG000|COMPLETED|Overall Study||418||
48282335|NCT00921687|101014278|FG001|COMPLETED|Overall Study||363||
48282336|NCT00921687|101014277|FG000|NOT COMPLETED|Overall Study||0||
48282337|NCT00921687|101014278|FG001|NOT COMPLETED|Overall Study||0||
48282338|NCT01099215|101014279|FG000|STARTED|Overall Study||11||
48282339|NCT01099215|101014280|FG001|STARTED|Overall Study||10||
48282340|NCT01099215|101014279|FG000|COMPLETED|Overall Study||10||
48570604|NCT02589639|101727870|FG000|COMPLETED|Overall Study||80||
48570605|NCT02589639|101727871|FG001|COMPLETED|Overall Study||79||
48570606|NCT02589639|101727872|FG002|COMPLETED|Overall Study||86||
48570607|NCT02589639|101727870|FG000|NOT COMPLETED|Overall Study||10||
48570608|NCT02589639|101727871|FG001|NOT COMPLETED|Overall Study||10||
48570609|NCT02589639|101727872|FG002|NOT COMPLETED|Overall Study||4||
48570610|NCT03532425|101727873|FG000|STARTED|Overall Study||14||
48570611|NCT03532425|101727874|FG001|STARTED|Overall Study||14||
48570612|NCT03532425|101727873|FG000|COMPLETED|Overall Study||14||
48282341|NCT01099215|101014280|FG001|COMPLETED|Overall Study||9||
48282342|NCT01099215|101014279|FG000|NOT COMPLETED|Overall Study||1||
48282343|NCT01099215|101014280|FG001|NOT COMPLETED|Overall Study||1||
48282344|NCT02187159|101014281|FG000|STARTED|Overall Study||318||
48282345|NCT02187159|101014282|FG001|STARTED|Overall Study||317||
48282346|NCT02187159|101014283|FG002|STARTED|Overall Study||318||
48570613|NCT03532425|101727874|FG001|COMPLETED|Overall Study||13||
48570614|NCT03532425|101727873|FG000|NOT COMPLETED|Overall Study||0||
48570615|NCT03532425|101727874|FG001|NOT COMPLETED|Overall Study||1||
48570616|NCT01174823|101727875|FG000|STARTED|Overall Study||122||
48570617|NCT01174823|101727876|FG001|STARTED|Overall Study||123||
48570618|NCT01174823|101727875|FG000|COMPLETED|Overall Study||115||
48570619|NCT01174823|101727876|FG001|COMPLETED|Overall Study||119||
48570620|NCT01174823|101727875|FG000|NOT COMPLETED|Overall Study||7||
48570621|NCT01174823|101727876|FG001|NOT COMPLETED|Overall Study||4||
48570622|NCT00767455|101727877|FG000|STARTED|Overall Study||59||
48282347|NCT02187159|101014284|FG003|STARTED|Overall Study||317||
48282348|NCT02187159|101014281|FG000|COMPLETED|Overall Study||249||
48282349|NCT02187159|101014282|FG001|COMPLETED|Overall Study||238||
48282350|NCT02187159|101014283|FG002|COMPLETED|Overall Study||241||
48282351|NCT02187159|101014284|FG003|COMPLETED|Overall Study||221||
48282352|NCT02187159|101014281|FG000|NOT COMPLETED|Overall Study||69||
48282353|NCT02187159|101014282|FG001|NOT COMPLETED|Overall Study||79||
48282354|NCT02187159|101014283|FG002|NOT COMPLETED|Overall Study||77||
48282355|NCT02187159|101014284|FG003|NOT COMPLETED|Overall Study||96||
48282356|NCT00444275|101014285|FG000|STARTED|Initial Treatment Phase||2156||
48282357|NCT00444275|101014286|FG001|STARTED|Initial Treatment Phase||873||
48282358|NCT00444275|101014287|FG002|STARTED|Initial Treatment Phase||0||
48282359|NCT00444275|101014288|FG003|STARTED|Initial Treatment Phase||0||
48282360|NCT00444275|101014289|FG004|STARTED|Initial Treatment Phase||0||
48282361|NCT00444275|101014285|FG000|COMPLETED|Initial Treatment Phase||1908||
48282362|NCT00444275|101014286|FG001|COMPLETED|Initial Treatment Phase||777||
48282363|NCT00444275|101014287|FG002|COMPLETED|Initial Treatment Phase||0||
48282364|NCT00444275|101014288|FG003|COMPLETED|Initial Treatment Phase||0||
48282365|NCT00444275|101014289|FG004|COMPLETED|Initial Treatment Phase||0||
48282366|NCT00444275|101014285|FG000|NOT COMPLETED|Initial Treatment Phase||248||
48282367|NCT00444275|101014286|FG001|NOT COMPLETED|Initial Treatment Phase||96||
48282368|NCT00444275|101014287|FG002|NOT COMPLETED|Initial Treatment Phase||0||
48282369|NCT00444275|101014288|FG003|NOT COMPLETED|Initial Treatment Phase||0||
48282370|NCT00444275|101014289|FG004|NOT COMPLETED|Initial Treatment Phase||0||
48282371|NCT00444275|101014285|FG000|STARTED|Maintenance Treatment Phase||0||
48282372|NCT00444275|101014286|FG001|STARTED|Maintenance Treatment Phase||0||
48282373|NCT00444275|101014287|FG002|STARTED|Maintenance Treatment Phase||908||
48282374|NCT00444275|101014288|FG003|STARTED|Maintenance Treatment Phase||897||
48282375|NCT00444275|101014289|FG004|STARTED|Maintenance Treatment Phase||880||
48282376|NCT00444275|101014285|FG000|COMPLETED|Maintenance Treatment Phase||0||
48282377|NCT00444275|101014286|FG001|COMPLETED|Maintenance Treatment Phase||0||
48282378|NCT00444275|101014287|FG002|COMPLETED|Maintenance Treatment Phase||747||
48282379|NCT00444275|101014288|FG003|COMPLETED|Maintenance Treatment Phase||764||
48282380|NCT00444275|101014289|FG004|COMPLETED|Maintenance Treatment Phase||701||
48282381|NCT00444275|101014285|FG000|NOT COMPLETED|Maintenance Treatment Phase||0||
48282382|NCT00444275|101014286|FG001|NOT COMPLETED|Maintenance Treatment Phase||0||
48282383|NCT00444275|101014287|FG002|NOT COMPLETED|Maintenance Treatment Phase||161||
48282384|NCT00444275|101014288|FG003|NOT COMPLETED|Maintenance Treatment Phase||133||
48282385|NCT00444275|101014289|FG004|NOT COMPLETED|Maintenance Treatment Phase||179||
48282386|NCT00662818|101014290|FG000|STARTED|Period 1 (6 Weeks)||84||
48282387|NCT00662818|101014291|FG001|STARTED|Period 1 (6 Weeks)||81||
48282388|NCT00662818|101014290|FG000|Treated|Period 1 (6 Weeks)||56||
48282389|NCT00662818|101014291|FG001|Treated|Period 1 (6 Weeks)||58||
48282390|NCT00662818|101014290|FG000|COMPLETED|Period 1 (6 Weeks)||56||
48282391|NCT00662818|101014291|FG001|COMPLETED|Period 1 (6 Weeks)||58||
48282392|NCT00662818|101014290|FG000|NOT COMPLETED|Period 1 (6 Weeks)||28||
48282393|NCT00662818|101014291|FG001|NOT COMPLETED|Period 1 (6 Weeks)||23||
48282394|NCT00662818|101014290|FG000|STARTED|Wash-Out (14 Days)||56||
48282395|NCT00662818|101014291|FG001|STARTED|Wash-Out (14 Days)||58||
48282396|NCT00662818|101014290|FG000|COMPLETED|Wash-Out (14 Days)||51||
48282397|NCT00662818|101014291|FG001|COMPLETED|Wash-Out (14 Days)||53||
48282398|NCT00662818|101014290|FG000|NOT COMPLETED|Wash-Out (14 Days)||5||
48282399|NCT00662818|101014291|FG001|NOT COMPLETED|Wash-Out (14 Days)||5||
48282400|NCT00662818|101014290|FG000|STARTED|Period 2 (6 Weeks)||51||
48570623|NCT00767455|101727877|FG000|COMPLETED|Overall Study||40||
48570624|NCT00767455|101727877|FG000|NOT COMPLETED|Overall Study||19||
48570625|NCT03193853|101727878|FG000|STARTED|Overall Study||10||
48699994|NCT00853242|102053909|FG001|Treated|Overall Study||49||
48282401|NCT00662818|101014291|FG001|STARTED|Period 2 (6 Weeks)||53||
48282402|NCT00662818|101014290|FG000|COMPLETED|Period 2 (6 Weeks)||38||
48282403|NCT00662818|101014291|FG001|COMPLETED|Period 2 (6 Weeks)||41||
48282404|NCT00662818|101014290|FG000|NOT COMPLETED|Period 2 (6 Weeks)||13||
48282405|NCT00662818|101014291|FG001|NOT COMPLETED|Period 2 (6 Weeks)||12||
48282406|NCT01415531|101014292|FG000|STARTED|Overall Study||214||
48282407|NCT01415531|101014293|FG001|STARTED|Overall Study||427||
48282408|NCT01415531|101014292|FG000|COMPLETED|Overall Study||189||
48282409|NCT01415531|101014293|FG001|COMPLETED|Overall Study||390||
48282410|NCT01415531|101014292|FG000|NOT COMPLETED|Overall Study||25||
48282411|NCT01415531|101014293|FG001|NOT COMPLETED|Overall Study||37||
48282412|NCT01242800|101014294|FG000|STARTED|Overall Study||131||
48282413|NCT01242800|101014295|FG001|STARTED|Overall Study||125||
48397094|NCT02460978|101302541|FG001|NOT COMPLETED|Overall Study||25||
48570626|NCT03193853|101727878|FG000|COMPLETED|Overall Study||4||
48570627|NCT03193853|101727878|FG000|NOT COMPLETED|Overall Study||6||
48699995|NCT00853242|102053910|FG002|Treated|Overall Study||48||
48282414|NCT01242800|101014294|FG000|COMPLETED|Overall Study||131||
48282415|NCT01242800|101014295|FG001|COMPLETED|Overall Study||106||
48282416|NCT01242800|101014294|FG000|NOT COMPLETED|Overall Study||0||
48124507|NCT04551105|100630401|FG001|NOT COMPLETED|The 1st Study Sessions||0||0
48124508|NCT04551105|100630400|FG000|STARTED|The 2st Study Sessions (5 Weeks Later)||8||314
48124509|NCT04551105|100630401|FG001|STARTED|The 2st Study Sessions (5 Weeks Later)||8||314
48124510|NCT04551105|100630400|FG000|COMPLETED|The 2st Study Sessions (5 Weeks Later)||8||314
48124511|NCT04551105|100630401|FG001|COMPLETED|The 2st Study Sessions (5 Weeks Later)||8||314
48124512|NCT04551105|100630400|FG000|NOT COMPLETED|The 2st Study Sessions (5 Weeks Later)||0||0
48124513|NCT04551105|100630401|FG001|NOT COMPLETED|The 2st Study Sessions (5 Weeks Later)||0||0
48124514|NCT04589559|100630402|FG000|STARTED|Overall Study||10||
48124515|NCT04589559|100630402|FG000|COMPLETED|Overall Study||10||
48124516|NCT04589559|100630402|FG000|NOT COMPLETED|Overall Study||0||
48124517|NCT05226104|100630403|FG000|STARTED|Overall Study||27||
48124518|NCT05226104|100630403|FG000|COMPLETED|Overall Study||24||
48124519|NCT05226104|100630403|FG000|NOT COMPLETED|Overall Study||3||
48124520|NCT02031276|100630404|FG000|STARTED|Period 1 Double-blind IV||39||
48124521|NCT02031276|100630405|FG001|STARTED|Period 1 Double-blind IV||41||
48124522|NCT02031276|100630406|FG002|STARTED|Period 1 Double-blind IV||41||
48124523|NCT02031276|100630404|FG000|COMPLETED|Period 1 Double-blind IV||33||
48124524|NCT02031276|100630405|FG001|COMPLETED|Period 1 Double-blind IV||35||
48124525|NCT02031276|100630406|FG002|COMPLETED|Period 1 Double-blind IV||40||
48124526|NCT02031276|100630404|FG000|NOT COMPLETED|Period 1 Double-blind IV||6||
48124527|NCT02031276|100630405|FG001|NOT COMPLETED|Period 1 Double-blind IV||6||
48124528|NCT02031276|100630406|FG002|NOT COMPLETED|Period 1 Double-blind IV||1||
48124529|NCT02031276|100630404|FG000|STARTED|Period 2 Open-label Risankizumab IV||33||
48124530|NCT02031276|100630405|FG001|STARTED|Period 2 Open-label Risankizumab IV||35||
48124531|NCT02031276|100630406|FG002|STARTED|Period 2 Open-label Risankizumab IV||39||
48124532|NCT02031276|100630404|FG000|COMPLETED|Period 2 Open-label Risankizumab IV||29||
48124533|NCT02031276|100630405|FG001|COMPLETED|Period 2 Open-label Risankizumab IV||33||
48124534|NCT02031276|100630406|FG002|COMPLETED|Period 2 Open-label Risankizumab IV||38||
48124535|NCT02031276|100630404|FG000|NOT COMPLETED|Period 2 Open-label Risankizumab IV||4||
48124536|NCT02031276|100630405|FG001|NOT COMPLETED|Period 2 Open-label Risankizumab IV||2||
48124537|NCT02031276|100630406|FG002|NOT COMPLETED|Period 2 Open-label Risankizumab IV||1||
48124538|NCT02031276|100630404|FG000|STARTED|Period 3 Open-label Risankizumab SC||19||
48124539|NCT02031276|100630405|FG001|STARTED|Period 3 Open-label Risankizumab SC||22||
48124540|NCT02031276|100630406|FG002|STARTED|Period 3 Open-label Risankizumab SC||21||
48124541|NCT02031276|100630404|FG000|COMPLETED|Period 3 Open-label Risankizumab SC||16||
48124542|NCT02031276|100630405|FG001|COMPLETED|Period 3 Open-label Risankizumab SC||19||
48124543|NCT02031276|100630406|FG002|COMPLETED|Period 3 Open-label Risankizumab SC||19||
48124544|NCT02031276|100630404|FG000|NOT COMPLETED|Period 3 Open-label Risankizumab SC||3||
48124545|NCT02031276|100630405|FG001|NOT COMPLETED|Period 3 Open-label Risankizumab SC||3||
48124546|NCT02031276|100630406|FG002|NOT COMPLETED|Period 3 Open-label Risankizumab SC||2||
48124547|NCT03525834|100630407|FG000|STARTED|Overall Study||40||
48124548|NCT03525834|100630407|FG000|COMPLETED|Overall Study||39||
48124549|NCT03525834|100630407|FG000|NOT COMPLETED|Overall Study||1||
48282417|NCT01242800|101014295|FG001|NOT COMPLETED|Overall Study||19||
48282418|NCT02738203|101014296|FG000|STARTED|Overall Study||110||
48282419|NCT02738203|101014297|FG001|STARTED|Overall Study||110||
48282420|NCT02738203|101014296|FG000|COMPLETED|Overall Study||108||
48282421|NCT02738203|101014297|FG001|COMPLETED|Overall Study||107||
48282422|NCT02738203|101014296|FG000|NOT COMPLETED|Overall Study||2||
48570628|NCT00799474|101727879|FG000|STARTED|Overall Study||609||
48570629|NCT00799474|101727879|FG000|COMPLETED|Overall Study||609||
48570630|NCT00799474|101727879|FG000|NOT COMPLETED|Overall Study||0||
48570631|NCT00728260|101727880|FG000|STARTED|Overall Study||1421||
48570632|NCT00728260|101727880|FG000|COMPLETED|Overall Study||1421||
48570633|NCT00728260|101727880|FG000|NOT COMPLETED|Overall Study||0||
48570634|NCT04547985|101727881|FG000|STARTED|1st Clinic Visit (1 Week)||6||
48124550|NCT02984020|100630408|FG000|STARTED|Overall Study||1041||
48124551|NCT02984020|100630408|FG000|COMPLETED|Overall Study||1009||
48124552|NCT02984020|100630408|FG000|NOT COMPLETED|Overall Study||32||
48124553|NCT02430077|100630409|FG000|STARTED|First Intervention 4 Months||5||
48124554|NCT02430077|100630410|FG001|STARTED|First Intervention 4 Months||5||
48124555|NCT02430077|100630409|FG000|COMPLETED|First Intervention 4 Months||5||
48124556|NCT02430077|100630410|FG001|COMPLETED|First Intervention 4 Months||5||
48124557|NCT02430077|100630409|FG000|NOT COMPLETED|First Intervention 4 Months||0||
48282423|NCT02738203|101014297|FG001|NOT COMPLETED|Overall Study||3||
48282424|NCT01888900|101014298|FG000|STARTED|Overall Study||22||
48282425|NCT01888900|101014299|FG001|STARTED|Overall Study||13||
48282426|NCT01888900|101014298|FG000|COMPLETED|Overall Study||22|2 failures were switched from DUAL treatment to QUAD treatment.|
48282427|NCT01888900|101014299|FG001|COMPLETED|Overall Study||11|2 failures were switched from DUAL treatment to QUAD treatment.|
48570635|NCT04547985|101727882|FG001|STARTED|1st Clinic Visit (1 Week)||3||
48570636|NCT04547985|101727881|FG000|COMPLETED|1st Clinic Visit (1 Week)||6||
48592803|NCT01764997|101783185|FG003|NOT COMPLETED|Run-in Period||0||
48282428|NCT01888900|101014298|FG000|NOT COMPLETED|Overall Study||0||
48282429|NCT01888900|101014299|FG001|NOT COMPLETED|Overall Study||2||
48282430|NCT00307684|101014300|FG000|STARTED|Open Label Phase||0||
48282431|NCT00307684|101014301|FG001|STARTED|Open Label Phase||0||
48124558|NCT02430077|100630410|FG001|NOT COMPLETED|First Intervention 4 Months||0||
48282432|NCT00307684|101014302|FG002|STARTED|Open Label Phase||155||
48282433|NCT00307684|101014300|FG000|COMPLETED|Open Label Phase||0||
48282434|NCT00307684|101014301|FG001|COMPLETED|Open Label Phase||0||
48282435|NCT00307684|101014302|FG002|COMPLETED|Open Label Phase||99||
48282436|NCT00307684|101014300|FG000|NOT COMPLETED|Open Label Phase||0||
48282437|NCT00307684|101014301|FG001|NOT COMPLETED|Open Label Phase||0||
48282438|NCT00307684|101014302|FG002|NOT COMPLETED|Open Label Phase||56||
48282439|NCT00307684|101014300|FG000|STARTED|Double Blind Phase||23||
48282440|NCT00307684|101014301|FG001|STARTED|Double Blind Phase||22||
48282441|NCT00307684|101014302|FG002|STARTED|Double Blind Phase||0||
48282442|NCT00307684|101014300|FG000|COMPLETED|Double Blind Phase||21||
48282443|NCT00307684|101014301|FG001|COMPLETED|Double Blind Phase||17||
48282444|NCT00307684|101014302|FG002|COMPLETED|Double Blind Phase||0||
48282445|NCT00307684|101014300|FG000|NOT COMPLETED|Double Blind Phase||2||
48282446|NCT00307684|101014301|FG001|NOT COMPLETED|Double Blind Phase||5||
48570637|NCT04547985|101727882|FG001|COMPLETED|1st Clinic Visit (1 Week)||3||
48570638|NCT04547985|101727881|FG000|NOT COMPLETED|1st Clinic Visit (1 Week)||0||
48570639|NCT04547985|101727882|FG001|NOT COMPLETED|1st Clinic Visit (1 Week)||0||
48570640|NCT04547985|101727881|FG000|STARTED|2nd Clinic Visit (4 Weeks)||4||
48570641|NCT04547985|101727882|FG001|STARTED|2nd Clinic Visit (4 Weeks)||1||
48570642|NCT04547985|101727881|FG000|COMPLETED|2nd Clinic Visit (4 Weeks)||4||
48282447|NCT00307684|101014302|FG002|NOT COMPLETED|Double Blind Phase||0||
48282448|NCT01080716|101014303|FG000|STARTED|Part 1||14||
48282449|NCT01080716|101014304|FG001|STARTED|Part 1||6||
48282450|NCT01080716|101014305|FG002|STARTED|Part 1||0||
48282451|NCT01080716|101014306|FG003|STARTED|Part 1||0||
48282452|NCT01080716|101014303|FG000|COMPLETED|Part 1||13||
48282453|NCT01080716|101014304|FG001|COMPLETED|Part 1||6||
48282454|NCT01080716|101014305|FG002|COMPLETED|Part 1||0||
48282455|NCT01080716|101014306|FG003|COMPLETED|Part 1||0||
48282456|NCT01080716|101014303|FG000|NOT COMPLETED|Part 1||1||
48282457|NCT01080716|101014304|FG001|NOT COMPLETED|Part 1||0||
48282458|NCT01080716|101014305|FG002|NOT COMPLETED|Part 1||0||
48282459|NCT01080716|101014306|FG003|NOT COMPLETED|Part 1||0||
48282460|NCT01080716|101014303|FG000|STARTED|Part 2||0||
48282461|NCT01080716|101014304|FG001|STARTED|Part 2||0||
48282462|NCT01080716|101014305|FG002|STARTED|Part 2||10||
48282463|NCT01080716|101014306|FG003|STARTED|Part 2||10||
48282464|NCT01080716|101014303|FG000|COMPLETED|Part 2||0||
48282465|NCT01080716|101014304|FG001|COMPLETED|Part 2||0||
48282466|NCT01080716|101014305|FG002|COMPLETED|Part 2||10||
48282467|NCT01080716|101014306|FG003|COMPLETED|Part 2||10||
48282468|NCT01080716|101014303|FG000|NOT COMPLETED|Part 2||0||
48282469|NCT01080716|101014304|FG001|NOT COMPLETED|Part 2||0||
48282470|NCT01080716|101014305|FG002|NOT COMPLETED|Part 2||0||
48282471|NCT01080716|101014306|FG003|NOT COMPLETED|Part 2||0||
48282472|NCT02930226|101014307|FG000|STARTED|Overall Study||4||
48282473|NCT02930226|101014308|FG001|STARTED|Overall Study||4||
48282474|NCT02930226|101014309|FG002|STARTED|Overall Study||4||
48282475|NCT02930226|101014310|FG003|STARTED|Overall Study||4||
48282476|NCT02930226|101014311|FG004|STARTED|Overall Study||4||
48282477|NCT02930226|101014312|FG005|STARTED|Overall Study||4||
48282478|NCT02930226|101014307|FG000|COMPLETED|Overall Study||4||
48282479|NCT02930226|101014308|FG001|COMPLETED|Overall Study||4||
48282480|NCT02930226|101014309|FG002|COMPLETED|Overall Study||4||
48282481|NCT02930226|101014310|FG003|COMPLETED|Overall Study||4||
48282482|NCT02930226|101014311|FG004|COMPLETED|Overall Study||3||
48282483|NCT02930226|101014312|FG005|COMPLETED|Overall Study||4||
48282484|NCT02930226|101014307|FG000|NOT COMPLETED|Overall Study||0||
48282485|NCT02930226|101014308|FG001|NOT COMPLETED|Overall Study||0||
48570643|NCT04547985|101727882|FG001|COMPLETED|2nd Clinic Visit (4 Weeks)||1||
48570644|NCT04547985|101727881|FG000|NOT COMPLETED|2nd Clinic Visit (4 Weeks)||0||
48570645|NCT04547985|101727882|FG001|NOT COMPLETED|2nd Clinic Visit (4 Weeks)||0||
48282486|NCT02930226|101014309|FG002|NOT COMPLETED|Overall Study||0||
48282487|NCT02930226|101014310|FG003|NOT COMPLETED|Overall Study||0||
48282488|NCT02930226|101014311|FG004|NOT COMPLETED|Overall Study||1||
48282489|NCT02930226|101014312|FG005|NOT COMPLETED|Overall Study||0||
48282490|NCT04289051|101014313|FG000|STARTED|Overall Study||13||
48282491|NCT04289051|101014314|FG001|STARTED|Overall Study||13||
48570646|NCT04547985|101727881|FG000|STARTED|3rd Clinic Visit (8 Weeks)||4||
48282492|NCT04289051|101014315|FG002|STARTED|Overall Study||13||
48282493|NCT04289051|101014313|FG000|First Intervention (2 Weeks)|Overall Study||13||
48282494|NCT04289051|101014314|FG001|First Intervention (2 Weeks)|Overall Study||13||
48282495|NCT04289051|101014315|FG002|First Intervention (2 Weeks)|Overall Study||11||
48282496|NCT04289051|101014313|FG000|Washout (1 Week)|Overall Study||13||
48282497|NCT04289051|101014314|FG001|Washout (1 Week)|Overall Study||13||
48570647|NCT04547985|101727882|FG001|STARTED|3rd Clinic Visit (8 Weeks)||1||
48570648|NCT04547985|101727881|FG000|COMPLETED|3rd Clinic Visit (8 Weeks)||4||
48570649|NCT04547985|101727882|FG001|COMPLETED|3rd Clinic Visit (8 Weeks)||1||
48592804|NCT01764997|101783186|FG004|NOT COMPLETED|Run-in Period||0||
48282498|NCT04289051|101014315|FG002|Washout (1 Week)|Overall Study||11||
48282499|NCT04289051|101014313|FG000|Second Intervention (2 Weeks)|Overall Study||13||
48282500|NCT04289051|101014314|FG001|Second Intervention (2 Weeks)|Overall Study||13||
48282501|NCT04289051|101014315|FG002|Second Intervention (2 Weeks)|Overall Study||11||
48282502|NCT04289051|101014313|FG000|Washout (1 Week)|Overall Study||13||
48282503|NCT04289051|101014314|FG001|Washout (1 Week)|Overall Study||13||
48282504|NCT04289051|101014315|FG002|Washout (1 Week)|Overall Study||11||
48282505|NCT04289051|101014313|FG000|Third Intervention (2 Weeks)|Overall Study||13||
48282506|NCT04289051|101014314|FG001|Third Intervention (2 Weeks)|Overall Study||13||
48282507|NCT04289051|101014315|FG002|Third Intervention (2 Weeks)|Overall Study||11||
48282508|NCT04289051|101014313|FG000|COMPLETED|Overall Study||13||
48282509|NCT04289051|101014314|FG001|COMPLETED|Overall Study||13||
48282510|NCT04289051|101014315|FG002|COMPLETED|Overall Study||11||
48282511|NCT04289051|101014313|FG000|NOT COMPLETED|Overall Study||0||
48282512|NCT04289051|101014314|FG001|NOT COMPLETED|Overall Study||0||
48282513|NCT04289051|101014315|FG002|NOT COMPLETED|Overall Study||2||
48282514|NCT00557947|101014316|FG000|STARTED|Overall Study||83||
48282515|NCT00557947|101014316|FG000|COMPLETED|Overall Study||83||
48282516|NCT00557947|101014316|FG000|NOT COMPLETED|Overall Study||0||
48282517|NCT01879722|101014317|FG000|STARTED|Overall Study||7||
48282518|NCT01879722|101014318|FG001|STARTED|Overall Study||8||
48397095|NCT02460978|101302542|FG002|NOT COMPLETED|Overall Study||33||
48397096|NCT00033371|101302543|FG000|STARTED|Overall Study||55||
48397097|NCT00033371|101302544|FG001|STARTED|Overall Study||57||
48397098|NCT00033371|101302543|FG000|COMPLETED|Overall Study||49||
48570650|NCT04547985|101727881|FG000|NOT COMPLETED|3rd Clinic Visit (8 Weeks)||0||
48570651|NCT04547985|101727882|FG001|NOT COMPLETED|3rd Clinic Visit (8 Weeks)||0||
48570652|NCT04547985|101727881|FG000|STARTED|Follow Up (12 Weeks)||4||
48570653|NCT04547985|101727882|FG001|STARTED|Follow Up (12 Weeks)||1||
48570654|NCT04547985|101727881|FG000|COMPLETED|Follow Up (12 Weeks)||4||
48570655|NCT04547985|101727882|FG001|COMPLETED|Follow Up (12 Weeks)||1||
48570656|NCT04547985|101727881|FG000|NOT COMPLETED|Follow Up (12 Weeks)||0||
48570657|NCT04547985|101727882|FG001|NOT COMPLETED|Follow Up (12 Weeks)||0||
48570658|NCT03866512|101727883|FG000|STARTED|Overall Study||11||
48570659|NCT03866512|101727884|FG001|STARTED|Overall Study||14||
48570660|NCT03866512|101727885|FG002|STARTED|Overall Study||12||
48570661|NCT03866512|101727883|FG000|COMPLETED|Overall Study||10||
48570662|NCT03866512|101727884|FG001|COMPLETED|Overall Study||11||
48570663|NCT03866512|101727885|FG002|COMPLETED|Overall Study||9||
48570664|NCT03866512|101727883|FG000|NOT COMPLETED|Overall Study||1||
48282519|NCT01879722|101014319|FG002|STARTED|Overall Study||7||
48282520|NCT01879722|101014320|FG003|STARTED|Overall Study||8||
48282521|NCT01879722|101014321|FG004|STARTED|Overall Study||8||
48397099|NCT00033371|101302544|FG001|COMPLETED|Overall Study||47||
48397100|NCT00033371|101302543|FG000|NOT COMPLETED|Overall Study||6||
48397101|NCT00033371|101302544|FG001|NOT COMPLETED|Overall Study||10||
48397102|NCT01425853|101302545|FG000|STARTED|Overall Study||304||
48397103|NCT01425853|101302546|FG001|STARTED|Overall Study||302||
48397104|NCT01425853|101302545|FG000|Safety Population|Overall Study||304||
48397105|NCT01425853|101302546|FG001|Safety Population|Overall Study||299||
48570665|NCT03866512|101727884|FG001|NOT COMPLETED|Overall Study||3||
48570666|NCT03866512|101727885|FG002|NOT COMPLETED|Overall Study||3||
48570667|NCT02174510|101727886|FG000|STARTED|Overall Study||8||
48570668|NCT02174510|101727887|FG001|STARTED|Overall Study||8||
48570669|NCT02174510|101727888|FG002|STARTED|Overall Study||12||
48282522|NCT01879722|101014322|FG005|STARTED|Overall Study||9||
48282523|NCT01879722|101014323|FG006|STARTED|Overall Study||8||
48282524|NCT01879722|101014324|FG007|STARTED|Overall Study||8||
48282525|NCT01879722|101014325|FG008|STARTED|Overall Study||8||
48282526|NCT01879722|101014326|FG009|STARTED|Overall Study||6||
48282527|NCT01879722|101014317|FG000|COMPLETED|Overall Study||7||
48282528|NCT01879722|101014318|FG001|COMPLETED|Overall Study||7||
48282529|NCT01879722|101014319|FG002|COMPLETED|Overall Study||7||
48282530|NCT01879722|101014320|FG003|COMPLETED|Overall Study||7||
48282531|NCT01879722|101014321|FG004|COMPLETED|Overall Study||7||
48282532|NCT01879722|101014322|FG005|COMPLETED|Overall Study||9||
48282533|NCT01879722|101014323|FG006|COMPLETED|Overall Study||8||
48282534|NCT01879722|101014324|FG007|COMPLETED|Overall Study||7||
48282535|NCT01879722|101014325|FG008|COMPLETED|Overall Study||6||
48282536|NCT01879722|101014326|FG009|COMPLETED|Overall Study||6||
48397106|NCT01425853|101302545|FG000|Per Protocol (PP)|Overall Study||264||
48397107|NCT01425853|101302546|FG001|Per Protocol (PP)|Overall Study||258||
48397108|NCT01425853|101302545|FG000|COMPLETED|Overall Study||240||
48397109|NCT01425853|101302546|FG001|COMPLETED|Overall Study||225||
48397110|NCT01425853|101302545|FG000|NOT COMPLETED|Overall Study||64||
48570670|NCT02174510|101727889|FG003|STARTED|Overall Study||9||
48570671|NCT02174510|101727886|FG000|COMPLETED|Overall Study||8||
48570672|NCT02174510|101727887|FG001|COMPLETED|Overall Study||8||
48282537|NCT01879722|101014317|FG000|NOT COMPLETED|Overall Study||0||
48282538|NCT01879722|101014318|FG001|NOT COMPLETED|Overall Study||1||
48282539|NCT01879722|101014319|FG002|NOT COMPLETED|Overall Study||0||
48282540|NCT01879722|101014320|FG003|NOT COMPLETED|Overall Study||1||
48282541|NCT01879722|101014321|FG004|NOT COMPLETED|Overall Study||1||
48397111|NCT01425853|101302546|FG001|NOT COMPLETED|Overall Study||77||
48397112|NCT00981747|101302547|FG000|STARTED|Losartan||12||
48397113|NCT00981747|101302547|FG000|Started Losartan|Losartan||12||
48282542|NCT01879722|101014322|FG005|NOT COMPLETED|Overall Study||0||
48570673|NCT02174510|101727888|FG002|COMPLETED|Overall Study||12||
48397114|NCT00981747|101302547|FG000|Completed Losartan|Losartan||10||
48397115|NCT00981747|101302547|FG000|COMPLETED|Losartan||10||
48397116|NCT00981747|101302547|FG000|NOT COMPLETED|Losartan||2||
48397117|NCT00981747|101302547|FG000|STARTED|Placebo Oral Tablet||10||
48397118|NCT00981747|101302547|FG000|Started Placebo Oral Tablet|Placebo Oral Tablet||10||
48397119|NCT00981747|101302547|FG000|Completed Placebo Oral Tablet|Placebo Oral Tablet||9||
48397120|NCT00981747|101302547|FG000|COMPLETED|Placebo Oral Tablet||9||
48397121|NCT00981747|101302547|FG000|NOT COMPLETED|Placebo Oral Tablet||1||
48397122|NCT00981747|101302547|FG000|STARTED|Sildenafil||9||
48397123|NCT00981747|101302547|FG000|Started Sildenafil|Sildenafil||9||
48699996|NCT00853242|102053911|FG003|Treated|Overall Study||50||
48699997|NCT00853242|102053912|FG004|Treated|Overall Study||50||
48699998|NCT00853242|102053913|FG005|Treated|Overall Study||51||
48699999|NCT00853242|102053914|FG006|Treated|Overall Study||48||
48700000|NCT00853242|102053908|FG000|COMPLETED|Overall Study||47||
48700001|NCT00853242|102053909|FG001|COMPLETED|Overall Study||47||
48700002|NCT00853242|102053910|FG002|COMPLETED|Overall Study||46||
48700003|NCT00853242|102053911|FG003|COMPLETED|Overall Study||46||
48700004|NCT00853242|102053912|FG004|COMPLETED|Overall Study||46||
48124559|NCT02430077|100630409|FG000|STARTED|Washout 4 Months||5||
48124560|NCT02430077|100630410|FG001|STARTED|Washout 4 Months||5||
48124561|NCT02430077|100630409|FG000|COMPLETED|Washout 4 Months||5||
48124562|NCT02430077|100630410|FG001|COMPLETED|Washout 4 Months||5||
48124563|NCT02430077|100630409|FG000|NOT COMPLETED|Washout 4 Months||0||
48124564|NCT02430077|100630410|FG001|NOT COMPLETED|Washout 4 Months||0||
48124565|NCT02430077|100630409|FG000|STARTED|Second Intervention 4 Months||5||
48124566|NCT02430077|100630410|FG001|STARTED|Second Intervention 4 Months||5||
48124567|NCT02430077|100630409|FG000|COMPLETED|Second Intervention 4 Months||5||
48124568|NCT02430077|100630410|FG001|COMPLETED|Second Intervention 4 Months||5||
48124569|NCT02430077|100630409|FG000|NOT COMPLETED|Second Intervention 4 Months||0||
48124570|NCT02430077|100630410|FG001|NOT COMPLETED|Second Intervention 4 Months||0||
48124571|NCT03487913|100630411|FG000|STARTED|Overall Study||9||
48124572|NCT03487913|100630412|FG001|STARTED|Overall Study||7||
48124573|NCT03487913|100630413|FG002|STARTED|Overall Study||8||
48124574|NCT03487913|100630414|FG003|STARTED|Overall Study||7||
48124575|NCT03487913|100630411|FG000|COMPLETED|Overall Study||9||
48124576|NCT03487913|100630412|FG001|COMPLETED|Overall Study||7||
48124577|NCT03487913|100630413|FG002|COMPLETED|Overall Study||8||
48124578|NCT03487913|100630414|FG003|COMPLETED|Overall Study||7||
48124579|NCT03487913|100630411|FG000|NOT COMPLETED|Overall Study||0||
48124580|NCT03487913|100630412|FG001|NOT COMPLETED|Overall Study||0||
48124581|NCT03487913|100630413|FG002|NOT COMPLETED|Overall Study||0||
48124582|NCT03487913|100630414|FG003|NOT COMPLETED|Overall Study||0||
48124583|NCT03853707|100630415|FG000|STARTED|Overall Study||10||
48124584|NCT03853707|100630416|FG001|STARTED|Overall Study||12||
48124585|NCT03853707|100630417|FG002|STARTED|Overall Study||6||
48124586|NCT03853707|100630415|FG000|COMPLETED|Overall Study||10||
48124587|NCT03853707|100630416|FG001|COMPLETED|Overall Study||12||
48124588|NCT03853707|100630417|FG002|COMPLETED|Overall Study||6||
48124589|NCT03853707|100630415|FG000|NOT COMPLETED|Overall Study||0||
48124590|NCT03853707|100630416|FG001|NOT COMPLETED|Overall Study||0||
48124591|NCT03853707|100630417|FG002|NOT COMPLETED|Overall Study||0||
48124592|NCT00844194|100630418|FG000|STARTED|Overall Study||78||
48397124|NCT00981747|101302547|FG000|Completed Sildenafil|Sildenafil||9||
48700005|NCT00853242|102053913|FG005|COMPLETED|Overall Study||49||
48700006|NCT00853242|102053914|FG006|COMPLETED|Overall Study||44||
48700007|NCT00853242|102053908|FG000|NOT COMPLETED|Overall Study||3||
48700008|NCT00853242|102053909|FG001|NOT COMPLETED|Overall Study||3||
48700009|NCT00853242|102053910|FG002|NOT COMPLETED|Overall Study||3||
48700010|NCT00853242|102053911|FG003|NOT COMPLETED|Overall Study||4||
48700011|NCT00853242|102053912|FG004|NOT COMPLETED|Overall Study||4||
48700012|NCT00853242|102053913|FG005|NOT COMPLETED|Overall Study||2||
48700013|NCT00853242|102053914|FG006|NOT COMPLETED|Overall Study||5||
48124593|NCT00844194|100630419|FG001|STARTED|Overall Study||30||
48124594|NCT00844194|100630418|FG000|COMPLETED|Overall Study||53||
48124595|NCT00844194|100630419|FG001|COMPLETED|Overall Study||22||
48124596|NCT00844194|100630418|FG000|NOT COMPLETED|Overall Study||25||
48124597|NCT00844194|100630419|FG001|NOT COMPLETED|Overall Study||8||
48124598|NCT02799082|100630420|FG000|STARTED|Overall Study||41||
48124599|NCT02799082|100630421|FG001|STARTED|Overall Study||81||
48124600|NCT02799082|100630420|FG000|COMPLETED|Overall Study||37||
48124601|NCT02799082|100630421|FG001|COMPLETED|Overall Study||77||
48700014|NCT01380197|102053915|FG000|STARTED|Overall Study||20||
48700015|NCT01380197|102053916|FG001|STARTED|Overall Study||20||
48700016|NCT01380197|102053915|FG000|COMPLETED|Overall Study||20||
48700017|NCT01380197|102053916|FG001|COMPLETED|Overall Study||20||
48124602|NCT02799082|100630420|FG000|NOT COMPLETED|Overall Study||4||
48124603|NCT02799082|100630421|FG001|NOT COMPLETED|Overall Study||4||
48397125|NCT00981747|101302547|FG000|COMPLETED|Sildenafil||9||
48397126|NCT00981747|101302547|FG000|NOT COMPLETED|Sildenafil||0||
48124604|NCT01263873|100630422|FG000|STARTED|Overall Study||30||
48124605|NCT01263873|100630423|FG001|STARTED|Overall Study||30||
48124606|NCT01263873|100630422|FG000|COMPLETED|Overall Study||29||
48397127|NCT00981747|101302547|FG000|STARTED|Sildenafil and Losartan||9||
48124607|NCT01263873|100630423|FG001|COMPLETED|Overall Study||29||
48124608|NCT01263873|100630422|FG000|NOT COMPLETED|Overall Study||1||
48124609|NCT01263873|100630423|FG001|NOT COMPLETED|Overall Study||1||
48124610|NCT01933334|100630424|FG000|STARTED|Overall Study||32||
48124611|NCT01933334|100630425|FG001|STARTED|Overall Study||31||
48124612|NCT01933334|100630424|FG000|COMPLETED|Overall Study||27||
48124613|NCT01933334|100630425|FG001|COMPLETED|Overall Study||29||
48124614|NCT01933334|100630424|FG000|NOT COMPLETED|Overall Study||5||
48282543|NCT01879722|101014323|FG006|NOT COMPLETED|Overall Study||0||
48282544|NCT01879722|101014324|FG007|NOT COMPLETED|Overall Study||1||
48124615|NCT01933334|100630425|FG001|NOT COMPLETED|Overall Study||2||
48124616|NCT01470027|100630426|FG000|STARTED|Overall Study||16||
48124617|NCT01470027|100630427|FG001|STARTED|Overall Study||15||
48124618|NCT01470027|100630428|FG002|STARTED|Overall Study||16||
48124619|NCT01470027|100630426|FG000|COMPLETED|Overall Study||15||
48124620|NCT01470027|100630427|FG001|COMPLETED|Overall Study||14||
48282545|NCT01879722|101014325|FG008|NOT COMPLETED|Overall Study||2||
48282546|NCT01879722|101014326|FG009|NOT COMPLETED|Overall Study||0||
48282547|NCT01757197|101014327|FG000|STARTED|Overall Study||2||
48282548|NCT01757197|101014327|FG000|COMPLETED|Overall Study||0||
48282549|NCT01757197|101014327|FG000|NOT COMPLETED|Overall Study||2||
48282550|NCT01302067|101014328|FG000|STARTED|Overall Study||790||
48282551|NCT01302067|101014329|FG001|STARTED|Overall Study||386||
48700018|NCT01380197|102053915|FG000|NOT COMPLETED|Overall Study||0||
48700019|NCT01380197|102053916|FG001|NOT COMPLETED|Overall Study||0||
48700020|NCT00951080|102053917|FG000|STARTED|Overall Study||64||
48700021|NCT00951080|102053918|FG001|STARTED|Overall Study||68||
48700022|NCT00951080|102053917|FG000|COMPLETED|Overall Study||38||
48700023|NCT00951080|102053918|FG001|COMPLETED|Overall Study||41||
48700024|NCT00951080|102053917|FG000|NOT COMPLETED|Overall Study||26||
48700025|NCT00951080|102053918|FG001|NOT COMPLETED|Overall Study||27||
48700026|NCT03570918|102053919|FG000|STARTED|Period 1||1||
48700027|NCT03570918|102053920|FG001|STARTED|Period 1||1||
48700028|NCT03570918|102053921|FG002|STARTED|Period 1||4||
48700029|NCT03570918|102053922|FG003|STARTED|Period 1||3||
48700030|NCT03570918|102053923|FG004|STARTED|Period 1||3||
48700031|NCT03570918|102053924|FG005|STARTED|Period 1||3||
48700032|NCT03570918|102053925|FG006|STARTED|Period 1||3||
48700033|NCT03570918|102053926|FG007|STARTED|Period 1||3||
48700034|NCT03570918|102053927|FG008|STARTED|Period 1||0||
48700035|NCT03570918|102053919|FG000|COMPLETED|Period 1||1||
48700036|NCT03570918|102053920|FG001|COMPLETED|Period 1||1||
48700037|NCT03570918|102053921|FG002|COMPLETED|Period 1||4||
48124621|NCT01470027|100630428|FG002|COMPLETED|Overall Study||15||
48124622|NCT01470027|100630426|FG000|NOT COMPLETED|Overall Study||1||
48124623|NCT01470027|100630427|FG001|NOT COMPLETED|Overall Study||1||
48124624|NCT01470027|100630428|FG002|NOT COMPLETED|Overall Study||1||
48124625|NCT04067141|100630429|FG000|STARTED|First Intervention||35||
48124626|NCT04067141|100630430|FG001|STARTED|First Intervention||35||
48124627|NCT04067141|100630429|FG000|COMPLETED|First Intervention||35||
48124628|NCT04067141|100630430|FG001|COMPLETED|First Intervention||34||
48124629|NCT04067141|100630429|FG000|NOT COMPLETED|First Intervention||0||
48124630|NCT04067141|100630430|FG001|NOT COMPLETED|First Intervention||1||
48124631|NCT04067141|100630429|FG000|STARTED|Second Intervention||34||
48124632|NCT04067141|100630430|FG001|STARTED|Second Intervention||33||
48124633|NCT04067141|100630429|FG000|COMPLETED|Second Intervention||34||
48124634|NCT04067141|100630430|FG001|COMPLETED|Second Intervention||31||
48124635|NCT04067141|100630429|FG000|NOT COMPLETED|Second Intervention||0||
48124636|NCT04067141|100630430|FG001|NOT COMPLETED|Second Intervention||2||
48124637|NCT00634647|100630431|FG000|STARTED|Overall Study||24||
48124638|NCT00634647|100630431|FG000|COMPLETED|Overall Study||17||
48124639|NCT00634647|100630431|FG000|NOT COMPLETED|Overall Study||7||
48124640|NCT05789875|100630432|FG000|STARTED|Overall Study||28||
48124641|NCT05789875|100630432|FG000|COMPLETED|Overall Study||22||
48700038|NCT03570918|102053922|FG003|COMPLETED|Period 1||3||
48700039|NCT03570918|102053923|FG004|COMPLETED|Period 1||3||
48700040|NCT03570918|102053924|FG005|COMPLETED|Period 1||3||
48700041|NCT03570918|102053925|FG006|COMPLETED|Period 1||3||
48700042|NCT03570918|102053926|FG007|COMPLETED|Period 1||3||
48700043|NCT03570918|102053927|FG008|COMPLETED|Period 1||0||
48700044|NCT03570918|102053919|FG000|NOT COMPLETED|Period 1||0||
48700045|NCT03570918|102053920|FG001|NOT COMPLETED|Period 1||0||
48700046|NCT03570918|102053921|FG002|NOT COMPLETED|Period 1||0||
48124642|NCT05789875|100630432|FG000|NOT COMPLETED|Overall Study||6||
48124643|NCT00194012|100630433|FG000|STARTED|Randomized Phase||31||
48282552|NCT01302067|101014330|FG002|STARTED|Overall Study||779||
48282553|NCT01302067|101014328|FG000|COMPLETED|Overall Study||712||
48282554|NCT01302067|101014329|FG001|COMPLETED|Overall Study||352||
48700047|NCT03570918|102053922|FG003|NOT COMPLETED|Period 1||0||
48700048|NCT03570918|102053923|FG004|NOT COMPLETED|Period 1||0||
48700049|NCT03570918|102053924|FG005|NOT COMPLETED|Period 1||0||
48700050|NCT03570918|102053925|FG006|NOT COMPLETED|Period 1||0||
48700051|NCT03570918|102053926|FG007|NOT COMPLETED|Period 1||0||
48700052|NCT03570918|102053927|FG008|NOT COMPLETED|Period 1||0||
48700053|NCT03570918|102053919|FG000|STARTED|Period 2||0||
48282555|NCT01302067|101014330|FG002|COMPLETED|Overall Study||681||
48282556|NCT01302067|101014328|FG000|NOT COMPLETED|Overall Study||78||
48282557|NCT01302067|101014329|FG001|NOT COMPLETED|Overall Study||34||
48282558|NCT01302067|101014330|FG002|NOT COMPLETED|Overall Study||98||
48282559|NCT01796548|101014331|FG000|STARTED|Overall Study||17||
48282560|NCT01796548|101014331|FG000|Treated|Overall Study||15||
48282561|NCT01796548|101014331|FG000|COMPLETED|Overall Study||14||
48282562|NCT01796548|101014331|FG000|NOT COMPLETED|Overall Study||3||
48282563|NCT01353859|101014332|FG000|STARTED|Overall Study||39||
48282564|NCT01353859|101014332|FG000|COMPLETED|Overall Study||35||
48282565|NCT01353859|101014332|FG000|NOT COMPLETED|Overall Study||4||
48282566|NCT00297427|101014333|FG000|STARTED|Phase 1: Initial Intervention||64||
48397128|NCT00981747|101302547|FG000|Started Sildenafil and Losartan|Sildenafil and Losartan||9||
48397129|NCT00981747|101302547|FG000|Completed Sildenafil and Losartan|Sildenafil and Losartan||9||
48397130|NCT00981747|101302547|FG000|COMPLETED|Sildenafil and Losartan||9||
48397131|NCT00981747|101302547|FG000|NOT COMPLETED|Sildenafil and Losartan||0||
48397132|NCT00607126|101302548|FG000|STARTED|Overall Study||17||
48397133|NCT00607126|101302549|FG001|STARTED|Overall Study||19||
48397134|NCT00607126|101302548|FG000|COMPLETED|Overall Study||17||
48397135|NCT00607126|101302549|FG001|COMPLETED|Overall Study||19||
48397136|NCT00607126|101302548|FG000|NOT COMPLETED|Overall Study||0||
48397137|NCT00607126|101302549|FG001|NOT COMPLETED|Overall Study||0||
48397138|NCT03034057|101302550|FG000|STARTED|Overall Study||169||
48397139|NCT03034057|101302550|FG000|COMPLETED|Overall Study||114||
48397140|NCT03034057|101302550|FG000|NOT COMPLETED|Overall Study||55||
48397141|NCT01548417|101302551|FG000|STARTED|Overall Study||28||
48397142|NCT01548417|101302552|FG001|STARTED|Overall Study||28||
48397143|NCT01548417|101302551|FG000|COMPLETED|Overall Study||28||
48397144|NCT01548417|101302552|FG001|COMPLETED|Overall Study||26||
48397145|NCT01548417|101302551|FG000|NOT COMPLETED|Overall Study||0||
48397146|NCT01548417|101302552|FG001|NOT COMPLETED|Overall Study||2||
48397147|NCT00695500|101302553|FG000|STARTED|Overall Study||24||
48397148|NCT00695500|101302554|FG001|STARTED|Overall Study||22||
48397149|NCT00695500|101302553|FG000|COMPLETED|Overall Study||21||
48397150|NCT00695500|101302554|FG001|COMPLETED|Overall Study||17||
48397151|NCT00695500|101302553|FG000|NOT COMPLETED|Overall Study||3||
48397152|NCT00695500|101302554|FG001|NOT COMPLETED|Overall Study||5||
48397153|NCT01444898|101302555|FG000|STARTED|Overall Study||10||
48397154|NCT01444898|101302555|FG000|COMPLETED|Overall Study||9||
48397155|NCT01444898|101302555|FG000|NOT COMPLETED|Overall Study||1||
48397156|NCT01665768|101302556|FG000|STARTED|Overall Study||49||
48700054|NCT03570918|102053920|FG001|STARTED|Period 2||0||
48700055|NCT03570918|102053921|FG002|STARTED|Period 2||0||
48700056|NCT03570918|102053922|FG003|STARTED|Period 2||0||
48700057|NCT03570918|102053923|FG004|STARTED|Period 2||0||
48700058|NCT03570918|102053924|FG005|STARTED|Period 2||0||
48700059|NCT03570918|102053925|FG006|STARTED|Period 2||0||
48700060|NCT03570918|102053926|FG007|STARTED|Period 2||0||
48700061|NCT03570918|102053927|FG008|STARTED|Period 2||3||
48700062|NCT03570918|102053919|FG000|COMPLETED|Period 2||0||
48700063|NCT03570918|102053920|FG001|COMPLETED|Period 2||0||
48700064|NCT03570918|102053921|FG002|COMPLETED|Period 2||0||
48700065|NCT03570918|102053922|FG003|COMPLETED|Period 2||0||
48700066|NCT03570918|102053923|FG004|COMPLETED|Period 2||0||
48700067|NCT03570918|102053924|FG005|COMPLETED|Period 2||0||
48700068|NCT03570918|102053925|FG006|COMPLETED|Period 2||0||
48700069|NCT03570918|102053926|FG007|COMPLETED|Period 2||0||
48700070|NCT03570918|102053927|FG008|COMPLETED|Period 2||3||
48700071|NCT03570918|102053919|FG000|NOT COMPLETED|Period 2||0||
48700072|NCT03570918|102053920|FG001|NOT COMPLETED|Period 2||0||
48700073|NCT03570918|102053921|FG002|NOT COMPLETED|Period 2||0||
48700074|NCT03570918|102053922|FG003|NOT COMPLETED|Period 2||0||
48700075|NCT03570918|102053923|FG004|NOT COMPLETED|Period 2||0||
48700076|NCT03570918|102053924|FG005|NOT COMPLETED|Period 2||0||
48282567|NCT00297427|101014334|FG001|STARTED|Phase 1: Initial Intervention||63||
48282568|NCT00297427|101014333|FG000|COMPLETED|Phase 1: Initial Intervention||56||
48397157|NCT01665768|101302556|FG000|COMPLETED|Overall Study||26||
48397158|NCT01665768|101302556|FG000|NOT COMPLETED|Overall Study||23||
48397159|NCT01253187|101302557|FG000|STARTED|Period 1||7||
48570674|NCT02174510|101727889|FG003|COMPLETED|Overall Study||9||
48700077|NCT03570918|102053925|FG006|NOT COMPLETED|Period 2||0||
48700078|NCT03570918|102053926|FG007|NOT COMPLETED|Period 2||0||
48700079|NCT03570918|102053927|FG008|NOT COMPLETED|Period 2||0||
48700080|NCT00185380|102053928|FG000|STARTED|Overall Study||240||
48282569|NCT00297427|101014334|FG001|COMPLETED|Phase 1: Initial Intervention||54||
48282570|NCT00297427|101014333|FG000|NOT COMPLETED|Phase 1: Initial Intervention||8||
48397160|NCT01253187|101302558|FG001|STARTED|Period 1||8||
48397161|NCT01253187|101302559|FG002|STARTED|Period 1||7||
48397162|NCT01253187|101302560|FG003|STARTED|Period 1||7||
48397163|NCT01253187|101302561|FG004|STARTED|Period 1||9||
48700081|NCT00185380|102053929|FG001|STARTED|Overall Study||246||
48124644|NCT00194012|100630434|FG001|STARTED|Randomized Phase||31||
48124645|NCT00194012|100630433|FG000|Received More Than One Dose|Randomized Phase||30||
48124646|NCT00194012|100630434|FG001|Received More Than One Dose|Randomized Phase||29||
48124647|NCT00194012|100630433|FG000|COMPLETED|Randomized Phase||15||
48124648|NCT00194012|100630434|FG001|COMPLETED|Randomized Phase||6||
48124649|NCT00194012|100630433|FG000|NOT COMPLETED|Randomized Phase||16||
48124650|NCT00194012|100630434|FG001|NOT COMPLETED|Randomized Phase||25||
48124651|NCT00194012|100630433|FG000|STARTED|Open Label Extension (OLE)||22||
48282571|NCT00297427|101014334|FG001|NOT COMPLETED|Phase 1: Initial Intervention||9||
48282572|NCT00297427|101014333|FG000|STARTED|Phase 2: Optional Crossover for Sham||54||
48282573|NCT00297427|101014334|FG001|STARTED|Phase 2: Optional Crossover for Sham||0||
48282574|NCT00297427|101014333|FG000|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham||42||
48282575|NCT00297427|101014334|FG001|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham||0||
48282576|NCT00297427|101014333|FG000|COMPLETED|Phase 2: Optional Crossover for Sham||38||
48282577|NCT00297427|101014334|FG001|COMPLETED|Phase 2: Optional Crossover for Sham||0||
48282578|NCT00297427|101014333|FG000|NOT COMPLETED|Phase 2: Optional Crossover for Sham||16||
48282579|NCT00297427|101014334|FG001|NOT COMPLETED|Phase 2: Optional Crossover for Sham||0||
48282580|NCT00297427|101014333|FG000|STARTED|Phase 3: Follow-up Post-True Acupuncture||94||
48282581|NCT00297427|101014334|FG001|STARTED|Phase 3: Follow-up Post-True Acupuncture||0||
48282582|NCT00297427|101014333|FG000|COMPLETED|Phase 3: Follow-up Post-True Acupuncture||60||
48282583|NCT00297427|101014334|FG001|COMPLETED|Phase 3: Follow-up Post-True Acupuncture||0||
48282584|NCT00297427|101014333|FG000|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||34||
48282585|NCT00297427|101014334|FG001|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||0||
48700082|NCT00185380|102053930|FG002|STARTED|Overall Study||256||
48282586|NCT04811131|101014335|FG000|STARTED|Overall Study||34||
48700083|NCT00185380|102053928|FG000|Subjects Received Treatment|Overall Study||239||
48700084|NCT00185380|102053929|FG001|Subjects Received Treatment|Overall Study||245||
48700085|NCT00185380|102053930|FG002|Subjects Received Treatment|Overall Study||254||
48700086|NCT00185380|102053928|FG000|COMPLETED|Overall Study||174||
48700087|NCT00185380|102053929|FG001|COMPLETED|Overall Study||174||
48700088|NCT00185380|102053930|FG002|COMPLETED|Overall Study||182||
48700089|NCT00185380|102053928|FG000|NOT COMPLETED|Overall Study||66||
48700090|NCT00185380|102053929|FG001|NOT COMPLETED|Overall Study||72||
48700091|NCT00185380|102053930|FG002|NOT COMPLETED|Overall Study||74||
48700092|NCT01205061|102053931|FG000|STARTED|Overall Study||162||
48700093|NCT01205061|102053931|FG000|Emervel Deep Lidocaine in Left NLF Followed by Juvederm Ultra in Right NLF|Overall Study||80||
48700094|NCT01205061|102053931|FG000|Juvederm Ultra in Left NLF Followed by Emervel Deep Lidocaine in Right NLF|Overall Study||82||
48282587|NCT04811131|101014336|FG001|STARTED|Overall Study||37||
48282588|NCT04811131|101014337|FG002|STARTED|Overall Study||31||
48282589|NCT04811131|101014338|FG003|STARTED|Overall Study||12||
48700095|NCT01205061|102053931|FG000|COMPLETED|Overall Study||136||
48700096|NCT01205061|102053931|FG000|NOT COMPLETED|Overall Study||26||
48570675|NCT02174510|101727886|FG000|NOT COMPLETED|Overall Study||0||
48570676|NCT02174510|101727887|FG001|NOT COMPLETED|Overall Study||0||
48570677|NCT02174510|101727888|FG002|NOT COMPLETED|Overall Study||0||
48570678|NCT02174510|101727889|FG003|NOT COMPLETED|Overall Study||0||
48570679|NCT01218087|101727890|FG000|STARTED|Overall Study||42||
48570680|NCT01218087|101727891|FG001|STARTED|Overall Study||41||
48570681|NCT01218087|101727890|FG000|COMPLETED|Overall Study||27||
48570682|NCT01218087|101727891|FG001|COMPLETED|Overall Study||35||
48570683|NCT01218087|101727890|FG000|NOT COMPLETED|Overall Study||15||
48570684|NCT01218087|101727891|FG001|NOT COMPLETED|Overall Study||6||
48570685|NCT00715273|101727892|FG000|STARTED|Overall Study||71||
48570686|NCT00715273|101727893|FG001|STARTED|Overall Study||73||
48570687|NCT00715273|101727894|FG002|STARTED|Overall Study||73||
48570688|NCT00715273|101727892|FG000|COMPLETED|Overall Study||63||
48570689|NCT00715273|101727893|FG001|COMPLETED|Overall Study||65||
48570690|NCT00715273|101727894|FG002|COMPLETED|Overall Study||68||
48570691|NCT00715273|101727892|FG000|NOT COMPLETED|Overall Study||8||
48570692|NCT00715273|101727893|FG001|NOT COMPLETED|Overall Study||8||
48570693|NCT00715273|101727894|FG002|NOT COMPLETED|Overall Study||5||
48570694|NCT04537234|101727895|FG000|STARTED|Overall Study||82||
48570695|NCT04537234|101727896|FG001|STARTED|Overall Study||83||
48570696|NCT04537234|101727895|FG000|COMPLETED|Overall Study||80||
48570697|NCT04537234|101727896|FG001|COMPLETED|Overall Study||83||
48570698|NCT04537234|101727895|FG000|NOT COMPLETED|Overall Study||2||
48570699|NCT04537234|101727896|FG001|NOT COMPLETED|Overall Study||0||
48570700|NCT03319732|101727897|FG000|STARTED|Overall Study||323||
48570701|NCT03319732|101727897|FG000|COMPLETED|Overall Study||218||
48570702|NCT03319732|101727897|FG000|NOT COMPLETED|Overall Study||105||
48570703|NCT02914613|101727898|FG000|STARTED|Overall Study||22||
48570704|NCT02914613|101727899|FG001|STARTED|Overall Study||22||
48570705|NCT02914613|101727898|FG000|COMPLETED|Overall Study||20||
48570706|NCT02914613|101727899|FG001|COMPLETED|Overall Study||20||
48700097|NCT01295840|102053932|FG000|STARTED|Overall Study||51||
48700098|NCT01295840|102053932|FG000|COMPLETED|Overall Study||50||
48700099|NCT01295840|102053932|FG000|NOT COMPLETED|Overall Study||1||
48700100|NCT05243745|102053933|FG000|STARTED|Overall Study||29||
48700101|NCT05243745|102053934|FG001|STARTED|Overall Study||31||
48700102|NCT05243745|102053935|FG002|STARTED|Overall Study||31||
48700103|NCT05243745|102053936|FG003|STARTED|Overall Study||29||
48397164|NCT01253187|101302562|FG005|STARTED|Period 1||6||
48397165|NCT01253187|101302557|FG000|COMPLETED|Period 1||7||
48397166|NCT01253187|101302558|FG001|COMPLETED|Period 1||8||
48397167|NCT01253187|101302559|FG002|COMPLETED|Period 1||7||
48397168|NCT01253187|101302560|FG003|COMPLETED|Period 1||7||
48397169|NCT01253187|101302561|FG004|COMPLETED|Period 1||9||
48397170|NCT01253187|101302562|FG005|COMPLETED|Period 1||6||
48397171|NCT01253187|101302557|FG000|NOT COMPLETED|Period 1||0||
48397172|NCT01253187|101302558|FG001|NOT COMPLETED|Period 1||0||
48397173|NCT01253187|101302559|FG002|NOT COMPLETED|Period 1||0||
48397174|NCT01253187|101302560|FG003|NOT COMPLETED|Period 1||0||
48397175|NCT01253187|101302561|FG004|NOT COMPLETED|Period 1||0||
48397176|NCT01253187|101302562|FG005|NOT COMPLETED|Period 1||0||
48397177|NCT01253187|101302557|FG000|STARTED|Period 2||7||
48397178|NCT01253187|101302558|FG001|STARTED|Period 2||8||
48570707|NCT02914613|101727898|FG000|NOT COMPLETED|Overall Study||2||
48570708|NCT02914613|101727899|FG001|NOT COMPLETED|Overall Study||2||
48570709|NCT03382834|101730849|FG000|STARTED|Step 1||21||
48570710|NCT03382834|101730850|FG001|STARTED|Step 1||10||
48570711|NCT03382834|101730849|FG000|COMPLETED|Step 1||21|Completed Step 1 of the study.|
48570712|NCT03382834|101730850|FG001|COMPLETED|Step 1||9|Completed Step 1 of the study.|
48570713|NCT03382834|101730849|FG000|NOT COMPLETED|Step 1||0||
48570714|NCT03382834|101730850|FG001|NOT COMPLETED|Step 1||1||
48570715|NCT03382834|101730849|FG000|STARTED|Step 2||21||
48570716|NCT03382834|101730850|FG001|STARTED|Step 2||9||
48570717|NCT03382834|101730849|FG000|COMPLETED|Step 2||17||
48570718|NCT03382834|101730850|FG001|COMPLETED|Step 2||7||
48570719|NCT03382834|101730849|FG000|NOT COMPLETED|Step 2||4||
48570720|NCT03382834|101730850|FG001|NOT COMPLETED|Step 2||2||
48570721|NCT04013672|101730851|FG000|STARTED|Overall Study||41||
48570722|NCT04013672|101730852|FG001|STARTED|Overall Study||0||
48570723|NCT04013672|101730851|FG000|COMPLETED|Overall Study||32||
48397179|NCT01253187|101302559|FG002|STARTED|Period 2||7||
48397180|NCT01253187|101302560|FG003|STARTED|Period 2||7||
48397181|NCT01253187|101302561|FG004|STARTED|Period 2||9||
48397182|NCT01253187|101302562|FG005|STARTED|Period 2||6||
48397183|NCT01253187|101302557|FG000|COMPLETED|Period 2||7||
48397184|NCT01253187|101302558|FG001|COMPLETED|Period 2||8||
48397185|NCT01253187|101302559|FG002|COMPLETED|Period 2||7||
48397186|NCT01253187|101302560|FG003|COMPLETED|Period 2||7||
48397187|NCT01253187|101302561|FG004|COMPLETED|Period 2||8||
48397188|NCT01253187|101302562|FG005|COMPLETED|Period 2||6||
48397189|NCT01253187|101302557|FG000|NOT COMPLETED|Period 2||0||
48397190|NCT01253187|101302558|FG001|NOT COMPLETED|Period 2||0||
48397191|NCT01253187|101302559|FG002|NOT COMPLETED|Period 2||0||
48397192|NCT01253187|101302560|FG003|NOT COMPLETED|Period 2||0||
48397193|NCT01253187|101302561|FG004|NOT COMPLETED|Period 2||1||
48397194|NCT01253187|101302562|FG005|NOT COMPLETED|Period 2||0||
48397195|NCT01253187|101302557|FG000|STARTED|Period 3||7||
48397196|NCT01253187|101302558|FG001|STARTED|Period 3||8||
48397197|NCT01253187|101302559|FG002|STARTED|Period 3||7||
48397198|NCT01253187|101302560|FG003|STARTED|Period 3||7||
48397199|NCT01253187|101302561|FG004|STARTED|Period 3||8||
48397200|NCT01253187|101302562|FG005|STARTED|Period 3||6||
48570724|NCT04013672|101730852|FG001|COMPLETED|Overall Study||0||
48570725|NCT04013672|101730851|FG000|NOT COMPLETED|Overall Study||9||
48570726|NCT04013672|101730852|FG001|NOT COMPLETED|Overall Study||0||
48570727|NCT00410813|101730853|FG000|STARTED|Overall Study||43||
48570728|NCT00410813|101730854|FG001|STARTED|Overall Study||42||
48570729|NCT00410813|101730853|FG000|Eligible|Overall Study||41||
48570730|NCT00410813|101730854|FG001|Eligible|Overall Study||38||
48570731|NCT00410813|101730853|FG000|COMPLETED|Overall Study||0||
48570732|NCT00410813|101730854|FG001|COMPLETED|Overall Study||0||
48700104|NCT05243745|102053933|FG000|COMPLETED|Overall Study||29||
48700105|NCT05243745|102053934|FG001|COMPLETED|Overall Study||31||
48700106|NCT05243745|102053935|FG002|COMPLETED|Overall Study||30||
48700107|NCT05243745|102053936|FG003|COMPLETED|Overall Study||28||
48700108|NCT05243745|102053933|FG000|NOT COMPLETED|Overall Study||0||
48700109|NCT05243745|102053934|FG001|NOT COMPLETED|Overall Study||0||
48700110|NCT05243745|102053935|FG002|NOT COMPLETED|Overall Study||1||
48700111|NCT05243745|102053936|FG003|NOT COMPLETED|Overall Study||1||
48397201|NCT01253187|101302557|FG000|COMPLETED|Period 3||6||
48397202|NCT01253187|101302558|FG001|COMPLETED|Period 3||7||
48397203|NCT01253187|101302559|FG002|COMPLETED|Period 3||7||
48397204|NCT01253187|101302560|FG003|COMPLETED|Period 3||7||
48397205|NCT01253187|101302561|FG004|COMPLETED|Period 3||7||
48397206|NCT01253187|101302562|FG005|COMPLETED|Period 3||6||
48397207|NCT01253187|101302557|FG000|NOT COMPLETED|Period 3||1||
48570733|NCT00410813|101730853|FG000|NOT COMPLETED|Overall Study||43||
48700112|NCT00473668|102053937|FG000|STARTED|Overall Study||100||
48700113|NCT00473668|102053938|FG001|STARTED|Overall Study||100||
48700114|NCT00473668|102053939|FG002|STARTED|Overall Study||99||
48397208|NCT01253187|101302558|FG001|NOT COMPLETED|Period 3||1||
48397209|NCT01253187|101302559|FG002|NOT COMPLETED|Period 3||0||
48397210|NCT01253187|101302560|FG003|NOT COMPLETED|Period 3||0||
48397211|NCT01253187|101302561|FG004|NOT COMPLETED|Period 3||1||
48570734|NCT00410813|101730854|FG001|NOT COMPLETED|Overall Study||42||
48570735|NCT02748213|101730855|FG000|STARTED|Overall Study||113||
48570736|NCT02748213|101730856|FG001|STARTED|Overall Study||112||
48570737|NCT02748213|101730855|FG000|Treated|Overall Study||112||
48570738|NCT02748213|101730856|FG001|Treated|Overall Study||110||
48570739|NCT02748213|101730855|FG000|COMPLETED|Overall Study||0||
48570740|NCT02748213|101730856|FG001|COMPLETED|Overall Study||0||
48700115|NCT00473668|102053937|FG000|COMPLETED|Overall Study||95||
48700116|NCT00473668|102053938|FG001|COMPLETED|Overall Study||89||
48700117|NCT00473668|102053939|FG002|COMPLETED|Overall Study||89||
48700118|NCT00473668|102053937|FG000|NOT COMPLETED|Overall Study||5||
48700119|NCT00473668|102053938|FG001|NOT COMPLETED|Overall Study||11||
48700120|NCT00473668|102053939|FG002|NOT COMPLETED|Overall Study||10||
48700121|NCT00812006|102053940|FG000|STARTED|Overall Study||36||
48124652|NCT00194012|100630434|FG001|STARTED|Open Label Extension (OLE)||21||
48124653|NCT00194012|100630433|FG000|COMPLETED|Open Label Extension (OLE)||17||
48700122|NCT00812006|102053941|FG001|STARTED|Overall Study||36||
48700123|NCT00812006|102053942|FG002|STARTED|Overall Study||36||
48700124|NCT00812006|102053940|FG000|COMPLETED|Overall Study||30||
48700125|NCT00812006|102053941|FG001|COMPLETED|Overall Study||33||
48700126|NCT00812006|102053942|FG002|COMPLETED|Overall Study||30||
48700127|NCT00812006|102053940|FG000|NOT COMPLETED|Overall Study||6||
48700128|NCT00812006|102053941|FG001|NOT COMPLETED|Overall Study||3||
48700129|NCT00812006|102053942|FG002|NOT COMPLETED|Overall Study||6||
48124654|NCT00194012|100630434|FG001|COMPLETED|Open Label Extension (OLE)||15||
48124655|NCT00194012|100630433|FG000|NOT COMPLETED|Open Label Extension (OLE)||5||
48124656|NCT00194012|100630434|FG001|NOT COMPLETED|Open Label Extension (OLE)||6||
48124657|NCT02293005|100630435|FG000|STARTED|Overall Study||26||
48124658|NCT02293005|100630435|FG000|COMPLETED|Overall Study||0||
48124659|NCT02293005|100630435|FG000|NOT COMPLETED|Overall Study||26||
48124660|NCT02203019|100630436|FG000|STARTED|Overall Study||19|Duration of mechanical ventilation|
48124661|NCT02203019|100630437|FG001|STARTED|Overall Study||17|Duration of mechanical ventilation|
48124662|NCT02203019|100630436|FG000|COMPLETED|Overall Study||19||
48124663|NCT02203019|100630437|FG001|COMPLETED|Overall Study||17||
48124664|NCT02203019|100630436|FG000|NOT COMPLETED|Overall Study||0||
48124665|NCT02203019|100630437|FG001|NOT COMPLETED|Overall Study||0||
48124666|NCT02165722|100630438|FG000|STARTED|Overall Study||1971||9
48124667|NCT02165722|100630439|FG001|STARTED|Overall Study||2202||11
48124668|NCT02165722|100630438|FG000|COMPLETED|Overall Study||1971||9
48124669|NCT02165722|100630439|FG001|COMPLETED|Overall Study||2202||11
48124670|NCT02165722|100630438|FG000|NOT COMPLETED|Overall Study||0||0
48124671|NCT02165722|100630439|FG001|NOT COMPLETED|Overall Study||0||0
48124672|NCT03143829|100630440|FG000|STARTED|Overall Study||38||
48124673|NCT03143829|100630441|FG001|STARTED|Overall Study||42||
48124674|NCT03143829|100630440|FG000|COMPLETED|Overall Study||33||
48124675|NCT03143829|100630441|FG001|COMPLETED|Overall Study||32||
48124676|NCT03143829|100630440|FG000|NOT COMPLETED|Overall Study||5||
48124677|NCT03143829|100630441|FG001|NOT COMPLETED|Overall Study||10||
48124678|NCT03169153|100630442|FG000|STARTED|Period 1, First 30 Days of Wear||42|Randomized and exposed|
48124679|NCT03169153|100630443|FG001|STARTED|Period 1, First 30 Days of Wear||39|Randomized and exposed|
48124680|NCT03169153|100630442|FG000|COMPLETED|Period 1, First 30 Days of Wear||39||
48124681|NCT03169153|100630443|FG001|COMPLETED|Period 1, First 30 Days of Wear||35||
48124682|NCT03169153|100630442|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||3||
48124683|NCT03169153|100630443|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||4||
48124684|NCT03169153|100630442|FG000|STARTED|Period 2, Second 30 Days of Wear||39||
48124685|NCT03169153|100630443|FG001|STARTED|Period 2, Second 30 Days of Wear||34||
48124686|NCT03169153|100630442|FG000|COMPLETED|Period 2, Second 30 Days of Wear||37||
48397212|NCT01253187|101302562|FG005|NOT COMPLETED|Period 3||0||
48397213|NCT01875510|101302563|FG000|STARTED|Overall Study||40||
48397214|NCT01875510|101302564|FG001|STARTED|Overall Study||40||
48397215|NCT01875510|101302563|FG000|COMPLETED|Overall Study||40||
48570741|NCT02748213|101730855|FG000|NOT COMPLETED|Overall Study||113||
48700130|NCT01893411|102053943|FG000|STARTED|Overall Study||156||
48700131|NCT01893411|102053944|FG001|STARTED|Overall Study||77||
48700132|NCT01893411|102053945|FG002|STARTED|Overall Study||78||
48700133|NCT01893411|102053943|FG000|COMPLETED|Overall Study||139||
48124687|NCT03169153|100630443|FG001|COMPLETED|Period 2, Second 30 Days of Wear||32||
48124688|NCT03169153|100630442|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||2||
48700134|NCT01893411|102053944|FG001|COMPLETED|Overall Study||70||
48700135|NCT01893411|102053945|FG002|COMPLETED|Overall Study||69||
48700136|NCT01893411|102053943|FG000|NOT COMPLETED|Overall Study||17||
48700137|NCT01893411|102053944|FG001|NOT COMPLETED|Overall Study||7||
48700138|NCT01893411|102053945|FG002|NOT COMPLETED|Overall Study||9||
48397216|NCT01875510|101302564|FG001|COMPLETED|Overall Study||40||
48570742|NCT02748213|101730856|FG001|NOT COMPLETED|Overall Study||112||
48124689|NCT03169153|100630443|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||2||
48124690|NCT00575588|100630444|FG000|STARTED|Overall Study||428||
48124691|NCT00575588|100630445|FG001|STARTED|Overall Study||430||
48124692|NCT00575588|100630444|FG000|COMPLETED|Overall Study||165||
48124693|NCT00575588|100630445|FG001|COMPLETED|Overall Study||147||
48124694|NCT00575588|100630444|FG000|NOT COMPLETED|Overall Study||263||
48124695|NCT00575588|100630445|FG001|NOT COMPLETED|Overall Study||283||
48124696|NCT01312961|100630446|FG000|STARTED|Overall Study||52||
48124697|NCT01312961|100630447|FG001|STARTED|Overall Study||52||
48124698|NCT01312961|100630446|FG000|Treated|Overall Study||52||
48124699|NCT01312961|100630447|FG001|Treated|Overall Study||52||
48124700|NCT01312961|100630446|FG000|COMPLETED|Overall Study||35||
48124701|NCT01312961|100630447|FG001|COMPLETED|Overall Study||45||
48124702|NCT01312961|100630446|FG000|NOT COMPLETED|Overall Study||17||
48124703|NCT01312961|100630447|FG001|NOT COMPLETED|Overall Study||7||
48124704|NCT00583492|100630448|FG000|STARTED|Overall Study||21||
48124705|NCT00583492|100630449|FG001|STARTED|Overall Study||23||
48124706|NCT00583492|100630448|FG000|COMPLETED|Overall Study||21||
48124707|NCT00583492|100630449|FG001|COMPLETED|Overall Study||23||
48124708|NCT00583492|100630448|FG000|NOT COMPLETED|Overall Study||0||
48124709|NCT00583492|100630449|FG001|NOT COMPLETED|Overall Study||0||
48124710|NCT03735420|100630450|FG000|STARTED|Overall Study||16||
48124711|NCT03735420|100630451|FG001|STARTED|Overall Study||14||
48124712|NCT03735420|100630450|FG000|COMPLETED|Overall Study||16||
48124713|NCT03735420|100630451|FG001|COMPLETED|Overall Study||14||
48124714|NCT03735420|100630450|FG000|NOT COMPLETED|Overall Study||0||
48124715|NCT03735420|100630451|FG001|NOT COMPLETED|Overall Study||0||
48282590|NCT04811131|101014335|FG000|COMPLETED|Overall Study||0||
48282591|NCT04811131|101014336|FG001|COMPLETED|Overall Study||0||
48282592|NCT04811131|101014337|FG002|COMPLETED|Overall Study||0||
48397217|NCT01875510|101302563|FG000|NOT COMPLETED|Overall Study||0||
48397218|NCT01875510|101302564|FG001|NOT COMPLETED|Overall Study||0||
48570743|NCT00326716|101730857|FG000|STARTED|Pre-Natal Mothers||20||
48570744|NCT00326716|101730858|FG001|STARTED|Pre-Natal Mothers||21||
48570745|NCT00326716|101730859|FG002|STARTED|Pre-Natal Mothers||0||
48570746|NCT00326716|101730860|FG003|STARTED|Pre-Natal Mothers||0||
48570747|NCT00326716|101730857|FG000|COMPLETED|Pre-Natal Mothers||19||
48570748|NCT00326716|101730858|FG001|COMPLETED|Pre-Natal Mothers||19||
48570749|NCT00326716|101730859|FG002|COMPLETED|Pre-Natal Mothers||0||
48570750|NCT00326716|101730860|FG003|COMPLETED|Pre-Natal Mothers||0||
48700139|NCT00676520|102053946|FG000|STARTED|Overall Study||8040||
48700140|NCT00676520|102053946|FG000|COMPLETED|Overall Study||7309||
48700141|NCT00676520|102053946|FG000|NOT COMPLETED|Overall Study||731||
48700142|NCT03305081|102053947|FG000|STARTED|Overall Study||25||
48700143|NCT03305081|102053948|FG001|STARTED|Overall Study||20||
48570751|NCT00326716|101730857|FG000|NOT COMPLETED|Pre-Natal Mothers||1||
48570752|NCT00326716|101730858|FG001|NOT COMPLETED|Pre-Natal Mothers||2||
48570753|NCT00326716|101730859|FG002|NOT COMPLETED|Pre-Natal Mothers||0||
48570754|NCT00326716|101730860|FG003|NOT COMPLETED|Pre-Natal Mothers||0||
48570755|NCT00326716|101730857|FG000|STARTED|Infants||0||
48570756|NCT00326716|101730858|FG001|STARTED|Infants||0||
48570757|NCT00326716|101730859|FG002|STARTED|Infants||20||
48570758|NCT00326716|101730860|FG003|STARTED|Infants||20||
48570759|NCT00326716|101730857|FG000|COMPLETED|Infants||0||
48570760|NCT00326716|101730858|FG001|COMPLETED|Infants||0||
48570761|NCT00326716|101730859|FG002|COMPLETED|Infants||20||
48570762|NCT00326716|101730860|FG003|COMPLETED|Infants||20||
48570763|NCT00326716|101730857|FG000|NOT COMPLETED|Infants||0||
48570764|NCT00326716|101730858|FG001|NOT COMPLETED|Infants||0||
48570765|NCT00326716|101730859|FG002|NOT COMPLETED|Infants||0||
48570766|NCT00326716|101730860|FG003|NOT COMPLETED|Infants||0||
48700144|NCT03305081|102053947|FG000|COMPLETED|Overall Study||15||
48700145|NCT03305081|102053948|FG001|COMPLETED|Overall Study||5||
48700146|NCT03305081|102053947|FG000|NOT COMPLETED|Overall Study||10||
48124716|NCT01858194|100630452|FG000|STARTED|Overall Study||8||
48124717|NCT01858194|100630453|FG001|STARTED|Overall Study||9||
48124718|NCT01858194|100630452|FG000|COMPLETED|Overall Study||8||
48124719|NCT01858194|100630453|FG001|COMPLETED|Overall Study||7||
48700147|NCT03305081|102053948|FG001|NOT COMPLETED|Overall Study||15||
48124720|NCT01858194|100630452|FG000|NOT COMPLETED|Overall Study||0||
48124721|NCT01858194|100630453|FG001|NOT COMPLETED|Overall Study||2||
48124722|NCT00234884|100630454|FG000|STARTED|Overall Study||3435||
48124723|NCT00234884|100630454|FG000|COMPLETED|Overall Study||1805||
48124724|NCT00234884|100630454|FG000|NOT COMPLETED|Overall Study||1630||
48124725|NCT01032694|100630455|FG000|STARTED|Overall Study||20||
48124726|NCT01032694|100630456|FG001|STARTED|Overall Study||10||
48124727|NCT01032694|100630455|FG000|COMPLETED|Overall Study||20||
48124728|NCT01032694|100630456|FG001|COMPLETED|Overall Study||10||
48700148|NCT00445211|102053949|FG000|STARTED|Overall Study||23||
48124729|NCT01032694|100630455|FG000|NOT COMPLETED|Overall Study||0||
48124730|NCT01032694|100630456|FG001|NOT COMPLETED|Overall Study||0||
48124731|NCT01384539|100630457|FG000|STARTED|Overall Study||64||
48124732|NCT01384539|100630458|FG001|STARTED|Overall Study||64||
48124733|NCT01384539|100630457|FG000|COMPLETED|Overall Study||58||
48570767|NCT03456804|101730861|FG000|STARTED|Overall Study||13||
48570768|NCT03456804|101730861|FG000|COMPLETED|Overall Study||13||
48124734|NCT01384539|100630458|FG001|COMPLETED|Overall Study||57||
48124735|NCT01384539|100630457|FG000|NOT COMPLETED|Overall Study||6||
48124736|NCT01384539|100630458|FG001|NOT COMPLETED|Overall Study||7||
48124737|NCT02443298|100630459|FG000|STARTED|Overall Study||105||
48124738|NCT02443298|100630460|FG001|STARTED|Overall Study||109||
48124739|NCT02443298|100630459|FG000|COMPLETED|Overall Study||101||
48124740|NCT02443298|100630460|FG001|COMPLETED|Overall Study||104||
48124741|NCT02443298|100630459|FG000|NOT COMPLETED|Overall Study||4||
48124742|NCT02443298|100630460|FG001|NOT COMPLETED|Overall Study||5||
48124743|NCT03678181|100630461|FG000|STARTED|Overall Study||332||
48124744|NCT03678181|100630462|FG001|STARTED|Overall Study||333||
48124745|NCT03678181|100630463|FG002|STARTED|Overall Study||85||
48124746|NCT03678181|100630461|FG000|COMPLETED|Overall Study||332||
48124747|NCT03678181|100630462|FG001|COMPLETED|Overall Study||333||
48124748|NCT03678181|100630463|FG002|COMPLETED|Overall Study||85||
48124749|NCT03678181|100630461|FG000|NOT COMPLETED|Overall Study||0||
48124750|NCT03678181|100630462|FG001|NOT COMPLETED|Overall Study||0||
48124751|NCT03678181|100630463|FG002|NOT COMPLETED|Overall Study||0||
48124752|NCT01959581|100630464|FG000|STARTED|Overall Study||30||
48124753|NCT01959581|100630464|FG000|COMPLETED|Overall Study||25||
48124754|NCT01959581|100630464|FG000|NOT COMPLETED|Overall Study||5||
48124755|NCT01736852|100630465|FG000|STARTED|Overall Study||65||
48124756|NCT01736852|100630466|FG001|STARTED|Overall Study||64||
48124757|NCT01736852|100630465|FG000|COMPLETED|Overall Study||63||
48124758|NCT01736852|100630466|FG001|COMPLETED|Overall Study||61||
48124759|NCT01736852|100630465|FG000|NOT COMPLETED|Overall Study||2||
48124760|NCT01736852|100630466|FG001|NOT COMPLETED|Overall Study||3||
48124761|NCT02732847|100630467|FG000|STARTED|Overall Study||75||
48124762|NCT02732847|100630468|FG001|STARTED|Overall Study||74||
48124763|NCT02732847|100630467|FG000|COMPLETED|Overall Study||33||
48124764|NCT02732847|100630468|FG001|COMPLETED|Overall Study||32||
48397219|NCT00351819|101302565|FG000|STARTED|Overall Study||43||
48397220|NCT00351819|101302566|FG001|STARTED|Overall Study||41||
48397221|NCT00351819|101302565|FG000|COMPLETED|Overall Study||36||
48397222|NCT00351819|101302566|FG001|COMPLETED|Overall Study||29||
48397223|NCT00351819|101302565|FG000|NOT COMPLETED|Overall Study||7||
48124765|NCT02732847|100630467|FG000|NOT COMPLETED|Overall Study||42||
48124766|NCT02732847|100630468|FG001|NOT COMPLETED|Overall Study||42||
48124767|NCT00023673|100630469|FG000|STARTED|Overall Study||8||
48124768|NCT00023673|100630470|FG001|STARTED|Overall Study||9||
48124769|NCT00023673|100630471|FG002|STARTED|Overall Study||0||
48124770|NCT00023673|100630472|FG003|STARTED|Overall Study||46||
48124771|NCT00023673|100630469|FG000|COMPLETED|Overall Study||8||
48124772|NCT00023673|100630470|FG001|COMPLETED|Overall Study||9||
48124773|NCT00023673|100630471|FG002|COMPLETED|Overall Study||0||
48124774|NCT00023673|100630472|FG003|COMPLETED|Overall Study||44||
48124775|NCT00023673|100630469|FG000|NOT COMPLETED|Overall Study||0||
48124776|NCT00023673|100630470|FG001|NOT COMPLETED|Overall Study||0||
48124777|NCT00023673|100630471|FG002|NOT COMPLETED|Overall Study||0||
48124778|NCT00023673|100630472|FG003|NOT COMPLETED|Overall Study||2||
48124779|NCT03732248|100630473|FG000|STARTED|Overall Study||11||
48124780|NCT03732248|100630474|FG001|STARTED|Overall Study||10||
48124781|NCT03732248|100630473|FG000|COMPLETED|Overall Study||10||
48124782|NCT03732248|100630474|FG001|COMPLETED|Overall Study||10||
48124783|NCT03732248|100630473|FG000|NOT COMPLETED|Overall Study||1||
48124784|NCT03732248|100630474|FG001|NOT COMPLETED|Overall Study||0||
48124785|NCT02770391|100630475|FG000|STARTED|Overall Study||54||
48124786|NCT02770391|100630475|FG000|COMPLETED|Overall Study||48||
48124787|NCT02770391|100630475|FG000|NOT COMPLETED|Overall Study||6||
48124788|NCT01151553|100630476|FG000|STARTED|Overall Study||5||
48124789|NCT01151553|100630476|FG000|COMPLETED|Overall Study||5||
48124790|NCT01151553|100630476|FG000|NOT COMPLETED|Overall Study||0||
48124791|NCT03832192|100630477|FG000|STARTED|Overall Study||152||
48397224|NCT00351819|101302566|FG001|NOT COMPLETED|Overall Study||12||
48397225|NCT01125293|101302567|FG000|STARTED|Overall Study||3||
48397226|NCT01125293|101302568|FG001|STARTED|Overall Study||3||
48397227|NCT01125293|101302569|FG002|STARTED|Overall Study||4||
48570769|NCT03456804|101730861|FG000|NOT COMPLETED|Overall Study||0||
48124792|NCT03832192|100630478|FG001|STARTED|Overall Study||149||
48124793|NCT03832192|100630477|FG000|COMPLETED|Overall Study||0||
48397228|NCT01125293|101302570|FG003|STARTED|Overall Study||3||
48124794|NCT03832192|100630478|FG001|COMPLETED|Overall Study||0||
48124795|NCT03832192|100630477|FG000|NOT COMPLETED|Overall Study||152||
48124796|NCT03832192|100630478|FG001|NOT COMPLETED|Overall Study||149||
48124797|NCT01274637|100630479|FG000|STARTED|Overall Study||30||
48124798|NCT01274637|100630480|FG001|STARTED|Overall Study||32||
48124799|NCT01274637|100630479|FG000|COMPLETED|Overall Study||30||
48124800|NCT01274637|100630480|FG001|COMPLETED|Overall Study||30||
48124801|NCT01274637|100630479|FG000|NOT COMPLETED|Overall Study||0||
48124802|NCT01274637|100630480|FG001|NOT COMPLETED|Overall Study||2||
48124803|NCT02610140|100630481|FG000|STARTED|Randomization and Treatment Period||166|Randomized|
48124804|NCT02610140|100630482|FG001|STARTED|Randomization and Treatment Period||82|Randomized|
48124805|NCT02610140|100630481|FG000|Participants Received Treatment|Randomization and Treatment Period||163||
48124806|NCT02610140|100630482|FG001|Participants Received Treatment|Randomization and Treatment Period||72||
48124807|NCT02610140|100630481|FG000|COMPLETED|Randomization and Treatment Period||0||
48124808|NCT02610140|100630482|FG001|COMPLETED|Randomization and Treatment Period||0||
48124809|NCT02610140|100630481|FG000|NOT COMPLETED|Randomization and Treatment Period||166||
48124810|NCT02610140|100630482|FG001|NOT COMPLETED|Randomization and Treatment Period||82||
48124811|NCT02610140|100630481|FG000|STARTED|Safety Follow-up||102|Safety follow-up performed|
48124812|NCT02610140|100630482|FG001|STARTED|Safety Follow-up||45|Safety follow-up performed|
48124813|NCT02610140|100630481|FG000|COMPLETED|Safety Follow-up||57||
48124814|NCT02610140|100630482|FG001|COMPLETED|Safety Follow-up||21||
48124815|NCT02610140|100630481|FG000|NOT COMPLETED|Safety Follow-up||45||
48124816|NCT02610140|100630482|FG001|NOT COMPLETED|Safety Follow-up||24||
48124817|NCT02610140|100630481|FG000|STARTED|Active Follow-up||48||
48124818|NCT02610140|100630482|FG001|STARTED|Active Follow-up||26||
48124819|NCT02610140|100630481|FG000|COMPLETED|Active Follow-up||0||
48124820|NCT02610140|100630482|FG001|COMPLETED|Active Follow-up||0||
48124821|NCT02610140|100630481|FG000|NOT COMPLETED|Active Follow-up||48||
48124822|NCT02610140|100630482|FG001|NOT COMPLETED|Active Follow-up||26||
48570770|NCT01514292|101730862|FG000|STARTED|Overall Study||72||
48570771|NCT01514292|101730862|FG000|COMPLETED|Overall Study||72||
48570772|NCT01514292|101730862|FG000|NOT COMPLETED|Overall Study||0||
48570773|NCT02858583|101730863|FG000|STARTED|Overall Study||12||
48570774|NCT02858583|101730864|FG001|STARTED|Overall Study||15||
48124823|NCT02610140|100630481|FG000|STARTED|Long-term Follow-up||123||
48124824|NCT02610140|100630482|FG001|STARTED|Long-term Follow-up||66||
48124825|NCT02610140|100630481|FG000|COMPLETED|Long-term Follow-up||0||
48124826|NCT02610140|100630482|FG001|COMPLETED|Long-term Follow-up||0||
48124827|NCT02610140|100630481|FG000|NOT COMPLETED|Long-term Follow-up||123||
48124828|NCT02610140|100630482|FG001|NOT COMPLETED|Long-term Follow-up||66||
48124829|NCT02663128|100630483|FG000|STARTED|Period 1||3||
48124830|NCT02663128|100630484|FG001|STARTED|Period 1||3||
48124831|NCT02663128|100630485|FG002|STARTED|Period 1||3||
48124832|NCT02663128|100630486|FG003|STARTED|Period 1||3||
48124833|NCT02663128|100630487|FG004|STARTED|Period 1||3||
48124834|NCT02663128|100630488|FG005|STARTED|Period 1||3||
48124835|NCT02663128|100630483|FG000|Received at Least One Dose of Study Drug|Period 1||3||
48124836|NCT02663128|100630484|FG001|Received at Least One Dose of Study Drug|Period 1||3||
48124837|NCT02663128|100630485|FG002|Received at Least One Dose of Study Drug|Period 1||3||
48124838|NCT02663128|100630486|FG003|Received at Least One Dose of Study Drug|Period 1||3||
48124839|NCT02663128|100630487|FG004|Received at Least One Dose of Study Drug|Period 1||3||
48124840|NCT02663128|100630488|FG005|Received at Least One Dose of Study Drug|Period 1||3||
48124841|NCT02663128|100630483|FG000|COMPLETED|Period 1||3||
48124842|NCT02663128|100630484|FG001|COMPLETED|Period 1||3||
48124843|NCT02663128|100630485|FG002|COMPLETED|Period 1||3||
48124844|NCT02663128|100630486|FG003|COMPLETED|Period 1||3||
48124845|NCT02663128|100630487|FG004|COMPLETED|Period 1||3||
48124846|NCT02663128|100630488|FG005|COMPLETED|Period 1||3||
48124847|NCT02663128|100630483|FG000|NOT COMPLETED|Period 1||0||
48124848|NCT02663128|100630484|FG001|NOT COMPLETED|Period 1||0||
48124849|NCT02663128|100630485|FG002|NOT COMPLETED|Period 1||0||
48124850|NCT02663128|100630486|FG003|NOT COMPLETED|Period 1||0||
48124851|NCT02663128|100630487|FG004|NOT COMPLETED|Period 1||0||
48570775|NCT02858583|101730863|FG000|COMPLETED|Overall Study||11||
48124852|NCT02663128|100630488|FG005|NOT COMPLETED|Period 1||0||
48124853|NCT02663128|100630483|FG000|STARTED|Period 2||3||
48124854|NCT02663128|100630484|FG001|STARTED|Period 2||3||
48124855|NCT02663128|100630485|FG002|STARTED|Period 2||3||
48124856|NCT02663128|100630486|FG003|STARTED|Period 2||3||
48124857|NCT02663128|100630487|FG004|STARTED|Period 2||3||
48570776|NCT02858583|101730864|FG001|COMPLETED|Overall Study||14||
48570777|NCT02858583|101730863|FG000|NOT COMPLETED|Overall Study||1||
48124858|NCT02663128|100630488|FG005|STARTED|Period 2||3||
48124859|NCT02663128|100630483|FG000|COMPLETED|Period 2||3||
48124860|NCT02663128|100630484|FG001|COMPLETED|Period 2||3||
48124861|NCT02663128|100630485|FG002|COMPLETED|Period 2||3||
48124862|NCT02663128|100630486|FG003|COMPLETED|Period 2||3||
48124863|NCT02663128|100630487|FG004|COMPLETED|Period 2||2||
48124864|NCT02663128|100630488|FG005|COMPLETED|Period 2||3||
48124865|NCT02663128|100630483|FG000|NOT COMPLETED|Period 2||0||
48124866|NCT02663128|100630484|FG001|NOT COMPLETED|Period 2||0||
48124867|NCT02663128|100630485|FG002|NOT COMPLETED|Period 2||0||
48124868|NCT02663128|100630486|FG003|NOT COMPLETED|Period 2||0||
48124869|NCT02663128|100630487|FG004|NOT COMPLETED|Period 2||1||
48124870|NCT02663128|100630488|FG005|NOT COMPLETED|Period 2||0||
48124871|NCT02663128|100630483|FG000|STARTED|Period 3||3||
48124872|NCT02663128|100630484|FG001|STARTED|Period 3||3||
48124873|NCT02663128|100630485|FG002|STARTED|Period 3||3||
48124874|NCT02663128|100630486|FG003|STARTED|Period 3||3||
48124875|NCT02663128|100630487|FG004|STARTED|Period 3||2||
48124876|NCT02663128|100630488|FG005|STARTED|Period 3||3||
48124877|NCT02663128|100630483|FG000|COMPLETED|Period 3||3||
48124878|NCT02663128|100630484|FG001|COMPLETED|Period 3||3||
48124879|NCT02663128|100630485|FG002|COMPLETED|Period 3||3||
48124880|NCT02663128|100630486|FG003|COMPLETED|Period 3||3||
48124881|NCT02663128|100630487|FG004|COMPLETED|Period 3||2||
48124882|NCT02663128|100630488|FG005|COMPLETED|Period 3||3||
48124883|NCT02663128|100630483|FG000|NOT COMPLETED|Period 3||0||
48124884|NCT02663128|100630484|FG001|NOT COMPLETED|Period 3||0||
48124885|NCT02663128|100630485|FG002|NOT COMPLETED|Period 3||0||
48124886|NCT02663128|100630486|FG003|NOT COMPLETED|Period 3||0||
48124887|NCT02663128|100630487|FG004|NOT COMPLETED|Period 3||0||
48124888|NCT02663128|100630488|FG005|NOT COMPLETED|Period 3||0||
48124889|NCT02052466|100630489|FG000|STARTED|Overall Study||32||
48124890|NCT02052466|100630489|FG000|COMPLETED|Overall Study||30||
48124891|NCT02052466|100630489|FG000|NOT COMPLETED|Overall Study||2||
48124892|NCT01166984|100630490|FG000|STARTED|Overall Study||5||
48124893|NCT01166984|100630491|FG001|STARTED|Overall Study||5||
48124894|NCT01166984|100630492|FG002|STARTED|Overall Study||5||
48124895|NCT01166984|100630493|FG003|STARTED|Overall Study||5||
48124896|NCT01166984|100630494|FG004|STARTED|Overall Study||5||
48124897|NCT01166984|100630490|FG000|COMPLETED|Overall Study||5||
48124898|NCT01166984|100630491|FG001|COMPLETED|Overall Study||5||
48124899|NCT01166984|100630492|FG002|COMPLETED|Overall Study||5||
48124900|NCT01166984|100630493|FG003|COMPLETED|Overall Study||5||
48124901|NCT01166984|100630494|FG004|COMPLETED|Overall Study||5||
48124902|NCT01166984|100630490|FG000|NOT COMPLETED|Overall Study||0||
48124903|NCT01166984|100630491|FG001|NOT COMPLETED|Overall Study||0||
48124904|NCT01166984|100630492|FG002|NOT COMPLETED|Overall Study||0||
48124905|NCT01166984|100630493|FG003|NOT COMPLETED|Overall Study||0||
48124906|NCT01166984|100630494|FG004|NOT COMPLETED|Overall Study||0||
48124907|NCT01353339|100630495|FG000|STARTED|Overall Study||76||
48124908|NCT01353339|100630496|FG001|STARTED|Overall Study||78||
48124909|NCT01353339|100630495|FG000|Discontinued Intervention|Overall Study||12||
48124910|NCT01353339|100630496|FG001|Discontinued Intervention|Overall Study||14||
48124911|NCT01353339|100630495|FG000|Incomplete Follow-up|Overall Study||22||
48124912|NCT01353339|100630496|FG001|Incomplete Follow-up|Overall Study||28||
48124913|NCT01353339|100630495|FG000|COMPLETED|Overall Study||76||
48124914|NCT01353339|100630496|FG001|COMPLETED|Overall Study||78||
48124915|NCT01353339|100630495|FG000|NOT COMPLETED|Overall Study||0||
48124916|NCT01353339|100630496|FG001|NOT COMPLETED|Overall Study||0||
48124917|NCT01430130|100630497|FG000|STARTED|Overall Study||12||
48124918|NCT01430130|100630497|FG000|COMPLETED|Overall Study||10||
48124919|NCT01430130|100630497|FG000|NOT COMPLETED|Overall Study||2||
48124920|NCT04011475|100630498|FG000|STARTED|Overall Study||239||
48124921|NCT04011475|100630499|FG001|STARTED|Overall Study||937||
48124922|NCT04011475|100630500|FG002|STARTED|Overall Study||441||
48124923|NCT04011475|100630498|FG000|Propensity Score Matched Cohort|Overall Study||114|Eligible patients matching via propensity score to balance the baseline characteristics between study groups.|
48124924|NCT04011475|100630499|FG001|Propensity Score Matched Cohort|Overall Study||114|Eligible patients matching via propensity score to balance the baseline characteristics between study groups.|
48124925|NCT04011475|100630500|FG002|Propensity Score Matched Cohort|Overall Study||114|Eligible patients matching via propensity score to balance the baseline characteristics between study groups.|
48570778|NCT02858583|101730864|FG001|NOT COMPLETED|Overall Study||1||
48570779|NCT03476187|101730865|FG000|STARTED|Overall Study||257||
48570780|NCT03476187|101730865|FG000|COMPLETED|Overall Study||245||
48570781|NCT03476187|101730865|FG000|NOT COMPLETED|Overall Study||12||
48570782|NCT05047211|101730866|FG000|STARTED|Overall Study||20||
48570783|NCT05047211|101730867|FG001|STARTED|Overall Study||20||
48570784|NCT05047211|101730866|FG000|COMPLETED|Overall Study||12||
48124926|NCT04011475|100630498|FG000|COMPLETED|Overall Study||239||
48124927|NCT04011475|100630499|FG001|COMPLETED|Overall Study||937||
48397229|NCT01125293|101302571|FG004|STARTED|Overall Study||10||
48570785|NCT05047211|101730867|FG001|COMPLETED|Overall Study||15||
48570786|NCT05047211|101730866|FG000|NOT COMPLETED|Overall Study||8||
48570787|NCT05047211|101730867|FG001|NOT COMPLETED|Overall Study||5||
48570788|NCT01288937|101730868|FG000|STARTED|Overall Study||4||
48124928|NCT04011475|100630500|FG002|COMPLETED|Overall Study||441||
48124929|NCT04011475|100630498|FG000|NOT COMPLETED|Overall Study||0||
48124930|NCT04011475|100630499|FG001|NOT COMPLETED|Overall Study||0||
48124931|NCT04011475|100630500|FG002|NOT COMPLETED|Overall Study||0||
48124932|NCT00345579|100630501|FG000|STARTED|Overall Study||3278||
48124933|NCT00345579|100630502|FG001|STARTED|Overall Study||1113||
48124934|NCT00345579|100630501|FG000|COMPLETED|Overall Study||3114||
48124935|NCT00345579|100630502|FG001|COMPLETED|Overall Study||1048||
48124936|NCT00345579|100630501|FG000|NOT COMPLETED|Overall Study||164||
48124937|NCT00345579|100630502|FG001|NOT COMPLETED|Overall Study||65||
48570789|NCT01288937|101730869|FG001|STARTED|Overall Study||2||
48570790|NCT01288937|101730868|FG000|COMPLETED|Overall Study||3||
48124938|NCT03189914|100630503|FG000|STARTED|Overall Study||8||
48124939|NCT03189914|100630504|FG001|STARTED|Overall Study||38||
48397230|NCT01125293|101302572|FG005|STARTED|Overall Study||23||
48397231|NCT01125293|101302567|FG000|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3||
48397232|NCT01125293|101302568|FG001|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3||
48570791|NCT01288937|101730869|FG001|COMPLETED|Overall Study||2||
48570792|NCT01288937|101730868|FG000|NOT COMPLETED|Overall Study||1||
48570793|NCT01288937|101730869|FG001|NOT COMPLETED|Overall Study||0||
48570794|NCT00602836|101730870|FG000|STARTED|Overall Study||44||
48570795|NCT00602836|101730870|FG000|COMPLETED|Overall Study||39||
48570796|NCT00602836|101730870|FG000|NOT COMPLETED|Overall Study||5||
48124940|NCT03189914|100630503|FG000|Completed Cycle 1|Overall Study||6||
48124941|NCT03189914|100630504|FG001|Completed Cycle 1|Overall Study||31||
48124942|NCT03189914|100630503|FG000|COMPLETED|Overall Study||1||
48124943|NCT03189914|100630504|FG001|COMPLETED|Overall Study||4||
48124944|NCT03189914|100630503|FG000|NOT COMPLETED|Overall Study||7||
48124945|NCT03189914|100630504|FG001|NOT COMPLETED|Overall Study||34||
48124946|NCT00690755|100630505|FG000|STARTED|Overall Study||30||
48124947|NCT00690755|100630506|FG001|STARTED|Overall Study||0||
48124948|NCT00690755|100630507|FG002|STARTED|Overall Study||97||
48124949|NCT00690755|100630508|FG003|STARTED|Overall Study||20||
48124950|NCT00690755|100630509|FG004|STARTED|Overall Study||0||
48124951|NCT00690755|100630510|FG005|STARTED|Overall Study||10||
48124952|NCT00690755|100630511|FG006|STARTED|Overall Study||0||
48570797|NCT03147690|101730871|FG000|STARTED|Overall Study||74||
48570798|NCT03147690|101730871|FG000|COMPLETED|Overall Study||71||
48570799|NCT03147690|101730871|FG000|NOT COMPLETED|Overall Study||3||
48570800|NCT00454246|101730872|FG000|STARTED|Overall Study||73||
48570801|NCT00454246|101730873|FG001|STARTED|Overall Study||29||
48570802|NCT00454246|101730874|FG002|STARTED|Overall Study||9||
48570803|NCT00454246|101730872|FG000|COMPLETED|Overall Study||0||
48570804|NCT00454246|101730873|FG001|COMPLETED|Overall Study||0||
48124953|NCT00690755|100630505|FG000|COMPLETED|Overall Study||28||
48124954|NCT00690755|100630506|FG001|COMPLETED|Overall Study||0||
48124955|NCT00690755|100630507|FG002|COMPLETED|Overall Study||51||
48124956|NCT00690755|100630508|FG003|COMPLETED|Overall Study||15||
48124957|NCT00690755|100630509|FG004|COMPLETED|Overall Study||0||
48124958|NCT00690755|100630510|FG005|COMPLETED|Overall Study||6||
48124959|NCT00690755|100630511|FG006|COMPLETED|Overall Study||0||
48124960|NCT00690755|100630505|FG000|NOT COMPLETED|Overall Study||2||
48124961|NCT00690755|100630506|FG001|NOT COMPLETED|Overall Study||0||
48124962|NCT00690755|100630507|FG002|NOT COMPLETED|Overall Study||46||
48124963|NCT00690755|100630508|FG003|NOT COMPLETED|Overall Study||5||
48124964|NCT00690755|100630509|FG004|NOT COMPLETED|Overall Study||0||
48124965|NCT00690755|100630510|FG005|NOT COMPLETED|Overall Study||4||
48124966|NCT00690755|100630511|FG006|NOT COMPLETED|Overall Study||0||
48397233|NCT01125293|101302569|FG002|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3||
48397234|NCT01125293|101302570|FG003|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3||
48397235|NCT01125293|101302571|FG004|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||0||
48397236|NCT01125293|101302572|FG005|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||0||
48397237|NCT01125293|101302567|FG000|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all participants were considered as 'Not Completed' and reason off-treatment is provided.|
48570805|NCT00454246|101730874|FG002|COMPLETED|Overall Study||0||
48570806|NCT00454246|101730872|FG000|NOT COMPLETED|Overall Study||73||
48124967|NCT00298038|100630512|FG000|STARTED|Overall Study||140||
48124968|NCT00298038|100630513|FG001|STARTED|Overall Study||159||
48124969|NCT00298038|100630512|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||140||
48124970|NCT00298038|100630513|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||159||
48124971|NCT00298038|100630512|FG000|COMPLETED|Overall Study||88||
48124972|NCT00298038|100630513|FG001|COMPLETED|Overall Study||66||
48124973|NCT00298038|100630512|FG000|NOT COMPLETED|Overall Study||52||
48124974|NCT00298038|100630513|FG001|NOT COMPLETED|Overall Study||93||
48397238|NCT01125293|101302568|FG001|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all participants were considered as 'Not Completed' and reason off-treatment is provided.|
48570807|NCT00454246|101730873|FG001|NOT COMPLETED|Overall Study||29||
48570808|NCT00454246|101730874|FG002|NOT COMPLETED|Overall Study||9||
48570809|NCT02473250|101730875|FG000|STARTED|Overall Study||40||
48570810|NCT02473250|101730875|FG000|COMPLETED|Overall Study||20||
48570811|NCT02473250|101730875|FG000|NOT COMPLETED|Overall Study||20||
48570812|NCT03482453|101730876|FG000|STARTED|Part 1 (1 Day)||10||
48124975|NCT01575561|100630514|FG000|STARTED|Overall Study||377||
48124976|NCT01575561|100630514|FG000|COMPLETED|Overall Study||338||
48124977|NCT01575561|100630514|FG000|NOT COMPLETED|Overall Study||39||
48124978|NCT01700816|100630515|FG000|STARTED|Overall Study||21||
48124979|NCT01700816|100630516|FG001|STARTED|Overall Study||19||
48124980|NCT01700816|100630515|FG000|COMPLETED|Overall Study||21||
48124981|NCT01700816|100630516|FG001|COMPLETED|Overall Study||19||
48124982|NCT01700816|100630515|FG000|NOT COMPLETED|Overall Study||0||
48570813|NCT03482453|101730877|FG001|STARTED|Part 1 (1 Day)||6||
48570814|NCT03482453|101730878|FG002|STARTED|Part 1 (1 Day)||6||
48124983|NCT01700816|100630516|FG001|NOT COMPLETED|Overall Study||0||
48124984|NCT02841644|100630517|FG000|STARTED|Overall Study||60||
48397239|NCT01125293|101302569|FG002|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all participants were considered as 'Not Completed' and reason off-treatment is provided.|
48397240|NCT01125293|101302570|FG003|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all participants were considered as 'Not Completed' and reason off-treatment is provided.|
48397241|NCT01125293|101302571|FG004|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all participants were considered as 'Not Completed' and reason off-treatment is provided.|
48397242|NCT01125293|101302572|FG005|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all participants were considered as 'Not Completed' and reason off-treatment is provided.|
48397243|NCT01125293|101302567|FG000|NOT COMPLETED|Overall Study||3||
48397244|NCT01125293|101302568|FG001|NOT COMPLETED|Overall Study||3||
48397245|NCT01125293|101302569|FG002|NOT COMPLETED|Overall Study||4||
48397246|NCT01125293|101302570|FG003|NOT COMPLETED|Overall Study||3||
48397247|NCT01125293|101302571|FG004|NOT COMPLETED|Overall Study||10||
48700149|NCT00445211|102053950|FG001|STARTED|Overall Study||23||
48700150|NCT00445211|102053949|FG000|COMPLETED|Overall Study||23||
48700151|NCT00445211|102053950|FG001|COMPLETED|Overall Study||23||
48397248|NCT01125293|101302572|FG005|NOT COMPLETED|Overall Study||23||
48397249|NCT03984838|101302573|FG000|STARTED|Overall Study||16||
48397250|NCT03984838|101302573|FG000|COMPLETED|Overall Study||16||
48397251|NCT03984838|101302573|FG000|NOT COMPLETED|Overall Study||0||
48397252|NCT00425100|101302574|FG000|STARTED|Overall Study||516||
48397253|NCT00425100|101302574|FG000|COMPLETED|Overall Study||463||
48397254|NCT00425100|101302574|FG000|NOT COMPLETED|Overall Study||53||
48397255|NCT03365947|101302575|FG000|STARTED|Overall Study||4||
48397256|NCT03365947|101302576|FG001|STARTED|Overall Study||4||
48282593|NCT04811131|101014338|FG003|COMPLETED|Overall Study||0||
48282594|NCT04811131|101014335|FG000|NOT COMPLETED|Overall Study||34||
48282595|NCT04811131|101014336|FG001|NOT COMPLETED|Overall Study||37||
48397257|NCT03365947|101302577|FG002|STARTED|Overall Study||4||
48397258|NCT03365947|101302578|FG003|STARTED|Overall Study||4||
48397259|NCT03365947|101302579|FG004|STARTED|Overall Study||4||
48397260|NCT03365947|101302580|FG005|STARTED|Overall Study||10||
48397261|NCT03365947|101302581|FG006|STARTED|Overall Study||8||
48282596|NCT04811131|101014337|FG002|NOT COMPLETED|Overall Study||31||
48282597|NCT04811131|101014338|FG003|NOT COMPLETED|Overall Study||12||
48282598|NCT00836745|101014339|FG000|STARTED|Overall Study||36||
48397262|NCT03365947|101302582|FG007|STARTED|Overall Study||8||
48397263|NCT03365947|101302583|FG008|STARTED|Overall Study||8||
48282599|NCT00836745|101014339|FG000|COMPLETED|Overall Study||15||
48282600|NCT00836745|101014339|FG000|NOT COMPLETED|Overall Study||21||
48282601|NCT00621777|101014340|FG000|STARTED|Open Phase||203||
48397264|NCT03365947|101302584|FG009|STARTED|Overall Study||8||
48397265|NCT03365947|101302585|FG010|STARTED|Overall Study||8||
48397266|NCT03365947|101302586|FG011|STARTED|Overall Study||8||
48397267|NCT03365947|101302587|FG012|STARTED|Overall Study||4||
48397268|NCT03365947|101302588|FG013|STARTED|Overall Study||4||
48397269|NCT03365947|101302589|FG014|STARTED|Overall Study||4||
48397270|NCT03365947|101302590|FG015|STARTED|Overall Study||4||
48397271|NCT03365947|101302591|FG016|STARTED|Overall Study||4||
48397272|NCT03365947|101302592|FG017|STARTED|Overall Study||4||
48570815|NCT03482453|101730879|FG003|STARTED|Part 1 (1 Day)||6||
48397273|NCT03365947|101302593|FG018|STARTED|Overall Study||12||
48570816|NCT03482453|101730880|FG004|STARTED|Part 1 (1 Day)||6||
48570817|NCT03482453|101730881|FG005|STARTED|Part 1 (1 Day)||6||
48570818|NCT03482453|101730882|FG006|STARTED|Part 1 (1 Day)||0||
48282602|NCT00621777|101014341|FG001|STARTED|Open Phase||0||
48282603|NCT00621777|101014340|FG000|COMPLETED|Open Phase||87||
48282604|NCT00621777|101014341|FG001|COMPLETED|Open Phase||0||
48282605|NCT00621777|101014340|FG000|NOT COMPLETED|Open Phase||116||
48282606|NCT00621777|101014341|FG001|NOT COMPLETED|Open Phase||0||
48570819|NCT03482453|101730883|FG007|STARTED|Part 1 (1 Day)||0||
48570820|NCT03482453|101730884|FG008|STARTED|Part 1 (1 Day)||0||
48570821|NCT03482453|101730885|FG009|STARTED|Part 1 (1 Day)||0||
48570822|NCT03482453|101730886|FG010|STARTED|Part 1 (1 Day)||0||
48570823|NCT03482453|101730887|FG011|STARTED|Part 1 (1 Day)||0||
48570824|NCT03482453|101730876|FG000|COMPLETED|Part 1 (1 Day)||10||
48570825|NCT03482453|101730877|FG001|COMPLETED|Part 1 (1 Day)||6||
48570826|NCT03482453|101730878|FG002|COMPLETED|Part 1 (1 Day)||6||
48570827|NCT03482453|101730879|FG003|COMPLETED|Part 1 (1 Day)||6||
48570828|NCT03482453|101730880|FG004|COMPLETED|Part 1 (1 Day)||6||
48570829|NCT03482453|101730881|FG005|COMPLETED|Part 1 (1 Day)||6||
48570830|NCT03482453|101730882|FG006|COMPLETED|Part 1 (1 Day)||0||
48570831|NCT03482453|101730883|FG007|COMPLETED|Part 1 (1 Day)||0||
48570832|NCT03482453|101730884|FG008|COMPLETED|Part 1 (1 Day)||0||
48570833|NCT03482453|101730885|FG009|COMPLETED|Part 1 (1 Day)||0||
48570834|NCT03482453|101730886|FG010|COMPLETED|Part 1 (1 Day)||0||
48570835|NCT03482453|101730887|FG011|COMPLETED|Part 1 (1 Day)||0||
48570836|NCT03482453|101730876|FG000|NOT COMPLETED|Part 1 (1 Day)||0||
48570837|NCT03482453|101730877|FG001|NOT COMPLETED|Part 1 (1 Day)||0||
48570838|NCT03482453|101730878|FG002|NOT COMPLETED|Part 1 (1 Day)||0||
48570839|NCT03482453|101730879|FG003|NOT COMPLETED|Part 1 (1 Day)||0||
48570840|NCT03482453|101730880|FG004|NOT COMPLETED|Part 1 (1 Day)||0||
48397274|NCT03365947|101302575|FG000|COMPLETED|Overall Study||4||
48124985|NCT02841644|100630518|FG001|STARTED|Overall Study||120||
48124986|NCT02841644|100630517|FG000|COMPLETED|Overall Study||60||
48124987|NCT02841644|100630518|FG001|COMPLETED|Overall Study||120||
48124988|NCT02841644|100630517|FG000|NOT COMPLETED|Overall Study||0||
48124989|NCT02841644|100630518|FG001|NOT COMPLETED|Overall Study||0||
48124990|NCT01046110|100630519|FG000|STARTED|Overall Study||229||
48124991|NCT01046110|100630520|FG001|STARTED|Overall Study||229||
48124992|NCT01046110|100630519|FG000|Exposed|Overall Study||226||
48124993|NCT01046110|100630520|FG001|Exposed|Overall Study||228||
48124994|NCT01046110|100630519|FG000|COMPLETED|Overall Study||174||
48124995|NCT01046110|100630520|FG001|COMPLETED|Overall Study||174||
48124996|NCT01046110|100630519|FG000|NOT COMPLETED|Overall Study||55||
48124997|NCT01046110|100630520|FG001|NOT COMPLETED|Overall Study||55||
48124998|NCT02673697|100630521|FG000|STARTED|Overall Study||453|Randomized|
48124999|NCT02673697|100630522|FG001|STARTED|Overall Study||457|Randomized|
48125000|NCT02673697|100630521|FG000|Implanted|Overall Study||450||
48125001|NCT02673697|100630522|FG001|Implanted|Overall Study||446||
48125002|NCT02673697|100630521|FG000|Per-Protocol Population|Overall Study||407||
48125003|NCT02673697|100630522|FG001|Per-Protocol Population|Overall Study||412||
48125004|NCT02673697|100630521|FG000|COMPLETED|Overall Study||0||
48125005|NCT02673697|100630522|FG001|COMPLETED|Overall Study||0||
48125006|NCT02673697|100630521|FG000|NOT COMPLETED|Overall Study||453||
48125007|NCT02673697|100630522|FG001|NOT COMPLETED|Overall Study||457||
48125008|NCT00995449|100630523|FG000|STARTED|Overall Study||0||
48125009|NCT00995449|100630524|FG001|STARTED|Overall Study||0||
48125010|NCT00995449|100630525|FG002|STARTED|Overall Study||7||
48125011|NCT00995449|100630526|FG003|STARTED|Overall Study||2||
48125012|NCT00995449|100630523|FG000|COMPLETED|Overall Study||0||
48125013|NCT00995449|100630524|FG001|COMPLETED|Overall Study||0||
48125014|NCT00995449|100630525|FG002|COMPLETED|Overall Study||5||
48125015|NCT00995449|100630526|FG003|COMPLETED|Overall Study||2||
48125016|NCT00995449|100630523|FG000|NOT COMPLETED|Overall Study||0||
48125017|NCT00995449|100630524|FG001|NOT COMPLETED|Overall Study||0||
48125018|NCT00995449|100630525|FG002|NOT COMPLETED|Overall Study||2||
48125019|NCT00995449|100630526|FG003|NOT COMPLETED|Overall Study||0||
48125020|NCT00088218|100630527|FG000|STARTED|Overall Study||16||
48125021|NCT00088218|100630528|FG001|STARTED|Overall Study||79||
48125022|NCT00088218|100630527|FG000|COMPLETED|Overall Study||16||
48125023|NCT00088218|100630528|FG001|COMPLETED|Overall Study||79||
48125024|NCT00088218|100630527|FG000|NOT COMPLETED|Overall Study||0||
48125025|NCT00088218|100630528|FG001|NOT COMPLETED|Overall Study||0||
48125026|NCT00759967|100630529|FG000|STARTED|First Intervention||10||
48125027|NCT00759967|100630530|FG001|STARTED|First Intervention||9||
48125028|NCT00759967|100630529|FG000|COMPLETED|First Intervention||10||
48125029|NCT00759967|100630530|FG001|COMPLETED|First Intervention||9||
48125030|NCT00759967|100630529|FG000|NOT COMPLETED|First Intervention||0||
48125031|NCT00759967|100630530|FG001|NOT COMPLETED|First Intervention||0||
48125032|NCT00759967|100630529|FG000|STARTED|Second Intervention||10||
48125033|NCT00759967|100630530|FG001|STARTED|Second Intervention||9||
48125034|NCT00759967|100630529|FG000|COMPLETED|Second Intervention||8||
48125035|NCT00759967|100630530|FG001|COMPLETED|Second Intervention||9||
48125036|NCT00759967|100630529|FG000|NOT COMPLETED|Second Intervention||2||
48125037|NCT00759967|100630530|FG001|NOT COMPLETED|Second Intervention||0||
48125038|NCT04318210|100630531|FG000|STARTED|Overall Study||229||
48397275|NCT03365947|101302576|FG001|COMPLETED|Overall Study||4||
48397276|NCT03365947|101302577|FG002|COMPLETED|Overall Study||4||
48397277|NCT03365947|101302578|FG003|COMPLETED|Overall Study||4||
48397278|NCT03365947|101302579|FG004|COMPLETED|Overall Study||4||
48397279|NCT03365947|101302580|FG005|COMPLETED|Overall Study||9||
48397280|NCT03365947|101302581|FG006|COMPLETED|Overall Study||8||
48397281|NCT03365947|101302582|FG007|COMPLETED|Overall Study||8||
48397282|NCT03365947|101302583|FG008|COMPLETED|Overall Study||8||
48397283|NCT03365947|101302584|FG009|COMPLETED|Overall Study||8||
48397284|NCT03365947|101302585|FG010|COMPLETED|Overall Study||8||
48125039|NCT04318210|100630531|FG000|COMPLETED|Overall Study||153||
48125040|NCT04318210|100630531|FG000|NOT COMPLETED|Overall Study||76||
48125041|NCT01193556|100630532|FG000|STARTED|Overall Study||26||
48125042|NCT01193556|100630533|FG001|STARTED|Overall Study||25||
48125043|NCT01193556|100630532|FG000|COMPLETED|Overall Study||0||
48125044|NCT01193556|100630533|FG001|COMPLETED|Overall Study||0||
48125045|NCT01193556|100630532|FG000|NOT COMPLETED|Overall Study||26||
48125046|NCT01193556|100630533|FG001|NOT COMPLETED|Overall Study||25||
48125047|NCT05580575|100630534|FG000|STARTED|Overall Study||31||
48125048|NCT05580575|100630535|FG001|STARTED|Overall Study||32||
48125049|NCT05580575|100630534|FG000|COMPLETED|Overall Study||28||
48125050|NCT05580575|100630535|FG001|COMPLETED|Overall Study||31||
48125051|NCT05580575|100630534|FG000|NOT COMPLETED|Overall Study||3||
48125052|NCT05580575|100630535|FG001|NOT COMPLETED|Overall Study||1||
48125053|NCT04121962|100630536|FG000|STARTED|Overall Study||64||
48125054|NCT04121962|100630537|FG001|STARTED|Overall Study||55||
48397285|NCT03365947|101302586|FG011|COMPLETED|Overall Study||8||
48125055|NCT04121962|100630536|FG000|COMPLETED|Overall Study||22||
48125056|NCT04121962|100630537|FG001|COMPLETED|Overall Study||16||
48397286|NCT03365947|101302587|FG012|COMPLETED|Overall Study||4||
48570841|NCT03482453|101730881|FG005|NOT COMPLETED|Part 1 (1 Day)||0||
48570842|NCT03482453|101730882|FG006|NOT COMPLETED|Part 1 (1 Day)||0||
48570843|NCT03482453|101730883|FG007|NOT COMPLETED|Part 1 (1 Day)||0||
48570844|NCT03482453|101730884|FG008|NOT COMPLETED|Part 1 (1 Day)||0||
48570845|NCT03482453|101730885|FG009|NOT COMPLETED|Part 1 (1 Day)||0||
48570846|NCT03482453|101730886|FG010|NOT COMPLETED|Part 1 (1 Day)||0||
48570847|NCT03482453|101730887|FG011|NOT COMPLETED|Part 1 (1 Day)||0||
48570848|NCT03482453|101730876|FG000|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
48570849|NCT03482453|101730877|FG001|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
48570850|NCT03482453|101730878|FG002|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
48570851|NCT03482453|101730879|FG003|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
48570852|NCT03482453|101730880|FG004|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
48570853|NCT03482453|101730881|FG005|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
48570854|NCT03482453|101730882|FG006|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||3||
48570855|NCT03482453|101730883|FG007|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||3||
48570856|NCT03482453|101730884|FG008|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||5||
48570857|NCT03482453|101730885|FG009|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||5||
48570858|NCT03482453|101730886|FG010|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||7||
48570859|NCT03482453|101730887|FG011|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||6||
48570860|NCT03482453|101730876|FG000|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
48700152|NCT00445211|102053949|FG000|NOT COMPLETED|Overall Study||0||
48700153|NCT00445211|102053950|FG001|NOT COMPLETED|Overall Study||0||
48700154|NCT02998203|102053951|FG000|STARTED|First Period (40 Days)||67||3
48700155|NCT02998203|102053952|FG001|STARTED|First Period (40 Days)||124||3
48700156|NCT02998203|102053951|FG000|COMPLETED|First Period (40 Days)||43||3
48700157|NCT02998203|102053952|FG001|COMPLETED|First Period (40 Days)||124||3
48700158|NCT02998203|102053951|FG000|NOT COMPLETED|First Period (40 Days)||24||0
48700159|NCT02998203|102053952|FG001|NOT COMPLETED|First Period (40 Days)||0||0
48700160|NCT02998203|102053951|FG000|STARTED|Second Period (40 Days)||43||3
48700161|NCT02998203|102053952|FG001|STARTED|Second Period (40 Days)||124||3
48700162|NCT02998203|102053951|FG000|COMPLETED|Second Period (40 Days)||43||3
48700163|NCT02998203|102053952|FG001|COMPLETED|Second Period (40 Days)||106||3
48700164|NCT02998203|102053951|FG000|NOT COMPLETED|Second Period (40 Days)||0||0
48700165|NCT02998203|102053952|FG001|NOT COMPLETED|Second Period (40 Days)||18||0
48700166|NCT03831191|102053953|FG000|STARTED|Induction Period (16 Weeks)||33||
48700167|NCT03831191|102053954|FG001|STARTED|Induction Period (16 Weeks)||35||
48700168|NCT03831191|102053955|FG002|STARTED|Induction Period (16 Weeks)||34||
48700169|NCT03831191|102053956|FG003|STARTED|Induction Period (16 Weeks)||34||
48700170|NCT03831191|102053957|FG004|STARTED|Induction Period (16 Weeks)||0||
48700171|NCT03831191|102053958|FG005|STARTED|Induction Period (16 Weeks)||0||
48700172|NCT03831191|102053959|FG006|STARTED|Induction Period (16 Weeks)||0||
48700173|NCT03831191|102053960|FG007|STARTED|Induction Period (16 Weeks)||0||
48700174|NCT03831191|102053961|FG008|STARTED|Induction Period (16 Weeks)||0||
48700175|NCT03831191|102053962|FG009|STARTED|Induction Period (16 Weeks)||0||
48700176|NCT03831191|102053963|FG010|STARTED|Induction Period (16 Weeks)||0||
48700177|NCT03831191|102053964|FG011|STARTED|Induction Period (16 Weeks)||0||
48700178|NCT03831191|102053965|FG012|STARTED|Induction Period (16 Weeks)||0||
48700179|NCT03831191|102053966|FG013|STARTED|Induction Period (16 Weeks)||0||
48700180|NCT03831191|102053967|FG014|STARTED|Induction Period (16 Weeks)||0||
48700181|NCT03831191|102053953|FG000|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||33||
48700182|NCT03831191|102053954|FG001|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||35||
48700183|NCT03831191|102053955|FG002|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||34||
48700184|NCT03831191|102053956|FG003|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||33||
48700185|NCT03831191|102053957|FG004|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
48700186|NCT03831191|102053958|FG005|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
48700187|NCT03831191|102053959|FG006|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
48700188|NCT03831191|102053960|FG007|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
48700189|NCT03831191|102053961|FG008|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
48700190|NCT03831191|102053962|FG009|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
48700191|NCT03831191|102053963|FG010|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
48700192|NCT03831191|102053964|FG011|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
48570861|NCT03482453|101730877|FG001|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
48570862|NCT03482453|101730878|FG002|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
48570863|NCT03482453|101730879|FG003|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
48570864|NCT03482453|101730880|FG004|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
48570865|NCT03482453|101730881|FG005|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
48700193|NCT03831191|102053965|FG012|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
48570866|NCT03482453|101730882|FG006|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||3||
48700194|NCT03831191|102053966|FG013|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
48282607|NCT00621777|101014340|FG000|STARTED|Randomized Phase||40||
48282608|NCT00621777|101014341|FG001|STARTED|Randomized Phase||47||
48282609|NCT00621777|101014340|FG000|COMPLETED|Randomized Phase||33||
48282610|NCT00621777|101014341|FG001|COMPLETED|Randomized Phase||28||
48282611|NCT00621777|101014340|FG000|NOT COMPLETED|Randomized Phase||7||
48282612|NCT00621777|101014341|FG001|NOT COMPLETED|Randomized Phase||19||
48570867|NCT03482453|101730883|FG007|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||3||
48570868|NCT03482453|101730884|FG008|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||5||
48570869|NCT03482453|101730885|FG009|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||5||
48570870|NCT03482453|101730886|FG010|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||6||
48570871|NCT03482453|101730887|FG011|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||6||
48570872|NCT03482453|101730876|FG000|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
48570873|NCT03482453|101730877|FG001|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
48570874|NCT03482453|101730878|FG002|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
48570875|NCT03482453|101730879|FG003|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
48570876|NCT03482453|101730880|FG004|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
48570877|NCT03482453|101730881|FG005|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
48570878|NCT03482453|101730882|FG006|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
48570879|NCT03482453|101730883|FG007|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
48570880|NCT03482453|101730884|FG008|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
48570881|NCT03482453|101730885|FG009|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
48570882|NCT03482453|101730886|FG010|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||1||
48570883|NCT03482453|101730887|FG011|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
48570884|NCT03482453|101730876|FG000|STARTED|Parts 2, 3 Washout Period (7 Days)||0||
48570885|NCT03482453|101730877|FG001|STARTED|Parts 2, 3 Washout Period (7 Days)||0||
48570886|NCT03482453|101730878|FG002|STARTED|Parts 2, 3 Washout Period (7 Days)||0||
48570887|NCT03482453|101730879|FG003|STARTED|Parts 2, 3 Washout Period (7 Days)||0||
48570888|NCT03482453|101730880|FG004|STARTED|Parts 2, 3 Washout Period (7 Days)||0||
48570889|NCT03482453|101730881|FG005|STARTED|Parts 2, 3 Washout Period (7 Days)||0||
48570890|NCT03482453|101730882|FG006|STARTED|Parts 2, 3 Washout Period (7 Days)||3||
48570891|NCT03482453|101730883|FG007|STARTED|Parts 2, 3 Washout Period (7 Days)||3||
48570892|NCT03482453|101730884|FG008|STARTED|Parts 2, 3 Washout Period (7 Days)||5||
48570893|NCT03482453|101730885|FG009|STARTED|Parts 2, 3 Washout Period (7 Days)||5||
48570894|NCT03482453|101730886|FG010|STARTED|Parts 2, 3 Washout Period (7 Days)||6||
48570895|NCT03482453|101730887|FG011|STARTED|Parts 2, 3 Washout Period (7 Days)||6||
48570896|NCT03482453|101730876|FG000|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
48570897|NCT03482453|101730877|FG001|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
48570898|NCT03482453|101730878|FG002|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
48570899|NCT03482453|101730879|FG003|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
48570900|NCT03482453|101730880|FG004|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
48570901|NCT03482453|101730881|FG005|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
48570902|NCT03482453|101730882|FG006|COMPLETED|Parts 2, 3 Washout Period (7 Days)||3||
48570903|NCT03482453|101730883|FG007|COMPLETED|Parts 2, 3 Washout Period (7 Days)||3||
48570904|NCT03482453|101730884|FG008|COMPLETED|Parts 2, 3 Washout Period (7 Days)||5||
48570905|NCT03482453|101730885|FG009|COMPLETED|Parts 2, 3 Washout Period (7 Days)||5||
48570906|NCT03482453|101730886|FG010|COMPLETED|Parts 2, 3 Washout Period (7 Days)||6||
48570907|NCT03482453|101730887|FG011|COMPLETED|Parts 2, 3 Washout Period (7 Days)||6||
48570908|NCT03482453|101730876|FG000|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
48570909|NCT03482453|101730877|FG001|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
48570910|NCT03482453|101730878|FG002|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
48570911|NCT03482453|101730879|FG003|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
48570912|NCT03482453|101730880|FG004|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
48570913|NCT03482453|101730881|FG005|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
48570914|NCT03482453|101730882|FG006|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
48570915|NCT03482453|101730883|FG007|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
48570916|NCT03482453|101730884|FG008|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
48570917|NCT03482453|101730885|FG009|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
48570918|NCT03482453|101730886|FG010|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
48570919|NCT03482453|101730887|FG011|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
48570920|NCT03482453|101730876|FG000|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
48570921|NCT03482453|101730877|FG001|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
48570922|NCT03482453|101730878|FG002|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
48570923|NCT03482453|101730879|FG003|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
48570924|NCT03482453|101730880|FG004|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
48282613|NCT00336700|101014342|FG000|STARTED|Overall Study||25||
48282614|NCT00336700|101014342|FG000|COMPLETED|Overall Study||25||
48282615|NCT00336700|101014342|FG000|NOT COMPLETED|Overall Study||0||
48282616|NCT00379288|101014343|FG000|STARTED|Overall Study||141||
48282617|NCT00379288|101014344|FG001|STARTED|Overall Study||130||
48282618|NCT00379288|101014345|FG002|STARTED|Overall Study||68||
48282619|NCT00379288|101014346|FG003|STARTED|Overall Study||65||
48570925|NCT03482453|101730881|FG005|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
48570926|NCT03482453|101730882|FG006|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||3||
48570927|NCT03482453|101730883|FG007|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||3||
48570928|NCT03482453|101730884|FG008|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||5||
48570929|NCT03482453|101730885|FG009|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||5||
48570930|NCT03482453|101730886|FG010|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||6||
48570931|NCT03482453|101730887|FG011|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||6||
48570932|NCT03482453|101730876|FG000|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
48570933|NCT03482453|101730877|FG001|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
48570934|NCT03482453|101730878|FG002|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
48570935|NCT03482453|101730879|FG003|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
48570936|NCT03482453|101730880|FG004|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
48570937|NCT03482453|101730881|FG005|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
48570938|NCT03482453|101730882|FG006|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||3||
48570939|NCT03482453|101730883|FG007|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||3||
48570940|NCT03482453|101730884|FG008|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||5||
48570941|NCT03482453|101730885|FG009|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||5||
48570942|NCT03482453|101730886|FG010|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||6||
48570943|NCT03482453|101730887|FG011|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||6||
48570944|NCT03482453|101730876|FG000|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
48570945|NCT03482453|101730877|FG001|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
48570946|NCT03482453|101730878|FG002|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
48570947|NCT03482453|101730879|FG003|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
48570948|NCT03482453|101730880|FG004|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
48570949|NCT03482453|101730881|FG005|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
48570950|NCT03482453|101730882|FG006|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
48570951|NCT03482453|101730883|FG007|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
48570952|NCT03482453|101730884|FG008|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
48570953|NCT03482453|101730885|FG009|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
48570954|NCT03482453|101730886|FG010|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
48570955|NCT03482453|101730887|FG011|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
48570956|NCT01934582|101730888|FG000|STARTED|Overall Study||13||
48570957|NCT01934582|101730888|FG000|COMPLETED|Overall Study||13||
48570958|NCT01934582|101730888|FG000|NOT COMPLETED|Overall Study||0||
48570959|NCT01019694|101730889|FG000|STARTED|Overall Study||157||
48570960|NCT01019694|101730890|FG001|STARTED|Overall Study||156||
48570961|NCT01019694|101730891|FG002|STARTED|Overall Study||157||
48570962|NCT01019694|101730889|FG000|COMPLETED|Overall Study||133||
48570963|NCT01019694|101730890|FG001|COMPLETED|Overall Study||118||
48570964|NCT01019694|101730891|FG002|COMPLETED|Overall Study||110||
48570965|NCT01019694|101730889|FG000|NOT COMPLETED|Overall Study||24||
48700195|NCT03831191|102053967|FG014|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
48700196|NCT03831191|102053953|FG000|COMPLETED|Induction Period (16 Weeks)||10||
48700197|NCT03831191|102053954|FG001|COMPLETED|Induction Period (16 Weeks)||14||
48700198|NCT03831191|102053955|FG002|COMPLETED|Induction Period (16 Weeks)||13||
48700199|NCT03831191|102053956|FG003|COMPLETED|Induction Period (16 Weeks)||11||
48700200|NCT03831191|102053957|FG004|COMPLETED|Induction Period (16 Weeks)||0||
48700201|NCT03831191|102053958|FG005|COMPLETED|Induction Period (16 Weeks)||0||
48125057|NCT04121962|100630536|FG000|NOT COMPLETED|Overall Study||42||
48125058|NCT04121962|100630537|FG001|NOT COMPLETED|Overall Study||39||
48125059|NCT04279925|100630538|FG000|STARTED|Overall Study||4||
48125060|NCT04279925|100630539|FG001|STARTED|Overall Study||5||
48125061|NCT04279925|100630538|FG000|COMPLETED|Overall Study||4||
48125062|NCT04279925|100630539|FG001|COMPLETED|Overall Study||5||
48125063|NCT04279925|100630538|FG000|NOT COMPLETED|Overall Study||0||
48125064|NCT04279925|100630539|FG001|NOT COMPLETED|Overall Study||0||
48125065|NCT00358735|100630540|FG000|STARTED|Overall Study||204||
48125066|NCT00358735|100630541|FG001|STARTED|Overall Study||207||
48570966|NCT01019694|101730890|FG001|NOT COMPLETED|Overall Study||38||
48700202|NCT03831191|102053959|FG006|COMPLETED|Induction Period (16 Weeks)||0||
48700203|NCT03831191|102053960|FG007|COMPLETED|Induction Period (16 Weeks)||0||
48700204|NCT03831191|102053961|FG008|COMPLETED|Induction Period (16 Weeks)||0||
48700205|NCT03831191|102053962|FG009|COMPLETED|Induction Period (16 Weeks)||0||
48700206|NCT03831191|102053963|FG010|COMPLETED|Induction Period (16 Weeks)||0||
48700207|NCT03831191|102053964|FG011|COMPLETED|Induction Period (16 Weeks)||0||
48700208|NCT03831191|102053965|FG012|COMPLETED|Induction Period (16 Weeks)||0||
48700209|NCT03831191|102053966|FG013|COMPLETED|Induction Period (16 Weeks)||0||
48700210|NCT03831191|102053967|FG014|COMPLETED|Induction Period (16 Weeks)||0||
48700211|NCT03831191|102053953|FG000|NOT COMPLETED|Induction Period (16 Weeks)||23||
48125067|NCT00358735|100630540|FG000|Completed Safety|Overall Study||198||
48125068|NCT00358735|100630541|FG001|Completed Safety|Overall Study||194||
48125069|NCT00358735|100630540|FG000|Not Completed Safety|Overall Study||6||
48570967|NCT01019694|101730891|FG002|NOT COMPLETED|Overall Study||47||
48700212|NCT03831191|102053954|FG001|NOT COMPLETED|Induction Period (16 Weeks)||21||
48700213|NCT03831191|102053955|FG002|NOT COMPLETED|Induction Period (16 Weeks)||21||
48700214|NCT03831191|102053956|FG003|NOT COMPLETED|Induction Period (16 Weeks)||23||
48700215|NCT03831191|102053957|FG004|NOT COMPLETED|Induction Period (16 Weeks)||0||
48700216|NCT03831191|102053958|FG005|NOT COMPLETED|Induction Period (16 Weeks)||0||
48700217|NCT03831191|102053959|FG006|NOT COMPLETED|Induction Period (16 Weeks)||0||
48700218|NCT03831191|102053960|FG007|NOT COMPLETED|Induction Period (16 Weeks)||0||
48700219|NCT03831191|102053961|FG008|NOT COMPLETED|Induction Period (16 Weeks)||0||
48700220|NCT03831191|102053962|FG009|NOT COMPLETED|Induction Period (16 Weeks)||0||
48700221|NCT03831191|102053963|FG010|NOT COMPLETED|Induction Period (16 Weeks)||0||
48700222|NCT03831191|102053964|FG011|NOT COMPLETED|Induction Period (16 Weeks)||0||
48700223|NCT03831191|102053965|FG012|NOT COMPLETED|Induction Period (16 Weeks)||0||
48700224|NCT03831191|102053966|FG013|NOT COMPLETED|Induction Period (16 Weeks)||0||
48700225|NCT03831191|102053967|FG014|NOT COMPLETED|Induction Period (16 Weeks)||0||
48700226|NCT03831191|102053953|FG000|STARTED|Maintenance Period (36 Weeks)||0||
48700227|NCT03831191|102053954|FG001|STARTED|Maintenance Period (36 Weeks)||0||
48700228|NCT03831191|102053955|FG002|STARTED|Maintenance Period (36 Weeks)||0||
48700229|NCT03831191|102053956|FG003|STARTED|Maintenance Period (36 Weeks)||0||
48700230|NCT03831191|102053957|FG004|STARTED|Maintenance Period (36 Weeks)||4||
48700231|NCT03831191|102053958|FG005|STARTED|Maintenance Period (36 Weeks)||5||
48700232|NCT03831191|102053959|FG006|STARTED|Maintenance Period (36 Weeks)||2||
48700233|NCT03831191|102053960|FG007|STARTED|Maintenance Period (36 Weeks)||4||
48700234|NCT03831191|102053961|FG008|STARTED|Maintenance Period (36 Weeks)||8||
48700235|NCT03831191|102053962|FG009|STARTED|Maintenance Period (36 Weeks)||1||
48700236|NCT03831191|102053963|FG010|STARTED|Maintenance Period (36 Weeks)||4||
48700237|NCT03831191|102053964|FG011|STARTED|Maintenance Period (36 Weeks)||8||
48700238|NCT03831191|102053965|FG012|STARTED|Maintenance Period (36 Weeks)||1||
48700239|NCT03831191|102053966|FG013|STARTED|Maintenance Period (36 Weeks)||1||
48700240|NCT03831191|102053967|FG014|STARTED|Maintenance Period (36 Weeks)||9||
48700241|NCT03831191|102053953|FG000|COMPLETED|Maintenance Period (36 Weeks)||0||
48700242|NCT03831191|102053954|FG001|COMPLETED|Maintenance Period (36 Weeks)||0||
48700243|NCT03831191|102053955|FG002|COMPLETED|Maintenance Period (36 Weeks)||0||
48700244|NCT03831191|102053956|FG003|COMPLETED|Maintenance Period (36 Weeks)||0||
48700245|NCT03831191|102053957|FG004|COMPLETED|Maintenance Period (36 Weeks)||0||
48700246|NCT03831191|102053958|FG005|COMPLETED|Maintenance Period (36 Weeks)||0||
48700247|NCT03831191|102053959|FG006|COMPLETED|Maintenance Period (36 Weeks)||0||
48700248|NCT03831191|102053960|FG007|COMPLETED|Maintenance Period (36 Weeks)||0||
48700249|NCT03831191|102053961|FG008|COMPLETED|Maintenance Period (36 Weeks)||0||
48700250|NCT03831191|102053962|FG009|COMPLETED|Maintenance Period (36 Weeks)||0||
48700251|NCT03831191|102053963|FG010|COMPLETED|Maintenance Period (36 Weeks)||0||
48700252|NCT03831191|102053964|FG011|COMPLETED|Maintenance Period (36 Weeks)||1||
48700253|NCT03831191|102053965|FG012|COMPLETED|Maintenance Period (36 Weeks)||0||
48700254|NCT03831191|102053966|FG013|COMPLETED|Maintenance Period (36 Weeks)||0||
48700255|NCT03831191|102053967|FG014|COMPLETED|Maintenance Period (36 Weeks)||0||
48700256|NCT03831191|102053953|FG000|NOT COMPLETED|Maintenance Period (36 Weeks)||0||
48700257|NCT03831191|102053954|FG001|NOT COMPLETED|Maintenance Period (36 Weeks)||0||
48700258|NCT03831191|102053955|FG002|NOT COMPLETED|Maintenance Period (36 Weeks)||0||
48125070|NCT00358735|100630541|FG001|Not Completed Safety|Overall Study||13||
48125071|NCT00358735|100630540|FG000|COMPLETED|Overall Study||196||
48125072|NCT00358735|100630541|FG001|COMPLETED|Overall Study||190||
48125073|NCT00358735|100630540|FG000|NOT COMPLETED|Overall Study||8||
48125074|NCT00358735|100630541|FG001|NOT COMPLETED|Overall Study||17||
48125075|NCT01390246|100630542|FG000|STARTED|Overall Study||30||
48125076|NCT01390246|100630543|FG001|STARTED|Overall Study||35||
48125077|NCT01390246|100630542|FG000|Visit 2: Quit Day|Overall Study||24||
48125078|NCT01390246|100630543|FG001|Visit 2: Quit Day|Overall Study||24||
48125079|NCT01390246|100630542|FG000|Visit 6: End of Treatment|Overall Study||15||
48125080|NCT01390246|100630543|FG001|Visit 6: End of Treatment|Overall Study||15||
48125081|NCT01390246|100630542|FG000|Visit 7: 36-38 Weeks Gestation|Overall Study||10||
48125082|NCT01390246|100630543|FG001|Visit 7: 36-38 Weeks Gestation|Overall Study||10||
48125083|NCT01390246|100630542|FG000|COMPLETED|Overall Study||10||
48125084|NCT01390246|100630543|FG001|COMPLETED|Overall Study||10||
48125085|NCT01390246|100630542|FG000|NOT COMPLETED|Overall Study||20||
48125086|NCT01390246|100630543|FG001|NOT COMPLETED|Overall Study||25||
48125087|NCT03403634|100630544|FG000|STARTED|Overall Study||19||
48125088|NCT03403634|100630544|FG000|Treated|Overall Study||15||
48125089|NCT03403634|100630544|FG000|COMPLETED|Overall Study||12||
48125090|NCT03403634|100630544|FG000|NOT COMPLETED|Overall Study||7||
48125091|NCT01884350|100630545|FG000|STARTED|Primary Efficacy Analysis Set (24 Weeks)||583|"Primary Efficacy Analysis set:~All randomized patients."|
48125092|NCT01884350|100630546|FG001|STARTED|Primary Efficacy Analysis Set (24 Weeks)||579|"Primary Efficacy Analysis set:~All randomized patients."|
48125093|NCT01884350|100630547|FG002|STARTED|Primary Efficacy Analysis Set (24 Weeks)||0|"Primary Efficacy Analysis set:~All randomized patients."|
48125094|NCT01884350|100630545|FG000|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||604|All randomized patients who received any study drug.|
48125095|NCT01884350|100630546|FG001|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||558|All randomized patients who received any study drug.|
48125096|NCT01884350|100630547|FG002|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||0|All randomized patients who received any study drug.|
48125097|NCT01884350|100630545|FG000|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||529||
48125098|NCT01884350|100630546|FG001|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||525||
48125099|NCT01884350|100630547|FG002|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||0||
48125100|NCT01884350|100630545|FG000|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||54||
48125101|NCT01884350|100630546|FG001|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||54||
48125102|NCT01884350|100630547|FG002|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||0||
48125103|NCT01884350|100630545|FG000|STARTED|Primary Efficacy Analysis Set (48 Weeks)||583|Primary Efficacy Analysis Set. 1 completed initial period but was not rand. to 2nd 24-week period|
48125104|NCT01884350|100630546|FG001|STARTED|Primary Efficacy Analysis Set (48 Weeks)||263|Primary Efficacy Analysis Set. 1 completed initial period but was not rand. to 2nd 24-week period|
48125105|NCT01884350|100630547|FG002|STARTED|Primary Efficacy Analysis Set (48 Weeks)||261|Primary Efficacy Analysis Set. 1 completed initial period but was not rand. to 2nd 24-week period|
48700259|NCT03831191|102053956|FG003|NOT COMPLETED|Maintenance Period (36 Weeks)||0||
48700260|NCT03831191|102053957|FG004|NOT COMPLETED|Maintenance Period (36 Weeks)||4||
48282620|NCT00379288|101014343|FG000|COMPLETED|Overall Study||122||
48282621|NCT00379288|101014344|FG001|COMPLETED|Overall Study||108||
48282622|NCT00379288|101014345|FG002|COMPLETED|Overall Study||58||
48125106|NCT01884350|100630545|FG000|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||604|All randomized patients who received any study drug.|
48125107|NCT01884350|100630546|FG001|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||308|All randomized patients who received any study drug.|
48125108|NCT01884350|100630547|FG002|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||223|All randomized patients who received any study drug.|
48125109|NCT01884350|100630545|FG000|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||503||
48125110|NCT01884350|100630546|FG001|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||250||
48125111|NCT01884350|100630547|FG002|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||250||
48282623|NCT00379288|101014346|FG003|COMPLETED|Overall Study||57||
48282624|NCT00379288|101014343|FG000|NOT COMPLETED|Overall Study||19||
48282625|NCT00379288|101014344|FG001|NOT COMPLETED|Overall Study||22||
48570968|NCT01566539|101730892|FG000|STARTED|Main Study Period||101||
48570969|NCT01566539|101730893|FG001|STARTED|Main Study Period||100||
48570970|NCT01566539|101730894|FG002|STARTED|Main Study Period||104||
48570971|NCT01566539|101730895|FG003|STARTED|Main Study Period||0||
48700261|NCT03831191|102053958|FG005|NOT COMPLETED|Maintenance Period (36 Weeks)||5||
48125112|NCT01884350|100630545|FG000|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||80||
48125113|NCT01884350|100630546|FG001|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||13||
48125114|NCT01884350|100630547|FG002|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||11||
48282626|NCT00379288|101014345|FG002|NOT COMPLETED|Overall Study||10||
48282627|NCT00379288|101014346|FG003|NOT COMPLETED|Overall Study||8||
48282628|NCT03248492|101014347|FG000|STARTED|Overall Study||50||
48282629|NCT03248492|101014348|FG001|STARTED|Overall Study||48||
48282630|NCT03248492|101014349|FG002|STARTED|Overall Study||21||
48282631|NCT03248492|101014350|FG003|STARTED|Overall Study||130||
48282632|NCT03248492|101014351|FG004|STARTED|Overall Study||4||
48282633|NCT03248492|101014347|FG000|COMPLETED|Overall Study||0|Data from the Ongoing and Discontinued participants are presented as of data cutoff on 21 March 2019|
48397287|NCT03365947|101302588|FG013|COMPLETED|Overall Study||4||
48570972|NCT01566539|101730896|FG004|STARTED|Main Study Period||40||
48570973|NCT01566539|101730897|FG005|STARTED|Main Study Period||43||
48570974|NCT01566539|101730898|FG006|STARTED|Main Study Period||30||
48570975|NCT01566539|101730899|FG007|STARTED|Main Study Period||30||
48570976|NCT01566539|101730900|FG008|STARTED|Main Study Period||1||
48570977|NCT01566539|101730892|FG000|COMPLETED|Main Study Period||100||
48570978|NCT01566539|101730893|FG001|COMPLETED|Main Study Period||100||
48570979|NCT01566539|101730894|FG002|COMPLETED|Main Study Period||104||
48570980|NCT01566539|101730895|FG003|COMPLETED|Main Study Period||0||
48570981|NCT01566539|101730896|FG004|COMPLETED|Main Study Period||40||
48570982|NCT01566539|101730897|FG005|COMPLETED|Main Study Period||40||
48570983|NCT01566539|101730898|FG006|COMPLETED|Main Study Period||30||
48700262|NCT03831191|102053959|FG006|NOT COMPLETED|Maintenance Period (36 Weeks)||2||
48700263|NCT03831191|102053960|FG007|NOT COMPLETED|Maintenance Period (36 Weeks)||4||
48700264|NCT03831191|102053961|FG008|NOT COMPLETED|Maintenance Period (36 Weeks)||8||
48700265|NCT03831191|102053962|FG009|NOT COMPLETED|Maintenance Period (36 Weeks)||1||
48700266|NCT03831191|102053963|FG010|NOT COMPLETED|Maintenance Period (36 Weeks)||4||
48700267|NCT03831191|102053964|FG011|NOT COMPLETED|Maintenance Period (36 Weeks)||7||
48700268|NCT03831191|102053965|FG012|NOT COMPLETED|Maintenance Period (36 Weeks)||1||
48700269|NCT03831191|102053966|FG013|NOT COMPLETED|Maintenance Period (36 Weeks)||1||
48700270|NCT03831191|102053967|FG014|NOT COMPLETED|Maintenance Period (36 Weeks)||9||
48700271|NCT03831191|102053953|FG000|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700272|NCT03831191|102053954|FG001|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700273|NCT03831191|102053955|FG002|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700274|NCT03831191|102053956|FG003|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700275|NCT03831191|102053957|FG004|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700276|NCT03831191|102053958|FG005|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700277|NCT03831191|102053959|FG006|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700278|NCT03831191|102053960|FG007|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48570984|NCT01566539|101730899|FG007|COMPLETED|Main Study Period||30||
48570985|NCT01566539|101730900|FG008|COMPLETED|Main Study Period||1||
48570986|NCT01566539|101730892|FG000|NOT COMPLETED|Main Study Period||1||
48570987|NCT01566539|101730893|FG001|NOT COMPLETED|Main Study Period||0||
48570988|NCT01566539|101730894|FG002|NOT COMPLETED|Main Study Period||0||
48570989|NCT01566539|101730895|FG003|NOT COMPLETED|Main Study Period||0||
48570990|NCT01566539|101730896|FG004|NOT COMPLETED|Main Study Period||0||
48700279|NCT03831191|102053961|FG008|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700280|NCT03831191|102053962|FG009|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700281|NCT03831191|102053963|FG010|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700282|NCT03831191|102053964|FG011|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700283|NCT03831191|102053965|FG012|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48282634|NCT03248492|101014348|FG001|COMPLETED|Overall Study||0|Data from the Ongoing and Discontinued participants are presented as of data cutoff on 21 March 2019|
48282635|NCT03248492|101014349|FG002|COMPLETED|Overall Study||0|Data from the Ongoing and Discontinued participants are presented as of data cutoff on 21 March 2019|
48700284|NCT03831191|102053966|FG013|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700285|NCT03831191|102053967|FG014|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48282636|NCT03248492|101014350|FG003|COMPLETED|Overall Study||0|Data from the Ongoing and Discontinued participants are presented as of data cutoff on 21 March 2019|
48570991|NCT01566539|101730897|FG005|NOT COMPLETED|Main Study Period||3||
48570992|NCT01566539|101730898|FG006|NOT COMPLETED|Main Study Period||0||
48570993|NCT01566539|101730899|FG007|NOT COMPLETED|Main Study Period||0||
48570994|NCT01566539|101730900|FG008|NOT COMPLETED|Main Study Period||0||
48570995|NCT01566539|101730892|FG000|STARTED|Within Subject Group||0||
48570996|NCT01566539|101730893|FG001|STARTED|Within Subject Group||0||
48570997|NCT01566539|101730894|FG002|STARTED|Within Subject Group||0||
48570998|NCT01566539|101730895|FG003|STARTED|Within Subject Group||156||
48570999|NCT01566539|101730896|FG004|STARTED|Within Subject Group||0||
48571000|NCT01566539|101730897|FG005|STARTED|Within Subject Group||0||
48571001|NCT01566539|101730898|FG006|STARTED|Within Subject Group||0||
48571002|NCT01566539|101730899|FG007|STARTED|Within Subject Group||0||
48571003|NCT01566539|101730900|FG008|STARTED|Within Subject Group||0||
48571004|NCT01566539|101730892|FG000|COMPLETED|Within Subject Group||0||
48571005|NCT01566539|101730893|FG001|COMPLETED|Within Subject Group||0||
48571006|NCT01566539|101730894|FG002|COMPLETED|Within Subject Group||0||
48571007|NCT01566539|101730895|FG003|COMPLETED|Within Subject Group||153||
48571008|NCT01566539|101730896|FG004|COMPLETED|Within Subject Group||0||
48571009|NCT01566539|101730897|FG005|COMPLETED|Within Subject Group||0||
48571010|NCT01566539|101730898|FG006|COMPLETED|Within Subject Group||0||
48571011|NCT01566539|101730899|FG007|COMPLETED|Within Subject Group||0||
48571012|NCT01566539|101730900|FG008|COMPLETED|Within Subject Group||0||
48700286|NCT03831191|102053953|FG000|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700287|NCT03831191|102053954|FG001|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700288|NCT03831191|102053955|FG002|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700289|NCT03831191|102053956|FG003|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700290|NCT03831191|102053957|FG004|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700291|NCT03831191|102053958|FG005|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700292|NCT03831191|102053959|FG006|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700293|NCT03831191|102053960|FG007|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700294|NCT03831191|102053961|FG008|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700295|NCT03831191|102053962|FG009|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700296|NCT03831191|102053963|FG010|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700297|NCT03831191|102053964|FG011|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48571013|NCT01566539|101730892|FG000|NOT COMPLETED|Within Subject Group||0||
48571014|NCT01566539|101730893|FG001|NOT COMPLETED|Within Subject Group||0||
48571015|NCT01566539|101730894|FG002|NOT COMPLETED|Within Subject Group||0||
48282637|NCT03248492|101014351|FG004|COMPLETED|Overall Study||0|Data from the Ongoing and Discontinued participants are presented as of data cutoff on 21 March 2019|
48282638|NCT03248492|101014347|FG000|NOT COMPLETED|Overall Study||50||
48282639|NCT03248492|101014348|FG001|NOT COMPLETED|Overall Study||48||
48282640|NCT03248492|101014349|FG002|NOT COMPLETED|Overall Study||21||
48571016|NCT01566539|101730895|FG003|NOT COMPLETED|Within Subject Group||3||
48571017|NCT01566539|101730896|FG004|NOT COMPLETED|Within Subject Group||0||
48571018|NCT01566539|101730897|FG005|NOT COMPLETED|Within Subject Group||0||
48571019|NCT01566539|101730898|FG006|NOT COMPLETED|Within Subject Group||0||
48571020|NCT01566539|101730899|FG007|NOT COMPLETED|Within Subject Group||0||
48571021|NCT01566539|101730900|FG008|NOT COMPLETED|Within Subject Group||0||
48571022|NCT00302328|101730901|FG000|STARTED|Overall Study||25||
48571023|NCT00302328|101730902|FG001|STARTED|Overall Study||35||
48571024|NCT00302328|101730903|FG002|STARTED|Overall Study||18||
48571025|NCT00302328|101730901|FG000|COMPLETED|Overall Study||25||
48571026|NCT00302328|101730902|FG001|COMPLETED|Overall Study||34||
48571027|NCT00302328|101730903|FG002|COMPLETED|Overall Study||18||
48571028|NCT00302328|101730901|FG000|NOT COMPLETED|Overall Study||0||
48571029|NCT00302328|101730902|FG001|NOT COMPLETED|Overall Study||1||
48571030|NCT00302328|101730903|FG002|NOT COMPLETED|Overall Study||0||
48571031|NCT04138953|101730904|FG000|STARTED|Overall Study||20||
48571032|NCT04138953|101730905|FG001|STARTED|Overall Study||20||
48571033|NCT04138953|101730906|FG002|STARTED|Overall Study||24||
48571034|NCT04138953|101730904|FG000|COMPLETED|Overall Study||20||
48571035|NCT04138953|101730905|FG001|COMPLETED|Overall Study||20||
48571036|NCT04138953|101730906|FG002|COMPLETED|Overall Study||24||
48571037|NCT04138953|101730904|FG000|NOT COMPLETED|Overall Study||0||
48571038|NCT04138953|101730905|FG001|NOT COMPLETED|Overall Study||0||
48571039|NCT04138953|101730906|FG002|NOT COMPLETED|Overall Study||0||
48571040|NCT02476578|101730907|FG000|STARTED|Overall Study||4310||
48571041|NCT02476578|101730908|FG001|STARTED|Overall Study||4274||
48571042|NCT02476578|101730907|FG000|Died Before Email Was Sent|Overall Study||35|Died before 9.11.2015|
48571043|NCT02476578|101730908|FG001|Died Before Email Was Sent|Overall Study||43|Died before 9.11.2015|
48571044|NCT02476578|101730907|FG000|Left Before End of Trial|Overall Study||6|Left district before 9.11.2016|
48571045|NCT02476578|101730908|FG001|Left Before End of Trial|Overall Study||13|Left district before 9.11.2016|
48571046|NCT02476578|101730907|FG000|COMPLETED|Overall Study||4269|Included in final analysis|
48571047|NCT02476578|101730908|FG001|COMPLETED|Overall Study||4218|Included in final analysis|
48571048|NCT02476578|101730907|FG000|NOT COMPLETED|Overall Study||41||
48571049|NCT02476578|101730908|FG001|NOT COMPLETED|Overall Study||56||
48571050|NCT00383760|101730909|FG000|STARTED|Overall Study||15||
48571051|NCT00383760|101730909|FG000|COMPLETED|Overall Study||15||
48571052|NCT00383760|101730909|FG000|NOT COMPLETED|Overall Study||0||
48571053|NCT00833105|101730910|FG000|STARTED|Overall Study||13||
48571054|NCT00833105|101730910|FG000|COMPLETED|Overall Study||10||
48571055|NCT00833105|101730910|FG000|NOT COMPLETED|Overall Study||3||
48571056|NCT04545008|101730911|FG000|STARTED|Overall Study||2||
48571057|NCT04545008|101730911|FG000|COMPLETED|Overall Study||2||
48571058|NCT04545008|101730911|FG000|NOT COMPLETED|Overall Study||0||
48571059|NCT02920008|101730912|FG000|STARTED|Overall Study||148||
48571060|NCT02920008|101730913|FG001|STARTED|Overall Study||154||
48571061|NCT02920008|101730912|FG000|Safety Analysis Set|Overall Study||145|Safety analysis set included data from all participants randomly assigned to study treatment who received any amount of study treatment or any component of a multi-dose study treatment regimen.|
48571062|NCT02920008|101730913|FG001|Safety Analysis Set|Overall Study||147|Safety analysis set included data from all participants randomly assigned to study treatment who received any amount of study treatment or any component of a multi-dose study treatment regimen.|
48571063|NCT02920008|101730912|FG000|COMPLETED|Overall Study||28||
48571064|NCT02920008|101730913|FG001|COMPLETED|Overall Study||20||
48571065|NCT02920008|101730912|FG000|NOT COMPLETED|Overall Study||120||
48571066|NCT02920008|101730913|FG001|NOT COMPLETED|Overall Study||134||
48571067|NCT02743936|101730914|FG000|STARTED|Overall Study||32||
48571068|NCT02743936|101730915|FG001|STARTED|Overall Study||32||
48282641|NCT03248492|101014350|FG003|NOT COMPLETED|Overall Study||130||
48282642|NCT03248492|101014351|FG004|NOT COMPLETED|Overall Study||4||
48282643|NCT05132127|101014352|FG000|STARTED|Overall Study||7||
48282644|NCT05132127|101014352|FG000|COMPLETED|Overall Study||6||
48571069|NCT02743936|101730914|FG000|COMPLETED|Overall Study||32||
48571070|NCT02743936|101730915|FG001|COMPLETED|Overall Study||32||
48571071|NCT02743936|101730914|FG000|NOT COMPLETED|Overall Study||0||
48571072|NCT02743936|101730915|FG001|NOT COMPLETED|Overall Study||0||
48571073|NCT00676364|101730916|FG000|STARTED|Overall Study||57||
48571074|NCT00676364|101730917|FG001|STARTED|Overall Study||57||
48282645|NCT05132127|101014352|FG000|NOT COMPLETED|Overall Study||1||
48282646|NCT04552899|101014353|FG000|STARTED|Overall Study||331||
48282647|NCT04552899|101014354|FG001|STARTED|Overall Study||333||
48282648|NCT04552899|101014353|FG000|No Treatment|Overall Study||1|Participants who were randomized but didn't receive any treatment.|
48282649|NCT04552899|101014354|FG001|No Treatment|Overall Study||3|Participants who were randomized but didn't receive any treatment.|
48282650|NCT04552899|101014353|FG000|COMPLETED|Overall Study||56||
48282651|NCT04552899|101014354|FG001|COMPLETED|Overall Study||49||
48282652|NCT04552899|101014353|FG000|NOT COMPLETED|Overall Study||275||
48282653|NCT04552899|101014354|FG001|NOT COMPLETED|Overall Study||284||
48282654|NCT00439231|101014355|FG000|STARTED|Overall Study||33||
48282655|NCT00439231|101014355|FG000|COMPLETED|Overall Study||5||
48282656|NCT00439231|101014355|FG000|NOT COMPLETED|Overall Study||28||
48282657|NCT02549196|101014356|FG000|STARTED|Overall Study||8||
48282658|NCT02549196|101014357|FG001|STARTED|Overall Study||1||
48282659|NCT02549196|101014358|FG002|STARTED|Overall Study||6||
48397288|NCT03365947|101302589|FG014|COMPLETED|Overall Study||4||
48397289|NCT03365947|101302590|FG015|COMPLETED|Overall Study||4||
48397290|NCT03365947|101302591|FG016|COMPLETED|Overall Study||4||
48397291|NCT03365947|101302592|FG017|COMPLETED|Overall Study||4||
48397292|NCT03365947|101302593|FG018|COMPLETED|Overall Study||12||
48397293|NCT03365947|101302575|FG000|NOT COMPLETED|Overall Study||0||
48397294|NCT03365947|101302576|FG001|NOT COMPLETED|Overall Study||0||
48397295|NCT03365947|101302577|FG002|NOT COMPLETED|Overall Study||0||
48397296|NCT03365947|101302578|FG003|NOT COMPLETED|Overall Study||0||
48397297|NCT03365947|101302579|FG004|NOT COMPLETED|Overall Study||0||
48397298|NCT03365947|101302580|FG005|NOT COMPLETED|Overall Study||1||
48397299|NCT03365947|101302581|FG006|NOT COMPLETED|Overall Study||0||
48397300|NCT03365947|101302582|FG007|NOT COMPLETED|Overall Study||0||
48397301|NCT03365947|101302583|FG008|NOT COMPLETED|Overall Study||0||
48397302|NCT03365947|101302584|FG009|NOT COMPLETED|Overall Study||0||
48397303|NCT03365947|101302585|FG010|NOT COMPLETED|Overall Study||0||
48397304|NCT03365947|101302586|FG011|NOT COMPLETED|Overall Study||0||
48397305|NCT03365947|101302587|FG012|NOT COMPLETED|Overall Study||0||
48397306|NCT03365947|101302588|FG013|NOT COMPLETED|Overall Study||0||
48397307|NCT03365947|101302589|FG014|NOT COMPLETED|Overall Study||0||
48397308|NCT03365947|101302590|FG015|NOT COMPLETED|Overall Study||0||
48397309|NCT03365947|101302591|FG016|NOT COMPLETED|Overall Study||0||
48397310|NCT03365947|101302592|FG017|NOT COMPLETED|Overall Study||0||
48397311|NCT03365947|101302593|FG018|NOT COMPLETED|Overall Study||0||
48397312|NCT01494987|101302594|FG000|STARTED|Overall Study||216||
48397313|NCT01494987|101302595|FG001|STARTED|Overall Study||215||
48397314|NCT01494987|101302594|FG000|COMPLETED|Overall Study||188||
48397315|NCT01494987|101302595|FG001|COMPLETED|Overall Study||187||
48397316|NCT01494987|101302594|FG000|NOT COMPLETED|Overall Study||28||
48397317|NCT01494987|101302595|FG001|NOT COMPLETED|Overall Study||28||
48397318|NCT03383627|101302596|FG000|STARTED|Overall Study||80||
48397319|NCT03383627|101302596|FG000|COMPLETED|Overall Study||80||
48397320|NCT03383627|101302596|FG000|NOT COMPLETED|Overall Study||0||
48397321|NCT03242590|101302597|FG000|STARTED|Overall Study||95||
48397322|NCT03242590|101302597|FG000|COMPLETED|Overall Study||95||
48397323|NCT03242590|101302597|FG000|NOT COMPLETED|Overall Study||0||
48397324|NCT02067533|101302598|FG000|STARTED|Overall Study||45||
48397325|NCT02067533|101302599|FG001|STARTED|Overall Study||46||
48397326|NCT02067533|101302598|FG000|COMPLETED|Overall Study||41||
48397327|NCT02067533|101302599|FG001|COMPLETED|Overall Study||44||
48397328|NCT02067533|101302598|FG000|NOT COMPLETED|Overall Study||4||
48397329|NCT02067533|101302599|FG001|NOT COMPLETED|Overall Study||2||
48397330|NCT03061812|101302600|FG000|STARTED|Overall Study||148||
48397331|NCT03061812|101302601|FG001|STARTED|Overall Study||296||
48397332|NCT03061812|101302600|FG000|COMPLETED|Overall Study||148|Participants who were off study as of 04 December 2019.|
48397333|NCT03061812|101302601|FG001|COMPLETED|Overall Study||296|Participants who were off study as of 04 December 2019.|
48397334|NCT03061812|101302600|FG000|NOT COMPLETED|Overall Study||0||
48397335|NCT03061812|101302601|FG001|NOT COMPLETED|Overall Study||0||
48397336|NCT02267278|101302602|FG000|STARTED|Overall Study||25||
48397337|NCT02267278|101302602|FG000|COMPLETED|Overall Study||20||
48397338|NCT02267278|101302602|FG000|NOT COMPLETED|Overall Study||5||
48397339|NCT00442260|101302603|FG000|STARTED|Overall Study||2||
48397340|NCT00442260|101302603|FG000|COMPLETED|Overall Study||2||
48397341|NCT00442260|101302603|FG000|NOT COMPLETED|Overall Study||0||
48397342|NCT04968353|101302604|FG000|STARTED|Overall Study||20||20
48397343|NCT04968353|101302605|FG001|STARTED|Overall Study||15||15
48397344|NCT04968353|101302606|FG002|STARTED|Overall Study||16||16
48397345|NCT04968353|101302607|FG003|STARTED|Overall Study||22||23
48397346|NCT04968353|101302604|FG000|COMPLETED|Overall Study||19||19
48397347|NCT04968353|101302605|FG001|COMPLETED|Overall Study||15||15
48397348|NCT04968353|101302606|FG002|COMPLETED|Overall Study||14||14
48397349|NCT04968353|101302607|FG003|COMPLETED|Overall Study||22||23
48397350|NCT04968353|101302604|FG000|NOT COMPLETED|Overall Study||1||1
48397351|NCT04968353|101302605|FG001|NOT COMPLETED|Overall Study||0||0
48397352|NCT04968353|101302606|FG002|NOT COMPLETED|Overall Study||2||2
48397353|NCT04968353|101302607|FG003|NOT COMPLETED|Overall Study||0||0
48397354|NCT02088541|101302608|FG000|STARTED|Overall Study||71||
48282660|NCT02549196|101014359|FG003|STARTED|Overall Study||13||
48282661|NCT02549196|101014356|FG000|COMPLETED|Overall Study||7||
48282662|NCT02549196|101014357|FG001|COMPLETED|Overall Study||1||
48282663|NCT02549196|101014358|FG002|COMPLETED|Overall Study||5||
48282664|NCT02549196|101014359|FG003|COMPLETED|Overall Study||12||
48282665|NCT02549196|101014356|FG000|NOT COMPLETED|Overall Study||1||
48282666|NCT02549196|101014357|FG001|NOT COMPLETED|Overall Study||0||
48282667|NCT02549196|101014358|FG002|NOT COMPLETED|Overall Study||1||
48282668|NCT02549196|101014359|FG003|NOT COMPLETED|Overall Study||1||
48282669|NCT01691768|101014360|FG000|STARTED|Overall Study||189||
48282670|NCT01691768|101014361|FG001|STARTED|Overall Study||183||
48282671|NCT01691768|101014360|FG000|COMPLETED|Overall Study||174||
48282672|NCT01691768|101014361|FG001|COMPLETED|Overall Study||167||
48282673|NCT01691768|101014360|FG000|NOT COMPLETED|Overall Study||15||
48282674|NCT01691768|101014361|FG001|NOT COMPLETED|Overall Study||16||
48282675|NCT01605916|101014362|FG000|STARTED|Overall Study||4||
48282676|NCT01605916|101014363|FG001|STARTED|Overall Study||4||
48282677|NCT01605916|101014364|FG002|STARTED|Overall Study||4||
48282678|NCT01605916|101014365|FG003|STARTED|Overall Study||6||
48282679|NCT01605916|101014366|FG004|STARTED|Overall Study||7||
48571075|NCT00676364|101730916|FG000|COMPLETED|Overall Study||57||
48571076|NCT00676364|101730917|FG001|COMPLETED|Overall Study||57||
48571077|NCT00676364|101730916|FG000|NOT COMPLETED|Overall Study||0||
48571078|NCT00676364|101730917|FG001|NOT COMPLETED|Overall Study||0||
48571079|NCT01470248|101730918|FG000|STARTED|Overall Study||20||
48571080|NCT01470248|101730918|FG000|COMPLETED|Overall Study||19||
48571081|NCT01470248|101730918|FG000|NOT COMPLETED|Overall Study||1||
48571082|NCT04557215|101730919|FG000|STARTED|Overall Study||15||
48571083|NCT04557215|101730920|FG001|STARTED|Overall Study||15||
48571084|NCT04557215|101730921|FG002|STARTED|Overall Study||15||
48571085|NCT04557215|101730919|FG000|COMPLETED|Overall Study||15||
48571086|NCT04557215|101730920|FG001|COMPLETED|Overall Study||15||
48571087|NCT04557215|101730921|FG002|COMPLETED|Overall Study||15||
48571088|NCT04557215|101730919|FG000|NOT COMPLETED|Overall Study||0||
48571089|NCT04557215|101730920|FG001|NOT COMPLETED|Overall Study||0||
48571090|NCT04557215|101730921|FG002|NOT COMPLETED|Overall Study||0||
48571091|NCT02915705|101730922|FG000|STARTED|Treatment Period||32||
48571092|NCT02915705|101730923|FG001|STARTED|Treatment Period||29||
48571093|NCT02915705|101730922|FG000|Completed Week 40|Treatment Period||32||
48571094|NCT02915705|101730923|FG001|Completed Week 40|Treatment Period||29||
48571095|NCT02915705|101730922|FG000|Completed Week 64|Treatment Period||32||
48282680|NCT01605916|101014362|FG000|COMPLETED|Overall Study||0||
48282681|NCT01605916|101014363|FG001|COMPLETED|Overall Study||0||
48571096|NCT02915705|101730923|FG001|Completed Week 64|Treatment Period||29||
48571097|NCT02915705|101730922|FG000|COMPLETED|Treatment Period||32||
48571098|NCT02915705|101730923|FG001|COMPLETED|Treatment Period||29||
48282682|NCT01605916|101014364|FG002|COMPLETED|Overall Study||1||
48282683|NCT01605916|101014365|FG003|COMPLETED|Overall Study||0||
48282684|NCT01605916|101014366|FG004|COMPLETED|Overall Study||1||
48282685|NCT01605916|101014362|FG000|NOT COMPLETED|Overall Study||4||
48282686|NCT01605916|101014363|FG001|NOT COMPLETED|Overall Study||4||
48282687|NCT01605916|101014364|FG002|NOT COMPLETED|Overall Study||3||
48282688|NCT01605916|101014365|FG003|NOT COMPLETED|Overall Study||6||
48571099|NCT02915705|101730922|FG000|NOT COMPLETED|Treatment Period||0||
48571100|NCT02915705|101730923|FG001|NOT COMPLETED|Treatment Period||0||
48571101|NCT02915705|101730922|FG000|STARTED|Long Term Extension Period||26||
48571102|NCT02915705|101730923|FG001|STARTED|Long Term Extension Period||25||
48571103|NCT02915705|101730922|FG000|COMPLETED|Long Term Extension Period||26||
48571104|NCT02915705|101730923|FG001|COMPLETED|Long Term Extension Period||25||
48571105|NCT02915705|101730922|FG000|NOT COMPLETED|Long Term Extension Period||0||
48571106|NCT02915705|101730923|FG001|NOT COMPLETED|Long Term Extension Period||0||
48571107|NCT02844933|101730924|FG000|STARTED|Overall Study||4||
48571108|NCT02844933|101730925|FG001|STARTED|Overall Study||3||
48571109|NCT02844933|101730924|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4||
48571110|NCT02844933|101730925|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3||
48571111|NCT02844933|101730924|FG000|COMPLETED|Overall Study||1||
48571112|NCT02844933|101730925|FG001|COMPLETED|Overall Study||1||
48571113|NCT02844933|101730924|FG000|NOT COMPLETED|Overall Study||3||
48571114|NCT02844933|101730925|FG001|NOT COMPLETED|Overall Study||2||
48571115|NCT02215200|101730926|FG000|STARTED|Overall Study||29||
48571116|NCT02215200|101730927|FG001|STARTED|Overall Study||29||
48571117|NCT02215200|101730928|FG002|STARTED|Overall Study||31||
48571118|NCT02215200|101730926|FG000|COMPLETED|Overall Study||29||
48571119|NCT02215200|101730927|FG001|COMPLETED|Overall Study||28||
48571120|NCT02215200|101730928|FG002|COMPLETED|Overall Study||30||
48571121|NCT02215200|101730926|FG000|NOT COMPLETED|Overall Study||0||
48571122|NCT02215200|101730927|FG001|NOT COMPLETED|Overall Study||1||
48571123|NCT02215200|101730928|FG002|NOT COMPLETED|Overall Study||1||
48571124|NCT01209949|101730929|FG000|STARTED|Overall Study||30||
48571125|NCT01209949|101730929|FG000|COMPLETED|Overall Study||27||
48571126|NCT01209949|101730929|FG000|NOT COMPLETED|Overall Study||3||
48571127|NCT00658723|101730930|FG000|STARTED|Overall Study||60||
48571128|NCT00658723|101730931|FG001|STARTED|Overall Study||30||
48571129|NCT00658723|101730932|FG002|STARTED|Overall Study||51||
48571130|NCT00658723|101730930|FG000|COMPLETED|Overall Study||56||
48571131|NCT00658723|101730931|FG001|COMPLETED|Overall Study||26||
48571132|NCT00658723|101730932|FG002|COMPLETED|Overall Study||44||
48571133|NCT00658723|101730930|FG000|NOT COMPLETED|Overall Study||4||
48571134|NCT00658723|101730931|FG001|NOT COMPLETED|Overall Study||4||
48571135|NCT00658723|101730932|FG002|NOT COMPLETED|Overall Study||7||
48571136|NCT03124368|101730933|FG000|STARTED|Overall Study||2||
48571137|NCT03124368|101730934|FG001|STARTED|Overall Study||4||
48571138|NCT03124368|101730933|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2||
48700298|NCT03831191|102053965|FG012|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700299|NCT03831191|102053966|FG013|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700300|NCT03831191|102053967|FG014|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700301|NCT03831191|102053953|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700302|NCT03831191|102053954|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700303|NCT03831191|102053955|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700304|NCT03831191|102053956|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48571139|NCT03124368|101730934|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4||
48571140|NCT03124368|101730933|FG000|COMPLETED|Overall Study||2||
48571141|NCT03124368|101730934|FG001|COMPLETED|Overall Study||4||
48571142|NCT03124368|101730933|FG000|NOT COMPLETED|Overall Study||0||
48571143|NCT03124368|101730934|FG001|NOT COMPLETED|Overall Study||0||
48571144|NCT00291876|101730935|FG000|STARTED|Month 138||107||
48571145|NCT00291876|101730935|FG000|COMPLETED|Month 138||107||
48571146|NCT00291876|101730935|FG000|NOT COMPLETED|Month 138||0||
48571147|NCT00291876|101730935|FG000|STARTED|Month 150||117||
48571148|NCT00291876|101730935|FG000|COMPLETED|Month 150||117||
48571149|NCT00291876|101730935|FG000|NOT COMPLETED|Month 150||0||
48571150|NCT00291876|101730935|FG000|STARTED|Month 162||127||
48571151|NCT00291876|101730935|FG000|COMPLETED|Month 162||127||
48571152|NCT00291876|101730935|FG000|NOT COMPLETED|Month 162||0||
48571153|NCT00291876|101730935|FG000|STARTED|Month 174||127||
48571154|NCT00291876|101730935|FG000|COMPLETED|Month 174||127||
48700305|NCT03831191|102053957|FG004|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700306|NCT03831191|102053958|FG005|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700307|NCT03831191|102053959|FG006|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48571155|NCT00291876|101730935|FG000|NOT COMPLETED|Month 174||0||
48571156|NCT00291876|101730935|FG000|STARTED|Month 186||129||
48571157|NCT00291876|101730935|FG000|COMPLETED|Month 186||129||
48571158|NCT00291876|101730935|FG000|NOT COMPLETED|Month 186||0||
48571159|NCT00291876|101730935|FG000|STARTED|Month 198||135||
48571160|NCT00291876|101730935|FG000|COMPLETED|Month 198||135||
48571161|NCT00291876|101730935|FG000|NOT COMPLETED|Month 198||0||
48571162|NCT00291876|101730935|FG000|STARTED|Month 210||124||
48571163|NCT00291876|101730935|FG000|COMPLETED|Month 210||124||
48571164|NCT00291876|101730935|FG000|NOT COMPLETED|Month 210||0||
48571165|NCT00291876|101730935|FG000|STARTED|Month 222||114||
48571166|NCT00291876|101730935|FG000|COMPLETED|Month 222||114||
48571167|NCT00291876|101730935|FG000|NOT COMPLETED|Month 222||0||
48571168|NCT00291876|101730935|FG000|STARTED|Month 234||110||
48571169|NCT00291876|101730935|FG000|COMPLETED|Month 234||110||
48571170|NCT00291876|101730935|FG000|NOT COMPLETED|Month 234||0||
48571171|NCT00291876|101730935|FG000|STARTED|Month 246||116||
48571172|NCT00291876|101730935|FG000|COMPLETED|Month 246||116||
48571173|NCT00291876|101730935|FG000|NOT COMPLETED|Month 246||0||
48571174|NCT00356603|101730936|FG000|STARTED|Overall Study||39||
48571175|NCT00356603|101730937|FG001|STARTED|Overall Study||36||
48571176|NCT00356603|101730936|FG000|COMPLETED|Overall Study||33||
48571177|NCT00356603|101730937|FG001|COMPLETED|Overall Study||33||
48571178|NCT00356603|101730936|FG000|NOT COMPLETED|Overall Study||6||
48571179|NCT00356603|101730937|FG001|NOT COMPLETED|Overall Study||3||
48571180|NCT00492648|101730938|FG000|STARTED|Month 30 (109671 Study)||4||
48571181|NCT00492648|101730939|FG001|STARTED|Month 30 (109671 Study)||30||
48571182|NCT00492648|101730938|FG000|COMPLETED|Month 30 (109671 Study)||4||
48571183|NCT00492648|101730939|FG001|COMPLETED|Month 30 (109671 Study)||29||
48571184|NCT00492648|101730938|FG000|NOT COMPLETED|Month 30 (109671 Study)||0||
48571185|NCT00492648|101730939|FG001|NOT COMPLETED|Month 30 (109671 Study)||1||
48571186|NCT00492648|101730938|FG000|STARTED|Month 42 (109674 Study)||3||
48571187|NCT00492648|101730939|FG001|STARTED|Month 42 (109674 Study)||20||
48571188|NCT00492648|101730938|FG000|COMPLETED|Month 42 (109674 Study)||3||
48571189|NCT00492648|101730939|FG001|COMPLETED|Month 42 (109674 Study)||20||
48571190|NCT00492648|101730938|FG000|NOT COMPLETED|Month 42 (109674 Study)||0||
48571191|NCT00492648|101730939|FG001|NOT COMPLETED|Month 42 (109674 Study)||0||
48571192|NCT03612596|101730940|FG000|STARTED|0 - 12 Weeks||20||
48571193|NCT03612596|101730941|FG001|STARTED|0 - 12 Weeks||20||
48571194|NCT03612596|101730940|FG000|COMPLETED|0 - 12 Weeks||18||
48571195|NCT03612596|101730941|FG001|COMPLETED|0 - 12 Weeks||19||
48571196|NCT03612596|101730940|FG000|NOT COMPLETED|0 - 12 Weeks||2||
48571197|NCT03612596|101730941|FG001|NOT COMPLETED|0 - 12 Weeks||1||
48571198|NCT03612596|101730940|FG000|STARTED|12 - 24 Weeks||18||
48571199|NCT03612596|101730941|FG001|STARTED|12 - 24 Weeks||19||
48571200|NCT03612596|101730940|FG000|COMPLETED|12 - 24 Weeks||18||
48571201|NCT03612596|101730941|FG001|COMPLETED|12 - 24 Weeks||19||
48571202|NCT03612596|101730940|FG000|NOT COMPLETED|12 - 24 Weeks||0||
48571203|NCT03612596|101730941|FG001|NOT COMPLETED|12 - 24 Weeks||0||
48571204|NCT04632069|101730942|FG000|STARTED|Overall Study||10||
48571205|NCT04632069|101730942|FG000|COMPLETED|Overall Study||10||
48571206|NCT04632069|101730942|FG000|NOT COMPLETED|Overall Study||0||
48571207|NCT01483027|101730943|FG000|STARTED|Overall Study||215||
48571208|NCT01483027|101730944|FG001|STARTED|Overall Study||213||
48571209|NCT01483027|101730943|FG000|COMPLETED|Overall Study||169||
48571210|NCT01483027|101730944|FG001|COMPLETED|Overall Study||153||
48571211|NCT01483027|101730943|FG000|NOT COMPLETED|Overall Study||46||
48571212|NCT01483027|101730944|FG001|NOT COMPLETED|Overall Study||60||
48571213|NCT04074941|101730945|FG000|STARTED|Overall Study||11||
48571214|NCT04074941|101730946|FG001|STARTED|Overall Study||9||
48571215|NCT04074941|101730945|FG000|COMPLETED|Overall Study||11||
48571216|NCT04074941|101730946|FG001|COMPLETED|Overall Study||9||
48571217|NCT04074941|101730945|FG000|NOT COMPLETED|Overall Study||0||
48571218|NCT04074941|101730946|FG001|NOT COMPLETED|Overall Study||0||
48571219|NCT02573181|101730947|FG000|STARTED|Overall Study||127||
48571220|NCT02573181|101730948|FG001|STARTED|Overall Study||126||
48125115|NCT00982319|100630548|FG000|STARTED|Overall Study||17||
48571221|NCT02573181|101730947|FG000|Vaccinated|Overall Study||127||
48571222|NCT02573181|101730948|FG001|Vaccinated|Overall Study||126||
48571223|NCT02573181|101730947|FG000|COMPLETED|Overall Study||127||
48571224|NCT02573181|101730948|FG001|COMPLETED|Overall Study||126||
48571225|NCT02573181|101730947|FG000|NOT COMPLETED|Overall Study||0||
48571226|NCT02573181|101730948|FG001|NOT COMPLETED|Overall Study||0||
48571227|NCT00887575|101730949|FG000|STARTED|Phase I||6||
48571228|NCT00887575|101730950|FG001|STARTED|Phase I||6||
48571229|NCT00887575|101730951|FG002|STARTED|Phase I||3||
48571230|NCT00887575|101730949|FG000|COMPLETED|Phase I||6||
48571231|NCT00887575|101730950|FG001|COMPLETED|Phase I||0||
48125116|NCT00982319|100630549|FG001|STARTED|Overall Study||17||
48571232|NCT00887575|101730951|FG002|COMPLETED|Phase I||0||
48571233|NCT00887575|101730949|FG000|NOT COMPLETED|Phase I||0||
48571234|NCT00887575|101730950|FG001|NOT COMPLETED|Phase I||6||
48571235|NCT00887575|101730951|FG002|NOT COMPLETED|Phase I||3||
48571236|NCT00887575|101730949|FG000|STARTED|Phase II - Neoadjuvant Therapy||41||
48571237|NCT00887575|101730950|FG001|STARTED|Phase II - Neoadjuvant Therapy||0||
48571238|NCT00887575|101730951|FG002|STARTED|Phase II - Neoadjuvant Therapy||0||
48571239|NCT00887575|101730949|FG000|COMPLETED|Phase II - Neoadjuvant Therapy||16||
48571240|NCT00887575|101730950|FG001|COMPLETED|Phase II - Neoadjuvant Therapy||0||
48571241|NCT00887575|101730951|FG002|COMPLETED|Phase II - Neoadjuvant Therapy||0||
48571242|NCT00887575|101730949|FG000|NOT COMPLETED|Phase II - Neoadjuvant Therapy||25||
48571243|NCT00887575|101730950|FG001|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0||
48571244|NCT00887575|101730951|FG002|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0||
48571245|NCT00887575|101730949|FG000|STARTED|Phase II - Maintenance Therapy||8||
48571246|NCT00887575|101730950|FG001|STARTED|Phase II - Maintenance Therapy||0||
48571247|NCT00887575|101730951|FG002|STARTED|Phase II - Maintenance Therapy||0||
48571248|NCT00887575|101730949|FG000|COMPLETED|Phase II - Maintenance Therapy||6||
48571249|NCT00887575|101730950|FG001|COMPLETED|Phase II - Maintenance Therapy||0||
48571250|NCT00887575|101730951|FG002|COMPLETED|Phase II - Maintenance Therapy||0||
48571251|NCT00887575|101730949|FG000|NOT COMPLETED|Phase II - Maintenance Therapy||2||
48571252|NCT00887575|101730950|FG001|NOT COMPLETED|Phase II - Maintenance Therapy||0||
48571253|NCT00887575|101730951|FG002|NOT COMPLETED|Phase II - Maintenance Therapy||0||
48571254|NCT04668248|101730952|FG000|STARTED|Overall Study||24||
48571255|NCT04668248|101730953|FG001|STARTED|Overall Study||23||
48571256|NCT04668248|101730952|FG000|Sick|Overall Study||1||
48571257|NCT04668248|101730953|FG001|Sick|Overall Study||0||
48571258|NCT04668248|101730952|FG000|Schedule Change|Overall Study||4||
48571259|NCT04668248|101730953|FG001|Schedule Change|Overall Study||0||
48571260|NCT04668248|101730952|FG000|Did Not Complete Training in Time|Overall Study||0||
48571261|NCT04668248|101730953|FG001|Did Not Complete Training in Time|Overall Study||2||
48571262|NCT04668248|101730952|FG000|COMPLETED|Overall Study||19||
48571263|NCT04668248|101730953|FG001|COMPLETED|Overall Study||21||
48571264|NCT04668248|101730952|FG000|NOT COMPLETED|Overall Study||5||
48571265|NCT04668248|101730953|FG001|NOT COMPLETED|Overall Study||2||
48571266|NCT02406027|101730954|FG000|STARTED|Double-blind Treatment Phase (Period 1)||35||
48571267|NCT02406027|101730955|FG001|STARTED|Double-blind Treatment Phase (Period 1)||29||
48571268|NCT02406027|101730956|FG002|STARTED|Double-blind Treatment Phase (Period 1)||26||
48571269|NCT02406027|101730957|FG003|STARTED|Double-blind Treatment Phase (Period 1)||0||
48571270|NCT02406027|101730958|FG004|STARTED|Double-blind Treatment Phase (Period 1)||0||
48571271|NCT02406027|101730959|FG005|STARTED|Double-blind Treatment Phase (Period 1)||0||
48571272|NCT02406027|101730960|FG006|STARTED|Double-blind Treatment Phase (Period 1)||0||
48571273|NCT02406027|101730954|FG000|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||6||
48571274|NCT02406027|101730955|FG001|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||8||
48571275|NCT02406027|101730956|FG002|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||6||
48571276|NCT02406027|101730957|FG003|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0||
48571277|NCT02406027|101730958|FG004|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0||
48571278|NCT02406027|101730959|FG005|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0||
48571279|NCT02406027|101730960|FG006|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0||
48571280|NCT02406027|101730954|FG000|Prodromal|Double-blind Treatment Phase (Period 1)||29||
48571281|NCT02406027|101730955|FG001|Prodromal|Double-blind Treatment Phase (Period 1)||21||
48571282|NCT02406027|101730956|FG002|Prodromal|Double-blind Treatment Phase (Period 1)||20||
48571283|NCT02406027|101730957|FG003|Prodromal|Double-blind Treatment Phase (Period 1)||0||
48571284|NCT02406027|101730958|FG004|Prodromal|Double-blind Treatment Phase (Period 1)||0||
48571285|NCT02406027|101730959|FG005|Prodromal|Double-blind Treatment Phase (Period 1)||0||
48571286|NCT02406027|101730960|FG006|Prodromal|Double-blind Treatment Phase (Period 1)||0||
48571287|NCT02406027|101730954|FG000|COMPLETED|Double-blind Treatment Phase (Period 1)||29||
48571288|NCT02406027|101730955|FG001|COMPLETED|Double-blind Treatment Phase (Period 1)||26||
48571289|NCT02406027|101730956|FG002|COMPLETED|Double-blind Treatment Phase (Period 1)||22||
48571290|NCT02406027|101730957|FG003|COMPLETED|Double-blind Treatment Phase (Period 1)||0||
48571291|NCT02406027|101730958|FG004|COMPLETED|Double-blind Treatment Phase (Period 1)||0||
48571292|NCT02406027|101730959|FG005|COMPLETED|Double-blind Treatment Phase (Period 1)||0||
48571293|NCT02406027|101730960|FG006|COMPLETED|Double-blind Treatment Phase (Period 1)||0||
48571294|NCT02406027|101730954|FG000|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||6||
48571295|NCT02406027|101730955|FG001|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||3||
48571296|NCT02406027|101730956|FG002|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||4||
48700308|NCT03831191|102053960|FG007|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700309|NCT03831191|102053961|FG008|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48125117|NCT00982319|100630548|FG000|COMPLETED|Overall Study||15||
48571297|NCT02406027|101730957|FG003|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0||
48571298|NCT02406027|101730958|FG004|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0||
48571299|NCT02406027|101730959|FG005|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0||
48571300|NCT02406027|101730960|FG006|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0||
48700310|NCT03831191|102053962|FG009|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48571301|NCT02406027|101730954|FG000|STARTED|Open-label Phase (Period 2)||0||
48571302|NCT02406027|101730955|FG001|STARTED|Open-label Phase (Period 2)||0||
48571303|NCT02406027|101730956|FG002|STARTED|Open-label Phase (Period 2)||0||
48571304|NCT02406027|101730957|FG003|STARTED|Open-label Phase (Period 2)||15||
48571305|NCT02406027|101730958|FG004|STARTED|Open-label Phase (Period 2)||14||
48282689|NCT01605916|101014366|FG004|NOT COMPLETED|Overall Study||6||
48282690|NCT03223662|101014367|FG000|STARTED|Overall Study||2||
48571306|NCT02406027|101730959|FG005|STARTED|Open-label Phase (Period 2)||26||
48571307|NCT02406027|101730960|FG006|STARTED|Open-label Phase (Period 2)||22||
48571308|NCT02406027|101730954|FG000|COMPLETED|Open-label Phase (Period 2)||0||
48571309|NCT02406027|101730955|FG001|COMPLETED|Open-label Phase (Period 2)||0||
48571310|NCT02406027|101730956|FG002|COMPLETED|Open-label Phase (Period 2)||0||
48571311|NCT02406027|101730957|FG003|COMPLETED|Open-label Phase (Period 2)||0||
48571312|NCT02406027|101730958|FG004|COMPLETED|Open-label Phase (Period 2)||0||
48571313|NCT02406027|101730959|FG005|COMPLETED|Open-label Phase (Period 2)||0||
48571314|NCT02406027|101730960|FG006|COMPLETED|Open-label Phase (Period 2)||0||
48571315|NCT02406027|101730954|FG000|NOT COMPLETED|Open-label Phase (Period 2)||0||
48571316|NCT02406027|101730955|FG001|NOT COMPLETED|Open-label Phase (Period 2)||0||
48571317|NCT02406027|101730956|FG002|NOT COMPLETED|Open-label Phase (Period 2)||0||
48571318|NCT02406027|101730957|FG003|NOT COMPLETED|Open-label Phase (Period 2)||15||
48571319|NCT02406027|101730958|FG004|NOT COMPLETED|Open-label Phase (Period 2)||14||
48571320|NCT02406027|101730959|FG005|NOT COMPLETED|Open-label Phase (Period 2)||26||
48571321|NCT02406027|101730960|FG006|NOT COMPLETED|Open-label Phase (Period 2)||22||
48571322|NCT00382200|101730961|FG000|STARTED|Overall Study||5||
48571323|NCT00382200|101730962|FG001|STARTED|Overall Study||14||
48571324|NCT00382200|101730963|FG002|STARTED|Overall Study||7||
48571325|NCT00382200|101730964|FG003|STARTED|Overall Study||28||
48571326|NCT00382200|101730961|FG000|COMPLETED|Overall Study||5||
48571327|NCT00382200|101730962|FG001|COMPLETED|Overall Study||14||
48571328|NCT00382200|101730963|FG002|COMPLETED|Overall Study||7||
48571329|NCT00382200|101730964|FG003|COMPLETED|Overall Study||28||
48571330|NCT00382200|101730961|FG000|NOT COMPLETED|Overall Study||0||
48571331|NCT00382200|101730962|FG001|NOT COMPLETED|Overall Study||0||
48571332|NCT00382200|101730963|FG002|NOT COMPLETED|Overall Study||0||
48571333|NCT00382200|101730964|FG003|NOT COMPLETED|Overall Study||0||
48571334|NCT04463251|101730965|FG000|STARTED|Overall Study||34||
48282691|NCT03223662|101014367|FG000|COMPLETED|Overall Study||0||
48282692|NCT03223662|101014367|FG000|NOT COMPLETED|Overall Study||2||
48571335|NCT04463251|101730966|FG001|STARTED|Overall Study||34||
48571336|NCT04463251|101730967|FG002|STARTED|Overall Study||34||
48571337|NCT04463251|101730965|FG000|Safety Set|Overall Study||34||
48571338|NCT04463251|101730966|FG001|Safety Set|Overall Study||34||
48571339|NCT04463251|101730967|FG002|Safety Set|Overall Study||34||
48571340|NCT04463251|101730965|FG000|Full Analysis Set|Overall Study||34|One patient in the Placebo arm was excluded from FAS population due to absence of High-sensitivity C-reactive protein (hsCRP) baseline measurement (the central laboratory was notable to perform an assay due to hemolysis)|
48282693|NCT03149809|101014368|FG000|STARTED|Overall Study||36||
48282694|NCT03149809|101014369|FG001|STARTED|Overall Study||41||
48571341|NCT04463251|101730966|FG001|Full Analysis Set|Overall Study||34|One patient in the Placebo arm was excluded from FAS population due to absence of High-sensitivity C-reactive protein (hsCRP) baseline measurement (the central laboratory was notable to perform an assay due to hemolysis)|
48571342|NCT04463251|101730967|FG002|Full Analysis Set|Overall Study||33|One patient in the Placebo arm was excluded from FAS population due to absence of High-sensitivity C-reactive protein (hsCRP) baseline measurement (the central laboratory was notable to perform an assay due to hemolysis)|
48571343|NCT04463251|101730965|FG000|Per Protocol Set|Overall Study||30||
48571344|NCT04463251|101730966|FG001|Per Protocol Set|Overall Study||31||
48571345|NCT04463251|101730967|FG002|Per Protocol Set|Overall Study||31||
48571346|NCT04463251|101730965|FG000|Completed the Study Per Protocol|Overall Study||33||
48571347|NCT04463251|101730966|FG001|Completed the Study Per Protocol|Overall Study||30||
48571348|NCT04463251|101730967|FG002|Completed the Study Per Protocol|Overall Study||31||
48571349|NCT04463251|101730965|FG000|COMPLETED|Overall Study||33||
48571350|NCT04463251|101730966|FG001|COMPLETED|Overall Study||30||
48571351|NCT04463251|101730967|FG002|COMPLETED|Overall Study||31||
48571352|NCT04463251|101730965|FG000|NOT COMPLETED|Overall Study||1||
48571353|NCT04463251|101730966|FG001|NOT COMPLETED|Overall Study||4||
48571354|NCT04463251|101730967|FG002|NOT COMPLETED|Overall Study||3||
48571355|NCT01624740|101730968|FG000|STARTED|First Intervention (3-4 Days)||9||
48571356|NCT01624740|101730969|FG001|STARTED|First Intervention (3-4 Days)||9||
48571357|NCT01624740|101730968|FG000|COMPLETED|First Intervention (3-4 Days)||9||
48571358|NCT01624740|101730969|FG001|COMPLETED|First Intervention (3-4 Days)||9||
48571359|NCT01624740|101730968|FG000|NOT COMPLETED|First Intervention (3-4 Days)||0||
48571360|NCT01624740|101730969|FG001|NOT COMPLETED|First Intervention (3-4 Days)||0||
48571361|NCT01624740|101730968|FG000|STARTED|Washout (1 Hour)||9||
48571362|NCT01624740|101730969|FG001|STARTED|Washout (1 Hour)||9||
48571363|NCT01624740|101730968|FG000|COMPLETED|Washout (1 Hour)||9||
48571364|NCT01624740|101730969|FG001|COMPLETED|Washout (1 Hour)||9||
48571365|NCT01624740|101730968|FG000|NOT COMPLETED|Washout (1 Hour)||0||
48571366|NCT01624740|101730969|FG001|NOT COMPLETED|Washout (1 Hour)||0||
48571367|NCT01624740|101730968|FG000|STARTED|Second Intervention (3-4 Days)||9||
48571368|NCT01624740|101730969|FG001|STARTED|Second Intervention (3-4 Days)||9||
48571369|NCT01624740|101730968|FG000|COMPLETED|Second Intervention (3-4 Days)||8||
48571370|NCT01624740|101730969|FG001|COMPLETED|Second Intervention (3-4 Days)||9||
48571371|NCT01624740|101730968|FG000|NOT COMPLETED|Second Intervention (3-4 Days)||1||
48571372|NCT01624740|101730969|FG001|NOT COMPLETED|Second Intervention (3-4 Days)||0||
48571373|NCT03291431|101730970|FG000|STARTED|Overall Study||8||
48571374|NCT03291431|101730971|FG001|STARTED|Overall Study||9||
48571375|NCT03291431|101730970|FG000|COMPLETED|Overall Study||5||
48571376|NCT03291431|101730971|FG001|COMPLETED|Overall Study||7||
48571377|NCT03291431|101730970|FG000|NOT COMPLETED|Overall Study||3||
48571378|NCT03291431|101730971|FG001|NOT COMPLETED|Overall Study||2||
48571379|NCT01605552|101730972|FG000|STARTED|Overall Study||13||
48571380|NCT01605552|101730973|FG001|STARTED|Overall Study||16||
48571381|NCT01605552|101730972|FG000|COMPLETED|Overall Study||7||
48571382|NCT01605552|101730973|FG001|COMPLETED|Overall Study||14||
48571383|NCT01605552|101730972|FG000|NOT COMPLETED|Overall Study||6||
48571384|NCT01605552|101730973|FG001|NOT COMPLETED|Overall Study||2||
48571385|NCT01068678|101730974|FG000|STARTED|Overall Study||230||
48571386|NCT01068678|101730975|FG001|STARTED|Overall Study||230||
48571387|NCT01068678|101730974|FG000|Exposed|Overall Study||227||
48571388|NCT01068678|101730975|FG001|Exposed|Overall Study||229||
48571389|NCT01068678|101730974|FG000|COMPLETED|Overall Study||192||
48571390|NCT01068678|101730975|FG001|COMPLETED|Overall Study||206||
48571391|NCT01068678|101730974|FG000|NOT COMPLETED|Overall Study||38||
48571392|NCT01068678|101730975|FG001|NOT COMPLETED|Overall Study||24||
48571393|NCT01754129|101730976|FG000|STARTED|Overall Study||148||
48571394|NCT01754129|101730976|FG000|Visit 1 (Enrollment Day)|Overall Study||145||
48571395|NCT01754129|101730976|FG000|Visit 2 (Year 1)|Overall Study||129||
48571396|NCT01754129|101730976|FG000|Visit 3 (Year 2)|Overall Study||115||
48571397|NCT01754129|101730976|FG000|COMPLETED|Overall Study||115||
48571398|NCT01754129|101730976|FG000|NOT COMPLETED|Overall Study||33||
48282695|NCT03149809|101014368|FG000|COMPLETED|Overall Study||36||
48700311|NCT03831191|102053963|FG010|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700312|NCT03831191|102053964|FG011|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700313|NCT03831191|102053965|FG012|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700314|NCT03831191|102053966|FG013|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48282696|NCT03149809|101014369|FG001|COMPLETED|Overall Study||37||
48282697|NCT03149809|101014368|FG000|NOT COMPLETED|Overall Study||0||
48282698|NCT03149809|101014369|FG001|NOT COMPLETED|Overall Study||4||
48282699|NCT01145898|101014370|FG000|STARTED|6-month Treatment||12||
48571399|NCT00347009|101730977|FG000|STARTED|Overall Study||155||
48571400|NCT00347009|101730977|FG000|COMPLETED|Overall Study||128||
48282700|NCT01145898|101014371|FG001|STARTED|6-month Treatment||44||
48282701|NCT01145898|101014370|FG000|COMPLETED|6-month Treatment||12||
48282702|NCT01145898|101014371|FG001|COMPLETED|6-month Treatment||44||
48571401|NCT00347009|101730977|FG000|NOT COMPLETED|Overall Study||27||
48571402|NCT01208974|101730978|FG000|STARTED|NAC-Sparing Mastectomy||21||
48571403|NCT01208974|101730979|FG001|STARTED|NAC-Sparing Mastectomy||0||
48571404|NCT01208974|101730980|FG002|STARTED|NAC-Sparing Mastectomy||0||
48571405|NCT01208974|101730981|FG003|STARTED|NAC-Sparing Mastectomy||0||
48571406|NCT01208974|101730978|FG000|COMPLETED|NAC-Sparing Mastectomy||21||
48571407|NCT01208974|101730979|FG001|COMPLETED|NAC-Sparing Mastectomy||0||
48282703|NCT01145898|101014370|FG000|NOT COMPLETED|6-month Treatment||0||
48571408|NCT01208974|101730980|FG002|COMPLETED|NAC-Sparing Mastectomy||0||
48571409|NCT01208974|101730981|FG003|COMPLETED|NAC-Sparing Mastectomy||0||
48282704|NCT01145898|101014371|FG001|NOT COMPLETED|6-month Treatment||0||
48571410|NCT01208974|101730978|FG000|NOT COMPLETED|NAC-Sparing Mastectomy||0||
48571411|NCT01208974|101730979|FG001|NOT COMPLETED|NAC-Sparing Mastectomy||0||
48571412|NCT01208974|101730980|FG002|NOT COMPLETED|NAC-Sparing Mastectomy||0||
48571413|NCT01208974|101730981|FG003|NOT COMPLETED|NAC-Sparing Mastectomy||0||
48571414|NCT01208974|101730978|FG000|STARTED|Post-Mastectomy Period (Weeks 1 to 4)||21||
48571415|NCT01208974|101730979|FG001|STARTED|Post-Mastectomy Period (Weeks 1 to 4)||0||
48571416|NCT01208974|101730980|FG002|STARTED|Post-Mastectomy Period (Weeks 1 to 4)||0||
48571417|NCT01208974|101730981|FG003|STARTED|Post-Mastectomy Period (Weeks 1 to 4)||0||
48571418|NCT01208974|101730978|FG000|COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||18||
48571419|NCT01208974|101730979|FG001|COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0||
48571420|NCT01208974|101730980|FG002|COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0||
48571421|NCT01208974|101730981|FG003|COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0||
48571422|NCT01208974|101730978|FG000|NOT COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||3||
48571423|NCT01208974|101730979|FG001|NOT COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0||
48571424|NCT01208974|101730980|FG002|NOT COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0||
48571425|NCT01208974|101730981|FG003|NOT COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0||
48571426|NCT01208974|101730978|FG000|STARTED|Prophylactic NAC RT (Weeks 5 to 8)||0||
48571427|NCT01208974|101730979|FG001|STARTED|Prophylactic NAC RT (Weeks 5 to 8)||6||
48571428|NCT01208974|101730980|FG002|STARTED|Prophylactic NAC RT (Weeks 5 to 8)||6||
48571429|NCT01208974|101730981|FG003|STARTED|Prophylactic NAC RT (Weeks 5 to 8)||6||
48571430|NCT01208974|101730978|FG000|Cohort 1: Starting Dose|Prophylactic NAC RT (Weeks 5 to 8)||0||
48571431|NCT01208974|101730979|FG001|Cohort 1: Starting Dose|Prophylactic NAC RT (Weeks 5 to 8)||6||
48571432|NCT01208974|101730980|FG002|Cohort 1: Starting Dose|Prophylactic NAC RT (Weeks 5 to 8)||0||
48571433|NCT01208974|101730981|FG003|Cohort 1: Starting Dose|Prophylactic NAC RT (Weeks 5 to 8)||0||
48571434|NCT01208974|101730978|FG000|Cohort 2: 1st Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0||
48571435|NCT01208974|101730979|FG001|Cohort 2: 1st Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0||
48571436|NCT01208974|101730980|FG002|Cohort 2: 1st Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||6||
48571437|NCT01208974|101730981|FG003|Cohort 2: 1st Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0||
48571438|NCT01208974|101730978|FG000|Cohort 3: 2nd Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0||
48571439|NCT01208974|101730979|FG001|Cohort 3: 2nd Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0||
48571440|NCT01208974|101730980|FG002|Cohort 3: 2nd Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0||
48571441|NCT01208974|101730981|FG003|Cohort 3: 2nd Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||6||
48571442|NCT01208974|101730978|FG000|COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0||
48571443|NCT01208974|101730979|FG001|COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||6||
48571444|NCT01208974|101730980|FG002|COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||6||
48571445|NCT01208974|101730981|FG003|COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||6||
48571446|NCT01208974|101730978|FG000|NOT COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0||
48571447|NCT01208974|101730979|FG001|NOT COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0||
48571448|NCT01208974|101730980|FG002|NOT COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0||
48571449|NCT01208974|101730981|FG003|NOT COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0||
48571450|NCT02739789|101730982|FG000|STARTED|First fMRI Scan||9||
48571451|NCT02739789|101730983|FG001|STARTED|First fMRI Scan||10||
48571452|NCT02739789|101730982|FG000|COMPLETED|First fMRI Scan||9||
48571453|NCT02739789|101730983|FG001|COMPLETED|First fMRI Scan||10||
48571454|NCT02739789|101730982|FG000|NOT COMPLETED|First fMRI Scan||0||
48571455|NCT02739789|101730983|FG001|NOT COMPLETED|First fMRI Scan||0||
48571456|NCT02739789|101730982|FG000|STARTED|~1 Week Waiting Period||9||
48571457|NCT02739789|101730983|FG001|STARTED|~1 Week Waiting Period||10||
48571458|NCT02739789|101730982|FG000|COMPLETED|~1 Week Waiting Period||9||
48571459|NCT02739789|101730983|FG001|COMPLETED|~1 Week Waiting Period||7||
48571460|NCT02739789|101730982|FG000|NOT COMPLETED|~1 Week Waiting Period||0||
48571461|NCT02739789|101730983|FG001|NOT COMPLETED|~1 Week Waiting Period||3||
48571462|NCT02739789|101730982|FG000|STARTED|Second fMRI Scan||9||
48571463|NCT02739789|101730983|FG001|STARTED|Second fMRI Scan||7||
48571464|NCT02739789|101730982|FG000|COMPLETED|Second fMRI Scan||9||
48571465|NCT02739789|101730983|FG001|COMPLETED|Second fMRI Scan||7||
48571466|NCT02739789|101730982|FG000|NOT COMPLETED|Second fMRI Scan||0||
48571467|NCT02739789|101730983|FG001|NOT COMPLETED|Second fMRI Scan||0||
48571468|NCT00282113|101730984|FG000|STARTED|Overall Study||31||
48571469|NCT00282113|101730985|FG001|STARTED|Overall Study||30||
48571470|NCT00282113|101730986|FG002|STARTED|Overall Study||29||
48571471|NCT00282113|101730984|FG000|COMPLETED|Overall Study||30||
48571472|NCT00282113|101730985|FG001|COMPLETED|Overall Study||30||
48571473|NCT00282113|101730986|FG002|COMPLETED|Overall Study||29||
48571474|NCT00282113|101730984|FG000|NOT COMPLETED|Overall Study||1||
48571475|NCT00282113|101730985|FG001|NOT COMPLETED|Overall Study||0||
48571476|NCT00282113|101730986|FG002|NOT COMPLETED|Overall Study||0||
48571477|NCT03635515|101730987|FG000|STARTED|Overall Study||44||
48571478|NCT03635515|101730988|FG001|STARTED|Overall Study||43||
48571479|NCT03635515|101730987|FG000|COMPLETED|Overall Study||38||
48571480|NCT03635515|101730988|FG001|COMPLETED|Overall Study||38||
48571481|NCT03635515|101730987|FG000|NOT COMPLETED|Overall Study||6||
48571482|NCT03635515|101730988|FG001|NOT COMPLETED|Overall Study||5||
48571483|NCT00406367|101730989|FG000|STARTED|Main Period - 6 to 20 Weeks||75||
48571484|NCT00406367|101730990|FG001|STARTED|Main Period - 6 to 20 Weeks||34||
48571485|NCT00406367|101730989|FG000|COMPLETED|Main Period - 6 to 20 Weeks||70||
48125118|NCT00982319|100630549|FG001|COMPLETED|Overall Study||15||
48125119|NCT00982319|100630548|FG000|NOT COMPLETED|Overall Study||2||
48125120|NCT00982319|100630549|FG001|NOT COMPLETED|Overall Study||2||
48125121|NCT00499369|100630550|FG000|STARTED|Overall Study||16||
48125122|NCT00499369|100630551|FG001|STARTED|Overall Study||18||
48125123|NCT00499369|100630552|FG002|STARTED|Overall Study||17||
48125124|NCT00499369|100630553|FG003|STARTED|Overall Study||9||
48125125|NCT00499369|100630554|FG004|STARTED|Overall Study||12||
48125126|NCT00499369|100630550|FG000|Eligible|Overall Study||14||
48125127|NCT00499369|100630551|FG001|Eligible|Overall Study||16||
48125128|NCT00499369|100630552|FG002|Eligible|Overall Study||16||
48125129|NCT00499369|100630553|FG003|Eligible|Overall Study||8||
48125130|NCT00499369|100630554|FG004|Eligible|Overall Study||12||
48125131|NCT00499369|100630550|FG000|COMPLETED|Overall Study||0||
48125132|NCT00499369|100630551|FG001|COMPLETED|Overall Study||0||
48125133|NCT00499369|100630552|FG002|COMPLETED|Overall Study||0||
48125134|NCT00499369|100630553|FG003|COMPLETED|Overall Study||0||
48125135|NCT00499369|100630554|FG004|COMPLETED|Overall Study||0||
48125136|NCT00499369|100630550|FG000|NOT COMPLETED|Overall Study||16||
48125137|NCT00499369|100630551|FG001|NOT COMPLETED|Overall Study||18||
48125138|NCT00499369|100630552|FG002|NOT COMPLETED|Overall Study||17||
48125139|NCT00499369|100630553|FG003|NOT COMPLETED|Overall Study||9||
48125140|NCT00499369|100630554|FG004|NOT COMPLETED|Overall Study||12||
48125141|NCT03728582|100630555|FG000|STARTED|Intervention Period 1 (up to 6 Weeks)||3||
48125142|NCT03728582|100630556|FG001|STARTED|Intervention Period 1 (up to 6 Weeks)||5||
48125143|NCT03728582|100630555|FG000|COMPLETED|Intervention Period 1 (up to 6 Weeks)||3||
48125144|NCT03728582|100630556|FG001|COMPLETED|Intervention Period 1 (up to 6 Weeks)||4||
48125145|NCT03728582|100630555|FG000|NOT COMPLETED|Intervention Period 1 (up to 6 Weeks)||0||
48125146|NCT03728582|100630556|FG001|NOT COMPLETED|Intervention Period 1 (up to 6 Weeks)||1||
48571486|NCT00406367|101730990|FG001|COMPLETED|Main Period - 6 to 20 Weeks||32||
48571487|NCT00406367|101730989|FG000|NOT COMPLETED|Main Period - 6 to 20 Weeks||5||
48571488|NCT00406367|101730990|FG001|NOT COMPLETED|Main Period - 6 to 20 Weeks||2||
48571489|NCT00406367|101730989|FG000|STARTED|Open-Label Ext. Period - up to 68 Weeks||102||
48571490|NCT00406367|101730990|FG001|STARTED|Open-Label Ext. Period - up to 68 Weeks||0||
48571491|NCT00406367|101730989|FG000|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||82||
48571492|NCT00406367|101730990|FG001|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0||
48571493|NCT00406367|101730989|FG000|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||20||
48571494|NCT00406367|101730990|FG001|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0||
48125147|NCT03728582|100630555|FG000|STARTED|Washout (8 Weeks)||3||
48125148|NCT03728582|100630556|FG001|STARTED|Washout (8 Weeks)||4||
48125149|NCT03728582|100630555|FG000|COMPLETED|Washout (8 Weeks)||2||
48125150|NCT03728582|100630556|FG001|COMPLETED|Washout (8 Weeks)||4||
48125151|NCT03728582|100630555|FG000|NOT COMPLETED|Washout (8 Weeks)||1||
48125152|NCT03728582|100630556|FG001|NOT COMPLETED|Washout (8 Weeks)||0||
48571495|NCT06110494|101730991|FG000|STARTED|Overall Study||11||11
48700315|NCT03831191|102053967|FG014|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
48700316|NCT01687088|102053968|FG000|STARTED|Overall Study||50||
48700317|NCT01687088|102053969|FG001|STARTED|Overall Study||50||
48700318|NCT01687088|102053968|FG000|COMPLETED|Overall Study||50||
48700319|NCT01687088|102053969|FG001|COMPLETED|Overall Study||50||
48700320|NCT01687088|102053968|FG000|NOT COMPLETED|Overall Study||0||
48125153|NCT03728582|100630555|FG000|STARTED|Intervention Period 2 (Up to 6 Weeks)||2||
48571496|NCT06110494|101730992|FG001|STARTED|Overall Study||11||11
48571497|NCT06110494|101730993|FG002|STARTED|Overall Study||10||10
48571498|NCT06110494|101730991|FG000|COMPLETED|Overall Study||8||8
48700321|NCT01687088|102053969|FG001|NOT COMPLETED|Overall Study||0||
48125154|NCT03728582|100630556|FG001|STARTED|Intervention Period 2 (Up to 6 Weeks)||4||
48125155|NCT03728582|100630555|FG000|COMPLETED|Intervention Period 2 (Up to 6 Weeks)||2||
48125156|NCT03728582|100630556|FG001|COMPLETED|Intervention Period 2 (Up to 6 Weeks)||4||
48125157|NCT03728582|100630555|FG000|NOT COMPLETED|Intervention Period 2 (Up to 6 Weeks)||0||
48125158|NCT03728582|100630556|FG001|NOT COMPLETED|Intervention Period 2 (Up to 6 Weeks)||0||
48125159|NCT01326780|100630557|FG000|STARTED|Overall Study||106||
48125160|NCT01326780|100630558|FG001|STARTED|Overall Study||109||
48571499|NCT06110494|101730992|FG001|COMPLETED|Overall Study||10||10
48571500|NCT06110494|101730993|FG002|COMPLETED|Overall Study||9||9
48571501|NCT06110494|101730991|FG000|NOT COMPLETED|Overall Study||3||3
48571502|NCT06110494|101730992|FG001|NOT COMPLETED|Overall Study||1||1
48571503|NCT06110494|101730993|FG002|NOT COMPLETED|Overall Study||1||1
48700322|NCT03070171|102053970|FG000|STARTED|Treatment Period 1 + Washout||80||
48125161|NCT01326780|100630559|FG002|STARTED|Overall Study||109||
48125162|NCT01326780|100630560|FG003|STARTED|Overall Study||107||
48125163|NCT01326780|100630557|FG000|COMPLETED|Overall Study||93||
48125164|NCT01326780|100630558|FG001|COMPLETED|Overall Study||100||
48125165|NCT01326780|100630559|FG002|COMPLETED|Overall Study||103||
48125166|NCT01326780|100630560|FG003|COMPLETED|Overall Study||94||
48125167|NCT01326780|100630557|FG000|NOT COMPLETED|Overall Study||13||
48125168|NCT01326780|100630558|FG001|NOT COMPLETED|Overall Study||9||
48125169|NCT01326780|100630559|FG002|NOT COMPLETED|Overall Study||6||
48125170|NCT01326780|100630560|FG003|NOT COMPLETED|Overall Study||13||
48125171|NCT03653429|100630561|FG000|STARTED|Overall Study||49||
48125172|NCT03653429|100630562|FG001|STARTED|Overall Study||51||
48125173|NCT03653429|100630561|FG000|COMPLETED|Overall Study||45||
48125174|NCT03653429|100630562|FG001|COMPLETED|Overall Study||41||
48125175|NCT03653429|100630561|FG000|NOT COMPLETED|Overall Study||4||
48125176|NCT03653429|100630562|FG001|NOT COMPLETED|Overall Study||10||
48125177|NCT00765245|100630563|FG000|STARTED|Overall Study||22||
48125178|NCT00765245|100630564|FG001|STARTED|Overall Study||22||
48125179|NCT00765245|100630563|FG000|COMPLETED|Overall Study||9||
48125180|NCT00765245|100630564|FG001|COMPLETED|Overall Study||20||
48125181|NCT00765245|100630563|FG000|NOT COMPLETED|Overall Study||13||
48700323|NCT03070171|102053971|FG001|STARTED|Treatment Period 1 + Washout||80||
48700324|NCT03070171|102053970|FG000|COMPLETED|Treatment Period 1 + Washout||80||
48700325|NCT03070171|102053971|FG001|COMPLETED|Treatment Period 1 + Washout||80||
48700326|NCT03070171|102053970|FG000|NOT COMPLETED|Treatment Period 1 + Washout||0||
48700327|NCT03070171|102053971|FG001|NOT COMPLETED|Treatment Period 1 + Washout||0||
48125182|NCT00765245|100630564|FG001|NOT COMPLETED|Overall Study||2||
48125183|NCT01643473|100630565|FG000|STARTED|Overall Study||21||
48125184|NCT01643473|100630566|FG001|STARTED|Overall Study||21||
48125185|NCT01643473|100630565|FG000|COMPLETED|Overall Study||20||
48125186|NCT01643473|100630566|FG001|COMPLETED|Overall Study||21||
48125187|NCT01643473|100630565|FG000|NOT COMPLETED|Overall Study||1||
48125188|NCT01643473|100630566|FG001|NOT COMPLETED|Overall Study||0||
48125189|NCT00377676|100630567|FG000|STARTED|Overall Study||2054||
48125190|NCT00377676|100630568|FG001|STARTED|Overall Study||1016||
48125191|NCT00377676|100630567|FG000|COMPLETED|Overall Study||1093||
48125192|NCT00377676|100630568|FG001|COMPLETED|Overall Study||694||
48125193|NCT00377676|100630567|FG000|NOT COMPLETED|Overall Study||961||
48125194|NCT00377676|100630568|FG001|NOT COMPLETED|Overall Study||322||
48125195|NCT02595684|100630569|FG000|STARTED|Overall Study||9||
48125196|NCT02595684|100630570|FG001|STARTED|Overall Study||9||
48125197|NCT02595684|100630569|FG000|COMPLETED|Overall Study||9||
48125198|NCT02595684|100630570|FG001|COMPLETED|Overall Study||9||
48125199|NCT02595684|100630569|FG000|NOT COMPLETED|Overall Study||0||
48125200|NCT02595684|100630570|FG001|NOT COMPLETED|Overall Study||0||
48125201|NCT02838420|100630571|FG000|STARTED|Overall Study||125||
48125202|NCT02838420|100630572|FG001|STARTED|Overall Study||62||
48125203|NCT02838420|100630571|FG000|COMPLETED|Overall Study||0||
48125204|NCT02838420|100630572|FG001|COMPLETED|Overall Study||0||
48125205|NCT02838420|100630571|FG000|NOT COMPLETED|Overall Study||125||
48125206|NCT02838420|100630572|FG001|NOT COMPLETED|Overall Study||62||
48125207|NCT01813019|100630573|FG000|STARTED|Overall Study||24||
48125208|NCT01813019|100630574|FG001|STARTED|Overall Study||26||
48125209|NCT01813019|100630573|FG000|COMPLETED|Overall Study||17||
48125210|NCT01813019|100630574|FG001|COMPLETED|Overall Study||20||
48125211|NCT01813019|100630573|FG000|NOT COMPLETED|Overall Study||7||
48125212|NCT01813019|100630574|FG001|NOT COMPLETED|Overall Study||6||
48125213|NCT03598998|100630575|FG000|STARTED|Overall Study||7||
48125214|NCT03598998|100630576|FG001|STARTED|Overall Study||6||
48125215|NCT03598998|100630575|FG000|COMPLETED|Overall Study||7||
48125216|NCT03598998|100630576|FG001|COMPLETED|Overall Study||6||
48700328|NCT03070171|102053970|FG000|STARTED|Treatment Period 2 + Washout||80||
48700329|NCT03070171|102053971|FG001|STARTED|Treatment Period 2 + Washout||80||
48700330|NCT03070171|102053970|FG000|COMPLETED|Treatment Period 2 + Washout||80||
48700331|NCT03070171|102053971|FG001|COMPLETED|Treatment Period 2 + Washout||79||
48125217|NCT03598998|100630575|FG000|NOT COMPLETED|Overall Study||0||
48125218|NCT03598998|100630576|FG001|NOT COMPLETED|Overall Study||0||
48125219|NCT02144675|100630577|FG000|STARTED|Overall Study||13||
48125220|NCT02144675|100630578|FG001|STARTED|Overall Study||14||
48125221|NCT02144675|100630577|FG000|COMPLETED|Overall Study||13||
48125222|NCT02144675|100630578|FG001|COMPLETED|Overall Study||14||
48125223|NCT02144675|100630577|FG000|NOT COMPLETED|Overall Study||0||
48282705|NCT01145898|101014370|FG000|STARTED|3-year Treatment||12||
48125224|NCT02144675|100630578|FG001|NOT COMPLETED|Overall Study||0||
48125225|NCT02199691|100630579|FG000|STARTED|Overall Study||505||
48125226|NCT02199691|100630580|FG001|STARTED|Overall Study||507||
48125227|NCT02199691|100630581|FG002|STARTED|Overall Study||403||
48125228|NCT02199691|100630582|FG003|STARTED|Overall Study||300||
48125229|NCT02199691|100630579|FG000|Safety Analysis Set (SafAS)|Overall Study||503|SafAS:participants who received at least 1 dose of study vaccine(s) \& had any safety data available.|
48125230|NCT02199691|100630580|FG001|Safety Analysis Set (SafAS)|Overall Study||501|SafAS:participants who received at least 1 dose of study vaccine(s) \& had any safety data available.|
48141435|NCT01780922|100670428|FG005|COMPLETED|First Intervention (1 Day)||2||
48125231|NCT02199691|100630581|FG002|Safety Analysis Set (SafAS)|Overall Study||392|SafAS:participants who received at least 1 dose of study vaccine(s) \& had any safety data available.|
48125232|NCT02199691|100630582|FG003|Safety Analysis Set (SafAS)|Overall Study||296|SafAS:participants who received at least 1 dose of study vaccine(s) \& had any safety data available.|
48125233|NCT02199691|100630579|FG000|COMPLETED|Overall Study||495||
48125234|NCT02199691|100630580|FG001|COMPLETED|Overall Study||500||
48125235|NCT02199691|100630581|FG002|COMPLETED|Overall Study||376||
48125236|NCT02199691|100630582|FG003|COMPLETED|Overall Study||270||
48125237|NCT02199691|100630579|FG000|NOT COMPLETED|Overall Study||10||
48125238|NCT02199691|100630580|FG001|NOT COMPLETED|Overall Study||7||
48125239|NCT02199691|100630581|FG002|NOT COMPLETED|Overall Study||27||
48125240|NCT02199691|100630582|FG003|NOT COMPLETED|Overall Study||30||
48125241|NCT01818336|100630583|FG000|STARTED|Overall Study||391||
48125242|NCT01818336|100630584|FG001|STARTED|Overall Study||59||
48125243|NCT01818336|100630583|FG000|COMPLETED|Overall Study||391||
48125244|NCT01818336|100630584|FG001|COMPLETED|Overall Study||47||
48125245|NCT01818336|100630583|FG000|NOT COMPLETED|Overall Study||0||
48125246|NCT01818336|100630584|FG001|NOT COMPLETED|Overall Study||12||
48125247|NCT02604589|100630585|FG000|STARTED|Overall Study||3||
48125248|NCT02604589|100630586|FG001|STARTED|Overall Study||5||
48125249|NCT02604589|100630587|FG002|STARTED|Overall Study||2||
48125250|NCT02604589|100630585|FG000|COMPLETED|Overall Study||3||
48125251|NCT02604589|100630586|FG001|COMPLETED|Overall Study||5||
48125252|NCT02604589|100630587|FG002|COMPLETED|Overall Study||1||
48125253|NCT02604589|100630585|FG000|NOT COMPLETED|Overall Study||0||
48125254|NCT02604589|100630586|FG001|NOT COMPLETED|Overall Study||0||
48125255|NCT02604589|100630587|FG002|NOT COMPLETED|Overall Study||1||
48125256|NCT02266381|100630588|FG000|STARTED|Overall Study||150||
48125257|NCT02266381|100630589|FG001|STARTED|Overall Study||150||
48125258|NCT02266381|100630590|FG002|STARTED|Overall Study||150||
48125259|NCT02266381|100630588|FG000|COMPLETED|Overall Study||147||
48125260|NCT02266381|100630589|FG001|COMPLETED|Overall Study||145||
48125261|NCT02266381|100630590|FG002|COMPLETED|Overall Study||146||
48125262|NCT02266381|100630588|FG000|NOT COMPLETED|Overall Study||3||
48125263|NCT02266381|100630589|FG001|NOT COMPLETED|Overall Study||5||
48125264|NCT02266381|100630590|FG002|NOT COMPLETED|Overall Study||4||
48125265|NCT00096941|100630591|FG000|STARTED|Overall Study||3||
48125266|NCT00096941|100630591|FG000|COMPLETED|Overall Study||0||
48125267|NCT00096941|100630591|FG000|NOT COMPLETED|Overall Study||3||
48125268|NCT04394351|100630592|FG000|STARTED|Part A (16 Weeks)||34||
48125269|NCT04394351|100630593|FG001|STARTED|Part A (16 Weeks)||31||
48125270|NCT04394351|100630594|FG002|STARTED|Part A (16 Weeks)||37||
48125271|NCT04394351|100630595|FG003|STARTED|Part A (16 Weeks)||0||
48125272|NCT04394351|100630596|FG004|STARTED|Part A (16 Weeks)||0||
48125273|NCT04394351|100630597|FG005|STARTED|Part A (16 Weeks)||0||
48125274|NCT04394351|100630598|FG006|STARTED|Part A (16 Weeks)||0||
48125275|NCT04394351|100630599|FG007|STARTED|Part A (16 Weeks)||0||
48125276|NCT04394351|100630592|FG000|COMPLETED|Part A (16 Weeks)||33||
48125277|NCT04394351|100630593|FG001|COMPLETED|Part A (16 Weeks)||29||
48125278|NCT04394351|100630594|FG002|COMPLETED|Part A (16 Weeks)||37||
48125279|NCT04394351|100630595|FG003|COMPLETED|Part A (16 Weeks)||0||
48125280|NCT04394351|100630596|FG004|COMPLETED|Part A (16 Weeks)||0||
48125281|NCT04394351|100630597|FG005|COMPLETED|Part A (16 Weeks)||0||
48125282|NCT04394351|100630598|FG006|COMPLETED|Part A (16 Weeks)||0||
48125283|NCT04394351|100630599|FG007|COMPLETED|Part A (16 Weeks)||0||
48125284|NCT04394351|100630592|FG000|NOT COMPLETED|Part A (16 Weeks)||1||
48125285|NCT04394351|100630593|FG001|NOT COMPLETED|Part A (16 Weeks)||2||
48125286|NCT04394351|100630594|FG002|NOT COMPLETED|Part A (16 Weeks)||0||
48125287|NCT04394351|100630595|FG003|NOT COMPLETED|Part A (16 Weeks)||0||
48125288|NCT04394351|100630596|FG004|NOT COMPLETED|Part A (16 Weeks)||0||
48125289|NCT04394351|100630597|FG005|NOT COMPLETED|Part A (16 Weeks)||0||
48125290|NCT04394351|100630598|FG006|NOT COMPLETED|Part A (16 Weeks)||0||
48125291|NCT04394351|100630599|FG007|NOT COMPLETED|Part A (16 Weeks)||0||
48125292|NCT04394351|100630592|FG000|STARTED|Part B (36 Weeks)||0||
48125293|NCT04394351|100630593|FG001|STARTED|Part B (36 Weeks)||0||
48125294|NCT04394351|100630594|FG002|STARTED|Part B (36 Weeks)||0||
48125295|NCT04394351|100630595|FG003|STARTED|Part B (36 Weeks)||14||
48125296|NCT04394351|100630596|FG004|STARTED|Part B (36 Weeks)||18||
48397355|NCT02088541|101302609|FG001|STARTED|Overall Study||27||
48125297|NCT04394351|100630597|FG005|STARTED|Part B (36 Weeks)||29||
48125298|NCT04394351|100630598|FG006|STARTED|Part B (36 Weeks)||37||
48282706|NCT01145898|101014371|FG001|STARTED|3-year Treatment||44||
48125299|NCT04394351|100630599|FG007|STARTED|Part B (36 Weeks)||0||
48125300|NCT04394351|100630592|FG000|COMPLETED|Part B (36 Weeks)||0||
48125301|NCT04394351|100630593|FG001|COMPLETED|Part B (36 Weeks)||0||
48125302|NCT04394351|100630594|FG002|COMPLETED|Part B (36 Weeks)||0||
48125303|NCT04394351|100630595|FG003|COMPLETED|Part B (36 Weeks)||14||
48125304|NCT04394351|100630596|FG004|COMPLETED|Part B (36 Weeks)||18||
48125305|NCT04394351|100630597|FG005|COMPLETED|Part B (36 Weeks)||29||
48125306|NCT04394351|100630598|FG006|COMPLETED|Part B (36 Weeks)||36||
48125307|NCT04394351|100630599|FG007|COMPLETED|Part B (36 Weeks)||0||
48125308|NCT04394351|100630592|FG000|NOT COMPLETED|Part B (36 Weeks)||0||
48125309|NCT04394351|100630593|FG001|NOT COMPLETED|Part B (36 Weeks)||0||
48397356|NCT02088541|101302610|FG002|STARTED|Overall Study||117||
48125310|NCT04394351|100630594|FG002|NOT COMPLETED|Part B (36 Weeks)||0||
48125311|NCT04394351|100630595|FG003|NOT COMPLETED|Part B (36 Weeks)||0||
48125312|NCT04394351|100630596|FG004|NOT COMPLETED|Part B (36 Weeks)||0||
48125313|NCT04394351|100630597|FG005|NOT COMPLETED|Part B (36 Weeks)||0||
48125314|NCT04394351|100630598|FG006|NOT COMPLETED|Part B (36 Weeks)||1||
48125315|NCT04394351|100630599|FG007|NOT COMPLETED|Part B (36 Weeks)||0||
48125316|NCT01802411|100630600|FG000|STARTED|Overall Study||96||
48125317|NCT01802411|100630601|FG001|STARTED|Overall Study||95||
48125318|NCT01802411|100630600|FG000|COMPLETED|Overall Study||82||
48125319|NCT01802411|100630601|FG001|COMPLETED|Overall Study||74||
48125320|NCT01802411|100630600|FG000|NOT COMPLETED|Overall Study||14||
48125321|NCT01802411|100630601|FG001|NOT COMPLETED|Overall Study||21||
48125322|NCT00962429|100630602|FG000|STARTED|Overall Study||0||
48125323|NCT00962429|100630603|FG001|STARTED|Overall Study||0||
48125324|NCT00962429|100630602|FG000|COMPLETED|Overall Study||0||
48125325|NCT00962429|100630603|FG001|COMPLETED|Overall Study||0||
48125326|NCT00962429|100630602|FG000|NOT COMPLETED|Overall Study||0||
48125327|NCT00962429|100630603|FG001|NOT COMPLETED|Overall Study||0||
48125328|NCT02822794|100630604|FG000|STARTED|Overall Study||57||
48125329|NCT02822794|100630605|FG001|STARTED|Overall Study||60||
48125330|NCT02822794|100630604|FG000|COMPLETED|Overall Study||56||
48125331|NCT02822794|100630605|FG001|COMPLETED|Overall Study||60||
48125332|NCT02822794|100630604|FG000|NOT COMPLETED|Overall Study||1||
48125333|NCT02822794|100630605|FG001|NOT COMPLETED|Overall Study||0||
48125334|NCT00883389|100630606|FG000|STARTED|Overall Study||26||
48125335|NCT00883389|100630606|FG000|COMPLETED|Overall Study||26||
48125336|NCT00883389|100630606|FG000|NOT COMPLETED|Overall Study||0||
48125337|NCT00786916|100630607|FG000|STARTED|Overall Study||39||
48125338|NCT00786916|100630608|FG001|STARTED|Overall Study||36||
48700332|NCT03070171|102053970|FG000|NOT COMPLETED|Treatment Period 2 + Washout||0||
48700333|NCT03070171|102053971|FG001|NOT COMPLETED|Treatment Period 2 + Washout||1||
48700334|NCT03070171|102053970|FG000|STARTED|Treatment Period 3 + Washout||80||
48700335|NCT03070171|102053971|FG001|STARTED|Treatment Period 3 + Washout||79||
48700336|NCT03070171|102053970|FG000|COMPLETED|Treatment Period 3 + Washout||80||
48700337|NCT03070171|102053971|FG001|COMPLETED|Treatment Period 3 + Washout||79||
48700338|NCT03070171|102053970|FG000|NOT COMPLETED|Treatment Period 3 + Washout||0||
48700339|NCT03070171|102053971|FG001|NOT COMPLETED|Treatment Period 3 + Washout||0||
48700340|NCT03070171|102053970|FG000|STARTED|Treatment Period 4 + Washout||80||
48700341|NCT03070171|102053971|FG001|STARTED|Treatment Period 4 + Washout||79||
48700342|NCT03070171|102053970|FG000|COMPLETED|Treatment Period 4 + Washout||80||
48700343|NCT03070171|102053971|FG001|COMPLETED|Treatment Period 4 + Washout||78||
48125339|NCT00786916|100630609|FG002|STARTED|Overall Study||34||
48125340|NCT00786916|100630607|FG000|COMPLETED|Overall Study||39||
48125341|NCT00786916|100630608|FG001|COMPLETED|Overall Study||36||
48125342|NCT00786916|100630609|FG002|COMPLETED|Overall Study||34||
48700344|NCT03070171|102053970|FG000|NOT COMPLETED|Treatment Period 4 + Washout||0||
48700345|NCT03070171|102053971|FG001|NOT COMPLETED|Treatment Period 4 + Washout||1||
48700346|NCT01110330|102053972|FG000|STARTED|Overall Study||119||
48700347|NCT01110330|102053973|FG001|STARTED|Overall Study||230||
48700348|NCT01110330|102053974|FG002|STARTED|Overall Study||234||
48700349|NCT01110330|102053972|FG000|Positive Baseline Culture Set|Overall Study||56||
48125343|NCT00786916|100630607|FG000|NOT COMPLETED|Overall Study||0||
48125344|NCT00786916|100630608|FG001|NOT COMPLETED|Overall Study||0||
48125345|NCT00786916|100630609|FG002|NOT COMPLETED|Overall Study||0||
48125346|NCT01975389|100630610|FG000|STARTED|Overall Study||5283||
48125347|NCT01975389|100630611|FG001|STARTED|Overall Study||5281||
48125348|NCT01975389|100630610|FG000|Treated|Overall Study||5279||
48125349|NCT01975389|100630611|FG001|Treated|Overall Study||5276||
48700350|NCT01110330|102053973|FG001|Positive Baseline Culture Set|Overall Study||111||
48700351|NCT01110330|102053974|FG002|Positive Baseline Culture Set|Overall Study||114||
48700352|NCT01110330|102053972|FG000|COMPLETED|Overall Study||104||
48700353|NCT01110330|102053973|FG001|COMPLETED|Overall Study||207||
48700354|NCT01110330|102053974|FG002|COMPLETED|Overall Study||208||
48700355|NCT01110330|102053972|FG000|NOT COMPLETED|Overall Study||15||
48700356|NCT01110330|102053973|FG001|NOT COMPLETED|Overall Study||23||
48700357|NCT01110330|102053974|FG002|NOT COMPLETED|Overall Study||26||
48700358|NCT03269968|102053975|FG000|STARTED|Overall Study||0||
48700359|NCT03269968|102053976|FG001|STARTED|Overall Study||0||
48700360|NCT03269968|102053975|FG000|COMPLETED|Overall Study||0||
48700361|NCT03269968|102053976|FG001|COMPLETED|Overall Study||0||
48700362|NCT03269968|102053975|FG000|NOT COMPLETED|Overall Study||0||
48125350|NCT01975389|100630610|FG000|COMPLETED|Overall Study||5031||
48125351|NCT01975389|100630611|FG001|COMPLETED|Overall Study||5045||
48125352|NCT01975389|100630610|FG000|NOT COMPLETED|Overall Study||252||
48125353|NCT01975389|100630611|FG001|NOT COMPLETED|Overall Study||236||
48125354|NCT01958918|100630612|FG000|STARTED|Overall Study||356|patients randomized|
48125355|NCT01958918|100630613|FG001|STARTED|Overall Study||356|patients randomized|
48125356|NCT01958918|100630612|FG000|Full Analysis Set|Overall Study||353||
48700363|NCT03269968|102053976|FG001|NOT COMPLETED|Overall Study||0||
48700364|NCT02793817|102053977|FG000|STARTED|Overall Study||261||
48125357|NCT01958918|100630613|FG001|Full Analysis Set|Overall Study||354||
48125358|NCT01958918|100630612|FG000|COMPLETED|Overall Study||313|completed overall|
48125359|NCT01958918|100630613|FG001|COMPLETED|Overall Study||314|completed overall|
48125360|NCT01958918|100630612|FG000|NOT COMPLETED|Overall Study||43||
48125361|NCT01958918|100630613|FG001|NOT COMPLETED|Overall Study||42||
48125362|NCT01709318|100630614|FG000|STARTED|Overall Study||82||
48125363|NCT01709318|100630615|FG001|STARTED|Overall Study||85||
48125364|NCT01709318|100630616|FG002|STARTED|Overall Study||77||
48125365|NCT01709318|100630617|FG003|STARTED|Overall Study||78||
48125366|NCT01709318|100630618|FG004|STARTED|Overall Study||78||
48125367|NCT01709318|100630619|FG005|STARTED|Overall Study||84||
48125368|NCT01709318|100630620|FG006|STARTED|Overall Study||182||
48125369|NCT01709318|100630614|FG000|Treated|Overall Study||79||
48125370|NCT01709318|100630615|FG001|Treated|Overall Study||85||
48125371|NCT01709318|100630616|FG002|Treated|Overall Study||78||
48125372|NCT01709318|100630617|FG003|Treated|Overall Study||77||
48125373|NCT01709318|100630618|FG004|Treated|Overall Study||77||
48125374|NCT01709318|100630619|FG005|Treated|Overall Study||86||
48125375|NCT01709318|100630620|FG006|Treated|Overall Study||178||
48125376|NCT01709318|100630614|FG000|COMPLETED|Overall Study||73||
48125377|NCT01709318|100630615|FG001|COMPLETED|Overall Study||78||
48125378|NCT01709318|100630616|FG002|COMPLETED|Overall Study||71||
48125379|NCT01709318|100630617|FG003|COMPLETED|Overall Study||72||
48125380|NCT01709318|100630618|FG004|COMPLETED|Overall Study||74||
48571504|NCT00775229|101730994|FG000|STARTED|Overall Study||25||
48571505|NCT00775229|101730995|FG001|STARTED|Overall Study||26||
48571506|NCT00775229|101730994|FG000|COMPLETED|Overall Study||20||
48125381|NCT01709318|100630619|FG005|COMPLETED|Overall Study||80||
48125382|NCT01709318|100630620|FG006|COMPLETED|Overall Study||171||
48125383|NCT01709318|100630614|FG000|NOT COMPLETED|Overall Study||9||
48125384|NCT01709318|100630615|FG001|NOT COMPLETED|Overall Study||7||
48125385|NCT01709318|100630616|FG002|NOT COMPLETED|Overall Study||6||
48125386|NCT01709318|100630617|FG003|NOT COMPLETED|Overall Study||6||
48125387|NCT01709318|100630618|FG004|NOT COMPLETED|Overall Study||4||
48125388|NCT01709318|100630619|FG005|NOT COMPLETED|Overall Study||4||
48125389|NCT01709318|100630620|FG006|NOT COMPLETED|Overall Study||11||
48125390|NCT01700946|100630621|FG000|STARTED|Overall Study||18||
48125391|NCT01700946|100630622|FG001|STARTED|Overall Study||24||
48125392|NCT01700946|100630621|FG000|COMPLETED|Overall Study||7||
48125393|NCT01700946|100630622|FG001|COMPLETED|Overall Study||7||
48125394|NCT01700946|100630621|FG000|NOT COMPLETED|Overall Study||11||
48125395|NCT01700946|100630622|FG001|NOT COMPLETED|Overall Study||17||
48125396|NCT01163682|100630623|FG000|STARTED|Overall Study||31||
48125397|NCT01163682|100630624|FG001|STARTED|Overall Study||32||
48125398|NCT01163682|100630623|FG000|COMPLETED|Overall Study||25||
48125399|NCT01163682|100630624|FG001|COMPLETED|Overall Study||23||
48125400|NCT01163682|100630623|FG000|NOT COMPLETED|Overall Study||6||
48125401|NCT01163682|100630624|FG001|NOT COMPLETED|Overall Study||9||
48125402|NCT01431508|100630625|FG000|STARTED|Overall Study||15||
48125403|NCT01431508|100630625|FG000|COMPLETED|Overall Study||13||
48571507|NCT00775229|101730995|FG001|COMPLETED|Overall Study||24||
48571508|NCT00775229|101730994|FG000|NOT COMPLETED|Overall Study||5||
48571509|NCT00775229|101730995|FG001|NOT COMPLETED|Overall Study||2||
48571510|NCT00740792|101730996|FG000|STARTED|Overall Study||193||
48571511|NCT00740792|101730997|FG001|STARTED|Overall Study||194||
48571512|NCT00740792|101730998|FG002|STARTED|Overall Study||189||
48125404|NCT01431508|100630625|FG000|NOT COMPLETED|Overall Study||2||
48125405|NCT05063734|100630626|FG000|STARTED|Overall Study||7||
48125406|NCT05063734|100630627|FG001|STARTED|Overall Study||9||
48125407|NCT05063734|100630626|FG000|COMPLETED|Overall Study||6||
48571513|NCT00740792|101730999|FG003|STARTED|Overall Study||200||
48571514|NCT00740792|101730996|FG000|COMPLETED|Overall Study||183||
48571515|NCT00740792|101730997|FG001|COMPLETED|Overall Study||186||
48571516|NCT00740792|101730998|FG002|COMPLETED|Overall Study||180||
48571517|NCT00740792|101730999|FG003|COMPLETED|Overall Study||190||
48571518|NCT00740792|101730996|FG000|NOT COMPLETED|Overall Study||10||
48571519|NCT00740792|101730997|FG001|NOT COMPLETED|Overall Study||8||
48125408|NCT05063734|100630627|FG001|COMPLETED|Overall Study||9||
48125409|NCT05063734|100630626|FG000|NOT COMPLETED|Overall Study||1||
48125410|NCT05063734|100630627|FG001|NOT COMPLETED|Overall Study||0||
48125411|NCT03286140|100630628|FG000|STARTED|Overall Study||226||
48125412|NCT03286140|100630629|FG001|STARTED|Overall Study||224||
48125413|NCT03286140|100630628|FG000|6-week Follow-up|Overall Study||224||
48125414|NCT03286140|100630629|FG001|6-week Follow-up|Overall Study||223||
48125415|NCT03286140|100630628|FG000|6-month Follow-up|Overall Study||215||
48125416|NCT03286140|100630629|FG001|6-month Follow-up|Overall Study||213||
48125417|NCT03286140|100630628|FG000|12-month Follow-up|Overall Study||203||
48125418|NCT03286140|100630629|FG001|12-month Follow-up|Overall Study||204||
48125419|NCT03286140|100630628|FG000|COMPLETED|Overall Study||211||
48125420|NCT03286140|100630629|FG001|COMPLETED|Overall Study||208||
48125421|NCT03286140|100630628|FG000|NOT COMPLETED|Overall Study||15||
48125422|NCT03286140|100630629|FG001|NOT COMPLETED|Overall Study||16||
48571520|NCT00740792|101730998|FG002|NOT COMPLETED|Overall Study||9||
48571521|NCT00740792|101730999|FG003|NOT COMPLETED|Overall Study||10||
48571522|NCT02684097|101731000|FG000|STARTED|Overall Study||15||
48571523|NCT02684097|101731001|FG001|STARTED|Overall Study||7||
48571524|NCT02684097|101731000|FG000|COMPLETED|Overall Study||2||
48125423|NCT01085318|100630630|FG000|STARTED|Overall Study||23||
48125424|NCT01085318|100630631|FG001|STARTED|Overall Study||15||
48125425|NCT01085318|100630630|FG000|COMPLETED|Overall Study||21||
48125426|NCT01085318|100630631|FG001|COMPLETED|Overall Study||15||
48125427|NCT01085318|100630630|FG000|NOT COMPLETED|Overall Study||2||
48125428|NCT01085318|100630631|FG001|NOT COMPLETED|Overall Study||0||
48125429|NCT00346034|100630632|FG000|STARTED|Overall Study||357||
48125430|NCT00346034|100630632|FG000|COMPLETED|Overall Study||300||
48125431|NCT00346034|100630632|FG000|NOT COMPLETED|Overall Study||57||
48125432|NCT01578551|100630633|FG000|STARTED|Overall Study||19||
48125433|NCT01578551|100630634|FG001|STARTED|Overall Study||6||
48125434|NCT01578551|100630633|FG000|COMPLETED|Overall Study||18||
48125435|NCT01578551|100630634|FG001|COMPLETED|Overall Study||6||
48125436|NCT01578551|100630633|FG000|NOT COMPLETED|Overall Study||1||
48125437|NCT01578551|100630634|FG001|NOT COMPLETED|Overall Study||0||
48125438|NCT03323099|100630635|FG000|STARTED|Overall Study||251||
48125439|NCT03323099|100630636|FG001|STARTED|Overall Study||248||
48125440|NCT03323099|100630635|FG000|COMPLETED|Overall Study||136||
48125441|NCT03323099|100630636|FG001|COMPLETED|Overall Study||184||
48125442|NCT03323099|100630635|FG000|NOT COMPLETED|Overall Study||115||
48700365|NCT02793817|102053978|FG001|STARTED|Overall Study||259||
48700366|NCT02793817|102053977|FG000|COMPLETED|Overall Study||258||
48700367|NCT02793817|102053978|FG001|COMPLETED|Overall Study||254||
48700368|NCT02793817|102053977|FG000|NOT COMPLETED|Overall Study||3||
48700369|NCT02793817|102053978|FG001|NOT COMPLETED|Overall Study||5||
48125443|NCT03323099|100630636|FG001|NOT COMPLETED|Overall Study||64||
48125444|NCT01313559|100630637|FG000|STARTED|Overall Study||4||
48125445|NCT01313559|100630638|FG001|STARTED|Overall Study||2||
48125446|NCT01313559|100630637|FG000|COMPLETED|Overall Study||0||
48125447|NCT01313559|100630638|FG001|COMPLETED|Overall Study||0||
48125448|NCT01313559|100630637|FG000|NOT COMPLETED|Overall Study||4||
48125449|NCT01313559|100630638|FG001|NOT COMPLETED|Overall Study||2||
48125450|NCT02517580|100630639|FG000|STARTED|Overall Study||60||
48125451|NCT02517580|100630639|FG000|COMPLETED|Overall Study||56||
48125452|NCT02517580|100630639|FG000|NOT COMPLETED|Overall Study||4||
48125453|NCT02202135|100630640|FG000|STARTED|Overall Study||4||
48125454|NCT02202135|100630640|FG000|COMPLETED|Overall Study||4||
48125455|NCT02202135|100630640|FG000|NOT COMPLETED|Overall Study||0||
48125456|NCT03009110|100630641|FG000|STARTED|Overall Study||816||
48125457|NCT03009110|100630642|FG001|STARTED|Overall Study||808||
48125458|NCT03009110|100630641|FG000|COMPLETED|Overall Study||806||
48125459|NCT03009110|100630642|FG001|COMPLETED|Overall Study||802||
48125460|NCT03009110|100630641|FG000|NOT COMPLETED|Overall Study||10||
48125461|NCT03009110|100630642|FG001|NOT COMPLETED|Overall Study||6||
48125462|NCT03204942|100630643|FG000|STARTED|Overall Study||23||
48125463|NCT03204942|100630644|FG001|STARTED|Overall Study||23||
48125464|NCT03204942|100630645|FG002|STARTED|Overall Study||23||
48125465|NCT03204942|100630643|FG000|COMPLETED|Overall Study||23||
48125466|NCT03204942|100630644|FG001|COMPLETED|Overall Study||23||
48125467|NCT03204942|100630645|FG002|COMPLETED|Overall Study||23||
48125468|NCT03204942|100630643|FG000|NOT COMPLETED|Overall Study||0||
48125469|NCT03204942|100630644|FG001|NOT COMPLETED|Overall Study||0||
48125470|NCT03204942|100630645|FG002|NOT COMPLETED|Overall Study||0||
48125471|NCT00821626|100630646|FG000|STARTED|Overall Study||60||
48125472|NCT00821626|100630647|FG001|STARTED|Overall Study||33||
48125473|NCT00821626|100630646|FG000|COMPLETED|Overall Study||60||
48125474|NCT00821626|100630647|FG001|COMPLETED|Overall Study||33||
48125475|NCT00821626|100630646|FG000|NOT COMPLETED|Overall Study||0||
48125476|NCT00821626|100630647|FG001|NOT COMPLETED|Overall Study||0||
48125477|NCT01060384|100630648|FG000|STARTED|Overall Study||6||
48125478|NCT01060384|100630649|FG001|STARTED|Overall Study||4||
48125479|NCT01060384|100630650|FG002|STARTED|Overall Study||0||
48125480|NCT01060384|100630651|FG003|STARTED|Overall Study||0||
48125481|NCT01060384|100630652|FG004|STARTED|Overall Study||36||
48125482|NCT01060384|100630648|FG000|COMPLETED|Overall Study||6||
48700370|NCT04397939|102053979|FG000|STARTED|Overall Study||3208||
48700371|NCT04397939|102053980|FG001|STARTED|Overall Study||319||
48125483|NCT01060384|100630649|FG001|COMPLETED|Overall Study||3||
48125484|NCT01060384|100630650|FG002|COMPLETED|Overall Study||0||
48125485|NCT01060384|100630651|FG003|COMPLETED|Overall Study||0||
48125486|NCT01060384|100630652|FG004|COMPLETED|Overall Study||34||
48571525|NCT02684097|101731001|FG001|COMPLETED|Overall Study||1||
48700372|NCT04397939|102053981|FG002|STARTED|Overall Study||1168||
48125487|NCT01060384|100630648|FG000|NOT COMPLETED|Overall Study||0||
48125488|NCT01060384|100630649|FG001|NOT COMPLETED|Overall Study||1||
48125489|NCT01060384|100630650|FG002|NOT COMPLETED|Overall Study||0||
48125490|NCT01060384|100630651|FG003|NOT COMPLETED|Overall Study||0||
48125491|NCT01060384|100630652|FG004|NOT COMPLETED|Overall Study||2||
48125492|NCT01412424|100630653|FG000|STARTED|Core Treatment Period||155||
48125493|NCT01412424|100630653|FG000|COMPLETED|Core Treatment Period||102||
48125494|NCT01412424|100630653|FG000|NOT COMPLETED|Core Treatment Period||53||
48125495|NCT01412424|100630653|FG000|STARTED|Extension Treatment Period||88||
48125496|NCT01412424|100630653|FG000|COMPLETED|Extension Treatment Period||82||
48125497|NCT01412424|100630653|FG000|NOT COMPLETED|Extension Treatment Period||6||
48700373|NCT04397939|102053979|FG000|COMPLETED|Overall Study||3208||
48125498|NCT02104557|100630654|FG000|STARTED|Overall Study||362||
48125499|NCT02104557|100630654|FG000|Safety Population|Overall Study||337||
48125500|NCT02104557|100630654|FG000|COMPLETED|Overall Study||185||
48125501|NCT02104557|100630654|FG000|NOT COMPLETED|Overall Study||177||
48125502|NCT00539526|100630655|FG000|STARTED|Overall Study||35||
48125503|NCT00539526|100630656|FG001|STARTED|Overall Study||33||
48125504|NCT00539526|100630657|FG002|STARTED|Overall Study||38||
48125505|NCT00539526|100630655|FG000|COMPLETED|Overall Study||32||
48125506|NCT00539526|100630656|FG001|COMPLETED|Overall Study||31||
48125507|NCT00539526|100630657|FG002|COMPLETED|Overall Study||36||
48125508|NCT00539526|100630655|FG000|NOT COMPLETED|Overall Study||3||
48125509|NCT00539526|100630656|FG001|NOT COMPLETED|Overall Study||2||
48125510|NCT00539526|100630657|FG002|NOT COMPLETED|Overall Study||2||
48125511|NCT00829621|100630658|FG000|STARTED|Overall Study||8||
48125512|NCT00829621|100630659|FG001|STARTED|Overall Study||12||
48125513|NCT00829621|100630658|FG000|COMPLETED|Overall Study||4||
48125514|NCT00829621|100630659|FG001|COMPLETED|Overall Study||8||
48125515|NCT00829621|100630658|FG000|NOT COMPLETED|Overall Study||4||
48125516|NCT00829621|100630659|FG001|NOT COMPLETED|Overall Study||4||
48125517|NCT03495908|100630660|FG000|STARTED|Overall Study||69||
48125518|NCT03495908|100630661|FG001|STARTED|Overall Study||67||
48125519|NCT03495908|100630660|FG000|COMPLETED|Overall Study||59||
48125520|NCT03495908|100630661|FG001|COMPLETED|Overall Study||54||
48125521|NCT03495908|100630660|FG000|NOT COMPLETED|Overall Study||10||
48125522|NCT03495908|100630661|FG001|NOT COMPLETED|Overall Study||13||
48125523|NCT00129259|100630662|FG000|STARTED|Overall Study||52||
48125524|NCT00129259|100630663|FG001|STARTED|Overall Study||25||
48125525|NCT00129259|100630662|FG000|Received All or Part of Cycle 1|Overall Study||52||
48125526|NCT00129259|100630663|FG001|Received All or Part of Cycle 1|Overall Study||0||
48125527|NCT00129259|100630662|FG000|Received All or Part of Cycle 2|Overall Study||40||
48125528|NCT00129259|100630663|FG001|Received All or Part of Cycle 2|Overall Study||0||
48125529|NCT00129259|100630662|FG000|COMPLETED|Overall Study||49||
48125530|NCT00129259|100630663|FG001|COMPLETED|Overall Study||22||
48125531|NCT00129259|100630662|FG000|NOT COMPLETED|Overall Study||3||
48125532|NCT00129259|100630663|FG001|NOT COMPLETED|Overall Study||3||
48125533|NCT02200042|100630664|FG000|STARTED|Overall Study||0||
48125534|NCT02200042|100630665|FG001|STARTED|Overall Study||1||
48125535|NCT02200042|100630664|FG000|COMPLETED|Overall Study||0||
48125536|NCT02200042|100630665|FG001|COMPLETED|Overall Study||0||
48125537|NCT02200042|100630664|FG000|NOT COMPLETED|Overall Study||0||
48125538|NCT02200042|100630665|FG001|NOT COMPLETED|Overall Study||1||
48125539|NCT00752908|100633649|FG000|STARTED|Overall Study||14||
48125540|NCT00752908|100633650|FG001|STARTED|Overall Study||13||
48125541|NCT00752908|100633649|FG000|COMPLETED|Overall Study||14||
48125542|NCT00752908|100633650|FG001|COMPLETED|Overall Study||13||
48125543|NCT00752908|100633649|FG000|NOT COMPLETED|Overall Study||0||
48125544|NCT00752908|100633650|FG001|NOT COMPLETED|Overall Study||0||
48282707|NCT01145898|101014370|FG000|COMPLETED|3-year Treatment||9||
48125545|NCT01092195|100633651|FG000|STARTED|Overall Study||23||
48125546|NCT01092195|100633652|FG001|STARTED|Overall Study||21||
48125547|NCT01092195|100633653|FG002|STARTED|Overall Study||20||
48125548|NCT01092195|100633651|FG000|COMPLETED|Overall Study||23||
48125549|NCT01092195|100633652|FG001|COMPLETED|Overall Study||21||
48125550|NCT01092195|100633653|FG002|COMPLETED|Overall Study||20||
48282708|NCT01145898|101014371|FG001|COMPLETED|3-year Treatment||28||
48125551|NCT01092195|100633651|FG000|NOT COMPLETED|Overall Study||0||
48125552|NCT01092195|100633652|FG001|NOT COMPLETED|Overall Study||0||
48282709|NCT01145898|101014370|FG000|NOT COMPLETED|3-year Treatment||3||
48125553|NCT01092195|100633653|FG002|NOT COMPLETED|Overall Study||0||
48125554|NCT02936076|100633654|FG000|STARTED|Overall Study||25||
48125555|NCT02936076|100633655|FG001|STARTED|Overall Study||24||
48125556|NCT02936076|100633654|FG000|COMPLETED|Overall Study||19||
48125557|NCT02936076|100633655|FG001|COMPLETED|Overall Study||20||
48125558|NCT02936076|100633654|FG000|NOT COMPLETED|Overall Study||6||
48125559|NCT02936076|100633655|FG001|NOT COMPLETED|Overall Study||4||
48125560|NCT03115424|100633656|FG000|STARTED|Overall Study||12||
48125561|NCT03115424|100633657|FG001|STARTED|Overall Study||9||
48125562|NCT03115424|100633658|FG002|STARTED|Overall Study||25||
48125563|NCT03115424|100633656|FG000|COMPLETED|Overall Study||12||
48125564|NCT03115424|100633657|FG001|COMPLETED|Overall Study||9||
48125565|NCT03115424|100633658|FG002|COMPLETED|Overall Study||25||
48125566|NCT03115424|100633656|FG000|NOT COMPLETED|Overall Study||0||
48125567|NCT03115424|100633657|FG001|NOT COMPLETED|Overall Study||0||
48125568|NCT03115424|100633658|FG002|NOT COMPLETED|Overall Study||0||
48125569|NCT05209191|100633659|FG000|STARTED|Overall Study||102||
48125570|NCT05209191|100633659|FG000|COMPLETED|Overall Study||102||
48125571|NCT05209191|100633659|FG000|NOT COMPLETED|Overall Study||0||
48125572|NCT00389818|100633660|FG000|STARTED|Overall Study||43||
48125573|NCT00389818|100633660|FG000|COMPLETED|Overall Study||40||
48125574|NCT00389818|100633660|FG000|NOT COMPLETED|Overall Study||3||
48571526|NCT02684097|101731000|FG000|NOT COMPLETED|Overall Study||13||
48571527|NCT02684097|101731001|FG001|NOT COMPLETED|Overall Study||6||
48571528|NCT04325568|101731002|FG000|STARTED|Overall Study||25||
48571529|NCT04325568|101731002|FG000|COMPLETED|Overall Study||25||
48571530|NCT04325568|101731002|FG000|NOT COMPLETED|Overall Study||0||
48571531|NCT00333983|101731003|FG000|STARTED|Overall Study||20||
48571532|NCT00333983|101731004|FG001|STARTED|Overall Study||21||
48571533|NCT00333983|101731005|FG002|STARTED|Overall Study||21||
48571534|NCT00333983|101731003|FG000|COMPLETED|Overall Study||17||
48571535|NCT00333983|101731004|FG001|COMPLETED|Overall Study||16||
48571536|NCT00333983|101731005|FG002|COMPLETED|Overall Study||19||
48571537|NCT00333983|101731003|FG000|NOT COMPLETED|Overall Study||3||
48700374|NCT04397939|102053980|FG001|COMPLETED|Overall Study||319||
48700375|NCT04397939|102053981|FG002|COMPLETED|Overall Study||1168||
48125575|NCT03156023|100633661|FG000|STARTED|Overall Study||8||
48125576|NCT03156023|100633662|FG001|STARTED|Overall Study||7||
48125577|NCT03156023|100633663|FG002|STARTED|Overall Study||6||
48125578|NCT03156023|100633664|FG003|STARTED|Overall Study||6||
48125579|NCT03156023|100633665|FG004|STARTED|Overall Study||7||
48125580|NCT03156023|100633661|FG000|COMPLETED|Overall Study||7||
48125581|NCT03156023|100633662|FG001|COMPLETED|Overall Study||7||
48125582|NCT03156023|100633663|FG002|COMPLETED|Overall Study||4||
48125583|NCT03156023|100633664|FG003|COMPLETED|Overall Study||5||
48125584|NCT03156023|100633665|FG004|COMPLETED|Overall Study||5||
48125585|NCT03156023|100633661|FG000|NOT COMPLETED|Overall Study||1||
48125586|NCT03156023|100633662|FG001|NOT COMPLETED|Overall Study||0||
48125587|NCT03156023|100633663|FG002|NOT COMPLETED|Overall Study||2||
48125588|NCT03156023|100633664|FG003|NOT COMPLETED|Overall Study||1||
48125589|NCT03156023|100633665|FG004|NOT COMPLETED|Overall Study||2||
48125590|NCT00646958|100633666|FG000|STARTED|Overall Study||51||
48125591|NCT00646958|100633667|FG001|STARTED|Overall Study||50||
48125592|NCT00646958|100633668|FG002|STARTED|Overall Study||49||
48125593|NCT00646958|100633666|FG000|COMPLETED|Overall Study||40||
48125594|NCT00646958|100633667|FG001|COMPLETED|Overall Study||41||
48125595|NCT00646958|100633668|FG002|COMPLETED|Overall Study||40||
48125596|NCT00646958|100633666|FG000|NOT COMPLETED|Overall Study||11||
48125597|NCT00646958|100633667|FG001|NOT COMPLETED|Overall Study||9||
48125598|NCT00646958|100633668|FG002|NOT COMPLETED|Overall Study||9||
48125599|NCT05423509|100633669|FG000|STARTED|Overall Study||9||
48571538|NCT00333983|101731004|FG001|NOT COMPLETED|Overall Study||5||
48571539|NCT00333983|101731005|FG002|NOT COMPLETED|Overall Study||2||
48571540|NCT00478777|101731006|FG000|STARTED|Overall Study||150||
48571541|NCT00478777|101731006|FG000|Safety and Full Analysis Set (FAS)|Overall Study||144||
48700376|NCT04397939|102053979|FG000|NOT COMPLETED|Overall Study||0||
48125600|NCT05423509|100633670|FG001|STARTED|Overall Study||12||
48125601|NCT05423509|100633669|FG000|COMPLETED|Overall Study||9||
48125602|NCT05423509|100633670|FG001|COMPLETED|Overall Study||10||
48125603|NCT05423509|100633669|FG000|NOT COMPLETED|Overall Study||0||
48125604|NCT05423509|100633670|FG001|NOT COMPLETED|Overall Study||2||
48125605|NCT03823651|100633671|FG000|STARTED|Overall Study||13||
48125606|NCT03823651|100633672|FG001|STARTED|Overall Study||11||
48125607|NCT03823651|100633671|FG000|COMPLETED|Overall Study||7||
48125608|NCT03823651|100633672|FG001|COMPLETED|Overall Study||5||
48125609|NCT03823651|100633671|FG000|NOT COMPLETED|Overall Study||6||
48125610|NCT03823651|100633672|FG001|NOT COMPLETED|Overall Study||6||
48125611|NCT04666441|100633673|FG000|STARTED|Overall Study||82|Started = Randomized and treated|
48125612|NCT04666441|100633674|FG001|STARTED|Overall Study||165|Started = Randomized and treated|
48125613|NCT04666441|100633675|FG002|STARTED|Overall Study||162|Started = Randomized and treated|
48571542|NCT00478777|101731006|FG000|COMPLETED|Overall Study||73||
48571543|NCT00478777|101731006|FG000|NOT COMPLETED|Overall Study||77||
48571544|NCT03668119|101731007|FG000|STARTED|Pre-treatment||136|Randomized|
48571545|NCT03668119|101731008|FG001|STARTED|Pre-treatment||76|Randomized|
48571546|NCT03668119|101731007|FG000|bTMB-H Started|Pre-treatment||80|Randomized in a salvage setting|
48571547|NCT03668119|101731008|FG001|bTMB-H Started|Pre-treatment||45|Randomized in a salvage setting|
48571548|NCT03668119|101731007|FG000|tTMB-H Started|Pre-treatment||88|Randomized in a salvage setting|
48571549|NCT03668119|101731008|FG001|tTMB-H Started|Pre-treatment||47|Randomized in a salvage setting|
48571550|NCT03668119|101731007|FG000|COMPLETED|Pre-treatment||135|Treated|
48700377|NCT04397939|102053980|FG001|NOT COMPLETED|Overall Study||0||
48700378|NCT04397939|102053981|FG002|NOT COMPLETED|Overall Study||0||
48700379|NCT00962741|102053982|FG000|STARTED|Overall Study||127||
48125614|NCT04666441|100633676|FG003|STARTED|Overall Study||165|Started = Randomized and treated|
48125615|NCT04666441|100633677|FG004|STARTED|Overall Study||166|Started = Randomized and treated|
48125616|NCT04666441|100633678|FG005|STARTED|Overall Study||82|Started = Randomized and treated|
48125617|NCT04666441|100633679|FG006|STARTED|Overall Study||163|Started = Randomized and treated|
48571551|NCT03668119|101731008|FG001|COMPLETED|Pre-treatment||76|Treated|
48700380|NCT00962741|102053982|FG000|COMPLETED|Overall Study||119||
48700381|NCT00962741|102053982|FG000|NOT COMPLETED|Overall Study||8||
48700382|NCT00281099|102053983|FG000|STARTED|Overall Study||513||
48700383|NCT00281099|102053984|FG001|STARTED|Overall Study||518||
48700384|NCT00281099|102053983|FG000|COMPLETED|Overall Study||308||
48700385|NCT00281099|102053984|FG001|COMPLETED|Overall Study||296||
48700386|NCT00281099|102053983|FG000|NOT COMPLETED|Overall Study||205||
48700387|NCT00281099|102053984|FG001|NOT COMPLETED|Overall Study||222||
48700388|NCT01139411|102053985|FG000|STARTED|Overall Study||26||
48700389|NCT01139411|102053986|FG001|STARTED|Overall Study||23||
48700390|NCT01139411|102053985|FG000|COMPLETED|Overall Study||24||
48700391|NCT01139411|102053986|FG001|COMPLETED|Overall Study||19||
48700392|NCT01139411|102053985|FG000|NOT COMPLETED|Overall Study||2||
48700393|NCT01139411|102053986|FG001|NOT COMPLETED|Overall Study||4||
48700394|NCT01694121|102053987|FG000|STARTED|Overall Study||228||
48700395|NCT01694121|102053988|FG001|STARTED|Overall Study||227||
48700396|NCT01694121|102053987|FG000|COMPLETED|Overall Study||227||
48700397|NCT01694121|102053988|FG001|COMPLETED|Overall Study||227||
48700398|NCT01694121|102053987|FG000|NOT COMPLETED|Overall Study||1||
48700399|NCT01694121|102053988|FG001|NOT COMPLETED|Overall Study||0||
48700400|NCT01406938|102053989|FG000|STARTED|Induction Period||482||
48700401|NCT01406938|102053990|FG001|STARTED|Induction Period||484||
48700402|NCT01406938|102053991|FG002|STARTED|Induction Period||0||
48700403|NCT01406938|102053992|FG003|STARTED|Induction Period||0||
48700404|NCT01406938|102053993|FG004|STARTED|Induction Period||0||
48700405|NCT01406938|102053994|FG005|STARTED|Induction Period||0||
48700406|NCT01406938|102053989|FG000|FAS:Patients Assigned Study Treatment|Induction Period||482||
48700407|NCT01406938|102053990|FG001|FAS:Patients Assigned Study Treatment|Induction Period||483||
48700408|NCT01406938|102053991|FG002|FAS:Patients Assigned Study Treatment|Induction Period||0||
48571552|NCT03668119|101731007|FG000|NOT COMPLETED|Pre-treatment||1||
48571553|NCT03668119|101731008|FG001|NOT COMPLETED|Pre-treatment||0||
48571554|NCT03668119|101731007|FG000|STARTED|Treatment||135|Treated|
48571555|NCT03668119|101731008|FG001|STARTED|Treatment||76|Treated|
48571556|NCT03668119|101731007|FG000|bTMB-H Started|Treatment||83|Treated|
48571557|NCT03668119|101731008|FG001|bTMB-H Started|Treatment||47|Treated|
48571558|NCT03668119|101731007|FG000|tTMB-H Started|Treatment||94|Treated|
48700409|NCT01406938|102053992|FG003|FAS:Patients Assigned Study Treatment|Induction Period||0||
48700410|NCT01406938|102053993|FG004|FAS:Patients Assigned Study Treatment|Induction Period||0||
48700411|NCT01406938|102053994|FG005|FAS:Patients Assigned Study Treatment|Induction Period||0||
48700412|NCT01406938|102053989|FG000|COMPLETED|Induction Period||464||
48700413|NCT01406938|102053990|FG001|COMPLETED|Induction Period||464||
48700414|NCT01406938|102053991|FG002|COMPLETED|Induction Period||0||
48700415|NCT01406938|102053992|FG003|COMPLETED|Induction Period||0||
48700416|NCT01406938|102053993|FG004|COMPLETED|Induction Period||0||
48700417|NCT01406938|102053994|FG005|COMPLETED|Induction Period||0||
48700418|NCT01406938|102053989|FG000|NOT COMPLETED|Induction Period||18||
48700419|NCT01406938|102053990|FG001|NOT COMPLETED|Induction Period||20||
48700420|NCT01406938|102053991|FG002|NOT COMPLETED|Induction Period||0||
48700421|NCT01406938|102053992|FG003|NOT COMPLETED|Induction Period||0||
48700422|NCT01406938|102053993|FG004|NOT COMPLETED|Induction Period||0||
48571559|NCT03668119|101731008|FG001|tTMB-H Started|Treatment||50|Treated|
48571560|NCT03668119|101731007|FG000|Arm B Rollover|Treatment||0||
48700423|NCT01406938|102053994|FG005|NOT COMPLETED|Induction Period||0||
48700424|NCT01406938|102053989|FG000|STARTED|Maintenance Period||0||
48700425|NCT01406938|102053990|FG001|STARTED|Maintenance Period||0||
48700426|NCT01406938|102053991|FG002|STARTED|Maintenance Period||203||
48700427|NCT01406938|102053992|FG003|STARTED|Maintenance Period||217||
48700428|NCT01406938|102053993|FG004|STARTED|Maintenance Period||206||
48700429|NCT01406938|102053994|FG005|STARTED|Maintenance Period||217||
48700430|NCT01406938|102053989|FG000|FAS: Patients Assigned Treatment Drug|Maintenance Period||0||
48700431|NCT01406938|102053990|FG001|FAS: Patients Assigned Treatment Drug|Maintenance Period||0||
48700432|NCT01406938|102053991|FG002|FAS: Patients Assigned Treatment Drug|Maintenance Period||203||
48700433|NCT01406938|102053992|FG003|FAS: Patients Assigned Treatment Drug|Maintenance Period||216||
48700434|NCT01406938|102053993|FG004|FAS: Patients Assigned Treatment Drug|Maintenance Period||206||
48700435|NCT01406938|102053994|FG005|FAS: Patients Assigned Treatment Drug|Maintenance Period||217||
48700436|NCT01406938|102053989|FG000|COMPLETED|Maintenance Period||0||
48700437|NCT01406938|102053990|FG001|COMPLETED|Maintenance Period||0||
48282710|NCT01145898|101014371|FG001|NOT COMPLETED|3-year Treatment||16||
48282711|NCT01200589|101014372|FG000|STARTED|Overall Study||219||
48282712|NCT01200589|101014373|FG001|STARTED|Overall Study||219||
48282713|NCT01200589|101014372|FG000|Intent-to-treat (ITT) Analysis Set|Overall Study||219||
48282714|NCT01200589|101014373|FG001|Intent-to-treat (ITT) Analysis Set|Overall Study||219||
48282715|NCT01200589|101014372|FG000|Safety Set|Overall Study||217||
48282716|NCT01200589|101014373|FG001|Safety Set|Overall Study||218||
48282717|NCT01200589|101014372|FG000|COMPLETED|Overall Study||29||
48282718|NCT01200589|101014373|FG001|COMPLETED|Overall Study||30||
48282719|NCT01200589|101014372|FG000|NOT COMPLETED|Overall Study||190||
48397357|NCT02088541|101302611|FG003|STARTED|Overall Study||44||
48571561|NCT03668119|101731008|FG001|Arm B Rollover|Treatment||22||
48571562|NCT03668119|101731007|FG000|COMPLETED|Treatment||0|Continuing in the treatment period|
48571563|NCT03668119|101731008|FG001|COMPLETED|Treatment||0|Continuing in the treatment period|
48571564|NCT03668119|101731007|FG000|NOT COMPLETED|Treatment||135||
48571565|NCT03668119|101731008|FG001|NOT COMPLETED|Treatment||76||
48700438|NCT01406938|102053991|FG002|COMPLETED|Maintenance Period||186||
48700439|NCT01406938|102053992|FG003|COMPLETED|Maintenance Period||199||
48700440|NCT01406938|102053993|FG004|COMPLETED|Maintenance Period||181||
48700441|NCT01406938|102053994|FG005|COMPLETED|Maintenance Period||201||
48700442|NCT01406938|102053989|FG000|NOT COMPLETED|Maintenance Period||0||
48700443|NCT01406938|102053990|FG001|NOT COMPLETED|Maintenance Period||0||
48571566|NCT00839800|101731009|FG000|STARTED|Overall Study||1049||
48571567|NCT00839800|101731010|FG001|STARTED|Overall Study||1042||
48571568|NCT00839800|101731009|FG000|COMPLETED|Overall Study||956||
48571569|NCT00839800|101731010|FG001|COMPLETED|Overall Study||932||
48571570|NCT00839800|101731009|FG000|NOT COMPLETED|Overall Study||93||
48571571|NCT00839800|101731010|FG001|NOT COMPLETED|Overall Study||110||
48700444|NCT01406938|102053991|FG002|NOT COMPLETED|Maintenance Period||17||
48700445|NCT01406938|102053992|FG003|NOT COMPLETED|Maintenance Period||18||
48700446|NCT01406938|102053993|FG004|NOT COMPLETED|Maintenance Period||25||
48700447|NCT01406938|102053994|FG005|NOT COMPLETED|Maintenance Period||16||
48700448|NCT01406938|102053989|FG000|STARTED|Follow up||26||
48700449|NCT01406938|102053990|FG001|STARTED|Follow up||23||
48700450|NCT01406938|102053991|FG002|STARTED|Follow up||40||
48700451|NCT01406938|102053992|FG003|STARTED|Follow up||39||
48700452|NCT01406938|102053993|FG004|STARTED|Follow up||40||
48700453|NCT01406938|102053994|FG005|STARTED|Follow up||35||
48700454|NCT01406938|102053989|FG000|COMPLETED|Follow up||18||
48282720|NCT01200589|101014373|FG001|NOT COMPLETED|Overall Study||189||
48282721|NCT03063125|101017025|FG000|STARTED|Overall Study||25||
48282722|NCT03063125|101017025|FG000|COMPLETED|Overall Study||23||
48282723|NCT03063125|101017025|FG000|NOT COMPLETED|Overall Study||2||
48571572|NCT00644917|101731011|FG000|STARTED|Overall Study||38||
48282724|NCT02581631|101017026|FG000|STARTED|Overall Study||42||
48282725|NCT02581631|101017027|FG001|STARTED|Overall Study||33||
48571573|NCT00644917|101731011|FG000|COMPLETED|Overall Study||36||
48571574|NCT00644917|101731011|FG000|NOT COMPLETED|Overall Study||2||
48571575|NCT01628198|101731012|FG000|STARTED|Overall Study||38||
48571576|NCT01628198|101731012|FG000|COMPLETED|Overall Study||20||
48571577|NCT01628198|101731012|FG000|NOT COMPLETED|Overall Study||18||
48700455|NCT01406938|102053990|FG001|COMPLETED|Follow up||18||
48700456|NCT01406938|102053991|FG002|COMPLETED|Follow up||32||
48700457|NCT01406938|102053992|FG003|COMPLETED|Follow up||36||
48700458|NCT01406938|102053993|FG004|COMPLETED|Follow up||31||
48700459|NCT01406938|102053994|FG005|COMPLETED|Follow up||32||
48700460|NCT01406938|102053989|FG000|NOT COMPLETED|Follow up||8||
48700461|NCT01406938|102053990|FG001|NOT COMPLETED|Follow up||5||
48700462|NCT01406938|102053991|FG002|NOT COMPLETED|Follow up||8||
48282726|NCT02581631|101017028|FG002|STARTED|Overall Study||29||
48282727|NCT02581631|101017029|FG003|STARTED|Overall Study||10||
48282728|NCT02581631|101017030|FG004|STARTED|Overall Study||30||
48282729|NCT02581631|101017026|FG000|Phase 1 DLT Evaluable Participants|Overall Study||2||
48282730|NCT02581631|101017027|FG001|Phase 1 DLT Evaluable Participants|Overall Study||1||
48282731|NCT02581631|101017028|FG002|Phase 1 DLT Evaluable Participants|Overall Study||3||
48282732|NCT02581631|101017029|FG003|Phase 1 DLT Evaluable Participants|Overall Study||0||
48282733|NCT02581631|101017030|FG004|Phase 1 DLT Evaluable Participants|Overall Study||0||
48397358|NCT02088541|101302612|FG004|STARTED|Overall Study||58||
48700463|NCT01406938|102053992|FG003|NOT COMPLETED|Follow up||3||
48700464|NCT01406938|102053993|FG004|NOT COMPLETED|Follow up||9||
48700465|NCT01406938|102053994|FG005|NOT COMPLETED|Follow up||3||
48700466|NCT05151445|102053995|FG000|STARTED|Overall Study||20|Intended recruitment goal for study was 20|
48571578|NCT02324504|101731013|FG000|STARTED|Overall Study||60||
48571579|NCT02324504|101731013|FG000|COMPLETED|Overall Study||60||
48571580|NCT02324504|101731013|FG000|NOT COMPLETED|Overall Study||0||
48571581|NCT02667704|101731014|FG000|STARTED|Treatment Period 1||13||
48282734|NCT02581631|101017026|FG000|Completed Phase 1 DLT Evaluation|Overall Study||2||
48282735|NCT02581631|101017027|FG001|Completed Phase 1 DLT Evaluation|Overall Study||1||
48282736|NCT02581631|101017028|FG002|Completed Phase 1 DLT Evaluation|Overall Study||3||
48571582|NCT02667704|101731014|FG000|COMPLETED|Treatment Period 1||13||
48571583|NCT02667704|101731014|FG000|NOT COMPLETED|Treatment Period 1||0||
48571584|NCT02667704|101731014|FG000|STARTED|Treatment Period 2||13||
48571585|NCT02667704|101731014|FG000|COMPLETED|Treatment Period 2||13||
48571586|NCT02667704|101731014|FG000|NOT COMPLETED|Treatment Period 2||0||
48125618|NCT04666441|100633680|FG007|STARTED|Overall Study||164|Started = Randomized and treated|
48125619|NCT04666441|100633673|FG000|COMPLETED|Overall Study||80||
48125620|NCT04666441|100633674|FG001|COMPLETED|Overall Study||160||
48125621|NCT04666441|100633675|FG002|COMPLETED|Overall Study||158||
48125622|NCT04666441|100633676|FG003|COMPLETED|Overall Study||161||
48282737|NCT02581631|101017029|FG003|Completed Phase 1 DLT Evaluation|Overall Study||0||
48571587|NCT00981812|101731015|FG000|STARTED|Overall Study||20||
48571588|NCT00981812|101731015|FG000|COMPLETED|Overall Study||20||
48571589|NCT00981812|101731015|FG000|NOT COMPLETED|Overall Study||0||
48282738|NCT02581631|101017030|FG004|Completed Phase 1 DLT Evaluation|Overall Study||0||
48571590|NCT02211209|101731016|FG000|STARTED|Overall Study||34||
48571591|NCT02211209|101731017|FG001|STARTED|Overall Study||33||
48571592|NCT02211209|101731016|FG000|Dosed|Overall Study||33||
48571593|NCT02211209|101731017|FG001|Dosed|Overall Study||33||
48571594|NCT02211209|101731016|FG000|COMPLETED|Overall Study||32||
48571595|NCT02211209|101731017|FG001|COMPLETED|Overall Study||19||
48571596|NCT02211209|101731016|FG000|NOT COMPLETED|Overall Study||2||
48571597|NCT02211209|101731017|FG001|NOT COMPLETED|Overall Study||14||
48571598|NCT02275819|101731018|FG000|STARTED|Overall Study||5||
48571599|NCT02275819|101731019|FG001|STARTED|Overall Study||6||
48571600|NCT02275819|101731018|FG000|COMPLETED|Overall Study||5||
48571601|NCT02275819|101731019|FG001|COMPLETED|Overall Study||5||
48571602|NCT02275819|101731018|FG000|NOT COMPLETED|Overall Study||0||
48571603|NCT02275819|101731019|FG001|NOT COMPLETED|Overall Study||1||
48571604|NCT02649842|101731020|FG000|STARTED|Overall Study||101||
48571605|NCT02649842|101731020|FG000|COMPLETED|Overall Study||101||
48571606|NCT02649842|101731020|FG000|NOT COMPLETED|Overall Study||0||
48571607|NCT00789698|101731021|FG000|STARTED|Overall Study||72||
48571608|NCT00789698|101731022|FG001|STARTED|Overall Study||79||
48571609|NCT00789698|101731023|FG002|STARTED|Overall Study||56||
48571610|NCT00789698|101731024|FG003|STARTED|Overall Study||85||
48571611|NCT00789698|101731021|FG000|COMPLETED|Overall Study||32||
48571612|NCT00789698|101731022|FG001|COMPLETED|Overall Study||46||
48571613|NCT00789698|101731023|FG002|COMPLETED|Overall Study||29||
48700467|NCT05151445|102053995|FG000|Week 4|Overall Study||18||
48700468|NCT05151445|102053995|FG000|Week 8|Overall Study||18||
48700469|NCT05151445|102053995|FG000|COMPLETED|Overall Study||17||
48571614|NCT00789698|101731024|FG003|COMPLETED|Overall Study||33||
48571615|NCT00789698|101731021|FG000|NOT COMPLETED|Overall Study||40||
48571616|NCT00789698|101731022|FG001|NOT COMPLETED|Overall Study||33||
48571617|NCT00789698|101731023|FG002|NOT COMPLETED|Overall Study||27||
48571618|NCT00789698|101731024|FG003|NOT COMPLETED|Overall Study||52||
48571619|NCT00921557|101731025|FG000|STARTED|Weeks 0-48 (on Study Treatment)||17||
48571620|NCT00921557|101731026|FG001|STARTED|Weeks 0-48 (on Study Treatment)||17||
48571621|NCT00921557|101731027|FG002|STARTED|Weeks 0-48 (on Study Treatment)||18||
48125623|NCT04666441|100633677|FG004|COMPLETED|Overall Study||166||
48125624|NCT04666441|100633678|FG005|COMPLETED|Overall Study||79||
48571622|NCT00921557|101731025|FG000|COMPLETED|Weeks 0-48 (on Study Treatment)||15||
48571623|NCT00921557|101731026|FG001|COMPLETED|Weeks 0-48 (on Study Treatment)||17||
48571624|NCT00921557|101731027|FG002|COMPLETED|Weeks 0-48 (on Study Treatment)||18||
48571625|NCT00921557|101731025|FG000|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||2||
48571626|NCT00921557|101731026|FG001|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0||
48571627|NCT00921557|101731027|FG002|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0||
48571628|NCT00921557|101731025|FG000|STARTED|Weeks 48-96 (on Study Treatment)||15||
48125625|NCT04666441|100633679|FG006|COMPLETED|Overall Study||158||
48125626|NCT04666441|100633680|FG007|COMPLETED|Overall Study||160||
48282739|NCT02581631|101017026|FG000|COMPLETED|Overall Study||0||
48282740|NCT02581631|101017027|FG001|COMPLETED|Overall Study||0||
48282741|NCT02581631|101017028|FG002|COMPLETED|Overall Study||0||
48571629|NCT00921557|101731026|FG001|STARTED|Weeks 48-96 (on Study Treatment)||17||
48700470|NCT05151445|102053995|FG000|NOT COMPLETED|Overall Study||3||
48125627|NCT04666441|100633673|FG000|NOT COMPLETED|Overall Study||2||
48282742|NCT02581631|101017029|FG003|COMPLETED|Overall Study||0||
48571630|NCT00921557|101731027|FG002|STARTED|Weeks 48-96 (on Study Treatment)||18||
48571631|NCT00921557|101731025|FG000|COMPLETED|Weeks 48-96 (on Study Treatment)||15||
48571632|NCT00921557|101731026|FG001|COMPLETED|Weeks 48-96 (on Study Treatment)||16||
48571633|NCT00921557|101731027|FG002|COMPLETED|Weeks 48-96 (on Study Treatment)||17||
48571634|NCT00921557|101731025|FG000|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||0||
48571635|NCT00921557|101731026|FG001|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1||
48571636|NCT00921557|101731027|FG002|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1||
48571637|NCT00921557|101731025|FG000|STARTED|Weeks 96-144 (Off Study Treatment)||15||
48571638|NCT00921557|101731026|FG001|STARTED|Weeks 96-144 (Off Study Treatment)||16||
48571639|NCT00921557|101731027|FG002|STARTED|Weeks 96-144 (Off Study Treatment)||17||
48571640|NCT00921557|101731025|FG000|COMPLETED|Weeks 96-144 (Off Study Treatment)||12||
48571641|NCT00921557|101731026|FG001|COMPLETED|Weeks 96-144 (Off Study Treatment)||15||
48571642|NCT00921557|101731027|FG002|COMPLETED|Weeks 96-144 (Off Study Treatment)||16||
48571643|NCT00921557|101731025|FG000|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||3||
48571644|NCT00921557|101731026|FG001|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1||
48571645|NCT00921557|101731027|FG002|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1||
48571646|NCT00746564|101731028|FG000|STARTED|Overall Study||75||
48571647|NCT00746564|101731028|FG000|COMPLETED|Overall Study||73||
48571648|NCT00746564|101731028|FG000|NOT COMPLETED|Overall Study||2||
48571649|NCT02729051|101731029|FG000|STARTED|Overall Study||527||
48571650|NCT02729051|101731030|FG001|STARTED|Overall Study||528||
48571651|NCT02729051|101731029|FG000|COMPLETED|Overall Study||497||
48571652|NCT02729051|101731030|FG001|COMPLETED|Overall Study||496||
48571653|NCT02729051|101731029|FG000|NOT COMPLETED|Overall Study||30||
48571654|NCT02729051|101731030|FG001|NOT COMPLETED|Overall Study||32||
48571655|NCT02027545|101731031|FG000|STARTED|Overall Study||261||
48571656|NCT02027545|101731032|FG001|STARTED|Overall Study||175||
48571657|NCT02027545|101731031|FG000|COMPLETED|Overall Study||258||
48571658|NCT02027545|101731032|FG001|COMPLETED|Overall Study||173||
48571659|NCT02027545|101731031|FG000|NOT COMPLETED|Overall Study||3||
48571660|NCT02027545|101731032|FG001|NOT COMPLETED|Overall Study||2||
48571661|NCT02565628|101731033|FG000|STARTED|Overall Study||10||
48571662|NCT02565628|101731034|FG001|STARTED|Overall Study||9||
48571663|NCT02565628|101731033|FG000|Received Treatment|Overall Study||10||
48571664|NCT02565628|101731034|FG001|Received Treatment|Overall Study||9||
48571665|NCT02565628|101731033|FG000|COMPLETED|Overall Study||10||
48571666|NCT02565628|101731034|FG001|COMPLETED|Overall Study||9||
48571667|NCT02565628|101731033|FG000|NOT COMPLETED|Overall Study||0||
48571668|NCT02565628|101731034|FG001|NOT COMPLETED|Overall Study||0||
48571669|NCT00708552|101731035|FG000|STARTED|Overall Study||145||
48571670|NCT00708552|101731036|FG001|STARTED|Overall Study||145||
48571671|NCT00708552|101731037|FG002|STARTED|Overall Study||133||
48571672|NCT00708552|101731038|FG003|STARTED|Overall Study||151||
48571673|NCT00708552|101731035|FG000|COMPLETED|Overall Study||118||
48571674|NCT00708552|101731036|FG001|COMPLETED|Overall Study||127||
48700471|NCT01491789|102053996|FG000|STARTED|Overall Study||18||
48700472|NCT01491789|102053996|FG000|COMPLETED|Overall Study||14||
48700473|NCT01491789|102053996|FG000|NOT COMPLETED|Overall Study||4||
48700474|NCT00054327|102053997|FG000|STARTED|Overall Study||11||
48700475|NCT00054327|102053998|FG001|STARTED|Overall Study||4||
48700476|NCT00054327|102053999|FG002|STARTED|Overall Study||3||
48700477|NCT00054327|102054000|FG003|STARTED|Overall Study||4||
48700478|NCT00054327|102054001|FG004|STARTED|Overall Study||10||
48571675|NCT00708552|101731037|FG002|COMPLETED|Overall Study||118||
48571676|NCT00708552|101731038|FG003|COMPLETED|Overall Study||130||
48571677|NCT00708552|101731035|FG000|NOT COMPLETED|Overall Study||27||
48571678|NCT00708552|101731036|FG001|NOT COMPLETED|Overall Study||18||
48571679|NCT00708552|101731037|FG002|NOT COMPLETED|Overall Study||15||
48571680|NCT00708552|101731038|FG003|NOT COMPLETED|Overall Study||21||
48571681|NCT00955409|101731039|FG000|STARTED|Overall Study||21||
48571682|NCT00955409|101731040|FG001|STARTED|Overall Study||6||
48571683|NCT00955409|101731041|FG002|STARTED|Overall Study||41||
48571684|NCT00955409|101731042|FG003|STARTED|Overall Study||25||
48571685|NCT00955409|101731043|FG004|STARTED|Overall Study||5||
48571686|NCT00955409|101731044|FG005|STARTED|Overall Study||9||
48571687|NCT00955409|101731045|FG006|STARTED|Overall Study||27||
48571688|NCT00955409|101731046|FG007|STARTED|Overall Study||6||
48571689|NCT00955409|101731047|FG008|STARTED|Overall Study||16||
48571690|NCT00955409|101731048|FG009|STARTED|Overall Study||4||
48571691|NCT00955409|101731039|FG000|Treated|Overall Study||21||
48571692|NCT00955409|101731040|FG001|Treated|Overall Study||6||
48700479|NCT00054327|102054002|FG005|STARTED|Overall Study||2||
48700480|NCT00054327|102053997|FG000|COMPLETED|Overall Study||10||
48700481|NCT00054327|102053998|FG001|COMPLETED|Overall Study||4||
48700482|NCT00054327|102053999|FG002|COMPLETED|Overall Study||3||
48700483|NCT00054327|102054000|FG003|COMPLETED|Overall Study||4||
48700484|NCT00054327|102054001|FG004|COMPLETED|Overall Study||10||
48700485|NCT00054327|102054002|FG005|COMPLETED|Overall Study||2||
48571693|NCT00955409|101731041|FG002|Treated|Overall Study||41||
48571694|NCT00955409|101731042|FG003|Treated|Overall Study||24||
48571695|NCT00955409|101731043|FG004|Treated|Overall Study||5||
48700486|NCT00054327|102053997|FG000|NOT COMPLETED|Overall Study||1||
48700487|NCT00054327|102053998|FG001|NOT COMPLETED|Overall Study||0||
48700488|NCT00054327|102053999|FG002|NOT COMPLETED|Overall Study||0||
48700489|NCT00054327|102054000|FG003|NOT COMPLETED|Overall Study||0||
48571696|NCT00955409|101731044|FG005|Treated|Overall Study||9||
48571697|NCT00955409|101731045|FG006|Treated|Overall Study||27||
48571698|NCT00955409|101731046|FG007|Treated|Overall Study||6||
48571699|NCT00955409|101731047|FG008|Treated|Overall Study||16||
48571700|NCT00955409|101731048|FG009|Treated|Overall Study||4||
48571701|NCT00955409|101731039|FG000|Completed Treatment|Overall Study||12||
48571702|NCT00955409|101731040|FG001|Completed Treatment|Overall Study||5||
48571703|NCT00955409|101731041|FG002|Completed Treatment|Overall Study||15||
48571704|NCT00955409|101731042|FG003|Completed Treatment|Overall Study||17||
48571705|NCT00955409|101731043|FG004|Completed Treatment|Overall Study||3||
48571706|NCT00955409|101731044|FG005|Completed Treatment|Overall Study||7||
48571707|NCT00955409|101731045|FG006|Completed Treatment|Overall Study||4||
48571708|NCT00955409|101731046|FG007|Completed Treatment|Overall Study||3||
48571709|NCT00955409|101731047|FG008|Completed Treatment|Overall Study||2||
48700490|NCT00054327|102054001|FG004|NOT COMPLETED|Overall Study||0||
48571710|NCT00955409|101731048|FG009|Completed Treatment|Overall Study||4||
48571711|NCT00955409|101731039|FG000|COMPLETED|Overall Study||11||
48571712|NCT00955409|101731040|FG001|COMPLETED|Overall Study||5||
48700491|NCT00054327|102054002|FG005|NOT COMPLETED|Overall Study||0||
48700492|NCT01667224|102054003|FG000|STARTED|Overall Study||40||
48700493|NCT01667224|102054004|FG001|STARTED|Overall Study||40||
48700494|NCT01667224|102054003|FG000|COMPLETED|Overall Study||36||
48700495|NCT01667224|102054004|FG001|COMPLETED|Overall Study||38||
48700496|NCT01667224|102054003|FG000|NOT COMPLETED|Overall Study||4||
48700497|NCT01667224|102054004|FG001|NOT COMPLETED|Overall Study||2||
48700498|NCT00666588|102054005|FG000|STARTED|Overall Study||18||
48700499|NCT00666588|102054006|FG001|STARTED|Overall Study||6||
48700500|NCT00666588|102054007|FG002|STARTED|Overall Study||6||
48700501|NCT00666588|102054008|FG003|STARTED|Overall Study||22||
48571713|NCT00955409|101731041|FG002|COMPLETED|Overall Study||15||
48571714|NCT00955409|101731042|FG003|COMPLETED|Overall Study||17||
48571715|NCT00955409|101731043|FG004|COMPLETED|Overall Study||3||
48571716|NCT00955409|101731044|FG005|COMPLETED|Overall Study||6||
48571717|NCT00955409|101731045|FG006|COMPLETED|Overall Study||3||
48571718|NCT00955409|101731046|FG007|COMPLETED|Overall Study||2||
48571719|NCT00955409|101731047|FG008|COMPLETED|Overall Study||2||
48571720|NCT00955409|101731048|FG009|COMPLETED|Overall Study||3||
48571721|NCT00955409|101731039|FG000|NOT COMPLETED|Overall Study||10||
48571722|NCT00955409|101731040|FG001|NOT COMPLETED|Overall Study||1||
48700502|NCT00666588|102054005|FG000|COMPLETED|Overall Study||14||
48700503|NCT00666588|102054006|FG001|COMPLETED|Overall Study||6||
48700504|NCT00666588|102054007|FG002|COMPLETED|Overall Study||6||
48700505|NCT00666588|102054008|FG003|COMPLETED|Overall Study||20||
48700506|NCT00666588|102054005|FG000|NOT COMPLETED|Overall Study||4||
48700507|NCT00666588|102054006|FG001|NOT COMPLETED|Overall Study||0||
48700508|NCT00666588|102054007|FG002|NOT COMPLETED|Overall Study||0||
48700509|NCT00666588|102054008|FG003|NOT COMPLETED|Overall Study||2||
48700510|NCT02975999|102054009|FG000|STARTED|Overall Study||6||
48700511|NCT02975999|102054010|FG001|STARTED|Overall Study||6||
48571723|NCT00955409|101731041|FG002|NOT COMPLETED|Overall Study||26||
48571724|NCT00955409|101731042|FG003|NOT COMPLETED|Overall Study||8||
48571725|NCT00955409|101731043|FG004|NOT COMPLETED|Overall Study||2||
48571726|NCT00955409|101731044|FG005|NOT COMPLETED|Overall Study||3||
48571727|NCT00955409|101731045|FG006|NOT COMPLETED|Overall Study||24||
48571728|NCT00955409|101731046|FG007|NOT COMPLETED|Overall Study||4||
48571729|NCT00955409|101731047|FG008|NOT COMPLETED|Overall Study||14||
48571730|NCT00955409|101731048|FG009|NOT COMPLETED|Overall Study||1||
48571731|NCT01326104|101731049|FG000|STARTED|Overall Study||7||
48571732|NCT01326104|101731050|FG001|STARTED|Overall Study||19||
48571733|NCT01326104|101731049|FG000|COMPLETED|Overall Study||7||
48571734|NCT01326104|101731050|FG001|COMPLETED|Overall Study||15||
48571735|NCT01326104|101731049|FG000|NOT COMPLETED|Overall Study||0||
48571736|NCT01326104|101731050|FG001|NOT COMPLETED|Overall Study||4||
48571737|NCT04306965|101731051|FG000|STARTED|Overall Study||10||
48571738|NCT04306965|101731051|FG000|COMPLETED|Overall Study||4||
48571739|NCT04306965|101731051|FG000|NOT COMPLETED|Overall Study||6||
48571740|NCT04089904|101731052|FG000|STARTED|Overall Study||3||
48571741|NCT04089904|101731052|FG000|COMPLETED|Overall Study||3||
48571742|NCT04089904|101731052|FG000|NOT COMPLETED|Overall Study||0||
48571743|NCT02088905|101731053|FG000|STARTED|Overall Study||13||
48571744|NCT02088905|101731054|FG001|STARTED|Overall Study||10||
48571745|NCT02088905|101731053|FG000|Week 9|Overall Study||10|Last Observation Carried Forward for 10 treatment and 9 wait list who completed Week 9 Assessment|
48571746|NCT02088905|101731054|FG001|Week 9|Overall Study||9|Last Observation Carried Forward for 10 treatment and 9 wait list who completed Week 9 Assessment|
48571747|NCT02088905|101731053|FG000|COMPLETED|Overall Study||8|Last Observation Carried Forward for 10 treatment and 9 wait list who completed Week 9 Assessment|
48571748|NCT02088905|101731054|FG001|COMPLETED|Overall Study||9|Last Observation Carried Forward for 10 treatment and 9 wait list who completed Week 9 Assessment|
48571749|NCT02088905|101731053|FG000|NOT COMPLETED|Overall Study||5||
48571750|NCT02088905|101731054|FG001|NOT COMPLETED|Overall Study||1||
48571751|NCT02464163|101731055|FG000|STARTED|Overall Study||102||
48571752|NCT02464163|101731056|FG001|STARTED|Overall Study||102||
48571753|NCT02464163|101731057|FG002|STARTED|Overall Study||102||
48571754|NCT02464163|101731058|FG003|STARTED|Overall Study||101||
48571755|NCT02464163|101731055|FG000|COMPLETED|Overall Study||99||
48571756|NCT02464163|101731056|FG001|COMPLETED|Overall Study||94||
48571757|NCT02464163|101731057|FG002|COMPLETED|Overall Study||97||
48571758|NCT02464163|101731058|FG003|COMPLETED|Overall Study||96||
48571759|NCT02464163|101731055|FG000|NOT COMPLETED|Overall Study||3||
48571760|NCT02464163|101731056|FG001|NOT COMPLETED|Overall Study||8||
48571761|NCT02464163|101731057|FG002|NOT COMPLETED|Overall Study||5||
48571762|NCT02464163|101731058|FG003|NOT COMPLETED|Overall Study||5||
48571763|NCT00734162|101731059|FG000|STARTED|Randomized Phase (Through Week 72)||10||
48571764|NCT00734162|101731060|FG001|STARTED|Randomized Phase (Through Week 72)||42||
48571765|NCT00734162|101731061|FG002|STARTED|Randomized Phase (Through Week 72)||13||
48571766|NCT00734162|101731062|FG003|STARTED|Randomized Phase (Through Week 72)||41||
48571767|NCT00734162|101731059|FG000|COMPLETED|Randomized Phase (Through Week 72)||10||
48571768|NCT00734162|101731060|FG001|COMPLETED|Randomized Phase (Through Week 72)||41||
48571769|NCT00734162|101731061|FG002|COMPLETED|Randomized Phase (Through Week 72)||13||
48571770|NCT00734162|101731062|FG003|COMPLETED|Randomized Phase (Through Week 72)||37||
48571771|NCT00734162|101731059|FG000|NOT COMPLETED|Randomized Phase (Through Week 72)||0||
48571772|NCT00734162|101731060|FG001|NOT COMPLETED|Randomized Phase (Through Week 72)||1||
48571773|NCT00734162|101731061|FG002|NOT COMPLETED|Randomized Phase (Through Week 72)||0||
48571774|NCT00734162|101731062|FG003|NOT COMPLETED|Randomized Phase (Through Week 72)||4||
48571775|NCT00734162|101731059|FG000|STARTED|Open-Label Phase||10||
48571776|NCT00734162|101731060|FG001|STARTED|Open-Label Phase||41||
48571777|NCT00734162|101731061|FG002|STARTED|Open-Label Phase||13||
48700512|NCT02975999|102054009|FG000|COMPLETED|Overall Study||6||
48700513|NCT02975999|102054010|FG001|COMPLETED|Overall Study||6||
48700514|NCT02975999|102054009|FG000|NOT COMPLETED|Overall Study||0||
48700515|NCT02975999|102054010|FG001|NOT COMPLETED|Overall Study||0||
48700516|NCT01257568|102054011|FG000|STARTED|Overall Study||40||42
48571778|NCT00734162|101731062|FG003|STARTED|Open-Label Phase||39||
48571779|NCT00734162|101731059|FG000|COMPLETED|Open-Label Phase||7||
48571780|NCT00734162|101731060|FG001|COMPLETED|Open-Label Phase||39||
48571781|NCT00734162|101731061|FG002|COMPLETED|Open-Label Phase||12||
48571782|NCT00734162|101731062|FG003|COMPLETED|Open-Label Phase||36||
48571783|NCT00734162|101731059|FG000|NOT COMPLETED|Open-Label Phase||3||
48571784|NCT00734162|101731060|FG001|NOT COMPLETED|Open-Label Phase||2||
48571785|NCT00734162|101731061|FG002|NOT COMPLETED|Open-Label Phase||1||
48571786|NCT00734162|101731062|FG003|NOT COMPLETED|Open-Label Phase||3||
48700517|NCT01257568|102054011|FG000|COMPLETED|Overall Study||7||9
48700518|NCT01257568|102054011|FG000|NOT COMPLETED|Overall Study||33||33
48571787|NCT01081769|101731063|FG000|STARTED|Whole Intent-to-Treat||376||
48571788|NCT01081769|101731064|FG001|STARTED|Whole Intent-to-Treat||388||
48571789|NCT01081769|101731063|FG000|COMPLETED|Whole Intent-to-Treat||352||
48571790|NCT01081769|101731064|FG001|COMPLETED|Whole Intent-to-Treat||363||
48571791|NCT01081769|101731063|FG000|NOT COMPLETED|Whole Intent-to-Treat||24||
48571792|NCT01081769|101731064|FG001|NOT COMPLETED|Whole Intent-to-Treat||25||
48571793|NCT01081769|101731063|FG000|STARTED|CORE Intent-To-Treat||352||
48571794|NCT01081769|101731064|FG001|STARTED|CORE Intent-To-Treat||363||
48571795|NCT01081769|101731063|FG000|COMPLETED|CORE Intent-To-Treat||272||
48571796|NCT01081769|101731064|FG001|COMPLETED|CORE Intent-To-Treat||266||
48571797|NCT01081769|101731063|FG000|NOT COMPLETED|CORE Intent-To-Treat||80||
48571798|NCT01081769|101731064|FG001|NOT COMPLETED|CORE Intent-To-Treat||97||
48571799|NCT02203721|101731065|FG000|STARTED|Overall Study||148||
48571800|NCT02203721|101731066|FG001|STARTED|Overall Study||151||
48571801|NCT02203721|101731065|FG000|COMPLETED|Overall Study||147||
48571802|NCT02203721|101731066|FG001|COMPLETED|Overall Study||148||
48571803|NCT02203721|101731065|FG000|NOT COMPLETED|Overall Study||1||
48571804|NCT02203721|101731066|FG001|NOT COMPLETED|Overall Study||3||
48571805|NCT02143973|101731067|FG000|STARTED|Overall Study||167||
48571806|NCT02143973|101731067|FG000|COMPLETED|Overall Study||101||
48571807|NCT02143973|101731067|FG000|NOT COMPLETED|Overall Study||66||
48571808|NCT02400996|101731068|FG000|STARTED|Overall Study||40||
48571809|NCT02400996|101731068|FG000|COMPLETED|Overall Study||40||
48571810|NCT02400996|101731068|FG000|NOT COMPLETED|Overall Study||0||
48571811|NCT00072280|101731069|FG000|STARTED|Treatment||3||
48571812|NCT00072280|101731070|FG001|STARTED|Treatment||4||
48571813|NCT00072280|101731069|FG000|COMPLETED|Treatment||2||
48571814|NCT00072280|101731070|FG001|COMPLETED|Treatment||2||
48571815|NCT00072280|101731069|FG000|NOT COMPLETED|Treatment||1||
48571816|NCT00072280|101731070|FG001|NOT COMPLETED|Treatment||2||
48571817|NCT00072280|101731069|FG000|STARTED|Follow-up||2||
48571818|NCT00072280|101731070|FG001|STARTED|Follow-up||2||
48571819|NCT00072280|101731069|FG000|COMPLETED|Follow-up||0||
48571820|NCT00072280|101731070|FG001|COMPLETED|Follow-up||0||
48571821|NCT00072280|101731069|FG000|NOT COMPLETED|Follow-up||2||
48571822|NCT00072280|101731070|FG001|NOT COMPLETED|Follow-up||2||
48571823|NCT01417156|101731071|FG000|STARTED|Overall Study||20||
48700519|NCT01054560|102054012|FG000|STARTED|Overall Study||58||
48700520|NCT01054560|102054013|FG001|STARTED|Overall Study||55||
48125628|NCT04666441|100633674|FG001|NOT COMPLETED|Overall Study||5||
48125629|NCT04666441|100633675|FG002|NOT COMPLETED|Overall Study||4||
48125630|NCT04666441|100633676|FG003|NOT COMPLETED|Overall Study||4||
48125631|NCT04666441|100633677|FG004|NOT COMPLETED|Overall Study||0||
48125632|NCT04666441|100633678|FG005|NOT COMPLETED|Overall Study||3||
48125633|NCT04666441|100633679|FG006|NOT COMPLETED|Overall Study||5||
48125634|NCT04666441|100633680|FG007|NOT COMPLETED|Overall Study||4||
48125635|NCT01723904|100633681|FG000|STARTED|Overall Study||90||
48125636|NCT01723904|100633681|FG000|COMPLETED|Overall Study||79||
48125637|NCT01723904|100633681|FG000|NOT COMPLETED|Overall Study||11||
48125638|NCT00304070|100633682|FG000|STARTED|Overall Study||24||
48125639|NCT00304070|100633683|FG001|STARTED|Overall Study||15||
48125640|NCT00304070|100633684|FG002|STARTED|Overall Study||39||
48700521|NCT01054560|102054012|FG000|COMPLETED|Overall Study||45||
48700522|NCT01054560|102054013|FG001|COMPLETED|Overall Study||27||
48700523|NCT01054560|102054012|FG000|NOT COMPLETED|Overall Study||13||
48125641|NCT00304070|100633682|FG000|COMPLETED|Overall Study||21||
48125642|NCT00304070|100633683|FG001|COMPLETED|Overall Study||8||
48125643|NCT00304070|100633684|FG002|COMPLETED|Overall Study||27||
48125644|NCT00304070|100633682|FG000|NOT COMPLETED|Overall Study||3||
48125645|NCT00304070|100633683|FG001|NOT COMPLETED|Overall Study||7||
48125646|NCT00304070|100633684|FG002|NOT COMPLETED|Overall Study||12||
48125647|NCT01016834|100633685|FG000|STARTED|Overall Study||242||
48125648|NCT01016834|100633685|FG000|COMPLETED|Overall Study||220||
48125649|NCT01016834|100633685|FG000|NOT COMPLETED|Overall Study||22||
48125650|NCT02284828|100633686|FG000|STARTED|Overall Study||26||
48125651|NCT02284828|100633686|FG000|COMPLETED|Overall Study||22||
48125652|NCT02284828|100633686|FG000|NOT COMPLETED|Overall Study||4||
48125653|NCT02486406|100633687|FG000|STARTED|Overall Study||12||
48125654|NCT02486406|100633688|FG001|STARTED|Overall Study||26||
48125655|NCT02486406|100633689|FG002|STARTED|Overall Study||12||
48125656|NCT02486406|100633690|FG003|STARTED|Overall Study||14||
48125657|NCT02486406|100633687|FG000|COMPLETED|Overall Study||10||
48125658|NCT02486406|100633688|FG001|COMPLETED|Overall Study||23||
48125659|NCT02486406|100633689|FG002|COMPLETED|Overall Study||10||
48571824|NCT01417156|101731071|FG000|COMPLETED|Overall Study||6||
48571825|NCT01417156|101731071|FG000|NOT COMPLETED|Overall Study||14||
48571826|NCT03417557|101731072|FG000|STARTED|1st Intervention (3 Hours)||8||
48571827|NCT03417557|101731073|FG001|STARTED|1st Intervention (3 Hours)||9||
48571828|NCT03417557|101731072|FG000|COMPLETED|1st Intervention (3 Hours)||8||
48571829|NCT03417557|101731073|FG001|COMPLETED|1st Intervention (3 Hours)||9||
48571830|NCT03417557|101731072|FG000|NOT COMPLETED|1st Intervention (3 Hours)||0||
48571831|NCT03417557|101731073|FG001|NOT COMPLETED|1st Intervention (3 Hours)||0||
48571832|NCT03417557|101731072|FG000|STARTED|2nd Intervention (3 Hours)||9||
48700524|NCT01054560|102054013|FG001|NOT COMPLETED|Overall Study||28||
48125660|NCT02486406|100633690|FG003|COMPLETED|Overall Study||10||
48125661|NCT02486406|100633687|FG000|NOT COMPLETED|Overall Study||2||
48125662|NCT02486406|100633688|FG001|NOT COMPLETED|Overall Study||3||
48125663|NCT02486406|100633689|FG002|NOT COMPLETED|Overall Study||2||
48125664|NCT02486406|100633690|FG003|NOT COMPLETED|Overall Study||4||
48125665|NCT02617589|100633691|FG000|STARTED|Randomization||280||
48125666|NCT02617589|100633692|FG001|STARTED|Randomization||280||
48125667|NCT02617589|100633691|FG000|COMPLETED|Randomization||278||
48125668|NCT02617589|100633692|FG001|COMPLETED|Randomization||275||
48125669|NCT02617589|100633691|FG000|NOT COMPLETED|Randomization||2||
48125670|NCT02617589|100633692|FG001|NOT COMPLETED|Randomization||5||
48125671|NCT02617589|100633691|FG000|STARTED|Treatment||278||
48125672|NCT02617589|100633692|FG001|STARTED|Treatment||275||
48125673|NCT02617589|100633691|FG000|COMPLETED|Treatment||0||
48125674|NCT02617589|100633692|FG001|COMPLETED|Treatment||76||
48125675|NCT02617589|100633691|FG000|NOT COMPLETED|Treatment||278||
48125676|NCT02617589|100633692|FG001|NOT COMPLETED|Treatment||199||
48125677|NCT00955877|100633693|FG000|STARTED|Overall Study||6||
48125678|NCT00955877|100633694|FG001|STARTED|Overall Study||0||
48125679|NCT00955877|100633695|FG002|STARTED|Overall Study||7||
48125680|NCT00955877|100633693|FG000|COMPLETED|Overall Study||6||
48125681|NCT00955877|100633694|FG001|COMPLETED|Overall Study||0||
48125682|NCT00955877|100633695|FG002|COMPLETED|Overall Study||7||
48125683|NCT00955877|100633693|FG000|NOT COMPLETED|Overall Study||0||
48125684|NCT00955877|100633694|FG001|NOT COMPLETED|Overall Study||0||
48125685|NCT00955877|100633695|FG002|NOT COMPLETED|Overall Study||0||
48125686|NCT01993719|100633696|FG000|STARTED|First Drug Administration||8||
48125687|NCT01993719|100633697|FG001|STARTED|First Drug Administration||11||
48125688|NCT01993719|100633698|FG002|STARTED|First Drug Administration||3||
48125689|NCT01993719|100633699|FG003|STARTED|First Drug Administration||9||
48125690|NCT01993719|100633700|FG004|STARTED|First Drug Administration||2||
48125691|NCT01993719|100633696|FG000|COMPLETED|First Drug Administration||7||
48125692|NCT01993719|100633697|FG001|COMPLETED|First Drug Administration||11||
48125693|NCT01993719|100633698|FG002|COMPLETED|First Drug Administration||3||
48125694|NCT01993719|100633699|FG003|COMPLETED|First Drug Administration||9||
48125695|NCT01993719|100633700|FG004|COMPLETED|First Drug Administration||2||
48125696|NCT01993719|100633696|FG000|NOT COMPLETED|First Drug Administration||1||
48125697|NCT01993719|100633697|FG001|NOT COMPLETED|First Drug Administration||0||
48125698|NCT01993719|100633698|FG002|NOT COMPLETED|First Drug Administration||0||
48125699|NCT01993719|100633699|FG003|NOT COMPLETED|First Drug Administration||0||
48125700|NCT01993719|100633700|FG004|NOT COMPLETED|First Drug Administration||0||
48125701|NCT01993719|100633696|FG000|STARTED|Retreatment After First Drug Administrat||0||
48125702|NCT01993719|100633697|FG001|STARTED|Retreatment After First Drug Administrat||0||
48125703|NCT01993719|100633698|FG002|STARTED|Retreatment After First Drug Administrat||3||
48125704|NCT01993719|100633699|FG003|STARTED|Retreatment After First Drug Administrat||0||
48125705|NCT01993719|100633700|FG004|STARTED|Retreatment After First Drug Administrat||2||
48125706|NCT01993719|100633696|FG000|COMPLETED|Retreatment After First Drug Administrat||0||
48125707|NCT01993719|100633697|FG001|COMPLETED|Retreatment After First Drug Administrat||0||
48125708|NCT01993719|100633698|FG002|COMPLETED|Retreatment After First Drug Administrat||3||
48125709|NCT01993719|100633699|FG003|COMPLETED|Retreatment After First Drug Administrat||0||
48125710|NCT01993719|100633700|FG004|COMPLETED|Retreatment After First Drug Administrat||2||
48125711|NCT01993719|100633696|FG000|NOT COMPLETED|Retreatment After First Drug Administrat||0||
48125712|NCT01993719|100633697|FG001|NOT COMPLETED|Retreatment After First Drug Administrat||0||
48125713|NCT01993719|100633698|FG002|NOT COMPLETED|Retreatment After First Drug Administrat||0||
48125714|NCT01993719|100633699|FG003|NOT COMPLETED|Retreatment After First Drug Administrat||0||
48125715|NCT01993719|100633700|FG004|NOT COMPLETED|Retreatment After First Drug Administrat||0||
48125716|NCT02348489|100633701|FG000|STARTED|Overall Study||408||
48125717|NCT02348489|100633702|FG001|STARTED|Overall Study||407||
48125718|NCT02348489|100633701|FG000|COMPLETED|Overall Study||55||
48125719|NCT02348489|100633702|FG001|COMPLETED|Overall Study||40||
48125720|NCT02348489|100633701|FG000|NOT COMPLETED|Overall Study||353||
48125721|NCT02348489|100633702|FG001|NOT COMPLETED|Overall Study||367||
48125722|NCT03054844|100633703|FG000|STARTED|Overall Study||28||
48125723|NCT03054844|100633704|FG001|STARTED|Overall Study||27||
48125724|NCT03054844|100633703|FG000|COMPLETED|Overall Study||25||
48125725|NCT03054844|100633704|FG001|COMPLETED|Overall Study||26||
48125726|NCT03054844|100633703|FG000|NOT COMPLETED|Overall Study||3||
48125727|NCT03054844|100633704|FG001|NOT COMPLETED|Overall Study||1||
48125728|NCT01083433|100633705|FG000|STARTED|Overall Study||22||
48282743|NCT02581631|101017030|FG004|COMPLETED|Overall Study||0||
48125729|NCT01083433|100633706|FG001|STARTED|Overall Study||23||
48125730|NCT01083433|100633707|FG002|STARTED|Overall Study||23||
48125731|NCT01083433|100633705|FG000|COMPLETED|Overall Study||20||
48125732|NCT01083433|100633706|FG001|COMPLETED|Overall Study||17||
48125733|NCT01083433|100633707|FG002|COMPLETED|Overall Study||18||
48125734|NCT01083433|100633705|FG000|NOT COMPLETED|Overall Study||2||
48282744|NCT02581631|101017026|FG000|NOT COMPLETED|Overall Study||42||
48125735|NCT01083433|100633706|FG001|NOT COMPLETED|Overall Study||6||
48125736|NCT01083433|100633707|FG002|NOT COMPLETED|Overall Study||5||
48125737|NCT00889421|100633708|FG000|STARTED|Overall Study||3||
48125738|NCT00889421|100633708|FG000|COMPLETED|Overall Study||0||
48125739|NCT00889421|100633708|FG000|NOT COMPLETED|Overall Study||3||
48125740|NCT04788147|100633709|FG000|STARTED|Overall Study||11||
48571833|NCT03417557|101731073|FG001|STARTED|2nd Intervention (3 Hours)||8||
48571834|NCT03417557|101731072|FG000|COMPLETED|2nd Intervention (3 Hours)||9||
48571835|NCT03417557|101731073|FG001|COMPLETED|2nd Intervention (3 Hours)||8||
48571836|NCT03417557|101731072|FG000|NOT COMPLETED|2nd Intervention (3 Hours)||0||
48571837|NCT03417557|101731073|FG001|NOT COMPLETED|2nd Intervention (3 Hours)||0||
48571838|NCT02187198|101731074|FG000|STARTED|Overall Study||5||
48571839|NCT02187198|101731075|FG001|STARTED|Overall Study||4||
48571840|NCT02187198|101731074|FG000|COMPLETED|Overall Study||4||
48571841|NCT02187198|101731075|FG001|COMPLETED|Overall Study||3||
48571842|NCT02187198|101731074|FG000|NOT COMPLETED|Overall Study||1||
48571843|NCT02187198|101731075|FG001|NOT COMPLETED|Overall Study||1||
48700525|NCT02302092|102054014|FG000|STARTED|Overall Study||6||
48700526|NCT02302092|102054015|FG001|STARTED|Overall Study||7||
48700527|NCT02302092|102054014|FG000|COMPLETED|Overall Study||6||
48700528|NCT02302092|102054015|FG001|COMPLETED|Overall Study||7||
48700529|NCT02302092|102054014|FG000|NOT COMPLETED|Overall Study||0||
48700530|NCT02302092|102054015|FG001|NOT COMPLETED|Overall Study||0||
48700531|NCT01005316|102054016|FG000|STARTED|Overall Study||50||
48700532|NCT01005316|102054017|FG001|STARTED|Overall Study||97||
48700533|NCT01005316|102054018|FG002|STARTED|Overall Study||16||
48700534|NCT01005316|102054019|FG003|STARTED|Overall Study||127||
48700535|NCT01005316|102054016|FG000|COMPLETED|Overall Study||0||
48700536|NCT01005316|102054017|FG001|COMPLETED|Overall Study||21||
48571844|NCT01757535|101731076|FG000|STARTED|Overall Study||238|Treatment Phase|
48571845|NCT01757535|101731077|FG001|STARTED|Overall Study||234|Treatment Phase|
48571846|NCT01757535|101731076|FG000|Received Treatment|Overall Study||236||
48571847|NCT01757535|101731077|FG001|Received Treatment|Overall Study||233||
48700537|NCT01005316|102054018|FG002|COMPLETED|Overall Study||5||
48700538|NCT01005316|102054019|FG003|COMPLETED|Overall Study||19||
48700539|NCT01005316|102054016|FG000|NOT COMPLETED|Overall Study||50||
48700540|NCT01005316|102054017|FG001|NOT COMPLETED|Overall Study||76||
48700541|NCT01005316|102054018|FG002|NOT COMPLETED|Overall Study||11||
48700542|NCT01005316|102054019|FG003|NOT COMPLETED|Overall Study||108||
48700543|NCT00336284|102054020|FG000|STARTED|Overall Study||977||
48700544|NCT00336284|102054021|FG001|STARTED|Overall Study||473||
48700545|NCT00336284|102054020|FG000|COMPLETED|Overall Study||741||
48700546|NCT00336284|102054021|FG001|COMPLETED|Overall Study||322||
48700547|NCT00336284|102054020|FG000|NOT COMPLETED|Overall Study||236||
48125741|NCT04788147|100633710|FG001|STARTED|Overall Study||19||
48125742|NCT04788147|100633709|FG000|Enrolled (Received FDG Injection)|Overall Study||8||
48125743|NCT04788147|100633710|FG001|Enrolled (Received FDG Injection)|Overall Study||9||
48125744|NCT04788147|100633709|FG000|COMPLETED|Overall Study||6||
48125745|NCT04788147|100633710|FG001|COMPLETED|Overall Study||9||
48125746|NCT04788147|100633709|FG000|NOT COMPLETED|Overall Study||5||
48125747|NCT04788147|100633710|FG001|NOT COMPLETED|Overall Study||10||
48125748|NCT03586869|100633711|FG000|STARTED|Overall Study||3||
48125749|NCT03586869|100633711|FG000|COMPLETED|Overall Study||0||
48125750|NCT03586869|100633711|FG000|NOT COMPLETED|Overall Study||3||
48282745|NCT02581631|101017027|FG001|NOT COMPLETED|Overall Study||33||
48571848|NCT01757535|101731076|FG000|COMPLETED|Overall Study||45|Completed = treatment ongoing|
48700548|NCT00336284|102054021|FG001|NOT COMPLETED|Overall Study||151||
48700549|NCT01942161|102054022|FG000|STARTED|Overall Study||35||
48700550|NCT01942161|102054023|FG001|STARTED|Overall Study||30||
48700551|NCT01942161|102054024|FG002|STARTED|Overall Study||41||
48700552|NCT01942161|102054022|FG000|COMPLETED|Overall Study||27||
48700553|NCT01942161|102054023|FG001|COMPLETED|Overall Study||24||
48700554|NCT01942161|102054024|FG002|COMPLETED|Overall Study||35||
48125751|NCT01663636|100633712|FG000|STARTED|Infant SMS Reminder Feasibility Study||160||
48125752|NCT01663636|100633713|FG001|STARTED|Infant SMS Reminder Feasibility Study||161||
48571849|NCT01757535|101731077|FG001|COMPLETED|Overall Study||26|Completed = treatment ongoing|
48571850|NCT01757535|101731076|FG000|NOT COMPLETED|Overall Study||193||
48571851|NCT01757535|101731077|FG001|NOT COMPLETED|Overall Study||208||
48571852|NCT01139125|101731078|FG000|STARTED|Overall Study||3||
48571853|NCT01139125|101731078|FG000|COMPLETED|Overall Study||2||
48571854|NCT01139125|101731078|FG000|NOT COMPLETED|Overall Study||1||
48571855|NCT05136885|101731079|FG000|STARTED|Overall Study||120||
48571856|NCT05136885|101731080|FG001|STARTED|Overall Study||41||
48571857|NCT05136885|101731079|FG000|COMPLETED|Overall Study||92||
48700555|NCT01942161|102054022|FG000|NOT COMPLETED|Overall Study||8||
48700556|NCT01942161|102054023|FG001|NOT COMPLETED|Overall Study||6||
48700557|NCT01942161|102054024|FG002|NOT COMPLETED|Overall Study||6||
48700558|NCT04086693|102054025|FG000|STARTED|Overall Study||175||
48700559|NCT04086693|102054026|FG001|STARTED|Overall Study||175||
48700560|NCT04086693|102054025|FG000|COMPLETED|Overall Study||174||
48700561|NCT04086693|102054026|FG001|COMPLETED|Overall Study||171||
48700562|NCT04086693|102054025|FG000|NOT COMPLETED|Overall Study||1||
48125753|NCT01663636|100633712|FG000|COMPLETED|Infant SMS Reminder Feasibility Study||135||
48125754|NCT01663636|100633713|FG001|COMPLETED|Infant SMS Reminder Feasibility Study||130||
48125755|NCT01663636|100633712|FG000|NOT COMPLETED|Infant SMS Reminder Feasibility Study||25||
48125756|NCT01663636|100633713|FG001|NOT COMPLETED|Infant SMS Reminder Feasibility Study||31||
48125757|NCT01663636|100633712|FG000|STARTED|Parent SMS Acceptability Assessment||135||
48125758|NCT01663636|100633713|FG001|STARTED|Parent SMS Acceptability Assessment||130||
48125759|NCT01663636|100633712|FG000|COMPLETED|Parent SMS Acceptability Assessment||135||
48125760|NCT01663636|100633713|FG001|COMPLETED|Parent SMS Acceptability Assessment||130||
48125761|NCT01663636|100633712|FG000|NOT COMPLETED|Parent SMS Acceptability Assessment||0||
48125762|NCT01663636|100633713|FG001|NOT COMPLETED|Parent SMS Acceptability Assessment||0||
48125763|NCT03238001|100633714|FG000|STARTED|Visit 1 (Primary Endpoint Cohort)||436||
48125764|NCT03238001|100633714|FG000|COMPLETED|Visit 1 (Primary Endpoint Cohort)||432||
48125765|NCT03238001|100633714|FG000|NOT COMPLETED|Visit 1 (Primary Endpoint Cohort)||4||
48125766|NCT03238001|100633714|FG000|STARTED|Visit 2 (Secondary Endpoint Cohort)||432||
48125767|NCT03238001|100633714|FG000|COMPLETED|Visit 2 (Secondary Endpoint Cohort)||403||
48125768|NCT03238001|100633714|FG000|NOT COMPLETED|Visit 2 (Secondary Endpoint Cohort)||29||
48125769|NCT02074735|100633715|FG000|STARTED|Overall Study||29||
48125770|NCT02074735|100633716|FG001|STARTED|Overall Study||33||
48125771|NCT02074735|100633715|FG000|COMPLETED|Overall Study||26||
48125772|NCT02074735|100633716|FG001|COMPLETED|Overall Study||29||
48125773|NCT02074735|100633715|FG000|NOT COMPLETED|Overall Study||3||
48125774|NCT02074735|100633716|FG001|NOT COMPLETED|Overall Study||4||
48125775|NCT01003249|100633717|FG000|STARTED|First Intervention (4 Weeks)||7||
48125776|NCT01003249|100633718|FG001|STARTED|First Intervention (4 Weeks)||5||
48125777|NCT01003249|100633717|FG000|Received Intervention|First Intervention (4 Weeks)||7||
48125778|NCT01003249|100633718|FG001|Received Intervention|First Intervention (4 Weeks)||5||
48125779|NCT01003249|100633717|FG000|COMPLETED|First Intervention (4 Weeks)||5||
48125780|NCT01003249|100633718|FG001|COMPLETED|First Intervention (4 Weeks)||3||
48125781|NCT01003249|100633717|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2||
48125782|NCT01003249|100633718|FG001|NOT COMPLETED|First Intervention (4 Weeks)||2||
48125783|NCT01003249|100633717|FG000|STARTED|Washout (3 Weeks)||4||
48125784|NCT01003249|100633718|FG001|STARTED|Washout (3 Weeks)||3||
48125785|NCT01003249|100633717|FG000|COMPLETED|Washout (3 Weeks)||4||
48125786|NCT01003249|100633718|FG001|COMPLETED|Washout (3 Weeks)||3||
48125787|NCT01003249|100633717|FG000|NOT COMPLETED|Washout (3 Weeks)||0||
48125788|NCT01003249|100633718|FG001|NOT COMPLETED|Washout (3 Weeks)||0||
48125789|NCT01003249|100633717|FG000|STARTED|Second Intervention (4 Weeks)||4||
48125790|NCT01003249|100633718|FG001|STARTED|Second Intervention (4 Weeks)||3||
48125791|NCT01003249|100633717|FG000|COMPLETED|Second Intervention (4 Weeks)||3||
48125792|NCT01003249|100633718|FG001|COMPLETED|Second Intervention (4 Weeks)||2||
48125793|NCT01003249|100633717|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1||
48125794|NCT01003249|100633718|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1||
48125795|NCT01458171|100633719|FG000|STARTED|Overall Study||23||
48125796|NCT01458171|100633719|FG000|COMPLETED|Overall Study||22||
48125797|NCT01458171|100633719|FG000|NOT COMPLETED|Overall Study||1||
48125798|NCT03054909|100633720|FG000|STARTED|Overall Study||3||
48125799|NCT03054909|100633721|FG001|STARTED|Overall Study||4||
48125800|NCT03054909|100633720|FG000|COMPLETED|Overall Study||3||
48125801|NCT03054909|100633721|FG001|COMPLETED|Overall Study||4||
48125802|NCT03054909|100633720|FG000|NOT COMPLETED|Overall Study||0||
48125803|NCT03054909|100633721|FG001|NOT COMPLETED|Overall Study||0||
48125804|NCT04934670|100633722|FG000|STARTED|Overall Study||7||
48125805|NCT04934670|100633723|FG001|STARTED|Overall Study||5||
48125806|NCT04934670|100633722|FG000|COMPLETED|Overall Study||2||
48125807|NCT04934670|100633723|FG001|COMPLETED|Overall Study||1||
48125808|NCT04934670|100633722|FG000|NOT COMPLETED|Overall Study||5||
48125809|NCT04934670|100633723|FG001|NOT COMPLETED|Overall Study||4||
48125810|NCT00503841|100633724|FG000|STARTED|Overall Study||44||
48125811|NCT00503841|100633724|FG000|COMPLETED|Overall Study||0||
48125812|NCT00503841|100633724|FG000|NOT COMPLETED|Overall Study||44||
48125813|NCT02259608|100633725|FG000|STARTED|Overall Study||15||
48125814|NCT02259608|100633725|FG000|COMPLETED|Overall Study||15||
48125815|NCT02259608|100633725|FG000|NOT COMPLETED|Overall Study||0||
48125816|NCT03136068|100633726|FG000|STARTED|Overall Study||88||
48125817|NCT03136068|100633727|FG001|STARTED|Overall Study||90||
48125818|NCT03136068|100633726|FG000|COMPLETED|Overall Study||86||
48125819|NCT03136068|100633727|FG001|COMPLETED|Overall Study||89||
48125820|NCT03136068|100633726|FG000|NOT COMPLETED|Overall Study||2||
48125821|NCT03136068|100633727|FG001|NOT COMPLETED|Overall Study||1||
48125822|NCT00642304|100633728|FG000|STARTED|Overall Study||20||
48125823|NCT00642304|100633728|FG000|COMPLETED|Overall Study||14||
48125824|NCT00642304|100633728|FG000|NOT COMPLETED|Overall Study||6||
48125825|NCT03348904|100633729|FG000|STARTED|Overall Study||0||
48125826|NCT03348904|100633730|FG001|STARTED|Overall Study||2||
48125827|NCT03348904|100633731|FG002|STARTED|Overall Study||0||
48125828|NCT03348904|100633729|FG000|COMPLETED|Overall Study||0||
48125829|NCT03348904|100633730|FG001|COMPLETED|Overall Study||1||
48125830|NCT03348904|100633731|FG002|COMPLETED|Overall Study||0||
48125831|NCT03348904|100633729|FG000|NOT COMPLETED|Overall Study||0||
48125832|NCT03348904|100633730|FG001|NOT COMPLETED|Overall Study||1||
48125833|NCT03348904|100633731|FG002|NOT COMPLETED|Overall Study||0||
48125834|NCT00701389|100633732|FG000|STARTED|Period 1||6||
48125835|NCT00701389|100633733|FG001|STARTED|Period 1||6||
48125836|NCT00701389|100633734|FG002|STARTED|Period 1||6||
48125837|NCT00701389|100633735|FG003|STARTED|Period 1||6||
48125838|NCT00701389|100633732|FG000|COMPLETED|Period 1||6||
48125839|NCT00701389|100633733|FG001|COMPLETED|Period 1||6||
48125840|NCT00701389|100633734|FG002|COMPLETED|Period 1||6||
48125841|NCT00701389|100633735|FG003|COMPLETED|Period 1||6||
48125842|NCT00701389|100633732|FG000|NOT COMPLETED|Period 1||0||
48125843|NCT00701389|100633733|FG001|NOT COMPLETED|Period 1||0||
48125844|NCT00701389|100633734|FG002|NOT COMPLETED|Period 1||0||
48125845|NCT00701389|100633735|FG003|NOT COMPLETED|Period 1||0||
48125846|NCT00701389|100633732|FG000|STARTED|Period 2||6||
48125847|NCT00701389|100633733|FG001|STARTED|Period 2||6||
48125848|NCT00701389|100633734|FG002|STARTED|Period 2||6||
48125849|NCT00701389|100633735|FG003|STARTED|Period 2||6||
48125850|NCT00701389|100633732|FG000|COMPLETED|Period 2||6||
48125851|NCT00701389|100633733|FG001|COMPLETED|Period 2||6||
48125852|NCT00701389|100633734|FG002|COMPLETED|Period 2||6||
48125853|NCT00701389|100633735|FG003|COMPLETED|Period 2||6||
48125854|NCT00701389|100633732|FG000|NOT COMPLETED|Period 2||0||
48125855|NCT00701389|100633733|FG001|NOT COMPLETED|Period 2||0||
48125856|NCT00701389|100633734|FG002|NOT COMPLETED|Period 2||0||
48125857|NCT00701389|100633735|FG003|NOT COMPLETED|Period 2||0||
48125858|NCT00701389|100633732|FG000|STARTED|Period 3||6||
48125859|NCT00701389|100633733|FG001|STARTED|Period 3||6||
48125860|NCT00701389|100633734|FG002|STARTED|Period 3||6||
48125861|NCT00701389|100633735|FG003|STARTED|Period 3||6||
48125862|NCT00701389|100633732|FG000|COMPLETED|Period 3||6||
48125863|NCT00701389|100633733|FG001|COMPLETED|Period 3||6||
48125864|NCT00701389|100633734|FG002|COMPLETED|Period 3||6||
48125865|NCT00701389|100633735|FG003|COMPLETED|Period 3||6||
48125866|NCT00701389|100633732|FG000|NOT COMPLETED|Period 3||0||
48125867|NCT00701389|100633733|FG001|NOT COMPLETED|Period 3||0||
48125868|NCT00701389|100633734|FG002|NOT COMPLETED|Period 3||0||
48125869|NCT00701389|100633735|FG003|NOT COMPLETED|Period 3||0||
48571858|NCT05136885|101731080|FG001|COMPLETED|Overall Study||37||
48571859|NCT05136885|101731079|FG000|NOT COMPLETED|Overall Study||28||
48571860|NCT05136885|101731080|FG001|NOT COMPLETED|Overall Study||4||
48571861|NCT01732640|101731081|FG000|STARTED|Overall Study||6||
48571862|NCT01732640|101731082|FG001|STARTED|Overall Study||3||
48571863|NCT01732640|101731081|FG000|COMPLETED|Overall Study||6||
48571864|NCT01732640|101731082|FG001|COMPLETED|Overall Study||1||
48571865|NCT01732640|101731081|FG000|NOT COMPLETED|Overall Study||0||
48571866|NCT01732640|101731082|FG001|NOT COMPLETED|Overall Study||2||
48571867|NCT00679211|101731083|FG000|STARTED|Overall Study||110||
48571868|NCT00679211|101731083|FG000|COMPLETED|Overall Study||0||
48571869|NCT00679211|101731083|FG000|NOT COMPLETED|Overall Study||110||
48571870|NCT02792062|101731084|FG000|STARTED|Intervention Period 1 (6 Days)||2||
48571871|NCT02792062|101731085|FG001|STARTED|Intervention Period 1 (6 Days)||2||
48571872|NCT02792062|101731086|FG002|STARTED|Intervention Period 1 (6 Days)||2||
48125870|NCT00701389|100633732|FG000|STARTED|Period 4||6||
48125871|NCT00701389|100633733|FG001|STARTED|Period 4||6||
48125872|NCT00701389|100633734|FG002|STARTED|Period 4||6||
48125873|NCT00701389|100633735|FG003|STARTED|Period 4||6||
48125874|NCT00701389|100633732|FG000|COMPLETED|Period 4||6||
48125875|NCT00701389|100633733|FG001|COMPLETED|Period 4||6||
48125876|NCT00701389|100633734|FG002|COMPLETED|Period 4||6||
48125877|NCT00701389|100633735|FG003|COMPLETED|Period 4||6||
48125878|NCT00701389|100633732|FG000|NOT COMPLETED|Period 4||0||
48125879|NCT00701389|100633733|FG001|NOT COMPLETED|Period 4||0||
48125880|NCT00701389|100633734|FG002|NOT COMPLETED|Period 4||0||
48125881|NCT00701389|100633735|FG003|NOT COMPLETED|Period 4||0||
48125882|NCT01282710|100633736|FG000|STARTED|Overall Study||20||
48125883|NCT01282710|100633736|FG000|COMPLETED|Overall Study||20||
48571873|NCT02792062|101731087|FG003|STARTED|Intervention Period 1 (6 Days)||2||
48571874|NCT02792062|101731088|FG004|STARTED|Intervention Period 1 (6 Days)||2||
48571875|NCT02792062|101731089|FG005|STARTED|Intervention Period 1 (6 Days)||2||
48571876|NCT02792062|101731084|FG000|COMPLETED|Intervention Period 1 (6 Days)||2||
48571877|NCT02792062|101731085|FG001|COMPLETED|Intervention Period 1 (6 Days)||2||
48571878|NCT02792062|101731086|FG002|COMPLETED|Intervention Period 1 (6 Days)||2||
48571879|NCT02792062|101731087|FG003|COMPLETED|Intervention Period 1 (6 Days)||2||
48571880|NCT02792062|101731088|FG004|COMPLETED|Intervention Period 1 (6 Days)||2||
48125884|NCT01282710|100633736|FG000|NOT COMPLETED|Overall Study||0||
48125885|NCT02261818|100633737|FG000|STARTED|Overall Study||30||
48125886|NCT02261818|100633737|FG000|COMPLETED|Overall Study||27||
48125887|NCT02261818|100633737|FG000|NOT COMPLETED|Overall Study||3||
48125888|NCT02270060|100633738|FG000|STARTED|Overall Study||20||
48125889|NCT02270060|100633739|FG001|STARTED|Overall Study||20||
48571881|NCT02792062|101731089|FG005|COMPLETED|Intervention Period 1 (6 Days)||2||
48571882|NCT02792062|101731084|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0||
48571883|NCT02792062|101731085|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0||
48571884|NCT02792062|101731086|FG002|NOT COMPLETED|Intervention Period 1 (6 Days)||0||
48571885|NCT02792062|101731087|FG003|NOT COMPLETED|Intervention Period 1 (6 Days)||0||
48125890|NCT02270060|100633740|FG002|STARTED|Overall Study||20||
48125891|NCT02270060|100633738|FG000|COMPLETED|Overall Study||20||
48125892|NCT02270060|100633739|FG001|COMPLETED|Overall Study||20||
48125893|NCT02270060|100633740|FG002|COMPLETED|Overall Study||20||
48125894|NCT02270060|100633738|FG000|NOT COMPLETED|Overall Study||0||
48125895|NCT02270060|100633739|FG001|NOT COMPLETED|Overall Study||0||
48125896|NCT02270060|100633740|FG002|NOT COMPLETED|Overall Study||0||
48125897|NCT00006411|100633741|FG000|STARTED|Overall Study||707||
48125898|NCT00006411|100633742|FG001|STARTED|Overall Study||383||
48125899|NCT00006411|100633741|FG000|COMPLETED|Overall Study||707||
48125900|NCT00006411|100633742|FG001|COMPLETED|Overall Study||383||
48125901|NCT00006411|100633741|FG000|NOT COMPLETED|Overall Study||0||
48125902|NCT00006411|100633742|FG001|NOT COMPLETED|Overall Study||0||
48125903|NCT01785524|100633743|FG000|STARTED|Overall Study||7||
48125904|NCT01785524|100633744|FG001|STARTED|Overall Study||4||
48125905|NCT01785524|100633743|FG000|COMPLETED|Overall Study||5||
48125906|NCT01785524|100633744|FG001|COMPLETED|Overall Study||2||
48125907|NCT01785524|100633743|FG000|NOT COMPLETED|Overall Study||2||
48125908|NCT01785524|100633744|FG001|NOT COMPLETED|Overall Study||2||
48125909|NCT00320216|100633745|FG000|STARTED|Overall Study||64||
48125910|NCT00320216|100633746|FG001|STARTED|Overall Study||64||
48125911|NCT00320216|100633747|FG002|STARTED|Overall Study||64||
48125912|NCT00320216|100633748|FG003|STARTED|Overall Study||64||
48125913|NCT00320216|100633749|FG004|STARTED|Overall Study||64||
48125914|NCT00320216|100633745|FG000|COMPLETED|Overall Study||48||
48125915|NCT00320216|100633746|FG001|COMPLETED|Overall Study||54||
48125916|NCT00320216|100633747|FG002|COMPLETED|Overall Study||58||
48125917|NCT00320216|100633748|FG003|COMPLETED|Overall Study||61||
48125918|NCT00320216|100633749|FG004|COMPLETED|Overall Study||58||
48125919|NCT00320216|100633745|FG000|NOT COMPLETED|Overall Study||16||
48125920|NCT00320216|100633746|FG001|NOT COMPLETED|Overall Study||10||
48125921|NCT00320216|100633747|FG002|NOT COMPLETED|Overall Study||6||
48125922|NCT00320216|100633748|FG003|NOT COMPLETED|Overall Study||3||
48125923|NCT00320216|100633749|FG004|NOT COMPLETED|Overall Study||6||
48125924|NCT02252081|100633750|FG000|STARTED|Overall Study||30||
48125925|NCT02252081|100633751|FG001|STARTED|Overall Study||30||
48125926|NCT02252081|100633750|FG000|COMPLETED|Overall Study||24||
48125927|NCT02252081|100633751|FG001|COMPLETED|Overall Study||26||
48125928|NCT02252081|100633750|FG000|NOT COMPLETED|Overall Study||6||
48125929|NCT02252081|100633751|FG001|NOT COMPLETED|Overall Study||4||
48125930|NCT02530619|100633752|FG000|STARTED|Registered for Study||26||
48125931|NCT02530619|100633752|FG000|Registered|Registered for Study||26||
48125932|NCT02530619|100633752|FG000|Received 1st Dose of Alisertib|Registered for Study||24||
48125933|NCT02530619|100633752|FG000|COMPLETED|Registered for Study||24||
48125934|NCT02530619|100633752|FG000|NOT COMPLETED|Registered for Study||2||
48125935|NCT02530619|100633752|FG000|STARTED|Completed 1st Cycle of Treatment||24||
48125936|NCT02530619|100633752|FG000|COMPLETED|Completed 1st Cycle of Treatment||24||
48282746|NCT02581631|101017028|FG002|NOT COMPLETED|Overall Study||29||
48282747|NCT02581631|101017029|FG003|NOT COMPLETED|Overall Study||10||
48282748|NCT02581631|101017030|FG004|NOT COMPLETED|Overall Study||30||
48282749|NCT03386110|101017031|FG000|STARTED|Overall Study||56||
48282750|NCT03386110|101017032|FG001|STARTED|Overall Study||44||
48282751|NCT03386110|101017031|FG000|COMPLETED|Overall Study||41||
48397359|NCT02088541|101302608|FG000|Safety Population|Overall Study||71||
48571886|NCT02792062|101731088|FG004|NOT COMPLETED|Intervention Period 1 (6 Days)||0||
48571887|NCT02792062|101731089|FG005|NOT COMPLETED|Intervention Period 1 (6 Days)||0||
48571888|NCT02792062|101731084|FG000|STARTED|Washout Period (at Least 14 Days)||2||
48571889|NCT02792062|101731085|FG001|STARTED|Washout Period (at Least 14 Days)||2||
48571890|NCT02792062|101731086|FG002|STARTED|Washout Period (at Least 14 Days)||2||
48571891|NCT02792062|101731087|FG003|STARTED|Washout Period (at Least 14 Days)||2||
48571892|NCT02792062|101731088|FG004|STARTED|Washout Period (at Least 14 Days)||2||
48125937|NCT02530619|100633752|FG000|NOT COMPLETED|Completed 1st Cycle of Treatment||0||
48125938|NCT02530619|100633752|FG000|STARTED|Continued Treatment Cycles 2 Through 6||24||
48125939|NCT02530619|100633752|FG000|COMPLETED|Continued Treatment Cycles 2 Through 6||14||
48571893|NCT02792062|101731089|FG005|STARTED|Washout Period (at Least 14 Days)||2||
48571894|NCT02792062|101731084|FG000|COMPLETED|Washout Period (at Least 14 Days)||2||
48125940|NCT02530619|100633752|FG000|NOT COMPLETED|Continued Treatment Cycles 2 Through 6||10||
48125941|NCT02530619|100633752|FG000|STARTED|Continued Treatment Cycle 7+||14||
48125942|NCT02530619|100633752|FG000|COMPLETED|Continued Treatment Cycle 7+||14||
48125943|NCT02530619|100633752|FG000|NOT COMPLETED|Continued Treatment Cycle 7+||0||
48125944|NCT02530619|100633752|FG000|STARTED|Follow-up Period (6 Months)||21|3 patients are still on treatment and have not entered the follow-up period.|
48125945|NCT02530619|100633752|FG000|COMPLETED|Follow-up Period (6 Months)||10||
48125946|NCT02530619|100633752|FG000|NOT COMPLETED|Follow-up Period (6 Months)||11||
48282752|NCT03386110|101017032|FG001|COMPLETED|Overall Study||38||
48125947|NCT04292301|100633753|FG000|STARTED|Overall Study||92||
48125948|NCT04292301|100633753|FG000|COMPLETED|Overall Study||89||
48571895|NCT02792062|101731085|FG001|COMPLETED|Washout Period (at Least 14 Days)||2||
48125949|NCT04292301|100633753|FG000|NOT COMPLETED|Overall Study||3||
48282753|NCT03386110|101017031|FG000|NOT COMPLETED|Overall Study||15||
48125950|NCT01969838|100633754|FG000|STARTED|Double-blind Phase||215||
48125951|NCT01969838|100633755|FG001|STARTED|Double-blind Phase||217||
48125952|NCT01969838|100633756|FG002|STARTED|Double-blind Phase||0||
48125953|NCT01969838|100633757|FG003|STARTED|Double-blind Phase||0||
48125954|NCT01969838|100633754|FG000|COMPLETED|Double-blind Phase||188||
48125955|NCT01969838|100633755|FG001|COMPLETED|Double-blind Phase||208||
48125956|NCT01969838|100633756|FG002|COMPLETED|Double-blind Phase||0||
48125957|NCT01969838|100633757|FG003|COMPLETED|Double-blind Phase||0||
48125958|NCT01969838|100633754|FG000|NOT COMPLETED|Double-blind Phase||27||
48125959|NCT01969838|100633755|FG001|NOT COMPLETED|Double-blind Phase||9||
48125960|NCT01969838|100633756|FG002|NOT COMPLETED|Double-blind Phase||0||
48125961|NCT01969838|100633757|FG003|NOT COMPLETED|Double-blind Phase||0||
48125962|NCT01969838|100633754|FG000|STARTED|Open-label Phase||0||
48125963|NCT01969838|100633755|FG001|STARTED|Open-label Phase||0||
48125964|NCT01969838|100633756|FG002|STARTED|Open-label Phase||171||
48125965|NCT01969838|100633757|FG003|STARTED|Open-label Phase||197||
48125966|NCT01969838|100633754|FG000|COMPLETED|Open-label Phase||0|Defined as completing survival follow-up for a period of up to 5 years from randomization.|
48125967|NCT01969838|100633755|FG001|COMPLETED|Open-label Phase||0|Defined as completing survival follow-up for a period of up to 5 years from randomization.|
48125968|NCT01969838|100633756|FG002|COMPLETED|Open-label Phase||1|Defined as completing survival follow-up for a period of up to 5 years from randomization.|
48125969|NCT01969838|100633757|FG003|COMPLETED|Open-label Phase||0|Defined as completing survival follow-up for a period of up to 5 years from randomization.|
48125970|NCT01969838|100633754|FG000|NOT COMPLETED|Open-label Phase||0||
48125971|NCT01969838|100633755|FG001|NOT COMPLETED|Open-label Phase||0||
48125972|NCT01969838|100633756|FG002|NOT COMPLETED|Open-label Phase||170||
48125973|NCT01969838|100633757|FG003|NOT COMPLETED|Open-label Phase||197||
48125974|NCT00289341|100633758|FG000|STARTED|Overall Study||12||
48125975|NCT00289341|100633759|FG001|STARTED|Overall Study||12||
48125976|NCT00289341|100633758|FG000|COMPLETED|Overall Study||12||
48125977|NCT00289341|100633759|FG001|COMPLETED|Overall Study||12||
48125978|NCT00289341|100633758|FG000|NOT COMPLETED|Overall Study||0||
48125979|NCT00289341|100633759|FG001|NOT COMPLETED|Overall Study||0||
48125980|NCT02139644|100633760|FG000|STARTED|Run-In Period (Pre-assignment)||787||
48125981|NCT02139644|100633761|FG001|STARTED|Run-In Period (Pre-assignment)||0||
48125982|NCT02139644|100633762|FG002|STARTED|Run-In Period (Pre-assignment)||0||
48125983|NCT02139644|100633763|FG003|STARTED|Run-In Period (Pre-assignment)||0||
48125984|NCT02139644|100633764|FG004|STARTED|Run-In Period (Pre-assignment)||0||
48282754|NCT03386110|101017032|FG001|NOT COMPLETED|Overall Study||6||
48282755|NCT00924027|101017033|FG000|STARTED|Overall Study||28||
48282756|NCT00924027|101017034|FG001|STARTED|Overall Study||0||
48125985|NCT02139644|100633765|FG005|STARTED|Run-In Period (Pre-assignment)||0||
48125986|NCT02139644|100633760|FG000|COMPLETED|Run-In Period (Pre-assignment)||647||
48125987|NCT02139644|100633761|FG001|COMPLETED|Run-In Period (Pre-assignment)||0||
48125988|NCT02139644|100633762|FG002|COMPLETED|Run-In Period (Pre-assignment)||0||
48125989|NCT02139644|100633763|FG003|COMPLETED|Run-In Period (Pre-assignment)||0||
48125990|NCT02139644|100633764|FG004|COMPLETED|Run-In Period (Pre-assignment)||0||
48282757|NCT00924027|101017035|FG002|STARTED|Overall Study||0||
48282758|NCT00924027|101017036|FG003|STARTED|Overall Study||15||
48125991|NCT02139644|100633765|FG005|COMPLETED|Run-In Period (Pre-assignment)||0||
48125992|NCT02139644|100633760|FG000|NOT COMPLETED|Run-In Period (Pre-assignment)||140||
48125993|NCT02139644|100633761|FG001|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
48125994|NCT02139644|100633762|FG002|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
48125995|NCT02139644|100633763|FG003|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
48125996|NCT02139644|100633764|FG004|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
48125997|NCT02139644|100633765|FG005|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
48125998|NCT02139644|100633760|FG000|STARTED|Treatment Period||0||
48125999|NCT02139644|100633761|FG001|STARTED|Treatment Period||129||
48126000|NCT02139644|100633762|FG002|STARTED|Treatment Period||129||
48282759|NCT00924027|101017033|FG000|Started Brachytherapy|Overall Study||27||
48282760|NCT00924027|101017034|FG001|Started Brachytherapy|Overall Study||0||
48126001|NCT02139644|100633763|FG003|STARTED|Treatment Period||130||
48126002|NCT02139644|100633764|FG004|STARTED|Treatment Period||129||
48126003|NCT02139644|100633765|FG005|STARTED|Treatment Period||130||
48126004|NCT02139644|100633760|FG000|COMPLETED|Treatment Period||0||
48126005|NCT02139644|100633761|FG001|COMPLETED|Treatment Period||126||
48126006|NCT02139644|100633762|FG002|COMPLETED|Treatment Period||121||
48126007|NCT02139644|100633763|FG003|COMPLETED|Treatment Period||121||
48126008|NCT02139644|100633764|FG004|COMPLETED|Treatment Period||121||
48126009|NCT02139644|100633765|FG005|COMPLETED|Treatment Period||113||
48126010|NCT02139644|100633760|FG000|NOT COMPLETED|Treatment Period||0||
48126011|NCT02139644|100633761|FG001|NOT COMPLETED|Treatment Period||3||
48126012|NCT02139644|100633762|FG002|NOT COMPLETED|Treatment Period||8||
48126013|NCT02139644|100633763|FG003|NOT COMPLETED|Treatment Period||9||
48126014|NCT02139644|100633764|FG004|NOT COMPLETED|Treatment Period||8||
48126015|NCT02139644|100633765|FG005|NOT COMPLETED|Treatment Period||17||
48126016|NCT00047463|100633766|FG000|STARTED|Overall Study||13||
48126017|NCT00047463|100633767|FG001|STARTED|Overall Study||22||
48282761|NCT00924027|101017035|FG002|Started Brachytherapy|Overall Study||0||
48282762|NCT00924027|101017036|FG003|Started Brachytherapy|Overall Study||14||
48126018|NCT00047463|100633766|FG000|COMPLETED|Overall Study||13||
48126019|NCT00047463|100633767|FG001|COMPLETED|Overall Study||19||
48126020|NCT00047463|100633766|FG000|NOT COMPLETED|Overall Study||0||
48126021|NCT00047463|100633767|FG001|NOT COMPLETED|Overall Study||3||
48126022|NCT03402243|100633768|FG000|STARTED|Overall Study||16|Number of participants who were informed of their randomization and contributed to the analysis|
48126023|NCT03402243|100633769|FG001|STARTED|Overall Study||15|Number of participants who were informed of their randomization and contributed to the analysis|
48126024|NCT03402243|100633770|FG002|STARTED|Overall Study||16|Number of participants who were informed of their randomization and contributed to the analysis|
48126025|NCT03402243|100633768|FG000|COMPLETED|Overall Study||13||
48126026|NCT03402243|100633769|FG001|COMPLETED|Overall Study||12||
48126027|NCT03402243|100633770|FG002|COMPLETED|Overall Study||14||
48126028|NCT03402243|100633768|FG000|NOT COMPLETED|Overall Study||3||
48126029|NCT03402243|100633769|FG001|NOT COMPLETED|Overall Study||3||
48126030|NCT03402243|100633770|FG002|NOT COMPLETED|Overall Study||2||
48126031|NCT02554773|100633771|FG000|STARTED|Original Dose Regimen (SAS 1)||34||
48126032|NCT02554773|100633772|FG001|STARTED|Original Dose Regimen (SAS 1)||0||
48126033|NCT02554773|100633771|FG000|COMPLETED|Original Dose Regimen (SAS 1)||18||
48126034|NCT02554773|100633772|FG001|COMPLETED|Original Dose Regimen (SAS 1)||0||
48126035|NCT02554773|100633771|FG000|NOT COMPLETED|Original Dose Regimen (SAS 1)||16||
48126036|NCT02554773|100633772|FG001|NOT COMPLETED|Original Dose Regimen (SAS 1)||0||
48126037|NCT02554773|100633771|FG000|STARTED|AT-Based Dose Regimen (SAS 2)||0||
48126038|NCT02554773|100633772|FG001|STARTED|AT-Based Dose Regimen (SAS 2)||18||
48126039|NCT02554773|100633771|FG000|COMPLETED|AT-Based Dose Regimen (SAS 2)||0||
48126040|NCT02554773|100633772|FG001|COMPLETED|AT-Based Dose Regimen (SAS 2)||12||
48126041|NCT02554773|100633771|FG000|NOT COMPLETED|AT-Based Dose Regimen (SAS 2)||0||
48126042|NCT02554773|100633772|FG001|NOT COMPLETED|AT-Based Dose Regimen (SAS 2)||6||
48126043|NCT00359762|100633773|FG000|STARTED|Period II||514||
48126044|NCT00359762|100633774|FG001|STARTED|Period II||0||
48126045|NCT00359762|100633775|FG002|STARTED|Period II||0||
48126046|NCT00359762|100633776|FG003|STARTED|Period II||0||
48126047|NCT00359762|100633777|FG004|STARTED|Period II||515||
48126048|NCT00359762|100633773|FG000|Intent to Treat (ITT) Safety Population|Period II||508||
48126049|NCT00359762|100633774|FG001|Intent to Treat (ITT) Safety Population|Period II||0||
48126050|NCT00359762|100633775|FG002|Intent to Treat (ITT) Safety Population|Period II||0||
48126051|NCT00359762|100633776|FG003|Intent to Treat (ITT) Safety Population|Period II||0||
48282763|NCT00924027|101017033|FG000|Completed Brachytherapy|Overall Study||26||
48282764|NCT00924027|101017034|FG001|Completed Brachytherapy|Overall Study||0||
48282765|NCT00924027|101017035|FG002|Completed Brachytherapy|Overall Study||0||
48282766|NCT00924027|101017036|FG003|Completed Brachytherapy|Overall Study||14||
48282767|NCT00924027|101017033|FG000|Follow-up Period Active|Overall Study||0||
48282768|NCT00924027|101017034|FG001|Follow-up Period Active|Overall Study||0||
48282769|NCT00924027|101017035|FG002|Follow-up Period Active|Overall Study||0||
48282770|NCT00924027|101017036|FG003|Follow-up Period Active|Overall Study||1||
48282771|NCT00924027|101017033|FG000|Follow-Up Period Completed|Overall Study||20||
48282772|NCT00924027|101017034|FG001|Follow-Up Period Completed|Overall Study||0||
48282773|NCT00924027|101017035|FG002|Follow-Up Period Completed|Overall Study||0||
48282774|NCT00924027|101017036|FG003|Follow-Up Period Completed|Overall Study||13||
48282775|NCT00924027|101017033|FG000|COMPLETED|Overall Study||20||
48282776|NCT00924027|101017034|FG001|COMPLETED|Overall Study||0||
48282777|NCT00924027|101017035|FG002|COMPLETED|Overall Study||0||
48282778|NCT00924027|101017036|FG003|COMPLETED|Overall Study||13||
48282779|NCT00924027|101017033|FG000|NOT COMPLETED|Overall Study||8||
48282780|NCT00924027|101017034|FG001|NOT COMPLETED|Overall Study||0||
48282781|NCT00924027|101017035|FG002|NOT COMPLETED|Overall Study||0||
48282782|NCT00924027|101017036|FG003|NOT COMPLETED|Overall Study||2||
48282783|NCT01467882|101017037|FG000|STARTED|Overall Study||44||
48282784|NCT01467882|101017037|FG000|COMPLETED|Overall Study||44||
48282785|NCT01467882|101017037|FG000|NOT COMPLETED|Overall Study||0||
48282786|NCT00688870|101017038|FG000|STARTED|Infant Series||84||
48282787|NCT00688870|101017039|FG001|STARTED|Infant Series||84||
48282788|NCT00688870|101017038|FG000|Vaccinated Dose 1|Infant Series||83||
48126052|NCT00359762|100633777|FG004|Intent to Treat (ITT) Safety Population|Period II||511||
48126053|NCT00359762|100633773|FG000|ITT Efficacy Population|Period II||487||
48282789|NCT00688870|101017039|FG001|Vaccinated Dose 1|Infant Series||84||
48282790|NCT00688870|101017038|FG000|Vaccinated Dose 2|Infant Series||80||
48282791|NCT00688870|101017039|FG001|Vaccinated Dose 2|Infant Series||84||
48282792|NCT00688870|101017038|FG000|Vaccinated Dose 3|Infant Series||80||
48126054|NCT00359762|100633774|FG001|ITT Efficacy Population|Period II||0||
48126055|NCT00359762|100633775|FG002|ITT Efficacy Population|Period II||0||
48126056|NCT00359762|100633776|FG003|ITT Efficacy Population|Period II||0||
48126057|NCT00359762|100633777|FG004|ITT Efficacy Population|Period II||490||
48126058|NCT00359762|100633773|FG000|Met Primary Endpoint|Period II||262||
48282793|NCT00688870|101017039|FG001|Vaccinated Dose 3|Infant Series||84||
48282794|NCT00688870|101017038|FG000|COMPLETED|Infant Series||80||
48282795|NCT00688870|101017039|FG001|COMPLETED|Infant Series||84||
48282796|NCT00688870|101017038|FG000|NOT COMPLETED|Infant Series||4||
48282797|NCT00688870|101017039|FG001|NOT COMPLETED|Infant Series||0||
48126059|NCT00359762|100633774|FG001|Met Primary Endpoint|Period II||0||
48126060|NCT00359762|100633775|FG002|Met Primary Endpoint|Period II||0||
48126061|NCT00359762|100633776|FG003|Met Primary Endpoint|Period II||0||
48126062|NCT00359762|100633777|FG004|Met Primary Endpoint|Period II||203||
48126063|NCT00359762|100633773|FG000|Without Treatment Failure|Period II||124||
48282798|NCT00688870|101017038|FG000|STARTED|After Infant Series||80||
48700563|NCT04086693|102054026|FG001|NOT COMPLETED|Overall Study||4||
48700564|NCT00803400|102054027|FG000|STARTED|Overall Study||75||
48700565|NCT00803400|102054028|FG001|STARTED|Overall Study||75||
48700566|NCT00803400|102054027|FG000|COMPLETED|Overall Study||55||
48700567|NCT00803400|102054028|FG001|COMPLETED|Overall Study||51||
48700568|NCT00803400|102054027|FG000|NOT COMPLETED|Overall Study||20||
48700569|NCT00803400|102054028|FG001|NOT COMPLETED|Overall Study||24||
48700570|NCT01519791|102054029|FG000|STARTED|Overall Study||219||
48126064|NCT00359762|100633774|FG001|Without Treatment Failure|Period II||0||
48282799|NCT00688870|101017039|FG001|STARTED|After Infant Series||84||
48282800|NCT00688870|101017038|FG000|COMPLETED|After Infant Series||80||
48700571|NCT01519791|102054030|FG001|STARTED|Overall Study||660||
48700572|NCT01519791|102054029|FG000|Completed Week 52|Overall Study||143||
48700573|NCT01519791|102054030|FG001|Completed Week 52|Overall Study||500||
48700574|NCT01519791|102054029|FG000|COMPLETED|Overall Study||67||
48700575|NCT01519791|102054030|FG001|COMPLETED|Overall Study||292||
48126065|NCT00359762|100633775|FG002|Without Treatment Failure|Period II||0||
48126066|NCT00359762|100633776|FG003|Without Treatment Failure|Period II||0||
48126067|NCT00359762|100633777|FG004|Without Treatment Failure|Period II||138||
48571896|NCT02792062|101731086|FG002|COMPLETED|Washout Period (at Least 14 Days)||2||
48571897|NCT02792062|101731087|FG003|COMPLETED|Washout Period (at Least 14 Days)||2||
48571898|NCT02792062|101731088|FG004|COMPLETED|Washout Period (at Least 14 Days)||2||
48571899|NCT02792062|101731089|FG005|COMPLETED|Washout Period (at Least 14 Days)||2||
48571900|NCT02792062|101731084|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48700576|NCT01519791|102054029|FG000|NOT COMPLETED|Overall Study||152||
48700577|NCT01519791|102054030|FG001|NOT COMPLETED|Overall Study||368||
48700578|NCT02039219|102054031|FG000|STARTED|Treatment||11||
48700579|NCT02039219|102054032|FG001|STARTED|Treatment||8||
48126068|NCT00359762|100633773|FG000|COMPLETED|Period II||386||
48126069|NCT00359762|100633774|FG001|COMPLETED|Period II||0||
48126070|NCT00359762|100633775|FG002|COMPLETED|Period II||0||
48126071|NCT00359762|100633776|FG003|COMPLETED|Period II||0||
48126072|NCT00359762|100633777|FG004|COMPLETED|Period II||341||
48126073|NCT00359762|100633773|FG000|NOT COMPLETED|Period II||128||
48282801|NCT00688870|101017039|FG001|COMPLETED|After Infant Series||84||
48282802|NCT00688870|101017038|FG000|NOT COMPLETED|After Infant Series||0||
48282803|NCT00688870|101017039|FG001|NOT COMPLETED|After Infant Series||0||
48282804|NCT00688870|101017038|FG000|STARTED|Toddler Dose||80||
48282805|NCT00688870|101017039|FG001|STARTED|Toddler Dose||84||
48282806|NCT00688870|101017038|FG000|COMPLETED|Toddler Dose||80||
48282807|NCT00688870|101017039|FG001|COMPLETED|Toddler Dose||84||
48282808|NCT00688870|101017038|FG000|NOT COMPLETED|Toddler Dose||0||
48282809|NCT00688870|101017039|FG001|NOT COMPLETED|Toddler Dose||0||
48282810|NCT04677179|101017040|FG000|STARTED|Induction Treatment Period||32||
48282811|NCT04677179|101017041|FG001|STARTED|Induction Treatment Period||35||
48282812|NCT04677179|101017042|FG002|STARTED|Induction Treatment Period||14||
48282813|NCT04677179|101017043|FG003|STARTED|Induction Treatment Period||0||
48282814|NCT04677179|101017044|FG004|STARTED|Induction Treatment Period||0||
48282815|NCT04677179|101017045|FG005|STARTED|Induction Treatment Period||0||
48282816|NCT04677179|101017046|FG006|STARTED|Induction Treatment Period||0||
48126074|NCT00359762|100633774|FG001|NOT COMPLETED|Period II||0||
48126075|NCT00359762|100633775|FG002|NOT COMPLETED|Period II||0||
48126076|NCT00359762|100633776|FG003|NOT COMPLETED|Period II||0||
48126077|NCT00359762|100633777|FG004|NOT COMPLETED|Period II||174||
48126078|NCT00359762|100633773|FG000|STARTED|Period III||0||
48126079|NCT00359762|100633774|FG001|STARTED|Period III||77||
48126080|NCT00359762|100633775|FG002|STARTED|Period III||77||
48126081|NCT00359762|100633776|FG003|STARTED|Period III||166||
48126082|NCT00359762|100633777|FG004|STARTED|Period III||0||
48126083|NCT00359762|100633773|FG000|Extension ITT Safety Population|Period III||0||
48126084|NCT00359762|100633774|FG001|Extension ITT Safety Population|Period III||74||
48126085|NCT00359762|100633775|FG002|Extension ITT Safety Population|Period III||76||
48126086|NCT00359762|100633776|FG003|Extension ITT Safety Population|Period III||166||
48126087|NCT00359762|100633777|FG004|Extension ITT Safety Population|Period III||0||
48126088|NCT00359762|100633773|FG000|Extension ITT Efficacy Population|Period III||0||
48126089|NCT00359762|100633774|FG001|Extension ITT Efficacy Population|Period III||73||
48126090|NCT00359762|100633775|FG002|Extension ITT Efficacy Population|Period III||75||
48282817|NCT04677179|101017047|FG007|STARTED|Induction Treatment Period||0||
48282818|NCT04677179|101017048|FG008|STARTED|Induction Treatment Period||0||
48282819|NCT04677179|101017049|FG009|STARTED|Induction Treatment Period||0||
48282820|NCT04677179|101017040|FG000|Received at Least One Dose of Study Drug|Induction Treatment Period||32||
48282821|NCT04677179|101017041|FG001|Received at Least One Dose of Study Drug|Induction Treatment Period||35||
48282822|NCT04677179|101017042|FG002|Received at Least One Dose of Study Drug|Induction Treatment Period||14||
48282823|NCT04677179|101017043|FG003|Received at Least One Dose of Study Drug|Induction Treatment Period||0||
48571901|NCT02792062|101731085|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48571902|NCT02792062|101731086|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48571903|NCT02792062|101731087|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48571904|NCT02792062|101731088|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48571905|NCT02792062|101731089|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48571906|NCT02792062|101731084|FG000|STARTED|Intervention Period 2 (6 Days)||2||
48571907|NCT02792062|101731085|FG001|STARTED|Intervention Period 2 (6 Days)||2||
48571908|NCT02792062|101731086|FG002|STARTED|Intervention Period 2 (6 Days)||2||
48571909|NCT02792062|101731087|FG003|STARTED|Intervention Period 2 (6 Days)||2||
48571910|NCT02792062|101731088|FG004|STARTED|Intervention Period 2 (6 Days)||2||
48571911|NCT02792062|101731089|FG005|STARTED|Intervention Period 2 (6 Days)||2||
48571912|NCT02792062|101731084|FG000|COMPLETED|Intervention Period 2 (6 Days)||2||
48571913|NCT02792062|101731085|FG001|COMPLETED|Intervention Period 2 (6 Days)||2||
48571914|NCT02792062|101731086|FG002|COMPLETED|Intervention Period 2 (6 Days)||2||
48571915|NCT02792062|101731087|FG003|COMPLETED|Intervention Period 2 (6 Days)||2||
48571916|NCT02792062|101731088|FG004|COMPLETED|Intervention Period 2 (6 Days)||2||
48700580|NCT02039219|102054031|FG000|COMPLETED|Treatment||7||
48700581|NCT02039219|102054032|FG001|COMPLETED|Treatment||6||
48700582|NCT02039219|102054031|FG000|NOT COMPLETED|Treatment||4||
48571917|NCT02792062|101731089|FG005|COMPLETED|Intervention Period 2 (6 Days)||2||
48571918|NCT02792062|101731084|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0||
48571919|NCT02792062|101731085|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0||
48571920|NCT02792062|101731086|FG002|NOT COMPLETED|Intervention Period 2 (6 Days)||0||
48571921|NCT02792062|101731087|FG003|NOT COMPLETED|Intervention Period 2 (6 Days)||0||
48571922|NCT02792062|101731088|FG004|NOT COMPLETED|Intervention Period 2 (6 Days)||0||
48571923|NCT02792062|101731089|FG005|NOT COMPLETED|Intervention Period 2 (6 Days)||0||
48571924|NCT02792062|101731084|FG000|STARTED|Washout Period (at Least 14 Days)||2||
48571925|NCT02792062|101731085|FG001|STARTED|Washout Period (at Least 14 Days)||2||
48571926|NCT02792062|101731086|FG002|STARTED|Washout Period (at Least 14 Days)||2||
48571927|NCT02792062|101731087|FG003|STARTED|Washout Period (at Least 14 Days)||2||
48571928|NCT02792062|101731088|FG004|STARTED|Washout Period (at Least 14 Days)||2||
48571929|NCT02792062|101731089|FG005|STARTED|Washout Period (at Least 14 Days)||2||
48571930|NCT02792062|101731084|FG000|COMPLETED|Washout Period (at Least 14 Days)||1||
48571931|NCT02792062|101731085|FG001|COMPLETED|Washout Period (at Least 14 Days)||2||
48571932|NCT02792062|101731086|FG002|COMPLETED|Washout Period (at Least 14 Days)||2||
48571933|NCT02792062|101731087|FG003|COMPLETED|Washout Period (at Least 14 Days)||2||
48571934|NCT02792062|101731088|FG004|COMPLETED|Washout Period (at Least 14 Days)||2||
48571935|NCT02792062|101731089|FG005|COMPLETED|Washout Period (at Least 14 Days)||2||
48571936|NCT02792062|101731084|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||1||
48571937|NCT02792062|101731085|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48571938|NCT02792062|101731086|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48571939|NCT02792062|101731087|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48571940|NCT02792062|101731088|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48571941|NCT02792062|101731089|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48571942|NCT02792062|101731084|FG000|STARTED|Intervention Period 3 (6 Days)||1||
48571943|NCT02792062|101731085|FG001|STARTED|Intervention Period 3 (6 Days)||2||
48571944|NCT02792062|101731086|FG002|STARTED|Intervention Period 3 (6 Days)||2||
48571945|NCT02792062|101731087|FG003|STARTED|Intervention Period 3 (6 Days)||2||
48571946|NCT02792062|101731088|FG004|STARTED|Intervention Period 3 (6 Days)||2||
48571947|NCT02792062|101731089|FG005|STARTED|Intervention Period 3 (6 Days)||2||
48571948|NCT02792062|101731084|FG000|COMPLETED|Intervention Period 3 (6 Days)||1||
48571949|NCT02792062|101731085|FG001|COMPLETED|Intervention Period 3 (6 Days)||2||
48571950|NCT02792062|101731086|FG002|COMPLETED|Intervention Period 3 (6 Days)||2||
48571951|NCT02792062|101731087|FG003|COMPLETED|Intervention Period 3 (6 Days)||2||
48571952|NCT02792062|101731088|FG004|COMPLETED|Intervention Period 3 (6 Days)||2||
48571953|NCT02792062|101731089|FG005|COMPLETED|Intervention Period 3 (6 Days)||2||
48571954|NCT02792062|101731084|FG000|NOT COMPLETED|Intervention Period 3 (6 Days)||0||
48571955|NCT02792062|101731085|FG001|NOT COMPLETED|Intervention Period 3 (6 Days)||0||
48571956|NCT02792062|101731086|FG002|NOT COMPLETED|Intervention Period 3 (6 Days)||0||
48571957|NCT02792062|101731087|FG003|NOT COMPLETED|Intervention Period 3 (6 Days)||0||
48571958|NCT02792062|101731088|FG004|NOT COMPLETED|Intervention Period 3 (6 Days)||0||
48126091|NCT00359762|100633776|FG003|Extension ITT Efficacy Population|Period III||164||
48126092|NCT00359762|100633777|FG004|Extension ITT Efficacy Population|Period III||0||
48571959|NCT02792062|101731089|FG005|NOT COMPLETED|Intervention Period 3 (6 Days)||0||
48571960|NCT02653144|101731090|FG000|STARTED|Overall Study||30||
48571961|NCT02653144|101731091|FG001|STARTED|Overall Study||28||
48571962|NCT02653144|101731092|FG002|STARTED|Overall Study||31||
48571963|NCT02653144|101731090|FG000|COMPLETED|Overall Study||30||
48571964|NCT02653144|101731091|FG001|COMPLETED|Overall Study||28||
48571965|NCT02653144|101731092|FG002|COMPLETED|Overall Study||31||
48126093|NCT00359762|100633773|FG000|COMPLETED|Period III||0||
48126094|NCT00359762|100633774|FG001|COMPLETED|Period III||48||
48126095|NCT00359762|100633775|FG002|COMPLETED|Period III||47||
48126096|NCT00359762|100633776|FG003|COMPLETED|Period III||101||
48126097|NCT00359762|100633777|FG004|COMPLETED|Period III||0||
48126098|NCT00359762|100633773|FG000|NOT COMPLETED|Period III||0||
48571966|NCT02653144|101731090|FG000|NOT COMPLETED|Overall Study||0||
48571967|NCT02653144|101731091|FG001|NOT COMPLETED|Overall Study||0||
48571968|NCT02653144|101731092|FG002|NOT COMPLETED|Overall Study||0||
48571969|NCT06343467|101731093|FG000|STARTED|Overall Study||19||
48571970|NCT06343467|101731094|FG001|STARTED|Overall Study||47||
48571971|NCT06343467|101731093|FG000|COMPLETED|Overall Study||19||
48571972|NCT06343467|101731094|FG001|COMPLETED|Overall Study||47||
48571973|NCT06343467|101731093|FG000|NOT COMPLETED|Overall Study||0||
48126099|NCT00359762|100633774|FG001|NOT COMPLETED|Period III||29||
48126100|NCT00359762|100633775|FG002|NOT COMPLETED|Period III||30||
48126101|NCT00359762|100633776|FG003|NOT COMPLETED|Period III||65||
48126102|NCT00359762|100633777|FG004|NOT COMPLETED|Period III||0||
48126103|NCT00359762|100633773|FG000|STARTED|Period I||0||
48571974|NCT06343467|101731094|FG001|NOT COMPLETED|Overall Study||0||
48571975|NCT02434146|101731095|FG000|STARTED|Overall Study||3||
48571976|NCT02434146|101731095|FG000|COMPLETED|Overall Study||3||
48571977|NCT02434146|101731095|FG000|NOT COMPLETED|Overall Study||0||
48571978|NCT03656068|101731096|FG000|STARTED|Overall Study||21||
48571979|NCT03656068|101731096|FG000|COMPLETED|Overall Study||16||
48571980|NCT03656068|101731096|FG000|NOT COMPLETED|Overall Study||5||
48571981|NCT02549859|101731097|FG000|STARTED|Visit 1||11||
48571982|NCT02549859|101731097|FG000|COMPLETED|Visit 1||11||
48571983|NCT02549859|101731097|FG000|NOT COMPLETED|Visit 1||0||
48571984|NCT02549859|101731097|FG000|STARTED|Long-term 60 Hz DBS||11||
48571985|NCT02549859|101731097|FG000|COMPLETED|Long-term 60 Hz DBS||10||
48571986|NCT02549859|101731097|FG000|NOT COMPLETED|Long-term 60 Hz DBS||1||
48571987|NCT02549859|101731097|FG000|STARTED|Visit 2||10||
48571988|NCT02549859|101731097|FG000|COMPLETED|Visit 2||10||
48571989|NCT02549859|101731097|FG000|NOT COMPLETED|Visit 2||0||
48571990|NCT01580670|101731098|FG000|STARTED|Induction Period (Week 0 to 14)||14||
48571991|NCT01580670|101731098|FG000|COMPLETED|Induction Period (Week 0 to 14)||14||
48571992|NCT01580670|101731098|FG000|NOT COMPLETED|Induction Period (Week 0 to 14)||0||
48571993|NCT01580670|101731098|FG000|STARTED|Maintenance Period (Week 14 to 54)||14||
48571994|NCT01580670|101731098|FG000|COMPLETED|Maintenance Period (Week 14 to 54)||12||
48571995|NCT01580670|101731098|FG000|NOT COMPLETED|Maintenance Period (Week 14 to 54)||2||
48571996|NCT00766636|101731099|FG000|STARTED|Overall Study||3||
48571997|NCT00766636|101731100|FG001|STARTED|Overall Study||2||
48571998|NCT00766636|101731099|FG000|COMPLETED|Overall Study||0||
48571999|NCT00766636|101731100|FG001|COMPLETED|Overall Study||0||
48572000|NCT00766636|101731099|FG000|NOT COMPLETED|Overall Study||3||
48572001|NCT00766636|101731100|FG001|NOT COMPLETED|Overall Study||2||
48572002|NCT03446027|101731101|FG000|STARTED|Overall Study||102||
48572003|NCT03446027|101731102|FG001|STARTED|Overall Study||98||
48700583|NCT02039219|102054032|FG001|NOT COMPLETED|Treatment||2||
48700584|NCT02039219|102054031|FG000|STARTED|Follow up||7||
48700585|NCT02039219|102054032|FG001|STARTED|Follow up||6||
48700586|NCT02039219|102054031|FG000|COMPLETED|Follow up||7||
48700587|NCT02039219|102054032|FG001|COMPLETED|Follow up||5||
48700588|NCT02039219|102054031|FG000|NOT COMPLETED|Follow up||0||
48700589|NCT02039219|102054032|FG001|NOT COMPLETED|Follow up||1||
48700590|NCT00654836|102054033|FG000|STARTED|Overall Study||32||
48700591|NCT00654836|102054033|FG000|COMPLETED|Overall Study||32||
48700592|NCT00654836|102054033|FG000|NOT COMPLETED|Overall Study||0||
48700593|NCT00223808|102054034|FG000|STARTED|Overall Study||22||
48700594|NCT00223808|102054035|FG001|STARTED|Overall Study||22||
48700595|NCT00223808|102054036|FG002|STARTED|Overall Study||23||
48700596|NCT00223808|102054034|FG000|COMPLETED|Overall Study||19||
48700597|NCT00223808|102054035|FG001|COMPLETED|Overall Study||17||
48700598|NCT00223808|102054036|FG002|COMPLETED|Overall Study||18||
48700599|NCT00223808|102054034|FG000|NOT COMPLETED|Overall Study||3||
48572004|NCT03446027|101731101|FG000|COMPLETED|Overall Study||78||
48572005|NCT03446027|101731102|FG001|COMPLETED|Overall Study||80||
48572006|NCT03446027|101731101|FG000|NOT COMPLETED|Overall Study||24||
48572007|NCT03446027|101731102|FG001|NOT COMPLETED|Overall Study||18||
48572008|NCT00572936|101731103|FG000|STARTED|First Intervention||4||
48572009|NCT00572936|101731104|FG001|STARTED|First Intervention||4||
48572010|NCT00572936|101731105|FG002|STARTED|First Intervention||5||
48572011|NCT00572936|101731106|FG003|STARTED|First Intervention||5||
48572012|NCT00572936|101731107|FG004|STARTED|First Intervention||5||
48572013|NCT00572936|101731108|FG005|STARTED|First Intervention||5||
48572014|NCT00572936|101731103|FG000|COMPLETED|First Intervention||4||
48572015|NCT00572936|101731104|FG001|COMPLETED|First Intervention||4||
48572016|NCT00572936|101731105|FG002|COMPLETED|First Intervention||5||
48572017|NCT00572936|101731106|FG003|COMPLETED|First Intervention||5||
48572018|NCT00572936|101731107|FG004|COMPLETED|First Intervention||5||
48572019|NCT00572936|101731108|FG005|COMPLETED|First Intervention||5||
48572020|NCT00572936|101731103|FG000|NOT COMPLETED|First Intervention||0||
48572021|NCT00572936|101731104|FG001|NOT COMPLETED|First Intervention||0||
48572022|NCT00572936|101731105|FG002|NOT COMPLETED|First Intervention||0||
48572023|NCT00572936|101731106|FG003|NOT COMPLETED|First Intervention||0||
48572024|NCT00572936|101731107|FG004|NOT COMPLETED|First Intervention||0||
48572025|NCT00572936|101731108|FG005|NOT COMPLETED|First Intervention||0||
48572026|NCT00572936|101731103|FG000|STARTED|Second Intervention||4||
48572027|NCT00572936|101731104|FG001|STARTED|Second Intervention||3||
48572028|NCT00572936|101731105|FG002|STARTED|Second Intervention||4||
48572029|NCT00572936|101731106|FG003|STARTED|Second Intervention||5||
48572030|NCT00572936|101731107|FG004|STARTED|Second Intervention||4||
48572031|NCT00572936|101731108|FG005|STARTED|Second Intervention||5||
48572032|NCT00572936|101731103|FG000|COMPLETED|Second Intervention||4||
48572033|NCT00572936|101731104|FG001|COMPLETED|Second Intervention||3||
48572034|NCT00572936|101731105|FG002|COMPLETED|Second Intervention||4||
48572035|NCT00572936|101731106|FG003|COMPLETED|Second Intervention||5||
48572036|NCT00572936|101731107|FG004|COMPLETED|Second Intervention||4||
48572037|NCT00572936|101731108|FG005|COMPLETED|Second Intervention||5||
48572038|NCT00572936|101731103|FG000|NOT COMPLETED|Second Intervention||0||
48572039|NCT00572936|101731104|FG001|NOT COMPLETED|Second Intervention||0||
48572040|NCT00572936|101731105|FG002|NOT COMPLETED|Second Intervention||0||
48572041|NCT00572936|101731106|FG003|NOT COMPLETED|Second Intervention||0||
48572042|NCT00572936|101731107|FG004|NOT COMPLETED|Second Intervention||0||
48700600|NCT00223808|102054035|FG001|NOT COMPLETED|Overall Study||5||
48700601|NCT00223808|102054036|FG002|NOT COMPLETED|Overall Study||5||
48700602|NCT03503591|102054037|FG000|STARTED|Overall Study||109||
48700603|NCT03503591|102054037|FG000|COMPLETED|Overall Study||109||
48700604|NCT03503591|102054037|FG000|NOT COMPLETED|Overall Study||0||
48700605|NCT00283803|102054038|FG000|STARTED|Overall Study||32||
48700606|NCT00283803|102054038|FG000|COMPLETED|Overall Study||19||
48700607|NCT00283803|102054038|FG000|NOT COMPLETED|Overall Study||13||
48700608|NCT01089413|102054039|FG000|STARTED|Overall Study||201||
48700609|NCT01089413|102054039|FG000|Received Bevacizumab in First Line|Overall Study||199||
48572043|NCT00572936|101731108|FG005|NOT COMPLETED|Second Intervention||0||
48572044|NCT00572936|101731103|FG000|STARTED|Third Intervention||4||
48572045|NCT00572936|101731104|FG001|STARTED|Third Intervention||3||
48572046|NCT00572936|101731105|FG002|STARTED|Third Intervention||4||
48572047|NCT00572936|101731106|FG003|STARTED|Third Intervention||5||
48572048|NCT00572936|101731107|FG004|STARTED|Third Intervention||3||
48572049|NCT00572936|101731108|FG005|STARTED|Third Intervention||5||
48572050|NCT00572936|101731103|FG000|COMPLETED|Third Intervention||4||
48572051|NCT00572936|101731104|FG001|COMPLETED|Third Intervention||3||
48572052|NCT00572936|101731105|FG002|COMPLETED|Third Intervention||4||
48572053|NCT00572936|101731106|FG003|COMPLETED|Third Intervention||5||
48572054|NCT00572936|101731107|FG004|COMPLETED|Third Intervention||3||
48572055|NCT00572936|101731108|FG005|COMPLETED|Third Intervention||5||
48572056|NCT00572936|101731103|FG000|NOT COMPLETED|Third Intervention||0||
48572057|NCT00572936|101731104|FG001|NOT COMPLETED|Third Intervention||0||
48572058|NCT00572936|101731105|FG002|NOT COMPLETED|Third Intervention||0||
48572059|NCT00572936|101731106|FG003|NOT COMPLETED|Third Intervention||0||
48572060|NCT00572936|101731107|FG004|NOT COMPLETED|Third Intervention||0||
48572061|NCT00572936|101731108|FG005|NOT COMPLETED|Third Intervention||0||
48700610|NCT01089413|102054039|FG000|COMPLETED|Overall Study||0||
48700611|NCT01089413|102054039|FG000|NOT COMPLETED|Overall Study||201||
48700612|NCT01801436|102054040|FG000|STARTED|Overall Study||14||
48700613|NCT01801436|102054040|FG000|COMPLETED|Overall Study||5||
48700614|NCT01801436|102054040|FG000|NOT COMPLETED|Overall Study||9||
48700615|NCT03403361|102054041|FG000|STARTED|Overall Study||36||
48700616|NCT03403361|102054041|FG000|COMPLETED|Overall Study||20||
48700617|NCT03403361|102054041|FG000|NOT COMPLETED|Overall Study||16||
48700618|NCT00098748|102054042|FG000|STARTED|Assigned to Study Treatment||63||
48700619|NCT00098748|102054043|FG001|STARTED|Assigned to Study Treatment||63||
48700620|NCT00098748|102054044|FG002|STARTED|Assigned to Study Treatment||64||
48700621|NCT00098748|102054042|FG000|COMPLETED|Assigned to Study Treatment||63||
48700622|NCT00098748|102054043|FG001|COMPLETED|Assigned to Study Treatment||61||
48700623|NCT00098748|102054044|FG002|COMPLETED|Assigned to Study Treatment||62||
48700624|NCT00098748|102054042|FG000|NOT COMPLETED|Assigned to Study Treatment||0||
48126104|NCT00359762|100633774|FG001|STARTED|Period I||0||
48126105|NCT00359762|100633775|FG002|STARTED|Period I||0||
48126106|NCT00359762|100633776|FG003|STARTED|Period I||0||
48126107|NCT00359762|100633777|FG004|STARTED|Period I||0||
48126108|NCT00359762|100633773|FG000|COMPLETED|Period I||0||
48126109|NCT00359762|100633774|FG001|COMPLETED|Period I||0||
48700625|NCT00098748|102054043|FG001|NOT COMPLETED|Assigned to Study Treatment||2||
48700626|NCT00098748|102054044|FG002|NOT COMPLETED|Assigned to Study Treatment||2||
48126110|NCT00359762|100633775|FG002|COMPLETED|Period I||0||
48126111|NCT00359762|100633776|FG003|COMPLETED|Period I||0||
48126112|NCT00359762|100633777|FG004|COMPLETED|Period I||0||
48126113|NCT00359762|100633773|FG000|NOT COMPLETED|Period I||0||
48126114|NCT00359762|100633774|FG001|NOT COMPLETED|Period I||0||
48126115|NCT00359762|100633775|FG002|NOT COMPLETED|Period I||0||
48126116|NCT00359762|100633776|FG003|NOT COMPLETED|Period I||0||
48126117|NCT00359762|100633777|FG004|NOT COMPLETED|Period I||0||
48126118|NCT03864614|100633778|FG000|STARTED|Overall Study||513||
48126119|NCT03864614|100633779|FG001|STARTED|Overall Study||645||
48126120|NCT03864614|100633780|FG002|STARTED|Overall Study||80||
48126121|NCT03864614|100633781|FG003|STARTED|Overall Study||277||
48126122|NCT03864614|100633778|FG000|Dosed With SAGE-217 Within This Study|Overall Study||513||
48126123|NCT03864614|100633779|FG001|Dosed With SAGE-217 Within This Study|Overall Study||645||
48126124|NCT03864614|100633780|FG002|Dosed With SAGE-217 Within This Study|Overall Study||80||
48126125|NCT03864614|100633781|FG003|Dosed With SAGE-217 Within This Study|Overall Study||118||
48126126|NCT03864614|100633778|FG000|COMPLETED|Overall Study||213||
48572062|NCT03645395|101731109|FG000|STARTED|Part 1 (Up to 6 Months)||3||
48572063|NCT03645395|101731110|FG001|STARTED|Part 1 (Up to 6 Months)||3||
48572064|NCT03645395|101731111|FG002|STARTED|Part 1 (Up to 6 Months)||3||
48572065|NCT03645395|101731112|FG003|STARTED|Part 1 (Up to 6 Months)||0||
48572066|NCT03645395|101731109|FG000|COMPLETED|Part 1 (Up to 6 Months)||1||
48572067|NCT03645395|101731110|FG001|COMPLETED|Part 1 (Up to 6 Months)||0||
48572068|NCT03645395|101731111|FG002|COMPLETED|Part 1 (Up to 6 Months)||0||
48572069|NCT03645395|101731112|FG003|COMPLETED|Part 1 (Up to 6 Months)||0||
48572070|NCT03645395|101731109|FG000|NOT COMPLETED|Part 1 (Up to 6 Months)||2||
48572071|NCT03645395|101731110|FG001|NOT COMPLETED|Part 1 (Up to 6 Months)||3||
48572072|NCT03645395|101731111|FG002|NOT COMPLETED|Part 1 (Up to 6 Months)||3||
48572073|NCT03645395|101731112|FG003|NOT COMPLETED|Part 1 (Up to 6 Months)||0||
48572074|NCT03645395|101731109|FG000|STARTED|Part 2 (Up to 6 Months)||0||
48572075|NCT03645395|101731110|FG001|STARTED|Part 2 (Up to 6 Months)||0||
48572076|NCT03645395|101731111|FG002|STARTED|Part 2 (Up to 6 Months)||0||
48700627|NCT00098748|102054042|FG000|STARTED|Received Study Treatment||63||
48700628|NCT00098748|102054043|FG001|STARTED|Received Study Treatment||61||
48700629|NCT00098748|102054044|FG002|STARTED|Received Study Treatment||62||
48700630|NCT00098748|102054042|FG000|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||57||
48700631|NCT00098748|102054043|FG001|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||52||
48700632|NCT00098748|102054044|FG002|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||58||
48700633|NCT00098748|102054042|FG000|COMPLETED|Received Study Treatment||15||
48572077|NCT03645395|101731112|FG003|STARTED|Part 2 (Up to 6 Months)||0||
48572078|NCT03645395|101731109|FG000|COMPLETED|Part 2 (Up to 6 Months)||0||
48572079|NCT03645395|101731110|FG001|COMPLETED|Part 2 (Up to 6 Months)||0||
48572080|NCT03645395|101731111|FG002|COMPLETED|Part 2 (Up to 6 Months)||0||
48572081|NCT03645395|101731112|FG003|COMPLETED|Part 2 (Up to 6 Months)||0||
48572082|NCT03645395|101731109|FG000|NOT COMPLETED|Part 2 (Up to 6 Months)||0||
48126127|NCT03864614|100633779|FG001|COMPLETED|Overall Study||236||
48126128|NCT03864614|100633780|FG002|COMPLETED|Overall Study||76||
48126129|NCT03864614|100633781|FG003|COMPLETED|Overall Study||69||
48572083|NCT03645395|101731110|FG001|NOT COMPLETED|Part 2 (Up to 6 Months)||0||
48572084|NCT03645395|101731111|FG002|NOT COMPLETED|Part 2 (Up to 6 Months)||0||
48572085|NCT03645395|101731112|FG003|NOT COMPLETED|Part 2 (Up to 6 Months)||0||
48572086|NCT00546377|101731113|FG000|STARTED|Overall Study||50||
48700634|NCT00098748|102054043|FG001|COMPLETED|Received Study Treatment||25||
48700635|NCT00098748|102054044|FG002|COMPLETED|Received Study Treatment||18||
48700636|NCT00098748|102054042|FG000|NOT COMPLETED|Received Study Treatment||48||
48700637|NCT00098748|102054043|FG001|NOT COMPLETED|Received Study Treatment||36||
48700638|NCT00098748|102054044|FG002|NOT COMPLETED|Received Study Treatment||44||
48700639|NCT00098748|102054042|FG000|STARTED|Continued on Open-Label Treatment||15||
48126130|NCT03864614|100633778|FG000|NOT COMPLETED|Overall Study||300||
48126131|NCT03864614|100633779|FG001|NOT COMPLETED|Overall Study||409||
48126132|NCT03864614|100633780|FG002|NOT COMPLETED|Overall Study||4||
48126133|NCT03864614|100633781|FG003|NOT COMPLETED|Overall Study||208||
48126134|NCT02742103|100633782|FG000|STARTED|Overall Study||55||
48126135|NCT02742103|100633783|FG001|STARTED|Overall Study||28||
48126136|NCT02742103|100633782|FG000|COMPLETED|Overall Study||46||
48126137|NCT02742103|100633783|FG001|COMPLETED|Overall Study||23||
48126138|NCT02742103|100633782|FG000|NOT COMPLETED|Overall Study||9||
48126139|NCT02742103|100633783|FG001|NOT COMPLETED|Overall Study||5||
48126140|NCT03843502|100633784|FG000|STARTED|Overall Study||5||
48126141|NCT03843502|100633785|FG001|STARTED|Overall Study||5||
48126142|NCT03843502|100633784|FG000|COMPLETED|Overall Study||5||
48126143|NCT03843502|100633785|FG001|COMPLETED|Overall Study||5||
48126144|NCT03843502|100633784|FG000|NOT COMPLETED|Overall Study||0||
48126145|NCT03843502|100633785|FG001|NOT COMPLETED|Overall Study||0||
48126146|NCT01459796|100633786|FG000|STARTED|Overall Study||94||
48126147|NCT01459796|100633787|FG001|STARTED|Overall Study||126||
48126148|NCT01459796|100633786|FG000|COMPLETED|Overall Study||0||
48126149|NCT01459796|100633787|FG001|COMPLETED|Overall Study||0||
48126150|NCT01459796|100633786|FG000|NOT COMPLETED|Overall Study||94||
48126151|NCT01459796|100633787|FG001|NOT COMPLETED|Overall Study||126||
48126152|NCT00612066|100633788|FG000|STARTED|Overall Study||2||
48126153|NCT00612066|100633788|FG000|COMPLETED|Overall Study||1||
48126154|NCT00612066|100633788|FG000|NOT COMPLETED|Overall Study||1||
48126155|NCT01639001|100633789|FG000|STARTED|Overall Study||104||
48126156|NCT01639001|100633790|FG001|STARTED|Overall Study||103||
48126157|NCT01639001|100633789|FG000|Treated|Overall Study||104||
48126158|NCT01639001|100633790|FG001|Treated|Overall Study||101||
48126159|NCT01639001|100633789|FG000|COMPLETED|Overall Study||29|"Completed refers to either those patients who switched to commercial supplies of crizotinib or those patients who were in survival follow up, when the Sponsor sent a written End of Study notification to the study sites."|
48126160|NCT01639001|100633790|FG001|COMPLETED|Overall Study||26|"Completed refers to either those patients who switched to commercial supplies of crizotinib or those patients who were in survival follow up, when the Sponsor sent a written End of Study notification to the study sites."|
48126161|NCT01639001|100633789|FG000|NOT COMPLETED|Overall Study||75||
48126162|NCT01639001|100633790|FG001|NOT COMPLETED|Overall Study||77||
48126163|NCT02595567|100633791|FG000|STARTED|Overall Study||25||
48126164|NCT02595567|100633791|FG000|COMPLETED|Overall Study||25||
48126165|NCT02595567|100633791|FG000|NOT COMPLETED|Overall Study||0||
48126166|NCT01075321|100633792|FG000|STARTED|Overall Study||7||
48126167|NCT01075321|100633793|FG001|STARTED|Overall Study||9||
48126168|NCT01075321|100633794|FG002|STARTED|Overall Study||9||
48126169|NCT01075321|100633795|FG003|STARTED|Overall Study||33||
48126170|NCT01075321|100633792|FG000|COMPLETED|Overall Study||6||
48126171|NCT01075321|100633793|FG001|COMPLETED|Overall Study||9||
48126172|NCT01075321|100633794|FG002|COMPLETED|Overall Study||7||
48126173|NCT01075321|100633795|FG003|COMPLETED|Overall Study||31||
48126174|NCT01075321|100633792|FG000|NOT COMPLETED|Overall Study||1||
48126175|NCT01075321|100633793|FG001|NOT COMPLETED|Overall Study||0||
48126176|NCT01075321|100633794|FG002|NOT COMPLETED|Overall Study||2||
48126177|NCT01075321|100633795|FG003|NOT COMPLETED|Overall Study||2||
48126178|NCT03219333|100633796|FG000|STARTED|Overall Study||128||
48126179|NCT03219333|100633797|FG001|STARTED|Overall Study||91||
48126180|NCT03219333|100633796|FG000|Treated|Overall Study||125||
48126181|NCT03219333|100633797|FG001|Treated|Overall Study||89||
48126182|NCT03219333|100633796|FG000|COMPLETED|Overall Study||0||
48126183|NCT03219333|100633797|FG001|COMPLETED|Overall Study||0||
48126184|NCT03219333|100633796|FG000|NOT COMPLETED|Overall Study||128||
48126185|NCT03219333|100633797|FG001|NOT COMPLETED|Overall Study||91||
48572087|NCT00546377|101731113|FG000|COMPLETED|Overall Study||43||
48572088|NCT00546377|101731113|FG000|NOT COMPLETED|Overall Study||7||
48572089|NCT00795002|101731114|FG000|STARTED|Overall Study||37||
48572090|NCT00795002|101731115|FG001|STARTED|Overall Study||37||
48572091|NCT00795002|101731114|FG000|COMPLETED|Overall Study||37||
48572092|NCT00795002|101731115|FG001|COMPLETED|Overall Study||37||
48126186|NCT04535037|100633798|FG000|STARTED|Overall Study||249||
48126187|NCT04535037|100633799|FG001|STARTED|Overall Study||251||
48126188|NCT04535037|100633798|FG000|COMPLETED|Overall Study||237||
48126189|NCT04535037|100633799|FG001|COMPLETED|Overall Study||233||
48126190|NCT04535037|100633798|FG000|NOT COMPLETED|Overall Study||12||
48126191|NCT04535037|100633799|FG001|NOT COMPLETED|Overall Study||18||
48126192|NCT00861341|100633800|FG000|STARTED|Overall Study||40||
48126193|NCT00861341|100633800|FG000|COMPLETED|Overall Study||38||
48126194|NCT00861341|100633800|FG000|NOT COMPLETED|Overall Study||2||
48126195|NCT03588572|100633801|FG000|STARTED|Visitation 1||22||
48126196|NCT03588572|100633802|FG001|STARTED|Visitation 1||21||
48126197|NCT03588572|100633801|FG000|COMPLETED|Visitation 1||21||
48572093|NCT00795002|101731114|FG000|NOT COMPLETED|Overall Study||0||
48572094|NCT00795002|101731115|FG001|NOT COMPLETED|Overall Study||0||
48572095|NCT02504827|101731116|FG000|STARTED|Overall Study||12||
48572096|NCT02504827|101731116|FG000|COMPLETED|Overall Study||11||
48572097|NCT02504827|101731116|FG000|NOT COMPLETED|Overall Study||1||
48572098|NCT03806933|101731117|FG000|STARTED|Main Period||61||
48572099|NCT03806933|101731118|FG001|STARTED|Main Period||60||
48572100|NCT03806933|101731119|FG002|STARTED|Main Period||61||
48282824|NCT04677179|101017044|FG004|Received at Least One Dose of Study Drug|Induction Treatment Period||0||
48282825|NCT04677179|101017045|FG005|Received at Least One Dose of Study Drug|Induction Treatment Period||0||
48282826|NCT04677179|101017046|FG006|Received at Least One Dose of Study Drug|Induction Treatment Period||0||
48282827|NCT04677179|101017047|FG007|Received at Least One Dose of Study Drug|Induction Treatment Period||0||
48282828|NCT04677179|101017048|FG008|Received at Least One Dose of Study Drug|Induction Treatment Period||0||
48572101|NCT03806933|101731120|FG003|STARTED|Main Period||59||
48126198|NCT03588572|100633802|FG001|COMPLETED|Visitation 1||20||
48126199|NCT03588572|100633801|FG000|NOT COMPLETED|Visitation 1||1||
48126200|NCT03588572|100633802|FG001|NOT COMPLETED|Visitation 1||1||
48126201|NCT03588572|100633801|FG000|STARTED|Visitation 2||21||
48126202|NCT03588572|100633802|FG001|STARTED|Visitation 2||20||
48126203|NCT03588572|100633801|FG000|COMPLETED|Visitation 2||19||
48126204|NCT03588572|100633802|FG001|COMPLETED|Visitation 2||18||
48126205|NCT03588572|100633801|FG000|NOT COMPLETED|Visitation 2||2||
48126206|NCT03588572|100633802|FG001|NOT COMPLETED|Visitation 2||2||
48126207|NCT03588572|100633801|FG000|STARTED|Visitation 3||19||
48126208|NCT03588572|100633802|FG001|STARTED|Visitation 3||18||
48126209|NCT03588572|100633801|FG000|COMPLETED|Visitation 3||16||
48126210|NCT03588572|100633802|FG001|COMPLETED|Visitation 3||16||
48126211|NCT03588572|100633801|FG000|NOT COMPLETED|Visitation 3||3||
48126212|NCT03588572|100633802|FG001|NOT COMPLETED|Visitation 3||2||
48126213|NCT02880852|100633803|FG000|STARTED|Overall Study||20||
48126214|NCT02880852|100633803|FG000|COMPLETED|Overall Study||20||
48126215|NCT02880852|100633803|FG000|NOT COMPLETED|Overall Study||0||
48126216|NCT02703844|100633804|FG000|STARTED|Randomized Controlled Portion||23||
48126217|NCT02703844|100633805|FG001|STARTED|Randomized Controlled Portion||23||
48126218|NCT02703844|100633804|FG000|COMPLETED|Randomized Controlled Portion||16||
48126219|NCT02703844|100633805|FG001|COMPLETED|Randomized Controlled Portion||17||
48126220|NCT02703844|100633804|FG000|NOT COMPLETED|Randomized Controlled Portion||7||
48126221|NCT02703844|100633805|FG001|NOT COMPLETED|Randomized Controlled Portion||6||
48397360|NCT02088541|101302609|FG001|Safety Population|Overall Study||27||
48126222|NCT02703844|100633804|FG000|STARTED|Cross-Over to Active||0|Cross-over portion was only offered to those who were randomized to placebo in the randomized portion of the study. Not all participants from the placebo group of the randomized controlled period chose to move into the cross-over period and receive active treatment|
48126223|NCT02703844|100633805|FG001|STARTED|Cross-Over to Active||14|Cross-over portion was only offered to those who were randomized to placebo in the randomized portion of the study. Not all participants from the placebo group of the randomized controlled period chose to move into the cross-over period and receive active treatment|
48572102|NCT03806933|101731117|FG000|Safety Evaluation Set (SES)|Main Period||62|One participant randomized to NT 201 100 U dose group was actually treated with NT 201 20 U. The participant was re-assigned to the Pooled: NT 201 20 U dose group for safety analyses.|
48572103|NCT03806933|101731118|FG001|Safety Evaluation Set (SES)|Main Period||60|One participant randomized to NT 201 100 U dose group was actually treated with NT 201 20 U. The participant was re-assigned to the Pooled: NT 201 20 U dose group for safety analyses.|
48572104|NCT03806933|101731119|FG002|Safety Evaluation Set (SES)|Main Period||61|One participant randomized to NT 201 100 U dose group was actually treated with NT 201 20 U. The participant was re-assigned to the Pooled: NT 201 20 U dose group for safety analyses.|
48572105|NCT03806933|101731120|FG003|Safety Evaluation Set (SES)|Main Period||58|One participant randomized to NT 201 100 U dose group was actually treated with NT 201 20 U. The participant was re-assigned to the Pooled: NT 201 20 U dose group for safety analyses.|
48397361|NCT02088541|101302610|FG002|Safety Population|Overall Study||115||
48700640|NCT00098748|102054043|FG001|STARTED|Continued on Open-Label Treatment||25||
48700641|NCT00098748|102054044|FG002|STARTED|Continued on Open-Label Treatment||0||
48700642|NCT00098748|102054042|FG000|COMPLETED|Continued on Open-Label Treatment||7||
48700643|NCT00098748|102054043|FG001|COMPLETED|Continued on Open-Label Treatment||10||
48700644|NCT00098748|102054044|FG002|COMPLETED|Continued on Open-Label Treatment||0||
48700645|NCT00098748|102054042|FG000|NOT COMPLETED|Continued on Open-Label Treatment||8||
48700646|NCT00098748|102054043|FG001|NOT COMPLETED|Continued on Open-Label Treatment||15||
48700647|NCT00098748|102054044|FG002|NOT COMPLETED|Continued on Open-Label Treatment||0||
48700648|NCT00441142|102054045|FG000|STARTED|Overall Study||6||
48700649|NCT00441142|102054046|FG001|STARTED|Overall Study||7||
48700650|NCT00441142|102054047|FG002|STARTED|Overall Study||29||
48700651|NCT00441142|102054048|FG003|STARTED|Overall Study||69||
48700652|NCT00441142|102054045|FG000|COMPLETED|Overall Study||0||
48700653|NCT00441142|102054046|FG001|COMPLETED|Overall Study||0||
48700654|NCT00441142|102054047|FG002|COMPLETED|Overall Study||7||
48700655|NCT00441142|102054048|FG003|COMPLETED|Overall Study||1||
48700656|NCT00441142|102054045|FG000|NOT COMPLETED|Overall Study||6||
48700657|NCT00441142|102054046|FG001|NOT COMPLETED|Overall Study||7||
48700658|NCT00441142|102054047|FG002|NOT COMPLETED|Overall Study||22||
48700659|NCT00441142|102054048|FG003|NOT COMPLETED|Overall Study||68||
48700660|NCT03119181|102054049|FG000|STARTED|Overall Study||19||
48282829|NCT04677179|101017049|FG009|Received at Least One Dose of Study Drug|Induction Treatment Period||0||
48282830|NCT04677179|101017040|FG000|COMPLETED|Induction Treatment Period||19||
48282831|NCT04677179|101017041|FG001|COMPLETED|Induction Treatment Period||22||
48282832|NCT04677179|101017042|FG002|COMPLETED|Induction Treatment Period||12||
48282833|NCT04677179|101017043|FG003|COMPLETED|Induction Treatment Period||0||
48282834|NCT04677179|101017044|FG004|COMPLETED|Induction Treatment Period||0||
48282835|NCT04677179|101017045|FG005|COMPLETED|Induction Treatment Period||0||
48282836|NCT04677179|101017046|FG006|COMPLETED|Induction Treatment Period||0||
48282837|NCT04677179|101017047|FG007|COMPLETED|Induction Treatment Period||0||
48282838|NCT04677179|101017048|FG008|COMPLETED|Induction Treatment Period||0||
48282839|NCT04677179|101017049|FG009|COMPLETED|Induction Treatment Period||0||
48282840|NCT04677179|101017040|FG000|NOT COMPLETED|Induction Treatment Period||13||
48282841|NCT04677179|101017041|FG001|NOT COMPLETED|Induction Treatment Period||13||
48282842|NCT04677179|101017042|FG002|NOT COMPLETED|Induction Treatment Period||2||
48397362|NCT02088541|101302611|FG003|Safety Population|Overall Study||39||
48397363|NCT02088541|101302612|FG004|Safety Population|Overall Study||45||
48397364|NCT02088541|101302608|FG000|Intent-to-treat (ITT) Population|Overall Study||0||
48397365|NCT02088541|101302609|FG001|Intent-to-treat (ITT) Population|Overall Study||0||
48572106|NCT03806933|101731117|FG000|COMPLETED|Main Period||57||
48572107|NCT03806933|101731118|FG001|COMPLETED|Main Period||57||
48572108|NCT03806933|101731119|FG002|COMPLETED|Main Period||59||
48572109|NCT03806933|101731120|FG003|COMPLETED|Main Period||56||
48397366|NCT02088541|101302610|FG002|Intent-to-treat (ITT) Population|Overall Study||118||
48397367|NCT02088541|101302611|FG003|Intent-to-treat (ITT) Population|Overall Study||0||
48572110|NCT03806933|101731117|FG000|NOT COMPLETED|Main Period||4||
48572111|NCT03806933|101731118|FG001|NOT COMPLETED|Main Period||3||
48572112|NCT03806933|101731119|FG002|NOT COMPLETED|Main Period||2||
48572113|NCT03806933|101731120|FG003|NOT COMPLETED|Main Period||3||
48572114|NCT03806933|101731117|FG000|STARTED|OLEX Period||52||
48572115|NCT03806933|101731118|FG001|STARTED|OLEX Period||53||
48572116|NCT03806933|101731119|FG002|STARTED|OLEX Period||56||
48700661|NCT03119181|102054050|FG001|STARTED|Overall Study||21||
48700662|NCT03119181|102054049|FG000|COMPLETED|Overall Study||19||
48700663|NCT03119181|102054050|FG001|COMPLETED|Overall Study||21||
48700664|NCT03119181|102054049|FG000|NOT COMPLETED|Overall Study||0||
48700665|NCT03119181|102054050|FG001|NOT COMPLETED|Overall Study||0||
48700666|NCT00646763|102054051|FG000|STARTED|Overall Study||18||
48700667|NCT00646763|102054052|FG001|STARTED|Overall Study||17||
48700668|NCT00646763|102054051|FG000|COMPLETED|Overall Study||18||
48700669|NCT00646763|102054052|FG001|COMPLETED|Overall Study||17||
48700670|NCT00646763|102054051|FG000|NOT COMPLETED|Overall Study||0||
48282843|NCT04677179|101017043|FG003|NOT COMPLETED|Induction Treatment Period||0||
48282844|NCT04677179|101017044|FG004|NOT COMPLETED|Induction Treatment Period||0||
48282845|NCT04677179|101017045|FG005|NOT COMPLETED|Induction Treatment Period||0||
48282846|NCT04677179|101017046|FG006|NOT COMPLETED|Induction Treatment Period||0||
48282847|NCT04677179|101017047|FG007|NOT COMPLETED|Induction Treatment Period||0||
48282848|NCT04677179|101017048|FG008|NOT COMPLETED|Induction Treatment Period||0||
48282849|NCT04677179|101017049|FG009|NOT COMPLETED|Induction Treatment Period||0||
48282850|NCT04677179|101017040|FG000|STARTED|Maintenance Treatment Period||0||
48397368|NCT02088541|101302612|FG004|Intent-to-treat (ITT) Population|Overall Study||57||
48572117|NCT03806933|101731120|FG003|STARTED|OLEX Period||50||
48700671|NCT00646763|102054052|FG001|NOT COMPLETED|Overall Study||0||
48572118|NCT03806933|101731117|FG000|COMPLETED|OLEX Period||52||
48572119|NCT03806933|101731118|FG001|COMPLETED|OLEX Period||53||
48700672|NCT02480166|102054053|FG000|STARTED|Overall Study||20||
48700673|NCT02480166|102054054|FG001|STARTED|Overall Study||36||
48700674|NCT02480166|102054055|FG002|STARTED|Overall Study||4||
48700675|NCT02480166|102054053|FG000|COMPLETED|Overall Study||20||
48282851|NCT04677179|101017041|FG001|STARTED|Maintenance Treatment Period||0||
48282852|NCT04677179|101017042|FG002|STARTED|Maintenance Treatment Period||0||
48282853|NCT04677179|101017043|FG003|STARTED|Maintenance Treatment Period||8||
48282854|NCT04677179|101017044|FG004|STARTED|Maintenance Treatment Period||10||
48397369|NCT02088541|101302608|FG000|COMPLETED|Overall Study||0||
48397370|NCT02088541|101302609|FG001|COMPLETED|Overall Study||0||
48397371|NCT02088541|101302610|FG002|COMPLETED|Overall Study||0||
48397372|NCT02088541|101302611|FG003|COMPLETED|Overall Study||0||
48397373|NCT02088541|101302612|FG004|COMPLETED|Overall Study||0||
48397374|NCT02088541|101302608|FG000|NOT COMPLETED|Overall Study||71||
48126224|NCT02703844|100633804|FG000|COMPLETED|Cross-Over to Active||0|Participants were allowed to use the active study device for up to 4 months. Completed is those who used the study device for the full 4 months.|
48126225|NCT02703844|100633805|FG001|COMPLETED|Cross-Over to Active||5|Participants were allowed to use the active study device for up to 4 months. Completed is those who used the study device for the full 4 months.|
48126226|NCT02703844|100633804|FG000|NOT COMPLETED|Cross-Over to Active||0||
48397375|NCT02088541|101302609|FG001|NOT COMPLETED|Overall Study||27||
48397376|NCT02088541|101302610|FG002|NOT COMPLETED|Overall Study||117||
48397377|NCT02088541|101302611|FG003|NOT COMPLETED|Overall Study||44||
48397378|NCT02088541|101302612|FG004|NOT COMPLETED|Overall Study||58||
48397379|NCT03175562|101302613|FG000|STARTED|Overall Study||240||
48397380|NCT03175562|101302613|FG000|Test Product|Overall Study||240|All participants received both the study treatments in a single semi-occlusive patch.|
48397381|NCT03175562|101302613|FG000|Negative Control|Overall Study||240|All participants received both the study treatments in a single semi-occlusive patch.|
48397382|NCT03175562|101302613|FG000|COMPLETED|Overall Study||224||
48397383|NCT03175562|101302613|FG000|NOT COMPLETED|Overall Study||16||
48572120|NCT03806933|101731119|FG002|COMPLETED|OLEX Period||56||
48126227|NCT02703844|100633805|FG001|NOT COMPLETED|Cross-Over to Active||9||
48126228|NCT01358981|100633806|FG000|STARTED|Period 1||2||
48126229|NCT01358981|100633807|FG001|STARTED|Period 1||2||
48126230|NCT01358981|100633808|FG002|STARTED|Period 1||2||
48126231|NCT01358981|100633809|FG003|STARTED|Period 1||2||
48126232|NCT01358981|100633810|FG004|STARTED|Period 1||3||
48126233|NCT01358981|100633811|FG005|STARTED|Period 1||3||
48126234|NCT01358981|100633812|FG006|STARTED|Period 1||3||
48126235|NCT01358981|100633806|FG000|Received at Least 1dose of Study Drug|Period 1||2||
48126236|NCT01358981|100633807|FG001|Received at Least 1dose of Study Drug|Period 1||2||
48126237|NCT01358981|100633808|FG002|Received at Least 1dose of Study Drug|Period 1||2||
48126238|NCT01358981|100633809|FG003|Received at Least 1dose of Study Drug|Period 1||2||
48126239|NCT01358981|100633810|FG004|Received at Least 1dose of Study Drug|Period 1||3||
48126240|NCT01358981|100633811|FG005|Received at Least 1dose of Study Drug|Period 1||3||
48126241|NCT01358981|100633812|FG006|Received at Least 1dose of Study Drug|Period 1||3||
48126242|NCT01358981|100633806|FG000|COMPLETED|Period 1||2||
48126243|NCT01358981|100633807|FG001|COMPLETED|Period 1||2||
48126244|NCT01358981|100633808|FG002|COMPLETED|Period 1||2||
48126245|NCT01358981|100633809|FG003|COMPLETED|Period 1||1||
48126246|NCT01358981|100633810|FG004|COMPLETED|Period 1||3||
48126247|NCT01358981|100633811|FG005|COMPLETED|Period 1||3||
48126248|NCT01358981|100633812|FG006|COMPLETED|Period 1||3||
48126249|NCT01358981|100633806|FG000|NOT COMPLETED|Period 1||0||
48126250|NCT01358981|100633807|FG001|NOT COMPLETED|Period 1||0||
48126251|NCT01358981|100633808|FG002|NOT COMPLETED|Period 1||0||
48126252|NCT01358981|100633809|FG003|NOT COMPLETED|Period 1||1||
48126253|NCT01358981|100633810|FG004|NOT COMPLETED|Period 1||0||
48126254|NCT01358981|100633811|FG005|NOT COMPLETED|Period 1||0||
48126255|NCT01358981|100633812|FG006|NOT COMPLETED|Period 1||0||
48126256|NCT01358981|100633806|FG000|STARTED|Period 2||2||
48126257|NCT01358981|100633807|FG001|STARTED|Period 2||2||
48126258|NCT01358981|100633808|FG002|STARTED|Period 2||2||
48126259|NCT01358981|100633809|FG003|STARTED|Period 2||2||
48126260|NCT01358981|100633810|FG004|STARTED|Period 2||3||
48126261|NCT01358981|100633811|FG005|STARTED|Period 2||3||
48126262|NCT01358981|100633812|FG006|STARTED|Period 2||3||
48126263|NCT01358981|100633806|FG000|COMPLETED|Period 2||2||
48126264|NCT01358981|100633807|FG001|COMPLETED|Period 2||2||
48126265|NCT01358981|100633808|FG002|COMPLETED|Period 2||2||
48126266|NCT01358981|100633809|FG003|COMPLETED|Period 2||2||
48126267|NCT01358981|100633810|FG004|COMPLETED|Period 2||3||
48126268|NCT01358981|100633811|FG005|COMPLETED|Period 2||3||
48126269|NCT01358981|100633812|FG006|COMPLETED|Period 2||3||
48126270|NCT01358981|100633806|FG000|NOT COMPLETED|Period 2||0||
48126271|NCT01358981|100633807|FG001|NOT COMPLETED|Period 2||0||
48126272|NCT01358981|100633808|FG002|NOT COMPLETED|Period 2||0||
48126273|NCT01358981|100633809|FG003|NOT COMPLETED|Period 2||0||
48126274|NCT01358981|100633810|FG004|NOT COMPLETED|Period 2||0||
48126275|NCT01358981|100633811|FG005|NOT COMPLETED|Period 2||0||
48126276|NCT01358981|100633812|FG006|NOT COMPLETED|Period 2||0||
48126277|NCT01358981|100633806|FG000|STARTED|Period 3||2||
48126278|NCT01358981|100633807|FG001|STARTED|Period 3||2||
48126279|NCT01358981|100633808|FG002|STARTED|Period 3||2||
48126280|NCT01358981|100633809|FG003|STARTED|Period 3||2||
48126281|NCT01358981|100633810|FG004|STARTED|Period 3||3||
48126282|NCT01358981|100633811|FG005|STARTED|Period 3||3||
48126283|NCT01358981|100633812|FG006|STARTED|Period 3||3||
48126284|NCT01358981|100633806|FG000|COMPLETED|Period 3||2||
48282855|NCT04677179|101017045|FG005|STARTED|Maintenance Treatment Period||5||
48282856|NCT04677179|101017046|FG006|STARTED|Maintenance Treatment Period||0||
48282857|NCT04677179|101017047|FG007|STARTED|Maintenance Treatment Period||0||
48282858|NCT04677179|101017048|FG008|STARTED|Maintenance Treatment Period||0||
48282859|NCT04677179|101017049|FG009|STARTED|Maintenance Treatment Period||0||
48397384|NCT02971293|101302614|FG000|STARTED|Overall Study||42|3-way, complete crossover. Each patient received all 3 treatments in turn; randomised sequence.|
48397385|NCT02971293|101302614|FG000|COMPLETED|Overall Study||31||
48397386|NCT02971293|101302614|FG000|NOT COMPLETED|Overall Study||11||
48397387|NCT02979444|101302615|FG000|STARTED|Overall Study||405||
48397388|NCT02979444|101302616|FG001|STARTED|Overall Study||310||
48397389|NCT02979444|101302617|FG002|STARTED|Overall Study||159||
48397390|NCT02979444|101302615|FG000|COMPLETED|Overall Study||382||
48397391|NCT02979444|101302616|FG001|COMPLETED|Overall Study||293||
48397392|NCT02979444|101302617|FG002|COMPLETED|Overall Study||149||
48397393|NCT02979444|101302615|FG000|NOT COMPLETED|Overall Study||23||
48397394|NCT02979444|101302616|FG001|NOT COMPLETED|Overall Study||17||
48397395|NCT02979444|101302617|FG002|NOT COMPLETED|Overall Study||10||
48700676|NCT02480166|102054054|FG001|COMPLETED|Overall Study||36||
48700677|NCT02480166|102054055|FG002|COMPLETED|Overall Study||4||
48700678|NCT02480166|102054053|FG000|NOT COMPLETED|Overall Study||0||
48282860|NCT04677179|101017040|FG000|COMPLETED|Maintenance Treatment Period||0||
48282861|NCT04677179|101017041|FG001|COMPLETED|Maintenance Treatment Period||0||
48282862|NCT04677179|101017042|FG002|COMPLETED|Maintenance Treatment Period||0||
48397396|NCT00756678|101302618|FG000|STARTED|Overall Study||51||
48397397|NCT00756678|101302618|FG000|COMPLETED|Overall Study||50||
48397398|NCT00756678|101302618|FG000|NOT COMPLETED|Overall Study||1||
48397399|NCT04839393|101302619|FG000|STARTED|Overall Study||4||
48397400|NCT04839393|101302620|FG001|STARTED|Overall Study||4||
48397401|NCT04839393|101302621|FG002|STARTED|Overall Study||19||
48397402|NCT04839393|101302619|FG000|Received Treatment|Overall Study||4||
48397403|NCT04839393|101302620|FG001|Received Treatment|Overall Study||4||
48397404|NCT04839393|101302621|FG002|Received Treatment|Overall Study||19||
48397405|NCT04839393|101302619|FG000|COMPLETED|Overall Study||4||
48397406|NCT04839393|101302620|FG001|COMPLETED|Overall Study||4||
48397407|NCT04839393|101302621|FG002|COMPLETED|Overall Study||16||
48397408|NCT04839393|101302619|FG000|NOT COMPLETED|Overall Study||0||
48397409|NCT04839393|101302620|FG001|NOT COMPLETED|Overall Study||0||
48397410|NCT04839393|101302621|FG002|NOT COMPLETED|Overall Study||3||
48397411|NCT01592006|101302622|FG000|STARTED|Overall Study||3||
48397412|NCT01592006|101302622|FG000|COMPLETED|Overall Study||3||
48397413|NCT01592006|101302622|FG000|NOT COMPLETED|Overall Study||0||
48397414|NCT05301803|101302623|FG000|STARTED|Overall Study||27||
48397415|NCT05301803|101302623|FG000|COMPLETED|Overall Study||25||
48397416|NCT05301803|101302623|FG000|NOT COMPLETED|Overall Study||2||
48397417|NCT01262599|101302624|FG000|STARTED|Overall Study||16||
48397418|NCT01262599|101302625|FG001|STARTED|Overall Study||16||
48397419|NCT01262599|101302624|FG000|COMPLETED|Overall Study||16||
48397420|NCT01262599|101302625|FG001|COMPLETED|Overall Study||16||
48397421|NCT01262599|101302624|FG000|NOT COMPLETED|Overall Study||0||
48397422|NCT01262599|101302625|FG001|NOT COMPLETED|Overall Study||0||
48397423|NCT01090102|101302626|FG000|STARTED|First 12 Weeks||15||
48397424|NCT01090102|101302627|FG001|STARTED|First 12 Weeks||18||
48397425|NCT01090102|101302626|FG000|COMPLETED|First 12 Weeks||11||
48397426|NCT01090102|101302627|FG001|COMPLETED|First 12 Weeks||16||
48397427|NCT01090102|101302626|FG000|NOT COMPLETED|First 12 Weeks||4||
48397428|NCT01090102|101302627|FG001|NOT COMPLETED|First 12 Weeks||2||
48397429|NCT01090102|101302626|FG000|STARTED|Second 12 Weeks||11||
48397430|NCT01090102|101302627|FG001|STARTED|Second 12 Weeks||16||
48397431|NCT01090102|101302626|FG000|COMPLETED|Second 12 Weeks||11||
48397432|NCT01090102|101302627|FG001|COMPLETED|Second 12 Weeks||15||
48397433|NCT01090102|101302626|FG000|NOT COMPLETED|Second 12 Weeks||0||
48397434|NCT01090102|101302627|FG001|NOT COMPLETED|Second 12 Weeks||1||
48397435|NCT01061567|101302628|FG000|STARTED|Overall Study||1814||
48397436|NCT01061567|101302628|FG000|COMPLETED|Overall Study||1738||
48700679|NCT02480166|102054054|FG001|NOT COMPLETED|Overall Study||0||
48282863|NCT04677179|101017043|FG003|COMPLETED|Maintenance Treatment Period||0||
48397437|NCT01061567|101302628|FG000|NOT COMPLETED|Overall Study||76||
48282864|NCT04677179|101017044|FG004|COMPLETED|Maintenance Treatment Period||0||
48397438|NCT04128527|101302629|FG000|STARTED|Overall Study||16||
48397439|NCT04128527|101302629|FG000|COMPLETED|Overall Study||16||
48397440|NCT04128527|101302629|FG000|NOT COMPLETED|Overall Study||0||
48397441|NCT00762268|101302630|FG000|STARTED|Overall Study||12||
48397442|NCT00762268|101302631|FG001|STARTED|Overall Study||11||
48397443|NCT00762268|101302630|FG000|COMPLETED|Overall Study||9||
48397444|NCT00762268|101302631|FG001|COMPLETED|Overall Study||8||
48397445|NCT00762268|101302630|FG000|NOT COMPLETED|Overall Study||3||
48397446|NCT00762268|101302631|FG001|NOT COMPLETED|Overall Study||3||
48397447|NCT01851863|101302632|FG000|STARTED|Overall Study||65||
48397448|NCT01851863|101302633|FG001|STARTED|Overall Study||66||
48397449|NCT01851863|101302634|FG002|STARTED|Overall Study||65||
48397450|NCT01851863|101302635|FG003|STARTED|Overall Study||66||
48700680|NCT02480166|102054055|FG002|NOT COMPLETED|Overall Study||0||
48700681|NCT01709422|102054056|FG000|STARTED|Overall Study||70||
48397451|NCT01851863|101302632|FG000|COMPLETED|Overall Study||60||
48397452|NCT01851863|101302633|FG001|COMPLETED|Overall Study||57||
48397453|NCT01851863|101302634|FG002|COMPLETED|Overall Study||60||
48397454|NCT01851863|101302635|FG003|COMPLETED|Overall Study||63||
48397455|NCT01851863|101302632|FG000|NOT COMPLETED|Overall Study||5||
48397456|NCT01851863|101302633|FG001|NOT COMPLETED|Overall Study||9||
48397457|NCT01851863|101302634|FG002|NOT COMPLETED|Overall Study||5||
48397458|NCT01851863|101302635|FG003|NOT COMPLETED|Overall Study||3||
48397459|NCT03168555|101302636|FG000|STARTED|Visit 1 (Pro-operative)||23||
48397460|NCT03168555|101302636|FG000|COMPLETED|Visit 1 (Pro-operative)||22||
48397461|NCT03168555|101302636|FG000|NOT COMPLETED|Visit 1 (Pro-operative)||1||
48397462|NCT03168555|101302636|FG000|STARTED|Visit 2 (Post-operative)||22||
48700682|NCT01709422|102054057|FG001|STARTED|Overall Study||70||
48700683|NCT01709422|102054056|FG000|COMPLETED|Overall Study||70||
48126285|NCT01358981|100633807|FG001|COMPLETED|Period 3||2||
48126286|NCT01358981|100633808|FG002|COMPLETED|Period 3||2||
48126287|NCT01358981|100633809|FG003|COMPLETED|Period 3||2||
48126288|NCT01358981|100633810|FG004|COMPLETED|Period 3||3||
48126289|NCT01358981|100633811|FG005|COMPLETED|Period 3||3||
48126290|NCT01358981|100633812|FG006|COMPLETED|Period 3||3||
48126291|NCT01358981|100633806|FG000|NOT COMPLETED|Period 3||0||
48126292|NCT01358981|100633807|FG001|NOT COMPLETED|Period 3||0||
48126293|NCT01358981|100633808|FG002|NOT COMPLETED|Period 3||0||
48126294|NCT01358981|100633809|FG003|NOT COMPLETED|Period 3||0||
48126295|NCT01358981|100633810|FG004|NOT COMPLETED|Period 3||0||
48126296|NCT01358981|100633811|FG005|NOT COMPLETED|Period 3||0||
48126297|NCT01358981|100633812|FG006|NOT COMPLETED|Period 3||0||
48126298|NCT01358981|100633806|FG000|STARTED|Period 4||2||
48126299|NCT01358981|100633807|FG001|STARTED|Period 4||2||
48126300|NCT01358981|100633808|FG002|STARTED|Period 4||2||
48126301|NCT01358981|100633809|FG003|STARTED|Period 4||2||
48126302|NCT01358981|100633810|FG004|STARTED|Period 4||0||
48126303|NCT01358981|100633811|FG005|STARTED|Period 4||0||
48397463|NCT03168555|101302636|FG000|COMPLETED|Visit 2 (Post-operative)||18||
48397464|NCT03168555|101302636|FG000|NOT COMPLETED|Visit 2 (Post-operative)||4||
48397465|NCT00355134|101302637|FG000|STARTED|Core Phase||370||
48397466|NCT00355134|101302638|FG001|STARTED|Core Phase||358||
48397467|NCT00355134|101302639|FG002|STARTED|Core Phase||355||
48397468|NCT00355134|101302640|FG003|STARTED|Core Phase||0||
48397469|NCT00355134|101302641|FG004|STARTED|Core Phase||0||
48397470|NCT00355134|101302637|FG000|COMPLETED|Core Phase||251||
48397471|NCT00355134|101302638|FG001|COMPLETED|Core Phase||272||
48397472|NCT00355134|101302639|FG002|COMPLETED|Core Phase||255||
48397473|NCT00355134|101302640|FG003|COMPLETED|Core Phase||0||
48397474|NCT00355134|101302641|FG004|COMPLETED|Core Phase||0||
48397475|NCT00355134|101302637|FG000|NOT COMPLETED|Core Phase||119||
48397476|NCT00355134|101302638|FG001|NOT COMPLETED|Core Phase||86||
48397477|NCT00355134|101302639|FG002|NOT COMPLETED|Core Phase||100||
48397478|NCT00355134|101302640|FG003|NOT COMPLETED|Core Phase||0||
48397479|NCT00355134|101302641|FG004|NOT COMPLETED|Core Phase||0||
48397480|NCT00355134|101302637|FG000|STARTED|Extension Phase||203||
48397481|NCT00355134|101302638|FG001|STARTED|Extension Phase||217||
48397482|NCT00355134|101302639|FG002|STARTED|Extension Phase||0||
48397483|NCT00355134|101302640|FG003|STARTED|Extension Phase||105||
48397484|NCT00355134|101302641|FG004|STARTED|Extension Phase||107||
48397485|NCT00355134|101302637|FG000|COMPLETED|Extension Phase||172||
48397486|NCT00355134|101302638|FG001|COMPLETED|Extension Phase||180||
48397487|NCT00355134|101302639|FG002|COMPLETED|Extension Phase||0||
48397488|NCT00355134|101302640|FG003|COMPLETED|Extension Phase||89||
48397489|NCT00355134|101302641|FG004|COMPLETED|Extension Phase||88||
48397490|NCT00355134|101302637|FG000|NOT COMPLETED|Extension Phase||31||
48397491|NCT00355134|101302638|FG001|NOT COMPLETED|Extension Phase||37||
48397492|NCT00355134|101302639|FG002|NOT COMPLETED|Extension Phase||0||
48397493|NCT00355134|101302640|FG003|NOT COMPLETED|Extension Phase||16||
48397494|NCT00355134|101302641|FG004|NOT COMPLETED|Extension Phase||19||
48397495|NCT00656084|101302642|FG000|STARTED|Overall Study||16||
48397496|NCT00656084|101302642|FG000|COMPLETED|Overall Study||9||
48397497|NCT00656084|101302642|FG000|NOT COMPLETED|Overall Study||7||
48126304|NCT01358981|100633812|FG006|STARTED|Period 4||0||
48126305|NCT01358981|100633806|FG000|COMPLETED|Period 4||2||
48126306|NCT01358981|100633807|FG001|COMPLETED|Period 4||2||
48126307|NCT01358981|100633808|FG002|COMPLETED|Period 4||2||
48126308|NCT01358981|100633809|FG003|COMPLETED|Period 4||2||
48126309|NCT01358981|100633810|FG004|COMPLETED|Period 4||0||
48126310|NCT01358981|100633811|FG005|COMPLETED|Period 4||0||
48126311|NCT01358981|100633812|FG006|COMPLETED|Period 4||0||
48126312|NCT01358981|100633806|FG000|NOT COMPLETED|Period 4||0||
48126313|NCT01358981|100633807|FG001|NOT COMPLETED|Period 4||0||
48126314|NCT01358981|100633808|FG002|NOT COMPLETED|Period 4||0||
48126315|NCT01358981|100633809|FG003|NOT COMPLETED|Period 4||0||
48397498|NCT00431496|101302643|FG000|STARTED|Overall Study||71||
48397499|NCT00431496|101302643|FG000|COMPLETED|Overall Study||60||
48397500|NCT00431496|101302643|FG000|NOT COMPLETED|Overall Study||11||
48126316|NCT01358981|100633810|FG004|NOT COMPLETED|Period 4||0||
48126317|NCT01358981|100633811|FG005|NOT COMPLETED|Period 4||0||
48126318|NCT01358981|100633812|FG006|NOT COMPLETED|Period 4||0||
48572121|NCT03806933|101731120|FG003|COMPLETED|OLEX Period||49||
48572122|NCT03806933|101731117|FG000|NOT COMPLETED|OLEX Period||0||
48572123|NCT03806933|101731118|FG001|NOT COMPLETED|OLEX Period||0||
48572124|NCT03806933|101731119|FG002|NOT COMPLETED|OLEX Period||0||
48572125|NCT03806933|101731120|FG003|NOT COMPLETED|OLEX Period||1||
48572126|NCT01417741|101731121|FG000|STARTED|Overall Study||75||
48572127|NCT01417741|101731122|FG001|STARTED|Overall Study||86||
48572128|NCT01417741|101731121|FG000|COMPLETED|Overall Study||75|Of the children who received the standard therapy, only 69 recived the post op day one phone call.|
48126319|NCT02921412|100633813|FG000|STARTED|Overall Study||36||
48572129|NCT01417741|101731122|FG001|COMPLETED|Overall Study||86|Of the children who received the standard therapy, only 69 recived the post op day one phone call.|
48572130|NCT01417741|101731121|FG000|NOT COMPLETED|Overall Study||0||
48572131|NCT01417741|101731122|FG001|NOT COMPLETED|Overall Study||0||
48572132|NCT00957684|101731123|FG000|STARTED|PART I||102||
48572133|NCT00957684|101731124|FG001|STARTED|PART I||98||
48126320|NCT02921412|100633813|FG000|COMPLETED|Overall Study||36||
48572134|NCT00957684|101731125|FG002|STARTED|PART I||100||
48572135|NCT00957684|101731126|FG003|STARTED|PART I||102||
48572136|NCT00957684|101731127|FG004|STARTED|PART I||0||
48572137|NCT00957684|101731123|FG000|Randomised (Safety Population)|PART I||102||
48572138|NCT00957684|101731124|FG001|Randomised (Safety Population)|PART I||98||
48572139|NCT00957684|101731125|FG002|Randomised (Safety Population)|PART I||100||
48126321|NCT02921412|100633813|FG000|NOT COMPLETED|Overall Study||0||
48126322|NCT04188041|100633814|FG000|STARTED|Aim 1: Key Informant Interviews||25||
48126323|NCT04188041|100633815|FG001|STARTED|Aim 1: Key Informant Interviews||0||
48126324|NCT04188041|100633816|FG002|STARTED|Aim 1: Key Informant Interviews||0||
48126325|NCT04188041|100633814|FG000|COMPLETED|Aim 1: Key Informant Interviews||24||
48126326|NCT04188041|100633815|FG001|COMPLETED|Aim 1: Key Informant Interviews||0||
48126327|NCT04188041|100633816|FG002|COMPLETED|Aim 1: Key Informant Interviews||0||
48126328|NCT04188041|100633814|FG000|NOT COMPLETED|Aim 1: Key Informant Interviews||1||
48126329|NCT04188041|100633815|FG001|NOT COMPLETED|Aim 1: Key Informant Interviews||0||
48126330|NCT04188041|100633816|FG002|NOT COMPLETED|Aim 1: Key Informant Interviews||0||
48126331|NCT04188041|100633814|FG000|STARTED|Aim 2: RI LTBI ECHO Program Participants||4||
48282865|NCT04677179|101017045|FG005|COMPLETED|Maintenance Treatment Period||0||
48282866|NCT04677179|101017046|FG006|COMPLETED|Maintenance Treatment Period||0||
48282867|NCT04677179|101017047|FG007|COMPLETED|Maintenance Treatment Period||0||
48282868|NCT04677179|101017048|FG008|COMPLETED|Maintenance Treatment Period||0||
48282869|NCT04677179|101017049|FG009|COMPLETED|Maintenance Treatment Period||0||
48282870|NCT04677179|101017040|FG000|NOT COMPLETED|Maintenance Treatment Period||0||
48282871|NCT04677179|101017041|FG001|NOT COMPLETED|Maintenance Treatment Period||0||
48282872|NCT04677179|101017042|FG002|NOT COMPLETED|Maintenance Treatment Period||0||
48282873|NCT04677179|101017043|FG003|NOT COMPLETED|Maintenance Treatment Period||8||
48282874|NCT04677179|101017044|FG004|NOT COMPLETED|Maintenance Treatment Period||10||
48282875|NCT04677179|101017045|FG005|NOT COMPLETED|Maintenance Treatment Period||5||
48282876|NCT04677179|101017046|FG006|NOT COMPLETED|Maintenance Treatment Period||0||
48282877|NCT04677179|101017047|FG007|NOT COMPLETED|Maintenance Treatment Period||0||
48282878|NCT04677179|101017048|FG008|NOT COMPLETED|Maintenance Treatment Period||0||
48282879|NCT04677179|101017049|FG009|NOT COMPLETED|Maintenance Treatment Period||0||
48282880|NCT04677179|101017040|FG000|STARTED|Extension Treatment Period||0||
48282881|NCT04677179|101017041|FG001|STARTED|Extension Treatment Period||0||
48282882|NCT04677179|101017042|FG002|STARTED|Extension Treatment Period||0||
48282883|NCT04677179|101017043|FG003|STARTED|Extension Treatment Period||0||
48282884|NCT04677179|101017044|FG004|STARTED|Extension Treatment Period||0||
48282885|NCT04677179|101017045|FG005|STARTED|Extension Treatment Period||0||
48282886|NCT04677179|101017046|FG006|STARTED|Extension Treatment Period||26||
48572140|NCT00957684|101731126|FG003|Randomised (Safety Population)|PART I||102||
48572141|NCT00957684|101731127|FG004|Randomised (Safety Population)|PART I||0||
48572142|NCT00957684|101731123|FG000|Intention-to-treat (ITT) Population|PART I||98||
48572143|NCT00957684|101731124|FG001|Intention-to-treat (ITT) Population|PART I||98||
48572144|NCT00957684|101731125|FG002|Intention-to-treat (ITT) Population|PART I||99||
48572145|NCT00957684|101731126|FG003|Intention-to-treat (ITT) Population|PART I||102||
48282887|NCT04677179|101017047|FG007|STARTED|Extension Treatment Period||0||
48282888|NCT04677179|101017048|FG008|STARTED|Extension Treatment Period||0||
48282889|NCT04677179|101017049|FG009|STARTED|Extension Treatment Period||0||
48572146|NCT00957684|101731127|FG004|Intention-to-treat (ITT) Population|PART I||0||
48572147|NCT00957684|101731123|FG000|Per-protocol (PP)Population|PART I||72||
48572148|NCT00957684|101731124|FG001|Per-protocol (PP)Population|PART I||86||
48572149|NCT00957684|101731125|FG002|Per-protocol (PP)Population|PART I||94||
48700684|NCT01709422|102054057|FG001|COMPLETED|Overall Study||70||
48572150|NCT00957684|101731126|FG003|Per-protocol (PP)Population|PART I||91||
48572151|NCT00957684|101731127|FG004|Per-protocol (PP)Population|PART I||0||
48126332|NCT04188041|100633815|FG001|STARTED|Aim 2: RI LTBI ECHO Program Participants||8||
48126333|NCT04188041|100633816|FG002|STARTED|Aim 2: RI LTBI ECHO Program Participants||0||
48126334|NCT04188041|100633814|FG000|COMPLETED|Aim 2: RI LTBI ECHO Program Participants||3||
48126335|NCT04188041|100633815|FG001|COMPLETED|Aim 2: RI LTBI ECHO Program Participants||5||
48126336|NCT04188041|100633816|FG002|COMPLETED|Aim 2: RI LTBI ECHO Program Participants||0||
48700685|NCT01709422|102054056|FG000|NOT COMPLETED|Overall Study||0||
48700686|NCT01709422|102054057|FG001|NOT COMPLETED|Overall Study||0||
48700687|NCT04463693|102054058|FG000|STARTED|Overall Study||5||
48700688|NCT04463693|102054058|FG000|COMPLETED|Overall Study||5||
48700689|NCT04463693|102054058|FG000|NOT COMPLETED|Overall Study||0||
48700690|NCT04848220|102054059|FG000|STARTED|Overall Study||10||
48700691|NCT04848220|102054060|FG001|STARTED|Overall Study||10||
48700692|NCT04848220|102054061|FG002|STARTED|Overall Study||9||
48700693|NCT04848220|102054059|FG000|Treated|Overall Study||10||
48700694|NCT04848220|102054060|FG001|Treated|Overall Study||8||
48700695|NCT04848220|102054061|FG002|Treated|Overall Study||9||
48700696|NCT04848220|102054059|FG000|COMPLETED|Overall Study||10||
48126337|NCT04188041|100633814|FG000|NOT COMPLETED|Aim 2: RI LTBI ECHO Program Participants||1||
48126338|NCT04188041|100633815|FG001|NOT COMPLETED|Aim 2: RI LTBI ECHO Program Participants||3||
48126339|NCT04188041|100633816|FG002|NOT COMPLETED|Aim 2: RI LTBI ECHO Program Participants||0||
48126340|NCT04188041|100633814|FG000|STARTED|Aim 3: Retrospective Chart Review||0||
48126341|NCT04188041|100633815|FG001|STARTED|Aim 3: Retrospective Chart Review||0||
48126342|NCT04188041|100633816|FG002|STARTED|Aim 3: Retrospective Chart Review||51||
48126343|NCT04188041|100633814|FG000|COMPLETED|Aim 3: Retrospective Chart Review||0||
48126344|NCT04188041|100633815|FG001|COMPLETED|Aim 3: Retrospective Chart Review||0||
48126345|NCT04188041|100633816|FG002|COMPLETED|Aim 3: Retrospective Chart Review||51||
48126346|NCT04188041|100633814|FG000|NOT COMPLETED|Aim 3: Retrospective Chart Review||0||
48126347|NCT04188041|100633815|FG001|NOT COMPLETED|Aim 3: Retrospective Chart Review||0||
48126348|NCT04188041|100633816|FG002|NOT COMPLETED|Aim 3: Retrospective Chart Review||0||
48126349|NCT02277626|100633817|FG000|STARTED|Overall Study||6||
48126350|NCT02277626|100633818|FG001|STARTED|Overall Study||9||
48126351|NCT02277626|100633817|FG000|COMPLETED|Overall Study||6||
48126352|NCT02277626|100633818|FG001|COMPLETED|Overall Study||9||
48126353|NCT02277626|100633817|FG000|NOT COMPLETED|Overall Study||0||
48126354|NCT02277626|100633818|FG001|NOT COMPLETED|Overall Study||0||
48126355|NCT02715765|100633819|FG000|STARTED|Overall Study||3||
48126356|NCT02715765|100633820|FG001|STARTED|Overall Study||0||
48126357|NCT02715765|100633821|FG002|STARTED|Overall Study||0||
48126358|NCT02715765|100633819|FG000|COMPLETED|Overall Study||0||
48126359|NCT02715765|100633820|FG001|COMPLETED|Overall Study||0||
48126360|NCT02715765|100633821|FG002|COMPLETED|Overall Study||0||
48126361|NCT02715765|100633819|FG000|NOT COMPLETED|Overall Study||3||
48126362|NCT02715765|100633820|FG001|NOT COMPLETED|Overall Study||0||
48126363|NCT02715765|100633821|FG002|NOT COMPLETED|Overall Study||0||
48126364|NCT00652457|100633822|FG000|STARTED|Overall Study||23||
48126365|NCT00652457|100633823|FG001|STARTED|Overall Study||27||
48126366|NCT00652457|100633822|FG000|COMPLETED|Overall Study||23||
48126367|NCT00652457|100633823|FG001|COMPLETED|Overall Study||27||
48126368|NCT00652457|100633822|FG000|NOT COMPLETED|Overall Study||0||
48126369|NCT00652457|100633823|FG001|NOT COMPLETED|Overall Study||0||
48126370|NCT01826825|100633824|FG000|STARTED|Overall Study||100||
48126371|NCT01826825|100633825|FG001|STARTED|Overall Study||100||
48126372|NCT01826825|100633824|FG000|COMPLETED|Overall Study||100||
48126373|NCT01826825|100633825|FG001|COMPLETED|Overall Study||98||
48126374|NCT01826825|100633824|FG000|NOT COMPLETED|Overall Study||0||
48126375|NCT01826825|100633825|FG001|NOT COMPLETED|Overall Study||2||
48126376|NCT04260191|100633826|FG000|STARTED|Overall Study||6||
48126377|NCT04260191|100633827|FG001|STARTED|Overall Study||4||
48126378|NCT04260191|100633828|FG002|STARTED|Overall Study||5||
48126379|NCT04260191|100633826|FG000|Received AMG 910|Overall Study||6||
48126380|NCT04260191|100633827|FG001|Received AMG 910|Overall Study||4||
48700697|NCT04848220|102054060|FG001|COMPLETED|Overall Study||8||
48700698|NCT04848220|102054061|FG002|COMPLETED|Overall Study||9||
48700699|NCT04848220|102054059|FG000|NOT COMPLETED|Overall Study||0||
48700700|NCT04848220|102054060|FG001|NOT COMPLETED|Overall Study||2||
48700701|NCT04848220|102054061|FG002|NOT COMPLETED|Overall Study||0||
48700702|NCT04765644|102054062|FG000|STARTED|Overall Study||22||
48700703|NCT04765644|102054063|FG001|STARTED|Overall Study||22||
48700704|NCT04765644|102054062|FG000|COMPLETED|Overall Study||20||
48126381|NCT04260191|100633828|FG002|Received AMG 910|Overall Study||5||
48126382|NCT04260191|100633826|FG000|COMPLETED|Overall Study||1||
48126383|NCT04260191|100633827|FG001|COMPLETED|Overall Study||0||
48126384|NCT04260191|100633828|FG002|COMPLETED|Overall Study||0||
48126385|NCT04260191|100633826|FG000|NOT COMPLETED|Overall Study||5||
48126386|NCT04260191|100633827|FG001|NOT COMPLETED|Overall Study||4||
48126387|NCT04260191|100633828|FG002|NOT COMPLETED|Overall Study||5||
48126388|NCT05244525|100633829|FG000|STARTED|Overall Study||30||
48126389|NCT05244525|100633830|FG001|STARTED|Overall Study||30||
48126390|NCT05244525|100633829|FG000|COMPLETED|Overall Study||30||
48700705|NCT04765644|102054063|FG001|COMPLETED|Overall Study||20||
48700706|NCT04765644|102054062|FG000|NOT COMPLETED|Overall Study||2||
48700707|NCT04765644|102054063|FG001|NOT COMPLETED|Overall Study||2||
48700708|NCT02141633|102054064|FG000|STARTED|Overall Study||16||
48126391|NCT05244525|100633830|FG001|COMPLETED|Overall Study||30||
48126392|NCT05244525|100633829|FG000|NOT COMPLETED|Overall Study||0||
48126393|NCT05244525|100633830|FG001|NOT COMPLETED|Overall Study||0||
48126394|NCT02658851|100633831|FG000|STARTED|Overall Study||100||
48126395|NCT02658851|100633831|FG000|COMPLETED|Overall Study||100||
48126396|NCT02658851|100633831|FG000|NOT COMPLETED|Overall Study||0||
48126397|NCT03370341|100633832|FG000|STARTED|Overall Study||21||
48126398|NCT03370341|100633833|FG001|STARTED|Overall Study||20||
48126399|NCT03370341|100633832|FG000|COMPLETED|Overall Study||21||
48126400|NCT03370341|100633833|FG001|COMPLETED|Overall Study||19||
48126401|NCT03370341|100633832|FG000|NOT COMPLETED|Overall Study||0||
48126402|NCT03370341|100633833|FG001|NOT COMPLETED|Overall Study||1||
48126403|NCT01767116|100633834|FG000|STARTED|Overall Study||210||
48126404|NCT01767116|100633835|FG001|STARTED|Overall Study||209||
48126405|NCT01767116|100633834|FG000|COMPLETED|Overall Study||208||
48126406|NCT01767116|100633835|FG001|COMPLETED|Overall Study||207||
48126407|NCT01767116|100633834|FG000|NOT COMPLETED|Overall Study||2||
48126408|NCT01767116|100633835|FG001|NOT COMPLETED|Overall Study||2||
48126409|NCT02096835|100633836|FG000|STARTED|Overall Study||53||
48126410|NCT02096835|100633837|FG001|STARTED|Overall Study||53||
48126411|NCT02096835|100633838|FG002|STARTED|Overall Study||51||
48126412|NCT02096835|100633836|FG000|COMPLETED|Overall Study||50||
48126413|NCT02096835|100633837|FG001|COMPLETED|Overall Study||53||
48126414|NCT02096835|100633838|FG002|COMPLETED|Overall Study||50||
48126415|NCT02096835|100633836|FG000|NOT COMPLETED|Overall Study||3||
48126416|NCT02096835|100633837|FG001|NOT COMPLETED|Overall Study||0||
48126417|NCT02096835|100633838|FG002|NOT COMPLETED|Overall Study||1||
48126418|NCT02256111|100633839|FG000|STARTED|Overall Study||13||
48126419|NCT02256111|100633840|FG001|STARTED|Overall Study||13||
48126420|NCT02256111|100633839|FG000|COMPLETED|Overall Study||13||
48126421|NCT02256111|100633840|FG001|COMPLETED|Overall Study||13||
48126422|NCT02256111|100633839|FG000|NOT COMPLETED|Overall Study||0||
48126423|NCT02256111|100633840|FG001|NOT COMPLETED|Overall Study||0||
48126424|NCT03511521|100633841|FG000|STARTED|Overall Study||2||
48126425|NCT03511521|100633842|FG001|STARTED|Overall Study||1||
48126426|NCT03511521|100633841|FG000|COMPLETED|Overall Study||2||
48126427|NCT03511521|100633842|FG001|COMPLETED|Overall Study||1||
48126428|NCT03511521|100633841|FG000|NOT COMPLETED|Overall Study||0||
48126429|NCT03511521|100633842|FG001|NOT COMPLETED|Overall Study||0||
48126430|NCT03029208|100633843|FG000|STARTED|Overall Study||157||
48126431|NCT03029208|100633844|FG001|STARTED|Overall Study||155||
48126432|NCT03029208|100633843|FG000|COMPLETED|Overall Study||155||
48126433|NCT03029208|100633844|FG001|COMPLETED|Overall Study||151||
48126434|NCT03029208|100633843|FG000|NOT COMPLETED|Overall Study||2||
48126435|NCT03029208|100633844|FG001|NOT COMPLETED|Overall Study||4||
48126436|NCT01994486|100633845|FG000|STARTED|Overall Study||20||
48126437|NCT01994486|100633845|FG000|COMPLETED|Overall Study||20||
48126438|NCT01994486|100633845|FG000|NOT COMPLETED|Overall Study||0||
48126439|NCT00127673|100633846|FG000|STARTED|Overall Study||48||
48700709|NCT02141633|102054065|FG001|STARTED|Overall Study||15||
48700710|NCT02141633|102054064|FG000|COMPLETED|Overall Study||15||
48700711|NCT02141633|102054065|FG001|COMPLETED|Overall Study||15||
48126440|NCT00127673|100633847|FG001|STARTED|Overall Study||61||
48126441|NCT00127673|100633848|FG002|STARTED|Overall Study||55||
48126442|NCT00127673|100633849|FG003|STARTED|Overall Study||36||
48126443|NCT00127673|100633846|FG000|COMPLETED|Overall Study||23||
48126444|NCT00127673|100633847|FG001|COMPLETED|Overall Study||44||
48126445|NCT00127673|100633848|FG002|COMPLETED|Overall Study||35||
48126446|NCT00127673|100633849|FG003|COMPLETED|Overall Study||25||
48126447|NCT00127673|100633846|FG000|NOT COMPLETED|Overall Study||25||
48126448|NCT00127673|100633847|FG001|NOT COMPLETED|Overall Study||17||
48700712|NCT02141633|102054064|FG000|NOT COMPLETED|Overall Study||1||
48700713|NCT02141633|102054065|FG001|NOT COMPLETED|Overall Study||0||
48700714|NCT01120236|102054066|FG000|STARTED|Overall Study||105||
48700715|NCT01120236|102054067|FG001|STARTED|Overall Study||106||
48700716|NCT01120236|102054066|FG000|Ineligble|Overall Study||0||
48700717|NCT01120236|102054067|FG001|Ineligble|Overall Study||1||
48126449|NCT00127673|100633848|FG002|NOT COMPLETED|Overall Study||20||
48282890|NCT04677179|101017040|FG000|COMPLETED|Extension Treatment Period||0||
48700718|NCT01120236|102054066|FG000|COMPLETED|Overall Study||105||
48700719|NCT01120236|102054067|FG001|COMPLETED|Overall Study||105||
48126450|NCT00127673|100633849|FG003|NOT COMPLETED|Overall Study||11||
48126451|NCT01260922|100633850|FG000|STARTED|First Intervention||13||
48126452|NCT01260922|100633851|FG001|STARTED|First Intervention||13||
48126453|NCT01260922|100633850|FG000|COMPLETED|First Intervention||13||
48126454|NCT01260922|100633851|FG001|COMPLETED|First Intervention||12||
48126455|NCT01260922|100633850|FG000|NOT COMPLETED|First Intervention||0||
48126456|NCT01260922|100633851|FG001|NOT COMPLETED|First Intervention||1||
48126457|NCT01260922|100633850|FG000|STARTED|Washout of 28 Days||13||
48126458|NCT01260922|100633851|FG001|STARTED|Washout of 28 Days||12||
48126459|NCT01260922|100633850|FG000|COMPLETED|Washout of 28 Days||9||
48126460|NCT01260922|100633851|FG001|COMPLETED|Washout of 28 Days||10||
48126461|NCT01260922|100633850|FG000|NOT COMPLETED|Washout of 28 Days||4||
48126462|NCT01260922|100633851|FG001|NOT COMPLETED|Washout of 28 Days||2||
48126463|NCT01260922|100633850|FG000|STARTED|Second Intervention||9||
48126464|NCT01260922|100633851|FG001|STARTED|Second Intervention||10||
48126465|NCT01260922|100633850|FG000|COMPLETED|Second Intervention||9||
48126466|NCT01260922|100633851|FG001|COMPLETED|Second Intervention||8||
48126467|NCT01260922|100633850|FG000|NOT COMPLETED|Second Intervention||0||
48126468|NCT01260922|100633851|FG001|NOT COMPLETED|Second Intervention||2||
48126469|NCT00509197|100633852|FG000|STARTED|Overall Study||6||
48126470|NCT00509197|100633853|FG001|STARTED|Overall Study||6||
48126471|NCT00509197|100633852|FG000|COMPLETED|Overall Study||6||
48126472|NCT00509197|100633853|FG001|COMPLETED|Overall Study||6||
48126473|NCT00509197|100633852|FG000|NOT COMPLETED|Overall Study||0||
48126474|NCT00509197|100633853|FG001|NOT COMPLETED|Overall Study||0||
48126475|NCT04223856|100633854|FG000|STARTED|Overall Study||442||
48126476|NCT04223856|100633855|FG001|STARTED|Overall Study||444||
48126477|NCT04223856|100633854|FG000|Treated|Overall Study||440||
48126478|NCT04223856|100633855|FG001|Treated|Overall Study||433||
48126479|NCT04223856|100633854|FG000|COMPLETED|Overall Study||8||
48126480|NCT04223856|100633855|FG001|COMPLETED|Overall Study||244||
48126481|NCT04223856|100633854|FG000|NOT COMPLETED|Overall Study||434||
48126482|NCT04223856|100633855|FG001|NOT COMPLETED|Overall Study||200||
48126483|NCT02766608|100633856|FG000|STARTED|Overall Study||655|mITT Population|
48126484|NCT02766608|100633857|FG001|STARTED|Overall Study||637|mITT Population|
48126485|NCT02766608|100633858|FG002|STARTED|Overall Study||644|mITT Population|
48126486|NCT02766608|100633859|FG003|STARTED|Overall Study||206|mITT Population|
48126487|NCT02766608|100633860|FG004|STARTED|Overall Study||219|mITT Population|
48126488|NCT02766608|100633856|FG000|COMPLETED|Overall Study||576|Completed Treatment|
48126489|NCT02766608|100633857|FG001|COMPLETED|Overall Study||567|Completed Treatment|
48126490|NCT02766608|100633858|FG002|COMPLETED|Overall Study||554|Completed Treatment|
48126491|NCT02766608|100633859|FG003|COMPLETED|Overall Study||169|Completed Treatment|
48126492|NCT02766608|100633860|FG004|COMPLETED|Overall Study||190|Completed Treatment|
48126493|NCT02766608|100633856|FG000|NOT COMPLETED|Overall Study||79||
48126494|NCT02766608|100633857|FG001|NOT COMPLETED|Overall Study||70||
48126495|NCT02766608|100633858|FG002|NOT COMPLETED|Overall Study||90||
48126496|NCT02766608|100633859|FG003|NOT COMPLETED|Overall Study||37||
48126497|NCT02766608|100633860|FG004|NOT COMPLETED|Overall Study||29||
48126498|NCT01778465|100633861|FG000|STARTED|First Intervention (7 Days)||3||
48126499|NCT01778465|100633862|FG001|STARTED|First Intervention (7 Days)||4||
48126500|NCT01778465|100633861|FG000|COMPLETED|First Intervention (7 Days)||3||
48126501|NCT01778465|100633862|FG001|COMPLETED|First Intervention (7 Days)||4||
48126502|NCT01778465|100633861|FG000|NOT COMPLETED|First Intervention (7 Days)||0||
48126503|NCT01778465|100633862|FG001|NOT COMPLETED|First Intervention (7 Days)||0||
48126504|NCT01778465|100633861|FG000|STARTED|Second Intervention (7 Days)||3||
48126505|NCT01778465|100633862|FG001|STARTED|Second Intervention (7 Days)||4||
48126506|NCT01778465|100633861|FG000|COMPLETED|Second Intervention (7 Days)||3||
48126507|NCT01778465|100633862|FG001|COMPLETED|Second Intervention (7 Days)||4||
48126508|NCT01778465|100633861|FG000|NOT COMPLETED|Second Intervention (7 Days)||0||
48126509|NCT01778465|100633862|FG001|NOT COMPLETED|Second Intervention (7 Days)||0||
48126510|NCT02349711|100633863|FG000|STARTED|Overall Study||87||
48126511|NCT02349711|100633864|FG001|STARTED|Overall Study||86||
48126512|NCT02349711|100633863|FG000|COMPLETED|Overall Study||84||
48126513|NCT02349711|100633864|FG001|COMPLETED|Overall Study||84||
48126514|NCT02349711|100633863|FG000|NOT COMPLETED|Overall Study||3||
48126515|NCT02349711|100633864|FG001|NOT COMPLETED|Overall Study||2||
48126516|NCT01775137|100633865|FG000|STARTED|Overall Study||45||
48126517|NCT01775137|100633865|FG000|COMPLETED|Overall Study||34||
48126518|NCT01775137|100633865|FG000|NOT COMPLETED|Overall Study||11||
48126519|NCT00812929|100633866|FG000|STARTED|Treatment Period 1||5||
48126520|NCT00812929|100633867|FG001|STARTED|Treatment Period 1||4||
48126521|NCT00812929|100633868|FG002|STARTED|Treatment Period 1||5||
48126522|NCT00812929|100633869|FG003|STARTED|Treatment Period 1||4||
48126523|NCT00812929|100633870|FG004|STARTED|Treatment Period 1||5||
48126524|NCT00812929|100633871|FG005|STARTED|Treatment Period 1||5||
48126525|NCT00812929|100633872|FG006|STARTED|Treatment Period 1||5||
48126526|NCT00812929|100633873|FG007|STARTED|Treatment Period 1||5||
48126527|NCT00812929|100633874|FG008|STARTED|Treatment Period 1||4||
48126528|NCT00812929|100633875|FG009|STARTED|Treatment Period 1||5||
48126529|NCT00812929|100633866|FG000|COMPLETED|Treatment Period 1||5||
48126530|NCT00812929|100633867|FG001|COMPLETED|Treatment Period 1||4||
48126531|NCT00812929|100633868|FG002|COMPLETED|Treatment Period 1||5||
48126532|NCT00812929|100633869|FG003|COMPLETED|Treatment Period 1||4||
48126533|NCT00812929|100633870|FG004|COMPLETED|Treatment Period 1||5||
48126534|NCT00812929|100633871|FG005|COMPLETED|Treatment Period 1||5||
48126535|NCT00812929|100633872|FG006|COMPLETED|Treatment Period 1||5||
48126536|NCT00812929|100633873|FG007|COMPLETED|Treatment Period 1||5||
48126537|NCT00812929|100633874|FG008|COMPLETED|Treatment Period 1||4||
48126538|NCT00812929|100633875|FG009|COMPLETED|Treatment Period 1||5||
48126539|NCT00812929|100633866|FG000|NOT COMPLETED|Treatment Period 1||0||
48126540|NCT00812929|100633867|FG001|NOT COMPLETED|Treatment Period 1||0||
48126541|NCT00812929|100633868|FG002|NOT COMPLETED|Treatment Period 1||0||
48126542|NCT00812929|100633869|FG003|NOT COMPLETED|Treatment Period 1||0||
48126543|NCT00812929|100633870|FG004|NOT COMPLETED|Treatment Period 1||0||
48126544|NCT00812929|100633871|FG005|NOT COMPLETED|Treatment Period 1||0||
48126545|NCT00812929|100633872|FG006|NOT COMPLETED|Treatment Period 1||0||
48126546|NCT00812929|100633873|FG007|NOT COMPLETED|Treatment Period 1||0||
48126547|NCT00812929|100633874|FG008|NOT COMPLETED|Treatment Period 1||0||
48126548|NCT00812929|100633875|FG009|NOT COMPLETED|Treatment Period 1||0||
48126549|NCT00812929|100633866|FG000|STARTED|Washout Period 1 (7 Days)||5||
48126550|NCT00812929|100633867|FG001|STARTED|Washout Period 1 (7 Days)||4||
48126551|NCT00812929|100633868|FG002|STARTED|Washout Period 1 (7 Days)||5||
48126552|NCT00812929|100633869|FG003|STARTED|Washout Period 1 (7 Days)||4||
48126553|NCT00812929|100633870|FG004|STARTED|Washout Period 1 (7 Days)||5||
48126554|NCT00812929|100633871|FG005|STARTED|Washout Period 1 (7 Days)||5||
48126555|NCT00812929|100633872|FG006|STARTED|Washout Period 1 (7 Days)||5||
48126556|NCT00812929|100633873|FG007|STARTED|Washout Period 1 (7 Days)||5||
48126557|NCT00812929|100633874|FG008|STARTED|Washout Period 1 (7 Days)||4||
48126558|NCT00812929|100633875|FG009|STARTED|Washout Period 1 (7 Days)||5||
48126559|NCT00812929|100633866|FG000|COMPLETED|Washout Period 1 (7 Days)||5||
48126560|NCT00812929|100633867|FG001|COMPLETED|Washout Period 1 (7 Days)||4||
48126561|NCT00812929|100633868|FG002|COMPLETED|Washout Period 1 (7 Days)||4||
48126562|NCT00812929|100633869|FG003|COMPLETED|Washout Period 1 (7 Days)||4||
48126563|NCT00812929|100633870|FG004|COMPLETED|Washout Period 1 (7 Days)||5||
48397501|NCT02808507|101302644|FG000|STARTED|Overall Study||1929||
48397502|NCT02808507|101302645|FG001|STARTED|Overall Study||1413||
48397503|NCT02808507|101302646|FG002|STARTED|Overall Study||1510||
48397504|NCT02808507|101302644|FG000|COMPLETED|Overall Study||1929||
48397505|NCT02808507|101302645|FG001|COMPLETED|Overall Study||1413||
48397506|NCT02808507|101302646|FG002|COMPLETED|Overall Study||1510||
48397507|NCT02808507|101302644|FG000|NOT COMPLETED|Overall Study||0||
48397508|NCT02808507|101302645|FG001|NOT COMPLETED|Overall Study||0||
48397509|NCT02808507|101302646|FG002|NOT COMPLETED|Overall Study||0||
48397510|NCT01766219|101302647|FG000|STARTED|Overall Study||4||
48397511|NCT01766219|101302648|FG001|STARTED|Overall Study||2||
48397512|NCT01766219|101302649|FG002|STARTED|Overall Study||11||
48397513|NCT01766219|101302647|FG000|COMPLETED|Overall Study||4||
48397514|NCT01766219|101302648|FG001|COMPLETED|Overall Study||2||
48397515|NCT01766219|101302649|FG002|COMPLETED|Overall Study||11||
48397516|NCT01766219|101302647|FG000|NOT COMPLETED|Overall Study||0||
48397517|NCT01766219|101302648|FG001|NOT COMPLETED|Overall Study||0||
48397518|NCT01766219|101302649|FG002|NOT COMPLETED|Overall Study||0||
48397519|NCT02052141|101302650|FG000|STARTED|Intervention Period 1||5||
48397520|NCT02052141|101302651|FG001|STARTED|Intervention Period 1||7||
48397521|NCT02052141|101302650|FG000|COMPLETED|Intervention Period 1||5||
48397522|NCT02052141|101302651|FG001|COMPLETED|Intervention Period 1||7||
48397523|NCT02052141|101302650|FG000|NOT COMPLETED|Intervention Period 1||0||
48397524|NCT02052141|101302651|FG001|NOT COMPLETED|Intervention Period 1||0||
48397525|NCT02052141|101302650|FG000|STARTED|Intervention Period 2||5||
48126564|NCT00812929|100633871|FG005|COMPLETED|Washout Period 1 (7 Days)||5||
48126565|NCT00812929|100633872|FG006|COMPLETED|Washout Period 1 (7 Days)||5||
48126566|NCT00812929|100633873|FG007|COMPLETED|Washout Period 1 (7 Days)||5||
48126567|NCT00812929|100633874|FG008|COMPLETED|Washout Period 1 (7 Days)||4||
48126568|NCT00812929|100633875|FG009|COMPLETED|Washout Period 1 (7 Days)||5||
48126569|NCT00812929|100633866|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48126570|NCT00812929|100633867|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48397526|NCT02052141|101302651|FG001|STARTED|Intervention Period 2||7||
48397527|NCT02052141|101302650|FG000|COMPLETED|Intervention Period 2||5||
48126571|NCT00812929|100633868|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||1||
48126572|NCT00812929|100633869|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48126573|NCT00812929|100633870|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48126574|NCT00812929|100633871|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48126575|NCT00812929|100633872|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48126576|NCT00812929|100633873|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48126577|NCT00812929|100633874|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48126578|NCT00812929|100633875|FG009|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48126579|NCT00812929|100633866|FG000|STARTED|Treatment Period 2||5||
48397528|NCT02052141|101302651|FG001|COMPLETED|Intervention Period 2||7||
48397529|NCT02052141|101302650|FG000|NOT COMPLETED|Intervention Period 2||0||
48397530|NCT02052141|101302651|FG001|NOT COMPLETED|Intervention Period 2||0||
48397531|NCT03380000|101302652|FG000|STARTED|First Intervention (1day)||8||
48397532|NCT03380000|101302653|FG001|STARTED|First Intervention (1day)||8||
48397533|NCT03380000|101302652|FG000|COMPLETED|First Intervention (1day)||8||
48397534|NCT03380000|101302653|FG001|COMPLETED|First Intervention (1day)||8||
48397535|NCT03380000|101302652|FG000|NOT COMPLETED|First Intervention (1day)||0||
48397536|NCT03380000|101302653|FG001|NOT COMPLETED|First Intervention (1day)||0||
48397537|NCT03380000|101302652|FG000|STARTED|Washout (>7days)||8||
48397538|NCT03380000|101302653|FG001|STARTED|Washout (>7days)||8||
48572152|NCT00957684|101731123|FG000|COMPLETED|PART I||71||
48126580|NCT00812929|100633867|FG001|STARTED|Treatment Period 2||4||
48126581|NCT00812929|100633868|FG002|STARTED|Treatment Period 2||4||
48126582|NCT00812929|100633869|FG003|STARTED|Treatment Period 2||4||
48126583|NCT00812929|100633870|FG004|STARTED|Treatment Period 2||5||
48126584|NCT00812929|100633871|FG005|STARTED|Treatment Period 2||5||
48397539|NCT03380000|101302652|FG000|COMPLETED|Washout (>7days)||8||
48397540|NCT03380000|101302653|FG001|COMPLETED|Washout (>7days)||8||
48397541|NCT03380000|101302652|FG000|NOT COMPLETED|Washout (>7days)||0||
48572153|NCT00957684|101731124|FG001|COMPLETED|PART I||85||
48126585|NCT00812929|100633872|FG006|STARTED|Treatment Period 2||5||
48126586|NCT00812929|100633873|FG007|STARTED|Treatment Period 2||5||
48126587|NCT00812929|100633874|FG008|STARTED|Treatment Period 2||4||
48126588|NCT00812929|100633875|FG009|STARTED|Treatment Period 2||5||
48126589|NCT00812929|100633866|FG000|COMPLETED|Treatment Period 2||5||
48126590|NCT00812929|100633867|FG001|COMPLETED|Treatment Period 2||4||
48126591|NCT00812929|100633868|FG002|COMPLETED|Treatment Period 2||4||
48126592|NCT00812929|100633869|FG003|COMPLETED|Treatment Period 2||4||
48126593|NCT00812929|100633870|FG004|COMPLETED|Treatment Period 2||5||
48126594|NCT00812929|100633871|FG005|COMPLETED|Treatment Period 2||5||
48126595|NCT00812929|100633872|FG006|COMPLETED|Treatment Period 2||5||
48126596|NCT00812929|100633873|FG007|COMPLETED|Treatment Period 2||5||
48126597|NCT00812929|100633874|FG008|COMPLETED|Treatment Period 2||4||
48126598|NCT00812929|100633875|FG009|COMPLETED|Treatment Period 2||5||
48126599|NCT00812929|100633866|FG000|NOT COMPLETED|Treatment Period 2||0||
48126600|NCT00812929|100633867|FG001|NOT COMPLETED|Treatment Period 2||0||
48126601|NCT00812929|100633868|FG002|NOT COMPLETED|Treatment Period 2||0||
48126602|NCT00812929|100633869|FG003|NOT COMPLETED|Treatment Period 2||0||
48126603|NCT00812929|100633870|FG004|NOT COMPLETED|Treatment Period 2||0||
48126604|NCT00812929|100633871|FG005|NOT COMPLETED|Treatment Period 2||0||
48126605|NCT00812929|100633872|FG006|NOT COMPLETED|Treatment Period 2||0||
48126606|NCT00812929|100633873|FG007|NOT COMPLETED|Treatment Period 2||0||
48126607|NCT00812929|100633874|FG008|NOT COMPLETED|Treatment Period 2||0||
48126608|NCT00812929|100633875|FG009|NOT COMPLETED|Treatment Period 2||0||
48126609|NCT00812929|100633866|FG000|STARTED|Washout Period 2 (7 Days)||5||
48126610|NCT00812929|100633867|FG001|STARTED|Washout Period 2 (7 Days)||4||
48126611|NCT00812929|100633868|FG002|STARTED|Washout Period 2 (7 Days)||4||
48126612|NCT00812929|100633869|FG003|STARTED|Washout Period 2 (7 Days)||4||
48126613|NCT00812929|100633870|FG004|STARTED|Washout Period 2 (7 Days)||5||
48126614|NCT00812929|100633871|FG005|STARTED|Washout Period 2 (7 Days)||5||
48126615|NCT00812929|100633872|FG006|STARTED|Washout Period 2 (7 Days)||5||
48126616|NCT00812929|100633873|FG007|STARTED|Washout Period 2 (7 Days)||5||
48126617|NCT00812929|100633874|FG008|STARTED|Washout Period 2 (7 Days)||4||
48126618|NCT00812929|100633875|FG009|STARTED|Washout Period 2 (7 Days)||5||
48126619|NCT00812929|100633866|FG000|COMPLETED|Washout Period 2 (7 Days)||5||
48126620|NCT00812929|100633867|FG001|COMPLETED|Washout Period 2 (7 Days)||4||
48126621|NCT00812929|100633868|FG002|COMPLETED|Washout Period 2 (7 Days)||4||
48126622|NCT00812929|100633869|FG003|COMPLETED|Washout Period 2 (7 Days)||4||
48126623|NCT00812929|100633870|FG004|COMPLETED|Washout Period 2 (7 Days)||5||
48126624|NCT00812929|100633871|FG005|COMPLETED|Washout Period 2 (7 Days)||5||
48126625|NCT00812929|100633872|FG006|COMPLETED|Washout Period 2 (7 Days)||5||
48126626|NCT00812929|100633873|FG007|COMPLETED|Washout Period 2 (7 Days)||5||
48126627|NCT00812929|100633874|FG008|COMPLETED|Washout Period 2 (7 Days)||4||
48126628|NCT00812929|100633875|FG009|COMPLETED|Washout Period 2 (7 Days)||4||
48126629|NCT00812929|100633866|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48282891|NCT04677179|101017041|FG001|COMPLETED|Extension Treatment Period||0||
48282892|NCT04677179|101017042|FG002|COMPLETED|Extension Treatment Period||0||
48282893|NCT04677179|101017043|FG003|COMPLETED|Extension Treatment Period||0||
48282894|NCT04677179|101017044|FG004|COMPLETED|Extension Treatment Period||0||
48282895|NCT04677179|101017045|FG005|COMPLETED|Extension Treatment Period||0||
48282896|NCT04677179|101017046|FG006|COMPLETED|Extension Treatment Period||0||
48282897|NCT04677179|101017047|FG007|COMPLETED|Extension Treatment Period||0||
48282898|NCT04677179|101017048|FG008|COMPLETED|Extension Treatment Period||0||
48282899|NCT04677179|101017049|FG009|COMPLETED|Extension Treatment Period||0||
48282900|NCT04677179|101017040|FG000|NOT COMPLETED|Extension Treatment Period||0||
48282901|NCT04677179|101017041|FG001|NOT COMPLETED|Extension Treatment Period||0||
48282902|NCT04677179|101017042|FG002|NOT COMPLETED|Extension Treatment Period||0||
48282903|NCT04677179|101017043|FG003|NOT COMPLETED|Extension Treatment Period||0||
48282904|NCT04677179|101017044|FG004|NOT COMPLETED|Extension Treatment Period||0||
48282905|NCT04677179|101017045|FG005|NOT COMPLETED|Extension Treatment Period||0||
48282906|NCT04677179|101017046|FG006|NOT COMPLETED|Extension Treatment Period||26||
48282907|NCT04677179|101017047|FG007|NOT COMPLETED|Extension Treatment Period||0||
48282908|NCT04677179|101017048|FG008|NOT COMPLETED|Extension Treatment Period||0||
48282909|NCT04677179|101017049|FG009|NOT COMPLETED|Extension Treatment Period||0||
48282910|NCT04677179|101017040|FG000|STARTED|Post-Treatment Follow-up Period||0||
48282911|NCT04677179|101017041|FG001|STARTED|Post-Treatment Follow-up Period||0||
48126630|NCT00812929|100633867|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48126631|NCT00812929|100633868|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48126632|NCT00812929|100633869|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48397542|NCT03380000|101302653|FG001|NOT COMPLETED|Washout (>7days)||0||
48572154|NCT00957684|101731125|FG002|COMPLETED|PART I||90||
48126633|NCT00812929|100633870|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48126634|NCT00812929|100633871|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48397543|NCT03380000|101302652|FG000|STARTED|Second Intervention (1day)||8||
48397544|NCT03380000|101302653|FG001|STARTED|Second Intervention (1day)||8||
48397545|NCT03380000|101302652|FG000|COMPLETED|Second Intervention (1day)||8||
48397546|NCT03380000|101302653|FG001|COMPLETED|Second Intervention (1day)||8||
48397547|NCT03380000|101302652|FG000|NOT COMPLETED|Second Intervention (1day)||0||
48397548|NCT03380000|101302653|FG001|NOT COMPLETED|Second Intervention (1day)||0||
48397549|NCT04266158|101302654|FG000|STARTED|Overall Study||0||
48397550|NCT04266158|101302654|FG000|COMPLETED|Overall Study||0||
48397551|NCT04266158|101302654|FG000|NOT COMPLETED|Overall Study||0||
48397552|NCT00379236|101302655|FG000|STARTED|Double-blind||293||
48397553|NCT00379236|101302656|FG001|STARTED|Double-blind||295||
48397554|NCT00379236|101302657|FG002|STARTED|Double-blind||0||
48397555|NCT00379236|101302655|FG000|COMPLETED|Double-blind||257||
48397556|NCT00379236|101302656|FG001|COMPLETED|Double-blind||259||
48397557|NCT00379236|101302657|FG002|COMPLETED|Double-blind||0||
48397558|NCT00379236|101302655|FG000|NOT COMPLETED|Double-blind||36||
48397559|NCT00379236|101302656|FG001|NOT COMPLETED|Double-blind||36||
48397560|NCT00379236|101302657|FG002|NOT COMPLETED|Double-blind||0||
48397561|NCT00379236|101302655|FG000|STARTED|Open-label Extension||0||
48397562|NCT00379236|101302656|FG001|STARTED|Open-label Extension||0||
48397563|NCT00379236|101302657|FG002|STARTED|Open-label Extension||433||
48397564|NCT00379236|101302655|FG000|COMPLETED|Open-label Extension||0||
48397565|NCT00379236|101302656|FG001|COMPLETED|Open-label Extension||0||
48397566|NCT00379236|101302657|FG002|COMPLETED|Open-label Extension||378||
48397567|NCT00379236|101302655|FG000|NOT COMPLETED|Open-label Extension||0||
48397568|NCT00379236|101302656|FG001|NOT COMPLETED|Open-label Extension||0||
48397569|NCT00379236|101302657|FG002|NOT COMPLETED|Open-label Extension||55||
48397570|NCT02057068|101302658|FG000|STARTED|Overall Study||60|12 beta test dyads included in the intervention group, thus they were not randomized.|
48397571|NCT02057068|101302659|FG001|STARTED|Overall Study||36|12 beta test dyads included in the intervention group, thus they were not randomized.|
48397572|NCT02057068|101302658|FG000|COMPLETED|Overall Study||52||
48397573|NCT02057068|101302659|FG001|COMPLETED|Overall Study||28||
48397574|NCT02057068|101302658|FG000|NOT COMPLETED|Overall Study||8||
48397575|NCT02057068|101302659|FG001|NOT COMPLETED|Overall Study||8||
48397576|NCT02025829|101302660|FG000|STARTED|Overall Study||3||
48397577|NCT02025829|101302661|FG001|STARTED|Overall Study||11||
48397578|NCT02025829|101302660|FG000|COMPLETED|Overall Study||3||
48397579|NCT02025829|101302661|FG001|COMPLETED|Overall Study||11||
48397580|NCT02025829|101302660|FG000|NOT COMPLETED|Overall Study||0||
48397581|NCT02025829|101302661|FG001|NOT COMPLETED|Overall Study||0||
48572155|NCT00957684|101731126|FG003|COMPLETED|PART I||84||
48572156|NCT00957684|101731127|FG004|COMPLETED|PART I||0||
48572157|NCT00957684|101731123|FG000|NOT COMPLETED|PART I||31||
48572158|NCT00957684|101731124|FG001|NOT COMPLETED|PART I||13||
48126635|NCT00812929|100633872|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48126636|NCT00812929|100633873|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48397582|NCT00416312|101302662|FG000|STARTED|Overall Study||9||
48397583|NCT00416312|101302662|FG000|Conventional Dosimetry|Overall Study||9||
48397584|NCT00416312|101302662|FG000|Patient-specific Dosimetry|Overall Study||9||
48397585|NCT00416312|101302662|FG000|COMPLETED|Overall Study||7||
48126637|NCT00812929|100633874|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48126638|NCT00812929|100633875|FG009|NOT COMPLETED|Washout Period 2 (7 Days)||1||
48126639|NCT00812929|100633866|FG000|STARTED|Treatment Period 3||5||
48126640|NCT00812929|100633867|FG001|STARTED|Treatment Period 3||4||
48126641|NCT00812929|100633868|FG002|STARTED|Treatment Period 3||4||
48126642|NCT00812929|100633869|FG003|STARTED|Treatment Period 3||4||
48126643|NCT00812929|100633870|FG004|STARTED|Treatment Period 3||5||
48126644|NCT00812929|100633871|FG005|STARTED|Treatment Period 3||5||
48126645|NCT00812929|100633872|FG006|STARTED|Treatment Period 3||5||
48126646|NCT00812929|100633873|FG007|STARTED|Treatment Period 3||5||
48126647|NCT00812929|100633874|FG008|STARTED|Treatment Period 3||4||
48126648|NCT00812929|100633875|FG009|STARTED|Treatment Period 3||4||
48126649|NCT00812929|100633866|FG000|COMPLETED|Treatment Period 3||5||
48126650|NCT00812929|100633867|FG001|COMPLETED|Treatment Period 3||4||
48397586|NCT00416312|101302662|FG000|NOT COMPLETED|Overall Study||2||
48397587|NCT01961089|101302663|FG000|STARTED|Overall Study||40||
48572159|NCT00957684|101731125|FG002|NOT COMPLETED|PART I||10||
48572160|NCT00957684|101731126|FG003|NOT COMPLETED|PART I||18||
48572161|NCT00957684|101731127|FG004|NOT COMPLETED|PART I||0||
48572162|NCT00957684|101731123|FG000|STARTED|PART II||0||
48126651|NCT00812929|100633868|FG002|COMPLETED|Treatment Period 3||4||
48126652|NCT00812929|100633869|FG003|COMPLETED|Treatment Period 3||4||
48126653|NCT00812929|100633870|FG004|COMPLETED|Treatment Period 3||5||
48126654|NCT00812929|100633871|FG005|COMPLETED|Treatment Period 3||5||
48397588|NCT01961089|101302663|FG000|COMPLETED|Overall Study||40||
48397589|NCT01961089|101302663|FG000|NOT COMPLETED|Overall Study||0||
48397590|NCT04018612|101302664|FG000|STARTED|Overall Study||44||
48397591|NCT04018612|101302665|FG001|STARTED|Overall Study||44||
48397592|NCT04018612|101302666|FG002|STARTED|Overall Study||22||
48126655|NCT00812929|100633872|FG006|COMPLETED|Treatment Period 3||5||
48126656|NCT00812929|100633873|FG007|COMPLETED|Treatment Period 3||5||
48572163|NCT00957684|101731124|FG001|STARTED|PART II||0||
48126657|NCT00812929|100633874|FG008|COMPLETED|Treatment Period 3||4||
48126658|NCT00812929|100633875|FG009|COMPLETED|Treatment Period 3||4||
48126659|NCT00812929|100633866|FG000|NOT COMPLETED|Treatment Period 3||0||
48126660|NCT00812929|100633867|FG001|NOT COMPLETED|Treatment Period 3||0||
48126661|NCT00812929|100633868|FG002|NOT COMPLETED|Treatment Period 3||0||
48126662|NCT00812929|100633869|FG003|NOT COMPLETED|Treatment Period 3||0||
48126663|NCT00812929|100633870|FG004|NOT COMPLETED|Treatment Period 3||0||
48126664|NCT00812929|100633871|FG005|NOT COMPLETED|Treatment Period 3||0||
48126665|NCT00812929|100633872|FG006|NOT COMPLETED|Treatment Period 3||0||
48282912|NCT04677179|101017042|FG002|STARTED|Post-Treatment Follow-up Period||0||
48282913|NCT04677179|101017043|FG003|STARTED|Post-Treatment Follow-up Period||0||
48282914|NCT04677179|101017044|FG004|STARTED|Post-Treatment Follow-up Period||0||
48282915|NCT04677179|101017045|FG005|STARTED|Post-Treatment Follow-up Period||0||
48282916|NCT04677179|101017046|FG006|STARTED|Post-Treatment Follow-up Period||0||
48282917|NCT04677179|101017047|FG007|STARTED|Post-Treatment Follow-up Period||25||
48126666|NCT00812929|100633873|FG007|NOT COMPLETED|Treatment Period 3||0||
48126667|NCT00812929|100633874|FG008|NOT COMPLETED|Treatment Period 3||0||
48126668|NCT00812929|100633875|FG009|NOT COMPLETED|Treatment Period 3||0||
48126669|NCT00812929|100633866|FG000|STARTED|Washout Period 3 (7 Days)||5||
48126670|NCT00812929|100633867|FG001|STARTED|Washout Period 3 (7 Days)||4||
48126671|NCT00812929|100633868|FG002|STARTED|Washout Period 3 (7 Days)||4||
48126672|NCT00812929|100633869|FG003|STARTED|Washout Period 3 (7 Days)||4||
48126673|NCT00812929|100633870|FG004|STARTED|Washout Period 3 (7 Days)||5||
48126674|NCT00812929|100633871|FG005|STARTED|Washout Period 3 (7 Days)||5||
48126675|NCT00812929|100633872|FG006|STARTED|Washout Period 3 (7 Days)||5||
48126676|NCT00812929|100633873|FG007|STARTED|Washout Period 3 (7 Days)||5||
48126677|NCT00812929|100633874|FG008|STARTED|Washout Period 3 (7 Days)||4||
48126678|NCT00812929|100633875|FG009|STARTED|Washout Period 3 (7 Days)||4||
48126679|NCT00812929|100633866|FG000|COMPLETED|Washout Period 3 (7 Days)||5||
48282918|NCT04677179|101017048|FG008|STARTED|Post-Treatment Follow-up Period||30||
48282919|NCT04677179|101017049|FG009|STARTED|Post-Treatment Follow-up Period||11||
48282920|NCT04677179|101017040|FG000|COMPLETED|Post-Treatment Follow-up Period||0||
48282921|NCT04677179|101017041|FG001|COMPLETED|Post-Treatment Follow-up Period||0||
48282922|NCT04677179|101017042|FG002|COMPLETED|Post-Treatment Follow-up Period||0||
48282923|NCT04677179|101017043|FG003|COMPLETED|Post-Treatment Follow-up Period||0||
48282924|NCT04677179|101017044|FG004|COMPLETED|Post-Treatment Follow-up Period||0||
48282925|NCT04677179|101017045|FG005|COMPLETED|Post-Treatment Follow-up Period||0||
48282926|NCT04677179|101017046|FG006|COMPLETED|Post-Treatment Follow-up Period||0||
48282927|NCT04677179|101017047|FG007|COMPLETED|Post-Treatment Follow-up Period||0||
48282928|NCT04677179|101017048|FG008|COMPLETED|Post-Treatment Follow-up Period||0||
48282929|NCT04677179|101017049|FG009|COMPLETED|Post-Treatment Follow-up Period||0||
48282930|NCT04677179|101017040|FG000|NOT COMPLETED|Post-Treatment Follow-up Period||0||
48282931|NCT04677179|101017041|FG001|NOT COMPLETED|Post-Treatment Follow-up Period||0||
48282932|NCT04677179|101017042|FG002|NOT COMPLETED|Post-Treatment Follow-up Period||0||
48282933|NCT04677179|101017043|FG003|NOT COMPLETED|Post-Treatment Follow-up Period||0||
48282934|NCT04677179|101017044|FG004|NOT COMPLETED|Post-Treatment Follow-up Period||0||
48282935|NCT04677179|101017045|FG005|NOT COMPLETED|Post-Treatment Follow-up Period||0||
48282936|NCT04677179|101017046|FG006|NOT COMPLETED|Post-Treatment Follow-up Period||0||
48282937|NCT04677179|101017047|FG007|NOT COMPLETED|Post-Treatment Follow-up Period||25||
48282938|NCT04677179|101017048|FG008|NOT COMPLETED|Post-Treatment Follow-up Period||30||
48282939|NCT04677179|101017049|FG009|NOT COMPLETED|Post-Treatment Follow-up Period||11||
48282940|NCT00532493|101017050|FG000|STARTED|Overall Study||152||
48282941|NCT00532493|101017051|FG001|STARTED|Overall Study||152||
48282942|NCT00532493|101017050|FG000|COMPLETED|Overall Study||122||
48282943|NCT00532493|101017051|FG001|COMPLETED|Overall Study||123||
48282944|NCT00532493|101017050|FG000|NOT COMPLETED|Overall Study||30||
48282945|NCT00532493|101017051|FG001|NOT COMPLETED|Overall Study||29||
48282946|NCT01050790|101017052|FG000|STARTED|Overall Study||17||
48282947|NCT01050790|101017052|FG000|COMPLETED|Overall Study||16||
48282948|NCT01050790|101017052|FG000|NOT COMPLETED|Overall Study||1||
48282949|NCT00473265|101017053|FG000|STARTED|Overall Study||68||
48282950|NCT00473265|101017053|FG000|COMPLETED|Overall Study||48||
48126680|NCT00812929|100633867|FG001|COMPLETED|Washout Period 3 (7 Days)||4||
48126681|NCT00812929|100633868|FG002|COMPLETED|Washout Period 3 (7 Days)||4||
48126682|NCT00812929|100633869|FG003|COMPLETED|Washout Period 3 (7 Days)||4||
48126683|NCT00812929|100633870|FG004|COMPLETED|Washout Period 3 (7 Days)||5||
48126684|NCT00812929|100633871|FG005|COMPLETED|Washout Period 3 (7 Days)||4||
48126685|NCT00812929|100633872|FG006|COMPLETED|Washout Period 3 (7 Days)||5||
48282951|NCT00473265|101017053|FG000|NOT COMPLETED|Overall Study||20||
48282952|NCT01488877|101017054|FG000|STARTED|Initial Randomization||1||
48282953|NCT01488877|101017055|FG001|STARTED|Initial Randomization||5||
48282954|NCT01488877|101017056|FG002|STARTED|Initial Randomization||0||
48282955|NCT01488877|101017054|FG000|COMPLETED|Initial Randomization||1||
48126686|NCT00812929|100633873|FG007|COMPLETED|Washout Period 3 (7 Days)||5||
48126687|NCT00812929|100633874|FG008|COMPLETED|Washout Period 3 (7 Days)||4||
48126688|NCT00812929|100633875|FG009|COMPLETED|Washout Period 3 (7 Days)||4||
48126689|NCT00812929|100633866|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48126690|NCT00812929|100633867|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48397593|NCT04018612|101302664|FG000|COMPLETED|Overall Study||43||
48126691|NCT00812929|100633868|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48126692|NCT00812929|100633869|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48126693|NCT00812929|100633870|FG004|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48397594|NCT04018612|101302665|FG001|COMPLETED|Overall Study||44||
48397595|NCT04018612|101302666|FG002|COMPLETED|Overall Study||21||
48397596|NCT04018612|101302664|FG000|NOT COMPLETED|Overall Study||1||
48572164|NCT00957684|101731125|FG002|STARTED|PART II||0||
48126694|NCT00812929|100633871|FG005|NOT COMPLETED|Washout Period 3 (7 Days)||1||
48126695|NCT00812929|100633872|FG006|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48126696|NCT00812929|100633873|FG007|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48126697|NCT00812929|100633874|FG008|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48126698|NCT00812929|100633875|FG009|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48126699|NCT00812929|100633866|FG000|STARTED|Treatment Period 4||5||
48572165|NCT00957684|101731126|FG003|STARTED|PART II||0||
48572166|NCT00957684|101731127|FG004|STARTED|PART II||314||
48572167|NCT00957684|101731123|FG000|Patients Entered Part II|PART II||0||
48572168|NCT00957684|101731124|FG001|Patients Entered Part II|PART II||0||
48572169|NCT00957684|101731125|FG002|Patients Entered Part II|PART II||0||
48700720|NCT01120236|102054066|FG000|NOT COMPLETED|Overall Study||0||
48700721|NCT01120236|102054067|FG001|NOT COMPLETED|Overall Study||1||
48700722|NCT00960011|102054068|FG000|STARTED|Overall Study||33||
48397597|NCT04018612|101302665|FG001|NOT COMPLETED|Overall Study||0||
48397598|NCT04018612|101302666|FG002|NOT COMPLETED|Overall Study||1||
48397599|NCT00927758|101302667|FG000|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4||
48397600|NCT00927758|101302668|FG001|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4||
48397601|NCT00927758|101302669|FG002|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4||
48397602|NCT00927758|101302670|FG003|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3||
48126700|NCT00812929|100633867|FG001|STARTED|Treatment Period 4||4||
48126701|NCT00812929|100633868|FG002|STARTED|Treatment Period 4||4||
48126702|NCT00812929|100633869|FG003|STARTED|Treatment Period 4||4||
48126703|NCT00812929|100633870|FG004|STARTED|Treatment Period 4||5||
48397603|NCT00927758|101302671|FG004|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3||
48397604|NCT00927758|101302672|FG005|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4||
48397605|NCT00927758|101302667|FG000|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4||
48397606|NCT00927758|101302668|FG001|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4||
48397607|NCT00927758|101302669|FG002|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4||
48397608|NCT00927758|101302670|FG003|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||2||
48397609|NCT00927758|101302671|FG004|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3||
48397610|NCT00927758|101302672|FG005|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3||
48397611|NCT00927758|101302667|FG000|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4||
48572170|NCT00957684|101731126|FG003|Patients Entered Part II|PART II||0||
48572171|NCT00957684|101731127|FG004|Patients Entered Part II|PART II||314||
48572172|NCT00957684|101731123|FG000|COMPLETED|PART II||0||
48700723|NCT00960011|102054069|FG001|STARTED|Overall Study||25||
48700724|NCT00960011|102054068|FG000|COMPLETED|Overall Study||22||
48700725|NCT00960011|102054069|FG001|COMPLETED|Overall Study||23||
48700726|NCT00960011|102054068|FG000|NOT COMPLETED|Overall Study||11||
48700727|NCT00960011|102054069|FG001|NOT COMPLETED|Overall Study||2||
48700728|NCT00978380|102054070|FG000|STARTED|Overall Study||63||
48700729|NCT00978380|102054070|FG000|COMPLETED|Overall Study||44||
48700730|NCT00978380|102054070|FG000|NOT COMPLETED|Overall Study||19||
48700731|NCT04049266|102054071|FG000|STARTED|Overall Study||277||
48700732|NCT04049266|102054072|FG001|STARTED|Overall Study||280||
48700733|NCT04049266|102054071|FG000|COMPLETED|Overall Study||240|Completed is defined as participants who completed treatment through Year 1.|
48700734|NCT04049266|102054072|FG001|COMPLETED|Overall Study||254|Completed is defined as participants who completed treatment through Year 1.|
48700735|NCT04049266|102054071|FG000|NOT COMPLETED|Overall Study||37||
48700736|NCT04049266|102054072|FG001|NOT COMPLETED|Overall Study||26||
48700737|NCT02954406|102054073|FG000|STARTED|Overall Study||3||
48700738|NCT02954406|102054074|FG001|STARTED|Overall Study||6||
48700739|NCT02954406|102054075|FG002|STARTED|Overall Study||6||
48700740|NCT02954406|102054076|FG003|STARTED|Overall Study||6||
48397612|NCT00927758|101302668|FG001|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4||
48572173|NCT00957684|101731124|FG001|COMPLETED|PART II||0||
48572174|NCT00957684|101731125|FG002|COMPLETED|PART II||0||
48572175|NCT00957684|101731126|FG003|COMPLETED|PART II||0||
48572176|NCT00957684|101731127|FG004|COMPLETED|PART II||239||
48700741|NCT02954406|102054077|FG004|STARTED|Overall Study||7||
48572177|NCT00957684|101731123|FG000|NOT COMPLETED|PART II||0||
48572178|NCT00957684|101731124|FG001|NOT COMPLETED|PART II||0||
48700742|NCT02954406|102054078|FG005|STARTED|Overall Study||3||
48700743|NCT02954406|102054079|FG006|STARTED|Overall Study||3||
48700744|NCT02954406|102054080|FG007|STARTED|Overall Study||2||
48700745|NCT02954406|102054081|FG008|STARTED|Overall Study||4||
48700746|NCT02954406|102054082|FG009|STARTED|Overall Study||3||
48700747|NCT02954406|102054083|FG010|STARTED|Overall Study||0||
48126704|NCT00812929|100633871|FG005|STARTED|Treatment Period 4||4||
48126705|NCT00812929|100633872|FG006|STARTED|Treatment Period 4||5||
48700748|NCT02954406|102054073|FG000|COMPLETED|Overall Study||0||
48700749|NCT02954406|102054074|FG001|COMPLETED|Overall Study||0||
48126706|NCT00812929|100633873|FG007|STARTED|Treatment Period 4||5||
48126707|NCT00812929|100633874|FG008|STARTED|Treatment Period 4||4||
48126708|NCT00812929|100633875|FG009|STARTED|Treatment Period 4||4||
48126709|NCT00812929|100633866|FG000|COMPLETED|Treatment Period 4||5||
48126710|NCT00812929|100633867|FG001|COMPLETED|Treatment Period 4||4||
48126711|NCT00812929|100633868|FG002|COMPLETED|Treatment Period 4||4||
48126712|NCT00812929|100633869|FG003|COMPLETED|Treatment Period 4||4||
48126713|NCT00812929|100633870|FG004|COMPLETED|Treatment Period 4||5||
48126714|NCT00812929|100633871|FG005|COMPLETED|Treatment Period 4||4||
48126715|NCT00812929|100633872|FG006|COMPLETED|Treatment Period 4||5||
48126716|NCT00812929|100633873|FG007|COMPLETED|Treatment Period 4||5||
48126717|NCT00812929|100633874|FG008|COMPLETED|Treatment Period 4||4||
48126718|NCT00812929|100633875|FG009|COMPLETED|Treatment Period 4||4||
48126719|NCT00812929|100633866|FG000|NOT COMPLETED|Treatment Period 4||0||
48126720|NCT00812929|100633867|FG001|NOT COMPLETED|Treatment Period 4||0||
48126721|NCT00812929|100633868|FG002|NOT COMPLETED|Treatment Period 4||0||
48126722|NCT00812929|100633869|FG003|NOT COMPLETED|Treatment Period 4||0||
48126723|NCT00812929|100633870|FG004|NOT COMPLETED|Treatment Period 4||0||
48126724|NCT00812929|100633871|FG005|NOT COMPLETED|Treatment Period 4||0||
48572179|NCT00957684|101731125|FG002|NOT COMPLETED|PART II||0||
48572180|NCT00957684|101731126|FG003|NOT COMPLETED|PART II||0||
48572181|NCT00957684|101731127|FG004|NOT COMPLETED|PART II||75||
48572182|NCT03915587|101731128|FG000|STARTED|Overall Study||7||
48572183|NCT03915587|101731129|FG001|STARTED|Overall Study||16||
48572184|NCT03915587|101731128|FG000|COMPLETED|Overall Study||7||
48572185|NCT03915587|101731129|FG001|COMPLETED|Overall Study||16||
48572186|NCT03915587|101731128|FG000|NOT COMPLETED|Overall Study||0||
48572187|NCT03915587|101731129|FG001|NOT COMPLETED|Overall Study||0||
48700750|NCT02954406|102054075|FG002|COMPLETED|Overall Study||0||
48572188|NCT03020992|101731130|FG000|STARTED|Overall Study||89||
48572189|NCT03020992|101731130|FG000|COMPLETED|Overall Study||83||
48572190|NCT03020992|101731130|FG000|NOT COMPLETED|Overall Study||6||
48572191|NCT04973267|101731131|FG000|STARTED|Overall Study||37||
48572192|NCT04973267|101731132|FG001|STARTED|Overall Study||36||
48572193|NCT04973267|101731131|FG000|COMPLETED|Overall Study||37||
48572194|NCT04973267|101731132|FG001|COMPLETED|Overall Study||36||
48572195|NCT04973267|101731131|FG000|NOT COMPLETED|Overall Study||0||
48572196|NCT04973267|101731132|FG001|NOT COMPLETED|Overall Study||0||
48572197|NCT04002115|101731133|FG000|STARTED|Overall Study||2||
48572198|NCT04002115|101731133|FG000|COMPLETED|Overall Study||2||
48572199|NCT04002115|101731133|FG000|NOT COMPLETED|Overall Study||0||
48572200|NCT00179660|101731134|FG000|STARTED|Overall Study||50||
48572201|NCT00179660|101731134|FG000|Received Study Drug|Overall Study||49||
48700751|NCT02954406|102054076|FG003|COMPLETED|Overall Study||0||
48700752|NCT02954406|102054077|FG004|COMPLETED|Overall Study||0||
48700753|NCT02954406|102054078|FG005|COMPLETED|Overall Study||0||
48700754|NCT02954406|102054079|FG006|COMPLETED|Overall Study||0||
48700755|NCT02954406|102054080|FG007|COMPLETED|Overall Study||0||
48700756|NCT02954406|102054081|FG008|COMPLETED|Overall Study||0||
48700757|NCT02954406|102054082|FG009|COMPLETED|Overall Study||0||
48700758|NCT02954406|102054083|FG010|COMPLETED|Overall Study||0||
48700759|NCT02954406|102054073|FG000|NOT COMPLETED|Overall Study||3||
48700760|NCT02954406|102054074|FG001|NOT COMPLETED|Overall Study||6||
48126725|NCT00812929|100633872|FG006|NOT COMPLETED|Treatment Period 4||0||
48126726|NCT00812929|100633873|FG007|NOT COMPLETED|Treatment Period 4||0||
48126727|NCT00812929|100633874|FG008|NOT COMPLETED|Treatment Period 4||0||
48126728|NCT00812929|100633875|FG009|NOT COMPLETED|Treatment Period 4||0||
48126729|NCT00812929|100633866|FG000|STARTED|Washout Period 4 (7 Days)||5||
48282956|NCT01488877|101017055|FG001|COMPLETED|Initial Randomization||5||
48572202|NCT00179660|101731134|FG000|Completed 12 Cycles of Treatment|Overall Study||12||
48572203|NCT00179660|101731134|FG000|COMPLETED|Overall Study||0||
48700761|NCT02954406|102054075|FG002|NOT COMPLETED|Overall Study||6||
48700762|NCT02954406|102054076|FG003|NOT COMPLETED|Overall Study||6||
48700763|NCT02954406|102054077|FG004|NOT COMPLETED|Overall Study||7||
48700764|NCT02954406|102054078|FG005|NOT COMPLETED|Overall Study||3||
48700765|NCT02954406|102054079|FG006|NOT COMPLETED|Overall Study||3||
48700766|NCT02954406|102054080|FG007|NOT COMPLETED|Overall Study||2||
48700767|NCT02954406|102054081|FG008|NOT COMPLETED|Overall Study||4||
48700768|NCT02954406|102054082|FG009|NOT COMPLETED|Overall Study||3||
48700769|NCT02954406|102054083|FG010|NOT COMPLETED|Overall Study||0||
48700770|NCT03350256|102054084|FG000|STARTED|Overall Study||60||
48700771|NCT03350256|102054084|FG000|Spinal Cord Stimulation Trial|Overall Study||50||
48700772|NCT03350256|102054084|FG000|Permanent Implant|Overall Study||35||
48700773|NCT03350256|102054084|FG000|1 Month Follow up|Overall Study||30||
48700774|NCT03350256|102054084|FG000|3 Month Follow up|Overall Study||27||
48700775|NCT03350256|102054084|FG000|6 Month Follow up|Overall Study||24||
48126730|NCT00812929|100633867|FG001|STARTED|Washout Period 4 (7 Days)||4||
48126731|NCT00812929|100633868|FG002|STARTED|Washout Period 4 (7 Days)||4||
48126732|NCT00812929|100633869|FG003|STARTED|Washout Period 4 (7 Days)||4||
48572204|NCT00179660|101731134|FG000|NOT COMPLETED|Overall Study||50||
48572205|NCT00952068|101734973|FG000|STARTED|Overall Study||47||
48572206|NCT00952068|101734973|FG000|COMPLETED|Overall Study||40||
48700776|NCT03350256|102054084|FG000|COMPLETED|Overall Study||24||
48700777|NCT03350256|102054084|FG000|NOT COMPLETED|Overall Study||36||
48700778|NCT00730041|102054085|FG000|STARTED|Overall Study||26||
48700779|NCT00730041|102054086|FG001|STARTED|Overall Study||25||
48700780|NCT00730041|102054085|FG000|COMPLETED|Overall Study||26||
48700781|NCT00730041|102054086|FG001|COMPLETED|Overall Study||23||
48700782|NCT00730041|102054085|FG000|NOT COMPLETED|Overall Study||0||
48700783|NCT00730041|102054086|FG001|NOT COMPLETED|Overall Study||2||
48397613|NCT00927758|101302669|FG002|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4||
48397614|NCT00927758|101302670|FG003|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||2||
48397615|NCT00927758|101302671|FG004|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3||
48397616|NCT00927758|101302672|FG005|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3||
48397617|NCT00927758|101302667|FG000|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0||
48397618|NCT00927758|101302668|FG001|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0||
48397619|NCT00927758|101302669|FG002|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0||
48397620|NCT00927758|101302670|FG003|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1||
48572207|NCT00952068|101734973|FG000|NOT COMPLETED|Overall Study||7||
48572208|NCT02235064|101734974|FG000|STARTED|Overall Study||1||
48282957|NCT01488877|101017056|FG002|COMPLETED|Initial Randomization||0||
48282958|NCT01488877|101017054|FG000|NOT COMPLETED|Initial Randomization||0||
48282959|NCT01488877|101017055|FG001|NOT COMPLETED|Initial Randomization||0||
48282960|NCT01488877|101017056|FG002|NOT COMPLETED|Initial Randomization||0||
48282961|NCT01488877|101017054|FG000|STARTED|Re-randomization||0||
48282962|NCT01488877|101017055|FG001|STARTED|Re-randomization||0||
48282963|NCT01488877|101017056|FG002|STARTED|Re-randomization||3||
48282964|NCT01488877|101017054|FG000|COMPLETED|Re-randomization||0||
48282965|NCT01488877|101017055|FG001|COMPLETED|Re-randomization||0||
48282966|NCT01488877|101017056|FG002|COMPLETED|Re-randomization||3||
48282967|NCT01488877|101017054|FG000|NOT COMPLETED|Re-randomization||0||
48282968|NCT01488877|101017055|FG001|NOT COMPLETED|Re-randomization||0||
48282969|NCT01488877|101017056|FG002|NOT COMPLETED|Re-randomization||0||
48282970|NCT05007080|101017057|FG000|STARTED|Overall Study||51||
48282971|NCT05007080|101017058|FG001|STARTED|Overall Study||50||
48282972|NCT05007080|101017059|FG002|STARTED|Overall Study||51||
48282973|NCT05007080|101017060|FG003|STARTED|Overall Study||49||
48282974|NCT05007080|101017061|FG004|STARTED|Overall Study||49||
48572209|NCT02235064|101734975|FG001|STARTED|Overall Study||1||
48572210|NCT02235064|101734974|FG000|COMPLETED|Overall Study||1||
48572211|NCT02235064|101734975|FG001|COMPLETED|Overall Study||1||
48572212|NCT02235064|101734974|FG000|NOT COMPLETED|Overall Study||0||
48700784|NCT00244933|102054087|FG000|STARTED|Overall Study||19||
48700785|NCT00244933|102054087|FG000|COMPLETED|Overall Study||17||
48700786|NCT00244933|102054087|FG000|NOT COMPLETED|Overall Study||2||
48700787|NCT02403817|102054088|FG000|STARTED|Overall Study||28||
48700788|NCT02403817|102054089|FG001|STARTED|Overall Study||2||
48700789|NCT02403817|102054088|FG000|COMPLETED|Overall Study||23||
48700790|NCT02403817|102054089|FG001|COMPLETED|Overall Study||2||
48282975|NCT05007080|101017062|FG005|STARTED|Overall Study||50||
48282976|NCT05007080|101017057|FG000|Vaccinated|Overall Study||51||
48282977|NCT05007080|101017058|FG001|Vaccinated|Overall Study||50||
48282978|NCT05007080|101017059|FG002|Vaccinated|Overall Study||51||
48397621|NCT00927758|101302671|FG004|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0||
48397622|NCT00927758|101302672|FG005|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1||
48572213|NCT02235064|101734975|FG001|NOT COMPLETED|Overall Study||0||
48572214|NCT00975611|101734976|FG000|STARTED|Overall Study||22||
48572215|NCT00975611|101734976|FG000|COMPLETED|Overall Study||5||
48572216|NCT00975611|101734976|FG000|NOT COMPLETED|Overall Study||17||
48572217|NCT01894841|101734977|FG000|STARTED|Overall Study||52||
48572218|NCT01894841|101734978|FG001|STARTED|Overall Study||53||
48572219|NCT01894841|101734977|FG000|COMPLETED|Overall Study||34||
48572220|NCT01894841|101734978|FG001|COMPLETED|Overall Study||44||
48572221|NCT01894841|101734977|FG000|NOT COMPLETED|Overall Study||18||
48572222|NCT01894841|101734978|FG001|NOT COMPLETED|Overall Study||9||
48572223|NCT00940823|101734979|FG000|STARTED|Overall Study||124||
48572224|NCT00940823|101734980|FG001|STARTED|Overall Study||114||
48572225|NCT00940823|101734979|FG000|COMPLETED|Overall Study||89||
48572226|NCT00940823|101734980|FG001|COMPLETED|Overall Study||82||
48572227|NCT00940823|101734979|FG000|NOT COMPLETED|Overall Study||35||
48572228|NCT00940823|101734980|FG001|NOT COMPLETED|Overall Study||32||
48700791|NCT02403817|102054088|FG000|NOT COMPLETED|Overall Study||5||
48700792|NCT02403817|102054089|FG001|NOT COMPLETED|Overall Study||0||
48700793|NCT01457014|102054090|FG000|STARTED|First Night||74||
48700794|NCT01457014|102054091|FG001|STARTED|First Night||0||
48700795|NCT01457014|102054092|FG002|STARTED|First Night||0||
48700796|NCT01457014|102054093|FG003|STARTED|First Night||0||
48700797|NCT01457014|102054090|FG000|COMPLETED|First Night||34||
48700798|NCT01457014|102054091|FG001|COMPLETED|First Night||0||
48700799|NCT01457014|102054092|FG002|COMPLETED|First Night||0||
48700800|NCT01457014|102054093|FG003|COMPLETED|First Night||0||
48700801|NCT01457014|102054090|FG000|NOT COMPLETED|First Night||40||
48700802|NCT01457014|102054091|FG001|NOT COMPLETED|First Night||0||
48700803|NCT01457014|102054092|FG002|NOT COMPLETED|First Night||0||
48282979|NCT05007080|101017060|FG003|Vaccinated|Overall Study||49||
48572229|NCT04144413|101734981|FG000|STARTED|Period 1: Open-Label Treatment Phase||350||
48572230|NCT04144413|101734982|FG001|STARTED|Period 1: Open-Label Treatment Phase||0||
48572231|NCT04144413|101734983|FG002|STARTED|Period 1: Open-Label Treatment Phase||0||
48572232|NCT04144413|101734981|FG000|COMPLETED|Period 1: Open-Label Treatment Phase||288||
48572233|NCT04144413|101734982|FG001|COMPLETED|Period 1: Open-Label Treatment Phase||0||
48572234|NCT04144413|101734983|FG002|COMPLETED|Period 1: Open-Label Treatment Phase||0||
48572235|NCT04144413|101734981|FG000|NOT COMPLETED|Period 1: Open-Label Treatment Phase||62||
48572236|NCT04144413|101734982|FG001|NOT COMPLETED|Period 1: Open-Label Treatment Phase||0||
48572237|NCT04144413|101734983|FG002|NOT COMPLETED|Period 1: Open-Label Treatment Phase||0||
48572238|NCT04144413|101734981|FG000|STARTED|Period 2: Masked Treatment Phase||0||
48572239|NCT04144413|101734982|FG001|STARTED|Period 2: Masked Treatment Phase||148||
48572240|NCT04144413|101734983|FG002|STARTED|Period 2: Masked Treatment Phase||97||
48572241|NCT04144413|101734981|FG000|COMPLETED|Period 2: Masked Treatment Phase||0||
48572242|NCT04144413|101734982|FG001|COMPLETED|Period 2: Masked Treatment Phase||137||
48572243|NCT04144413|101734983|FG002|COMPLETED|Period 2: Masked Treatment Phase||86||
48572244|NCT04144413|101734981|FG000|NOT COMPLETED|Period 2: Masked Treatment Phase||0||
48572245|NCT04144413|101734982|FG001|NOT COMPLETED|Period 2: Masked Treatment Phase||11||
48572246|NCT04144413|101734983|FG002|NOT COMPLETED|Period 2: Masked Treatment Phase||11||
48572247|NCT03018080|101734984|FG000|STARTED|Overall Study||21||
48572248|NCT03018080|101734985|FG001|STARTED|Overall Study||19||
48572249|NCT03018080|101734984|FG000|COMPLETED|Overall Study||9||
48572250|NCT03018080|101734985|FG001|COMPLETED|Overall Study||0||
48572251|NCT03018080|101734984|FG000|NOT COMPLETED|Overall Study||12||
48572252|NCT03018080|101734985|FG001|NOT COMPLETED|Overall Study||19||
48572253|NCT00454363|101734986|FG000|STARTED|Overall Study||20||
48572254|NCT00454363|101734987|FG001|STARTED|Overall Study||31||
48572255|NCT00454363|101734986|FG000|COMPLETED|Overall Study||15||
48572256|NCT00454363|101734987|FG001|COMPLETED|Overall Study||29||
48572257|NCT00454363|101734986|FG000|NOT COMPLETED|Overall Study||5||
48572258|NCT00454363|101734987|FG001|NOT COMPLETED|Overall Study||2||
48572259|NCT05125848|101734988|FG000|STARTED|Overall Study||15||
48572260|NCT05125848|101734988|FG000|COMPLETED|Overall Study||15||
48572261|NCT05125848|101734988|FG000|NOT COMPLETED|Overall Study||0||
48572262|NCT02395848|101734989|FG000|STARTED|Overall Study||31||
48572263|NCT02395848|101734989|FG000|COMPLETED|Overall Study||29||
48572264|NCT02395848|101734989|FG000|NOT COMPLETED|Overall Study||2||
48572265|NCT00653133|101734990|FG000|STARTED|Overall Study||1324||
48572266|NCT00653133|101734991|FG001|STARTED|Overall Study||497||
48700804|NCT01457014|102054093|FG003|NOT COMPLETED|First Night||0||
48126733|NCT00812929|100633870|FG004|STARTED|Washout Period 4 (7 Days)||5||
48126734|NCT00812929|100633871|FG005|STARTED|Washout Period 4 (7 Days)||4||
48126735|NCT00812929|100633872|FG006|STARTED|Washout Period 4 (7 Days)||5||
48126736|NCT00812929|100633873|FG007|STARTED|Washout Period 4 (7 Days)||5||
48126737|NCT00812929|100633874|FG008|STARTED|Washout Period 4 (7 Days)||4||
48126738|NCT00812929|100633875|FG009|STARTED|Washout Period 4 (7 Days)||4||
48126739|NCT00812929|100633866|FG000|COMPLETED|Washout Period 4 (7 Days)||5||
48126740|NCT00812929|100633867|FG001|COMPLETED|Washout Period 4 (7 Days)||4||
48126741|NCT00812929|100633868|FG002|COMPLETED|Washout Period 4 (7 Days)||4||
48126742|NCT00812929|100633869|FG003|COMPLETED|Washout Period 4 (7 Days)||4||
48126743|NCT00812929|100633870|FG004|COMPLETED|Washout Period 4 (7 Days)||5||
48126744|NCT00812929|100633871|FG005|COMPLETED|Washout Period 4 (7 Days)||4||
48126745|NCT00812929|100633872|FG006|COMPLETED|Washout Period 4 (7 Days)||5||
48126746|NCT00812929|100633873|FG007|COMPLETED|Washout Period 4 (7 Days)||5||
48126747|NCT00812929|100633874|FG008|COMPLETED|Washout Period 4 (7 Days)||4||
48126748|NCT00812929|100633875|FG009|COMPLETED|Washout Period 4 (7 Days)||4||
48126749|NCT00812929|100633866|FG000|NOT COMPLETED|Washout Period 4 (7 Days)||0||
48126750|NCT00812929|100633867|FG001|NOT COMPLETED|Washout Period 4 (7 Days)||0||
48126751|NCT00812929|100633868|FG002|NOT COMPLETED|Washout Period 4 (7 Days)||0||
48126752|NCT00812929|100633869|FG003|NOT COMPLETED|Washout Period 4 (7 Days)||0||
48126753|NCT00812929|100633870|FG004|NOT COMPLETED|Washout Period 4 (7 Days)||0||
48282980|NCT05007080|101017061|FG004|Vaccinated|Overall Study||49||
48572267|NCT00653133|101734990|FG000|COMPLETED|Overall Study||1324||
48572268|NCT00653133|101734991|FG001|COMPLETED|Overall Study||497||
48572269|NCT00653133|101734990|FG000|NOT COMPLETED|Overall Study||0||
48282981|NCT05007080|101017062|FG005|Vaccinated|Overall Study||49||
48282982|NCT05007080|101017057|FG000|COMPLETED|Overall Study||49||
48572270|NCT00653133|101734991|FG001|NOT COMPLETED|Overall Study||0||
48572271|NCT04411810|101734992|FG000|STARTED|Overall Study||149||378
48126754|NCT00812929|100633871|FG005|NOT COMPLETED|Washout Period 4 (7 Days)||0||
48126755|NCT00812929|100633872|FG006|NOT COMPLETED|Washout Period 4 (7 Days)||0||
48572272|NCT04411810|101734992|FG000|Participants Completed Telemedicine Evaluation Visit|Overall Study||148||377
48572273|NCT04411810|101734992|FG000|Participants Completed In-Person Evaluation Visit|Overall Study||148||377
48572274|NCT04411810|101734992|FG000|COMPLETED|Overall Study||147||375
48572275|NCT04411810|101734992|FG000|NOT COMPLETED|Overall Study||2||3
48126756|NCT00812929|100633873|FG007|NOT COMPLETED|Washout Period 4 (7 Days)||0||
48572276|NCT03777436|101734993|FG000|STARTED|Placebo-controlled Phase||146||
48572277|NCT03777436|101734994|FG001|STARTED|Placebo-controlled Phase||143||
48572278|NCT03777436|101734995|FG002|STARTED|Placebo-controlled Phase||0||
48572279|NCT03777436|101734993|FG000|Took at Least 1 Dose of Investigational Product (IP)|Placebo-controlled Phase||145||
48572280|NCT03777436|101734994|FG001|Took at Least 1 Dose of Investigational Product (IP)|Placebo-controlled Phase||143||
48572281|NCT03777436|101734995|FG002|Took at Least 1 Dose of Investigational Product (IP)|Placebo-controlled Phase||0||
48572282|NCT03777436|101734993|FG000|COMPLETED|Placebo-controlled Phase||111||
48572283|NCT03777436|101734994|FG001|COMPLETED|Placebo-controlled Phase||119||
48572284|NCT03777436|101734995|FG002|COMPLETED|Placebo-controlled Phase||0||
48572285|NCT03777436|101734993|FG000|NOT COMPLETED|Placebo-controlled Phase||35||
48572286|NCT03777436|101734994|FG001|NOT COMPLETED|Placebo-controlled Phase||24||
48572287|NCT03777436|101734995|FG002|NOT COMPLETED|Placebo-controlled Phase||0||
48572288|NCT03777436|101734993|FG000|STARTED|Apremilast Extension Phase||0||
48572289|NCT03777436|101734994|FG001|STARTED|Apremilast Extension Phase||0||
48572290|NCT03777436|101734995|FG002|STARTED|Apremilast Extension Phase||229||
48572291|NCT03777436|101734993|FG000|Took at Least 1 Dose of IP|Apremilast Extension Phase||0||
48572292|NCT03777436|101734994|FG001|Took at Least 1 Dose of IP|Apremilast Extension Phase||0||
48572293|NCT03777436|101734995|FG002|Took at Least 1 Dose of IP|Apremilast Extension Phase||228||
48572294|NCT03777436|101734993|FG000|COMPLETED|Apremilast Extension Phase||0||
48572295|NCT03777436|101734994|FG001|COMPLETED|Apremilast Extension Phase||0||
48572296|NCT03777436|101734995|FG002|COMPLETED|Apremilast Extension Phase||201||
48572297|NCT03777436|101734993|FG000|NOT COMPLETED|Apremilast Extension Phase||0||
48572298|NCT03777436|101734994|FG001|NOT COMPLETED|Apremilast Extension Phase||0||
48572299|NCT03777436|101734995|FG002|NOT COMPLETED|Apremilast Extension Phase||28||
48572300|NCT02347774|101734996|FG000|STARTED|Study Participation||214||
48572301|NCT02347774|101734997|FG001|STARTED|Study Participation||214||
48572302|NCT02347774|101734998|FG002|STARTED|Study Participation||213||
48572303|NCT02347774|101734996|FG000|COMPLETED|Study Participation||199||
48572304|NCT02347774|101734997|FG001|COMPLETED|Study Participation||193||
48572305|NCT02347774|101734998|FG002|COMPLETED|Study Participation||188||
48572306|NCT02347774|101734996|FG000|NOT COMPLETED|Study Participation||15||
48572307|NCT02347774|101734997|FG001|NOT COMPLETED|Study Participation||21||
48572308|NCT02347774|101734998|FG002|NOT COMPLETED|Study Participation||25||
48572309|NCT02347774|101734996|FG000|STARTED|On Study Treatment||214||
48572310|NCT02347774|101734997|FG001|STARTED|On Study Treatment||214||
48572311|NCT02347774|101734998|FG002|STARTED|On Study Treatment||213||
48572312|NCT02347774|101734996|FG000|COMPLETED|On Study Treatment||190||
48572313|NCT02347774|101734997|FG001|COMPLETED|On Study Treatment||183||
48572314|NCT02347774|101734998|FG002|COMPLETED|On Study Treatment||177||
48572315|NCT02347774|101734996|FG000|NOT COMPLETED|On Study Treatment||24||
48572316|NCT02347774|101734997|FG001|NOT COMPLETED|On Study Treatment||31||
48572317|NCT02347774|101734998|FG002|NOT COMPLETED|On Study Treatment||36||
48572318|NCT00862823|101734999|FG000|STARTED|First Intervention||6||
48572319|NCT00862823|101735000|FG001|STARTED|First Intervention||10||
48572320|NCT00862823|101734999|FG000|COMPLETED|First Intervention||5||
48572321|NCT00862823|101735000|FG001|COMPLETED|First Intervention||9||
48572322|NCT00862823|101734999|FG000|NOT COMPLETED|First Intervention||1||
48572323|NCT00862823|101735000|FG001|NOT COMPLETED|First Intervention||1||
48572324|NCT00862823|101734999|FG000|STARTED|Washout Period of 2 Weeks||5||
48126757|NCT00812929|100633874|FG008|NOT COMPLETED|Washout Period 4 (7 Days)||0||
48126758|NCT00812929|100633875|FG009|NOT COMPLETED|Washout Period 4 (7 Days)||0||
48572325|NCT00862823|101735000|FG001|STARTED|Washout Period of 2 Weeks||9||
48572326|NCT00862823|101734999|FG000|COMPLETED|Washout Period of 2 Weeks||5||
48572327|NCT00862823|101735000|FG001|COMPLETED|Washout Period of 2 Weeks||9||
48572328|NCT00862823|101734999|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0||
48572329|NCT00862823|101735000|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0||
48572330|NCT00862823|101734999|FG000|STARTED|Second Intervention||5||
48572331|NCT00862823|101735000|FG001|STARTED|Second Intervention||9||
48572332|NCT00862823|101734999|FG000|COMPLETED|Second Intervention||5||
48572333|NCT00862823|101735000|FG001|COMPLETED|Second Intervention||9||
48572334|NCT00862823|101734999|FG000|NOT COMPLETED|Second Intervention||0||
48572335|NCT00862823|101735000|FG001|NOT COMPLETED|Second Intervention||0||
48572336|NCT01294696|101735001|FG000|STARTED|Overall Study||1261||
48572337|NCT01294696|101735001|FG000|COMPLETED|Overall Study||1187||
48572338|NCT01294696|101735001|FG000|NOT COMPLETED|Overall Study||74||
48126759|NCT00812929|100633866|FG000|STARTED|Treatment Period 5||5||
48126760|NCT00812929|100633867|FG001|STARTED|Treatment Period 5||4||
48572339|NCT02780713|101735002|FG000|STARTED|Period 1: Variant A (100mg)||14|Participants received AZD9496 in 5-sequential treatment periods.|
48572340|NCT02780713|101735003|FG001|STARTED|Period 1: Variant A (100mg)||0|Participants received AZD9496 in 5-sequential treatment periods.|
48572341|NCT02780713|101735004|FG002|STARTED|Period 1: Variant A (100mg)||0|Participants received AZD9496 in 5-sequential treatment periods.|
48572342|NCT02780713|101735005|FG003|STARTED|Period 1: Variant A (100mg)||0|Participants received AZD9496 in 5-sequential treatment periods.|
48572343|NCT02780713|101735006|FG004|STARTED|Period 1: Variant A (100mg)||0|Participants received AZD9496 in 5-sequential treatment periods.|
48572344|NCT02780713|101735002|FG000|COMPLETED|Period 1: Variant A (100mg)||14|12 participants received and completed treatment and 2 participants withdrew from the study|
48572345|NCT02780713|101735003|FG001|COMPLETED|Period 1: Variant A (100mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
48572346|NCT02780713|101735004|FG002|COMPLETED|Period 1: Variant A (100mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
48572347|NCT02780713|101735005|FG003|COMPLETED|Period 1: Variant A (100mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
48572348|NCT02780713|101735006|FG004|COMPLETED|Period 1: Variant A (100mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
48572349|NCT02780713|101735002|FG000|NOT COMPLETED|Period 1: Variant A (100mg)||0||
48572350|NCT02780713|101735003|FG001|NOT COMPLETED|Period 1: Variant A (100mg)||0||
48572351|NCT02780713|101735004|FG002|NOT COMPLETED|Period 1: Variant A (100mg)||0||
48572352|NCT02780713|101735005|FG003|NOT COMPLETED|Period 1: Variant A (100mg)||0||
48572353|NCT02780713|101735006|FG004|NOT COMPLETED|Period 1: Variant A (100mg)||0||
48126761|NCT00812929|100633868|FG002|STARTED|Treatment Period 5||4||
48126762|NCT00812929|100633869|FG003|STARTED|Treatment Period 5||4||
48126763|NCT00812929|100633870|FG004|STARTED|Treatment Period 5||5||
48126764|NCT00812929|100633871|FG005|STARTED|Treatment Period 5||4||
48126765|NCT00812929|100633872|FG006|STARTED|Treatment Period 5||5||
48126766|NCT00812929|100633873|FG007|STARTED|Treatment Period 5||5||
48126767|NCT00812929|100633874|FG008|STARTED|Treatment Period 5||4||
48126768|NCT00812929|100633875|FG009|STARTED|Treatment Period 5||4||
48126769|NCT00812929|100633866|FG000|COMPLETED|Treatment Period 5||5||
48126770|NCT00812929|100633867|FG001|COMPLETED|Treatment Period 5||4||
48126771|NCT00812929|100633868|FG002|COMPLETED|Treatment Period 5||4||
48126772|NCT00812929|100633869|FG003|COMPLETED|Treatment Period 5||4||
48126773|NCT00812929|100633870|FG004|COMPLETED|Treatment Period 5||5||
48126774|NCT00812929|100633871|FG005|COMPLETED|Treatment Period 5||4||
48126775|NCT00812929|100633872|FG006|COMPLETED|Treatment Period 5||5||
48126776|NCT00812929|100633873|FG007|COMPLETED|Treatment Period 5||5||
48126777|NCT00812929|100633874|FG008|COMPLETED|Treatment Period 5||4||
48126778|NCT00812929|100633875|FG009|COMPLETED|Treatment Period 5||4||
48126779|NCT00812929|100633866|FG000|NOT COMPLETED|Treatment Period 5||0||
48126780|NCT00812929|100633867|FG001|NOT COMPLETED|Treatment Period 5||0||
48126781|NCT00812929|100633868|FG002|NOT COMPLETED|Treatment Period 5||0||
48126782|NCT00812929|100633869|FG003|NOT COMPLETED|Treatment Period 5||0||
48126783|NCT00812929|100633870|FG004|NOT COMPLETED|Treatment Period 5||0||
48126784|NCT00812929|100633871|FG005|NOT COMPLETED|Treatment Period 5||0||
48126785|NCT00812929|100633872|FG006|NOT COMPLETED|Treatment Period 5||0||
48126786|NCT00812929|100633873|FG007|NOT COMPLETED|Treatment Period 5||0||
48126787|NCT00812929|100633874|FG008|NOT COMPLETED|Treatment Period 5||0||
48126788|NCT00812929|100633875|FG009|NOT COMPLETED|Treatment Period 5||0||
48572354|NCT02780713|101735002|FG000|STARTED|Period 2: Reference (100mg)||0||
48572355|NCT02780713|101735003|FG001|STARTED|Period 2: Reference (100mg)||14||
48572356|NCT02780713|101735004|FG002|STARTED|Period 2: Reference (100mg)||0||
48572357|NCT02780713|101735005|FG003|STARTED|Period 2: Reference (100mg)||0||
48572358|NCT02780713|101735006|FG004|STARTED|Period 2: Reference (100mg)||0||
48572359|NCT02780713|101735002|FG000|COMPLETED|Period 2: Reference (100mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
48572360|NCT02780713|101735003|FG001|COMPLETED|Period 2: Reference (100mg)||14|12 participants received and completed treatment and 2 participants withdrew from the study|
48572361|NCT02780713|101735004|FG002|COMPLETED|Period 2: Reference (100mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
48592805|NCT01764997|101783182|FG000|STARTED|Study Drug Treatment Period||0||
48700805|NCT01457014|102054090|FG000|STARTED|Second Night||0||
48126789|NCT01856140|100633876|FG000|STARTED|Overall Study||6||
48126790|NCT01856140|100633877|FG001|STARTED|Overall Study||6||
48126791|NCT01856140|100633876|FG000|COMPLETED|Overall Study||6||
48126792|NCT01856140|100633877|FG001|COMPLETED|Overall Study||6||
48126793|NCT01856140|100633876|FG000|NOT COMPLETED|Overall Study||0||
48126794|NCT01856140|100633877|FG001|NOT COMPLETED|Overall Study||0||
48126795|NCT01438411|100633878|FG000|STARTED|Overall Study||53||
48126796|NCT01438411|100633878|FG000|COMPLETED|Overall Study||40||
48126797|NCT01438411|100633878|FG000|NOT COMPLETED|Overall Study||13||
48126798|NCT02086591|100633879|FG000|STARTED|Overall Study||7||
48126799|NCT02086591|100633879|FG000|COMPLETED|Overall Study||2||
48126800|NCT02086591|100633879|FG000|NOT COMPLETED|Overall Study||5||
48126801|NCT00113516|100633880|FG000|STARTED|Part 1||84||
48126802|NCT00113516|100633881|FG001|STARTED|Part 1||0||
48126803|NCT00113516|100633880|FG000|COMPLETED|Part 1||0||
48126804|NCT00113516|100633881|FG001|COMPLETED|Part 1||0||
48126805|NCT00113516|100633880|FG000|NOT COMPLETED|Part 1||84||
48126806|NCT00113516|100633881|FG001|NOT COMPLETED|Part 1||0||
48126807|NCT00113516|100633880|FG000|STARTED|Part 2||0||
48126808|NCT00113516|100633881|FG001|STARTED|Part 2||66||
48126809|NCT00113516|100633880|FG000|COMPLETED|Part 2||0||
48126810|NCT00113516|100633881|FG001|COMPLETED|Part 2||0||
48126811|NCT00113516|100633880|FG000|NOT COMPLETED|Part 2||0||
48126812|NCT00113516|100633881|FG001|NOT COMPLETED|Part 2||66||
48126813|NCT01962974|100633882|FG000|STARTED|Overall Study||7||
48126814|NCT01962974|100633882|FG000|COMPLETED|Overall Study||0||
48126815|NCT01962974|100633882|FG000|NOT COMPLETED|Overall Study||7||
48126816|NCT02120924|100633883|FG000|STARTED|Overall Study||404||
48126817|NCT02120924|100633884|FG001|STARTED|Overall Study||403||
48126818|NCT02120924|100633885|FG002|STARTED|Overall Study||202||
48126819|NCT02120924|100633883|FG000|COMPLETED|Overall Study||362||
48126820|NCT02120924|100633884|FG001|COMPLETED|Overall Study||357||
48126821|NCT02120924|100633885|FG002|COMPLETED|Overall Study||173||
48126822|NCT02120924|100633883|FG000|NOT COMPLETED|Overall Study||42||
48126823|NCT02120924|100633884|FG001|NOT COMPLETED|Overall Study||46||
48126824|NCT02120924|100633885|FG002|NOT COMPLETED|Overall Study||29||
48126825|NCT02464969|100633886|FG000|STARTED|Main Phase (Day 1 to Day 84)||155||
48126826|NCT02464969|100633887|FG001|STARTED|Main Phase (Day 1 to Day 84)||74||
48126827|NCT02464969|100633886|FG000|COMPLETED|Main Phase (Day 1 to Day 84)||138||
48700806|NCT01457014|102054091|FG001|STARTED|Second Night||12||
48700807|NCT01457014|102054092|FG002|STARTED|Second Night||11||
48700808|NCT01457014|102054093|FG003|STARTED|Second Night||11||
48700809|NCT01457014|102054090|FG000|COMPLETED|Second Night||0||
48126828|NCT02464969|100633887|FG001|COMPLETED|Main Phase (Day 1 to Day 84)||65||
48126829|NCT02464969|100633886|FG000|NOT COMPLETED|Main Phase (Day 1 to Day 84)||17||
48126830|NCT02464969|100633887|FG001|NOT COMPLETED|Main Phase (Day 1 to Day 84)||9||
48126831|NCT02464969|100633886|FG000|STARTED|Extension Phase (Day 85 to Day 168)||53||
48126832|NCT02464969|100633887|FG001|STARTED|Extension Phase (Day 85 to Day 168)||0||
48126833|NCT02464969|100633886|FG000|COMPLETED|Extension Phase (Day 85 to Day 168)||50||
48126834|NCT02464969|100633887|FG001|COMPLETED|Extension Phase (Day 85 to Day 168)||0||
48126835|NCT02464969|100633886|FG000|NOT COMPLETED|Extension Phase (Day 85 to Day 168)||3||
48126836|NCT02464969|100633887|FG001|NOT COMPLETED|Extension Phase (Day 85 to Day 168)||0||
48126837|NCT00614939|100633888|FG000|STARTED|Overall Study||85||
48126838|NCT00614939|100633889|FG001|STARTED|Overall Study||85||
48126839|NCT00614939|100633888|FG000|COMPLETED|Overall Study||50||
48126840|NCT00614939|100633889|FG001|COMPLETED|Overall Study||42||
48126841|NCT00614939|100633888|FG000|NOT COMPLETED|Overall Study||35||
48126842|NCT00614939|100633889|FG001|NOT COMPLETED|Overall Study||43||
48126843|NCT03394924|100633890|FG000|STARTED|Overall Study||31||
48126844|NCT03394924|100633891|FG001|STARTED|Overall Study||28||
48126845|NCT03394924|100633892|FG002|STARTED|Overall Study||9||
48126846|NCT03394924|100633890|FG000|COMPLETED|Overall Study||28||
48126847|NCT03394924|100633891|FG001|COMPLETED|Overall Study||22||
48126848|NCT03394924|100633892|FG002|COMPLETED|Overall Study||9||
48126849|NCT03394924|100633890|FG000|NOT COMPLETED|Overall Study||3||
48126850|NCT03394924|100633891|FG001|NOT COMPLETED|Overall Study||6||
48126851|NCT03394924|100633892|FG002|NOT COMPLETED|Overall Study||0||
48126852|NCT00779246|100633893|FG000|STARTED|Overall Study||750||
48126853|NCT00779246|100633894|FG001|STARTED|Overall Study||768||
48126854|NCT00779246|100633893|FG000|COMPLETED|Overall Study||717||
48126855|NCT00779246|100633894|FG001|COMPLETED|Overall Study||715||
48126856|NCT00779246|100633893|FG000|NOT COMPLETED|Overall Study||33||
48126857|NCT00779246|100633894|FG001|NOT COMPLETED|Overall Study||53||
48126858|NCT01038921|100633895|FG000|STARTED|Overall Study||19||
48126859|NCT01038921|100633896|FG001|STARTED|Overall Study||20||
48126860|NCT01038921|100633895|FG000|COMPLETED|Overall Study||17||
48126861|NCT01038921|100633896|FG001|COMPLETED|Overall Study||20||
48126862|NCT01038921|100633895|FG000|NOT COMPLETED|Overall Study||2||
48126863|NCT01038921|100633896|FG001|NOT COMPLETED|Overall Study||0||
48126864|NCT01379963|100633897|FG000|STARTED|Overall Study||780||
48126865|NCT01379963|100633897|FG000|COMPLETED|Overall Study||780||
48700810|NCT01457014|102054091|FG001|COMPLETED|Second Night||12||
48126866|NCT01379963|100633897|FG000|NOT COMPLETED|Overall Study||0||
48126867|NCT03221257|100633898|FG000|STARTED|Overall Study||24||
48700811|NCT01457014|102054092|FG002|COMPLETED|Second Night||11||
48126868|NCT03221257|100633899|FG001|STARTED|Overall Study||27||
48126869|NCT03221257|100633898|FG000|COMPLETED|Overall Study||23||
48282983|NCT05007080|101017058|FG001|COMPLETED|Overall Study||46||
48282984|NCT05007080|101017059|FG002|COMPLETED|Overall Study||50||
48700812|NCT01457014|102054093|FG003|COMPLETED|Second Night||11||
48126870|NCT03221257|100633899|FG001|COMPLETED|Overall Study||25||
48126871|NCT03221257|100633898|FG000|NOT COMPLETED|Overall Study||1||
48126872|NCT03221257|100633899|FG001|NOT COMPLETED|Overall Study||2||
48126873|NCT01923181|100633900|FG000|STARTED|Overall Study||70||
48126874|NCT01923181|100633901|FG001|STARTED|Overall Study||70||
48126875|NCT01923181|100633902|FG002|STARTED|Overall Study||69||
48126876|NCT01923181|100633903|FG003|STARTED|Overall Study||70||
48126877|NCT01923181|100633904|FG004|STARTED|Overall Study||71||
48126878|NCT01923181|100633905|FG005|STARTED|Overall Study||70||
48126879|NCT01923181|100633906|FG006|STARTED|Overall Study||70||
48126880|NCT01923181|100633907|FG007|STARTED|Overall Study||69||
48126881|NCT01923181|100633908|FG008|STARTED|Overall Study||71||
48126882|NCT01923181|100633900|FG000|Full Analysis Set (FAS)|Overall Study||70||
48282985|NCT05007080|101017060|FG003|COMPLETED|Overall Study||45||
48282986|NCT05007080|101017061|FG004|COMPLETED|Overall Study||47||
48700813|NCT01457014|102054090|FG000|NOT COMPLETED|Second Night||0||
48700814|NCT01457014|102054091|FG001|NOT COMPLETED|Second Night||0||
48700815|NCT01457014|102054092|FG002|NOT COMPLETED|Second Night||0||
48700816|NCT01457014|102054093|FG003|NOT COMPLETED|Second Night||0||
48700817|NCT01457014|102054090|FG000|STARTED|Third Night||0||
48126883|NCT01923181|100633901|FG001|Full Analysis Set (FAS)|Overall Study||70||
48126884|NCT01923181|100633902|FG002|Full Analysis Set (FAS)|Overall Study||69||
48126885|NCT01923181|100633903|FG003|Full Analysis Set (FAS)|Overall Study||70||
48126886|NCT01923181|100633904|FG004|Full Analysis Set (FAS)|Overall Study||71||
48126887|NCT01923181|100633905|FG005|Full Analysis Set (FAS)|Overall Study||70||
48126888|NCT01923181|100633906|FG006|Full Analysis Set (FAS)|Overall Study||70||
48126889|NCT01923181|100633907|FG007|Full Analysis Set (FAS)|Overall Study||69||
48126890|NCT01923181|100633908|FG008|Full Analysis Set (FAS)|Overall Study||71||
48126891|NCT01923181|100633900|FG000|Safety Analysis Set (SAS)|Overall Study||70||
48126892|NCT01923181|100633901|FG001|Safety Analysis Set (SAS)|Overall Study||70||
48126893|NCT01923181|100633902|FG002|Safety Analysis Set (SAS)|Overall Study||69||
48126894|NCT01923181|100633903|FG003|Safety Analysis Set (SAS)|Overall Study||70||
48126895|NCT01923181|100633904|FG004|Safety Analysis Set (SAS)|Overall Study||71||
48126896|NCT01923181|100633905|FG005|Safety Analysis Set (SAS)|Overall Study||70||
48126897|NCT01923181|100633906|FG006|Safety Analysis Set (SAS)|Overall Study||70||
48126898|NCT01923181|100633907|FG007|Safety Analysis Set (SAS)|Overall Study||69||
48126899|NCT01923181|100633908|FG008|Safety Analysis Set (SAS)|Overall Study||71||
48126900|NCT01923181|100633900|FG000|COMPLETED|Overall Study||67||
48126901|NCT01923181|100633901|FG001|COMPLETED|Overall Study||64||
48126902|NCT01923181|100633902|FG002|COMPLETED|Overall Study||67||
48126903|NCT01923181|100633903|FG003|COMPLETED|Overall Study||65||
48126904|NCT01923181|100633904|FG004|COMPLETED|Overall Study||63||
48126905|NCT01923181|100633905|FG005|COMPLETED|Overall Study||66||
48126906|NCT01923181|100633906|FG006|COMPLETED|Overall Study||62||
48126907|NCT01923181|100633907|FG007|COMPLETED|Overall Study||61||
48126908|NCT01923181|100633908|FG008|COMPLETED|Overall Study||68||
48126909|NCT01923181|100633900|FG000|NOT COMPLETED|Overall Study||3||
48126910|NCT01923181|100633901|FG001|NOT COMPLETED|Overall Study||6||
48126911|NCT01923181|100633902|FG002|NOT COMPLETED|Overall Study||2||
48126912|NCT01923181|100633903|FG003|NOT COMPLETED|Overall Study||5||
48126913|NCT01923181|100633904|FG004|NOT COMPLETED|Overall Study||8||
48126914|NCT01923181|100633905|FG005|NOT COMPLETED|Overall Study||4||
48126915|NCT01923181|100633906|FG006|NOT COMPLETED|Overall Study||8||
48126916|NCT01923181|100633907|FG007|NOT COMPLETED|Overall Study||8||
48126917|NCT01923181|100633908|FG008|NOT COMPLETED|Overall Study||3||
48126918|NCT01324024|100633909|FG000|STARTED|First Intervention (4 Weeks)||18||
48126919|NCT01324024|100633910|FG001|STARTED|First Intervention (4 Weeks)||17||
48126920|NCT01324024|100633909|FG000|COMPLETED|First Intervention (4 Weeks)||18||
48126921|NCT01324024|100633910|FG001|COMPLETED|First Intervention (4 Weeks)||17||
48126922|NCT01324024|100633909|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0||
48126923|NCT01324024|100633910|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0||
48126924|NCT01324024|100633909|FG000|STARTED|Washout (2 Weeks)||18||
48126925|NCT01324024|100633910|FG001|STARTED|Washout (2 Weeks)||17||
48126926|NCT01324024|100633909|FG000|COMPLETED|Washout (2 Weeks)||18||
48126927|NCT01324024|100633910|FG001|COMPLETED|Washout (2 Weeks)||17||
48126928|NCT01324024|100633909|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
48126929|NCT01324024|100633910|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
48126930|NCT01324024|100633909|FG000|STARTED|Second Intervention (4 Weeks)||18||
48126931|NCT01324024|100633910|FG001|STARTED|Second Intervention (4 Weeks)||17||
48126932|NCT01324024|100633909|FG000|COMPLETED|Second Intervention (4 Weeks)||16||
48282987|NCT05007080|101017062|FG005|COMPLETED|Overall Study||45||
48282988|NCT05007080|101017057|FG000|NOT COMPLETED|Overall Study||2||
48282989|NCT05007080|101017058|FG001|NOT COMPLETED|Overall Study||4||
48282990|NCT05007080|101017059|FG002|NOT COMPLETED|Overall Study||1||
48282991|NCT05007080|101017060|FG003|NOT COMPLETED|Overall Study||4||
48282992|NCT05007080|101017061|FG004|NOT COMPLETED|Overall Study||2||
48700818|NCT01457014|102054091|FG001|STARTED|Third Night||11||
48700819|NCT01457014|102054092|FG002|STARTED|Third Night||11||
48700820|NCT01457014|102054093|FG003|STARTED|Third Night||12||
48700821|NCT01457014|102054090|FG000|COMPLETED|Third Night||0||
48282993|NCT05007080|101017062|FG005|NOT COMPLETED|Overall Study||5||
48700822|NCT01457014|102054091|FG001|COMPLETED|Third Night||11||
48700823|NCT01457014|102054092|FG002|COMPLETED|Third Night||11||
48126933|NCT01324024|100633910|FG001|COMPLETED|Second Intervention (4 Weeks)||16||
48126934|NCT01324024|100633909|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||2||
48126935|NCT01324024|100633910|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1||
48126936|NCT00672477|100633911|FG000|STARTED|Overall Study||116||
48126937|NCT00672477|100633912|FG001|STARTED|Overall Study||114||
48126938|NCT00672477|100633911|FG000|COMPLETED|Overall Study||89||
48282994|NCT00703937|101017063|FG000|STARTED|Overall Study||343||
48700824|NCT01457014|102054093|FG003|COMPLETED|Third Night||12||
48700825|NCT01457014|102054090|FG000|NOT COMPLETED|Third Night||0||
48572362|NCT02780713|101735005|FG003|COMPLETED|Period 2: Reference (100mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
48572363|NCT02780713|101735006|FG004|COMPLETED|Period 2: Reference (100mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
48126939|NCT00672477|100633912|FG001|COMPLETED|Overall Study||88||
48126940|NCT00672477|100633911|FG000|NOT COMPLETED|Overall Study||27||
48126941|NCT00672477|100633912|FG001|NOT COMPLETED|Overall Study||26||
48126942|NCT00403546|100633913|FG000|STARTED|Signed Informed Consent/Open-Label||131||
48126943|NCT00403546|100633914|FG001|STARTED|Signed Informed Consent/Open-Label||0||
48126944|NCT00403546|100633915|FG002|STARTED|Signed Informed Consent/Open-Label||0||
48126945|NCT00403546|100633913|FG000|COMPLETED|Signed Informed Consent/Open-Label||103||
48126946|NCT00403546|100633914|FG001|COMPLETED|Signed Informed Consent/Open-Label||0||
48126947|NCT00403546|100633915|FG002|COMPLETED|Signed Informed Consent/Open-Label||0||
48126948|NCT00403546|100633913|FG000|NOT COMPLETED|Signed Informed Consent/Open-Label||28||
48126949|NCT00403546|100633914|FG001|NOT COMPLETED|Signed Informed Consent/Open-Label||0||
48126950|NCT00403546|100633915|FG002|NOT COMPLETED|Signed Informed Consent/Open-Label||0||
48126951|NCT00403546|100633913|FG000|STARTED|Screening Phase||103||
48126952|NCT00403546|100633914|FG001|STARTED|Screening Phase||0||
48126953|NCT00403546|100633915|FG002|STARTED|Screening Phase||0||
48126954|NCT00403546|100633913|FG000|COMPLETED|Screening Phase||75||
48126955|NCT00403546|100633914|FG001|COMPLETED|Screening Phase||0||
48126956|NCT00403546|100633915|FG002|COMPLETED|Screening Phase||0||
48126957|NCT00403546|100633913|FG000|NOT COMPLETED|Screening Phase||28||
48126958|NCT00403546|100633914|FG001|NOT COMPLETED|Screening Phase||0||
48126959|NCT00403546|100633915|FG002|NOT COMPLETED|Screening Phase||0||
48126960|NCT00403546|100633913|FG000|STARTED|Randomized Trial||0||
48126961|NCT00403546|100633914|FG001|STARTED|Randomized Trial||38||
48397623|NCT00927758|101302667|FG000|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4||
48397624|NCT00927758|101302668|FG001|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4||
48397625|NCT00927758|101302669|FG002|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4||
48397626|NCT00927758|101302670|FG003|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||2||
48572364|NCT02780713|101735002|FG000|NOT COMPLETED|Period 2: Reference (100mg)||0||
48126962|NCT00403546|100633915|FG002|STARTED|Randomized Trial||37||
48126963|NCT00403546|100633913|FG000|COMPLETED|Randomized Trial||0||
48126964|NCT00403546|100633914|FG001|COMPLETED|Randomized Trial||21||
48126965|NCT00403546|100633915|FG002|COMPLETED|Randomized Trial||21||
48126966|NCT00403546|100633913|FG000|NOT COMPLETED|Randomized Trial||0||
48126967|NCT00403546|100633914|FG001|NOT COMPLETED|Randomized Trial||17||
48126968|NCT00403546|100633915|FG002|NOT COMPLETED|Randomized Trial||16||
48126969|NCT00097591|100633916|FG000|STARTED|Overall Study||6813||
48126970|NCT00097591|100633917|FG001|STARTED|Overall Study||6795||
48397627|NCT00927758|101302671|FG004|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3||
48397628|NCT00927758|101302672|FG005|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3||
48397629|NCT00927758|101302667|FG000|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4||
48397630|NCT00927758|101302668|FG001|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4||
48397631|NCT00927758|101302669|FG002|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3||
48397632|NCT00927758|101302670|FG003|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||1||
48397633|NCT00927758|101302671|FG004|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3||
48700826|NCT01457014|102054091|FG001|NOT COMPLETED|Third Night||0||
48126971|NCT00097591|100633916|FG000|COMPLETED|Overall Study||6403||
48126972|NCT00097591|100633917|FG001|COMPLETED|Overall Study||6401||
48126973|NCT00097591|100633916|FG000|NOT COMPLETED|Overall Study||410||
48126974|NCT00097591|100633917|FG001|NOT COMPLETED|Overall Study||394||
48126975|NCT03226652|100633918|FG000|STARTED|Overall Study||101||
48126976|NCT03226652|100633918|FG000|COMPLETED|Overall Study||101||
48126977|NCT03226652|100633918|FG000|NOT COMPLETED|Overall Study||0||
48126978|NCT02170727|100633919|FG000|STARTED|Overall Study||138||
48126979|NCT02170727|100633920|FG001|STARTED|Overall Study||31||
48126980|NCT02170727|100633919|FG000|COMPLETED|Overall Study||135||
48126981|NCT02170727|100633920|FG001|COMPLETED|Overall Study||31||
48126982|NCT02170727|100633919|FG000|NOT COMPLETED|Overall Study||3||
48126983|NCT02170727|100633920|FG001|NOT COMPLETED|Overall Study||0||
48126984|NCT02710630|100633921|FG000|STARTED|Period 1||7||
48126985|NCT02710630|100633922|FG001|STARTED|Period 1||7||
48126986|NCT02710630|100633923|FG002|STARTED|Period 1||7||
48126987|NCT02710630|100633924|FG003|STARTED|Period 1||7||
48126988|NCT02710630|100633925|FG004|STARTED|Period 1||7||
48126989|NCT02710630|100633921|FG000|COMPLETED|Period 1||7||
48126990|NCT02710630|100633922|FG001|COMPLETED|Period 1||7||
48126991|NCT02710630|100633923|FG002|COMPLETED|Period 1||7||
48126992|NCT02710630|100633924|FG003|COMPLETED|Period 1||7||
48126993|NCT02710630|100633925|FG004|COMPLETED|Period 1||7||
48126994|NCT02710630|100633921|FG000|NOT COMPLETED|Period 1||0||
48126995|NCT02710630|100633922|FG001|NOT COMPLETED|Period 1||0||
48126996|NCT02710630|100633923|FG002|NOT COMPLETED|Period 1||0||
48126997|NCT02710630|100633924|FG003|NOT COMPLETED|Period 1||0||
48126998|NCT02710630|100633925|FG004|NOT COMPLETED|Period 1||0||
48126999|NCT02710630|100633921|FG000|STARTED|Period 2||7||
48127000|NCT02710630|100633922|FG001|STARTED|Period 2||7||
48127001|NCT02710630|100633923|FG002|STARTED|Period 2||7||
48127002|NCT02710630|100633924|FG003|STARTED|Period 2||7||
48127003|NCT02710630|100633925|FG004|STARTED|Period 2||7||
48127004|NCT02710630|100633921|FG000|Not Treated|Period 2||1||
48127005|NCT02710630|100633922|FG001|Not Treated|Period 2||0||
48127006|NCT02710630|100633923|FG002|Not Treated|Period 2||0||
48127007|NCT02710630|100633924|FG003|Not Treated|Period 2||0||
48127008|NCT02710630|100633925|FG004|Not Treated|Period 2||0||
48127009|NCT02710630|100633921|FG000|COMPLETED|Period 2||7||
48127010|NCT02710630|100633922|FG001|COMPLETED|Period 2||7||
48127011|NCT02710630|100633923|FG002|COMPLETED|Period 2||7||
48127012|NCT02710630|100633924|FG003|COMPLETED|Period 2||7||
48127013|NCT02710630|100633925|FG004|COMPLETED|Period 2||7||
48127014|NCT02710630|100633921|FG000|NOT COMPLETED|Period 2||0||
48127015|NCT02710630|100633922|FG001|NOT COMPLETED|Period 2||0||
48127016|NCT02710630|100633923|FG002|NOT COMPLETED|Period 2||0||
48127017|NCT02710630|100633924|FG003|NOT COMPLETED|Period 2||0||
48127018|NCT02710630|100633925|FG004|NOT COMPLETED|Period 2||0||
48127019|NCT02710630|100633921|FG000|STARTED|Period 3||7||
48127020|NCT02710630|100633922|FG001|STARTED|Period 3||7||
48127021|NCT02710630|100633923|FG002|STARTED|Period 3||7||
48127022|NCT02710630|100633924|FG003|STARTED|Period 3||7||
48127023|NCT02710630|100633925|FG004|STARTED|Period 3||7||
48127024|NCT02710630|100633921|FG000|COMPLETED|Period 3||7||
48127025|NCT02710630|100633922|FG001|COMPLETED|Period 3||7||
48127026|NCT02710630|100633923|FG002|COMPLETED|Period 3||7||
48127027|NCT02710630|100633924|FG003|COMPLETED|Period 3||7||
48127028|NCT02710630|100633925|FG004|COMPLETED|Period 3||7||
48127029|NCT02710630|100633921|FG000|NOT COMPLETED|Period 3||0||
48127030|NCT02710630|100633922|FG001|NOT COMPLETED|Period 3||0||
48127031|NCT02710630|100633923|FG002|NOT COMPLETED|Period 3||0||
48127032|NCT02710630|100633924|FG003|NOT COMPLETED|Period 3||0||
48127033|NCT02710630|100633925|FG004|NOT COMPLETED|Period 3||0||
48127034|NCT02710630|100633921|FG000|STARTED|Period 4||7||
48127035|NCT02710630|100633922|FG001|STARTED|Period 4||7||
48127036|NCT02710630|100633923|FG002|STARTED|Period 4||7||
48127037|NCT02710630|100633924|FG003|STARTED|Period 4||7||
48127038|NCT02710630|100633925|FG004|STARTED|Period 4||7||
48127039|NCT02710630|100633921|FG000|COMPLETED|Period 4||7||
48127040|NCT02710630|100633922|FG001|COMPLETED|Period 4||7||
48127041|NCT02710630|100633923|FG002|COMPLETED|Period 4||7||
48700827|NCT01457014|102054092|FG002|NOT COMPLETED|Third Night||0||
48700828|NCT01457014|102054093|FG003|NOT COMPLETED|Third Night||0||
48700829|NCT01457014|102054090|FG000|STARTED|Fourth Night||0||
48127042|NCT02710630|100633924|FG003|COMPLETED|Period 4||7||
48127043|NCT02710630|100633925|FG004|COMPLETED|Period 4||7||
48127044|NCT02710630|100633921|FG000|NOT COMPLETED|Period 4||0||
48127045|NCT02710630|100633922|FG001|NOT COMPLETED|Period 4||0||
48127046|NCT02710630|100633923|FG002|NOT COMPLETED|Period 4||0||
48127047|NCT02710630|100633924|FG003|NOT COMPLETED|Period 4||0||
48127048|NCT02710630|100633925|FG004|NOT COMPLETED|Period 4||0||
48127049|NCT02710630|100633921|FG000|STARTED|Period 5||7||
48127050|NCT02710630|100633922|FG001|STARTED|Period 5||7||
48127051|NCT02710630|100633923|FG002|STARTED|Period 5||7||
48127052|NCT02710630|100633924|FG003|STARTED|Period 5||7||
48127053|NCT02710630|100633925|FG004|STARTED|Period 5||7||
48127054|NCT02710630|100633921|FG000|COMPLETED|Period 5||7||
48127055|NCT02710630|100633922|FG001|COMPLETED|Period 5||7||
48127056|NCT02710630|100633923|FG002|COMPLETED|Period 5||7||
48127057|NCT02710630|100633924|FG003|COMPLETED|Period 5||7||
48127058|NCT02710630|100633925|FG004|COMPLETED|Period 5||7||
48127059|NCT02710630|100633921|FG000|NOT COMPLETED|Period 5||0||
48127060|NCT02710630|100633922|FG001|NOT COMPLETED|Period 5||0||
48127061|NCT02710630|100633923|FG002|NOT COMPLETED|Period 5||0||
48127062|NCT02710630|100633924|FG003|NOT COMPLETED|Period 5||0||
48127063|NCT02710630|100633925|FG004|NOT COMPLETED|Period 5||0||
48700830|NCT01457014|102054091|FG001|STARTED|Fourth Night||11||
48700831|NCT01457014|102054092|FG002|STARTED|Fourth Night||12||
48700832|NCT01457014|102054093|FG003|STARTED|Fourth Night||11||
48700833|NCT01457014|102054090|FG000|COMPLETED|Fourth Night||0||
48127064|NCT02710630|100633921|FG000|STARTED|Period 6||7||
48127065|NCT02710630|100633922|FG001|STARTED|Period 6||7||
48127066|NCT02710630|100633923|FG002|STARTED|Period 6||7||
48127067|NCT02710630|100633924|FG003|STARTED|Period 6||7||
48127068|NCT02710630|100633925|FG004|STARTED|Period 6||7||
48127069|NCT02710630|100633921|FG000|COMPLETED|Period 6||7||
48127070|NCT02710630|100633922|FG001|COMPLETED|Period 6||7||
48127071|NCT02710630|100633923|FG002|COMPLETED|Period 6||7||
48127072|NCT02710630|100633924|FG003|COMPLETED|Period 6||7||
48127073|NCT02710630|100633925|FG004|COMPLETED|Period 6||7||
48127074|NCT02710630|100633921|FG000|NOT COMPLETED|Period 6||0||
48700834|NCT01457014|102054091|FG001|COMPLETED|Fourth Night||11||
48127075|NCT02710630|100633922|FG001|NOT COMPLETED|Period 6||0||
48127076|NCT02710630|100633923|FG002|NOT COMPLETED|Period 6||0||
48127077|NCT02710630|100633924|FG003|NOT COMPLETED|Period 6||0||
48127078|NCT02710630|100633925|FG004|NOT COMPLETED|Period 6||0||
48127079|NCT01591681|100633926|FG000|STARTED|Overall Study||49||
48127080|NCT01591681|100633926|FG000|COMPLETED|Overall Study||45||
48127081|NCT01591681|100633926|FG000|NOT COMPLETED|Overall Study||4||
48127082|NCT01787604|100633927|FG000|STARTED|Overall Study||32||
48127083|NCT01787604|100633928|FG001|STARTED|Overall Study||32||
48127084|NCT01787604|100633927|FG000|COMPLETED|Overall Study||28||
48700835|NCT01457014|102054092|FG002|COMPLETED|Fourth Night||12||
48127085|NCT01787604|100633928|FG001|COMPLETED|Overall Study||28||
48127086|NCT01787604|100633927|FG000|NOT COMPLETED|Overall Study||4||
48127087|NCT01787604|100633928|FG001|NOT COMPLETED|Overall Study||4||
48127088|NCT02207829|100633929|FG000|STARTED|Overall Study||509||
48127089|NCT02207829|100633930|FG001|STARTED|Overall Study||508||
48127090|NCT02207829|100633929|FG000|COMPLETED|Overall Study||467||
48397634|NCT00927758|101302672|FG005|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||2||
48397635|NCT00927758|101302667|FG000|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4||
48397636|NCT00927758|101302668|FG001|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4||
48397637|NCT00927758|101302669|FG002|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3||
48397638|NCT00927758|101302670|FG003|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1||
48397639|NCT00927758|101302671|FG004|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3||
48127091|NCT02207829|100633930|FG001|COMPLETED|Overall Study||474||
48127092|NCT02207829|100633929|FG000|NOT COMPLETED|Overall Study||42||
48127093|NCT02207829|100633930|FG001|NOT COMPLETED|Overall Study||34||
48127094|NCT00466323|100633931|FG000|STARTED|Overall Study||117||
48127095|NCT00466323|100633932|FG001|STARTED|Overall Study||115||
48127096|NCT00466323|100633931|FG000|COMPLETED|Overall Study||89||
48127097|NCT00466323|100633932|FG001|COMPLETED|Overall Study||92||
48127098|NCT00466323|100633931|FG000|NOT COMPLETED|Overall Study||28||
48127099|NCT00466323|100633932|FG001|NOT COMPLETED|Overall Study||23||
48127100|NCT04523129|100633933|FG000|STARTED|Overall Study||423||
48127101|NCT04523129|100633934|FG001|STARTED|Overall Study||411||
48127102|NCT04523129|100633933|FG000|COMPLETED|Overall Study||415||
48127103|NCT04523129|100633934|FG001|COMPLETED|Overall Study||402||
48127104|NCT04523129|100633933|FG000|NOT COMPLETED|Overall Study||8||
48127105|NCT04523129|100633934|FG001|NOT COMPLETED|Overall Study||9||
48127106|NCT01714024|100633935|FG000|STARTED|Overall Study||13||
48127107|NCT01714024|100633936|FG001|STARTED|Overall Study||18||
48127108|NCT01714024|100633937|FG002|STARTED|Overall Study||11||
48127109|NCT01714024|100633935|FG000|COMPLETED|Overall Study||12||
48127110|NCT01714024|100633936|FG001|COMPLETED|Overall Study||12||
48127111|NCT01714024|100633937|FG002|COMPLETED|Overall Study||8||
48397640|NCT00927758|101302672|FG005|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||2||
48397641|NCT00927758|101302667|FG000|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0||
48397642|NCT00927758|101302668|FG001|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0||
48397643|NCT00927758|101302669|FG002|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1||
48397644|NCT00927758|101302670|FG003|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1||
48127112|NCT01714024|100633935|FG000|NOT COMPLETED|Overall Study||1||
48127113|NCT01714024|100633936|FG001|NOT COMPLETED|Overall Study||6||
48127114|NCT01714024|100633937|FG002|NOT COMPLETED|Overall Study||3||
48127115|NCT03231371|100633938|FG000|STARTED|Overall Study||22||
48127116|NCT03231371|100633938|FG000|Optional and Age Limited (12 Yrs+) MRI|Overall Study||9||
48127117|NCT03231371|100633938|FG000|COMPLETED|Overall Study||9||
48127118|NCT03231371|100633938|FG000|NOT COMPLETED|Overall Study||13||
48127119|NCT01794949|100633939|FG000|STARTED|Overall Study||7||
48127120|NCT01794949|100633940|FG001|STARTED|Overall Study||1||
48127121|NCT01794949|100633939|FG000|6 Month Follow-up|Overall Study||6||
48127122|NCT01794949|100633940|FG001|6 Month Follow-up|Overall Study||1||
48127123|NCT01794949|100633939|FG000|COMPLETED|Overall Study||6||
48127124|NCT01794949|100633940|FG001|COMPLETED|Overall Study||1||
48127125|NCT01794949|100633939|FG000|NOT COMPLETED|Overall Study||1||
48127126|NCT01794949|100633940|FG001|NOT COMPLETED|Overall Study||0||
48127127|NCT02647359|100633941|FG000|STARTED|Stage 1: Double-Masked Period (48 Weeks)||26||
48127128|NCT02647359|100633942|FG001|STARTED|Stage 1: Double-Masked Period (48 Weeks)||13||
48127129|NCT02647359|100633941|FG000|Received at Least 1 Dose of Study Drug|Stage 1: Double-Masked Period (48 Weeks)||26||
48127130|NCT02647359|100633942|FG001|Received at Least 1 Dose of Study Drug|Stage 1: Double-Masked Period (48 Weeks)||13||
48127131|NCT02647359|100633941|FG000|COMPLETED|Stage 1: Double-Masked Period (48 Weeks)||22||
48127132|NCT02647359|100633942|FG001|COMPLETED|Stage 1: Double-Masked Period (48 Weeks)||12||
48127133|NCT02647359|100633941|FG000|NOT COMPLETED|Stage 1: Double-Masked Period (48 Weeks)||4||
48397645|NCT00927758|101302671|FG004|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0||
48397646|NCT00927758|101302672|FG005|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1||
48397647|NCT00927758|101302667|FG000|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4||
48397648|NCT00927758|101302668|FG001|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4||
48397649|NCT00927758|101302669|FG002|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3||
48700836|NCT01457014|102054093|FG003|COMPLETED|Fourth Night||11||
48127134|NCT02647359|100633942|FG001|NOT COMPLETED|Stage 1: Double-Masked Period (48 Weeks)||1||
48127135|NCT02647359|100633941|FG000|STARTED|Stage 2: Open-Label Extension (96 Weeks)||22||
48127136|NCT02647359|100633942|FG001|STARTED|Stage 2: Open-Label Extension (96 Weeks)||11||
48127137|NCT02647359|100633941|FG000|COMPLETED|Stage 2: Open-Label Extension (96 Weeks)||12||
48127138|NCT02647359|100633942|FG001|COMPLETED|Stage 2: Open-Label Extension (96 Weeks)||7||
48127139|NCT02647359|100633941|FG000|NOT COMPLETED|Stage 2: Open-Label Extension (96 Weeks)||10||
48127140|NCT02647359|100633942|FG001|NOT COMPLETED|Stage 2: Open-Label Extension (96 Weeks)||4||
48127141|NCT02647359|100633941|FG000|STARTED|Open-Label Sub-Study (96 Weeks)||10||
48127142|NCT02647359|100633942|FG001|STARTED|Open-Label Sub-Study (96 Weeks)||7||
48127143|NCT02647359|100633941|FG000|COMPLETED|Open-Label Sub-Study (96 Weeks)||2||
48282995|NCT00703937|101017064|FG001|STARTED|Overall Study||360||
48282996|NCT00703937|101017063|FG000|COMPLETED|Overall Study||278||
48282997|NCT00703937|101017064|FG001|COMPLETED|Overall Study||267||
48282998|NCT00703937|101017063|FG000|NOT COMPLETED|Overall Study||65||
48282999|NCT00703937|101017064|FG001|NOT COMPLETED|Overall Study||93||
48283000|NCT01034176|101017065|FG000|STARTED|Overall Study||22||
48283001|NCT01034176|101017066|FG001|STARTED|Overall Study||21||
48283002|NCT01034176|101017065|FG000|COMPLETED|Overall Study||20||
48283003|NCT01034176|101017066|FG001|COMPLETED|Overall Study||19||
48283004|NCT01034176|101017065|FG000|NOT COMPLETED|Overall Study||2||
48283005|NCT01034176|101017066|FG001|NOT COMPLETED|Overall Study||2||
48283006|NCT00610740|101017067|FG000|STARTED|Overall Study||18||
48283007|NCT00610740|101017067|FG000|COMPLETED|Overall Study||18||
48283008|NCT00610740|101017067|FG000|NOT COMPLETED|Overall Study||0||
48283009|NCT00482690|101017068|FG000|STARTED|Overall Study||35||
48283010|NCT00482690|101017068|FG000|COMPLETED|Overall Study||17||
48283011|NCT00482690|101017068|FG000|NOT COMPLETED|Overall Study||18||
48283012|NCT00741390|101017069|FG000|STARTED|Visit 1||62||
48283013|NCT00741390|101017070|FG001|STARTED|Visit 1||63||
48283014|NCT00741390|101017071|FG002|STARTED|Visit 1||62||
48283015|NCT00741390|101017072|FG003|STARTED|Visit 1||63||
48283016|NCT00741390|101017069|FG000|COMPLETED|Visit 1||60||
48283017|NCT00741390|101017070|FG001|COMPLETED|Visit 1||63||
48397650|NCT00927758|101302670|FG003|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||1||
48397651|NCT00927758|101302671|FG004|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3||
48397652|NCT00927758|101302672|FG005|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||2||
48397653|NCT00927758|101302667|FG000|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4||
48397654|NCT00927758|101302668|FG001|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4||
48397655|NCT00927758|101302669|FG002|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3||
48397656|NCT00927758|101302670|FG003|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||1||
48397657|NCT00927758|101302671|FG004|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3||
48397658|NCT00927758|101302672|FG005|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||2||
48127144|NCT02647359|100633942|FG001|COMPLETED|Open-Label Sub-Study (96 Weeks)||3||
48127145|NCT02647359|100633941|FG000|NOT COMPLETED|Open-Label Sub-Study (96 Weeks)||8||
48127146|NCT02647359|100633942|FG001|NOT COMPLETED|Open-Label Sub-Study (96 Weeks)||4||
48127147|NCT01602315|100633943|FG000|STARTED|Overall Study||16||
48127148|NCT01602315|100633944|FG001|STARTED|Overall Study||5||
48127149|NCT01602315|100633945|FG002|STARTED|Overall Study||18||
48127150|NCT01602315|100633946|FG003|STARTED|Overall Study||6||
48127151|NCT01602315|100633947|FG004|STARTED|Overall Study||71||
48127152|NCT01602315|100633948|FG005|STARTED|Overall Study||35||
48127153|NCT01602315|100633949|FG006|STARTED|Overall Study||29||
48127154|NCT01602315|100633943|FG000|COMPLETED|Overall Study||0||
48127155|NCT01602315|100633944|FG001|COMPLETED|Overall Study||0||
48127156|NCT01602315|100633945|FG002|COMPLETED|Overall Study||0||
48127157|NCT01602315|100633946|FG003|COMPLETED|Overall Study||0||
48127158|NCT01602315|100633947|FG004|COMPLETED|Overall Study||0||
48127159|NCT01602315|100633948|FG005|COMPLETED|Overall Study||0||
48127160|NCT01602315|100633949|FG006|COMPLETED|Overall Study||0||
48127161|NCT01602315|100633943|FG000|NOT COMPLETED|Overall Study||16||
48127162|NCT01602315|100633944|FG001|NOT COMPLETED|Overall Study||5||
48127163|NCT01602315|100633945|FG002|NOT COMPLETED|Overall Study||18||
48127164|NCT01602315|100633946|FG003|NOT COMPLETED|Overall Study||6||
48283018|NCT00741390|101017071|FG002|COMPLETED|Visit 1||55||
48283019|NCT00741390|101017072|FG003|COMPLETED|Visit 1||62||
48283020|NCT00741390|101017069|FG000|NOT COMPLETED|Visit 1||2||
48283021|NCT00741390|101017070|FG001|NOT COMPLETED|Visit 1||0||
48283022|NCT00741390|101017071|FG002|NOT COMPLETED|Visit 1||7||
48283023|NCT00741390|101017072|FG003|NOT COMPLETED|Visit 1||1||
48283024|NCT00741390|101017069|FG000|STARTED|Visit 2||59||
48283025|NCT00741390|101017070|FG001|STARTED|Visit 2||61||
48283026|NCT00741390|101017071|FG002|STARTED|Visit 2||55||
48283027|NCT00741390|101017072|FG003|STARTED|Visit 2||61||
48283028|NCT00741390|101017069|FG000|COMPLETED|Visit 2||59||
48283029|NCT00741390|101017070|FG001|COMPLETED|Visit 2||61||
48283030|NCT00741390|101017071|FG002|COMPLETED|Visit 2||54||
48283031|NCT00741390|101017072|FG003|COMPLETED|Visit 2||60||
48283032|NCT00741390|101017069|FG000|NOT COMPLETED|Visit 2||0||
48283033|NCT00741390|101017070|FG001|NOT COMPLETED|Visit 2||0||
48397659|NCT00927758|101302667|FG000|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0||
48397660|NCT00927758|101302668|FG001|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0||
48397661|NCT00927758|101302669|FG002|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0||
48397662|NCT00927758|101302670|FG003|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0||
48397663|NCT00927758|101302671|FG004|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0||
48397664|NCT00927758|101302672|FG005|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0||
48127165|NCT01602315|100633947|FG004|NOT COMPLETED|Overall Study||71||
48127166|NCT01602315|100633948|FG005|NOT COMPLETED|Overall Study||35||
48283034|NCT00741390|101017071|FG002|NOT COMPLETED|Visit 2||1||
48283035|NCT00741390|101017072|FG003|NOT COMPLETED|Visit 2||1||
48283036|NCT00935818|101017073|FG000|STARTED|Overall Study||249||
48283037|NCT00935818|101017074|FG001|STARTED|Overall Study||257||
48283038|NCT00935818|101017073|FG000|End of Medication Phase|Overall Study||182||
48283039|NCT00935818|101017074|FG001|End of Medication Phase|Overall Study||184||
48283040|NCT00935818|101017073|FG000|COMPLETED|Overall Study||158||
48283041|NCT00935818|101017074|FG001|COMPLETED|Overall Study||157||
48283042|NCT00935818|101017073|FG000|NOT COMPLETED|Overall Study||91||
48283043|NCT00935818|101017074|FG001|NOT COMPLETED|Overall Study||100||
48283044|NCT01639560|101017075|FG000|STARTED|Overall Study||45||
48283045|NCT01639560|101017076|FG001|STARTED|Overall Study||48||
48283046|NCT01639560|101017075|FG000|End of Treatment|Overall Study||28||
48283047|NCT01639560|101017076|FG001|End of Treatment|Overall Study||20||
48283048|NCT01639560|101017075|FG000|COMPLETED|Overall Study||26||
48283049|NCT01639560|101017076|FG001|COMPLETED|Overall Study||19||
48283050|NCT01639560|101017075|FG000|NOT COMPLETED|Overall Study||19||
48283051|NCT01639560|101017076|FG001|NOT COMPLETED|Overall Study||29||
48283052|NCT00872989|101017077|FG000|STARTED|Overall Study||66||
48283053|NCT00872989|101017078|FG001|STARTED|Overall Study||63||
48283054|NCT00872989|101017077|FG000|COMPLETED|Overall Study||1||
48283055|NCT00872989|101017078|FG001|COMPLETED|Overall Study||0||
48283056|NCT00872989|101017077|FG000|NOT COMPLETED|Overall Study||65||
48283057|NCT00872989|101017078|FG001|NOT COMPLETED|Overall Study||63||
48283058|NCT04189952|101017079|FG000|STARTED|Treatment Period||2||
48397665|NCT05742841|101302673|FG000|STARTED|Overall Study||22||
48397666|NCT05742841|101302673|FG000|COMPLETED|Overall Study||20||
48397667|NCT05742841|101302673|FG000|NOT COMPLETED|Overall Study||2||
48397668|NCT02197897|101302674|FG000|STARTED|Overall Study||15||
48397669|NCT02197897|101302674|FG000|COMPLETED|Overall Study||14||
48397670|NCT02197897|101302674|FG000|NOT COMPLETED|Overall Study||1||
48283059|NCT04189952|101017079|FG000|COMPLETED|Treatment Period||2||
48283060|NCT04189952|101017079|FG000|NOT COMPLETED|Treatment Period||0||
48283061|NCT04189952|101017079|FG000|STARTED|Follow-up Period||2||
48283062|NCT04189952|101017079|FG000|COMPLETED|Follow-up Period||0||
48283063|NCT04189952|101017079|FG000|NOT COMPLETED|Follow-up Period||2||
48283064|NCT02577822|101017080|FG000|STARTED|Overall Study||27||
48283065|NCT02577822|101017081|FG001|STARTED|Overall Study||33||
48283066|NCT02577822|101017080|FG000|COMPLETED|Overall Study||21||
48283067|NCT02577822|101017081|FG001|COMPLETED|Overall Study||20||
48397671|NCT03725293|101302675|FG000|STARTED|Overall Study||106||
48397672|NCT03725293|101302676|FG001|STARTED|Overall Study||106||
48397673|NCT03725293|101302675|FG000|COMPLETED|Overall Study||94||
48283068|NCT02577822|101017080|FG000|NOT COMPLETED|Overall Study||6||
48283069|NCT02577822|101017081|FG001|NOT COMPLETED|Overall Study||13||
48283070|NCT03250234|101017082|FG000|STARTED|Overall Study||6||
48283071|NCT03250234|101017083|FG001|STARTED|Overall Study||6||
48283072|NCT03250234|101017082|FG000|COMPLETED|Overall Study||6||
48283073|NCT03250234|101017083|FG001|COMPLETED|Overall Study||6||
48283074|NCT03250234|101017082|FG000|NOT COMPLETED|Overall Study||0||
48283075|NCT03250234|101017083|FG001|NOT COMPLETED|Overall Study||0||
48283076|NCT02334423|101017084|FG000|STARTED|Overall Study||246||
48283077|NCT02334423|101017085|FG001|STARTED|Overall Study||84||
48397674|NCT03725293|101302676|FG001|COMPLETED|Overall Study||97||
48397675|NCT03725293|101302675|FG000|NOT COMPLETED|Overall Study||12||
48283078|NCT02334423|101017084|FG000|COMPLETED|Overall Study||236||
48283079|NCT02334423|101017085|FG001|COMPLETED|Overall Study||81||
48283080|NCT02334423|101017084|FG000|NOT COMPLETED|Overall Study||10||
48283081|NCT02334423|101017085|FG001|NOT COMPLETED|Overall Study||3||
48283082|NCT03814031|101017086|FG000|STARTED|Overall Study||26||
48283083|NCT03814031|101017087|FG001|STARTED|Overall Study||71||
48283084|NCT03814031|101017086|FG000|COMPLETED|Overall Study||26||
48283085|NCT03814031|101017087|FG001|COMPLETED|Overall Study||71||
48283086|NCT03814031|101017086|FG000|NOT COMPLETED|Overall Study||0||
48283087|NCT03814031|101017087|FG001|NOT COMPLETED|Overall Study||0||
48397676|NCT03725293|101302676|FG001|NOT COMPLETED|Overall Study||9||
48397677|NCT00802867|101302677|FG000|STARTED|Overall Study||989||
48700837|NCT01457014|102054090|FG000|NOT COMPLETED|Fourth Night||0||
48283088|NCT00414908|101017088|FG000|STARTED|Overall Study||25||
48283089|NCT00414908|101017089|FG001|STARTED|Overall Study||29||
48283090|NCT00414908|101017088|FG000|COMPLETED|Overall Study||24||
48283091|NCT00414908|101017089|FG001|COMPLETED|Overall Study||28||
48283092|NCT00414908|101017088|FG000|NOT COMPLETED|Overall Study||1||
48283093|NCT00414908|101017089|FG001|NOT COMPLETED|Overall Study||1||
48283094|NCT04019990|101017090|FG000|STARTED|Overall Study||13||
48283095|NCT04019990|101017091|FG001|STARTED|Overall Study||15||
48283096|NCT04019990|101017090|FG000|COMPLETED|Overall Study||12||
48283097|NCT04019990|101017091|FG001|COMPLETED|Overall Study||12||
48283098|NCT04019990|101017090|FG000|NOT COMPLETED|Overall Study||1||
48283099|NCT04019990|101017091|FG001|NOT COMPLETED|Overall Study||3||
48397678|NCT00802867|101302677|FG000|COMPLETED|Overall Study||976||
48397679|NCT00802867|101302677|FG000|NOT COMPLETED|Overall Study||13||
48397680|NCT02650895|101302678|FG000|STARTED|Overall Study||10||
48397681|NCT02650895|101302679|FG001|STARTED|Overall Study||6||
48397682|NCT02650895|101302680|FG002|STARTED|Overall Study||6||
48397683|NCT02650895|101302681|FG003|STARTED|Overall Study||6||
48397684|NCT02650895|101302682|FG004|STARTED|Overall Study||6||
48397685|NCT02650895|101302683|FG005|STARTED|Overall Study||6||
48397686|NCT02650895|101302678|FG000|COMPLETED|Overall Study||10||
48397687|NCT02650895|101302679|FG001|COMPLETED|Overall Study||5||
48283100|NCT04138576|101017092|FG000|STARTED|Overall Study||381||
48283101|NCT04138576|101017092|FG000|COMPLETED|Overall Study||365||
48397688|NCT02650895|101302680|FG002|COMPLETED|Overall Study||6||
48700838|NCT01457014|102054091|FG001|NOT COMPLETED|Fourth Night||0||
48700839|NCT01457014|102054092|FG002|NOT COMPLETED|Fourth Night||0||
48283102|NCT04138576|101017092|FG000|NOT COMPLETED|Overall Study||16||
48283103|NCT03466073|101017093|FG000|STARTED|Overall Study||6||
48283104|NCT03466073|101017094|FG001|STARTED|Overall Study||2||
48283105|NCT03466073|101017095|FG002|STARTED|Overall Study||6||
48283106|NCT03466073|101017096|FG003|STARTED|Overall Study||6||
48283107|NCT03466073|101017097|FG004|STARTED|Overall Study||6||
48283108|NCT03466073|101017098|FG005|STARTED|Overall Study||7||
48283109|NCT03466073|101017093|FG000|COMPLETED|Overall Study||5||
48283110|NCT03466073|101017094|FG001|COMPLETED|Overall Study||2||
48283111|NCT03466073|101017095|FG002|COMPLETED|Overall Study||6||
48283112|NCT03466073|101017096|FG003|COMPLETED|Overall Study||6||
48283113|NCT03466073|101017097|FG004|COMPLETED|Overall Study||6||
48283114|NCT03466073|101017098|FG005|COMPLETED|Overall Study||6||
48283115|NCT03466073|101017093|FG000|NOT COMPLETED|Overall Study||1||
48572365|NCT02780713|101735003|FG001|NOT COMPLETED|Period 2: Reference (100mg)||0||
48572366|NCT02780713|101735004|FG002|NOT COMPLETED|Period 2: Reference (100mg)||0||
48572367|NCT02780713|101735005|FG003|NOT COMPLETED|Period 2: Reference (100mg)||0||
48572368|NCT02780713|101735006|FG004|NOT COMPLETED|Period 2: Reference (100mg)||0||
48572369|NCT02780713|101735002|FG000|STARTED|Period 3: Variant B (100mg)||0||
48572370|NCT02780713|101735003|FG001|STARTED|Period 3: Variant B (100mg)||0||
48572371|NCT02780713|101735004|FG002|STARTED|Period 3: Variant B (100mg)||14||
48572372|NCT02780713|101735005|FG003|STARTED|Period 3: Variant B (100mg)||0||
48572373|NCT02780713|101735006|FG004|STARTED|Period 3: Variant B (100mg)||0||
48572374|NCT02780713|101735002|FG000|COMPLETED|Period 3: Variant B (100mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
48572375|NCT02780713|101735003|FG001|COMPLETED|Period 3: Variant B (100mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
48572376|NCT02780713|101735004|FG002|COMPLETED|Period 3: Variant B (100mg)||12|12 participants received and completed treatment and 2 participants withdrew from the study|
48572377|NCT02780713|101735005|FG003|COMPLETED|Period 3: Variant B (100mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
48572378|NCT02780713|101735006|FG004|COMPLETED|Period 3: Variant B (100mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
48572379|NCT02780713|101735002|FG000|NOT COMPLETED|Period 3: Variant B (100mg)||0||
48572380|NCT02780713|101735003|FG001|NOT COMPLETED|Period 3: Variant B (100mg)||0||
48572381|NCT02780713|101735004|FG002|NOT COMPLETED|Period 3: Variant B (100mg)||2||
48572382|NCT02780713|101735005|FG003|NOT COMPLETED|Period 3: Variant B (100mg)||0||
48572383|NCT02780713|101735006|FG004|NOT COMPLETED|Period 3: Variant B (100mg)||0||
48572384|NCT02780713|101735002|FG000|STARTED|Period 4: Variant C (100mg)||0||
48572385|NCT02780713|101735003|FG001|STARTED|Period 4: Variant C (100mg)||0||
48572386|NCT02780713|101735004|FG002|STARTED|Period 4: Variant C (100mg)||0||
48572387|NCT02780713|101735005|FG003|STARTED|Period 4: Variant C (100mg)||12||
48572388|NCT02780713|101735006|FG004|STARTED|Period 4: Variant C (100mg)||0||
48572389|NCT02780713|101735002|FG000|COMPLETED|Period 4: Variant C (100mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
48572390|NCT02780713|101735003|FG001|COMPLETED|Period 4: Variant C (100mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
48572391|NCT02780713|101735004|FG002|COMPLETED|Period 4: Variant C (100mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
48572392|NCT02780713|101735005|FG003|COMPLETED|Period 4: Variant C (100mg)||12|12 participants received and completed treatment and 2 participants withdrew from the study|
48572393|NCT02780713|101735006|FG004|COMPLETED|Period 4: Variant C (100mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
48572394|NCT02780713|101735002|FG000|NOT COMPLETED|Period 4: Variant C (100mg)||0||
48572395|NCT02780713|101735003|FG001|NOT COMPLETED|Period 4: Variant C (100mg)||0||
48700840|NCT01457014|102054093|FG003|NOT COMPLETED|Fourth Night||0||
48700841|NCT01074463|102054094|FG000|STARTED|First Intervention||12||
48700842|NCT01074463|102054095|FG001|STARTED|First Intervention||12||
48700843|NCT01074463|102054094|FG000|COMPLETED|First Intervention||12||
48700844|NCT01074463|102054095|FG001|COMPLETED|First Intervention||12||
48700845|NCT01074463|102054094|FG000|NOT COMPLETED|First Intervention||0||
48700846|NCT01074463|102054095|FG001|NOT COMPLETED|First Intervention||0||
48700847|NCT01074463|102054094|FG000|STARTED|Washout of 7 Days||12||
48283116|NCT03466073|101017094|FG001|NOT COMPLETED|Overall Study||0||
48283117|NCT03466073|101017095|FG002|NOT COMPLETED|Overall Study||0||
48283118|NCT03466073|101017096|FG003|NOT COMPLETED|Overall Study||0||
48283119|NCT03466073|101017097|FG004|NOT COMPLETED|Overall Study||0||
48283120|NCT03466073|101017098|FG005|NOT COMPLETED|Overall Study||1||
48397689|NCT02650895|101302681|FG003|COMPLETED|Overall Study||6||
48397690|NCT02650895|101302682|FG004|COMPLETED|Overall Study||6||
48397691|NCT02650895|101302683|FG005|COMPLETED|Overall Study||6||
48397692|NCT02650895|101302678|FG000|NOT COMPLETED|Overall Study||0||
48397693|NCT02650895|101302679|FG001|NOT COMPLETED|Overall Study||1||
48397694|NCT02650895|101302680|FG002|NOT COMPLETED|Overall Study||0||
48127167|NCT01602315|100633949|FG006|NOT COMPLETED|Overall Study||29||
48127168|NCT02418546|100638138|FG000|STARTED|Overall Study||26||
48127169|NCT02418546|100638139|FG001|STARTED|Overall Study||26||
48127170|NCT02418546|100638140|FG002|STARTED|Overall Study||26||
48127171|NCT02418546|100638138|FG000|COMPLETED|Overall Study||19||
48127172|NCT02418546|100638139|FG001|COMPLETED|Overall Study||20||
48127173|NCT02418546|100638140|FG002|COMPLETED|Overall Study||23||
48127174|NCT02418546|100638138|FG000|NOT COMPLETED|Overall Study||7||
48127175|NCT02418546|100638139|FG001|NOT COMPLETED|Overall Study||6||
48127176|NCT02418546|100638140|FG002|NOT COMPLETED|Overall Study||3||
48127177|NCT00767000|100638141|FG000|STARTED|54-week Study||119||
48127178|NCT00767000|100638142|FG001|STARTED|54-week Study||117||
48397695|NCT02650895|101302681|FG003|NOT COMPLETED|Overall Study||0||
48397696|NCT02650895|101302682|FG004|NOT COMPLETED|Overall Study||0||
48397697|NCT02650895|101302683|FG005|NOT COMPLETED|Overall Study||0||
48127179|NCT00767000|100638143|FG002|STARTED|54-week Study||117||
48127180|NCT00767000|100638144|FG003|STARTED|54-week Study||229||
48127181|NCT00767000|100638145|FG004|STARTED|54-week Study||231||
48127182|NCT00767000|100638141|FG000|COMPLETED|54-week Study||11||
48127183|NCT00767000|100638142|FG001|COMPLETED|54-week Study||4||
48127184|NCT00767000|100638143|FG002|COMPLETED|54-week Study||8||
48127185|NCT00767000|100638144|FG003|COMPLETED|54-week Study||4||
48127186|NCT00767000|100638145|FG004|COMPLETED|54-week Study||7||
48397698|NCT00469209|101302684|FG000|STARTED|Overall Study||20||
48397699|NCT00469209|101302685|FG001|STARTED|Overall Study||20||
48397700|NCT00469209|101302686|FG002|STARTED|Overall Study||20||
48397701|NCT00469209|101302684|FG000|COMPLETED|Overall Study||19||
48397702|NCT00469209|101302685|FG001|COMPLETED|Overall Study||20||
48397703|NCT00469209|101302686|FG002|COMPLETED|Overall Study||19||
48397704|NCT00469209|101302684|FG000|NOT COMPLETED|Overall Study||1||
48397705|NCT00469209|101302685|FG001|NOT COMPLETED|Overall Study||0||
48397706|NCT00469209|101302686|FG002|NOT COMPLETED|Overall Study||1||
48397707|NCT01742091|101302687|FG000|STARTED|Overall Study||9||
48397708|NCT01742091|101302688|FG001|STARTED|Overall Study||11||
48397709|NCT01742091|101302689|FG002|STARTED|Overall Study||10||
48397710|NCT01742091|101302690|FG003|STARTED|Overall Study||9||
48397711|NCT01742091|101302691|FG004|STARTED|Overall Study||8||
48127187|NCT00767000|100638141|FG000|NOT COMPLETED|54-week Study||108||
48397712|NCT01742091|101302692|FG005|STARTED|Overall Study||12||
48397713|NCT01742091|101302687|FG000|RECEIVED STUDY DRUG|Overall Study||9||
48397714|NCT01742091|101302688|FG001|RECEIVED STUDY DRUG|Overall Study||11||
48397715|NCT01742091|101302689|FG002|RECEIVED STUDY DRUG|Overall Study||10||
48397716|NCT01742091|101302690|FG003|RECEIVED STUDY DRUG|Overall Study||9||
48397717|NCT01742091|101302691|FG004|RECEIVED STUDY DRUG|Overall Study||8||
48127188|NCT00767000|100638142|FG001|NOT COMPLETED|54-week Study||113||
48127189|NCT00767000|100638143|FG002|NOT COMPLETED|54-week Study||109||
48127190|NCT00767000|100638144|FG003|NOT COMPLETED|54-week Study||225||
48127191|NCT00767000|100638145|FG004|NOT COMPLETED|54-week Study||224||
48127192|NCT00767000|100638141|FG000|STARTED|Optional 104-week Extension||7||
48127193|NCT00767000|100638142|FG001|STARTED|Optional 104-week Extension||3||
48397718|NCT01742091|101302692|FG005|RECEIVED STUDY DRUG|Overall Study||12||
48397719|NCT01742091|101302687|FG000|COMPLETED|Overall Study||9||
48397720|NCT01742091|101302688|FG001|COMPLETED|Overall Study||11||
48397721|NCT01742091|101302689|FG002|COMPLETED|Overall Study||10||
48397722|NCT01742091|101302690|FG003|COMPLETED|Overall Study||8||
48572396|NCT02780713|101735004|FG002|NOT COMPLETED|Period 4: Variant C (100mg)||0||
48572397|NCT02780713|101735005|FG003|NOT COMPLETED|Period 4: Variant C (100mg)||0||
48572398|NCT02780713|101735006|FG004|NOT COMPLETED|Period 4: Variant C (100mg)||0||
48572399|NCT02780713|101735002|FG000|STARTED|Period 5: Variant B (300mg)||0||
48572400|NCT02780713|101735003|FG001|STARTED|Period 5: Variant B (300mg)||0||
48572401|NCT02780713|101735004|FG002|STARTED|Period 5: Variant B (300mg)||0||
48572402|NCT02780713|101735005|FG003|STARTED|Period 5: Variant B (300mg)||0||
48572403|NCT02780713|101735006|FG004|STARTED|Period 5: Variant B (300mg)||12||
48572404|NCT02780713|101735002|FG000|COMPLETED|Period 5: Variant B (300mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
48572405|NCT02780713|101735003|FG001|COMPLETED|Period 5: Variant B (300mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
48572406|NCT02780713|101735004|FG002|COMPLETED|Period 5: Variant B (300mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
48572407|NCT02780713|101735005|FG003|COMPLETED|Period 5: Variant B (300mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
48572408|NCT02780713|101735006|FG004|COMPLETED|Period 5: Variant B (300mg)||12|12 participants received and completed treatment and 2 participants withdrew from the study|
48700848|NCT01074463|102054095|FG001|STARTED|Washout of 7 Days||12||
48700849|NCT01074463|102054094|FG000|COMPLETED|Washout of 7 Days||12||
48700850|NCT01074463|102054095|FG001|COMPLETED|Washout of 7 Days||12||
48700851|NCT01074463|102054094|FG000|NOT COMPLETED|Washout of 7 Days||0||
48700852|NCT01074463|102054095|FG001|NOT COMPLETED|Washout of 7 Days||0||
48700853|NCT01074463|102054094|FG000|STARTED|Second Intervention||12||
48700854|NCT01074463|102054095|FG001|STARTED|Second Intervention||12||
48700855|NCT01074463|102054094|FG000|COMPLETED|Second Intervention||12||
48700856|NCT01074463|102054095|FG001|COMPLETED|Second Intervention||12||
48127194|NCT00767000|100638143|FG002|STARTED|Optional 104-week Extension||7||
48700857|NCT01074463|102054094|FG000|NOT COMPLETED|Second Intervention||0||
48700858|NCT01074463|102054095|FG001|NOT COMPLETED|Second Intervention||0||
48700859|NCT02609841|102054096|FG000|STARTED|Overall Study||240||
48700860|NCT02609841|102054096|FG000|COMPLETED|Overall Study||212||
48700861|NCT02609841|102054096|FG000|NOT COMPLETED|Overall Study||28||
48700862|NCT03911752|102054097|FG000|STARTED|Overall Study||8||
48700863|NCT03911752|102054098|FG001|STARTED|Overall Study||2||
48700864|NCT03911752|102054099|FG002|STARTED|Overall Study||2||
48127195|NCT00767000|100638144|FG003|STARTED|Optional 104-week Extension||2||
48127196|NCT00767000|100638145|FG004|STARTED|Optional 104-week Extension||4||
48127197|NCT00767000|100638141|FG000|COMPLETED|Optional 104-week Extension||0||
48127198|NCT00767000|100638142|FG001|COMPLETED|Optional 104-week Extension||0||
48127199|NCT00767000|100638143|FG002|COMPLETED|Optional 104-week Extension||0||
48127200|NCT00767000|100638144|FG003|COMPLETED|Optional 104-week Extension||0||
48397723|NCT01742091|101302691|FG004|COMPLETED|Overall Study||7||
48397724|NCT01742091|101302692|FG005|COMPLETED|Overall Study||10||
48397725|NCT01742091|101302687|FG000|NOT COMPLETED|Overall Study||0||
48397726|NCT01742091|101302688|FG001|NOT COMPLETED|Overall Study||0||
48397727|NCT01742091|101302689|FG002|NOT COMPLETED|Overall Study||0||
48397728|NCT01742091|101302690|FG003|NOT COMPLETED|Overall Study||1||
48397729|NCT01742091|101302691|FG004|NOT COMPLETED|Overall Study||1||
48397730|NCT01742091|101302692|FG005|NOT COMPLETED|Overall Study||2||
48397731|NCT00389441|101302693|FG000|STARTED|Overall Study||52||
48397732|NCT00389441|101302693|FG000|COMPLETED|Overall Study||0||
48397733|NCT00389441|101302693|FG000|NOT COMPLETED|Overall Study||52||
48397734|NCT00701103|101302694|FG000|STARTED|Overall Study||5||
48397735|NCT00701103|101302695|FG001|STARTED|Overall Study||3||
48397736|NCT00701103|101302696|FG002|STARTED|Overall Study||8||
48397737|NCT00701103|101302697|FG003|STARTED|Overall Study||6||
48397738|NCT00701103|101302698|FG004|STARTED|Overall Study||6||
48397739|NCT00701103|101302699|FG005|STARTED|Overall Study||6||
48397740|NCT00701103|101302700|FG006|STARTED|Overall Study||8||
48397741|NCT00701103|101302701|FG007|STARTED|Overall Study||7||
48397742|NCT00701103|101302702|FG008|STARTED|Overall Study||9||
48397743|NCT00701103|101302703|FG009|STARTED|Overall Study||11||
48397744|NCT00701103|101302704|FG010|STARTED|Overall Study||11||
48397745|NCT00701103|101302694|FG000|COMPLETED|Overall Study||0||
48397746|NCT00701103|101302695|FG001|COMPLETED|Overall Study||0||
48397747|NCT00701103|101302696|FG002|COMPLETED|Overall Study||0||
48127201|NCT00767000|100638145|FG004|COMPLETED|Optional 104-week Extension||0||
48127202|NCT00767000|100638141|FG000|NOT COMPLETED|Optional 104-week Extension||7||
48572409|NCT02780713|101735002|FG000|NOT COMPLETED|Period 5: Variant B (300mg)||0||
48572410|NCT02780713|101735003|FG001|NOT COMPLETED|Period 5: Variant B (300mg)||0||
48572411|NCT02780713|101735004|FG002|NOT COMPLETED|Period 5: Variant B (300mg)||0||
48572412|NCT02780713|101735005|FG003|NOT COMPLETED|Period 5: Variant B (300mg)||0||
48572413|NCT02780713|101735006|FG004|NOT COMPLETED|Period 5: Variant B (300mg)||0||
48572414|NCT00086138|101735007|FG000|STARTED|Overall Study||64||
48127203|NCT00767000|100638142|FG001|NOT COMPLETED|Optional 104-week Extension||3||
48127204|NCT00767000|100638143|FG002|NOT COMPLETED|Optional 104-week Extension||7||
48127205|NCT00767000|100638144|FG003|NOT COMPLETED|Optional 104-week Extension||2||
48127206|NCT00767000|100638145|FG004|NOT COMPLETED|Optional 104-week Extension||4||
48127207|NCT03738150|100638146|FG000|STARTED|Base Study||21||
48127208|NCT03738150|100638146|FG000|COMPLETED|Base Study||20||
48127209|NCT03738150|100638146|FG000|NOT COMPLETED|Base Study||1||
48127210|NCT03738150|100638146|FG000|STARTED|Extension Study||20||
48127211|NCT03738150|100638146|FG000|COMPLETED|Extension Study||19||
48127212|NCT03738150|100638146|FG000|NOT COMPLETED|Extension Study||1||
48127213|NCT01307501|100638147|FG000|STARTED|Overall Study||40||60
48127214|NCT01307501|100638147|FG000|Intent-to-Treat (ITT) Population|Overall Study||40|Participants for whom cryoablation via Galil Medical Cryoablation System was attempted or performed.|60
48127215|NCT01307501|100638147|FG000|COMPLETED|Overall Study||17||23
48283121|NCT02314780|101017099|FG000|STARTED|Overall Study||9||
48283122|NCT02314780|101017100|FG001|STARTED|Overall Study||10||
48283123|NCT02314780|101017101|FG002|STARTED|Overall Study||8||
48283124|NCT02314780|101017099|FG000|COMPLETED|Overall Study||9||
48283125|NCT02314780|101017100|FG001|COMPLETED|Overall Study||7||
48283126|NCT02314780|101017101|FG002|COMPLETED|Overall Study||8||
48572415|NCT00086138|101735008|FG001|STARTED|Overall Study||67||
48572416|NCT00086138|101735007|FG000|COMPLETED|Overall Study||60||
48572417|NCT00086138|101735008|FG001|COMPLETED|Overall Study||64||
48572418|NCT00086138|101735007|FG000|NOT COMPLETED|Overall Study||4||
48700865|NCT03911752|102054097|FG000|COMPLETED|Overall Study||8||
48700866|NCT03911752|102054098|FG001|COMPLETED|Overall Study||2||
48283127|NCT02314780|101017099|FG000|NOT COMPLETED|Overall Study||0||
48283128|NCT02314780|101017100|FG001|NOT COMPLETED|Overall Study||3||
48283129|NCT02314780|101017101|FG002|NOT COMPLETED|Overall Study||0||
48283130|NCT02765802|101017102|FG000|STARTED|Overall Study||14||
48283131|NCT02765802|101017103|FG001|STARTED|Overall Study||19||
48283132|NCT02765802|101017102|FG000|COMPLETED|Overall Study||14||
48283133|NCT02765802|101017103|FG001|COMPLETED|Overall Study||19||
48283134|NCT02765802|101017102|FG000|NOT COMPLETED|Overall Study||0||
48283135|NCT02765802|101017103|FG001|NOT COMPLETED|Overall Study||0||
48283136|NCT03535597|101017104|FG000|STARTED|Overall Study||96||
48283137|NCT03535597|101017105|FG001|STARTED|Overall Study||100||
48283138|NCT03535597|101017106|FG002|STARTED|Overall Study||73||
48283139|NCT03535597|101017107|FG003|STARTED|Overall Study||86||
48283140|NCT03535597|101017104|FG000|COMPLETED|Overall Study||96||
48283141|NCT03535597|101017105|FG001|COMPLETED|Overall Study||100||
48283142|NCT03535597|101017106|FG002|COMPLETED|Overall Study||73||
48700867|NCT03911752|102054099|FG002|COMPLETED|Overall Study||2||
48700868|NCT03911752|102054097|FG000|NOT COMPLETED|Overall Study||0||
48700869|NCT03911752|102054098|FG001|NOT COMPLETED|Overall Study||0||
48700870|NCT03911752|102054099|FG002|NOT COMPLETED|Overall Study||0||
48700871|NCT01471028|102054100|FG000|STARTED|VTI-208||96||
48700872|NCT01471028|102054101|FG001|STARTED|VTI-208||107||
48127216|NCT01307501|100638147|FG000|NOT COMPLETED|Overall Study||23||37
48127217|NCT00968617|100638148|FG000|STARTED|Overall Study||7||
48283143|NCT03535597|101017107|FG003|COMPLETED|Overall Study||86||
48283144|NCT03535597|101017104|FG000|NOT COMPLETED|Overall Study||0||
48283145|NCT03535597|101017105|FG001|NOT COMPLETED|Overall Study||0||
48283146|NCT03535597|101017106|FG002|NOT COMPLETED|Overall Study||0||
48283147|NCT03535597|101017107|FG003|NOT COMPLETED|Overall Study||0||
48572419|NCT00086138|101735008|FG001|NOT COMPLETED|Overall Study||3||
48572420|NCT02498444|101735009|FG000|STARTED|Overall Study||16||
48700873|NCT01471028|102054100|FG000|COMPLETED|VTI-208||56||
48700874|NCT01471028|102054101|FG001|COMPLETED|VTI-208||63||
48700875|NCT01471028|102054100|FG000|NOT COMPLETED|VTI-208||40||
48700876|NCT01471028|102054101|FG001|NOT COMPLETED|VTI-208||44||
48397748|NCT00701103|101302697|FG003|COMPLETED|Overall Study||0||
48397749|NCT00701103|101302698|FG004|COMPLETED|Overall Study||0||
48397750|NCT00701103|101302699|FG005|COMPLETED|Overall Study||0||
48397751|NCT00701103|101302700|FG006|COMPLETED|Overall Study||0||
48397752|NCT00701103|101302701|FG007|COMPLETED|Overall Study||0||
48397753|NCT00701103|101302702|FG008|COMPLETED|Overall Study||0||
48397754|NCT00701103|101302703|FG009|COMPLETED|Overall Study||0||
48572421|NCT02498444|101735010|FG001|STARTED|Overall Study||18||
48572422|NCT02498444|101735009|FG000|COMPLETED|Overall Study||12||
48283148|NCT01394978|101017108|FG000|STARTED|Overall Study||168||
48283149|NCT01394978|101017109|FG001|STARTED|Overall Study||276||
48283150|NCT01394978|101017108|FG000|COMPLETED|Overall Study||147||
48572423|NCT02498444|101735010|FG001|COMPLETED|Overall Study||18||
48572424|NCT02498444|101735009|FG000|NOT COMPLETED|Overall Study||4||
48572425|NCT02498444|101735010|FG001|NOT COMPLETED|Overall Study||0||
48572426|NCT03546491|101735011|FG000|STARTED|Overall Study||32||
48572427|NCT03546491|101735011|FG000|Recieved Test Product 1|Overall Study||32|This was a 2 treatment, 3 period crossover design, each subject saw one treatment twice.|
48572428|NCT03546491|101735011|FG000|Received Test Product 2|Overall Study||32|This was a 2 treatment, 3 period crossover design, each subject saw one treatment twice.|
48572429|NCT03546491|101735011|FG000|COMPLETED|Overall Study||30||
48283151|NCT01394978|101017109|FG001|COMPLETED|Overall Study||245||
48283152|NCT01394978|101017108|FG000|NOT COMPLETED|Overall Study||21||
48283153|NCT01394978|101017109|FG001|NOT COMPLETED|Overall Study||31||
48283154|NCT00550589|101017110|FG000|STARTED|Overall Study||33||
48283155|NCT00550589|101017110|FG000|COMPLETED|Overall Study||33||
48283156|NCT00550589|101017110|FG000|NOT COMPLETED|Overall Study||0||
48283157|NCT04601870|101017111|FG000|STARTED|Overall Study||38||
48283158|NCT04601870|101017112|FG001|STARTED|Overall Study||30||
48283159|NCT04601870|101017113|FG002|STARTED|Overall Study||30||
48283160|NCT04601870|101017111|FG000|COMPLETED|Overall Study||38||
48283161|NCT04601870|101017112|FG001|COMPLETED|Overall Study||30||
48283162|NCT04601870|101017113|FG002|COMPLETED|Overall Study||30||
48283163|NCT04601870|101017111|FG000|NOT COMPLETED|Overall Study||0||
48283164|NCT04601870|101017112|FG001|NOT COMPLETED|Overall Study||0||
48283165|NCT04601870|101017113|FG002|NOT COMPLETED|Overall Study||0||
48283166|NCT01910181|101017114|FG000|STARTED|Overall Study||46||
48283167|NCT01910181|101017114|FG000|PK Cohort|Overall Study||20||
48283168|NCT01910181|101017114|FG000|Expansion Cohort|Overall Study||26||
48283169|NCT01910181|101017114|FG000|COMPLETED|Overall Study||0||
48283170|NCT01910181|101017114|FG000|NOT COMPLETED|Overall Study||46||
48283171|NCT04873401|101017115|FG000|STARTED|Overall Study||271||
48283172|NCT04873401|101017116|FG001|STARTED|Overall Study||227||
48283173|NCT04873401|101017115|FG000|COMPLETED|Overall Study||263||
48283174|NCT04873401|101017116|FG001|COMPLETED|Overall Study||223||
48283175|NCT04873401|101017115|FG000|NOT COMPLETED|Overall Study||8||
48283176|NCT04873401|101017116|FG001|NOT COMPLETED|Overall Study||4||
48283177|NCT03446781|101017117|FG000|STARTED|Overall Study||214||
48283178|NCT03446781|101017118|FG001|STARTED|Overall Study||208||
48283179|NCT03446781|101017117|FG000|COMPLETED|Overall Study||186||
48283180|NCT03446781|101017118|FG001|COMPLETED|Overall Study||191||
48283181|NCT03446781|101017117|FG000|NOT COMPLETED|Overall Study||28||
48283182|NCT03446781|101017118|FG001|NOT COMPLETED|Overall Study||17||
48283183|NCT01814813|101017119|FG000|STARTED|Overall Study||29||
48283184|NCT01814813|101017120|FG001|STARTED|Overall Study||30||
48283185|NCT01814813|101017121|FG002|STARTED|Overall Study||31||
48283186|NCT01814813|101017119|FG000|COMPLETED|Overall Study||29||
48283187|NCT01814813|101017120|FG001|COMPLETED|Overall Study||30||
48283188|NCT01814813|101017121|FG002|COMPLETED|Overall Study||31||
48283189|NCT01814813|101017119|FG000|NOT COMPLETED|Overall Study||0||
48283190|NCT01814813|101017120|FG001|NOT COMPLETED|Overall Study||0||
48283191|NCT01814813|101017121|FG002|NOT COMPLETED|Overall Study||0||
48283192|NCT03432260|101017122|FG000|STARTED|Overall Study||4||
48283193|NCT03432260|101017123|FG001|STARTED|Overall Study||3||
48397755|NCT00701103|101302704|FG010|COMPLETED|Overall Study||0||
48397756|NCT00701103|101302694|FG000|NOT COMPLETED|Overall Study||5||
48397757|NCT00701103|101302695|FG001|NOT COMPLETED|Overall Study||3||
48397758|NCT00701103|101302696|FG002|NOT COMPLETED|Overall Study||8||
48397759|NCT00701103|101302697|FG003|NOT COMPLETED|Overall Study||6||
48397760|NCT00701103|101302698|FG004|NOT COMPLETED|Overall Study||6||
48397761|NCT00701103|101302699|FG005|NOT COMPLETED|Overall Study||6||
48397762|NCT00701103|101302700|FG006|NOT COMPLETED|Overall Study||8||
48397763|NCT00701103|101302701|FG007|NOT COMPLETED|Overall Study||7||
48397764|NCT00701103|101302702|FG008|NOT COMPLETED|Overall Study||9||
48397765|NCT00701103|101302703|FG009|NOT COMPLETED|Overall Study||11||
48397766|NCT00701103|101302704|FG010|NOT COMPLETED|Overall Study||11||
48397767|NCT03395223|101302705|FG000|STARTED|Overall Study||7||
48397768|NCT03395223|101302705|FG000|Treatment Completed|Overall Study||7||
48283194|NCT03432260|101017124|FG002|STARTED|Overall Study||4||
48283195|NCT03432260|101017125|FG003|STARTED|Overall Study||4||
48283196|NCT03432260|101017126|FG004|STARTED|Overall Study||4||
48283197|NCT03432260|101017122|FG000|COMPLETED|Overall Study||3||
48283198|NCT03432260|101017123|FG001|COMPLETED|Overall Study||2||
48283199|NCT03432260|101017124|FG002|COMPLETED|Overall Study||4||
48283200|NCT03432260|101017125|FG003|COMPLETED|Overall Study||4||
48397769|NCT03395223|101302705|FG000|COMPLETED|Overall Study||3||
48397770|NCT03395223|101302705|FG000|NOT COMPLETED|Overall Study||4||
48397771|NCT01484561|101302706|FG000|STARTED|Overall Study||97||
48397772|NCT01484561|101302707|FG001|STARTED|Overall Study||51||
48397773|NCT01484561|101302706|FG000|COMPLETED|Overall Study||88||
48397774|NCT01484561|101302707|FG001|COMPLETED|Overall Study||45||
48397775|NCT01484561|101302706|FG000|NOT COMPLETED|Overall Study||9||
48397776|NCT01484561|101302707|FG001|NOT COMPLETED|Overall Study||6||
48397777|NCT03379376|101302708|FG000|STARTED|Overall Study||10||
48397778|NCT03379376|101302708|FG000|COMPLETED|Overall Study||5||
48397779|NCT03379376|101302708|FG000|NOT COMPLETED|Overall Study||5||
48397780|NCT00796003|101302709|FG000|STARTED|Overall Study||3||
48397781|NCT00796003|101302710|FG001|STARTED|Overall Study||36||
48397782|NCT00796003|101302709|FG000|Treated|Overall Study||3||
48397783|NCT00796003|101302710|FG001|Treated|Overall Study||34||
48397784|NCT00796003|101302709|FG000|COMPLETED|Overall Study||0||
48397785|NCT00796003|101302710|FG001|COMPLETED|Overall Study||7||
48397786|NCT00796003|101302709|FG000|NOT COMPLETED|Overall Study||3||
48397787|NCT00796003|101302710|FG001|NOT COMPLETED|Overall Study||29||
48397788|NCT01268943|101302711|FG000|STARTED|Overall Study||6||
48397789|NCT01268943|101302712|FG001|STARTED|Overall Study||3||
48397790|NCT01268943|101302713|FG002|STARTED|Overall Study||3||
48397791|NCT01268943|101302714|FG003|STARTED|Overall Study||6||
48397792|NCT01268943|101302711|FG000|COMPLETED|Overall Study||6||
48397793|NCT01268943|101302712|FG001|COMPLETED|Overall Study||3||
48397794|NCT01268943|101302713|FG002|COMPLETED|Overall Study||3||
48572430|NCT03546491|101735011|FG000|NOT COMPLETED|Overall Study||2||
48572431|NCT02428309|101735012|FG000|STARTED|Overall Study||1||
48572432|NCT02428309|101735012|FG000|COMPLETED|Overall Study||1||
48572433|NCT02428309|101735012|FG000|NOT COMPLETED|Overall Study||0||
48572434|NCT01684943|101735013|FG000|STARTED|Overall Study||29||
48572435|NCT01684943|101735014|FG001|STARTED|Overall Study||3||
48572436|NCT01684943|101735015|FG002|STARTED|Overall Study||1||
48572437|NCT01684943|101735013|FG000|COMPLETED|Overall Study||20||
48572438|NCT01684943|101735014|FG001|COMPLETED|Overall Study||2||
48572439|NCT01684943|101735015|FG002|COMPLETED|Overall Study||0||
48572440|NCT01684943|101735013|FG000|NOT COMPLETED|Overall Study||9||
48572441|NCT01684943|101735014|FG001|NOT COMPLETED|Overall Study||1||
48572442|NCT01684943|101735015|FG002|NOT COMPLETED|Overall Study||1||
48572443|NCT02266797|101735016|FG000|STARTED|Overall Study||1||
48700877|NCT01471028|102054100|FG000|STARTED|VTI-208E||56||
48700878|NCT01471028|102054101|FG001|STARTED|VTI-208E||63||
48700879|NCT01471028|102054100|FG000|Database Lock, 31 July 2015|VTI-208E||56||
48700880|NCT01471028|102054101|FG001|Database Lock, 31 July 2015|VTI-208E||63||
48700881|NCT01471028|102054100|FG000|COMPLETED|VTI-208E||48||
48700882|NCT01471028|102054101|FG001|COMPLETED|VTI-208E||51||
48700883|NCT01471028|102054100|FG000|NOT COMPLETED|VTI-208E||8||
48700884|NCT01471028|102054101|FG001|NOT COMPLETED|VTI-208E||12||
48700885|NCT01294306|102054102|FG000|STARTED|Overall Study||45||
48700886|NCT01294306|102054103|FG001|STARTED|Overall Study||35||
48700887|NCT01294306|102054102|FG000|COMPLETED|Overall Study||45||
48700888|NCT01294306|102054103|FG001|COMPLETED|Overall Study||35||
48700889|NCT01294306|102054102|FG000|NOT COMPLETED|Overall Study||0||
48700890|NCT01294306|102054103|FG001|NOT COMPLETED|Overall Study||0||
48700891|NCT04659174|102054104|FG000|STARTED|Overall Study||68|Started treatment|
48700892|NCT04659174|102054105|FG001|STARTED|Overall Study||84|Started treatment|
48700893|NCT04659174|102054104|FG000|COMPLETED|Overall Study||19|Completed treatment|
48700894|NCT04659174|102054105|FG001|COMPLETED|Overall Study||16|Completed treatment|
48700895|NCT04659174|102054104|FG000|NOT COMPLETED|Overall Study||49||
48700896|NCT04659174|102054105|FG001|NOT COMPLETED|Overall Study||68||
48397795|NCT01268943|101302714|FG003|COMPLETED|Overall Study||6||
48397796|NCT01268943|101302711|FG000|NOT COMPLETED|Overall Study||0||
48397797|NCT01268943|101302712|FG001|NOT COMPLETED|Overall Study||0||
48397798|NCT01268943|101302713|FG002|NOT COMPLETED|Overall Study||0||
48397799|NCT01268943|101302714|FG003|NOT COMPLETED|Overall Study||0||
48397800|NCT02560493|101302715|FG000|STARTED|Overall Study||23||
48397801|NCT02560493|101302716|FG001|STARTED|Overall Study||23||
48397802|NCT02560493|101302715|FG000|COMPLETED|Overall Study||22||
48397803|NCT02560493|101302716|FG001|COMPLETED|Overall Study||23||
48397804|NCT02560493|101302715|FG000|NOT COMPLETED|Overall Study||1||
48397805|NCT02560493|101302716|FG001|NOT COMPLETED|Overall Study||0||
48397806|NCT01745913|101302717|FG000|STARTED|Overall Study||1||
48397807|NCT01745913|101302718|FG001|STARTED|Overall Study||1||
48397808|NCT01745913|101302717|FG000|COMPLETED|Overall Study||0||
48397809|NCT01745913|101302718|FG001|COMPLETED|Overall Study||0||
48397810|NCT01745913|101302717|FG000|NOT COMPLETED|Overall Study||1||
48572444|NCT02266797|101735017|FG001|STARTED|Overall Study||3||
48572445|NCT02266797|101735016|FG000|COMPLETED|Overall Study||1||
48397811|NCT01745913|101302718|FG001|NOT COMPLETED|Overall Study||1||
48397812|NCT01015820|101302719|FG000|STARTED|Overall Study||15||
48397813|NCT01015820|101302720|FG001|STARTED|Overall Study||15||
48572446|NCT02266797|101735017|FG001|COMPLETED|Overall Study||2||
48700897|NCT01795495|102054106|FG000|STARTED|Overall Study||20||
48700898|NCT01795495|102054107|FG001|STARTED|Overall Study||22||
48700899|NCT01795495|102054108|FG002|STARTED|Overall Study||21||
48700900|NCT01795495|102054106|FG000|COMPLETED|Overall Study||19||
48700901|NCT01795495|102054107|FG001|COMPLETED|Overall Study||22||
48700902|NCT01795495|102054108|FG002|COMPLETED|Overall Study||19||
48700903|NCT01795495|102054106|FG000|NOT COMPLETED|Overall Study||1||
48700904|NCT01795495|102054107|FG001|NOT COMPLETED|Overall Study||0||
48700905|NCT01795495|102054108|FG002|NOT COMPLETED|Overall Study||2||
48700906|NCT02959853|102054109|FG000|STARTED|Overall Study||11||
48700907|NCT02959853|102054110|FG001|STARTED|Overall Study||12||
48397814|NCT01015820|101302719|FG000|COMPLETED|Overall Study||14||
48397815|NCT01015820|101302720|FG001|COMPLETED|Overall Study||15||
48397816|NCT01015820|101302719|FG000|NOT COMPLETED|Overall Study||1||
48397817|NCT01015820|101302720|FG001|NOT COMPLETED|Overall Study||0||
48397818|NCT00719537|101302721|FG000|STARTED|Overall Study||2||
48572447|NCT02266797|101735016|FG000|NOT COMPLETED|Overall Study||0||
48572448|NCT02266797|101735017|FG001|NOT COMPLETED|Overall Study||1||
48572449|NCT02730403|101735018|FG000|STARTED|Overall Study||211||
48572450|NCT02730403|101735018|FG000|COMPLETED|Overall Study||157||
48572451|NCT02730403|101735018|FG000|NOT COMPLETED|Overall Study||54||
48572452|NCT02199795|101735019|FG000|STARTED|Overall Study||4||
48572453|NCT02199795|101735020|FG001|STARTED|Overall Study||3||
48572454|NCT02199795|101735019|FG000|COMPLETED|Overall Study||2||
48572455|NCT02199795|101735020|FG001|COMPLETED|Overall Study||3||
48572456|NCT02199795|101735019|FG000|NOT COMPLETED|Overall Study||2||
48572457|NCT02199795|101735020|FG001|NOT COMPLETED|Overall Study||0||
48572458|NCT01732458|101735021|FG000|STARTED|Overall Study||60||
48572459|NCT01732458|101735022|FG001|STARTED|Overall Study||58||
48572460|NCT01732458|101735023|FG002|STARTED|Overall Study||58||
48572461|NCT01732458|101735024|FG003|STARTED|Overall Study||52||
48572462|NCT01732458|101735021|FG000|Treated|Overall Study||57||
48572463|NCT01732458|101735022|FG001|Treated|Overall Study||55||
48572464|NCT01732458|101735023|FG002|Treated|Overall Study||56||
48572465|NCT01732458|101735024|FG003|Treated|Overall Study||52||
48572466|NCT01732458|101735021|FG000|COMPLETED|Overall Study||57||
48572467|NCT01732458|101735022|FG001|COMPLETED|Overall Study||53||
48572468|NCT01732458|101735023|FG002|COMPLETED|Overall Study||55||
48572469|NCT01732458|101735024|FG003|COMPLETED|Overall Study||50||
48572470|NCT01732458|101735021|FG000|NOT COMPLETED|Overall Study||3||
48572471|NCT01732458|101735022|FG001|NOT COMPLETED|Overall Study||5||
48572472|NCT01732458|101735023|FG002|NOT COMPLETED|Overall Study||3||
48572473|NCT01732458|101735024|FG003|NOT COMPLETED|Overall Study||2||
48572474|NCT01866111|101735025|FG000|STARTED|Double-blind Period of Study YKP3089C017||108||
48572475|NCT01866111|101735026|FG001|STARTED|Double-blind Period of Study YKP3089C017||108||
48572476|NCT01866111|101735027|FG002|STARTED|Double-blind Period of Study YKP3089C017||110||
48572477|NCT01866111|101735028|FG003|STARTED|Double-blind Period of Study YKP3089C017||111||
48572478|NCT01866111|101735025|FG000|COMPLETED|Double-blind Period of Study YKP3089C017||94||
48572479|NCT01866111|101735026|FG001|COMPLETED|Double-blind Period of Study YKP3089C017||95||
48700908|NCT02959853|102054109|FG000|COMPLETED|Overall Study||7||
48700909|NCT02959853|102054110|FG001|COMPLETED|Overall Study||10||
48700910|NCT02959853|102054109|FG000|NOT COMPLETED|Overall Study||4||
48700911|NCT02959853|102054110|FG001|NOT COMPLETED|Overall Study||2||
48700912|NCT01549886|102054111|FG000|STARTED|Overall Study||2||
48700913|NCT01549886|102054112|FG001|STARTED|Overall Study||3||
48700914|NCT01549886|102054111|FG000|COMPLETED|Overall Study||0||
48700915|NCT01549886|102054112|FG001|COMPLETED|Overall Study||0||
48700916|NCT01549886|102054111|FG000|NOT COMPLETED|Overall Study||2||
48397819|NCT00719537|101302722|FG001|STARTED|Overall Study||1||
48397820|NCT00719537|101302721|FG000|COMPLETED|Overall Study||1||
48397821|NCT00719537|101302722|FG001|COMPLETED|Overall Study||0||
48397822|NCT00719537|101302721|FG000|NOT COMPLETED|Overall Study||1||
48397823|NCT00719537|101302722|FG001|NOT COMPLETED|Overall Study||1||
48397824|NCT01373918|101302723|FG000|STARTED|Overall Study||20||
48397825|NCT01373918|101302724|FG001|STARTED|Overall Study||16||
48397826|NCT01373918|101302723|FG000|COMPLETED|Overall Study||20||
48397827|NCT01373918|101302724|FG001|COMPLETED|Overall Study||15||
48397828|NCT01373918|101302723|FG000|NOT COMPLETED|Overall Study||0||
48397829|NCT01373918|101302724|FG001|NOT COMPLETED|Overall Study||1||
48397830|NCT02096042|101302725|FG000|STARTED|Overall Study||1||
48397831|NCT02096042|101302726|FG001|STARTED|Overall Study||0||
48397832|NCT02096042|101302727|FG002|STARTED|Overall Study||0||
48397833|NCT02096042|101302725|FG000|COMPLETED|Overall Study||0||
48397834|NCT02096042|101302726|FG001|COMPLETED|Overall Study||0||
48397835|NCT02096042|101302727|FG002|COMPLETED|Overall Study||0||
48397836|NCT02096042|101302725|FG000|NOT COMPLETED|Overall Study||1||
48397837|NCT02096042|101302726|FG001|NOT COMPLETED|Overall Study||0||
48397838|NCT02096042|101302727|FG002|NOT COMPLETED|Overall Study||0||
48397839|NCT02307318|101302728|FG000|STARTED|Overall Study||51||
48572480|NCT01866111|101735027|FG002|COMPLETED|Double-blind Period of Study YKP3089C017||90||
48572481|NCT01866111|101735028|FG003|COMPLETED|Double-blind Period of Study YKP3089C017||81||
48572482|NCT01866111|101735025|FG000|NOT COMPLETED|Double-blind Period of Study YKP3089C017||14||
48572483|NCT01866111|101735026|FG001|NOT COMPLETED|Double-blind Period of Study YKP3089C017||13||
48700917|NCT01549886|102054112|FG001|NOT COMPLETED|Overall Study||3||
48700918|NCT00726037|102054113|FG000|STARTED|Overall Study||7||
48700919|NCT00726037|102054113|FG000|COMPLETED|Overall Study||7||
48397840|NCT02307318|101302728|FG000|COMPLETED|Overall Study||51||
48397841|NCT02307318|101302728|FG000|NOT COMPLETED|Overall Study||0||
48397842|NCT03000686|101302729|FG000|STARTED|Part 1, Period 1 (1 Day)||5||
48397843|NCT03000686|101302730|FG001|STARTED|Part 1, Period 1 (1 Day)||6||
48397844|NCT03000686|101302731|FG002|STARTED|Part 1, Period 1 (1 Day)||0||
48397845|NCT03000686|101302732|FG003|STARTED|Part 1, Period 1 (1 Day)||0||
48397846|NCT03000686|101302729|FG000|COMPLETED|Part 1, Period 1 (1 Day)||5||
48397847|NCT03000686|101302730|FG001|COMPLETED|Part 1, Period 1 (1 Day)||5||
48397848|NCT03000686|101302731|FG002|COMPLETED|Part 1, Period 1 (1 Day)||0||
48397849|NCT03000686|101302732|FG003|COMPLETED|Part 1, Period 1 (1 Day)||0||
48397850|NCT03000686|101302729|FG000|NOT COMPLETED|Part 1, Period 1 (1 Day)||0||
48397851|NCT03000686|101302730|FG001|NOT COMPLETED|Part 1, Period 1 (1 Day)||1||
48397852|NCT03000686|101302731|FG002|NOT COMPLETED|Part 1, Period 1 (1 Day)||0||
48397853|NCT03000686|101302732|FG003|NOT COMPLETED|Part 1, Period 1 (1 Day)||0||
48397854|NCT03000686|101302729|FG000|STARTED|Part 1, Wash-out (Up to 14 Days)||5||
48397855|NCT03000686|101302730|FG001|STARTED|Part 1, Wash-out (Up to 14 Days)||5||
48397856|NCT03000686|101302731|FG002|STARTED|Part 1, Wash-out (Up to 14 Days)||0||
48397857|NCT03000686|101302732|FG003|STARTED|Part 1, Wash-out (Up to 14 Days)||0||
48397858|NCT03000686|101302729|FG000|COMPLETED|Part 1, Wash-out (Up to 14 Days)||5||
48397859|NCT03000686|101302730|FG001|COMPLETED|Part 1, Wash-out (Up to 14 Days)||5||
48397860|NCT03000686|101302731|FG002|COMPLETED|Part 1, Wash-out (Up to 14 Days)||0||
48397861|NCT03000686|101302732|FG003|COMPLETED|Part 1, Wash-out (Up to 14 Days)||0||
48127218|NCT00968617|100638148|FG000|COMPLETED|Overall Study||1||
48127219|NCT00968617|100638148|FG000|NOT COMPLETED|Overall Study||6||
48127220|NCT01047683|100638149|FG000|STARTED|Overall Study||76||
48127221|NCT01047683|100638150|FG001|STARTED|Overall Study||76||
48127222|NCT01047683|100638151|FG002|STARTED|Overall Study||77||
48127223|NCT01047683|100638149|FG000|COMPLETED|Overall Study||71||
48127224|NCT01047683|100638150|FG001|COMPLETED|Overall Study||70||
48127225|NCT01047683|100638151|FG002|COMPLETED|Overall Study||74||
48127226|NCT01047683|100638149|FG000|NOT COMPLETED|Overall Study||5||
48127227|NCT01047683|100638150|FG001|NOT COMPLETED|Overall Study||6||
48127228|NCT01047683|100638151|FG002|NOT COMPLETED|Overall Study||3||
48127229|NCT00975975|100638152|FG000|STARTED|Overall Study||17||
48127230|NCT00975975|100638152|FG000|COMPLETED|Overall Study||11||
48127231|NCT00975975|100638152|FG000|NOT COMPLETED|Overall Study||6||
48127232|NCT02731131|100638153|FG000|STARTED|Overall Study||6||
48127233|NCT02731131|100638154|FG001|STARTED|Overall Study||6||
48127234|NCT02731131|100638153|FG000|COMPLETED|Overall Study||6||
48127235|NCT02731131|100638154|FG001|COMPLETED|Overall Study||4||
48127236|NCT02731131|100638153|FG000|NOT COMPLETED|Overall Study||0||
48397862|NCT03000686|101302729|FG000|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0||
48397863|NCT03000686|101302730|FG001|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0||
48397864|NCT03000686|101302731|FG002|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0||
48397865|NCT03000686|101302732|FG003|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0||
48397866|NCT03000686|101302729|FG000|STARTED|Part 1, Period 2 (1 Day)||5||
48397867|NCT03000686|101302730|FG001|STARTED|Part 1, Period 2 (1 Day)||5||
48397868|NCT03000686|101302731|FG002|STARTED|Part 1, Period 2 (1 Day)||0||
48572484|NCT01866111|101735027|FG002|NOT COMPLETED|Double-blind Period of Study YKP3089C017||20||
48397869|NCT03000686|101302732|FG003|STARTED|Part 1, Period 2 (1 Day)||0||
48397870|NCT03000686|101302729|FG000|COMPLETED|Part 1, Period 2 (1 Day)||5||
48397871|NCT03000686|101302730|FG001|COMPLETED|Part 1, Period 2 (1 Day)||5||
48397872|NCT03000686|101302731|FG002|COMPLETED|Part 1, Period 2 (1 Day)||0||
48397873|NCT03000686|101302732|FG003|COMPLETED|Part 1, Period 2 (1 Day)||0||
48397874|NCT03000686|101302729|FG000|NOT COMPLETED|Part 1, Period 2 (1 Day)||0||
48397875|NCT03000686|101302730|FG001|NOT COMPLETED|Part 1, Period 2 (1 Day)||0||
48397876|NCT03000686|101302731|FG002|NOT COMPLETED|Part 1, Period 2 (1 Day)||0||
48397877|NCT03000686|101302732|FG003|NOT COMPLETED|Part 1, Period 2 (1 Day)||0||
48397878|NCT03000686|101302729|FG000|STARTED|Part 2, Period 1 (1 Day)||0||
48397879|NCT03000686|101302730|FG001|STARTED|Part 2, Period 1 (1 Day)||0||
48397880|NCT03000686|101302731|FG002|STARTED|Part 2, Period 1 (1 Day)||3||
48397881|NCT03000686|101302732|FG003|STARTED|Part 2, Period 1 (1 Day)||3||
48397882|NCT03000686|101302729|FG000|COMPLETED|Part 2, Period 1 (1 Day)||0||
48397883|NCT03000686|101302730|FG001|COMPLETED|Part 2, Period 1 (1 Day)||0||
48397884|NCT03000686|101302731|FG002|COMPLETED|Part 2, Period 1 (1 Day)||3||
48397885|NCT03000686|101302732|FG003|COMPLETED|Part 2, Period 1 (1 Day)||3||
48127237|NCT02731131|100638154|FG001|NOT COMPLETED|Overall Study||2||
48127238|NCT00746603|100638155|FG000|STARTED|Overall Study||3||
48127239|NCT00746603|100638155|FG000|COMPLETED|Overall Study||3||
48127240|NCT00746603|100638155|FG000|NOT COMPLETED|Overall Study||0||
48127241|NCT01033747|100638156|FG000|STARTED|Overall Study||51||
48127242|NCT01033747|100638157|FG001|STARTED|Overall Study||19||
48127243|NCT01033747|100638156|FG000|COMPLETED|Overall Study||14||
48127244|NCT01033747|100638157|FG001|COMPLETED|Overall Study||4||
48127245|NCT01033747|100638156|FG000|NOT COMPLETED|Overall Study||37||
48127246|NCT01033747|100638157|FG001|NOT COMPLETED|Overall Study||15||
48127247|NCT02080091|100638158|FG000|STARTED|Overall Study||25||
48397886|NCT03000686|101302729|FG000|NOT COMPLETED|Part 2, Period 1 (1 Day)||0||
48397887|NCT03000686|101302730|FG001|NOT COMPLETED|Part 2, Period 1 (1 Day)||0||
48572485|NCT01866111|101735028|FG003|NOT COMPLETED|Double-blind Period of Study YKP3089C017||30||
48572486|NCT01866111|101735025|FG000|STARTED|Open-label Extension Study YKP3089C017||91|Study is ongoing|
48572487|NCT01866111|101735026|FG001|STARTED|Open-label Extension Study YKP3089C017||95|Study is ongoing|
48572488|NCT01866111|101735027|FG002|STARTED|Open-label Extension Study YKP3089C017||90|Study is ongoing|
48572489|NCT01866111|101735028|FG003|STARTED|Open-label Extension Study YKP3089C017||80|Study is ongoing|
48572490|NCT01866111|101735025|FG000|COMPLETED|Open-label Extension Study YKP3089C017||26|OLE terminated in US|
48572491|NCT01866111|101735026|FG001|COMPLETED|Open-label Extension Study YKP3089C017||28|OLE terminated in US|
48572492|NCT01866111|101735027|FG002|COMPLETED|Open-label Extension Study YKP3089C017||27|OLE terminated in US|
48572493|NCT01866111|101735028|FG003|COMPLETED|Open-label Extension Study YKP3089C017||28|OLE terminated in US|
48572494|NCT01866111|101735025|FG000|NOT COMPLETED|Open-label Extension Study YKP3089C017||65||
48572495|NCT01866111|101735026|FG001|NOT COMPLETED|Open-label Extension Study YKP3089C017||67||
48572496|NCT01866111|101735027|FG002|NOT COMPLETED|Open-label Extension Study YKP3089C017||63||
48572497|NCT01866111|101735028|FG003|NOT COMPLETED|Open-label Extension Study YKP3089C017||52||
48572498|NCT01342770|101735029|FG000|STARTED|Overall Study||6||
48572499|NCT01342770|101735029|FG000|COMPLETED|Overall Study||6||
48572500|NCT01342770|101735029|FG000|NOT COMPLETED|Overall Study||0||
48572501|NCT03876743|101735030|FG000|STARTED|Overall Study||54||
48572502|NCT03876743|101735031|FG001|STARTED|Overall Study||51||
48572503|NCT03876743|101735032|FG002|STARTED|Overall Study||46||
48572504|NCT03876743|101735033|FG003|STARTED|Overall Study||50||
48700920|NCT00726037|102054113|FG000|NOT COMPLETED|Overall Study||0||
48700921|NCT00733291|102054114|FG000|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||13||
48700922|NCT00733291|102054115|FG001|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17||
48700923|NCT00733291|102054116|FG002|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17||
48700924|NCT00733291|102054117|FG003|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17||
48700925|NCT00733291|102054114|FG000|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||13||
48700926|NCT00733291|102054115|FG001|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17||
48700927|NCT00733291|102054116|FG002|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17||
48700928|NCT00733291|102054117|FG003|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17||
48700929|NCT00733291|102054114|FG000|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0||
48700930|NCT00733291|102054115|FG001|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0||
48700931|NCT00733291|102054116|FG002|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0||
48700932|NCT00733291|102054117|FG003|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0||
48700933|NCT00733291|102054114|FG000|STARTED|Washout Period, 3 Days (+/-1 Day)||13||
48283201|NCT03432260|101017126|FG004|COMPLETED|Overall Study||3||
48283202|NCT03432260|101017122|FG000|NOT COMPLETED|Overall Study||1||
48283203|NCT03432260|101017123|FG001|NOT COMPLETED|Overall Study||1||
48283204|NCT03432260|101017124|FG002|NOT COMPLETED|Overall Study||0||
48283205|NCT03432260|101017125|FG003|NOT COMPLETED|Overall Study||0||
48283206|NCT03432260|101017126|FG004|NOT COMPLETED|Overall Study||1||
48283207|NCT01427751|101017127|FG000|STARTED|Overall Study||154||
48283208|NCT01427751|101017128|FG001|STARTED|Overall Study||153||
48283209|NCT01427751|101017127|FG000|COMPLETED|Overall Study||112||
48283210|NCT01427751|101017128|FG001|COMPLETED|Overall Study||139||
48283211|NCT01427751|101017127|FG000|NOT COMPLETED|Overall Study||42||
48283212|NCT01427751|101017128|FG001|NOT COMPLETED|Overall Study||14||
48283213|NCT00653523|101017129|FG000|STARTED|Overall Study||151||
48283214|NCT00653523|101017129|FG000|COMPLETED|Overall Study||132||
48572505|NCT03876743|101735030|FG000|COMPLETED|Overall Study||48||
48572506|NCT03876743|101735031|FG001|COMPLETED|Overall Study||47||
48572507|NCT03876743|101735032|FG002|COMPLETED|Overall Study||42||
48572508|NCT03876743|101735033|FG003|COMPLETED|Overall Study||43||
48572509|NCT03876743|101735030|FG000|NOT COMPLETED|Overall Study||6||
48572510|NCT03876743|101735031|FG001|NOT COMPLETED|Overall Study||4||
48572511|NCT03876743|101735032|FG002|NOT COMPLETED|Overall Study||4||
48572512|NCT03876743|101735033|FG003|NOT COMPLETED|Overall Study||7||
48572513|NCT00656292|101735034|FG000|STARTED|Overall Study||32||
48700934|NCT00733291|102054115|FG001|STARTED|Washout Period, 3 Days (+/-1 Day)||17||
48700935|NCT00733291|102054116|FG002|STARTED|Washout Period, 3 Days (+/-1 Day)||17||
48700936|NCT00733291|102054117|FG003|STARTED|Washout Period, 3 Days (+/-1 Day)||17||
48700937|NCT00733291|102054114|FG000|COMPLETED|Washout Period, 3 Days (+/-1 Day)||12||
48700938|NCT00733291|102054115|FG001|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17||
48700939|NCT00733291|102054116|FG002|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17||
48700940|NCT00733291|102054117|FG003|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17||
48700941|NCT00733291|102054114|FG000|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||1||
48700942|NCT00733291|102054115|FG001|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0||
48700943|NCT00733291|102054116|FG002|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0||
48283215|NCT00653523|101017129|FG000|NOT COMPLETED|Overall Study||19||
48283216|NCT00888628|101017130|FG000|STARTED|Overall Study||7||
48283217|NCT00888628|101017130|FG000|Enrolled|Overall Study||7||
48283218|NCT00888628|101017130|FG000|Screen Failure|Overall Study||2||
48283219|NCT00888628|101017130|FG000|Withdrawn|Overall Study||1||
48283220|NCT00888628|101017130|FG000|Transplanted|Overall Study||4||
48283221|NCT00888628|101017130|FG000|COMPLETED|Overall Study||4||
48283222|NCT00888628|101017130|FG000|NOT COMPLETED|Overall Study||3||
48572514|NCT00656292|101735035|FG001|STARTED|Overall Study||29||
48572515|NCT00656292|101735034|FG000|COMPLETED|Overall Study||29||
48572516|NCT00656292|101735035|FG001|COMPLETED|Overall Study||24||
48572517|NCT00656292|101735034|FG000|NOT COMPLETED|Overall Study||3||
48572518|NCT00656292|101735035|FG001|NOT COMPLETED|Overall Study||5||
48572519|NCT00181285|101735036|FG000|STARTED|Overall Study||27||
48572520|NCT00181285|101735037|FG001|STARTED|Overall Study||25||
48572521|NCT00181285|101735036|FG000|COMPLETED|Overall Study||27||
48572522|NCT00181285|101735037|FG001|COMPLETED|Overall Study||25||
48572523|NCT00181285|101735036|FG000|NOT COMPLETED|Overall Study||0||
48572524|NCT00181285|101735037|FG001|NOT COMPLETED|Overall Study||0||
48572525|NCT03386994|101735038|FG000|STARTED|Overall Study||204|At inclusion visit (T0)|
48572526|NCT03386994|101735038|FG000|COMPLETED|Overall Study||166|At 12 month visit (T12)|
48127248|NCT02080091|100638158|FG000|COMPLETED|Overall Study||0||
48127249|NCT02080091|100638158|FG000|NOT COMPLETED|Overall Study||25||
48127250|NCT01427712|100638159|FG000|STARTED|Overall Study||24||
48127251|NCT01427712|100638159|FG000|Collected CRFs|Overall Study||21||
48127252|NCT01427712|100638159|FG000|Safety Analysis Set|Overall Study||21||
48127253|NCT01427712|100638159|FG000|COMPLETED|Overall Study||17||
48127254|NCT01427712|100638159|FG000|NOT COMPLETED|Overall Study||7||
48127255|NCT02829034|100638160|FG000|STARTED|Overall Study||14||
48127256|NCT02829034|100638161|FG001|STARTED|Overall Study||8||
48127257|NCT02829034|100638160|FG000|COMPLETED|Overall Study||9||
48127258|NCT02829034|100638161|FG001|COMPLETED|Overall Study||6||
48127259|NCT02829034|100638160|FG000|NOT COMPLETED|Overall Study||5||
48127260|NCT02829034|100638161|FG001|NOT COMPLETED|Overall Study||2||
48127261|NCT01351805|100638162|FG000|STARTED|Overall Study||6463||
48127262|NCT01351805|100638163|FG001|STARTED|Overall Study||6464||
48127263|NCT01351805|100638164|FG002|STARTED|Overall Study||6470||
48127264|NCT01351805|100638165|FG003|STARTED|Overall Study||6474||
48127265|NCT01351805|100638162|FG000|COMPLETED|Overall Study||6463||
48127266|NCT01351805|100638163|FG001|COMPLETED|Overall Study||6464||
48127267|NCT01351805|100638164|FG002|COMPLETED|Overall Study||6470||
48283223|NCT03097484|101017131|FG000|STARTED|Overall Study||19||
48283224|NCT03097484|101017132|FG001|STARTED|Overall Study||19||
48283225|NCT03097484|101017131|FG000|COMPLETED|Overall Study||19||
48283226|NCT03097484|101017132|FG001|COMPLETED|Overall Study||19||
48283227|NCT03097484|101017131|FG000|NOT COMPLETED|Overall Study||0||
48283228|NCT03097484|101017132|FG001|NOT COMPLETED|Overall Study||0||
48283229|NCT00531453|101017133|FG000|STARTED|Overall Study||49||
48397888|NCT03000686|101302731|FG002|NOT COMPLETED|Part 2, Period 1 (1 Day)||0||
48397889|NCT03000686|101302732|FG003|NOT COMPLETED|Part 2, Period 1 (1 Day)||0||
48397890|NCT03000686|101302729|FG000|STARTED|Part 2, Wash-out (Up to 14 Days)||0||
48283230|NCT00531453|101017134|FG001|STARTED|Overall Study||49||
48397891|NCT03000686|101302730|FG001|STARTED|Part 2, Wash-out (Up to 14 Days)||0||
48397892|NCT03000686|101302731|FG002|STARTED|Part 2, Wash-out (Up to 14 Days)||3||
48397893|NCT03000686|101302732|FG003|STARTED|Part 2, Wash-out (Up to 14 Days)||3||
48397894|NCT03000686|101302729|FG000|COMPLETED|Part 2, Wash-out (Up to 14 Days)||0||
48397895|NCT03000686|101302730|FG001|COMPLETED|Part 2, Wash-out (Up to 14 Days)||0||
48397896|NCT03000686|101302731|FG002|COMPLETED|Part 2, Wash-out (Up to 14 Days)||3||
48397897|NCT03000686|101302732|FG003|COMPLETED|Part 2, Wash-out (Up to 14 Days)||3||
48397898|NCT03000686|101302729|FG000|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0||
48397899|NCT03000686|101302730|FG001|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0||
48572527|NCT03386994|101735038|FG000|NOT COMPLETED|Overall Study||38||
48572528|NCT03759587|101735039|FG000|STARTED|Overall Study||19||
48572529|NCT03759587|101735039|FG000|Response Evaluable Set|Overall Study||5|Response-evaluable analysis set includes participants who had measurable disease at baseline.|
48572530|NCT03759587|101735039|FG000|COMPLETED|Overall Study||0||
48572531|NCT03759587|101735039|FG000|NOT COMPLETED|Overall Study||19||
48572532|NCT03674112|101735040|FG000|STARTED|Treatment Cross-Over (Cycles 1 to 6)||80||
48572533|NCT03674112|101735041|FG001|STARTED|Treatment Cross-Over (Cycles 1 to 6)||80||
48572534|NCT03674112|101735040|FG000|Completed Cross-Over Treatment|Treatment Cross-Over (Cycles 1 to 6)||80|Received all 6 cycles of cross-over treatment|
48572535|NCT03674112|101735041|FG001|Completed Cross-Over Treatment|Treatment Cross-Over (Cycles 1 to 6)||80|Received all 6 cycles of cross-over treatment|
48700944|NCT00733291|102054117|FG003|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0||
48127268|NCT01351805|100638165|FG003|COMPLETED|Overall Study||6474||
48127269|NCT01351805|100638162|FG000|NOT COMPLETED|Overall Study||0||
48127270|NCT01351805|100638163|FG001|NOT COMPLETED|Overall Study||0||
48127271|NCT01351805|100638164|FG002|NOT COMPLETED|Overall Study||0||
48127272|NCT01351805|100638165|FG003|NOT COMPLETED|Overall Study||0||
48127273|NCT01754714|100638166|FG000|STARTED|Overall Study||27||
48127274|NCT01754714|100638167|FG001|STARTED|Overall Study||27||
48127275|NCT01754714|100638168|FG002|STARTED|Overall Study||26||
48127276|NCT01754714|100638169|FG003|STARTED|Overall Study||28||
48127277|NCT01754714|100638166|FG000|COMPLETED|Overall Study||27||
48127278|NCT01754714|100638167|FG001|COMPLETED|Overall Study||26||
48127279|NCT01754714|100638168|FG002|COMPLETED|Overall Study||24||
48127280|NCT01754714|100638169|FG003|COMPLETED|Overall Study||27||
48283231|NCT00531453|101017133|FG000|COMPLETED|Overall Study||49||
48283232|NCT00531453|101017134|FG001|COMPLETED|Overall Study||49||
48572536|NCT03674112|101735040|FG000|COMPLETED|Treatment Cross-Over (Cycles 1 to 6)||79|Completed the Treatment Cross-Over Period|
48127281|NCT01754714|100638166|FG000|NOT COMPLETED|Overall Study||0||
48127282|NCT01754714|100638167|FG001|NOT COMPLETED|Overall Study||1||
48127283|NCT01754714|100638168|FG002|NOT COMPLETED|Overall Study||2||
48127284|NCT01754714|100638169|FG003|NOT COMPLETED|Overall Study||1||
48127285|NCT00293540|100638170|FG000|STARTED|Overall Study||122||
48127286|NCT00293540|100638171|FG001|STARTED|Overall Study||127||
48127287|NCT00293540|100638170|FG000|COMPLETED|Overall Study||115||
48127288|NCT00293540|100638171|FG001|COMPLETED|Overall Study||119||
48127289|NCT00293540|100638170|FG000|NOT COMPLETED|Overall Study||7||
48397900|NCT03000686|101302731|FG002|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0||
48397901|NCT03000686|101302732|FG003|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0||
48397902|NCT03000686|101302729|FG000|STARTED|Part 2, Period 2 (1 Day)||0||
48127290|NCT00293540|100638171|FG001|NOT COMPLETED|Overall Study||8||
48127291|NCT03333746|100638172|FG000|STARTED|Overall Study||1||
48127292|NCT03333746|100638172|FG000|COMPLETED|Overall Study||0||
48127293|NCT03333746|100638172|FG000|NOT COMPLETED|Overall Study||1||
48127294|NCT03766646|100638173|FG000|STARTED|Overall Study||19||
48127295|NCT03766646|100638174|FG001|STARTED|Overall Study||15||
48127296|NCT03766646|100638173|FG000|COMPLETED|Overall Study||18||
48127297|NCT03766646|100638174|FG001|COMPLETED|Overall Study||12||
48127298|NCT03766646|100638173|FG000|NOT COMPLETED|Overall Study||1||
48127299|NCT03766646|100638174|FG001|NOT COMPLETED|Overall Study||3||
48127300|NCT02041429|100638175|FG000|STARTED|Overall Study||3||
48127301|NCT02041429|100638176|FG001|STARTED|Overall Study||4||
48127302|NCT02041429|100638177|FG002|STARTED|Overall Study||7||
48127303|NCT02041429|100638178|FG003|STARTED|Overall Study||6||
48127304|NCT02041429|100638175|FG000|Treated|Overall Study||3||
48127305|NCT02041429|100638176|FG001|Treated|Overall Study||3||
48127306|NCT02041429|100638177|FG002|Treated|Overall Study||7||
48127307|NCT02041429|100638178|FG003|Treated|Overall Study||6||
48127308|NCT02041429|100638175|FG000|Evaluable for Dose Limiting Toxicity|Overall Study||3||
48127309|NCT02041429|100638176|FG001|Evaluable for Dose Limiting Toxicity|Overall Study||3||
48127310|NCT02041429|100638177|FG002|Evaluable for Dose Limiting Toxicity|Overall Study||6||
48127311|NCT02041429|100638178|FG003|Evaluable for Dose Limiting Toxicity|Overall Study||6||
48127312|NCT02041429|100638175|FG000|COMPLETED|Overall Study||0||
48127313|NCT02041429|100638176|FG001|COMPLETED|Overall Study||0||
48127314|NCT02041429|100638177|FG002|COMPLETED|Overall Study||0||
48127315|NCT02041429|100638178|FG003|COMPLETED|Overall Study||0||
48127316|NCT02041429|100638175|FG000|NOT COMPLETED|Overall Study||3||
48127317|NCT02041429|100638176|FG001|NOT COMPLETED|Overall Study||4||
48127318|NCT02041429|100638177|FG002|NOT COMPLETED|Overall Study||7||
48127319|NCT02041429|100638178|FG003|NOT COMPLETED|Overall Study||6||
48127320|NCT00298233|100638179|FG000|STARTED|Overall Study||39||
48127321|NCT00298233|100638180|FG001|STARTED|Overall Study||41||
48127322|NCT00298233|100638181|FG002|STARTED|Overall Study||122||
48127323|NCT00298233|100638182|FG003|STARTED|Overall Study||124||
48127324|NCT00298233|100638179|FG000|COMPLETED|Overall Study||39||
48127325|NCT00298233|100638180|FG001|COMPLETED|Overall Study||41||
48127326|NCT00298233|100638181|FG002|COMPLETED|Overall Study||122||
48127327|NCT00298233|100638182|FG003|COMPLETED|Overall Study||124||
48127328|NCT00298233|100638179|FG000|NOT COMPLETED|Overall Study||0||
48397903|NCT03000686|101302730|FG001|STARTED|Part 2, Period 2 (1 Day)||0||
48127329|NCT00298233|100638180|FG001|NOT COMPLETED|Overall Study||0||
48127330|NCT00298233|100638181|FG002|NOT COMPLETED|Overall Study||0||
48127331|NCT00298233|100638182|FG003|NOT COMPLETED|Overall Study||0||
48127332|NCT01154634|100638183|FG000|STARTED|Period 1 - First Intervention||4||
48127333|NCT01154634|100638184|FG001|STARTED|Period 1 - First Intervention||7||
48397904|NCT03000686|101302731|FG002|STARTED|Part 2, Period 2 (1 Day)||3||
48397905|NCT03000686|101302732|FG003|STARTED|Part 2, Period 2 (1 Day)||3||
48397906|NCT03000686|101302729|FG000|COMPLETED|Part 2, Period 2 (1 Day)||0||
48397907|NCT03000686|101302730|FG001|COMPLETED|Part 2, Period 2 (1 Day)||0||
48127334|NCT01154634|100638185|FG002|STARTED|Period 1 - First Intervention||4||
48127335|NCT01154634|100638186|FG003|STARTED|Period 1 - First Intervention||5||
48127336|NCT01154634|100638183|FG000|COMPLETED|Period 1 - First Intervention||4||
48127337|NCT01154634|100638184|FG001|COMPLETED|Period 1 - First Intervention||7||
48127338|NCT01154634|100638185|FG002|COMPLETED|Period 1 - First Intervention||4||
48127339|NCT01154634|100638186|FG003|COMPLETED|Period 1 - First Intervention||5||
48127340|NCT01154634|100638183|FG000|NOT COMPLETED|Period 1 - First Intervention||0||
48127341|NCT01154634|100638184|FG001|NOT COMPLETED|Period 1 - First Intervention||0||
48127342|NCT01154634|100638185|FG002|NOT COMPLETED|Period 1 - First Intervention||0||
48127343|NCT01154634|100638186|FG003|NOT COMPLETED|Period 1 - First Intervention||0||
48397908|NCT03000686|101302731|FG002|COMPLETED|Part 2, Period 2 (1 Day)||3||
48127344|NCT01154634|100638183|FG000|STARTED|Period 2 - Washout||4||
48127345|NCT01154634|100638184|FG001|STARTED|Period 2 - Washout||7||
48127346|NCT01154634|100638185|FG002|STARTED|Period 2 - Washout||4||
48127347|NCT01154634|100638186|FG003|STARTED|Period 2 - Washout||5||
48127348|NCT01154634|100638183|FG000|COMPLETED|Period 2 - Washout||4||
48127349|NCT01154634|100638184|FG001|COMPLETED|Period 2 - Washout||7||
48127350|NCT01154634|100638185|FG002|COMPLETED|Period 2 - Washout||4||
48127351|NCT01154634|100638186|FG003|COMPLETED|Period 2 - Washout||5||
48397909|NCT03000686|101302732|FG003|COMPLETED|Part 2, Period 2 (1 Day)||3||
48283233|NCT00531453|101017133|FG000|NOT COMPLETED|Overall Study||0||
48283234|NCT00531453|101017134|FG001|NOT COMPLETED|Overall Study||0||
48283235|NCT00467285|101017135|FG000|STARTED|Overall Study||32||
48283236|NCT00467285|101017136|FG001|STARTED|Overall Study||64||
48283237|NCT00467285|101017135|FG000|COMPLETED|Overall Study||28||
48283238|NCT00467285|101017136|FG001|COMPLETED|Overall Study||60||
48283239|NCT00467285|101017135|FG000|NOT COMPLETED|Overall Study||4||
48283240|NCT00467285|101017136|FG001|NOT COMPLETED|Overall Study||4||
48572537|NCT03674112|101735041|FG001|COMPLETED|Treatment Cross-Over (Cycles 1 to 6)||80|Completed the Treatment Cross-Over Period|
48572538|NCT03674112|101735040|FG000|NOT COMPLETED|Treatment Cross-Over (Cycles 1 to 6)||1||
48572539|NCT03674112|101735041|FG001|NOT COMPLETED|Treatment Cross-Over (Cycles 1 to 6)||0||
48572540|NCT03674112|101735040|FG000|STARTED|Treatment Continuation (Cycles 7 to ≤18)||79||
48700945|NCT00733291|102054114|FG000|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||12||
48127352|NCT01154634|100638183|FG000|NOT COMPLETED|Period 2 - Washout||0||
48127353|NCT01154634|100638184|FG001|NOT COMPLETED|Period 2 - Washout||0||
48283241|NCT01033422|101017137|FG000|STARTED|Overall Study||34||
48283242|NCT01033422|101017138|FG001|STARTED|Overall Study||32||
48283243|NCT01033422|101017139|FG002|STARTED|Overall Study||23||
48283244|NCT01033422|101017137|FG000|COMPLETED|Overall Study||33||
48283245|NCT01033422|101017138|FG001|COMPLETED|Overall Study||28||
48283246|NCT01033422|101017139|FG002|COMPLETED|Overall Study||22||
48283247|NCT01033422|101017137|FG000|NOT COMPLETED|Overall Study||1||
48283248|NCT01033422|101017138|FG001|NOT COMPLETED|Overall Study||4||
48283249|NCT01033422|101017139|FG002|NOT COMPLETED|Overall Study||1||
48283250|NCT00003453|101017140|FG000|STARTED|Overall Study||6||
48283251|NCT00003453|101017140|FG000|COMPLETED|Overall Study||5||
48283252|NCT00003453|101017140|FG000|NOT COMPLETED|Overall Study||1||
48283253|NCT03836716|101017141|FG000|STARTED|Overall Study||120||
48283254|NCT03836716|101017141|FG000|COMPLETED|Overall Study||0||
48283255|NCT03836716|101017141|FG000|NOT COMPLETED|Overall Study||120||
48283256|NCT04339959|101017142|FG000|STARTED|Overall Study||10||
48283257|NCT04339959|101017143|FG001|STARTED|Overall Study||5||
48283258|NCT04339959|101017144|FG002|STARTED|Overall Study||9||
48283259|NCT04339959|101017145|FG003|STARTED|Overall Study||9||
48283260|NCT04339959|101017142|FG000|COMPLETED|Overall Study||10||
48283261|NCT04339959|101017143|FG001|COMPLETED|Overall Study||5||
48572541|NCT03674112|101735041|FG001|STARTED|Treatment Continuation (Cycles 7 to ≤18)||80||
48572542|NCT03674112|101735040|FG000|Received PH FDC SC for Treatment Continuation|Treatment Continuation (Cycles 7 to ≤18)||70||
48572543|NCT03674112|101735041|FG001|Received PH FDC SC for Treatment Continuation|Treatment Continuation (Cycles 7 to ≤18)||68||
48572544|NCT03674112|101735040|FG000|Received P+H IV for Treatment Continuation|Treatment Continuation (Cycles 7 to ≤18)||9||
48572545|NCT03674112|101735041|FG001|Received P+H IV for Treatment Continuation|Treatment Continuation (Cycles 7 to ≤18)||12||
48572546|NCT03674112|101735040|FG000|Completed Continuation Treatment|Treatment Continuation (Cycles 7 to ≤18)||78|Received all cycles of continuation treatment (from Cycle 7 up to 18 total cycles of neo/adjuvant treatment)|
48572547|NCT03674112|101735041|FG001|Completed Continuation Treatment|Treatment Continuation (Cycles 7 to ≤18)||77|Received all cycles of continuation treatment (from Cycle 7 up to 18 total cycles of neo/adjuvant treatment)|
48572548|NCT03674112|101735040|FG000|COMPLETED|Treatment Continuation (Cycles 7 to ≤18)||78|Completed the Treatment Continuation Period|
48572549|NCT03674112|101735041|FG001|COMPLETED|Treatment Continuation (Cycles 7 to ≤18)||77|Completed the Treatment Continuation Period|
48710825|NCT03446053|102078033|FG003|STARTED|Overall Study||7||
48127354|NCT01154634|100638185|FG002|NOT COMPLETED|Period 2 - Washout||0||
48127355|NCT01154634|100638186|FG003|NOT COMPLETED|Period 2 - Washout||0||
48283262|NCT04339959|101017144|FG002|COMPLETED|Overall Study||9||
48283263|NCT04339959|101017145|FG003|COMPLETED|Overall Study||9||
48283264|NCT04339959|101017142|FG000|NOT COMPLETED|Overall Study||0||
48283265|NCT04339959|101017143|FG001|NOT COMPLETED|Overall Study||0||
48283266|NCT04339959|101017144|FG002|NOT COMPLETED|Overall Study||0||
48283267|NCT04339959|101017145|FG003|NOT COMPLETED|Overall Study||0||
48283268|NCT03422198|101017146|FG000|STARTED|Overall Study||54||
48283269|NCT03422198|101017147|FG001|STARTED|Overall Study||54||
48283270|NCT03422198|101017146|FG000|COMPLETED|Overall Study||54||
48283271|NCT03422198|101017147|FG001|COMPLETED|Overall Study||54||
48283272|NCT03422198|101017146|FG000|NOT COMPLETED|Overall Study||0||
48283273|NCT03422198|101017147|FG001|NOT COMPLETED|Overall Study||0||
48283274|NCT01983254|101017148|FG000|STARTED|Overall Study||125||
48283275|NCT01983254|101017149|FG001|STARTED|Overall Study||136||
48283276|NCT01983254|101017148|FG000|Interview 1|Overall Study||125||
48283277|NCT01983254|101017149|FG001|Interview 1|Overall Study||136||
48283278|NCT01983254|101017148|FG000|Interview 2|Overall Study||95||
48283279|NCT01983254|101017149|FG001|Interview 2|Overall Study||110||
48283280|NCT01983254|101017148|FG000|Interview 3|Overall Study||91||
48283281|NCT01983254|101017149|FG001|Interview 3|Overall Study||106||
48283282|NCT01983254|101017148|FG000|COMPLETED|Overall Study||91||
48283283|NCT01983254|101017149|FG001|COMPLETED|Overall Study||106||
48283284|NCT01983254|101017148|FG000|NOT COMPLETED|Overall Study||34||
48283285|NCT01983254|101017149|FG001|NOT COMPLETED|Overall Study||30||
48283286|NCT01867333|101017150|FG000|STARTED|Overall Study||29||
48283287|NCT01867333|101017151|FG001|STARTED|Overall Study||28||
48283288|NCT01867333|101017150|FG000|COMPLETED|Overall Study||21||
48283289|NCT01867333|101017151|FG001|COMPLETED|Overall Study||23||
48127356|NCT01154634|100638183|FG000|STARTED|Period 3- Second Intervention||4||
48127357|NCT01154634|100638184|FG001|STARTED|Period 3- Second Intervention||7||
48127358|NCT01154634|100638185|FG002|STARTED|Period 3- Second Intervention||4||
48127359|NCT01154634|100638186|FG003|STARTED|Period 3- Second Intervention||5||
48127360|NCT01154634|100638183|FG000|COMPLETED|Period 3- Second Intervention||4||
48127361|NCT01154634|100638184|FG001|COMPLETED|Period 3- Second Intervention||7||
48127362|NCT01154634|100638185|FG002|COMPLETED|Period 3- Second Intervention||4||
48127363|NCT01154634|100638186|FG003|COMPLETED|Period 3- Second Intervention||5||
48127364|NCT01154634|100638183|FG000|NOT COMPLETED|Period 3- Second Intervention||0||
48127365|NCT01154634|100638184|FG001|NOT COMPLETED|Period 3- Second Intervention||0||
48127366|NCT01154634|100638185|FG002|NOT COMPLETED|Period 3- Second Intervention||0||
48127367|NCT01154634|100638186|FG003|NOT COMPLETED|Period 3- Second Intervention||0||
48127368|NCT01154634|100638183|FG000|STARTED|Period 4 - Washout||4||
48127369|NCT01154634|100638184|FG001|STARTED|Period 4 - Washout||7||
48127370|NCT01154634|100638185|FG002|STARTED|Period 4 - Washout||4||
48127371|NCT01154634|100638186|FG003|STARTED|Period 4 - Washout||5||
48127372|NCT01154634|100638183|FG000|COMPLETED|Period 4 - Washout||4||
48127373|NCT01154634|100638184|FG001|COMPLETED|Period 4 - Washout||7||
48127374|NCT01154634|100638185|FG002|COMPLETED|Period 4 - Washout||4||
48127375|NCT01154634|100638186|FG003|COMPLETED|Period 4 - Washout||5||
48127376|NCT01154634|100638183|FG000|NOT COMPLETED|Period 4 - Washout||0||
48127377|NCT01154634|100638184|FG001|NOT COMPLETED|Period 4 - Washout||0||
48127378|NCT01154634|100638185|FG002|NOT COMPLETED|Period 4 - Washout||0||
48127379|NCT01154634|100638186|FG003|NOT COMPLETED|Period 4 - Washout||0||
48127380|NCT01154634|100638183|FG000|STARTED|Period 5 - Third Intervention||4||
48127381|NCT01154634|100638184|FG001|STARTED|Period 5 - Third Intervention||7||
48127382|NCT01154634|100638185|FG002|STARTED|Period 5 - Third Intervention||4||
48127383|NCT01154634|100638186|FG003|STARTED|Period 5 - Third Intervention||5||
48127384|NCT01154634|100638183|FG000|COMPLETED|Period 5 - Third Intervention||4||
48127385|NCT01154634|100638184|FG001|COMPLETED|Period 5 - Third Intervention||7||
48397910|NCT03000686|101302729|FG000|NOT COMPLETED|Part 2, Period 2 (1 Day)||0||
48397911|NCT03000686|101302730|FG001|NOT COMPLETED|Part 2, Period 2 (1 Day)||0||
48397912|NCT03000686|101302731|FG002|NOT COMPLETED|Part 2, Period 2 (1 Day)||0||
48397913|NCT03000686|101302732|FG003|NOT COMPLETED|Part 2, Period 2 (1 Day)||0||
48397914|NCT02352103|101302733|FG000|STARTED|Overall Study||60||
48397915|NCT02352103|101302734|FG001|STARTED|Overall Study||60||
48127386|NCT01154634|100638185|FG002|COMPLETED|Period 5 - Third Intervention||4||
48127387|NCT01154634|100638186|FG003|COMPLETED|Period 5 - Third Intervention||5||
48127388|NCT01154634|100638183|FG000|NOT COMPLETED|Period 5 - Third Intervention||0||
48127389|NCT01154634|100638184|FG001|NOT COMPLETED|Period 5 - Third Intervention||0||
48127390|NCT01154634|100638185|FG002|NOT COMPLETED|Period 5 - Third Intervention||0||
48127391|NCT01154634|100638186|FG003|NOT COMPLETED|Period 5 - Third Intervention||0||
48397916|NCT02352103|101302733|FG000|COMPLETED|Overall Study||60||
48127392|NCT01154634|100638183|FG000|STARTED|Period 6 - Washout||4||
48127393|NCT01154634|100638184|FG001|STARTED|Period 6 - Washout||7||
48127394|NCT01154634|100638185|FG002|STARTED|Period 6 - Washout||4||
48127395|NCT01154634|100638186|FG003|STARTED|Period 6 - Washout||5||
48127396|NCT01154634|100638183|FG000|COMPLETED|Period 6 - Washout||4||
48127397|NCT01154634|100638184|FG001|COMPLETED|Period 6 - Washout||7||
48127398|NCT01154634|100638185|FG002|COMPLETED|Period 6 - Washout||4||
48127399|NCT01154634|100638186|FG003|COMPLETED|Period 6 - Washout||5||
48127400|NCT01154634|100638183|FG000|NOT COMPLETED|Period 6 - Washout||0||
48127401|NCT01154634|100638184|FG001|NOT COMPLETED|Period 6 - Washout||0||
48127402|NCT01154634|100638185|FG002|NOT COMPLETED|Period 6 - Washout||0||
48127403|NCT01154634|100638186|FG003|NOT COMPLETED|Period 6 - Washout||0||
48127404|NCT01154634|100638183|FG000|STARTED|Period 7 - Fourth Intervention||4||
48127405|NCT01154634|100638184|FG001|STARTED|Period 7 - Fourth Intervention||7||
48397917|NCT02352103|101302734|FG001|COMPLETED|Overall Study||59||
48127406|NCT01154634|100638185|FG002|STARTED|Period 7 - Fourth Intervention||4||
48127407|NCT01154634|100638186|FG003|STARTED|Period 7 - Fourth Intervention||5||
48127408|NCT01154634|100638183|FG000|COMPLETED|Period 7 - Fourth Intervention||4||
48127409|NCT01154634|100638184|FG001|COMPLETED|Period 7 - Fourth Intervention||7||
48127410|NCT01154634|100638185|FG002|COMPLETED|Period 7 - Fourth Intervention||4||
48127411|NCT01154634|100638186|FG003|COMPLETED|Period 7 - Fourth Intervention||5||
48127412|NCT01154634|100638183|FG000|NOT COMPLETED|Period 7 - Fourth Intervention||0||
48283290|NCT01867333|101017150|FG000|NOT COMPLETED|Overall Study||8||
48127413|NCT01154634|100638184|FG001|NOT COMPLETED|Period 7 - Fourth Intervention||0||
48127414|NCT01154634|100638185|FG002|NOT COMPLETED|Period 7 - Fourth Intervention||0||
48127415|NCT01154634|100638186|FG003|NOT COMPLETED|Period 7 - Fourth Intervention||0||
48127416|NCT00085410|100638187|FG000|STARTED|Overall Study||20||
48127417|NCT00085410|100638187|FG000|COMPLETED|Overall Study||20||
48127418|NCT00085410|100638187|FG000|NOT COMPLETED|Overall Study||0||
48283291|NCT01867333|101017151|FG001|NOT COMPLETED|Overall Study||5||
48283292|NCT01789567|101017152|FG000|STARTED|Overall Study||20||
48283293|NCT01789567|101017152|FG000|COMPLETED|Overall Study||14||
48283294|NCT01789567|101017152|FG000|NOT COMPLETED|Overall Study||6||
48283295|NCT01967147|101017153|FG000|STARTED|Overall Study||112||
48283296|NCT01967147|101017154|FG001|STARTED|Overall Study||102||
48283297|NCT01967147|101017153|FG000|COMPLETED|Overall Study||99||
48283298|NCT01967147|101017154|FG001|COMPLETED|Overall Study||82||
48283299|NCT01967147|101017153|FG000|NOT COMPLETED|Overall Study||13||
48283300|NCT01967147|101017154|FG001|NOT COMPLETED|Overall Study||20||
48283301|NCT00141219|101017155|FG000|STARTED|Overall Study||162||
48283302|NCT00141219|101017156|FG001|STARTED|Overall Study||78||
48283303|NCT00141219|101017155|FG000|COMPLETED|Overall Study||138||
48283304|NCT00141219|101017156|FG001|COMPLETED|Overall Study||62||
48283305|NCT00141219|101017155|FG000|NOT COMPLETED|Overall Study||24||
48572550|NCT03674112|101735040|FG000|NOT COMPLETED|Treatment Continuation (Cycles 7 to ≤18)||1||
48572551|NCT03674112|101735041|FG001|NOT COMPLETED|Treatment Continuation (Cycles 7 to ≤18)||3||
48572552|NCT03674112|101735040|FG000|STARTED|Follow-Up Period (≥3 Years)||80|Participants who discontinued previous treatment periods but remained in the study continued into the follow-up period.|
48572553|NCT03674112|101735041|FG001|STARTED|Follow-Up Period (≥3 Years)||79|Participants who discontinued previous treatment periods but remained in the study continued into the follow-up period.|
48572554|NCT03674112|101735040|FG000|COMPLETED|Follow-Up Period (≥3 Years)||73||
48572555|NCT03674112|101735041|FG001|COMPLETED|Follow-Up Period (≥3 Years)||75||
48572556|NCT03674112|101735040|FG000|NOT COMPLETED|Follow-Up Period (≥3 Years)||7||
48572557|NCT03674112|101735041|FG001|NOT COMPLETED|Follow-Up Period (≥3 Years)||4||
48572558|NCT00570687|101735042|FG000|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
48572559|NCT00570687|101735043|FG001|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
48572560|NCT00570687|101735044|FG002|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
48572561|NCT00570687|101735045|FG003|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
48572562|NCT00570687|101735046|FG004|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3||
48572563|NCT00570687|101735047|FG005|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3||
48572564|NCT00570687|101735048|FG006|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3||
48572565|NCT00570687|101735049|FG007|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3||
48572566|NCT00570687|101735050|FG008|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3||
48700946|NCT00733291|102054115|FG001|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17||
48700947|NCT00733291|102054116|FG002|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17||
48700948|NCT00733291|102054117|FG003|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17||
48700949|NCT00733291|102054114|FG000|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||12||
48700950|NCT00733291|102054115|FG001|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17||
48700951|NCT00733291|102054116|FG002|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17||
48127419|NCT02056301|100638188|FG000|STARTED|Overall Study||33||
48127420|NCT02056301|100638189|FG001|STARTED|Overall Study||29||
48127421|NCT02056301|100638188|FG000|COMPLETED|Overall Study||31||
48127422|NCT02056301|100638189|FG001|COMPLETED|Overall Study||23||
48127423|NCT02056301|100638188|FG000|NOT COMPLETED|Overall Study||2||
48127424|NCT02056301|100638189|FG001|NOT COMPLETED|Overall Study||6||
48127425|NCT01462344|100638190|FG000|STARTED|Overall Study||3107||
48127426|NCT01462344|100638191|FG001|STARTED|Overall Study||3101||
48127427|NCT01462344|100638190|FG000|COMPLETED|Overall Study||2724||
48283306|NCT00141219|101017156|FG001|NOT COMPLETED|Overall Study||16||
48283307|NCT03103490|101017157|FG000|STARTED|Overall Study||28||
48283308|NCT03103490|101017157|FG000|COMPLETED|Overall Study||28||
48283309|NCT03103490|101017157|FG000|NOT COMPLETED|Overall Study||0||
48283310|NCT02075073|101017158|FG000|STARTED|Overall Study||36||
48283311|NCT02075073|101017159|FG001|STARTED|Overall Study||37||
48283312|NCT02075073|101017160|FG002|STARTED|Overall Study||36||
48283313|NCT02075073|101017158|FG000|COMPLETED|Overall Study||36||
48283314|NCT02075073|101017159|FG001|COMPLETED|Overall Study||36||
48283315|NCT02075073|101017160|FG002|COMPLETED|Overall Study||36||
48283316|NCT02075073|101017158|FG000|NOT COMPLETED|Overall Study||0||
48283317|NCT02075073|101017159|FG001|NOT COMPLETED|Overall Study||1||
48283318|NCT02075073|101017160|FG002|NOT COMPLETED|Overall Study||0||
48283319|NCT00657020|101017161|FG000|STARTED|PERIOD 1||11||
48283320|NCT00657020|101017162|FG001|STARTED|PERIOD 1||12||
48572567|NCT00570687|101735051|FG009|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3||
48572568|NCT00570687|101735042|FG000|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
48283321|NCT00657020|101017161|FG000|COMPLETED|PERIOD 1||11||
48283322|NCT00657020|101017162|FG001|COMPLETED|PERIOD 1||11||
48283323|NCT00657020|101017161|FG000|NOT COMPLETED|PERIOD 1||0||
48283324|NCT00657020|101017162|FG001|NOT COMPLETED|PERIOD 1||1||
48283325|NCT00657020|101017161|FG000|STARTED|PERIOD 2||11||
48283326|NCT00657020|101017162|FG001|STARTED|PERIOD 2||11||
48397918|NCT02352103|101302733|FG000|NOT COMPLETED|Overall Study||0||
48397919|NCT02352103|101302734|FG001|NOT COMPLETED|Overall Study||1||
48397920|NCT01042938|101302735|FG000|STARTED|Overall Study||17||
48397921|NCT01042938|101302736|FG001|STARTED|Overall Study||18||
48397922|NCT01042938|101302735|FG000|COMPLETED|Overall Study||14||
48397923|NCT01042938|101302736|FG001|COMPLETED|Overall Study||16||
48397924|NCT01042938|101302735|FG000|NOT COMPLETED|Overall Study||3||
48397925|NCT01042938|101302736|FG001|NOT COMPLETED|Overall Study||2||
48397926|NCT03004976|101302737|FG000|STARTED|Overall Study||52||
48397927|NCT03004976|101302738|FG001|STARTED|Overall Study||27||
48397928|NCT03004976|101302737|FG000|COMPLETED|Overall Study||39||
48397929|NCT03004976|101302738|FG001|COMPLETED|Overall Study||21||
48397930|NCT03004976|101302737|FG000|NOT COMPLETED|Overall Study||13||
48397931|NCT03004976|101302738|FG001|NOT COMPLETED|Overall Study||6||
48397932|NCT01153893|101306196|FG000|STARTED|Overall Study||68||
48397933|NCT01153893|101306197|FG001|STARTED|Overall Study||36||
48397934|NCT01153893|101306196|FG000|COMPLETED|Overall Study||67||
48397935|NCT01153893|101306197|FG001|COMPLETED|Overall Study||36||
48397936|NCT01153893|101306196|FG000|NOT COMPLETED|Overall Study||1||
48397937|NCT01153893|101306197|FG001|NOT COMPLETED|Overall Study||0||
48397938|NCT03949621|101306198|FG000|STARTED|Overall Study||12||
48397939|NCT03949621|101306199|FG001|STARTED|Overall Study||12||
48397940|NCT03949621|101306198|FG000|COMPLETED|Overall Study||12||
48397941|NCT03949621|101306199|FG001|COMPLETED|Overall Study||12||
48397942|NCT03949621|101306198|FG000|NOT COMPLETED|Overall Study||0||
48397943|NCT03949621|101306199|FG001|NOT COMPLETED|Overall Study||0||
48572569|NCT00570687|101735043|FG001|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
48572570|NCT00570687|101735044|FG002|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
48572571|NCT00570687|101735045|FG003|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
48572572|NCT00570687|101735046|FG004|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3||
48572573|NCT00570687|101735047|FG005|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3||
48572574|NCT00570687|101735048|FG006|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3||
48572575|NCT00570687|101735049|FG007|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3||
48572576|NCT00570687|101735050|FG008|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3||
48572577|NCT00570687|101735051|FG009|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3||
48572578|NCT00570687|101735042|FG000|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
48700952|NCT00733291|102054117|FG003|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17||
48283327|NCT00657020|101017161|FG000|COMPLETED|PERIOD 2||11||
48283328|NCT00657020|101017162|FG001|COMPLETED|PERIOD 2||11||
48283329|NCT00657020|101017161|FG000|NOT COMPLETED|PERIOD 2||0||
48283330|NCT00657020|101017162|FG001|NOT COMPLETED|PERIOD 2||0||
48283331|NCT02141451|101017163|FG000|STARTED|Overall Study||3||
48283332|NCT02141451|101017164|FG001|STARTED|Overall Study||4||
48283333|NCT02141451|101017165|FG002|STARTED|Overall Study||7||
48283334|NCT02141451|101017166|FG003|STARTED|Overall Study||16||
48283335|NCT02141451|101017163|FG000|COMPLETED|Overall Study||3||
48283336|NCT02141451|101017164|FG001|COMPLETED|Overall Study||2||
48283337|NCT02141451|101017165|FG002|COMPLETED|Overall Study||2||
48283338|NCT02141451|101017166|FG003|COMPLETED|Overall Study||7||
48397944|NCT04583969|101306200|FG000|STARTED|Overall Study||272||
48397945|NCT04583969|101306201|FG001|STARTED|Overall Study||255||
48397946|NCT04583969|101306200|FG000|COMPLETED|Overall Study||215||
48397947|NCT04583969|101306201|FG001|COMPLETED|Overall Study||196||
48397948|NCT04583969|101306200|FG000|NOT COMPLETED|Overall Study||57||
48397949|NCT04583969|101306201|FG001|NOT COMPLETED|Overall Study||59||
48397950|NCT05034614|101306202|FG000|STARTED|Overall Study||357||
48397951|NCT05034614|101306203|FG001|STARTED|Overall Study||399||
48397952|NCT05034614|101306202|FG000|COMPLETED|Overall Study||357||
48397953|NCT05034614|101306203|FG001|COMPLETED|Overall Study||399||
48397954|NCT05034614|101306202|FG000|NOT COMPLETED|Overall Study||0||
48397955|NCT05034614|101306203|FG001|NOT COMPLETED|Overall Study||0||
48397956|NCT01248364|101306204|FG000|STARTED|Overall Study||32||
48397957|NCT01248364|101306205|FG001|STARTED|Overall Study||34||
48397958|NCT01248364|101306206|FG002|STARTED|Overall Study||13||
48283339|NCT02141451|101017163|FG000|NOT COMPLETED|Overall Study||0||
48283340|NCT02141451|101017164|FG001|NOT COMPLETED|Overall Study||2||
48283341|NCT02141451|101017165|FG002|NOT COMPLETED|Overall Study||5||
48283342|NCT02141451|101017166|FG003|NOT COMPLETED|Overall Study||9||
48283343|NCT00296400|101017167|FG000|STARTED|Overall Study||70||
48397959|NCT01248364|101306207|FG003|STARTED|Overall Study||12||
48397960|NCT01248364|101306204|FG000|Completed Acute Phase:Single Dose, Day 1|Overall Study||32||
48397961|NCT01248364|101306205|FG001|Completed Acute Phase:Single Dose, Day 1|Overall Study||34||
48397962|NCT01248364|101306206|FG002|Completed Acute Phase:Single Dose, Day 1|Overall Study||13||
48397963|NCT01248364|101306207|FG003|Completed Acute Phase:Single Dose, Day 1|Overall Study||12||
48397964|NCT01248364|101306204|FG000|Completed Chronic Phase:28-day Treatment|Overall Study||32||
48397965|NCT01248364|101306205|FG001|Completed Chronic Phase:28-day Treatment|Overall Study||33||
48397966|NCT01248364|101306206|FG002|Completed Chronic Phase:28-day Treatment|Overall Study||13||
48397967|NCT01248364|101306207|FG003|Completed Chronic Phase:28-day Treatment|Overall Study||0||
48397968|NCT01248364|101306204|FG000|COMPLETED|Overall Study||32||
48397969|NCT01248364|101306205|FG001|COMPLETED|Overall Study||33||
48397970|NCT01248364|101306206|FG002|COMPLETED|Overall Study||13||
48283344|NCT00296400|101017168|FG001|STARTED|Overall Study||87||
48283345|NCT00296400|101017169|FG002|STARTED|Overall Study||80||
48283346|NCT00296400|101017167|FG000|COMPLETED|Overall Study||53||
48283347|NCT00296400|101017168|FG001|COMPLETED|Overall Study||69||
48283348|NCT00296400|101017169|FG002|COMPLETED|Overall Study||67||
48283349|NCT00296400|101017167|FG000|NOT COMPLETED|Overall Study||17||
48283350|NCT00296400|101017168|FG001|NOT COMPLETED|Overall Study||18||
48283351|NCT00296400|101017169|FG002|NOT COMPLETED|Overall Study||13||
48283352|NCT00470366|101017170|FG000|STARTED|Overall Study||60||
48283353|NCT00470366|101017170|FG000|COMPLETED|Overall Study||56||
48283354|NCT00470366|101017170|FG000|NOT COMPLETED|Overall Study||4||
48283355|NCT02871258|101017171|FG000|STARTED|Overall Study||8||
48283356|NCT02871258|101017171|FG000|COMPLETED|Overall Study||8||
48283357|NCT02871258|101017171|FG000|NOT COMPLETED|Overall Study||0||
48283358|NCT01879059|101017172|FG000|STARTED|Overall Study||13||
48283359|NCT01879059|101017172|FG000|COMPLETED|Overall Study||13||
48283360|NCT01879059|101017172|FG000|NOT COMPLETED|Overall Study||0||
48283361|NCT01171807|101017173|FG000|STARTED|Overall Study||21||
48283362|NCT01171807|101017174|FG001|STARTED|Overall Study||12||
48283363|NCT01171807|101017173|FG000|Intention to Treat (ITT) Population|Overall Study||21||
48283364|NCT01171807|101017174|FG001|Intention to Treat (ITT) Population|Overall Study||12||
48283365|NCT01171807|101017173|FG000|Per Protocol (PP) Population|Overall Study||18||
48397971|NCT01248364|101306207|FG003|COMPLETED|Overall Study||12||
48397972|NCT01248364|101306204|FG000|NOT COMPLETED|Overall Study||0||
48397973|NCT01248364|101306205|FG001|NOT COMPLETED|Overall Study||1||
48397974|NCT01248364|101306206|FG002|NOT COMPLETED|Overall Study||0||
48397975|NCT01248364|101306207|FG003|NOT COMPLETED|Overall Study||0||
48700953|NCT00733291|102054114|FG000|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0||
48700954|NCT00733291|102054115|FG001|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0||
48700955|NCT00733291|102054116|FG002|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0||
48700956|NCT00733291|102054117|FG003|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0||
48700957|NCT01352221|102054118|FG000|STARTED|Double-blind Phase||64||
48700958|NCT01352221|102054119|FG001|STARTED|Double-blind Phase||64||
48700959|NCT01352221|102054120|FG002|STARTED|Double-blind Phase||0||
48700960|NCT01352221|102054121|FG003|STARTED|Double-blind Phase||0||
48700961|NCT01352221|102054118|FG000|COMPLETED|Double-blind Phase||55||
48700962|NCT01352221|102054119|FG001|COMPLETED|Double-blind Phase||53||
48283366|NCT01171807|101017174|FG001|Per Protocol (PP) Population|Overall Study||11||
48283367|NCT01171807|101017173|FG000|Safety (SAF) Population|Overall Study||21||
48700963|NCT01352221|102054120|FG002|COMPLETED|Double-blind Phase||0||
48700964|NCT01352221|102054121|FG003|COMPLETED|Double-blind Phase||0||
48283368|NCT01171807|101017174|FG001|Safety (SAF) Population|Overall Study||12||
48283369|NCT01171807|101017173|FG000|COMPLETED|Overall Study||15||
48283370|NCT01171807|101017174|FG001|COMPLETED|Overall Study||8||
48283371|NCT01171807|101017173|FG000|NOT COMPLETED|Overall Study||6||
48283372|NCT01171807|101017174|FG001|NOT COMPLETED|Overall Study||4||
48283373|NCT01131182|101017175|FG000|STARTED|Overall Study||529||
48283374|NCT01131182|101017176|FG001|STARTED|Overall Study||537||
48283375|NCT01131182|101017175|FG000|COMPLETED|Overall Study||513||
48283376|NCT01131182|101017176|FG001|COMPLETED|Overall Study||521||
48283377|NCT01131182|101017175|FG000|NOT COMPLETED|Overall Study||16||
48283378|NCT01131182|101017176|FG001|NOT COMPLETED|Overall Study||16||
48283379|NCT02704754|101017177|FG000|STARTED|Overall Study||21||
48283380|NCT02704754|101017178|FG001|STARTED|Overall Study||20||
48283381|NCT02704754|101017177|FG000|COMPLETED|Overall Study||18||
48283382|NCT02704754|101017178|FG001|COMPLETED|Overall Study||19||
48283383|NCT02704754|101017177|FG000|NOT COMPLETED|Overall Study||3||
48283384|NCT02704754|101017178|FG001|NOT COMPLETED|Overall Study||1||
48283385|NCT00925132|101017179|FG000|STARTED|Overall Study||5||
48283386|NCT00925132|101017180|FG001|STARTED|Overall Study||4||
48397976|NCT00830804|101306208|FG000|STARTED|Overall Study||112||
48397977|NCT00830804|101306208|FG000|COMPLETED|Overall Study||97||
48397978|NCT00830804|101306208|FG000|NOT COMPLETED|Overall Study||15||
48397979|NCT00659126|101306209|FG000|STARTED|Overall Study||15||
48283387|NCT00925132|101017181|FG002|STARTED|Overall Study||4||
48283388|NCT00925132|101017182|FG003|STARTED|Overall Study||4||
48283389|NCT00925132|101017183|FG004|STARTED|Overall Study||22||
48283390|NCT00925132|101017179|FG000|COMPLETED|Overall Study||3||
48283391|NCT00925132|101017180|FG001|COMPLETED|Overall Study||4||
48283392|NCT00925132|101017181|FG002|COMPLETED|Overall Study||4||
48283393|NCT00925132|101017182|FG003|COMPLETED|Overall Study||4||
48283394|NCT00925132|101017183|FG004|COMPLETED|Overall Study||17||
48283395|NCT00925132|101017179|FG000|NOT COMPLETED|Overall Study||2||
48397980|NCT00659126|101306210|FG001|STARTED|Overall Study||25||
48397981|NCT00659126|101306209|FG000|COMPLETED|Overall Study||12||
48397982|NCT00659126|101306210|FG001|COMPLETED|Overall Study||21||
48397983|NCT00659126|101306209|FG000|NOT COMPLETED|Overall Study||3||
48397984|NCT00659126|101306210|FG001|NOT COMPLETED|Overall Study||4||
48572579|NCT00570687|101735043|FG001|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
48572580|NCT00570687|101735044|FG002|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
48572581|NCT00570687|101735045|FG003|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
48572582|NCT00570687|101735046|FG004|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
48572583|NCT00570687|101735047|FG005|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
48572584|NCT00570687|101735048|FG006|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
48572585|NCT00570687|101735049|FG007|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
48572586|NCT00570687|101735050|FG008|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
48572587|NCT00570687|101735051|FG009|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
48572588|NCT00570687|101735042|FG000|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0||
48572589|NCT00570687|101735043|FG001|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0||
48572590|NCT00570687|101735044|FG002|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0||
48572591|NCT00570687|101735045|FG003|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0||
48572592|NCT00570687|101735046|FG004|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3||
48572593|NCT00570687|101735047|FG005|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3||
48572594|NCT00570687|101735048|FG006|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3||
48572595|NCT00570687|101735049|FG007|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3||
48572596|NCT00570687|101735050|FG008|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3||
48572597|NCT00570687|101735051|FG009|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3||
48572598|NCT00570687|101735042|FG000|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0||
48127428|NCT01462344|100638191|FG001|COMPLETED|Overall Study||2751||
48127429|NCT01462344|100638190|FG000|NOT COMPLETED|Overall Study||383||
48283396|NCT00925132|101017180|FG001|NOT COMPLETED|Overall Study||0||
48283397|NCT00925132|101017181|FG002|NOT COMPLETED|Overall Study||0||
48283398|NCT00925132|101017182|FG003|NOT COMPLETED|Overall Study||0||
48283399|NCT00925132|101017183|FG004|NOT COMPLETED|Overall Study||5||
48283400|NCT03705832|101017184|FG000|STARTED|Overall Study||21||
48283401|NCT03705832|101017185|FG001|STARTED|Overall Study||13||
48283402|NCT03705832|101017184|FG000|COMPLETED|Overall Study||20||
48283403|NCT03705832|101017185|FG001|COMPLETED|Overall Study||12||
48283404|NCT03705832|101017184|FG000|NOT COMPLETED|Overall Study||1||
48283405|NCT03705832|101017185|FG001|NOT COMPLETED|Overall Study||1||
48283406|NCT00423943|101017186|FG000|STARTED|Overall Study||19||
48283407|NCT00423943|101017187|FG001|STARTED|Overall Study||14||
48283408|NCT00423943|101017186|FG000|COMPLETED|Overall Study||16||
48283409|NCT00423943|101017187|FG001|COMPLETED|Overall Study||13||
48283410|NCT00423943|101017186|FG000|NOT COMPLETED|Overall Study||3||
48283411|NCT00423943|101017187|FG001|NOT COMPLETED|Overall Study||1||
48283412|NCT03572387|101017188|FG000|STARTED|Treatment Phase 1 - 3 Cycles||6||
48283413|NCT03572387|101017189|FG001|STARTED|Treatment Phase 1 - 3 Cycles||8||
48283414|NCT03572387|101017188|FG000|COMPLETED|Treatment Phase 1 - 3 Cycles||6||
48283415|NCT03572387|101017189|FG001|COMPLETED|Treatment Phase 1 - 3 Cycles||8||
48283416|NCT03572387|101017188|FG000|NOT COMPLETED|Treatment Phase 1 - 3 Cycles||0||
48283417|NCT03572387|101017189|FG001|NOT COMPLETED|Treatment Phase 1 - 3 Cycles||0||
48283418|NCT03572387|101017188|FG000|STARTED|Treatment Phase 2 - 3 Cycles||6||
48283419|NCT03572387|101017189|FG001|STARTED|Treatment Phase 2 - 3 Cycles||8||
48283420|NCT03572387|101017188|FG000|COMPLETED|Treatment Phase 2 - 3 Cycles||6||
48283421|NCT03572387|101017189|FG001|COMPLETED|Treatment Phase 2 - 3 Cycles||8||
48283422|NCT03572387|101017188|FG000|NOT COMPLETED|Treatment Phase 2 - 3 Cycles||0||
48283423|NCT03572387|101017189|FG001|NOT COMPLETED|Treatment Phase 2 - 3 Cycles||0||
48283424|NCT01895101|101017190|FG000|STARTED|Overall Study||250||
48283425|NCT01895101|101017191|FG001|STARTED|Overall Study||250||
48283426|NCT01895101|101017192|FG002|STARTED|Overall Study||250||
48397985|NCT01527110|101306211|FG000|STARTED|Overall Study||21||
48397986|NCT01527110|101306211|FG000|COMPLETED|Overall Study||20||
48397987|NCT01527110|101306211|FG000|NOT COMPLETED|Overall Study||1||
48397988|NCT03326583|101306212|FG000|STARTED|Pre-Treatment||27||
48397989|NCT03326583|101306212|FG000|COMPLETED|Pre-Treatment||26||
48397990|NCT03326583|101306212|FG000|NOT COMPLETED|Pre-Treatment||1||
48397991|NCT03326583|101306212|FG000|STARTED|Treatment||26||
48397992|NCT03326583|101306212|FG000|COMPLETED|Treatment||24||
48397993|NCT03326583|101306212|FG000|NOT COMPLETED|Treatment||2||
48283427|NCT01895101|101017190|FG000|COMPLETED|Overall Study||249||
48283428|NCT01895101|101017191|FG001|COMPLETED|Overall Study||245||
48283429|NCT01895101|101017192|FG002|COMPLETED|Overall Study||245||
48283430|NCT01895101|101017190|FG000|NOT COMPLETED|Overall Study||1||
48283431|NCT01895101|101017191|FG001|NOT COMPLETED|Overall Study||5||
48283432|NCT01895101|101017192|FG002|NOT COMPLETED|Overall Study||5||
48397994|NCT03326583|101306212|FG000|STARTED|Post-Treatment||24||
48397995|NCT03326583|101306212|FG000|COMPLETED|Post-Treatment||24||
48397996|NCT03326583|101306212|FG000|NOT COMPLETED|Post-Treatment||0||
48397997|NCT00669032|101306213|FG000|STARTED|Overall Study||153||
48397998|NCT00669032|101306214|FG001|STARTED|Overall Study||153||
48397999|NCT00669032|101306213|FG000|COMPLETED|Overall Study||109||
48398000|NCT00669032|101306214|FG001|COMPLETED|Overall Study||94||
48398001|NCT00669032|101306213|FG000|NOT COMPLETED|Overall Study||44||
48398002|NCT00669032|101306214|FG001|NOT COMPLETED|Overall Study||59||
48398003|NCT02228824|101306215|FG000|STARTED|Overall Study||118||
48398004|NCT02228824|101306216|FG001|STARTED|Overall Study||120||
48398005|NCT02228824|101306215|FG000|COMPLETED|Overall Study||89||
48398006|NCT02228824|101306216|FG001|COMPLETED|Overall Study||98||
48398007|NCT02228824|101306215|FG000|NOT COMPLETED|Overall Study||29||
48398008|NCT02228824|101306216|FG001|NOT COMPLETED|Overall Study||22||
48398009|NCT04821960|101306217|FG000|STARTED|Overall Study||41||
48398010|NCT04821960|101306218|FG001|STARTED|Overall Study||40||
48398011|NCT04821960|101306217|FG000|COMPLETED|Overall Study||36||
48398012|NCT04821960|101306218|FG001|COMPLETED|Overall Study||30||
48398013|NCT04821960|101306217|FG000|NOT COMPLETED|Overall Study||5||
48398014|NCT04821960|101306218|FG001|NOT COMPLETED|Overall Study||10||
48398015|NCT00996593|101306219|FG000|STARTED|Dosimetric and Therapeutic Treatment||43||
48398016|NCT00996593|101306219|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0||
48398017|NCT00996593|101306219|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||43||
48398018|NCT00996593|101306219|FG000|STARTED|Long-Term Follow-Up||9||
48398019|NCT00996593|101306219|FG000|COMPLETED|Long-Term Follow-Up||6||
48398020|NCT00996593|101306219|FG000|NOT COMPLETED|Long-Term Follow-Up||3||
48398021|NCT00023712|101306220|FG000|STARTED|Overall Study||28||
48398022|NCT00023712|101306221|FG001|STARTED|Overall Study||30||
48398023|NCT00023712|101306220|FG000|COMPLETED|Overall Study||26||
48398024|NCT00023712|101306221|FG001|COMPLETED|Overall Study||29||
48398025|NCT00023712|101306220|FG000|NOT COMPLETED|Overall Study||2||
48398026|NCT00023712|101306221|FG001|NOT COMPLETED|Overall Study||1||
48398027|NCT01611298|101306222|FG000|STARTED|Overall Study||7||
48398028|NCT01611298|101306222|FG000|COMPLETED|Overall Study||5||
48398029|NCT01611298|101306222|FG000|NOT COMPLETED|Overall Study||2||
48398030|NCT00105560|101306223|FG000|STARTED|Overall Study||59||
48398031|NCT00105560|101306223|FG000|COMPLETED|Overall Study||58||
48398032|NCT00105560|101306223|FG000|NOT COMPLETED|Overall Study||1||
48572599|NCT00570687|101735043|FG001|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0||
48572600|NCT00570687|101735044|FG002|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0||
48572601|NCT00570687|101735045|FG003|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0||
48572602|NCT00570687|101735046|FG004|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3||
48572603|NCT00570687|101735047|FG005|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3||
48572604|NCT00570687|101735048|FG006|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3||
48572605|NCT00570687|101735049|FG007|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3||
48572606|NCT00570687|101735050|FG008|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3||
48572607|NCT00570687|101735051|FG009|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3||
48572608|NCT00570687|101735042|FG000|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0||
48572609|NCT00570687|101735043|FG001|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0||
48572610|NCT00570687|101735044|FG002|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0||
48572611|NCT00570687|101735045|FG003|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0||
48572612|NCT00570687|101735046|FG004|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0||
48572613|NCT00570687|101735047|FG005|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0||
48398033|NCT01332097|101306224|FG000|STARTED|Overall Study||31||
48398034|NCT01332097|101306225|FG001|STARTED|Overall Study||30||
48398035|NCT01332097|101306226|FG002|STARTED|Overall Study||25||
48398036|NCT01332097|101306227|FG003|STARTED|Overall Study||27||
48398037|NCT01332097|101306228|FG004|STARTED|Overall Study||25||
48398038|NCT01332097|101306229|FG005|STARTED|Overall Study||45||
48398039|NCT01332097|101306224|FG000|COMPLETED|Overall Study||30||
48398040|NCT01332097|101306225|FG001|COMPLETED|Overall Study||26||
48398041|NCT01332097|101306226|FG002|COMPLETED|Overall Study||23||
48398042|NCT01332097|101306227|FG003|COMPLETED|Overall Study||24||
48398043|NCT01332097|101306228|FG004|COMPLETED|Overall Study||22||
48398044|NCT01332097|101306229|FG005|COMPLETED|Overall Study||44||
48398045|NCT01332097|101306224|FG000|NOT COMPLETED|Overall Study||1||
48398046|NCT01332097|101306225|FG001|NOT COMPLETED|Overall Study||4||
48398047|NCT01332097|101306226|FG002|NOT COMPLETED|Overall Study||2||
48398048|NCT01332097|101306227|FG003|NOT COMPLETED|Overall Study||3||
48398049|NCT01332097|101306228|FG004|NOT COMPLETED|Overall Study||3||
48398050|NCT01332097|101306229|FG005|NOT COMPLETED|Overall Study||1||
48398051|NCT00094835|101306230|FG000|STARTED|Overall Study||9||
48398052|NCT00094835|101306231|FG001|STARTED|Overall Study||11||
48398053|NCT00094835|101306232|FG002|STARTED|Overall Study||7||
48398054|NCT00094835|101306233|FG003|STARTED|Overall Study||5||
48398055|NCT00094835|101306234|FG004|STARTED|Overall Study||7||
48398056|NCT00094835|101306235|FG005|STARTED|Overall Study||6||
48398057|NCT00094835|101306236|FG006|STARTED|Overall Study||6||
48398058|NCT00094835|101306230|FG000|Treated With Motesanib|Overall Study||6||
48398059|NCT00094835|101306231|FG001|Treated With Motesanib|Overall Study||11||
48398060|NCT00094835|101306232|FG002|Treated With Motesanib|Overall Study||6||
48398061|NCT00094835|101306233|FG003|Treated With Motesanib|Overall Study||4||
48572614|NCT00570687|101735048|FG006|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0||
48572615|NCT00570687|101735049|FG007|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0||
48572616|NCT00570687|101735050|FG008|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0||
48572617|NCT00570687|101735051|FG009|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0||
48127430|NCT01462344|100638191|FG001|NOT COMPLETED|Overall Study||350||
48127431|NCT03634579|100638192|FG000|STARTED|Overall Study||9||
48127432|NCT03634579|100638192|FG000|COMPLETED|Overall Study||0||
48127433|NCT03634579|100638192|FG000|NOT COMPLETED|Overall Study||9||
48572618|NCT00570687|101735042|FG000|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
48572619|NCT00570687|101735043|FG001|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
48572620|NCT00570687|101735044|FG002|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
48572621|NCT00570687|101735045|FG003|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
48572622|NCT00570687|101735046|FG004|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3||
48572623|NCT00570687|101735047|FG005|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3||
48572624|NCT00570687|101735048|FG006|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3||
48572625|NCT00570687|101735049|FG007|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3||
48572626|NCT00570687|101735050|FG008|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3||
48572627|NCT00570687|101735051|FG009|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3||
48572628|NCT00570687|101735042|FG000|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
48572629|NCT00570687|101735043|FG001|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
48572630|NCT00570687|101735044|FG002|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
48572631|NCT00570687|101735045|FG003|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
48572632|NCT00570687|101735046|FG004|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3||
48572633|NCT00570687|101735047|FG005|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3||
48572634|NCT00570687|101735048|FG006|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3||
48572635|NCT00570687|101735049|FG007|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3||
48572636|NCT00570687|101735050|FG008|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3||
48572637|NCT00570687|101735051|FG009|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3||
48572638|NCT00570687|101735042|FG000|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
48572639|NCT00570687|101735043|FG001|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
48572640|NCT00570687|101735044|FG002|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
48572641|NCT00570687|101735045|FG003|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
48572642|NCT00570687|101735046|FG004|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
48572643|NCT00570687|101735047|FG005|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
48572644|NCT00570687|101735048|FG006|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
48572645|NCT00570687|101735049|FG007|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
48572646|NCT00570687|101735050|FG008|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
48572647|NCT00570687|101735051|FG009|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
48572648|NCT00570687|101735042|FG000|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0||
48572649|NCT00570687|101735043|FG001|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0||
48572650|NCT00570687|101735044|FG002|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0||
48572651|NCT00570687|101735045|FG003|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0||
48572652|NCT00570687|101735046|FG004|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3||
48572653|NCT00570687|101735047|FG005|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3||
48572654|NCT00570687|101735048|FG006|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3||
48572655|NCT00570687|101735049|FG007|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3||
48572656|NCT00570687|101735050|FG008|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3||
48572657|NCT00570687|101735051|FG009|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3||
48572658|NCT00570687|101735042|FG000|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0||
48572659|NCT00570687|101735043|FG001|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0||
48572660|NCT00570687|101735044|FG002|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0||
48572661|NCT00570687|101735045|FG003|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0||
48572662|NCT00570687|101735046|FG004|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3||
48572663|NCT00570687|101735047|FG005|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3||
48572664|NCT00570687|101735048|FG006|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3||
48572665|NCT00570687|101735049|FG007|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3||
48572666|NCT00570687|101735050|FG008|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3||
48572667|NCT00570687|101735051|FG009|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3||
48572668|NCT00570687|101735042|FG000|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0||
48572669|NCT00570687|101735043|FG001|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0||
48572670|NCT00570687|101735044|FG002|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0||
48572671|NCT00570687|101735045|FG003|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0||
48572672|NCT00570687|101735046|FG004|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0||
48572673|NCT00570687|101735047|FG005|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0||
48572674|NCT00570687|101735048|FG006|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0||
48127434|NCT01898195|100638193|FG000|STARTED|Varenicline Adherence||53||
48127435|NCT01898195|100638194|FG001|STARTED|Varenicline Adherence||54||
48127436|NCT01898195|100638195|FG002|STARTED|Varenicline Adherence||51||
48127437|NCT01898195|100638193|FG000|COMPLETED|Varenicline Adherence||18||
48127438|NCT01898195|100638194|FG001|COMPLETED|Varenicline Adherence||16||
48127439|NCT01898195|100638195|FG002|COMPLETED|Varenicline Adherence||15||
48127440|NCT01898195|100638193|FG000|NOT COMPLETED|Varenicline Adherence||35||
48127441|NCT01898195|100638194|FG001|NOT COMPLETED|Varenicline Adherence||38||
48572675|NCT00570687|101735049|FG007|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0||
48572676|NCT00570687|101735050|FG008|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0||
48572677|NCT00570687|101735051|FG009|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0||
48572678|NCT00570687|101735042|FG000|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
48572679|NCT00570687|101735043|FG001|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
48572680|NCT00570687|101735044|FG002|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
48572681|NCT00570687|101735045|FG003|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
48572682|NCT00570687|101735046|FG004|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3||
48572683|NCT00570687|101735047|FG005|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3||
48572684|NCT00570687|101735048|FG006|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3||
48127442|NCT01898195|100638195|FG002|NOT COMPLETED|Varenicline Adherence||36||
48127443|NCT01898195|100638193|FG000|STARTED|Smoking Abstinence||53||
48127444|NCT01898195|100638194|FG001|STARTED|Smoking Abstinence||54||
48127445|NCT01898195|100638195|FG002|STARTED|Smoking Abstinence||51||
48127446|NCT01898195|100638193|FG000|COMPLETED|Smoking Abstinence||18||
48283433|NCT00581555|101017193|FG000|STARTED|Overall Study||62||
48283434|NCT00581555|101017194|FG001|STARTED|Overall Study||58||
48283435|NCT00581555|101017193|FG000|COMPLETED|Overall Study||19||
48572685|NCT00570687|101735049|FG007|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3||
48572686|NCT00570687|101735050|FG008|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3||
48572687|NCT00570687|101735051|FG009|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3||
48700965|NCT01352221|102054118|FG000|NOT COMPLETED|Double-blind Phase||9||
48283436|NCT00581555|101017194|FG001|COMPLETED|Overall Study||38||
48283437|NCT00581555|101017193|FG000|NOT COMPLETED|Overall Study||43||
48283438|NCT00581555|101017194|FG001|NOT COMPLETED|Overall Study||20||
48283439|NCT00312923|101017195|FG000|STARTED|Overall Study||28||
48283440|NCT00312923|101017196|FG001|STARTED|Overall Study||26||
48283441|NCT00312923|101017195|FG000|COMPLETED|Overall Study||19||
48283442|NCT00312923|101017196|FG001|COMPLETED|Overall Study||20||
48283443|NCT00312923|101017195|FG000|NOT COMPLETED|Overall Study||9||
48283444|NCT00312923|101017196|FG001|NOT COMPLETED|Overall Study||6||
48283445|NCT01630694|101017197|FG000|STARTED|Overall Study||12||
48283446|NCT01630694|101017198|FG001|STARTED|Overall Study||16||
48283447|NCT01630694|101017197|FG000|COMPLETED|Overall Study||12||
48283448|NCT01630694|101017198|FG001|COMPLETED|Overall Study||16||
48283449|NCT01630694|101017197|FG000|NOT COMPLETED|Overall Study||0||
48283450|NCT01630694|101017198|FG001|NOT COMPLETED|Overall Study||0||
48283451|NCT04343872|101017199|FG000|STARTED|Overall Study||29||2
48283452|NCT04343872|101017200|FG001|STARTED|Overall Study||7||2
48283453|NCT04343872|101017199|FG000|COMPLETED|Overall Study||23||2
48283454|NCT04343872|101017200|FG001|COMPLETED|Overall Study||4||2
48283455|NCT04343872|101017199|FG000|NOT COMPLETED|Overall Study||6||0
48283456|NCT04343872|101017200|FG001|NOT COMPLETED|Overall Study||3||0
48283457|NCT01767701|101017201|FG000|STARTED|Overall Study||20||
48283458|NCT01767701|101017201|FG000|COMPLETED|Overall Study||20||
48283459|NCT01767701|101017201|FG000|NOT COMPLETED|Overall Study||0||
48283460|NCT01139580|101017202|FG000|STARTED|Overall Study||181||
48283461|NCT01139580|101017203|FG001|STARTED|Overall Study||182||
48283462|NCT01139580|101017202|FG000|COMPLETED|Overall Study||158||
48283463|NCT01139580|101017203|FG001|COMPLETED|Overall Study||164||
48283464|NCT01139580|101017202|FG000|NOT COMPLETED|Overall Study||23||
48283465|NCT01139580|101017203|FG001|NOT COMPLETED|Overall Study||18||
48283466|NCT01986075|101017204|FG000|STARTED|Initial CBT + CM (Pre-randomization)||0||
48283467|NCT01986075|101017205|FG001|STARTED|Initial CBT + CM (Pre-randomization)||0||
48283468|NCT01986075|101017206|FG002|STARTED|Initial CBT + CM (Pre-randomization)||145||
48283469|NCT01986075|101017204|FG000|COMPLETED|Initial CBT + CM (Pre-randomization)||0||
48283470|NCT01986075|101017205|FG001|COMPLETED|Initial CBT + CM (Pre-randomization)||0||
48283471|NCT01986075|101017206|FG002|COMPLETED|Initial CBT + CM (Pre-randomization)||86||
48283472|NCT01986075|101017204|FG000|NOT COMPLETED|Initial CBT + CM (Pre-randomization)||0||
48283473|NCT01986075|101017205|FG001|NOT COMPLETED|Initial CBT + CM (Pre-randomization)||0||
48283474|NCT01986075|101017206|FG002|NOT COMPLETED|Initial CBT + CM (Pre-randomization)||59||
48283475|NCT01986075|101017204|FG000|STARTED|Randomized Intervention||45||
48283476|NCT01986075|101017205|FG001|STARTED|Randomized Intervention||41||
48283477|NCT01986075|101017206|FG002|STARTED|Randomized Intervention||0||
48283478|NCT01986075|101017204|FG000|COMPLETED|Randomized Intervention||30||
48283479|NCT01986075|101017205|FG001|COMPLETED|Randomized Intervention||27||
48283480|NCT01986075|101017206|FG002|COMPLETED|Randomized Intervention||0||
48283481|NCT01986075|101017204|FG000|NOT COMPLETED|Randomized Intervention||15||
48283482|NCT01986075|101017205|FG001|NOT COMPLETED|Randomized Intervention||14||
48398062|NCT00094835|101306234|FG004|Treated With Motesanib|Overall Study||7||
48398063|NCT00094835|101306235|FG005|Treated With Motesanib|Overall Study||5||
48283483|NCT01986075|101017206|FG002|NOT COMPLETED|Randomized Intervention||0||
48283484|NCT00116753|101017207|FG000|STARTED|Overall Study||153||
48283485|NCT00116753|101017208|FG001|STARTED|Overall Study||155||
48398064|NCT00094835|101306236|FG006|Treated With Motesanib|Overall Study||6||
48398065|NCT00094835|101306230|FG000|COMPLETED|Overall Study||5||
48398066|NCT00094835|101306231|FG001|COMPLETED|Overall Study||8||
48572688|NCT00570687|101735042|FG000|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
48572689|NCT00570687|101735043|FG001|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
48283486|NCT00116753|101017209|FG002|STARTED|Overall Study||152||
48283487|NCT00116753|101017207|FG000|ITT Population|Overall Study||150||
48283488|NCT00116753|101017208|FG001|ITT Population|Overall Study||150||
48283489|NCT00116753|101017209|FG002|ITT Population|Overall Study||147||
48283490|NCT00116753|101017207|FG000|COMPLETED|Overall Study||121||
48283491|NCT00116753|101017208|FG001|COMPLETED|Overall Study||125||
48283492|NCT00116753|101017209|FG002|COMPLETED|Overall Study||128||
48283493|NCT00116753|101017207|FG000|NOT COMPLETED|Overall Study||32||
48283494|NCT00116753|101017208|FG001|NOT COMPLETED|Overall Study||30||
48283495|NCT00116753|101017209|FG002|NOT COMPLETED|Overall Study||24||
48283496|NCT01302860|101017210|FG000|STARTED|Overall Study||17||
48283497|NCT01302860|101017210|FG000|COMPLETED|Overall Study||17||
48283498|NCT01302860|101017210|FG000|NOT COMPLETED|Overall Study||0||
48283499|NCT00620282|101017211|FG000|STARTED|Overall Study||16||
48283500|NCT00620282|101017212|FG001|STARTED|Overall Study||16||
48283501|NCT00620282|101017213|FG002|STARTED|Overall Study||17||
48283502|NCT00620282|101017211|FG000|COMPLETED|Overall Study||16||
48283503|NCT00620282|101017212|FG001|COMPLETED|Overall Study||14||
48283504|NCT00620282|101017213|FG002|COMPLETED|Overall Study||16||
48283505|NCT00620282|101017211|FG000|NOT COMPLETED|Overall Study||0||
48398067|NCT00094835|101306232|FG002|COMPLETED|Overall Study||4||
48398068|NCT00094835|101306233|FG003|COMPLETED|Overall Study||4||
48398069|NCT00094835|101306234|FG004|COMPLETED|Overall Study||3||
48283506|NCT00620282|101017212|FG001|NOT COMPLETED|Overall Study||2||
48283507|NCT00620282|101017213|FG002|NOT COMPLETED|Overall Study||1||
48283508|NCT01247285|101017214|FG000|STARTED|First Intervention||13||
48283509|NCT01247285|101017215|FG001|STARTED|First Intervention||13||
48283510|NCT01247285|101017214|FG000|COMPLETED|First Intervention||13||
48283511|NCT01247285|101017215|FG001|COMPLETED|First Intervention||13||
48283512|NCT01247285|101017214|FG000|NOT COMPLETED|First Intervention||0||
48283513|NCT01247285|101017215|FG001|NOT COMPLETED|First Intervention||0||
48283514|NCT01247285|101017214|FG000|STARTED|Washout of 28 Days||13||
48283515|NCT01247285|101017215|FG001|STARTED|Washout of 28 Days||13||
48283516|NCT01247285|101017214|FG000|COMPLETED|Washout of 28 Days||13||
48283517|NCT01247285|101017215|FG001|COMPLETED|Washout of 28 Days||13||
48283518|NCT01247285|101017214|FG000|NOT COMPLETED|Washout of 28 Days||0||
48283519|NCT01247285|101017215|FG001|NOT COMPLETED|Washout of 28 Days||0||
48283520|NCT01247285|101017214|FG000|STARTED|Second Intervention||13||
48283521|NCT01247285|101017215|FG001|STARTED|Second Intervention||13||
48283522|NCT01247285|101017214|FG000|COMPLETED|Second Intervention||13||
48283523|NCT01247285|101017215|FG001|COMPLETED|Second Intervention||13||
48283524|NCT01247285|101017214|FG000|NOT COMPLETED|Second Intervention||0||
48283525|NCT01247285|101017215|FG001|NOT COMPLETED|Second Intervention||0||
48283526|NCT00560560|101017216|FG000|STARTED|Overall Study||85||
48283527|NCT00560560|101017217|FG001|STARTED|Overall Study||83||
48283528|NCT00560560|101017216|FG000|COMPLETED|Overall Study||0||
48283529|NCT00560560|101017217|FG001|COMPLETED|Overall Study||0||
48283530|NCT00560560|101017216|FG000|NOT COMPLETED|Overall Study||85||
48283531|NCT00560560|101017217|FG001|NOT COMPLETED|Overall Study||83||
48283532|NCT01850446|101017218|FG000|STARTED|Overall Study||92||
48283533|NCT01850446|101017219|FG001|STARTED|Overall Study||92||
48283534|NCT01850446|101017218|FG000|COMPLETED|Overall Study||87||
48398070|NCT00094835|101306235|FG005|COMPLETED|Overall Study||3||
48398071|NCT00094835|101306236|FG006|COMPLETED|Overall Study||4||
48283535|NCT01850446|101017219|FG001|COMPLETED|Overall Study||90||
48283536|NCT01850446|101017218|FG000|NOT COMPLETED|Overall Study||5||
48283537|NCT01850446|101017219|FG001|NOT COMPLETED|Overall Study||2||
48283538|NCT00412061|101017220|FG000|STARTED|Double Blind Phase||216||
48283539|NCT00412061|101017221|FG001|STARTED|Double Blind Phase||213||
48283540|NCT00412061|101017220|FG000|Safety Set|Double Blind Phase||215||
48283541|NCT00412061|101017221|FG001|Safety Set|Double Blind Phase||211||
48283542|NCT00412061|101017220|FG000|COMPLETED|Double Blind Phase||0||
48283543|NCT00412061|101017221|FG001|COMPLETED|Double Blind Phase||0||
48283544|NCT00412061|101017220|FG000|NOT COMPLETED|Double Blind Phase||216||
48283545|NCT00412061|101017221|FG001|NOT COMPLETED|Double Blind Phase||213||
48283546|NCT00412061|101017220|FG000|STARTED|Open Label Phase||0||
48283547|NCT00412061|101017221|FG001|STARTED|Open Label Phase||170||
48283548|NCT00412061|101017220|FG000|COMPLETED|Open Label Phase||0||
48283549|NCT00412061|101017221|FG001|COMPLETED|Open Label Phase||0||
48283550|NCT00412061|101017220|FG000|NOT COMPLETED|Open Label Phase||0||
48283551|NCT00412061|101017221|FG001|NOT COMPLETED|Open Label Phase||170||
48283552|NCT03292432|101017222|FG000|STARTED|Overall Study||46|Number enrolled|
48283553|NCT03292432|101017223|FG001|STARTED|Overall Study||43|Number enrolled|
48283554|NCT03292432|101017222|FG000|Started Study Intervention|Overall Study||45|Number starting intervention|
48283555|NCT03292432|101017223|FG001|Started Study Intervention|Overall Study||43|Number starting intervention|
48283556|NCT03292432|101017222|FG000|COMPLETED|Overall Study||31||
48283557|NCT03292432|101017223|FG001|COMPLETED|Overall Study||32||
48283558|NCT03292432|101017222|FG000|NOT COMPLETED|Overall Study||15||
48283559|NCT03292432|101017223|FG001|NOT COMPLETED|Overall Study||11||
48283560|NCT00944073|101017224|FG000|STARTED|Overall Study||292||
48283561|NCT00944073|101017225|FG001|STARTED|Overall Study||291||
48283562|NCT00944073|101017224|FG000|COMPLETED|Overall Study||287||
48283563|NCT00944073|101017225|FG001|COMPLETED|Overall Study||287||
48283564|NCT00944073|101017224|FG000|NOT COMPLETED|Overall Study||5||
48283565|NCT00944073|101017225|FG001|NOT COMPLETED|Overall Study||4||
48283566|NCT00670631|101017226|FG000|STARTED|Overall Study||0||
48283567|NCT00670631|101017226|FG000|COMPLETED|Overall Study||0||
48283568|NCT00670631|101017226|FG000|NOT COMPLETED|Overall Study||0||
48283569|NCT01621568|101017227|FG000|STARTED|Treatment Week 1-4||41||
48283570|NCT01621568|101017228|FG001|STARTED|Treatment Week 1-4||15||
48398072|NCT00094835|101306230|FG000|NOT COMPLETED|Overall Study||4||
48398073|NCT00094835|101306231|FG001|NOT COMPLETED|Overall Study||3||
48700966|NCT01352221|102054119|FG001|NOT COMPLETED|Double-blind Phase||11||
48283571|NCT01621568|101017227|FG000|COMPLETED|Treatment Week 1-4||41||
48398074|NCT00094835|101306232|FG002|NOT COMPLETED|Overall Study||3||
48398075|NCT00094835|101306233|FG003|NOT COMPLETED|Overall Study||1||
48572690|NCT00570687|101735044|FG002|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
48283572|NCT01621568|101017228|FG001|COMPLETED|Treatment Week 1-4||15||
48283573|NCT01621568|101017227|FG000|NOT COMPLETED|Treatment Week 1-4||0||
48283574|NCT01621568|101017228|FG001|NOT COMPLETED|Treatment Week 1-4||0||
48283575|NCT01621568|101017227|FG000|STARTED|Week 5-6 No Treatment||41||
48283576|NCT01621568|101017228|FG001|STARTED|Week 5-6 No Treatment||15||
48283577|NCT01621568|101017227|FG000|COMPLETED|Week 5-6 No Treatment||39||
48283578|NCT01621568|101017228|FG001|COMPLETED|Week 5-6 No Treatment||15||
48700967|NCT01352221|102054120|FG002|NOT COMPLETED|Double-blind Phase||0||
48572691|NCT00570687|101735045|FG003|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
48572692|NCT00570687|101735046|FG004|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3||
48127447|NCT01898195|100638194|FG001|COMPLETED|Smoking Abstinence||16||
48127448|NCT01898195|100638195|FG002|COMPLETED|Smoking Abstinence||15||
48127449|NCT01898195|100638193|FG000|NOT COMPLETED|Smoking Abstinence||35||
48127450|NCT01898195|100638194|FG001|NOT COMPLETED|Smoking Abstinence||38||
48127451|NCT01898195|100638195|FG002|NOT COMPLETED|Smoking Abstinence||36||
48127452|NCT03330834|100638196|FG000|STARTED|Overall Study||1||
48127453|NCT03330834|100638196|FG000|COMPLETED|Overall Study||1||
48127454|NCT03330834|100638196|FG000|NOT COMPLETED|Overall Study||0||
48127455|NCT02317575|100638197|FG000|STARTED|Period 1||5||
48127456|NCT02317575|100638198|FG001|STARTED|Period 1||6||
48127457|NCT02317575|100638199|FG002|STARTED|Period 1||6||
48127458|NCT02317575|100638200|FG003|STARTED|Period 1||6||
48127459|NCT02317575|100638201|FG004|STARTED|Period 1||6||
48127460|NCT02317575|100638197|FG000|Received at Least 1 Dose of Study Drug|Period 1||5||
48127461|NCT02317575|100638198|FG001|Received at Least 1 Dose of Study Drug|Period 1||5||
48127462|NCT02317575|100638199|FG002|Received at Least 1 Dose of Study Drug|Period 1||6||
48127463|NCT02317575|100638200|FG003|Received at Least 1 Dose of Study Drug|Period 1||6||
48127464|NCT02317575|100638201|FG004|Received at Least 1 Dose of Study Drug|Period 1||6||
48127465|NCT02317575|100638197|FG000|COMPLETED|Period 1||4||
48127466|NCT02317575|100638198|FG001|COMPLETED|Period 1||5||
48127467|NCT02317575|100638199|FG002|COMPLETED|Period 1||6||
48127468|NCT02317575|100638200|FG003|COMPLETED|Period 1||6||
48127469|NCT02317575|100638201|FG004|COMPLETED|Period 1||6||
48127470|NCT02317575|100638197|FG000|NOT COMPLETED|Period 1||1||
48127471|NCT02317575|100638198|FG001|NOT COMPLETED|Period 1||1||
48127472|NCT02317575|100638199|FG002|NOT COMPLETED|Period 1||0||
48127473|NCT02317575|100638200|FG003|NOT COMPLETED|Period 1||0||
48127474|NCT02317575|100638201|FG004|NOT COMPLETED|Period 1||0||
48127475|NCT02317575|100638197|FG000|STARTED|Period 2||4||
48127476|NCT02317575|100638198|FG001|STARTED|Period 2||5||
48127477|NCT02317575|100638199|FG002|STARTED|Period 2||6||
48127478|NCT02317575|100638200|FG003|STARTED|Period 2||6||
48127479|NCT02317575|100638201|FG004|STARTED|Period 2||6||
48127480|NCT02317575|100638197|FG000|COMPLETED|Period 2||4||
48127481|NCT02317575|100638198|FG001|COMPLETED|Period 2||5||
48127482|NCT02317575|100638199|FG002|COMPLETED|Period 2||6||
48127483|NCT02317575|100638200|FG003|COMPLETED|Period 2||6||
48127484|NCT02317575|100638201|FG004|COMPLETED|Period 2||6||
48127485|NCT02317575|100638197|FG000|NOT COMPLETED|Period 2||0||
48127486|NCT02317575|100638198|FG001|NOT COMPLETED|Period 2||0||
48127487|NCT02317575|100638199|FG002|NOT COMPLETED|Period 2||0||
48572693|NCT00570687|101735047|FG005|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3||
48572694|NCT00570687|101735048|FG006|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3||
48572695|NCT00570687|101735049|FG007|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3||
48572696|NCT00570687|101735050|FG008|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3||
48127488|NCT02317575|100638200|FG003|NOT COMPLETED|Period 2||0||
48127489|NCT02317575|100638201|FG004|NOT COMPLETED|Period 2||0||
48127490|NCT02317575|100638197|FG000|STARTED|Period 3||4||
48127491|NCT02317575|100638198|FG001|STARTED|Period 3||5||
48127492|NCT02317575|100638199|FG002|STARTED|Period 3||6||
48127493|NCT02317575|100638200|FG003|STARTED|Period 3||6||
48127494|NCT02317575|100638201|FG004|STARTED|Period 3||6||
48127495|NCT02317575|100638197|FG000|COMPLETED|Period 3||4||
48127496|NCT02317575|100638198|FG001|COMPLETED|Period 3||5||
48283579|NCT01621568|101017227|FG000|NOT COMPLETED|Week 5-6 No Treatment||2||
48283580|NCT01621568|101017228|FG001|NOT COMPLETED|Week 5-6 No Treatment||0||
48572697|NCT00570687|101735051|FG009|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3||
48127497|NCT02317575|100638199|FG002|COMPLETED|Period 3||6||
48127498|NCT02317575|100638200|FG003|COMPLETED|Period 3||6||
48127499|NCT02317575|100638201|FG004|COMPLETED|Period 3||6||
48127500|NCT02317575|100638197|FG000|NOT COMPLETED|Period 3||0||
48127501|NCT02317575|100638198|FG001|NOT COMPLETED|Period 3||0||
48127502|NCT02317575|100638199|FG002|NOT COMPLETED|Period 3||0||
48127503|NCT02317575|100638200|FG003|NOT COMPLETED|Period 3||0||
48127504|NCT02317575|100638201|FG004|NOT COMPLETED|Period 3||0||
48127505|NCT02317575|100638197|FG000|STARTED|Period 4||4||
48127506|NCT02317575|100638198|FG001|STARTED|Period 4||5||
48127507|NCT02317575|100638199|FG002|STARTED|Period 4||6||
48127508|NCT02317575|100638200|FG003|STARTED|Period 4||6||
48127509|NCT02317575|100638201|FG004|STARTED|Period 4||6||
48127510|NCT02317575|100638197|FG000|COMPLETED|Period 4||4||
48127511|NCT02317575|100638198|FG001|COMPLETED|Period 4||5||
48127512|NCT02317575|100638199|FG002|COMPLETED|Period 4||6||
48127513|NCT02317575|100638200|FG003|COMPLETED|Period 4||6||
48127514|NCT02317575|100638201|FG004|COMPLETED|Period 4||6||
48127515|NCT02317575|100638197|FG000|NOT COMPLETED|Period 4||0||
48127516|NCT02317575|100638198|FG001|NOT COMPLETED|Period 4||0||
48127517|NCT02317575|100638199|FG002|NOT COMPLETED|Period 4||0||
48127518|NCT02317575|100638200|FG003|NOT COMPLETED|Period 4||0||
48127519|NCT02317575|100638201|FG004|NOT COMPLETED|Period 4||0||
48127520|NCT02317575|100638197|FG000|STARTED|Period 5||4||
48127521|NCT02317575|100638198|FG001|STARTED|Period 5||5||
48127522|NCT02317575|100638199|FG002|STARTED|Period 5||6||
48127523|NCT02317575|100638200|FG003|STARTED|Period 5||6||
48127524|NCT02317575|100638201|FG004|STARTED|Period 5||6||
48127525|NCT02317575|100638197|FG000|COMPLETED|Period 5||4||
48127526|NCT02317575|100638198|FG001|COMPLETED|Period 5||5||
48127527|NCT02317575|100638199|FG002|COMPLETED|Period 5||6||
48127528|NCT02317575|100638200|FG003|COMPLETED|Period 5||6||
48127529|NCT02317575|100638201|FG004|COMPLETED|Period 5||6||
48127530|NCT02317575|100638197|FG000|NOT COMPLETED|Period 5||0||
48127531|NCT02317575|100638198|FG001|NOT COMPLETED|Period 5||0||
48127532|NCT02317575|100638199|FG002|NOT COMPLETED|Period 5||0||
48127533|NCT02317575|100638200|FG003|NOT COMPLETED|Period 5||0||
48127534|NCT02317575|100638201|FG004|NOT COMPLETED|Period 5||0||
48127535|NCT00721526|100638202|FG000|STARTED|Overall Study||41|Intent-to-treat sample|
48127536|NCT00721526|100638202|FG000|Received Study Medication|Overall Study||40||
48127537|NCT00721526|100638202|FG000|Completed Week 1 Follow-up|Overall Study||38||
48127538|NCT00721526|100638202|FG000|Completed Week 2 Follow-up|Overall Study||37||
48127539|NCT00721526|100638202|FG000|Completed Week 4 Follow-up|Overall Study||36||
48127540|NCT00721526|100638202|FG000|Completed Week 6 Follow-up|Overall Study||35||
48127541|NCT00721526|100638202|FG000|Completed Week 8 Follow-up|Overall Study||32||
48127542|NCT00721526|100638202|FG000|Completed Week 10 Follow-up|Overall Study||29||
48127543|NCT00721526|100638202|FG000|Completed Week 12 Follow-up|Overall Study||27||
48127544|NCT00721526|100638202|FG000|Completed Week 16 Follow-up|Overall Study||26|End of treatment|
48127545|NCT00721526|100638202|FG000|COMPLETED|Overall Study||20|28 week followup|
48127546|NCT00721526|100638202|FG000|NOT COMPLETED|Overall Study||21||
48127547|NCT03062891|100638203|FG000|STARTED|Overall Study||99||
48127548|NCT03062891|100638204|FG001|STARTED|Overall Study||100||
48127549|NCT03062891|100638203|FG000|Mid-intervention|Overall Study||68||
48127550|NCT03062891|100638204|FG001|Mid-intervention|Overall Study||74||
48127551|NCT03062891|100638203|FG000|End of Intervention|Overall Study||67||
48127552|NCT03062891|100638204|FG001|End of Intervention|Overall Study||78||
48127553|NCT03062891|100638203|FG000|Followup|Overall Study||47||
48127554|NCT03062891|100638204|FG001|Followup|Overall Study||62||
48572698|NCT00570687|101735042|FG000|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
48127555|NCT03062891|100638203|FG000|COMPLETED|Overall Study||47||
48127556|NCT03062891|100638204|FG001|COMPLETED|Overall Study||62||
48127557|NCT03062891|100638203|FG000|NOT COMPLETED|Overall Study||52||
48127558|NCT03062891|100638204|FG001|NOT COMPLETED|Overall Study||38||
48127559|NCT01701375|100638205|FG000|STARTED|Overall Study||2||
48127560|NCT01701375|100638205|FG000|COMPLETED|Overall Study||2||
48127561|NCT01701375|100638205|FG000|NOT COMPLETED|Overall Study||0||
48127562|NCT02061345|100638206|FG000|STARTED|Overall Study||6||
48127563|NCT02061345|100638207|FG001|STARTED|Overall Study||5||
48127564|NCT02061345|100638206|FG000|COMPLETED|Overall Study||6||
48283581|NCT01712659|101017229|FG000|STARTED|Dose Escalation||1||
48283582|NCT01712659|101017230|FG001|STARTED|Dose Escalation||5||
48127565|NCT02061345|100638207|FG001|COMPLETED|Overall Study||5||
48127566|NCT02061345|100638206|FG000|NOT COMPLETED|Overall Study||0||
48127567|NCT02061345|100638207|FG001|NOT COMPLETED|Overall Study||0||
48127568|NCT04321460|100638208|FG000|STARTED|Overall Study||260||
48127569|NCT04321460|100638209|FG001|STARTED|Overall Study||260||
48127570|NCT04321460|100638208|FG000|Intention to Treat (ITT) Population|Overall Study||260||
48127571|NCT04321460|100638209|FG001|Intention to Treat (ITT) Population|Overall Study||260||
48127572|NCT04321460|100638208|FG000|Per-protocol (PP) Population|Overall Study||252||
48127573|NCT04321460|100638209|FG001|Per-protocol (PP) Population|Overall Study||248||
48127574|NCT04321460|100638208|FG000|COMPLETED|Overall Study||259||
48127575|NCT04321460|100638209|FG001|COMPLETED|Overall Study||259||
48127576|NCT04321460|100638208|FG000|NOT COMPLETED|Overall Study||1||
48127577|NCT04321460|100638209|FG001|NOT COMPLETED|Overall Study||1||
48127578|NCT02391948|100638210|FG000|STARTED|Baseline||227||
48700968|NCT01352221|102054121|FG003|NOT COMPLETED|Double-blind Phase||0||
48700969|NCT01352221|102054118|FG000|STARTED|Open-label Phase||0||
48700970|NCT01352221|102054119|FG001|STARTED|Open-label Phase||0||
48700971|NCT01352221|102054120|FG002|STARTED|Open-label Phase||50||
48127579|NCT02391948|100638211|FG001|STARTED|Baseline||161||
48127580|NCT02391948|100638212|FG002|STARTED|Baseline||80||
48127581|NCT02391948|100638213|FG003|STARTED|Baseline||129||
48127582|NCT02391948|100638214|FG004|STARTED|Baseline||111||
48127583|NCT02391948|100638210|FG000|COMPLETED|Baseline||227||
48127584|NCT02391948|100638211|FG001|COMPLETED|Baseline||161||
48127585|NCT02391948|100638212|FG002|COMPLETED|Baseline||80||
48127586|NCT02391948|100638213|FG003|COMPLETED|Baseline||129||
48127587|NCT02391948|100638214|FG004|COMPLETED|Baseline||111||
48127588|NCT02391948|100638210|FG000|NOT COMPLETED|Baseline||0||
48127589|NCT02391948|100638211|FG001|NOT COMPLETED|Baseline||0||
48127590|NCT02391948|100638212|FG002|NOT COMPLETED|Baseline||0||
48127591|NCT02391948|100638213|FG003|NOT COMPLETED|Baseline||0||
48127592|NCT02391948|100638214|FG004|NOT COMPLETED|Baseline||0||
48127593|NCT02391948|100638210|FG000|STARTED|6-month Assessment||227||
48127594|NCT02391948|100638211|FG001|STARTED|6-month Assessment||161||
48127595|NCT02391948|100638212|FG002|STARTED|6-month Assessment||80||
48127596|NCT02391948|100638213|FG003|STARTED|6-month Assessment||129||
48127597|NCT02391948|100638214|FG004|STARTED|6-month Assessment||111||
48127598|NCT02391948|100638210|FG000|COMPLETED|6-month Assessment||148||
48127599|NCT02391948|100638211|FG001|COMPLETED|6-month Assessment||105||
48127600|NCT02391948|100638212|FG002|COMPLETED|6-month Assessment||49||
48127601|NCT02391948|100638213|FG003|COMPLETED|6-month Assessment||84||
48127602|NCT02391948|100638214|FG004|COMPLETED|6-month Assessment||85||
48127603|NCT02391948|100638210|FG000|NOT COMPLETED|6-month Assessment||79||
48127604|NCT02391948|100638211|FG001|NOT COMPLETED|6-month Assessment||56||
48127605|NCT02391948|100638212|FG002|NOT COMPLETED|6-month Assessment||31||
48127606|NCT02391948|100638213|FG003|NOT COMPLETED|6-month Assessment||45||
48127607|NCT02391948|100638214|FG004|NOT COMPLETED|6-month Assessment||26||
48127608|NCT02391948|100638210|FG000|STARTED|12-month Assessment||225||
48127609|NCT02391948|100638211|FG001|STARTED|12-month Assessment||156||
48127610|NCT02391948|100638212|FG002|STARTED|12-month Assessment||77||
48127611|NCT02391948|100638213|FG003|STARTED|12-month Assessment||125||
48127612|NCT02391948|100638214|FG004|STARTED|12-month Assessment||109||
48127613|NCT02391948|100638210|FG000|COMPLETED|12-month Assessment||217||
48127614|NCT02391948|100638211|FG001|COMPLETED|12-month Assessment||147||
48127615|NCT02391948|100638212|FG002|COMPLETED|12-month Assessment||73||
48127616|NCT02391948|100638213|FG003|COMPLETED|12-month Assessment||116||
48127617|NCT02391948|100638214|FG004|COMPLETED|12-month Assessment||103||
48127618|NCT02391948|100638210|FG000|NOT COMPLETED|12-month Assessment||8||
48127619|NCT02391948|100638211|FG001|NOT COMPLETED|12-month Assessment||9||
48127620|NCT02391948|100638212|FG002|NOT COMPLETED|12-month Assessment||4||
48127621|NCT02391948|100638213|FG003|NOT COMPLETED|12-month Assessment||9||
48127622|NCT02391948|100638214|FG004|NOT COMPLETED|12-month Assessment||6||
48127623|NCT02391948|100638210|FG000|STARTED|18-month Assessment||219||
48127624|NCT02391948|100638211|FG001|STARTED|18-month Assessment||151||
48127625|NCT02391948|100638212|FG002|STARTED|18-month Assessment||74||
48127626|NCT02391948|100638213|FG003|STARTED|18-month Assessment||119||
48127627|NCT02391948|100638214|FG004|STARTED|18-month Assessment||105||
48127628|NCT02391948|100638210|FG000|COMPLETED|18-month Assessment||147||
48127629|NCT02391948|100638211|FG001|COMPLETED|18-month Assessment||101||
48127630|NCT02391948|100638212|FG002|COMPLETED|18-month Assessment||48||
48127631|NCT02391948|100638213|FG003|COMPLETED|18-month Assessment||83||
48127632|NCT02391948|100638214|FG004|COMPLETED|18-month Assessment||75||
48127633|NCT02391948|100638210|FG000|NOT COMPLETED|18-month Assessment||72||
48127634|NCT02391948|100638211|FG001|NOT COMPLETED|18-month Assessment||50||
48127635|NCT02391948|100638212|FG002|NOT COMPLETED|18-month Assessment||26||
48127636|NCT02391948|100638213|FG003|NOT COMPLETED|18-month Assessment||36||
48127637|NCT02391948|100638214|FG004|NOT COMPLETED|18-month Assessment||30||
48127638|NCT02391948|100638210|FG000|STARTED|24-month Assessment||149||
48127639|NCT02391948|100638211|FG001|STARTED|24-month Assessment||107||
48127640|NCT02391948|100638212|FG002|STARTED|24-month Assessment||51||
48700972|NCT01352221|102054121|FG003|STARTED|Open-label Phase||47||
48127641|NCT02391948|100638213|FG003|STARTED|24-month Assessment||84||
48127642|NCT02391948|100638214|FG004|STARTED|24-month Assessment||79||
48127643|NCT02391948|100638210|FG000|COMPLETED|24-month Assessment||135||
48127644|NCT02391948|100638211|FG001|COMPLETED|24-month Assessment||97||
48127645|NCT02391948|100638212|FG002|COMPLETED|24-month Assessment||48||
48127646|NCT02391948|100638213|FG003|COMPLETED|24-month Assessment||75||
48127647|NCT02391948|100638214|FG004|COMPLETED|24-month Assessment||69||
48127648|NCT02391948|100638210|FG000|NOT COMPLETED|24-month Assessment||14||
48127649|NCT02391948|100638211|FG001|NOT COMPLETED|24-month Assessment||10||
48127650|NCT02391948|100638212|FG002|NOT COMPLETED|24-month Assessment||3||
48700973|NCT01352221|102054118|FG000|COMPLETED|Open-label Phase||0||
48700974|NCT01352221|102054119|FG001|COMPLETED|Open-label Phase||0||
48700975|NCT01352221|102054120|FG002|COMPLETED|Open-label Phase||37||
48700976|NCT01352221|102054121|FG003|COMPLETED|Open-label Phase||36||
48700977|NCT01352221|102054118|FG000|NOT COMPLETED|Open-label Phase||0||
48700978|NCT01352221|102054119|FG001|NOT COMPLETED|Open-label Phase||0||
48700979|NCT01352221|102054120|FG002|NOT COMPLETED|Open-label Phase||13||
48700980|NCT01352221|102054121|FG003|NOT COMPLETED|Open-label Phase||11||
48700981|NCT03231917|102054122|FG000|STARTED|Overall Study||60||
48700982|NCT03231917|102054123|FG001|STARTED|Overall Study||61||
48700983|NCT03231917|102054122|FG000|COMPLETED|Overall Study||60||
48700984|NCT03231917|102054123|FG001|COMPLETED|Overall Study||61||
48700985|NCT03231917|102054122|FG000|NOT COMPLETED|Overall Study||0||
48700986|NCT03231917|102054123|FG001|NOT COMPLETED|Overall Study||0||
48700987|NCT03368053|102054124|FG000|STARTED|Overall Study||36||
48700988|NCT03368053|102054124|FG000|COMPLETED|Overall Study||36||
48700989|NCT03368053|102054124|FG000|NOT COMPLETED|Overall Study||0||
48700990|NCT02899650|102054125|FG000|STARTED|Overall Study||15||
48700991|NCT02899650|102054126|FG001|STARTED|Overall Study||10||
48127651|NCT02391948|100638213|FG003|NOT COMPLETED|24-month Assessment||9||
48127652|NCT02391948|100638214|FG004|NOT COMPLETED|24-month Assessment||10||
48127653|NCT00009737|100638215|FG000|STARTED|Overall Study||1004||
48127654|NCT00009737|100638216|FG001|STARTED|Overall Study||983||
48127655|NCT00009737|100638215|FG000|COMPLETED|Overall Study||834||
48127656|NCT00009737|100638216|FG001|COMPLETED|Overall Study||860||
48127657|NCT00009737|100638215|FG000|NOT COMPLETED|Overall Study||170||
48700992|NCT02899650|102054127|FG002|STARTED|Overall Study||14||
48700993|NCT02899650|102054128|FG003|STARTED|Overall Study||0||
48700994|NCT02899650|102054125|FG000|COMPLETED|Overall Study||15||
48700995|NCT02899650|102054126|FG001|COMPLETED|Overall Study||10||
48700996|NCT02899650|102054127|FG002|COMPLETED|Overall Study||14||
48700997|NCT02899650|102054128|FG003|COMPLETED|Overall Study||0||
48700998|NCT02899650|102054125|FG000|NOT COMPLETED|Overall Study||0||
48700999|NCT02899650|102054126|FG001|NOT COMPLETED|Overall Study||0||
48701000|NCT02899650|102054127|FG002|NOT COMPLETED|Overall Study||0||
48127658|NCT00009737|100638216|FG001|NOT COMPLETED|Overall Study||123||
48127659|NCT03021187|100638217|FG000|STARTED|Overall Study||184||
48127660|NCT03021187|100638218|FG001|STARTED|Overall Study||182||
48127661|NCT03021187|100638219|FG002|STARTED|Overall Study||181||
48127662|NCT03021187|100638220|FG003|STARTED|Overall Study||184||
48127663|NCT03021187|100638217|FG000|Exposed|Overall Study||184||
48701001|NCT02899650|102054128|FG003|NOT COMPLETED|Overall Study||0||
48701002|NCT03655301|102054129|FG000|STARTED|Overall Study||13||
48701003|NCT03655301|102054129|FG000|COMPLETED|Overall Study||13||
48701004|NCT03655301|102054129|FG000|NOT COMPLETED|Overall Study||0||
48701005|NCT01751906|102054130|FG000|STARTED|Overall Study||1322||
48701006|NCT01751906|102054131|FG001|STARTED|Overall Study||686||
48701007|NCT01751906|102054130|FG000|COMPLETED|Overall Study||1059||
48127664|NCT03021187|100638218|FG001|Exposed|Overall Study||181||
48127665|NCT03021187|100638219|FG002|Exposed|Overall Study||181||
48127666|NCT03021187|100638220|FG003|Exposed|Overall Study||184||
48127667|NCT03021187|100638217|FG000|Full Analysis Set (FAS)|Overall Study||184||
48127668|NCT03021187|100638218|FG001|Full Analysis Set (FAS)|Overall Study||182||
48127669|NCT03021187|100638219|FG002|Full Analysis Set (FAS)|Overall Study||181||
48127670|NCT03021187|100638220|FG003|Full Analysis Set (FAS)|Overall Study||184||
48127671|NCT03021187|100638217|FG000|Safety Analysis Set (SAS)|Overall Study||184||
48127672|NCT03021187|100638218|FG001|Safety Analysis Set (SAS)|Overall Study||181||
48127673|NCT03021187|100638219|FG002|Safety Analysis Set (SAS)|Overall Study||181||
48127674|NCT03021187|100638220|FG003|Safety Analysis Set (SAS)|Overall Study||184||
48127675|NCT03021187|100638217|FG000|COMPLETED|Overall Study||174||
48127676|NCT03021187|100638218|FG001|COMPLETED|Overall Study||173||
48127677|NCT03021187|100638219|FG002|COMPLETED|Overall Study||175||
48127678|NCT03021187|100638220|FG003|COMPLETED|Overall Study||175||
48127679|NCT03021187|100638217|FG000|NOT COMPLETED|Overall Study||10||
48127680|NCT03021187|100638218|FG001|NOT COMPLETED|Overall Study||9||
48127681|NCT03021187|100638219|FG002|NOT COMPLETED|Overall Study||6||
48127682|NCT03021187|100638220|FG003|NOT COMPLETED|Overall Study||9||
48127683|NCT02606136|100638221|FG000|STARTED|Main Study (104 Weeks)||21||
48127684|NCT02606136|100638221|FG000|Received at Least 1 Dose of Study Drug|Main Study (104 Weeks)||21||
48127685|NCT02606136|100638221|FG000|COMPLETED|Main Study (104 Weeks)||15||
48127686|NCT02606136|100638221|FG000|NOT COMPLETED|Main Study (104 Weeks)||6||
48127687|NCT02606136|100638221|FG000|STARTED|OLE (Up to 208 Weeks)||15||
48127688|NCT02606136|100638221|FG000|Received at Least 1 Dose of Study Drug|OLE (Up to 208 Weeks)||15||
48127689|NCT02606136|100638221|FG000|COMPLETED|OLE (Up to 208 Weeks)||0||
48127690|NCT02606136|100638221|FG000|NOT COMPLETED|OLE (Up to 208 Weeks)||15||
48127691|NCT02667912|100638222|FG000|STARTED|Overall Study||28||
48127692|NCT02667912|100638223|FG001|STARTED|Overall Study||27||
48127693|NCT02667912|100638222|FG000|Six Months|Overall Study||27||
48127694|NCT02667912|100638223|FG001|Six Months|Overall Study||24||
48127695|NCT02667912|100638222|FG000|COMPLETED|Overall Study||23||
48127696|NCT02667912|100638223|FG001|COMPLETED|Overall Study||24||
48127697|NCT02667912|100638222|FG000|NOT COMPLETED|Overall Study||5||
48127698|NCT02667912|100638223|FG001|NOT COMPLETED|Overall Study||3||
48283583|NCT01712659|101017231|FG002|STARTED|Dose Escalation||1||
48283584|NCT01712659|101017232|FG003|STARTED|Dose Escalation||0||
48283585|NCT01712659|101017233|FG004|STARTED|Dose Escalation||0||
48283586|NCT01712659|101017229|FG000|COMPLETED|Dose Escalation||1||
48283587|NCT01712659|101017230|FG001|COMPLETED|Dose Escalation||3||
48283588|NCT01712659|101017231|FG002|COMPLETED|Dose Escalation||1||
48283589|NCT01712659|101017232|FG003|COMPLETED|Dose Escalation||0||
48283590|NCT01712659|101017233|FG004|COMPLETED|Dose Escalation||0||
48283591|NCT01712659|101017229|FG000|NOT COMPLETED|Dose Escalation||0||
48283592|NCT01712659|101017230|FG001|NOT COMPLETED|Dose Escalation||2||
48283593|NCT01712659|101017231|FG002|NOT COMPLETED|Dose Escalation||0||
48283594|NCT01712659|101017232|FG003|NOT COMPLETED|Dose Escalation||0||
48283595|NCT01712659|101017233|FG004|NOT COMPLETED|Dose Escalation||0||
48283596|NCT01712659|101017229|FG000|STARTED|Dose Expansion||12||
48283597|NCT01712659|101017230|FG001|STARTED|Dose Expansion||0||
48127699|NCT00766415|100638224|FG000|STARTED|Overall Study||25||
48127700|NCT00766415|100638225|FG001|STARTED|Overall Study||27||
48127701|NCT00766415|100638224|FG000|COMPLETED|Overall Study||25||
48127702|NCT00766415|100638225|FG001|COMPLETED|Overall Study||26||
48127703|NCT00766415|100638224|FG000|NOT COMPLETED|Overall Study||0||
48127704|NCT00766415|100638225|FG001|NOT COMPLETED|Overall Study||1||
48127705|NCT05051241|100638226|FG000|STARTED|Dose Escalation||4||
48127706|NCT05051241|100638227|FG001|STARTED|Dose Escalation||3||
48127707|NCT05051241|100638228|FG002|STARTED|Dose Escalation||4||
48127708|NCT05051241|100638229|FG003|STARTED|Dose Escalation||7||
48127709|NCT05051241|100638230|FG004|STARTED|Dose Escalation||4||
48127710|NCT05051241|100638231|FG005|STARTED|Dose Escalation||4||
48127711|NCT05051241|100638232|FG006|STARTED|Dose Escalation||6||
48127712|NCT05051241|100638233|FG007|STARTED|Dose Escalation||9||
48127713|NCT05051241|100638234|FG008|STARTED|Dose Escalation||6||
48283598|NCT01712659|101017231|FG002|STARTED|Dose Expansion||0||
48283599|NCT01712659|101017232|FG003|STARTED|Dose Expansion||0||
48127714|NCT05051241|100638235|FG009|STARTED|Dose Escalation||0||
48127715|NCT05051241|100638226|FG000|COMPLETED|Dose Escalation||4||
48127716|NCT05051241|100638227|FG001|COMPLETED|Dose Escalation||3||
48127717|NCT05051241|100638228|FG002|COMPLETED|Dose Escalation||4||
48127718|NCT05051241|100638229|FG003|COMPLETED|Dose Escalation||7||
48127719|NCT05051241|100638230|FG004|COMPLETED|Dose Escalation||4||
48127720|NCT05051241|100638231|FG005|COMPLETED|Dose Escalation||4||
48127721|NCT05051241|100638232|FG006|COMPLETED|Dose Escalation||6||
48127722|NCT05051241|100638233|FG007|COMPLETED|Dose Escalation||9||
48127723|NCT05051241|100638234|FG008|COMPLETED|Dose Escalation||6||
48127724|NCT05051241|100638235|FG009|COMPLETED|Dose Escalation||0||
48283600|NCT01712659|101017233|FG004|STARTED|Dose Expansion||0||
48283601|NCT01712659|101017229|FG000|COMPLETED|Dose Expansion||10||
48283602|NCT01712659|101017230|FG001|COMPLETED|Dose Expansion||0||
48283603|NCT01712659|101017231|FG002|COMPLETED|Dose Expansion||0||
48283604|NCT01712659|101017232|FG003|COMPLETED|Dose Expansion||0||
48283605|NCT01712659|101017233|FG004|COMPLETED|Dose Expansion||0||
48283606|NCT01712659|101017229|FG000|NOT COMPLETED|Dose Expansion||2||
48283607|NCT01712659|101017230|FG001|NOT COMPLETED|Dose Expansion||0||
48283608|NCT01712659|101017231|FG002|NOT COMPLETED|Dose Expansion||0||
48283609|NCT01712659|101017232|FG003|NOT COMPLETED|Dose Expansion||0||
48283610|NCT01712659|101017233|FG004|NOT COMPLETED|Dose Expansion||0||
48283611|NCT01712659|101017229|FG000|STARTED|Participants Re-Enrolled and Treated||0||
48283612|NCT01712659|101017230|FG001|STARTED|Participants Re-Enrolled and Treated||1||
48283613|NCT01712659|101017231|FG002|STARTED|Participants Re-Enrolled and Treated||0||
48283614|NCT01712659|101017232|FG003|STARTED|Participants Re-Enrolled and Treated||0||
48283615|NCT01712659|101017233|FG004|STARTED|Participants Re-Enrolled and Treated||0||
48283616|NCT01712659|101017229|FG000|COMPLETED|Participants Re-Enrolled and Treated||0||
48283617|NCT01712659|101017230|FG001|COMPLETED|Participants Re-Enrolled and Treated||1||
48283618|NCT01712659|101017231|FG002|COMPLETED|Participants Re-Enrolled and Treated||0||
48283619|NCT01712659|101017232|FG003|COMPLETED|Participants Re-Enrolled and Treated||0||
48283620|NCT01712659|101017233|FG004|COMPLETED|Participants Re-Enrolled and Treated||0||
48283621|NCT01712659|101017229|FG000|NOT COMPLETED|Participants Re-Enrolled and Treated||0||
48283622|NCT01712659|101017230|FG001|NOT COMPLETED|Participants Re-Enrolled and Treated||0||
48283623|NCT01712659|101017231|FG002|NOT COMPLETED|Participants Re-Enrolled and Treated||0||
48283624|NCT01712659|101017232|FG003|NOT COMPLETED|Participants Re-Enrolled and Treated||0||
48283625|NCT01712659|101017233|FG004|NOT COMPLETED|Participants Re-Enrolled and Treated||0||
48283626|NCT01014143|101017234|FG000|STARTED|First Intervention||10||
48283627|NCT01014143|101017235|FG001|STARTED|First Intervention||9||
48283628|NCT01014143|101017236|FG002|STARTED|First Intervention||9||
48283629|NCT01014143|101017234|FG000|COMPLETED|First Intervention||10||
48283630|NCT01014143|101017235|FG001|COMPLETED|First Intervention||9||
48283631|NCT01014143|101017236|FG002|COMPLETED|First Intervention||9||
48283632|NCT01014143|101017234|FG000|NOT COMPLETED|First Intervention||0||
48283633|NCT01014143|101017235|FG001|NOT COMPLETED|First Intervention||0||
48283634|NCT01014143|101017236|FG002|NOT COMPLETED|First Intervention||0||
48283635|NCT01014143|101017234|FG000|STARTED|Washout Period After 1st Intervention||10||
48283636|NCT01014143|101017235|FG001|STARTED|Washout Period After 1st Intervention||9||
48283637|NCT01014143|101017236|FG002|STARTED|Washout Period After 1st Intervention||9||
48283638|NCT01014143|101017234|FG000|COMPLETED|Washout Period After 1st Intervention||10||
48283639|NCT01014143|101017235|FG001|COMPLETED|Washout Period After 1st Intervention||9||
48283640|NCT01014143|101017236|FG002|COMPLETED|Washout Period After 1st Intervention||9||
48283641|NCT01014143|101017234|FG000|NOT COMPLETED|Washout Period After 1st Intervention||0||
48283642|NCT01014143|101017235|FG001|NOT COMPLETED|Washout Period After 1st Intervention||0||
48283643|NCT01014143|101017236|FG002|NOT COMPLETED|Washout Period After 1st Intervention||0||
48283644|NCT01014143|101017234|FG000|STARTED|Second Intervention||10||
48283645|NCT01014143|101017235|FG001|STARTED|Second Intervention||9||
48283646|NCT01014143|101017236|FG002|STARTED|Second Intervention||9||
48283647|NCT01014143|101017234|FG000|COMPLETED|Second Intervention||8||
48283648|NCT01014143|101017235|FG001|COMPLETED|Second Intervention||9||
48283649|NCT01014143|101017236|FG002|COMPLETED|Second Intervention||9||
48283650|NCT01014143|101017234|FG000|NOT COMPLETED|Second Intervention||2||
48283651|NCT01014143|101017235|FG001|NOT COMPLETED|Second Intervention||0||
48283652|NCT01014143|101017236|FG002|NOT COMPLETED|Second Intervention||0||
48283653|NCT01014143|101017234|FG000|STARTED|Washout After 2nd Intervention||8||
48283654|NCT01014143|101017235|FG001|STARTED|Washout After 2nd Intervention||9||
48283655|NCT01014143|101017236|FG002|STARTED|Washout After 2nd Intervention||9||
48127725|NCT05051241|100638226|FG000|NOT COMPLETED|Dose Escalation||0||
48127726|NCT05051241|100638227|FG001|NOT COMPLETED|Dose Escalation||0||
48127727|NCT05051241|100638228|FG002|NOT COMPLETED|Dose Escalation||0||
48127728|NCT05051241|100638229|FG003|NOT COMPLETED|Dose Escalation||0||
48127729|NCT05051241|100638230|FG004|NOT COMPLETED|Dose Escalation||0||
48127730|NCT05051241|100638231|FG005|NOT COMPLETED|Dose Escalation||0||
48283656|NCT01014143|101017234|FG000|COMPLETED|Washout After 2nd Intervention||8||
48283657|NCT01014143|101017235|FG001|COMPLETED|Washout After 2nd Intervention||9||
48283658|NCT01014143|101017236|FG002|COMPLETED|Washout After 2nd Intervention||9||
48283659|NCT01014143|101017234|FG000|NOT COMPLETED|Washout After 2nd Intervention||0||
48283660|NCT01014143|101017235|FG001|NOT COMPLETED|Washout After 2nd Intervention||0||
48283661|NCT01014143|101017236|FG002|NOT COMPLETED|Washout After 2nd Intervention||0||
48283662|NCT01014143|101017234|FG000|STARTED|Third Intervention||8||
48283663|NCT01014143|101017235|FG001|STARTED|Third Intervention||9||
48283664|NCT01014143|101017236|FG002|STARTED|Third Intervention||9||
48283665|NCT01014143|101017234|FG000|COMPLETED|Third Intervention||8||
48283666|NCT01014143|101017235|FG001|COMPLETED|Third Intervention||9||
48283667|NCT01014143|101017236|FG002|COMPLETED|Third Intervention||9||
48283668|NCT01014143|101017234|FG000|NOT COMPLETED|Third Intervention||0||
48283669|NCT01014143|101017235|FG001|NOT COMPLETED|Third Intervention||0||
48283670|NCT01014143|101017236|FG002|NOT COMPLETED|Third Intervention||0||
48283671|NCT00578461|101017237|FG000|STARTED|Overall Study||26||
48283672|NCT00578461|101017237|FG000|COMPLETED|Overall Study||26||
48283673|NCT00578461|101017237|FG000|NOT COMPLETED|Overall Study||0||
48283674|NCT04129216|101017238|FG000|STARTED|Overall Study||10||
48283675|NCT04129216|101017239|FG001|STARTED|Overall Study||10||
48283676|NCT04129216|101017240|FG002|STARTED|Overall Study||10||
48283677|NCT04129216|101017238|FG000|COMPLETED|Overall Study||10||
48283678|NCT04129216|101017239|FG001|COMPLETED|Overall Study||10||
48283679|NCT04129216|101017240|FG002|COMPLETED|Overall Study||10||
48283680|NCT04129216|101017238|FG000|NOT COMPLETED|Overall Study||0||
48283681|NCT04129216|101017239|FG001|NOT COMPLETED|Overall Study||0||
48283682|NCT04129216|101017240|FG002|NOT COMPLETED|Overall Study||0||
48283683|NCT01182194|101017241|FG000|STARTED|First Intervention||16||
48283684|NCT01182194|101017242|FG001|STARTED|First Intervention||16||
48283685|NCT01182194|101017241|FG000|COMPLETED|First Intervention||16||
48283686|NCT01182194|101017242|FG001|COMPLETED|First Intervention||16||
48283687|NCT01182194|101017241|FG000|NOT COMPLETED|First Intervention||0||
48398076|NCT00094835|101306234|FG004|NOT COMPLETED|Overall Study||4||
48398077|NCT00094835|101306235|FG005|NOT COMPLETED|Overall Study||3||
48398078|NCT00094835|101306236|FG006|NOT COMPLETED|Overall Study||2||
48398079|NCT01990703|101306237|FG000|STARTED|Overall Study||147||
48398080|NCT01990703|101306238|FG001|STARTED|Overall Study||138||
48398081|NCT01990703|101306237|FG000|COMPLETED|Overall Study||108||
48398082|NCT01990703|101306238|FG001|COMPLETED|Overall Study||93||
48398083|NCT01990703|101306237|FG000|NOT COMPLETED|Overall Study||39||
48398084|NCT01990703|101306238|FG001|NOT COMPLETED|Overall Study||45||
48398085|NCT00706394|101306239|FG000|STARTED|Overall Study||19||
48398086|NCT00706394|101306239|FG000|COMPLETED|Overall Study||8||
48398087|NCT00706394|101306239|FG000|NOT COMPLETED|Overall Study||11||
48398088|NCT01981109|101306240|FG000|STARTED|Overall Study||225||
48398089|NCT01981109|101306240|FG000|COMPLETED|Overall Study||1||
48398090|NCT01981109|101306240|FG000|NOT COMPLETED|Overall Study||224||
48398091|NCT04644484|101306241|FG000|STARTED|Overall Study||750||
48398092|NCT04644484|101306242|FG001|STARTED|Overall Study||250||
48398093|NCT04644484|101306241|FG000|COMPLETED|Overall Study||750||
48398094|NCT04644484|101306242|FG001|COMPLETED|Overall Study||250||
48398095|NCT04644484|101306241|FG000|NOT COMPLETED|Overall Study||0||
48398096|NCT04644484|101306242|FG001|NOT COMPLETED|Overall Study||0||
48701008|NCT01751906|102054131|FG001|COMPLETED|Overall Study||555||
48701009|NCT01751906|102054130|FG000|NOT COMPLETED|Overall Study||263||
48701010|NCT01751906|102054131|FG001|NOT COMPLETED|Overall Study||131||
48701011|NCT05487040|102054132|FG000|STARTED|Overall Study||3||
48701012|NCT05487040|102054133|FG001|STARTED|Overall Study||12||
48701013|NCT05487040|102054132|FG000|COMPLETED|Overall Study||3||
48701014|NCT05487040|102054133|FG001|COMPLETED|Overall Study||12||
48701015|NCT05487040|102054132|FG000|NOT COMPLETED|Overall Study||0||
48701016|NCT05487040|102054133|FG001|NOT COMPLETED|Overall Study||0||
48283688|NCT01182194|101017242|FG001|NOT COMPLETED|First Intervention||0||
48283689|NCT01182194|101017241|FG000|STARTED|Washout of 28 Days||16||
48398097|NCT00718523|101306243|FG000|STARTED|Overall Study||84||
48398098|NCT00718523|101306244|FG001|STARTED|Overall Study||86||
48398099|NCT00718523|101306243|FG000|COMPLETED|Overall Study||66||
48398100|NCT00718523|101306244|FG001|COMPLETED|Overall Study||62||
48398101|NCT00718523|101306243|FG000|NOT COMPLETED|Overall Study||18||
48398102|NCT00718523|101306244|FG001|NOT COMPLETED|Overall Study||24||
48283690|NCT01182194|101017242|FG001|STARTED|Washout of 28 Days||16||
48398103|NCT01302691|101306245|FG000|STARTED|Overall Study||164||
48398104|NCT01302691|101306246|FG001|STARTED|Overall Study||163||
48398105|NCT01302691|101306245|FG000|COMPLETED|Overall Study||154||
48398106|NCT01302691|101306246|FG001|COMPLETED|Overall Study||157||
48398107|NCT01302691|101306245|FG000|NOT COMPLETED|Overall Study||10||
48398108|NCT01302691|101306246|FG001|NOT COMPLETED|Overall Study||6||
48398109|NCT01902004|101306247|FG000|STARTED|Overall Study||48||
48398110|NCT01902004|101306248|FG001|STARTED|Overall Study||47||
48398111|NCT01902004|101306247|FG000|COMPLETED|Overall Study||33||
48398112|NCT01902004|101306248|FG001|COMPLETED|Overall Study||29||
48398113|NCT01902004|101306247|FG000|NOT COMPLETED|Overall Study||15||
48398114|NCT01902004|101306248|FG001|NOT COMPLETED|Overall Study||18||
48398115|NCT01562678|101306249|FG000|STARTED|Overall Study||14||
48701017|NCT02447250|102054134|FG000|STARTED|First Dose (180 mcg Albuterol)||14||
48701018|NCT02447250|102054134|FG000|COMPLETED|First Dose (180 mcg Albuterol)||14||
48701019|NCT02447250|102054134|FG000|NOT COMPLETED|First Dose (180 mcg Albuterol)||0||
48701020|NCT02447250|102054134|FG000|STARTED|Second Dose (270 mcg Albuterol)||14||
48701021|NCT02447250|102054134|FG000|COMPLETED|Second Dose (270 mcg Albuterol)||13||
48701022|NCT02447250|102054134|FG000|NOT COMPLETED|Second Dose (270 mcg Albuterol)||1||
48701023|NCT02447250|102054134|FG000|STARTED|Third Dose (360 mcg Albuterol)||13||
48701024|NCT02447250|102054134|FG000|COMPLETED|Third Dose (360 mcg Albuterol)||8||
48283691|NCT01182194|101017241|FG000|COMPLETED|Washout of 28 Days||15||
48283692|NCT01182194|101017242|FG001|COMPLETED|Washout of 28 Days||16||
48398116|NCT01562678|101306250|FG001|STARTED|Overall Study||14||
48398117|NCT01562678|101306249|FG000|COMPLETED|Overall Study||8||
48398118|NCT01562678|101306250|FG001|COMPLETED|Overall Study||12||
48398119|NCT01562678|101306249|FG000|NOT COMPLETED|Overall Study||6||
48398120|NCT01562678|101306250|FG001|NOT COMPLETED|Overall Study||2||
48701025|NCT02447250|102054134|FG000|NOT COMPLETED|Third Dose (360 mcg Albuterol)||5||
48701026|NCT00920387|102054135|FG000|STARTED|Stage 1||8||
48701027|NCT00920387|102054136|FG001|STARTED|Stage 1||4||
48701028|NCT00920387|102054137|FG002|STARTED|Stage 1||0||
48701029|NCT00920387|102054135|FG000|COMPLETED|Stage 1||7||
48127731|NCT05051241|100638232|FG006|NOT COMPLETED|Dose Escalation||0||
48127732|NCT05051241|100638233|FG007|NOT COMPLETED|Dose Escalation||0||
48127733|NCT05051241|100638234|FG008|NOT COMPLETED|Dose Escalation||0||
48127734|NCT05051241|100638235|FG009|NOT COMPLETED|Dose Escalation||0||
48127735|NCT05051241|100638226|FG000|STARTED|Dose Expansion||0||
48127736|NCT05051241|100638227|FG001|STARTED|Dose Expansion||0||
48127737|NCT05051241|100638228|FG002|STARTED|Dose Expansion||0||
48127738|NCT05051241|100638229|FG003|STARTED|Dose Expansion||0||
48127739|NCT05051241|100638230|FG004|STARTED|Dose Expansion||0||
48283693|NCT01182194|101017241|FG000|NOT COMPLETED|Washout of 28 Days||1||
48127740|NCT05051241|100638231|FG005|STARTED|Dose Expansion||0||
48127741|NCT05051241|100638232|FG006|STARTED|Dose Expansion||0||
48127742|NCT05051241|100638233|FG007|STARTED|Dose Expansion||0||
48127743|NCT05051241|100638234|FG008|STARTED|Dose Expansion||0||
48127744|NCT05051241|100638235|FG009|STARTED|Dose Expansion||3||
48127745|NCT05051241|100638226|FG000|COMPLETED|Dose Expansion||0||
48127746|NCT05051241|100638227|FG001|COMPLETED|Dose Expansion||0||
48127747|NCT05051241|100638228|FG002|COMPLETED|Dose Expansion||0||
48127748|NCT05051241|100638229|FG003|COMPLETED|Dose Expansion||0||
48127749|NCT05051241|100638230|FG004|COMPLETED|Dose Expansion||0||
48127750|NCT05051241|100638231|FG005|COMPLETED|Dose Expansion||0||
48127751|NCT05051241|100638232|FG006|COMPLETED|Dose Expansion||0||
48127752|NCT05051241|100638233|FG007|COMPLETED|Dose Expansion||0||
48127753|NCT05051241|100638234|FG008|COMPLETED|Dose Expansion||0||
48127754|NCT05051241|100638235|FG009|COMPLETED|Dose Expansion||3||
48127755|NCT05051241|100638226|FG000|NOT COMPLETED|Dose Expansion||0||
48127756|NCT05051241|100638227|FG001|NOT COMPLETED|Dose Expansion||0||
48127757|NCT05051241|100638228|FG002|NOT COMPLETED|Dose Expansion||0||
48127758|NCT05051241|100638229|FG003|NOT COMPLETED|Dose Expansion||0||
48127759|NCT05051241|100638230|FG004|NOT COMPLETED|Dose Expansion||0||
48127760|NCT05051241|100638231|FG005|NOT COMPLETED|Dose Expansion||0||
48127761|NCT05051241|100638232|FG006|NOT COMPLETED|Dose Expansion||0||
48127762|NCT05051241|100638233|FG007|NOT COMPLETED|Dose Expansion||0||
48127763|NCT05051241|100638234|FG008|NOT COMPLETED|Dose Expansion||0||
48127764|NCT05051241|100638235|FG009|NOT COMPLETED|Dose Expansion||0||
48127765|NCT00127608|100638236|FG000|STARTED|Overall Study||36||503
48127766|NCT00127608|100638236|FG000|COMPLETED|Overall Study||35||472
48127767|NCT00127608|100638236|FG000|NOT COMPLETED|Overall Study||1||31
48127768|NCT04408963|100638237|FG000|STARTED|Overall Study||5||
48127769|NCT04408963|100638238|FG001|STARTED|Overall Study||5||
48572699|NCT00570687|101735043|FG001|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
48572700|NCT00570687|101735044|FG002|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
48572701|NCT00570687|101735045|FG003|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
48127770|NCT04408963|100638237|FG000|Received Study Product|Overall Study||5||
48127771|NCT04408963|100638238|FG001|Received Study Product|Overall Study||5||
48127772|NCT04408963|100638237|FG000|COMPLETED|Overall Study||5||
48127773|NCT04408963|100638238|FG001|COMPLETED|Overall Study||5||
48127774|NCT04408963|100638237|FG000|NOT COMPLETED|Overall Study||0||
48127775|NCT04408963|100638238|FG001|NOT COMPLETED|Overall Study||0||
48127776|NCT03811912|100638239|FG000|STARTED|Overall Study||29||
48127777|NCT03811912|100638240|FG001|STARTED|Overall Study||28||
48127778|NCT03811912|100638239|FG000|Safety Population|Overall Study||29|Safety Population included all participants who received study drug. Participants in the safety population were analyzed according to the actual dosing regimen received during the study.|
48127779|NCT03811912|100638240|FG001|Safety Population|Overall Study||28|Safety Population included all participants who received study drug. Participants in the safety population were analyzed according to the actual dosing regimen received during the study.|
48283694|NCT01182194|101017242|FG001|NOT COMPLETED|Washout of 28 Days||0||
48283695|NCT01182194|101017241|FG000|STARTED|Second Intervention||15||
48283696|NCT01182194|101017242|FG001|STARTED|Second Intervention||16||
48283697|NCT01182194|101017241|FG000|COMPLETED|Second Intervention||15||
48283698|NCT01182194|101017242|FG001|COMPLETED|Second Intervention||16||
48283699|NCT01182194|101017241|FG000|NOT COMPLETED|Second Intervention||0||
48283700|NCT01182194|101017242|FG001|NOT COMPLETED|Second Intervention||0||
48283701|NCT04371198|101017243|FG000|STARTED|Overall Study||20||
48283702|NCT04371198|101017243|FG000|COMPLETED|Overall Study||16||
48283703|NCT04371198|101017243|FG000|NOT COMPLETED|Overall Study||4||
48283704|NCT03748992|101017244|FG000|STARTED|Overall Study||10||
48283705|NCT03748992|101017244|FG000|COMPLETED|Overall Study||10||
48283706|NCT03748992|101017244|FG000|NOT COMPLETED|Overall Study||0||
48283707|NCT00461513|101017245|FG000|STARTED|Overall Study||187||
48572702|NCT00570687|101735046|FG004|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
48572703|NCT00570687|101735047|FG005|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
48572704|NCT00570687|101735048|FG006|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
48127780|NCT03811912|100638239|FG000|COMPLETED|Overall Study||25||
48127781|NCT03811912|100638240|FG001|COMPLETED|Overall Study||26||
48127782|NCT03811912|100638239|FG000|NOT COMPLETED|Overall Study||4||
48127783|NCT03811912|100638240|FG001|NOT COMPLETED|Overall Study||2||
48127784|NCT01807585|100638241|FG000|STARTED|Overall Study||20|Date of first Baseline Visit|
48127785|NCT01807585|100638242|FG001|STARTED|Overall Study||108|Date of first Baseline Visit|
48283708|NCT00461513|101017246|FG001|STARTED|Overall Study||197||
48283709|NCT00461513|101017245|FG000|COMPLETED|Overall Study||165||
48127786|NCT01807585|100638243|FG002|STARTED|Overall Study||114|Date of first Baseline Visit|
48127787|NCT01807585|100638241|FG000|3 Mos|Overall Study||20|Primary endpoint|
48127788|NCT01807585|100638242|FG001|3 Mos|Overall Study||108|Primary endpoint|
48127789|NCT01807585|100638243|FG002|3 Mos|Overall Study||113|Primary endpoint|
48127790|NCT01807585|100638241|FG000|COMPLETED|Overall Study||19||
48127791|NCT01807585|100638242|FG001|COMPLETED|Overall Study||104||
48127792|NCT01807585|100638243|FG002|COMPLETED|Overall Study||108||
48127793|NCT01807585|100638241|FG000|NOT COMPLETED|Overall Study||1||
48127794|NCT01807585|100638242|FG001|NOT COMPLETED|Overall Study||4||
48127795|NCT01807585|100638243|FG002|NOT COMPLETED|Overall Study||6||
48127796|NCT01037309|100638244|FG000|STARTED|Subcutaneous Cohort 1 - 6||3||
48127797|NCT01037309|100638245|FG001|STARTED|Subcutaneous Cohort 1 - 6||3||
48127798|NCT01037309|100638246|FG002|STARTED|Subcutaneous Cohort 1 - 6||3||
48127799|NCT01037309|100638247|FG003|STARTED|Subcutaneous Cohort 1 - 6||3||
48127800|NCT01037309|100638248|FG004|STARTED|Subcutaneous Cohort 1 - 6||3||
48127801|NCT01037309|100638249|FG005|STARTED|Subcutaneous Cohort 1 - 6||3||
48127802|NCT01037309|100638250|FG006|STARTED|Subcutaneous Cohort 1 - 6||0||
48127803|NCT01037309|100638251|FG007|STARTED|Subcutaneous Cohort 1 - 6||0||
48127804|NCT01037309|100638252|FG008|STARTED|Subcutaneous Cohort 1 - 6||0||
48127805|NCT01037309|100638244|FG000|COMPLETED|Subcutaneous Cohort 1 - 6||3||
48127806|NCT01037309|100638245|FG001|COMPLETED|Subcutaneous Cohort 1 - 6||3||
48127807|NCT01037309|100638246|FG002|COMPLETED|Subcutaneous Cohort 1 - 6||3||
48127808|NCT01037309|100638247|FG003|COMPLETED|Subcutaneous Cohort 1 - 6||3||
48127809|NCT01037309|100638248|FG004|COMPLETED|Subcutaneous Cohort 1 - 6||3||
48127810|NCT01037309|100638249|FG005|COMPLETED|Subcutaneous Cohort 1 - 6||3||
48127811|NCT01037309|100638250|FG006|COMPLETED|Subcutaneous Cohort 1 - 6||0||
48127812|NCT01037309|100638251|FG007|COMPLETED|Subcutaneous Cohort 1 - 6||0||
48127813|NCT01037309|100638252|FG008|COMPLETED|Subcutaneous Cohort 1 - 6||0||
48127814|NCT01037309|100638244|FG000|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0||
48127815|NCT01037309|100638245|FG001|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0||
48127816|NCT01037309|100638246|FG002|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0||
48127817|NCT01037309|100638247|FG003|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0||
48127818|NCT01037309|100638248|FG004|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0||
48127819|NCT01037309|100638249|FG005|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0||
48127820|NCT01037309|100638250|FG006|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0||
48127821|NCT01037309|100638251|FG007|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0||
48127822|NCT01037309|100638252|FG008|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0||
48127823|NCT01037309|100638244|FG000|STARTED|Intravenous Period 7 - 9||0||
48127824|NCT01037309|100638245|FG001|STARTED|Intravenous Period 7 - 9||0||
48127825|NCT01037309|100638246|FG002|STARTED|Intravenous Period 7 - 9||0||
48127826|NCT01037309|100638247|FG003|STARTED|Intravenous Period 7 - 9||0||
48127827|NCT01037309|100638248|FG004|STARTED|Intravenous Period 7 - 9||0||
48127828|NCT01037309|100638249|FG005|STARTED|Intravenous Period 7 - 9||0||
48127829|NCT01037309|100638250|FG006|STARTED|Intravenous Period 7 - 9||3||
48127830|NCT01037309|100638251|FG007|STARTED|Intravenous Period 7 - 9||3||
48127831|NCT01037309|100638252|FG008|STARTED|Intravenous Period 7 - 9||3||
48127832|NCT01037309|100638244|FG000|COMPLETED|Intravenous Period 7 - 9||0||
48127833|NCT01037309|100638245|FG001|COMPLETED|Intravenous Period 7 - 9||0||
48127834|NCT01037309|100638246|FG002|COMPLETED|Intravenous Period 7 - 9||0||
48127835|NCT01037309|100638247|FG003|COMPLETED|Intravenous Period 7 - 9||0||
48127836|NCT01037309|100638248|FG004|COMPLETED|Intravenous Period 7 - 9||0||
48127837|NCT01037309|100638249|FG005|COMPLETED|Intravenous Period 7 - 9||0||
48127838|NCT01037309|100638250|FG006|COMPLETED|Intravenous Period 7 - 9||3||
48127839|NCT01037309|100638251|FG007|COMPLETED|Intravenous Period 7 - 9||3||
48127840|NCT01037309|100638252|FG008|COMPLETED|Intravenous Period 7 - 9||3||
48127841|NCT01037309|100638244|FG000|NOT COMPLETED|Intravenous Period 7 - 9||0||
48127842|NCT01037309|100638245|FG001|NOT COMPLETED|Intravenous Period 7 - 9||0||
48127843|NCT01037309|100638246|FG002|NOT COMPLETED|Intravenous Period 7 - 9||0||
48127844|NCT01037309|100638247|FG003|NOT COMPLETED|Intravenous Period 7 - 9||0||
48127845|NCT01037309|100638248|FG004|NOT COMPLETED|Intravenous Period 7 - 9||0||
48283710|NCT00461513|101017246|FG001|COMPLETED|Overall Study||172||
48127846|NCT01037309|100638249|FG005|NOT COMPLETED|Intravenous Period 7 - 9||0||
48127847|NCT01037309|100638250|FG006|NOT COMPLETED|Intravenous Period 7 - 9||0||
48127848|NCT01037309|100638251|FG007|NOT COMPLETED|Intravenous Period 7 - 9||0||
48127849|NCT01037309|100638252|FG008|NOT COMPLETED|Intravenous Period 7 - 9||0||
48283711|NCT00461513|101017245|FG000|NOT COMPLETED|Overall Study||22||
48283712|NCT00461513|101017246|FG001|NOT COMPLETED|Overall Study||25||
48283713|NCT03500159|101017247|FG000|STARTED|Overall Study||2||
48283714|NCT03500159|101017248|FG001|STARTED|Overall Study||1||
48127850|NCT01751568|100638253|FG000|STARTED|Overall Study||13||
48127851|NCT01751568|100638254|FG001|STARTED|Overall Study||14||
48127852|NCT01751568|100638255|FG002|STARTED|Overall Study||13||
48127853|NCT01751568|100638253|FG000|COMPLETED|Overall Study||12||
48127854|NCT01751568|100638254|FG001|COMPLETED|Overall Study||14||
48127855|NCT01751568|100638255|FG002|COMPLETED|Overall Study||13||
48127856|NCT01751568|100638253|FG000|NOT COMPLETED|Overall Study||1||
48127857|NCT01751568|100638254|FG001|NOT COMPLETED|Overall Study||0||
48127858|NCT01751568|100638255|FG002|NOT COMPLETED|Overall Study||0||
48283715|NCT03500159|101017247|FG000|COMPLETED|Overall Study||0||
48127859|NCT00766376|100638256|FG000|STARTED|Overall Study||151||
48127860|NCT00766376|100638256|FG000|COMPLETED|Overall Study||124||
48127861|NCT00766376|100638256|FG000|NOT COMPLETED|Overall Study||27||
48127862|NCT00659646|100638257|FG000|STARTED|Overall Study||38||
48127863|NCT00659646|100638258|FG001|STARTED|Overall Study||18||
48127864|NCT00659646|100638257|FG000|COMPLETED|Overall Study||23||
48127865|NCT00659646|100638258|FG001|COMPLETED|Overall Study||10||
48127866|NCT00659646|100638257|FG000|NOT COMPLETED|Overall Study||15||
48127867|NCT00659646|100638258|FG001|NOT COMPLETED|Overall Study||8||
48127868|NCT00630877|100638259|FG000|STARTED|Overall Study||91||
48127869|NCT00630877|100638260|FG001|STARTED|Overall Study||90||
48127870|NCT00630877|100638261|FG002|STARTED|Overall Study||90||
48127871|NCT00630877|100638259|FG000|COMPLETED|Overall Study||72||
48127872|NCT00630877|100638260|FG001|COMPLETED|Overall Study||75||
48127873|NCT00630877|100638261|FG002|COMPLETED|Overall Study||80||
48127874|NCT00630877|100638259|FG000|NOT COMPLETED|Overall Study||19||
48127875|NCT00630877|100638260|FG001|NOT COMPLETED|Overall Study||15||
48127876|NCT00630877|100638261|FG002|NOT COMPLETED|Overall Study||10||
48127877|NCT01682837|100638262|FG000|STARTED|Baseline||35||
48127878|NCT01682837|100638262|FG000|COMPLETED|Baseline||30||
48127879|NCT01682837|100638262|FG000|NOT COMPLETED|Baseline||5||
48127880|NCT01682837|100638262|FG000|STARTED|First Intervention (4 Weeks)||30||
48127881|NCT01682837|100638262|FG000|Received KMgCit|First Intervention (4 Weeks)||8||
48127882|NCT01682837|100638262|FG000|Received KCit|First Intervention (4 Weeks)||8||
48127883|NCT01682837|100638262|FG000|Received KCl|First Intervention (4 Weeks)||7||
48127884|NCT01682837|100638262|FG000|Received Placebo|First Intervention (4 Weeks)||7||
48127885|NCT01682837|100638262|FG000|COMPLETED|First Intervention (4 Weeks)||30||
48127886|NCT01682837|100638262|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0||
48127887|NCT01682837|100638262|FG000|STARTED|Second Intervention (4 Weeks)||30||
48127888|NCT01682837|100638262|FG000|Received KMgCit|Second Intervention (4 Weeks)||7||
48127889|NCT01682837|100638262|FG000|Received KCit|Second Intervention (4 Weeks)||6||
48127890|NCT01682837|100638262|FG000|Received KCl|Second Intervention (4 Weeks)||8||
48127891|NCT01682837|100638262|FG000|Received Placebo|Second Intervention (4 Weeks)||9||
48127892|NCT01682837|100638262|FG000|COMPLETED|Second Intervention (4 Weeks)||30||
48127893|NCT01682837|100638262|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0||
48127894|NCT01682837|100638262|FG000|STARTED|Third Intervention (4 Weeks)||30||
48127895|NCT01682837|100638262|FG000|Received KMgCit|Third Intervention (4 Weeks)||9||
48127896|NCT01682837|100638262|FG000|Received KCit|Third Intervention (4 Weeks)||7||
48127897|NCT01682837|100638262|FG000|Received KCl|Third Intervention (4 Weeks)||7||
48127898|NCT01682837|100638262|FG000|Received Placebo|Third Intervention (4 Weeks)||7||
48127899|NCT01682837|100638262|FG000|COMPLETED|Third Intervention (4 Weeks)||30||
48127900|NCT01682837|100638262|FG000|NOT COMPLETED|Third Intervention (4 Weeks)||0||
48127901|NCT01682837|100638262|FG000|STARTED|Fourth Intervention (4 Weeks)||30||
48127902|NCT01682837|100638262|FG000|Received KMgCit|Fourth Intervention (4 Weeks)||6||
48127903|NCT01682837|100638262|FG000|Received KCit|Fourth Intervention (4 Weeks)||9||
48127904|NCT01682837|100638262|FG000|Received KCl|Fourth Intervention (4 Weeks)||8||
48127905|NCT01682837|100638262|FG000|Received Placebo|Fourth Intervention (4 Weeks)||7||
48127906|NCT01682837|100638262|FG000|COMPLETED|Fourth Intervention (4 Weeks)||30||
48127907|NCT01682837|100638262|FG000|NOT COMPLETED|Fourth Intervention (4 Weeks)||0||
48127908|NCT03891524|100638263|FG000|STARTED|Overall Study||34||
48127909|NCT03891524|100638264|FG001|STARTED|Overall Study||150||
48127910|NCT03891524|100638265|FG002|STARTED|Overall Study||153||
48127911|NCT03891524|100638266|FG003|STARTED|Overall Study||150||
48127912|NCT03891524|100638267|FG004|STARTED|Overall Study||149||
48127913|NCT03891524|100638268|FG005|STARTED|Overall Study||152||
48127914|NCT03891524|100638269|FG006|STARTED|Overall Study||153||
48127915|NCT03891524|100638270|FG007|STARTED|Overall Study||301||
48127916|NCT03891524|100638263|FG000|Safety Analysis Set|Overall Study||33||
48127917|NCT03891524|100638264|FG001|Safety Analysis Set|Overall Study||150||
48127918|NCT03891524|100638265|FG002|Safety Analysis Set|Overall Study||148||
48127919|NCT03891524|100638266|FG003|Safety Analysis Set|Overall Study||148||
48283716|NCT03500159|101017248|FG001|COMPLETED|Overall Study||0||
48572705|NCT00570687|101735049|FG007|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
48572706|NCT00570687|101735050|FG008|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
48572707|NCT00570687|101735051|FG009|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
48572708|NCT00570687|101735042|FG000|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0||
48572709|NCT00570687|101735043|FG001|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0||
48572710|NCT00570687|101735044|FG002|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0||
48572711|NCT00570687|101735045|FG003|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0||
48127920|NCT03891524|100638267|FG004|Safety Analysis Set|Overall Study||147||
48127921|NCT03891524|100638268|FG005|Safety Analysis Set|Overall Study||149||
48127922|NCT03891524|100638269|FG006|Safety Analysis Set|Overall Study||148||
48127923|NCT03891524|100638270|FG007|Safety Analysis Set|Overall Study||296||
48127924|NCT03891524|100638263|FG000|COMPLETED|Overall Study||34||
48127925|NCT03891524|100638264|FG001|COMPLETED|Overall Study||149||
48127926|NCT03891524|100638265|FG002|COMPLETED|Overall Study||151||
48127927|NCT03891524|100638266|FG003|COMPLETED|Overall Study||149||
48283717|NCT03500159|101017247|FG000|NOT COMPLETED|Overall Study||2||
48127928|NCT03891524|100638267|FG004|COMPLETED|Overall Study||147||
48127929|NCT03891524|100638268|FG005|COMPLETED|Overall Study||150||
48127930|NCT03891524|100638269|FG006|COMPLETED|Overall Study||151||
48127931|NCT03891524|100638270|FG007|COMPLETED|Overall Study||299||
48127932|NCT03891524|100638263|FG000|NOT COMPLETED|Overall Study||0||
48127933|NCT03891524|100638264|FG001|NOT COMPLETED|Overall Study||1||
48127934|NCT03891524|100638265|FG002|NOT COMPLETED|Overall Study||2||
48127935|NCT03891524|100638266|FG003|NOT COMPLETED|Overall Study||1||
48127936|NCT03891524|100638267|FG004|NOT COMPLETED|Overall Study||2||
48127937|NCT03891524|100638268|FG005|NOT COMPLETED|Overall Study||2||
48127938|NCT03891524|100638269|FG006|NOT COMPLETED|Overall Study||2||
48127939|NCT03891524|100638270|FG007|NOT COMPLETED|Overall Study||2||
48127940|NCT03217136|100638271|FG000|STARTED|Overall Study||71||
48127941|NCT03217136|100638272|FG001|STARTED|Overall Study||23||
48127942|NCT03217136|100638271|FG000|Treated|Overall Study||70||
48127943|NCT03217136|100638272|FG001|Treated|Overall Study||21||
48127944|NCT03217136|100638271|FG000|COMPLETED|Overall Study||67||
48127945|NCT03217136|100638272|FG001|COMPLETED|Overall Study||20||
48127946|NCT03217136|100638271|FG000|NOT COMPLETED|Overall Study||4||
48127947|NCT03217136|100638272|FG001|NOT COMPLETED|Overall Study||3||
48127948|NCT02660359|100638273|FG000|STARTED|Overall Study||86|Subjects randomised and treated in DBPC cycle|
48127949|NCT02660359|100638274|FG001|STARTED|Overall Study||86|Subjects randomised and treated in DBPC cycle|
48127950|NCT02660359|100638275|FG002|STARTED|Overall Study||85|Subjects randomised and treated in DBPC cycle|
48127951|NCT02660359|100638273|FG000|Subjects Entered in the Dysport Cycles|Overall Study||56||
48127952|NCT02660359|100638274|FG001|Subjects Entered in the Dysport Cycles|Overall Study||86||
48127953|NCT02660359|100638275|FG002|Subjects Entered in the Dysport Cycles|Overall Study||85||
48127954|NCT02660359|100638273|FG000|COMPLETED|Overall Study||0|Subjects completed the study in the Dysport cycles|
48127955|NCT02660359|100638274|FG001|COMPLETED|Overall Study||0|Subjects completed the study in the Dysport cycles|
48127956|NCT02660359|100638275|FG002|COMPLETED|Overall Study||1|Subjects completed the study in the Dysport cycles|
48127957|NCT02660359|100638273|FG000|NOT COMPLETED|Overall Study||86||
48127958|NCT02660359|100638274|FG001|NOT COMPLETED|Overall Study||86||
48127959|NCT02660359|100638275|FG002|NOT COMPLETED|Overall Study||84||
48127960|NCT04095858|100638276|FG000|STARTED|Overall Study||3||
48127961|NCT04095858|100638277|FG001|STARTED|Overall Study||4||
48127962|NCT04095858|100638276|FG000|COMPLETED|Overall Study||0||
48127963|NCT04095858|100638277|FG001|COMPLETED|Overall Study||0||
48127964|NCT04095858|100638276|FG000|NOT COMPLETED|Overall Study||3||
48127965|NCT04095858|100638277|FG001|NOT COMPLETED|Overall Study||4||
48127966|NCT02573324|100638278|FG000|STARTED|Overall Study||341|Randomized|
48127967|NCT02573324|100638279|FG001|STARTED|Overall Study||344|Randomized|
48127968|NCT02573324|100638280|FG002|STARTED|Overall Study||6|Randomized|
48127969|NCT02573324|100638278|FG000|Received Randomized Study Drug|Overall Study||337||
48127970|NCT02573324|100638279|FG001|Received Randomized Study Drug|Overall Study||344||
48127971|NCT02573324|100638280|FG002|Received Randomized Study Drug|Overall Study||6||
48127972|NCT02573324|100638278|FG000|Entered Adjuvant Phase|Overall Study||285||
48127973|NCT02573324|100638279|FG001|Entered Adjuvant Phase|Overall Study||273||
48127974|NCT02573324|100638280|FG002|Entered Adjuvant Phase|Overall Study||6||
48127975|NCT02573324|100638278|FG000|Entered Follow-Up Phase|Overall Study||328||
48127976|NCT02573324|100638279|FG001|Entered Follow-Up Phase|Overall Study||326||
48127977|NCT02573324|100638280|FG002|Entered Follow-Up Phase|Overall Study||5||
48127978|NCT02573324|100638278|FG000|COMPLETED|Overall Study||0||
48127979|NCT02573324|100638279|FG001|COMPLETED|Overall Study||0||
48127980|NCT02573324|100638280|FG002|COMPLETED|Overall Study||0||
48127981|NCT02573324|100638278|FG000|NOT COMPLETED|Overall Study||341||
48127982|NCT02573324|100638279|FG001|NOT COMPLETED|Overall Study||344||
48127983|NCT02573324|100638280|FG002|NOT COMPLETED|Overall Study||6||
48127984|NCT03846024|100638281|FG000|STARTED|Overall Study||12||
48127985|NCT03846024|100638282|FG001|STARTED|Overall Study||15||
48127986|NCT03846024|100638281|FG000|COMPLETED|Overall Study||11||
48127987|NCT03846024|100638282|FG001|COMPLETED|Overall Study||14||
48127988|NCT03846024|100638281|FG000|NOT COMPLETED|Overall Study||1||
48127989|NCT03846024|100638282|FG001|NOT COMPLETED|Overall Study||1||
48127990|NCT01059617|100638283|FG000|STARTED|Overall Study||33||
48127991|NCT01059617|100638284|FG001|STARTED|Overall Study||34||
48127992|NCT01059617|100638285|FG002|STARTED|Overall Study||33||
48127993|NCT01059617|100638286|FG003|STARTED|Overall Study||33||
48127994|NCT01059617|100638283|FG000|COMPLETED|Overall Study||26||
48127995|NCT01059617|100638284|FG001|COMPLETED|Overall Study||33||
48127996|NCT01059617|100638285|FG002|COMPLETED|Overall Study||25||
48127997|NCT01059617|100638286|FG003|COMPLETED|Overall Study||27||
48127998|NCT01059617|100638283|FG000|NOT COMPLETED|Overall Study||7||
48127999|NCT01059617|100638284|FG001|NOT COMPLETED|Overall Study||1||
48128000|NCT01059617|100638285|FG002|NOT COMPLETED|Overall Study||8||
48128001|NCT01059617|100638286|FG003|NOT COMPLETED|Overall Study||6||
48128002|NCT03834194|100638287|FG000|STARTED|Overall Study||4||
48128003|NCT03834194|100638288|FG001|STARTED|Overall Study||5||
48128004|NCT03834194|100638289|FG002|STARTED|Overall Study||5||
48128005|NCT03834194|100638290|FG003|STARTED|Overall Study||5||
48128006|NCT03834194|100638291|FG004|STARTED|Overall Study||5||
48128007|NCT03834194|100638292|FG005|STARTED|Overall Study||5||
48128008|NCT03834194|100638293|FG006|STARTED|Overall Study||5||
48128009|NCT03834194|100638294|FG007|STARTED|Overall Study||5||
48128010|NCT03834194|100638287|FG000|COMPLETED|Overall Study||3||
48128011|NCT03834194|100638288|FG001|COMPLETED|Overall Study||4||
48128012|NCT03834194|100638289|FG002|COMPLETED|Overall Study||4||
48128013|NCT03834194|100638290|FG003|COMPLETED|Overall Study||5||
48128014|NCT03834194|100638291|FG004|COMPLETED|Overall Study||5||
48128015|NCT03834194|100638292|FG005|COMPLETED|Overall Study||4||
48128016|NCT03834194|100638293|FG006|COMPLETED|Overall Study||5||
48128017|NCT03834194|100638294|FG007|COMPLETED|Overall Study||5||
48128018|NCT03834194|100638287|FG000|NOT COMPLETED|Overall Study||1||
48128019|NCT03834194|100638288|FG001|NOT COMPLETED|Overall Study||1||
48128020|NCT03834194|100638289|FG002|NOT COMPLETED|Overall Study||1||
48128021|NCT03834194|100638290|FG003|NOT COMPLETED|Overall Study||0||
48128022|NCT03834194|100638291|FG004|NOT COMPLETED|Overall Study||0||
48128023|NCT03834194|100638292|FG005|NOT COMPLETED|Overall Study||1||
48128024|NCT03834194|100638293|FG006|NOT COMPLETED|Overall Study||0||
48128025|NCT03834194|100638294|FG007|NOT COMPLETED|Overall Study||0||
48128026|NCT01877421|100638295|FG000|STARTED|Phase 1||2||
48128027|NCT01877421|100638296|FG001|STARTED|Phase 1||1||
48128028|NCT01877421|100638297|FG002|STARTED|Phase 1||4||
48128029|NCT01877421|100638298|FG003|STARTED|Phase 1||2||
48128030|NCT01877421|100638299|FG004|STARTED|Phase 1||4||
48128031|NCT01877421|100638300|FG005|STARTED|Phase 1||2||
48128032|NCT01877421|100638301|FG006|STARTED|Phase 1||4||
48128033|NCT01877421|100638302|FG007|STARTED|Phase 1||2||
48128034|NCT01877421|100638303|FG008|STARTED|Phase 1||7||
48128035|NCT01877421|100638304|FG009|STARTED|Phase 1||3||
48128036|NCT01877421|100638305|FG010|STARTED|Phase 1||7||
48128037|NCT01877421|100638306|FG011|STARTED|Phase 1||3||
48128038|NCT01877421|100638307|FG012|STARTED|Phase 1||7||
48128039|NCT01877421|100638308|FG013|STARTED|Phase 1||3||
48128040|NCT01877421|100638309|FG014|STARTED|Phase 1||7||
48128041|NCT01877421|100638310|FG015|STARTED|Phase 1||3||
48128042|NCT01877421|100638311|FG016|STARTED|Phase 1||7||
48128043|NCT01877421|100638312|FG017|STARTED|Phase 1||3||
48128044|NCT01877421|100638295|FG000|COMPLETED|Phase 1||2||
48128045|NCT01877421|100638296|FG001|COMPLETED|Phase 1||1||
48572712|NCT00570687|101735046|FG004|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3||
48572713|NCT00570687|101735047|FG005|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3||
48572714|NCT00570687|101735048|FG006|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3||
48572715|NCT00570687|101735049|FG007|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3||
48572716|NCT00570687|101735050|FG008|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3||
48572717|NCT00570687|101735051|FG009|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3||
48572718|NCT00570687|101735042|FG000|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0||
48572719|NCT00570687|101735043|FG001|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0||
48572720|NCT00570687|101735044|FG002|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0||
48572721|NCT00570687|101735045|FG003|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0||
48572722|NCT00570687|101735046|FG004|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0||
48128046|NCT01877421|100638297|FG002|COMPLETED|Phase 1||4||
48128047|NCT01877421|100638298|FG003|COMPLETED|Phase 1||2||
48128048|NCT01877421|100638299|FG004|COMPLETED|Phase 1||4||
48128049|NCT01877421|100638300|FG005|COMPLETED|Phase 1||2||
48128050|NCT01877421|100638301|FG006|COMPLETED|Phase 1||4||
48128051|NCT01877421|100638302|FG007|COMPLETED|Phase 1||2||
48283718|NCT03500159|101017248|FG001|NOT COMPLETED|Overall Study||1||
48283719|NCT00381615|101017249|FG000|STARTED|Overall Study||48||
48283720|NCT00381615|101017250|FG001|STARTED|Overall Study||50||
48283721|NCT00381615|101017251|FG002|STARTED|Overall Study||25||
48128052|NCT01877421|100638303|FG008|COMPLETED|Phase 1||7||
48128053|NCT01877421|100638304|FG009|COMPLETED|Phase 1||3||
48128054|NCT01877421|100638305|FG010|COMPLETED|Phase 1||7||
48128055|NCT01877421|100638306|FG011|COMPLETED|Phase 1||3||
48128056|NCT01877421|100638307|FG012|COMPLETED|Phase 1||7||
48128057|NCT01877421|100638308|FG013|COMPLETED|Phase 1||3||
48128058|NCT01877421|100638309|FG014|COMPLETED|Phase 1||7||
48128059|NCT01877421|100638310|FG015|COMPLETED|Phase 1||3||
48283722|NCT00381615|101017252|FG003|STARTED|Overall Study||24||
48283723|NCT00381615|101017249|FG000|COMPLETED|Overall Study||44||
48283724|NCT00381615|101017250|FG001|COMPLETED|Overall Study||45||
48572723|NCT00570687|101735047|FG005|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0||
48572724|NCT00570687|101735048|FG006|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1||
48128060|NCT01877421|100638311|FG016|COMPLETED|Phase 1||7||
48128061|NCT01877421|100638312|FG017|COMPLETED|Phase 1||3||
48128062|NCT01877421|100638295|FG000|NOT COMPLETED|Phase 1||0||
48128063|NCT01877421|100638296|FG001|NOT COMPLETED|Phase 1||0||
48128064|NCT01877421|100638297|FG002|NOT COMPLETED|Phase 1||0||
48128065|NCT01877421|100638298|FG003|NOT COMPLETED|Phase 1||0||
48128066|NCT01877421|100638299|FG004|NOT COMPLETED|Phase 1||0||
48128067|NCT01877421|100638300|FG005|NOT COMPLETED|Phase 1||0||
48128068|NCT01877421|100638301|FG006|NOT COMPLETED|Phase 1||0||
48128069|NCT01877421|100638302|FG007|NOT COMPLETED|Phase 1||0||
48128070|NCT01877421|100638303|FG008|NOT COMPLETED|Phase 1||0||
48128071|NCT01877421|100638304|FG009|NOT COMPLETED|Phase 1||0||
48128072|NCT01877421|100638305|FG010|NOT COMPLETED|Phase 1||0||
48128073|NCT01877421|100638306|FG011|NOT COMPLETED|Phase 1||0||
48128074|NCT01877421|100638307|FG012|NOT COMPLETED|Phase 1||0||
48572725|NCT00570687|101735049|FG007|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0||
48572726|NCT00570687|101735050|FG008|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1||
48572727|NCT00570687|101735051|FG009|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0||
48572728|NCT00570687|101735042|FG000|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0||
48572729|NCT00570687|101735043|FG001|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0||
48128075|NCT01877421|100638308|FG013|NOT COMPLETED|Phase 1||0||
48128076|NCT01877421|100638309|FG014|NOT COMPLETED|Phase 1||0||
48128077|NCT01877421|100638310|FG015|NOT COMPLETED|Phase 1||0||
48128078|NCT01877421|100638311|FG016|NOT COMPLETED|Phase 1||0||
48128079|NCT01877421|100638312|FG017|NOT COMPLETED|Phase 1||0||
48128080|NCT01877421|100638295|FG000|STARTED|Phase 2||0||
48128081|NCT01877421|100638296|FG001|STARTED|Phase 2||0||
48128082|NCT01877421|100638297|FG002|STARTED|Phase 2||4||
48128083|NCT01877421|100638298|FG003|STARTED|Phase 2||2||
48128084|NCT01877421|100638299|FG004|STARTED|Phase 2||7||
48128085|NCT01877421|100638300|FG005|STARTED|Phase 2||3||
48128086|NCT01877421|100638301|FG006|STARTED|Phase 2||7||
48128087|NCT01877421|100638302|FG007|STARTED|Phase 2||2||
48128088|NCT01877421|100638303|FG008|STARTED|Phase 2||6||
48128089|NCT01877421|100638304|FG009|STARTED|Phase 2||3||
48128090|NCT01877421|100638305|FG010|STARTED|Phase 2||7||
48128091|NCT01877421|100638306|FG011|STARTED|Phase 2||3||
48128092|NCT01877421|100638307|FG012|STARTED|Phase 2||7||
48128093|NCT01877421|100638308|FG013|STARTED|Phase 2||3||
48128094|NCT01877421|100638309|FG014|STARTED|Phase 2||7||
48128095|NCT01877421|100638310|FG015|STARTED|Phase 2||3||
48128096|NCT01877421|100638311|FG016|STARTED|Phase 2||0||
48128097|NCT01877421|100638312|FG017|STARTED|Phase 2||0||
48128098|NCT01877421|100638295|FG000|COMPLETED|Phase 2||0||
48128099|NCT01877421|100638296|FG001|COMPLETED|Phase 2||0||
48283725|NCT00381615|101017251|FG002|COMPLETED|Overall Study||24||
48283726|NCT00381615|101017252|FG003|COMPLETED|Overall Study||22||
48283727|NCT00381615|101017249|FG000|NOT COMPLETED|Overall Study||4||
48283728|NCT00381615|101017250|FG001|NOT COMPLETED|Overall Study||5||
48283729|NCT00381615|101017251|FG002|NOT COMPLETED|Overall Study||1||
48283730|NCT00381615|101017252|FG003|NOT COMPLETED|Overall Study||2||
48283731|NCT05062759|101017253|FG000|STARTED|Overall Study||35||
48283732|NCT05062759|101017254|FG001|STARTED|Overall Study||35||
48283733|NCT05062759|101017253|FG000|COMPLETED|Overall Study||34||
48283734|NCT05062759|101017254|FG001|COMPLETED|Overall Study||34||
48283735|NCT05062759|101017253|FG000|NOT COMPLETED|Overall Study||1||
48283736|NCT05062759|101017254|FG001|NOT COMPLETED|Overall Study||1||
48283737|NCT02224690|101017255|FG000|STARTED|Overall Study||86||
48283738|NCT02224690|101017256|FG001|STARTED|Overall Study||85||
48283739|NCT02224690|101017255|FG000|Safety Analysis Set|Overall Study||86|Received at least 1 dose of IMP; analyzed as per actual treatment received.|
48283740|NCT02224690|101017256|FG001|Safety Analysis Set|Overall Study||85|Received at least 1 dose of IMP; analyzed as per actual treatment received.|
48283741|NCT02224690|101017255|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||86|Received at least 1 dose of IMP with at least 1 post-baseline efficacy endpoint measurement.|
48283742|NCT02224690|101017256|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||85|Received at least 1 dose of IMP with at least 1 post-baseline efficacy endpoint measurement.|
48283743|NCT02224690|101017255|FG000|COMPLETED|Overall Study||72||
48283744|NCT02224690|101017256|FG001|COMPLETED|Overall Study||84||
48283745|NCT02224690|101017255|FG000|NOT COMPLETED|Overall Study||14||
48283746|NCT02224690|101017256|FG001|NOT COMPLETED|Overall Study||1||
48572730|NCT00570687|101735044|FG002|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0||
48572731|NCT00570687|101735045|FG003|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0||
48572732|NCT00570687|101735046|FG004|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3||
48701030|NCT00920387|102054136|FG001|COMPLETED|Stage 1||4||
48701031|NCT00920387|102054137|FG002|COMPLETED|Stage 1||0||
48701032|NCT00920387|102054135|FG000|NOT COMPLETED|Stage 1||1||
48701033|NCT00920387|102054136|FG001|NOT COMPLETED|Stage 1||0||
48701034|NCT00920387|102054137|FG002|NOT COMPLETED|Stage 1||0||
48701035|NCT00920387|102054135|FG000|STARTED|Stage 2||0||
48701036|NCT00920387|102054136|FG001|STARTED|Stage 2||0||
48128100|NCT01877421|100638297|FG002|COMPLETED|Phase 2||4||
48128101|NCT01877421|100638298|FG003|COMPLETED|Phase 2||2||
48128102|NCT01877421|100638299|FG004|COMPLETED|Phase 2||7||
48128103|NCT01877421|100638300|FG005|COMPLETED|Phase 2||3||
48128104|NCT01877421|100638301|FG006|COMPLETED|Phase 2||6||
48128105|NCT01877421|100638302|FG007|COMPLETED|Phase 2||2||
48128106|NCT01877421|100638303|FG008|COMPLETED|Phase 2||5||
48128107|NCT01877421|100638304|FG009|COMPLETED|Phase 2||3||
48128108|NCT01877421|100638305|FG010|COMPLETED|Phase 2||5||
48128109|NCT01877421|100638306|FG011|COMPLETED|Phase 2||3||
48128110|NCT01877421|100638307|FG012|COMPLETED|Phase 2||6||
48128111|NCT01877421|100638308|FG013|COMPLETED|Phase 2||3||
48128112|NCT01877421|100638309|FG014|COMPLETED|Phase 2||7||
48128113|NCT01877421|100638310|FG015|COMPLETED|Phase 2||2||
48701037|NCT00920387|102054137|FG002|STARTED|Stage 2||3||
48398121|NCT00555568|101306251|FG000|STARTED|Overall Study||100||
48398122|NCT00555568|101306252|FG001|STARTED|Overall Study||98||
48398123|NCT00555568|101306253|FG002|STARTED|Overall Study||100||
48398124|NCT00555568|101306251|FG000|COMPLETED|Overall Study||74||
48398125|NCT00555568|101306252|FG001|COMPLETED|Overall Study||82||
48398126|NCT00555568|101306253|FG002|COMPLETED|Overall Study||84||
48398127|NCT00555568|101306251|FG000|NOT COMPLETED|Overall Study||26||
48398128|NCT00555568|101306252|FG001|NOT COMPLETED|Overall Study||16||
48398129|NCT00555568|101306253|FG002|NOT COMPLETED|Overall Study||16||
48398130|NCT00062647|101306254|FG000|STARTED|Overall Study||30||
48398131|NCT00062647|101306255|FG001|STARTED|Overall Study||30||
48398132|NCT00062647|101306254|FG000|COMPLETED|Overall Study||14||
48398133|NCT00062647|101306255|FG001|COMPLETED|Overall Study||17||
48398134|NCT00062647|101306254|FG000|NOT COMPLETED|Overall Study||16||
48398135|NCT00062647|101306255|FG001|NOT COMPLETED|Overall Study||13||
48398136|NCT05103475|101306256|FG000|STARTED|Overall Study||18||
48398137|NCT05103475|101306257|FG001|STARTED|Overall Study||18||
48398138|NCT05103475|101306256|FG000|COMPLETED|Overall Study||11|Because of the way that our primary outcomes are defined, all Veterans were included in primary outcome analyses. The definition we used for 'Completed' is the number of Veterans who completed a post-participation survey; please note that post-participation surveys were sent to all 36 Veterans who were randomized, including those who dropped out of yoga classes.|
48398139|NCT05103475|101306257|FG001|COMPLETED|Overall Study||15|Because of the way that our primary outcomes are defined, all Veterans were included in primary outcome analyses. The definition we used for 'Completed' is the number of Veterans who completed a post-participation survey; please note that post-participation surveys were sent to all 36 Veterans who were randomized, including those who dropped out of yoga classes.|
48398140|NCT05103475|101306256|FG000|NOT COMPLETED|Overall Study||7||
48398141|NCT05103475|101306257|FG001|NOT COMPLETED|Overall Study||3||
48398142|NCT01576120|101306258|FG000|STARTED|Overall Study||21||
48398143|NCT01576120|101306259|FG001|STARTED|Overall Study||19||
48398144|NCT01576120|101306258|FG000|COMPLETED|Overall Study||21||
48398145|NCT01576120|101306259|FG001|COMPLETED|Overall Study||19||
48398146|NCT01576120|101306258|FG000|NOT COMPLETED|Overall Study||0||
48398147|NCT01576120|101306259|FG001|NOT COMPLETED|Overall Study||0||
48398148|NCT01089569|101306260|FG000|STARTED|Overall Study||20||
48398149|NCT01089569|101306261|FG001|STARTED|Overall Study||20||
48398150|NCT01089569|101306262|FG002|STARTED|Overall Study||20||
48398151|NCT01089569|101306260|FG000|COMPLETED|Overall Study||16||
48398152|NCT01089569|101306261|FG001|COMPLETED|Overall Study||17||
48398153|NCT01089569|101306262|FG002|COMPLETED|Overall Study||16||
48398154|NCT01089569|101306260|FG000|NOT COMPLETED|Overall Study||4||
48398155|NCT01089569|101306261|FG001|NOT COMPLETED|Overall Study||3||
48398156|NCT01089569|101306262|FG002|NOT COMPLETED|Overall Study||4||
48398157|NCT02186561|101306263|FG000|STARTED|Enrollment||197|Participants Consented and Assessed for Eligibility|
48398158|NCT02186561|101306263|FG000|COMPLETED|Enrollment||141|Enrolled Participants in Whom Deployment of the Investigational Device was Attempted- ITT Population|
48398159|NCT02186561|101306263|FG000|NOT COMPLETED|Enrollment||56||
48398160|NCT02186561|101306263|FG000|STARTED|Subjects Implanted With Device||141|Participants with an Attempted Investigational Device Implant|
48398161|NCT02186561|101306263|FG000|COMPLETED|Subjects Implanted With Device||141|Participants with a Successful Investigational Device Implant|
48398162|NCT02186561|101306263|FG000|NOT COMPLETED|Subjects Implanted With Device||0||
48283747|NCT05398237|101017257|FG000|STARTED|Overall Study||31||
48283748|NCT05398237|101017257|FG000|COMPLETED|Overall Study||30||
48283749|NCT05398237|101017257|FG000|NOT COMPLETED|Overall Study||1||
48283750|NCT00577577|101017258|FG000|STARTED|Overall Study||34||
48283751|NCT00577577|101017259|FG001|STARTED|Overall Study||35||
48283752|NCT00577577|101017258|FG000|Received Treatment|Overall Study||34||
48283753|NCT00577577|101017259|FG001|Received Treatment|Overall Study||35||
48283754|NCT00577577|101017258|FG000|COMPLETED|Overall Study||29||
48283755|NCT00577577|101017259|FG001|COMPLETED|Overall Study||30||
48283756|NCT00577577|101017258|FG000|NOT COMPLETED|Overall Study||5||
48283757|NCT00577577|101017259|FG001|NOT COMPLETED|Overall Study||5||
48283758|NCT01942590|101017260|FG000|STARTED|Overall Study||8||
48283759|NCT01942590|101017261|FG001|STARTED|Overall Study||5||
48283760|NCT01942590|101017260|FG000|COMPLETED|Overall Study||7||
48283761|NCT01942590|101017261|FG001|COMPLETED|Overall Study||4||
48572733|NCT00570687|101735047|FG005|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3||
48572734|NCT00570687|101735048|FG006|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2||
48572735|NCT00570687|101735049|FG007|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3||
48572736|NCT00570687|101735050|FG008|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2||
48572737|NCT00570687|101735051|FG009|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3||
48572738|NCT00570687|101735042|FG000|STARTED|Clamp 1 (1 Day) - Orig Protocol||0||
48283762|NCT01942590|101017260|FG000|NOT COMPLETED|Overall Study||1||
48283763|NCT01942590|101017261|FG001|NOT COMPLETED|Overall Study||1||
48283764|NCT01427595|101017262|FG000|STARTED|Overall Study||25||
48283765|NCT01427595|101017262|FG000|COMPLETED|Overall Study||12||
48283766|NCT01427595|101017262|FG000|NOT COMPLETED|Overall Study||13||
48283767|NCT01142232|101017263|FG000|STARTED|Overall Study||3||
48283768|NCT01142232|101017264|FG001|STARTED|Overall Study||4||
48283769|NCT01142232|101017265|FG002|STARTED|Overall Study||3||
48283770|NCT01142232|101017266|FG003|STARTED|Overall Study||6||
48283771|NCT01142232|101017267|FG004|STARTED|Overall Study||44||
48572739|NCT00570687|101735043|FG001|STARTED|Clamp 1 (1 Day) - Orig Protocol||0||
48572740|NCT00570687|101735044|FG002|STARTED|Clamp 1 (1 Day) - Orig Protocol||0||
48572741|NCT00570687|101735045|FG003|STARTED|Clamp 1 (1 Day) - Orig Protocol||0||
48572742|NCT00570687|101735046|FG004|STARTED|Clamp 1 (1 Day) - Orig Protocol||0||
48572743|NCT00570687|101735047|FG005|STARTED|Clamp 1 (1 Day) - Orig Protocol||0||
48572744|NCT00570687|101735048|FG006|STARTED|Clamp 1 (1 Day) - Orig Protocol||1||
48283772|NCT01142232|101017263|FG000|COMPLETED|Overall Study||0||
48283773|NCT01142232|101017264|FG001|COMPLETED|Overall Study||0||
48283774|NCT01142232|101017265|FG002|COMPLETED|Overall Study||0||
48283775|NCT01142232|101017266|FG003|COMPLETED|Overall Study||1||
48283776|NCT01142232|101017267|FG004|COMPLETED|Overall Study||10||
48283777|NCT01142232|101017263|FG000|NOT COMPLETED|Overall Study||3||
48283778|NCT01142232|101017264|FG001|NOT COMPLETED|Overall Study||4||
48572745|NCT00570687|101735049|FG007|STARTED|Clamp 1 (1 Day) - Orig Protocol||0||
48572746|NCT00570687|101735050|FG008|STARTED|Clamp 1 (1 Day) - Orig Protocol||1||
48572747|NCT00570687|101735051|FG009|STARTED|Clamp 1 (1 Day) - Orig Protocol||0||
48572748|NCT00570687|101735042|FG000|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
48572749|NCT00570687|101735043|FG001|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
48572750|NCT00570687|101735044|FG002|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
48572751|NCT00570687|101735045|FG003|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
48572752|NCT00570687|101735046|FG004|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
48572753|NCT00570687|101735047|FG005|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
48572754|NCT00570687|101735048|FG006|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1||
48283779|NCT01142232|101017265|FG002|NOT COMPLETED|Overall Study||3||
48283780|NCT01142232|101017266|FG003|NOT COMPLETED|Overall Study||5||
48283781|NCT01142232|101017267|FG004|NOT COMPLETED|Overall Study||34||
48283782|NCT02029872|101017268|FG000|STARTED|Overall Study||9||
48283783|NCT02029872|101017269|FG001|STARTED|Overall Study||9||
48283784|NCT02029872|101017268|FG000|COMPLETED|Overall Study||7||
48283785|NCT02029872|101017269|FG001|COMPLETED|Overall Study||6||
48283786|NCT02029872|101017268|FG000|NOT COMPLETED|Overall Study||2||
48283787|NCT02029872|101017269|FG001|NOT COMPLETED|Overall Study||3||
48283788|NCT04513652|101017270|FG000|STARTED|Overall Study||60||
48283789|NCT04513652|101017271|FG001|STARTED|Overall Study||60||
48283790|NCT04513652|101017270|FG000|COMPLETED|Overall Study||60||
48283791|NCT04513652|101017271|FG001|COMPLETED|Overall Study||60||
48283792|NCT04513652|101017270|FG000|NOT COMPLETED|Overall Study||0||
48283793|NCT04513652|101017271|FG001|NOT COMPLETED|Overall Study||0||
48283794|NCT00371683|101017272|FG000|STARTED|DB Treatment Period-Randomized Patients||1599||
48283795|NCT00371683|101017273|FG001|STARTED|DB Treatment Period-Randomized Patients||1596||
48283796|NCT00371683|101017272|FG000|COMPLETED|DB Treatment Period-Randomized Patients||1509||
48283797|NCT00371683|101017273|FG001|COMPLETED|DB Treatment Period-Randomized Patients||1489||
48283798|NCT00371683|101017272|FG000|NOT COMPLETED|DB Treatment Period-Randomized Patients||90||
48283799|NCT00371683|101017273|FG001|NOT COMPLETED|DB Treatment Period-Randomized Patients||107||
48283800|NCT00371683|101017272|FG000|STARTED|Follow-Up Period - Randomized Patients||1553||
48283801|NCT00371683|101017273|FG001|STARTED|Follow-Up Period - Randomized Patients||1533||
48283802|NCT00371683|101017272|FG000|COMPLETED|Follow-Up Period - Randomized Patients||1492||
48283803|NCT00371683|101017273|FG001|COMPLETED|Follow-Up Period - Randomized Patients||1461||
48283804|NCT00371683|101017272|FG000|NOT COMPLETED|Follow-Up Period - Randomized Patients||61||
48283805|NCT00371683|101017273|FG001|NOT COMPLETED|Follow-Up Period - Randomized Patients||72||
48283806|NCT02150343|101017274|FG000|STARTED|Overall Study||180||
48283807|NCT02150343|101017275|FG001|STARTED|Overall Study||178||
48283808|NCT02150343|101017276|FG002|STARTED|Overall Study||178||
48283809|NCT02150343|101017277|FG003|STARTED|Overall Study||178||
48283810|NCT02150343|101017274|FG000|COMPLETED|Overall Study||159||
48283811|NCT02150343|101017275|FG001|COMPLETED|Overall Study||158||
48283812|NCT02150343|101017276|FG002|COMPLETED|Overall Study||166||
48283813|NCT02150343|101017277|FG003|COMPLETED|Overall Study||168||
48283814|NCT02150343|101017274|FG000|NOT COMPLETED|Overall Study||21||
48283815|NCT02150343|101017275|FG001|NOT COMPLETED|Overall Study||20||
48283816|NCT02150343|101017276|FG002|NOT COMPLETED|Overall Study||12||
48283817|NCT02150343|101017277|FG003|NOT COMPLETED|Overall Study||10||
48283818|NCT03367429|101017278|FG000|STARTED|Overall Study||0||
48283819|NCT03367429|101017279|FG001|STARTED|Overall Study||1||
48283820|NCT03367429|101017280|FG002|STARTED|Overall Study||2||
48283821|NCT03367429|101017278|FG000|COMPLETED|Overall Study||0||
48283822|NCT03367429|101017279|FG001|COMPLETED|Overall Study||1||
48283823|NCT03367429|101017280|FG002|COMPLETED|Overall Study||2||
48283824|NCT03367429|101017278|FG000|NOT COMPLETED|Overall Study||0||
48283825|NCT03367429|101017279|FG001|NOT COMPLETED|Overall Study||0||
48283826|NCT03367429|101017280|FG002|NOT COMPLETED|Overall Study||0||
48283827|NCT03918499|101017281|FG000|STARTED|Overall Study||9||
48283828|NCT03918499|101017281|FG000|COMPLETED|Overall Study||9||
48283829|NCT03918499|101017281|FG000|NOT COMPLETED|Overall Study||0||
48283830|NCT02926898|101017282|FG000|STARTED|Overall Study||43||
48283831|NCT02926898|101017283|FG001|STARTED|Overall Study||44||
48283832|NCT02926898|101017282|FG000|COMPLETED|Overall Study||36||
48283833|NCT02926898|101017283|FG001|COMPLETED|Overall Study||41||
48283834|NCT02926898|101017282|FG000|NOT COMPLETED|Overall Study||7||
48283835|NCT02926898|101017283|FG001|NOT COMPLETED|Overall Study||3||
48283836|NCT02548845|101017284|FG000|STARTED|Overall Study||70||
48283837|NCT02548845|101017284|FG000|COMPLETED|Overall Study||70||
48283838|NCT02548845|101017284|FG000|NOT COMPLETED|Overall Study||0||
48283839|NCT01278173|101017285|FG000|STARTED|Overall Study||65||
48283840|NCT01278173|101017285|FG000|COMPLETED|Overall Study||38||
48283841|NCT01278173|101017285|FG000|NOT COMPLETED|Overall Study||27||
48283842|NCT02062593|101017286|FG000|STARTED|Overall Study||105||
48283843|NCT02062593|101017287|FG001|STARTED|Overall Study||95||
48283844|NCT02062593|101017286|FG000|COMPLETED|Overall Study||105||
48283845|NCT02062593|101017287|FG001|COMPLETED|Overall Study||91||
48283846|NCT02062593|101017286|FG000|NOT COMPLETED|Overall Study||0||
48283847|NCT02062593|101017287|FG001|NOT COMPLETED|Overall Study||4||
48283848|NCT04245228|101017288|FG000|STARTED|Overall Study||30|enroll first patients|
48283849|NCT04245228|101017289|FG001|STARTED|Overall Study||30|enroll first patients|
48283850|NCT04245228|101017288|FG000|COMPLETED|Overall Study||30||
48283851|NCT04245228|101017289|FG001|COMPLETED|Overall Study||27||
48283852|NCT04245228|101017288|FG000|NOT COMPLETED|Overall Study||0||
48283853|NCT04245228|101017289|FG001|NOT COMPLETED|Overall Study||3||
48283854|NCT01533597|101017290|FG000|STARTED|Overall Study||35||
48283855|NCT01533597|101017291|FG001|STARTED|Overall Study||35||
48283856|NCT01533597|101017290|FG000|COMPLETED|Overall Study||29||
48283857|NCT01533597|101017291|FG001|COMPLETED|Overall Study||25||
48283858|NCT01533597|101017290|FG000|NOT COMPLETED|Overall Study||6||
48283859|NCT01533597|101017291|FG001|NOT COMPLETED|Overall Study||10||
48283860|NCT02723331|101017292|FG000|STARTED|Overall Study||19||
48283861|NCT02723331|101017293|FG001|STARTED|Overall Study||29||
48283862|NCT02723331|101017292|FG000|COMPLETED|Overall Study||3||
48283863|NCT02723331|101017293|FG001|COMPLETED|Overall Study||5||
48283864|NCT02723331|101017292|FG000|NOT COMPLETED|Overall Study||16||
48283865|NCT02723331|101017293|FG001|NOT COMPLETED|Overall Study||24||
48283866|NCT01445301|101017294|FG000|STARTED|Overall Study||204||
48283867|NCT01445301|101017295|FG001|STARTED|Overall Study||297||
48283868|NCT01445301|101017296|FG002|STARTED|Overall Study||299||
48283869|NCT01445301|101017294|FG000|COMPLETED|Overall Study||183||
48283870|NCT01445301|101017295|FG001|COMPLETED|Overall Study||262||
48283871|NCT01445301|101017296|FG002|COMPLETED|Overall Study||290||
48283872|NCT01445301|101017294|FG000|NOT COMPLETED|Overall Study||21||
48283873|NCT01445301|101017295|FG001|NOT COMPLETED|Overall Study||35||
48283874|NCT01445301|101017296|FG002|NOT COMPLETED|Overall Study||9||
48283875|NCT00421954|101017297|FG000|STARTED|Overall Study||0||
48283876|NCT00421954|101017297|FG000|COMPLETED|Overall Study||0||
48283877|NCT00421954|101017297|FG000|NOT COMPLETED|Overall Study||0||
48572755|NCT00570687|101735049|FG007|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
48572756|NCT00570687|101735050|FG008|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1||
48572757|NCT00570687|101735051|FG009|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
48572758|NCT00570687|101735042|FG000|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
48572759|NCT00570687|101735043|FG001|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
48572760|NCT00570687|101735044|FG002|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
48572761|NCT00570687|101735045|FG003|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
48572762|NCT00570687|101735046|FG004|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
48572763|NCT00570687|101735047|FG005|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
48572764|NCT00570687|101735048|FG006|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
48572765|NCT00570687|101735049|FG007|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
48572766|NCT00570687|101735050|FG008|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
48572767|NCT00570687|101735051|FG009|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
48572768|NCT00570687|101735042|FG000|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0||
48572769|NCT00570687|101735043|FG001|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0||
48572770|NCT00570687|101735044|FG002|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0||
48572771|NCT00570687|101735045|FG003|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0||
48572772|NCT00570687|101735046|FG004|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0||
48572773|NCT00570687|101735047|FG005|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0||
48572774|NCT00570687|101735048|FG006|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1||
48572775|NCT00570687|101735049|FG007|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0||
48572776|NCT00570687|101735050|FG008|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1||
48572777|NCT00570687|101735051|FG009|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0||
48572778|NCT00570687|101735042|FG000|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
48572779|NCT00570687|101735043|FG001|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
48572780|NCT00570687|101735044|FG002|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
48572781|NCT00570687|101735045|FG003|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
48572782|NCT00570687|101735046|FG004|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
48128114|NCT01877421|100638311|FG016|COMPLETED|Phase 2||0||
48128115|NCT01877421|100638312|FG017|COMPLETED|Phase 2||0||
48128116|NCT01877421|100638295|FG000|NOT COMPLETED|Phase 2||0||
48128117|NCT01877421|100638296|FG001|NOT COMPLETED|Phase 2||0||
48283878|NCT03282240|101017298|FG000|STARTED|Overall Study||1777||
48572783|NCT00570687|101735047|FG005|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
48572784|NCT00570687|101735048|FG006|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1||
48572785|NCT00570687|101735049|FG007|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
48128118|NCT01877421|100638297|FG002|NOT COMPLETED|Phase 2||0||
48128119|NCT01877421|100638298|FG003|NOT COMPLETED|Phase 2||0||
48128120|NCT01877421|100638299|FG004|NOT COMPLETED|Phase 2||0||
48283879|NCT03282240|101017299|FG001|STARTED|Overall Study||443||
48283880|NCT03282240|101017300|FG002|STARTED|Overall Study||450||
48283881|NCT03282240|101017298|FG000|COMPLETED|Overall Study||1767||
48283882|NCT03282240|101017299|FG001|COMPLETED|Overall Study||440||
48283883|NCT03282240|101017300|FG002|COMPLETED|Overall Study||447||
48283884|NCT03282240|101017298|FG000|NOT COMPLETED|Overall Study||10||
48283885|NCT03282240|101017299|FG001|NOT COMPLETED|Overall Study||3||
48283886|NCT03282240|101017300|FG002|NOT COMPLETED|Overall Study||3||
48572786|NCT00570687|101735050|FG008|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
48572787|NCT00570687|101735051|FG009|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
48572788|NCT00570687|101735042|FG000|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
48572789|NCT00570687|101735043|FG001|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
48572790|NCT00570687|101735044|FG002|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
48572791|NCT00570687|101735045|FG003|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
48572792|NCT00570687|101735046|FG004|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
48572793|NCT00570687|101735047|FG005|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
48572794|NCT00570687|101735048|FG006|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
48572795|NCT00570687|101735049|FG007|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
48572796|NCT00570687|101735050|FG008|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1||
48572797|NCT00570687|101735051|FG009|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
48572798|NCT00570687|101735042|FG000|STARTED|Clamp 2 (1 Day) - Orig Protocol||0||
48572799|NCT00570687|101735043|FG001|STARTED|Clamp 2 (1 Day) - Orig Protocol||0||
48128121|NCT01877421|100638300|FG005|NOT COMPLETED|Phase 2||0||
48128122|NCT01877421|100638301|FG006|NOT COMPLETED|Phase 2||1||
48128123|NCT01877421|100638302|FG007|NOT COMPLETED|Phase 2||0||
48128124|NCT01877421|100638303|FG008|NOT COMPLETED|Phase 2||1||
48128125|NCT01877421|100638304|FG009|NOT COMPLETED|Phase 2||0||
48128126|NCT01877421|100638305|FG010|NOT COMPLETED|Phase 2||2||
48128127|NCT01877421|100638306|FG011|NOT COMPLETED|Phase 2||0||
48128128|NCT01877421|100638307|FG012|NOT COMPLETED|Phase 2||1||
48128129|NCT01877421|100638308|FG013|NOT COMPLETED|Phase 2||0||
48283887|NCT01901341|101017301|FG000|STARTED|Overall Study||22||
48283888|NCT01901341|101017302|FG001|STARTED|Overall Study||22||
48283889|NCT01901341|101017301|FG000|Received at Least 1 Dose of Study Drug|Overall Study||22||
48283890|NCT01901341|101017302|FG001|Received at Least 1 Dose of Study Drug|Overall Study||22||
48283891|NCT01901341|101017301|FG000|COMPLETED|Overall Study||2||
48283892|NCT01901341|101017302|FG001|COMPLETED|Overall Study||1||
48283893|NCT01901341|101017301|FG000|NOT COMPLETED|Overall Study||20||
48283894|NCT01901341|101017302|FG001|NOT COMPLETED|Overall Study||21||
48283895|NCT02874924|101021367|FG000|STARTED|Overall Study||14||
48283896|NCT02874924|101021368|FG001|STARTED|Overall Study||14||
48283897|NCT02874924|101021369|FG002|STARTED|Overall Study||6||
48283898|NCT02874924|101021367|FG000|COMPLETED|Overall Study||11||
48283899|NCT02874924|101021368|FG001|COMPLETED|Overall Study||14||
48283900|NCT02874924|101021369|FG002|COMPLETED|Overall Study||6||
48283901|NCT02874924|101021367|FG000|NOT COMPLETED|Overall Study||3||
48283902|NCT02874924|101021368|FG001|NOT COMPLETED|Overall Study||0||
48283903|NCT02874924|101021369|FG002|NOT COMPLETED|Overall Study||0||
48283904|NCT01737827|101021370|FG000|STARTED|Overall Study||8|All patients enrolled|
48283905|NCT01737827|101021371|FG001|STARTED|Overall Study||28|All patients enrolled|
48283906|NCT01737827|101021372|FG002|STARTED|Overall Study||2|All patients enrolled|
48283907|NCT01737827|101021370|FG000|Dose-Determining Part|Overall Study||8|Patients enrolled in the Dose-Determining part of the study|
48283908|NCT01737827|101021371|FG001|Dose-Determining Part|Overall Study||0|Patients enrolled in the Dose-Determining part of the study|
48283909|NCT01737827|101021372|FG002|Dose-Determining Part|Overall Study||0|Patients enrolled in the Dose-Determining part of the study|
48283910|NCT01737827|101021370|FG000|Dose Expansion Part: c-MET High|Overall Study||0|Patients enrolled in the Dose Expansion part of the study with c-MET High|
48283911|NCT01737827|101021371|FG001|Dose Expansion Part: c-MET High|Overall Study||8|Patients enrolled in the Dose Expansion part of the study with c-MET High|
48572800|NCT00570687|101735044|FG002|STARTED|Clamp 2 (1 Day) - Orig Protocol||0||
48572801|NCT00570687|101735045|FG003|STARTED|Clamp 2 (1 Day) - Orig Protocol||0||
48572802|NCT00570687|101735046|FG004|STARTED|Clamp 2 (1 Day) - Orig Protocol||0||
48572803|NCT00570687|101735047|FG005|STARTED|Clamp 2 (1 Day) - Orig Protocol||0||
48572804|NCT00570687|101735048|FG006|STARTED|Clamp 2 (1 Day) - Orig Protocol||1||
48572805|NCT00570687|101735049|FG007|STARTED|Clamp 2 (1 Day) - Orig Protocol||0||
48128130|NCT01877421|100638309|FG014|NOT COMPLETED|Phase 2||0||
48128131|NCT01877421|100638310|FG015|NOT COMPLETED|Phase 2||1||
48128132|NCT01877421|100638311|FG016|NOT COMPLETED|Phase 2||0||
48701038|NCT00920387|102054135|FG000|COMPLETED|Stage 2||0||
48701039|NCT00920387|102054136|FG001|COMPLETED|Stage 2||0||
48701040|NCT00920387|102054137|FG002|COMPLETED|Stage 2||3||
48701041|NCT00920387|102054135|FG000|NOT COMPLETED|Stage 2||0||
48701042|NCT00920387|102054136|FG001|NOT COMPLETED|Stage 2||0||
48701043|NCT00920387|102054137|FG002|NOT COMPLETED|Stage 2||0||
48701044|NCT05312632|102054138|FG000|STARTED|Overall Study||201||
48701045|NCT05312632|102054138|FG000|Safety Analysis Population|Overall Study||199||
48701046|NCT05312632|102054138|FG000|Full Analysis Population|Overall Study||196||
48128133|NCT01877421|100638312|FG017|NOT COMPLETED|Phase 2||0||
48128134|NCT02158039|100638313|FG000|STARTED|Overall Study||33||
48128135|NCT02158039|100638313|FG000|COMPLETED|Overall Study||23||
48128136|NCT02158039|100638313|FG000|NOT COMPLETED|Overall Study||10||
48128137|NCT03295201|100638314|FG000|STARTED|Overall Study||11||
48572806|NCT00570687|101735050|FG008|STARTED|Clamp 2 (1 Day) - Orig Protocol||0||
48572807|NCT00570687|101735051|FG009|STARTED|Clamp 2 (1 Day) - Orig Protocol||0||
48572808|NCT00570687|101735042|FG000|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
48572809|NCT00570687|101735043|FG001|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
48572810|NCT00570687|101735044|FG002|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
48572811|NCT00570687|101735045|FG003|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
48572812|NCT00570687|101735046|FG004|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
48572813|NCT00570687|101735047|FG005|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
48572814|NCT00570687|101735048|FG006|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||1||
48572815|NCT00570687|101735049|FG007|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
48572816|NCT00570687|101735050|FG008|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
48572817|NCT00570687|101735051|FG009|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
48128138|NCT03295201|100638315|FG001|STARTED|Overall Study||11||
48128139|NCT03295201|100638314|FG000|COMPLETED|Overall Study||10||
48128140|NCT03295201|100638315|FG001|COMPLETED|Overall Study||9||
48128141|NCT03295201|100638314|FG000|NOT COMPLETED|Overall Study||1||
48128142|NCT03295201|100638315|FG001|NOT COMPLETED|Overall Study||2||
48128143|NCT04153409|100638316|FG000|STARTED|Overall Study||10||
48128144|NCT04153409|100638317|FG001|STARTED|Overall Study||11||
48128145|NCT04153409|100638316|FG000|COMPLETED|Overall Study||8||
48128146|NCT04153409|100638317|FG001|COMPLETED|Overall Study||9||
48128147|NCT04153409|100638316|FG000|NOT COMPLETED|Overall Study||2||
48128148|NCT04153409|100638317|FG001|NOT COMPLETED|Overall Study||2||
48128149|NCT03971617|100638318|FG000|STARTED|Overall Study||1||
48128150|NCT03971617|100638319|FG001|STARTED|Overall Study||1||
48128151|NCT03971617|100638318|FG000|COMPLETED|Overall Study||1||
48128152|NCT03971617|100638319|FG001|COMPLETED|Overall Study||1||
48128153|NCT03971617|100638318|FG000|NOT COMPLETED|Overall Study||0||
48128154|NCT03971617|100638319|FG001|NOT COMPLETED|Overall Study||0||
48128155|NCT00105027|100638320|FG000|STARTED|Overall Study||88||
48128156|NCT00105027|100638321|FG001|STARTED|Overall Study||92||
48128157|NCT00105027|100638322|FG002|STARTED|Overall Study||91||
48128158|NCT00105027|100638323|FG003|STARTED|Overall Study||137||
48128159|NCT00105027|100638324|FG004|STARTED|Overall Study||136||
48128160|NCT00105027|100638325|FG005|STARTED|Overall Study||138||
48128161|NCT00105027|100638320|FG000|COMPLETED|Overall Study||73||
48128162|NCT00105027|100638321|FG001|COMPLETED|Overall Study||83||
48128163|NCT00105027|100638322|FG002|COMPLETED|Overall Study||82||
48128164|NCT00105027|100638323|FG003|COMPLETED|Overall Study||121||
48128165|NCT00105027|100638324|FG004|COMPLETED|Overall Study||121||
48128166|NCT00105027|100638325|FG005|COMPLETED|Overall Study||125||
48128167|NCT00105027|100638320|FG000|NOT COMPLETED|Overall Study||15||
48128168|NCT00105027|100638321|FG001|NOT COMPLETED|Overall Study||9||
48128169|NCT00105027|100638322|FG002|NOT COMPLETED|Overall Study||9||
48128170|NCT00105027|100638323|FG003|NOT COMPLETED|Overall Study||16||
48128171|NCT00105027|100638324|FG004|NOT COMPLETED|Overall Study||15||
48128172|NCT00105027|100638325|FG005|NOT COMPLETED|Overall Study||13||
48128173|NCT00384085|100638326|FG000|STARTED|Overall Study||195||
48128174|NCT00384085|100638327|FG001|STARTED|Overall Study||196||
48128175|NCT00384085|100638328|FG002|STARTED|Overall Study||197||
48128176|NCT00384085|100638326|FG000|Intent-To-Treat (ITT)|Overall Study||195||
48128177|NCT00384085|100638327|FG001|Intent-To-Treat (ITT)|Overall Study||196||
48128178|NCT00384085|100638328|FG002|Intent-To-Treat (ITT)|Overall Study||197||
48128179|NCT00384085|100638326|FG000|Treated (Safety Population)|Overall Study||194||
48128180|NCT00384085|100638327|FG001|Treated (Safety Population)|Overall Study||194||
48572818|NCT00570687|101735042|FG000|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
48128181|NCT00384085|100638328|FG002|Treated (Safety Population)|Overall Study||194||
48128182|NCT00384085|100638326|FG000|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||187||
48128183|NCT00384085|100638327|FG001|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||186||
48128184|NCT00384085|100638328|FG002|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||189||
48128185|NCT00384085|100638326|FG000|COMPLETED|Overall Study||156||
48128186|NCT00384085|100638327|FG001|COMPLETED|Overall Study||150||
48128187|NCT00384085|100638328|FG002|COMPLETED|Overall Study||141||
48128188|NCT00384085|100638326|FG000|NOT COMPLETED|Overall Study||39||
48128189|NCT00384085|100638327|FG001|NOT COMPLETED|Overall Study||46||
48128190|NCT00384085|100638328|FG002|NOT COMPLETED|Overall Study||56||
48128191|NCT02388321|100638329|FG000|STARTED|Overall Study||11||
48128192|NCT02388321|100638330|FG001|STARTED|Overall Study||11||
48128193|NCT02388321|100638329|FG000|COMPLETED|Overall Study||11||
48128194|NCT02388321|100638330|FG001|COMPLETED|Overall Study||11||
48128195|NCT02388321|100638329|FG000|NOT COMPLETED|Overall Study||0||
48128196|NCT02388321|100638330|FG001|NOT COMPLETED|Overall Study||0||
48572819|NCT00570687|101735043|FG001|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
48128197|NCT02161718|100638331|FG000|STARTED|Open-Label ALKS 3831 Period||255||
48128198|NCT02161718|100638332|FG001|STARTED|Open-Label ALKS 3831 Period||0||
48128199|NCT02161718|100638333|FG002|STARTED|Open-Label ALKS 3831 Period||0||
48128200|NCT02161718|100638331|FG000|COMPLETED|Open-Label ALKS 3831 Period||234||
48128201|NCT02161718|100638332|FG001|COMPLETED|Open-Label ALKS 3831 Period||0||
48128202|NCT02161718|100638333|FG002|COMPLETED|Open-Label ALKS 3831 Period||0||
48128203|NCT02161718|100638331|FG000|NOT COMPLETED|Open-Label ALKS 3831 Period||21||
48128204|NCT02161718|100638332|FG001|NOT COMPLETED|Open-Label ALKS 3831 Period||0||
48128205|NCT02161718|100638333|FG002|NOT COMPLETED|Open-Label ALKS 3831 Period||0||
48128206|NCT02161718|100638331|FG000|STARTED|Post- Randomization Period||0||
48128207|NCT02161718|100638332|FG001|STARTED|Post- Randomization Period||112||
48128208|NCT02161718|100638333|FG002|STARTED|Post- Randomization Period||117||
48128209|NCT02161718|100638331|FG000|COMPLETED|Post- Randomization Period||0||
48128210|NCT02161718|100638332|FG001|COMPLETED|Post- Randomization Period||53||
48128211|NCT02161718|100638333|FG002|COMPLETED|Post- Randomization Period||58||
48128212|NCT02161718|100638331|FG000|NOT COMPLETED|Post- Randomization Period||0||
48128213|NCT02161718|100638332|FG001|NOT COMPLETED|Post- Randomization Period||59||
48128214|NCT02161718|100638333|FG002|NOT COMPLETED|Post- Randomization Period||59||
48128215|NCT02823145|100638334|FG000|STARTED|Enrollment||1||
48128216|NCT02823145|100638335|FG001|STARTED|Enrollment||374||
48128217|NCT02823145|100638334|FG000|COMPLETED|Enrollment||0||
48128218|NCT02823145|100638335|FG001|COMPLETED|Enrollment||374||
48128219|NCT02823145|100638334|FG000|NOT COMPLETED|Enrollment||1||
48128220|NCT02823145|100638335|FG001|NOT COMPLETED|Enrollment||0||
48128221|NCT02823145|100638334|FG000|STARTED|Treatment||0||
48128222|NCT02823145|100638335|FG001|STARTED|Treatment||374||
48701047|NCT05312632|102054138|FG000|COMPLETED|Overall Study||162||
48701048|NCT05312632|102054138|FG000|NOT COMPLETED|Overall Study||39||
48701049|NCT02220855|102054139|FG000|STARTED|Overall Study||14||
48128223|NCT02823145|100638334|FG000|COMPLETED|Treatment||0||
48128224|NCT02823145|100638335|FG001|COMPLETED|Treatment||49||
48128225|NCT02823145|100638334|FG000|NOT COMPLETED|Treatment||0||
48128226|NCT02823145|100638335|FG001|NOT COMPLETED|Treatment||325||
48128227|NCT01337245|100638336|FG000|STARTED|Overall Study||26||
48128228|NCT01337245|100638336|FG000|COMPLETED|Overall Study||25||
48128229|NCT01337245|100638336|FG000|NOT COMPLETED|Overall Study||1||
48128230|NCT00499889|100638337|FG000|STARTED|Overall Study||42||
48128231|NCT00499889|100638337|FG000|COMPLETED|Overall Study||41||
48128232|NCT00499889|100638337|FG000|NOT COMPLETED|Overall Study||1||
48128233|NCT01640301|100638338|FG000|STARTED|Overall Study||13||
48128234|NCT01640301|100638339|FG001|STARTED|Overall Study||15||
48128235|NCT01640301|100638338|FG000|COMPLETED|Overall Study||13||
48128236|NCT01640301|100638339|FG001|COMPLETED|Overall Study||7||
48128237|NCT01640301|100638338|FG000|NOT COMPLETED|Overall Study||0||
48128238|NCT01640301|100638339|FG001|NOT COMPLETED|Overall Study||8||
48128239|NCT03791398|100638340|FG000|STARTED|Overall Study||13||
48128240|NCT03791398|100638341|FG001|STARTED|Overall Study||0||
48128241|NCT03791398|100638342|FG002|STARTED|Overall Study||0||
48128242|NCT03791398|100638340|FG000|COMPLETED|Overall Study||11||
48128243|NCT03791398|100638341|FG001|COMPLETED|Overall Study||0||
48128244|NCT03791398|100638342|FG002|COMPLETED|Overall Study||0||
48128245|NCT03791398|100638340|FG000|NOT COMPLETED|Overall Study||2||
48128246|NCT03791398|100638341|FG001|NOT COMPLETED|Overall Study||0||
48128247|NCT03791398|100638342|FG002|NOT COMPLETED|Overall Study||0||
48128248|NCT01972061|100638343|FG000|STARTED|Overall Study||1||
48128249|NCT01972061|100638344|FG001|STARTED|Overall Study||23||
48128250|NCT01972061|100638345|FG002|STARTED|Overall Study||20||
48128251|NCT01972061|100638343|FG000|COMPLETED|Overall Study||1||
48128252|NCT01972061|100638344|FG001|COMPLETED|Overall Study||23||
48128253|NCT01972061|100638345|FG002|COMPLETED|Overall Study||20||
48128254|NCT01972061|100638343|FG000|NOT COMPLETED|Overall Study||0||
48128255|NCT01972061|100638344|FG001|NOT COMPLETED|Overall Study||0||
48128256|NCT01972061|100638345|FG002|NOT COMPLETED|Overall Study||0||
48128257|NCT02639884|100638346|FG000|STARTED|Overall Study||51||
48128258|NCT02639884|100638346|FG000|COMPLETED|Overall Study||47||
48128259|NCT02639884|100638346|FG000|NOT COMPLETED|Overall Study||4||
48128260|NCT02480621|100638347|FG000|STARTED|Randomization||44||
48128261|NCT02480621|100638348|FG001|STARTED|Randomization||40||
48128262|NCT02480621|100638347|FG000|COMPLETED|Randomization||43||
48128263|NCT02480621|100638348|FG001|COMPLETED|Randomization||39||
48128264|NCT02480621|100638347|FG000|NOT COMPLETED|Randomization||1||
48128265|NCT02480621|100638348|FG001|NOT COMPLETED|Randomization||1||
48128266|NCT02480621|100638347|FG000|STARTED|Follow Up||43||
48701050|NCT02220855|102054139|FG000|COMPLETED|Overall Study||0||
48701051|NCT02220855|102054139|FG000|NOT COMPLETED|Overall Study||14||
48128267|NCT02480621|100638348|FG001|STARTED|Follow Up||39||
48128268|NCT02480621|100638347|FG000|COMPLETED|Follow Up||39||
48128269|NCT02480621|100638348|FG001|COMPLETED|Follow Up||37||
48128270|NCT02480621|100638347|FG000|NOT COMPLETED|Follow Up||4||
48128271|NCT02480621|100638348|FG001|NOT COMPLETED|Follow Up||2||
48128272|NCT01925183|100638349|FG000|STARTED|Overall Study||3||
48128273|NCT01925183|100638350|FG001|STARTED|Overall Study||3||
48128274|NCT01925183|100638349|FG000|COMPLETED|Overall Study||2||
48128275|NCT01925183|100638350|FG001|COMPLETED|Overall Study||3||
48128276|NCT01925183|100638349|FG000|NOT COMPLETED|Overall Study||1||
48128277|NCT01925183|100638350|FG001|NOT COMPLETED|Overall Study||0||
48128278|NCT04572633|100638351|FG000|STARTED|Overall Study||47||
48701052|NCT00585494|102054140|FG000|STARTED|Overall Study||300||
48128279|NCT04572633|100638351|FG000|COMPLETED|Overall Study||0|No participant completed the trial at 30 days. Primary outcomes were analyzed at 30 days. Follow up is ongoing.|
48128280|NCT04572633|100638351|FG000|NOT COMPLETED|Overall Study||47||
48283912|NCT01737827|101021372|FG002|Dose Expansion Part: c-MET High|Overall Study||2|Patients enrolled in the Dose Expansion part of the study with c-MET High|
48283913|NCT01737827|101021370|FG000|Dose Expansion Part: c-MET Low|Overall Study||0|Patients enrolled in the Dose Expansion part of the study with c-MET Low|
48572820|NCT00570687|101735044|FG002|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
48572821|NCT00570687|101735045|FG003|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
48572822|NCT00570687|101735046|FG004|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
48572823|NCT00570687|101735047|FG005|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
48572824|NCT00570687|101735048|FG006|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
48572825|NCT00570687|101735049|FG007|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
48572826|NCT00570687|101735050|FG008|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
48572827|NCT00570687|101735051|FG009|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
48572828|NCT00570687|101735042|FG000|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0||
48572829|NCT00570687|101735043|FG001|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0||
48701053|NCT00585494|102054140|FG000|COMPLETED|Overall Study||244||
48701054|NCT00585494|102054140|FG000|NOT COMPLETED|Overall Study||56||
48701055|NCT00948857|102054141|FG000|STARTED|Overall Study||3||
48701056|NCT00948857|102054142|FG001|STARTED|Overall Study||2||
48701057|NCT00948857|102054141|FG000|COMPLETED|Overall Study||2||
48128281|NCT02866682|100638352|FG000|STARTED|Overall Study||39||
48128282|NCT02866682|100638353|FG001|STARTED|Overall Study||132||
48128283|NCT02866682|100638352|FG000|COMPLETED|Overall Study||39||
48128284|NCT02866682|100638353|FG001|COMPLETED|Overall Study||120||
48128285|NCT02866682|100638352|FG000|NOT COMPLETED|Overall Study||0||
48128286|NCT02866682|100638353|FG001|NOT COMPLETED|Overall Study||12||
48128287|NCT02942160|100638354|FG000|STARTED|Overall Study||259||
48128288|NCT02942160|100638354|FG000|EN3835-202 Participants|Overall Study||222||
48128289|NCT02942160|100638354|FG000|EN3835 Treated Subjects in EN3835-202|Overall Study||200||
48128290|NCT02942160|100638354|FG000|COMPLETED|Overall Study||156||
48128291|NCT02942160|100638354|FG000|NOT COMPLETED|Overall Study||103||
48128292|NCT00363766|100638355|FG000|STARTED|Overall Study||32||
48128293|NCT00363766|100638356|FG001|STARTED|Overall Study||20||
48128294|NCT00363766|100638355|FG000|COMPLETED|Overall Study||0||
48128295|NCT00363766|100638356|FG001|COMPLETED|Overall Study||0||
48128296|NCT00363766|100638355|FG000|NOT COMPLETED|Overall Study||32||
48128297|NCT00363766|100638356|FG001|NOT COMPLETED|Overall Study||20||
48128298|NCT01702233|100638357|FG000|STARTED|Overall Study||72||
48128299|NCT01702233|100638358|FG001|STARTED|Overall Study||67||
48128300|NCT01702233|100638359|FG002|STARTED|Overall Study||36||
48128301|NCT01702233|100638357|FG000|Full Analysis Set (ITT)|Overall Study||66||
48128302|NCT01702233|100638358|FG001|Full Analysis Set (ITT)|Overall Study||63||
48128303|NCT01702233|100638359|FG002|Full Analysis Set (ITT)|Overall Study||31||
48128304|NCT01702233|100638357|FG000|Per Protocol Set|Overall Study||58||
48128305|NCT01702233|100638358|FG001|Per Protocol Set|Overall Study||58||
48128306|NCT01702233|100638359|FG002|Per Protocol Set|Overall Study||27||
48128307|NCT01702233|100638357|FG000|COMPLETED|Overall Study||66||
48128308|NCT01702233|100638358|FG001|COMPLETED|Overall Study||64||
48128309|NCT01702233|100638359|FG002|COMPLETED|Overall Study||31||
48128310|NCT01702233|100638357|FG000|NOT COMPLETED|Overall Study||6||
48128311|NCT01702233|100638358|FG001|NOT COMPLETED|Overall Study||3||
48128312|NCT01702233|100638359|FG002|NOT COMPLETED|Overall Study||5||
48128313|NCT01543256|100638360|FG000|STARTED|Overall Study||80||
48128314|NCT01543256|100638361|FG001|STARTED|Overall Study||84||
48128315|NCT01543256|100638360|FG000|COMPLETED|Overall Study||62||
48128316|NCT01543256|100638361|FG001|COMPLETED|Overall Study||70||
48128317|NCT01543256|100638360|FG000|NOT COMPLETED|Overall Study||18||
48128318|NCT01543256|100638361|FG001|NOT COMPLETED|Overall Study||14||
48128319|NCT04289753|100638362|FG000|STARTED|Overall Study||18709||30
48128320|NCT04289753|100638363|FG001|STARTED|Overall Study||18425||30
48128321|NCT04289753|100638362|FG000|COMPLETED|Overall Study||18709||30
48128322|NCT04289753|100638363|FG001|COMPLETED|Overall Study||18425||30
48128323|NCT04289753|100638362|FG000|NOT COMPLETED|Overall Study||0||0
48128324|NCT04289753|100638363|FG001|NOT COMPLETED|Overall Study||0||0
48128325|NCT03224468|100638364|FG000|STARTED|Overall Study||173||
48128326|NCT03224468|100638365|FG001|STARTED|Overall Study||96||
48128327|NCT03224468|100638364|FG000|COMPLETED|Overall Study||105||
48128328|NCT03224468|100638365|FG001|COMPLETED|Overall Study||81||
48128329|NCT03224468|100638364|FG000|NOT COMPLETED|Overall Study||68||
48128330|NCT03224468|100638365|FG001|NOT COMPLETED|Overall Study||15||
48128331|NCT01831089|100638366|FG000|STARTED|Cohort I: Dose Level 1||3||
48572830|NCT00570687|101735044|FG002|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0||
48701058|NCT00948857|102054142|FG001|COMPLETED|Overall Study||2||
48701059|NCT00948857|102054141|FG000|NOT COMPLETED|Overall Study||1||
48701060|NCT00948857|102054142|FG001|NOT COMPLETED|Overall Study||0||
48701061|NCT00176488|102054143|FG000|STARTED|Overall Study||31||
48701062|NCT00176488|102054143|FG000|COMPLETED|Overall Study||30||
48128332|NCT01831089|100638367|FG001|STARTED|Cohort I: Dose Level 1||0||
48128333|NCT01831089|100638368|FG002|STARTED|Cohort I: Dose Level 1||0||
48128334|NCT01831089|100638369|FG003|STARTED|Cohort I: Dose Level 1||0||
48701063|NCT00176488|102054143|FG000|NOT COMPLETED|Overall Study||1||
48701064|NCT03319953|102054144|FG000|STARTED|Period 1 (Day 1 to 14)||3||
48701065|NCT03319953|102054145|FG001|STARTED|Period 1 (Day 1 to 14)||4||
48128335|NCT01831089|100638370|FG004|STARTED|Cohort I: Dose Level 1||0||
48128336|NCT01831089|100638371|FG005|STARTED|Cohort I: Dose Level 1||0||
48128337|NCT01831089|100638366|FG000|COMPLETED|Cohort I: Dose Level 1||0||
48128338|NCT01831089|100638367|FG001|COMPLETED|Cohort I: Dose Level 1||0||
48128339|NCT01831089|100638368|FG002|COMPLETED|Cohort I: Dose Level 1||0||
48128340|NCT01831089|100638369|FG003|COMPLETED|Cohort I: Dose Level 1||0||
48128341|NCT01831089|100638370|FG004|COMPLETED|Cohort I: Dose Level 1||0||
48128342|NCT01831089|100638371|FG005|COMPLETED|Cohort I: Dose Level 1||0||
48128343|NCT01831089|100638366|FG000|NOT COMPLETED|Cohort I: Dose Level 1||3||
48128344|NCT01831089|100638367|FG001|NOT COMPLETED|Cohort I: Dose Level 1||0||
48128345|NCT01831089|100638368|FG002|NOT COMPLETED|Cohort I: Dose Level 1||0||
48128346|NCT01831089|100638369|FG003|NOT COMPLETED|Cohort I: Dose Level 1||0||
48128347|NCT01831089|100638370|FG004|NOT COMPLETED|Cohort I: Dose Level 1||0||
48128348|NCT01831089|100638371|FG005|NOT COMPLETED|Cohort I: Dose Level 1||0||
48128349|NCT01831089|100638366|FG000|STARTED|Cohort II: Dose Level 2||0||
48128350|NCT01831089|100638367|FG001|STARTED|Cohort II: Dose Level 2||3||
48128351|NCT01831089|100638368|FG002|STARTED|Cohort II: Dose Level 2||0||
48128352|NCT01831089|100638369|FG003|STARTED|Cohort II: Dose Level 2||0||
48128353|NCT01831089|100638370|FG004|STARTED|Cohort II: Dose Level 2||0||
48283914|NCT01737827|101021371|FG001|Dose Expansion Part: c-MET Low|Overall Study||20|Patients enrolled in the Dose Expansion part of the study with c-MET Low|
48283915|NCT01737827|101021372|FG002|Dose Expansion Part: c-MET Low|Overall Study||0|Patients enrolled in the Dose Expansion part of the study with c-MET Low|
48283916|NCT01737827|101021370|FG000|Safety Set|Overall Study||9|All patients who received at least one dose of INC280. Patients were analyzed according to the treatment they actually received.|
48283917|NCT01737827|101021371|FG001|Safety Set|Overall Study||27|All patients who received at least one dose of INC280. Patients were analyzed according to the treatment they actually received.|
48283918|NCT01737827|101021372|FG002|Safety Set|Overall Study||2|All patients who received at least one dose of INC280. Patients were analyzed according to the treatment they actually received.|
48283919|NCT01737827|101021370|FG000|COMPLETED|Overall Study||0||
48283920|NCT01737827|101021371|FG001|COMPLETED|Overall Study||0||
48572831|NCT00570687|101735045|FG003|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0||
48572832|NCT00570687|101735046|FG004|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0||
48572833|NCT00570687|101735047|FG005|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0||
48572834|NCT00570687|101735048|FG006|STARTED|Washout 5 (7-21 Days) - Orig Protocol||1||
48572835|NCT00570687|101735049|FG007|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0||
48572836|NCT00570687|101735050|FG008|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0||
48572837|NCT00570687|101735051|FG009|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0||
48572838|NCT00570687|101735042|FG000|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
48572839|NCT00570687|101735043|FG001|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
48572840|NCT00570687|101735044|FG002|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
48572841|NCT00570687|101735045|FG003|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
48572842|NCT00570687|101735046|FG004|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
48572843|NCT00570687|101735047|FG005|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
48572844|NCT00570687|101735048|FG006|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
48572845|NCT00570687|101735049|FG007|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
48572846|NCT00570687|101735050|FG008|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
48572847|NCT00570687|101735051|FG009|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
48572848|NCT00570687|101735042|FG000|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
48572849|NCT00570687|101735043|FG001|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
48572850|NCT00570687|101735044|FG002|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
48572851|NCT00570687|101735045|FG003|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
48572852|NCT00570687|101735046|FG004|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
48572853|NCT00570687|101735047|FG005|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
48572854|NCT00570687|101735048|FG006|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||1||
48572855|NCT00570687|101735049|FG007|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
48572856|NCT00570687|101735050|FG008|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
48572857|NCT00570687|101735051|FG009|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
48572858|NCT00570687|101735042|FG000|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4||
48572859|NCT00570687|101735043|FG001|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2||
48572860|NCT00570687|101735044|FG002|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2||
48572861|NCT00570687|101735045|FG003|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4||
48572862|NCT00570687|101735046|FG004|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0||
48572863|NCT00570687|101735047|FG005|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0||
48701066|NCT03319953|102054146|FG002|STARTED|Period 1 (Day 1 to 14)||9||
48701067|NCT03319953|102054147|FG003|STARTED|Period 1 (Day 1 to 14)||7||
48701068|NCT03319953|102054144|FG000|COMPLETED|Period 1 (Day 1 to 14)||3|Completed = Participants who completed study treatment.|
48701069|NCT03319953|102054145|FG001|COMPLETED|Period 1 (Day 1 to 14)||4|Completed = Participants who completed study treatment.|
48128354|NCT01831089|100638371|FG005|STARTED|Cohort II: Dose Level 2||0||
48128355|NCT01831089|100638366|FG000|COMPLETED|Cohort II: Dose Level 2||0||
48128356|NCT01831089|100638367|FG001|COMPLETED|Cohort II: Dose Level 2||0||
48128357|NCT01831089|100638368|FG002|COMPLETED|Cohort II: Dose Level 2||0||
48128358|NCT01831089|100638369|FG003|COMPLETED|Cohort II: Dose Level 2||0||
48128359|NCT01831089|100638370|FG004|COMPLETED|Cohort II: Dose Level 2||0||
48128360|NCT01831089|100638371|FG005|COMPLETED|Cohort II: Dose Level 2||0||
48128361|NCT01831089|100638366|FG000|NOT COMPLETED|Cohort II: Dose Level 2||0||
48128362|NCT01831089|100638367|FG001|NOT COMPLETED|Cohort II: Dose Level 2||3||
48128363|NCT01831089|100638368|FG002|NOT COMPLETED|Cohort II: Dose Level 2||0||
48128364|NCT01831089|100638369|FG003|NOT COMPLETED|Cohort II: Dose Level 2||0||
48128365|NCT01831089|100638370|FG004|NOT COMPLETED|Cohort II: Dose Level 2||0||
48128366|NCT01831089|100638371|FG005|NOT COMPLETED|Cohort II: Dose Level 2||0||
48128367|NCT01831089|100638366|FG000|STARTED|Cohort III: Dose Level 3||0||
48128368|NCT01831089|100638367|FG001|STARTED|Cohort III: Dose Level 3||0||
48128369|NCT01831089|100638368|FG002|STARTED|Cohort III: Dose Level 3||6||
48128370|NCT01831089|100638369|FG003|STARTED|Cohort III: Dose Level 3||0||
48128371|NCT01831089|100638370|FG004|STARTED|Cohort III: Dose Level 3||0||
48128372|NCT01831089|100638371|FG005|STARTED|Cohort III: Dose Level 3||0||
48128373|NCT01831089|100638366|FG000|COMPLETED|Cohort III: Dose Level 3||0||
48128374|NCT01831089|100638367|FG001|COMPLETED|Cohort III: Dose Level 3||0||
48128375|NCT01831089|100638368|FG002|COMPLETED|Cohort III: Dose Level 3||0||
48128376|NCT01831089|100638369|FG003|COMPLETED|Cohort III: Dose Level 3||0||
48128377|NCT01831089|100638370|FG004|COMPLETED|Cohort III: Dose Level 3||0||
48128378|NCT01831089|100638371|FG005|COMPLETED|Cohort III: Dose Level 3||0||
48128379|NCT01831089|100638366|FG000|NOT COMPLETED|Cohort III: Dose Level 3||0||
48128380|NCT01831089|100638367|FG001|NOT COMPLETED|Cohort III: Dose Level 3||0||
48128381|NCT01831089|100638368|FG002|NOT COMPLETED|Cohort III: Dose Level 3||6||
48128382|NCT01831089|100638369|FG003|NOT COMPLETED|Cohort III: Dose Level 3||0||
48128383|NCT01831089|100638370|FG004|NOT COMPLETED|Cohort III: Dose Level 3||0||
48128384|NCT01831089|100638371|FG005|NOT COMPLETED|Cohort III: Dose Level 3||0||
48128385|NCT01831089|100638366|FG000|STARTED|Cohort IV: Dose Level 4||0||
48128386|NCT01831089|100638367|FG001|STARTED|Cohort IV: Dose Level 4||0||
48128387|NCT01831089|100638368|FG002|STARTED|Cohort IV: Dose Level 4||0||
48128388|NCT01831089|100638369|FG003|STARTED|Cohort IV: Dose Level 4||6||
48128389|NCT01831089|100638370|FG004|STARTED|Cohort IV: Dose Level 4||0||
48128390|NCT01831089|100638371|FG005|STARTED|Cohort IV: Dose Level 4||0||
48128391|NCT01831089|100638366|FG000|COMPLETED|Cohort IV: Dose Level 4||0||
48128392|NCT01831089|100638367|FG001|COMPLETED|Cohort IV: Dose Level 4||0||
48128393|NCT01831089|100638368|FG002|COMPLETED|Cohort IV: Dose Level 4||0||
48128394|NCT01831089|100638369|FG003|COMPLETED|Cohort IV: Dose Level 4||0||
48128395|NCT01831089|100638370|FG004|COMPLETED|Cohort IV: Dose Level 4||0||
48128396|NCT01831089|100638371|FG005|COMPLETED|Cohort IV: Dose Level 4||0||
48128397|NCT01831089|100638366|FG000|NOT COMPLETED|Cohort IV: Dose Level 4||0||
48128398|NCT01831089|100638367|FG001|NOT COMPLETED|Cohort IV: Dose Level 4||0||
48128399|NCT01831089|100638368|FG002|NOT COMPLETED|Cohort IV: Dose Level 4||0||
48128400|NCT01831089|100638369|FG003|NOT COMPLETED|Cohort IV: Dose Level 4||6||
48128401|NCT01831089|100638370|FG004|NOT COMPLETED|Cohort IV: Dose Level 4||0||
48128402|NCT01831089|100638371|FG005|NOT COMPLETED|Cohort IV: Dose Level 4||0||
48128403|NCT01831089|100638366|FG000|STARTED|Cohort V: Dose Level 5||0||
48128404|NCT01831089|100638367|FG001|STARTED|Cohort V: Dose Level 5||0||
48128405|NCT01831089|100638368|FG002|STARTED|Cohort V: Dose Level 5||0||
48128406|NCT01831089|100638369|FG003|STARTED|Cohort V: Dose Level 5||0||
48128407|NCT01831089|100638370|FG004|STARTED|Cohort V: Dose Level 5||37||
48128408|NCT01831089|100638371|FG005|STARTED|Cohort V: Dose Level 5||0||
48398163|NCT02186561|101306263|FG000|STARTED|30-Day Post Index Procedure Visit||141|Participants implanted with the investigational device.|
48398164|NCT02186561|101306263|FG000|COMPLETED|30-Day Post Index Procedure Visit||140|Participants Implanted with the Investigational Device that Completed the 30 Day Visit|
48398165|NCT02186561|101306263|FG000|NOT COMPLETED|30-Day Post Index Procedure Visit||1||
48398166|NCT02186561|101306263|FG000|STARTED|180- Day Post Index Procedure Visit||141|Participants implanted with the investigational device.|
48398167|NCT02186561|101306263|FG000|COMPLETED|180- Day Post Index Procedure Visit||134|Participants Implanted with the Investigational Device that Completed the 30 Day Visit|
48398168|NCT02186561|101306263|FG000|NOT COMPLETED|180- Day Post Index Procedure Visit||7||
48701070|NCT03319953|102054146|FG002|COMPLETED|Period 1 (Day 1 to 14)||9|Completed = Participants who completed study treatment.|
48701071|NCT03319953|102054147|FG003|COMPLETED|Period 1 (Day 1 to 14)||7|Completed = Participants who completed study treatment.|
48701072|NCT03319953|102054144|FG000|NOT COMPLETED|Period 1 (Day 1 to 14)||0||
48701073|NCT03319953|102054145|FG001|NOT COMPLETED|Period 1 (Day 1 to 14)||0||
48701074|NCT03319953|102054146|FG002|NOT COMPLETED|Period 1 (Day 1 to 14)||0||
48128409|NCT01831089|100638366|FG000|COMPLETED|Cohort V: Dose Level 5||0||
48398169|NCT02186561|101306263|FG000|STARTED|1- Year Post Index Procedure Visit||141|Participants implanted with the investigational device.|
48404075|NCT03689972|101321767|FG001|NOT COMPLETED|Part 1 (Day 1 up to Week 72)||49||
48701075|NCT03319953|102054147|FG003|NOT COMPLETED|Period 1 (Day 1 to 14)||0||
48701076|NCT03319953|102054144|FG000|STARTED|Washout Period (Day 15 to 49)||3||
48128410|NCT01831089|100638367|FG001|COMPLETED|Cohort V: Dose Level 5||0||
48128411|NCT01831089|100638368|FG002|COMPLETED|Cohort V: Dose Level 5||0||
48128412|NCT01831089|100638369|FG003|COMPLETED|Cohort V: Dose Level 5||0||
48128413|NCT01831089|100638370|FG004|COMPLETED|Cohort V: Dose Level 5||0||
48128414|NCT01831089|100638371|FG005|COMPLETED|Cohort V: Dose Level 5||0||
48128415|NCT01831089|100638366|FG000|NOT COMPLETED|Cohort V: Dose Level 5||0||
48128416|NCT01831089|100638367|FG001|NOT COMPLETED|Cohort V: Dose Level 5||0||
48128417|NCT01831089|100638368|FG002|NOT COMPLETED|Cohort V: Dose Level 5||0||
48128418|NCT01831089|100638369|FG003|NOT COMPLETED|Cohort V: Dose Level 5||0||
48128419|NCT01831089|100638370|FG004|NOT COMPLETED|Cohort V: Dose Level 5||37||
48128420|NCT01831089|100638371|FG005|NOT COMPLETED|Cohort V: Dose Level 5||0||
48128421|NCT01831089|100638366|FG000|STARTED|Cohort B: Arm B||0||
48128422|NCT01831089|100638367|FG001|STARTED|Cohort B: Arm B||0||
48572864|NCT00570687|101735048|FG006|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0||
48572865|NCT00570687|101735049|FG007|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0||
48128423|NCT01831089|100638368|FG002|STARTED|Cohort B: Arm B||0||
48128424|NCT01831089|100638369|FG003|STARTED|Cohort B: Arm B||0||
48128425|NCT01831089|100638370|FG004|STARTED|Cohort B: Arm B||0||
48128426|NCT01831089|100638371|FG005|STARTED|Cohort B: Arm B||14||
48128427|NCT01831089|100638366|FG000|COMPLETED|Cohort B: Arm B||0||
48128428|NCT01831089|100638367|FG001|COMPLETED|Cohort B: Arm B||0||
48128429|NCT01831089|100638368|FG002|COMPLETED|Cohort B: Arm B||0||
48128430|NCT01831089|100638369|FG003|COMPLETED|Cohort B: Arm B||0||
48128431|NCT01831089|100638370|FG004|COMPLETED|Cohort B: Arm B||0||
48128432|NCT01831089|100638371|FG005|COMPLETED|Cohort B: Arm B||0||
48128433|NCT01831089|100638366|FG000|NOT COMPLETED|Cohort B: Arm B||0||
48128434|NCT01831089|100638367|FG001|NOT COMPLETED|Cohort B: Arm B||0||
48128435|NCT01831089|100638368|FG002|NOT COMPLETED|Cohort B: Arm B||0||
48128436|NCT01831089|100638369|FG003|NOT COMPLETED|Cohort B: Arm B||0||
48128437|NCT01831089|100638370|FG004|NOT COMPLETED|Cohort B: Arm B||0||
48128438|NCT01831089|100638371|FG005|NOT COMPLETED|Cohort B: Arm B||14||
48128439|NCT01694706|100638372|FG000|STARTED|Overall Study||5||
48128440|NCT01694706|100638373|FG001|STARTED|Overall Study||5||
48128441|NCT01694706|100638374|FG002|STARTED|Overall Study||5||
48128442|NCT01694706|100638372|FG000|Received Faldaprevir|Overall Study||5||
48128443|NCT01694706|100638373|FG001|Received Faldaprevir|Overall Study||5||
48128444|NCT01694706|100638374|FG002|Received Faldaprevir|Overall Study||5||
48128445|NCT01694706|100638372|FG000|Received Faldaprevir +OMP|Overall Study||5||
48128446|NCT01694706|100638373|FG001|Received Faldaprevir +OMP|Overall Study||5||
48128447|NCT01694706|100638374|FG002|Received Faldaprevir +OMP|Overall Study||5||
48128448|NCT01694706|100638372|FG000|Received Faldaprevir Fed|Overall Study||4||
48128449|NCT01694706|100638373|FG001|Received Faldaprevir Fed|Overall Study||5||
48128450|NCT01694706|100638374|FG002|Received Faldaprevir Fed|Overall Study||5||
48128451|NCT01694706|100638372|FG000|COMPLETED|Overall Study||4||
48128452|NCT01694706|100638373|FG001|COMPLETED|Overall Study||4||
48128453|NCT01694706|100638374|FG002|COMPLETED|Overall Study||5||
48128454|NCT01694706|100638372|FG000|NOT COMPLETED|Overall Study||1||
48128455|NCT01694706|100638373|FG001|NOT COMPLETED|Overall Study||1||
48128456|NCT01694706|100638374|FG002|NOT COMPLETED|Overall Study||0||
48128457|NCT04193202|100638375|FG000|STARTED|Overall Study||208||
48128458|NCT04193202|100638376|FG001|STARTED|Overall Study||211||
48128459|NCT04193202|100638375|FG000|Treated|Overall Study||206||
48128460|NCT04193202|100638376|FG001|Treated|Overall Study||209||
48128461|NCT04193202|100638375|FG000|COMPLETED|Overall Study||192||
48128462|NCT04193202|100638376|FG001|COMPLETED|Overall Study||201||
48128463|NCT04193202|100638375|FG000|NOT COMPLETED|Overall Study||16||
48128464|NCT04193202|100638376|FG001|NOT COMPLETED|Overall Study||10||
48128465|NCT02033005|100638377|FG000|STARTED|Overall Study||80||
48128466|NCT02033005|100638378|FG001|STARTED|Overall Study||9||
48572866|NCT00570687|101735050|FG008|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0||
48572867|NCT00570687|101735051|FG009|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0||
48572868|NCT00570687|101735042|FG000|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4||
48572869|NCT00570687|101735043|FG001|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2||
48572870|NCT00570687|101735044|FG002|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2||
48572871|NCT00570687|101735045|FG003|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4||
48572872|NCT00570687|101735046|FG004|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0||
48572873|NCT00570687|101735047|FG005|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0||
48572874|NCT00570687|101735048|FG006|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0||
48572875|NCT00570687|101735049|FG007|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0||
48572876|NCT00570687|101735050|FG008|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0||
48572877|NCT00570687|101735051|FG009|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0||
48128467|NCT02033005|100638379|FG002|STARTED|Overall Study||35||
48128468|NCT02033005|100638377|FG000|COMPLETED|Overall Study||36||
48128469|NCT02033005|100638378|FG001|COMPLETED|Overall Study||9||
48128470|NCT02033005|100638379|FG002|COMPLETED|Overall Study||25||
48128471|NCT02033005|100638377|FG000|NOT COMPLETED|Overall Study||44||
48283921|NCT01737827|101021372|FG002|COMPLETED|Overall Study||0||
48128472|NCT02033005|100638378|FG001|NOT COMPLETED|Overall Study||0||
48572878|NCT00570687|101735042|FG000|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0||
48572879|NCT00570687|101735043|FG001|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0||
48128473|NCT02033005|100638379|FG002|NOT COMPLETED|Overall Study||10||
48283922|NCT01737827|101021370|FG000|NOT COMPLETED|Overall Study||8||
48128474|NCT01071395|100638380|FG000|STARTED|Overall Study||36||
48128475|NCT01071395|100638381|FG001|STARTED|Overall Study||32||
48128476|NCT01071395|100638380|FG000|COMPLETED|Overall Study||31||
48128477|NCT01071395|100638381|FG001|COMPLETED|Overall Study||30||
48128478|NCT01071395|100638380|FG000|NOT COMPLETED|Overall Study||5||
48128479|NCT01071395|100638381|FG001|NOT COMPLETED|Overall Study||2||
48572880|NCT00570687|101735044|FG002|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0||
48572881|NCT00570687|101735045|FG003|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0||
48572882|NCT00570687|101735046|FG004|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0||
48572883|NCT00570687|101735047|FG005|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0||
48572884|NCT00570687|101735048|FG006|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0||
48572885|NCT00570687|101735049|FG007|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0||
48128480|NCT03207750|100638382|FG000|STARTED|Overall Study||632||
48128481|NCT03207750|100638383|FG001|STARTED|Overall Study||640||
48128482|NCT03207750|100638382|FG000|COMPLETED|Overall Study||574||
48128483|NCT03207750|100638383|FG001|COMPLETED|Overall Study||574||
48128484|NCT03207750|100638382|FG000|NOT COMPLETED|Overall Study||58||
48128485|NCT03207750|100638383|FG001|NOT COMPLETED|Overall Study||66||
48128486|NCT01669343|100638384|FG000|STARTED|Part A: All Patients||121||
48128487|NCT01669343|100638384|FG000|COMPLETED|Part A: All Patients||112||
48128488|NCT01669343|100638384|FG000|NOT COMPLETED|Part A: All Patients||9||
48128489|NCT01669343|100638384|FG000|STARTED|Part B: Patients With BMI>=25||48|By study design, only patients with BMI\>=25 was eligible for Part B|
48128490|NCT01669343|100638384|FG000|COMPLETED|Part B: Patients With BMI>=25||31||
48128491|NCT01669343|100638384|FG000|NOT COMPLETED|Part B: Patients With BMI>=25||17||
48128492|NCT01148810|100638385|FG000|STARTED|Overall Study||8||
48128493|NCT01148810|100638386|FG001|STARTED|Overall Study||10||
48128494|NCT01148810|100638385|FG000|COMPLETED|Overall Study||7||
48128495|NCT01148810|100638386|FG001|COMPLETED|Overall Study||5||
48128496|NCT01148810|100638385|FG000|NOT COMPLETED|Overall Study||1||
48128497|NCT01148810|100638386|FG001|NOT COMPLETED|Overall Study||5||
48128498|NCT03483623|100638387|FG000|STARTED|Overall Study||44||
48128499|NCT03483623|100638387|FG000|Started NATO WELP|Overall Study||44||
48128500|NCT03483623|100638387|FG000|Completeded NATO WELP|Overall Study||43||
48128501|NCT03483623|100638387|FG000|Started NATO FIS|Overall Study||44||
48128502|NCT03483623|100638387|FG000|Completed NATO FIS|Overall Study||43||
48128503|NCT03483623|100638387|FG000|Started RAVEN WELP|Overall Study||44||
48128504|NCT03483623|100638387|FG000|Completed RAVEN WELP|Overall Study||43||
48128505|NCT03483623|100638387|FG000|Started RAVEN FIS|Overall Study||44||
48128506|NCT03483623|100638387|FG000|Completed RAVEN FIS|Overall Study||43||
48128507|NCT03483623|100638387|FG000|COMPLETED|Overall Study||43||
48128508|NCT03483623|100638387|FG000|NOT COMPLETED|Overall Study||1||
48128509|NCT02684591|100638388|FG000|STARTED|Overall Study||25||
48128510|NCT02684591|100638389|FG001|STARTED|Overall Study||25||
48128511|NCT02684591|100638388|FG000|COMPLETED|Overall Study||24||
48128512|NCT02684591|100638389|FG001|COMPLETED|Overall Study||22||
48128513|NCT02684591|100638388|FG000|NOT COMPLETED|Overall Study||1||
48572886|NCT00570687|101735050|FG008|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0||
48572887|NCT00570687|101735051|FG009|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0||
48572888|NCT00570687|101735042|FG000|STARTED|Washout 1 (7-21 Days) - Amendment 1||4||
48572889|NCT00570687|101735043|FG001|STARTED|Washout 1 (7-21 Days) - Amendment 1||2||
48572890|NCT00570687|101735044|FG002|STARTED|Washout 1 (7-21 Days) - Amendment 1||2||
48572891|NCT00570687|101735045|FG003|STARTED|Washout 1 (7-21 Days) - Amendment 1||4||
48572892|NCT00570687|101735046|FG004|STARTED|Washout 1 (7-21 Days) - Amendment 1||0||
48572893|NCT00570687|101735047|FG005|STARTED|Washout 1 (7-21 Days) - Amendment 1||0||
48572894|NCT00570687|101735048|FG006|STARTED|Washout 1 (7-21 Days) - Amendment 1||0||
48572895|NCT00570687|101735049|FG007|STARTED|Washout 1 (7-21 Days) - Amendment 1||0||
48572896|NCT00570687|101735050|FG008|STARTED|Washout 1 (7-21 Days) - Amendment 1||0||
48572897|NCT00570687|101735051|FG009|STARTED|Washout 1 (7-21 Days) - Amendment 1||0||
48128514|NCT02684591|100638389|FG001|NOT COMPLETED|Overall Study||3||
48128515|NCT01984398|100638390|FG000|STARTED|Treatment Period 1||4||
48128516|NCT01984398|100638391|FG001|STARTED|Treatment Period 1||4||
48128517|NCT01984398|100638392|FG002|STARTED|Treatment Period 1||4||
48128518|NCT01984398|100638393|FG003|STARTED|Treatment Period 1||4||
48128519|NCT01984398|100638390|FG000|COMPLETED|Treatment Period 1||4||
48128520|NCT01984398|100638391|FG001|COMPLETED|Treatment Period 1||4||
48283923|NCT01737827|101021371|FG001|NOT COMPLETED|Overall Study||28||
48572898|NCT00570687|101735042|FG000|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4||
48128521|NCT01984398|100638392|FG002|COMPLETED|Treatment Period 1||4||
48128522|NCT01984398|100638393|FG003|COMPLETED|Treatment Period 1||4||
48128523|NCT01984398|100638390|FG000|NOT COMPLETED|Treatment Period 1||0||
48128524|NCT01984398|100638391|FG001|NOT COMPLETED|Treatment Period 1||0||
48128525|NCT01984398|100638392|FG002|NOT COMPLETED|Treatment Period 1||0||
48128526|NCT01984398|100638393|FG003|NOT COMPLETED|Treatment Period 1||0||
48128527|NCT01984398|100638390|FG000|STARTED|Washout Period of 5 to 7 Days||4||
48128528|NCT01984398|100638391|FG001|STARTED|Washout Period of 5 to 7 Days||4||
48128529|NCT01984398|100638392|FG002|STARTED|Washout Period of 5 to 7 Days||4||
48128530|NCT01984398|100638393|FG003|STARTED|Washout Period of 5 to 7 Days||4||
48128531|NCT01984398|100638390|FG000|COMPLETED|Washout Period of 5 to 7 Days||4||
48128532|NCT01984398|100638391|FG001|COMPLETED|Washout Period of 5 to 7 Days||4||
48128533|NCT01984398|100638392|FG002|COMPLETED|Washout Period of 5 to 7 Days||4||
48128534|NCT01984398|100638393|FG003|COMPLETED|Washout Period of 5 to 7 Days||4||
48128535|NCT01984398|100638390|FG000|NOT COMPLETED|Washout Period of 5 to 7 Days||0||
48128536|NCT01984398|100638391|FG001|NOT COMPLETED|Washout Period of 5 to 7 Days||0||
48128537|NCT01984398|100638392|FG002|NOT COMPLETED|Washout Period of 5 to 7 Days||0||
48128538|NCT01984398|100638393|FG003|NOT COMPLETED|Washout Period of 5 to 7 Days||0||
48128539|NCT01984398|100638390|FG000|STARTED|Treatment Period 2||4||
48128540|NCT01984398|100638391|FG001|STARTED|Treatment Period 2||4||
48128541|NCT01984398|100638392|FG002|STARTED|Treatment Period 2||4||
48128542|NCT01984398|100638393|FG003|STARTED|Treatment Period 2||4||
48128543|NCT01984398|100638390|FG000|COMPLETED|Treatment Period 2||4||
48128544|NCT01984398|100638391|FG001|COMPLETED|Treatment Period 2||4||
48128545|NCT01984398|100638392|FG002|COMPLETED|Treatment Period 2||4||
48128546|NCT01984398|100638393|FG003|COMPLETED|Treatment Period 2||4||
48128547|NCT01984398|100638390|FG000|NOT COMPLETED|Treatment Period 2||0||
48128548|NCT01984398|100638391|FG001|NOT COMPLETED|Treatment Period 2||0||
48128549|NCT01984398|100638392|FG002|NOT COMPLETED|Treatment Period 2||0||
48128550|NCT01984398|100638393|FG003|NOT COMPLETED|Treatment Period 2||0||
48128551|NCT00153101|100638394|FG000|STARTED|Overall Study||8502||
48128552|NCT00153101|100638395|FG001|STARTED|Overall Study||8542||
48128553|NCT00153101|100638396|FG002|STARTED|Overall Study||8576||
48128554|NCT00153101|100638397|FG003|STARTED|Overall Study||2954||
48128555|NCT00153101|100638398|FG004|STARTED|Overall Study||2972||
48128556|NCT00153101|100638394|FG000|COMPLETED|Overall Study||8485||
48128557|NCT00153101|100638395|FG001|COMPLETED|Overall Study||8524||
48128558|NCT00153101|100638396|FG002|COMPLETED|Overall Study||8561||
48128559|NCT00153101|100638397|FG003|COMPLETED|Overall Study||2946||
48128560|NCT00153101|100638398|FG004|COMPLETED|Overall Study||2962||
48128561|NCT00153101|100638394|FG000|NOT COMPLETED|Overall Study||17||
48128562|NCT00153101|100638395|FG001|NOT COMPLETED|Overall Study||18||
48128563|NCT00153101|100638396|FG002|NOT COMPLETED|Overall Study||15||
48128564|NCT00153101|100638397|FG003|NOT COMPLETED|Overall Study||8||
48128565|NCT00153101|100638398|FG004|NOT COMPLETED|Overall Study||10||
48128566|NCT05036642|100638399|FG000|STARTED|Pilot Phase||1||
48128567|NCT05036642|100638400|FG001|STARTED|Pilot Phase||0||
48128568|NCT05036642|100638399|FG000|COMPLETED|Pilot Phase||1||
48128569|NCT05036642|100638400|FG001|COMPLETED|Pilot Phase||0||
48128570|NCT05036642|100638399|FG000|NOT COMPLETED|Pilot Phase||0||
48128571|NCT05036642|100638400|FG001|NOT COMPLETED|Pilot Phase||0||
48128572|NCT05036642|100638399|FG000|STARTED|Evaluation Phase||0||
48128573|NCT05036642|100638400|FG001|STARTED|Evaluation Phase||11||
48128574|NCT05036642|100638399|FG000|COMPLETED|Evaluation Phase||0||
48128575|NCT05036642|100638400|FG001|COMPLETED|Evaluation Phase||11||
48128576|NCT05036642|100638399|FG000|NOT COMPLETED|Evaluation Phase||0||
48128577|NCT05036642|100638400|FG001|NOT COMPLETED|Evaluation Phase||0||
48128578|NCT01954017|100638401|FG000|STARTED|Overall Study||36||
48128579|NCT01954017|100638402|FG001|STARTED|Overall Study||33||
48128580|NCT01954017|100638403|FG002|STARTED|Overall Study||34||
48128581|NCT01954017|100638401|FG000|COMPLETED|Overall Study||31||
48128582|NCT01954017|100638402|FG001|COMPLETED|Overall Study||25||
48128583|NCT01954017|100638403|FG002|COMPLETED|Overall Study||21||
48128584|NCT01954017|100638401|FG000|NOT COMPLETED|Overall Study||5||
48128585|NCT01954017|100638402|FG001|NOT COMPLETED|Overall Study||8||
48128586|NCT01954017|100638403|FG002|NOT COMPLETED|Overall Study||13||
48128587|NCT03669081|100638404|FG000|STARTED|Overall Study||34||
48128588|NCT03669081|100638405|FG001|STARTED|Overall Study||30||
48128589|NCT03669081|100638404|FG000|COMPLETED|Overall Study||33||
48128590|NCT03669081|100638405|FG001|COMPLETED|Overall Study||29||
48128591|NCT03669081|100638404|FG000|NOT COMPLETED|Overall Study||1||
48128592|NCT03669081|100638405|FG001|NOT COMPLETED|Overall Study||1||
48128593|NCT02890381|100638406|FG000|STARTED|Overall Study||11||
48128594|NCT02890381|100638407|FG001|STARTED|Overall Study||6||
48128595|NCT02890381|100638406|FG000|COMPLETED|Overall Study||11||
48128596|NCT02890381|100638407|FG001|COMPLETED|Overall Study||6||
48128597|NCT02890381|100638406|FG000|NOT COMPLETED|Overall Study||0||
48128598|NCT02890381|100638407|FG001|NOT COMPLETED|Overall Study||0||
48128599|NCT01595516|100638408|FG000|STARTED|Overall Study||16||
48128600|NCT01595516|100638409|FG001|STARTED|Overall Study||16||
48128601|NCT01595516|100638410|FG002|STARTED|Overall Study||12||
48128602|NCT01595516|100638408|FG000|COMPLETED|Overall Study||16||
48128603|NCT01595516|100638409|FG001|COMPLETED|Overall Study||16||
48128604|NCT01595516|100638410|FG002|COMPLETED|Overall Study||12||
48128605|NCT01595516|100638408|FG000|NOT COMPLETED|Overall Study||0||
48128606|NCT01595516|100638409|FG001|NOT COMPLETED|Overall Study||0||
48128607|NCT01595516|100638410|FG002|NOT COMPLETED|Overall Study||0||
48128608|NCT03510481|100638411|FG000|STARTED|Year 1||69||
48128609|NCT03510481|100638412|FG001|STARTED|Year 1||70||
48128610|NCT03510481|100638413|FG002|STARTED|Year 1||36||
48128611|NCT03510481|100638414|FG003|STARTED|Year 1||35||
48128612|NCT03510481|100638411|FG000|COMPLETED|Year 1||56||
48128613|NCT03510481|100638412|FG001|COMPLETED|Year 1||61||
48128614|NCT03510481|100638413|FG002|COMPLETED|Year 1||34||
48128615|NCT03510481|100638414|FG003|COMPLETED|Year 1||31||
48128616|NCT03510481|100638411|FG000|NOT COMPLETED|Year 1||13||
48128617|NCT03510481|100638412|FG001|NOT COMPLETED|Year 1||9||
48128618|NCT03510481|100638413|FG002|NOT COMPLETED|Year 1||2||
48128619|NCT03510481|100638414|FG003|NOT COMPLETED|Year 1||4||
48128620|NCT03510481|100638411|FG000|STARTED|Year 2 - Booster Dose||46||
48128621|NCT03510481|100638412|FG001|STARTED|Year 2 - Booster Dose||52||
48128622|NCT03510481|100638413|FG002|STARTED|Year 2 - Booster Dose||25||
48128623|NCT03510481|100638414|FG003|STARTED|Year 2 - Booster Dose||19||
48128624|NCT03510481|100638411|FG000|COMPLETED|Year 2 - Booster Dose||42||
48128625|NCT03510481|100638412|FG001|COMPLETED|Year 2 - Booster Dose||49||
48128626|NCT03510481|100638413|FG002|COMPLETED|Year 2 - Booster Dose||23||
48128627|NCT03510481|100638414|FG003|COMPLETED|Year 2 - Booster Dose||18||
48128628|NCT03510481|100638411|FG000|NOT COMPLETED|Year 2 - Booster Dose||4||
48128629|NCT03510481|100638412|FG001|NOT COMPLETED|Year 2 - Booster Dose||3||
48128630|NCT03510481|100638413|FG002|NOT COMPLETED|Year 2 - Booster Dose||2||
48128631|NCT03510481|100638414|FG003|NOT COMPLETED|Year 2 - Booster Dose||1||
48128632|NCT04574362|100638415|FG000|STARTED|Overall Study||716||
48128633|NCT04574362|100638416|FG001|STARTED|Overall Study||715||
48128634|NCT04574362|100638415|FG000|Treated|Overall Study||668||
48128635|NCT04574362|100638416|FG001|Treated|Overall Study||674||
48128636|NCT04574362|100638415|FG000|COMPLETED|Overall Study||709||
48128637|NCT04574362|100638416|FG001|COMPLETED|Overall Study||704||
48128638|NCT04574362|100638415|FG000|NOT COMPLETED|Overall Study||7||
48128639|NCT04574362|100638416|FG001|NOT COMPLETED|Overall Study||11||
48128640|NCT02066298|100638417|FG000|STARTED|Overall Study||49||
48128641|NCT02066298|100638418|FG001|STARTED|Overall Study||48||
48128642|NCT02066298|100638419|FG002|STARTED|Overall Study||50||
48128643|NCT02066298|100638420|FG003|STARTED|Overall Study||51||
48128644|NCT02066298|100638421|FG004|STARTED|Overall Study||47||
48128645|NCT02066298|100638422|FG005|STARTED|Overall Study||50||
48128646|NCT02066298|100638417|FG000|Completed 1st Period|Overall Study||44||
48128647|NCT02066298|100638418|FG001|Completed 1st Period|Overall Study||47||
48128648|NCT02066298|100638419|FG002|Completed 1st Period|Overall Study||45||
48128649|NCT02066298|100638420|FG003|Completed 1st Period|Overall Study||48||
48398170|NCT02186561|101306263|FG000|COMPLETED|1- Year Post Index Procedure Visit||139|Participants Implanted with the Investigational Device that Completed the 1 Year Visit|
48398171|NCT02186561|101306263|FG000|NOT COMPLETED|1- Year Post Index Procedure Visit||2||
48398172|NCT02186561|101306263|FG000|STARTED|2 - Year Post Index Procedure Visit||141|Participants implanted with the investigational device.|
48398173|NCT02186561|101306263|FG000|COMPLETED|2 - Year Post Index Procedure Visit||134|Participants Implanted with the Investigational Device that Completed the 2 Year Visit|
48398174|NCT02186561|101306263|FG000|NOT COMPLETED|2 - Year Post Index Procedure Visit||7||
48398175|NCT02186561|101306263|FG000|STARTED|3 - Year Post Index Procedure Visit||141|Participants implanted with the investigational device.|
48398176|NCT02186561|101306263|FG000|COMPLETED|3 - Year Post Index Procedure Visit||128|Participants Implanted with the Investigational Device that Completed the 3 Year Visit|
48398177|NCT02186561|101306263|FG000|NOT COMPLETED|3 - Year Post Index Procedure Visit||13||
48398178|NCT01570309|101306264|FG000|STARTED|Overall Study||48||
48398179|NCT01570309|101306265|FG001|STARTED|Overall Study||48||
48398180|NCT01570309|101306264|FG000|COMPLETED|Overall Study||45||
48398181|NCT01570309|101306265|FG001|COMPLETED|Overall Study||45||
48398182|NCT01570309|101306264|FG000|NOT COMPLETED|Overall Study||3||
48398183|NCT01570309|101306265|FG001|NOT COMPLETED|Overall Study||3||
48398184|NCT04399980|101306266|FG000|STARTED|Overall Study||21||
48398185|NCT04399980|101306267|FG001|STARTED|Overall Study||19||
48398186|NCT04399980|101306266|FG000|COMPLETED|Overall Study||21||
48398187|NCT04399980|101306267|FG001|COMPLETED|Overall Study||19||
48398188|NCT04399980|101306266|FG000|NOT COMPLETED|Overall Study||0||
48398189|NCT04399980|101306267|FG001|NOT COMPLETED|Overall Study||0||
48398190|NCT03934203|101306268|FG000|STARTED|Overall Study||3||
48398191|NCT03934203|101306269|FG001|STARTED|Overall Study||3||
48398192|NCT03934203|101306270|FG002|STARTED|Overall Study||3||
48398193|NCT03934203|101306271|FG003|STARTED|Overall Study||3||
48398194|NCT03934203|101306272|FG004|STARTED|Overall Study||4||
48398195|NCT03934203|101306273|FG005|STARTED|Overall Study||3||
48398196|NCT03934203|101306274|FG006|STARTED|Overall Study||4||
48398197|NCT03934203|101306275|FG007|STARTED|Overall Study||3||
48572899|NCT00570687|101735043|FG001|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2||
48128650|NCT02066298|100638421|FG004|Completed 1st Period|Overall Study||46||
48128651|NCT02066298|100638422|FG005|Completed 1st Period|Overall Study||45||
48128652|NCT02066298|100638417|FG000|Completed 2nd Period|Overall Study||41||
48128653|NCT02066298|100638418|FG001|Completed 2nd Period|Overall Study||41||
48128654|NCT02066298|100638419|FG002|Completed 2nd Period|Overall Study||41||
48128655|NCT02066298|100638420|FG003|Completed 2nd Period|Overall Study||46||
48128656|NCT02066298|100638421|FG004|Completed 2nd Period|Overall Study||42||
48128657|NCT02066298|100638422|FG005|Completed 2nd Period|Overall Study||41||
48128658|NCT02066298|100638417|FG000|Completed 3rd Period|Overall Study||40||
48128659|NCT02066298|100638418|FG001|Completed 3rd Period|Overall Study||40||
48128660|NCT02066298|100638419|FG002|Completed 3rd Period|Overall Study||40||
48128661|NCT02066298|100638420|FG003|Completed 3rd Period|Overall Study||45||
48398198|NCT03934203|101306276|FG008|STARTED|Overall Study||3||
48398199|NCT03934203|101306277|FG009|STARTED|Overall Study||3||
48128662|NCT02066298|100638421|FG004|Completed 3rd Period|Overall Study||38||
48128663|NCT02066298|100638422|FG005|Completed 3rd Period|Overall Study||38||
48128664|NCT02066298|100638417|FG000|COMPLETED|Overall Study||40||
48128665|NCT02066298|100638418|FG001|COMPLETED|Overall Study||40||
48128666|NCT02066298|100638419|FG002|COMPLETED|Overall Study||40||
48128667|NCT02066298|100638420|FG003|COMPLETED|Overall Study||45||
48128668|NCT02066298|100638421|FG004|COMPLETED|Overall Study||38||
48128669|NCT02066298|100638422|FG005|COMPLETED|Overall Study||38||
48128670|NCT02066298|100638417|FG000|NOT COMPLETED|Overall Study||9||
48128671|NCT02066298|100638418|FG001|NOT COMPLETED|Overall Study||8||
48128672|NCT02066298|100638419|FG002|NOT COMPLETED|Overall Study||10||
48128673|NCT02066298|100638420|FG003|NOT COMPLETED|Overall Study||6||
48128674|NCT02066298|100638421|FG004|NOT COMPLETED|Overall Study||9||
48128675|NCT02066298|100638422|FG005|NOT COMPLETED|Overall Study||12||
48128676|NCT00659165|100638423|FG000|STARTED|Overall Study||5||
48128677|NCT00659165|100638424|FG001|STARTED|Overall Study||5||
48128678|NCT00659165|100638423|FG000|COMPLETED|Overall Study||5||
48128679|NCT00659165|100638424|FG001|COMPLETED|Overall Study||5||
48128680|NCT00659165|100638423|FG000|NOT COMPLETED|Overall Study||0||
48128681|NCT00659165|100638424|FG001|NOT COMPLETED|Overall Study||0||
48128682|NCT02717949|100638425|FG000|STARTED|Overall Study||0|data not reported due to confidentiality|
48128683|NCT02717949|100638426|FG001|STARTED|Overall Study||0|data not reported due to confidentiality|
48128684|NCT02717949|100638425|FG000|COMPLETED|Overall Study||0||
48128685|NCT02717949|100638426|FG001|COMPLETED|Overall Study||0||
48128686|NCT02717949|100638425|FG000|NOT COMPLETED|Overall Study||0||
48128687|NCT02717949|100638426|FG001|NOT COMPLETED|Overall Study||0||
48128688|NCT02352493|100638427|FG000|STARTED|Overall Study||8||
48128689|NCT02352493|100638428|FG001|STARTED|Overall Study||3||
48128690|NCT02352493|100638429|FG002|STARTED|Overall Study||3||
48128691|NCT02352493|100638430|FG003|STARTED|Overall Study||3||
48128692|NCT02352493|100638431|FG004|STARTED|Overall Study||3||
48128693|NCT02352493|100638432|FG005|STARTED|Overall Study||3||
48128694|NCT02352493|100638433|FG006|STARTED|Overall Study||3||
48128695|NCT02352493|100638434|FG007|STARTED|Overall Study||3||
48128696|NCT02352493|100638435|FG008|STARTED|Overall Study||3||
48128697|NCT02352493|100638436|FG009|STARTED|Overall Study||6||
48128698|NCT02352493|100638437|FG010|STARTED|Overall Study||3||
48128699|NCT02352493|100638438|FG011|STARTED|Overall Study||3||
48128700|NCT02352493|100638439|FG012|STARTED|Overall Study||3||
48128701|NCT02352493|100638440|FG013|STARTED|Overall Study||3||
48128702|NCT02352493|100638441|FG014|STARTED|Overall Study||3||
48128703|NCT02352493|100638442|FG015|STARTED|Overall Study||3||
48128704|NCT02352493|100638443|FG016|STARTED|Overall Study||3||
48128705|NCT02352493|100638444|FG017|STARTED|Overall Study||3||
48572900|NCT00570687|101735044|FG002|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2||
48572901|NCT00570687|101735045|FG003|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4||
48572902|NCT00570687|101735046|FG004|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0||
48572903|NCT00570687|101735047|FG005|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0||
48572904|NCT00570687|101735048|FG006|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0||
48572905|NCT00570687|101735049|FG007|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0||
48572906|NCT00570687|101735050|FG008|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0||
48572907|NCT00570687|101735051|FG009|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0||
48572908|NCT00570687|101735042|FG000|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0||
48128706|NCT02352493|100638427|FG000|COMPLETED|Overall Study||8||
48128707|NCT02352493|100638428|FG001|COMPLETED|Overall Study||3||
48128708|NCT02352493|100638429|FG002|COMPLETED|Overall Study||3||
48128709|NCT02352493|100638430|FG003|COMPLETED|Overall Study||3||
48128710|NCT02352493|100638431|FG004|COMPLETED|Overall Study||3||
48128711|NCT02352493|100638432|FG005|COMPLETED|Overall Study||3||
48128712|NCT02352493|100638433|FG006|COMPLETED|Overall Study||2||
48128713|NCT02352493|100638434|FG007|COMPLETED|Overall Study||3||
48128714|NCT02352493|100638435|FG008|COMPLETED|Overall Study||1||
48128715|NCT02352493|100638436|FG009|COMPLETED|Overall Study||5||
48128716|NCT02352493|100638437|FG010|COMPLETED|Overall Study||3||
48128717|NCT02352493|100638438|FG011|COMPLETED|Overall Study||3||
48128718|NCT02352493|100638439|FG012|COMPLETED|Overall Study||2||
48128719|NCT02352493|100638440|FG013|COMPLETED|Overall Study||1||
48128720|NCT02352493|100638441|FG014|COMPLETED|Overall Study||2||
48128721|NCT02352493|100638442|FG015|COMPLETED|Overall Study||3||
48128722|NCT02352493|100638443|FG016|COMPLETED|Overall Study||3||
48572909|NCT00570687|101735043|FG001|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0||
48572910|NCT00570687|101735044|FG002|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0||
48572911|NCT00570687|101735045|FG003|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0||
48572912|NCT00570687|101735046|FG004|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0||
48572913|NCT00570687|101735047|FG005|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0||
48128723|NCT02352493|100638444|FG017|COMPLETED|Overall Study||3||
48128724|NCT02352493|100638427|FG000|NOT COMPLETED|Overall Study||0||
48128725|NCT02352493|100638428|FG001|NOT COMPLETED|Overall Study||0||
48128726|NCT02352493|100638429|FG002|NOT COMPLETED|Overall Study||0||
48128727|NCT02352493|100638430|FG003|NOT COMPLETED|Overall Study||0||
48128728|NCT02352493|100638431|FG004|NOT COMPLETED|Overall Study||0||
48128729|NCT02352493|100638432|FG005|NOT COMPLETED|Overall Study||0||
48128730|NCT02352493|100638433|FG006|NOT COMPLETED|Overall Study||1||
48128731|NCT02352493|100638434|FG007|NOT COMPLETED|Overall Study||0||
48128732|NCT02352493|100638435|FG008|NOT COMPLETED|Overall Study||2||
48128733|NCT02352493|100638436|FG009|NOT COMPLETED|Overall Study||1||
48128734|NCT02352493|100638437|FG010|NOT COMPLETED|Overall Study||0||
48128735|NCT02352493|100638438|FG011|NOT COMPLETED|Overall Study||0||
48128736|NCT02352493|100638439|FG012|NOT COMPLETED|Overall Study||1||
48128737|NCT02352493|100638440|FG013|NOT COMPLETED|Overall Study||2||
48128738|NCT02352493|100638441|FG014|NOT COMPLETED|Overall Study||1||
48128739|NCT02352493|100638442|FG015|NOT COMPLETED|Overall Study||0||
48128740|NCT02352493|100638443|FG016|NOT COMPLETED|Overall Study||0||
48128741|NCT02352493|100638444|FG017|NOT COMPLETED|Overall Study||0||
48128742|NCT00511862|100638445|FG000|STARTED|Overall Study||61||
48128743|NCT00511862|100638446|FG001|STARTED|Overall Study||43||
48128744|NCT00511862|100638447|FG002|STARTED|Overall Study||47||
48128745|NCT00511862|100638445|FG000|COMPLETED|Overall Study||61||
48128746|NCT00511862|100638446|FG001|COMPLETED|Overall Study||43||
48128747|NCT00511862|100638447|FG002|COMPLETED|Overall Study||47||
48128748|NCT00511862|100638445|FG000|NOT COMPLETED|Overall Study||0||
48128749|NCT00511862|100638446|FG001|NOT COMPLETED|Overall Study||0||
48128750|NCT00511862|100638447|FG002|NOT COMPLETED|Overall Study||0||
48128751|NCT00439777|100638448|FG000|STARTED|Treatment Period||2420||
48128752|NCT00439777|100638449|FG001|STARTED|Treatment Period||2413||
48128753|NCT00439777|100638448|FG000|Participants Received Treatment|Treatment Period||2412||
48128754|NCT00439777|100638449|FG001|Participants Received Treatment|Treatment Period||2405||
48128755|NCT00439777|100638448|FG000|COMPLETED|Treatment Period||2001||
48128756|NCT00439777|100638449|FG001|COMPLETED|Treatment Period||1954||
48128757|NCT00439777|100638448|FG000|NOT COMPLETED|Treatment Period||419||
48128758|NCT00439777|100638449|FG001|NOT COMPLETED|Treatment Period||459||
48128759|NCT00439777|100638448|FG000|STARTED|Observational Period||2206||
48128760|NCT00439777|100638449|FG001|STARTED|Observational Period||2197||
48128761|NCT00439777|100638448|FG000|COMPLETED|Observational Period||2165||
48128762|NCT00439777|100638449|FG001|COMPLETED|Observational Period||2156||
48128763|NCT00439777|100638448|FG000|NOT COMPLETED|Observational Period||41||
48128764|NCT00439777|100638449|FG001|NOT COMPLETED|Observational Period||41||
48128765|NCT02401672|100638450|FG000|STARTED|Overall Study||22||
48128766|NCT02401672|100638451|FG001|STARTED|Overall Study||20||
48128767|NCT02401672|100638450|FG000|COMPLETED|Overall Study||21||
48128768|NCT02401672|100638451|FG001|COMPLETED|Overall Study||17||
48128769|NCT02401672|100638450|FG000|NOT COMPLETED|Overall Study||1||
48128770|NCT02401672|100638451|FG001|NOT COMPLETED|Overall Study||3||
48128771|NCT02291718|100638452|FG000|STARTED|Overall Study||50||
48128772|NCT02291718|100638453|FG001|STARTED|Overall Study||50||
48128773|NCT02291718|100638454|FG002|STARTED|Overall Study||50||
48128774|NCT02291718|100638452|FG000|COMPLETED|Overall Study||50||
48572914|NCT00570687|101735048|FG006|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0||
48572915|NCT00570687|101735049|FG007|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0||
48572916|NCT00570687|101735050|FG008|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0||
48572917|NCT00570687|101735051|FG009|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0||
48572918|NCT00570687|101735042|FG000|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4||
48572919|NCT00570687|101735043|FG001|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2||
48572920|NCT00570687|101735044|FG002|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2||
48572921|NCT00570687|101735045|FG003|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4||
48572922|NCT00570687|101735046|FG004|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0||
48572923|NCT00570687|101735047|FG005|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0||
48572924|NCT00570687|101735048|FG006|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0||
48572925|NCT00570687|101735049|FG007|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0||
48572926|NCT00570687|101735050|FG008|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0||
48572927|NCT00570687|101735051|FG009|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0||
48283924|NCT01737827|101021372|FG002|NOT COMPLETED|Overall Study||2||
48283925|NCT01529203|101021373|FG000|STARTED|Overall Study||60||
48283926|NCT01529203|101021373|FG000|COMPLETED|Overall Study||57||
48283927|NCT01529203|101021373|FG000|NOT COMPLETED|Overall Study||3||
48283928|NCT01293487|101021374|FG000|STARTED|Overall Study||6||
48283929|NCT01293487|101021375|FG001|STARTED|Overall Study||6||
48398200|NCT03934203|101306278|FG010|STARTED|Overall Study||3||
48572928|NCT00570687|101735042|FG000|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4||
48572929|NCT00570687|101735043|FG001|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2||
48572930|NCT00570687|101735044|FG002|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2||
48572931|NCT00570687|101735045|FG003|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4||
48572932|NCT00570687|101735046|FG004|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0||
48572933|NCT00570687|101735047|FG005|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0||
48572934|NCT00570687|101735048|FG006|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0||
48572935|NCT00570687|101735049|FG007|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0||
48572936|NCT00570687|101735050|FG008|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0||
48572937|NCT00570687|101735051|FG009|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0||
48572938|NCT00570687|101735042|FG000|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0||
48572939|NCT00570687|101735043|FG001|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0||
48572940|NCT00570687|101735044|FG002|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0||
48572941|NCT00570687|101735045|FG003|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0||
48572942|NCT00570687|101735046|FG004|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0||
48572943|NCT00570687|101735047|FG005|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0||
48572944|NCT00570687|101735048|FG006|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0||
48128775|NCT02291718|100638453|FG001|COMPLETED|Overall Study||50||
48128776|NCT02291718|100638454|FG002|COMPLETED|Overall Study||50||
48128777|NCT02291718|100638452|FG000|NOT COMPLETED|Overall Study||0||
48128778|NCT02291718|100638453|FG001|NOT COMPLETED|Overall Study||0||
48128779|NCT02291718|100638454|FG002|NOT COMPLETED|Overall Study||0||
48128780|NCT04177693|100638455|FG000|STARTED|Overall Study||16||
48128781|NCT04177693|100638456|FG001|STARTED|Overall Study||11||
48128782|NCT04177693|100638457|FG002|STARTED|Overall Study||12||
48572945|NCT00570687|101735049|FG007|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0||
48572946|NCT00570687|101735050|FG008|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0||
48572947|NCT00570687|101735051|FG009|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0||
48572948|NCT00570687|101735042|FG000|STARTED|Washout 2 (8 Weeks) - Amendment 1||4||
48572949|NCT00570687|101735043|FG001|STARTED|Washout 2 (8 Weeks) - Amendment 1||2||
48572950|NCT00570687|101735044|FG002|STARTED|Washout 2 (8 Weeks) - Amendment 1||2||
48572951|NCT00570687|101735045|FG003|STARTED|Washout 2 (8 Weeks) - Amendment 1||4||
48572952|NCT00570687|101735046|FG004|STARTED|Washout 2 (8 Weeks) - Amendment 1||0||
48572953|NCT00570687|101735047|FG005|STARTED|Washout 2 (8 Weeks) - Amendment 1||0||
48572954|NCT00570687|101735048|FG006|STARTED|Washout 2 (8 Weeks) - Amendment 1||0||
48572955|NCT00570687|101735049|FG007|STARTED|Washout 2 (8 Weeks) - Amendment 1||0||
48572956|NCT00570687|101735050|FG008|STARTED|Washout 2 (8 Weeks) - Amendment 1||0||
48572957|NCT00570687|101735051|FG009|STARTED|Washout 2 (8 Weeks) - Amendment 1||0||
48572958|NCT00570687|101735042|FG000|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4||
48572959|NCT00570687|101735043|FG001|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2||
48128783|NCT04177693|100638455|FG000|COMPLETED|Overall Study||14||
48128784|NCT04177693|100638456|FG001|COMPLETED|Overall Study||11||
48128785|NCT04177693|100638457|FG002|COMPLETED|Overall Study||11||
48128786|NCT04177693|100638455|FG000|NOT COMPLETED|Overall Study||2||
48128787|NCT04177693|100638456|FG001|NOT COMPLETED|Overall Study||0||
48128788|NCT04177693|100638457|FG002|NOT COMPLETED|Overall Study||1||
48128789|NCT00781326|100638458|FG000|STARTED|Phase I||6||
48128790|NCT00781326|100638458|FG000|COMPLETED|Phase I||2||
48283930|NCT01293487|101021376|FG002|STARTED|Overall Study||6||
48283931|NCT01293487|101021377|FG003|STARTED|Overall Study||6||
48283932|NCT01293487|101021378|FG004|STARTED|Overall Study||8||
48283933|NCT01293487|101021379|FG005|STARTED|Overall Study||8||
48128791|NCT00781326|100638458|FG000|NOT COMPLETED|Phase I||4||
48398201|NCT03934203|101306279|FG011|STARTED|Overall Study||3||
48398202|NCT03934203|101306280|FG012|STARTED|Overall Study||3||
48398203|NCT03934203|101306281|FG013|STARTED|Overall Study||3||
48398204|NCT03934203|101306282|FG014|STARTED|Overall Study||3||
48398205|NCT03934203|101306268|FG000|COMPLETED|Overall Study||3||
48398206|NCT03934203|101306269|FG001|COMPLETED|Overall Study||3||
48398207|NCT03934203|101306270|FG002|COMPLETED|Overall Study||2||
48398208|NCT03934203|101306271|FG003|COMPLETED|Overall Study||3||
48398209|NCT03934203|101306272|FG004|COMPLETED|Overall Study||3||
48398210|NCT03934203|101306273|FG005|COMPLETED|Overall Study||3||
48398211|NCT03934203|101306274|FG006|COMPLETED|Overall Study||2||
48398212|NCT03934203|101306275|FG007|COMPLETED|Overall Study||3||
48398213|NCT03934203|101306276|FG008|COMPLETED|Overall Study||3||
48398214|NCT03934203|101306277|FG009|COMPLETED|Overall Study||3||
48398215|NCT03934203|101306278|FG010|COMPLETED|Overall Study||3||
48398216|NCT03934203|101306279|FG011|COMPLETED|Overall Study||3||
48398217|NCT03934203|101306280|FG012|COMPLETED|Overall Study||3||
48398218|NCT03934203|101306281|FG013|COMPLETED|Overall Study||2||
48398219|NCT03934203|101306282|FG014|COMPLETED|Overall Study||3||
48398220|NCT03934203|101306268|FG000|NOT COMPLETED|Overall Study||0||
48398221|NCT03934203|101306269|FG001|NOT COMPLETED|Overall Study||0||
48398222|NCT03934203|101306270|FG002|NOT COMPLETED|Overall Study||1||
48398223|NCT03934203|101306271|FG003|NOT COMPLETED|Overall Study||0||
48128792|NCT00781326|100638458|FG000|STARTED|Phase 2||0||
48128793|NCT00781326|100638458|FG000|COMPLETED|Phase 2||0||
48128794|NCT00781326|100638458|FG000|NOT COMPLETED|Phase 2||0||
48398224|NCT03934203|101306272|FG004|NOT COMPLETED|Overall Study||1||
48398225|NCT03934203|101306273|FG005|NOT COMPLETED|Overall Study||0||
48398226|NCT03934203|101306274|FG006|NOT COMPLETED|Overall Study||2||
48398227|NCT03934203|101306275|FG007|NOT COMPLETED|Overall Study||0||
48398228|NCT03934203|101306276|FG008|NOT COMPLETED|Overall Study||0||
48398229|NCT03934203|101306277|FG009|NOT COMPLETED|Overall Study||0||
48398230|NCT03934203|101306278|FG010|NOT COMPLETED|Overall Study||0||
48398231|NCT03934203|101306279|FG011|NOT COMPLETED|Overall Study||0||
48398232|NCT03934203|101306280|FG012|NOT COMPLETED|Overall Study||0||
48398233|NCT03934203|101306281|FG013|NOT COMPLETED|Overall Study||1||
48398234|NCT03934203|101306282|FG014|NOT COMPLETED|Overall Study||0||
48398235|NCT00050622|101306283|FG000|STARTED|Overall Study||154||
48128795|NCT03073603|100638459|FG000|STARTED|Overall Study||128||
48128796|NCT03073603|100638460|FG001|STARTED|Overall Study||131||
48128797|NCT03073603|100638459|FG000|COMPLETED|Overall Study||106||
48283934|NCT01293487|101021380|FG006|STARTED|Overall Study||8||
48283935|NCT01293487|101021381|FG007|STARTED|Overall Study||20||
48283936|NCT01293487|101021374|FG000|COMPLETED|Overall Study||6||
48283937|NCT01293487|101021375|FG001|COMPLETED|Overall Study||6||
48283938|NCT01293487|101021376|FG002|COMPLETED|Overall Study||6||
48283939|NCT01293487|101021377|FG003|COMPLETED|Overall Study||5||
48283940|NCT01293487|101021378|FG004|COMPLETED|Overall Study||8||
48283941|NCT01293487|101021379|FG005|COMPLETED|Overall Study||8||
48283942|NCT01293487|101021380|FG006|COMPLETED|Overall Study||8||
48283943|NCT01293487|101021381|FG007|COMPLETED|Overall Study||18||
48283944|NCT01293487|101021374|FG000|NOT COMPLETED|Overall Study||0||
48283945|NCT01293487|101021375|FG001|NOT COMPLETED|Overall Study||0||
48283946|NCT01293487|101021376|FG002|NOT COMPLETED|Overall Study||0||
48283947|NCT01293487|101021377|FG003|NOT COMPLETED|Overall Study||1||
48283948|NCT01293487|101021378|FG004|NOT COMPLETED|Overall Study||0||
48283949|NCT01293487|101021379|FG005|NOT COMPLETED|Overall Study||0||
48283950|NCT01293487|101021380|FG006|NOT COMPLETED|Overall Study||0||
48283951|NCT01293487|101021381|FG007|NOT COMPLETED|Overall Study||2||
48283952|NCT02334982|101021382|FG000|STARTED|Overall Study||6||
48283953|NCT02334982|101021383|FG001|STARTED|Overall Study||5||
48283954|NCT02334982|101021384|FG002|STARTED|Overall Study||6||
48283955|NCT02334982|101021385|FG003|STARTED|Overall Study||6||
48283956|NCT02334982|101021386|FG004|STARTED|Overall Study||6||
48283957|NCT02334982|101021387|FG005|STARTED|Overall Study||6||
48283958|NCT02334982|101021388|FG006|STARTED|Overall Study||12||
48283959|NCT02334982|101021382|FG000|COMPLETED|Overall Study||6||
48283960|NCT02334982|101021383|FG001|COMPLETED|Overall Study||5||
48283961|NCT02334982|101021384|FG002|COMPLETED|Overall Study||6||
48283962|NCT02334982|101021385|FG003|COMPLETED|Overall Study||6||
48283963|NCT02334982|101021386|FG004|COMPLETED|Overall Study||6||
48283964|NCT02334982|101021387|FG005|COMPLETED|Overall Study||6||
48283965|NCT02334982|101021388|FG006|COMPLETED|Overall Study||12||
48398236|NCT00050622|101306283|FG000|COMPLETED|Overall Study||153||
48398237|NCT00050622|101306283|FG000|NOT COMPLETED|Overall Study||1||
48283966|NCT02334982|101021382|FG000|NOT COMPLETED|Overall Study||0||
48283967|NCT02334982|101021383|FG001|NOT COMPLETED|Overall Study||0||
48283968|NCT02334982|101021384|FG002|NOT COMPLETED|Overall Study||0||
48283969|NCT02334982|101021385|FG003|NOT COMPLETED|Overall Study||0||
48283970|NCT02334982|101021386|FG004|NOT COMPLETED|Overall Study||0||
48283971|NCT02334982|101021387|FG005|NOT COMPLETED|Overall Study||0||
48398238|NCT04285853|101306284|FG000|STARTED|Overall Study||49||
48710826|NCT03446053|102078034|FG004|STARTED|Overall Study||6||
48128798|NCT03073603|100638460|FG001|COMPLETED|Overall Study||123||
48398239|NCT04285853|101306285|FG001|STARTED|Overall Study||49||
48398240|NCT04285853|101306284|FG000|COMPLETED|Overall Study||39||
48398241|NCT04285853|101306285|FG001|COMPLETED|Overall Study||44||
48398242|NCT04285853|101306284|FG000|NOT COMPLETED|Overall Study||10||
48398243|NCT04285853|101306285|FG001|NOT COMPLETED|Overall Study||5||
48398244|NCT03028467|101306286|FG000|STARTED|Overall Study||4||
48398245|NCT03028467|101306287|FG001|STARTED|Overall Study||3||
48398246|NCT03028467|101306288|FG002|STARTED|Overall Study||4||
48398247|NCT03028467|101306289|FG003|STARTED|Overall Study||4||
48398248|NCT03028467|101306286|FG000|COMPLETED|Overall Study||4||
48398249|NCT03028467|101306287|FG001|COMPLETED|Overall Study||3||
48398250|NCT03028467|101306288|FG002|COMPLETED|Overall Study||4||
48398251|NCT03028467|101306289|FG003|COMPLETED|Overall Study||4||
48398252|NCT03028467|101306286|FG000|NOT COMPLETED|Overall Study||0||
48398253|NCT03028467|101306287|FG001|NOT COMPLETED|Overall Study||0||
48398254|NCT03028467|101306288|FG002|NOT COMPLETED|Overall Study||0||
48398255|NCT03028467|101306289|FG003|NOT COMPLETED|Overall Study||0||
48398256|NCT02157103|101306290|FG000|STARTED|Overall Study||3||
48128799|NCT03073603|100638459|FG000|NOT COMPLETED|Overall Study||22||
48128800|NCT03073603|100638460|FG001|NOT COMPLETED|Overall Study||8||
48128801|NCT02117570|100638461|FG000|STARTED|Stage 1 Participants Aged 50 to 64 Years||6||
48128802|NCT02117570|100638462|FG001|STARTED|Stage 1 Participants Aged 50 to 64 Years||18||
48701077|NCT03319953|102054145|FG001|STARTED|Washout Period (Day 15 to 49)||4||
48398257|NCT02157103|101306290|FG000|COMPLETED|Overall Study||3||
48398258|NCT02157103|101306290|FG000|NOT COMPLETED|Overall Study||0||
48398259|NCT01809197|101306291|FG000|STARTED|Overall Study||187||
48398260|NCT01809197|101306292|FG001|STARTED|Overall Study||185||
48398261|NCT01809197|101306291|FG000|COMPLETED|Overall Study||177||
48398262|NCT01809197|101306292|FG001|COMPLETED|Overall Study||177||
48398263|NCT01809197|101306291|FG000|NOT COMPLETED|Overall Study||10||
48701078|NCT03319953|102054146|FG002|STARTED|Washout Period (Day 15 to 49)||9||
48128803|NCT02117570|100638463|FG002|STARTED|Stage 1 Participants Aged 50 to 64 Years||18||
48128804|NCT02117570|100638461|FG000|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||6||
48398264|NCT01809197|101306292|FG001|NOT COMPLETED|Overall Study||8||
48572960|NCT00570687|101735044|FG002|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2||
48572961|NCT00570687|101735045|FG003|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4||
48572962|NCT00570687|101735046|FG004|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0||
48572963|NCT00570687|101735047|FG005|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0||
48572964|NCT00570687|101735048|FG006|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0||
48572965|NCT00570687|101735049|FG007|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0||
48572966|NCT00570687|101735050|FG008|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0||
48572967|NCT00570687|101735051|FG009|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0||
48701079|NCT03319953|102054147|FG003|STARTED|Washout Period (Day 15 to 49)||7||
48398265|NCT00418717|101306293|FG000|STARTED|Treatment Period A - Weeks 1-4||42||
48398266|NCT00418717|101306293|FG000|COMPLETED|Treatment Period A - Weeks 1-4||41||
48398267|NCT00418717|101306293|FG000|NOT COMPLETED|Treatment Period A - Weeks 1-4||1||
48398268|NCT00418717|101306293|FG000|STARTED|Treatment Period B - Weeks 5-12||41||
48398269|NCT00418717|101306293|FG000|COMPLETED|Treatment Period B - Weeks 5-12||39||
48398270|NCT00418717|101306293|FG000|NOT COMPLETED|Treatment Period B - Weeks 5-12||2||
48398271|NCT02120352|101306294|FG000|STARTED|Induction Period (20 Weeks)||309||
48398272|NCT02120352|101306295|FG001|STARTED|Induction Period (20 Weeks)||0||
48398273|NCT02120352|101306296|FG002|STARTED|Induction Period (20 Weeks)||0||
48398274|NCT02120352|101306297|FG003|STARTED|Induction Period (20 Weeks)||0||
48398275|NCT02120352|101306298|FG004|STARTED|Induction Period (20 Weeks)||0||
48398276|NCT02120352|101306299|FG005|STARTED|Induction Period (20 Weeks)||0||
48398277|NCT02120352|101306300|FG006|STARTED|Induction Period (20 Weeks)||0||
48572968|NCT00570687|101735042|FG000|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0||
48572969|NCT00570687|101735043|FG001|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0||
48572970|NCT00570687|101735044|FG002|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0||
48572971|NCT00570687|101735045|FG003|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0||
48572972|NCT00570687|101735046|FG004|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0||
48572973|NCT00570687|101735047|FG005|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0||
48572974|NCT00570687|101735048|FG006|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0||
48572975|NCT00570687|101735049|FG007|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0||
48572976|NCT00570687|101735050|FG008|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0||
48572977|NCT00570687|101735051|FG009|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0||
48572978|NCT00570687|101735042|FG000|STARTED|Clamp 1 (1 Day) - Amendment 1||4||
48572979|NCT00570687|101735043|FG001|STARTED|Clamp 1 (1 Day) - Amendment 1||2||
48572980|NCT00570687|101735044|FG002|STARTED|Clamp 1 (1 Day) - Amendment 1||2||
48572981|NCT00570687|101735045|FG003|STARTED|Clamp 1 (1 Day) - Amendment 1||4||
48572982|NCT00570687|101735046|FG004|STARTED|Clamp 1 (1 Day) - Amendment 1||0||
48572983|NCT00570687|101735047|FG005|STARTED|Clamp 1 (1 Day) - Amendment 1||0||
48572984|NCT00570687|101735048|FG006|STARTED|Clamp 1 (1 Day) - Amendment 1||0||
48572985|NCT00570687|101735049|FG007|STARTED|Clamp 1 (1 Day) - Amendment 1||0||
48572986|NCT00570687|101735050|FG008|STARTED|Clamp 1 (1 Day) - Amendment 1||0||
48572987|NCT00570687|101735051|FG009|STARTED|Clamp 1 (1 Day) - Amendment 1||0||
48572988|NCT00570687|101735042|FG000|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4||
48398278|NCT02120352|101306294|FG000|COMPLETED|Induction Period (20 Weeks)||288||
48398279|NCT02120352|101306295|FG001|COMPLETED|Induction Period (20 Weeks)||0||
48128805|NCT02117570|100638462|FG001|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18||
48398280|NCT02120352|101306296|FG002|COMPLETED|Induction Period (20 Weeks)||0||
48398281|NCT02120352|101306297|FG003|COMPLETED|Induction Period (20 Weeks)||0||
48398282|NCT02120352|101306298|FG004|COMPLETED|Induction Period (20 Weeks)||0||
48398283|NCT02120352|101306299|FG005|COMPLETED|Induction Period (20 Weeks)||0||
48398284|NCT02120352|101306300|FG006|COMPLETED|Induction Period (20 Weeks)||0||
48398285|NCT02120352|101306294|FG000|NOT COMPLETED|Induction Period (20 Weeks)||21||
48398286|NCT02120352|101306295|FG001|NOT COMPLETED|Induction Period (20 Weeks)||0||
48398287|NCT02120352|101306296|FG002|NOT COMPLETED|Induction Period (20 Weeks)||0||
48398288|NCT02120352|101306297|FG003|NOT COMPLETED|Induction Period (20 Weeks)||0||
48128806|NCT02117570|100638463|FG002|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18||
48128807|NCT02117570|100638461|FG000|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||6||
48398289|NCT02120352|101306298|FG004|NOT COMPLETED|Induction Period (20 Weeks)||0||
48398290|NCT02120352|101306299|FG005|NOT COMPLETED|Induction Period (20 Weeks)||0||
48398291|NCT02120352|101306300|FG006|NOT COMPLETED|Induction Period (20 Weeks)||0||
48398292|NCT02120352|101306294|FG000|STARTED|Maintenance Period (Up to Week 96)||0|2 participants did not enter Maintenance phase as they had Day 1 viral loads \>50 copies/milliliter.|
48398293|NCT02120352|101306295|FG001|STARTED|Maintenance Period (Up to Week 96)||115|2 participants did not enter Maintenance phase as they had Day 1 viral loads \>50 copies/milliliter.|
48398294|NCT02120352|101306296|FG002|STARTED|Maintenance Period (Up to Week 96)||115|2 participants did not enter Maintenance phase as they had Day 1 viral loads \>50 copies/milliliter.|
48398295|NCT02120352|101306297|FG003|STARTED|Maintenance Period (Up to Week 96)||56|2 participants did not enter Maintenance phase as they had Day 1 viral loads \>50 copies/milliliter.|
48398296|NCT02120352|101306298|FG004|STARTED|Maintenance Period (Up to Week 96)||0|2 participants did not enter Maintenance phase as they had Day 1 viral loads \>50 copies/milliliter.|
48398297|NCT02120352|101306299|FG005|STARTED|Maintenance Period (Up to Week 96)||0|2 participants did not enter Maintenance phase as they had Day 1 viral loads \>50 copies/milliliter.|
48398298|NCT02120352|101306300|FG006|STARTED|Maintenance Period (Up to Week 96)||0|2 participants did not enter Maintenance phase as they had Day 1 viral loads \>50 copies/milliliter.|
48398299|NCT02120352|101306294|FG000|COMPLETED|Maintenance Period (Up to Week 96)||0||
48398300|NCT02120352|101306295|FG001|COMPLETED|Maintenance Period (Up to Week 96)||110||
48398301|NCT02120352|101306296|FG002|COMPLETED|Maintenance Period (Up to Week 96)||101||
48398302|NCT02120352|101306297|FG003|COMPLETED|Maintenance Period (Up to Week 96)||47||
48398303|NCT02120352|101306298|FG004|COMPLETED|Maintenance Period (Up to Week 96)||0||
48398304|NCT02120352|101306299|FG005|COMPLETED|Maintenance Period (Up to Week 96)||0||
48398305|NCT02120352|101306300|FG006|COMPLETED|Maintenance Period (Up to Week 96)||0||
48398306|NCT02120352|101306294|FG000|NOT COMPLETED|Maintenance Period (Up to Week 96)||0||
48398307|NCT02120352|101306295|FG001|NOT COMPLETED|Maintenance Period (Up to Week 96)||5||
48398308|NCT02120352|101306296|FG002|NOT COMPLETED|Maintenance Period (Up to Week 96)||14||
48398309|NCT02120352|101306297|FG003|NOT COMPLETED|Maintenance Period (Up to Week 96)||9||
48398310|NCT02120352|101306298|FG004|NOT COMPLETED|Maintenance Period (Up to Week 96)||0||
48398311|NCT02120352|101306299|FG005|NOT COMPLETED|Maintenance Period (Up to Week 96)||0||
48572989|NCT00570687|101735043|FG001|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2||
48572990|NCT00570687|101735044|FG002|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2||
48572991|NCT00570687|101735045|FG003|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4||
48572992|NCT00570687|101735046|FG004|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0||
48572993|NCT00570687|101735047|FG005|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0||
48572994|NCT00570687|101735048|FG006|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0||
48128808|NCT02117570|100638462|FG001|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18||
48128809|NCT02117570|100638463|FG002|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18||
48283972|NCT02334982|101021388|FG006|NOT COMPLETED|Overall Study||0||
48398312|NCT02120352|101306300|FG006|NOT COMPLETED|Maintenance Period (Up to Week 96)||0||
48398313|NCT02120352|101306294|FG000|STARTED|Extension Period (Week 97 to Study End)||0||
48398314|NCT02120352|101306295|FG001|STARTED|Extension Period (Week 97 to Study End)||107||
48398315|NCT02120352|101306296|FG002|STARTED|Extension Period (Week 97 to Study End)||101||
48398316|NCT02120352|101306297|FG003|STARTED|Extension Period (Week 97 to Study End)||0||
48398317|NCT02120352|101306298|FG004|STARTED|Extension Period (Week 97 to Study End)||34||
48398318|NCT02120352|101306299|FG005|STARTED|Extension Period (Week 97 to Study End)||10||
48398319|NCT02120352|101306300|FG006|STARTED|Extension Period (Week 97 to Study End)||0||
48398320|NCT02120352|101306294|FG000|COMPLETED|Extension Period (Week 97 to Study End)||0||
48398321|NCT02120352|101306295|FG001|COMPLETED|Extension Period (Week 97 to Study End)||92||
48398322|NCT02120352|101306296|FG002|COMPLETED|Extension Period (Week 97 to Study End)||76||
48398323|NCT02120352|101306297|FG003|COMPLETED|Extension Period (Week 97 to Study End)||0||
48398324|NCT02120352|101306298|FG004|COMPLETED|Extension Period (Week 97 to Study End)||26||
48398325|NCT02120352|101306299|FG005|COMPLETED|Extension Period (Week 97 to Study End)||8||
48572995|NCT00570687|101735049|FG007|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0||
48572996|NCT00570687|101735050|FG008|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0||
48572997|NCT00570687|101735051|FG009|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0||
48572998|NCT00570687|101735042|FG000|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0||
48572999|NCT00570687|101735043|FG001|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0||
48573000|NCT00570687|101735044|FG002|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0||
48573001|NCT00570687|101735045|FG003|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0||
48128810|NCT02117570|100638461|FG000|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||6||
48128811|NCT02117570|100638462|FG001|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||17||
48128812|NCT02117570|100638463|FG002|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||18||
48128813|NCT02117570|100638461|FG000|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||5||
48128814|NCT02117570|100638462|FG001|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||15||
48128815|NCT02117570|100638463|FG002|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||17||
48128816|NCT02117570|100638461|FG000|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1||
48128817|NCT02117570|100638462|FG001|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||3||
48128818|NCT02117570|100638463|FG002|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1||
48128819|NCT02117570|100638461|FG000|STARTED|Stage 2 Participants Aged 65 to 85 Years||21||
48128820|NCT02117570|100638462|FG001|STARTED|Stage 2 Participants Aged 65 to 85 Years||62||
48128821|NCT02117570|100638463|FG002|STARTED|Stage 2 Participants Aged 65 to 85 Years||60||
48128822|NCT02117570|100638461|FG000|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||21||
48128823|NCT02117570|100638462|FG001|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||61||
48128824|NCT02117570|100638463|FG002|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||60||
48128825|NCT02117570|100638461|FG000|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||17||
48128826|NCT02117570|100638462|FG001|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||53||
48128827|NCT02117570|100638463|FG002|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||50||
48128828|NCT02117570|100638461|FG000|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||4||
48128829|NCT02117570|100638462|FG001|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12||
48128830|NCT02117570|100638463|FG002|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12||
48128831|NCT02117570|100638461|FG000|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||20||
48128832|NCT02117570|100638462|FG001|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||59||
48128833|NCT02117570|100638463|FG002|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||54||
48128834|NCT02117570|100638461|FG000|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||1||
48128835|NCT02117570|100638462|FG001|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||3||
48128836|NCT02117570|100638463|FG002|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||6||
48128837|NCT01045447|100638464|FG000|STARTED|Overall Study||232||
48128838|NCT01045447|100638465|FG001|STARTED|Overall Study||233||
48128839|NCT01045447|100638464|FG000|Exposed|Overall Study||230||
48128840|NCT01045447|100638465|FG001|Exposed|Overall Study||233||
48128841|NCT01045447|100638464|FG000|COMPLETED|Overall Study||196||
48128842|NCT01045447|100638465|FG001|COMPLETED|Overall Study||205||
48128843|NCT01045447|100638464|FG000|NOT COMPLETED|Overall Study||36||
48128844|NCT01045447|100638465|FG001|NOT COMPLETED|Overall Study||28||
48128845|NCT01504438|100638466|FG000|STARTED|Overall Study||48||
48128846|NCT01504438|100638467|FG001|STARTED|Overall Study||50||
48128847|NCT01504438|100638466|FG000|COMPLETED|Overall Study||22||
48128848|NCT01504438|100638467|FG001|COMPLETED|Overall Study||25||
48128849|NCT01504438|100638466|FG000|NOT COMPLETED|Overall Study||26||
48128850|NCT01504438|100638467|FG001|NOT COMPLETED|Overall Study||25||
48128851|NCT02283528|100638468|FG000|STARTED|Overall Study||26||
48128852|NCT02283528|100638469|FG001|STARTED|Overall Study||24||
48128853|NCT02283528|100638468|FG000|COMPLETED|Overall Study||26||
48128854|NCT02283528|100638469|FG001|COMPLETED|Overall Study||24||
48128855|NCT02283528|100638468|FG000|NOT COMPLETED|Overall Study||0||
48128856|NCT02283528|100638469|FG001|NOT COMPLETED|Overall Study||0||
48128857|NCT02453113|100638470|FG000|STARTED|Overall Study||10||
48128858|NCT02453113|100638470|FG000|COMPLETED|Overall Study||10||
48128859|NCT02453113|100638470|FG000|NOT COMPLETED|Overall Study||0||
48128860|NCT02033889|100638471|FG000|STARTED|Overall Study||209||
48128861|NCT02033889|100638472|FG001|STARTED|Overall Study||207||
48128862|NCT02033889|100638473|FG002|STARTED|Overall Study||205||
48128863|NCT02033889|100638471|FG000|COMPLETED|Overall Study||175||
48128864|NCT02033889|100638472|FG001|COMPLETED|Overall Study||187||
48128865|NCT02033889|100638473|FG002|COMPLETED|Overall Study||180||
48128866|NCT02033889|100638471|FG000|NOT COMPLETED|Overall Study||34||
48283973|NCT01679405|101021389|FG000|STARTED|Overall Study||3||
48283974|NCT01679405|101021390|FG001|STARTED|Overall Study||6||
48283975|NCT01679405|101021389|FG000|COMPLETED|Overall Study||1||
48283976|NCT01679405|101021390|FG001|COMPLETED|Overall Study||1||
48283977|NCT01679405|101021389|FG000|NOT COMPLETED|Overall Study||2||
48128867|NCT02033889|100638472|FG001|NOT COMPLETED|Overall Study||20||
48128868|NCT02033889|100638473|FG002|NOT COMPLETED|Overall Study||25||
48128869|NCT05282004|100638474|FG000|STARTED|Overall Study||36||
48128870|NCT05282004|100638474|FG000|COMPLETED|Overall Study||34||
48128871|NCT05282004|100638474|FG000|NOT COMPLETED|Overall Study||2||
48128872|NCT02015234|100638475|FG000|STARTED|Overall Study||79||
48128873|NCT02015234|100638476|FG001|STARTED|Overall Study||79||
48128874|NCT02015234|100638475|FG000|COMPLETED|Overall Study||43||
48128875|NCT02015234|100638476|FG001|COMPLETED|Overall Study||54||
48128876|NCT02015234|100638475|FG000|NOT COMPLETED|Overall Study||36||
48128877|NCT02015234|100638476|FG001|NOT COMPLETED|Overall Study||25||
48128878|NCT00723801|100638477|FG000|STARTED|Overall Study||20||
48128879|NCT00723801|100638478|FG001|STARTED|Overall Study||20||
48128880|NCT00723801|100638477|FG000|COMPLETED|Overall Study||17||
48128881|NCT00723801|100638478|FG001|COMPLETED|Overall Study||17||
48128882|NCT00723801|100638477|FG000|NOT COMPLETED|Overall Study||3||
48128883|NCT00723801|100638478|FG001|NOT COMPLETED|Overall Study||3||
48128884|NCT00182689|100638479|FG000|STARTED|Overall Study||40||
48128885|NCT00182689|100638480|FG001|STARTED|Overall Study||49||
48128886|NCT00182689|100638479|FG000|Eligible|Overall Study||39||
48128887|NCT00182689|100638480|FG001|Eligible|Overall Study||45||
48128888|NCT00182689|100638479|FG000|Eligible and Began Protocol Therapy|Overall Study||38||
48128889|NCT00182689|100638480|FG001|Eligible and Began Protocol Therapy|Overall Study||45||
48128890|NCT00182689|100638479|FG000|COMPLETED|Overall Study||0||
48128891|NCT00182689|100638480|FG001|COMPLETED|Overall Study||0||
48128892|NCT00182689|100638479|FG000|NOT COMPLETED|Overall Study||40||
48128893|NCT00182689|100638480|FG001|NOT COMPLETED|Overall Study||49||
48128894|NCT03021759|100638481|FG000|STARTED|Overall Study||1566||
48128895|NCT03021759|100638482|FG001|STARTED|Overall Study||1743||
48128896|NCT03021759|100638483|FG002|STARTED|Overall Study||1465||
48128897|NCT03021759|100638481|FG000|COMPLETED|Overall Study||1566||
48128898|NCT03021759|100638482|FG001|COMPLETED|Overall Study||1743||
48128899|NCT03021759|100638483|FG002|COMPLETED|Overall Study||1465||
48128900|NCT03021759|100638481|FG000|NOT COMPLETED|Overall Study||0||
48128901|NCT03021759|100638482|FG001|NOT COMPLETED|Overall Study||0||
48128902|NCT03021759|100638483|FG002|NOT COMPLETED|Overall Study||0||
48128903|NCT01040130|100638484|FG000|STARTED|Overall Study||25||
48128904|NCT01040130|100638485|FG001|STARTED|Overall Study||25||
48128905|NCT01040130|100638486|FG002|STARTED|Overall Study||25||
48128906|NCT01040130|100638487|FG003|STARTED|Overall Study||25||
48398326|NCT02120352|101306300|FG006|COMPLETED|Extension Period (Week 97 to Study End)||0||
48398327|NCT02120352|101306294|FG000|NOT COMPLETED|Extension Period (Week 97 to Study End)||0||
48573002|NCT00570687|101735046|FG004|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0||
48573003|NCT00570687|101735047|FG005|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0||
48573004|NCT00570687|101735048|FG006|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0||
48573005|NCT00570687|101735049|FG007|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0||
48573006|NCT00570687|101735050|FG008|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0||
48573007|NCT00570687|101735051|FG009|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0||
48573008|NCT00570687|101735042|FG000|STARTED|Washout 3 (7-21 Days) - Amendment 1||4||
48573009|NCT00570687|101735043|FG001|STARTED|Washout 3 (7-21 Days) - Amendment 1||2||
48573010|NCT00570687|101735044|FG002|STARTED|Washout 3 (7-21 Days) - Amendment 1||2||
48573011|NCT00570687|101735045|FG003|STARTED|Washout 3 (7-21 Days) - Amendment 1||4||
48573012|NCT00570687|101735046|FG004|STARTED|Washout 3 (7-21 Days) - Amendment 1||0||
48573013|NCT00570687|101735047|FG005|STARTED|Washout 3 (7-21 Days) - Amendment 1||0||
48573014|NCT00570687|101735048|FG006|STARTED|Washout 3 (7-21 Days) - Amendment 1||0||
48573015|NCT00570687|101735049|FG007|STARTED|Washout 3 (7-21 Days) - Amendment 1||0||
48573016|NCT00570687|101735050|FG008|STARTED|Washout 3 (7-21 Days) - Amendment 1||0||
48573017|NCT00570687|101735051|FG009|STARTED|Washout 3 (7-21 Days) - Amendment 1||0||
48573018|NCT00570687|101735042|FG000|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4||
48573019|NCT00570687|101735043|FG001|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2||
48573020|NCT00570687|101735044|FG002|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2||
48701080|NCT03319953|102054144|FG000|COMPLETED|Washout Period (Day 15 to 49)||3||
48701081|NCT03319953|102054145|FG001|COMPLETED|Washout Period (Day 15 to 49)||4||
48128907|NCT01040130|100638488|FG004|STARTED|Overall Study||25||
48128908|NCT01040130|100638489|FG005|STARTED|Overall Study||26||
48128909|NCT01040130|100638484|FG000|COMPLETED|Overall Study||22||
48128910|NCT01040130|100638485|FG001|COMPLETED|Overall Study||22||
48128911|NCT01040130|100638486|FG002|COMPLETED|Overall Study||23||
48128912|NCT01040130|100638487|FG003|COMPLETED|Overall Study||20||
48128913|NCT01040130|100638488|FG004|COMPLETED|Overall Study||25||
48128914|NCT01040130|100638489|FG005|COMPLETED|Overall Study||22||
48128915|NCT01040130|100638484|FG000|NOT COMPLETED|Overall Study||3||
48573021|NCT00570687|101735045|FG003|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4||
48573022|NCT00570687|101735046|FG004|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0||
48701082|NCT03319953|102054146|FG002|COMPLETED|Washout Period (Day 15 to 49)||9||
48701083|NCT03319953|102054147|FG003|COMPLETED|Washout Period (Day 15 to 49)||7||
48128916|NCT01040130|100638485|FG001|NOT COMPLETED|Overall Study||3||
48128917|NCT01040130|100638486|FG002|NOT COMPLETED|Overall Study||2||
48128918|NCT01040130|100638487|FG003|NOT COMPLETED|Overall Study||5||
48128919|NCT01040130|100638488|FG004|NOT COMPLETED|Overall Study||0||
48128920|NCT01040130|100638489|FG005|NOT COMPLETED|Overall Study||4||
48128921|NCT01621373|100638490|FG000|STARTED|Overall Study||50||
48128922|NCT01621373|100638490|FG000|COMPLETED|Overall Study||50||
48128923|NCT01621373|100638490|FG000|NOT COMPLETED|Overall Study||0||
48128924|NCT02745626|100638491|FG000|STARTED|Overall Study||24||
48128925|NCT02745626|100638492|FG001|STARTED|Overall Study||22||
48128926|NCT02745626|100638493|FG002|STARTED|Overall Study||22||
48128927|NCT02745626|100638491|FG000|COMPLETED|Overall Study||21||
48128928|NCT02745626|100638492|FG001|COMPLETED|Overall Study||16||
48128929|NCT02745626|100638493|FG002|COMPLETED|Overall Study||19||
48128930|NCT02745626|100638491|FG000|NOT COMPLETED|Overall Study||3||
48128931|NCT02745626|100638492|FG001|NOT COMPLETED|Overall Study||6||
48128932|NCT02745626|100638493|FG002|NOT COMPLETED|Overall Study||3||
48128933|NCT01286818|100638494|FG000|STARTED|Overall Study||6||
48128934|NCT01286818|100638494|FG000|Completed DLT Assessment Period|Overall Study||5||
48283978|NCT01679405|101021390|FG001|NOT COMPLETED|Overall Study||5||
48283979|NCT00572039|101021391|FG000|STARTED|Overall Study||121||
48283980|NCT00572039|101021392|FG001|STARTED|Overall Study||120||
48283981|NCT00572039|101021391|FG000|COMPLETED|Overall Study||105||
48283982|NCT00572039|101021392|FG001|COMPLETED|Overall Study||110||
48283983|NCT00572039|101021391|FG000|NOT COMPLETED|Overall Study||16||
48283984|NCT00572039|101021392|FG001|NOT COMPLETED|Overall Study||10||
48283985|NCT03656510|101021393|FG000|STARTED|Overall Study||50||
48283986|NCT03656510|101021394|FG001|STARTED|Overall Study||49||
48283987|NCT03656510|101021395|FG002|STARTED|Overall Study||48||
48283988|NCT03656510|101021396|FG003|STARTED|Overall Study||34||
48283989|NCT03656510|101021397|FG004|STARTED|Overall Study||34||
48283990|NCT03656510|101021398|FG005|STARTED|Overall Study||31||
48283991|NCT03656510|101021393|FG000|COMPLETED|Overall Study||48||
48283992|NCT03656510|101021394|FG001|COMPLETED|Overall Study||48||
48283993|NCT03656510|101021395|FG002|COMPLETED|Overall Study||48||
48283994|NCT03656510|101021396|FG003|COMPLETED|Overall Study||33||
48283995|NCT03656510|101021397|FG004|COMPLETED|Overall Study||34||
48283996|NCT03656510|101021398|FG005|COMPLETED|Overall Study||31||
48283997|NCT03656510|101021393|FG000|NOT COMPLETED|Overall Study||2||
48283998|NCT03656510|101021394|FG001|NOT COMPLETED|Overall Study||1||
48283999|NCT03656510|101021395|FG002|NOT COMPLETED|Overall Study||0||
48284000|NCT03656510|101021396|FG003|NOT COMPLETED|Overall Study||1||
48284001|NCT03656510|101021397|FG004|NOT COMPLETED|Overall Study||0||
48284002|NCT03656510|101021398|FG005|NOT COMPLETED|Overall Study||0||
48284003|NCT05718466|101021399|FG000|STARTED|Overall Study||18||
48284004|NCT05718466|101021400|FG001|STARTED|Overall Study||17||
48284005|NCT05718466|101021399|FG000|COMPLETED|Overall Study||17||
48284006|NCT05718466|101021400|FG001|COMPLETED|Overall Study||14||
48284007|NCT05718466|101021399|FG000|NOT COMPLETED|Overall Study||1||
48284008|NCT05718466|101021400|FG001|NOT COMPLETED|Overall Study||3||
48284009|NCT01768637|101021401|FG000|STARTED|Overall Study||29|Signed consent|
48284010|NCT01768637|101021402|FG001|STARTED|Overall Study||19|Signed consent|
48284011|NCT01768637|101021401|FG000|Completed Visit 1|Overall Study||28||
48284012|NCT01768637|101021402|FG001|Completed Visit 1|Overall Study||16||
48284013|NCT01768637|101021401|FG000|Completed Visit 2|Overall Study||26||
48284014|NCT01768637|101021402|FG001|Completed Visit 2|Overall Study||13||
48284015|NCT01768637|101021401|FG000|COMPLETED|Overall Study||26|completed visit 3|
48284016|NCT01768637|101021402|FG001|COMPLETED|Overall Study||12|completed visit 3|
48284017|NCT01768637|101021401|FG000|NOT COMPLETED|Overall Study||3||
48284018|NCT01768637|101021402|FG001|NOT COMPLETED|Overall Study||7||
48284019|NCT05020327|101021403|FG000|STARTED|Overall Study||28||
48284020|NCT05020327|101021404|FG001|STARTED|Overall Study||6||
48284021|NCT05020327|101021405|FG002|STARTED|Overall Study||6||
48284022|NCT05020327|101021403|FG000|COMPLETED|Overall Study||12||
48284023|NCT05020327|101021404|FG001|COMPLETED|Overall Study||5||
48284024|NCT05020327|101021405|FG002|COMPLETED|Overall Study||6||
48284025|NCT05020327|101021403|FG000|NOT COMPLETED|Overall Study||16||
48284026|NCT05020327|101021404|FG001|NOT COMPLETED|Overall Study||1||
48284027|NCT05020327|101021405|FG002|NOT COMPLETED|Overall Study||0||
48284028|NCT02437253|101021406|FG000|STARTED|Overall Study||1||
48284029|NCT02437253|101021407|FG001|STARTED|Overall Study||1||
48284030|NCT02437253|101021406|FG000|COMPLETED|Overall Study||1||
48284031|NCT02437253|101021407|FG001|COMPLETED|Overall Study||1||
48284032|NCT02437253|101021406|FG000|NOT COMPLETED|Overall Study||0||
48284033|NCT02437253|101021407|FG001|NOT COMPLETED|Overall Study||0||
48284034|NCT00682851|101021408|FG000|STARTED|Overall Study||251||
48284035|NCT00682851|101021409|FG001|STARTED|Overall Study||268||
48284036|NCT00682851|101021408|FG000|COMPLETED|Overall Study||251||
48284037|NCT00682851|101021409|FG001|COMPLETED|Overall Study||268||
48284038|NCT00682851|101021408|FG000|NOT COMPLETED|Overall Study||0||
48284039|NCT00682851|101021409|FG001|NOT COMPLETED|Overall Study||0||
48284040|NCT00540046|101021410|FG000|STARTED|Overall Study||104||
48284041|NCT00540046|101021411|FG001|STARTED|Overall Study||111||
48284042|NCT00540046|101021410|FG000|COMPLETED|Overall Study||71||
48284043|NCT00540046|101021411|FG001|COMPLETED|Overall Study||88||
48284044|NCT00540046|101021410|FG000|NOT COMPLETED|Overall Study||33||
48284045|NCT00540046|101021411|FG001|NOT COMPLETED|Overall Study||23||
48398328|NCT02120352|101306295|FG001|NOT COMPLETED|Extension Period (Week 97 to Study End)||15||
48284046|NCT01151410|101021412|FG000|STARTED|Overall Study||104||
48284047|NCT01151410|101021413|FG001|STARTED|Overall Study||104||
48284048|NCT01151410|101021412|FG000|Safety Set (SAF)|Overall Study||105||
48284049|NCT01151410|101021413|FG001|Safety Set (SAF)|Overall Study||103||
48284050|NCT01151410|101021412|FG000|COMPLETED|Overall Study||93||
48284051|NCT01151410|101021413|FG001|COMPLETED|Overall Study||89||
48284052|NCT01151410|101021412|FG000|NOT COMPLETED|Overall Study||11||
48284053|NCT01151410|101021413|FG001|NOT COMPLETED|Overall Study||15||
48284054|NCT00215137|101021414|FG000|STARTED|Open Label Escitalopram||14||
48284055|NCT00215137|101021415|FG001|STARTED|Open Label Escitalopram||0||
48284056|NCT00215137|101021416|FG002|STARTED|Open Label Escitalopram||0||
48284057|NCT00215137|101021414|FG000|COMPLETED|Open Label Escitalopram||13||
48284058|NCT00215137|101021415|FG001|COMPLETED|Open Label Escitalopram||0||
48284059|NCT00215137|101021416|FG002|COMPLETED|Open Label Escitalopram||0||
48284060|NCT00215137|101021414|FG000|NOT COMPLETED|Open Label Escitalopram||1||
48398329|NCT02120352|101306296|FG002|NOT COMPLETED|Extension Period (Week 97 to Study End)||25||
48398330|NCT02120352|101306297|FG003|NOT COMPLETED|Extension Period (Week 97 to Study End)||0||
48398331|NCT02120352|101306298|FG004|NOT COMPLETED|Extension Period (Week 97 to Study End)||8||
48398332|NCT02120352|101306299|FG005|NOT COMPLETED|Extension Period (Week 97 to Study End)||2||
48701084|NCT03319953|102054144|FG000|NOT COMPLETED|Washout Period (Day 15 to 49)||0||
48701085|NCT03319953|102054145|FG001|NOT COMPLETED|Washout Period (Day 15 to 49)||0||
48701086|NCT03319953|102054146|FG002|NOT COMPLETED|Washout Period (Day 15 to 49)||0||
48701087|NCT03319953|102054147|FG003|NOT COMPLETED|Washout Period (Day 15 to 49)||0||
48701088|NCT03319953|102054144|FG000|STARTED|Period 2 (Day 49 to 154)||3||
48701089|NCT03319953|102054145|FG001|STARTED|Period 2 (Day 49 to 154)||4||
48701090|NCT03319953|102054146|FG002|STARTED|Period 2 (Day 49 to 154)||9||
48701091|NCT03319953|102054147|FG003|STARTED|Period 2 (Day 49 to 154)||7||
48701092|NCT03319953|102054144|FG000|Treated|Period 2 (Day 49 to 154)||2|3 participants discontinued before receiving their respective treatment, per sequence, in Period 2.|
48701093|NCT03319953|102054145|FG001|Treated|Period 2 (Day 49 to 154)||4|3 participants discontinued before receiving their respective treatment, per sequence, in Period 2.|
48701094|NCT03319953|102054146|FG002|Treated|Period 2 (Day 49 to 154)||8|3 participants discontinued before receiving their respective treatment, per sequence, in Period 2.|
48701095|NCT03319953|102054147|FG003|Treated|Period 2 (Day 49 to 154)||6|3 participants discontinued before receiving their respective treatment, per sequence, in Period 2.|
48701096|NCT03319953|102054144|FG000|COMPLETED|Period 2 (Day 49 to 154)||2|Completed = Participants who completed study treatment.|
48128935|NCT01286818|100638494|FG000|COMPLETED|Overall Study||6||
48128936|NCT01286818|100638494|FG000|NOT COMPLETED|Overall Study||0||
48128937|NCT01931839|100638495|FG000|STARTED|Overall Study||335||
48128938|NCT01931839|100638496|FG001|STARTED|Overall Study||178||
48128939|NCT01931839|100638497|FG002|STARTED|Overall Study||340||
48128940|NCT01931839|100638498|FG003|STARTED|Overall Study||176||
48128941|NCT01931839|100638499|FG004|STARTED|Overall Study||19||
48128942|NCT01931839|100638500|FG005|STARTED|Overall Study||55||
48128943|NCT01931839|100638501|FG006|STARTED|Overall Study||60||
48128944|NCT01931839|100638495|FG000|Full Analysis Set (As Randomized)|Overall Study||334||
48398333|NCT02120352|101306300|FG006|NOT COMPLETED|Extension Period (Week 97 to Study End)||0||
48398334|NCT02120352|101306294|FG000|STARTED|Long-Term Follow-up Period (52 Weeks)||0||
48398335|NCT02120352|101306295|FG001|STARTED|Long-Term Follow-up Period (52 Weeks)||0||
48128945|NCT01931839|100638496|FG001|Full Analysis Set (As Randomized)|Overall Study||179||
48128946|NCT01931839|100638497|FG002|Full Analysis Set (As Randomized)|Overall Study||340||
48128947|NCT01931839|100638498|FG003|Full Analysis Set (As Randomized)|Overall Study||176||
48128948|NCT01931839|100638499|FG004|Full Analysis Set (As Randomized)|Overall Study||19||
48128949|NCT01931839|100638500|FG005|Full Analysis Set (As Randomized)|Overall Study||55||
48128950|NCT01931839|100638501|FG006|Full Analysis Set (As Randomized)|Overall Study||60||
48128951|NCT01931839|100638495|FG000|Safety Analysis Set (As Dosed)|Overall Study||335||
48128952|NCT01931839|100638496|FG001|Safety Analysis Set (As Dosed)|Overall Study||178||
48128953|NCT01931839|100638497|FG002|Safety Analysis Set (As Dosed)|Overall Study||340||
48128954|NCT01931839|100638498|FG003|Safety Analysis Set (As Dosed)|Overall Study||176||
48128955|NCT01931839|100638499|FG004|Safety Analysis Set (As Dosed)|Overall Study||19||
48128956|NCT01931839|100638500|FG005|Safety Analysis Set (As Dosed)|Overall Study||55||
48128957|NCT01931839|100638501|FG006|Safety Analysis Set (As Dosed)|Overall Study||60||
48128958|NCT01931839|100638495|FG000|COMPLETED|Overall Study||294||
48128959|NCT01931839|100638496|FG001|COMPLETED|Overall Study||152||
48128960|NCT01931839|100638497|FG002|COMPLETED|Overall Study||301||
48128961|NCT01931839|100638498|FG003|COMPLETED|Overall Study||162||
48128962|NCT01931839|100638499|FG004|COMPLETED|Overall Study||18||
48128963|NCT01931839|100638500|FG005|COMPLETED|Overall Study||50||
48128964|NCT01931839|100638501|FG006|COMPLETED|Overall Study||56||
48128965|NCT01931839|100638495|FG000|NOT COMPLETED|Overall Study||41||
48128966|NCT01931839|100638496|FG001|NOT COMPLETED|Overall Study||26||
48398336|NCT02120352|101306296|FG002|STARTED|Long-Term Follow-up Period (52 Weeks)||0||
48398337|NCT02120352|101306297|FG003|STARTED|Long-Term Follow-up Period (52 Weeks)||0||
48398338|NCT02120352|101306298|FG004|STARTED|Long-Term Follow-up Period (52 Weeks)||0||
48398339|NCT02120352|101306299|FG005|STARTED|Long-Term Follow-up Period (52 Weeks)||0||
48398340|NCT02120352|101306300|FG006|STARTED|Long-Term Follow-up Period (52 Weeks)||43||
48398341|NCT02120352|101306294|FG000|COMPLETED|Long-Term Follow-up Period (52 Weeks)||0||
48398342|NCT02120352|101306295|FG001|COMPLETED|Long-Term Follow-up Period (52 Weeks)||0||
48128967|NCT01931839|100638497|FG002|NOT COMPLETED|Overall Study||39||
48128968|NCT01931839|100638498|FG003|NOT COMPLETED|Overall Study||14||
48128969|NCT01931839|100638499|FG004|NOT COMPLETED|Overall Study||1||
48128970|NCT01931839|100638500|FG005|NOT COMPLETED|Overall Study||5||
48398343|NCT02120352|101306296|FG002|COMPLETED|Long-Term Follow-up Period (52 Weeks)||0||
48398344|NCT02120352|101306297|FG003|COMPLETED|Long-Term Follow-up Period (52 Weeks)||0||
48701097|NCT03319953|102054145|FG001|COMPLETED|Period 2 (Day 49 to 154)||4|Completed = Participants who completed study treatment.|
48701098|NCT03319953|102054146|FG002|COMPLETED|Period 2 (Day 49 to 154)||8|Completed = Participants who completed study treatment.|
48398345|NCT02120352|101306298|FG004|COMPLETED|Long-Term Follow-up Period (52 Weeks)||0||
48128971|NCT01931839|100638501|FG006|NOT COMPLETED|Overall Study||4||
48128972|NCT02223390|100638502|FG000|STARTED|Overall Study||32||
48701099|NCT03319953|102054147|FG003|COMPLETED|Period 2 (Day 49 to 154)||6|Completed = Participants who completed study treatment.|
48701100|NCT03319953|102054144|FG000|NOT COMPLETED|Period 2 (Day 49 to 154)||1||
48701101|NCT03319953|102054145|FG001|NOT COMPLETED|Period 2 (Day 49 to 154)||0||
48701102|NCT03319953|102054146|FG002|NOT COMPLETED|Period 2 (Day 49 to 154)||1||
48701103|NCT03319953|102054147|FG003|NOT COMPLETED|Period 2 (Day 49 to 154)||1||
48701104|NCT01059682|102054148|FG000|STARTED|Overall Study||474||
48701105|NCT01059682|102054149|FG001|STARTED|Overall Study||462||
48701106|NCT01059682|102054148|FG000|COMPLETED|Overall Study||464||
48701107|NCT01059682|102054149|FG001|COMPLETED|Overall Study||444||
48701108|NCT01059682|102054148|FG000|NOT COMPLETED|Overall Study||10||
48128973|NCT02223390|100638503|FG001|STARTED|Overall Study||32||
48128974|NCT02223390|100638502|FG000|COMPLETED|Overall Study||23||
48128975|NCT02223390|100638503|FG001|COMPLETED|Overall Study||28||
48398346|NCT02120352|101306299|FG005|COMPLETED|Long-Term Follow-up Period (52 Weeks)||0||
48398347|NCT02120352|101306300|FG006|COMPLETED|Long-Term Follow-up Period (52 Weeks)||37||
48398348|NCT02120352|101306294|FG000|NOT COMPLETED|Long-Term Follow-up Period (52 Weeks)||0||
48398349|NCT02120352|101306295|FG001|NOT COMPLETED|Long-Term Follow-up Period (52 Weeks)||0||
48573023|NCT00570687|101735047|FG005|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0||
48573024|NCT00570687|101735048|FG006|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0||
48573025|NCT00570687|101735049|FG007|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0||
48573026|NCT00570687|101735050|FG008|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0||
48573027|NCT00570687|101735051|FG009|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0||
48573028|NCT00570687|101735042|FG000|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0||
48573029|NCT00570687|101735043|FG001|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0||
48573030|NCT00570687|101735044|FG002|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0||
48573031|NCT00570687|101735045|FG003|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0||
48701109|NCT01059682|102054149|FG001|NOT COMPLETED|Overall Study||18||
48128976|NCT02223390|100638502|FG000|NOT COMPLETED|Overall Study||9||
48128977|NCT02223390|100638503|FG001|NOT COMPLETED|Overall Study||4||
48128978|NCT00793910|100638504|FG000|STARTED|Overall Study||53||
48128979|NCT00793910|100638505|FG001|STARTED|Overall Study||53||
48128980|NCT00793910|100638504|FG000|COMPLETED|Overall Study||48||
48128981|NCT00793910|100638505|FG001|COMPLETED|Overall Study||46||
48128982|NCT00793910|100638504|FG000|NOT COMPLETED|Overall Study||5||
48128983|NCT00793910|100638505|FG001|NOT COMPLETED|Overall Study||7||
48284061|NCT00215137|101021415|FG001|NOT COMPLETED|Open Label Escitalopram||0||
48284062|NCT00215137|101021416|FG002|NOT COMPLETED|Open Label Escitalopram||0||
48284063|NCT00215137|101021414|FG000|STARTED|Randomization Period||0||
48284064|NCT00215137|101021415|FG001|STARTED|Randomization Period||7||
48284065|NCT00215137|101021416|FG002|STARTED|Randomization Period||5||
48284066|NCT00215137|101021414|FG000|COMPLETED|Randomization Period||0||
48284067|NCT00215137|101021415|FG001|COMPLETED|Randomization Period||5||
48284068|NCT00215137|101021416|FG002|COMPLETED|Randomization Period||5||
48284069|NCT00215137|101021414|FG000|NOT COMPLETED|Randomization Period||0||
48284070|NCT00215137|101021415|FG001|NOT COMPLETED|Randomization Period||2||
48284071|NCT00215137|101021416|FG002|NOT COMPLETED|Randomization Period||0||
48284072|NCT00795366|101021417|FG000|STARTED|Overall Study||42||
48284073|NCT00795366|101021418|FG001|STARTED|Overall Study||54||
48284074|NCT00795366|101021417|FG000|COMPLETED|Overall Study||42||
48284075|NCT00795366|101021418|FG001|COMPLETED|Overall Study||54||
48284076|NCT00795366|101021417|FG000|NOT COMPLETED|Overall Study||0||
48284077|NCT00795366|101021418|FG001|NOT COMPLETED|Overall Study||0||
48284078|NCT01204398|101021419|FG000|STARTED|Overall Study||27||
48284079|NCT01204398|101021419|FG000|COMPLETED|Overall Study||26||
48284080|NCT01204398|101021419|FG000|NOT COMPLETED|Overall Study||1||
48284081|NCT01146782|101021420|FG000|STARTED|Screening Cohort||367||
48284082|NCT01146782|101021420|FG000|COMPLETED|Screening Cohort||146||
48284083|NCT01146782|101021420|FG000|NOT COMPLETED|Screening Cohort||221||
48284084|NCT01146782|101021420|FG000|STARTED|Safety Cohort||146||
48284085|NCT01146782|101021420|FG000|COMPLETED|Safety Cohort||63||
48284086|NCT01146782|101021420|FG000|NOT COMPLETED|Safety Cohort||83||
48284087|NCT01146782|101021420|FG000|STARTED|Primary Endpoint Cohort||63||
48284088|NCT01146782|101021420|FG000|COMPLETED|Primary Endpoint Cohort||57||
48284089|NCT01146782|101021420|FG000|NOT COMPLETED|Primary Endpoint Cohort||6||
48284090|NCT02914275|101021421|FG000|STARTED|Overall Study||1687|(Randomized)|
48284091|NCT02914275|101021422|FG001|STARTED|Overall Study||563|(Randomized)|
48284092|NCT02914275|101021421|FG000|Included in Clinical Database / FAS|Overall Study||1684||
48284093|NCT02914275|101021422|FG001|Included in Clinical Database / FAS|Overall Study||563||
48284094|NCT02914275|101021421|FG000|COMPLETED|Overall Study||1566||
48284095|NCT02914275|101021422|FG001|COMPLETED|Overall Study||521||
48284096|NCT02914275|101021421|FG000|NOT COMPLETED|Overall Study||121||
48284097|NCT02914275|101021422|FG001|NOT COMPLETED|Overall Study||42||
48284098|NCT01021215|101021423|FG000|STARTED|Overall Study||60||
48284099|NCT01021215|101021424|FG001|STARTED|Overall Study||20||
48284100|NCT01021215|101021423|FG000|Received Allocated Intervention|Overall Study||60||
48284101|NCT01021215|101021424|FG001|Received Allocated Intervention|Overall Study||20||
48284102|NCT01021215|101021423|FG000|COMPLETED|Overall Study||57||
48284103|NCT01021215|101021424|FG001|COMPLETED|Overall Study||20||
48398350|NCT02120352|101306296|FG002|NOT COMPLETED|Long-Term Follow-up Period (52 Weeks)||0||
48701110|NCT02345772|102054150|FG000|STARTED|Overall Study||4||
48701111|NCT02345772|102054150|FG000|COMPLETED|Overall Study||0||
48701112|NCT02345772|102054150|FG000|NOT COMPLETED|Overall Study||4||
48701113|NCT03713398|102054151|FG000|STARTED|Overall Study||50||
48701114|NCT03713398|102054152|FG001|STARTED|Overall Study||50||
48701115|NCT03713398|102054151|FG000|COMPLETED|Overall Study||24||
48701116|NCT03713398|102054152|FG001|COMPLETED|Overall Study||23||
48701117|NCT03713398|102054151|FG000|NOT COMPLETED|Overall Study||26||
48701118|NCT03713398|102054152|FG001|NOT COMPLETED|Overall Study||27||
48701119|NCT03802344|102054153|FG000|STARTED|Overall Study||213||
48701120|NCT03802344|102054154|FG001|STARTED|Overall Study||209||
48701121|NCT03802344|102054155|FG002|STARTED|Overall Study||68||
48701122|NCT03802344|102054153|FG000|COMPLETED|Overall Study||205||
48701123|NCT03802344|102054154|FG001|COMPLETED|Overall Study||203||
48701124|NCT03802344|102054155|FG002|COMPLETED|Overall Study||55||
48701125|NCT03802344|102054153|FG000|NOT COMPLETED|Overall Study||8||
48701126|NCT03802344|102054154|FG001|NOT COMPLETED|Overall Study||6||
48701127|NCT03802344|102054155|FG002|NOT COMPLETED|Overall Study||13||
48701128|NCT05141708|102054156|FG000|STARTED|Overall Study||33||
48701129|NCT05141708|102054156|FG000|COMPLETED|Overall Study||33||
48701130|NCT05141708|102054156|FG000|NOT COMPLETED|Overall Study||0||
48701131|NCT05858450|102054157|FG000|STARTED|Overall Study||244900||
48701132|NCT05858450|102054158|FG001|STARTED|Overall Study||143743||
48701133|NCT05858450|102054159|FG002|STARTED|Overall Study||843860||
48701134|NCT05858450|102054160|FG003|STARTED|Overall Study||382835||
48701135|NCT05858450|102054161|FG004|STARTED|Overall Study||225680||
48701136|NCT05858450|102054162|FG005|STARTED|Overall Study||1601978||
48701137|NCT05858450|102054157|FG000|COMPLETED|Overall Study||244900||
48701138|NCT05858450|102054158|FG001|COMPLETED|Overall Study||143743||
48701139|NCT05858450|102054159|FG002|COMPLETED|Overall Study||843860||
48701140|NCT05858450|102054160|FG003|COMPLETED|Overall Study||382835||
48701141|NCT05858450|102054161|FG004|COMPLETED|Overall Study||225680||
48701142|NCT05858450|102054162|FG005|COMPLETED|Overall Study||1601978||
48701143|NCT05858450|102054157|FG000|NOT COMPLETED|Overall Study||0||
48701144|NCT05858450|102054158|FG001|NOT COMPLETED|Overall Study||0||
48128984|NCT02371369|100638506|FG000|STARTED|Part 1||61||
48128985|NCT02371369|100638507|FG001|STARTED|Part 1||59||
48128986|NCT02371369|100638506|FG000|COMPLETED|Part 1||52||
48128987|NCT02371369|100638507|FG001|COMPLETED|Part 1||48||
48128988|NCT02371369|100638506|FG000|NOT COMPLETED|Part 1||9||
48128989|NCT02371369|100638507|FG001|NOT COMPLETED|Part 1||11||
48128990|NCT02371369|100638506|FG000|STARTED|Part 2||48||
48128991|NCT02371369|100638507|FG001|STARTED|Part 2||30||
48701145|NCT05858450|102054159|FG002|NOT COMPLETED|Overall Study||0||
48701146|NCT05858450|102054160|FG003|NOT COMPLETED|Overall Study||0||
48701147|NCT05858450|102054161|FG004|NOT COMPLETED|Overall Study||0||
48701148|NCT05858450|102054162|FG005|NOT COMPLETED|Overall Study||0||
48701149|NCT00349921|102054163|FG000|STARTED|First Spinal Injection||10||
48701150|NCT00349921|102054164|FG001|STARTED|First Spinal Injection||10||
48701151|NCT00349921|102054165|FG002|STARTED|First Spinal Injection||1||
48701152|NCT00349921|102054166|FG003|STARTED|First Spinal Injection||1||
48701153|NCT00349921|102054163|FG000|COMPLETED|First Spinal Injection||9||
48701154|NCT00349921|102054164|FG001|COMPLETED|First Spinal Injection||10||
48128992|NCT02371369|100638506|FG000|COMPLETED|Part 2||0||
48128993|NCT02371369|100638507|FG001|COMPLETED|Part 2||0||
48128994|NCT02371369|100638506|FG000|NOT COMPLETED|Part 2||48||
48128995|NCT02371369|100638507|FG001|NOT COMPLETED|Part 2||30||
48128996|NCT02753751|100638508|FG000|STARTED|Overall Study||2971||
48128997|NCT02753751|100638509|FG001|STARTED|Overall Study||3059||
48128998|NCT02753751|100638508|FG000|COMPLETED|Overall Study||2971||
48128999|NCT02753751|100638509|FG001|COMPLETED|Overall Study||3059||
48129000|NCT02753751|100638508|FG000|NOT COMPLETED|Overall Study||0||
48129001|NCT02753751|100638509|FG001|NOT COMPLETED|Overall Study||0||
48129002|NCT01978119|100638510|FG000|STARTED|Treatment Period 1 (12 Weeks)||40||
48129003|NCT01978119|100638511|FG001|STARTED|Treatment Period 1 (12 Weeks)||42||
48284104|NCT01021215|101021423|FG000|NOT COMPLETED|Overall Study||3||
48284105|NCT01021215|101021424|FG001|NOT COMPLETED|Overall Study||0||
48284106|NCT00484289|101021425|FG000|STARTED|Long Term Phase||13||
48284107|NCT00484289|101021426|FG001|STARTED|Long Term Phase||178||
48284108|NCT00484289|101021427|FG002|STARTED|Long Term Phase||26||
48284109|NCT00484289|101021425|FG000|COMPLETED|Long Term Phase||10||
48284110|NCT00484289|101021426|FG001|COMPLETED|Long Term Phase||142||
48284111|NCT00484289|101021427|FG002|COMPLETED|Long Term Phase||10||
48284112|NCT00484289|101021425|FG000|NOT COMPLETED|Long Term Phase||3||
48284113|NCT00484289|101021426|FG001|NOT COMPLETED|Long Term Phase||36||
48284114|NCT00484289|101021427|FG002|NOT COMPLETED|Long Term Phase||16||
48284115|NCT00484289|101021425|FG000|STARTED|Post Marketing Phase||10||
48284116|NCT00484289|101021426|FG001|STARTED|Post Marketing Phase||142||
48284117|NCT00484289|101021427|FG002|STARTED|Post Marketing Phase||10||
48701155|NCT00349921|102054165|FG002|COMPLETED|First Spinal Injection||0||
48701156|NCT00349921|102054166|FG003|COMPLETED|First Spinal Injection||1||
48701157|NCT00349921|102054163|FG000|NOT COMPLETED|First Spinal Injection||1||
48701158|NCT00349921|102054164|FG001|NOT COMPLETED|First Spinal Injection||0||
48701159|NCT00349921|102054165|FG002|NOT COMPLETED|First Spinal Injection||1||
48284118|NCT00484289|101021425|FG000|COMPLETED|Post Marketing Phase||10||
48284119|NCT00484289|101021426|FG001|COMPLETED|Post Marketing Phase||141||
48284120|NCT00484289|101021427|FG002|COMPLETED|Post Marketing Phase||10||
48284121|NCT00484289|101021425|FG000|NOT COMPLETED|Post Marketing Phase||0||
48284122|NCT00484289|101021426|FG001|NOT COMPLETED|Post Marketing Phase||1||
48284123|NCT00484289|101021427|FG002|NOT COMPLETED|Post Marketing Phase||0||
48284124|NCT05559476|101021428|FG000|STARTED|Overall Study||516||
48284125|NCT05559476|101021429|FG001|STARTED|Overall Study||513||
48398351|NCT02120352|101306297|FG003|NOT COMPLETED|Long-Term Follow-up Period (52 Weeks)||0||
48398352|NCT02120352|101306298|FG004|NOT COMPLETED|Long-Term Follow-up Period (52 Weeks)||0||
48398353|NCT02120352|101306299|FG005|NOT COMPLETED|Long-Term Follow-up Period (52 Weeks)||0||
48398354|NCT02120352|101306300|FG006|NOT COMPLETED|Long-Term Follow-up Period (52 Weeks)||6||
48398355|NCT00640146|101306301|FG000|STARTED|Overall Study||19||
48398356|NCT00640146|101306302|FG001|STARTED|Overall Study||18||
48398357|NCT00640146|101306301|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18|Modified intent-to treat (MITT)/Safety population|
48398358|NCT00640146|101306302|FG001|Received at Least 1 Dose of Study Drug|Overall Study||15|Modified intent-to treat (MITT)/Safety population|
48398359|NCT00640146|101306301|FG000|COMPLETED|Overall Study||15||
48701160|NCT00349921|102054166|FG003|NOT COMPLETED|First Spinal Injection||0||
48701161|NCT00349921|102054163|FG000|STARTED|Second Spinal Injection||9||
48701162|NCT00349921|102054164|FG001|STARTED|Second Spinal Injection||10||
48701163|NCT00349921|102054165|FG002|STARTED|Second Spinal Injection||0||
48701164|NCT00349921|102054166|FG003|STARTED|Second Spinal Injection||1||
48701165|NCT00349921|102054163|FG000|COMPLETED|Second Spinal Injection||9||
48701166|NCT00349921|102054164|FG001|COMPLETED|Second Spinal Injection||10||
48701167|NCT00349921|102054165|FG002|COMPLETED|Second Spinal Injection||0||
48701168|NCT00349921|102054166|FG003|COMPLETED|Second Spinal Injection||1||
48701169|NCT00349921|102054163|FG000|NOT COMPLETED|Second Spinal Injection||0||
48701170|NCT00349921|102054164|FG001|NOT COMPLETED|Second Spinal Injection||0||
48701171|NCT00349921|102054165|FG002|NOT COMPLETED|Second Spinal Injection||0||
48701172|NCT00349921|102054166|FG003|NOT COMPLETED|Second Spinal Injection||0||
48701173|NCT01892436|102054167|FG000|STARTED|Overall Study||147||
48701174|NCT01892436|102054168|FG001|STARTED|Overall Study||161||
48701175|NCT01892436|102054169|FG002|STARTED|Overall Study||74||
48701176|NCT01892436|102054170|FG003|STARTED|Overall Study||75||
48701177|NCT01892436|102054167|FG000|COMPLETED|Overall Study||124||
48701178|NCT01892436|102054168|FG001|COMPLETED|Overall Study||132||
48701179|NCT01892436|102054169|FG002|COMPLETED|Overall Study||63||
48701180|NCT01892436|102054170|FG003|COMPLETED|Overall Study||61||
48701181|NCT01892436|102054167|FG000|NOT COMPLETED|Overall Study||23||
48701182|NCT01892436|102054168|FG001|NOT COMPLETED|Overall Study||29||
48701183|NCT01892436|102054169|FG002|NOT COMPLETED|Overall Study||11||
48701184|NCT01892436|102054170|FG003|NOT COMPLETED|Overall Study||14||
48701185|NCT01671293|102054171|FG000|STARTED|Overall Study||36||
48701186|NCT01671293|102054172|FG001|STARTED|Overall Study||34||
48701187|NCT01671293|102054171|FG000|COMPLETED|Overall Study||33||
48701188|NCT01671293|102054172|FG001|COMPLETED|Overall Study||32||
48701189|NCT01671293|102054171|FG000|NOT COMPLETED|Overall Study||3||
48701190|NCT01671293|102054172|FG001|NOT COMPLETED|Overall Study||2||
48398360|NCT00640146|101306302|FG001|COMPLETED|Overall Study||12||
48398361|NCT00640146|101306301|FG000|NOT COMPLETED|Overall Study||4||
48398362|NCT00640146|101306302|FG001|NOT COMPLETED|Overall Study||6||
48398363|NCT04454138|101306303|FG000|STARTED|Overall Study||65||
48398364|NCT04454138|101306304|FG001|STARTED|Overall Study||77||
48398365|NCT04454138|101306303|FG000|COMPLETED|Overall Study||65||
48398366|NCT04454138|101306304|FG001|COMPLETED|Overall Study||77||
48398367|NCT04454138|101306303|FG000|NOT COMPLETED|Overall Study||0||
48398368|NCT04454138|101306304|FG001|NOT COMPLETED|Overall Study||0||
48398369|NCT05343585|101306305|FG000|STARTED|Overall Study||24||
48701191|NCT04357730|102054173|FG000|STARTED|Phase 1||17||
48701192|NCT04357730|102054174|FG001|STARTED|Phase 1||19||
48284126|NCT05559476|101021428|FG000|COMPLETED|Overall Study||493||
48284127|NCT05559476|101021429|FG001|COMPLETED|Overall Study||485||
48284128|NCT05559476|101021428|FG000|NOT COMPLETED|Overall Study||23||
48284129|NCT05559476|101021429|FG001|NOT COMPLETED|Overall Study||28||
48284130|NCT00232544|101021430|FG000|STARTED|Overall Study||124||
48284131|NCT00232544|101021431|FG001|STARTED|Overall Study||126||
48398370|NCT05343585|101306305|FG000|COMPLETED|Overall Study||24||
48398371|NCT05343585|101306305|FG000|NOT COMPLETED|Overall Study||0||
48398372|NCT02709109|101306306|FG000|STARTED|Treatment Period 1 (28 Days)||49||
48398373|NCT02709109|101306307|FG001|STARTED|Treatment Period 1 (28 Days)||47||
48701193|NCT04357730|102054175|FG002|STARTED|Phase 1||0||
48701194|NCT04357730|102054173|FG000|COMPLETED|Phase 1||17||
48701195|NCT04357730|102054174|FG001|COMPLETED|Phase 1||19||
48701196|NCT04357730|102054175|FG002|COMPLETED|Phase 1||0||
48701197|NCT04357730|102054173|FG000|NOT COMPLETED|Phase 1||0||
48701198|NCT04357730|102054174|FG001|NOT COMPLETED|Phase 1||0||
48701199|NCT04357730|102054175|FG002|NOT COMPLETED|Phase 1||0||
48284132|NCT00232544|101021430|FG000|COMPLETED|Overall Study||104||
48284133|NCT00232544|101021431|FG001|COMPLETED|Overall Study||111||
48284134|NCT00232544|101021430|FG000|NOT COMPLETED|Overall Study||20||
48284135|NCT00232544|101021431|FG001|NOT COMPLETED|Overall Study||15||
48701200|NCT04357730|102054173|FG000|STARTED|Phase 2||8||
48573032|NCT00570687|101735046|FG004|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0||
48573033|NCT00570687|101735047|FG005|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0||
48573034|NCT00570687|101735048|FG006|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0||
48573035|NCT00570687|101735049|FG007|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0||
48573036|NCT00570687|101735050|FG008|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0||
48573037|NCT00570687|101735051|FG009|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0||
48573038|NCT00570687|101735042|FG000|STARTED|Clamp 2 (1 Day) - Amendment 1||4||
48573039|NCT00570687|101735043|FG001|STARTED|Clamp 2 (1 Day) - Amendment 1||2||
48573040|NCT00570687|101735044|FG002|STARTED|Clamp 2 (1 Day) - Amendment 1||2||
48573041|NCT00570687|101735045|FG003|STARTED|Clamp 2 (1 Day) - Amendment 1||4||
48573042|NCT00570687|101735046|FG004|STARTED|Clamp 2 (1 Day) - Amendment 1||0||
48573043|NCT00570687|101735047|FG005|STARTED|Clamp 2 (1 Day) - Amendment 1||0||
48573044|NCT00570687|101735048|FG006|STARTED|Clamp 2 (1 Day) - Amendment 1||0||
48573045|NCT00570687|101735049|FG007|STARTED|Clamp 2 (1 Day) - Amendment 1||0||
48573046|NCT00570687|101735050|FG008|STARTED|Clamp 2 (1 Day) - Amendment 1||0||
48573047|NCT00570687|101735051|FG009|STARTED|Clamp 2 (1 Day) - Amendment 1||0||
48573048|NCT00570687|101735042|FG000|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4||
48573049|NCT00570687|101735043|FG001|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2||
48573050|NCT00570687|101735044|FG002|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2||
48573051|NCT00570687|101735045|FG003|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4||
48573052|NCT00570687|101735046|FG004|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0||
48129004|NCT01978119|100638510|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||38||
48129005|NCT01978119|100638511|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||42||
48398374|NCT02709109|101306308|FG002|STARTED|Treatment Period 1 (28 Days)||22||
48398375|NCT02709109|101306309|FG003|STARTED|Treatment Period 1 (28 Days)||24||
48398376|NCT02709109|101306306|FG000|COMPLETED|Treatment Period 1 (28 Days)||45||
48398377|NCT02709109|101306307|FG001|COMPLETED|Treatment Period 1 (28 Days)||42||
48398378|NCT02709109|101306308|FG002|COMPLETED|Treatment Period 1 (28 Days)||21||
48573053|NCT00570687|101735047|FG005|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0||
48573054|NCT00570687|101735048|FG006|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0||
48129006|NCT01978119|100638510|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2||
48398379|NCT02709109|101306309|FG003|COMPLETED|Treatment Period 1 (28 Days)||24||
48398380|NCT02709109|101306306|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||4||
48398381|NCT02709109|101306307|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||5||
48573055|NCT00570687|101735049|FG007|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0||
48573056|NCT00570687|101735050|FG008|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0||
48573057|NCT00570687|101735051|FG009|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0||
48573058|NCT00570687|101735042|FG000|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0||
48573059|NCT00570687|101735043|FG001|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0||
48573060|NCT00570687|101735044|FG002|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0||
48573061|NCT00570687|101735045|FG003|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0||
48573062|NCT00570687|101735046|FG004|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0||
48573063|NCT00570687|101735047|FG005|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0||
48573064|NCT00570687|101735048|FG006|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0||
48573065|NCT00570687|101735049|FG007|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0||
48573066|NCT00570687|101735050|FG008|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0||
48573067|NCT00570687|101735051|FG009|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0||
48573068|NCT01609010|101735052|FG000|STARTED|Overall Study||156||
48573069|NCT01609010|101735053|FG001|STARTED|Overall Study||157||
48573070|NCT01609010|101735052|FG000|Entering Cycle 2|Overall Study||120||
48573071|NCT01609010|101735053|FG001|Entering Cycle 2|Overall Study||124||
48573072|NCT01609010|101735052|FG000|COMPLETED|Overall Study||113||
48573073|NCT01609010|101735053|FG001|COMPLETED|Overall Study||120||
48573074|NCT01609010|101735052|FG000|NOT COMPLETED|Overall Study||43||
48129007|NCT01978119|100638511|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||0||
48129008|NCT01978119|100638510|FG000|STARTED|Washout Period 1 (3 Weeks)||38||
48398382|NCT02709109|101306308|FG002|NOT COMPLETED|Treatment Period 1 (28 Days)||1||
48398383|NCT02709109|101306309|FG003|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
48398384|NCT02709109|101306306|FG000|STARTED|Washout Period (28 Days)||45||
48398385|NCT02709109|101306307|FG001|STARTED|Washout Period (28 Days)||42||
48398386|NCT02709109|101306308|FG002|STARTED|Washout Period (28 Days)||21||
48398387|NCT02709109|101306309|FG003|STARTED|Washout Period (28 Days)||24||
48398388|NCT02709109|101306306|FG000|COMPLETED|Washout Period (28 Days)||43||
48398389|NCT02709109|101306307|FG001|COMPLETED|Washout Period (28 Days)||40||
48398390|NCT02709109|101306308|FG002|COMPLETED|Washout Period (28 Days)||18||
48398391|NCT02709109|101306309|FG003|COMPLETED|Washout Period (28 Days)||24||
48398392|NCT02709109|101306306|FG000|NOT COMPLETED|Washout Period (28 Days)||2||
48398393|NCT02709109|101306307|FG001|NOT COMPLETED|Washout Period (28 Days)||2||
48398394|NCT02709109|101306308|FG002|NOT COMPLETED|Washout Period (28 Days)||3||
48398395|NCT02709109|101306309|FG003|NOT COMPLETED|Washout Period (28 Days)||0||
48398396|NCT02709109|101306306|FG000|STARTED|Treatment Period 2 (28 Days)||43||
48398397|NCT02709109|101306307|FG001|STARTED|Treatment Period 2 (28 Days)||40||
48398398|NCT02709109|101306308|FG002|STARTED|Treatment Period 2 (28 Days)||18||
48398399|NCT02709109|101306309|FG003|STARTED|Treatment Period 2 (28 Days)||24||
48573075|NCT01609010|101735053|FG001|NOT COMPLETED|Overall Study||37||
48573076|NCT00686829|101735054|FG000|STARTED|Overall Study||79|Number of participants who were previously enrolled in study ACTG A5211 who received ≥1 dose of VCV in P04100.|
48573077|NCT00686829|101735054|FG000|COMPLETED|Overall Study||0||
48573078|NCT00686829|101735054|FG000|NOT COMPLETED|Overall Study||79||
48573079|NCT02508077|101735055|FG000|STARTED|Overall Study||1||
48573080|NCT02508077|101735055|FG000|COMPLETED|Overall Study||1||
48573081|NCT02508077|101735055|FG000|NOT COMPLETED|Overall Study||0||
48573082|NCT02948751|101735056|FG000|STARTED|Overall Study||14||
48701201|NCT04357730|102054174|FG001|STARTED|Phase 2||0||
48701202|NCT04357730|102054175|FG002|STARTED|Phase 2||6||
48129009|NCT01978119|100638511|FG001|STARTED|Washout Period 1 (3 Weeks)||42||
48129010|NCT01978119|100638510|FG000|COMPLETED|Washout Period 1 (3 Weeks)||38||
48129011|NCT01978119|100638511|FG001|COMPLETED|Washout Period 1 (3 Weeks)||42||
48129012|NCT01978119|100638510|FG000|NOT COMPLETED|Washout Period 1 (3 Weeks)||0||
48129013|NCT01978119|100638511|FG001|NOT COMPLETED|Washout Period 1 (3 Weeks)||0||
48129014|NCT01978119|100638510|FG000|STARTED|Treatment Period 2 (12 Weeks)||38||
48129015|NCT01978119|100638511|FG001|STARTED|Treatment Period 2 (12 Weeks)||42||
48129016|NCT01978119|100638510|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||38||
48129017|NCT01978119|100638511|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||40||
48129018|NCT01978119|100638510|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||0||
48129019|NCT01978119|100638511|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||2||
48129020|NCT01003418|100638512|FG000|STARTED|Overall Study||5||
48129021|NCT01003418|100638513|FG001|STARTED|Overall Study||3||
48129022|NCT01003418|100638512|FG000|COMPLETED|Overall Study||5||
48129023|NCT01003418|100638513|FG001|COMPLETED|Overall Study||3||
48129024|NCT01003418|100638512|FG000|NOT COMPLETED|Overall Study||0||
48284136|NCT01238900|101021432|FG000|STARTED|6 Months Post Stent Placement||23||
48129025|NCT01003418|100638513|FG001|NOT COMPLETED|Overall Study||0||
48284137|NCT01238900|101021432|FG000|COMPLETED|6 Months Post Stent Placement||23||
48284138|NCT01238900|101021432|FG000|NOT COMPLETED|6 Months Post Stent Placement||0||
48284139|NCT01238900|101021432|FG000|STARTED|<12 Months Post Stent Removal||23||
48284140|NCT01238900|101021432|FG000|COMPLETED|<12 Months Post Stent Removal||18||
48284141|NCT01238900|101021432|FG000|NOT COMPLETED|<12 Months Post Stent Removal||5||
48284142|NCT02981108|101021433|FG000|STARTED|Overall Study||6||
48284143|NCT02981108|101021434|FG001|STARTED|Overall Study||6||
48284144|NCT02981108|101021435|FG002|STARTED|Overall Study||8||
48284145|NCT02981108|101021436|FG003|STARTED|Overall Study||6||
48284146|NCT02981108|101021437|FG004|STARTED|Overall Study||30||
48284147|NCT02981108|101021438|FG005|STARTED|Overall Study||33||
48284148|NCT02981108|101021439|FG006|STARTED|Overall Study||31||
48284149|NCT02981108|101021440|FG007|STARTED|Overall Study||244||
48284150|NCT02981108|101021433|FG000|COMPLETED|Overall Study||5|Discontinuation of treatment|
48284151|NCT02981108|101021434|FG001|COMPLETED|Overall Study||6|Discontinuation of treatment|
48284152|NCT02981108|101021435|FG002|COMPLETED|Overall Study||7|Discontinuation of treatment|
48284153|NCT02981108|101021436|FG003|COMPLETED|Overall Study||6|Discontinuation of treatment|
48284154|NCT02981108|101021437|FG004|COMPLETED|Overall Study||21|Discontinuation of treatment|
48573083|NCT02948751|101735056|FG000|COMPLETED|Overall Study||14||
48284155|NCT02981108|101021438|FG005|COMPLETED|Overall Study||15|Discontinuation of treatment|
48284156|NCT02981108|101021439|FG006|COMPLETED|Overall Study||13|Discontinuation of treatment|
48284157|NCT02981108|101021440|FG007|COMPLETED|Overall Study||62|Discontinuation of treatment|
48129026|NCT00856856|100638514|FG000|STARTED|Baseline||101||
48129027|NCT00856856|100638514|FG000|COMPLETED|Baseline||101||
48129028|NCT00856856|100638514|FG000|NOT COMPLETED|Baseline||0||
48129029|NCT00856856|100638514|FG000|STARTED|30-day Clinical Follow-up||101||
48129030|NCT00856856|100638514|FG000|COMPLETED|30-day Clinical Follow-up||101||
48129031|NCT00856856|100638514|FG000|NOT COMPLETED|30-day Clinical Follow-up||0||
48129032|NCT00856856|100638514|FG000|STARTED|180-day Clinical Follow-up||101||
48129033|NCT00856856|100638514|FG000|COMPLETED|180-day Clinical Follow-up||101||
48129034|NCT00856856|100638514|FG000|NOT COMPLETED|180-day Clinical Follow-up||0||
48129035|NCT00856856|100638514|FG000|STARTED|270-day Clinical Follow-up||101||
48129036|NCT00856856|100638514|FG000|COMPLETED|270-day Clinical Follow-up||101||
48129037|NCT00856856|100638514|FG000|NOT COMPLETED|270-day Clinical Follow-up||0||
48129038|NCT00856856|100638514|FG000|STARTED|1-year Clinical Follow-up||101||
48129039|NCT00856856|100638514|FG000|COMPLETED|1-year Clinical Follow-up||101||
48129040|NCT00856856|100638514|FG000|NOT COMPLETED|1-year Clinical Follow-up||0||
48129041|NCT00856856|100638514|FG000|STARTED|2-year Clinical Follow-up||101||
48129042|NCT00856856|100638514|FG000|COMPLETED|2-year Clinical Follow-up||100||
48284158|NCT02981108|101021433|FG000|NOT COMPLETED|Overall Study||1||
48573084|NCT02948751|101735056|FG000|NOT COMPLETED|Overall Study||0||
48573085|NCT02492984|101735057|FG000|STARTED|Overall Study||73||
48573086|NCT02492984|101735058|FG001|STARTED|Overall Study||14||
48284159|NCT02981108|101021434|FG001|NOT COMPLETED|Overall Study||0||
48284160|NCT02981108|101021435|FG002|NOT COMPLETED|Overall Study||1||
48284161|NCT02981108|101021436|FG003|NOT COMPLETED|Overall Study||0||
48284162|NCT02981108|101021437|FG004|NOT COMPLETED|Overall Study||9||
48284163|NCT02981108|101021438|FG005|NOT COMPLETED|Overall Study||18||
48284164|NCT02981108|101021439|FG006|NOT COMPLETED|Overall Study||18||
48284165|NCT02981108|101021440|FG007|NOT COMPLETED|Overall Study||182||
48284166|NCT01775475|101021441|FG000|STARTED|Overall Study||4||
48284167|NCT01775475|101021442|FG001|STARTED|Overall Study||3||
48284168|NCT01775475|101021441|FG000|COMPLETED|Overall Study||1||
48284169|NCT01775475|101021442|FG001|COMPLETED|Overall Study||0||
48284170|NCT01775475|101021441|FG000|NOT COMPLETED|Overall Study||3||
48284171|NCT01775475|101021442|FG001|NOT COMPLETED|Overall Study||3||
48284172|NCT03189745|101021443|FG000|STARTED|Overall Study||170||
48573087|NCT02492984|101735057|FG000|COMPLETED|Overall Study||70||
48573088|NCT02492984|101735058|FG001|COMPLETED|Overall Study||14||
48573089|NCT02492984|101735057|FG000|NOT COMPLETED|Overall Study||3||
48573090|NCT02492984|101735058|FG001|NOT COMPLETED|Overall Study||0||
48573091|NCT02748356|101735059|FG000|STARTED|Overall Study||7||
48129043|NCT00856856|100638514|FG000|NOT COMPLETED|2-year Clinical Follow-up||1||
48284173|NCT03189745|101021444|FG001|STARTED|Overall Study||59||
48284174|NCT03189745|101021443|FG000|COMPLETED|Overall Study||169||
48284175|NCT03189745|101021444|FG001|COMPLETED|Overall Study||58||
48284176|NCT03189745|101021443|FG000|NOT COMPLETED|Overall Study||1||
48284177|NCT03189745|101021444|FG001|NOT COMPLETED|Overall Study||1||
48284178|NCT00882687|101021445|FG000|STARTED|Overall Study||15||
48284179|NCT00882687|101021446|FG001|STARTED|Overall Study||15||
48284180|NCT00882687|101021447|FG002|STARTED|Overall Study||15||
48284181|NCT00882687|101021448|FG003|STARTED|Overall Study||15||
48284182|NCT00882687|101021445|FG000|COMPLETED|Overall Study||13||
48573092|NCT02748356|101735059|FG000|COMPLETED|Overall Study||6||
48573093|NCT02748356|101735059|FG000|NOT COMPLETED|Overall Study||1||
48573094|NCT00101166|101735060|FG000|STARTED|Overall Study||28||
48573095|NCT00101166|101735060|FG000|COMPLETED|Overall Study||18||
48573096|NCT00101166|101735060|FG000|NOT COMPLETED|Overall Study||10||
48573097|NCT02564900|101735061|FG000|STARTED|Dose Escalation||3||
48573098|NCT02564900|101735062|FG001|STARTED|Dose Escalation||3||
48573099|NCT02564900|101735063|FG002|STARTED|Dose Escalation||3||
48573100|NCT02564900|101735064|FG003|STARTED|Dose Escalation||6||
48573101|NCT02564900|101735065|FG004|STARTED|Dose Escalation||6||
48573102|NCT02564900|101735066|FG005|STARTED|Dose Escalation||6||
48573103|NCT02564900|101735067|FG006|STARTED|Dose Escalation||0||
48573104|NCT02564900|101735068|FG007|STARTED|Dose Escalation||0||
48573105|NCT02564900|101735069|FG008|STARTED|Dose Escalation||0||
48573106|NCT02564900|101735070|FG009|STARTED|Dose Escalation||0||
48573107|NCT02564900|101735071|FG010|STARTED|Dose Escalation||0||
48573108|NCT02564900|101735072|FG011|STARTED|Dose Escalation||0||
48573109|NCT02564900|101735073|FG012|STARTED|Dose Escalation||0||
48573110|NCT02564900|101735074|FG013|STARTED|Dose Escalation||0||
48573111|NCT02564900|101735075|FG014|STARTED|Dose Escalation||0||
48129044|NCT00856856|100638514|FG000|STARTED|3-year Clinical Follow-up||100||
48129045|NCT00856856|100638514|FG000|COMPLETED|3-year Clinical Follow-up||100||
48284183|NCT00882687|101021446|FG001|COMPLETED|Overall Study||13||
48284184|NCT00882687|101021447|FG002|COMPLETED|Overall Study||12||
48284185|NCT00882687|101021448|FG003|COMPLETED|Overall Study||13||
48398400|NCT02709109|101306306|FG000|COMPLETED|Treatment Period 2 (28 Days)||41||
48398401|NCT02709109|101306307|FG001|COMPLETED|Treatment Period 2 (28 Days)||36||
48398402|NCT02709109|101306308|FG002|COMPLETED|Treatment Period 2 (28 Days)||15||
48398403|NCT02709109|101306309|FG003|COMPLETED|Treatment Period 2 (28 Days)||24||
48398404|NCT02709109|101306306|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||2||
48398405|NCT02709109|101306307|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||4||
48398406|NCT02709109|101306308|FG002|NOT COMPLETED|Treatment Period 2 (28 Days)||3||
48398407|NCT02709109|101306309|FG003|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
48398408|NCT02455388|101306310|FG000|STARTED|Overall Study||18||
48398409|NCT02455388|101306311|FG001|STARTED|Overall Study||15||
48398410|NCT02455388|101306312|FG002|STARTED|Overall Study||337||
48398411|NCT02455388|101306310|FG000|COMPLETED|Overall Study||17||
48398412|NCT02455388|101306311|FG001|COMPLETED|Overall Study||15||
48398413|NCT02455388|101306312|FG002|COMPLETED|Overall Study||326||
48398414|NCT02455388|101306310|FG000|NOT COMPLETED|Overall Study||1||
48398415|NCT02455388|101306311|FG001|NOT COMPLETED|Overall Study||0||
48398416|NCT02455388|101306312|FG002|NOT COMPLETED|Overall Study||11||
48398417|NCT01665872|101306313|FG000|STARTED|Screening||172|Eligibility based on CES-D score, live in public housing site or receive section 8 or RAP.|
48129046|NCT00856856|100638514|FG000|NOT COMPLETED|3-year Clinical Follow-up||0||
48129047|NCT00856856|100638514|FG000|STARTED|4-year Clinical Follow-up||100||
48129048|NCT00856856|100638514|FG000|COMPLETED|4-year Clinical Follow-up||99||
48129049|NCT00856856|100638514|FG000|NOT COMPLETED|4-year Clinical Follow-up||1||
48129050|NCT00856856|100638514|FG000|STARTED|5-year Clinical Follow-up||100||
48129051|NCT00856856|100638514|FG000|COMPLETED|5-year Clinical Follow-up||100||
48129052|NCT00856856|100638514|FG000|NOT COMPLETED|5-year Clinical Follow-up||0||
48129053|NCT01072682|100638515|FG000|STARTED|Overall Study||35||
48129054|NCT01072682|100638515|FG000|COMPLETED|Overall Study||35||
48129055|NCT01072682|100638515|FG000|NOT COMPLETED|Overall Study||0||
48129056|NCT03036566|100638516|FG000|STARTED|Overall Study||30||
48398418|NCT01665872|101306314|FG001|STARTED|Screening||172|Eligibility based on CES-D score, live in public housing site or receive section 8 or RAP.|
48398419|NCT01665872|101306313|FG000|COMPLETED|Screening||172|All participants completed screening.|
48398420|NCT01665872|101306314|FG001|COMPLETED|Screening||172|All participants completed screening.|
48398421|NCT01665872|101306313|FG000|NOT COMPLETED|Screening||0||
48398422|NCT01665872|101306314|FG001|NOT COMPLETED|Screening||0||
48398423|NCT01665872|101306313|FG000|STARTED|Treatment||87|Participants who started treatment completed an intake (only a subset of those screened).|
48398424|NCT01665872|101306314|FG001|STARTED|Treatment||67|Participants who started treatment completed an intake (only a subset of those screened).|
48398425|NCT01665872|101306313|FG000|COMPLETED|Treatment||72|Attended at least 2 classes in the 8 class Stress Management course|
48398426|NCT01665872|101306314|FG001|COMPLETED|Treatment||50|Attended at least 2 classes in the 8 class Stress Management course|
48398427|NCT01665872|101306313|FG000|NOT COMPLETED|Treatment||15||
48398428|NCT01665872|101306314|FG001|NOT COMPLETED|Treatment||17||
48398429|NCT01665872|101306313|FG000|STARTED|6 Month Follow-up||72|Those eligible for 6 month follow-up, were class completers (as defined above).|
48404076|NCT03689972|101321768|FG002|NOT COMPLETED|Part 1 (Day 1 up to Week 72)||0||
48129057|NCT03036566|100638516|FG000|COMPLETED|Overall Study||27||
48398430|NCT01665872|101306314|FG001|STARTED|6 Month Follow-up||50|Those eligible for 6 month follow-up, were class completers (as defined above).|
48398431|NCT01665872|101306313|FG000|COMPLETED|6 Month Follow-up||66|Attended and completed the 6 month follow-up assessment.|
48398432|NCT01665872|101306314|FG001|COMPLETED|6 Month Follow-up||49|Attended and completed the 6 month follow-up assessment.|
48398433|NCT01665872|101306313|FG000|NOT COMPLETED|6 Month Follow-up||6||
48398434|NCT01665872|101306314|FG001|NOT COMPLETED|6 Month Follow-up||1||
48398435|NCT01665872|101306313|FG000|STARTED|12 Month Follow-up||72|Those eligible for 12 month follow-up, were class completers (as defined above).|
48398436|NCT01665872|101306314|FG001|STARTED|12 Month Follow-up||50|Those eligible for 12 month follow-up, were class completers (as defined above).|
48398437|NCT01665872|101306313|FG000|COMPLETED|12 Month Follow-up||58|Attended and completed the 12 month follow-up assessment.|
48398438|NCT01665872|101306314|FG001|COMPLETED|12 Month Follow-up||47|Attended and completed the 12 month follow-up assessment.|
48398439|NCT01665872|101306313|FG000|NOT COMPLETED|12 Month Follow-up||14||
48398440|NCT01665872|101306314|FG001|NOT COMPLETED|12 Month Follow-up||3||
48398441|NCT03934541|101306315|FG000|STARTED|Overall Study||5||
48398442|NCT03934541|101306316|FG001|STARTED|Overall Study||15||
48398443|NCT03934541|101306317|FG002|STARTED|Overall Study||1||
48398444|NCT03934541|101306318|FG003|STARTED|Overall Study||3||
48398445|NCT03934541|101306315|FG000|COMPLETED|Overall Study||5||
48398446|NCT03934541|101306316|FG001|COMPLETED|Overall Study||14||
48398447|NCT03934541|101306317|FG002|COMPLETED|Overall Study||1||
48573112|NCT02564900|101735061|FG000|COMPLETED|Dose Escalation||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019|
48573113|NCT02564900|101735062|FG001|COMPLETED|Dose Escalation||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019|
48573114|NCT02564900|101735063|FG002|COMPLETED|Dose Escalation||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019|
48573115|NCT02564900|101735064|FG003|COMPLETED|Dose Escalation||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019|
48573116|NCT02564900|101735065|FG004|COMPLETED|Dose Escalation||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019|
48573117|NCT02564900|101735066|FG005|COMPLETED|Dose Escalation||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019|
48573118|NCT02564900|101735067|FG006|COMPLETED|Dose Escalation||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019|
48573119|NCT02564900|101735068|FG007|COMPLETED|Dose Escalation||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019|
48573120|NCT02564900|101735069|FG008|COMPLETED|Dose Escalation||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019|
48573121|NCT02564900|101735070|FG009|COMPLETED|Dose Escalation||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019|
48129058|NCT03036566|100638516|FG000|NOT COMPLETED|Overall Study||3||
48398448|NCT03934541|101306318|FG003|COMPLETED|Overall Study||3||
48398449|NCT03934541|101306315|FG000|NOT COMPLETED|Overall Study||0||
48398450|NCT03934541|101306316|FG001|NOT COMPLETED|Overall Study||1||
48398451|NCT03934541|101306317|FG002|NOT COMPLETED|Overall Study||0||
48398452|NCT03934541|101306318|FG003|NOT COMPLETED|Overall Study||0||
48398453|NCT02360371|101306319|FG000|STARTED|Overall Study||13||
48398454|NCT02360371|101306320|FG001|STARTED|Overall Study||84||
48398455|NCT02360371|101306319|FG000|Placebo (Oral)|Overall Study||13||
48398456|NCT02360371|101306320|FG001|Placebo (Oral)|Overall Study||69||
48398457|NCT02360371|101306319|FG000|Hydromorphone (Oral) 2mg|Overall Study||13||
48398458|NCT02360371|101306320|FG001|Hydromorphone (Oral) 2mg|Overall Study||69||
48398459|NCT02360371|101306319|FG000|Hydromorphone (Oral) 4mg|Overall Study||13||
48398460|NCT02360371|101306320|FG001|Hydromorphone (Oral) 4mg|Overall Study||69||
48398461|NCT02360371|101306319|FG000|Hydromorphone (Oral) 8mg|Overall Study||13||
48398462|NCT02360371|101306320|FG001|Hydromorphone (Oral) 8mg|Overall Study||69||
48398463|NCT02360371|101306319|FG000|COMPLETED|Overall Study||13||
48398464|NCT02360371|101306320|FG001|COMPLETED|Overall Study||69||
48398465|NCT02360371|101306319|FG000|NOT COMPLETED|Overall Study||0||
48398466|NCT02360371|101306320|FG001|NOT COMPLETED|Overall Study||15||
48573122|NCT02564900|101735071|FG010|COMPLETED|Dose Escalation||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019|
48592806|NCT01764997|101783183|FG001|STARTED|Study Drug Treatment Period||17||
48398467|NCT03483116|101306321|FG000|STARTED|Overall Study||178||
48398468|NCT03483116|101306322|FG001|STARTED|Overall Study||179||
48573123|NCT02564900|101735072|FG011|COMPLETED|Dose Escalation||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019|
48573124|NCT02564900|101735073|FG012|COMPLETED|Dose Escalation||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019|
48573125|NCT02564900|101735074|FG013|COMPLETED|Dose Escalation||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019|
48573126|NCT02564900|101735075|FG014|COMPLETED|Dose Escalation||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019|
48573127|NCT02564900|101735061|FG000|NOT COMPLETED|Dose Escalation||3||
48573128|NCT02564900|101735062|FG001|NOT COMPLETED|Dose Escalation||3||
48573129|NCT02564900|101735063|FG002|NOT COMPLETED|Dose Escalation||3||
48701203|NCT04357730|102054173|FG000|COMPLETED|Phase 2||8||
48701204|NCT04357730|102054174|FG001|COMPLETED|Phase 2||0||
48701205|NCT04357730|102054175|FG002|COMPLETED|Phase 2||6||
48701206|NCT04357730|102054173|FG000|NOT COMPLETED|Phase 2||0||
48398469|NCT03483116|101306323|FG002|STARTED|Overall Study||175||
48398470|NCT03483116|101306324|FG003|STARTED|Overall Study||179||
48398471|NCT03483116|101306321|FG000|COMPLETED|Overall Study||150||
48398472|NCT03483116|101306322|FG001|COMPLETED|Overall Study||156||
48398473|NCT03483116|101306323|FG002|COMPLETED|Overall Study||149||
48398474|NCT03483116|101306324|FG003|COMPLETED|Overall Study||148||
48398475|NCT03483116|101306321|FG000|NOT COMPLETED|Overall Study||28||
48398476|NCT03483116|101306322|FG001|NOT COMPLETED|Overall Study||23||
48398477|NCT03483116|101306323|FG002|NOT COMPLETED|Overall Study||26||
48398478|NCT03483116|101306324|FG003|NOT COMPLETED|Overall Study||31||
48398479|NCT03339401|101306325|FG000|STARTED|Overall Study||20||
48398480|NCT03339401|101306326|FG001|STARTED|Overall Study||9||
48573130|NCT02564900|101735064|FG003|NOT COMPLETED|Dose Escalation||6||
48573131|NCT02564900|101735065|FG004|NOT COMPLETED|Dose Escalation||6||
48573132|NCT02564900|101735066|FG005|NOT COMPLETED|Dose Escalation||6||
48573133|NCT02564900|101735067|FG006|NOT COMPLETED|Dose Escalation||0||
48573134|NCT02564900|101735068|FG007|NOT COMPLETED|Dose Escalation||0||
48573135|NCT02564900|101735069|FG008|NOT COMPLETED|Dose Escalation||0||
48573136|NCT02564900|101735070|FG009|NOT COMPLETED|Dose Escalation||0||
48573137|NCT02564900|101735071|FG010|NOT COMPLETED|Dose Escalation||0||
48573138|NCT02564900|101735072|FG011|NOT COMPLETED|Dose Escalation||0||
48573139|NCT02564900|101735073|FG012|NOT COMPLETED|Dose Escalation||0||
48573140|NCT02564900|101735074|FG013|NOT COMPLETED|Dose Escalation||0||
48573141|NCT02564900|101735075|FG014|NOT COMPLETED|Dose Escalation||0||
48573142|NCT02564900|101735061|FG000|STARTED|Dose Expansion||0|Only the Dose Expansion Phase is being presented.|
48573143|NCT02564900|101735062|FG001|STARTED|Dose Expansion||0|Only the Dose Expansion Phase is being presented.|
48573144|NCT02564900|101735063|FG002|STARTED|Dose Expansion||0|Only the Dose Expansion Phase is being presented.|
48573145|NCT02564900|101735064|FG003|STARTED|Dose Expansion||0|Only the Dose Expansion Phase is being presented.|
48701207|NCT04357730|102054174|FG001|NOT COMPLETED|Phase 2||0||
48701208|NCT04357730|102054175|FG002|NOT COMPLETED|Phase 2||0||
48701209|NCT01560637|102054176|FG000|STARTED|Overall Study||470||
48701210|NCT01560637|102054176|FG000|COMPLETED|Overall Study||272||
48701211|NCT01560637|102054176|FG000|NOT COMPLETED|Overall Study||198||
48701212|NCT02450383|102054177|FG000|STARTED|Overall Study||10||
48701213|NCT02450383|102054178|FG001|STARTED|Overall Study||10||
48701214|NCT02450383|102054177|FG000|COMPLETED|Overall Study||10||
48701215|NCT02450383|102054178|FG001|COMPLETED|Overall Study||10||
48701216|NCT02450383|102054177|FG000|NOT COMPLETED|Overall Study||0||
48701217|NCT02450383|102054178|FG001|NOT COMPLETED|Overall Study||0||
48701218|NCT01431014|102054179|FG000|STARTED|Overall Study||34||
48701219|NCT01431014|102054180|FG001|STARTED|Overall Study||34||
48701220|NCT01431014|102054179|FG000|COMPLETED|Overall Study||31||
48398481|NCT03339401|101306325|FG000|COMPLETED|Overall Study||11||
48573146|NCT02564900|101735065|FG004|STARTED|Dose Expansion||0|Only the Dose Expansion Phase is being presented.|
48573147|NCT02564900|101735066|FG005|STARTED|Dose Expansion||0|Only the Dose Expansion Phase is being presented.|
48573148|NCT02564900|101735067|FG006|STARTED|Dose Expansion||49|Only the Dose Expansion Phase is being presented.|
48573149|NCT02564900|101735068|FG007|STARTED|Dose Expansion||62|Only the Dose Expansion Phase is being presented.|
48573150|NCT02564900|101735069|FG008|STARTED|Dose Expansion||20|Only the Dose Expansion Phase is being presented.|
48573151|NCT02564900|101735070|FG009|STARTED|Dose Expansion||33|Only the Dose Expansion Phase is being presented.|
48573152|NCT02564900|101735071|FG010|STARTED|Dose Expansion||17|Only the Dose Expansion Phase is being presented.|
48573153|NCT02564900|101735072|FG011|STARTED|Dose Expansion||24|Only the Dose Expansion Phase is being presented.|
48573154|NCT02564900|101735073|FG012|STARTED|Dose Expansion||18|Only the Dose Expansion Phase is being presented.|
48573155|NCT02564900|101735074|FG013|STARTED|Dose Expansion||20|Only the Dose Expansion Phase is being presented.|
48573156|NCT02564900|101735075|FG014|STARTED|Dose Expansion||22|Only the Dose Expansion Phase is being presented.|
48573157|NCT02564900|101735061|FG000|Enrolled, But Not Dosed|Dose Expansion||0||
48573158|NCT02564900|101735062|FG001|Enrolled, But Not Dosed|Dose Expansion||0||
48701221|NCT01431014|102054180|FG001|COMPLETED|Overall Study||25||
48701222|NCT01431014|102054179|FG000|NOT COMPLETED|Overall Study||3||
48129059|NCT03556761|100642575|FG000|STARTED|Overall Study||192||
48129060|NCT03556761|100642576|FG001|STARTED|Overall Study||192||
48129061|NCT03556761|100642575|FG000|COMPLETED|Overall Study||168||
48129062|NCT03556761|100642576|FG001|COMPLETED|Overall Study||163||
48701223|NCT01431014|102054180|FG001|NOT COMPLETED|Overall Study||9||
48701224|NCT01439971|102054181|FG000|STARTED|Overall Study||1||
48701225|NCT01439971|102054182|FG001|STARTED|Overall Study||7||
48701226|NCT01439971|102054183|FG002|STARTED|Overall Study||8||
48701227|NCT01439971|102054184|FG003|STARTED|Overall Study||6||
48701228|NCT01439971|102054185|FG004|STARTED|Overall Study||7||
48701229|NCT01439971|102054181|FG000|Received Treatment|Overall Study||1||
48701230|NCT01439971|102054182|FG001|Received Treatment|Overall Study||6||
48701231|NCT01439971|102054183|FG002|Received Treatment|Overall Study||6||
48701232|NCT01439971|102054184|FG003|Received Treatment|Overall Study||6||
48701233|NCT01439971|102054185|FG004|Received Treatment|Overall Study||6||
48129063|NCT03556761|100642575|FG000|NOT COMPLETED|Overall Study||24||
48129064|NCT03556761|100642576|FG001|NOT COMPLETED|Overall Study||29||
48129065|NCT00836641|100642577|FG000|STARTED|Overall Study||36||
48129066|NCT00836641|100642578|FG001|STARTED|Overall Study||34||
48573159|NCT02564900|101735063|FG002|Enrolled, But Not Dosed|Dose Expansion||0||
48573160|NCT02564900|101735064|FG003|Enrolled, But Not Dosed|Dose Expansion||0||
48573161|NCT02564900|101735065|FG004|Enrolled, But Not Dosed|Dose Expansion||0||
48573162|NCT02564900|101735066|FG005|Enrolled, But Not Dosed|Dose Expansion||0||
48573163|NCT02564900|101735067|FG006|Enrolled, But Not Dosed|Dose Expansion||1||
48573164|NCT02564900|101735068|FG007|Enrolled, But Not Dosed|Dose Expansion||1||
48573165|NCT02564900|101735069|FG008|Enrolled, But Not Dosed|Dose Expansion||0||
48573166|NCT02564900|101735070|FG009|Enrolled, But Not Dosed|Dose Expansion||0||
48573167|NCT02564900|101735071|FG010|Enrolled, But Not Dosed|Dose Expansion||0||
48573168|NCT02564900|101735072|FG011|Enrolled, But Not Dosed|Dose Expansion||0||
48573169|NCT02564900|101735073|FG012|Enrolled, But Not Dosed|Dose Expansion||0||
48573170|NCT02564900|101735074|FG013|Enrolled, But Not Dosed|Dose Expansion||0||
48573171|NCT02564900|101735075|FG014|Enrolled, But Not Dosed|Dose Expansion||1||
48573172|NCT02564900|101735061|FG000|COMPLETED|Dose Expansion||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019.|
48573173|NCT02564900|101735062|FG001|COMPLETED|Dose Expansion||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019.|
48573174|NCT02564900|101735063|FG002|COMPLETED|Dose Expansion||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019.|
48573175|NCT02564900|101735064|FG003|COMPLETED|Dose Expansion||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019.|
48573176|NCT02564900|101735065|FG004|COMPLETED|Dose Expansion||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019.|
48573177|NCT02564900|101735066|FG005|COMPLETED|Dose Expansion||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019.|
48701234|NCT01439971|102054181|FG000|COMPLETED|Overall Study||1||
48701235|NCT01439971|102054182|FG001|COMPLETED|Overall Study||6||
48701236|NCT01439971|102054183|FG002|COMPLETED|Overall Study||6||
48701237|NCT01439971|102054184|FG003|COMPLETED|Overall Study||6||
48701238|NCT01439971|102054185|FG004|COMPLETED|Overall Study||6||
48701239|NCT01439971|102054181|FG000|NOT COMPLETED|Overall Study||0||
48701240|NCT01439971|102054182|FG001|NOT COMPLETED|Overall Study||1||
48701241|NCT01439971|102054183|FG002|NOT COMPLETED|Overall Study||2||
48129067|NCT00836641|100642577|FG000|COMPLETED|Overall Study||36||
48129068|NCT00836641|100642578|FG001|COMPLETED|Overall Study||34||
48701242|NCT01439971|102054184|FG003|NOT COMPLETED|Overall Study||0||
48129069|NCT00836641|100642577|FG000|NOT COMPLETED|Overall Study||0||
48129070|NCT00836641|100642578|FG001|NOT COMPLETED|Overall Study||0||
48129071|NCT04695691|100642579|FG000|STARTED|Overall Study||104||
48701243|NCT01439971|102054185|FG004|NOT COMPLETED|Overall Study||1||
48701244|NCT02084706|102054186|FG000|STARTED|Overall Study||29||
48701245|NCT02084706|102054187|FG001|STARTED|Overall Study||31||
48701246|NCT02084706|102054186|FG000|COMPLETED|Overall Study||29||
48129072|NCT04695691|100642579|FG000|COMPLETED|Overall Study||76||
48398482|NCT03339401|101306326|FG001|COMPLETED|Overall Study||5||
48573178|NCT02564900|101735067|FG006|COMPLETED|Dose Expansion||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019.|
48573179|NCT02564900|101735068|FG007|COMPLETED|Dose Expansion||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019.|
48701247|NCT02084706|102054187|FG001|COMPLETED|Overall Study||31||
48701248|NCT02084706|102054186|FG000|NOT COMPLETED|Overall Study||0||
48701249|NCT02084706|102054187|FG001|NOT COMPLETED|Overall Study||0||
48284186|NCT00882687|101021445|FG000|NOT COMPLETED|Overall Study||2||
48592807|NCT01764997|101783184|FG002|STARTED|Study Drug Treatment Period||13||
48701250|NCT03116828|102054188|FG000|STARTED|Overall Study||44||
48701251|NCT03116828|102054189|FG001|STARTED|Overall Study||58||
48701252|NCT03116828|102054188|FG000|COMPLETED|Overall Study||36||
48701253|NCT03116828|102054189|FG001|COMPLETED|Overall Study||37||
48701254|NCT03116828|102054188|FG000|NOT COMPLETED|Overall Study||8||
48129073|NCT04695691|100642579|FG000|NOT COMPLETED|Overall Study||28||
48129074|NCT02417246|100642580|FG000|STARTED|Phase 1 Brand Name Metoprolol ER||24||
48129075|NCT02417246|100642581|FG001|STARTED|Phase 1 Brand Name Metoprolol ER||24||
48129076|NCT02417246|100642580|FG000|COMPLETED|Phase 1 Brand Name Metoprolol ER||20||
48129077|NCT02417246|100642581|FG001|COMPLETED|Phase 1 Brand Name Metoprolol ER||20||
48129078|NCT02417246|100642580|FG000|NOT COMPLETED|Phase 1 Brand Name Metoprolol ER||4||
48129079|NCT02417246|100642581|FG001|NOT COMPLETED|Phase 1 Brand Name Metoprolol ER||4||
48129080|NCT02417246|100642580|FG000|STARTED|Phase 2 1st Generic Administered||20||
48129081|NCT02417246|100642581|FG001|STARTED|Phase 2 1st Generic Administered||20||
48129082|NCT02417246|100642580|FG000|COMPLETED|Phase 2 1st Generic Administered||19||
48129083|NCT02417246|100642581|FG001|COMPLETED|Phase 2 1st Generic Administered||20||
48129084|NCT02417246|100642580|FG000|NOT COMPLETED|Phase 2 1st Generic Administered||1||
48129085|NCT02417246|100642581|FG001|NOT COMPLETED|Phase 2 1st Generic Administered||0||
48129086|NCT02417246|100642580|FG000|STARTED|Phase 3 Brand Name Metoprolol ER #2||19|One patient completed Phase 2 but did not start Phase 3. His data were included in analysis.|
48129087|NCT02417246|100642581|FG001|STARTED|Phase 3 Brand Name Metoprolol ER #2||20|One patient completed Phase 2 but did not start Phase 3. His data were included in analysis.|
48129088|NCT02417246|100642580|FG000|COMPLETED|Phase 3 Brand Name Metoprolol ER #2||18||
48129089|NCT02417246|100642581|FG001|COMPLETED|Phase 3 Brand Name Metoprolol ER #2||20||
48129090|NCT02417246|100642580|FG000|NOT COMPLETED|Phase 3 Brand Name Metoprolol ER #2||1||
48129091|NCT02417246|100642581|FG001|NOT COMPLETED|Phase 3 Brand Name Metoprolol ER #2||0||
48129092|NCT02417246|100642580|FG000|STARTED|Phase 4 2nd Generic Administered||18||
48129093|NCT02417246|100642581|FG001|STARTED|Phase 4 2nd Generic Administered||20||
48129094|NCT02417246|100642580|FG000|COMPLETED|Phase 4 2nd Generic Administered||18||
48129095|NCT02417246|100642581|FG001|COMPLETED|Phase 4 2nd Generic Administered||20||
48129096|NCT02417246|100642580|FG000|NOT COMPLETED|Phase 4 2nd Generic Administered||0||
48129097|NCT02417246|100642581|FG001|NOT COMPLETED|Phase 4 2nd Generic Administered||0||
48129098|NCT01465334|100642582|FG000|STARTED|Overall Study||15||
48129099|NCT01465334|100642583|FG001|STARTED|Overall Study||15||
48129100|NCT01465334|100642582|FG000|Complete Part A Induction|Overall Study||12||
48129101|NCT01465334|100642583|FG001|Complete Part A Induction|Overall Study||15||
48129102|NCT01465334|100642582|FG000|Complete Part B Induction|Overall Study||7||
48129103|NCT01465334|100642583|FG001|Complete Part B Induction|Overall Study||15||
48129104|NCT01465334|100642582|FG000|Eligible for Allogeneic Transplant|Overall Study||9||
48129105|NCT01465334|100642583|FG001|Eligible for Allogeneic Transplant|Overall Study||9||
48129106|NCT01465334|100642582|FG000|COMPLETED|Overall Study||13||
48129107|NCT01465334|100642583|FG001|COMPLETED|Overall Study||9||
48129108|NCT01465334|100642582|FG000|NOT COMPLETED|Overall Study||2||
48129109|NCT01465334|100642583|FG001|NOT COMPLETED|Overall Study||6||
48129110|NCT04964089|100642584|FG000|STARTED|Overall Study||276||
48129111|NCT04964089|100642585|FG001|STARTED|Overall Study||281||
48129112|NCT04964089|100642584|FG000|COMPLETED|Overall Study||253||
48129113|NCT04964089|100642585|FG001|COMPLETED|Overall Study||268||
48129114|NCT04964089|100642584|FG000|NOT COMPLETED|Overall Study||23||
48129115|NCT04964089|100642585|FG001|NOT COMPLETED|Overall Study||13||
48129116|NCT00932893|100642586|FG000|STARTED|Overall Study||173||
48129117|NCT00932893|100642587|FG001|STARTED|Overall Study||174||
48129118|NCT00932893|100642586|FG000|Treated|Overall Study||172||
48129119|NCT00932893|100642587|FG001|Treated|Overall Study||171||
48129120|NCT00932893|100642586|FG000|COMPLETED|Overall Study||40||
48129121|NCT00932893|100642587|FG001|COMPLETED|Overall Study||4||
48129122|NCT00932893|100642586|FG000|NOT COMPLETED|Overall Study||133||
48129123|NCT00932893|100642587|FG001|NOT COMPLETED|Overall Study||170||
48129124|NCT02138214|100642588|FG000|STARTED|Overall Study||30||
48129125|NCT02138214|100642589|FG001|STARTED|Overall Study||30||
48129126|NCT02138214|100642590|FG002|STARTED|Overall Study||30||
48129127|NCT02138214|100642588|FG000|Analyzed for Baseline Measures|Overall Study||30||
48129128|NCT02138214|100642589|FG001|Analyzed for Baseline Measures|Overall Study||29||
48129129|NCT02138214|100642590|FG002|Analyzed for Baseline Measures|Overall Study||30||
48129130|NCT02138214|100642588|FG000|COMPLETED|Overall Study||30||
48129131|NCT02138214|100642589|FG001|COMPLETED|Overall Study||26||
48129132|NCT02138214|100642590|FG002|COMPLETED|Overall Study||26||
48129133|NCT02138214|100642588|FG000|NOT COMPLETED|Overall Study||0||
48129134|NCT02138214|100642589|FG001|NOT COMPLETED|Overall Study||4||
48129135|NCT02138214|100642590|FG002|NOT COMPLETED|Overall Study||4||
48129136|NCT02504645|100642591|FG000|STARTED|Overall Study||101||
48129137|NCT02504645|100642592|FG001|STARTED|Overall Study||101||
48129138|NCT02504645|100642591|FG000|COMPLETED|Overall Study||77||
48129139|NCT02504645|100642592|FG001|COMPLETED|Overall Study||76||
48129140|NCT02504645|100642591|FG000|NOT COMPLETED|Overall Study||24||
48129141|NCT02504645|100642592|FG001|NOT COMPLETED|Overall Study||25||
48129142|NCT01358526|100642593|FG000|STARTED|Open-label Titration Period||1095||
48129143|NCT01358526|100642594|FG001|STARTED|Open-label Titration Period||0||
48398483|NCT03339401|101306325|FG000|NOT COMPLETED|Overall Study||9||
48129144|NCT01358526|100642595|FG002|STARTED|Open-label Titration Period||0||
48129145|NCT01358526|100642593|FG000|COMPLETED|Open-label Titration Period||601||
48129146|NCT01358526|100642594|FG001|COMPLETED|Open-label Titration Period||0||
48129147|NCT01358526|100642595|FG002|COMPLETED|Open-label Titration Period||0||
48129148|NCT01358526|100642593|FG000|NOT COMPLETED|Open-label Titration Period||494||
48573180|NCT02564900|101735069|FG008|COMPLETED|Dose Expansion||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019.|
48573181|NCT02564900|101735070|FG009|COMPLETED|Dose Expansion||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019.|
48129149|NCT01358526|100642594|FG001|NOT COMPLETED|Open-label Titration Period||0||
48129150|NCT01358526|100642595|FG002|NOT COMPLETED|Open-label Titration Period||0||
48129151|NCT01358526|100642593|FG000|STARTED|Double-blind Phase||0||
48129152|NCT01358526|100642594|FG001|STARTED|Double-blind Phase||298||
48129153|NCT01358526|100642595|FG002|STARTED|Double-blind Phase||302||
48129154|NCT01358526|100642593|FG000|COMPLETED|Double-blind Phase||0||
48129155|NCT01358526|100642594|FG001|COMPLETED|Double-blind Phase||218||
48129156|NCT01358526|100642595|FG002|COMPLETED|Double-blind Phase||181||
48129157|NCT01358526|100642593|FG000|NOT COMPLETED|Double-blind Phase||0||
48129158|NCT01358526|100642594|FG001|NOT COMPLETED|Double-blind Phase||80||
48129159|NCT01358526|100642595|FG002|NOT COMPLETED|Double-blind Phase||121||
48129160|NCT03892889|100642596|FG000|STARTED|Overall Study||277||
48129161|NCT03892889|100642596|FG000|COMPLETED|Overall Study||73||
48129162|NCT03892889|100642596|FG000|NOT COMPLETED|Overall Study||204||
48129163|NCT02806986|100642597|FG000|STARTED|Treatment Stage 1||61||
48129164|NCT02806986|100642597|FG000|COMPLETED|Treatment Stage 1||60||
48129165|NCT02806986|100642597|FG000|NOT COMPLETED|Treatment Stage 1||1||
48129166|NCT02806986|100642597|FG000|STARTED|Treatment Stage 2||60||
48129167|NCT02806986|100642597|FG000|COMPLETED|Treatment Stage 2||55||
48129168|NCT02806986|100642597|FG000|NOT COMPLETED|Treatment Stage 2||5||
48129169|NCT03017508|100642598|FG000|STARTED|Overall Study||12||
48129170|NCT03017508|100642599|FG001|STARTED|Overall Study||10||
48129171|NCT03017508|100642598|FG000|First Intervention (1 Day)|Overall Study||12||
48129172|NCT03017508|100642599|FG001|First Intervention (1 Day)|Overall Study||10||
48129173|NCT03017508|100642598|FG000|Washout (2-10 Days)|Overall Study||12||
48129174|NCT03017508|100642599|FG001|Washout (2-10 Days)|Overall Study||10||
48129175|NCT03017508|100642598|FG000|Second Intervention (1 Day)|Overall Study||12||
48129176|NCT03017508|100642599|FG001|Second Intervention (1 Day)|Overall Study||10||
48129177|NCT03017508|100642598|FG000|COMPLETED|Overall Study||12||
48129178|NCT03017508|100642599|FG001|COMPLETED|Overall Study||10||
48129179|NCT03017508|100642598|FG000|NOT COMPLETED|Overall Study||0||
48129180|NCT03017508|100642599|FG001|NOT COMPLETED|Overall Study||0||
48129181|NCT03283670|100642600|FG000|STARTED|Placebo Gas||24||
48129182|NCT03283670|100642600|FG000|COMPLETED|Placebo Gas||22||
48129183|NCT03283670|100642600|FG000|NOT COMPLETED|Placebo Gas||2||
48129184|NCT03283670|100642600|FG000|STARTED|25% Nitrous Oxide||24||
48129185|NCT03283670|100642600|FG000|COMPLETED|25% Nitrous Oxide||20||
48129186|NCT03283670|100642600|FG000|NOT COMPLETED|25% Nitrous Oxide||4||
48129187|NCT03283670|100642600|FG000|STARTED|50% Nitrous Oxide||24||
48129188|NCT03283670|100642600|FG000|COMPLETED|50% Nitrous Oxide||23||
48129189|NCT03283670|100642600|FG000|NOT COMPLETED|50% Nitrous Oxide||1||
48129190|NCT03971643|100642601|FG000|STARTED|Overall Study||6||
48129191|NCT03971643|100642602|FG001|STARTED|Overall Study||6||
48129192|NCT03971643|100642603|FG002|STARTED|Overall Study||7||
48129193|NCT03971643|100642601|FG000|Completed Until Day 99 (Evaluable)|Overall Study||6||
48129194|NCT03971643|100642602|FG001|Completed Until Day 99 (Evaluable)|Overall Study||4||
48129195|NCT03971643|100642603|FG002|Completed Until Day 99 (Evaluable)|Overall Study||7||
48129196|NCT03971643|100642601|FG000|COMPLETED|Overall Study||1||
48129197|NCT03971643|100642602|FG001|COMPLETED|Overall Study||3||
48129198|NCT03971643|100642603|FG002|COMPLETED|Overall Study||6||
48129199|NCT03971643|100642601|FG000|NOT COMPLETED|Overall Study||5||
48129200|NCT03971643|100642602|FG001|NOT COMPLETED|Overall Study||3||
48129201|NCT03971643|100642603|FG002|NOT COMPLETED|Overall Study||1||
48129202|NCT02259621|100642604|FG000|STARTED|Overall Study||9||
48129203|NCT02259621|100642605|FG001|STARTED|Overall Study||16||
48129204|NCT02259621|100642606|FG002|STARTED|Overall Study||14||
48129205|NCT02259621|100642604|FG000|COMPLETED|Overall Study||9||
48129206|NCT02259621|100642605|FG001|COMPLETED|Overall Study||16||
48129207|NCT02259621|100642606|FG002|COMPLETED|Overall Study||14||
48129208|NCT02259621|100642604|FG000|NOT COMPLETED|Overall Study||0||
48129209|NCT02259621|100642605|FG001|NOT COMPLETED|Overall Study||0||
48284187|NCT00882687|101021446|FG001|NOT COMPLETED|Overall Study||2||
48573182|NCT02564900|101735071|FG010|COMPLETED|Dose Expansion||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019.|
48573183|NCT02564900|101735072|FG011|COMPLETED|Dose Expansion||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019.|
48592808|NCT01764997|101783185|FG003|STARTED|Study Drug Treatment Period||13||
48129210|NCT02259621|100642606|FG002|NOT COMPLETED|Overall Study||0||
48129211|NCT01542528|100642607|FG000|STARTED|Overall Study||61||
48129212|NCT01542528|100642608|FG001|STARTED|Overall Study||56||
48129213|NCT01542528|100642607|FG000|COMPLETED|Overall Study||49||
48129214|NCT01542528|100642608|FG001|COMPLETED|Overall Study||49||
48129215|NCT01542528|100642607|FG000|NOT COMPLETED|Overall Study||12||
48129216|NCT01542528|100642608|FG001|NOT COMPLETED|Overall Study||7||
48129217|NCT03095417|100642609|FG000|STARTED|Overall Study||41||
48129218|NCT03095417|100642610|FG001|STARTED|Overall Study||41||
48129219|NCT03095417|100642611|FG002|STARTED|Overall Study||36||
48129220|NCT03095417|100642612|FG003|STARTED|Overall Study||35||
48129221|NCT03095417|100642609|FG000|COMPLETED|Overall Study||28||
48129222|NCT03095417|100642610|FG001|COMPLETED|Overall Study||30||
48129223|NCT03095417|100642611|FG002|COMPLETED|Overall Study||27||
48129224|NCT03095417|100642612|FG003|COMPLETED|Overall Study||24||
48129225|NCT03095417|100642609|FG000|NOT COMPLETED|Overall Study||13||
48129226|NCT03095417|100642610|FG001|NOT COMPLETED|Overall Study||11||
48129227|NCT03095417|100642611|FG002|NOT COMPLETED|Overall Study||9||
48129228|NCT03095417|100642612|FG003|NOT COMPLETED|Overall Study||11||
48129229|NCT01265953|100642613|FG000|STARTED|Overall Study||50||
48129230|NCT01265953|100642614|FG001|STARTED|Overall Study||48||
48129231|NCT01265953|100642613|FG000|COMPLETED|Overall Study||45||
48129232|NCT01265953|100642614|FG001|COMPLETED|Overall Study||45||
48129233|NCT01265953|100642613|FG000|NOT COMPLETED|Overall Study||5||
48129234|NCT01265953|100642614|FG001|NOT COMPLETED|Overall Study||3||
48129235|NCT02032901|100642615|FG000|STARTED|Treatment Period (12 Weeks)||101||
48129236|NCT02032901|100642616|FG001|STARTED|Treatment Period (12 Weeks)||51||
48129237|NCT02032901|100642615|FG000|COMPLETED|Treatment Period (12 Weeks)||100||
48129238|NCT02032901|100642616|FG001|COMPLETED|Treatment Period (12 Weeks)||51||
48129239|NCT02032901|100642615|FG000|NOT COMPLETED|Treatment Period (12 Weeks)||1||
48129240|NCT02032901|100642616|FG001|NOT COMPLETED|Treatment Period (12 Weeks)||0||
48129241|NCT02032901|100642615|FG000|STARTED|Follow-Up Period (24 Weeks)||101||
48129242|NCT02032901|100642616|FG001|STARTED|Follow-Up Period (24 Weeks)||51||
48129243|NCT02032901|100642615|FG000|COMPLETED|Follow-Up Period (24 Weeks)||101||
48129244|NCT02032901|100642616|FG001|COMPLETED|Follow-Up Period (24 Weeks)||50||
48129245|NCT02032901|100642615|FG000|NOT COMPLETED|Follow-Up Period (24 Weeks)||0||
48129246|NCT02032901|100642616|FG001|NOT COMPLETED|Follow-Up Period (24 Weeks)||1||
48129247|NCT00701051|100642617|FG000|STARTED|Screening||90||
48129248|NCT00701051|100642618|FG001|STARTED|Screening||0||
48129249|NCT00701051|100642619|FG002|STARTED|Screening||0||
48129250|NCT00701051|100642617|FG000|COMPLETED|Screening||31||
48129251|NCT00701051|100642618|FG001|COMPLETED|Screening||0||
48129252|NCT00701051|100642619|FG002|COMPLETED|Screening||0||
48129253|NCT00701051|100642617|FG000|NOT COMPLETED|Screening||59||
48129254|NCT00701051|100642618|FG001|NOT COMPLETED|Screening||0||
48129255|NCT00701051|100642619|FG002|NOT COMPLETED|Screening||0||
48701255|NCT03116828|102054189|FG001|NOT COMPLETED|Overall Study||21||
48701256|NCT00790647|102054190|FG000|STARTED|Overall Study||10||
48701257|NCT00790647|102054190|FG000|COMPLETED|Overall Study||9||
48701258|NCT00790647|102054190|FG000|NOT COMPLETED|Overall Study||1||
48701259|NCT01113008|102054191|FG000|STARTED|Overall Study||133||
48701260|NCT01113008|102054192|FG001|STARTED|Overall Study||133||
48129256|NCT00701051|100642617|FG000|STARTED|Exercise Intervention||0||
48129257|NCT00701051|100642618|FG001|STARTED|Exercise Intervention||19||
48129258|NCT00701051|100642619|FG002|STARTED|Exercise Intervention||12||
48129259|NCT00701051|100642617|FG000|COMPLETED|Exercise Intervention||0||
48398484|NCT03339401|101306326|FG001|NOT COMPLETED|Overall Study||4||
48398485|NCT00088972|101306327|FG000|STARTED|Overall Study||3||
48398486|NCT00088972|101306328|FG001|STARTED|Overall Study||5||
48398487|NCT00088972|101306327|FG000|COMPLETED|Overall Study||1||
48129260|NCT00701051|100642618|FG001|COMPLETED|Exercise Intervention||14||
48129261|NCT00701051|100642619|FG002|COMPLETED|Exercise Intervention||9||
48129262|NCT00701051|100642617|FG000|NOT COMPLETED|Exercise Intervention||0||
48129263|NCT00701051|100642618|FG001|NOT COMPLETED|Exercise Intervention||5||
48129264|NCT00701051|100642619|FG002|NOT COMPLETED|Exercise Intervention||3||
48129265|NCT00701051|100642617|FG000|STARTED|Detraining Intervention (Optional)||0||
48129266|NCT00701051|100642618|FG001|STARTED|Detraining Intervention (Optional)||6||
48129267|NCT00701051|100642619|FG002|STARTED|Detraining Intervention (Optional)||6||
48129268|NCT00701051|100642617|FG000|COMPLETED|Detraining Intervention (Optional)||0||
48129269|NCT00701051|100642618|FG001|COMPLETED|Detraining Intervention (Optional)||6||
48129270|NCT00701051|100642619|FG002|COMPLETED|Detraining Intervention (Optional)||6||
48129271|NCT00701051|100642617|FG000|NOT COMPLETED|Detraining Intervention (Optional)||0||
48129272|NCT00701051|100642618|FG001|NOT COMPLETED|Detraining Intervention (Optional)||0||
48129273|NCT00701051|100642619|FG002|NOT COMPLETED|Detraining Intervention (Optional)||0||
48129274|NCT01298063|100642620|FG000|STARTED|Overall Study||8||
48398488|NCT00088972|101306328|FG001|COMPLETED|Overall Study||1||
48398489|NCT00088972|101306327|FG000|NOT COMPLETED|Overall Study||2||
48398490|NCT00088972|101306328|FG001|NOT COMPLETED|Overall Study||4||
48398491|NCT01369225|101306329|FG000|STARTED|Overall Study||6||
48398492|NCT01369225|101306330|FG001|STARTED|Overall Study||3||
48398493|NCT01369225|101306331|FG002|STARTED|Overall Study||12||
48398494|NCT01369225|101306332|FG003|STARTED|Overall Study||10||
48398495|NCT01369225|101306333|FG004|STARTED|Overall Study||12||
48129275|NCT01298063|100642621|FG001|STARTED|Overall Study||3||
48129276|NCT01298063|100642622|FG002|STARTED|Overall Study||8||
48129277|NCT01298063|100642623|FG003|STARTED|Overall Study||8||
48129278|NCT01298063|100642624|FG004|STARTED|Overall Study||8||
48129279|NCT01298063|100642620|FG000|COMPLETED|Overall Study||8||
48701261|NCT01113008|102054191|FG000|COMPLETED|Overall Study||133||
48701262|NCT01113008|102054192|FG001|COMPLETED|Overall Study||133||
48701263|NCT01113008|102054191|FG000|NOT COMPLETED|Overall Study||0||
48129280|NCT01298063|100642621|FG001|COMPLETED|Overall Study||3||
48129281|NCT01298063|100642622|FG002|COMPLETED|Overall Study||8||
48398496|NCT01369225|101306334|FG005|STARTED|Overall Study||9||
48129282|NCT01298063|100642623|FG003|COMPLETED|Overall Study||8||
48129283|NCT01298063|100642624|FG004|COMPLETED|Overall Study||8||
48129284|NCT01298063|100642620|FG000|NOT COMPLETED|Overall Study||0||
48129285|NCT01298063|100642621|FG001|NOT COMPLETED|Overall Study||0||
48129286|NCT01298063|100642622|FG002|NOT COMPLETED|Overall Study||0||
48129287|NCT01298063|100642623|FG003|NOT COMPLETED|Overall Study||0||
48129288|NCT01298063|100642624|FG004|NOT COMPLETED|Overall Study||0||
48129289|NCT02805257|100642625|FG000|STARTED|Overall Study||60||
48129290|NCT02805257|100642626|FG001|STARTED|Overall Study||59||
48129291|NCT02805257|100642625|FG000|COMPLETED|Overall Study||53||
48129292|NCT02805257|100642626|FG001|COMPLETED|Overall Study||52||
48129293|NCT02805257|100642625|FG000|NOT COMPLETED|Overall Study||7||
48129294|NCT02805257|100642626|FG001|NOT COMPLETED|Overall Study||7||
48129295|NCT02641080|100642627|FG000|STARTED|Overall Study||40||
48129296|NCT02641080|100642628|FG001|STARTED|Overall Study||40||
48129297|NCT02641080|100642627|FG000|COMPLETED|Overall Study||38||
48129298|NCT02641080|100642628|FG001|COMPLETED|Overall Study||33||
48129299|NCT02641080|100642627|FG000|NOT COMPLETED|Overall Study||2||
48129300|NCT02641080|100642628|FG001|NOT COMPLETED|Overall Study||7||
48129301|NCT02908269|100642629|FG000|STARTED|Overall Study||60||
48129302|NCT02908269|100642630|FG001|STARTED|Overall Study||60||
48129303|NCT02908269|100642631|FG002|STARTED|Overall Study||60||
48129304|NCT02908269|100642629|FG000|COMPLETED|Overall Study||60||
48129305|NCT02908269|100642630|FG001|COMPLETED|Overall Study||60||
48129306|NCT02908269|100642631|FG002|COMPLETED|Overall Study||60||
48129307|NCT02908269|100642629|FG000|NOT COMPLETED|Overall Study||0||
48129308|NCT02908269|100642630|FG001|NOT COMPLETED|Overall Study||0||
48129309|NCT02908269|100642631|FG002|NOT COMPLETED|Overall Study||0||
48129310|NCT01722331|100642632|FG000|STARTED|Part 1||308||
48129311|NCT01722331|100642633|FG001|STARTED|Part 1||249||
48129312|NCT01722331|100642634|FG002|STARTED|Part 1||41||
48129313|NCT01722331|100642635|FG003|STARTED|Part 1||19||
48129314|NCT01722331|100642636|FG004|STARTED|Part 1||9||
48129315|NCT01722331|100642637|FG005|STARTED|Part 1||72||
48129316|NCT01722331|100642638|FG006|STARTED|Part 1||74||
48129317|NCT01722331|100642632|FG000|COMPLETED|Part 1||298||
48129318|NCT01722331|100642633|FG001|COMPLETED|Part 1||249||
48129319|NCT01722331|100642634|FG002|COMPLETED|Part 1||32||
48129320|NCT01722331|100642635|FG003|COMPLETED|Part 1||19||
48129321|NCT01722331|100642636|FG004|COMPLETED|Part 1||0||
48129322|NCT01722331|100642637|FG005|COMPLETED|Part 1||72||
48129323|NCT01722331|100642638|FG006|COMPLETED|Part 1||74||
48129324|NCT01722331|100642632|FG000|NOT COMPLETED|Part 1||10||
48129325|NCT01722331|100642633|FG001|NOT COMPLETED|Part 1||0||
48129326|NCT01722331|100642634|FG002|NOT COMPLETED|Part 1||9||
48129327|NCT01722331|100642635|FG003|NOT COMPLETED|Part 1||0||
48398497|NCT01369225|101306329|FG000|COMPLETED|Overall Study||4||
48398498|NCT01369225|101306330|FG001|COMPLETED|Overall Study||3||
48398499|NCT01369225|101306331|FG002|COMPLETED|Overall Study||9||
48398500|NCT01369225|101306332|FG003|COMPLETED|Overall Study||8||
48398501|NCT01369225|101306333|FG004|COMPLETED|Overall Study||10||
48398502|NCT01369225|101306334|FG005|COMPLETED|Overall Study||9||
48398503|NCT01369225|101306329|FG000|NOT COMPLETED|Overall Study||2||
48573184|NCT02564900|101735073|FG012|COMPLETED|Dose Expansion||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019.|
48592809|NCT01764997|101783186|FG004|STARTED|Study Drug Treatment Period||322||
48129328|NCT01722331|100642636|FG004|NOT COMPLETED|Part 1||9||
48129329|NCT01722331|100642637|FG005|NOT COMPLETED|Part 1||0||
48129330|NCT01722331|100642638|FG006|NOT COMPLETED|Part 1||0||
48129331|NCT01722331|100642632|FG000|STARTED|Part 2||298||
48129332|NCT01722331|100642633|FG001|STARTED|Part 2||249||
48129333|NCT01722331|100642634|FG002|STARTED|Part 2||31||
48129334|NCT01722331|100642635|FG003|STARTED|Part 2||19||
48129335|NCT01722331|100642636|FG004|STARTED|Part 2||0||
48129336|NCT01722331|100642637|FG005|STARTED|Part 2||72||
48398504|NCT01369225|101306330|FG001|NOT COMPLETED|Overall Study||0||
48398505|NCT01369225|101306331|FG002|NOT COMPLETED|Overall Study||3||
48398506|NCT01369225|101306332|FG003|NOT COMPLETED|Overall Study||2||
48398507|NCT01369225|101306333|FG004|NOT COMPLETED|Overall Study||2||
48129337|NCT01722331|100642638|FG006|STARTED|Part 2||74||
48129338|NCT01722331|100642632|FG000|COMPLETED|Part 2||279||
48129339|NCT01722331|100642633|FG001|COMPLETED|Part 2||249||
48129340|NCT01722331|100642634|FG002|COMPLETED|Part 2||0||
48129341|NCT01722331|100642635|FG003|COMPLETED|Part 2||19||
48129342|NCT01722331|100642636|FG004|COMPLETED|Part 2||0||
48398508|NCT01369225|101306334|FG005|NOT COMPLETED|Overall Study||0||
48398509|NCT00602771|101306335|FG000|STARTED|Overall Study||63||
48129343|NCT01722331|100642637|FG005|COMPLETED|Part 2||62||
48129344|NCT01722331|100642638|FG006|COMPLETED|Part 2||67||
48129345|NCT01722331|100642632|FG000|NOT COMPLETED|Part 2||19||
48129346|NCT01722331|100642633|FG001|NOT COMPLETED|Part 2||0||
48129347|NCT01722331|100642634|FG002|NOT COMPLETED|Part 2||31||
48129348|NCT01722331|100642635|FG003|NOT COMPLETED|Part 2||0||
48129349|NCT01722331|100642636|FG004|NOT COMPLETED|Part 2||0||
48129350|NCT01722331|100642637|FG005|NOT COMPLETED|Part 2||10||
48129351|NCT01722331|100642638|FG006|NOT COMPLETED|Part 2||7||
48129352|NCT01722331|100642632|FG000|STARTED|Part 3||279||
48129353|NCT01722331|100642633|FG001|STARTED|Part 3||249||
48573185|NCT02564900|101735074|FG013|COMPLETED|Dose Expansion||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019.|
48573186|NCT02564900|101735075|FG014|COMPLETED|Dose Expansion||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019.|
48573187|NCT02564900|101735061|FG000|NOT COMPLETED|Dose Expansion||0||
48573188|NCT02564900|101735062|FG001|NOT COMPLETED|Dose Expansion||0||
48573189|NCT02564900|101735063|FG002|NOT COMPLETED|Dose Expansion||0||
48573190|NCT02564900|101735064|FG003|NOT COMPLETED|Dose Expansion||0||
48573191|NCT02564900|101735065|FG004|NOT COMPLETED|Dose Expansion||0||
48573192|NCT02564900|101735066|FG005|NOT COMPLETED|Dose Expansion||0||
48573193|NCT02564900|101735067|FG006|NOT COMPLETED|Dose Expansion||49||
48573194|NCT02564900|101735068|FG007|NOT COMPLETED|Dose Expansion||62||
48573195|NCT02564900|101735069|FG008|NOT COMPLETED|Dose Expansion||20||
48573196|NCT02564900|101735070|FG009|NOT COMPLETED|Dose Expansion||33||
48573197|NCT02564900|101735071|FG010|NOT COMPLETED|Dose Expansion||17||
48573198|NCT02564900|101735072|FG011|NOT COMPLETED|Dose Expansion||24||
48573199|NCT02564900|101735073|FG012|NOT COMPLETED|Dose Expansion||18||
48573200|NCT02564900|101735074|FG013|NOT COMPLETED|Dose Expansion||20||
48573201|NCT02564900|101735075|FG014|NOT COMPLETED|Dose Expansion||22||
48573202|NCT02110758|101735076|FG000|STARTED|Baseline: August 2011-July 2013||0||
48573203|NCT02110758|101735077|FG001|STARTED|Baseline: August 2011-July 2013||0||
48573204|NCT02110758|101735078|FG002|STARTED|Baseline: August 2011-July 2013||9832||
48573205|NCT02110758|101735079|FG003|STARTED|Baseline: August 2011-July 2013||18994||
48573206|NCT02110758|101735080|FG004|STARTED|Baseline: August 2011-July 2013||308||
48573207|NCT02110758|101735076|FG000|COMPLETED|Baseline: August 2011-July 2013||0|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
48573208|NCT02110758|101735077|FG001|COMPLETED|Baseline: August 2011-July 2013||0|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
48573209|NCT02110758|101735078|FG002|COMPLETED|Baseline: August 2011-July 2013||9832|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
48573210|NCT02110758|101735079|FG003|COMPLETED|Baseline: August 2011-July 2013||18994|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
48573211|NCT02110758|101735080|FG004|COMPLETED|Baseline: August 2011-July 2013||308|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
48573212|NCT02110758|101735076|FG000|NOT COMPLETED|Baseline: August 2011-July 2013||0||
48573213|NCT02110758|101735077|FG001|NOT COMPLETED|Baseline: August 2011-July 2013||0||
48573214|NCT02110758|101735078|FG002|NOT COMPLETED|Baseline: August 2011-July 2013||0||
48573215|NCT02110758|101735079|FG003|NOT COMPLETED|Baseline: August 2011-July 2013||0||
48573216|NCT02110758|101735080|FG004|NOT COMPLETED|Baseline: August 2011-July 2013||0||
48573217|NCT02110758|101735076|FG000|STARTED|Start-Up: August 2013-June 2014||175||
48701264|NCT01113008|102054192|FG001|NOT COMPLETED|Overall Study||0||
48701265|NCT02769338|102054193|FG000|STARTED|Baseline Period||162||6
48701266|NCT02769338|102054194|FG001|STARTED|Baseline Period||973||36
48701267|NCT02769338|102054193|FG000|COMPLETED|Baseline Period||162||6
48573218|NCT02110758|101735077|FG001|STARTED|Start-Up: August 2013-June 2014||431||
48573219|NCT02110758|101735078|FG002|STARTED|Start-Up: August 2013-June 2014||8057||
48573220|NCT02110758|101735079|FG003|STARTED|Start-Up: August 2013-June 2014||12883||
48573221|NCT02110758|101735080|FG004|STARTED|Start-Up: August 2013-June 2014||0||
48573222|NCT02110758|101735076|FG000|COMPLETED|Start-Up: August 2013-June 2014||175|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
48573223|NCT02110758|101735077|FG001|COMPLETED|Start-Up: August 2013-June 2014||431|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
48573224|NCT02110758|101735078|FG002|COMPLETED|Start-Up: August 2013-June 2014||8057|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
48573225|NCT02110758|101735079|FG003|COMPLETED|Start-Up: August 2013-June 2014||12883|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
48573226|NCT02110758|101735080|FG004|COMPLETED|Start-Up: August 2013-June 2014||0|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
48573227|NCT02110758|101735076|FG000|NOT COMPLETED|Start-Up: August 2013-June 2014||0||
48573228|NCT02110758|101735077|FG001|NOT COMPLETED|Start-Up: August 2013-June 2014||0||
48573229|NCT02110758|101735078|FG002|NOT COMPLETED|Start-Up: August 2013-June 2014||0||
48701268|NCT02769338|102054194|FG001|COMPLETED|Baseline Period||973||36
48701269|NCT02769338|102054193|FG000|NOT COMPLETED|Baseline Period||0||0
48701270|NCT02769338|102054194|FG001|NOT COMPLETED|Baseline Period||0||0
48573230|NCT02110758|101735079|FG003|NOT COMPLETED|Start-Up: August 2013-June 2014||0||
48573231|NCT02110758|101735080|FG004|NOT COMPLETED|Start-Up: August 2013-June 2014||0||
48573232|NCT02110758|101735076|FG000|STARTED|Intervention: July 2014-December 2015||0||
48573233|NCT02110758|101735077|FG001|STARTED|Intervention: July 2014-December 2015||0||
48573234|NCT02110758|101735078|FG002|STARTED|Intervention: July 2014-December 2015||10106||
48573235|NCT02110758|101735079|FG003|STARTED|Intervention: July 2014-December 2015||33012||
48573236|NCT02110758|101735080|FG004|STARTED|Intervention: July 2014-December 2015||0||
48573237|NCT02110758|101735076|FG000|COMPLETED|Intervention: July 2014-December 2015||0|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
48573238|NCT02110758|101735077|FG001|COMPLETED|Intervention: July 2014-December 2015||0|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
48701271|NCT02769338|102054193|FG000|STARTED|Active Implementation Period||189||6
48573239|NCT02110758|101735078|FG002|COMPLETED|Intervention: July 2014-December 2015||10106|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
48573240|NCT02110758|101735079|FG003|COMPLETED|Intervention: July 2014-December 2015||33012|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
48573241|NCT02110758|101735080|FG004|COMPLETED|Intervention: July 2014-December 2015||0|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
48573242|NCT02110758|101735076|FG000|NOT COMPLETED|Intervention: July 2014-December 2015||0||
48573243|NCT02110758|101735077|FG001|NOT COMPLETED|Intervention: July 2014-December 2015||0||
48573244|NCT02110758|101735078|FG002|NOT COMPLETED|Intervention: July 2014-December 2015||0||
48573245|NCT02110758|101735079|FG003|NOT COMPLETED|Intervention: July 2014-December 2015||0||
48573246|NCT02110758|101735080|FG004|NOT COMPLETED|Intervention: July 2014-December 2015||0||
48573247|NCT02110758|101735076|FG000|STARTED|Follow-Up: January-July 2016||81||
48573248|NCT02110758|101735077|FG001|STARTED|Follow-Up: January-July 2016||179||
48701272|NCT02769338|102054194|FG001|STARTED|Active Implementation Period||968||36
48701273|NCT02769338|102054193|FG000|COMPLETED|Active Implementation Period||189||6
48701274|NCT02769338|102054194|FG001|COMPLETED|Active Implementation Period||968||36
48701275|NCT02769338|102054193|FG000|NOT COMPLETED|Active Implementation Period||0||0
48129354|NCT01722331|100642634|FG002|STARTED|Part 3||0||
48129355|NCT01722331|100642635|FG003|STARTED|Part 3||19||
48129356|NCT01722331|100642636|FG004|STARTED|Part 3||0||
48129357|NCT01722331|100642637|FG005|STARTED|Part 3||62||
48129358|NCT01722331|100642638|FG006|STARTED|Part 3||67||
48129359|NCT01722331|100642632|FG000|COMPLETED|Part 3||264||
48129360|NCT01722331|100642633|FG001|COMPLETED|Part 3||232||
48129361|NCT01722331|100642634|FG002|COMPLETED|Part 3||0||
48129362|NCT01722331|100642635|FG003|COMPLETED|Part 3||18||
48129363|NCT01722331|100642636|FG004|COMPLETED|Part 3||0||
48129364|NCT01722331|100642637|FG005|COMPLETED|Part 3||59||
48129365|NCT01722331|100642638|FG006|COMPLETED|Part 3||65||
48129366|NCT01722331|100642632|FG000|NOT COMPLETED|Part 3||15||
48129367|NCT01722331|100642633|FG001|NOT COMPLETED|Part 3||17||
48129368|NCT01722331|100642634|FG002|NOT COMPLETED|Part 3||0||
48129369|NCT01722331|100642635|FG003|NOT COMPLETED|Part 3||1||
48129370|NCT01722331|100642636|FG004|NOT COMPLETED|Part 3||0||
48129371|NCT01722331|100642637|FG005|NOT COMPLETED|Part 3||3||
48129372|NCT01722331|100642638|FG006|NOT COMPLETED|Part 3||2||
48129373|NCT02473614|100642639|FG000|STARTED|First Intervention (3 Weeks)||6||
48129374|NCT02473614|100642640|FG001|STARTED|First Intervention (3 Weeks)||5||
48129375|NCT02473614|100642639|FG000|COMPLETED|First Intervention (3 Weeks)||5||
48129376|NCT02473614|100642640|FG001|COMPLETED|First Intervention (3 Weeks)||5||
48129377|NCT02473614|100642639|FG000|NOT COMPLETED|First Intervention (3 Weeks)||1||
48129378|NCT02473614|100642640|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0||
48129379|NCT02473614|100642639|FG000|STARTED|Wash Out Period (3 Weeks)||5||
48129380|NCT02473614|100642640|FG001|STARTED|Wash Out Period (3 Weeks)||5||
48129381|NCT02473614|100642639|FG000|COMPLETED|Wash Out Period (3 Weeks)||5||
48129382|NCT02473614|100642640|FG001|COMPLETED|Wash Out Period (3 Weeks)||5||
48129383|NCT02473614|100642639|FG000|NOT COMPLETED|Wash Out Period (3 Weeks)||0||
48129384|NCT02473614|100642640|FG001|NOT COMPLETED|Wash Out Period (3 Weeks)||0||
48129385|NCT02473614|100642639|FG000|STARTED|Second Intervention (3 Weeks)||5||
48129386|NCT02473614|100642640|FG001|STARTED|Second Intervention (3 Weeks)||5||
48129387|NCT02473614|100642639|FG000|COMPLETED|Second Intervention (3 Weeks)||5||
48129388|NCT02473614|100642640|FG001|COMPLETED|Second Intervention (3 Weeks)||5||
48129389|NCT02473614|100642639|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0||
48129390|NCT02473614|100642640|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0||
48129391|NCT00875394|100642641|FG000|STARTED|Overall Study||36||
48129392|NCT00875394|100642642|FG001|STARTED|Overall Study||23||
48129393|NCT00875394|100642643|FG002|STARTED|Overall Study||9||
48129394|NCT00875394|100642641|FG000|COMPLETED|Overall Study||36||
48129395|NCT00875394|100642642|FG001|COMPLETED|Overall Study||23||
48129396|NCT00875394|100642643|FG002|COMPLETED|Overall Study||9||
48129397|NCT00875394|100642641|FG000|NOT COMPLETED|Overall Study||0||
48129398|NCT00875394|100642642|FG001|NOT COMPLETED|Overall Study||0||
48129399|NCT00875394|100642643|FG002|NOT COMPLETED|Overall Study||0||
48129400|NCT01114646|100642644|FG000|STARTED|Overall Study||66||
48129401|NCT01114646|100642645|FG001|STARTED|Overall Study||64||
48129402|NCT01114646|100642644|FG000|COMPLETED|Overall Study||63||
48129403|NCT01114646|100642645|FG001|COMPLETED|Overall Study||62||
48129404|NCT01114646|100642644|FG000|NOT COMPLETED|Overall Study||3||
48573249|NCT02110758|101735078|FG002|STARTED|Follow-Up: January-July 2016||6451||
48129405|NCT01114646|100642645|FG001|NOT COMPLETED|Overall Study||2||
48129406|NCT00982020|100642646|FG000|STARTED|Overall Study||102||
48129407|NCT00982020|100642647|FG001|STARTED|Overall Study||101||
48129408|NCT00982020|100642646|FG000|Received at Least 1 Dose of Study Drug|Overall Study||102||
48129409|NCT00982020|100642647|FG001|Received at Least 1 Dose of Study Drug|Overall Study||101||
48129410|NCT00982020|100642646|FG000|COMPLETED|Overall Study||45||
48129411|NCT00982020|100642647|FG001|COMPLETED|Overall Study||37||
48129412|NCT00982020|100642646|FG000|NOT COMPLETED|Overall Study||57||
48701276|NCT02769338|102054194|FG001|NOT COMPLETED|Active Implementation Period||0||0
48701277|NCT01579565|102054195|FG000|STARTED|Randomized||207||
48701278|NCT01579565|102054196|FG001|STARTED|Randomized||209||
48701279|NCT01579565|102054195|FG000|COMPLETED|Randomized||202||
48573250|NCT02110758|101735079|FG003|STARTED|Follow-Up: January-July 2016||24392||
48573251|NCT02110758|101735080|FG004|STARTED|Follow-Up: January-July 2016||349||
48573252|NCT02110758|101735076|FG000|COMPLETED|Follow-Up: January-July 2016||81|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
48573253|NCT02110758|101735077|FG001|COMPLETED|Follow-Up: January-July 2016||179|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
48573254|NCT02110758|101735078|FG002|COMPLETED|Follow-Up: January-July 2016||6451|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
48573255|NCT02110758|101735079|FG003|COMPLETED|Follow-Up: January-July 2016||24392|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
48701280|NCT01579565|102054196|FG001|COMPLETED|Randomized||204||
48129413|NCT00982020|100642647|FG001|NOT COMPLETED|Overall Study||64||
48129414|NCT03794089|100642648|FG000|STARTED|Overall Study||17||
48129415|NCT03794089|100642649|FG001|STARTED|Overall Study||18||
48129416|NCT03794089|100642648|FG000|Completed 4-week Assessment|Overall Study||16||
48129417|NCT03794089|100642649|FG001|Completed 4-week Assessment|Overall Study||18||
48129418|NCT03794089|100642648|FG000|Completed 8-week Assessment|Overall Study||14||
48129419|NCT03794089|100642649|FG001|Completed 8-week Assessment|Overall Study||18||
48129420|NCT03794089|100642648|FG000|Completed 12-week Assessment|Overall Study||13||
48129421|NCT03794089|100642649|FG001|Completed 12-week Assessment|Overall Study||17||
48129422|NCT03794089|100642648|FG000|COMPLETED|Overall Study||11||
48129423|NCT03794089|100642649|FG001|COMPLETED|Overall Study||17||
48129424|NCT03794089|100642648|FG000|NOT COMPLETED|Overall Study||6||
48129425|NCT03794089|100642649|FG001|NOT COMPLETED|Overall Study||1||
48129426|NCT03855189|100642650|FG000|STARTED|Overall Study||113||
48129427|NCT03855189|100642651|FG001|STARTED|Overall Study||116||
48129428|NCT03855189|100642652|FG002|STARTED|Overall Study||116||
48129429|NCT03855189|100642650|FG000|Treated|Overall Study||112||
48129430|NCT03855189|100642651|FG001|Treated|Overall Study||116||
48129431|NCT03855189|100642652|FG002|Treated|Overall Study||116||
48129432|NCT03855189|100642650|FG000|COMPLETED|Overall Study||103||
48129433|NCT03855189|100642651|FG001|COMPLETED|Overall Study||109||
48129434|NCT03855189|100642652|FG002|COMPLETED|Overall Study||110||
48129435|NCT03855189|100642650|FG000|NOT COMPLETED|Overall Study||10||
48129436|NCT03855189|100642651|FG001|NOT COMPLETED|Overall Study||7||
48129437|NCT03855189|100642652|FG002|NOT COMPLETED|Overall Study||6||
48284188|NCT00882687|101021447|FG002|NOT COMPLETED|Overall Study||3||
48284189|NCT00882687|101021448|FG003|NOT COMPLETED|Overall Study||2||
48129438|NCT01731171|100642653|FG000|STARTED|Overall Study||33||
48129439|NCT01731171|100642654|FG001|STARTED|Overall Study||33||
48129440|NCT01731171|100642653|FG000|COMPLETED|Overall Study||26||
48129441|NCT01731171|100642654|FG001|COMPLETED|Overall Study||26||
48129442|NCT01731171|100642653|FG000|NOT COMPLETED|Overall Study||7||
48129443|NCT01731171|100642654|FG001|NOT COMPLETED|Overall Study||7||
48129444|NCT01539291|100642655|FG000|STARTED|Study GS-US-312-0116||106||
48129445|NCT01539291|100642656|FG001|STARTED|Study GS-US-312-0116||4||
48129446|NCT01539291|100642657|FG002|STARTED|Study GS-US-312-0116||42||
48129447|NCT01539291|100642658|FG003|STARTED|Study GS-US-312-0116||44||
48129448|NCT01539291|100642655|FG000|COMPLETED|Study GS-US-312-0116||81||
48129449|NCT01539291|100642656|FG001|COMPLETED|Study GS-US-312-0116||4||
48129450|NCT01539291|100642657|FG002|COMPLETED|Study GS-US-312-0116||42||
48129451|NCT01539291|100642658|FG003|COMPLETED|Study GS-US-312-0116||44||
48129452|NCT01539291|100642655|FG000|NOT COMPLETED|Study GS-US-312-0116||25||
48129453|NCT01539291|100642656|FG001|NOT COMPLETED|Study GS-US-312-0116||0||
48129454|NCT01539291|100642657|FG002|NOT COMPLETED|Study GS-US-312-0116||0||
48129455|NCT01539291|100642658|FG003|NOT COMPLETED|Study GS-US-312-0116||0||
48129456|NCT01539291|100642655|FG000|STARTED|Study GS-US-312-0117||71||
48129457|NCT01539291|100642656|FG001|STARTED|Study GS-US-312-0117||4||
48129458|NCT01539291|100642657|FG002|STARTED|Study GS-US-312-0117||42||
48129459|NCT01539291|100642658|FG003|STARTED|Study GS-US-312-0117||44||
48129460|NCT01539291|100642655|FG000|COMPLETED|Study GS-US-312-0117||30||
48129461|NCT01539291|100642656|FG001|COMPLETED|Study GS-US-312-0117||2||
48129462|NCT01539291|100642657|FG002|COMPLETED|Study GS-US-312-0117||20||
48129463|NCT01539291|100642658|FG003|COMPLETED|Study GS-US-312-0117||18||
48129464|NCT01539291|100642655|FG000|NOT COMPLETED|Study GS-US-312-0117||41||
48129465|NCT01539291|100642656|FG001|NOT COMPLETED|Study GS-US-312-0117||2||
48284190|NCT03965689|101021449|FG000|STARTED|Overall Study||27||
48284191|NCT03965689|101021449|FG000|COMPLETED|Overall Study||25||
48129466|NCT01539291|100642657|FG002|NOT COMPLETED|Study GS-US-312-0117||22||
48129467|NCT01539291|100642658|FG003|NOT COMPLETED|Study GS-US-312-0117||26||
48129468|NCT00958919|100642659|FG000|STARTED|First Intervention||7||
48129469|NCT00958919|100642660|FG001|STARTED|First Intervention||7||
48129470|NCT00958919|100642659|FG000|COMPLETED|First Intervention||7||
48129471|NCT00958919|100642660|FG001|COMPLETED|First Intervention||7||
48129472|NCT00958919|100642659|FG000|NOT COMPLETED|First Intervention||0||
48573256|NCT02110758|101735080|FG004|COMPLETED|Follow-Up: January-July 2016||349|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
48129473|NCT00958919|100642660|FG001|NOT COMPLETED|First Intervention||0||
48129474|NCT00958919|100642659|FG000|STARTED|Second Intervention||7||
48129475|NCT00958919|100642660|FG001|STARTED|Second Intervention||7||
48129476|NCT00958919|100642659|FG000|COMPLETED|Second Intervention||7||
48573257|NCT02110758|101735076|FG000|NOT COMPLETED|Follow-Up: January-July 2016||0||
48129477|NCT00958919|100642660|FG001|COMPLETED|Second Intervention||7||
48129478|NCT00958919|100642659|FG000|NOT COMPLETED|Second Intervention||0||
48129479|NCT00958919|100642660|FG001|NOT COMPLETED|Second Intervention||0||
48129480|NCT03907501|100642661|FG000|STARTED|Overall Study||7||
48129481|NCT03907501|100642662|FG001|STARTED|Overall Study||6||
48129482|NCT03907501|100642663|FG002|STARTED|Overall Study||5||
48129483|NCT03907501|100642661|FG000|COMPLETED|Overall Study||6||
48129484|NCT03907501|100642662|FG001|COMPLETED|Overall Study||5||
48129485|NCT03907501|100642663|FG002|COMPLETED|Overall Study||5||
48129486|NCT03907501|100642661|FG000|NOT COMPLETED|Overall Study||1||
48129487|NCT03907501|100642662|FG001|NOT COMPLETED|Overall Study||1||
48129488|NCT03907501|100642663|FG002|NOT COMPLETED|Overall Study||0||
48129489|NCT00727857|100642664|FG000|STARTED|Overall Study||201||
48129490|NCT00727857|100642665|FG001|STARTED|Overall Study||189||
48573258|NCT02110758|101735077|FG001|NOT COMPLETED|Follow-Up: January-July 2016||0||
48573259|NCT02110758|101735078|FG002|NOT COMPLETED|Follow-Up: January-July 2016||0||
48573260|NCT02110758|101735079|FG003|NOT COMPLETED|Follow-Up: January-July 2016||0||
48573261|NCT02110758|101735080|FG004|NOT COMPLETED|Follow-Up: January-July 2016||0||
48573262|NCT02744430|101735081|FG000|STARTED|Overall Study||17||
48573263|NCT02744430|101735082|FG001|STARTED|Overall Study||16||
48573264|NCT02744430|101735081|FG000|COMPLETED|Overall Study||17||
48573265|NCT02744430|101735082|FG001|COMPLETED|Overall Study||16||
48573266|NCT02744430|101735081|FG000|NOT COMPLETED|Overall Study||0||
48573267|NCT02744430|101735082|FG001|NOT COMPLETED|Overall Study||0||
48129491|NCT00727857|100642666|FG002|STARTED|Overall Study||210||
48129492|NCT00727857|100642664|FG000|COMPLETED|Overall Study||157||
48129493|NCT00727857|100642665|FG001|COMPLETED|Overall Study||125||
48129494|NCT00727857|100642666|FG002|COMPLETED|Overall Study||142||
48129495|NCT00727857|100642664|FG000|NOT COMPLETED|Overall Study||44||
48573268|NCT00150488|101735083|FG000|STARTED|Overall Study||53||
48573269|NCT00150488|101735083|FG000|COMPLETED|Overall Study||53||
48573270|NCT00150488|101735083|FG000|NOT COMPLETED|Overall Study||0||
48573271|NCT02819973|101735084|FG000|STARTED|Overall Study||114||
48573272|NCT02819973|101735085|FG001|STARTED|Overall Study||114||
48573273|NCT02819973|101735086|FG002|STARTED|Overall Study||115||
48573274|NCT02819973|101735084|FG000|COMPLETED|Overall Study||108||
48573275|NCT02819973|101735085|FG001|COMPLETED|Overall Study||111||
48573276|NCT02819973|101735086|FG002|COMPLETED|Overall Study||111||
48573277|NCT02819973|101735084|FG000|NOT COMPLETED|Overall Study||6||
48573278|NCT02819973|101735085|FG001|NOT COMPLETED|Overall Study||3||
48573279|NCT02819973|101735086|FG002|NOT COMPLETED|Overall Study||4||
48573280|NCT02099786|101735087|FG000|STARTED|Overall Study||24||
48129496|NCT00727857|100642665|FG001|NOT COMPLETED|Overall Study||64||
48129497|NCT00727857|100642666|FG002|NOT COMPLETED|Overall Study||68||
48129498|NCT04378933|100642667|FG000|STARTED|Overall Study||17||
48129499|NCT04378933|100642668|FG001|STARTED|Overall Study||17||
48129500|NCT04378933|100642667|FG000|COMPLETED|Overall Study||17||
48129501|NCT04378933|100642668|FG001|COMPLETED|Overall Study||17||
48129502|NCT04378933|100642667|FG000|NOT COMPLETED|Overall Study||0||
48129503|NCT04378933|100642668|FG001|NOT COMPLETED|Overall Study||0||
48129504|NCT00840970|100642669|FG000|STARTED|Overall Study||7||14
48129505|NCT00840970|100642670|FG001|STARTED|Overall Study||38||76
48129506|NCT00840970|100642671|FG002|STARTED|Overall Study||5||10
48129507|NCT00840970|100642669|FG000|COMPLETED|Overall Study||7||14
48129508|NCT00840970|100642670|FG001|COMPLETED|Overall Study||38||76
48129509|NCT00840970|100642671|FG002|COMPLETED|Overall Study||4||8
48129510|NCT00840970|100642669|FG000|NOT COMPLETED|Overall Study||0||0
48129511|NCT00840970|100642670|FG001|NOT COMPLETED|Overall Study||0||0
48129512|NCT00840970|100642671|FG002|NOT COMPLETED|Overall Study||1||2
48129513|NCT01312909|100642672|FG000|STARTED|Overall Study||109||
48129514|NCT01312909|100642673|FG001|STARTED|Overall Study||103||
48129515|NCT01312909|100642674|FG002|STARTED|Overall Study||100||
48129516|NCT01312909|100642672|FG000|Treated|Overall Study||108||
48129517|NCT01312909|100642673|FG001|Treated|Overall Study||100||
48129518|NCT01312909|100642674|FG002|Treated|Overall Study||99||
48129519|NCT01312909|100642672|FG000|COMPLETED|Overall Study||67||
48129520|NCT01312909|100642673|FG001|COMPLETED|Overall Study||67||
48129521|NCT01312909|100642674|FG002|COMPLETED|Overall Study||53||
48129522|NCT01312909|100642672|FG000|NOT COMPLETED|Overall Study||42||
48129523|NCT01312909|100642673|FG001|NOT COMPLETED|Overall Study||36||
48129524|NCT01312909|100642674|FG002|NOT COMPLETED|Overall Study||47||
48129525|NCT01172938|100642675|FG000|STARTED|Placebo-controlled Phase (Week 0-24)||168||
48129526|NCT01172938|100642676|FG001|STARTED|Placebo-controlled Phase (Week 0-24)||168||
48129527|NCT01172938|100642677|FG002|STARTED|Placebo-controlled Phase (Week 0-24)||168||
48129528|NCT01172938|100642678|FG003|STARTED|Placebo-controlled Phase (Week 0-24)||0||
48129529|NCT01172938|100642679|FG004|STARTED|Placebo-controlled Phase (Week 0-24)||0||
48129530|NCT01172938|100642680|FG005|STARTED|Placebo-controlled Phase (Week 0-24)||0||
48129531|NCT01172938|100642681|FG006|STARTED|Placebo-controlled Phase (Week 0-24)||0||
48129532|NCT01172938|100642682|FG007|STARTED|Placebo-controlled Phase (Week 0-24)||0||
48573281|NCT02099786|101735088|FG001|STARTED|Overall Study||23||
48573282|NCT02099786|101735087|FG000|Program Eval 1|Overall Study||24||
48573283|NCT02099786|101735088|FG001|Program Eval 1|Overall Study||23||
48129533|NCT01172938|100642683|FG008|STARTED|Placebo-controlled Phase (Week 0-24)||0||
48129534|NCT01172938|100642675|FG000|Received Treatment|Placebo-controlled Phase (Week 0-24)||168||
48129535|NCT01172938|100642676|FG001|Received Treatment|Placebo-controlled Phase (Week 0-24)||168||
48129536|NCT01172938|100642677|FG002|Received Treatment|Placebo-controlled Phase (Week 0-24)||168||
48129537|NCT01172938|100642678|FG003|Received Treatment|Placebo-controlled Phase (Week 0-24)||0||
48129538|NCT01172938|100642679|FG004|Received Treatment|Placebo-controlled Phase (Week 0-24)||0||
48129539|NCT01172938|100642680|FG005|Received Treatment|Placebo-controlled Phase (Week 0-24)||0||
48129540|NCT01172938|100642681|FG006|Received Treatment|Placebo-controlled Phase (Week 0-24)||0||
48129541|NCT01172938|100642682|FG007|Received Treatment|Placebo-controlled Phase (Week 0-24)||0||
48129542|NCT01172938|100642683|FG008|Received Treatment|Placebo-controlled Phase (Week 0-24)||0||
48129543|NCT01172938|100642675|FG000|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158||
48129544|NCT01172938|100642676|FG001|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158||
48129545|NCT01172938|100642677|FG002|Completed Week 16|Placebo-controlled Phase (Week 0-24)||154||
48129546|NCT01172938|100642678|FG003|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0||
48129547|NCT01172938|100642679|FG004|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0||
48129548|NCT01172938|100642680|FG005|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0||
48129549|NCT01172938|100642681|FG006|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0||
48129550|NCT01172938|100642682|FG007|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0||
48129551|NCT01172938|100642683|FG008|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0||
48129552|NCT01172938|100642675|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||107||
48129553|NCT01172938|100642676|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||78||
48573284|NCT02099786|101735087|FG000|Program Eval 2|Overall Study||23||
48573285|NCT02099786|101735088|FG001|Program Eval 2|Overall Study||19||
48573286|NCT02099786|101735087|FG000|Program Eval 3|Overall Study||21||
48573287|NCT02099786|101735088|FG001|Program Eval 3|Overall Study||15||
48573288|NCT02099786|101735087|FG000|COMPLETED|Overall Study||21||
48573289|NCT02099786|101735088|FG001|COMPLETED|Overall Study||15||
48573290|NCT02099786|101735087|FG000|NOT COMPLETED|Overall Study||3||
48701281|NCT01579565|102054195|FG000|NOT COMPLETED|Randomized||5||
48284192|NCT03965689|101021449|FG000|NOT COMPLETED|Overall Study||2||
48573291|NCT02099786|101735088|FG001|NOT COMPLETED|Overall Study||8||
48573292|NCT05188261|101735089|FG000|STARTED|Overall Study||8||
48573293|NCT05188261|101735090|FG001|STARTED|Overall Study||6||
48573294|NCT05188261|101735091|FG002|STARTED|Overall Study||6||
48129554|NCT01172938|100642677|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||58||
48129555|NCT01172938|100642678|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0||
48129556|NCT01172938|100642679|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0||
48129557|NCT01172938|100642680|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0||
48129558|NCT01172938|100642681|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0||
48129559|NCT01172938|100642682|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0||
48129560|NCT01172938|100642683|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0||
48573295|NCT05188261|101735092|FG003|STARTED|Overall Study||6||
48129561|NCT01172938|100642675|FG000|COMPLETED|Placebo-controlled Phase (Week 0-24)||150||
48129562|NCT01172938|100642676|FG001|COMPLETED|Placebo-controlled Phase (Week 0-24)||146||
48129563|NCT01172938|100642677|FG002|COMPLETED|Placebo-controlled Phase (Week 0-24)||148||
48129564|NCT01172938|100642678|FG003|COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
48129565|NCT01172938|100642679|FG004|COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
48129566|NCT01172938|100642680|FG005|COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
48129567|NCT01172938|100642681|FG006|COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
48129568|NCT01172938|100642682|FG007|COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
48129569|NCT01172938|100642683|FG008|COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
48129570|NCT01172938|100642675|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||18||
48129571|NCT01172938|100642676|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||22||
48129572|NCT01172938|100642677|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||20||
48129573|NCT01172938|100642678|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
48129574|NCT01172938|100642679|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
48129575|NCT01172938|100642680|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
48129576|NCT01172938|100642681|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
48129577|NCT01172938|100642682|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
48129578|NCT01172938|100642683|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
48129579|NCT01172938|100642675|FG000|STARTED|Active Treatment Phase (Weeks 25-52)||0||
48129580|NCT01172938|100642676|FG001|STARTED|Active Treatment Phase (Weeks 25-52)||136||
48129581|NCT01172938|100642677|FG002|STARTED|Active Treatment Phase (Weeks 25-52)||145||
48129582|NCT01172938|100642678|FG003|STARTED|Active Treatment Phase (Weeks 25-52)||51||
48129583|NCT01172938|100642679|FG004|STARTED|Active Treatment Phase (Weeks 25-52)||23||
48129584|NCT01172938|100642680|FG005|STARTED|Active Treatment Phase (Weeks 25-52)||49||
48129585|NCT01172938|100642681|FG006|STARTED|Active Treatment Phase (Weeks 25-52)||24||
48129586|NCT01172938|100642682|FG007|STARTED|Active Treatment Phase (Weeks 25-52)||0||
48129587|NCT01172938|100642683|FG008|STARTED|Active Treatment Phase (Weeks 25-52)||0||
48129588|NCT01172938|100642675|FG000|COMPLETED|Active Treatment Phase (Weeks 25-52)||0||
48129589|NCT01172938|100642676|FG001|COMPLETED|Active Treatment Phase (Weeks 25-52)||124||
48129590|NCT01172938|100642677|FG002|COMPLETED|Active Treatment Phase (Weeks 25-52)||130||
48129591|NCT01172938|100642678|FG003|COMPLETED|Active Treatment Phase (Weeks 25-52)||44||
48129592|NCT01172938|100642679|FG004|COMPLETED|Active Treatment Phase (Weeks 25-52)||19||
48129593|NCT01172938|100642680|FG005|COMPLETED|Active Treatment Phase (Weeks 25-52)||34||
48129594|NCT01172938|100642681|FG006|COMPLETED|Active Treatment Phase (Weeks 25-52)||22||
48129595|NCT01172938|100642682|FG007|COMPLETED|Active Treatment Phase (Weeks 25-52)||0||
48129596|NCT01172938|100642683|FG008|COMPLETED|Active Treatment Phase (Weeks 25-52)||0||
48129597|NCT01172938|100642675|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0||
48129598|NCT01172938|100642676|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||12||
48129599|NCT01172938|100642677|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15||
48129600|NCT01172938|100642678|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||7||
48129601|NCT01172938|100642679|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||4||
48129602|NCT01172938|100642680|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15||
48129603|NCT01172938|100642681|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||2||
48129604|NCT01172938|100642682|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0||
48129605|NCT01172938|100642683|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0||
48129606|NCT01172938|100642675|FG000|STARTED|Active-Treatment Phase (Weeks 52-104)||0||
48129607|NCT01172938|100642676|FG001|STARTED|Active-Treatment Phase (Weeks 52-104)||118||
48129608|NCT01172938|100642677|FG002|STARTED|Active-Treatment Phase (Weeks 52-104)||121||
48129609|NCT01172938|100642678|FG003|STARTED|Active-Treatment Phase (Weeks 52-104)||0||
48129610|NCT01172938|100642679|FG004|STARTED|Active-Treatment Phase (Weeks 52-104)||0||
48129611|NCT01172938|100642680|FG005|STARTED|Active-Treatment Phase (Weeks 52-104)||0||
48129612|NCT01172938|100642681|FG006|STARTED|Active-Treatment Phase (Weeks 52-104)||0||
48129613|NCT01172938|100642682|FG007|STARTED|Active-Treatment Phase (Weeks 52-104)||61||
48129614|NCT01172938|100642683|FG008|STARTED|Active-Treatment Phase (Weeks 52-104)||49||
48129615|NCT01172938|100642675|FG000|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0||
48129616|NCT01172938|100642676|FG001|COMPLETED|Active-Treatment Phase (Weeks 52-104)||95||
48129617|NCT01172938|100642677|FG002|COMPLETED|Active-Treatment Phase (Weeks 52-104)||100||
48129618|NCT01172938|100642678|FG003|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0||
48129619|NCT01172938|100642679|FG004|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0||
48129620|NCT01172938|100642680|FG005|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0||
48129621|NCT01172938|100642681|FG006|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0||
48129622|NCT01172938|100642682|FG007|COMPLETED|Active-Treatment Phase (Weeks 52-104)||46||
48129623|NCT01172938|100642683|FG008|COMPLETED|Active-Treatment Phase (Weeks 52-104)||45||
48129624|NCT01172938|100642675|FG000|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0||
48129625|NCT01172938|100642676|FG001|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||23||
48129626|NCT01172938|100642677|FG002|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||21||
48129627|NCT01172938|100642678|FG003|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0||
48129628|NCT01172938|100642679|FG004|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0||
48129629|NCT01172938|100642680|FG005|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0||
48129630|NCT01172938|100642681|FG006|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0||
48129631|NCT01172938|100642682|FG007|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||15||
48129632|NCT01172938|100642683|FG008|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||4||
48129633|NCT01172938|100642675|FG000|STARTED|Active-Treatment Phase Weeks (104-156)||0||
48129634|NCT01172938|100642676|FG001|STARTED|Active-Treatment Phase Weeks (104-156)||95||
48129635|NCT01172938|100642677|FG002|STARTED|Active-Treatment Phase Weeks (104-156)||100||
48129636|NCT01172938|100642678|FG003|STARTED|Active-Treatment Phase Weeks (104-156)||0||
48129637|NCT01172938|100642679|FG004|STARTED|Active-Treatment Phase Weeks (104-156)||0||
48129638|NCT01172938|100642680|FG005|STARTED|Active-Treatment Phase Weeks (104-156)||0||
48129639|NCT01172938|100642681|FG006|STARTED|Active-Treatment Phase Weeks (104-156)||0||
48129640|NCT01172938|100642682|FG007|STARTED|Active-Treatment Phase Weeks (104-156)||46||
48129641|NCT01172938|100642683|FG008|STARTED|Active-Treatment Phase Weeks (104-156)||45||
48129642|NCT01172938|100642675|FG000|COMPLETED|Active-Treatment Phase Weeks (104-156)||0||
48129643|NCT01172938|100642676|FG001|COMPLETED|Active-Treatment Phase Weeks (104-156)||84||
48129644|NCT01172938|100642677|FG002|COMPLETED|Active-Treatment Phase Weeks (104-156)||93||
48129645|NCT01172938|100642678|FG003|COMPLETED|Active-Treatment Phase Weeks (104-156)||0||
48701282|NCT01579565|102054196|FG001|NOT COMPLETED|Randomized||5||
48701283|NCT01579565|102054195|FG000|STARTED|Treated||202||
48701284|NCT01579565|102054196|FG001|STARTED|Treated||204||
48701285|NCT01579565|102054195|FG000|COMPLETED|Treated||200||
48701286|NCT01579565|102054196|FG001|COMPLETED|Treated||201||
48129646|NCT01172938|100642679|FG004|COMPLETED|Active-Treatment Phase Weeks (104-156)||0||
48129647|NCT01172938|100642680|FG005|COMPLETED|Active-Treatment Phase Weeks (104-156)||0||
48701287|NCT01579565|102054195|FG000|NOT COMPLETED|Treated||2||
48701288|NCT01579565|102054196|FG001|NOT COMPLETED|Treated||3||
48701289|NCT01229254|102054197|FG000|STARTED|Overall Study||42||
48398510|NCT00602771|101306336|FG001|STARTED|Overall Study||21||
48398511|NCT00602771|101306335|FG000|COMPLETED|Overall Study||62||
48398512|NCT00602771|101306336|FG001|COMPLETED|Overall Study||21||
48398513|NCT00602771|101306335|FG000|NOT COMPLETED|Overall Study||1||
48701290|NCT01229254|102054198|FG001|STARTED|Overall Study||74||
48701291|NCT01229254|102054199|FG002|STARTED|Overall Study||73||
48129648|NCT01172938|100642681|FG006|COMPLETED|Active-Treatment Phase Weeks (104-156)||0||
48129649|NCT01172938|100642682|FG007|COMPLETED|Active-Treatment Phase Weeks (104-156)||41||
48129650|NCT01172938|100642683|FG008|COMPLETED|Active-Treatment Phase Weeks (104-156)||41||
48129651|NCT01172938|100642675|FG000|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0||
48129652|NCT01172938|100642676|FG001|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||11||
48129653|NCT01172938|100642677|FG002|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||7||
48129654|NCT01172938|100642678|FG003|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0||
48129655|NCT01172938|100642679|FG004|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0||
48129656|NCT01172938|100642680|FG005|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0||
48398514|NCT00602771|101306336|FG001|NOT COMPLETED|Overall Study||0||
48398515|NCT02910219|101306337|FG000|STARTED|Overall Study||27||
48398516|NCT02910219|101306338|FG001|STARTED|Overall Study||26||
48701292|NCT01229254|102054197|FG000|COMPLETED|Overall Study||27||
48129657|NCT01172938|100642681|FG006|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0||
48129658|NCT01172938|100642682|FG007|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||5||
48129659|NCT01172938|100642683|FG008|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||4||
48129660|NCT01172938|100642675|FG000|STARTED|Active-Treatment Phase (Weeks 156-208)||0||
48129661|NCT01172938|100642676|FG001|STARTED|Active-Treatment Phase (Weeks 156-208)||84||
48129662|NCT01172938|100642677|FG002|STARTED|Active-Treatment Phase (Weeks 156-208)||93||
48129663|NCT01172938|100642678|FG003|STARTED|Active-Treatment Phase (Weeks 156-208)||0||
48129664|NCT01172938|100642679|FG004|STARTED|Active-Treatment Phase (Weeks 156-208)||0||
48129665|NCT01172938|100642680|FG005|STARTED|Active-Treatment Phase (Weeks 156-208)||0||
48129666|NCT01172938|100642681|FG006|STARTED|Active-Treatment Phase (Weeks 156-208)||0||
48129667|NCT01172938|100642682|FG007|STARTED|Active-Treatment Phase (Weeks 156-208)||41||
48129668|NCT01172938|100642683|FG008|STARTED|Active-Treatment Phase (Weeks 156-208)||41||
48129669|NCT01172938|100642675|FG000|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0||
48129670|NCT01172938|100642676|FG001|COMPLETED|Active-Treatment Phase (Weeks 156-208)||75||
48129671|NCT01172938|100642677|FG002|COMPLETED|Active-Treatment Phase (Weeks 156-208)||88||
48284193|NCT01775124|101021450|FG000|STARTED|Core Period||168||
48701293|NCT01229254|102054198|FG001|COMPLETED|Overall Study||58||
48701294|NCT01229254|102054199|FG002|COMPLETED|Overall Study||61||
48701295|NCT01229254|102054197|FG000|NOT COMPLETED|Overall Study||15||
48701296|NCT01229254|102054198|FG001|NOT COMPLETED|Overall Study||16||
48701297|NCT01229254|102054199|FG002|NOT COMPLETED|Overall Study||12||
48701298|NCT01271010|102054200|FG000|STARTED|Overall Study||89||
48701299|NCT01271010|102054200|FG000|COMPLETED|Overall Study||28||
48701300|NCT01271010|102054200|FG000|NOT COMPLETED|Overall Study||61||
48701301|NCT02545517|102054201|FG000|STARTED|Overall Study||126||
48701302|NCT02545517|102054202|FG001|STARTED|Overall Study||157||
48701303|NCT02545517|102054203|FG002|STARTED|Overall Study||176||
48701304|NCT02545517|102054201|FG000|COMPLETED|Overall Study||98||
48701305|NCT02545517|102054202|FG001|COMPLETED|Overall Study||123||
48701306|NCT02545517|102054203|FG002|COMPLETED|Overall Study||135||
48701307|NCT02545517|102054201|FG000|NOT COMPLETED|Overall Study||28||
48701308|NCT02545517|102054202|FG001|NOT COMPLETED|Overall Study||34||
48701309|NCT02545517|102054203|FG002|NOT COMPLETED|Overall Study||41||
48284194|NCT01775124|101021451|FG001|STARTED|Core Period||166||
48284195|NCT01775124|101021450|FG000|Full Analysis Set|Core Period||167||
48284196|NCT01775124|101021451|FG001|Full Analysis Set|Core Period||166||
48284197|NCT01775124|101021450|FG000|Per Protocol Set|Core Period||157||
48284198|NCT01775124|101021451|FG001|Per Protocol Set|Core Period||155||
48284199|NCT01775124|101021450|FG000|Safety Set|Core Period||166||
48284200|NCT01775124|101021451|FG001|Safety Set|Core Period||166||
48284201|NCT01775124|101021450|FG000|COMPLETED|Core Period||157||
48284202|NCT01775124|101021451|FG001|COMPLETED|Core Period||156||
48284203|NCT01775124|101021450|FG000|NOT COMPLETED|Core Period||11||
48284204|NCT01775124|101021451|FG001|NOT COMPLETED|Core Period||10||
48284205|NCT01775124|101021450|FG000|STARTED|Extension Period||157||
48284206|NCT01775124|101021451|FG001|STARTED|Extension Period||156||
48284207|NCT01775124|101021450|FG000|COMPLETED|Extension Period||145||
48284208|NCT01775124|101021451|FG001|COMPLETED|Extension Period||138||
48284209|NCT01775124|101021450|FG000|NOT COMPLETED|Extension Period||12||
48284210|NCT01775124|101021451|FG001|NOT COMPLETED|Extension Period||18||
48284211|NCT04410523|101021452|FG000|STARTED|Overall Study||36||
48284212|NCT04410523|101021453|FG001|STARTED|Overall Study||37||
48284213|NCT04410523|101021454|FG002|STARTED|Overall Study||37||
48284214|NCT04410523|101021455|FG003|STARTED|Overall Study||76||
48398517|NCT02910219|101306337|FG000|COMPLETED|Overall Study||26||
48398518|NCT02910219|101306338|FG001|COMPLETED|Overall Study||25||
48398519|NCT02910219|101306337|FG000|NOT COMPLETED|Overall Study||1||
48398520|NCT02910219|101306338|FG001|NOT COMPLETED|Overall Study||1||
48573296|NCT05188261|101735093|FG004|STARTED|Overall Study||6||
48573297|NCT05188261|101735089|FG000|COMPLETED|Overall Study||8||
48573298|NCT05188261|101735090|FG001|COMPLETED|Overall Study||6||
48573299|NCT05188261|101735091|FG002|COMPLETED|Overall Study||6||
48573300|NCT05188261|101735092|FG003|COMPLETED|Overall Study||6||
48573301|NCT05188261|101735093|FG004|COMPLETED|Overall Study||6||
48573302|NCT05188261|101735089|FG000|NOT COMPLETED|Overall Study||0||
48573303|NCT05188261|101735090|FG001|NOT COMPLETED|Overall Study||0||
48573304|NCT05188261|101735091|FG002|NOT COMPLETED|Overall Study||0||
48573305|NCT05188261|101735092|FG003|NOT COMPLETED|Overall Study||0||
48573306|NCT05188261|101735093|FG004|NOT COMPLETED|Overall Study||0||
48573307|NCT01721096|101735094|FG000|STARTED|Overall Study||323||
48573308|NCT01721096|101735095|FG001|STARTED|Overall Study||213||
48573309|NCT01721096|101735094|FG000|COMPLETED|Overall Study||3||
48573310|NCT01721096|101735095|FG001|COMPLETED|Overall Study||9||
48573311|NCT01721096|101735094|FG000|NOT COMPLETED|Overall Study||320||
48701310|NCT04085458|102054204|FG000|STARTED|Overall Study||32||
48701311|NCT04085458|102054204|FG000|COMPLETED|Overall Study||27||
48701312|NCT04085458|102054204|FG000|NOT COMPLETED|Overall Study||5||
48701313|NCT00882583|102054205|FG000|STARTED|Overall Study||7||
48701314|NCT00882583|102054206|FG001|STARTED|Overall Study||12||
48701315|NCT00882583|102054205|FG000|COMPLETED|Overall Study||6||
48701316|NCT00882583|102054206|FG001|COMPLETED|Overall Study||11||
48701317|NCT00882583|102054205|FG000|NOT COMPLETED|Overall Study||1||
48701318|NCT00882583|102054206|FG001|NOT COMPLETED|Overall Study||1||
48701319|NCT03487588|102054207|FG000|STARTED|Overall Study||41||
48701320|NCT03487588|102054207|FG000|COMPLETED|Overall Study||41||
48701321|NCT03487588|102054207|FG000|NOT COMPLETED|Overall Study||0||
48701322|NCT01024972|102054208|FG000|STARTED|Overall Study||16||
48701323|NCT01024972|102054209|FG001|STARTED|Overall Study||15||
48701324|NCT01024972|102054208|FG000|COMPLETED|Overall Study||16||
48701325|NCT01024972|102054209|FG001|COMPLETED|Overall Study||15||
48701326|NCT01024972|102054208|FG000|NOT COMPLETED|Overall Study||0||
48701327|NCT01024972|102054209|FG001|NOT COMPLETED|Overall Study||0||
48284215|NCT04410523|101021456|FG004|STARTED|Overall Study||74||
48573312|NCT01721096|101735095|FG001|NOT COMPLETED|Overall Study||204||
48573313|NCT04164732|101735096|FG000|STARTED|Treatment run-in Period||46||
48284216|NCT04410523|101021457|FG005|STARTED|Overall Study||75||
48284217|NCT04410523|101021452|FG000|COMPLETED|Overall Study||32||
48398521|NCT00407550|101306339|FG000|STARTED|Overall Study||10||
48573314|NCT04164732|101735097|FG001|STARTED|Treatment run-in Period||0||
48573315|NCT04164732|101735098|FG002|STARTED|Treatment run-in Period||0||
48573316|NCT04164732|101735096|FG000|COMPLETED|Treatment run-in Period||40||
48701328|NCT00737568|102054210|FG000|STARTED|Treatment Period Through Week 240||141||
48701329|NCT00737568|102054211|FG001|STARTED|Treatment Period Through Week 240||139||
48701330|NCT00737568|102054210|FG000|COMPLETED|Treatment Period Through Week 240||121||
48398522|NCT00407550|101306340|FG001|STARTED|Overall Study||9||
48398523|NCT00407550|101306339|FG000|COMPLETED|Overall Study||7||
48398524|NCT00407550|101306340|FG001|COMPLETED|Overall Study||5||
48398525|NCT00407550|101306339|FG000|NOT COMPLETED|Overall Study||3||
48398526|NCT00407550|101306340|FG001|NOT COMPLETED|Overall Study||4||
48398527|NCT00856986|101306341|FG000|STARTED|Run-in Period, Weeks -12-0||161||
48398528|NCT00856986|101306342|FG001|STARTED|Run-in Period, Weeks -12-0||162||
48398529|NCT00856986|101306343|FG002|STARTED|Run-in Period, Weeks -12-0||498||
48398530|NCT00856986|101306344|FG003|STARTED|Run-in Period, Weeks -12-0||167||
48398531|NCT00856986|101306345|FG004|STARTED|Run-in Period, Weeks -12-0||0||
48573317|NCT04164732|101735097|FG001|COMPLETED|Treatment run-in Period||0||
48573318|NCT04164732|101735098|FG002|COMPLETED|Treatment run-in Period||0||
48573319|NCT04164732|101735096|FG000|NOT COMPLETED|Treatment run-in Period||6||
48573320|NCT04164732|101735097|FG001|NOT COMPLETED|Treatment run-in Period||0||
48573321|NCT04164732|101735098|FG002|NOT COMPLETED|Treatment run-in Period||0||
48573322|NCT04164732|101735096|FG000|STARTED|Randomized Treatment Period||0||
48573323|NCT04164732|101735097|FG001|STARTED|Randomized Treatment Period||20||
48573324|NCT04164732|101735098|FG002|STARTED|Randomized Treatment Period||20||
48573325|NCT04164732|101735096|FG000|Randomized Analysis Set|Randomized Treatment Period||0|The randomized analysis set (RAS) consisted of all randomized patients.|
48573326|NCT04164732|101735097|FG001|Randomized Analysis Set|Randomized Treatment Period||20|The randomized analysis set (RAS) consisted of all randomized patients.|
48573327|NCT04164732|101735098|FG002|Randomized Analysis Set|Randomized Treatment Period||20|The randomized analysis set (RAS) consisted of all randomized patients.|
48573328|NCT04164732|101735096|FG000|Per Protocol Analysis Set|Randomized Treatment Period||0|The per-protocol analysis set (PPS) is a subset of the RAS that consists of all randomized patients who had no major protocol deviations with relevant impact on pharmacodynamics/efficacy data and who are at least 80% compliant with the overall study drug administration.|
48573329|NCT04164732|101735097|FG001|Per Protocol Analysis Set|Randomized Treatment Period||19|The per-protocol analysis set (PPS) is a subset of the RAS that consists of all randomized patients who had no major protocol deviations with relevant impact on pharmacodynamics/efficacy data and who are at least 80% compliant with the overall study drug administration.|
48573330|NCT04164732|101735098|FG002|Per Protocol Analysis Set|Randomized Treatment Period||19|The per-protocol analysis set (PPS) is a subset of the RAS that consists of all randomized patients who had no major protocol deviations with relevant impact on pharmacodynamics/efficacy data and who are at least 80% compliant with the overall study drug administration.|
48573331|NCT04164732|101735096|FG000|COMPLETED|Randomized Treatment Period||0||
48573332|NCT04164732|101735097|FG001|COMPLETED|Randomized Treatment Period||17||
48573333|NCT04164732|101735098|FG002|COMPLETED|Randomized Treatment Period||19||
48573334|NCT04164732|101735096|FG000|NOT COMPLETED|Randomized Treatment Period||0||
48573335|NCT04164732|101735097|FG001|NOT COMPLETED|Randomized Treatment Period||3||
48573336|NCT04164732|101735098|FG002|NOT COMPLETED|Randomized Treatment Period||1||
48573337|NCT03693612|101735099|FG000|STARTED|Overall Study||1||
48701331|NCT00737568|102054211|FG001|COMPLETED|Treatment Period Through Week 240||118||
48701332|NCT00737568|102054210|FG000|NOT COMPLETED|Treatment Period Through Week 240||20||
48701333|NCT00737568|102054211|FG001|NOT COMPLETED|Treatment Period Through Week 240||21||
48701334|NCT00737568|102054210|FG000|STARTED|Treatment-Free Follow-up (TFFU) Period||38||
48701335|NCT00737568|102054211|FG001|STARTED|Treatment-Free Follow-up (TFFU) Period||37||
48701336|NCT00737568|102054210|FG000|COMPLETED|Treatment-Free Follow-up (TFFU) Period||12||
48701337|NCT00737568|102054211|FG001|COMPLETED|Treatment-Free Follow-up (TFFU) Period||19||
48701338|NCT00737568|102054210|FG000|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||26||
48701339|NCT00737568|102054211|FG001|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||18||
48701340|NCT01734395|102054212|FG000|STARTED|Overall Study||1882||
48701341|NCT01734395|102054212|FG000|COMPLETED|Overall Study||1472||
48701342|NCT01734395|102054212|FG000|NOT COMPLETED|Overall Study||410||
48701343|NCT00350870|102054213|FG000|STARTED|Overall Study||27||
48701344|NCT00350870|102054214|FG001|STARTED|Overall Study||28||
48701345|NCT00350870|102054215|FG002|STARTED|Overall Study||22||
48701346|NCT00350870|102054216|FG003|STARTED|Overall Study||22||
48129672|NCT01172938|100642678|FG003|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0||
48129673|NCT01172938|100642679|FG004|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0||
48129674|NCT01172938|100642680|FG005|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0||
48129675|NCT01172938|100642681|FG006|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0||
48129676|NCT01172938|100642682|FG007|COMPLETED|Active-Treatment Phase (Weeks 156-208)||32||
48129677|NCT01172938|100642683|FG008|COMPLETED|Active-Treatment Phase (Weeks 156-208)||34||
48129678|NCT01172938|100642675|FG000|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0||
48129679|NCT01172938|100642676|FG001|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9||
48129680|NCT01172938|100642677|FG002|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||5||
48129681|NCT01172938|100642678|FG003|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0||
48129682|NCT01172938|100642679|FG004|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0||
48129683|NCT01172938|100642680|FG005|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0||
48284218|NCT04410523|101021453|FG001|COMPLETED|Overall Study||32||
48398532|NCT00856986|101306341|FG000|COMPLETED|Run-in Period, Weeks -12-0||161||
48398533|NCT00856986|101306342|FG001|COMPLETED|Run-in Period, Weeks -12-0||162||
48398534|NCT00856986|101306343|FG002|COMPLETED|Run-in Period, Weeks -12-0||498||
48398535|NCT00856986|101306344|FG003|COMPLETED|Run-in Period, Weeks -12-0||0||
48573338|NCT03693612|101735100|FG001|STARTED|Overall Study||1||
48573339|NCT03693612|101735101|FG002|STARTED|Overall Study||5||
48573340|NCT03693612|101735102|FG003|STARTED|Overall Study||3||
48573341|NCT03693612|101735103|FG004|STARTED|Overall Study||16||
48573342|NCT03693612|101735104|FG005|STARTED|Overall Study||0||
48573343|NCT03693612|101735105|FG006|STARTED|Overall Study||0||
48573344|NCT03693612|101735099|FG000|COMPLETED|Overall Study||1||
48573345|NCT03693612|101735100|FG001|COMPLETED|Overall Study||0||
48573346|NCT03693612|101735101|FG002|COMPLETED|Overall Study||4||
48573347|NCT03693612|101735102|FG003|COMPLETED|Overall Study||3||
48573348|NCT03693612|101735103|FG004|COMPLETED|Overall Study||10||
48284219|NCT04410523|101021454|FG002|COMPLETED|Overall Study||35||
48284220|NCT04410523|101021455|FG003|COMPLETED|Overall Study||69||
48284221|NCT04410523|101021456|FG004|COMPLETED|Overall Study||71||
48284222|NCT04410523|101021457|FG005|COMPLETED|Overall Study||65||
48284223|NCT04410523|101021452|FG000|NOT COMPLETED|Overall Study||4||
48284224|NCT04410523|101021453|FG001|NOT COMPLETED|Overall Study||5||
48284225|NCT04410523|101021454|FG002|NOT COMPLETED|Overall Study||2||
48573349|NCT03693612|101735104|FG005|COMPLETED|Overall Study||0||
48573350|NCT03693612|101735105|FG006|COMPLETED|Overall Study||0||
48573351|NCT03693612|101735099|FG000|NOT COMPLETED|Overall Study||0||
48701347|NCT00350870|102054213|FG000|Had at Least 1 Day of Med|Overall Study||19||
48701348|NCT00350870|102054214|FG001|Had at Least 1 Day of Med|Overall Study||24||
48701349|NCT00350870|102054215|FG002|Had at Least 1 Day of Med|Overall Study||18||
48701350|NCT00350870|102054216|FG003|Had at Least 1 Day of Med|Overall Study||19||
48701351|NCT00350870|102054213|FG000|COMPLETED|Overall Study||5||
48129684|NCT01172938|100642681|FG006|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0||
48129685|NCT01172938|100642682|FG007|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9||
48129686|NCT01172938|100642683|FG008|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||7||
48129687|NCT01172938|100642675|FG000|STARTED|Active-Treatment Phase (Weeks 208-260)||0||
48129688|NCT01172938|100642676|FG001|STARTED|Active-Treatment Phase (Weeks 208-260)||75||
48129689|NCT01172938|100642677|FG002|STARTED|Active-Treatment Phase (Weeks 208-260)||88||
48129690|NCT01172938|100642678|FG003|STARTED|Active-Treatment Phase (Weeks 208-260)||0||
48129691|NCT01172938|100642679|FG004|STARTED|Active-Treatment Phase (Weeks 208-260)||0||
48129692|NCT01172938|100642680|FG005|STARTED|Active-Treatment Phase (Weeks 208-260)||0||
48129693|NCT01172938|100642681|FG006|STARTED|Active-Treatment Phase (Weeks 208-260)||0||
48129694|NCT01172938|100642682|FG007|STARTED|Active-Treatment Phase (Weeks 208-260)||32||
48129695|NCT01172938|100642683|FG008|STARTED|Active-Treatment Phase (Weeks 208-260)||34||
48129696|NCT01172938|100642675|FG000|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0||
48129697|NCT01172938|100642676|FG001|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0||
48129698|NCT01172938|100642677|FG002|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0||
48129699|NCT01172938|100642678|FG003|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0||
48129700|NCT01172938|100642679|FG004|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0||
48284226|NCT04410523|101021455|FG003|NOT COMPLETED|Overall Study||7||
48284227|NCT04410523|101021456|FG004|NOT COMPLETED|Overall Study||3||
48284228|NCT04410523|101021457|FG005|NOT COMPLETED|Overall Study||10||
48284229|NCT03459443|101021458|FG000|STARTED|Overall Study||22||
48284230|NCT03459443|101021458|FG000|Received at Least 1 Dose of Study Drug|Overall Study||22||
48284231|NCT03459443|101021458|FG000|COMPLETED|Overall Study||0||
48284232|NCT03459443|101021458|FG000|NOT COMPLETED|Overall Study||22||
48573352|NCT03693612|101735100|FG001|NOT COMPLETED|Overall Study||1||
48573353|NCT03693612|101735101|FG002|NOT COMPLETED|Overall Study||1||
48573354|NCT03693612|101735102|FG003|NOT COMPLETED|Overall Study||0||
48573355|NCT03693612|101735103|FG004|NOT COMPLETED|Overall Study||6||
48573356|NCT03693612|101735104|FG005|NOT COMPLETED|Overall Study||0||
48573357|NCT03693612|101735105|FG006|NOT COMPLETED|Overall Study||0||
48573358|NCT03318861|101735106|FG000|STARTED|Overall Study||3||
48573359|NCT03318861|101735107|FG001|STARTED|Overall Study||4||
48573360|NCT03318861|101735108|FG002|STARTED|Overall Study||3||
48573361|NCT03318861|101735109|FG003|STARTED|Overall Study||4||
48573362|NCT03318861|101735110|FG004|STARTED|Overall Study||3||
48701352|NCT00350870|102054214|FG001|COMPLETED|Overall Study||11||
48701353|NCT00350870|102054215|FG002|COMPLETED|Overall Study||6||
48701354|NCT00350870|102054216|FG003|COMPLETED|Overall Study||7||
48701355|NCT00350870|102054213|FG000|NOT COMPLETED|Overall Study||22||
48701356|NCT00350870|102054214|FG001|NOT COMPLETED|Overall Study||17||
48284233|NCT04308395|101021459|FG000|STARTED|Overall Study||108||
48284234|NCT04308395|101021459|FG000|COMPLETED|Overall Study||3||
48284235|NCT04308395|101021459|FG000|NOT COMPLETED|Overall Study||105||
48284236|NCT02316002|101021460|FG000|STARTED|Overall Study||51||
48284237|NCT02316002|101021460|FG000|COMPLETED|Overall Study||45||
48701357|NCT00350870|102054215|FG002|NOT COMPLETED|Overall Study||16||
48284238|NCT02316002|101021460|FG000|NOT COMPLETED|Overall Study||6||
48573363|NCT03318861|101735106|FG000|COMPLETED|Overall Study||0||
48573364|NCT03318861|101735107|FG001|COMPLETED|Overall Study||0||
48573365|NCT03318861|101735108|FG002|COMPLETED|Overall Study||0||
48573366|NCT03318861|101735109|FG003|COMPLETED|Overall Study||0||
48573367|NCT03318861|101735110|FG004|COMPLETED|Overall Study||0||
48701358|NCT00350870|102054216|FG003|NOT COMPLETED|Overall Study||15||
48701359|NCT00459875|102054217|FG000|STARTED|Overall Study||24||
48573368|NCT03318861|101735106|FG000|NOT COMPLETED|Overall Study||3||
48573369|NCT03318861|101735107|FG001|NOT COMPLETED|Overall Study||4||
48573370|NCT03318861|101735108|FG002|NOT COMPLETED|Overall Study||3||
48573371|NCT03318861|101735109|FG003|NOT COMPLETED|Overall Study||4||
48573372|NCT03318861|101735110|FG004|NOT COMPLETED|Overall Study||3||
48573373|NCT00931255|101735111|FG000|STARTED|Overall Study||17||
48573374|NCT00931255|101735112|FG001|STARTED|Overall Study||15||
48573375|NCT00931255|101735111|FG000|COMPLETED|Overall Study||15||
48573376|NCT00931255|101735112|FG001|COMPLETED|Overall Study||12||
48573377|NCT00931255|101735111|FG000|NOT COMPLETED|Overall Study||2||
48573378|NCT00931255|101735112|FG001|NOT COMPLETED|Overall Study||3||
48573379|NCT04042623|101735113|FG000|STARTED|Overall Study||1||
48398536|NCT00856986|101306345|FG004|COMPLETED|Run-in Period, Weeks -12-0||0||
48398537|NCT00856986|101306341|FG000|NOT COMPLETED|Run-in Period, Weeks -12-0||0||
48573380|NCT04042623|101735113|FG000|COMPLETED|Overall Study||0||
48573381|NCT04042623|101735113|FG000|NOT COMPLETED|Overall Study||1||
48573382|NCT03935425|101735114|FG000|STARTED|Overall Study||25||
48573383|NCT03935425|101735115|FG001|STARTED|Overall Study||25||
48573384|NCT03935425|101735114|FG000|COMPLETED|Overall Study||24||
48573385|NCT03935425|101735115|FG001|COMPLETED|Overall Study||24||
48573386|NCT03935425|101735114|FG000|NOT COMPLETED|Overall Study||1||
48573387|NCT03935425|101735115|FG001|NOT COMPLETED|Overall Study||1||
48573388|NCT01737710|101735116|FG000|STARTED|Overall Study||114||
48573389|NCT01737710|101735117|FG001|STARTED|Overall Study||105||
48573390|NCT01737710|101735118|FG002|STARTED|Overall Study||105||
48573391|NCT01737710|101735119|FG003|STARTED|Overall Study||23||
48573392|NCT01737710|101735120|FG004|STARTED|Overall Study||21||
48573393|NCT01737710|101735116|FG000|COMPLETED|Overall Study||112||
48573394|NCT01737710|101735117|FG001|COMPLETED|Overall Study||101||
48573395|NCT01737710|101735118|FG002|COMPLETED|Overall Study||102||
48573396|NCT01737710|101735119|FG003|COMPLETED|Overall Study||23||
48573397|NCT01737710|101735120|FG004|COMPLETED|Overall Study||21||
48573398|NCT01737710|101735116|FG000|NOT COMPLETED|Overall Study||2||
48573399|NCT01737710|101735117|FG001|NOT COMPLETED|Overall Study||4||
48573400|NCT01737710|101735118|FG002|NOT COMPLETED|Overall Study||3||
48573401|NCT01737710|101735119|FG003|NOT COMPLETED|Overall Study||0||
48573402|NCT01737710|101735120|FG004|NOT COMPLETED|Overall Study||0||
48573403|NCT05251337|101735121|FG000|STARTED|Overall Study||24||
48573404|NCT05251337|101735122|FG001|STARTED|Overall Study||21||
48573405|NCT05251337|101735123|FG002|STARTED|Overall Study||26||
48573406|NCT05251337|101735124|FG003|STARTED|Overall Study||21||
48573407|NCT05251337|101735121|FG000|COMPLETED|Overall Study||19||
48573408|NCT05251337|101735122|FG001|COMPLETED|Overall Study||15||
48573409|NCT05251337|101735123|FG002|COMPLETED|Overall Study||20||
48573410|NCT05251337|101735124|FG003|COMPLETED|Overall Study||17||
48573411|NCT05251337|101735121|FG000|NOT COMPLETED|Overall Study||5||
48573412|NCT05251337|101735122|FG001|NOT COMPLETED|Overall Study||6||
48573413|NCT05251337|101735123|FG002|NOT COMPLETED|Overall Study||6||
48573414|NCT05251337|101735124|FG003|NOT COMPLETED|Overall Study||4||
48573415|NCT02282813|101735125|FG000|STARTED|Overall Study||103||
48573416|NCT02282813|101735126|FG001|STARTED|Overall Study||153||
48573417|NCT02282813|101735127|FG002|STARTED|Overall Study||42||
48573418|NCT02282813|101735125|FG000|COMPLETED|Overall Study||91||
48573419|NCT02282813|101735126|FG001|COMPLETED|Overall Study||130||
48573420|NCT02282813|101735127|FG002|COMPLETED|Overall Study||39||
48573421|NCT02282813|101735125|FG000|NOT COMPLETED|Overall Study||12||
48573422|NCT02282813|101735126|FG001|NOT COMPLETED|Overall Study||23||
48573423|NCT02282813|101735127|FG002|NOT COMPLETED|Overall Study||3||
48573424|NCT01500382|101735128|FG000|STARTED|Treatment Period 1||1||
48573425|NCT01500382|101735129|FG001|STARTED|Treatment Period 1||1||
48573426|NCT01500382|101735130|FG002|STARTED|Treatment Period 1||1||
48573427|NCT01500382|101735131|FG003|STARTED|Treatment Period 1||1||
48284239|NCT01590082|101021461|FG000|STARTED|Overall Study||11||
48284240|NCT01590082|101021462|FG001|STARTED|Overall Study||1||
48284241|NCT01590082|101021461|FG000|COMPLETED|Overall Study||9||
48284242|NCT01590082|101021462|FG001|COMPLETED|Overall Study||1||
48284243|NCT01590082|101021461|FG000|NOT COMPLETED|Overall Study||2||
48284244|NCT01590082|101021462|FG001|NOT COMPLETED|Overall Study||0||
48398538|NCT00856986|101306342|FG001|NOT COMPLETED|Run-in Period, Weeks -12-0||0||
48398539|NCT00856986|101306343|FG002|NOT COMPLETED|Run-in Period, Weeks -12-0||0||
48573428|NCT01500382|101735128|FG000|COMPLETED|Treatment Period 1||1||
48573429|NCT01500382|101735129|FG001|COMPLETED|Treatment Period 1||1||
48573430|NCT01500382|101735130|FG002|COMPLETED|Treatment Period 1||1||
48573431|NCT01500382|101735131|FG003|COMPLETED|Treatment Period 1||1||
48573432|NCT01500382|101735128|FG000|NOT COMPLETED|Treatment Period 1||0||
48573433|NCT01500382|101735129|FG001|NOT COMPLETED|Treatment Period 1||0||
48573434|NCT01500382|101735130|FG002|NOT COMPLETED|Treatment Period 1||0||
48284245|NCT00993668|101021463|FG000|STARTED|Single-Blind Period||114||
48284246|NCT00993668|101021464|FG001|STARTED|Single-Blind Period||110||
48284247|NCT00993668|101021463|FG000|COMPLETED|Single-Blind Period||110||
48284248|NCT00993668|101021464|FG001|COMPLETED|Single-Blind Period||107||
48284249|NCT00993668|101021463|FG000|NOT COMPLETED|Single-Blind Period||4||
48398540|NCT00856986|101306344|FG003|NOT COMPLETED|Run-in Period, Weeks -12-0||167||
48573435|NCT01500382|101735131|FG003|NOT COMPLETED|Treatment Period 1||0||
48398541|NCT00856986|101306345|FG004|NOT COMPLETED|Run-in Period, Weeks -12-0||0||
48398542|NCT00856986|101306341|FG000|STARTED|Main Period, Weeks 0-26||161||
48398543|NCT00856986|101306342|FG001|STARTED|Main Period, Weeks 0-26||162||
48398544|NCT00856986|101306343|FG002|STARTED|Main Period, Weeks 0-26||498||
48398545|NCT00856986|101306344|FG003|STARTED|Main Period, Weeks 0-26||0||
48398546|NCT00856986|101306345|FG004|STARTED|Main Period, Weeks 0-26||0||
48398547|NCT00856986|101306341|FG000|COMPLETED|Main Period, Weeks 0-26||127||
48398548|NCT00856986|101306342|FG001|COMPLETED|Main Period, Weeks 0-26||144||
48398549|NCT00856986|101306343|FG002|COMPLETED|Main Period, Weeks 0-26||470||
48398550|NCT00856986|101306344|FG003|COMPLETED|Main Period, Weeks 0-26||0||
48573436|NCT01500382|101735128|FG000|STARTED|Washout Period||1||
48573437|NCT01500382|101735129|FG001|STARTED|Washout Period||1||
48573438|NCT01500382|101735130|FG002|STARTED|Washout Period||1||
48284250|NCT00993668|101021464|FG001|NOT COMPLETED|Single-Blind Period||3||
48284251|NCT00993668|101021463|FG000|STARTED|Open-Label Period||109||
48284252|NCT00993668|101021464|FG001|STARTED|Open-Label Period||106||
48284253|NCT00993668|101021463|FG000|COMPLETED|Open-Label Period||86||
48701360|NCT00459875|102054217|FG000|COMPLETED|Overall Study||21||
48701361|NCT00459875|102054217|FG000|NOT COMPLETED|Overall Study||3||
48701362|NCT01369641|102054218|FG000|STARTED|Overall Study||1||
48701363|NCT01369641|102054218|FG000|COMPLETED|Overall Study||0||
48701364|NCT01369641|102054218|FG000|NOT COMPLETED|Overall Study||1||
48573439|NCT01500382|101735131|FG003|STARTED|Washout Period||1||
48573440|NCT01500382|101735128|FG000|COMPLETED|Washout Period||1||
48573441|NCT01500382|101735129|FG001|COMPLETED|Washout Period||1||
48573442|NCT01500382|101735130|FG002|COMPLETED|Washout Period||0||
48573443|NCT01500382|101735131|FG003|COMPLETED|Washout Period||1||
48573444|NCT01500382|101735128|FG000|NOT COMPLETED|Washout Period||0||
48701365|NCT03650803|102054219|FG000|STARTED|Overall Study||14||
48701366|NCT03650803|102054219|FG000|COMPLETED|Overall Study||8||
48701367|NCT03650803|102054219|FG000|NOT COMPLETED|Overall Study||6||
48701368|NCT01468207|102054220|FG000|STARTED|Treatment Period 1||154||
48701369|NCT01468207|102054221|FG001|STARTED|Treatment Period 1||153||
48701370|NCT01468207|102054222|FG002|STARTED|Treatment Period 1||0||
48701371|NCT01468207|102054223|FG003|STARTED|Treatment Period 1||0||
48701372|NCT01468207|102054224|FG004|STARTED|Treatment Period 1||0||
48701373|NCT01468207|102054225|FG005|STARTED|Treatment Period 1||0||
48701374|NCT01468207|102054220|FG000|Received Study Drug|Treatment Period 1||152||
48701375|NCT01468207|102054221|FG001|Received Study Drug|Treatment Period 1||153||
48284254|NCT00993668|101021464|FG001|COMPLETED|Open-Label Period||91||
48284255|NCT00993668|101021463|FG000|NOT COMPLETED|Open-Label Period||23||
48284256|NCT00993668|101021464|FG001|NOT COMPLETED|Open-Label Period||15||
48284257|NCT02663518|101021465|FG000|STARTED|Part 1: Phase 1a Escalation||3||
48284258|NCT02663518|101021466|FG001|STARTED|Part 1: Phase 1a Escalation||3||
48284259|NCT02663518|101021467|FG002|STARTED|Part 1: Phase 1a Escalation||7||
48398551|NCT00856986|101306345|FG004|COMPLETED|Main Period, Weeks 0-26||0||
48398552|NCT00856986|101306341|FG000|NOT COMPLETED|Main Period, Weeks 0-26||34||
48398553|NCT00856986|101306342|FG001|NOT COMPLETED|Main Period, Weeks 0-26||18||
48398554|NCT00856986|101306343|FG002|NOT COMPLETED|Main Period, Weeks 0-26||28||
48573445|NCT01500382|101735129|FG001|NOT COMPLETED|Washout Period||0||
48701376|NCT01468207|102054222|FG002|Received Study Drug|Treatment Period 1||0||
48701377|NCT01468207|102054223|FG003|Received Study Drug|Treatment Period 1||0||
48701378|NCT01468207|102054224|FG004|Received Study Drug|Treatment Period 1||0||
48701379|NCT01468207|102054225|FG005|Received Study Drug|Treatment Period 1||0||
48701380|NCT01468207|102054220|FG000|COMPLETED|Treatment Period 1||145||
48701381|NCT01468207|102054221|FG001|COMPLETED|Treatment Period 1||145||
48701382|NCT01468207|102054222|FG002|COMPLETED|Treatment Period 1||0||
48701383|NCT01468207|102054223|FG003|COMPLETED|Treatment Period 1||0||
48701384|NCT01468207|102054224|FG004|COMPLETED|Treatment Period 1||0||
48701385|NCT01468207|102054225|FG005|COMPLETED|Treatment Period 1||0||
48701386|NCT01468207|102054220|FG000|NOT COMPLETED|Treatment Period 1||9||
48701387|NCT01468207|102054221|FG001|NOT COMPLETED|Treatment Period 1||8||
48701388|NCT01468207|102054222|FG002|NOT COMPLETED|Treatment Period 1||0||
48701389|NCT01468207|102054223|FG003|NOT COMPLETED|Treatment Period 1||0||
48701390|NCT01468207|102054224|FG004|NOT COMPLETED|Treatment Period 1||0||
48701391|NCT01468207|102054225|FG005|NOT COMPLETED|Treatment Period 1||0||
48701392|NCT01468207|102054220|FG000|STARTED|Treatment Period 2||0||
48701393|NCT01468207|102054221|FG001|STARTED|Treatment Period 2||0||
48701394|NCT01468207|102054222|FG002|STARTED|Treatment Period 2||145||
48701395|NCT01468207|102054223|FG003|STARTED|Treatment Period 2||49||
48701396|NCT01468207|102054224|FG004|STARTED|Treatment Period 2||48||
48701397|NCT01468207|102054225|FG005|STARTED|Treatment Period 2||48||
48284260|NCT02663518|101021468|FG003|STARTED|Part 1: Phase 1a Escalation||5||
48398555|NCT00856986|101306344|FG003|NOT COMPLETED|Main Period, Weeks 0-26||0||
48398556|NCT00856986|101306345|FG004|NOT COMPLETED|Main Period, Weeks 0-26||0||
48284261|NCT02663518|101021469|FG004|STARTED|Part 1: Phase 1a Escalation||0||
48398557|NCT00856986|101306341|FG000|STARTED|Extension Period, Weeks 26-52||127||
48398558|NCT00856986|101306342|FG001|STARTED|Extension Period, Weeks 26-52||144||
48573446|NCT01500382|101735130|FG002|NOT COMPLETED|Washout Period||1||
48573447|NCT01500382|101735131|FG003|NOT COMPLETED|Washout Period||0||
48573448|NCT01500382|101735128|FG000|STARTED|Treatment Period 2||1||
48573449|NCT01500382|101735129|FG001|STARTED|Treatment Period 2||1||
48573450|NCT01500382|101735130|FG002|STARTED|Treatment Period 2||0||
48129701|NCT01172938|100642680|FG005|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0||
48129702|NCT01172938|100642681|FG006|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0||
48129703|NCT01172938|100642682|FG007|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||25||
48129704|NCT01172938|100642683|FG008|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0||
48129705|NCT01172938|100642675|FG000|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0||
48129706|NCT01172938|100642676|FG001|COMPLETED|Active-Treatment Phase (Weeks 208-260)||72||
48129707|NCT01172938|100642677|FG002|COMPLETED|Active-Treatment Phase (Weeks 208-260)||80||
48129708|NCT01172938|100642678|FG003|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0||
48129709|NCT01172938|100642679|FG004|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0||
48129710|NCT01172938|100642680|FG005|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0||
48129711|NCT01172938|100642681|FG006|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0||
48129712|NCT01172938|100642682|FG007|COMPLETED|Active-Treatment Phase (Weeks 208-260)||29||
48129713|NCT01172938|100642683|FG008|COMPLETED|Active-Treatment Phase (Weeks 208-260)||32||
48129714|NCT01172938|100642675|FG000|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0||
48129715|NCT01172938|100642676|FG001|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3||
48129716|NCT01172938|100642677|FG002|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||8||
48573451|NCT01500382|101735131|FG003|STARTED|Treatment Period 2||1||
48701398|NCT01468207|102054220|FG000|COMPLETED|Treatment Period 2||0||
48701399|NCT01468207|102054221|FG001|COMPLETED|Treatment Period 2||0||
48701400|NCT01468207|102054222|FG002|COMPLETED|Treatment Period 2||93||
48701401|NCT01468207|102054223|FG003|COMPLETED|Treatment Period 2||22||
48129717|NCT01172938|100642678|FG003|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0||
48129718|NCT01172938|100642679|FG004|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0||
48129719|NCT01172938|100642680|FG005|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0||
48573452|NCT01500382|101735128|FG000|COMPLETED|Treatment Period 2||1||
48573453|NCT01500382|101735129|FG001|COMPLETED|Treatment Period 2||1||
48573454|NCT01500382|101735130|FG002|COMPLETED|Treatment Period 2||0||
48573455|NCT01500382|101735131|FG003|COMPLETED|Treatment Period 2||1||
48573456|NCT01500382|101735128|FG000|NOT COMPLETED|Treatment Period 2||0||
48573457|NCT01500382|101735129|FG001|NOT COMPLETED|Treatment Period 2||0||
48701402|NCT01468207|102054224|FG004|COMPLETED|Treatment Period 2||27||
48701403|NCT01468207|102054225|FG005|COMPLETED|Treatment Period 2||28||
48701404|NCT01468207|102054220|FG000|NOT COMPLETED|Treatment Period 2||0||
48701405|NCT01468207|102054221|FG001|NOT COMPLETED|Treatment Period 2||0||
48701406|NCT01468207|102054222|FG002|NOT COMPLETED|Treatment Period 2||52||
48701407|NCT01468207|102054223|FG003|NOT COMPLETED|Treatment Period 2||27||
48701408|NCT01468207|102054224|FG004|NOT COMPLETED|Treatment Period 2||21||
48701409|NCT01468207|102054225|FG005|NOT COMPLETED|Treatment Period 2||20||
48129720|NCT01172938|100642681|FG006|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0||
48129721|NCT01172938|100642682|FG007|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3||
48129722|NCT01172938|100642683|FG008|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||2||
48129723|NCT01842789|100642684|FG000|STARTED|Overall Study||10||
48129724|NCT01842789|100642685|FG001|STARTED|Overall Study||8||
48129725|NCT01842789|100642684|FG000|COMPLETED|Overall Study||10||
48129726|NCT01842789|100642685|FG001|COMPLETED|Overall Study||8||
48129727|NCT01842789|100642684|FG000|NOT COMPLETED|Overall Study||0||
48573458|NCT01500382|101735130|FG002|NOT COMPLETED|Treatment Period 2||0||
48573459|NCT01500382|101735131|FG003|NOT COMPLETED|Treatment Period 2||0||
48573460|NCT00955955|101735132|FG000|STARTED|Overall Study||19||
48129728|NCT01842789|100642685|FG001|NOT COMPLETED|Overall Study||0||
48129729|NCT00019682|100642686|FG000|STARTED|Overall Study||94||
48129730|NCT00019682|100642687|FG001|STARTED|Overall Study||91||
48129731|NCT00019682|100642686|FG000|COMPLETED|Overall Study||93||
48129732|NCT00019682|100642687|FG001|COMPLETED|Overall Study||85||
48129733|NCT00019682|100642686|FG000|NOT COMPLETED|Overall Study||1||
48129734|NCT00019682|100642687|FG001|NOT COMPLETED|Overall Study||6||
48284262|NCT02663518|101021470|FG005|STARTED|Part 1: Phase 1a Escalation||0||
48284263|NCT02663518|101021471|FG006|STARTED|Part 1: Phase 1a Escalation||0||
48284264|NCT02663518|101021472|FG007|STARTED|Part 1: Phase 1a Escalation||0||
48284265|NCT02663518|101021473|FG008|STARTED|Part 1: Phase 1a Escalation||0||
48573461|NCT00955955|101735133|FG001|STARTED|Overall Study||28||
48573462|NCT00955955|101735134|FG002|STARTED|Overall Study||28||
48573463|NCT00955955|101735132|FG000|COMPLETED|Overall Study||17||
48573464|NCT00955955|101735133|FG001|COMPLETED|Overall Study||28||
48573465|NCT00955955|101735134|FG002|COMPLETED|Overall Study||28||
48573466|NCT00955955|101735132|FG000|NOT COMPLETED|Overall Study||2||
48284266|NCT02663518|101021474|FG009|STARTED|Part 1: Phase 1a Escalation||0||
48284267|NCT02663518|101021475|FG010|STARTED|Part 1: Phase 1a Escalation||0||
48573467|NCT00955955|101735133|FG001|NOT COMPLETED|Overall Study||0||
48573468|NCT00955955|101735134|FG002|NOT COMPLETED|Overall Study||0||
48573469|NCT01014169|101735135|FG000|STARTED|Overall Study||65||
48573470|NCT01014169|101735136|FG001|STARTED|Overall Study||61||
48573471|NCT01014169|101735135|FG000|COMPLETED|Overall Study||58||
48573472|NCT01014169|101735136|FG001|COMPLETED|Overall Study||48||
48573473|NCT01014169|101735135|FG000|NOT COMPLETED|Overall Study||7||
48573474|NCT01014169|101735136|FG001|NOT COMPLETED|Overall Study||13||
48573475|NCT02417142|101735137|FG000|STARTED|Overall Study||35||
48573476|NCT02417142|101735138|FG001|STARTED|Overall Study||35||
48573477|NCT02417142|101735137|FG000|COMPLETED|Overall Study||19||
48573478|NCT02417142|101735138|FG001|COMPLETED|Overall Study||22||
48573479|NCT02417142|101735137|FG000|NOT COMPLETED|Overall Study||16||
48573480|NCT02417142|101735138|FG001|NOT COMPLETED|Overall Study||13||
48573481|NCT01920958|101735139|FG000|STARTED|Overall Study||233||
48573482|NCT01920958|101735139|FG000|COMPLETED|Overall Study||228||
48573483|NCT01920958|101735139|FG000|NOT COMPLETED|Overall Study||5||
48573484|NCT01163851|101735140|FG000|STARTED|Overall Study||13||
48573485|NCT01163851|101735141|FG001|STARTED|Overall Study||12||
48284268|NCT02663518|101021476|FG011|STARTED|Part 1: Phase 1a Escalation||0||
48284269|NCT02663518|101021477|FG012|STARTED|Part 1: Phase 1a Escalation||0||
48573486|NCT01163851|101735140|FG000|Treated|Overall Study||12||
48573487|NCT01163851|101735141|FG001|Treated|Overall Study||12||
48573488|NCT01163851|101735140|FG000|COMPLETED|Overall Study||12||
48129735|NCT05101252|100642688|FG000|STARTED|Overall Study||37||
48129736|NCT05101252|100642689|FG001|STARTED|Overall Study||37||
48284270|NCT02663518|101021478|FG013|STARTED|Part 1: Phase 1a Escalation||0||
48284271|NCT02663518|101021465|FG000|COMPLETED|Part 1: Phase 1a Escalation||0||
48129737|NCT05101252|100642688|FG000|COMPLETED|Overall Study||35||
48129738|NCT05101252|100642689|FG001|COMPLETED|Overall Study||34||
48573489|NCT01163851|101735141|FG001|COMPLETED|Overall Study||11||
48573490|NCT01163851|101735140|FG000|NOT COMPLETED|Overall Study||1||
48573491|NCT01163851|101735141|FG001|NOT COMPLETED|Overall Study||1||
48573492|NCT01827267|101735142|FG000|STARTED|Overall Study||18|Number of subjects randomized|
48573493|NCT01827267|101735143|FG001|STARTED|Overall Study||44|Number of subjects randomized|
48573494|NCT01827267|101735142|FG000|Received Study Drug|Overall Study||17||
48573495|NCT01827267|101735143|FG001|Received Study Drug|Overall Study||43||
48573496|NCT01827267|101735142|FG000|Crossed Over to Neratinib + Temsirolimus|Overall Study||11||
48573497|NCT01827267|101735143|FG001|Crossed Over to Neratinib + Temsirolimus|Overall Study||0||
48284272|NCT02663518|101021466|FG001|COMPLETED|Part 1: Phase 1a Escalation||0||
48284273|NCT02663518|101021467|FG002|COMPLETED|Part 1: Phase 1a Escalation||0||
48284274|NCT02663518|101021468|FG003|COMPLETED|Part 1: Phase 1a Escalation||1||
48284275|NCT02663518|101021469|FG004|COMPLETED|Part 1: Phase 1a Escalation||0||
48284276|NCT02663518|101021470|FG005|COMPLETED|Part 1: Phase 1a Escalation||0||
48284277|NCT02663518|101021471|FG006|COMPLETED|Part 1: Phase 1a Escalation||0||
48284278|NCT02663518|101021472|FG007|COMPLETED|Part 1: Phase 1a Escalation||0||
48284279|NCT02663518|101021473|FG008|COMPLETED|Part 1: Phase 1a Escalation||0||
48284280|NCT02663518|101021474|FG009|COMPLETED|Part 1: Phase 1a Escalation||0||
48284281|NCT02663518|101021475|FG010|COMPLETED|Part 1: Phase 1a Escalation||0||
48284282|NCT02663518|101021476|FG011|COMPLETED|Part 1: Phase 1a Escalation||0||
48284283|NCT02663518|101021477|FG012|COMPLETED|Part 1: Phase 1a Escalation||0||
48284284|NCT02663518|101021478|FG013|COMPLETED|Part 1: Phase 1a Escalation||0||
48284285|NCT02663518|101021465|FG000|NOT COMPLETED|Part 1: Phase 1a Escalation||3||
48284286|NCT02663518|101021466|FG001|NOT COMPLETED|Part 1: Phase 1a Escalation||3||
48573498|NCT01827267|101735142|FG000|COMPLETED|Overall Study||13|Subjects completed study upon death.|
48573499|NCT01827267|101735143|FG001|COMPLETED|Overall Study||32|Subjects completed study upon death.|
48573500|NCT01827267|101735142|FG000|NOT COMPLETED|Overall Study||5||
48573501|NCT01827267|101735143|FG001|NOT COMPLETED|Overall Study||12||
48573502|NCT01743560|101735144|FG000|STARTED|Overall Study||52||
48573503|NCT01743560|101735144|FG000|Full Analysis Set (FAS)|Overall Study||49||
48284287|NCT02663518|101021467|FG002|NOT COMPLETED|Part 1: Phase 1a Escalation||7||
48284288|NCT02663518|101021468|FG003|NOT COMPLETED|Part 1: Phase 1a Escalation||4||
48284289|NCT02663518|101021469|FG004|NOT COMPLETED|Part 1: Phase 1a Escalation||0||
48284290|NCT02663518|101021470|FG005|NOT COMPLETED|Part 1: Phase 1a Escalation||0||
48284291|NCT02663518|101021471|FG006|NOT COMPLETED|Part 1: Phase 1a Escalation||0||
48284292|NCT02663518|101021472|FG007|NOT COMPLETED|Part 1: Phase 1a Escalation||0||
48284293|NCT02663518|101021473|FG008|NOT COMPLETED|Part 1: Phase 1a Escalation||0||
48284294|NCT02663518|101021474|FG009|NOT COMPLETED|Part 1: Phase 1a Escalation||0||
48284295|NCT02663518|101021475|FG010|NOT COMPLETED|Part 1: Phase 1a Escalation||0||
48284296|NCT02663518|101021476|FG011|NOT COMPLETED|Part 1: Phase 1a Escalation||0||
48284297|NCT02663518|101021477|FG012|NOT COMPLETED|Part 1: Phase 1a Escalation||0||
48284298|NCT02663518|101021478|FG013|NOT COMPLETED|Part 1: Phase 1a Escalation||0||
48284299|NCT02663518|101021465|FG000|STARTED|Part 2 and 3: Phase 1b Expansion||0||
48284300|NCT02663518|101021466|FG001|STARTED|Part 2 and 3: Phase 1b Expansion||0||
48284301|NCT02663518|101021467|FG002|STARTED|Part 2 and 3: Phase 1b Expansion||0||
48284302|NCT02663518|101021468|FG003|STARTED|Part 2 and 3: Phase 1b Expansion||0||
48284303|NCT02663518|101021469|FG004|STARTED|Part 2 and 3: Phase 1b Expansion||107||
48284304|NCT02663518|101021470|FG005|STARTED|Part 2 and 3: Phase 1b Expansion||11||
48573504|NCT01743560|101735144|FG000|Safety Analysis Set (SAF)|Overall Study||49||
48573505|NCT01743560|101735144|FG000|COMPLETED|Overall Study||9||
48573506|NCT01743560|101735144|FG000|NOT COMPLETED|Overall Study||43||
48573507|NCT01932060|101735145|FG000|STARTED|Overall Study||27||
48573508|NCT01932060|101735146|FG001|STARTED|Overall Study||24||
48573509|NCT01932060|101735145|FG000|COMPLETED|Overall Study||27||
48573510|NCT01932060|101735146|FG001|COMPLETED|Overall Study||24||
48573511|NCT01932060|101735145|FG000|NOT COMPLETED|Overall Study||0||
48573512|NCT01932060|101735146|FG001|NOT COMPLETED|Overall Study||0||
48573513|NCT02826486|101735147|FG000|STARTED|Overall Study||37||
48573514|NCT02826486|101735148|FG001|STARTED|Overall Study||43||
48573515|NCT02826486|101735147|FG000|COMPLETED|Overall Study||0||
48573516|NCT02826486|101735148|FG001|COMPLETED|Overall Study||0||
48573517|NCT02826486|101735147|FG000|NOT COMPLETED|Overall Study||37||
48573518|NCT02826486|101735148|FG001|NOT COMPLETED|Overall Study||43||
48573519|NCT03421210|101735149|FG000|STARTED|Overall Study||88||
48284305|NCT02663518|101021471|FG006|STARTED|Part 2 and 3: Phase 1b Expansion||40||
48284306|NCT02663518|101021472|FG007|STARTED|Part 2 and 3: Phase 1b Expansion||42||
48284307|NCT02663518|101021473|FG008|STARTED|Part 2 and 3: Phase 1b Expansion||0||
48284308|NCT02663518|101021474|FG009|STARTED|Part 2 and 3: Phase 1b Expansion||0||
48284309|NCT02663518|101021475|FG010|STARTED|Part 2 and 3: Phase 1b Expansion||0||
48573520|NCT03421210|101735149|FG000|Received Functional Magnetic Resonance Imaging (fMRI)|Overall Study||42||
48573521|NCT03421210|101735149|FG000|COMPLETED|Overall Study||35||
48573522|NCT03421210|101735149|FG000|NOT COMPLETED|Overall Study||53||
48573523|NCT01579084|101735150|FG000|STARTED|Overall Study||8||
48573524|NCT01579084|101735151|FG001|STARTED|Overall Study||8||
48573525|NCT01579084|101735152|FG002|STARTED|Overall Study||8||
48573526|NCT01579084|101735153|FG003|STARTED|Overall Study||8||
48573527|NCT01579084|101735154|FG004|STARTED|Overall Study||8||
48573528|NCT01579084|101735155|FG005|STARTED|Overall Study||8||
48573529|NCT01579084|101735156|FG006|STARTED|Overall Study||4||
48284310|NCT02663518|101021476|FG011|STARTED|Part 2 and 3: Phase 1b Expansion||0||
48284311|NCT02663518|101021477|FG012|STARTED|Part 2 and 3: Phase 1b Expansion||0||
48284312|NCT02663518|101021478|FG013|STARTED|Part 2 and 3: Phase 1b Expansion||0||
48284313|NCT02663518|101021465|FG000|COMPLETED|Part 2 and 3: Phase 1b Expansion||0||
48284314|NCT02663518|101021466|FG001|COMPLETED|Part 2 and 3: Phase 1b Expansion||0||
48284315|NCT02663518|101021467|FG002|COMPLETED|Part 2 and 3: Phase 1b Expansion||0||
48284316|NCT02663518|101021468|FG003|COMPLETED|Part 2 and 3: Phase 1b Expansion||0||
48284317|NCT02663518|101021469|FG004|COMPLETED|Part 2 and 3: Phase 1b Expansion||29||
48284318|NCT02663518|101021470|FG005|COMPLETED|Part 2 and 3: Phase 1b Expansion||10||
48284319|NCT02663518|101021471|FG006|COMPLETED|Part 2 and 3: Phase 1b Expansion||6||
48284320|NCT02663518|101021472|FG007|COMPLETED|Part 2 and 3: Phase 1b Expansion||15||
48284321|NCT02663518|101021473|FG008|COMPLETED|Part 2 and 3: Phase 1b Expansion||0||
48284322|NCT02663518|101021474|FG009|COMPLETED|Part 2 and 3: Phase 1b Expansion||0||
48284323|NCT02663518|101021475|FG010|COMPLETED|Part 2 and 3: Phase 1b Expansion||0||
48284324|NCT02663518|101021476|FG011|COMPLETED|Part 2 and 3: Phase 1b Expansion||0||
48398559|NCT00856986|101306343|FG002|STARTED|Extension Period, Weeks 26-52||470||
48398560|NCT00856986|101306344|FG003|STARTED|Extension Period, Weeks 26-52||0||
48398561|NCT00856986|101306345|FG004|STARTED|Extension Period, Weeks 26-52||0||
48398562|NCT00856986|101306341|FG000|Enrolled in Extension|Extension Period, Weeks 26-52||122||
48398563|NCT00856986|101306342|FG001|Enrolled in Extension|Extension Period, Weeks 26-52||140||
48398564|NCT00856986|101306343|FG002|Enrolled in Extension|Extension Period, Weeks 26-52||461||
48129739|NCT05101252|100642688|FG000|NOT COMPLETED|Overall Study||2||
48129740|NCT05101252|100642689|FG001|NOT COMPLETED|Overall Study||3||
48129741|NCT00345397|100642690|FG000|STARTED|Overall Study||7||
48129742|NCT00345397|100642690|FG000|COMPLETED|Overall Study||6||
48129743|NCT00345397|100642690|FG000|NOT COMPLETED|Overall Study||1||
48129744|NCT02448303|100642691|FG000|STARTED|Overall Study||38||
48573530|NCT01579084|101735157|FG007|STARTED|Overall Study||4||
48573531|NCT01579084|101735158|FG008|STARTED|Overall Study||4||
48573532|NCT01579084|101735159|FG009|STARTED|Overall Study||4||
48573533|NCT01579084|101735150|FG000|COMPLETED|Overall Study||8||
48573534|NCT01579084|101735151|FG001|COMPLETED|Overall Study||8||
48573535|NCT01579084|101735152|FG002|COMPLETED|Overall Study||8||
48573536|NCT01579084|101735153|FG003|COMPLETED|Overall Study||8||
48573537|NCT01579084|101735154|FG004|COMPLETED|Overall Study||8||
48573538|NCT01579084|101735155|FG005|COMPLETED|Overall Study||8||
48573539|NCT01579084|101735156|FG006|COMPLETED|Overall Study||4||
48129745|NCT02448303|100642692|FG001|STARTED|Overall Study||36||
48129746|NCT02448303|100642691|FG000|Enrolled|Overall Study||38||
48284325|NCT02663518|101021477|FG012|COMPLETED|Part 2 and 3: Phase 1b Expansion||0||
48284326|NCT02663518|101021478|FG013|COMPLETED|Part 2 and 3: Phase 1b Expansion||0||
48398565|NCT00856986|101306344|FG003|Enrolled in Extension|Extension Period, Weeks 26-52||0||
48398566|NCT00856986|101306345|FG004|Enrolled in Extension|Extension Period, Weeks 26-52||0||
48398567|NCT00856986|101306341|FG000|COMPLETED|Extension Period, Weeks 26-52||108||
48398568|NCT00856986|101306342|FG001|COMPLETED|Extension Period, Weeks 26-52||130||
48398569|NCT00856986|101306343|FG002|COMPLETED|Extension Period, Weeks 26-52||432||
48398570|NCT00856986|101306344|FG003|COMPLETED|Extension Period, Weeks 26-52||0||
48573540|NCT01579084|101735157|FG007|COMPLETED|Overall Study||4||
48701410|NCT01418703|102054226|FG000|STARTED|Overall Study||13||
48701411|NCT01418703|102054227|FG001|STARTED|Overall Study||13||
48701412|NCT01418703|102054228|FG002|STARTED|Overall Study||6||
48701413|NCT01418703|102054229|FG003|STARTED|Overall Study||6||
48701414|NCT01418703|102054226|FG000|COMPLETED|Overall Study||13||
48129747|NCT02448303|100642692|FG001|Enrolled|Overall Study||36||
48129748|NCT02448303|100642691|FG000|Received Study Medication|Overall Study||33||
48129749|NCT02448303|100642692|FG001|Received Study Medication|Overall Study||35||
48284327|NCT02663518|101021465|FG000|NOT COMPLETED|Part 2 and 3: Phase 1b Expansion||0||
48284328|NCT02663518|101021466|FG001|NOT COMPLETED|Part 2 and 3: Phase 1b Expansion||0||
48284329|NCT02663518|101021467|FG002|NOT COMPLETED|Part 2 and 3: Phase 1b Expansion||0||
48284330|NCT02663518|101021468|FG003|NOT COMPLETED|Part 2 and 3: Phase 1b Expansion||0||
48284331|NCT02663518|101021469|FG004|NOT COMPLETED|Part 2 and 3: Phase 1b Expansion||78||
48284332|NCT02663518|101021470|FG005|NOT COMPLETED|Part 2 and 3: Phase 1b Expansion||1||
48284333|NCT02663518|101021471|FG006|NOT COMPLETED|Part 2 and 3: Phase 1b Expansion||34||
48284334|NCT02663518|101021472|FG007|NOT COMPLETED|Part 2 and 3: Phase 1b Expansion||27||
48284335|NCT02663518|101021473|FG008|NOT COMPLETED|Part 2 and 3: Phase 1b Expansion||0||
48398571|NCT00856986|101306345|FG004|COMPLETED|Extension Period, Weeks 26-52||0||
48573541|NCT01579084|101735158|FG008|COMPLETED|Overall Study||4||
48573542|NCT01579084|101735159|FG009|COMPLETED|Overall Study||4||
48573543|NCT01579084|101735150|FG000|NOT COMPLETED|Overall Study||0||
48573544|NCT01579084|101735151|FG001|NOT COMPLETED|Overall Study||0||
48701415|NCT01418703|102054227|FG001|COMPLETED|Overall Study||13||
48129750|NCT02448303|100642691|FG000|Discontinued Study|Overall Study||38||
48284336|NCT02663518|101021474|FG009|NOT COMPLETED|Part 2 and 3: Phase 1b Expansion||0||
48284337|NCT02663518|101021475|FG010|NOT COMPLETED|Part 2 and 3: Phase 1b Expansion||0||
48284338|NCT02663518|101021476|FG011|NOT COMPLETED|Part 2 and 3: Phase 1b Expansion||0||
48398572|NCT00856986|101306341|FG000|NOT COMPLETED|Extension Period, Weeks 26-52||19||
48398573|NCT00856986|101306342|FG001|NOT COMPLETED|Extension Period, Weeks 26-52||14||
48284339|NCT02663518|101021477|FG012|NOT COMPLETED|Part 2 and 3: Phase 1b Expansion||0||
48284340|NCT02663518|101021478|FG013|NOT COMPLETED|Part 2 and 3: Phase 1b Expansion||0||
48284341|NCT02663518|101021465|FG000|STARTED|Part 4: Phase 1b Dose Optimization||0||
48284342|NCT02663518|101021466|FG001|STARTED|Part 4: Phase 1b Dose Optimization||0||
48284343|NCT02663518|101021467|FG002|STARTED|Part 4: Phase 1b Dose Optimization||0||
48284344|NCT02663518|101021468|FG003|STARTED|Part 4: Phase 1b Dose Optimization||0||
48284345|NCT02663518|101021469|FG004|STARTED|Part 4: Phase 1b Dose Optimization||0||
48284346|NCT02663518|101021470|FG005|STARTED|Part 4: Phase 1b Dose Optimization||0||
48284347|NCT02663518|101021471|FG006|STARTED|Part 4: Phase 1b Dose Optimization||0||
48284348|NCT02663518|101021472|FG007|STARTED|Part 4: Phase 1b Dose Optimization||0||
48284349|NCT02663518|101021473|FG008|STARTED|Part 4: Phase 1b Dose Optimization||3||
48284350|NCT02663518|101021474|FG009|STARTED|Part 4: Phase 1b Dose Optimization||3||
48284351|NCT02663518|101021475|FG010|STARTED|Part 4: Phase 1b Dose Optimization||6||
48284352|NCT02663518|101021476|FG011|STARTED|Part 4: Phase 1b Dose Optimization||3||
48284353|NCT02663518|101021477|FG012|STARTED|Part 4: Phase 1b Dose Optimization||12||
48284354|NCT02663518|101021478|FG013|STARTED|Part 4: Phase 1b Dose Optimization||4||
48284355|NCT02663518|101021465|FG000|COMPLETED|Part 4: Phase 1b Dose Optimization||0||
48284356|NCT02663518|101021466|FG001|COMPLETED|Part 4: Phase 1b Dose Optimization||0||
48284357|NCT02663518|101021467|FG002|COMPLETED|Part 4: Phase 1b Dose Optimization||0||
48398574|NCT00856986|101306343|FG002|NOT COMPLETED|Extension Period, Weeks 26-52||38||
48398575|NCT00856986|101306344|FG003|NOT COMPLETED|Extension Period, Weeks 26-52||0||
48398576|NCT00856986|101306345|FG004|NOT COMPLETED|Extension Period, Weeks 26-52||0||
48398577|NCT03170258|101306346|FG000|STARTED|Overall Study||46||
48398578|NCT03170258|101306347|FG001|STARTED|Overall Study||0||
48398579|NCT03170258|101306346|FG000|COMPLETED|Overall Study||39||
48398580|NCT03170258|101306347|FG001|COMPLETED|Overall Study||0||
48398581|NCT03170258|101306346|FG000|NOT COMPLETED|Overall Study||7||
48398582|NCT03170258|101306347|FG001|NOT COMPLETED|Overall Study||0||
48398583|NCT00609804|101306348|FG000|STARTED|Overall Study||25||
48398584|NCT00609804|101306349|FG001|STARTED|Overall Study||28||
48398585|NCT00609804|101306348|FG000|COMPLETED|Overall Study||0||
48398586|NCT00609804|101306349|FG001|COMPLETED|Overall Study||0||
48398587|NCT00609804|101306348|FG000|NOT COMPLETED|Overall Study||25||
48398588|NCT00609804|101306349|FG001|NOT COMPLETED|Overall Study||28||
48398589|NCT02905825|101306350|FG000|STARTED|Overall Study||53||
48398590|NCT02905825|101306350|FG000|COMPLETED|Overall Study||41||
48398591|NCT02905825|101306350|FG000|NOT COMPLETED|Overall Study||12||
48398592|NCT03136484|101306351|FG000|STARTED|Overall Study||394||
48398593|NCT03136484|101306352|FG001|STARTED|Overall Study||394||
48398594|NCT03136484|101306351|FG000|Exposed|Overall Study||392||
48398595|NCT03136484|101306352|FG001|Exposed|Overall Study||394||
48398596|NCT03136484|101306351|FG000|COMPLETED|Overall Study||367||
48398597|NCT03136484|101306352|FG001|COMPLETED|Overall Study||372||
48398598|NCT03136484|101306351|FG000|NOT COMPLETED|Overall Study||27||
48398599|NCT03136484|101306352|FG001|NOT COMPLETED|Overall Study||22||
48284358|NCT02663518|101021468|FG003|COMPLETED|Part 4: Phase 1b Dose Optimization||0||
48284359|NCT02663518|101021469|FG004|COMPLETED|Part 4: Phase 1b Dose Optimization||0||
48284360|NCT02663518|101021470|FG005|COMPLETED|Part 4: Phase 1b Dose Optimization||0||
48284361|NCT02663518|101021471|FG006|COMPLETED|Part 4: Phase 1b Dose Optimization||0||
48284362|NCT02663518|101021472|FG007|COMPLETED|Part 4: Phase 1b Dose Optimization||0||
48284363|NCT02663518|101021473|FG008|COMPLETED|Part 4: Phase 1b Dose Optimization||3||
48284364|NCT02663518|101021474|FG009|COMPLETED|Part 4: Phase 1b Dose Optimization||1||
48284365|NCT02663518|101021475|FG010|COMPLETED|Part 4: Phase 1b Dose Optimization||3||
48284366|NCT02663518|101021476|FG011|COMPLETED|Part 4: Phase 1b Dose Optimization||0||
48284367|NCT02663518|101021477|FG012|COMPLETED|Part 4: Phase 1b Dose Optimization||4||
48284368|NCT02663518|101021478|FG013|COMPLETED|Part 4: Phase 1b Dose Optimization||1||
48284369|NCT02663518|101021465|FG000|NOT COMPLETED|Part 4: Phase 1b Dose Optimization||0||
48284370|NCT02663518|101021466|FG001|NOT COMPLETED|Part 4: Phase 1b Dose Optimization||0||
48284371|NCT02663518|101021467|FG002|NOT COMPLETED|Part 4: Phase 1b Dose Optimization||0||
48284372|NCT02663518|101021468|FG003|NOT COMPLETED|Part 4: Phase 1b Dose Optimization||0||
48398600|NCT03186261|101306353|FG000|STARTED|Overall Study||22||22
48398601|NCT03186261|101306354|FG001|STARTED|Overall Study||22||22
48398602|NCT03186261|101306353|FG000|COMPLETED|Overall Study||22||22
48398603|NCT03186261|101306354|FG001|COMPLETED|Overall Study||22||22
48398604|NCT03186261|101306353|FG000|NOT COMPLETED|Overall Study||0||0
48398605|NCT03186261|101306354|FG001|NOT COMPLETED|Overall Study||0||0
48398606|NCT00239356|101306355|FG000|STARTED|Overall Study||97||
48398607|NCT00239356|101306356|FG001|STARTED|Overall Study||20||
48398608|NCT00239356|101306355|FG000|COMPLETED|Overall Study||58||
48398609|NCT00239356|101306356|FG001|COMPLETED|Overall Study||11||
48398610|NCT00239356|101306355|FG000|NOT COMPLETED|Overall Study||39||
48398611|NCT00239356|101306356|FG001|NOT COMPLETED|Overall Study||9||
48398612|NCT02571972|101306357|FG000|STARTED|Overall Study||14||
48398613|NCT02571972|101306357|FG000|COMPLETED|Overall Study||10||
48398614|NCT02571972|101306357|FG000|NOT COMPLETED|Overall Study||4||
48573545|NCT01579084|101735152|FG002|NOT COMPLETED|Overall Study||0||
48573546|NCT01579084|101735153|FG003|NOT COMPLETED|Overall Study||0||
48573547|NCT01579084|101735154|FG004|NOT COMPLETED|Overall Study||0||
48573548|NCT01579084|101735155|FG005|NOT COMPLETED|Overall Study||0||
48573549|NCT01579084|101735156|FG006|NOT COMPLETED|Overall Study||0||
48573550|NCT01579084|101735157|FG007|NOT COMPLETED|Overall Study||0||
48573551|NCT01579084|101735158|FG008|NOT COMPLETED|Overall Study||0||
48573552|NCT01579084|101735159|FG009|NOT COMPLETED|Overall Study||0||
48573553|NCT03491462|101735160|FG000|STARTED|Overall Study||160||
48573554|NCT03491462|101735161|FG001|STARTED|Overall Study||79||
48573555|NCT03491462|101735160|FG000|COMPLETED|Overall Study||122||
48573556|NCT03491462|101735161|FG001|COMPLETED|Overall Study||63||
48573557|NCT03491462|101735160|FG000|NOT COMPLETED|Overall Study||38||
48573558|NCT03491462|101735161|FG001|NOT COMPLETED|Overall Study||16||
48573559|NCT00552396|101735162|FG000|STARTED|Overall Study||4||
48573560|NCT00552396|101735163|FG001|STARTED|Overall Study||3||
48573561|NCT00552396|101735164|FG002|STARTED|Overall Study||3||
48573562|NCT00552396|101735165|FG003|STARTED|Overall Study||6||
48573563|NCT00552396|101735166|FG004|STARTED|Overall Study||3||
48573564|NCT00552396|101735167|FG005|STARTED|Overall Study||3||
48573565|NCT00552396|101735168|FG006|STARTED|Overall Study||10||
48573566|NCT00552396|101735162|FG000|COMPLETED|Overall Study||1||
48573567|NCT00552396|101735163|FG001|COMPLETED|Overall Study||0||
48573568|NCT00552396|101735164|FG002|COMPLETED|Overall Study||0||
48573569|NCT00552396|101735165|FG003|COMPLETED|Overall Study||0||
48573570|NCT00552396|101735166|FG004|COMPLETED|Overall Study||0||
48573571|NCT00552396|101735167|FG005|COMPLETED|Overall Study||0||
48573572|NCT00552396|101735168|FG006|COMPLETED|Overall Study||1||
48573573|NCT00552396|101735162|FG000|NOT COMPLETED|Overall Study||3||
48573574|NCT00552396|101735163|FG001|NOT COMPLETED|Overall Study||3||
48573575|NCT00552396|101735164|FG002|NOT COMPLETED|Overall Study||3||
48573576|NCT00552396|101735165|FG003|NOT COMPLETED|Overall Study||6||
48573577|NCT00552396|101735166|FG004|NOT COMPLETED|Overall Study||3||
48573578|NCT00552396|101735167|FG005|NOT COMPLETED|Overall Study||3||
48573579|NCT00552396|101735168|FG006|NOT COMPLETED|Overall Study||9||
48573580|NCT01220466|101735169|FG000|STARTED|Overall Study||11||
48573581|NCT01220466|101735170|FG001|STARTED|Overall Study||56||
48573582|NCT01220466|101735171|FG002|STARTED|Overall Study||10||
48573583|NCT01220466|101735169|FG000|COMPLETED|Overall Study||11||
48573584|NCT01220466|101735170|FG001|COMPLETED|Overall Study||56||
48573585|NCT01220466|101735171|FG002|COMPLETED|Overall Study||10||
48573586|NCT01220466|101735169|FG000|NOT COMPLETED|Overall Study||0||
48573587|NCT01220466|101735170|FG001|NOT COMPLETED|Overall Study||0||
48573588|NCT01220466|101735171|FG002|NOT COMPLETED|Overall Study||0||
48573589|NCT04283149|101735172|FG000|STARTED|Overall Study||327||327
48573590|NCT04283149|101735173|FG001|STARTED|Overall Study||327||302
48573591|NCT04283149|101735172|FG000|Postoperative Month 6|Overall Study||321||321
48573592|NCT04283149|101735173|FG001|Postoperative Month 6|Overall Study||321||298
48573593|NCT04283149|101735172|FG000|COMPLETED|Overall Study||0||0
48573594|NCT04283149|101735173|FG001|COMPLETED|Overall Study||0||0
48573595|NCT04283149|101735172|FG000|NOT COMPLETED|Overall Study||327||327
48573596|NCT04283149|101735173|FG001|NOT COMPLETED|Overall Study||327||302
48573597|NCT02414243|101735174|FG000|STARTED|Overall Study||19|41 randomized but 1 patient left study after randomization|
48573598|NCT02414243|101735175|FG001|STARTED|Overall Study||21|41 randomized but 1 patient left study after randomization|
48573599|NCT02414243|101735174|FG000|Moved to the Other Group|Overall Study||17||
48573600|NCT02414243|101735175|FG001|Moved to the Other Group|Overall Study||20||
48573601|NCT02414243|101735174|FG000|Entered Open Challenge at Home|Overall Study||17||
48573602|NCT02414243|101735175|FG001|Entered Open Challenge at Home|Overall Study||20||
48573603|NCT02414243|101735174|FG000|COMPLETED|Overall Study||13||
48573604|NCT02414243|101735175|FG001|COMPLETED|Overall Study||17||
48573605|NCT02414243|101735174|FG000|NOT COMPLETED|Overall Study||6||
48573606|NCT02414243|101735175|FG001|NOT COMPLETED|Overall Study||4||
48573607|NCT01726270|101735176|FG000|STARTED|Part 1, Self-Selection Phase||689||
48573608|NCT01726270|101735176|FG000|COMPLETED|Part 1, Self-Selection Phase||679||
48573609|NCT01726270|101735176|FG000|NOT COMPLETED|Part 1, Self-Selection Phase||10||
48573610|NCT01726270|101735176|FG000|STARTED|Eligibility for Part 2||389||
48573611|NCT01726270|101735176|FG000|COMPLETED|Eligibility for Part 2||369||
48573612|NCT01726270|101735176|FG000|NOT COMPLETED|Eligibility for Part 2||20||
48573613|NCT01726270|101735176|FG000|STARTED|Part 2, Actual-Use Phase||369||
48573614|NCT01726270|101735176|FG000|COMPLETED|Part 2, Actual-Use Phase||330||
48573615|NCT01726270|101735176|FG000|NOT COMPLETED|Part 2, Actual-Use Phase||39||
48573616|NCT02918565|101735177|FG000|STARTED|Overall Study||220||
48573617|NCT02918565|101735178|FG001|STARTED|Overall Study||213||
48573618|NCT02918565|101735179|FG002|STARTED|Overall Study||232||
48573619|NCT02918565|101735180|FG003|STARTED|Overall Study||224||
48573620|NCT02918565|101735181|FG004|STARTED|Overall Study||242||
48573621|NCT02918565|101735177|FG000|COMPLETED|Overall Study||213||
48573622|NCT02918565|101735178|FG001|COMPLETED|Overall Study||202||
48573623|NCT02918565|101735179|FG002|COMPLETED|Overall Study||221||
48573624|NCT02918565|101735180|FG003|COMPLETED|Overall Study||216||
48573625|NCT02918565|101735181|FG004|COMPLETED|Overall Study||231||
48573626|NCT02918565|101735177|FG000|NOT COMPLETED|Overall Study||7||
48573627|NCT02918565|101735178|FG001|NOT COMPLETED|Overall Study||11||
48573628|NCT02918565|101735179|FG002|NOT COMPLETED|Overall Study||11||
48573629|NCT02918565|101735180|FG003|NOT COMPLETED|Overall Study||8||
48573630|NCT02918565|101735181|FG004|NOT COMPLETED|Overall Study||11||
48573631|NCT00593684|101735182|FG000|STARTED|Overall Study||25||
48573632|NCT00593684|101735183|FG001|STARTED|Overall Study||25||
48573633|NCT00593684|101735182|FG000|COMPLETED|Overall Study||23||
48573634|NCT00593684|101735183|FG001|COMPLETED|Overall Study||24||
48573635|NCT00593684|101735182|FG000|NOT COMPLETED|Overall Study||2||
48573636|NCT00593684|101735183|FG001|NOT COMPLETED|Overall Study||1||
48573637|NCT03771560|101735184|FG000|STARTED|Overall Study||18||
48573638|NCT03771560|101735184|FG000|COMPLETED|Overall Study||12||
48573639|NCT03771560|101735184|FG000|NOT COMPLETED|Overall Study||6||
48573640|NCT03278613|101735185|FG000|STARTED|Overall Study||111||
48573641|NCT03278613|101735186|FG001|STARTED|Overall Study||55||
48573642|NCT03278613|101735185|FG000|COMPLETED|Overall Study||108||
48573643|NCT03278613|101735186|FG001|COMPLETED|Overall Study||54||
48573644|NCT03278613|101735185|FG000|NOT COMPLETED|Overall Study||3||
48573645|NCT03278613|101735186|FG001|NOT COMPLETED|Overall Study||1||
48573646|NCT01057810|101735187|FG000|STARTED|Overall Study||199||
48573647|NCT01057810|101735188|FG001|STARTED|Overall Study||399||
48573648|NCT01057810|101735187|FG000|COMPLETED|Overall Study||1||
48573649|NCT01057810|101735188|FG001|COMPLETED|Overall Study||1||
48573650|NCT01057810|101735187|FG000|NOT COMPLETED|Overall Study||198||
48573651|NCT01057810|101735188|FG001|NOT COMPLETED|Overall Study||398||
48573652|NCT01436370|101735189|FG000|STARTED|Overall Study||6||
48573653|NCT01436370|101735190|FG001|STARTED|Overall Study||6||
48573654|NCT01436370|101735191|FG002|STARTED|Overall Study||10||
48573655|NCT01436370|101735192|FG003|STARTED|Overall Study||10||
48573656|NCT01436370|101735193|FG004|STARTED|Overall Study||19||
48129751|NCT02448303|100642692|FG001|Discontinued Study|Overall Study||36||
48129752|NCT02448303|100642691|FG000|COMPLETED|Overall Study||0||
48129753|NCT02448303|100642692|FG001|COMPLETED|Overall Study||0||
48129754|NCT02448303|100642691|FG000|NOT COMPLETED|Overall Study||38||
48129755|NCT02448303|100642692|FG001|NOT COMPLETED|Overall Study||36||
48573657|NCT01436370|101735194|FG005|STARTED|Overall Study||19||
48573658|NCT01436370|101735195|FG006|STARTED|Overall Study||16||
48573659|NCT01436370|101735196|FG007|STARTED|Overall Study||16||
48573660|NCT01436370|101735189|FG000|COMPLETED|Overall Study||6||
48573661|NCT01436370|101735190|FG001|COMPLETED|Overall Study||6||
48573662|NCT01436370|101735191|FG002|COMPLETED|Overall Study||10||
48573663|NCT01436370|101735192|FG003|COMPLETED|Overall Study||10||
48573664|NCT01436370|101735193|FG004|COMPLETED|Overall Study||18||
48573665|NCT01436370|101735194|FG005|COMPLETED|Overall Study||19||
48573666|NCT01436370|101735195|FG006|COMPLETED|Overall Study||16||
48573667|NCT01436370|101735196|FG007|COMPLETED|Overall Study||16||
48573668|NCT01436370|101735189|FG000|NOT COMPLETED|Overall Study||0||
48573669|NCT01436370|101735190|FG001|NOT COMPLETED|Overall Study||0||
48573670|NCT01436370|101735191|FG002|NOT COMPLETED|Overall Study||0||
48573671|NCT01436370|101735192|FG003|NOT COMPLETED|Overall Study||0||
48573672|NCT01436370|101735193|FG004|NOT COMPLETED|Overall Study||1||
48573673|NCT01436370|101735194|FG005|NOT COMPLETED|Overall Study||0||
48573674|NCT01436370|101735195|FG006|NOT COMPLETED|Overall Study||0||
48573675|NCT01436370|101735196|FG007|NOT COMPLETED|Overall Study||0||
48573676|NCT02596971|101735197|FG000|STARTED|Overall Study||42||
48573677|NCT02596971|101735198|FG001|STARTED|Overall Study||7||
48573678|NCT02596971|101735199|FG002|STARTED|Overall Study||42||
48573679|NCT02596971|101735197|FG000|COMPLETED|Overall Study||32||
48573680|NCT02596971|101735198|FG001|COMPLETED|Overall Study||5||
48573681|NCT02596971|101735199|FG002|COMPLETED|Overall Study||33||
48573682|NCT02596971|101735197|FG000|NOT COMPLETED|Overall Study||10||
48573683|NCT02596971|101735198|FG001|NOT COMPLETED|Overall Study||2||
48573684|NCT02596971|101735199|FG002|NOT COMPLETED|Overall Study||9||
48573685|NCT02798380|101735200|FG000|STARTED|Overall Study||30||
48573686|NCT02798380|101735200|FG000|COMPLETED|Overall Study||30||
48573687|NCT02798380|101735200|FG000|NOT COMPLETED|Overall Study||0||
48573688|NCT02104739|101735201|FG000|STARTED|First Intervention (1 Day)||2||
48573689|NCT02104739|101735202|FG001|STARTED|First Intervention (1 Day)||5||
48573690|NCT02104739|101735203|FG002|STARTED|First Intervention (1 Day)||2||
48573691|NCT02104739|101735204|FG003|STARTED|First Intervention (1 Day)||8||
48573692|NCT02104739|101735205|FG004|STARTED|First Intervention (1 Day)||0||
48129756|NCT01525082|100642693|FG000|STARTED|Overall Study||20||
48129757|NCT01525082|100642693|FG000|COMPLETED|Overall Study||19|Completion defined as assessment for clinical response after 3 cycles of treatment.|
48129758|NCT01525082|100642693|FG000|NOT COMPLETED|Overall Study||1||
48129759|NCT02509624|100642694|FG000|STARTED|Overall Study||10||
48129760|NCT02509624|100642695|FG001|STARTED|Overall Study||10||
48129761|NCT02509624|100642696|FG002|STARTED|Overall Study||10||
48129762|NCT02509624|100642697|FG003|STARTED|Overall Study||22||
48129763|NCT02509624|100642694|FG000|COMPLETED|Overall Study||10||
48129764|NCT02509624|100642695|FG001|COMPLETED|Overall Study||10||
48129765|NCT02509624|100642696|FG002|COMPLETED|Overall Study||10||
48129766|NCT02509624|100642697|FG003|COMPLETED|Overall Study||22||
48129767|NCT02509624|100642694|FG000|NOT COMPLETED|Overall Study||0||
48129768|NCT02509624|100642695|FG001|NOT COMPLETED|Overall Study||0||
48129769|NCT02509624|100642696|FG002|NOT COMPLETED|Overall Study||0||
48129770|NCT02509624|100642697|FG003|NOT COMPLETED|Overall Study||0||
48129771|NCT01252251|100642698|FG000|STARTED|Overall Study||14||
48129772|NCT01252251|100642698|FG000|COMPLETED|Overall Study||13||
48129773|NCT01252251|100642698|FG000|NOT COMPLETED|Overall Study||1||
48129774|NCT00262834|100642699|FG000|STARTED|Overall Study||25||
48129775|NCT00262834|100642700|FG001|STARTED|Overall Study||29||
48129776|NCT00262834|100642699|FG000|COMPLETED|Overall Study||24||
48129777|NCT00262834|100642700|FG001|COMPLETED|Overall Study||25||
48129778|NCT00262834|100642699|FG000|NOT COMPLETED|Overall Study||1||
48129779|NCT00262834|100642700|FG001|NOT COMPLETED|Overall Study||4||
48129780|NCT01055639|100642701|FG000|STARTED|Overall Study||66||
48129781|NCT01055639|100642702|FG001|STARTED|Overall Study||60||
48129782|NCT01055639|100642701|FG000|COMPLETED|Overall Study||45||
48129783|NCT01055639|100642702|FG001|COMPLETED|Overall Study||31||
48129784|NCT01055639|100642701|FG000|NOT COMPLETED|Overall Study||21||
48129785|NCT01055639|100642702|FG001|NOT COMPLETED|Overall Study||29||
48129786|NCT01965067|100642703|FG000|STARTED|Overall Study||30||
48129787|NCT01965067|100642704|FG001|STARTED|Overall Study||30||
48129788|NCT01965067|100642703|FG000|COMPLETED|Overall Study||30||
48129789|NCT01965067|100642704|FG001|COMPLETED|Overall Study||30||
48129790|NCT01965067|100642703|FG000|NOT COMPLETED|Overall Study||0||
48129791|NCT01965067|100642704|FG001|NOT COMPLETED|Overall Study||0||
48129792|NCT03086447|100642705|FG000|STARTED|Overall Study||132||
48573693|NCT02104739|101735206|FG005|STARTED|First Intervention (1 Day)||3||
48573694|NCT02104739|101735207|FG006|STARTED|First Intervention (1 Day)||0||
48573695|NCT02104739|101735201|FG000|COMPLETED|First Intervention (1 Day)||2||
48129793|NCT03086447|100642706|FG001|STARTED|Overall Study||130||
48129794|NCT03086447|100642705|FG000|COMPLETED|Overall Study||121||
48129795|NCT03086447|100642706|FG001|COMPLETED|Overall Study||110||
48129796|NCT03086447|100642705|FG000|NOT COMPLETED|Overall Study||11||
48129797|NCT03086447|100642706|FG001|NOT COMPLETED|Overall Study||20||
48129798|NCT00023452|100642707|FG000|STARTED|Overall Study||3908||
48129799|NCT00023452|100642708|FG001|STARTED|Overall Study||4145||
48129800|NCT00023452|100642707|FG000|Randomized|Overall Study||3190||
48129801|NCT00023452|100642708|FG001|Randomized|Overall Study||3174||
48129802|NCT00023452|100642707|FG000|Enrolled as Part of a Cluster|Overall Study||718||
48129803|NCT00023452|100642708|FG001|Enrolled as Part of a Cluster|Overall Study||971||
48129804|NCT00023452|100642707|FG000|Completed Treatment|Overall Study||2585||
48129805|NCT00023452|100642708|FG001|Completed Treatment|Overall Study||3273||
48129806|NCT00023452|100642707|FG000|Not Treated|Overall Study||149||
48573696|NCT02104739|101735202|FG001|COMPLETED|First Intervention (1 Day)||4||
48573697|NCT02104739|101735203|FG002|COMPLETED|First Intervention (1 Day)||2||
48573698|NCT02104739|101735204|FG003|COMPLETED|First Intervention (1 Day)||7||
48573699|NCT02104739|101735205|FG004|COMPLETED|First Intervention (1 Day)||0||
48573700|NCT02104739|101735206|FG005|COMPLETED|First Intervention (1 Day)||3||
48573701|NCT02104739|101735207|FG006|COMPLETED|First Intervention (1 Day)||0||
48573702|NCT02104739|101735201|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48573703|NCT02104739|101735202|FG001|NOT COMPLETED|First Intervention (1 Day)||1||
48573704|NCT02104739|101735203|FG002|NOT COMPLETED|First Intervention (1 Day)||0||
48573705|NCT02104739|101735204|FG003|NOT COMPLETED|First Intervention (1 Day)||1||
48573706|NCT02104739|101735205|FG004|NOT COMPLETED|First Intervention (1 Day)||0||
48573707|NCT02104739|101735206|FG005|NOT COMPLETED|First Intervention (1 Day)||0||
48573708|NCT02104739|101735207|FG006|NOT COMPLETED|First Intervention (1 Day)||0||
48573709|NCT02104739|101735201|FG000|STARTED|Washout (Min of 10 and Max of 107 Days)||1||
48573710|NCT02104739|101735202|FG001|STARTED|Washout (Min of 10 and Max of 107 Days)||4||
48129807|NCT00023452|100642708|FG001|Not Treated|Overall Study||105||
48129808|NCT00023452|100642707|FG000|Completed Study|Overall Study||3174||
48129809|NCT00023452|100642708|FG001|Completed Study|Overall Study||3475||
48129810|NCT00023452|100642707|FG000|COMPLETED|Overall Study||2585||
48129811|NCT00023452|100642708|FG001|COMPLETED|Overall Study||3273||
48129812|NCT00023452|100642707|FG000|NOT COMPLETED|Overall Study||1323||
48129813|NCT00023452|100642708|FG001|NOT COMPLETED|Overall Study||872||
48129814|NCT05819749|100642709|FG000|STARTED|Overall Study||12||
48129815|NCT05819749|100642709|FG000|COMPLETED|Overall Study||11||
48129816|NCT05819749|100642709|FG000|NOT COMPLETED|Overall Study||1||
48129817|NCT01255358|100642710|FG000|STARTED|Overall Study||22||
48129818|NCT01255358|100642710|FG000|COMPLETED|Overall Study||18||
48129819|NCT01255358|100642710|FG000|NOT COMPLETED|Overall Study||4||
48129820|NCT04174521|100642711|FG000|STARTED|Overall Study||20670||
48129821|NCT04174521|100642711|FG000|COMPLETED|Overall Study||20670||
48129822|NCT04174521|100642711|FG000|NOT COMPLETED|Overall Study||0||
48129823|NCT01116934|100642712|FG000|STARTED|Overall Study||8||
48129824|NCT01116934|100642713|FG001|STARTED|Overall Study||9||
48129825|NCT01116934|100642712|FG000|COMPLETED|Overall Study||8||
48129826|NCT01116934|100642713|FG001|COMPLETED|Overall Study||9||
48129827|NCT01116934|100642712|FG000|NOT COMPLETED|Overall Study||0||
48129828|NCT01116934|100642713|FG001|NOT COMPLETED|Overall Study||0||
48129829|NCT04631666|100642714|FG000|STARTED|Overall Study||3||
48129830|NCT04631666|100642715|FG001|STARTED|Overall Study||3||
48129831|NCT04631666|100642716|FG002|STARTED|Overall Study||3||
48129832|NCT04631666|100642717|FG003|STARTED|Overall Study||6||
48129833|NCT04631666|100642718|FG004|STARTED|Overall Study||3||
48129834|NCT04631666|100642719|FG005|STARTED|Overall Study||26||
48129835|NCT04631666|100642720|FG006|STARTED|Overall Study||13||
48129836|NCT04631666|100642714|FG000|COMPLETED|Overall Study||3||
48129837|NCT04631666|100642715|FG001|COMPLETED|Overall Study||3||
48129838|NCT04631666|100642716|FG002|COMPLETED|Overall Study||3||
48129839|NCT04631666|100642717|FG003|COMPLETED|Overall Study||6||
48129840|NCT04631666|100642718|FG004|COMPLETED|Overall Study||3||
48129841|NCT04631666|100642719|FG005|COMPLETED|Overall Study||26||
48129842|NCT04631666|100642720|FG006|COMPLETED|Overall Study||13||
48129843|NCT04631666|100642714|FG000|NOT COMPLETED|Overall Study||0||
48129844|NCT04631666|100642715|FG001|NOT COMPLETED|Overall Study||0||
48129845|NCT04631666|100642716|FG002|NOT COMPLETED|Overall Study||0||
48129846|NCT04631666|100642717|FG003|NOT COMPLETED|Overall Study||0||
48129847|NCT04631666|100642718|FG004|NOT COMPLETED|Overall Study||0||
48129848|NCT04631666|100642719|FG005|NOT COMPLETED|Overall Study||0||
48129849|NCT04631666|100642720|FG006|NOT COMPLETED|Overall Study||0||
48129850|NCT00616967|100642721|FG000|STARTED|Overall Study||6||
48129851|NCT00616967|100642722|FG001|STARTED|Overall Study||31||
48129852|NCT00616967|100642723|FG002|STARTED|Overall Study||31||
48129853|NCT00616967|100642721|FG000|COMPLETED|Overall Study||6||
48129854|NCT00616967|100642722|FG001|COMPLETED|Overall Study||31||
48129855|NCT00616967|100642723|FG002|COMPLETED|Overall Study||30||
48129856|NCT00616967|100642721|FG000|NOT COMPLETED|Overall Study||0||
48129857|NCT00616967|100642722|FG001|NOT COMPLETED|Overall Study||0||
48129858|NCT00616967|100642723|FG002|NOT COMPLETED|Overall Study||1||
48129859|NCT00245557|100642724|FG000|STARTED|Overall Study||17||
48129860|NCT00245557|100642725|FG001|STARTED|Overall Study||26||
48129861|NCT00245557|100642724|FG000|COMPLETED|Overall Study||11||
48129862|NCT00245557|100642725|FG001|COMPLETED|Overall Study||10||
48129863|NCT00245557|100642724|FG000|NOT COMPLETED|Overall Study||6||
48129864|NCT00245557|100642725|FG001|NOT COMPLETED|Overall Study||16||
48129865|NCT00352534|100642726|FG000|STARTED|Initial Staging||211||
48129866|NCT00352534|100642727|FG001|STARTED|Initial Staging||597||
48129867|NCT00352534|100642728|FG002|STARTED|Initial Staging||0||
48129868|NCT00352534|100642729|FG003|STARTED|Initial Staging||0||
48129869|NCT00352534|100642730|FG004|STARTED|Initial Staging||0||
48129870|NCT00352534|100642731|FG005|STARTED|Initial Staging||0||
48129871|NCT00352534|100642732|FG006|STARTED|Initial Staging||0||
48129872|NCT00352534|100642726|FG000|COMPLETED|Initial Staging||203||
48129873|NCT00352534|100642727|FG001|COMPLETED|Initial Staging||588||
48129874|NCT00352534|100642728|FG002|COMPLETED|Initial Staging||0||
48129875|NCT00352534|100642729|FG003|COMPLETED|Initial Staging||0||
48129876|NCT00352534|100642730|FG004|COMPLETED|Initial Staging||0||
48129877|NCT00352534|100642731|FG005|COMPLETED|Initial Staging||0||
48129878|NCT00352534|100642732|FG006|COMPLETED|Initial Staging||0||
48129879|NCT00352534|100642726|FG000|NOT COMPLETED|Initial Staging||8||
48129880|NCT00352534|100642727|FG001|NOT COMPLETED|Initial Staging||9||
48129881|NCT00352534|100642728|FG002|NOT COMPLETED|Initial Staging||0||
48129882|NCT00352534|100642729|FG003|NOT COMPLETED|Initial Staging||0||
48129883|NCT00352534|100642730|FG004|NOT COMPLETED|Initial Staging||0||
48129884|NCT00352534|100642731|FG005|NOT COMPLETED|Initial Staging||0||
48129885|NCT00352534|100642732|FG006|NOT COMPLETED|Initial Staging||0||
48129886|NCT00352534|100642726|FG000|STARTED|Final Risk Group Assignment||0||
48129887|NCT00352534|100642727|FG001|STARTED|Final Risk Group Assignment||0||
48129888|NCT00352534|100642728|FG002|STARTED|Final Risk Group Assignment||119||
48129889|NCT00352534|100642729|FG003|STARTED|Final Risk Group Assignment||52||
48129890|NCT00352534|100642730|FG004|STARTED|Final Risk Group Assignment||32||
48129891|NCT00352534|100642731|FG005|STARTED|Final Risk Group Assignment||548||
48129892|NCT00352534|100642732|FG006|STARTED|Final Risk Group Assignment||40||
48129893|NCT00352534|100642726|FG000|COMPLETED|Final Risk Group Assignment||0||
48129894|NCT00352534|100642727|FG001|COMPLETED|Final Risk Group Assignment||0||
48129895|NCT00352534|100642728|FG002|COMPLETED|Final Risk Group Assignment||116||
48129896|NCT00352534|100642729|FG003|COMPLETED|Final Risk Group Assignment||49||
48129897|NCT00352534|100642730|FG004|COMPLETED|Final Risk Group Assignment||31||
48129898|NCT00352534|100642731|FG005|COMPLETED|Final Risk Group Assignment||503||
48129899|NCT00352534|100642732|FG006|COMPLETED|Final Risk Group Assignment||1||
48129900|NCT00352534|100642726|FG000|NOT COMPLETED|Final Risk Group Assignment||0||
48129901|NCT00352534|100642727|FG001|NOT COMPLETED|Final Risk Group Assignment||0||
48129902|NCT00352534|100642728|FG002|NOT COMPLETED|Final Risk Group Assignment||3||
48129903|NCT00352534|100642729|FG003|NOT COMPLETED|Final Risk Group Assignment||3||
48129904|NCT00352534|100642730|FG004|NOT COMPLETED|Final Risk Group Assignment||1||
48129905|NCT00352534|100642731|FG005|NOT COMPLETED|Final Risk Group Assignment||45||
48129906|NCT00352534|100642732|FG006|NOT COMPLETED|Final Risk Group Assignment||39||
48129907|NCT02062502|100642733|FG000|STARTED|Overall Study||306||
48129908|NCT02062502|100642734|FG001|STARTED|Overall Study||305||
48129909|NCT02062502|100642733|FG000|Vaccinated Dose 1|Overall Study||306||
48129910|NCT02062502|100642734|FG001|Vaccinated Dose 1|Overall Study||305||
48129911|NCT02062502|100642733|FG000|COMPLETED|Overall Study||263||
48129912|NCT02062502|100642734|FG001|COMPLETED|Overall Study||270||
48129913|NCT02062502|100642733|FG000|NOT COMPLETED|Overall Study||43||
48129914|NCT02062502|100642734|FG001|NOT COMPLETED|Overall Study||35||
48129915|NCT03421197|100642735|FG000|STARTED|Overall Study||105||
48129916|NCT03421197|100642736|FG001|STARTED|Overall Study||107||
48129917|NCT03421197|100642737|FG002|STARTED|Overall Study||107||
48129918|NCT03421197|100642738|FG003|STARTED|Overall Study||107||
48129919|NCT03421197|100642735|FG000|COMPLETED|Overall Study||67||
48129920|NCT03421197|100642736|FG001|COMPLETED|Overall Study||68||
48129921|NCT03421197|100642737|FG002|COMPLETED|Overall Study||56||
48129922|NCT03421197|100642738|FG003|COMPLETED|Overall Study||62||
48129923|NCT03421197|100642735|FG000|NOT COMPLETED|Overall Study||38||
48129924|NCT03421197|100642736|FG001|NOT COMPLETED|Overall Study||39||
48129925|NCT03421197|100642737|FG002|NOT COMPLETED|Overall Study||51||
48129926|NCT03421197|100642738|FG003|NOT COMPLETED|Overall Study||45||
48129927|NCT01921348|100642739|FG000|STARTED|Overall Study||9||
48129928|NCT01921348|100642740|FG001|STARTED|Overall Study||9||
48701416|NCT01418703|102054228|FG002|COMPLETED|Overall Study||6||
48701417|NCT01418703|102054229|FG003|COMPLETED|Overall Study||6||
48701418|NCT01418703|102054226|FG000|NOT COMPLETED|Overall Study||0||
48701419|NCT01418703|102054227|FG001|NOT COMPLETED|Overall Study||0||
48701420|NCT01418703|102054228|FG002|NOT COMPLETED|Overall Study||0||
48701421|NCT01418703|102054229|FG003|NOT COMPLETED|Overall Study||0||
48701422|NCT00642434|102054230|FG000|STARTED|Overall Study||10||
48701423|NCT00642434|102054231|FG001|STARTED|Overall Study||12||
48701424|NCT00642434|102054230|FG000|Number of Participants Treated|Overall Study||10||
48701425|NCT00642434|102054231|FG001|Number of Participants Treated|Overall Study||12||
48701426|NCT00642434|102054230|FG000|COMPLETED|Overall Study||10||
48129929|NCT01921348|100642739|FG000|COMPLETED|Overall Study||8||
48129930|NCT01921348|100642740|FG001|COMPLETED|Overall Study||7||
48129931|NCT01921348|100642739|FG000|NOT COMPLETED|Overall Study||1||
48129932|NCT01921348|100642740|FG001|NOT COMPLETED|Overall Study||2||
48129933|NCT00795600|100642741|FG000|STARTED|Overall Study||25||
48129934|NCT00795600|100642742|FG001|STARTED|Overall Study||35||
48129935|NCT00795600|100642741|FG000|Exposed to Drug|Overall Study||24||
48129936|NCT00795600|100642742|FG001|Exposed to Drug|Overall Study||35||
48129937|NCT00795600|100642741|FG000|COMPLETED|Overall Study||21||
48129938|NCT00795600|100642742|FG001|COMPLETED|Overall Study||31||
48129939|NCT00795600|100642741|FG000|NOT COMPLETED|Overall Study||4||
48129940|NCT00795600|100642742|FG001|NOT COMPLETED|Overall Study||4||
48129941|NCT04450823|100642743|FG000|STARTED|Overall Study||61||
48701427|NCT00642434|102054231|FG001|COMPLETED|Overall Study||12||
48701428|NCT00642434|102054230|FG000|NOT COMPLETED|Overall Study||0||
48701429|NCT00642434|102054231|FG001|NOT COMPLETED|Overall Study||0||
48701430|NCT05260073|102054232|FG000|STARTED|Overall Study||300||
48701431|NCT05260073|102054232|FG000|Full Analysis Set|Overall Study||290|Full Analysis Set (FAS) included all participants who received at least one dose of tirbanibulin during the study observation period of 8-weeks related to primary endpoint, as part of usual care and had at least some data pertaining to the key variables studied at relevant timepoints, post-baseline.|
48701432|NCT05260073|102054232|FG000|COMPLETED|Overall Study||279||
48701433|NCT05260073|102054232|FG000|NOT COMPLETED|Overall Study||21||
48701434|NCT02576041|102054233|FG000|STARTED|Placebo (run-in)||18||
48701435|NCT02576041|102054233|FG000|COMPLETED|Placebo (run-in)||18||
48701436|NCT02576041|102054233|FG000|NOT COMPLETED|Placebo (run-in)||0||
48701437|NCT02576041|102054233|FG000|STARTED|Bilastine (Active Treatement)||18||
48701438|NCT02576041|102054233|FG000|COMPLETED|Bilastine (Active Treatement)||18||
48701439|NCT02576041|102054233|FG000|NOT COMPLETED|Bilastine (Active Treatement)||0||
48701440|NCT04925076|102054234|FG000|STARTED|Overall Study||10||
48701441|NCT04925076|102054235|FG001|STARTED|Overall Study||17||
48701442|NCT04925076|102054236|FG002|STARTED|Overall Study||12||
48701443|NCT04925076|102054237|FG003|STARTED|Overall Study||14||
48701444|NCT04925076|102054238|FG004|STARTED|Overall Study||12||
48129942|NCT04450823|100642743|FG000|COMPLETED|Overall Study||58||
48129943|NCT04450823|100642743|FG000|NOT COMPLETED|Overall Study||3||
48129944|NCT03103282|100642744|FG000|STARTED|Overall Study||65||
48129945|NCT03103282|100642744|FG000|COMPLETED|Overall Study||65||
48129946|NCT03103282|100642744|FG000|NOT COMPLETED|Overall Study||0||
48129947|NCT00099983|100642745|FG000|STARTED|Overall Study||147||
48129948|NCT00099983|100642746|FG001|STARTED|Overall Study||149||
48129949|NCT00099983|100642745|FG000|COMPLETED|Overall Study||123||
48129950|NCT00099983|100642746|FG001|COMPLETED|Overall Study||124||
48129951|NCT00099983|100642745|FG000|NOT COMPLETED|Overall Study||24||
48129952|NCT00099983|100642746|FG001|NOT COMPLETED|Overall Study||25||
48129953|NCT04258020|100642747|FG000|STARTED|Overall Study||4||
48129954|NCT04258020|100642748|FG001|STARTED|Overall Study||0||
48129955|NCT04258020|100642747|FG000|COMPLETED|Overall Study||3||
48129956|NCT04258020|100642748|FG001|COMPLETED|Overall Study||0||
48284373|NCT02663518|101021469|FG004|NOT COMPLETED|Part 4: Phase 1b Dose Optimization||0||
48284374|NCT02663518|101021470|FG005|NOT COMPLETED|Part 4: Phase 1b Dose Optimization||0||
48129957|NCT04258020|100642747|FG000|NOT COMPLETED|Overall Study||1||
48129958|NCT04258020|100642748|FG001|NOT COMPLETED|Overall Study||0||
48129959|NCT01808313|100642749|FG000|STARTED|Overall Study||133||
48129960|NCT01808313|100642749|FG000|COMPLETED|Overall Study||123||
48129961|NCT01808313|100642749|FG000|NOT COMPLETED|Overall Study||10||
48129962|NCT03963895|100642750|FG000|STARTED|Pre-dose Period (Study Days -7, -5, -2)||12||
48129963|NCT03963895|100642751|FG001|STARTED|Pre-dose Period (Study Days -7, -5, -2)||12||
48129964|NCT03963895|100642752|FG002|STARTED|Pre-dose Period (Study Days -7, -5, -2)||12||
48129965|NCT03963895|100642750|FG000|COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||12||
48129966|NCT03963895|100642751|FG001|COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||12||
48129967|NCT03963895|100642752|FG002|COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||12||
48129968|NCT03963895|100642750|FG000|NOT COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||0||
48129969|NCT03963895|100642751|FG001|NOT COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||0||
48129970|NCT03963895|100642752|FG002|NOT COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||0||
48129971|NCT03963895|100642750|FG000|STARTED|Dosing Period (Study Day 1)||12||
48129972|NCT03963895|100642751|FG001|STARTED|Dosing Period (Study Day 1)||12||
48129973|NCT03963895|100642752|FG002|STARTED|Dosing Period (Study Day 1)||12||
48129974|NCT03963895|100642750|FG000|COMPLETED|Dosing Period (Study Day 1)||12||
48129975|NCT03963895|100642751|FG001|COMPLETED|Dosing Period (Study Day 1)||12||
48129976|NCT03963895|100642752|FG002|COMPLETED|Dosing Period (Study Day 1)||12||
48129977|NCT03963895|100642750|FG000|NOT COMPLETED|Dosing Period (Study Day 1)||0||
48129978|NCT03963895|100642751|FG001|NOT COMPLETED|Dosing Period (Study Day 1)||0||
48129979|NCT03963895|100642752|FG002|NOT COMPLETED|Dosing Period (Study Day 1)||0||
48129980|NCT03963895|100642750|FG000|STARTED|Recovery Period (Study Day 3)||12||
48129981|NCT03963895|100642751|FG001|STARTED|Recovery Period (Study Day 3)||12||
48129982|NCT03963895|100642752|FG002|STARTED|Recovery Period (Study Day 3)||12||
48129983|NCT03963895|100642750|FG000|COMPLETED|Recovery Period (Study Day 3)||12||
48129984|NCT03963895|100642751|FG001|COMPLETED|Recovery Period (Study Day 3)||12||
48129985|NCT03963895|100642752|FG002|COMPLETED|Recovery Period (Study Day 3)||12||
48129986|NCT03963895|100642750|FG000|NOT COMPLETED|Recovery Period (Study Day 3)||0||
48129987|NCT03963895|100642751|FG001|NOT COMPLETED|Recovery Period (Study Day 3)||0||
48129988|NCT03963895|100642752|FG002|NOT COMPLETED|Recovery Period (Study Day 3)||0||
48129989|NCT03963895|100642750|FG000|STARTED|Follow-up Period (Study Day 14)||12||
48129990|NCT03963895|100642751|FG001|STARTED|Follow-up Period (Study Day 14)||12||
48129991|NCT03963895|100642752|FG002|STARTED|Follow-up Period (Study Day 14)||12||
48284375|NCT02663518|101021471|FG006|NOT COMPLETED|Part 4: Phase 1b Dose Optimization||0||
48284376|NCT02663518|101021472|FG007|NOT COMPLETED|Part 4: Phase 1b Dose Optimization||0||
48284377|NCT02663518|101021473|FG008|NOT COMPLETED|Part 4: Phase 1b Dose Optimization||0||
48284378|NCT02663518|101021474|FG009|NOT COMPLETED|Part 4: Phase 1b Dose Optimization||2||
48284379|NCT02663518|101021475|FG010|NOT COMPLETED|Part 4: Phase 1b Dose Optimization||3||
48284380|NCT02663518|101021476|FG011|NOT COMPLETED|Part 4: Phase 1b Dose Optimization||3||
48284381|NCT02663518|101021477|FG012|NOT COMPLETED|Part 4: Phase 1b Dose Optimization||8||
48284382|NCT02663518|101021478|FG013|NOT COMPLETED|Part 4: Phase 1b Dose Optimization||3||
48129992|NCT03963895|100642750|FG000|COMPLETED|Follow-up Period (Study Day 14)||12||
48129993|NCT03963895|100642751|FG001|COMPLETED|Follow-up Period (Study Day 14)||11||
48129994|NCT03963895|100642752|FG002|COMPLETED|Follow-up Period (Study Day 14)||12||
48129995|NCT03963895|100642750|FG000|NOT COMPLETED|Follow-up Period (Study Day 14)||0||
48129996|NCT03963895|100642751|FG001|NOT COMPLETED|Follow-up Period (Study Day 14)||1||
48129997|NCT03963895|100642752|FG002|NOT COMPLETED|Follow-up Period (Study Day 14)||0||
48129998|NCT01253343|100642753|FG000|STARTED|Overall Study||9||
48129999|NCT01253343|100642754|FG001|STARTED|Overall Study||8||
48130000|NCT01253343|100642753|FG000|COMPLETED|Overall Study||9||
48130001|NCT01253343|100642754|FG001|COMPLETED|Overall Study||8||
48284383|NCT00697697|101021479|FG000|STARTED|Overall Study||94||
48284384|NCT00697697|101021480|FG001|STARTED|Overall Study||98||
48284385|NCT00697697|101021479|FG000|COMPLETED|Overall Study||45||
48130002|NCT01253343|100642753|FG000|NOT COMPLETED|Overall Study||0||
48130003|NCT01253343|100642754|FG001|NOT COMPLETED|Overall Study||0||
48130004|NCT01490060|100642755|FG000|STARTED|Cycle 1||11||
48284386|NCT00697697|101021480|FG001|COMPLETED|Overall Study||44||
48284387|NCT00697697|101021479|FG000|NOT COMPLETED|Overall Study||49||
48284388|NCT00697697|101021480|FG001|NOT COMPLETED|Overall Study||54||
48284389|NCT00752557|101021481|FG000|STARTED|Overall Study||17||
48130005|NCT01490060|100642756|FG001|STARTED|Cycle 1||13||
48130006|NCT01490060|100642757|FG002|STARTED|Cycle 1||12||
48130007|NCT01490060|100642758|FG003|STARTED|Cycle 1||11||
48130008|NCT01490060|100642755|FG000|COMPLETED|Cycle 1||11||
48130009|NCT01490060|100642756|FG001|COMPLETED|Cycle 1||12||
48130010|NCT01490060|100642757|FG002|COMPLETED|Cycle 1||9||
48130011|NCT01490060|100642758|FG003|COMPLETED|Cycle 1||8||
48130012|NCT01490060|100642755|FG000|NOT COMPLETED|Cycle 1||0||
48130013|NCT01490060|100642756|FG001|NOT COMPLETED|Cycle 1||1||
48284390|NCT00752557|101021482|FG001|STARTED|Overall Study||16||
48284391|NCT00752557|101021483|FG002|STARTED|Overall Study||17||
48284392|NCT00752557|101021481|FG000|COMPLETED|Overall Study||12||
48284393|NCT00752557|101021482|FG001|COMPLETED|Overall Study||11||
48284394|NCT00752557|101021483|FG002|COMPLETED|Overall Study||11||
48284395|NCT00752557|101021481|FG000|NOT COMPLETED|Overall Study||5||
48284396|NCT00752557|101021482|FG001|NOT COMPLETED|Overall Study||5||
48284397|NCT00752557|101021483|FG002|NOT COMPLETED|Overall Study||6||
48284398|NCT02656329|101021484|FG000|STARTED|Overall Study||164||
48284399|NCT02656329|101021485|FG001|STARTED|Overall Study||157||
48284400|NCT02656329|101021484|FG000|COMPLETED|Overall Study||0||
48284401|NCT02656329|101021485|FG001|COMPLETED|Overall Study||0||
48398615|NCT00587301|101306358|FG000|STARTED|Overall Study||119||
48398616|NCT00587301|101306358|FG000|COMPLETED|Overall Study||74||
48398617|NCT00587301|101306358|FG000|NOT COMPLETED|Overall Study||45||
48398618|NCT01978600|101306359|FG000|STARTED|Overall Study||44||
48398619|NCT01978600|101306360|FG001|STARTED|Overall Study||42||
48398620|NCT01978600|101306359|FG000|COMPLETED|Overall Study||44||
48398621|NCT01978600|101306360|FG001|COMPLETED|Overall Study||42||
48398622|NCT01978600|101306359|FG000|NOT COMPLETED|Overall Study||0||
48573711|NCT02104739|101735203|FG002|STARTED|Washout (Min of 10 and Max of 107 Days)||2||
48573712|NCT02104739|101735204|FG003|STARTED|Washout (Min of 10 and Max of 107 Days)||7||
48130014|NCT01490060|100642757|FG002|NOT COMPLETED|Cycle 1||3||
48398623|NCT01978600|101306360|FG001|NOT COMPLETED|Overall Study||0||
48130015|NCT01490060|100642758|FG003|NOT COMPLETED|Cycle 1||3||
48130016|NCT01490060|100642755|FG000|STARTED|Cycle 2||11||
48130017|NCT01490060|100642756|FG001|STARTED|Cycle 2||12||
48130018|NCT01490060|100642757|FG002|STARTED|Cycle 2||9||
48130019|NCT01490060|100642758|FG003|STARTED|Cycle 2||8||
48130020|NCT01490060|100642755|FG000|COMPLETED|Cycle 2||9||
48130021|NCT01490060|100642756|FG001|COMPLETED|Cycle 2||11||
48130022|NCT01490060|100642757|FG002|COMPLETED|Cycle 2||8||
48130023|NCT01490060|100642758|FG003|COMPLETED|Cycle 2||8||
48130024|NCT01490060|100642755|FG000|NOT COMPLETED|Cycle 2||2||
48130025|NCT01490060|100642756|FG001|NOT COMPLETED|Cycle 2||1||
48573713|NCT02104739|101735205|FG004|STARTED|Washout (Min of 10 and Max of 107 Days)||0||
48573714|NCT02104739|101735206|FG005|STARTED|Washout (Min of 10 and Max of 107 Days)||2||
48573715|NCT02104739|101735207|FG006|STARTED|Washout (Min of 10 and Max of 107 Days)||0||
48130026|NCT01490060|100642757|FG002|NOT COMPLETED|Cycle 2||1||
48130027|NCT01490060|100642758|FG003|NOT COMPLETED|Cycle 2||0||
48130028|NCT02473952|100642759|FG000|STARTED|Overall Study||30||
48130029|NCT02473952|100642760|FG001|STARTED|Overall Study||32||
48130030|NCT02473952|100642759|FG000|COMPLETED|Overall Study||28||
48130031|NCT02473952|100642760|FG001|COMPLETED|Overall Study||24||
48130032|NCT02473952|100642759|FG000|NOT COMPLETED|Overall Study||2||
48130033|NCT02473952|100642760|FG001|NOT COMPLETED|Overall Study||8||
48130034|NCT01272934|100642761|FG000|STARTED|Overall Study||102||
48130035|NCT01272934|100642762|FG001|STARTED|Overall Study||103||
48130036|NCT01272934|100642761|FG000|COMPLETED|Overall Study||102||
48130037|NCT01272934|100642762|FG001|COMPLETED|Overall Study||101||
48130038|NCT01272934|100642761|FG000|NOT COMPLETED|Overall Study||0||
48130039|NCT01272934|100642762|FG001|NOT COMPLETED|Overall Study||2||
48284402|NCT02656329|101021484|FG000|NOT COMPLETED|Overall Study||164||
48284403|NCT02656329|101021485|FG001|NOT COMPLETED|Overall Study||157||
48284404|NCT01156792|101021486|FG000|STARTED|Overall Study||162||
48284405|NCT01156792|101021486|FG000|COMPLETED|Overall Study||93||
48284406|NCT01156792|101021486|FG000|NOT COMPLETED|Overall Study||69||
48284407|NCT02483000|101021487|FG000|STARTED|Overall Study||3||
48284408|NCT02483000|101021487|FG000|COMPLETED|Overall Study||3||
48284409|NCT02483000|101021487|FG000|NOT COMPLETED|Overall Study||0||
48284410|NCT02552368|101021488|FG000|STARTED|Overall Study||23||
48284411|NCT02552368|101021488|FG000|COMPLETED|Overall Study||10||
48284412|NCT02552368|101021488|FG000|NOT COMPLETED|Overall Study||13||
48284413|NCT01920854|101021489|FG000|STARTED|Overall Study||12||
48398624|NCT00961116|101306361|FG000|STARTED|First Intervention||27||
48398625|NCT00961116|101306362|FG001|STARTED|First Intervention||27||
48398626|NCT00961116|101306361|FG000|COMPLETED|First Intervention||27||
48398627|NCT00961116|101306362|FG001|COMPLETED|First Intervention||27||
48130040|NCT01046643|100642763|FG000|STARTED|First Period Treatment or Placebo||9||
48130041|NCT01046643|100642764|FG001|STARTED|First Period Treatment or Placebo||7||
48130042|NCT01046643|100642765|FG002|STARTED|First Period Treatment or Placebo||7||
48130043|NCT01046643|100642766|FG003|STARTED|First Period Treatment or Placebo||7||
48130044|NCT01046643|100642763|FG000|COMPLETED|First Period Treatment or Placebo||9||
48284414|NCT01920854|101021490|FG001|STARTED|Overall Study||6||
48398628|NCT00961116|101306361|FG000|NOT COMPLETED|First Intervention||0||
48130045|NCT01046643|100642764|FG001|COMPLETED|First Period Treatment or Placebo||6||
48573716|NCT02104739|101735201|FG000|COMPLETED|Washout (Min of 10 and Max of 107 Days)||1||
48573717|NCT02104739|101735202|FG001|COMPLETED|Washout (Min of 10 and Max of 107 Days)||4||
48573718|NCT02104739|101735203|FG002|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2||
48573719|NCT02104739|101735204|FG003|COMPLETED|Washout (Min of 10 and Max of 107 Days)||7||
48284415|NCT01920854|101021491|FG002|STARTED|Overall Study||6||
48398629|NCT00961116|101306362|FG001|NOT COMPLETED|First Intervention||0||
48398630|NCT00961116|101306361|FG000|STARTED|Washout Period of 7 Days||27||
48398631|NCT00961116|101306362|FG001|STARTED|Washout Period of 7 Days||27||
48398632|NCT00961116|101306361|FG000|COMPLETED|Washout Period of 7 Days||25||
48398633|NCT00961116|101306362|FG001|COMPLETED|Washout Period of 7 Days||24||
48398634|NCT00961116|101306361|FG000|NOT COMPLETED|Washout Period of 7 Days||2||
48398635|NCT00961116|101306362|FG001|NOT COMPLETED|Washout Period of 7 Days||3||
48398636|NCT00961116|101306361|FG000|STARTED|Second Intervention||25||
48398637|NCT00961116|101306362|FG001|STARTED|Second Intervention||24||
48398638|NCT00961116|101306361|FG000|COMPLETED|Second Intervention||25||
48398639|NCT00961116|101306362|FG001|COMPLETED|Second Intervention||24||
48398640|NCT00961116|101306361|FG000|NOT COMPLETED|Second Intervention||0||
48398641|NCT00961116|101306362|FG001|NOT COMPLETED|Second Intervention||0||
48398642|NCT00636441|101306363|FG000|STARTED|Overall Study||6||
48398643|NCT00636441|101306364|FG001|STARTED|Overall Study||7||
48398644|NCT00636441|101306365|FG002|STARTED|Overall Study||6||
48398645|NCT00636441|101306366|FG003|STARTED|Overall Study||6||
48398646|NCT00636441|101306367|FG004|STARTED|Overall Study||6||
48398647|NCT00636441|101306368|FG005|STARTED|Overall Study||7||
48398648|NCT00636441|101306369|FG006|STARTED|Overall Study||18||
48573720|NCT02104739|101735205|FG004|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
48701445|NCT04925076|102054239|FG005|STARTED|Overall Study||23||
48284416|NCT01920854|101021492|FG003|STARTED|Overall Study||6||
48284417|NCT01920854|101021493|FG004|STARTED|Overall Study||6||
48284418|NCT01920854|101021494|FG005|STARTED|Overall Study||6||
48284419|NCT01920854|101021495|FG006|STARTED|Overall Study||6||
48284420|NCT01920854|101021489|FG000|COMPLETED|Overall Study||11||
48284421|NCT01920854|101021490|FG001|COMPLETED|Overall Study||6||
48284422|NCT01920854|101021491|FG002|COMPLETED|Overall Study||6||
48284423|NCT01920854|101021492|FG003|COMPLETED|Overall Study||6||
48284424|NCT01920854|101021493|FG004|COMPLETED|Overall Study||5||
48284425|NCT01920854|101021494|FG005|COMPLETED|Overall Study||6||
48284426|NCT01920854|101021495|FG006|COMPLETED|Overall Study||5||
48284427|NCT01920854|101021489|FG000|NOT COMPLETED|Overall Study||1||
48284428|NCT01920854|101021490|FG001|NOT COMPLETED|Overall Study||0||
48284429|NCT01920854|101021491|FG002|NOT COMPLETED|Overall Study||0||
48284430|NCT01920854|101021492|FG003|NOT COMPLETED|Overall Study||0||
48284431|NCT01920854|101021493|FG004|NOT COMPLETED|Overall Study||1||
48284432|NCT01920854|101021494|FG005|NOT COMPLETED|Overall Study||0||
48284433|NCT01920854|101021495|FG006|NOT COMPLETED|Overall Study||1||
48284434|NCT00833833|101021496|FG000|STARTED|Phase 1 (as of 01 April 2011)||6||
48284435|NCT00833833|101021497|FG001|STARTED|Phase 1 (as of 01 April 2011)||8||
48284436|NCT00833833|101021498|FG002|STARTED|Phase 1 (as of 01 April 2011)||14||
48284437|NCT00833833|101021499|FG003|STARTED|Phase 1 (as of 01 April 2011)||10||
48284438|NCT00833833|101021500|FG004|STARTED|Phase 1 (as of 01 April 2011)||0||
48284439|NCT00833833|101021501|FG005|STARTED|Phase 1 (as of 01 April 2011)||0||
48284440|NCT00833833|101021496|FG000|COMPLETED|Phase 1 (as of 01 April 2011)||2||
48284441|NCT00833833|101021497|FG001|COMPLETED|Phase 1 (as of 01 April 2011)||3||
48284442|NCT00833833|101021498|FG002|COMPLETED|Phase 1 (as of 01 April 2011)||5||
48398649|NCT00636441|101306363|FG000|Assigned Treatment|Overall Study||6||
48398650|NCT00636441|101306364|FG001|Assigned Treatment|Overall Study||7||
48398651|NCT00636441|101306365|FG002|Assigned Treatment|Overall Study||6||
48398652|NCT00636441|101306366|FG003|Assigned Treatment|Overall Study||6||
48398653|NCT00636441|101306367|FG004|Assigned Treatment|Overall Study||6||
48398654|NCT00636441|101306368|FG005|Assigned Treatment|Overall Study||7||
48398655|NCT00636441|101306369|FG006|Assigned Treatment|Overall Study||1||
48398656|NCT00636441|101306363|FG000|COMPLETED|Overall Study||6||
48398657|NCT00636441|101306364|FG001|COMPLETED|Overall Study||6||
48398658|NCT00636441|101306365|FG002|COMPLETED|Overall Study||5||
48398659|NCT00636441|101306366|FG003|COMPLETED|Overall Study||6||
48398660|NCT00636441|101306367|FG004|COMPLETED|Overall Study||6||
48398661|NCT00636441|101306368|FG005|COMPLETED|Overall Study||6||
48398662|NCT00636441|101306369|FG006|COMPLETED|Overall Study||0||
48398663|NCT00636441|101306363|FG000|NOT COMPLETED|Overall Study||0||
48398664|NCT00636441|101306364|FG001|NOT COMPLETED|Overall Study||1||
48398665|NCT00636441|101306365|FG002|NOT COMPLETED|Overall Study||1||
48398666|NCT00636441|101306366|FG003|NOT COMPLETED|Overall Study||0||
48398667|NCT00636441|101306367|FG004|NOT COMPLETED|Overall Study||0||
48398668|NCT00636441|101306368|FG005|NOT COMPLETED|Overall Study||1||
48398669|NCT00636441|101306369|FG006|NOT COMPLETED|Overall Study||18||
48398670|NCT00323310|101306370|FG000|STARTED|Overall Study||92||
48398671|NCT00323310|101306370|FG000|COMPLETED|Overall Study||89||
48398672|NCT00323310|101306370|FG000|NOT COMPLETED|Overall Study||3||
48398673|NCT00700063|101306371|FG000|STARTED|Overall Study||33||
48398674|NCT00700063|101306372|FG001|STARTED|Overall Study||34||
48398675|NCT00700063|101306373|FG002|STARTED|Overall Study||33||
48398676|NCT00700063|101306374|FG003|STARTED|Overall Study||33||
48398677|NCT00700063|101306375|FG004|STARTED|Overall Study||33||
48398678|NCT00700063|101306376|FG005|STARTED|Overall Study||34||
48284443|NCT00833833|101021499|FG003|COMPLETED|Phase 1 (as of 01 April 2011)||4||
48284444|NCT00833833|101021500|FG004|COMPLETED|Phase 1 (as of 01 April 2011)||0||
48284445|NCT00833833|101021501|FG005|COMPLETED|Phase 1 (as of 01 April 2011)||0||
48284446|NCT00833833|101021496|FG000|NOT COMPLETED|Phase 1 (as of 01 April 2011)||4||
48284447|NCT00833833|101021497|FG001|NOT COMPLETED|Phase 1 (as of 01 April 2011)||5||
48284448|NCT00833833|101021498|FG002|NOT COMPLETED|Phase 1 (as of 01 April 2011)||9||
48284449|NCT00833833|101021499|FG003|NOT COMPLETED|Phase 1 (as of 01 April 2011)||6||
48284450|NCT00833833|101021500|FG004|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0||
48284451|NCT00833833|101021501|FG005|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0||
48284452|NCT00833833|101021496|FG000|STARTED|Phase 2 (as of 01 April 2011)||0||
48284453|NCT00833833|101021497|FG001|STARTED|Phase 2 (as of 01 April 2011)||0||
48284454|NCT00833833|101021498|FG002|STARTED|Phase 2 (as of 01 April 2011)||0||
48284455|NCT00833833|101021499|FG003|STARTED|Phase 2 (as of 01 April 2011)||0||
48284456|NCT00833833|101021500|FG004|STARTED|Phase 2 (as of 01 April 2011)||113||
48284457|NCT00833833|101021501|FG005|STARTED|Phase 2 (as of 01 April 2011)||108||
48284458|NCT00833833|101021496|FG000|Safety Population|Phase 2 (as of 01 April 2011)||0||
48284459|NCT00833833|101021497|FG001|Safety Population|Phase 2 (as of 01 April 2011)||0||
48284460|NCT00833833|101021498|FG002|Safety Population|Phase 2 (as of 01 April 2011)||0||
48284461|NCT00833833|101021499|FG003|Safety Population|Phase 2 (as of 01 April 2011)||0||
48284462|NCT00833833|101021500|FG004|Safety Population|Phase 2 (as of 01 April 2011)||112||
48284463|NCT00833833|101021501|FG005|Safety Population|Phase 2 (as of 01 April 2011)||107||
48284464|NCT00833833|101021496|FG000|COMPLETED|Phase 2 (as of 01 April 2011)||0||
48398679|NCT00700063|101306377|FG006|STARTED|Overall Study||32||
48398680|NCT00700063|101306378|FG007|STARTED|Overall Study||33||
48398681|NCT00700063|101306371|FG000|COMPLETED|Overall Study||32||
48398682|NCT00700063|101306372|FG001|COMPLETED|Overall Study||34||
48398683|NCT00700063|101306373|FG002|COMPLETED|Overall Study||33||
48398684|NCT00700063|101306374|FG003|COMPLETED|Overall Study||31||
48398685|NCT00700063|101306375|FG004|COMPLETED|Overall Study||31||
48398686|NCT00700063|101306376|FG005|COMPLETED|Overall Study||34||
48398687|NCT00700063|101306377|FG006|COMPLETED|Overall Study||32||
48398688|NCT00700063|101306378|FG007|COMPLETED|Overall Study||33||
48398689|NCT00700063|101306371|FG000|NOT COMPLETED|Overall Study||1||
48398690|NCT00700063|101306372|FG001|NOT COMPLETED|Overall Study||0||
48398691|NCT00700063|101306373|FG002|NOT COMPLETED|Overall Study||0||
48398692|NCT00700063|101306374|FG003|NOT COMPLETED|Overall Study||2||
48398693|NCT00700063|101306375|FG004|NOT COMPLETED|Overall Study||2||
48398694|NCT00700063|101306376|FG005|NOT COMPLETED|Overall Study||0||
48398695|NCT00700063|101306377|FG006|NOT COMPLETED|Overall Study||0||
48398696|NCT00700063|101306378|FG007|NOT COMPLETED|Overall Study||0||
48398697|NCT03209362|101306379|FG000|STARTED|Overall Study||39||
48398698|NCT03209362|101306380|FG001|STARTED|Overall Study||41||
48398699|NCT03209362|101306379|FG000|COMPLETED|Overall Study||37||
48398700|NCT03209362|101306380|FG001|COMPLETED|Overall Study||38||
48398701|NCT03209362|101306379|FG000|NOT COMPLETED|Overall Study||2||
48573721|NCT02104739|101735206|FG005|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2||
48573722|NCT02104739|101735207|FG006|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
48398702|NCT03209362|101306380|FG001|NOT COMPLETED|Overall Study||3||
48398703|NCT01759160|101306381|FG000|STARTED|Overall Study||30||
48398704|NCT01759160|101306382|FG001|STARTED|Overall Study||30||
48398705|NCT01759160|101306381|FG000|COMPLETED|Overall Study||30||
48398706|NCT01759160|101306382|FG001|COMPLETED|Overall Study||30||
48398707|NCT01759160|101306381|FG000|NOT COMPLETED|Overall Study||0||
48398708|NCT01759160|101306382|FG001|NOT COMPLETED|Overall Study||0||
48398709|NCT03030183|101306383|FG000|STARTED|Overall Study||3||
48398710|NCT03030183|101306383|FG000|COMPLETED|Overall Study||3||
48398711|NCT03030183|101306383|FG000|NOT COMPLETED|Overall Study||0||
48398712|NCT01842646|101306384|FG000|STARTED|Overall Study||35||
48398713|NCT01842646|101306384|FG000|COMPLETED|Overall Study||35||
48398714|NCT01842646|101306384|FG000|NOT COMPLETED|Overall Study||0||
48398715|NCT04605159|101306385|FG000|STARTED|Overall Study||3557||
48573723|NCT02104739|101735201|FG000|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
48284465|NCT00833833|101021497|FG001|COMPLETED|Phase 2 (as of 01 April 2011)||0||
48284466|NCT00833833|101021498|FG002|COMPLETED|Phase 2 (as of 01 April 2011)||0||
48284467|NCT00833833|101021499|FG003|COMPLETED|Phase 2 (as of 01 April 2011)||0||
48284468|NCT00833833|101021500|FG004|COMPLETED|Phase 2 (as of 01 April 2011)||58||
48284469|NCT00833833|101021501|FG005|COMPLETED|Phase 2 (as of 01 April 2011)||47||
48284470|NCT00833833|101021496|FG000|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0||
48284471|NCT00833833|101021497|FG001|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0||
48284472|NCT00833833|101021498|FG002|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0||
48398716|NCT04605159|101306386|FG001|STARTED|Overall Study||1771||
48398717|NCT04605159|101306387|FG002|STARTED|Overall Study||3494||
48398718|NCT04605159|101306388|FG003|STARTED|Overall Study||1741||
48398719|NCT04605159|101306385|FG000|COMPLETED|Overall Study||3374||
48398720|NCT04605159|101306386|FG001|COMPLETED|Overall Study||1657||
48398721|NCT04605159|101306387|FG002|COMPLETED|Overall Study||3236||
48398722|NCT04605159|101306388|FG003|COMPLETED|Overall Study||1583||
48398723|NCT04605159|101306385|FG000|NOT COMPLETED|Overall Study||183||
48284473|NCT00833833|101021499|FG003|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0||
48284474|NCT00833833|101021500|FG004|NOT COMPLETED|Phase 2 (as of 01 April 2011)||55||
48284475|NCT00833833|101021501|FG005|NOT COMPLETED|Phase 2 (as of 01 April 2011)||61||
48284476|NCT02516332|101021502|FG000|STARTED|Overall Study||52||
48284477|NCT02516332|101021503|FG001|STARTED|Overall Study||53||
48284478|NCT02516332|101021504|FG002|STARTED|Overall Study||23||
48284479|NCT02516332|101021502|FG000|COMPLETED|Overall Study||50||
48284480|NCT02516332|101021503|FG001|COMPLETED|Overall Study||52||
48284481|NCT02516332|101021504|FG002|COMPLETED|Overall Study||21||
48284482|NCT02516332|101021502|FG000|NOT COMPLETED|Overall Study||2||
48284483|NCT02516332|101021503|FG001|NOT COMPLETED|Overall Study||1||
48284484|NCT02516332|101021504|FG002|NOT COMPLETED|Overall Study||2||
48284485|NCT02235831|101021505|FG000|STARTED|Period 1, First 5 Days of Wear||4||
48284486|NCT02235831|101021506|FG001|STARTED|Period 1, First 5 Days of Wear||4||
48284487|NCT02235831|101021507|FG002|STARTED|Period 1, First 5 Days of Wear||4||
48284488|NCT02235831|101021508|FG003|STARTED|Period 1, First 5 Days of Wear||4||
48284489|NCT02235831|101021509|FG004|STARTED|Period 1, First 5 Days of Wear||4||
48284490|NCT02235831|101021510|FG005|STARTED|Period 1, First 5 Days of Wear||4||
48284491|NCT02235831|101021505|FG000|COMPLETED|Period 1, First 5 Days of Wear||4||
48284492|NCT02235831|101021506|FG001|COMPLETED|Period 1, First 5 Days of Wear||4||
48284493|NCT02235831|101021507|FG002|COMPLETED|Period 1, First 5 Days of Wear||4||
48284494|NCT02235831|101021508|FG003|COMPLETED|Period 1, First 5 Days of Wear||4||
48284495|NCT02235831|101021509|FG004|COMPLETED|Period 1, First 5 Days of Wear||4||
48284496|NCT02235831|101021510|FG005|COMPLETED|Period 1, First 5 Days of Wear||4||
48284497|NCT02235831|101021505|FG000|NOT COMPLETED|Period 1, First 5 Days of Wear||0||
48284498|NCT02235831|101021506|FG001|NOT COMPLETED|Period 1, First 5 Days of Wear||0||
48284499|NCT02235831|101021507|FG002|NOT COMPLETED|Period 1, First 5 Days of Wear||0||
48284500|NCT02235831|101021508|FG003|NOT COMPLETED|Period 1, First 5 Days of Wear||0||
48284501|NCT02235831|101021509|FG004|NOT COMPLETED|Period 1, First 5 Days of Wear||0||
48284502|NCT02235831|101021510|FG005|NOT COMPLETED|Period 1, First 5 Days of Wear||0||
48284503|NCT02235831|101021505|FG000|STARTED|Period 2, Second 5 Days of Wear||4||
48284504|NCT02235831|101021506|FG001|STARTED|Period 2, Second 5 Days of Wear||4||
48284505|NCT02235831|101021507|FG002|STARTED|Period 2, Second 5 Days of Wear||4||
48284506|NCT02235831|101021508|FG003|STARTED|Period 2, Second 5 Days of Wear||4||
48284507|NCT02235831|101021509|FG004|STARTED|Period 2, Second 5 Days of Wear||4||
48284508|NCT02235831|101021510|FG005|STARTED|Period 2, Second 5 Days of Wear||4||
48284509|NCT02235831|101021505|FG000|COMPLETED|Period 2, Second 5 Days of Wear||4||
48284510|NCT02235831|101021506|FG001|COMPLETED|Period 2, Second 5 Days of Wear||4||
48284511|NCT02235831|101021507|FG002|COMPLETED|Period 2, Second 5 Days of Wear||4||
48284512|NCT02235831|101021508|FG003|COMPLETED|Period 2, Second 5 Days of Wear||4||
48284513|NCT02235831|101021509|FG004|COMPLETED|Period 2, Second 5 Days of Wear||4||
48284514|NCT02235831|101021510|FG005|COMPLETED|Period 2, Second 5 Days of Wear||4||
48284515|NCT02235831|101021505|FG000|NOT COMPLETED|Period 2, Second 5 Days of Wear||0||
48284516|NCT02235831|101021506|FG001|NOT COMPLETED|Period 2, Second 5 Days of Wear||0||
48284517|NCT02235831|101021507|FG002|NOT COMPLETED|Period 2, Second 5 Days of Wear||0||
48284518|NCT02235831|101021508|FG003|NOT COMPLETED|Period 2, Second 5 Days of Wear||0||
48284519|NCT02235831|101021509|FG004|NOT COMPLETED|Period 2, Second 5 Days of Wear||0||
48284520|NCT02235831|101021510|FG005|NOT COMPLETED|Period 2, Second 5 Days of Wear||0||
48284521|NCT02235831|101021505|FG000|STARTED|Period 3, Third 5 Days of Wear||4||
48284522|NCT02235831|101021506|FG001|STARTED|Period 3, Third 5 Days of Wear||4||
48284523|NCT02235831|101021507|FG002|STARTED|Period 3, Third 5 Days of Wear||4||
48284524|NCT02235831|101021508|FG003|STARTED|Period 3, Third 5 Days of Wear||4||
48284525|NCT02235831|101021509|FG004|STARTED|Period 3, Third 5 Days of Wear||4||
48284526|NCT02235831|101021510|FG005|STARTED|Period 3, Third 5 Days of Wear||4||
48284527|NCT02235831|101021505|FG000|COMPLETED|Period 3, Third 5 Days of Wear||4||
48284528|NCT02235831|101021506|FG001|COMPLETED|Period 3, Third 5 Days of Wear||4||
48284529|NCT02235831|101021507|FG002|COMPLETED|Period 3, Third 5 Days of Wear||4||
48284530|NCT02235831|101021508|FG003|COMPLETED|Period 3, Third 5 Days of Wear||4||
48284531|NCT02235831|101021509|FG004|COMPLETED|Period 3, Third 5 Days of Wear||4||
48284532|NCT02235831|101021510|FG005|COMPLETED|Period 3, Third 5 Days of Wear||4||
48284533|NCT02235831|101021505|FG000|NOT COMPLETED|Period 3, Third 5 Days of Wear||0||
48284534|NCT02235831|101021506|FG001|NOT COMPLETED|Period 3, Third 5 Days of Wear||0||
48284535|NCT02235831|101021507|FG002|NOT COMPLETED|Period 3, Third 5 Days of Wear||0||
48284536|NCT02235831|101021508|FG003|NOT COMPLETED|Period 3, Third 5 Days of Wear||0||
48284537|NCT02235831|101021509|FG004|NOT COMPLETED|Period 3, Third 5 Days of Wear||0||
48284538|NCT02235831|101021510|FG005|NOT COMPLETED|Period 3, Third 5 Days of Wear||0||
48284539|NCT04485858|101021511|FG000|STARTED|Overall Study||10||
48284540|NCT04485858|101021511|FG000|Implantations in Israel, France, Canada|Overall Study||10||
48284541|NCT04485858|101021511|FG000|Improved Visual Acuity at Some Point Throughout the Study|Overall Study||8||
48284542|NCT04485858|101021511|FG000|VA Improvement at Their Last Follow up Visit They Attended (After 6-24 Months From Surgery)|Overall Study||4||
48284543|NCT04485858|101021511|FG000|COMPLETED|Overall Study||5||
48284544|NCT04485858|101021511|FG000|NOT COMPLETED|Overall Study||5||
48284545|NCT04279392|101021512|FG000|STARTED|Overall Study||3||
48284546|NCT04279392|101021513|FG001|STARTED|Overall Study||7||
48284547|NCT04279392|101021512|FG000|COMPLETED|Overall Study||2||
48284548|NCT04279392|101021513|FG001|COMPLETED|Overall Study||7||
48284549|NCT04279392|101021512|FG000|NOT COMPLETED|Overall Study||1||
48284550|NCT04279392|101021513|FG001|NOT COMPLETED|Overall Study||0||
48284551|NCT01005459|101021514|FG000|STARTED|Overall Study||23||
48284552|NCT01005459|101021515|FG001|STARTED|Overall Study||23||
48284553|NCT01005459|101021514|FG000|COMPLETED|Overall Study||23||
48284554|NCT01005459|101021515|FG001|COMPLETED|Overall Study||23||
48284555|NCT01005459|101021514|FG000|NOT COMPLETED|Overall Study||0||
48284556|NCT01005459|101021515|FG001|NOT COMPLETED|Overall Study||0||
48284557|NCT03797677|101021516|FG000|STARTED|Overall Study||10||
48284558|NCT03797677|101021516|FG000|COMPLETED|Overall Study||10||
48284559|NCT03797677|101021516|FG000|NOT COMPLETED|Overall Study||0||
48284560|NCT01147601|101021517|FG000|STARTED|Overall Study||5||
48284561|NCT01147601|101021518|FG001|STARTED|Overall Study||1||
48284562|NCT01147601|101021517|FG000|COMPLETED|Overall Study||2||
48284563|NCT01147601|101021518|FG001|COMPLETED|Overall Study||1||
48284564|NCT01147601|101021517|FG000|NOT COMPLETED|Overall Study||3||
48284565|NCT01147601|101021518|FG001|NOT COMPLETED|Overall Study||0||
48284566|NCT03178643|101021519|FG000|STARTED|Overall Study||81||
48284567|NCT03178643|101021520|FG001|STARTED|Overall Study||83||
48284568|NCT03178643|101021521|FG002|STARTED|Overall Study||82||
48284569|NCT03178643|101021519|FG000|COMPLETED|Overall Study||75||
48284570|NCT03178643|101021520|FG001|COMPLETED|Overall Study||67||
48284571|NCT03178643|101021521|FG002|COMPLETED|Overall Study||71||
48284572|NCT03178643|101021519|FG000|NOT COMPLETED|Overall Study||6||
48284573|NCT03178643|101021520|FG001|NOT COMPLETED|Overall Study||16||
48284574|NCT03178643|101021521|FG002|NOT COMPLETED|Overall Study||11||
48284575|NCT03796962|101021522|FG000|STARTED|Overall Study||114||
48284576|NCT03796962|101021523|FG001|STARTED|Overall Study||51||
48284577|NCT03796962|101021524|FG002|STARTED|Overall Study||46||
48284578|NCT03796962|101021525|FG003|STARTED|Overall Study||114||
48284579|NCT03796962|101021522|FG000|COMPLETED|Overall Study||88||
48284580|NCT03796962|101021523|FG001|COMPLETED|Overall Study||43||
48284581|NCT03796962|101021524|FG002|COMPLETED|Overall Study||45||
48284582|NCT03796962|101021525|FG003|COMPLETED|Overall Study||109||
48284583|NCT03796962|101021522|FG000|NOT COMPLETED|Overall Study||26||
48284584|NCT03796962|101021523|FG001|NOT COMPLETED|Overall Study||8||
48284585|NCT03796962|101021524|FG002|NOT COMPLETED|Overall Study||1||
48284586|NCT03796962|101021525|FG003|NOT COMPLETED|Overall Study||5||
48284587|NCT03358251|101021526|FG000|STARTED|Overall Study||34||
48284588|NCT03358251|101021526|FG000|COMPLETED|Overall Study||34||
48284589|NCT03358251|101021526|FG000|NOT COMPLETED|Overall Study||0||
48284590|NCT00998335|101021527|FG000|STARTED|Initial Treatment (Months 0 - 3)||30||
48284591|NCT00998335|101021528|FG001|STARTED|Initial Treatment (Months 0 - 3)||0||
48284592|NCT00998335|101021527|FG000|COMPLETED|Initial Treatment (Months 0 - 3)||30||
48284593|NCT00998335|101021528|FG001|COMPLETED|Initial Treatment (Months 0 - 3)||0||
48284594|NCT00998335|101021527|FG000|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0||
48284595|NCT00998335|101021528|FG001|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0||
48284596|NCT00998335|101021527|FG000|STARTED|Randomized Period (Months 3 to 6)||8||
48284597|NCT00998335|101021528|FG001|STARTED|Randomized Period (Months 3 to 6)||22||
48284598|NCT00998335|101021527|FG000|COMPLETED|Randomized Period (Months 3 to 6)||8||
48284599|NCT00998335|101021528|FG001|COMPLETED|Randomized Period (Months 3 to 6)||20||
48284600|NCT00998335|101021527|FG000|NOT COMPLETED|Randomized Period (Months 3 to 6)||0||
48284601|NCT00998335|101021528|FG001|NOT COMPLETED|Randomized Period (Months 3 to 6)||2||
48284602|NCT01833845|101021529|FG000|STARTED|Overall Study||4||
48284603|NCT01833845|101021529|FG000|COMPLETED|Overall Study||4||
48284604|NCT01833845|101021529|FG000|NOT COMPLETED|Overall Study||0||
48284605|NCT00744757|101021530|FG000|STARTED|Overall Study||37||
48284606|NCT00744757|101021530|FG000|COMPLETED|Overall Study||16||
48284607|NCT00744757|101021530|FG000|NOT COMPLETED|Overall Study||21||
48284608|NCT00166712|101021531|FG000|STARTED|Overall Study||24||
48284609|NCT00166712|101021532|FG001|STARTED|Overall Study||16||
48284610|NCT00166712|101021531|FG000|Phase 1|Overall Study||22||
48284611|NCT00166712|101021532|FG001|Phase 1|Overall Study||12||
48284612|NCT00166712|101021531|FG000|Phase 2a|Overall Study||19||
48284613|NCT00166712|101021532|FG001|Phase 2a|Overall Study||12||
48284614|NCT00166712|101021531|FG000|Phase 2b|Overall Study||3||
48284615|NCT00166712|101021532|FG001|Phase 2b|Overall Study||0||
48284616|NCT00166712|101021531|FG000|Phase 3|Overall Study||0||
48284617|NCT00166712|101021532|FG001|Phase 3|Overall Study||0||
48284618|NCT00166712|101021531|FG000|COMPLETED|Overall Study||22||
48284619|NCT00166712|101021532|FG001|COMPLETED|Overall Study||11||
48284620|NCT00166712|101021531|FG000|NOT COMPLETED|Overall Study||2||
48284621|NCT00166712|101021532|FG001|NOT COMPLETED|Overall Study||5||
48284622|NCT04602221|101021533|FG000|STARTED|Overall Study||3||
48284623|NCT04602221|101021534|FG001|STARTED|Overall Study||2||
48284624|NCT04602221|101021535|FG002|STARTED|Overall Study||2||
48284625|NCT04602221|101021536|FG003|STARTED|Overall Study||2||
48284626|NCT04602221|101021537|FG004|STARTED|Overall Study||2||
48284627|NCT04602221|101021538|FG005|STARTED|Overall Study||2||
48284628|NCT04602221|101021539|FG006|STARTED|Overall Study||2||
48284629|NCT04602221|101021540|FG007|STARTED|Overall Study||2||
48284630|NCT04602221|101021541|FG008|STARTED|Overall Study||2||
48398724|NCT04605159|101306386|FG001|NOT COMPLETED|Overall Study||114||
48398725|NCT04605159|101306387|FG002|NOT COMPLETED|Overall Study||258||
48398726|NCT04605159|101306388|FG003|NOT COMPLETED|Overall Study||158||
48398727|NCT03167541|101306389|FG000|STARTED|First Intervention||9||
48573724|NCT02104739|101735202|FG001|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
48284631|NCT04602221|101021542|FG009|STARTED|Overall Study||2||
48284632|NCT04602221|101021543|FG010|STARTED|Overall Study||2||
48284633|NCT04602221|101021544|FG011|STARTED|Overall Study||2||
48284634|NCT04602221|101021545|FG012|STARTED|Overall Study||3||
48284635|NCT04602221|101021546|FG013|STARTED|Overall Study||2||
48284636|NCT04602221|101021547|FG014|STARTED|Overall Study||2||
48284637|NCT04602221|101021548|FG015|STARTED|Overall Study||3||
48284638|NCT04602221|101021549|FG016|STARTED|Overall Study||2||
48284639|NCT04602221|101021550|FG017|STARTED|Overall Study||3||
48284640|NCT04602221|101021533|FG000|COMPLETED|Overall Study||3||
48284641|NCT04602221|101021534|FG001|COMPLETED|Overall Study||2||
48284642|NCT04602221|101021535|FG002|COMPLETED|Overall Study||1||
48573725|NCT02104739|101735203|FG002|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
48573726|NCT02104739|101735204|FG003|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
48284643|NCT04602221|101021536|FG003|COMPLETED|Overall Study||2||
48284644|NCT04602221|101021537|FG004|COMPLETED|Overall Study||2||
48284645|NCT04602221|101021538|FG005|COMPLETED|Overall Study||1||
48284646|NCT04602221|101021539|FG006|COMPLETED|Overall Study||2||
48284647|NCT04602221|101021540|FG007|COMPLETED|Overall Study||2||
48284648|NCT04602221|101021541|FG008|COMPLETED|Overall Study||2||
48284649|NCT04602221|101021542|FG009|COMPLETED|Overall Study||2||
48284650|NCT04602221|101021543|FG010|COMPLETED|Overall Study||2||
48284651|NCT04602221|101021544|FG011|COMPLETED|Overall Study||2||
48284652|NCT04602221|101021545|FG012|COMPLETED|Overall Study||2||
48284653|NCT04602221|101021546|FG013|COMPLETED|Overall Study||2||
48284654|NCT04602221|101021547|FG014|COMPLETED|Overall Study||2||
48284655|NCT04602221|101021548|FG015|COMPLETED|Overall Study||2||
48284656|NCT04602221|101021549|FG016|COMPLETED|Overall Study||2||
48284657|NCT04602221|101021550|FG017|COMPLETED|Overall Study||2||
48284658|NCT04602221|101021533|FG000|NOT COMPLETED|Overall Study||0||
48284659|NCT04602221|101021534|FG001|NOT COMPLETED|Overall Study||0||
48284660|NCT04602221|101021535|FG002|NOT COMPLETED|Overall Study||1||
48284661|NCT04602221|101021536|FG003|NOT COMPLETED|Overall Study||0||
48284662|NCT04602221|101021537|FG004|NOT COMPLETED|Overall Study||0||
48284663|NCT04602221|101021538|FG005|NOT COMPLETED|Overall Study||1||
48284664|NCT04602221|101021539|FG006|NOT COMPLETED|Overall Study||0||
48284665|NCT04602221|101021540|FG007|NOT COMPLETED|Overall Study||0||
48284666|NCT04602221|101021541|FG008|NOT COMPLETED|Overall Study||0||
48284667|NCT04602221|101021542|FG009|NOT COMPLETED|Overall Study||0||
48284668|NCT04602221|101021543|FG010|NOT COMPLETED|Overall Study||0||
48284669|NCT04602221|101021544|FG011|NOT COMPLETED|Overall Study||0||
48284670|NCT04602221|101021545|FG012|NOT COMPLETED|Overall Study||1||
48284671|NCT04602221|101021546|FG013|NOT COMPLETED|Overall Study||0||
48284672|NCT04602221|101021547|FG014|NOT COMPLETED|Overall Study||0||
48284673|NCT04602221|101021548|FG015|NOT COMPLETED|Overall Study||1||
48284674|NCT04602221|101021549|FG016|NOT COMPLETED|Overall Study||0||
48284675|NCT04602221|101021550|FG017|NOT COMPLETED|Overall Study||1||
48284676|NCT00928018|101021551|FG000|STARTED|Overall Study||66||
48284677|NCT00928018|101021552|FG001|STARTED|Overall Study||73||
48284678|NCT00928018|101021551|FG000|COMPLETED|Overall Study||65||
48284679|NCT00928018|101021552|FG001|COMPLETED|Overall Study||73||
48284680|NCT00928018|101021551|FG000|NOT COMPLETED|Overall Study||1||
48284681|NCT00928018|101021552|FG001|NOT COMPLETED|Overall Study||0||
48398728|NCT03167541|101306390|FG001|STARTED|First Intervention||9||
48398729|NCT03167541|101306389|FG000|COMPLETED|First Intervention||9||
48398730|NCT03167541|101306390|FG001|COMPLETED|First Intervention||9||
48398731|NCT03167541|101306389|FG000|NOT COMPLETED|First Intervention||0||
48398732|NCT03167541|101306390|FG001|NOT COMPLETED|First Intervention||0||
48573727|NCT02104739|101735205|FG004|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
48573728|NCT02104739|101735206|FG005|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
48573729|NCT02104739|101735207|FG006|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
48284682|NCT02618642|101021553|FG000|STARTED|Before 10 PILER Irradiation Treatments||15||
48284683|NCT02618642|101021554|FG001|STARTED|Before 10 PILER Irradiation Treatments||15||
48284684|NCT02618642|101021555|FG002|STARTED|Before 10 PILER Irradiation Treatments||15||
48398733|NCT03167541|101306389|FG000|STARTED|Washout: 5-8 Days||9||
48398734|NCT03167541|101306390|FG001|STARTED|Washout: 5-8 Days||9||
48398735|NCT03167541|101306389|FG000|COMPLETED|Washout: 5-8 Days||9||
48398736|NCT03167541|101306390|FG001|COMPLETED|Washout: 5-8 Days||9||
48398737|NCT03167541|101306389|FG000|NOT COMPLETED|Washout: 5-8 Days||0||
48284685|NCT02618642|101021556|FG003|STARTED|Before 10 PILER Irradiation Treatments||15||
48284686|NCT02618642|101021553|FG000|COMPLETED|Before 10 PILER Irradiation Treatments||15||
48284687|NCT02618642|101021554|FG001|COMPLETED|Before 10 PILER Irradiation Treatments||15||
48284688|NCT02618642|101021555|FG002|COMPLETED|Before 10 PILER Irradiation Treatments||15||
48284689|NCT02618642|101021556|FG003|COMPLETED|Before 10 PILER Irradiation Treatments||15||
48284690|NCT02618642|101021553|FG000|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0||
48284691|NCT02618642|101021554|FG001|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0||
48573730|NCT02104739|101735201|FG000|STARTED|Second Intervention (1 Day)||1||
48573731|NCT02104739|101735202|FG001|STARTED|Second Intervention (1 Day)||4||
48573732|NCT02104739|101735203|FG002|STARTED|Second Intervention (1 Day)||2||
48573733|NCT02104739|101735204|FG003|STARTED|Second Intervention (1 Day)||7||
48573734|NCT02104739|101735205|FG004|STARTED|Second Intervention (1 Day)||0||
48573735|NCT02104739|101735206|FG005|STARTED|Second Intervention (1 Day)||2||
48573736|NCT02104739|101735207|FG006|STARTED|Second Intervention (1 Day)||0||
48573737|NCT02104739|101735201|FG000|COMPLETED|Second Intervention (1 Day)||1||
48573738|NCT02104739|101735202|FG001|COMPLETED|Second Intervention (1 Day)||4||
48573739|NCT02104739|101735203|FG002|COMPLETED|Second Intervention (1 Day)||2||
48573740|NCT02104739|101735204|FG003|COMPLETED|Second Intervention (1 Day)||7||
48573741|NCT02104739|101735205|FG004|COMPLETED|Second Intervention (1 Day)||0||
48130046|NCT01046643|100642765|FG002|COMPLETED|First Period Treatment or Placebo||7||
48130047|NCT01046643|100642766|FG003|COMPLETED|First Period Treatment or Placebo||7||
48130048|NCT01046643|100642763|FG000|NOT COMPLETED|First Period Treatment or Placebo||0||
48130049|NCT01046643|100642764|FG001|NOT COMPLETED|First Period Treatment or Placebo||1||
48130050|NCT01046643|100642765|FG002|NOT COMPLETED|First Period Treatment or Placebo||0||
48398738|NCT03167541|101306390|FG001|NOT COMPLETED|Washout: 5-8 Days||0||
48398739|NCT03167541|101306389|FG000|STARTED|Second Intervention||9||
48398740|NCT03167541|101306390|FG001|STARTED|Second Intervention||9||
48398741|NCT03167541|101306389|FG000|COMPLETED|Second Intervention||9||
48398742|NCT03167541|101306390|FG001|COMPLETED|Second Intervention||9||
48398743|NCT03167541|101306389|FG000|NOT COMPLETED|Second Intervention||0||
48573742|NCT02104739|101735206|FG005|COMPLETED|Second Intervention (1 Day)||2||
48573743|NCT02104739|101735207|FG006|COMPLETED|Second Intervention (1 Day)||0||
48573744|NCT02104739|101735201|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48130051|NCT01046643|100642766|FG003|NOT COMPLETED|First Period Treatment or Placebo||0||
48130052|NCT01046643|100642763|FG000|STARTED|Washout Period||9||
48130053|NCT01046643|100642764|FG001|STARTED|Washout Period||6||
48130054|NCT01046643|100642765|FG002|STARTED|Washout Period||7||
48130055|NCT01046643|100642766|FG003|STARTED|Washout Period||7||
48130056|NCT01046643|100642763|FG000|COMPLETED|Washout Period||9||
48130057|NCT01046643|100642764|FG001|COMPLETED|Washout Period||6||
48130058|NCT01046643|100642765|FG002|COMPLETED|Washout Period||7||
48130059|NCT01046643|100642766|FG003|COMPLETED|Washout Period||7||
48130060|NCT01046643|100642763|FG000|NOT COMPLETED|Washout Period||0||
48130061|NCT01046643|100642764|FG001|NOT COMPLETED|Washout Period||0||
48130062|NCT01046643|100642765|FG002|NOT COMPLETED|Washout Period||0||
48130063|NCT01046643|100642766|FG003|NOT COMPLETED|Washout Period||0||
48130064|NCT01046643|100642763|FG000|STARTED|Second Period Treatment or Placebo||9||
48130065|NCT01046643|100642764|FG001|STARTED|Second Period Treatment or Placebo||6||
48130066|NCT01046643|100642765|FG002|STARTED|Second Period Treatment or Placebo||7||
48130067|NCT01046643|100642766|FG003|STARTED|Second Period Treatment or Placebo||7||
48573745|NCT02104739|101735202|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48573746|NCT02104739|101735203|FG002|NOT COMPLETED|Second Intervention (1 Day)||0||
48130068|NCT01046643|100642763|FG000|COMPLETED|Second Period Treatment or Placebo||9||
48130069|NCT01046643|100642764|FG001|COMPLETED|Second Period Treatment or Placebo||6||
48130070|NCT01046643|100642765|FG002|COMPLETED|Second Period Treatment or Placebo||7||
48130071|NCT01046643|100642766|FG003|COMPLETED|Second Period Treatment or Placebo||7||
48130072|NCT01046643|100642763|FG000|NOT COMPLETED|Second Period Treatment or Placebo||0||
48130073|NCT01046643|100642764|FG001|NOT COMPLETED|Second Period Treatment or Placebo||0||
48130074|NCT01046643|100642765|FG002|NOT COMPLETED|Second Period Treatment or Placebo||0||
48130075|NCT01046643|100642766|FG003|NOT COMPLETED|Second Period Treatment or Placebo||0||
48130076|NCT01027910|100642767|FG000|STARTED|Overall Study||6||
48130077|NCT01027910|100642768|FG001|STARTED|Overall Study||14||
48130078|NCT01027910|100642767|FG000|COMPLETED|Overall Study||6||
48573747|NCT02104739|101735204|FG003|NOT COMPLETED|Second Intervention (1 Day)||0||
48573748|NCT02104739|101735205|FG004|NOT COMPLETED|Second Intervention (1 Day)||0||
48398744|NCT03167541|101306390|FG001|NOT COMPLETED|Second Intervention||0||
48398745|NCT04925947|101306391|FG000|STARTED|Overall Study||4||
48398746|NCT04925947|101306391|FG000|COMPLETED|Overall Study||4||
48398747|NCT04925947|101306391|FG000|NOT COMPLETED|Overall Study||0||
48573749|NCT02104739|101735206|FG005|NOT COMPLETED|Second Intervention (1 Day)||0||
48573750|NCT02104739|101735207|FG006|NOT COMPLETED|Second Intervention (1 Day)||0||
48573751|NCT02104739|101735201|FG000|STARTED|Washout (Min of 10 and Max of 107 Days)||1||
48573752|NCT02104739|101735202|FG001|STARTED|Washout (Min of 10 and Max of 107 Days)||4||
48573753|NCT02104739|101735203|FG002|STARTED|Washout (Min of 10 and Max of 107 Days)||2||
48573754|NCT02104739|101735204|FG003|STARTED|Washout (Min of 10 and Max of 107 Days)||7||
48573755|NCT02104739|101735205|FG004|STARTED|Washout (Min of 10 and Max of 107 Days)||0||
48573756|NCT02104739|101735206|FG005|STARTED|Washout (Min of 10 and Max of 107 Days)||2||
48573757|NCT02104739|101735207|FG006|STARTED|Washout (Min of 10 and Max of 107 Days)||0||
48573758|NCT02104739|101735201|FG000|COMPLETED|Washout (Min of 10 and Max of 107 Days)||1||
48398748|NCT02677623|101306392|FG000|STARTED|Overall Study||33||
48398749|NCT02677623|101306393|FG001|STARTED|Overall Study||32||
48398750|NCT02677623|101306394|FG002|STARTED|Overall Study||32||
48398751|NCT02677623|101306395|FG003|STARTED|Overall Study||33||
48130079|NCT01027910|100642768|FG001|COMPLETED|Overall Study||14||
48398752|NCT02677623|101306392|FG000|COMPLETED|Overall Study||33||
48398753|NCT02677623|101306393|FG001|COMPLETED|Overall Study||32||
48398754|NCT02677623|101306394|FG002|COMPLETED|Overall Study||32||
48398755|NCT02677623|101306395|FG003|COMPLETED|Overall Study||33||
48398756|NCT02677623|101306392|FG000|NOT COMPLETED|Overall Study||0||
48398757|NCT02677623|101306393|FG001|NOT COMPLETED|Overall Study||0||
48398758|NCT02677623|101306394|FG002|NOT COMPLETED|Overall Study||0||
48398759|NCT02677623|101306395|FG003|NOT COMPLETED|Overall Study||0||
48701446|NCT04925076|102054240|FG006|STARTED|Overall Study||18||
48701447|NCT04925076|102054241|FG007|STARTED|Overall Study||19||
48701448|NCT04925076|102054234|FG000|COMPLETED|Overall Study||10||
48701449|NCT04925076|102054235|FG001|COMPLETED|Overall Study||17||
48398760|NCT04807101|101306396|FG000|STARTED|Overall Study||152||
48398761|NCT04807101|101306397|FG001|STARTED|Overall Study||148||
48398762|NCT04807101|101306396|FG000|COMPLETED|Overall Study||152||
48398763|NCT04807101|101306397|FG001|COMPLETED|Overall Study||148||
48398764|NCT04807101|101306396|FG000|NOT COMPLETED|Overall Study||0||
48398765|NCT04807101|101306397|FG001|NOT COMPLETED|Overall Study||0||
48398766|NCT01360229|101306398|FG000|STARTED|Overall Study||47||
48398767|NCT01360229|101306399|FG001|STARTED|Overall Study||47||
48398768|NCT01360229|101306398|FG000|COMPLETED|Overall Study||44||
48398769|NCT01360229|101306399|FG001|COMPLETED|Overall Study||45||
48398770|NCT01360229|101306398|FG000|NOT COMPLETED|Overall Study||3||
48398771|NCT01360229|101306399|FG001|NOT COMPLETED|Overall Study||2||
48398772|NCT04055467|101306400|FG000|STARTED|Overall Study||15||
48398773|NCT04055467|101306400|FG000|COMPLETED|Overall Study||3||
48573759|NCT02104739|101735202|FG001|COMPLETED|Washout (Min of 10 and Max of 107 Days)||4||
48573760|NCT02104739|101735203|FG002|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2||
48573761|NCT02104739|101735204|FG003|COMPLETED|Washout (Min of 10 and Max of 107 Days)||7||
48573762|NCT02104739|101735205|FG004|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
48573763|NCT02104739|101735206|FG005|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2||
48573764|NCT02104739|101735207|FG006|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
48573765|NCT02104739|101735201|FG000|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
48573766|NCT02104739|101735202|FG001|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
48573767|NCT02104739|101735203|FG002|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
48573768|NCT02104739|101735204|FG003|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
48573769|NCT02104739|101735205|FG004|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
48573770|NCT02104739|101735206|FG005|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
48573771|NCT02104739|101735207|FG006|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
48573772|NCT02104739|101735201|FG000|STARTED|Third Intervention (1 Day)||1||
48573773|NCT02104739|101735202|FG001|STARTED|Third Intervention (1 Day)||4||
48573774|NCT02104739|101735203|FG002|STARTED|Third Intervention (1 Day)||2||
48573775|NCT02104739|101735204|FG003|STARTED|Third Intervention (1 Day)||7||
48573776|NCT02104739|101735205|FG004|STARTED|Third Intervention (1 Day)||0||
48573777|NCT02104739|101735206|FG005|STARTED|Third Intervention (1 Day)||2||
48573778|NCT02104739|101735207|FG006|STARTED|Third Intervention (1 Day)||0||
48573779|NCT02104739|101735201|FG000|COMPLETED|Third Intervention (1 Day)||1||
48573780|NCT02104739|101735202|FG001|COMPLETED|Third Intervention (1 Day)||4||
48573781|NCT02104739|101735203|FG002|COMPLETED|Third Intervention (1 Day)||2||
48573782|NCT02104739|101735204|FG003|COMPLETED|Third Intervention (1 Day)||7||
48573783|NCT02104739|101735205|FG004|COMPLETED|Third Intervention (1 Day)||0||
48573784|NCT02104739|101735206|FG005|COMPLETED|Third Intervention (1 Day)||2||
48573785|NCT02104739|101735207|FG006|COMPLETED|Third Intervention (1 Day)||0||
48573786|NCT02104739|101735201|FG000|NOT COMPLETED|Third Intervention (1 Day)||0||
48573787|NCT02104739|101735202|FG001|NOT COMPLETED|Third Intervention (1 Day)||0||
48573788|NCT02104739|101735203|FG002|NOT COMPLETED|Third Intervention (1 Day)||0||
48573789|NCT02104739|101735204|FG003|NOT COMPLETED|Third Intervention (1 Day)||0||
48573790|NCT02104739|101735205|FG004|NOT COMPLETED|Third Intervention (1 Day)||0||
48573791|NCT02104739|101735206|FG005|NOT COMPLETED|Third Intervention (1 Day)||0||
48573792|NCT02104739|101735207|FG006|NOT COMPLETED|Third Intervention (1 Day)||0||
48573793|NCT02104739|101735201|FG000|STARTED|Washout (Min of 10 and Max of 323 Days)||0||
48701450|NCT04925076|102054236|FG002|COMPLETED|Overall Study||12||
48701451|NCT04925076|102054237|FG003|COMPLETED|Overall Study||14||
48701452|NCT04925076|102054238|FG004|COMPLETED|Overall Study||12||
48701453|NCT04925076|102054239|FG005|COMPLETED|Overall Study||23||
48701454|NCT04925076|102054240|FG006|COMPLETED|Overall Study||18||
48701455|NCT04925076|102054241|FG007|COMPLETED|Overall Study||19||
48701456|NCT04925076|102054234|FG000|NOT COMPLETED|Overall Study||0||
48701457|NCT04925076|102054235|FG001|NOT COMPLETED|Overall Study||0||
48701458|NCT04925076|102054236|FG002|NOT COMPLETED|Overall Study||0||
48701459|NCT04925076|102054237|FG003|NOT COMPLETED|Overall Study||0||
48701460|NCT04925076|102054238|FG004|NOT COMPLETED|Overall Study||0||
48701461|NCT04925076|102054239|FG005|NOT COMPLETED|Overall Study||0||
48701462|NCT04925076|102054240|FG006|NOT COMPLETED|Overall Study||0||
48701463|NCT04925076|102054241|FG007|NOT COMPLETED|Overall Study||0||
48701464|NCT01364558|102057501|FG000|STARTED|Dose One||8||
48701465|NCT01364558|102057502|FG001|STARTED|Dose One||8||
48701466|NCT01364558|102057503|FG002|STARTED|Dose One||8||
48701467|NCT01364558|102057501|FG000|COMPLETED|Dose One||8||
48701468|NCT01364558|102057502|FG001|COMPLETED|Dose One||8||
48701469|NCT01364558|102057503|FG002|COMPLETED|Dose One||8||
48701470|NCT01364558|102057501|FG000|NOT COMPLETED|Dose One||0||
48701471|NCT01364558|102057502|FG001|NOT COMPLETED|Dose One||0||
48701472|NCT01364558|102057503|FG002|NOT COMPLETED|Dose One||0||
48701473|NCT01364558|102057501|FG000|STARTED|Dose Two||8||
48701474|NCT01364558|102057502|FG001|STARTED|Dose Two||8||
48701475|NCT01364558|102057503|FG002|STARTED|Dose Two||8||
48701476|NCT01364558|102057501|FG000|COMPLETED|Dose Two||8||
48701477|NCT01364558|102057502|FG001|COMPLETED|Dose Two||8||
48701478|NCT01364558|102057503|FG002|COMPLETED|Dose Two||8||
48573794|NCT02104739|101735202|FG001|STARTED|Washout (Min of 10 and Max of 323 Days)||0||
48573795|NCT02104739|101735203|FG002|STARTED|Washout (Min of 10 and Max of 323 Days)||0||
48573796|NCT02104739|101735204|FG003|STARTED|Washout (Min of 10 and Max of 323 Days)||0||
48573797|NCT02104739|101735205|FG004|STARTED|Washout (Min of 10 and Max of 323 Days)||0||
48573798|NCT02104739|101735206|FG005|STARTED|Washout (Min of 10 and Max of 323 Days)||0||
48573799|NCT02104739|101735207|FG006|STARTED|Washout (Min of 10 and Max of 323 Days)||8||
48573800|NCT02104739|101735201|FG000|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0||
48573801|NCT02104739|101735202|FG001|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0||
48701479|NCT01364558|102057501|FG000|NOT COMPLETED|Dose Two||0||
48701480|NCT01364558|102057502|FG001|NOT COMPLETED|Dose Two||0||
48701481|NCT01364558|102057503|FG002|NOT COMPLETED|Dose Two||0||
48701482|NCT01364558|102057501|FG000|STARTED|Dose Three||8||
48701483|NCT01364558|102057502|FG001|STARTED|Dose Three||8||
48701484|NCT01364558|102057503|FG002|STARTED|Dose Three||8||
48701485|NCT01364558|102057501|FG000|COMPLETED|Dose Three||8||
48701486|NCT01364558|102057502|FG001|COMPLETED|Dose Three||8||
48701487|NCT01364558|102057503|FG002|COMPLETED|Dose Three||8||
48701488|NCT01364558|102057501|FG000|NOT COMPLETED|Dose Three||0||
48701489|NCT01364558|102057502|FG001|NOT COMPLETED|Dose Three||0||
48130080|NCT01027910|100642767|FG000|NOT COMPLETED|Overall Study||0||
48130081|NCT01027910|100642768|FG001|NOT COMPLETED|Overall Study||0||
48130082|NCT02348216|100642769|FG000|STARTED|Overall Study||8||
48130083|NCT02348216|100642770|FG001|STARTED|Overall Study||81||
48130084|NCT02348216|100642771|FG002|STARTED|Overall Study||30||
48130085|NCT02348216|100642772|FG003|STARTED|Overall Study||42||
48130086|NCT02348216|100642773|FG004|STARTED|Overall Study||46||
48130087|NCT02348216|100642774|FG005|STARTED|Overall Study||58||
48130088|NCT02348216|100642775|FG006|STARTED|Overall Study||42||
48130089|NCT02348216|100642769|FG000|COMPLETED|Overall Study||0||
48130090|NCT02348216|100642770|FG001|COMPLETED|Overall Study||0||
48130091|NCT02348216|100642771|FG002|COMPLETED|Overall Study||0||
48130092|NCT02348216|100642772|FG003|COMPLETED|Overall Study||0||
48130093|NCT02348216|100642773|FG004|COMPLETED|Overall Study||0||
48130094|NCT02348216|100642774|FG005|COMPLETED|Overall Study||0||
48701490|NCT01364558|102057503|FG002|NOT COMPLETED|Dose Three||0||
48701491|NCT04011826|102057504|FG000|STARTED|Overall Study||45||
48701492|NCT04011826|102057504|FG000|COMPLETED|Overall Study||45||
48701493|NCT04011826|102057504|FG000|NOT COMPLETED|Overall Study||0||
48130095|NCT02348216|100642775|FG006|COMPLETED|Overall Study||0||
48130096|NCT02348216|100642769|FG000|NOT COMPLETED|Overall Study||8||
48130097|NCT02348216|100642770|FG001|NOT COMPLETED|Overall Study||81||
48130098|NCT02348216|100642771|FG002|NOT COMPLETED|Overall Study||30||
48130099|NCT02348216|100642772|FG003|NOT COMPLETED|Overall Study||42||
48130100|NCT02348216|100642773|FG004|NOT COMPLETED|Overall Study||46||
48130101|NCT02348216|100642774|FG005|NOT COMPLETED|Overall Study||58||
48130102|NCT02348216|100642775|FG006|NOT COMPLETED|Overall Study||42||
48130103|NCT02162810|100642776|FG000|STARTED|Overall Study||17||
48130104|NCT02162810|100642777|FG001|STARTED|Overall Study||11||
48130105|NCT02162810|100642776|FG000|COMPLETED|Overall Study||12||
48701494|NCT00633074|102057505|FG000|STARTED|Overall Study||360||
48701495|NCT00633074|102057506|FG001|STARTED|Overall Study||360||
48701496|NCT00633074|102057505|FG000|COMPLETED|Overall Study||359||
48701497|NCT00633074|102057506|FG001|COMPLETED|Overall Study||360||
48130106|NCT02162810|100642777|FG001|COMPLETED|Overall Study||10||
48130107|NCT02162810|100642776|FG000|NOT COMPLETED|Overall Study||5||
48130108|NCT02162810|100642777|FG001|NOT COMPLETED|Overall Study||1||
48701498|NCT00633074|102057505|FG000|NOT COMPLETED|Overall Study||1||
48130109|NCT01614210|100642778|FG000|STARTED|Overall Study||52||
48701499|NCT00633074|102057506|FG001|NOT COMPLETED|Overall Study||0||
48701500|NCT00585221|102057507|FG000|STARTED|Overall Study||8||
48573802|NCT02104739|101735203|FG002|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0||
48573803|NCT02104739|101735204|FG003|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0||
48573804|NCT02104739|101735205|FG004|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0||
48573805|NCT02104739|101735206|FG005|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0||
48573806|NCT02104739|101735207|FG006|COMPLETED|Washout (Min of 10 and Max of 323 Days)||7||
48573807|NCT02104739|101735201|FG000|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0||
48573808|NCT02104739|101735202|FG001|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0||
48573809|NCT02104739|101735203|FG002|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0||
48573810|NCT02104739|101735204|FG003|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0||
48573811|NCT02104739|101735205|FG004|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0||
48573812|NCT02104739|101735206|FG005|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0||
48573813|NCT02104739|101735207|FG006|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||1||
48573814|NCT02104739|101735201|FG000|STARTED|Extension Phase (6 Weeks)||0||
48573815|NCT02104739|101735202|FG001|STARTED|Extension Phase (6 Weeks)||0||
48573816|NCT02104739|101735203|FG002|STARTED|Extension Phase (6 Weeks)||0||
48573817|NCT02104739|101735204|FG003|STARTED|Extension Phase (6 Weeks)||0||
48573818|NCT02104739|101735205|FG004|STARTED|Extension Phase (6 Weeks)||0||
48573819|NCT02104739|101735206|FG005|STARTED|Extension Phase (6 Weeks)||0||
48573820|NCT02104739|101735207|FG006|STARTED|Extension Phase (6 Weeks)||8||
48573821|NCT02104739|101735201|FG000|COMPLETED|Extension Phase (6 Weeks)||0||
48573822|NCT02104739|101735202|FG001|COMPLETED|Extension Phase (6 Weeks)||0||
48573823|NCT02104739|101735203|FG002|COMPLETED|Extension Phase (6 Weeks)||0||
48573824|NCT02104739|101735204|FG003|COMPLETED|Extension Phase (6 Weeks)||0||
48573825|NCT02104739|101735205|FG004|COMPLETED|Extension Phase (6 Weeks)||0||
48573826|NCT02104739|101735206|FG005|COMPLETED|Extension Phase (6 Weeks)||0||
48573827|NCT02104739|101735207|FG006|COMPLETED|Extension Phase (6 Weeks)||7||
48573828|NCT02104739|101735201|FG000|NOT COMPLETED|Extension Phase (6 Weeks)||0||
48573829|NCT02104739|101735202|FG001|NOT COMPLETED|Extension Phase (6 Weeks)||0||
48573830|NCT02104739|101735203|FG002|NOT COMPLETED|Extension Phase (6 Weeks)||0||
48573831|NCT02104739|101735204|FG003|NOT COMPLETED|Extension Phase (6 Weeks)||0||
48573832|NCT02104739|101735205|FG004|NOT COMPLETED|Extension Phase (6 Weeks)||0||
48573833|NCT02104739|101735206|FG005|NOT COMPLETED|Extension Phase (6 Weeks)||0||
48573834|NCT02104739|101735207|FG006|NOT COMPLETED|Extension Phase (6 Weeks)||1||
48573835|NCT01921322|101735208|FG000|STARTED|Overall Study||57||
48573836|NCT01921322|101735209|FG001|STARTED|Overall Study||61||
48573837|NCT01921322|101735208|FG000|COMPLETED|Overall Study||42||
48573838|NCT01921322|101735209|FG001|COMPLETED|Overall Study||44||
48573839|NCT01921322|101735208|FG000|NOT COMPLETED|Overall Study||15||
48701501|NCT00585221|102057507|FG000|COMPLETED|Overall Study||0||
48701502|NCT00585221|102057507|FG000|NOT COMPLETED|Overall Study||8||
48701503|NCT01706497|102057508|FG000|STARTED|Overall Study||177||
48701504|NCT01706497|102057508|FG000|COMPLETED|Overall Study||177||
48701505|NCT01706497|102057508|FG000|NOT COMPLETED|Overall Study||0||
48701506|NCT02247011|102057509|FG000|STARTED|Overall Study||1100||
48701507|NCT02247011|102057509|FG000|COMPLETED|Overall Study||975||
48284692|NCT02618642|101021555|FG002|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0||
48701508|NCT02247011|102057509|FG000|NOT COMPLETED|Overall Study||125||
48701509|NCT00064259|102057510|FG000|STARTED|Overall Study||4||
48701510|NCT00064259|102057511|FG001|STARTED|Overall Study||4||
48701511|NCT00064259|102057512|FG002|STARTED|Overall Study||6||
48573840|NCT01921322|101735209|FG001|NOT COMPLETED|Overall Study||17||
48573841|NCT01944878|101735210|FG000|STARTED|Overall Study||127||
48573842|NCT01944878|101735211|FG001|STARTED|Overall Study||328||
48573843|NCT01944878|101735210|FG000|COMPLETED|Overall Study||127||
48573844|NCT01944878|101735211|FG001|COMPLETED|Overall Study||328||
48573845|NCT01944878|101735210|FG000|NOT COMPLETED|Overall Study||0||
48573846|NCT01944878|101735211|FG001|NOT COMPLETED|Overall Study||0||
48573847|NCT01284348|101735212|FG000|STARTED|Overall Study||14||
48573848|NCT01284348|101735213|FG001|STARTED|Overall Study||12||
48701512|NCT00064259|102057513|FG003|STARTED|Overall Study||1||
48701513|NCT00064259|102057510|FG000|COMPLETED|Overall Study||3||
48284693|NCT02618642|101021556|FG003|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0||
48284694|NCT02618642|101021553|FG000|STARTED|After 10 PILER Irradiation Treatments||15||
48284695|NCT02618642|101021554|FG001|STARTED|After 10 PILER Irradiation Treatments||15||
48284696|NCT02618642|101021555|FG002|STARTED|After 10 PILER Irradiation Treatments||15||
48284697|NCT02618642|101021556|FG003|STARTED|After 10 PILER Irradiation Treatments||15||
48284698|NCT02618642|101021553|FG000|COMPLETED|After 10 PILER Irradiation Treatments||15||
48284699|NCT02618642|101021554|FG001|COMPLETED|After 10 PILER Irradiation Treatments||15||
48284700|NCT02618642|101021555|FG002|COMPLETED|After 10 PILER Irradiation Treatments||15||
48284701|NCT02618642|101021556|FG003|COMPLETED|After 10 PILER Irradiation Treatments||15||
48284702|NCT02618642|101021553|FG000|NOT COMPLETED|After 10 PILER Irradiation Treatments||0||
48284703|NCT02618642|101021554|FG001|NOT COMPLETED|After 10 PILER Irradiation Treatments||0||
48284704|NCT02618642|101021555|FG002|NOT COMPLETED|After 10 PILER Irradiation Treatments||0||
48284705|NCT02618642|101021556|FG003|NOT COMPLETED|After 10 PILER Irradiation Treatments||0||
48284706|NCT00700427|101021557|FG000|STARTED|Study Period 2 (Open-Label Acute Trx)||2017||
48284707|NCT00700427|101021558|FG001|STARTED|Study Period 2 (Open-Label Acute Trx)||0||
48573849|NCT01284348|101735212|FG000|Treated|Overall Study||14||
48573850|NCT01284348|101735213|FG001|Treated|Overall Study||11||
48573851|NCT01284348|101735212|FG000|COMPLETED|Overall Study||4||
48573852|NCT01284348|101735213|FG001|COMPLETED|Overall Study||0||
48573853|NCT01284348|101735212|FG000|NOT COMPLETED|Overall Study||10||
48573854|NCT01284348|101735213|FG001|NOT COMPLETED|Overall Study||12||
48573855|NCT01430754|101735214|FG000|STARTED|Run-In Phase||57||
48573856|NCT01430754|101735215|FG001|STARTED|Run-In Phase||0||
48573857|NCT01430754|101735214|FG000|Entrained - After Run-In Phase|Run-In Phase||24||
48573858|NCT01430754|101735215|FG001|Entrained - After Run-In Phase|Run-In Phase||0||
48573859|NCT01430754|101735214|FG000|COMPLETED|Run-In Phase||20||
48573860|NCT01430754|101735215|FG001|COMPLETED|Run-In Phase||0||
48573861|NCT01430754|101735214|FG000|NOT COMPLETED|Run-In Phase||37||
48573862|NCT01430754|101735215|FG001|NOT COMPLETED|Run-In Phase||0||
48573863|NCT01430754|101735214|FG000|STARTED|Randomized Phase||10||
48284708|NCT00700427|101021559|FG002|STARTED|Study Period 2 (Open-Label Acute Trx)||0||
48398774|NCT04055467|101306400|FG000|NOT COMPLETED|Overall Study||12||
48573864|NCT01430754|101735215|FG001|STARTED|Randomized Phase||10||
48573865|NCT01430754|101735214|FG000|COMPLETED|Randomized Phase||10||
48573866|NCT01430754|101735215|FG001|COMPLETED|Randomized Phase||10||
48573867|NCT01430754|101735214|FG000|NOT COMPLETED|Randomized Phase||0||
48573868|NCT01430754|101735215|FG001|NOT COMPLETED|Randomized Phase||0||
48573869|NCT01262287|101735216|FG000|STARTED|Overall Study||20||
48573870|NCT01262287|101735217|FG001|STARTED|Overall Study||19||
48573871|NCT01262287|101735216|FG000|COMPLETED|Overall Study||18||
48573872|NCT01262287|101735217|FG001|COMPLETED|Overall Study||18||
48573873|NCT01262287|101735216|FG000|NOT COMPLETED|Overall Study||2||
48573874|NCT01262287|101735217|FG001|NOT COMPLETED|Overall Study||1||
48573875|NCT00832572|101735218|FG000|STARTED|Period 1||3||
48573876|NCT00832572|101735219|FG001|STARTED|Period 1||2||
48398775|NCT01109069|101306401|FG000|STARTED|Overall Study||199||
48398776|NCT01109069|101306401|FG000|COMPLETED|Overall Study||106||
48130110|NCT01614210|100642778|FG000|COMPLETED|Overall Study||52||
48130111|NCT01614210|100642778|FG000|NOT COMPLETED|Overall Study||0||
48130112|NCT00450424|100642779|FG000|STARTED|Overall Study||122||
48130113|NCT00450424|100642780|FG001|STARTED|Overall Study||117||
48130114|NCT00450424|100642779|FG000|COMPLETED|Overall Study||102||
48701514|NCT00064259|102057511|FG001|COMPLETED|Overall Study||4||
48701515|NCT00064259|102057512|FG002|COMPLETED|Overall Study||6||
48701516|NCT00064259|102057513|FG003|COMPLETED|Overall Study||0||
48284709|NCT00700427|101021560|FG003|STARTED|Study Period 2 (Open-Label Acute Trx)||0||
48284710|NCT00700427|101021561|FG004|STARTED|Study Period 2 (Open-Label Acute Trx)||0||
48284711|NCT00700427|101021557|FG000|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||2011||
48398777|NCT01109069|101306401|FG000|NOT COMPLETED|Overall Study||93||
48398778|NCT03027388|101306402|FG000|STARTED|Overall Study||7||
48701517|NCT00064259|102057510|FG000|NOT COMPLETED|Overall Study||1||
48701518|NCT00064259|102057511|FG001|NOT COMPLETED|Overall Study||0||
48701519|NCT00064259|102057512|FG002|NOT COMPLETED|Overall Study||0||
48701520|NCT00064259|102057513|FG003|NOT COMPLETED|Overall Study||1||
48701521|NCT05935878|102057514|FG000|STARTED|Overall Study||23||
48284712|NCT00700427|101021558|FG001|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0||
48284713|NCT00700427|101021559|FG002|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0||
48284714|NCT00700427|101021560|FG003|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0||
48284715|NCT00700427|101021561|FG004|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0||
48284716|NCT00700427|101021557|FG000|COMPLETED|Study Period 2 (Open-Label Acute Trx)||1006||
48284717|NCT00700427|101021558|FG001|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0||
48284718|NCT00700427|101021559|FG002|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0||
48284719|NCT00700427|101021560|FG003|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0||
48701522|NCT05935878|102057515|FG001|STARTED|Overall Study||24||
48701523|NCT05935878|102057514|FG000|1 Year|Overall Study||22||
48701524|NCT05935878|102057515|FG001|1 Year|Overall Study||21||
48701525|NCT05935878|102057514|FG000|2 Years|Overall Study||22||
48701526|NCT05935878|102057515|FG001|2 Years|Overall Study||21||
48701527|NCT05935878|102057514|FG000|5 Years|Overall Study||19||
48701528|NCT05935878|102057515|FG001|5 Years|Overall Study||20||
48701529|NCT05935878|102057514|FG000|10 Years|Overall Study||16||
48701530|NCT05935878|102057515|FG001|10 Years|Overall Study||15||
48701531|NCT05935878|102057514|FG000|COMPLETED|Overall Study||16||
48398779|NCT03027388|101306402|FG000|COMPLETED|Overall Study||7||
48398780|NCT03027388|101306402|FG000|NOT COMPLETED|Overall Study||0||
48284720|NCT00700427|101021561|FG004|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0||
48398781|NCT00360685|101306403|FG000|STARTED|Overall Study||47||
48398782|NCT00360685|101306404|FG001|STARTED|Overall Study||42||
48398783|NCT00360685|101306403|FG000|COMPLETED|Overall Study||47||
48398784|NCT00360685|101306404|FG001|COMPLETED|Overall Study||42||
48398785|NCT00360685|101306403|FG000|NOT COMPLETED|Overall Study||0||
48398786|NCT00360685|101306404|FG001|NOT COMPLETED|Overall Study||0||
48398787|NCT01525667|101306405|FG000|STARTED|Overall Study||7||
48398788|NCT01525667|101306406|FG001|STARTED|Overall Study||6||
48701532|NCT05935878|102057515|FG001|COMPLETED|Overall Study||15||
48701533|NCT05935878|102057514|FG000|NOT COMPLETED|Overall Study||7||
48701534|NCT05935878|102057515|FG001|NOT COMPLETED|Overall Study||9||
48701535|NCT01116024|102057516|FG000|STARTED|Overall Study||148||
48398789|NCT01525667|101306407|FG002|STARTED|Overall Study||7||
48398790|NCT01525667|101306405|FG000|COMPLETED|Overall Study||7||
48398791|NCT01525667|101306406|FG001|COMPLETED|Overall Study||6||
48701536|NCT01116024|102057516|FG000|COMPLETED|Overall Study||96||
48701537|NCT01116024|102057516|FG000|NOT COMPLETED|Overall Study||52||
48701538|NCT00561002|102057517|FG000|STARTED|Overall Study||23||
48701539|NCT00561002|102057518|FG001|STARTED|Overall Study||9||
48701540|NCT00561002|102057517|FG000|COMPLETED|Overall Study||23||
48701541|NCT00561002|102057518|FG001|COMPLETED|Overall Study||9||
48701542|NCT00561002|102057517|FG000|NOT COMPLETED|Overall Study||0||
48130115|NCT00450424|100642780|FG001|COMPLETED|Overall Study||106||
48130116|NCT00450424|100642779|FG000|NOT COMPLETED|Overall Study||20||
48130117|NCT00450424|100642780|FG001|NOT COMPLETED|Overall Study||11||
48130118|NCT03738865|100642781|FG000|STARTED|Overall Study||66||
48130119|NCT03738865|100642782|FG001|STARTED|Overall Study||66||
48130120|NCT03738865|100642781|FG000|COMPLETED|Overall Study||61||
48130121|NCT03738865|100642782|FG001|COMPLETED|Overall Study||62||
48130122|NCT03738865|100642781|FG000|NOT COMPLETED|Overall Study||5||
48130123|NCT03738865|100642782|FG001|NOT COMPLETED|Overall Study||4||
48130124|NCT04287920|100642783|FG000|STARTED|Overall Study||6||
48130125|NCT04287920|100642784|FG001|STARTED|Overall Study||6||
48130126|NCT04287920|100642783|FG000|COMPLETED|Overall Study||5||
48130127|NCT04287920|100642784|FG001|COMPLETED|Overall Study||2||
48130128|NCT04287920|100642783|FG000|NOT COMPLETED|Overall Study||1||
48130129|NCT04287920|100642784|FG001|NOT COMPLETED|Overall Study||4||
48130130|NCT00922428|100642785|FG000|STARTED|Overall Study||1389||
48130131|NCT00922428|100642785|FG000|COMPLETED|Overall Study||1374||
48130132|NCT00922428|100642785|FG000|NOT COMPLETED|Overall Study||15||
48130133|NCT02377986|100642786|FG000|STARTED|Overall Study||5||
48130134|NCT02377986|100642786|FG000|COMPLETED|Overall Study||5||
48130135|NCT02377986|100642786|FG000|NOT COMPLETED|Overall Study||0||
48130136|NCT01870843|100642787|FG000|STARTED|Overall Study||261||
48130137|NCT01870843|100642787|FG000|COMPLETED|Overall Study||208||
48130138|NCT01870843|100642787|FG000|NOT COMPLETED|Overall Study||53||
48130139|NCT01219738|100642788|FG000|STARTED|Overall Study||20||
48130140|NCT01219738|100642788|FG000|Budesonide 360|Overall Study||20||
48130141|NCT01219738|100642788|FG000|Budesonide 720|Overall Study||20||
48130142|NCT01219738|100642788|FG000|Budesonide 1440|Overall Study||20||
48130143|NCT01219738|100642788|FG000|Budesonide 720- 4 Times|Overall Study||20||
48130144|NCT01219738|100642788|FG000|COMPLETED|Overall Study||20||
48130145|NCT01219738|100642788|FG000|NOT COMPLETED|Overall Study||0||
48130146|NCT02467777|100642789|FG000|STARTED|Overall Study||23||
48130147|NCT02467777|100642790|FG001|STARTED|Overall Study||27||
48130148|NCT02467777|100642789|FG000|COMPLETED|Overall Study||23||
48130149|NCT02467777|100642790|FG001|COMPLETED|Overall Study||27||
48130150|NCT02467777|100642789|FG000|NOT COMPLETED|Overall Study||0||
48130151|NCT02467777|100642790|FG001|NOT COMPLETED|Overall Study||0||
48130152|NCT02819726|100642791|FG000|STARTED|Part A (All Participants)||98|Received at least 1 infusion of study treatment in Part A|
48130153|NCT02819726|100642792|FG001|STARTED|Part A (All Participants)||98|Received at least 1 infusion of study treatment in Part A|
48130154|NCT02819726|100642793|FG002|STARTED|Part A (All Participants)||98|Received at least 1 infusion of study treatment in Part A|
48130155|NCT02819726|100642794|FG003|STARTED|Part A (All Participants)||0|Received at least 1 infusion of study treatment in Part A|
48130156|NCT02819726|100642791|FG000|COMPLETED|Part A (All Participants)||92||
48130157|NCT02819726|100642792|FG001|COMPLETED|Part A (All Participants)||88||
48130158|NCT02819726|100642793|FG002|COMPLETED|Part A (All Participants)||87||
48130159|NCT02819726|100642794|FG003|COMPLETED|Part A (All Participants)||0||
48130160|NCT02819726|100642791|FG000|NOT COMPLETED|Part A (All Participants)||6||
48130161|NCT02819726|100642792|FG001|NOT COMPLETED|Part A (All Participants)||10||
48130162|NCT02819726|100642793|FG002|NOT COMPLETED|Part A (All Participants)||11||
48130163|NCT02819726|100642794|FG003|NOT COMPLETED|Part A (All Participants)||0||
48130164|NCT02819726|100642791|FG000|STARTED|Part B (All Participants)||73|Received at least 1 infusion of treatment in Part B. 220 participants were re-treated in Part B|
48130165|NCT02819726|100642792|FG001|STARTED|Part B (All Participants)||70|Received at least 1 infusion of treatment in Part B. 220 participants were re-treated in Part B|
48130166|NCT02819726|100642793|FG002|STARTED|Part B (All Participants)||39|Received at least 1 infusion of treatment in Part B. 220 participants were re-treated in Part B|
48130167|NCT02819726|100642794|FG003|STARTED|Part B (All Participants)||38|Received at least 1 infusion of treatment in Part B. 220 participants were re-treated in Part B|
48130168|NCT02819726|100642791|FG000|COMPLETED|Part B (All Participants)||70||
48130169|NCT02819726|100642792|FG001|COMPLETED|Part B (All Participants)||68||
48130170|NCT02819726|100642793|FG002|COMPLETED|Part B (All Participants)||35||
48130171|NCT02819726|100642794|FG003|COMPLETED|Part B (All Participants)||36||
48130172|NCT02819726|100642791|FG000|NOT COMPLETED|Part B (All Participants)||3||
48701543|NCT00561002|102057518|FG001|NOT COMPLETED|Overall Study||0||
48701544|NCT02652208|102057519|FG000|STARTED|Overall Study||17||
48701545|NCT02652208|102057520|FG001|STARTED|Overall Study||17||
48130173|NCT02819726|100642792|FG001|NOT COMPLETED|Part B (All Participants)||2||
48130174|NCT02819726|100642793|FG002|NOT COMPLETED|Part B (All Participants)||4||
48130175|NCT02819726|100642794|FG003|NOT COMPLETED|Part B (All Participants)||2||
48284721|NCT00700427|101021557|FG000|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||1011||
48284722|NCT00700427|101021558|FG001|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0||
48284723|NCT00700427|101021559|FG002|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0||
48701546|NCT02652208|102057519|FG000|COMPLETED|Overall Study||13||
48701547|NCT02652208|102057520|FG001|COMPLETED|Overall Study||15||
48701548|NCT02652208|102057519|FG000|NOT COMPLETED|Overall Study||4||
48130176|NCT03965052|100642795|FG000|STARTED|Overall Study||12||
48130177|NCT03965052|100642796|FG001|STARTED|Overall Study||12||
48130178|NCT03965052|100642795|FG000|COMPLETED|Overall Study||11||
48130179|NCT03965052|100642796|FG001|COMPLETED|Overall Study||12||
48130180|NCT03965052|100642795|FG000|NOT COMPLETED|Overall Study||1||
48130181|NCT03965052|100642796|FG001|NOT COMPLETED|Overall Study||0||
48130182|NCT00423436|100642797|FG000|STARTED|Overall Study||35||
48130183|NCT00423436|100642798|FG001|STARTED|Overall Study||33||
48130184|NCT00423436|100642797|FG000|COMPLETED|Overall Study||35||
48130185|NCT00423436|100642798|FG001|COMPLETED|Overall Study||33||
48130186|NCT00423436|100642797|FG000|NOT COMPLETED|Overall Study||0||
48130187|NCT00423436|100642798|FG001|NOT COMPLETED|Overall Study||0||
48130188|NCT01496352|100642799|FG000|STARTED|Overall Study||24||
48130189|NCT01496352|100642800|FG001|STARTED|Overall Study||6||
48130190|NCT01496352|100642799|FG000|COMPLETED|Overall Study||24||
48130191|NCT01496352|100642800|FG001|COMPLETED|Overall Study||6||
48130192|NCT01496352|100642799|FG000|NOT COMPLETED|Overall Study||0||
48573877|NCT00832572|101735218|FG000|COMPLETED|Period 1||3||
48573878|NCT00832572|101735219|FG001|COMPLETED|Period 1||2||
48573879|NCT00832572|101735218|FG000|NOT COMPLETED|Period 1||0||
48573880|NCT00832572|101735219|FG001|NOT COMPLETED|Period 1||0||
48573881|NCT00832572|101735218|FG000|STARTED|Period 2||3||
48701549|NCT02652208|102057520|FG001|NOT COMPLETED|Overall Study||2||
48701550|NCT00791479|102057521|FG000|STARTED|Overall Study||35||
48130193|NCT01496352|100642800|FG001|NOT COMPLETED|Overall Study||0||
48130194|NCT00910481|100642801|FG000|STARTED|Overall Study||151||
48130195|NCT00910481|100642802|FG001|STARTED|Overall Study||150||
48130196|NCT00910481|100642801|FG000|COMPLETED|Overall Study||151||
48130197|NCT00910481|100642802|FG001|COMPLETED|Overall Study||150||
48130198|NCT00910481|100642801|FG000|NOT COMPLETED|Overall Study||0||
48130199|NCT00910481|100642802|FG001|NOT COMPLETED|Overall Study||0||
48130200|NCT01748994|100642803|FG000|STARTED|Overall Study||31||
48130201|NCT01748994|100642804|FG001|STARTED|Overall Study||32||
48130202|NCT01748994|100642803|FG000|COMPLETED|Overall Study||23||
48130203|NCT01748994|100642804|FG001|COMPLETED|Overall Study||26||
48130204|NCT01748994|100642803|FG000|NOT COMPLETED|Overall Study||8||
48130205|NCT01748994|100642804|FG001|NOT COMPLETED|Overall Study||6||
48130206|NCT00661492|100642805|FG000|STARTED|Overall Study||75||
48130207|NCT00661492|100642806|FG001|STARTED|Overall Study||40||
48130208|NCT00661492|100642805|FG000|COMPLETED|Overall Study||7||
48130209|NCT00661492|100642806|FG001|COMPLETED|Overall Study||11||
48130210|NCT00661492|100642805|FG000|NOT COMPLETED|Overall Study||68||
48130211|NCT00661492|100642806|FG001|NOT COMPLETED|Overall Study||29||
48130212|NCT01202773|100642807|FG000|STARTED|Overall Study||153||
48130213|NCT01202773|100642808|FG001|STARTED|Overall Study||148||
48130214|NCT01202773|100642809|FG002|STARTED|Overall Study||155||
48130215|NCT01202773|100642807|FG000|Received at Least 1 Dose of Study Drug|Overall Study||153||
48130216|NCT01202773|100642808|FG001|Received at Least 1 Dose of Study Drug|Overall Study||147||
48130217|NCT01202773|100642809|FG002|Received at Least 1 Dose of Study Drug|Overall Study||154||
48130218|NCT01202773|100642807|FG000|Week 16 NR|Overall Study||23||
48130219|NCT01202773|100642808|FG001|Week 16 NR|Overall Study||33||
48130220|NCT01202773|100642809|FG002|Week 16 NR|Overall Study||37||
48130221|NCT01202773|100642807|FG000|Post-Treatment Follow-Up Population|Overall Study||46||
48130222|NCT01202773|100642808|FG001|Post-Treatment Follow-Up Population|Overall Study||36||
48130223|NCT01202773|100642809|FG002|Post-Treatment Follow-Up Population|Overall Study||51||
48130224|NCT01202773|100642807|FG000|COMPLETED|Overall Study||96||
48130225|NCT01202773|100642808|FG001|COMPLETED|Overall Study||105||
48130226|NCT01202773|100642809|FG002|COMPLETED|Overall Study||100||
48130227|NCT01202773|100642807|FG000|NOT COMPLETED|Overall Study||57||
48130228|NCT01202773|100642808|FG001|NOT COMPLETED|Overall Study||43||
48130229|NCT01202773|100642809|FG002|NOT COMPLETED|Overall Study||55||
48130230|NCT03346759|100642810|FG000|STARTED|Enrollment to Baseline Data Collected||15||
48130231|NCT03346759|100642811|FG001|STARTED|Enrollment to Baseline Data Collected||13||
48130232|NCT03346759|100642810|FG000|COMPLETED|Enrollment to Baseline Data Collected||13||
48130233|NCT03346759|100642811|FG001|COMPLETED|Enrollment to Baseline Data Collected||10||
48130234|NCT03346759|100642810|FG000|NOT COMPLETED|Enrollment to Baseline Data Collected||2||
48130235|NCT03346759|100642811|FG001|NOT COMPLETED|Enrollment to Baseline Data Collected||3||
48130236|NCT03346759|100642810|FG000|STARTED|First Menstrual Cycle||13||
48130237|NCT03346759|100642811|FG001|STARTED|First Menstrual Cycle||10||
48130238|NCT03346759|100642810|FG000|COMPLETED|First Menstrual Cycle||12||
48130239|NCT03346759|100642811|FG001|COMPLETED|First Menstrual Cycle||10||
48130240|NCT03346759|100642810|FG000|NOT COMPLETED|First Menstrual Cycle||1||
48130241|NCT03346759|100642811|FG001|NOT COMPLETED|First Menstrual Cycle||0||
48573882|NCT00832572|101735219|FG001|STARTED|Period 2||2||
48573883|NCT00832572|101735218|FG000|COMPLETED|Period 2||3||
48701551|NCT00791479|102057522|FG001|STARTED|Overall Study||34||
48130242|NCT03346759|100642810|FG000|STARTED|Second Menstrual Cycle||12||
48130243|NCT03346759|100642811|FG001|STARTED|Second Menstrual Cycle||10||
48130244|NCT03346759|100642810|FG000|COMPLETED|Second Menstrual Cycle||11||
48130245|NCT03346759|100642811|FG001|COMPLETED|Second Menstrual Cycle||10||
48573884|NCT00832572|101735219|FG001|COMPLETED|Period 2||2||
48573885|NCT00832572|101735218|FG000|NOT COMPLETED|Period 2||0||
48130246|NCT03346759|100642810|FG000|NOT COMPLETED|Second Menstrual Cycle||1||
48130247|NCT03346759|100642811|FG001|NOT COMPLETED|Second Menstrual Cycle||0||
48130248|NCT03346759|100642810|FG000|STARTED|Third Menstrual Cycle||11||
48130249|NCT03346759|100642811|FG001|STARTED|Third Menstrual Cycle||10||
48130250|NCT03346759|100642810|FG000|COMPLETED|Third Menstrual Cycle||11||
48130251|NCT03346759|100642811|FG001|COMPLETED|Third Menstrual Cycle||10||
48130252|NCT03346759|100642810|FG000|NOT COMPLETED|Third Menstrual Cycle||0||
48130253|NCT03346759|100642811|FG001|NOT COMPLETED|Third Menstrual Cycle||0||
48130254|NCT01607905|100642812|FG000|STARTED|Overall Study||60||
48130255|NCT01607905|100642813|FG001|STARTED|Overall Study||20||
48130256|NCT01607905|100642814|FG002|STARTED|Overall Study||21||
48130257|NCT01607905|100642815|FG003|STARTED|Overall Study||21||
48130258|NCT01607905|100642816|FG004|STARTED|Overall Study||7||
48130259|NCT01607905|100642817|FG005|STARTED|Overall Study||15||
48130260|NCT01607905|100642818|FG006|STARTED|Overall Study||47||
48130261|NCT01607905|100642812|FG000|Received Study Drug|Overall Study||59||
48130262|NCT01607905|100642813|FG001|Received Study Drug|Overall Study||20||
48130263|NCT01607905|100642814|FG002|Received Study Drug|Overall Study||21||
48130264|NCT01607905|100642815|FG003|Received Study Drug|Overall Study||21||
48130265|NCT01607905|100642816|FG004|Received Study Drug|Overall Study||6||
48130266|NCT01607905|100642817|FG005|Received Study Drug|Overall Study||15||
48130267|NCT01607905|100642818|FG006|Received Study Drug|Overall Study||47||
48130268|NCT01607905|100642812|FG000|Low Dose (<30 mg/m^2)|Overall Study||16||
48130269|NCT01607905|100642813|FG001|Low Dose (<30 mg/m^2)|Overall Study||5||
48130270|NCT01607905|100642814|FG002|Low Dose (<30 mg/m^2)|Overall Study||3||
48130271|NCT01607905|100642815|FG003|Low Dose (<30 mg/m^2)|Overall Study||0||
48130272|NCT01607905|100642816|FG004|Low Dose (<30 mg/m^2)|Overall Study||0||
48130273|NCT01607905|100642817|FG005|Low Dose (<30 mg/m^2)|Overall Study||2||
48130274|NCT01607905|100642818|FG006|Low Dose (<30 mg/m^2)|Overall Study||8||
48130275|NCT01607905|100642812|FG000|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||27||
48130276|NCT01607905|100642813|FG001|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||11||
48130277|NCT01607905|100642814|FG002|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||15||
48130278|NCT01607905|100642815|FG003|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||8||
48130279|NCT01607905|100642816|FG004|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||6||
48130280|NCT01607905|100642817|FG005|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||3||
48130281|NCT01607905|100642818|FG006|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||21||
48130282|NCT01607905|100642812|FG000|High Dose (>= 55 mg/m^2)|Overall Study||16||
48130283|NCT01607905|100642813|FG001|High Dose (>= 55 mg/m^2)|Overall Study||4||
48130284|NCT01607905|100642814|FG002|High Dose (>= 55 mg/m^2)|Overall Study||3||
48701552|NCT00791479|102057523|FG002|STARTED|Overall Study||34||
48701553|NCT00791479|102057524|FG003|STARTED|Overall Study||29||
48701554|NCT00791479|102057525|FG004|STARTED|Overall Study||3||
48701555|NCT00791479|102057526|FG005|STARTED|Overall Study||32||
48701556|NCT00791479|102057521|FG000|Received at Least One Dose of Study Drug|Overall Study||35||
48701557|NCT00791479|102057522|FG001|Received at Least One Dose of Study Drug|Overall Study||34||
48130285|NCT01607905|100642815|FG003|High Dose (>= 55 mg/m^2)|Overall Study||13||
48573886|NCT00832572|101735219|FG001|NOT COMPLETED|Period 2||0||
48573887|NCT04168112|101735220|FG000|STARTED|Overall Study||10||
48573888|NCT04168112|101735221|FG001|STARTED|Overall Study||10||
48573889|NCT04168112|101735220|FG000|COMPLETED|Overall Study||8||
48573890|NCT04168112|101735221|FG001|COMPLETED|Overall Study||10||
48573891|NCT04168112|101735220|FG000|NOT COMPLETED|Overall Study||2||
48573892|NCT04168112|101735221|FG001|NOT COMPLETED|Overall Study||0||
48573893|NCT02612623|101735222|FG000|STARTED|Overall Study||8|Randomized|
48573894|NCT02612623|101735223|FG001|STARTED|Overall Study||6|Randomized|
48701558|NCT00791479|102057523|FG002|Received at Least One Dose of Study Drug|Overall Study||34||
48701559|NCT00791479|102057524|FG003|Received at Least One Dose of Study Drug|Overall Study||29||
48701560|NCT00791479|102057525|FG004|Received at Least One Dose of Study Drug|Overall Study||3||
48701561|NCT00791479|102057526|FG005|Received at Least One Dose of Study Drug|Overall Study||32||
48701562|NCT00791479|102057521|FG000|COMPLETED|Overall Study||33||
48701563|NCT00791479|102057522|FG001|COMPLETED|Overall Study||31||
48701564|NCT00791479|102057523|FG002|COMPLETED|Overall Study||34||
48701565|NCT00791479|102057524|FG003|COMPLETED|Overall Study||25||
48701566|NCT00791479|102057525|FG004|COMPLETED|Overall Study||0||
48701567|NCT00791479|102057526|FG005|COMPLETED|Overall Study||29||
48701568|NCT00791479|102057521|FG000|NOT COMPLETED|Overall Study||2||
48130286|NCT01607905|100642816|FG004|High Dose (>= 55 mg/m^2)|Overall Study||0||
48130287|NCT01607905|100642817|FG005|High Dose (>= 55 mg/m^2)|Overall Study||10||
48130288|NCT01607905|100642818|FG006|High Dose (>= 55 mg/m^2)|Overall Study||18||
48130289|NCT01607905|100642812|FG000|COMPLETED|Overall Study||0|Participants who completed study treatment.|
48130290|NCT01607905|100642813|FG001|COMPLETED|Overall Study||0|Participants who completed study treatment.|
48130291|NCT01607905|100642814|FG002|COMPLETED|Overall Study||0|Participants who completed study treatment.|
48130292|NCT01607905|100642815|FG003|COMPLETED|Overall Study||0|Participants who completed study treatment.|
48130293|NCT01607905|100642816|FG004|COMPLETED|Overall Study||0|Participants who completed study treatment.|
48130294|NCT01607905|100642817|FG005|COMPLETED|Overall Study||0|Participants who completed study treatment.|
48130295|NCT01607905|100642818|FG006|COMPLETED|Overall Study||0|Participants who completed study treatment.|
48130296|NCT01607905|100642812|FG000|NOT COMPLETED|Overall Study||60||
48130297|NCT01607905|100642813|FG001|NOT COMPLETED|Overall Study||20||
48130298|NCT01607905|100642814|FG002|NOT COMPLETED|Overall Study||21||
48130299|NCT01607905|100642815|FG003|NOT COMPLETED|Overall Study||21||
48130300|NCT01607905|100642816|FG004|NOT COMPLETED|Overall Study||7||
48130301|NCT01607905|100642817|FG005|NOT COMPLETED|Overall Study||15||
48130302|NCT01607905|100642818|FG006|NOT COMPLETED|Overall Study||47||
48130303|NCT03165045|100642819|FG000|STARTED|Visit 1||1351||
48130304|NCT03165045|100642819|FG000|COMPLETED|Visit 1||1322||
48130305|NCT03165045|100642819|FG000|NOT COMPLETED|Visit 1||29||
48130306|NCT03165045|100642819|FG000|STARTED|Visit 2||1322||
48130307|NCT03165045|100642819|FG000|COMPLETED|Visit 2||1140||
48130308|NCT03165045|100642819|FG000|NOT COMPLETED|Visit 2||182||
48130309|NCT02691455|100642820|FG000|STARTED|Overall Study||23||23
48130310|NCT02691455|100642821|FG001|STARTED|Overall Study||22||22
48130311|NCT02691455|100642820|FG000|Randomized|Overall Study||23||23
48130312|NCT02691455|100642821|FG001|Randomized|Overall Study||22||22
48130313|NCT02691455|100642820|FG000|Received Assigned Intervention|Overall Study||22||22
48130314|NCT02691455|100642821|FG001|Received Assigned Intervention|Overall Study||20||20
48130315|NCT02691455|100642820|FG000|Week 1 Follow up|Overall Study||22||22
48130316|NCT02691455|100642821|FG001|Week 1 Follow up|Overall Study||19||19
48130317|NCT02691455|100642820|FG000|Month 1 Follow up|Overall Study||22||22
48130318|NCT02691455|100642821|FG001|Month 1 Follow up|Overall Study||18||18
48130319|NCT02691455|100642820|FG000|Month 3 Follow up|Overall Study||21||21
48130320|NCT02691455|100642821|FG001|Month 3 Follow up|Overall Study||18||18
48130321|NCT02691455|100642820|FG000|Month 6 Follow up|Overall Study||19||19
48130322|NCT02691455|100642821|FG001|Month 6 Follow up|Overall Study||19||19
48130323|NCT02691455|100642820|FG000|Month 12 Follow up|Overall Study||16||16
48130324|NCT02691455|100642821|FG001|Month 12 Follow up|Overall Study||16||16
48130325|NCT02691455|100642820|FG000|Year 2 Follow up|Overall Study||6||6
48130326|NCT02691455|100642821|FG001|Year 2 Follow up|Overall Study||9||9
48130327|NCT02691455|100642820|FG000|Year 3 Follow up|Overall Study||7||7
48573895|NCT02612623|101735224|FG002|STARTED|Overall Study||6|Randomized|
48573896|NCT02612623|101735225|FG003|STARTED|Overall Study||4|Randomized|
48573897|NCT02612623|101735222|FG000|Treated|Overall Study||8||
48573898|NCT02612623|101735223|FG001|Treated|Overall Study||5||
48573899|NCT02612623|101735224|FG002|Treated|Overall Study||6||
48573900|NCT02612623|101735225|FG003|Treated|Overall Study||4||
48573901|NCT02612623|101735222|FG000|COMPLETED|Overall Study||7||
48573902|NCT02612623|101735223|FG001|COMPLETED|Overall Study||5||
48573903|NCT02612623|101735224|FG002|COMPLETED|Overall Study||5||
48573904|NCT02612623|101735225|FG003|COMPLETED|Overall Study||4||
48573905|NCT02612623|101735222|FG000|NOT COMPLETED|Overall Study||1||
48573906|NCT02612623|101735223|FG001|NOT COMPLETED|Overall Study||1||
48573907|NCT02612623|101735224|FG002|NOT COMPLETED|Overall Study||1||
48573908|NCT02612623|101735225|FG003|NOT COMPLETED|Overall Study||0||
48573909|NCT00154284|101735226|FG000|STARTED|Overall Study||59||
48573910|NCT00154284|101735227|FG001|STARTED|Overall Study||55||
48573911|NCT00154284|101735226|FG000|Intent to Treat (ITT) Population|Overall Study||57||
48130328|NCT02691455|100642821|FG001|Year 3 Follow up|Overall Study||5||5
48130329|NCT02691455|100642820|FG000|COMPLETED|Overall Study||7||7
48130330|NCT02691455|100642821|FG001|COMPLETED|Overall Study||5||5
48130331|NCT02691455|100642820|FG000|NOT COMPLETED|Overall Study||16||16
48130332|NCT02691455|100642821|FG001|NOT COMPLETED|Overall Study||17||17
48130333|NCT05219877|100642822|FG000|STARTED|Overall Study||67||
48130334|NCT05219877|100642823|FG001|STARTED|Overall Study||67||
48130335|NCT05219877|100642822|FG000|COMPLETED|Overall Study||63||
48130336|NCT05219877|100642823|FG001|COMPLETED|Overall Study||63||
48130337|NCT05219877|100642822|FG000|NOT COMPLETED|Overall Study||4||
48130338|NCT05219877|100642823|FG001|NOT COMPLETED|Overall Study||4||
48130339|NCT02318329|100642824|FG000|STARTED|Overall Study||3||
48130340|NCT02318329|100642825|FG001|STARTED|Overall Study||4||
48130341|NCT02318329|100642826|FG002|STARTED|Overall Study||3||
48130342|NCT02318329|100642827|FG003|STARTED|Overall Study||3||
48130343|NCT02318329|100642828|FG004|STARTED|Overall Study||3||
48130344|NCT02318329|100642829|FG005|STARTED|Overall Study||3||
48284724|NCT00700427|101021560|FG003|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0||
48573912|NCT00154284|101735227|FG001|Intent to Treat (ITT) Population|Overall Study||53||
48573913|NCT00154284|101735226|FG000|COMPLETED|Overall Study||52||
48573914|NCT00154284|101735227|FG001|COMPLETED|Overall Study||42||
48573915|NCT00154284|101735226|FG000|NOT COMPLETED|Overall Study||7||
48573916|NCT00154284|101735227|FG001|NOT COMPLETED|Overall Study||13||
48573917|NCT01202578|101735228|FG000|STARTED|Overall Study||53||
48130345|NCT02318329|100642830|FG006|STARTED|Overall Study||1||
48130346|NCT02318329|100642831|FG007|STARTED|Overall Study||1||
48130347|NCT02318329|100642832|FG008|STARTED|Overall Study||6||
48130348|NCT02318329|100642833|FG009|STARTED|Overall Study||52||
48130349|NCT02318329|100642824|FG000|COMPLETED|Overall Study||0||
48130350|NCT02318329|100642825|FG001|COMPLETED|Overall Study||0||
48573918|NCT01202578|101735228|FG000|COMPLETED|Overall Study||53||
48573919|NCT01202578|101735228|FG000|NOT COMPLETED|Overall Study||0||
48130351|NCT02318329|100642826|FG002|COMPLETED|Overall Study||0||
48573920|NCT03318497|101735229|FG000|STARTED|Overall Study||6||
48573921|NCT03318497|101735229|FG000|COMPLETED|Overall Study||2||
48573922|NCT03318497|101735229|FG000|NOT COMPLETED|Overall Study||4||
48573923|NCT04520997|101735230|FG000|STARTED|Overall Study||32||
48573924|NCT04520997|101735231|FG001|STARTED|Overall Study||30||
48573925|NCT04520997|101735230|FG000|Treated|Overall Study||31|One participant randomized in Down-up but not treated.|
48573926|NCT04520997|101735231|FG001|Treated|Overall Study||29|One participant randomized in Down-up but not treated.|
48130352|NCT02318329|100642827|FG003|COMPLETED|Overall Study||0||
48130353|NCT02318329|100642828|FG004|COMPLETED|Overall Study||0||
48130354|NCT02318329|100642829|FG005|COMPLETED|Overall Study||0||
48130355|NCT02318329|100642830|FG006|COMPLETED|Overall Study||0||
48130356|NCT02318329|100642831|FG007|COMPLETED|Overall Study||0||
48130357|NCT02318329|100642832|FG008|COMPLETED|Overall Study||0||
48130358|NCT02318329|100642833|FG009|COMPLETED|Overall Study||0||
48130359|NCT02318329|100642824|FG000|NOT COMPLETED|Overall Study||3||
48130360|NCT02318329|100642825|FG001|NOT COMPLETED|Overall Study||4||
48130361|NCT02318329|100642826|FG002|NOT COMPLETED|Overall Study||3||
48130362|NCT02318329|100642827|FG003|NOT COMPLETED|Overall Study||3||
48130363|NCT02318329|100642828|FG004|NOT COMPLETED|Overall Study||3||
48130364|NCT02318329|100642829|FG005|NOT COMPLETED|Overall Study||3||
48130365|NCT02318329|100642830|FG006|NOT COMPLETED|Overall Study||1||
48130366|NCT02318329|100642831|FG007|NOT COMPLETED|Overall Study||1||
48130367|NCT02318329|100642832|FG008|NOT COMPLETED|Overall Study||6||
48130368|NCT02318329|100642833|FG009|NOT COMPLETED|Overall Study||52||
48130369|NCT00226941|100642834|FG000|STARTED|Overall Study||6||
48130370|NCT00226941|100642835|FG001|STARTED|Overall Study||6||
48130371|NCT00226941|100642836|FG002|STARTED|Overall Study||4||
48130372|NCT00226941|100642837|FG003|STARTED|Overall Study||7||
48701569|NCT00791479|102057522|FG001|NOT COMPLETED|Overall Study||3||
48701570|NCT00791479|102057523|FG002|NOT COMPLETED|Overall Study||0||
48701571|NCT00791479|102057524|FG003|NOT COMPLETED|Overall Study||4||
48701572|NCT00791479|102057525|FG004|NOT COMPLETED|Overall Study||3||
48701573|NCT00791479|102057526|FG005|NOT COMPLETED|Overall Study||3||
48701574|NCT00365105|102057527|FG000|STARTED|Overall Study||129||
48130373|NCT00226941|100642834|FG000|COMPLETED|Overall Study||6||
48130374|NCT00226941|100642835|FG001|COMPLETED|Overall Study||6||
48130375|NCT00226941|100642836|FG002|COMPLETED|Overall Study||4||
48130376|NCT00226941|100642837|FG003|COMPLETED|Overall Study||5||
48130377|NCT00226941|100642834|FG000|NOT COMPLETED|Overall Study||0||
48130378|NCT00226941|100642835|FG001|NOT COMPLETED|Overall Study||0||
48701575|NCT00365105|102057528|FG001|STARTED|Overall Study||132||
48130379|NCT00226941|100642836|FG002|NOT COMPLETED|Overall Study||0||
48573927|NCT04520997|101735230|FG000|Safety Population|Overall Study||32||
48701576|NCT00365105|102057527|FG000|Eligible|Overall Study||124||
48701577|NCT00365105|102057528|FG001|Eligible|Overall Study||124||
48701578|NCT00365105|102057527|FG000|Eligible With Adverse Event Data|Overall Study||123||
48701579|NCT00365105|102057528|FG001|Eligible With Adverse Event Data|Overall Study||124||
48701580|NCT00365105|102057527|FG000|COMPLETED|Overall Study||124|Subjects contributing any data to analysis are considered to have completed the study|
48701581|NCT00365105|102057528|FG001|COMPLETED|Overall Study||124|Subjects contributing any data to analysis are considered to have completed the study|
48130380|NCT00226941|100642837|FG003|NOT COMPLETED|Overall Study||2||
48130381|NCT01105533|100642838|FG000|STARTED|Overall Study||1||
48130382|NCT01105533|100642839|FG001|STARTED|Overall Study||1||
48573928|NCT04520997|101735231|FG001|Safety Population|Overall Study||29||
48573929|NCT04520997|101735230|FG000|MITT (Modified Intention-to-treat) Population|Overall Study||31|One participant was withdrawn after first treatment in Down-up and therefore not included in MITT population.|
48573930|NCT04520997|101735231|FG001|MITT (Modified Intention-to-treat) Population|Overall Study||29|One participant was withdrawn after first treatment in Down-up and therefore not included in MITT population.|
48573931|NCT04520997|101735230|FG000|COMPLETED|Overall Study||30||
48573932|NCT04520997|101735231|FG001|COMPLETED|Overall Study||28||
48573933|NCT04520997|101735230|FG000|NOT COMPLETED|Overall Study||2||
48573934|NCT04520997|101735231|FG001|NOT COMPLETED|Overall Study||2||
48573935|NCT01234870|101735232|FG000|STARTED|Overall Study||40||
48573936|NCT01234870|101735232|FG000|COMPLETED|Overall Study||40||
48573937|NCT01234870|101735232|FG000|NOT COMPLETED|Overall Study||0||
48573938|NCT03515811|101735233|FG000|STARTED|Overall Study||51||
48573939|NCT03515811|101735234|FG001|STARTED|Overall Study||85||
48573940|NCT03515811|101735233|FG000|COMPLETED|Overall Study||46||
48573941|NCT03515811|101735234|FG001|COMPLETED|Overall Study||77||
48573942|NCT03515811|101735233|FG000|NOT COMPLETED|Overall Study||5||
48573943|NCT03515811|101735234|FG001|NOT COMPLETED|Overall Study||8||
48573944|NCT03831113|101735235|FG000|STARTED|Overall Study||1||
48573945|NCT03831113|101735236|FG001|STARTED|Overall Study||12||
48573946|NCT03831113|101735235|FG000|COMPLETED|Overall Study||1||
48701582|NCT00365105|102057527|FG000|NOT COMPLETED|Overall Study||5||
48701583|NCT00365105|102057528|FG001|NOT COMPLETED|Overall Study||8||
48130383|NCT01105533|100642840|FG002|STARTED|Overall Study||3||
48130384|NCT01105533|100642841|FG003|STARTED|Overall Study||3||
48130385|NCT01105533|100642842|FG004|STARTED|Overall Study||7||
48130386|NCT01105533|100642843|FG005|STARTED|Overall Study||7||
48130387|NCT01105533|100642844|FG006|STARTED|Overall Study||8||
48130388|NCT01105533|100642845|FG007|STARTED|Overall Study||4||
48130389|NCT01105533|100642846|FG008|STARTED|Overall Study||12||
48130390|NCT01105533|100642838|FG000|COMPLETED|Overall Study||0||
48130391|NCT01105533|100642839|FG001|COMPLETED|Overall Study||0||
48130392|NCT01105533|100642840|FG002|COMPLETED|Overall Study||0||
48130393|NCT01105533|100642841|FG003|COMPLETED|Overall Study||0||
48130394|NCT01105533|100642842|FG004|COMPLETED|Overall Study||0||
48130395|NCT01105533|100642843|FG005|COMPLETED|Overall Study||0||
48130396|NCT01105533|100642844|FG006|COMPLETED|Overall Study||0||
48130397|NCT01105533|100642845|FG007|COMPLETED|Overall Study||0||
48130398|NCT01105533|100642846|FG008|COMPLETED|Overall Study||0||
48130399|NCT01105533|100642838|FG000|NOT COMPLETED|Overall Study||1||
48130400|NCT01105533|100642839|FG001|NOT COMPLETED|Overall Study||1||
48130401|NCT01105533|100642840|FG002|NOT COMPLETED|Overall Study||3||
48130402|NCT01105533|100642841|FG003|NOT COMPLETED|Overall Study||3||
48130403|NCT01105533|100642842|FG004|NOT COMPLETED|Overall Study||7||
48130404|NCT01105533|100642843|FG005|NOT COMPLETED|Overall Study||7||
48130405|NCT01105533|100642844|FG006|NOT COMPLETED|Overall Study||8||
48130406|NCT01105533|100642845|FG007|NOT COMPLETED|Overall Study||4||
48130407|NCT01105533|100642846|FG008|NOT COMPLETED|Overall Study||12||
48130408|NCT00558285|100642847|FG000|STARTED|Overall Study||50||
48130409|NCT00558285|100642848|FG001|STARTED|Overall Study||51||
48130410|NCT00558285|100642849|FG002|STARTED|Overall Study||51||
48130411|NCT00558285|100642850|FG003|STARTED|Overall Study||52||
48130412|NCT00558285|100642851|FG004|STARTED|Overall Study||53||
48130413|NCT00558285|100642847|FG000|Safety: Received Study Drug|Overall Study||49||
48130414|NCT00558285|100642848|FG001|Safety: Received Study Drug|Overall Study||51||
48130415|NCT00558285|100642849|FG002|Safety: Received Study Drug|Overall Study||51||
48130416|NCT00558285|100642850|FG003|Safety: Received Study Drug|Overall Study||51||
48130417|NCT00558285|100642851|FG004|Safety: Received Study Drug|Overall Study||53||
48130418|NCT00558285|100642847|FG000|COMPLETED|Overall Study||44||
48130419|NCT00558285|100642848|FG001|COMPLETED|Overall Study||48||
48573947|NCT03831113|101735236|FG001|COMPLETED|Overall Study||1||
48573948|NCT03831113|101735235|FG000|NOT COMPLETED|Overall Study||0||
48573949|NCT03831113|101735236|FG001|NOT COMPLETED|Overall Study||11||
48573950|NCT02230904|101735237|FG000|STARTED|Overall Study||29||
48573951|NCT02230904|101735238|FG001|STARTED|Overall Study||28||
48573952|NCT02230904|101735237|FG000|COMPLETED|Overall Study||29||
48573953|NCT02230904|101735238|FG001|COMPLETED|Overall Study||27||
48573954|NCT02230904|101735237|FG000|NOT COMPLETED|Overall Study||0||
48573955|NCT02230904|101735238|FG001|NOT COMPLETED|Overall Study||1||
48573956|NCT03782012|101735239|FG000|STARTED|Overall Study||145||
48573957|NCT03782012|101735240|FG001|STARTED|Overall Study||96||
48573958|NCT03782012|101735239|FG000|Cohort 1|Overall Study||87||
48573959|NCT03782012|101735240|FG001|Cohort 1|Overall Study||58||
48573960|NCT03782012|101735239|FG000|Cohort 2|Overall Study||58||
48573961|NCT03782012|101735240|FG001|Cohort 2|Overall Study||38||
48573962|NCT03782012|101735239|FG000|COMPLETED|Overall Study||145||
48573963|NCT03782012|101735240|FG001|COMPLETED|Overall Study||96||
48573964|NCT03782012|101735239|FG000|NOT COMPLETED|Overall Study||0||
48573965|NCT03782012|101735240|FG001|NOT COMPLETED|Overall Study||0||
48573966|NCT01266291|101735241|FG000|STARTED|Overall Study||1||
48573967|NCT01266291|101735241|FG000|COMPLETED|Overall Study||0||
48573968|NCT01266291|101735241|FG000|NOT COMPLETED|Overall Study||1||
48573969|NCT00604591|101735242|FG000|STARTED|First Intervention (Day 1 to Day 8)||14||
48573970|NCT00604591|101735243|FG001|STARTED|First Intervention (Day 1 to Day 8)||14||
48573971|NCT00604591|101735242|FG000|COMPLETED|First Intervention (Day 1 to Day 8)||14||
48573972|NCT00604591|101735243|FG001|COMPLETED|First Intervention (Day 1 to Day 8)||14||
48573973|NCT00604591|101735242|FG000|NOT COMPLETED|First Intervention (Day 1 to Day 8)||0||
48573974|NCT00604591|101735243|FG001|NOT COMPLETED|First Intervention (Day 1 to Day 8)||0||
48573975|NCT00604591|101735242|FG000|STARTED|Washout (Day 9 to Day 14)||14||
48573976|NCT00604591|101735243|FG001|STARTED|Washout (Day 9 to Day 14)||14||
48573977|NCT00604591|101735242|FG000|COMPLETED|Washout (Day 9 to Day 14)||14||
48573978|NCT00604591|101735243|FG001|COMPLETED|Washout (Day 9 to Day 14)||14||
48573979|NCT00604591|101735242|FG000|NOT COMPLETED|Washout (Day 9 to Day 14)||0||
48573980|NCT00604591|101735243|FG001|NOT COMPLETED|Washout (Day 9 to Day 14)||0||
48573981|NCT00604591|101735242|FG000|STARTED|Second Intervention (Day 15 to Day 24)||14||
48573982|NCT00604591|101735243|FG001|STARTED|Second Intervention (Day 15 to Day 24)||14||
48573983|NCT00604591|101735242|FG000|COMPLETED|Second Intervention (Day 15 to Day 24)||14||
48573984|NCT00604591|101735243|FG001|COMPLETED|Second Intervention (Day 15 to Day 24)||14||
48573985|NCT00604591|101735242|FG000|NOT COMPLETED|Second Intervention (Day 15 to Day 24)||0||
48573986|NCT00604591|101735243|FG001|NOT COMPLETED|Second Intervention (Day 15 to Day 24)||0||
48573987|NCT01996254|101735244|FG000|STARTED|Overall Study||5||
48130420|NCT00558285|100642849|FG002|COMPLETED|Overall Study||46||
48130421|NCT00558285|100642850|FG003|COMPLETED|Overall Study||48||
48130422|NCT00558285|100642851|FG004|COMPLETED|Overall Study||49||
48130423|NCT00558285|100642847|FG000|NOT COMPLETED|Overall Study||6||
48130424|NCT00558285|100642848|FG001|NOT COMPLETED|Overall Study||3||
48130425|NCT00558285|100642849|FG002|NOT COMPLETED|Overall Study||5||
48130426|NCT00558285|100642850|FG003|NOT COMPLETED|Overall Study||4||
48573988|NCT01996254|101735245|FG001|STARTED|Overall Study||14||
48573989|NCT01996254|101735246|FG002|STARTED|Overall Study||14||
48130427|NCT00558285|100642851|FG004|NOT COMPLETED|Overall Study||4||
48130428|NCT03465540|100642852|FG000|STARTED|Overall Study||2||
48130429|NCT03465540|100642853|FG001|STARTED|Overall Study||6||
48130430|NCT03465540|100642854|FG002|STARTED|Overall Study||4||
48130431|NCT03465540|100642855|FG003|STARTED|Overall Study||4||
48130432|NCT03465540|100642856|FG004|STARTED|Overall Study||5||
48130433|NCT03465540|100642857|FG005|STARTED|Overall Study||3||
48130434|NCT03465540|100642852|FG000|Received AMG 397|Overall Study||2||
48130435|NCT03465540|100642853|FG001|Received AMG 397|Overall Study||6||
48130436|NCT03465540|100642854|FG002|Received AMG 397|Overall Study||4||
48130437|NCT03465540|100642855|FG003|Received AMG 397|Overall Study||4||
48130438|NCT03465540|100642856|FG004|Received AMG 397|Overall Study||5||
48130439|NCT03465540|100642857|FG005|Received AMG 397|Overall Study||3||
48130440|NCT03465540|100642852|FG000|COMPLETED|Overall Study||1|Completed Study|
48130441|NCT03465540|100642853|FG001|COMPLETED|Overall Study||2|Completed Study|
48130442|NCT03465540|100642854|FG002|COMPLETED|Overall Study||1|Completed Study|
48130443|NCT03465540|100642855|FG003|COMPLETED|Overall Study||1|Completed Study|
48130444|NCT03465540|100642856|FG004|COMPLETED|Overall Study||1|Completed Study|
48130445|NCT03465540|100642857|FG005|COMPLETED|Overall Study||1|Completed Study|
48130446|NCT03465540|100642852|FG000|NOT COMPLETED|Overall Study||1||
48130447|NCT03465540|100642853|FG001|NOT COMPLETED|Overall Study||4||
48130448|NCT03465540|100642854|FG002|NOT COMPLETED|Overall Study||3||
48130449|NCT03465540|100642855|FG003|NOT COMPLETED|Overall Study||3||
48130450|NCT03465540|100642856|FG004|NOT COMPLETED|Overall Study||4||
48130451|NCT03465540|100642857|FG005|NOT COMPLETED|Overall Study||2||
48130452|NCT05520138|100642858|FG000|STARTED|Overall Study||2911||
48130453|NCT05520138|100642859|FG001|STARTED|Overall Study||2595||
48130454|NCT05520138|100642858|FG000|COMPLETED|Overall Study||2911||
48130455|NCT05520138|100642859|FG001|COMPLETED|Overall Study||2595||
48130456|NCT05520138|100642858|FG000|NOT COMPLETED|Overall Study||0||
48130457|NCT05520138|100642859|FG001|NOT COMPLETED|Overall Study||0||
48130458|NCT02019719|100642860|FG000|STARTED|Overall Study||19||
48130459|NCT02019719|100642861|FG001|STARTED|Overall Study||19||
48130460|NCT02019719|100642862|FG002|STARTED|Overall Study||20||
48130461|NCT02019719|100642863|FG003|STARTED|Overall Study||19||
48130462|NCT02019719|100642864|FG004|STARTED|Overall Study||20||
48130463|NCT02019719|100642860|FG000|COMPLETED|Overall Study||13||
48130464|NCT02019719|100642861|FG001|COMPLETED|Overall Study||18||
48130465|NCT02019719|100642862|FG002|COMPLETED|Overall Study||20||
48130466|NCT02019719|100642863|FG003|COMPLETED|Overall Study||17||
48130467|NCT02019719|100642864|FG004|COMPLETED|Overall Study||18||
48130468|NCT02019719|100642860|FG000|NOT COMPLETED|Overall Study||6||
48130469|NCT02019719|100642861|FG001|NOT COMPLETED|Overall Study||1||
48130470|NCT02019719|100642862|FG002|NOT COMPLETED|Overall Study||0||
48130471|NCT02019719|100642863|FG003|NOT COMPLETED|Overall Study||2||
48130472|NCT02019719|100642864|FG004|NOT COMPLETED|Overall Study||2||
48130473|NCT02696850|100642865|FG000|STARTED|Overall Study||40||
48130474|NCT02696850|100642866|FG001|STARTED|Overall Study||40||
48130475|NCT02696850|100642865|FG000|COMPLETED|Overall Study||29||
48130476|NCT02696850|100642866|FG001|COMPLETED|Overall Study||32||
48130477|NCT02696850|100642865|FG000|NOT COMPLETED|Overall Study||11||
48130478|NCT02696850|100642866|FG001|NOT COMPLETED|Overall Study||8||
48130479|NCT00835406|100642867|FG000|STARTED|Period: First Intervention||70||
48130480|NCT00835406|100642868|FG001|STARTED|Period: First Intervention||70||
48130481|NCT00835406|100642867|FG000|COMPLETED|Period: First Intervention||68||
48130482|NCT00835406|100642868|FG001|COMPLETED|Period: First Intervention||69||
48130483|NCT00835406|100642867|FG000|NOT COMPLETED|Period: First Intervention||2||
48130484|NCT00835406|100642868|FG001|NOT COMPLETED|Period: First Intervention||1||
48130485|NCT00835406|100642867|FG000|STARTED|Period: Washout of 7 Days||68||
48130486|NCT00835406|100642868|FG001|STARTED|Period: Washout of 7 Days||69||
48130487|NCT00835406|100642867|FG000|COMPLETED|Period: Washout of 7 Days||68||
48130488|NCT00835406|100642868|FG001|COMPLETED|Period: Washout of 7 Days||67||
48130489|NCT00835406|100642867|FG000|NOT COMPLETED|Period: Washout of 7 Days||0||
48130490|NCT00835406|100642868|FG001|NOT COMPLETED|Period: Washout of 7 Days||2||
48130491|NCT00835406|100642867|FG000|STARTED|Period: Second Intervention||68||
48130492|NCT00835406|100642868|FG001|STARTED|Period: Second Intervention||67||
48130493|NCT00835406|100642867|FG000|COMPLETED|Period: Second Intervention||68||
48130494|NCT00835406|100642868|FG001|COMPLETED|Period: Second Intervention||67||
48130495|NCT00835406|100642867|FG000|NOT COMPLETED|Period: Second Intervention||0||
48130496|NCT00835406|100642868|FG001|NOT COMPLETED|Period: Second Intervention||0||
48130497|NCT03864900|100642869|FG000|STARTED|Overall Study||36||
48130498|NCT03864900|100642870|FG001|STARTED|Overall Study||36||
48130499|NCT03864900|100642869|FG000|COMPLETED|Overall Study||33||
48130500|NCT03864900|100642870|FG001|COMPLETED|Overall Study||30||
48130501|NCT03864900|100642869|FG000|NOT COMPLETED|Overall Study||3||
48130502|NCT03864900|100642870|FG001|NOT COMPLETED|Overall Study||6||
48130503|NCT00406029|100642871|FG000|STARTED|Overall Study||49||
48130504|NCT00406029|100642872|FG001|STARTED|Overall Study||49||
48130505|NCT00406029|100642873|FG002|STARTED|Overall Study||49||
48130506|NCT00406029|100642874|FG003|STARTED|Overall Study||57||
48130507|NCT00406029|100642875|FG004|STARTED|Overall Study||49||
48130508|NCT00406029|100642871|FG000|Treated|Overall Study||49||
48130509|NCT00406029|100642872|FG001|Treated|Overall Study||49||
48130510|NCT00406029|100642873|FG002|Treated|Overall Study||47||
48130511|NCT00406029|100642874|FG003|Treated|Overall Study||54||
48130512|NCT00406029|100642875|FG004|Treated|Overall Study||47||
48130513|NCT00406029|100642871|FG000|COMPLETED|Overall Study||33||
48130514|NCT00406029|100642872|FG001|COMPLETED|Overall Study||41||
48130515|NCT00406029|100642873|FG002|COMPLETED|Overall Study||39||
48573990|NCT01996254|101735244|FG000|Safety Set|Overall Study||5|All subjects that underwent Lead placement|
48573991|NCT01996254|101735245|FG001|Safety Set|Overall Study||14|All subjects that underwent Lead placement|
48573992|NCT01996254|101735246|FG002|Safety Set|Overall Study||14|All subjects that underwent Lead placement|
48573993|NCT01996254|101735244|FG000|Full Analysis Set|Overall Study||0|Subjects from the Revised Study Design that enrolled and met all eligibility prior to Lead placement|
48592810|NCT01764997|101783182|FG000|COMPLETED|Study Drug Treatment Period||0||
48701584|NCT01631747|102057529|FG000|STARTED|Randomization Through End of Pregnancy||141||
48701585|NCT01631747|102057530|FG001|STARTED|Randomization Through End of Pregnancy||140||
48701586|NCT01631747|102057529|FG000|COMPLETED|Randomization Through End of Pregnancy||140||
48701587|NCT01631747|102057530|FG001|COMPLETED|Randomization Through End of Pregnancy||140||
48701588|NCT01631747|102057529|FG000|NOT COMPLETED|Randomization Through End of Pregnancy||1||
48701589|NCT01631747|102057530|FG001|NOT COMPLETED|Randomization Through End of Pregnancy||0||
48701590|NCT01631747|102057529|FG000|STARTED|Live Birth||140||
48701591|NCT01631747|102057530|FG001|STARTED|Live Birth||140||
48701592|NCT01631747|102057529|FG000|COMPLETED|Live Birth||136||
48701593|NCT01631747|102057530|FG001|COMPLETED|Live Birth||139||
48701594|NCT01631747|102057529|FG000|NOT COMPLETED|Live Birth||4||
48130516|NCT00406029|100642874|FG003|COMPLETED|Overall Study||40||
48130517|NCT00406029|100642875|FG004|COMPLETED|Overall Study||41||
48701595|NCT01631747|102057530|FG001|NOT COMPLETED|Live Birth||1||
48573994|NCT01996254|101735245|FG001|Full Analysis Set|Overall Study||12|Subjects from the Revised Study Design that enrolled and met all eligibility prior to Lead placement|
48573995|NCT01996254|101735246|FG002|Full Analysis Set|Overall Study||14|Subjects from the Revised Study Design that enrolled and met all eligibility prior to Lead placement|
48573996|NCT01996254|101735244|FG000|Long Term Analysis Set|Overall Study||0|Full Analysis Set with imputed data for missed visits and exclusion due to early termination.|
48573997|NCT01996254|101735245|FG001|Long Term Analysis Set|Overall Study||12|Full Analysis Set with imputed data for missed visits and exclusion due to early termination.|
48573998|NCT01996254|101735246|FG002|Long Term Analysis Set|Overall Study||14|Full Analysis Set with imputed data for missed visits and exclusion due to early termination.|
48573999|NCT01996254|101735244|FG000|Per Protocol Set|Overall Study||0|Full Analysis Set with adequate diary completion, paresthesia coverage, and continued eligibility|
48574000|NCT01996254|101735245|FG001|Per Protocol Set|Overall Study||10|Full Analysis Set with adequate diary completion, paresthesia coverage, and continued eligibility|
48574001|NCT01996254|101735246|FG002|Per Protocol Set|Overall Study||13|Full Analysis Set with adequate diary completion, paresthesia coverage, and continued eligibility|
48574002|NCT01996254|101735244|FG000|COMPLETED|Overall Study||4||
48574003|NCT01996254|101735245|FG001|COMPLETED|Overall Study||9||
48574004|NCT01996254|101735246|FG002|COMPLETED|Overall Study||6||
48574005|NCT01996254|101735244|FG000|NOT COMPLETED|Overall Study||1||
48574006|NCT01996254|101735245|FG001|NOT COMPLETED|Overall Study||5||
48574007|NCT01996254|101735246|FG002|NOT COMPLETED|Overall Study||8||
48701596|NCT01631747|102057529|FG000|STARTED|One Year Infant Outcomes||136||
48701597|NCT01631747|102057530|FG001|STARTED|One Year Infant Outcomes||139||
48701598|NCT01631747|102057529|FG000|COMPLETED|One Year Infant Outcomes||123||
48701599|NCT01631747|102057530|FG001|COMPLETED|One Year Infant Outcomes||130||
48701600|NCT01631747|102057529|FG000|NOT COMPLETED|One Year Infant Outcomes||13||
48701601|NCT01631747|102057530|FG001|NOT COMPLETED|One Year Infant Outcomes||9||
48701602|NCT01703208|102057531|FG000|STARTED|Overall Study||2100||
48701603|NCT01703208|102057532|FG001|STARTED|Overall Study||2102||
48701604|NCT01703208|102057531|FG000|Treated|Overall Study||2092||
48130518|NCT00406029|100642871|FG000|NOT COMPLETED|Overall Study||16||
48130519|NCT00406029|100642872|FG001|NOT COMPLETED|Overall Study||8||
48130520|NCT00406029|100642873|FG002|NOT COMPLETED|Overall Study||10||
48130521|NCT00406029|100642874|FG003|NOT COMPLETED|Overall Study||17||
48130522|NCT00406029|100642875|FG004|NOT COMPLETED|Overall Study||8||
48574008|NCT04994691|101735247|FG000|STARTED|Overall Study||315||
48574009|NCT04994691|101735248|FG001|STARTED|Overall Study||315||
48574010|NCT04994691|101735249|FG002|STARTED|Overall Study||315||
48701605|NCT01703208|102057532|FG001|Treated|Overall Study||2100||
48701606|NCT01703208|102057531|FG000|COMPLETED|Overall Study||0||
48701607|NCT01703208|102057532|FG001|COMPLETED|Overall Study||0||
48130523|NCT01243333|100642876|FG000|STARTED|Overall Study||26||
48701608|NCT01703208|102057531|FG000|NOT COMPLETED|Overall Study||2100||
48701609|NCT01703208|102057532|FG001|NOT COMPLETED|Overall Study||2102||
48701610|NCT01302834|102057533|FG000|STARTED|Overall Study||424||
48701611|NCT01302834|102057534|FG001|STARTED|Overall Study||425||
48130524|NCT01243333|100642876|FG000|COMPLETED|Overall Study||18||
48130525|NCT01243333|100642876|FG000|NOT COMPLETED|Overall Study||8||
48130526|NCT02886572|100642877|FG000|STARTED|Overall Study||40||
48130527|NCT02886572|100642877|FG000|Survival Analysis Population|Overall Study||40|All subjects were included in the survival analysis including 8 subjects who died prior to the first MRI.|
48130528|NCT02886572|100642877|FG000|Distant Brain Recurrence|Overall Study||32||
48130529|NCT02886572|100642877|FG000|Local Recurrence|Overall Study||32||
48130530|NCT02886572|100642877|FG000|Time to Neurologic Death|Overall Study||32||
48130531|NCT02886572|100642877|FG000|SRS Related Adverse Events|Overall Study||32||
48701612|NCT01302834|102057533|FG000|Eligible|Overall Study||406|All eligible participants|
48701613|NCT01302834|102057534|FG001|Eligible|Overall Study||399|All eligible participants|
48701614|NCT01302834|102057533|FG000|Started Treatment|Overall Study||398|Eligible and started study treatment|
48701615|NCT01302834|102057534|FG001|Started Treatment|Overall Study||394|Eligible and started study treatment|
48701616|NCT01302834|102057533|FG000|AE Assessed 1 Month Post-treatment (PT)|Overall Study||369|Eligible, started study treatment, and had adverse events (AE) assessment 1 month post-treatment|
48710727|NCT02699450|102078000|FG001|Received at Least One Dose of Study Drug|Overall Study||55|Safety Population|
48130532|NCT02886572|100642877|FG000|COMPLETED|Overall Study||32||
48130533|NCT02886572|100642877|FG000|NOT COMPLETED|Overall Study||8||
48130534|NCT00924950|100642878|FG000|STARTED|Overall Study||30||
48130535|NCT00924950|100642878|FG000|COMPLETED|Overall Study||28||
48130536|NCT00924950|100642878|FG000|NOT COMPLETED|Overall Study||2||
48130537|NCT00803634|100642879|FG000|STARTED|Overall Study||51||
48130538|NCT00803634|100642880|FG001|STARTED|Overall Study||53||
48130539|NCT00803634|100642879|FG000|mITT (Dosed & Have Confirmed AHF)|Overall Study||44||
48130540|NCT00803634|100642880|FG001|mITT (Dosed & Have Confirmed AHF)|Overall Study||41||
48130541|NCT00803634|100642879|FG000|COMPLETED|Overall Study||45||
48130542|NCT00803634|100642880|FG001|COMPLETED|Overall Study||48||
48130543|NCT00803634|100642879|FG000|NOT COMPLETED|Overall Study||6||
48130544|NCT00803634|100642880|FG001|NOT COMPLETED|Overall Study||5||
48130545|NCT00022516|100642881|FG000|STARTED|Overall Study||542||
48130546|NCT00022516|100642882|FG001|STARTED|Overall Study||544||
48130547|NCT00022516|100642881|FG000|COMPLETED|Overall Study||539||
48130548|NCT00022516|100642882|FG001|COMPLETED|Overall Study||314||
48130549|NCT00022516|100642881|FG000|NOT COMPLETED|Overall Study||3||
48130550|NCT00022516|100642882|FG001|NOT COMPLETED|Overall Study||230||
48130551|NCT00560833|100642883|FG000|STARTED|Overall Study||317||
48574011|NCT04994691|101735247|FG000|COMPLETED|Overall Study||315||
48574012|NCT04994691|101735248|FG001|COMPLETED|Overall Study||315||
48574013|NCT04994691|101735249|FG002|COMPLETED|Overall Study||315||
48574014|NCT04994691|101735247|FG000|NOT COMPLETED|Overall Study||0||
48574015|NCT04994691|101735248|FG001|NOT COMPLETED|Overall Study||0||
48574016|NCT04994691|101735249|FG002|NOT COMPLETED|Overall Study||0||
48574017|NCT02275546|101735250|FG000|STARTED|Treatment Period 1||81||
48574018|NCT02275546|101735251|FG001|STARTED|Treatment Period 1||83||
48701617|NCT01302834|102057534|FG001|AE Assessed 1 Month Post-treatment (PT)|Overall Study||363|Eligible, started study treatment, and had adverse events (AE) assessment 1 month post-treatment|
48710728|NCT02699450|102078001|FG002|Received at Least One Dose of Study Drug|Overall Study||80|Safety Population|
48574019|NCT02275546|101735250|FG000|COMPLETED|Treatment Period 1||81||
48574020|NCT02275546|101735251|FG001|COMPLETED|Treatment Period 1||83||
48574021|NCT02275546|101735250|FG000|NOT COMPLETED|Treatment Period 1||0||
48574022|NCT02275546|101735251|FG001|NOT COMPLETED|Treatment Period 1||0||
48574023|NCT02275546|101735250|FG000|STARTED|Treatment Period 2||81||
48574024|NCT02275546|101735251|FG001|STARTED|Treatment Period 2||83||
48574025|NCT02275546|101735250|FG000|COMPLETED|Treatment Period 2||79||
48574026|NCT02275546|101735251|FG001|COMPLETED|Treatment Period 2||81||
48574027|NCT02275546|101735250|FG000|NOT COMPLETED|Treatment Period 2||2||
48574028|NCT02275546|101735251|FG001|NOT COMPLETED|Treatment Period 2||2||
48574029|NCT00441129|101735252|FG000|STARTED|Overall Study||60||
48574030|NCT00441129|101735253|FG001|STARTED|Overall Study||55||
48574031|NCT00441129|101735252|FG000|COMPLETED|Overall Study||54||
48574032|NCT00441129|101735253|FG001|COMPLETED|Overall Study||41||
48574033|NCT00441129|101735252|FG000|NOT COMPLETED|Overall Study||6||
48574034|NCT00441129|101735253|FG001|NOT COMPLETED|Overall Study||14||
48130552|NCT00560833|100642884|FG001|STARTED|Overall Study||155||
48130553|NCT00560833|100642885|FG002|STARTED|Overall Study||160||
48130554|NCT00560833|100642886|FG003|STARTED|Overall Study||155||
48130555|NCT00560833|100642887|FG004|STARTED|Overall Study||156||
48130556|NCT00560833|100642883|FG000|Treated|Overall Study||317||
48130557|NCT00560833|100642884|FG001|Treated|Overall Study||154||
48130558|NCT00560833|100642885|FG002|Treated|Overall Study||160||
48130559|NCT00560833|100642886|FG003|Treated|Overall Study||155||
48130560|NCT00560833|100642887|FG004|Treated|Overall Study||155||
48574035|NCT04707469|101735254|FG000|STARTED|Overall Study||536||
48574036|NCT04707469|101735255|FG001|STARTED|Overall Study||535||
48574037|NCT04707469|101735256|FG002|STARTED|Overall Study||535||
48574038|NCT04707469|101735254|FG000|Treated|Overall Study||534||
48574039|NCT04707469|101735255|FG001|Treated|Overall Study||534||
48574040|NCT04707469|101735256|FG002|Treated|Overall Study||534||
48574041|NCT04707469|101735254|FG000|Full Analysis Set (FAS)|Overall Study||536||
48574042|NCT04707469|101735255|FG001|Full Analysis Set (FAS)|Overall Study||535||
48574043|NCT04707469|101735256|FG002|Full Analysis Set (FAS)|Overall Study||535||
48574044|NCT04707469|101735254|FG000|Safety Analysis Set (SAS)|Overall Study||534||
48130561|NCT00560833|100642883|FG000|COMPLETED|Overall Study||273||
48130562|NCT00560833|100642884|FG001|COMPLETED|Overall Study||129||
48130563|NCT00560833|100642885|FG002|COMPLETED|Overall Study||121||
48130564|NCT00560833|100642886|FG003|COMPLETED|Overall Study||124||
48130565|NCT00560833|100642887|FG004|COMPLETED|Overall Study||114||
48130566|NCT00560833|100642883|FG000|NOT COMPLETED|Overall Study||44||
48130567|NCT00560833|100642884|FG001|NOT COMPLETED|Overall Study||26||
48130568|NCT00560833|100642885|FG002|NOT COMPLETED|Overall Study||39||
48130569|NCT00560833|100642886|FG003|NOT COMPLETED|Overall Study||31||
48130570|NCT00560833|100642887|FG004|NOT COMPLETED|Overall Study||42||
48130571|NCT01814722|100642888|FG000|STARTED|Overall Study||36||
48130572|NCT01814722|100642889|FG001|STARTED|Overall Study||21||
48130573|NCT01814722|100642890|FG002|STARTED|Overall Study||6||
48574045|NCT04707469|101735255|FG001|Safety Analysis Set (SAS)|Overall Study||534||
48574046|NCT04707469|101735256|FG002|Safety Analysis Set (SAS)|Overall Study||534||
48574047|NCT04707469|101735254|FG000|COMPLETED|Overall Study||507||
48130574|NCT01814722|100642888|FG000|COMPLETED|Overall Study||36||
48130575|NCT01814722|100642889|FG001|COMPLETED|Overall Study||21||
48130576|NCT01814722|100642890|FG002|COMPLETED|Overall Study||6||
48130577|NCT01814722|100642888|FG000|NOT COMPLETED|Overall Study||0||
48130578|NCT01814722|100642889|FG001|NOT COMPLETED|Overall Study||0||
48130579|NCT01814722|100642890|FG002|NOT COMPLETED|Overall Study||0||
48130580|NCT01557946|100642891|FG000|STARTED|Overall Study||20||
48284725|NCT00700427|101021561|FG004|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0||
48284726|NCT00700427|101021557|FG000|STARTED|Study Period 3A (Blinded Maintenance)||0||
48130581|NCT01557946|100642892|FG001|STARTED|Overall Study||12||
48130582|NCT01557946|100642891|FG000|COMPLETED|Overall Study||17||
48130583|NCT01557946|100642892|FG001|COMPLETED|Overall Study||12||
48130584|NCT01557946|100642891|FG000|NOT COMPLETED|Overall Study||3||
48130585|NCT01557946|100642892|FG001|NOT COMPLETED|Overall Study||0||
48130586|NCT03328897|100642893|FG000|STARTED|Randomized-treatment Epoch||168|Randomized|
48130587|NCT03328897|100642894|FG001|STARTED|Randomized-treatment Epoch||167|Randomized|
48130588|NCT03328897|100642895|FG002|STARTED|Randomized-treatment Epoch||83|Randomized|
48130589|NCT03328897|100642893|FG000|Full Analysis Set (FAS)|Randomized-treatment Epoch||167|includes all randomized patients who took at least one dose of study medication.|
48130590|NCT03328897|100642894|FG001|Full Analysis Set (FAS)|Randomized-treatment Epoch||167|includes all randomized patients who took at least one dose of study medication.|
48130591|NCT03328897|100642895|FG002|Full Analysis Set (FAS)|Randomized-treatment Epoch||83|includes all randomized patients who took at least one dose of study medication.|
48130592|NCT03328897|100642893|FG000|COMPLETED|Randomized-treatment Epoch||152|Completed randomized-treatment epoch|
48574048|NCT04707469|101735255|FG001|COMPLETED|Overall Study||490||
48574049|NCT04707469|101735256|FG002|COMPLETED|Overall Study||505||
48574050|NCT04707469|101735254|FG000|NOT COMPLETED|Overall Study||29||
48574051|NCT04707469|101735255|FG001|NOT COMPLETED|Overall Study||45||
48574052|NCT04707469|101735256|FG002|NOT COMPLETED|Overall Study||30||
48574053|NCT01464164|101735257|FG000|STARTED|Overall Study||3||
48574054|NCT01464164|101735258|FG001|STARTED|Overall Study||4||
48574055|NCT01464164|101735259|FG002|STARTED|Overall Study||4||
48574056|NCT01464164|101735260|FG003|STARTED|Overall Study||2||
48574057|NCT01464164|101735261|FG004|STARTED|Overall Study||3||
48574058|NCT01464164|101735262|FG005|STARTED|Overall Study||0||
48574059|NCT01464164|101735263|FG006|STARTED|Overall Study||3||
48574060|NCT01464164|101735257|FG000|COMPLETED|Overall Study||3||
48574061|NCT01464164|101735258|FG001|COMPLETED|Overall Study||2||
48574062|NCT01464164|101735259|FG002|COMPLETED|Overall Study||2||
48574063|NCT01464164|101735260|FG003|COMPLETED|Overall Study||2||
48574064|NCT01464164|101735261|FG004|COMPLETED|Overall Study||3||
48574065|NCT01464164|101735262|FG005|COMPLETED|Overall Study||0||
48574066|NCT01464164|101735263|FG006|COMPLETED|Overall Study||1||
48574067|NCT01464164|101735257|FG000|NOT COMPLETED|Overall Study||0||
48574068|NCT01464164|101735258|FG001|NOT COMPLETED|Overall Study||2||
48574069|NCT01464164|101735259|FG002|NOT COMPLETED|Overall Study||2||
48574070|NCT01464164|101735260|FG003|NOT COMPLETED|Overall Study||0||
48574071|NCT01464164|101735261|FG004|NOT COMPLETED|Overall Study||0||
48130593|NCT03328897|100642894|FG001|COMPLETED|Randomized-treatment Epoch||162|Completed randomized-treatment epoch|
48130594|NCT03328897|100642895|FG002|COMPLETED|Randomized-treatment Epoch||81|Completed randomized-treatment epoch|
48130595|NCT03328897|100642893|FG000|NOT COMPLETED|Randomized-treatment Epoch||16||
48130596|NCT03328897|100642894|FG001|NOT COMPLETED|Randomized-treatment Epoch||5||
48130597|NCT03328897|100642895|FG002|NOT COMPLETED|Randomized-treatment Epoch||2||
48130598|NCT03328897|100642893|FG000|STARTED|Follow-up Epoch||161|Entered follow-up epoch|
48130599|NCT03328897|100642894|FG001|STARTED|Follow-up Epoch||163|Entered follow-up epoch|
48284727|NCT00700427|101021558|FG001|STARTED|Study Period 3A (Blinded Maintenance)||1005||
48284728|NCT00700427|101021559|FG002|STARTED|Study Period 3A (Blinded Maintenance)||0||
48574072|NCT01464164|101735262|FG005|NOT COMPLETED|Overall Study||0||
48574073|NCT01464164|101735263|FG006|NOT COMPLETED|Overall Study||2||
48574074|NCT00300885|101735264|FG000|STARTED|Treatment||464||
48574075|NCT00300885|101735265|FG001|STARTED|Treatment||462||
48574076|NCT00300885|101735264|FG000|Received Treatment|Treatment||463||
48574077|NCT00300885|101735265|FG001|Received Treatment|Treatment||459||
48574078|NCT00300885|101735264|FG000|COMPLETED|Treatment||91||
48574079|NCT00300885|101735265|FG001|COMPLETED|Treatment||88||
48710729|NCT02699450|102077999|FG000|Completed up to Week 24|Overall Study||81||
48574080|NCT00300885|101735264|FG000|NOT COMPLETED|Treatment||373||
48574081|NCT00300885|101735265|FG001|NOT COMPLETED|Treatment||374||
48574082|NCT00300885|101735264|FG000|STARTED|Follow-up||354||
48574083|NCT00300885|101735265|FG001|STARTED|Follow-up||369||
48574084|NCT00300885|101735264|FG000|COMPLETED|Follow-up||176||
48574085|NCT00300885|101735265|FG001|COMPLETED|Follow-up||174||
48574086|NCT00300885|101735264|FG000|NOT COMPLETED|Follow-up||178||
48574087|NCT00300885|101735265|FG001|NOT COMPLETED|Follow-up||195||
48574088|NCT00140244|101735266|FG000|STARTED|Intervention 1||3||
48574089|NCT00140244|101735267|FG001|STARTED|Intervention 1||4||
48574090|NCT00140244|101735266|FG000|COMPLETED|Intervention 1||3||
48574091|NCT00140244|101735267|FG001|COMPLETED|Intervention 1||4||
48130600|NCT03328897|100642895|FG002|STARTED|Follow-up Epoch||81|Entered follow-up epoch|
48130601|NCT03328897|100642893|FG000|COMPLETED|Follow-up Epoch||153|Completed follow-up epoch|
48130602|NCT03328897|100642894|FG001|COMPLETED|Follow-up Epoch||160|Completed follow-up epoch|
48130603|NCT03328897|100642895|FG002|COMPLETED|Follow-up Epoch||79|Completed follow-up epoch|
48574092|NCT00140244|101735266|FG000|NOT COMPLETED|Intervention 1||0||
48574093|NCT00140244|101735267|FG001|NOT COMPLETED|Intervention 1||0||
48574094|NCT00140244|101735266|FG000|STARTED|Washout||3||
48574095|NCT00140244|101735267|FG001|STARTED|Washout||4||
48574096|NCT00140244|101735266|FG000|COMPLETED|Washout||3||
48574097|NCT00140244|101735267|FG001|COMPLETED|Washout||4||
48130604|NCT03328897|100642893|FG000|NOT COMPLETED|Follow-up Epoch||8||
48130605|NCT03328897|100642894|FG001|NOT COMPLETED|Follow-up Epoch||3||
48130606|NCT03328897|100642895|FG002|NOT COMPLETED|Follow-up Epoch||2||
48130607|NCT01992536|100642896|FG000|STARTED|Overall Study||26||
48130608|NCT01992536|100642897|FG001|STARTED|Overall Study||25||
48130609|NCT01992536|100642898|FG002|STARTED|Overall Study||17||
48130610|NCT01992536|100642899|FG003|STARTED|Overall Study||24||
48130611|NCT01992536|100642900|FG004|STARTED|Overall Study||11||
48130612|NCT01992536|100642901|FG005|STARTED|Overall Study||21||
48130613|NCT01992536|100642902|FG006|STARTED|Overall Study||7||
48130614|NCT01992536|100642903|FG007|STARTED|Overall Study||21||
48130615|NCT01992536|100642904|FG008|STARTED|Overall Study||19||
48130616|NCT01992536|100642905|FG009|STARTED|Overall Study||19||
48130617|NCT01992536|100642896|FG000|COMPLETED|Overall Study||22||
48130618|NCT01992536|100642897|FG001|COMPLETED|Overall Study||22||
48130619|NCT01992536|100642898|FG002|COMPLETED|Overall Study||16||
48130620|NCT01992536|100642899|FG003|COMPLETED|Overall Study||22||
48130621|NCT01992536|100642900|FG004|COMPLETED|Overall Study||11||
48701618|NCT01302834|102057533|FG000|AE Assessed 3 Months PT|Overall Study||359|Eligible, started study treatment, and had adverse events assessment 3 months post-treatment|
48130622|NCT01992536|100642901|FG005|COMPLETED|Overall Study||20||
48130623|NCT01992536|100642902|FG006|COMPLETED|Overall Study||0||
48130624|NCT01992536|100642903|FG007|COMPLETED|Overall Study||21||
48130625|NCT01992536|100642904|FG008|COMPLETED|Overall Study||18||
48130626|NCT01992536|100642905|FG009|COMPLETED|Overall Study||18||
48130627|NCT01992536|100642896|FG000|NOT COMPLETED|Overall Study||4||
48130628|NCT01992536|100642897|FG001|NOT COMPLETED|Overall Study||3||
48130629|NCT01992536|100642898|FG002|NOT COMPLETED|Overall Study||1||
48130630|NCT01992536|100642899|FG003|NOT COMPLETED|Overall Study||2||
48130631|NCT01992536|100642900|FG004|NOT COMPLETED|Overall Study||0||
48130632|NCT01992536|100642901|FG005|NOT COMPLETED|Overall Study||1||
48130633|NCT01992536|100642902|FG006|NOT COMPLETED|Overall Study||7||
48130634|NCT01992536|100642903|FG007|NOT COMPLETED|Overall Study||0||
48130635|NCT01992536|100642904|FG008|NOT COMPLETED|Overall Study||1||
48130636|NCT01992536|100642905|FG009|NOT COMPLETED|Overall Study||1||
48130637|NCT01774903|100642906|FG000|STARTED|Overall Study||45||
48130638|NCT01774903|100642906|FG000|COMPLETED|Overall Study||34||
48130639|NCT01774903|100642906|FG000|NOT COMPLETED|Overall Study||11||
48130640|NCT00432380|100642907|FG000|STARTED|Overall Study||150||
48130641|NCT00432380|100642908|FG001|STARTED|Overall Study||150||
48130642|NCT00432380|100642909|FG002|STARTED|Overall Study||75||
48130643|NCT00432380|100642907|FG000|COMPLETED|Overall Study||146||
48130644|NCT00432380|100642908|FG001|COMPLETED|Overall Study||146||
48130645|NCT00432380|100642909|FG002|COMPLETED|Overall Study||74||
48130646|NCT00432380|100642907|FG000|NOT COMPLETED|Overall Study||4||
48130647|NCT00432380|100642908|FG001|NOT COMPLETED|Overall Study||4||
48130648|NCT00432380|100642909|FG002|NOT COMPLETED|Overall Study||1||
48574098|NCT00140244|101735266|FG000|NOT COMPLETED|Washout||0||
48130649|NCT02451748|100642910|FG000|STARTED|Overall Study||12||
48130650|NCT02451748|100642911|FG001|STARTED|Overall Study||15||
48130651|NCT02451748|100642910|FG000|Participants With Evaluable Data at Visit 1|Overall Study||0||
48130652|NCT02451748|100642911|FG001|Participants With Evaluable Data at Visit 1|Overall Study||10||
48130653|NCT02451748|100642910|FG000|Participants With Evaluable Data at Visit 2|Overall Study||0||
48130654|NCT02451748|100642911|FG001|Participants With Evaluable Data at Visit 2|Overall Study||10||
48574099|NCT00140244|101735267|FG001|NOT COMPLETED|Washout||0||
48574100|NCT00140244|101735266|FG000|STARTED|Intervention 2||3||
48574101|NCT00140244|101735267|FG001|STARTED|Intervention 2||4||
48574102|NCT00140244|101735266|FG000|COMPLETED|Intervention 2||3||
48574103|NCT00140244|101735267|FG001|COMPLETED|Intervention 2||2||
48130655|NCT02451748|100642910|FG000|Participants With Evaluable Data at Visit 3|Overall Study||0||
48574104|NCT00140244|101735266|FG000|NOT COMPLETED|Intervention 2||0||
48574105|NCT00140244|101735267|FG001|NOT COMPLETED|Intervention 2||2||
48574106|NCT02527746|101735268|FG000|STARTED|Overall Study||6||
48130656|NCT02451748|100642911|FG001|Participants With Evaluable Data at Visit 3|Overall Study||5||
48130657|NCT02451748|100642910|FG000|COMPLETED|Overall Study||0||
48130658|NCT02451748|100642911|FG001|COMPLETED|Overall Study||5||
48574107|NCT02527746|101735269|FG001|STARTED|Overall Study||6||
48701619|NCT01302834|102057534|FG001|AE Assessed 3 Months PT|Overall Study||367|Eligible, started study treatment, and had adverse events assessment 3 months post-treatment|
48701620|NCT01302834|102057533|FG000|AE Assessed 6 Months PT|Overall Study||361|Eligible, started study treatment, and had adverse events assessment 6 months post-treatment|
48701621|NCT01302834|102057534|FG001|AE Assessed 6 Months PT|Overall Study||352|Eligible, started study treatment, and had adverse events assessment 6 months post-treatment|
48701622|NCT01302834|102057533|FG000|AE Assessment 1 Year PT|Overall Study||360|Eligible, started study treatment, and had adverse events assessment 1 year post-treatment|
48701623|NCT01302834|102057534|FG001|AE Assessment 1 Year PT|Overall Study||351|Eligible, started study treatment, and had adverse events assessment 1 year post-treatment|
48701624|NCT01302834|102057533|FG000|AE Assessed 2 Years PT|Overall Study||311|Eligible, started study treatment, and had adverse events assessment 2 years post-treatment|
48701625|NCT01302834|102057534|FG001|AE Assessed 2 Years PT|Overall Study||303|Eligible, started study treatment, and had adverse events assessment 2 years post-treatment|
48701626|NCT01302834|102057533|FG000|AE Assessed 5 Years PT|Overall Study||92|Eligible, started study treatment, and had adverse events assessment 5 years post-treatment|
48701627|NCT01302834|102057534|FG001|AE Assessed 5 Years PT|Overall Study||86|Eligible, started study treatment, and had adverse events assessment 5 years post-treatment|
48701628|NCT01302834|102057533|FG000|Dental Health Assessed 1 Year PT|Overall Study||267|Eligible, started study treatment, and had dental health assessment 1 year post-treatment|
48701629|NCT01302834|102057534|FG001|Dental Health Assessed 1 Year PT|Overall Study||267|Eligible, started study treatment, and had dental health assessment 1 year post-treatment|
48701630|NCT01302834|102057533|FG000|Dental Health Assessed 2 Years PT|Overall Study||208|Eligible, started study treatment, and had dental health assessment 2 years post-treatment|
48701631|NCT01302834|102057534|FG001|Dental Health Assessed 2 Years PT|Overall Study||201|Eligible, started study treatment, and had dental health assessment 2 years post-treatment|
48701632|NCT01302834|102057533|FG000|Dental Health Assessed 5 Years PT|Overall Study||44|Eligible, started study treatment, and had dental health assessment 5 years post-treatment|
48701633|NCT01302834|102057534|FG001|Dental Health Assessed 5 Years PT|Overall Study||43|Eligible, started study treatment, and had dental health assessment 5 years post-treatment|
48701634|NCT01302834|102057533|FG000|Feeding Tube Assessed|Overall Study||368|Eligible, started study treatment, and had feeding tube assessment 1 year post-treatment|
48701635|NCT01302834|102057534|FG001|Feeding Tube Assessed|Overall Study||356|Eligible, started study treatment, and had feeding tube assessment 1 year post-treatment|
48710827|NCT03446053|102078035|FG005|STARTED|Overall Study||6||
48398792|NCT01525667|101306407|FG002|COMPLETED|Overall Study||7||
48398793|NCT01525667|101306405|FG000|NOT COMPLETED|Overall Study||0||
48398794|NCT01525667|101306406|FG001|NOT COMPLETED|Overall Study||0||
48398795|NCT01525667|101306407|FG002|NOT COMPLETED|Overall Study||0||
48398796|NCT03807245|101306408|FG000|STARTED|Overall Study||24||
48398797|NCT03807245|101306409|FG001|STARTED|Overall Study||24||
48398798|NCT03807245|101306410|FG002|STARTED|Overall Study||12||
48398799|NCT03807245|101306408|FG000|COMPLETED|Overall Study||23||
48398800|NCT03807245|101306409|FG001|COMPLETED|Overall Study||24||
48398801|NCT03807245|101306410|FG002|COMPLETED|Overall Study||12||
48398802|NCT03807245|101306408|FG000|NOT COMPLETED|Overall Study||1||
48130659|NCT02451748|100642910|FG000|NOT COMPLETED|Overall Study||12||
48130660|NCT02451748|100642911|FG001|NOT COMPLETED|Overall Study||10||
48130661|NCT03574129|100642912|FG000|STARTED|Overall Study||578||
48130662|NCT03574129|100642913|FG001|STARTED|Overall Study||488||
48398803|NCT03807245|101306409|FG001|NOT COMPLETED|Overall Study||0||
48398804|NCT03807245|101306410|FG002|NOT COMPLETED|Overall Study||0||
48398805|NCT03621189|101306411|FG000|STARTED|Overall Study||40||
48398806|NCT03621189|101306412|FG001|STARTED|Overall Study||40||
48398807|NCT03621189|101306411|FG000|COMPLETED|Overall Study||40||
48398808|NCT03621189|101306412|FG001|COMPLETED|Overall Study||35||
48398809|NCT03621189|101306411|FG000|NOT COMPLETED|Overall Study||0||
48398810|NCT03621189|101306412|FG001|NOT COMPLETED|Overall Study||5||
48398811|NCT05151367|101306413|FG000|STARTED|Overall Study||78||
48398812|NCT05151367|101306414|FG001|STARTED|Overall Study||76||
48398813|NCT05151367|101306413|FG000|COMPLETED|Overall Study||78||
48398814|NCT05151367|101306414|FG001|COMPLETED|Overall Study||76||
48398815|NCT05151367|101306413|FG000|NOT COMPLETED|Overall Study||0||
48398816|NCT05151367|101306414|FG001|NOT COMPLETED|Overall Study||0||
48398817|NCT01068717|101306415|FG000|STARTED|Period 1: Treatment Schedule Phase 1||7||
48398818|NCT01068717|101306416|FG001|STARTED|Period 1: Treatment Schedule Phase 1||6||
48130663|NCT03574129|100642912|FG000|COMPLETED|Overall Study||506||
48130664|NCT03574129|100642913|FG001|COMPLETED|Overall Study||440||
48130665|NCT03574129|100642912|FG000|NOT COMPLETED|Overall Study||72||
48130666|NCT03574129|100642913|FG001|NOT COMPLETED|Overall Study||48||
48130667|NCT01854554|100642914|FG000|STARTED|Overall Study||42||
48398819|NCT01068717|101306417|FG002|STARTED|Period 1: Treatment Schedule Phase 1||7||
48398820|NCT01068717|101306418|FG003|STARTED|Period 1: Treatment Schedule Phase 1||7||
48130668|NCT01854554|100642915|FG001|STARTED|Overall Study||48||
48130669|NCT01854554|100642914|FG000|COMPLETED|Overall Study||28||
48130670|NCT01854554|100642915|FG001|COMPLETED|Overall Study||39||
48130671|NCT01854554|100642914|FG000|NOT COMPLETED|Overall Study||14||
48130672|NCT01854554|100642915|FG001|NOT COMPLETED|Overall Study||9||
48398821|NCT01068717|101306415|FG000|COMPLETED|Period 1: Treatment Schedule Phase 1||6||
48398822|NCT01068717|101306416|FG001|COMPLETED|Period 1: Treatment Schedule Phase 1||6||
48398823|NCT01068717|101306417|FG002|COMPLETED|Period 1: Treatment Schedule Phase 1||7||
48130673|NCT02755935|100642916|FG000|STARTED|Overall Study||24||
48130674|NCT02755935|100642916|FG000|COMPLETED|Overall Study||22||
48130675|NCT02755935|100642916|FG000|NOT COMPLETED|Overall Study||2||
48284729|NCT00700427|101021560|FG003|STARTED|Study Period 3A (Blinded Maintenance)||0||
48284730|NCT00700427|101021561|FG004|STARTED|Study Period 3A (Blinded Maintenance)||0||
48284731|NCT00700427|101021557|FG000|COMPLETED|Study Period 3A (Blinded Maintenance)||0||
48284732|NCT00700427|101021558|FG001|COMPLETED|Study Period 3A (Blinded Maintenance)||524||
48284733|NCT00700427|101021559|FG002|COMPLETED|Study Period 3A (Blinded Maintenance)||0||
48284734|NCT00700427|101021560|FG003|COMPLETED|Study Period 3A (Blinded Maintenance)||0||
48284735|NCT00700427|101021561|FG004|COMPLETED|Study Period 3A (Blinded Maintenance)||0||
48574108|NCT02527746|101735270|FG002|STARTED|Overall Study||6||
48574109|NCT02527746|101735268|FG000|COMPLETED|Overall Study||6||
48574110|NCT02527746|101735269|FG001|COMPLETED|Overall Study||6||
48574111|NCT02527746|101735270|FG002|COMPLETED|Overall Study||6||
48574112|NCT02527746|101735268|FG000|NOT COMPLETED|Overall Study||0||
48574113|NCT02527746|101735269|FG001|NOT COMPLETED|Overall Study||0||
48574114|NCT02527746|101735270|FG002|NOT COMPLETED|Overall Study||0||
48574115|NCT00953654|101735271|FG000|STARTED|Overall Study||10||
48574116|NCT00953654|101735272|FG001|STARTED|Overall Study||10||
48574117|NCT00953654|101735273|FG002|STARTED|Overall Study||10||
48574118|NCT00953654|101735271|FG000|COMPLETED|Overall Study||10||
48574119|NCT00953654|101735272|FG001|COMPLETED|Overall Study||10||
48574120|NCT00953654|101735273|FG002|COMPLETED|Overall Study||10||
48574121|NCT00953654|101735271|FG000|NOT COMPLETED|Overall Study||0||
48574122|NCT00953654|101735272|FG001|NOT COMPLETED|Overall Study||0||
48574123|NCT00953654|101735273|FG002|NOT COMPLETED|Overall Study||0||
48574124|NCT00842023|101735274|FG000|STARTED|Overall Study||45||
48574125|NCT00842023|101735275|FG001|STARTED|Overall Study||44||
48574126|NCT00842023|101735274|FG000|COMPLETED|Overall Study||45||
48574127|NCT00842023|101735275|FG001|COMPLETED|Overall Study||44||
48574128|NCT00842023|101735274|FG000|NOT COMPLETED|Overall Study||0||
48574129|NCT00842023|101735275|FG001|NOT COMPLETED|Overall Study||0||
48574130|NCT01985932|101735276|FG000|STARTED|Overall Study||15||
48130676|NCT00148343|100642917|FG000|STARTED|Overall Study||54||
48130677|NCT00148343|100642918|FG001|STARTED|Overall Study||56||
48130678|NCT00148343|100642917|FG000|COMPLETED|Overall Study||39||
48130679|NCT00148343|100642918|FG001|COMPLETED|Overall Study||45||
48130680|NCT00148343|100642917|FG000|NOT COMPLETED|Overall Study||15||
48130681|NCT00148343|100642918|FG001|NOT COMPLETED|Overall Study||11||
48130682|NCT04443218|100642919|FG000|STARTED|Overall Study||220||
48130683|NCT04443218|100642919|FG000|COMPLETED|Overall Study||187||
48130684|NCT04443218|100642919|FG000|NOT COMPLETED|Overall Study||33||
48130685|NCT03893448|100642920|FG000|STARTED|Overall Study||860||
48130686|NCT03893448|100642921|FG001|STARTED|Overall Study||860||
48130687|NCT03893448|100642920|FG000|Treated|Overall Study||858||
48130688|NCT03893448|100642921|FG001|Treated|Overall Study||856||
48130689|NCT03893448|100642920|FG000|COMPLETED|Overall Study||758||
48284736|NCT00700427|101021557|FG000|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0||
48284737|NCT00700427|101021558|FG001|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||481||
48284738|NCT00700427|101021559|FG002|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0||
48284739|NCT00700427|101021560|FG003|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0||
48284740|NCT00700427|101021561|FG004|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0||
48284741|NCT00700427|101021557|FG000|STARTED|Study Period 3B (Randomized Withdrawal)||0||
48284742|NCT00700427|101021558|FG001|STARTED|Study Period 3B (Randomized Withdrawal)||0||
48284743|NCT00700427|101021559|FG002|STARTED|Study Period 3B (Randomized Withdrawal)||266||
48284744|NCT00700427|101021560|FG003|STARTED|Study Period 3B (Randomized Withdrawal)||258||
48284745|NCT00700427|101021561|FG004|STARTED|Study Period 3B (Randomized Withdrawal)||0||
48284746|NCT00700427|101021557|FG000|COMPLETED|Study Period 3B (Randomized Withdrawal)||0||
48284747|NCT00700427|101021558|FG001|COMPLETED|Study Period 3B (Randomized Withdrawal)||0||
48284748|NCT00700427|101021559|FG002|COMPLETED|Study Period 3B (Randomized Withdrawal)||184||
48284749|NCT00700427|101021560|FG003|COMPLETED|Study Period 3B (Randomized Withdrawal)||165||
48284750|NCT00700427|101021561|FG004|COMPLETED|Study Period 3B (Randomized Withdrawal)||0||
48284751|NCT00700427|101021557|FG000|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0||
48130690|NCT03893448|100642921|FG001|COMPLETED|Overall Study||734||
48284752|NCT00700427|101021558|FG001|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0||
48284753|NCT00700427|101021559|FG002|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||82||
48398824|NCT01068717|101306418|FG003|COMPLETED|Period 1: Treatment Schedule Phase 1||7||
48398825|NCT01068717|101306415|FG000|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||1||
48574131|NCT01985932|101735276|FG000|COMPLETED|Overall Study||15||
48574132|NCT01985932|101735276|FG000|NOT COMPLETED|Overall Study||0||
48574133|NCT00375973|101735277|FG000|STARTED|Overall Study||30||
48574134|NCT00375973|101735278|FG001|STARTED|Overall Study||30||
48710730|NCT02699450|102078000|FG001|Completed up to Week 24|Overall Study||53||
48130691|NCT03893448|100642920|FG000|NOT COMPLETED|Overall Study||102||
48130692|NCT03893448|100642921|FG001|NOT COMPLETED|Overall Study||126||
48130693|NCT02660944|100642922|FG000|STARTED|Overall Study||42||
48130694|NCT02660944|100642923|FG001|STARTED|Overall Study||22||
48130695|NCT02660944|100642922|FG000|COMPLETED|Overall Study||25||
48130696|NCT02660944|100642923|FG001|COMPLETED|Overall Study||12||
48574135|NCT00375973|101735277|FG000|COMPLETED|Overall Study||20||
48574136|NCT00375973|101735278|FG001|COMPLETED|Overall Study||28||
48574137|NCT00375973|101735277|FG000|NOT COMPLETED|Overall Study||10||
48574138|NCT00375973|101735278|FG001|NOT COMPLETED|Overall Study||2||
48574139|NCT02934698|101735279|FG000|STARTED|Overall Study||2||
48574140|NCT02934698|101735279|FG000|COMPLETED|Overall Study||2||
48574141|NCT02934698|101735279|FG000|NOT COMPLETED|Overall Study||0||
48574142|NCT01904526|101735280|FG000|STARTED|Overall Study||5||
48574143|NCT01904526|101735280|FG000|COMPLETED|Overall Study||5||
48574144|NCT01904526|101735280|FG000|NOT COMPLETED|Overall Study||0||
48574145|NCT01868022|101735281|FG000|STARTED|Overall Study||3||
48574146|NCT01868022|101735282|FG001|STARTED|Overall Study||3||
48574147|NCT01868022|101735283|FG002|STARTED|Overall Study||14||
48574148|NCT01868022|101735284|FG003|STARTED|Overall Study||3||
48574149|NCT01868022|101735285|FG004|STARTED|Overall Study||3||
48574150|NCT01868022|101735286|FG005|STARTED|Overall Study||3||
48574151|NCT01868022|101735287|FG006|STARTED|Overall Study||3||
48574152|NCT01868022|101735288|FG007|STARTED|Overall Study||25||
48574153|NCT01868022|101735289|FG008|STARTED|Overall Study||8||
48574154|NCT01868022|101735281|FG000|COMPLETED|Overall Study||3||
48574155|NCT01868022|101735282|FG001|COMPLETED|Overall Study||3||
48574156|NCT01868022|101735283|FG002|COMPLETED|Overall Study||13||
48574157|NCT01868022|101735284|FG003|COMPLETED|Overall Study||2||
48574158|NCT01868022|101735285|FG004|COMPLETED|Overall Study||1||
48574159|NCT01868022|101735286|FG005|COMPLETED|Overall Study||2||
48574160|NCT01868022|101735287|FG006|COMPLETED|Overall Study||3||
48574161|NCT01868022|101735288|FG007|COMPLETED|Overall Study||16||
48574162|NCT01868022|101735289|FG008|COMPLETED|Overall Study||6||
48574163|NCT01868022|101735281|FG000|NOT COMPLETED|Overall Study||0||
48574164|NCT01868022|101735282|FG001|NOT COMPLETED|Overall Study||0||
48574165|NCT01868022|101735283|FG002|NOT COMPLETED|Overall Study||1||
48574166|NCT01868022|101735284|FG003|NOT COMPLETED|Overall Study||1||
48574167|NCT01868022|101735285|FG004|NOT COMPLETED|Overall Study||2||
48574168|NCT01868022|101735286|FG005|NOT COMPLETED|Overall Study||1||
48574169|NCT01868022|101735287|FG006|NOT COMPLETED|Overall Study||0||
48574170|NCT01868022|101735288|FG007|NOT COMPLETED|Overall Study||9||
48574171|NCT01868022|101735289|FG008|NOT COMPLETED|Overall Study||2||
48574172|NCT02393950|101735290|FG000|STARTED|Overall Study||9||
48574173|NCT02393950|101735291|FG001|STARTED|Overall Study||9||
48574174|NCT02393950|101735290|FG000|Period 1|Overall Study||8||
48574175|NCT02393950|101735291|FG001|Period 1|Overall Study||8||
48574176|NCT02393950|101735290|FG000|Period 2|Overall Study||8||
48574177|NCT02393950|101735291|FG001|Period 2|Overall Study||8||
48574178|NCT02393950|101735290|FG000|Period 3|Overall Study||8||
48574179|NCT02393950|101735291|FG001|Period 3|Overall Study||8||
48574180|NCT02393950|101735290|FG000|Period 4|Overall Study||8||
48701636|NCT01302834|102057533|FG000|Progressed|Overall Study||76|Eligible and experienced local, regional, or distant progression or death|
48701637|NCT01302834|102057534|FG001|Progressed|Overall Study||122|Eligible and experienced local, regional, or distant progression or death|
48701638|NCT01302834|102057533|FG000|COMPLETED|Overall Study||406|Subjects contributing any data to analysis are considered to have completed the study|
48701639|NCT01302834|102057534|FG001|COMPLETED|Overall Study||399|Subjects contributing any data to analysis are considered to have completed the study|
48701640|NCT01302834|102057533|FG000|NOT COMPLETED|Overall Study||18||
48701641|NCT01302834|102057534|FG001|NOT COMPLETED|Overall Study||26||
48701642|NCT04309370|102057535|FG000|STARTED|Overall Study||7||
48701643|NCT04309370|102057536|FG001|STARTED|Overall Study||7||
48574181|NCT02393950|101735291|FG001|Period 4|Overall Study||8||
48574182|NCT02393950|101735290|FG000|COMPLETED|Overall Study||8||
48574183|NCT02393950|101735291|FG001|COMPLETED|Overall Study||8||
48574184|NCT02393950|101735290|FG000|NOT COMPLETED|Overall Study||1||
48574185|NCT02393950|101735291|FG001|NOT COMPLETED|Overall Study||1||
48130697|NCT02660944|100642922|FG000|NOT COMPLETED|Overall Study||17||
48130698|NCT02660944|100642923|FG001|NOT COMPLETED|Overall Study||10||
48130699|NCT01538745|100642924|FG000|STARTED|Overall Study||24||
48130700|NCT01538745|100642925|FG001|STARTED|Overall Study||21||
48130701|NCT01538745|100642924|FG000|COMPLETED|Overall Study||24||
48130702|NCT01538745|100642925|FG001|COMPLETED|Overall Study||21||
48130703|NCT01538745|100642924|FG000|NOT COMPLETED|Overall Study||0||
48130704|NCT01538745|100642925|FG001|NOT COMPLETED|Overall Study||0||
48130705|NCT01913041|100642926|FG000|STARTED|Overall Study||869||
48130706|NCT01913041|100642926|FG000|COMPLETED|Overall Study||830||
48130707|NCT01913041|100642926|FG000|NOT COMPLETED|Overall Study||39||
48130708|NCT01762761|100642927|FG000|STARTED|Overall Study||51||
48130709|NCT01762761|100642928|FG001|STARTED|Overall Study||104||
48130710|NCT01762761|100642927|FG000|COMPLETED|Overall Study||12||
48130711|NCT01762761|100642928|FG001|COMPLETED|Overall Study||39||
48130712|NCT01762761|100642927|FG000|NOT COMPLETED|Overall Study||39||
48284754|NCT00700427|101021560|FG003|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||93||
48284755|NCT00700427|101021561|FG004|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0||
48284756|NCT00700427|101021557|FG000|STARTED|Study Period 4 (Open-Label Extension)||0||
48284757|NCT00700427|101021558|FG001|STARTED|Study Period 4 (Open-Label Extension)||0||
48284758|NCT00700427|101021559|FG002|STARTED|Study Period 4 (Open-Label Extension)||0||
48284759|NCT00700427|101021560|FG003|STARTED|Study Period 4 (Open-Label Extension)||0||
48284760|NCT00700427|101021561|FG004|STARTED|Study Period 4 (Open-Label Extension)||180||
48284761|NCT00700427|101021557|FG000|COMPLETED|Study Period 4 (Open-Label Extension)||0||
48574186|NCT02225860|101735292|FG000|STARTED|Overall Study||17||
48574187|NCT02225860|101735293|FG001|STARTED|Overall Study||17||
48574188|NCT02225860|101735292|FG000|COMPLETED|Overall Study||16||
48574189|NCT02225860|101735293|FG001|COMPLETED|Overall Study||17||
48574190|NCT02225860|101735292|FG000|NOT COMPLETED|Overall Study||1||
48574191|NCT02225860|101735293|FG001|NOT COMPLETED|Overall Study||0||
48574192|NCT03850496|101735294|FG000|STARTED|Overall Study||26||
48574193|NCT03850496|101735295|FG001|STARTED|Overall Study||25||
48574194|NCT03850496|101735296|FG002|STARTED|Overall Study||25||
48574195|NCT03850496|101735294|FG000|COMPLETED|Overall Study||25||
48574196|NCT03850496|101735295|FG001|COMPLETED|Overall Study||24||
48574197|NCT03850496|101735296|FG002|COMPLETED|Overall Study||21||
48574198|NCT03850496|101735294|FG000|NOT COMPLETED|Overall Study||1||
48574199|NCT03850496|101735295|FG001|NOT COMPLETED|Overall Study||1||
48701644|NCT04309370|102057535|FG000|COMPLETED|Overall Study||7||
48701645|NCT04309370|102057536|FG001|COMPLETED|Overall Study||7||
48701646|NCT04309370|102057535|FG000|NOT COMPLETED|Overall Study||0||
48701647|NCT04309370|102057536|FG001|NOT COMPLETED|Overall Study||0||
48701648|NCT03199053|102057537|FG000|STARTED|ST Period||81||
48701649|NCT03199053|102057538|FG001|STARTED|ST Period||88||
48701650|NCT03199053|102057539|FG002|STARTED|ST Period||76||
48701651|NCT03199053|102057537|FG000|Week 14 no Uptitration Randomisation|ST Period||39|Excluded from Uptitration Randomised Participants Data Set.|
48701652|NCT03199053|102057538|FG001|Week 14 no Uptitration Randomisation|ST Period||36|Excluded from Uptitration Randomised Participants Data Set.|
48701653|NCT03199053|102057539|FG002|Week 14 no Uptitration Randomisation|ST Period||0|Excluded from Uptitration Randomised Participants Data Set.|
48701654|NCT03199053|102057537|FG000|Week 14 Uptitration Randomisation|ST Period||42|Included in Uptitration Randomised Participants Data Set.|
48710731|NCT02699450|102078001|FG002|Completed up to Week 24|Overall Study||73||
48130713|NCT01762761|100642928|FG001|NOT COMPLETED|Overall Study||65||
48130714|NCT04726709|100642929|FG000|STARTED|Overall Study||16||
48130715|NCT04726709|100642930|FG001|STARTED|Overall Study||14||
48130716|NCT04726709|100642929|FG000|COMPLETED|Overall Study||14||
48130717|NCT04726709|100642930|FG001|COMPLETED|Overall Study||12||
48130718|NCT04726709|100642929|FG000|NOT COMPLETED|Overall Study||2||
48130719|NCT04726709|100642930|FG001|NOT COMPLETED|Overall Study||2||
48574200|NCT03850496|101735296|FG002|NOT COMPLETED|Overall Study||4||
48574201|NCT01620190|101735297|FG000|STARTED|Overall Study||26||
48574202|NCT01620190|101735297|FG000|COMPLETED|Overall Study||26||
48574203|NCT01620190|101735297|FG000|NOT COMPLETED|Overall Study||0||
48574204|NCT02147158|101735298|FG000|STARTED|Treatment Course 1||55||
48398826|NCT01068717|101306416|FG001|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0||
48398827|NCT01068717|101306417|FG002|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0||
48398828|NCT01068717|101306418|FG003|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0||
48284762|NCT00700427|101021558|FG001|COMPLETED|Study Period 4 (Open-Label Extension)||0||
48284763|NCT00700427|101021559|FG002|COMPLETED|Study Period 4 (Open-Label Extension)||0||
48284764|NCT00700427|101021560|FG003|COMPLETED|Study Period 4 (Open-Label Extension)||0||
48284765|NCT00700427|101021561|FG004|COMPLETED|Study Period 4 (Open-Label Extension)||96||
48284766|NCT00700427|101021557|FG000|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0||
48284767|NCT00700427|101021558|FG001|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0||
48284768|NCT00700427|101021559|FG002|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0||
48284769|NCT00700427|101021560|FG003|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0||
48284770|NCT00700427|101021561|FG004|NOT COMPLETED|Study Period 4 (Open-Label Extension)||84||
48284771|NCT00952120|101021562|FG000|STARTED|Overall Study||52||
48284772|NCT00952120|101021563|FG001|STARTED|Overall Study||47||
48284773|NCT00952120|101021564|FG002|STARTED|Overall Study||5||
48284774|NCT00952120|101021562|FG000|COMPLETED|Overall Study||52||
48284775|NCT00952120|101021563|FG001|COMPLETED|Overall Study||47||
48284776|NCT00952120|101021564|FG002|COMPLETED|Overall Study||5||
48284777|NCT00952120|101021562|FG000|NOT COMPLETED|Overall Study||0||
48284778|NCT00952120|101021563|FG001|NOT COMPLETED|Overall Study||0||
48284779|NCT00952120|101021564|FG002|NOT COMPLETED|Overall Study||0||
48284780|NCT03412747|101021565|FG000|STARTED|Initial Treatment Period: Wk0-Wk16||161||
48284781|NCT03412747|101021566|FG001|STARTED|Initial Treatment Period: Wk0-Wk16||158||
48284782|NCT03412747|101021567|FG002|STARTED|Initial Treatment Period: Wk0-Wk16||159||
48284783|NCT03412747|101021565|FG000|COMPLETED|Initial Treatment Period: Wk0-Wk16||154||
48284784|NCT03412747|101021566|FG001|COMPLETED|Initial Treatment Period: Wk0-Wk16||153||
48284785|NCT03412747|101021567|FG002|COMPLETED|Initial Treatment Period: Wk0-Wk16||150||
48284786|NCT03412747|101021565|FG000|NOT COMPLETED|Initial Treatment Period: Wk0-Wk16||7||
48284787|NCT03412747|101021566|FG001|NOT COMPLETED|Initial Treatment Period: Wk0-Wk16||5||
48284788|NCT03412747|101021567|FG002|NOT COMPLETED|Initial Treatment Period: Wk0-Wk16||9||
48284789|NCT03412747|101021565|FG000|STARTED|Maintenance Treatment Period: Wk16-Wk24||154||
48284790|NCT03412747|101021566|FG001|STARTED|Maintenance Treatment Period: Wk16-Wk24||153||
48398829|NCT01068717|101306415|FG000|STARTED|Period 2: Treatment Schedule Phase 2||6||
48398830|NCT01068717|101306416|FG001|STARTED|Period 2: Treatment Schedule Phase 2||6||
48398831|NCT01068717|101306417|FG002|STARTED|Period 2: Treatment Schedule Phase 2||7||
48574205|NCT02147158|101735299|FG001|STARTED|Treatment Course 1||47||
48574206|NCT02147158|101735300|FG002|STARTED|Treatment Course 1||107||
48574207|NCT02147158|101735301|FG003|STARTED|Treatment Course 1||110||
48574208|NCT02147158|101735302|FG004|STARTED|Treatment Course 1||55||
48574209|NCT02147158|101735303|FG005|STARTED|Treatment Course 1||58||
48574210|NCT02147158|101735298|FG000|COMPLETED|Treatment Course 1||51||
48574211|NCT02147158|101735299|FG001|COMPLETED|Treatment Course 1||38||
48574212|NCT02147158|101735300|FG002|COMPLETED|Treatment Course 1||99||
48574213|NCT02147158|101735301|FG003|COMPLETED|Treatment Course 1||97||
48574214|NCT02147158|101735302|FG004|COMPLETED|Treatment Course 1||49||
48574215|NCT02147158|101735303|FG005|COMPLETED|Treatment Course 1||50||
48574216|NCT02147158|101735298|FG000|NOT COMPLETED|Treatment Course 1||4||
48574217|NCT02147158|101735299|FG001|NOT COMPLETED|Treatment Course 1||9||
48574218|NCT02147158|101735300|FG002|NOT COMPLETED|Treatment Course 1||8||
48574219|NCT02147158|101735301|FG003|NOT COMPLETED|Treatment Course 1||13||
48574220|NCT02147158|101735302|FG004|NOT COMPLETED|Treatment Course 1||6||
48574221|NCT02147158|101735303|FG005|NOT COMPLETED|Treatment Course 1||8||
48574222|NCT02147158|101735298|FG000|STARTED|Off-Treatment Interval 1||51||
48574223|NCT02147158|101735299|FG001|STARTED|Off-Treatment Interval 1||38||
48574224|NCT02147158|101735300|FG002|STARTED|Off-Treatment Interval 1||99||
48574225|NCT02147158|101735301|FG003|STARTED|Off-Treatment Interval 1||97||
48574226|NCT02147158|101735302|FG004|STARTED|Off-Treatment Interval 1||49||
48284791|NCT03412747|101021567|FG002|STARTED|Maintenance Treatment Period: Wk16-Wk24||150||
48398832|NCT01068717|101306418|FG003|STARTED|Period 2: Treatment Schedule Phase 2||7||
48574227|NCT02147158|101735303|FG005|STARTED|Off-Treatment Interval 1||50||
48574228|NCT02147158|101735298|FG000|COMPLETED|Off-Treatment Interval 1||41||
48574229|NCT02147158|101735299|FG001|COMPLETED|Off-Treatment Interval 1||34||
48398833|NCT01068717|101306415|FG000|COMPLETED|Period 2: Treatment Schedule Phase 2||6||
48574230|NCT02147158|101735300|FG002|COMPLETED|Off-Treatment Interval 1||84||
48574231|NCT02147158|101735301|FG003|COMPLETED|Off-Treatment Interval 1||82||
48701655|NCT03199053|102057538|FG001|Week 14 Uptitration Randomisation|ST Period||52|Included in Uptitration Randomised Participants Data Set.|
48701656|NCT03199053|102057539|FG002|Week 14 Uptitration Randomisation|ST Period||0|Included in Uptitration Randomised Participants Data Set.|
48701657|NCT03199053|102057537|FG000|COMPLETED|ST Period||76||
48701658|NCT03199053|102057538|FG001|COMPLETED|ST Period||83||
48130720|NCT03041415|100645710|FG000|STARTED|Overall Study||140||5
48130721|NCT03041415|100645711|FG001|STARTED|Overall Study||160||5
48130722|NCT03041415|100645710|FG000|COMPLETED|Overall Study||123||5
48130723|NCT03041415|100645711|FG001|COMPLETED|Overall Study||145||5
48130724|NCT03041415|100645710|FG000|NOT COMPLETED|Overall Study||17||0
48130725|NCT03041415|100645711|FG001|NOT COMPLETED|Overall Study||15||0
48130726|NCT03349710|100645712|FG000|STARTED|Randomized||12|= Participants Randomized|
48130727|NCT03349710|100645713|FG001|STARTED|Randomized||10|= Participants Randomized|
48130728|NCT03349710|100645714|FG002|STARTED|Randomized||27|= Participants Randomized|
48130729|NCT03349710|100645715|FG003|STARTED|Randomized||25|= Participants Randomized|
48130730|NCT03349710|100645712|FG000|COMPLETED|Randomized||12|= Participants Treated|
48130731|NCT03349710|100645713|FG001|COMPLETED|Randomized||10|= Participants Treated|
48130732|NCT03349710|100645714|FG002|COMPLETED|Randomized||27|= Participants Treated|
48130733|NCT03349710|100645715|FG003|COMPLETED|Randomized||24|= Participants Treated|
48130734|NCT03349710|100645712|FG000|NOT COMPLETED|Randomized||0||
48130735|NCT03349710|100645713|FG001|NOT COMPLETED|Randomized||0||
48130736|NCT03349710|100645714|FG002|NOT COMPLETED|Randomized||0||
48130737|NCT03349710|100645715|FG003|NOT COMPLETED|Randomized||1||
48130738|NCT03349710|100645712|FG000|STARTED|Treatment Period||12|= Participants Treated|
48130739|NCT03349710|100645713|FG001|STARTED|Treatment Period||10|= Participants Treated|
48130740|NCT03349710|100645714|FG002|STARTED|Treatment Period||27|= Participants Treated|
48130741|NCT03349710|100645715|FG003|STARTED|Treatment Period||24|= Participants Treated|
48130742|NCT03349710|100645712|FG000|COMPLETED|Treatment Period||0|= Continuing Treatment|
48130743|NCT03349710|100645713|FG001|COMPLETED|Treatment Period||0|= Continuing Treatment|
48130744|NCT03349710|100645714|FG002|COMPLETED|Treatment Period||0|= Continuing Treatment|
48130745|NCT03349710|100645715|FG003|COMPLETED|Treatment Period||0|= Continuing Treatment|
48701659|NCT03199053|102057539|FG002|COMPLETED|ST Period||68||
48130746|NCT03349710|100645712|FG000|NOT COMPLETED|Treatment Period||12||
48130747|NCT03349710|100645713|FG001|NOT COMPLETED|Treatment Period||10||
48130748|NCT03349710|100645714|FG002|NOT COMPLETED|Treatment Period||27||
48130749|NCT03349710|100645715|FG003|NOT COMPLETED|Treatment Period||24||
48130750|NCT02627677|100645716|FG000|STARTED|Overall Study||11||
48130751|NCT02627677|100645717|FG001|STARTED|Overall Study||21||
48130752|NCT02627677|100645718|FG002|STARTED|Overall Study||12||
48130753|NCT02627677|100645716|FG000|COMPLETED|Overall Study||0||
48130754|NCT02627677|100645717|FG001|COMPLETED|Overall Study||0||
48130755|NCT02627677|100645718|FG002|COMPLETED|Overall Study||0||
48130756|NCT02627677|100645716|FG000|NOT COMPLETED|Overall Study||11||
48130757|NCT02627677|100645717|FG001|NOT COMPLETED|Overall Study||21||
48130758|NCT02627677|100645718|FG002|NOT COMPLETED|Overall Study||12||
48574232|NCT02147158|101735302|FG004|COMPLETED|Off-Treatment Interval 1||41||
48574233|NCT02147158|101735303|FG005|COMPLETED|Off-Treatment Interval 1||45||
48574234|NCT02147158|101735298|FG000|NOT COMPLETED|Off-Treatment Interval 1||10||
48574235|NCT02147158|101735299|FG001|NOT COMPLETED|Off-Treatment Interval 1||4||
48574236|NCT02147158|101735300|FG002|NOT COMPLETED|Off-Treatment Interval 1||15||
48574237|NCT02147158|101735301|FG003|NOT COMPLETED|Off-Treatment Interval 1||15||
48574238|NCT02147158|101735302|FG004|NOT COMPLETED|Off-Treatment Interval 1||8||
48574239|NCT02147158|101735303|FG005|NOT COMPLETED|Off-Treatment Interval 1||5||
48574240|NCT02147158|101735298|FG000|STARTED|Treatment Course 2||41||
48574241|NCT02147158|101735299|FG001|STARTED|Treatment Course 2||34||
48574242|NCT02147158|101735300|FG002|STARTED|Treatment Course 2||84||
48574243|NCT02147158|101735301|FG003|STARTED|Treatment Course 2||82||
48284792|NCT03412747|101021565|FG000|COMPLETED|Maintenance Treatment Period: Wk16-Wk24||149||
48284793|NCT03412747|101021566|FG001|COMPLETED|Maintenance Treatment Period: Wk16-Wk24||152||
48284794|NCT03412747|101021567|FG002|COMPLETED|Maintenance Treatment Period: Wk16-Wk24||149||
48284795|NCT03412747|101021565|FG000|NOT COMPLETED|Maintenance Treatment Period: Wk16-Wk24||5||
48284796|NCT03412747|101021566|FG001|NOT COMPLETED|Maintenance Treatment Period: Wk16-Wk24||1||
48284797|NCT03412747|101021567|FG002|NOT COMPLETED|Maintenance Treatment Period: Wk16-Wk24||1||
48284798|NCT03412747|101021565|FG000|STARTED|Maintenance Treatment Period: Wk24-Wk56||149||
48284799|NCT03412747|101021566|FG001|STARTED|Maintenance Treatment Period: Wk24-Wk56||152||
48284800|NCT03412747|101021567|FG002|STARTED|Maintenance Treatment Period: Wk24-Wk56||149||
48284801|NCT03412747|101021565|FG000|COMPLETED|Maintenance Treatment Period: Wk24-Wk56||143||
48284802|NCT03412747|101021566|FG001|COMPLETED|Maintenance Treatment Period: Wk24-Wk56||143||
48284803|NCT03412747|101021567|FG002|COMPLETED|Maintenance Treatment Period: Wk24-Wk56||133||
48284804|NCT03412747|101021565|FG000|NOT COMPLETED|Maintenance Treatment Period: Wk24-Wk56||6||
48284805|NCT03412747|101021566|FG001|NOT COMPLETED|Maintenance Treatment Period: Wk24-Wk56||9||
48284806|NCT03412747|101021567|FG002|NOT COMPLETED|Maintenance Treatment Period: Wk24-Wk56||16||
48284807|NCT02734576|101021568|FG000|STARTED|Overall Study||10||
48284808|NCT02734576|101021568|FG000|COMPLETED|Overall Study||10||
48284809|NCT02734576|101021568|FG000|NOT COMPLETED|Overall Study||0||
48574244|NCT02147158|101735302|FG004|STARTED|Treatment Course 2||41||
48574245|NCT02147158|101735303|FG005|STARTED|Treatment Course 2||45||
48574246|NCT02147158|101735298|FG000|COMPLETED|Treatment Course 2||40||
48574247|NCT02147158|101735299|FG001|COMPLETED|Treatment Course 2||29||
48574248|NCT02147158|101735300|FG002|COMPLETED|Treatment Course 2||79||
48574249|NCT02147158|101735301|FG003|COMPLETED|Treatment Course 2||77||
48574250|NCT02147158|101735302|FG004|COMPLETED|Treatment Course 2||41||
48574251|NCT02147158|101735303|FG005|COMPLETED|Treatment Course 2||43||
48574252|NCT02147158|101735298|FG000|NOT COMPLETED|Treatment Course 2||1||
48574253|NCT02147158|101735299|FG001|NOT COMPLETED|Treatment Course 2||5||
48574254|NCT02147158|101735300|FG002|NOT COMPLETED|Treatment Course 2||5||
48574255|NCT02147158|101735301|FG003|NOT COMPLETED|Treatment Course 2||5||
48574256|NCT02147158|101735302|FG004|NOT COMPLETED|Treatment Course 2||0||
48574257|NCT02147158|101735303|FG005|NOT COMPLETED|Treatment Course 2||2||
48574258|NCT02147158|101735298|FG000|STARTED|Off-Treatment Interval 2||40||
48574259|NCT02147158|101735299|FG001|STARTED|Off-Treatment Interval 2||29||
48701660|NCT03199053|102057537|FG000|NOT COMPLETED|ST Period||5||
48701661|NCT03199053|102057538|FG001|NOT COMPLETED|ST Period||5||
48701662|NCT03199053|102057539|FG002|NOT COMPLETED|ST Period||8||
48701663|NCT03199053|102057537|FG000|STARTED|LT Period||76||
48701664|NCT03199053|102057538|FG001|STARTED|LT Period||83||
48701665|NCT03199053|102057539|FG002|STARTED|LT Period||68||
48701666|NCT03199053|102057537|FG000|Randomised Withdrawal Patients Data Set|LT Period||13||
48701667|NCT03199053|102057538|FG001|Randomised Withdrawal Patients Data Set|LT Period||25||
48701668|NCT03199053|102057539|FG002|Randomised Withdrawal Patients Data Set|LT Period||8||
48701669|NCT03199053|102057537|FG000|Excluded From Randomised Withdrawal Patients Data Set|LT Period||68||
48701670|NCT03199053|102057538|FG001|Excluded From Randomised Withdrawal Patients Data Set|LT Period||63||
48701671|NCT03199053|102057539|FG002|Excluded From Randomised Withdrawal Patients Data Set|LT Period||68||
48701672|NCT03199053|102057537|FG000|Randomised to Continue Metformin|LT Period||6|Pre-specified in the statistical analysis plan, only participants who continued or discontinued metformin after the third randomization were collected.|
48701673|NCT03199053|102057538|FG001|Randomised to Continue Metformin|LT Period||12|Pre-specified in the statistical analysis plan, only participants who continued or discontinued metformin after the third randomization were collected.|
48710732|NCT02699450|102077999|FG000|COMPLETED|Overall Study||75|Completed Study (per pre-specified criteria)|
48574260|NCT02147158|101735300|FG002|STARTED|Off-Treatment Interval 2||79||
48574261|NCT02147158|101735301|FG003|STARTED|Off-Treatment Interval 2||77||
48574262|NCT02147158|101735302|FG004|STARTED|Off-Treatment Interval 2||41||
48574263|NCT02147158|101735303|FG005|STARTED|Off-Treatment Interval 2||43||
48574264|NCT02147158|101735298|FG000|COMPLETED|Off-Treatment Interval 2||36||
48574265|NCT02147158|101735299|FG001|COMPLETED|Off-Treatment Interval 2||25||
48574266|NCT02147158|101735300|FG002|COMPLETED|Off-Treatment Interval 2||69||
48574267|NCT02147158|101735301|FG003|COMPLETED|Off-Treatment Interval 2||66||
48574268|NCT02147158|101735302|FG004|COMPLETED|Off-Treatment Interval 2||39||
48574269|NCT02147158|101735303|FG005|COMPLETED|Off-Treatment Interval 2||39||
48574270|NCT02147158|101735298|FG000|NOT COMPLETED|Off-Treatment Interval 2||4||
48574271|NCT02147158|101735299|FG001|NOT COMPLETED|Off-Treatment Interval 2||4||
48574272|NCT02147158|101735300|FG002|NOT COMPLETED|Off-Treatment Interval 2||10||
48574273|NCT02147158|101735301|FG003|NOT COMPLETED|Off-Treatment Interval 2||11||
48284810|NCT00979134|101021569|FG000|STARTED|Overall Study||43||
48284811|NCT00979134|101021570|FG001|STARTED|Overall Study||6||
48284812|NCT00979134|101021571|FG002|STARTED|Overall Study||45||
48284813|NCT00979134|101021569|FG000|COMPLETED|Overall Study||10||
48284814|NCT00979134|101021570|FG001|COMPLETED|Overall Study||0||
48284815|NCT00979134|101021571|FG002|COMPLETED|Overall Study||5||
48284816|NCT00979134|101021569|FG000|NOT COMPLETED|Overall Study||33||
48284817|NCT00979134|101021570|FG001|NOT COMPLETED|Overall Study||6||
48284818|NCT00979134|101021571|FG002|NOT COMPLETED|Overall Study||40||
48284819|NCT00735475|101021572|FG000|STARTED|Overall Study||631||
48284820|NCT00735475|101021573|FG001|STARTED|Overall Study||637||
48284821|NCT00735475|101021572|FG000|COMPLETED|Overall Study||623||
48284822|NCT00735475|101021573|FG001|COMPLETED|Overall Study||626||
48284823|NCT00735475|101021572|FG000|NOT COMPLETED|Overall Study||8||
48284824|NCT00735475|101021573|FG001|NOT COMPLETED|Overall Study||11||
48284825|NCT04075994|101021574|FG000|STARTED|Overall Study||123||
48284826|NCT04075994|101021575|FG001|STARTED|Overall Study||120||
48284827|NCT04075994|101021574|FG000|COMPLETED|Overall Study||110||
48284828|NCT04075994|101021575|FG001|COMPLETED|Overall Study||108||
48284829|NCT04075994|101021574|FG000|NOT COMPLETED|Overall Study||13||
48284830|NCT04075994|101021575|FG001|NOT COMPLETED|Overall Study||12||
48398834|NCT01068717|101306416|FG001|COMPLETED|Period 2: Treatment Schedule Phase 2||6||
48398835|NCT01068717|101306417|FG002|COMPLETED|Period 2: Treatment Schedule Phase 2||7||
48398836|NCT01068717|101306418|FG003|COMPLETED|Period 2: Treatment Schedule Phase 2||7||
48398837|NCT01068717|101306415|FG000|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0||
48398838|NCT01068717|101306416|FG001|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0||
48398839|NCT01068717|101306417|FG002|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0||
48398840|NCT01068717|101306418|FG003|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0||
48398841|NCT01068717|101306415|FG000|STARTED|Period 3: Treatment Schedule Phase 3||7||
48284831|NCT04725240|101021576|FG000|STARTED|Overall Study||18||
48284832|NCT04725240|101021576|FG000|COMPLETED|Overall Study||16||
48284833|NCT04725240|101021576|FG000|NOT COMPLETED|Overall Study||2||
48284834|NCT02083107|101021577|FG000|STARTED|Overall Study||212||
48284835|NCT02083107|101021578|FG001|STARTED|Overall Study||212||
48284836|NCT02083107|101021579|FG002|STARTED|Overall Study||212||
48284837|NCT02083107|101021577|FG000|COMPLETED|Overall Study||212||
48398842|NCT01068717|101306416|FG001|STARTED|Period 3: Treatment Schedule Phase 3||6||
48398843|NCT01068717|101306417|FG002|STARTED|Period 3: Treatment Schedule Phase 3||7||
48398844|NCT01068717|101306418|FG003|STARTED|Period 3: Treatment Schedule Phase 3||7||
48398845|NCT01068717|101306415|FG000|COMPLETED|Period 3: Treatment Schedule Phase 3||7||
48398846|NCT01068717|101306416|FG001|COMPLETED|Period 3: Treatment Schedule Phase 3||6||
48398847|NCT01068717|101306417|FG002|COMPLETED|Period 3: Treatment Schedule Phase 3||7||
48398848|NCT01068717|101306418|FG003|COMPLETED|Period 3: Treatment Schedule Phase 3||7||
48398849|NCT01068717|101306415|FG000|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0||
48398850|NCT01068717|101306416|FG001|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0||
48574274|NCT02147158|101735302|FG004|NOT COMPLETED|Off-Treatment Interval 2||2||
48574275|NCT02147158|101735303|FG005|NOT COMPLETED|Off-Treatment Interval 2||4||
48574276|NCT03656692|101735304|FG000|STARTED|Overall Study||5||
48574277|NCT03656692|101735304|FG000|COMPLETED|Overall Study||2||
48574278|NCT03656692|101735304|FG000|NOT COMPLETED|Overall Study||3||
48574279|NCT02964208|101735305|FG000|STARTED|Overall Study||520||
48574280|NCT02964208|101735305|FG000|COMPLETED|Overall Study||396||
48701674|NCT03199053|102057539|FG002|Randomised to Continue Metformin|LT Period||2|Pre-specified in the statistical analysis plan, only participants who continued or discontinued metformin after the third randomization were collected.|
48701675|NCT03199053|102057537|FG000|Randomised Metformin Withdrawal|LT Period||7|Pre-specified in the statistical analysis plan, only participants who continued or discontinued metformin after the third randomization were collected.|
48284838|NCT02083107|101021578|FG001|COMPLETED|Overall Study||212||
48284839|NCT02083107|101021579|FG002|COMPLETED|Overall Study||212||
48284840|NCT02083107|101021577|FG000|NOT COMPLETED|Overall Study||0||
48574281|NCT02964208|101735305|FG000|NOT COMPLETED|Overall Study||124||
48574282|NCT03426124|101735306|FG000|STARTED|Overall Study||991||
48574283|NCT03426124|101735307|FG001|STARTED|Overall Study||489||
48574284|NCT03426124|101735306|FG000|COMPLETED|Overall Study||941||
48574285|NCT03426124|101735307|FG001|COMPLETED|Overall Study||251||
48574286|NCT03426124|101735306|FG000|NOT COMPLETED|Overall Study||50||
48574287|NCT03426124|101735307|FG001|NOT COMPLETED|Overall Study||238||
48574288|NCT02209519|101735308|FG000|STARTED|Overall Study||107||
48574289|NCT02209519|101735309|FG001|STARTED|Overall Study||107||
48574290|NCT02209519|101735308|FG000|COMPLETED|Overall Study||107||
48574291|NCT02209519|101735309|FG001|COMPLETED|Overall Study||107||
48574292|NCT02209519|101735308|FG000|NOT COMPLETED|Overall Study||0||
48574293|NCT02209519|101735309|FG001|NOT COMPLETED|Overall Study||0||
48574294|NCT00430573|101735310|FG000|STARTED|Overall Study||10||
48574295|NCT00430573|101735310|FG000|COMPLETED|Overall Study||5||
48574296|NCT00430573|101735310|FG000|NOT COMPLETED|Overall Study||5||
48574297|NCT02861586|101735311|FG000|STARTED|Overall Study||51||
48574298|NCT02861586|101735312|FG001|STARTED|Overall Study||18||
48574299|NCT02861586|101735313|FG002|STARTED|Overall Study||47||
48574300|NCT02861586|101735314|FG003|STARTED|Overall Study||16||
48574301|NCT02861586|101735315|FG004|STARTED|Overall Study||47||
48574302|NCT02861586|101735316|FG005|STARTED|Overall Study||50||
48574303|NCT02861586|101735317|FG006|STARTED|Overall Study||18||
48574304|NCT02861586|101735318|FG007|STARTED|Overall Study||16||
48574305|NCT02861586|101735311|FG000|COMPLETED|Overall Study||47||
48574306|NCT02861586|101735312|FG001|COMPLETED|Overall Study||15||
48574307|NCT02861586|101735313|FG002|COMPLETED|Overall Study||46||
48574308|NCT02861586|101735314|FG003|COMPLETED|Overall Study||16||
48574309|NCT02861586|101735315|FG004|COMPLETED|Overall Study||47||
48574310|NCT02861586|101735316|FG005|COMPLETED|Overall Study||45||
48574311|NCT02861586|101735317|FG006|COMPLETED|Overall Study||17||
48574312|NCT02861586|101735318|FG007|COMPLETED|Overall Study||16||
48574313|NCT02861586|101735311|FG000|NOT COMPLETED|Overall Study||4||
48574314|NCT02861586|101735312|FG001|NOT COMPLETED|Overall Study||3||
48574315|NCT02861586|101735313|FG002|NOT COMPLETED|Overall Study||1||
48574316|NCT02861586|101735314|FG003|NOT COMPLETED|Overall Study||0||
48574317|NCT02861586|101735315|FG004|NOT COMPLETED|Overall Study||0||
48574318|NCT02861586|101735316|FG005|NOT COMPLETED|Overall Study||5||
48574319|NCT02861586|101735317|FG006|NOT COMPLETED|Overall Study||1||
48574320|NCT02861586|101735318|FG007|NOT COMPLETED|Overall Study||0||
48574321|NCT02201108|101735319|FG000|STARTED|Double-blind Period (up to Week 96)||57|Randomized and treated participants.|
48574322|NCT02201108|101735320|FG001|STARTED|Double-blind Period (up to Week 96)||109|Randomized and treated participants.|
48574323|NCT02201108|101735319|FG000|COMPLETED|Double-blind Period (up to Week 96)||53||
48574324|NCT02201108|101735320|FG001|COMPLETED|Double-blind Period (up to Week 96)||102||
48574325|NCT02201108|101735319|FG000|NOT COMPLETED|Double-blind Period (up to Week 96)||4||
48574326|NCT02201108|101735320|FG001|NOT COMPLETED|Double-blind Period (up to Week 96)||7||
48574327|NCT02201108|101735319|FG000|STARTED|Open Label Period (up to Week 192)||52|Post completion of DB treatment period, only eligible participants entered OL treatment period.|
48574328|NCT02201108|101735320|FG001|STARTED|Open Label Period (up to Week 192)||100|Post completion of DB treatment period, only eligible participants entered OL treatment period.|
48574329|NCT02201108|101735319|FG000|COMPLETED|Open Label Period (up to Week 192)||31||
48574330|NCT02201108|101735320|FG001|COMPLETED|Open Label Period (up to Week 192)||73||
48574331|NCT02201108|101735319|FG000|NOT COMPLETED|Open Label Period (up to Week 192)||21||
48574332|NCT02201108|101735320|FG001|NOT COMPLETED|Open Label Period (up to Week 192)||27||
48574333|NCT00135512|101735321|FG000|STARTED|Overall Study||234||
48574334|NCT00135512|101735321|FG000|COMPLETED|Overall Study||111||
48574335|NCT00135512|101735321|FG000|NOT COMPLETED|Overall Study||123||
48574336|NCT04478695|101735322|FG000|STARTED|Overall Study||1||
48574337|NCT04478695|101735323|FG001|STARTED|Overall Study||0||
48574338|NCT04478695|101735322|FG000|Received AMG 330|Overall Study||1||
48701676|NCT03199053|102057538|FG001|Randomised Metformin Withdrawal|LT Period||13|Pre-specified in the statistical analysis plan, only participants who continued or discontinued metformin after the third randomization were collected.|
48701677|NCT03199053|102057539|FG002|Randomised Metformin Withdrawal|LT Period||6|Pre-specified in the statistical analysis plan, only participants who continued or discontinued metformin after the third randomization were collected.|
48701678|NCT03199053|102057537|FG000|COMPLETED|LT Period||75||
48701679|NCT03199053|102057538|FG001|COMPLETED|LT Period||79||
48574339|NCT04478695|101735323|FG001|Received AMG 330|Overall Study||0||
48574340|NCT04478695|101735322|FG000|Received Pembrolizumab|Overall Study||0||
48574341|NCT04478695|101735323|FG001|Received Pembrolizumab|Overall Study||0||
48574342|NCT04478695|101735322|FG000|Received Dexamethasone|Overall Study||1||
48701680|NCT03199053|102057539|FG002|COMPLETED|LT Period||61||
48701681|NCT03199053|102057537|FG000|NOT COMPLETED|LT Period||1||
48701682|NCT03199053|102057538|FG001|NOT COMPLETED|LT Period||4||
48701683|NCT03199053|102057539|FG002|NOT COMPLETED|LT Period||7||
48701684|NCT03199053|102057537|FG000|STARTED|Non-treatment Follow-up Period||74||
48701685|NCT03199053|102057538|FG001|STARTED|Non-treatment Follow-up Period||77||
48701686|NCT03199053|102057539|FG002|STARTED|Non-treatment Follow-up Period||59||
48574343|NCT04478695|101735323|FG001|Received Dexamethasone|Overall Study||0||
48574344|NCT04478695|101735322|FG000|COMPLETED|Overall Study||0||
48574345|NCT04478695|101735323|FG001|COMPLETED|Overall Study||0||
48574346|NCT04478695|101735322|FG000|NOT COMPLETED|Overall Study||1||
48284841|NCT02083107|101021578|FG001|NOT COMPLETED|Overall Study||0||
48284842|NCT02083107|101021579|FG002|NOT COMPLETED|Overall Study||0||
48284843|NCT00905515|101021580|FG000|STARTED|Overall Study||21||
48284844|NCT00905515|101021581|FG001|STARTED|Overall Study||20||
48284845|NCT00905515|101021582|FG002|STARTED|Overall Study||22||
48284846|NCT00905515|101021580|FG000|COMPLETED|Overall Study||19||
48284847|NCT00905515|101021581|FG001|COMPLETED|Overall Study||20||
48284848|NCT00905515|101021582|FG002|COMPLETED|Overall Study||20||
48284849|NCT00905515|101021580|FG000|NOT COMPLETED|Overall Study||2||
48284850|NCT00905515|101021581|FG001|NOT COMPLETED|Overall Study||0||
48284851|NCT00905515|101021582|FG002|NOT COMPLETED|Overall Study||2||
48284852|NCT00923260|101021583|FG000|STARTED|Overall Study||12||
48398851|NCT01068717|101306417|FG002|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0||
48398852|NCT01068717|101306418|FG003|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0||
48398853|NCT01068717|101306415|FG000|STARTED|Period 4: Treatment Schedule Phase 4||7||
48130759|NCT05039268|100645719|FG000|STARTED|Overall Study||8||
48130760|NCT05039268|100645720|FG001|STARTED|Overall Study||8||
48130761|NCT05039268|100645719|FG000|COMPLETED|Overall Study||8||
48130762|NCT05039268|100645720|FG001|COMPLETED|Overall Study||8||
48130763|NCT05039268|100645719|FG000|NOT COMPLETED|Overall Study||0||
48130764|NCT05039268|100645720|FG001|NOT COMPLETED|Overall Study||0||
48130765|NCT01229228|100645721|FG000|STARTED|Overall Study||51||
48130766|NCT01229228|100645722|FG001|STARTED|Overall Study||51||
48130767|NCT01229228|100645723|FG002|STARTED|Overall Study||50||
48130768|NCT01229228|100645724|FG003|STARTED|Overall Study||51||
48130769|NCT01229228|100645725|FG004|STARTED|Overall Study||51||
48130770|NCT01229228|100645721|FG000|COMPLETED|Overall Study||50||
48130771|NCT01229228|100645722|FG001|COMPLETED|Overall Study||51||
48130772|NCT01229228|100645723|FG002|COMPLETED|Overall Study||49||
48130773|NCT01229228|100645724|FG003|COMPLETED|Overall Study||51||
48130774|NCT01229228|100645725|FG004|COMPLETED|Overall Study||50||
48130775|NCT01229228|100645721|FG000|NOT COMPLETED|Overall Study||1||
48130776|NCT01229228|100645722|FG001|NOT COMPLETED|Overall Study||0||
48130777|NCT01229228|100645723|FG002|NOT COMPLETED|Overall Study||1||
48130778|NCT01229228|100645724|FG003|NOT COMPLETED|Overall Study||0||
48130779|NCT01229228|100645725|FG004|NOT COMPLETED|Overall Study||1||
48130780|NCT02596451|100645726|FG000|STARTED|Overall Study||385||
48130781|NCT02596451|100645727|FG001|STARTED|Overall Study||392||
48130782|NCT02596451|100645728|FG002|STARTED|Overall Study||387||
48130783|NCT02596451|100645726|FG000|COMPLETED|Overall Study||381||
48130784|NCT02596451|100645727|FG001|COMPLETED|Overall Study||374||
48130785|NCT02596451|100645728|FG002|COMPLETED|Overall Study||373||
48130786|NCT02596451|100645726|FG000|NOT COMPLETED|Overall Study||4||
48130787|NCT02596451|100645727|FG001|NOT COMPLETED|Overall Study||18||
48130788|NCT02596451|100645728|FG002|NOT COMPLETED|Overall Study||14||
48130789|NCT01301963|100645729|FG000|STARTED|Overall Study||5||
48398854|NCT01068717|101306416|FG001|STARTED|Period 4: Treatment Schedule Phase 4||6||
48398855|NCT01068717|101306417|FG002|STARTED|Period 4: Treatment Schedule Phase 4||7||
48398856|NCT01068717|101306418|FG003|STARTED|Period 4: Treatment Schedule Phase 4||7||
48398857|NCT01068717|101306415|FG000|COMPLETED|Period 4: Treatment Schedule Phase 4||7||
48398858|NCT01068717|101306416|FG001|COMPLETED|Period 4: Treatment Schedule Phase 4||6||
48398859|NCT01068717|101306417|FG002|COMPLETED|Period 4: Treatment Schedule Phase 4||7||
48398860|NCT01068717|101306418|FG003|COMPLETED|Period 4: Treatment Schedule Phase 4||7||
48398861|NCT01068717|101306415|FG000|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0||
48398862|NCT01068717|101306416|FG001|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0||
48398863|NCT01068717|101306417|FG002|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0||
48398864|NCT01068717|101306418|FG003|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0||
48398865|NCT01807949|101306419|FG000|STARTED|Overall Study||187||
48398866|NCT01807949|101306420|FG001|STARTED|Overall Study||187||
48574347|NCT04478695|101735323|FG001|NOT COMPLETED|Overall Study||0||
48398867|NCT01807949|101306421|FG002|STARTED|Overall Study||189||
48130790|NCT01301963|100645730|FG001|STARTED|Overall Study||4||
48398868|NCT01807949|101306419|FG000|COMPLETED|Overall Study||185||
48398869|NCT01807949|101306420|FG001|COMPLETED|Overall Study||180||
48398870|NCT01807949|101306421|FG002|COMPLETED|Overall Study||180||
48398871|NCT01807949|101306419|FG000|NOT COMPLETED|Overall Study||2||
48398872|NCT01807949|101306420|FG001|NOT COMPLETED|Overall Study||7||
48398873|NCT01807949|101306421|FG002|NOT COMPLETED|Overall Study||9||
48130791|NCT01301963|100645729|FG000|COMPLETED|Overall Study||5||
48284853|NCT00923260|101021584|FG001|STARTED|Overall Study||12||
48284854|NCT00923260|101021583|FG000|COMPLETED|Overall Study||11||
48284855|NCT00923260|101021584|FG001|COMPLETED|Overall Study||11||
48398874|NCT01392742|101306422|FG000|STARTED|Overall Study||443||
48130792|NCT01301963|100645730|FG001|COMPLETED|Overall Study||4||
48130793|NCT01301963|100645729|FG000|NOT COMPLETED|Overall Study||0||
48130794|NCT01301963|100645730|FG001|NOT COMPLETED|Overall Study||0||
48130795|NCT00347308|100645731|FG000|STARTED|Overall Study||40||
48130796|NCT00347308|100645731|FG000|COMPLETED|Overall Study||40||
48130797|NCT00347308|100645731|FG000|NOT COMPLETED|Overall Study||0||
48130798|NCT02663817|100645732|FG000|STARTED|Overall Study||52||
48284856|NCT00923260|101021583|FG000|NOT COMPLETED|Overall Study||1||
48284857|NCT00923260|101021584|FG001|NOT COMPLETED|Overall Study||1||
48574348|NCT00245128|101735324|FG000|STARTED|Overall Study||10||
48574349|NCT00245128|101735324|FG000|COMPLETED|Overall Study||0||
48574350|NCT00245128|101735324|FG000|NOT COMPLETED|Overall Study||10||
48574351|NCT00729612|101735325|FG000|STARTED|Overall Study||63||
48574352|NCT00729612|101735325|FG000|Died Before Cycle 1|Overall Study||1||
48574353|NCT00729612|101735325|FG000|Received Cycle 1|Overall Study||62||
48574354|NCT00729612|101735325|FG000|Did Not Receive Cycle 2|Overall Study||7||
48574355|NCT00729612|101735325|FG000|Received Cycle 2|Overall Study||54||
48701687|NCT03199053|102057537|FG000|COMPLETED|Non-treatment Follow-up Period||67||
48130799|NCT02663817|100645732|FG000|COMPLETED|Overall Study||50||
48130800|NCT02663817|100645732|FG000|NOT COMPLETED|Overall Study||2||
48130801|NCT02338362|100645733|FG000|STARTED|Overall Study||11||
48130802|NCT02338362|100645734|FG001|STARTED|Overall Study||11||
48130803|NCT02338362|100645733|FG000|COMPLETED|Overall Study||10||
48130804|NCT02338362|100645734|FG001|COMPLETED|Overall Study||10||
48130805|NCT02338362|100645733|FG000|NOT COMPLETED|Overall Study||1||
48130806|NCT02338362|100645734|FG001|NOT COMPLETED|Overall Study||1||
48130807|NCT02873923|100645735|FG000|STARTED|Overall Study||2846||
48130808|NCT02873923|100645735|FG000|COMPLETED|Overall Study||2846||
48130809|NCT02873923|100645735|FG000|NOT COMPLETED|Overall Study||0||
48130810|NCT02692248|100645736|FG000|STARTED|Overall Study||64||
48130811|NCT02692248|100645736|FG000|COMPLETED|Overall Study||64||
48130812|NCT02692248|100645736|FG000|NOT COMPLETED|Overall Study||0||
48130813|NCT01591746|100645737|FG000|STARTED|Overall Study||68||
48130814|NCT01591746|100645738|FG001|STARTED|Overall Study||63||
48130815|NCT01591746|100645737|FG000|COMPLETED|Overall Study||68||
48130816|NCT01591746|100645738|FG001|COMPLETED|Overall Study||63||
48130817|NCT01591746|100645737|FG000|NOT COMPLETED|Overall Study||0||
48130818|NCT01591746|100645738|FG001|NOT COMPLETED|Overall Study||0||
48130819|NCT01573702|100645739|FG000|STARTED|Overall Study||25||
48130820|NCT01573702|100645739|FG000|COMPLETED|Overall Study||25||
48130821|NCT01573702|100645739|FG000|NOT COMPLETED|Overall Study||0||
48130822|NCT01319318|100645740|FG000|STARTED|Overall Study||25||
48130823|NCT01319318|100645740|FG000|COMPLETED|Overall Study||25||
48130824|NCT01319318|100645740|FG000|NOT COMPLETED|Overall Study||0||
48130825|NCT00618657|100645741|FG000|STARTED|Overall Study||42||
48130826|NCT00618657|100645742|FG001|STARTED|Overall Study||85||
48130827|NCT00618657|100645741|FG000|COMPLETED|Overall Study||42||
48130828|NCT00618657|100645742|FG001|COMPLETED|Overall Study||85||
48130829|NCT00618657|100645741|FG000|NOT COMPLETED|Overall Study||0||
48130830|NCT00618657|100645742|FG001|NOT COMPLETED|Overall Study||0||
48130831|NCT04495712|100645743|FG000|STARTED|Overall Study||44||
48130832|NCT04495712|100645744|FG001|STARTED|Overall Study||46||
48130833|NCT04495712|100645743|FG000|COMPLETED|Overall Study||44||
48130834|NCT04495712|100645744|FG001|COMPLETED|Overall Study||46||
48284858|NCT01844687|101021585|FG000|STARTED|Visit 1||50||
48284859|NCT01844687|101021585|FG000|COMPLETED|Visit 1||42||
48284860|NCT01844687|101021585|FG000|NOT COMPLETED|Visit 1||8||
48284861|NCT01844687|101021585|FG000|STARTED|Visit 2||42||
48284862|NCT01844687|101021585|FG000|COMPLETED|Visit 2||40||
48284863|NCT01844687|101021585|FG000|NOT COMPLETED|Visit 2||2||
48284864|NCT01844687|101021585|FG000|STARTED|Visit 3||40||
48284865|NCT01844687|101021585|FG000|COMPLETED|Visit 3||35||
48284866|NCT01844687|101021585|FG000|NOT COMPLETED|Visit 3||5||
48284867|NCT01844687|101021585|FG000|STARTED|Visit 4||35||
48284868|NCT01844687|101021585|FG000|COMPLETED|Visit 4||31||
48284869|NCT01844687|101021585|FG000|NOT COMPLETED|Visit 4||4||
48284870|NCT01844687|101021585|FG000|STARTED|Visit 5||31||
48284871|NCT01844687|101021585|FG000|COMPLETED|Visit 5||31||
48284872|NCT01844687|101021585|FG000|NOT COMPLETED|Visit 5||0||
48284873|NCT01844687|101021585|FG000|STARTED|Visit 6||31||
48284874|NCT01844687|101021585|FG000|COMPLETED|Visit 6||31||
48284875|NCT01844687|101021585|FG000|NOT COMPLETED|Visit 6||0||
48574356|NCT00729612|101735325|FG000|Died After Cycle 2 Before Response Eval|Overall Study||1||
48574357|NCT00729612|101735325|FG000|COMPLETED|Overall Study||53||
48574358|NCT00729612|101735325|FG000|NOT COMPLETED|Overall Study||10||
48574359|NCT03158038|101735326|FG000|STARTED|Overall Study||240||
48574360|NCT03158038|101735327|FG001|STARTED|Overall Study||60||
48701688|NCT03199053|102057538|FG001|COMPLETED|Non-treatment Follow-up Period||68||
48130835|NCT04495712|100645743|FG000|NOT COMPLETED|Overall Study||0||
48130836|NCT04495712|100645744|FG001|NOT COMPLETED|Overall Study||0||
48130837|NCT02669329|100645745|FG000|STARTED|Overall Study||30||60
48130838|NCT02669329|100645745|FG000|COMPLETED|Overall Study||30||60
48130839|NCT02669329|100645745|FG000|NOT COMPLETED|Overall Study||0||0
48130840|NCT04256733|100645746|FG000|STARTED|Overall Study||11||
48130841|NCT04256733|100645747|FG001|STARTED|Overall Study||8||
48130842|NCT04256733|100645746|FG000|COMPLETED|Overall Study||8||
48130843|NCT04256733|100645747|FG001|COMPLETED|Overall Study||6||
48130844|NCT04256733|100645746|FG000|NOT COMPLETED|Overall Study||3||
48130845|NCT04256733|100645747|FG001|NOT COMPLETED|Overall Study||2||
48130846|NCT01233817|100645748|FG000|STARTED|Overall Study||12||
48130847|NCT01233817|100645748|FG000|COMPLETED|Overall Study||9||
48284876|NCT01844687|101021585|FG000|STARTED|Visit 7||31||
48284877|NCT01844687|101021585|FG000|COMPLETED|Visit 7||31||
48284878|NCT01844687|101021585|FG000|NOT COMPLETED|Visit 7||0||
48284879|NCT01844687|101021585|FG000|STARTED|Visit 8||31||
48284880|NCT01844687|101021585|FG000|COMPLETED|Visit 8||31||
48701689|NCT03199053|102057539|FG002|COMPLETED|Non-treatment Follow-up Period||52||
48701690|NCT03199053|102057537|FG000|NOT COMPLETED|Non-treatment Follow-up Period||7||
48130848|NCT01233817|100645748|FG000|NOT COMPLETED|Overall Study||3||
48130849|NCT03268811|100645749|FG000|STARTED|Overall Study||7||
48130850|NCT03268811|100645750|FG001|STARTED|Overall Study||2||
48130851|NCT03268811|100645749|FG000|COMPLETED|Overall Study||7||
48130852|NCT03268811|100645750|FG001|COMPLETED|Overall Study||1||
48130853|NCT03268811|100645749|FG000|NOT COMPLETED|Overall Study||0||
48130854|NCT03268811|100645750|FG001|NOT COMPLETED|Overall Study||1||
48130855|NCT03373591|100645751|FG000|STARTED|Overall Study||75||
48398875|NCT01392742|101306422|FG000|COMPLETED|Overall Study||242||
48398876|NCT01392742|101306422|FG000|NOT COMPLETED|Overall Study||201||
48398877|NCT01421069|101306423|FG000|STARTED|Parent Study||127||
48398878|NCT01421069|101306423|FG000|COMPLETED|Parent Study||119||
48398879|NCT01421069|101306423|FG000|NOT COMPLETED|Parent Study||8||
48701691|NCT03199053|102057538|FG001|NOT COMPLETED|Non-treatment Follow-up Period||9||
48701692|NCT03199053|102057539|FG002|NOT COMPLETED|Non-treatment Follow-up Period||7||
48701693|NCT03352557|102057540|FG000|STARTED|PC Period: Day 1 to Week 78||214||
48701694|NCT03352557|102057541|FG001|STARTED|PC Period: Day 1 to Week 78||58||
48701695|NCT03352557|102057542|FG002|STARTED|PC Period: Day 1 to Week 78||58||
48701696|NCT03352557|102057543|FG003|STARTED|PC Period: Day 1 to Week 78||106||
48701697|NCT03352557|102057544|FG004|STARTED|PC Period: Day 1 to Week 78||218||
48701698|NCT03352557|102057545|FG005|STARTED|PC Period: Day 1 to Week 78||0||
48701699|NCT03352557|102057546|FG006|STARTED|PC Period: Day 1 to Week 78||0||
48701700|NCT03352557|102057547|FG007|STARTED|PC Period: Day 1 to Week 78||0||
48701701|NCT03352557|102057548|FG008|STARTED|PC Period: Day 1 to Week 78||0||
48701702|NCT03352557|102057549|FG009|STARTED|PC Period: Day 1 to Week 78||0||
48701703|NCT03352557|102057540|FG000|Safety Analysis Set|PC Period: Day 1 to Week 78||214|Safety Analysis Set = Dosed Participants|
48701704|NCT03352557|102057541|FG001|Safety Analysis Set|PC Period: Day 1 to Week 78||58|Safety Analysis Set = Dosed Participants|
48398880|NCT01421069|101306423|FG000|STARTED|Overall Period for Extension Study||109||
48398881|NCT01421069|101306423|FG000|Enrolled Into Active Treatment Period|Overall Period for Extension Study||99||
48398882|NCT01421069|101306423|FG000|Enrolled Into Observational Period|Overall Period for Extension Study||10||
48398883|NCT01421069|101306423|FG000|COMPLETED|Overall Period for Extension Study||84||
48398884|NCT01421069|101306423|FG000|NOT COMPLETED|Overall Period for Extension Study||25||
48398885|NCT01421069|101306423|FG000|STARTED|Active Treatment Period||99||
48398886|NCT01421069|101306423|FG000|ERA|Active Treatment Period||31||
48398887|NCT01421069|101306423|FG000|PsA|Active Treatment Period||23||
48398888|NCT01421069|101306423|FG000|COMPLETED|Active Treatment Period||27||
48398889|NCT01421069|101306423|FG000|NOT COMPLETED|Active Treatment Period||72||
48398890|NCT01421069|101306423|FG000|STARTED|2a. Withdrawal Period||30||
48398891|NCT01421069|101306423|FG000|ERA|2a. Withdrawal Period||9||
48398892|NCT01421069|101306423|FG000|PsA|2a. Withdrawal Period||5||
48398893|NCT01421069|101306423|FG000|COMPLETED|2a. Withdrawal Period||7||
48398894|NCT01421069|101306423|FG000|NOT COMPLETED|2a. Withdrawal Period||23||
48398895|NCT01421069|101306423|FG000|STARTED|2b. Retreatment Period||13||
48398896|NCT01421069|101306423|FG000|ERA|2b. Retreatment Period||2||
48398897|NCT01421069|101306423|FG000|PsA|2b. Retreatment Period||3||
48398898|NCT01421069|101306423|FG000|COMPLETED|2b. Retreatment Period||5||
48398899|NCT01421069|101306423|FG000|NOT COMPLETED|2b. Retreatment Period||8||
48701705|NCT03352557|102057542|FG002|Safety Analysis Set|PC Period: Day 1 to Week 78||58|Safety Analysis Set = Dosed Participants|
48701706|NCT03352557|102057543|FG003|Safety Analysis Set|PC Period: Day 1 to Week 78||106|Safety Analysis Set = Dosed Participants|
48701707|NCT03352557|102057544|FG004|Safety Analysis Set|PC Period: Day 1 to Week 78||214|Safety Analysis Set = Dosed Participants|
48701708|NCT03352557|102057545|FG005|Safety Analysis Set|PC Period: Day 1 to Week 78||0|Safety Analysis Set = Dosed Participants|
48701709|NCT03352557|102057546|FG006|Safety Analysis Set|PC Period: Day 1 to Week 78||0|Safety Analysis Set = Dosed Participants|
48701710|NCT03352557|102057547|FG007|Safety Analysis Set|PC Period: Day 1 to Week 78||0|Safety Analysis Set = Dosed Participants|
48701711|NCT03352557|102057548|FG008|Safety Analysis Set|PC Period: Day 1 to Week 78||0|Safety Analysis Set = Dosed Participants|
48701712|NCT03352557|102057549|FG009|Safety Analysis Set|PC Period: Day 1 to Week 78||0|Safety Analysis Set = Dosed Participants|
48701713|NCT03352557|102057540|FG000|Full Analysis Set (FAS)|PC Period: Day 1 to Week 78||214||
48701714|NCT03352557|102057541|FG001|Full Analysis Set (FAS)|PC Period: Day 1 to Week 78||58||
48398900|NCT01421069|101306423|FG000|STARTED|Observational Period||53||
48701715|NCT03352557|102057542|FG002|Full Analysis Set (FAS)|PC Period: Day 1 to Week 78||58||
48701716|NCT03352557|102057543|FG003|Full Analysis Set (FAS)|PC Period: Day 1 to Week 78||106||
48701717|NCT03352557|102057544|FG004|Full Analysis Set (FAS)|PC Period: Day 1 to Week 78||214||
48701718|NCT03352557|102057545|FG005|Full Analysis Set (FAS)|PC Period: Day 1 to Week 78||0||
48701719|NCT03352557|102057546|FG006|Full Analysis Set (FAS)|PC Period: Day 1 to Week 78||0||
48701720|NCT03352557|102057547|FG007|Full Analysis Set (FAS)|PC Period: Day 1 to Week 78||0||
48130856|NCT03373591|100645752|FG001|STARTED|Overall Study||71||
48398901|NCT01421069|101306423|FG000|COMPLETED|Observational Period||45||
48284881|NCT01844687|101021585|FG000|NOT COMPLETED|Visit 8||0||
48398902|NCT01421069|101306423|FG000|NOT COMPLETED|Observational Period||8||
48398903|NCT00260195|101306424|FG000|STARTED|Overall Study||39||
48398904|NCT00260195|101306425|FG001|STARTED|Overall Study||37||
48284882|NCT01827475|101021586|FG000|STARTED|Overall Study||30||
48284883|NCT01827475|101021587|FG001|STARTED|Overall Study||30||
48284884|NCT01827475|101021588|FG002|STARTED|Overall Study||30||
48284885|NCT01827475|101021586|FG000|COMPLETED|Overall Study||30||
48284886|NCT01827475|101021587|FG001|COMPLETED|Overall Study||30||
48284887|NCT01827475|101021588|FG002|COMPLETED|Overall Study||30||
48701721|NCT03352557|102057548|FG008|Full Analysis Set (FAS)|PC Period: Day 1 to Week 78||0||
48701722|NCT03352557|102057549|FG009|Full Analysis Set (FAS)|PC Period: Day 1 to Week 78||0||
48701723|NCT03352557|102057540|FG000|Antidrug Antibody (ADA) Evaluable Set|PC Period: Day 1 to Week 78||211||
48701724|NCT03352557|102057541|FG001|Antidrug Antibody (ADA) Evaluable Set|PC Period: Day 1 to Week 78||57||
48701725|NCT03352557|102057542|FG002|Antidrug Antibody (ADA) Evaluable Set|PC Period: Day 1 to Week 78||57||
48701726|NCT03352557|102057543|FG003|Antidrug Antibody (ADA) Evaluable Set|PC Period: Day 1 to Week 78||105||
48701727|NCT03352557|102057544|FG004|Antidrug Antibody (ADA) Evaluable Set|PC Period: Day 1 to Week 78||212||
48701728|NCT03352557|102057545|FG005|Antidrug Antibody (ADA) Evaluable Set|PC Period: Day 1 to Week 78||0||
48701729|NCT03352557|102057546|FG006|Antidrug Antibody (ADA) Evaluable Set|PC Period: Day 1 to Week 78||0||
48701730|NCT03352557|102057547|FG007|Antidrug Antibody (ADA) Evaluable Set|PC Period: Day 1 to Week 78||0||
48701731|NCT03352557|102057548|FG008|Antidrug Antibody (ADA) Evaluable Set|PC Period: Day 1 to Week 78||0||
48284888|NCT01827475|101021586|FG000|NOT COMPLETED|Overall Study||0||
48701732|NCT03352557|102057549|FG009|Antidrug Antibody (ADA) Evaluable Set|PC Period: Day 1 to Week 78||0||
48701733|NCT03352557|102057540|FG000|COMPLETED|PC Period: Day 1 to Week 78||172||
48701734|NCT03352557|102057541|FG001|COMPLETED|PC Period: Day 1 to Week 78||48||
48701735|NCT03352557|102057542|FG002|COMPLETED|PC Period: Day 1 to Week 78||50||
48701736|NCT03352557|102057543|FG003|COMPLETED|PC Period: Day 1 to Week 78||91||
48701737|NCT03352557|102057544|FG004|COMPLETED|PC Period: Day 1 to Week 78||175||
48284889|NCT01827475|101021587|FG001|NOT COMPLETED|Overall Study||0||
48284890|NCT01827475|101021588|FG002|NOT COMPLETED|Overall Study||0||
48284891|NCT01004848|101021589|FG000|STARTED|Overall Study||210||
48284892|NCT01004848|101021590|FG001|STARTED|Overall Study||192||
48284893|NCT01004848|101021589|FG000|COMPLETED|Overall Study||155||
48284894|NCT01004848|101021590|FG001|COMPLETED|Overall Study||147||
48284895|NCT01004848|101021589|FG000|NOT COMPLETED|Overall Study||55||
48284896|NCT01004848|101021590|FG001|NOT COMPLETED|Overall Study||45||
48284897|NCT02295553|101021591|FG000|STARTED|Overall Study||14||
48284898|NCT02295553|101021592|FG001|STARTED|Overall Study||14||
48284899|NCT02295553|101021593|FG002|STARTED|Overall Study||14||
48284900|NCT02295553|101021594|FG003|STARTED|Overall Study||14||
48284901|NCT02295553|101021591|FG000|COMPLETED|Overall Study||14||
48284902|NCT02295553|101021592|FG001|COMPLETED|Overall Study||14||
48284903|NCT02295553|101021593|FG002|COMPLETED|Overall Study||13||
48284904|NCT02295553|101021594|FG003|COMPLETED|Overall Study||13||
48284905|NCT02295553|101021591|FG000|NOT COMPLETED|Overall Study||0||
48398905|NCT00260195|101306424|FG000|COMPLETED|Overall Study||39||
48284906|NCT02295553|101021592|FG001|NOT COMPLETED|Overall Study||0||
48284907|NCT02295553|101021593|FG002|NOT COMPLETED|Overall Study||1||
48284908|NCT02295553|101021594|FG003|NOT COMPLETED|Overall Study||1||
48284909|NCT01281969|101021595|FG000|STARTED|Overall Study||18||
48398906|NCT00260195|101306425|FG001|COMPLETED|Overall Study||37||
48130857|NCT03373591|100645753|FG002|STARTED|Overall Study||73||
48130858|NCT03373591|100645751|FG000|COMPLETED|Overall Study||75||
48130859|NCT03373591|100645752|FG001|COMPLETED|Overall Study||71||
48130860|NCT03373591|100645753|FG002|COMPLETED|Overall Study||73||
48130861|NCT03373591|100645751|FG000|NOT COMPLETED|Overall Study||0||
48574361|NCT03158038|101735326|FG000|COMPLETED|Overall Study||240||
48574362|NCT03158038|101735327|FG001|COMPLETED|Overall Study||60||
48574363|NCT03158038|101735326|FG000|NOT COMPLETED|Overall Study||0||
48574364|NCT03158038|101735327|FG001|NOT COMPLETED|Overall Study||0||
48574365|NCT00078767|101735328|FG000|STARTED|Overall Study||12||
48574366|NCT00078767|101735329|FG001|STARTED|Overall Study||12||
48574367|NCT00078767|101735328|FG000|COMPLETED|Overall Study||11||
48574368|NCT00078767|101735329|FG001|COMPLETED|Overall Study||11||
48574369|NCT00078767|101735328|FG000|NOT COMPLETED|Overall Study||1||
48574370|NCT00078767|101735329|FG001|NOT COMPLETED|Overall Study||1||
48574371|NCT01516008|101735330|FG000|STARTED|Overall Study||114||
48574372|NCT01516008|101735331|FG001|STARTED|Overall Study||121||
48574373|NCT01516008|101735332|FG002|STARTED|Overall Study||117||
48574374|NCT01516008|101735330|FG000|COMPLETED|Overall Study||69||
48574375|NCT01516008|101735331|FG001|COMPLETED|Overall Study||105||
48574376|NCT01516008|101735332|FG002|COMPLETED|Overall Study||99||
48574377|NCT01516008|101735330|FG000|NOT COMPLETED|Overall Study||45||
48574378|NCT01516008|101735331|FG001|NOT COMPLETED|Overall Study||16||
48574379|NCT01516008|101735332|FG002|NOT COMPLETED|Overall Study||18||
48574380|NCT00485732|101738318|FG000|STARTED|Overall Study||149||
48574381|NCT00485732|101738319|FG001|STARTED|Overall Study||76||
48574382|NCT00485732|101738318|FG000|COMPLETED|Overall Study||141||
48574383|NCT00485732|101738319|FG001|COMPLETED|Overall Study||67||
48574384|NCT00485732|101738318|FG000|NOT COMPLETED|Overall Study||8||
48574385|NCT00485732|101738319|FG001|NOT COMPLETED|Overall Study||9||
48701738|NCT03352557|102057545|FG005|COMPLETED|PC Period: Day 1 to Week 78||0||
48701739|NCT03352557|102057546|FG006|COMPLETED|PC Period: Day 1 to Week 78||0||
48701740|NCT03352557|102057547|FG007|COMPLETED|PC Period: Day 1 to Week 78||0||
48701741|NCT03352557|102057548|FG008|COMPLETED|PC Period: Day 1 to Week 78||0||
48701742|NCT03352557|102057549|FG009|COMPLETED|PC Period: Day 1 to Week 78||0||
48701743|NCT03352557|102057540|FG000|NOT COMPLETED|PC Period: Day 1 to Week 78||42||
48701744|NCT03352557|102057541|FG001|NOT COMPLETED|PC Period: Day 1 to Week 78||10||
48701745|NCT03352557|102057542|FG002|NOT COMPLETED|PC Period: Day 1 to Week 78||8||
48701746|NCT03352557|102057543|FG003|NOT COMPLETED|PC Period: Day 1 to Week 78||15||
48701747|NCT03352557|102057544|FG004|NOT COMPLETED|PC Period: Day 1 to Week 78||43||
48701748|NCT03352557|102057545|FG005|NOT COMPLETED|PC Period: Day 1 to Week 78||0||
48701749|NCT03352557|102057546|FG006|NOT COMPLETED|PC Period: Day 1 to Week 78||0||
48701750|NCT03352557|102057547|FG007|NOT COMPLETED|PC Period: Day 1 to Week 78||0||
48701751|NCT03352557|102057548|FG008|NOT COMPLETED|PC Period: Day 1 to Week 78||0||
48130862|NCT03373591|100645752|FG001|NOT COMPLETED|Overall Study||0||
48130863|NCT03373591|100645753|FG002|NOT COMPLETED|Overall Study||0||
48130864|NCT01863017|100645754|FG000|STARTED|Overall Study||12||
48130865|NCT01863017|100645755|FG001|STARTED|Overall Study||19||
48574386|NCT00687271|101738320|FG000|STARTED|Overall Study||94||
48574387|NCT00687271|101738321|FG001|STARTED|Overall Study||96||
48574388|NCT00687271|101738322|FG002|STARTED|Overall Study||96||
48701752|NCT03352557|102057549|FG009|NOT COMPLETED|PC Period: Day 1 to Week 78||0||
48701753|NCT03352557|102057540|FG000|STARTED|LTE Period: Week 80 to Week 173||0||
48701754|NCT03352557|102057541|FG001|STARTED|LTE Period: Week 80 to Week 173||0||
48701755|NCT03352557|102057542|FG002|STARTED|LTE Period: Week 80 to Week 173||0||
48701756|NCT03352557|102057543|FG003|STARTED|LTE Period: Week 80 to Week 173||0||
48701757|NCT03352557|102057544|FG004|STARTED|LTE Period: Week 80 to Week 173||0||
48701758|NCT03352557|102057545|FG005|STARTED|LTE Period: Week 80 to Week 173||46||
48701759|NCT03352557|102057546|FG006|STARTED|LTE Period: Week 80 to Week 173||49||
48701760|NCT03352557|102057547|FG007|STARTED|LTE Period: Week 80 to Week 173||90||
48701761|NCT03352557|102057548|FG008|STARTED|LTE Period: Week 80 to Week 173||169||
48701762|NCT03352557|102057549|FG009|STARTED|LTE Period: Week 80 to Week 173||167||
48574389|NCT00687271|101738323|FG003|STARTED|Overall Study||48||
48701763|NCT03352557|102057540|FG000|Safety Analysis Set|LTE Period: Week 80 to Week 173||0|Safety Analysis Set = Dosed Participants|
48701764|NCT03352557|102057541|FG001|Safety Analysis Set|LTE Period: Week 80 to Week 173||0|Safety Analysis Set = Dosed Participants|
48701765|NCT03352557|102057542|FG002|Safety Analysis Set|LTE Period: Week 80 to Week 173||0|Safety Analysis Set = Dosed Participants|
48701766|NCT03352557|102057543|FG003|Safety Analysis Set|LTE Period: Week 80 to Week 173||0|Safety Analysis Set = Dosed Participants|
48701767|NCT03352557|102057544|FG004|Safety Analysis Set|LTE Period: Week 80 to Week 173||0|Safety Analysis Set = Dosed Participants|
48130866|NCT01863017|100645754|FG000|Normal Weight Participants|Overall Study||5||
48130867|NCT01863017|100645755|FG001|Normal Weight Participants|Overall Study||5||
48574390|NCT00687271|101738320|FG000|Treated|Overall Study||94||
48574391|NCT00687271|101738321|FG001|Treated|Overall Study||95||
48574392|NCT00687271|101738322|FG002|Treated|Overall Study||96||
48574393|NCT00687271|101738323|FG003|Treated|Overall Study||48||
48574394|NCT00687271|101738320|FG000|COMPLETED|Overall Study||91||
48574395|NCT00687271|101738321|FG001|COMPLETED|Overall Study||90||
48574396|NCT00687271|101738322|FG002|COMPLETED|Overall Study||91||
48574397|NCT00687271|101738323|FG003|COMPLETED|Overall Study||48||
48574398|NCT00687271|101738320|FG000|NOT COMPLETED|Overall Study||3||
48284910|NCT01281969|101021596|FG001|STARTED|Overall Study||18||
48284911|NCT01281969|101021597|FG002|STARTED|Overall Study||12||
48284912|NCT01281969|101021595|FG000|COMPLETED|Overall Study||17||
48284913|NCT01281969|101021596|FG001|COMPLETED|Overall Study||18||
48574399|NCT00687271|101738321|FG001|NOT COMPLETED|Overall Study||6||
48574400|NCT00687271|101738322|FG002|NOT COMPLETED|Overall Study||5||
48574401|NCT00687271|101738323|FG003|NOT COMPLETED|Overall Study||0||
48574402|NCT00688662|101738324|FG000|STARTED|Overall Study||141||
48574403|NCT00688662|101738325|FG001|STARTED|Overall Study||73||
48574404|NCT00688662|101738324|FG000|COMPLETED|Overall Study||118||
48574405|NCT00688662|101738325|FG001|COMPLETED|Overall Study||55||
48574406|NCT00688662|101738324|FG000|NOT COMPLETED|Overall Study||23||
48574407|NCT00688662|101738325|FG001|NOT COMPLETED|Overall Study||18||
48574408|NCT00389532|101738326|FG000|STARTED|Overall Study||60||
48574409|NCT00389532|101738327|FG001|STARTED|Overall Study||56||
48284914|NCT01281969|101021597|FG002|COMPLETED|Overall Study||0||
48574410|NCT00389532|101738326|FG000|COMPLETED|Overall Study||60||
48574411|NCT00389532|101738327|FG001|COMPLETED|Overall Study||56||
48574412|NCT00389532|101738326|FG000|NOT COMPLETED|Overall Study||0||
48284915|NCT01281969|101021595|FG000|NOT COMPLETED|Overall Study||1||
48284916|NCT01281969|101021596|FG001|NOT COMPLETED|Overall Study||0||
48284917|NCT01281969|101021597|FG002|NOT COMPLETED|Overall Study||12||
48284918|NCT02158052|101021598|FG000|STARTED|Overall Study||1||
48574413|NCT00389532|101738327|FG001|NOT COMPLETED|Overall Study||0||
48574414|NCT00461773|101738328|FG000|STARTED|Overall Study||3||
48574415|NCT00461773|101738329|FG001|STARTED|Overall Study||2||
48574416|NCT00461773|101738328|FG000|COMPLETED|Overall Study||3||
48398907|NCT00260195|101306424|FG000|NOT COMPLETED|Overall Study||0||
48398908|NCT00260195|101306425|FG001|NOT COMPLETED|Overall Study||0||
48398909|NCT00293241|101306426|FG000|STARTED|Overall Study||299||
48398910|NCT00293241|101306427|FG001|STARTED|Overall Study||306||
48398911|NCT00293241|101306426|FG000|COMPLETED|Overall Study||263||
48398912|NCT00293241|101306427|FG001|COMPLETED|Overall Study||265||
48398913|NCT00293241|101306426|FG000|NOT COMPLETED|Overall Study||36||
48398914|NCT00293241|101306427|FG001|NOT COMPLETED|Overall Study||41||
48398915|NCT04362813|101306428|FG000|STARTED|Overall Study||227|Ranomized participants|
48398916|NCT04362813|101306429|FG001|STARTED|Overall Study||227|Ranomized participants|
48398917|NCT04362813|101306428|FG000|Safety Set|Overall Study||225|The Safety Set included all participants who received at least one dose of double-blind treatment|
48398918|NCT04362813|101306429|FG001|Safety Set|Overall Study||223|The Safety Set included all participants who received at least one dose of double-blind treatment|
48398919|NCT04362813|101306428|FG000|Completed Day 29|Overall Study||211||
48398920|NCT04362813|101306429|FG001|Completed Day 29|Overall Study||206||
48398921|NCT04362813|101306428|FG000|COMPLETED|Overall Study||209||
48398922|NCT04362813|101306429|FG001|COMPLETED|Overall Study||202||
48398923|NCT04362813|101306428|FG000|NOT COMPLETED|Overall Study||18||
48398924|NCT04362813|101306429|FG001|NOT COMPLETED|Overall Study||25||
48398925|NCT00912340|101306430|FG000|STARTED|Overall Study||24||
48398926|NCT00912340|101306431|FG001|STARTED|Overall Study||30||
48398927|NCT00912340|101306432|FG002|STARTED|Overall Study||4||
48574417|NCT00461773|101738329|FG001|COMPLETED|Overall Study||2||
48574418|NCT00461773|101738328|FG000|NOT COMPLETED|Overall Study||0||
48398928|NCT00912340|101306430|FG000|COMPLETED|Overall Study||22||
48398929|NCT00912340|101306431|FG001|COMPLETED|Overall Study||26||
48398930|NCT00912340|101306432|FG002|COMPLETED|Overall Study||0||
48398931|NCT00912340|101306430|FG000|NOT COMPLETED|Overall Study||2||
48574419|NCT00461773|101738329|FG001|NOT COMPLETED|Overall Study||0||
48398932|NCT00912340|101306431|FG001|NOT COMPLETED|Overall Study||4||
48398933|NCT00912340|101306432|FG002|NOT COMPLETED|Overall Study||4||
48398934|NCT01906476|101306433|FG000|STARTED|Overall Study||157||
48398935|NCT01906476|101306434|FG001|STARTED|Overall Study||155||
48398936|NCT01906476|101306433|FG000|COMPLETED|Overall Study||140||
48398937|NCT01906476|101306434|FG001|COMPLETED|Overall Study||139||
48398938|NCT01906476|101306433|FG000|NOT COMPLETED|Overall Study||17||
48398939|NCT01906476|101306434|FG001|NOT COMPLETED|Overall Study||16||
48398940|NCT00109005|101306435|FG000|STARTED|Overall Study||8||
48398941|NCT00109005|101306436|FG001|STARTED|Overall Study||9||
48398942|NCT00109005|101306435|FG000|COMPLETED|Overall Study||8||
48398943|NCT00109005|101306436|FG001|COMPLETED|Overall Study||9||
48398944|NCT00109005|101306435|FG000|NOT COMPLETED|Overall Study||0||
48398945|NCT00109005|101306436|FG001|NOT COMPLETED|Overall Study||0||
48398946|NCT00813917|101306437|FG000|STARTED|Overall Study||38||
48398947|NCT00813917|101306438|FG001|STARTED|Overall Study||38||
48398948|NCT00813917|101306437|FG000|COMPLETED|Overall Study||32||
48398949|NCT00813917|101306438|FG001|COMPLETED|Overall Study||32||
48398950|NCT00813917|101306437|FG000|NOT COMPLETED|Overall Study||6||
48398951|NCT00813917|101306438|FG001|NOT COMPLETED|Overall Study||6||
48398952|NCT00732641|101306439|FG000|STARTED|Overall Study||123||
48398953|NCT00732641|101306440|FG001|STARTED|Overall Study||121||
48398954|NCT00732641|101306439|FG000|COMPLETED|Overall Study||17||
48398955|NCT00732641|101306440|FG001|COMPLETED|Overall Study||9||
48398956|NCT00732641|101306439|FG000|NOT COMPLETED|Overall Study||106||
48398957|NCT00732641|101306440|FG001|NOT COMPLETED|Overall Study||112||
48398958|NCT00953225|101306441|FG000|STARTED|Overall Study||46||
48398959|NCT00953225|101306442|FG001|STARTED|Overall Study||37||
48398960|NCT00953225|101306441|FG000|COMPLETED|Overall Study||44||
48398961|NCT00953225|101306442|FG001|COMPLETED|Overall Study||37||
48398962|NCT00953225|101306441|FG000|NOT COMPLETED|Overall Study||2||
48398963|NCT00953225|101306442|FG001|NOT COMPLETED|Overall Study||0||
48398964|NCT03693404|101306443|FG000|STARTED|Overall Study||109||
48398965|NCT03693404|101306444|FG001|STARTED|Overall Study||81||
48398966|NCT03693404|101306443|FG000|COMPLETED|Overall Study||108||
48398967|NCT03693404|101306444|FG001|COMPLETED|Overall Study||75||
48398968|NCT03693404|101306443|FG000|NOT COMPLETED|Overall Study||1||
48398969|NCT03693404|101306444|FG001|NOT COMPLETED|Overall Study||6||
48398970|NCT01072448|101306445|FG000|STARTED|Overall Study||163||
48398971|NCT01072448|101306446|FG001|STARTED|Overall Study||160||
48398972|NCT01072448|101306445|FG000|COMPLETED|Overall Study||144||
48398973|NCT01072448|101306446|FG001|COMPLETED|Overall Study||130||
48398974|NCT01072448|101306445|FG000|NOT COMPLETED|Overall Study||19||
48398975|NCT01072448|101306446|FG001|NOT COMPLETED|Overall Study||30||
48398976|NCT03536923|101306447|FG000|STARTED|Overall Study||23||
48398977|NCT03536923|101306447|FG000|COMPLETED|Overall Study||23||
48398978|NCT03536923|101306447|FG000|NOT COMPLETED|Overall Study||0||
48398979|NCT00660075|101306448|FG000|STARTED|First Intervention (Week 1 to Week 6)||18||
48398980|NCT00660075|101306449|FG001|STARTED|First Intervention (Week 1 to Week 6)||18||
48398981|NCT00660075|101306448|FG000|COMPLETED|First Intervention (Week 1 to Week 6)||18||
48398982|NCT00660075|101306449|FG001|COMPLETED|First Intervention (Week 1 to Week 6)||18||
48398983|NCT00660075|101306448|FG000|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0||
48398984|NCT00660075|101306449|FG001|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0||
48398985|NCT00660075|101306448|FG000|STARTED|Washout Period (Week 7 to Week 10)||18||
48398986|NCT00660075|101306449|FG001|STARTED|Washout Period (Week 7 to Week 10)||18||
48398987|NCT00660075|101306448|FG000|COMPLETED|Washout Period (Week 7 to Week 10)||18||
48398988|NCT00660075|101306449|FG001|COMPLETED|Washout Period (Week 7 to Week 10)||18||
48398989|NCT00660075|101306448|FG000|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0||
48398990|NCT00660075|101306449|FG001|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0||
48398991|NCT00660075|101306448|FG000|STARTED|Second Intervention (Week 11 to Week 16||18||
48398992|NCT00660075|101306449|FG001|STARTED|Second Intervention (Week 11 to Week 16||18||
48398993|NCT00660075|101306448|FG000|COMPLETED|Second Intervention (Week 11 to Week 16||18||
48398994|NCT00660075|101306449|FG001|COMPLETED|Second Intervention (Week 11 to Week 16||18||
48398995|NCT00660075|101306448|FG000|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0||
48398996|NCT00660075|101306449|FG001|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0||
48398997|NCT02254551|101306450|FG000|STARTED|Dose Escalation||7||
48398998|NCT02254551|101306450|FG000|Cohort 1: LDE225 400mg|Dose Escalation||7||
48398999|NCT02254551|101306450|FG000|Cohort 2: LDE225 600mg|Dose Escalation||0||
48399000|NCT02254551|101306450|FG000|Cohort 3: LDE225 800mg|Dose Escalation||0||
48399001|NCT02254551|101306450|FG000|COMPLETED|Dose Escalation||4||
48399002|NCT02254551|101306450|FG000|NOT COMPLETED|Dose Escalation||3||
48399003|NCT02254551|101306450|FG000|STARTED|Expansion||0||
48399004|NCT02254551|101306450|FG000|COMPLETED|Expansion||0||
48399005|NCT02254551|101306450|FG000|NOT COMPLETED|Expansion||0||
48399006|NCT02254551|101306450|FG000|STARTED|Maintenance||0||
48399007|NCT02254551|101306450|FG000|COMPLETED|Maintenance||0||
48399008|NCT02254551|101306450|FG000|NOT COMPLETED|Maintenance||0||
48399009|NCT00967226|101306451|FG000|STARTED|Overall Study||11||
48399010|NCT00967226|101306452|FG001|STARTED|Overall Study||8||
48399011|NCT00967226|101306451|FG000|COMPLETED|Overall Study||9||
48399012|NCT00967226|101306452|FG001|COMPLETED|Overall Study||2||
48399013|NCT00967226|101306451|FG000|NOT COMPLETED|Overall Study||2||
48399014|NCT00967226|101306452|FG001|NOT COMPLETED|Overall Study||6||
48399015|NCT02135900|101306453|FG000|STARTED|Overall Study||32||
48399016|NCT02135900|101306453|FG000|COMPLETED|Overall Study||32||
48574420|NCT03461952|101738330|FG000|STARTED|Overall Study||2||
48284919|NCT02158052|101021599|FG001|STARTED|Overall Study||1||
48284920|NCT02158052|101021598|FG000|COMPLETED|Overall Study||1||
48284921|NCT02158052|101021599|FG001|COMPLETED|Overall Study||1||
48284922|NCT02158052|101021598|FG000|NOT COMPLETED|Overall Study||0||
48284923|NCT02158052|101021599|FG001|NOT COMPLETED|Overall Study||0||
48284924|NCT00692276|101021600|FG000|STARTED|Randomized Population||190||
48284925|NCT00692276|101021601|FG001|STARTED|Randomized Population||201||
48284926|NCT00692276|101021600|FG000|COMPLETED|Randomized Population||190||
48284927|NCT00692276|101021601|FG001|COMPLETED|Randomized Population||201||
48284928|NCT00692276|101021600|FG000|NOT COMPLETED|Randomized Population||0||
48284929|NCT00692276|101021601|FG001|NOT COMPLETED|Randomized Population||0||
48284930|NCT00692276|101021600|FG000|STARTED|Completed 24 Months||190||
48284931|NCT00692276|101021601|FG001|STARTED|Completed 24 Months||201||
48284932|NCT00692276|101021600|FG000|COMPLETED|Completed 24 Months||183||
48284933|NCT00692276|101021601|FG001|COMPLETED|Completed 24 Months||187||
48284934|NCT00692276|101021600|FG000|NOT COMPLETED|Completed 24 Months||7||
48284935|NCT00692276|101021601|FG001|NOT COMPLETED|Completed 24 Months||14||
48284936|NCT00903006|101021602|FG000|STARTED|Overall Study||2||
48399017|NCT02135900|101306453|FG000|NOT COMPLETED|Overall Study||0||
48399018|NCT03215667|101306454|FG000|STARTED|Overall Study||9||
48399019|NCT03215667|101306454|FG000|COMPLETED|Overall Study||5||
48399020|NCT03215667|101306454|FG000|NOT COMPLETED|Overall Study||4||
48399021|NCT00763243|101306455|FG000|STARTED|Waiting Period||9||
48399022|NCT00763243|101306455|FG000|COMPLETED|Waiting Period||9||
48399023|NCT00763243|101306455|FG000|NOT COMPLETED|Waiting Period||0||
48399024|NCT00763243|101306455|FG000|STARTED|Training Period||9||
48399025|NCT00763243|101306455|FG000|COMPLETED|Training Period||9||
48399026|NCT00763243|101306455|FG000|NOT COMPLETED|Training Period||0||
48399027|NCT00763243|101306455|FG000|STARTED|1-Month Follow-Up Period||9||
48399028|NCT00763243|101306455|FG000|COMPLETED|1-Month Follow-Up Period||9||
48399029|NCT00763243|101306455|FG000|NOT COMPLETED|1-Month Follow-Up Period||0||
48574421|NCT03461952|101738331|FG001|STARTED|Overall Study||2||
48574422|NCT03461952|101738330|FG000|COMPLETED|Overall Study||2||
48574423|NCT03461952|101738331|FG001|COMPLETED|Overall Study||2||
48284937|NCT00903006|101021603|FG001|STARTED|Overall Study||3||
48284938|NCT00903006|101021604|FG002|STARTED|Overall Study||1||
48284939|NCT00903006|101021605|FG003|STARTED|Overall Study||0||
48284940|NCT00903006|101021602|FG000|COMPLETED|Overall Study||0||
48284941|NCT00903006|101021603|FG001|COMPLETED|Overall Study||0||
48284942|NCT00903006|101021604|FG002|COMPLETED|Overall Study||0||
48284943|NCT00903006|101021605|FG003|COMPLETED|Overall Study||0||
48284944|NCT00903006|101021602|FG000|NOT COMPLETED|Overall Study||2||
48284945|NCT00903006|101021603|FG001|NOT COMPLETED|Overall Study||3||
48284946|NCT00903006|101021604|FG002|NOT COMPLETED|Overall Study||1||
48284947|NCT00903006|101021605|FG003|NOT COMPLETED|Overall Study||0||
48284948|NCT00895154|101021606|FG000|STARTED|Overall Study||8||
48284949|NCT00895154|101021607|FG001|STARTED|Overall Study||10||
48284950|NCT00895154|101021606|FG000|Follow Up|Overall Study||7||
48284951|NCT00895154|101021607|FG001|Follow Up|Overall Study||8||
48284952|NCT00895154|101021606|FG000|COMPLETED|Overall Study||7||
48284953|NCT00895154|101021607|FG001|COMPLETED|Overall Study||8||
48284954|NCT00895154|101021606|FG000|NOT COMPLETED|Overall Study||1||
48284955|NCT00895154|101021607|FG001|NOT COMPLETED|Overall Study||2||
48284956|NCT02047903|101021608|FG000|STARTED|Overall Study||161||
48284957|NCT02047903|101021608|FG000|Treated|Overall Study||152||
48284958|NCT02047903|101021608|FG000|COMPLETED|Overall Study||102||
48284959|NCT02047903|101021608|FG000|NOT COMPLETED|Overall Study||59||
48284960|NCT03702231|101021609|FG000|STARTED|Overall Study||58||
48284961|NCT03702231|101021610|FG001|STARTED|Overall Study||30||
48284962|NCT03702231|101021611|FG002|STARTED|Overall Study||28||
48284963|NCT03702231|101021609|FG000|COMPLETED|Overall Study||56||
48399030|NCT00763243|101306455|FG000|STARTED|6-Month Follow-Up Period||9||
48399031|NCT00763243|101306455|FG000|COMPLETED|6-Month Follow-Up Period||9||
48399032|NCT00763243|101306455|FG000|NOT COMPLETED|6-Month Follow-Up Period||0||
48399033|NCT02023918|101306456|FG000|STARTED|Overall Study||6||
48399034|NCT02023918|101306456|FG000|COMPLETED|Overall Study||6||
48284964|NCT03702231|101021610|FG001|COMPLETED|Overall Study||26||
48284965|NCT03702231|101021611|FG002|COMPLETED|Overall Study||24||
48284966|NCT03702231|101021609|FG000|NOT COMPLETED|Overall Study||2||
48284967|NCT03702231|101021610|FG001|NOT COMPLETED|Overall Study||4||
48284968|NCT03702231|101021611|FG002|NOT COMPLETED|Overall Study||4||
48284969|NCT03527550|101021612|FG000|STARTED|Overall Study||24||
48284970|NCT03527550|101021613|FG001|STARTED|Overall Study||22||
48284971|NCT03527550|101021612|FG000|COMPLETED|Overall Study||15||
48284972|NCT03527550|101021613|FG001|COMPLETED|Overall Study||19||
48284973|NCT03527550|101021612|FG000|NOT COMPLETED|Overall Study||9||
48284974|NCT03527550|101021613|FG001|NOT COMPLETED|Overall Study||3||
48399035|NCT02023918|101306456|FG000|NOT COMPLETED|Overall Study||0||
48399036|NCT01200160|101306457|FG000|STARTED|Overall Study||128||
48399037|NCT01200160|101306457|FG000|COMPLETED|Overall Study||66||
48399038|NCT01200160|101306457|FG000|NOT COMPLETED|Overall Study||62||
48399039|NCT00537680|101306458|FG000|STARTED|Overall Study||22||
48399040|NCT00537680|101306459|FG001|STARTED|Overall Study||24||
48399041|NCT00537680|101306460|FG002|STARTED|Overall Study||24||
48399042|NCT00537680|101306458|FG000|COMPLETED|Overall Study||22||
48399043|NCT00537680|101306459|FG001|COMPLETED|Overall Study||22||
48399044|NCT00537680|101306460|FG002|COMPLETED|Overall Study||24||
48399045|NCT00537680|101306458|FG000|NOT COMPLETED|Overall Study||0||
48399046|NCT00537680|101306459|FG001|NOT COMPLETED|Overall Study||2||
48399047|NCT00537680|101306460|FG002|NOT COMPLETED|Overall Study||0||
48399048|NCT01432457|101306461|FG000|STARTED|Overall Study||306||
48399049|NCT01432457|101306462|FG001|STARTED|Overall Study||306||
48399050|NCT01432457|101306463|FG002|STARTED|Overall Study||312||
48399051|NCT01432457|101306461|FG000|COMPLETED|Overall Study||269||
48399052|NCT01432457|101306462|FG001|COMPLETED|Overall Study||258||
48399053|NCT01432457|101306463|FG002|COMPLETED|Overall Study||253||
48399054|NCT01432457|101306461|FG000|NOT COMPLETED|Overall Study||37||
48399055|NCT01432457|101306462|FG001|NOT COMPLETED|Overall Study||48||
48399056|NCT01432457|101306463|FG002|NOT COMPLETED|Overall Study||59||
48399057|NCT03446612|101306464|FG000|STARTED|Overall Study||2||
48399058|NCT03446612|101306465|FG001|STARTED|Overall Study||3||
48399059|NCT03446612|101306464|FG000|COMPLETED|Overall Study||2||
48399060|NCT03446612|101306465|FG001|COMPLETED|Overall Study||2||
48701768|NCT03352557|102057545|FG005|Safety Analysis Set|LTE Period: Week 80 to Week 173||45|Safety Analysis Set = Dosed Participants|
48701769|NCT03352557|102057546|FG006|Safety Analysis Set|LTE Period: Week 80 to Week 173||49|Safety Analysis Set = Dosed Participants|
48701770|NCT03352557|102057547|FG007|Safety Analysis Set|LTE Period: Week 80 to Week 173||89|Safety Analysis Set = Dosed Participants|
48701771|NCT03352557|102057548|FG008|Safety Analysis Set|LTE Period: Week 80 to Week 173||168|Safety Analysis Set = Dosed Participants|
48701772|NCT03352557|102057549|FG009|Safety Analysis Set|LTE Period: Week 80 to Week 173||165|Safety Analysis Set = Dosed Participants|
48701773|NCT03352557|102057540|FG000|COMPLETED|LTE Period: Week 80 to Week 173||0||
48701774|NCT03352557|102057541|FG001|COMPLETED|LTE Period: Week 80 to Week 173||0||
48701775|NCT03352557|102057542|FG002|COMPLETED|LTE Period: Week 80 to Week 173||0||
48701776|NCT03352557|102057543|FG003|COMPLETED|LTE Period: Week 80 to Week 173||0||
48701777|NCT03352557|102057544|FG004|COMPLETED|LTE Period: Week 80 to Week 173||0||
48701778|NCT03352557|102057545|FG005|COMPLETED|LTE Period: Week 80 to Week 173||0||
48701779|NCT03352557|102057546|FG006|COMPLETED|LTE Period: Week 80 to Week 173||0||
48701780|NCT03352557|102057547|FG007|COMPLETED|LTE Period: Week 80 to Week 173||0||
48701781|NCT03352557|102057548|FG008|COMPLETED|LTE Period: Week 80 to Week 173||0||
48701782|NCT03352557|102057549|FG009|COMPLETED|LTE Period: Week 80 to Week 173||0||
48701783|NCT03352557|102057540|FG000|NOT COMPLETED|LTE Period: Week 80 to Week 173||0||
48701784|NCT03352557|102057541|FG001|NOT COMPLETED|LTE Period: Week 80 to Week 173||0||
48701785|NCT03352557|102057542|FG002|NOT COMPLETED|LTE Period: Week 80 to Week 173||0||
48701786|NCT03352557|102057543|FG003|NOT COMPLETED|LTE Period: Week 80 to Week 173||0||
48710828|NCT03446053|102078030|FG000|Randomized Set|Overall Study||2||
48284975|NCT02632526|101021614|FG000|STARTED|Overall Study||36||
48284976|NCT02632526|101021615|FG001|STARTED|Overall Study||12||
48284977|NCT02632526|101021616|FG002|STARTED|Overall Study||24||
48284978|NCT02632526|101021617|FG003|STARTED|Overall Study||12||
48284979|NCT02632526|101021618|FG004|STARTED|Overall Study||4||
48284980|NCT02632526|101021619|FG005|STARTED|Overall Study||8||
48284981|NCT02632526|101021614|FG000|COMPLETED|Overall Study||36||
48284982|NCT02632526|101021615|FG001|COMPLETED|Overall Study||12||
48284983|NCT02632526|101021616|FG002|COMPLETED|Overall Study||24||
48284984|NCT02632526|101021617|FG003|COMPLETED|Overall Study||12||
48284985|NCT02632526|101021618|FG004|COMPLETED|Overall Study||4||
48284986|NCT02632526|101021619|FG005|COMPLETED|Overall Study||8||
48284987|NCT02632526|101021614|FG000|NOT COMPLETED|Overall Study||0||
48284988|NCT02632526|101021615|FG001|NOT COMPLETED|Overall Study||0||
48284989|NCT02632526|101021616|FG002|NOT COMPLETED|Overall Study||0||
48399061|NCT03446612|101306464|FG000|NOT COMPLETED|Overall Study||0||
48399062|NCT03446612|101306465|FG001|NOT COMPLETED|Overall Study||1||
48399063|NCT00677560|101306466|FG000|STARTED|Overall Study||20||
48399064|NCT00677560|101306467|FG001|STARTED|Overall Study||23||
48399065|NCT00677560|101306468|FG002|STARTED|Overall Study||29||
48130868|NCT01863017|100645754|FG000|Obese Participants|Overall Study||4||
48130869|NCT01863017|100645755|FG001|Obese Participants|Overall Study||7||
48130870|NCT01863017|100645754|FG000|Participants With PWS|Overall Study||3|Prader-Willi syndrome (PWS)|
48130871|NCT01863017|100645755|FG001|Participants With PWS|Overall Study||7|Prader-Willi syndrome (PWS)|
48130872|NCT01863017|100645754|FG000|COMPLETED|Overall Study||12||
48130873|NCT01863017|100645755|FG001|COMPLETED|Overall Study||19||
48130874|NCT01863017|100645754|FG000|NOT COMPLETED|Overall Study||0||
48130875|NCT01863017|100645755|FG001|NOT COMPLETED|Overall Study||0||
48130876|NCT00443547|100645756|FG000|STARTED|Overall Study||89||
48130877|NCT00443547|100645757|FG001|STARTED|Overall Study||88||
48130878|NCT00443547|100645758|FG002|STARTED|Overall Study||48||
48130879|NCT00443547|100645759|FG003|STARTED|Overall Study||6||
48130880|NCT00443547|100645756|FG000|Evaluated at 12 Months|Overall Study||58||
48130881|NCT00443547|100645757|FG001|Evaluated at 12 Months|Overall Study||55||
48130882|NCT00443547|100645758|FG002|Evaluated at 12 Months|Overall Study||37||
48130883|NCT00443547|100645759|FG003|Evaluated at 12 Months|Overall Study||5||
48130884|NCT00443547|100645756|FG000|COMPLETED|Overall Study||44||
48130885|NCT00443547|100645757|FG001|COMPLETED|Overall Study||46||
48130886|NCT00443547|100645758|FG002|COMPLETED|Overall Study||27||
48130887|NCT00443547|100645759|FG003|COMPLETED|Overall Study||4||
48130888|NCT00443547|100645756|FG000|NOT COMPLETED|Overall Study||45||
48130889|NCT00443547|100645757|FG001|NOT COMPLETED|Overall Study||42||
48130890|NCT00443547|100645758|FG002|NOT COMPLETED|Overall Study||21||
48130891|NCT00443547|100645759|FG003|NOT COMPLETED|Overall Study||2||
48130892|NCT00819182|100645760|FG000|STARTED|Overall Study||88||
48399066|NCT00677560|101306469|FG003|STARTED|Overall Study||20||
48399067|NCT00677560|101306470|FG004|STARTED|Overall Study||34||
48399068|NCT00677560|101306466|FG000|COMPLETED|Overall Study||5||
48399069|NCT00677560|101306467|FG001|COMPLETED|Overall Study||13||
48399070|NCT00677560|101306468|FG002|COMPLETED|Overall Study||6||
48399071|NCT00677560|101306469|FG003|COMPLETED|Overall Study||3||
48399072|NCT00677560|101306470|FG004|COMPLETED|Overall Study||21||
48399073|NCT00677560|101306466|FG000|NOT COMPLETED|Overall Study||15||
48399074|NCT00677560|101306467|FG001|NOT COMPLETED|Overall Study||10||
48399075|NCT00677560|101306468|FG002|NOT COMPLETED|Overall Study||23||
48399076|NCT00677560|101306469|FG003|NOT COMPLETED|Overall Study||17||
48399077|NCT00677560|101306470|FG004|NOT COMPLETED|Overall Study||13||
48399078|NCT00565812|101306471|FG000|STARTED|Overall Study||485||
48399079|NCT00565812|101306472|FG001|STARTED|Overall Study||486||
48399080|NCT00565812|101306473|FG002|STARTED|Overall Study||486||
48399081|NCT00565812|101306471|FG000|COMPLETED|Overall Study||341||
48399082|NCT00565812|101306472|FG001|COMPLETED|Overall Study||351||
48399083|NCT00565812|101306473|FG002|COMPLETED|Overall Study||356||
48574424|NCT03461952|101738330|FG000|NOT COMPLETED|Overall Study||0||
48574425|NCT03461952|101738331|FG001|NOT COMPLETED|Overall Study||0||
48574426|NCT01931475|101738332|FG000|STARTED|Period 1: Double-Blind Treatment Phase||205||
48574427|NCT01931475|101738333|FG001|STARTED|Period 1: Double-Blind Treatment Phase||202||
48574428|NCT01931475|101738332|FG000|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||199||
48574429|NCT01931475|101738333|FG001|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||198||
48574430|NCT01931475|101738332|FG000|COMPLETED|Period 1: Double-Blind Treatment Phase||166||
48574431|NCT01931475|101738333|FG001|COMPLETED|Period 1: Double-Blind Treatment Phase||176||
48574432|NCT01931475|101738332|FG000|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||39||
48574433|NCT01931475|101738333|FG001|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||26||
48574434|NCT01931475|101738332|FG000|STARTED|Period 2: Extension Treatment Phase||166||
48574435|NCT01931475|101738333|FG001|STARTED|Period 2: Extension Treatment Phase||176||
48574436|NCT01931475|101738332|FG000|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||166||
48574437|NCT01931475|101738333|FG001|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||175||
48574438|NCT01931475|101738332|FG000|COMPLETED|Period 2: Extension Treatment Phase||162||
48574439|NCT01931475|101738333|FG001|COMPLETED|Period 2: Extension Treatment Phase||157||
48574440|NCT01931475|101738332|FG000|NOT COMPLETED|Period 2: Extension Treatment Phase||4||
48574441|NCT01931475|101738333|FG001|NOT COMPLETED|Period 2: Extension Treatment Phase||19||
48574442|NCT01754350|101738334|FG000|STARTED|Overall Study||25||
48574443|NCT01754350|101738335|FG001|STARTED|Overall Study||25||
48574444|NCT01754350|101738334|FG000|COMPLETED|Overall Study||20||
48574445|NCT01754350|101738335|FG001|COMPLETED|Overall Study||22||
48574446|NCT01754350|101738334|FG000|NOT COMPLETED|Overall Study||5||
48574447|NCT01754350|101738335|FG001|NOT COMPLETED|Overall Study||3||
48574448|NCT01560234|101738336|FG000|STARTED|Overall Study||16||
48574449|NCT01560234|101738337|FG001|STARTED|Overall Study||4||
48574450|NCT01560234|101738338|FG002|STARTED|Overall Study||4||
48130893|NCT00819182|100645761|FG001|STARTED|Overall Study||86||
48130894|NCT00819182|100645762|FG002|STARTED|Overall Study||44||
48399084|NCT00565812|101306471|FG000|NOT COMPLETED|Overall Study||144||
48130895|NCT00819182|100645760|FG000|Week 16 Visit|Overall Study||75||
48130896|NCT00819182|100645761|FG001|Week 16 Visit|Overall Study||78||
48130897|NCT00819182|100645762|FG002|Week 16 Visit|Overall Study||43||
48130898|NCT00819182|100645760|FG000|COMPLETED|Overall Study||75||
48399085|NCT00565812|101306472|FG001|NOT COMPLETED|Overall Study||135||
48399086|NCT00565812|101306473|FG002|NOT COMPLETED|Overall Study||130||
48574451|NCT01560234|101738339|FG003|STARTED|Overall Study||3||
48574452|NCT01560234|101738340|FG004|STARTED|Overall Study||4||
48574453|NCT01560234|101738341|FG005|STARTED|Overall Study||4||
48574454|NCT01560234|101738342|FG006|STARTED|Overall Study||4||
48574455|NCT01560234|101738343|FG007|STARTED|Overall Study||8||
48574456|NCT01560234|101738336|FG000|COMPLETED|Overall Study||13||
48574457|NCT01560234|101738337|FG001|COMPLETED|Overall Study||4||
48574458|NCT01560234|101738338|FG002|COMPLETED|Overall Study||3||
48574459|NCT01560234|101738339|FG003|COMPLETED|Overall Study||3||
48574460|NCT01560234|101738340|FG004|COMPLETED|Overall Study||4||
48574461|NCT01560234|101738341|FG005|COMPLETED|Overall Study||2||
48574462|NCT01560234|101738342|FG006|COMPLETED|Overall Study||4||
48574463|NCT01560234|101738343|FG007|COMPLETED|Overall Study||6||
48574464|NCT01560234|101738336|FG000|NOT COMPLETED|Overall Study||3||
48574465|NCT01560234|101738337|FG001|NOT COMPLETED|Overall Study||0||
48574466|NCT01560234|101738338|FG002|NOT COMPLETED|Overall Study||1||
48574467|NCT01560234|101738339|FG003|NOT COMPLETED|Overall Study||0||
48574468|NCT01560234|101738340|FG004|NOT COMPLETED|Overall Study||0||
48574469|NCT01560234|101738341|FG005|NOT COMPLETED|Overall Study||2||
48701787|NCT03352557|102057544|FG004|NOT COMPLETED|LTE Period: Week 80 to Week 173||0||
48701788|NCT03352557|102057545|FG005|NOT COMPLETED|LTE Period: Week 80 to Week 173||46||
48701789|NCT03352557|102057546|FG006|NOT COMPLETED|LTE Period: Week 80 to Week 173||49||
48701790|NCT03352557|102057547|FG007|NOT COMPLETED|LTE Period: Week 80 to Week 173||90||
48701791|NCT03352557|102057548|FG008|NOT COMPLETED|LTE Period: Week 80 to Week 173||169||
48130899|NCT00819182|100645761|FG001|COMPLETED|Overall Study||78||
48130900|NCT00819182|100645762|FG002|COMPLETED|Overall Study||43||
48130901|NCT00819182|100645760|FG000|NOT COMPLETED|Overall Study||13||
48130902|NCT00819182|100645761|FG001|NOT COMPLETED|Overall Study||8||
48130903|NCT00819182|100645762|FG002|NOT COMPLETED|Overall Study||1||
48130904|NCT02099006|100645763|FG000|STARTED|Overall Study||9||
48130905|NCT02099006|100645763|FG000|Received Placebo|Overall Study||9||
48130906|NCT02099006|100645763|FG000|Received Amitriptyline/ Baclofen|Overall Study||7||
48130907|NCT02099006|100645763|FG000|Received Ketoprofen|Overall Study||3||
48130908|NCT02099006|100645763|FG000|Received Loperamide|Overall Study||7||
48130909|NCT02099006|100645763|FG000|Received Ketamine|Overall Study||6||
48130910|NCT02099006|100645763|FG000|Received Gabapentin|Overall Study||8||
48130911|NCT02099006|100645763|FG000|COMPLETED|Overall Study||8||
48130912|NCT02099006|100645763|FG000|NOT COMPLETED|Overall Study||1||
48130913|NCT00389324|100645764|FG000|STARTED|Run-In Phase||21||
48130914|NCT00389324|100645764|FG000|COMPLETED|Run-In Phase||18||
48130915|NCT00389324|100645764|FG000|NOT COMPLETED|Run-In Phase||3||
48130916|NCT00389324|100645764|FG000|STARTED|Intravenous Phase||32||
48130917|NCT00389324|100645764|FG000|COMPLETED|Intravenous Phase||32||
48130918|NCT00389324|100645764|FG000|NOT COMPLETED|Intravenous Phase||0||
48130919|NCT00389324|100645764|FG000|STARTED|Subcutaneous Phase||32||
48130920|NCT00389324|100645764|FG000|COMPLETED|Subcutaneous Phase||25||
48130921|NCT00389324|100645764|FG000|NOT COMPLETED|Subcutaneous Phase||7||
48130922|NCT04757649|100645765|FG000|STARTED|Overall Study||9||
48130923|NCT04757649|100645765|FG000|COMPLETED|Overall Study||7||
48130924|NCT04757649|100645765|FG000|NOT COMPLETED|Overall Study||2||
48130925|NCT02060890|100645766|FG000|STARTED|Overall Study||20||
48130926|NCT02060890|100645766|FG000|COMPLETED|Overall Study||16||
48130927|NCT02060890|100645766|FG000|NOT COMPLETED|Overall Study||4||
48130928|NCT01198600|100645767|FG000|STARTED|Phase 1: Period One, 30 Days of Wear||35||
48130929|NCT01198600|100645768|FG001|STARTED|Phase 1: Period One, 30 Days of Wear||37||
48130930|NCT01198600|100645769|FG002|STARTED|Phase 1: Period One, 30 Days of Wear||0||
48130931|NCT01198600|100645770|FG003|STARTED|Phase 1: Period One, 30 Days of Wear||0||
48130932|NCT01198600|100645767|FG000|COMPLETED|Phase 1: Period One, 30 Days of Wear||33||
48130933|NCT01198600|100645768|FG001|COMPLETED|Phase 1: Period One, 30 Days of Wear||36||
48130934|NCT01198600|100645769|FG002|COMPLETED|Phase 1: Period One, 30 Days of Wear||0||
48130935|NCT01198600|100645770|FG003|COMPLETED|Phase 1: Period One, 30 Days of Wear||0||
48574470|NCT01560234|101738342|FG006|NOT COMPLETED|Overall Study||0||
48701792|NCT03352557|102057549|FG009|NOT COMPLETED|LTE Period: Week 80 to Week 173||167||
48130936|NCT01198600|100645767|FG000|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||2||
48130937|NCT01198600|100645768|FG001|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||1||
48130938|NCT01198600|100645769|FG002|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0||
48701793|NCT02585830|102057550|FG000|STARTED|Overall Study||25||
48701794|NCT02585830|102057550|FG000|COMPLETED|Overall Study||22||
48574471|NCT01560234|101738343|FG007|NOT COMPLETED|Overall Study||2||
48574472|NCT04134767|101738344|FG000|STARTED|Overall Study||111||6
48701795|NCT02585830|102057550|FG000|NOT COMPLETED|Overall Study||3||
48130939|NCT01198600|100645770|FG003|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0||
48130940|NCT01198600|100645767|FG000|STARTED|Phase 1: Period Two, 30 Days of Wear||32||
48130941|NCT01198600|100645768|FG001|STARTED|Phase 1: Period Two, 30 Days of Wear||36||
48130942|NCT01198600|100645769|FG002|STARTED|Phase 1: Period Two, 30 Days of Wear||0||
48574473|NCT04134767|101738345|FG001|STARTED|Overall Study||123||6
48574474|NCT04134767|101738344|FG000|COMPLETED|Overall Study||67||6
48574475|NCT04134767|101738345|FG001|COMPLETED|Overall Study||81||6
48574476|NCT04134767|101738344|FG000|NOT COMPLETED|Overall Study||44||0
48574477|NCT04134767|101738345|FG001|NOT COMPLETED|Overall Study||42||0
48574478|NCT01896128|101738346|FG000|STARTED|Overall Study||8||
48574479|NCT01896128|101738347|FG001|STARTED|Overall Study||11||
48574480|NCT01896128|101738346|FG000|COMPLETED|Overall Study||5||
48574481|NCT01896128|101738347|FG001|COMPLETED|Overall Study||8||
48130943|NCT01198600|100645770|FG003|STARTED|Phase 1: Period Two, 30 Days of Wear||0||
48130944|NCT01198600|100645767|FG000|COMPLETED|Phase 1: Period Two, 30 Days of Wear||32||
48130945|NCT01198600|100645768|FG001|COMPLETED|Phase 1: Period Two, 30 Days of Wear||35||
48130946|NCT01198600|100645769|FG002|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0||
48130947|NCT01198600|100645770|FG003|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0||
48130948|NCT01198600|100645767|FG000|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0||
48130949|NCT01198600|100645768|FG001|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||1||
48130950|NCT01198600|100645769|FG002|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0||
48130951|NCT01198600|100645770|FG003|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0||
48130952|NCT01198600|100645767|FG000|STARTED|Phase 2: 56 Days of Wear||0||
48130953|NCT01198600|100645768|FG001|STARTED|Phase 2: 56 Days of Wear||0||
48130954|NCT01198600|100645769|FG002|STARTED|Phase 2: 56 Days of Wear||67||
48130955|NCT01198600|100645770|FG003|STARTED|Phase 2: 56 Days of Wear||0||
48130956|NCT01198600|100645767|FG000|COMPLETED|Phase 2: 56 Days of Wear||0||
48130957|NCT01198600|100645768|FG001|COMPLETED|Phase 2: 56 Days of Wear||0||
48130958|NCT01198600|100645769|FG002|COMPLETED|Phase 2: 56 Days of Wear||62||
48130959|NCT01198600|100645770|FG003|COMPLETED|Phase 2: 56 Days of Wear||0||
48130960|NCT01198600|100645767|FG000|NOT COMPLETED|Phase 2: 56 Days of Wear||0||
48130961|NCT01198600|100645768|FG001|NOT COMPLETED|Phase 2: 56 Days of Wear||0||
48130962|NCT01198600|100645769|FG002|NOT COMPLETED|Phase 2: 56 Days of Wear||5||
48130963|NCT01198600|100645770|FG003|NOT COMPLETED|Phase 2: 56 Days of Wear||0||
48130964|NCT01198600|100645767|FG000|STARTED|Phase 3: 43 Days of Wear||0||
48130965|NCT01198600|100645768|FG001|STARTED|Phase 3: 43 Days of Wear||0||
48130966|NCT01198600|100645769|FG002|STARTED|Phase 3: 43 Days of Wear||0||
48130967|NCT01198600|100645770|FG003|STARTED|Phase 3: 43 Days of Wear||38||
48130968|NCT01198600|100645767|FG000|COMPLETED|Phase 3: 43 Days of Wear||0||
48130969|NCT01198600|100645768|FG001|COMPLETED|Phase 3: 43 Days of Wear||0||
48130970|NCT01198600|100645769|FG002|COMPLETED|Phase 3: 43 Days of Wear||0||
48130971|NCT01198600|100645770|FG003|COMPLETED|Phase 3: 43 Days of Wear||38||
48130972|NCT01198600|100645767|FG000|NOT COMPLETED|Phase 3: 43 Days of Wear||0||
48130973|NCT01198600|100645768|FG001|NOT COMPLETED|Phase 3: 43 Days of Wear||0||
48130974|NCT01198600|100645769|FG002|NOT COMPLETED|Phase 3: 43 Days of Wear||0||
48130975|NCT01198600|100645770|FG003|NOT COMPLETED|Phase 3: 43 Days of Wear||0||
48130976|NCT03067441|100645771|FG000|STARTED|Overall Study||492||
48130977|NCT03067441|100645772|FG001|STARTED|Overall Study||970||
48130978|NCT03067441|100645771|FG000|COMPLETED|Overall Study||459||
48130979|NCT03067441|100645772|FG001|COMPLETED|Overall Study||913||
48130980|NCT03067441|100645771|FG000|NOT COMPLETED|Overall Study||33||
48130981|NCT03067441|100645772|FG001|NOT COMPLETED|Overall Study||57||
48130982|NCT02842060|100645773|FG000|STARTED|Overall Study||120||
48130983|NCT02842060|100645774|FG001|STARTED|Overall Study||60||
48130984|NCT02842060|100645773|FG000|COMPLETED|Overall Study||120||
48130985|NCT02842060|100645774|FG001|COMPLETED|Overall Study||60||
48130986|NCT02842060|100645773|FG000|NOT COMPLETED|Overall Study||0||
48130987|NCT02842060|100645774|FG001|NOT COMPLETED|Overall Study||0||
48130988|NCT04408469|100645775|FG000|STARTED|Overall Study||60||
48130989|NCT04408469|100645776|FG001|STARTED|Overall Study||60||
48130990|NCT04408469|100645775|FG000|Baseline|Overall Study||60||
48130991|NCT04408469|100645776|FG001|Baseline|Overall Study||60||
48130992|NCT04408469|100645775|FG000|4-month Post-baseline|Overall Study||41||
48130993|NCT04408469|100645776|FG001|4-month Post-baseline|Overall Study||53||
48130994|NCT04408469|100645775|FG000|8-month Post-baseline|Overall Study||48||
48130995|NCT04408469|100645776|FG001|8-month Post-baseline|Overall Study||49||
48574482|NCT01896128|101738346|FG000|NOT COMPLETED|Overall Study||3||
48574483|NCT01896128|101738347|FG001|NOT COMPLETED|Overall Study||3||
48574484|NCT00728468|101738348|FG000|STARTED|Overall Study||16||
48574485|NCT00728468|101738348|FG000|Treated|Overall Study||15||
48574486|NCT00728468|101738348|FG000|COMPLETED|Overall Study||0||
48574487|NCT00728468|101738348|FG000|NOT COMPLETED|Overall Study||16||
48574488|NCT01455597|101738349|FG000|STARTED|Overall Study||101||
48574489|NCT01455597|101738350|FG001|STARTED|Overall Study||56||
48574490|NCT01455597|101738351|FG002|STARTED|Overall Study||100||
48574491|NCT01455597|101738352|FG003|STARTED|Overall Study||52||
48574492|NCT01455597|101738349|FG000|All-Participants-Treated Population|Overall Study||101|All enrolled participants who received at least 1 dose of study drug in Study PR-04509.|
48574493|NCT01455597|101738350|FG001|All-Participants-Treated Population|Overall Study||56|All enrolled participants who received at least 1 dose of study drug in Study PR-04509.|
48574494|NCT01455597|101738351|FG002|All-Participants-Treated Population|Overall Study||99|All enrolled participants who received at least 1 dose of study drug in Study PR-04509.|
48130996|NCT04408469|100645775|FG000|COMPLETED|Overall Study||48||
48130997|NCT04408469|100645776|FG001|COMPLETED|Overall Study||49||
48130998|NCT04408469|100645775|FG000|NOT COMPLETED|Overall Study||12||
48130999|NCT04408469|100645776|FG001|NOT COMPLETED|Overall Study||11||
48131000|NCT03359096|100645777|FG000|STARTED|HGNS Washout (1 Week)||31||
48131001|NCT03359096|100645778|FG001|STARTED|HGNS Washout (1 Week)||32||
48131002|NCT03359096|100645777|FG000|COMPLETED|HGNS Washout (1 Week)||31||
48131003|NCT03359096|100645778|FG001|COMPLETED|HGNS Washout (1 Week)||31||
48131004|NCT03359096|100645777|FG000|NOT COMPLETED|HGNS Washout (1 Week)||0||
48131005|NCT03359096|100645778|FG001|NOT COMPLETED|HGNS Washout (1 Week)||1||
48131006|NCT03359096|100645777|FG000|STARTED|First Intervention (4 Weeks)||31||
48131007|NCT03359096|100645778|FG001|STARTED|First Intervention (4 Weeks)||31||
48131008|NCT03359096|100645777|FG000|COMPLETED|First Intervention (4 Weeks)||29||
48131009|NCT03359096|100645778|FG001|COMPLETED|First Intervention (4 Weeks)||31||
48131010|NCT03359096|100645777|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2||
48131011|NCT03359096|100645778|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0||
48131012|NCT03359096|100645777|FG000|STARTED|HGNS Washout (1 Week)||29||
48131013|NCT03359096|100645778|FG001|STARTED|HGNS Washout (1 Week)||31||
48131014|NCT03359096|100645777|FG000|COMPLETED|HGNS Washout (1 Week)||29||
48131015|NCT03359096|100645778|FG001|COMPLETED|HGNS Washout (1 Week)||31||
48131016|NCT03359096|100645777|FG000|NOT COMPLETED|HGNS Washout (1 Week)||0||
48131017|NCT03359096|100645778|FG001|NOT COMPLETED|HGNS Washout (1 Week)||0||
48131018|NCT03359096|100645777|FG000|STARTED|Second Intervention (4 Weeks)||29||
48131019|NCT03359096|100645778|FG001|STARTED|Second Intervention (4 Weeks)||31||
48131020|NCT03359096|100645777|FG000|COMPLETED|Second Intervention (4 Weeks)||29||
48131021|NCT03359096|100645778|FG001|COMPLETED|Second Intervention (4 Weeks)||31||
48131022|NCT03359096|100645777|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0||
48131023|NCT03359096|100645778|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0||
48131024|NCT01286779|100645779|FG000|STARTED|Overall Study||115||
48131025|NCT01286779|100645779|FG000|COMPLETED|Overall Study||96||
48574495|NCT01455597|101738352|FG003|All-Participants-Treated Population|Overall Study||52|All enrolled participants who received at least 1 dose of study drug in Study PR-04509.|
48574496|NCT01455597|101738349|FG000|COMPLETED|Overall Study||84||
48574497|NCT01455597|101738350|FG001|COMPLETED|Overall Study||48||
48574498|NCT01455597|101738351|FG002|COMPLETED|Overall Study||80||
48574499|NCT01455597|101738352|FG003|COMPLETED|Overall Study||42||
48574500|NCT01455597|101738349|FG000|NOT COMPLETED|Overall Study||17||
48574501|NCT01455597|101738350|FG001|NOT COMPLETED|Overall Study||8||
48131026|NCT01286779|100645779|FG000|NOT COMPLETED|Overall Study||19||
48131027|NCT00383435|100645780|FG000|STARTED|26-Week Double-Blind Treatment Period||217||
48131028|NCT00383435|100645781|FG001|STARTED|26-Week Double-Blind Treatment Period||207||
48131029|NCT00383435|100645782|FG002|STARTED|26-Week Double-Blind Treatment Period||210||
48131030|NCT00383435|100645783|FG003|STARTED|26-Week Double-Blind Treatment Period||209||
48131031|NCT00383435|100645784|FG004|STARTED|26-Week Double-Blind Treatment Period||212||
48131032|NCT00383435|100645780|FG000|COMPLETED|26-Week Double-Blind Treatment Period||176||
48131033|NCT00383435|100645781|FG001|COMPLETED|26-Week Double-Blind Treatment Period||169||
48131034|NCT00383435|100645782|FG002|COMPLETED|26-Week Double-Blind Treatment Period||164||
48131035|NCT00383435|100645783|FG003|COMPLETED|26-Week Double-Blind Treatment Period||172||
48131036|NCT00383435|100645784|FG004|COMPLETED|26-Week Double-Blind Treatment Period||159||
48131037|NCT00383435|100645780|FG000|NOT COMPLETED|26-Week Double-Blind Treatment Period||41||
48131038|NCT00383435|100645781|FG001|NOT COMPLETED|26-Week Double-Blind Treatment Period||38||
48131039|NCT00383435|100645782|FG002|NOT COMPLETED|26-Week Double-Blind Treatment Period||46||
48131040|NCT00383435|100645783|FG003|NOT COMPLETED|26-Week Double-Blind Treatment Period||37||
48131041|NCT00383435|100645784|FG004|NOT COMPLETED|26-Week Double-Blind Treatment Period||53||
48131042|NCT00383435|100645780|FG000|STARTED|26-Week Treatment Safety Extension||131||
48131043|NCT00383435|100645781|FG001|STARTED|26-Week Treatment Safety Extension||130||
48131044|NCT00383435|100645782|FG002|STARTED|26-Week Treatment Safety Extension||124||
48131045|NCT00383435|100645783|FG003|STARTED|26-Week Treatment Safety Extension||131||
48131046|NCT00383435|100645784|FG004|STARTED|26-Week Treatment Safety Extension||13||
48131047|NCT00383435|100645780|FG000|COMPLETED|26-Week Treatment Safety Extension||117||
48131048|NCT00383435|100645781|FG001|COMPLETED|26-Week Treatment Safety Extension||121||
48131049|NCT00383435|100645782|FG002|COMPLETED|26-Week Treatment Safety Extension||108||
48131050|NCT00383435|100645783|FG003|COMPLETED|26-Week Treatment Safety Extension||116||
48131051|NCT00383435|100645784|FG004|COMPLETED|26-Week Treatment Safety Extension||10||
48131052|NCT00383435|100645780|FG000|NOT COMPLETED|26-Week Treatment Safety Extension||14||
48131053|NCT00383435|100645781|FG001|NOT COMPLETED|26-Week Treatment Safety Extension||9||
48574502|NCT01455597|101738351|FG002|NOT COMPLETED|Overall Study||20||
48574503|NCT01455597|101738352|FG003|NOT COMPLETED|Overall Study||10||
48574504|NCT01134107|101738353|FG000|STARTED|Period 1-First Treatment Intervention||67||
48574505|NCT01134107|101738354|FG001|STARTED|Period 1-First Treatment Intervention||66||
48131054|NCT00383435|100645782|FG002|NOT COMPLETED|26-Week Treatment Safety Extension||16||
48574506|NCT01134107|101738353|FG000|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66||
48574507|NCT01134107|101738354|FG001|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66||
48574508|NCT01134107|101738353|FG000|COMPLETED|Period 1-First Treatment Intervention||61||
48574509|NCT01134107|101738354|FG001|COMPLETED|Period 1-First Treatment Intervention||61||
48574510|NCT01134107|101738353|FG000|NOT COMPLETED|Period 1-First Treatment Intervention||6||
48574511|NCT01134107|101738354|FG001|NOT COMPLETED|Period 1-First Treatment Intervention||5||
48574512|NCT01134107|101738353|FG000|STARTED|Period 2-Second Treatment Intervention||61||
48574513|NCT01134107|101738354|FG001|STARTED|Period 2-Second Treatment Intervention||61||
48574514|NCT01134107|101738353|FG000|COMPLETED|Period 2-Second Treatment Intervention||57||
48131055|NCT00383435|100645783|FG003|NOT COMPLETED|26-Week Treatment Safety Extension||15||
48131056|NCT00383435|100645784|FG004|NOT COMPLETED|26-Week Treatment Safety Extension||3||
48574515|NCT01134107|101738354|FG001|COMPLETED|Period 2-Second Treatment Intervention||61||
48574516|NCT01134107|101738353|FG000|NOT COMPLETED|Period 2-Second Treatment Intervention||4||
48574517|NCT01134107|101738354|FG001|NOT COMPLETED|Period 2-Second Treatment Intervention||0||
48574518|NCT00550745|101738355|FG000|STARTED|Overall Study||6000||
48574519|NCT00550745|101738356|FG001|STARTED|Overall Study||5999||
48574520|NCT00550745|101738355|FG000|COMPLETED|Overall Study||5913||
48131057|NCT02055352|100645785|FG000|STARTED|Overall Study||109||
48131058|NCT02055352|100645786|FG001|STARTED|Overall Study||113||
48131059|NCT02055352|100645785|FG000|Per-Protocol Set (PPS)|Overall Study||108||
48131060|NCT02055352|100645786|FG001|Per-Protocol Set (PPS)|Overall Study||111||
48131061|NCT02055352|100645785|FG000|COMPLETED|Overall Study||103||
48131062|NCT02055352|100645786|FG001|COMPLETED|Overall Study||96||
48284990|NCT02632526|101021617|FG003|NOT COMPLETED|Overall Study||0||
48284991|NCT02632526|101021618|FG004|NOT COMPLETED|Overall Study||0||
48284992|NCT02632526|101021619|FG005|NOT COMPLETED|Overall Study||0||
48284993|NCT03426605|101021620|FG000|STARTED|Overall Study||6||
48284994|NCT03426605|101021621|FG001|STARTED|Overall Study||3||
48284995|NCT03426605|101021622|FG002|STARTED|Overall Study||4||
48284996|NCT03426605|101021623|FG003|STARTED|Overall Study||4||
48284997|NCT03426605|101021620|FG000|COMPLETED|Overall Study||0||
48284998|NCT03426605|101021621|FG001|COMPLETED|Overall Study||0||
48284999|NCT03426605|101021622|FG002|COMPLETED|Overall Study||0||
48285000|NCT03426605|101021623|FG003|COMPLETED|Overall Study||0||
48285001|NCT03426605|101021620|FG000|NOT COMPLETED|Overall Study||6||
48285002|NCT03426605|101021621|FG001|NOT COMPLETED|Overall Study||3||
48285003|NCT03426605|101021622|FG002|NOT COMPLETED|Overall Study||4||
48285004|NCT03426605|101021623|FG003|NOT COMPLETED|Overall Study||4||
48285005|NCT01191268|101021624|FG000|STARTED|Overall Study||295||
48285006|NCT01191268|101021625|FG001|STARTED|Overall Study||293||
48285007|NCT01191268|101021626|FG002|STARTED|Overall Study||296||
48285008|NCT01191268|101021624|FG000|Received at Least One Dose of Study Drug|Overall Study||295||
48285009|NCT01191268|101021625|FG001|Received at Least One Dose of Study Drug|Overall Study||293||
48285010|NCT01191268|101021626|FG002|Received at Least One Dose of Study Drug|Overall Study||296||
48285011|NCT01191268|101021624|FG000|COMPLETED|Overall Study||237||
48574521|NCT00550745|101738356|FG001|COMPLETED|Overall Study||5939||
48574522|NCT00550745|101738355|FG000|NOT COMPLETED|Overall Study||87||
48574523|NCT00550745|101738356|FG001|NOT COMPLETED|Overall Study||60||
48574524|NCT01222520|101738357|FG000|STARTED|Open-label run-in Period||0||
48574525|NCT01222520|101738358|FG001|STARTED|Open-label run-in Period||197||
48574526|NCT01222520|101738357|FG000|COMPLETED|Open-label run-in Period||0||
48574527|NCT01222520|101738358|FG001|COMPLETED|Open-label run-in Period||174||
48399087|NCT01804257|101306474|FG000|STARTED|Overall Study||28||
48574528|NCT01222520|101738357|FG000|NOT COMPLETED|Open-label run-in Period||0||
48399088|NCT01804257|101306474|FG000|COMPLETED|Overall Study||27||
48399089|NCT01804257|101306474|FG000|NOT COMPLETED|Overall Study||1||
48399090|NCT02337686|101306475|FG000|STARTED|Overall Study||15||
48399091|NCT02337686|101306475|FG000|COMPLETED|Overall Study||14||
48399092|NCT02337686|101306475|FG000|NOT COMPLETED|Overall Study||1||
48399093|NCT01660230|101306476|FG000|STARTED|Overall Study||4||
48399094|NCT01660230|101306477|FG001|STARTED|Overall Study||4||
48399095|NCT01660230|101306478|FG002|STARTED|Overall Study||4||
48399096|NCT01660230|101306479|FG003|STARTED|Overall Study||4||
48399097|NCT01660230|101306480|FG004|STARTED|Overall Study||4||
48399098|NCT01660230|101306481|FG005|STARTED|Overall Study||2||
48399099|NCT01660230|101306482|FG006|STARTED|Overall Study||4||
48399100|NCT01660230|101306483|FG007|STARTED|Overall Study||6||
48399101|NCT01660230|101306484|FG008|STARTED|Overall Study||6||
48399102|NCT01660230|101306485|FG009|STARTED|Overall Study||6||
48399103|NCT01660230|101306486|FG010|STARTED|Overall Study||6||
48399104|NCT01660230|101306487|FG011|STARTED|Overall Study||14||
48399105|NCT01660230|101306476|FG000|COMPLETED|Overall Study||4||
48399106|NCT01660230|101306477|FG001|COMPLETED|Overall Study||4||
48399107|NCT01660230|101306478|FG002|COMPLETED|Overall Study||4||
48399108|NCT01660230|101306479|FG003|COMPLETED|Overall Study||4||
48399109|NCT01660230|101306480|FG004|COMPLETED|Overall Study||4||
48399110|NCT01660230|101306481|FG005|COMPLETED|Overall Study||2||
48399111|NCT01660230|101306482|FG006|COMPLETED|Overall Study||4||
48399112|NCT01660230|101306483|FG007|COMPLETED|Overall Study||6||
48399113|NCT01660230|101306484|FG008|COMPLETED|Overall Study||6||
48399114|NCT01660230|101306485|FG009|COMPLETED|Overall Study||6||
48399115|NCT01660230|101306486|FG010|COMPLETED|Overall Study||6||
48399116|NCT01660230|101306487|FG011|COMPLETED|Overall Study||14||
48574529|NCT01222520|101738358|FG001|NOT COMPLETED|Open-label run-in Period||23||
48574530|NCT01222520|101738357|FG000|STARTED|Double-blind Period||87||
48574531|NCT01222520|101738358|FG001|STARTED|Double-blind Period||87||
48574532|NCT01222520|101738357|FG000|COMPLETED|Double-blind Period||86||
48574533|NCT01222520|101738358|FG001|COMPLETED|Double-blind Period||85||
48574534|NCT01222520|101738357|FG000|NOT COMPLETED|Double-blind Period||1||
48574535|NCT01222520|101738358|FG001|NOT COMPLETED|Double-blind Period||2||
48574536|NCT00435708|101738359|FG000|STARTED|Overall Study||41||
48574537|NCT00435708|101738360|FG001|STARTED|Overall Study||40||
48574538|NCT00435708|101738359|FG000|COMPLETED|Overall Study||37||
48574539|NCT00435708|101738360|FG001|COMPLETED|Overall Study||38||
48574540|NCT00435708|101738359|FG000|NOT COMPLETED|Overall Study||4||
48399117|NCT01660230|101306476|FG000|NOT COMPLETED|Overall Study||0||
48399118|NCT01660230|101306477|FG001|NOT COMPLETED|Overall Study||0||
48399119|NCT01660230|101306478|FG002|NOT COMPLETED|Overall Study||0||
48399120|NCT01660230|101306479|FG003|NOT COMPLETED|Overall Study||0||
48399121|NCT01660230|101306480|FG004|NOT COMPLETED|Overall Study||0||
48399122|NCT01660230|101306481|FG005|NOT COMPLETED|Overall Study||0||
48399123|NCT01660230|101306482|FG006|NOT COMPLETED|Overall Study||0||
48399124|NCT01660230|101306483|FG007|NOT COMPLETED|Overall Study||0||
48399125|NCT01660230|101306484|FG008|NOT COMPLETED|Overall Study||0||
48574541|NCT00435708|101738360|FG001|NOT COMPLETED|Overall Study||2||
48574542|NCT02965729|101738361|FG000|STARTED|Overall Study||24||
48574543|NCT02965729|101738362|FG001|STARTED|Overall Study||25||
48574544|NCT02965729|101738363|FG002|STARTED|Overall Study||56||
48574545|NCT02965729|101738361|FG000|COMPLETED|Overall Study||17||
48574546|NCT02965729|101738362|FG001|COMPLETED|Overall Study||22||
48399126|NCT01660230|101306485|FG009|NOT COMPLETED|Overall Study||0||
48399127|NCT01660230|101306486|FG010|NOT COMPLETED|Overall Study||0||
48399128|NCT01660230|101306487|FG011|NOT COMPLETED|Overall Study||0||
48399129|NCT04423757|101306488|FG000|STARTED|Overall Study||21||
48399130|NCT04423757|101306489|FG001|STARTED|Overall Study||24||
48399131|NCT04423757|101306488|FG000|Treated|Overall Study||20||
48399132|NCT04423757|101306489|FG001|Treated|Overall Study||23||
48399133|NCT04423757|101306488|FG000|COMPLETED|Overall Study||18|Based on completion of protocol specified treatment.|
48399134|NCT04423757|101306489|FG001|COMPLETED|Overall Study||23|Based on completion of protocol specified treatment.|
48399135|NCT04423757|101306488|FG000|NOT COMPLETED|Overall Study||3||
48131063|NCT02055352|100645785|FG000|NOT COMPLETED|Overall Study||6||
48131064|NCT02055352|100645786|FG001|NOT COMPLETED|Overall Study||17||
48131065|NCT02553330|100645787|FG000|STARTED|Overall Study||12||
48574547|NCT02965729|101738363|FG002|COMPLETED|Overall Study||45||
48574548|NCT02965729|101738361|FG000|NOT COMPLETED|Overall Study||7||
48574549|NCT02965729|101738362|FG001|NOT COMPLETED|Overall Study||3||
48574550|NCT02965729|101738363|FG002|NOT COMPLETED|Overall Study||11||
48574551|NCT02095691|101738364|FG000|STARTED|Overall Study||19||
48574552|NCT02095691|101738364|FG000|COMPLETED|Overall Study||18||
48574553|NCT02095691|101738364|FG000|NOT COMPLETED|Overall Study||1||
48574554|NCT02842580|101738365|FG000|STARTED|Overall Study||11||
48574555|NCT02842580|101738366|FG001|STARTED|Overall Study||10||
48574556|NCT02842580|101738365|FG000|COMPLETED|Overall Study||11||
48574557|NCT02842580|101738366|FG001|COMPLETED|Overall Study||10||
48574558|NCT02842580|101738365|FG000|NOT COMPLETED|Overall Study||0||
48574559|NCT02842580|101738366|FG001|NOT COMPLETED|Overall Study||0||
48574560|NCT00610155|101738367|FG000|STARTED|Period 1||4||
48574561|NCT00610155|101738368|FG001|STARTED|Period 1||3||
48574562|NCT00610155|101738369|FG002|STARTED|Period 1||4||
48574563|NCT00610155|101738370|FG003|STARTED|Period 1||3||
48574564|NCT00610155|101738371|FG004|STARTED|Period 1||3||
48701796|NCT01190475|102057551|FG000|STARTED|Overall Study||2||
48701797|NCT01190475|102057552|FG001|STARTED|Overall Study||2||
48701798|NCT01190475|102057553|FG002|STARTED|Overall Study||2||
48131066|NCT02553330|100645788|FG001|STARTED|Overall Study||39||
48131067|NCT02553330|100645789|FG002|STARTED|Overall Study||39||
48131068|NCT02553330|100645787|FG000|COMPLETED|Overall Study||7||
48574565|NCT00610155|101738372|FG005|STARTED|Period 1||1||
48574566|NCT00610155|101738367|FG000|COMPLETED|Period 1||4||
48574567|NCT00610155|101738368|FG001|COMPLETED|Period 1||3||
48574568|NCT00610155|101738369|FG002|COMPLETED|Period 1||3||
48574569|NCT00610155|101738370|FG003|COMPLETED|Period 1||3||
48574570|NCT00610155|101738371|FG004|COMPLETED|Period 1||3||
48701799|NCT01190475|102057551|FG000|COMPLETED|Overall Study||2||
48701800|NCT01190475|102057552|FG001|COMPLETED|Overall Study||2||
48701801|NCT01190475|102057553|FG002|COMPLETED|Overall Study||1||
48701802|NCT01190475|102057551|FG000|NOT COMPLETED|Overall Study||0||
48701803|NCT01190475|102057552|FG001|NOT COMPLETED|Overall Study||0||
48285012|NCT01191268|101021625|FG001|COMPLETED|Overall Study||238||
48285013|NCT01191268|101021626|FG002|COMPLETED|Overall Study||244||
48285014|NCT01191268|101021624|FG000|NOT COMPLETED|Overall Study||58||
48701804|NCT01190475|102057553|FG002|NOT COMPLETED|Overall Study||1||
48701805|NCT01126268|102057554|FG000|STARTED|Overall Study||38||
48131069|NCT02553330|100645788|FG001|COMPLETED|Overall Study||0||
48574571|NCT00610155|101738372|FG005|COMPLETED|Period 1||1||
48574572|NCT00610155|101738367|FG000|NOT COMPLETED|Period 1||0||
48574573|NCT00610155|101738368|FG001|NOT COMPLETED|Period 1||0||
48574574|NCT00610155|101738369|FG002|NOT COMPLETED|Period 1||1||
48574575|NCT00610155|101738370|FG003|NOT COMPLETED|Period 1||0||
48574576|NCT00610155|101738371|FG004|NOT COMPLETED|Period 1||0||
48574577|NCT00610155|101738372|FG005|NOT COMPLETED|Period 1||0||
48574578|NCT00610155|101738367|FG000|STARTED|Washout Period 1 (7 Days)||4||
48574579|NCT00610155|101738368|FG001|STARTED|Washout Period 1 (7 Days)||3||
48574580|NCT00610155|101738369|FG002|STARTED|Washout Period 1 (7 Days)||3||
48574581|NCT00610155|101738370|FG003|STARTED|Washout Period 1 (7 Days)||3||
48574582|NCT00610155|101738371|FG004|STARTED|Washout Period 1 (7 Days)||3||
48574583|NCT00610155|101738372|FG005|STARTED|Washout Period 1 (7 Days)||1||
48574584|NCT00610155|101738367|FG000|COMPLETED|Washout Period 1 (7 Days)||4||
48131070|NCT02553330|100645789|FG002|COMPLETED|Overall Study||2||
48131071|NCT02553330|100645787|FG000|NOT COMPLETED|Overall Study||5||
48131072|NCT02553330|100645788|FG001|NOT COMPLETED|Overall Study||39||
48131073|NCT02553330|100645789|FG002|NOT COMPLETED|Overall Study||37||
48131074|NCT04558346|100645790|FG000|STARTED|Overall Study||8||
48131075|NCT04558346|100645791|FG001|STARTED|Overall Study||15||
48131076|NCT04558346|100645790|FG000|COMPLETED|Overall Study||6||
48131077|NCT04558346|100645791|FG001|COMPLETED|Overall Study||13||
48131078|NCT04558346|100645790|FG000|NOT COMPLETED|Overall Study||2||
48131079|NCT04558346|100645791|FG001|NOT COMPLETED|Overall Study||2||
48131080|NCT01332305|100645792|FG000|STARTED|Overall Study||41||
48131081|NCT01332305|100645793|FG001|STARTED|Overall Study||48||
48574585|NCT00610155|101738368|FG001|COMPLETED|Washout Period 1 (7 Days)||3||
48574586|NCT00610155|101738369|FG002|COMPLETED|Washout Period 1 (7 Days)||3||
48701806|NCT01126268|102057554|FG000|COMPLETED|Overall Study||37||
48131082|NCT01332305|100645794|FG002|STARTED|Overall Study||45||
48131083|NCT01332305|100645795|FG003|STARTED|Overall Study||38||
48131084|NCT01332305|100645796|FG004|STARTED|Overall Study||45||
48131085|NCT01332305|100645792|FG000|COMPLETED|Overall Study||31||
48131086|NCT01332305|100645793|FG001|COMPLETED|Overall Study||34||
48285015|NCT01191268|101021625|FG001|NOT COMPLETED|Overall Study||55||
48574587|NCT00610155|101738370|FG003|COMPLETED|Washout Period 1 (7 Days)||3||
48574588|NCT00610155|101738371|FG004|COMPLETED|Washout Period 1 (7 Days)||3||
48574589|NCT00610155|101738372|FG005|COMPLETED|Washout Period 1 (7 Days)||1||
48574590|NCT00610155|101738367|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48701807|NCT01126268|102057554|FG000|NOT COMPLETED|Overall Study||1||
48701808|NCT03515226|102057555|FG000|STARTED|Overall Study||10||
48131087|NCT01332305|100645794|FG002|COMPLETED|Overall Study||31||
48131088|NCT01332305|100645795|FG003|COMPLETED|Overall Study||30||
48574591|NCT00610155|101738368|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48574592|NCT00610155|101738369|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48574593|NCT00610155|101738370|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48574594|NCT00610155|101738371|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48574595|NCT00610155|101738372|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48574596|NCT00610155|101738367|FG000|STARTED|Period 2||4||
48574597|NCT00610155|101738368|FG001|STARTED|Period 2||3||
48574598|NCT00610155|101738369|FG002|STARTED|Period 2||3||
48574599|NCT00610155|101738370|FG003|STARTED|Period 2||3||
48574600|NCT00610155|101738371|FG004|STARTED|Period 2||3||
48574601|NCT00610155|101738372|FG005|STARTED|Period 2||1||
48701809|NCT03515226|102057556|FG001|STARTED|Overall Study||15||
48701810|NCT03515226|102057555|FG000|COMPLETED|Overall Study||8||
48701811|NCT03515226|102057556|FG001|COMPLETED|Overall Study||11||
48701812|NCT03515226|102057555|FG000|NOT COMPLETED|Overall Study||2||
48574602|NCT00610155|101738367|FG000|COMPLETED|Period 2||4||
48701813|NCT03515226|102057556|FG001|NOT COMPLETED|Overall Study||4||
48701814|NCT03505788|102057557|FG000|STARTED|Overall Study||260||
48701815|NCT03505788|102057558|FG001|STARTED|Overall Study||259||
48701816|NCT03505788|102057557|FG000|COMPLETED|Overall Study||257||
48701817|NCT03505788|102057558|FG001|COMPLETED|Overall Study||254||
48701818|NCT03505788|102057557|FG000|NOT COMPLETED|Overall Study||3||
48701819|NCT03505788|102057558|FG001|NOT COMPLETED|Overall Study||5||
48701820|NCT02222909|102057559|FG000|STARTED|Overall Study||2637||11
48701821|NCT02222909|102057560|FG001|STARTED|Overall Study||4130||11
48701822|NCT02222909|102057559|FG000|COMPLETED|Overall Study||2637||10
48701823|NCT02222909|102057560|FG001|COMPLETED|Overall Study||4130||10
48701824|NCT02222909|102057559|FG000|NOT COMPLETED|Overall Study||0||1
48701825|NCT02222909|102057560|FG001|NOT COMPLETED|Overall Study||0||1
48701826|NCT03915574|102057561|FG000|STARTED|Overall Study||70||
48701827|NCT03915574|102057562|FG001|STARTED|Overall Study||70||
48701828|NCT03915574|102057561|FG000|COMPLETED|Overall Study||70||
48701829|NCT03915574|102057562|FG001|COMPLETED|Overall Study||66||
48701830|NCT03915574|102057561|FG000|NOT COMPLETED|Overall Study||0||
48701831|NCT03915574|102057562|FG001|NOT COMPLETED|Overall Study||4||
48701832|NCT00096174|102057563|FG000|STARTED|Overall Study||69||
48701833|NCT00096174|102057563|FG000|Began Protocol Therapy|Overall Study||66||
48131089|NCT01332305|100645796|FG004|COMPLETED|Overall Study||33||
48131090|NCT01332305|100645792|FG000|NOT COMPLETED|Overall Study||10||
48701834|NCT00096174|102057563|FG000|Eligible and Treated|Overall Study||60||
48701835|NCT00096174|102057563|FG000|COMPLETED|Overall Study||7||
48701836|NCT00096174|102057563|FG000|NOT COMPLETED|Overall Study||62||
48131091|NCT01332305|100645793|FG001|NOT COMPLETED|Overall Study||14||
48131092|NCT01332305|100645794|FG002|NOT COMPLETED|Overall Study||14||
48574603|NCT00610155|101738368|FG001|COMPLETED|Period 2||3||
48701837|NCT02379221|102057564|FG000|STARTED|Overall Study||49||
48701838|NCT02379221|102057564|FG000|COMPLETED|Overall Study||48||
48701839|NCT02379221|102057564|FG000|NOT COMPLETED|Overall Study||1||
48701840|NCT04323137|102057565|FG000|STARTED|Overall Study||11667||
48701841|NCT04323137|102057566|FG001|STARTED|Overall Study||11639||
48701842|NCT04323137|102057567|FG002|STARTED|Overall Study||11652||
48399136|NCT04423757|101306489|FG001|NOT COMPLETED|Overall Study||1||
48399137|NCT00424346|101306490|FG000|STARTED|Core Study||71||
48399138|NCT00424346|101306491|FG001|STARTED|Core Study||64||
48399139|NCT00424346|101306492|FG002|STARTED|Core Study||69||
48399140|NCT00424346|101306493|FG003|STARTED|Core Study||70||
48399141|NCT00424346|101306490|FG000|COMPLETED|Core Study||62||
48399142|NCT00424346|101306491|FG001|COMPLETED|Core Study||56||
48399143|NCT00424346|101306492|FG002|COMPLETED|Core Study||65||
48399144|NCT00424346|101306493|FG003|COMPLETED|Core Study||63||
48399145|NCT00424346|101306490|FG000|NOT COMPLETED|Core Study||9||
48399146|NCT00424346|101306491|FG001|NOT COMPLETED|Core Study||8||
48399147|NCT00424346|101306492|FG002|NOT COMPLETED|Core Study||4||
48399148|NCT00424346|101306493|FG003|NOT COMPLETED|Core Study||7||
48399149|NCT00424346|101306490|FG000|STARTED|Extension Phase||0||
48399150|NCT00424346|101306491|FG001|STARTED|Extension Phase||110||
48399151|NCT00424346|101306492|FG002|STARTED|Extension Phase||59||
48399152|NCT00424346|101306493|FG003|STARTED|Extension Phase||58||
48399153|NCT00424346|101306490|FG000|COMPLETED|Extension Phase||0||
48399154|NCT00424346|101306491|FG001|COMPLETED|Extension Phase||8||
48399155|NCT00424346|101306492|FG002|COMPLETED|Extension Phase||4||
48399156|NCT00424346|101306493|FG003|COMPLETED|Extension Phase||3||
48399157|NCT00424346|101306490|FG000|NOT COMPLETED|Extension Phase||0||
48399158|NCT00424346|101306491|FG001|NOT COMPLETED|Extension Phase||102||
48131093|NCT01332305|100645795|FG003|NOT COMPLETED|Overall Study||8||
48131094|NCT01332305|100645796|FG004|NOT COMPLETED|Overall Study||12||
48399159|NCT00424346|101306492|FG002|NOT COMPLETED|Extension Phase||55||
48399160|NCT00424346|101306493|FG003|NOT COMPLETED|Extension Phase||55||
48399161|NCT01146951|101306494|FG000|STARTED|Overall Study||29||
48399162|NCT01146951|101306495|FG001|STARTED|Overall Study||30||
48399163|NCT01146951|101306494|FG000|COMPLETED|Overall Study||25||
48399164|NCT01146951|101306495|FG001|COMPLETED|Overall Study||29||
48399165|NCT01146951|101306494|FG000|NOT COMPLETED|Overall Study||4||
48399166|NCT01146951|101306495|FG001|NOT COMPLETED|Overall Study||1||
48399167|NCT02171819|101306496|FG000|STARTED|Overall Study||31||
48399168|NCT02171819|101306497|FG001|STARTED|Overall Study||32||
48399169|NCT02171819|101306498|FG002|STARTED|Overall Study||12||
48399170|NCT02171819|101306496|FG000|COMPLETED|Overall Study||31||
48399171|NCT02171819|101306497|FG001|COMPLETED|Overall Study||32||
48399172|NCT02171819|101306498|FG002|COMPLETED|Overall Study||12||
48399173|NCT02171819|101306496|FG000|NOT COMPLETED|Overall Study||0||
48399174|NCT02171819|101306497|FG001|NOT COMPLETED|Overall Study||0||
48399175|NCT02171819|101306498|FG002|NOT COMPLETED|Overall Study||0||
48399176|NCT02988219|101306499|FG000|STARTED|Overall Study||25||
48574604|NCT00610155|101738369|FG002|COMPLETED|Period 2||3||
48574605|NCT00610155|101738370|FG003|COMPLETED|Period 2||3||
48574606|NCT00610155|101738371|FG004|COMPLETED|Period 2||3||
48574607|NCT00610155|101738372|FG005|COMPLETED|Period 2||1||
48574608|NCT00610155|101738367|FG000|NOT COMPLETED|Period 2||0||
48399177|NCT02988219|101306500|FG001|STARTED|Overall Study||25||
48574609|NCT00610155|101738368|FG001|NOT COMPLETED|Period 2||0||
48574610|NCT00610155|101738369|FG002|NOT COMPLETED|Period 2||0||
48574611|NCT00610155|101738370|FG003|NOT COMPLETED|Period 2||0||
48574612|NCT00610155|101738371|FG004|NOT COMPLETED|Period 2||0||
48574613|NCT00610155|101738372|FG005|NOT COMPLETED|Period 2||0||
48574614|NCT00610155|101738367|FG000|STARTED|Washout Period 2 (7 Days)||4||
48574615|NCT00610155|101738368|FG001|STARTED|Washout Period 2 (7 Days)||3||
48574616|NCT00610155|101738369|FG002|STARTED|Washout Period 2 (7 Days)||3||
48574617|NCT00610155|101738370|FG003|STARTED|Washout Period 2 (7 Days)||3||
48574618|NCT00610155|101738371|FG004|STARTED|Washout Period 2 (7 Days)||3||
48574619|NCT00610155|101738372|FG005|STARTED|Washout Period 2 (7 Days)||1||
48574620|NCT00610155|101738367|FG000|COMPLETED|Washout Period 2 (7 Days)||4||
48574621|NCT00610155|101738368|FG001|COMPLETED|Washout Period 2 (7 Days)||3||
48399178|NCT02988219|101306499|FG000|COMPLETED|Overall Study||24||
48399179|NCT02988219|101306500|FG001|COMPLETED|Overall Study||22||
48399180|NCT02988219|101306499|FG000|NOT COMPLETED|Overall Study||1||
48399181|NCT02988219|101306500|FG001|NOT COMPLETED|Overall Study||3||
48399182|NCT03515213|101306501|FG000|STARTED|Overall Study||9||
48399183|NCT03515213|101306502|FG001|STARTED|Overall Study||1||
48399184|NCT03515213|101306501|FG000|COMPLETED|Overall Study||9||
48399185|NCT03515213|101306502|FG001|COMPLETED|Overall Study||1||
48399186|NCT03515213|101306501|FG000|NOT COMPLETED|Overall Study||0||
48399187|NCT03515213|101306502|FG001|NOT COMPLETED|Overall Study||0||
48399188|NCT01614912|101309061|FG000|STARTED|Overall Study||284||
48399189|NCT01614912|101309061|FG000|COMPLETED|Overall Study||159||
48399190|NCT01614912|101309061|FG000|NOT COMPLETED|Overall Study||125||
48131095|NCT00462384|100645797|FG000|STARTED|Overall Study||39||
48131096|NCT00462384|100645797|FG000|COMPLETED|Overall Study||30||
48399191|NCT01000025|101309062|FG000|STARTED|Overall Study||480||
48399192|NCT01000025|101309063|FG001|STARTED|Overall Study||240||
48399193|NCT01000025|101309062|FG000|COMPLETED|Overall Study||12||
48574622|NCT00610155|101738369|FG002|COMPLETED|Washout Period 2 (7 Days)||3||
48574623|NCT00610155|101738370|FG003|COMPLETED|Washout Period 2 (7 Days)||3||
48399194|NCT01000025|101309063|FG001|COMPLETED|Overall Study||2||
48574624|NCT00610155|101738371|FG004|COMPLETED|Washout Period 2 (7 Days)||3||
48574625|NCT00610155|101738372|FG005|COMPLETED|Washout Period 2 (7 Days)||1||
48574626|NCT00610155|101738367|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48574627|NCT00610155|101738368|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48574628|NCT00610155|101738369|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48574629|NCT00610155|101738370|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48574630|NCT00610155|101738371|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48574631|NCT00610155|101738372|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48574632|NCT00610155|101738367|FG000|STARTED|Period 3||4||
48574633|NCT00610155|101738368|FG001|STARTED|Period 3||3||
48574634|NCT00610155|101738369|FG002|STARTED|Period 3||3||
48574635|NCT00610155|101738370|FG003|STARTED|Period 3||3||
48574636|NCT00610155|101738371|FG004|STARTED|Period 3||3||
48574637|NCT00610155|101738372|FG005|STARTED|Period 3||1||
48574638|NCT00610155|101738367|FG000|COMPLETED|Period 3||3||
48574639|NCT00610155|101738368|FG001|COMPLETED|Period 3||3||
48574640|NCT00610155|101738369|FG002|COMPLETED|Period 3||3||
48574641|NCT00610155|101738370|FG003|COMPLETED|Period 3||3||
48574642|NCT00610155|101738371|FG004|COMPLETED|Period 3||3||
48574643|NCT00610155|101738372|FG005|COMPLETED|Period 3||1||
48574644|NCT00610155|101738367|FG000|NOT COMPLETED|Period 3||1||
48574645|NCT00610155|101738368|FG001|NOT COMPLETED|Period 3||0||
48574646|NCT00610155|101738369|FG002|NOT COMPLETED|Period 3||0||
48574647|NCT00610155|101738370|FG003|NOT COMPLETED|Period 3||0||
48574648|NCT00610155|101738371|FG004|NOT COMPLETED|Period 3||0||
48701843|NCT04323137|102057568|FG003|STARTED|Overall Study||11644||
48701844|NCT04323137|102057569|FG004|STARTED|Overall Study||46898||
48574649|NCT00610155|101738372|FG005|NOT COMPLETED|Period 3||0||
48574650|NCT00942890|101738373|FG000|STARTED|Overall Study||21||
48574651|NCT00942890|101738374|FG001|STARTED|Overall Study||23||
48574652|NCT00942890|101738373|FG000|COMPLETED|Overall Study||21||
48574653|NCT00942890|101738374|FG001|COMPLETED|Overall Study||23||
48574654|NCT00942890|101738373|FG000|NOT COMPLETED|Overall Study||0||
48574655|NCT00942890|101738374|FG001|NOT COMPLETED|Overall Study||0||
48574656|NCT01113385|101738375|FG000|STARTED|Overall Study||7||
48574657|NCT01113385|101738375|FG000|COMPLETED|Overall Study||7||
48574658|NCT01113385|101738375|FG000|NOT COMPLETED|Overall Study||0||
48574659|NCT00887315|101738376|FG000|STARTED|Overall Study||7||
48574660|NCT00887315|101738377|FG001|STARTED|Overall Study||4||
48574661|NCT00887315|101738376|FG000|COMPLETED|Overall Study||0||
48574662|NCT00887315|101738377|FG001|COMPLETED|Overall Study||0||
48574663|NCT00887315|101738376|FG000|NOT COMPLETED|Overall Study||7||
48574664|NCT00887315|101738377|FG001|NOT COMPLETED|Overall Study||4||
48574665|NCT03991299|101738378|FG000|STARTED|Overall Study||4||
48574666|NCT03991299|101738378|FG000|COMPLETED|Overall Study||0||
48574667|NCT03991299|101738378|FG000|NOT COMPLETED|Overall Study||4||
48574668|NCT02821338|101738379|FG000|STARTED|Overall Study||15|All completed subjects received two rounds of Lamictal and Lamotrigine.|
48574669|NCT02821338|101738380|FG001|STARTED|Overall Study||15|All completed subjects received two rounds of Lamictal and Lamotrigine.|
48574670|NCT02821338|101738379|FG000|COMPLETED|Overall Study||12||
48574671|NCT02821338|101738380|FG001|COMPLETED|Overall Study||13||
48574672|NCT02821338|101738379|FG000|NOT COMPLETED|Overall Study||3||
48574673|NCT02821338|101738380|FG001|NOT COMPLETED|Overall Study||2||
48574674|NCT00885664|101738381|FG000|STARTED|Overall Study||60||
48574675|NCT00885664|101738381|FG000|COMPLETED|Overall Study||48||
48574676|NCT00885664|101738381|FG000|NOT COMPLETED|Overall Study||12||
48574677|NCT01684423|101738382|FG000|STARTED|Overall Study||11||
48574678|NCT01684423|101738383|FG001|STARTED|Overall Study||13||
48574679|NCT01684423|101738384|FG002|STARTED|Overall Study||13||
48574680|NCT01684423|101738385|FG003|STARTED|Overall Study||19||
48574681|NCT01684423|101738386|FG004|STARTED|Overall Study||7||
48574682|NCT01684423|101738382|FG000|COMPLETED|Overall Study||11||
48574683|NCT01684423|101738383|FG001|COMPLETED|Overall Study||13||
48574684|NCT01684423|101738384|FG002|COMPLETED|Overall Study||12||
48574685|NCT01684423|101738385|FG003|COMPLETED|Overall Study||19||
48574686|NCT01684423|101738386|FG004|COMPLETED|Overall Study||7||
48574687|NCT01684423|101738382|FG000|NOT COMPLETED|Overall Study||0||
48574688|NCT01684423|101738383|FG001|NOT COMPLETED|Overall Study||0||
48701845|NCT04323137|102057570|FG005|STARTED|Overall Study||24149||
48701846|NCT04323137|102057565|FG000|COMPLETED|Overall Study||11667||
48574689|NCT01684423|101738384|FG002|NOT COMPLETED|Overall Study||1||
48574690|NCT01684423|101738385|FG003|NOT COMPLETED|Overall Study||0||
48574691|NCT01684423|101738386|FG004|NOT COMPLETED|Overall Study||0||
48574692|NCT00267969|101738387|FG000|STARTED|Controlled Period||255||
48574693|NCT00267969|101738388|FG001|STARTED|Controlled Period||255||
48574694|NCT00267969|101738389|FG002|STARTED|Controlled Period||256||
48574695|NCT00267969|101738390|FG003|STARTED|Controlled Period||0||
48574696|NCT00267969|101738391|FG004|STARTED|Controlled Period||0||
48574697|NCT00267969|101738392|FG005|STARTED|Controlled Period||0||
48574698|NCT00267969|101738393|FG006|STARTED|Controlled Period||0||
48574699|NCT00267969|101738387|FG000|COMPLETED|Controlled Period||243||
48574700|NCT00267969|101738388|FG001|COMPLETED|Controlled Period||254||
48701847|NCT04323137|102057566|FG001|COMPLETED|Overall Study||11639||
48574701|NCT00267969|101738389|FG002|COMPLETED|Controlled Period||245||
48574702|NCT00267969|101738390|FG003|COMPLETED|Controlled Period||0||
48574703|NCT00267969|101738391|FG004|COMPLETED|Controlled Period||0||
48131097|NCT00462384|100645797|FG000|NOT COMPLETED|Overall Study||9||
48131098|NCT00253864|100645798|FG000|STARTED|Overall Study||48||
48131099|NCT00253864|100645799|FG001|STARTED|Overall Study||42||
48131100|NCT00253864|100645798|FG000|COMPLETED|Overall Study||43||
48399195|NCT01000025|101309062|FG000|NOT COMPLETED|Overall Study||468||
48399196|NCT01000025|101309063|FG001|NOT COMPLETED|Overall Study||238||
48399197|NCT01590212|101309064|FG000|STARTED|Overall Study||12||
48399198|NCT01590212|101309065|FG001|STARTED|Overall Study||9||
48399199|NCT01590212|101309066|FG002|STARTED|Overall Study||14||
48399200|NCT01590212|101309064|FG000|Baseline (Pre-intervention)|Overall Study||10||
48399201|NCT01590212|101309065|FG001|Baseline (Pre-intervention)|Overall Study||9||
48399202|NCT01590212|101309066|FG002|Baseline (Pre-intervention)|Overall Study||12||
48399203|NCT01590212|101309064|FG000|Post-intervention|Overall Study||7||
48399204|NCT01590212|101309065|FG001|Post-intervention|Overall Study||6||
48399205|NCT01590212|101309066|FG002|Post-intervention|Overall Study||10||
48399206|NCT01590212|101309064|FG000|COMPLETED|Overall Study||9||
48399207|NCT01590212|101309065|FG001|COMPLETED|Overall Study||5||
48399208|NCT01590212|101309066|FG002|COMPLETED|Overall Study||9||
48399209|NCT01590212|101309064|FG000|NOT COMPLETED|Overall Study||3||
48399210|NCT01590212|101309065|FG001|NOT COMPLETED|Overall Study||4||
48399211|NCT01590212|101309066|FG002|NOT COMPLETED|Overall Study||5||
48399212|NCT01449955|101309067|FG000|STARTED|Overall Study||28||
48399213|NCT01449955|101309068|FG001|STARTED|Overall Study||26||
48399214|NCT01449955|101309067|FG000|COMPLETED|Overall Study||27||
48131101|NCT00253864|100645799|FG001|COMPLETED|Overall Study||34||
48131102|NCT00253864|100645798|FG000|NOT COMPLETED|Overall Study||5||
48131103|NCT00253864|100645799|FG001|NOT COMPLETED|Overall Study||8||
48131104|NCT01226745|100645800|FG000|STARTED|Overall Study||80||
48131105|NCT01226745|100645801|FG001|STARTED|Overall Study||87||
48131106|NCT01226745|100645802|FG002|STARTED|Overall Study||89||
48399215|NCT01449955|101309068|FG001|COMPLETED|Overall Study||24||
48399216|NCT01449955|101309067|FG000|NOT COMPLETED|Overall Study||1||
48399217|NCT01449955|101309068|FG001|NOT COMPLETED|Overall Study||2||
48399218|NCT01156532|101309069|FG000|STARTED|Overall Study||30||
48399219|NCT01156532|101309069|FG000|COMPLETED|Overall Study||28||
48574704|NCT00267969|101738392|FG005|COMPLETED|Controlled Period||0||
48574705|NCT00267969|101738393|FG006|COMPLETED|Controlled Period||0||
48574706|NCT00267969|101738387|FG000|NOT COMPLETED|Controlled Period||12||
48574707|NCT00267969|101738388|FG001|NOT COMPLETED|Controlled Period||1||
48574708|NCT00267969|101738389|FG002|NOT COMPLETED|Controlled Period||11||
48574709|NCT00267969|101738390|FG003|NOT COMPLETED|Controlled Period||0||
48574710|NCT00267969|101738391|FG004|NOT COMPLETED|Controlled Period||0||
48574711|NCT00267969|101738392|FG005|NOT COMPLETED|Controlled Period||0||
48574712|NCT00267969|101738393|FG006|NOT COMPLETED|Controlled Period||0||
48574713|NCT00267969|101738387|FG000|STARTED|After Controlled Period||0||
48574714|NCT00267969|101738388|FG001|STARTED|After Controlled Period||0||
48574715|NCT00267969|101738389|FG002|STARTED|After Controlled Period||0||
48574716|NCT00267969|101738390|FG003|STARTED|After Controlled Period||123||
48574717|NCT00267969|101738391|FG004|STARTED|After Controlled Period||120||
48574718|NCT00267969|101738392|FG005|STARTED|After Controlled Period||254||
48574719|NCT00267969|101738393|FG006|STARTED|After Controlled Period||245||
48574720|NCT00267969|101738387|FG000|COMPLETED|After Controlled Period||0||
48574721|NCT00267969|101738388|FG001|COMPLETED|After Controlled Period||0||
48574722|NCT00267969|101738389|FG002|COMPLETED|After Controlled Period||0||
48574723|NCT00267969|101738390|FG003|COMPLETED|After Controlled Period||87||
48574724|NCT00267969|101738391|FG004|COMPLETED|After Controlled Period||85||
48574725|NCT00267969|101738392|FG005|COMPLETED|After Controlled Period||172||
48574726|NCT00267969|101738393|FG006|COMPLETED|After Controlled Period||173||
48574727|NCT00267969|101738387|FG000|NOT COMPLETED|After Controlled Period||0||
48574728|NCT00267969|101738388|FG001|NOT COMPLETED|After Controlled Period||0||
48574729|NCT00267969|101738389|FG002|NOT COMPLETED|After Controlled Period||0||
48574730|NCT00267969|101738390|FG003|NOT COMPLETED|After Controlled Period||36||
48574731|NCT00267969|101738391|FG004|NOT COMPLETED|After Controlled Period||35||
48574732|NCT00267969|101738392|FG005|NOT COMPLETED|After Controlled Period||82||
48574733|NCT00267969|101738393|FG006|NOT COMPLETED|After Controlled Period||72||
48574734|NCT02035202|101738394|FG000|STARTED|Overall Study||85||
48574735|NCT02035202|101738395|FG001|STARTED|Overall Study||85||
48399220|NCT01156532|101309069|FG000|NOT COMPLETED|Overall Study||2||
48399221|NCT01176240|101309070|FG000|STARTED|Study 306A||24||
48399222|NCT01176240|101309071|FG001|STARTED|Study 306A||27||
48574736|NCT02035202|101738396|FG002|STARTED|Overall Study||85||
48574737|NCT02035202|101738394|FG000|COMPLETED|Overall Study||77||
48574738|NCT02035202|101738395|FG001|COMPLETED|Overall Study||69||
48574739|NCT02035202|101738396|FG002|COMPLETED|Overall Study||83||
48574740|NCT02035202|101738394|FG000|NOT COMPLETED|Overall Study||8||
48574741|NCT02035202|101738395|FG001|NOT COMPLETED|Overall Study||16||
48574742|NCT02035202|101738396|FG002|NOT COMPLETED|Overall Study||2||
48399223|NCT01176240|101309070|FG000|COMPLETED|Study 306A||21||
48701848|NCT04323137|102057567|FG002|COMPLETED|Overall Study||11652||
48131107|NCT01226745|100645803|FG003|STARTED|Overall Study||29||
48131108|NCT01226745|100645804|FG004|STARTED|Overall Study||26||
48131109|NCT01226745|100645805|FG005|STARTED|Overall Study||29||
48399224|NCT01176240|101309071|FG001|COMPLETED|Study 306A||24||
48574743|NCT00713258|101738397|FG000|STARTED|Overall Study||41||
48574744|NCT00713258|101738398|FG001|STARTED|Overall Study||34||
48574745|NCT00713258|101738397|FG000|COMPLETED|Overall Study||36||
48574746|NCT00713258|101738398|FG001|COMPLETED|Overall Study||28||
48574747|NCT00713258|101738397|FG000|NOT COMPLETED|Overall Study||5||
48574748|NCT00713258|101738398|FG001|NOT COMPLETED|Overall Study||6||
48574749|NCT03887442|101738399|FG000|STARTED|Overall Study||9||
48574750|NCT03887442|101738400|FG001|STARTED|Overall Study||8||
48574751|NCT03887442|101738399|FG000|COMPLETED|Overall Study||8||
48574752|NCT03887442|101738400|FG001|COMPLETED|Overall Study||8||
48574753|NCT03887442|101738399|FG000|NOT COMPLETED|Overall Study||1||
48574754|NCT03887442|101738400|FG001|NOT COMPLETED|Overall Study||0||
48574755|NCT01091662|101738401|FG000|STARTED|Overall Study||58||
48574756|NCT01091662|101738402|FG001|STARTED|Overall Study||114||
48574757|NCT01091662|101738401|FG000|COMPLETED|Overall Study||41||
48574758|NCT01091662|101738402|FG001|COMPLETED|Overall Study||80||
48574759|NCT01091662|101738401|FG000|NOT COMPLETED|Overall Study||17||
48574760|NCT01091662|101738402|FG001|NOT COMPLETED|Overall Study||34||
48574761|NCT04157296|101738403|FG000|STARTED|Overall Study||6||
48574762|NCT04157296|101738404|FG001|STARTED|Overall Study||15||
48574763|NCT04157296|101738403|FG000|COMPLETED|Overall Study||6||
48574764|NCT04157296|101738404|FG001|COMPLETED|Overall Study||12||
48574765|NCT04157296|101738403|FG000|NOT COMPLETED|Overall Study||0||
48574766|NCT04157296|101738404|FG001|NOT COMPLETED|Overall Study||3||
48574767|NCT00665431|101738405|FG000|STARTED|Overall Study||243||
48574768|NCT00665431|101738406|FG001|STARTED|Overall Study||245||
48574769|NCT00665431|101738407|FG002|STARTED|Overall Study||122||
48574770|NCT00665431|101738405|FG000|COMPLETED|Overall Study||203||
48574771|NCT00665431|101738406|FG001|COMPLETED|Overall Study||188||
48574772|NCT00665431|101738407|FG002|COMPLETED|Overall Study||98||
48574773|NCT00665431|101738405|FG000|NOT COMPLETED|Overall Study||40||
48574774|NCT00665431|101738406|FG001|NOT COMPLETED|Overall Study||57||
48574775|NCT00665431|101738407|FG002|NOT COMPLETED|Overall Study||24||
48574776|NCT04244084|101738408|FG000|STARTED|Overall Study||118||
48574777|NCT04244084|101738409|FG001|STARTED|Overall Study||122||
48574778|NCT04244084|101738408|FG000|COMPLETED|Overall Study||118||
48574779|NCT04244084|101738409|FG001|COMPLETED|Overall Study||122||
48574780|NCT04244084|101738408|FG000|NOT COMPLETED|Overall Study||0||
48574781|NCT04244084|101738409|FG001|NOT COMPLETED|Overall Study||0||
48574782|NCT00379080|101738410|FG000|STARTED|Overall Study||6||
48574783|NCT00379080|101738411|FG001|STARTED|Overall Study||19||
48574784|NCT00379080|101738412|FG002|STARTED|Overall Study||31||
48574785|NCT00379080|101738410|FG000|COMPLETED|Overall Study||6||
48574786|NCT00379080|101738411|FG001|COMPLETED|Overall Study||15||
48574787|NCT00379080|101738412|FG002|COMPLETED|Overall Study||31||
48574788|NCT00379080|101738410|FG000|NOT COMPLETED|Overall Study||0||
48574789|NCT00379080|101738411|FG001|NOT COMPLETED|Overall Study||4||
48574790|NCT00379080|101738412|FG002|NOT COMPLETED|Overall Study||0||
48574791|NCT04747886|101738413|FG000|STARTED|Overall Study||14||
48574792|NCT04747886|101738414|FG001|STARTED|Overall Study||20||
48574793|NCT04747886|101738413|FG000|COMPLETED|Overall Study||13||
48574794|NCT04747886|101738414|FG001|COMPLETED|Overall Study||16||
48574795|NCT04747886|101738413|FG000|NOT COMPLETED|Overall Study||1||
48574796|NCT04747886|101738414|FG001|NOT COMPLETED|Overall Study||4||
48574797|NCT00561392|101738415|FG000|STARTED|Overall Study||208||
48574798|NCT00561392|101738415|FG000|COMPLETED|Overall Study||155||
48574799|NCT00561392|101738415|FG000|NOT COMPLETED|Overall Study||53||
48574800|NCT01575834|101738416|FG000|STARTED|Overall Study||3591||
48574801|NCT01575834|101738417|FG001|STARTED|Overall Study||3589||
48574802|NCT01575834|101738416|FG000|Received Double-blind Treatment|Overall Study||3582||
48574803|NCT01575834|101738417|FG001|Received Double-blind Treatment|Overall Study||3575||
48574804|NCT01575834|101738416|FG000|Completed Double-blind Period|Overall Study||3205||
48574805|NCT01575834|101738417|FG001|Completed Double-blind Period|Overall Study||3185||
48574806|NCT01575834|101738416|FG000|Completed 24-month Study Period|Overall Study||3032||
48574807|NCT01575834|101738417|FG001|Completed 24-month Study Period|Overall Study||2994||
48574808|NCT01575834|101738416|FG000|COMPLETED|Overall Study||2892||
48574809|NCT01575834|101738417|FG001|COMPLETED|Overall Study||2851||
48574810|NCT01575834|101738416|FG000|NOT COMPLETED|Overall Study||699||
48574811|NCT01575834|101738417|FG001|NOT COMPLETED|Overall Study||738||
48574812|NCT00945035|101738418|FG000|STARTED|Period 1||18||
48574813|NCT00945035|101738419|FG001|STARTED|Period 1||18||
48574814|NCT00945035|101738418|FG000|COMPLETED|Period 1||18||
48574815|NCT00945035|101738419|FG001|COMPLETED|Period 1||18||
48574816|NCT00945035|101738418|FG000|NOT COMPLETED|Period 1||0||
48574817|NCT00945035|101738419|FG001|NOT COMPLETED|Period 1||0||
48574818|NCT00945035|101738418|FG000|STARTED|Period 2||18||
48574819|NCT00945035|101738419|FG001|STARTED|Period 2||18||
48574820|NCT00945035|101738418|FG000|COMPLETED|Period 2||18||
48574821|NCT00945035|101738419|FG001|COMPLETED|Period 2||18||
48574822|NCT00945035|101738418|FG000|NOT COMPLETED|Period 2||0||
48574823|NCT00945035|101738419|FG001|NOT COMPLETED|Period 2||0||
48574824|NCT00582608|101738420|FG000|STARTED|Overall Study||12||
48574825|NCT00582608|101738420|FG000|COMPLETED|Overall Study||0||
48574826|NCT00582608|101738420|FG000|NOT COMPLETED|Overall Study||12||
48574827|NCT04332081|101738421|FG000|STARTED|Overall Study||20||
48131110|NCT01226745|100645800|FG000|COMPLETED|Overall Study||63||
48131111|NCT01226745|100645801|FG001|COMPLETED|Overall Study||71||
48131112|NCT01226745|100645802|FG002|COMPLETED|Overall Study||69||
48399225|NCT01176240|101309070|FG000|NOT COMPLETED|Study 306A||3||
48399226|NCT01176240|101309071|FG001|NOT COMPLETED|Study 306A||3||
48399227|NCT01176240|101309070|FG000|STARTED|Study 306B||89||
48399228|NCT01176240|101309071|FG001|STARTED|Study 306B||85||
48399229|NCT01176240|101309070|FG000|Took at Least 1 Dose of Study Drug|Study 306B||87||
48399230|NCT01176240|101309071|FG001|Took at Least 1 Dose of Study Drug|Study 306B||84||
48399231|NCT01176240|101309070|FG000|1 wk of Stable Dosing and Visit 4|Study 306B||69||
48399232|NCT01176240|101309071|FG001|1 wk of Stable Dosing and Visit 4|Study 306B||78||
48399233|NCT01176240|101309070|FG000|2 wk of Stable Dosing and Visit 5|Study 306B||68||
48399234|NCT01176240|101309071|FG001|2 wk of Stable Dosing and Visit 5|Study 306B||75||
48574828|NCT04332081|101738422|FG001|STARTED|Overall Study||60||
48574829|NCT04332081|101738421|FG000|COMPLETED|Overall Study||20||
48574830|NCT04332081|101738422|FG001|COMPLETED|Overall Study||60||
48574831|NCT04332081|101738421|FG000|NOT COMPLETED|Overall Study||0||
48574832|NCT04332081|101738422|FG001|NOT COMPLETED|Overall Study||0||
48574833|NCT02647723|101738423|FG000|STARTED|Overall Study||112||
48574834|NCT02647723|101738424|FG001|STARTED|Overall Study||56||
48574835|NCT02647723|101738423|FG000|COMPLETED|Overall Study||112||
48574836|NCT02647723|101738424|FG001|COMPLETED|Overall Study||56||
48574837|NCT02647723|101738423|FG000|NOT COMPLETED|Overall Study||0||
48131113|NCT01226745|100645803|FG003|COMPLETED|Overall Study||24||
48131114|NCT01226745|100645804|FG004|COMPLETED|Overall Study||22||
48131115|NCT01226745|100645805|FG005|COMPLETED|Overall Study||24||
48131116|NCT01226745|100645800|FG000|NOT COMPLETED|Overall Study||17||
48131117|NCT01226745|100645801|FG001|NOT COMPLETED|Overall Study||16||
48131118|NCT01226745|100645802|FG002|NOT COMPLETED|Overall Study||20||
48131119|NCT01226745|100645803|FG003|NOT COMPLETED|Overall Study||5||
48574838|NCT02647723|101738424|FG001|NOT COMPLETED|Overall Study||0||
48574839|NCT00863356|101738425|FG000|STARTED|Overall Study||20||
48574840|NCT00863356|101738425|FG000|COMPLETED|Overall Study||20||
48574841|NCT00863356|101738425|FG000|NOT COMPLETED|Overall Study||0||
48574842|NCT02935179|101738426|FG000|STARTED|Overall Study||30||
48574843|NCT02935179|101738427|FG001|STARTED|Overall Study||30||
48574844|NCT02935179|101738426|FG000|COMPLETED|Overall Study||29||
48131120|NCT01226745|100645804|FG004|NOT COMPLETED|Overall Study||4||
48131121|NCT01226745|100645805|FG005|NOT COMPLETED|Overall Study||5||
48131122|NCT01385059|100645806|FG000|STARTED|Overall Study||4||
48131123|NCT01385059|100645807|FG001|STARTED|Overall Study||7||
48131124|NCT01385059|100645806|FG000|COMPLETED|Overall Study||4||
48131125|NCT01385059|100645807|FG001|COMPLETED|Overall Study||7||
48131126|NCT01385059|100645806|FG000|NOT COMPLETED|Overall Study||0||
48131127|NCT01385059|100645807|FG001|NOT COMPLETED|Overall Study||0||
48131128|NCT01519206|100645808|FG000|STARTED|Overall Study||32||
48131129|NCT01519206|100645808|FG000|COMPLETED|Overall Study||27||
48131130|NCT01519206|100645808|FG000|NOT COMPLETED|Overall Study||5||
48285016|NCT01191268|101021626|FG002|NOT COMPLETED|Overall Study||52||
48285017|NCT01942785|101021627|FG000|STARTED|Overall Study||54||
48285018|NCT01942785|101021627|FG000|COMPLETED|Overall Study||50||
48285019|NCT01942785|101021627|FG000|NOT COMPLETED|Overall Study||4||
48285020|NCT05543187|101021628|FG000|STARTED|Overall Study||3||
48285021|NCT05543187|101021629|FG001|STARTED|Overall Study||2||
48285022|NCT05543187|101021628|FG000|Dosed TAK-625 150 mcg/kg|Overall Study||3|TAK-625 orally, BID for 1 week in Dose Escalation Period.|
48285023|NCT05543187|101021629|FG001|Dosed TAK-625 150 mcg/kg|Overall Study||2|TAK-625 orally, BID for 1 week in Dose Escalation Period.|
48285024|NCT05543187|101021628|FG000|Dosed TAK-625 300 mcg/kg|Overall Study||3|TAK-625 orally, BID for 1 week in Dose Escalation Period.|
48285025|NCT05543187|101021629|FG001|Dosed TAK-625 300 mcg/kg|Overall Study||2|TAK-625 orally, BID for 1 week in Dose Escalation Period.|
48285026|NCT05543187|101021628|FG000|Dosed TAK-625 450 mcg/kg|Overall Study||3|TAK-625 orally, BID for 1 week in Dose Escalation Period.|
48285027|NCT05543187|101021629|FG001|Dosed TAK-625 450 mcg/kg|Overall Study||2|TAK-625 orally, BID for 1 week in Dose Escalation Period.|
48285028|NCT05543187|101021628|FG000|Dosed TAK-625 600 mcg/kg|Overall Study||3|TAK-625 orally, BID for 1 week in Dose Escalation Period and for up to 22 weeks after Dose Escalation Period.|
48285029|NCT05543187|101021629|FG001|Dosed TAK-625 600 mcg/kg|Overall Study||2|TAK-625 orally, BID for 1 week in Dose Escalation Period and for up to 22 weeks after Dose Escalation Period.|
48285030|NCT05543187|101021628|FG000|COMPLETED|Overall Study||0||
48574845|NCT02935179|101738427|FG001|COMPLETED|Overall Study||29||
48574846|NCT02935179|101738426|FG000|NOT COMPLETED|Overall Study||1||
48574847|NCT02935179|101738427|FG001|NOT COMPLETED|Overall Study||1||
48574848|NCT02844543|101738428|FG000|STARTED|Overall Study||155||
48574849|NCT02844543|101738428|FG000|COMPLETED|Overall Study||150||
48131131|NCT02546544|100645809|FG000|STARTED|Overall Study||16||
48131132|NCT02546544|100645809|FG000|Received Allocated Intervention|Overall Study||16||
48131133|NCT02546544|100645809|FG000|COMPLETED|Overall Study||0||
48131134|NCT02546544|100645809|FG000|NOT COMPLETED|Overall Study||16||
48131135|NCT02357836|100645810|FG000|STARTED|Overall Study||13||
48131136|NCT02357836|100645810|FG000|COMPLETED|Overall Study||13||
48131137|NCT02357836|100645810|FG000|NOT COMPLETED|Overall Study||0||
48131138|NCT00693992|100645811|FG000|STARTED|Overall Study||106||
48131139|NCT00693992|100645812|FG001|STARTED|Overall Study||104||
48701849|NCT04323137|102057568|FG003|COMPLETED|Overall Study||11644||
48701850|NCT04323137|102057569|FG004|COMPLETED|Overall Study||46898||
48701851|NCT04323137|102057570|FG005|COMPLETED|Overall Study||24149||
48701852|NCT04323137|102057565|FG000|NOT COMPLETED|Overall Study||0||
48701853|NCT04323137|102057566|FG001|NOT COMPLETED|Overall Study||0||
48701854|NCT04323137|102057567|FG002|NOT COMPLETED|Overall Study||0||
48285031|NCT05543187|101021629|FG001|COMPLETED|Overall Study||0||
48285032|NCT05543187|101021628|FG000|NOT COMPLETED|Overall Study||3||
48285033|NCT05543187|101021629|FG001|NOT COMPLETED|Overall Study||2||
48285034|NCT00844532|101021630|FG000|STARTED|Overall Study||151||
48285035|NCT00844532|101021630|FG000|COMPLETED|Overall Study||112||
48285036|NCT00844532|101021630|FG000|NOT COMPLETED|Overall Study||39||
48285037|NCT00766363|101021631|FG000|STARTED|Overall Study||12||
48285038|NCT00766363|101021632|FG001|STARTED|Overall Study||13||
48285039|NCT00766363|101021633|FG002|STARTED|Overall Study||12||
48285040|NCT00766363|101021634|FG003|STARTED|Overall Study||12||
48285041|NCT00766363|101021631|FG000|SAFETY POPULATION|Overall Study||12||
48285042|NCT00766363|101021632|FG001|SAFETY POPULATION|Overall Study||13||
48285043|NCT00766363|101021633|FG002|SAFETY POPULATION|Overall Study||11||
48285044|NCT00766363|101021634|FG003|SAFETY POPULATION|Overall Study||13||
48285045|NCT00766363|101021631|FG000|PK POPULATION|Overall Study||12||
48285046|NCT00766363|101021632|FG001|PK POPULATION|Overall Study||13||
48285047|NCT00766363|101021633|FG002|PK POPULATION|Overall Study||10||
48285048|NCT00766363|101021634|FG003|PK POPULATION|Overall Study||13||
48285049|NCT00766363|101021631|FG000|COMPLETED|Overall Study||11||
48285050|NCT00766363|101021632|FG001|COMPLETED|Overall Study||12||
48285051|NCT00766363|101021633|FG002|COMPLETED|Overall Study||12||
48285052|NCT00766363|101021634|FG003|COMPLETED|Overall Study||12||
48285053|NCT00766363|101021631|FG000|NOT COMPLETED|Overall Study||1||
48399235|NCT01176240|101309070|FG000|4 wk of Stable Dosing and Visit 6|Study 306B||67||
48399236|NCT01176240|101309071|FG001|4 wk of Stable Dosing and Visit 6|Study 306B||73||
48399237|NCT01176240|101309070|FG000|COMPLETED|Study 306B||63||
48399238|NCT01176240|101309071|FG001|COMPLETED|Study 306B||68||
48399239|NCT01176240|101309070|FG000|NOT COMPLETED|Study 306B||26||
48399240|NCT01176240|101309071|FG001|NOT COMPLETED|Study 306B||17||
48399241|NCT00423592|101309072|FG000|STARTED|Overall Study||36||
48399242|NCT00423592|101309072|FG000|Completed Preliminary Analysis Cut-off|Overall Study||34||
48399243|NCT00423592|101309072|FG000|COMPLETED|Overall Study||29||
48399244|NCT00423592|101309072|FG000|NOT COMPLETED|Overall Study||7||
48399245|NCT01915095|101309073|FG000|STARTED|Overall Study||10||
48399246|NCT01915095|101309074|FG001|STARTED|Overall Study||10||
48399247|NCT01915095|101309075|FG002|STARTED|Overall Study||5||
48399248|NCT01915095|101309076|FG003|STARTED|Overall Study||8||
48399249|NCT01915095|101309077|FG004|STARTED|Overall Study||9||
48399250|NCT01915095|101309073|FG000|SCI|Overall Study||5||
48399251|NCT01915095|101309074|FG001|SCI|Overall Study||5||
48399252|NCT01915095|101309075|FG002|SCI|Overall Study||5||
48399253|NCT01915095|101309076|FG003|SCI|Overall Study||8||
48399254|NCT01915095|101309077|FG004|SCI|Overall Study||9||
48399255|NCT01915095|101309073|FG000|Control|Overall Study||5||
48399256|NCT01915095|101309074|FG001|Control|Overall Study||5||
48399257|NCT01915095|101309075|FG002|Control|Overall Study||0||
48399258|NCT01915095|101309076|FG003|Control|Overall Study||0||
48399259|NCT01915095|101309077|FG004|Control|Overall Study||0||
48399260|NCT01915095|101309073|FG000|COMPLETED|Overall Study||10||
48399261|NCT01915095|101309074|FG001|COMPLETED|Overall Study||10||
48399262|NCT01915095|101309075|FG002|COMPLETED|Overall Study||5||
48399263|NCT01915095|101309076|FG003|COMPLETED|Overall Study||4||
48399264|NCT01915095|101309077|FG004|COMPLETED|Overall Study||3||
48399265|NCT01915095|101309073|FG000|NOT COMPLETED|Overall Study||0||
48399266|NCT01915095|101309074|FG001|NOT COMPLETED|Overall Study||0||
48399267|NCT01915095|101309075|FG002|NOT COMPLETED|Overall Study||0||
48399268|NCT01915095|101309076|FG003|NOT COMPLETED|Overall Study||4||
48399269|NCT01915095|101309077|FG004|NOT COMPLETED|Overall Study||6||
48399270|NCT04965116|101309078|FG000|STARTED|Overall Study||10||
48399271|NCT04965116|101309079|FG001|STARTED|Overall Study||10||
48399272|NCT04965116|101309080|FG002|STARTED|Overall Study||10||
48399273|NCT04965116|101309078|FG000|COMPLETED|Overall Study||10||
48701855|NCT04323137|102057568|FG003|NOT COMPLETED|Overall Study||0||
48285054|NCT00766363|101021632|FG001|NOT COMPLETED|Overall Study||1||
48285055|NCT00766363|101021633|FG002|NOT COMPLETED|Overall Study||0||
48285056|NCT00766363|101021634|FG003|NOT COMPLETED|Overall Study||0||
48285057|NCT02884908|101021635|FG000|STARTED|Overall Study||32|Total randomized.|
48285058|NCT02884908|101021636|FG001|STARTED|Overall Study||25|Total randomized.|
48285059|NCT02884908|101021635|FG000|African American|Overall Study||30||
48399274|NCT04965116|101309079|FG001|COMPLETED|Overall Study||10||
48399275|NCT04965116|101309080|FG002|COMPLETED|Overall Study||10||
48399276|NCT04965116|101309078|FG000|NOT COMPLETED|Overall Study||0||
48399277|NCT04965116|101309079|FG001|NOT COMPLETED|Overall Study||0||
48399278|NCT04965116|101309080|FG002|NOT COMPLETED|Overall Study||0||
48399279|NCT01457924|101309081|FG000|STARTED|Treatment Phase (Weeks 0-24)||67||
48399280|NCT01457924|101309082|FG001|STARTED|Treatment Phase (Weeks 0-24)||34||
48399281|NCT01457924|101309083|FG002|STARTED|Treatment Phase (Weeks 0-24)||32||
48399282|NCT01457924|101309084|FG003|STARTED|Treatment Phase (Weeks 0-24)||34||
48574850|NCT02844543|101738428|FG000|NOT COMPLETED|Overall Study||5||
48574851|NCT01453088|101738429|FG000|STARTED|Overall Study||32||
48574852|NCT01453088|101738430|FG001|STARTED|Overall Study||31||
48574853|NCT01453088|101738429|FG000|COMPLETED|Overall Study||28||
48574854|NCT01453088|101738430|FG001|COMPLETED|Overall Study||31||
48574855|NCT01453088|101738429|FG000|NOT COMPLETED|Overall Study||4||
48574856|NCT01453088|101738430|FG001|NOT COMPLETED|Overall Study||0||
48574857|NCT00996125|101738431|FG000|STARTED|Overall Study||374||
48574858|NCT00996125|101738432|FG001|STARTED|Overall Study||376||
48574859|NCT00996125|101738431|FG000|COMPLETED|Overall Study||369||
48574860|NCT00996125|101738432|FG001|COMPLETED|Overall Study||365||
48574861|NCT00996125|101738431|FG000|NOT COMPLETED|Overall Study||5||
48574862|NCT00996125|101738432|FG001|NOT COMPLETED|Overall Study||11||
48574863|NCT01437995|101738433|FG000|STARTED|Overall Study||151||
48574864|NCT01437995|101738434|FG001|STARTED|Overall Study||149||
48574865|NCT01437995|101738435|FG002|STARTED|Overall Study||155||
48574866|NCT01437995|101738433|FG000|Included in Treatment Failure Analysis|Overall Study||150||
48574867|NCT01437995|101738434|FG001|Included in Treatment Failure Analysis|Overall Study||146||
48574868|NCT01437995|101738435|FG002|Included in Treatment Failure Analysis|Overall Study||151||
48701856|NCT04323137|102057569|FG004|NOT COMPLETED|Overall Study||0||
48701857|NCT04323137|102057570|FG005|NOT COMPLETED|Overall Study||0||
48701858|NCT00395135|102057571|FG000|STARTED|Year 1||1595||
48574869|NCT01437995|101738433|FG000|COMPLETED|Overall Study||140||
48574870|NCT01437995|101738434|FG001|COMPLETED|Overall Study||131||
48574871|NCT01437995|101738435|FG002|COMPLETED|Overall Study||135||
48574872|NCT01437995|101738433|FG000|NOT COMPLETED|Overall Study||11||
48574873|NCT01437995|101738434|FG001|NOT COMPLETED|Overall Study||18||
48574874|NCT01437995|101738435|FG002|NOT COMPLETED|Overall Study||20||
48131140|NCT00693992|100645811|FG000|COMPLETED|Overall Study||106||
48131141|NCT00693992|100645812|FG001|COMPLETED|Overall Study||104||
48131142|NCT00693992|100645811|FG000|NOT COMPLETED|Overall Study||0||
48131143|NCT00693992|100645812|FG001|NOT COMPLETED|Overall Study||0||
48131144|NCT03564496|100645813|FG000|STARTED|Overall Study||27||
48285060|NCT02884908|101021636|FG001|African American|Overall Study||24||
48574875|NCT02654977|101738436|FG000|STARTED|Overall Study||11||
48574876|NCT02654977|101738436|FG000|COMPLETED|Overall Study||4||
48574877|NCT02654977|101738436|FG000|NOT COMPLETED|Overall Study||7||
48574878|NCT04075682|101738437|FG000|STARTED|Overall Study||108||
48574879|NCT04075682|101738438|FG001|STARTED|Overall Study||94||
48574880|NCT04075682|101738439|FG002|STARTED|Overall Study||94||
48574881|NCT04075682|101738440|FG003|STARTED|Overall Study||91||
48574882|NCT04075682|101738437|FG000|COMPLETED|Overall Study||101||
48574883|NCT04075682|101738438|FG001|COMPLETED|Overall Study||87||
48574884|NCT04075682|101738439|FG002|COMPLETED|Overall Study||90||
48574885|NCT04075682|101738440|FG003|COMPLETED|Overall Study||89||
48574886|NCT04075682|101738437|FG000|NOT COMPLETED|Overall Study||7||
48574887|NCT04075682|101738438|FG001|NOT COMPLETED|Overall Study||7||
48574888|NCT04075682|101738439|FG002|NOT COMPLETED|Overall Study||4||
48574889|NCT04075682|101738440|FG003|NOT COMPLETED|Overall Study||2||
48574890|NCT04344028|101738441|FG000|STARTED|Overall Study||66||
48574891|NCT04344028|101738442|FG001|STARTED|Overall Study||68||
48574892|NCT04344028|101738443|FG002|STARTED|Overall Study||66||
48574893|NCT04344028|101738444|FG003|STARTED|Overall Study||63||
48574894|NCT04344028|101738445|FG004|STARTED|Overall Study||12||
48574895|NCT04344028|101738446|FG005|STARTED|Overall Study||12||
48574896|NCT04344028|101738441|FG000|COMPLETED|Overall Study||45||
48574897|NCT04344028|101738442|FG001|COMPLETED|Overall Study||49||
48574898|NCT04344028|101738443|FG002|COMPLETED|Overall Study||50||
48574899|NCT04344028|101738444|FG003|COMPLETED|Overall Study||49||
48574900|NCT04344028|101738445|FG004|COMPLETED|Overall Study||9||
48574901|NCT04344028|101738446|FG005|COMPLETED|Overall Study||11||
48574902|NCT04344028|101738441|FG000|NOT COMPLETED|Overall Study||21||
48574903|NCT04344028|101738442|FG001|NOT COMPLETED|Overall Study||19||
48574904|NCT04344028|101738443|FG002|NOT COMPLETED|Overall Study||16||
48574905|NCT04344028|101738444|FG003|NOT COMPLETED|Overall Study||14||
48701859|NCT00395135|102057572|FG001|STARTED|Year 1||1587||
48701860|NCT00395135|102057573|FG002|STARTED|Year 1||0||
48701861|NCT00395135|102057574|FG003|STARTED|Year 1||0||
48701862|NCT00395135|102057575|FG004|STARTED|Year 1||0||
48701863|NCT00395135|102057571|FG000|COMPLETED|Year 1||883||
48701864|NCT00395135|102057572|FG001|COMPLETED|Year 1||716||
48701865|NCT00395135|102057573|FG002|COMPLETED|Year 1||0||
48701866|NCT00395135|102057574|FG003|COMPLETED|Year 1||0||
48701867|NCT00395135|102057575|FG004|COMPLETED|Year 1||0||
48131145|NCT03564496|100645814|FG001|STARTED|Overall Study||40||
48285061|NCT02884908|101021635|FG000|Took 1 Dose of Study Medication|Overall Study||26||
48574906|NCT04344028|101738445|FG004|NOT COMPLETED|Overall Study||3||
48574907|NCT04344028|101738446|FG005|NOT COMPLETED|Overall Study||1||
48574908|NCT00556933|101738447|FG000|STARTED|Single vs. Divided-dose rATG Induction||45||
48574909|NCT00556933|101738448|FG001|STARTED|Single vs. Divided-dose rATG Induction||45||
48574910|NCT00556933|101738449|FG002|STARTED|Single vs. Divided-dose rATG Induction||45||
48701868|NCT00395135|102057571|FG000|NOT COMPLETED|Year 1||712||
48701869|NCT00395135|102057572|FG001|NOT COMPLETED|Year 1||871||
48701870|NCT00395135|102057573|FG002|NOT COMPLETED|Year 1||0||
48574911|NCT00556933|101738450|FG003|STARTED|Single vs. Divided-dose rATG Induction||45||
48574912|NCT00556933|101738447|FG000|COMPLETED|Single vs. Divided-dose rATG Induction||43||
48574913|NCT00556933|101738448|FG001|COMPLETED|Single vs. Divided-dose rATG Induction||37||
48574914|NCT00556933|101738449|FG002|COMPLETED|Single vs. Divided-dose rATG Induction||39||
48574915|NCT00556933|101738450|FG003|COMPLETED|Single vs. Divided-dose rATG Induction||43||
48574916|NCT00556933|101738447|FG000|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2||
48574917|NCT00556933|101738448|FG001|NOT COMPLETED|Single vs. Divided-dose rATG Induction||8||
48574918|NCT00556933|101738449|FG002|NOT COMPLETED|Single vs. Divided-dose rATG Induction||6||
48574919|NCT00556933|101738450|FG003|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2||
48574920|NCT00556933|101738447|FG000|STARTED|CNI Withdrawal vs. Minimization||43||
48574921|NCT00556933|101738448|FG001|STARTED|CNI Withdrawal vs. Minimization||37||
48574922|NCT00556933|101738449|FG002|STARTED|CNI Withdrawal vs. Minimization||39||
48574923|NCT00556933|101738450|FG003|STARTED|CNI Withdrawal vs. Minimization||43||
48574924|NCT00556933|101738447|FG000|COMPLETED|CNI Withdrawal vs. Minimization||42||
48574925|NCT00556933|101738448|FG001|COMPLETED|CNI Withdrawal vs. Minimization||33||
48574926|NCT00556933|101738449|FG002|COMPLETED|CNI Withdrawal vs. Minimization||36||
48574927|NCT00556933|101738450|FG003|COMPLETED|CNI Withdrawal vs. Minimization||41||
48574928|NCT00556933|101738447|FG000|NOT COMPLETED|CNI Withdrawal vs. Minimization||1||
48574929|NCT00556933|101738448|FG001|NOT COMPLETED|CNI Withdrawal vs. Minimization||4||
48574930|NCT00556933|101738449|FG002|NOT COMPLETED|CNI Withdrawal vs. Minimization||3||
48574931|NCT00556933|101738450|FG003|NOT COMPLETED|CNI Withdrawal vs. Minimization||2||
48574932|NCT03512210|101738451|FG000|STARTED|Step 1: MINMON Intervention||400||
48574933|NCT03512210|101738451|FG000|COMPLETED|Step 1: MINMON Intervention||396||
48574934|NCT03512210|101738451|FG000|NOT COMPLETED|Step 1: MINMON Intervention||4||
48574935|NCT03512210|101738451|FG000|STARTED|Step 2:Post-MINMON||396||
48574936|NCT03512210|101738451|FG000|COMPLETED|Step 2:Post-MINMON||362||
48574937|NCT03512210|101738451|FG000|NOT COMPLETED|Step 2:Post-MINMON||34||
48574938|NCT04339101|101738452|FG000|STARTED|Overall Study||59||
48574939|NCT04339101|101738452|FG000|COMPLETED|Overall Study||59||
48574940|NCT04339101|101738452|FG000|NOT COMPLETED|Overall Study||0||
48574941|NCT03691207|101738453|FG000|STARTED|Overall Study||45||
48574942|NCT03691207|101738454|FG001|STARTED|Overall Study||42||
48574943|NCT03691207|101738453|FG000|COMPLETED|Overall Study||0||
48574944|NCT03691207|101738454|FG001|COMPLETED|Overall Study||0||
48574945|NCT03691207|101738453|FG000|NOT COMPLETED|Overall Study||45||
48574946|NCT03691207|101738454|FG001|NOT COMPLETED|Overall Study||42||
48574947|NCT02760004|101738455|FG000|STARTED|Overall Study||150||5
48574948|NCT02760004|101738456|FG001|STARTED|Overall Study||162||5
48574949|NCT02760004|101738455|FG000|COMPLETED|Overall Study||137||5
48574950|NCT02760004|101738456|FG001|COMPLETED|Overall Study||140||5
48574951|NCT02760004|101738455|FG000|NOT COMPLETED|Overall Study||13||0
48574952|NCT02760004|101738456|FG001|NOT COMPLETED|Overall Study||22||0
48574953|NCT04574908|101738457|FG000|STARTED|Overall Study||431||
48574954|NCT04574908|101738458|FG001|STARTED|Overall Study||448||
48574955|NCT04574908|101738457|FG000|COMPLETED|Overall Study||431||
48574956|NCT04574908|101738458|FG001|COMPLETED|Overall Study||448||
48574957|NCT04574908|101738457|FG000|NOT COMPLETED|Overall Study||0||
48574958|NCT04574908|101738458|FG001|NOT COMPLETED|Overall Study||0||
48574959|NCT05140382|101738459|FG000|STARTED|Overall Study||31||
48574960|NCT05140382|101738460|FG001|STARTED|Overall Study||2||
48574961|NCT05140382|101738461|FG002|STARTED|Overall Study||19||
48574962|NCT05140382|101738459|FG000|COMPLETED|Overall Study||0||
48574963|NCT05140382|101738460|FG001|COMPLETED|Overall Study||0||
48574964|NCT05140382|101738461|FG002|COMPLETED|Overall Study||0||
48574965|NCT05140382|101738459|FG000|NOT COMPLETED|Overall Study||31||
48574966|NCT05140382|101738460|FG001|NOT COMPLETED|Overall Study||2||
48574967|NCT05140382|101738461|FG002|NOT COMPLETED|Overall Study||19||
48574968|NCT00423332|101738462|FG000|STARTED|Overall Study||53||
48574969|NCT00423332|101738463|FG001|STARTED|Overall Study||18||
48574970|NCT00423332|101738462|FG000|Continuing After Unblinding|Overall Study||44||
48574971|NCT00423332|101738463|FG001|Continuing After Unblinding|Overall Study||14||
48574972|NCT00423332|101738462|FG000|Ongoing at Data Cut Off (8th March 2009)|Overall Study||22||
48574973|NCT00423332|101738463|FG001|Ongoing at Data Cut Off (8th March 2009)|Overall Study||4||
48701871|NCT00395135|102057574|FG003|NOT COMPLETED|Year 1||0||
48701872|NCT00395135|102057575|FG004|NOT COMPLETED|Year 1||0||
48701873|NCT00395135|102057571|FG000|STARTED|Year 2||0||
48574974|NCT00423332|101738462|FG000|COMPLETED|Overall Study||44||
48574975|NCT00423332|101738463|FG001|COMPLETED|Overall Study||11||
48574976|NCT00423332|101738462|FG000|NOT COMPLETED|Overall Study||9||
48574977|NCT00423332|101738463|FG001|NOT COMPLETED|Overall Study||7||
48574978|NCT00831311|101738464|FG000|STARTED|Overall Study||312||
48574979|NCT00831311|101738465|FG001|STARTED|Overall Study||312||
48574980|NCT00831311|101738464|FG000|COMPLETED|Overall Study||300||
48574981|NCT00831311|101738465|FG001|COMPLETED|Overall Study||304||
48574982|NCT00831311|101738464|FG000|NOT COMPLETED|Overall Study||12||
48574983|NCT00831311|101738465|FG001|NOT COMPLETED|Overall Study||8||
48574984|NCT02308540|101738466|FG000|STARTED|Overall Study||17||
48574985|NCT02308540|101738467|FG001|STARTED|Overall Study||17||
48574986|NCT02308540|101738468|FG002|STARTED|Overall Study||56||
48701874|NCT00395135|102057572|FG001|STARTED|Year 2||0||
48574987|NCT02308540|101738469|FG003|STARTED|Overall Study||56||
48574988|NCT02308540|101738470|FG004|STARTED|Overall Study||100||
48574989|NCT02308540|101738471|FG005|STARTED|Overall Study||100||
48574990|NCT02308540|101738466|FG000|Randomized|Overall Study||17||
48574991|NCT02308540|101738467|FG001|Randomized|Overall Study||17||
48574992|NCT02308540|101738468|FG002|Randomized|Overall Study||56||
48574993|NCT02308540|101738469|FG003|Randomized|Overall Study||56||
48574994|NCT02308540|101738470|FG004|Randomized|Overall Study||100||
48574995|NCT02308540|101738471|FG005|Randomized|Overall Study||100||
48574996|NCT02308540|101738466|FG000|Vaccinated|Overall Study||17||
48574997|NCT02308540|101738467|FG001|Vaccinated|Overall Study||17||
48574998|NCT02308540|101738468|FG002|Vaccinated|Overall Study||56||
48574999|NCT02308540|101738469|FG003|Vaccinated|Overall Study||56||
48575000|NCT02308540|101738470|FG004|Vaccinated|Overall Study||100||
48575001|NCT02308540|101738471|FG005|Vaccinated|Overall Study||100||
48575002|NCT02308540|101738466|FG000|COMPLETED|Overall Study||17||
48575003|NCT02308540|101738467|FG001|COMPLETED|Overall Study||17||
48575004|NCT02308540|101738468|FG002|COMPLETED|Overall Study||56||
48575005|NCT02308540|101738469|FG003|COMPLETED|Overall Study||56||
48575006|NCT02308540|101738470|FG004|COMPLETED|Overall Study||100||
48575007|NCT02308540|101738471|FG005|COMPLETED|Overall Study||99||
48575008|NCT02308540|101738466|FG000|NOT COMPLETED|Overall Study||0||
48575009|NCT02308540|101738467|FG001|NOT COMPLETED|Overall Study||0||
48575010|NCT02308540|101738468|FG002|NOT COMPLETED|Overall Study||0||
48575011|NCT02308540|101738469|FG003|NOT COMPLETED|Overall Study||0||
48575012|NCT02308540|101738470|FG004|NOT COMPLETED|Overall Study||0||
48575013|NCT02308540|101738471|FG005|NOT COMPLETED|Overall Study||1||
48575014|NCT00178685|101738472|FG000|STARTED|Overall Study||172||
48575015|NCT00178685|101738473|FG001|STARTED|Overall Study||324||
48575016|NCT00178685|101738474|FG002|STARTED|Overall Study||324||
48575017|NCT00178685|101738472|FG000|COMPLETED|Overall Study||61||
48575018|NCT00178685|101738473|FG001|COMPLETED|Overall Study||120||
48575019|NCT00178685|101738474|FG002|COMPLETED|Overall Study||128||
48575020|NCT00178685|101738472|FG000|NOT COMPLETED|Overall Study||111||
48575021|NCT00178685|101738473|FG001|NOT COMPLETED|Overall Study||204||
48575022|NCT00178685|101738474|FG002|NOT COMPLETED|Overall Study||196||
48575023|NCT00638716|101738475|FG000|STARTED|Overall Study||50||
48575024|NCT00638716|101738476|FG001|STARTED|Overall Study||52||
48575025|NCT00638716|101738477|FG002|STARTED|Overall Study||58||
48575026|NCT00638716|101738475|FG000|COMPLETED|Overall Study||43||
48575027|NCT00638716|101738476|FG001|COMPLETED|Overall Study||37||
48575028|NCT00638716|101738477|FG002|COMPLETED|Overall Study||46||
48575029|NCT00638716|101738475|FG000|NOT COMPLETED|Overall Study||7||
48575030|NCT00638716|101738476|FG001|NOT COMPLETED|Overall Study||15||
48575031|NCT00638716|101738477|FG002|NOT COMPLETED|Overall Study||12||
48575032|NCT03058705|101738478|FG000|STARTED|Overall Study||10||
48575033|NCT03058705|101738478|FG000|COMPLETED|Overall Study||6||
48575034|NCT03058705|101738478|FG000|NOT COMPLETED|Overall Study||4||
48575035|NCT02411396|101738479|FG000|STARTED|Overall Study||483|First participant enrolled on 4/30/2015 at Johns Hopkins|
48575036|NCT02411396|101738479|FG000|COMPLETED|Overall Study||442||
48575037|NCT02411396|101738479|FG000|NOT COMPLETED|Overall Study||41||
48575038|NCT00356122|101738480|FG000|STARTED|TREATMENT||53||
48575039|NCT00356122|101738480|FG000|COMPLETED|TREATMENT||8||
48575040|NCT00356122|101738480|FG000|NOT COMPLETED|TREATMENT||45||
48575041|NCT00356122|101738480|FG000|STARTED|FOLLOW-UP||53||
48575042|NCT00356122|101738480|FG000|COMPLETED|FOLLOW-UP||12||
48575043|NCT00356122|101738480|FG000|NOT COMPLETED|FOLLOW-UP||41||
48575044|NCT00693238|101738481|FG000|STARTED|Overall Study||122||
48575045|NCT00693238|101738482|FG001|STARTED|Overall Study||106||
48575046|NCT00693238|101738481|FG000|COMPLETED|Overall Study||122||
48575047|NCT00693238|101738482|FG001|COMPLETED|Overall Study||106||
48575048|NCT00693238|101738481|FG000|NOT COMPLETED|Overall Study||0||
48575049|NCT00693238|101738482|FG001|NOT COMPLETED|Overall Study||0||
48575050|NCT00820248|101738483|FG000|STARTED|Overall Study||160||
48575051|NCT00820248|101738484|FG001|STARTED|Overall Study||160||
48575052|NCT00820248|101738483|FG000|Received Protocol Treatment|Overall Study||156|Only treated patients were evaluated for adverse event.|
48575053|NCT00820248|101738484|FG001|Received Protocol Treatment|Overall Study||159|Only treated patients were evaluated for adverse event.|
48575054|NCT00820248|101738483|FG000|COMPLETED|Overall Study||156||
48575055|NCT00820248|101738484|FG001|COMPLETED|Overall Study||159||
48575056|NCT00820248|101738483|FG000|NOT COMPLETED|Overall Study||4||
48575057|NCT00820248|101738484|FG001|NOT COMPLETED|Overall Study||1||
48575058|NCT01543178|101738485|FG000|STARTED|Open-label Period||2583||
48575059|NCT01543178|101738486|FG001|STARTED|Open-label Period||0||
48575060|NCT01543178|101738487|FG002|STARTED|Open-label Period||0||
48575061|NCT01543178|101738485|FG000|COMPLETED|Open-label Period||636||
48575062|NCT01543178|101738486|FG001|COMPLETED|Open-label Period||0||
48575063|NCT01543178|101738487|FG002|COMPLETED|Open-label Period||0||
48575064|NCT01543178|101738485|FG000|NOT COMPLETED|Open-label Period||1947||
48575065|NCT01543178|101738486|FG001|NOT COMPLETED|Open-label Period||0||
48575066|NCT01543178|101738487|FG002|NOT COMPLETED|Open-label Period||0||
48575067|NCT01543178|101738485|FG000|STARTED|Double-blind Period||0||
48575068|NCT01543178|101738486|FG001|STARTED|Double-blind Period||328||
48575069|NCT01543178|101738487|FG002|STARTED|Double-blind Period||308||
48575070|NCT01543178|101738485|FG000|COMPLETED|Double-blind Period||0||
48575071|NCT01543178|101738486|FG001|COMPLETED|Double-blind Period||284||
48575072|NCT01543178|101738487|FG002|COMPLETED|Double-blind Period||271||
48575073|NCT01543178|101738485|FG000|NOT COMPLETED|Double-blind Period||0||
48575074|NCT01543178|101738486|FG001|NOT COMPLETED|Double-blind Period||44||
48575075|NCT01543178|101738487|FG002|NOT COMPLETED|Double-blind Period||37||
48575076|NCT04081610|101738488|FG000|STARTED|Overall Study||16||32
48575077|NCT04081610|101738489|FG001|STARTED|Overall Study||18||36
48575078|NCT04081610|101738488|FG000|COMPLETED|Overall Study||16||32
48575079|NCT04081610|101738489|FG001|COMPLETED|Overall Study||18||36
48575080|NCT04081610|101738488|FG000|NOT COMPLETED|Overall Study||0||0
48575081|NCT04081610|101738489|FG001|NOT COMPLETED|Overall Study||0||0
48575082|NCT03086967|101738490|FG000|STARTED|Overall Study||103||
48575083|NCT03086967|101738491|FG001|STARTED|Overall Study||101||
48575084|NCT03086967|101738490|FG000|COMPLETED|Overall Study||101||
48575085|NCT03086967|101738491|FG001|COMPLETED|Overall Study||99||
48575086|NCT03086967|101738490|FG000|NOT COMPLETED|Overall Study||2||
48575087|NCT03086967|101738491|FG001|NOT COMPLETED|Overall Study||2||
48575088|NCT01029782|101738492|FG000|STARTED|Overall Study||102|All patients randomized were allocated to study arms|
48575089|NCT01029782|101738493|FG001|STARTED|Overall Study||104|All patients randomized were allocated to study arms|
48575090|NCT01029782|101738492|FG000|COMPLETED|Overall Study||99|All patients remaining in the study arms at the 72 hour endpoint|
48575091|NCT01029782|101738493|FG001|COMPLETED|Overall Study||96|All patients remaining in the study arms at the 72 hour endpoint|
48575092|NCT01029782|101738492|FG000|NOT COMPLETED|Overall Study||3||
48575093|NCT01029782|101738493|FG001|NOT COMPLETED|Overall Study||8||
48575094|NCT00754234|101738494|FG000|STARTED|Overall Study||16||
48575095|NCT00754234|101738494|FG000|COMPLETED|Overall Study||13||
48575096|NCT00754234|101738494|FG000|NOT COMPLETED|Overall Study||3||
48575097|NCT02582684|101738495|FG000|STARTED|Overall Study||122||
48575098|NCT02582684|101738495|FG000|COMPLETED|Overall Study||105||
48575099|NCT02582684|101738495|FG000|NOT COMPLETED|Overall Study||17||
48575100|NCT05253573|101738496|FG000|STARTED|Overall Study||40||
48575101|NCT05253573|101738497|FG001|STARTED|Overall Study||40||
48575102|NCT05253573|101738496|FG000|Cancer Patients/Survivors|Overall Study||15||
48575103|NCT05253573|101738497|FG001|Cancer Patients/Survivors|Overall Study||15||
48575104|NCT05253573|101738496|FG000|Caregivers|Overall Study||25||
48575105|NCT05253573|101738497|FG001|Caregivers|Overall Study||25||
48575106|NCT05253573|101738496|FG000|Completed Cancer Patients/Survivors|Overall Study||14||
48575107|NCT05253573|101738497|FG001|Completed Cancer Patients/Survivors|Overall Study||15||
48575108|NCT05253573|101738496|FG000|Completed Caregivers|Overall Study||25||
48575109|NCT05253573|101738497|FG001|Completed Caregivers|Overall Study||25||
48575110|NCT05253573|101738496|FG000|COMPLETED|Overall Study||39||
48575111|NCT05253573|101738497|FG001|COMPLETED|Overall Study||40||
48575112|NCT05253573|101738496|FG000|NOT COMPLETED|Overall Study||1||
48575113|NCT05253573|101738497|FG001|NOT COMPLETED|Overall Study||0||
48575114|NCT00606554|101738498|FG000|STARTED|Overall Study||15||
48575115|NCT00606554|101738499|FG001|STARTED|Overall Study||18||
48575116|NCT00606554|101738498|FG000|COMPLETED|Overall Study||15||
48575117|NCT00606554|101738499|FG001|COMPLETED|Overall Study||18||
48575118|NCT00606554|101738498|FG000|NOT COMPLETED|Overall Study||0||
48575119|NCT00606554|101738499|FG001|NOT COMPLETED|Overall Study||0||
48575120|NCT01986933|101738500|FG000|STARTED|Placebo-controlled (Part A)||53|Patients were randomly assigned (1:1:1:1:1 ratio) to one of four active treatment groups and one placebo group in double-blind fashion.|
48575121|NCT01986933|101738501|FG001|STARTED|Placebo-controlled (Part A)||53|Patients were randomly assigned (1:1:1:1:1 ratio) to one of four active treatment groups and one placebo group in double-blind fashion.|
48575122|NCT01986933|101738502|FG002|STARTED|Placebo-controlled (Part A)||54|Patients were randomly assigned (1:1:1:1:1 ratio) to one of four active treatment groups and one placebo group in double-blind fashion.|
48575123|NCT01986933|101738503|FG003|STARTED|Placebo-controlled (Part A)||52|Patients were randomly assigned (1:1:1:1:1 ratio) to one of four active treatment groups and one placebo group in double-blind fashion.|
48575124|NCT01986933|101738504|FG004|STARTED|Placebo-controlled (Part A)||52|Patients were randomly assigned (1:1:1:1:1 ratio) to one of four active treatment groups and one placebo group in double-blind fashion.|
48575125|NCT01986933|101738500|FG000|COMPLETED|Placebo-controlled (Part A)||44||
48575126|NCT01986933|101738501|FG001|COMPLETED|Placebo-controlled (Part A)||44||
48575127|NCT01986933|101738502|FG002|COMPLETED|Placebo-controlled (Part A)||45||
48575128|NCT01986933|101738503|FG003|COMPLETED|Placebo-controlled (Part A)||45||
48575129|NCT01986933|101738504|FG004|COMPLETED|Placebo-controlled (Part A)||38||
48575130|NCT01986933|101738500|FG000|NOT COMPLETED|Placebo-controlled (Part A)||9||
48575131|NCT01986933|101738501|FG001|NOT COMPLETED|Placebo-controlled (Part A)||9||
48575132|NCT01986933|101738502|FG002|NOT COMPLETED|Placebo-controlled (Part A)||9||
48131146|NCT03564496|100645815|FG002|STARTED|Overall Study||6||
48131147|NCT03564496|100645813|FG000|COMPLETED|Overall Study||26||
48131148|NCT03564496|100645814|FG001|COMPLETED|Overall Study||36||
48131149|NCT03564496|100645815|FG002|COMPLETED|Overall Study||6||
48131150|NCT03564496|100645813|FG000|NOT COMPLETED|Overall Study||1||
48131151|NCT03564496|100645814|FG001|NOT COMPLETED|Overall Study||4||
48131152|NCT03564496|100645815|FG002|NOT COMPLETED|Overall Study||0||
48131153|NCT01194674|100645816|FG000|STARTED|Overall Study||2||
48131154|NCT01194674|100645816|FG000|COMPLETED|Overall Study||2||
48575133|NCT01986933|101738503|FG003|NOT COMPLETED|Placebo-controlled (Part A)||7||
48575134|NCT01986933|101738504|FG004|NOT COMPLETED|Placebo-controlled (Part A)||14||
48575135|NCT01986933|101738500|FG000|STARTED|Active-to-active (Part B)||0|Data from patients who were randomized to Nemoliozumab groups in Part A and initiated Part B were analyzed.|
48575136|NCT01986933|101738501|FG001|STARTED|Active-to-active (Part B)||41|Data from patients who were randomized to Nemoliozumab groups in Part A and initiated Part B were analyzed.|
48575137|NCT01986933|101738502|FG002|STARTED|Active-to-active (Part B)||38|Data from patients who were randomized to Nemoliozumab groups in Part A and initiated Part B were analyzed.|
48575138|NCT01986933|101738503|FG003|STARTED|Active-to-active (Part B)||39|Data from patients who were randomized to Nemoliozumab groups in Part A and initiated Part B were analyzed.|
48575139|NCT01986933|101738504|FG004|STARTED|Active-to-active (Part B)||35|Data from patients who were randomized to Nemoliozumab groups in Part A and initiated Part B were analyzed.|
48575140|NCT01986933|101738500|FG000|COMPLETED|Active-to-active (Part B)||0||
48575141|NCT01986933|101738501|FG001|COMPLETED|Active-to-active (Part B)||31||
48575142|NCT01986933|101738502|FG002|COMPLETED|Active-to-active (Part B)||28||
48575143|NCT01986933|101738503|FG003|COMPLETED|Active-to-active (Part B)||30||
48575144|NCT01986933|101738504|FG004|COMPLETED|Active-to-active (Part B)||19||
48575145|NCT01986933|101738500|FG000|NOT COMPLETED|Active-to-active (Part B)||0||
48575146|NCT01986933|101738501|FG001|NOT COMPLETED|Active-to-active (Part B)||10||
48575147|NCT01986933|101738502|FG002|NOT COMPLETED|Active-to-active (Part B)||10||
48575148|NCT01986933|101738503|FG003|NOT COMPLETED|Active-to-active (Part B)||9||
48575149|NCT01986933|101738504|FG004|NOT COMPLETED|Active-to-active (Part B)||16||
48575150|NCT01986933|101738500|FG000|STARTED|Placebo-to-active (Part B)||0|Data from patients who were randomized to placebo group in Part A and initiated Part B were analyzed.|
48575151|NCT01986933|101738501|FG001|STARTED|Placebo-to-active (Part B)||13|Data from patients who were randomized to placebo group in Part A and initiated Part B were analyzed.|
48575152|NCT01986933|101738502|FG002|STARTED|Placebo-to-active (Part B)||12|Data from patients who were randomized to placebo group in Part A and initiated Part B were analyzed.|
48575153|NCT01986933|101738503|FG003|STARTED|Placebo-to-active (Part B)||13|Data from patients who were randomized to placebo group in Part A and initiated Part B were analyzed.|
48575154|NCT01986933|101738504|FG004|STARTED|Placebo-to-active (Part B)||0|Data from patients who were randomized to placebo group in Part A and initiated Part B were analyzed.|
48575155|NCT01986933|101738500|FG000|COMPLETED|Placebo-to-active (Part B)||0||
48575156|NCT01986933|101738501|FG001|COMPLETED|Placebo-to-active (Part B)||8||
48575157|NCT01986933|101738502|FG002|COMPLETED|Placebo-to-active (Part B)||7||
48575158|NCT01986933|101738503|FG003|COMPLETED|Placebo-to-active (Part B)||8||
48575159|NCT01986933|101738504|FG004|COMPLETED|Placebo-to-active (Part B)||0||
48575160|NCT01986933|101738500|FG000|NOT COMPLETED|Placebo-to-active (Part B)||0||
48575161|NCT01986933|101738501|FG001|NOT COMPLETED|Placebo-to-active (Part B)||5||
48575162|NCT01986933|101738502|FG002|NOT COMPLETED|Placebo-to-active (Part B)||5||
48575163|NCT01986933|101738503|FG003|NOT COMPLETED|Placebo-to-active (Part B)||5||
48575164|NCT01986933|101738504|FG004|NOT COMPLETED|Placebo-to-active (Part B)||0||
48575165|NCT02477332|101738505|FG000|STARTED|Overall Study||43||
48575166|NCT02477332|101738506|FG001|STARTED|Overall Study||84||
48575167|NCT02477332|101738507|FG002|STARTED|Overall Study||85||
48575168|NCT02477332|101738508|FG003|STARTED|Overall Study||85||
48575169|NCT02477332|101738509|FG004|STARTED|Overall Study||43||
48131155|NCT01194674|100645816|FG000|NOT COMPLETED|Overall Study||0||
48131156|NCT02391402|100645817|FG000|STARTED|Overall Study||39||
48131157|NCT02391402|100645818|FG001|STARTED|Overall Study||34||
48131158|NCT02391402|100645817|FG000|COMPLETED|Overall Study||30||
48131159|NCT02391402|100645818|FG001|COMPLETED|Overall Study||26||
48131160|NCT02391402|100645817|FG000|NOT COMPLETED|Overall Study||9||
48131161|NCT02391402|100645818|FG001|NOT COMPLETED|Overall Study||8||
48131162|NCT00965523|100645819|FG000|STARTED|Study 221||81||
48131163|NCT00965523|100645819|FG000|COMPLETED|Study 221||74||
48131164|NCT00965523|100645819|FG000|NOT COMPLETED|Study 221||7||
48131165|NCT00965523|100645819|FG000|STARTED|Study 224||6||
48131166|NCT00965523|100645819|FG000|COMPLETED|Study 224||0||
48131167|NCT00965523|100645819|FG000|NOT COMPLETED|Study 224||6||
48131168|NCT00003498|100645820|FG000|STARTED|Overall Study||5||
48131169|NCT00003498|100645820|FG000|COMPLETED|Overall Study||1||
48131170|NCT00003498|100645820|FG000|NOT COMPLETED|Overall Study||4||
48131171|NCT02194621|100645821|FG000|STARTED|Overall Study||43||
48131172|NCT02194621|100645822|FG001|STARTED|Overall Study||42||
48131173|NCT02194621|100645823|FG002|STARTED|Overall Study||43||
48131174|NCT02194621|100645821|FG000|COMPLETED|Overall Study||37||
48131175|NCT02194621|100645822|FG001|COMPLETED|Overall Study||36||
48285062|NCT02884908|101021636|FG001|Took 1 Dose of Study Medication|Overall Study||18||
48285063|NCT02884908|101021635|FG000|COMPLETED|Overall Study||19|Completed 12-week assessment|
48131176|NCT02194621|100645823|FG002|COMPLETED|Overall Study||34||
48131177|NCT02194621|100645821|FG000|NOT COMPLETED|Overall Study||6||
48131178|NCT02194621|100645822|FG001|NOT COMPLETED|Overall Study||6||
48131179|NCT02194621|100645823|FG002|NOT COMPLETED|Overall Study||9||
48131180|NCT02331134|100645824|FG000|STARTED|Overall Study||9||
48131181|NCT02331134|100645824|FG000|COMPLETED|Overall Study||8||
48285064|NCT02884908|101021636|FG001|COMPLETED|Overall Study||7|Completed 12-week assessment|
48285065|NCT02884908|101021635|FG000|NOT COMPLETED|Overall Study||13||
48285066|NCT02884908|101021636|FG001|NOT COMPLETED|Overall Study||18||
48285067|NCT04797650|101021637|FG000|STARTED|Overall Study||130||
48285068|NCT04797650|101021638|FG001|STARTED|Overall Study||258||
48285069|NCT04797650|101021639|FG002|STARTED|Overall Study||129||
48285070|NCT04797650|101021637|FG000|Efficacy Population|Overall Study||127|Efficacy population included all participants who were randomized in the study and dispensed study drug during the treatment period.|
48285071|NCT04797650|101021638|FG001|Efficacy Population|Overall Study||249|Efficacy population included all participants who were randomized in the study and dispensed study drug during the treatment period.|
48285072|NCT04797650|101021639|FG002|Efficacy Population|Overall Study||127|Efficacy population included all participants who were randomized in the study and dispensed study drug during the treatment period.|
48285073|NCT04797650|101021637|FG000|Safety Population|Overall Study||130|Safety population included all participants who received study drug during the treatment period|
48399283|NCT01457924|101309085|FG004|STARTED|Treatment Phase (Weeks 0-24)||64||
48399284|NCT01457924|101309081|FG000|Completed to Week 12|Treatment Phase (Weeks 0-24)||65||
48575170|NCT02477332|101738510|FG005|STARTED|Overall Study||42||
48575171|NCT02477332|101738505|FG000|COMPLETED|Overall Study||40||
48575172|NCT02477332|101738506|FG001|COMPLETED|Overall Study||77||
48575173|NCT02477332|101738507|FG002|COMPLETED|Overall Study||73||
48575174|NCT02477332|101738508|FG003|COMPLETED|Overall Study||72||
48701875|NCT00395135|102057573|FG002|STARTED|Year 2||573||
48701876|NCT00395135|102057574|FG003|STARTED|Year 2||283||
48701877|NCT00395135|102057575|FG004|STARTED|Year 2||697||
48701878|NCT00395135|102057571|FG000|COMPLETED|Year 2||0||
48701879|NCT00395135|102057572|FG001|COMPLETED|Year 2||0||
48701880|NCT00395135|102057573|FG002|COMPLETED|Year 2||426||
48701881|NCT00395135|102057574|FG003|COMPLETED|Year 2||195||
48701882|NCT00395135|102057575|FG004|COMPLETED|Year 2||507||
48701883|NCT00395135|102057571|FG000|NOT COMPLETED|Year 2||0||
48701884|NCT00395135|102057572|FG001|NOT COMPLETED|Year 2||0||
48701885|NCT00395135|102057573|FG002|NOT COMPLETED|Year 2||147||
48701886|NCT00395135|102057574|FG003|NOT COMPLETED|Year 2||88||
48701887|NCT00395135|102057575|FG004|NOT COMPLETED|Year 2||190||
48131182|NCT02331134|100645824|FG000|NOT COMPLETED|Overall Study||1||
48131183|NCT03832946|100645825|FG000|STARTED|Overall Study||102||
48131184|NCT03832946|100645826|FG001|STARTED|Overall Study||70||
48131185|NCT03832946|100645825|FG000|COMPLETED|Overall Study||55||
48131186|NCT03832946|100645826|FG001|COMPLETED|Overall Study||38||
48131187|NCT03832946|100645825|FG000|NOT COMPLETED|Overall Study||47||
48131188|NCT03832946|100645826|FG001|NOT COMPLETED|Overall Study||32||
48131189|NCT01734512|100645827|FG000|STARTED|Overall Study||65||
48399285|NCT01457924|101309082|FG001|Completed to Week 12|Treatment Phase (Weeks 0-24)||31||
48399286|NCT01457924|101309083|FG002|Completed to Week 12|Treatment Phase (Weeks 0-24)||30||
48399287|NCT01457924|101309084|FG003|Completed to Week 12|Treatment Phase (Weeks 0-24)||33||
48131190|NCT01734512|100645827|FG000|COMPLETED|Overall Study||65||
48575175|NCT02477332|101738509|FG004|COMPLETED|Overall Study||39||
48575176|NCT02477332|101738510|FG005|COMPLETED|Overall Study||37||
48575177|NCT02477332|101738505|FG000|NOT COMPLETED|Overall Study||3||
48575178|NCT02477332|101738506|FG001|NOT COMPLETED|Overall Study||7||
48575179|NCT02477332|101738507|FG002|NOT COMPLETED|Overall Study||12||
48575180|NCT02477332|101738508|FG003|NOT COMPLETED|Overall Study||13||
48575181|NCT02477332|101738509|FG004|NOT COMPLETED|Overall Study||4||
48575182|NCT02477332|101738510|FG005|NOT COMPLETED|Overall Study||5||
48575183|NCT00305084|101738511|FG000|STARTED|Overall Study||3||
48701888|NCT00695955|102057576|FG000|STARTED|Cohort 1||362||
48701889|NCT00695955|102057576|FG000|COMPLETED|Cohort 1||260||
48701890|NCT00695955|102057576|FG000|NOT COMPLETED|Cohort 1||102||
48701891|NCT00695955|102057576|FG000|STARTED|Cohort 2||307||
48701892|NCT00695955|102057576|FG000|COMPLETED|Cohort 2||203||
48131191|NCT01734512|100645827|FG000|NOT COMPLETED|Overall Study||0||
48131192|NCT01136291|100645828|FG000|STARTED|Overall Study||40||
48131193|NCT01136291|100645829|FG001|STARTED|Overall Study||42||
48131194|NCT01136291|100645828|FG000|Follow|Overall Study||40||
48131195|NCT01136291|100645829|FG001|Follow|Overall Study||42||
48131196|NCT01136291|100645828|FG000|COMPLETED|Overall Study||39||
48131197|NCT01136291|100645829|FG001|COMPLETED|Overall Study||41||
48131198|NCT01136291|100645828|FG000|NOT COMPLETED|Overall Study||1||
48131199|NCT01136291|100645829|FG001|NOT COMPLETED|Overall Study||1||
48701893|NCT00695955|102057576|FG000|NOT COMPLETED|Cohort 2||104||
48701894|NCT00347438|102057577|FG000|STARTED|Overall Study||18||
48701895|NCT00347438|102057577|FG000|COMPLETED|Overall Study||16||
48701896|NCT00347438|102057577|FG000|NOT COMPLETED|Overall Study||2||
48701897|NCT02704702|102057578|FG000|STARTED|Overall Study||6||
48701898|NCT02704702|102057579|FG001|STARTED|Overall Study||6||
48701899|NCT02704702|102057580|FG002|STARTED|Overall Study||6||
48701900|NCT02704702|102057581|FG003|STARTED|Overall Study||6||
48701901|NCT02704702|102057582|FG004|STARTED|Overall Study||6||
48701902|NCT02704702|102057583|FG005|STARTED|Overall Study||6||
48701903|NCT02704702|102057578|FG000|COMPLETED|Overall Study||5||
48701904|NCT02704702|102057579|FG001|COMPLETED|Overall Study||6||
48701905|NCT02704702|102057580|FG002|COMPLETED|Overall Study||6||
48701906|NCT02704702|102057581|FG003|COMPLETED|Overall Study||5||
48701907|NCT02704702|102057582|FG004|COMPLETED|Overall Study||4||
48701908|NCT02704702|102057583|FG005|COMPLETED|Overall Study||4||
48701909|NCT02704702|102057578|FG000|NOT COMPLETED|Overall Study||1||
48701910|NCT02704702|102057579|FG001|NOT COMPLETED|Overall Study||0||
48701911|NCT02704702|102057580|FG002|NOT COMPLETED|Overall Study||0||
48701912|NCT02704702|102057581|FG003|NOT COMPLETED|Overall Study||1||
48131200|NCT00093145|100645830|FG000|STARTED|Overall Study||32||
48131201|NCT00093145|100645830|FG000|At Least One Response Assessment|Overall Study||31||
48131202|NCT00093145|100645830|FG000|COMPLETED|Overall Study||15||
48131203|NCT00093145|100645830|FG000|NOT COMPLETED|Overall Study||17||
48131204|NCT02582905|100645831|FG000|STARTED|Overall Study||29||
48131205|NCT02582905|100645832|FG001|STARTED|Overall Study||30||
48575184|NCT00305084|101738512|FG001|STARTED|Overall Study||3||
48575185|NCT00305084|101738513|FG002|STARTED|Overall Study||3||
48575186|NCT00305084|101738514|FG003|STARTED|Overall Study||3||
48575187|NCT00305084|101738515|FG004|STARTED|Overall Study||3||
48575188|NCT00305084|101738511|FG000|COMPLETED|Overall Study||3||
48575189|NCT00305084|101738512|FG001|COMPLETED|Overall Study||3||
48575190|NCT00305084|101738513|FG002|COMPLETED|Overall Study||3||
48575191|NCT00305084|101738514|FG003|COMPLETED|Overall Study||3||
48575192|NCT00305084|101738515|FG004|COMPLETED|Overall Study||3||
48575193|NCT00305084|101738511|FG000|NOT COMPLETED|Overall Study||0||
48575194|NCT00305084|101738512|FG001|NOT COMPLETED|Overall Study||0||
48131206|NCT02582905|100645833|FG002|STARTED|Overall Study||37||
48131207|NCT02582905|100645831|FG000|COMPLETED|Overall Study||18||
48131208|NCT02582905|100645832|FG001|COMPLETED|Overall Study||20||
48131209|NCT02582905|100645833|FG002|COMPLETED|Overall Study||23||
48131210|NCT02582905|100645831|FG000|NOT COMPLETED|Overall Study||11||
48131211|NCT02582905|100645832|FG001|NOT COMPLETED|Overall Study||10||
48131212|NCT02582905|100645833|FG002|NOT COMPLETED|Overall Study||14||
48131213|NCT01218646|100645834|FG000|STARTED|Overall Study||225||
48131214|NCT01218646|100645835|FG001|STARTED|Overall Study||225||
48131215|NCT01218646|100645836|FG002|STARTED|Overall Study||225||
48131216|NCT01218646|100645837|FG003|STARTED|Overall Study||64||
48131217|NCT01218646|100645834|FG000|COMPLETED|Overall Study||224||
48131218|NCT01218646|100645835|FG001|COMPLETED|Overall Study||225||
48131219|NCT01218646|100645836|FG002|COMPLETED|Overall Study||223||
48131220|NCT01218646|100645837|FG003|COMPLETED|Overall Study||63||
48285074|NCT04797650|101021638|FG001|Safety Population|Overall Study||256|Safety population included all participants who received study drug during the treatment period|
48285075|NCT04797650|101021639|FG002|Safety Population|Overall Study||129|Safety population included all participants who received study drug during the treatment period|
48285076|NCT04797650|101021637|FG000|COMPLETED|Overall Study||119||
48285077|NCT04797650|101021638|FG001|COMPLETED|Overall Study||233||
48285078|NCT04797650|101021639|FG002|COMPLETED|Overall Study||120||
48285079|NCT04797650|101021637|FG000|NOT COMPLETED|Overall Study||11||
48575195|NCT00305084|101738513|FG002|NOT COMPLETED|Overall Study||0||
48575196|NCT00305084|101738514|FG003|NOT COMPLETED|Overall Study||0||
48575197|NCT00305084|101738515|FG004|NOT COMPLETED|Overall Study||0||
48575198|NCT00039871|101738516|FG000|STARTED|Overall Study||2312||
48575199|NCT00039871|101738516|FG000|COMPLETED|Overall Study||928||
48575200|NCT00039871|101738516|FG000|NOT COMPLETED|Overall Study||1384||
48575201|NCT03003494|101738517|FG000|STARTED|Overall Study||306||
48575202|NCT03003494|101738517|FG000|COMPLETED|Overall Study||278||
48575203|NCT03003494|101738517|FG000|NOT COMPLETED|Overall Study||28||
48575204|NCT02249728|101738518|FG000|STARTED|Part One (4 Days)||6||
48575205|NCT02249728|101738518|FG000|COMPLETED|Part One (4 Days)||6||
48575206|NCT02249728|101738518|FG000|NOT COMPLETED|Part One (4 Days)||0||
48575207|NCT02249728|101738518|FG000|STARTED|Part Two (up to 6 Days)||6||
48575208|NCT02249728|101738518|FG000|COMPLETED|Part Two (up to 6 Days)||6||
48701913|NCT02704702|102057582|FG004|NOT COMPLETED|Overall Study||2||
48701914|NCT02704702|102057583|FG005|NOT COMPLETED|Overall Study||2||
48575209|NCT02249728|101738518|FG000|NOT COMPLETED|Part Two (up to 6 Days)||0||
48575210|NCT00464490|101738519|FG000|STARTED|Overall Study||21||
48701915|NCT03998670|102057584|FG000|STARTED|Overall Study||28||
48701916|NCT03998670|102057585|FG001|STARTED|Overall Study||29||
48701917|NCT03998670|102057584|FG000|COMPLETED|Overall Study||25||
48701918|NCT03998670|102057585|FG001|COMPLETED|Overall Study||25||
48701919|NCT03998670|102057584|FG000|NOT COMPLETED|Overall Study||3||
48701920|NCT03998670|102057585|FG001|NOT COMPLETED|Overall Study||4||
48131221|NCT01218646|100645834|FG000|NOT COMPLETED|Overall Study||1||
48131222|NCT01218646|100645835|FG001|NOT COMPLETED|Overall Study||0||
48131223|NCT01218646|100645836|FG002|NOT COMPLETED|Overall Study||2||
48131224|NCT01218646|100645837|FG003|NOT COMPLETED|Overall Study||1||
48131225|NCT02707055|100645838|FG000|STARTED|Phase 1||18||
48131226|NCT02707055|100645839|FG001|STARTED|Phase 1||19||
48131227|NCT02707055|100645838|FG000|COMPLETED|Phase 1||17||
48131228|NCT02707055|100645839|FG001|COMPLETED|Phase 1||16||
48131229|NCT02707055|100645838|FG000|NOT COMPLETED|Phase 1||1||
48131230|NCT02707055|100645839|FG001|NOT COMPLETED|Phase 1||3||
48131231|NCT02707055|100645838|FG000|STARTED|Washout Period||17||
48131232|NCT02707055|100645839|FG001|STARTED|Washout Period||16||
48131233|NCT02707055|100645838|FG000|COMPLETED|Washout Period||17||
48131234|NCT02707055|100645839|FG001|COMPLETED|Washout Period||16||
48575211|NCT00464490|101738520|FG001|STARTED|Overall Study||21||
48575212|NCT00464490|101738519|FG000|COMPLETED|Overall Study||10||
48701921|NCT02324205|102057586|FG000|STARTED|Overall Study||196||
48701922|NCT02324205|102057586|FG000|COMPLETED|Overall Study||159||
48131235|NCT02707055|100645838|FG000|NOT COMPLETED|Washout Period||0||
48131236|NCT02707055|100645839|FG001|NOT COMPLETED|Washout Period||0||
48131237|NCT02707055|100645838|FG000|STARTED|Phase 2||17||
48131238|NCT02707055|100645839|FG001|STARTED|Phase 2||16||
48131239|NCT02707055|100645838|FG000|COMPLETED|Phase 2||16||
48131240|NCT02707055|100645839|FG001|COMPLETED|Phase 2||14||
48131241|NCT02707055|100645838|FG000|NOT COMPLETED|Phase 2||1||
48131242|NCT02707055|100645839|FG001|NOT COMPLETED|Phase 2||2||
48131243|NCT04602624|100645840|FG000|STARTED|Overall Study||26||
48131244|NCT04602624|100645840|FG000|COMPLETED|Overall Study||24||
48131245|NCT04602624|100645840|FG000|NOT COMPLETED|Overall Study||2||
48131246|NCT00353704|100645841|FG000|STARTED|Overall Study||25||
48131247|NCT00353704|100645842|FG001|STARTED|Overall Study||25||
48131248|NCT00353704|100645841|FG000|COMPLETED|Overall Study||22||
48131249|NCT00353704|100645842|FG001|COMPLETED|Overall Study||24||
48131250|NCT00353704|100645841|FG000|NOT COMPLETED|Overall Study||3||
48131251|NCT00353704|100645842|FG001|NOT COMPLETED|Overall Study||1||
48131252|NCT00214136|100645843|FG000|STARTED|Overall Study||30||
48131253|NCT00214136|100645843|FG000|COMPLETED|Overall Study||25|All participants completed treatment per protocol; 5 died greater than 30 days after last treatment.|
48131254|NCT00214136|100645843|FG000|NOT COMPLETED|Overall Study||5||
48131255|NCT00613951|100645844|FG000|STARTED|Overall Study||61||
48131256|NCT00613951|100645845|FG001|STARTED|Overall Study||59||
48131257|NCT00613951|100645846|FG002|STARTED|Overall Study||62||
48131258|NCT00613951|100645844|FG000|Exposed|Overall Study||60||
48131259|NCT00613951|100645845|FG001|Exposed|Overall Study||59||
48131260|NCT00613951|100645846|FG002|Exposed|Overall Study||62||
48131261|NCT00613951|100645844|FG000|COMPLETED|Overall Study||54||
48131262|NCT00613951|100645845|FG001|COMPLETED|Overall Study||54||
48399288|NCT01457924|101309085|FG004|Completed to Week 12|Treatment Phase (Weeks 0-24)||60||
48399289|NCT01457924|101309081|FG000|COMPLETED|Treatment Phase (Weeks 0-24)||64||
48399290|NCT01457924|101309082|FG001|COMPLETED|Treatment Phase (Weeks 0-24)||29||
48399291|NCT01457924|101309083|FG002|COMPLETED|Treatment Phase (Weeks 0-24)||30||
48131263|NCT00613951|100645846|FG002|COMPLETED|Overall Study||57||
48131264|NCT00613951|100645844|FG000|NOT COMPLETED|Overall Study||7||
48131265|NCT00613951|100645845|FG001|NOT COMPLETED|Overall Study||5||
48131266|NCT00613951|100645846|FG002|NOT COMPLETED|Overall Study||5||
48131267|NCT02239510|100645847|FG000|STARTED|Overall Study||5||
48131268|NCT02239510|100645848|FG001|STARTED|Overall Study||4||
48131269|NCT02239510|100645847|FG000|COMPLETED|Overall Study||3||
48131270|NCT02239510|100645848|FG001|COMPLETED|Overall Study||3||
48131271|NCT02239510|100645847|FG000|NOT COMPLETED|Overall Study||2||
48131272|NCT02239510|100645848|FG001|NOT COMPLETED|Overall Study||1||
48131273|NCT02899728|100645849|FG000|STARTED|Overall Study||5||
48131274|NCT02899728|100645850|FG001|STARTED|Overall Study||3||
48131275|NCT02899728|100645849|FG000|COMPLETED|Overall Study||4||
48131276|NCT02899728|100645850|FG001|COMPLETED|Overall Study||2||
48131277|NCT02899728|100645849|FG000|NOT COMPLETED|Overall Study||1||
48131278|NCT02899728|100645850|FG001|NOT COMPLETED|Overall Study||1||
48131279|NCT02308033|100645851|FG000|STARTED|Overall Study||102||
48131280|NCT02308033|100645852|FG001|STARTED|Overall Study||102||
48131281|NCT02308033|100645851|FG000|COMPLETED|Overall Study||76||
48131282|NCT02308033|100645852|FG001|COMPLETED|Overall Study||83||
48131283|NCT02308033|100645851|FG000|NOT COMPLETED|Overall Study||26||
48131284|NCT02308033|100645852|FG001|NOT COMPLETED|Overall Study||19||
48399292|NCT01457924|101309084|FG003|COMPLETED|Treatment Phase (Weeks 0-24)||33||
48399293|NCT01457924|101309085|FG004|COMPLETED|Treatment Phase (Weeks 0-24)||58||
48575213|NCT00464490|101738520|FG001|COMPLETED|Overall Study||10||
48131285|NCT02258477|100645853|FG000|STARTED|First Intervention (1 Week)||10||
48131286|NCT02258477|100645854|FG001|STARTED|First Intervention (1 Week)||9||
48131287|NCT02258477|100645855|FG002|STARTED|First Intervention (1 Week)||9||
48131288|NCT02258477|100645856|FG003|STARTED|First Intervention (1 Week)||9||
48131289|NCT02258477|100645853|FG000|COMPLETED|First Intervention (1 Week)||9||
48131290|NCT02258477|100645854|FG001|COMPLETED|First Intervention (1 Week)||8||
48131291|NCT02258477|100645855|FG002|COMPLETED|First Intervention (1 Week)||9||
48131292|NCT02258477|100645856|FG003|COMPLETED|First Intervention (1 Week)||9||
48131293|NCT02258477|100645853|FG000|NOT COMPLETED|First Intervention (1 Week)||1||
48131294|NCT02258477|100645854|FG001|NOT COMPLETED|First Intervention (1 Week)||1||
48131295|NCT02258477|100645855|FG002|NOT COMPLETED|First Intervention (1 Week)||0||
48131296|NCT02258477|100645856|FG003|NOT COMPLETED|First Intervention (1 Week)||0||
48131297|NCT02258477|100645853|FG000|STARTED|Second Intervention (1 Week)||9||
48131298|NCT02258477|100645854|FG001|STARTED|Second Intervention (1 Week)||8||
48131299|NCT02258477|100645855|FG002|STARTED|Second Intervention (1 Week)||9||
48131300|NCT02258477|100645856|FG003|STARTED|Second Intervention (1 Week)||9||
48131301|NCT02258477|100645853|FG000|COMPLETED|Second Intervention (1 Week)||9||
48575214|NCT00464490|101738519|FG000|NOT COMPLETED|Overall Study||11||
48131302|NCT02258477|100645854|FG001|COMPLETED|Second Intervention (1 Week)||8||
48131303|NCT02258477|100645855|FG002|COMPLETED|Second Intervention (1 Week)||8||
48131304|NCT02258477|100645856|FG003|COMPLETED|Second Intervention (1 Week)||8||
48131305|NCT02258477|100645853|FG000|NOT COMPLETED|Second Intervention (1 Week)||0||
48131306|NCT02258477|100645854|FG001|NOT COMPLETED|Second Intervention (1 Week)||0||
48131307|NCT02258477|100645855|FG002|NOT COMPLETED|Second Intervention (1 Week)||1||
48399294|NCT01457924|101309081|FG000|NOT COMPLETED|Treatment Phase (Weeks 0-24)||3||
48399295|NCT01457924|101309082|FG001|NOT COMPLETED|Treatment Phase (Weeks 0-24)||5||
48399296|NCT01457924|101309083|FG002|NOT COMPLETED|Treatment Phase (Weeks 0-24)||2||
48399297|NCT01457924|101309084|FG003|NOT COMPLETED|Treatment Phase (Weeks 0-24)||1||
48285080|NCT04797650|101021638|FG001|NOT COMPLETED|Overall Study||25||
48285081|NCT04797650|101021639|FG002|NOT COMPLETED|Overall Study||9||
48285082|NCT01993927|101021640|FG000|STARTED|Overall Study||742||
48285083|NCT01993927|101021640|FG000|COMPLETED|Overall Study||713||
48285084|NCT01993927|101021640|FG000|NOT COMPLETED|Overall Study||29||
48285085|NCT02523599|101021641|FG000|STARTED|Overall Study||204||
48285086|NCT02523599|101021642|FG001|STARTED|Overall Study||101||
48285087|NCT02523599|101021641|FG000|Randomized But Not Treated|Overall Study||1||
48285088|NCT02523599|101021642|FG001|Randomized But Not Treated|Overall Study||0||
48285089|NCT02523599|101021641|FG000|COMPLETED|Overall Study||196||
48285090|NCT02523599|101021642|FG001|COMPLETED|Overall Study||100||
48285091|NCT02523599|101021641|FG000|NOT COMPLETED|Overall Study||8||
48285092|NCT02523599|101021642|FG001|NOT COMPLETED|Overall Study||1||
48285093|NCT01160289|101021643|FG000|STARTED|Screening, Washout, and Lead-In Period||894||
48285094|NCT01160289|101021644|FG001|STARTED|Screening, Washout, and Lead-In Period||0||
48285095|NCT01160289|101021645|FG002|STARTED|Screening, Washout, and Lead-In Period||0||
48399298|NCT01457924|101309085|FG004|NOT COMPLETED|Treatment Phase (Weeks 0-24)||6||
48399299|NCT01457924|101309081|FG000|STARTED|FUP (Weeks 24-48)||66|A total of 221 par. entered the FUP, including 7 of the 17 par. who were withdrawn before Week 24.|
48399300|NCT01457924|101309082|FG001|STARTED|FUP (Weeks 24-48)||31|A total of 221 par. entered the FUP, including 7 of the 17 par. who were withdrawn before Week 24.|
48399301|NCT01457924|101309083|FG002|STARTED|FUP (Weeks 24-48)||32|A total of 221 par. entered the FUP, including 7 of the 17 par. who were withdrawn before Week 24.|
48399302|NCT01457924|101309084|FG003|STARTED|FUP (Weeks 24-48)||33|A total of 221 par. entered the FUP, including 7 of the 17 par. who were withdrawn before Week 24.|
48399303|NCT01457924|101309085|FG004|STARTED|FUP (Weeks 24-48)||59|A total of 221 par. entered the FUP, including 7 of the 17 par. who were withdrawn before Week 24.|
48575215|NCT00464490|101738520|FG001|NOT COMPLETED|Overall Study||11||
48701923|NCT02324205|102057586|FG000|NOT COMPLETED|Overall Study||37||
48701924|NCT01895543|102057587|FG000|STARTED|Overall Study||411||
48701925|NCT01895543|102057587|FG000|Safety Analysis Set|Overall Study||409||
48701926|NCT01895543|102057587|FG000|Per Protocol Analysis Set|Overall Study||380||
48575216|NCT02097238|101738521|FG000|STARTED|Overall Study||19||
48575217|NCT02097238|101738521|FG000|COMPLETED|Overall Study||0||
48575218|NCT02097238|101738521|FG000|NOT COMPLETED|Overall Study||19||
48575219|NCT01435304|101738522|FG000|STARTED|Overall Study||50||
48575220|NCT01435304|101738523|FG001|STARTED|Overall Study||50||
48575221|NCT01435304|101738522|FG000|COMPLETED|Overall Study||50||
48575222|NCT01435304|101738523|FG001|COMPLETED|Overall Study||50||
48575223|NCT01435304|101738522|FG000|NOT COMPLETED|Overall Study||0||
48575224|NCT01435304|101738523|FG001|NOT COMPLETED|Overall Study||0||
48575225|NCT02955355|101738524|FG000|STARTED|Overall Study||85||
48575226|NCT02955355|101738524|FG000|COMPLETED|Overall Study||0||
48575227|NCT02955355|101738524|FG000|NOT COMPLETED|Overall Study||85||
48575228|NCT04740827|101738525|FG000|STARTED|Double-blind Treatment (Up to Week 12)||158||
48575229|NCT04740827|101738526|FG001|STARTED|Double-blind Treatment (Up to Week 12)||157||
48575230|NCT04740827|101738525|FG000|Safety Population|Double-blind Treatment (Up to Week 12)||157|Safety population consisted of all participants who received at least 1 dose of study intervention.|
48575231|NCT04740827|101738526|FG001|Safety Population|Double-blind Treatment (Up to Week 12)||156|Safety population consisted of all participants who received at least 1 dose of study intervention.|
48575232|NCT04740827|101738525|FG000|Modified Intent-to-Treat (mITT) Population|Double-blind Treatment (Up to Week 12)||154|mITT population consisted of all randomized participants who received at least 1 dose of study intervention, had an evaluable baseline period of eDiary data, and had at least 1 evaluable postbaseline 4-week period (Weeks 1 to 4, 5 to 8, and 9 to 12) of eDiary data during the double-blind treatment period.|
48575233|NCT04740827|101738526|FG001|Modified Intent-to-Treat (mITT) Population|Double-blind Treatment (Up to Week 12)||151|mITT population consisted of all randomized participants who received at least 1 dose of study intervention, had an evaluable baseline period of eDiary data, and had at least 1 evaluable postbaseline 4-week period (Weeks 1 to 4, 5 to 8, and 9 to 12) of eDiary data during the double-blind treatment period.|
48701927|NCT01895543|102057587|FG000|COMPLETED|Overall Study||282||
48701928|NCT01895543|102057587|FG000|NOT COMPLETED|Overall Study||129||
48701929|NCT01166373|102057588|FG000|STARTED|Overall Study||95|Randomized in Primary OPTIMAL Trial|
48701930|NCT01166373|102057589|FG001|STARTED|Overall Study||91|Randomized in Primary OPTIMAL Trial|
48701931|NCT01166373|102057590|FG002|STARTED|Overall Study||91|Randomized in Primary OPTIMAL Trial|
48701932|NCT01166373|102057591|FG003|STARTED|Overall Study||97|Randomized in Primary OPTIMAL Trial|
48701933|NCT01166373|102057588|FG000|Completed OPTIMAL Year 2 Visit|Overall Study||81||
48399304|NCT01457924|101309081|FG000|COMPLETED|FUP (Weeks 24-48)||63||
48399305|NCT01457924|101309082|FG001|COMPLETED|FUP (Weeks 24-48)||30||
48399306|NCT01457924|101309083|FG002|COMPLETED|FUP (Weeks 24-48)||30||
48399307|NCT01457924|101309084|FG003|COMPLETED|FUP (Weeks 24-48)||32||
48399308|NCT01457924|101309085|FG004|COMPLETED|FUP (Weeks 24-48)||57||
48399309|NCT01457924|101309081|FG000|NOT COMPLETED|FUP (Weeks 24-48)||3||
48399310|NCT01457924|101309082|FG001|NOT COMPLETED|FUP (Weeks 24-48)||1||
48399311|NCT01457924|101309083|FG002|NOT COMPLETED|FUP (Weeks 24-48)||2||
48399312|NCT01457924|101309084|FG003|NOT COMPLETED|FUP (Weeks 24-48)||1||
48399313|NCT01457924|101309085|FG004|NOT COMPLETED|FUP (Weeks 24-48)||2||
48399314|NCT01457924|101309081|FG000|STARTED|Individualized FUP (Weeks 48+)||16|Par. whose CD19+ B lymphocyte counts had not recovered to lower limit of normal entered IFU phase.|
48399315|NCT01457924|101309082|FG001|STARTED|Individualized FUP (Weeks 48+)||18|Par. whose CD19+ B lymphocyte counts had not recovered to lower limit of normal entered IFU phase.|
48399316|NCT01457924|101309083|FG002|STARTED|Individualized FUP (Weeks 48+)||16|Par. whose CD19+ B lymphocyte counts had not recovered to lower limit of normal entered IFU phase.|
48399317|NCT01457924|101309084|FG003|STARTED|Individualized FUP (Weeks 48+)||20|Par. whose CD19+ B lymphocyte counts had not recovered to lower limit of normal entered IFU phase.|
48399318|NCT01457924|101309085|FG004|STARTED|Individualized FUP (Weeks 48+)||42|Par. whose CD19+ B lymphocyte counts had not recovered to lower limit of normal entered IFU phase.|
48399319|NCT01457924|101309081|FG000|COMPLETED|Individualized FUP (Weeks 48+)||11||
48399320|NCT01457924|101309082|FG001|COMPLETED|Individualized FUP (Weeks 48+)||14||
48701934|NCT01166373|102057589|FG001|Completed OPTIMAL Year 2 Visit|Overall Study||80||
48701935|NCT01166373|102057590|FG002|Completed OPTIMAL Year 2 Visit|Overall Study||79||
48701936|NCT01166373|102057591|FG003|Completed OPTIMAL Year 2 Visit|Overall Study||87||
48285096|NCT01160289|101021646|FG003|STARTED|Screening, Washout, and Lead-In Period||0||
48285097|NCT01160289|101021647|FG004|STARTED|Screening, Washout, and Lead-In Period||0||
48285098|NCT01160289|101021648|FG005|STARTED|Screening, Washout, and Lead-In Period||0||
48285099|NCT01160289|101021643|FG000|COMPLETED|Screening, Washout, and Lead-In Period||410||
48399321|NCT01457924|101309083|FG002|COMPLETED|Individualized FUP (Weeks 48+)||12||
48399322|NCT01457924|101309084|FG003|COMPLETED|Individualized FUP (Weeks 48+)||15||
48399323|NCT01457924|101309085|FG004|COMPLETED|Individualized FUP (Weeks 48+)||36||
48399324|NCT01457924|101309081|FG000|NOT COMPLETED|Individualized FUP (Weeks 48+)||5||
48399325|NCT01457924|101309082|FG001|NOT COMPLETED|Individualized FUP (Weeks 48+)||4||
48399326|NCT01457924|101309083|FG002|NOT COMPLETED|Individualized FUP (Weeks 48+)||4||
48399327|NCT01457924|101309084|FG003|NOT COMPLETED|Individualized FUP (Weeks 48+)||5||
48399328|NCT01457924|101309085|FG004|NOT COMPLETED|Individualized FUP (Weeks 48+)||6||
48399329|NCT00865046|101309086|FG000|STARTED|Overall Study||63||
48399330|NCT00865046|101309087|FG001|STARTED|Overall Study||64||
48399331|NCT00865046|101309088|FG002|STARTED|Overall Study||63||
48399332|NCT00865046|101309086|FG000|COMPLETED|Overall Study||57||
48399333|NCT00865046|101309087|FG001|COMPLETED|Overall Study||59||
48399334|NCT00865046|101309088|FG002|COMPLETED|Overall Study||62||
48399335|NCT00865046|101309086|FG000|NOT COMPLETED|Overall Study||6||
48399336|NCT00865046|101309087|FG001|NOT COMPLETED|Overall Study||5||
48701937|NCT01166373|102057588|FG000|Randomized to Video|Overall Study||32|Prior to E-OPTIMAL consent. Used only to assess recruitment and retention regardless of treatment|
48701938|NCT01166373|102057589|FG001|Randomized to Video|Overall Study||43|Prior to E-OPTIMAL consent. Used only to assess recruitment and retention regardless of treatment|
48701939|NCT01166373|102057590|FG002|Randomized to Video|Overall Study||38|Prior to E-OPTIMAL consent. Used only to assess recruitment and retention regardless of treatment|
48285100|NCT01160289|101021644|FG001|COMPLETED|Screening, Washout, and Lead-In Period||0||
48285101|NCT01160289|101021645|FG002|COMPLETED|Screening, Washout, and Lead-In Period||0||
48285102|NCT01160289|101021646|FG003|COMPLETED|Screening, Washout, and Lead-In Period||0||
48285103|NCT01160289|101021647|FG004|COMPLETED|Screening, Washout, and Lead-In Period||0||
48285104|NCT01160289|101021648|FG005|COMPLETED|Screening, Washout, and Lead-In Period||0||
48285105|NCT01160289|101021643|FG000|NOT COMPLETED|Screening, Washout, and Lead-In Period||484||
48285106|NCT01160289|101021644|FG001|NOT COMPLETED|Screening, Washout, and Lead-In Period||0||
48285107|NCT01160289|101021645|FG002|NOT COMPLETED|Screening, Washout, and Lead-In Period||0||
48285108|NCT01160289|101021646|FG003|NOT COMPLETED|Screening, Washout, and Lead-In Period||0||
48285109|NCT01160289|101021647|FG004|NOT COMPLETED|Screening, Washout, and Lead-In Period||0||
48285110|NCT01160289|101021648|FG005|NOT COMPLETED|Screening, Washout, and Lead-In Period||0||
48285111|NCT01160289|101021643|FG000|STARTED|Post-Randomization Period||0||
48285112|NCT01160289|101021644|FG001|STARTED|Post-Randomization Period||85||
48399337|NCT00865046|101309088|FG002|NOT COMPLETED|Overall Study||1||
48399338|NCT02715804|101309089|FG000|STARTED|Overall Study||327||
48399339|NCT02715804|101309090|FG001|STARTED|Overall Study||165||
48399340|NCT02715804|101309089|FG000|Received at Least 1 Dose of Study Drug|Overall Study||323||
48399341|NCT02715804|101309090|FG001|Received at Least 1 Dose of Study Drug|Overall Study||158||
48399342|NCT02715804|101309089|FG000|Safety Population|Overall Study||325|Received at least 1 dose of study medication, and analyzed according to the treatment they received.|
48701940|NCT01166373|102057591|FG003|Randomized to Video|Overall Study||40|Prior to E-OPTIMAL consent. Used only to assess recruitment and retention regardless of treatment|
48710829|NCT03446053|102078031|FG001|Randomized Set|Overall Study||6||
48285113|NCT01160289|101021645|FG002|STARTED|Post-Randomization Period||97||
48285114|NCT01160289|101021646|FG003|STARTED|Post-Randomization Period||52||
48285115|NCT01160289|101021647|FG004|STARTED|Post-Randomization Period||89||
48285116|NCT01160289|101021648|FG005|STARTED|Post-Randomization Period||87||
48285117|NCT01160289|101021643|FG000|Received at Least 1 Dose of Study Drug|Post-Randomization Period||0||
48285118|NCT01160289|101021644|FG001|Received at Least 1 Dose of Study Drug|Post-Randomization Period||85||
48285119|NCT01160289|101021645|FG002|Received at Least 1 Dose of Study Drug|Post-Randomization Period||97||
48285120|NCT01160289|101021646|FG003|Received at Least 1 Dose of Study Drug|Post-Randomization Period||52||
48285121|NCT01160289|101021647|FG004|Received at Least 1 Dose of Study Drug|Post-Randomization Period||89||
48285122|NCT01160289|101021648|FG005|Received at Least 1 Dose of Study Drug|Post-Randomization Period||87||
48285123|NCT01160289|101021643|FG000|COMPLETED|Post-Randomization Period||0||
48285124|NCT01160289|101021644|FG001|COMPLETED|Post-Randomization Period||65||
48285125|NCT01160289|101021645|FG002|COMPLETED|Post-Randomization Period||73||
48285126|NCT01160289|101021646|FG003|COMPLETED|Post-Randomization Period||31||
48285127|NCT01160289|101021647|FG004|COMPLETED|Post-Randomization Period||80||
48285128|NCT01160289|101021648|FG005|COMPLETED|Post-Randomization Period||73||
48285129|NCT01160289|101021643|FG000|NOT COMPLETED|Post-Randomization Period||0||
48285130|NCT01160289|101021644|FG001|NOT COMPLETED|Post-Randomization Period||20||
48399343|NCT02715804|101309090|FG001|Safety Population|Overall Study||156|Received at least 1 dose of study medication, and analyzed according to the treatment they received.|
48399344|NCT02715804|101309089|FG000|COMPLETED|Overall Study||98||
48399345|NCT02715804|101309090|FG001|COMPLETED|Overall Study||52||
48399346|NCT02715804|101309089|FG000|NOT COMPLETED|Overall Study||229||
48131308|NCT02258477|100645856|FG003|NOT COMPLETED|Second Intervention (1 Week)||1||
48399347|NCT02715804|101309090|FG001|NOT COMPLETED|Overall Study||113||
48399348|NCT01931150|101309091|FG000|STARTED|Overall Study||5||
48399349|NCT01931150|101309092|FG001|STARTED|Overall Study||6||
48399350|NCT01931150|101309091|FG000|COMPLETED|Overall Study||4||
48399351|NCT01931150|101309092|FG001|COMPLETED|Overall Study||4||
48399352|NCT01931150|101309091|FG000|NOT COMPLETED|Overall Study||1||
48399353|NCT01931150|101309092|FG001|NOT COMPLETED|Overall Study||2||
48399354|NCT02896192|101309093|FG000|STARTED|Titration Period (2 to 12 Weeks)||15||
48399355|NCT02896192|101309093|FG000|Treated|Titration Period (2 to 12 Weeks)||15||
48399356|NCT02896192|101309093|FG000|COMPLETED|Titration Period (2 to 12 Weeks)||15||
48399357|NCT02896192|101309093|FG000|NOT COMPLETED|Titration Period (2 to 12 Weeks)||0||
48399358|NCT02896192|101309093|FG000|STARTED|Open-Label Period (10 Weeks)||15||
48399359|NCT02896192|101309093|FG000|COMPLETED|Open-Label Period (10 Weeks)||13||
48399360|NCT02896192|101309093|FG000|NOT COMPLETED|Open-Label Period (10 Weeks)||2||
48399361|NCT02896192|101309093|FG000|STARTED|Double-Blind Withdrawal Period (8 Weeks)||13||
48399362|NCT02896192|101309093|FG000|COMPLETED|Double-Blind Withdrawal Period (8 Weeks)||13||
48701941|NCT01166373|102057588|FG000|Randomized to No Video|Overall Study||45|Prior to E-OPTIMAL consent. Used only to assess recruitment and retention regardless of treatment|
48701942|NCT01166373|102057589|FG001|Randomized to No Video|Overall Study||30|Prior to E-OPTIMAL consent. Used only to assess recruitment and retention regardless of treatment|
48701943|NCT01166373|102057590|FG002|Randomized to No Video|Overall Study||34|Prior to E-OPTIMAL consent. Used only to assess recruitment and retention regardless of treatment|
48701944|NCT01166373|102057591|FG003|Randomized to No Video|Overall Study||42|Prior to E-OPTIMAL consent. Used only to assess recruitment and retention regardless of treatment|
48701945|NCT01166373|102057588|FG000|Consented to Participate E-OPTIMAL|Overall Study||72||
48131309|NCT02258477|100645853|FG000|STARTED|Third Intervention (1 Week)||9||
48131310|NCT02258477|100645854|FG001|STARTED|Third Intervention (1 Week)||8||
48131311|NCT02258477|100645855|FG002|STARTED|Third Intervention (1 Week)||8||
48131312|NCT02258477|100645856|FG003|STARTED|Third Intervention (1 Week)||8||
48131313|NCT02258477|100645853|FG000|COMPLETED|Third Intervention (1 Week)||9||
48131314|NCT02258477|100645854|FG001|COMPLETED|Third Intervention (1 Week)||8||
48131315|NCT02258477|100645855|FG002|COMPLETED|Third Intervention (1 Week)||8||
48131316|NCT02258477|100645856|FG003|COMPLETED|Third Intervention (1 Week)||8||
48131317|NCT02258477|100645853|FG000|NOT COMPLETED|Third Intervention (1 Week)||0||
48131318|NCT02258477|100645854|FG001|NOT COMPLETED|Third Intervention (1 Week)||0||
48131319|NCT02258477|100645855|FG002|NOT COMPLETED|Third Intervention (1 Week)||0||
48285131|NCT01160289|101021645|FG002|NOT COMPLETED|Post-Randomization Period||24||
48285132|NCT01160289|101021646|FG003|NOT COMPLETED|Post-Randomization Period||21||
48285133|NCT01160289|101021647|FG004|NOT COMPLETED|Post-Randomization Period||9||
48285134|NCT01160289|101021648|FG005|NOT COMPLETED|Post-Randomization Period||14||
48285135|NCT00700258|101021649|FG000|STARTED|Overall Study||1520||
48285136|NCT00700258|101021649|FG000|Participants With mRCC|Overall Study||1435||
48285137|NCT00700258|101021649|FG000|Participants With MCL|Overall Study||59||
48285138|NCT00700258|101021649|FG000|Participants With GIST|Overall Study||26||
48285139|NCT00700258|101021649|FG000|Participants With mRCC Who Received Temsirolimus|Overall Study||605||
48285140|NCT00700258|101021649|FG000|Participants With mRCC Who Received Sunitinib|Overall Study||702||
48285141|NCT00700258|101021649|FG000|Participants With mRCC Who Received Axitinib|Overall Study||237||
48285142|NCT00700258|101021649|FG000|Participants With MCL Who Received Temsirolimus|Overall Study||59||
48399363|NCT02896192|101309093|FG000|NOT COMPLETED|Double-Blind Withdrawal Period (8 Weeks)||0||
48399364|NCT02896192|101309093|FG000|STARTED|Open-Label Period (32 Weeks)||13||
48701946|NCT01166373|102057589|FG001|Consented to Participate E-OPTIMAL|Overall Study||66||
48701947|NCT01166373|102057590|FG002|Consented to Participate E-OPTIMAL|Overall Study||69||
48399365|NCT02896192|101309093|FG000|COMPLETED|Open-Label Period (32 Weeks)||12||
48399366|NCT02896192|101309093|FG000|NOT COMPLETED|Open-Label Period (32 Weeks)||1||
48399367|NCT00049504|101309094|FG000|STARTED|Overall Study||55||
48399368|NCT00049504|101309094|FG000|COMPLETED|Overall Study||55||
48399369|NCT00049504|101309094|FG000|NOT COMPLETED|Overall Study||0||
48399370|NCT00361218|101309095|FG000|STARTED|Overall Study||53||
48399371|NCT00361218|101309095|FG000|Completed Baseline Assessment|Overall Study||47||
48399372|NCT00361218|101309095|FG000|COMPLETED|Overall Study||30||
48399373|NCT00361218|101309095|FG000|NOT COMPLETED|Overall Study||23||
48399374|NCT00129740|101309096|FG000|STARTED|Overall Study||148||
48399375|NCT00129740|101309096|FG000|COMPLETED|Overall Study||148||
48399376|NCT00129740|101309096|FG000|NOT COMPLETED|Overall Study||0||
48399377|NCT02074904|101309097|FG000|STARTED|Overall Study||1||
48399378|NCT02074904|101309098|FG001|STARTED|Overall Study||0||
48399379|NCT02074904|101309097|FG000|COMPLETED|Overall Study||1||
48399380|NCT02074904|101309098|FG001|COMPLETED|Overall Study||0||
48399381|NCT02074904|101309097|FG000|NOT COMPLETED|Overall Study||0||
48399382|NCT02074904|101309098|FG001|NOT COMPLETED|Overall Study||0||
48399383|NCT00047008|101309099|FG000|STARTED|Overall Study||372||
48399384|NCT00047008|101309100|FG001|STARTED|Overall Study||371||
48399385|NCT00047008|101309099|FG000|COMPLETED|Overall Study||361||
48399386|NCT00047008|101309100|FG001|COMPLETED|Overall Study||360||
48399387|NCT00047008|101309099|FG000|NOT COMPLETED|Overall Study||11||
48399388|NCT00047008|101309100|FG001|NOT COMPLETED|Overall Study||11||
48399389|NCT01181141|101309101|FG000|STARTED|Overall Study||62||
48399390|NCT01181141|101309102|FG001|STARTED|Overall Study||30||
48399391|NCT01181141|101309101|FG000|Safety Analysis Population|Overall Study||59||
48399392|NCT01181141|101309102|FG001|Safety Analysis Population|Overall Study||29||
48399393|NCT01181141|101309101|FG000|COMPLETED|Overall Study||50||
48399394|NCT01181141|101309102|FG001|COMPLETED|Overall Study||26||
48399395|NCT01181141|101309101|FG000|NOT COMPLETED|Overall Study||12||
48399396|NCT01181141|101309102|FG001|NOT COMPLETED|Overall Study||4||
48399397|NCT01598207|101309103|FG000|STARTED|Overall Study||7||
48399398|NCT01598207|101309104|FG001|STARTED|Overall Study||6||
48399399|NCT01598207|101309103|FG000|COMPLETED|Overall Study||6||
48399400|NCT01598207|101309104|FG001|COMPLETED|Overall Study||6||
48399401|NCT01598207|101309103|FG000|NOT COMPLETED|Overall Study||1||
48399402|NCT01598207|101309104|FG001|NOT COMPLETED|Overall Study||0||
48399403|NCT04186663|101309105|FG000|STARTED|Overall Study||59||
48399404|NCT04186663|101309105|FG000|COMPLETED|Overall Study||55||
48399405|NCT04186663|101309105|FG000|NOT COMPLETED|Overall Study||4||
48399406|NCT00410904|101309106|FG000|STARTED|Overall Study||40||
48399407|NCT00410904|101309107|FG001|STARTED|Overall Study||20||
48399408|NCT00410904|101309106|FG000|COMPLETED|Overall Study||40||
48399409|NCT00410904|101309107|FG001|COMPLETED|Overall Study||20||
48399410|NCT00410904|101309106|FG000|NOT COMPLETED|Overall Study||0||
48399411|NCT00410904|101309107|FG001|NOT COMPLETED|Overall Study||0||
48399412|NCT04446299|101309108|FG000|STARTED|Overall Study||259||
48399413|NCT04446299|101309109|FG001|STARTED|Overall Study||260||
48399414|NCT04446299|101309108|FG000|COMPLETED|Overall Study||220||
48399415|NCT04446299|101309109|FG001|COMPLETED|Overall Study||230||
48399416|NCT04446299|101309108|FG000|NOT COMPLETED|Overall Study||39||
48399417|NCT04446299|101309109|FG001|NOT COMPLETED|Overall Study||30||
48399418|NCT00105183|101309110|FG000|STARTED|Overall Study||82||
48399419|NCT00105183|101309111|FG001|STARTED|Overall Study||79||
48399420|NCT00105183|101309112|FG002|STARTED|Overall Study||62||
48399421|NCT00105183|101309110|FG000|COMPLETED|Overall Study||60||
48399422|NCT00105183|101309111|FG001|COMPLETED|Overall Study||60||
48399423|NCT00105183|101309112|FG002|COMPLETED|Overall Study||39||
48399424|NCT00105183|101309110|FG000|NOT COMPLETED|Overall Study||22||
48399425|NCT00105183|101309111|FG001|NOT COMPLETED|Overall Study||19||
48399426|NCT00105183|101309112|FG002|NOT COMPLETED|Overall Study||23||
48399427|NCT00608842|101309113|FG000|STARTED|Overall Study||15||
48399428|NCT00608842|101309114|FG001|STARTED|Overall Study||15||
48399429|NCT00608842|101309115|FG002|STARTED|Overall Study||15||
48399430|NCT00608842|101309116|FG003|STARTED|Overall Study||17||
48399431|NCT00608842|101309113|FG000|COMPLETED|Overall Study||14||
48399432|NCT00608842|101309114|FG001|COMPLETED|Overall Study||14||
48399433|NCT00608842|101309115|FG002|COMPLETED|Overall Study||13||
48399434|NCT00608842|101309116|FG003|COMPLETED|Overall Study||16||
48399435|NCT00608842|101309113|FG000|NOT COMPLETED|Overall Study||1||
48399436|NCT00608842|101309114|FG001|NOT COMPLETED|Overall Study||1||
48399437|NCT00608842|101309115|FG002|NOT COMPLETED|Overall Study||2||
48399438|NCT00608842|101309116|FG003|NOT COMPLETED|Overall Study||1||
48399439|NCT01311895|101309117|FG000|STARTED|Overall Study||175||
48399440|NCT01311895|101309118|FG001|STARTED|Overall Study||175||
48399441|NCT01311895|101309117|FG000|COMPLETED|Overall Study||175||
48399442|NCT01311895|101309118|FG001|COMPLETED|Overall Study||175||
48399443|NCT01311895|101309117|FG000|NOT COMPLETED|Overall Study||0||
48399444|NCT01311895|101309118|FG001|NOT COMPLETED|Overall Study||0||
48404077|NCT03689972|101321769|FG003|NOT COMPLETED|Part 1 (Day 1 up to Week 72)||0||
48404078|NCT03689972|101321770|FG004|NOT COMPLETED|Part 1 (Day 1 up to Week 72)||0||
48701948|NCT01166373|102057591|FG003|Consented to Participate E-OPTIMAL|Overall Study||78||
48701949|NCT01166373|102057588|FG000|Completed E-OPTIMAL Year 3 Visit|Overall Study||70||
48701950|NCT01166373|102057589|FG001|Completed E-OPTIMAL Year 3 Visit|Overall Study||66||
48701951|NCT01166373|102057590|FG002|Completed E-OPTIMAL Year 3 Visit|Overall Study||66||
48701952|NCT01166373|102057591|FG003|Completed E-OPTIMAL Year 3 Visit|Overall Study||77||
48701953|NCT01166373|102057588|FG000|Completed E-OPTIMAL Year 4 Visit|Overall Study||67||
48701954|NCT01166373|102057589|FG001|Completed E-OPTIMAL Year 4 Visit|Overall Study||61||
48701955|NCT01166373|102057590|FG002|Completed E-OPTIMAL Year 4 Visit|Overall Study||63||
48701956|NCT01166373|102057591|FG003|Completed E-OPTIMAL Year 4 Visit|Overall Study||68||
48701957|NCT01166373|102057588|FG000|Completed E-OPTIMAL Year 5 Visit|Overall Study||62||
48701958|NCT01166373|102057589|FG001|Completed E-OPTIMAL Year 5 Visit|Overall Study||56||
48701959|NCT01166373|102057590|FG002|Completed E-OPTIMAL Year 5 Visit|Overall Study||62||
48701960|NCT01166373|102057591|FG003|Completed E-OPTIMAL Year 5 Visit|Overall Study||64||
48701961|NCT01166373|102057588|FG000|COMPLETED|Overall Study||90|Included in Primary Analysis|
48701962|NCT01166373|102057589|FG001|COMPLETED|Overall Study||87|Included in Primary Analysis|
48701963|NCT01166373|102057590|FG002|COMPLETED|Overall Study||87|Included in Primary Analysis|
48701964|NCT01166373|102057591|FG003|COMPLETED|Overall Study||92|Included in Primary Analysis|
48701965|NCT01166373|102057588|FG000|NOT COMPLETED|Overall Study||5||
48701966|NCT01166373|102057589|FG001|NOT COMPLETED|Overall Study||4||
48701967|NCT01166373|102057590|FG002|NOT COMPLETED|Overall Study||4||
48701968|NCT01166373|102057591|FG003|NOT COMPLETED|Overall Study||5||
48701969|NCT03905265|102057592|FG000|STARTED|Overall Study||4||
48701970|NCT03905265|102057593|FG001|STARTED|Overall Study||4||
48701971|NCT03905265|102057594|FG002|STARTED|Overall Study||6||
48285143|NCT00700258|101021649|FG000|Participants With GIST Who Received Sunitinib|Overall Study||26||
48285144|NCT00700258|101021649|FG000|COMPLETED|Overall Study||289||
48285145|NCT00700258|101021649|FG000|NOT COMPLETED|Overall Study||1231||
48285146|NCT02724969|101021650|FG000|STARTED|Overall Study||126||
48701972|NCT03905265|102057595|FG003|STARTED|Overall Study||8||
48701973|NCT03905265|102057592|FG000|COMPLETED|Overall Study||3||
48701974|NCT03905265|102057593|FG001|COMPLETED|Overall Study||3||
48701975|NCT03905265|102057594|FG002|COMPLETED|Overall Study||6||
48701976|NCT03905265|102057595|FG003|COMPLETED|Overall Study||8||
48701977|NCT03905265|102057592|FG000|NOT COMPLETED|Overall Study||1||
48701978|NCT03905265|102057593|FG001|NOT COMPLETED|Overall Study||1||
48701979|NCT03905265|102057594|FG002|NOT COMPLETED|Overall Study||0||
48701980|NCT03905265|102057595|FG003|NOT COMPLETED|Overall Study||0||
48701981|NCT02750345|102057596|FG000|STARTED|Intervention 1||4||
48701982|NCT02750345|102057597|FG001|STARTED|Intervention 1||4||
48701983|NCT02750345|102057598|FG002|STARTED|Intervention 1||4||
48701984|NCT02750345|102057599|FG003|STARTED|Intervention 1||4||
48701985|NCT02750345|102057600|FG004|STARTED|Intervention 1||4||
48701986|NCT02750345|102057601|FG005|STARTED|Intervention 1||4||
48285147|NCT02724969|101021651|FG001|STARTED|Overall Study||124||
48285148|NCT02724969|101021650|FG000|COMPLETED|Overall Study||111||
48285149|NCT02724969|101021651|FG001|COMPLETED|Overall Study||113||
48285150|NCT02724969|101021650|FG000|NOT COMPLETED|Overall Study||15||
48285151|NCT02724969|101021651|FG001|NOT COMPLETED|Overall Study||11||
48285152|NCT03256851|101021652|FG000|STARTED|Overall Study||10||
48285153|NCT03256851|101021653|FG001|STARTED|Overall Study||10||
48285154|NCT03256851|101021652|FG000|COMPLETED|Overall Study||9||
48285155|NCT03256851|101021653|FG001|COMPLETED|Overall Study||10||
48285156|NCT03256851|101021652|FG000|NOT COMPLETED|Overall Study||1||
48285157|NCT03256851|101021653|FG001|NOT COMPLETED|Overall Study||0||
48285158|NCT02424734|101021654|FG000|STARTED|Overall Study||4||
48285159|NCT02424734|101021655|FG001|STARTED|Overall Study||5||
48285160|NCT02424734|101021656|FG002|STARTED|Overall Study||2||
48285161|NCT02424734|101021654|FG000|Treated|Overall Study||4||
48285162|NCT02424734|101021655|FG001|Treated|Overall Study||5||
48285163|NCT02424734|101021656|FG002|Treated|Overall Study||2||
48701987|NCT02750345|102057596|FG000|COMPLETED|Intervention 1||4||
48701988|NCT02750345|102057597|FG001|COMPLETED|Intervention 1||4||
48701989|NCT02750345|102057598|FG002|COMPLETED|Intervention 1||4||
48701990|NCT02750345|102057599|FG003|COMPLETED|Intervention 1||4||
48701991|NCT02750345|102057600|FG004|COMPLETED|Intervention 1||3||
48285164|NCT02424734|101021654|FG000|COMPLETED|Overall Study||2||
48285165|NCT02424734|101021655|FG001|COMPLETED|Overall Study||3||
48285166|NCT02424734|101021656|FG002|COMPLETED|Overall Study||2||
48285167|NCT02424734|101021654|FG000|NOT COMPLETED|Overall Study||2||
48285168|NCT02424734|101021655|FG001|NOT COMPLETED|Overall Study||2||
48285169|NCT02424734|101021656|FG002|NOT COMPLETED|Overall Study||0||
48701992|NCT02750345|102057601|FG005|COMPLETED|Intervention 1||4||
48701993|NCT02750345|102057596|FG000|NOT COMPLETED|Intervention 1||0||
48701994|NCT02750345|102057597|FG001|NOT COMPLETED|Intervention 1||0||
48701995|NCT02750345|102057598|FG002|NOT COMPLETED|Intervention 1||0||
48701996|NCT02750345|102057599|FG003|NOT COMPLETED|Intervention 1||0||
48701997|NCT02750345|102057600|FG004|NOT COMPLETED|Intervention 1||1||
48701998|NCT02750345|102057601|FG005|NOT COMPLETED|Intervention 1||0||
48701999|NCT02750345|102057596|FG000|STARTED|Intervention 2||4||
48702000|NCT02750345|102057597|FG001|STARTED|Intervention 2||4||
48702001|NCT02750345|102057598|FG002|STARTED|Intervention 2||4||
48285170|NCT01077271|101021657|FG000|STARTED|Overall Study||124||
48285171|NCT01077271|101021657|FG000|Participants Treated With Palivizumab|Overall Study||120||
48285172|NCT01077271|101021657|FG000|Number of Participants Analyzed|Overall Study||120||
48285173|NCT01077271|101021657|FG000|COMPLETED|Overall Study||102||
48285174|NCT01077271|101021657|FG000|NOT COMPLETED|Overall Study||22||
48404079|NCT03689972|101321766|FG000|STARTED|Part 2:Run-in Period (Week73uptoWeek107)||0||
48702002|NCT02750345|102057599|FG003|STARTED|Intervention 2||4||
48702003|NCT02750345|102057600|FG004|STARTED|Intervention 2||3||
48702004|NCT02750345|102057601|FG005|STARTED|Intervention 2||4||
48575234|NCT04740827|101738525|FG000|Off-treatment Hypothetical Estimand (OTHE) Population|Double-blind Treatment (Up to Week 12)||155|OTHE population consisted of all randomized participants who received at least 1 dose of study intervention, had an evaluable baseline period of eDiary data, and had at least 1 evaluable postbaseline 4-week period (Weeks 1 to 4, 5 to 8, 9 to 12) of eDiary data, regardless of whether on study intervention or off study intervention.|
48575235|NCT04740827|101738526|FG001|Off-treatment Hypothetical Estimand (OTHE) Population|Double-blind Treatment (Up to Week 12)||154|OTHE population consisted of all randomized participants who received at least 1 dose of study intervention, had an evaluable baseline period of eDiary data, and had at least 1 evaluable postbaseline 4-week period (Weeks 1 to 4, 5 to 8, 9 to 12) of eDiary data, regardless of whether on study intervention or off study intervention.|
48575236|NCT04740827|101738525|FG000|COMPLETED|Double-blind Treatment (Up to Week 12)||151||
48575237|NCT04740827|101738526|FG001|COMPLETED|Double-blind Treatment (Up to Week 12)||144||
48702005|NCT02750345|102057596|FG000|COMPLETED|Intervention 2||4||
48702006|NCT02750345|102057597|FG001|COMPLETED|Intervention 2||4||
48702007|NCT02750345|102057598|FG002|COMPLETED|Intervention 2||4||
48702008|NCT02750345|102057599|FG003|COMPLETED|Intervention 2||4||
48702009|NCT02750345|102057600|FG004|COMPLETED|Intervention 2||3||
48702010|NCT02750345|102057601|FG005|COMPLETED|Intervention 2||4||
48702011|NCT02750345|102057596|FG000|NOT COMPLETED|Intervention 2||0||
48702012|NCT02750345|102057597|FG001|NOT COMPLETED|Intervention 2||0||
48702013|NCT02750345|102057598|FG002|NOT COMPLETED|Intervention 2||0||
48702014|NCT02750345|102057599|FG003|NOT COMPLETED|Intervention 2||0||
48702015|NCT02750345|102057600|FG004|NOT COMPLETED|Intervention 2||0||
48702016|NCT02750345|102057601|FG005|NOT COMPLETED|Intervention 2||0||
48702017|NCT02750345|102057596|FG000|STARTED|Intervention 3||4||
48702018|NCT02750345|102057597|FG001|STARTED|Intervention 3||4||
48702019|NCT02750345|102057598|FG002|STARTED|Intervention 3||4||
48702020|NCT02750345|102057599|FG003|STARTED|Intervention 3||4||
48702021|NCT02750345|102057600|FG004|STARTED|Intervention 3||3||
48702022|NCT02750345|102057601|FG005|STARTED|Intervention 3||4||
48702023|NCT02750345|102057596|FG000|COMPLETED|Intervention 3||4||
48285175|NCT02338973|101021658|FG000|STARTED|Overall Study||4||
48404080|NCT03689972|101321767|FG001|STARTED|Part 2:Run-in Period (Week73uptoWeek107)||0||
48575238|NCT04740827|101738525|FG000|NOT COMPLETED|Double-blind Treatment (Up to Week 12)||7||
48575239|NCT04740827|101738526|FG001|NOT COMPLETED|Double-blind Treatment (Up to Week 12)||13||
48702024|NCT02750345|102057597|FG001|COMPLETED|Intervention 3||4||
48702025|NCT02750345|102057598|FG002|COMPLETED|Intervention 3||4||
48702026|NCT02750345|102057599|FG003|COMPLETED|Intervention 3||4||
48702027|NCT02750345|102057600|FG004|COMPLETED|Intervention 3||3||
48702028|NCT02750345|102057601|FG005|COMPLETED|Intervention 3||4||
48702029|NCT02750345|102057596|FG000|NOT COMPLETED|Intervention 3||0||
48702030|NCT02750345|102057597|FG001|NOT COMPLETED|Intervention 3||0||
48702031|NCT02750345|102057598|FG002|NOT COMPLETED|Intervention 3||0||
48702032|NCT02750345|102057599|FG003|NOT COMPLETED|Intervention 3||0||
48702033|NCT02750345|102057600|FG004|NOT COMPLETED|Intervention 3||0||
48702034|NCT02750345|102057601|FG005|NOT COMPLETED|Intervention 3||0||
48702035|NCT00541866|102057602|FG000|STARTED|Overall Study||41||
48702036|NCT00541866|102057603|FG001|STARTED|Overall Study||18||
48702037|NCT00541866|102057604|FG002|STARTED|Overall Study||17||
48702038|NCT00541866|102057605|FG003|STARTED|Overall Study||16||
48702039|NCT00541866|102057606|FG004|STARTED|Overall Study||18||
48702040|NCT00541866|102057602|FG000|COMPLETED|Overall Study||7||
48702041|NCT00541866|102057603|FG001|COMPLETED|Overall Study||0||
48702042|NCT00541866|102057604|FG002|COMPLETED|Overall Study||2||
48702043|NCT00541866|102057605|FG003|COMPLETED|Overall Study||0||
48702044|NCT00541866|102057606|FG004|COMPLETED|Overall Study||3||
48702045|NCT00541866|102057602|FG000|NOT COMPLETED|Overall Study||34||
48702046|NCT00541866|102057603|FG001|NOT COMPLETED|Overall Study||18||
48702047|NCT00541866|102057604|FG002|NOT COMPLETED|Overall Study||15||
48702048|NCT00541866|102057605|FG003|NOT COMPLETED|Overall Study||16||
48702049|NCT00541866|102057606|FG004|NOT COMPLETED|Overall Study||15||
48702050|NCT02080481|102057607|FG000|STARTED|Overall Study||68||
48702051|NCT02080481|102057608|FG001|STARTED|Overall Study||67||
48702052|NCT02080481|102057607|FG000|COMPLETED|Overall Study||67|The patients completed the study were included in the analysis|
48702053|NCT02080481|102057608|FG001|COMPLETED|Overall Study||67|The patients completed the study were included in the analysis|
48702054|NCT02080481|102057607|FG000|NOT COMPLETED|Overall Study||1||
48702055|NCT02080481|102057608|FG001|NOT COMPLETED|Overall Study||0||
48702056|NCT01945216|102057609|FG000|STARTED|Overall Study||3317||
48702057|NCT01945216|102057609|FG000|COMPLETED|Overall Study||3218||
48702058|NCT01945216|102057609|FG000|NOT COMPLETED|Overall Study||99||
48702059|NCT01007435|102057610|FG000|STARTED|Overall Study||289||
48702060|NCT01007435|102057611|FG001|STARTED|Overall Study||290||
48702061|NCT01007435|102057612|FG002|STARTED|Overall Study||291||
48399445|NCT03597503|101309119|FG000|STARTED|Overall Study||20|Number of subjects is based on the Safety Population, defined as all subjects who received at least 1 dose of study drug and had at least one post-baseline safety assessment.|
48285176|NCT02338973|101021658|FG000|Rod-cone Dystrophy (RCD)|Overall Study||2||
48131320|NCT02258477|100645856|FG003|NOT COMPLETED|Third Intervention (1 Week)||0||
48131321|NCT02258477|100645853|FG000|STARTED|Fourth Intervention (1 Week)||9||
48131322|NCT02258477|100645854|FG001|STARTED|Fourth Intervention (1 Week)||8||
48399446|NCT03597503|101309120|FG001|STARTED|Overall Study||21|Number of subjects is based on the Safety Population, defined as all subjects who received at least 1 dose of study drug and had at least one post-baseline safety assessment.|
48399447|NCT03597503|101309119|FG000|Treated|Overall Study||20||
48399448|NCT03597503|101309120|FG001|Treated|Overall Study||21||
48399449|NCT03597503|101309119|FG000|COMPLETED|Overall Study||18||
48399450|NCT03597503|101309120|FG001|COMPLETED|Overall Study||17||
48399451|NCT03597503|101309119|FG000|NOT COMPLETED|Overall Study||2||
48399452|NCT03597503|101309120|FG001|NOT COMPLETED|Overall Study||4||
48399453|NCT03012594|101309121|FG000|STARTED|Overall Study||12||
48399454|NCT03012594|101309121|FG000|COMPLETED|Overall Study||9||
48399455|NCT03012594|101309121|FG000|NOT COMPLETED|Overall Study||3||
48399456|NCT03554850|101309122|FG000|STARTED|Overall Study||201||
48399457|NCT03554850|101309122|FG000|COMPLETED|Overall Study||190||
48399458|NCT03554850|101309122|FG000|NOT COMPLETED|Overall Study||11||
48399459|NCT00838695|101309123|FG000|STARTED|Overall Study||42||
48399460|NCT00838695|101309124|FG001|STARTED|Overall Study||64||
48399461|NCT00838695|101309123|FG000|COMPLETED|Overall Study||42||
48399462|NCT00838695|101309124|FG001|COMPLETED|Overall Study||64||
48399463|NCT00838695|101309123|FG000|NOT COMPLETED|Overall Study||0||
48399464|NCT00838695|101309124|FG001|NOT COMPLETED|Overall Study||0||
48399465|NCT01471639|101309125|FG000|STARTED|Overall Study||37||
48399466|NCT01471639|101309125|FG000|COMPLETED|Overall Study||37||
48399467|NCT01471639|101309125|FG000|NOT COMPLETED|Overall Study||0||
48399468|NCT01263444|101309126|FG000|STARTED|Overall Study||47||
48575240|NCT04740827|101738525|FG000|STARTED|Follow-up Period (Week 13 to Week 16)||43|Of 295 participants who completed the double-blind period 87 participants entered the follow-up period. Participants who rolled over directly at Week 12 to study 3101-312-002 \[NCT04686136\] did not enter the safety-follow up period.|
48575241|NCT04740827|101738526|FG001|STARTED|Follow-up Period (Week 13 to Week 16)||44|Of 295 participants who completed the double-blind period 87 participants entered the follow-up period. Participants who rolled over directly at Week 12 to study 3101-312-002 \[NCT04686136\] did not enter the safety-follow up period.|
48575242|NCT04740827|101738525|FG000|COMPLETED|Follow-up Period (Week 13 to Week 16)||42||
48575243|NCT04740827|101738526|FG001|COMPLETED|Follow-up Period (Week 13 to Week 16)||44||
48575244|NCT04740827|101738525|FG000|NOT COMPLETED|Follow-up Period (Week 13 to Week 16)||1||
48131323|NCT02258477|100645855|FG002|STARTED|Fourth Intervention (1 Week)||8||
48131324|NCT02258477|100645856|FG003|STARTED|Fourth Intervention (1 Week)||8||
48131325|NCT02258477|100645853|FG000|COMPLETED|Fourth Intervention (1 Week)||9||
48131326|NCT02258477|100645854|FG001|COMPLETED|Fourth Intervention (1 Week)||8||
48131327|NCT02258477|100645855|FG002|COMPLETED|Fourth Intervention (1 Week)||8||
48131328|NCT02258477|100645856|FG003|COMPLETED|Fourth Intervention (1 Week)||8||
48131329|NCT02258477|100645853|FG000|NOT COMPLETED|Fourth Intervention (1 Week)||0||
48285177|NCT02338973|101021658|FG000|Enhanced S-Cone Syndrome (ESCS)|Overall Study||2||
48285178|NCT02338973|101021658|FG000|COMPLETED|Overall Study||4||
48285179|NCT02338973|101021658|FG000|NOT COMPLETED|Overall Study||0||
48285180|NCT00353522|101021659|FG000|STARTED|Overall Study||89||
48285181|NCT00353522|101021660|FG001|STARTED|Overall Study||46||
48285182|NCT00353522|101021659|FG000|COMPLETED|Overall Study||74||
48399469|NCT01263444|101309126|FG000|COMPLETED|Overall Study||37||
48399470|NCT01263444|101309126|FG000|NOT COMPLETED|Overall Study||10||
48399471|NCT02566109|101309127|FG000|STARTED|Overall Study||6||
48399472|NCT02566109|101309127|FG000|COMPLETED|Overall Study||5||
48399473|NCT02566109|101309127|FG000|NOT COMPLETED|Overall Study||1||
48399474|NCT00651313|101309128|FG000|STARTED|Overall Study||41||
48131330|NCT02258477|100645854|FG001|NOT COMPLETED|Fourth Intervention (1 Week)||0||
48131331|NCT02258477|100645855|FG002|NOT COMPLETED|Fourth Intervention (1 Week)||0||
48131332|NCT02258477|100645856|FG003|NOT COMPLETED|Fourth Intervention (1 Week)||0||
48285183|NCT00353522|101021660|FG001|COMPLETED|Overall Study||37||
48285184|NCT00353522|101021659|FG000|NOT COMPLETED|Overall Study||15||
48285185|NCT00353522|101021660|FG001|NOT COMPLETED|Overall Study||9||
48285186|NCT02545933|101021661|FG000|STARTED|Overall Study||44||
48285187|NCT02545933|101021662|FG001|STARTED|Overall Study||43||
48285188|NCT02545933|101021663|FG002|STARTED|Overall Study||43||
48285189|NCT02545933|101021661|FG000|COMPLETED|Overall Study||38||
48285190|NCT02545933|101021662|FG001|COMPLETED|Overall Study||40||
48399475|NCT00651313|101309129|FG001|STARTED|Overall Study||43||
48399476|NCT00651313|101309128|FG000|COMPLETED|Overall Study||35||
48285191|NCT02545933|101021663|FG002|COMPLETED|Overall Study||39||
48399477|NCT00651313|101309129|FG001|COMPLETED|Overall Study||37||
48399478|NCT00651313|101309128|FG000|NOT COMPLETED|Overall Study||6||
48399479|NCT00651313|101309129|FG001|NOT COMPLETED|Overall Study||6||
48399480|NCT01106391|101309130|FG000|STARTED|Overall Study||60||
48399481|NCT01106391|101309130|FG000|COMPLETED|Overall Study||41|Completed is defined as subjects completed 5 years follow up.|
48399482|NCT01106391|101309130|FG000|NOT COMPLETED|Overall Study||19||
48399483|NCT01363258|101309131|FG000|STARTED|Overall Study||54||
48399484|NCT01363258|101309132|FG001|STARTED|Overall Study||46||
48399485|NCT01363258|101309131|FG000|COMPLETED|Overall Study||54||
48399486|NCT01363258|101309132|FG001|COMPLETED|Overall Study||46||
48399487|NCT01363258|101309131|FG000|NOT COMPLETED|Overall Study||0||
48399488|NCT01363258|101309132|FG001|NOT COMPLETED|Overall Study||0||
48399489|NCT01822223|101309133|FG000|STARTED|Overall Study||10||
48399490|NCT01822223|101309134|FG001|STARTED|Overall Study||10||
48399491|NCT01822223|101309133|FG000|COMPLETED|Overall Study||10||
48575245|NCT04740827|101738526|FG001|NOT COMPLETED|Follow-up Period (Week 13 to Week 16)||0||
48575246|NCT01948193|101738527|FG000|STARTED|Overall Study||177||
48575247|NCT01948193|101738527|FG000|COMPLETED|Overall Study||168||
48575248|NCT01948193|101738527|FG000|NOT COMPLETED|Overall Study||9||
48575249|NCT05486091|101738528|FG000|STARTED|Overall Study||4||
48575250|NCT05486091|101738528|FG000|COMPLETED|Overall Study||1||
48575251|NCT05486091|101738528|FG000|NOT COMPLETED|Overall Study||3||
48575252|NCT01718535|101738529|FG000|STARTED|Overall Study||131||
48575253|NCT01718535|101738530|FG001|STARTED|Overall Study||95||
48575254|NCT01718535|101738531|FG002|STARTED|Overall Study||19||
48702062|NCT01007435|102057613|FG003|STARTED|Overall Study||292||
48702063|NCT01007435|102057610|FG000|COMPLETED|Overall Study||226||
48702064|NCT01007435|102057611|FG001|COMPLETED|Overall Study||231||
48702065|NCT01007435|102057612|FG002|COMPLETED|Overall Study||227||
48702066|NCT01007435|102057613|FG003|COMPLETED|Overall Study||236||
48702067|NCT01007435|102057610|FG000|NOT COMPLETED|Overall Study||63||
48702068|NCT01007435|102057611|FG001|NOT COMPLETED|Overall Study||59||
48702069|NCT01007435|102057612|FG002|NOT COMPLETED|Overall Study||64||
48702070|NCT01007435|102057613|FG003|NOT COMPLETED|Overall Study||56||
48702071|NCT00096226|102057614|FG000|STARTED|Overall Study||60||
48702072|NCT00096226|102057614|FG000|Eligible|Overall Study||57||
48702073|NCT00096226|102057614|FG000|Eligible and Underwent Surgery|Overall Study||37||
48702074|NCT00096226|102057614|FG000|COMPLETED|Overall Study||57||
48702075|NCT00096226|102057614|FG000|NOT COMPLETED|Overall Study||3||
48702076|NCT01044212|102057615|FG000|STARTED|Overall Study||35||
48702077|NCT01044212|102057616|FG001|STARTED|Overall Study||37||
48702078|NCT01044212|102057615|FG000|COMPLETED|Overall Study||30||
48702079|NCT01044212|102057616|FG001|COMPLETED|Overall Study||30||
48702080|NCT01044212|102057615|FG000|NOT COMPLETED|Overall Study||5||
48399492|NCT01822223|101309134|FG001|COMPLETED|Overall Study||9||
48399493|NCT01822223|101309133|FG000|NOT COMPLETED|Overall Study||0||
48399494|NCT01822223|101309134|FG001|NOT COMPLETED|Overall Study||1||
48399495|NCT01079195|101309135|FG000|STARTED|Overall Study||15873||
48399496|NCT01079195|101309135|FG000|COMPLETED|Overall Study||14442||
48399497|NCT01079195|101309135|FG000|NOT COMPLETED|Overall Study||1431||
48399498|NCT02766907|101309136|FG000|STARTED|Overall Study||10||
48399499|NCT02766907|101309137|FG001|STARTED|Overall Study||10||
48399500|NCT02766907|101309136|FG000|COMPLETED|Overall Study||9||
48399501|NCT02766907|101309137|FG001|COMPLETED|Overall Study||9||
48399502|NCT02766907|101309136|FG000|NOT COMPLETED|Overall Study||1||
48399503|NCT02766907|101309137|FG001|NOT COMPLETED|Overall Study||1||
48575255|NCT01718535|101738532|FG003|STARTED|Overall Study||8||
48575256|NCT01718535|101738533|FG004|STARTED|Overall Study||1||
48575257|NCT01718535|101738534|FG005|STARTED|Overall Study||40||
48575258|NCT01718535|101738535|FG006|STARTED|Overall Study||11||
48575259|NCT01718535|101738536|FG007|STARTED|Overall Study||6||
48575260|NCT01718535|101738537|FG008|STARTED|Overall Study||15||
48575261|NCT01718535|101738538|FG009|STARTED|Overall Study||1||
48575262|NCT01718535|101738529|FG000|First Pass|Overall Study||128||
48575263|NCT01718535|101738530|FG001|First Pass|Overall Study||94||
48575264|NCT01718535|101738531|FG002|First Pass|Overall Study||19||
48575265|NCT01718535|101738532|FG003|First Pass|Overall Study||7||
48575266|NCT01718535|101738533|FG004|First Pass|Overall Study||1||
48575267|NCT01718535|101738534|FG005|First Pass|Overall Study||39||
48575268|NCT01718535|101738535|FG006|First Pass|Overall Study||11||
48575269|NCT01718535|101738536|FG007|First Pass|Overall Study||6||
48575270|NCT01718535|101738537|FG008|First Pass|Overall Study||15||
48575271|NCT01718535|101738538|FG009|First Pass|Overall Study||1||
48575272|NCT01718535|101738529|FG000|COMPLETED|Overall Study||130||
48575273|NCT01718535|101738530|FG001|COMPLETED|Overall Study||95||
48575274|NCT01718535|101738531|FG002|COMPLETED|Overall Study||19||
48575275|NCT01718535|101738532|FG003|COMPLETED|Overall Study||7||
48575276|NCT01718535|101738533|FG004|COMPLETED|Overall Study||1||
48575277|NCT01718535|101738534|FG005|COMPLETED|Overall Study||40||
48575278|NCT01718535|101738535|FG006|COMPLETED|Overall Study||11||
48575279|NCT01718535|101738536|FG007|COMPLETED|Overall Study||6||
48575280|NCT01718535|101738537|FG008|COMPLETED|Overall Study||15||
48575281|NCT01718535|101738538|FG009|COMPLETED|Overall Study||1||
48575282|NCT01718535|101738529|FG000|NOT COMPLETED|Overall Study||1||
48575283|NCT01718535|101738530|FG001|NOT COMPLETED|Overall Study||0||
48575284|NCT01718535|101738531|FG002|NOT COMPLETED|Overall Study||0||
48575285|NCT01718535|101738532|FG003|NOT COMPLETED|Overall Study||1||
48575286|NCT01718535|101738533|FG004|NOT COMPLETED|Overall Study||0||
48575287|NCT01718535|101738534|FG005|NOT COMPLETED|Overall Study||0||
48575288|NCT01718535|101738535|FG006|NOT COMPLETED|Overall Study||0||
48575289|NCT01718535|101738536|FG007|NOT COMPLETED|Overall Study||0||
48575290|NCT01718535|101738537|FG008|NOT COMPLETED|Overall Study||0||
48575291|NCT01718535|101738538|FG009|NOT COMPLETED|Overall Study||0||
48575292|NCT00288366|101738539|FG000|STARTED|Overall Study||23||
48575293|NCT00288366|101738540|FG001|STARTED|Overall Study||26||
48575294|NCT00288366|101738539|FG000|COMPLETED|Overall Study||23||
48575295|NCT00288366|101738540|FG001|COMPLETED|Overall Study||26||
48575296|NCT00288366|101738539|FG000|NOT COMPLETED|Overall Study||0||
48575297|NCT00288366|101738540|FG001|NOT COMPLETED|Overall Study||0||
48575298|NCT00877487|101738541|FG000|STARTED|Open-label Treatment Phase||123||
48575299|NCT00877487|101738542|FG001|STARTED|Open-label Treatment Phase||0||
48575300|NCT00877487|101738541|FG000|COMPLETED|Open-label Treatment Phase||116||
48575301|NCT00877487|101738542|FG001|COMPLETED|Open-label Treatment Phase||0||
48575302|NCT00877487|101738541|FG000|NOT COMPLETED|Open-label Treatment Phase||7||
48575303|NCT00877487|101738542|FG001|NOT COMPLETED|Open-label Treatment Phase||0||
48575304|NCT00877487|101738541|FG000|STARTED|Double-blind Randomized Withdrawal Phase||56||
48575305|NCT00877487|101738542|FG001|STARTED|Double-blind Randomized Withdrawal Phase||60||
48575306|NCT00877487|101738541|FG000|COMPLETED|Double-blind Randomized Withdrawal Phase||50||
48575307|NCT00877487|101738542|FG001|COMPLETED|Double-blind Randomized Withdrawal Phase||13||
48575308|NCT00877487|101738541|FG000|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||6||
48575309|NCT00877487|101738542|FG001|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||47||
48575310|NCT00402688|101738543|FG000|STARTED|Overall Study||81||
48575311|NCT00402688|101738544|FG001|STARTED|Overall Study||81||
48575312|NCT00402688|101738545|FG002|STARTED|Overall Study||80||
48575313|NCT00402688|101738543|FG000|COMPLETED|Overall Study||60||
48575314|NCT00402688|101738544|FG001|COMPLETED|Overall Study||65||
48575315|NCT00402688|101738545|FG002|COMPLETED|Overall Study||65||
48575316|NCT00402688|101738543|FG000|NOT COMPLETED|Overall Study||21||
48575317|NCT00402688|101738544|FG001|NOT COMPLETED|Overall Study||16||
48575318|NCT00402688|101738545|FG002|NOT COMPLETED|Overall Study||15||
48575319|NCT04468347|101738546|FG000|STARTED|Overall Study||6||
48575320|NCT04468347|101738547|FG001|STARTED|Overall Study||11||
48575321|NCT04468347|101738548|FG002|STARTED|Overall Study||47||
48575322|NCT04468347|101738549|FG003|STARTED|Overall Study||25||
48575323|NCT04468347|101738546|FG000|Baseline Flortacuipir PET Scan|Overall Study||5||
48575324|NCT04468347|101738547|FG001|Baseline Flortacuipir PET Scan|Overall Study||11||
48575325|NCT04468347|101738548|FG002|Baseline Flortacuipir PET Scan|Overall Study||45||
48575326|NCT04468347|101738549|FG003|Baseline Flortacuipir PET Scan|Overall Study||25||
48575327|NCT04468347|101738546|FG000|COMPLETED|Overall Study||4||
48575328|NCT04468347|101738547|FG001|COMPLETED|Overall Study||10||
48575329|NCT04468347|101738548|FG002|COMPLETED|Overall Study||41||
48575330|NCT04468347|101738549|FG003|COMPLETED|Overall Study||21||
48575331|NCT04468347|101738546|FG000|NOT COMPLETED|Overall Study||2||
48575332|NCT04468347|101738547|FG001|NOT COMPLETED|Overall Study||1||
48575333|NCT04468347|101738548|FG002|NOT COMPLETED|Overall Study||6||
48575334|NCT04468347|101738549|FG003|NOT COMPLETED|Overall Study||4||
48575335|NCT00356135|101738550|FG000|STARTED|Overall Study||47||
48575336|NCT00356135|101738551|FG001|STARTED|Overall Study||48||
48575337|NCT00356135|101738552|FG002|STARTED|Overall Study||44||
48131333|NCT04102501|100645857|FG000|STARTED|Overall Study||33||
48131334|NCT04102501|100645858|FG001|STARTED|Overall Study||32||
48131335|NCT04102501|100645857|FG000|11 Month Visit|Overall Study||25||
48131336|NCT04102501|100645858|FG001|11 Month Visit|Overall Study||20||
48131337|NCT04102501|100645857|FG000|COMPLETED|Overall Study||25||
48131338|NCT04102501|100645858|FG001|COMPLETED|Overall Study||20||
48131339|NCT04102501|100645857|FG000|NOT COMPLETED|Overall Study||8||
48131340|NCT04102501|100645858|FG001|NOT COMPLETED|Overall Study||12||
48575338|NCT00356135|101738550|FG000|COMPLETED|Overall Study||43||
48575339|NCT00356135|101738551|FG001|COMPLETED|Overall Study||46||
48575340|NCT00356135|101738552|FG002|COMPLETED|Overall Study||39||
48575341|NCT00356135|101738550|FG000|NOT COMPLETED|Overall Study||4||
48575342|NCT00356135|101738551|FG001|NOT COMPLETED|Overall Study||2||
48575343|NCT00356135|101738552|FG002|NOT COMPLETED|Overall Study||5||
48575344|NCT00853645|101738553|FG000|STARTED|Overall Study||6||
48575345|NCT00853645|101738553|FG000|COMPLETED|Overall Study||6||
48575346|NCT00853645|101738553|FG000|NOT COMPLETED|Overall Study||0||
48575347|NCT02257489|101738554|FG000|STARTED|Overall Study||6||
48575348|NCT02257489|101738555|FG001|STARTED|Overall Study||6||
48575349|NCT02257489|101738556|FG002|STARTED|Overall Study||6||
48575350|NCT02257489|101738557|FG003|STARTED|Overall Study||6||
48575351|NCT02257489|101738558|FG004|STARTED|Overall Study||6||
48575352|NCT02257489|101738559|FG005|STARTED|Overall Study||6||
48575353|NCT02257489|101738560|FG006|STARTED|Overall Study||6||
48575354|NCT02257489|101738561|FG007|STARTED|Overall Study||10||
48575355|NCT02257489|101738562|FG008|STARTED|Overall Study||6||
48575356|NCT02257489|101738554|FG000|COMPLETED|Overall Study||6||
48575357|NCT02257489|101738555|FG001|COMPLETED|Overall Study||6||
48575358|NCT02257489|101738556|FG002|COMPLETED|Overall Study||6||
48575359|NCT02257489|101738557|FG003|COMPLETED|Overall Study||5||
48575360|NCT02257489|101738558|FG004|COMPLETED|Overall Study||6||
48575361|NCT02257489|101738559|FG005|COMPLETED|Overall Study||6||
48575362|NCT02257489|101738560|FG006|COMPLETED|Overall Study||6||
48575363|NCT02257489|101738561|FG007|COMPLETED|Overall Study||10||
48575364|NCT02257489|101738562|FG008|COMPLETED|Overall Study||6||
48575365|NCT02257489|101738554|FG000|NOT COMPLETED|Overall Study||0||
48575366|NCT02257489|101738555|FG001|NOT COMPLETED|Overall Study||0||
48575367|NCT02257489|101738556|FG002|NOT COMPLETED|Overall Study||0||
48575368|NCT02257489|101738557|FG003|NOT COMPLETED|Overall Study||1||
48575369|NCT02257489|101738558|FG004|NOT COMPLETED|Overall Study||0||
48575370|NCT02257489|101738559|FG005|NOT COMPLETED|Overall Study||0||
48575371|NCT02257489|101738560|FG006|NOT COMPLETED|Overall Study||0||
48575372|NCT02257489|101738561|FG007|NOT COMPLETED|Overall Study||0||
48575373|NCT02257489|101738562|FG008|NOT COMPLETED|Overall Study||0||
48131341|NCT03403725|100645859|FG000|STARTED|Overall Study||1||
48131342|NCT03403725|100645860|FG001|STARTED|Overall Study||1||
48575374|NCT02126579|101738563|FG000|STARTED|Overall Study||5||
48575375|NCT02126579|101738564|FG001|STARTED|Overall Study||7||
48575376|NCT02126579|101738565|FG002|STARTED|Overall Study||4||
48575377|NCT02126579|101738566|FG003|STARTED|Overall Study||6||
48575378|NCT02126579|101738567|FG004|STARTED|Overall Study||16||
48575379|NCT02126579|101738568|FG005|STARTED|Overall Study||6||
48575380|NCT02126579|101738569|FG006|STARTED|Overall Study||6||
48575381|NCT02126579|101738563|FG000|Received at Least 3 Vaccines|Overall Study||5||
48575382|NCT02126579|101738564|FG001|Received at Least 3 Vaccines|Overall Study||7||
48575383|NCT02126579|101738565|FG002|Received at Least 3 Vaccines|Overall Study||4||
48575384|NCT02126579|101738566|FG003|Received at Least 3 Vaccines|Overall Study||6||
48575385|NCT02126579|101738567|FG004|Received at Least 3 Vaccines|Overall Study||16||
48575386|NCT02126579|101738568|FG005|Received at Least 3 Vaccines|Overall Study||6||
48575387|NCT02126579|101738569|FG006|Received at Least 3 Vaccines|Overall Study||6||
48575388|NCT02126579|101738563|FG000|COMPLETED|Overall Study||5|Completed all 6 vaccines|
48575389|NCT02126579|101738564|FG001|COMPLETED|Overall Study||7|Completed all 6 vaccines|
48575390|NCT02126579|101738565|FG002|COMPLETED|Overall Study||4|Completed all 6 vaccines|
48575391|NCT02126579|101738566|FG003|COMPLETED|Overall Study||5|Completed all 6 vaccines|
48575392|NCT02126579|101738567|FG004|COMPLETED|Overall Study||16|Completed all 6 vaccines|
48575393|NCT02126579|101738568|FG005|COMPLETED|Overall Study||6|Completed all 6 vaccines|
48575394|NCT02126579|101738569|FG006|COMPLETED|Overall Study||5|Completed all 6 vaccines|
48575395|NCT02126579|101738563|FG000|NOT COMPLETED|Overall Study||0||
48575396|NCT02126579|101738564|FG001|NOT COMPLETED|Overall Study||0||
48575397|NCT02126579|101738565|FG002|NOT COMPLETED|Overall Study||0||
48575398|NCT02126579|101738566|FG003|NOT COMPLETED|Overall Study||1||
48575399|NCT02126579|101738567|FG004|NOT COMPLETED|Overall Study||0||
48575400|NCT02126579|101738568|FG005|NOT COMPLETED|Overall Study||0||
48575401|NCT02126579|101738569|FG006|NOT COMPLETED|Overall Study||1||
48575402|NCT05333601|101738570|FG000|STARTED|Overall Study||44||
48575403|NCT05333601|101738570|FG000|COMPLETED|Overall Study||31||
48575404|NCT05333601|101738570|FG000|NOT COMPLETED|Overall Study||13||
48575405|NCT04506463|101738571|FG000|STARTED|Overall Study||103||
48575406|NCT04506463|101738572|FG001|STARTED|Overall Study||83||
48575407|NCT04506463|101738573|FG002|STARTED|Overall Study||76||
48575408|NCT04506463|101738574|FG003|STARTED|Overall Study||28||
48575409|NCT04506463|101738575|FG004|STARTED|Overall Study||79||
48575410|NCT04506463|101738576|FG005|STARTED|Overall Study||28||
48575411|NCT04506463|101738571|FG000|COMPLETED|Overall Study||98||
48575412|NCT04506463|101738572|FG001|COMPLETED|Overall Study||80||
48575413|NCT04506463|101738573|FG002|COMPLETED|Overall Study||66||
48575414|NCT04506463|101738574|FG003|COMPLETED|Overall Study||27||
48575415|NCT04506463|101738575|FG004|COMPLETED|Overall Study||71||
48575416|NCT04506463|101738576|FG005|COMPLETED|Overall Study||27||
48285192|NCT02545933|101021661|FG000|NOT COMPLETED|Overall Study||6||
48285193|NCT02545933|101021662|FG001|NOT COMPLETED|Overall Study||3||
48285194|NCT02545933|101021663|FG002|NOT COMPLETED|Overall Study||4||
48285195|NCT01085968|101021664|FG000|STARTED|Overall Study||29||
48285196|NCT01085968|101021665|FG001|STARTED|Overall Study||25||
48285197|NCT01085968|101021664|FG000|COMPLETED|Overall Study||19||
48285198|NCT01085968|101021665|FG001|COMPLETED|Overall Study||21||
48285199|NCT01085968|101021664|FG000|NOT COMPLETED|Overall Study||10||
48285200|NCT01085968|101021665|FG001|NOT COMPLETED|Overall Study||4||
48285201|NCT04227704|101021666|FG000|STARTED|Overall Study||8||
48285202|NCT04227704|101021667|FG001|STARTED|Overall Study||9||
48285203|NCT04227704|101021668|FG002|STARTED|Overall Study||8||
48285204|NCT04227704|101021666|FG000|COMPLETED|Overall Study||7||
48285205|NCT04227704|101021667|FG001|COMPLETED|Overall Study||8||
48285206|NCT04227704|101021668|FG002|COMPLETED|Overall Study||8||
48285207|NCT04227704|101021666|FG000|NOT COMPLETED|Overall Study||1||
48285208|NCT04227704|101021667|FG001|NOT COMPLETED|Overall Study||1||
48285209|NCT04227704|101021668|FG002|NOT COMPLETED|Overall Study||0||
48285210|NCT03661762|101021669|FG000|STARTED|Overall Study||18||
48285211|NCT03661762|101021669|FG000|COMPLETED|Overall Study||10||
48285212|NCT03661762|101021669|FG000|NOT COMPLETED|Overall Study||8||
48285213|NCT01090479|101021670|FG000|STARTED|Overall Study||50||
48285214|NCT01090479|101021671|FG001|STARTED|Overall Study||50||
48285215|NCT01090479|101021670|FG000|COMPLETED|Overall Study||50||
48285216|NCT01090479|101021671|FG001|COMPLETED|Overall Study||50||
48285217|NCT01090479|101021670|FG000|NOT COMPLETED|Overall Study||0||
48399504|NCT00606177|101309138|FG000|STARTED|Overall Study||55||
48399505|NCT00606177|101309139|FG001|STARTED|Overall Study||44||
48399506|NCT00606177|101309138|FG000|COMPLETED|Overall Study||28||
48399507|NCT00606177|101309139|FG001|COMPLETED|Overall Study||19||
48399508|NCT00606177|101309138|FG000|NOT COMPLETED|Overall Study||27||
48399509|NCT00606177|101309139|FG001|NOT COMPLETED|Overall Study||25||
48399510|NCT02679781|101309140|FG000|STARTED|Overall Study||37||
48399511|NCT02679781|101309141|FG001|STARTED|Overall Study||33||
48575417|NCT04506463|101738571|FG000|NOT COMPLETED|Overall Study||5||
48575418|NCT04506463|101738572|FG001|NOT COMPLETED|Overall Study||3||
48575419|NCT04506463|101738573|FG002|NOT COMPLETED|Overall Study||10||
48575420|NCT04506463|101738574|FG003|NOT COMPLETED|Overall Study||1||
48575421|NCT04506463|101738575|FG004|NOT COMPLETED|Overall Study||8||
48575422|NCT04506463|101738576|FG005|NOT COMPLETED|Overall Study||1||
48575423|NCT02973503|101738577|FG000|STARTED|Overall Study||117||
48285218|NCT01090479|101021671|FG001|NOT COMPLETED|Overall Study||0||
48285219|NCT01820585|101021672|FG000|STARTED|Overall Study||131||
48399512|NCT02679781|101309140|FG000|COMPLETED|Overall Study||30||
48575424|NCT02973503|101738577|FG000|COMPLETED|Overall Study||117||
48575425|NCT02973503|101738577|FG000|NOT COMPLETED|Overall Study||0||
48575426|NCT02737930|101738578|FG000|STARTED|Overall Study||5||
48575427|NCT02737930|101738579|FG001|STARTED|Overall Study||7||
48399513|NCT02679781|101309141|FG001|COMPLETED|Overall Study||30||
48399514|NCT02679781|101309140|FG000|NOT COMPLETED|Overall Study||7||
48285220|NCT01820585|101021673|FG001|STARTED|Overall Study||130||
48285221|NCT01820585|101021674|FG002|STARTED|Overall Study||135||
48399515|NCT02679781|101309141|FG001|NOT COMPLETED|Overall Study||3||
48399516|NCT00753623|101309142|FG000|STARTED|Phase I (14 Days)||11||
48575428|NCT02737930|101738578|FG000|COMPLETED|Overall Study||5||
48285222|NCT01820585|101021675|FG003|STARTED|Overall Study||132||
48285223|NCT01820585|101021672|FG000|Randomized and Treated|Overall Study||131||
48285224|NCT01820585|101021673|FG001|Randomized and Treated|Overall Study||130||
48285225|NCT01820585|101021674|FG002|Randomized and Treated|Overall Study||135||
48285226|NCT01820585|101021675|FG003|Randomized and Treated|Overall Study||132||
48285227|NCT01820585|101021672|FG000|Full Analysis Set|Overall Study||131||
48285228|NCT01820585|101021673|FG001|Full Analysis Set|Overall Study||130||
48285229|NCT01820585|101021674|FG002|Full Analysis Set|Overall Study||135||
48285230|NCT01820585|101021675|FG003|Full Analysis Set|Overall Study||129||
48285231|NCT01820585|101021672|FG000|Completed Titration Period|Overall Study||128||
48285232|NCT01820585|101021673|FG001|Completed Titration Period|Overall Study||125||
48285233|NCT01820585|101021674|FG002|Completed Titration Period|Overall Study||131||
48285234|NCT01820585|101021675|FG003|Completed Titration Period|Overall Study||126||
48285235|NCT01820585|101021672|FG000|Entered Maintenance Period|Overall Study||128||
48285236|NCT01820585|101021673|FG001|Entered Maintenance Period|Overall Study||124||
48285237|NCT01820585|101021674|FG002|Entered Maintenance Period|Overall Study||131||
48399517|NCT00753623|101309143|FG001|STARTED|Phase I (14 Days)||12||
48399518|NCT00753623|101309142|FG000|COMPLETED|Phase I (14 Days)||9||
48399519|NCT00753623|101309143|FG001|COMPLETED|Phase I (14 Days)||8||
48399520|NCT00753623|101309142|FG000|NOT COMPLETED|Phase I (14 Days)||2||
48399521|NCT00753623|101309143|FG001|NOT COMPLETED|Phase I (14 Days)||4||
48399522|NCT00753623|101309142|FG000|STARTED|Washout (7 Days)||9||
48399523|NCT00753623|101309143|FG001|STARTED|Washout (7 Days)||8||
48399524|NCT00753623|101309142|FG000|COMPLETED|Washout (7 Days)||8||
48399525|NCT00753623|101309143|FG001|COMPLETED|Washout (7 Days)||8||
48399526|NCT00753623|101309142|FG000|NOT COMPLETED|Washout (7 Days)||1||
48399527|NCT00753623|101309143|FG001|NOT COMPLETED|Washout (7 Days)||0||
48399528|NCT00753623|101309142|FG000|STARTED|Phase II (14 Days)||8||
48399529|NCT00753623|101309143|FG001|STARTED|Phase II (14 Days)||8||
48399530|NCT00753623|101309142|FG000|COMPLETED|Phase II (14 Days)||8||
48399531|NCT00753623|101309143|FG001|COMPLETED|Phase II (14 Days)||7||
48399532|NCT00753623|101309142|FG000|NOT COMPLETED|Phase II (14 Days)||0||
48399533|NCT00753623|101309143|FG001|NOT COMPLETED|Phase II (14 Days)||1||
48399534|NCT01983878|101309144|FG000|STARTED|Overall Study||36||
48399535|NCT01983878|101309144|FG000|Received At Least One Dose of Study Drug|Overall Study||36||
48399536|NCT01983878|101309144|FG000|COMPLETED|Overall Study||36||
48399537|NCT01983878|101309144|FG000|NOT COMPLETED|Overall Study||0||
48399538|NCT03364491|101309145|FG000|STARTED|Overall Study||5529||
48399539|NCT03364491|101309146|FG001|STARTED|Overall Study||5471||
48399540|NCT03364491|101309145|FG000|COMPLETED|Overall Study||5529||
48399541|NCT03364491|101309146|FG001|COMPLETED|Overall Study||5471||
48399542|NCT03364491|101309145|FG000|NOT COMPLETED|Overall Study||0||
48399543|NCT03364491|101309146|FG001|NOT COMPLETED|Overall Study||0||
48399544|NCT02533401|101309147|FG000|STARTED|Overall Study||34||
48399545|NCT02533401|101309147|FG000|COMPLETED|Overall Study||23||
48399546|NCT02533401|101309147|FG000|NOT COMPLETED|Overall Study||11||
48399547|NCT01060098|101309148|FG000|STARTED|Overall Study||25||
48399548|NCT01060098|101309149|FG001|STARTED|Overall Study||15||
48399549|NCT01060098|101309150|FG002|STARTED|Overall Study||8||
48399550|NCT01060098|101309148|FG000|COMPLETED|Overall Study||25||
48399551|NCT01060098|101309149|FG001|COMPLETED|Overall Study||15||
48399552|NCT01060098|101309150|FG002|COMPLETED|Overall Study||8||
48399553|NCT01060098|101309148|FG000|NOT COMPLETED|Overall Study||0||
48399554|NCT01060098|101309149|FG001|NOT COMPLETED|Overall Study||0||
48399555|NCT01060098|101309150|FG002|NOT COMPLETED|Overall Study||0||
48399556|NCT00550277|101309151|FG000|STARTED|Overall Study||20||
48285238|NCT01820585|101021675|FG003|Entered Maintenance Period|Overall Study||123||
48285239|NCT01820585|101021672|FG000|Completed Maintenance Period|Overall Study||105||
48285240|NCT01820585|101021673|FG001|Completed Maintenance Period|Overall Study||98||
48285241|NCT01820585|101021674|FG002|Completed Maintenance Period|Overall Study||101||
48285242|NCT01820585|101021675|FG003|Completed Maintenance Period|Overall Study||84||
48285243|NCT01820585|101021672|FG000|COMPLETED|Overall Study||104||
48285244|NCT01820585|101021673|FG001|COMPLETED|Overall Study||98||
48399557|NCT00550277|101309151|FG000|COMPLETED|Overall Study||11||
48399558|NCT00550277|101309151|FG000|NOT COMPLETED|Overall Study||9||
48399559|NCT02238782|101309152|FG000|STARTED|Overall Study||12||
48399560|NCT02238782|101309152|FG000|Subjects Treated|Overall Study||12||
48399561|NCT02238782|101309152|FG000|COMPLETED|Overall Study||12||
48399562|NCT02238782|101309152|FG000|NOT COMPLETED|Overall Study||0||
48399563|NCT02448914|101309153|FG000|STARTED|First Intervention (1 Day)||6||
48399564|NCT02448914|101309154|FG001|STARTED|First Intervention (1 Day)||5||
48399565|NCT02448914|101309153|FG000|COMPLETED|First Intervention (1 Day)||6||
48399566|NCT02448914|101309154|FG001|COMPLETED|First Intervention (1 Day)||5||
48575429|NCT02737930|101738579|FG001|COMPLETED|Overall Study||6||
48575430|NCT02737930|101738578|FG000|NOT COMPLETED|Overall Study||0||
48575431|NCT02737930|101738579|FG001|NOT COMPLETED|Overall Study||1||
48575432|NCT00596817|101738580|FG000|STARTED|Open-label Period||0||
48575433|NCT00596817|101738581|FG001|STARTED|Open-label Period||639||
48575434|NCT00596817|101738580|FG000|COMPLETED|Open-label Period||0||
48575435|NCT00596817|101738581|FG001|COMPLETED|Open-label Period||492||
48575436|NCT00596817|101738580|FG000|NOT COMPLETED|Open-label Period||0||
48575437|NCT00596817|101738581|FG001|NOT COMPLETED|Open-label Period||147||
48575438|NCT00596817|101738580|FG000|STARTED|Open-label Period to Double-blind Period||0||
48575439|NCT00596817|101738581|FG001|STARTED|Open-label Period to Double-blind Period||492||
48575440|NCT00596817|101738580|FG000|COMPLETED|Open-label Period to Double-blind Period||0||
48575441|NCT00596817|101738581|FG001|COMPLETED|Open-label Period to Double-blind Period||400||
48575442|NCT00596817|101738580|FG000|NOT COMPLETED|Open-label Period to Double-blind Period||0||
48575443|NCT00596817|101738581|FG001|NOT COMPLETED|Open-label Period to Double-blind Period||92||
48575444|NCT00596817|101738580|FG000|STARTED|Double-blind Period||192||
48575445|NCT00596817|101738581|FG001|STARTED|Double-blind Period||204||
48575446|NCT00596817|101738580|FG000|COMPLETED|Double-blind Period||104||
48575447|NCT00596817|101738581|FG001|COMPLETED|Double-blind Period||125||
48575448|NCT00596817|101738580|FG000|NOT COMPLETED|Double-blind Period||88||
48575449|NCT00596817|101738581|FG001|NOT COMPLETED|Double-blind Period||79||
48575450|NCT01118741|101738582|FG000|STARTED|Overall Study||9||
48575451|NCT01118741|101738583|FG001|STARTED|Overall Study||10||
48575452|NCT01118741|101738582|FG000|COMPLETED|Overall Study||9||
48575453|NCT01118741|101738583|FG001|COMPLETED|Overall Study||10||
48575454|NCT01118741|101738582|FG000|NOT COMPLETED|Overall Study||0||
48575455|NCT01118741|101738583|FG001|NOT COMPLETED|Overall Study||0||
48575456|NCT00977080|101738584|FG000|STARTED|Overall Study||62||
48575457|NCT00977080|101738585|FG001|STARTED|Overall Study||64||
48575458|NCT00977080|101738586|FG002|STARTED|Overall Study||72||
48575459|NCT00977080|101738587|FG003|STARTED|Overall Study||70||
48575460|NCT00977080|101738584|FG000|COMPLETED|Overall Study||50||
48575461|NCT00977080|101738585|FG001|COMPLETED|Overall Study||44||
48575462|NCT00977080|101738586|FG002|COMPLETED|Overall Study||56||
48702081|NCT01044212|102057616|FG001|NOT COMPLETED|Overall Study||7||
48702082|NCT01972308|102057617|FG000|STARTED|Overall Study||156||
48285245|NCT01820585|101021674|FG002|COMPLETED|Overall Study||101||
48285246|NCT01820585|101021675|FG003|COMPLETED|Overall Study||83||
48285247|NCT01820585|101021672|FG000|NOT COMPLETED|Overall Study||27||
48285248|NCT01820585|101021673|FG001|NOT COMPLETED|Overall Study||32||
48575463|NCT00977080|101738587|FG003|COMPLETED|Overall Study||53||
48702083|NCT01972308|102057618|FG001|STARTED|Overall Study||156||
48285249|NCT01820585|101021674|FG002|NOT COMPLETED|Overall Study||34||
48575464|NCT00977080|101738584|FG000|NOT COMPLETED|Overall Study||12||
48575465|NCT00977080|101738585|FG001|NOT COMPLETED|Overall Study||20||
48575466|NCT00977080|101738586|FG002|NOT COMPLETED|Overall Study||16||
48575467|NCT00977080|101738587|FG003|NOT COMPLETED|Overall Study||17||
48702084|NCT01972308|102057617|FG000|COMPLETED|Overall Study||148||
48702085|NCT01972308|102057618|FG001|COMPLETED|Overall Study||148||
48702086|NCT01972308|102057617|FG000|NOT COMPLETED|Overall Study||8||
48702087|NCT01972308|102057618|FG001|NOT COMPLETED|Overall Study||8||
48702088|NCT00519376|102057619|FG000|STARTED|Treatment Period 1||2||
48702089|NCT00519376|102057620|FG001|STARTED|Treatment Period 1||2||
48702090|NCT00519376|102057621|FG002|STARTED|Treatment Period 1||2||
48702091|NCT00519376|102057622|FG003|STARTED|Treatment Period 1||2||
48702092|NCT00519376|102057623|FG004|STARTED|Treatment Period 1||1||
48702093|NCT00519376|102057624|FG005|STARTED|Treatment Period 1||1||
48702094|NCT00519376|102057625|FG006|STARTED|Treatment Period 1||1||
48702095|NCT00519376|102057626|FG007|STARTED|Treatment Period 1||1||
48702096|NCT00519376|102057627|FG008|STARTED|Treatment Period 1||1||
48702097|NCT00519376|102057628|FG009|STARTED|Treatment Period 1||1||
48702098|NCT00519376|102057629|FG010|STARTED|Treatment Period 1||1||
48702099|NCT00519376|102057630|FG011|STARTED|Treatment Period 1||1||
48702100|NCT00519376|102057631|FG012|STARTED|Treatment Period 1||1||
48702101|NCT00519376|102057632|FG013|STARTED|Treatment Period 1||1||
48702102|NCT00519376|102057633|FG014|STARTED|Treatment Period 1||1||
48702103|NCT00519376|102057634|FG015|STARTED|Treatment Period 1||1||
48702104|NCT00519376|102057619|FG000|COMPLETED|Treatment Period 1||2||
48702105|NCT00519376|102057620|FG001|COMPLETED|Treatment Period 1||2||
48702106|NCT00519376|102057621|FG002|COMPLETED|Treatment Period 1||2||
48702107|NCT00519376|102057622|FG003|COMPLETED|Treatment Period 1||2||
48702108|NCT00519376|102057623|FG004|COMPLETED|Treatment Period 1||1||
48702109|NCT00519376|102057624|FG005|COMPLETED|Treatment Period 1||1||
48702110|NCT00519376|102057625|FG006|COMPLETED|Treatment Period 1||1||
48285250|NCT01820585|101021675|FG003|NOT COMPLETED|Overall Study||49||
48285251|NCT03647488|101021676|FG000|STARTED|Overall Study||18||
48575468|NCT02530125|101738588|FG000|STARTED|Completed Treatment||4||
48575469|NCT02530125|101738588|FG000|COMPLETED|Completed Treatment||3||
48131343|NCT03403725|100645861|FG002|STARTED|Overall Study||1||
48131344|NCT03403725|100645862|FG003|STARTED|Overall Study||1||
48131345|NCT03403725|100645863|FG004|STARTED|Overall Study||1||
48131346|NCT03403725|100645864|FG005|STARTED|Overall Study||6||
48575470|NCT02530125|101738588|FG000|NOT COMPLETED|Completed Treatment||1||
48575471|NCT02530125|101738588|FG000|STARTED|Followed for Survival for 2 Years||3||
48131347|NCT03403725|100645865|FG006|STARTED|Overall Study||6||
48131348|NCT03403725|100645866|FG007|STARTED|Overall Study||3||
48131349|NCT03403725|100645867|FG008|STARTED|Overall Study||3||
48131350|NCT03403725|100645868|FG009|STARTED|Overall Study||4||
48131351|NCT03403725|100645869|FG010|STARTED|Overall Study||1||
48131352|NCT03403725|100645859|FG000|COMPLETED|Overall Study||1||
48131353|NCT03403725|100645860|FG001|COMPLETED|Overall Study||1||
48131354|NCT03403725|100645861|FG002|COMPLETED|Overall Study||1||
48131355|NCT03403725|100645862|FG003|COMPLETED|Overall Study||1||
48131356|NCT03403725|100645863|FG004|COMPLETED|Overall Study||1||
48399567|NCT02448914|101309153|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48575472|NCT02530125|101738588|FG000|COMPLETED|Followed for Survival for 2 Years||0||
48575473|NCT02530125|101738588|FG000|NOT COMPLETED|Followed for Survival for 2 Years||3||
48575474|NCT03474731|101738589|FG000|STARTED|Overall Study||198||14
48575475|NCT03474731|101738590|FG001|STARTED|Overall Study||200||15
48575476|NCT03474731|101738591|FG002|STARTED|Overall Study||120||15
48575477|NCT03474731|101738592|FG003|STARTED|Overall Study||183||15
48575478|NCT03474731|101738589|FG000|COMPLETED|Overall Study||150||14
48575479|NCT03474731|101738590|FG001|COMPLETED|Overall Study||144||13
48575480|NCT03474731|101738591|FG002|COMPLETED|Overall Study||91||15
48575481|NCT03474731|101738592|FG003|COMPLETED|Overall Study||138||15
48575482|NCT03474731|101738589|FG000|NOT COMPLETED|Overall Study||48||0
48575483|NCT03474731|101738590|FG001|NOT COMPLETED|Overall Study||56||2
48575484|NCT03474731|101738591|FG002|NOT COMPLETED|Overall Study||29||0
48575485|NCT03474731|101738592|FG003|NOT COMPLETED|Overall Study||45||0
48575486|NCT04724538|101738593|FG000|STARTED|Overall Study||11||
48575487|NCT04724538|101738594|FG001|STARTED|Overall Study||14||
48575488|NCT04724538|101738593|FG000|COMPLETED|Overall Study||11||
48575489|NCT04724538|101738594|FG001|COMPLETED|Overall Study||14||
48575490|NCT04724538|101738593|FG000|NOT COMPLETED|Overall Study||0||
48575491|NCT04724538|101738594|FG001|NOT COMPLETED|Overall Study||0||
48575492|NCT00026494|101738595|FG000|STARTED|Overall Study||7||
48575493|NCT00026494|101738596|FG001|STARTED|Overall Study||4||
48575494|NCT00026494|101738597|FG002|STARTED|Overall Study||22||
48575495|NCT00026494|101738598|FG003|STARTED|Overall Study||16||
48575496|NCT00026494|101738595|FG000|COMPLETED|Overall Study||5||
48575497|NCT00026494|101738596|FG001|COMPLETED|Overall Study||4||
48575498|NCT00026494|101738597|FG002|COMPLETED|Overall Study||16||
48575499|NCT00026494|101738598|FG003|COMPLETED|Overall Study||16||
48575500|NCT00026494|101738595|FG000|NOT COMPLETED|Overall Study||2||
48575501|NCT00026494|101738596|FG001|NOT COMPLETED|Overall Study||0||
48575502|NCT00026494|101738597|FG002|NOT COMPLETED|Overall Study||6||
48575503|NCT00026494|101738598|FG003|NOT COMPLETED|Overall Study||0||
48575504|NCT00616343|101738599|FG000|STARTED|Overall Study||9||
48575505|NCT00616343|101738599|FG000|COMPLETED|Overall Study||9||
48575506|NCT00616343|101738599|FG000|NOT COMPLETED|Overall Study||0||
48575507|NCT00603902|101738600|FG000|STARTED|Overall Study||802||
48575508|NCT00603902|101738601|FG001|STARTED|Overall Study||1603||
48575509|NCT00603902|101738602|FG002|STARTED|Overall Study||1603||
48575510|NCT00603902|101738600|FG000|COMPLETED|Overall Study||473||
48575511|NCT00603902|101738601|FG001|COMPLETED|Overall Study||917||
48575512|NCT00603902|101738602|FG002|COMPLETED|Overall Study||834||
48575513|NCT00603902|101738600|FG000|NOT COMPLETED|Overall Study||329||
48575514|NCT00603902|101738601|FG001|NOT COMPLETED|Overall Study||686||
48131357|NCT03403725|100645864|FG005|COMPLETED|Overall Study||6||
48131358|NCT03403725|100645865|FG006|COMPLETED|Overall Study||6||
48131359|NCT03403725|100645866|FG007|COMPLETED|Overall Study||3||
48131360|NCT03403725|100645867|FG008|COMPLETED|Overall Study||3||
48131361|NCT03403725|100645868|FG009|COMPLETED|Overall Study||4||
48131362|NCT03403725|100645869|FG010|COMPLETED|Overall Study||1||
48131363|NCT03403725|100645859|FG000|NOT COMPLETED|Overall Study||0||
48575515|NCT00603902|101738602|FG002|NOT COMPLETED|Overall Study||769||
48575516|NCT04316104|101738603|FG000|STARTED|Overall Study||24||
48575517|NCT04316104|101738603|FG000|COMPLETED|Overall Study||21||
48575518|NCT04316104|101738603|FG000|NOT COMPLETED|Overall Study||3||
48575519|NCT02122887|101738604|FG000|STARTED|Overall Study||60||
48575520|NCT02122887|101738605|FG001|STARTED|Overall Study||41||
48575521|NCT02122887|101738604|FG000|COMPLETED|Overall Study||40||
48575522|NCT02122887|101738605|FG001|COMPLETED|Overall Study||39||
48575523|NCT02122887|101738604|FG000|NOT COMPLETED|Overall Study||20||
48575524|NCT02122887|101738605|FG001|NOT COMPLETED|Overall Study||2||
48575525|NCT05326529|101738606|FG000|STARTED|Overall Study||19||
48575526|NCT05326529|101738607|FG001|STARTED|Overall Study||19||
48575527|NCT05326529|101738608|FG002|STARTED|Overall Study||19||
48575528|NCT05326529|101738606|FG000|COMPLETED|Overall Study||19||
48131364|NCT03403725|100645860|FG001|NOT COMPLETED|Overall Study||0||
48131365|NCT03403725|100645861|FG002|NOT COMPLETED|Overall Study||0||
48131366|NCT03403725|100645862|FG003|NOT COMPLETED|Overall Study||0||
48131367|NCT03403725|100645863|FG004|NOT COMPLETED|Overall Study||0||
48131368|NCT03403725|100645864|FG005|NOT COMPLETED|Overall Study||0||
48131369|NCT03403725|100645865|FG006|NOT COMPLETED|Overall Study||0||
48131370|NCT03403725|100645866|FG007|NOT COMPLETED|Overall Study||0||
48131371|NCT03403725|100645867|FG008|NOT COMPLETED|Overall Study||0||
48575529|NCT05326529|101738607|FG001|COMPLETED|Overall Study||18||
48575530|NCT05326529|101738608|FG002|COMPLETED|Overall Study||17||
48575531|NCT05326529|101738606|FG000|NOT COMPLETED|Overall Study||0||
48131372|NCT03403725|100645868|FG009|NOT COMPLETED|Overall Study||0||
48575532|NCT05326529|101738607|FG001|NOT COMPLETED|Overall Study||1||
48575533|NCT05326529|101738608|FG002|NOT COMPLETED|Overall Study||2||
48575534|NCT00022698|101738609|FG000|STARTED|Overall Study||15||
48575535|NCT00022698|101738610|FG001|STARTED|Overall Study||52||
48575536|NCT00022698|101738609|FG000|COMPLETED|Overall Study||7||
48575537|NCT00022698|101738610|FG001|COMPLETED|Overall Study||17||
48575538|NCT00022698|101738609|FG000|NOT COMPLETED|Overall Study||8||
48575539|NCT00022698|101738610|FG001|NOT COMPLETED|Overall Study||35||
48575540|NCT00006178|101738611|FG000|STARTED|Overall Study||12||
48575541|NCT00006178|101738611|FG000|COMPLETED|Overall Study||12||
48702111|NCT00519376|102057626|FG007|COMPLETED|Treatment Period 1||1||
48702112|NCT00519376|102057627|FG008|COMPLETED|Treatment Period 1||1||
48702113|NCT00519376|102057628|FG009|COMPLETED|Treatment Period 1||1||
48702114|NCT00519376|102057629|FG010|COMPLETED|Treatment Period 1||1||
48702115|NCT00519376|102057630|FG011|COMPLETED|Treatment Period 1||1||
48702116|NCT00519376|102057631|FG012|COMPLETED|Treatment Period 1||1||
48702117|NCT00519376|102057632|FG013|COMPLETED|Treatment Period 1||1||
48702118|NCT00519376|102057633|FG014|COMPLETED|Treatment Period 1||1||
48702119|NCT00519376|102057634|FG015|COMPLETED|Treatment Period 1||1||
48702120|NCT00519376|102057619|FG000|NOT COMPLETED|Treatment Period 1||0||
48702121|NCT00519376|102057620|FG001|NOT COMPLETED|Treatment Period 1||0||
48131373|NCT03403725|100645869|FG010|NOT COMPLETED|Overall Study||0||
48131374|NCT01889420|100645870|FG000|STARTED|Overall Study||1||
48131375|NCT01889420|100645870|FG000|COMPLETED|Overall Study||1||
48131376|NCT01889420|100645870|FG000|NOT COMPLETED|Overall Study||0||
48131377|NCT02807948|100645871|FG000|STARTED|Overall Study||132||
48131378|NCT02807948|100645872|FG001|STARTED|Overall Study||57||
48131379|NCT02807948|100645871|FG000|COMPLETED|Overall Study||131||
48131380|NCT02807948|100645872|FG001|COMPLETED|Overall Study||57||
48131381|NCT02807948|100645871|FG000|NOT COMPLETED|Overall Study||1||
48131382|NCT02807948|100645872|FG001|NOT COMPLETED|Overall Study||0||
48131383|NCT01043874|100645873|FG000|STARTED|Overall Study||45||
48131384|NCT01043874|100645873|FG000|COMPLETED|Overall Study||39||
48399568|NCT02448914|101309154|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48399569|NCT02448914|101309153|FG000|STARTED|Second Intervention (1 Day)||6||
48399570|NCT02448914|101309154|FG001|STARTED|Second Intervention (1 Day)||5||
48399571|NCT02448914|101309153|FG000|COMPLETED|Second Intervention (1 Day)||6||
48399572|NCT02448914|101309154|FG001|COMPLETED|Second Intervention (1 Day)||5||
48399573|NCT02448914|101309153|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48399574|NCT02448914|101309154|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48399575|NCT02420795|101309155|FG000|STARTED|Overall Study||4||
48399576|NCT02420795|101309156|FG001|STARTED|Overall Study||2||
48399577|NCT02420795|101309157|FG002|STARTED|Overall Study||5||
48399578|NCT02420795|101309155|FG000|COMPLETED|Overall Study||0||
48399579|NCT02420795|101309156|FG001|COMPLETED|Overall Study||0||
48399580|NCT02420795|101309157|FG002|COMPLETED|Overall Study||0||
48399581|NCT02420795|101309155|FG000|NOT COMPLETED|Overall Study||4||
48399582|NCT02420795|101309156|FG001|NOT COMPLETED|Overall Study||2||
48399583|NCT02420795|101309157|FG002|NOT COMPLETED|Overall Study||5||
48399584|NCT00150345|101309158|FG000|STARTED|Overall Study||81||
48399585|NCT00150345|101309159|FG001|STARTED|Overall Study||66||
48399586|NCT00150345|101309158|FG000|COMPLETED|Overall Study||47||
48399587|NCT00150345|101309159|FG001|COMPLETED|Overall Study||34||
48399588|NCT00150345|101309158|FG000|NOT COMPLETED|Overall Study||34||
48399589|NCT00150345|101309159|FG001|NOT COMPLETED|Overall Study||32||
48399590|NCT02484898|101309160|FG000|STARTED|Overall Study||200||
48399591|NCT02484898|101309160|FG000|COMPLETED|Overall Study||182||
48399592|NCT02484898|101309160|FG000|NOT COMPLETED|Overall Study||18||
48399593|NCT01947894|101309161|FG000|STARTED|Overall Study||247||
48399594|NCT01947894|101309162|FG001|STARTED|Overall Study||42||
48399595|NCT01947894|101309163|FG002|STARTED|Overall Study||88||
48399596|NCT01947894|101309161|FG000|Treated|Overall Study||246||
48399597|NCT01947894|101309162|FG001|Treated|Overall Study||41||
48399598|NCT01947894|101309163|FG002|Treated|Overall Study||87||
48399599|NCT01947894|101309161|FG000|COMPLETED|Overall Study||160||
48399600|NCT01947894|101309162|FG001|COMPLETED|Overall Study||24||
48399601|NCT01947894|101309163|FG002|COMPLETED|Overall Study||61||
48399602|NCT01947894|101309161|FG000|NOT COMPLETED|Overall Study||87||
48399603|NCT01947894|101309162|FG001|NOT COMPLETED|Overall Study||18||
48399604|NCT01947894|101309163|FG002|NOT COMPLETED|Overall Study||27||
48399605|NCT04083404|101309164|FG000|STARTED|Overall Study||202||
48399606|NCT04083404|101309164|FG000|COMPLETED|Overall Study||202||
48702122|NCT00519376|102057621|FG002|NOT COMPLETED|Treatment Period 1||0||
48702123|NCT00519376|102057622|FG003|NOT COMPLETED|Treatment Period 1||0||
48702124|NCT00519376|102057623|FG004|NOT COMPLETED|Treatment Period 1||0||
48702125|NCT00519376|102057624|FG005|NOT COMPLETED|Treatment Period 1||0||
48131385|NCT01043874|100645873|FG000|NOT COMPLETED|Overall Study||6||
48131386|NCT02039505|100645874|FG000|STARTED|Induction Phase (Week 0 to Week 14)||82||
48131387|NCT02039505|100645875|FG001|STARTED|Induction Phase (Week 0 to Week 14)||164||
48131388|NCT02039505|100645876|FG002|STARTED|Induction Phase (Week 0 to Week 14)||46||
48131389|NCT02039505|100645877|FG003|STARTED|Induction Phase (Week 0 to Week 14)||0||
48131390|NCT02039505|100645878|FG004|STARTED|Induction Phase (Week 0 to Week 14)||0||
48399607|NCT04083404|101309164|FG000|NOT COMPLETED|Overall Study||0||
48399608|NCT03380026|101309165|FG000|STARTED|Overall Study||28||
48399609|NCT03380026|101309165|FG000|Half of Body Assigned to Treatment With Valchlor Only|Overall Study||28|Side of body from each patient assigned to treatment with Valchlor only, assigned randomly at enrollment.|
48404081|NCT03689972|101321768|FG002|STARTED|Part 2:Run-in Period (Week73uptoWeek107)||158||
48702126|NCT00519376|102057625|FG006|NOT COMPLETED|Treatment Period 1||0||
48702127|NCT00519376|102057626|FG007|NOT COMPLETED|Treatment Period 1||0||
48131391|NCT02039505|100645879|FG005|STARTED|Induction Phase (Week 0 to Week 14)||0||
48131392|NCT02039505|100645880|FG006|STARTED|Induction Phase (Week 0 to Week 14)||0||
48575542|NCT00006178|101738611|FG000|NOT COMPLETED|Overall Study||0||
48575543|NCT02992236|101738612|FG000|STARTED|Overall Study||8||
48575544|NCT02992236|101738613|FG001|STARTED|Overall Study||8||
48575545|NCT02992236|101738612|FG000|COMPLETED|Overall Study||8||
48575546|NCT02992236|101738613|FG001|COMPLETED|Overall Study||8||
48575547|NCT02992236|101738612|FG000|NOT COMPLETED|Overall Study||0||
48575548|NCT02992236|101738613|FG001|NOT COMPLETED|Overall Study||0||
48575549|NCT03097341|101738614|FG000|STARTED|Overall Study||4||
48575550|NCT03097341|101738615|FG001|STARTED|Overall Study||4||
48575551|NCT03097341|101738616|FG002|STARTED|Overall Study||4||
48575552|NCT03097341|101738617|FG003|STARTED|Overall Study||4||
48575553|NCT03097341|101738618|FG004|STARTED|Overall Study||5||
48575554|NCT03097341|101738614|FG000|COMPLETED|Overall Study||4||
48575555|NCT03097341|101738615|FG001|COMPLETED|Overall Study||4||
48575556|NCT03097341|101738616|FG002|COMPLETED|Overall Study||4||
48575557|NCT03097341|101738617|FG003|COMPLETED|Overall Study||4||
48575558|NCT03097341|101738618|FG004|COMPLETED|Overall Study||5||
48575559|NCT03097341|101738614|FG000|NOT COMPLETED|Overall Study||0||
48575560|NCT03097341|101738615|FG001|NOT COMPLETED|Overall Study||0||
48575561|NCT03097341|101738616|FG002|NOT COMPLETED|Overall Study||0||
48575562|NCT03097341|101738617|FG003|NOT COMPLETED|Overall Study||0||
48575563|NCT03097341|101738618|FG004|NOT COMPLETED|Overall Study||0||
48575564|NCT01340872|101738619|FG000|STARTED|Double-blind Phase||64||
48575565|NCT01340872|101738620|FG001|STARTED|Double-blind Phase||64||
48575566|NCT01340872|101738621|FG002|STARTED|Double-blind Phase||0||
48575567|NCT01340872|101738622|FG003|STARTED|Double-blind Phase||0||
48575568|NCT01340872|101738619|FG000|COMPLETED|Double-blind Phase||55||
48575569|NCT01340872|101738620|FG001|COMPLETED|Double-blind Phase||53||
48575570|NCT01340872|101738621|FG002|COMPLETED|Double-blind Phase||0||
48575571|NCT01340872|101738622|FG003|COMPLETED|Double-blind Phase||0||
48575572|NCT01340872|101738619|FG000|NOT COMPLETED|Double-blind Phase||9||
48575573|NCT01340872|101738620|FG001|NOT COMPLETED|Double-blind Phase||11||
48575574|NCT01340872|101738621|FG002|NOT COMPLETED|Double-blind Phase||0||
48575575|NCT01340872|101738622|FG003|NOT COMPLETED|Double-blind Phase||0||
48575576|NCT01340872|101738619|FG000|STARTED|Open-label Phase||0||
48575577|NCT01340872|101738620|FG001|STARTED|Open-label Phase||0||
48131393|NCT02039505|100645874|FG000|COMPLETED|Induction Phase (Week 0 to Week 14)||78||
48131394|NCT02039505|100645875|FG001|COMPLETED|Induction Phase (Week 0 to Week 14)||155||
48131395|NCT02039505|100645876|FG002|COMPLETED|Induction Phase (Week 0 to Week 14)||36||
48131396|NCT02039505|100645877|FG003|COMPLETED|Induction Phase (Week 0 to Week 14)||0||
48131397|NCT02039505|100645878|FG004|COMPLETED|Induction Phase (Week 0 to Week 14)||0||
48131398|NCT02039505|100645879|FG005|COMPLETED|Induction Phase (Week 0 to Week 14)||0||
48131399|NCT02039505|100645880|FG006|COMPLETED|Induction Phase (Week 0 to Week 14)||0||
48131400|NCT02039505|100645874|FG000|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||4||
48131401|NCT02039505|100645875|FG001|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||9||
48131402|NCT02039505|100645876|FG002|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||10||
48131403|NCT02039505|100645877|FG003|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0||
48131404|NCT02039505|100645878|FG004|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0||
48131405|NCT02039505|100645879|FG005|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0||
48131406|NCT02039505|100645880|FG006|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0||
48131407|NCT02039505|100645874|FG000|STARTED|Maintenance Phase (Week 14 to Week 60)||0|Participants who achieved clinical response at Week 10 entered into the maintenance phase.|
48131408|NCT02039505|100645875|FG001|STARTED|Maintenance Phase (Week 14 to Week 60)||0|Participants who achieved clinical response at Week 10 entered into the maintenance phase.|
48131409|NCT02039505|100645876|FG002|STARTED|Maintenance Phase (Week 14 to Week 60)||0|Participants who achieved clinical response at Week 10 entered into the maintenance phase.|
48131410|NCT02039505|100645877|FG003|STARTED|Maintenance Phase (Week 14 to Week 60)||42|Participants who achieved clinical response at Week 10 entered into the maintenance phase.|
48131411|NCT02039505|100645878|FG004|STARTED|Maintenance Phase (Week 14 to Week 60)||41|Participants who achieved clinical response at Week 10 entered into the maintenance phase.|
48131412|NCT02039505|100645879|FG005|STARTED|Maintenance Phase (Week 14 to Week 60)||26|Participants who achieved clinical response at Week 10 entered into the maintenance phase.|
48141436|NCT01780922|100670423|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48575578|NCT01340872|101738621|FG002|STARTED|Open-label Phase||50||
48575579|NCT01340872|101738622|FG003|STARTED|Open-label Phase||47||
48575580|NCT01340872|101738619|FG000|COMPLETED|Open-label Phase||0||
48575581|NCT01340872|101738620|FG001|COMPLETED|Open-label Phase||0||
48575582|NCT01340872|101738621|FG002|COMPLETED|Open-label Phase||37||
48575583|NCT01340872|101738622|FG003|COMPLETED|Open-label Phase||36||
48575584|NCT01340872|101738619|FG000|NOT COMPLETED|Open-label Phase||0||
48575585|NCT01340872|101738620|FG001|NOT COMPLETED|Open-label Phase||0||
48575586|NCT01340872|101738621|FG002|NOT COMPLETED|Open-label Phase||13||
48575587|NCT01340872|101738622|FG003|NOT COMPLETED|Open-label Phase||11||
48575588|NCT04192071|101738623|FG000|STARTED|Overall Study||31||
48575589|NCT04192071|101738624|FG001|STARTED|Overall Study||35||
48575590|NCT04192071|101738625|FG002|STARTED|Overall Study||25||
48575591|NCT04192071|101738626|FG003|STARTED|Overall Study||48||
48575592|NCT04192071|101738623|FG000|COMPLETED|Overall Study||31||
48575593|NCT04192071|101738624|FG001|COMPLETED|Overall Study||35||
48575594|NCT04192071|101738625|FG002|COMPLETED|Overall Study||25||
48285252|NCT03647488|101021677|FG001|STARTED|Overall Study||0||
48285253|NCT03647488|101021678|FG002|STARTED|Overall Study||0||
48285254|NCT03647488|101021676|FG000|COMPLETED|Overall Study||0||
48285255|NCT03647488|101021677|FG001|COMPLETED|Overall Study||0||
48285256|NCT03647488|101021678|FG002|COMPLETED|Overall Study||0||
48285257|NCT03647488|101021676|FG000|NOT COMPLETED|Overall Study||18||
48285258|NCT03647488|101021677|FG001|NOT COMPLETED|Overall Study||0||
48285259|NCT03647488|101021678|FG002|NOT COMPLETED|Overall Study||0||
48285260|NCT01096823|101021679|FG000|STARTED|Overall Study||14||
48285261|NCT01096823|101021680|FG001|STARTED|Overall Study||16||
48285262|NCT01096823|101021679|FG000|COMPLETED|Overall Study||11||
48285263|NCT01096823|101021680|FG001|COMPLETED|Overall Study||15||
48285264|NCT01096823|101021679|FG000|NOT COMPLETED|Overall Study||3||
48285265|NCT01096823|101021680|FG001|NOT COMPLETED|Overall Study||1||
48285266|NCT05326815|101021681|FG000|STARTED|Overall Study||54||
48285267|NCT05326815|101021681|FG000|COMPLETED|Overall Study||40||
48285268|NCT05326815|101021681|FG000|NOT COMPLETED|Overall Study||14||
48285269|NCT01290029|101021682|FG000|STARTED|Overall Study||14||
48285270|NCT01290029|101021682|FG000|Received Study Treatment|Overall Study||12||
48285271|NCT01290029|101021682|FG000|COMPLETED|Overall Study||12||
48285272|NCT01290029|101021682|FG000|NOT COMPLETED|Overall Study||2||
48285273|NCT00669682|101021683|FG000|STARTED|Overall Study||9||
48285274|NCT00669682|101021683|FG000|COMPLETED|Overall Study||9||
48285275|NCT00669682|101021683|FG000|NOT COMPLETED|Overall Study||0||
48285276|NCT00574873|101021684|FG000|STARTED|Overall Study||250||
48285277|NCT00574873|101021685|FG001|STARTED|Overall Study||252||
48285278|NCT00574873|101021684|FG000|Treated|Overall Study||248||
48285279|NCT00574873|101021685|FG001|Treated|Overall Study||251||
48285280|NCT00574873|101021684|FG000|COMPLETED|Overall Study||12||
48285281|NCT00574873|101021685|FG001|COMPLETED|Overall Study||1||
48285282|NCT00574873|101021684|FG000|NOT COMPLETED|Overall Study||238||
48285283|NCT00574873|101021685|FG001|NOT COMPLETED|Overall Study||251||
48285284|NCT00948766|101021686|FG000|STARTED|Core Study||356||
48285285|NCT00948766|101021687|FG001|STARTED|Core Study||360||
48285286|NCT00948766|101021686|FG000|Exposed to Study Medication|Core Study||355||
48285287|NCT00948766|101021687|FG001|Exposed to Study Medication|Core Study||359||
48285288|NCT00948766|101021686|FG000|COMPLETED|Core Study||229||
48285289|NCT00948766|101021687|FG001|COMPLETED|Core Study||234||
48285290|NCT00948766|101021686|FG000|NOT COMPLETED|Core Study||127||
48285291|NCT00948766|101021687|FG001|NOT COMPLETED|Core Study||126||
48285292|NCT00948766|101021686|FG000|STARTED|Extension Study||397||
48285293|NCT00948766|101021687|FG001|STARTED|Extension Study||0||
48285294|NCT00948766|101021686|FG000|Exposed to Study Medication|Extension Study||396||
48285295|NCT00948766|101021687|FG001|Exposed to Study Medication|Extension Study||0||
48285296|NCT00948766|101021686|FG000|COMPLETED|Extension Study||306||
48285297|NCT00948766|101021687|FG001|COMPLETED|Extension Study||0||
48285298|NCT00948766|101021686|FG000|NOT COMPLETED|Extension Study||91||
48285299|NCT00948766|101021687|FG001|NOT COMPLETED|Extension Study||0||
48285300|NCT03139669|101021688|FG000|STARTED|Overall Study||45||
48285301|NCT03139669|101021688|FG000|COMPLETED|Overall Study||45||
48285302|NCT03139669|101021688|FG000|NOT COMPLETED|Overall Study||0||
48285303|NCT03484273|101021689|FG000|STARTED|Overall Study||32||
48285304|NCT03484273|101021689|FG000|COMPLETED|Overall Study||30||
48285305|NCT03484273|101021689|FG000|NOT COMPLETED|Overall Study||2||
48285306|NCT00734097|101021690|FG000|STARTED|Screening||337||
48285307|NCT00734097|101021690|FG000|COMPLETED|Screening||317||
48285308|NCT00734097|101021690|FG000|NOT COMPLETED|Screening||20||
48285309|NCT00734097|101021690|FG000|STARTED|Open Label||317||
48285310|NCT00734097|101021690|FG000|Safety Analysis|Open Label||317||
48285311|NCT00734097|101021690|FG000|Full Analysis|Open Label||311||
48285312|NCT00734097|101021690|FG000|Per Protocol|Open Label||301||
48285313|NCT00734097|101021690|FG000|COMPLETED|Open Label||301||
48285314|NCT00734097|101021690|FG000|NOT COMPLETED|Open Label||16||
48285315|NCT00822523|101021691|FG000|STARTED|Overall Study||5||
48285316|NCT00822523|101021692|FG001|STARTED|Overall Study||4||
48285317|NCT00822523|101021693|FG002|STARTED|Overall Study||4||
48285318|NCT00822523|101021691|FG000|COMPLETED|Overall Study||5||
48285319|NCT00822523|101021692|FG001|COMPLETED|Overall Study||4||
48285320|NCT00822523|101021693|FG002|COMPLETED|Overall Study||4||
48285321|NCT00822523|101021691|FG000|NOT COMPLETED|Overall Study||0||
48285322|NCT00822523|101021692|FG001|NOT COMPLETED|Overall Study||0||
48285323|NCT00822523|101021693|FG002|NOT COMPLETED|Overall Study||0||
48285324|NCT00833261|101021694|FG000|STARTED|Overall Study||37||
48285325|NCT00833261|101021694|FG000|COMPLETED|Overall Study||33||
48285326|NCT00833261|101021694|FG000|NOT COMPLETED|Overall Study||4||
48285327|NCT00860847|101021695|FG000|STARTED|Overall Study||32||
48285328|NCT00860847|101021696|FG001|STARTED|Overall Study||33||
48285329|NCT00860847|101021695|FG000|COMPLETED|Overall Study||28||
48285330|NCT00860847|101021696|FG001|COMPLETED|Overall Study||28||
48285331|NCT00860847|101021695|FG000|NOT COMPLETED|Overall Study||4||
48285332|NCT00860847|101021696|FG001|NOT COMPLETED|Overall Study||5||
48285333|NCT01656733|101026115|FG000|STARTED|Overall Study||67|Baseline Visit (randomization)|
48285334|NCT01656733|101026116|FG001|STARTED|Overall Study||70|Baseline Visit (randomization)|
48285335|NCT01656733|101026115|FG000|Visit 1 (1 Week After Quit Date)|Overall Study||45||
48575595|NCT04192071|101738626|FG003|COMPLETED|Overall Study||48||
48575596|NCT04192071|101738623|FG000|NOT COMPLETED|Overall Study||0||
48575597|NCT04192071|101738624|FG001|NOT COMPLETED|Overall Study||0||
48575598|NCT04192071|101738625|FG002|NOT COMPLETED|Overall Study||0||
48575599|NCT04192071|101738626|FG003|NOT COMPLETED|Overall Study||0||
48575600|NCT00491556|101738627|FG000|STARTED|Entry-Week (WK) 48: EXP/Standard Care||75||
48575601|NCT00491556|101738628|FG001|STARTED|Entry-Week (WK) 48: EXP/Standard Care||27||
48575602|NCT00491556|101738627|FG000|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||53||
48575603|NCT00491556|101738628|FG001|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||27||
48575604|NCT00491556|101738627|FG000|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||49||
48575605|NCT00491556|101738628|FG001|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||27||
48575606|NCT00491556|101738627|FG000|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||26||
48575607|NCT00491556|101738628|FG001|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||0||
48575608|NCT00491556|101738627|FG000|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||49||
48575609|NCT00491556|101738628|FG001|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||27||
48575610|NCT00491556|101738627|FG000|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||25||
48575611|NCT00491556|101738628|FG001|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||22||
48575612|NCT00491556|101738627|FG000|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||24||
48575613|NCT00491556|101738628|FG001|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||5||
48575614|NCT00758485|101738629|FG000|STARTED|Overall Study||70||
48575615|NCT00758485|101738630|FG001|STARTED|Overall Study||70||
48575616|NCT00758485|101738629|FG000|TREATED|Overall Study||69||
48575617|NCT00758485|101738630|FG001|TREATED|Overall Study||68||
48575618|NCT00758485|101738629|FG000|COMPLETED|Overall Study||69||
48575619|NCT00758485|101738630|FG001|COMPLETED|Overall Study||67||
48575620|NCT00758485|101738629|FG000|NOT COMPLETED|Overall Study||1||
48575621|NCT00758485|101738630|FG001|NOT COMPLETED|Overall Study||3||
48575622|NCT01631149|101738631|FG000|STARTED|Overall Study||12||
48575623|NCT01631149|101738632|FG001|STARTED|Overall Study||12||
48575624|NCT01631149|101738631|FG000|COMPLETED|Overall Study||12||
48575625|NCT01631149|101738632|FG001|COMPLETED|Overall Study||12||
48575626|NCT01631149|101738631|FG000|NOT COMPLETED|Overall Study||0||
48575627|NCT01631149|101738632|FG001|NOT COMPLETED|Overall Study||0||
48575628|NCT00537576|101738633|FG000|STARTED|Overall Study||3||
48575629|NCT00537576|101738634|FG001|STARTED|Overall Study||3||
48575630|NCT00537576|101738635|FG002|STARTED|Overall Study||3||
48575631|NCT00537576|101738636|FG003|STARTED|Overall Study||1||
48575632|NCT00537576|101738637|FG004|STARTED|Overall Study||1||
48575633|NCT00537576|101738638|FG005|STARTED|Overall Study||1||
48575634|NCT00537576|101738633|FG000|COMPLETED|Overall Study||3||
48575635|NCT00537576|101738634|FG001|COMPLETED|Overall Study||3||
48575636|NCT00537576|101738635|FG002|COMPLETED|Overall Study||3||
48575637|NCT00537576|101738636|FG003|COMPLETED|Overall Study||1||
48575638|NCT00537576|101738637|FG004|COMPLETED|Overall Study||1||
48575639|NCT00537576|101738638|FG005|COMPLETED|Overall Study||1||
48575640|NCT00537576|101738633|FG000|NOT COMPLETED|Overall Study||0||
48575641|NCT00537576|101738634|FG001|NOT COMPLETED|Overall Study||0||
48575642|NCT00537576|101738635|FG002|NOT COMPLETED|Overall Study||0||
48575643|NCT00537576|101738636|FG003|NOT COMPLETED|Overall Study||0||
48575644|NCT00537576|101738637|FG004|NOT COMPLETED|Overall Study||0||
48575645|NCT00537576|101738638|FG005|NOT COMPLETED|Overall Study||0||
48575646|NCT00468481|101738639|FG000|STARTED|Overall Study||291||
48575647|NCT00468481|101738640|FG001|STARTED|Overall Study||94||
48575648|NCT00468481|101738639|FG000|Subjects Treated|Overall Study||285||
48575649|NCT00468481|101738640|FG001|Subjects Treated|Overall Study||94||
48575650|NCT00468481|101738639|FG000|COMPLETED|Overall Study||203||
48575651|NCT00468481|101738640|FG001|COMPLETED|Overall Study||70||
48575652|NCT00468481|101738639|FG000|NOT COMPLETED|Overall Study||88||
48575653|NCT00468481|101738640|FG001|NOT COMPLETED|Overall Study||24||
48575654|NCT03197038|101738641|FG000|STARTED|Overall Study||22||
48575655|NCT03197038|101738642|FG001|STARTED|Overall Study||17||
48575656|NCT03197038|101738641|FG000|COMPLETED|Overall Study||18||
48575657|NCT03197038|101738642|FG001|COMPLETED|Overall Study||17||
48575658|NCT03197038|101738641|FG000|NOT COMPLETED|Overall Study||4||
48575659|NCT03197038|101738642|FG001|NOT COMPLETED|Overall Study||0||
48575660|NCT01136356|101738643|FG000|STARTED|First Intervention||6||
48575661|NCT01136356|101738644|FG001|STARTED|First Intervention||6||
48575662|NCT01136356|101738643|FG000|COMPLETED|First Intervention||6||
48575663|NCT01136356|101738644|FG001|COMPLETED|First Intervention||6||
48575664|NCT01136356|101738643|FG000|NOT COMPLETED|First Intervention||0||
48575665|NCT01136356|101738644|FG001|NOT COMPLETED|First Intervention||0||
48575666|NCT01136356|101738643|FG000|STARTED|First 18-day Withdrawal||6||
48575667|NCT01136356|101738644|FG001|STARTED|First 18-day Withdrawal||6||
48575668|NCT01136356|101738643|FG000|COMPLETED|First 18-day Withdrawal||2||
48575669|NCT01136356|101738644|FG001|COMPLETED|First 18-day Withdrawal||6||
48575670|NCT01136356|101738643|FG000|NOT COMPLETED|First 18-day Withdrawal||4||
48702128|NCT00519376|102057627|FG008|NOT COMPLETED|Treatment Period 1||0||
48575671|NCT01136356|101738644|FG001|NOT COMPLETED|First 18-day Withdrawal||0||
48575672|NCT01136356|101738643|FG000|STARTED|Second Intervention||2||
48575673|NCT01136356|101738644|FG001|STARTED|Second Intervention||6||
48575674|NCT01136356|101738643|FG000|COMPLETED|Second Intervention||2||
48575675|NCT01136356|101738644|FG001|COMPLETED|Second Intervention||6||
48575676|NCT01136356|101738643|FG000|NOT COMPLETED|Second Intervention||0||
48575677|NCT01136356|101738644|FG001|NOT COMPLETED|Second Intervention||0||
48575678|NCT01136356|101738643|FG000|STARTED|Second 18-day Withdrawal||2||
48575679|NCT01136356|101738644|FG001|STARTED|Second 18-day Withdrawal||6||
48575680|NCT01136356|101738643|FG000|COMPLETED|Second 18-day Withdrawal||2||
48575681|NCT01136356|101738644|FG001|COMPLETED|Second 18-day Withdrawal||5||
48575682|NCT01136356|101738643|FG000|NOT COMPLETED|Second 18-day Withdrawal||0||
48575683|NCT01136356|101738644|FG001|NOT COMPLETED|Second 18-day Withdrawal||1||
48575684|NCT00823069|101738645|FG000|STARTED|Overall Study||60||
48575685|NCT00823069|101738645|FG000|COMPLETED|Overall Study||60||
48575686|NCT00823069|101738645|FG000|NOT COMPLETED|Overall Study||0||
48575687|NCT00237458|101738646|FG000|STARTED|Overall Study||7||
48575688|NCT00237458|101738646|FG000|COMPLETED|Overall Study||4||
48575689|NCT00237458|101738646|FG000|NOT COMPLETED|Overall Study||3||
48575690|NCT03226769|101741190|FG000|STARTED|Overall Study||29||
48575691|NCT03226769|101741191|FG001|STARTED|Overall Study||28||
48575692|NCT03226769|101741190|FG000|COMPLETED|Overall Study||29||
48575693|NCT03226769|101741191|FG001|COMPLETED|Overall Study||27||
48575694|NCT03226769|101741190|FG000|NOT COMPLETED|Overall Study||0||
48575695|NCT03226769|101741191|FG001|NOT COMPLETED|Overall Study||1||
48575696|NCT03220204|101741192|FG000|STARTED|Overall Study||15||
48575697|NCT03220204|101741193|FG001|STARTED|Overall Study||15||
48575698|NCT03220204|101741194|FG002|STARTED|Overall Study||15||
48575699|NCT03220204|101741192|FG000|COMPLETED|Overall Study||14||
48575700|NCT03220204|101741193|FG001|COMPLETED|Overall Study||13||
48575701|NCT03220204|101741194|FG002|COMPLETED|Overall Study||12||
48575702|NCT03220204|101741192|FG000|NOT COMPLETED|Overall Study||1||
48575703|NCT03220204|101741193|FG001|NOT COMPLETED|Overall Study||2||
48575704|NCT03220204|101741194|FG002|NOT COMPLETED|Overall Study||3||
48575705|NCT00356148|101741195|FG000|STARTED|Overall Study||189||
48575706|NCT00356148|101741196|FG001|STARTED|Overall Study||183||
48575707|NCT00356148|101741195|FG000|COMPLETED|Overall Study||187||
48575708|NCT00356148|101741196|FG001|COMPLETED|Overall Study||182||
48575709|NCT00356148|101741195|FG000|NOT COMPLETED|Overall Study||2||
48575710|NCT00356148|101741196|FG001|NOT COMPLETED|Overall Study||1||
48575711|NCT00471081|101741197|FG000|STARTED|Active Phase||160||
48575712|NCT00471081|101741198|FG001|STARTED|Active Phase||189||
48575713|NCT00471081|101741197|FG000|COMPLETED|Active Phase||158||
48575714|NCT00471081|101741198|FG001|COMPLETED|Active Phase||176||
48575715|NCT00471081|101741197|FG000|NOT COMPLETED|Active Phase||2||
48575716|NCT00471081|101741198|FG001|NOT COMPLETED|Active Phase||13||
48575717|NCT00471081|101741197|FG000|STARTED|Extended Safety Follow-Up||160||
48575718|NCT00471081|101741198|FG001|STARTED|Extended Safety Follow-Up||189||
48575719|NCT00471081|101741197|FG000|COMPLETED|Extended Safety Follow-Up||158||
48575720|NCT00471081|101741198|FG001|COMPLETED|Extended Safety Follow-Up||176||
48575721|NCT00471081|101741197|FG000|NOT COMPLETED|Extended Safety Follow-Up||2||
48575722|NCT00471081|101741198|FG001|NOT COMPLETED|Extended Safety Follow-Up||13||
48575723|NCT01023477|101741199|FG000|STARTED|Overall Study||7||
48575724|NCT01023477|101741200|FG001|STARTED|Overall Study||5||
48575725|NCT01023477|101741199|FG000|COMPLETED|Overall Study||7||
48575726|NCT01023477|101741200|FG001|COMPLETED|Overall Study||5||
48575727|NCT01023477|101741199|FG000|NOT COMPLETED|Overall Study||0||
48575728|NCT01023477|101741200|FG001|NOT COMPLETED|Overall Study||0||
48575729|NCT03811093|101741201|FG000|STARTED|Overall Study||20||
48575730|NCT03811093|101741202|FG001|STARTED|Overall Study||19||
48575731|NCT03811093|101741201|FG000|COMPLETED|Overall Study||18||
48575732|NCT03811093|101741202|FG001|COMPLETED|Overall Study||15||
48575733|NCT03811093|101741201|FG000|NOT COMPLETED|Overall Study||2||
48575734|NCT03811093|101741202|FG001|NOT COMPLETED|Overall Study||4||
48575735|NCT02635425|101741203|FG000|STARTED|Overall Study||15||
48575736|NCT02635425|101741204|FG001|STARTED|Overall Study||15||
48575737|NCT02635425|101741203|FG000|COMPLETED|Overall Study||15||
48575738|NCT02635425|101741204|FG001|COMPLETED|Overall Study||15||
48575739|NCT02635425|101741203|FG000|NOT COMPLETED|Overall Study||0||
48575740|NCT02635425|101741204|FG001|NOT COMPLETED|Overall Study||0||
48575741|NCT01127451|101741205|FG000|STARTED|Overall Study||43||
48575742|NCT01127451|101741206|FG001|STARTED|Overall Study||32||
48575743|NCT01127451|101741205|FG000|Safety Analysis Set|Overall Study||43||
48575744|NCT01127451|101741206|FG001|Safety Analysis Set|Overall Study||32||
48575745|NCT01127451|101741205|FG000|Modified Intent-to-Treat (MITT)|Overall Study||42||
48575746|NCT01127451|101741206|FG001|Modified Intent-to-Treat (MITT)|Overall Study||32||
48575747|NCT01127451|101741205|FG000|COMPLETED|Overall Study||0||
48575748|NCT01127451|101741206|FG001|COMPLETED|Overall Study||0||
48575749|NCT01127451|101741205|FG000|NOT COMPLETED|Overall Study||43||
48575750|NCT01127451|101741206|FG001|NOT COMPLETED|Overall Study||32||
48575751|NCT03763929|101741207|FG000|STARTED|Overall Study||2||
48575752|NCT03763929|101741208|FG001|STARTED|Overall Study||4||
48575753|NCT03763929|101741207|FG000|COMPLETED|Overall Study||2||
48575754|NCT03763929|101741208|FG001|COMPLETED|Overall Study||4||
48575755|NCT03763929|101741207|FG000|NOT COMPLETED|Overall Study||0||
48575756|NCT03763929|101741208|FG001|NOT COMPLETED|Overall Study||0||
48575757|NCT02403479|101741209|FG000|STARTED|Overall Study||10||
48575758|NCT02403479|101741210|FG001|STARTED|Overall Study||12||
48575759|NCT02403479|101741209|FG000|COMPLETED|Overall Study||8||
48575760|NCT02403479|101741210|FG001|COMPLETED|Overall Study||12||
48575761|NCT02403479|101741209|FG000|NOT COMPLETED|Overall Study||2||
48575762|NCT02403479|101741210|FG001|NOT COMPLETED|Overall Study||0||
48575763|NCT03055338|101741211|FG000|STARTED|Overall Study||90||
48575764|NCT03055338|101741212|FG001|STARTED|Overall Study||45||
48575765|NCT03055338|101741213|FG002|STARTED|Overall Study||89||
48575766|NCT03055338|101741211|FG000|COMPLETED|Overall Study||72||
48575767|NCT03055338|101741212|FG001|COMPLETED|Overall Study||34||
48575768|NCT03055338|101741213|FG002|COMPLETED|Overall Study||77||
48575769|NCT03055338|101741211|FG000|NOT COMPLETED|Overall Study||18||
48575770|NCT03055338|101741212|FG001|NOT COMPLETED|Overall Study||11||
48575771|NCT03055338|101741213|FG002|NOT COMPLETED|Overall Study||12||
48575772|NCT04545567|101741214|FG000|STARTED|Overall Study||10||
48575773|NCT04545567|101741215|FG001|STARTED|Overall Study||11||
48575774|NCT04545567|101741214|FG000|COMPLETED|Overall Study||9||
48575775|NCT04545567|101741215|FG001|COMPLETED|Overall Study||9||
48575776|NCT04545567|101741214|FG000|NOT COMPLETED|Overall Study||1||
48575777|NCT04545567|101741215|FG001|NOT COMPLETED|Overall Study||2||
48575778|NCT04096482|101741216|FG000|STARTED|Overall Study||6||
48575779|NCT04096482|101741216|FG000|COMPLETED|Overall Study||6||
48575780|NCT04096482|101741216|FG000|NOT COMPLETED|Overall Study||0||
48575781|NCT02285166|101741217|FG000|STARTED|Overall Study||15330||
48575782|NCT02285166|101741217|FG000|COMPLETED|Overall Study||14364||
48575783|NCT02285166|101741217|FG000|NOT COMPLETED|Overall Study||966||
48575784|NCT02119455|101741218|FG000|STARTED|Overall Study||20||
48575785|NCT02119455|101741219|FG001|STARTED|Overall Study||20||
48575786|NCT02119455|101741218|FG000|COMPLETED|Overall Study||20||
48285336|NCT01656733|101026116|FG001|Visit 1 (1 Week After Quit Date)|Overall Study||42||
48285337|NCT01656733|101026115|FG000|Visit 2 (2 Weeks After Quit Date)|Overall Study||32||
48575787|NCT02119455|101741219|FG001|COMPLETED|Overall Study||17||
48575788|NCT02119455|101741218|FG000|NOT COMPLETED|Overall Study||0||
48702129|NCT00519376|102057628|FG009|NOT COMPLETED|Treatment Period 1||0||
48702130|NCT00519376|102057629|FG010|NOT COMPLETED|Treatment Period 1||0||
48702131|NCT00519376|102057630|FG011|NOT COMPLETED|Treatment Period 1||0||
48702132|NCT00519376|102057631|FG012|NOT COMPLETED|Treatment Period 1||0||
48285338|NCT01656733|101026116|FG001|Visit 2 (2 Weeks After Quit Date)|Overall Study||44||
48285339|NCT01656733|101026115|FG000|Visit 3 (3 Weeks After Quit Date)|Overall Study||33||
48575789|NCT02119455|101741219|FG001|NOT COMPLETED|Overall Study||3||
48575790|NCT01046903|101741220|FG000|STARTED|Overall Study||503||
48575791|NCT01046903|101741220|FG000|COMPLETED|Overall Study||475||
48575792|NCT01046903|101741220|FG000|NOT COMPLETED|Overall Study||28||
48575793|NCT03050775|101741221|FG000|STARTED|Overall Study||35||
48575794|NCT03050775|101741222|FG001|STARTED|Overall Study||35||
48575795|NCT03050775|101741221|FG000|COMPLETED|Overall Study||35||
48575796|NCT03050775|101741222|FG001|COMPLETED|Overall Study||35||
48575797|NCT03050775|101741221|FG000|NOT COMPLETED|Overall Study||0||
48575798|NCT03050775|101741222|FG001|NOT COMPLETED|Overall Study||0||
48575799|NCT04571645|101741223|FG000|STARTED|Overall Study||5||
48575800|NCT04571645|101741224|FG001|STARTED|Overall Study||4||
48575801|NCT04571645|101741223|FG000|COMPLETED|Overall Study||5||
48575802|NCT04571645|101741224|FG001|COMPLETED|Overall Study||4||
48575803|NCT04571645|101741223|FG000|NOT COMPLETED|Overall Study||0||
48575804|NCT04571645|101741224|FG001|NOT COMPLETED|Overall Study||0||
48575805|NCT01094561|101741225|FG000|STARTED|Overall Study||23||
48575806|NCT01094561|101741225|FG000|COMPLETED|Overall Study||17||
48702133|NCT00519376|102057632|FG013|NOT COMPLETED|Treatment Period 1||0||
48702134|NCT00519376|102057633|FG014|NOT COMPLETED|Treatment Period 1||0||
48285340|NCT01656733|101026116|FG001|Visit 3 (3 Weeks After Quit Date)|Overall Study||34||
48285341|NCT01656733|101026115|FG000|Visit 4 (4 Weeks After Quit Date)|Overall Study||32||
48285342|NCT01656733|101026116|FG001|Visit 4 (4 Weeks After Quit Date)|Overall Study||30||
48285343|NCT01656733|101026115|FG000|Visit 5 (6 Weeks After Quit Date)|Overall Study||37||
48285344|NCT01656733|101026116|FG001|Visit 5 (6 Weeks After Quit Date)|Overall Study||36||
48285345|NCT01656733|101026115|FG000|Visit 6 ( 32-36 Weeks Gestation)|Overall Study||39||
48702135|NCT00519376|102057634|FG015|NOT COMPLETED|Treatment Period 1||0||
48702136|NCT00519376|102057619|FG000|STARTED|Washout Period 1||2||
48285346|NCT01656733|101026116|FG001|Visit 6 ( 32-36 Weeks Gestation)|Overall Study||47||
48285347|NCT01656733|101026115|FG000|Participants With Perinatal Outcomes|Overall Study||67||
48285348|NCT01656733|101026116|FG001|Participants With Perinatal Outcomes|Overall Study||66||
48285349|NCT01656733|101026115|FG000|Visit 7 (1 Month Postpartum) Phone Call|Overall Study||47||
48285350|NCT01656733|101026116|FG001|Visit 7 (1 Month Postpartum) Phone Call|Overall Study||50||
48575807|NCT01094561|101741225|FG000|NOT COMPLETED|Overall Study||6||
48575808|NCT00576420|101741226|FG000|STARTED|Overall Study||26||
48575809|NCT00576420|101741227|FG001|STARTED|Overall Study||24||
48575810|NCT00576420|101741228|FG002|STARTED|Overall Study||23||
48575811|NCT00576420|101741226|FG000|COMPLETED|Overall Study||26||
48575812|NCT00576420|101741227|FG001|COMPLETED|Overall Study||24||
48575813|NCT00576420|101741228|FG002|COMPLETED|Overall Study||22||
48575814|NCT00576420|101741226|FG000|NOT COMPLETED|Overall Study||0||
48575815|NCT00576420|101741227|FG001|NOT COMPLETED|Overall Study||0||
48575816|NCT00576420|101741228|FG002|NOT COMPLETED|Overall Study||1||
48575817|NCT00860535|101741229|FG000|STARTED|Overall Study||9||
48575818|NCT00860535|101741229|FG000|DISCONTINUED|Overall Study||1||
48575819|NCT00860535|101741229|FG000|COMPLETED|Overall Study||8||
48575820|NCT00860535|101741229|FG000|NOT COMPLETED|Overall Study||1||
48575821|NCT02439814|101741230|FG000|STARTED|Overall Study||11||
48575822|NCT02439814|101741231|FG001|STARTED|Overall Study||10||
48575823|NCT02439814|101741230|FG000|COMPLETED|Overall Study||11||
48131413|NCT02039505|100645880|FG006|STARTED|Maintenance Phase (Week 14 to Week 60)||0|Participants who achieved clinical response at Week 10 entered into the maintenance phase.|
48131414|NCT02039505|100645874|FG000|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0||
48131415|NCT02039505|100645875|FG001|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0||
48131416|NCT02039505|100645876|FG002|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0||
48131417|NCT02039505|100645877|FG003|COMPLETED|Maintenance Phase (Week 14 to Week 60)||18||
48131418|NCT02039505|100645878|FG004|COMPLETED|Maintenance Phase (Week 14 to Week 60)||30||
48575824|NCT02439814|101741231|FG001|COMPLETED|Overall Study||10||
48575825|NCT02439814|101741230|FG000|NOT COMPLETED|Overall Study||0||
48575826|NCT02439814|101741231|FG001|NOT COMPLETED|Overall Study||0||
48575827|NCT03861988|101741232|FG000|STARTED|Overall Study||5||
48575828|NCT03861988|101741233|FG001|STARTED|Overall Study||20||
48575829|NCT03861988|101741234|FG002|STARTED|Overall Study||20||
48575830|NCT03861988|101741232|FG000|COMPLETED|Overall Study||5||
48575831|NCT03861988|101741233|FG001|COMPLETED|Overall Study||19||
48575832|NCT03861988|101741234|FG002|COMPLETED|Overall Study||19||
48575833|NCT03861988|101741232|FG000|NOT COMPLETED|Overall Study||0||
48285351|NCT01656733|101026115|FG000|Visit 8 (6 Months Postpartum)|Overall Study||30||
48285352|NCT01656733|101026116|FG001|Visit 8 (6 Months Postpartum)|Overall Study||28||
48285353|NCT01656733|101026115|FG000|COMPLETED|Overall Study||67||
48285354|NCT01656733|101026116|FG001|COMPLETED|Overall Study||66||
48285355|NCT01656733|101026115|FG000|NOT COMPLETED|Overall Study||0||
48575834|NCT03861988|101741233|FG001|NOT COMPLETED|Overall Study||1||
48575835|NCT03861988|101741234|FG002|NOT COMPLETED|Overall Study||1||
48575836|NCT04112043|101741235|FG000|STARTED|Overall Study||17||
48575837|NCT04112043|101741236|FG001|STARTED|Overall Study||18||
48575838|NCT04112043|101741237|FG002|STARTED|Overall Study||19||
48575839|NCT04112043|101741235|FG000|COMPLETED|Overall Study||15||
48575840|NCT04112043|101741236|FG001|COMPLETED|Overall Study||16||
48575841|NCT04112043|101741237|FG002|COMPLETED|Overall Study||18||
48575842|NCT04112043|101741235|FG000|NOT COMPLETED|Overall Study||2||
48575843|NCT04112043|101741236|FG001|NOT COMPLETED|Overall Study||2||
48575844|NCT04112043|101741237|FG002|NOT COMPLETED|Overall Study||1||
48575845|NCT00570141|101741238|FG000|STARTED|Overall Study||13||
48575846|NCT00570141|101741238|FG000|COMPLETED|Overall Study||10||
48575847|NCT00570141|101741238|FG000|NOT COMPLETED|Overall Study||3||
48575848|NCT00322231|101741239|FG000|STARTED|Period 1||51||
48575849|NCT00322231|101741240|FG001|STARTED|Period 1||50||
48575850|NCT00322231|101741239|FG000|COMPLETED|Period 1||51||
48575851|NCT00322231|101741240|FG001|COMPLETED|Period 1||50||
48575852|NCT00322231|101741239|FG000|NOT COMPLETED|Period 1||0||
48575853|NCT00322231|101741240|FG001|NOT COMPLETED|Period 1||0||
48575854|NCT00322231|101741239|FG000|STARTED|Period 2||51||
48575855|NCT00322231|101741240|FG001|STARTED|Period 2||49||
48575856|NCT00322231|101741239|FG000|COMPLETED|Period 2||51||
48131419|NCT02039505|100645879|FG005|COMPLETED|Maintenance Phase (Week 14 to Week 60)||12||
48131420|NCT02039505|100645880|FG006|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0||
48131421|NCT02039505|100645874|FG000|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0||
48131422|NCT02039505|100645875|FG001|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0||
48131423|NCT02039505|100645876|FG002|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0||
48131424|NCT02039505|100645877|FG003|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||24||
48131425|NCT02039505|100645878|FG004|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||11||
48131426|NCT02039505|100645879|FG005|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||14||
48131427|NCT02039505|100645880|FG006|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0||
48141437|NCT01780922|100670424|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48141438|NCT01780922|100670425|FG002|NOT COMPLETED|First Intervention (1 Day)||0||
48141439|NCT01780922|100670426|FG003|NOT COMPLETED|First Intervention (1 Day)||0||
48141440|NCT01780922|100670427|FG004|NOT COMPLETED|First Intervention (1 Day)||0||
48285356|NCT01656733|101026116|FG001|NOT COMPLETED|Overall Study||4||
48285357|NCT00297232|101026117|FG000|STARTED|Overall Study||1094||
48285358|NCT00297232|101026117|FG000|COMPLETED|Overall Study||489||
48285359|NCT00297232|101026117|FG000|NOT COMPLETED|Overall Study||605||
48285360|NCT00069108|101026118|FG000|STARTED|Overall Study||313||
48285361|NCT00069108|101026119|FG001|STARTED|Overall Study||314||
48285362|NCT00069108|101026118|FG000|COMPLETED|Overall Study||100||
48285363|NCT00069108|101026119|FG001|COMPLETED|Overall Study||95||
48575857|NCT00322231|101741240|FG001|COMPLETED|Period 2||49||
48575858|NCT00322231|101741239|FG000|NOT COMPLETED|Period 2||0||
48575859|NCT00322231|101741240|FG001|NOT COMPLETED|Period 2||0||
48575860|NCT04511520|101741241|FG000|STARTED|Overall Study||24||
48575861|NCT04511520|101741242|FG001|STARTED|Overall Study||24||
48575862|NCT04511520|101741243|FG002|STARTED|Overall Study||24||
48575863|NCT04511520|101741241|FG000|COMPLETED|Overall Study||24||
48575864|NCT04511520|101741242|FG001|COMPLETED|Overall Study||24||
48575865|NCT04511520|101741243|FG002|COMPLETED|Overall Study||24||
48575866|NCT04511520|101741241|FG000|NOT COMPLETED|Overall Study||0||
48575867|NCT04511520|101741242|FG001|NOT COMPLETED|Overall Study||0||
48575868|NCT04511520|101741243|FG002|NOT COMPLETED|Overall Study||0||
48575869|NCT05393869|101741244|FG000|STARTED|Overall Study||407||
48575870|NCT05393869|101741245|FG001|STARTED|Overall Study||407||
48575871|NCT05393869|101741246|FG002|STARTED|Overall Study||407||
48285364|NCT00069108|101026118|FG000|NOT COMPLETED|Overall Study||213||
48285365|NCT00069108|101026119|FG001|NOT COMPLETED|Overall Study||219||
48285366|NCT02433340|101026120|FG000|STARTED|Overall Study||42||
48575872|NCT05393869|101741247|FG003|STARTED|Overall Study||407||
48131428|NCT02039505|100645874|FG000|STARTED|Open-Label (Week 10 up to Week 154)||0|33 out of 292 participants from induction/maintenance phase did not enter the open-label cohort.|
48131429|NCT02039505|100645875|FG001|STARTED|Open-Label (Week 10 up to Week 154)||0|33 out of 292 participants from induction/maintenance phase did not enter the open-label cohort.|
48131430|NCT02039505|100645876|FG002|STARTED|Open-Label (Week 10 up to Week 154)||0|33 out of 292 participants from induction/maintenance phase did not enter the open-label cohort.|
48131431|NCT02039505|100645877|FG003|STARTED|Open-Label (Week 10 up to Week 154)||0|33 out of 292 participants from induction/maintenance phase did not enter the open-label cohort.|
48131432|NCT02039505|100645878|FG004|STARTED|Open-Label (Week 10 up to Week 154)||0|33 out of 292 participants from induction/maintenance phase did not enter the open-label cohort.|
48285367|NCT02433340|101026121|FG001|STARTED|Overall Study||37||
48575873|NCT05393869|101741248|FG004|STARTED|Overall Study||407||
48575874|NCT05393869|101741249|FG005|STARTED|Overall Study||407||
48131433|NCT02039505|100645879|FG005|STARTED|Open-Label (Week 10 up to Week 154)||0|33 out of 292 participants from induction/maintenance phase did not enter the open-label cohort.|
48131434|NCT02039505|100645880|FG006|STARTED|Open-Label (Week 10 up to Week 154)||259|33 out of 292 participants from induction/maintenance phase did not enter the open-label cohort.|
48131435|NCT02039505|100645874|FG000|COMPLETED|Open-Label (Week 10 up to Week 154)||0||
48131436|NCT02039505|100645875|FG001|COMPLETED|Open-Label (Week 10 up to Week 154)||0||
48131437|NCT02039505|100645876|FG002|COMPLETED|Open-Label (Week 10 up to Week 154)||0||
48131438|NCT02039505|100645877|FG003|COMPLETED|Open-Label (Week 10 up to Week 154)||0||
48131439|NCT02039505|100645878|FG004|COMPLETED|Open-Label (Week 10 up to Week 154)||0||
48131440|NCT02039505|100645879|FG005|COMPLETED|Open-Label (Week 10 up to Week 154)||0||
48131441|NCT02039505|100645880|FG006|COMPLETED|Open-Label (Week 10 up to Week 154)||188||
48131442|NCT02039505|100645874|FG000|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0||
48131443|NCT02039505|100645875|FG001|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0||
48131444|NCT02039505|100645876|FG002|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0||
48131445|NCT02039505|100645877|FG003|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0||
48131446|NCT02039505|100645878|FG004|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0||
48131447|NCT02039505|100645879|FG005|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0||
48131448|NCT02039505|100645880|FG006|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||71||
48131449|NCT01243450|100645881|FG000|STARTED|Overall Study||401||
48131450|NCT01243450|100645882|FG001|STARTED|Overall Study||135||
48131451|NCT01243450|100645883|FG002|STARTED|Overall Study||404||
48131452|NCT01243450|100645881|FG000|COMPLETED|Overall Study||318||
48131453|NCT01243450|100645882|FG001|COMPLETED|Overall Study||110||
48131454|NCT01243450|100645883|FG002|COMPLETED|Overall Study||337||
48131455|NCT01243450|100645881|FG000|NOT COMPLETED|Overall Study||83||
48131456|NCT01243450|100645882|FG001|NOT COMPLETED|Overall Study||25||
48131457|NCT01243450|100645883|FG002|NOT COMPLETED|Overall Study||67||
48131458|NCT02255110|100645884|FG000|STARTED|Overall Study||6||
48131459|NCT02255110|100645884|FG000|COMPLETED|Overall Study||6||
48131460|NCT02255110|100645884|FG000|NOT COMPLETED|Overall Study||0||
48131461|NCT02548962|100645885|FG000|STARTED|Overall Study||8||
48131462|NCT02548962|100645886|FG001|STARTED|Overall Study||3||
48131463|NCT02548962|100645885|FG000|COMPLETED|Overall Study||7||
48131464|NCT02548962|100645886|FG001|COMPLETED|Overall Study||3||
48131465|NCT02548962|100645885|FG000|NOT COMPLETED|Overall Study||1||
48131466|NCT02548962|100645886|FG001|NOT COMPLETED|Overall Study||0||
48131467|NCT01143259|100645887|FG000|STARTED|Overall Study||136||
48131468|NCT01143259|100645888|FG001|STARTED|Overall Study||138||
48131469|NCT01143259|100645887|FG000|COMPLETED|Overall Study||113||
48131470|NCT01143259|100645888|FG001|COMPLETED|Overall Study||118||
48131471|NCT01143259|100645887|FG000|NOT COMPLETED|Overall Study||23||
48131472|NCT01143259|100645888|FG001|NOT COMPLETED|Overall Study||20||
48131473|NCT03936244|100645889|FG000|STARTED|Overall Study||57||
48131474|NCT03936244|100645890|FG001|STARTED|Overall Study||43||
48575875|NCT05393869|101741250|FG006|STARTED|Overall Study||407||
48575876|NCT05393869|101741244|FG000|COMPLETED|Overall Study||400||
48575877|NCT05393869|101741245|FG001|COMPLETED|Overall Study||405||
48285368|NCT02433340|101026122|FG002|STARTED|Overall Study||39||
48285369|NCT02433340|101026123|FG003|STARTED|Overall Study||40||
48285370|NCT02433340|101026120|FG000|COMPLETED|Overall Study||40||
48285371|NCT02433340|101026121|FG001|COMPLETED|Overall Study||35||
48285372|NCT02433340|101026122|FG002|COMPLETED|Overall Study||37||
48285373|NCT02433340|101026123|FG003|COMPLETED|Overall Study||38||
48285374|NCT02433340|101026120|FG000|NOT COMPLETED|Overall Study||2||
48285375|NCT02433340|101026121|FG001|NOT COMPLETED|Overall Study||2||
48575878|NCT05393869|101741246|FG002|COMPLETED|Overall Study||398||
48575879|NCT05393869|101741247|FG003|COMPLETED|Overall Study||404||
48575880|NCT05393869|101741248|FG004|COMPLETED|Overall Study||402||
48131475|NCT03936244|100645889|FG000|COMPLETED|Overall Study||45||
48131476|NCT03936244|100645890|FG001|COMPLETED|Overall Study||39||
48131477|NCT03936244|100645889|FG000|NOT COMPLETED|Overall Study||12||
48131478|NCT03936244|100645890|FG001|NOT COMPLETED|Overall Study||4||
48131479|NCT00734305|100645891|FG000|STARTED|Overall Study||7||
48131480|NCT00734305|100645892|FG001|STARTED|Overall Study||3||
48131481|NCT00734305|100645893|FG002|STARTED|Overall Study||4||
48131482|NCT00734305|100645894|FG003|STARTED|Overall Study||3||
48131483|NCT00734305|100645895|FG004|STARTED|Overall Study||5||
48131484|NCT00734305|100645896|FG005|STARTED|Overall Study||4||
48131485|NCT00734305|100645897|FG006|STARTED|Overall Study||18||
48131486|NCT00734305|100645891|FG000|COMPLETED|Overall Study||6||
48131487|NCT00734305|100645892|FG001|COMPLETED|Overall Study||3||
48131488|NCT00734305|100645893|FG002|COMPLETED|Overall Study||4||
48131489|NCT00734305|100645894|FG003|COMPLETED|Overall Study||3||
48131490|NCT00734305|100645895|FG004|COMPLETED|Overall Study||5||
48131491|NCT00734305|100645896|FG005|COMPLETED|Overall Study||4||
48131492|NCT00734305|100645897|FG006|COMPLETED|Overall Study||18||
48131493|NCT00734305|100645891|FG000|NOT COMPLETED|Overall Study||1||
48131494|NCT00734305|100645892|FG001|NOT COMPLETED|Overall Study||0||
48131495|NCT00734305|100645893|FG002|NOT COMPLETED|Overall Study||0||
48131496|NCT00734305|100645894|FG003|NOT COMPLETED|Overall Study||0||
48131497|NCT00734305|100645895|FG004|NOT COMPLETED|Overall Study||0||
48131498|NCT00734305|100645896|FG005|NOT COMPLETED|Overall Study||0||
48131499|NCT00734305|100645897|FG006|NOT COMPLETED|Overall Study||0||
48131500|NCT03314987|100645898|FG000|STARTED|Overall Study||153||
48131501|NCT03314987|100645899|FG001|STARTED|Overall Study||146||
48131502|NCT03314987|100645898|FG000|COMPLETED|Overall Study||140||
48131503|NCT03314987|100645899|FG001|COMPLETED|Overall Study||133||
48131504|NCT03314987|100645898|FG000|NOT COMPLETED|Overall Study||13||
48131505|NCT03314987|100645899|FG001|NOT COMPLETED|Overall Study||13||
48131506|NCT00968669|100645900|FG000|STARTED|Overall Study||82||
48131507|NCT00968669|100645901|FG001|STARTED|Overall Study||81||
48131508|NCT00968669|100645902|FG002|STARTED|Overall Study||83||
48131509|NCT00968669|100645903|FG003|STARTED|Overall Study||81||
48131510|NCT00968669|100645900|FG000|COMPLETED|Overall Study||64||
48131511|NCT00968669|100645901|FG001|COMPLETED|Overall Study||63||
48131512|NCT00968669|100645902|FG002|COMPLETED|Overall Study||72||
48131513|NCT00968669|100645903|FG003|COMPLETED|Overall Study||72||
48131514|NCT00968669|100645900|FG000|NOT COMPLETED|Overall Study||18||
48702137|NCT00519376|102057620|FG001|STARTED|Washout Period 1||2||
48702138|NCT00519376|102057621|FG002|STARTED|Washout Period 1||2||
48702139|NCT00519376|102057622|FG003|STARTED|Washout Period 1||2||
48702140|NCT00519376|102057623|FG004|STARTED|Washout Period 1||1||
48702141|NCT00519376|102057624|FG005|STARTED|Washout Period 1||1||
48131515|NCT00968669|100645901|FG001|NOT COMPLETED|Overall Study||18||
48131516|NCT00968669|100645902|FG002|NOT COMPLETED|Overall Study||11||
48131517|NCT00968669|100645903|FG003|NOT COMPLETED|Overall Study||9||
48131518|NCT01076400|100645904|FG000|STARTED|Overall Study||7||
48131519|NCT01076400|100645905|FG001|STARTED|Overall Study||0||
48131520|NCT01076400|100645906|FG002|STARTED|Overall Study||0||
48131521|NCT01076400|100645904|FG000|COMPLETED|Overall Study||0||
48131522|NCT01076400|100645905|FG001|COMPLETED|Overall Study||0||
48131523|NCT01076400|100645906|FG002|COMPLETED|Overall Study||0||
48131524|NCT01076400|100645904|FG000|NOT COMPLETED|Overall Study||7||
48131525|NCT01076400|100645905|FG001|NOT COMPLETED|Overall Study||0||
48131526|NCT01076400|100645906|FG002|NOT COMPLETED|Overall Study||0||
48131527|NCT00724971|100645907|FG000|STARTED|Overall Study||10||
48131528|NCT00724971|100645907|FG000|COMPLETED|Overall Study||4||
48131529|NCT00724971|100645907|FG000|NOT COMPLETED|Overall Study||6||
48131530|NCT02114892|100645908|FG000|STARTED|Overall Study||12||
48131531|NCT02114892|100645909|FG001|STARTED|Overall Study||12||
48131532|NCT02114892|100645908|FG000|COMPLETED|Overall Study||11||
48131533|NCT02114892|100645909|FG001|COMPLETED|Overall Study||10||
48702142|NCT00519376|102057625|FG006|STARTED|Washout Period 1||1||
48702143|NCT00519376|102057626|FG007|STARTED|Washout Period 1||1||
48702144|NCT00519376|102057627|FG008|STARTED|Washout Period 1||1||
48131534|NCT02114892|100645908|FG000|NOT COMPLETED|Overall Study||1||
48131535|NCT02114892|100645909|FG001|NOT COMPLETED|Overall Study||2||
48131536|NCT02073968|100645910|FG000|STARTED|Overall Study||35||
48131537|NCT02073968|100645910|FG000|COMPLETED|Overall Study||35||
48131538|NCT02073968|100645910|FG000|NOT COMPLETED|Overall Study||0||
48702145|NCT00519376|102057628|FG009|STARTED|Washout Period 1||1||
48702146|NCT00519376|102057629|FG010|STARTED|Washout Period 1||1||
48131539|NCT02013765|100645911|FG000|STARTED|Overall Study||5||
48131540|NCT02013765|100645911|FG000|COMPLETED|Overall Study||4||
48131541|NCT02013765|100645911|FG000|NOT COMPLETED|Overall Study||1||
48131542|NCT00059475|100645912|FG000|STARTED|Overall Study||33||
48131543|NCT00059475|100645913|FG001|STARTED|Overall Study||2||
48131544|NCT00059475|100645914|FG002|STARTED|Overall Study||24||
48131545|NCT00059475|100645915|FG003|STARTED|Overall Study||3||
48131546|NCT00059475|100645916|FG004|STARTED|Overall Study||33||
48131547|NCT00059475|100645917|FG005|STARTED|Overall Study||2||
48131548|NCT00059475|100645918|FG006|STARTED|Overall Study||34||
48131549|NCT00059475|100645919|FG007|STARTED|Overall Study||7||
48131550|NCT00059475|100645912|FG000|COMPLETED|Overall Study||33||
48131551|NCT00059475|100645913|FG001|COMPLETED|Overall Study||2||
48131552|NCT00059475|100645914|FG002|COMPLETED|Overall Study||24||
48131553|NCT00059475|100645915|FG003|COMPLETED|Overall Study||3||
48131554|NCT00059475|100645916|FG004|COMPLETED|Overall Study||33||
48131555|NCT00059475|100645917|FG005|COMPLETED|Overall Study||2||
48131556|NCT00059475|100645918|FG006|COMPLETED|Overall Study||34||
48131557|NCT00059475|100645919|FG007|COMPLETED|Overall Study||7||
48131558|NCT00059475|100645912|FG000|NOT COMPLETED|Overall Study||0||
48131559|NCT00059475|100645913|FG001|NOT COMPLETED|Overall Study||0||
48131560|NCT00059475|100645914|FG002|NOT COMPLETED|Overall Study||0||
48131561|NCT00059475|100645915|FG003|NOT COMPLETED|Overall Study||0||
48131562|NCT00059475|100645916|FG004|NOT COMPLETED|Overall Study||0||
48131563|NCT00059475|100645917|FG005|NOT COMPLETED|Overall Study||0||
48131564|NCT00059475|100645918|FG006|NOT COMPLETED|Overall Study||0||
48131565|NCT00059475|100645919|FG007|NOT COMPLETED|Overall Study||0||
48131566|NCT02343458|100645920|FG000|STARTED|Overall Study||555||
48131567|NCT02343458|100645921|FG001|STARTED|Overall Study||483||
48131568|NCT02343458|100645922|FG002|STARTED|Overall Study||480||
48131569|NCT02343458|100645923|FG003|STARTED|Overall Study||238||
48131570|NCT02343458|100645920|FG000|COMPLETED|Overall Study||494|1 subject has been captured in CSR who completed the study but had no follow up phone call.|
48131571|NCT02343458|100645921|FG001|COMPLETED|Overall Study||417|1 subject has been captured in CSR who completed the study but had no follow up phone call.|
48131572|NCT02343458|100645922|FG002|COMPLETED|Overall Study||417|1 subject has been captured in CSR who completed the study but had no follow up phone call.|
48131573|NCT02343458|100645923|FG003|COMPLETED|Overall Study||200|1 subject has been captured in CSR who completed the study but had no follow up phone call.|
48131574|NCT02343458|100645920|FG000|NOT COMPLETED|Overall Study||61||
48131575|NCT02343458|100645921|FG001|NOT COMPLETED|Overall Study||66||
48131576|NCT02343458|100645922|FG002|NOT COMPLETED|Overall Study||63||
48131577|NCT02343458|100645923|FG003|NOT COMPLETED|Overall Study||38||
48131578|NCT03701555|100645924|FG000|STARTED|Part 1 (Day 1)||3||
48131579|NCT03701555|100645925|FG001|STARTED|Part 1 (Day 1)||3||
48131580|NCT03701555|100645926|FG002|STARTED|Part 1 (Day 1)||3||
48131581|NCT03701555|100645927|FG003|STARTED|Part 1 (Day 1)||3||
48131582|NCT03701555|100645928|FG004|STARTED|Part 1 (Day 1)||3||
48131583|NCT03701555|100645929|FG005|STARTED|Part 1 (Day 1)||3||
48131584|NCT03701555|100645930|FG006|STARTED|Part 1 (Day 1)||3||
48131585|NCT03701555|100645931|FG007|STARTED|Part 1 (Day 1)||3||
48131586|NCT03701555|100645932|FG008|STARTED|Part 1 (Day 1)||3||
48285376|NCT02433340|101026122|FG002|NOT COMPLETED|Overall Study||2||
48285377|NCT02433340|101026123|FG003|NOT COMPLETED|Overall Study||2||
48285378|NCT03463161|101026124|FG000|STARTED|Overall Study||2||
48285379|NCT03463161|101026124|FG000|COMPLETED|Overall Study||2||
48285380|NCT03463161|101026124|FG000|NOT COMPLETED|Overall Study||0||
48285381|NCT04609306|101026125|FG000|STARTED|Overall Study||18||
48285382|NCT04609306|101026126|FG001|STARTED|Overall Study||18||
48285383|NCT04609306|101026125|FG000|COMPLETED|Overall Study||18||
48702147|NCT00519376|102057630|FG011|STARTED|Washout Period 1||1||
48702148|NCT00519376|102057631|FG012|STARTED|Washout Period 1||1||
48702149|NCT00519376|102057632|FG013|STARTED|Washout Period 1||1||
48702150|NCT00519376|102057633|FG014|STARTED|Washout Period 1||1||
48702151|NCT00519376|102057634|FG015|STARTED|Washout Period 1||1||
48702152|NCT00519376|102057619|FG000|COMPLETED|Washout Period 1||2||
48702153|NCT00519376|102057620|FG001|COMPLETED|Washout Period 1||2||
48702154|NCT00519376|102057621|FG002|COMPLETED|Washout Period 1||2||
48702155|NCT00519376|102057622|FG003|COMPLETED|Washout Period 1||2||
48702156|NCT00519376|102057623|FG004|COMPLETED|Washout Period 1||1||
48702157|NCT00519376|102057624|FG005|COMPLETED|Washout Period 1||1||
48702158|NCT00519376|102057625|FG006|COMPLETED|Washout Period 1||1||
48702159|NCT00519376|102057626|FG007|COMPLETED|Washout Period 1||1||
48702160|NCT00519376|102057627|FG008|COMPLETED|Washout Period 1||1||
48702161|NCT00519376|102057628|FG009|COMPLETED|Washout Period 1||1||
48702162|NCT00519376|102057629|FG010|COMPLETED|Washout Period 1||1||
48702163|NCT00519376|102057630|FG011|COMPLETED|Washout Period 1||1||
48702164|NCT00519376|102057631|FG012|COMPLETED|Washout Period 1||1||
48702165|NCT00519376|102057632|FG013|COMPLETED|Washout Period 1||1||
48702166|NCT00519376|102057633|FG014|COMPLETED|Washout Period 1||1||
48131587|NCT03701555|100645933|FG009|STARTED|Part 1 (Day 1)||1||
48131588|NCT03701555|100645934|FG010|STARTED|Part 1 (Day 1)||0||
48131589|NCT03701555|100645935|FG011|STARTED|Part 1 (Day 1)||0||
48131590|NCT03701555|100645936|FG012|STARTED|Part 1 (Day 1)||0||
48131591|NCT03701555|100645937|FG013|STARTED|Part 1 (Day 1)||0||
48285384|NCT04609306|101026126|FG001|COMPLETED|Overall Study||18||
48285385|NCT04609306|101026125|FG000|NOT COMPLETED|Overall Study||0||
48285386|NCT04609306|101026126|FG001|NOT COMPLETED|Overall Study||0||
48285387|NCT03261700|101026127|FG000|STARTED|Overall Study||30||
48285388|NCT03261700|101026128|FG001|STARTED|Overall Study||30||
48285389|NCT03261700|101026127|FG000|COMPLETED|Overall Study||29||
48131592|NCT03701555|100645938|FG014|STARTED|Part 1 (Day 1)||0||
48131593|NCT03701555|100645939|FG015|STARTED|Part 1 (Day 1)||0||
48702167|NCT00519376|102057634|FG015|COMPLETED|Washout Period 1||1||
48702168|NCT00519376|102057619|FG000|NOT COMPLETED|Washout Period 1||0||
48702169|NCT00519376|102057620|FG001|NOT COMPLETED|Washout Period 1||0||
48702170|NCT00519376|102057621|FG002|NOT COMPLETED|Washout Period 1||0||
48131594|NCT03701555|100645940|FG016|STARTED|Part 1 (Day 1)||0||
48285390|NCT03261700|101026128|FG001|COMPLETED|Overall Study||30||
48575881|NCT05393869|101741249|FG005|COMPLETED|Overall Study||403||
48575882|NCT05393869|101741250|FG006|COMPLETED|Overall Study||404||
48575883|NCT05393869|101741244|FG000|NOT COMPLETED|Overall Study||7||
48575884|NCT05393869|101741245|FG001|NOT COMPLETED|Overall Study||2||
48575885|NCT05393869|101741246|FG002|NOT COMPLETED|Overall Study||9||
48131595|NCT03701555|100645941|FG017|STARTED|Part 1 (Day 1)||0||
48131596|NCT03701555|100645942|FG018|STARTED|Part 1 (Day 1)||0||
48131597|NCT03701555|100645943|FG019|STARTED|Part 1 (Day 1)||0||
48131598|NCT03701555|100645944|FG020|STARTED|Part 1 (Day 1)||0||
48131599|NCT03701555|100645945|FG021|STARTED|Part 1 (Day 1)||0||
48131600|NCT03701555|100645946|FG022|STARTED|Part 1 (Day 1)||0||
48131601|NCT03701555|100645947|FG023|STARTED|Part 1 (Day 1)||0||
48131602|NCT03701555|100645948|FG024|STARTED|Part 1 (Day 1)||0||
48131603|NCT03701555|100645949|FG025|STARTED|Part 1 (Day 1)||0||
48131604|NCT03701555|100645950|FG026|STARTED|Part 1 (Day 1)||0||
48131605|NCT03701555|100645951|FG027|STARTED|Part 1 (Day 1)||0||
48131606|NCT03701555|100645952|FG028|STARTED|Part 1 (Day 1)||0||
48131607|NCT03701555|100645953|FG029|STARTED|Part 1 (Day 1)||0||
48131608|NCT03701555|100645954|FG030|STARTED|Part 1 (Day 1)||0||
48131609|NCT03701555|100645955|FG031|STARTED|Part 1 (Day 1)||0||
48131610|NCT03701555|100645956|FG032|STARTED|Part 1 (Day 1)||0||
48131611|NCT03701555|100645957|FG033|STARTED|Part 1 (Day 1)||0||
48131612|NCT03701555|100645958|FG034|STARTED|Part 1 (Day 1)||0||
48131613|NCT03701555|100645959|FG035|STARTED|Part 1 (Day 1)||0||
48131614|NCT03701555|100645924|FG000|COMPLETED|Part 1 (Day 1)||3||
48131615|NCT03701555|100645925|FG001|COMPLETED|Part 1 (Day 1)||3||
48131616|NCT03701555|100645926|FG002|COMPLETED|Part 1 (Day 1)||3||
48131617|NCT03701555|100645927|FG003|COMPLETED|Part 1 (Day 1)||3||
48131618|NCT03701555|100645928|FG004|COMPLETED|Part 1 (Day 1)||3||
48131619|NCT03701555|100645929|FG005|COMPLETED|Part 1 (Day 1)||3||
48131620|NCT03701555|100645930|FG006|COMPLETED|Part 1 (Day 1)||3||
48131621|NCT03701555|100645931|FG007|COMPLETED|Part 1 (Day 1)||3||
48131622|NCT03701555|100645932|FG008|COMPLETED|Part 1 (Day 1)||3||
48131623|NCT03701555|100645933|FG009|COMPLETED|Part 1 (Day 1)||1||
48131624|NCT03701555|100645934|FG010|COMPLETED|Part 1 (Day 1)||0||
48131625|NCT03701555|100645935|FG011|COMPLETED|Part 1 (Day 1)||0||
48131626|NCT03701555|100645936|FG012|COMPLETED|Part 1 (Day 1)||0||
48131627|NCT03701555|100645937|FG013|COMPLETED|Part 1 (Day 1)||0||
48131628|NCT03701555|100645938|FG014|COMPLETED|Part 1 (Day 1)||0||
48131629|NCT03701555|100645939|FG015|COMPLETED|Part 1 (Day 1)||0||
48131630|NCT03701555|100645940|FG016|COMPLETED|Part 1 (Day 1)||0||
48131631|NCT03701555|100645941|FG017|COMPLETED|Part 1 (Day 1)||0||
48131632|NCT03701555|100645942|FG018|COMPLETED|Part 1 (Day 1)||0||
48131633|NCT03701555|100645943|FG019|COMPLETED|Part 1 (Day 1)||0||
48131634|NCT03701555|100645944|FG020|COMPLETED|Part 1 (Day 1)||0||
48131635|NCT03701555|100645945|FG021|COMPLETED|Part 1 (Day 1)||0||
48131636|NCT03701555|100645946|FG022|COMPLETED|Part 1 (Day 1)||0||
48131637|NCT03701555|100645947|FG023|COMPLETED|Part 1 (Day 1)||0||
48131638|NCT03701555|100645948|FG024|COMPLETED|Part 1 (Day 1)||0||
48131639|NCT03701555|100645949|FG025|COMPLETED|Part 1 (Day 1)||0||
48131640|NCT03701555|100645950|FG026|COMPLETED|Part 1 (Day 1)||0||
48131641|NCT03701555|100645951|FG027|COMPLETED|Part 1 (Day 1)||0||
48131642|NCT03701555|100645952|FG028|COMPLETED|Part 1 (Day 1)||0||
48131643|NCT03701555|100645953|FG029|COMPLETED|Part 1 (Day 1)||0||
48131644|NCT03701555|100645954|FG030|COMPLETED|Part 1 (Day 1)||0||
48131645|NCT03701555|100645955|FG031|COMPLETED|Part 1 (Day 1)||0||
48131646|NCT03701555|100645956|FG032|COMPLETED|Part 1 (Day 1)||0||
48131647|NCT03701555|100645957|FG033|COMPLETED|Part 1 (Day 1)||0||
48131648|NCT03701555|100645958|FG034|COMPLETED|Part 1 (Day 1)||0||
48131649|NCT03701555|100645959|FG035|COMPLETED|Part 1 (Day 1)||0||
48575886|NCT05393869|101741247|FG003|NOT COMPLETED|Overall Study||3||
48575887|NCT05393869|101741248|FG004|NOT COMPLETED|Overall Study||5||
48575888|NCT05393869|101741249|FG005|NOT COMPLETED|Overall Study||4||
48575889|NCT05393869|101741250|FG006|NOT COMPLETED|Overall Study||3||
48575890|NCT01680861|101741251|FG000|STARTED|Early Post-transplant Period||16||
48575891|NCT01680861|101741252|FG001|STARTED|Early Post-transplant Period||16||
48575892|NCT01680861|101741251|FG000|COMPLETED|Early Post-transplant Period||15||
48575893|NCT01680861|101741252|FG001|COMPLETED|Early Post-transplant Period||15||
48131650|NCT03701555|100645924|FG000|NOT COMPLETED|Part 1 (Day 1)||0||
48131651|NCT03701555|100645925|FG001|NOT COMPLETED|Part 1 (Day 1)||0||
48131652|NCT03701555|100645926|FG002|NOT COMPLETED|Part 1 (Day 1)||0||
48131653|NCT03701555|100645927|FG003|NOT COMPLETED|Part 1 (Day 1)||0||
48131654|NCT03701555|100645928|FG004|NOT COMPLETED|Part 1 (Day 1)||0||
48131655|NCT03701555|100645929|FG005|NOT COMPLETED|Part 1 (Day 1)||0||
48131656|NCT03701555|100645930|FG006|NOT COMPLETED|Part 1 (Day 1)||0||
48131657|NCT03701555|100645931|FG007|NOT COMPLETED|Part 1 (Day 1)||0||
48702171|NCT00519376|102057622|FG003|NOT COMPLETED|Washout Period 1||0||
48131658|NCT03701555|100645932|FG008|NOT COMPLETED|Part 1 (Day 1)||0||
48131659|NCT03701555|100645933|FG009|NOT COMPLETED|Part 1 (Day 1)||0||
48131660|NCT03701555|100645934|FG010|NOT COMPLETED|Part 1 (Day 1)||0||
48131661|NCT03701555|100645935|FG011|NOT COMPLETED|Part 1 (Day 1)||0||
48131662|NCT03701555|100645936|FG012|NOT COMPLETED|Part 1 (Day 1)||0||
48131663|NCT03701555|100645937|FG013|NOT COMPLETED|Part 1 (Day 1)||0||
48131664|NCT03701555|100645938|FG014|NOT COMPLETED|Part 1 (Day 1)||0||
48575894|NCT01680861|101741251|FG000|NOT COMPLETED|Early Post-transplant Period||1||
48575895|NCT01680861|101741252|FG001|NOT COMPLETED|Early Post-transplant Period||1||
48575896|NCT01680861|101741251|FG000|STARTED|First 12 Months Post-transplant||15||
48575897|NCT01680861|101741252|FG001|STARTED|First 12 Months Post-transplant||15||
48575898|NCT01680861|101741251|FG000|COMPLETED|First 12 Months Post-transplant||15||
48575899|NCT01680861|101741252|FG001|COMPLETED|First 12 Months Post-transplant||15||
48575900|NCT01680861|101741251|FG000|NOT COMPLETED|First 12 Months Post-transplant||0||
48575901|NCT01680861|101741252|FG001|NOT COMPLETED|First 12 Months Post-transplant||0||
48575902|NCT01295671|101741253|FG000|STARTED|Overall Study||67||
48575903|NCT01295671|101741254|FG001|STARTED|Overall Study||67||
48575904|NCT01295671|101741255|FG002|STARTED|Overall Study||69||
48575905|NCT01295671|101741253|FG000|COMPLETED|Overall Study||60||
48575906|NCT01295671|101741254|FG001|COMPLETED|Overall Study||60||
48575907|NCT01295671|101741255|FG002|COMPLETED|Overall Study||66||
48575908|NCT01295671|101741253|FG000|NOT COMPLETED|Overall Study||7||
48575909|NCT01295671|101741254|FG001|NOT COMPLETED|Overall Study||7||
48575910|NCT01295671|101741255|FG002|NOT COMPLETED|Overall Study||3||
48575911|NCT00782795|101741256|FG000|STARTED|Overall Study||17||
48575912|NCT00782795|101741257|FG001|STARTED|Overall Study||8||
48575913|NCT00782795|101741256|FG000|6 Weeks (1st Apptment)|Overall Study||16||
48575914|NCT00782795|101741257|FG001|6 Weeks (1st Apptment)|Overall Study||7||
48575915|NCT00782795|101741256|FG000|24 Week Appointment|Overall Study||16||
48575916|NCT00782795|101741257|FG001|24 Week Appointment|Overall Study||7||
48575917|NCT00782795|101741256|FG000|COMPLETED|Overall Study||16||
48575918|NCT00782795|101741257|FG001|COMPLETED|Overall Study||6||
48575919|NCT00782795|101741256|FG000|NOT COMPLETED|Overall Study||1||
48575920|NCT00782795|101741257|FG001|NOT COMPLETED|Overall Study||2||
48575921|NCT01030783|101741258|FG000|STARTED|Overall Study||260||
48575922|NCT01030783|101741259|FG001|STARTED|Overall Study||257||
48575923|NCT01030783|101741258|FG000|COMPLETED|Overall Study||211||
48575924|NCT01030783|101741259|FG001|COMPLETED|Overall Study||231||
48575925|NCT01030783|101741258|FG000|NOT COMPLETED|Overall Study||49||
48575926|NCT01030783|101741259|FG001|NOT COMPLETED|Overall Study||26||
48575927|NCT04657198|101741260|FG000|STARTED|Overall Study||40||
48575928|NCT04657198|101741261|FG001|STARTED|Overall Study||39||
48575929|NCT04657198|101741262|FG002|STARTED|Overall Study||43||
48575930|NCT04657198|101741260|FG000|COMPLETED|Overall Study||39||
48575931|NCT04657198|101741261|FG001|COMPLETED|Overall Study||39||
48575932|NCT04657198|101741262|FG002|COMPLETED|Overall Study||43||
48575933|NCT04657198|101741260|FG000|NOT COMPLETED|Overall Study||1||
48575934|NCT04657198|101741261|FG001|NOT COMPLETED|Overall Study||0||
48575935|NCT04657198|101741262|FG002|NOT COMPLETED|Overall Study||0||
48575936|NCT03527589|101741263|FG000|STARTED|Overall Study||499||
48575937|NCT03527589|101741263|FG000|COMPLETED|Overall Study||487||
48575938|NCT03527589|101741263|FG000|NOT COMPLETED|Overall Study||12||
48575939|NCT02880475|101741264|FG000|STARTED|Overall Study||13||
48575940|NCT02880475|101741265|FG001|STARTED|Overall Study||17||
48575941|NCT02880475|101741264|FG000|COMPLETED|Overall Study||13||
48575942|NCT02880475|101741265|FG001|COMPLETED|Overall Study||17||
48575943|NCT02880475|101741264|FG000|NOT COMPLETED|Overall Study||0||
48575944|NCT02880475|101741265|FG001|NOT COMPLETED|Overall Study||0||
48575945|NCT04087720|101741266|FG000|STARTED|Overall Study||20||
48575946|NCT04087720|101741266|FG000|COMPLETED|Overall Study||15||
48575947|NCT04087720|101741266|FG000|NOT COMPLETED|Overall Study||5||
48575948|NCT01634048|101741267|FG000|STARTED|Overall Study||21||
48575949|NCT01634048|101741268|FG001|STARTED|Overall Study||18||
48575950|NCT01634048|101741267|FG000|COMPLETED|Overall Study||15||
48575951|NCT01634048|101741268|FG001|COMPLETED|Overall Study||15||
48575952|NCT01634048|101741267|FG000|NOT COMPLETED|Overall Study||6||
48575953|NCT01634048|101741268|FG001|NOT COMPLETED|Overall Study||3||
48575954|NCT02640677|101741269|FG000|STARTED|Overall Study||2||
48575955|NCT02640677|101741269|FG000|COMPLETED|Overall Study||0||
48575956|NCT02640677|101741269|FG000|NOT COMPLETED|Overall Study||2||
48575957|NCT02112045|101741270|FG000|STARTED|Overall Study||45||
48575958|NCT02112045|101741271|FG001|STARTED|Overall Study||45||
48575959|NCT02112045|101741270|FG000|COMPLETED|Overall Study||44||
48575960|NCT02112045|101741271|FG001|COMPLETED|Overall Study||45||
48702172|NCT00519376|102057623|FG004|NOT COMPLETED|Washout Period 1||0||
48702173|NCT00519376|102057624|FG005|NOT COMPLETED|Washout Period 1||0||
48575961|NCT02112045|101741270|FG000|NOT COMPLETED|Overall Study||1||
48575962|NCT02112045|101741271|FG001|NOT COMPLETED|Overall Study||0||
48575963|NCT01582854|101741272|FG000|STARTED|Overall Study||248||
48575964|NCT01582854|101741273|FG001|STARTED|Overall Study||255||
48575965|NCT01582854|101741272|FG000|COMPLETED|Overall Study||212||
48575966|NCT01582854|101741273|FG001|COMPLETED|Overall Study||221||
48575967|NCT01582854|101741272|FG000|NOT COMPLETED|Overall Study||36||
48575968|NCT01582854|101741273|FG001|NOT COMPLETED|Overall Study||34||
48575969|NCT02999269|101741274|FG000|STARTED|Overall Study||20||
48575970|NCT02999269|101741275|FG001|STARTED|Overall Study||20||
48575971|NCT02999269|101741276|FG002|STARTED|Overall Study||20||
48575972|NCT02999269|101741274|FG000|COMPLETED|Overall Study||16||
48575973|NCT02999269|101741275|FG001|COMPLETED|Overall Study||15||
48575974|NCT02999269|101741276|FG002|COMPLETED|Overall Study||16||
48575975|NCT02999269|101741274|FG000|NOT COMPLETED|Overall Study||4||
48131665|NCT03701555|100645939|FG015|NOT COMPLETED|Part 1 (Day 1)||0||
48131666|NCT03701555|100645940|FG016|NOT COMPLETED|Part 1 (Day 1)||0||
48131667|NCT03701555|100645941|FG017|NOT COMPLETED|Part 1 (Day 1)||0||
48131668|NCT03701555|100645942|FG018|NOT COMPLETED|Part 1 (Day 1)||0||
48131669|NCT03701555|100645943|FG019|NOT COMPLETED|Part 1 (Day 1)||0||
48131670|NCT03701555|100645944|FG020|NOT COMPLETED|Part 1 (Day 1)||0||
48131671|NCT03701555|100645945|FG021|NOT COMPLETED|Part 1 (Day 1)||0||
48131672|NCT03701555|100645946|FG022|NOT COMPLETED|Part 1 (Day 1)||0||
48131673|NCT03701555|100645947|FG023|NOT COMPLETED|Part 1 (Day 1)||0||
48131674|NCT03701555|100645948|FG024|NOT COMPLETED|Part 1 (Day 1)||0||
48131675|NCT03701555|100645949|FG025|NOT COMPLETED|Part 1 (Day 1)||0||
48131676|NCT03701555|100645950|FG026|NOT COMPLETED|Part 1 (Day 1)||0||
48131677|NCT03701555|100645951|FG027|NOT COMPLETED|Part 1 (Day 1)||0||
48131678|NCT03701555|100645952|FG028|NOT COMPLETED|Part 1 (Day 1)||0||
48131679|NCT03701555|100645953|FG029|NOT COMPLETED|Part 1 (Day 1)||0||
48131680|NCT03701555|100645954|FG030|NOT COMPLETED|Part 1 (Day 1)||0||
48131681|NCT03701555|100645955|FG031|NOT COMPLETED|Part 1 (Day 1)||0||
48131682|NCT03701555|100645956|FG032|NOT COMPLETED|Part 1 (Day 1)||0||
48131683|NCT03701555|100645957|FG033|NOT COMPLETED|Part 1 (Day 1)||0||
48131684|NCT03701555|100645958|FG034|NOT COMPLETED|Part 1 (Day 1)||0||
48131685|NCT03701555|100645959|FG035|NOT COMPLETED|Part 1 (Day 1)||0||
48131686|NCT03701555|100645924|FG000|STARTED|Part 2 (Day 1)||0||
48131687|NCT03701555|100645925|FG001|STARTED|Part 2 (Day 1)||0||
48131688|NCT03701555|100645926|FG002|STARTED|Part 2 (Day 1)||0||
48131689|NCT03701555|100645927|FG003|STARTED|Part 2 (Day 1)||0||
48131690|NCT03701555|100645928|FG004|STARTED|Part 2 (Day 1)||0||
48131691|NCT03701555|100645929|FG005|STARTED|Part 2 (Day 1)||0||
48131692|NCT03701555|100645930|FG006|STARTED|Part 2 (Day 1)||0||
48131693|NCT03701555|100645931|FG007|STARTED|Part 2 (Day 1)||0||
48131694|NCT03701555|100645932|FG008|STARTED|Part 2 (Day 1)||0||
48131695|NCT03701555|100645933|FG009|STARTED|Part 2 (Day 1)||0||
48131696|NCT03701555|100645934|FG010|STARTED|Part 2 (Day 1)||5||
48131697|NCT03701555|100645935|FG011|STARTED|Part 2 (Day 1)||3||
48131698|NCT03701555|100645936|FG012|STARTED|Part 2 (Day 1)||2||
48131699|NCT03701555|100645937|FG013|STARTED|Part 2 (Day 1)||3||
48131700|NCT03701555|100645938|FG014|STARTED|Part 2 (Day 1)||2||
48702174|NCT00519376|102057625|FG006|NOT COMPLETED|Washout Period 1||0||
48702175|NCT00519376|102057626|FG007|NOT COMPLETED|Washout Period 1||0||
48702176|NCT00519376|102057627|FG008|NOT COMPLETED|Washout Period 1||0||
48702177|NCT00519376|102057628|FG009|NOT COMPLETED|Washout Period 1||0||
48702178|NCT00519376|102057629|FG010|NOT COMPLETED|Washout Period 1||0||
48702179|NCT00519376|102057630|FG011|NOT COMPLETED|Washout Period 1||0||
48702180|NCT00519376|102057631|FG012|NOT COMPLETED|Washout Period 1||0||
48702181|NCT00519376|102057632|FG013|NOT COMPLETED|Washout Period 1||0||
48702182|NCT00519376|102057633|FG014|NOT COMPLETED|Washout Period 1||0||
48702183|NCT00519376|102057634|FG015|NOT COMPLETED|Washout Period 1||0||
48702184|NCT00519376|102057619|FG000|STARTED|Treatment Period 2||2||
48131701|NCT03701555|100645939|FG015|STARTED|Part 2 (Day 1)||4||
48131702|NCT03701555|100645940|FG016|STARTED|Part 2 (Day 1)||7||
48131703|NCT03701555|100645941|FG017|STARTED|Part 2 (Day 1)||7||
48131704|NCT03701555|100645942|FG018|STARTED|Part 2 (Day 1)||4||
48131705|NCT03701555|100645943|FG019|STARTED|Part 2 (Day 1)||4||
48131706|NCT03701555|100645944|FG020|STARTED|Part 2 (Day 1)||4||
48131707|NCT03701555|100645945|FG021|STARTED|Part 2 (Day 1)||4||
48131708|NCT03701555|100645946|FG022|STARTED|Part 2 (Day 1)||4||
48131709|NCT03701555|100645947|FG023|STARTED|Part 2 (Day 1)||4||
48131710|NCT03701555|100645948|FG024|STARTED|Part 2 (Day 1)||0||
48131711|NCT03701555|100645949|FG025|STARTED|Part 2 (Day 1)||0||
48131712|NCT03701555|100645950|FG026|STARTED|Part 2 (Day 1)||0||
48131713|NCT03701555|100645951|FG027|STARTED|Part 2 (Day 1)||0||
48131714|NCT03701555|100645952|FG028|STARTED|Part 2 (Day 1)||0||
48131715|NCT03701555|100645953|FG029|STARTED|Part 2 (Day 1)||0||
48131716|NCT03701555|100645954|FG030|STARTED|Part 2 (Day 1)||0||
48131717|NCT03701555|100645955|FG031|STARTED|Part 2 (Day 1)||0||
48131718|NCT03701555|100645956|FG032|STARTED|Part 2 (Day 1)||0||
48131719|NCT03701555|100645957|FG033|STARTED|Part 2 (Day 1)||0||
48131720|NCT03701555|100645958|FG034|STARTED|Part 2 (Day 1)||0||
48131721|NCT03701555|100645959|FG035|STARTED|Part 2 (Day 1)||0||
48131722|NCT03701555|100645924|FG000|COMPLETED|Part 2 (Day 1)||0||
48131723|NCT03701555|100645925|FG001|COMPLETED|Part 2 (Day 1)||0||
48131724|NCT03701555|100645926|FG002|COMPLETED|Part 2 (Day 1)||0||
48131725|NCT03701555|100645927|FG003|COMPLETED|Part 2 (Day 1)||0||
48131726|NCT03701555|100645928|FG004|COMPLETED|Part 2 (Day 1)||0||
48131727|NCT03701555|100645929|FG005|COMPLETED|Part 2 (Day 1)||0||
48131728|NCT03701555|100645930|FG006|COMPLETED|Part 2 (Day 1)||0||
48131729|NCT03701555|100645931|FG007|COMPLETED|Part 2 (Day 1)||0||
48131730|NCT03701555|100645932|FG008|COMPLETED|Part 2 (Day 1)||0||
48131731|NCT03701555|100645933|FG009|COMPLETED|Part 2 (Day 1)||0||
48131732|NCT03701555|100645934|FG010|COMPLETED|Part 2 (Day 1)||2||
48131733|NCT03701555|100645935|FG011|COMPLETED|Part 2 (Day 1)||2||
48131734|NCT03701555|100645936|FG012|COMPLETED|Part 2 (Day 1)||2||
48131735|NCT03701555|100645937|FG013|COMPLETED|Part 2 (Day 1)||1||
48131736|NCT03701555|100645938|FG014|COMPLETED|Part 2 (Day 1)||2||
48131737|NCT03701555|100645939|FG015|COMPLETED|Part 2 (Day 1)||2||
48702185|NCT00519376|102057620|FG001|STARTED|Treatment Period 2||2||
48131738|NCT03701555|100645940|FG016|COMPLETED|Part 2 (Day 1)||4||
48399610|NCT03380026|101309165|FG000|Half of Body Assigned to Treatment With Valchlor and Triamcinolone Acetonide|Overall Study||28|Side of body from each patient assigned to treatment with both Valchlor and Triamcinolone, assigned randomly at enrollment.|
48399611|NCT03380026|101309165|FG000|COMPLETED|Overall Study||25||
48399612|NCT03380026|101309165|FG000|NOT COMPLETED|Overall Study||3||
48131739|NCT03701555|100645941|FG017|COMPLETED|Part 2 (Day 1)||5||
48131740|NCT03701555|100645942|FG018|COMPLETED|Part 2 (Day 1)||4||
48131741|NCT03701555|100645943|FG019|COMPLETED|Part 2 (Day 1)||4||
48131742|NCT03701555|100645944|FG020|COMPLETED|Part 2 (Day 1)||4||
48131743|NCT03701555|100645945|FG021|COMPLETED|Part 2 (Day 1)||3||
48131744|NCT03701555|100645946|FG022|COMPLETED|Part 2 (Day 1)||4||
48131745|NCT03701555|100645947|FG023|COMPLETED|Part 2 (Day 1)||3||
48131746|NCT03701555|100645948|FG024|COMPLETED|Part 2 (Day 1)||0||
48131747|NCT03701555|100645949|FG025|COMPLETED|Part 2 (Day 1)||0||
48131748|NCT03701555|100645950|FG026|COMPLETED|Part 2 (Day 1)||0||
48131749|NCT03701555|100645951|FG027|COMPLETED|Part 2 (Day 1)||0||
48131750|NCT03701555|100645952|FG028|COMPLETED|Part 2 (Day 1)||0||
48131751|NCT03701555|100645953|FG029|COMPLETED|Part 2 (Day 1)||0||
48131752|NCT03701555|100645954|FG030|COMPLETED|Part 2 (Day 1)||0||
48131753|NCT03701555|100645955|FG031|COMPLETED|Part 2 (Day 1)||0||
48131754|NCT03701555|100645956|FG032|COMPLETED|Part 2 (Day 1)||0||
48131755|NCT03701555|100645957|FG033|COMPLETED|Part 2 (Day 1)||0||
48131756|NCT03701555|100645958|FG034|COMPLETED|Part 2 (Day 1)||0||
48131757|NCT03701555|100645959|FG035|COMPLETED|Part 2 (Day 1)||0||
48131758|NCT03701555|100645924|FG000|NOT COMPLETED|Part 2 (Day 1)||0||
48131759|NCT03701555|100645925|FG001|NOT COMPLETED|Part 2 (Day 1)||0||
48131760|NCT03701555|100645926|FG002|NOT COMPLETED|Part 2 (Day 1)||0||
48131761|NCT03701555|100645927|FG003|NOT COMPLETED|Part 2 (Day 1)||0||
48131762|NCT03701555|100645928|FG004|NOT COMPLETED|Part 2 (Day 1)||0||
48131763|NCT03701555|100645929|FG005|NOT COMPLETED|Part 2 (Day 1)||0||
48131764|NCT03701555|100645930|FG006|NOT COMPLETED|Part 2 (Day 1)||0||
48131765|NCT03701555|100645931|FG007|NOT COMPLETED|Part 2 (Day 1)||0||
48131766|NCT03701555|100645932|FG008|NOT COMPLETED|Part 2 (Day 1)||0||
48131767|NCT03701555|100645933|FG009|NOT COMPLETED|Part 2 (Day 1)||0||
48131768|NCT03701555|100645934|FG010|NOT COMPLETED|Part 2 (Day 1)||3||
48131769|NCT03701555|100645935|FG011|NOT COMPLETED|Part 2 (Day 1)||1||
48131770|NCT03701555|100645936|FG012|NOT COMPLETED|Part 2 (Day 1)||0||
48131771|NCT03701555|100645937|FG013|NOT COMPLETED|Part 2 (Day 1)||2||
48131772|NCT03701555|100645938|FG014|NOT COMPLETED|Part 2 (Day 1)||0||
48131773|NCT03701555|100645939|FG015|NOT COMPLETED|Part 2 (Day 1)||2||
48131774|NCT03701555|100645940|FG016|NOT COMPLETED|Part 2 (Day 1)||3||
48131775|NCT03701555|100645941|FG017|NOT COMPLETED|Part 2 (Day 1)||2||
48131776|NCT03701555|100645942|FG018|NOT COMPLETED|Part 2 (Day 1)||0||
48131777|NCT03701555|100645943|FG019|NOT COMPLETED|Part 2 (Day 1)||0||
48131778|NCT03701555|100645944|FG020|NOT COMPLETED|Part 2 (Day 1)||0||
48131779|NCT03701555|100645945|FG021|NOT COMPLETED|Part 2 (Day 1)||1||
48131780|NCT03701555|100645946|FG022|NOT COMPLETED|Part 2 (Day 1)||0||
48131781|NCT03701555|100645947|FG023|NOT COMPLETED|Part 2 (Day 1)||1||
48131782|NCT03701555|100645948|FG024|NOT COMPLETED|Part 2 (Day 1)||0||
48131783|NCT03701555|100645949|FG025|NOT COMPLETED|Part 2 (Day 1)||0||
48131784|NCT03701555|100645950|FG026|NOT COMPLETED|Part 2 (Day 1)||0||
48131785|NCT03701555|100645951|FG027|NOT COMPLETED|Part 2 (Day 1)||0||
48131786|NCT03701555|100645952|FG028|NOT COMPLETED|Part 2 (Day 1)||0||
48131787|NCT03701555|100645953|FG029|NOT COMPLETED|Part 2 (Day 1)||0||
48131788|NCT03701555|100645954|FG030|NOT COMPLETED|Part 2 (Day 1)||0||
48131789|NCT03701555|100645955|FG031|NOT COMPLETED|Part 2 (Day 1)||0||
48131790|NCT03701555|100645956|FG032|NOT COMPLETED|Part 2 (Day 1)||0||
48131791|NCT03701555|100645957|FG033|NOT COMPLETED|Part 2 (Day 1)||0||
48131792|NCT03701555|100645958|FG034|NOT COMPLETED|Part 2 (Day 1)||0||
48131793|NCT03701555|100645959|FG035|NOT COMPLETED|Part 2 (Day 1)||0||
48131794|NCT03701555|100645924|FG000|STARTED|Part 3 (Day 1)||0||
48131795|NCT03701555|100645925|FG001|STARTED|Part 3 (Day 1)||0||
48131796|NCT03701555|100645926|FG002|STARTED|Part 3 (Day 1)||0||
48131797|NCT03701555|100645927|FG003|STARTED|Part 3 (Day 1)||0||
48131798|NCT03701555|100645928|FG004|STARTED|Part 3 (Day 1)||0||
48131799|NCT03701555|100645929|FG005|STARTED|Part 3 (Day 1)||0||
48131800|NCT03701555|100645930|FG006|STARTED|Part 3 (Day 1)||0||
48131801|NCT03701555|100645931|FG007|STARTED|Part 3 (Day 1)||0||
48131802|NCT03701555|100645932|FG008|STARTED|Part 3 (Day 1)||0||
48131803|NCT03701555|100645933|FG009|STARTED|Part 3 (Day 1)||0||
48131804|NCT03701555|100645934|FG010|STARTED|Part 3 (Day 1)||0||
48131805|NCT03701555|100645935|FG011|STARTED|Part 3 (Day 1)||0||
48131806|NCT03701555|100645936|FG012|STARTED|Part 3 (Day 1)||0||
48131807|NCT03701555|100645937|FG013|STARTED|Part 3 (Day 1)||0||
48131808|NCT03701555|100645938|FG014|STARTED|Part 3 (Day 1)||0||
48131809|NCT03701555|100645939|FG015|STARTED|Part 3 (Day 1)||0||
48131810|NCT03701555|100645940|FG016|STARTED|Part 3 (Day 1)||0||
48131811|NCT03701555|100645941|FG017|STARTED|Part 3 (Day 1)||0||
48131812|NCT03701555|100645942|FG018|STARTED|Part 3 (Day 1)||0||
48131813|NCT03701555|100645943|FG019|STARTED|Part 3 (Day 1)||0||
48131814|NCT03701555|100645944|FG020|STARTED|Part 3 (Day 1)||0||
48131815|NCT03701555|100645945|FG021|STARTED|Part 3 (Day 1)||0||
48131816|NCT03701555|100645946|FG022|STARTED|Part 3 (Day 1)||0||
48131817|NCT03701555|100645947|FG023|STARTED|Part 3 (Day 1)||0||
48131818|NCT03701555|100645948|FG024|STARTED|Part 3 (Day 1)||3||
48131819|NCT03701555|100645949|FG025|STARTED|Part 3 (Day 1)||5||
48131820|NCT03701555|100645950|FG026|STARTED|Part 3 (Day 1)||2||
48131821|NCT03701555|100645951|FG027|STARTED|Part 3 (Day 1)||5||
48131822|NCT03701555|100645952|FG028|STARTED|Part 3 (Day 1)||3||
48131823|NCT03701555|100645953|FG029|STARTED|Part 3 (Day 1)||4||
48131824|NCT03701555|100645954|FG030|STARTED|Part 3 (Day 1)||4||
48131825|NCT03701555|100645955|FG031|STARTED|Part 3 (Day 1)||6||
48131826|NCT03701555|100645956|FG032|STARTED|Part 3 (Day 1)||7||
48131827|NCT03701555|100645957|FG033|STARTED|Part 3 (Day 1)||9||
48131828|NCT03701555|100645958|FG034|STARTED|Part 3 (Day 1)||0||
48131829|NCT03701555|100645959|FG035|STARTED|Part 3 (Day 1)||0||
48131830|NCT03701555|100645924|FG000|COMPLETED|Part 3 (Day 1)||0||
48131831|NCT03701555|100645925|FG001|COMPLETED|Part 3 (Day 1)||0||
48131832|NCT03701555|100645926|FG002|COMPLETED|Part 3 (Day 1)||0||
48131833|NCT03701555|100645927|FG003|COMPLETED|Part 3 (Day 1)||0||
48131834|NCT03701555|100645928|FG004|COMPLETED|Part 3 (Day 1)||0||
48702186|NCT00519376|102057621|FG002|STARTED|Treatment Period 2||2||
48702187|NCT00519376|102057622|FG003|STARTED|Treatment Period 2||2||
48131835|NCT03701555|100645929|FG005|COMPLETED|Part 3 (Day 1)||0||
48131836|NCT03701555|100645930|FG006|COMPLETED|Part 3 (Day 1)||0||
48131837|NCT03701555|100645931|FG007|COMPLETED|Part 3 (Day 1)||0||
48285391|NCT03261700|101026127|FG000|NOT COMPLETED|Overall Study||1||
48285392|NCT03261700|101026128|FG001|NOT COMPLETED|Overall Study||0||
48285393|NCT00600886|101026129|FG000|STARTED|Core Phase - Full Analysis Set (FAS)||176||
48285394|NCT00600886|101026130|FG001|STARTED|Core Phase - Full Analysis Set (FAS)||182||
48285395|NCT00600886|101026129|FG000|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29||
48285396|NCT00600886|101026130|FG001|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29||
48285397|NCT00600886|101026129|FG000|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||38||
48285398|NCT00600886|101026130|FG001|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||81||
48285399|NCT00600886|101026129|FG000|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||74||
48285400|NCT00600886|101026130|FG001|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||46||
48285401|NCT00600886|101026129|FG000|COMPLETED|Core Phase - Full Analysis Set (FAS)||141||
48285402|NCT00600886|101026130|FG001|COMPLETED|Core Phase - Full Analysis Set (FAS)||156||
48285403|NCT00600886|101026129|FG000|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||35||
48285404|NCT00600886|101026130|FG001|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||26||
48285405|NCT00600886|101026129|FG000|STARTED|Extension - Same Treatment (FAS)||74||
48399613|NCT04547998|101309166|FG000|STARTED|Overall Study||25||25
48399614|NCT04547998|101309167|FG001|STARTED|Overall Study||25||25
48399615|NCT04547998|101309166|FG000|COMPLETED|Overall Study||25||25
48399616|NCT04547998|101309167|FG001|COMPLETED|Overall Study||25||25
48399617|NCT04547998|101309166|FG000|NOT COMPLETED|Overall Study||0||0
48399618|NCT04547998|101309167|FG001|NOT COMPLETED|Overall Study||0||0
48399619|NCT00524043|101309168|FG000|STARTED|Overall Study||64||
48399620|NCT00524043|101309169|FG001|STARTED|Overall Study||70||
48399621|NCT00524043|101309170|FG002|STARTED|Overall Study||66||
48399622|NCT00524043|101309168|FG000|COMPLETED|Overall Study||34||
48399623|NCT00524043|101309169|FG001|COMPLETED|Overall Study||42||
48285406|NCT00600886|101026130|FG001|STARTED|Extension - Same Treatment (FAS)||46||
48285407|NCT00600886|101026129|FG000|Completed Study at Month 26|Extension - Same Treatment (FAS)||0||
48285408|NCT00600886|101026130|FG001|Completed Study at Month 26|Extension - Same Treatment (FAS)||31||
48285409|NCT00600886|101026129|FG000|Completed Study After Month 26|Extension - Same Treatment (FAS)||28||
48285410|NCT00600886|101026130|FG001|Completed Study After Month 26|Extension - Same Treatment (FAS)||4||
48399624|NCT00524043|101309170|FG002|COMPLETED|Overall Study||35||
48399625|NCT00524043|101309168|FG000|NOT COMPLETED|Overall Study||30||
48399626|NCT00524043|101309169|FG001|NOT COMPLETED|Overall Study||28||
48399627|NCT00524043|101309170|FG002|NOT COMPLETED|Overall Study||31||
48399628|NCT04209400|101309171|FG000|STARTED|Overall Study||50||
48399629|NCT04209400|101309172|FG001|STARTED|Overall Study||50||
48399630|NCT04209400|101309171|FG000|COMPLETED|Overall Study||50||
48399631|NCT04209400|101309172|FG001|COMPLETED|Overall Study||49||
48399632|NCT04209400|101309171|FG000|NOT COMPLETED|Overall Study||0||
48399633|NCT04209400|101309172|FG001|NOT COMPLETED|Overall Study||1||
48399634|NCT01329341|101309173|FG000|STARTED|Overall Study||60||
48399635|NCT01329341|101309173|FG000|COMPLETED|Overall Study||16||
48399636|NCT01329341|101309173|FG000|NOT COMPLETED|Overall Study||44||
48399637|NCT03125018|101309174|FG000|STARTED|Overall Study||13||
48399638|NCT03125018|101309174|FG000|COMPLETED|Overall Study||13||
48399639|NCT03125018|101309174|FG000|NOT COMPLETED|Overall Study||0||
48399640|NCT03241589|101309175|FG000|STARTED|Overall Study||109||
48399641|NCT03241589|101309176|FG001|STARTED|Overall Study||357||
48399642|NCT03241589|101309175|FG000|COMPLETED|Overall Study||109||
48399643|NCT03241589|101309176|FG001|COMPLETED|Overall Study||357||
48399644|NCT03241589|101309175|FG000|NOT COMPLETED|Overall Study||0||
48399645|NCT03241589|101309176|FG001|NOT COMPLETED|Overall Study||0||
48131838|NCT03701555|100645932|FG008|COMPLETED|Part 3 (Day 1)||0||
48131839|NCT03701555|100645933|FG009|COMPLETED|Part 3 (Day 1)||0||
48131840|NCT03701555|100645934|FG010|COMPLETED|Part 3 (Day 1)||0||
48131841|NCT03701555|100645935|FG011|COMPLETED|Part 3 (Day 1)||0||
48131842|NCT03701555|100645936|FG012|COMPLETED|Part 3 (Day 1)||0||
48702188|NCT00519376|102057623|FG004|STARTED|Treatment Period 2||1||
48285411|NCT00600886|101026129|FG000|Discontinued After Month 26|Extension - Same Treatment (FAS)||23||
48285412|NCT00600886|101026130|FG001|Discontinued After Month 26|Extension - Same Treatment (FAS)||1||
48285413|NCT00600886|101026129|FG000|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||23||
48285414|NCT00600886|101026130|FG001|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||10||
48285415|NCT00600886|101026129|FG000|COMPLETED|Extension - Same Treatment (FAS)||28||
48399646|NCT05263921|101309177|FG000|STARTED|Overall Study||3||
48285416|NCT00600886|101026130|FG001|COMPLETED|Extension - Same Treatment (FAS)||35||
48285417|NCT00600886|101026129|FG000|NOT COMPLETED|Extension - Same Treatment (FAS)||46||
48285418|NCT00600886|101026130|FG001|NOT COMPLETED|Extension - Same Treatment (FAS)||11||
48285419|NCT00600886|101026129|FG000|STARTED|Extension - After Crossover (CAS)||81||
48399647|NCT05263921|101309178|FG001|STARTED|Overall Study||3||
48399648|NCT05263921|101309179|FG002|STARTED|Overall Study||3||
48399649|NCT05263921|101309180|FG003|STARTED|Overall Study||3||
48399650|NCT05263921|101309177|FG000|COMPLETED|Overall Study||3||
48399651|NCT05263921|101309178|FG001|COMPLETED|Overall Study||3||
48399652|NCT05263921|101309179|FG002|COMPLETED|Overall Study||2||
48399653|NCT05263921|101309180|FG003|COMPLETED|Overall Study||3||
48399654|NCT05263921|101309177|FG000|NOT COMPLETED|Overall Study||0||
48399655|NCT05263921|101309178|FG001|NOT COMPLETED|Overall Study||0||
48399656|NCT05263921|101309179|FG002|NOT COMPLETED|Overall Study||1||
48399657|NCT05263921|101309180|FG003|NOT COMPLETED|Overall Study||0||
48399658|NCT00136838|101309181|FG000|STARTED|First Intervention ( 5 Days)||6||
48399659|NCT00136838|101309182|FG001|STARTED|First Intervention ( 5 Days)||6||
48399660|NCT00136838|101309181|FG000|COMPLETED|First Intervention ( 5 Days)||6||
48399661|NCT00136838|101309182|FG001|COMPLETED|First Intervention ( 5 Days)||6||
48575976|NCT02999269|101741275|FG001|NOT COMPLETED|Overall Study||5||
48575977|NCT02999269|101741276|FG002|NOT COMPLETED|Overall Study||4||
48575978|NCT04109391|101741277|FG000|STARTED|Overall Study||175||
48575979|NCT04109391|101741278|FG001|STARTED|Overall Study||82||
48575980|NCT04109391|101741279|FG002|STARTED|Overall Study||81||
48575981|NCT04109391|101741277|FG000|COMPLETED|Overall Study||165||
48575982|NCT04109391|101741278|FG001|COMPLETED|Overall Study||77||
48575983|NCT04109391|101741279|FG002|COMPLETED|Overall Study||77||
48575984|NCT04109391|101741277|FG000|NOT COMPLETED|Overall Study||10||
48575985|NCT04109391|101741278|FG001|NOT COMPLETED|Overall Study||5||
48575986|NCT04109391|101741279|FG002|NOT COMPLETED|Overall Study||4||
48575987|NCT01186692|101741280|FG000|STARTED|Overall Study||131||
48575988|NCT01186692|101741280|FG000|COMPLETED|Overall Study||99||
48575989|NCT01186692|101741280|FG000|NOT COMPLETED|Overall Study||32||
48575990|NCT05020665|101741281|FG000|STARTED|Overall Study||8||
48575991|NCT05020665|101741282|FG001|STARTED|Overall Study||7||
48575992|NCT05020665|101741281|FG000|COMPLETED|Overall Study||0||
48575993|NCT05020665|101741282|FG001|COMPLETED|Overall Study||0||
48575994|NCT05020665|101741281|FG000|NOT COMPLETED|Overall Study||8||
48575995|NCT05020665|101741282|FG001|NOT COMPLETED|Overall Study||7||
48575996|NCT00725361|101741283|FG000|STARTED|Overall Study||20||
48575997|NCT00725361|101741283|FG000|COMPLETED|Overall Study||16||
48575998|NCT00725361|101741283|FG000|NOT COMPLETED|Overall Study||4||
48575999|NCT01568034|101741284|FG000|STARTED|Overall Study||2||
48576000|NCT01568034|101741285|FG001|STARTED|Overall Study||2||
48576001|NCT01568034|101741286|FG002|STARTED|Overall Study||3||
48576002|NCT01568034|101741287|FG003|STARTED|Overall Study||3||
48576003|NCT01568034|101741284|FG000|25 mg BIA 9-1067|Overall Study||2||
48576004|NCT01568034|101741285|FG001|25 mg BIA 9-1067|Overall Study||2||
48576005|NCT01568034|101741286|FG002|25 mg BIA 9-1067|Overall Study||3||
48576006|NCT01568034|101741287|FG003|25 mg BIA 9-1067|Overall Study||3||
48576007|NCT01568034|101741284|FG000|50 mg BIA 9-1067|Overall Study||2||
48576008|NCT01568034|101741285|FG001|50 mg BIA 9-1067|Overall Study||2||
48576009|NCT01568034|101741286|FG002|50 mg BIA 9-1067|Overall Study||3||
48576010|NCT01568034|101741287|FG003|50 mg BIA 9-1067|Overall Study||3||
48576011|NCT01568034|101741284|FG000|100 mg BIA 9-1067|Overall Study||2||
48576012|NCT01568034|101741285|FG001|100 mg BIA 9-1067|Overall Study||2||
48576013|NCT01568034|101741286|FG002|100 mg BIA 9-1067|Overall Study||3||
48576014|NCT01568034|101741287|FG003|100 mg BIA 9-1067|Overall Study||3||
48576015|NCT01568034|101741284|FG000|Placebo|Overall Study||1||
48576016|NCT01568034|101741285|FG001|Placebo|Overall Study||2||
48576017|NCT01568034|101741286|FG002|Placebo|Overall Study||3||
48576018|NCT01568034|101741287|FG003|Placebo|Overall Study||3||
48576019|NCT01568034|101741284|FG000|COMPLETED|Overall Study||1||
48576020|NCT01568034|101741285|FG001|COMPLETED|Overall Study||2||
48576021|NCT01568034|101741286|FG002|COMPLETED|Overall Study||3||
48576022|NCT01568034|101741287|FG003|COMPLETED|Overall Study||3||
48576023|NCT01568034|101741284|FG000|NOT COMPLETED|Overall Study||1||
48576024|NCT01568034|101741285|FG001|NOT COMPLETED|Overall Study||0||
48576025|NCT01568034|101741286|FG002|NOT COMPLETED|Overall Study||0||
48576026|NCT01568034|101741287|FG003|NOT COMPLETED|Overall Study||0||
48576027|NCT02418156|101741288|FG000|STARTED|Overall Study||38||
48576028|NCT02418156|101741288|FG000|COMPLETED|Overall Study||21||
48576029|NCT02418156|101741288|FG000|NOT COMPLETED|Overall Study||17||
48285420|NCT00600886|101026130|FG001|STARTED|Extension - After Crossover (CAS)||38||
48285421|NCT00600886|101026129|FG000|Completed Study at Month 26|Extension - After Crossover (CAS)||0||
48285422|NCT00600886|101026130|FG001|Completed Study at Month 26|Extension - After Crossover (CAS)||25||
48285423|NCT00600886|101026129|FG000|Completed After Month 26|Extension - After Crossover (CAS)||19||
48285424|NCT00600886|101026130|FG001|Completed After Month 26|Extension - After Crossover (CAS)||0||
48285425|NCT00600886|101026129|FG000|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||31||
48285426|NCT00600886|101026130|FG001|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||13||
48285427|NCT00600886|101026129|FG000|Discontinued After M26|Extension - After Crossover (CAS)||31||
48285428|NCT00600886|101026130|FG001|Discontinued After M26|Extension - After Crossover (CAS)||0||
48285429|NCT00600886|101026129|FG000|COMPLETED|Extension - After Crossover (CAS)||19||
48285430|NCT00600886|101026130|FG001|COMPLETED|Extension - After Crossover (CAS)||25||
48285431|NCT00600886|101026129|FG000|NOT COMPLETED|Extension - After Crossover (CAS)||62||
48285432|NCT00600886|101026130|FG001|NOT COMPLETED|Extension - After Crossover (CAS)||13||
48285433|NCT01886378|101026131|FG000|STARTED|Overall Study||29||
48285434|NCT01886378|101026131|FG000|Completed 24 Weeks of UX007 Treatment|Overall Study||25||
48285435|NCT01886378|101026131|FG000|COMPLETED|Overall Study||24||
48285436|NCT01886378|101026131|FG000|NOT COMPLETED|Overall Study||5||
48285437|NCT00712673|101026132|FG000|STARTED|Overall Study||85||
48285438|NCT00712673|101026133|FG001|STARTED|Overall Study||85||
48285439|NCT00712673|101026134|FG002|STARTED|Overall Study||255||
48285440|NCT00712673|101026135|FG003|STARTED|Overall Study||255||
48285441|NCT00712673|101026132|FG000|Safety Population|Overall Study||85||
48285442|NCT00712673|101026133|FG001|Safety Population|Overall Study||85||
48285443|NCT00712673|101026134|FG002|Safety Population|Overall Study||255||
48285444|NCT00712673|101026135|FG003|Safety Population|Overall Study||255||
48285445|NCT00712673|101026132|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study||85||
48576030|NCT00957593|101741289|FG000|STARTED|Overall Study||127||
48576031|NCT00957593|101741290|FG001|STARTED|Overall Study||125||
48576032|NCT00957593|101741289|FG000|COMPLETED|Overall Study||127||
48576033|NCT00957593|101741290|FG001|COMPLETED|Overall Study||125||
48576034|NCT00957593|101741289|FG000|NOT COMPLETED|Overall Study||0||
48131843|NCT03701555|100645937|FG013|COMPLETED|Part 3 (Day 1)||0||
48131844|NCT03701555|100645938|FG014|COMPLETED|Part 3 (Day 1)||0||
48131845|NCT03701555|100645939|FG015|COMPLETED|Part 3 (Day 1)||0||
48131846|NCT03701555|100645940|FG016|COMPLETED|Part 3 (Day 1)||0||
48131847|NCT03701555|100645941|FG017|COMPLETED|Part 3 (Day 1)||0||
48131848|NCT03701555|100645942|FG018|COMPLETED|Part 3 (Day 1)||0||
48131849|NCT03701555|100645943|FG019|COMPLETED|Part 3 (Day 1)||0||
48131850|NCT03701555|100645944|FG020|COMPLETED|Part 3 (Day 1)||0||
48131851|NCT03701555|100645945|FG021|COMPLETED|Part 3 (Day 1)||0||
48131852|NCT03701555|100645946|FG022|COMPLETED|Part 3 (Day 1)||0||
48131853|NCT03701555|100645947|FG023|COMPLETED|Part 3 (Day 1)||0||
48131854|NCT03701555|100645948|FG024|COMPLETED|Part 3 (Day 1)||2||
48576035|NCT00957593|101741290|FG001|NOT COMPLETED|Overall Study||0||
48576036|NCT01942486|101741291|FG000|STARTED|Overall Study||35||
48576037|NCT01942486|101741291|FG000|COMPLETED|Overall Study||8||
48576038|NCT01942486|101741291|FG000|NOT COMPLETED|Overall Study||27||
48576039|NCT04606394|101741292|FG000|STARTED|Overall Study||45||
48131855|NCT03701555|100645949|FG025|COMPLETED|Part 3 (Day 1)||4||
48285446|NCT00712673|101026133|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||85||
48285447|NCT00712673|101026134|FG002|Modified Intent-to-Treat(mITT)Population|Overall Study||255||
48285448|NCT00712673|101026135|FG003|Modified Intent-to-Treat(mITT)Population|Overall Study||255||
48576040|NCT04606394|101741292|FG000|COMPLETED|Overall Study||30||
48576041|NCT04606394|101741292|FG000|NOT COMPLETED|Overall Study||15||
48702189|NCT00519376|102057624|FG005|STARTED|Treatment Period 2||1||
48131856|NCT03701555|100645950|FG026|COMPLETED|Part 3 (Day 1)||1||
48131857|NCT03701555|100645951|FG027|COMPLETED|Part 3 (Day 1)||5||
48131858|NCT03701555|100645952|FG028|COMPLETED|Part 3 (Day 1)||3||
48131859|NCT03701555|100645953|FG029|COMPLETED|Part 3 (Day 1)||2||
48131860|NCT03701555|100645954|FG030|COMPLETED|Part 3 (Day 1)||3||
48131861|NCT03701555|100645955|FG031|COMPLETED|Part 3 (Day 1)||3||
48131862|NCT03701555|100645956|FG032|COMPLETED|Part 3 (Day 1)||5||
48131863|NCT03701555|100645957|FG033|COMPLETED|Part 3 (Day 1)||7||
48131864|NCT03701555|100645958|FG034|COMPLETED|Part 3 (Day 1)||0||
48131865|NCT03701555|100645959|FG035|COMPLETED|Part 3 (Day 1)||0||
48131866|NCT03701555|100645924|FG000|NOT COMPLETED|Part 3 (Day 1)||0||
48131867|NCT03701555|100645925|FG001|NOT COMPLETED|Part 3 (Day 1)||0||
48131868|NCT03701555|100645926|FG002|NOT COMPLETED|Part 3 (Day 1)||0||
48576042|NCT02317276|101741293|FG000|STARTED|Overall Study||11||
48576043|NCT02317276|101741293|FG000|COMPLETED|Overall Study||5||
48576044|NCT02317276|101741293|FG000|NOT COMPLETED|Overall Study||6||
48576045|NCT01677312|101741294|FG000|STARTED|Overall Study||36||
48576046|NCT01677312|101741295|FG001|STARTED|Overall Study||36||
48576047|NCT01677312|101741294|FG000|COMPLETED|Overall Study||36||
48131869|NCT03701555|100645927|FG003|NOT COMPLETED|Part 3 (Day 1)||0||
48576048|NCT01677312|101741295|FG001|COMPLETED|Overall Study||36||
48576049|NCT01677312|101741294|FG000|NOT COMPLETED|Overall Study||0||
48576050|NCT01677312|101741295|FG001|NOT COMPLETED|Overall Study||0||
48576051|NCT02120833|101741296|FG000|STARTED|Overall Study||39||
48576052|NCT02120833|101741297|FG001|STARTED|Overall Study||12||
48576053|NCT02120833|101741296|FG000|COMPLETED|Overall Study||35||
48576054|NCT02120833|101741297|FG001|COMPLETED|Overall Study||11||
48576055|NCT02120833|101741296|FG000|NOT COMPLETED|Overall Study||4||
48576056|NCT02120833|101741297|FG001|NOT COMPLETED|Overall Study||1||
48576057|NCT03070002|101741298|FG000|STARTED|3 Cycles of Treatment||1||
48576058|NCT03070002|101741298|FG000|COMPLETED|3 Cycles of Treatment||1||
48576059|NCT03070002|101741298|FG000|NOT COMPLETED|3 Cycles of Treatment||0||
48576060|NCT03070002|101741298|FG000|STARTED|Follow up for 2 Years||1|Everyone that receives treatment on study goes into the follow up phase|
48576061|NCT03070002|101741298|FG000|COMPLETED|Follow up for 2 Years||0||
48576062|NCT03070002|101741298|FG000|NOT COMPLETED|Follow up for 2 Years||1||
48576063|NCT03139578|101741299|FG000|STARTED|Period 1||12||
48576064|NCT03139578|101741300|FG001|STARTED|Period 1||13||
48576065|NCT03139578|101741301|FG002|STARTED|Period 1||12||
48576066|NCT03139578|101741302|FG003|STARTED|Period 1||13||
48576067|NCT03139578|101741299|FG000|Discontinued|Period 1||0||
48576068|NCT03139578|101741300|FG001|Discontinued|Period 1||0||
48576069|NCT03139578|101741301|FG002|Discontinued|Period 1||0||
48576070|NCT03139578|101741302|FG003|Discontinued|Period 1||0||
48576071|NCT03139578|101741299|FG000|COMPLETED|Period 1||12||
48576072|NCT03139578|101741300|FG001|COMPLETED|Period 1||13||
48576073|NCT03139578|101741301|FG002|COMPLETED|Period 1||12||
48576074|NCT03139578|101741302|FG003|COMPLETED|Period 1||13||
48576075|NCT03139578|101741299|FG000|NOT COMPLETED|Period 1||0||
48576076|NCT03139578|101741300|FG001|NOT COMPLETED|Period 1||0||
48576077|NCT03139578|101741301|FG002|NOT COMPLETED|Period 1||0||
48576078|NCT03139578|101741302|FG003|NOT COMPLETED|Period 1||0||
48576079|NCT03139578|101741299|FG000|STARTED|Period 2||12||
48576080|NCT03139578|101741300|FG001|STARTED|Period 2||13||
48576081|NCT03139578|101741301|FG002|STARTED|Period 2||12||
48576082|NCT03139578|101741302|FG003|STARTED|Period 2||13||
48576083|NCT03139578|101741299|FG000|Discontinued|Period 2||0||
48576084|NCT03139578|101741300|FG001|Discontinued|Period 2||0||
48576085|NCT03139578|101741301|FG002|Discontinued|Period 2||0||
48576086|NCT03139578|101741302|FG003|Discontinued|Period 2||0||
48576087|NCT03139578|101741299|FG000|COMPLETED|Period 2||12||
48576088|NCT03139578|101741300|FG001|COMPLETED|Period 2||13||
48131870|NCT03701555|100645928|FG004|NOT COMPLETED|Part 3 (Day 1)||0||
48131871|NCT03701555|100645929|FG005|NOT COMPLETED|Part 3 (Day 1)||0||
48131872|NCT03701555|100645930|FG006|NOT COMPLETED|Part 3 (Day 1)||0||
48131873|NCT03701555|100645931|FG007|NOT COMPLETED|Part 3 (Day 1)||0||
48576089|NCT03139578|101741301|FG002|COMPLETED|Period 2||12||
48576090|NCT03139578|101741302|FG003|COMPLETED|Period 2||13||
48576091|NCT03139578|101741299|FG000|NOT COMPLETED|Period 2||0||
48576092|NCT03139578|101741300|FG001|NOT COMPLETED|Period 2||0||
48576093|NCT03139578|101741301|FG002|NOT COMPLETED|Period 2||0||
48576094|NCT03139578|101741302|FG003|NOT COMPLETED|Period 2||0||
48576095|NCT01681212|101741303|FG000|STARTED|Overall Study||21||
48576096|NCT01681212|101741303|FG000|Received Treatment|Overall Study||15||
48576097|NCT01681212|101741303|FG000|COMPLETED|Overall Study||15||
48576098|NCT01681212|101741303|FG000|NOT COMPLETED|Overall Study||6||
48576099|NCT01106911|101741304|FG000|STARTED|Overall Study||1085||
48576100|NCT01106911|101741304|FG000|COMPLETED|Overall Study||1080||
48576101|NCT01106911|101741304|FG000|NOT COMPLETED|Overall Study||5||
48576102|NCT00821964|101741305|FG000|STARTED|Overall Study||15||
48576103|NCT00821964|101741305|FG000|Evaluable for Clinical Response|Overall Study||14||
48576104|NCT00821964|101741305|FG000|Evaluable for Pathologic Response|Overall Study||7||
48576105|NCT00821964|101741305|FG000|COMPLETED|Overall Study||9||
48576106|NCT00821964|101741305|FG000|NOT COMPLETED|Overall Study||6||
48576107|NCT03979807|101741306|FG000|STARTED|Overall Study||3876||
48576108|NCT03979807|101741307|FG001|STARTED|Overall Study||7420||
48576109|NCT03979807|101741306|FG000|COMPLETED|Overall Study||3876||
48576110|NCT03979807|101741307|FG001|COMPLETED|Overall Study||7420||
48702190|NCT00519376|102057625|FG006|STARTED|Treatment Period 2||1||
48702191|NCT00519376|102057626|FG007|STARTED|Treatment Period 2||1||
48576111|NCT03979807|101741306|FG000|NOT COMPLETED|Overall Study||0||
48576112|NCT03979807|101741307|FG001|NOT COMPLETED|Overall Study||0||
48576113|NCT01998932|101741308|FG000|STARTED|Overall Study||28||
48285449|NCT00712673|101026132|FG000|Subgroup for Standardized Meal Test|Overall Study||85||
48285450|NCT00712673|101026133|FG001|Subgroup for Standardized Meal Test|Overall Study||0||
48702192|NCT00519376|102057627|FG008|STARTED|Treatment Period 2||1||
48702193|NCT00519376|102057628|FG009|STARTED|Treatment Period 2||1||
48702194|NCT00519376|102057629|FG010|STARTED|Treatment Period 2||1||
48576114|NCT01998932|101741308|FG000|COMPLETED|Overall Study||28||
48576115|NCT01998932|101741308|FG000|NOT COMPLETED|Overall Study||0||
48576116|NCT02531971|101741309|FG000|STARTED|Overall Study||11||
48702195|NCT00519376|102057630|FG011|STARTED|Treatment Period 2||1||
48702196|NCT00519376|102057631|FG012|STARTED|Treatment Period 2||1||
48702197|NCT00519376|102057632|FG013|STARTED|Treatment Period 2||1||
48576117|NCT02531971|101741310|FG001|STARTED|Overall Study||13||
48285451|NCT00712673|101026134|FG002|Subgroup for Standardized Meal Test|Overall Study||255||
48576118|NCT02531971|101741309|FG000|COMPLETED|Overall Study||11||
48576119|NCT02531971|101741310|FG001|COMPLETED|Overall Study||13||
48576120|NCT02531971|101741309|FG000|NOT COMPLETED|Overall Study||0||
48702198|NCT00519376|102057633|FG014|STARTED|Treatment Period 2||1||
48702199|NCT00519376|102057634|FG015|STARTED|Treatment Period 2||1||
48576121|NCT02531971|101741310|FG001|NOT COMPLETED|Overall Study||0||
48576122|NCT02527434|101741311|FG000|STARTED|Overall Study||32|Full Analysis Set (FAS)|
48576123|NCT02527434|101741312|FG001|STARTED|Overall Study||12|Full Analysis Set (FAS)|
48576124|NCT02527434|101741313|FG002|STARTED|Overall Study||20|Full Analysis Set (FAS)|
48576125|NCT02527434|101741311|FG000|Started Retreatment Phase (COMBO)|Overall Study||7|COMBO Analysis Set|
48576126|NCT02527434|101741312|FG001|Started Retreatment Phase (COMBO)|Overall Study||5|COMBO Analysis Set|
48576127|NCT02527434|101741313|FG002|Started Retreatment Phase (COMBO)|Overall Study||4|COMBO Analysis Set|
48576128|NCT02527434|101741311|FG000|Started Retreatment Phase (MEDI)|Overall Study||4|MEDI Analysis Set|
48576129|NCT02527434|101741312|FG001|Started Retreatment Phase (MEDI)|Overall Study||0|MEDI Analysis Set|
48576130|NCT02527434|101741313|FG002|Started Retreatment Phase (MEDI)|Overall Study||1|MEDI Analysis Set|
48576131|NCT02527434|101741311|FG000|COMPLETED|Overall Study||4||
48576132|NCT02527434|101741312|FG001|COMPLETED|Overall Study||1||
48576133|NCT02527434|101741313|FG002|COMPLETED|Overall Study||0||
48576134|NCT02527434|101741311|FG000|NOT COMPLETED|Overall Study||28||
48576135|NCT02527434|101741312|FG001|NOT COMPLETED|Overall Study||11||
48576136|NCT02527434|101741313|FG002|NOT COMPLETED|Overall Study||20||
48576137|NCT01750697|101741314|FG000|STARTED|Overall Study||25|Remission Induction Phase (Day 1 to Month 6)|
48576138|NCT01750697|101741314|FG000|Completed|Overall Study||25|Remission Induction Phase (Day 1 to Month 6)|
48576139|NCT01750697|101741314|FG000|Follow-up Phase|Overall Study||24|(Month 6 to Month 18)|
48576140|NCT01750697|101741314|FG000|COMPLETED|Overall Study||16|Completed until CCO (Month 18 up to 4.5 years)|
48576141|NCT01750697|101741314|FG000|NOT COMPLETED|Overall Study||9||
48576142|NCT00497289|101741315|FG000|STARTED|Overall Study||24||
48576143|NCT00497289|101741316|FG001|STARTED|Overall Study||24||
48576144|NCT00497289|101741315|FG000|COMPLETED|Overall Study||19||
48576145|NCT00497289|101741316|FG001|COMPLETED|Overall Study||18||
48576146|NCT00497289|101741315|FG000|NOT COMPLETED|Overall Study||5||
48576147|NCT00497289|101741316|FG001|NOT COMPLETED|Overall Study||6||
48576148|NCT02118727|101741317|FG000|STARTED|Overall Study||58||
48576149|NCT02118727|101741318|FG001|STARTED|Overall Study||31||
48576150|NCT02118727|101741317|FG000|COMPLETED|Overall Study||33||
48576151|NCT02118727|101741318|FG001|COMPLETED|Overall Study||20||
48576152|NCT02118727|101741317|FG000|NOT COMPLETED|Overall Study||25||
48576153|NCT02118727|101741318|FG001|NOT COMPLETED|Overall Study||11||
48576154|NCT01972438|101741319|FG000|STARTED|Baseline-Month 3 Crossover Period||9||
48576155|NCT01972438|101741320|FG001|STARTED|Baseline-Month 3 Crossover Period||9||
48576156|NCT01972438|101741319|FG000|COMPLETED|Baseline-Month 3 Crossover Period||6||
48576157|NCT01972438|101741320|FG001|COMPLETED|Baseline-Month 3 Crossover Period||6||
48576158|NCT01972438|101741319|FG000|NOT COMPLETED|Baseline-Month 3 Crossover Period||3||
48576159|NCT01972438|101741320|FG001|NOT COMPLETED|Baseline-Month 3 Crossover Period||3||
48576160|NCT01972438|101741319|FG000|STARTED|Months 3-6 Crossover Period||6||
48576161|NCT01972438|101741320|FG001|STARTED|Months 3-6 Crossover Period||7||
48576162|NCT01972438|101741319|FG000|COMPLETED|Months 3-6 Crossover Period||6||
48576163|NCT01972438|101741320|FG001|COMPLETED|Months 3-6 Crossover Period||6||
48576164|NCT01972438|101741319|FG000|NOT COMPLETED|Months 3-6 Crossover Period||0||
48576165|NCT01972438|101741320|FG001|NOT COMPLETED|Months 3-6 Crossover Period||1||
48576166|NCT01972438|101741319|FG000|STARTED|Months 6-12 Study Period||6||
48576167|NCT01972438|101741320|FG001|STARTED|Months 6-12 Study Period||6||
48576168|NCT01972438|101741319|FG000|COMPLETED|Months 6-12 Study Period||3||
48576169|NCT01972438|101741320|FG001|COMPLETED|Months 6-12 Study Period||4||
48576170|NCT01972438|101741319|FG000|NOT COMPLETED|Months 6-12 Study Period||3||
48576171|NCT01972438|101741320|FG001|NOT COMPLETED|Months 6-12 Study Period||2||
48576172|NCT01972438|101741319|FG000|STARTED|Post Month 12 Study Period||3||
48576173|NCT01972438|101741320|FG001|STARTED|Post Month 12 Study Period||4||
48285452|NCT00712673|101026135|FG003|Subgroup for Standardized Meal Test|Overall Study||0||
48285453|NCT00712673|101026132|FG000|COMPLETED|Overall Study||64||
48285454|NCT00712673|101026133|FG001|COMPLETED|Overall Study||64||
48285455|NCT00712673|101026134|FG002|COMPLETED|Overall Study||198||
48576174|NCT01972438|101741319|FG000|COMPLETED|Post Month 12 Study Period||0||
48576175|NCT01972438|101741320|FG001|COMPLETED|Post Month 12 Study Period||0||
48576176|NCT01972438|101741319|FG000|NOT COMPLETED|Post Month 12 Study Period||3||
48576177|NCT01972438|101741320|FG001|NOT COMPLETED|Post Month 12 Study Period||4||
48576178|NCT01682226|101741321|FG000|STARTED|Overall Study||84||
48576179|NCT01682226|101741321|FG000|COMPLETED|Overall Study||78||
48576180|NCT01682226|101741321|FG000|NOT COMPLETED|Overall Study||6||
48285456|NCT00712673|101026135|FG003|COMPLETED|Overall Study||185||
48285457|NCT00712673|101026132|FG000|NOT COMPLETED|Overall Study||21||
48285458|NCT00712673|101026133|FG001|NOT COMPLETED|Overall Study||21||
48285459|NCT00712673|101026134|FG002|NOT COMPLETED|Overall Study||57||
48576181|NCT02841280|101741322|FG000|STARTED|Overall Study||81||
48576182|NCT02841280|101741323|FG001|STARTED|Overall Study||79||
48576183|NCT02841280|101741322|FG000|COMPLETED|Overall Study||67||
48576184|NCT02841280|101741323|FG001|COMPLETED|Overall Study||73||
48576185|NCT02841280|101741322|FG000|NOT COMPLETED|Overall Study||14||
48576186|NCT02841280|101741323|FG001|NOT COMPLETED|Overall Study||6||
48285460|NCT00712673|101026135|FG003|NOT COMPLETED|Overall Study||70||
48285461|NCT00309959|101026136|FG000|STARTED|Overall Study||37||
48285462|NCT00309959|101026136|FG000|COMPLETED|Overall Study||35|Eligible and treated patients|
48285463|NCT00309959|101026136|FG000|NOT COMPLETED|Overall Study||2||
48285464|NCT04493502|101026137|FG000|STARTED|Double Blind Treatment (Week 0 - 16)||24||
48285465|NCT04493502|101026138|FG001|STARTED|Double Blind Treatment (Week 0 - 16)||48||
48285466|NCT04493502|101026137|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment (Week 0 - 16)||22||
48285467|NCT04493502|101026138|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment (Week 0 - 16)||45||
48285468|NCT04493502|101026137|FG000|COMPLETED|Double Blind Treatment (Week 0 - 16)||14||
48285469|NCT04493502|101026138|FG001|COMPLETED|Double Blind Treatment (Week 0 - 16)||38||
48285470|NCT04493502|101026137|FG000|NOT COMPLETED|Double Blind Treatment (Week 0 - 16)||10||
48285471|NCT04493502|101026138|FG001|NOT COMPLETED|Double Blind Treatment (Week 0 - 16)||10||
48285472|NCT04493502|101026137|FG000|STARTED|Open-label Extension (Week 16 - 36)||14||
48285473|NCT04493502|101026138|FG001|STARTED|Open-label Extension (Week 16 - 36)||38||
48285474|NCT04493502|101026137|FG000|Received at Least One Dose of Study Drug|Open-label Extension (Week 16 - 36)||13||
48285475|NCT04493502|101026138|FG001|Received at Least One Dose of Study Drug|Open-label Extension (Week 16 - 36)||36||
48285476|NCT04493502|101026137|FG000|COMPLETED|Open-label Extension (Week 16 - 36)||10||
48285477|NCT04493502|101026138|FG001|COMPLETED|Open-label Extension (Week 16 - 36)||29||
48285478|NCT04493502|101026137|FG000|NOT COMPLETED|Open-label Extension (Week 16 - 36)||4||
48285479|NCT04493502|101026138|FG001|NOT COMPLETED|Open-label Extension (Week 16 - 36)||9||
48285480|NCT04493502|101026137|FG000|STARTED|Post-treatment Follow-up (10 Weeks)||10||
48285481|NCT04493502|101026138|FG001|STARTED|Post-treatment Follow-up (10 Weeks)||29||
48285482|NCT04493502|101026137|FG000|COMPLETED|Post-treatment Follow-up (10 Weeks)||8||
48285483|NCT04493502|101026138|FG001|COMPLETED|Post-treatment Follow-up (10 Weeks)||24||
48285484|NCT04493502|101026137|FG000|NOT COMPLETED|Post-treatment Follow-up (10 Weeks)||2||
48285485|NCT04493502|101026138|FG001|NOT COMPLETED|Post-treatment Follow-up (10 Weeks)||5||
48285486|NCT01008319|101026139|FG000|STARTED|Overall Study||60||
48285487|NCT01008319|101026140|FG001|STARTED|Overall Study||60||
48285488|NCT01008319|101026139|FG000|COMPLETED|Overall Study||60||
48285489|NCT01008319|101026140|FG001|COMPLETED|Overall Study||60||
48285490|NCT01008319|101026139|FG000|NOT COMPLETED|Overall Study||0||
48285491|NCT01008319|101026140|FG001|NOT COMPLETED|Overall Study||0||
48285492|NCT02876159|101026141|FG000|STARTED|Overall Study||10||
48285493|NCT02876159|101026142|FG001|STARTED|Overall Study||10||
48285494|NCT02876159|101026141|FG000|COMPLETED|Overall Study||10||
48285495|NCT02876159|101026142|FG001|COMPLETED|Overall Study||10||
48702200|NCT00519376|102057619|FG000|COMPLETED|Treatment Period 2||2||
48702201|NCT00519376|102057620|FG001|COMPLETED|Treatment Period 2||2||
48702202|NCT00519376|102057621|FG002|COMPLETED|Treatment Period 2||2||
48702203|NCT00519376|102057622|FG003|COMPLETED|Treatment Period 2||2||
48702204|NCT00519376|102057623|FG004|COMPLETED|Treatment Period 2||1||
48702205|NCT00519376|102057624|FG005|COMPLETED|Treatment Period 2||1||
48702206|NCT00519376|102057625|FG006|COMPLETED|Treatment Period 2||1||
48702207|NCT00519376|102057626|FG007|COMPLETED|Treatment Period 2||1||
48702208|NCT00519376|102057627|FG008|COMPLETED|Treatment Period 2||1||
48399662|NCT00136838|101309181|FG000|NOT COMPLETED|First Intervention ( 5 Days)||0||
48399663|NCT00136838|101309182|FG001|NOT COMPLETED|First Intervention ( 5 Days)||0||
48399664|NCT00136838|101309181|FG000|STARTED|Second Intervention ( 5 Days)||6||
48399665|NCT00136838|101309182|FG001|STARTED|Second Intervention ( 5 Days)||6||
48399666|NCT00136838|101309181|FG000|COMPLETED|Second Intervention ( 5 Days)||6||
48399667|NCT00136838|101309182|FG001|COMPLETED|Second Intervention ( 5 Days)||6||
48399668|NCT00136838|101309181|FG000|NOT COMPLETED|Second Intervention ( 5 Days)||0||
48399669|NCT00136838|101309182|FG001|NOT COMPLETED|Second Intervention ( 5 Days)||0||
48399670|NCT00254163|101309183|FG000|STARTED|Overall Study||92||
48576187|NCT06098339|101741324|FG000|STARTED|Period 1: First Intervention 28-32 Days||25||
48576188|NCT06098339|101741325|FG001|STARTED|Period 1: First Intervention 28-32 Days||28||
48576189|NCT06098339|101741324|FG000|COMPLETED|Period 1: First Intervention 28-32 Days||24||
48576190|NCT06098339|101741325|FG001|COMPLETED|Period 1: First Intervention 28-32 Days||26||
48576191|NCT06098339|101741324|FG000|NOT COMPLETED|Period 1: First Intervention 28-32 Days||1||
48702209|NCT00519376|102057628|FG009|COMPLETED|Treatment Period 2||1||
48702210|NCT00519376|102057629|FG010|COMPLETED|Treatment Period 2||1||
48702211|NCT00519376|102057630|FG011|COMPLETED|Treatment Period 2||1||
48702212|NCT00519376|102057631|FG012|COMPLETED|Treatment Period 2||0||
48702213|NCT00519376|102057632|FG013|COMPLETED|Treatment Period 2||1||
48702214|NCT00519376|102057633|FG014|COMPLETED|Treatment Period 2||1||
48399671|NCT00254163|101309184|FG001|STARTED|Overall Study||92||
48399672|NCT00254163|101309183|FG000|COMPLETED|Overall Study||47||
48399673|NCT00254163|101309184|FG001|COMPLETED|Overall Study||46||
48399674|NCT00254163|101309183|FG000|NOT COMPLETED|Overall Study||45||
48399675|NCT00254163|101309184|FG001|NOT COMPLETED|Overall Study||46||
48576192|NCT06098339|101741325|FG001|NOT COMPLETED|Period 1: First Intervention 28-32 Days||2||
48576193|NCT06098339|101741324|FG000|STARTED|Period 2: Second Intervention 28-32 Days||24||
48702215|NCT00519376|102057634|FG015|COMPLETED|Treatment Period 2||1||
48702216|NCT00519376|102057619|FG000|NOT COMPLETED|Treatment Period 2||0||
48702217|NCT00519376|102057620|FG001|NOT COMPLETED|Treatment Period 2||0||
48285496|NCT02876159|101026141|FG000|NOT COMPLETED|Overall Study||0||
48131874|NCT03701555|100645932|FG008|NOT COMPLETED|Part 3 (Day 1)||0||
48131875|NCT03701555|100645933|FG009|NOT COMPLETED|Part 3 (Day 1)||0||
48131876|NCT03701555|100645934|FG010|NOT COMPLETED|Part 3 (Day 1)||0||
48131877|NCT03701555|100645935|FG011|NOT COMPLETED|Part 3 (Day 1)||0||
48131878|NCT03701555|100645936|FG012|NOT COMPLETED|Part 3 (Day 1)||0||
48131879|NCT03701555|100645937|FG013|NOT COMPLETED|Part 3 (Day 1)||0||
48131880|NCT03701555|100645938|FG014|NOT COMPLETED|Part 3 (Day 1)||0||
48131881|NCT03701555|100645939|FG015|NOT COMPLETED|Part 3 (Day 1)||0||
48131882|NCT03701555|100645940|FG016|NOT COMPLETED|Part 3 (Day 1)||0||
48131883|NCT03701555|100645941|FG017|NOT COMPLETED|Part 3 (Day 1)||0||
48131884|NCT03701555|100645942|FG018|NOT COMPLETED|Part 3 (Day 1)||0||
48131885|NCT03701555|100645943|FG019|NOT COMPLETED|Part 3 (Day 1)||0||
48131886|NCT03701555|100645944|FG020|NOT COMPLETED|Part 3 (Day 1)||0||
48131887|NCT03701555|100645945|FG021|NOT COMPLETED|Part 3 (Day 1)||0||
48131888|NCT03701555|100645946|FG022|NOT COMPLETED|Part 3 (Day 1)||0||
48131889|NCT03701555|100645947|FG023|NOT COMPLETED|Part 3 (Day 1)||0||
48131890|NCT03701555|100645948|FG024|NOT COMPLETED|Part 3 (Day 1)||1||
48131891|NCT03701555|100645949|FG025|NOT COMPLETED|Part 3 (Day 1)||1||
48131892|NCT03701555|100645950|FG026|NOT COMPLETED|Part 3 (Day 1)||1||
48131893|NCT03701555|100645951|FG027|NOT COMPLETED|Part 3 (Day 1)||0||
48131894|NCT03701555|100645952|FG028|NOT COMPLETED|Part 3 (Day 1)||0||
48131895|NCT03701555|100645953|FG029|NOT COMPLETED|Part 3 (Day 1)||2||
48131896|NCT03701555|100645954|FG030|NOT COMPLETED|Part 3 (Day 1)||1||
48131897|NCT03701555|100645955|FG031|NOT COMPLETED|Part 3 (Day 1)||3||
48131898|NCT03701555|100645956|FG032|NOT COMPLETED|Part 3 (Day 1)||2||
48131899|NCT03701555|100645957|FG033|NOT COMPLETED|Part 3 (Day 1)||2||
48131900|NCT03701555|100645958|FG034|NOT COMPLETED|Part 3 (Day 1)||0||
48131901|NCT03701555|100645959|FG035|NOT COMPLETED|Part 3 (Day 1)||0||
48131902|NCT03701555|100645924|FG000|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
48131903|NCT03701555|100645925|FG001|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
48131904|NCT03701555|100645926|FG002|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
48131905|NCT03701555|100645927|FG003|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
48131906|NCT03701555|100645928|FG004|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
48131907|NCT03701555|100645929|FG005|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
48131908|NCT03701555|100645930|FG006|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
48131909|NCT03701555|100645931|FG007|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
48131910|NCT03701555|100645932|FG008|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
48131911|NCT03701555|100645933|FG009|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
48131912|NCT03701555|100645934|FG010|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
48131913|NCT03701555|100645935|FG011|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
48131914|NCT03701555|100645936|FG012|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
48131915|NCT03701555|100645937|FG013|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
48131916|NCT03701555|100645938|FG014|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
48131917|NCT03701555|100645939|FG015|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
48131918|NCT03701555|100645940|FG016|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
48131919|NCT03701555|100645941|FG017|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
48131920|NCT03701555|100645942|FG018|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
48131921|NCT03701555|100645943|FG019|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
48131922|NCT03701555|100645944|FG020|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
48131923|NCT03701555|100645945|FG021|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
48131924|NCT03701555|100645946|FG022|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
48131925|NCT03701555|100645947|FG023|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
48131926|NCT03701555|100645948|FG024|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
48131927|NCT03701555|100645949|FG025|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
48131928|NCT03701555|100645950|FG026|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
48131929|NCT03701555|100645951|FG027|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
48131930|NCT03701555|100645952|FG028|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
48131931|NCT03701555|100645953|FG029|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
48131932|NCT03701555|100645954|FG030|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
48131933|NCT03701555|100645955|FG031|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
48131934|NCT03701555|100645956|FG032|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
48131935|NCT03701555|100645957|FG033|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
48285497|NCT02876159|101026142|FG001|NOT COMPLETED|Overall Study||0||
48285498|NCT01035073|101026143|FG000|STARTED|Overall Study||0||
48285499|NCT01035073|101026143|FG000|COMPLETED|Overall Study||0||
48285500|NCT01035073|101026143|FG000|NOT COMPLETED|Overall Study||0||
48285501|NCT00688103|101026144|FG000|STARTED|Overall Study||74||
48131936|NCT03701555|100645958|FG034|STARTED|Part 4, Period 1 (Days 1 to 5)||3||
48285502|NCT00688103|101026145|FG001|STARTED|Overall Study||77||
48285503|NCT00688103|101026144|FG000|Actually Treated|Overall Study||71||
48285504|NCT00688103|101026145|FG001|Actually Treated|Overall Study||76||
48131937|NCT03701555|100645959|FG035|STARTED|Part 4, Period 1 (Days 1 to 5)||3||
48131938|NCT03701555|100645924|FG000|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131939|NCT03701555|100645925|FG001|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131940|NCT03701555|100645926|FG002|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131941|NCT03701555|100645927|FG003|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48285505|NCT00688103|101026144|FG000|COMPLETED|Overall Study||44||
48131942|NCT03701555|100645928|FG004|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131943|NCT03701555|100645929|FG005|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131944|NCT03701555|100645930|FG006|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131945|NCT03701555|100645931|FG007|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131946|NCT03701555|100645932|FG008|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131947|NCT03701555|100645933|FG009|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131948|NCT03701555|100645934|FG010|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131949|NCT03701555|100645935|FG011|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131950|NCT03701555|100645936|FG012|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131951|NCT03701555|100645937|FG013|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131952|NCT03701555|100645938|FG014|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131953|NCT03701555|100645939|FG015|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131954|NCT03701555|100645940|FG016|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131955|NCT03701555|100645941|FG017|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131956|NCT03701555|100645942|FG018|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131957|NCT03701555|100645943|FG019|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131958|NCT03701555|100645944|FG020|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131959|NCT03701555|100645945|FG021|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131960|NCT03701555|100645946|FG022|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131961|NCT03701555|100645947|FG023|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131962|NCT03701555|100645948|FG024|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131963|NCT03701555|100645949|FG025|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131964|NCT03701555|100645950|FG026|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131965|NCT03701555|100645951|FG027|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131966|NCT03701555|100645952|FG028|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131967|NCT03701555|100645953|FG029|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131968|NCT03701555|100645954|FG030|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131969|NCT03701555|100645955|FG031|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131970|NCT03701555|100645956|FG032|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131971|NCT03701555|100645957|FG033|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131972|NCT03701555|100645958|FG034|COMPLETED|Part 4, Period 1 (Days 1 to 5)||3||
48131973|NCT03701555|100645959|FG035|COMPLETED|Part 4, Period 1 (Days 1 to 5)||3||
48131974|NCT03701555|100645924|FG000|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131975|NCT03701555|100645925|FG001|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131976|NCT03701555|100645926|FG002|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131977|NCT03701555|100645927|FG003|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131978|NCT03701555|100645928|FG004|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131979|NCT03701555|100645929|FG005|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131980|NCT03701555|100645930|FG006|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131981|NCT03701555|100645931|FG007|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131982|NCT03701555|100645932|FG008|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131983|NCT03701555|100645933|FG009|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131984|NCT03701555|100645934|FG010|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131985|NCT03701555|100645935|FG011|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131986|NCT03701555|100645936|FG012|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131987|NCT03701555|100645937|FG013|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131988|NCT03701555|100645938|FG014|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131989|NCT03701555|100645939|FG015|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131990|NCT03701555|100645940|FG016|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131991|NCT03701555|100645941|FG017|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131992|NCT03701555|100645942|FG018|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131993|NCT03701555|100645943|FG019|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131994|NCT03701555|100645944|FG020|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131995|NCT03701555|100645945|FG021|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131996|NCT03701555|100645946|FG022|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131997|NCT03701555|100645947|FG023|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131998|NCT03701555|100645948|FG024|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48131999|NCT03701555|100645949|FG025|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48132000|NCT03701555|100645950|FG026|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48132001|NCT03701555|100645951|FG027|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48132002|NCT03701555|100645952|FG028|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48132003|NCT03701555|100645953|FG029|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48132004|NCT03701555|100645954|FG030|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48132005|NCT03701555|100645955|FG031|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48132006|NCT03701555|100645956|FG032|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48132007|NCT03701555|100645957|FG033|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48132008|NCT03701555|100645958|FG034|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48132009|NCT03701555|100645959|FG035|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
48132010|NCT03701555|100645924|FG000|STARTED|Part 4, Washout Period (3 Days)||0||
48132011|NCT03701555|100645925|FG001|STARTED|Part 4, Washout Period (3 Days)||0||
48132012|NCT03701555|100645926|FG002|STARTED|Part 4, Washout Period (3 Days)||0||
48132013|NCT03701555|100645927|FG003|STARTED|Part 4, Washout Period (3 Days)||0||
48285506|NCT00688103|101026145|FG001|COMPLETED|Overall Study||64||
48132014|NCT03701555|100645928|FG004|STARTED|Part 4, Washout Period (3 Days)||0||
48132015|NCT03701555|100645929|FG005|STARTED|Part 4, Washout Period (3 Days)||0||
48132016|NCT03701555|100645930|FG006|STARTED|Part 4, Washout Period (3 Days)||0||
48132017|NCT03701555|100645931|FG007|STARTED|Part 4, Washout Period (3 Days)||0||
48132018|NCT03701555|100645932|FG008|STARTED|Part 4, Washout Period (3 Days)||0||
48132019|NCT03701555|100645933|FG009|STARTED|Part 4, Washout Period (3 Days)||0||
48132020|NCT03701555|100645934|FG010|STARTED|Part 4, Washout Period (3 Days)||0||
48132021|NCT03701555|100645935|FG011|STARTED|Part 4, Washout Period (3 Days)||0||
48132022|NCT03701555|100645936|FG012|STARTED|Part 4, Washout Period (3 Days)||0||
48132023|NCT03701555|100645937|FG013|STARTED|Part 4, Washout Period (3 Days)||0||
48132024|NCT03701555|100645938|FG014|STARTED|Part 4, Washout Period (3 Days)||0||
48132025|NCT03701555|100645939|FG015|STARTED|Part 4, Washout Period (3 Days)||0||
48132026|NCT03701555|100645940|FG016|STARTED|Part 4, Washout Period (3 Days)||0||
48132027|NCT03701555|100645941|FG017|STARTED|Part 4, Washout Period (3 Days)||0||
48132028|NCT03701555|100645942|FG018|STARTED|Part 4, Washout Period (3 Days)||0||
48132029|NCT03701555|100645943|FG019|STARTED|Part 4, Washout Period (3 Days)||0||
48132030|NCT03701555|100645944|FG020|STARTED|Part 4, Washout Period (3 Days)||0||
48132031|NCT03701555|100645945|FG021|STARTED|Part 4, Washout Period (3 Days)||0||
48132032|NCT03701555|100645946|FG022|STARTED|Part 4, Washout Period (3 Days)||0||
48132033|NCT03701555|100645947|FG023|STARTED|Part 4, Washout Period (3 Days)||0||
48132034|NCT03701555|100645948|FG024|STARTED|Part 4, Washout Period (3 Days)||0||
48132035|NCT03701555|100645949|FG025|STARTED|Part 4, Washout Period (3 Days)||0||
48132036|NCT03701555|100645950|FG026|STARTED|Part 4, Washout Period (3 Days)||0||
48132037|NCT03701555|100645951|FG027|STARTED|Part 4, Washout Period (3 Days)||0||
48132038|NCT03701555|100645952|FG028|STARTED|Part 4, Washout Period (3 Days)||0||
48132039|NCT03701555|100645953|FG029|STARTED|Part 4, Washout Period (3 Days)||0||
48132040|NCT03701555|100645954|FG030|STARTED|Part 4, Washout Period (3 Days)||0||
48132041|NCT03701555|100645955|FG031|STARTED|Part 4, Washout Period (3 Days)||0||
48132042|NCT03701555|100645956|FG032|STARTED|Part 4, Washout Period (3 Days)||0||
48132043|NCT03701555|100645957|FG033|STARTED|Part 4, Washout Period (3 Days)||0||
48132044|NCT03701555|100645958|FG034|STARTED|Part 4, Washout Period (3 Days)||3||
48132045|NCT03701555|100645959|FG035|STARTED|Part 4, Washout Period (3 Days)||3||
48132046|NCT03701555|100645924|FG000|COMPLETED|Part 4, Washout Period (3 Days)||0||
48132047|NCT03701555|100645925|FG001|COMPLETED|Part 4, Washout Period (3 Days)||0||
48132048|NCT03701555|100645926|FG002|COMPLETED|Part 4, Washout Period (3 Days)||0||
48132049|NCT03701555|100645927|FG003|COMPLETED|Part 4, Washout Period (3 Days)||0||
48132050|NCT03701555|100645928|FG004|COMPLETED|Part 4, Washout Period (3 Days)||0||
48132051|NCT03701555|100645929|FG005|COMPLETED|Part 4, Washout Period (3 Days)||0||
48132052|NCT03701555|100645930|FG006|COMPLETED|Part 4, Washout Period (3 Days)||0||
48132053|NCT03701555|100645931|FG007|COMPLETED|Part 4, Washout Period (3 Days)||0||
48132054|NCT03701555|100645932|FG008|COMPLETED|Part 4, Washout Period (3 Days)||0||
48132055|NCT03701555|100645933|FG009|COMPLETED|Part 4, Washout Period (3 Days)||0||
48132056|NCT03701555|100645934|FG010|COMPLETED|Part 4, Washout Period (3 Days)||0||
48702218|NCT00519376|102057621|FG002|NOT COMPLETED|Treatment Period 2||0||
48702219|NCT00519376|102057622|FG003|NOT COMPLETED|Treatment Period 2||0||
48702220|NCT00519376|102057623|FG004|NOT COMPLETED|Treatment Period 2||0||
48702221|NCT00519376|102057624|FG005|NOT COMPLETED|Treatment Period 2||0||
48702222|NCT00519376|102057625|FG006|NOT COMPLETED|Treatment Period 2||0||
48702223|NCT00519376|102057626|FG007|NOT COMPLETED|Treatment Period 2||0||
48702224|NCT00519376|102057627|FG008|NOT COMPLETED|Treatment Period 2||0||
48702225|NCT00519376|102057628|FG009|NOT COMPLETED|Treatment Period 2||0||
48702226|NCT00519376|102057629|FG010|NOT COMPLETED|Treatment Period 2||0||
48702227|NCT00519376|102057630|FG011|NOT COMPLETED|Treatment Period 2||0||
48132057|NCT03701555|100645935|FG011|COMPLETED|Part 4, Washout Period (3 Days)||0||
48132058|NCT03701555|100645936|FG012|COMPLETED|Part 4, Washout Period (3 Days)||0||
48132059|NCT03701555|100645937|FG013|COMPLETED|Part 4, Washout Period (3 Days)||0||
48132060|NCT03701555|100645938|FG014|COMPLETED|Part 4, Washout Period (3 Days)||0||
48132061|NCT03701555|100645939|FG015|COMPLETED|Part 4, Washout Period (3 Days)||0||
48132062|NCT03701555|100645940|FG016|COMPLETED|Part 4, Washout Period (3 Days)||0||
48132063|NCT03701555|100645941|FG017|COMPLETED|Part 4, Washout Period (3 Days)||0||
48132064|NCT03701555|100645942|FG018|COMPLETED|Part 4, Washout Period (3 Days)||0||
48132065|NCT03701555|100645943|FG019|COMPLETED|Part 4, Washout Period (3 Days)||0||
48132066|NCT03701555|100645944|FG020|COMPLETED|Part 4, Washout Period (3 Days)||0||
48132067|NCT03701555|100645945|FG021|COMPLETED|Part 4, Washout Period (3 Days)||0||
48132068|NCT03701555|100645946|FG022|COMPLETED|Part 4, Washout Period (3 Days)||0||
48132069|NCT03701555|100645947|FG023|COMPLETED|Part 4, Washout Period (3 Days)||0||
48132070|NCT03701555|100645948|FG024|COMPLETED|Part 4, Washout Period (3 Days)||0||
48132071|NCT03701555|100645949|FG025|COMPLETED|Part 4, Washout Period (3 Days)||0||
48132072|NCT03701555|100645950|FG026|COMPLETED|Part 4, Washout Period (3 Days)||0||
48132073|NCT03701555|100645951|FG027|COMPLETED|Part 4, Washout Period (3 Days)||0||
48132074|NCT03701555|100645952|FG028|COMPLETED|Part 4, Washout Period (3 Days)||0||
48132075|NCT03701555|100645953|FG029|COMPLETED|Part 4, Washout Period (3 Days)||0||
48132076|NCT03701555|100645954|FG030|COMPLETED|Part 4, Washout Period (3 Days)||0||
48132077|NCT03701555|100645955|FG031|COMPLETED|Part 4, Washout Period (3 Days)||0||
48702228|NCT00519376|102057631|FG012|NOT COMPLETED|Treatment Period 2||1||
48702229|NCT00519376|102057632|FG013|NOT COMPLETED|Treatment Period 2||0||
48132078|NCT03701555|100645956|FG032|COMPLETED|Part 4, Washout Period (3 Days)||0||
48132079|NCT03701555|100645957|FG033|COMPLETED|Part 4, Washout Period (3 Days)||0||
48132080|NCT03701555|100645958|FG034|COMPLETED|Part 4, Washout Period (3 Days)||3||
48132081|NCT03701555|100645959|FG035|COMPLETED|Part 4, Washout Period (3 Days)||3||
48132082|NCT03701555|100645924|FG000|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132083|NCT03701555|100645925|FG001|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132084|NCT03701555|100645926|FG002|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132085|NCT03701555|100645927|FG003|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132086|NCT03701555|100645928|FG004|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132087|NCT03701555|100645929|FG005|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132088|NCT03701555|100645930|FG006|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132089|NCT03701555|100645931|FG007|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132090|NCT03701555|100645932|FG008|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132091|NCT03701555|100645933|FG009|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132092|NCT03701555|100645934|FG010|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132093|NCT03701555|100645935|FG011|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132094|NCT03701555|100645936|FG012|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132095|NCT03701555|100645937|FG013|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132096|NCT03701555|100645938|FG014|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132097|NCT03701555|100645939|FG015|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132098|NCT03701555|100645940|FG016|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132099|NCT03701555|100645941|FG017|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48285507|NCT00688103|101026144|FG000|NOT COMPLETED|Overall Study||30||
48285508|NCT00688103|101026145|FG001|NOT COMPLETED|Overall Study||13||
48285509|NCT03866473|101026146|FG000|STARTED|Phase 1||69||69
48702230|NCT00519376|102057633|FG014|NOT COMPLETED|Treatment Period 2||0||
48132100|NCT03701555|100645942|FG018|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132101|NCT03701555|100645943|FG019|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132102|NCT03701555|100645944|FG020|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132103|NCT03701555|100645945|FG021|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132104|NCT03701555|100645946|FG022|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132105|NCT03701555|100645947|FG023|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132106|NCT03701555|100645948|FG024|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132107|NCT03701555|100645949|FG025|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132108|NCT03701555|100645950|FG026|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132109|NCT03701555|100645951|FG027|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132110|NCT03701555|100645952|FG028|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132111|NCT03701555|100645953|FG029|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132112|NCT03701555|100645954|FG030|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132113|NCT03701555|100645955|FG031|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132114|NCT03701555|100645956|FG032|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132115|NCT03701555|100645957|FG033|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132116|NCT03701555|100645958|FG034|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132117|NCT03701555|100645959|FG035|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
48132118|NCT03701555|100645924|FG000|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
48132119|NCT03701555|100645925|FG001|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
48132120|NCT03701555|100645926|FG002|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
48132121|NCT03701555|100645927|FG003|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
48132122|NCT03701555|100645928|FG004|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
48132123|NCT03701555|100645929|FG005|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
48702231|NCT00519376|102057634|FG015|NOT COMPLETED|Treatment Period 2||0||
48702232|NCT00519376|102057619|FG000|STARTED|Washout Period 2||2||
48702233|NCT00519376|102057620|FG001|STARTED|Washout Period 2||2||
48702234|NCT00519376|102057621|FG002|STARTED|Washout Period 2||2||
48702235|NCT00519376|102057622|FG003|STARTED|Washout Period 2||2||
48702236|NCT00519376|102057623|FG004|STARTED|Washout Period 2||1||
48702237|NCT00519376|102057624|FG005|STARTED|Washout Period 2||1||
48702238|NCT00519376|102057625|FG006|STARTED|Washout Period 2||1||
48702239|NCT00519376|102057626|FG007|STARTED|Washout Period 2||1||
48702240|NCT00519376|102057627|FG008|STARTED|Washout Period 2||1||
48702241|NCT00519376|102057628|FG009|STARTED|Washout Period 2||1||
48132124|NCT03701555|100645930|FG006|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
48132125|NCT03701555|100645931|FG007|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
48132126|NCT03701555|100645932|FG008|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
48132127|NCT03701555|100645933|FG009|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
48132128|NCT03701555|100645934|FG010|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
48132129|NCT03701555|100645935|FG011|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
48132130|NCT03701555|100645936|FG012|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
48132131|NCT03701555|100645937|FG013|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
48132132|NCT03701555|100645938|FG014|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
48285510|NCT03866473|101026147|FG001|STARTED|Phase 1||66||66
48285511|NCT03866473|101026146|FG000|COMPLETED|Phase 1||68||68
48702242|NCT00519376|102057629|FG010|STARTED|Washout Period 2||1||
48702243|NCT00519376|102057630|FG011|STARTED|Washout Period 2||1||
48702244|NCT00519376|102057631|FG012|STARTED|Washout Period 2||0||
48132133|NCT03701555|100645939|FG015|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
48132134|NCT03701555|100645940|FG016|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
48132135|NCT03701555|100645941|FG017|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
48132136|NCT03701555|100645942|FG018|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
48132137|NCT03701555|100645943|FG019|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
48285512|NCT03866473|101026147|FG001|COMPLETED|Phase 1||66||66
48285513|NCT03866473|101026146|FG000|NOT COMPLETED|Phase 1||1||1
48285514|NCT03866473|101026147|FG001|NOT COMPLETED|Phase 1||0||0
48285515|NCT03866473|101026146|FG000|STARTED|Phase 2||62||62
48285516|NCT03866473|101026147|FG001|STARTED|Phase 2||61||61
48285517|NCT03866473|101026146|FG000|COMPLETED|Phase 2||60||60
48285518|NCT03866473|101026147|FG001|COMPLETED|Phase 2||58||58
48285519|NCT03866473|101026146|FG000|NOT COMPLETED|Phase 2||2||2
48285520|NCT03866473|101026147|FG001|NOT COMPLETED|Phase 2||3||3
48285521|NCT00598273|101026148|FG000|STARTED|Overall Study||161||
48576194|NCT06098339|101741325|FG001|STARTED|Period 2: Second Intervention 28-32 Days||26||
48132138|NCT03701555|100645944|FG020|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
48132139|NCT03701555|100645945|FG021|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
48132140|NCT03701555|100645946|FG022|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
48132141|NCT03701555|100645947|FG023|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
48132142|NCT03701555|100645948|FG024|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
48132143|NCT03701555|100645949|FG025|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
48132144|NCT03701555|100645950|FG026|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
48132145|NCT03701555|100645951|FG027|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
48132146|NCT03701555|100645952|FG028|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
48132147|NCT03701555|100645953|FG029|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
48132148|NCT03701555|100645954|FG030|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
48132149|NCT03701555|100645955|FG031|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
48132150|NCT03701555|100645956|FG032|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
48132151|NCT03701555|100645957|FG033|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
48132152|NCT03701555|100645958|FG034|STARTED|Part 4, Period 2 (Days 1 to 5)||3||
48132153|NCT03701555|100645959|FG035|STARTED|Part 4, Period 2 (Days 1 to 5)||3||
48132154|NCT03701555|100645924|FG000|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132155|NCT03701555|100645925|FG001|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132156|NCT03701555|100645926|FG002|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132157|NCT03701555|100645927|FG003|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132158|NCT03701555|100645928|FG004|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132159|NCT03701555|100645929|FG005|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132160|NCT03701555|100645930|FG006|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132161|NCT03701555|100645931|FG007|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132162|NCT03701555|100645932|FG008|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132163|NCT03701555|100645933|FG009|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132164|NCT03701555|100645934|FG010|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132165|NCT03701555|100645935|FG011|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132166|NCT03701555|100645936|FG012|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132167|NCT03701555|100645937|FG013|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132168|NCT03701555|100645938|FG014|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132169|NCT03701555|100645939|FG015|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132170|NCT03701555|100645940|FG016|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132171|NCT03701555|100645941|FG017|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132172|NCT03701555|100645942|FG018|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132173|NCT03701555|100645943|FG019|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132174|NCT03701555|100645944|FG020|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132175|NCT03701555|100645945|FG021|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48285522|NCT00598273|101026149|FG001|STARTED|Overall Study||165||
48285523|NCT00598273|101026150|FG002|STARTED|Overall Study||164||
48285524|NCT00598273|101026148|FG000|COMPLETED|Overall Study||120||
48285525|NCT00598273|101026149|FG001|COMPLETED|Overall Study||127||
48576195|NCT06098339|101741324|FG000|COMPLETED|Period 2: Second Intervention 28-32 Days||24||
48576196|NCT06098339|101741325|FG001|COMPLETED|Period 2: Second Intervention 28-32 Days||26||
48576197|NCT06098339|101741324|FG000|NOT COMPLETED|Period 2: Second Intervention 28-32 Days||0||
48576198|NCT06098339|101741325|FG001|NOT COMPLETED|Period 2: Second Intervention 28-32 Days||0||
48576199|NCT03865316|101741326|FG000|STARTED|Overall Study||108||
48576200|NCT03865316|101741326|FG000|COMPLETED|Overall Study||100||
48576201|NCT03865316|101741326|FG000|NOT COMPLETED|Overall Study||8||
48576202|NCT01166438|101741327|FG000|STARTED|Double-blind Phase: 1st 6 Months||122||
48576203|NCT01166438|101741328|FG001|STARTED|Double-blind Phase: 1st 6 Months||127||
48702245|NCT00519376|102057632|FG013|STARTED|Washout Period 2||1||
48702246|NCT00519376|102057633|FG014|STARTED|Washout Period 2||1||
48132176|NCT03701555|100645946|FG022|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132177|NCT03701555|100645947|FG023|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132178|NCT03701555|100645948|FG024|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48285526|NCT00598273|101026150|FG002|COMPLETED|Overall Study||125||
48285527|NCT00598273|101026148|FG000|NOT COMPLETED|Overall Study||41||
48285528|NCT00598273|101026149|FG001|NOT COMPLETED|Overall Study||38||
48285529|NCT00598273|101026150|FG002|NOT COMPLETED|Overall Study||39||
48702247|NCT00519376|102057634|FG015|STARTED|Washout Period 2||1||
48285530|NCT01049217|101026151|FG000|STARTED|Overall Study||183||
48285531|NCT01049217|101026152|FG001|STARTED|Overall Study||194||
48285532|NCT01049217|101026151|FG000|Treated|Overall Study||183||
48285533|NCT01049217|101026152|FG001|Treated|Overall Study||192||
48285534|NCT01049217|101026151|FG000|COMPLETED|Overall Study||127||
48285535|NCT01049217|101026152|FG001|COMPLETED|Overall Study||131||
48285536|NCT01049217|101026151|FG000|NOT COMPLETED|Overall Study||56||
48285537|NCT01049217|101026152|FG001|NOT COMPLETED|Overall Study||63||
48285538|NCT01164644|101026153|FG000|STARTED|Overall Study||12||
48285539|NCT01164644|101026154|FG001|STARTED|Overall Study||14||
48285540|NCT01164644|101026153|FG000|COMPLETED|Overall Study||9||
48285541|NCT01164644|101026154|FG001|COMPLETED|Overall Study||13||
48285542|NCT01164644|101026153|FG000|NOT COMPLETED|Overall Study||3||
48285543|NCT01164644|101026154|FG001|NOT COMPLETED|Overall Study||1||
48285544|NCT02842827|101026155|FG000|STARTED|Overall Study||3||
48285545|NCT02842827|101026156|FG001|STARTED|Overall Study||6||
48285546|NCT02842827|101026157|FG002|STARTED|Overall Study||4||
48285547|NCT02842827|101026158|FG003|STARTED|Overall Study||6||
48285548|NCT02842827|101026159|FG004|STARTED|Overall Study||5||
48576204|NCT01166438|101741327|FG000|Treated|Double-blind Phase: 1st 6 Months||121||
48576205|NCT01166438|101741328|FG001|Treated|Double-blind Phase: 1st 6 Months||126||
48132179|NCT03701555|100645949|FG025|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132180|NCT03701555|100645950|FG026|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132181|NCT03701555|100645951|FG027|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48285549|NCT02842827|101026160|FG005|STARTED|Overall Study||9||
48285550|NCT02842827|101026161|FG006|STARTED|Overall Study||4||
48285551|NCT02842827|101026162|FG007|STARTED|Overall Study||8||
48285552|NCT02842827|101026155|FG000|Treated|Overall Study||3||
48285553|NCT02842827|101026156|FG001|Treated|Overall Study||6||
48285554|NCT02842827|101026157|FG002|Treated|Overall Study||4||
48285555|NCT02842827|101026158|FG003|Treated|Overall Study||6||
48285556|NCT02842827|101026159|FG004|Treated|Overall Study||5||
48132182|NCT03701555|100645952|FG028|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132183|NCT03701555|100645953|FG029|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132184|NCT03701555|100645954|FG030|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132185|NCT03701555|100645955|FG031|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132186|NCT03701555|100645956|FG032|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132187|NCT03701555|100645957|FG033|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132188|NCT03701555|100645958|FG034|COMPLETED|Part 4, Period 2 (Days 1 to 5)||3||
48132189|NCT03701555|100645959|FG035|COMPLETED|Part 4, Period 2 (Days 1 to 5)||3||
48132190|NCT03701555|100645924|FG000|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132191|NCT03701555|100645925|FG001|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132192|NCT03701555|100645926|FG002|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132193|NCT03701555|100645927|FG003|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132194|NCT03701555|100645928|FG004|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132195|NCT03701555|100645929|FG005|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132196|NCT03701555|100645930|FG006|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132197|NCT03701555|100645931|FG007|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132198|NCT03701555|100645932|FG008|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132199|NCT03701555|100645933|FG009|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132200|NCT03701555|100645934|FG010|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132201|NCT03701555|100645935|FG011|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132202|NCT03701555|100645936|FG012|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132203|NCT03701555|100645937|FG013|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132204|NCT03701555|100645938|FG014|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132205|NCT03701555|100645939|FG015|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132206|NCT03701555|100645940|FG016|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132207|NCT03701555|100645941|FG017|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132208|NCT03701555|100645942|FG018|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132209|NCT03701555|100645943|FG019|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132210|NCT03701555|100645944|FG020|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132211|NCT03701555|100645945|FG021|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132212|NCT03701555|100645946|FG022|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48285557|NCT02842827|101026160|FG005|Treated|Overall Study||9||
48285558|NCT02842827|101026161|FG006|Treated|Overall Study||4||
48399676|NCT01997281|101309185|FG000|STARTED|Overall Study||7||
48576206|NCT01166438|101741327|FG000|COMPLETED|Double-blind Phase: 1st 6 Months||113||
48576207|NCT01166438|101741328|FG001|COMPLETED|Double-blind Phase: 1st 6 Months||118||
48132213|NCT03701555|100645947|FG023|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132214|NCT03701555|100645948|FG024|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132215|NCT03701555|100645949|FG025|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48285559|NCT02842827|101026162|FG007|Treated|Overall Study||8||
48285560|NCT02842827|101026155|FG000|COMPLETED|Overall Study||0||
48285561|NCT02842827|101026156|FG001|COMPLETED|Overall Study||0||
48285562|NCT02842827|101026157|FG002|COMPLETED|Overall Study||0||
48285563|NCT02842827|101026158|FG003|COMPLETED|Overall Study||0||
48399677|NCT01997281|101309186|FG001|STARTED|Overall Study||7||
48285564|NCT02842827|101026159|FG004|COMPLETED|Overall Study||0||
48285565|NCT02842827|101026160|FG005|COMPLETED|Overall Study||1||
48285566|NCT02842827|101026161|FG006|COMPLETED|Overall Study||0||
48285567|NCT02842827|101026162|FG007|COMPLETED|Overall Study||2||
48285568|NCT02842827|101026155|FG000|NOT COMPLETED|Overall Study||3||
48285569|NCT02842827|101026156|FG001|NOT COMPLETED|Overall Study||6||
48285570|NCT02842827|101026157|FG002|NOT COMPLETED|Overall Study||4||
48285571|NCT02842827|101026158|FG003|NOT COMPLETED|Overall Study||6||
48285572|NCT02842827|101026159|FG004|NOT COMPLETED|Overall Study||5||
48285573|NCT02842827|101026160|FG005|NOT COMPLETED|Overall Study||8||
48285574|NCT02842827|101026161|FG006|NOT COMPLETED|Overall Study||4||
48285575|NCT02842827|101026162|FG007|NOT COMPLETED|Overall Study||6||
48285576|NCT03539887|101026163|FG000|STARTED|Overall Study||17||
48285577|NCT03539887|101026164|FG001|STARTED|Overall Study||11||
48285578|NCT03539887|101026163|FG000|COMPLETED|Overall Study||17||
48285579|NCT03539887|101026164|FG001|COMPLETED|Overall Study||11||
48285580|NCT03539887|101026163|FG000|NOT COMPLETED|Overall Study||0||
48285581|NCT03539887|101026164|FG001|NOT COMPLETED|Overall Study||0||
48285582|NCT00522873|101026165|FG000|STARTED|Overall Study||490||
48285583|NCT00522873|101026166|FG001|STARTED|Overall Study||172||
48285584|NCT00522873|101026165|FG000|Received Treatment|Overall Study||489||
48285585|NCT00522873|101026166|FG001|Received Treatment|Overall Study||172||
48285586|NCT00522873|101026165|FG000|COMPLETED|Overall Study||394||
48285587|NCT00522873|101026166|FG001|COMPLETED|Overall Study||128||
48285588|NCT00522873|101026165|FG000|NOT COMPLETED|Overall Study||96||
48285589|NCT00522873|101026166|FG001|NOT COMPLETED|Overall Study||44||
48285590|NCT00461032|101026167|FG000|STARTED|Overall Study||582||
48285591|NCT00461032|101026168|FG001|STARTED|Overall Study||580||
48285592|NCT00461032|101026167|FG000|COMPLETED|Overall Study||545||
48285593|NCT00461032|101026168|FG001|COMPLETED|Overall Study||536||
48285594|NCT00461032|101026167|FG000|NOT COMPLETED|Overall Study||37||
48285595|NCT00461032|101026168|FG001|NOT COMPLETED|Overall Study||44||
48285596|NCT01135537|101026169|FG000|STARTED|Overall Study||30||
48285597|NCT01135537|101026169|FG000|COMPLETED|Overall Study||17||
48285598|NCT01135537|101026169|FG000|NOT COMPLETED|Overall Study||13||
48285599|NCT02390245|101026170|FG000|STARTED|Phase I. Telemedicine Screening||906||
48285600|NCT02390245|101026171|FG001|STARTED|Phase I. Telemedicine Screening||0||
48285601|NCT02390245|101026172|FG002|STARTED|Phase I. Telemedicine Screening||0||
48285602|NCT02390245|101026170|FG000|COMPLETED|Phase I. Telemedicine Screening||906||
48285603|NCT02390245|101026171|FG001|COMPLETED|Phase I. Telemedicine Screening||0||
48285604|NCT02390245|101026172|FG002|COMPLETED|Phase I. Telemedicine Screening||0||
48285605|NCT02390245|101026170|FG000|NOT COMPLETED|Phase I. Telemedicine Screening||0||
48285606|NCT02390245|101026171|FG001|NOT COMPLETED|Phase I. Telemedicine Screening||0||
48285607|NCT02390245|101026172|FG002|NOT COMPLETED|Phase I. Telemedicine Screening||0||
48285608|NCT02390245|101026170|FG000|STARTED|Phase 2. Randomization Into 2 Groups||0||
48285609|NCT02390245|101026171|FG001|STARTED|Phase 2. Randomization Into 2 Groups||275||
48285610|NCT02390245|101026172|FG002|STARTED|Phase 2. Randomization Into 2 Groups||276||
48285611|NCT02390245|101026170|FG000|COMPLETED|Phase 2. Randomization Into 2 Groups||0||
48285612|NCT02390245|101026171|FG001|COMPLETED|Phase 2. Randomization Into 2 Groups||172||
48285613|NCT02390245|101026172|FG002|COMPLETED|Phase 2. Randomization Into 2 Groups||172||
48285614|NCT02390245|101026170|FG000|NOT COMPLETED|Phase 2. Randomization Into 2 Groups||0||
48285615|NCT02390245|101026171|FG001|NOT COMPLETED|Phase 2. Randomization Into 2 Groups||103||
48285616|NCT02390245|101026172|FG002|NOT COMPLETED|Phase 2. Randomization Into 2 Groups||104||
48285617|NCT02390245|101026170|FG000|STARTED|Phase 3. Ophthalmic Follow-up Adherence||0||
48576208|NCT01166438|101741327|FG000|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9||
48576209|NCT01166438|101741328|FG001|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9||
48576210|NCT01166438|101741327|FG000|STARTED|Off Treatment Follow-up Phase||85||
48285618|NCT02390245|101026171|FG001|STARTED|Phase 3. Ophthalmic Follow-up Adherence||172||
48285619|NCT02390245|101026172|FG002|STARTED|Phase 3. Ophthalmic Follow-up Adherence||172||
48285620|NCT02390245|101026170|FG000|COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||0||
48285621|NCT02390245|101026171|FG001|COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||77||
48285622|NCT02390245|101026172|FG002|COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||66||
48576211|NCT01166438|101741328|FG001|STARTED|Off Treatment Follow-up Phase||89||
48576212|NCT01166438|101741327|FG000|COMPLETED|Off Treatment Follow-up Phase||51||
48285623|NCT02390245|101026170|FG000|NOT COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||0||
48285624|NCT02390245|101026171|FG001|NOT COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||95||
48285625|NCT02390245|101026172|FG002|NOT COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||106||
48285626|NCT02699086|101026173|FG000|STARTED|Overall Study||0||
48285627|NCT02699086|101026174|FG001|STARTED|Overall Study||6||
48285628|NCT02699086|101026173|FG000|COMPLETED|Overall Study||0||
48285629|NCT02699086|101026174|FG001|COMPLETED|Overall Study||6||
48285630|NCT02699086|101026173|FG000|NOT COMPLETED|Overall Study||0||
48285631|NCT02699086|101026174|FG001|NOT COMPLETED|Overall Study||0||
48285632|NCT00560066|101026175|FG000|STARTED|Overall Study||396||
48285633|NCT00560066|101026176|FG001|STARTED|Overall Study||1002||
48576213|NCT01166438|101741328|FG001|COMPLETED|Off Treatment Follow-up Phase||33||
48576214|NCT01166438|101741327|FG000|NOT COMPLETED|Off Treatment Follow-up Phase||34||
48576215|NCT01166438|101741328|FG001|NOT COMPLETED|Off Treatment Follow-up Phase||56||
48285634|NCT00560066|101026175|FG000|COMPLETED|Overall Study||390||
48285635|NCT00560066|101026176|FG001|COMPLETED|Overall Study||980||
48285636|NCT00560066|101026175|FG000|NOT COMPLETED|Overall Study||6||
48285637|NCT00560066|101026176|FG001|NOT COMPLETED|Overall Study||22||
48285638|NCT00194987|101026177|FG000|STARTED|Overall Study||51||
48285639|NCT00194987|101026178|FG001|STARTED|Overall Study||51||
48285640|NCT00194987|101026177|FG000|COMPLETED|Overall Study||51||
48285641|NCT00194987|101026178|FG001|COMPLETED|Overall Study||48||
48285642|NCT00194987|101026177|FG000|NOT COMPLETED|Overall Study||0||
48285643|NCT00194987|101026178|FG001|NOT COMPLETED|Overall Study||3||
48285644|NCT01815138|101026179|FG000|STARTED|Overall Study||34||
48285645|NCT01815138|101026180|FG001|STARTED|Overall Study||37||
48285646|NCT01815138|101026179|FG000|COMPLETED|Overall Study||26||
48285647|NCT01815138|101026180|FG001|COMPLETED|Overall Study||31||
48285648|NCT01815138|101026179|FG000|NOT COMPLETED|Overall Study||8||
48285649|NCT01815138|101026180|FG001|NOT COMPLETED|Overall Study||6||
48285650|NCT02980731|101026181|FG000|STARTED|Overall Study||210||
48285651|NCT02980731|101026181|FG000|COMPLETED|Overall Study||0||
48285652|NCT02980731|101026181|FG000|NOT COMPLETED|Overall Study||210||
48285653|NCT02689518|101026182|FG000|STARTED|Overall Study||49||
48285654|NCT02689518|101026182|FG000|COMPLETED|Overall Study||46||
48285655|NCT02689518|101026182|FG000|NOT COMPLETED|Overall Study||3||
48285656|NCT02073747|101026183|FG000|STARTED|Overall Study||15||
48285657|NCT02073747|101026184|FG001|STARTED|Overall Study||15||
48285658|NCT02073747|101026183|FG000|COMPLETED|Overall Study||14||
48285659|NCT02073747|101026184|FG001|COMPLETED|Overall Study||14||
48285660|NCT02073747|101026183|FG000|NOT COMPLETED|Overall Study||1||
48285661|NCT02073747|101026184|FG001|NOT COMPLETED|Overall Study||1||
48285662|NCT02760277|101026185|FG000|STARTED|Vamorolone 0.25 mg/kg/Day||12||
48285663|NCT02760277|101026186|FG001|STARTED|Vamorolone 0.25 mg/kg/Day||0||
48285664|NCT02760277|101026187|FG002|STARTED|Vamorolone 0.25 mg/kg/Day||0||
48285665|NCT02760277|101026188|FG003|STARTED|Vamorolone 0.25 mg/kg/Day||0||
48285666|NCT02760277|101026185|FG000|COMPLETED|Vamorolone 0.25 mg/kg/Day||12||
48285667|NCT02760277|101026186|FG001|COMPLETED|Vamorolone 0.25 mg/kg/Day||0||
48285668|NCT02760277|101026187|FG002|COMPLETED|Vamorolone 0.25 mg/kg/Day||0||
48285669|NCT02760277|101026188|FG003|COMPLETED|Vamorolone 0.25 mg/kg/Day||0||
48285670|NCT02760277|101026185|FG000|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0||
48285671|NCT02760277|101026186|FG001|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0||
48285672|NCT02760277|101026187|FG002|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0||
48285673|NCT02760277|101026188|FG003|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0||
48285674|NCT02760277|101026185|FG000|STARTED|0.75 mg/kg/Day||0||
48285675|NCT02760277|101026186|FG001|STARTED|0.75 mg/kg/Day||12||
48285676|NCT02760277|101026187|FG002|STARTED|0.75 mg/kg/Day||0||
48285677|NCT02760277|101026188|FG003|STARTED|0.75 mg/kg/Day||0||
48285678|NCT02760277|101026185|FG000|COMPLETED|0.75 mg/kg/Day||0||
48285679|NCT02760277|101026186|FG001|COMPLETED|0.75 mg/kg/Day||12||
48285680|NCT02760277|101026187|FG002|COMPLETED|0.75 mg/kg/Day||0||
48285681|NCT02760277|101026188|FG003|COMPLETED|0.75 mg/kg/Day||0||
48285682|NCT02760277|101026185|FG000|NOT COMPLETED|0.75 mg/kg/Day||0||
48285683|NCT02760277|101026186|FG001|NOT COMPLETED|0.75 mg/kg/Day||0||
48285684|NCT02760277|101026187|FG002|NOT COMPLETED|0.75 mg/kg/Day||0||
48285685|NCT02760277|101026188|FG003|NOT COMPLETED|0.75 mg/kg/Day||0||
48285686|NCT02760277|101026185|FG000|STARTED|2.0 mg/kg/Day||0||
48285687|NCT02760277|101026186|FG001|STARTED|2.0 mg/kg/Day||0||
48285688|NCT02760277|101026187|FG002|STARTED|2.0 mg/kg/Day||12||
48285689|NCT02760277|101026188|FG003|STARTED|2.0 mg/kg/Day||0||
48285690|NCT02760277|101026185|FG000|COMPLETED|2.0 mg/kg/Day||0||
48285691|NCT02760277|101026186|FG001|COMPLETED|2.0 mg/kg/Day||0||
48285692|NCT02760277|101026187|FG002|COMPLETED|2.0 mg/kg/Day||12||
48285693|NCT02760277|101026188|FG003|COMPLETED|2.0 mg/kg/Day||0||
48285694|NCT02760277|101026185|FG000|NOT COMPLETED|2.0 mg/kg/Day||0||
48285695|NCT02760277|101026186|FG001|NOT COMPLETED|2.0 mg/kg/Day||0||
48285696|NCT02760277|101026187|FG002|NOT COMPLETED|2.0 mg/kg/Day||0||
48576216|NCT02548728|101741329|FG000|STARTED|Overall Study||6||
48576217|NCT02548728|101741330|FG001|STARTED|Overall Study||6||
48576218|NCT02548728|101741329|FG000|COMPLETED|Overall Study||6||
48285697|NCT02760277|101026188|FG003|NOT COMPLETED|2.0 mg/kg/Day||0||
48285698|NCT02760277|101026185|FG000|STARTED|6.0 mg/kg/Day||0||
48576219|NCT02548728|101741330|FG001|COMPLETED|Overall Study||6||
48576220|NCT02548728|101741329|FG000|NOT COMPLETED|Overall Study||0||
48576221|NCT02548728|101741330|FG001|NOT COMPLETED|Overall Study||0||
48576222|NCT02860130|101741331|FG000|STARTED|Overall Study||17||
48285699|NCT02760277|101026186|FG001|STARTED|6.0 mg/kg/Day||0||
48285700|NCT02760277|101026187|FG002|STARTED|6.0 mg/kg/Day||0||
48285701|NCT02760277|101026188|FG003|STARTED|6.0 mg/kg/Day||12||
48285702|NCT02760277|101026185|FG000|COMPLETED|6.0 mg/kg/Day||0||
48285703|NCT02760277|101026186|FG001|COMPLETED|6.0 mg/kg/Day||0||
48285704|NCT02760277|101026187|FG002|COMPLETED|6.0 mg/kg/Day||0||
48285705|NCT02760277|101026188|FG003|COMPLETED|6.0 mg/kg/Day||12||
48285706|NCT02760277|101026185|FG000|NOT COMPLETED|6.0 mg/kg/Day||0||
48285707|NCT02760277|101026186|FG001|NOT COMPLETED|6.0 mg/kg/Day||0||
48285708|NCT02760277|101026187|FG002|NOT COMPLETED|6.0 mg/kg/Day||0||
48285709|NCT02760277|101026188|FG003|NOT COMPLETED|6.0 mg/kg/Day||0||
48576223|NCT02860130|101741332|FG001|STARTED|Overall Study||17||
48285710|NCT00841555|101026189|FG000|STARTED|Overall Study||3||
48285711|NCT00841555|101026190|FG001|STARTED|Overall Study||3||
48285712|NCT00841555|101026191|FG002|STARTED|Overall Study||3||
48285713|NCT00841555|101026189|FG000|COMPLETED|Overall Study||3||
48285714|NCT00841555|101026190|FG001|COMPLETED|Overall Study||3||
48285715|NCT00841555|101026191|FG002|COMPLETED|Overall Study||3||
48285716|NCT00841555|101026189|FG000|NOT COMPLETED|Overall Study||0||
48285717|NCT00841555|101026190|FG001|NOT COMPLETED|Overall Study||0||
48285718|NCT00841555|101026191|FG002|NOT COMPLETED|Overall Study||0||
48285719|NCT01262677|101026192|FG000|STARTED|Overall Study||100||
48285720|NCT01262677|101026193|FG001|STARTED|Overall Study||113||
48285721|NCT01262677|101026194|FG002|STARTED|Overall Study||110||
48285722|NCT01262677|101026192|FG000|COMPLETED|Overall Study||91||
48285723|NCT01262677|101026193|FG001|COMPLETED|Overall Study||98||
48285724|NCT01262677|101026194|FG002|COMPLETED|Overall Study||98||
48285725|NCT01262677|101026192|FG000|NOT COMPLETED|Overall Study||9||
48285726|NCT01262677|101026193|FG001|NOT COMPLETED|Overall Study||15||
48285727|NCT01262677|101026194|FG002|NOT COMPLETED|Overall Study||12||
48285728|NCT00994682|101026195|FG000|STARTED|Double Bilnd||51||
48285729|NCT00994682|101026196|FG001|STARTED|Double Bilnd||50||
48285730|NCT00994682|101026195|FG000|COMPLETED|Double Bilnd||42||
48285731|NCT00994682|101026196|FG001|COMPLETED|Double Bilnd||41||
48285732|NCT00994682|101026195|FG000|NOT COMPLETED|Double Bilnd||9||
48285733|NCT00994682|101026196|FG001|NOT COMPLETED|Double Bilnd||9||
48285734|NCT00994682|101026195|FG000|STARTED|Pioglitazone Open Label||42||
48285735|NCT00994682|101026196|FG001|STARTED|Pioglitazone Open Label||41||
48285736|NCT00994682|101026195|FG000|COMPLETED|Pioglitazone Open Label||29||
48285737|NCT00994682|101026196|FG001|COMPLETED|Pioglitazone Open Label||34||
48285738|NCT00994682|101026195|FG000|NOT COMPLETED|Pioglitazone Open Label||13||
48285739|NCT00994682|101026196|FG001|NOT COMPLETED|Pioglitazone Open Label||7||
48285740|NCT00434213|101026197|FG000|STARTED|Overall Study||309||
48285741|NCT00434213|101026197|FG000|COMPLETED|Overall Study||260||
48576224|NCT02860130|101741331|FG000|COMPLETED|Overall Study||10||
48576225|NCT02860130|101741332|FG001|COMPLETED|Overall Study||8||
48576226|NCT02860130|101741331|FG000|NOT COMPLETED|Overall Study||7||
48576227|NCT02860130|101741332|FG001|NOT COMPLETED|Overall Study||9||
48576228|NCT01298544|101741333|FG000|STARTED|Overall Study||335||
48132216|NCT03701555|100645950|FG026|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132217|NCT03701555|100645951|FG027|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132218|NCT03701555|100645952|FG028|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132219|NCT03701555|100645953|FG029|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132220|NCT03701555|100645954|FG030|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132221|NCT03701555|100645955|FG031|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132222|NCT03701555|100645956|FG032|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132223|NCT03701555|100645957|FG033|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132224|NCT03701555|100645958|FG034|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132225|NCT03701555|100645959|FG035|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
48132226|NCT00353275|100645960|FG000|STARTED|Overall Study||2||
48285742|NCT00434213|101026197|FG000|NOT COMPLETED|Overall Study||49||
48285743|NCT00903682|101026198|FG000|STARTED|Overall Study||79||
48285744|NCT00903682|101026199|FG001|STARTED|Overall Study||78||
48285745|NCT00903682|101026198|FG000|COMPLETED|Overall Study||63||
48285746|NCT00903682|101026199|FG001|COMPLETED|Overall Study||63||
48285747|NCT00903682|101026198|FG000|NOT COMPLETED|Overall Study||16||
48285748|NCT00903682|101026199|FG001|NOT COMPLETED|Overall Study||15||
48285749|NCT00825825|101026200|FG000|STARTED|First Medication Period (14 Days)||6||
48285750|NCT00825825|101026201|FG001|STARTED|First Medication Period (14 Days)||4||
48285751|NCT00825825|101026202|FG002|STARTED|First Medication Period (14 Days)||3||
48285752|NCT00825825|101026203|FG003|STARTED|First Medication Period (14 Days)||5||
48285753|NCT00825825|101026204|FG004|STARTED|First Medication Period (14 Days)||4||
48132227|NCT00353275|100645961|FG001|STARTED|Overall Study||3||
48132228|NCT00353275|100645960|FG000|COMPLETED|Overall Study||2||
48132229|NCT00353275|100645961|FG001|COMPLETED|Overall Study||3||
48132230|NCT00353275|100645960|FG000|NOT COMPLETED|Overall Study||0||
48132231|NCT00353275|100645961|FG001|NOT COMPLETED|Overall Study||0||
48285754|NCT00825825|101026205|FG005|STARTED|First Medication Period (14 Days)||5||
48285755|NCT00825825|101026200|FG000|COMPLETED|First Medication Period (14 Days)||3||
48285756|NCT00825825|101026201|FG001|COMPLETED|First Medication Period (14 Days)||4||
48576229|NCT01298544|101741333|FG000|COMPLETED|Overall Study||335||
48576230|NCT01298544|101741333|FG000|NOT COMPLETED|Overall Study||0||
48576231|NCT04105218|101741334|FG000|STARTED|Overall Study||6||
48576232|NCT04105218|101741335|FG001|STARTED|Overall Study||6||
48576233|NCT04105218|101741334|FG000|Completed First Condition|Overall Study||0||
48576234|NCT04105218|101741335|FG001|Completed First Condition|Overall Study||1||
48132232|NCT00799812|100645962|FG000|STARTED|Overall Study||335||1324
48132233|NCT00799812|100645962|FG000|CHG Swabstick (3 @ Once)|Overall Study||139||276
48285757|NCT00825825|101026202|FG002|COMPLETED|First Medication Period (14 Days)||2||
48285758|NCT00825825|101026203|FG003|COMPLETED|First Medication Period (14 Days)||5||
48576235|NCT04105218|101741334|FG000|Completed Second Condition|Overall Study||0||
48576236|NCT04105218|101741335|FG001|Completed Second Condition|Overall Study||0||
48702248|NCT00519376|102057619|FG000|COMPLETED|Washout Period 2||2||
48576237|NCT04105218|101741334|FG000|COMPLETED|Overall Study||0||
48576238|NCT04105218|101741335|FG001|COMPLETED|Overall Study||0||
48576239|NCT04105218|101741334|FG000|NOT COMPLETED|Overall Study||6||
48576240|NCT04105218|101741335|FG001|NOT COMPLETED|Overall Study||6||
48576241|NCT00932373|101741336|FG000|STARTED|Overall Study||3||
48576242|NCT00932373|101741337|FG001|STARTED|Overall Study||1||
48576243|NCT00932373|101741338|FG002|STARTED|Overall Study||1||
48576244|NCT00932373|101741339|FG003|STARTED|Overall Study||1||
48576245|NCT00932373|101741340|FG004|STARTED|Overall Study||15||
48576246|NCT00932373|101741341|FG005|STARTED|Overall Study||3||
48576247|NCT00932373|101741342|FG006|STARTED|Overall Study||3||
48576248|NCT00932373|101741343|FG007|STARTED|Overall Study||3||
48576249|NCT00932373|101741344|FG008|STARTED|Overall Study||3||
48576250|NCT00932373|101741345|FG009|STARTED|Overall Study||16||
48702249|NCT00519376|102057620|FG001|COMPLETED|Washout Period 2||2||
48702250|NCT00519376|102057621|FG002|COMPLETED|Washout Period 2||2||
48702251|NCT00519376|102057622|FG003|COMPLETED|Washout Period 2||2||
48702252|NCT00519376|102057623|FG004|COMPLETED|Washout Period 2||1||
48702253|NCT00519376|102057624|FG005|COMPLETED|Washout Period 2||1||
48702254|NCT00519376|102057625|FG006|COMPLETED|Washout Period 2||1||
48702255|NCT00519376|102057626|FG007|COMPLETED|Washout Period 2||1||
48702256|NCT00519376|102057627|FG008|COMPLETED|Washout Period 2||1||
48702257|NCT00519376|102057628|FG009|COMPLETED|Washout Period 2||1||
48702258|NCT00519376|102057629|FG010|COMPLETED|Washout Period 2||1||
48702259|NCT00519376|102057630|FG011|COMPLETED|Washout Period 2||1||
48702260|NCT00519376|102057631|FG012|COMPLETED|Washout Period 2||0||
48702261|NCT00519376|102057632|FG013|COMPLETED|Washout Period 2||1||
48702262|NCT00519376|102057633|FG014|COMPLETED|Washout Period 2||1||
48702263|NCT00519376|102057634|FG015|COMPLETED|Washout Period 2||1||
48702264|NCT00519376|102057619|FG000|NOT COMPLETED|Washout Period 2||0||
48576251|NCT00932373|101741346|FG010|STARTED|Overall Study||3||
48576252|NCT00932373|101741336|FG000|COMPLETED|Overall Study||0||
48576253|NCT00932373|101741337|FG001|COMPLETED|Overall Study||0||
48576254|NCT00932373|101741338|FG002|COMPLETED|Overall Study||0||
48576255|NCT00932373|101741339|FG003|COMPLETED|Overall Study||1||
48576256|NCT00932373|101741340|FG004|COMPLETED|Overall Study||1||
48576257|NCT00932373|101741341|FG005|COMPLETED|Overall Study||0||
48576258|NCT00932373|101741342|FG006|COMPLETED|Overall Study||2||
48576259|NCT00932373|101741343|FG007|COMPLETED|Overall Study||0||
48576260|NCT00932373|101741344|FG008|COMPLETED|Overall Study||1||
48576261|NCT00932373|101741345|FG009|COMPLETED|Overall Study||3||
48576262|NCT00932373|101741346|FG010|COMPLETED|Overall Study||0||
48576263|NCT00932373|101741336|FG000|NOT COMPLETED|Overall Study||3||
48576264|NCT00932373|101741337|FG001|NOT COMPLETED|Overall Study||1||
48576265|NCT00932373|101741338|FG002|NOT COMPLETED|Overall Study||1||
48576266|NCT00932373|101741339|FG003|NOT COMPLETED|Overall Study||0||
48576267|NCT00932373|101741340|FG004|NOT COMPLETED|Overall Study||14||
48576268|NCT00932373|101741341|FG005|NOT COMPLETED|Overall Study||3||
48576269|NCT00932373|101741342|FG006|NOT COMPLETED|Overall Study||1||
48576270|NCT00932373|101741343|FG007|NOT COMPLETED|Overall Study||3||
48576271|NCT00932373|101741344|FG008|NOT COMPLETED|Overall Study||2||
48576272|NCT00932373|101741345|FG009|NOT COMPLETED|Overall Study||13||
48576273|NCT00932373|101741346|FG010|NOT COMPLETED|Overall Study||3||
48576274|NCT00603590|101741347|FG000|STARTED|Overall Study||241||
48576275|NCT00603590|101741348|FG001|STARTED|Overall Study||234||
48576276|NCT00603590|101741347|FG000|One Month|Overall Study||204||
48576277|NCT00603590|101741348|FG001|One Month|Overall Study||212||
48702265|NCT00519376|102057620|FG001|NOT COMPLETED|Washout Period 2||0||
48702266|NCT00519376|102057621|FG002|NOT COMPLETED|Washout Period 2||0||
48702267|NCT00519376|102057622|FG003|NOT COMPLETED|Washout Period 2||0||
48702268|NCT00519376|102057623|FG004|NOT COMPLETED|Washout Period 2||0||
48702269|NCT00519376|102057624|FG005|NOT COMPLETED|Washout Period 2||0||
48702270|NCT00519376|102057625|FG006|NOT COMPLETED|Washout Period 2||0||
48702271|NCT00519376|102057626|FG007|NOT COMPLETED|Washout Period 2||0||
48702272|NCT00519376|102057627|FG008|NOT COMPLETED|Washout Period 2||0||
48702273|NCT00519376|102057628|FG009|NOT COMPLETED|Washout Period 2||0||
48576278|NCT00603590|101741347|FG000|Four Months|Overall Study||187||
48576279|NCT00603590|101741348|FG001|Four Months|Overall Study||200||
48576280|NCT00603590|101741347|FG000|Eight Months|Overall Study||178||
48576281|NCT00603590|101741348|FG001|Eight Months|Overall Study||194||
48576282|NCT00603590|101741347|FG000|COMPLETED|Overall Study||165||
48576283|NCT00603590|101741348|FG001|COMPLETED|Overall Study||183||
48576284|NCT00603590|101741347|FG000|NOT COMPLETED|Overall Study||76||
48576285|NCT00603590|101741348|FG001|NOT COMPLETED|Overall Study||51||
48576286|NCT01959464|101741349|FG000|STARTED|Overall Study||10||
48576287|NCT01959464|101741350|FG001|STARTED|Overall Study||10||
48576288|NCT01959464|101741349|FG000|COMPLETED|Overall Study||9||
48576289|NCT01959464|101741350|FG001|COMPLETED|Overall Study||10||
48576290|NCT01959464|101741349|FG000|NOT COMPLETED|Overall Study||1||
48702274|NCT00519376|102057629|FG010|NOT COMPLETED|Washout Period 2||0||
48702275|NCT00519376|102057630|FG011|NOT COMPLETED|Washout Period 2||0||
48702276|NCT00519376|102057631|FG012|NOT COMPLETED|Washout Period 2||0||
48702277|NCT00519376|102057632|FG013|NOT COMPLETED|Washout Period 2||0||
48576291|NCT01959464|101741350|FG001|NOT COMPLETED|Overall Study||0||
48576292|NCT00280397|101741351|FG000|STARTED|Overall Study||27||
48576293|NCT00280397|101741351|FG000|COMPLETED|Overall Study||26||
48576294|NCT00280397|101741351|FG000|NOT COMPLETED|Overall Study||1||
48576295|NCT03625466|101741352|FG000|STARTED|Placebo-controlled Period (48 Weeks)||16||
48576296|NCT03625466|101741353|FG001|STARTED|Placebo-controlled Period (48 Weeks)||35||
48576297|NCT03625466|101741354|FG002|STARTED|Placebo-controlled Period (48 Weeks)||0||
48576298|NCT03625466|101741352|FG000|COMPLETED|Placebo-controlled Period (48 Weeks)||16||
48576299|NCT03625466|101741353|FG001|COMPLETED|Placebo-controlled Period (48 Weeks)||33||
48576300|NCT03625466|101741354|FG002|COMPLETED|Placebo-controlled Period (48 Weeks)||0||
48576301|NCT03625466|101741352|FG000|NOT COMPLETED|Placebo-controlled Period (48 Weeks)||0||
48576302|NCT03625466|101741353|FG001|NOT COMPLETED|Placebo-controlled Period (48 Weeks)||2||
48576303|NCT03625466|101741354|FG002|NOT COMPLETED|Placebo-controlled Period (48 Weeks)||0||
48576304|NCT03625466|101741352|FG000|STARTED|Open-label Period (48 Weeks)||0||
48576305|NCT03625466|101741353|FG001|STARTED|Open-label Period (48 Weeks)||0||
48576306|NCT03625466|101741354|FG002|STARTED|Open-label Period (48 Weeks)||49||
48702278|NCT00519376|102057633|FG014|NOT COMPLETED|Washout Period 2||0||
48702279|NCT00519376|102057634|FG015|NOT COMPLETED|Washout Period 2||0||
48702280|NCT00519376|102057619|FG000|STARTED|Treatment Period 3||2||
48702281|NCT00519376|102057620|FG001|STARTED|Treatment Period 3||2||
48702282|NCT00519376|102057621|FG002|STARTED|Treatment Period 3||2||
48702283|NCT00519376|102057622|FG003|STARTED|Treatment Period 3||2||
48702284|NCT00519376|102057623|FG004|STARTED|Treatment Period 3||1||
48702285|NCT00519376|102057624|FG005|STARTED|Treatment Period 3||1||
48285759|NCT00825825|101026204|FG004|COMPLETED|First Medication Period (14 Days)||4||
48285760|NCT00825825|101026205|FG005|COMPLETED|First Medication Period (14 Days)||3||
48285761|NCT00825825|101026200|FG000|NOT COMPLETED|First Medication Period (14 Days)||3||
48702286|NCT00519376|102057625|FG006|STARTED|Treatment Period 3||1||
48702287|NCT00519376|102057626|FG007|STARTED|Treatment Period 3||1||
48702288|NCT00519376|102057627|FG008|STARTED|Treatment Period 3||1||
48702289|NCT00519376|102057628|FG009|STARTED|Treatment Period 3||1||
48702290|NCT00519376|102057629|FG010|STARTED|Treatment Period 3||1||
48702291|NCT00519376|102057630|FG011|STARTED|Treatment Period 3||1||
48702292|NCT00519376|102057631|FG012|STARTED|Treatment Period 3||0||
48702293|NCT00519376|102057632|FG013|STARTED|Treatment Period 3||1||
48702294|NCT00519376|102057633|FG014|STARTED|Treatment Period 3||1||
48702295|NCT00519376|102057634|FG015|STARTED|Treatment Period 3||1||
48702296|NCT00519376|102057619|FG000|COMPLETED|Treatment Period 3||2||
48702297|NCT00519376|102057620|FG001|COMPLETED|Treatment Period 3||2||
48285762|NCT00825825|101026201|FG001|NOT COMPLETED|First Medication Period (14 Days)||0||
48285763|NCT00825825|101026202|FG002|NOT COMPLETED|First Medication Period (14 Days)||1||
48285764|NCT00825825|101026203|FG003|NOT COMPLETED|First Medication Period (14 Days)||0||
48285765|NCT00825825|101026204|FG004|NOT COMPLETED|First Medication Period (14 Days)||0||
48285766|NCT00825825|101026205|FG005|NOT COMPLETED|First Medication Period (14 Days)||2||
48285767|NCT00825825|101026200|FG000|STARTED|First Washout Period (14 Days)||3||
48285768|NCT00825825|101026201|FG001|STARTED|First Washout Period (14 Days)||4||
48285769|NCT00825825|101026202|FG002|STARTED|First Washout Period (14 Days)||2||
48285770|NCT00825825|101026203|FG003|STARTED|First Washout Period (14 Days)||5||
48285771|NCT00825825|101026204|FG004|STARTED|First Washout Period (14 Days)||4||
48285772|NCT00825825|101026205|FG005|STARTED|First Washout Period (14 Days)||3||
48285773|NCT00825825|101026200|FG000|COMPLETED|First Washout Period (14 Days)||3||
48576307|NCT03625466|101741352|FG000|COMPLETED|Open-label Period (48 Weeks)||0||
48702298|NCT00519376|102057621|FG002|COMPLETED|Treatment Period 3||2||
48702299|NCT00519376|102057622|FG003|COMPLETED|Treatment Period 3||2||
48702300|NCT00519376|102057623|FG004|COMPLETED|Treatment Period 3||1||
48702301|NCT00519376|102057624|FG005|COMPLETED|Treatment Period 3||1||
48702302|NCT00519376|102057625|FG006|COMPLETED|Treatment Period 3||1||
48702303|NCT00519376|102057626|FG007|COMPLETED|Treatment Period 3||1||
48702304|NCT00519376|102057627|FG008|COMPLETED|Treatment Period 3||1||
48702305|NCT00519376|102057628|FG009|COMPLETED|Treatment Period 3||1||
48702306|NCT00519376|102057629|FG010|COMPLETED|Treatment Period 3||1||
48285774|NCT00825825|101026201|FG001|COMPLETED|First Washout Period (14 Days)||4||
48285775|NCT00825825|101026202|FG002|COMPLETED|First Washout Period (14 Days)||2||
48285776|NCT00825825|101026203|FG003|COMPLETED|First Washout Period (14 Days)||5||
48285777|NCT00825825|101026204|FG004|COMPLETED|First Washout Period (14 Days)||4||
48285778|NCT00825825|101026205|FG005|COMPLETED|First Washout Period (14 Days)||3||
48285779|NCT00825825|101026200|FG000|NOT COMPLETED|First Washout Period (14 Days)||0||
48576308|NCT03625466|101741353|FG001|COMPLETED|Open-label Period (48 Weeks)||0||
48399678|NCT01997281|101309185|FG000|Withdrawal|Overall Study||1||
48399679|NCT01997281|101309186|FG001|Withdrawal|Overall Study||0||
48399680|NCT01997281|101309185|FG000|COMPLETED|Overall Study||6||
48399681|NCT01997281|101309186|FG001|COMPLETED|Overall Study||7||
48399682|NCT01997281|101309185|FG000|NOT COMPLETED|Overall Study||1||
48285780|NCT00825825|101026201|FG001|NOT COMPLETED|First Washout Period (14 Days)||0||
48285781|NCT00825825|101026202|FG002|NOT COMPLETED|First Washout Period (14 Days)||0||
48285782|NCT00825825|101026203|FG003|NOT COMPLETED|First Washout Period (14 Days)||0||
48285783|NCT00825825|101026204|FG004|NOT COMPLETED|First Washout Period (14 Days)||0||
48285784|NCT00825825|101026205|FG005|NOT COMPLETED|First Washout Period (14 Days)||0||
48285785|NCT00825825|101026200|FG000|STARTED|Second Medication Period (14 Days)||3||
48285786|NCT00825825|101026201|FG001|STARTED|Second Medication Period (14 Days)||4||
48285787|NCT00825825|101026202|FG002|STARTED|Second Medication Period (14 Days)||2||
48285788|NCT00825825|101026203|FG003|STARTED|Second Medication Period (14 Days)||5||
48285789|NCT00825825|101026204|FG004|STARTED|Second Medication Period (14 Days)||4||
48285790|NCT00825825|101026205|FG005|STARTED|Second Medication Period (14 Days)||3||
48285791|NCT00825825|101026200|FG000|COMPLETED|Second Medication Period (14 Days)||1||
48285792|NCT00825825|101026201|FG001|COMPLETED|Second Medication Period (14 Days)||4||
48285793|NCT00825825|101026202|FG002|COMPLETED|Second Medication Period (14 Days)||2||
48285794|NCT00825825|101026203|FG003|COMPLETED|Second Medication Period (14 Days)||3||
48285795|NCT00825825|101026204|FG004|COMPLETED|Second Medication Period (14 Days)||3||
48285796|NCT00825825|101026205|FG005|COMPLETED|Second Medication Period (14 Days)||3||
48285797|NCT00825825|101026200|FG000|NOT COMPLETED|Second Medication Period (14 Days)||2||
48285798|NCT00825825|101026201|FG001|NOT COMPLETED|Second Medication Period (14 Days)||0||
48285799|NCT00825825|101026202|FG002|NOT COMPLETED|Second Medication Period (14 Days)||0||
48285800|NCT00825825|101026203|FG003|NOT COMPLETED|Second Medication Period (14 Days)||2||
48285801|NCT00825825|101026204|FG004|NOT COMPLETED|Second Medication Period (14 Days)||1||
48285802|NCT00825825|101026205|FG005|NOT COMPLETED|Second Medication Period (14 Days)||0||
48285803|NCT00825825|101026200|FG000|STARTED|Second Washout Period (14 Days)||1||
48285804|NCT00825825|101026201|FG001|STARTED|Second Washout Period (14 Days)||4||
48285805|NCT00825825|101026202|FG002|STARTED|Second Washout Period (14 Days)||2||
48285806|NCT00825825|101026203|FG003|STARTED|Second Washout Period (14 Days)||3||
48285807|NCT00825825|101026204|FG004|STARTED|Second Washout Period (14 Days)||3||
48285808|NCT00825825|101026205|FG005|STARTED|Second Washout Period (14 Days)||3||
48285809|NCT00825825|101026200|FG000|COMPLETED|Second Washout Period (14 Days)||1||
48285810|NCT00825825|101026201|FG001|COMPLETED|Second Washout Period (14 Days)||4||
48285811|NCT00825825|101026202|FG002|COMPLETED|Second Washout Period (14 Days)||2||
48285812|NCT00825825|101026203|FG003|COMPLETED|Second Washout Period (14 Days)||3||
48399683|NCT01997281|101309186|FG001|NOT COMPLETED|Overall Study||0||
48399684|NCT02033850|101309187|FG000|STARTED|Overall Study||23||
48399685|NCT02033850|101309188|FG001|STARTED|Overall Study||23||
48399686|NCT02033850|101309187|FG000|COMPLETED|Overall Study||21||
48399687|NCT02033850|101309188|FG001|COMPLETED|Overall Study||22||
48399688|NCT02033850|101309187|FG000|NOT COMPLETED|Overall Study||2||
48399689|NCT02033850|101309188|FG001|NOT COMPLETED|Overall Study||1||
48399690|NCT01153672|101309189|FG000|STARTED|Overall Study||8||
48399691|NCT01153672|101309189|FG000|COMPLETED|Overall Study||6||
48399692|NCT01153672|101309189|FG000|NOT COMPLETED|Overall Study||2||
48399693|NCT03363165|101309190|FG000|STARTED|3-month Follow-up||18||
48399694|NCT03363165|101309191|FG001|STARTED|3-month Follow-up||21||
48399695|NCT03363165|101309190|FG000|COMPLETED|3-month Follow-up||18||
48285813|NCT00825825|101026204|FG004|COMPLETED|Second Washout Period (14 Days)||3||
48285814|NCT00825825|101026205|FG005|COMPLETED|Second Washout Period (14 Days)||3||
48285815|NCT00825825|101026200|FG000|NOT COMPLETED|Second Washout Period (14 Days)||0||
48285816|NCT00825825|101026201|FG001|NOT COMPLETED|Second Washout Period (14 Days)||0||
48285817|NCT00825825|101026202|FG002|NOT COMPLETED|Second Washout Period (14 Days)||0||
48285818|NCT00825825|101026203|FG003|NOT COMPLETED|Second Washout Period (14 Days)||0||
48285819|NCT00825825|101026204|FG004|NOT COMPLETED|Second Washout Period (14 Days)||0||
48285820|NCT00825825|101026205|FG005|NOT COMPLETED|Second Washout Period (14 Days)||0||
48285821|NCT00825825|101026200|FG000|STARTED|Third Medication Period (14 Days)||1||
48285822|NCT00825825|101026201|FG001|STARTED|Third Medication Period (14 Days)||4||
48285823|NCT00825825|101026202|FG002|STARTED|Third Medication Period (14 Days)||2||
48285824|NCT00825825|101026203|FG003|STARTED|Third Medication Period (14 Days)||3||
48285825|NCT00825825|101026204|FG004|STARTED|Third Medication Period (14 Days)||3||
48285826|NCT00825825|101026205|FG005|STARTED|Third Medication Period (14 Days)||3||
48399696|NCT03363165|101309191|FG001|COMPLETED|3-month Follow-up||20||
48399697|NCT03363165|101309190|FG000|NOT COMPLETED|3-month Follow-up||0||
48399698|NCT03363165|101309191|FG001|NOT COMPLETED|3-month Follow-up||1||
48399699|NCT03363165|101309190|FG000|STARTED|6-month Follow-up||18||
48399700|NCT03363165|101309191|FG001|STARTED|6-month Follow-up||21||
48285827|NCT00825825|101026200|FG000|COMPLETED|Third Medication Period (14 Days)||1||
48399701|NCT03363165|101309190|FG000|COMPLETED|6-month Follow-up||17||
48399702|NCT03363165|101309191|FG001|COMPLETED|6-month Follow-up||19||
48399703|NCT03363165|101309190|FG000|NOT COMPLETED|6-month Follow-up||1||
48399704|NCT03363165|101309191|FG001|NOT COMPLETED|6-month Follow-up||2||
48399705|NCT03363165|101309190|FG000|STARTED|12-month Follow-up||18||
48399706|NCT03363165|101309191|FG001|STARTED|12-month Follow-up||21||
48399707|NCT03363165|101309190|FG000|COMPLETED|12-month Follow-up||16||
48399708|NCT03363165|101309191|FG001|COMPLETED|12-month Follow-up||19||
48399709|NCT03363165|101309190|FG000|NOT COMPLETED|12-month Follow-up||2||
48399710|NCT03363165|101309191|FG001|NOT COMPLETED|12-month Follow-up||2||
48399711|NCT01313078|101309192|FG000|STARTED|Overall Study||4||
48399712|NCT01313078|101309192|FG000|COMPLETED|Overall Study||1||
48702307|NCT00519376|102057630|FG011|COMPLETED|Treatment Period 3||1||
48702308|NCT00519376|102057631|FG012|COMPLETED|Treatment Period 3||0||
48702309|NCT00519376|102057632|FG013|COMPLETED|Treatment Period 3||1||
48702310|NCT00519376|102057633|FG014|COMPLETED|Treatment Period 3||1||
48702311|NCT00519376|102057634|FG015|COMPLETED|Treatment Period 3||1||
48702312|NCT00519376|102057619|FG000|NOT COMPLETED|Treatment Period 3||0||
48702313|NCT00519376|102057620|FG001|NOT COMPLETED|Treatment Period 3||0||
48702314|NCT00519376|102057621|FG002|NOT COMPLETED|Treatment Period 3||0||
48702315|NCT00519376|102057622|FG003|NOT COMPLETED|Treatment Period 3||0||
48702316|NCT00519376|102057623|FG004|NOT COMPLETED|Treatment Period 3||0||
48702317|NCT00519376|102057624|FG005|NOT COMPLETED|Treatment Period 3||0||
48702318|NCT00519376|102057625|FG006|NOT COMPLETED|Treatment Period 3||0||
48285828|NCT00825825|101026201|FG001|COMPLETED|Third Medication Period (14 Days)||2||
48285829|NCT00825825|101026202|FG002|COMPLETED|Third Medication Period (14 Days)||2||
48285830|NCT00825825|101026203|FG003|COMPLETED|Third Medication Period (14 Days)||3||
48285831|NCT00825825|101026204|FG004|COMPLETED|Third Medication Period (14 Days)||3||
48285832|NCT00825825|101026205|FG005|COMPLETED|Third Medication Period (14 Days)||1||
48285833|NCT00825825|101026200|FG000|NOT COMPLETED|Third Medication Period (14 Days)||0||
48285834|NCT00825825|101026201|FG001|NOT COMPLETED|Third Medication Period (14 Days)||2||
48285835|NCT00825825|101026202|FG002|NOT COMPLETED|Third Medication Period (14 Days)||0||
48285836|NCT00825825|101026203|FG003|NOT COMPLETED|Third Medication Period (14 Days)||0||
48285837|NCT00825825|101026204|FG004|NOT COMPLETED|Third Medication Period (14 Days)||0||
48285838|NCT00825825|101026205|FG005|NOT COMPLETED|Third Medication Period (14 Days)||2||
48285839|NCT01119105|101026206|FG000|STARTED|Overall Study||70||
48285840|NCT01119105|101026207|FG001|STARTED|Overall Study||72||
48285841|NCT01119105|101026208|FG002|STARTED|Overall Study||68||
48285842|NCT01119105|101026206|FG000|COMPLETED|Overall Study||66||
48285843|NCT01119105|101026207|FG001|COMPLETED|Overall Study||66||
48285844|NCT01119105|101026208|FG002|COMPLETED|Overall Study||60||
48285845|NCT01119105|101026206|FG000|NOT COMPLETED|Overall Study||4||
48285846|NCT01119105|101026207|FG001|NOT COMPLETED|Overall Study||6||
48285847|NCT01119105|101026208|FG002|NOT COMPLETED|Overall Study||8||
48285848|NCT03694275|101026209|FG000|STARTED|Overall Study||8||
48285849|NCT03694275|101026210|FG001|STARTED|Overall Study||12||
48285850|NCT03694275|101026209|FG000|COMPLETED|Overall Study||8||
48399713|NCT01313078|101309192|FG000|NOT COMPLETED|Overall Study||3||
48399714|NCT01175590|101309193|FG000|STARTED|Overall Study||347||
48399715|NCT01175590|101309194|FG001|STARTED|Overall Study||171||
48399716|NCT01175590|101309193|FG000|Modified Intent to Treat Population|Overall Study||212||
48399717|NCT01175590|101309194|FG001|Modified Intent to Treat Population|Overall Study||87||
48399718|NCT01175590|101309193|FG000|Safety Population|Overall Study||344||
48399719|NCT01175590|101309194|FG001|Safety Population|Overall Study||170||
48399720|NCT01175590|101309193|FG000|COMPLETED|Overall Study||335||
48399721|NCT01175590|101309194|FG001|COMPLETED|Overall Study||161||
48399722|NCT01175590|101309193|FG000|NOT COMPLETED|Overall Study||12||
48399723|NCT01175590|101309194|FG001|NOT COMPLETED|Overall Study||10||
48399724|NCT02076334|101309195|FG000|STARTED|Overall Study||21||
48399725|NCT02076334|101309196|FG001|STARTED|Overall Study||21||
48702319|NCT00519376|102057626|FG007|NOT COMPLETED|Treatment Period 3||0||
48702320|NCT00519376|102057627|FG008|NOT COMPLETED|Treatment Period 3||0||
48702321|NCT00519376|102057628|FG009|NOT COMPLETED|Treatment Period 3||0||
48702322|NCT00519376|102057629|FG010|NOT COMPLETED|Treatment Period 3||0||
48702323|NCT00519376|102057630|FG011|NOT COMPLETED|Treatment Period 3||0||
48702324|NCT00519376|102057631|FG012|NOT COMPLETED|Treatment Period 3||0||
48702325|NCT00519376|102057632|FG013|NOT COMPLETED|Treatment Period 3||0||
48702326|NCT00519376|102057633|FG014|NOT COMPLETED|Treatment Period 3||0||
48702327|NCT00519376|102057634|FG015|NOT COMPLETED|Treatment Period 3||0||
48702328|NCT00519376|102057619|FG000|STARTED|Washout Period 3||2||
48702329|NCT00519376|102057620|FG001|STARTED|Washout Period 3||2||
48702330|NCT00519376|102057621|FG002|STARTED|Washout Period 3||2||
48702331|NCT00519376|102057622|FG003|STARTED|Washout Period 3||2||
48702332|NCT00519376|102057623|FG004|STARTED|Washout Period 3||1||
48702333|NCT00519376|102057624|FG005|STARTED|Washout Period 3||1||
48702334|NCT00519376|102057625|FG006|STARTED|Washout Period 3||1||
48702335|NCT00519376|102057626|FG007|STARTED|Washout Period 3||1||
48702336|NCT00519376|102057627|FG008|STARTED|Washout Period 3||1||
48702337|NCT00519376|102057628|FG009|STARTED|Washout Period 3||1||
48702338|NCT00519376|102057629|FG010|STARTED|Washout Period 3||1||
48702339|NCT00519376|102057630|FG011|STARTED|Washout Period 3||1||
48702340|NCT00519376|102057631|FG012|STARTED|Washout Period 3||0||
48702341|NCT00519376|102057632|FG013|STARTED|Washout Period 3||1||
48399726|NCT02076334|101309197|FG002|STARTED|Overall Study||21||
48399727|NCT02076334|101309198|FG003|STARTED|Overall Study||21||
48399728|NCT02076334|101309195|FG000|COMPLETED|Overall Study||20||
48399729|NCT02076334|101309196|FG001|COMPLETED|Overall Study||20||
48576309|NCT03625466|101741354|FG002|COMPLETED|Open-label Period (48 Weeks)||48||
48576310|NCT03625466|101741352|FG000|NOT COMPLETED|Open-label Period (48 Weeks)||0||
48576311|NCT03625466|101741353|FG001|NOT COMPLETED|Open-label Period (48 Weeks)||0||
48576312|NCT03625466|101741354|FG002|NOT COMPLETED|Open-label Period (48 Weeks)||1||
48576313|NCT06175026|101741355|FG000|STARTED|Overall Study||441||
48702342|NCT00519376|102057633|FG014|STARTED|Washout Period 3||1||
48702343|NCT00519376|102057634|FG015|STARTED|Washout Period 3||1||
48702344|NCT00519376|102057619|FG000|COMPLETED|Washout Period 3||2||
48702345|NCT00519376|102057620|FG001|COMPLETED|Washout Period 3||2||
48702346|NCT00519376|102057621|FG002|COMPLETED|Washout Period 3||2||
48702347|NCT00519376|102057622|FG003|COMPLETED|Washout Period 3||2||
48702348|NCT00519376|102057623|FG004|COMPLETED|Washout Period 3||1||
48702349|NCT00519376|102057624|FG005|COMPLETED|Washout Period 3||1||
48702350|NCT00519376|102057625|FG006|COMPLETED|Washout Period 3||1||
48702351|NCT00519376|102057626|FG007|COMPLETED|Washout Period 3||1||
48702352|NCT00519376|102057627|FG008|COMPLETED|Washout Period 3||1||
48702353|NCT00519376|102057628|FG009|COMPLETED|Washout Period 3||1||
48285851|NCT03694275|101026210|FG001|COMPLETED|Overall Study||10||
48285852|NCT03694275|101026209|FG000|NOT COMPLETED|Overall Study||0||
48285853|NCT03694275|101026210|FG001|NOT COMPLETED|Overall Study||2||
48285854|NCT04988867|101026211|FG000|STARTED|Overall Study||15||
48285855|NCT04988867|101026211|FG000|COMPLETED|Overall Study||0||
48285856|NCT04988867|101026211|FG000|NOT COMPLETED|Overall Study||15||
48285857|NCT01157676|101026212|FG000|STARTED|Enrollment||174||
48399730|NCT02076334|101309197|FG002|COMPLETED|Overall Study||20||
48399731|NCT02076334|101309198|FG003|COMPLETED|Overall Study||20||
48399732|NCT02076334|101309195|FG000|NOT COMPLETED|Overall Study||1||
48399733|NCT02076334|101309196|FG001|NOT COMPLETED|Overall Study||1||
48399734|NCT02076334|101309197|FG002|NOT COMPLETED|Overall Study||1||
48399735|NCT02076334|101309198|FG003|NOT COMPLETED|Overall Study||1||
48399736|NCT00612339|101309199|FG000|STARTED|Overall Study||41||
48576314|NCT06175026|101741356|FG001|STARTED|Overall Study||446||
48702354|NCT00519376|102057629|FG010|COMPLETED|Washout Period 3||1||
48702355|NCT00519376|102057630|FG011|COMPLETED|Washout Period 3||1||
48702356|NCT00519376|102057631|FG012|COMPLETED|Washout Period 3||0||
48702357|NCT00519376|102057632|FG013|COMPLETED|Washout Period 3||1||
48702358|NCT00519376|102057633|FG014|COMPLETED|Washout Period 3||1||
48702359|NCT00519376|102057634|FG015|COMPLETED|Washout Period 3||1||
48285858|NCT01157676|101026213|FG001|STARTED|Enrollment||176||
48285859|NCT01157676|101026212|FG000|COMPLETED|Enrollment||174||
48702360|NCT00519376|102057619|FG000|NOT COMPLETED|Washout Period 3||0||
48702361|NCT00519376|102057620|FG001|NOT COMPLETED|Washout Period 3||0||
48702362|NCT00519376|102057621|FG002|NOT COMPLETED|Washout Period 3||0||
48285860|NCT01157676|101026213|FG001|COMPLETED|Enrollment||176||
48285861|NCT01157676|101026212|FG000|NOT COMPLETED|Enrollment||0||
48285862|NCT01157676|101026213|FG001|NOT COMPLETED|Enrollment||0||
48285863|NCT01157676|101026212|FG000|STARTED|Randomization||174||
48576315|NCT06175026|101741357|FG002|STARTED|Overall Study||431||
48576316|NCT06175026|101741358|FG003|STARTED|Overall Study||435||
48702363|NCT00519376|102057622|FG003|NOT COMPLETED|Washout Period 3||0||
48702364|NCT00519376|102057623|FG004|NOT COMPLETED|Washout Period 3||0||
48702365|NCT00519376|102057624|FG005|NOT COMPLETED|Washout Period 3||0||
48702366|NCT00519376|102057625|FG006|NOT COMPLETED|Washout Period 3||0||
48702367|NCT00519376|102057626|FG007|NOT COMPLETED|Washout Period 3||0||
48702368|NCT00519376|102057627|FG008|NOT COMPLETED|Washout Period 3||0||
48702369|NCT00519376|102057628|FG009|NOT COMPLETED|Washout Period 3||0||
48702370|NCT00519376|102057629|FG010|NOT COMPLETED|Washout Period 3||0||
48702371|NCT00519376|102057630|FG011|NOT COMPLETED|Washout Period 3||0||
48285864|NCT01157676|101026213|FG001|STARTED|Randomization||176||
48285865|NCT01157676|101026212|FG000|COMPLETED|Randomization||153||
48399737|NCT00612339|101309199|FG000|COMPLETED|Overall Study||41||
48576317|NCT06175026|101741355|FG000|COMPLETED|Overall Study||441||
48702372|NCT00519376|102057631|FG012|NOT COMPLETED|Washout Period 3||0||
48702373|NCT00519376|102057632|FG013|NOT COMPLETED|Washout Period 3||0||
48702374|NCT00519376|102057633|FG014|NOT COMPLETED|Washout Period 3||0||
48702375|NCT00519376|102057634|FG015|NOT COMPLETED|Washout Period 3||0||
48702376|NCT00519376|102057619|FG000|STARTED|Treatment Period 4||2||
48285866|NCT01157676|101026213|FG001|COMPLETED|Randomization||159||
48285867|NCT01157676|101026212|FG000|NOT COMPLETED|Randomization||21||
48399738|NCT00612339|101309199|FG000|NOT COMPLETED|Overall Study||0||
48576318|NCT06175026|101741356|FG001|COMPLETED|Overall Study||446||
48576319|NCT06175026|101741357|FG002|COMPLETED|Overall Study||431||
48702377|NCT00519376|102057620|FG001|STARTED|Treatment Period 4||2||
48702378|NCT00519376|102057621|FG002|STARTED|Treatment Period 4||2||
48702379|NCT00519376|102057622|FG003|STARTED|Treatment Period 4||2||
48576320|NCT06175026|101741358|FG003|COMPLETED|Overall Study||435||
48576321|NCT06175026|101741355|FG000|NOT COMPLETED|Overall Study||0||
48576322|NCT06175026|101741356|FG001|NOT COMPLETED|Overall Study||0||
48576323|NCT06175026|101741357|FG002|NOT COMPLETED|Overall Study||0||
48576324|NCT06175026|101741358|FG003|NOT COMPLETED|Overall Study||0||
48576325|NCT01355575|101741359|FG000|STARTED|Overall Study||15||
48285868|NCT01157676|101026213|FG001|NOT COMPLETED|Randomization||17||
48285869|NCT01157676|101026212|FG000|STARTED|Surgery||153||
48285870|NCT01157676|101026213|FG001|STARTED|Surgery||159||
48576326|NCT01355575|101741359|FG000|COMPLETED|Overall Study||13||
48576327|NCT01355575|101741359|FG000|NOT COMPLETED|Overall Study||2||
48576328|NCT04170738|101741360|FG000|STARTED|Overall Study||26||
48576329|NCT04170738|101741361|FG001|STARTED|Overall Study||7||
48576330|NCT04170738|101741360|FG000|COMPLETED|Overall Study||11||
48576331|NCT04170738|101741361|FG001|COMPLETED|Overall Study||7||
48576332|NCT04170738|101741360|FG000|NOT COMPLETED|Overall Study||15||
48576333|NCT04170738|101741361|FG001|NOT COMPLETED|Overall Study||0||
48576334|NCT01387516|101741362|FG000|STARTED|Overall Study||80||
48576335|NCT01387516|101741363|FG001|STARTED|Overall Study||68||
48576336|NCT01387516|101741364|FG002|STARTED|Overall Study||79||
48576337|NCT01387516|101741365|FG003|STARTED|Overall Study||69||
48285871|NCT01157676|101026212|FG000|COMPLETED|Surgery||152|wrong procedure due to screen failure (n=2), failure to notify surgeon of randomization (n=2).|
48399739|NCT02443805|101309200|FG000|STARTED|Overall Study||802||
48576338|NCT01387516|101741362|FG000|COMPLETED|Overall Study||75||
48576339|NCT01387516|101741363|FG001|COMPLETED|Overall Study||63||
48576340|NCT01387516|101741364|FG002|COMPLETED|Overall Study||75||
48576341|NCT01387516|101741365|FG003|COMPLETED|Overall Study||65||
48576342|NCT01387516|101741362|FG000|NOT COMPLETED|Overall Study||5||
48576343|NCT01387516|101741363|FG001|NOT COMPLETED|Overall Study||5||
48576344|NCT01387516|101741364|FG002|NOT COMPLETED|Overall Study||4||
48702380|NCT00519376|102057623|FG004|STARTED|Treatment Period 4||1||
48702381|NCT00519376|102057624|FG005|STARTED|Treatment Period 4||1||
48702382|NCT00519376|102057625|FG006|STARTED|Treatment Period 4||1||
48702383|NCT00519376|102057626|FG007|STARTED|Treatment Period 4||1||
48702384|NCT00519376|102057627|FG008|STARTED|Treatment Period 4||1||
48702385|NCT00519376|102057628|FG009|STARTED|Treatment Period 4||1||
48702386|NCT00519376|102057629|FG010|STARTED|Treatment Period 4||1||
48702387|NCT00519376|102057630|FG011|STARTED|Treatment Period 4||1||
48702388|NCT00519376|102057631|FG012|STARTED|Treatment Period 4||0||
48702389|NCT00519376|102057632|FG013|STARTED|Treatment Period 4||1||
48702390|NCT00519376|102057633|FG014|STARTED|Treatment Period 4||1||
48702391|NCT00519376|102057634|FG015|STARTED|Treatment Period 4||1||
48702392|NCT00519376|102057619|FG000|COMPLETED|Treatment Period 4||2||
48576345|NCT01387516|101741365|FG003|NOT COMPLETED|Overall Study||4||
48576346|NCT00667823|101741366|FG000|STARTED|Overall Study||550||
48576347|NCT00667823|101741366|FG000|COMPLETED|Overall Study||334||
48576348|NCT00667823|101741366|FG000|NOT COMPLETED|Overall Study||216||
48576349|NCT02649439|101741367|FG000|STARTED|Overall Study||40||
48576350|NCT02649439|101741368|FG001|STARTED|Overall Study||40||
48576351|NCT02649439|101741367|FG000|COMPLETED|Overall Study||13||
48576352|NCT02649439|101741368|FG001|COMPLETED|Overall Study||12||
48576353|NCT02649439|101741367|FG000|NOT COMPLETED|Overall Study||27||
48576354|NCT02649439|101741368|FG001|NOT COMPLETED|Overall Study||28||
48702393|NCT00519376|102057620|FG001|COMPLETED|Treatment Period 4||2||
48702394|NCT00519376|102057621|FG002|COMPLETED|Treatment Period 4||1||
48702395|NCT00519376|102057622|FG003|COMPLETED|Treatment Period 4||2||
48702396|NCT00519376|102057623|FG004|COMPLETED|Treatment Period 4||1||
48702397|NCT00519376|102057624|FG005|COMPLETED|Treatment Period 4||1||
48702398|NCT00519376|102057625|FG006|COMPLETED|Treatment Period 4||1||
48702399|NCT00519376|102057626|FG007|COMPLETED|Treatment Period 4||1||
48576355|NCT00596687|101741369|FG000|STARTED|Overall Study||118||
48576356|NCT00596687|101741370|FG001|STARTED|Overall Study||116||
48576357|NCT00596687|101741369|FG000|COMPLETED|Overall Study||104||
48576358|NCT00596687|101741370|FG001|COMPLETED|Overall Study||107||
48576359|NCT00596687|101741369|FG000|NOT COMPLETED|Overall Study||14||
48576360|NCT00596687|101741370|FG001|NOT COMPLETED|Overall Study||9||
48576361|NCT03192306|101741371|FG000|STARTED|Overall Study||227||
48702400|NCT00519376|102057627|FG008|COMPLETED|Treatment Period 4||1||
48702401|NCT00519376|102057628|FG009|COMPLETED|Treatment Period 4||1||
48702402|NCT00519376|102057629|FG010|COMPLETED|Treatment Period 4||1||
48702403|NCT00519376|102057630|FG011|COMPLETED|Treatment Period 4||1||
48702404|NCT00519376|102057631|FG012|COMPLETED|Treatment Period 4||0||
48576362|NCT03192306|101741372|FG001|STARTED|Overall Study||224||
48576363|NCT03192306|101741371|FG000|Modified Intent to Treat (MITT)|Overall Study||76|MITT represents data collected from enrolled subjects who developed a cold sore and treated.|
48576364|NCT03192306|101741372|FG001|Modified Intent to Treat (MITT)|Overall Study||80|MITT represents data collected from enrolled subjects who developed a cold sore and treated.|
48576365|NCT03192306|101741371|FG000|COMPLETED|Overall Study||75||
48576366|NCT03192306|101741372|FG001|COMPLETED|Overall Study||79||
48576367|NCT03192306|101741371|FG000|NOT COMPLETED|Overall Study||152||
48576368|NCT03192306|101741372|FG001|NOT COMPLETED|Overall Study||145||
48576369|NCT00984568|101741373|FG000|STARTED|Overall Study||15||
48702405|NCT00519376|102057632|FG013|COMPLETED|Treatment Period 4||1||
48132234|NCT00799812|100645962|FG000|CHG Swabstick Sequential|Overall Study||138||273
48132235|NCT00799812|100645962|FG000|Hibiclens|Overall Study||133||264
48132236|NCT00799812|100645962|FG000|Sterile Water Swab (3 @ Once)|Overall Study||132||260
48132237|NCT00799812|100645962|FG000|Sterile Water Swabstick (Sequential)|Overall Study||126||251
48132238|NCT00799812|100645962|FG000|COMPLETED|Overall Study||335||1324
48132239|NCT00799812|100645962|FG000|NOT COMPLETED|Overall Study||0||0
48132240|NCT01303627|100645963|FG000|STARTED|Overall Study||21||
48132241|NCT01303627|100645964|FG001|STARTED|Overall Study||21||
48132242|NCT01303627|100645963|FG000|COMPLETED|Overall Study||21||
48132243|NCT01303627|100645964|FG001|COMPLETED|Overall Study||20||
48132244|NCT01303627|100645963|FG000|NOT COMPLETED|Overall Study||0||
48285872|NCT01157676|101026213|FG001|COMPLETED|Surgery||150|wrong procedure due to screen failure (n=2), failure to notify surgeon of randomization (n=2).|
48285873|NCT01157676|101026212|FG000|NOT COMPLETED|Surgery||1||
48285874|NCT01157676|101026213|FG001|NOT COMPLETED|Surgery||9||
48285875|NCT01127893|101026214|FG000|STARTED|Overall Study||1||
48285876|NCT01127893|101026214|FG000|COMPLETED|Overall Study||0||
48285877|NCT01127893|101026214|FG000|NOT COMPLETED|Overall Study||1||
48576370|NCT00984568|101741374|FG001|STARTED|Overall Study||13||
48576371|NCT00984568|101741373|FG000|COMPLETED|Overall Study||7||
48132245|NCT01303627|100645964|FG001|NOT COMPLETED|Overall Study||1||
48132246|NCT02855060|100645965|FG000|STARTED|Overall Study||22||
48132247|NCT02855060|100645966|FG001|STARTED|Overall Study||28||
48132248|NCT02855060|100645965|FG000|COMPLETED|Overall Study||20||
48132249|NCT02855060|100645966|FG001|COMPLETED|Overall Study||23||
48132250|NCT02855060|100645965|FG000|NOT COMPLETED|Overall Study||2||
48132251|NCT02855060|100645966|FG001|NOT COMPLETED|Overall Study||5||
48132252|NCT01798550|100645967|FG000|STARTED|Overall Study||30||
48132253|NCT01798550|100645968|FG001|STARTED|Overall Study||32||
48132254|NCT01798550|100645967|FG000|COMPLETED|Overall Study||28||
48132255|NCT01798550|100645968|FG001|COMPLETED|Overall Study||26||
48132256|NCT01798550|100645967|FG000|NOT COMPLETED|Overall Study||2||
48132257|NCT01798550|100645968|FG001|NOT COMPLETED|Overall Study||6||
48132258|NCT02283814|100645969|FG000|STARTED|Overall Study||16||
48132259|NCT02283814|100645970|FG001|STARTED|Overall Study||16||
48132260|NCT02283814|100645969|FG000|COMPLETED|Overall Study||13||
48132261|NCT02283814|100645970|FG001|COMPLETED|Overall Study||14||
48132262|NCT02283814|100645969|FG000|NOT COMPLETED|Overall Study||3||
48132263|NCT02283814|100645970|FG001|NOT COMPLETED|Overall Study||2||
48285878|NCT03699826|101026215|FG000|STARTED|Overall Study||1||
48576372|NCT00984568|101741374|FG001|COMPLETED|Overall Study||7||
48576373|NCT00984568|101741373|FG000|NOT COMPLETED|Overall Study||8||
48576374|NCT00984568|101741374|FG001|NOT COMPLETED|Overall Study||6||
48576375|NCT01517763|101741375|FG000|STARTED|Overall Study||0||
48576376|NCT01517763|101741376|FG001|STARTED|Overall Study||0||
48576377|NCT01517763|101741377|FG002|STARTED|Overall Study||0||
48576378|NCT01517763|101741375|FG000|COMPLETED|Overall Study||0||
48576379|NCT01517763|101741376|FG001|COMPLETED|Overall Study||0||
48576380|NCT01517763|101741377|FG002|COMPLETED|Overall Study||0||
48576381|NCT01517763|101741375|FG000|NOT COMPLETED|Overall Study||0||
48576382|NCT01517763|101741376|FG001|NOT COMPLETED|Overall Study||0||
48576383|NCT01517763|101741377|FG002|NOT COMPLETED|Overall Study||0||
48576384|NCT01483963|101741378|FG000|STARTED|Overall Study||10||
48576385|NCT01483963|101741379|FG001|STARTED|Overall Study||10||
48285879|NCT03699826|101026215|FG000|COMPLETED|Overall Study||1||
48285880|NCT03699826|101026215|FG000|NOT COMPLETED|Overall Study||0||
48576386|NCT01483963|101741380|FG002|STARTED|Overall Study||10||
48576387|NCT01483963|101741381|FG003|STARTED|Overall Study||10||
48576388|NCT01483963|101741382|FG004|STARTED|Overall Study||10||
48576389|NCT01483963|101741378|FG000|COMPLETED|Overall Study||10||
48576390|NCT01483963|101741379|FG001|COMPLETED|Overall Study||10||
48576391|NCT01483963|101741380|FG002|COMPLETED|Overall Study||10||
48576392|NCT01483963|101741381|FG003|COMPLETED|Overall Study||10||
48576393|NCT01483963|101741382|FG004|COMPLETED|Overall Study||10||
48576394|NCT01483963|101741378|FG000|NOT COMPLETED|Overall Study||0||
48576395|NCT01483963|101741379|FG001|NOT COMPLETED|Overall Study||0||
48576396|NCT01483963|101741380|FG002|NOT COMPLETED|Overall Study||0||
48576397|NCT01483963|101741381|FG003|NOT COMPLETED|Overall Study||0||
48576398|NCT01483963|101741382|FG004|NOT COMPLETED|Overall Study||0||
48132264|NCT03783923|100645971|FG000|STARTED|Placebo-Controlled Period (26 Weeks)||5||
48132265|NCT03783923|100645972|FG001|STARTED|Placebo-Controlled Period (26 Weeks)||6||
48132266|NCT03783923|100645971|FG000|Safety Population|Placebo-Controlled Period (26 Weeks)||5|Safety population included all enrolled participants who received at least 1 dose of deflazacort.|
48132267|NCT03783923|100645972|FG001|Safety Population|Placebo-Controlled Period (26 Weeks)||2|Safety population included all enrolled participants who received at least 1 dose of deflazacort.|
48132268|NCT03783923|100645971|FG000|COMPLETED|Placebo-Controlled Period (26 Weeks)||1|Open-label transition|
48132269|NCT03783923|100645972|FG001|COMPLETED|Placebo-Controlled Period (26 Weeks)||2|Open-label transition|
48576399|NCT02013141|101741383|FG000|STARTED|Overall Study||14||
48576400|NCT02013141|101741384|FG001|STARTED|Overall Study||7||
48576401|NCT02013141|101741385|FG002|STARTED|Overall Study||1||
48576402|NCT02013141|101741383|FG000|COMPLETED|Overall Study||14||
48576403|NCT02013141|101741384|FG001|COMPLETED|Overall Study||7||
48576404|NCT02013141|101741385|FG002|COMPLETED|Overall Study||1||
48132270|NCT03783923|100645971|FG000|NOT COMPLETED|Placebo-Controlled Period (26 Weeks)||4||
48132271|NCT03783923|100645972|FG001|NOT COMPLETED|Placebo-Controlled Period (26 Weeks)||4||
48132272|NCT03783923|100645971|FG000|STARTED|Open-Label Extension (26 Weeks)||1|Transited to Protocol V4 and Dosed under Open-Label|
48132273|NCT03783923|100645972|FG001|STARTED|Open-Label Extension (26 Weeks)||2|Transited to Protocol V4 and Dosed under Open-Label|
48132274|NCT03783923|100645971|FG000|COMPLETED|Open-Label Extension (26 Weeks)||0||
48132275|NCT03783923|100645972|FG001|COMPLETED|Open-Label Extension (26 Weeks)||0||
48132276|NCT03783923|100645971|FG000|NOT COMPLETED|Open-Label Extension (26 Weeks)||1||
48132277|NCT03783923|100645972|FG001|NOT COMPLETED|Open-Label Extension (26 Weeks)||2||
48132278|NCT02121847|100645973|FG000|STARTED|Overall Study||40||
48132279|NCT02121847|100645973|FG000|COMPLETED|Overall Study||37||
48132280|NCT02121847|100645973|FG000|NOT COMPLETED|Overall Study||3||
48132281|NCT04000165|100645974|FG000|STARTED|Overall Study||17||
48132282|NCT04000165|100645974|FG000|Completed Study at 50 mg Dose|Overall Study||7||
48132283|NCT04000165|100645974|FG000|Escalated to 100 mg|Overall Study||10||
48132284|NCT04000165|100645974|FG000|COMPLETED|Overall Study||15||
48132285|NCT04000165|100645974|FG000|NOT COMPLETED|Overall Study||2||
48132286|NCT02995967|100645975|FG000|STARTED|Overall Study||1||
48132287|NCT02995967|100645976|FG001|STARTED|Overall Study||2||
48132288|NCT02995967|100645975|FG000|COMPLETED|Overall Study||1||
48132289|NCT02995967|100645976|FG001|COMPLETED|Overall Study||2||
48132290|NCT02995967|100645975|FG000|NOT COMPLETED|Overall Study||0||
48132291|NCT02995967|100645976|FG001|NOT COMPLETED|Overall Study||0||
48132292|NCT01592708|100645977|FG000|STARTED|Overall Study||96||
48132293|NCT01592708|100645978|FG001|STARTED|Overall Study||137||
48132294|NCT01592708|100645977|FG000|COMPLETED|Overall Study||93||
48132295|NCT01592708|100645978|FG001|COMPLETED|Overall Study||137||
48132296|NCT01592708|100645977|FG000|NOT COMPLETED|Overall Study||3||
48132297|NCT01592708|100645978|FG001|NOT COMPLETED|Overall Study||0||
48132298|NCT04755595|100645979|FG000|STARTED|Overall Study||20||
48132299|NCT04755595|100645979|FG000|COMPLETED|Overall Study||19||
48132300|NCT04755595|100645979|FG000|NOT COMPLETED|Overall Study||1||
48132301|NCT00434057|100645980|FG000|STARTED|Overall Study||1383||
48132302|NCT00434057|100645980|FG000|COMPLETED|Overall Study||1382||
48132303|NCT00434057|100645980|FG000|NOT COMPLETED|Overall Study||1||
48132304|NCT00408993|100645981|FG000|STARTED|Overall Study||106||
48132305|NCT00408993|100645982|FG001|STARTED|Overall Study||109||
48132306|NCT00408993|100645981|FG000|COMPLETED|Overall Study||87||
48132307|NCT00408993|100645982|FG001|COMPLETED|Overall Study||92||
48132308|NCT00408993|100645981|FG000|NOT COMPLETED|Overall Study||19||
48132309|NCT00408993|100645982|FG001|NOT COMPLETED|Overall Study||17||
48132310|NCT03660683|100645983|FG000|STARTED|Overall Study||4||
48132311|NCT03660683|100645984|FG001|STARTED|Overall Study||5||
48132312|NCT03660683|100645985|FG002|STARTED|Overall Study||6||
48132313|NCT03660683|100645983|FG000|COMPLETED|Overall Study||4||
48132314|NCT03660683|100645984|FG001|COMPLETED|Overall Study||5||
48132315|NCT03660683|100645985|FG002|COMPLETED|Overall Study||6||
48132316|NCT03660683|100645983|FG000|NOT COMPLETED|Overall Study||0||
48132317|NCT03660683|100645984|FG001|NOT COMPLETED|Overall Study||0||
48132318|NCT03660683|100645985|FG002|NOT COMPLETED|Overall Study||0||
48132319|NCT00659269|100645986|FG000|STARTED|Overall Study||157||
48132320|NCT00659269|100645987|FG001|STARTED|Overall Study||162||
48132321|NCT00659269|100645986|FG000|Group 1 (Heavy Metals)|Overall Study||52||
48132322|NCT00659269|100645987|FG001|Group 1 (Heavy Metals)|Overall Study||52||
48132323|NCT00659269|100645986|FG000|Group 2 (Vinca Alkaloids)|Overall Study||12||
48132324|NCT00659269|100645987|FG001|Group 2 (Vinca Alkaloids)|Overall Study||12||
48132325|NCT00659269|100645986|FG000|Group 3 (Taxanes)|Overall Study||92||
48132326|NCT00659269|100645987|FG001|Group 3 (Taxanes)|Overall Study||97||
48132327|NCT00659269|100645986|FG000|COMPLETED|Overall Study||156||
48132328|NCT00659269|100645987|FG001|COMPLETED|Overall Study||161||
48132329|NCT00659269|100645986|FG000|NOT COMPLETED|Overall Study||1||
48132330|NCT00659269|100645987|FG001|NOT COMPLETED|Overall Study||1||
48132331|NCT02863991|100645988|FG000|STARTED|Overall Study||2||
48132332|NCT02863991|100645989|FG001|STARTED|Overall Study||15||
48132333|NCT02863991|100645988|FG000|COMPLETED|Overall Study||0||
48132334|NCT02863991|100645989|FG001|COMPLETED|Overall Study||3||
48132335|NCT02863991|100645988|FG000|NOT COMPLETED|Overall Study||2||
48132336|NCT02863991|100645989|FG001|NOT COMPLETED|Overall Study||12||
48132337|NCT00374842|100645990|FG000|STARTED|Overall Study||100||
48132338|NCT00374842|100645991|FG001|STARTED|Overall Study||100||
48132339|NCT00374842|100645992|FG002|STARTED|Overall Study||100||
48132340|NCT00374842|100645990|FG000|COMPLETED|Overall Study||100||
48132341|NCT00374842|100645991|FG001|COMPLETED|Overall Study||100||
48132342|NCT00374842|100645992|FG002|COMPLETED|Overall Study||100||
48132343|NCT00374842|100645990|FG000|NOT COMPLETED|Overall Study||0||
48132344|NCT00374842|100645991|FG001|NOT COMPLETED|Overall Study||0||
48132345|NCT00374842|100645992|FG002|NOT COMPLETED|Overall Study||0||
48132346|NCT00759109|100645993|FG000|STARTED|Overall Study||74||
48132347|NCT00759109|100645994|FG001|STARTED|Overall Study||76||
48132348|NCT00759109|100645993|FG000|COMPLETED|Overall Study||35||
48132349|NCT00759109|100645994|FG001|COMPLETED|Overall Study||41||
48132350|NCT00759109|100645993|FG000|NOT COMPLETED|Overall Study||39||
48132351|NCT00759109|100645994|FG001|NOT COMPLETED|Overall Study||35||
48702406|NCT00519376|102057633|FG014|COMPLETED|Treatment Period 4||1||
48702407|NCT00519376|102057634|FG015|COMPLETED|Treatment Period 4||1||
48702408|NCT00519376|102057619|FG000|NOT COMPLETED|Treatment Period 4||0||
48702409|NCT00519376|102057620|FG001|NOT COMPLETED|Treatment Period 4||0||
48702410|NCT00519376|102057621|FG002|NOT COMPLETED|Treatment Period 4||1||
48702411|NCT00519376|102057622|FG003|NOT COMPLETED|Treatment Period 4||0||
48702412|NCT00519376|102057623|FG004|NOT COMPLETED|Treatment Period 4||0||
48702413|NCT00519376|102057624|FG005|NOT COMPLETED|Treatment Period 4||0||
48702414|NCT00519376|102057625|FG006|NOT COMPLETED|Treatment Period 4||0||
48702415|NCT00519376|102057626|FG007|NOT COMPLETED|Treatment Period 4||0||
48702416|NCT00519376|102057627|FG008|NOT COMPLETED|Treatment Period 4||0||
48702417|NCT00519376|102057628|FG009|NOT COMPLETED|Treatment Period 4||0||
48702418|NCT00519376|102057629|FG010|NOT COMPLETED|Treatment Period 4||0||
48702419|NCT00519376|102057630|FG011|NOT COMPLETED|Treatment Period 4||0||
48702420|NCT00519376|102057631|FG012|NOT COMPLETED|Treatment Period 4||0||
48702421|NCT00519376|102057632|FG013|NOT COMPLETED|Treatment Period 4||0||
48702422|NCT00519376|102057633|FG014|NOT COMPLETED|Treatment Period 4||0||
48702423|NCT00519376|102057634|FG015|NOT COMPLETED|Treatment Period 4||0||
48702424|NCT02292758|102057635|FG000|STARTED|Overall Study||19||
48702425|NCT02292758|102057636|FG001|STARTED|Overall Study||17||
48702426|NCT02292758|102057635|FG000|COMPLETED|Overall Study||19||
48702427|NCT02292758|102057636|FG001|COMPLETED|Overall Study||17||
48702428|NCT02292758|102057635|FG000|NOT COMPLETED|Overall Study||0||
48702429|NCT02292758|102057636|FG001|NOT COMPLETED|Overall Study||0||
48702430|NCT05289271|102057637|FG000|STARTED|Overall Study||86|Allocated participants|
48702431|NCT05289271|102057638|FG001|STARTED|Overall Study||82|Allocated participants|
48702432|NCT05289271|102057637|FG000|Treated|Overall Study||85||
48702433|NCT05289271|102057638|FG001|Treated|Overall Study||82||
48702434|NCT05289271|102057637|FG000|COMPLETED|Overall Study||85||
48702435|NCT05289271|102057638|FG001|COMPLETED|Overall Study||82||
48702436|NCT05289271|102057637|FG000|NOT COMPLETED|Overall Study||1||
48702437|NCT05289271|102057638|FG001|NOT COMPLETED|Overall Study||0||
48702438|NCT02442310|102057639|FG000|STARTED|Overall Study||20||
48702439|NCT02442310|102057639|FG000|COMPLETED|Overall Study||17||
48702440|NCT02442310|102057639|FG000|NOT COMPLETED|Overall Study||3||
48702441|NCT05593913|102057640|FG000|STARTED|Overall Study||986||
48702442|NCT05593913|102057640|FG000|COMPLETED|Overall Study||947||
48702443|NCT05593913|102057640|FG000|NOT COMPLETED|Overall Study||39||
48702444|NCT03232645|102057641|FG000|STARTED|Overall Study||62||
48702445|NCT03232645|102057641|FG000|COMPLETED|Overall Study||58||
48702446|NCT03232645|102057641|FG000|NOT COMPLETED|Overall Study||4||
48702447|NCT01165112|102057642|FG000|STARTED|Overall Study||48||
48702448|NCT01165112|102057642|FG000|COMPLETED|Overall Study||48||
48702449|NCT01165112|102057642|FG000|NOT COMPLETED|Overall Study||0||
48702450|NCT01923363|102057643|FG000|STARTED|Overall Study||29||
48702451|NCT01923363|102057643|FG000|COMPLETED|Overall Study||28||
48702452|NCT01923363|102057643|FG000|NOT COMPLETED|Overall Study||1||
48702453|NCT02074345|102057644|FG000|STARTED|Overall Study||31||
48702454|NCT02074345|102057644|FG000|COMPLETED|Overall Study||31||
48702455|NCT02074345|102057644|FG000|NOT COMPLETED|Overall Study||0||
48702456|NCT01939002|102057645|FG000|STARTED|Overall Study||103||
48702457|NCT01939002|102057646|FG001|STARTED|Overall Study||98||
48702458|NCT01939002|102057645|FG000|COMPLETED|Overall Study||84||
48702459|NCT01939002|102057646|FG001|COMPLETED|Overall Study||80||
48702460|NCT01939002|102057645|FG000|NOT COMPLETED|Overall Study||19||
48702461|NCT01939002|102057646|FG001|NOT COMPLETED|Overall Study||18||
48702462|NCT00503581|102057647|FG000|STARTED|Overall Study||3||
48702463|NCT00503581|102057648|FG001|STARTED|Overall Study||4||
48702464|NCT00503581|102057649|FG002|STARTED|Overall Study||2||
48702465|NCT00503581|102057647|FG000|COMPLETED|Overall Study||0||
48702466|NCT00503581|102057648|FG001|COMPLETED|Overall Study||0||
48702467|NCT00503581|102057649|FG002|COMPLETED|Overall Study||0||
48702468|NCT00503581|102057647|FG000|NOT COMPLETED|Overall Study||3||
48702469|NCT00503581|102057648|FG001|NOT COMPLETED|Overall Study||4||
48702470|NCT00503581|102057649|FG002|NOT COMPLETED|Overall Study||2||
48702471|NCT00252694|102057650|FG000|STARTED|Overall Study||951||
48702472|NCT00252694|102057651|FG001|STARTED|Overall Study||954||
48702473|NCT00252694|102057650|FG000|COMPLETED|Overall Study||807||
48702474|NCT00252694|102057651|FG001|COMPLETED|Overall Study||800||
48702475|NCT00252694|102057650|FG000|NOT COMPLETED|Overall Study||144||
48702476|NCT00252694|102057651|FG001|NOT COMPLETED|Overall Study||154||
48702477|NCT04027049|102057652|FG000|STARTED|Overall Study||14||
48702478|NCT04027049|102057653|FG001|STARTED|Overall Study||11||
48702479|NCT04027049|102057652|FG000|COMPLETED|Overall Study||12||
48702480|NCT04027049|102057653|FG001|COMPLETED|Overall Study||11||
48702481|NCT04027049|102057652|FG000|NOT COMPLETED|Overall Study||2||
48702482|NCT04027049|102057653|FG001|NOT COMPLETED|Overall Study||0||
48702483|NCT00396136|102057654|FG000|STARTED|Overall Study||221||
48702484|NCT00396136|102057654|FG000|COMPLETED|Overall Study||96||
48702485|NCT00396136|102057654|FG000|NOT COMPLETED|Overall Study||125||
48702486|NCT00712725|102057655|FG000|STARTED|Overall Study||169||
48702487|NCT00712725|102057656|FG001|STARTED|Overall Study||39||
48702488|NCT00712725|102057657|FG002|STARTED|Overall Study||57||
48702489|NCT00712725|102057658|FG003|STARTED|Overall Study||84||
48132352|NCT03047447|100645995|FG000|STARTED|Overall Study||10||
48132353|NCT03047447|100645996|FG001|STARTED|Overall Study||10||
48132354|NCT03047447|100645997|FG002|STARTED|Overall Study||10||
48132355|NCT03047447|100645995|FG000|COMPLETED|Overall Study||10||
48132356|NCT03047447|100645996|FG001|COMPLETED|Overall Study||10||
48132357|NCT03047447|100645997|FG002|COMPLETED|Overall Study||10||
48132358|NCT03047447|100645995|FG000|NOT COMPLETED|Overall Study||0||
48132359|NCT03047447|100645996|FG001|NOT COMPLETED|Overall Study||0||
48132360|NCT03047447|100645997|FG002|NOT COMPLETED|Overall Study||0||
48132361|NCT01153633|100645998|FG000|STARTED|Overall Study||17||
48132362|NCT01153633|100645999|FG001|STARTED|Overall Study||17||
48132363|NCT01153633|100645998|FG000|COMPLETED|Overall Study||13||
48132364|NCT01153633|100645999|FG001|COMPLETED|Overall Study||13||
48132365|NCT01153633|100645998|FG000|NOT COMPLETED|Overall Study||4||
48132366|NCT01153633|100645999|FG001|NOT COMPLETED|Overall Study||4||
48132367|NCT00111657|100646000|FG000|STARTED|Overall Study||37||
48132368|NCT00111657|100646000|FG000|COMPLETED|Overall Study||21||
48132369|NCT00111657|100646000|FG000|NOT COMPLETED|Overall Study||16||
48132370|NCT01932164|100646001|FG000|STARTED|Overall Study||5||
48132371|NCT01932164|100646001|FG000|Cleft Lip and Palate|Overall Study||5||
48132372|NCT01932164|100646001|FG000|Cleft Lip and Palate|Overall Study||5||
48132373|NCT01932164|100646001|FG000|Cleft Lip and Palate|Overall Study||5||
48132374|NCT01932164|100646001|FG000|Cleft Lip and Palate|Overall Study||5||
48132375|NCT01932164|100646001|FG000|Cleft Lip and Palate|Overall Study||5||
48132376|NCT01932164|100646001|FG000|COMPLETED|Overall Study||5||
48132377|NCT01932164|100646001|FG000|NOT COMPLETED|Overall Study||0||
48132378|NCT00809757|100646002|FG000|STARTED|Overall Study||68||
48702490|NCT00712725|102057659|FG004|STARTED|Overall Study||86||
48702491|NCT00712725|102057660|FG005|STARTED|Overall Study||84||
48702492|NCT00712725|102057661|FG006|STARTED|Overall Study||83||
48702493|NCT00712725|102057662|FG007|STARTED|Overall Study||74||
48702494|NCT00712725|102057655|FG000|COMPLETED|Overall Study||140||
48702495|NCT00712725|102057656|FG001|COMPLETED|Overall Study||33||
48702496|NCT00712725|102057657|FG002|COMPLETED|Overall Study||47||
48702497|NCT00712725|102057658|FG003|COMPLETED|Overall Study||67||
48702498|NCT00712725|102057659|FG004|COMPLETED|Overall Study||67||
48702499|NCT00712725|102057660|FG005|COMPLETED|Overall Study||68||
48702500|NCT00712725|102057661|FG006|COMPLETED|Overall Study||61||
48702501|NCT00712725|102057662|FG007|COMPLETED|Overall Study||63||
48702502|NCT00712725|102057655|FG000|NOT COMPLETED|Overall Study||29||
48132379|NCT00809757|100646003|FG001|STARTED|Overall Study||65||
48132380|NCT00809757|100646004|FG002|STARTED|Overall Study||64||
48132381|NCT00809757|100646002|FG000|COMPLETED|Overall Study||62||
48132382|NCT00809757|100646003|FG001|COMPLETED|Overall Study||60||
48132383|NCT00809757|100646004|FG002|COMPLETED|Overall Study||53||
48132384|NCT00809757|100646002|FG000|NOT COMPLETED|Overall Study||6||
48132385|NCT00809757|100646003|FG001|NOT COMPLETED|Overall Study||5||
48132386|NCT00809757|100646004|FG002|NOT COMPLETED|Overall Study||11||
48132387|NCT05077267|100646005|FG000|STARTED|Treatment Period||28||
48132388|NCT05077267|100646006|FG001|STARTED|Treatment Period||103||
48132389|NCT05077267|100646007|FG002|STARTED|Treatment Period||66||
48132390|NCT05077267|100646005|FG000|COMPLETED|Treatment Period||28||
48132391|NCT05077267|100646006|FG001|COMPLETED|Treatment Period||101||
48132392|NCT05077267|100646007|FG002|COMPLETED|Treatment Period||66||
48132393|NCT05077267|100646005|FG000|NOT COMPLETED|Treatment Period||0||
48132394|NCT05077267|100646006|FG001|NOT COMPLETED|Treatment Period||2||
48132395|NCT05077267|100646007|FG002|NOT COMPLETED|Treatment Period||0||
48132396|NCT05077267|100646005|FG000|STARTED|Follow-up Period||28|Subject could participate in follow-up even if not completing the treatment period.|
48132397|NCT05077267|100646006|FG001|STARTED|Follow-up Period||103|Subject could participate in follow-up even if not completing the treatment period.|
48132398|NCT05077267|100646007|FG002|STARTED|Follow-up Period||66|Subject could participate in follow-up even if not completing the treatment period.|
48132399|NCT05077267|100646005|FG000|COMPLETED|Follow-up Period||28||
48132400|NCT05077267|100646006|FG001|COMPLETED|Follow-up Period||3||
48132401|NCT05077267|100646007|FG002|COMPLETED|Follow-up Period||0||
48132402|NCT05077267|100646005|FG000|NOT COMPLETED|Follow-up Period||0||
48132403|NCT05077267|100646006|FG001|NOT COMPLETED|Follow-up Period||100||
48132404|NCT05077267|100646007|FG002|NOT COMPLETED|Follow-up Period||66||
48132405|NCT02331992|100646008|FG000|STARTED|Overall Study||34||
48132406|NCT02331992|100646008|FG000|COMPLETED|Overall Study||34||
48132407|NCT02331992|100646008|FG000|NOT COMPLETED|Overall Study||0||
48702503|NCT00712725|102057656|FG001|NOT COMPLETED|Overall Study||6||
48702504|NCT00712725|102057657|FG002|NOT COMPLETED|Overall Study||10||
48702505|NCT00712725|102057658|FG003|NOT COMPLETED|Overall Study||17||
48702506|NCT00712725|102057659|FG004|NOT COMPLETED|Overall Study||19||
48702507|NCT00712725|102057660|FG005|NOT COMPLETED|Overall Study||16||
48702508|NCT00712725|102057661|FG006|NOT COMPLETED|Overall Study||22||
48702509|NCT00712725|102057662|FG007|NOT COMPLETED|Overall Study||11||
48132408|NCT02564198|100648468|FG000|STARTED|Overall Study||8||
48132409|NCT02564198|100648469|FG001|STARTED|Overall Study||15||
48702510|NCT00090233|102057663|FG000|STARTED|Overall Study||34644||
48702511|NCT00090233|102057664|FG001|STARTED|Overall Study||34630||
48702512|NCT00090233|102057663|FG000|Vaccinated at Visit 1|Overall Study||34035||
48702513|NCT00090233|102057664|FG001|Vaccinated at Visit 1|Overall Study||34003||
48132410|NCT02564198|100648470|FG002|STARTED|Overall Study||6||
48132411|NCT02564198|100648468|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8||
48132412|NCT02564198|100648469|FG001|Received at Least 1 Dose of Study Drug|Overall Study||15||
48132413|NCT02564198|100648470|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
48132414|NCT02564198|100648468|FG000|COMPLETED|Overall Study||6||
48132415|NCT02564198|100648469|FG001|COMPLETED|Overall Study||10||
48132416|NCT02564198|100648470|FG002|COMPLETED|Overall Study||6||
48132417|NCT02564198|100648468|FG000|NOT COMPLETED|Overall Study||2||
48132418|NCT02564198|100648469|FG001|NOT COMPLETED|Overall Study||5||
48132419|NCT02564198|100648470|FG002|NOT COMPLETED|Overall Study||0||
48132420|NCT00736996|100648471|FG000|STARTED|Overall Study||25||
48132421|NCT00736996|100648472|FG001|STARTED|Overall Study||26||
48132422|NCT00736996|100648473|FG002|STARTED|Overall Study||27||
48132423|NCT00736996|100648471|FG000|COMPLETED|Overall Study||24||
48132424|NCT00736996|100648472|FG001|COMPLETED|Overall Study||17||
48132425|NCT00736996|100648473|FG002|COMPLETED|Overall Study||25||
48132426|NCT00736996|100648471|FG000|NOT COMPLETED|Overall Study||1||
48132427|NCT00736996|100648472|FG001|NOT COMPLETED|Overall Study||9||
48132428|NCT00736996|100648473|FG002|NOT COMPLETED|Overall Study||2||
48132429|NCT01645709|100648474|FG000|STARTED|Overall Study||0||
48132430|NCT01645709|100648475|FG001|STARTED|Overall Study||0||
48132431|NCT01645709|100648474|FG000|COMPLETED|Overall Study||0||
48132432|NCT01645709|100648475|FG001|COMPLETED|Overall Study||0||
48132433|NCT01645709|100648474|FG000|NOT COMPLETED|Overall Study||0||
48132434|NCT01645709|100648475|FG001|NOT COMPLETED|Overall Study||0||
48132435|NCT00618514|100648476|FG000|STARTED|Overall Study||36||
48132436|NCT00618514|100648477|FG001|STARTED|Overall Study||38||
48132437|NCT00618514|100648478|FG002|STARTED|Overall Study||16||
48132438|NCT00618514|100648476|FG000|COMPLETED|Overall Study||25||
48132439|NCT00618514|100648477|FG001|COMPLETED|Overall Study||26||
48132440|NCT00618514|100648478|FG002|COMPLETED|Overall Study||12||
48132441|NCT00618514|100648476|FG000|NOT COMPLETED|Overall Study||11||
48132442|NCT00618514|100648477|FG001|NOT COMPLETED|Overall Study||12||
48132443|NCT00618514|100648478|FG002|NOT COMPLETED|Overall Study||4||
48132444|NCT00366626|100648479|FG000|STARTED|Overall Study||38||
48132445|NCT00366626|100648480|FG001|STARTED|Overall Study||45||
48132446|NCT00366626|100648479|FG000|COMPLETED|Overall Study||38||
48132447|NCT00366626|100648480|FG001|COMPLETED|Overall Study||45||
48132448|NCT00366626|100648479|FG000|NOT COMPLETED|Overall Study||0||
48132449|NCT00366626|100648480|FG001|NOT COMPLETED|Overall Study||0||
48132450|NCT02536508|100648481|FG000|STARTED|Overall Study||194|Safety population|
48132451|NCT02536508|100648482|FG001|STARTED|Overall Study||174|Safety population|
48132452|NCT02536508|100648483|FG002|STARTED|Overall Study||88|Safety population|
48132453|NCT02536508|100648481|FG000|COMPLETED|Overall Study||142||
48132454|NCT02536508|100648482|FG001|COMPLETED|Overall Study||130||
48132455|NCT02536508|100648483|FG002|COMPLETED|Overall Study||65||
48132456|NCT02536508|100648481|FG000|NOT COMPLETED|Overall Study||52||
48132457|NCT02536508|100648482|FG001|NOT COMPLETED|Overall Study||44||
48132458|NCT02536508|100648483|FG002|NOT COMPLETED|Overall Study||23||
48132459|NCT01181921|100648484|FG000|STARTED|Overall Study||1||
48132460|NCT01181921|100648484|FG000|COMPLETED|Overall Study||0||
48132461|NCT01181921|100648484|FG000|NOT COMPLETED|Overall Study||1||
48132462|NCT01196975|100648485|FG000|STARTED|Overall Study||423||
48132463|NCT01196975|100648486|FG001|STARTED|Overall Study||424||
48132464|NCT01196975|100648487|FG002|STARTED|Overall Study||425||
48132465|NCT01196975|100648488|FG003|STARTED|Overall Study||213||
48132466|NCT01196975|100648489|FG004|STARTED|Overall Study||218||
48132467|NCT01196975|100648485|FG000|COMPLETED|Overall Study||408||
48132468|NCT01196975|100648486|FG001|COMPLETED|Overall Study||415||
48132469|NCT01196975|100648487|FG002|COMPLETED|Overall Study||420||
48132470|NCT01196975|100648488|FG003|COMPLETED|Overall Study||207||
48132471|NCT01196975|100648489|FG004|COMPLETED|Overall Study||205||
48132472|NCT01196975|100648485|FG000|NOT COMPLETED|Overall Study||15||
48132473|NCT01196975|100648486|FG001|NOT COMPLETED|Overall Study||9||
48132474|NCT01196975|100648487|FG002|NOT COMPLETED|Overall Study||5||
48132475|NCT01196975|100648488|FG003|NOT COMPLETED|Overall Study||6||
48132476|NCT01196975|100648489|FG004|NOT COMPLETED|Overall Study||13||
48132477|NCT00437489|100648490|FG000|STARTED|Overall Study||25||
48132478|NCT00437489|100648491|FG001|STARTED|Overall Study||24||
48132479|NCT00437489|100648490|FG000|COMPLETED|Overall Study||2||
48132480|NCT00437489|100648491|FG001|COMPLETED|Overall Study||2||
48132481|NCT00437489|100648490|FG000|NOT COMPLETED|Overall Study||23||
48132482|NCT00437489|100648491|FG001|NOT COMPLETED|Overall Study||22||
48132483|NCT00003457|100648492|FG000|STARTED|Overall Study||40||
48132484|NCT00003457|100648492|FG000|COMPLETED|Overall Study||31||
48132485|NCT00003457|100648492|FG000|NOT COMPLETED|Overall Study||9||
48132486|NCT01296568|100648493|FG000|STARTED|[^14C]LY2603618 Single Dose and Washout||3||
48132487|NCT01296568|100648493|FG000|COMPLETED|[^14C]LY2603618 Single Dose and Washout||3||
48132488|NCT01296568|100648493|FG000|NOT COMPLETED|[^14C]LY2603618 Single Dose and Washout||0||
48132489|NCT01296568|100648493|FG000|STARTED|Continued Access Phase||3||
48132490|NCT01296568|100648493|FG000|COMPLETED|Continued Access Phase||0||
48132491|NCT01296568|100648493|FG000|NOT COMPLETED|Continued Access Phase||3||
48132492|NCT03091751|100648494|FG000|STARTED|Overall Study||22||
48132493|NCT03091751|100648494|FG000|COMPLETED|Overall Study||22||
48132494|NCT03091751|100648494|FG000|NOT COMPLETED|Overall Study||0||
48132495|NCT01165281|100648495|FG000|STARTED|Overall Study||168||
48132496|NCT01165281|100648496|FG001|STARTED|Overall Study||172||
48132497|NCT01165281|100648495|FG000|COMPLETED|Overall Study||110||
48132498|NCT01165281|100648496|FG001|COMPLETED|Overall Study||121||
48132499|NCT01165281|100648495|FG000|NOT COMPLETED|Overall Study||58||
48132500|NCT01165281|100648496|FG001|NOT COMPLETED|Overall Study||51||
48132501|NCT05711069|100648497|FG000|STARTED|Overall Study||23||
48132502|NCT05711069|100648498|FG001|STARTED|Overall Study||22||
48132503|NCT05711069|100648497|FG000|COMPLETED|Overall Study||19||
48132504|NCT05711069|100648498|FG001|COMPLETED|Overall Study||17||
48132505|NCT05711069|100648497|FG000|NOT COMPLETED|Overall Study||4||
48132506|NCT05711069|100648498|FG001|NOT COMPLETED|Overall Study||5||
48132507|NCT02519504|100648499|FG000|STARTED|Overall Study||319|Completed the initial online survey|
48132508|NCT02519504|100648500|FG001|STARTED|Overall Study||247|Completed the initial online survey|
48132509|NCT02519504|100648499|FG000|Attended Direct Testing|Overall Study||212||
48132510|NCT02519504|100648500|FG001|Attended Direct Testing|Overall Study||149||
48132511|NCT02519504|100648499|FG000|COMPLETED|Overall Study||206|Had complete information from the direct testing visit.|
48399740|NCT02443805|101309201|FG001|STARTED|Overall Study||805||
48399741|NCT02443805|101309200|FG000|COMPLETED|Overall Study||589||
48399742|NCT02443805|101309201|FG001|COMPLETED|Overall Study||678||
48399743|NCT02443805|101309200|FG000|NOT COMPLETED|Overall Study||213||
48576405|NCT02013141|101741383|FG000|NOT COMPLETED|Overall Study||0||
48702514|NCT00090233|102057663|FG000|Vaccinated at Visit 2|Overall Study||31052||
48702515|NCT00090233|102057664|FG001|Vaccinated at Visit 2|Overall Study||31066||
48702516|NCT00090233|102057663|FG000|Vaccinated at Visit 3|Overall Study||29667||
48702517|NCT00090233|102057664|FG001|Vaccinated at Visit 3|Overall Study||29598||
48702518|NCT00090233|102057663|FG000|COMPLETED|Overall Study||29645||
48702519|NCT00090233|102057664|FG001|COMPLETED|Overall Study||29565||
48576406|NCT02013141|101741384|FG001|NOT COMPLETED|Overall Study||0||
48576407|NCT02013141|101741385|FG002|NOT COMPLETED|Overall Study||0||
48576408|NCT01221272|101741386|FG000|STARTED|Period 1||41||
48702520|NCT00090233|102057663|FG000|NOT COMPLETED|Overall Study||4999||
48702521|NCT00090233|102057664|FG001|NOT COMPLETED|Overall Study||5065||
48132512|NCT02519504|100648500|FG001|COMPLETED|Overall Study||144|Had complete information from the direct testing visit.|
48132513|NCT02519504|100648499|FG000|NOT COMPLETED|Overall Study||113||
48132514|NCT02519504|100648500|FG001|NOT COMPLETED|Overall Study||103||
48132515|NCT00680407|100648501|FG000|STARTED|Overall Study||26||
48132516|NCT00680407|100648502|FG001|STARTED|Overall Study||27||
48132517|NCT00680407|100648503|FG002|STARTED|Overall Study||25||
48132518|NCT00680407|100648501|FG000|COMPLETED|Overall Study||18||
48132519|NCT00680407|100648502|FG001|COMPLETED|Overall Study||22||
48132520|NCT00680407|100648503|FG002|COMPLETED|Overall Study||22||
48132521|NCT00680407|100648501|FG000|NOT COMPLETED|Overall Study||8||
48132522|NCT00680407|100648502|FG001|NOT COMPLETED|Overall Study||5||
48132523|NCT00680407|100648503|FG002|NOT COMPLETED|Overall Study||3||
48132524|NCT04798781|100648504|FG000|STARTED|Overall Study||16||
48132525|NCT04798781|100648504|FG000|COMPLETED|Overall Study||15||
48132526|NCT04798781|100648504|FG000|NOT COMPLETED|Overall Study||1||
48132527|NCT01184014|100648505|FG000|STARTED|Overall Study||35||
48132528|NCT01184014|100648506|FG001|STARTED|Overall Study||37||
48132529|NCT01184014|100648505|FG000|COMPLETED|Overall Study||30||
48132530|NCT01184014|100648506|FG001|COMPLETED|Overall Study||31||
48132531|NCT01184014|100648505|FG000|NOT COMPLETED|Overall Study||5||
48132532|NCT01184014|100648506|FG001|NOT COMPLETED|Overall Study||6||
48132533|NCT02613481|100648507|FG000|STARTED|Overall Study||50||
48132534|NCT02613481|100648507|FG000|COMPLETED|Overall Study||41||
48132535|NCT02613481|100648507|FG000|NOT COMPLETED|Overall Study||9||
48132536|NCT04844281|100648508|FG000|STARTED|Overall Study||30||
48132537|NCT04844281|100648508|FG000|COMPLETED|Overall Study||30||
48132538|NCT04844281|100648508|FG000|NOT COMPLETED|Overall Study||0||
48399744|NCT02443805|101309201|FG001|NOT COMPLETED|Overall Study||127||
48399745|NCT00688545|101309202|FG000|STARTED|Overall Study||55||
48576409|NCT01221272|101741387|FG001|STARTED|Period 1||40||
48576410|NCT01221272|101741386|FG000|COMPLETED|Period 1||39||
48576411|NCT01221272|101741387|FG001|COMPLETED|Period 1||38||
48702522|NCT05818956|102057665|FG000|STARTED|Treatment Period 1 (2 Days)||4||
48702523|NCT05818956|102057666|FG001|STARTED|Treatment Period 1 (2 Days)||4||
48702524|NCT05818956|102057667|FG002|STARTED|Treatment Period 1 (2 Days)||4||
48576412|NCT01221272|101741386|FG000|NOT COMPLETED|Period 1||2||
48576413|NCT01221272|101741387|FG001|NOT COMPLETED|Period 1||2||
48702525|NCT05818956|102057668|FG003|STARTED|Treatment Period 1 (2 Days)||4||
48702526|NCT05818956|102057669|FG004|STARTED|Treatment Period 1 (2 Days)||4||
48702527|NCT05818956|102057670|FG005|STARTED|Treatment Period 1 (2 Days)||4||
48576414|NCT01221272|101741386|FG000|STARTED|Period 2||39||
48576415|NCT01221272|101741387|FG001|STARTED|Period 2||39||
48576416|NCT01221272|101741386|FG000|COMPLETED|Period 2||39||
48576417|NCT01221272|101741387|FG001|COMPLETED|Period 2||37||
48576418|NCT01221272|101741386|FG000|NOT COMPLETED|Period 2||0||
48576419|NCT01221272|101741387|FG001|NOT COMPLETED|Period 2||2||
48576420|NCT01570361|101741388|FG000|STARTED|Overall Study||128||
48576421|NCT01570361|101741389|FG001|STARTED|Overall Study||127||
48576422|NCT01570361|101741388|FG000|Received Study Treatment|Overall Study||102||
48576423|NCT01570361|101741389|FG001|Received Study Treatment|Overall Study||123||
48576424|NCT01570361|101741388|FG000|Cross-over (AAD Therapy to RF Ablation)|Overall Study||0||
48576425|NCT01570361|101741389|FG001|Cross-over (AAD Therapy to RF Ablation)|Overall Study||15||
48576426|NCT01570361|101741388|FG000|AAD Therapy Only|Overall Study||0||
48576427|NCT01570361|101741389|FG001|AAD Therapy Only|Overall Study||108||
48576428|NCT01570361|101741388|FG000|COMPLETED|Overall Study||46||
48576429|NCT01570361|101741389|FG001|COMPLETED|Overall Study||52||
48576430|NCT01570361|101741388|FG000|NOT COMPLETED|Overall Study||82||
48576431|NCT01570361|101741389|FG001|NOT COMPLETED|Overall Study||75||
48576432|NCT00232739|101741390|FG000|STARTED|Overall Study||100||
48576433|NCT00232739|101741390|FG000|COMPLETED|Overall Study||91||
48576434|NCT00232739|101741390|FG000|NOT COMPLETED|Overall Study||9||
48576435|NCT00520533|101741391|FG000|STARTED|Overall Study||8||
48576436|NCT00520533|101741391|FG000|COMPLETED|Overall Study||4||
48576437|NCT00520533|101741391|FG000|NOT COMPLETED|Overall Study||4||
48576438|NCT01876810|101741392|FG000|STARTED|Overall Study||14||
48702528|NCT05818956|102057665|FG000|COMPLETED|Treatment Period 1 (2 Days)||4||
48702529|NCT05818956|102057666|FG001|COMPLETED|Treatment Period 1 (2 Days)||4||
48702530|NCT05818956|102057667|FG002|COMPLETED|Treatment Period 1 (2 Days)||4||
48702531|NCT05818956|102057668|FG003|COMPLETED|Treatment Period 1 (2 Days)||4||
48285881|NCT01263665|101026216|FG000|STARTED|Overall Study||71||
48285882|NCT01263665|101026216|FG000|COMPLETED|Overall Study||62||
48285883|NCT01263665|101026216|FG000|NOT COMPLETED|Overall Study||9||
48576439|NCT01876810|101741393|FG001|STARTED|Overall Study||14||
48702532|NCT05818956|102057669|FG004|COMPLETED|Treatment Period 1 (2 Days)||4||
48702533|NCT05818956|102057670|FG005|COMPLETED|Treatment Period 1 (2 Days)||4||
48702534|NCT05818956|102057665|FG000|NOT COMPLETED|Treatment Period 1 (2 Days)||0||
48702535|NCT05818956|102057666|FG001|NOT COMPLETED|Treatment Period 1 (2 Days)||0||
48702536|NCT05818956|102057667|FG002|NOT COMPLETED|Treatment Period 1 (2 Days)||0||
48702537|NCT05818956|102057668|FG003|NOT COMPLETED|Treatment Period 1 (2 Days)||0||
48702538|NCT05818956|102057669|FG004|NOT COMPLETED|Treatment Period 1 (2 Days)||0||
48702539|NCT05818956|102057670|FG005|NOT COMPLETED|Treatment Period 1 (2 Days)||0||
48702540|NCT05818956|102057665|FG000|STARTED|Washout Period 1 (4 Days)||4||
48702541|NCT05818956|102057666|FG001|STARTED|Washout Period 1 (4 Days)||4||
48702542|NCT05818956|102057667|FG002|STARTED|Washout Period 1 (4 Days)||4||
48702543|NCT05818956|102057668|FG003|STARTED|Washout Period 1 (4 Days)||4||
48702544|NCT05818956|102057669|FG004|STARTED|Washout Period 1 (4 Days)||4||
48702545|NCT05818956|102057670|FG005|STARTED|Washout Period 1 (4 Days)||4||
48702546|NCT05818956|102057665|FG000|COMPLETED|Washout Period 1 (4 Days)||4||
48702547|NCT05818956|102057666|FG001|COMPLETED|Washout Period 1 (4 Days)||4||
48702548|NCT05818956|102057667|FG002|COMPLETED|Washout Period 1 (4 Days)||4||
48702549|NCT05818956|102057668|FG003|COMPLETED|Washout Period 1 (4 Days)||4||
48702550|NCT05818956|102057669|FG004|COMPLETED|Washout Period 1 (4 Days)||4||
48702551|NCT05818956|102057670|FG005|COMPLETED|Washout Period 1 (4 Days)||4||
48702552|NCT05818956|102057665|FG000|NOT COMPLETED|Washout Period 1 (4 Days)||0||
48702553|NCT05818956|102057666|FG001|NOT COMPLETED|Washout Period 1 (4 Days)||0||
48702554|NCT05818956|102057667|FG002|NOT COMPLETED|Washout Period 1 (4 Days)||0||
48702555|NCT05818956|102057668|FG003|NOT COMPLETED|Washout Period 1 (4 Days)||0||
48702556|NCT05818956|102057669|FG004|NOT COMPLETED|Washout Period 1 (4 Days)||0||
48285884|NCT00803751|101026217|FG000|STARTED|Overall Study||26||
48576440|NCT01876810|101741392|FG000|COMPLETED|Overall Study||14||
48576441|NCT01876810|101741393|FG001|COMPLETED|Overall Study||13||
48576442|NCT01876810|101741392|FG000|NOT COMPLETED|Overall Study||0||
48576443|NCT01876810|101741393|FG001|NOT COMPLETED|Overall Study||1||
48576444|NCT03425396|101741394|FG000|STARTED|Overall Study||55||
48702557|NCT05818956|102057670|FG005|NOT COMPLETED|Washout Period 1 (4 Days)||0||
48702558|NCT05818956|102057665|FG000|STARTED|Treatment Period 2 (2 Days)||4||
48702559|NCT05818956|102057666|FG001|STARTED|Treatment Period 2 (2 Days)||4||
48702560|NCT05818956|102057667|FG002|STARTED|Treatment Period 2 (2 Days)||4||
48702561|NCT05818956|102057668|FG003|STARTED|Treatment Period 2 (2 Days)||4||
48702562|NCT05818956|102057669|FG004|STARTED|Treatment Period 2 (2 Days)||4||
48285885|NCT00803751|101026218|FG001|STARTED|Overall Study||23||
48576445|NCT03425396|101741395|FG001|STARTED|Overall Study||54||
48576446|NCT03425396|101741396|FG002|STARTED|Overall Study||54||
48702563|NCT05818956|102057670|FG005|STARTED|Treatment Period 2 (2 Days)||4||
48702564|NCT05818956|102057665|FG000|COMPLETED|Treatment Period 2 (2 Days)||4||
48576447|NCT03425396|101741397|FG003|STARTED|Overall Study||8||
48576448|NCT03425396|101741398|FG004|STARTED|Overall Study||54||
48702565|NCT05818956|102057666|FG001|COMPLETED|Treatment Period 2 (2 Days)||4||
48702566|NCT05818956|102057667|FG002|COMPLETED|Treatment Period 2 (2 Days)||4||
48702567|NCT05818956|102057668|FG003|COMPLETED|Treatment Period 2 (2 Days)||4||
48702568|NCT05818956|102057669|FG004|COMPLETED|Treatment Period 2 (2 Days)||4||
48702569|NCT05818956|102057670|FG005|COMPLETED|Treatment Period 2 (2 Days)||4||
48702570|NCT05818956|102057665|FG000|NOT COMPLETED|Treatment Period 2 (2 Days)||0||
48702571|NCT05818956|102057666|FG001|NOT COMPLETED|Treatment Period 2 (2 Days)||0||
48702572|NCT05818956|102057667|FG002|NOT COMPLETED|Treatment Period 2 (2 Days)||0||
48702573|NCT05818956|102057668|FG003|NOT COMPLETED|Treatment Period 2 (2 Days)||0||
48702574|NCT05818956|102057669|FG004|NOT COMPLETED|Treatment Period 2 (2 Days)||0||
48702575|NCT05818956|102057670|FG005|NOT COMPLETED|Treatment Period 2 (2 Days)||0||
48702576|NCT05818956|102057665|FG000|STARTED|Washout Period 2 (4 Days)||4||
48702577|NCT05818956|102057666|FG001|STARTED|Washout Period 2 (4 Days)||4||
48702578|NCT05818956|102057667|FG002|STARTED|Washout Period 2 (4 Days)||4||
48702579|NCT05818956|102057668|FG003|STARTED|Washout Period 2 (4 Days)||4||
48702580|NCT05818956|102057669|FG004|STARTED|Washout Period 2 (4 Days)||4||
48702581|NCT05818956|102057670|FG005|STARTED|Washout Period 2 (4 Days)||4||
48702582|NCT05818956|102057665|FG000|COMPLETED|Washout Period 2 (4 Days)||4||
48702583|NCT05818956|102057666|FG001|COMPLETED|Washout Period 2 (4 Days)||4||
48702584|NCT05818956|102057667|FG002|COMPLETED|Washout Period 2 (4 Days)||4||
48702585|NCT05818956|102057668|FG003|COMPLETED|Washout Period 2 (4 Days)||4||
48702586|NCT05818956|102057669|FG004|COMPLETED|Washout Period 2 (4 Days)||4||
48702587|NCT05818956|102057670|FG005|COMPLETED|Washout Period 2 (4 Days)||4||
48702588|NCT05818956|102057665|FG000|NOT COMPLETED|Washout Period 2 (4 Days)||0||
48702589|NCT05818956|102057666|FG001|NOT COMPLETED|Washout Period 2 (4 Days)||0||
48702590|NCT05818956|102057667|FG002|NOT COMPLETED|Washout Period 2 (4 Days)||0||
48702591|NCT05818956|102057668|FG003|NOT COMPLETED|Washout Period 2 (4 Days)||0||
48702592|NCT05818956|102057669|FG004|NOT COMPLETED|Washout Period 2 (4 Days)||0||
48702593|NCT05818956|102057670|FG005|NOT COMPLETED|Washout Period 2 (4 Days)||0||
48132539|NCT03867734|100648509|FG000|STARTED|Overall Study||32||
48132540|NCT03867734|100648509|FG000|COMPLETED|Overall Study||30||
48132541|NCT03867734|100648509|FG000|NOT COMPLETED|Overall Study||2||
48132542|NCT02525133|100648510|FG000|STARTED|Overall Study||213||
48132543|NCT02525133|100648511|FG001|STARTED|Overall Study||106||
48132544|NCT02525133|100648510|FG000|Randomized But Not Treated|Overall Study||4||
48132545|NCT02525133|100648511|FG001|Randomized But Not Treated|Overall Study||0||
48132546|NCT02525133|100648510|FG000|COMPLETED|Overall Study||203||
48132547|NCT02525133|100648511|FG001|COMPLETED|Overall Study||103||
48132548|NCT02525133|100648510|FG000|NOT COMPLETED|Overall Study||10||
48285886|NCT00803751|101026217|FG000|COMPLETED|Overall Study||26||
48285887|NCT00803751|101026218|FG001|COMPLETED|Overall Study||23||
48285888|NCT00803751|101026217|FG000|NOT COMPLETED|Overall Study||0||
48285889|NCT00803751|101026218|FG001|NOT COMPLETED|Overall Study||0||
48576449|NCT03425396|101741394|FG000|Completed End of Treatment Visit|Overall Study||53||
48576450|NCT03425396|101741395|FG001|Completed End of Treatment Visit|Overall Study||52||
48576451|NCT03425396|101741396|FG002|Completed End of Treatment Visit|Overall Study||51||
48576452|NCT03425396|101741397|FG003|Completed End of Treatment Visit|Overall Study||7||
48576453|NCT03425396|101741398|FG004|Completed End of Treatment Visit|Overall Study||53||
48576454|NCT03425396|101741394|FG000|Completed Post-therapy Evaluation Visit|Overall Study||53||
48576455|NCT03425396|101741395|FG001|Completed Post-therapy Evaluation Visit|Overall Study||49||
48576456|NCT03425396|101741396|FG002|Completed Post-therapy Evaluation Visit|Overall Study||51||
48576457|NCT03425396|101741397|FG003|Completed Post-therapy Evaluation Visit|Overall Study||7||
48576458|NCT03425396|101741398|FG004|Completed Post-therapy Evaluation Visit|Overall Study||54||
48702594|NCT05818956|102057665|FG000|STARTED|Treatment Period 3 (2 Days)||4||
48702595|NCT05818956|102057666|FG001|STARTED|Treatment Period 3 (2 Days)||4||
48702596|NCT05818956|102057667|FG002|STARTED|Treatment Period 3 (2 Days)||4||
48702597|NCT05818956|102057668|FG003|STARTED|Treatment Period 3 (2 Days)||4||
48132549|NCT02525133|100648511|FG001|NOT COMPLETED|Overall Study||3||
48132550|NCT01617629|100648512|FG000|STARTED|Overall Study||9||
48132551|NCT01617629|100648512|FG000|COMPLETED|Overall Study||3||
48132552|NCT01617629|100648512|FG000|NOT COMPLETED|Overall Study||6||
48132553|NCT01946711|100648513|FG000|STARTED|Overall Study||8||
48132554|NCT01946711|100648514|FG001|STARTED|Overall Study||6||
48132555|NCT01946711|100648513|FG000|COMPLETED|Overall Study||8||
48702598|NCT05818956|102057669|FG004|STARTED|Treatment Period 3 (2 Days)||4||
48132556|NCT01946711|100648514|FG001|COMPLETED|Overall Study||6||
48285890|NCT05332145|101026219|FG000|STARTED|Overall Study||35||
48702599|NCT05818956|102057670|FG005|STARTED|Treatment Period 3 (2 Days)||4||
48702600|NCT05818956|102057665|FG000|COMPLETED|Treatment Period 3 (2 Days)||4||
48702601|NCT05818956|102057666|FG001|COMPLETED|Treatment Period 3 (2 Days)||4||
48702602|NCT05818956|102057667|FG002|COMPLETED|Treatment Period 3 (2 Days)||4||
48702603|NCT05818956|102057668|FG003|COMPLETED|Treatment Period 3 (2 Days)||4||
48702604|NCT05818956|102057669|FG004|COMPLETED|Treatment Period 3 (2 Days)||4||
48702605|NCT05818956|102057670|FG005|COMPLETED|Treatment Period 3 (2 Days)||4||
48702606|NCT05818956|102057665|FG000|NOT COMPLETED|Treatment Period 3 (2 Days)||0||
48285891|NCT05332145|101026219|FG000|COMPLETED|Overall Study||33||
48576459|NCT03425396|101741394|FG000|Completed Final Follow-up Visit|Overall Study||53||
48576460|NCT03425396|101741395|FG001|Completed Final Follow-up Visit|Overall Study||47||
48576461|NCT03425396|101741396|FG002|Completed Final Follow-up Visit|Overall Study||51||
48576462|NCT03425396|101741397|FG003|Completed Final Follow-up Visit|Overall Study||7||
48576463|NCT03425396|101741398|FG004|Completed Final Follow-up Visit|Overall Study||53||
48576464|NCT03425396|101741394|FG000|COMPLETED|Overall Study||53||
48702607|NCT05818956|102057666|FG001|NOT COMPLETED|Treatment Period 3 (2 Days)||0||
48285892|NCT05332145|101026219|FG000|NOT COMPLETED|Overall Study||2||
48285893|NCT04004936|101026220|FG000|STARTED|Overall Study||36||
48285894|NCT04004936|101026221|FG001|STARTED|Overall Study||38||
48285895|NCT04004936|101026220|FG000|COMPLETED|Overall Study||36||
48285896|NCT04004936|101026221|FG001|COMPLETED|Overall Study||38||
48285897|NCT04004936|101026220|FG000|NOT COMPLETED|Overall Study||0||
48285898|NCT04004936|101026221|FG001|NOT COMPLETED|Overall Study||0||
48285899|NCT00979810|101026222|FG000|STARTED|Overall Study||11||
48285900|NCT00979810|101026222|FG000|COMPLETED|Overall Study||11||
48285901|NCT00979810|101026222|FG000|NOT COMPLETED|Overall Study||0||
48285902|NCT02478710|101026223|FG000|STARTED|Overall Study||10||
48285903|NCT02478710|101026224|FG001|STARTED|Overall Study||6||
48285904|NCT02478710|101026223|FG000|COMPLETED|Overall Study||10||
48702608|NCT05818956|102057667|FG002|NOT COMPLETED|Treatment Period 3 (2 Days)||0||
48702609|NCT05818956|102057668|FG003|NOT COMPLETED|Treatment Period 3 (2 Days)||0||
48702610|NCT05818956|102057669|FG004|NOT COMPLETED|Treatment Period 3 (2 Days)||0||
48702611|NCT05818956|102057670|FG005|NOT COMPLETED|Treatment Period 3 (2 Days)||0||
48702612|NCT02250807|102057671|FG000|STARTED|Overall Study||40||
48702613|NCT02250807|102057671|FG000|COMPLETED|Overall Study||40||
48702614|NCT02250807|102057671|FG000|NOT COMPLETED|Overall Study||0||
48702615|NCT01265563|102057672|FG000|STARTED|Overall Study||16||
48285905|NCT02478710|101026224|FG001|COMPLETED|Overall Study||6||
48285906|NCT02478710|101026223|FG000|NOT COMPLETED|Overall Study||0||
48285907|NCT02478710|101026224|FG001|NOT COMPLETED|Overall Study||0||
48285908|NCT03356626|101026225|FG000|STARTED|Overall Study||61||
48285909|NCT03356626|101026226|FG001|STARTED|Overall Study||65||
48285910|NCT03356626|101026227|FG002|STARTED|Overall Study||63||
48285911|NCT03356626|101026225|FG000|COMPLETED|Overall Study||57||
48285912|NCT03356626|101026226|FG001|COMPLETED|Overall Study||60||
48285913|NCT03356626|101026227|FG002|COMPLETED|Overall Study||57||
48285914|NCT03356626|101026225|FG000|NOT COMPLETED|Overall Study||4||
48285915|NCT03356626|101026226|FG001|NOT COMPLETED|Overall Study||5||
48285916|NCT03356626|101026227|FG002|NOT COMPLETED|Overall Study||6||
48285917|NCT02383056|101026228|FG000|STARTED|Overall Study||7||
48285918|NCT02383056|101026229|FG001|STARTED|Overall Study||7||
48285919|NCT02383056|101026228|FG000|COMPLETED|Overall Study||6||
48285920|NCT02383056|101026229|FG001|COMPLETED|Overall Study||5||
48285921|NCT02383056|101026228|FG000|NOT COMPLETED|Overall Study||1||
48285922|NCT02383056|101026229|FG001|NOT COMPLETED|Overall Study||2||
48285923|NCT02781844|101026230|FG000|STARTED|Treatment Period 1||5||
48285924|NCT02781844|101026231|FG001|STARTED|Treatment Period 1||4||
48576465|NCT03425396|101741395|FG001|COMPLETED|Overall Study||47||
48576466|NCT03425396|101741396|FG002|COMPLETED|Overall Study||51||
48576467|NCT03425396|101741397|FG003|COMPLETED|Overall Study||7||
48576468|NCT03425396|101741398|FG004|COMPLETED|Overall Study||53||
48576469|NCT03425396|101741394|FG000|NOT COMPLETED|Overall Study||2||
48576470|NCT03425396|101741395|FG001|NOT COMPLETED|Overall Study||7||
48576471|NCT03425396|101741396|FG002|NOT COMPLETED|Overall Study||3||
48576472|NCT03425396|101741397|FG003|NOT COMPLETED|Overall Study||1||
48576473|NCT03425396|101741398|FG004|NOT COMPLETED|Overall Study||1||
48576474|NCT01916681|101741399|FG000|STARTED|Overall Study||123||
48576475|NCT01916681|101741400|FG001|STARTED|Overall Study||120||
48576476|NCT01916681|101741401|FG002|STARTED|Overall Study||123||
48576477|NCT01916681|101741402|FG003|STARTED|Overall Study||125||
48702616|NCT01265563|102057673|FG001|STARTED|Overall Study||13||
48702617|NCT01265563|102057674|FG002|STARTED|Overall Study||17||
48285925|NCT02781844|101026232|FG002|STARTED|Treatment Period 1||4||
48576478|NCT01916681|101741399|FG000|COMPLETED|Overall Study||123||
48576479|NCT01916681|101741400|FG001|COMPLETED|Overall Study||120||
48576480|NCT01916681|101741401|FG002|COMPLETED|Overall Study||123||
48576481|NCT01916681|101741402|FG003|COMPLETED|Overall Study||125||
48576482|NCT01916681|101741399|FG000|NOT COMPLETED|Overall Study||0||
48576483|NCT01916681|101741400|FG001|NOT COMPLETED|Overall Study||0||
48702618|NCT01265563|102057675|FG003|STARTED|Overall Study||16||
48702619|NCT01265563|102057676|FG004|STARTED|Overall Study||16||
48285926|NCT02781844|101026233|FG003|STARTED|Treatment Period 1||4||
48702620|NCT01265563|102057672|FG000|COMPLETED|Overall Study||16||
48702621|NCT01265563|102057673|FG001|COMPLETED|Overall Study||12||
48702622|NCT01265563|102057674|FG002|COMPLETED|Overall Study||16||
48702623|NCT01265563|102057675|FG003|COMPLETED|Overall Study||16||
48285927|NCT02781844|101026234|FG004|STARTED|Treatment Period 1||4||
48285928|NCT02781844|101026235|FG005|STARTED|Treatment Period 1||5||
48576484|NCT01916681|101741401|FG002|NOT COMPLETED|Overall Study||0||
48576485|NCT01916681|101741402|FG003|NOT COMPLETED|Overall Study||0||
48576486|NCT01540487|101741403|FG000|STARTED|Overall Study||24||
48576487|NCT01540487|101741404|FG001|STARTED|Overall Study||24||
48576488|NCT01540487|101741403|FG000|COMPLETED|Overall Study||23||
48285929|NCT02781844|101026236|FG006|STARTED|Treatment Period 1||4||
48285930|NCT02781844|101026237|FG007|STARTED|Treatment Period 1||4||
48285931|NCT02781844|101026230|FG000|COMPLETED|Treatment Period 1||5||
48285932|NCT02781844|101026231|FG001|COMPLETED|Treatment Period 1||4||
48702624|NCT01265563|102057676|FG004|COMPLETED|Overall Study||14||
48285933|NCT02781844|101026232|FG002|COMPLETED|Treatment Period 1||4||
48285934|NCT02781844|101026233|FG003|COMPLETED|Treatment Period 1||4||
48285935|NCT02781844|101026234|FG004|COMPLETED|Treatment Period 1||4||
48285936|NCT02781844|101026235|FG005|COMPLETED|Treatment Period 1||4||
48285937|NCT02781844|101026236|FG006|COMPLETED|Treatment Period 1||4||
48285938|NCT02781844|101026237|FG007|COMPLETED|Treatment Period 1||4||
48285939|NCT02781844|101026230|FG000|NOT COMPLETED|Treatment Period 1||0||
48399746|NCT00688545|101309203|FG001|STARTED|Overall Study||219||
48399747|NCT00688545|101309202|FG000|Switched Treatment at Least Once|Overall Study||6||
48399748|NCT00688545|101309203|FG001|Switched Treatment at Least Once|Overall Study||13||
48576489|NCT01540487|101741404|FG001|COMPLETED|Overall Study||24||
48576490|NCT01540487|101741403|FG000|NOT COMPLETED|Overall Study||1||
48702625|NCT01265563|102057672|FG000|NOT COMPLETED|Overall Study||0||
48702626|NCT01265563|102057673|FG001|NOT COMPLETED|Overall Study||1||
48702627|NCT01265563|102057674|FG002|NOT COMPLETED|Overall Study||1||
48702628|NCT01265563|102057675|FG003|NOT COMPLETED|Overall Study||0||
48702629|NCT01265563|102057676|FG004|NOT COMPLETED|Overall Study||2||
48702630|NCT03354546|102057677|FG000|STARTED|Overall Study||415704||
48702631|NCT03354546|102057678|FG001|STARTED|Overall Study||95581||
48285940|NCT02781844|101026231|FG001|NOT COMPLETED|Treatment Period 1||0||
48285941|NCT02781844|101026232|FG002|NOT COMPLETED|Treatment Period 1||0||
48285942|NCT02781844|101026233|FG003|NOT COMPLETED|Treatment Period 1||0||
48285943|NCT02781844|101026234|FG004|NOT COMPLETED|Treatment Period 1||0||
48285944|NCT02781844|101026235|FG005|NOT COMPLETED|Treatment Period 1||1||
48285945|NCT02781844|101026236|FG006|NOT COMPLETED|Treatment Period 1||0||
48285946|NCT02781844|101026237|FG007|NOT COMPLETED|Treatment Period 1||0||
48285947|NCT02781844|101026230|FG000|STARTED|Treatment Period 2||5||
48285948|NCT02781844|101026231|FG001|STARTED|Treatment Period 2||4||
48285949|NCT02781844|101026232|FG002|STARTED|Treatment Period 2||4||
48285950|NCT02781844|101026233|FG003|STARTED|Treatment Period 2||4||
48285951|NCT02781844|101026234|FG004|STARTED|Treatment Period 2||4||
48285952|NCT02781844|101026235|FG005|STARTED|Treatment Period 2||4||
48285953|NCT02781844|101026236|FG006|STARTED|Treatment Period 2||4||
48285954|NCT02781844|101026237|FG007|STARTED|Treatment Period 2||4||
48399749|NCT00688545|101309202|FG000|COMPLETED|Overall Study||50||
48576491|NCT01540487|101741404|FG001|NOT COMPLETED|Overall Study||0||
48576492|NCT03521102|101741405|FG000|STARTED|Overall Study||81||
48576493|NCT03521102|101741406|FG001|STARTED|Overall Study||81||
48576494|NCT03521102|101741405|FG000|COMPLETED|Overall Study||81||
48576495|NCT03521102|101741406|FG001|COMPLETED|Overall Study||81||
48576496|NCT03521102|101741405|FG000|NOT COMPLETED|Overall Study||0||
48576497|NCT03521102|101741406|FG001|NOT COMPLETED|Overall Study||0||
48576498|NCT01814696|101741407|FG000|STARTED|Overall Study||15||
48576499|NCT01814696|101741408|FG001|STARTED|Overall Study||11||
48576500|NCT01814696|101741407|FG000|COMPLETED|Overall Study||13||
48576501|NCT01814696|101741408|FG001|COMPLETED|Overall Study||11||
48576502|NCT01814696|101741407|FG000|NOT COMPLETED|Overall Study||2||
48702632|NCT03354546|102057677|FG000|COMPLETED|Overall Study||415704||
48702633|NCT03354546|102057678|FG001|COMPLETED|Overall Study||95581||
48702634|NCT03354546|102057677|FG000|NOT COMPLETED|Overall Study||0||
48702635|NCT03354546|102057678|FG001|NOT COMPLETED|Overall Study||0||
48285955|NCT02781844|101026230|FG000|COMPLETED|Treatment Period 2||5||
48285956|NCT02781844|101026231|FG001|COMPLETED|Treatment Period 2||4||
48285957|NCT02781844|101026232|FG002|COMPLETED|Treatment Period 2||4||
48285958|NCT02781844|101026233|FG003|COMPLETED|Treatment Period 2||4||
48285959|NCT02781844|101026234|FG004|COMPLETED|Treatment Period 2||4||
48285960|NCT02781844|101026235|FG005|COMPLETED|Treatment Period 2||4||
48285961|NCT02781844|101026236|FG006|COMPLETED|Treatment Period 2||4||
48285962|NCT02781844|101026237|FG007|COMPLETED|Treatment Period 2||4||
48285963|NCT02781844|101026230|FG000|NOT COMPLETED|Treatment Period 2||0||
48285964|NCT02781844|101026231|FG001|NOT COMPLETED|Treatment Period 2||0||
48285965|NCT02781844|101026232|FG002|NOT COMPLETED|Treatment Period 2||0||
48285966|NCT02781844|101026233|FG003|NOT COMPLETED|Treatment Period 2||0||
48399750|NCT00688545|101309203|FG001|COMPLETED|Overall Study||204||
48399751|NCT00688545|101309202|FG000|NOT COMPLETED|Overall Study||5||
48285967|NCT02781844|101026234|FG004|NOT COMPLETED|Treatment Period 2||0||
48285968|NCT02781844|101026235|FG005|NOT COMPLETED|Treatment Period 2||0||
48399752|NCT00688545|101309203|FG001|NOT COMPLETED|Overall Study||15||
48576503|NCT01814696|101741408|FG001|NOT COMPLETED|Overall Study||0||
48576504|NCT01069510|101741409|FG000|STARTED|Overall Study||8||
48576505|NCT01069510|101741410|FG001|STARTED|Overall Study||7||
48576506|NCT01069510|101741409|FG000|COMPLETED|Overall Study||8||
48576507|NCT01069510|101741410|FG001|COMPLETED|Overall Study||7||
48576508|NCT01069510|101741409|FG000|NOT COMPLETED|Overall Study||0||
48576509|NCT01069510|101741410|FG001|NOT COMPLETED|Overall Study||0||
48702636|NCT02513485|102057679|FG000|STARTED|Overall Study||28||
48702637|NCT02513485|102057680|FG001|STARTED|Overall Study||29||
48702638|NCT02513485|102057679|FG000|COMPLETED|Overall Study||27||
48702639|NCT02513485|102057680|FG001|COMPLETED|Overall Study||29||
48702640|NCT02513485|102057679|FG000|NOT COMPLETED|Overall Study||1||
48702641|NCT02513485|102057680|FG001|NOT COMPLETED|Overall Study||0||
48702642|NCT01451931|102057681|FG000|STARTED|Overall Study||909||
48702643|NCT01451931|102057682|FG001|STARTED|Overall Study||901||
48702644|NCT01451931|102057683|FG002|STARTED|Overall Study||966||
48702645|NCT01451931|102057681|FG000|Baseline Data Collection|Overall Study||908||
48702646|NCT01451931|102057682|FG001|Baseline Data Collection|Overall Study||893||
48702647|NCT01451931|102057683|FG002|Baseline Data Collection|Overall Study||958||
48702648|NCT01451931|102057681|FG000|6-month Follow up|Overall Study||876||
48702649|NCT01451931|102057682|FG001|6-month Follow up|Overall Study||843||
48702650|NCT01451931|102057683|FG002|6-month Follow up|Overall Study||923||
48702651|NCT01451931|102057681|FG000|COMPLETED|Overall Study||876||
48702652|NCT01451931|102057682|FG001|COMPLETED|Overall Study||843||
48702653|NCT01451931|102057683|FG002|COMPLETED|Overall Study||923||
48702654|NCT01451931|102057681|FG000|NOT COMPLETED|Overall Study||33||
48285969|NCT02781844|101026236|FG006|NOT COMPLETED|Treatment Period 2||0||
48285970|NCT02781844|101026237|FG007|NOT COMPLETED|Treatment Period 2||0||
48285971|NCT00189488|101026238|FG000|STARTED|Overall Study||78||
48285972|NCT00189488|101026239|FG001|STARTED|Overall Study||77||
48285973|NCT00189488|101026238|FG000|Received Palifermin/Placebo|Overall Study||75||
48285974|NCT00189488|101026239|FG001|Received Palifermin/Placebo|Overall Study||76||
48285975|NCT00189488|101026238|FG000|COMPLETED|Overall Study||63||
48285976|NCT00189488|101026239|FG001|COMPLETED|Overall Study||55||
48285977|NCT00189488|101026238|FG000|NOT COMPLETED|Overall Study||15||
48285978|NCT00189488|101026239|FG001|NOT COMPLETED|Overall Study||22||
48285979|NCT00730275|101026240|FG000|STARTED|Overall Study||9||
48285980|NCT00730275|101026241|FG001|STARTED|Overall Study||9||
48285981|NCT00730275|101026242|FG002|STARTED|Overall Study||8||
48285982|NCT00730275|101026243|FG003|STARTED|Overall Study||9||
48285983|NCT00730275|101026240|FG000|COMPLETED|Overall Study||9||
48285984|NCT00730275|101026241|FG001|COMPLETED|Overall Study||9||
48285985|NCT00730275|101026242|FG002|COMPLETED|Overall Study||8||
48285986|NCT00730275|101026243|FG003|COMPLETED|Overall Study||8||
48576510|NCT02919969|101741411|FG000|STARTED|Overall Study||32||
48576511|NCT02919969|101741411|FG000|COMPLETED|Overall Study||1||
48576512|NCT02919969|101741411|FG000|NOT COMPLETED|Overall Study||31||
48399753|NCT00570362|101309204|FG000|STARTED|Overall Study||19||
48576513|NCT02993146|101741412|FG000|STARTED|Overall Study||1||
48576514|NCT02993146|101741413|FG001|STARTED|Overall Study||1||
48576515|NCT02993146|101741414|FG002|STARTED|Overall Study||7||
48576516|NCT02993146|101741415|FG003|STARTED|Overall Study||2||
48576517|NCT02993146|101741412|FG000|COMPLETED|Overall Study||1||
48576518|NCT02993146|101741413|FG001|COMPLETED|Overall Study||1||
48576519|NCT02993146|101741414|FG002|COMPLETED|Overall Study||6||
48576520|NCT02993146|101741415|FG003|COMPLETED|Overall Study||1||
48285987|NCT00730275|101026240|FG000|NOT COMPLETED|Overall Study||0||
48285988|NCT00730275|101026241|FG001|NOT COMPLETED|Overall Study||0||
48285989|NCT00730275|101026242|FG002|NOT COMPLETED|Overall Study||0||
48576521|NCT02993146|101741412|FG000|NOT COMPLETED|Overall Study||0||
48576522|NCT02993146|101741413|FG001|NOT COMPLETED|Overall Study||0||
48576523|NCT02993146|101741414|FG002|NOT COMPLETED|Overall Study||1||
48576524|NCT02993146|101741415|FG003|NOT COMPLETED|Overall Study||1||
48576525|NCT02713256|101741416|FG000|STARTED|Overall Study||15||
48576526|NCT02713256|101741416|FG000|COMPLETED|Overall Study||15||
48576527|NCT02713256|101741416|FG000|NOT COMPLETED|Overall Study||0||
48576528|NCT01135329|101741417|FG000|STARTED|Overall Study||15||
48576529|NCT01135329|101741417|FG000|COMPLETED|Overall Study||15||
48576530|NCT01135329|101741417|FG000|NOT COMPLETED|Overall Study||0||
48576531|NCT02616146|101741418|FG000|STARTED|Overall Study||1512||
48576532|NCT02616146|101741419|FG001|STARTED|Overall Study||504||
48576533|NCT02616146|101741418|FG000|COMPLETED|Overall Study||0||
48702655|NCT01451931|102057682|FG001|NOT COMPLETED|Overall Study||58||
48702656|NCT01451931|102057683|FG002|NOT COMPLETED|Overall Study||43||
48702657|NCT02752958|102057684|FG000|STARTED|Overall Study||75||
48285990|NCT00730275|101026243|FG003|NOT COMPLETED|Overall Study||1||
48285991|NCT03623373|101026244|FG000|STARTED|Overall Study||13||
48285992|NCT03623373|101026244|FG000|COMPLETED|Overall Study||13||
48285993|NCT03623373|101026244|FG000|NOT COMPLETED|Overall Study||0||
48285994|NCT01963923|101026245|FG000|STARTED|3 Weeks Post-surgery||20||
48285995|NCT01963923|101026246|FG001|STARTED|3 Weeks Post-surgery||20||
48285996|NCT01963923|101026245|FG000|COMPLETED|3 Weeks Post-surgery||12||
48285997|NCT01963923|101026246|FG001|COMPLETED|3 Weeks Post-surgery||10||
48285998|NCT01963923|101026245|FG000|NOT COMPLETED|3 Weeks Post-surgery||8||
48285999|NCT01963923|101026246|FG001|NOT COMPLETED|3 Weeks Post-surgery||10||
48286000|NCT01963923|101026245|FG000|STARTED|3 Months Post-surgery||12||
48286001|NCT01963923|101026246|FG001|STARTED|3 Months Post-surgery||10||
48286002|NCT01963923|101026245|FG000|COMPLETED|3 Months Post-surgery||10||
48576534|NCT02616146|101741419|FG001|COMPLETED|Overall Study||0||
48576535|NCT02616146|101741418|FG000|NOT COMPLETED|Overall Study||1512||
48576536|NCT02616146|101741419|FG001|NOT COMPLETED|Overall Study||504||
48576537|NCT03436693|101741420|FG000|STARTED|Overall Study||154||
48576538|NCT03436693|101741421|FG001|STARTED|Overall Study||154||
48576539|NCT03436693|101741420|FG000|COMPLETED|Overall Study||124||
48576540|NCT03436693|101741421|FG001|COMPLETED|Overall Study||127||
48576541|NCT03436693|101741420|FG000|NOT COMPLETED|Overall Study||30||
48576542|NCT03436693|101741421|FG001|NOT COMPLETED|Overall Study||27||
48576543|NCT00285207|101741422|FG000|STARTED|Overall Study||70||
48576544|NCT00285207|101741423|FG001|STARTED|Overall Study||77||
48576545|NCT00285207|101741422|FG000|Treated|Overall Study||63||
48576546|NCT00285207|101741423|FG001|Treated|Overall Study||75||
48576547|NCT00285207|101741422|FG000|COMPLETED|Overall Study||61||
48576548|NCT00285207|101741423|FG001|COMPLETED|Overall Study||71||
48576549|NCT00285207|101741422|FG000|NOT COMPLETED|Overall Study||9||
48576550|NCT00285207|101741423|FG001|NOT COMPLETED|Overall Study||6||
48576551|NCT01696929|101741424|FG000|STARTED|Overall Study||6||
48576552|NCT01696929|101741424|FG000|COMPLETED|Overall Study||5||
48576553|NCT01696929|101741424|FG000|NOT COMPLETED|Overall Study||1||
48576554|NCT02237196|101741425|FG000|STARTED|Overall Study||32||
48576555|NCT02237196|101741426|FG001|STARTED|Overall Study||31||
48576556|NCT02237196|101741427|FG002|STARTED|Overall Study||30||
48576557|NCT02237196|101741428|FG003|STARTED|Overall Study||28||
48576558|NCT02237196|101741425|FG000|COMPLETED|Overall Study||24||
48576559|NCT02237196|101741426|FG001|COMPLETED|Overall Study||25||
48576560|NCT02237196|101741427|FG002|COMPLETED|Overall Study||20||
48702658|NCT02752958|102057684|FG000|COMPLETED|Overall Study||66||
48702659|NCT02752958|102057684|FG000|NOT COMPLETED|Overall Study||9||
48286003|NCT01963923|101026246|FG001|COMPLETED|3 Months Post-surgery||9||
48576561|NCT02237196|101741428|FG003|COMPLETED|Overall Study||17||
48576562|NCT02237196|101741425|FG000|NOT COMPLETED|Overall Study||8||
48576563|NCT02237196|101741426|FG001|NOT COMPLETED|Overall Study||6||
48576564|NCT02237196|101741427|FG002|NOT COMPLETED|Overall Study||10||
48576565|NCT02237196|101741428|FG003|NOT COMPLETED|Overall Study||11||
48576566|NCT02042950|101744545|FG000|STARTED|Overall Study||4||
48576567|NCT02042950|101744545|FG000|COMPLETED|Overall Study||0||
48576568|NCT02042950|101744545|FG000|NOT COMPLETED|Overall Study||4||
48576569|NCT02401048|101744546|FG000|STARTED|Overall Study||27||
48576570|NCT02401048|101744547|FG001|STARTED|Overall Study||34||
48576571|NCT02401048|101744546|FG000|COMPLETED|Overall Study||5||
48576572|NCT02401048|101744547|FG001|COMPLETED|Overall Study||4||
48576573|NCT02401048|101744546|FG000|NOT COMPLETED|Overall Study||22||
48576574|NCT02401048|101744547|FG001|NOT COMPLETED|Overall Study||30||
48576575|NCT00892151|101744548|FG000|STARTED|Overall Study||51||
48576576|NCT00892151|101744548|FG000|COMPLETED|Overall Study||50||
48576577|NCT00892151|101744548|FG000|NOT COMPLETED|Overall Study||1||
48576578|NCT04382755|101744549|FG000|STARTED|Overall Study||55|randomized patients|
48576579|NCT04382755|101744550|FG001|STARTED|Overall Study||26|randomized patients|
48576580|NCT04382755|101744549|FG000|Treated|Overall Study||54|patients that received at least 1 intervention|
48576581|NCT04382755|101744550|FG001|Treated|Overall Study||24|patients that received at least 1 intervention|
48576582|NCT04382755|101744549|FG000|COMPLETED|Overall Study||54|included in safety and primary analysis|
48576583|NCT04382755|101744550|FG001|COMPLETED|Overall Study||24|included in safety and primary analysis|
48576584|NCT04382755|101744549|FG000|NOT COMPLETED|Overall Study||1||
48576585|NCT04382755|101744550|FG001|NOT COMPLETED|Overall Study||2||
48576586|NCT00457002|101744551|FG000|STARTED|Overall Study||3255||
48576587|NCT00457002|101744552|FG001|STARTED|Overall Study||3273||
48576588|NCT00457002|101744551|FG000|COMPLETED|Overall Study||2442||
48576589|NCT00457002|101744552|FG001|COMPLETED|Overall Study||2516||
48576590|NCT00457002|101744551|FG000|NOT COMPLETED|Overall Study||813||
48576591|NCT00457002|101744552|FG001|NOT COMPLETED|Overall Study||757||
48576592|NCT01816711|101744553|FG000|STARTED|Overall Study||121||
48576593|NCT01816711|101744554|FG001|STARTED|Overall Study||83||
48702660|NCT01289353|102057685|FG000|STARTED|Overall Study||92||
48576594|NCT01816711|101744553|FG000|COMPLETED|Overall Study||121||
48576595|NCT01816711|101744554|FG001|COMPLETED|Overall Study||83||
48286004|NCT01963923|101026245|FG000|NOT COMPLETED|3 Months Post-surgery||2||
48286005|NCT01963923|101026246|FG001|NOT COMPLETED|3 Months Post-surgery||1||
48286006|NCT00192647|101026247|FG000|STARTED|Overall Study||448||
48702661|NCT01289353|102057685|FG000|COMPLETED|Overall Study||90||
48286007|NCT00192647|101026248|FG001|STARTED|Overall Study||448||
48286008|NCT00192647|101026247|FG000|Treated|Overall Study||433||
48576596|NCT01816711|101744553|FG000|NOT COMPLETED|Overall Study||0||
48576597|NCT01816711|101744554|FG001|NOT COMPLETED|Overall Study||0||
48576598|NCT03040804|101744555|FG000|STARTED|Overall Study||2||
48576599|NCT03040804|101744555|FG000|COMPLETED|Overall Study||2||
48576600|NCT03040804|101744555|FG000|NOT COMPLETED|Overall Study||0||
48576601|NCT05209464|101744556|FG000|STARTED|Overall Study||8||
48576602|NCT05209464|101744556|FG000|COMPLETED|Overall Study||7||
48576603|NCT05209464|101744556|FG000|NOT COMPLETED|Overall Study||1||
48576604|NCT04010747|101744557|FG000|STARTED|Overall Study||53||
48576605|NCT04010747|101744558|FG001|STARTED|Overall Study||18||
48576606|NCT04010747|101744557|FG000|COMPLETED|Overall Study||53||
48576607|NCT04010747|101744558|FG001|COMPLETED|Overall Study||18||
48576608|NCT04010747|101744557|FG000|NOT COMPLETED|Overall Study||0||
48576609|NCT04010747|101744558|FG001|NOT COMPLETED|Overall Study||0||
48576610|NCT01289639|101744559|FG000|STARTED|Overall Study||5||
48576611|NCT01289639|101744560|FG001|STARTED|Overall Study||6||
48576612|NCT01289639|101744561|FG002|STARTED|Overall Study||0||
48576613|NCT01289639|101744559|FG000|COMPLETED|Overall Study||4||
48576614|NCT01289639|101744560|FG001|COMPLETED|Overall Study||6||
48576615|NCT01289639|101744561|FG002|COMPLETED|Overall Study||0||
48576616|NCT01289639|101744559|FG000|NOT COMPLETED|Overall Study||1||
48576617|NCT01289639|101744560|FG001|NOT COMPLETED|Overall Study||0||
48576618|NCT01289639|101744561|FG002|NOT COMPLETED|Overall Study||0||
48576619|NCT03641326|101744562|FG000|STARTED|Overall Study||2||
48576620|NCT03641326|101744563|FG001|STARTED|Overall Study||3||
48576621|NCT03641326|101744562|FG000|COMPLETED|Overall Study||2||
48576622|NCT03641326|101744563|FG001|COMPLETED|Overall Study||3||
48576623|NCT03641326|101744562|FG000|NOT COMPLETED|Overall Study||0||
48576624|NCT03641326|101744563|FG001|NOT COMPLETED|Overall Study||0||
48576625|NCT01842633|101744564|FG000|STARTED|Overall Study||65||
48576626|NCT01842633|101744565|FG001|STARTED|Overall Study||66||
48132557|NCT01946711|100648513|FG000|NOT COMPLETED|Overall Study||0||
48132558|NCT01946711|100648514|FG001|NOT COMPLETED|Overall Study||0||
48132559|NCT02646423|100648515|FG000|STARTED|Overall Study||742||
48132560|NCT02646423|100648516|FG001|STARTED|Overall Study||743||
48132561|NCT02646423|100648515|FG000|COMPLETED|Overall Study||735||
48132562|NCT02646423|100648516|FG001|COMPLETED|Overall Study||735||
48132563|NCT02646423|100648515|FG000|NOT COMPLETED|Overall Study||7||
48132564|NCT02646423|100648516|FG001|NOT COMPLETED|Overall Study||8||
48132565|NCT00504829|100648517|FG000|STARTED|Overall Study||73||
48132566|NCT00504829|100648518|FG001|STARTED|Overall Study||74||
48132567|NCT00504829|100648519|FG002|STARTED|Overall Study||73||
48132568|NCT00504829|100648517|FG000|COMPLETED|Overall Study||67||
48132569|NCT00504829|100648518|FG001|COMPLETED|Overall Study||70||
48132570|NCT00504829|100648519|FG002|COMPLETED|Overall Study||63||
48132571|NCT00504829|100648517|FG000|NOT COMPLETED|Overall Study||6||
48132572|NCT00504829|100648518|FG001|NOT COMPLETED|Overall Study||4||
48132573|NCT00504829|100648519|FG002|NOT COMPLETED|Overall Study||10||
48132574|NCT04329104|100648520|FG000|STARTED|Dose Escalation Study - 5 mg/kg||6||
48132575|NCT04329104|100648521|FG001|STARTED|Dose Escalation Study - 5 mg/kg||0||
48132576|NCT04329104|100648522|FG002|STARTED|Dose Escalation Study - 5 mg/kg||0||
48132577|NCT04329104|100648523|FG003|STARTED|Dose Escalation Study - 5 mg/kg||0||
48132578|NCT04329104|100648524|FG004|STARTED|Dose Escalation Study - 5 mg/kg||0||
48132579|NCT04329104|100648525|FG005|STARTED|Dose Escalation Study - 5 mg/kg||0||
48132580|NCT04329104|100648520|FG000|COMPLETED|Dose Escalation Study - 5 mg/kg||6||
48132581|NCT04329104|100648521|FG001|COMPLETED|Dose Escalation Study - 5 mg/kg||0||
48132582|NCT04329104|100648522|FG002|COMPLETED|Dose Escalation Study - 5 mg/kg||0||
48132583|NCT04329104|100648523|FG003|COMPLETED|Dose Escalation Study - 5 mg/kg||0||
48132584|NCT04329104|100648524|FG004|COMPLETED|Dose Escalation Study - 5 mg/kg||0||
48132585|NCT04329104|100648525|FG005|COMPLETED|Dose Escalation Study - 5 mg/kg||0||
48132586|NCT04329104|100648520|FG000|NOT COMPLETED|Dose Escalation Study - 5 mg/kg||0||
48132587|NCT04329104|100648521|FG001|NOT COMPLETED|Dose Escalation Study - 5 mg/kg||0||
48132588|NCT04329104|100648522|FG002|NOT COMPLETED|Dose Escalation Study - 5 mg/kg||0||
48132589|NCT04329104|100648523|FG003|NOT COMPLETED|Dose Escalation Study - 5 mg/kg||0||
48132590|NCT04329104|100648524|FG004|NOT COMPLETED|Dose Escalation Study - 5 mg/kg||0||
48132591|NCT04329104|100648525|FG005|NOT COMPLETED|Dose Escalation Study - 5 mg/kg||0||
48132592|NCT04329104|100648520|FG000|STARTED|Dose Escalation Study - 10 mg/kg||0||
48132593|NCT04329104|100648521|FG001|STARTED|Dose Escalation Study - 10 mg/kg||6||
48132594|NCT04329104|100648522|FG002|STARTED|Dose Escalation Study - 10 mg/kg||0||
48132595|NCT04329104|100648523|FG003|STARTED|Dose Escalation Study - 10 mg/kg||0||
48132596|NCT04329104|100648524|FG004|STARTED|Dose Escalation Study - 10 mg/kg||0||
48132597|NCT04329104|100648525|FG005|STARTED|Dose Escalation Study - 10 mg/kg||0||
48286009|NCT00192647|101026248|FG001|Treated|Overall Study||438||
48286010|NCT00192647|101026247|FG000|COMPLETED|Overall Study||320||
48576627|NCT01842633|101744566|FG002|STARTED|Overall Study||34||
48576628|NCT01842633|101744564|FG000|COMPLETED|Overall Study||62||
48576629|NCT01842633|101744565|FG001|COMPLETED|Overall Study||64||
48576630|NCT01842633|101744566|FG002|COMPLETED|Overall Study||34||
48576631|NCT01842633|101744564|FG000|NOT COMPLETED|Overall Study||3||
48576632|NCT01842633|101744565|FG001|NOT COMPLETED|Overall Study||2||
48286011|NCT00192647|101026248|FG001|COMPLETED|Overall Study||302||
48286012|NCT00192647|101026247|FG000|NOT COMPLETED|Overall Study||128||
48286013|NCT00192647|101026248|FG001|NOT COMPLETED|Overall Study||146||
48286014|NCT00819390|101026249|FG000|STARTED|Overall Study||16||
48286015|NCT00819390|101026250|FG001|STARTED|Overall Study||17||
48286016|NCT00819390|101026251|FG002|STARTED|Overall Study||18||
48286017|NCT00819390|101026252|FG003|STARTED|Overall Study||19||
48286018|NCT00819390|101026249|FG000|COMPLETED|Overall Study||13||
48286019|NCT00819390|101026250|FG001|COMPLETED|Overall Study||16||
48286020|NCT00819390|101026251|FG002|COMPLETED|Overall Study||17||
48286021|NCT00819390|101026252|FG003|COMPLETED|Overall Study||19||
48286022|NCT00819390|101026249|FG000|NOT COMPLETED|Overall Study||3||
48286023|NCT00819390|101026250|FG001|NOT COMPLETED|Overall Study||1||
48286024|NCT00819390|101026251|FG002|NOT COMPLETED|Overall Study||1||
48286025|NCT00819390|101026252|FG003|NOT COMPLETED|Overall Study||0||
48286026|NCT00768079|101026253|FG000|STARTED|Overall Study||38||
48286027|NCT00768079|101026254|FG001|STARTED|Overall Study||36||
48286028|NCT00768079|101026255|FG002|STARTED|Overall Study||36||
48286029|NCT00768079|101026253|FG000|COMPLETED|Overall Study||36||
48286030|NCT00768079|101026254|FG001|COMPLETED|Overall Study||35||
48286031|NCT00768079|101026255|FG002|COMPLETED|Overall Study||32||
48286032|NCT00768079|101026253|FG000|NOT COMPLETED|Overall Study||2||
48286033|NCT00768079|101026254|FG001|NOT COMPLETED|Overall Study||1||
48286034|NCT00768079|101026255|FG002|NOT COMPLETED|Overall Study||4||
48286035|NCT02374671|101026256|FG000|STARTED|Observation (Deferred Implantation)||0||0
48286036|NCT02374671|101026257|FG001|STARTED|Observation (Deferred Implantation)||0||0
48286037|NCT02374671|101026258|FG002|STARTED|Observation (Deferred Implantation)||31||62
48286038|NCT02374671|101026256|FG000|COMPLETED|Observation (Deferred Implantation)||0||0
48286039|NCT02374671|101026257|FG001|COMPLETED|Observation (Deferred Implantation)||0||0
48286040|NCT02374671|101026258|FG002|COMPLETED|Observation (Deferred Implantation)||26||52
48286041|NCT02374671|101026256|FG000|NOT COMPLETED|Observation (Deferred Implantation)||0||0
48286042|NCT02374671|101026257|FG001|NOT COMPLETED|Observation (Deferred Implantation)||0||0
48286043|NCT02374671|101026258|FG002|NOT COMPLETED|Observation (Deferred Implantation)||5||10
48286044|NCT02374671|101026256|FG000|STARTED|Implantation- Nonrandomized & Randomized||306||604
48286045|NCT02374671|101026257|FG001|STARTED|Implantation- Nonrandomized & Randomized||28||55
48286046|NCT02374671|101026258|FG002|STARTED|Implantation- Nonrandomized & Randomized||26||49
48286047|NCT02374671|101026256|FG000|COMPLETED|Implantation- Nonrandomized & Randomized||281||571
48286048|NCT02374671|101026257|FG001|COMPLETED|Implantation- Nonrandomized & Randomized||27||53
48286049|NCT02374671|101026258|FG002|COMPLETED|Implantation- Nonrandomized & Randomized||23||44
48286050|NCT02374671|101026256|FG000|NOT COMPLETED|Implantation- Nonrandomized & Randomized||25||33
48286051|NCT02374671|101026257|FG001|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1||2
48286052|NCT02374671|101026258|FG002|NOT COMPLETED|Implantation- Nonrandomized & Randomized||3||5
48286053|NCT00262951|101026259|FG000|STARTED|Overall Study||23||
48286054|NCT00262951|101026259|FG000|COMPLETED|Overall Study||7||
48286055|NCT00262951|101026259|FG000|NOT COMPLETED|Overall Study||16||
48286056|NCT02440451|101026260|FG000|STARTED|Overall Study||15|Started the intervention protocol.|
48286057|NCT02440451|101026260|FG000|COMPLETED|Overall Study||15|Completed the intervention protocol.|
48286058|NCT02440451|101026260|FG000|NOT COMPLETED|Overall Study||0||
48286059|NCT01030406|101026261|FG000|STARTED|Overall Study||10||
48286060|NCT01030406|101026262|FG001|STARTED|Overall Study||10||
48286061|NCT01030406|101026263|FG002|STARTED|Overall Study||10||
48286062|NCT01030406|101026264|FG003|STARTED|Overall Study||10||
48286063|NCT01030406|101026265|FG004|STARTED|Overall Study||9||
48286064|NCT01030406|101026261|FG000|COMPLETED|Overall Study||10||
48286065|NCT01030406|101026262|FG001|COMPLETED|Overall Study||10||
48286066|NCT01030406|101026263|FG002|COMPLETED|Overall Study||9||
48286067|NCT01030406|101026264|FG003|COMPLETED|Overall Study||9||
48286068|NCT01030406|101026265|FG004|COMPLETED|Overall Study||9||
48286069|NCT01030406|101026261|FG000|NOT COMPLETED|Overall Study||0||
48286070|NCT01030406|101026262|FG001|NOT COMPLETED|Overall Study||0||
48286071|NCT01030406|101026263|FG002|NOT COMPLETED|Overall Study||1||
48286072|NCT01030406|101026264|FG003|NOT COMPLETED|Overall Study||1||
48286073|NCT01030406|101026265|FG004|NOT COMPLETED|Overall Study||0||
48286074|NCT00468104|101026266|FG000|STARTED|First Intervention||54||
48286075|NCT00468104|101026267|FG001|STARTED|First Intervention||46||
48286076|NCT00468104|101026266|FG000|COMPLETED|First Intervention||45||
48286077|NCT00468104|101026267|FG001|COMPLETED|First Intervention||45||
48286078|NCT00468104|101026266|FG000|NOT COMPLETED|First Intervention||9||
48286079|NCT00468104|101026267|FG001|NOT COMPLETED|First Intervention||1||
48286080|NCT00468104|101026266|FG000|STARTED|Second Intervention||8||
48286081|NCT00468104|101026267|FG001|STARTED|Second Intervention||41||
48286082|NCT00468104|101026266|FG000|COMPLETED|Second Intervention||3||
48286083|NCT00468104|101026267|FG001|COMPLETED|Second Intervention||37||
48286084|NCT00468104|101026266|FG000|NOT COMPLETED|Second Intervention||5||
48286085|NCT00468104|101026267|FG001|NOT COMPLETED|Second Intervention||4||
48286086|NCT03075410|101026268|FG000|STARTED|Part A-Period 1 (14 Days)||2||
48286087|NCT03075410|101026269|FG001|STARTED|Part A-Period 1 (14 Days)||1||
48286088|NCT03075410|101026270|FG002|STARTED|Part A-Period 1 (14 Days)||2||
48286089|NCT03075410|101026271|FG003|STARTED|Part A-Period 1 (14 Days)||1||
48286090|NCT03075410|101026272|FG004|STARTED|Part A-Period 1 (14 Days)||2||
48286091|NCT03075410|101026273|FG005|STARTED|Part A-Period 1 (14 Days)||1||
48286092|NCT03075410|101026274|FG006|STARTED|Part A-Period 1 (14 Days)||0||
48286093|NCT03075410|101026275|FG007|STARTED|Part A-Period 1 (14 Days)||0||
48286094|NCT03075410|101026276|FG008|STARTED|Part A-Period 1 (14 Days)||0||
48286095|NCT03075410|101026268|FG000|COMPLETED|Part A-Period 1 (14 Days)||2||
48286096|NCT03075410|101026269|FG001|COMPLETED|Part A-Period 1 (14 Days)||1||
48286097|NCT03075410|101026270|FG002|COMPLETED|Part A-Period 1 (14 Days)||2||
48286098|NCT03075410|101026271|FG003|COMPLETED|Part A-Period 1 (14 Days)||1||
48286099|NCT03075410|101026272|FG004|COMPLETED|Part A-Period 1 (14 Days)||2||
48286100|NCT03075410|101026273|FG005|COMPLETED|Part A-Period 1 (14 Days)||1||
48286101|NCT03075410|101026274|FG006|COMPLETED|Part A-Period 1 (14 Days)||0||
48286102|NCT03075410|101026275|FG007|COMPLETED|Part A-Period 1 (14 Days)||0||
48286103|NCT03075410|101026276|FG008|COMPLETED|Part A-Period 1 (14 Days)||0||
48286104|NCT03075410|101026268|FG000|NOT COMPLETED|Part A-Period 1 (14 Days)||0||
48286105|NCT03075410|101026269|FG001|NOT COMPLETED|Part A-Period 1 (14 Days)||0||
48286106|NCT03075410|101026270|FG002|NOT COMPLETED|Part A-Period 1 (14 Days)||0||
48286107|NCT03075410|101026271|FG003|NOT COMPLETED|Part A-Period 1 (14 Days)||0||
48286108|NCT03075410|101026272|FG004|NOT COMPLETED|Part A-Period 1 (14 Days)||0||
48286109|NCT03075410|101026273|FG005|NOT COMPLETED|Part A-Period 1 (14 Days)||0||
48286110|NCT03075410|101026274|FG006|NOT COMPLETED|Part A-Period 1 (14 Days)||0||
48286111|NCT03075410|101026275|FG007|NOT COMPLETED|Part A-Period 1 (14 Days)||0||
48286112|NCT03075410|101026276|FG008|NOT COMPLETED|Part A-Period 1 (14 Days)||0||
48286113|NCT03075410|101026268|FG000|STARTED|Part A-Washout Period 1 (14 Days)||2||
48286114|NCT03075410|101026269|FG001|STARTED|Part A-Washout Period 1 (14 Days)||1||
48286115|NCT03075410|101026270|FG002|STARTED|Part A-Washout Period 1 (14 Days)||2||
48576633|NCT01842633|101744566|FG002|NOT COMPLETED|Overall Study||0||
48576634|NCT00813813|101744567|FG000|STARTED|Overall Study||7||
48576635|NCT00813813|101744568|FG001|STARTED|Overall Study||25||
48576636|NCT00813813|101744567|FG000|COMPLETED|Overall Study||4||
48576637|NCT00813813|101744568|FG001|COMPLETED|Overall Study||16||
48576638|NCT00813813|101744567|FG000|NOT COMPLETED|Overall Study||3||
48576639|NCT00813813|101744568|FG001|NOT COMPLETED|Overall Study||9||
48576640|NCT01077154|101744569|FG000|STARTED|Overall Study||2253||
48576641|NCT01077154|101744570|FG001|STARTED|Overall Study||2256||
48132598|NCT04329104|100648520|FG000|COMPLETED|Dose Escalation Study - 10 mg/kg||0||
48286116|NCT03075410|101026271|FG003|STARTED|Part A-Washout Period 1 (14 Days)||1||
48399754|NCT00570362|101309205|FG001|STARTED|Overall Study||30||
48576642|NCT01077154|101744569|FG000|Received Study Drug|Overall Study||2229||
48576643|NCT01077154|101744570|FG001|Received Study Drug|Overall Study||2230||
48576644|NCT01077154|101744569|FG000|COMPLETED|Overall Study||27||
48132599|NCT04329104|100648521|FG001|COMPLETED|Dose Escalation Study - 10 mg/kg||6||
48132600|NCT04329104|100648522|FG002|COMPLETED|Dose Escalation Study - 10 mg/kg||0||
48132601|NCT04329104|100648523|FG003|COMPLETED|Dose Escalation Study - 10 mg/kg||0||
48132602|NCT04329104|100648524|FG004|COMPLETED|Dose Escalation Study - 10 mg/kg||0||
48132603|NCT04329104|100648525|FG005|COMPLETED|Dose Escalation Study - 10 mg/kg||0||
48132604|NCT04329104|100648520|FG000|NOT COMPLETED|Dose Escalation Study - 10 mg/kg||0||
48132605|NCT04329104|100648521|FG001|NOT COMPLETED|Dose Escalation Study - 10 mg/kg||0||
48132606|NCT04329104|100648522|FG002|NOT COMPLETED|Dose Escalation Study - 10 mg/kg||0||
48132607|NCT04329104|100648523|FG003|NOT COMPLETED|Dose Escalation Study - 10 mg/kg||0||
48132608|NCT04329104|100648524|FG004|NOT COMPLETED|Dose Escalation Study - 10 mg/kg||0||
48132609|NCT04329104|100648525|FG005|NOT COMPLETED|Dose Escalation Study - 10 mg/kg||0||
48132610|NCT04329104|100648520|FG000|STARTED|Dose Escalation Study - 40 mg/kg||0||
48132611|NCT04329104|100648521|FG001|STARTED|Dose Escalation Study - 40 mg/kg||0||
48132612|NCT04329104|100648522|FG002|STARTED|Dose Escalation Study - 40 mg/kg||6||
48132613|NCT04329104|100648523|FG003|STARTED|Dose Escalation Study - 40 mg/kg||0||
48132614|NCT04329104|100648524|FG004|STARTED|Dose Escalation Study - 40 mg/kg||0||
48132615|NCT04329104|100648525|FG005|STARTED|Dose Escalation Study - 40 mg/kg||0||
48132616|NCT04329104|100648520|FG000|COMPLETED|Dose Escalation Study - 40 mg/kg||0||
48132617|NCT04329104|100648521|FG001|COMPLETED|Dose Escalation Study - 40 mg/kg||0||
48132618|NCT04329104|100648522|FG002|COMPLETED|Dose Escalation Study - 40 mg/kg||6||
48132619|NCT04329104|100648523|FG003|COMPLETED|Dose Escalation Study - 40 mg/kg||0||
48132620|NCT04329104|100648524|FG004|COMPLETED|Dose Escalation Study - 40 mg/kg||0||
48132621|NCT04329104|100648525|FG005|COMPLETED|Dose Escalation Study - 40 mg/kg||0||
48132622|NCT04329104|100648520|FG000|NOT COMPLETED|Dose Escalation Study - 40 mg/kg||0||
48132623|NCT04329104|100648521|FG001|NOT COMPLETED|Dose Escalation Study - 40 mg/kg||0||
48132624|NCT04329104|100648522|FG002|NOT COMPLETED|Dose Escalation Study - 40 mg/kg||0||
48132625|NCT04329104|100648523|FG003|NOT COMPLETED|Dose Escalation Study - 40 mg/kg||0||
48132626|NCT04329104|100648524|FG004|NOT COMPLETED|Dose Escalation Study - 40 mg/kg||0||
48286117|NCT03075410|101026272|FG004|STARTED|Part A-Washout Period 1 (14 Days)||2||
48286118|NCT03075410|101026273|FG005|STARTED|Part A-Washout Period 1 (14 Days)||1||
48286119|NCT03075410|101026274|FG006|STARTED|Part A-Washout Period 1 (14 Days)||0||
48286120|NCT03075410|101026275|FG007|STARTED|Part A-Washout Period 1 (14 Days)||0||
48286121|NCT03075410|101026276|FG008|STARTED|Part A-Washout Period 1 (14 Days)||0||
48576645|NCT01077154|101744570|FG001|COMPLETED|Overall Study||28||
48576646|NCT01077154|101744569|FG000|NOT COMPLETED|Overall Study||2226||
48576647|NCT01077154|101744570|FG001|NOT COMPLETED|Overall Study||2228||
48576648|NCT02901067|101744571|FG000|STARTED|Overall Study||19||
48576649|NCT02901067|101744572|FG001|STARTED|Overall Study||18||
48576650|NCT02901067|101744571|FG000|COMPLETED|Overall Study||19||
48576651|NCT02901067|101744572|FG001|COMPLETED|Overall Study||18||
48576652|NCT02901067|101744571|FG000|NOT COMPLETED|Overall Study||0||
48576653|NCT02901067|101744572|FG001|NOT COMPLETED|Overall Study||0||
48576654|NCT00529308|101744573|FG000|STARTED|Overall Study||9||
48576655|NCT00529308|101744574|FG001|STARTED|Overall Study||11||
48576656|NCT00529308|101744573|FG000|COMPLETED|Overall Study||8||
48576657|NCT00529308|101744574|FG001|COMPLETED|Overall Study||10||
48576658|NCT00529308|101744573|FG000|NOT COMPLETED|Overall Study||1||
48576659|NCT00529308|101744574|FG001|NOT COMPLETED|Overall Study||1||
48576660|NCT01309360|101744575|FG000|STARTED|Overall Study||40||
48576661|NCT01309360|101744576|FG001|STARTED|Overall Study||40||
48576662|NCT01309360|101744577|FG002|STARTED|Overall Study||40||
48576663|NCT01309360|101744575|FG000|COMPLETED|Overall Study||40||
48576664|NCT01309360|101744576|FG001|COMPLETED|Overall Study||40||
48576665|NCT01309360|101744577|FG002|COMPLETED|Overall Study||40||
48576666|NCT01309360|101744575|FG000|NOT COMPLETED|Overall Study||0||
48576667|NCT01309360|101744576|FG001|NOT COMPLETED|Overall Study||0||
48576668|NCT01309360|101744577|FG002|NOT COMPLETED|Overall Study||0||
48576669|NCT02145260|101744578|FG000|STARTED|Overall Study||69|Started|
48576670|NCT02145260|101744579|FG001|STARTED|Overall Study||70|Started|
48576671|NCT02145260|101744578|FG000|COMPLETED|Overall Study||69|Completed follow up|
48576672|NCT02145260|101744579|FG001|COMPLETED|Overall Study||70|Completed follow up|
48576673|NCT02145260|101744578|FG000|NOT COMPLETED|Overall Study||0||
48576674|NCT02145260|101744579|FG001|NOT COMPLETED|Overall Study||0||
48576675|NCT01263782|101744580|FG000|STARTED|Overall Study||6||
48576676|NCT01263782|101744581|FG001|STARTED|Overall Study||6||
48576677|NCT01263782|101744582|FG002|STARTED|Overall Study||6||
48576678|NCT01263782|101744583|FG003|STARTED|Overall Study||6||
48576679|NCT01263782|101744580|FG000|COMPLETED|Overall Study||6||
48576680|NCT01263782|101744581|FG001|COMPLETED|Overall Study||6||
48576681|NCT01263782|101744582|FG002|COMPLETED|Overall Study||3||
48132627|NCT04329104|100648525|FG005|NOT COMPLETED|Dose Escalation Study - 40 mg/kg||0||
48132628|NCT04329104|100648520|FG000|STARTED|Efficacy Study||0||
48576682|NCT01263782|101744583|FG003|COMPLETED|Overall Study||5||
48576683|NCT01263782|101744580|FG000|NOT COMPLETED|Overall Study||0||
48576684|NCT01263782|101744581|FG001|NOT COMPLETED|Overall Study||0||
48576685|NCT01263782|101744582|FG002|NOT COMPLETED|Overall Study||3||
48576686|NCT01263782|101744583|FG003|NOT COMPLETED|Overall Study||1||
48576687|NCT03670836|101744584|FG000|STARTED|Intent-to-treat Population (ITT)||153|Enrollment period was from Nov 2018|
48576688|NCT03670836|101744585|FG001|STARTED|Intent-to-treat Population (ITT)||154|Enrollment period was from Nov 2018|
48576689|NCT03670836|101744584|FG000|COMPLETED|Intent-to-treat Population (ITT)||152|Jan 31st 2021|
48576690|NCT03670836|101744585|FG001|COMPLETED|Intent-to-treat Population (ITT)||151|Jan 31st 2021|
48576691|NCT03670836|101744584|FG000|NOT COMPLETED|Intent-to-treat Population (ITT)||1||
48576692|NCT03670836|101744585|FG001|NOT COMPLETED|Intent-to-treat Population (ITT)||3||
48576693|NCT03670836|101744584|FG000|STARTED|Per Protocol Population (PP)||152|Patients randomized to each group|
48576694|NCT03670836|101744585|FG001|STARTED|Per Protocol Population (PP)||151|Patients randomized to each group|
48576695|NCT03670836|101744584|FG000|COMPLETED|Per Protocol Population (PP)||138|Completed the protocol|
48576696|NCT03670836|101744585|FG001|COMPLETED|Per Protocol Population (PP)||134|Completed the protocol|
48576697|NCT03670836|101744584|FG000|NOT COMPLETED|Per Protocol Population (PP)||14||
48576698|NCT03670836|101744585|FG001|NOT COMPLETED|Per Protocol Population (PP)||17||
48576699|NCT01960907|101744586|FG000|STARTED|Overall Study||158||
48576700|NCT01960907|101744587|FG001|STARTED|Overall Study||154||
48576701|NCT01960907|101744586|FG000|COMPLETED|Overall Study||122||
48576702|NCT01960907|101744587|FG001|COMPLETED|Overall Study||109||
48576703|NCT01960907|101744586|FG000|NOT COMPLETED|Overall Study||36||
48576704|NCT01960907|101744587|FG001|NOT COMPLETED|Overall Study||45||
48576705|NCT00481351|101744588|FG000|STARTED|Overall Study||13||
48576706|NCT00481351|101744589|FG001|STARTED|Overall Study||12||
48576707|NCT00481351|101744588|FG000|COMPLETED|Overall Study||13||
48576708|NCT00481351|101744589|FG001|COMPLETED|Overall Study||12||
48576709|NCT00481351|101744588|FG000|NOT COMPLETED|Overall Study||0||
48576710|NCT00481351|101744589|FG001|NOT COMPLETED|Overall Study||0||
48576711|NCT03526874|101744590|FG000|STARTED|Overall Study||29||
48576712|NCT03526874|101744591|FG001|STARTED|Overall Study||29||
48576713|NCT03526874|101744590|FG000|COMPLETED|Overall Study||29||
48576714|NCT03526874|101744591|FG001|COMPLETED|Overall Study||29||
48576715|NCT03526874|101744590|FG000|NOT COMPLETED|Overall Study||0||
48576716|NCT03526874|101744591|FG001|NOT COMPLETED|Overall Study||0||
48576717|NCT03687684|101744592|FG000|STARTED|Overall Study||4||
48576718|NCT03687684|101744593|FG001|STARTED|Overall Study||2||
48576719|NCT03687684|101744594|FG002|STARTED|Overall Study||2||
48576720|NCT03687684|101744595|FG003|STARTED|Overall Study||6||
48576721|NCT03687684|101744596|FG004|STARTED|Overall Study||6||
48576722|NCT03687684|101744597|FG005|STARTED|Overall Study||6||
48576723|NCT03687684|101744598|FG006|STARTED|Overall Study||6||
48576724|NCT03687684|101744599|FG007|STARTED|Overall Study||2||
48576725|NCT03687684|101744600|FG008|STARTED|Overall Study||6||
48576726|NCT03687684|101744592|FG000|COMPLETED|Overall Study||4||
48576727|NCT03687684|101744593|FG001|COMPLETED|Overall Study||2||
48576728|NCT03687684|101744594|FG002|COMPLETED|Overall Study||2||
48576729|NCT03687684|101744595|FG003|COMPLETED|Overall Study||6||
48576730|NCT03687684|101744596|FG004|COMPLETED|Overall Study||6||
48576731|NCT03687684|101744597|FG005|COMPLETED|Overall Study||6||
48576732|NCT03687684|101744598|FG006|COMPLETED|Overall Study||6||
48576733|NCT03687684|101744599|FG007|COMPLETED|Overall Study||2||
48576734|NCT03687684|101744600|FG008|COMPLETED|Overall Study||6||
48576735|NCT03687684|101744592|FG000|NOT COMPLETED|Overall Study||0||
48576736|NCT03687684|101744593|FG001|NOT COMPLETED|Overall Study||0||
48576737|NCT03687684|101744594|FG002|NOT COMPLETED|Overall Study||0||
48576738|NCT03687684|101744595|FG003|NOT COMPLETED|Overall Study||0||
48576739|NCT03687684|101744596|FG004|NOT COMPLETED|Overall Study||0||
48576740|NCT03687684|101744597|FG005|NOT COMPLETED|Overall Study||0||
48576741|NCT03687684|101744598|FG006|NOT COMPLETED|Overall Study||0||
48576742|NCT03687684|101744599|FG007|NOT COMPLETED|Overall Study||0||
48576743|NCT03687684|101744600|FG008|NOT COMPLETED|Overall Study||0||
48576744|NCT04894916|101744601|FG000|STARTED|Overall Study||59||
48576745|NCT04894916|101744601|FG000|COMPLETED|Overall Study||53||
48576746|NCT04894916|101744601|FG000|NOT COMPLETED|Overall Study||6||
48576747|NCT01515865|101744602|FG000|STARTED|Part A (Open-label)||98||
48576748|NCT01515865|101744603|FG001|STARTED|Part A (Open-label)||0||
48576749|NCT01515865|101744604|FG002|STARTED|Part A (Open-label)||0||
48576750|NCT01515865|101744602|FG000|COMPLETED|Part A (Open-label)||95||
48576751|NCT01515865|101744603|FG001|COMPLETED|Part A (Open-label)||0||
48576752|NCT01515865|101744604|FG002|COMPLETED|Part A (Open-label)||0||
48576753|NCT01515865|101744602|FG000|NOT COMPLETED|Part A (Open-label)||3||
48576754|NCT01515865|101744603|FG001|NOT COMPLETED|Part A (Open-label)||0||
48576755|NCT01515865|101744604|FG002|NOT COMPLETED|Part A (Open-label)||0||
48576756|NCT01515865|101744602|FG000|STARTED|Part B (Open-label)||71||
48576757|NCT01515865|101744603|FG001|STARTED|Part B (Open-label)||0||
48576758|NCT01515865|101744604|FG002|STARTED|Part B (Open-label)||0||
48576759|NCT01515865|101744602|FG000|COMPLETED|Part B (Open-label)||69||
48576760|NCT01515865|101744603|FG001|COMPLETED|Part B (Open-label)||0||
48576761|NCT01515865|101744604|FG002|COMPLETED|Part B (Open-label)||0||
48576762|NCT01515865|101744602|FG000|NOT COMPLETED|Part B (Open-label)||2||
48576763|NCT01515865|101744603|FG001|NOT COMPLETED|Part B (Open-label)||0||
48576764|NCT01515865|101744604|FG002|NOT COMPLETED|Part B (Open-label)||0||
48576765|NCT01515865|101744602|FG000|STARTED|Part C (Randomized)||0||
48576766|NCT01515865|101744603|FG001|STARTED|Part C (Randomized)||33||
48576767|NCT01515865|101744604|FG002|STARTED|Part C (Randomized)||34||
48576768|NCT01515865|101744602|FG000|COMPLETED|Part C (Randomized)||0||
48576769|NCT01515865|101744603|FG001|COMPLETED|Part C (Randomized)||33||
48576770|NCT01515865|101744604|FG002|COMPLETED|Part C (Randomized)||34||
48576771|NCT01515865|101744602|FG000|NOT COMPLETED|Part C (Randomized)||0||
48576772|NCT01515865|101744603|FG001|NOT COMPLETED|Part C (Randomized)||0||
48576773|NCT01515865|101744604|FG002|NOT COMPLETED|Part C (Randomized)||0||
48576774|NCT01397825|101744605|FG000|STARTED|Overall Study||13||
48399755|NCT00570362|101309204|FG000|COMPLETED|Overall Study||19||
48399756|NCT00570362|101309205|FG001|COMPLETED|Overall Study||30||
48399757|NCT00570362|101309204|FG000|NOT COMPLETED|Overall Study||0||
48399758|NCT00570362|101309205|FG001|NOT COMPLETED|Overall Study||0||
48399759|NCT02657434|101309206|FG000|STARTED|Overall Study||286||
48399760|NCT02657434|101309207|FG001|STARTED|Overall Study||292||
48576775|NCT01397825|101744606|FG001|STARTED|Overall Study||4||
48576776|NCT01397825|101744607|FG002|STARTED|Overall Study||25||
48576777|NCT01397825|101744608|FG003|STARTED|Overall Study||3||
48576778|NCT01397825|101744609|FG004|STARTED|Overall Study||0||
48576779|NCT01397825|101744605|FG000|COMPLETED|Overall Study||0||
48576780|NCT01397825|101744606|FG001|COMPLETED|Overall Study||0||
48576781|NCT01397825|101744607|FG002|COMPLETED|Overall Study||0||
48576782|NCT01397825|101744608|FG003|COMPLETED|Overall Study||0||
48576783|NCT01397825|101744609|FG004|COMPLETED|Overall Study||0||
48576784|NCT01397825|101744605|FG000|NOT COMPLETED|Overall Study||13||
48576785|NCT01397825|101744606|FG001|NOT COMPLETED|Overall Study||4||
48576786|NCT01397825|101744607|FG002|NOT COMPLETED|Overall Study||25||
48576787|NCT01397825|101744608|FG003|NOT COMPLETED|Overall Study||3||
48576788|NCT01397825|101744609|FG004|NOT COMPLETED|Overall Study||0||
48576789|NCT00125242|101744610|FG000|STARTED|Overall Study||94||
48576790|NCT00125242|101744611|FG001|STARTED|Overall Study||16||
48576791|NCT00125242|101744610|FG000|COMPLETED|Overall Study||87||
48576792|NCT00125242|101744611|FG001|COMPLETED|Overall Study||14||
48576793|NCT00125242|101744610|FG000|NOT COMPLETED|Overall Study||7||
48576794|NCT00125242|101744611|FG001|NOT COMPLETED|Overall Study||2||
48576795|NCT00445588|101744612|FG000|STARTED|Overall Study||56||
48576796|NCT00445588|101744612|FG000|COMPLETED|Overall Study||56||
48576797|NCT00445588|101744612|FG000|NOT COMPLETED|Overall Study||0||
48576798|NCT02693002|101744613|FG000|STARTED|Overall Study||2||
48576799|NCT02693002|101744614|FG001|STARTED|Overall Study||2||
48576800|NCT02693002|101744613|FG000|COMPLETED|Overall Study||1||
48576801|NCT02693002|101744614|FG001|COMPLETED|Overall Study||2||
48576802|NCT02693002|101744613|FG000|NOT COMPLETED|Overall Study||1||
48576803|NCT02693002|101744614|FG001|NOT COMPLETED|Overall Study||0||
48576804|NCT01129440|101744615|FG000|STARTED|Overall Study||297||
48576805|NCT01129440|101744616|FG001|STARTED|Overall Study||300||
48576806|NCT01129440|101744615|FG000|12 Month Follow-up|Overall Study||249||
48576807|NCT01129440|101744616|FG001|12 Month Follow-up|Overall Study||256||
48576808|NCT01129440|101744615|FG000|24 Month Follow-up|Overall Study||239||
48576809|NCT01129440|101744616|FG001|24 Month Follow-up|Overall Study||258||
48576810|NCT01129440|101744615|FG000|COMPLETED|Overall Study||246||
48576811|NCT01129440|101744616|FG001|COMPLETED|Overall Study||258||
48576812|NCT01129440|101744615|FG000|NOT COMPLETED|Overall Study||51||
48576813|NCT01129440|101744616|FG001|NOT COMPLETED|Overall Study||42||
48576814|NCT02754427|101744617|FG000|STARTED|Overall Study||21||
48576815|NCT02754427|101744618|FG001|STARTED|Overall Study||20||
48576816|NCT02754427|101744617|FG000|COMPLETED|Overall Study||21||
48576817|NCT02754427|101744618|FG001|COMPLETED|Overall Study||19||
48576818|NCT02754427|101744617|FG000|NOT COMPLETED|Overall Study||0||
48576819|NCT02754427|101744618|FG001|NOT COMPLETED|Overall Study||1||
48576820|NCT02016105|101744619|FG000|STARTED|TREATMENT PERIOD 1||231||
48576821|NCT02016105|101744620|FG001|STARTED|TREATMENT PERIOD 1||234||
48576822|NCT02016105|101744621|FG002|STARTED|TREATMENT PERIOD 1||0||
48576823|NCT02016105|101744622|FG003|STARTED|TREATMENT PERIOD 1||0||
48576824|NCT02016105|101744623|FG004|STARTED|TREATMENT PERIOD 1||0||
48576825|NCT02016105|101744624|FG005|STARTED|TREATMENT PERIOD 1||0||
48576826|NCT02016105|101744619|FG000|COMPLETED|TREATMENT PERIOD 1||201||
48399761|NCT02657434|101309206|FG000|COMPLETED|Overall Study||0||
48399762|NCT02657434|101309207|FG001|COMPLETED|Overall Study||0||
48576827|NCT02016105|101744620|FG001|COMPLETED|TREATMENT PERIOD 1||201||
48576828|NCT02016105|101744621|FG002|COMPLETED|TREATMENT PERIOD 1||0||
48576829|NCT02016105|101744622|FG003|COMPLETED|TREATMENT PERIOD 1||0||
48576830|NCT02016105|101744623|FG004|COMPLETED|TREATMENT PERIOD 1||0||
48576831|NCT02016105|101744624|FG005|COMPLETED|TREATMENT PERIOD 1||0||
48576832|NCT02016105|101744619|FG000|NOT COMPLETED|TREATMENT PERIOD 1||30||
48576833|NCT02016105|101744620|FG001|NOT COMPLETED|TREATMENT PERIOD 1||33||
48576834|NCT02016105|101744621|FG002|NOT COMPLETED|TREATMENT PERIOD 1||0||
48576835|NCT02016105|101744622|FG003|NOT COMPLETED|TREATMENT PERIOD 1||0||
48576836|NCT02016105|101744623|FG004|NOT COMPLETED|TREATMENT PERIOD 1||0||
48399763|NCT02657434|101309206|FG000|NOT COMPLETED|Overall Study||286||
48399764|NCT02657434|101309207|FG001|NOT COMPLETED|Overall Study||292||
48399765|NCT02574481|101309208|FG000|STARTED|Overall Study||309||
48399766|NCT02574481|101309209|FG001|STARTED|Overall Study||156||
48576837|NCT02016105|101744624|FG005|NOT COMPLETED|TREATMENT PERIOD 1||0||
48576838|NCT02016105|101744619|FG000|STARTED|TREATMENT PERIOD 2||0||
48576839|NCT02016105|101744620|FG001|STARTED|TREATMENT PERIOD 2||0||
48576840|NCT02016105|101744621|FG002|STARTED|TREATMENT PERIOD 2||63||
48576841|NCT02016105|101744622|FG003|STARTED|TREATMENT PERIOD 2||127||
48576842|NCT02016105|101744623|FG004|STARTED|TREATMENT PERIOD 2||63||
48576843|NCT02016105|101744624|FG005|STARTED|TREATMENT PERIOD 2||126||
48576844|NCT02016105|101744619|FG000|COMPLETED|TREATMENT PERIOD 2||0||
48576845|NCT02016105|101744620|FG001|COMPLETED|TREATMENT PERIOD 2||0||
48576846|NCT02016105|101744621|FG002|COMPLETED|TREATMENT PERIOD 2||57||
48576847|NCT02016105|101744622|FG003|COMPLETED|TREATMENT PERIOD 2||116||
48576848|NCT02016105|101744623|FG004|COMPLETED|TREATMENT PERIOD 2||59||
48576849|NCT02016105|101744624|FG005|COMPLETED|TREATMENT PERIOD 2||112||
48576850|NCT02016105|101744619|FG000|NOT COMPLETED|TREATMENT PERIOD 2||0||
48576851|NCT02016105|101744620|FG001|NOT COMPLETED|TREATMENT PERIOD 2||0||
48576852|NCT02016105|101744621|FG002|NOT COMPLETED|TREATMENT PERIOD 2||6||
48576853|NCT02016105|101744622|FG003|NOT COMPLETED|TREATMENT PERIOD 2||11||
48576854|NCT02016105|101744623|FG004|NOT COMPLETED|TREATMENT PERIOD 2||4||
48576855|NCT02016105|101744624|FG005|NOT COMPLETED|TREATMENT PERIOD 2||14||
48576856|NCT02016105|101744619|FG000|STARTED|EXTENSION PERIOD||0||
48576857|NCT02016105|101744620|FG001|STARTED|EXTENSION PERIOD||0||
48576858|NCT02016105|101744621|FG002|STARTED|EXTENSION PERIOD||52||
48576859|NCT02016105|101744622|FG003|STARTED|EXTENSION PERIOD||109||
48576860|NCT02016105|101744623|FG004|STARTED|EXTENSION PERIOD||56||
48576861|NCT02016105|101744624|FG005|STARTED|EXTENSION PERIOD||106||
48576862|NCT02016105|101744619|FG000|COMPLETED|EXTENSION PERIOD||0||
48576863|NCT02016105|101744620|FG001|COMPLETED|EXTENSION PERIOD||0||
48576864|NCT02016105|101744621|FG002|COMPLETED|EXTENSION PERIOD||47||
48576865|NCT02016105|101744622|FG003|COMPLETED|EXTENSION PERIOD||104||
48576866|NCT02016105|101744623|FG004|COMPLETED|EXTENSION PERIOD||50||
48576867|NCT02016105|101744624|FG005|COMPLETED|EXTENSION PERIOD||100||
48576868|NCT02016105|101744619|FG000|NOT COMPLETED|EXTENSION PERIOD||0||
48576869|NCT02016105|101744620|FG001|NOT COMPLETED|EXTENSION PERIOD||0||
48576870|NCT02016105|101744621|FG002|NOT COMPLETED|EXTENSION PERIOD||5||
48576871|NCT02016105|101744622|FG003|NOT COMPLETED|EXTENSION PERIOD||5||
48576872|NCT02016105|101744623|FG004|NOT COMPLETED|EXTENSION PERIOD||6||
48576873|NCT02016105|101744624|FG005|NOT COMPLETED|EXTENSION PERIOD||6||
48576874|NCT00835224|101744625|FG000|STARTED|Overall Study||34||
48576875|NCT00835224|101744625|FG000|COMPLETED|Overall Study||24||
48576876|NCT00835224|101744625|FG000|NOT COMPLETED|Overall Study||10||
48576877|NCT03493815|101744626|FG000|STARTED|Overall Study||42||
48576878|NCT03493815|101744627|FG001|STARTED|Overall Study||43||
48576879|NCT03493815|101744626|FG000|COMPLETED|Overall Study||33||
48576880|NCT03493815|101744627|FG001|COMPLETED|Overall Study||32||
48576881|NCT03493815|101744626|FG000|NOT COMPLETED|Overall Study||9||
48576882|NCT03493815|101744627|FG001|NOT COMPLETED|Overall Study||11||
48576883|NCT00002931|101744628|FG000|STARTED|Overall Study||48||
48576884|NCT00002931|101744628|FG000|COMPLETED|Overall Study||46||
48576885|NCT00002931|101744628|FG000|NOT COMPLETED|Overall Study||2||
48576886|NCT02782923|101744629|FG000|STARTED|Overall Study||19||
48576887|NCT02782923|101744629|FG000|COMPLETED|Overall Study||4||
48576888|NCT02782923|101744629|FG000|NOT COMPLETED|Overall Study||15||
48576889|NCT00789256|101744630|FG000|STARTED|Overall Study||14||
48576890|NCT00789256|101744631|FG001|STARTED|Overall Study||12||
48576891|NCT00789256|101744630|FG000|COMPLETED|Overall Study||14||
48576892|NCT00789256|101744631|FG001|COMPLETED|Overall Study||12||
48576893|NCT00789256|101744630|FG000|NOT COMPLETED|Overall Study||0||
48576894|NCT00789256|101744631|FG001|NOT COMPLETED|Overall Study||0||
48576895|NCT00247611|101744632|FG000|STARTED|Baselined||304||
48576896|NCT00247611|101744633|FG001|STARTED|Baselined||290||
48576897|NCT00247611|101744632|FG000|COMPLETED|Baselined||287||
48399767|NCT02574481|101309210|FG002|STARTED|Overall Study||50||
48399768|NCT02574481|101309211|FG003|STARTED|Overall Study||13||
48576898|NCT00247611|101744633|FG001|COMPLETED|Baselined||277||
48576899|NCT00247611|101744632|FG000|NOT COMPLETED|Baselined||17||
48576900|NCT00247611|101744633|FG001|NOT COMPLETED|Baselined||13||
48576901|NCT00247611|101744632|FG000|STARTED|Intention to Treat Sample||304||
48576902|NCT00247611|101744633|FG001|STARTED|Intention to Treat Sample||290||
48576903|NCT00247611|101744632|FG000|COMPLETED|Intention to Treat Sample||287||
48576904|NCT00247611|101744633|FG001|COMPLETED|Intention to Treat Sample||277||
48576905|NCT00247611|101744632|FG000|NOT COMPLETED|Intention to Treat Sample||17||
48576906|NCT00247611|101744633|FG001|NOT COMPLETED|Intention to Treat Sample||13||
48576907|NCT00247611|101744632|FG000|STARTED|On Protocol Sample||287||
48576908|NCT00247611|101744633|FG001|STARTED|On Protocol Sample||277||
48576909|NCT00247611|101744632|FG000|COMPLETED|On Protocol Sample||176||
48576910|NCT00247611|101744633|FG001|COMPLETED|On Protocol Sample||152||
48576911|NCT00247611|101744632|FG000|NOT COMPLETED|On Protocol Sample||111||
48702662|NCT01289353|102057685|FG000|NOT COMPLETED|Overall Study||2||
48702663|NCT01610557|102057686|FG000|STARTED|36-Week Randomized Crossover Phase||16||
48702664|NCT01610557|102057687|FG001|STARTED|36-Week Randomized Crossover Phase||13||
48702665|NCT01610557|102057688|FG002|STARTED|36-Week Randomized Crossover Phase||14||
48702666|NCT01610557|102057689|FG003|STARTED|36-Week Randomized Crossover Phase||13||
48702667|NCT01610557|102057690|FG004|STARTED|36-Week Randomized Crossover Phase||0||
48702668|NCT01610557|102057686|FG000|COMPLETED|36-Week Randomized Crossover Phase||16||
48702669|NCT01610557|102057687|FG001|COMPLETED|36-Week Randomized Crossover Phase||12||
48702670|NCT01610557|102057688|FG002|COMPLETED|36-Week Randomized Crossover Phase||14||
48702671|NCT01610557|102057689|FG003|COMPLETED|36-Week Randomized Crossover Phase||13||
48702672|NCT01610557|102057690|FG004|COMPLETED|36-Week Randomized Crossover Phase||0||
48702673|NCT01610557|102057686|FG000|NOT COMPLETED|36-Week Randomized Crossover Phase||0||
48702674|NCT01610557|102057687|FG001|NOT COMPLETED|36-Week Randomized Crossover Phase||1||
48702675|NCT01610557|102057688|FG002|NOT COMPLETED|36-Week Randomized Crossover Phase||0||
48702676|NCT01610557|102057689|FG003|NOT COMPLETED|36-Week Randomized Crossover Phase||0||
48702677|NCT01610557|102057690|FG004|NOT COMPLETED|36-Week Randomized Crossover Phase||0||
48702678|NCT01610557|102057686|FG000|STARTED|Post-36-Week Extension Phase||0||
48702679|NCT01610557|102057687|FG001|STARTED|Post-36-Week Extension Phase||0||
48702680|NCT01610557|102057688|FG002|STARTED|Post-36-Week Extension Phase||0||
48702681|NCT01610557|102057689|FG003|STARTED|Post-36-Week Extension Phase||0||
48702682|NCT01610557|102057690|FG004|STARTED|Post-36-Week Extension Phase||55||
48702683|NCT01610557|102057686|FG000|COMPLETED|Post-36-Week Extension Phase||0||
48702684|NCT01610557|102057687|FG001|COMPLETED|Post-36-Week Extension Phase||0||
48702685|NCT01610557|102057688|FG002|COMPLETED|Post-36-Week Extension Phase||0||
48702686|NCT01610557|102057689|FG003|COMPLETED|Post-36-Week Extension Phase||0||
48702687|NCT01610557|102057690|FG004|COMPLETED|Post-36-Week Extension Phase||52||
48702688|NCT01610557|102057686|FG000|NOT COMPLETED|Post-36-Week Extension Phase||0||
48702689|NCT01610557|102057687|FG001|NOT COMPLETED|Post-36-Week Extension Phase||0||
48702690|NCT01610557|102057688|FG002|NOT COMPLETED|Post-36-Week Extension Phase||0||
48702691|NCT01610557|102057689|FG003|NOT COMPLETED|Post-36-Week Extension Phase||0||
48702692|NCT01610557|102057690|FG004|NOT COMPLETED|Post-36-Week Extension Phase||3||
48702693|NCT02019108|102057691|FG000|STARTED|Overall Study||40||
48702694|NCT02019108|102057692|FG001|STARTED|Overall Study||39||
48702695|NCT02019108|102057691|FG000|Baseline (Week 0)|Overall Study||40||
48702696|NCT02019108|102057692|FG001|Baseline (Week 0)|Overall Study||39||
48702697|NCT02019108|102057691|FG000|Follow-up (Week 17)|Overall Study||38||
48702698|NCT02019108|102057692|FG001|Follow-up (Week 17)|Overall Study||36||
48702699|NCT02019108|102057691|FG000|Retention (Week 21)|Overall Study||35||
48702700|NCT02019108|102057692|FG001|Retention (Week 21)|Overall Study||32||
48702701|NCT02019108|102057691|FG000|COMPLETED|Overall Study||35||
48702702|NCT02019108|102057692|FG001|COMPLETED|Overall Study||32||
48702703|NCT02019108|102057691|FG000|NOT COMPLETED|Overall Study||5||
48702704|NCT02019108|102057692|FG001|NOT COMPLETED|Overall Study||7||
48702705|NCT01610713|102057693|FG000|STARTED|Overall Study||77||
48702706|NCT01610713|102057694|FG001|STARTED|Overall Study||77||
48702707|NCT01610713|102057693|FG000|COMPLETED|Overall Study||71||
48702708|NCT01610713|102057694|FG001|COMPLETED|Overall Study||76||
48702709|NCT01610713|102057693|FG000|NOT COMPLETED|Overall Study||6||
48702710|NCT01610713|102057694|FG001|NOT COMPLETED|Overall Study||1||
48702711|NCT03298984|102057695|FG000|STARTED|Overall Study||3||
48702712|NCT03298984|102057696|FG001|STARTED|Overall Study||3||
48702713|NCT03298984|102057697|FG002|STARTED|Overall Study||3||
48702714|NCT03298984|102057698|FG003|STARTED|Overall Study||23||
48702715|NCT03298984|102057695|FG000|COMPLETED|Overall Study||2||
48702716|NCT03298984|102057696|FG001|COMPLETED|Overall Study||2||
48702717|NCT03298984|102057697|FG002|COMPLETED|Overall Study||1||
48702718|NCT03298984|102057698|FG003|COMPLETED|Overall Study||8||
48702719|NCT03298984|102057695|FG000|NOT COMPLETED|Overall Study||1||
48702720|NCT03298984|102057696|FG001|NOT COMPLETED|Overall Study||1||
48702721|NCT03298984|102057697|FG002|NOT COMPLETED|Overall Study||2||
48702722|NCT03298984|102057698|FG003|NOT COMPLETED|Overall Study||15||
48702723|NCT00608023|102057699|FG000|STARTED|Overall Study||92||
48702724|NCT00608023|102057700|FG001|STARTED|Overall Study||85||
48702725|NCT00608023|102057701|FG002|STARTED|Overall Study||86||
48702726|NCT00608023|102057699|FG000|COMPLETED|Overall Study||80||
48702727|NCT00608023|102057700|FG001|COMPLETED|Overall Study||63||
48702728|NCT00608023|102057701|FG002|COMPLETED|Overall Study||72||
48702729|NCT00608023|102057699|FG000|NOT COMPLETED|Overall Study||12||
48702730|NCT00608023|102057700|FG001|NOT COMPLETED|Overall Study||22||
48702731|NCT00608023|102057701|FG002|NOT COMPLETED|Overall Study||14||
48702732|NCT00385944|102057702|FG000|STARTED|Loading Dose||0||
48702733|NCT00385944|102057703|FG001|STARTED|Loading Dose||0||
48702734|NCT00385944|102057704|FG002|STARTED|Loading Dose||56||
48702735|NCT00385944|102057702|FG000|COMPLETED|Loading Dose||0||
48702736|NCT00385944|102057703|FG001|COMPLETED|Loading Dose||0||
48399769|NCT02574481|101309208|FG000|COMPLETED|Overall Study||195||
48399770|NCT02574481|101309209|FG001|COMPLETED|Overall Study||102||
48399771|NCT02574481|101309210|FG002|COMPLETED|Overall Study||25||
48399772|NCT02574481|101309211|FG003|COMPLETED|Overall Study||8||
48399773|NCT02574481|101309208|FG000|NOT COMPLETED|Overall Study||114||
48399774|NCT02574481|101309209|FG001|NOT COMPLETED|Overall Study||54||
48399775|NCT02574481|101309210|FG002|NOT COMPLETED|Overall Study||25||
48399776|NCT02574481|101309211|FG003|NOT COMPLETED|Overall Study||5||
48399777|NCT02320214|101309212|FG000|STARTED|Overall Study||30||
48399778|NCT02320214|101309212|FG000|COMPLETED|Overall Study||30||
48399779|NCT02320214|101309212|FG000|NOT COMPLETED|Overall Study||0||
48399780|NCT01952288|101309213|FG000|STARTED|Overall Study||3||
48399781|NCT01952288|101309214|FG001|STARTED|Overall Study||2||
48399782|NCT01952288|101309213|FG000|COMPLETED|Overall Study||3||
48399783|NCT01952288|101309214|FG001|COMPLETED|Overall Study||2||
48399784|NCT01952288|101309213|FG000|NOT COMPLETED|Overall Study||0||
48399785|NCT01952288|101309214|FG001|NOT COMPLETED|Overall Study||0||
48399786|NCT02925312|101309215|FG000|STARTED|Overall Study||125||
48399787|NCT02925312|101309216|FG001|STARTED|Overall Study||294||
48399788|NCT02925312|101309215|FG000|COMPLETED|Overall Study||98||
48399789|NCT02925312|101309216|FG001|COMPLETED|Overall Study||294||
48399790|NCT02925312|101309215|FG000|NOT COMPLETED|Overall Study||27||
48399791|NCT02925312|101309216|FG001|NOT COMPLETED|Overall Study||0||
48399792|NCT02690168|101309217|FG000|STARTED|Overall Study||6||
48399793|NCT02690168|101309217|FG000|COMPLETED|Overall Study||6||
48399794|NCT02690168|101309217|FG000|NOT COMPLETED|Overall Study||0||
48399795|NCT00517413|101309218|FG000|STARTED|Overall Study||163||
48399796|NCT00517413|101309218|FG000|COMPLETED|Overall Study||102||
48399797|NCT00517413|101309218|FG000|NOT COMPLETED|Overall Study||61||
48399798|NCT01468701|101309219|FG000|STARTED|Overall Study||4964||
48399799|NCT01468701|101309220|FG001|STARTED|Overall Study||5103||
48399800|NCT01468701|101309221|FG002|STARTED|Overall Study||1784||
48399801|NCT01468701|101309222|FG003|STARTED|Overall Study||715||
48576912|NCT00247611|101744633|FG001|NOT COMPLETED|On Protocol Sample||125||
48576913|NCT02142959|101744634|FG000|STARTED|Overall Study||64||
48576914|NCT02142959|101744635|FG001|STARTED|Overall Study||62||
48576915|NCT02142959|101744636|FG002|STARTED|Overall Study||61||
48576916|NCT02142959|101744634|FG000|COMPLETED|Overall Study||59||
48576917|NCT02142959|101744635|FG001|COMPLETED|Overall Study||59||
48576918|NCT02142959|101744636|FG002|COMPLETED|Overall Study||55||
48576919|NCT02142959|101744634|FG000|NOT COMPLETED|Overall Study||5||
48576920|NCT02142959|101744635|FG001|NOT COMPLETED|Overall Study||3||
48576921|NCT02142959|101744636|FG002|NOT COMPLETED|Overall Study||6||
48576922|NCT03508726|101744637|FG000|STARTED|Overall Study||6||
48576923|NCT03508726|101744638|FG001|STARTED|Overall Study||19||
48576924|NCT03508726|101744637|FG000|COMPLETED|Overall Study||6||
48576925|NCT03508726|101744638|FG001|COMPLETED|Overall Study||18||
48576926|NCT03508726|101744637|FG000|NOT COMPLETED|Overall Study||0||
48576927|NCT03508726|101744638|FG001|NOT COMPLETED|Overall Study||1||
48576928|NCT01862250|101744639|FG000|STARTED|Overall Study||12||
48576929|NCT01862250|101744639|FG000|COMPLETED|Overall Study||8||
48576930|NCT01862250|101744639|FG000|NOT COMPLETED|Overall Study||4||
48576931|NCT00090493|101744640|FG000|STARTED|Overall Study||4||
48576932|NCT00090493|101744640|FG000|COMPLETED|Overall Study||2||
48576933|NCT00090493|101744640|FG000|NOT COMPLETED|Overall Study||2||
48576934|NCT03090958|101744641|FG000|STARTED|Overall Study||20||
48576935|NCT03090958|101744641|FG000|COMPLETED|Overall Study||20||
48576936|NCT03090958|101744641|FG000|NOT COMPLETED|Overall Study||0||
48576937|NCT00638222|101744642|FG000|STARTED|Overall Study||0||
48576938|NCT00638222|101744643|FG001|STARTED|Overall Study||0||
48576939|NCT00638222|101744644|FG002|STARTED|Overall Study||6||
48576940|NCT00638222|101744642|FG000|COMPLETED|Overall Study||0||
48576941|NCT00638222|101744643|FG001|COMPLETED|Overall Study||0||
48576942|NCT00638222|101744644|FG002|COMPLETED|Overall Study||6||
48576943|NCT00638222|101744642|FG000|NOT COMPLETED|Overall Study||0||
48576944|NCT00638222|101744643|FG001|NOT COMPLETED|Overall Study||0||
48576945|NCT00638222|101744644|FG002|NOT COMPLETED|Overall Study||0||
48576946|NCT00911612|101744645|FG000|STARTED|Overall Study||12||
48576947|NCT00911612|101744646|FG001|STARTED|Overall Study||12||
48576948|NCT00911612|101744645|FG000|COMPLETED|Overall Study||12||
48576949|NCT00911612|101744646|FG001|COMPLETED|Overall Study||12||
48576950|NCT00911612|101744645|FG000|NOT COMPLETED|Overall Study||0||
48576951|NCT00911612|101744646|FG001|NOT COMPLETED|Overall Study||0||
48576952|NCT04594070|101744647|FG000|STARTED|Overall Study||8||
48576953|NCT04594070|101744648|FG001|STARTED|Overall Study||6||
48576954|NCT04594070|101744647|FG000|COMPLETED|Overall Study||0||
48399802|NCT01468701|101309223|FG004|STARTED|Overall Study||1736||
48399803|NCT01468701|101309224|FG005|STARTED|Overall Study||128||
48399804|NCT01468701|101309225|FG006|STARTED|Overall Study||1209||
48399805|NCT01468701|101309226|FG007|STARTED|Overall Study||5||
48399806|NCT01468701|101309227|FG008|STARTED|Overall Study||3879||
48576955|NCT04594070|101744648|FG001|COMPLETED|Overall Study||0||
48576956|NCT04594070|101744647|FG000|NOT COMPLETED|Overall Study||8||
48576957|NCT04594070|101744648|FG001|NOT COMPLETED|Overall Study||6||
48399807|NCT01468701|101309228|FG009|STARTED|Overall Study||4962||
48576958|NCT02907918|101744649|FG000|STARTED|Overall Study||26||
48399808|NCT01468701|101309229|FG010|STARTED|Overall Study||4054||
48399809|NCT01468701|101309230|FG011|STARTED|Overall Study||4538||
48399810|NCT01468701|101309231|FG012|STARTED|Overall Study||333||
48399811|NCT01468701|101309232|FG013|STARTED|Overall Study||2182||
48399812|NCT01468701|101309233|FG014|STARTED|Overall Study||214||
48399813|NCT01468701|101309234|FG015|STARTED|Overall Study||1418||
48399814|NCT01468701|101309235|FG016|STARTED|Overall Study||11||
48399815|NCT01468701|101309219|FG000|All Eligible Patient|Overall Study||4873||
48399816|NCT01468701|101309220|FG001|All Eligible Patient|Overall Study||4963||
48399817|NCT01468701|101309221|FG002|All Eligible Patient|Overall Study||1755||
48399818|NCT01468701|101309222|FG003|All Eligible Patient|Overall Study||703||
48399819|NCT01468701|101309223|FG004|All Eligible Patient|Overall Study||1714||
48399820|NCT01468701|101309224|FG005|All Eligible Patient|Overall Study||126||
48399821|NCT01468701|101309225|FG006|All Eligible Patient|Overall Study||1170||
48399822|NCT01468701|101309226|FG007|All Eligible Patient|Overall Study||4||
48399823|NCT01468701|101309227|FG008|All Eligible Patient|Overall Study||3839||
48399824|NCT01468701|101309228|FG009|All Eligible Patient|Overall Study||4836||
48399825|NCT01468701|101309229|FG010|All Eligible Patient|Overall Study||4015||
48399826|NCT01468701|101309230|FG011|All Eligible Patient|Overall Study||4505||
48399827|NCT01468701|101309231|FG012|All Eligible Patient|Overall Study||332||
48399828|NCT01468701|101309232|FG013|All Eligible Patient|Overall Study||2163||
48399829|NCT01468701|101309233|FG014|All Eligible Patient|Overall Study||213||
48399830|NCT01468701|101309234|FG015|All Eligible Patient|Overall Study||1386||
48399831|NCT01468701|101309235|FG016|All Eligible Patient|Overall Study||11||
48399832|NCT01468701|101309219|FG000|COMPLETED|Overall Study||3965||
48399833|NCT01468701|101309220|FG001|COMPLETED|Overall Study||0||
48399834|NCT01468701|101309221|FG002|COMPLETED|Overall Study||0||
48399835|NCT01468701|101309222|FG003|COMPLETED|Overall Study||0||
48399836|NCT01468701|101309223|FG004|COMPLETED|Overall Study||0||
48399837|NCT01468701|101309224|FG005|COMPLETED|Overall Study||0||
48399838|NCT01468701|101309225|FG006|COMPLETED|Overall Study||0||
48399839|NCT01468701|101309226|FG007|COMPLETED|Overall Study||0||
48399840|NCT01468701|101309227|FG008|COMPLETED|Overall Study||3219||
48399841|NCT01468701|101309228|FG009|COMPLETED|Overall Study||3780||
48399842|NCT01468701|101309229|FG010|COMPLETED|Overall Study||3256||
48702737|NCT00385944|102057704|FG002|COMPLETED|Loading Dose||56||
48702738|NCT00385944|102057702|FG000|NOT COMPLETED|Loading Dose||0||
48702739|NCT00385944|102057703|FG001|NOT COMPLETED|Loading Dose||0||
48702740|NCT00385944|102057704|FG002|NOT COMPLETED|Loading Dose||0||
48702741|NCT00385944|102057702|FG000|STARTED|1st Maintenance Dose Period||29||
48702742|NCT00385944|102057703|FG001|STARTED|1st Maintenance Dose Period||25||
48399843|NCT01468701|101309230|FG011|COMPLETED|Overall Study||3672||
48399844|NCT01468701|101309231|FG012|COMPLETED|Overall Study||284||
48399845|NCT01468701|101309232|FG013|COMPLETED|Overall Study||1712||
48399846|NCT01468701|101309233|FG014|COMPLETED|Overall Study||151||
48399847|NCT01468701|101309234|FG015|COMPLETED|Overall Study||1056||
48399848|NCT01468701|101309235|FG016|COMPLETED|Overall Study||10||
48399849|NCT01468701|101309219|FG000|NOT COMPLETED|Overall Study||999||
48399850|NCT01468701|101309220|FG001|NOT COMPLETED|Overall Study||5103||
48399851|NCT01468701|101309221|FG002|NOT COMPLETED|Overall Study||1784||
48399852|NCT01468701|101309222|FG003|NOT COMPLETED|Overall Study||715||
48399853|NCT01468701|101309223|FG004|NOT COMPLETED|Overall Study||1736||
48399854|NCT01468701|101309224|FG005|NOT COMPLETED|Overall Study||128||
48399855|NCT01468701|101309225|FG006|NOT COMPLETED|Overall Study||1209||
48702743|NCT00385944|102057704|FG002|STARTED|1st Maintenance Dose Period||0||
48702744|NCT00385944|102057702|FG000|COMPLETED|1st Maintenance Dose Period||25||
48702745|NCT00385944|102057703|FG001|COMPLETED|1st Maintenance Dose Period||24||
48702746|NCT00385944|102057704|FG002|COMPLETED|1st Maintenance Dose Period||0||
48702747|NCT00385944|102057702|FG000|NOT COMPLETED|1st Maintenance Dose Period||4||
48702748|NCT00385944|102057703|FG001|NOT COMPLETED|1st Maintenance Dose Period||1||
48399856|NCT01468701|101309226|FG007|NOT COMPLETED|Overall Study||5||
48399857|NCT01468701|101309227|FG008|NOT COMPLETED|Overall Study||660||
48399858|NCT01468701|101309228|FG009|NOT COMPLETED|Overall Study||1182||
48399859|NCT01468701|101309229|FG010|NOT COMPLETED|Overall Study||798||
48399860|NCT01468701|101309230|FG011|NOT COMPLETED|Overall Study||866||
48399861|NCT01468701|101309231|FG012|NOT COMPLETED|Overall Study||49||
48399862|NCT01468701|101309232|FG013|NOT COMPLETED|Overall Study||470||
48399863|NCT01468701|101309233|FG014|NOT COMPLETED|Overall Study||63||
48399864|NCT01468701|101309234|FG015|NOT COMPLETED|Overall Study||362||
48399865|NCT01468701|101309235|FG016|NOT COMPLETED|Overall Study||1||
48399866|NCT01496274|101309236|FG000|STARTED|Overall Study||40||
48399867|NCT01496274|101309237|FG001|STARTED|Overall Study||23||
48399868|NCT01496274|101309236|FG000|COMPLETED|Overall Study||37||
48399869|NCT01496274|101309237|FG001|COMPLETED|Overall Study||18||
48399870|NCT01496274|101309236|FG000|NOT COMPLETED|Overall Study||3||
48399871|NCT01496274|101309237|FG001|NOT COMPLETED|Overall Study||5||
48399872|NCT01333098|101309238|FG000|STARTED|Overall Study||15||
48399873|NCT01333098|101309238|FG000|COMPLETED|Overall Study||12||
48399874|NCT01333098|101309238|FG000|NOT COMPLETED|Overall Study||3||
48399875|NCT02580240|101309239|FG000|STARTED|Overall Study||62||
48399876|NCT02580240|101309240|FG001|STARTED|Overall Study||58||
48702749|NCT00385944|102057704|FG002|NOT COMPLETED|1st Maintenance Dose Period||0||
48702750|NCT00385944|102057702|FG000|STARTED|2nd Maintenance Dose Period||24||
48702751|NCT00385944|102057703|FG001|STARTED|2nd Maintenance Dose Period||22||
48702752|NCT00385944|102057704|FG002|STARTED|2nd Maintenance Dose Period||0||
48702753|NCT00385944|102057702|FG000|COMPLETED|2nd Maintenance Dose Period||22||
48702754|NCT00385944|102057703|FG001|COMPLETED|2nd Maintenance Dose Period||19||
48702755|NCT00385944|102057704|FG002|COMPLETED|2nd Maintenance Dose Period||0||
48702756|NCT00385944|102057702|FG000|NOT COMPLETED|2nd Maintenance Dose Period||2||
48702757|NCT00385944|102057703|FG001|NOT COMPLETED|2nd Maintenance Dose Period||3||
48702758|NCT00385944|102057704|FG002|NOT COMPLETED|2nd Maintenance Dose Period||0||
48702759|NCT02649218|102057705|FG000|STARTED|Overall Study||226||
48702760|NCT02649218|102057705|FG000|COMPLETED|Overall Study||201||
48702761|NCT02649218|102057705|FG000|NOT COMPLETED|Overall Study||25||
48702762|NCT03596047|102057706|FG000|STARTED|Overall Study||40||
48702763|NCT03596047|102057707|FG001|STARTED|Overall Study||40||
48399877|NCT02580240|101309239|FG000|COMPLETED|Overall Study||60||
48399878|NCT02580240|101309240|FG001|COMPLETED|Overall Study||58||
48399879|NCT02580240|101309239|FG000|NOT COMPLETED|Overall Study||2||
48399880|NCT02580240|101309240|FG001|NOT COMPLETED|Overall Study||0||
48399881|NCT01587274|101309241|FG000|STARTED|Overall Study||108||
48399882|NCT01587274|101309242|FG001|STARTED|Overall Study||108||
48399883|NCT01587274|101309243|FG002|STARTED|Overall Study||107||
48399884|NCT01587274|101309241|FG000|COMPLETED|Overall Study||104||
48399885|NCT01587274|101309242|FG001|COMPLETED|Overall Study||103||
48399886|NCT01587274|101309243|FG002|COMPLETED|Overall Study||104||
48399887|NCT01587274|101309241|FG000|NOT COMPLETED|Overall Study||4||
48399888|NCT01587274|101309242|FG001|NOT COMPLETED|Overall Study||5||
48399889|NCT01587274|101309243|FG002|NOT COMPLETED|Overall Study||3||
48132629|NCT04329104|100648521|FG001|STARTED|Efficacy Study||0||
48132630|NCT04329104|100648522|FG002|STARTED|Efficacy Study||0||
48132631|NCT04329104|100648523|FG003|STARTED|Efficacy Study||110||
48399890|NCT03073213|101309244|FG000|STARTED|Single Dose Period||12||
48399891|NCT03073213|101309245|FG001|STARTED|Single Dose Period||0||
48399892|NCT03073213|101309246|FG002|STARTED|Single Dose Period||0||
48399893|NCT03073213|101309244|FG000|COMPLETED|Single Dose Period||12||
48399894|NCT03073213|101309245|FG001|COMPLETED|Single Dose Period||0||
48399895|NCT03073213|101309246|FG002|COMPLETED|Single Dose Period||0||
48399896|NCT03073213|101309244|FG000|NOT COMPLETED|Single Dose Period||0||
48399897|NCT03073213|101309245|FG001|NOT COMPLETED|Single Dose Period||0||
48702764|NCT03596047|102057706|FG000|COMPLETED|Overall Study||33||
48702765|NCT03596047|102057707|FG001|COMPLETED|Overall Study||34||
48702766|NCT03596047|102057706|FG000|NOT COMPLETED|Overall Study||7||
48132632|NCT04329104|100648524|FG004|STARTED|Efficacy Study||110||
48132633|NCT04329104|100648525|FG005|STARTED|Efficacy Study||110||
48286122|NCT03075410|101026268|FG000|COMPLETED|Part A-Washout Period 1 (14 Days)||2||
48286123|NCT03075410|101026269|FG001|COMPLETED|Part A-Washout Period 1 (14 Days)||1||
48286124|NCT03075410|101026270|FG002|COMPLETED|Part A-Washout Period 1 (14 Days)||2||
48286125|NCT03075410|101026271|FG003|COMPLETED|Part A-Washout Period 1 (14 Days)||1||
48286126|NCT03075410|101026272|FG004|COMPLETED|Part A-Washout Period 1 (14 Days)||2||
48286127|NCT03075410|101026273|FG005|COMPLETED|Part A-Washout Period 1 (14 Days)||1||
48286128|NCT03075410|101026274|FG006|COMPLETED|Part A-Washout Period 1 (14 Days)||0||
48286129|NCT03075410|101026275|FG007|COMPLETED|Part A-Washout Period 1 (14 Days)||0||
48286130|NCT03075410|101026276|FG008|COMPLETED|Part A-Washout Period 1 (14 Days)||0||
48286131|NCT03075410|101026268|FG000|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0||
48286132|NCT03075410|101026269|FG001|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0||
48286133|NCT03075410|101026270|FG002|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0||
48286134|NCT03075410|101026271|FG003|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0||
48286135|NCT03075410|101026272|FG004|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0||
48286136|NCT03075410|101026273|FG005|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0||
48286137|NCT03075410|101026274|FG006|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0||
48286138|NCT03075410|101026275|FG007|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0||
48286139|NCT03075410|101026276|FG008|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0||
48286140|NCT03075410|101026268|FG000|STARTED|Part A-Period 2 (14 Days)||2||
48286141|NCT03075410|101026269|FG001|STARTED|Part A-Period 2 (14 Days)||1||
48286142|NCT03075410|101026270|FG002|STARTED|Part A-Period 2 (14 Days)||2||
48286143|NCT03075410|101026271|FG003|STARTED|Part A-Period 2 (14 Days)||1||
48286144|NCT03075410|101026272|FG004|STARTED|Part A-Period 2 (14 Days)||2||
48286145|NCT03075410|101026273|FG005|STARTED|Part A-Period 2 (14 Days)||1||
48286146|NCT03075410|101026274|FG006|STARTED|Part A-Period 2 (14 Days)||0||
48286147|NCT03075410|101026275|FG007|STARTED|Part A-Period 2 (14 Days)||0||
48286148|NCT03075410|101026276|FG008|STARTED|Part A-Period 2 (14 Days)||0||
48286149|NCT03075410|101026268|FG000|COMPLETED|Part A-Period 2 (14 Days)||1||
48286150|NCT03075410|101026269|FG001|COMPLETED|Part A-Period 2 (14 Days)||1||
48399898|NCT03073213|101309246|FG002|NOT COMPLETED|Single Dose Period||0||
48399899|NCT03073213|101309244|FG000|STARTED|Multiple Dose Period||0||
48399900|NCT03073213|101309245|FG001|STARTED|Multiple Dose Period||14||
48399901|NCT03073213|101309246|FG002|STARTED|Multiple Dose Period||15||
48702767|NCT03596047|102057707|FG001|NOT COMPLETED|Overall Study||6||
48702768|NCT02901054|102057708|FG000|STARTED|Overall Study||19||
48702769|NCT02901054|102057708|FG000|COMPLETED|Overall Study||15||
48132634|NCT04329104|100648520|FG000|COMPLETED|Efficacy Study||0||
48132635|NCT04329104|100648521|FG001|COMPLETED|Efficacy Study||0||
48132636|NCT04329104|100648522|FG002|COMPLETED|Efficacy Study||0||
48132637|NCT04329104|100648523|FG003|COMPLETED|Efficacy Study||105||
48132638|NCT04329104|100648524|FG004|COMPLETED|Efficacy Study||104||
48132639|NCT04329104|100648525|FG005|COMPLETED|Efficacy Study||102||
48132640|NCT04329104|100648520|FG000|NOT COMPLETED|Efficacy Study||0||
48132641|NCT04329104|100648521|FG001|NOT COMPLETED|Efficacy Study||0||
48132642|NCT04329104|100648522|FG002|NOT COMPLETED|Efficacy Study||0||
48132643|NCT04329104|100648523|FG003|NOT COMPLETED|Efficacy Study||5||
48132644|NCT04329104|100648524|FG004|NOT COMPLETED|Efficacy Study||6||
48132645|NCT04329104|100648525|FG005|NOT COMPLETED|Efficacy Study||8||
48132646|NCT04644328|100648526|FG000|STARTED|Thanksgiving Period||0||410
48576959|NCT02907918|101744649|FG000|COMPLETED|Overall Study||26||
48576960|NCT02907918|101744649|FG000|NOT COMPLETED|Overall Study||0||
48576961|NCT01015131|101744650|FG000|STARTED|Overall Study||44||
48576962|NCT01015131|101744650|FG000|COMPLETED|Overall Study||36||
48576963|NCT01015131|101744650|FG000|NOT COMPLETED|Overall Study||8||
48576964|NCT02411448|101744651|FG000|STARTED|Overall Study||14||
48576965|NCT02411448|101744652|FG001|STARTED|Overall Study||224||
48576966|NCT02411448|101744653|FG002|STARTED|Overall Study||225||
48576967|NCT02411448|101744651|FG000|Received at Least One Dose of Study Drug|Overall Study||14||
48576968|NCT02411448|101744652|FG001|Received at Least One Dose of Study Drug|Overall Study||221||
48576969|NCT02411448|101744653|FG002|Received at Least One Dose of Study Drug|Overall Study||225||
48576970|NCT02411448|101744651|FG000|COMPLETED|Overall Study||10||
48576971|NCT02411448|101744652|FG001|COMPLETED|Overall Study||141||
48576972|NCT02411448|101744653|FG002|COMPLETED|Overall Study||173||
48576973|NCT02411448|101744651|FG000|NOT COMPLETED|Overall Study||4||
48576974|NCT02411448|101744652|FG001|NOT COMPLETED|Overall Study||83||
48576975|NCT02411448|101744653|FG002|NOT COMPLETED|Overall Study||52||
48576976|NCT02907892|101744654|FG000|STARTED|Overall Study||277||
48576977|NCT02907892|101744655|FG001|STARTED|Overall Study||276||
48576978|NCT02907892|101744654|FG000|COMPLETED|Overall Study||250||
48576979|NCT02907892|101744655|FG001|COMPLETED|Overall Study||236||
48576980|NCT02907892|101744654|FG000|NOT COMPLETED|Overall Study||27||
48576981|NCT02907892|101744655|FG001|NOT COMPLETED|Overall Study||40||
48576982|NCT01069185|101744656|FG000|STARTED|Overall Study||47||
48576983|NCT01069185|101744657|FG001|STARTED|Overall Study||45||
48576984|NCT01069185|101744656|FG000|COMPLETED|Overall Study||47||
48576985|NCT01069185|101744657|FG001|COMPLETED|Overall Study||45||
48576986|NCT01069185|101744656|FG000|NOT COMPLETED|Overall Study||0||
48132647|NCT04644328|100648527|FG001|STARTED|Thanksgiving Period||0||410
48132648|NCT04644328|100648526|FG000|COMPLETED|Thanksgiving Period||0||410
48132649|NCT04644328|100648527|FG001|COMPLETED|Thanksgiving Period||0||410
48132650|NCT04644328|100648526|FG000|NOT COMPLETED|Thanksgiving Period||0||0
48132651|NCT04644328|100648527|FG001|NOT COMPLETED|Thanksgiving Period||0||0
48132652|NCT04644328|100648526|FG000|STARTED|Christmas Period||0||386
48132653|NCT04644328|100648527|FG001|STARTED|Christmas Period||0||381
48576987|NCT01069185|101744657|FG001|NOT COMPLETED|Overall Study||0||
48576988|NCT05985980|101744658|FG000|STARTED|Overall Study||47||
48576989|NCT05985980|101744658|FG000|COMPLETED|Overall Study||43||
48576990|NCT05985980|101744658|FG000|NOT COMPLETED|Overall Study||4||
48576991|NCT02551770|101744659|FG000|STARTED|Overall Study||51||167
48576992|NCT02551770|101744660|FG001|STARTED|Overall Study||51||170
48576993|NCT02551770|101744659|FG000|COMPLETED|Overall Study||48||162
48576994|NCT02551770|101744660|FG001|COMPLETED|Overall Study||48||162
48576995|NCT02551770|101744659|FG000|NOT COMPLETED|Overall Study||3||5
48576996|NCT02551770|101744660|FG001|NOT COMPLETED|Overall Study||3||8
48576997|NCT02049814|101744661|FG000|STARTED|Overall Study||248||
48132654|NCT04644328|100648526|FG000|COMPLETED|Christmas Period||0||386
48132655|NCT04644328|100648527|FG001|COMPLETED|Christmas Period||0||381
48132656|NCT04644328|100648526|FG000|NOT COMPLETED|Christmas Period||0||0
48132657|NCT04644328|100648527|FG001|NOT COMPLETED|Christmas Period||0||0
48132658|NCT00673049|100648528|FG000|STARTED|Before Progression on Erlotinib||292||
48132659|NCT00673049|100648529|FG001|STARTED|Before Progression on Erlotinib||290||
48576998|NCT02049814|101744662|FG001|STARTED|Overall Study||246||
48576999|NCT02049814|101744661|FG000|Safety Set|Overall Study||248||
48577000|NCT02049814|101744662|FG001|Safety Set|Overall Study||245||
48577001|NCT02049814|101744661|FG000|COMPLETED|Overall Study||219||
48577002|NCT02049814|101744662|FG001|COMPLETED|Overall Study||219||
48577003|NCT02049814|101744661|FG000|NOT COMPLETED|Overall Study||29||
48577004|NCT02049814|101744662|FG001|NOT COMPLETED|Overall Study||27||
48577005|NCT01878149|101744663|FG000|STARTED|Overall Study||21||
48577006|NCT01878149|101744664|FG001|STARTED|Overall Study||17||
48577007|NCT01878149|101744663|FG000|COMPLETED|Overall Study||19||
48577008|NCT01878149|101744664|FG001|COMPLETED|Overall Study||15||
48577009|NCT01878149|101744663|FG000|NOT COMPLETED|Overall Study||2||
48577010|NCT01878149|101744664|FG001|NOT COMPLETED|Overall Study||2||
48577011|NCT01014988|101744665|FG000|STARTED|Overall Study||130||
48577012|NCT01014988|101744666|FG001|STARTED|Overall Study||7||
48577013|NCT01014988|101744667|FG002|STARTED|Overall Study||11||
48577014|NCT01014988|101744668|FG003|STARTED|Overall Study||12||
48577015|NCT01014988|101744669|FG004|STARTED|Overall Study||27||
48132660|NCT00673049|100648530|FG002|STARTED|Before Progression on Erlotinib||1||
48132661|NCT00673049|100648531|FG003|STARTED|Before Progression on Erlotinib||0||
48132662|NCT00673049|100648528|FG000|Treated|Before Progression on Erlotinib||289||
48132663|NCT00673049|100648529|FG001|Treated|Before Progression on Erlotinib||289||
48132664|NCT00673049|100648530|FG002|Treated|Before Progression on Erlotinib||1||
48132665|NCT00673049|100648531|FG003|Treated|Before Progression on Erlotinib||0||
48132666|NCT00673049|100648528|FG000|COMPLETED|Before Progression on Erlotinib||0||
48132667|NCT00673049|100648529|FG001|COMPLETED|Before Progression on Erlotinib||0||
48132668|NCT00673049|100648530|FG002|COMPLETED|Before Progression on Erlotinib||0||
48132669|NCT00673049|100648531|FG003|COMPLETED|Before Progression on Erlotinib||0||
48399902|NCT03073213|101309244|FG000|Participants Enrolled From Single Dose|Multiple Dose Period||0||
48399903|NCT03073213|101309245|FG001|Participants Enrolled From Single Dose|Multiple Dose Period||7||
48399904|NCT03073213|101309246|FG002|Participants Enrolled From Single Dose|Multiple Dose Period||2||
48399905|NCT03073213|101309244|FG000|COMPLETED|Multiple Dose Period||0||
48399906|NCT03073213|101309245|FG001|COMPLETED|Multiple Dose Period||14||
48399907|NCT03073213|101309246|FG002|COMPLETED|Multiple Dose Period||14||
48399908|NCT03073213|101309244|FG000|NOT COMPLETED|Multiple Dose Period||0||
48399909|NCT03073213|101309245|FG001|NOT COMPLETED|Multiple Dose Period||0||
48399910|NCT03073213|101309246|FG002|NOT COMPLETED|Multiple Dose Period||1||
48399911|NCT00412113|101309247|FG000|STARTED|Overall Study||123||
48399912|NCT00412113|101309248|FG001|STARTED|Overall Study||122||
48399913|NCT00412113|101309247|FG000|Received Treatment|Overall Study||122||
48132670|NCT00673049|100648528|FG000|NOT COMPLETED|Before Progression on Erlotinib||292||
48132671|NCT00673049|100648529|FG001|NOT COMPLETED|Before Progression on Erlotinib||290||
48132672|NCT00673049|100648530|FG002|NOT COMPLETED|Before Progression on Erlotinib||1||
48132673|NCT00673049|100648531|FG003|NOT COMPLETED|Before Progression on Erlotinib||0||
48132674|NCT00673049|100648528|FG000|STARTED|After Progression on Erlotinib||0||
48132675|NCT00673049|100648529|FG001|STARTED|After Progression on Erlotinib||0||
48132676|NCT00673049|100648530|FG002|STARTED|After Progression on Erlotinib||0||
48132677|NCT00673049|100648531|FG003|STARTED|After Progression on Erlotinib||83||
48132678|NCT00673049|100648528|FG000|COMPLETED|After Progression on Erlotinib||0||
48132679|NCT00673049|100648529|FG001|COMPLETED|After Progression on Erlotinib||0||
48132680|NCT00673049|100648530|FG002|COMPLETED|After Progression on Erlotinib||0||
48132681|NCT00673049|100648531|FG003|COMPLETED|After Progression on Erlotinib||0||
48132682|NCT00673049|100648528|FG000|NOT COMPLETED|After Progression on Erlotinib||0||
48132683|NCT00673049|100648529|FG001|NOT COMPLETED|After Progression on Erlotinib||0||
48132684|NCT00673049|100648530|FG002|NOT COMPLETED|After Progression on Erlotinib||0||
48132685|NCT00673049|100648531|FG003|NOT COMPLETED|After Progression on Erlotinib||83||
48132686|NCT02763384|100648532|FG000|STARTED|Overall Study||12||
48132687|NCT02763384|100648532|FG000|COMPLETED|Overall Study||10||
48132688|NCT02763384|100648532|FG000|NOT COMPLETED|Overall Study||2||
48132689|NCT00680316|100648533|FG000|STARTED|Overall Study||1||
48132690|NCT00680316|100648534|FG001|STARTED|Overall Study||2||
48132691|NCT00680316|100648533|FG000|COMPLETED|Overall Study||1||
48132692|NCT00680316|100648534|FG001|COMPLETED|Overall Study||2||
48132693|NCT00680316|100648533|FG000|NOT COMPLETED|Overall Study||0||
48132694|NCT00680316|100648534|FG001|NOT COMPLETED|Overall Study||0||
48132695|NCT01329029|100648535|FG000|STARTED|Overall Study||973||
48132696|NCT01329029|100648536|FG001|STARTED|Overall Study||972||
48132697|NCT01329029|100648535|FG000|Full Analysis Set (FAS)|Overall Study||969||
48132698|NCT01329029|100648536|FG001|Full Analysis Set (FAS)|Overall Study||966||
48132699|NCT01329029|100648535|FG000|Safety Population|Overall Study||968||
48132700|NCT01329029|100648536|FG001|Safety Population|Overall Study||967||
48132701|NCT01329029|100648535|FG000|COMPLETED|Overall Study||704||
48132702|NCT01329029|100648536|FG001|COMPLETED|Overall Study||780||
48132703|NCT01329029|100648535|FG000|NOT COMPLETED|Overall Study||269||
48132704|NCT01329029|100648536|FG001|NOT COMPLETED|Overall Study||192||
48132705|NCT01995123|100648537|FG000|STARTED|Overall Study||63||
48132706|NCT01995123|100648538|FG001|STARTED|Overall Study||61||
48132707|NCT01995123|100648537|FG000|COMPLETED|Overall Study||45||
48132708|NCT01995123|100648538|FG001|COMPLETED|Overall Study||46||
48132709|NCT01995123|100648537|FG000|NOT COMPLETED|Overall Study||18||
48132710|NCT01995123|100648538|FG001|NOT COMPLETED|Overall Study||15||
48132711|NCT01173848|100648539|FG000|STARTED|Overall Study||8||
48399914|NCT00412113|101309248|FG001|Received Treatment|Overall Study||122||
48399915|NCT00412113|101309247|FG000|COMPLETED|Overall Study||111||
48399916|NCT00412113|101309248|FG001|COMPLETED|Overall Study||107||
48132712|NCT01173848|100648540|FG001|STARTED|Overall Study||11||
48132713|NCT01173848|100648539|FG000|COMPLETED|Overall Study||4||
48132714|NCT01173848|100648540|FG001|COMPLETED|Overall Study||3||
48132715|NCT01173848|100648539|FG000|NOT COMPLETED|Overall Study||4||
48132716|NCT01173848|100648540|FG001|NOT COMPLETED|Overall Study||8||
48132717|NCT02571452|100648541|FG000|STARTED|Overall Study Treatment||47|Randomized to Treatment Arm|
48132718|NCT02571452|100648542|FG001|STARTED|Overall Study Treatment||46|Randomized to Treatment Arm|
48132719|NCT02571452|100648541|FG000|COMPLETED|Overall Study Treatment||47|Completed Treatment|
48132720|NCT02571452|100648542|FG001|COMPLETED|Overall Study Treatment||45|Completed Treatment|
48132721|NCT02571452|100648541|FG000|NOT COMPLETED|Overall Study Treatment||0||
48132722|NCT02571452|100648542|FG001|NOT COMPLETED|Overall Study Treatment||1||
48132723|NCT02571452|100648541|FG000|STARTED|Overall Study 6-Month Follow-up||47|Scheduled for 6-Month Follow-up Assessment|
48132724|NCT02571452|100648542|FG001|STARTED|Overall Study 6-Month Follow-up||0|Scheduled for 6-Month Follow-up Assessment|
48132725|NCT02571452|100648541|FG000|COMPLETED|Overall Study 6-Month Follow-up||42||
48132726|NCT02571452|100648542|FG001|COMPLETED|Overall Study 6-Month Follow-up||0||
48132727|NCT02571452|100648541|FG000|NOT COMPLETED|Overall Study 6-Month Follow-up||5||
48132728|NCT02571452|100648542|FG001|NOT COMPLETED|Overall Study 6-Month Follow-up||0||
48132729|NCT00898677|100648543|FG000|STARTED|Overall Study||180||
48132730|NCT00898677|100648544|FG001|STARTED|Overall Study||455||
48132731|NCT00898677|100648545|FG002|STARTED|Overall Study||455||
48132732|NCT00898677|100648546|FG003|STARTED|Overall Study||178||
48132733|NCT00898677|100648543|FG000|Patients Treated|Overall Study||164||
48132734|NCT00898677|100648544|FG001|Patients Treated|Overall Study||387||
48132735|NCT00898677|100648545|FG002|Patients Treated|Overall Study||388||
48132736|NCT00898677|100648546|FG003|Patients Treated|Overall Study||160||
48132737|NCT00898677|100648543|FG000|COMPLETED|Overall Study||163||
48132738|NCT00898677|100648544|FG001|COMPLETED|Overall Study||386||
48132739|NCT00898677|100648545|FG002|COMPLETED|Overall Study||383||
48132740|NCT00898677|100648546|FG003|COMPLETED|Overall Study||159||
48132741|NCT00898677|100648543|FG000|NOT COMPLETED|Overall Study||17||
48132742|NCT00898677|100648544|FG001|NOT COMPLETED|Overall Study||69||
48132743|NCT00898677|100648545|FG002|NOT COMPLETED|Overall Study||72||
48132744|NCT00898677|100648546|FG003|NOT COMPLETED|Overall Study||19||
48132745|NCT00710424|100648547|FG000|STARTED|Overall Study||149||
48132746|NCT00710424|100648548|FG001|STARTED|Overall Study||148||
48132747|NCT00710424|100648547|FG000|COMPLETED|Overall Study||105||
48132748|NCT00710424|100648548|FG001|COMPLETED|Overall Study||125||
48132749|NCT00710424|100648547|FG000|NOT COMPLETED|Overall Study||44||
48132750|NCT00710424|100648548|FG001|NOT COMPLETED|Overall Study||23||
48132751|NCT03023891|100648549|FG000|STARTED|Overall Study||18||
48132752|NCT03023891|100648549|FG000|COMPLETED|Overall Study||18||
48132753|NCT03023891|100648549|FG000|NOT COMPLETED|Overall Study||0||
48132754|NCT01289067|100648550|FG000|STARTED|Overall Study||13||
48132755|NCT01289067|100648550|FG000|COMPLETED|Overall Study||13||
48132756|NCT01289067|100648550|FG000|NOT COMPLETED|Overall Study||0||
48132757|NCT01286259|100648551|FG000|STARTED|Overall Study||16||
48132758|NCT01286259|100648551|FG000|COMPLETED|Overall Study||16||
48132759|NCT01286259|100648551|FG000|NOT COMPLETED|Overall Study||0||
48132760|NCT04159688|100648552|FG000|STARTED|Overall Study||8||
48132761|NCT04159688|100648552|FG000|COMPLETED|Overall Study||7||
48132762|NCT04159688|100648552|FG000|NOT COMPLETED|Overall Study||1||
48132763|NCT04389840|100648553|FG000|STARTED|Overall Study||6||
48132764|NCT04389840|100648554|FG001|STARTED|Overall Study||6||
48132765|NCT04389840|100648555|FG002|STARTED|Overall Study||8||
48132766|NCT04389840|100648556|FG003|STARTED|Overall Study||4||
48132767|NCT04389840|100648557|FG004|STARTED|Overall Study||2||
48132768|NCT04389840|100648558|FG005|STARTED|Overall Study||1||
48132769|NCT04389840|100648553|FG000|Intent-to-Treat Analysis Set|Overall Study||6||
48132770|NCT04389840|100648554|FG001|Intent-to-Treat Analysis Set|Overall Study||6||
48132771|NCT04389840|100648555|FG002|Intent-to-Treat Analysis Set|Overall Study||8||
48132772|NCT04389840|100648556|FG003|Intent-to-Treat Analysis Set|Overall Study||4||
48132773|NCT04389840|100648557|FG004|Intent-to-Treat Analysis Set|Overall Study||2||
48132774|NCT04389840|100648558|FG005|Intent-to-Treat Analysis Set|Overall Study||1||
48132775|NCT04389840|100648553|FG000|Safety Analysis Set|Overall Study||6||
48132776|NCT04389840|100648554|FG001|Safety Analysis Set|Overall Study||6||
48132777|NCT04389840|100648555|FG002|Safety Analysis Set|Overall Study||8||
48132778|NCT04389840|100648556|FG003|Safety Analysis Set|Overall Study||3||
48132779|NCT04389840|100648557|FG004|Safety Analysis Set|Overall Study||2||
48132780|NCT04389840|100648558|FG005|Safety Analysis Set|Overall Study||1||
48132781|NCT04389840|100648553|FG000|COMPLETED|Overall Study||4||
48132782|NCT04389840|100648554|FG001|COMPLETED|Overall Study||5||
48132783|NCT04389840|100648555|FG002|COMPLETED|Overall Study||8||
48132784|NCT04389840|100648556|FG003|COMPLETED|Overall Study||3||
48132785|NCT04389840|100648557|FG004|COMPLETED|Overall Study||1||
48132786|NCT04389840|100648558|FG005|COMPLETED|Overall Study||1||
48132787|NCT04389840|100648553|FG000|NOT COMPLETED|Overall Study||2||
48132788|NCT04389840|100648554|FG001|NOT COMPLETED|Overall Study||1||
48132789|NCT04389840|100648555|FG002|NOT COMPLETED|Overall Study||0||
48132790|NCT04389840|100648556|FG003|NOT COMPLETED|Overall Study||1||
48132791|NCT04389840|100648557|FG004|NOT COMPLETED|Overall Study||1||
48132792|NCT04389840|100648558|FG005|NOT COMPLETED|Overall Study||0||
48132793|NCT01592435|100648559|FG000|STARTED|Overall Study||76||
48132794|NCT01592435|100648559|FG000|COMPLETED|Overall Study||76||
48132795|NCT01592435|100648559|FG000|NOT COMPLETED|Overall Study||0||
48132796|NCT04598152|100648560|FG000|STARTED|Overall Study||3||
48132797|NCT04598152|100648561|FG001|STARTED|Overall Study||1||
48132798|NCT04598152|100648560|FG000|COMPLETED|Overall Study||3||
48132799|NCT04598152|100648561|FG001|COMPLETED|Overall Study||0||
48132800|NCT04598152|100648560|FG000|NOT COMPLETED|Overall Study||0||
48132801|NCT04598152|100648561|FG001|NOT COMPLETED|Overall Study||1||
48132802|NCT00801827|100648562|FG000|STARTED|Overall Study||5||
48132803|NCT00801827|100648562|FG000|COMPLETED|Overall Study||5||
48132804|NCT00801827|100648562|FG000|NOT COMPLETED|Overall Study||0||
48132805|NCT01131312|100648563|FG000|STARTED|Overall Study||1839||
48132806|NCT01131312|100648564|FG001|STARTED|Overall Study||1385||
48132807|NCT01131312|100648565|FG002|STARTED|Overall Study||1836||
48132808|NCT01131312|100648563|FG000|COMPLETED|Overall Study||1414||
48132809|NCT01131312|100648564|FG001|COMPLETED|Overall Study||1156||
48132810|NCT01131312|100648565|FG002|COMPLETED|Overall Study||1485||
48132811|NCT01131312|100648563|FG000|NOT COMPLETED|Overall Study||425||
48132812|NCT01131312|100648564|FG001|NOT COMPLETED|Overall Study||229||
48132813|NCT01131312|100648565|FG002|NOT COMPLETED|Overall Study||351||
48132814|NCT01259713|100648566|FG000|STARTED|Overall Study||237||
48132815|NCT01259713|100648567|FG001|STARTED|Overall Study||118||
48132816|NCT01259713|100648566|FG000|COMPLETED|Overall Study||142||
48132817|NCT01259713|100648567|FG001|COMPLETED|Overall Study||77||
48577016|NCT01014988|101744670|FG005|STARTED|Overall Study||14||
48577017|NCT01014988|101744665|FG000|COMPLETED|Overall Study||107||
48577018|NCT01014988|101744666|FG001|COMPLETED|Overall Study||7||
48577019|NCT01014988|101744667|FG002|COMPLETED|Overall Study||9||
48577020|NCT01014988|101744668|FG003|COMPLETED|Overall Study||12||
48577021|NCT01014988|101744669|FG004|COMPLETED|Overall Study||26||
48577022|NCT01014988|101744670|FG005|COMPLETED|Overall Study||11||
48577023|NCT01014988|101744665|FG000|NOT COMPLETED|Overall Study||23||
48577024|NCT01014988|101744666|FG001|NOT COMPLETED|Overall Study||0||
48577025|NCT01014988|101744667|FG002|NOT COMPLETED|Overall Study||2||
48577026|NCT01014988|101744668|FG003|NOT COMPLETED|Overall Study||0||
48577027|NCT01014988|101744669|FG004|NOT COMPLETED|Overall Study||1||
48577028|NCT01014988|101744670|FG005|NOT COMPLETED|Overall Study||3||
48702770|NCT02901054|102057708|FG000|NOT COMPLETED|Overall Study||4||
48702771|NCT01352442|102057709|FG000|STARTED|Overall Study||151||
48702772|NCT01352442|102057709|FG000|COMPLETED|Overall Study||139||
48702773|NCT01352442|102057709|FG000|NOT COMPLETED|Overall Study||12||
48702774|NCT03015649|102057710|FG000|STARTED|Overall Study||34||
48702775|NCT03015649|102057710|FG000|COMPLETED|Overall Study||34||
48702776|NCT03015649|102057710|FG000|NOT COMPLETED|Overall Study||0||
48132818|NCT01259713|100648566|FG000|NOT COMPLETED|Overall Study||95||
48132819|NCT01259713|100648567|FG001|NOT COMPLETED|Overall Study||41||
48132820|NCT01359735|100648568|FG000|STARTED|Overall Study||4||
48132821|NCT01359735|100648569|FG001|STARTED|Overall Study||4||
48132822|NCT01359735|100648568|FG000|COMPLETED|Overall Study||4||
48132823|NCT01359735|100648569|FG001|COMPLETED|Overall Study||4||
48132824|NCT01359735|100648568|FG000|NOT COMPLETED|Overall Study||0||
48132825|NCT01359735|100648569|FG001|NOT COMPLETED|Overall Study||0||
48132826|NCT02621606|100648570|FG000|STARTED|Overall Study||3||
48132827|NCT02621606|100648571|FG001|STARTED|Overall Study||7||
48132828|NCT02621606|100648572|FG002|STARTED|Overall Study||10||
48132829|NCT02621606|100648570|FG000|Treated|Overall Study||3||
48132830|NCT02621606|100648571|FG001|Treated|Overall Study||7||
48132831|NCT02621606|100648572|FG002|Treated|Overall Study||10||
48132832|NCT02621606|100648570|FG000|COMPLETED|Overall Study||3||
48577029|NCT03274999|101744671|FG000|STARTED|First Intervention (Day 0)||5||
48577030|NCT03274999|101744672|FG001|STARTED|First Intervention (Day 0)||5||
48577031|NCT03274999|101744671|FG000|COMPLETED|First Intervention (Day 0)||5||
48577032|NCT03274999|101744672|FG001|COMPLETED|First Intervention (Day 0)||5||
48577033|NCT03274999|101744671|FG000|NOT COMPLETED|First Intervention (Day 0)||0||
48577034|NCT03274999|101744672|FG001|NOT COMPLETED|First Intervention (Day 0)||0||
48577035|NCT03274999|101744671|FG000|STARTED|Second Intervention (Day 14)||5||
48577036|NCT03274999|101744672|FG001|STARTED|Second Intervention (Day 14)||5||
48577037|NCT03274999|101744671|FG000|COMPLETED|Second Intervention (Day 14)||5||
48577038|NCT03274999|101744672|FG001|COMPLETED|Second Intervention (Day 14)||5||
48577039|NCT03274999|101744671|FG000|NOT COMPLETED|Second Intervention (Day 14)||0||
48702777|NCT04924530|102057711|FG000|STARTED|Period 1||7||
48702778|NCT04924530|102057712|FG001|STARTED|Period 1||3||
48702779|NCT04924530|102057713|FG002|STARTED|Period 1||4||
48702780|NCT04924530|102057714|FG003|STARTED|Period 1||2||
48702781|NCT04924530|102057715|FG004|STARTED|Period 1||4||
48702782|NCT04924530|102057716|FG005|STARTED|Period 1||4||
48702783|NCT04924530|102057711|FG000|COMPLETED|Period 1||7||
48702784|NCT04924530|102057712|FG001|COMPLETED|Period 1||3||
48702785|NCT04924530|102057713|FG002|COMPLETED|Period 1||4||
48577040|NCT03274999|101744672|FG001|NOT COMPLETED|Second Intervention (Day 14)||0||
48577041|NCT04292912|101744673|FG000|STARTED|Overall Study||16||
48702786|NCT04924530|102057714|FG003|COMPLETED|Period 1||2||
48132833|NCT02621606|100648571|FG001|COMPLETED|Overall Study||6||
48132834|NCT02621606|100648572|FG002|COMPLETED|Overall Study||10||
48132835|NCT02621606|100648570|FG000|NOT COMPLETED|Overall Study||0||
48132836|NCT02621606|100648571|FG001|NOT COMPLETED|Overall Study||1||
48132837|NCT02621606|100648572|FG002|NOT COMPLETED|Overall Study||0||
48132838|NCT05348681|100648573|FG000|STARTED|Overall Study||17||
48702787|NCT04924530|102057715|FG004|COMPLETED|Period 1||4||
48702788|NCT04924530|102057716|FG005|COMPLETED|Period 1||4||
48702789|NCT04924530|102057711|FG000|NOT COMPLETED|Period 1||0||
48702790|NCT04924530|102057712|FG001|NOT COMPLETED|Period 1||0||
48702791|NCT04924530|102057713|FG002|NOT COMPLETED|Period 1||0||
48702792|NCT04924530|102057714|FG003|NOT COMPLETED|Period 1||0||
48702793|NCT04924530|102057715|FG004|NOT COMPLETED|Period 1||0||
48702794|NCT04924530|102057716|FG005|NOT COMPLETED|Period 1||0||
48702795|NCT04924530|102057711|FG000|STARTED|Period 2||7||
48702796|NCT04924530|102057712|FG001|STARTED|Period 2||3||
48702797|NCT04924530|102057713|FG002|STARTED|Period 2||4||
48702798|NCT04924530|102057714|FG003|STARTED|Period 2||2||
48702799|NCT04924530|102057715|FG004|STARTED|Period 2||4||
48702800|NCT04924530|102057716|FG005|STARTED|Period 2||4||
48702801|NCT04924530|102057711|FG000|COMPLETED|Period 2||7||
48702802|NCT04924530|102057712|FG001|COMPLETED|Period 2||3||
48702803|NCT04924530|102057713|FG002|COMPLETED|Period 2||4||
48702804|NCT04924530|102057714|FG003|COMPLETED|Period 2||2||
48702805|NCT04924530|102057715|FG004|COMPLETED|Period 2||4||
48702806|NCT04924530|102057716|FG005|COMPLETED|Period 2||4||
48702807|NCT04924530|102057711|FG000|NOT COMPLETED|Period 2||0||
48702808|NCT04924530|102057712|FG001|NOT COMPLETED|Period 2||0||
48702809|NCT04924530|102057713|FG002|NOT COMPLETED|Period 2||0||
48286151|NCT03075410|101026270|FG002|COMPLETED|Part A-Period 2 (14 Days)||1||
48286152|NCT03075410|101026271|FG003|COMPLETED|Part A-Period 2 (14 Days)||1||
48286153|NCT03075410|101026272|FG004|COMPLETED|Part A-Period 2 (14 Days)||2||
48286154|NCT03075410|101026273|FG005|COMPLETED|Part A-Period 2 (14 Days)||1||
48286155|NCT03075410|101026274|FG006|COMPLETED|Part A-Period 2 (14 Days)||0||
48286156|NCT03075410|101026275|FG007|COMPLETED|Part A-Period 2 (14 Days)||0||
48286157|NCT03075410|101026276|FG008|COMPLETED|Part A-Period 2 (14 Days)||0||
48286158|NCT03075410|101026268|FG000|NOT COMPLETED|Part A-Period 2 (14 Days)||1||
48702810|NCT04924530|102057714|FG003|NOT COMPLETED|Period 2||0||
48702811|NCT04924530|102057715|FG004|NOT COMPLETED|Period 2||0||
48702812|NCT04924530|102057716|FG005|NOT COMPLETED|Period 2||0||
48702813|NCT04924530|102057711|FG000|STARTED|Period 3||7||
48702814|NCT04924530|102057712|FG001|STARTED|Period 3||3||
48702815|NCT04924530|102057713|FG002|STARTED|Period 3||4||
48702816|NCT04924530|102057714|FG003|STARTED|Period 3||2||
48702817|NCT04924530|102057715|FG004|STARTED|Period 3||4||
48702818|NCT04924530|102057716|FG005|STARTED|Period 3||4||
48702819|NCT04924530|102057711|FG000|COMPLETED|Period 3||7||
48702820|NCT04924530|102057712|FG001|COMPLETED|Period 3||3||
48702821|NCT04924530|102057713|FG002|COMPLETED|Period 3||4||
48702822|NCT04924530|102057714|FG003|COMPLETED|Period 3||2||
48702823|NCT04924530|102057715|FG004|COMPLETED|Period 3||4||
48702824|NCT04924530|102057716|FG005|COMPLETED|Period 3||4||
48702825|NCT04924530|102057711|FG000|NOT COMPLETED|Period 3||0||
48702826|NCT04924530|102057712|FG001|NOT COMPLETED|Period 3||0||
48702827|NCT04924530|102057713|FG002|NOT COMPLETED|Period 3||0||
48286159|NCT03075410|101026269|FG001|NOT COMPLETED|Part A-Period 2 (14 Days)||0||
48399917|NCT00412113|101309247|FG000|NOT COMPLETED|Overall Study||12||
48702828|NCT04924530|102057714|FG003|NOT COMPLETED|Period 3||0||
48702829|NCT04924530|102057715|FG004|NOT COMPLETED|Period 3||0||
48702830|NCT04924530|102057716|FG005|NOT COMPLETED|Period 3||0||
48702831|NCT03195660|102057717|FG000|STARTED|Overall Study||2||
48702832|NCT03195660|102057717|FG000|COMPLETED|Overall Study||0||
48702833|NCT03195660|102057717|FG000|NOT COMPLETED|Overall Study||2||
48702834|NCT04599959|102057718|FG000|STARTED|Overall Study||151||
48702835|NCT04599959|102057718|FG000|COMPLETED|Overall Study||151||
48702836|NCT04599959|102057718|FG000|NOT COMPLETED|Overall Study||0||
48702837|NCT03222973|102057719|FG000|STARTED|Part 1 (Week 0 to Week 72)||131||
48702838|NCT03222973|102057720|FG001|STARTED|Part 1 (Week 0 to Week 72)||132||
48132839|NCT05348681|100648574|FG001|STARTED|Overall Study||8||
48132840|NCT05348681|100648573|FG000|COMPLETED|Overall Study||4||
48132841|NCT05348681|100648574|FG001|COMPLETED|Overall Study||2||
48577042|NCT04292912|101744673|FG000|COMPLETED|Overall Study||9||
48132842|NCT05348681|100648573|FG000|NOT COMPLETED|Overall Study||13||
48132843|NCT05348681|100648574|FG001|NOT COMPLETED|Overall Study||6||
48132844|NCT03870763|100648575|FG000|STARTED|Overall Study||2||
48132845|NCT03870763|100648576|FG001|STARTED|Overall Study||6||
48132846|NCT03870763|100648577|FG002|STARTED|Overall Study||3||
48132847|NCT03870763|100648575|FG000|COMPLETED|Overall Study||2||
48132848|NCT03870763|100648576|FG001|COMPLETED|Overall Study||3||
48132849|NCT03870763|100648577|FG002|COMPLETED|Overall Study||2||
48132850|NCT03870763|100648575|FG000|NOT COMPLETED|Overall Study||0||
48132851|NCT03870763|100648576|FG001|NOT COMPLETED|Overall Study||3||
48132852|NCT03870763|100648577|FG002|NOT COMPLETED|Overall Study||1||
48132853|NCT00993447|100648578|FG000|STARTED|Overall Study||401||
48132854|NCT00993447|100648579|FG001|STARTED|Overall Study||199||
48132855|NCT00993447|100648578|FG000|COMPLETED|Overall Study||364||
48132856|NCT00993447|100648579|FG001|COMPLETED|Overall Study||180||
48132857|NCT00993447|100648578|FG000|NOT COMPLETED|Overall Study||37||
48577043|NCT04292912|101744673|FG000|NOT COMPLETED|Overall Study||7||
48132858|NCT00993447|100648579|FG001|NOT COMPLETED|Overall Study||19||
48132859|NCT01156701|100648580|FG000|STARTED|Overall Study||257||
48132860|NCT01156701|100648581|FG001|STARTED|Overall Study||1007||
48577044|NCT02024607|101744674|FG000|STARTED|Overall Study||115||
48577045|NCT02024607|101744675|FG001|STARTED|Overall Study||41||
48577046|NCT02024607|101744676|FG002|STARTED|Overall Study||87||
48577047|NCT02024607|101744677|FG003|STARTED|Overall Study||156||
48577048|NCT02024607|101744678|FG004|STARTED|Overall Study||40||
48577049|NCT02024607|101744679|FG005|STARTED|Overall Study||54||
48132861|NCT01156701|100648582|FG002|STARTED|Overall Study||163716||
48132862|NCT01156701|100648583|FG003|STARTED|Overall Study||6725||
48132863|NCT01156701|100648580|FG000|COMPLETED|Overall Study||257||
48132864|NCT01156701|100648581|FG001|COMPLETED|Overall Study||1007||
48132865|NCT01156701|100648582|FG002|COMPLETED|Overall Study||163716||
48577050|NCT02024607|101744680|FG006|STARTED|Overall Study||2||
48577051|NCT02024607|101744674|FG000|COMPLETED|Overall Study||115||
48577052|NCT02024607|101744675|FG001|COMPLETED|Overall Study||41||
48577053|NCT02024607|101744676|FG002|COMPLETED|Overall Study||87||
48577054|NCT02024607|101744677|FG003|COMPLETED|Overall Study||156||
48577055|NCT02024607|101744678|FG004|COMPLETED|Overall Study||40||
48577056|NCT02024607|101744679|FG005|COMPLETED|Overall Study||54||
48577057|NCT02024607|101744680|FG006|COMPLETED|Overall Study||2||
48577058|NCT02024607|101744674|FG000|NOT COMPLETED|Overall Study||0||
48577059|NCT02024607|101744675|FG001|NOT COMPLETED|Overall Study||0||
48577060|NCT02024607|101744676|FG002|NOT COMPLETED|Overall Study||0||
48702839|NCT03222973|102057721|FG002|STARTED|Part 1 (Week 0 to Week 72)||0||
48702840|NCT03222973|102057722|FG003|STARTED|Part 1 (Week 0 to Week 72)||0||
48702841|NCT03222973|102057719|FG000|Intent-to-treat (ITT) Population|Part 1 (Week 0 to Week 72)||131||
48132866|NCT01156701|100648583|FG003|COMPLETED|Overall Study||6725||
48132867|NCT01156701|100648580|FG000|NOT COMPLETED|Overall Study||0||
48132868|NCT01156701|100648581|FG001|NOT COMPLETED|Overall Study||0||
48132869|NCT01156701|100648582|FG002|NOT COMPLETED|Overall Study||0||
48132870|NCT01156701|100648583|FG003|NOT COMPLETED|Overall Study||0||
48132871|NCT03750487|100648584|FG000|STARTED|Overall Study||10||
48132872|NCT03750487|100648585|FG001|STARTED|Overall Study||4||
48132873|NCT03750487|100648584|FG000|COMPLETED|Overall Study||10||
48132874|NCT03750487|100648585|FG001|COMPLETED|Overall Study||4||
48132875|NCT03750487|100648584|FG000|NOT COMPLETED|Overall Study||0||
48132876|NCT03750487|100648585|FG001|NOT COMPLETED|Overall Study||0||
48132877|NCT01203189|100648586|FG000|STARTED|First 4 Weeks Treatment||10||
48132878|NCT01203189|100648587|FG001|STARTED|First 4 Weeks Treatment||10||
48577061|NCT02024607|101744677|FG003|NOT COMPLETED|Overall Study||0||
48577062|NCT02024607|101744678|FG004|NOT COMPLETED|Overall Study||0||
48577063|NCT02024607|101744679|FG005|NOT COMPLETED|Overall Study||0||
48577064|NCT02024607|101744680|FG006|NOT COMPLETED|Overall Study||0||
48577065|NCT04999163|101744681|FG000|STARTED|Overall Study||11||
48702842|NCT03222973|102057720|FG001|Intent-to-treat (ITT) Population|Part 1 (Week 0 to Week 72)||132||
48577066|NCT04999163|101744682|FG001|STARTED|Overall Study||9||
48577067|NCT04999163|101744681|FG000|COMPLETED|Overall Study||8||
48577068|NCT04999163|101744682|FG001|COMPLETED|Overall Study||9||
48577069|NCT04999163|101744681|FG000|NOT COMPLETED|Overall Study||3||
48577070|NCT04999163|101744682|FG001|NOT COMPLETED|Overall Study||0||
48577071|NCT00814333|101744683|FG000|STARTED|Enrollment||1||
48577072|NCT00814333|101744684|FG001|STARTED|Enrollment||0||
48577073|NCT00814333|101744683|FG000|COMPLETED|Enrollment||0||
48577074|NCT00814333|101744684|FG001|COMPLETED|Enrollment||0||
48577075|NCT00814333|101744683|FG000|NOT COMPLETED|Enrollment||1||
48577076|NCT00814333|101744684|FG001|NOT COMPLETED|Enrollment||0||
48577077|NCT00814333|101744683|FG000|STARTED|Treatment Period||0||
48132879|NCT01203189|100648588|FG002|STARTED|First 4 Weeks Treatment||3||
48132880|NCT01203189|100648586|FG000|COMPLETED|First 4 Weeks Treatment||8||
48132881|NCT01203189|100648587|FG001|COMPLETED|First 4 Weeks Treatment||8||
48132882|NCT01203189|100648588|FG002|COMPLETED|First 4 Weeks Treatment||3||
48577078|NCT00814333|101744684|FG001|STARTED|Treatment Period||0||
48132883|NCT01203189|100648586|FG000|NOT COMPLETED|First 4 Weeks Treatment||2||
48132884|NCT01203189|100648587|FG001|NOT COMPLETED|First 4 Weeks Treatment||2||
48132885|NCT01203189|100648588|FG002|NOT COMPLETED|First 4 Weeks Treatment||0||
48132886|NCT01203189|100648586|FG000|STARTED|Cross Over Period 4 Weeks Treatment||0||
48399918|NCT00412113|101309248|FG001|NOT COMPLETED|Overall Study||15||
48399919|NCT02758119|101309249|FG000|STARTED|Overall Study||41||
48399920|NCT02758119|101309250|FG001|STARTED|Overall Study||41||
48399921|NCT02758119|101309249|FG000|COMPLETED|Overall Study||39||
48132887|NCT01203189|100648587|FG001|STARTED|Cross Over Period 4 Weeks Treatment||0||
48702843|NCT03222973|102057721|FG002|Intent-to-treat (ITT) Population|Part 1 (Week 0 to Week 72)||0||
48702844|NCT03222973|102057722|FG003|Intent-to-treat (ITT) Population|Part 1 (Week 0 to Week 72)||0||
48702845|NCT03222973|102057719|FG000|Safety Population|Part 1 (Week 0 to Week 72)||131||
48702846|NCT03222973|102057720|FG001|Safety Population|Part 1 (Week 0 to Week 72)||132||
48702847|NCT03222973|102057721|FG002|Safety Population|Part 1 (Week 0 to Week 72)||0||
48702848|NCT03222973|102057722|FG003|Safety Population|Part 1 (Week 0 to Week 72)||0||
48702849|NCT03222973|102057719|FG000|COMPLETED|Part 1 (Week 0 to Week 72)||107||
48702850|NCT03222973|102057720|FG001|COMPLETED|Part 1 (Week 0 to Week 72)||118||
48702851|NCT03222973|102057721|FG002|COMPLETED|Part 1 (Week 0 to Week 72)||0||
48702852|NCT03222973|102057722|FG003|COMPLETED|Part 1 (Week 0 to Week 72)||0||
48702853|NCT03222973|102057719|FG000|NOT COMPLETED|Part 1 (Week 0 to Week 72)||24||
48702854|NCT03222973|102057720|FG001|NOT COMPLETED|Part 1 (Week 0 to Week 72)||14||
48702855|NCT03222973|102057721|FG002|NOT COMPLETED|Part 1 (Week 0 to Week 72)||0||
48702856|NCT03222973|102057722|FG003|NOT COMPLETED|Part 1 (Week 0 to Week 72)||0||
48702857|NCT03222973|102057719|FG000|STARTED|Part 2 (Week 73 to Week 168)||0||
48702858|NCT03222973|102057720|FG001|STARTED|Part 2 (Week 73 to Week 168)||0||
48702859|NCT03222973|102057721|FG002|STARTED|Part 2 (Week 73 to Week 168)||101||
48702860|NCT03222973|102057722|FG003|STARTED|Part 2 (Week 73 to Week 168)||113||
48702861|NCT03222973|102057719|FG000|ITT Population|Part 2 (Week 73 to Week 168)||0||
48702862|NCT03222973|102057720|FG001|ITT Population|Part 2 (Week 73 to Week 168)||0||
48702863|NCT03222973|102057721|FG002|ITT Population|Part 2 (Week 73 to Week 168)||100||
48702864|NCT03222973|102057722|FG003|ITT Population|Part 2 (Week 73 to Week 168)||113||
48702865|NCT03222973|102057719|FG000|Safety Population|Part 2 (Week 73 to Week 168)||0||
48702866|NCT03222973|102057720|FG001|Safety Population|Part 2 (Week 73 to Week 168)||0||
48702867|NCT03222973|102057721|FG002|Safety Population|Part 2 (Week 73 to Week 168)||100||
48702868|NCT03222973|102057722|FG003|Safety Population|Part 2 (Week 73 to Week 168)||113||
48702869|NCT03222973|102057719|FG000|COMPLETED|Part 2 (Week 73 to Week 168)||0||
48702870|NCT03222973|102057720|FG001|COMPLETED|Part 2 (Week 73 to Week 168)||0||
48702871|NCT03222973|102057721|FG002|COMPLETED|Part 2 (Week 73 to Week 168)||0||
48702872|NCT03222973|102057722|FG003|COMPLETED|Part 2 (Week 73 to Week 168)||0||
48702873|NCT03222973|102057719|FG000|NOT COMPLETED|Part 2 (Week 73 to Week 168)||0||
48702874|NCT03222973|102057720|FG001|NOT COMPLETED|Part 2 (Week 73 to Week 168)||0||
48702875|NCT03222973|102057721|FG002|NOT COMPLETED|Part 2 (Week 73 to Week 168)||101||
48702876|NCT03222973|102057722|FG003|NOT COMPLETED|Part 2 (Week 73 to Week 168)||113||
48702877|NCT04452435|102057723|FG000|STARTED|Screening||51||
48702878|NCT04452435|102057724|FG001|STARTED|Screening||55||
48702879|NCT04452435|102057723|FG000|COMPLETED|Screening||51||
48702880|NCT04452435|102057724|FG001|COMPLETED|Screening||55||
48702881|NCT04452435|102057723|FG000|NOT COMPLETED|Screening||0||
48702882|NCT04452435|102057724|FG001|NOT COMPLETED|Screening||0||
48702883|NCT04452435|102057723|FG000|STARTED|Treatment Period||51||
48702884|NCT04452435|102057724|FG001|STARTED|Treatment Period||55||
48702885|NCT04452435|102057723|FG000|COMPLETED|Treatment Period||45||
48702886|NCT04452435|102057724|FG001|COMPLETED|Treatment Period||43||
48702887|NCT04452435|102057723|FG000|NOT COMPLETED|Treatment Period||6||
48702888|NCT04452435|102057724|FG001|NOT COMPLETED|Treatment Period||12||
48132888|NCT01203189|100648588|FG002|STARTED|Cross Over Period 4 Weeks Treatment||3||
48132889|NCT01203189|100648586|FG000|COMPLETED|Cross Over Period 4 Weeks Treatment||0||
48132890|NCT01203189|100648587|FG001|COMPLETED|Cross Over Period 4 Weeks Treatment||0||
48399922|NCT02758119|101309250|FG001|COMPLETED|Overall Study||40||
48702889|NCT04452435|102057723|FG000|STARTED|Follow-up||45||
48702890|NCT04452435|102057724|FG001|STARTED|Follow-up||43||
48702891|NCT04452435|102057723|FG000|COMPLETED|Follow-up||45||
48702892|NCT04452435|102057724|FG001|COMPLETED|Follow-up||42||
48702893|NCT04452435|102057723|FG000|NOT COMPLETED|Follow-up||0||
48702894|NCT04452435|102057724|FG001|NOT COMPLETED|Follow-up||1||
48702895|NCT01257230|102057725|FG000|STARTED|Overall Study||138||
48702896|NCT01257230|102057726|FG001|STARTED|Overall Study||125||
48702897|NCT01257230|102057727|FG002|STARTED|Overall Study||135||
48702898|NCT01257230|102057725|FG000|COMPLETED|Overall Study||132||
48702899|NCT01257230|102057726|FG001|COMPLETED|Overall Study||115||
48399923|NCT02758119|101309249|FG000|NOT COMPLETED|Overall Study||2||
48399924|NCT02758119|101309250|FG001|NOT COMPLETED|Overall Study||1||
48399925|NCT03970824|101309251|FG000|STARTED|Overall Study||103||
48399926|NCT03970824|101309252|FG001|STARTED|Overall Study||103||
48577079|NCT00814333|101744683|FG000|COMPLETED|Treatment Period||0||
48399927|NCT03970824|101309253|FG002|STARTED|Overall Study||106||
48399928|NCT03970824|101309251|FG000|COMPLETED|Overall Study||101||
48577080|NCT00814333|101744684|FG001|COMPLETED|Treatment Period||0||
48577081|NCT00814333|101744683|FG000|NOT COMPLETED|Treatment Period||0||
48577082|NCT00814333|101744684|FG001|NOT COMPLETED|Treatment Period||0||
48577083|NCT00582816|101744685|FG000|STARTED|Overall Study||9||
48577084|NCT00582816|101744685|FG000|COMPLETED|Overall Study||6||
48577085|NCT00582816|101744685|FG000|NOT COMPLETED|Overall Study||3||
48577086|NCT01011465|101744686|FG000|STARTED|Overall Study||36||
48577087|NCT01011465|101744687|FG001|STARTED|Overall Study||20||
48132891|NCT01203189|100648588|FG002|COMPLETED|Cross Over Period 4 Weeks Treatment||3||
48132892|NCT01203189|100648586|FG000|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0||
48132893|NCT01203189|100648587|FG001|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0||
48132894|NCT01203189|100648588|FG002|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0||
48132895|NCT01308580|100648589|FG000|STARTED|Overall Study||598||
48132896|NCT01308580|100648590|FG001|STARTED|Overall Study||602||
48577088|NCT01011465|101744688|FG002|STARTED|Overall Study||36||
48577089|NCT01011465|101744689|FG003|STARTED|Overall Study||18||
48577090|NCT01011465|101744690|FG004|STARTED|Overall Study||47||
48577091|NCT01011465|101744691|FG005|STARTED|Overall Study||29||
48577092|NCT01011465|101744692|FG006|STARTED|Overall Study||52||
48577093|NCT01011465|101744693|FG007|STARTED|Overall Study||32||
48577094|NCT01011465|101744686|FG000|COMPLETED|Overall Study||34||
48577095|NCT01011465|101744687|FG001|COMPLETED|Overall Study||19||
48577096|NCT01011465|101744688|FG002|COMPLETED|Overall Study||36||
48577097|NCT01011465|101744689|FG003|COMPLETED|Overall Study||18||
48132897|NCT01308580|100648589|FG000|Treated|Overall Study||587||
48132898|NCT01308580|100648590|FG001|Treated|Overall Study||588||
48132899|NCT01308580|100648589|FG000|COMPLETED|Overall Study||586||
48132900|NCT01308580|100648590|FG001|COMPLETED|Overall Study||595||
48132901|NCT01308580|100648589|FG000|NOT COMPLETED|Overall Study||12||
48132902|NCT01308580|100648590|FG001|NOT COMPLETED|Overall Study||7||
48132903|NCT02802345|100648591|FG000|STARTED|Overall Study||136||
48286160|NCT03075410|101026270|FG002|NOT COMPLETED|Part A-Period 2 (14 Days)||1||
48286161|NCT03075410|101026271|FG003|NOT COMPLETED|Part A-Period 2 (14 Days)||0||
48286162|NCT03075410|101026272|FG004|NOT COMPLETED|Part A-Period 2 (14 Days)||0||
48286163|NCT03075410|101026273|FG005|NOT COMPLETED|Part A-Period 2 (14 Days)||0||
48286164|NCT03075410|101026274|FG006|NOT COMPLETED|Part A-Period 2 (14 Days)||0||
48286165|NCT03075410|101026275|FG007|NOT COMPLETED|Part A-Period 2 (14 Days)||0||
48286166|NCT03075410|101026276|FG008|NOT COMPLETED|Part A-Period 2 (14 Days)||0||
48286167|NCT03075410|101026268|FG000|STARTED|Part A-Washout Period 2 (14 Days)||1||
48286168|NCT03075410|101026269|FG001|STARTED|Part A-Washout Period 2 (14 Days)||1||
48286169|NCT03075410|101026270|FG002|STARTED|Part A-Washout Period 2 (14 Days)||1||
48286170|NCT03075410|101026271|FG003|STARTED|Part A-Washout Period 2 (14 Days)||1||
48286171|NCT03075410|101026272|FG004|STARTED|Part A-Washout Period 2 (14 Days)||2||
48286172|NCT03075410|101026273|FG005|STARTED|Part A-Washout Period 2 (14 Days)||1||
48286173|NCT03075410|101026274|FG006|STARTED|Part A-Washout Period 2 (14 Days)||0||
48286174|NCT03075410|101026275|FG007|STARTED|Part A-Washout Period 2 (14 Days)||0||
48286175|NCT03075410|101026276|FG008|STARTED|Part A-Washout Period 2 (14 Days)||0||
48286176|NCT03075410|101026268|FG000|COMPLETED|Part A-Washout Period 2 (14 Days)||1||
48286177|NCT03075410|101026269|FG001|COMPLETED|Part A-Washout Period 2 (14 Days)||1||
48286178|NCT03075410|101026270|FG002|COMPLETED|Part A-Washout Period 2 (14 Days)||1||
48286179|NCT03075410|101026271|FG003|COMPLETED|Part A-Washout Period 2 (14 Days)||1||
48399929|NCT03970824|101309252|FG001|COMPLETED|Overall Study||100||
48577098|NCT01011465|101744690|FG004|COMPLETED|Overall Study||46||
48577099|NCT01011465|101744691|FG005|COMPLETED|Overall Study||29||
48577100|NCT01011465|101744692|FG006|COMPLETED|Overall Study||51||
48577101|NCT01011465|101744693|FG007|COMPLETED|Overall Study||32||
48577102|NCT01011465|101744686|FG000|NOT COMPLETED|Overall Study||2||
48577103|NCT01011465|101744687|FG001|NOT COMPLETED|Overall Study||1||
48577104|NCT01011465|101744688|FG002|NOT COMPLETED|Overall Study||0||
48577105|NCT01011465|101744689|FG003|NOT COMPLETED|Overall Study||0||
48577106|NCT01011465|101744690|FG004|NOT COMPLETED|Overall Study||1||
48577107|NCT01011465|101744691|FG005|NOT COMPLETED|Overall Study||0||
48577108|NCT01011465|101744692|FG006|NOT COMPLETED|Overall Study||1||
48577109|NCT01011465|101744693|FG007|NOT COMPLETED|Overall Study||0||
48577110|NCT00744965|101744694|FG000|STARTED|Overall Study||197||
48577111|NCT00744965|101744695|FG001|STARTED|Overall Study||198||
48577112|NCT00744965|101744694|FG000|COMPLETED|Overall Study||186||
48577113|NCT00744965|101744695|FG001|COMPLETED|Overall Study||189||
48577114|NCT00744965|101744694|FG000|NOT COMPLETED|Overall Study||11||
48577115|NCT00744965|101744695|FG001|NOT COMPLETED|Overall Study||9||
48577116|NCT04553471|101744696|FG000|STARTED|Overall Study||70||
48577117|NCT04553471|101744696|FG000|COMPLETED|Overall Study||66||
48577118|NCT04553471|101744696|FG000|NOT COMPLETED|Overall Study||4||
48577119|NCT03728348|101744697|FG000|STARTED|Overall Study||983||
48577120|NCT03728348|101744697|FG000|Did Not Complete Study Procedures|Overall Study||107||
48577121|NCT03728348|101744697|FG000|Multi-target DNA Test Excluded|Overall Study||15||
48577122|NCT03728348|101744697|FG000|Colonoscopy Excluded|Overall Study||19||
48577123|NCT03728348|101744697|FG000|COMPLETED|Overall Study||842||
48577124|NCT03728348|101744697|FG000|NOT COMPLETED|Overall Study||141||
48577125|NCT03224598|101744698|FG000|STARTED|Overall Study||9||
48577126|NCT03224598|101744699|FG001|STARTED|Overall Study||17||
48577127|NCT03224598|101744700|FG002|STARTED|Overall Study||13||
48577128|NCT03224598|101744698|FG000|COMPLETED|Overall Study||9||
48577129|NCT03224598|101744699|FG001|COMPLETED|Overall Study||14||
48577130|NCT03224598|101744700|FG002|COMPLETED|Overall Study||13||
48577131|NCT03224598|101744698|FG000|NOT COMPLETED|Overall Study||0||
48577132|NCT03224598|101744699|FG001|NOT COMPLETED|Overall Study||3||
48577133|NCT03224598|101744700|FG002|NOT COMPLETED|Overall Study||0||
48577134|NCT03821259|101744701|FG000|STARTED|Overall Study||88||
48577135|NCT03821259|101744701|FG000|COMPLETED|Overall Study||88||
48577136|NCT03821259|101744701|FG000|NOT COMPLETED|Overall Study||0||
48577137|NCT02783469|101744702|FG000|STARTED|Overall Study||1915||
48577138|NCT02783469|101744702|FG000|COMPLETED|Overall Study||1915||
48577139|NCT02783469|101744702|FG000|NOT COMPLETED|Overall Study||0||
48577140|NCT00627445|101744703|FG000|STARTED|Overall Study||219||
48577141|NCT00627445|101744704|FG001|STARTED|Overall Study||222||
48577142|NCT00627445|101744703|FG000|Exposed to Study Drug|Overall Study||219||
48577143|NCT00627445|101744704|FG001|Exposed to Study Drug|Overall Study||222||
48577144|NCT00627445|101744703|FG000|COMPLETED|Overall Study||210||
48577145|NCT00627445|101744704|FG001|COMPLETED|Overall Study||210||
48577146|NCT00627445|101744703|FG000|NOT COMPLETED|Overall Study||9||
48577147|NCT00627445|101744704|FG001|NOT COMPLETED|Overall Study||12||
48577148|NCT00685399|101744705|FG000|STARTED|Treatment Period 1||16||
48577149|NCT00685399|101744706|FG001|STARTED|Treatment Period 1||0||
48577150|NCT00685399|101744707|FG002|STARTED|Treatment Period 1||0||
48577151|NCT00685399|101744708|FG003|STARTED|Treatment Period 1||0||
48577152|NCT00685399|101744709|FG004|STARTED|Treatment Period 1||0||
48577153|NCT00685399|101744710|FG005|STARTED|Treatment Period 1||0||
48702900|NCT01257230|102057727|FG002|COMPLETED|Overall Study||129||
48702901|NCT01257230|102057725|FG000|NOT COMPLETED|Overall Study||6||
48702902|NCT01257230|102057726|FG001|NOT COMPLETED|Overall Study||10||
48702903|NCT01257230|102057727|FG002|NOT COMPLETED|Overall Study||6||
48577154|NCT00685399|101744711|FG006|STARTED|Treatment Period 1||0||
48577155|NCT00685399|101744712|FG007|STARTED|Treatment Period 1||0||
48577156|NCT00685399|101744705|FG000|COMPLETED|Treatment Period 1||10||
48577157|NCT00685399|101744706|FG001|COMPLETED|Treatment Period 1||0||
48577158|NCT00685399|101744707|FG002|COMPLETED|Treatment Period 1||0||
48577159|NCT00685399|101744708|FG003|COMPLETED|Treatment Period 1||0||
48577160|NCT00685399|101744709|FG004|COMPLETED|Treatment Period 1||0||
48577161|NCT00685399|101744710|FG005|COMPLETED|Treatment Period 1||0||
48577162|NCT00685399|101744711|FG006|COMPLETED|Treatment Period 1||0||
48577163|NCT00685399|101744712|FG007|COMPLETED|Treatment Period 1||0||
48577164|NCT00685399|101744705|FG000|NOT COMPLETED|Treatment Period 1||6||
48577165|NCT00685399|101744706|FG001|NOT COMPLETED|Treatment Period 1||0||
48577166|NCT00685399|101744707|FG002|NOT COMPLETED|Treatment Period 1||0||
48577167|NCT00685399|101744708|FG003|NOT COMPLETED|Treatment Period 1||0||
48577168|NCT00685399|101744709|FG004|NOT COMPLETED|Treatment Period 1||0||
48577169|NCT00685399|101744710|FG005|NOT COMPLETED|Treatment Period 1||0||
48577170|NCT00685399|101744711|FG006|NOT COMPLETED|Treatment Period 1||0||
48577171|NCT00685399|101744712|FG007|NOT COMPLETED|Treatment Period 1||0||
48577172|NCT00685399|101744705|FG000|STARTED|Treatment Period 2||0||
48577173|NCT00685399|101744706|FG001|STARTED|Treatment Period 2||14||
48577174|NCT00685399|101744707|FG002|STARTED|Treatment Period 2||5||
48577175|NCT00685399|101744708|FG003|STARTED|Treatment Period 2||0||
48577176|NCT00685399|101744709|FG004|STARTED|Treatment Period 2||4||
48577177|NCT00685399|101744710|FG005|STARTED|Treatment Period 2||12||
48577178|NCT00685399|101744711|FG006|STARTED|Treatment Period 2||13||
48399930|NCT03970824|101309253|FG002|COMPLETED|Overall Study||102||
48399931|NCT03970824|101309251|FG000|NOT COMPLETED|Overall Study||2||
48399932|NCT03970824|101309252|FG001|NOT COMPLETED|Overall Study||3||
48399933|NCT03970824|101309253|FG002|NOT COMPLETED|Overall Study||4||
48399934|NCT00493467|101309254|FG000|STARTED|Overall Study||31||
48399935|NCT00493467|101309254|FG000|COMPLETED|Overall Study||30||
48399936|NCT00493467|101309254|FG000|NOT COMPLETED|Overall Study||1||
48577179|NCT00685399|101744712|FG007|STARTED|Treatment Period 2||12||
48577180|NCT00685399|101744705|FG000|COMPLETED|Treatment Period 2||0||
48577181|NCT00685399|101744706|FG001|COMPLETED|Treatment Period 2||2||
48577182|NCT00685399|101744707|FG002|COMPLETED|Treatment Period 2||2||
48577183|NCT00685399|101744708|FG003|COMPLETED|Treatment Period 2||0||
48577184|NCT00685399|101744709|FG004|COMPLETED|Treatment Period 2||4||
48577185|NCT00685399|101744710|FG005|COMPLETED|Treatment Period 2||10||
48577186|NCT00685399|101744711|FG006|COMPLETED|Treatment Period 2||13||
48577187|NCT00685399|101744712|FG007|COMPLETED|Treatment Period 2||10||
48577188|NCT00685399|101744705|FG000|NOT COMPLETED|Treatment Period 2||0||
48577189|NCT00685399|101744706|FG001|NOT COMPLETED|Treatment Period 2||12||
48577190|NCT00685399|101744707|FG002|NOT COMPLETED|Treatment Period 2||3||
48577191|NCT00685399|101744708|FG003|NOT COMPLETED|Treatment Period 2||0||
48577192|NCT00685399|101744709|FG004|NOT COMPLETED|Treatment Period 2||0||
48577193|NCT00685399|101744710|FG005|NOT COMPLETED|Treatment Period 2||2||
48577194|NCT00685399|101744711|FG006|NOT COMPLETED|Treatment Period 2||0||
48577195|NCT00685399|101744712|FG007|NOT COMPLETED|Treatment Period 2||2||
48577196|NCT00685399|101744705|FG000|STARTED|Extension||0||
48702904|NCT00433160|102057728|FG000|STARTED|52-Week Double-Blind (DB) Period||137||
48702905|NCT00433160|102057729|FG001|STARTED|52-Week Double-Blind (DB) Period||70||
48702906|NCT00433160|102057728|FG000|Received Treatment|52-Week Double-Blind (DB) Period||136||
48702907|NCT00433160|102057729|FG001|Received Treatment|52-Week Double-Blind (DB) Period||68||
48702908|NCT00433160|102057728|FG000|COMPLETED|52-Week Double-Blind (DB) Period||120||
48702909|NCT00433160|102057729|FG001|COMPLETED|52-Week Double-Blind (DB) Period||60||
48702910|NCT00433160|102057728|FG000|NOT COMPLETED|52-Week Double-Blind (DB) Period||17||
48702911|NCT00433160|102057729|FG001|NOT COMPLETED|52-Week Double-Blind (DB) Period||10||
48702912|NCT00433160|102057728|FG000|STARTED|76 Weeks, 24-Week Open Label (OL) Period||119||
48702913|NCT00433160|102057729|FG001|STARTED|76 Weeks, 24-Week Open Label (OL) Period||59||
48399937|NCT01437267|101309255|FG000|STARTED|Overall Study||20||
48399938|NCT01437267|101309256|FG001|STARTED|Overall Study||20||
48399939|NCT01437267|101309257|FG002|STARTED|Overall Study||20||
48399940|NCT01437267|101309258|FG003|STARTED|Overall Study||20||
48577197|NCT00685399|101744706|FG001|STARTED|Extension||0||
48577198|NCT00685399|101744707|FG002|STARTED|Extension||0||
48702914|NCT00433160|102057728|FG000|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||119||
48702915|NCT00433160|102057729|FG001|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||59||
48399941|NCT01437267|101309259|FG004|STARTED|Overall Study||20||
48399942|NCT01437267|101309260|FG005|STARTED|Overall Study||20||
48399943|NCT01437267|101309255|FG000|COMPLETED|Overall Study||20||
48399944|NCT01437267|101309256|FG001|COMPLETED|Overall Study||19||
48399945|NCT01437267|101309257|FG002|COMPLETED|Overall Study||20||
48399946|NCT01437267|101309258|FG003|COMPLETED|Overall Study||19||
48399947|NCT01437267|101309259|FG004|COMPLETED|Overall Study||20||
48399948|NCT01437267|101309260|FG005|COMPLETED|Overall Study||20||
48399949|NCT01437267|101309255|FG000|NOT COMPLETED|Overall Study||0||
48399950|NCT01437267|101309256|FG001|NOT COMPLETED|Overall Study||1||
48399951|NCT01437267|101309257|FG002|NOT COMPLETED|Overall Study||0||
48399952|NCT01437267|101309258|FG003|NOT COMPLETED|Overall Study||1||
48399953|NCT01437267|101309259|FG004|NOT COMPLETED|Overall Study||0||
48399954|NCT01437267|101309260|FG005|NOT COMPLETED|Overall Study||0||
48399955|NCT04206670|101309261|FG000|STARTED|Overall Study||148||
48399956|NCT04206670|101309262|FG001|STARTED|Overall Study||68||
48577199|NCT00685399|101744708|FG003|STARTED|Extension||28||
48702916|NCT00433160|102057728|FG000|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||113||
48399957|NCT04206670|101309261|FG000|COMPLETED|Overall Study||124||
48399958|NCT04206670|101309262|FG001|COMPLETED|Overall Study||65||
48399959|NCT04206670|101309261|FG000|NOT COMPLETED|Overall Study||24||
48399960|NCT04206670|101309262|FG001|NOT COMPLETED|Overall Study||3||
48399961|NCT00915538|101309263|FG000|STARTED|Overall Study||8||
48577200|NCT00685399|101744709|FG004|STARTED|Extension||0||
48702917|NCT00433160|102057729|FG001|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||55||
48702918|NCT00433160|102057728|FG000|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||6||
48702919|NCT00433160|102057729|FG001|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||4||
48702920|NCT00433160|102057728|FG000|STARTED|104 Weeks, 28-Week OL Period||102||
48132904|NCT02802345|100648592|FG001|STARTED|Overall Study||138||
48132905|NCT02802345|100648591|FG000|Treated|Overall Study||136||
48577201|NCT00685399|101744710|FG005|STARTED|Extension||0||
48577202|NCT00685399|101744711|FG006|STARTED|Extension||0||
48702921|NCT00433160|102057729|FG001|STARTED|104 Weeks, 28-Week OL Period||50||
48132906|NCT02802345|100648592|FG001|Treated|Overall Study||137||
48132907|NCT02802345|100648591|FG000|COMPLETED|Overall Study||104|Completed Nintedanib treatment|
48132908|NCT02802345|100648592|FG001|COMPLETED|Overall Study||108|Completed Nintedanib treatment|
48132909|NCT02802345|100648591|FG000|NOT COMPLETED|Overall Study||32||
48132910|NCT02802345|100648592|FG001|NOT COMPLETED|Overall Study||30||
48132911|NCT01389973|100648593|FG000|STARTED|Overall Study||20||
48399962|NCT00915538|101309264|FG001|STARTED|Overall Study||8||
48399963|NCT00915538|101309263|FG000|COMPLETED|Overall Study||8||
48399964|NCT00915538|101309264|FG001|COMPLETED|Overall Study||8||
48399965|NCT00915538|101309263|FG000|NOT COMPLETED|Overall Study||0||
48399966|NCT00915538|101309264|FG001|NOT COMPLETED|Overall Study||0||
48399967|NCT02527564|101309265|FG000|STARTED|Double-blind Phase (1 Week)||23||
48399968|NCT02527564|101309266|FG001|STARTED|Double-blind Phase (1 Week)||25||
48399969|NCT02527564|101309267|FG002|STARTED|Double-blind Phase (1 Week)||0||
48399970|NCT02527564|101309265|FG000|Received Allocated Intervention|Double-blind Phase (1 Week)||19||
48399971|NCT02527564|101309266|FG001|Received Allocated Intervention|Double-blind Phase (1 Week)||17||
48399972|NCT02527564|101309267|FG002|Received Allocated Intervention|Double-blind Phase (1 Week)||0||
48399973|NCT02527564|101309265|FG000|COMPLETED|Double-blind Phase (1 Week)||22||
48399974|NCT02527564|101309266|FG001|COMPLETED|Double-blind Phase (1 Week)||24||
48399975|NCT02527564|101309267|FG002|COMPLETED|Double-blind Phase (1 Week)||0||
48399976|NCT02527564|101309265|FG000|NOT COMPLETED|Double-blind Phase (1 Week)||1||
48399977|NCT02527564|101309266|FG001|NOT COMPLETED|Double-blind Phase (1 Week)||1||
48399978|NCT02527564|101309267|FG002|NOT COMPLETED|Double-blind Phase (1 Week)||0||
48399979|NCT02527564|101309265|FG000|STARTED|Open-label Phase (3 Months)||0||
48399980|NCT02527564|101309266|FG001|STARTED|Open-label Phase (3 Months)||0||
48399981|NCT02527564|101309267|FG002|STARTED|Open-label Phase (3 Months)||46||
48399982|NCT02527564|101309265|FG000|COMPLETED|Open-label Phase (3 Months)||0||
48399983|NCT02527564|101309266|FG001|COMPLETED|Open-label Phase (3 Months)||0||
48399984|NCT02527564|101309267|FG002|COMPLETED|Open-label Phase (3 Months)||26||
48399985|NCT02527564|101309265|FG000|NOT COMPLETED|Open-label Phase (3 Months)||0||
48399986|NCT02527564|101309266|FG001|NOT COMPLETED|Open-label Phase (3 Months)||0||
48399987|NCT02527564|101309267|FG002|NOT COMPLETED|Open-label Phase (3 Months)||20||
48399988|NCT00981682|101309268|FG000|STARTED|Overall Study||376||
48399989|NCT00981682|101309268|FG000|COMPLETED|Overall Study||234||
48399990|NCT00981682|101309268|FG000|NOT COMPLETED|Overall Study||142||
48399991|NCT03927911|101309269|FG000|STARTED|Overall Study||0||
48399992|NCT03927911|101309270|FG001|STARTED|Overall Study||17||
48399993|NCT03927911|101309271|FG002|STARTED|Overall Study||0||
48399994|NCT03927911|101309272|FG003|STARTED|Overall Study||3||
48399995|NCT03927911|101309273|FG004|STARTED|Overall Study||13||
48399996|NCT03927911|101309274|FG005|STARTED|Overall Study||32||
48399997|NCT03927911|101309269|FG000|COMPLETED|Overall Study||0||
48399998|NCT03927911|101309270|FG001|COMPLETED|Overall Study||15||
48577203|NCT00685399|101744712|FG007|STARTED|Extension||0||
48132912|NCT01389973|100648593|FG000|COMPLETED|Overall Study||0||
48132913|NCT01389973|100648593|FG000|NOT COMPLETED|Overall Study||20||
48132914|NCT01760954|100648594|FG000|STARTED|Treatment Period (6 Months)||149||
48132915|NCT01760954|100648595|FG001|STARTED|Treatment Period (6 Months)||138||
48132916|NCT01760954|100648596|FG002|STARTED|Treatment Period (6 Months)||108||
48132917|NCT01760954|100648597|FG003|STARTED|Treatment Period (6 Months)||109||
48132918|NCT01760954|100648594|FG000|COMPLETED|Treatment Period (6 Months)||116||
48132919|NCT01760954|100648595|FG001|COMPLETED|Treatment Period (6 Months)||110||
48132920|NCT01760954|100648596|FG002|COMPLETED|Treatment Period (6 Months)||87||
48132921|NCT01760954|100648597|FG003|COMPLETED|Treatment Period (6 Months)||83||
48132922|NCT01760954|100648594|FG000|NOT COMPLETED|Treatment Period (6 Months)||33||
48132923|NCT01760954|100648595|FG001|NOT COMPLETED|Treatment Period (6 Months)||28||
48132924|NCT01760954|100648596|FG002|NOT COMPLETED|Treatment Period (6 Months)||21||
48132925|NCT01760954|100648597|FG003|NOT COMPLETED|Treatment Period (6 Months)||26||
48132926|NCT01760954|100648594|FG000|STARTED|Post-treatment Follow-up (12 Months)||126|Participants who completed the 6-month Treatment Period or prematurely discontinued could enter PTFU|
48132927|NCT01760954|100648595|FG001|STARTED|Post-treatment Follow-up (12 Months)||118|Participants who completed the 6-month Treatment Period or prematurely discontinued could enter PTFU|
48141441|NCT01780922|100670428|FG005|NOT COMPLETED|First Intervention (1 Day)||0||
48141442|NCT01780922|100670423|FG000|STARTED|Washout (7 Days)||2||
48399999|NCT03927911|101309271|FG002|COMPLETED|Overall Study||0||
48400000|NCT03927911|101309272|FG003|COMPLETED|Overall Study||1||
48400001|NCT03927911|101309273|FG004|COMPLETED|Overall Study||13||
48577204|NCT00685399|101744705|FG000|COMPLETED|Extension||0||
48577205|NCT00685399|101744706|FG001|COMPLETED|Extension||0||
48132928|NCT01760954|100648596|FG002|STARTED|Post-treatment Follow-up (12 Months)||86|Participants who completed the 6-month Treatment Period or prematurely discontinued could enter PTFU|
48132929|NCT01760954|100648597|FG003|STARTED|Post-treatment Follow-up (12 Months)||87|Participants who completed the 6-month Treatment Period or prematurely discontinued could enter PTFU|
48132930|NCT01760954|100648594|FG000|COMPLETED|Post-treatment Follow-up (12 Months)||96||
48400002|NCT03927911|101309274|FG005|COMPLETED|Overall Study||25||
48400003|NCT03927911|101309269|FG000|NOT COMPLETED|Overall Study||0||
48400004|NCT03927911|101309270|FG001|NOT COMPLETED|Overall Study||2||
48577206|NCT00685399|101744707|FG002|COMPLETED|Extension||0||
48577207|NCT00685399|101744708|FG003|COMPLETED|Extension||21||
48577208|NCT00685399|101744709|FG004|COMPLETED|Extension||0||
48577209|NCT00685399|101744710|FG005|COMPLETED|Extension||0||
48577210|NCT00685399|101744711|FG006|COMPLETED|Extension||0||
48577211|NCT00685399|101744712|FG007|COMPLETED|Extension||0||
48577212|NCT00685399|101744705|FG000|NOT COMPLETED|Extension||0||
48577213|NCT00685399|101744706|FG001|NOT COMPLETED|Extension||0||
48577214|NCT00685399|101744707|FG002|NOT COMPLETED|Extension||0||
48577215|NCT00685399|101744708|FG003|NOT COMPLETED|Extension||7||
48577216|NCT00685399|101744709|FG004|NOT COMPLETED|Extension||0||
48702922|NCT00433160|102057728|FG000|Received Treatment|104 Weeks, 28-Week OL Period||102||
48702923|NCT00433160|102057729|FG001|Received Treatment|104 Weeks, 28-Week OL Period||50||
48702924|NCT00433160|102057728|FG000|COMPLETED|104 Weeks, 28-Week OL Period||92||
48702925|NCT00433160|102057729|FG001|COMPLETED|104 Weeks, 28-Week OL Period||47||
48702926|NCT00433160|102057728|FG000|NOT COMPLETED|104 Weeks, 28-Week OL Period||10||
48702927|NCT00433160|102057729|FG001|NOT COMPLETED|104 Weeks, 28-Week OL Period||3||
48702928|NCT00072293|102057730|FG000|STARTED|Overall Study||465||
48702929|NCT00072293|102057731|FG001|STARTED|Overall Study||469||
48702930|NCT00072293|102057730|FG000|COMPLETED|Overall Study||464||
48132931|NCT01760954|100648595|FG001|COMPLETED|Post-treatment Follow-up (12 Months)||83||
48577217|NCT00685399|101744710|FG005|NOT COMPLETED|Extension||0||
48577218|NCT00685399|101744711|FG006|NOT COMPLETED|Extension||0||
48702931|NCT00072293|102057731|FG001|COMPLETED|Overall Study||467||
48702932|NCT00072293|102057730|FG000|NOT COMPLETED|Overall Study||1||
48702933|NCT00072293|102057731|FG001|NOT COMPLETED|Overall Study||2||
48400005|NCT03927911|101309271|FG002|NOT COMPLETED|Overall Study||0||
48400006|NCT03927911|101309272|FG003|NOT COMPLETED|Overall Study||2||
48702934|NCT00873041|102057732|FG000|STARTED|Core Study||55||
48702935|NCT00873041|102057733|FG001|STARTED|Core Study||55||
48702936|NCT00873041|102057734|FG002|STARTED|Core Study||56||
48702937|NCT00873041|102057732|FG000|COMPLETED|Core Study||48||
48702938|NCT00873041|102057733|FG001|COMPLETED|Core Study||49||
48577219|NCT00685399|101744712|FG007|NOT COMPLETED|Extension||0||
48577220|NCT01371110|101744713|FG000|STARTED|Overall Study||1||
48577221|NCT01371110|101744714|FG001|STARTED|Overall Study||2||
48577222|NCT01371110|101744713|FG000|COMPLETED|Overall Study||1||
48577223|NCT01371110|101744714|FG001|COMPLETED|Overall Study||2||
48702939|NCT00873041|102057734|FG002|COMPLETED|Core Study||51||
48702940|NCT00873041|102057732|FG000|NOT COMPLETED|Core Study||7||
48702941|NCT00873041|102057733|FG001|NOT COMPLETED|Core Study||6||
48702942|NCT00873041|102057734|FG002|NOT COMPLETED|Core Study||5||
48702943|NCT00873041|102057732|FG000|STARTED|Extension Study||41||
48702944|NCT00873041|102057733|FG001|STARTED|Extension Study||44||
48577224|NCT01371110|101744713|FG000|NOT COMPLETED|Overall Study||0||
48577225|NCT01371110|101744714|FG001|NOT COMPLETED|Overall Study||0||
48577226|NCT00427921|101744715|FG000|STARTED|Overall Study||304||
48577227|NCT00427921|101744715|FG000|COMPLETED|Overall Study||254||
48577228|NCT00427921|101744715|FG000|NOT COMPLETED|Overall Study||50||
48577229|NCT02058537|101744716|FG000|STARTED|Overall Study||3||
48577230|NCT02058537|101744716|FG000|COMPLETED|Overall Study||2||
48702945|NCT00873041|102057734|FG002|STARTED|Extension Study||48||
48702946|NCT00873041|102057732|FG000|COMPLETED|Extension Study||40||
48702947|NCT00873041|102057733|FG001|COMPLETED|Extension Study||44||
48702948|NCT00873041|102057734|FG002|COMPLETED|Extension Study||46||
48702949|NCT00873041|102057732|FG000|NOT COMPLETED|Extension Study||1||
48702950|NCT00873041|102057733|FG001|NOT COMPLETED|Extension Study||0||
48702951|NCT00873041|102057734|FG002|NOT COMPLETED|Extension Study||2||
48702952|NCT00290771|102057735|FG000|STARTED|Overall Study||131||
48702953|NCT00290771|102057736|FG001|STARTED|Overall Study||100||
48702954|NCT00290771|102057735|FG000|COMPLETED|Overall Study||4||
48702955|NCT00290771|102057736|FG001|COMPLETED|Overall Study||3||
48702956|NCT00290771|102057735|FG000|NOT COMPLETED|Overall Study||127||
48702957|NCT00290771|102057736|FG001|NOT COMPLETED|Overall Study||97||
48702958|NCT00729677|102057737|FG000|STARTED|Overall Study||64||
48702959|NCT00729677|102057737|FG000|COMPLETED|Overall Study||64||
48702960|NCT00729677|102057737|FG000|NOT COMPLETED|Overall Study||0||
48702961|NCT00470093|102057738|FG000|STARTED|Overall Study||2||
48702962|NCT00470093|102057738|FG000|COMPLETED|Overall Study||0||
48702963|NCT00470093|102057738|FG000|NOT COMPLETED|Overall Study||2||
48702964|NCT01180894|102057739|FG000|STARTED|Overall Study||75||
48702965|NCT01180894|102057740|FG001|STARTED|Overall Study||75||
48702966|NCT01180894|102057739|FG000|COMPLETED|Overall Study||75||
48702967|NCT01180894|102057740|FG001|COMPLETED|Overall Study||75||
48702968|NCT01180894|102057739|FG000|NOT COMPLETED|Overall Study||0||
48702969|NCT01180894|102057740|FG001|NOT COMPLETED|Overall Study||0||
48702970|NCT01443364|102057741|FG000|STARTED|Overall Study||132||
48702971|NCT01443364|102057741|FG000|COMPLETED|Overall Study||91||
48702972|NCT01443364|102057741|FG000|NOT COMPLETED|Overall Study||41||
48702973|NCT00132691|102057742|FG000|STARTED|Overall Study||129||
48702974|NCT00132691|102057743|FG001|STARTED|Overall Study||126||
48702975|NCT00132691|102057742|FG000|COMPLETED|Overall Study||118||
48702976|NCT00132691|102057743|FG001|COMPLETED|Overall Study||114||
48702977|NCT00132691|102057742|FG000|NOT COMPLETED|Overall Study||11||
48702978|NCT00132691|102057743|FG001|NOT COMPLETED|Overall Study||12||
48400007|NCT03927911|101309273|FG004|NOT COMPLETED|Overall Study||0||
48400008|NCT03927911|101309274|FG005|NOT COMPLETED|Overall Study||7||
48400009|NCT00968708|101309275|FG000|STARTED|Overall Study||2679||
48577231|NCT02058537|101744716|FG000|NOT COMPLETED|Overall Study||1||
48400010|NCT00968708|101309276|FG001|STARTED|Overall Study||2701||
48400011|NCT00968708|101309275|FG000|Treated|Overall Study||2676||
48400012|NCT00968708|101309276|FG001|Treated|Overall Study||2698||
48577232|NCT01194999|101744717|FG000|STARTED|Overall Study||132||
48577233|NCT01194999|101744717|FG000|COMPLETED|Overall Study||115||
48577234|NCT01194999|101744717|FG000|NOT COMPLETED|Overall Study||17||
48577235|NCT00555464|101744718|FG000|STARTED|Overall Study||4||
48577236|NCT00555464|101744719|FG001|STARTED|Overall Study||4||
48577237|NCT00555464|101744718|FG000|COMPLETED|Overall Study||4||
48577238|NCT00555464|101744719|FG001|COMPLETED|Overall Study||1||
48577239|NCT00555464|101744718|FG000|NOT COMPLETED|Overall Study||0||
48577240|NCT00555464|101744719|FG001|NOT COMPLETED|Overall Study||3||
48577241|NCT00930774|101744720|FG000|STARTED|Overall Study||25||
48702979|NCT02185014|102057744|FG000|STARTED|Overall Study||252||
48702980|NCT02185014|102057744|FG000|COMPLETED|Overall Study||198||
48702981|NCT02185014|102057744|FG000|NOT COMPLETED|Overall Study||54||
48702982|NCT00294645|102057745|FG000|STARTED|Overall Study||295||
48702983|NCT00294645|102057746|FG001|STARTED|Overall Study||602||
48702984|NCT00294645|102057745|FG000|COMPLETED|Overall Study||247||
48702985|NCT00294645|102057746|FG001|COMPLETED|Overall Study||510||
48702986|NCT00294645|102057745|FG000|NOT COMPLETED|Overall Study||48||
48702987|NCT00294645|102057746|FG001|NOT COMPLETED|Overall Study||92||
48702988|NCT01032954|102057747|FG000|STARTED|Overall Study||30||
48577242|NCT00930774|101744721|FG001|STARTED|Overall Study||25||
48577243|NCT00930774|101744722|FG002|STARTED|Overall Study||24||
48577244|NCT00930774|101744723|FG003|STARTED|Overall Study||25||
48577245|NCT00930774|101744720|FG000|COMPLETED|Overall Study||24||
48577246|NCT00930774|101744721|FG001|COMPLETED|Overall Study||16||
48577247|NCT00930774|101744722|FG002|COMPLETED|Overall Study||22||
48577248|NCT00930774|101744723|FG003|COMPLETED|Overall Study||25||
48577249|NCT00930774|101744720|FG000|NOT COMPLETED|Overall Study||1||
48577250|NCT00930774|101744721|FG001|NOT COMPLETED|Overall Study||9||
48577251|NCT00930774|101744722|FG002|NOT COMPLETED|Overall Study||2||
48577252|NCT00930774|101744723|FG003|NOT COMPLETED|Overall Study||0||
48577253|NCT00459290|101744724|FG000|STARTED|Overall Study||24||
48577254|NCT00459290|101744724|FG000|COMPLETED|Overall Study||19||
48702989|NCT01032954|102057748|FG001|STARTED|Overall Study||30||
48702990|NCT01032954|102057749|FG002|STARTED|Overall Study||30||
48702991|NCT01032954|102057747|FG000|COMPLETED|Overall Study||26||
48702992|NCT01032954|102057748|FG001|COMPLETED|Overall Study||29||
48702993|NCT01032954|102057749|FG002|COMPLETED|Overall Study||30||
48702994|NCT01032954|102057747|FG000|NOT COMPLETED|Overall Study||4||
48577255|NCT00459290|101744724|FG000|NOT COMPLETED|Overall Study||5||
48577256|NCT03219840|101744725|FG000|STARTED|Overall Study||38||
48577257|NCT03219840|101744726|FG001|STARTED|Overall Study||31||
48577258|NCT03219840|101744725|FG000|Day 1 Visit for 1st Period|Overall Study||37||
48577259|NCT03219840|101744726|FG001|Day 1 Visit for 1st Period|Overall Study||31||
48577260|NCT03219840|101744725|FG000|1st Intervention Period of 21 Days|Overall Study||34||
48577261|NCT03219840|101744726|FG001|1st Intervention Period of 21 Days|Overall Study||31||
48577262|NCT03219840|101744725|FG000|Day 22 Visit for 1st Period|Overall Study||34||
48577263|NCT03219840|101744726|FG001|Day 22 Visit for 1st Period|Overall Study||31||
48577264|NCT03219840|101744725|FG000|Washout Period of 21 Days|Overall Study||34||
48577265|NCT03219840|101744726|FG001|Washout Period of 21 Days|Overall Study||31||
48577266|NCT03219840|101744725|FG000|Day 1 Visit for 2nd Period|Overall Study||34||
48577267|NCT03219840|101744726|FG001|Day 1 Visit for 2nd Period|Overall Study||31||
48577268|NCT03219840|101744725|FG000|2nd Intervention Period of 21 Days|Overall Study||34||
48577269|NCT03219840|101744726|FG001|2nd Intervention Period of 21 Days|Overall Study||31||
48577270|NCT03219840|101744725|FG000|Day 22 Visit for 2nd Period|Overall Study||34||
48577271|NCT03219840|101744726|FG001|Day 22 Visit for 2nd Period|Overall Study||31||
48577272|NCT03219840|101744725|FG000|COMPLETED|Overall Study||34||
48577273|NCT03219840|101744726|FG001|COMPLETED|Overall Study||31||
48577274|NCT03219840|101744725|FG000|NOT COMPLETED|Overall Study||4||
48577275|NCT03219840|101744726|FG001|NOT COMPLETED|Overall Study||0||
48577276|NCT01334827|101744727|FG000|STARTED|Overall Study||48||
48577277|NCT01334827|101744727|FG000|COMPLETED|Overall Study||48||
48577278|NCT01334827|101744727|FG000|NOT COMPLETED|Overall Study||0||
48577279|NCT03451591|101744728|FG000|STARTED|Randomisation||90||
48577280|NCT03451591|101744729|FG001|STARTED|Randomisation||91||
48577281|NCT03451591|101744730|FG002|STARTED|Randomisation||91||
48702995|NCT01032954|102057748|FG001|NOT COMPLETED|Overall Study||1||
48702996|NCT01032954|102057749|FG002|NOT COMPLETED|Overall Study||0||
48702997|NCT03466099|102057750|FG000|STARTED|Overall Study||41||
48702998|NCT03466099|102057751|FG001|STARTED|Overall Study||44||
48702999|NCT03466099|102057752|FG002|STARTED|Overall Study||45||
48703000|NCT03466099|102057750|FG000|Treated|Overall Study||41||
48703001|NCT03466099|102057751|FG001|Treated|Overall Study||44||
48703002|NCT03466099|102057752|FG002|Treated|Overall Study||44||
48703003|NCT03466099|102057750|FG000|COMPLETED|Overall Study||24||
48577282|NCT03451591|101744731|FG003|STARTED|Randomisation||91||
48577283|NCT03451591|101744728|FG000|COMPLETED|Randomisation||90||
48577284|NCT03451591|101744729|FG001|COMPLETED|Randomisation||91||
48577285|NCT03451591|101744730|FG002|COMPLETED|Randomisation||91||
48577286|NCT03451591|101744731|FG003|COMPLETED|Randomisation||91||
48577287|NCT03451591|101744728|FG000|NOT COMPLETED|Randomisation||0||
48577288|NCT03451591|101744729|FG001|NOT COMPLETED|Randomisation||0||
48577289|NCT03451591|101744730|FG002|NOT COMPLETED|Randomisation||0||
48577290|NCT03451591|101744731|FG003|NOT COMPLETED|Randomisation||0||
48577291|NCT03451591|101744728|FG000|STARTED|SAE Reporting - Exposure to IMP||181||
48577292|NCT03451591|101744729|FG001|STARTED|SAE Reporting - Exposure to IMP||182||
48577293|NCT03451591|101744730|FG002|STARTED|SAE Reporting - Exposure to IMP||91||
48577294|NCT03451591|101744731|FG003|STARTED|SAE Reporting - Exposure to IMP||91||
48703004|NCT03466099|102057751|FG001|COMPLETED|Overall Study||30||
48703005|NCT03466099|102057752|FG002|COMPLETED|Overall Study||28||
48577295|NCT03451591|101744728|FG000|COMPLETED|SAE Reporting - Exposure to IMP||181||
48577296|NCT03451591|101744729|FG001|COMPLETED|SAE Reporting - Exposure to IMP||182||
48703006|NCT03466099|102057750|FG000|NOT COMPLETED|Overall Study||17||
48577297|NCT03451591|101744730|FG002|COMPLETED|SAE Reporting - Exposure to IMP||91||
48577298|NCT03451591|101744731|FG003|COMPLETED|SAE Reporting - Exposure to IMP||91||
48577299|NCT03451591|101744728|FG000|NOT COMPLETED|SAE Reporting - Exposure to IMP||0||
48577300|NCT03451591|101744729|FG001|NOT COMPLETED|SAE Reporting - Exposure to IMP||0||
48577301|NCT03451591|101744730|FG002|NOT COMPLETED|SAE Reporting - Exposure to IMP||0||
48577302|NCT03451591|101744731|FG003|NOT COMPLETED|SAE Reporting - Exposure to IMP||0||
48577303|NCT03451591|101744728|FG000|STARTED|Randomisation to 12 Month Follow Up||90||
48577304|NCT03451591|101744729|FG001|STARTED|Randomisation to 12 Month Follow Up||91||
48577305|NCT03451591|101744730|FG002|STARTED|Randomisation to 12 Month Follow Up||91||
48577306|NCT03451591|101744731|FG003|STARTED|Randomisation to 12 Month Follow Up||91||
48577307|NCT03451591|101744728|FG000|COMPLETED|Randomisation to 12 Month Follow Up||70||
48577308|NCT03451591|101744729|FG001|COMPLETED|Randomisation to 12 Month Follow Up||70||
48577309|NCT03451591|101744730|FG002|COMPLETED|Randomisation to 12 Month Follow Up||81||
48577310|NCT03451591|101744731|FG003|COMPLETED|Randomisation to 12 Month Follow Up||87||
48577311|NCT03451591|101744728|FG000|NOT COMPLETED|Randomisation to 12 Month Follow Up||20||
48577312|NCT03451591|101744729|FG001|NOT COMPLETED|Randomisation to 12 Month Follow Up||21||
48577313|NCT03451591|101744730|FG002|NOT COMPLETED|Randomisation to 12 Month Follow Up||10||
48577314|NCT03451591|101744731|FG003|NOT COMPLETED|Randomisation to 12 Month Follow Up||4||
48577315|NCT00048893|101744732|FG000|STARTED|Overall Study||37||
48577316|NCT00048893|101744732|FG000|COMPLETED|Overall Study||37||
48577317|NCT00048893|101744732|FG000|NOT COMPLETED|Overall Study||0||
48577318|NCT02101736|101744733|FG000|STARTED|Overall Study||23||
48577319|NCT02101736|101744734|FG001|STARTED|Overall Study||22||
48577320|NCT02101736|101744733|FG000|COMPLETED|Overall Study||19||
48577321|NCT02101736|101744734|FG001|COMPLETED|Overall Study||21||
48577322|NCT02101736|101744733|FG000|NOT COMPLETED|Overall Study||4||
48577323|NCT02101736|101744734|FG001|NOT COMPLETED|Overall Study||1||
48577324|NCT02276560|101744735|FG000|STARTED|Overall Study||1||
48577325|NCT02276560|101744736|FG001|STARTED|Overall Study||0||
48577326|NCT02276560|101744737|FG002|STARTED|Overall Study||0||
48577327|NCT02276560|101744735|FG000|COMPLETED|Overall Study||0||
48577328|NCT02276560|101744736|FG001|COMPLETED|Overall Study||0||
48577329|NCT02276560|101744737|FG002|COMPLETED|Overall Study||0||
48577330|NCT02276560|101744735|FG000|NOT COMPLETED|Overall Study||1||
48577331|NCT02276560|101744736|FG001|NOT COMPLETED|Overall Study||0||
48577332|NCT02276560|101744737|FG002|NOT COMPLETED|Overall Study||0||
48577333|NCT01135381|101744738|FG000|STARTED|Overall Study||189||
48577334|NCT01135381|101744739|FG001|STARTED|Overall Study||185||
48577335|NCT01135381|101744740|FG002|STARTED|Overall Study||69||
48577336|NCT01135381|101744741|FG003|STARTED|Overall Study||68||
48577337|NCT01135381|101744738|FG000|COMPLETED|Overall Study||168||
48577338|NCT01135381|101744739|FG001|COMPLETED|Overall Study||178||
48577339|NCT01135381|101744740|FG002|COMPLETED|Overall Study||65||
48577340|NCT01135381|101744741|FG003|COMPLETED|Overall Study||67||
48577341|NCT01135381|101744738|FG000|NOT COMPLETED|Overall Study||21||
48577342|NCT01135381|101744739|FG001|NOT COMPLETED|Overall Study||7||
48577343|NCT01135381|101744740|FG002|NOT COMPLETED|Overall Study||4||
48577344|NCT01135381|101744741|FG003|NOT COMPLETED|Overall Study||1||
48703007|NCT03466099|102057751|FG001|NOT COMPLETED|Overall Study||14||
48703008|NCT03466099|102057752|FG002|NOT COMPLETED|Overall Study||17||
48703009|NCT00724854|102057753|FG000|STARTED|Overall Study||1010||
48703010|NCT00724854|102057754|FG001|STARTED|Overall Study||72||
48703011|NCT00724854|102057753|FG000|COMPLETED|Overall Study||607||
48703012|NCT00724854|102057754|FG001|COMPLETED|Overall Study||41||
48703013|NCT00724854|102057753|FG000|NOT COMPLETED|Overall Study||403||
48703014|NCT00724854|102057754|FG001|NOT COMPLETED|Overall Study||31||
48132932|NCT01760954|100648596|FG002|COMPLETED|Post-treatment Follow-up (12 Months)||65||
48132933|NCT01760954|100648597|FG003|COMPLETED|Post-treatment Follow-up (12 Months)||67||
48132934|NCT01760954|100648594|FG000|NOT COMPLETED|Post-treatment Follow-up (12 Months)||30||
48703015|NCT05426031|102057755|FG000|STARTED|Overall Study||65||
48132935|NCT01760954|100648595|FG001|NOT COMPLETED|Post-treatment Follow-up (12 Months)||35||
48577345|NCT04480424|101744742|FG000|STARTED|Overall Study||50||
48577346|NCT04480424|101744743|FG001|STARTED|Overall Study||50||
48577347|NCT04480424|101744742|FG000|COMPLETED|Overall Study||28||
48577348|NCT04480424|101744743|FG001|COMPLETED|Overall Study||24||
48577349|NCT04480424|101744742|FG000|NOT COMPLETED|Overall Study||22||
48577350|NCT04480424|101744743|FG001|NOT COMPLETED|Overall Study||26||
48577351|NCT03412734|101744744|FG000|STARTED|Overall Study||47||
48577352|NCT03412734|101744745|FG001|STARTED|Overall Study||41||
48577353|NCT03412734|101744744|FG000|COMPLETED|Overall Study||44||
48132936|NCT01760954|100648596|FG002|NOT COMPLETED|Post-treatment Follow-up (12 Months)||21||
48141443|NCT01780922|100670424|FG001|STARTED|Washout (7 Days)||2||
48577354|NCT03412734|101744745|FG001|COMPLETED|Overall Study||41||
48577355|NCT03412734|101744744|FG000|NOT COMPLETED|Overall Study||3||
48577356|NCT03412734|101744745|FG001|NOT COMPLETED|Overall Study||0||
48577357|NCT02714595|101744746|FG000|STARTED|Overall Study||101||
48577358|NCT02714595|101744747|FG001|STARTED|Overall Study||51||
48577359|NCT02714595|101744746|FG000|Received Treatment|Overall Study||101|Safety population|
48577360|NCT02714595|101744747|FG001|Received Treatment|Overall Study||49|Safety population|
48703016|NCT05426031|102057756|FG001|STARTED|Overall Study||65||
48132937|NCT01760954|100648597|FG003|NOT COMPLETED|Post-treatment Follow-up (12 Months)||20||
48132938|NCT01075074|100648598|FG000|STARTED|Overall Study||25||
48703017|NCT05426031|102057755|FG000|COMPLETED|Overall Study||62||
48703018|NCT05426031|102057756|FG001|COMPLETED|Overall Study||63||
48703019|NCT05426031|102057755|FG000|NOT COMPLETED|Overall Study||3||
48703020|NCT05426031|102057756|FG001|NOT COMPLETED|Overall Study||2||
48703021|NCT02013206|102057757|FG000|STARTED|Overall Study||29||
48703022|NCT02013206|102057758|FG001|STARTED|Overall Study||23||
48703023|NCT02013206|102057757|FG000|Received Study Drug|Overall Study||26||
48703024|NCT02013206|102057758|FG001|Received Study Drug|Overall Study||23||
48703025|NCT02013206|102057757|FG000|COMPLETED|Overall Study||2||
48703026|NCT02013206|102057758|FG001|COMPLETED|Overall Study||1||
48703027|NCT02013206|102057757|FG000|NOT COMPLETED|Overall Study||27||
48703028|NCT02013206|102057758|FG001|NOT COMPLETED|Overall Study||22||
48703029|NCT01535599|102057759|FG000|STARTED|Overall Study||347||
48703030|NCT01535599|102057760|FG001|STARTED|Overall Study||346||
48703031|NCT01535599|102057759|FG000|COMPLETED|Overall Study||297||
48703032|NCT01535599|102057760|FG001|COMPLETED|Overall Study||250||
48703033|NCT01535599|102057759|FG000|NOT COMPLETED|Overall Study||50||
48703034|NCT01535599|102057760|FG001|NOT COMPLETED|Overall Study||96||
48703035|NCT01777217|102057761|FG000|STARTED|Overall Study||4||
48703036|NCT01777217|102057762|FG001|STARTED|Overall Study||4||
48703037|NCT01777217|102057761|FG000|COMPLETED|Overall Study||4||
48703038|NCT01777217|102057762|FG001|COMPLETED|Overall Study||4||
48703039|NCT01777217|102057761|FG000|NOT COMPLETED|Overall Study||0||
48703040|NCT01777217|102057762|FG001|NOT COMPLETED|Overall Study||0||
48703041|NCT03040011|102057763|FG000|STARTED|Received Randomized Study Intervention||25||
48703042|NCT03040011|102057764|FG001|STARTED|Received Randomized Study Intervention||25||
48703043|NCT03040011|102057765|FG002|STARTED|Received Randomized Study Intervention||25||
48703044|NCT03040011|102057763|FG000|COMPLETED|Received Randomized Study Intervention||25||
48703045|NCT03040011|102057764|FG001|COMPLETED|Received Randomized Study Intervention||25||
48703046|NCT03040011|102057765|FG002|COMPLETED|Received Randomized Study Intervention||25||
48703047|NCT03040011|102057763|FG000|NOT COMPLETED|Received Randomized Study Intervention||0||
48703048|NCT03040011|102057764|FG001|NOT COMPLETED|Received Randomized Study Intervention||0||
48703049|NCT03040011|102057765|FG002|NOT COMPLETED|Received Randomized Study Intervention||0||
48703050|NCT03040011|102057763|FG000|STARTED|Primary Outcome Follow Up||25||
48703051|NCT03040011|102057764|FG001|STARTED|Primary Outcome Follow Up||25||
48703052|NCT03040011|102057765|FG002|STARTED|Primary Outcome Follow Up||25||
48703053|NCT03040011|102057763|FG000|COMPLETED|Primary Outcome Follow Up||21|Outcome data are provided for all patients who underwent study intervention by intention to treat.|
48703054|NCT03040011|102057764|FG001|COMPLETED|Primary Outcome Follow Up||24|Outcome data are provided for all patients who underwent study intervention by intention to treat.|
48703055|NCT03040011|102057765|FG002|COMPLETED|Primary Outcome Follow Up||24|Outcome data are provided for all patients who underwent study intervention by intention to treat.|
48703056|NCT03040011|102057763|FG000|NOT COMPLETED|Primary Outcome Follow Up||4||
48703057|NCT03040011|102057764|FG001|NOT COMPLETED|Primary Outcome Follow Up||1||
48703058|NCT03040011|102057765|FG002|NOT COMPLETED|Primary Outcome Follow Up||1||
48703059|NCT01239381|102057766|FG000|STARTED|Overall Study||92||
48703060|NCT01239381|102057766|FG000|COMPLETED|Overall Study||90||
48703061|NCT01239381|102057766|FG000|NOT COMPLETED|Overall Study||2||
48703062|NCT01220973|102057767|FG000|STARTED|Overall Study||27||
48703063|NCT01220973|102057767|FG000|COMPLETED|Overall Study||23||
48703064|NCT01220973|102057767|FG000|NOT COMPLETED|Overall Study||4||
48703065|NCT00688324|102057768|FG000|STARTED|Overall Study||36||
48703066|NCT00688324|102057768|FG000|COMPLETED|Overall Study||28||
48703067|NCT00688324|102057768|FG000|NOT COMPLETED|Overall Study||8||
48703068|NCT01035463|102057769|FG000|STARTED|Overall Study||6||
48703069|NCT01035463|102057770|FG001|STARTED|Overall Study||3||
48703070|NCT01035463|102057771|FG002|STARTED|Overall Study||6||
48703071|NCT01035463|102057772|FG003|STARTED|Overall Study||4||
48703072|NCT01035463|102057773|FG004|STARTED|Overall Study||7||
48703073|NCT01035463|102057774|FG005|STARTED|Overall Study||33||
48703074|NCT01035463|102057769|FG000|COMPLETED|Overall Study||6||
48703075|NCT01035463|102057770|FG001|COMPLETED|Overall Study||1||
48703076|NCT01035463|102057771|FG002|COMPLETED|Overall Study||1||
48703077|NCT01035463|102057772|FG003|COMPLETED|Overall Study||2||
48703078|NCT01035463|102057773|FG004|COMPLETED|Overall Study||1||
48703079|NCT01035463|102057774|FG005|COMPLETED|Overall Study||15||
48703080|NCT01035463|102057769|FG000|NOT COMPLETED|Overall Study||0||
48703081|NCT01035463|102057770|FG001|NOT COMPLETED|Overall Study||2||
48703082|NCT01035463|102057771|FG002|NOT COMPLETED|Overall Study||5||
48703083|NCT01035463|102057772|FG003|NOT COMPLETED|Overall Study||2||
48703084|NCT01035463|102057773|FG004|NOT COMPLETED|Overall Study||6||
48703085|NCT01035463|102057774|FG005|NOT COMPLETED|Overall Study||18||
48703086|NCT01854632|102057775|FG000|STARTED|Overall Study||1174||
48703087|NCT01854632|102057776|FG001|STARTED|Overall Study||587||
48132939|NCT01075074|100648599|FG001|STARTED|Overall Study||25||
48400013|NCT00968708|101309275|FG000|COMPLETED|Overall Study||2361||
48132940|NCT01075074|100648600|FG002|STARTED|Overall Study||25||
48703088|NCT01854632|102057775|FG000|COMPLETED|Overall Study||1148||
48703089|NCT01854632|102057776|FG001|COMPLETED|Overall Study||574||
48703090|NCT01854632|102057775|FG000|NOT COMPLETED|Overall Study||26||
48132941|NCT01075074|100648598|FG000|COMPLETED|Overall Study||24||
48132942|NCT01075074|100648599|FG001|COMPLETED|Overall Study||23||
48132943|NCT01075074|100648600|FG002|COMPLETED|Overall Study||23||
48132944|NCT01075074|100648598|FG000|NOT COMPLETED|Overall Study||1||
48132945|NCT01075074|100648599|FG001|NOT COMPLETED|Overall Study||2||
48132946|NCT01075074|100648600|FG002|NOT COMPLETED|Overall Study||2||
48132947|NCT00395044|100648601|FG000|STARTED|Overall Study||25||
48577361|NCT02714595|101744746|FG000|Carbapenem-resistant Microbiological Intent-to-treat|Overall Study||80|CR Micro-ITT population; See definition in Baseline Characteristics section|
48577362|NCT02714595|101744747|FG001|Carbapenem-resistant Microbiological Intent-to-treat|Overall Study||38|CR Micro-ITT population; See definition in Baseline Characteristics section|
48577363|NCT02714595|101744746|FG000|COMPLETED|Overall Study||69||
48577364|NCT02714595|101744747|FG001|COMPLETED|Overall Study||38||
48577365|NCT02714595|101744746|FG000|NOT COMPLETED|Overall Study||32||
48577366|NCT02714595|101744747|FG001|NOT COMPLETED|Overall Study||13||
48577367|NCT00994461|101744748|FG000|STARTED|Overall Study||76||
48577368|NCT00994461|101744749|FG001|STARTED|Overall Study||76||
48577369|NCT00994461|101744750|FG002|STARTED|Overall Study||37||
48577370|NCT00994461|101744748|FG000|COMPLETED|Overall Study||74||
48577371|NCT00994461|101744749|FG001|COMPLETED|Overall Study||75||
48577372|NCT00994461|101744750|FG002|COMPLETED|Overall Study||37||
48577373|NCT00994461|101744748|FG000|NOT COMPLETED|Overall Study||2||
48577374|NCT00994461|101744749|FG001|NOT COMPLETED|Overall Study||1||
48577375|NCT00994461|101744750|FG002|NOT COMPLETED|Overall Study||0||
48577376|NCT04132804|101744751|FG000|STARTED|Overall Study||31||
48132948|NCT00395044|100648602|FG001|STARTED|Overall Study||25||
48132949|NCT00395044|100648601|FG000|COMPLETED|Overall Study||7||
48132950|NCT00395044|100648602|FG001|COMPLETED|Overall Study||11||
48132951|NCT00395044|100648601|FG000|NOT COMPLETED|Overall Study||18||
48132952|NCT00395044|100648602|FG001|NOT COMPLETED|Overall Study||14||
48132953|NCT05799495|100648603|FG000|STARTED|Treatment (Up to 5 Days)||40||
48132954|NCT05799495|100648604|FG001|STARTED|Treatment (Up to 5 Days)||40||
48132955|NCT05799495|100648605|FG002|STARTED|Treatment (Up to 5 Days)||80||
48132956|NCT05799495|100648606|FG003|STARTED|Treatment (Up to 5 Days)||80||
48132957|NCT05799495|100648603|FG000|Treated|Treatment (Up to 5 Days)||40||
48132958|NCT05799495|100648604|FG001|Treated|Treatment (Up to 5 Days)||39||
48132959|NCT05799495|100648605|FG002|Treated|Treatment (Up to 5 Days)||79||
48132960|NCT05799495|100648606|FG003|Treated|Treatment (Up to 5 Days)||79||
48132961|NCT05799495|100648603|FG000|COMPLETED|Treatment (Up to 5 Days)||39||
48132962|NCT05799495|100648604|FG001|COMPLETED|Treatment (Up to 5 Days)||36||
48132963|NCT05799495|100648605|FG002|COMPLETED|Treatment (Up to 5 Days)||77||
48132964|NCT05799495|100648606|FG003|COMPLETED|Treatment (Up to 5 Days)||75||
48132965|NCT05799495|100648603|FG000|NOT COMPLETED|Treatment (Up to 5 Days)||1||
48132966|NCT05799495|100648604|FG001|NOT COMPLETED|Treatment (Up to 5 Days)||4||
48132967|NCT05799495|100648605|FG002|NOT COMPLETED|Treatment (Up to 5 Days)||3||
48132968|NCT05799495|100648606|FG003|NOT COMPLETED|Treatment (Up to 5 Days)||5||
48132969|NCT05799495|100648603|FG000|STARTED|Follow Up (Up to 4 Weeks)||39||
48132970|NCT05799495|100648604|FG001|STARTED|Follow Up (Up to 4 Weeks)||37||
48132971|NCT05799495|100648605|FG002|STARTED|Follow Up (Up to 4 Weeks)||78||
48132972|NCT05799495|100648606|FG003|STARTED|Follow Up (Up to 4 Weeks)||76||
48132973|NCT05799495|100648603|FG000|COMPLETED|Follow Up (Up to 4 Weeks)||39||
48132974|NCT05799495|100648604|FG001|COMPLETED|Follow Up (Up to 4 Weeks)||37||
48132975|NCT05799495|100648605|FG002|COMPLETED|Follow Up (Up to 4 Weeks)||77||
48132976|NCT05799495|100648606|FG003|COMPLETED|Follow Up (Up to 4 Weeks)||76||
48132977|NCT05799495|100648603|FG000|NOT COMPLETED|Follow Up (Up to 4 Weeks)||0||
48132978|NCT05799495|100648604|FG001|NOT COMPLETED|Follow Up (Up to 4 Weeks)||0||
48132979|NCT05799495|100648605|FG002|NOT COMPLETED|Follow Up (Up to 4 Weeks)||1||
48132980|NCT05799495|100648606|FG003|NOT COMPLETED|Follow Up (Up to 4 Weeks)||0||
48132981|NCT01205685|100648607|FG000|STARTED|Overall Study||11||
48132982|NCT01205685|100648607|FG000|COMPLETED|Overall Study||0||
48132983|NCT01205685|100648607|FG000|NOT COMPLETED|Overall Study||11||
48577377|NCT04132804|101744751|FG000|COMPLETED|Overall Study||20||
48577378|NCT04132804|101744751|FG000|NOT COMPLETED|Overall Study||11||
48577379|NCT02892110|101744752|FG000|STARTED|Overall Study||35||
48132984|NCT03096418|100648608|FG000|STARTED|Overall Study||24||
48132985|NCT03096418|100648608|FG000|Paclitaxel Concentration Determine|Overall Study||15||
48132986|NCT03096418|100648608|FG000|Analyzed After First Dose|Overall Study||16||
48132987|NCT03096418|100648608|FG000|Analyzed After Third Dose|Overall Study||5||
48577380|NCT02892110|101744753|FG001|STARTED|Overall Study||37||
48577381|NCT02892110|101744752|FG000|COMPLETED|Overall Study||22||
48577382|NCT02892110|101744753|FG001|COMPLETED|Overall Study||25||
48132988|NCT03096418|100648608|FG000|Analyzed After Twelfth Dose|Overall Study||1||
48132989|NCT03096418|100648608|FG000|COMPLETED|Overall Study||24||
48132990|NCT03096418|100648608|FG000|NOT COMPLETED|Overall Study||0||
48132991|NCT04773587|100648609|FG000|STARTED|Overall Study||433||
48132992|NCT04773587|100648610|FG001|STARTED|Overall Study||221||
48132993|NCT04773587|100648609|FG000|COMPLETED|Overall Study||404||
48132994|NCT04773587|100648610|FG001|COMPLETED|Overall Study||208||
48132995|NCT04773587|100648609|FG000|NOT COMPLETED|Overall Study||29||
48132996|NCT04773587|100648610|FG001|NOT COMPLETED|Overall Study||13||
48132997|NCT00723177|100648611|FG000|STARTED|Overall Study||15||
48132998|NCT00723177|100648612|FG001|STARTED|Overall Study||14||
48132999|NCT00723177|100648613|FG002|STARTED|Overall Study||15||
48133000|NCT00723177|100648611|FG000|COMPLETED|Overall Study||10||
48133001|NCT00723177|100648612|FG001|COMPLETED|Overall Study||10||
48133002|NCT00723177|100648613|FG002|COMPLETED|Overall Study||10||
48133003|NCT00723177|100648611|FG000|NOT COMPLETED|Overall Study||5||
48133004|NCT00723177|100648612|FG001|NOT COMPLETED|Overall Study||4||
48133005|NCT00723177|100648613|FG002|NOT COMPLETED|Overall Study||5||
48133006|NCT00147966|100648614|FG000|STARTED|Overall Study||24||
48133007|NCT00147966|100648614|FG000|COMPLETED|Overall Study||24||
48133008|NCT00147966|100648614|FG000|NOT COMPLETED|Overall Study||0||
48133009|NCT01381172|100648615|FG000|STARTED|Overall Study||74||
48133010|NCT01381172|100648616|FG001|STARTED|Overall Study||86||
48133011|NCT01381172|100648615|FG000|COMPLETED|Overall Study||64||
48133012|NCT01381172|100648616|FG001|COMPLETED|Overall Study||73||
48133013|NCT01381172|100648615|FG000|NOT COMPLETED|Overall Study||10||
48577383|NCT02892110|101744752|FG000|NOT COMPLETED|Overall Study||13||
48577384|NCT02892110|101744753|FG001|NOT COMPLETED|Overall Study||12||
48577385|NCT02307279|101744754|FG000|STARTED|Overall Study||223||
48577386|NCT02307279|101744755|FG001|STARTED|Overall Study||213||
48703091|NCT01854632|102057776|FG001|NOT COMPLETED|Overall Study||13||
48703092|NCT02251561|102057777|FG000|STARTED|Overall Study||28||
48703093|NCT02251561|102057777|FG000|COMPLETED|Overall Study||28||
48577387|NCT02307279|101744754|FG000|COMPLETED|Overall Study||172||
48577388|NCT02307279|101744755|FG001|COMPLETED|Overall Study||152||
48577389|NCT02307279|101744754|FG000|NOT COMPLETED|Overall Study||51||
48577390|NCT02307279|101744755|FG001|NOT COMPLETED|Overall Study||61||
48577391|NCT02751931|101744756|FG000|STARTED|Overall Study||56||
48577392|NCT02751931|101744757|FG001|STARTED|Overall Study||35||
48577393|NCT02751931|101744756|FG000|Treated|Overall Study||55||
48577394|NCT02751931|101744757|FG001|Treated|Overall Study||31||
48577395|NCT02751931|101744756|FG000|COMPLETED|Overall Study||43||
48577396|NCT02751931|101744757|FG001|COMPLETED|Overall Study||27||
48577397|NCT02751931|101744756|FG000|NOT COMPLETED|Overall Study||13||
48577398|NCT02751931|101744757|FG001|NOT COMPLETED|Overall Study||8||
48577399|NCT01561703|101744758|FG000|STARTED|Overall Study||28||
48577400|NCT01561703|101744759|FG001|STARTED|Overall Study||30||
48577401|NCT01561703|101744758|FG000|COMPLETED|Overall Study||20||
48577402|NCT01561703|101744759|FG001|COMPLETED|Overall Study||24||
48577403|NCT01561703|101744758|FG000|NOT COMPLETED|Overall Study||8||
48577404|NCT01561703|101744759|FG001|NOT COMPLETED|Overall Study||6||
48577405|NCT01344824|101744760|FG000|STARTED|Overall Study||38||
48577406|NCT01344824|101744760|FG000|COMPLETED|Overall Study||1||
48577407|NCT01344824|101744760|FG000|NOT COMPLETED|Overall Study||37||
48577408|NCT01551264|101744761|FG000|STARTED|Overall Study||70|Enrolled and Randomized|
48577409|NCT01551264|101744762|FG001|STARTED|Overall Study||69|Enrolled and Randomized|
48577410|NCT01551264|101744761|FG000|Started Bracing|Overall Study||69||
48577411|NCT01551264|101744762|FG001|Started Bracing|Overall Study||67||
48577412|NCT01551264|101744761|FG000|Data for at Least One Follow-up After Brace Discontinuation Ascertained|Overall Study||44||
48577413|NCT01551264|101744762|FG001|Data for at Least One Follow-up After Brace Discontinuation Ascertained|Overall Study||55||
48703094|NCT02251561|102057777|FG000|NOT COMPLETED|Overall Study||0||
48703095|NCT01182805|102057778|FG000|STARTED|Overall Study||50||
48133014|NCT01381172|100648616|FG001|NOT COMPLETED|Overall Study||13||
48133015|NCT02181530|100648617|FG000|STARTED|Overall Study||43||
48133016|NCT02181530|100648617|FG000|COMPLETED|Overall Study||43||
48133017|NCT02181530|100648617|FG000|NOT COMPLETED|Overall Study||0||
48577414|NCT01551264|101744761|FG000|COMPLETED|Overall Study||38|One year follow-up after brace discontinuation ascertained|
48577415|NCT01551264|101744762|FG001|COMPLETED|Overall Study||41|One year follow-up after brace discontinuation ascertained|
48577416|NCT01551264|101744761|FG000|NOT COMPLETED|Overall Study||32||
48703096|NCT01182805|102057778|FG000|COMPLETED|Overall Study||50||
48703097|NCT01182805|102057778|FG000|NOT COMPLETED|Overall Study||0||
48133018|NCT01839734|100648618|FG000|STARTED|Overall Study||16||
48133019|NCT01839734|100648619|FG001|STARTED|Overall Study||4||
48133020|NCT01839734|100648618|FG000|COMPLETED|Overall Study||16||
48133021|NCT01839734|100648619|FG001|COMPLETED|Overall Study||4||
48133022|NCT01839734|100648618|FG000|NOT COMPLETED|Overall Study||0||
48133023|NCT01839734|100648619|FG001|NOT COMPLETED|Overall Study||0||
48133024|NCT03836053|100648620|FG000|STARTED|Overall Study||1||
48133025|NCT03836053|100648621|FG001|STARTED|Overall Study||12||
48133026|NCT03836053|100648622|FG002|STARTED|Overall Study||10||
48133027|NCT03836053|100648620|FG000|COMPLETED|Overall Study||0||
48133028|NCT03836053|100648621|FG001|COMPLETED|Overall Study||2||
48577417|NCT01551264|101744762|FG001|NOT COMPLETED|Overall Study||28||
48577418|NCT02173522|101744763|FG000|STARTED|Overall Study||4||
48577419|NCT02173522|101744764|FG001|STARTED|Overall Study||0||
48577420|NCT02173522|101744763|FG000|COMPLETED|Overall Study||4||
48577421|NCT02173522|101744764|FG001|COMPLETED|Overall Study||0||
48577422|NCT02173522|101744763|FG000|NOT COMPLETED|Overall Study||0||
48577423|NCT02173522|101744764|FG001|NOT COMPLETED|Overall Study||0||
48577424|NCT00443079|101744765|FG000|STARTED|Overall Study||3||
48577425|NCT00443079|101744766|FG001|STARTED|Overall Study||3||
48577426|NCT00443079|101744765|FG000|COMPLETED|Overall Study||3||
48577427|NCT00443079|101744766|FG001|COMPLETED|Overall Study||2||
48577428|NCT00443079|101744765|FG000|NOT COMPLETED|Overall Study||0||
48577429|NCT00443079|101744766|FG001|NOT COMPLETED|Overall Study||1||
48577430|NCT04347564|101744767|FG000|STARTED|Overall Study||45||
48577431|NCT04347564|101744767|FG000|COMPLETED|Overall Study||45||
48577432|NCT04347564|101744767|FG000|NOT COMPLETED|Overall Study||0||
48577433|NCT02863445|101744768|FG000|STARTED|Overall Study||35||
48577434|NCT02863445|101744769|FG001|STARTED|Overall Study||35||
48577435|NCT02863445|101744768|FG000|COMPLETED|Overall Study||35||
48577436|NCT02863445|101744769|FG001|COMPLETED|Overall Study||35||
48577437|NCT02863445|101744768|FG000|NOT COMPLETED|Overall Study||0||
48577438|NCT02863445|101744769|FG001|NOT COMPLETED|Overall Study||0||
48577439|NCT01256164|101744770|FG000|STARTED|Overall Study||47||
48577440|NCT01256164|101744771|FG001|STARTED|Overall Study||23||
48577441|NCT01256164|101744770|FG000|COMPLETED|Overall Study||47||
48577442|NCT01256164|101744771|FG001|COMPLETED|Overall Study||23||
48577443|NCT01256164|101744770|FG000|NOT COMPLETED|Overall Study||0||
48577444|NCT01256164|101744771|FG001|NOT COMPLETED|Overall Study||0||
48577445|NCT00863343|101744772|FG000|STARTED|Overall Study||17||
48577446|NCT00863343|101744773|FG001|STARTED|Overall Study||374||
48577447|NCT00863343|101744772|FG000|COMPLETED|Overall Study||17||
48577448|NCT00863343|101744773|FG001|COMPLETED|Overall Study||374||
48133029|NCT03836053|100648622|FG002|COMPLETED|Overall Study||0||
48133030|NCT03836053|100648620|FG000|NOT COMPLETED|Overall Study||1||
48133031|NCT03836053|100648621|FG001|NOT COMPLETED|Overall Study||10||
48133032|NCT03836053|100648622|FG002|NOT COMPLETED|Overall Study||10||
48133033|NCT00412087|100648623|FG000|STARTED|Overall Study||134||
48286180|NCT03075410|101026272|FG004|COMPLETED|Part A-Washout Period 2 (14 Days)||2||
48286181|NCT03075410|101026273|FG005|COMPLETED|Part A-Washout Period 2 (14 Days)||1||
48286182|NCT03075410|101026274|FG006|COMPLETED|Part A-Washout Period 2 (14 Days)||0||
48286183|NCT03075410|101026275|FG007|COMPLETED|Part A-Washout Period 2 (14 Days)||0||
48286184|NCT03075410|101026276|FG008|COMPLETED|Part A-Washout Period 2 (14 Days)||0||
48133034|NCT00412087|100648624|FG001|STARTED|Overall Study||131||
48133035|NCT00412087|100648623|FG000|COMPLETED|Overall Study||72||
48133036|NCT00412087|100648624|FG001|COMPLETED|Overall Study||66||
48286185|NCT03075410|101026268|FG000|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0||
48286186|NCT03075410|101026269|FG001|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0||
48286187|NCT03075410|101026270|FG002|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0||
48133037|NCT00412087|100648623|FG000|NOT COMPLETED|Overall Study||62||
48133038|NCT00412087|100648624|FG001|NOT COMPLETED|Overall Study||65||
48133039|NCT00659334|100648625|FG000|STARTED|Overall Study||46||
48286188|NCT03075410|101026271|FG003|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0||
48286189|NCT03075410|101026272|FG004|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0||
48286190|NCT03075410|101026273|FG005|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0||
48577449|NCT00863343|101744772|FG000|NOT COMPLETED|Overall Study||0||
48577450|NCT00863343|101744773|FG001|NOT COMPLETED|Overall Study||0||
48577451|NCT00869999|101744774|FG000|STARTED|Overall Study||26||
48577452|NCT00869999|101744774|FG000|COMPLETED|Overall Study||24||
48577453|NCT00869999|101744774|FG000|NOT COMPLETED|Overall Study||2||
48133040|NCT00659334|100648626|FG001|STARTED|Overall Study||41||
48133041|NCT00659334|100648627|FG002|STARTED|Overall Study||5||
48286191|NCT03075410|101026274|FG006|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0||
48286192|NCT03075410|101026275|FG007|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0||
48286193|NCT03075410|101026276|FG008|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0||
48286194|NCT03075410|101026268|FG000|STARTED|Part A-Period 3 (14 Days)||2||
48286195|NCT03075410|101026269|FG001|STARTED|Part A-Period 3 (14 Days)||1||
48286196|NCT03075410|101026270|FG002|STARTED|Part A-Period 3 (14 Days)||2||
48286197|NCT03075410|101026271|FG003|STARTED|Part A-Period 3 (14 Days)||1||
48286198|NCT03075410|101026272|FG004|STARTED|Part A-Period 3 (14 Days)||2||
48286199|NCT03075410|101026273|FG005|STARTED|Part A-Period 3 (14 Days)||1||
48577454|NCT02129777|101744775|FG000|STARTED|Double-Blind Period||24||
48577455|NCT02129777|101744776|FG001|STARTED|Double-Blind Period||24||
48577456|NCT02129777|101744777|FG002|STARTED|Double-Blind Period||24||
48133042|NCT00659334|100648628|FG003|STARTED|Overall Study||2||
48577457|NCT02129777|101744778|FG003|STARTED|Double-Blind Period||25||
48577458|NCT02129777|101744779|FG004|STARTED|Double-Blind Period||25||
48577459|NCT02129777|101744780|FG005|STARTED|Double-Blind Period||0||
48577460|NCT02129777|101744781|FG006|STARTED|Double-Blind Period||0||
48133043|NCT00659334|100648629|FG004|STARTED|Overall Study||1||
48133044|NCT00659334|100648630|FG005|STARTED|Overall Study||0||
48133045|NCT00659334|100648631|FG006|STARTED|Overall Study||21||
48703098|NCT03520348|102057779|FG000|STARTED|Overall Study||12||
48703099|NCT03520348|102057780|FG001|STARTED|Overall Study||12||
48703100|NCT03520348|102057779|FG000|COMPLETED|Overall Study||12||
48703101|NCT03520348|102057780|FG001|COMPLETED|Overall Study||12||
48703102|NCT03520348|102057779|FG000|NOT COMPLETED|Overall Study||0||
48703103|NCT03520348|102057780|FG001|NOT COMPLETED|Overall Study||0||
48703104|NCT00328562|102057781|FG000|STARTED|Overall Study||13||
48703105|NCT00328562|102057781|FG000|COMPLETED|Overall Study||12||
48703106|NCT00328562|102057781|FG000|NOT COMPLETED|Overall Study||1||
48703107|NCT01097642|102057782|FG000|STARTED|Overall Study||15||
48703108|NCT01097642|102057783|FG001|STARTED|Overall Study||25||
48703109|NCT01097642|102057782|FG000|COMPLETED|Overall Study||15||
48703110|NCT01097642|102057783|FG001|COMPLETED|Overall Study||25||
48703111|NCT01097642|102057782|FG000|NOT COMPLETED|Overall Study||0||
48703112|NCT01097642|102057783|FG001|NOT COMPLETED|Overall Study||0||
48703113|NCT03194568|102057784|FG000|STARTED|Overall Study||20||
48703114|NCT03194568|102057784|FG000|COMPLETED|Overall Study||16||
48703115|NCT03194568|102057784|FG000|NOT COMPLETED|Overall Study||4||
48703116|NCT02120300|102057785|FG000|STARTED|Overall Study||101||
48703117|NCT02120300|102057786|FG001|STARTED|Overall Study||5||
48703118|NCT02120300|102057787|FG002|STARTED|Overall Study||10||
48703119|NCT02120300|102057788|FG003|STARTED|Overall Study||6||
48703120|NCT02120300|102057785|FG000|COMPLETED|Overall Study||98||
48703121|NCT02120300|102057786|FG001|COMPLETED|Overall Study||5||
48286200|NCT03075410|101026274|FG006|STARTED|Part A-Period 3 (14 Days)||0||
48286201|NCT03075410|101026275|FG007|STARTED|Part A-Period 3 (14 Days)||0||
48286202|NCT03075410|101026276|FG008|STARTED|Part A-Period 3 (14 Days)||0||
48703122|NCT02120300|102057787|FG002|COMPLETED|Overall Study||10||
48703123|NCT02120300|102057788|FG003|COMPLETED|Overall Study||5||
48703124|NCT02120300|102057785|FG000|NOT COMPLETED|Overall Study||3||
48703125|NCT02120300|102057786|FG001|NOT COMPLETED|Overall Study||0||
48703126|NCT02120300|102057787|FG002|NOT COMPLETED|Overall Study||0||
48703127|NCT02120300|102057788|FG003|NOT COMPLETED|Overall Study||1||
48703128|NCT00503776|102057789|FG000|STARTED|Overall Study||8||
48703129|NCT00503776|102057790|FG001|STARTED|Overall Study||12||
48703130|NCT00503776|102057791|FG002|STARTED|Overall Study||12||
48703131|NCT00503776|102057792|FG003|STARTED|Overall Study||10||
48703132|NCT00503776|102057789|FG000|COMPLETED|Overall Study||7||
48703133|NCT00503776|102057790|FG001|COMPLETED|Overall Study||12||
48703134|NCT00503776|102057791|FG002|COMPLETED|Overall Study||10||
48703135|NCT00503776|102057792|FG003|COMPLETED|Overall Study||8||
48703136|NCT00503776|102057789|FG000|NOT COMPLETED|Overall Study||1||
48703137|NCT00503776|102057790|FG001|NOT COMPLETED|Overall Study||0||
48703138|NCT00503776|102057791|FG002|NOT COMPLETED|Overall Study||2||
48703139|NCT00503776|102057792|FG003|NOT COMPLETED|Overall Study||2||
48703140|NCT01357135|102057793|FG000|STARTED|Overall Study||1874||
48703141|NCT01357135|102057794|FG001|STARTED|Overall Study||733||
48703142|NCT01357135|102057795|FG002|STARTED|Overall Study||846||
48703143|NCT01357135|102057793|FG000|COMPLETED|Overall Study||1276||
48703144|NCT01357135|102057794|FG001|COMPLETED|Overall Study||510||
48703145|NCT01357135|102057795|FG002|COMPLETED|Overall Study||583||
48286203|NCT03075410|101026268|FG000|COMPLETED|Part A-Period 3 (14 Days)||1||
48286204|NCT03075410|101026269|FG001|COMPLETED|Part A-Period 3 (14 Days)||1||
48286205|NCT03075410|101026270|FG002|COMPLETED|Part A-Period 3 (14 Days)||2||
48286206|NCT03075410|101026271|FG003|COMPLETED|Part A-Period 3 (14 Days)||1||
48400014|NCT00968708|101309276|FG001|COMPLETED|Overall Study||2403||
48400015|NCT00968708|101309275|FG000|NOT COMPLETED|Overall Study||318||
48703146|NCT01357135|102057793|FG000|NOT COMPLETED|Overall Study||598||
48703147|NCT01357135|102057794|FG001|NOT COMPLETED|Overall Study||223||
48703148|NCT01357135|102057795|FG002|NOT COMPLETED|Overall Study||263||
48703149|NCT04028765|102057796|FG000|STARTED|Overall Study||52||
48703150|NCT04028765|102057797|FG001|STARTED|Overall Study||56||
48703151|NCT04028765|102057796|FG000|COMPLETED|Overall Study||52||
48703152|NCT04028765|102057797|FG001|COMPLETED|Overall Study||56||
48703153|NCT04028765|102057796|FG000|NOT COMPLETED|Overall Study||0||
48286207|NCT03075410|101026272|FG004|COMPLETED|Part A-Period 3 (14 Days)||2||
48286208|NCT03075410|101026273|FG005|COMPLETED|Part A-Period 3 (14 Days)||1||
48703154|NCT04028765|102057797|FG001|NOT COMPLETED|Overall Study||0||
48703155|NCT05422365|102057798|FG000|STARTED|Overall Study||32||
48703156|NCT05422365|102057798|FG000|COMPLETED|Overall Study||32||
48703157|NCT05422365|102057798|FG000|NOT COMPLETED|Overall Study||0||
48703158|NCT01340625|102057799|FG000|STARTED|First Intervention||18||
48703159|NCT01340625|102057800|FG001|STARTED|First Intervention||18||
48703160|NCT01340625|102057799|FG000|COMPLETED|First Intervention||17||
48703161|NCT01340625|102057800|FG001|COMPLETED|First Intervention||18||
48703162|NCT01340625|102057799|FG000|NOT COMPLETED|First Intervention||1||
48703163|NCT01340625|102057800|FG001|NOT COMPLETED|First Intervention||0||
48703164|NCT01340625|102057799|FG000|STARTED|Washout Period of 28 Days||17||
48703165|NCT01340625|102057800|FG001|STARTED|Washout Period of 28 Days||18||
48703166|NCT01340625|102057799|FG000|COMPLETED|Washout Period of 28 Days||16||
48286209|NCT03075410|101026274|FG006|COMPLETED|Part A-Period 3 (14 Days)||0||
48286210|NCT03075410|101026275|FG007|COMPLETED|Part A-Period 3 (14 Days)||0||
48286211|NCT03075410|101026276|FG008|COMPLETED|Part A-Period 3 (14 Days)||0||
48286212|NCT03075410|101026268|FG000|NOT COMPLETED|Part A-Period 3 (14 Days)||1||
48286213|NCT03075410|101026269|FG001|NOT COMPLETED|Part A-Period 3 (14 Days)||0||
48286214|NCT03075410|101026270|FG002|NOT COMPLETED|Part A-Period 3 (14 Days)||0||
48286215|NCT03075410|101026271|FG003|NOT COMPLETED|Part A-Period 3 (14 Days)||0||
48703167|NCT01340625|102057800|FG001|COMPLETED|Washout Period of 28 Days||18||
48133046|NCT00659334|100648625|FG000|COMPLETED|Overall Study||38||
48133047|NCT00659334|100648626|FG001|COMPLETED|Overall Study||36||
48133048|NCT00659334|100648627|FG002|COMPLETED|Overall Study||5||
48133049|NCT00659334|100648628|FG003|COMPLETED|Overall Study||2||
48133050|NCT00659334|100648629|FG004|COMPLETED|Overall Study||1||
48133051|NCT00659334|100648630|FG005|COMPLETED|Overall Study||0||
48133052|NCT00659334|100648631|FG006|COMPLETED|Overall Study||20||
48133053|NCT00659334|100648625|FG000|NOT COMPLETED|Overall Study||8||
48133054|NCT00659334|100648626|FG001|NOT COMPLETED|Overall Study||5||
48133055|NCT00659334|100648627|FG002|NOT COMPLETED|Overall Study||0||
48133056|NCT00659334|100648628|FG003|NOT COMPLETED|Overall Study||0||
48133057|NCT00659334|100648629|FG004|NOT COMPLETED|Overall Study||0||
48133058|NCT00659334|100648630|FG005|NOT COMPLETED|Overall Study||0||
48133059|NCT00659334|100648631|FG006|NOT COMPLETED|Overall Study||1||
48133060|NCT00874029|100648632|FG000|STARTED|Overall Study||137||
48133061|NCT00874029|100648632|FG000|COMPLETED|Overall Study||116||
48133062|NCT00874029|100648632|FG000|NOT COMPLETED|Overall Study||21||
48133063|NCT00567242|100648633|FG000|STARTED|Overall Study||7||
48133064|NCT00567242|100648634|FG001|STARTED|Overall Study||7||
48286216|NCT03075410|101026272|FG004|NOT COMPLETED|Part A-Period 3 (14 Days)||0||
48703168|NCT01340625|102057799|FG000|NOT COMPLETED|Washout Period of 28 Days||1||
48703169|NCT01340625|102057800|FG001|NOT COMPLETED|Washout Period of 28 Days||0||
48703170|NCT01340625|102057799|FG000|STARTED|Second Intervention||16||
48703171|NCT01340625|102057800|FG001|STARTED|Second Intervention||18||
48703172|NCT01340625|102057799|FG000|COMPLETED|Second Intervention||16||
48703173|NCT01340625|102057800|FG001|COMPLETED|Second Intervention||18||
48133065|NCT00567242|100648633|FG000|COMPLETED|Overall Study||7||
48133066|NCT00567242|100648634|FG001|COMPLETED|Overall Study||7||
48133067|NCT00567242|100648633|FG000|NOT COMPLETED|Overall Study||0||
48133068|NCT00567242|100648634|FG001|NOT COMPLETED|Overall Study||0||
48133069|NCT04483479|100648635|FG000|STARTED|Overall Study||27||
48133070|NCT04483479|100648635|FG000|COMPLETED|Overall Study||12||
48133071|NCT04483479|100648635|FG000|NOT COMPLETED|Overall Study||15||
48133072|NCT03431168|100648636|FG000|STARTED|Overall Study||155||
48133073|NCT03431168|100648637|FG001|STARTED|Overall Study||153||
48133074|NCT03431168|100648636|FG000|COMPLETED|Overall Study||132||
48133075|NCT03431168|100648637|FG001|COMPLETED|Overall Study||129||
48703174|NCT01340625|102057799|FG000|NOT COMPLETED|Second Intervention||0||
48703175|NCT01340625|102057800|FG001|NOT COMPLETED|Second Intervention||0||
48703176|NCT03359785|102057801|FG000|STARTED|Overall Study||8||
48703177|NCT03359785|102057802|FG001|STARTED|Overall Study||9||
48703178|NCT03359785|102057803|FG002|STARTED|Overall Study||7||
48703179|NCT03359785|102057804|FG003|STARTED|Overall Study||7||
48703180|NCT03359785|102057801|FG000|COMPLETED|Overall Study||6||
48703181|NCT03359785|102057802|FG001|COMPLETED|Overall Study||6||
48703182|NCT03359785|102057803|FG002|COMPLETED|Overall Study||5||
48703183|NCT03359785|102057804|FG003|COMPLETED|Overall Study||7||
48703184|NCT03359785|102057801|FG000|NOT COMPLETED|Overall Study||2||
48703185|NCT03359785|102057802|FG001|NOT COMPLETED|Overall Study||3||
48703186|NCT03359785|102057803|FG002|NOT COMPLETED|Overall Study||2||
48703187|NCT03359785|102057804|FG003|NOT COMPLETED|Overall Study||0||
48703188|NCT04726137|102057805|FG000|STARTED|Overall Study||906||
48703189|NCT04726137|102057805|FG000|COMPLETED|Overall Study||759||
48703190|NCT04726137|102057805|FG000|NOT COMPLETED|Overall Study||147||
48703191|NCT01044745|102057806|FG000|STARTED|Overall Study||20||
48703192|NCT01044745|102057806|FG000|COMPLETED|Overall Study||18||
48703193|NCT01044745|102057806|FG000|NOT COMPLETED|Overall Study||2||
48703194|NCT00875485|102057807|FG000|STARTED|Year 11||99||
48703195|NCT00875485|102057808|FG001|STARTED|Year 11||111||
48703196|NCT00875485|102057807|FG000|COMPLETED|Year 11||99||
48703197|NCT00875485|102057808|FG001|COMPLETED|Year 11||111||
48703198|NCT00875485|102057807|FG000|NOT COMPLETED|Year 11||0||
48703199|NCT00875485|102057808|FG001|NOT COMPLETED|Year 11||0||
48703200|NCT00875485|102057807|FG000|STARTED|Year 12||101||
48703201|NCT00875485|102057808|FG001|STARTED|Year 12||109||
48703202|NCT00875485|102057807|FG000|COMPLETED|Year 12||101||
48703203|NCT00875485|102057808|FG001|COMPLETED|Year 12||109||
48703204|NCT00875485|102057807|FG000|NOT COMPLETED|Year 12||0||
48703205|NCT00875485|102057808|FG001|NOT COMPLETED|Year 12||0||
48703206|NCT00875485|102057807|FG000|STARTED|Year 13||102||
48703207|NCT00875485|102057808|FG001|STARTED|Year 13||113||
48703208|NCT00875485|102057807|FG000|COMPLETED|Year 13||102||
48703209|NCT00875485|102057808|FG001|COMPLETED|Year 13||113||
48703210|NCT00875485|102057807|FG000|NOT COMPLETED|Year 13||0||
48703211|NCT00875485|102057808|FG001|NOT COMPLETED|Year 13||0||
48703212|NCT00875485|102057807|FG000|STARTED|Year 14||100||
48703213|NCT00875485|102057808|FG001|STARTED|Year 14||113||
48703214|NCT00875485|102057807|FG000|COMPLETED|Year 14||100||
48703215|NCT00875485|102057808|FG001|COMPLETED|Year 14||113||
48703216|NCT00875485|102057807|FG000|NOT COMPLETED|Year 14||0||
48703217|NCT00875485|102057808|FG001|NOT COMPLETED|Year 14||0||
48703218|NCT00875485|102057807|FG000|STARTED|Year 15||98||
48703219|NCT00875485|102057808|FG001|STARTED|Year 15||111||
48703220|NCT00875485|102057807|FG000|COMPLETED|Year 15||98||
48703221|NCT00875485|102057808|FG001|COMPLETED|Year 15||111||
48703222|NCT00875485|102057807|FG000|NOT COMPLETED|Year 15||0||
48703223|NCT00875485|102057808|FG001|NOT COMPLETED|Year 15||0||
48703224|NCT00875485|102057807|FG000|STARTED|Challenge Dose Epoch||8||
48703225|NCT00875485|102057808|FG001|STARTED|Challenge Dose Epoch||11||
48703226|NCT00875485|102057807|FG000|COMPLETED|Challenge Dose Epoch||7||
48703227|NCT00875485|102057808|FG001|COMPLETED|Challenge Dose Epoch||11||
48703228|NCT00875485|102057807|FG000|NOT COMPLETED|Challenge Dose Epoch||1||
48703229|NCT00875485|102057808|FG001|NOT COMPLETED|Challenge Dose Epoch||0||
48703230|NCT01380535|102057809|FG000|STARTED|Overall Study||29||
48703231|NCT01380535|102057810|FG001|STARTED|Overall Study||31||
48703232|NCT01380535|102057809|FG000|Baseline Population|Overall Study||29|All enrolled participants|
48703233|NCT01380535|102057810|FG001|Baseline Population|Overall Study||31|All enrolled participants|
48710733|NCT02699450|102078000|FG001|COMPLETED|Overall Study||50|Completed Study (per pre-specified criteria)|
48710734|NCT02699450|102078001|FG002|COMPLETED|Overall Study||67|Completed Study (per pre-specified criteria)|
48710735|NCT02699450|102077999|FG000|NOT COMPLETED|Overall Study||15||
48710736|NCT02699450|102078000|FG001|NOT COMPLETED|Overall Study||5||
48710737|NCT02699450|102078001|FG002|NOT COMPLETED|Overall Study||15||
48710738|NCT01514240|102078002|FG000|STARTED|Overall Study||56||
48710739|NCT01514240|102078003|FG001|STARTED|Overall Study||56||
48710740|NCT01514240|102078002|FG000|COMPLETED|Overall Study||50||
48710741|NCT01514240|102078003|FG001|COMPLETED|Overall Study||45||
48710742|NCT01514240|102078002|FG000|NOT COMPLETED|Overall Study||6||
48710743|NCT01514240|102078003|FG001|NOT COMPLETED|Overall Study||11||
48710744|NCT04066686|102078004|FG000|STARTED|Overall Study||14||
48710745|NCT04066686|102078005|FG001|STARTED|Overall Study||13||
48710746|NCT04066686|102078004|FG000|COMPLETED|Overall Study||12||
48710747|NCT04066686|102078005|FG001|COMPLETED|Overall Study||13||
48710748|NCT04066686|102078004|FG000|NOT COMPLETED|Overall Study||2||
48710749|NCT04066686|102078005|FG001|NOT COMPLETED|Overall Study||0||
48710750|NCT00168103|102078006|FG000|STARTED|Overall Study||40||
48710751|NCT00168103|102078007|FG001|STARTED|Overall Study||43||
48710752|NCT00168103|102078008|FG002|STARTED|Overall Study||42||
48710753|NCT00168103|102078009|FG003|STARTED|Overall Study||1||
48710754|NCT00168103|102078006|FG000|COMPLETED|Overall Study||38||
48710755|NCT00168103|102078007|FG001|COMPLETED|Overall Study||38||
48133076|NCT03431168|100648636|FG000|NOT COMPLETED|Overall Study||23||
48133077|NCT03431168|100648637|FG001|NOT COMPLETED|Overall Study||24||
48133078|NCT01748916|100648638|FG000|STARTED|Overall Study||2||
48133079|NCT01748916|100648639|FG001|STARTED|Overall Study||3||
48133080|NCT01748916|100648640|FG002|STARTED|Overall Study||2||
48577461|NCT02129777|101744775|FG000|COMPLETED|Double-Blind Period||17||
48577462|NCT02129777|101744776|FG001|COMPLETED|Double-Blind Period||16||
48577463|NCT02129777|101744777|FG002|COMPLETED|Double-Blind Period||20||
48577464|NCT02129777|101744778|FG003|COMPLETED|Double-Blind Period||18||
48577465|NCT02129777|101744779|FG004|COMPLETED|Double-Blind Period||18||
48577466|NCT02129777|101744780|FG005|COMPLETED|Double-Blind Period||0||
48577467|NCT02129777|101744781|FG006|COMPLETED|Double-Blind Period||0||
48577468|NCT02129777|101744775|FG000|NOT COMPLETED|Double-Blind Period||7||
48577469|NCT02129777|101744776|FG001|NOT COMPLETED|Double-Blind Period||8||
48577470|NCT02129777|101744777|FG002|NOT COMPLETED|Double-Blind Period||4||
48577471|NCT02129777|101744778|FG003|NOT COMPLETED|Double-Blind Period||7||
48577472|NCT02129777|101744779|FG004|NOT COMPLETED|Double-Blind Period||7||
48577473|NCT02129777|101744780|FG005|NOT COMPLETED|Double-Blind Period||0||
48577474|NCT02129777|101744781|FG006|NOT COMPLETED|Double-Blind Period||0||
48577475|NCT02129777|101744775|FG000|STARTED|Open-Label Period||0||
48577476|NCT02129777|101744776|FG001|STARTED|Open-Label Period||0||
48577477|NCT02129777|101744777|FG002|STARTED|Open-Label Period||0||
48577478|NCT02129777|101744778|FG003|STARTED|Open-Label Period||0||
48577479|NCT02129777|101744779|FG004|STARTED|Open-Label Period||0||
48577480|NCT02129777|101744780|FG005|STARTED|Open-Label Period||12||
48577481|NCT02129777|101744781|FG006|STARTED|Open-Label Period||48||
48577482|NCT02129777|101744775|FG000|COMPLETED|Open-Label Period||0||
48577483|NCT02129777|101744776|FG001|COMPLETED|Open-Label Period||0||
48577484|NCT02129777|101744777|FG002|COMPLETED|Open-Label Period||0||
48577485|NCT02129777|101744778|FG003|COMPLETED|Open-Label Period||0||
48286217|NCT03075410|101026273|FG005|NOT COMPLETED|Part A-Period 3 (14 Days)||0||
48286218|NCT03075410|101026274|FG006|NOT COMPLETED|Part A-Period 3 (14 Days)||0||
48286219|NCT03075410|101026275|FG007|NOT COMPLETED|Part A-Period 3 (14 Days)||0||
48577486|NCT02129777|101744779|FG004|COMPLETED|Open-Label Period||0||
48133081|NCT01748916|100648641|FG003|STARTED|Overall Study||3||
48133082|NCT01748916|100648642|FG004|STARTED|Overall Study||3||
48133083|NCT01748916|100648643|FG005|STARTED|Overall Study||3||
48133084|NCT01748916|100648638|FG000|COMPLETED|Overall Study||2||
48286220|NCT03075410|101026276|FG008|NOT COMPLETED|Part A-Period 3 (14 Days)||0||
48286221|NCT03075410|101026268|FG000|STARTED|Part A-Washout Period 3 (14 Days)||1||
48577487|NCT02129777|101744780|FG005|COMPLETED|Open-Label Period||0||
48577488|NCT02129777|101744781|FG006|COMPLETED|Open-Label Period||0||
48577489|NCT02129777|101744775|FG000|NOT COMPLETED|Open-Label Period||0||
48133085|NCT01748916|100648639|FG001|COMPLETED|Overall Study||3||
48133086|NCT01748916|100648640|FG002|COMPLETED|Overall Study||2||
48133087|NCT01748916|100648641|FG003|COMPLETED|Overall Study||3||
48133088|NCT01748916|100648642|FG004|COMPLETED|Overall Study||3||
48133089|NCT01748916|100648643|FG005|COMPLETED|Overall Study||3||
48133090|NCT01748916|100648638|FG000|NOT COMPLETED|Overall Study||0||
48133091|NCT01748916|100648639|FG001|NOT COMPLETED|Overall Study||0||
48133092|NCT01748916|100648640|FG002|NOT COMPLETED|Overall Study||0||
48577490|NCT02129777|101744776|FG001|NOT COMPLETED|Open-Label Period||0||
48577491|NCT02129777|101744777|FG002|NOT COMPLETED|Open-Label Period||0||
48577492|NCT02129777|101744778|FG003|NOT COMPLETED|Open-Label Period||0||
48577493|NCT02129777|101744779|FG004|NOT COMPLETED|Open-Label Period||0||
48577494|NCT02129777|101744780|FG005|NOT COMPLETED|Open-Label Period||12||
48577495|NCT02129777|101744781|FG006|NOT COMPLETED|Open-Label Period||48||
48133093|NCT01748916|100648641|FG003|NOT COMPLETED|Overall Study||0||
48133094|NCT01748916|100648642|FG004|NOT COMPLETED|Overall Study||0||
48133095|NCT01748916|100648643|FG005|NOT COMPLETED|Overall Study||0||
48133096|NCT00736242|100648644|FG000|STARTED|Overall Study||232||
48133097|NCT00736242|100648644|FG000|Participants in Safety Analysis Set|Overall Study||229||
48133098|NCT00736242|100648644|FG000|COMPLETED|Overall Study||107||
48133099|NCT00736242|100648644|FG000|NOT COMPLETED|Overall Study||125||
48133100|NCT02276482|100648645|FG000|STARTED|Overall Study||91||
48133101|NCT02276482|100648646|FG001|STARTED|Overall Study||29||
48133102|NCT02276482|100648645|FG000|COMPLETED|Overall Study||88||
48133103|NCT02276482|100648646|FG001|COMPLETED|Overall Study||28||
48703234|NCT01380535|102057809|FG000|Safety Population|Overall Study||28|All randomized participants who received at least 1 dose of study treatment, per treatment received.|
48133104|NCT02276482|100648645|FG000|NOT COMPLETED|Overall Study||3||
48133105|NCT02276482|100648646|FG001|NOT COMPLETED|Overall Study||1||
48133106|NCT03198000|100648647|FG000|STARTED|Overall Study||41||
48133107|NCT03198000|100648648|FG001|STARTED|Overall Study||38||
48133108|NCT03198000|100648649|FG002|STARTED|Overall Study||41||
48133109|NCT03198000|100648647|FG000|COMPLETED|Overall Study||41||
48133110|NCT03198000|100648648|FG001|COMPLETED|Overall Study||38||
48703235|NCT01380535|102057810|FG001|Safety Population|Overall Study||28|All randomized participants who received at least 1 dose of study treatment, per treatment received.|
48703236|NCT01380535|102057809|FG000|Intent-to-treat Population|Overall Study||29|All randomized subjects with baseline and post-treatment measurements, per assigned treatment|
48703237|NCT01380535|102057810|FG001|Intent-to-treat Population|Overall Study||24|All randomized subjects with baseline and post-treatment measurements, per assigned treatment|
48703238|NCT01380535|102057809|FG000|COMPLETED|Overall Study||22||
48703239|NCT01380535|102057810|FG001|COMPLETED|Overall Study||16||
48703240|NCT01380535|102057809|FG000|NOT COMPLETED|Overall Study||7||
48703241|NCT01380535|102057810|FG001|NOT COMPLETED|Overall Study||15||
48703242|NCT04895293|102057811|FG000|STARTED|Overall Study||5||
48703243|NCT04895293|102057811|FG000|COMPLETED|Overall Study||5||
48133111|NCT03198000|100648649|FG002|COMPLETED|Overall Study||41||
48133112|NCT03198000|100648647|FG000|NOT COMPLETED|Overall Study||0||
48133113|NCT03198000|100648648|FG001|NOT COMPLETED|Overall Study||0||
48133114|NCT03198000|100648649|FG002|NOT COMPLETED|Overall Study||0||
48133115|NCT00952653|100648650|FG000|STARTED|Period 1: MDZ Alone||28||
48133116|NCT00952653|100648650|FG000|COMPLETED|Period 1: MDZ Alone||28||
48133117|NCT00952653|100648650|FG000|NOT COMPLETED|Period 1: MDZ Alone||0||
48133118|NCT00952653|100648650|FG000|STARTED|Period 2: Coadministration DVS SR, MDZ||28||
48133119|NCT00952653|100648650|FG000|COMPLETED|Period 2: Coadministration DVS SR, MDZ||28||
48133120|NCT00952653|100648650|FG000|NOT COMPLETED|Period 2: Coadministration DVS SR, MDZ||0||
48133121|NCT00905580|100648651|FG000|STARTED|Overall Study||49||
48133122|NCT00905580|100648652|FG001|STARTED|Overall Study||50||
48133123|NCT00905580|100648651|FG000|COMPLETED|Overall Study||47||
48133124|NCT00905580|100648652|FG001|COMPLETED|Overall Study||47||
48133125|NCT00905580|100648651|FG000|NOT COMPLETED|Overall Study||2||
48133126|NCT00905580|100648652|FG001|NOT COMPLETED|Overall Study||3||
48133127|NCT00796718|100648653|FG000|STARTED|Overall Study||62||
48133128|NCT00796718|100648653|FG000|COMPLETED|Overall Study||53||
48133129|NCT00796718|100648653|FG000|NOT COMPLETED|Overall Study||9||
48133130|NCT02696317|100648654|FG000|STARTED|Habitual, 10 Days of Wear||42||
48703244|NCT04895293|102057811|FG000|NOT COMPLETED|Overall Study||0||
48703245|NCT03010137|102057812|FG000|STARTED|Overall Study||15||
48703246|NCT03010137|102057813|FG001|STARTED|Overall Study||15||
48703247|NCT03010137|102057812|FG000|COMPLETED|Overall Study||15||
48703248|NCT03010137|102057813|FG001|COMPLETED|Overall Study||15||
48703249|NCT03010137|102057812|FG000|NOT COMPLETED|Overall Study||0||
48703250|NCT03010137|102057813|FG001|NOT COMPLETED|Overall Study||0||
48133131|NCT02696317|100648655|FG001|STARTED|Habitual, 10 Days of Wear||40||
48133132|NCT02696317|100648654|FG000|COMPLETED|Habitual, 10 Days of Wear||40||
48133133|NCT02696317|100648655|FG001|COMPLETED|Habitual, 10 Days of Wear||36||
48133134|NCT02696317|100648654|FG000|NOT COMPLETED|Habitual, 10 Days of Wear||2||
48133135|NCT02696317|100648655|FG001|NOT COMPLETED|Habitual, 10 Days of Wear||4||
48133136|NCT02696317|100648654|FG000|STARTED|Period 1, 10 Days of Wear||40||
48133137|NCT02696317|100648655|FG001|STARTED|Period 1, 10 Days of Wear||36||
48133138|NCT02696317|100648654|FG000|COMPLETED|Period 1, 10 Days of Wear||40||
48133139|NCT02696317|100648655|FG001|COMPLETED|Period 1, 10 Days of Wear||36||
48133140|NCT02696317|100648654|FG000|NOT COMPLETED|Period 1, 10 Days of Wear||0||
48133141|NCT02696317|100648655|FG001|NOT COMPLETED|Period 1, 10 Days of Wear||0||
48133142|NCT02696317|100648654|FG000|STARTED|Period 2, 10 Days of Wear||40||
48133143|NCT02696317|100648655|FG001|STARTED|Period 2, 10 Days of Wear||36||
48133144|NCT02696317|100648654|FG000|COMPLETED|Period 2, 10 Days of Wear||39||
48133145|NCT02696317|100648655|FG001|COMPLETED|Period 2, 10 Days of Wear||36||
48133146|NCT02696317|100648654|FG000|NOT COMPLETED|Period 2, 10 Days of Wear||1||
48133147|NCT02696317|100648655|FG001|NOT COMPLETED|Period 2, 10 Days of Wear||0||
48703251|NCT00350363|102057814|FG000|STARTED|Overall Study||60||
48133148|NCT01546194|100648656|FG000|STARTED|Overall Study||100||
48133149|NCT01546194|100648657|FG001|STARTED|Overall Study||100||
48133150|NCT01546194|100648656|FG000|COMPLETED|Overall Study||64||
48133151|NCT01546194|100648657|FG001|COMPLETED|Overall Study||65||
48133152|NCT01546194|100648656|FG000|NOT COMPLETED|Overall Study||36||
48133153|NCT01546194|100648657|FG001|NOT COMPLETED|Overall Study||35||
48133154|NCT00746954|100648658|FG000|STARTED|Overall Study||3||
48286222|NCT03075410|101026269|FG001|STARTED|Part A-Washout Period 3 (14 Days)||1||
48286223|NCT03075410|101026270|FG002|STARTED|Part A-Washout Period 3 (14 Days)||2||
48286224|NCT03075410|101026271|FG003|STARTED|Part A-Washout Period 3 (14 Days)||1||
48286225|NCT03075410|101026272|FG004|STARTED|Part A-Washout Period 3 (14 Days)||2||
48286226|NCT03075410|101026273|FG005|STARTED|Part A-Washout Period 3 (14 Days)||1||
48286227|NCT03075410|101026274|FG006|STARTED|Part A-Washout Period 3 (14 Days)||0||
48286228|NCT03075410|101026275|FG007|STARTED|Part A-Washout Period 3 (14 Days)||0||
48286229|NCT03075410|101026276|FG008|STARTED|Part A-Washout Period 3 (14 Days)||0||
48286230|NCT03075410|101026268|FG000|COMPLETED|Part A-Washout Period 3 (14 Days)||1||
48286231|NCT03075410|101026269|FG001|COMPLETED|Part A-Washout Period 3 (14 Days)||1||
48286232|NCT03075410|101026270|FG002|COMPLETED|Part A-Washout Period 3 (14 Days)||2||
48286233|NCT03075410|101026271|FG003|COMPLETED|Part A-Washout Period 3 (14 Days)||1||
48286234|NCT03075410|101026272|FG004|COMPLETED|Part A-Washout Period 3 (14 Days)||2||
48286235|NCT03075410|101026273|FG005|COMPLETED|Part A-Washout Period 3 (14 Days)||1||
48286236|NCT03075410|101026274|FG006|COMPLETED|Part A-Washout Period 3 (14 Days)||0||
48286237|NCT03075410|101026275|FG007|COMPLETED|Part A-Washout Period 3 (14 Days)||0||
48286238|NCT03075410|101026276|FG008|COMPLETED|Part A-Washout Period 3 (14 Days)||0||
48577496|NCT04236141|101744782|FG000|STARTED|Overall Study||28||
48577497|NCT04236141|101744783|FG001|STARTED|Overall Study||14||
48577498|NCT04236141|101744782|FG000|Safety Population|Overall Study||27|Safety population included all randomized participants who received at least one dose of the study drug.|
48577499|NCT04236141|101744783|FG001|Safety Population|Overall Study||14|Safety population included all randomized participants who received at least one dose of the study drug.|
48577500|NCT04236141|101744782|FG000|Pharmacokinetic-Evaluable Population|Overall Study||27|Pharmacokinetic (PK)-evaluable population included all participants who had at least one evaluable PK sample post dose for at least one analyte.|
48577501|NCT04236141|101744783|FG001|Pharmacokinetic-Evaluable Population|Overall Study||0|Pharmacokinetic (PK)-evaluable population included all participants who had at least one evaluable PK sample post dose for at least one analyte.|
48577502|NCT04236141|101744782|FG000|Immunogenicity-Evaluable Population (Baseline Evaluable)|Overall Study||27|Immunogenicity-evaluable population included all participants with anti-drug antibody (ADA) assay results from baseline sample.|
48577503|NCT04236141|101744783|FG001|Immunogenicity-Evaluable Population (Baseline Evaluable)|Overall Study||14|Immunogenicity-evaluable population included all participants with anti-drug antibody (ADA) assay results from baseline sample.|
48577504|NCT04236141|101744782|FG000|Immunogenicity-Evaluable Population (Post-Baseline Evaluable)|Overall Study||24|Immunogenicity-evaluable population included all participants with at least one evaluable post-baseline ADA sample|
48577505|NCT04236141|101744783|FG001|Immunogenicity-Evaluable Population (Post-Baseline Evaluable)|Overall Study||0|Immunogenicity-evaluable population included all participants with at least one evaluable post-baseline ADA sample|
48577506|NCT04236141|101744782|FG000|Intent-to-treat Population|Overall Study||28|Intention-to-treat (ITT) population included all participants randomized, whether or not the participants received the assigned treatment.|
48577507|NCT04236141|101744783|FG001|Intent-to-treat Population|Overall Study||14|Intention-to-treat (ITT) population included all participants randomized, whether or not the participants received the assigned treatment.|
48577508|NCT04236141|101744782|FG000|COMPLETED|Overall Study||0||
48577509|NCT04236141|101744783|FG001|COMPLETED|Overall Study||0||
48577510|NCT04236141|101744782|FG000|NOT COMPLETED|Overall Study||28||
48703252|NCT00350363|102057814|FG000|COMPLETED|Overall Study||60||
48703253|NCT00350363|102057814|FG000|NOT COMPLETED|Overall Study||0||
48703254|NCT02438384|102057815|FG000|STARTED|Overall Study||25||
48286239|NCT03075410|101026268|FG000|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0||
48286240|NCT03075410|101026269|FG001|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0||
48286241|NCT03075410|101026270|FG002|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0||
48286242|NCT03075410|101026271|FG003|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0||
48286243|NCT03075410|101026272|FG004|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0||
48286244|NCT03075410|101026273|FG005|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0||
48286245|NCT03075410|101026274|FG006|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0||
48286246|NCT03075410|101026275|FG007|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0||
48286247|NCT03075410|101026276|FG008|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0||
48286248|NCT03075410|101026268|FG000|STARTED|Part A-Period 4 (14 Days)||1||
48286249|NCT03075410|101026269|FG001|STARTED|Part A-Period 4 (14 Days)||1||
48286250|NCT03075410|101026270|FG002|STARTED|Part A-Period 4 (14 Days)||2||
48286251|NCT03075410|101026271|FG003|STARTED|Part A-Period 4 (14 Days)||1||
48286252|NCT03075410|101026272|FG004|STARTED|Part A-Period 4 (14 Days)||2||
48286253|NCT03075410|101026273|FG005|STARTED|Part A-Period 4 (14 Days)||1||
48286254|NCT03075410|101026274|FG006|STARTED|Part A-Period 4 (14 Days)||0||
48286255|NCT03075410|101026275|FG007|STARTED|Part A-Period 4 (14 Days)||0||
48286256|NCT03075410|101026276|FG008|STARTED|Part A-Period 4 (14 Days)||0||
48577511|NCT04236141|101744783|FG001|NOT COMPLETED|Overall Study||14||
48577512|NCT00214786|101744784|FG000|STARTED|Overall Study||4||
48577513|NCT00214786|101744784|FG000|COMPLETED|Overall Study||1||
48577514|NCT00214786|101744784|FG000|NOT COMPLETED|Overall Study||3||
48703255|NCT02438384|102057816|FG001|STARTED|Overall Study||25||
48703256|NCT02438384|102057817|FG002|STARTED|Overall Study||25||
48703257|NCT02438384|102057815|FG000|COMPLETED|Overall Study||17||
48703258|NCT02438384|102057816|FG001|COMPLETED|Overall Study||19||
48286257|NCT03075410|101026268|FG000|COMPLETED|Part A-Period 4 (14 Days)||1||
48286258|NCT03075410|101026269|FG001|COMPLETED|Part A-Period 4 (14 Days)||1||
48577515|NCT04481789|101744785|FG000|STARTED|Period 1||32||
48577516|NCT04481789|101744786|FG001|STARTED|Period 1||34||
48577517|NCT04481789|101744787|FG002|STARTED|Period 1||3||
48577518|NCT04481789|101744788|FG003|STARTED|Period 1||3||
48577519|NCT04481789|101744789|FG004|STARTED|Period 1||3||
48577520|NCT04481789|101744790|FG005|STARTED|Period 1||3||
48577521|NCT04481789|101744785|FG000|COMPLETED|Period 1||31||
48577522|NCT04481789|101744786|FG001|COMPLETED|Period 1||34||
48703259|NCT02438384|102057817|FG002|COMPLETED|Overall Study||21||
48703260|NCT02438384|102057815|FG000|NOT COMPLETED|Overall Study||8||
48703261|NCT02438384|102057816|FG001|NOT COMPLETED|Overall Study||6||
48703262|NCT02438384|102057817|FG002|NOT COMPLETED|Overall Study||4||
48703263|NCT04243577|102057818|FG000|STARTED|First Intervention (1 Hour)||20||
48703264|NCT04243577|102057819|FG001|STARTED|First Intervention (1 Hour)||20||
48703265|NCT04243577|102057820|FG002|STARTED|First Intervention (1 Hour)||15||
48703266|NCT04243577|102057821|FG003|STARTED|First Intervention (1 Hour)||15||
48703267|NCT04243577|102057818|FG000|COMPLETED|First Intervention (1 Hour)||20||
48286259|NCT03075410|101026270|FG002|COMPLETED|Part A-Period 4 (14 Days)||2||
48286260|NCT03075410|101026271|FG003|COMPLETED|Part A-Period 4 (14 Days)||1||
48286261|NCT03075410|101026272|FG004|COMPLETED|Part A-Period 4 (14 Days)||2||
48286262|NCT03075410|101026273|FG005|COMPLETED|Part A-Period 4 (14 Days)||1||
48286263|NCT03075410|101026274|FG006|COMPLETED|Part A-Period 4 (14 Days)||0||
48286264|NCT03075410|101026275|FG007|COMPLETED|Part A-Period 4 (14 Days)||0||
48286265|NCT03075410|101026276|FG008|COMPLETED|Part A-Period 4 (14 Days)||0||
48286266|NCT03075410|101026268|FG000|NOT COMPLETED|Part A-Period 4 (14 Days)||0||
48286267|NCT03075410|101026269|FG001|NOT COMPLETED|Part A-Period 4 (14 Days)||0||
48286268|NCT03075410|101026270|FG002|NOT COMPLETED|Part A-Period 4 (14 Days)||0||
48286269|NCT03075410|101026271|FG003|NOT COMPLETED|Part A-Period 4 (14 Days)||0||
48286270|NCT03075410|101026272|FG004|NOT COMPLETED|Part A-Period 4 (14 Days)||0||
48286271|NCT03075410|101026273|FG005|NOT COMPLETED|Part A-Period 4 (14 Days)||0||
48286272|NCT03075410|101026274|FG006|NOT COMPLETED|Part A-Period 4 (14 Days)||0||
48286273|NCT03075410|101026275|FG007|NOT COMPLETED|Part A-Period 4 (14 Days)||0||
48703268|NCT04243577|102057819|FG001|COMPLETED|First Intervention (1 Hour)||20||
48703269|NCT04243577|102057820|FG002|COMPLETED|First Intervention (1 Hour)||15||
48703270|NCT04243577|102057821|FG003|COMPLETED|First Intervention (1 Hour)||15||
48286274|NCT03075410|101026276|FG008|NOT COMPLETED|Part A-Period 4 (14 Days)||0||
48286275|NCT03075410|101026268|FG000|STARTED|Part B (up to 28 Days)||0||
48286276|NCT03075410|101026269|FG001|STARTED|Part B (up to 28 Days)||0||
48286277|NCT03075410|101026270|FG002|STARTED|Part B (up to 28 Days)||0||
48286278|NCT03075410|101026271|FG003|STARTED|Part B (up to 28 Days)||0||
48286279|NCT03075410|101026272|FG004|STARTED|Part B (up to 28 Days)||0||
48286280|NCT03075410|101026273|FG005|STARTED|Part B (up to 28 Days)||0||
48286281|NCT03075410|101026274|FG006|STARTED|Part B (up to 28 Days)||4||
48286282|NCT03075410|101026275|FG007|STARTED|Part B (up to 28 Days)||7||
48286283|NCT03075410|101026276|FG008|STARTED|Part B (up to 28 Days)||8||
48286284|NCT03075410|101026268|FG000|COMPLETED|Part B (up to 28 Days)||0||
48286285|NCT03075410|101026269|FG001|COMPLETED|Part B (up to 28 Days)||0||
48286286|NCT03075410|101026270|FG002|COMPLETED|Part B (up to 28 Days)||0||
48286287|NCT03075410|101026271|FG003|COMPLETED|Part B (up to 28 Days)||0||
48286288|NCT03075410|101026272|FG004|COMPLETED|Part B (up to 28 Days)||0||
48286289|NCT03075410|101026273|FG005|COMPLETED|Part B (up to 28 Days)||0||
48577523|NCT04481789|101744787|FG002|COMPLETED|Period 1||3||
48577524|NCT04481789|101744788|FG003|COMPLETED|Period 1||3||
48577525|NCT04481789|101744789|FG004|COMPLETED|Period 1||3||
48577526|NCT04481789|101744790|FG005|COMPLETED|Period 1||3||
48577527|NCT04481789|101744785|FG000|NOT COMPLETED|Period 1||1||
48577528|NCT04481789|101744786|FG001|NOT COMPLETED|Period 1||0||
48577529|NCT04481789|101744787|FG002|NOT COMPLETED|Period 1||0||
48577530|NCT04481789|101744788|FG003|NOT COMPLETED|Period 1||0||
48703271|NCT04243577|102057818|FG000|NOT COMPLETED|First Intervention (1 Hour)||0||
48703272|NCT04243577|102057819|FG001|NOT COMPLETED|First Intervention (1 Hour)||0||
48703273|NCT04243577|102057820|FG002|NOT COMPLETED|First Intervention (1 Hour)||0||
48703274|NCT04243577|102057821|FG003|NOT COMPLETED|First Intervention (1 Hour)||0||
48703275|NCT04243577|102057818|FG000|STARTED|Washout (10 Minutes)||20||
48703276|NCT04243577|102057819|FG001|STARTED|Washout (10 Minutes)||20||
48703277|NCT04243577|102057820|FG002|STARTED|Washout (10 Minutes)||15||
48703278|NCT04243577|102057821|FG003|STARTED|Washout (10 Minutes)||15||
48703279|NCT04243577|102057818|FG000|COMPLETED|Washout (10 Minutes)||20||
48286290|NCT03075410|101026274|FG006|COMPLETED|Part B (up to 28 Days)||4||
48286291|NCT03075410|101026275|FG007|COMPLETED|Part B (up to 28 Days)||7||
48286292|NCT03075410|101026276|FG008|COMPLETED|Part B (up to 28 Days)||8||
48286293|NCT03075410|101026268|FG000|NOT COMPLETED|Part B (up to 28 Days)||0||
48577531|NCT04481789|101744789|FG004|NOT COMPLETED|Period 1||0||
48577532|NCT04481789|101744790|FG005|NOT COMPLETED|Period 1||0||
48577533|NCT04481789|101744785|FG000|STARTED|Period 2||31||
48577534|NCT04481789|101744786|FG001|STARTED|Period 2||34||
48577535|NCT04481789|101744787|FG002|STARTED|Period 2||3||
48286294|NCT03075410|101026269|FG001|NOT COMPLETED|Part B (up to 28 Days)||0||
48286295|NCT03075410|101026270|FG002|NOT COMPLETED|Part B (up to 28 Days)||0||
48577536|NCT04481789|101744788|FG003|STARTED|Period 2||3||
48577537|NCT04481789|101744789|FG004|STARTED|Period 2||3||
48286296|NCT03075410|101026271|FG003|NOT COMPLETED|Part B (up to 28 Days)||0||
48286297|NCT03075410|101026272|FG004|NOT COMPLETED|Part B (up to 28 Days)||0||
48286298|NCT03075410|101026273|FG005|NOT COMPLETED|Part B (up to 28 Days)||0||
48286299|NCT03075410|101026274|FG006|NOT COMPLETED|Part B (up to 28 Days)||0||
48286300|NCT03075410|101026275|FG007|NOT COMPLETED|Part B (up to 28 Days)||0||
48286301|NCT03075410|101026276|FG008|NOT COMPLETED|Part B (up to 28 Days)||0||
48286302|NCT01744392|101026277|FG000|STARTED|Overall Study||23||
48286303|NCT01744392|101026277|FG000|COMPLETED|Overall Study||22||
48286304|NCT01744392|101026277|FG000|NOT COMPLETED|Overall Study||1||
48400016|NCT00968708|101309276|FG001|NOT COMPLETED|Overall Study||298||
48400017|NCT00134017|101309277|FG000|STARTED|Overall Study||142||
48400018|NCT00134017|101309277|FG000|COMPLETED|Overall Study||142||
48400019|NCT00134017|101309277|FG000|NOT COMPLETED|Overall Study||0||
48400020|NCT02444936|101309278|FG000|STARTED|Overall Study||10||
48400021|NCT02444936|101309279|FG001|STARTED|Overall Study||12||
48400022|NCT02444936|101309278|FG000|COMPLETED|Overall Study||10||
48400023|NCT02444936|101309279|FG001|COMPLETED|Overall Study||12||
48400024|NCT02444936|101309278|FG000|NOT COMPLETED|Overall Study||0||
48400025|NCT02444936|101309279|FG001|NOT COMPLETED|Overall Study||0||
48400026|NCT00615459|101309280|FG000|STARTED|Period I||41||
48400027|NCT00615459|101309281|FG001|STARTED|Period I||41||
48400028|NCT00615459|101309282|FG002|STARTED|Period I||42||
48577538|NCT04481789|101744790|FG005|STARTED|Period 2||3||
48577539|NCT04481789|101744785|FG000|COMPLETED|Period 2||31||
48577540|NCT04481789|101744786|FG001|COMPLETED|Period 2||34||
48400029|NCT00615459|101309283|FG003|STARTED|Period I||43||
48400030|NCT00615459|101309280|FG000|COMPLETED|Period I||37||
48400031|NCT00615459|101309281|FG001|COMPLETED|Period I||40||
48400032|NCT00615459|101309282|FG002|COMPLETED|Period I||40||
48400033|NCT00615459|101309283|FG003|COMPLETED|Period I||42||
48400034|NCT00615459|101309280|FG000|NOT COMPLETED|Period I||4||
48400035|NCT00615459|101309281|FG001|NOT COMPLETED|Period I||1||
48400036|NCT00615459|101309282|FG002|NOT COMPLETED|Period I||2||
48400037|NCT00615459|101309283|FG003|NOT COMPLETED|Period I||1||
48400038|NCT00615459|101309280|FG000|STARTED|Period II||37||
48577541|NCT04481789|101744787|FG002|COMPLETED|Period 2||3||
48577542|NCT04481789|101744788|FG003|COMPLETED|Period 2||3||
48577543|NCT04481789|101744789|FG004|COMPLETED|Period 2||3||
48577544|NCT04481789|101744790|FG005|COMPLETED|Period 2||3||
48577545|NCT04481789|101744785|FG000|NOT COMPLETED|Period 2||0||
48577546|NCT04481789|101744786|FG001|NOT COMPLETED|Period 2||0||
48577547|NCT04481789|101744787|FG002|NOT COMPLETED|Period 2||0||
48577548|NCT04481789|101744788|FG003|NOT COMPLETED|Period 2||0||
48577549|NCT04481789|101744789|FG004|NOT COMPLETED|Period 2||0||
48577550|NCT04481789|101744790|FG005|NOT COMPLETED|Period 2||0||
48577551|NCT04481789|101744785|FG000|STARTED|Period 3||31||
48577552|NCT04481789|101744786|FG001|STARTED|Period 3||0||
48703280|NCT04243577|102057819|FG001|COMPLETED|Washout (10 Minutes)||20||
48703281|NCT04243577|102057820|FG002|COMPLETED|Washout (10 Minutes)||15||
48703282|NCT04243577|102057821|FG003|COMPLETED|Washout (10 Minutes)||15||
48703283|NCT04243577|102057818|FG000|NOT COMPLETED|Washout (10 Minutes)||0||
48703284|NCT04243577|102057819|FG001|NOT COMPLETED|Washout (10 Minutes)||0||
48703285|NCT04243577|102057820|FG002|NOT COMPLETED|Washout (10 Minutes)||0||
48703286|NCT04243577|102057821|FG003|NOT COMPLETED|Washout (10 Minutes)||0||
48703287|NCT04243577|102057818|FG000|STARTED|Second Intervention (1 Hour)||20||
48286305|NCT03170349|101026278|FG000|STARTED|At 30 Days Follow-up||124||
48286306|NCT03170349|101026278|FG000|COMPLETED|At 30 Days Follow-up||123||
48286307|NCT03170349|101026278|FG000|NOT COMPLETED|At 30 Days Follow-up||1||
48400039|NCT00615459|101309281|FG001|STARTED|Period II||40||
48400040|NCT00615459|101309282|FG002|STARTED|Period II||40||
48400041|NCT00615459|101309283|FG003|STARTED|Period II||42||
48400042|NCT00615459|101309280|FG000|COMPLETED|Period II||36||
48400043|NCT00615459|101309281|FG001|COMPLETED|Period II||40||
48400044|NCT00615459|101309282|FG002|COMPLETED|Period II||40||
48400045|NCT00615459|101309283|FG003|COMPLETED|Period II||41||
48400046|NCT00615459|101309280|FG000|NOT COMPLETED|Period II||1||
48400047|NCT00615459|101309281|FG001|NOT COMPLETED|Period II||0||
48400048|NCT00615459|101309282|FG002|NOT COMPLETED|Period II||0||
48400049|NCT00615459|101309283|FG003|NOT COMPLETED|Period II||1||
48400050|NCT00615459|101309280|FG000|STARTED|Period III||36||
48400051|NCT00615459|101309281|FG001|STARTED|Period III||40||
48400052|NCT00615459|101309282|FG002|STARTED|Period III||40||
48400053|NCT00615459|101309283|FG003|STARTED|Period III||41||
48400054|NCT00615459|101309280|FG000|COMPLETED|Period III||36||
48400055|NCT00615459|101309281|FG001|COMPLETED|Period III||37||
48400056|NCT00615459|101309282|FG002|COMPLETED|Period III||39||
48400057|NCT00615459|101309283|FG003|COMPLETED|Period III||41||
48400058|NCT00615459|101309280|FG000|NOT COMPLETED|Period III||0||
48400059|NCT00615459|101309281|FG001|NOT COMPLETED|Period III||3||
48577553|NCT04481789|101744787|FG002|STARTED|Period 3||3||
48703288|NCT04243577|102057819|FG001|STARTED|Second Intervention (1 Hour)||20||
48286308|NCT03170349|101026278|FG000|STARTED|At 6 Months Follow-up||123||
48400060|NCT00615459|101309282|FG002|NOT COMPLETED|Period III||1||
48400061|NCT00615459|101309283|FG003|NOT COMPLETED|Period III||0||
48400062|NCT03984812|101309284|FG000|STARTED|Part 1 (Up to Day 28)||6||
48400063|NCT03984812|101309285|FG001|STARTED|Part 1 (Up to Day 28)||6||
48577554|NCT04481789|101744788|FG003|STARTED|Period 3||3||
48577555|NCT04481789|101744789|FG004|STARTED|Period 3||3||
48577556|NCT04481789|101744790|FG005|STARTED|Period 3||3||
48577557|NCT04481789|101744785|FG000|COMPLETED|Period 3||31||
48577558|NCT04481789|101744786|FG001|COMPLETED|Period 3||0||
48577559|NCT04481789|101744787|FG002|COMPLETED|Period 3||3||
48577560|NCT04481789|101744788|FG003|COMPLETED|Period 3||3||
48577561|NCT04481789|101744789|FG004|COMPLETED|Period 3||3||
48577562|NCT04481789|101744790|FG005|COMPLETED|Period 3||3||
48577563|NCT04481789|101744785|FG000|NOT COMPLETED|Period 3||0||
48577564|NCT04481789|101744786|FG001|NOT COMPLETED|Period 3||0||
48577565|NCT04481789|101744787|FG002|NOT COMPLETED|Period 3||0||
48577566|NCT04481789|101744788|FG003|NOT COMPLETED|Period 3||0||
48577567|NCT04481789|101744789|FG004|NOT COMPLETED|Period 3||0||
48577568|NCT04481789|101744790|FG005|NOT COMPLETED|Period 3||0||
48577569|NCT00619892|101744791|FG000|STARTED|Overall Study||13||
48577570|NCT00619892|101744792|FG001|STARTED|Overall Study||13||
48577571|NCT00619892|101744791|FG000|COMPLETED|Overall Study||10||
48577572|NCT00619892|101744792|FG001|COMPLETED|Overall Study||11||
48577573|NCT00619892|101744791|FG000|NOT COMPLETED|Overall Study||3||
48577574|NCT00619892|101744792|FG001|NOT COMPLETED|Overall Study||2||
48577575|NCT01508130|101744793|FG000|STARTED|Overall Study||493||
48577576|NCT01508130|101744794|FG001|STARTED|Overall Study||142||
48577577|NCT01508130|101744793|FG000|mTRT|Overall Study||493||
48577578|NCT01508130|101744794|FG001|mTRT|Overall Study||142||
48577579|NCT01508130|101744793|FG000|COMPLETED|Overall Study||266||
48577580|NCT01508130|101744794|FG001|COMPLETED|Overall Study||73||
48577581|NCT01508130|101744793|FG000|NOT COMPLETED|Overall Study||227||
48577582|NCT01508130|101744794|FG001|NOT COMPLETED|Overall Study||69||
48577583|NCT01894100|101744795|FG000|STARTED|Overall Study||15||
48577584|NCT01894100|101744796|FG001|STARTED|Overall Study||15||
48577585|NCT01894100|101744795|FG000|COMPLETED|Overall Study||12||
48577586|NCT01894100|101744796|FG001|COMPLETED|Overall Study||14||
48577587|NCT01894100|101744795|FG000|NOT COMPLETED|Overall Study||3||
48577588|NCT01894100|101744796|FG001|NOT COMPLETED|Overall Study||1||
48577589|NCT01661088|101744797|FG000|STARTED|FOLFIRINOX||25||
48577590|NCT01661088|101744797|FG000|COMPLETED|FOLFIRINOX||21||
48577591|NCT01661088|101744797|FG000|NOT COMPLETED|FOLFIRINOX||4||
48577592|NCT01661088|101744797|FG000|STARTED|IMRT With FDR Gemcitabine||21||
48577593|NCT01661088|101744797|FG000|COMPLETED|IMRT With FDR Gemcitabine||19||
48577594|NCT01661088|101744797|FG000|NOT COMPLETED|IMRT With FDR Gemcitabine||2||
48577595|NCT03852264|101744798|FG000|STARTED|First Research Visit||30||
48577596|NCT03852264|101744799|FG001|STARTED|First Research Visit||25||
48577597|NCT03852264|101744798|FG000|COMPLETED|First Research Visit||30||
48577598|NCT03852264|101744799|FG001|COMPLETED|First Research Visit||25||
48577599|NCT03852264|101744798|FG000|NOT COMPLETED|First Research Visit||0||
48577600|NCT03852264|101744799|FG001|NOT COMPLETED|First Research Visit||0||
48577601|NCT03852264|101744798|FG000|STARTED|Second Research Visit||30||
48577602|NCT03852264|101744799|FG001|STARTED|Second Research Visit||25||
48577603|NCT03852264|101744798|FG000|COMPLETED|Second Research Visit||30||
48577604|NCT03852264|101744799|FG001|COMPLETED|Second Research Visit||25||
48577605|NCT03852264|101744798|FG000|NOT COMPLETED|Second Research Visit||0||
48577606|NCT03852264|101744799|FG001|NOT COMPLETED|Second Research Visit||0||
48577607|NCT03852264|101744798|FG000|STARTED|Third Research Visit||30||
48577608|NCT03852264|101744799|FG001|STARTED|Third Research Visit||25||
48577609|NCT03852264|101744798|FG000|COMPLETED|Third Research Visit||29||
48577610|NCT03852264|101744799|FG001|COMPLETED|Third Research Visit||25||
48577611|NCT03852264|101744798|FG000|NOT COMPLETED|Third Research Visit||1||
48577612|NCT03852264|101744799|FG001|NOT COMPLETED|Third Research Visit||0||
48577613|NCT00458536|101744800|FG000|STARTED|Overall Study||38||
48577614|NCT00458536|101744800|FG000|COMPLETED|Overall Study||19||
48577615|NCT00458536|101744800|FG000|NOT COMPLETED|Overall Study||19||
48577616|NCT00723008|101744801|FG000|STARTED|Enrollment||11||
48577617|NCT00723008|101744802|FG001|STARTED|Enrollment||9||
48577618|NCT00723008|101744801|FG000|COMPLETED|Enrollment||10||
48577619|NCT00723008|101744802|FG001|COMPLETED|Enrollment||9||
48577620|NCT00723008|101744801|FG000|NOT COMPLETED|Enrollment||1||
48577621|NCT00723008|101744802|FG001|NOT COMPLETED|Enrollment||0||
48577622|NCT00723008|101744801|FG000|STARTED|4-Week Double Blinded||10||
48577623|NCT00723008|101744802|FG001|STARTED|4-Week Double Blinded||9||
48577624|NCT00723008|101744801|FG000|COMPLETED|4-Week Double Blinded||5||
48577625|NCT00723008|101744802|FG001|COMPLETED|4-Week Double Blinded||4||
48577626|NCT00723008|101744801|FG000|NOT COMPLETED|4-Week Double Blinded||5||
48577627|NCT00723008|101744802|FG001|NOT COMPLETED|4-Week Double Blinded||5||
48577628|NCT00723008|101744801|FG000|STARTED|4-Week Unblinded Treatment||5||
48577629|NCT00723008|101744802|FG001|STARTED|4-Week Unblinded Treatment||4||
48577630|NCT00723008|101744801|FG000|COMPLETED|4-Week Unblinded Treatment||4||
48577631|NCT00723008|101744802|FG001|COMPLETED|4-Week Unblinded Treatment||3||
48577632|NCT00723008|101744801|FG000|NOT COMPLETED|4-Week Unblinded Treatment||1||
48577633|NCT00723008|101744802|FG001|NOT COMPLETED|4-Week Unblinded Treatment||1||
48577634|NCT02366637|101744803|FG000|STARTED|First Intervention Period||7||
48577635|NCT02366637|101744804|FG001|STARTED|First Intervention Period||6||
48577636|NCT02366637|101744803|FG000|COMPLETED|First Intervention Period||1||
48133155|NCT00746954|100648659|FG001|STARTED|Overall Study||3||
48133156|NCT00746954|100648660|FG002|STARTED|Overall Study||2||
48133157|NCT00746954|100648658|FG000|COMPLETED|Overall Study||3||
48133158|NCT00746954|100648659|FG001|COMPLETED|Overall Study||3||
48133159|NCT00746954|100648660|FG002|COMPLETED|Overall Study||2||
48133160|NCT00746954|100648658|FG000|NOT COMPLETED|Overall Study||0||
48133161|NCT00746954|100648659|FG001|NOT COMPLETED|Overall Study||0||
48133162|NCT00746954|100648660|FG002|NOT COMPLETED|Overall Study||0||
48133163|NCT01054729|100648661|FG000|STARTED|Overall Study||16||
48133164|NCT01054729|100648662|FG001|STARTED|Overall Study||19||
48133165|NCT01054729|100648663|FG002|STARTED|Overall Study||15||
48133166|NCT01054729|100648664|FG003|STARTED|Overall Study||14||
48133167|NCT01054729|100648661|FG000|Randomized and Treated|Overall Study||16||
48133168|NCT01054729|100648662|FG001|Randomized and Treated|Overall Study||18||
48133169|NCT01054729|100648663|FG002|Randomized and Treated|Overall Study||15||
48133170|NCT01054729|100648664|FG003|Randomized and Treated|Overall Study||14||
48133171|NCT01054729|100648661|FG000|COMPLETED|Overall Study||12||
48133172|NCT01054729|100648662|FG001|COMPLETED|Overall Study||14||
48133173|NCT01054729|100648663|FG002|COMPLETED|Overall Study||9||
48133174|NCT01054729|100648664|FG003|COMPLETED|Overall Study||11||
48133175|NCT01054729|100648661|FG000|NOT COMPLETED|Overall Study||4||
48133176|NCT01054729|100648662|FG001|NOT COMPLETED|Overall Study||5||
48133177|NCT01054729|100648663|FG002|NOT COMPLETED|Overall Study||6||
48133178|NCT01054729|100648664|FG003|NOT COMPLETED|Overall Study||3||
48133179|NCT01528228|100648665|FG000|STARTED|Overall Study||10||
48133180|NCT01528228|100648666|FG001|STARTED|Overall Study||10||
48133181|NCT01528228|100648665|FG000|COMPLETED|Overall Study||9||
48577637|NCT02366637|101744804|FG001|COMPLETED|First Intervention Period||1||
48577638|NCT02366637|101744803|FG000|NOT COMPLETED|First Intervention Period||6||
48577639|NCT02366637|101744804|FG001|NOT COMPLETED|First Intervention Period||5||
48577640|NCT02366637|101744803|FG000|STARTED|Washout Period 28 to 49 Days||1||
48577641|NCT02366637|101744804|FG001|STARTED|Washout Period 28 to 49 Days||1||
48577642|NCT02366637|101744803|FG000|COMPLETED|Washout Period 28 to 49 Days||1||
48577643|NCT02366637|101744804|FG001|COMPLETED|Washout Period 28 to 49 Days||1||
48577644|NCT02366637|101744803|FG000|NOT COMPLETED|Washout Period 28 to 49 Days||0||
48577645|NCT02366637|101744804|FG001|NOT COMPLETED|Washout Period 28 to 49 Days||0||
48577646|NCT02366637|101744803|FG000|STARTED|Second Intervention Period||1||
48577647|NCT02366637|101744804|FG001|STARTED|Second Intervention Period||1||
48577648|NCT02366637|101744803|FG000|COMPLETED|Second Intervention Period||0||
48577649|NCT02366637|101744804|FG001|COMPLETED|Second Intervention Period||0||
48577650|NCT02366637|101744803|FG000|NOT COMPLETED|Second Intervention Period||1||
48577651|NCT02366637|101744804|FG001|NOT COMPLETED|Second Intervention Period||1||
48577652|NCT03681288|101744805|FG000|STARTED|Overall Study||26||
48577653|NCT03681288|101744805|FG000|COMPLETED|Overall Study||18||
48577654|NCT03681288|101744805|FG000|NOT COMPLETED|Overall Study||8||
48286309|NCT03170349|101026278|FG000|COMPLETED|At 6 Months Follow-up||114||
48577655|NCT02977572|101744806|FG000|STARTED|Overall Study||58||
48577656|NCT02977572|101744807|FG001|STARTED|Overall Study||56||
48133182|NCT01528228|100648666|FG001|COMPLETED|Overall Study||9||
48286310|NCT03170349|101026278|FG000|NOT COMPLETED|At 6 Months Follow-up||9||
48577657|NCT02977572|101744806|FG000|COMPLETED|Overall Study||56||
48577658|NCT02977572|101744807|FG001|COMPLETED|Overall Study||54||
48577659|NCT02977572|101744806|FG000|NOT COMPLETED|Overall Study||2||
48133183|NCT01528228|100648665|FG000|NOT COMPLETED|Overall Study||1||
48133184|NCT01528228|100648666|FG001|NOT COMPLETED|Overall Study||1||
48133185|NCT01615029|100648667|FG000|STARTED|Overall Study||3||
48133186|NCT01615029|100648668|FG001|STARTED|Overall Study||3||
48133187|NCT01615029|100648669|FG002|STARTED|Overall Study||4||
48133188|NCT01615029|100648670|FG003|STARTED|Overall Study||3||
48133189|NCT01615029|100648671|FG004|STARTED|Overall Study||32||
48133190|NCT01615029|100648667|FG000|COMPLETED|Overall Study||0||
48133191|NCT01615029|100648668|FG001|COMPLETED|Overall Study||0||
48133192|NCT01615029|100648669|FG002|COMPLETED|Overall Study||0||
48133193|NCT01615029|100648670|FG003|COMPLETED|Overall Study||0||
48133194|NCT01615029|100648671|FG004|COMPLETED|Overall Study||0||
48133195|NCT01615029|100648667|FG000|NOT COMPLETED|Overall Study||3||
48133196|NCT01615029|100648668|FG001|NOT COMPLETED|Overall Study||3||
48133197|NCT01615029|100648669|FG002|NOT COMPLETED|Overall Study||4||
48286311|NCT03170349|101026278|FG000|STARTED|At 1 Year Follow-up||114||
48286312|NCT03170349|101026278|FG000|COMPLETED|At 1 Year Follow-up||106||
48577660|NCT02977572|101744807|FG001|NOT COMPLETED|Overall Study||2||
48577661|NCT03933618|101744808|FG000|STARTED|Baseline||4||
48577662|NCT03933618|101744809|FG001|STARTED|Baseline||4||
48577663|NCT03933618|101744810|FG002|STARTED|Baseline||4||
48577664|NCT03933618|101744811|FG003|STARTED|Baseline||4||
48577665|NCT03933618|101744812|FG004|STARTED|Baseline||4||
48577666|NCT03933618|101744813|FG005|STARTED|Baseline||4||
48577667|NCT03933618|101744808|FG000|COMPLETED|Baseline||4||
48577668|NCT03933618|101744809|FG001|COMPLETED|Baseline||4||
48577669|NCT03933618|101744810|FG002|COMPLETED|Baseline||4||
48577670|NCT03933618|101744811|FG003|COMPLETED|Baseline||4||
48577671|NCT03933618|101744812|FG004|COMPLETED|Baseline||4||
48577672|NCT03933618|101744813|FG005|COMPLETED|Baseline||4||
48577673|NCT03933618|101744808|FG000|NOT COMPLETED|Baseline||0||
48577674|NCT03933618|101744809|FG001|NOT COMPLETED|Baseline||0||
48577675|NCT03933618|101744810|FG002|NOT COMPLETED|Baseline||0||
48577676|NCT03933618|101744811|FG003|NOT COMPLETED|Baseline||0||
48577677|NCT03933618|101744812|FG004|NOT COMPLETED|Baseline||0||
48577678|NCT03933618|101744813|FG005|NOT COMPLETED|Baseline||0||
48577679|NCT03933618|101744808|FG000|STARTED|Baseline to Week 8||4||
48577680|NCT03933618|101744809|FG001|STARTED|Baseline to Week 8||4||
48286313|NCT03170349|101026278|FG000|NOT COMPLETED|At 1 Year Follow-up||8||
48286314|NCT03170349|101026278|FG000|STARTED|At 2 Year Follow-up||106||
48286315|NCT03170349|101026278|FG000|COMPLETED|At 2 Year Follow-up||88||
48286316|NCT03170349|101026278|FG000|NOT COMPLETED|At 2 Year Follow-up||18||
48286317|NCT03756129|101026279|FG000|STARTED|Overall Study||11||
48286318|NCT03756129|101026280|FG001|STARTED|Overall Study||10||
48577681|NCT03933618|101744810|FG002|STARTED|Baseline to Week 8||4||
48577682|NCT03933618|101744811|FG003|STARTED|Baseline to Week 8||4||
48577683|NCT03933618|101744812|FG004|STARTED|Baseline to Week 8||4||
48577684|NCT03933618|101744813|FG005|STARTED|Baseline to Week 8||4||
48577685|NCT03933618|101744808|FG000|COMPLETED|Baseline to Week 8||4||
48577686|NCT03933618|101744809|FG001|COMPLETED|Baseline to Week 8||4||
48577687|NCT03933618|101744810|FG002|COMPLETED|Baseline to Week 8||4||
48577688|NCT03933618|101744811|FG003|COMPLETED|Baseline to Week 8||4||
48577689|NCT03933618|101744812|FG004|COMPLETED|Baseline to Week 8||4||
48577690|NCT03933618|101744813|FG005|COMPLETED|Baseline to Week 8||4||
48577691|NCT03933618|101744808|FG000|NOT COMPLETED|Baseline to Week 8||0||
48577692|NCT03933618|101744809|FG001|NOT COMPLETED|Baseline to Week 8||0||
48577693|NCT03933618|101744810|FG002|NOT COMPLETED|Baseline to Week 8||0||
48577694|NCT03933618|101744811|FG003|NOT COMPLETED|Baseline to Week 8||0||
48577695|NCT03933618|101744812|FG004|NOT COMPLETED|Baseline to Week 8||0||
48577696|NCT03933618|101744813|FG005|NOT COMPLETED|Baseline to Week 8||0||
48577697|NCT03933618|101744808|FG000|STARTED|Week 8 to Week 16||4||
48577698|NCT03933618|101744809|FG001|STARTED|Week 8 to Week 16||4||
48577699|NCT03933618|101744810|FG002|STARTED|Week 8 to Week 16||4||
48577700|NCT03933618|101744811|FG003|STARTED|Week 8 to Week 16||4||
48577701|NCT03933618|101744812|FG004|STARTED|Week 8 to Week 16||4||
48286319|NCT03756129|101026281|FG002|STARTED|Overall Study||10||
48286320|NCT03756129|101026282|FG003|STARTED|Overall Study||9||
48286321|NCT03756129|101026283|FG004|STARTED|Overall Study||10||
48286322|NCT03756129|101026284|FG005|STARTED|Overall Study||20||
48286323|NCT03756129|101026279|FG000|COMPLETED|Overall Study||8||
48286324|NCT03756129|101026280|FG001|COMPLETED|Overall Study||8||
48286325|NCT03756129|101026281|FG002|COMPLETED|Overall Study||7||
48286326|NCT03756129|101026282|FG003|COMPLETED|Overall Study||6||
48286327|NCT03756129|101026283|FG004|COMPLETED|Overall Study||9||
48286328|NCT03756129|101026284|FG005|COMPLETED|Overall Study||15||
48286329|NCT03756129|101026279|FG000|NOT COMPLETED|Overall Study||3||
48286330|NCT03756129|101026280|FG001|NOT COMPLETED|Overall Study||2||
48286331|NCT03756129|101026281|FG002|NOT COMPLETED|Overall Study||3||
48286332|NCT03756129|101026282|FG003|NOT COMPLETED|Overall Study||3||
48286333|NCT03756129|101026283|FG004|NOT COMPLETED|Overall Study||1||
48286334|NCT03756129|101026284|FG005|NOT COMPLETED|Overall Study||5||
48286335|NCT04971681|101026285|FG000|STARTED|First Intervention||4||
48286336|NCT04971681|101026286|FG001|STARTED|First Intervention||5||
48286337|NCT04971681|101026285|FG000|COMPLETED|First Intervention||4||
48286338|NCT04971681|101026286|FG001|COMPLETED|First Intervention||5||
48286339|NCT04971681|101026285|FG000|NOT COMPLETED|First Intervention||0||
48286340|NCT04971681|101026286|FG001|NOT COMPLETED|First Intervention||0||
48286341|NCT04971681|101026285|FG000|STARTED|Washout (7-14 Days)||4||
48577702|NCT03933618|101744813|FG005|STARTED|Week 8 to Week 16||4||
48577703|NCT03933618|101744808|FG000|COMPLETED|Week 8 to Week 16||4||
48577704|NCT03933618|101744809|FG001|COMPLETED|Week 8 to Week 16||4||
48577705|NCT03933618|101744810|FG002|COMPLETED|Week 8 to Week 16||4||
48577706|NCT03933618|101744811|FG003|COMPLETED|Week 8 to Week 16||4||
48577707|NCT03933618|101744812|FG004|COMPLETED|Week 8 to Week 16||4||
48577708|NCT03933618|101744813|FG005|COMPLETED|Week 8 to Week 16||4||
48577709|NCT03933618|101744808|FG000|NOT COMPLETED|Week 8 to Week 16||0||
48577710|NCT03933618|101744809|FG001|NOT COMPLETED|Week 8 to Week 16||0||
48577711|NCT03933618|101744810|FG002|NOT COMPLETED|Week 8 to Week 16||0||
48577712|NCT03933618|101744811|FG003|NOT COMPLETED|Week 8 to Week 16||0||
48577713|NCT03933618|101744812|FG004|NOT COMPLETED|Week 8 to Week 16||0||
48577714|NCT03933618|101744813|FG005|NOT COMPLETED|Week 8 to Week 16||0||
48577715|NCT03933618|101744808|FG000|STARTED|Week 16 to Week 24||4||
48577716|NCT03933618|101744809|FG001|STARTED|Week 16 to Week 24||4||
48577717|NCT03933618|101744810|FG002|STARTED|Week 16 to Week 24||4||
48577718|NCT03933618|101744811|FG003|STARTED|Week 16 to Week 24||4||
48577719|NCT03933618|101744812|FG004|STARTED|Week 16 to Week 24||4||
48577720|NCT03933618|101744813|FG005|STARTED|Week 16 to Week 24||4||
48577721|NCT03933618|101744808|FG000|COMPLETED|Week 16 to Week 24||4||
48577722|NCT03933618|101744809|FG001|COMPLETED|Week 16 to Week 24||4||
48577723|NCT03933618|101744810|FG002|COMPLETED|Week 16 to Week 24||4||
48577724|NCT03933618|101744811|FG003|COMPLETED|Week 16 to Week 24||4||
48577725|NCT03933618|101744812|FG004|COMPLETED|Week 16 to Week 24||4||
48577726|NCT03933618|101744813|FG005|COMPLETED|Week 16 to Week 24||4||
48577727|NCT03933618|101744808|FG000|NOT COMPLETED|Week 16 to Week 24||0||
48577728|NCT03933618|101744809|FG001|NOT COMPLETED|Week 16 to Week 24||0||
48577729|NCT03933618|101744810|FG002|NOT COMPLETED|Week 16 to Week 24||0||
48577730|NCT03933618|101744811|FG003|NOT COMPLETED|Week 16 to Week 24||0||
48577731|NCT03933618|101744812|FG004|NOT COMPLETED|Week 16 to Week 24||0||
48577732|NCT03933618|101744813|FG005|NOT COMPLETED|Week 16 to Week 24||0||
48577733|NCT03433469|101744814|FG000|STARTED|Overall Study||27||
48577734|NCT03433469|101744814|FG000|COMPLETED|Overall Study||27||
48577735|NCT03433469|101744814|FG000|NOT COMPLETED|Overall Study||0||
48577736|NCT01435018|101744815|FG000|STARTED|Overall Study||135||
48577737|NCT01435018|101744816|FG001|STARTED|Overall Study||60||
48577738|NCT01435018|101744817|FG002|STARTED|Overall Study||139||
48577739|NCT01435018|101744815|FG000|COMPLETED|Overall Study||88||
48577740|NCT01435018|101744816|FG001|COMPLETED|Overall Study||26||
48577741|NCT01435018|101744817|FG002|COMPLETED|Overall Study||98||
48577742|NCT01435018|101744815|FG000|NOT COMPLETED|Overall Study||47||
48577743|NCT01435018|101744816|FG001|NOT COMPLETED|Overall Study||34||
48577744|NCT01435018|101744817|FG002|NOT COMPLETED|Overall Study||41||
48577745|NCT01668173|101744818|FG000|STARTED|Overall Study||7||
48577746|NCT01668173|101744818|FG000|COMPLETED|Overall Study||0||
48577747|NCT01668173|101744818|FG000|NOT COMPLETED|Overall Study||7||
48577748|NCT01122394|101744819|FG000|STARTED|Overall Study||66||
48577749|NCT01122394|101744820|FG001|STARTED|Overall Study||74||
48577750|NCT01122394|101744819|FG000|COMPLETED|Overall Study||63||
48577751|NCT01122394|101744820|FG001|COMPLETED|Overall Study||70||
48577752|NCT01122394|101744819|FG000|NOT COMPLETED|Overall Study||3||
48577753|NCT01122394|101744820|FG001|NOT COMPLETED|Overall Study||4||
48577754|NCT03055897|101744821|FG000|STARTED|Overall Study||15||
48577755|NCT03055897|101744821|FG000|COMPLETED|Overall Study||15||
48577756|NCT03055897|101744821|FG000|NOT COMPLETED|Overall Study||0||
48577757|NCT04300309|101747580|FG000|STARTED|Overall Study||22|All patients enrolled in the study|
48577758|NCT04300309|101747581|FG001|STARTED|Overall Study||6|All patients enrolled in the study|
48577759|NCT04300309|101747580|FG000|Full Analysis Set (FAS)|Overall Study||22|All patients that received any study treatment and had P. falciparum present at Screening visit|
48577760|NCT04300309|101747581|FG001|Full Analysis Set (FAS)|Overall Study||6|All patients that received any study treatment and had P. falciparum present at Screening visit|
48577761|NCT04300309|101747580|FG000|Per-Protocol Set (PPS)|Overall Study||17|Patients in the FAS who met the following criteria: a) Did not have important protocol deviations affecting efficacy; b) Took at least 80% of study medication; c) PCR corrected cure status at Day 29 could be defined.|
48577762|NCT04300309|101747581|FG001|Per-Protocol Set (PPS)|Overall Study||6|Patients in the FAS who met the following criteria: a) Did not have important protocol deviations affecting efficacy; b) Took at least 80% of study medication; c) PCR corrected cure status at Day 29 could be defined.|
48577763|NCT04300309|101747580|FG000|PK Set|Overall Study||22|Patients in the FAS who had evaluable pharmacokinetics (PK) parameter data|
48577764|NCT04300309|101747581|FG001|PK Set|Overall Study||6|Patients in the FAS who had evaluable pharmacokinetics (PK) parameter data|
48577765|NCT04300309|101747580|FG000|Completed Treatment Phase|Overall Study||22||
48577766|NCT04300309|101747581|FG001|Completed Treatment Phase|Overall Study||6||
48577767|NCT04300309|101747580|FG000|Completed Core Follow-up (43 Days)|Overall Study||22||
48577768|NCT04300309|101747581|FG001|Completed Core Follow-up (43 Days)|Overall Study||6||
48577769|NCT04300309|101747580|FG000|COMPLETED|Overall Study||21|Completed long-term follow up|
48577770|NCT04300309|101747581|FG001|COMPLETED|Overall Study||6|Completed long-term follow up|
48577771|NCT04300309|101747580|FG000|NOT COMPLETED|Overall Study||1||
48577772|NCT04300309|101747581|FG001|NOT COMPLETED|Overall Study||0||
48577773|NCT00794040|101747582|FG000|STARTED|Overall Study||25||
48577774|NCT00794040|101747583|FG001|STARTED|Overall Study||28||
48577775|NCT00794040|101747582|FG000|COMPLETED|Overall Study||22||
48577776|NCT00794040|101747583|FG001|COMPLETED|Overall Study||23||
48577777|NCT00794040|101747582|FG000|NOT COMPLETED|Overall Study||3||
48577778|NCT00794040|101747583|FG001|NOT COMPLETED|Overall Study||5||
48577779|NCT02880865|101747584|FG000|STARTED|Overall Study||314||
48577780|NCT02880865|101747585|FG001|STARTED|Overall Study||314||
48577781|NCT02880865|101747584|FG000|Received MMR Dose 1|Overall Study||314||
48577782|NCT02880865|101747585|FG001|Received MMR Dose 1|Overall Study||314||
48577783|NCT02880865|101747584|FG000|Received CD-JEV|Overall Study||314||
48577784|NCT02880865|101747585|FG001|Received CD-JEV|Overall Study||309||
48577785|NCT02880865|101747584|FG000|Received MMR Dose 2|Overall Study||313||
48577786|NCT02880865|101747585|FG001|Received MMR Dose 2|Overall Study||311||
48577787|NCT02880865|101747584|FG000|COMPLETED|Overall Study||313||
48577788|NCT02880865|101747585|FG001|COMPLETED|Overall Study||311||
48577789|NCT02880865|101747584|FG000|NOT COMPLETED|Overall Study||1||
48577790|NCT02880865|101747585|FG001|NOT COMPLETED|Overall Study||3||
48577791|NCT02055365|101747586|FG000|STARTED|Overall Study||10||
48286342|NCT04971681|101026286|FG001|STARTED|Washout (7-14 Days)||5||
48286343|NCT04971681|101026285|FG000|COMPLETED|Washout (7-14 Days)||4||
48286344|NCT04971681|101026286|FG001|COMPLETED|Washout (7-14 Days)||5||
48577792|NCT02055365|101747586|FG000|COMPLETED|Overall Study||9||
48577793|NCT02055365|101747586|FG000|NOT COMPLETED|Overall Study||1||
48577794|NCT00925938|101747587|FG000|STARTED|Overall Study||9||
48577795|NCT00925938|101747588|FG001|STARTED|Overall Study||25||
48286345|NCT04971681|101026285|FG000|NOT COMPLETED|Washout (7-14 Days)||0||
48286346|NCT04971681|101026286|FG001|NOT COMPLETED|Washout (7-14 Days)||0||
48286347|NCT04971681|101026285|FG000|STARTED|Second Intervention||4||
48286348|NCT04971681|101026286|FG001|STARTED|Second Intervention||5||
48577796|NCT00925938|101747589|FG002|STARTED|Overall Study||17||
48577797|NCT00925938|101747587|FG000|COMPLETED|Overall Study||9||
48577798|NCT00925938|101747588|FG001|COMPLETED|Overall Study||25||
48577799|NCT00925938|101747589|FG002|COMPLETED|Overall Study||17||
48577800|NCT00925938|101747587|FG000|NOT COMPLETED|Overall Study||0||
48133198|NCT01615029|100648670|FG003|NOT COMPLETED|Overall Study||3||
48133199|NCT01615029|100648671|FG004|NOT COMPLETED|Overall Study||32||
48133200|NCT00512135|100648672|FG000|STARTED|Overall Study||801||
48133201|NCT00512135|100648672|FG000|Treated|Overall Study||796||
48133202|NCT00512135|100648672|FG000|COMPLETED|Overall Study||717||
48133203|NCT00512135|100648672|FG000|NOT COMPLETED|Overall Study||84||
48133204|NCT02837744|100648673|FG000|STARTED|Overall Study||70||
48133205|NCT02837744|100648673|FG000|COMPLETED|Overall Study||70||
48133206|NCT02837744|100648673|FG000|NOT COMPLETED|Overall Study||0||
48577801|NCT00925938|101747588|FG001|NOT COMPLETED|Overall Study||0||
48577802|NCT00925938|101747589|FG002|NOT COMPLETED|Overall Study||0||
48577803|NCT02429778|101747590|FG000|STARTED|Overall Study||20||
48577804|NCT02429778|101747591|FG001|STARTED|Overall Study||20||
48577805|NCT02429778|101747590|FG000|COMPLETED|Overall Study||13||
48577806|NCT02429778|101747591|FG001|COMPLETED|Overall Study||20||
48577807|NCT02429778|101747590|FG000|NOT COMPLETED|Overall Study||7||
48577808|NCT02429778|101747591|FG001|NOT COMPLETED|Overall Study||0||
48577809|NCT01102257|101747592|FG000|STARTED|Overall Study||9||
48577810|NCT01102257|101747593|FG001|STARTED|Overall Study||9||
48577811|NCT01102257|101747592|FG000|COMPLETED|Overall Study||7||
48577812|NCT01102257|101747593|FG001|COMPLETED|Overall Study||9||
48577813|NCT01102257|101747592|FG000|NOT COMPLETED|Overall Study||2||
48577814|NCT01102257|101747593|FG001|NOT COMPLETED|Overall Study||0||
48577815|NCT00708214|101747594|FG000|STARTED|Overall Study||7||
48133207|NCT04575428|100648674|FG000|STARTED|Overall Study||4||
48133208|NCT04575428|100648674|FG000|COMPLETED|Overall Study||4||
48133209|NCT04575428|100648674|FG000|NOT COMPLETED|Overall Study||0||
48133210|NCT01751022|100648675|FG000|STARTED|Overall Study||499||
48133211|NCT01751022|100648676|FG001|STARTED|Overall Study||326||
48133212|NCT01751022|100648677|FG002|STARTED|Overall Study||300||
48133213|NCT01751022|100648675|FG000|COMPLETED|Overall Study||443||
48133214|NCT01751022|100648676|FG001|COMPLETED|Overall Study||282||
48133215|NCT01751022|100648677|FG002|COMPLETED|Overall Study||273||
48133216|NCT01751022|100648675|FG000|NOT COMPLETED|Overall Study||56||
48133217|NCT01751022|100648676|FG001|NOT COMPLETED|Overall Study||44||
48133218|NCT01751022|100648677|FG002|NOT COMPLETED|Overall Study||27||
48133219|NCT03579459|100648678|FG000|STARTED|Overall Study||330||
48133220|NCT03579459|100648679|FG001|STARTED|Overall Study||327||
48133221|NCT03579459|100648680|FG002|STARTED|Overall Study||328||
48133222|NCT03579459|100648681|FG003|STARTED|Overall Study||332||
48133223|NCT03579459|100648678|FG000|Dose 1|Overall Study||330||
48133224|NCT03579459|100648679|FG001|Dose 1|Overall Study||325||
48133225|NCT03579459|100648680|FG002|Dose 1|Overall Study||328||
48133226|NCT03579459|100648681|FG003|Dose 1|Overall Study||331||
48133227|NCT03579459|100648678|FG000|Dose 2|Overall Study||324||
48133228|NCT03579459|100648679|FG001|Dose 2|Overall Study||318||
48133229|NCT03579459|100648680|FG002|Dose 2|Overall Study||319||
48133230|NCT03579459|100648681|FG003|Dose 2|Overall Study||322||
48133231|NCT03579459|100648678|FG000|Dose 3|Overall Study||305||
48133232|NCT03579459|100648679|FG001|Dose 3|Overall Study||305||
48577816|NCT00708214|101747595|FG001|STARTED|Overall Study||13||
48577817|NCT00708214|101747596|FG002|STARTED|Overall Study||8||
48577818|NCT00708214|101747594|FG000|COMPLETED|Overall Study||0||
48577819|NCT00708214|101747595|FG001|COMPLETED|Overall Study||0||
48577820|NCT00708214|101747596|FG002|COMPLETED|Overall Study||0||
48577821|NCT00708214|101747594|FG000|NOT COMPLETED|Overall Study||7||
48133233|NCT03579459|100648680|FG002|Dose 3|Overall Study||307||
48133234|NCT03579459|100648681|FG003|Dose 3|Overall Study||309||
48133235|NCT03579459|100648678|FG000|COMPLETED|Overall Study||301||
48133236|NCT03579459|100648679|FG001|COMPLETED|Overall Study||304||
48577822|NCT00708214|101747595|FG001|NOT COMPLETED|Overall Study||13||
48577823|NCT00708214|101747596|FG002|NOT COMPLETED|Overall Study||8||
48577824|NCT03343704|101747597|FG000|STARTED|Overall Study||13||
48577825|NCT03343704|101747598|FG001|STARTED|Overall Study||6||
48577826|NCT03343704|101747597|FG000|COMPLETED|Overall Study||12||
48577827|NCT03343704|101747598|FG001|COMPLETED|Overall Study||4||
48133237|NCT03579459|100648680|FG002|COMPLETED|Overall Study||305||
48133238|NCT03579459|100648681|FG003|COMPLETED|Overall Study||308||
48133239|NCT03579459|100648678|FG000|NOT COMPLETED|Overall Study||29||
48133240|NCT03579459|100648679|FG001|NOT COMPLETED|Overall Study||23||
48133241|NCT03579459|100648680|FG002|NOT COMPLETED|Overall Study||23||
48133242|NCT03579459|100648681|FG003|NOT COMPLETED|Overall Study||24||
48133243|NCT00581945|100648682|FG000|STARTED|Overall Study||74||
48133244|NCT00581945|100648683|FG001|STARTED|Overall Study||73||
48133245|NCT00581945|100648682|FG000|COMPLETED|Overall Study||65||
48577828|NCT03343704|101747597|FG000|NOT COMPLETED|Overall Study||1||
48577829|NCT03343704|101747598|FG001|NOT COMPLETED|Overall Study||2||
48577830|NCT02582242|101747599|FG000|STARTED|Overall Study||220||
48577831|NCT02582242|101747600|FG001|STARTED|Overall Study||217||
48577832|NCT02582242|101747599|FG000|COMPLETED|Overall Study||200||
48577833|NCT02582242|101747600|FG001|COMPLETED|Overall Study||200||
48577834|NCT02582242|101747599|FG000|NOT COMPLETED|Overall Study||20||
48577835|NCT02582242|101747600|FG001|NOT COMPLETED|Overall Study||17||
48577836|NCT01339923|101747601|FG000|STARTED|Overall Study||253||
48577837|NCT01339923|101747602|FG001|STARTED|Overall Study||250||
48577838|NCT01339923|101747603|FG002|STARTED|Overall Study||251||
48577839|NCT01339923|101747604|FG003|STARTED|Overall Study||104||
48577840|NCT01339923|101747605|FG004|STARTED|Overall Study||300||
48577841|NCT01339923|101747606|FG005|STARTED|Overall Study||126||
48577842|NCT01339923|101747607|FG006|STARTED|Overall Study||125||
48577843|NCT01339923|101747601|FG000|COMPLETED|Overall Study||239||
48577844|NCT01339923|101747602|FG001|COMPLETED|Overall Study||234||
48577845|NCT01339923|101747603|FG002|COMPLETED|Overall Study||243||
48133246|NCT00581945|100648683|FG001|COMPLETED|Overall Study||63||
48133247|NCT00581945|100648682|FG000|NOT COMPLETED|Overall Study||9||
48133248|NCT00581945|100648683|FG001|NOT COMPLETED|Overall Study||10||
48577846|NCT01339923|101747604|FG003|COMPLETED|Overall Study||100||
48577847|NCT01339923|101747605|FG004|COMPLETED|Overall Study||295||
48577848|NCT01339923|101747606|FG005|COMPLETED|Overall Study||117||
48577849|NCT01339923|101747607|FG006|COMPLETED|Overall Study||111||
48577850|NCT01339923|101747601|FG000|NOT COMPLETED|Overall Study||14||
48577851|NCT01339923|101747602|FG001|NOT COMPLETED|Overall Study||16||
48577852|NCT01339923|101747603|FG002|NOT COMPLETED|Overall Study||8||
48577853|NCT01339923|101747604|FG003|NOT COMPLETED|Overall Study||4||
48577854|NCT01339923|101747605|FG004|NOT COMPLETED|Overall Study||5||
48577855|NCT01339923|101747606|FG005|NOT COMPLETED|Overall Study||9||
48577856|NCT01339923|101747607|FG006|NOT COMPLETED|Overall Study||14||
48577857|NCT03363776|101747608|FG000|STARTED|Overall Study||4|Started = Entering the treatment period|
48577858|NCT03363776|101747609|FG001|STARTED|Overall Study||3|Started = Entering the treatment period|
48577859|NCT03363776|101747610|FG002|STARTED|Overall Study||3|Started = Entering the treatment period|
48577860|NCT03363776|101747608|FG000|COMPLETED|Overall Study||1|Completed = Completing the treatment period|
48577861|NCT03363776|101747609|FG001|COMPLETED|Overall Study||0|Completed = Completing the treatment period|
48577862|NCT03363776|101747610|FG002|COMPLETED|Overall Study||1|Completed = Completing the treatment period|
48577863|NCT03363776|101747608|FG000|NOT COMPLETED|Overall Study||3||
48577864|NCT03363776|101747609|FG001|NOT COMPLETED|Overall Study||3||
48577865|NCT03363776|101747610|FG002|NOT COMPLETED|Overall Study||2||
48577866|NCT05107492|101747611|FG000|STARTED|Overall Study||9||
48577867|NCT05107492|101747612|FG001|STARTED|Overall Study||3||
48577868|NCT05107492|101747611|FG000|COMPLETED|Overall Study||8|Completion of the entire study including the follow-up phase|
48133249|NCT02061384|100648684|FG000|STARTED|Overall Study||10||
48133250|NCT02061384|100648685|FG001|STARTED|Overall Study||10||
48133251|NCT02061384|100648684|FG000|COMPLETED|Overall Study||10||
48133252|NCT02061384|100648685|FG001|COMPLETED|Overall Study||10||
48133253|NCT02061384|100648684|FG000|NOT COMPLETED|Overall Study||0||
48133254|NCT02061384|100648685|FG001|NOT COMPLETED|Overall Study||0||
48577869|NCT05107492|101747612|FG001|COMPLETED|Overall Study||3|Completion of the entire study including the follow-up phase|
48577870|NCT05107492|101747611|FG000|NOT COMPLETED|Overall Study||1||
48577871|NCT05107492|101747612|FG001|NOT COMPLETED|Overall Study||0||
48577872|NCT02879617|101747613|FG000|STARTED|Overall Study||47|Started Treatment|
48577873|NCT02879617|101747613|FG000|COMPLETED|Overall Study||47|Received at least one dose of the treatment and did not withdraw for reasons other than disease progression or toxicity before second treatment cycle|
48577874|NCT02879617|101747613|FG000|NOT COMPLETED|Overall Study||0||
48577875|NCT03617770|101747614|FG000|STARTED|Overall Study||9||
48577876|NCT03617770|101747615|FG001|STARTED|Overall Study||5||
48577877|NCT03617770|101747614|FG000|COMPLETED|Overall Study||8||
48133255|NCT01343056|100648686|FG000|STARTED|Overall Study||35||
48133256|NCT01343056|100648687|FG001|STARTED|Overall Study||36||
48577878|NCT03617770|101747615|FG001|COMPLETED|Overall Study||5||
48577879|NCT03617770|101747614|FG000|NOT COMPLETED|Overall Study||1||
48577880|NCT03617770|101747615|FG001|NOT COMPLETED|Overall Study||0||
48577881|NCT02278939|101747616|FG000|STARTED|Overall Study||33||
48133257|NCT01343056|100648688|FG002|STARTED|Overall Study||32||
48133258|NCT01343056|100648689|FG003|STARTED|Overall Study||38||
48133259|NCT01343056|100648686|FG000|COMPLETED|Overall Study||28||
48133260|NCT01343056|100648687|FG001|COMPLETED|Overall Study||31||
48133261|NCT01343056|100648688|FG002|COMPLETED|Overall Study||29||
48133262|NCT01343056|100648689|FG003|COMPLETED|Overall Study||29||
48133263|NCT01343056|100648686|FG000|NOT COMPLETED|Overall Study||7||
48133264|NCT01343056|100648687|FG001|NOT COMPLETED|Overall Study||5||
48133265|NCT01343056|100648688|FG002|NOT COMPLETED|Overall Study||3||
48133266|NCT01343056|100648689|FG003|NOT COMPLETED|Overall Study||9||
48133267|NCT01449305|100648690|FG000|STARTED|Overall Study||44||
48133268|NCT01449305|100648690|FG000|COMPLETED|Overall Study||42||
48133269|NCT01449305|100648690|FG000|NOT COMPLETED|Overall Study||2||
48133270|NCT01753193|100648691|FG000|STARTED|Overall Study||218||
48133271|NCT01753193|100648691|FG000|COMPLETED|Overall Study||172||
48133272|NCT01753193|100648691|FG000|NOT COMPLETED|Overall Study||46||
48133273|NCT01024387|100648692|FG000|STARTED|Overall Study||60||
48133274|NCT01024387|100648692|FG000|Evaluable for PFS|Overall Study||54|One of the patients uneval for resp was incl in PFS eval dataset which included follow-up for death.|
48133275|NCT01024387|100648692|FG000|Evaluable for Response|Overall Study||53|symptomatic deterioration (n=2), patient or MD decision (n=2 each), hypersensitivity reaction (n=1)|
48133276|NCT01024387|100648692|FG000|COMPLETED|Overall Study||0|Given treatment duration is not fixed, all patients are considered as 'Non Completed'.|
48577882|NCT02278939|101747617|FG001|STARTED|Overall Study||34||
48577883|NCT02278939|101747616|FG000|COMPLETED|Overall Study||28||
48577884|NCT02278939|101747617|FG001|COMPLETED|Overall Study||33||
48577885|NCT02278939|101747616|FG000|NOT COMPLETED|Overall Study||5||
48577886|NCT02278939|101747617|FG001|NOT COMPLETED|Overall Study||1||
48577887|NCT00334074|101747618|FG000|STARTED|Overall Study||30||
48577888|NCT00334074|101747618|FG000|COMPLETED|Overall Study||30||
48577889|NCT00334074|101747618|FG000|NOT COMPLETED|Overall Study||0||
48577890|NCT00507819|101747619|FG000|STARTED|First Intervention (6 Weeks)||14||
48577891|NCT00507819|101747620|FG001|STARTED|First Intervention (6 Weeks)||14||
48577892|NCT00507819|101747619|FG000|COMPLETED|First Intervention (6 Weeks)||14||
48577893|NCT00507819|101747620|FG001|COMPLETED|First Intervention (6 Weeks)||14||
48577894|NCT00507819|101747619|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0||
48577895|NCT00507819|101747620|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0||
48577896|NCT00507819|101747619|FG000|STARTED|Washout (6 Weeks)||14||
48577897|NCT00507819|101747620|FG001|STARTED|Washout (6 Weeks)||14||
48577898|NCT00507819|101747619|FG000|COMPLETED|Washout (6 Weeks)||13||
48577899|NCT00507819|101747620|FG001|COMPLETED|Washout (6 Weeks)||14||
48577900|NCT00507819|101747619|FG000|NOT COMPLETED|Washout (6 Weeks)||1||
48577901|NCT00507819|101747620|FG001|NOT COMPLETED|Washout (6 Weeks)||0||
48577902|NCT00507819|101747619|FG000|STARTED|Second Intervention (6 Weeks)||13||
48577903|NCT00507819|101747620|FG001|STARTED|Second Intervention (6 Weeks)||14||
48577904|NCT00507819|101747619|FG000|COMPLETED|Second Intervention (6 Weeks)||13||
48577905|NCT00507819|101747620|FG001|COMPLETED|Second Intervention (6 Weeks)||14||
48577906|NCT00507819|101747619|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0||
48577907|NCT00507819|101747620|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0||
48577908|NCT01976650|101747621|FG000|STARTED|Overall Study||724||
48577909|NCT01976650|101747621|FG000|COMPLETED|Overall Study||718||
48577910|NCT01976650|101747621|FG000|NOT COMPLETED|Overall Study||6||
48577911|NCT02171234|101747622|FG000|STARTED|Overall Study||8||
48577912|NCT02171234|101747623|FG001|STARTED|Overall Study||6||
48577913|NCT02171234|101747624|FG002|STARTED|Overall Study||6||
48577914|NCT02171234|101747625|FG003|STARTED|Overall Study||6||
48133277|NCT01024387|100648692|FG000|NOT COMPLETED|Overall Study||60||
48286349|NCT04971681|101026285|FG000|COMPLETED|Second Intervention||4||
48286350|NCT04971681|101026286|FG001|COMPLETED|Second Intervention||5||
48286351|NCT04971681|101026285|FG000|NOT COMPLETED|Second Intervention||0||
48286352|NCT04971681|101026286|FG001|NOT COMPLETED|Second Intervention||0||
48286353|NCT04971681|101026285|FG000|STARTED|Followup||4||
48133278|NCT03087591|100648693|FG000|STARTED|Overall Study||11||
48133279|NCT03087591|100648693|FG000|COMPLETED|Overall Study||9||
48133280|NCT03087591|100648693|FG000|NOT COMPLETED|Overall Study||2||
48133281|NCT00627705|100648694|FG000|STARTED|Overall Study||15||
48133282|NCT00627705|100648695|FG001|STARTED|Overall Study||18||
48133283|NCT00627705|100648694|FG000|COMPLETED|Overall Study||13||
48133284|NCT00627705|100648695|FG001|COMPLETED|Overall Study||12||
48133285|NCT00627705|100648694|FG000|NOT COMPLETED|Overall Study||2||
48133286|NCT00627705|100648695|FG001|NOT COMPLETED|Overall Study||6||
48133287|NCT01910519|100648696|FG000|STARTED|Overall Study||35||
48286354|NCT04971681|101026286|FG001|STARTED|Followup||5||
48133288|NCT01910519|100648697|FG001|STARTED|Overall Study||15||
48286355|NCT04971681|101026285|FG000|COMPLETED|Followup||3||
48286356|NCT04971681|101026286|FG001|COMPLETED|Followup||5||
48577915|NCT02171234|101747626|FG004|STARTED|Overall Study||6||
48577916|NCT02171234|101747622|FG000|COMPLETED|Overall Study||8||
48577917|NCT02171234|101747623|FG001|COMPLETED|Overall Study||6||
48577918|NCT02171234|101747624|FG002|COMPLETED|Overall Study||6||
48577919|NCT02171234|101747625|FG003|COMPLETED|Overall Study||6||
48577920|NCT02171234|101747626|FG004|COMPLETED|Overall Study||6||
48577921|NCT02171234|101747622|FG000|NOT COMPLETED|Overall Study||0||
48577922|NCT02171234|101747623|FG001|NOT COMPLETED|Overall Study||0||
48577923|NCT02171234|101747624|FG002|NOT COMPLETED|Overall Study||0||
48577924|NCT02171234|101747625|FG003|NOT COMPLETED|Overall Study||0||
48133289|NCT01910519|100648696|FG000|COMPLETED|Overall Study||31||
48133290|NCT01910519|100648697|FG001|COMPLETED|Overall Study||15||
48133291|NCT01910519|100648696|FG000|NOT COMPLETED|Overall Study||4||
48133292|NCT01910519|100648697|FG001|NOT COMPLETED|Overall Study||0||
48133293|NCT00714168|100648698|FG000|STARTED|Overall Study||165||
48133294|NCT00714168|100648699|FG001|STARTED|Overall Study||198||
48133295|NCT00714168|100648698|FG000|COMPLETED|Overall Study||121||
48133296|NCT00714168|100648699|FG001|COMPLETED|Overall Study||139||
48133297|NCT00714168|100648698|FG000|NOT COMPLETED|Overall Study||44||
48133298|NCT00714168|100648699|FG001|NOT COMPLETED|Overall Study||59||
48133299|NCT02265237|100648700|FG000|STARTED|As Enrolled (Overall Study)||59||
48133300|NCT02265237|100648701|FG001|STARTED|As Enrolled (Overall Study)||61||
48133301|NCT02265237|100648702|FG002|STARTED|As Enrolled (Overall Study)||61||
48133302|NCT02265237|100648703|FG003|STARTED|As Enrolled (Overall Study)||3||
48133303|NCT02265237|100648700|FG000|COMPLETED|As Enrolled (Overall Study)||54||
48133304|NCT02265237|100648701|FG001|COMPLETED|As Enrolled (Overall Study)||58||
48133305|NCT02265237|100648702|FG002|COMPLETED|As Enrolled (Overall Study)||51||
48133306|NCT02265237|100648703|FG003|COMPLETED|As Enrolled (Overall Study)||2||
48133307|NCT02265237|100648700|FG000|NOT COMPLETED|As Enrolled (Overall Study)||5||
48133308|NCT02265237|100648701|FG001|NOT COMPLETED|As Enrolled (Overall Study)||3||
48133309|NCT02265237|100648702|FG002|NOT COMPLETED|As Enrolled (Overall Study)||10||
48133310|NCT02265237|100648703|FG003|NOT COMPLETED|As Enrolled (Overall Study)||1||
48133311|NCT02265237|100648700|FG000|STARTED|As Treated (Overall Study)||60||
48133312|NCT02265237|100648701|FG001|STARTED|As Treated (Overall Study)||60||
48133313|NCT02265237|100648702|FG002|STARTED|As Treated (Overall Study)||61||
48133314|NCT02265237|100648703|FG003|STARTED|As Treated (Overall Study)||3||
48133315|NCT02265237|100648700|FG000|COMPLETED|As Treated (Overall Study)||55||
48133316|NCT02265237|100648701|FG001|COMPLETED|As Treated (Overall Study)||57||
48133317|NCT02265237|100648702|FG002|COMPLETED|As Treated (Overall Study)||51||
48133318|NCT02265237|100648703|FG003|COMPLETED|As Treated (Overall Study)||2||
48133319|NCT02265237|100648700|FG000|NOT COMPLETED|As Treated (Overall Study)||5||
48133320|NCT02265237|100648701|FG001|NOT COMPLETED|As Treated (Overall Study)||3||
48133321|NCT02265237|100648702|FG002|NOT COMPLETED|As Treated (Overall Study)||10||
48133322|NCT02265237|100648703|FG003|NOT COMPLETED|As Treated (Overall Study)||1||
48133323|NCT02160873|100648704|FG000|STARTED|Overall Study||6||
48133324|NCT02160873|100648705|FG001|STARTED|Overall Study||6||
48133325|NCT02160873|100648704|FG000|COMPLETED|Overall Study||6||
48133326|NCT02160873|100648705|FG001|COMPLETED|Overall Study||6||
48133327|NCT02160873|100648704|FG000|NOT COMPLETED|Overall Study||0||
48133328|NCT02160873|100648705|FG001|NOT COMPLETED|Overall Study||0||
48133329|NCT00086346|100648706|FG000|STARTED|Randomization||393||
48133330|NCT00086346|100648707|FG001|STARTED|Randomization||214||
48133331|NCT00086346|100648706|FG000|COMPLETED|Randomization||389||
48133332|NCT00086346|100648707|FG001|COMPLETED|Randomization||210||
48133333|NCT00086346|100648706|FG000|NOT COMPLETED|Randomization||4||
48133334|NCT00086346|100648707|FG001|NOT COMPLETED|Randomization||4||
48133335|NCT00086346|100648706|FG000|STARTED|Patients Dosed With Test Article||389||
48133336|NCT00086346|100648707|FG001|STARTED|Patients Dosed With Test Article||210||
48133337|NCT00086346|100648706|FG000|COMPLETED|Patients Dosed With Test Article||249||
48133338|NCT00086346|100648707|FG001|COMPLETED|Patients Dosed With Test Article||187||
48133339|NCT00086346|100648706|FG000|NOT COMPLETED|Patients Dosed With Test Article||140||
48133340|NCT00086346|100648707|FG001|NOT COMPLETED|Patients Dosed With Test Article||23||
48133341|NCT01344460|100648708|FG000|STARTED|Overall Study||315||
48133342|NCT01344460|100648708|FG000|Fulfilled Requirements of FAS Population|Overall Study||292||
48133343|NCT01344460|100648708|FG000|COMPLETED|Overall Study||312||
48133344|NCT01344460|100648708|FG000|NOT COMPLETED|Overall Study||3||
48133345|NCT03526900|100648709|FG000|STARTED|Overall Study||40||
48133346|NCT03526900|100648709|FG000|COMPLETED|Overall Study||40||
48133347|NCT03526900|100648709|FG000|NOT COMPLETED|Overall Study||0||
48133348|NCT00129987|100648710|FG000|STARTED|1st Educational Session||287||
48133349|NCT00129987|100648711|FG001|STARTED|1st Educational Session||280||
48133350|NCT00129987|100648710|FG000|COMPLETED|1st Educational Session||146||
48133351|NCT00129987|100648711|FG001|COMPLETED|1st Educational Session||171||
48133352|NCT00129987|100648710|FG000|NOT COMPLETED|1st Educational Session||141||
48133353|NCT00129987|100648711|FG001|NOT COMPLETED|1st Educational Session||109||
48133354|NCT00129987|100648710|FG000|STARTED|1 Year||146||
48133355|NCT00129987|100648711|FG001|STARTED|1 Year||171||
48133356|NCT00129987|100648710|FG000|COMPLETED|1 Year||114||
48133357|NCT00129987|100648711|FG001|COMPLETED|1 Year||150||
48133358|NCT00129987|100648710|FG000|NOT COMPLETED|1 Year||32||
48133359|NCT00129987|100648711|FG001|NOT COMPLETED|1 Year||21||
48133360|NCT03452917|100648712|FG000|STARTED|Overall Study||499||
48133361|NCT03452917|100648713|FG001|STARTED|Overall Study||500||
48133362|NCT03452917|100648714|FG002|STARTED|Overall Study||498||
48133363|NCT03452917|100648712|FG000|COMPLETED|Overall Study||499||
48133364|NCT03452917|100648713|FG001|COMPLETED|Overall Study||500||
48133365|NCT03452917|100648714|FG002|COMPLETED|Overall Study||498||
48133366|NCT03452917|100648712|FG000|NOT COMPLETED|Overall Study||0||
48133367|NCT03452917|100648713|FG001|NOT COMPLETED|Overall Study||0||
48133368|NCT03452917|100648714|FG002|NOT COMPLETED|Overall Study||0||
48133369|NCT03143218|100648715|FG000|STARTED|Overall Study||1965||
48133370|NCT03143218|100648716|FG001|STARTED|Overall Study||1988||
48133371|NCT03143218|100648717|FG002|STARTED|Overall Study||1967||
48133372|NCT03143218|100648715|FG000|COMPLETED|Overall Study||1716||
48133373|NCT03143218|100648716|FG001|COMPLETED|Overall Study||1734||
48133374|NCT03143218|100648717|FG002|COMPLETED|Overall Study||1740||
48133375|NCT03143218|100648715|FG000|NOT COMPLETED|Overall Study||249||
48133376|NCT03143218|100648716|FG001|NOT COMPLETED|Overall Study||254||
48133377|NCT03143218|100648717|FG002|NOT COMPLETED|Overall Study||227||
48133378|NCT00572572|100648718|FG000|STARTED|Overall Study||35||
48133379|NCT00572572|100648719|FG001|STARTED|Overall Study||34||
48133380|NCT00572572|100648718|FG000|COMPLETED|Overall Study||32||
48133381|NCT00572572|100648719|FG001|COMPLETED|Overall Study||28||
48133382|NCT00572572|100648718|FG000|NOT COMPLETED|Overall Study||3||
48133383|NCT00572572|100648719|FG001|NOT COMPLETED|Overall Study||6||
48133384|NCT00435370|100648720|FG000|STARTED|Overall Study||90||
48133385|NCT00435370|100648721|FG001|STARTED|Overall Study||89||
48133386|NCT00435370|100648720|FG000|COMPLETED|Overall Study||68||
48133387|NCT00435370|100648721|FG001|COMPLETED|Overall Study||69||
48133388|NCT00435370|100648720|FG000|NOT COMPLETED|Overall Study||22||
48133389|NCT00435370|100648721|FG001|NOT COMPLETED|Overall Study||20||
48133390|NCT01175226|100648722|FG000|STARTED|Overall Study||155||
48133391|NCT01175226|100648723|FG001|STARTED|Overall Study||145||
48133392|NCT01175226|100648722|FG000|COMPLETED|Overall Study||144||
48133393|NCT01175226|100648723|FG001|COMPLETED|Overall Study||140||
48133394|NCT01175226|100648722|FG000|NOT COMPLETED|Overall Study||11||
48133395|NCT01175226|100648723|FG001|NOT COMPLETED|Overall Study||5||
48133396|NCT04001829|100648724|FG000|STARTED|Overall Study||126||
48133397|NCT04001829|100648725|FG001|STARTED|Overall Study||123||
48133398|NCT04001829|100648724|FG000|Received Protocol Therapy|Overall Study||121||
48133399|NCT04001829|100648725|FG001|Received Protocol Therapy|Overall Study||118||
48133400|NCT04001829|100648724|FG000|High Risk Genotype Group|Overall Study||91|Of the 121 treated patients on arm A, 4 patients did not have genotype data.|
48133401|NCT04001829|100648725|FG001|High Risk Genotype Group|Overall Study||87|Of the 121 treated patients on arm A, 4 patients did not have genotype data.|
48133402|NCT04001829|100648724|FG000|Low Risk Genotype Group|Overall Study||26||
48133403|NCT04001829|100648725|FG001|Low Risk Genotype Group|Overall Study||31||
48133404|NCT04001829|100648724|FG000|COMPLETED|Overall Study||102||
48133405|NCT04001829|100648725|FG001|COMPLETED|Overall Study||102||
48133406|NCT04001829|100648724|FG000|NOT COMPLETED|Overall Study||24||
48133407|NCT04001829|100648725|FG001|NOT COMPLETED|Overall Study||21||
48133408|NCT03627403|100648726|FG000|STARTED|Overall Study||17||
48577925|NCT02171234|101747626|FG004|NOT COMPLETED|Overall Study||0||
48577926|NCT03180684|101747627|FG000|STARTED|Overall Study||25||
48577927|NCT03180684|101747628|FG001|STARTED|Overall Study||8||
48577928|NCT03180684|101747627|FG000|Modified Intent-to-Treat (mITT) Population|Overall Study||25|mITT population included all participants who received at least 1 dose of VGX-3100 + EP (with or without imiquimod) and had an analysis endpoint of interest.|
48577929|NCT03180684|101747628|FG001|Modified Intent-to-Treat (mITT) Population|Overall Study||8|mITT population included all participants who received at least 1 dose of VGX-3100 + EP (with or without imiquimod) and had an analysis endpoint of interest.|
48577930|NCT03180684|101747627|FG000|Safety Population|Overall Study||25|Safety population included all participants who received at least 1 dose of VGX-3100 (with or without EP).|
48577931|NCT03180684|101747628|FG001|Safety Population|Overall Study||8|Safety population included all participants who received at least 1 dose of VGX-3100 (with or without EP).|
48577932|NCT03180684|101747627|FG000|COMPLETED|Overall Study||17||
48577933|NCT03180684|101747628|FG001|COMPLETED|Overall Study||8||
48577934|NCT03180684|101747627|FG000|NOT COMPLETED|Overall Study||8||
48133409|NCT03627403|100648726|FG000|COMPLETED|Overall Study||17||
48133410|NCT03627403|100648726|FG000|NOT COMPLETED|Overall Study||0||
48133411|NCT00583557|100648727|FG000|STARTED|Overall Study||155||
48577935|NCT03180684|101747628|FG001|NOT COMPLETED|Overall Study||0||
48577936|NCT02235077|101747629|FG000|STARTED|Overall Study||182||
48577937|NCT02235077|101747630|FG001|STARTED|Overall Study||178||
48577938|NCT02235077|101747629|FG000|COMPLETED|Overall Study||164||
48577939|NCT02235077|101747630|FG001|COMPLETED|Overall Study||159||
48577940|NCT02235077|101747629|FG000|NOT COMPLETED|Overall Study||18||
48577941|NCT02235077|101747630|FG001|NOT COMPLETED|Overall Study||19||
48133412|NCT00583557|100648727|FG000|Received at Least 1 Dose Belimumab|Overall Study||153||
48133413|NCT00583557|100648727|FG000|COMPLETED|Overall Study||85||
48133414|NCT00583557|100648727|FG000|NOT COMPLETED|Overall Study||70||
48133415|NCT01242527|100648728|FG000|STARTED|Overall Study||99||
48133416|NCT01242527|100648729|FG001|STARTED|Overall Study||100||
48133417|NCT01242527|100648730|FG002|STARTED|Overall Study||101||
48133418|NCT01242527|100648731|FG003|STARTED|Overall Study||99||
48133419|NCT01242527|100648728|FG000|COMPLETED|Overall Study||94||
48133420|NCT01242527|100648729|FG001|COMPLETED|Overall Study||93||
48133421|NCT01242527|100648730|FG002|COMPLETED|Overall Study||87||
48133422|NCT01242527|100648731|FG003|COMPLETED|Overall Study||90||
48133423|NCT01242527|100648728|FG000|NOT COMPLETED|Overall Study||5||
48133424|NCT01242527|100648729|FG001|NOT COMPLETED|Overall Study||7||
48133425|NCT01242527|100648730|FG002|NOT COMPLETED|Overall Study||14||
48133426|NCT01242527|100648731|FG003|NOT COMPLETED|Overall Study||9||
48133427|NCT00941603|100648732|FG000|STARTED|Overall Study||104||
48133428|NCT00941603|100648733|FG001|STARTED|Overall Study||105||
48133429|NCT00941603|100648734|FG002|STARTED|Overall Study||104||
48133430|NCT00941603|100648735|FG003|STARTED|Overall Study||104||
48133431|NCT00941603|100648736|FG004|STARTED|Overall Study||105||
48133432|NCT00941603|100648737|FG005|STARTED|Overall Study||97||
48133433|NCT00941603|100648732|FG000|COMPLETED|Overall Study||93||
48133434|NCT00941603|100648733|FG001|COMPLETED|Overall Study||89||
48133435|NCT00941603|100648734|FG002|COMPLETED|Overall Study||99||
48133436|NCT00941603|100648735|FG003|COMPLETED|Overall Study||100||
48133437|NCT00941603|100648736|FG004|COMPLETED|Overall Study||101||
48133438|NCT00941603|100648737|FG005|COMPLETED|Overall Study||94||
48133439|NCT00941603|100648732|FG000|NOT COMPLETED|Overall Study||11||
48133440|NCT00941603|100648733|FG001|NOT COMPLETED|Overall Study||16||
48133441|NCT00941603|100648734|FG002|NOT COMPLETED|Overall Study||5||
48133442|NCT00941603|100648735|FG003|NOT COMPLETED|Overall Study||4||
48133443|NCT00941603|100648736|FG004|NOT COMPLETED|Overall Study||4||
48577942|NCT04484142|101747631|FG000|STARTED|Overall Study||137||
48577943|NCT04484142|101747631|FG000|COMPLETED|Overall Study||20||
48577944|NCT04484142|101747631|FG000|NOT COMPLETED|Overall Study||117||
48577945|NCT00872027|101747632|FG000|STARTED|Overall Study||7||
48577946|NCT00872027|101747633|FG001|STARTED|Overall Study||8||
48577947|NCT00872027|101747632|FG000|COMPLETED|Overall Study||7||
48133444|NCT00941603|100648737|FG005|NOT COMPLETED|Overall Study||3||
48133445|NCT01108081|100648738|FG000|STARTED|Overall Study||46||
48133446|NCT01108081|100648739|FG001|STARTED|Overall Study||42||
48133447|NCT01108081|100648740|FG002|STARTED|Overall Study||38||
48133448|NCT01108081|100648741|FG003|STARTED|Overall Study||43||
48133449|NCT01108081|100648738|FG000|COMPLETED|Overall Study||44||
48133450|NCT01108081|100648739|FG001|COMPLETED|Overall Study||40||
48133451|NCT01108081|100648740|FG002|COMPLETED|Overall Study||38||
48133452|NCT01108081|100648741|FG003|COMPLETED|Overall Study||39||
48577948|NCT00872027|101747633|FG001|COMPLETED|Overall Study||8||
48577949|NCT00872027|101747632|FG000|NOT COMPLETED|Overall Study||0||
48577950|NCT00872027|101747633|FG001|NOT COMPLETED|Overall Study||0||
48577951|NCT03573700|101747634|FG000|STARTED|Overall Study||6||
48577952|NCT03573700|101747635|FG001|STARTED|Overall Study||18||
48577953|NCT03573700|101747634|FG000|COMPLETED|Overall Study||6||
48577954|NCT03573700|101747635|FG001|COMPLETED|Overall Study||18||
48577955|NCT03573700|101747634|FG000|NOT COMPLETED|Overall Study||0||
48577956|NCT03573700|101747635|FG001|NOT COMPLETED|Overall Study||0||
48577957|NCT01944839|101747636|FG000|STARTED|Overall Study||309||
48577958|NCT01944839|101747637|FG001|STARTED|Overall Study||310||
48577959|NCT01944839|101747636|FG000|COMPLETED|Overall Study||287||
48577960|NCT01944839|101747637|FG001|COMPLETED|Overall Study||282||
48577961|NCT01944839|101747636|FG000|NOT COMPLETED|Overall Study||22||
48577962|NCT01944839|101747637|FG001|NOT COMPLETED|Overall Study||28||
48577963|NCT00003830|101747638|FG000|STARTED|Overall Study||2807||
48577964|NCT00003830|101747639|FG001|STARTED|Overall Study||2804||
48577965|NCT00003830|101747638|FG000|COMPLETED|Overall Study||1975||
48577966|NCT00003830|101747639|FG001|COMPLETED|Overall Study||2011||
48703289|NCT04243577|102057820|FG002|STARTED|Second Intervention (1 Hour)||15||
48703290|NCT04243577|102057821|FG003|STARTED|Second Intervention (1 Hour)||15||
48133453|NCT01108081|100648738|FG000|NOT COMPLETED|Overall Study||2||
48133454|NCT01108081|100648739|FG001|NOT COMPLETED|Overall Study||2||
48133455|NCT01108081|100648740|FG002|NOT COMPLETED|Overall Study||0||
48703291|NCT04243577|102057818|FG000|COMPLETED|Second Intervention (1 Hour)||20||
48133456|NCT01108081|100648741|FG003|NOT COMPLETED|Overall Study||4||
48133457|NCT02606838|100648742|FG000|STARTED|Overall Study||119||
48133458|NCT02606838|100648742|FG000|COMPLETED|Overall Study||119||
48133459|NCT02606838|100648742|FG000|NOT COMPLETED|Overall Study||0||
48133460|NCT03259035|100648743|FG000|STARTED|Stage 1: Chemotherapy||58||
48286357|NCT04971681|101026285|FG000|NOT COMPLETED|Followup||1||
48286358|NCT04971681|101026286|FG001|NOT COMPLETED|Followup||0||
48286359|NCT02476279|101026287|FG000|STARTED|Overall Study||975||
48286360|NCT02476279|101026288|FG001|STARTED|Overall Study||975||
48133461|NCT03259035|100648743|FG000|COMPLETED|Stage 1: Chemotherapy||58||
48286361|NCT02476279|101026287|FG000|COMPLETED|Overall Study||974|Completed follow-up for the primary and secondary endpoints|
48286362|NCT02476279|101026288|FG001|COMPLETED|Overall Study||974|Completed follow-up for the primary and secondary endpoints|
48286363|NCT02476279|101026287|FG000|NOT COMPLETED|Overall Study||1||
48286364|NCT02476279|101026288|FG001|NOT COMPLETED|Overall Study||1||
48286365|NCT05330312|101026289|FG000|STARTED|Pilot Investigation - Part 1||0||
48286366|NCT05330312|101026290|FG001|STARTED|Pilot Investigation - Part 1||0||
48577967|NCT00003830|101747638|FG000|NOT COMPLETED|Overall Study||832||
48577968|NCT00003830|101747639|FG001|NOT COMPLETED|Overall Study||793||
48703292|NCT04243577|102057819|FG001|COMPLETED|Second Intervention (1 Hour)||20||
48577969|NCT03503370|101747640|FG000|STARTED|Overall Study||88||
48577970|NCT03503370|101747641|FG001|STARTED|Overall Study||87||
48577971|NCT03503370|101747640|FG000|COMPLETED|Overall Study||85||
48577972|NCT03503370|101747641|FG001|COMPLETED|Overall Study||86||
48577973|NCT03503370|101747640|FG000|NOT COMPLETED|Overall Study||3||
48133462|NCT03259035|100648743|FG000|NOT COMPLETED|Stage 1: Chemotherapy||0||
48133463|NCT03259035|100648743|FG000|STARTED|Stage 2: Tumor Excision||56||
48133464|NCT03259035|100648743|FG000|COMPLETED|Stage 2: Tumor Excision||56||
48133465|NCT03259035|100648743|FG000|NOT COMPLETED|Stage 2: Tumor Excision||0||
48133466|NCT01337089|100648744|FG000|STARTED|Overall Study||660||
48577974|NCT03503370|101747641|FG001|NOT COMPLETED|Overall Study||1||
48577975|NCT01163318|101747642|FG000|STARTED|Overall Study||552||
48577976|NCT01163318|101747642|FG000|COMPLETED|Overall Study||284||
48577977|NCT01163318|101747642|FG000|NOT COMPLETED|Overall Study||268||
48577978|NCT03640559|101747643|FG000|STARTED|Overall Study||25||
48577979|NCT03640559|101747644|FG001|STARTED|Overall Study||25||
48577980|NCT03640559|101747643|FG000|COMPLETED|Overall Study||23||
48577981|NCT03640559|101747644|FG001|COMPLETED|Overall Study||24||
48577982|NCT03640559|101747643|FG000|NOT COMPLETED|Overall Study||2||
48577983|NCT03640559|101747644|FG001|NOT COMPLETED|Overall Study||1||
48577984|NCT03655470|101747645|FG000|STARTED|Overall Study||29||
48577985|NCT03655470|101747646|FG001|STARTED|Overall Study||30||
48577986|NCT03655470|101747645|FG000|COMPLETED|Overall Study||23||
48577987|NCT03655470|101747646|FG001|COMPLETED|Overall Study||23||
48577988|NCT03655470|101747645|FG000|NOT COMPLETED|Overall Study||6||
48577989|NCT03655470|101747646|FG001|NOT COMPLETED|Overall Study||7||
48577990|NCT00378508|101747647|FG000|STARTED|Overall Study||29||
48577991|NCT00378508|101747648|FG001|STARTED|Overall Study||34||
48577992|NCT00378508|101747647|FG000|Randomized|Overall Study||29||
48577993|NCT00378508|101747648|FG001|Randomized|Overall Study||34||
48577994|NCT00378508|101747647|FG000|Received Intervention/Placebo|Overall Study||28||
48577995|NCT00378508|101747648|FG001|Received Intervention/Placebo|Overall Study||31||
48577996|NCT00378508|101747647|FG000|COMPLETED|Overall Study||27||
48577997|NCT00378508|101747648|FG001|COMPLETED|Overall Study||31||
48577998|NCT00378508|101747647|FG000|NOT COMPLETED|Overall Study||2||
48577999|NCT00378508|101747648|FG001|NOT COMPLETED|Overall Study||3||
48578000|NCT05626673|101747649|FG000|STARTED|Overall Study||77||
48578001|NCT05626673|101747649|FG000|COMPLETED|Overall Study||72||
48578002|NCT05626673|101747649|FG000|NOT COMPLETED|Overall Study||5||
48578003|NCT02361346|101747650|FG000|STARTED|Part 1 and 2 ( Up to Day 112)||3||
48133467|NCT01337089|100648744|FG000|Received at Least 1 Dose of Study Drug|Overall Study||660||
48133468|NCT01337089|100648744|FG000|Safety Population|Overall Study||660||
48133469|NCT01337089|100648744|FG000|Efficacy Dataset|Overall Study||659||
48578004|NCT02361346|101747651|FG001|STARTED|Part 1 and 2 ( Up to Day 112)||3||
48578005|NCT02361346|101747652|FG002|STARTED|Part 1 and 2 ( Up to Day 112)||3||
48578006|NCT02361346|101747653|FG003|STARTED|Part 1 and 2 ( Up to Day 112)||4||
48578007|NCT02361346|101747654|FG004|STARTED|Part 1 and 2 ( Up to Day 112)||2||
48578008|NCT02361346|101747655|FG005|STARTED|Part 1 and 2 ( Up to Day 112)||6||
48578009|NCT02361346|101747656|FG006|STARTED|Part 1 and 2 ( Up to Day 112)||6||
48578010|NCT02361346|101747657|FG007|STARTED|Part 1 and 2 ( Up to Day 112)||0||
48578011|NCT02361346|101747658|FG008|STARTED|Part 1 and 2 ( Up to Day 112)||0||
48578012|NCT02361346|101747650|FG000|COMPLETED|Part 1 and 2 ( Up to Day 112)||3||
48578013|NCT02361346|101747651|FG001|COMPLETED|Part 1 and 2 ( Up to Day 112)||3||
48578014|NCT02361346|101747652|FG002|COMPLETED|Part 1 and 2 ( Up to Day 112)||3||
48578015|NCT02361346|101747653|FG003|COMPLETED|Part 1 and 2 ( Up to Day 112)||3||
48578016|NCT02361346|101747654|FG004|COMPLETED|Part 1 and 2 ( Up to Day 112)||0||
48578017|NCT02361346|101747655|FG005|COMPLETED|Part 1 and 2 ( Up to Day 112)||6||
48578018|NCT02361346|101747656|FG006|COMPLETED|Part 1 and 2 ( Up to Day 112)||6||
48578019|NCT02361346|101747657|FG007|COMPLETED|Part 1 and 2 ( Up to Day 112)||0||
48578020|NCT02361346|101747658|FG008|COMPLETED|Part 1 and 2 ( Up to Day 112)||0||
48578021|NCT02361346|101747650|FG000|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||0||
48578022|NCT02361346|101747651|FG001|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||0||
48578023|NCT02361346|101747652|FG002|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||0||
48578024|NCT02361346|101747653|FG003|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||1||
48578025|NCT02361346|101747654|FG004|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||2||
48578026|NCT02361346|101747655|FG005|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||0||
48578027|NCT02361346|101747656|FG006|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||0||
48578028|NCT02361346|101747657|FG007|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||0||
48578029|NCT02361346|101747658|FG008|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||0||
48578030|NCT02361346|101747650|FG000|STARTED|Part 3 (Up to Day 112)||0||
48578031|NCT02361346|101747651|FG001|STARTED|Part 3 (Up to Day 112)||0||
48578032|NCT02361346|101747652|FG002|STARTED|Part 3 (Up to Day 112)||0||
48578033|NCT02361346|101747653|FG003|STARTED|Part 3 (Up to Day 112)||0||
48578034|NCT02361346|101747654|FG004|STARTED|Part 3 (Up to Day 112)||0||
48578035|NCT02361346|101747655|FG005|STARTED|Part 3 (Up to Day 112)||0||
48578036|NCT02361346|101747656|FG006|STARTED|Part 3 (Up to Day 112)||0||
48578037|NCT02361346|101747657|FG007|STARTED|Part 3 (Up to Day 112)||11||
48578038|NCT02361346|101747658|FG008|STARTED|Part 3 (Up to Day 112)||0||
48578039|NCT02361346|101747650|FG000|COMPLETED|Part 3 (Up to Day 112)||0||
48578040|NCT02361346|101747651|FG001|COMPLETED|Part 3 (Up to Day 112)||0||
48578041|NCT02361346|101747652|FG002|COMPLETED|Part 3 (Up to Day 112)||0||
48578042|NCT02361346|101747653|FG003|COMPLETED|Part 3 (Up to Day 112)||0||
48578043|NCT02361346|101747654|FG004|COMPLETED|Part 3 (Up to Day 112)||0||
48578044|NCT02361346|101747655|FG005|COMPLETED|Part 3 (Up to Day 112)||0||
48578045|NCT02361346|101747656|FG006|COMPLETED|Part 3 (Up to Day 112)||0||
48133470|NCT01337089|100648744|FG000|COMPLETED|Overall Study||256||
48133471|NCT01337089|100648744|FG000|NOT COMPLETED|Overall Study||404||
48133472|NCT04782323|100648745|FG000|STARTED|Overall Study||98||
48578046|NCT02361346|101747657|FG007|COMPLETED|Part 3 (Up to Day 112)||0||
48578047|NCT02361346|101747658|FG008|COMPLETED|Part 3 (Up to Day 112)||0||
48578048|NCT02361346|101747650|FG000|NOT COMPLETED|Part 3 (Up to Day 112)||0||
48578049|NCT02361346|101747651|FG001|NOT COMPLETED|Part 3 (Up to Day 112)||0||
48578050|NCT02361346|101747652|FG002|NOT COMPLETED|Part 3 (Up to Day 112)||0||
48578051|NCT02361346|101747653|FG003|NOT COMPLETED|Part 3 (Up to Day 112)||0||
48578052|NCT02361346|101747654|FG004|NOT COMPLETED|Part 3 (Up to Day 112)||0||
48578053|NCT02361346|101747655|FG005|NOT COMPLETED|Part 3 (Up to Day 112)||0||
48578054|NCT02361346|101747656|FG006|NOT COMPLETED|Part 3 (Up to Day 112)||0||
48578055|NCT02361346|101747657|FG007|NOT COMPLETED|Part 3 (Up to Day 112)||11||
48578056|NCT02361346|101747658|FG008|NOT COMPLETED|Part 3 (Up to Day 112)||0||
48578057|NCT02361346|101747650|FG000|STARTED|Part 4 (Up to Day 112)||0||
48578058|NCT02361346|101747651|FG001|STARTED|Part 4 (Up to Day 112)||0||
48578059|NCT02361346|101747652|FG002|STARTED|Part 4 (Up to Day 112)||0||
48578060|NCT02361346|101747653|FG003|STARTED|Part 4 (Up to Day 112)||0||
48578061|NCT02361346|101747654|FG004|STARTED|Part 4 (Up to Day 112)||0||
48578062|NCT02361346|101747655|FG005|STARTED|Part 4 (Up to Day 112)||0||
48578063|NCT02361346|101747656|FG006|STARTED|Part 4 (Up to Day 112)||0||
48578064|NCT02361346|101747657|FG007|STARTED|Part 4 (Up to Day 112)||0||
48578065|NCT02361346|101747658|FG008|STARTED|Part 4 (Up to Day 112)||0||
48578066|NCT02361346|101747650|FG000|COMPLETED|Part 4 (Up to Day 112)||0||
48578067|NCT02361346|101747651|FG001|COMPLETED|Part 4 (Up to Day 112)||0||
48578068|NCT02361346|101747652|FG002|COMPLETED|Part 4 (Up to Day 112)||0||
48578069|NCT02361346|101747653|FG003|COMPLETED|Part 4 (Up to Day 112)||0||
48578070|NCT02361346|101747654|FG004|COMPLETED|Part 4 (Up to Day 112)||0||
48578071|NCT02361346|101747655|FG005|COMPLETED|Part 4 (Up to Day 112)||0||
48578072|NCT02361346|101747656|FG006|COMPLETED|Part 4 (Up to Day 112)||0||
48578073|NCT02361346|101747657|FG007|COMPLETED|Part 4 (Up to Day 112)||0||
48578074|NCT02361346|101747658|FG008|COMPLETED|Part 4 (Up to Day 112)||0||
48578075|NCT02361346|101747650|FG000|NOT COMPLETED|Part 4 (Up to Day 112)||0||
48578076|NCT02361346|101747651|FG001|NOT COMPLETED|Part 4 (Up to Day 112)||0||
48578077|NCT02361346|101747652|FG002|NOT COMPLETED|Part 4 (Up to Day 112)||0||
48578078|NCT02361346|101747653|FG003|NOT COMPLETED|Part 4 (Up to Day 112)||0||
48578079|NCT02361346|101747654|FG004|NOT COMPLETED|Part 4 (Up to Day 112)||0||
48578080|NCT02361346|101747655|FG005|NOT COMPLETED|Part 4 (Up to Day 112)||0||
48578081|NCT02361346|101747656|FG006|NOT COMPLETED|Part 4 (Up to Day 112)||0||
48133473|NCT04782323|100648746|FG001|STARTED|Overall Study||107||
48133474|NCT04782323|100648747|FG002|STARTED|Overall Study||107||
48133475|NCT04782323|100648748|FG003|STARTED|Overall Study||103||
48133476|NCT04782323|100648749|FG004|STARTED|Overall Study||106||
48286367|NCT05330312|101026291|FG002|STARTED|Pilot Investigation - Part 1||11||
48578082|NCT02361346|101747657|FG007|NOT COMPLETED|Part 4 (Up to Day 112)||0||
48578083|NCT02361346|101747658|FG008|NOT COMPLETED|Part 4 (Up to Day 112)||0||
48578084|NCT01431300|101747659|FG000|STARTED|Overall Study||11||
48578085|NCT01431300|101747660|FG001|STARTED|Overall Study||10||
48578086|NCT01431300|101747661|FG002|STARTED|Overall Study||10||
48578087|NCT01431300|101747659|FG000|COMPLETED|Overall Study||10||
48578088|NCT01431300|101747660|FG001|COMPLETED|Overall Study||10||
48578089|NCT01431300|101747661|FG002|COMPLETED|Overall Study||10||
48578090|NCT01431300|101747659|FG000|NOT COMPLETED|Overall Study||1||
48578091|NCT01431300|101747660|FG001|NOT COMPLETED|Overall Study||0||
48578092|NCT01431300|101747661|FG002|NOT COMPLETED|Overall Study||0||
48578093|NCT03129945|101747662|FG000|STARTED|Overall Study||15||
48578094|NCT03129945|101747663|FG001|STARTED|Overall Study||21||
48578095|NCT03129945|101747662|FG000|COMPLETED|Overall Study||15||
48133477|NCT04782323|100648750|FG005|STARTED|Overall Study||108||
48133478|NCT04782323|100648751|FG006|STARTED|Overall Study||101||
48133479|NCT04782323|100648752|FG007|STARTED|Overall Study||109||
48133480|NCT04782323|100648745|FG000|COMPLETED|Overall Study||96||
48578096|NCT03129945|101747663|FG001|COMPLETED|Overall Study||21||
48578097|NCT03129945|101747662|FG000|NOT COMPLETED|Overall Study||0||
48578098|NCT03129945|101747663|FG001|NOT COMPLETED|Overall Study||0||
48578099|NCT02362672|101747664|FG000|STARTED|Titration Phase||1189||
48578100|NCT02362672|101747665|FG001|STARTED|Titration Phase||0||
48578101|NCT02362672|101747666|FG002|STARTED|Titration Phase||0||
48578102|NCT02362672|101747664|FG000|COMPLETED|Titration Phase||610||
48703293|NCT04243577|102057820|FG002|COMPLETED|Second Intervention (1 Hour)||15||
48133481|NCT04782323|100648746|FG001|COMPLETED|Overall Study||106||
48133482|NCT04782323|100648747|FG002|COMPLETED|Overall Study||105||
48133483|NCT04782323|100648748|FG003|COMPLETED|Overall Study||103||
48133484|NCT04782323|100648749|FG004|COMPLETED|Overall Study||105||
48578103|NCT02362672|101747665|FG001|COMPLETED|Titration Phase||0||
48578104|NCT02362672|101747666|FG002|COMPLETED|Titration Phase||0||
48578105|NCT02362672|101747664|FG000|NOT COMPLETED|Titration Phase||579||
48578106|NCT02362672|101747665|FG001|NOT COMPLETED|Titration Phase||0||
48133485|NCT04782323|100648750|FG005|COMPLETED|Overall Study||105||
48133486|NCT04782323|100648751|FG006|COMPLETED|Overall Study||99||
48133487|NCT04782323|100648752|FG007|COMPLETED|Overall Study||106||
48133488|NCT04782323|100648745|FG000|NOT COMPLETED|Overall Study||2||
48133489|NCT04782323|100648746|FG001|NOT COMPLETED|Overall Study||1||
48133490|NCT04782323|100648747|FG002|NOT COMPLETED|Overall Study||2||
48133491|NCT04782323|100648748|FG003|NOT COMPLETED|Overall Study||0||
48133492|NCT04782323|100648749|FG004|NOT COMPLETED|Overall Study||1||
48133493|NCT04782323|100648750|FG005|NOT COMPLETED|Overall Study||3||
48133494|NCT04782323|100648751|FG006|NOT COMPLETED|Overall Study||2||
48133495|NCT04782323|100648752|FG007|NOT COMPLETED|Overall Study||3||
48133496|NCT03277313|100651269|FG000|STARTED|Epoch 1 (Six-week Ramp-up Period)||44||
48133497|NCT03277313|100651270|FG001|STARTED|Epoch 1 (Six-week Ramp-up Period)||0||
48133498|NCT03277313|100651269|FG000|COMPLETED|Epoch 1 (Six-week Ramp-up Period)||43||
48133499|NCT03277313|100651270|FG001|COMPLETED|Epoch 1 (Six-week Ramp-up Period)||0||
48133500|NCT03277313|100651269|FG000|NOT COMPLETED|Epoch 1 (Six-week Ramp-up Period)||1||
48133501|NCT03277313|100651270|FG001|NOT COMPLETED|Epoch 1 (Six-week Ramp-up Period)||0||
48133502|NCT03277313|100651269|FG000|STARTED|Epoch 2 (36 Months After Epoch 1)||0||
48133503|NCT03277313|100651270|FG001|STARTED|Epoch 2 (36 Months After Epoch 1)||43||
48133504|NCT03277313|100651269|FG000|COMPLETED|Epoch 2 (36 Months After Epoch 1)||0||
48133505|NCT03277313|100651270|FG001|COMPLETED|Epoch 2 (36 Months After Epoch 1)||34||
48133506|NCT03277313|100651269|FG000|NOT COMPLETED|Epoch 2 (36 Months After Epoch 1)||0||
48133507|NCT03277313|100651270|FG001|NOT COMPLETED|Epoch 2 (36 Months After Epoch 1)||9||
48133508|NCT00364858|100651271|FG000|STARTED|Overall Study||33||
48133509|NCT00364858|100651272|FG001|STARTED|Overall Study||62||
48133510|NCT00364858|100651271|FG000|COMPLETED|Overall Study||26||
48133511|NCT00364858|100651272|FG001|COMPLETED|Overall Study||40||
48133512|NCT00364858|100651271|FG000|NOT COMPLETED|Overall Study||7||
48133513|NCT00364858|100651272|FG001|NOT COMPLETED|Overall Study||22||
48133514|NCT01863680|100651273|FG000|STARTED|Overall Study||178||
48133515|NCT01863680|100651273|FG000|Subjects Started COS Treatment|Overall Study||169||
48133516|NCT01863680|100651273|FG000|Subjects Received hCG Injection|Overall Study||162||
48133517|NCT01863680|100651273|FG000|Subjects Received Study Drug|Overall Study||149||
48133518|NCT01863680|100651273|FG000|Subjects Who Have Undergone IVF/ET|Overall Study||123||
48133519|NCT01863680|100651273|FG000|COMPLETED|Overall Study||121||
48133520|NCT01863680|100651273|FG000|NOT COMPLETED|Overall Study||57||
48133521|NCT00650546|100651274|FG000|STARTED|Overall Study||8||
48133522|NCT00650546|100651274|FG000|COMPLETED|Overall Study||8||
48133523|NCT00650546|100651274|FG000|NOT COMPLETED|Overall Study||0||
48133524|NCT03264989|100651275|FG000|STARTED|Overall Study||45||
48133525|NCT03264989|100651276|FG001|STARTED|Overall Study||12||
48133526|NCT03264989|100651275|FG000|COMPLETED|Overall Study||0|Completed = Treatment ongoing. Not Completed = Discontinued from treatment|
48133527|NCT03264989|100651276|FG001|COMPLETED|Overall Study||0|Completed = Treatment ongoing. Not Completed = Discontinued from treatment|
48133528|NCT03264989|100651275|FG000|NOT COMPLETED|Overall Study||45||
48133529|NCT03264989|100651276|FG001|NOT COMPLETED|Overall Study||12||
48133530|NCT01175668|100651277|FG000|STARTED|Overall Study||34||
48133531|NCT01175668|100651278|FG001|STARTED|Overall Study||34||
48133532|NCT01175668|100651277|FG000|COMPLETED|Overall Study||32||
48133533|NCT01175668|100651278|FG001|COMPLETED|Overall Study||34||
48133534|NCT01175668|100651277|FG000|NOT COMPLETED|Overall Study||2||
48133535|NCT01175668|100651278|FG001|NOT COMPLETED|Overall Study||0||
48133536|NCT03647501|100651279|FG000|STARTED|Overall Study||25||
48133537|NCT03647501|100651280|FG001|STARTED|Overall Study||28||
48133538|NCT03647501|100651279|FG000|COMPLETED|Overall Study||24||
48578107|NCT02362672|101747666|FG002|NOT COMPLETED|Titration Phase||0||
48578108|NCT02362672|101747664|FG000|STARTED|Double-blind Maintenance Phase||0||
48578109|NCT02362672|101747665|FG001|STARTED|Double-blind Maintenance Phase||309||
48578110|NCT02362672|101747666|FG002|STARTED|Double-blind Maintenance Phase||301||
48578111|NCT02362672|101747664|FG000|COMPLETED|Double-blind Maintenance Phase||0||
48578112|NCT02362672|101747665|FG001|COMPLETED|Double-blind Maintenance Phase||249||
48578113|NCT02362672|101747666|FG002|COMPLETED|Double-blind Maintenance Phase||242||
48578114|NCT02362672|101747664|FG000|NOT COMPLETED|Double-blind Maintenance Phase||0||
48133539|NCT03647501|100651280|FG001|COMPLETED|Overall Study||26||
48133540|NCT03647501|100651279|FG000|NOT COMPLETED|Overall Study||1||
48133541|NCT03647501|100651280|FG001|NOT COMPLETED|Overall Study||2||
48133542|NCT02043782|100651281|FG000|STARTED|Period 1||7||
48133543|NCT02043782|100651282|FG001|STARTED|Period 1||6||
48133544|NCT02043782|100651283|FG002|STARTED|Period 1||7||
48133545|NCT02043782|100651284|FG003|STARTED|Period 1||6||
48133546|NCT02043782|100651285|FG004|STARTED|Period 1||6||
48133547|NCT02043782|100651286|FG005|STARTED|Period 1||6||
48578115|NCT02362672|101747665|FG001|NOT COMPLETED|Double-blind Maintenance Phase||60||
48578116|NCT02362672|101747666|FG002|NOT COMPLETED|Double-blind Maintenance Phase||59||
48578117|NCT00396032|101747667|FG000|STARTED|Overall Study||74||
48578118|NCT00396032|101747668|FG001|STARTED|Overall Study||76||
48133548|NCT02043782|100651281|FG000|COMPLETED|Period 1||7||
48133549|NCT02043782|100651282|FG001|COMPLETED|Period 1||6||
48133550|NCT02043782|100651283|FG002|COMPLETED|Period 1||6||
48133551|NCT02043782|100651284|FG003|COMPLETED|Period 1||6||
48133552|NCT02043782|100651285|FG004|COMPLETED|Period 1||6||
48133553|NCT02043782|100651286|FG005|COMPLETED|Period 1||6||
48133554|NCT02043782|100651281|FG000|NOT COMPLETED|Period 1||0||
48133555|NCT02043782|100651282|FG001|NOT COMPLETED|Period 1||0||
48133556|NCT02043782|100651283|FG002|NOT COMPLETED|Period 1||1||
48578119|NCT00396032|101747667|FG000|COMPLETED|Overall Study||70||
48133557|NCT02043782|100651284|FG003|NOT COMPLETED|Period 1||0||
48578120|NCT00396032|101747668|FG001|COMPLETED|Overall Study||71||
48133558|NCT02043782|100651285|FG004|NOT COMPLETED|Period 1||0||
48133559|NCT02043782|100651286|FG005|NOT COMPLETED|Period 1||0||
48133560|NCT02043782|100651281|FG000|STARTED|Period 2||7||
48133561|NCT02043782|100651282|FG001|STARTED|Period 2||6||
48133562|NCT02043782|100651283|FG002|STARTED|Period 2||6||
48133563|NCT02043782|100651284|FG003|STARTED|Period 2||6||
48133564|NCT02043782|100651285|FG004|STARTED|Period 2||6||
48133565|NCT02043782|100651286|FG005|STARTED|Period 2||6||
48133566|NCT02043782|100651281|FG000|COMPLETED|Period 2||7||
48133567|NCT02043782|100651282|FG001|COMPLETED|Period 2||6||
48133568|NCT02043782|100651283|FG002|COMPLETED|Period 2||6||
48133569|NCT02043782|100651284|FG003|COMPLETED|Period 2||6||
48133570|NCT02043782|100651285|FG004|COMPLETED|Period 2||6||
48133571|NCT02043782|100651286|FG005|COMPLETED|Period 2||6||
48133572|NCT02043782|100651281|FG000|NOT COMPLETED|Period 2||0||
48133573|NCT02043782|100651282|FG001|NOT COMPLETED|Period 2||0||
48286368|NCT05330312|101026289|FG000|COMPLETED|Pilot Investigation - Part 1||0||
48133574|NCT02043782|100651283|FG002|NOT COMPLETED|Period 2||0||
48133575|NCT02043782|100651284|FG003|NOT COMPLETED|Period 2||0||
48133576|NCT02043782|100651285|FG004|NOT COMPLETED|Period 2||0||
48133577|NCT02043782|100651286|FG005|NOT COMPLETED|Period 2||0||
48133578|NCT02043782|100651281|FG000|STARTED|Period 3||7||
48133579|NCT02043782|100651282|FG001|STARTED|Period 3||6||
48133580|NCT02043782|100651283|FG002|STARTED|Period 3||6||
48133581|NCT02043782|100651284|FG003|STARTED|Period 3||6||
48133582|NCT02043782|100651285|FG004|STARTED|Period 3||6||
48133583|NCT02043782|100651286|FG005|STARTED|Period 3||6||
48133584|NCT02043782|100651281|FG000|COMPLETED|Period 3||7||
48133585|NCT02043782|100651282|FG001|COMPLETED|Period 3||6||
48133586|NCT02043782|100651283|FG002|COMPLETED|Period 3||6||
48133587|NCT02043782|100651284|FG003|COMPLETED|Period 3||6||
48133588|NCT02043782|100651285|FG004|COMPLETED|Period 3||6||
48133589|NCT02043782|100651286|FG005|COMPLETED|Period 3||6||
48133590|NCT02043782|100651281|FG000|NOT COMPLETED|Period 3||0||
48133591|NCT02043782|100651282|FG001|NOT COMPLETED|Period 3||0||
48133592|NCT02043782|100651283|FG002|NOT COMPLETED|Period 3||0||
48133593|NCT02043782|100651284|FG003|NOT COMPLETED|Period 3||0||
48286369|NCT05330312|101026290|FG001|COMPLETED|Pilot Investigation - Part 1||0||
48286370|NCT05330312|101026291|FG002|COMPLETED|Pilot Investigation - Part 1||10||
48286371|NCT05330312|101026289|FG000|NOT COMPLETED|Pilot Investigation - Part 1||0||
48286372|NCT05330312|101026290|FG001|NOT COMPLETED|Pilot Investigation - Part 1||0||
48286373|NCT05330312|101026291|FG002|NOT COMPLETED|Pilot Investigation - Part 1||1||
48133594|NCT02043782|100651285|FG004|NOT COMPLETED|Period 3||0||
48133595|NCT02043782|100651286|FG005|NOT COMPLETED|Period 3||0||
48133596|NCT01660763|100651287|FG000|STARTED|Overall Study||315||
48133597|NCT01660763|100651288|FG001|STARTED|Overall Study||104||
48133598|NCT01660763|100651287|FG000|COMPLETED|Overall Study||215||
48133599|NCT01660763|100651288|FG001|COMPLETED|Overall Study||43||
48133600|NCT01660763|100651287|FG000|NOT COMPLETED|Overall Study||100||
48133601|NCT01660763|100651288|FG001|NOT COMPLETED|Overall Study||61||
48133602|NCT03424681|100651289|FG000|STARTED|Overall Study||6||
48133603|NCT03424681|100651290|FG001|STARTED|Overall Study||6||
48133604|NCT03424681|100651289|FG000|COMPLETED|Overall Study||6||
48133605|NCT03424681|100651290|FG001|COMPLETED|Overall Study||5||
48133606|NCT03424681|100651289|FG000|NOT COMPLETED|Overall Study||0||
48133607|NCT03424681|100651290|FG001|NOT COMPLETED|Overall Study||1||
48400064|NCT03984812|101309286|FG002|STARTED|Part 1 (Up to Day 28)||6||
48133608|NCT00856050|100651291|FG000|STARTED|Overall Study||26||
48133609|NCT00856050|100651291|FG000|COMPLETED|Overall Study||26||
48133610|NCT00856050|100651291|FG000|NOT COMPLETED|Overall Study||0||
48133611|NCT00817089|100651292|FG000|STARTED|First Alcohol Challenge||6||
48133612|NCT00817089|100651293|FG001|STARTED|First Alcohol Challenge||8||
48133613|NCT00817089|100651294|FG002|STARTED|First Alcohol Challenge||4||
48133614|NCT00817089|100651295|FG003|STARTED|First Alcohol Challenge||6||
48133615|NCT00817089|100651292|FG000|COMPLETED|First Alcohol Challenge||6||
48133616|NCT00817089|100651293|FG001|COMPLETED|First Alcohol Challenge||8||
48133617|NCT00817089|100651294|FG002|COMPLETED|First Alcohol Challenge||4||
48133618|NCT00817089|100651295|FG003|COMPLETED|First Alcohol Challenge||5||
48578121|NCT00396032|101747667|FG000|NOT COMPLETED|Overall Study||4||
48578122|NCT00396032|101747668|FG001|NOT COMPLETED|Overall Study||5||
48578123|NCT02422940|101747669|FG000|STARTED|Overall Study||152||
48578124|NCT02422940|101747670|FG001|STARTED|Overall Study||142||
48578125|NCT02422940|101747669|FG000|COMPLETED|Overall Study||31||
48578126|NCT02422940|101747670|FG001|COMPLETED|Overall Study||21||
48578127|NCT02422940|101747669|FG000|NOT COMPLETED|Overall Study||121||
48578128|NCT02422940|101747670|FG001|NOT COMPLETED|Overall Study||121||
48578129|NCT01665157|101747671|FG000|STARTED|Overall Study||60||
48578130|NCT01665157|101747672|FG001|STARTED|Overall Study||60||
48578131|NCT01665157|101747673|FG002|STARTED|Overall Study||60||
48578132|NCT01665157|101747671|FG000|COMPLETED|Overall Study||60||
48578133|NCT01665157|101747672|FG001|COMPLETED|Overall Study||60||
48578134|NCT01665157|101747673|FG002|COMPLETED|Overall Study||60||
48578135|NCT01665157|101747671|FG000|NOT COMPLETED|Overall Study||0||
48578136|NCT01665157|101747672|FG001|NOT COMPLETED|Overall Study||0||
48578137|NCT01665157|101747673|FG002|NOT COMPLETED|Overall Study||0||
48578138|NCT04133064|101747674|FG000|STARTED|Overall Study||234||
48286374|NCT05330312|101026289|FG000|STARTED|Pivotal Investigation - Part 2||54||
48286375|NCT05330312|101026290|FG001|STARTED|Pivotal Investigation - Part 2||54||
48286376|NCT05330312|101026291|FG002|STARTED|Pivotal Investigation - Part 2||0||
48286377|NCT05330312|101026289|FG000|COMPLETED|Pivotal Investigation - Part 2||46||
48286378|NCT05330312|101026290|FG001|COMPLETED|Pivotal Investigation - Part 2||46||
48286379|NCT05330312|101026291|FG002|COMPLETED|Pivotal Investigation - Part 2||0||
48286380|NCT05330312|101026289|FG000|NOT COMPLETED|Pivotal Investigation - Part 2||8||
48578139|NCT04133064|101747674|FG000|COMPLETED|Overall Study||215||
48578140|NCT04133064|101747674|FG000|NOT COMPLETED|Overall Study||19||
48578141|NCT02111577|101747675|FG000|STARTED|Overall Study||787||
48578142|NCT02111577|101747676|FG001|STARTED|Overall Study||395||
48578143|NCT02111577|101747675|FG000|COMPLETED|Overall Study||188||
48578144|NCT02111577|101747676|FG001|COMPLETED|Overall Study||106||
48578145|NCT02111577|101747675|FG000|NOT COMPLETED|Overall Study||599||
48578146|NCT02111577|101747676|FG001|NOT COMPLETED|Overall Study||289||
48578147|NCT02695160|101747677|FG000|STARTED|Overall Study||1||
48578148|NCT02695160|101747677|FG000|COMPLETED|Overall Study||0||
48578149|NCT02695160|101747677|FG000|NOT COMPLETED|Overall Study||1||
48578150|NCT01322490|101747678|FG000|STARTED|Treatment Period||432||
48578151|NCT01322490|101747679|FG001|STARTED|Treatment Period||432||
48578152|NCT01322490|101747680|FG002|STARTED|Treatment Period||433||
48578153|NCT01322490|101747678|FG000|Treated|Treatment Period||429||
48578154|NCT01322490|101747679|FG001|Treated|Treatment Period||429||
48578155|NCT01322490|101747680|FG002|Treated|Treatment Period||428||
48578156|NCT01322490|101747678|FG000|COMPLETED|Treatment Period||300||
48578157|NCT01322490|101747679|FG001|COMPLETED|Treatment Period||279||
48703294|NCT04243577|102057821|FG003|COMPLETED|Second Intervention (1 Hour)||15||
48703295|NCT04243577|102057818|FG000|NOT COMPLETED|Second Intervention (1 Hour)||0||
48703296|NCT04243577|102057819|FG001|NOT COMPLETED|Second Intervention (1 Hour)||0||
48703297|NCT04243577|102057820|FG002|NOT COMPLETED|Second Intervention (1 Hour)||0||
48703298|NCT04243577|102057821|FG003|NOT COMPLETED|Second Intervention (1 Hour)||0||
48703299|NCT00760435|102057822|FG000|STARTED|Overall Study||98||
48703300|NCT00760435|102057823|FG001|STARTED|Overall Study||98||
48703301|NCT00760435|102057822|FG000|COMPLETED|Overall Study||94||
48703302|NCT00760435|102057823|FG001|COMPLETED|Overall Study||93||
48703303|NCT00760435|102057822|FG000|NOT COMPLETED|Overall Study||4||
48578158|NCT01322490|101747680|FG002|COMPLETED|Treatment Period||280||
48578159|NCT01322490|101747678|FG000|NOT COMPLETED|Treatment Period||132||
48578160|NCT01322490|101747679|FG001|NOT COMPLETED|Treatment Period||153||
48578161|NCT01322490|101747680|FG002|NOT COMPLETED|Treatment Period||153||
48578162|NCT01322490|101747678|FG000|STARTED|Long Term Follow-up Period||409||
48578163|NCT01322490|101747679|FG001|STARTED|Long Term Follow-up Period||408||
48578164|NCT01322490|101747680|FG002|STARTED|Long Term Follow-up Period||413||
48703304|NCT00760435|102057823|FG001|NOT COMPLETED|Overall Study||5||
48578165|NCT01322490|101747678|FG000|COMPLETED|Long Term Follow-up Period||0||
48578166|NCT01322490|101747679|FG001|COMPLETED|Long Term Follow-up Period||0||
48286381|NCT05330312|101026290|FG001|NOT COMPLETED|Pivotal Investigation - Part 2||8||
48286382|NCT05330312|101026291|FG002|NOT COMPLETED|Pivotal Investigation - Part 2||0||
48286383|NCT00972205|101026292|FG000|STARTED|Overall Study||12||
48286384|NCT00972205|101026292|FG000|COMPLETED|Overall Study||12||
48286385|NCT00972205|101026292|FG000|NOT COMPLETED|Overall Study||0||
48286386|NCT01659853|101026293|FG000|STARTED|Treatment Period 1||35||
48286387|NCT01659853|101026294|FG001|STARTED|Treatment Period 1||35||
48286388|NCT01659853|101026293|FG000|COMPLETED|Treatment Period 1||35||
48578167|NCT01322490|101747680|FG002|COMPLETED|Long Term Follow-up Period||0||
48578168|NCT01322490|101747678|FG000|NOT COMPLETED|Long Term Follow-up Period||409||
48578169|NCT01322490|101747679|FG001|NOT COMPLETED|Long Term Follow-up Period||408||
48578170|NCT01322490|101747680|FG002|NOT COMPLETED|Long Term Follow-up Period||413||
48578171|NCT03964337|101747681|FG000|STARTED|Overall Study||3||
48578172|NCT03964337|101747682|FG001|STARTED|Overall Study||0||
48578173|NCT03964337|101747681|FG000|COMPLETED|Overall Study||3||
48578174|NCT03964337|101747682|FG001|COMPLETED|Overall Study||0||
48578175|NCT03964337|101747681|FG000|NOT COMPLETED|Overall Study||0||
48578176|NCT03964337|101747682|FG001|NOT COMPLETED|Overall Study||0||
48578177|NCT00474045|101747683|FG000|STARTED|Overall Study||233||
48578178|NCT00474045|101747684|FG001|STARTED|Overall Study||237||
48578179|NCT00474045|101747683|FG000|Exposed-All Subjects|Overall Study||233||
48286389|NCT01659853|101026294|FG001|COMPLETED|Treatment Period 1||35||
48286390|NCT01659853|101026293|FG000|NOT COMPLETED|Treatment Period 1||0||
48578180|NCT00474045|101747684|FG001|Exposed-All Subjects|Overall Study||232||
48578181|NCT00474045|101747683|FG000|Exposed-Pregnant Subjects|Overall Study||152||
48578182|NCT00474045|101747684|FG001|Exposed-Pregnant Subjects|Overall Study||158||
48703305|NCT01988662|102060467|FG000|STARTED|Overall Study||104||
48703306|NCT01988662|102060468|FG001|STARTED|Overall Study||101||
48703307|NCT01988662|102060467|FG000|COMPLETED|Overall Study||100||
48703308|NCT01988662|102060468|FG001|COMPLETED|Overall Study||99||
48703309|NCT01988662|102060467|FG000|NOT COMPLETED|Overall Study||4||
48703310|NCT01988662|102060468|FG001|NOT COMPLETED|Overall Study||2||
48703311|NCT04225676|102060469|FG000|STARTED|Overall Study||5||
48703312|NCT04225676|102060469|FG000|Full Analysis, Safety and Enrolled Sets|Overall Study||5||
48703313|NCT04225676|102060469|FG000|COMPLETED|Overall Study||0||
48703314|NCT04225676|102060469|FG000|NOT COMPLETED|Overall Study||5||
48703315|NCT02199314|102060470|FG000|STARTED|Overall Study||30||
48703316|NCT02199314|102060470|FG000|COMPLETED|Overall Study||14||
48703317|NCT02199314|102060470|FG000|NOT COMPLETED|Overall Study||16||
48703318|NCT01818739|102060471|FG000|STARTED|Overall Study||204||
48703319|NCT01818739|102060471|FG000|COMPLETED|Overall Study||204||
48703320|NCT01818739|102060471|FG000|NOT COMPLETED|Overall Study||0||
48703321|NCT00391469|102060472|FG000|STARTED|Overall Study||688||
48703322|NCT00391469|102060473|FG001|STARTED|Overall Study||671||
48703323|NCT00391469|102060472|FG000|COMPLETED|Overall Study||688||
48703324|NCT00391469|102060473|FG001|COMPLETED|Overall Study||671||
48703325|NCT00391469|102060472|FG000|NOT COMPLETED|Overall Study||0||
48703326|NCT00391469|102060473|FG001|NOT COMPLETED|Overall Study||0||
48703327|NCT01482169|102060474|FG000|STARTED|Overall Study||48||
48703328|NCT01482169|102060474|FG000|COMPLETED|Overall Study||46||
48703329|NCT01482169|102060474|FG000|NOT COMPLETED|Overall Study||2||
48703330|NCT02200328|102060475|FG000|STARTED|Overall Study||43||
48703331|NCT02200328|102060476|FG001|STARTED|Overall Study||33||
48703332|NCT02200328|102060475|FG000|COMPLETED|Overall Study||0||
48703333|NCT02200328|102060476|FG001|COMPLETED|Overall Study||0||
48703334|NCT02200328|102060475|FG000|NOT COMPLETED|Overall Study||43||
48703335|NCT02200328|102060476|FG001|NOT COMPLETED|Overall Study||33||
48703336|NCT01858545|102060477|FG000|STARTED|Overall Study||27||
48703337|NCT01858545|102060478|FG001|STARTED|Overall Study||29||
48703338|NCT01858545|102060477|FG000|COMPLETED|Overall Study||23||
48703339|NCT01858545|102060478|FG001|COMPLETED|Overall Study||23||
48703340|NCT01858545|102060477|FG000|NOT COMPLETED|Overall Study||4||
48703341|NCT01858545|102060478|FG001|NOT COMPLETED|Overall Study||6||
48703342|NCT01421303|102060479|FG000|STARTED|Overall Study||80||
48703343|NCT01421303|102060479|FG000|COMPLETED|Overall Study||58||
48703344|NCT01421303|102060479|FG000|NOT COMPLETED|Overall Study||22||
48703345|NCT02030080|102060480|FG000|STARTED|Overall Study||100||
48703346|NCT02030080|102060481|FG001|STARTED|Overall Study||64||
48703347|NCT02030080|102060482|FG002|STARTED|Overall Study||80||
48703348|NCT02030080|102060483|FG003|STARTED|Overall Study||44||
48286391|NCT01659853|101026294|FG001|NOT COMPLETED|Treatment Period 1||0||
48703349|NCT02030080|102060480|FG000|COMPLETED|Overall Study||100||
48703350|NCT02030080|102060481|FG001|COMPLETED|Overall Study||64||
48703351|NCT02030080|102060482|FG002|COMPLETED|Overall Study||80||
48703352|NCT02030080|102060483|FG003|COMPLETED|Overall Study||42||
48703353|NCT02030080|102060480|FG000|NOT COMPLETED|Overall Study||0||
48703354|NCT02030080|102060481|FG001|NOT COMPLETED|Overall Study||0||
48703355|NCT02030080|102060482|FG002|NOT COMPLETED|Overall Study||0||
48703356|NCT02030080|102060483|FG003|NOT COMPLETED|Overall Study||2||
48578183|NCT00474045|101747683|FG000|Pregnancies (for Exposed-pregnant)|Overall Study||152||
48578184|NCT00474045|101747684|FG001|Pregnancies (for Exposed-pregnant)|Overall Study||160||
48703357|NCT00895752|102060484|FG000|STARTED|Overall Study||6||
48703358|NCT00895752|102060484|FG000|COMPLETED|Overall Study||6||
48133619|NCT00817089|100651292|FG000|NOT COMPLETED|First Alcohol Challenge||0||
48133620|NCT00817089|100651293|FG001|NOT COMPLETED|First Alcohol Challenge||0||
48133621|NCT00817089|100651294|FG002|NOT COMPLETED|First Alcohol Challenge||0||
48133622|NCT00817089|100651295|FG003|NOT COMPLETED|First Alcohol Challenge||1||
48133623|NCT00817089|100651292|FG000|STARTED|Second Alcohol Challenge||6||
48133624|NCT00817089|100651293|FG001|STARTED|Second Alcohol Challenge||8||
48133625|NCT00817089|100651294|FG002|STARTED|Second Alcohol Challenge||4||
48133626|NCT00817089|100651295|FG003|STARTED|Second Alcohol Challenge||5||
48133627|NCT00817089|100651292|FG000|COMPLETED|Second Alcohol Challenge||6||
48133628|NCT00817089|100651293|FG001|COMPLETED|Second Alcohol Challenge||7||
48133629|NCT00817089|100651294|FG002|COMPLETED|Second Alcohol Challenge||4||
48133630|NCT00817089|100651295|FG003|COMPLETED|Second Alcohol Challenge||5||
48133631|NCT00817089|100651292|FG000|NOT COMPLETED|Second Alcohol Challenge||0||
48133632|NCT00817089|100651293|FG001|NOT COMPLETED|Second Alcohol Challenge||1||
48133633|NCT00817089|100651294|FG002|NOT COMPLETED|Second Alcohol Challenge||0||
48133634|NCT00817089|100651295|FG003|NOT COMPLETED|Second Alcohol Challenge||0||
48133635|NCT00237744|100651296|FG000|STARTED|Overall Study||11||
48133636|NCT00237744|100651297|FG001|STARTED|Overall Study||11||
48133637|NCT00237744|100651298|FG002|STARTED|Overall Study||18||
48133638|NCT00237744|100651296|FG000|COMPLETED|Overall Study||8||
48133639|NCT00237744|100651297|FG001|COMPLETED|Overall Study||10||
48133640|NCT00237744|100651298|FG002|COMPLETED|Overall Study||18||
48133641|NCT00237744|100651296|FG000|NOT COMPLETED|Overall Study||3||
48133642|NCT00237744|100651297|FG001|NOT COMPLETED|Overall Study||1||
48400065|NCT03984812|101309287|FG003|STARTED|Part 1 (Up to Day 28)||6||
48703359|NCT00895752|102060484|FG000|NOT COMPLETED|Overall Study||0||
48703360|NCT01814878|102060485|FG000|STARTED|Overall Study||162||
48703361|NCT01814878|102060486|FG001|STARTED|Overall Study||158||
48703362|NCT01814878|102060485|FG000|COMPLETED|Overall Study||116||
48703363|NCT01814878|102060486|FG001|COMPLETED|Overall Study||128||
48703364|NCT01814878|102060485|FG000|NOT COMPLETED|Overall Study||46||
48703365|NCT01814878|102060486|FG001|NOT COMPLETED|Overall Study||30||
48703366|NCT01467037|102060487|FG000|STARTED|Overall Study||374||
48703367|NCT01467037|102060487|FG000|COMPLETED|Overall Study||374||
48703368|NCT01467037|102060487|FG000|NOT COMPLETED|Overall Study||0||
48703369|NCT04096820|102060488|FG000|STARTED|Overall Study||67||
48703370|NCT04096820|102060488|FG000|COMPLETED|Overall Study||64||
48703371|NCT04096820|102060488|FG000|NOT COMPLETED|Overall Study||3||
48703372|NCT01222091|102060489|FG000|STARTED|Overall Study||5||
48703373|NCT01222091|102060490|FG001|STARTED|Overall Study||5||
48703374|NCT01222091|102060489|FG000|COMPLETED|Overall Study||5||
48703375|NCT01222091|102060490|FG001|COMPLETED|Overall Study||5||
48703376|NCT01222091|102060489|FG000|NOT COMPLETED|Overall Study||0||
48703377|NCT01222091|102060490|FG001|NOT COMPLETED|Overall Study||0||
48703378|NCT02449889|102060491|FG000|STARTED|Overall Study||58||
48703379|NCT02449889|102060492|FG001|STARTED|Overall Study||58||
48703380|NCT02449889|102060493|FG002|STARTED|Overall Study||60||
48703381|NCT02449889|102060491|FG000|COMPLETED|Overall Study||57||
48703382|NCT02449889|102060492|FG001|COMPLETED|Overall Study||52||
48703383|NCT02449889|102060493|FG002|COMPLETED|Overall Study||59||
48703384|NCT02449889|102060491|FG000|NOT COMPLETED|Overall Study||1||
48703385|NCT02449889|102060492|FG001|NOT COMPLETED|Overall Study||6||
48703386|NCT02449889|102060493|FG002|NOT COMPLETED|Overall Study||1||
48703387|NCT00005901|102060494|FG000|STARTED|Overall Study||19||
48703388|NCT00005901|102060495|FG001|STARTED|Overall Study||15||
48703389|NCT00005901|102060494|FG000|COMPLETED|Overall Study||19||
48703390|NCT00005901|102060495|FG001|COMPLETED|Overall Study||15||
48703391|NCT00005901|102060494|FG000|NOT COMPLETED|Overall Study||0||
48703392|NCT00005901|102060495|FG001|NOT COMPLETED|Overall Study||0||
48703393|NCT02509052|102060496|FG000|STARTED|Overall Study||3||
48703394|NCT02509052|102060497|FG001|STARTED|Overall Study||3||
48703395|NCT02509052|102060498|FG002|STARTED|Overall Study||6||
48703396|NCT02509052|102060496|FG000|COMPLETED|Overall Study||3||
48703397|NCT02509052|102060497|FG001|COMPLETED|Overall Study||3||
48703398|NCT02509052|102060498|FG002|COMPLETED|Overall Study||5||
48133643|NCT00237744|100651298|FG002|NOT COMPLETED|Overall Study||0||
48133644|NCT02219932|100651299|FG000|STARTED|Overall Study||319||
48133645|NCT02219932|100651300|FG001|STARTED|Overall Study||317||
48400066|NCT03984812|101309288|FG004|STARTED|Part 1 (Up to Day 28)||0||
48400067|NCT03984812|101309289|FG005|STARTED|Part 1 (Up to Day 28)||0||
48400068|NCT03984812|101309290|FG006|STARTED|Part 1 (Up to Day 28)||0||
48400069|NCT03984812|101309291|FG007|STARTED|Part 1 (Up to Day 28)||0||
48400070|NCT03984812|101309292|FG008|STARTED|Part 1 (Up to Day 28)||0||
48400071|NCT03984812|101309293|FG009|STARTED|Part 1 (Up to Day 28)||0||
48400072|NCT03984812|101309294|FG010|STARTED|Part 1 (Up to Day 28)||0||
48400073|NCT03984812|101309284|FG000|COMPLETED|Part 1 (Up to Day 28)||6||
48400074|NCT03984812|101309285|FG001|COMPLETED|Part 1 (Up to Day 28)||6||
48400075|NCT03984812|101309286|FG002|COMPLETED|Part 1 (Up to Day 28)||5||
48703399|NCT02509052|102060496|FG000|NOT COMPLETED|Overall Study||0||
48703400|NCT02509052|102060497|FG001|NOT COMPLETED|Overall Study||0||
48703401|NCT02509052|102060498|FG002|NOT COMPLETED|Overall Study||1||
48703402|NCT01975519|102060499|FG000|STARTED|Overall Study||3||
48703403|NCT01975519|102060500|FG001|STARTED|Overall Study||108||
48133646|NCT02219932|100651299|FG000|Randomized, Not Treated|Overall Study||0||
48133647|NCT02219932|100651300|FG001|Randomized, Not Treated|Overall Study||1||
48133648|NCT02219932|100651299|FG000|COMPLETED|Overall Study||254||
48133649|NCT02219932|100651300|FG001|COMPLETED|Overall Study||266||
48133650|NCT02219932|100651299|FG000|NOT COMPLETED|Overall Study||65||
48133651|NCT02219932|100651300|FG001|NOT COMPLETED|Overall Study||51||
48286392|NCT01659853|101026293|FG000|STARTED|Washout , 3 to 7 Days||35||
48286393|NCT01659853|101026294|FG001|STARTED|Washout , 3 to 7 Days||35||
48286394|NCT01659853|101026293|FG000|COMPLETED|Washout , 3 to 7 Days||33||
48286395|NCT01659853|101026294|FG001|COMPLETED|Washout , 3 to 7 Days||35||
48286396|NCT01659853|101026293|FG000|NOT COMPLETED|Washout , 3 to 7 Days||2||
48286397|NCT01659853|101026294|FG001|NOT COMPLETED|Washout , 3 to 7 Days||0||
48286398|NCT01659853|101026293|FG000|STARTED|Treatment Period 2||33||
48286399|NCT01659853|101026294|FG001|STARTED|Treatment Period 2||35||
48286400|NCT01659853|101026293|FG000|COMPLETED|Treatment Period 2||33||
48286401|NCT01659853|101026294|FG001|COMPLETED|Treatment Period 2||35||
48286402|NCT01659853|101026293|FG000|NOT COMPLETED|Treatment Period 2||0||
48286403|NCT01659853|101026294|FG001|NOT COMPLETED|Treatment Period 2||0||
48286404|NCT02679508|101026295|FG000|STARTED|Healing Phase||139||
48286405|NCT02679508|101026296|FG001|STARTED|Healing Phase||69||
48286406|NCT02679508|101026295|FG000|COMPLETED|Healing Phase||137||
48286407|NCT02679508|101026296|FG001|COMPLETED|Healing Phase||68||
48286408|NCT02679508|101026295|FG000|NOT COMPLETED|Healing Phase||2||
48286409|NCT02679508|101026296|FG001|NOT COMPLETED|Healing Phase||1||
48286410|NCT02679508|101026295|FG000|STARTED|Maintenance Phase||137||
48133652|NCT01629329|100651301|FG000|STARTED|Overall Study||0||
48133653|NCT01629329|100651302|FG001|STARTED|Overall Study||0||
48133654|NCT01629329|100651301|FG000|COMPLETED|Overall Study||0||
48133655|NCT01629329|100651302|FG001|COMPLETED|Overall Study||0||
48133656|NCT01629329|100651301|FG000|NOT COMPLETED|Overall Study||0||
48133657|NCT01629329|100651302|FG001|NOT COMPLETED|Overall Study||0||
48133658|NCT02730819|100651303|FG000|STARTED|Overall Study||19||
48133659|NCT02730819|100651303|FG000|Follow-up Week 2|Overall Study||15||
48133660|NCT02730819|100651303|FG000|Follow-up Week 4|Overall Study||16||
48133661|NCT02730819|100651303|FG000|Follow-up Week 8|Overall Study||14||
48133662|NCT02730819|100651303|FG000|Follow-up Week 12|Overall Study||11||
48133663|NCT02730819|100651303|FG000|Follow-up Week 16|Overall Study||11||
48133664|NCT02730819|100651303|FG000|Follow-up Week 20|Overall Study||10||
48133665|NCT02730819|100651303|FG000|COMPLETED|Overall Study||10||
48133666|NCT02730819|100651303|FG000|NOT COMPLETED|Overall Study||9||
48286411|NCT02679508|101026296|FG001|STARTED|Maintenance Phase||68||
48286412|NCT02679508|101026295|FG000|COMPLETED|Maintenance Phase||105||
48286413|NCT02679508|101026296|FG001|COMPLETED|Maintenance Phase||53||
48286414|NCT02679508|101026295|FG000|NOT COMPLETED|Maintenance Phase||32||
48400076|NCT03984812|101309287|FG003|COMPLETED|Part 1 (Up to Day 28)||6||
48400077|NCT03984812|101309288|FG004|COMPLETED|Part 1 (Up to Day 28)||0||
48133667|NCT00709722|100651304|FG000|STARTED|Overall Study||21||
48133668|NCT00709722|100651304|FG000|COMPLETED|Overall Study||20||
48133669|NCT00709722|100651304|FG000|NOT COMPLETED|Overall Study||1||
48133670|NCT03176693|100651305|FG000|STARTED|Overall Study||19||
48133671|NCT03176693|100651306|FG001|STARTED|Overall Study||20||
48133672|NCT03176693|100651305|FG000|COMPLETED|Overall Study||19||
48133673|NCT03176693|100651306|FG001|COMPLETED|Overall Study||20||
48133674|NCT03176693|100651305|FG000|NOT COMPLETED|Overall Study||0||
48133675|NCT03176693|100651306|FG001|NOT COMPLETED|Overall Study||0||
48133676|NCT03825380|100651307|FG000|STARTED|Overall Study||236||
48133677|NCT03825380|100651308|FG001|STARTED|Overall Study||249||
48133678|NCT03825380|100651307|FG000|COMPLETED|Overall Study||218||
48133679|NCT03825380|100651308|FG001|COMPLETED|Overall Study||227||
48133680|NCT03825380|100651307|FG000|NOT COMPLETED|Overall Study||18||
48133681|NCT03825380|100651308|FG001|NOT COMPLETED|Overall Study||22||
48133682|NCT03943095|100651309|FG000|STARTED|Overall Study||52||
48133683|NCT03943095|100651310|FG001|STARTED|Overall Study||52||
48133684|NCT03943095|100651309|FG000|COMPLETED|Overall Study||51||
48133685|NCT03943095|100651310|FG001|COMPLETED|Overall Study||51||
48133686|NCT03943095|100651309|FG000|NOT COMPLETED|Overall Study||1||
48286415|NCT02679508|101026296|FG001|NOT COMPLETED|Maintenance Phase||15||
48286416|NCT01001559|101026297|FG000|STARTED|Overall Study||95||
48286417|NCT01001559|101026298|FG001|STARTED|Overall Study||147||
48286418|NCT01001559|101026297|FG000|COMPLETED|Overall Study||95||
48400078|NCT03984812|101309289|FG005|COMPLETED|Part 1 (Up to Day 28)||0||
48400079|NCT03984812|101309290|FG006|COMPLETED|Part 1 (Up to Day 28)||0||
48133687|NCT03943095|100651310|FG001|NOT COMPLETED|Overall Study||1||
48133688|NCT02014116|100651311|FG000|STARTED|Overall Study||3||
48133689|NCT02014116|100651312|FG001|STARTED|Overall Study||4||
48133690|NCT02014116|100651313|FG002|STARTED|Overall Study||3||
48286419|NCT01001559|101026298|FG001|COMPLETED|Overall Study||147||
48286420|NCT01001559|101026297|FG000|NOT COMPLETED|Overall Study||0||
48286421|NCT01001559|101026298|FG001|NOT COMPLETED|Overall Study||0||
48286422|NCT02947087|101026299|FG000|STARTED|Overall Study||32||
48286423|NCT02947087|101026300|FG001|STARTED|Overall Study||16||
48286424|NCT02947087|101026299|FG000|COMPLETED|Overall Study||29||
48286425|NCT02947087|101026300|FG001|COMPLETED|Overall Study||14||
48286426|NCT02947087|101026299|FG000|NOT COMPLETED|Overall Study||3||
48578185|NCT00474045|101747683|FG000|COMPLETED|Overall Study||127||
48578186|NCT00474045|101747684|FG001|COMPLETED|Overall Study||136||
48578187|NCT00474045|101747683|FG000|NOT COMPLETED|Overall Study||106||
48578188|NCT00474045|101747684|FG001|NOT COMPLETED|Overall Study||101||
48578189|NCT02222545|101747685|FG000|STARTED|Overall Study||3||
48578190|NCT02222545|101747686|FG001|STARTED|Overall Study||3||
48578191|NCT02222545|101747687|FG002|STARTED|Overall Study||52||
48578192|NCT02222545|101747685|FG000|COMPLETED|Overall Study||2||
48578193|NCT02222545|101747686|FG001|COMPLETED|Overall Study||3||
48578194|NCT02222545|101747687|FG002|COMPLETED|Overall Study||27||
48578195|NCT02222545|101747685|FG000|NOT COMPLETED|Overall Study||1||
48578196|NCT02222545|101747686|FG001|NOT COMPLETED|Overall Study||0||
48578197|NCT02222545|101747687|FG002|NOT COMPLETED|Overall Study||25||
48578198|NCT01637922|101747688|FG000|STARTED|Overall Study||15||
48578199|NCT01637922|101747689|FG001|STARTED|Overall Study||19||
48578200|NCT01637922|101747688|FG000|COMPLETED|Overall Study||13||
48578201|NCT01637922|101747689|FG001|COMPLETED|Overall Study||14||
48578202|NCT01637922|101747688|FG000|NOT COMPLETED|Overall Study||2||
48578203|NCT01637922|101747689|FG001|NOT COMPLETED|Overall Study||5||
48578204|NCT00803790|101747690|FG000|STARTED|Period 1||125||
48578205|NCT00803790|101747691|FG001|STARTED|Period 1||126||
48578206|NCT00803790|101747692|FG002|STARTED|Period 1||32||
48578207|NCT00803790|101747693|FG003|STARTED|Period 1||35||
48578208|NCT00803790|101747690|FG000|COMPLETED|Period 1||116||
48578209|NCT00803790|101747691|FG001|COMPLETED|Period 1||114||
48578210|NCT00803790|101747692|FG002|COMPLETED|Period 1||31||
48578211|NCT00803790|101747693|FG003|COMPLETED|Period 1||31||
48578212|NCT00803790|101747690|FG000|NOT COMPLETED|Period 1||9||
48578213|NCT00803790|101747691|FG001|NOT COMPLETED|Period 1||12||
48578214|NCT00803790|101747692|FG002|NOT COMPLETED|Period 1||1||
48578215|NCT00803790|101747693|FG003|NOT COMPLETED|Period 1||4||
48578216|NCT00803790|101747690|FG000|STARTED|Period 2||116||
48578217|NCT00803790|101747691|FG001|STARTED|Period 2||114||
48578218|NCT00803790|101747692|FG002|STARTED|Period 2||31||
48578219|NCT00803790|101747693|FG003|STARTED|Period 2||31||
48578220|NCT00803790|101747690|FG000|COMPLETED|Period 2||114||
48578221|NCT00803790|101747691|FG001|COMPLETED|Period 2||114||
48578222|NCT00803790|101747692|FG002|COMPLETED|Period 2||30||
48578223|NCT00803790|101747693|FG003|COMPLETED|Period 2||30||
48578224|NCT00803790|101747690|FG000|NOT COMPLETED|Period 2||2||
48578225|NCT00803790|101747691|FG001|NOT COMPLETED|Period 2||0||
48578226|NCT00803790|101747692|FG002|NOT COMPLETED|Period 2||1||
48578227|NCT00803790|101747693|FG003|NOT COMPLETED|Period 2||1||
48578228|NCT04590586|101747694|FG000|STARTED|Overall Study||28||
48578229|NCT04590586|101747695|FG001|STARTED|Overall Study||1||
48578230|NCT04590586|101747696|FG002|STARTED|Overall Study||194||
48578231|NCT04590586|101747697|FG003|STARTED|Overall Study||184||
48286427|NCT02947087|101026300|FG001|NOT COMPLETED|Overall Study||2||
48286428|NCT03476707|101026301|FG000|STARTED|Overall Study||381||
48286429|NCT03476707|101026302|FG001|STARTED|Overall Study||470||
48286430|NCT03476707|101026301|FG000|COMPLETED|Overall Study||381||
48286431|NCT03476707|101026302|FG001|COMPLETED|Overall Study||470||
48286432|NCT03476707|101026301|FG000|NOT COMPLETED|Overall Study||0||
48286433|NCT03476707|101026302|FG001|NOT COMPLETED|Overall Study||0||
48286434|NCT00195091|101026303|FG000|STARTED|Overall Study||16||
48286435|NCT00195091|101026303|FG000|COMPLETED|Overall Study||0||
48286436|NCT00195091|101026303|FG000|NOT COMPLETED|Overall Study||16||
48286437|NCT00178126|101026304|FG000|STARTED|Overall Study||119||
48286438|NCT00178126|101026305|FG001|STARTED|Overall Study||113||
48286439|NCT00178126|101026304|FG000|COMPLETED|Overall Study||94||
48286440|NCT00178126|101026305|FG001|COMPLETED|Overall Study||86||
48286441|NCT00178126|101026304|FG000|NOT COMPLETED|Overall Study||25||
48578232|NCT04590586|101747698|FG004|STARTED|Overall Study||100||
48578233|NCT04590586|101747699|FG005|STARTED|Overall Study||8||
48578234|NCT04590586|101747694|FG000|Received Study Drug|Overall Study||27||
48578235|NCT04590586|101747695|FG001|Received Study Drug|Overall Study||1||
48578236|NCT04590586|101747696|FG002|Received Study Drug|Overall Study||189||
48578237|NCT04590586|101747697|FG003|Received Study Drug|Overall Study||182||
48578238|NCT04590586|101747698|FG004|Received Study Drug|Overall Study||95||
48578239|NCT04590586|101747699|FG005|Received Study Drug|Overall Study||7||
48578240|NCT04590586|101747694|FG000|Full Analysis Set|Overall Study||28|For each sub-protocol the full analysis set includes all participants randomized to the sub-protocol candidate agent as well as all participants who were randomized to any placebo arm included in the control arm of the candidate agent (i.e. shared placebo). The control arm for analysis of a candidate agent includes participants enrolled in any placebo group, regardless of sub-protocol, if certain criteria were met.|
48592811|NCT01764997|101783183|FG001|COMPLETED|Study Drug Treatment Period||16||
48286442|NCT00178126|101026305|FG001|NOT COMPLETED|Overall Study||27||
48286443|NCT03254485|101026306|FG000|STARTED|Overall Study||90||
48286444|NCT03254485|101026307|FG001|STARTED|Overall Study||7||
48286445|NCT03254485|101026308|FG002|STARTED|Overall Study||7||
48286446|NCT03254485|101026309|FG003|STARTED|Overall Study||92||
48286447|NCT03254485|101026306|FG000|COMPLETED|Overall Study||78||
48286448|NCT03254485|101026307|FG001|COMPLETED|Overall Study||7||
48286449|NCT03254485|101026308|FG002|COMPLETED|Overall Study||7||
48286450|NCT03254485|101026309|FG003|COMPLETED|Overall Study||77||
48578241|NCT04590586|101747695|FG001|Full Analysis Set|Overall Study||34|For each sub-protocol the full analysis set includes all participants randomized to the sub-protocol candidate agent as well as all participants who were randomized to any placebo arm included in the control arm of the candidate agent (i.e. shared placebo). The control arm for analysis of a candidate agent includes participants enrolled in any placebo group, regardless of sub-protocol, if certain criteria were met.|
48578242|NCT04590586|101747696|FG002|Full Analysis Set|Overall Study||194|For each sub-protocol the full analysis set includes all participants randomized to the sub-protocol candidate agent as well as all participants who were randomized to any placebo arm included in the control arm of the candidate agent (i.e. shared placebo). The control arm for analysis of a candidate agent includes participants enrolled in any placebo group, regardless of sub-protocol, if certain criteria were met.|
48578243|NCT04590586|101747697|FG003|Full Analysis Set|Overall Study||190|For each sub-protocol the full analysis set includes all participants randomized to the sub-protocol candidate agent as well as all participants who were randomized to any placebo arm included in the control arm of the candidate agent (i.e. shared placebo). The control arm for analysis of a candidate agent includes participants enrolled in any placebo group, regardless of sub-protocol, if certain criteria were met.|
48578244|NCT04590586|101747698|FG004|Full Analysis Set|Overall Study||100|For each sub-protocol the full analysis set includes all participants randomized to the sub-protocol candidate agent as well as all participants who were randomized to any placebo arm included in the control arm of the candidate agent (i.e. shared placebo). The control arm for analysis of a candidate agent includes participants enrolled in any placebo group, regardless of sub-protocol, if certain criteria were met.|
48578245|NCT04590586|101747699|FG005|Full Analysis Set|Overall Study||75|For each sub-protocol the full analysis set includes all participants randomized to the sub-protocol candidate agent as well as all participants who were randomized to any placebo arm included in the control arm of the candidate agent (i.e. shared placebo). The control arm for analysis of a candidate agent includes participants enrolled in any placebo group, regardless of sub-protocol, if certain criteria were met.|
48578246|NCT04590586|101747694|FG000|COMPLETED|Overall Study||15||
48286451|NCT03254485|101026306|FG000|NOT COMPLETED|Overall Study||12||
48286452|NCT03254485|101026307|FG001|NOT COMPLETED|Overall Study||0||
48286453|NCT03254485|101026308|FG002|NOT COMPLETED|Overall Study||0||
48286454|NCT03254485|101026309|FG003|NOT COMPLETED|Overall Study||15||
48286455|NCT03695237|101026310|FG000|STARTED|Overall Study||18||
48286456|NCT03695237|101026311|FG001|STARTED|Overall Study||27||
48286457|NCT03695237|101026310|FG000|COMPLETED|Overall Study||8||
48286458|NCT03695237|101026311|FG001|COMPLETED|Overall Study||20||
48286459|NCT03695237|101026310|FG000|NOT COMPLETED|Overall Study||10||
48286460|NCT03695237|101026311|FG001|NOT COMPLETED|Overall Study||7||
48286461|NCT02004353|101026312|FG000|STARTED|Overall Study||1518||
48286462|NCT02004353|101026312|FG000|COMPLETED|Overall Study||184||
48286463|NCT02004353|101026312|FG000|NOT COMPLETED|Overall Study||1334||
48286464|NCT02414932|101026313|FG000|STARTED|Overall Study||3||
48286465|NCT02414932|101026314|FG001|STARTED|Overall Study||3||
48286466|NCT02414932|101026313|FG000|COMPLETED|Overall Study||0||
48286467|NCT02414932|101026314|FG001|COMPLETED|Overall Study||0||
48286468|NCT02414932|101026313|FG000|NOT COMPLETED|Overall Study||3||
48286469|NCT02414932|101026314|FG001|NOT COMPLETED|Overall Study||3||
48286470|NCT03545503|101026315|FG000|STARTED|Overall Study||208||
48286471|NCT03545503|101026316|FG001|STARTED|Overall Study||220||
48286472|NCT03545503|101026315|FG000|COMPLETED|Overall Study||194||
48286473|NCT03545503|101026316|FG001|COMPLETED|Overall Study||204||
48286474|NCT03545503|101026315|FG000|NOT COMPLETED|Overall Study||14||
48286475|NCT03545503|101026316|FG001|NOT COMPLETED|Overall Study||16||
48578247|NCT04590586|101747695|FG001|COMPLETED|Overall Study||0||
48578248|NCT04590586|101747696|FG002|COMPLETED|Overall Study||139||
48578249|NCT04590586|101747697|FG003|COMPLETED|Overall Study||138||
48578250|NCT04590586|101747698|FG004|COMPLETED|Overall Study||70||
48578251|NCT04590586|101747699|FG005|COMPLETED|Overall Study||4||
48578252|NCT04590586|101747694|FG000|NOT COMPLETED|Overall Study||13||
48578253|NCT04590586|101747695|FG001|NOT COMPLETED|Overall Study||1||
48578254|NCT04590586|101747696|FG002|NOT COMPLETED|Overall Study||55||
48578255|NCT04590586|101747697|FG003|NOT COMPLETED|Overall Study||46||
48578256|NCT04590586|101747698|FG004|NOT COMPLETED|Overall Study||30||
48578257|NCT04590586|101747699|FG005|NOT COMPLETED|Overall Study||4||
48578258|NCT01075256|101747700|FG000|STARTED|Overall Study||64||
48578259|NCT01075256|101747701|FG001|STARTED|Overall Study||66||
48578260|NCT01075256|101747702|FG002|STARTED|Overall Study||65||
48578261|NCT01075256|101747700|FG000|COMPLETED|Overall Study||63||
48578262|NCT01075256|101747701|FG001|COMPLETED|Overall Study||66||
48578263|NCT01075256|101747702|FG002|COMPLETED|Overall Study||65||
48286476|NCT04877730|101026317|FG000|STARTED|Overall Study||5||
48286477|NCT04877730|101026318|FG001|STARTED|Overall Study||7||
48286478|NCT04877730|101026319|FG002|STARTED|Overall Study||7||
48286479|NCT04877730|101026320|FG003|STARTED|Overall Study||8||
48286480|NCT04877730|101026321|FG004|STARTED|Overall Study||4||
48286481|NCT04877730|101026322|FG005|STARTED|Overall Study||5||
48286482|NCT04877730|101026317|FG000|COMPLETED|Overall Study||5||
48286483|NCT04877730|101026318|FG001|COMPLETED|Overall Study||6||
48286484|NCT04877730|101026319|FG002|COMPLETED|Overall Study||7||
48286485|NCT04877730|101026320|FG003|COMPLETED|Overall Study||8||
48286486|NCT04877730|101026321|FG004|COMPLETED|Overall Study||4||
48286487|NCT04877730|101026322|FG005|COMPLETED|Overall Study||5||
48286488|NCT04877730|101026317|FG000|NOT COMPLETED|Overall Study||0||
48286489|NCT04877730|101026318|FG001|NOT COMPLETED|Overall Study||1||
48286490|NCT04877730|101026319|FG002|NOT COMPLETED|Overall Study||0||
48286491|NCT04877730|101026320|FG003|NOT COMPLETED|Overall Study||0||
48286492|NCT04877730|101026321|FG004|NOT COMPLETED|Overall Study||0||
48286493|NCT04877730|101026322|FG005|NOT COMPLETED|Overall Study||0||
48286494|NCT02442336|101026323|FG000|STARTED|Overall Study||80||
48286495|NCT02442336|101026323|FG000|Developmental Phase|Overall Study||6||
48286496|NCT02442336|101026323|FG000|Evaluation Phase|Overall Study||74||
48286497|NCT02442336|101026323|FG000|Provided Access to Intervention|Overall Study||55|55 participants were provided access to My Journey AHead. 44 participants logged in and viewed the program, whereas 11 participants did not log in or access the program.|
48286498|NCT02442336|101026323|FG000|COMPLETED|Overall Study||44||
48286499|NCT02442336|101026323|FG000|NOT COMPLETED|Overall Study||36||
48578264|NCT01075256|101747700|FG000|NOT COMPLETED|Overall Study||1||
48578265|NCT01075256|101747701|FG001|NOT COMPLETED|Overall Study||0||
48578266|NCT01075256|101747702|FG002|NOT COMPLETED|Overall Study||0||
48578267|NCT01089608|101747703|FG000|STARTED|Overall Study||43||
48286500|NCT03581825|101026324|FG000|STARTED|Period 1||31||
48286501|NCT03581825|101026325|FG001|STARTED|Period 1||31||
48286502|NCT03581825|101026324|FG000|COMPLETED|Period 1||30||
48286503|NCT03581825|101026325|FG001|COMPLETED|Period 1||31||
48578268|NCT01089608|101747704|FG001|STARTED|Overall Study||50||
48578269|NCT01089608|101747703|FG000|COMPLETED|Overall Study||43||
48578270|NCT01089608|101747704|FG001|COMPLETED|Overall Study||44||
48578271|NCT01089608|101747703|FG000|NOT COMPLETED|Overall Study||0||
48578272|NCT01089608|101747704|FG001|NOT COMPLETED|Overall Study||6||
48578273|NCT02887248|101747705|FG000|STARTED|Overall Study||3||
48578274|NCT02887248|101747705|FG000|COMPLETED|Overall Study||0||
48286504|NCT03581825|101026324|FG000|NOT COMPLETED|Period 1||1||
48286505|NCT03581825|101026325|FG001|NOT COMPLETED|Period 1||0||
48286506|NCT03581825|101026324|FG000|STARTED|Period 2||30||
48578275|NCT02887248|101747705|FG000|NOT COMPLETED|Overall Study||3||
48578276|NCT01264081|101747706|FG000|STARTED|Participants Screened||34||
48578277|NCT01264081|101747706|FG000|COMPLETED|Participants Screened||4||
48703404|NCT01975519|102060499|FG000|Phase 1b|Overall Study||3||
48578278|NCT01264081|101747706|FG000|NOT COMPLETED|Participants Screened||30||
48578279|NCT01264081|101747706|FG000|STARTED|Started Treatment||4||
48578280|NCT01264081|101747706|FG000|COMPLETED|Started Treatment||2||
48578281|NCT01264081|101747706|FG000|NOT COMPLETED|Started Treatment||2||
48578282|NCT01264081|101747706|FG000|STARTED|Analysis||2||
48578283|NCT01264081|101747706|FG000|COMPLETED|Analysis||2||
48286507|NCT03581825|101026325|FG001|STARTED|Period 2||31||
48286508|NCT03581825|101026324|FG000|COMPLETED|Period 2||30||
48286509|NCT03581825|101026325|FG001|COMPLETED|Period 2||30||
48286510|NCT03581825|101026324|FG000|NOT COMPLETED|Period 2||0||
48286511|NCT03581825|101026325|FG001|NOT COMPLETED|Period 2||1||
48286512|NCT03573583|101026326|FG000|STARTED|Overall Study||10||
48286513|NCT03573583|101026327|FG001|STARTED|Overall Study||11||
48286514|NCT03573583|101026326|FG000|COMPLETED|Overall Study||8||
48286515|NCT03573583|101026327|FG001|COMPLETED|Overall Study||10||
48286516|NCT03573583|101026326|FG000|NOT COMPLETED|Overall Study||2||
48286517|NCT03573583|101026327|FG001|NOT COMPLETED|Overall Study||1||
48286518|NCT02585232|101026328|FG000|STARTED|Overall Study||40|Dyads at Baseline in the CC group included n = 40 Caregivers and n = 32 Veterans with dementia. Dyads at Baseline in the CC+C group included n = 42 Caregivers and n = 30 Veterans with dementia.|
48286519|NCT02585232|101026329|FG001|STARTED|Overall Study||42|Dyads at Baseline in the CC group included n = 40 Caregivers and n = 32 Veterans with dementia. Dyads at Baseline in the CC+C group included n = 42 Caregivers and n = 30 Veterans with dementia.|
48286520|NCT02585232|101026328|FG000|COMPLETED|Overall Study||28|Dyads at 6-months in the CC group included n = 28 Caregivers and n = 17 Veterans with dementia. Dyads at 6-months in the CC+C group included n = 26 Caregivers and n = 16 Veterans with dementia.|
48286521|NCT02585232|101026329|FG001|COMPLETED|Overall Study||26|Dyads at 6-months in the CC group included n = 28 Caregivers and n = 17 Veterans with dementia. Dyads at 6-months in the CC+C group included n = 26 Caregivers and n = 16 Veterans with dementia.|
48286522|NCT02585232|101026328|FG000|NOT COMPLETED|Overall Study||12||
48286523|NCT02585232|101026329|FG001|NOT COMPLETED|Overall Study||16||
48286524|NCT00982995|101026330|FG000|STARTED|Overall Study||3||
48286525|NCT00982995|101026330|FG000|COMPLETED|Overall Study||3||
48286526|NCT00982995|101026330|FG000|NOT COMPLETED|Overall Study||0||
48286527|NCT03398213|101026331|FG000|STARTED|Overall Study||26||
48400080|NCT03984812|101309291|FG007|COMPLETED|Part 1 (Up to Day 28)||0||
48400081|NCT03984812|101309292|FG008|COMPLETED|Part 1 (Up to Day 28)||0||
48400082|NCT03984812|101309293|FG009|COMPLETED|Part 1 (Up to Day 28)||0||
48578284|NCT01264081|101747706|FG000|NOT COMPLETED|Analysis||0||
48578285|NCT00652626|101747707|FG000|STARTED|Initial Treatment Phase||5||
48578286|NCT00652626|101747708|FG001|STARTED|Initial Treatment Phase||5||
48578287|NCT00652626|101747709|FG002|STARTED|Initial Treatment Phase||7||
48578288|NCT00652626|101747710|FG003|STARTED|Initial Treatment Phase||6||
48578289|NCT00652626|101747711|FG004|STARTED|Initial Treatment Phase||8||
48578290|NCT00652626|101747712|FG005|STARTED|Initial Treatment Phase||0||
48578291|NCT00652626|101747713|FG006|STARTED|Initial Treatment Phase||0||
48578292|NCT00652626|101747707|FG000|Received Study Drug|Initial Treatment Phase||5||
48578293|NCT00652626|101747708|FG001|Received Study Drug|Initial Treatment Phase||5||
48578294|NCT00652626|101747709|FG002|Received Study Drug|Initial Treatment Phase||6||
48578295|NCT00652626|101747710|FG003|Received Study Drug|Initial Treatment Phase||5||
48578296|NCT00652626|101747711|FG004|Received Study Drug|Initial Treatment Phase||6||
48578297|NCT00652626|101747712|FG005|Received Study Drug|Initial Treatment Phase||0||
48286528|NCT03398213|101026332|FG001|STARTED|Overall Study||24||
48286529|NCT03398213|101026333|FG002|STARTED|Overall Study||22||
48286530|NCT03398213|101026331|FG000|COMPLETED|Overall Study||26||
48286531|NCT03398213|101026332|FG001|COMPLETED|Overall Study||24||
48286532|NCT03398213|101026333|FG002|COMPLETED|Overall Study||22||
48286533|NCT03398213|101026331|FG000|NOT COMPLETED|Overall Study||0||
48286534|NCT03398213|101026332|FG001|NOT COMPLETED|Overall Study||0||
48400083|NCT03984812|101309294|FG010|COMPLETED|Part 1 (Up to Day 28)||0||
48400084|NCT03984812|101309284|FG000|NOT COMPLETED|Part 1 (Up to Day 28)||0||
48400085|NCT03984812|101309285|FG001|NOT COMPLETED|Part 1 (Up to Day 28)||0||
48578298|NCT00652626|101747713|FG006|Received Study Drug|Initial Treatment Phase||0||
48578299|NCT00652626|101747707|FG000|COMPLETED|Initial Treatment Phase||5||
48578300|NCT00652626|101747708|FG001|COMPLETED|Initial Treatment Phase||5||
48578301|NCT00652626|101747709|FG002|COMPLETED|Initial Treatment Phase||6||
48578302|NCT00652626|101747710|FG003|COMPLETED|Initial Treatment Phase||5||
48578303|NCT00652626|101747711|FG004|COMPLETED|Initial Treatment Phase||5||
48578304|NCT00652626|101747712|FG005|COMPLETED|Initial Treatment Phase||0||
48578305|NCT00652626|101747713|FG006|COMPLETED|Initial Treatment Phase||0||
48578306|NCT00652626|101747707|FG000|NOT COMPLETED|Initial Treatment Phase||0||
48286535|NCT03398213|101026333|FG002|NOT COMPLETED|Overall Study||0||
48286536|NCT01474434|101026334|FG000|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||8||
48286537|NCT01474434|101026335|FG001|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||9||
48286538|NCT01474434|101026336|FG002|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||11||
48578307|NCT00652626|101747708|FG001|NOT COMPLETED|Initial Treatment Phase||0||
48578308|NCT00652626|101747709|FG002|NOT COMPLETED|Initial Treatment Phase||1||
48578309|NCT00652626|101747710|FG003|NOT COMPLETED|Initial Treatment Phase||1||
48578310|NCT00652626|101747711|FG004|NOT COMPLETED|Initial Treatment Phase||3||
48578311|NCT00652626|101747712|FG005|NOT COMPLETED|Initial Treatment Phase||0||
48578312|NCT00652626|101747713|FG006|NOT COMPLETED|Initial Treatment Phase||0||
48578313|NCT00652626|101747707|FG000|STARTED|Extension Phase||0||
48578314|NCT00652626|101747708|FG001|STARTED|Extension Phase||0||
48578315|NCT00652626|101747709|FG002|STARTED|Extension Phase||0||
48578316|NCT00652626|101747710|FG003|STARTED|Extension Phase||0||
48578317|NCT00652626|101747711|FG004|STARTED|Extension Phase||0||
48578318|NCT00652626|101747712|FG005|STARTED|Extension Phase||14||
48578319|NCT00652626|101747713|FG006|STARTED|Extension Phase||4||
48578320|NCT00652626|101747707|FG000|COMPLETED|Extension Phase||0||
48578321|NCT00652626|101747708|FG001|COMPLETED|Extension Phase||0||
48578322|NCT00652626|101747709|FG002|COMPLETED|Extension Phase||0||
48578323|NCT00652626|101747710|FG003|COMPLETED|Extension Phase||0||
48578324|NCT00652626|101747711|FG004|COMPLETED|Extension Phase||0||
48578325|NCT00652626|101747712|FG005|COMPLETED|Extension Phase||2||
48578326|NCT00652626|101747713|FG006|COMPLETED|Extension Phase||1||
48578327|NCT00652626|101747707|FG000|NOT COMPLETED|Extension Phase||0||
48578328|NCT00652626|101747708|FG001|NOT COMPLETED|Extension Phase||0||
48578329|NCT00652626|101747709|FG002|NOT COMPLETED|Extension Phase||0||
48578330|NCT00652626|101747710|FG003|NOT COMPLETED|Extension Phase||0||
48578331|NCT00652626|101747711|FG004|NOT COMPLETED|Extension Phase||0||
48578332|NCT00652626|101747712|FG005|NOT COMPLETED|Extension Phase||12||
48578333|NCT00652626|101747713|FG006|NOT COMPLETED|Extension Phase||3||
48578334|NCT01058993|101747714|FG000|STARTED|Overall Study||6||
48578335|NCT01058993|101747714|FG000|COMPLETED|Overall Study||6||
48578336|NCT01058993|101747714|FG000|NOT COMPLETED|Overall Study||0||
48578337|NCT01738503|101747715|FG000|STARTED|Induction/Stabilization (Days -14 to -1)||124||
48578338|NCT01738503|101747716|FG001|STARTED|Induction/Stabilization (Days -14 to -1)||0||
48578339|NCT01738503|101747717|FG002|STARTED|Induction/Stabilization (Days -14 to -1)||0||
48578340|NCT01738503|101747718|FG003|STARTED|Induction/Stabilization (Days -14 to -1)||0||
48578341|NCT01738503|101747719|FG004|STARTED|Induction/Stabilization (Days -14 to -1)||0||
48578342|NCT01738503|101747720|FG005|STARTED|Induction/Stabilization (Days -14 to -1)||0||
48578343|NCT01738503|101747721|FG006|STARTED|Induction/Stabilization (Days -14 to -1)||0||
48578344|NCT01738503|101747715|FG000|COMPLETED|Induction/Stabilization (Days -14 to -1)||89||
48578345|NCT01738503|101747716|FG001|COMPLETED|Induction/Stabilization (Days -14 to -1)||0||
48578346|NCT01738503|101747717|FG002|COMPLETED|Induction/Stabilization (Days -14 to -1)||0||
48578347|NCT01738503|101747718|FG003|COMPLETED|Induction/Stabilization (Days -14 to -1)||0||
48578348|NCT01738503|101747719|FG004|COMPLETED|Induction/Stabilization (Days -14 to -1)||0||
48578349|NCT01738503|101747720|FG005|COMPLETED|Induction/Stabilization (Days -14 to -1)||0||
48578350|NCT01738503|101747721|FG006|COMPLETED|Induction/Stabilization (Days -14 to -1)||0||
48578351|NCT01738503|101747715|FG000|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||35||
48578352|NCT01738503|101747716|FG001|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0||
48578353|NCT01738503|101747717|FG002|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0||
48578354|NCT01738503|101747718|FG003|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0||
48578355|NCT01738503|101747719|FG004|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0||
48578356|NCT01738503|101747720|FG005|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0||
48578357|NCT01738503|101747721|FG006|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0||
48578358|NCT01738503|101747715|FG000|STARTED|Treatment Period||0||
48578359|NCT01738503|101747716|FG001|STARTED|Treatment Period||15||
48578360|NCT01738503|101747717|FG002|STARTED|Treatment Period||15||
48578361|NCT01738503|101747718|FG003|STARTED|Treatment Period||15||
48578362|NCT01738503|101747719|FG004|STARTED|Treatment Period||15||
48703405|NCT01975519|102060500|FG001|Phase 1b|Overall Study||23||
48578363|NCT01738503|101747720|FG005|STARTED|Treatment Period||15||
48578364|NCT01738503|101747721|FG006|STARTED|Treatment Period||14||
48578365|NCT01738503|101747715|FG000|COMPLETED|Treatment Period||0||
48578366|NCT01738503|101747716|FG001|COMPLETED|Treatment Period||10||
48578367|NCT01738503|101747717|FG002|COMPLETED|Treatment Period||10||
48578368|NCT01738503|101747718|FG003|COMPLETED|Treatment Period||9||
48578369|NCT01738503|101747719|FG004|COMPLETED|Treatment Period||7||
48578370|NCT01738503|101747720|FG005|COMPLETED|Treatment Period||9||
48578371|NCT01738503|101747721|FG006|COMPLETED|Treatment Period||6||
48578372|NCT01738503|101747715|FG000|NOT COMPLETED|Treatment Period||0||
48578373|NCT01738503|101747716|FG001|NOT COMPLETED|Treatment Period||5||
48578374|NCT01738503|101747717|FG002|NOT COMPLETED|Treatment Period||5||
48578375|NCT01738503|101747718|FG003|NOT COMPLETED|Treatment Period||6||
48578376|NCT01738503|101747719|FG004|NOT COMPLETED|Treatment Period||8||
48286539|NCT01474434|101026337|FG003|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||13||
48578377|NCT01738503|101747720|FG005|NOT COMPLETED|Treatment Period||6||
48578378|NCT01738503|101747721|FG006|NOT COMPLETED|Treatment Period||8||
48578379|NCT01738503|101747715|FG000|STARTED|PET Imaging Sub-study||0||
48578380|NCT01738503|101747716|FG001|STARTED|PET Imaging Sub-study||0||
48578381|NCT01738503|101747717|FG002|STARTED|PET Imaging Sub-study||0||
48578382|NCT01738503|101747718|FG003|STARTED|PET Imaging Sub-study||0||
48578383|NCT01738503|101747719|FG004|STARTED|PET Imaging Sub-study||0||
48578384|NCT01738503|101747720|FG005|STARTED|PET Imaging Sub-study||3||
48578385|NCT01738503|101747721|FG006|STARTED|PET Imaging Sub-study||2||
48578386|NCT01738503|101747715|FG000|COMPLETED|PET Imaging Sub-study||0||
48578387|NCT01738503|101747716|FG001|COMPLETED|PET Imaging Sub-study||0||
48578388|NCT01738503|101747717|FG002|COMPLETED|PET Imaging Sub-study||0||
48578389|NCT01738503|101747718|FG003|COMPLETED|PET Imaging Sub-study||0||
48578390|NCT01738503|101747719|FG004|COMPLETED|PET Imaging Sub-study||0||
48578391|NCT01738503|101747720|FG005|COMPLETED|PET Imaging Sub-study||1||
48578392|NCT01738503|101747721|FG006|COMPLETED|PET Imaging Sub-study||1||
48578393|NCT01738503|101747715|FG000|NOT COMPLETED|PET Imaging Sub-study||0||
48578394|NCT01738503|101747716|FG001|NOT COMPLETED|PET Imaging Sub-study||0||
48578395|NCT01738503|101747717|FG002|NOT COMPLETED|PET Imaging Sub-study||0||
48578396|NCT01738503|101747718|FG003|NOT COMPLETED|PET Imaging Sub-study||0||
48578397|NCT01738503|101747719|FG004|NOT COMPLETED|PET Imaging Sub-study||0||
48578398|NCT01738503|101747720|FG005|NOT COMPLETED|PET Imaging Sub-study||2||
48578399|NCT01738503|101747721|FG006|NOT COMPLETED|PET Imaging Sub-study||1||
48578400|NCT00384839|101747722|FG000|STARTED|Overall Study||36||
48578401|NCT00384839|101747722|FG000|COMPLETED|Overall Study||28||
48578402|NCT00384839|101747722|FG000|NOT COMPLETED|Overall Study||8||
48578403|NCT03287635|101747723|FG000|STARTED|Overall Study||19||
48578404|NCT03287635|101747723|FG000|COMPLETED|Overall Study||12||
48578405|NCT03287635|101747723|FG000|NOT COMPLETED|Overall Study||7||
48578406|NCT01672710|101747724|FG000|STARTED|Controlled Comparison 5 Week Follow-up||22||
48578407|NCT01672710|101747725|FG001|STARTED|Controlled Comparison 5 Week Follow-up||10||
48578408|NCT01672710|101747724|FG000|COMPLETED|Controlled Comparison 5 Week Follow-up||22||
48578409|NCT01672710|101747725|FG001|COMPLETED|Controlled Comparison 5 Week Follow-up||10||
48578410|NCT01672710|101747724|FG000|NOT COMPLETED|Controlled Comparison 5 Week Follow-up||0||
48578411|NCT01672710|101747725|FG001|NOT COMPLETED|Controlled Comparison 5 Week Follow-up||0||
48578412|NCT01672710|101747724|FG000|STARTED|Waitlist Assessed After Sauna Regimen||22||
48286540|NCT01474434|101026334|FG000|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||7||
48286541|NCT01474434|101026335|FG001|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||9||
48286542|NCT01474434|101026336|FG002|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||10||
48286543|NCT01474434|101026337|FG003|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||11||
48286544|NCT01474434|101026334|FG000|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1||
48286545|NCT01474434|101026335|FG001|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||0||
48286546|NCT01474434|101026336|FG002|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1||
48286547|NCT01474434|101026337|FG003|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||2||
48286548|NCT01474434|101026334|FG000|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||7||
48286549|NCT01474434|101026335|FG001|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||9||
48286550|NCT01474434|101026336|FG002|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||10||
48286551|NCT01474434|101026337|FG003|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||11||
48286552|NCT01474434|101026334|FG000|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||7||
48286553|NCT01474434|101026335|FG001|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||9||
48286554|NCT01474434|101026336|FG002|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||10||
48286555|NCT01474434|101026337|FG003|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||11||
48286556|NCT01474434|101026334|FG000|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0||
48286557|NCT01474434|101026335|FG001|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0||
48286558|NCT01474434|101026336|FG002|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0||
48286559|NCT01474434|101026337|FG003|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0||
48286560|NCT02891408|101026338|FG000|STARTED|Overall Study||10||
48286561|NCT02891408|101026339|FG001|STARTED|Overall Study||10||
48286562|NCT02891408|101026340|FG002|STARTED|Overall Study||14||
48286563|NCT02891408|101026341|FG003|STARTED|Overall Study||10||
48286564|NCT02891408|101026342|FG004|STARTED|Overall Study||10||
48286565|NCT02891408|101026343|FG005|STARTED|Overall Study||10||
48286566|NCT02891408|101026344|FG006|STARTED|Overall Study||10||
48286567|NCT02891408|101026338|FG000|COMPLETED|Overall Study||10||
48286568|NCT02891408|101026339|FG001|COMPLETED|Overall Study||10||
48286569|NCT02891408|101026340|FG002|COMPLETED|Overall Study||13||
48286570|NCT02891408|101026341|FG003|COMPLETED|Overall Study||10||
48286571|NCT02891408|101026342|FG004|COMPLETED|Overall Study||10||
48578413|NCT01672710|101747725|FG001|STARTED|Waitlist Assessed After Sauna Regimen||10||
48578414|NCT01672710|101747724|FG000|COMPLETED|Waitlist Assessed After Sauna Regimen||22||
48578415|NCT01672710|101747725|FG001|COMPLETED|Waitlist Assessed After Sauna Regimen||9||
48578416|NCT01672710|101747724|FG000|NOT COMPLETED|Waitlist Assessed After Sauna Regimen||0||
48578417|NCT01672710|101747725|FG001|NOT COMPLETED|Waitlist Assessed After Sauna Regimen||1||
48578418|NCT01672710|101747724|FG000|STARTED|3 Month Follow up||22||
48286572|NCT02891408|101026343|FG005|COMPLETED|Overall Study||10||
48286573|NCT02891408|101026344|FG006|COMPLETED|Overall Study||10||
48286574|NCT02891408|101026338|FG000|NOT COMPLETED|Overall Study||0||
48286575|NCT02891408|101026339|FG001|NOT COMPLETED|Overall Study||0||
48286576|NCT02891408|101026340|FG002|NOT COMPLETED|Overall Study||1||
48286577|NCT02891408|101026341|FG003|NOT COMPLETED|Overall Study||0||
48286578|NCT02891408|101026342|FG004|NOT COMPLETED|Overall Study||0||
48578419|NCT01672710|101747725|FG001|STARTED|3 Month Follow up||9||
48578420|NCT01672710|101747724|FG000|COMPLETED|3 Month Follow up||16||
48578421|NCT01672710|101747725|FG001|COMPLETED|3 Month Follow up||5||
48578422|NCT01672710|101747724|FG000|NOT COMPLETED|3 Month Follow up||6||
48286579|NCT02891408|101026343|FG005|NOT COMPLETED|Overall Study||0||
48286580|NCT02891408|101026344|FG006|NOT COMPLETED|Overall Study||0||
48578423|NCT01672710|101747725|FG001|NOT COMPLETED|3 Month Follow up||4||
48578424|NCT01068730|101747726|FG000|STARTED|Period 1||7||
48578425|NCT01068730|101747727|FG001|STARTED|Period 1||7||
48578426|NCT01068730|101747728|FG002|STARTED|Period 1||7||
48286581|NCT04955444|101026345|FG000|STARTED|Overall Study||160||
48400086|NCT03984812|101309286|FG002|NOT COMPLETED|Part 1 (Up to Day 28)||1||
48133691|NCT02014116|100651314|FG003|STARTED|Overall Study||7||
48133692|NCT02014116|100651315|FG004|STARTED|Overall Study||2||
48133693|NCT02014116|100651316|FG005|STARTED|Overall Study||16||
48133694|NCT02014116|100651317|FG006|STARTED|Overall Study||1||
48133695|NCT02014116|100651318|FG007|STARTED|Overall Study||5||
48133696|NCT02014116|100651319|FG008|STARTED|Overall Study||10||
48133697|NCT02014116|100651311|FG000|Received at Least One Dose of Study Drug|Overall Study||3||
48133698|NCT02014116|100651312|FG001|Received at Least One Dose of Study Drug|Overall Study||4||
48133699|NCT02014116|100651313|FG002|Received at Least One Dose of Study Drug|Overall Study||3||
48578427|NCT01068730|101747729|FG003|STARTED|Period 1||7||
48578428|NCT01068730|101747726|FG000|COMPLETED|Period 1||7||
48578429|NCT01068730|101747727|FG001|COMPLETED|Period 1||7||
48578430|NCT01068730|101747728|FG002|COMPLETED|Period 1||7||
48578431|NCT01068730|101747729|FG003|COMPLETED|Period 1||7||
48578432|NCT01068730|101747726|FG000|NOT COMPLETED|Period 1||0||
48133700|NCT02014116|100651314|FG003|Received at Least One Dose of Study Drug|Overall Study||7||
48133701|NCT02014116|100651315|FG004|Received at Least One Dose of Study Drug|Overall Study||2||
48133702|NCT02014116|100651316|FG005|Received at Least One Dose of Study Drug|Overall Study||16||
48133703|NCT02014116|100651317|FG006|Received at Least One Dose of Study Drug|Overall Study||1||
48133704|NCT02014116|100651318|FG007|Received at Least One Dose of Study Drug|Overall Study||5||
48133705|NCT02014116|100651319|FG008|Received at Least One Dose of Study Drug|Overall Study||10||
48133706|NCT02014116|100651311|FG000|COMPLETED|Overall Study||0||
48133707|NCT02014116|100651312|FG001|COMPLETED|Overall Study||0||
48133708|NCT02014116|100651313|FG002|COMPLETED|Overall Study||0||
48133709|NCT02014116|100651314|FG003|COMPLETED|Overall Study||0||
48133710|NCT02014116|100651315|FG004|COMPLETED|Overall Study||0||
48133711|NCT02014116|100651316|FG005|COMPLETED|Overall Study||0||
48133712|NCT02014116|100651317|FG006|COMPLETED|Overall Study||0||
48133713|NCT02014116|100651318|FG007|COMPLETED|Overall Study||0||
48133714|NCT02014116|100651319|FG008|COMPLETED|Overall Study||0||
48133715|NCT02014116|100651311|FG000|NOT COMPLETED|Overall Study||3||
48133716|NCT02014116|100651312|FG001|NOT COMPLETED|Overall Study||4||
48133717|NCT02014116|100651313|FG002|NOT COMPLETED|Overall Study||3||
48133718|NCT02014116|100651314|FG003|NOT COMPLETED|Overall Study||7||
48133719|NCT02014116|100651315|FG004|NOT COMPLETED|Overall Study||2||
48133720|NCT02014116|100651316|FG005|NOT COMPLETED|Overall Study||16||
48133721|NCT02014116|100651317|FG006|NOT COMPLETED|Overall Study||1||
48133722|NCT02014116|100651318|FG007|NOT COMPLETED|Overall Study||5||
48133723|NCT02014116|100651319|FG008|NOT COMPLETED|Overall Study||10||
48133724|NCT02756624|100651320|FG000|STARTED|Overall Study||343||
48133725|NCT02756624|100651321|FG001|STARTED|Overall Study||173||
48133726|NCT02756624|100651320|FG000|COMPLETED|Overall Study||327||
48133727|NCT02756624|100651321|FG001|COMPLETED|Overall Study||166||
48133728|NCT02756624|100651320|FG000|NOT COMPLETED|Overall Study||16||
48578433|NCT01068730|101747727|FG001|NOT COMPLETED|Period 1||0||
48578434|NCT01068730|101747728|FG002|NOT COMPLETED|Period 1||0||
48578435|NCT01068730|101747729|FG003|NOT COMPLETED|Period 1||0||
48578436|NCT01068730|101747726|FG000|STARTED|Period 2||7||
48578437|NCT01068730|101747727|FG001|STARTED|Period 2||7||
48578438|NCT01068730|101747728|FG002|STARTED|Period 2||7||
48133729|NCT02756624|100651321|FG001|NOT COMPLETED|Overall Study||7||
48133730|NCT03535649|100651322|FG000|STARTED|Overall Study||105||
48133731|NCT03535649|100651322|FG000|COMPLETED|Overall Study||105||
48133732|NCT03535649|100651322|FG000|NOT COMPLETED|Overall Study||0||
48133733|NCT01776645|100651323|FG000|STARTED|Overall Study||28||
48133734|NCT01776645|100651324|FG001|STARTED|Overall Study||28||
48133735|NCT01776645|100651323|FG000|COMPLETED|Overall Study||14||
48133736|NCT01776645|100651324|FG001|COMPLETED|Overall Study||14||
48133737|NCT01776645|100651323|FG000|NOT COMPLETED|Overall Study||14||
48133738|NCT01776645|100651324|FG001|NOT COMPLETED|Overall Study||14||
48133739|NCT03043664|100651325|FG000|STARTED|Overall Study||22||
48133740|NCT03043664|100651325|FG000|COMPLETED|Overall Study||21||
48133741|NCT03043664|100651325|FG000|NOT COMPLETED|Overall Study||1||
48133742|NCT01568047|100651326|FG000|STARTED|Overall Study||10||
48133743|NCT01568047|100651327|FG001|STARTED|Overall Study||10||
48133744|NCT01568047|100651328|FG002|STARTED|Overall Study||10||
48133745|NCT01568047|100651329|FG003|STARTED|Overall Study||10||
48133746|NCT01568047|100651326|FG000|COMPLETED|Overall Study||9||
48133747|NCT01568047|100651327|FG001|COMPLETED|Overall Study||9||
48133748|NCT01568047|100651328|FG002|COMPLETED|Overall Study||9||
48133749|NCT01568047|100651329|FG003|COMPLETED|Overall Study||9||
48133750|NCT01568047|100651326|FG000|NOT COMPLETED|Overall Study||1||
48133751|NCT01568047|100651327|FG001|NOT COMPLETED|Overall Study||1||
48133752|NCT01568047|100651328|FG002|NOT COMPLETED|Overall Study||1||
48133753|NCT01568047|100651329|FG003|NOT COMPLETED|Overall Study||1||
48578439|NCT01068730|101747729|FG003|STARTED|Period 2||7||
48578440|NCT01068730|101747726|FG000|COMPLETED|Period 2||7||
48578441|NCT01068730|101747727|FG001|COMPLETED|Period 2||7||
48578442|NCT01068730|101747728|FG002|COMPLETED|Period 2||7||
48133754|NCT00319098|100651330|FG000|STARTED|Overall Study||3802||
48710756|NCT00168103|102078008|FG002|COMPLETED|Overall Study||41||
48133755|NCT00319098|100651331|FG001|STARTED|Overall Study||1269||
48133756|NCT00319098|100651330|FG000|COMPLETED|Overall Study||3667||
48578443|NCT01068730|101747729|FG003|COMPLETED|Period 2||7||
48133757|NCT00319098|100651331|FG001|COMPLETED|Overall Study||1237||
48133758|NCT00319098|100651330|FG000|NOT COMPLETED|Overall Study||135||
48133759|NCT00319098|100651331|FG001|NOT COMPLETED|Overall Study||32||
48133760|NCT02843568|100651332|FG000|STARTED|Overall Study||65||
48133761|NCT02843568|100651333|FG001|STARTED|Overall Study||57||
48133762|NCT02843568|100651332|FG000|Evaluable for Primary Analysis|Overall Study||61|Participants were excluded as they had a change in treatment.|
48133763|NCT02843568|100651333|FG001|Evaluable for Primary Analysis|Overall Study||55|Participants were excluded as they had a change in treatment.|
48133764|NCT02843568|100651332|FG000|SBRT Cohort (Analyzed for Toxicities)|Overall Study||30||
48133765|NCT02843568|100651333|FG001|SBRT Cohort (Analyzed for Toxicities)|Overall Study||31||
48133766|NCT02843568|100651332|FG000|Conventional Cohort (Analyzed for Toxicities)|Overall Study||31||
48133767|NCT02843568|100651333|FG001|Conventional Cohort (Analyzed for Toxicities)|Overall Study||24||
48133768|NCT02843568|100651332|FG000|Participants at 3 Months|Overall Study||57||
48133769|NCT02843568|100651333|FG001|Participants at 3 Months|Overall Study||51||
48133770|NCT02843568|100651332|FG000|Participants at 6 Months|Overall Study||53||
48133771|NCT02843568|100651333|FG001|Participants at 6 Months|Overall Study||43||
48133772|NCT02843568|100651332|FG000|Participants at 12 Months|Overall Study||43||
48133773|NCT02843568|100651333|FG001|Participants at 12 Months|Overall Study||34||
48133774|NCT02843568|100651332|FG000|Analyzed for Primary Endpoints|Overall Study||55||
48133775|NCT02843568|100651333|FG001|Analyzed for Primary Endpoints|Overall Study||51||
48133776|NCT02843568|100651332|FG000|COMPLETED|Overall Study||55||
48133777|NCT02843568|100651333|FG001|COMPLETED|Overall Study||51||
48133778|NCT02843568|100651332|FG000|NOT COMPLETED|Overall Study||10||
48133779|NCT02843568|100651333|FG001|NOT COMPLETED|Overall Study||6||
48133780|NCT00877448|100651334|FG000|STARTED|Overall Study||10||
48133781|NCT00877448|100651335|FG001|STARTED|Overall Study||10||
48133782|NCT00877448|100651336|FG002|STARTED|Overall Study||10||
48133783|NCT00877448|100651337|FG003|STARTED|Overall Study||10||
48133784|NCT00877448|100651338|FG004|STARTED|Overall Study||10||
48133785|NCT00877448|100651339|FG005|STARTED|Overall Study||10||
48133786|NCT00877448|100651340|FG006|STARTED|Overall Study||3||
48133787|NCT00877448|100651334|FG000|COMPLETED|Overall Study||10||
48133788|NCT00877448|100651335|FG001|COMPLETED|Overall Study||9||
48133789|NCT00877448|100651336|FG002|COMPLETED|Overall Study||10||
48133790|NCT00877448|100651337|FG003|COMPLETED|Overall Study||9||
48133791|NCT00877448|100651338|FG004|COMPLETED|Overall Study||10||
48133792|NCT00877448|100651339|FG005|COMPLETED|Overall Study||9||
48133793|NCT00877448|100651340|FG006|COMPLETED|Overall Study||3||
48133794|NCT00877448|100651334|FG000|NOT COMPLETED|Overall Study||0||
48133795|NCT00877448|100651335|FG001|NOT COMPLETED|Overall Study||1||
48133796|NCT00877448|100651336|FG002|NOT COMPLETED|Overall Study||0||
48133797|NCT00877448|100651337|FG003|NOT COMPLETED|Overall Study||1||
48133798|NCT00877448|100651338|FG004|NOT COMPLETED|Overall Study||0||
48133799|NCT00877448|100651339|FG005|NOT COMPLETED|Overall Study||1||
48133800|NCT00877448|100651340|FG006|NOT COMPLETED|Overall Study||0||
48133801|NCT01577706|100651341|FG000|STARTED|First Intervention (1 Day)||3||
48133802|NCT01577706|100651342|FG001|STARTED|First Intervention (1 Day)||1||
48133803|NCT01577706|100651343|FG002|STARTED|First Intervention (1 Day)||3||
48133804|NCT01577706|100651341|FG000|COMPLETED|First Intervention (1 Day)||3||
48133805|NCT01577706|100651342|FG001|COMPLETED|First Intervention (1 Day)||1||
48133806|NCT01577706|100651343|FG002|COMPLETED|First Intervention (1 Day)||3||
48133807|NCT01577706|100651341|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48133808|NCT01577706|100651342|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48133809|NCT01577706|100651343|FG002|NOT COMPLETED|First Intervention (1 Day)||0||
48133810|NCT01577706|100651341|FG000|STARTED|Washout (at Least 1 Week)||3||
48133811|NCT01577706|100651342|FG001|STARTED|Washout (at Least 1 Week)||1||
48133812|NCT01577706|100651343|FG002|STARTED|Washout (at Least 1 Week)||3||
48133813|NCT01577706|100651341|FG000|COMPLETED|Washout (at Least 1 Week)||3||
48133814|NCT01577706|100651342|FG001|COMPLETED|Washout (at Least 1 Week)||1||
48133815|NCT01577706|100651343|FG002|COMPLETED|Washout (at Least 1 Week)||3||
48133816|NCT01577706|100651341|FG000|NOT COMPLETED|Washout (at Least 1 Week)||0||
48133817|NCT01577706|100651342|FG001|NOT COMPLETED|Washout (at Least 1 Week)||0||
48133818|NCT01577706|100651343|FG002|NOT COMPLETED|Washout (at Least 1 Week)||0||
48133819|NCT01577706|100651341|FG000|STARTED|Second Intervention (1 Day)||3||
48133820|NCT01577706|100651342|FG001|STARTED|Second Intervention (1 Day)||1||
48133821|NCT01577706|100651343|FG002|STARTED|Second Intervention (1 Day)||3||
48133822|NCT01577706|100651341|FG000|COMPLETED|Second Intervention (1 Day)||3||
48133823|NCT01577706|100651342|FG001|COMPLETED|Second Intervention (1 Day)||1||
48133824|NCT01577706|100651343|FG002|COMPLETED|Second Intervention (1 Day)||3||
48133825|NCT01577706|100651341|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48133826|NCT01577706|100651342|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48133827|NCT01577706|100651343|FG002|NOT COMPLETED|Second Intervention (1 Day)||0||
48133828|NCT01577706|100651341|FG000|STARTED|Washout (at Least 1 Week)||3||
48133829|NCT01577706|100651342|FG001|STARTED|Washout (at Least 1 Week)||1||
48133830|NCT01577706|100651343|FG002|STARTED|Washout (at Least 1 Week)||3||
48133831|NCT01577706|100651341|FG000|COMPLETED|Washout (at Least 1 Week)||3||
48133832|NCT01577706|100651342|FG001|COMPLETED|Washout (at Least 1 Week)||1||
48133833|NCT01577706|100651343|FG002|COMPLETED|Washout (at Least 1 Week)||3||
48133834|NCT01577706|100651341|FG000|NOT COMPLETED|Washout (at Least 1 Week)||0||
48133835|NCT01577706|100651342|FG001|NOT COMPLETED|Washout (at Least 1 Week)||0||
48133836|NCT01577706|100651343|FG002|NOT COMPLETED|Washout (at Least 1 Week)||0||
48133837|NCT01577706|100651341|FG000|STARTED|Third Intervention (1 Day)||3||
48133838|NCT01577706|100651342|FG001|STARTED|Third Intervention (1 Day)||1||
48133839|NCT01577706|100651343|FG002|STARTED|Third Intervention (1 Day)||3||
48133840|NCT01577706|100651341|FG000|COMPLETED|Third Intervention (1 Day)||3||
48133841|NCT01577706|100651342|FG001|COMPLETED|Third Intervention (1 Day)||1||
48133842|NCT01577706|100651343|FG002|COMPLETED|Third Intervention (1 Day)||3||
48133843|NCT01577706|100651341|FG000|NOT COMPLETED|Third Intervention (1 Day)||0||
48133844|NCT01577706|100651342|FG001|NOT COMPLETED|Third Intervention (1 Day)||0||
48133845|NCT01577706|100651343|FG002|NOT COMPLETED|Third Intervention (1 Day)||0||
48133846|NCT01230593|100651344|FG000|STARTED|Overall Study||50||
48133847|NCT01230593|100651345|FG001|STARTED|Overall Study||50||
48133848|NCT01230593|100651346|FG002|STARTED|Overall Study||50||
48133849|NCT01230593|100651344|FG000|COMPLETED|Overall Study||35||
48133850|NCT01230593|100651345|FG001|COMPLETED|Overall Study||32||
48133851|NCT01230593|100651346|FG002|COMPLETED|Overall Study||38||
48133852|NCT01230593|100651344|FG000|NOT COMPLETED|Overall Study||15||
48133853|NCT01230593|100651345|FG001|NOT COMPLETED|Overall Study||18||
48133854|NCT01230593|100651346|FG002|NOT COMPLETED|Overall Study||12||
48133855|NCT04040985|100651347|FG000|STARTED|Overall Study||128||138
48133856|NCT04040985|100651347|FG000|COMPLETED|Overall Study||69|At the time this study was terminated early by the Sponsor, there were 17 participants enrolled that did not completed their final study visit. These participants were not considered to have withdrawn or discontinued from the study.|77
48133857|NCT04040985|100651347|FG000|NOT COMPLETED|Overall Study||59||61
48133858|NCT02312739|100651348|FG000|STARTED|Overall Study||36||
48133859|NCT02312739|100651349|FG001|STARTED|Overall Study||36||
48133860|NCT02312739|100651348|FG000|Withdrawn Prior to Procedure|Overall Study||6||
48133861|NCT02312739|100651349|FG001|Withdrawn Prior to Procedure|Overall Study||2||
48133862|NCT02312739|100651348|FG000|COMPLETED|Overall Study||30||
48133863|NCT02312739|100651349|FG001|COMPLETED|Overall Study||34||
48133864|NCT02312739|100651348|FG000|NOT COMPLETED|Overall Study||6||
48133865|NCT02312739|100651349|FG001|NOT COMPLETED|Overall Study||2||
48133866|NCT02571218|100651350|FG000|STARTED|Overall Study||40||
48133867|NCT02571218|100651351|FG001|STARTED|Overall Study||41||
48133868|NCT02571218|100651350|FG000|COMPLETED|Overall Study||40||
48133869|NCT02571218|100651351|FG001|COMPLETED|Overall Study||41||
48133870|NCT02571218|100651350|FG000|NOT COMPLETED|Overall Study||0||
48133871|NCT02571218|100651351|FG001|NOT COMPLETED|Overall Study||0||
48133872|NCT01617421|100651352|FG000|STARTED|Overall Study||18||
48133873|NCT01617421|100651352|FG000|COMPLETED|Overall Study||12||
48133874|NCT01617421|100651352|FG000|NOT COMPLETED|Overall Study||6||
48133875|NCT03980470|100651353|FG000|STARTED|Overall Study||50||
48133876|NCT03980470|100651353|FG000|COMPLETED|Overall Study||50||
48133877|NCT03980470|100651353|FG000|NOT COMPLETED|Overall Study||0||
48133878|NCT02078284|100651354|FG000|STARTED|Overall Study||5||
48133879|NCT02078284|100651355|FG001|STARTED|Overall Study||7||
48133880|NCT02078284|100651356|FG002|STARTED|Overall Study||6||
48133881|NCT02078284|100651357|FG003|STARTED|Overall Study||6||
48133882|NCT02078284|100651358|FG004|STARTED|Overall Study||4||
48133883|NCT02078284|100651354|FG000|COMPLETED|Overall Study||5||
48133884|NCT02078284|100651355|FG001|COMPLETED|Overall Study||7||
48133885|NCT02078284|100651356|FG002|COMPLETED|Overall Study||6||
48133886|NCT02078284|100651357|FG003|COMPLETED|Overall Study||6||
48133887|NCT02078284|100651358|FG004|COMPLETED|Overall Study||4||
48133888|NCT02078284|100651354|FG000|NOT COMPLETED|Overall Study||0||
48133889|NCT02078284|100651355|FG001|NOT COMPLETED|Overall Study||0||
48133890|NCT02078284|100651356|FG002|NOT COMPLETED|Overall Study||0||
48133891|NCT02078284|100651357|FG003|NOT COMPLETED|Overall Study||0||
48133892|NCT02078284|100651358|FG004|NOT COMPLETED|Overall Study||0||
48133893|NCT01140191|100651359|FG000|STARTED|Overall Study||1||
48133894|NCT01140191|100651359|FG000|COMPLETED|Overall Study||1||
48133895|NCT01140191|100651359|FG000|NOT COMPLETED|Overall Study||0||
48133896|NCT00581529|100651360|FG000|STARTED|Overall Study||34||
48133897|NCT00581529|100651360|FG000|COMPLETED|Overall Study||34||
48133898|NCT00581529|100651360|FG000|NOT COMPLETED|Overall Study||0||
48133899|NCT00724347|100651361|FG000|STARTED|Overall Study||18||
48133900|NCT00724347|100651361|FG000|Baseline Testing|Overall Study||18||
48133901|NCT00724347|100651361|FG000|COMPLETED|Overall Study||16||
48133902|NCT00724347|100651361|FG000|NOT COMPLETED|Overall Study||2||
48286582|NCT04955444|101026346|FG001|STARTED|Overall Study||80||
48133903|NCT03321981|100651362|FG000|STARTED|Overall Study||15||
48133904|NCT03321981|100651363|FG001|STARTED|Overall Study||39||
48133905|NCT03321981|100651364|FG002|STARTED|Overall Study||50||
48133906|NCT03321981|100651362|FG000|COMPLETED|Overall Study||0||
48133907|NCT03321981|100651363|FG001|COMPLETED|Overall Study||0||
48133908|NCT03321981|100651364|FG002|COMPLETED|Overall Study||0||
48133909|NCT03321981|100651362|FG000|NOT COMPLETED|Overall Study||15||
48133910|NCT03321981|100651363|FG001|NOT COMPLETED|Overall Study||39||
48133911|NCT03321981|100651364|FG002|NOT COMPLETED|Overall Study||50||
48133912|NCT00839072|100651365|FG000|STARTED|First Intervention Period||12||
48133913|NCT00839072|100651366|FG001|STARTED|First Intervention Period||12||
48133914|NCT00839072|100651365|FG000|COMPLETED|First Intervention Period||10||
48133915|NCT00839072|100651366|FG001|COMPLETED|First Intervention Period||11||
48133916|NCT00839072|100651365|FG000|NOT COMPLETED|First Intervention Period||2||
48286583|NCT04955444|101026345|FG000|COMPLETED|Overall Study||160||
48286584|NCT04955444|101026346|FG001|COMPLETED|Overall Study||80||
48286585|NCT04955444|101026345|FG000|NOT COMPLETED|Overall Study||0||
48286586|NCT04955444|101026346|FG001|NOT COMPLETED|Overall Study||0||
48286587|NCT03417895|101026347|FG000|STARTED|Overall Study||47||
48578444|NCT01068730|101747726|FG000|NOT COMPLETED|Period 2||0||
48133917|NCT00839072|100651366|FG001|NOT COMPLETED|First Intervention Period||1||
48133918|NCT00839072|100651365|FG000|STARTED|Washout Period of 7 Days||10||
48133919|NCT00839072|100651366|FG001|STARTED|Washout Period of 7 Days||11||
48133920|NCT00839072|100651365|FG000|COMPLETED|Washout Period of 7 Days||10||
48133921|NCT00839072|100651366|FG001|COMPLETED|Washout Period of 7 Days||11||
48133922|NCT00839072|100651365|FG000|NOT COMPLETED|Washout Period of 7 Days||0||
48133923|NCT00839072|100651366|FG001|NOT COMPLETED|Washout Period of 7 Days||0||
48133924|NCT00839072|100651365|FG000|STARTED|Second Intervention Period||10||
48133925|NCT00839072|100651366|FG001|STARTED|Second Intervention Period||11||
48133926|NCT00839072|100651365|FG000|COMPLETED|Second Intervention Period||9||
48133927|NCT00839072|100651366|FG001|COMPLETED|Second Intervention Period||11||
48133928|NCT00839072|100651365|FG000|NOT COMPLETED|Second Intervention Period||1||
48133929|NCT00839072|100651366|FG001|NOT COMPLETED|Second Intervention Period||0||
48133930|NCT01429259|100651367|FG000|STARTED|Overall Study||30||
48133931|NCT01429259|100651367|FG000|COMPLETED|Overall Study||30||
48133932|NCT01429259|100651367|FG000|NOT COMPLETED|Overall Study||0||
48133933|NCT03119766|100651368|FG000|STARTED|Overall Study||151||
48133934|NCT03119766|100651369|FG001|STARTED|Overall Study||158||
48133935|NCT03119766|100651368|FG000|COMPLETED|Overall Study||151||
48133936|NCT03119766|100651369|FG001|COMPLETED|Overall Study||158||
48133937|NCT03119766|100651368|FG000|NOT COMPLETED|Overall Study||0||
48133938|NCT03119766|100651369|FG001|NOT COMPLETED|Overall Study||0||
48133939|NCT00966940|100651370|FG000|STARTED|Period 1, First 6 Weeks||28||
48133940|NCT00966940|100651371|FG001|STARTED|Period 1, First 6 Weeks||23||
48133941|NCT00966940|100651370|FG000|COMPLETED|Period 1, First 6 Weeks||25||
48133942|NCT00966940|100651371|FG001|COMPLETED|Period 1, First 6 Weeks||23||
48133943|NCT00966940|100651370|FG000|NOT COMPLETED|Period 1, First 6 Weeks||3||
48133944|NCT00966940|100651371|FG001|NOT COMPLETED|Period 1, First 6 Weeks||0||
48133945|NCT00966940|100651370|FG000|STARTED|Period 2, Second 6 Weeks||25||
48133946|NCT00966940|100651371|FG001|STARTED|Period 2, Second 6 Weeks||23||
48133947|NCT00966940|100651370|FG000|COMPLETED|Period 2, Second 6 Weeks||25||
48133948|NCT00966940|100651371|FG001|COMPLETED|Period 2, Second 6 Weeks||23||
48133949|NCT00966940|100651370|FG000|NOT COMPLETED|Period 2, Second 6 Weeks||0||
48133950|NCT00966940|100651371|FG001|NOT COMPLETED|Period 2, Second 6 Weeks||0||
48133951|NCT02224729|100651372|FG000|STARTED|Overall Study||24||
48133952|NCT02224729|100651372|FG000|COMPLETED|Overall Study||24||
48133953|NCT02224729|100651372|FG000|NOT COMPLETED|Overall Study||0||
48133954|NCT04171700|100651373|FG000|STARTED|Overall Study||63||
48133955|NCT04171700|100651374|FG001|STARTED|Overall Study||20||
48133956|NCT04171700|100651373|FG000|COMPLETED|Overall Study||63||
48133957|NCT04171700|100651374|FG001|COMPLETED|Overall Study||20||
48133958|NCT04171700|100651373|FG000|NOT COMPLETED|Overall Study||0||
48286588|NCT03417895|101026348|FG001|STARTED|Overall Study||6||
48578445|NCT01068730|101747727|FG001|NOT COMPLETED|Period 2||0||
48578446|NCT01068730|101747728|FG002|NOT COMPLETED|Period 2||0||
48578447|NCT01068730|101747729|FG003|NOT COMPLETED|Period 2||0||
48578448|NCT01068730|101747726|FG000|STARTED|Period 3||7||
48578449|NCT01068730|101747727|FG001|STARTED|Period 3||7||
48133959|NCT04171700|100651374|FG001|NOT COMPLETED|Overall Study||0||
48133960|NCT01248884|100651375|FG000|STARTED|Overall Study||240||
48133961|NCT01248884|100651376|FG001|STARTED|Overall Study||242||
48133962|NCT01248884|100651377|FG002|STARTED|Overall Study||239||
48133963|NCT01248884|100651375|FG000|COMPLETED|Overall Study||238||
48133964|NCT01248884|100651376|FG001|COMPLETED|Overall Study||239||
48133965|NCT01248884|100651377|FG002|COMPLETED|Overall Study||238||
48133966|NCT01248884|100651375|FG000|NOT COMPLETED|Overall Study||2||
48133967|NCT01248884|100651376|FG001|NOT COMPLETED|Overall Study||3||
48133968|NCT01248884|100651377|FG002|NOT COMPLETED|Overall Study||1||
48286589|NCT03417895|101026349|FG002|STARTED|Overall Study||6||
48286590|NCT03417895|101026347|FG000|COMPLETED|Overall Study||47||
48578450|NCT01068730|101747728|FG002|STARTED|Period 3||7||
48133969|NCT01761747|100651378|FG000|STARTED|Overall Study||3||
48133970|NCT01761747|100651378|FG000|COMPLETED|Overall Study||2||
48133971|NCT01761747|100651378|FG000|NOT COMPLETED|Overall Study||1||
48578451|NCT01068730|101747729|FG003|STARTED|Period 3||7||
48578452|NCT01068730|101747726|FG000|COMPLETED|Period 3||6||
48578453|NCT01068730|101747727|FG001|COMPLETED|Period 3||7||
48133972|NCT01127178|100651379|FG000|STARTED|Dose Escalation: Treatment Phase||9||
48133973|NCT01127178|100651380|FG001|STARTED|Dose Escalation: Treatment Phase||3||
48133974|NCT01127178|100651379|FG000|COMPLETED|Dose Escalation: Treatment Phase||5||
48133975|NCT01127178|100651380|FG001|COMPLETED|Dose Escalation: Treatment Phase||3||
48133976|NCT01127178|100651379|FG000|NOT COMPLETED|Dose Escalation: Treatment Phase||4||
48286591|NCT03417895|101026348|FG001|COMPLETED|Overall Study||6||
48133977|NCT01127178|100651380|FG001|NOT COMPLETED|Dose Escalation: Treatment Phase||0||
48133978|NCT01127178|100651379|FG000|STARTED|Dose Escalation: Extension Phase||5||
48133979|NCT01127178|100651380|FG001|STARTED|Dose Escalation: Extension Phase||3||
48133980|NCT01127178|100651379|FG000|COMPLETED|Dose Escalation: Extension Phase||3||
48133981|NCT01127178|100651380|FG001|COMPLETED|Dose Escalation: Extension Phase||2||
48133982|NCT01127178|100651379|FG000|NOT COMPLETED|Dose Escalation: Extension Phase||2||
48133983|NCT01127178|100651380|FG001|NOT COMPLETED|Dose Escalation: Extension Phase||1||
48133984|NCT03326999|100651381|FG000|STARTED|Overall Study||30||
48133985|NCT03326999|100651382|FG001|STARTED|Overall Study||30||
48133986|NCT03326999|100651381|FG000|COMPLETED|Overall Study||30||
48578454|NCT01068730|101747728|FG002|COMPLETED|Period 3||7||
48578455|NCT01068730|101747729|FG003|COMPLETED|Period 3||7||
48578456|NCT01068730|101747726|FG000|NOT COMPLETED|Period 3||1||
48578457|NCT01068730|101747727|FG001|NOT COMPLETED|Period 3||0||
48578458|NCT01068730|101747728|FG002|NOT COMPLETED|Period 3||0||
48578459|NCT01068730|101747729|FG003|NOT COMPLETED|Period 3||0||
48578460|NCT01068730|101747726|FG000|STARTED|Period 4||6||
48578461|NCT01068730|101747727|FG001|STARTED|Period 4||7||
48578462|NCT01068730|101747728|FG002|STARTED|Period 4||7||
48578463|NCT01068730|101747729|FG003|STARTED|Period 4||7||
48578464|NCT01068730|101747726|FG000|COMPLETED|Period 4||6||
48578465|NCT01068730|101747727|FG001|COMPLETED|Period 4||6||
48578466|NCT01068730|101747728|FG002|COMPLETED|Period 4||7||
48578467|NCT01068730|101747729|FG003|COMPLETED|Period 4||7||
48578468|NCT01068730|101747726|FG000|NOT COMPLETED|Period 4||0||
48578469|NCT01068730|101747727|FG001|NOT COMPLETED|Period 4||1||
48578470|NCT01068730|101747728|FG002|NOT COMPLETED|Period 4||0||
48578471|NCT01068730|101747729|FG003|NOT COMPLETED|Period 4||0||
48578472|NCT00882778|101747730|FG000|STARTED|Overall Study||86||
48578473|NCT00882778|101747730|FG000|COMPLETED|Overall Study||86||
48578474|NCT00882778|101747730|FG000|NOT COMPLETED|Overall Study||0||
48578475|NCT00949403|101747731|FG000|STARTED|Overall Study||9||
48578476|NCT00949403|101747731|FG000|COMPLETED|Overall Study||9||
48578477|NCT00949403|101747731|FG000|NOT COMPLETED|Overall Study||0||
48578478|NCT02217410|101747732|FG000|STARTED|Overall Study||7||
48578479|NCT02217410|101747733|FG001|STARTED|Overall Study||34||
48578480|NCT02217410|101747734|FG002|STARTED|Overall Study||18||
48578481|NCT02217410|101747732|FG000|COMPLETED|Overall Study||6||
48578482|NCT02217410|101747733|FG001|COMPLETED|Overall Study||30||
48578483|NCT02217410|101747734|FG002|COMPLETED|Overall Study||13||
48578484|NCT02217410|101747732|FG000|NOT COMPLETED|Overall Study||1||
48578485|NCT02217410|101747733|FG001|NOT COMPLETED|Overall Study||4||
48133987|NCT03326999|100651382|FG001|COMPLETED|Overall Study||30||
48133988|NCT03326999|100651381|FG000|NOT COMPLETED|Overall Study||0||
48133989|NCT03326999|100651382|FG001|NOT COMPLETED|Overall Study||0||
48133990|NCT00724282|100651383|FG000|STARTED|Overall Study||20||
48133991|NCT00724282|100651383|FG000|COMPLETED|Overall Study||16||
48133992|NCT00724282|100651383|FG000|NOT COMPLETED|Overall Study||4||
48133993|NCT02328326|100651384|FG000|STARTED|Overall Study||246||
48133994|NCT02328326|100651385|FG001|STARTED|Overall Study||232||
48133995|NCT02328326|100651384|FG000|6-month Follow Up|Overall Study||221||
48133996|NCT02328326|100651385|FG001|6-month Follow Up|Overall Study||221||
48133997|NCT02328326|100651384|FG000|COMPLETED|Overall Study||224||
48133998|NCT02328326|100651385|FG001|COMPLETED|Overall Study||224||
48133999|NCT02328326|100651384|FG000|NOT COMPLETED|Overall Study||22||
48134000|NCT02328326|100651385|FG001|NOT COMPLETED|Overall Study||8||
48134001|NCT02246998|100651386|FG000|STARTED|Overall Study||18||
48134002|NCT02246998|100651387|FG001|STARTED|Overall Study||18||
48134003|NCT02246998|100651388|FG002|STARTED|Overall Study||18||
48134004|NCT02246998|100651389|FG003|STARTED|Overall Study||18||
48134005|NCT02246998|100651386|FG000|COMPLETED|Overall Study||16||
48134006|NCT02246998|100651387|FG001|COMPLETED|Overall Study||15||
48134007|NCT02246998|100651388|FG002|COMPLETED|Overall Study||15||
48134008|NCT02246998|100651389|FG003|COMPLETED|Overall Study||16||
48134009|NCT02246998|100651386|FG000|NOT COMPLETED|Overall Study||2||
48134010|NCT02246998|100651387|FG001|NOT COMPLETED|Overall Study||3||
48134011|NCT02246998|100651388|FG002|NOT COMPLETED|Overall Study||3||
48134012|NCT02246998|100651389|FG003|NOT COMPLETED|Overall Study||2||
48134013|NCT03321019|100651390|FG000|STARTED|Overall Study||19||
48134014|NCT03321019|100651391|FG001|STARTED|Overall Study||100||
48134015|NCT03321019|100651390|FG000|COMPLETED|Overall Study||19||
48134016|NCT03321019|100651391|FG001|COMPLETED|Overall Study||72||
48134017|NCT03321019|100651390|FG000|NOT COMPLETED|Overall Study||0||
48134018|NCT03321019|100651391|FG001|NOT COMPLETED|Overall Study||28||
48134019|NCT01159938|100651392|FG000|STARTED|First Study Period||26||
48134020|NCT01159938|100651393|FG001|STARTED|First Study Period||11||
48134021|NCT01159938|100651394|FG002|STARTED|First Study Period||11||
48134022|NCT01159938|100651395|FG003|STARTED|First Study Period||12||
48134023|NCT01159938|100651396|FG004|STARTED|First Study Period||12||
48134024|NCT01159938|100651392|FG000|Received at Least 1 Dose of Study Drug|First Study Period||0||
48134025|NCT01159938|100651393|FG001|Received at Least 1 Dose of Study Drug|First Study Period||11||
48578486|NCT02217410|101747734|FG002|NOT COMPLETED|Overall Study||5||
48578487|NCT02609607|101747735|FG000|STARTED|Overall Study||6||
48578488|NCT02609607|101747736|FG001|STARTED|Overall Study||5||
48134026|NCT01159938|100651394|FG002|Received at Least 1 Dose of Study Drug|First Study Period||11||
48134027|NCT01159938|100651395|FG003|Received at Least 1 Dose of Study Drug|First Study Period||12||
48134028|NCT01159938|100651396|FG004|Received at Least 1 Dose of Study Drug|First Study Period||12||
48134029|NCT01159938|100651392|FG000|Safety and Efficacy Analysis Population|First Study Period||25||
48134030|NCT01159938|100651393|FG001|Safety and Efficacy Analysis Population|First Study Period||11||
48134031|NCT01159938|100651394|FG002|Safety and Efficacy Analysis Population|First Study Period||11||
48134032|NCT01159938|100651395|FG003|Safety and Efficacy Analysis Population|First Study Period||12||
48134033|NCT01159938|100651396|FG004|Safety and Efficacy Analysis Population|First Study Period||12||
48134034|NCT01159938|100651392|FG000|COMPLETED|First Study Period||26||
48286592|NCT03417895|101026349|FG002|COMPLETED|Overall Study||6||
48286593|NCT03417895|101026347|FG000|NOT COMPLETED|Overall Study||0||
48286594|NCT03417895|101026348|FG001|NOT COMPLETED|Overall Study||0||
48286595|NCT03417895|101026349|FG002|NOT COMPLETED|Overall Study||0||
48286596|NCT02513719|101026350|FG000|STARTED|At 8 Months Clinical Follow-up||312||
48286597|NCT02513719|101026350|FG000|COMPLETED|At 8 Months Clinical Follow-up||312||
48286598|NCT02513719|101026350|FG000|NOT COMPLETED|At 8 Months Clinical Follow-up||0||
48703406|NCT01975519|102060499|FG000|Phase 2a Soft Tissue Sarcoma|Overall Study||0||
48703407|NCT01975519|102060500|FG001|Phase 2a Soft Tissue Sarcoma|Overall Study||63||
48703408|NCT01975519|102060499|FG000|Phase 2a Angiosarcoma Cohort|Overall Study||0||
48703409|NCT01975519|102060500|FG001|Phase 2a Angiosarcoma Cohort|Overall Study||22||
48286599|NCT02513719|101026350|FG000|STARTED|At 1 Year Clinical Follow-up||312||
48286600|NCT02513719|101026350|FG000|COMPLETED|At 1 Year Clinical Follow-up||305||
48578489|NCT02609607|101747735|FG000|COMPLETED|Overall Study||6||
48578490|NCT02609607|101747736|FG001|COMPLETED|Overall Study||4||
48578491|NCT02609607|101747735|FG000|NOT COMPLETED|Overall Study||0||
48578492|NCT02609607|101747736|FG001|NOT COMPLETED|Overall Study||1||
48578493|NCT02424630|101747737|FG000|STARTED|Overall Study||25||
48578494|NCT02424630|101747738|FG001|STARTED|Overall Study||27||
48578495|NCT02424630|101747737|FG000|COMPLETED|Overall Study||24||
48703410|NCT01975519|102060499|FG000|COMPLETED|Overall Study||3||
48286601|NCT02513719|101026350|FG000|NOT COMPLETED|At 1 Year Clinical Follow-up||7||
48286602|NCT02513719|101026350|FG000|STARTED|At 2 Years Clinical Follow-up||305||
48286603|NCT02513719|101026350|FG000|COMPLETED|At 2 Years Clinical Follow-up||300||
48286604|NCT02513719|101026350|FG000|NOT COMPLETED|At 2 Years Clinical Follow-up||5||
48286605|NCT02513719|101026350|FG000|STARTED|At 3 Years Clinical Follow-up||300||
48286606|NCT02513719|101026350|FG000|COMPLETED|At 3 Years Clinical Follow-up||289||
48286607|NCT02513719|101026350|FG000|NOT COMPLETED|At 3 Years Clinical Follow-up||11||
48286608|NCT02513719|101026350|FG000|STARTED|At 4 Years Clinical Follow-up||289||
48286609|NCT02513719|101026350|FG000|COMPLETED|At 4 Years Clinical Follow-up||273||
48286610|NCT02513719|101026350|FG000|NOT COMPLETED|At 4 Years Clinical Follow-up||16||
48286611|NCT02513719|101026350|FG000|STARTED|At 5 Years Clinical Follow-up||273||
48578496|NCT02424630|101747738|FG001|COMPLETED|Overall Study||24||
48578497|NCT02424630|101747737|FG000|NOT COMPLETED|Overall Study||1||
48578498|NCT02424630|101747738|FG001|NOT COMPLETED|Overall Study||3||
48578499|NCT00187681|101747739|FG000|STARTED|Overall Study||12||
48578500|NCT00187681|101747740|FG001|STARTED|Overall Study||8||
48578501|NCT00187681|101747739|FG000|COMPLETED|Overall Study||12||
48578502|NCT00187681|101747740|FG001|COMPLETED|Overall Study||8||
48578503|NCT00187681|101747739|FG000|NOT COMPLETED|Overall Study||0||
48578504|NCT00187681|101747740|FG001|NOT COMPLETED|Overall Study||0||
48578505|NCT01683266|101747741|FG000|STARTED|Overall Study||274||
48578506|NCT01683266|101747742|FG001|STARTED|Overall Study||275||
48578507|NCT01683266|101747741|FG000|Modified Intent-to-Treat Population|Overall Study||273||
48578508|NCT01683266|101747742|FG001|Modified Intent-to-Treat Population|Overall Study||273||
48578509|NCT01683266|101747741|FG000|COMPLETED|Overall Study||219||
48578510|NCT01683266|101747742|FG001|COMPLETED|Overall Study||225||
48578511|NCT01683266|101747741|FG000|NOT COMPLETED|Overall Study||55||
48286612|NCT02513719|101026350|FG000|COMPLETED|At 5 Years Clinical Follow-up||254||
48286613|NCT02513719|101026350|FG000|NOT COMPLETED|At 5 Years Clinical Follow-up||19||
48286614|NCT02859324|101026351|FG000|STARTED|Overall Study||7||
48286615|NCT02859324|101026352|FG001|STARTED|Overall Study||9||
48286616|NCT02859324|101026353|FG002|STARTED|Overall Study||5||
48578512|NCT01683266|101747742|FG001|NOT COMPLETED|Overall Study||50||
48578513|NCT01857583|101747743|FG000|STARTED|Overall Study||30||
48703411|NCT01975519|102060500|FG001|COMPLETED|Overall Study||108||
48134035|NCT01159938|100651393|FG001|COMPLETED|First Study Period||11||
48134036|NCT01159938|100651394|FG002|COMPLETED|First Study Period||10||
48134037|NCT01159938|100651395|FG003|COMPLETED|First Study Period||12||
48134038|NCT01159938|100651396|FG004|COMPLETED|First Study Period||12||
48134039|NCT01159938|100651392|FG000|NOT COMPLETED|First Study Period||0||
48134040|NCT01159938|100651393|FG001|NOT COMPLETED|First Study Period||0||
48134041|NCT01159938|100651394|FG002|NOT COMPLETED|First Study Period||1||
48134042|NCT01159938|100651395|FG003|NOT COMPLETED|First Study Period||0||
48134043|NCT01159938|100651396|FG004|NOT COMPLETED|First Study Period||0||
48134044|NCT01159938|100651392|FG000|STARTED|Second Study Period||0||
48134045|NCT01159938|100651393|FG001|STARTED|Second Study Period||11||
48134046|NCT01159938|100651394|FG002|STARTED|Second Study Period||10||
48134047|NCT01159938|100651395|FG003|STARTED|Second Study Period||12||
48134048|NCT01159938|100651396|FG004|STARTED|Second Study Period||12||
48134049|NCT01159938|100651392|FG000|COMPLETED|Second Study Period||0||
48134050|NCT01159938|100651393|FG001|COMPLETED|Second Study Period||11||
48134051|NCT01159938|100651394|FG002|COMPLETED|Second Study Period||10||
48286617|NCT02859324|101026351|FG000|COMPLETED|Overall Study||0|Completed = Did not discontinue study|
48286618|NCT02859324|101026352|FG001|COMPLETED|Overall Study||0|Completed = Did not discontinue study|
48286619|NCT02859324|101026353|FG002|COMPLETED|Overall Study||0|Completed = Did not discontinue study|
48286620|NCT02859324|101026351|FG000|NOT COMPLETED|Overall Study||7||
48286621|NCT02859324|101026352|FG001|NOT COMPLETED|Overall Study||9||
48578514|NCT01857583|101747744|FG001|STARTED|Overall Study||7||
48578515|NCT01857583|101747745|FG002|STARTED|Overall Study||22||
48578516|NCT01857583|101747746|FG003|STARTED|Overall Study||21||
48578517|NCT01857583|101747743|FG000|Safety Analysis Population|Overall Study||30||
48578518|NCT01857583|101747744|FG001|Safety Analysis Population|Overall Study||7||
48578519|NCT01857583|101747745|FG002|Safety Analysis Population|Overall Study||22||
48134052|NCT01159938|100651395|FG003|COMPLETED|Second Study Period||12||
48134053|NCT01159938|100651396|FG004|COMPLETED|Second Study Period||12||
48134054|NCT01159938|100651392|FG000|NOT COMPLETED|Second Study Period||0||
48134055|NCT01159938|100651393|FG001|NOT COMPLETED|Second Study Period||0||
48134056|NCT01159938|100651394|FG002|NOT COMPLETED|Second Study Period||0||
48134057|NCT01159938|100651395|FG003|NOT COMPLETED|Second Study Period||0||
48134058|NCT01159938|100651396|FG004|NOT COMPLETED|Second Study Period||0||
48134059|NCT00355082|100651397|FG000|STARTED|Double-Blind (DB) Treatment Phase||113||
48134060|NCT00355082|100651398|FG001|STARTED|Double-Blind (DB) Treatment Phase||113||
48134061|NCT00355082|100651399|FG002|STARTED|Double-Blind (DB) Treatment Phase||0||
48134062|NCT00355082|100651397|FG000|COMPLETED|Double-Blind (DB) Treatment Phase||94||
48134063|NCT00355082|100651398|FG001|COMPLETED|Double-Blind (DB) Treatment Phase||79||
48578520|NCT01857583|101747746|FG003|Safety Analysis Population|Overall Study||20||
48578521|NCT01857583|101747743|FG000|COMPLETED|Overall Study||29||
48578522|NCT01857583|101747744|FG001|COMPLETED|Overall Study||6||
48578523|NCT01857583|101747745|FG002|COMPLETED|Overall Study||19||
48578524|NCT01857583|101747746|FG003|COMPLETED|Overall Study||17||
48578525|NCT01857583|101747743|FG000|NOT COMPLETED|Overall Study||1||
48578526|NCT01857583|101747744|FG001|NOT COMPLETED|Overall Study||1||
48578527|NCT01857583|101747745|FG002|NOT COMPLETED|Overall Study||3||
48578528|NCT01857583|101747746|FG003|NOT COMPLETED|Overall Study||4||
48134064|NCT00355082|100651399|FG002|COMPLETED|Double-Blind (DB) Treatment Phase||0||
48286622|NCT02859324|101026353|FG002|NOT COMPLETED|Overall Study||5||
48286623|NCT02250092|101026354|FG000|STARTED|Overall Study||10||
48286624|NCT02250092|101026355|FG001|STARTED|Overall Study||10||
48286625|NCT02250092|101026354|FG000|COMPLETED|Overall Study||10||
48286626|NCT02250092|101026355|FG001|COMPLETED|Overall Study||10||
48286627|NCT02250092|101026354|FG000|NOT COMPLETED|Overall Study||0||
48286628|NCT02250092|101026355|FG001|NOT COMPLETED|Overall Study||0||
48286629|NCT04002401|101026356|FG000|STARTED|Overall Study||27||
48286630|NCT04002401|101026356|FG000|COMPLETED|Overall Study||0||
48286631|NCT04002401|101026356|FG000|NOT COMPLETED|Overall Study||27||
48286632|NCT02190045|101026357|FG000|STARTED|Overall Study||15||
48286633|NCT02190045|101026358|FG001|STARTED|Overall Study||15||
48578529|NCT01780038|101747747|FG000|STARTED|Overall Study||12||
48578530|NCT01780038|101747748|FG001|STARTED|Overall Study||12||
48578531|NCT01780038|101747747|FG000|COMPLETED|Overall Study||8||
48134065|NCT00355082|100651397|FG000|NOT COMPLETED|Double-Blind (DB) Treatment Phase||19||
48286634|NCT02190045|101026357|FG000|COMPLETED|Overall Study||12||
48578532|NCT01780038|101747748|FG001|COMPLETED|Overall Study||11||
48578533|NCT01780038|101747747|FG000|NOT COMPLETED|Overall Study||4||
48578534|NCT01780038|101747748|FG001|NOT COMPLETED|Overall Study||1||
48578535|NCT02064270|101747749|FG000|STARTED|Overall Study||263||
48578536|NCT02064270|101747750|FG001|STARTED|Overall Study||263||
48578537|NCT02064270|101747749|FG000|COMPLETED|Overall Study||201||
48703412|NCT01975519|102060499|FG000|NOT COMPLETED|Overall Study||0||
48703413|NCT01975519|102060500|FG001|NOT COMPLETED|Overall Study||0||
48703414|NCT00920218|102060501|FG000|STARTED|Overall Study||30||
48703415|NCT00920218|102060502|FG001|STARTED|Overall Study||29||
48703416|NCT00920218|102060503|FG002|STARTED|Overall Study||31||
48703417|NCT00920218|102060504|FG003|STARTED|Overall Study||30||
48703418|NCT00920218|102060501|FG000|COMPLETED|Overall Study||28||
48703419|NCT00920218|102060502|FG001|COMPLETED|Overall Study||24||
48703420|NCT00920218|102060503|FG002|COMPLETED|Overall Study||23||
48703421|NCT00920218|102060504|FG003|COMPLETED|Overall Study||23||
48703422|NCT00920218|102060501|FG000|NOT COMPLETED|Overall Study||2||
48703423|NCT00920218|102060502|FG001|NOT COMPLETED|Overall Study||5||
48703424|NCT00920218|102060503|FG002|NOT COMPLETED|Overall Study||8||
48703425|NCT00920218|102060504|FG003|NOT COMPLETED|Overall Study||7||
48703426|NCT00322023|102060505|FG000|STARTED|Overall Study||12||
48578538|NCT02064270|101747750|FG001|COMPLETED|Overall Study||231||
48578539|NCT02064270|101747749|FG000|NOT COMPLETED|Overall Study||62||
48578540|NCT02064270|101747750|FG001|NOT COMPLETED|Overall Study||32||
48578541|NCT01214083|101747751|FG000|STARTED|Overall Study||31||
48134066|NCT00355082|100651398|FG001|NOT COMPLETED|Double-Blind (DB) Treatment Phase||34||
48578542|NCT01214083|101747752|FG001|STARTED|Overall Study||33||
48578543|NCT01214083|101747753|FG002|STARTED|Overall Study||31||
48578544|NCT01214083|101747751|FG000|COMPLETED|Overall Study||19||
48578545|NCT01214083|101747752|FG001|COMPLETED|Overall Study||23||
48578546|NCT01214083|101747753|FG002|COMPLETED|Overall Study||21||
48578547|NCT01214083|101747751|FG000|NOT COMPLETED|Overall Study||12||
48578548|NCT01214083|101747752|FG001|NOT COMPLETED|Overall Study||10||
48578549|NCT01214083|101747753|FG002|NOT COMPLETED|Overall Study||10||
48578550|NCT00568061|101747754|FG000|STARTED|Overall Study||13||
48578551|NCT00568061|101747755|FG001|STARTED|Overall Study||16||
48578552|NCT00568061|101747754|FG000|COMPLETED|Overall Study||8||
48578553|NCT00568061|101747755|FG001|COMPLETED|Overall Study||14||
48578554|NCT00568061|101747754|FG000|NOT COMPLETED|Overall Study||5||
48578555|NCT00568061|101747755|FG001|NOT COMPLETED|Overall Study||2||
48578556|NCT04470544|101747756|FG000|STARTED|Overall Study||50||
48578557|NCT04470544|101747757|FG001|STARTED|Overall Study||50||
48578558|NCT04470544|101747756|FG000|COMPLETED|Overall Study||46||
48578559|NCT04470544|101747757|FG001|COMPLETED|Overall Study||44||
48578560|NCT04470544|101747756|FG000|NOT COMPLETED|Overall Study||4||
48578561|NCT04470544|101747757|FG001|NOT COMPLETED|Overall Study||6||
48703427|NCT00322023|102060506|FG001|STARTED|Overall Study||21||
48578562|NCT02993250|101747758|FG000|STARTED|Overall Study||22||
48578563|NCT02993250|101747759|FG001|STARTED|Overall Study||11||
48703428|NCT00322023|102060507|FG002|STARTED|Overall Study||22||
48578564|NCT02993250|101747758|FG000|COMPLETED|Overall Study||22||
48703429|NCT00322023|102060505|FG000|COMPLETED|Overall Study||12||
48703430|NCT00322023|102060506|FG001|COMPLETED|Overall Study||19||
48703431|NCT00322023|102060507|FG002|COMPLETED|Overall Study||16||
48400087|NCT03984812|101309287|FG003|NOT COMPLETED|Part 1 (Up to Day 28)||0||
48400088|NCT03984812|101309288|FG004|NOT COMPLETED|Part 1 (Up to Day 28)||0||
48400089|NCT03984812|101309289|FG005|NOT COMPLETED|Part 1 (Up to Day 28)||0||
48400090|NCT03984812|101309290|FG006|NOT COMPLETED|Part 1 (Up to Day 28)||0||
48400091|NCT03984812|101309291|FG007|NOT COMPLETED|Part 1 (Up to Day 28)||0||
48400092|NCT03984812|101309292|FG008|NOT COMPLETED|Part 1 (Up to Day 28)||0||
48400093|NCT03984812|101309293|FG009|NOT COMPLETED|Part 1 (Up to Day 28)||0||
48400094|NCT03984812|101309294|FG010|NOT COMPLETED|Part 1 (Up to Day 28)||0||
48400095|NCT03984812|101309284|FG000|STARTED|Part 2 (Up to Day 49)||0||
48400096|NCT03984812|101309285|FG001|STARTED|Part 2 (Up to Day 49)||0||
48400097|NCT03984812|101309286|FG002|STARTED|Part 2 (Up to Day 49)||0||
48400098|NCT03984812|101309287|FG003|STARTED|Part 2 (Up to Day 49)||0||
48400099|NCT03984812|101309288|FG004|STARTED|Part 2 (Up to Day 49)||0||
48578565|NCT02993250|101747759|FG001|COMPLETED|Overall Study||10||
48578566|NCT02993250|101747758|FG000|NOT COMPLETED|Overall Study||0||
48578567|NCT02993250|101747759|FG001|NOT COMPLETED|Overall Study||1||
48578568|NCT00638404|101747760|FG000|STARTED|Overall Study||200||
48578569|NCT00638404|101747761|FG001|STARTED|Overall Study||100||
48578570|NCT00638404|101747760|FG000|COMPLETED|Overall Study||192||
48578571|NCT00638404|101747761|FG001|COMPLETED|Overall Study||100||
48578572|NCT00638404|101747760|FG000|NOT COMPLETED|Overall Study||8||
48578573|NCT00638404|101747761|FG001|NOT COMPLETED|Overall Study||0||
48578574|NCT04531462|101747762|FG000|STARTED|Overall Study||64||
48578575|NCT04531462|101747763|FG001|STARTED|Overall Study||65||
48578576|NCT04531462|101747762|FG000|COMPLETED|Overall Study||58||
48578577|NCT04531462|101747763|FG001|COMPLETED|Overall Study||61||
48578578|NCT04531462|101747762|FG000|NOT COMPLETED|Overall Study||6||
48578579|NCT04531462|101747763|FG001|NOT COMPLETED|Overall Study||4||
48578580|NCT01736397|101747764|FG000|STARTED|Overall Study||75||
48578581|NCT01736397|101747765|FG001|STARTED|Overall Study||74||
48578582|NCT01736397|101747764|FG000|COMPLETED|Overall Study||61||
48578583|NCT01736397|101747765|FG001|COMPLETED|Overall Study||50||
48578584|NCT01736397|101747764|FG000|NOT COMPLETED|Overall Study||14||
48578585|NCT01736397|101747765|FG001|NOT COMPLETED|Overall Study||24||
48578586|NCT02438826|101747766|FG000|STARTED|Double-Blind Treatment Phase||123||
48578587|NCT02438826|101747767|FG001|STARTED|Double-Blind Treatment Phase||117||
48578588|NCT02438826|101747768|FG002|STARTED|Double-Blind Treatment Phase||0||
48578589|NCT02438826|101747769|FG003|STARTED|Double-Blind Treatment Phase||0||
48578590|NCT02438826|101747766|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||120||
48578591|NCT02438826|101747767|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||117||
48578592|NCT02438826|101747768|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||0||
48578593|NCT02438826|101747769|FG003|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||0||
48578594|NCT02438826|101747766|FG000|COMPLETED|Double-Blind Treatment Phase||117||
48578595|NCT02438826|101747767|FG001|COMPLETED|Double-Blind Treatment Phase||113||
48578596|NCT02438826|101747768|FG002|COMPLETED|Double-Blind Treatment Phase||0||
48578597|NCT02438826|101747769|FG003|COMPLETED|Double-Blind Treatment Phase||0||
48578598|NCT02438826|101747766|FG000|NOT COMPLETED|Double-Blind Treatment Phase||6||
48578599|NCT02438826|101747767|FG001|NOT COMPLETED|Double-Blind Treatment Phase||4||
48578600|NCT02438826|101747768|FG002|NOT COMPLETED|Double-Blind Treatment Phase||0||
48578601|NCT02438826|101747769|FG003|NOT COMPLETED|Double-Blind Treatment Phase||0||
48578602|NCT02438826|101747766|FG000|STARTED|Open-Label Treatment Phase||116||
48578603|NCT02438826|101747767|FG001|STARTED|Open-Label Treatment Phase||113||
48578604|NCT02438826|101747768|FG002|STARTED|Open-Label Treatment Phase||0||
48578605|NCT02438826|101747769|FG003|STARTED|Open-Label Treatment Phase||0||
48578606|NCT02438826|101747766|FG000|COMPLETED|Open-Label Treatment Phase||72||
48400100|NCT03984812|101309289|FG005|STARTED|Part 2 (Up to Day 49)||0||
48400101|NCT03984812|101309290|FG006|STARTED|Part 2 (Up to Day 49)||0||
48400102|NCT03984812|101309291|FG007|STARTED|Part 2 (Up to Day 49)||0||
48400103|NCT03984812|101309292|FG008|STARTED|Part 2 (Up to Day 49)||0||
48400104|NCT03984812|101309293|FG009|STARTED|Part 2 (Up to Day 49)||0||
48400105|NCT03984812|101309294|FG010|STARTED|Part 2 (Up to Day 49)||0||
48400106|NCT03984812|101309284|FG000|COMPLETED|Part 2 (Up to Day 49)||0||
48400107|NCT03984812|101309285|FG001|COMPLETED|Part 2 (Up to Day 49)||0||
48400108|NCT03984812|101309286|FG002|COMPLETED|Part 2 (Up to Day 49)||0||
48400109|NCT03984812|101309287|FG003|COMPLETED|Part 2 (Up to Day 49)||0||
48400110|NCT03984812|101309288|FG004|COMPLETED|Part 2 (Up to Day 49)||0||
48400111|NCT03984812|101309289|FG005|COMPLETED|Part 2 (Up to Day 49)||0||
48400112|NCT03984812|101309290|FG006|COMPLETED|Part 2 (Up to Day 49)||0||
48400113|NCT03984812|101309291|FG007|COMPLETED|Part 2 (Up to Day 49)||0||
48400114|NCT03984812|101309292|FG008|COMPLETED|Part 2 (Up to Day 49)||0||
48400115|NCT03984812|101309293|FG009|COMPLETED|Part 2 (Up to Day 49)||0||
48400116|NCT03984812|101309294|FG010|COMPLETED|Part 2 (Up to Day 49)||0||
48400117|NCT03984812|101309284|FG000|NOT COMPLETED|Part 2 (Up to Day 49)||0||
48400118|NCT03984812|101309285|FG001|NOT COMPLETED|Part 2 (Up to Day 49)||0||
48578607|NCT02438826|101747767|FG001|COMPLETED|Open-Label Treatment Phase||80||
48578608|NCT02438826|101747768|FG002|COMPLETED|Open-Label Treatment Phase||0||
48400119|NCT03984812|101309286|FG002|NOT COMPLETED|Part 2 (Up to Day 49)||0||
48400120|NCT03984812|101309287|FG003|NOT COMPLETED|Part 2 (Up to Day 49)||0||
48578609|NCT02438826|101747769|FG003|COMPLETED|Open-Label Treatment Phase||0||
48578610|NCT02438826|101747766|FG000|NOT COMPLETED|Open-Label Treatment Phase||44||
48578611|NCT02438826|101747767|FG001|NOT COMPLETED|Open-Label Treatment Phase||33||
48578612|NCT02438826|101747768|FG002|NOT COMPLETED|Open-Label Treatment Phase||0||
48578613|NCT02438826|101747769|FG003|NOT COMPLETED|Open-Label Treatment Phase||0||
48578614|NCT02438826|101747766|FG000|STARTED|Post-Treatment Phase||93||
48578615|NCT02438826|101747767|FG001|STARTED|Post-Treatment Phase||93||
48578616|NCT02438826|101747768|FG002|STARTED|Post-Treatment Phase||2||
48578617|NCT02438826|101747769|FG003|STARTED|Post-Treatment Phase||4||
48578618|NCT02438826|101747766|FG000|COMPLETED|Post-Treatment Phase||84||
48578619|NCT02438826|101747767|FG001|COMPLETED|Post-Treatment Phase||92||
48578620|NCT02438826|101747768|FG002|COMPLETED|Post-Treatment Phase||2||
48578621|NCT02438826|101747769|FG003|COMPLETED|Post-Treatment Phase||4||
48703432|NCT00322023|102060505|FG000|NOT COMPLETED|Overall Study||0||
48703433|NCT00322023|102060506|FG001|NOT COMPLETED|Overall Study||2||
48703434|NCT00322023|102060507|FG002|NOT COMPLETED|Overall Study||6||
48703435|NCT00090142|102060508|FG000|STARTED|Treatment Period I||31||
48703436|NCT00090142|102060509|FG001|STARTED|Treatment Period I||31||
48703437|NCT00090142|102060508|FG000|COMPLETED|Treatment Period I||26||
48578622|NCT02438826|101747766|FG000|NOT COMPLETED|Post-Treatment Phase||9||
48578623|NCT02438826|101747767|FG001|NOT COMPLETED|Post-Treatment Phase||1||
48578624|NCT02438826|101747768|FG002|NOT COMPLETED|Post-Treatment Phase||0||
48703438|NCT00090142|102060509|FG001|COMPLETED|Treatment Period I||28||
48286635|NCT02190045|101026358|FG001|COMPLETED|Overall Study||15||
48578625|NCT02438826|101747769|FG003|NOT COMPLETED|Post-Treatment Phase||0||
48578626|NCT04134429|101747770|FG000|STARTED|Overall Study||20||
48578627|NCT04134429|101747770|FG000|COMPLETED|Overall Study||19||
48578628|NCT04134429|101747770|FG000|NOT COMPLETED|Overall Study||1||
48578629|NCT01237041|101747771|FG000|STARTED|Overall Study||2||
48578630|NCT01237041|101747772|FG001|STARTED|Overall Study||3||
48578631|NCT01237041|101747773|FG002|STARTED|Overall Study||2||
48286636|NCT02190045|101026357|FG000|NOT COMPLETED|Overall Study||3||
48286637|NCT02190045|101026358|FG001|NOT COMPLETED|Overall Study||0||
48578632|NCT01237041|101747774|FG003|STARTED|Overall Study||5||
48578633|NCT01237041|101747775|FG004|STARTED|Overall Study||5||
48578634|NCT01237041|101747771|FG000|COMPLETED|Overall Study||2||
48703439|NCT00090142|102060508|FG000|NOT COMPLETED|Treatment Period I||5||
48703440|NCT00090142|102060509|FG001|NOT COMPLETED|Treatment Period I||3||
48703441|NCT00090142|102060508|FG000|STARTED|Treatment Period II||26||
48134067|NCT00355082|100651399|FG002|NOT COMPLETED|Double-Blind (DB) Treatment Phase||0||
48134068|NCT00355082|100651397|FG000|STARTED|Continuation Phase||184||
48134069|NCT00355082|100651398|FG001|STARTED|Continuation Phase||0||
48134070|NCT00355082|100651399|FG002|STARTED|Continuation Phase||11||
48134071|NCT00355082|100651397|FG000|COMPLETED|Continuation Phase||160||
48134072|NCT00355082|100651398|FG001|COMPLETED|Continuation Phase||0||
48134073|NCT00355082|100651399|FG002|COMPLETED|Continuation Phase||8||
48134074|NCT00355082|100651397|FG000|NOT COMPLETED|Continuation Phase||24||
48134075|NCT00355082|100651398|FG001|NOT COMPLETED|Continuation Phase||0||
48134076|NCT00355082|100651399|FG002|NOT COMPLETED|Continuation Phase||3||
48134077|NCT00822510|100651400|FG000|STARTED|Overall Study||38||
48134078|NCT00822510|100651401|FG001|STARTED|Overall Study||41||
48134079|NCT00822510|100651400|FG000|COMPLETED|Overall Study||35||
48134080|NCT00822510|100651401|FG001|COMPLETED|Overall Study||36||
48134081|NCT00822510|100651400|FG000|NOT COMPLETED|Overall Study||3||
48134082|NCT00822510|100651401|FG001|NOT COMPLETED|Overall Study||5||
48134083|NCT01782131|100651402|FG000|STARTED|Overall Study||293||
48134084|NCT01782131|100651403|FG001|STARTED|Overall Study||292||
48286638|NCT00911937|101026359|FG000|STARTED|Overall Study||487||
48286639|NCT00911937|101026360|FG001|STARTED|Overall Study||476||
48578635|NCT01237041|101747772|FG001|COMPLETED|Overall Study||3||
48578636|NCT01237041|101747773|FG002|COMPLETED|Overall Study||2||
48578637|NCT01237041|101747774|FG003|COMPLETED|Overall Study||5||
48578638|NCT01237041|101747775|FG004|COMPLETED|Overall Study||5||
48578639|NCT01237041|101747771|FG000|NOT COMPLETED|Overall Study||0||
48578640|NCT01237041|101747772|FG001|NOT COMPLETED|Overall Study||0||
48578641|NCT01237041|101747773|FG002|NOT COMPLETED|Overall Study||0||
48578642|NCT01237041|101747774|FG003|NOT COMPLETED|Overall Study||0||
48578643|NCT01237041|101747775|FG004|NOT COMPLETED|Overall Study||0||
48578644|NCT00626821|101747776|FG000|STARTED|Overall Study||3017||
48578645|NCT00626821|101747776|FG000|Quality of Life|Overall Study||2672||
48578646|NCT00626821|101747776|FG000|COMPLETED|Overall Study||2796||
48578647|NCT00626821|101747776|FG000|NOT COMPLETED|Overall Study||221||
48703442|NCT00090142|102060509|FG001|STARTED|Treatment Period II||28||
48703443|NCT00090142|102060508|FG000|COMPLETED|Treatment Period II||25||
48134085|NCT01782131|100651402|FG000|Treated|Overall Study||288||
48286640|NCT00911937|101026359|FG000|Treated|Overall Study||474||
48578648|NCT01053663|101747777|FG000|STARTED|Overall Study||9||
48578649|NCT01053663|101747777|FG000|COMPLETED|Overall Study||3||
48578650|NCT01053663|101747777|FG000|NOT COMPLETED|Overall Study||6||
48578651|NCT00095238|101747778|FG000|STARTED|Overall Study||2067||
48578652|NCT00095238|101747779|FG001|STARTED|Overall Study||2061||
48578653|NCT00095238|101747778|FG000|Safety (Treated) Population|Overall Study||2064||
48578654|NCT00095238|101747779|FG001|Safety (Treated) Population|Overall Study||2062||
48578655|NCT00095238|101747778|FG000|COMPLETED|Overall Study||1210||
48578656|NCT00095238|101747779|FG001|COMPLETED|Overall Study||1209||
48578657|NCT00095238|101747778|FG000|NOT COMPLETED|Overall Study||857||
48578658|NCT00095238|101747779|FG001|NOT COMPLETED|Overall Study||852||
48578659|NCT04672252|101747780|FG000|STARTED|Overall Study||53||
48578660|NCT04672252|101747781|FG001|STARTED|Overall Study||47||
48578661|NCT04672252|101747780|FG000|COMPLETED|Overall Study||52||
48578662|NCT04672252|101747781|FG001|COMPLETED|Overall Study||47||
48578663|NCT04672252|101747780|FG000|NOT COMPLETED|Overall Study||1||
48578664|NCT04672252|101747781|FG001|NOT COMPLETED|Overall Study||0||
48578665|NCT04501640|101747782|FG000|STARTED|Period 1 (5 Days)||6||
48578666|NCT04501640|101747783|FG001|STARTED|Period 1 (5 Days)||6||
48578667|NCT04501640|101747784|FG002|STARTED|Period 1 (5 Days)||6||
48578668|NCT04501640|101747785|FG003|STARTED|Period 1 (5 Days)||6||
48578669|NCT04501640|101747782|FG000|COMPLETED|Period 1 (5 Days)||6||
48578670|NCT04501640|101747783|FG001|COMPLETED|Period 1 (5 Days)||6||
48578671|NCT04501640|101747784|FG002|COMPLETED|Period 1 (5 Days)||6||
48578672|NCT04501640|101747785|FG003|COMPLETED|Period 1 (5 Days)||6||
48578673|NCT04501640|101747782|FG000|NOT COMPLETED|Period 1 (5 Days)||0||
48578674|NCT04501640|101747783|FG001|NOT COMPLETED|Period 1 (5 Days)||0||
48578675|NCT04501640|101747784|FG002|NOT COMPLETED|Period 1 (5 Days)||0||
48578676|NCT04501640|101747785|FG003|NOT COMPLETED|Period 1 (5 Days)||0||
48578677|NCT04501640|101747782|FG000|STARTED|Washout Period (10 Days)||6||
48578678|NCT04501640|101747783|FG001|STARTED|Washout Period (10 Days)||6||
48578679|NCT04501640|101747784|FG002|STARTED|Washout Period (10 Days)||6||
48578680|NCT04501640|101747785|FG003|STARTED|Washout Period (10 Days)||6||
48286641|NCT00911937|101026360|FG001|Treated|Overall Study||463||
48286642|NCT00911937|101026359|FG000|COMPLETED|Overall Study||400||
48286643|NCT00911937|101026360|FG001|COMPLETED|Overall Study||381||
48578681|NCT04501640|101747782|FG000|COMPLETED|Washout Period (10 Days)||6||
48578682|NCT04501640|101747783|FG001|COMPLETED|Washout Period (10 Days)||6||
48578683|NCT04501640|101747784|FG002|COMPLETED|Washout Period (10 Days)||6||
48578684|NCT04501640|101747785|FG003|COMPLETED|Washout Period (10 Days)||6||
48578685|NCT04501640|101747782|FG000|NOT COMPLETED|Washout Period (10 Days)||0||
48578686|NCT04501640|101747783|FG001|NOT COMPLETED|Washout Period (10 Days)||0||
48578687|NCT04501640|101747784|FG002|NOT COMPLETED|Washout Period (10 Days)||0||
48578688|NCT04501640|101747785|FG003|NOT COMPLETED|Washout Period (10 Days)||0||
48578689|NCT04501640|101747782|FG000|STARTED|Period 2 (5 Days)||6||
48578690|NCT04501640|101747783|FG001|STARTED|Period 2 (5 Days)||6||
48578691|NCT04501640|101747784|FG002|STARTED|Period 2 (5 Days)||6||
48578692|NCT04501640|101747785|FG003|STARTED|Period 2 (5 Days)||6||
48578693|NCT04501640|101747782|FG000|COMPLETED|Period 2 (5 Days)||6||
48578694|NCT04501640|101747783|FG001|COMPLETED|Period 2 (5 Days)||6||
48578695|NCT04501640|101747784|FG002|COMPLETED|Period 2 (5 Days)||6||
48578696|NCT04501640|101747785|FG003|COMPLETED|Period 2 (5 Days)||6||
48578697|NCT04501640|101747782|FG000|NOT COMPLETED|Period 2 (5 Days)||0||
48578698|NCT04501640|101747783|FG001|NOT COMPLETED|Period 2 (5 Days)||0||
48578699|NCT04501640|101747784|FG002|NOT COMPLETED|Period 2 (5 Days)||0||
48578700|NCT04501640|101747785|FG003|NOT COMPLETED|Period 2 (5 Days)||0||
48578701|NCT00693498|101747786|FG000|STARTED|Overall Study||81||
48578702|NCT00693498|101747787|FG001|STARTED|Overall Study||81||
48578703|NCT00693498|101747786|FG000|COMPLETED|Overall Study||81||
48286644|NCT00911937|101026359|FG000|NOT COMPLETED|Overall Study||87||
48286645|NCT00911937|101026360|FG001|NOT COMPLETED|Overall Study||95||
48286646|NCT01546636|101026361|FG000|STARTED|Overall Study||36||
48578704|NCT00693498|101747787|FG001|COMPLETED|Overall Study||81||
48286647|NCT01546636|101026362|FG001|STARTED|Overall Study||34||
48286648|NCT01546636|101026361|FG000|COMPLETED|Overall Study||36||
48286649|NCT01546636|101026362|FG001|COMPLETED|Overall Study||34||
48286650|NCT01546636|101026361|FG000|NOT COMPLETED|Overall Study||0||
48286651|NCT01546636|101026362|FG001|NOT COMPLETED|Overall Study||0||
48286652|NCT05462886|101026363|FG000|STARTED|Overall Study||86||
48578705|NCT00693498|101747786|FG000|NOT COMPLETED|Overall Study||0||
48578706|NCT00693498|101747787|FG001|NOT COMPLETED|Overall Study||0||
48578707|NCT01020006|101747788|FG000|STARTED|Overall Study||8||
48578708|NCT01020006|101747789|FG001|STARTED|Overall Study||18||
48578709|NCT01020006|101747790|FG002|STARTED|Overall Study||16||
48578710|NCT01020006|101747788|FG000|COMPLETED|Overall Study||0||
48286653|NCT05462886|101026363|FG000|COMPLETED|Overall Study||79||
48578711|NCT01020006|101747789|FG001|COMPLETED|Overall Study||0||
48578712|NCT01020006|101747790|FG002|COMPLETED|Overall Study||0||
48578713|NCT01020006|101747788|FG000|NOT COMPLETED|Overall Study||8||
48286654|NCT05462886|101026363|FG000|NOT COMPLETED|Overall Study||7||
48286655|NCT00974376|101026364|FG000|STARTED|Overall Study||75||
48286656|NCT00974376|101026365|FG001|STARTED|Overall Study||75||
48578714|NCT01020006|101747789|FG001|NOT COMPLETED|Overall Study||18||
48578715|NCT01020006|101747790|FG002|NOT COMPLETED|Overall Study||16||
48578716|NCT01711372|101747791|FG000|STARTED|Overall Study||66||
48578717|NCT01711372|101747792|FG001|STARTED|Overall Study||47||
48578718|NCT01711372|101747791|FG000|COMPLETED|Overall Study||66||
48578719|NCT01711372|101747792|FG001|COMPLETED|Overall Study||47||
48578720|NCT01711372|101747791|FG000|NOT COMPLETED|Overall Study||0||
48578721|NCT01711372|101747792|FG001|NOT COMPLETED|Overall Study||0||
48578722|NCT02865499|101747793|FG000|STARTED|Baseline||8||
48578723|NCT02865499|101747793|FG000|COMPLETED|Baseline||6||
48578724|NCT02865499|101747793|FG000|NOT COMPLETED|Baseline||2||
48578725|NCT02865499|101747793|FG000|STARTED|8 Weeks||6||
48578726|NCT02865499|101747793|FG000|COMPLETED|8 Weeks||6||
48134086|NCT01782131|100651403|FG001|Treated|Overall Study||287||
48134087|NCT01782131|100651402|FG000|COMPLETED|Overall Study||184||
48134088|NCT01782131|100651403|FG001|COMPLETED|Overall Study||177||
48578727|NCT02865499|101747793|FG000|NOT COMPLETED|8 Weeks||0||
48578728|NCT02865499|101747793|FG000|STARTED|12 Weeks||6||
48578729|NCT02865499|101747793|FG000|COMPLETED|12 Weeks||6||
48286657|NCT00974376|101026364|FG000|COMPLETED|Overall Study||41||
48286658|NCT00974376|101026365|FG001|COMPLETED|Overall Study||42||
48286659|NCT00974376|101026364|FG000|NOT COMPLETED|Overall Study||34||
48286660|NCT00974376|101026365|FG001|NOT COMPLETED|Overall Study||33||
48578730|NCT02865499|101747793|FG000|NOT COMPLETED|12 Weeks||0||
48578731|NCT00959374|101747794|FG000|STARTED|Overall Study||241||
48578732|NCT00959374|101747794|FG000|COMPLETED|Overall Study||218||
48578733|NCT00959374|101747794|FG000|NOT COMPLETED|Overall Study||23||
48578734|NCT00756561|101747795|FG000|STARTED|Overall Study||10||
48578735|NCT00756561|101747795|FG000|COMPLETED|Overall Study||10||
48578736|NCT00756561|101747795|FG000|NOT COMPLETED|Overall Study||0||
48578737|NCT02702388|101747796|FG000|STARTED|Overall Study||75||
48578738|NCT02702388|101747797|FG001|STARTED|Overall Study||77||
48578739|NCT02702388|101747796|FG000|COMPLETED|Overall Study||35||
48578740|NCT02702388|101747797|FG001|COMPLETED|Overall Study||26||
48578741|NCT02702388|101747796|FG000|NOT COMPLETED|Overall Study||40||
48578742|NCT02702388|101747797|FG001|NOT COMPLETED|Overall Study||51||
48703444|NCT00090142|102060509|FG001|COMPLETED|Treatment Period II||28||
48703445|NCT00090142|102060508|FG000|NOT COMPLETED|Treatment Period II||1||
48134089|NCT01782131|100651402|FG000|NOT COMPLETED|Overall Study||109||
48134090|NCT01782131|100651403|FG001|NOT COMPLETED|Overall Study||115||
48134091|NCT00566228|100651404|FG000|STARTED|Overall Study||62||
48134092|NCT00566228|100651405|FG001|STARTED|Overall Study||60||
48286661|NCT00370682|101026366|FG000|STARTED|Overall Study||40||
48286662|NCT00370682|101026367|FG001|STARTED|Overall Study||40||
48286663|NCT00370682|101026368|FG002|STARTED|Overall Study||40||
48286664|NCT00370682|101026366|FG000|COMPLETED|Overall Study||40||
48286665|NCT00370682|101026367|FG001|COMPLETED|Overall Study||37||
48286666|NCT00370682|101026368|FG002|COMPLETED|Overall Study||39||
48286667|NCT00370682|101026366|FG000|NOT COMPLETED|Overall Study||0||
48286668|NCT00370682|101026367|FG001|NOT COMPLETED|Overall Study||3||
48286669|NCT00370682|101026368|FG002|NOT COMPLETED|Overall Study||1||
48286670|NCT02121301|101026369|FG000|STARTED|Overall Study||30||
48286671|NCT02121301|101026370|FG001|STARTED|Overall Study||30||
48578743|NCT01841762|101747798|FG000|STARTED|Screening Period||335||
48578744|NCT01841762|101747798|FG000|COMPLETED|Screening Period||284||
48578745|NCT01841762|101747798|FG000|NOT COMPLETED|Screening Period||51||
48578746|NCT01841762|101747798|FG000|STARTED|Treatment Period||284||
48578747|NCT01841762|101747798|FG000|COMPLETED|Treatment Period||252||
48578748|NCT01841762|101747798|FG000|NOT COMPLETED|Treatment Period||32||
48578749|NCT01841762|101747798|FG000|STARTED|Post-Treatment Safety Follow-Up Period||284||
48578750|NCT01841762|101747798|FG000|COMPLETED|Post-Treatment Safety Follow-Up Period||269||
48578751|NCT01841762|101747798|FG000|NOT COMPLETED|Post-Treatment Safety Follow-Up Period||15||
48578752|NCT04532619|101747799|FG000|STARTED|Overall Study||21||
48703446|NCT00090142|102060509|FG001|NOT COMPLETED|Treatment Period II||0||
48703447|NCT00368836|102060510|FG000|STARTED|Phase II||350||
48703448|NCT00368836|102060510|FG000|COMPLETED|Phase II||329||
48703449|NCT00368836|102060510|FG000|NOT COMPLETED|Phase II||21||
48703450|NCT00368836|102060510|FG000|STARTED|Phase I Pre-op/Post-op||125||
48703451|NCT00368836|102060510|FG000|COMPLETED|Phase I Pre-op/Post-op||104||
48703452|NCT00368836|102060510|FG000|NOT COMPLETED|Phase I Pre-op/Post-op||21||
48134093|NCT00566228|100651404|FG000|COMPLETED|Overall Study||56||
48134094|NCT00566228|100651405|FG001|COMPLETED|Overall Study||55||
48134095|NCT00566228|100651404|FG000|NOT COMPLETED|Overall Study||6||
48134096|NCT00566228|100651405|FG001|NOT COMPLETED|Overall Study||5||
48134097|NCT04313634|100651406|FG000|STARTED|Overall Study||30||
48134098|NCT04313634|100651407|FG001|STARTED|Overall Study||14||
48134099|NCT04313634|100651408|FG002|STARTED|Overall Study||30||
48286672|NCT02121301|101026371|FG002|STARTED|Overall Study||31||
48286673|NCT02121301|101026369|FG000|COMPLETED|Overall Study||29||
48286674|NCT02121301|101026370|FG001|COMPLETED|Overall Study||26||
48578753|NCT04532619|101747800|FG001|STARTED|Overall Study||20||
48578754|NCT04532619|101747799|FG000|COMPLETED|Overall Study||18||
48578755|NCT04532619|101747800|FG001|COMPLETED|Overall Study||19||
48578756|NCT04532619|101747799|FG000|NOT COMPLETED|Overall Study||3||
48578757|NCT04532619|101747800|FG001|NOT COMPLETED|Overall Study||1||
48578758|NCT02207803|101747801|FG000|STARTED|Overall Study||125||
48703453|NCT01960998|102060511|FG000|STARTED|Overall Study||101||
48134100|NCT04313634|100651406|FG000|COMPLETED|Overall Study||27||
48134101|NCT04313634|100651407|FG001|COMPLETED|Overall Study||12||
48134102|NCT04313634|100651408|FG002|COMPLETED|Overall Study||28||
48134103|NCT04313634|100651406|FG000|NOT COMPLETED|Overall Study||3||
48134104|NCT04313634|100651407|FG001|NOT COMPLETED|Overall Study||2||
48134105|NCT04313634|100651408|FG002|NOT COMPLETED|Overall Study||2||
48134106|NCT01793792|100651409|FG000|STARTED|Overall Study||153||
48134107|NCT01793792|100651409|FG000|Treated|Overall Study||153||
48134108|NCT01793792|100651409|FG000|COMPLETED|Overall Study||141||
48134109|NCT01793792|100651409|FG000|NOT COMPLETED|Overall Study||12||
48134110|NCT02624804|100651410|FG000|STARTED|Overall Study||13||
48134111|NCT02624804|100651410|FG000|COMPLETED|Overall Study||8||
48134112|NCT02624804|100651410|FG000|NOT COMPLETED|Overall Study||5||
48134113|NCT03223298|100651411|FG000|STARTED|Overall Study||38||
48134114|NCT03223298|100651412|FG001|STARTED|Overall Study||37||
48134115|NCT03223298|100651411|FG000|Pre-op|Overall Study||38||
48134116|NCT03223298|100651412|FG001|Pre-op|Overall Study||37||
48134117|NCT03223298|100651411|FG000|Month 1 Post-op|Overall Study||34||
48134118|NCT03223298|100651412|FG001|Month 1 Post-op|Overall Study||32||
48134119|NCT03223298|100651411|FG000|Month 2 Post-op|Overall Study||22||
48134120|NCT03223298|100651412|FG001|Month 2 Post-op|Overall Study||28||
48134121|NCT03223298|100651411|FG000|Month 3 Post-op|Overall Study||23||
48134122|NCT03223298|100651412|FG001|Month 3 Post-op|Overall Study||27||
48134123|NCT03223298|100651411|FG000|COMPLETED|Overall Study||23||
48134124|NCT03223298|100651412|FG001|COMPLETED|Overall Study||27||
48134125|NCT03223298|100651411|FG000|NOT COMPLETED|Overall Study||15||
48134126|NCT03223298|100651412|FG001|NOT COMPLETED|Overall Study||10||
48134127|NCT04307186|100651413|FG000|STARTED|Period 1 - Gadobutrol||57||
48134128|NCT04307186|100651413|FG000|COMPLETED|Period 1 - Gadobutrol||56||
48134129|NCT04307186|100651413|FG000|NOT COMPLETED|Period 1 - Gadobutrol||1||
48134130|NCT04307186|100651413|FG000|STARTED|Washout 3-14 Days||56||
48134131|NCT04307186|100651413|FG000|COMPLETED|Washout 3-14 Days||53||
48134132|NCT04307186|100651413|FG000|NOT COMPLETED|Washout 3-14 Days||3||
48134133|NCT04307186|100651413|FG000|STARTED|Period 2 - Gadoquatrane||53||
48134134|NCT04307186|100651413|FG000|COMPLETED|Period 2 - Gadoquatrane||52||
48134135|NCT04307186|100651413|FG000|NOT COMPLETED|Period 2 - Gadoquatrane||1||
48134136|NCT01367262|100651414|FG000|STARTED|Overall Study||6||
48134137|NCT01367262|100651414|FG000|COMPLETED|Overall Study||6||
48134138|NCT01367262|100651414|FG000|NOT COMPLETED|Overall Study||0||
48134139|NCT03434119|100651415|FG000|STARTED|Overall Study||116||
48134140|NCT03434119|100651416|FG001|STARTED|Overall Study||125||
48134141|NCT03434119|100651415|FG000|Treated|Overall Study||115||
48134142|NCT03434119|100651416|FG001|Treated|Overall Study||125||
48134143|NCT03434119|100651415|FG000|COMPLETED|Overall Study||9||
48134144|NCT03434119|100651416|FG001|COMPLETED|Overall Study||12||
48134145|NCT03434119|100651415|FG000|NOT COMPLETED|Overall Study||107||
48134146|NCT03434119|100651416|FG001|NOT COMPLETED|Overall Study||113||
48134147|NCT03376321|100651417|FG000|STARTED|Overall Study||168||
48134148|NCT03376321|100651418|FG001|STARTED|Overall Study||166||
48134149|NCT03376321|100651417|FG000|Treated|Overall Study||163||
48134150|NCT03376321|100651418|FG001|Treated|Overall Study||163||
48134151|NCT03376321|100651417|FG000|COMPLETED|Overall Study||145||
48134152|NCT03376321|100651418|FG001|COMPLETED|Overall Study||141||
48134153|NCT03376321|100651417|FG000|NOT COMPLETED|Overall Study||23||
48134154|NCT03376321|100651418|FG001|NOT COMPLETED|Overall Study||25||
48134155|NCT00464542|100651419|FG000|STARTED|Pre-treatment||12||
48134156|NCT00464542|100651419|FG000|COMPLETED|Pre-treatment||10||
48134157|NCT00464542|100651419|FG000|NOT COMPLETED|Pre-treatment||2||
48134158|NCT00464542|100651419|FG000|STARTED|Post-treatment||10||
48134159|NCT00464542|100651419|FG000|COMPLETED|Post-treatment||10||
48134160|NCT00464542|100651419|FG000|NOT COMPLETED|Post-treatment||0||
48134161|NCT00388414|100651420|FG000|STARTED|First Intervention (8 Weeks)||7||
48134162|NCT00388414|100651421|FG001|STARTED|First Intervention (8 Weeks)||7||
48134163|NCT00388414|100651420|FG000|COMPLETED|First Intervention (8 Weeks)||7||
48134164|NCT00388414|100651421|FG001|COMPLETED|First Intervention (8 Weeks)||7||
48134165|NCT00388414|100651420|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0||
48134166|NCT00388414|100651421|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0||
48134167|NCT00388414|100651420|FG000|STARTED|Washout (1 Week)||7||
48134168|NCT00388414|100651421|FG001|STARTED|Washout (1 Week)||7||
48134169|NCT00388414|100651420|FG000|COMPLETED|Washout (1 Week)||7||
48134170|NCT00388414|100651421|FG001|COMPLETED|Washout (1 Week)||7||
48134171|NCT00388414|100651420|FG000|NOT COMPLETED|Washout (1 Week)||0||
48134172|NCT00388414|100651421|FG001|NOT COMPLETED|Washout (1 Week)||0||
48134173|NCT00388414|100651420|FG000|STARTED|Second Intervention (8 Weeks)||7||
48134174|NCT00388414|100651421|FG001|STARTED|Second Intervention (8 Weeks)||7||
48134175|NCT00388414|100651420|FG000|COMPLETED|Second Intervention (8 Weeks)||7||
48134176|NCT00388414|100651421|FG001|COMPLETED|Second Intervention (8 Weeks)||7||
48134177|NCT00388414|100651420|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0||
48134178|NCT00388414|100651421|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0||
48134179|NCT02854540|100651422|FG000|STARTED|Overall Study||13||
48134180|NCT02854540|100651422|FG000|COMPLETED|Overall Study||11||
48134181|NCT02854540|100651422|FG000|NOT COMPLETED|Overall Study||2||
48134182|NCT03646513|100651423|FG000|STARTED|Overall Study||4||
48134183|NCT03646513|100651423|FG000|COMPLETED|Overall Study||0||
48134184|NCT03646513|100651423|FG000|NOT COMPLETED|Overall Study||4||
48134185|NCT02493127|100651424|FG000|STARTED|Overall Study||61||
48134186|NCT02493127|100651425|FG001|STARTED|Overall Study||61||
48134187|NCT02493127|100651424|FG000|COMPLETED|Overall Study||60||
48134188|NCT02493127|100651425|FG001|COMPLETED|Overall Study||60||
48134189|NCT02493127|100651424|FG000|NOT COMPLETED|Overall Study||1||
48134190|NCT02493127|100651425|FG001|NOT COMPLETED|Overall Study||1||
48134191|NCT04642638|100651426|FG000|STARTED|Overall Study||151||
48134192|NCT04642638|100651427|FG001|STARTED|Overall Study||149||
48134193|NCT04642638|100651428|FG002|STARTED|Overall Study||50||
48134194|NCT04642638|100651429|FG003|STARTED|Overall Study||51||
48134195|NCT04642638|100651430|FG004|STARTED|Overall Study||603||
48134196|NCT04642638|100651431|FG005|STARTED|Overall Study||303||
48134197|NCT04642638|100651426|FG000|Intention-to-treat (ITT) Population|Overall Study||151|ITT population included all participants who were randomized.|
48134198|NCT04642638|100651427|FG001|Intention-to-treat (ITT) Population|Overall Study||149|ITT population included all participants who were randomized.|
48286675|NCT02121301|101026371|FG002|COMPLETED|Overall Study||30||
48286676|NCT02121301|101026369|FG000|NOT COMPLETED|Overall Study||1||
48286677|NCT02121301|101026370|FG001|NOT COMPLETED|Overall Study||4||
48286678|NCT02121301|101026371|FG002|NOT COMPLETED|Overall Study||1||
48286679|NCT00440999|101026372|FG000|STARTED|Overall Study||228||
48286680|NCT00440999|101026373|FG001|STARTED|Overall Study||228||
48286681|NCT00440999|101026372|FG000|COMPLETED|Overall Study||193||
48286682|NCT00440999|101026373|FG001|COMPLETED|Overall Study||187||
48286683|NCT00440999|101026372|FG000|NOT COMPLETED|Overall Study||35||
48286684|NCT00440999|101026373|FG001|NOT COMPLETED|Overall Study||41||
48286685|NCT01028027|101026374|FG000|STARTED|Overall Study||180||
48286686|NCT01028027|101026375|FG001|STARTED|Overall Study||177||
48286687|NCT01028027|101026374|FG000|COMPLETED|Overall Study||164||
48286688|NCT01028027|101026375|FG001|COMPLETED|Overall Study||164||
48286689|NCT01028027|101026374|FG000|NOT COMPLETED|Overall Study||16||
48286690|NCT01028027|101026375|FG001|NOT COMPLETED|Overall Study||13||
48134199|NCT04642638|100651428|FG002|Intention-to-treat (ITT) Population|Overall Study||50|ITT population included all participants who were randomized.|
48286691|NCT01390077|101026376|FG000|STARTED|Overall Study||8||
48286692|NCT01390077|101026376|FG000|Treatment|Overall Study||7||
48286693|NCT01390077|101026376|FG000|COMPLETED|Overall Study||7||
48286694|NCT01390077|101026376|FG000|NOT COMPLETED|Overall Study||1||
48286695|NCT02319759|101026377|FG000|STARTED|Week 0 - 16||49||
48286696|NCT02319759|101026378|FG001|STARTED|Week 0 - 16||0||
48286697|NCT02319759|101026379|FG002|STARTED|Week 0 - 16||100||
48400121|NCT03984812|101309288|FG004|NOT COMPLETED|Part 2 (Up to Day 49)||0||
48578759|NCT02207803|101747802|FG001|STARTED|Overall Study||125||
48134200|NCT04642638|100651429|FG003|Intention-to-treat (ITT) Population|Overall Study||51|ITT population included all participants who were randomized.|
48134201|NCT04642638|100651430|FG004|Intention-to-treat (ITT) Population|Overall Study||603|ITT population included all participants who were randomized.|
48134202|NCT04642638|100651431|FG005|Intention-to-treat (ITT) Population|Overall Study||303|ITT population included all participants who were randomized.|
48134203|NCT04642638|100651426|FG000|Per Protocol (PP) Population|Overall Study||141|PP population included all participants who received all doses of the trial intervention and had no key protocol violations.|
48134204|NCT04642638|100651427|FG001|Per Protocol (PP) Population|Overall Study||130|PP population included all participants who received all doses of the trial intervention and had no key protocol violations.|
48134205|NCT04642638|100651428|FG002|Per Protocol (PP) Population|Overall Study||47|PP population included all participants who received all doses of the trial intervention and had no key protocol violations.|
48141444|NCT01780922|100670425|FG002|STARTED|Washout (7 Days)||2||
48141445|NCT01780922|100670426|FG003|STARTED|Washout (7 Days)||2||
48286698|NCT02319759|101026380|FG003|STARTED|Week 0 - 16||0||
48286699|NCT02319759|101026381|FG004|STARTED|Week 0 - 16||0||
48286700|NCT02319759|101026377|FG000|COMPLETED|Week 0 - 16||48||
48286701|NCT02319759|101026378|FG001|COMPLETED|Week 0 - 16||0||
48286702|NCT02319759|101026379|FG002|COMPLETED|Week 0 - 16||99||
48286703|NCT02319759|101026380|FG003|COMPLETED|Week 0 - 16||0||
48286704|NCT02319759|101026381|FG004|COMPLETED|Week 0 - 16||0||
48286705|NCT02319759|101026377|FG000|NOT COMPLETED|Week 0 - 16||1||
48286706|NCT02319759|101026378|FG001|NOT COMPLETED|Week 0 - 16||0||
48286707|NCT02319759|101026379|FG002|NOT COMPLETED|Week 0 - 16||1||
48286708|NCT02319759|101026380|FG003|NOT COMPLETED|Week 0 - 16||0||
48286709|NCT02319759|101026381|FG004|NOT COMPLETED|Week 0 - 16||0||
48286710|NCT02319759|101026377|FG000|STARTED|Week 16 - 24||31||
48286711|NCT02319759|101026378|FG001|STARTED|Week 16 - 24||0||
48286712|NCT02319759|101026379|FG002|STARTED|Week 16 - 24||89||
48286713|NCT02319759|101026380|FG003|STARTED|Week 16 - 24||17||
48286714|NCT02319759|101026381|FG004|STARTED|Week 16 - 24||10||
48286715|NCT02319759|101026377|FG000|COMPLETED|Week 16 - 24||29||
48286716|NCT02319759|101026378|FG001|COMPLETED|Week 16 - 24||0||
48286717|NCT02319759|101026379|FG002|COMPLETED|Week 16 - 24||86||
48286718|NCT02319759|101026380|FG003|COMPLETED|Week 16 - 24||17||
48286719|NCT02319759|101026381|FG004|COMPLETED|Week 16 - 24||10||
48286720|NCT02319759|101026377|FG000|NOT COMPLETED|Week 16 - 24||2||
48286721|NCT02319759|101026378|FG001|NOT COMPLETED|Week 16 - 24||0||
48400122|NCT03984812|101309289|FG005|NOT COMPLETED|Part 2 (Up to Day 49)||0||
48400123|NCT03984812|101309290|FG006|NOT COMPLETED|Part 2 (Up to Day 49)||0||
48703454|NCT01960998|102060512|FG001|STARTED|Overall Study||96||
48703455|NCT01960998|102060511|FG000|COMPLETED|Overall Study||90||
48134206|NCT04642638|100651429|FG003|Per Protocol (PP) Population|Overall Study||48|PP population included all participants who received all doses of the trial intervention and had no key protocol violations.|
48134207|NCT04642638|100651430|FG004|Per Protocol (PP) Population|Overall Study||507|PP population included all participants who received all doses of the trial intervention and had no key protocol violations.|
48134208|NCT04642638|100651431|FG005|Per Protocol (PP) Population|Overall Study||261|PP population included all participants who received all doses of the trial intervention and had no key protocol violations.|
48134209|NCT04642638|100651426|FG000|Safety Population|Overall Study||151|Safety population included all participants who received at least 1 dose of the trial intervention.|
48134210|NCT04642638|100651427|FG001|Safety Population|Overall Study||147|Safety population included all participants who received at least 1 dose of the trial intervention.|
48134211|NCT04642638|100651428|FG002|Safety Population|Overall Study||50|Safety population included all participants who received at least 1 dose of the trial intervention.|
48134212|NCT04642638|100651429|FG003|Safety Population|Overall Study||51|Safety population included all participants who received at least 1 dose of the trial intervention.|
48134213|NCT04642638|100651430|FG004|Safety Population|Overall Study||601|Safety population included all participants who received at least 1 dose of the trial intervention.|
48134214|NCT04642638|100651431|FG005|Safety Population|Overall Study||302|Safety population included all participants who received at least 1 dose of the trial intervention.|
48134215|NCT04642638|100651426|FG000|COMPLETED|Overall Study||110||
48134216|NCT04642638|100651427|FG001|COMPLETED|Overall Study||98||
48134217|NCT04642638|100651428|FG002|COMPLETED|Overall Study||35||
48134218|NCT04642638|100651429|FG003|COMPLETED|Overall Study||39||
48134219|NCT04642638|100651430|FG004|COMPLETED|Overall Study||0||
48134220|NCT04642638|100651431|FG005|COMPLETED|Overall Study||0||
48134221|NCT04642638|100651426|FG000|NOT COMPLETED|Overall Study||41||
48134222|NCT04642638|100651427|FG001|NOT COMPLETED|Overall Study||51||
48134223|NCT04642638|100651428|FG002|NOT COMPLETED|Overall Study||15||
48134224|NCT04642638|100651429|FG003|NOT COMPLETED|Overall Study||12||
48134225|NCT04642638|100651430|FG004|NOT COMPLETED|Overall Study||603||
48134226|NCT04642638|100651431|FG005|NOT COMPLETED|Overall Study||303||
48134227|NCT00986999|100651432|FG000|STARTED|Overall Study||7||
48134228|NCT00986999|100651432|FG000|COMPLETED|Overall Study||6||
48134229|NCT00986999|100651432|FG000|NOT COMPLETED|Overall Study||1||
48134230|NCT01934218|100651433|FG000|STARTED|Double-blind Phase||404||
48134231|NCT01934218|100651434|FG001|STARTED|Double-blind Phase||410||
48134232|NCT01934218|100651433|FG000|Analyzed Participants|Double-blind Phase||402|5 subjects removed from ITT analyses because of no post treatment data. (Pre-defined)|
48134233|NCT01934218|100651434|FG001|Analyzed Participants|Double-blind Phase||407|5 subjects removed from ITT analyses because of no post treatment data. (Pre-defined)|
48134234|NCT01934218|100651433|FG000|COMPLETED|Double-blind Phase||356||
48134235|NCT01934218|100651434|FG001|COMPLETED|Double-blind Phase||356||
48134236|NCT01934218|100651433|FG000|NOT COMPLETED|Double-blind Phase||48||
48134237|NCT01934218|100651434|FG001|NOT COMPLETED|Double-blind Phase||54||
48134238|NCT01934218|100651433|FG000|STARTED|Open-Label Phase||316||
48134239|NCT01934218|100651434|FG001|STARTED|Open-Label Phase||328||
48134240|NCT01934218|100651433|FG000|COMPLETED|Open-Label Phase||290||
48134241|NCT01934218|100651434|FG001|COMPLETED|Open-Label Phase||304||
48134242|NCT01934218|100651433|FG000|NOT COMPLETED|Open-Label Phase||26||
48134243|NCT01934218|100651434|FG001|NOT COMPLETED|Open-Label Phase||24||
48134244|NCT00524134|100651435|FG000|STARTED|Overall Study||6||
48134245|NCT00524134|100651435|FG000|COMPLETED|Overall Study||4||
48134246|NCT00524134|100651435|FG000|NOT COMPLETED|Overall Study||2||
48134247|NCT00467870|100651436|FG000|STARTED|Overall Study||120||
48134248|NCT00467870|100651437|FG001|STARTED|Overall Study||117||
48134249|NCT00467870|100651438|FG002|STARTED|Overall Study||22||
48134250|NCT00467870|100651439|FG003|STARTED|Overall Study||112||
48134251|NCT00467870|100651440|FG004|STARTED|Overall Study||130||
48134252|NCT00467870|100651441|FG005|STARTED|Overall Study||23||
48134253|NCT00467870|100651436|FG000|COMPLETED|Overall Study||75||
48134254|NCT00467870|100651437|FG001|COMPLETED|Overall Study||74||
48134255|NCT00467870|100651438|FG002|COMPLETED|Overall Study||18||
48134256|NCT00467870|100651439|FG003|COMPLETED|Overall Study||79||
48134257|NCT00467870|100651440|FG004|COMPLETED|Overall Study||93||
48134258|NCT00467870|100651441|FG005|COMPLETED|Overall Study||21||
48134259|NCT00467870|100651436|FG000|NOT COMPLETED|Overall Study||45||
48134260|NCT00467870|100651437|FG001|NOT COMPLETED|Overall Study||43||
48134261|NCT00467870|100651438|FG002|NOT COMPLETED|Overall Study||4||
48134262|NCT00467870|100651439|FG003|NOT COMPLETED|Overall Study||33||
48134263|NCT00467870|100651440|FG004|NOT COMPLETED|Overall Study||37||
48134264|NCT00467870|100651441|FG005|NOT COMPLETED|Overall Study||2||
48703456|NCT01960998|102060512|FG001|COMPLETED|Overall Study||85||
48134265|NCT04458948|100651442|FG000|STARTED|Overall Study||28||
48134266|NCT04458948|100651442|FG000|COMPLETED|Overall Study||0||
48134267|NCT04458948|100651442|FG000|NOT COMPLETED|Overall Study||28||
48134268|NCT02896855|100651443|FG000|STARTED|Overall Study||121|Intent-to-Treat (ITT) Population|
48134269|NCT02896855|100651444|FG001|STARTED|Overall Study||122|Intent-to-Treat (ITT) Population|
48134270|NCT02896855|100651443|FG000|Received Any Study Treatment|Overall Study||120|Safety Population|
48141446|NCT01780922|100670427|FG004|STARTED|Washout (7 Days)||2||
48703457|NCT01960998|102060511|FG000|NOT COMPLETED|Overall Study||11||
48400124|NCT03984812|101309291|FG007|NOT COMPLETED|Part 2 (Up to Day 49)||0||
48400125|NCT03984812|101309292|FG008|NOT COMPLETED|Part 2 (Up to Day 49)||0||
48400126|NCT03984812|101309293|FG009|NOT COMPLETED|Part 2 (Up to Day 49)||0||
48400127|NCT03984812|101309294|FG010|NOT COMPLETED|Part 2 (Up to Day 49)||0||
48400128|NCT01855425|101309295|FG000|STARTED|Overall Study||96||
48400129|NCT01855425|101309295|FG000|COMPLETED|Overall Study||76||
48400130|NCT01855425|101309295|FG000|NOT COMPLETED|Overall Study||20||
48400131|NCT00081328|101309296|FG000|STARTED|Overall Study||232||
48134271|NCT02896855|100651444|FG001|Received Any Study Treatment|Overall Study||122|Safety Population|
48134272|NCT02896855|100651443|FG000|Crossed Over From Placebo to Receive Pertuzumab|Overall Study||12||
48134273|NCT02896855|100651444|FG001|Crossed Over From Placebo to Receive Pertuzumab|Overall Study||0||
48134274|NCT02896855|100651443|FG000|COMPLETED|Overall Study||49||
48134275|NCT02896855|100651444|FG001|COMPLETED|Overall Study||69||
48134276|NCT02896855|100651443|FG000|NOT COMPLETED|Overall Study||72||
48134277|NCT02896855|100651444|FG001|NOT COMPLETED|Overall Study||53||
48134278|NCT03809182|100651445|FG000|STARTED|Overall Study||20||
48134279|NCT03809182|100651446|FG001|STARTED|Overall Study||20||
48134280|NCT03809182|100651445|FG000|COMPLETED|Overall Study||20||
48134281|NCT03809182|100651446|FG001|COMPLETED|Overall Study||20||
48134282|NCT03809182|100651445|FG000|NOT COMPLETED|Overall Study||0||
48134283|NCT03809182|100651446|FG001|NOT COMPLETED|Overall Study||0||
48134284|NCT00563784|100651447|FG000|STARTED|Overall Study||68||
48134285|NCT00563784|100651447|FG000|COMPLETED|Overall Study||46||
48134286|NCT00563784|100651447|FG000|NOT COMPLETED|Overall Study||22||
48134287|NCT01773226|100651448|FG000|STARTED|Overall Study||11||
48400132|NCT00081328|101309297|FG001|STARTED|Overall Study||233||
48578760|NCT02207803|101747801|FG000|COMPLETED|Overall Study||110||
48134288|NCT01773226|100651448|FG000|COMPLETED|Overall Study||10||
48134289|NCT01773226|100651448|FG000|NOT COMPLETED|Overall Study||1||
48134290|NCT03085563|100651449|FG000|STARTED|Overall Study||19||
48134291|NCT03085563|100651450|FG001|STARTED|Overall Study||41||
48134292|NCT03085563|100651449|FG000|COMPLETED|Overall Study||19||
48134293|NCT03085563|100651450|FG001|COMPLETED|Overall Study||41||
48134294|NCT03085563|100651449|FG000|NOT COMPLETED|Overall Study||0||
48134295|NCT03085563|100651450|FG001|NOT COMPLETED|Overall Study||0||
48134296|NCT01800877|100651451|FG000|STARTED|Overall Study||60||
48134297|NCT01800877|100651452|FG001|STARTED|Overall Study||60||
48134298|NCT01800877|100651451|FG000|COMPLETED|Overall Study||58||
48134299|NCT01800877|100651452|FG001|COMPLETED|Overall Study||60||
48134300|NCT01800877|100651451|FG000|NOT COMPLETED|Overall Study||2||
48134301|NCT01800877|100651452|FG001|NOT COMPLETED|Overall Study||0||
48134302|NCT04198662|100651453|FG000|STARTED|Overall Study||11||
48134303|NCT04198662|100651454|FG001|STARTED|Overall Study||9||
48134304|NCT04198662|100651453|FG000|COMPLETED|Overall Study||11||
48134305|NCT04198662|100651454|FG001|COMPLETED|Overall Study||9||
48400133|NCT00081328|101309298|FG002|STARTED|Overall Study||234||
48400134|NCT00081328|101309296|FG000|COMPLETED|Overall Study||232||
48400135|NCT00081328|101309297|FG001|COMPLETED|Overall Study||233||
48400136|NCT00081328|101309298|FG002|COMPLETED|Overall Study||234||
48400137|NCT00081328|101309296|FG000|NOT COMPLETED|Overall Study||0||
48400138|NCT00081328|101309297|FG001|NOT COMPLETED|Overall Study||0||
48134306|NCT04198662|100651453|FG000|NOT COMPLETED|Overall Study||0||
48134307|NCT04198662|100651454|FG001|NOT COMPLETED|Overall Study||0||
48134308|NCT01306162|100651455|FG000|STARTED|Period 1||9||
48134309|NCT01306162|100651456|FG001|STARTED|Period 1||9||
48400139|NCT00081328|101309298|FG002|NOT COMPLETED|Overall Study||0||
48400140|NCT01661946|101309299|FG000|STARTED|Overall Study||5||
48400141|NCT01661946|101309300|FG001|STARTED|Overall Study||5||
48400142|NCT01661946|101309299|FG000|COMPLETED|Overall Study||5||
48400143|NCT01661946|101309300|FG001|COMPLETED|Overall Study||5||
48400144|NCT01661946|101309299|FG000|NOT COMPLETED|Overall Study||0||
48400145|NCT01661946|101309300|FG001|NOT COMPLETED|Overall Study||0||
48400146|NCT01712776|101309301|FG000|STARTED|Overall Study||50||
48400147|NCT01712776|101309302|FG001|STARTED|Overall Study||50||
48400148|NCT01712776|101309301|FG000|COMPLETED|Overall Study||50||
48400149|NCT01712776|101309302|FG001|COMPLETED|Overall Study||50||
48400150|NCT01712776|101309301|FG000|NOT COMPLETED|Overall Study||0||
48400151|NCT01712776|101309302|FG001|NOT COMPLETED|Overall Study||0||
48400152|NCT03947255|101309303|FG000|STARTED|Overall Study||6||
48400153|NCT03947255|101309304|FG001|STARTED|Overall Study||6||
48400154|NCT03947255|101309303|FG000|COMPLETED|Overall Study||0||
48400155|NCT03947255|101309304|FG001|COMPLETED|Overall Study||0||
48400156|NCT03947255|101309303|FG000|NOT COMPLETED|Overall Study||6||
48400157|NCT03947255|101309304|FG001|NOT COMPLETED|Overall Study||6||
48400158|NCT02517268|101309305|FG000|STARTED|Overall Study||40||
48400159|NCT02517268|101309306|FG001|STARTED|Overall Study||37||
48400160|NCT02517268|101309305|FG000|COMPLETED|Overall Study||39||
48400161|NCT02517268|101309306|FG001|COMPLETED|Overall Study||37||
48400162|NCT02517268|101309305|FG000|NOT COMPLETED|Overall Study||1||
48400163|NCT02517268|101309306|FG001|NOT COMPLETED|Overall Study||0||
48400164|NCT01324128|101309307|FG000|STARTED|Stage 1||710||
48400165|NCT01324128|101309308|FG001|STARTED|Stage 1||349||
48400166|NCT01324128|101309309|FG002|STARTED|Stage 1||0||
48134310|NCT01306162|100651457|FG002|STARTED|Period 1||9||
48134311|NCT01306162|100651458|FG003|STARTED|Period 1||9||
48703458|NCT01960998|102060512|FG001|NOT COMPLETED|Overall Study||11||
48134312|NCT01306162|100651455|FG000|COMPLETED|Period 1||9||
48134313|NCT01306162|100651456|FG001|COMPLETED|Period 1||9||
48134314|NCT01306162|100651457|FG002|COMPLETED|Period 1||9||
48400167|NCT01324128|101309310|FG003|STARTED|Stage 1||0||
48578761|NCT02207803|101747802|FG001|COMPLETED|Overall Study||108||
48703459|NCT02152371|102060513|FG000|STARTED|Overall Study||150||
48703460|NCT02152371|102060514|FG001|STARTED|Overall Study||150||
48134315|NCT01306162|100651458|FG003|COMPLETED|Period 1||8||
48134316|NCT01306162|100651455|FG000|NOT COMPLETED|Period 1||0||
48134317|NCT01306162|100651456|FG001|NOT COMPLETED|Period 1||0||
48134318|NCT01306162|100651457|FG002|NOT COMPLETED|Period 1||0||
48134319|NCT01306162|100651458|FG003|NOT COMPLETED|Period 1||1||
48134320|NCT01306162|100651455|FG000|STARTED|Washout 1||9||
48134321|NCT01306162|100651456|FG001|STARTED|Washout 1||9||
48134322|NCT01306162|100651457|FG002|STARTED|Washout 1||9||
48134323|NCT01306162|100651458|FG003|STARTED|Washout 1||8||
48134324|NCT01306162|100651455|FG000|COMPLETED|Washout 1||9||
48134325|NCT01306162|100651456|FG001|COMPLETED|Washout 1||8||
48134326|NCT01306162|100651457|FG002|COMPLETED|Washout 1||9||
48134327|NCT01306162|100651458|FG003|COMPLETED|Washout 1||8||
48134328|NCT01306162|100651455|FG000|NOT COMPLETED|Washout 1||0||
48134329|NCT01306162|100651456|FG001|NOT COMPLETED|Washout 1||1||
48134330|NCT01306162|100651457|FG002|NOT COMPLETED|Washout 1||0||
48134331|NCT01306162|100651458|FG003|NOT COMPLETED|Washout 1||0||
48134332|NCT01306162|100651455|FG000|STARTED|Period 2||9||
48134333|NCT01306162|100651456|FG001|STARTED|Period 2||8||
48134334|NCT01306162|100651457|FG002|STARTED|Period 2||9||
48134335|NCT01306162|100651458|FG003|STARTED|Period 2||8||
48134336|NCT01306162|100651455|FG000|COMPLETED|Period 2||9||
48134337|NCT01306162|100651456|FG001|COMPLETED|Period 2||8||
48134338|NCT01306162|100651457|FG002|COMPLETED|Period 2||9||
48134339|NCT01306162|100651458|FG003|COMPLETED|Period 2||8||
48134340|NCT01306162|100651455|FG000|NOT COMPLETED|Period 2||0||
48134341|NCT01306162|100651456|FG001|NOT COMPLETED|Period 2||0||
48134342|NCT01306162|100651457|FG002|NOT COMPLETED|Period 2||0||
48134343|NCT01306162|100651458|FG003|NOT COMPLETED|Period 2||0||
48134344|NCT01306162|100651455|FG000|STARTED|Period 3||9||
48134345|NCT01306162|100651456|FG001|STARTED|Period 3||8||
48134346|NCT01306162|100651457|FG002|STARTED|Period 3||9||
48134347|NCT01306162|100651458|FG003|STARTED|Period 3||8||
48134348|NCT01306162|100651455|FG000|COMPLETED|Period 3||9||
48134349|NCT01306162|100651456|FG001|COMPLETED|Period 3||8||
48134350|NCT01306162|100651457|FG002|COMPLETED|Period 3||9||
48134351|NCT01306162|100651458|FG003|COMPLETED|Period 3||8||
48134352|NCT01306162|100651455|FG000|NOT COMPLETED|Period 3||0||
48134353|NCT01306162|100651456|FG001|NOT COMPLETED|Period 3||0||
48134354|NCT01306162|100651457|FG002|NOT COMPLETED|Period 3||0||
48134355|NCT01306162|100651458|FG003|NOT COMPLETED|Period 3||0||
48134356|NCT01306162|100651455|FG000|STARTED|Washout 2||9||
48134357|NCT01306162|100651456|FG001|STARTED|Washout 2||8||
48134358|NCT01306162|100651457|FG002|STARTED|Washout 2||9||
48703461|NCT02152371|102060513|FG000|Received at Least 1 Dose of Study Drug.|Overall Study||150||
48134359|NCT01306162|100651458|FG003|STARTED|Washout 2||8||
48134360|NCT01306162|100651455|FG000|COMPLETED|Washout 2||9||
48134361|NCT01306162|100651456|FG001|COMPLETED|Washout 2||8||
48134362|NCT01306162|100651457|FG002|COMPLETED|Washout 2||9||
48134363|NCT01306162|100651458|FG003|COMPLETED|Washout 2||8||
48134364|NCT01306162|100651455|FG000|NOT COMPLETED|Washout 2||0||
48134365|NCT01306162|100651456|FG001|NOT COMPLETED|Washout 2||0||
48400168|NCT01324128|101309307|FG000|COMPLETED|Stage 1||515||
48400169|NCT01324128|101309308|FG001|COMPLETED|Stage 1||293||
48400170|NCT01324128|101309309|FG002|COMPLETED|Stage 1||0||
48400171|NCT01324128|101309310|FG003|COMPLETED|Stage 1||0||
48400172|NCT01324128|101309307|FG000|NOT COMPLETED|Stage 1||195||
48400173|NCT01324128|101309308|FG001|NOT COMPLETED|Stage 1||56||
48400174|NCT01324128|101309309|FG002|NOT COMPLETED|Stage 1||0||
48400175|NCT01324128|101309310|FG003|NOT COMPLETED|Stage 1||0||
48400176|NCT01324128|101309307|FG000|STARTED|Stage 2||0||
48400177|NCT01324128|101309308|FG001|STARTED|Stage 2||0||
48400178|NCT01324128|101309309|FG002|STARTED|Stage 2||50||
48400179|NCT01324128|101309310|FG003|STARTED|Stage 2||49||
48400180|NCT01324128|101309307|FG000|COMPLETED|Stage 2||0||
48134366|NCT01306162|100651457|FG002|NOT COMPLETED|Washout 2||0||
48134367|NCT01306162|100651458|FG003|NOT COMPLETED|Washout 2||0||
48134368|NCT01306162|100651455|FG000|STARTED|Period 4||9||
48134369|NCT01306162|100651456|FG001|STARTED|Period 4||8||
48134370|NCT01306162|100651457|FG002|STARTED|Period 4||9||
48134371|NCT01306162|100651458|FG003|STARTED|Period 4||8||
48134372|NCT01306162|100651455|FG000|COMPLETED|Period 4||9||
48134373|NCT01306162|100651456|FG001|COMPLETED|Period 4||8||
48134374|NCT01306162|100651457|FG002|COMPLETED|Period 4||9||
48134375|NCT01306162|100651458|FG003|COMPLETED|Period 4||8||
48134376|NCT01306162|100651455|FG000|NOT COMPLETED|Period 4||0||
48134377|NCT01306162|100651456|FG001|NOT COMPLETED|Period 4||0||
48134378|NCT01306162|100651457|FG002|NOT COMPLETED|Period 4||0||
48400181|NCT01324128|101309308|FG001|COMPLETED|Stage 2||0||
48400182|NCT01324128|101309309|FG002|COMPLETED|Stage 2||42||
48400183|NCT01324128|101309310|FG003|COMPLETED|Stage 2||46||
48400184|NCT01324128|101309307|FG000|NOT COMPLETED|Stage 2||0||
48400185|NCT01324128|101309308|FG001|NOT COMPLETED|Stage 2||0||
48578762|NCT02207803|101747801|FG000|NOT COMPLETED|Overall Study||15||
48134379|NCT01306162|100651458|FG003|NOT COMPLETED|Period 4||0||
48134380|NCT01944046|100651459|FG000|STARTED|Randomized to DB||146||
48134381|NCT01944046|100651460|FG001|STARTED|Randomized to DB||144||
48134382|NCT01944046|100651459|FG000|COMPLETED|Randomized to DB||125||
48134383|NCT01944046|100651460|FG001|COMPLETED|Randomized to DB||125||
48134384|NCT01944046|100651459|FG000|NOT COMPLETED|Randomized to DB||21||
48134385|NCT01944046|100651460|FG001|NOT COMPLETED|Randomized to DB||19||
48134386|NCT01944046|100651459|FG000|STARTED|Open Label Eligible and Consented||124|1 from each treatment group declined to consent for openlabel|
48134387|NCT01944046|100651460|FG001|STARTED|Open Label Eligible and Consented||124|1 from each treatment group declined to consent for openlabel|
48134388|NCT01944046|100651459|FG000|COMPLETED|Open Label Eligible and Consented||110||
48134389|NCT01944046|100651460|FG001|COMPLETED|Open Label Eligible and Consented||116||
48134390|NCT01944046|100651459|FG000|NOT COMPLETED|Open Label Eligible and Consented||14||
48134391|NCT01944046|100651460|FG001|NOT COMPLETED|Open Label Eligible and Consented||8||
48134392|NCT02169674|100651461|FG000|STARTED|Overall Study||137||
48134393|NCT02169674|100651462|FG001|STARTED|Overall Study||213||
48134394|NCT02169674|100651461|FG000|COMPLETED|Overall Study||105||
48134395|NCT02169674|100651462|FG001|COMPLETED|Overall Study||135||
48134396|NCT02169674|100651461|FG000|NOT COMPLETED|Overall Study||32||
48134397|NCT02169674|100651462|FG001|NOT COMPLETED|Overall Study||78||
48134398|NCT02648698|100651463|FG000|STARTED|Overall Study||60||
48134399|NCT02648698|100651464|FG001|STARTED|Overall Study||60||
48134400|NCT02648698|100651463|FG000|COMPLETED|Overall Study||59||
48400186|NCT01324128|101309309|FG002|NOT COMPLETED|Stage 2||8||
48578763|NCT02207803|101747802|FG001|NOT COMPLETED|Overall Study||17||
48134401|NCT02648698|100651464|FG001|COMPLETED|Overall Study||55||
48134402|NCT02648698|100651463|FG000|NOT COMPLETED|Overall Study||1||
48134403|NCT02648698|100651464|FG001|NOT COMPLETED|Overall Study||5||
48134404|NCT02576574|100651465|FG000|STARTED|Overall Study||366||
48134405|NCT02576574|100651466|FG001|STARTED|Overall Study||322||
48134406|NCT02576574|100651467|FG002|STARTED|Overall Study||526||
48134407|NCT02576574|100651465|FG000|Treated|Overall Study||361||
48134408|NCT02576574|100651466|FG001|Treated|Overall Study||318||
48134409|NCT02576574|100651467|FG002|Treated|Overall Study||500||
48134410|NCT02576574|100651465|FG000|COMPLETED|Overall Study||296||
48134411|NCT02576574|100651466|FG001|COMPLETED|Overall Study||252||
48134412|NCT02576574|100651467|FG002|COMPLETED|Overall Study||427||
48134413|NCT02576574|100651465|FG000|NOT COMPLETED|Overall Study||70||
48134414|NCT02576574|100651466|FG001|NOT COMPLETED|Overall Study||70||
48134415|NCT02576574|100651467|FG002|NOT COMPLETED|Overall Study||99||
48134416|NCT03694548|100651468|FG000|STARTED|Part A Survey||18||
48134417|NCT03694548|100651469|FG001|STARTED|Part A Survey||17||
48286722|NCT02319759|101026379|FG002|NOT COMPLETED|Week 16 - 24||3||
48286723|NCT02319759|101026380|FG003|NOT COMPLETED|Week 16 - 24||0||
48400187|NCT01324128|101309310|FG003|NOT COMPLETED|Stage 2||3||
48134418|NCT03694548|100651470|FG002|STARTED|Part A Survey||0||
48134419|NCT03694548|100651468|FG000|COMPLETED|Part A Survey||15||
48134420|NCT03694548|100651469|FG001|COMPLETED|Part A Survey||14||
48134421|NCT03694548|100651470|FG002|COMPLETED|Part A Survey||0||
48134422|NCT03694548|100651468|FG000|NOT COMPLETED|Part A Survey||3||
48134423|NCT03694548|100651469|FG001|NOT COMPLETED|Part A Survey||3||
48134424|NCT03694548|100651470|FG002|NOT COMPLETED|Part A Survey||0||
48134425|NCT03694548|100651468|FG000|STARTED|Part B Yoga Program||0||
48134426|NCT03694548|100651469|FG001|STARTED|Part B Yoga Program||0||
48134427|NCT03694548|100651470|FG002|STARTED|Part B Yoga Program||12||
48134428|NCT03694548|100651468|FG000|COMPLETED|Part B Yoga Program||0||
48578764|NCT00886743|101747803|FG000|STARTED|Overall Study||19||
48578765|NCT00886743|101747803|FG000|COMPLETED|Overall Study||15||
48578766|NCT00886743|101747803|FG000|NOT COMPLETED|Overall Study||4||
48578767|NCT02340715|101747804|FG000|STARTED|Overall Study||158||
48578768|NCT02340715|101747804|FG000|COMPLETED|Overall Study||158||
48578769|NCT02340715|101747804|FG000|NOT COMPLETED|Overall Study||0||
48134429|NCT03694548|100651469|FG001|COMPLETED|Part B Yoga Program||0||
48134430|NCT03694548|100651470|FG002|COMPLETED|Part B Yoga Program||1||
48134431|NCT03694548|100651468|FG000|NOT COMPLETED|Part B Yoga Program||0||
48134432|NCT03694548|100651469|FG001|NOT COMPLETED|Part B Yoga Program||0||
48134433|NCT03694548|100651470|FG002|NOT COMPLETED|Part B Yoga Program||11||
48134434|NCT01154166|100651471|FG000|STARTED|Overall Study||169||
48134435|NCT01154166|100651472|FG001|STARTED|Overall Study||175||
48134436|NCT01154166|100651471|FG000|COMPLETED|Overall Study||135||
48134437|NCT01154166|100651472|FG001|COMPLETED|Overall Study||163||
48286724|NCT02319759|101026381|FG004|NOT COMPLETED|Week 16 - 24||0||
48286725|NCT02319759|101026377|FG000|STARTED|Week 24 - 56||0||
48286726|NCT02319759|101026378|FG001|STARTED|Week 24 - 56||29||
48286727|NCT02319759|101026379|FG002|STARTED|Week 24 - 56||86||
48286728|NCT02319759|101026380|FG003|STARTED|Week 24 - 56||17||
48286729|NCT02319759|101026381|FG004|STARTED|Week 24 - 56||10||
48286730|NCT02319759|101026377|FG000|COMPLETED|Week 24 - 56||0||
48286731|NCT02319759|101026378|FG001|COMPLETED|Week 24 - 56||28||
48286732|NCT02319759|101026379|FG002|COMPLETED|Week 24 - 56||84||
48286733|NCT02319759|101026380|FG003|COMPLETED|Week 24 - 56||15||
48286734|NCT02319759|101026381|FG004|COMPLETED|Week 24 - 56||8||
48578770|NCT04439214|101747805|FG000|STARTED|Overall Study||47||
48134438|NCT01154166|100651471|FG000|NOT COMPLETED|Overall Study||34||
48134439|NCT01154166|100651472|FG001|NOT COMPLETED|Overall Study||12||
48134440|NCT00455195|100651473|FG000|STARTED|Double-blind Study AGLU02704||60||
48134441|NCT00455195|100651474|FG001|STARTED|Double-blind Study AGLU02704||30||
48134442|NCT00455195|100651473|FG000|COMPLETED|Double-blind Study AGLU02704||55||
48134443|NCT00455195|100651474|FG001|COMPLETED|Double-blind Study AGLU02704||26||
48134444|NCT00455195|100651473|FG000|NOT COMPLETED|Double-blind Study AGLU02704||5||
48134445|NCT00455195|100651474|FG001|NOT COMPLETED|Double-blind Study AGLU02704||4||
48134446|NCT00455195|100651473|FG000|STARTED|Extension Study AGLU03206||55||
48134447|NCT00455195|100651474|FG001|STARTED|Extension Study AGLU03206||26||
48134448|NCT00455195|100651473|FG000|COMPLETED|Extension Study AGLU03206||55||
48134449|NCT00455195|100651474|FG001|COMPLETED|Extension Study AGLU03206||26||
48134450|NCT00455195|100651473|FG000|NOT COMPLETED|Extension Study AGLU03206||0||
48134451|NCT00455195|100651474|FG001|NOT COMPLETED|Extension Study AGLU03206||0||
48134452|NCT01174342|100651475|FG000|STARTED|Overall Study||30||
48134453|NCT01174342|100651475|FG000|COMPLETED|Overall Study||26||
48134454|NCT01174342|100651475|FG000|NOT COMPLETED|Overall Study||4||
48134455|NCT01404312|100651476|FG000|STARTED|Overall Study||1496||
48134456|NCT01404312|100651477|FG001|STARTED|Overall Study||1504||
48134457|NCT01404312|100651476|FG000|COMPLETED|Overall Study||1198||
48134458|NCT01404312|100651477|FG001|COMPLETED|Overall Study||1193||
48134459|NCT01404312|100651476|FG000|NOT COMPLETED|Overall Study||298||
48134460|NCT01404312|100651477|FG001|NOT COMPLETED|Overall Study||311||
48134461|NCT01412944|100651478|FG000|STARTED|IV: Per Previous CAIN457A2304 Treatment||0||
48134462|NCT01412944|100651479|FG001|STARTED|IV: Per Previous CAIN457A2304 Treatment||0||
48134463|NCT01412944|100651480|FG002|STARTED|IV: Per Previous CAIN457A2304 Treatment||15||
48134464|NCT01412944|100651481|FG003|STARTED|IV: Per Previous CAIN457A2304 Treatment||6||
48134465|NCT01412944|100651482|FG004|STARTED|IV: Per Previous CAIN457A2304 Treatment||14||
48134466|NCT01412944|100651483|FG005|STARTED|IV: Per Previous CAIN457A2304 Treatment||8||
48134467|NCT01412944|100651478|FG000|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0||
48134468|NCT01412944|100651479|FG001|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0||
48134469|NCT01412944|100651480|FG002|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14||
48134470|NCT01412944|100651481|FG003|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6||
48134471|NCT01412944|100651482|FG004|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14||
48134472|NCT01412944|100651483|FG005|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6||
48134473|NCT01412944|100651478|FG000|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0||
48134474|NCT01412944|100651479|FG001|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0||
48134475|NCT01412944|100651480|FG002|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||1||
48134476|NCT01412944|100651481|FG003|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0||
48134477|NCT01412944|100651482|FG004|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0||
48134478|NCT01412944|100651483|FG005|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||2||
48134479|NCT01412944|100651478|FG000|STARTED|IV: Per CAIN457A2307||21||
48134480|NCT01412944|100651479|FG001|STARTED|IV: Per CAIN457A2307||22||
48134481|NCT01412944|100651480|FG002|STARTED|IV: Per CAIN457A2307||0||
48134482|NCT01412944|100651481|FG003|STARTED|IV: Per CAIN457A2307||0||
48134483|NCT01412944|100651482|FG004|STARTED|IV: Per CAIN457A2307||0||
48134484|NCT01412944|100651483|FG005|STARTED|IV: Per CAIN457A2307||0||
48134485|NCT01412944|100651478|FG000|COMPLETED|IV: Per CAIN457A2307||20||
48134486|NCT01412944|100651479|FG001|COMPLETED|IV: Per CAIN457A2307||20||
48134487|NCT01412944|100651480|FG002|COMPLETED|IV: Per CAIN457A2307||0||
48134488|NCT01412944|100651481|FG003|COMPLETED|IV: Per CAIN457A2307||0||
48134489|NCT01412944|100651482|FG004|COMPLETED|IV: Per CAIN457A2307||0||
48134490|NCT01412944|100651483|FG005|COMPLETED|IV: Per CAIN457A2307||0||
48134491|NCT01412944|100651478|FG000|NOT COMPLETED|IV: Per CAIN457A2307||1||
48134492|NCT01412944|100651479|FG001|NOT COMPLETED|IV: Per CAIN457A2307||2||
48134493|NCT01412944|100651480|FG002|NOT COMPLETED|IV: Per CAIN457A2307||0||
48134494|NCT01412944|100651481|FG003|NOT COMPLETED|IV: Per CAIN457A2307||0||
48134495|NCT01412944|100651482|FG004|NOT COMPLETED|IV: Per CAIN457A2307||0||
48134496|NCT01412944|100651483|FG005|NOT COMPLETED|IV: Per CAIN457A2307||0||
48134497|NCT01412944|100651478|FG000|STARTED|Entire: IV + Maintenance||0||
48134498|NCT01412944|100651479|FG001|STARTED|Entire: IV + Maintenance||0||
48134499|NCT01412944|100651480|FG002|STARTED|Entire: IV + Maintenance||15||
48134500|NCT01412944|100651481|FG003|STARTED|Entire: IV + Maintenance||6||
48134501|NCT01412944|100651482|FG004|STARTED|Entire: IV + Maintenance||14||
48134502|NCT01412944|100651483|FG005|STARTED|Entire: IV + Maintenance||8||
48134503|NCT01412944|100651478|FG000|COMPLETED|Entire: IV + Maintenance||0||
48134504|NCT01412944|100651479|FG001|COMPLETED|Entire: IV + Maintenance||0||
48134505|NCT01412944|100651480|FG002|COMPLETED|Entire: IV + Maintenance||14||
48134506|NCT01412944|100651481|FG003|COMPLETED|Entire: IV + Maintenance||5||
48134507|NCT01412944|100651482|FG004|COMPLETED|Entire: IV + Maintenance||11||
48134508|NCT01412944|100651483|FG005|COMPLETED|Entire: IV + Maintenance||6||
48134509|NCT01412944|100651478|FG000|NOT COMPLETED|Entire: IV + Maintenance||0||
48134510|NCT01412944|100651479|FG001|NOT COMPLETED|Entire: IV + Maintenance||0||
48134511|NCT01412944|100651480|FG002|NOT COMPLETED|Entire: IV + Maintenance||1||
48134512|NCT01412944|100651481|FG003|NOT COMPLETED|Entire: IV + Maintenance||1||
48134513|NCT01412944|100651482|FG004|NOT COMPLETED|Entire: IV + Maintenance||3||
48134514|NCT01412944|100651483|FG005|NOT COMPLETED|Entire: IV + Maintenance||2||
48134515|NCT01412944|100651478|FG000|STARTED|Entire: IV + Maintenance||21||
48134516|NCT01412944|100651479|FG001|STARTED|Entire: IV + Maintenance||22||
48134517|NCT01412944|100651480|FG002|STARTED|Entire: IV + Maintenance||0||
48134518|NCT01412944|100651481|FG003|STARTED|Entire: IV + Maintenance||0||
48134519|NCT01412944|100651482|FG004|STARTED|Entire: IV + Maintenance||0||
48286735|NCT02319759|101026377|FG000|NOT COMPLETED|Week 24 - 56||0||
48286736|NCT02319759|101026378|FG001|NOT COMPLETED|Week 24 - 56||1||
48286737|NCT02319759|101026379|FG002|NOT COMPLETED|Week 24 - 56||2||
48286738|NCT02319759|101026380|FG003|NOT COMPLETED|Week 24 - 56||2||
48286739|NCT02319759|101026381|FG004|NOT COMPLETED|Week 24 - 56||2||
48703462|NCT02152371|102060514|FG001|Received at Least 1 Dose of Study Drug.|Overall Study||150||
48703463|NCT02152371|102060513|FG000|COMPLETED|Overall Study||138||
48703464|NCT02152371|102060514|FG001|COMPLETED|Overall Study||134||
48703465|NCT02152371|102060513|FG000|NOT COMPLETED|Overall Study||12||
48703466|NCT02152371|102060514|FG001|NOT COMPLETED|Overall Study||16||
48703467|NCT02290691|102060515|FG000|STARTED|Overall Study||496||
48703468|NCT02290691|102060516|FG001|STARTED|Overall Study||488||
48703469|NCT02290691|102060515|FG000|COMPLETED|Overall Study||488||
48134520|NCT01412944|100651483|FG005|STARTED|Entire: IV + Maintenance||0||
48134521|NCT01412944|100651478|FG000|COMPLETED|Entire: IV + Maintenance||19||
48134522|NCT01412944|100651479|FG001|COMPLETED|Entire: IV + Maintenance||17||
48134523|NCT01412944|100651480|FG002|COMPLETED|Entire: IV + Maintenance||0||
48134524|NCT01412944|100651481|FG003|COMPLETED|Entire: IV + Maintenance||0||
48134525|NCT01412944|100651482|FG004|COMPLETED|Entire: IV + Maintenance||0||
48134526|NCT01412944|100651483|FG005|COMPLETED|Entire: IV + Maintenance||0||
48134527|NCT01412944|100651478|FG000|NOT COMPLETED|Entire: IV + Maintenance||2||
48134528|NCT01412944|100651479|FG001|NOT COMPLETED|Entire: IV + Maintenance||5||
48134529|NCT01412944|100651480|FG002|NOT COMPLETED|Entire: IV + Maintenance||0||
48134530|NCT01412944|100651481|FG003|NOT COMPLETED|Entire: IV + Maintenance||0||
48134531|NCT01412944|100651482|FG004|NOT COMPLETED|Entire: IV + Maintenance||0||
48134532|NCT01412944|100651483|FG005|NOT COMPLETED|Entire: IV + Maintenance||0||
48134533|NCT01412944|100651478|FG000|STARTED|Follow-up||0||
48134534|NCT01412944|100651479|FG001|STARTED|Follow-up||0||
48134535|NCT01412944|100651480|FG002|STARTED|Follow-up||2||
48134536|NCT01412944|100651481|FG003|STARTED|Follow-up||1||
48134537|NCT01412944|100651482|FG004|STARTED|Follow-up||2||
48134538|NCT01412944|100651483|FG005|STARTED|Follow-up||0||
48134539|NCT01412944|100651478|FG000|COMPLETED|Follow-up||0||
48134540|NCT01412944|100651479|FG001|COMPLETED|Follow-up||0||
48134541|NCT01412944|100651480|FG002|COMPLETED|Follow-up||2||
48134542|NCT01412944|100651481|FG003|COMPLETED|Follow-up||1||
48134543|NCT01412944|100651482|FG004|COMPLETED|Follow-up||2||
48134544|NCT01412944|100651483|FG005|COMPLETED|Follow-up||0||
48134545|NCT01412944|100651478|FG000|NOT COMPLETED|Follow-up||0||
48286740|NCT01183234|101026382|FG000|STARTED|First Intervention||14||
48286741|NCT01183234|101026383|FG001|STARTED|First Intervention||14||
48286742|NCT01183234|101026382|FG000|COMPLETED|First Intervention||13||
48286743|NCT01183234|101026383|FG001|COMPLETED|First Intervention||14||
48286744|NCT01183234|101026382|FG000|NOT COMPLETED|First Intervention||1||
48286745|NCT01183234|101026383|FG001|NOT COMPLETED|First Intervention||0||
48286746|NCT01183234|101026382|FG000|STARTED|Washout||13||
48286747|NCT01183234|101026383|FG001|STARTED|Washout||14||
48286748|NCT01183234|101026382|FG000|COMPLETED|Washout||13||
48286749|NCT01183234|101026383|FG001|COMPLETED|Washout||14||
48286750|NCT01183234|101026382|FG000|NOT COMPLETED|Washout||0||
48703470|NCT02290691|102060516|FG001|COMPLETED|Overall Study||479||
48703471|NCT02290691|102060515|FG000|NOT COMPLETED|Overall Study||8||
48703472|NCT02290691|102060516|FG001|NOT COMPLETED|Overall Study||9||
48134546|NCT01412944|100651479|FG001|NOT COMPLETED|Follow-up||0||
48134547|NCT01412944|100651480|FG002|NOT COMPLETED|Follow-up||0||
48134548|NCT01412944|100651481|FG003|NOT COMPLETED|Follow-up||0||
48134549|NCT01412944|100651482|FG004|NOT COMPLETED|Follow-up||0||
48134550|NCT01412944|100651483|FG005|NOT COMPLETED|Follow-up||0||
48134551|NCT05245864|100651484|FG000|STARTED|Overall Study||1||
48134552|NCT05245864|100651485|FG001|STARTED|Overall Study||1||
48134553|NCT05245864|100651484|FG000|COMPLETED|Overall Study||0||
48134554|NCT05245864|100651485|FG001|COMPLETED|Overall Study||0||
48134555|NCT05245864|100651484|FG000|NOT COMPLETED|Overall Study||1||
48134556|NCT05245864|100651485|FG001|NOT COMPLETED|Overall Study||1||
48134557|NCT01365494|100651486|FG000|STARTED|Overall Study||126||
48134558|NCT01365494|100651487|FG001|STARTED|Overall Study||124||
48286751|NCT01183234|101026383|FG001|NOT COMPLETED|Washout||0||
48286752|NCT01183234|101026382|FG000|STARTED|Second Intervention||13||
48286753|NCT01183234|101026383|FG001|STARTED|Second Intervention||14||
48286754|NCT01183234|101026382|FG000|COMPLETED|Second Intervention||13||
48286755|NCT01183234|101026383|FG001|COMPLETED|Second Intervention||14||
48286756|NCT01183234|101026382|FG000|NOT COMPLETED|Second Intervention||0||
48286757|NCT01183234|101026383|FG001|NOT COMPLETED|Second Intervention||0||
48286758|NCT02891837|101026384|FG000|STARTED|Overall Study||99||
48134559|NCT01365494|100651486|FG000|COMPLETED|Overall Study||124||
48134560|NCT01365494|100651487|FG001|COMPLETED|Overall Study||121||
48134561|NCT01365494|100651486|FG000|NOT COMPLETED|Overall Study||2||
48703473|NCT00484393|102060517|FG000|STARTED|Overall Study||4||
48286759|NCT02891837|101026385|FG001|STARTED|Overall Study||90||
48286760|NCT02891837|101026384|FG000|COMPLETED|Overall Study||96||
48286761|NCT02891837|101026385|FG001|COMPLETED|Overall Study||90||
48286762|NCT02891837|101026384|FG000|NOT COMPLETED|Overall Study||3||
48286763|NCT02891837|101026385|FG001|NOT COMPLETED|Overall Study||0||
48286764|NCT04595318|101026386|FG000|STARTED|First Intervention (Four Weeks)||3||
48286765|NCT04595318|101026387|FG001|STARTED|First Intervention (Four Weeks)||4||
48286766|NCT04595318|101026386|FG000|COMPLETED|First Intervention (Four Weeks)||3||
48286767|NCT04595318|101026387|FG001|COMPLETED|First Intervention (Four Weeks)||4||
48286768|NCT04595318|101026386|FG000|NOT COMPLETED|First Intervention (Four Weeks)||0||
48286769|NCT04595318|101026387|FG001|NOT COMPLETED|First Intervention (Four Weeks)||0||
48286770|NCT04595318|101026386|FG000|STARTED|Second Intervention (Four Weeks)||3||
48286771|NCT04595318|101026387|FG001|STARTED|Second Intervention (Four Weeks)||4||
48286772|NCT04595318|101026386|FG000|COMPLETED|Second Intervention (Four Weeks)||3||
48286773|NCT04595318|101026387|FG001|COMPLETED|Second Intervention (Four Weeks)||4||
48286774|NCT04595318|101026386|FG000|NOT COMPLETED|Second Intervention (Four Weeks)||0||
48286775|NCT04595318|101026387|FG001|NOT COMPLETED|Second Intervention (Four Weeks)||0||
48286776|NCT03606668|101026388|FG000|STARTED|Overall Study||20||
48286777|NCT03606668|101026388|FG000|COMPLETED|Overall Study||18||
48286778|NCT03606668|101026388|FG000|NOT COMPLETED|Overall Study||2||
48578771|NCT04439214|101747805|FG000|Eligible|Overall Study||42||
48578772|NCT04439214|101747805|FG000|Treated|Overall Study||47||
48578773|NCT04439214|101747805|FG000|Treated and Reported Adverse Event Data|Overall Study||46||
48578774|NCT04439214|101747805|FG000|Eligible and Treated|Overall Study||42||
48578775|NCT04439214|101747805|FG000|COMPLETED|Overall Study||0|Treatment continued until progression or intolerability. At the time of the final analysis of the data, 9 patients were still receiving protocol treatment.|
48578776|NCT04439214|101747805|FG000|NOT COMPLETED|Overall Study||47||
48578777|NCT01198158|101747806|FG000|STARTED|Overall Study||41||
48578778|NCT01198158|101747807|FG001|STARTED|Overall Study||36||
48578779|NCT01198158|101747806|FG000|COMPLETED|Overall Study||41||
48578780|NCT01198158|101747807|FG001|COMPLETED|Overall Study||36||
48578781|NCT01198158|101747806|FG000|NOT COMPLETED|Overall Study||0||
48578782|NCT01198158|101747807|FG001|NOT COMPLETED|Overall Study||0||
48578783|NCT01377922|101747808|FG000|STARTED|Overall Study||22||
48703474|NCT00484393|102060518|FG001|STARTED|Overall Study||3||
48703475|NCT00484393|102060517|FG000|COMPLETED|Overall Study||4||
48286779|NCT01981473|101026389|FG000|STARTED|Overall Study||202||
48286780|NCT01981473|101026390|FG001|STARTED|Overall Study||199||
48286781|NCT01981473|101026391|FG002|STARTED|Overall Study||204||
48286782|NCT01981473|101026389|FG000|COMPLETED|Overall Study||200||
48286783|NCT01981473|101026390|FG001|COMPLETED|Overall Study||199||
48286784|NCT01981473|101026391|FG002|COMPLETED|Overall Study||196||
48286785|NCT01981473|101026389|FG000|NOT COMPLETED|Overall Study||2||
48286786|NCT01981473|101026390|FG001|NOT COMPLETED|Overall Study||0||
48286787|NCT01981473|101026391|FG002|NOT COMPLETED|Overall Study||8||
48286788|NCT01052103|101026392|FG000|STARTED|Overall Study||84||
48286789|NCT01052103|101026393|FG001|STARTED|Overall Study||83||
48286790|NCT01052103|101026392|FG000|Received at Least 1 Dose of Study Drug|Overall Study||82||
48286791|NCT01052103|101026393|FG001|Received at Least 1 Dose of Study Drug|Overall Study||82||
48286792|NCT01052103|101026392|FG000|COMPLETED|Overall Study||50||
48286793|NCT01052103|101026393|FG001|COMPLETED|Overall Study||60||
48286794|NCT01052103|101026392|FG000|NOT COMPLETED|Overall Study||34||
48578784|NCT01377922|101747809|FG001|STARTED|Overall Study||16||
48578785|NCT01377922|101747808|FG000|COMPLETED|Overall Study||21||
48578786|NCT01377922|101747809|FG001|COMPLETED|Overall Study||16||
48578787|NCT01377922|101747808|FG000|NOT COMPLETED|Overall Study||1||
48578788|NCT01377922|101747809|FG001|NOT COMPLETED|Overall Study||0||
48578789|NCT00679029|101747810|FG000|STARTED|Overall Study||15||
48578790|NCT00679029|101747810|FG000|COMPLETED|Overall Study||10||
48578791|NCT00679029|101747810|FG000|NOT COMPLETED|Overall Study||5||
48578792|NCT02964507|101747811|FG000|STARTED|Overall Study||33||
48578793|NCT02964507|101747812|FG001|STARTED|Overall Study||12||
48578794|NCT02964507|101747813|FG002|STARTED|Overall Study||42||
48578795|NCT02964507|101747814|FG003|STARTED|Overall Study||7||
48578796|NCT02964507|101747815|FG004|STARTED|Overall Study||18||
48578797|NCT02964507|101747816|FG005|STARTED|Overall Study||11||
48578798|NCT02964507|101747817|FG006|STARTED|Overall Study||0||
48703476|NCT00484393|102060518|FG001|COMPLETED|Overall Study||3||
48703477|NCT00484393|102060517|FG000|NOT COMPLETED|Overall Study||0||
48703478|NCT00484393|102060518|FG001|NOT COMPLETED|Overall Study||0||
48703479|NCT01885208|102060519|FG000|STARTED|Overall Study||406||
48703480|NCT01885208|102060520|FG001|STARTED|Overall Study||407||
48286795|NCT01052103|101026393|FG001|NOT COMPLETED|Overall Study||23||
48286796|NCT03801473|101026394|FG000|STARTED|Overall Study||21||
48286797|NCT03801473|101026395|FG001|STARTED|Overall Study||21||
48286798|NCT03801473|101026394|FG000|COMPLETED|Overall Study||18||
48286799|NCT03801473|101026395|FG001|COMPLETED|Overall Study||19||
48286800|NCT03801473|101026394|FG000|NOT COMPLETED|Overall Study||3||
48578799|NCT02964507|101747818|FG007|STARTED|Overall Study||0||
48578800|NCT02964507|101747811|FG000|COMPLETED|Overall Study||7||
48578801|NCT02964507|101747812|FG001|COMPLETED|Overall Study||1||
48703481|NCT01885208|102060519|FG000|Exposed|Overall Study||404||
48578802|NCT02964507|101747813|FG002|COMPLETED|Overall Study||17||
48578803|NCT02964507|101747814|FG003|COMPLETED|Overall Study||1||
48578804|NCT02964507|101747815|FG004|COMPLETED|Overall Study||2||
48578805|NCT02964507|101747816|FG005|COMPLETED|Overall Study||3||
48703482|NCT01885208|102060520|FG001|Exposed|Overall Study||405||
48703483|NCT01885208|102060519|FG000|Premature Discontinuation of Treatment|Overall Study||82||
48703484|NCT01885208|102060520|FG001|Premature Discontinuation of Treatment|Overall Study||85||
48703485|NCT01885208|102060519|FG000|COMPLETED|Overall Study||374||
48703486|NCT01885208|102060520|FG001|COMPLETED|Overall Study||369||
48703487|NCT01885208|102060519|FG000|NOT COMPLETED|Overall Study||32||
48703488|NCT01885208|102060520|FG001|NOT COMPLETED|Overall Study||38||
48286801|NCT03801473|101026395|FG001|NOT COMPLETED|Overall Study||2||
48286802|NCT01675479|101026396|FG000|STARTED|Overall Study||69||135
48286803|NCT01675479|101026396|FG000|COMPLETED|Overall Study||58||112
48286804|NCT01675479|101026396|FG000|NOT COMPLETED|Overall Study||11||23
48286805|NCT01039792|101026397|FG000|STARTED|Overall Study||29||
48286806|NCT01039792|101026398|FG001|STARTED|Overall Study||28||
48286807|NCT01039792|101026397|FG000|COMPLETED|Overall Study||23||
48286808|NCT01039792|101026398|FG001|COMPLETED|Overall Study||27||
48286809|NCT01039792|101026397|FG000|NOT COMPLETED|Overall Study||6||
48286810|NCT01039792|101026398|FG001|NOT COMPLETED|Overall Study||1||
48286811|NCT02372136|101026399|FG000|STARTED|Overall Study||62||
48286812|NCT02372136|101026400|FG001|STARTED|Overall Study||58||
48286813|NCT02372136|101026399|FG000|COMPLETED|Overall Study||59||
48286814|NCT02372136|101026400|FG001|COMPLETED|Overall Study||57||
48286815|NCT02372136|101026399|FG000|NOT COMPLETED|Overall Study||3||
48286816|NCT02372136|101026400|FG001|NOT COMPLETED|Overall Study||1||
48286817|NCT01079663|101026401|FG000|STARTED|Overall Study||30||
48286818|NCT01079663|101026402|FG001|STARTED|Overall Study||30||
48286819|NCT01079663|101026401|FG000|COMPLETED|Overall Study||30||
48286820|NCT01079663|101026402|FG001|COMPLETED|Overall Study||26||
48286821|NCT01079663|101026401|FG000|NOT COMPLETED|Overall Study||0||
48578806|NCT02964507|101747817|FG006|COMPLETED|Overall Study||0||
48703489|NCT01648296|102060521|FG000|STARTED|Overall Study||11||
48286822|NCT01079663|101026402|FG001|NOT COMPLETED|Overall Study||4||
48286823|NCT03294148|101026403|FG000|STARTED|Overall Study||50||
48286824|NCT03294148|101026404|FG001|STARTED|Overall Study||51||
48286825|NCT03294148|101026405|FG002|STARTED|Overall Study||50||
48578807|NCT02964507|101747818|FG007|COMPLETED|Overall Study||0||
48578808|NCT02964507|101747811|FG000|NOT COMPLETED|Overall Study||26||
48578809|NCT02964507|101747812|FG001|NOT COMPLETED|Overall Study||11||
48578810|NCT02964507|101747813|FG002|NOT COMPLETED|Overall Study||25||
48578811|NCT02964507|101747814|FG003|NOT COMPLETED|Overall Study||6||
48578812|NCT02964507|101747815|FG004|NOT COMPLETED|Overall Study||16||
48578813|NCT02964507|101747816|FG005|NOT COMPLETED|Overall Study||8||
48703490|NCT01648296|102060522|FG001|STARTED|Overall Study||17||
48703491|NCT01648296|102060521|FG000|COMPLETED|Overall Study||11||
48578814|NCT02964507|101747817|FG006|NOT COMPLETED|Overall Study||0||
48578815|NCT02964507|101747818|FG007|NOT COMPLETED|Overall Study||0||
48578816|NCT04967885|101747819|FG000|STARTED|Week 1 Follow-Up||39||
48703492|NCT01648296|102060522|FG001|COMPLETED|Overall Study||17||
48703493|NCT01648296|102060521|FG000|NOT COMPLETED|Overall Study||0||
48703494|NCT01648296|102060522|FG001|NOT COMPLETED|Overall Study||0||
48703495|NCT00778258|102060523|FG000|STARTED|Overall Study||16||
48703496|NCT00778258|102060524|FG001|STARTED|Overall Study||5||
48703497|NCT00778258|102060525|FG002|STARTED|Overall Study||20||
48134562|NCT01365494|100651487|FG001|NOT COMPLETED|Overall Study||3||
48134563|NCT03131648|100651488|FG000|STARTED|Initial Treatment Period||603||
48134564|NCT03131648|100651489|FG001|STARTED|Initial Treatment Period||199||
48134565|NCT03131648|100651490|FG002|STARTED|Initial Treatment Period||0||
48134566|NCT03131648|100651491|FG003|STARTED|Initial Treatment Period||0||
48134567|NCT03131648|100651492|FG004|STARTED|Initial Treatment Period||0||
48134568|NCT03131648|100651493|FG005|STARTED|Initial Treatment Period||0||
48134569|NCT03131648|100651494|FG006|STARTED|Initial Treatment Period||0||
48134570|NCT03131648|100651495|FG007|STARTED|Initial Treatment Period||0||
48134571|NCT03131648|100651488|FG000|COMPLETED|Initial Treatment Period||550||
48286826|NCT03294148|101026403|FG000|COMPLETED|Overall Study||44||
48286827|NCT03294148|101026404|FG001|COMPLETED|Overall Study||44||
48286828|NCT03294148|101026405|FG002|COMPLETED|Overall Study||47||
48286829|NCT03294148|101026403|FG000|NOT COMPLETED|Overall Study||6||
48286830|NCT03294148|101026404|FG001|NOT COMPLETED|Overall Study||7||
48286831|NCT03294148|101026405|FG002|NOT COMPLETED|Overall Study||3||
48286832|NCT01946438|101026406|FG000|STARTED|Overall Study||52||
48286833|NCT01946438|101026407|FG001|STARTED|Overall Study||52||
48286834|NCT01946438|101026408|FG002|STARTED|Overall Study||52||
48286835|NCT01946438|101026409|FG003|STARTED|Overall Study||52||
48286836|NCT01946438|101026406|FG000|COMPLETED|Overall Study||50||
48286837|NCT01946438|101026407|FG001|COMPLETED|Overall Study||52||
48286838|NCT01946438|101026408|FG002|COMPLETED|Overall Study||51||
48286839|NCT01946438|101026409|FG003|COMPLETED|Overall Study||51||
48286840|NCT01946438|101026406|FG000|NOT COMPLETED|Overall Study||2||
48286841|NCT01946438|101026407|FG001|NOT COMPLETED|Overall Study||0||
48286842|NCT01946438|101026408|FG002|NOT COMPLETED|Overall Study||1||
48286843|NCT01946438|101026409|FG003|NOT COMPLETED|Overall Study||1||
48134572|NCT03131648|100651489|FG001|COMPLETED|Initial Treatment Period||179||
48286844|NCT02418676|101026410|FG000|STARTED|Overall Study||5||
48134573|NCT03131648|100651490|FG002|COMPLETED|Initial Treatment Period||0||
48134574|NCT03131648|100651491|FG003|COMPLETED|Initial Treatment Period||0||
48134575|NCT03131648|100651492|FG004|COMPLETED|Initial Treatment Period||0||
48134576|NCT03131648|100651493|FG005|COMPLETED|Initial Treatment Period||0||
48286845|NCT02418676|101026411|FG001|STARTED|Overall Study||5||
48286846|NCT02418676|101026412|FG002|STARTED|Overall Study||5||
48286847|NCT02418676|101026410|FG000|COMPLETED|Overall Study||5||
48286848|NCT02418676|101026411|FG001|COMPLETED|Overall Study||5||
48286849|NCT02418676|101026412|FG002|COMPLETED|Overall Study||5||
48578817|NCT04967885|101747820|FG001|STARTED|Week 1 Follow-Up||41||
48578818|NCT04967885|101747819|FG000|COMPLETED|Week 1 Follow-Up||32||
48578819|NCT04967885|101747820|FG001|COMPLETED|Week 1 Follow-Up||37||
48578820|NCT04967885|101747819|FG000|NOT COMPLETED|Week 1 Follow-Up||7||
48578821|NCT04967885|101747820|FG001|NOT COMPLETED|Week 1 Follow-Up||4||
48578822|NCT04967885|101747819|FG000|STARTED|Week 2 Follow-Up||39|If participants missed a follow-up, they were able to complete subsequent follow-ups.|
48578823|NCT04967885|101747820|FG001|STARTED|Week 2 Follow-Up||41|If participants missed a follow-up, they were able to complete subsequent follow-ups.|
48286850|NCT02418676|101026410|FG000|NOT COMPLETED|Overall Study||0||
48286851|NCT02418676|101026411|FG001|NOT COMPLETED|Overall Study||0||
48286852|NCT02418676|101026412|FG002|NOT COMPLETED|Overall Study||0||
48286853|NCT03316300|101026413|FG000|STARTED|Overall Study||61||61
48286854|NCT03316300|101026414|FG001|STARTED|Overall Study||59||59
48286855|NCT03316300|101026413|FG000|Treated (Underwent Surgery)|Overall Study||58|Participants who actually underwent surgery for either NT-501 or sham treatment|58
48286856|NCT03316300|101026414|FG001|Treated (Underwent Surgery)|Overall Study||57|Participants who actually underwent surgery for either NT-501 or sham treatment|57
48286857|NCT03316300|101026413|FG000|COMPLETED|Overall Study||53||53
48286858|NCT03316300|101026414|FG001|COMPLETED|Overall Study||52||52
48286859|NCT03316300|101026413|FG000|NOT COMPLETED|Overall Study||8||8
48286860|NCT03316300|101026414|FG001|NOT COMPLETED|Overall Study||7||7
48286861|NCT00936741|101026415|FG000|STARTED|Overall Study||30||
48286862|NCT00936741|101026415|FG000|COMPLETED|Overall Study||21||
48286863|NCT00936741|101026415|FG000|NOT COMPLETED|Overall Study||9||
48286864|NCT00893984|101029581|FG000|STARTED|Overall Study||6||
48286865|NCT00893984|101029581|FG000|COMPLETED|Overall Study||0||
48286866|NCT00893984|101029581|FG000|NOT COMPLETED|Overall Study||6||
48286867|NCT01981772|101029582|FG000|STARTED|Overall Study||45||
48286868|NCT01981772|101029583|FG001|STARTED|Overall Study||43||
48286869|NCT01981772|101029582|FG000|COMPLETED|Overall Study||45||
48286870|NCT01981772|101029583|FG001|COMPLETED|Overall Study||43||
48286871|NCT01981772|101029582|FG000|NOT COMPLETED|Overall Study||0||
48286872|NCT01981772|101029583|FG001|NOT COMPLETED|Overall Study||0||
48286873|NCT00294515|101029584|FG000|STARTED|Overall Study||166||
48286874|NCT00294515|101029585|FG001|STARTED|Overall Study||160||
48286875|NCT00294515|101029584|FG000|COMPLETED|Overall Study||132||
48286876|NCT00294515|101029585|FG001|COMPLETED|Overall Study||132||
48286877|NCT00294515|101029584|FG000|NOT COMPLETED|Overall Study||34||
48286878|NCT00294515|101029585|FG001|NOT COMPLETED|Overall Study||28||
48286879|NCT00190749|101029586|FG000|STARTED|Overall Study||68||
48286880|NCT00190749|101029587|FG001|STARTED|Overall Study||62||
48286881|NCT00190749|101029586|FG000|COMPLETED|Overall Study||42||
48286882|NCT00190749|101029587|FG001|COMPLETED|Overall Study||31||
48286883|NCT00190749|101029586|FG000|NOT COMPLETED|Overall Study||26||
48286884|NCT00190749|101029587|FG001|NOT COMPLETED|Overall Study||31||
48286885|NCT00446992|101029588|FG000|STARTED|Overall Study||30||
48286886|NCT00446992|101029588|FG000|COMPLETED|Overall Study||14||
48286887|NCT00446992|101029588|FG000|NOT COMPLETED|Overall Study||16||
48286888|NCT03834038|101029589|FG000|STARTED|Overall Study||158||
48286889|NCT03834038|101029589|FG000|Completion of 2-year Follow-up|Overall Study||132||
48286890|NCT03834038|101029589|FG000|COMPLETED|Overall Study||132||
48286891|NCT03834038|101029589|FG000|NOT COMPLETED|Overall Study||26||
48286892|NCT01535560|101029590|FG000|STARTED|Overall Study||274||
48286893|NCT01535560|101029591|FG001|STARTED|Overall Study||275||
48578824|NCT04967885|101747819|FG000|COMPLETED|Week 2 Follow-Up||25||
48578825|NCT04967885|101747820|FG001|COMPLETED|Week 2 Follow-Up||35||
48578826|NCT04967885|101747819|FG000|NOT COMPLETED|Week 2 Follow-Up||14||
48578827|NCT04967885|101747820|FG001|NOT COMPLETED|Week 2 Follow-Up||6||
48578828|NCT04967885|101747819|FG000|STARTED|Week 3 Follow-Up||39||
48578829|NCT04967885|101747820|FG001|STARTED|Week 3 Follow-Up||41||
48578830|NCT04967885|101747819|FG000|COMPLETED|Week 3 Follow-Up||23||
48578831|NCT04967885|101747820|FG001|COMPLETED|Week 3 Follow-Up||30||
48578832|NCT04967885|101747819|FG000|NOT COMPLETED|Week 3 Follow-Up||16||
48578833|NCT04967885|101747820|FG001|NOT COMPLETED|Week 3 Follow-Up||11||
48578834|NCT04967885|101747819|FG000|STARTED|Week 4 Follow-Up||39||
48578835|NCT04967885|101747820|FG001|STARTED|Week 4 Follow-Up||41||
48578836|NCT04967885|101747819|FG000|COMPLETED|Week 4 Follow-Up||23||
48578837|NCT04967885|101747820|FG001|COMPLETED|Week 4 Follow-Up||31||
48578838|NCT04967885|101747819|FG000|NOT COMPLETED|Week 4 Follow-Up||16||
48578839|NCT04967885|101747820|FG001|NOT COMPLETED|Week 4 Follow-Up||10||
48578840|NCT04967885|101747819|FG000|STARTED|EMI-II Intervention||39||
48286894|NCT01535560|101029590|FG000|COMPLETED|Overall Study||237||
48286895|NCT01535560|101029591|FG001|COMPLETED|Overall Study||179||
48286896|NCT01535560|101029590|FG000|NOT COMPLETED|Overall Study||37||
48286897|NCT01535560|101029591|FG001|NOT COMPLETED|Overall Study||96||
48286898|NCT00618982|101029592|FG000|STARTED|Overall Study||83||
48286899|NCT00618982|101029592|FG000|COMPLETED|Overall Study||33||
48286900|NCT00618982|101029592|FG000|NOT COMPLETED|Overall Study||50||
48286901|NCT03727438|101029593|FG000|STARTED|Baseline||88||
48578841|NCT04967885|101747820|FG001|STARTED|EMI-II Intervention||41||
48578842|NCT04967885|101747819|FG000|COMPLETED|EMI-II Intervention||25||
48578843|NCT04967885|101747820|FG001|COMPLETED|EMI-II Intervention||31||
48578844|NCT04967885|101747819|FG000|NOT COMPLETED|EMI-II Intervention||14||
48578845|NCT04967885|101747820|FG001|NOT COMPLETED|EMI-II Intervention||10||
48578846|NCT03600194|101747821|FG000|STARTED|Screening||38||
48578847|NCT03600194|101747822|FG001|STARTED|Screening||0||
48578848|NCT03600194|101747823|FG002|STARTED|Screening||0||
48578849|NCT03600194|101747821|FG000|COMPLETED|Screening||11||
48578850|NCT03600194|101747822|FG001|COMPLETED|Screening||0||
48578851|NCT03600194|101747823|FG002|COMPLETED|Screening||0||
48578852|NCT03600194|101747821|FG000|NOT COMPLETED|Screening||27||
48578853|NCT03600194|101747822|FG001|NOT COMPLETED|Screening||0||
48578854|NCT03600194|101747823|FG002|NOT COMPLETED|Screening||0||
48578855|NCT03600194|101747821|FG000|STARTED|In Lab Phase||0||
48578856|NCT03600194|101747822|FG001|STARTED|In Lab Phase||5||
48578857|NCT03600194|101747823|FG002|STARTED|In Lab Phase||6||
48578858|NCT03600194|101747821|FG000|COMPLETED|In Lab Phase||0||
48578859|NCT03600194|101747822|FG001|COMPLETED|In Lab Phase||5||
48578860|NCT03600194|101747823|FG002|COMPLETED|In Lab Phase||6||
48578861|NCT03600194|101747821|FG000|NOT COMPLETED|In Lab Phase||0||
48578862|NCT03600194|101747822|FG001|NOT COMPLETED|In Lab Phase||0||
48578863|NCT03600194|101747823|FG002|NOT COMPLETED|In Lab Phase||0||
48578864|NCT05758402|101747824|FG000|STARTED|Overall Study||181|All enrolled participants were included in the Full Analysis Set (FAS)|
48578865|NCT05758402|101747825|FG001|STARTED|Overall Study||187|All enrolled participants were included in the Full Analysis Set (FAS)|
48578866|NCT05758402|101747824|FG000|COMPLETED|Overall Study||181||
48578867|NCT05758402|101747825|FG001|COMPLETED|Overall Study||187||
48578868|NCT05758402|101747824|FG000|NOT COMPLETED|Overall Study||0||
48578869|NCT05758402|101747825|FG001|NOT COMPLETED|Overall Study||0||
48578870|NCT01258998|101747826|FG000|STARTED|Overall Study||60||
48578871|NCT01258998|101747826|FG000|COMPLETED|Overall Study||59||
48578872|NCT01258998|101747826|FG000|NOT COMPLETED|Overall Study||1||
48578873|NCT03567005|101747827|FG000|STARTED|Period 1, First 7 Days of Wear||29||
48578874|NCT03567005|101747828|FG001|STARTED|Period 1, First 7 Days of Wear||31||
48578875|NCT03567005|101747827|FG000|COMPLETED|Period 1, First 7 Days of Wear||29||
48578876|NCT03567005|101747828|FG001|COMPLETED|Period 1, First 7 Days of Wear||31||
48286902|NCT03727438|101029594|FG001|STARTED|Baseline||90||
48286903|NCT03727438|101029593|FG000|COMPLETED|Baseline||88||
48286904|NCT03727438|101029594|FG001|COMPLETED|Baseline||90||
48286905|NCT03727438|101029593|FG000|NOT COMPLETED|Baseline||0||
48286906|NCT03727438|101029594|FG001|NOT COMPLETED|Baseline||0||
48286907|NCT03727438|101029593|FG000|STARTED|Intervention Period||88||
48286908|NCT03727438|101029594|FG001|STARTED|Intervention Period||90||
48286909|NCT03727438|101029593|FG000|COMPLETED|Intervention Period||77||
48578877|NCT03567005|101747827|FG000|NOT COMPLETED|Period 1, First 7 Days of Wear||0||
48578878|NCT03567005|101747828|FG001|NOT COMPLETED|Period 1, First 7 Days of Wear||0||
48578879|NCT03567005|101747827|FG000|STARTED|Period 2, Second 7 Days of Wear||29||
48578880|NCT03567005|101747828|FG001|STARTED|Period 2, Second 7 Days of Wear||31||
48578881|NCT03567005|101747827|FG000|COMPLETED|Period 2, Second 7 Days of Wear||29||
48578882|NCT03567005|101747828|FG001|COMPLETED|Period 2, Second 7 Days of Wear||31||
48578883|NCT03567005|101747827|FG000|NOT COMPLETED|Period 2, Second 7 Days of Wear||0||
48578884|NCT03567005|101747828|FG001|NOT COMPLETED|Period 2, Second 7 Days of Wear||0||
48578885|NCT00900159|101747829|FG000|STARTED|First Intervention||11||
48286910|NCT03727438|101029594|FG001|COMPLETED|Intervention Period||88||
48286911|NCT03727438|101029593|FG000|NOT COMPLETED|Intervention Period||11||
48286912|NCT03727438|101029594|FG001|NOT COMPLETED|Intervention Period||2||
48578886|NCT00900159|101747830|FG001|STARTED|First Intervention||13||
48578887|NCT00900159|101747829|FG000|COMPLETED|First Intervention||11||
48578888|NCT00900159|101747830|FG001|COMPLETED|First Intervention||13||
48578889|NCT00900159|101747829|FG000|NOT COMPLETED|First Intervention||0||
48578890|NCT00900159|101747830|FG001|NOT COMPLETED|First Intervention||0||
48578891|NCT00900159|101747829|FG000|STARTED|Washout||11||
48578892|NCT00900159|101747830|FG001|STARTED|Washout||13||
48578893|NCT00900159|101747829|FG000|COMPLETED|Washout||11||
48578894|NCT00900159|101747830|FG001|COMPLETED|Washout||13||
48578895|NCT00900159|101747829|FG000|NOT COMPLETED|Washout||0||
48578896|NCT00900159|101747830|FG001|NOT COMPLETED|Washout||0||
48578897|NCT00900159|101747829|FG000|STARTED|Second Intervention||11||
48578898|NCT00900159|101747830|FG001|STARTED|Second Intervention||13||
48578899|NCT00900159|101747829|FG000|COMPLETED|Second Intervention||10||
48578900|NCT00900159|101747830|FG001|COMPLETED|Second Intervention||13||
48578901|NCT00900159|101747829|FG000|NOT COMPLETED|Second Intervention||1||
48578902|NCT00900159|101747830|FG001|NOT COMPLETED|Second Intervention||0||
48578903|NCT01502332|101747831|FG000|STARTED|Overall Study||157||
48578904|NCT01502332|101747832|FG001|STARTED|Overall Study||163||
48578905|NCT01502332|101747831|FG000|COMPLETED|Overall Study||157||
48578906|NCT01502332|101747832|FG001|COMPLETED|Overall Study||163||
48578907|NCT01502332|101747831|FG000|NOT COMPLETED|Overall Study||0||
48578908|NCT01502332|101747832|FG001|NOT COMPLETED|Overall Study||0||
48578909|NCT00857896|101747833|FG000|STARTED|Baseline to Week 4||21||
48578910|NCT00857896|101747833|FG000|COMPLETED|Baseline to Week 4||20||
48578911|NCT00857896|101747833|FG000|NOT COMPLETED|Baseline to Week 4||1||
48578912|NCT00857896|101747833|FG000|STARTED|Week 5 to Week 8||20||
48578913|NCT00857896|101747833|FG000|COMPLETED|Week 5 to Week 8||20||
48578914|NCT00857896|101747833|FG000|NOT COMPLETED|Week 5 to Week 8||0||
48578915|NCT02632409|101747834|FG000|STARTED|Randomized||356|= Randomized|
48578916|NCT02632409|101747835|FG001|STARTED|Randomized||353|= Randomized|
48578917|NCT02632409|101747834|FG000|COMPLETED|Randomized||348|= Treated|
48578918|NCT02632409|101747835|FG001|COMPLETED|Randomized||351|= Treated|
48578919|NCT02632409|101747834|FG000|NOT COMPLETED|Randomized||8||
48578920|NCT02632409|101747835|FG001|NOT COMPLETED|Randomized||2||
48578921|NCT02632409|101747834|FG000|STARTED|Treatment Period||348|= Randomized and Treated|
48578922|NCT02632409|101747835|FG001|STARTED|Treatment Period||351|= Randomized and Treated|
48578923|NCT02632409|101747834|FG000|COMPLETED|Treatment Period||132||
48578924|NCT02632409|101747835|FG001|COMPLETED|Treatment Period||143||
48578925|NCT02632409|101747834|FG000|NOT COMPLETED|Treatment Period||216||
48578926|NCT02632409|101747835|FG001|NOT COMPLETED|Treatment Period||208||
48578927|NCT00977314|101747836|FG000|STARTED|Overall Study||30||
48578928|NCT00977314|101747837|FG001|STARTED|Overall Study||5||
48703498|NCT00778258|102060526|FG003|STARTED|Overall Study||15||
48703499|NCT00778258|102060527|FG004|STARTED|Overall Study||6||
48703500|NCT00778258|102060528|FG005|STARTED|Overall Study||23||
48703501|NCT00778258|102060529|FG006|STARTED|Overall Study||34||
48703502|NCT00778258|102060530|FG007|STARTED|Overall Study||41||
48578929|NCT00977314|101747836|FG000|COMPLETED|Overall Study||28||
48578930|NCT00977314|101747837|FG001|COMPLETED|Overall Study||5||
48578931|NCT00977314|101747836|FG000|NOT COMPLETED|Overall Study||2||
48578932|NCT00977314|101747837|FG001|NOT COMPLETED|Overall Study||0||
48578933|NCT06303167|101747838|FG000|STARTED|Overall Study||19||
48578934|NCT06303167|101747838|FG000|Started Protocol Therapy|Overall Study||17||
48578935|NCT06303167|101747838|FG000|Eligible and Treated|Overall Study||16||
48578936|NCT06303167|101747838|FG000|Eligible, Treated and Mutation Status Confirmed|Overall Study||13|Primary efficacy analysis set|
48578937|NCT06303167|101747838|FG000|COMPLETED|Overall Study||0||
48578938|NCT06303167|101747838|FG000|NOT COMPLETED|Overall Study||19||
48578939|NCT01250873|101750757|FG000|STARTED|Period 1: LY2216684 (Days 1-3)||20||
48578940|NCT01250873|101750757|FG000|COMPLETED|Period 1: LY2216684 (Days 1-3)||18||
48578941|NCT01250873|101750757|FG000|NOT COMPLETED|Period 1: LY2216684 (Days 1-3)||2||
48578942|NCT01250873|101750757|FG000|STARTED|Period 2: Sertraline (Day 4, 5-10)||18||
48578943|NCT01250873|101750757|FG000|COMPLETED|Period 2: Sertraline (Day 4, 5-10)||18||
48578944|NCT01250873|101750757|FG000|NOT COMPLETED|Period 2: Sertraline (Day 4, 5-10)||0||
48578945|NCT01250873|101750757|FG000|STARTED|Period 3:LY2216684+Sertraline(Days11-13)||18||
48578946|NCT01250873|101750757|FG000|COMPLETED|Period 3:LY2216684+Sertraline(Days11-13)||17||
48578947|NCT01250873|101750757|FG000|NOT COMPLETED|Period 3:LY2216684+Sertraline(Days11-13)||1||
48578948|NCT02040857|101750758|FG000|STARTED|Overall Study||162||
48578949|NCT02040857|101750758|FG000|Treatment Discontinuation Evaluable|Overall Study||152||
48286913|NCT03727438|101029593|FG000|STARTED|8 Week Assessment||84||
48286914|NCT03727438|101029594|FG001|STARTED|8 Week Assessment||89||
48286915|NCT03727438|101029593|FG000|COMPLETED|8 Week Assessment||70||
48286916|NCT03727438|101029594|FG001|COMPLETED|8 Week Assessment||83||
48286917|NCT03727438|101029593|FG000|NOT COMPLETED|8 Week Assessment||14||
48286918|NCT03727438|101029594|FG001|NOT COMPLETED|8 Week Assessment||6||
48286919|NCT03727438|101029593|FG000|STARTED|6 mo Assessment||78||
48578950|NCT02040857|101750758|FG000|COMPLETED|Overall Study||102||
48578951|NCT02040857|101750758|FG000|NOT COMPLETED|Overall Study||60||
48578952|NCT04542421|101750759|FG000|STARTED|Overall Study||86||
48286920|NCT03727438|101029594|FG001|STARTED|6 mo Assessment||88||
48578953|NCT04542421|101750760|FG001|STARTED|Overall Study||298||
48578954|NCT04542421|101750759|FG000|COMPLETED|Overall Study||86||
48578955|NCT04542421|101750760|FG001|COMPLETED|Overall Study||298||
48578956|NCT04542421|101750759|FG000|NOT COMPLETED|Overall Study||0||
48578957|NCT04542421|101750760|FG001|NOT COMPLETED|Overall Study||0||
48703503|NCT00778258|102060531|FG008|STARTED|Overall Study||10||
48703504|NCT00778258|102060523|FG000|COMPLETED|Overall Study||9||
48703505|NCT00778258|102060524|FG001|COMPLETED|Overall Study||3||
48703506|NCT00778258|102060525|FG002|COMPLETED|Overall Study||10||
48578958|NCT00601172|101750761|FG000|STARTED|Overall Study||355||
48578959|NCT00601172|101750762|FG001|STARTED|Overall Study||355||
48578960|NCT00601172|101750761|FG000|COMPLETED|Overall Study||214||
48703507|NCT00778258|102060526|FG003|COMPLETED|Overall Study||12||
48703508|NCT00778258|102060527|FG004|COMPLETED|Overall Study||6||
48703509|NCT00778258|102060528|FG005|COMPLETED|Overall Study||13||
48703510|NCT00778258|102060529|FG006|COMPLETED|Overall Study||19||
48703511|NCT00778258|102060530|FG007|COMPLETED|Overall Study||26||
48134577|NCT03131648|100651494|FG006|COMPLETED|Initial Treatment Period||0||
48134578|NCT03131648|100651495|FG007|COMPLETED|Initial Treatment Period||0||
48134579|NCT03131648|100651488|FG000|NOT COMPLETED|Initial Treatment Period||53||
48134580|NCT03131648|100651489|FG001|NOT COMPLETED|Initial Treatment Period||20||
48134581|NCT03131648|100651490|FG002|NOT COMPLETED|Initial Treatment Period||0||
48134582|NCT03131648|100651491|FG003|NOT COMPLETED|Initial Treatment Period||0||
48578961|NCT00601172|101750762|FG001|COMPLETED|Overall Study||228||
48703512|NCT00778258|102060531|FG008|COMPLETED|Overall Study||6||
48703513|NCT00778258|102060523|FG000|NOT COMPLETED|Overall Study||7||
48703514|NCT00778258|102060524|FG001|NOT COMPLETED|Overall Study||2||
48703515|NCT00778258|102060525|FG002|NOT COMPLETED|Overall Study||10||
48703516|NCT00778258|102060526|FG003|NOT COMPLETED|Overall Study||3||
48578962|NCT00601172|101750761|FG000|NOT COMPLETED|Overall Study||141||
48578963|NCT00601172|101750762|FG001|NOT COMPLETED|Overall Study||127||
48578964|NCT03628339|101750763|FG000|STARTED|Treatment Period 1||12||
48578965|NCT03628339|101750764|FG001|STARTED|Treatment Period 1||0||
48578966|NCT03628339|101750763|FG000|COMPLETED|Treatment Period 1||12||
48578967|NCT03628339|101750764|FG001|COMPLETED|Treatment Period 1||0||
48578968|NCT03628339|101750763|FG000|NOT COMPLETED|Treatment Period 1||0||
48578969|NCT03628339|101750764|FG001|NOT COMPLETED|Treatment Period 1||0||
48578970|NCT03628339|101750763|FG000|STARTED|Treatment Period 2||0||
48578971|NCT03628339|101750764|FG001|STARTED|Treatment Period 2||12||
48578972|NCT03628339|101750763|FG000|COMPLETED|Treatment Period 2||0||
48578973|NCT03628339|101750764|FG001|COMPLETED|Treatment Period 2||12||
48578974|NCT03628339|101750763|FG000|NOT COMPLETED|Treatment Period 2||0||
48578975|NCT03628339|101750764|FG001|NOT COMPLETED|Treatment Period 2||0||
48578976|NCT03005327|101750765|FG000|STARTED|Initial Treatment Period (24 Weeks)||2||
48578977|NCT03005327|101750766|FG001|STARTED|Initial Treatment Period (24 Weeks)||2||
48578978|NCT03005327|101750767|FG002|STARTED|Initial Treatment Period (24 Weeks)||2||
48578979|NCT03005327|101750768|FG003|STARTED|Initial Treatment Period (24 Weeks)||2||
48578980|NCT03005327|101750765|FG000|Received at Least 1 Dose of Study Drug|Initial Treatment Period (24 Weeks)||2||
48578981|NCT03005327|101750766|FG001|Received at Least 1 Dose of Study Drug|Initial Treatment Period (24 Weeks)||2||
48578982|NCT03005327|101750767|FG002|Received at Least 1 Dose of Study Drug|Initial Treatment Period (24 Weeks)||2||
48578983|NCT03005327|101750768|FG003|Received at Least 1 Dose of Study Drug|Initial Treatment Period (24 Weeks)||2||
48578984|NCT03005327|101750765|FG000|COMPLETED|Initial Treatment Period (24 Weeks)||2||
48578985|NCT03005327|101750766|FG001|COMPLETED|Initial Treatment Period (24 Weeks)||1||
48134583|NCT03131648|100651492|FG004|NOT COMPLETED|Initial Treatment Period||0||
48134584|NCT03131648|100651493|FG005|NOT COMPLETED|Initial Treatment Period||0||
48134585|NCT03131648|100651494|FG006|NOT COMPLETED|Initial Treatment Period||0||
48134586|NCT03131648|100651495|FG007|NOT COMPLETED|Initial Treatment Period||0||
48134587|NCT03131648|100651488|FG000|STARTED|Open-label Treatment||0|Open-label treatment period was in parallel to the maintenance treatment period.|
48134588|NCT03131648|100651489|FG001|STARTED|Open-label Treatment||0|Open-label treatment period was in parallel to the maintenance treatment period.|
48134589|NCT03131648|100651490|FG002|STARTED|Open-label Treatment||0|Open-label treatment period was in parallel to the maintenance treatment period.|
48134590|NCT03131648|100651491|FG003|STARTED|Open-label Treatment||0|Open-label treatment period was in parallel to the maintenance treatment period.|
48134591|NCT03131648|100651492|FG004|STARTED|Open-label Treatment||0|Open-label treatment period was in parallel to the maintenance treatment period.|
48134592|NCT03131648|100651493|FG005|STARTED|Open-label Treatment||0|Open-label treatment period was in parallel to the maintenance treatment period.|
48134593|NCT03131648|100651494|FG006|STARTED|Open-label Treatment||564|Open-label treatment period was in parallel to the maintenance treatment period.|
48134594|NCT03131648|100651495|FG007|STARTED|Open-label Treatment||0|Open-label treatment period was in parallel to the maintenance treatment period.|
48134595|NCT03131648|100651488|FG000|COMPLETED|Open-label Treatment||0||
48578986|NCT03005327|101750767|FG002|COMPLETED|Initial Treatment Period (24 Weeks)||1||
48578987|NCT03005327|101750768|FG003|COMPLETED|Initial Treatment Period (24 Weeks)||2||
48703517|NCT00778258|102060527|FG004|NOT COMPLETED|Overall Study||0||
48703518|NCT00778258|102060528|FG005|NOT COMPLETED|Overall Study||10||
48134596|NCT03131648|100651489|FG001|COMPLETED|Open-label Treatment||0||
48134597|NCT03131648|100651490|FG002|COMPLETED|Open-label Treatment||0||
48578988|NCT03005327|101750765|FG000|NOT COMPLETED|Initial Treatment Period (24 Weeks)||0||
48703519|NCT00778258|102060529|FG006|NOT COMPLETED|Overall Study||15||
48703520|NCT00778258|102060530|FG007|NOT COMPLETED|Overall Study||15||
48578989|NCT03005327|101750766|FG001|NOT COMPLETED|Initial Treatment Period (24 Weeks)||1||
48578990|NCT03005327|101750767|FG002|NOT COMPLETED|Initial Treatment Period (24 Weeks)||1||
48578991|NCT03005327|101750768|FG003|NOT COMPLETED|Initial Treatment Period (24 Weeks)||0||
48578992|NCT03005327|101750765|FG000|STARTED|Extension Phase (56 Months)||2||
48578993|NCT03005327|101750766|FG001|STARTED|Extension Phase (56 Months)||0||
48578994|NCT03005327|101750767|FG002|STARTED|Extension Phase (56 Months)||1||
48578995|NCT03005327|101750768|FG003|STARTED|Extension Phase (56 Months)||2||
48578996|NCT03005327|101750765|FG000|COMPLETED|Extension Phase (56 Months)||2||
48578997|NCT03005327|101750766|FG001|COMPLETED|Extension Phase (56 Months)||0||
48578998|NCT03005327|101750767|FG002|COMPLETED|Extension Phase (56 Months)||1||
48578999|NCT03005327|101750768|FG003|COMPLETED|Extension Phase (56 Months)||2||
48579000|NCT03005327|101750765|FG000|NOT COMPLETED|Extension Phase (56 Months)||0||
48579001|NCT03005327|101750766|FG001|NOT COMPLETED|Extension Phase (56 Months)||0||
48579002|NCT03005327|101750767|FG002|NOT COMPLETED|Extension Phase (56 Months)||0||
48579003|NCT03005327|101750768|FG003|NOT COMPLETED|Extension Phase (56 Months)||0||
48579004|NCT04019613|101750769|FG000|STARTED|Overall Study||4||
48579005|NCT04019613|101750769|FG000|COMPLETED|Overall Study||4||
48579006|NCT04019613|101750769|FG000|NOT COMPLETED|Overall Study||0||
48579007|NCT00910208|101750770|FG000|STARTED|Overall Study||69||
48579008|NCT00910208|101750771|FG001|STARTED|Overall Study||72||
48579009|NCT00910208|101750772|FG002|STARTED|Overall Study||70||
48579010|NCT00910208|101750770|FG000|COMPLETED|Overall Study||67||
48579011|NCT00910208|101750771|FG001|COMPLETED|Overall Study||70||
48579012|NCT00910208|101750772|FG002|COMPLETED|Overall Study||69||
48579013|NCT00910208|101750770|FG000|NOT COMPLETED|Overall Study||2||
48134598|NCT03131648|100651491|FG003|COMPLETED|Open-label Treatment||0||
48134599|NCT03131648|100651492|FG004|COMPLETED|Open-label Treatment||0||
48134600|NCT03131648|100651493|FG005|COMPLETED|Open-label Treatment||0||
48134601|NCT03131648|100651494|FG006|COMPLETED|Open-label Treatment||446||
48134602|NCT03131648|100651495|FG007|COMPLETED|Open-label Treatment||0||
48134603|NCT03131648|100651488|FG000|NOT COMPLETED|Open-label Treatment||0||
48134604|NCT03131648|100651489|FG001|NOT COMPLETED|Open-label Treatment||0||
48134605|NCT03131648|100651490|FG002|NOT COMPLETED|Open-label Treatment||0||
48134606|NCT03131648|100651491|FG003|NOT COMPLETED|Open-label Treatment||0||
48134607|NCT03131648|100651492|FG004|NOT COMPLETED|Open-label Treatment||0||
48134608|NCT03131648|100651493|FG005|NOT COMPLETED|Open-label Treatment||0||
48134609|NCT03131648|100651494|FG006|NOT COMPLETED|Open-label Treatment||118||
48134610|NCT03131648|100651495|FG007|NOT COMPLETED|Open-label Treatment||0||
48134611|NCT03131648|100651488|FG000|STARTED|Maintenance Treatment Period||0|Maintenance treatment period was in parallel to the open-label treatment period.|
48134612|NCT03131648|100651489|FG001|STARTED|Maintenance Treatment Period||0|Maintenance treatment period was in parallel to the open-label treatment period.|
48134613|NCT03131648|100651490|FG002|STARTED|Maintenance Treatment Period||71|Maintenance treatment period was in parallel to the open-label treatment period.|
48134614|NCT03131648|100651491|FG003|STARTED|Maintenance Treatment Period||78|Maintenance treatment period was in parallel to the open-label treatment period.|
48134615|NCT03131648|100651492|FG004|STARTED|Maintenance Treatment Period||36|Maintenance treatment period was in parallel to the open-label treatment period.|
48134616|NCT03131648|100651493|FG005|STARTED|Maintenance Treatment Period||29|Maintenance treatment period was in parallel to the open-label treatment period.|
48134617|NCT03131648|100651494|FG006|STARTED|Maintenance Treatment Period||0|Maintenance treatment period was in parallel to the open-label treatment period.|
48134618|NCT03131648|100651495|FG007|STARTED|Maintenance Treatment Period||0|Maintenance treatment period was in parallel to the open-label treatment period.|
48134619|NCT03131648|100651488|FG000|COMPLETED|Maintenance Treatment Period||0||
48134620|NCT03131648|100651489|FG001|COMPLETED|Maintenance Treatment Period||0||
48134621|NCT03131648|100651490|FG002|COMPLETED|Maintenance Treatment Period||44||
48579014|NCT00910208|101750771|FG001|NOT COMPLETED|Overall Study||2||
48579015|NCT00910208|101750772|FG002|NOT COMPLETED|Overall Study||1||
48579016|NCT00671528|101750773|FG000|STARTED|Overall Study||1||
48579017|NCT00671528|101750774|FG001|STARTED|Overall Study||1||
48579018|NCT00671528|101750775|FG002|STARTED|Overall Study||1||
48579019|NCT00671528|101750773|FG000|COMPLETED|Overall Study||1||
48579020|NCT00671528|101750774|FG001|COMPLETED|Overall Study||1||
48579021|NCT00671528|101750775|FG002|COMPLETED|Overall Study||1||
48579022|NCT00671528|101750773|FG000|NOT COMPLETED|Overall Study||0||
48579023|NCT00671528|101750774|FG001|NOT COMPLETED|Overall Study||0||
48579024|NCT00671528|101750775|FG002|NOT COMPLETED|Overall Study||0||
48579025|NCT02107859|101750776|FG000|STARTED|Overall Study||61||
48579026|NCT02107859|101750776|FG000|As-treated Population|Overall Study||61|Received at .least 1 dose of study drug|
48579027|NCT02107859|101750776|FG000|Intent-to-treat (ITT) Population|Overall Study||60|All participants who had at least 1 post-baseline efficacy assessment.|
48134622|NCT03131648|100651491|FG003|COMPLETED|Maintenance Treatment Period||53||
48134623|NCT03131648|100651492|FG004|COMPLETED|Maintenance Treatment Period||21||
48134624|NCT03131648|100651493|FG005|COMPLETED|Maintenance Treatment Period||15||
48134625|NCT03131648|100651494|FG006|COMPLETED|Maintenance Treatment Period||0||
48134626|NCT03131648|100651495|FG007|COMPLETED|Maintenance Treatment Period||0||
48134627|NCT03131648|100651488|FG000|NOT COMPLETED|Maintenance Treatment Period||0||
48134628|NCT03131648|100651489|FG001|NOT COMPLETED|Maintenance Treatment Period||0||
48134629|NCT03131648|100651490|FG002|NOT COMPLETED|Maintenance Treatment Period||27||
48134630|NCT03131648|100651491|FG003|NOT COMPLETED|Maintenance Treatment Period||25||
48134631|NCT03131648|100651492|FG004|NOT COMPLETED|Maintenance Treatment Period||15||
48134632|NCT03131648|100651493|FG005|NOT COMPLETED|Maintenance Treatment Period||14||
48134633|NCT03131648|100651494|FG006|NOT COMPLETED|Maintenance Treatment Period||0||
48134634|NCT03131648|100651495|FG007|NOT COMPLETED|Maintenance Treatment Period||0||
48134635|NCT03131648|100651488|FG000|STARTED|Open-label (Short Term Extension)||0||
48134636|NCT03131648|100651489|FG001|STARTED|Open-label (Short Term Extension)||0||
48579028|NCT02107859|101750776|FG000|COMPLETED|Overall Study||0||
48579029|NCT02107859|101750776|FG000|NOT COMPLETED|Overall Study||61||
48579030|NCT02342197|101750777|FG000|STARTED|Overall Study||30||
48579031|NCT02342197|101750778|FG001|STARTED|Overall Study||30||
48579032|NCT02342197|101750777|FG000|COMPLETED|Overall Study||27||
48579033|NCT02342197|101750778|FG001|COMPLETED|Overall Study||28||
48134637|NCT03131648|100651490|FG002|STARTED|Open-label (Short Term Extension)||0||
48134638|NCT03131648|100651491|FG003|STARTED|Open-label (Short Term Extension)||0||
48134639|NCT03131648|100651492|FG004|STARTED|Open-label (Short Term Extension)||0||
48134640|NCT03131648|100651493|FG005|STARTED|Open-label (Short Term Extension)||0||
48134641|NCT03131648|100651494|FG006|STARTED|Open-label (Short Term Extension)||0||
48286921|NCT03727438|101029593|FG000|COMPLETED|6 mo Assessment||68||
48286922|NCT03727438|101029594|FG001|COMPLETED|6 mo Assessment||77||
48286923|NCT03727438|101029593|FG000|NOT COMPLETED|6 mo Assessment||10||
48286924|NCT03727438|101029594|FG001|NOT COMPLETED|6 mo Assessment||11||
48286925|NCT01621737|101029595|FG000|STARTED|Overall Study||0||
48286926|NCT01621737|101029595|FG000|COMPLETED|Overall Study||0||
48579034|NCT02342197|101750777|FG000|NOT COMPLETED|Overall Study||3||
48703521|NCT00778258|102060531|FG008|NOT COMPLETED|Overall Study||4||
48703522|NCT02557100|102060532|FG000|STARTED|Single Blind Treatment Period||40|= treated|
48703523|NCT02557100|102060533|FG001|STARTED|Single Blind Treatment Period||40|= treated|
48703524|NCT02557100|102060534|FG002|STARTED|Single Blind Treatment Period||0|= treated|
48703525|NCT02557100|102060532|FG000|COMPLETED|Single Blind Treatment Period||40|= completed treatment|
48703526|NCT02557100|102060533|FG001|COMPLETED|Single Blind Treatment Period||36|= completed treatment|
48703527|NCT02557100|102060534|FG002|COMPLETED|Single Blind Treatment Period||0|= completed treatment|
48703528|NCT02557100|102060532|FG000|NOT COMPLETED|Single Blind Treatment Period||0||
48703529|NCT02557100|102060533|FG001|NOT COMPLETED|Single Blind Treatment Period||4||
48703530|NCT02557100|102060534|FG002|NOT COMPLETED|Single Blind Treatment Period||0||
48703531|NCT02557100|102060532|FG000|STARTED|Transition to Open Label||40||
48579035|NCT02342197|101750778|FG001|NOT COMPLETED|Overall Study||2||
48579036|NCT01949844|101750779|FG000|STARTED|Overall Study||44||
48579037|NCT01949844|101750779|FG000|COMPLETED|Overall Study||44||
48579038|NCT01949844|101750779|FG000|NOT COMPLETED|Overall Study||0||
48579039|NCT00325156|101750780|FG000|STARTED|Overall Study||2590||
48579040|NCT00325156|101750780|FG000|COMPLETED|Overall Study||2478||
48579041|NCT00325156|101750780|FG000|NOT COMPLETED|Overall Study||112||
48579042|NCT02048826|101750781|FG000|STARTED|Overall Study||16||
48703532|NCT02557100|102060533|FG001|STARTED|Transition to Open Label||36||
48703533|NCT02557100|102060534|FG002|STARTED|Transition to Open Label||0||
48703534|NCT02557100|102060532|FG000|COMPLETED|Transition to Open Label||0||
48134642|NCT03131648|100651495|FG007|STARTED|Open-label (Short Term Extension)||65||
48134643|NCT03131648|100651488|FG000|COMPLETED|Open-label (Short Term Extension)||0||
48134644|NCT03131648|100651489|FG001|COMPLETED|Open-label (Short Term Extension)||0||
48134645|NCT03131648|100651490|FG002|COMPLETED|Open-label (Short Term Extension)||0||
48134646|NCT03131648|100651491|FG003|COMPLETED|Open-label (Short Term Extension)||0||
48134647|NCT03131648|100651492|FG004|COMPLETED|Open-label (Short Term Extension)||0||
48134648|NCT03131648|100651493|FG005|COMPLETED|Open-label (Short Term Extension)||0||
48134649|NCT03131648|100651494|FG006|COMPLETED|Open-label (Short Term Extension)||0||
48141447|NCT01780922|100670428|FG005|STARTED|Washout (7 Days)||2||
48286927|NCT01621737|101029595|FG000|NOT COMPLETED|Overall Study||0||
48286928|NCT00345293|101029596|FG000|STARTED|Overall Study||10||
48579043|NCT02048826|101750782|FG001|STARTED|Overall Study||15||
48579044|NCT02048826|101750781|FG000|COMPLETED|Overall Study||15||
48703535|NCT02557100|102060533|FG001|COMPLETED|Transition to Open Label||0||
48579045|NCT02048826|101750782|FG001|COMPLETED|Overall Study||15||
48579046|NCT02048826|101750781|FG000|NOT COMPLETED|Overall Study||1||
48579047|NCT02048826|101750782|FG001|NOT COMPLETED|Overall Study||0||
48703536|NCT02557100|102060534|FG002|COMPLETED|Transition to Open Label||0||
48703537|NCT02557100|102060532|FG000|NOT COMPLETED|Transition to Open Label||40||
48703538|NCT02557100|102060533|FG001|NOT COMPLETED|Transition to Open Label||36||
48703539|NCT02557100|102060534|FG002|NOT COMPLETED|Transition to Open Label||0||
48703540|NCT02557100|102060532|FG000|STARTED|Cumulative Abatacept Period||0||
48703541|NCT02557100|102060533|FG001|STARTED|Cumulative Abatacept Period||0||
48400188|NCT02873208|101309311|FG000|STARTED|Overall Study||265||
48400189|NCT02873208|101309311|FG000|COMPLETED|Overall Study||167||
48400190|NCT02873208|101309311|FG000|NOT COMPLETED|Overall Study||98||
48579048|NCT01217476|101750783|FG000|STARTED|Overall Study||105||
48579049|NCT01217476|101750784|FG001|STARTED|Overall Study||102||
48579050|NCT01217476|101750783|FG000|COMPLETED|Overall Study||93||
48703542|NCT02557100|102060534|FG002|STARTED|Cumulative Abatacept Period||76||
48579051|NCT01217476|101750784|FG001|COMPLETED|Overall Study||95||
48579052|NCT01217476|101750783|FG000|NOT COMPLETED|Overall Study||12||
48579053|NCT01217476|101750784|FG001|NOT COMPLETED|Overall Study||7||
48579054|NCT02258373|101750785|FG000|STARTED|Overall Study||149||
48703543|NCT02557100|102060532|FG000|COMPLETED|Cumulative Abatacept Period||0||
48703544|NCT02557100|102060533|FG001|COMPLETED|Cumulative Abatacept Period||0||
48703545|NCT02557100|102060534|FG002|COMPLETED|Cumulative Abatacept Period||72||
48703546|NCT02557100|102060532|FG000|NOT COMPLETED|Cumulative Abatacept Period||0||
48703547|NCT02557100|102060533|FG001|NOT COMPLETED|Cumulative Abatacept Period||0||
48703548|NCT02557100|102060534|FG002|NOT COMPLETED|Cumulative Abatacept Period||4||
48703549|NCT02570152|102060535|FG000|STARTED|Overall Study||2004|2004|
48134650|NCT03131648|100651495|FG007|COMPLETED|Open-label (Short Term Extension)||62||
48134651|NCT03131648|100651488|FG000|NOT COMPLETED|Open-label (Short Term Extension)||0||
48579055|NCT02258373|101750786|FG001|STARTED|Overall Study||77||
48579056|NCT02258373|101750785|FG000|COMPLETED|Overall Study||142||
48579057|NCT02258373|101750786|FG001|COMPLETED|Overall Study||75||
48579058|NCT02258373|101750785|FG000|NOT COMPLETED|Overall Study||7||
48579059|NCT02258373|101750786|FG001|NOT COMPLETED|Overall Study||2||
48579060|NCT00617890|101750787|FG000|STARTED|Overall Study||35||
48579061|NCT00617890|101750788|FG001|STARTED|Overall Study||33||
48579062|NCT00617890|101750789|FG002|STARTED|Overall Study||35||
48579063|NCT00617890|101750790|FG003|STARTED|Overall Study||116||
48579064|NCT00617890|101750787|FG000|Received Treatment|Overall Study||34||
48579065|NCT00617890|101750788|FG001|Received Treatment|Overall Study||33||
48579066|NCT00617890|101750789|FG002|Received Treatment|Overall Study||34||
48579067|NCT00617890|101750790|FG003|Received Treatment|Overall Study||115||
48579068|NCT00617890|101750787|FG000|COMPLETED|Overall Study||4||
48579069|NCT00617890|101750788|FG001|COMPLETED|Overall Study||5||
48579070|NCT00617890|101750789|FG002|COMPLETED|Overall Study||0||
48579071|NCT00617890|101750790|FG003|COMPLETED|Overall Study||1||
48579072|NCT00617890|101750787|FG000|NOT COMPLETED|Overall Study||31||
48579073|NCT00617890|101750788|FG001|NOT COMPLETED|Overall Study||28||
48579074|NCT00617890|101750789|FG002|NOT COMPLETED|Overall Study||35||
48579075|NCT00617890|101750790|FG003|NOT COMPLETED|Overall Study||115||
48579076|NCT02049905|101750791|FG000|STARTED|Overall Study||218||
48579077|NCT02049905|101750792|FG001|STARTED|Overall Study||215||
48579078|NCT02049905|101750791|FG000|Safety Population|Overall Study||213||
48579079|NCT02049905|101750792|FG001|Safety Population|Overall Study||207||
48579080|NCT02049905|101750791|FG000|COMPLETED|Overall Study||213|Completed defined as receiving at least one dose of study drug.|
48579081|NCT02049905|101750792|FG001|COMPLETED|Overall Study||207|Completed defined as receiving at least one dose of study drug.|
48579082|NCT02049905|101750791|FG000|NOT COMPLETED|Overall Study||5||
48579083|NCT02049905|101750792|FG001|NOT COMPLETED|Overall Study||8||
48579084|NCT04679311|101750793|FG000|STARTED|Overall Study||0||
48579085|NCT04679311|101750794|FG001|STARTED|Overall Study||2||
48579086|NCT04679311|101750793|FG000|COMPLETED|Overall Study||0||
48579087|NCT04679311|101750794|FG001|COMPLETED|Overall Study||0||
48579088|NCT04679311|101750793|FG000|NOT COMPLETED|Overall Study||0||
48703550|NCT02570152|102060535|FG000|COMPLETED|Overall Study||1989|1989|
48703551|NCT02570152|102060535|FG000|NOT COMPLETED|Overall Study||15||
48703552|NCT01920568|102060536|FG000|STARTED|Overall Study||326||
48703553|NCT01920568|102060537|FG001|STARTED|Overall Study||159||
48703554|NCT01920568|102060536|FG000|COMPLETED|Overall Study||175||
48134652|NCT03131648|100651489|FG001|NOT COMPLETED|Open-label (Short Term Extension)||0||
48134653|NCT03131648|100651490|FG002|NOT COMPLETED|Open-label (Short Term Extension)||0||
48134654|NCT03131648|100651491|FG003|NOT COMPLETED|Open-label (Short Term Extension)||0||
48134655|NCT03131648|100651492|FG004|NOT COMPLETED|Open-label (Short Term Extension)||0||
48134656|NCT03131648|100651493|FG005|NOT COMPLETED|Open-label (Short Term Extension)||0||
48579089|NCT04679311|101750794|FG001|NOT COMPLETED|Overall Study||2||
48134657|NCT03131648|100651494|FG006|NOT COMPLETED|Open-label (Short Term Extension)||0||
48134658|NCT03131648|100651495|FG007|NOT COMPLETED|Open-label (Short Term Extension)||3||
48400191|NCT02291445|101309312|FG000|STARTED|Overall Study||4||
48400192|NCT02291445|101309313|FG001|STARTED|Overall Study||4||
48400193|NCT02291445|101309312|FG000|COMPLETED|Overall Study||4||
48400194|NCT02291445|101309313|FG001|COMPLETED|Overall Study||4||
48579090|NCT00661609|101750795|FG000|STARTED|Overall Study||41||
48579091|NCT00661609|101750795|FG000|COMPLETED|Overall Study||0||
48579092|NCT00661609|101750795|FG000|NOT COMPLETED|Overall Study||41||
48579093|NCT00544115|101750796|FG000|STARTED|Overall Study||62||
48579094|NCT00544115|101750797|FG001|STARTED|Overall Study||17||
48579095|NCT00544115|101750798|FG002|STARTED|Overall Study||130||
48579096|NCT00544115|101750799|FG003|STARTED|Overall Study||4||
48703555|NCT01920568|102060537|FG001|COMPLETED|Overall Study||75||
48703556|NCT01920568|102060536|FG000|NOT COMPLETED|Overall Study||151||
48134659|NCT00856583|100651496|FG000|STARTED|Overall Study||4905||
48134660|NCT00856583|100651497|FG001|STARTED|Overall Study||4904||
48134661|NCT00856583|100651496|FG000|COMPLETED|Overall Study||1768||
48134662|NCT00856583|100651497|FG001|COMPLETED|Overall Study||2307||
48134663|NCT00856583|100651496|FG000|NOT COMPLETED|Overall Study||3137||
48134664|NCT00856583|100651497|FG001|NOT COMPLETED|Overall Study||2597||
48134665|NCT04634604|100651498|FG000|STARTED|Overall Study||9||
48134666|NCT04634604|100651499|FG001|STARTED|Overall Study||7||
48134667|NCT04634604|100651498|FG000|COMPLETED|Overall Study||9||
48134668|NCT04634604|100651499|FG001|COMPLETED|Overall Study||7||
48400195|NCT02291445|101309312|FG000|NOT COMPLETED|Overall Study||0||
48400196|NCT02291445|101309313|FG001|NOT COMPLETED|Overall Study||0||
48400197|NCT01400139|101309314|FG000|STARTED|HYD Core Study||922||
48400198|NCT01400139|101309314|FG000|COMPLETED|HYD Core Study||410||
48400199|NCT01400139|101309314|FG000|NOT COMPLETED|HYD Core Study||512||
48400200|NCT01400139|101309314|FG000|STARTED|HYD Extension Period||106||
48400201|NCT01400139|101309314|FG000|COMPLETED|HYD Extension Period||83||
48400202|NCT01400139|101309314|FG000|NOT COMPLETED|HYD Extension Period||23||
48400203|NCT02920450|101309315|FG000|STARTED|Overall Study||3||
48400204|NCT02920450|101309316|FG001|STARTED|Overall Study||0||
48400205|NCT02920450|101309317|FG002|STARTED|Overall Study||0||
48400206|NCT02920450|101309318|FG003|STARTED|Overall Study||0||
48134669|NCT04634604|100651498|FG000|NOT COMPLETED|Overall Study||0||
48134670|NCT04634604|100651499|FG001|NOT COMPLETED|Overall Study||0||
48134671|NCT00344682|100651500|FG000|STARTED|Overall Study||16||
48400207|NCT02920450|101309315|FG000|COMPLETED|Overall Study||1||
48400208|NCT02920450|101309316|FG001|COMPLETED|Overall Study||0||
48400209|NCT02920450|101309317|FG002|COMPLETED|Overall Study||0||
48400210|NCT02920450|101309318|FG003|COMPLETED|Overall Study||0||
48400211|NCT02920450|101309315|FG000|NOT COMPLETED|Overall Study||2||
48400212|NCT02920450|101309316|FG001|NOT COMPLETED|Overall Study||0||
48400213|NCT02920450|101309317|FG002|NOT COMPLETED|Overall Study||0||
48400214|NCT02920450|101309318|FG003|NOT COMPLETED|Overall Study||0||
48400215|NCT02046382|101309319|FG000|STARTED|Overall Study||65||
48134672|NCT00344682|100651501|FG001|STARTED|Overall Study||15||
48134673|NCT00344682|100651500|FG000|COMPLETED|Overall Study||12||
48134674|NCT00344682|100651501|FG001|COMPLETED|Overall Study||14||
48134675|NCT00344682|100651500|FG000|NOT COMPLETED|Overall Study||4||
48134676|NCT00344682|100651501|FG001|NOT COMPLETED|Overall Study||1||
48579097|NCT00544115|101750800|FG004|STARTED|Overall Study||40||
48579098|NCT00544115|101750801|FG005|STARTED|Overall Study||2||
48579099|NCT00544115|101750796|FG000|COMPLETED|Overall Study||62||
48579100|NCT00544115|101750797|FG001|COMPLETED|Overall Study||17||
48579101|NCT00544115|101750798|FG002|COMPLETED|Overall Study||130||
48579102|NCT00544115|101750799|FG003|COMPLETED|Overall Study||4||
48579103|NCT00544115|101750800|FG004|COMPLETED|Overall Study||40||
48579104|NCT00544115|101750801|FG005|COMPLETED|Overall Study||2||
48579105|NCT00544115|101750796|FG000|NOT COMPLETED|Overall Study||0||
48134677|NCT02830594|100651502|FG000|STARTED|Overall Study||14||
48134678|NCT02830594|100651502|FG000|COMPLETED|Overall Study||14||
48134679|NCT02830594|100651502|FG000|NOT COMPLETED|Overall Study||0||
48400216|NCT02046382|101309320|FG001|STARTED|Overall Study||67||
48400217|NCT02046382|101309319|FG000|COMPLETED|Overall Study||57||
48400218|NCT02046382|101309320|FG001|COMPLETED|Overall Study||47||
48400219|NCT02046382|101309319|FG000|NOT COMPLETED|Overall Study||8||
48400220|NCT02046382|101309320|FG001|NOT COMPLETED|Overall Study||20||
48400221|NCT02563925|101309321|FG000|STARTED|Overall Study||28||
48400222|NCT02563925|101309321|FG000|COMPLETED|Overall Study||26||
48400223|NCT02563925|101309321|FG000|NOT COMPLETED|Overall Study||2||
48400224|NCT01688999|101309322|FG000|STARTED|Overall Study||50||
48400225|NCT01688999|101309323|FG001|STARTED|Overall Study||6||
48400226|NCT01688999|101309324|FG002|STARTED|Overall Study||13||
48400227|NCT01688999|101309322|FG000|COMPLETED|Overall Study||42||
48400228|NCT01688999|101309323|FG001|COMPLETED|Overall Study||5||
48400229|NCT01688999|101309324|FG002|COMPLETED|Overall Study||10||
48400230|NCT01688999|101309322|FG000|NOT COMPLETED|Overall Study||8||
48400231|NCT01688999|101309323|FG001|NOT COMPLETED|Overall Study||1||
48400232|NCT01688999|101309324|FG002|NOT COMPLETED|Overall Study||3||
48400233|NCT03955055|101309325|FG000|STARTED|Overall Study||15||
48400234|NCT03955055|101309326|FG001|STARTED|Overall Study||20||
48400235|NCT03955055|101309325|FG000|COMPLETED|Overall Study||14||
48400236|NCT03955055|101309326|FG001|COMPLETED|Overall Study||18||
48400237|NCT03955055|101309325|FG000|NOT COMPLETED|Overall Study||1||
48400238|NCT03955055|101309326|FG001|NOT COMPLETED|Overall Study||2||
48579106|NCT00544115|101750797|FG001|NOT COMPLETED|Overall Study||0||
48134680|NCT03016871|100651503|FG000|STARTED|Overall Study||43||
48134681|NCT03016871|100651504|FG001|STARTED|Overall Study||35||
48134682|NCT03016871|100651503|FG000|COMPLETED|Overall Study||43||
48134683|NCT03016871|100651504|FG001|COMPLETED|Overall Study||35||
48400239|NCT02314598|101309327|FG000|STARTED|Overall Study||46||
48400240|NCT02314598|101309327|FG000|COMPLETED|Overall Study||46||
48400241|NCT02314598|101309327|FG000|NOT COMPLETED|Overall Study||0||
48400242|NCT02944513|101309328|FG000|STARTED|Overall Study||35||
48400243|NCT02944513|101309329|FG001|STARTED|Overall Study||33||
48400244|NCT02944513|101309328|FG000|COMPLETED|Overall Study||31||
48400245|NCT02944513|101309329|FG001|COMPLETED|Overall Study||32||
48400246|NCT02944513|101309328|FG000|NOT COMPLETED|Overall Study||4||
48400247|NCT02944513|101309329|FG001|NOT COMPLETED|Overall Study||1||
48400248|NCT00371540|101309330|FG000|STARTED|Overall Study||112||
48579107|NCT00544115|101750798|FG002|NOT COMPLETED|Overall Study||0||
48579108|NCT00544115|101750799|FG003|NOT COMPLETED|Overall Study||0||
48579109|NCT00544115|101750800|FG004|NOT COMPLETED|Overall Study||0||
48579110|NCT00544115|101750801|FG005|NOT COMPLETED|Overall Study||0||
48579111|NCT02727777|101750802|FG000|STARTED|Overall Study||4||
48579112|NCT02727777|101750803|FG001|STARTED|Overall Study||0||
48579113|NCT02727777|101750804|FG002|STARTED|Overall Study||0||
48579114|NCT02727777|101750802|FG000|COMPLETED|Overall Study||0||
48579115|NCT02727777|101750803|FG001|COMPLETED|Overall Study||0||
48579116|NCT02727777|101750804|FG002|COMPLETED|Overall Study||0||
48579117|NCT02727777|101750802|FG000|NOT COMPLETED|Overall Study||4||
48579118|NCT02727777|101750803|FG001|NOT COMPLETED|Overall Study||0||
48579119|NCT02727777|101750804|FG002|NOT COMPLETED|Overall Study||0||
48579120|NCT01644292|101750805|FG000|STARTED|Overall Study||2||
48579121|NCT01644292|101750805|FG000|COMPLETED|Overall Study||2||
48579122|NCT01644292|101750805|FG000|NOT COMPLETED|Overall Study||0||
48579123|NCT01609543|101750806|FG000|STARTED|Overall Study||62||
48579124|NCT01609543|101750806|FG000|COMPLETED|Overall Study||20||
48579125|NCT01609543|101750806|FG000|NOT COMPLETED|Overall Study||42||
48579126|NCT04431908|101750807|FG000|STARTED|Overall Study||1042||
48579127|NCT04431908|101750808|FG001|STARTED|Overall Study||278||
48579128|NCT04431908|101750807|FG000|COMPLETED|Overall Study||1042||
48579129|NCT04431908|101750808|FG001|COMPLETED|Overall Study||278||
48579130|NCT04431908|101750807|FG000|NOT COMPLETED|Overall Study||0||
48579131|NCT04431908|101750808|FG001|NOT COMPLETED|Overall Study||0||
48579132|NCT00986921|101750809|FG000|STARTED|Overall Study||25||
48579133|NCT00986921|101750810|FG001|STARTED|Overall Study||25||
48579134|NCT00986921|101750809|FG000|COMPLETED|Overall Study||24||
48579135|NCT00986921|101750810|FG001|COMPLETED|Overall Study||25||
48579136|NCT00986921|101750809|FG000|NOT COMPLETED|Overall Study||1||
48579137|NCT00986921|101750810|FG001|NOT COMPLETED|Overall Study||0||
48579138|NCT04392375|101750811|FG000|STARTED|Overall Study||55||
48579139|NCT04392375|101750812|FG001|STARTED|Overall Study||55||
48579140|NCT04392375|101750811|FG000|COMPLETED|Overall Study||53||
48579141|NCT04392375|101750812|FG001|COMPLETED|Overall Study||49||
48579142|NCT04392375|101750811|FG000|NOT COMPLETED|Overall Study||2||
48579143|NCT04392375|101750812|FG001|NOT COMPLETED|Overall Study||6||
48579144|NCT03233529|101750813|FG000|STARTED|Double-Blind Period (Day 1 to Day 15)||40||
48579145|NCT03233529|101750813|FG000|COMPLETED|Double-Blind Period (Day 1 to Day 15)||39||
48579146|NCT03233529|101750813|FG000|NOT COMPLETED|Double-Blind Period (Day 1 to Day 15)||1||
48400249|NCT00371540|101309331|FG001|STARTED|Overall Study||96||
48400250|NCT00371540|101309330|FG000|COMPLETED|Overall Study||102||
48579147|NCT03233529|101750813|FG000|STARTED|Open-Label Period (Day 15 to Day 71)||39||
48579148|NCT03233529|101750813|FG000|COMPLETED|Open-Label Period (Day 15 to Day 71)||38||
48579149|NCT03233529|101750813|FG000|NOT COMPLETED|Open-Label Period (Day 15 to Day 71)||1||
48579150|NCT00507728|101750814|FG000|STARTED|Randomization to Month 3||75||
48579151|NCT00507728|101750815|FG001|STARTED|Randomization to Month 3||89||
48579152|NCT00507728|101750816|FG002|STARTED|Randomization to Month 3||90||
48579153|NCT00507728|101750814|FG000|COMPLETED|Randomization to Month 3||60||
48579154|NCT00507728|101750815|FG001|COMPLETED|Randomization to Month 3||75||
48579155|NCT00507728|101750816|FG002|COMPLETED|Randomization to Month 3||70||
48579156|NCT00507728|101750814|FG000|NOT COMPLETED|Randomization to Month 3||15||
48400251|NCT00371540|101309331|FG001|COMPLETED|Overall Study||87||
48400252|NCT00371540|101309330|FG000|NOT COMPLETED|Overall Study||10||
48579157|NCT00507728|101750815|FG001|NOT COMPLETED|Randomization to Month 3||14||
48579158|NCT00507728|101750816|FG002|NOT COMPLETED|Randomization to Month 3||20||
48579159|NCT00507728|101750814|FG000|STARTED|From 3 Months to 6 Months||60||
48579160|NCT00507728|101750815|FG001|STARTED|From 3 Months to 6 Months||75||
48579161|NCT00507728|101750816|FG002|STARTED|From 3 Months to 6 Months||70||
48579162|NCT00507728|101750814|FG000|COMPLETED|From 3 Months to 6 Months||54||
48579163|NCT00507728|101750815|FG001|COMPLETED|From 3 Months to 6 Months||65||
48579164|NCT00507728|101750816|FG002|COMPLETED|From 3 Months to 6 Months||61||
48579165|NCT00507728|101750814|FG000|NOT COMPLETED|From 3 Months to 6 Months||6||
48579166|NCT00507728|101750815|FG001|NOT COMPLETED|From 3 Months to 6 Months||10||
48579167|NCT00507728|101750816|FG002|NOT COMPLETED|From 3 Months to 6 Months||9||
48579168|NCT00943150|101750817|FG000|STARTED|Overall Study||10||
48579169|NCT00943150|101750818|FG001|STARTED|Overall Study||10||
48703557|NCT01920568|102060537|FG001|NOT COMPLETED|Overall Study||84||
48134684|NCT03016871|100651503|FG000|NOT COMPLETED|Overall Study||0||
48134685|NCT03016871|100651504|FG001|NOT COMPLETED|Overall Study||0||
48134686|NCT04862143|100651505|FG000|STARTED|Overall Study||2||
48134687|NCT04862143|100651505|FG000|COMPLETED|Overall Study||0||
48579170|NCT00943150|101750817|FG000|COMPLETED|Overall Study||10||
48579171|NCT00943150|101750818|FG001|COMPLETED|Overall Study||10||
48579172|NCT00943150|101750817|FG000|NOT COMPLETED|Overall Study||0||
48579173|NCT00943150|101750818|FG001|NOT COMPLETED|Overall Study||0||
48579174|NCT01940887|101750819|FG000|STARTED|Year 1||322||
48579175|NCT01940887|101750820|FG001|STARTED|Year 1||320||
48134688|NCT04862143|100651505|FG000|NOT COMPLETED|Overall Study||2||
48134689|NCT02255175|100651506|FG000|STARTED|Overall Study||33||
48134690|NCT02255175|100651507|FG001|STARTED|Overall Study||31||
48134691|NCT02255175|100651506|FG000|COMPLETED|Overall Study||16||
48134692|NCT02255175|100651507|FG001|COMPLETED|Overall Study||19||
48134693|NCT02255175|100651506|FG000|NOT COMPLETED|Overall Study||17||
48134694|NCT02255175|100651507|FG001|NOT COMPLETED|Overall Study||12||
48134695|NCT02601313|100651508|FG000|STARTED|Overall Study||14||
48134696|NCT02601313|100651509|FG001|STARTED|Overall Study||74||
48703558|NCT02778555|102060538|FG000|STARTED|Overall Study||186||
48703559|NCT02778555|102060539|FG001|STARTED|Overall Study||209||
48134697|NCT02601313|100651510|FG002|STARTED|Overall Study||17||
48134698|NCT02601313|100651508|FG000|COMPLETED|Overall Study||8||
48134699|NCT02601313|100651509|FG001|COMPLETED|Overall Study||0||
48134700|NCT02601313|100651510|FG002|COMPLETED|Overall Study||0||
48134701|NCT02601313|100651508|FG000|NOT COMPLETED|Overall Study||6||
48134702|NCT02601313|100651509|FG001|NOT COMPLETED|Overall Study||74||
48134703|NCT02601313|100651510|FG002|NOT COMPLETED|Overall Study||17||
48134704|NCT01276587|100651511|FG000|STARTED|Overall Study||4||
48134705|NCT01276587|100651511|FG000|COMPLETED|Overall Study||4||
48134706|NCT01276587|100651511|FG000|NOT COMPLETED|Overall Study||0||
48134707|NCT00254982|100651512|FG000|STARTED|Overall Study||297||
48134708|NCT00254982|100651513|FG001|STARTED|Overall Study||296||
48134709|NCT00254982|100651512|FG000|COMPLETED|Overall Study||261||
48134710|NCT00254982|100651513|FG001|COMPLETED|Overall Study||265||
48134711|NCT00254982|100651512|FG000|NOT COMPLETED|Overall Study||36||
48134712|NCT00254982|100651513|FG001|NOT COMPLETED|Overall Study||31||
48134713|NCT02528214|100651514|FG000|STARTED|Overall Study||107||
48134714|NCT02528214|100651515|FG001|STARTED|Overall Study||103||
48134715|NCT02528214|100651514|FG000|Treated|Overall Study||107||
48134716|NCT02528214|100651515|FG001|Treated|Overall Study||103||
48134717|NCT02528214|100651514|FG000|COMPLETED|Overall Study||107||
48134718|NCT02528214|100651515|FG001|COMPLETED|Overall Study||100||
48134719|NCT02528214|100651514|FG000|NOT COMPLETED|Overall Study||0||
48134720|NCT02528214|100651515|FG001|NOT COMPLETED|Overall Study||3||
48134721|NCT00970502|100651516|FG000|STARTED|Overall Study||15||
48134722|NCT00970502|100651516|FG000|COMPLETED|Overall Study||14||
48134723|NCT00970502|100651516|FG000|NOT COMPLETED|Overall Study||1||
48134724|NCT01197950|100651517|FG000|STARTED|Overall Study||99||
48134725|NCT01197950|100651518|FG001|STARTED|Overall Study||103||
48134726|NCT01197950|100651519|FG002|STARTED|Overall Study||101||
48134727|NCT01197950|100651517|FG000|COMPLETED|Overall Study||83||
48134728|NCT01197950|100651518|FG001|COMPLETED|Overall Study||87||
48134729|NCT01197950|100651519|FG002|COMPLETED|Overall Study||83||
48579176|NCT01940887|101750819|FG000|COMPLETED|Year 1||283||
48579177|NCT01940887|101750820|FG001|COMPLETED|Year 1||297||
48579178|NCT01940887|101750819|FG000|NOT COMPLETED|Year 1||39||
48579179|NCT01940887|101750820|FG001|NOT COMPLETED|Year 1||23||
48579180|NCT01940887|101750819|FG000|STARTED|Year 2||283||
48579181|NCT01940887|101750820|FG001|STARTED|Year 2||297||
48579182|NCT01940887|101750819|FG000|COMPLETED|Year 2||66||
48579183|NCT01940887|101750820|FG001|COMPLETED|Year 2||75||
48579184|NCT01940887|101750819|FG000|NOT COMPLETED|Year 2||217||
48579185|NCT01940887|101750820|FG001|NOT COMPLETED|Year 2||222||
48703560|NCT02778555|102060540|FG002|STARTED|Overall Study||318||
48703561|NCT02778555|102060538|FG000|COMPLETED|Overall Study||131||
48703562|NCT02778555|102060539|FG001|COMPLETED|Overall Study||177||
48703563|NCT02778555|102060540|FG002|COMPLETED|Overall Study||211||
48703564|NCT02778555|102060538|FG000|NOT COMPLETED|Overall Study||55||
48579186|NCT02065375|101750821|FG000|STARTED|Overall Study||37||
48134730|NCT01197950|100651517|FG000|NOT COMPLETED|Overall Study||16||
48134731|NCT01197950|100651518|FG001|NOT COMPLETED|Overall Study||16||
48134732|NCT01197950|100651519|FG002|NOT COMPLETED|Overall Study||18||
48134733|NCT02493361|100651520|FG000|STARTED|Overall Study||24||
48134734|NCT02493361|100651520|FG000|Week 24 Assessment|Overall Study||21||
48134735|NCT02493361|100651520|FG000|COMPLETED|Overall Study||21||
48134736|NCT02493361|100651520|FG000|NOT COMPLETED|Overall Study||3||
48134737|NCT04266028|100651521|FG000|STARTED|Overall Study||4||
48134738|NCT04266028|100651522|FG001|STARTED|Overall Study||2||
48579187|NCT02065375|101750822|FG001|STARTED|Overall Study||33||
48703565|NCT02778555|102060539|FG001|NOT COMPLETED|Overall Study||32||
48134739|NCT04266028|100651523|FG002|STARTED|Overall Study||6||
48134740|NCT04266028|100651524|FG003|STARTED|Overall Study||2||
48134741|NCT04266028|100651525|FG004|STARTED|Overall Study||6||
48579188|NCT02065375|101750823|FG002|STARTED|Overall Study||39||
48703566|NCT02778555|102060540|FG002|NOT COMPLETED|Overall Study||107||
48579189|NCT02065375|101750821|FG000|Completed Treatment|Overall Study||19||
48579190|NCT02065375|101750822|FG001|Completed Treatment|Overall Study||15||
48579191|NCT02065375|101750823|FG002|Completed Treatment|Overall Study||25||
48579192|NCT02065375|101750821|FG000|COMPLETED|Overall Study||37||
48579193|NCT02065375|101750822|FG001|COMPLETED|Overall Study||33||
48579194|NCT02065375|101750823|FG002|COMPLETED|Overall Study||39||
48579195|NCT02065375|101750821|FG000|NOT COMPLETED|Overall Study||0||
48579196|NCT02065375|101750822|FG001|NOT COMPLETED|Overall Study||0||
48579197|NCT02065375|101750823|FG002|NOT COMPLETED|Overall Study||0||
48579198|NCT02387957|101750824|FG000|STARTED|Overall Study||21||
48579199|NCT02387957|101750825|FG001|STARTED|Overall Study||21||
48579200|NCT02387957|101750826|FG002|STARTED|Overall Study||21||
48579201|NCT02387957|101750824|FG000|COMPLETED|Overall Study||0||
48579202|NCT02387957|101750825|FG001|COMPLETED|Overall Study||0||
48579203|NCT02387957|101750826|FG002|COMPLETED|Overall Study||1||
48579204|NCT02387957|101750824|FG000|NOT COMPLETED|Overall Study||21||
48579205|NCT02387957|101750825|FG001|NOT COMPLETED|Overall Study||21||
48579206|NCT02387957|101750826|FG002|NOT COMPLETED|Overall Study||20||
48579207|NCT05217641|101750827|FG000|STARTED|Overall Study||18||
48579208|NCT05217641|101750828|FG001|STARTED|Overall Study||19||
48579209|NCT05217641|101750829|FG002|STARTED|Overall Study||17||
48579210|NCT05217641|101750830|FG003|STARTED|Overall Study||18||
48579211|NCT05217641|101750831|FG004|STARTED|Overall Study||18||
48579212|NCT05217641|101750832|FG005|STARTED|Overall Study||18||
48579213|NCT05217641|101750827|FG000|COMPLETED|Overall Study||16||
48579214|NCT05217641|101750828|FG001|COMPLETED|Overall Study||17||
48579215|NCT05217641|101750829|FG002|COMPLETED|Overall Study||17||
48579216|NCT05217641|101750830|FG003|COMPLETED|Overall Study||14||
48579217|NCT05217641|101750831|FG004|COMPLETED|Overall Study||14||
48579218|NCT05217641|101750832|FG005|COMPLETED|Overall Study||18||
48579219|NCT05217641|101750827|FG000|NOT COMPLETED|Overall Study||2||
48579220|NCT05217641|101750828|FG001|NOT COMPLETED|Overall Study||2||
48579221|NCT05217641|101750829|FG002|NOT COMPLETED|Overall Study||0||
48579222|NCT05217641|101750830|FG003|NOT COMPLETED|Overall Study||4||
48579223|NCT05217641|101750831|FG004|NOT COMPLETED|Overall Study||4||
48579224|NCT05217641|101750832|FG005|NOT COMPLETED|Overall Study||0||
48579225|NCT03063086|101750833|FG000|STARTED|Overall Study||19||
48579226|NCT03063086|101750834|FG001|STARTED|Overall Study||20||
48579227|NCT03063086|101750835|FG002|STARTED|Overall Study||18||
48579228|NCT03063086|101750836|FG003|STARTED|Overall Study||20||
48579229|NCT03063086|101750837|FG004|STARTED|Overall Study||20||
48579230|NCT03063086|101750838|FG005|STARTED|Overall Study||19||
48579231|NCT03063086|101750833|FG000|COMPLETED|Overall Study||16||
48579232|NCT03063086|101750834|FG001|COMPLETED|Overall Study||19||
48579233|NCT03063086|101750835|FG002|COMPLETED|Overall Study||17||
48579234|NCT03063086|101750836|FG003|COMPLETED|Overall Study||17||
48579235|NCT03063086|101750837|FG004|COMPLETED|Overall Study||20||
48579236|NCT03063086|101750838|FG005|COMPLETED|Overall Study||18||
48579237|NCT03063086|101750833|FG000|NOT COMPLETED|Overall Study||3||
48579238|NCT03063086|101750834|FG001|NOT COMPLETED|Overall Study||1||
48579239|NCT03063086|101750835|FG002|NOT COMPLETED|Overall Study||1||
48579240|NCT03063086|101750836|FG003|NOT COMPLETED|Overall Study||3||
48579241|NCT03063086|101750837|FG004|NOT COMPLETED|Overall Study||0||
48579242|NCT03063086|101750838|FG005|NOT COMPLETED|Overall Study||1||
48579243|NCT04445714|101750839|FG000|STARTED|Overall Study||196||
48579244|NCT04445714|101750839|FG000|COMPLETED|Overall Study||173||
48579245|NCT04445714|101750839|FG000|NOT COMPLETED|Overall Study||23||
48579246|NCT00809471|101750840|FG000|STARTED|Overall Study||130||
48579247|NCT00809471|101750841|FG001|STARTED|Overall Study||129||
48579248|NCT00809471|101750842|FG002|STARTED|Overall Study||131||
48579249|NCT00809471|101750840|FG000|COMPLETED|Overall Study||110||
48579250|NCT00809471|101750841|FG001|COMPLETED|Overall Study||109||
48579251|NCT00809471|101750842|FG002|COMPLETED|Overall Study||114||
48579252|NCT00809471|101750840|FG000|NOT COMPLETED|Overall Study||20||
48579253|NCT00809471|101750841|FG001|NOT COMPLETED|Overall Study||20||
48579254|NCT00809471|101750842|FG002|NOT COMPLETED|Overall Study||17||
48579255|NCT03039621|101750843|FG000|STARTED|Overall Study||143||
48579256|NCT03039621|101750844|FG001|STARTED|Overall Study||144||
48579257|NCT03039621|101750843|FG000|COMPLETED|Overall Study||131||
48579258|NCT03039621|101750844|FG001|COMPLETED|Overall Study||128||
48579259|NCT03039621|101750843|FG000|NOT COMPLETED|Overall Study||12||
48579260|NCT03039621|101750844|FG001|NOT COMPLETED|Overall Study||16||
48579261|NCT01868438|101750845|FG000|STARTED|First Intervention||30||
48579262|NCT01868438|101750846|FG001|STARTED|First Intervention||30||
48579263|NCT01868438|101750845|FG000|COMPLETED|First Intervention||23||
48579264|NCT01868438|101750846|FG001|COMPLETED|First Intervention||25||
48579265|NCT01868438|101750845|FG000|NOT COMPLETED|First Intervention||7||
48579266|NCT01868438|101750846|FG001|NOT COMPLETED|First Intervention||5||
48579267|NCT01868438|101750845|FG000|STARTED|Second Intervention||23||
48579268|NCT01868438|101750846|FG001|STARTED|Second Intervention||25||
48579269|NCT01868438|101750845|FG000|COMPLETED|Second Intervention||20||
48579270|NCT01868438|101750846|FG001|COMPLETED|Second Intervention||22||
48579271|NCT01868438|101750845|FG000|NOT COMPLETED|Second Intervention||3||
48579272|NCT01868438|101750846|FG001|NOT COMPLETED|Second Intervention||3||
48579273|NCT02989246|101750847|FG000|STARTED|Overall Study||32||
48579274|NCT02989246|101750847|FG000|COMPLETED|Overall Study||32||
48579275|NCT02989246|101750847|FG000|NOT COMPLETED|Overall Study||0||
48579276|NCT01941745|101750848|FG000|STARTED|Overall Study||22||
48579277|NCT01941745|101750849|FG001|STARTED|Overall Study||22||
48579278|NCT01941745|101750850|FG002|STARTED|Overall Study||21||
48579279|NCT01941745|101750851|FG003|STARTED|Overall Study||23||
48579280|NCT01941745|101750848|FG000|COMPLETED|Overall Study||22||
48579281|NCT01941745|101750849|FG001|COMPLETED|Overall Study||22||
48579282|NCT01941745|101750850|FG002|COMPLETED|Overall Study||21||
48579283|NCT01941745|101750851|FG003|COMPLETED|Overall Study||23||
48579284|NCT01941745|101750848|FG000|NOT COMPLETED|Overall Study||0||
48579285|NCT01941745|101750849|FG001|NOT COMPLETED|Overall Study||0||
48579286|NCT01941745|101750850|FG002|NOT COMPLETED|Overall Study||0||
48579287|NCT01941745|101750851|FG003|NOT COMPLETED|Overall Study||0||
48579288|NCT03728426|101750852|FG000|STARTED|Overall Study||10||
48579289|NCT03728426|101750852|FG000|COMPLETED|Overall Study||7||
48579290|NCT03728426|101750852|FG000|NOT COMPLETED|Overall Study||3||
48579291|NCT01828983|101750853|FG000|STARTED|Overall Study||80||
48579292|NCT01828983|101750854|FG001|STARTED|Overall Study||81||
48579293|NCT01828983|101750853|FG000|COMPLETED|Overall Study||80||
48579294|NCT01828983|101750854|FG001|COMPLETED|Overall Study||81||
48579295|NCT01828983|101750853|FG000|NOT COMPLETED|Overall Study||0||
48579296|NCT01828983|101750854|FG001|NOT COMPLETED|Overall Study||0||
48579297|NCT05875025|101750855|FG000|STARTED|Overall Study||10||
48579298|NCT05875025|101750856|FG001|STARTED|Overall Study||10||
48579299|NCT05875025|101750855|FG000|COMPLETED|Overall Study||10||
48579300|NCT05875025|101750856|FG001|COMPLETED|Overall Study||10||
48579301|NCT05875025|101750855|FG000|NOT COMPLETED|Overall Study||0||
48579302|NCT05875025|101750856|FG001|NOT COMPLETED|Overall Study||0||
48579303|NCT03773172|101750857|FG000|STARTED|First Intervention (3 Days)||2||
48579304|NCT03773172|101750858|FG001|STARTED|First Intervention (3 Days)||3||
48579305|NCT03773172|101750857|FG000|COMPLETED|First Intervention (3 Days)||2||
48579306|NCT03773172|101750858|FG001|COMPLETED|First Intervention (3 Days)||3||
48579307|NCT03773172|101750857|FG000|NOT COMPLETED|First Intervention (3 Days)||0||
48579308|NCT03773172|101750858|FG001|NOT COMPLETED|First Intervention (3 Days)||0||
48579309|NCT03773172|101750857|FG000|STARTED|Washout (6 to 8 Weeks)||2||
48579310|NCT03773172|101750858|FG001|STARTED|Washout (6 to 8 Weeks)||3||
48579311|NCT03773172|101750857|FG000|COMPLETED|Washout (6 to 8 Weeks)||2||
48579312|NCT03773172|101750858|FG001|COMPLETED|Washout (6 to 8 Weeks)||3||
48579313|NCT03773172|101750857|FG000|NOT COMPLETED|Washout (6 to 8 Weeks)||0||
48579314|NCT03773172|101750858|FG001|NOT COMPLETED|Washout (6 to 8 Weeks)||0||
48579315|NCT03773172|101750857|FG000|STARTED|Second Intervention (3 Days)||2||
48579316|NCT03773172|101750858|FG001|STARTED|Second Intervention (3 Days)||3||
48579317|NCT03773172|101750857|FG000|COMPLETED|Second Intervention (3 Days)||2||
48579318|NCT03773172|101750858|FG001|COMPLETED|Second Intervention (3 Days)||3||
48579319|NCT03773172|101750857|FG000|NOT COMPLETED|Second Intervention (3 Days)||0||
48579320|NCT03773172|101750858|FG001|NOT COMPLETED|Second Intervention (3 Days)||0||
48579321|NCT03260244|101750859|FG000|STARTED|Overall Study||1065||
48579322|NCT03260244|101750859|FG000|Treated|Overall Study||925||
48579323|NCT03260244|101750859|FG000|1-month Follow up|Overall Study||898||
48579324|NCT03260244|101750859|FG000|6-month Follow up|Overall Study||765||
48400253|NCT00371540|101309331|FG001|NOT COMPLETED|Overall Study||9||
48400254|NCT02693691|101309332|FG000|STARTED|Primary Endpoint Analysis (First 12M)||234||
48400255|NCT02693691|101309332|FG000|COMPLETED|Primary Endpoint Analysis (First 12M)||184||
48579325|NCT03260244|101750859|FG000|12-month Follow up|Overall Study||722||
48579326|NCT03260244|101750859|FG000|COMPLETED|Overall Study||779||
48579327|NCT03260244|101750859|FG000|NOT COMPLETED|Overall Study||286||
48579328|NCT02919423|101750860|FG000|STARTED|Overall Study||6||
48579329|NCT02919423|101750861|FG001|STARTED|Overall Study||25||
48579330|NCT02919423|101750860|FG000|COMPLETED|Overall Study||4||
48579331|NCT02919423|101750861|FG001|COMPLETED|Overall Study||16||
48579332|NCT02919423|101750860|FG000|NOT COMPLETED|Overall Study||2||
48579333|NCT02919423|101750861|FG001|NOT COMPLETED|Overall Study||9||
48579334|NCT01088672|101750862|FG000|STARTED|Overall Study||60||
48579335|NCT01088672|101750862|FG000|COMPLETED|Overall Study||60||
48579336|NCT01088672|101750862|FG000|NOT COMPLETED|Overall Study||0||
48579337|NCT00436475|101750863|FG000|STARTED|Overall Study||23||
48579338|NCT00436475|101750864|FG001|STARTED|Overall Study||23||
48579339|NCT00436475|101750865|FG002|STARTED|Overall Study||22||
48579340|NCT00436475|101750866|FG003|STARTED|Overall Study||24||
48579341|NCT00436475|101750863|FG000|COMPLETED|Overall Study||23||
48579342|NCT00436475|101750864|FG001|COMPLETED|Overall Study||22||
48579343|NCT00436475|101750865|FG002|COMPLETED|Overall Study||21||
48579344|NCT00436475|101750866|FG003|COMPLETED|Overall Study||22||
48579345|NCT00436475|101750863|FG000|NOT COMPLETED|Overall Study||0||
48579346|NCT00436475|101750864|FG001|NOT COMPLETED|Overall Study||1||
48400256|NCT02693691|101309332|FG000|NOT COMPLETED|Primary Endpoint Analysis (First 12M)||50||
48579347|NCT00436475|101750865|FG002|NOT COMPLETED|Overall Study||1||
48579348|NCT00436475|101750866|FG003|NOT COMPLETED|Overall Study||2||
48579349|NCT02282631|101750867|FG000|STARTED|Overall Study||14||
48579350|NCT02282631|101750868|FG001|STARTED|Overall Study||15||
48579351|NCT02282631|101750867|FG000|COMPLETED|Overall Study||12||
48579352|NCT02282631|101750868|FG001|COMPLETED|Overall Study||15||
48579353|NCT02282631|101750867|FG000|NOT COMPLETED|Overall Study||2||
48579354|NCT02282631|101750868|FG001|NOT COMPLETED|Overall Study||0||
48579355|NCT02309411|101750869|FG000|STARTED|Overall Study||25||
48579356|NCT02309411|101750870|FG001|STARTED|Overall Study||15||
48579357|NCT02309411|101750871|FG002|STARTED|Overall Study||6||
48579358|NCT02309411|101750869|FG000|COMPLETED|Overall Study||23||
48579359|NCT02309411|101750870|FG001|COMPLETED|Overall Study||14||
48579360|NCT02309411|101750871|FG002|COMPLETED|Overall Study||6||
48579361|NCT02309411|101750869|FG000|NOT COMPLETED|Overall Study||2||
48579362|NCT02309411|101750870|FG001|NOT COMPLETED|Overall Study||1||
48579363|NCT02309411|101750871|FG002|NOT COMPLETED|Overall Study||0||
48579364|NCT03502070|101750872|FG000|STARTED|Overall Study||47||
48579365|NCT03502070|101750872|FG000|COMPLETED|Overall Study||45||
48579366|NCT03502070|101750872|FG000|NOT COMPLETED|Overall Study||2||
48579367|NCT03522714|101750873|FG000|STARTED|Overall Study||38||
48579368|NCT03522714|101750874|FG001|STARTED|Overall Study||42||
48579369|NCT03522714|101750873|FG000|COMPLETED|Overall Study||28||
48579370|NCT03522714|101750874|FG001|COMPLETED|Overall Study||40||
48579371|NCT03522714|101750873|FG000|NOT COMPLETED|Overall Study||10||
48579372|NCT03522714|101750874|FG001|NOT COMPLETED|Overall Study||2||
48579373|NCT02782949|101750875|FG000|STARTED|Overall Study||24||
48579374|NCT02782949|101750876|FG001|STARTED|Overall Study||26||
48579375|NCT02782949|101750875|FG000|COMPLETED|Overall Study||23||
48579376|NCT02782949|101750876|FG001|COMPLETED|Overall Study||25||
48579377|NCT02782949|101750875|FG000|NOT COMPLETED|Overall Study||1||
48579378|NCT02782949|101750876|FG001|NOT COMPLETED|Overall Study||1||
48579379|NCT05367973|101750877|FG000|STARTED|Overall Study||11||
48579380|NCT05367973|101750878|FG001|STARTED|Overall Study||10||
48579381|NCT05367973|101750877|FG000|COMPLETED|Overall Study||11||
48579382|NCT05367973|101750878|FG001|COMPLETED|Overall Study||8||
48579383|NCT05367973|101750877|FG000|NOT COMPLETED|Overall Study||0||
48579384|NCT05367973|101750878|FG001|NOT COMPLETED|Overall Study||2||
48579385|NCT05152966|101750879|FG000|STARTED|Overall Study||20||
48579386|NCT05152966|101750879|FG000|COMPLETED|Overall Study||19||
48579387|NCT05152966|101750879|FG000|NOT COMPLETED|Overall Study||1||
48579388|NCT05478135|101750880|FG000|STARTED|Overall Study||27||
48579389|NCT05478135|101750880|FG000|COMPLETED|Overall Study||27||
48579390|NCT05478135|101750880|FG000|NOT COMPLETED|Overall Study||0||
48579391|NCT04229095|101750881|FG000|STARTED|Overall Study||14||
48579392|NCT04229095|101750882|FG001|STARTED|Overall Study||12||
48579393|NCT04229095|101750881|FG000|COMPLETED|Overall Study||14||
48579394|NCT04229095|101750882|FG001|COMPLETED|Overall Study||12||
48134742|NCT04266028|100651526|FG005|STARTED|Overall Study||2||
48579395|NCT04229095|101750881|FG000|NOT COMPLETED|Overall Study||0||
48579396|NCT04229095|101750882|FG001|NOT COMPLETED|Overall Study||0||
48579397|NCT00730730|101750883|FG000|STARTED|Overall Study||50||
48579398|NCT00730730|101750883|FG000|COMPLETED|Overall Study||50||
48579399|NCT00730730|101750883|FG000|NOT COMPLETED|Overall Study||0||
48579400|NCT02125786|101750884|FG000|STARTED|Overall Study||68||
48579401|NCT02125786|101750884|FG000|COMPLETED|Overall Study||9||
48579402|NCT02125786|101750884|FG000|NOT COMPLETED|Overall Study||59||
48579403|NCT00712543|101750885|FG000|STARTED|Day 1-7||23||
48134743|NCT04266028|100651527|FG006|STARTED|Overall Study||4||
48286929|NCT00345293|101029597|FG001|STARTED|Overall Study||3||
48579404|NCT00712543|101750886|FG001|STARTED|Day 1-7||27||
48579405|NCT00712543|101750885|FG000|COMPLETED|Day 1-7||23||
48579406|NCT00712543|101750886|FG001|COMPLETED|Day 1-7||27||
48579407|NCT00712543|101750885|FG000|NOT COMPLETED|Day 1-7||0||
48579408|NCT00712543|101750886|FG001|NOT COMPLETED|Day 1-7||0||
48579409|NCT00712543|101750885|FG000|STARTED|Day 8-14||23||
48286930|NCT00345293|101029596|FG000|COMPLETED|Overall Study||8||
48286931|NCT00345293|101029597|FG001|COMPLETED|Overall Study||3||
48286932|NCT00345293|101029596|FG000|NOT COMPLETED|Overall Study||2||
48286933|NCT00345293|101029597|FG001|NOT COMPLETED|Overall Study||0||
48579410|NCT00712543|101750886|FG001|STARTED|Day 8-14||27||
48579411|NCT00712543|101750885|FG000|COMPLETED|Day 8-14||23||
48579412|NCT00712543|101750886|FG001|COMPLETED|Day 8-14||25||
48579413|NCT00712543|101750885|FG000|NOT COMPLETED|Day 8-14||0||
48134744|NCT04266028|100651528|FG007|STARTED|Overall Study||1||
48134745|NCT04266028|100651521|FG000|COMPLETED|Overall Study||4||
48134746|NCT04266028|100651522|FG001|COMPLETED|Overall Study||2||
48134747|NCT04266028|100651523|FG002|COMPLETED|Overall Study||5||
48579414|NCT00712543|101750886|FG001|NOT COMPLETED|Day 8-14||2||
48579415|NCT04903496|101750887|FG000|STARTED|Study Period 2015||166056||
48579416|NCT04903496|101750888|FG001|STARTED|Study Period 2015||113787||
48579417|NCT04903496|101750889|FG002|STARTED|Study Period 2015||66525||
48579418|NCT04903496|101750890|FG003|STARTED|Study Period 2015||51640||
48134748|NCT04266028|100651524|FG003|COMPLETED|Overall Study||2||
48579419|NCT04903496|101750887|FG000|COMPLETED|Study Period 2015||166056||
48703567|NCT00404755|102060541|FG000|STARTED|Phase I (Bupropion)||17||
48703568|NCT00404755|102060541|FG000|COMPLETED|Phase I (Bupropion)||13||
48703569|NCT00404755|102060541|FG000|NOT COMPLETED|Phase I (Bupropion)||4||
48703570|NCT00404755|102060541|FG000|STARTED|Phase II (Escitalopram)||11|Escitalopram 10mg/d RX to those not improved in PhaseI for 1 wk, then to 20, maximal dose of 40mg/d|
48703571|NCT00404755|102060541|FG000|COMPLETED|Phase II (Escitalopram)||9||
48703572|NCT00404755|102060541|FG000|NOT COMPLETED|Phase II (Escitalopram)||2||
48134749|NCT04266028|100651525|FG004|COMPLETED|Overall Study||4||
48134750|NCT04266028|100651526|FG005|COMPLETED|Overall Study||2||
48134751|NCT04266028|100651527|FG006|COMPLETED|Overall Study||0||
48134752|NCT04266028|100651528|FG007|COMPLETED|Overall Study||0||
48134753|NCT04266028|100651521|FG000|NOT COMPLETED|Overall Study||0||
48134754|NCT04266028|100651522|FG001|NOT COMPLETED|Overall Study||0||
48134755|NCT04266028|100651523|FG002|NOT COMPLETED|Overall Study||1||
48134756|NCT04266028|100651524|FG003|NOT COMPLETED|Overall Study||0||
48134757|NCT04266028|100651525|FG004|NOT COMPLETED|Overall Study||2||
48134758|NCT04266028|100651526|FG005|NOT COMPLETED|Overall Study||0||
48134759|NCT04266028|100651527|FG006|NOT COMPLETED|Overall Study||4||
48134760|NCT04266028|100651528|FG007|NOT COMPLETED|Overall Study||1||
48134761|NCT00506493|100651529|FG000|STARTED|Overall Study||75||
48134762|NCT00506493|100651529|FG000|COMPLETED|Overall Study||64||
48134763|NCT00506493|100651529|FG000|NOT COMPLETED|Overall Study||11||
48134764|NCT01610700|100651530|FG000|STARTED|Overall Study||80||
48134765|NCT01610700|100651531|FG001|STARTED|Overall Study||80||
48134766|NCT01610700|100651530|FG000|COMPLETED|Overall Study||77||
48134767|NCT01610700|100651531|FG001|COMPLETED|Overall Study||77||
48134768|NCT01610700|100651530|FG000|NOT COMPLETED|Overall Study||3||
48134769|NCT01610700|100651531|FG001|NOT COMPLETED|Overall Study||3||
48134770|NCT01490632|100651532|FG000|STARTED|Part A: Initial Treatment Period||34||
48134771|NCT01490632|100651533|FG001|STARTED|Part A: Initial Treatment Period||32||
48134772|NCT01490632|100651534|FG002|STARTED|Part A: Initial Treatment Period||72||
48134773|NCT01490632|100651535|FG003|STARTED|Part A: Initial Treatment Period||64||
48134774|NCT01490632|100651536|FG004|STARTED|Part A: Initial Treatment Period||69||
48134775|NCT01490632|100651537|FG005|STARTED|Part A: Initial Treatment Period||0||
48134776|NCT01490632|100651538|FG006|STARTED|Part A: Initial Treatment Period||0||
48134777|NCT01490632|100651539|FG007|STARTED|Part A: Initial Treatment Period||0||
48134778|NCT01490632|100651540|FG008|STARTED|Part A: Initial Treatment Period||0||
48134779|NCT01490632|100651541|FG009|STARTED|Part A: Initial Treatment Period||0||
48134780|NCT01490632|100651542|FG010|STARTED|Part A: Initial Treatment Period||0||
48134781|NCT01490632|100651543|FG011|STARTED|Part A: Initial Treatment Period||0||
48134782|NCT01490632|100651544|FG012|STARTED|Part A: Initial Treatment Period||0||
48134783|NCT01490632|100651545|FG013|STARTED|Part A: Initial Treatment Period||0||
48134784|NCT01490632|100651546|FG014|STARTED|Part A: Initial Treatment Period||0||
48134785|NCT01490632|100651547|FG015|STARTED|Part A: Initial Treatment Period||0||
48134786|NCT01490632|100651548|FG016|STARTED|Part A: Initial Treatment Period||0||
48134787|NCT01490632|100651549|FG017|STARTED|Part A: Initial Treatment Period||0||
48134788|NCT01490632|100651550|FG018|STARTED|Part A: Initial Treatment Period||0||
48134789|NCT01490632|100651551|FG019|STARTED|Part A: Initial Treatment Period||0||
48134790|NCT01490632|100651532|FG000|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||34||
48134791|NCT01490632|100651533|FG001|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||32||
48134792|NCT01490632|100651534|FG002|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||72||
48134793|NCT01490632|100651535|FG003|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||64||
48286934|NCT02533531|101029598|FG000|STARTED|Overall Study||1||
48286935|NCT02533531|101029598|FG000|COMPLETED|Overall Study||0||
48286936|NCT02533531|101029598|FG000|NOT COMPLETED|Overall Study||1||
48286937|NCT03035201|101029599|FG000|STARTED|Overall Study||571||
48286938|NCT03035201|101029600|FG001|STARTED|Overall Study||553||
48286939|NCT03035201|101029601|FG002|STARTED|Overall Study||551||
48134794|NCT01490632|100651536|FG004|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||69||
48134795|NCT01490632|100651537|FG005|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0||
48134796|NCT01490632|100651538|FG006|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0||
48134797|NCT01490632|100651539|FG007|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0||
48134798|NCT01490632|100651540|FG008|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0||
48134799|NCT01490632|100651541|FG009|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0||
48134800|NCT01490632|100651542|FG010|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0||
48134801|NCT01490632|100651543|FG011|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0||
48134802|NCT01490632|100651544|FG012|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0||
48134803|NCT01490632|100651545|FG013|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0||
48286940|NCT03035201|101029602|FG003|STARTED|Overall Study||587||
48286941|NCT03035201|101029599|FG000|COMPLETED|Overall Study||444||
48286942|NCT03035201|101029600|FG001|COMPLETED|Overall Study||441||
48286943|NCT03035201|101029601|FG002|COMPLETED|Overall Study||441||
48286944|NCT03035201|101029602|FG003|COMPLETED|Overall Study||462||
48286945|NCT03035201|101029599|FG000|NOT COMPLETED|Overall Study||127||
48286946|NCT03035201|101029600|FG001|NOT COMPLETED|Overall Study||112||
48134804|NCT01490632|100651546|FG014|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0||
48134805|NCT01490632|100651547|FG015|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0||
48134806|NCT01490632|100651548|FG016|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0||
48134807|NCT01490632|100651549|FG017|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0||
48134808|NCT01490632|100651550|FG018|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0||
48134809|NCT01490632|100651551|FG019|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0||
48134810|NCT01490632|100651532|FG000|COMPLETED|Part A: Initial Treatment Period||27||
48134811|NCT01490632|100651533|FG001|COMPLETED|Part A: Initial Treatment Period||28||
48134812|NCT01490632|100651534|FG002|COMPLETED|Part A: Initial Treatment Period||67||
48134813|NCT01490632|100651535|FG003|COMPLETED|Part A: Initial Treatment Period||55||
48134814|NCT01490632|100651536|FG004|COMPLETED|Part A: Initial Treatment Period||52||
48134815|NCT01490632|100651537|FG005|COMPLETED|Part A: Initial Treatment Period||0||
48134816|NCT01490632|100651538|FG006|COMPLETED|Part A: Initial Treatment Period||0||
48134817|NCT01490632|100651539|FG007|COMPLETED|Part A: Initial Treatment Period||0||
48134818|NCT01490632|100651540|FG008|COMPLETED|Part A: Initial Treatment Period||0||
48134819|NCT01490632|100651541|FG009|COMPLETED|Part A: Initial Treatment Period||0||
48134820|NCT01490632|100651542|FG010|COMPLETED|Part A: Initial Treatment Period||0||
48134821|NCT01490632|100651543|FG011|COMPLETED|Part A: Initial Treatment Period||0||
48134822|NCT01490632|100651544|FG012|COMPLETED|Part A: Initial Treatment Period||0||
48134823|NCT01490632|100651545|FG013|COMPLETED|Part A: Initial Treatment Period||0||
48134824|NCT01490632|100651546|FG014|COMPLETED|Part A: Initial Treatment Period||0||
48134825|NCT01490632|100651547|FG015|COMPLETED|Part A: Initial Treatment Period||0||
48134826|NCT01490632|100651548|FG016|COMPLETED|Part A: Initial Treatment Period||0||
48134827|NCT01490632|100651549|FG017|COMPLETED|Part A: Initial Treatment Period||0||
48134828|NCT01490632|100651550|FG018|COMPLETED|Part A: Initial Treatment Period||0||
48134829|NCT01490632|100651551|FG019|COMPLETED|Part A: Initial Treatment Period||0||
48134830|NCT01490632|100651532|FG000|NOT COMPLETED|Part A: Initial Treatment Period||7||
48134831|NCT01490632|100651533|FG001|NOT COMPLETED|Part A: Initial Treatment Period||4||
48134832|NCT01490632|100651534|FG002|NOT COMPLETED|Part A: Initial Treatment Period||5||
48134833|NCT01490632|100651535|FG003|NOT COMPLETED|Part A: Initial Treatment Period||9||
48134834|NCT01490632|100651536|FG004|NOT COMPLETED|Part A: Initial Treatment Period||17||
48134835|NCT01490632|100651537|FG005|NOT COMPLETED|Part A: Initial Treatment Period||0||
48134836|NCT01490632|100651538|FG006|NOT COMPLETED|Part A: Initial Treatment Period||0||
48134837|NCT01490632|100651539|FG007|NOT COMPLETED|Part A: Initial Treatment Period||0||
48134838|NCT01490632|100651540|FG008|NOT COMPLETED|Part A: Initial Treatment Period||0||
48134839|NCT01490632|100651541|FG009|NOT COMPLETED|Part A: Initial Treatment Period||0||
48134840|NCT01490632|100651542|FG010|NOT COMPLETED|Part A: Initial Treatment Period||0||
48134841|NCT01490632|100651543|FG011|NOT COMPLETED|Part A: Initial Treatment Period||0||
48134842|NCT01490632|100651544|FG012|NOT COMPLETED|Part A: Initial Treatment Period||0||
48134843|NCT01490632|100651545|FG013|NOT COMPLETED|Part A: Initial Treatment Period||0||
48134844|NCT01490632|100651546|FG014|NOT COMPLETED|Part A: Initial Treatment Period||0||
48134845|NCT01490632|100651547|FG015|NOT COMPLETED|Part A: Initial Treatment Period||0||
48134846|NCT01490632|100651548|FG016|NOT COMPLETED|Part A: Initial Treatment Period||0||
48134847|NCT01490632|100651549|FG017|NOT COMPLETED|Part A: Initial Treatment Period||0||
48134848|NCT01490632|100651550|FG018|NOT COMPLETED|Part A: Initial Treatment Period||0||
48134849|NCT01490632|100651551|FG019|NOT COMPLETED|Part A: Initial Treatment Period||0||
48134850|NCT01490632|100651532|FG000|STARTED|Part B: Extension or Step-Up Period||0||
48134851|NCT01490632|100651533|FG001|STARTED|Part B: Extension or Step-Up Period||0||
48134852|NCT01490632|100651534|FG002|STARTED|Part B: Extension or Step-Up Period||0||
48134853|NCT01490632|100651535|FG003|STARTED|Part B: Extension or Step-Up Period||0||
48134854|NCT01490632|100651536|FG004|STARTED|Part B: Extension or Step-Up Period||0||
48134855|NCT01490632|100651537|FG005|STARTED|Part B: Extension or Step-Up Period||29||
48134856|NCT01490632|100651538|FG006|STARTED|Part B: Extension or Step-Up Period||64||
48134857|NCT01490632|100651539|FG007|STARTED|Part B: Extension or Step-Up Period||19||
48134858|NCT01490632|100651540|FG008|STARTED|Part B: Extension or Step-Up Period||16||
48134859|NCT01490632|100651541|FG009|STARTED|Part B: Extension or Step-Up Period||50||
48134860|NCT01490632|100651542|FG010|STARTED|Part B: Extension or Step-Up Period||43||
48134861|NCT01490632|100651543|FG011|STARTED|Part B: Extension or Step-Up Period||8||
48134862|NCT01490632|100651544|FG012|STARTED|Part B: Extension or Step-Up Period||0||
48134863|NCT01490632|100651545|FG013|STARTED|Part B: Extension or Step-Up Period||0||
48134864|NCT01490632|100651546|FG014|STARTED|Part B: Extension or Step-Up Period||0||
48134865|NCT01490632|100651547|FG015|STARTED|Part B: Extension or Step-Up Period||0||
48134866|NCT01490632|100651548|FG016|STARTED|Part B: Extension or Step-Up Period||0||
48134867|NCT01490632|100651549|FG017|STARTED|Part B: Extension or Step-Up Period||0||
48134868|NCT01490632|100651550|FG018|STARTED|Part B: Extension or Step-Up Period||0||
48134869|NCT01490632|100651551|FG019|STARTED|Part B: Extension or Step-Up Period||0||
48134870|NCT01490632|100651532|FG000|COMPLETED|Part B: Extension or Step-Up Period||0||
48134871|NCT01490632|100651533|FG001|COMPLETED|Part B: Extension or Step-Up Period||0||
48134872|NCT01490632|100651534|FG002|COMPLETED|Part B: Extension or Step-Up Period||0||
48134873|NCT01490632|100651535|FG003|COMPLETED|Part B: Extension or Step-Up Period||0||
48134874|NCT01490632|100651536|FG004|COMPLETED|Part B: Extension or Step-Up Period||0||
48134875|NCT01490632|100651537|FG005|COMPLETED|Part B: Extension or Step-Up Period||25||
48134876|NCT01490632|100651538|FG006|COMPLETED|Part B: Extension or Step-Up Period||51||
48134877|NCT01490632|100651539|FG007|COMPLETED|Part B: Extension or Step-Up Period||13||
48134878|NCT01490632|100651540|FG008|COMPLETED|Part B: Extension or Step-Up Period||6||
48134879|NCT01490632|100651541|FG009|COMPLETED|Part B: Extension or Step-Up Period||25||
48134880|NCT01490632|100651542|FG010|COMPLETED|Part B: Extension or Step-Up Period||22||
48134881|NCT01490632|100651543|FG011|COMPLETED|Part B: Extension or Step-Up Period||0||
48134882|NCT01490632|100651544|FG012|COMPLETED|Part B: Extension or Step-Up Period||0||
48134883|NCT01490632|100651545|FG013|COMPLETED|Part B: Extension or Step-Up Period||0||
48134884|NCT01490632|100651546|FG014|COMPLETED|Part B: Extension or Step-Up Period||0||
48134885|NCT01490632|100651547|FG015|COMPLETED|Part B: Extension or Step-Up Period||0||
48134886|NCT01490632|100651548|FG016|COMPLETED|Part B: Extension or Step-Up Period||0||
48134887|NCT01490632|100651549|FG017|COMPLETED|Part B: Extension or Step-Up Period||0||
48134888|NCT01490632|100651550|FG018|COMPLETED|Part B: Extension or Step-Up Period||0||
48134889|NCT01490632|100651551|FG019|COMPLETED|Part B: Extension or Step-Up Period||0||
48134890|NCT01490632|100651532|FG000|NOT COMPLETED|Part B: Extension or Step-Up Period||0||
48134891|NCT01490632|100651533|FG001|NOT COMPLETED|Part B: Extension or Step-Up Period||0||
48134892|NCT01490632|100651534|FG002|NOT COMPLETED|Part B: Extension or Step-Up Period||0||
48134893|NCT01490632|100651535|FG003|NOT COMPLETED|Part B: Extension or Step-Up Period||0||
48134894|NCT01490632|100651536|FG004|NOT COMPLETED|Part B: Extension or Step-Up Period||0||
48134895|NCT01490632|100651537|FG005|NOT COMPLETED|Part B: Extension or Step-Up Period||4||
48134896|NCT01490632|100651538|FG006|NOT COMPLETED|Part B: Extension or Step-Up Period||13||
48134897|NCT01490632|100651539|FG007|NOT COMPLETED|Part B: Extension or Step-Up Period||6||
48134898|NCT01490632|100651540|FG008|NOT COMPLETED|Part B: Extension or Step-Up Period||10||
48134899|NCT01490632|100651541|FG009|NOT COMPLETED|Part B: Extension or Step-Up Period||25||
48134900|NCT01490632|100651542|FG010|NOT COMPLETED|Part B: Extension or Step-Up Period||21||
48579420|NCT04903496|101750888|FG001|COMPLETED|Study Period 2015||113787||
48703573|NCT00404755|102060541|FG000|STARTED|Phase III (Imipramine)||3|imipramine 50mg/d increasing twice wkly by 50mg upto 200mg/d, to maxdose of 300mg/d II nonremitters|
48703574|NCT00404755|102060541|FG000|COMPLETED|Phase III (Imipramine)||3||
48703575|NCT00404755|102060541|FG000|NOT COMPLETED|Phase III (Imipramine)||0||
48703576|NCT01746511|102060542|FG000|STARTED|Overall Study||40||
48134901|NCT01490632|100651543|FG011|NOT COMPLETED|Part B: Extension or Step-Up Period||8||
48134902|NCT01490632|100651544|FG012|NOT COMPLETED|Part B: Extension or Step-Up Period||0||
48134903|NCT01490632|100651545|FG013|NOT COMPLETED|Part B: Extension or Step-Up Period||0||
48134904|NCT01490632|100651546|FG014|NOT COMPLETED|Part B: Extension or Step-Up Period||0||
48134905|NCT01490632|100651547|FG015|NOT COMPLETED|Part B: Extension or Step-Up Period||0||
48703577|NCT01746511|102060543|FG001|STARTED|Overall Study||39||
48703578|NCT01746511|102060542|FG000|COMPLETED|Overall Study||40||
48703579|NCT01746511|102060543|FG001|COMPLETED|Overall Study||39||
48703580|NCT01746511|102060542|FG000|NOT COMPLETED|Overall Study||0||
48703581|NCT01746511|102060543|FG001|NOT COMPLETED|Overall Study||0||
48703582|NCT00759356|102060544|FG000|STARTED|Overall Study||18||
48703583|NCT00759356|102060545|FG001|STARTED|Overall Study||18||
48134906|NCT01490632|100651548|FG016|NOT COMPLETED|Part B: Extension or Step-Up Period||0||
48134907|NCT01490632|100651549|FG017|NOT COMPLETED|Part B: Extension or Step-Up Period||0||
48134908|NCT01490632|100651550|FG018|NOT COMPLETED|Part B: Extension or Step-Up Period||0||
48134909|NCT01490632|100651551|FG019|NOT COMPLETED|Part B: Extension or Step-Up Period||0||
48134910|NCT01490632|100651532|FG000|STARTED|Part C: Washout or Step-Down Period||0||
48134911|NCT01490632|100651533|FG001|STARTED|Part C: Washout or Step-Down Period||0||
48286947|NCT03035201|101029601|FG002|NOT COMPLETED|Overall Study||110||
48286948|NCT03035201|101029602|FG003|NOT COMPLETED|Overall Study||125||
48286949|NCT05087979|101029603|FG000|STARTED|Overall Study||20||
48286950|NCT05087979|101029604|FG001|STARTED|Overall Study||20||
48286951|NCT05087979|101029603|FG000|COMPLETED|Overall Study||19||
48286952|NCT05087979|101029604|FG001|COMPLETED|Overall Study||20||
48286953|NCT05087979|101029603|FG000|NOT COMPLETED|Overall Study||1||
48579421|NCT04903496|101750889|FG002|COMPLETED|Study Period 2015||66525||
48579422|NCT04903496|101750890|FG003|COMPLETED|Study Period 2015||51640||
48579423|NCT04903496|101750887|FG000|NOT COMPLETED|Study Period 2015||0||
48579424|NCT04903496|101750888|FG001|NOT COMPLETED|Study Period 2015||0||
48579425|NCT04903496|101750889|FG002|NOT COMPLETED|Study Period 2015||0||
48579426|NCT04903496|101750890|FG003|NOT COMPLETED|Study Period 2015||0||
48579427|NCT04903496|101750887|FG000|STARTED|Study Period 2017||379826||
48579428|NCT04903496|101750888|FG001|STARTED|Study Period 2017||188681||
48579429|NCT04903496|101750889|FG002|STARTED|Study Period 2017||144484||
48579430|NCT04903496|101750890|FG003|STARTED|Study Period 2017||123839||
48579431|NCT04903496|101750887|FG000|COMPLETED|Study Period 2017||379826||
48579432|NCT04903496|101750888|FG001|COMPLETED|Study Period 2017||188681||
48579433|NCT04903496|101750889|FG002|COMPLETED|Study Period 2017||144484||
48579434|NCT04903496|101750890|FG003|COMPLETED|Study Period 2017||123839||
48579435|NCT04903496|101750887|FG000|NOT COMPLETED|Study Period 2017||0||
48579436|NCT04903496|101750888|FG001|NOT COMPLETED|Study Period 2017||0||
48703584|NCT00759356|102060544|FG000|COMPLETED|Overall Study||17||
48579437|NCT04903496|101750889|FG002|NOT COMPLETED|Study Period 2017||0||
48579438|NCT04903496|101750890|FG003|NOT COMPLETED|Study Period 2017||0||
48579439|NCT04903496|101750887|FG000|STARTED|Study Period 2019||576973||
48579440|NCT04903496|101750888|FG001|STARTED|Study Period 2019||253012||
48579441|NCT04903496|101750889|FG002|STARTED|Study Period 2019||198099||
48579442|NCT04903496|101750890|FG003|STARTED|Study Period 2019||205078||
48579443|NCT04903496|101750887|FG000|COMPLETED|Study Period 2019||576973||
48579444|NCT04903496|101750888|FG001|COMPLETED|Study Period 2019||253012||
48134912|NCT01490632|100651534|FG002|STARTED|Part C: Washout or Step-Down Period||0||
48134913|NCT01490632|100651535|FG003|STARTED|Part C: Washout or Step-Down Period||0||
48134914|NCT01490632|100651536|FG004|STARTED|Part C: Washout or Step-Down Period||0||
48134915|NCT01490632|100651537|FG005|STARTED|Part C: Washout or Step-Down Period||0||
48703585|NCT00759356|102060545|FG001|COMPLETED|Overall Study||15||
48703586|NCT00759356|102060544|FG000|NOT COMPLETED|Overall Study||1||
48703587|NCT00759356|102060545|FG001|NOT COMPLETED|Overall Study||3||
48703588|NCT01644695|102060546|FG000|STARTED|Overall Study||85||
48703589|NCT01644695|102060546|FG000|COMPLETED|Overall Study||85||
48703590|NCT01644695|102060546|FG000|NOT COMPLETED|Overall Study||0||
48703591|NCT02538419|102060547|FG000|STARTED|Overall Study||20||
48703592|NCT02538419|102060548|FG001|STARTED|Overall Study||20||
48703593|NCT02538419|102060547|FG000|COMPLETED|Overall Study||20||
48703594|NCT02538419|102060548|FG001|COMPLETED|Overall Study||20||
48134916|NCT01490632|100651538|FG006|STARTED|Part C: Washout or Step-Down Period||0||
48134917|NCT01490632|100651539|FG007|STARTED|Part C: Washout or Step-Down Period||0||
48134918|NCT01490632|100651540|FG008|STARTED|Part C: Washout or Step-Down Period||0||
48134919|NCT01490632|100651541|FG009|STARTED|Part C: Washout or Step-Down Period||0||
48134920|NCT01490632|100651542|FG010|STARTED|Part C: Washout or Step-Down Period||0||
48134921|NCT01490632|100651543|FG011|STARTED|Part C: Washout or Step-Down Period||0||
48134922|NCT01490632|100651544|FG012|STARTED|Part C: Washout or Step-Down Period||15||
48134923|NCT01490632|100651545|FG013|STARTED|Part C: Washout or Step-Down Period||16||
48703595|NCT02538419|102060547|FG000|NOT COMPLETED|Overall Study||0||
48134924|NCT01490632|100651546|FG014|STARTED|Part C: Washout or Step-Down Period||55||
48134925|NCT01490632|100651547|FG015|STARTED|Part C: Washout or Step-Down Period||55||
48579445|NCT04903496|101750889|FG002|COMPLETED|Study Period 2019||198099||
48579446|NCT04903496|101750890|FG003|COMPLETED|Study Period 2019||205078||
48579447|NCT04903496|101750887|FG000|NOT COMPLETED|Study Period 2019||0||
48579448|NCT04903496|101750888|FG001|NOT COMPLETED|Study Period 2019||0||
48579449|NCT04903496|101750889|FG002|NOT COMPLETED|Study Period 2019||0||
48579450|NCT04903496|101750890|FG003|NOT COMPLETED|Study Period 2019||0||
48579451|NCT01938430|101750891|FG000|STARTED|Overall Study||30||
48703596|NCT02538419|102060548|FG001|NOT COMPLETED|Overall Study||0||
48703597|NCT01145352|102060549|FG000|STARTED|Overall Study||113||
48703598|NCT01145352|102060549|FG000|COMPLETED|Overall Study||102||
48703599|NCT01145352|102060549|FG000|NOT COMPLETED|Overall Study||11||
48703600|NCT02692040|102060550|FG000|STARTED|Overall Study||10||
48703601|NCT02692040|102060551|FG001|STARTED|Overall Study||4||
48134926|NCT01490632|100651548|FG016|STARTED|Part C: Washout or Step-Down Period||0||
48134927|NCT01490632|100651549|FG017|STARTED|Part C: Washout or Step-Down Period||0||
48134928|NCT01490632|100651550|FG018|STARTED|Part C: Washout or Step-Down Period||0||
48141448|NCT01780922|100670423|FG000|COMPLETED|Washout (7 Days)||2||
48579452|NCT01938430|101750892|FG001|STARTED|Overall Study||29||
48579453|NCT01938430|101750893|FG002|STARTED|Overall Study||23||
48579454|NCT01938430|101750894|FG003|STARTED|Overall Study||26||
48579455|NCT01938430|101750895|FG004|STARTED|Overall Study||55||
48579456|NCT01938430|101750896|FG005|STARTED|Overall Study||56||
48579457|NCT01938430|101750897|FG006|STARTED|Overall Study||26||
48579458|NCT01938430|101750898|FG007|STARTED|Overall Study||25||
48579459|NCT01938430|101750899|FG008|STARTED|Overall Study||26||
48579460|NCT01938430|101750900|FG009|STARTED|Overall Study||26||
48579461|NCT01938430|101750901|FG010|STARTED|Overall Study||6||
48579462|NCT01938430|101750902|FG011|STARTED|Overall Study||4||
48579463|NCT01938430|101750903|FG012|STARTED|Overall Study||4||
48579464|NCT01938430|101750904|FG013|STARTED|Overall Study||3||
48579465|NCT01938430|101750891|FG000|COMPLETED|Overall Study||26||
48703602|NCT02692040|102060552|FG002|STARTED|Overall Study||5||
48703603|NCT02692040|102060553|FG003|STARTED|Overall Study||5||
48703604|NCT02692040|102060554|FG004|STARTED|Overall Study||4||
48703605|NCT02692040|102060555|FG005|STARTED|Overall Study||5||
48703606|NCT02692040|102060556|FG006|STARTED|Overall Study||5||
48703607|NCT02692040|102060557|FG007|STARTED|Overall Study||5||
48703608|NCT02692040|102060558|FG008|STARTED|Overall Study||5||
48703609|NCT02692040|102060559|FG009|STARTED|Overall Study||4||
48703610|NCT02692040|102060560|FG010|STARTED|Overall Study||5||
48579466|NCT01938430|101750892|FG001|COMPLETED|Overall Study||26||
48579467|NCT01938430|101750893|FG002|COMPLETED|Overall Study||18||
48579468|NCT01938430|101750894|FG003|COMPLETED|Overall Study||24||
48579469|NCT01938430|101750895|FG004|COMPLETED|Overall Study||55||
48579470|NCT01938430|101750896|FG005|COMPLETED|Overall Study||55||
48579471|NCT01938430|101750897|FG006|COMPLETED|Overall Study||24||
48579472|NCT01938430|101750898|FG007|COMPLETED|Overall Study||24||
48579473|NCT01938430|101750899|FG008|COMPLETED|Overall Study||22||
48579474|NCT01938430|101750900|FG009|COMPLETED|Overall Study||23||
48579475|NCT01938430|101750901|FG010|COMPLETED|Overall Study||3||
48579476|NCT01938430|101750902|FG011|COMPLETED|Overall Study||3||
48134929|NCT01490632|100651551|FG019|STARTED|Part C: Washout or Step-Down Period||0||
48134930|NCT01490632|100651532|FG000|COMPLETED|Part C: Washout or Step-Down Period||0||
48134931|NCT01490632|100651533|FG001|COMPLETED|Part C: Washout or Step-Down Period||0||
48134932|NCT01490632|100651534|FG002|COMPLETED|Part C: Washout or Step-Down Period||0||
48134933|NCT01490632|100651535|FG003|COMPLETED|Part C: Washout or Step-Down Period||0||
48134934|NCT01490632|100651536|FG004|COMPLETED|Part C: Washout or Step-Down Period||0||
48579477|NCT01938430|101750903|FG012|COMPLETED|Overall Study||4||
48579478|NCT01938430|101750904|FG013|COMPLETED|Overall Study||2||
48579479|NCT01938430|101750891|FG000|NOT COMPLETED|Overall Study||4||
48286954|NCT05087979|101029604|FG001|NOT COMPLETED|Overall Study||0||
48579480|NCT01938430|101750892|FG001|NOT COMPLETED|Overall Study||3||
48579481|NCT01938430|101750893|FG002|NOT COMPLETED|Overall Study||5||
48579482|NCT01938430|101750894|FG003|NOT COMPLETED|Overall Study||2||
48579483|NCT01938430|101750895|FG004|NOT COMPLETED|Overall Study||0||
48579484|NCT01938430|101750896|FG005|NOT COMPLETED|Overall Study||1||
48579485|NCT01938430|101750897|FG006|NOT COMPLETED|Overall Study||2||
48579486|NCT01938430|101750898|FG007|NOT COMPLETED|Overall Study||1||
48134935|NCT01490632|100651537|FG005|COMPLETED|Part C: Washout or Step-Down Period||0||
48134936|NCT01490632|100651538|FG006|COMPLETED|Part C: Washout or Step-Down Period||0||
48134937|NCT01490632|100651539|FG007|COMPLETED|Part C: Washout or Step-Down Period||0||
48134938|NCT01490632|100651540|FG008|COMPLETED|Part C: Washout or Step-Down Period||0||
48134939|NCT01490632|100651541|FG009|COMPLETED|Part C: Washout or Step-Down Period||0||
48134940|NCT01490632|100651542|FG010|COMPLETED|Part C: Washout or Step-Down Period||0||
48134941|NCT01490632|100651543|FG011|COMPLETED|Part C: Washout or Step-Down Period||0||
48134942|NCT01490632|100651544|FG012|COMPLETED|Part C: Washout or Step-Down Period||10||
48134943|NCT01490632|100651545|FG013|COMPLETED|Part C: Washout or Step-Down Period||6||
48134944|NCT01490632|100651546|FG014|COMPLETED|Part C: Washout or Step-Down Period||37||
48134945|NCT01490632|100651547|FG015|COMPLETED|Part C: Washout or Step-Down Period||18||
48134946|NCT01490632|100651548|FG016|COMPLETED|Part C: Washout or Step-Down Period||0||
48579487|NCT01938430|101750899|FG008|NOT COMPLETED|Overall Study||4||
48579488|NCT01938430|101750900|FG009|NOT COMPLETED|Overall Study||3||
48579489|NCT01938430|101750901|FG010|NOT COMPLETED|Overall Study||3||
48579490|NCT01938430|101750902|FG011|NOT COMPLETED|Overall Study||1||
48579491|NCT01938430|101750903|FG012|NOT COMPLETED|Overall Study||0||
48579492|NCT01938430|101750904|FG013|NOT COMPLETED|Overall Study||1||
48134947|NCT01490632|100651549|FG017|COMPLETED|Part C: Washout or Step-Down Period||0||
48579493|NCT01282372|101750905|FG000|STARTED|Overall Study||500||
48579494|NCT01282372|101750905|FG000|COMPLETED|Overall Study||421||
48579495|NCT01282372|101750905|FG000|NOT COMPLETED|Overall Study||79||
48579496|NCT01490073|101750906|FG000|STARTED|Overall Study||12||
48579497|NCT01490073|101750907|FG001|STARTED|Overall Study||12||
48579498|NCT01490073|101750906|FG000|COMPLETED|Overall Study||12||
48579499|NCT01490073|101750907|FG001|COMPLETED|Overall Study||12||
48579500|NCT01490073|101750906|FG000|NOT COMPLETED|Overall Study||0||
48579501|NCT01490073|101750907|FG001|NOT COMPLETED|Overall Study||0||
48579502|NCT01031836|101750908|FG000|STARTED|Stage I||5||
48579503|NCT01031836|101750909|FG001|STARTED|Stage I||5||
48579504|NCT01031836|101750910|FG002|STARTED|Stage I||5||
48579505|NCT01031836|101750911|FG003|STARTED|Stage I||5||
48579506|NCT01031836|101750912|FG004|STARTED|Stage I||5||
48579507|NCT01031836|101750913|FG005|STARTED|Stage I||5||
48579508|NCT01031836|101750908|FG000|COMPLETED|Stage I||4||
48579509|NCT01031836|101750909|FG001|COMPLETED|Stage I||3||
48579510|NCT01031836|101750910|FG002|COMPLETED|Stage I||5||
48579511|NCT01031836|101750911|FG003|COMPLETED|Stage I||5||
48579512|NCT01031836|101750912|FG004|COMPLETED|Stage I||5||
48579513|NCT01031836|101750913|FG005|COMPLETED|Stage I||4||
48579514|NCT01031836|101750908|FG000|NOT COMPLETED|Stage I||1||
48134948|NCT01490632|100651550|FG018|COMPLETED|Part C: Washout or Step-Down Period||0||
48134949|NCT01490632|100651551|FG019|COMPLETED|Part C: Washout or Step-Down Period||0||
48134950|NCT01490632|100651532|FG000|NOT COMPLETED|Part C: Washout or Step-Down Period||0||
48579515|NCT01031836|101750909|FG001|NOT COMPLETED|Stage I||2||
48579516|NCT01031836|101750910|FG002|NOT COMPLETED|Stage I||0||
48579517|NCT01031836|101750911|FG003|NOT COMPLETED|Stage I||0||
48579518|NCT01031836|101750912|FG004|NOT COMPLETED|Stage I||0||
48579519|NCT01031836|101750913|FG005|NOT COMPLETED|Stage I||1||
48579520|NCT01031836|101750908|FG000|STARTED|Stage II||3||
48579521|NCT01031836|101750909|FG001|STARTED|Stage II||1||
48579522|NCT01031836|101750910|FG002|STARTED|Stage II||4||
48579523|NCT01031836|101750911|FG003|STARTED|Stage II||4||
48579524|NCT01031836|101750912|FG004|STARTED|Stage II||5||
48579525|NCT01031836|101750913|FG005|STARTED|Stage II||4||
48703611|NCT02692040|102060561|FG011|STARTED|Overall Study||5||
48703612|NCT02692040|102060562|FG012|STARTED|Overall Study||6||
48703613|NCT02692040|102060563|FG013|STARTED|Overall Study||6||
48703614|NCT02692040|102060564|FG014|STARTED|Overall Study||6||
48703615|NCT02692040|102060565|FG015|STARTED|Overall Study||6||
48703616|NCT02692040|102060566|FG016|STARTED|Overall Study||4||
48703617|NCT02692040|102060550|FG000|COMPLETED|Overall Study||10||
48703618|NCT02692040|102060551|FG001|COMPLETED|Overall Study||4||
48703619|NCT02692040|102060552|FG002|COMPLETED|Overall Study||5||
48703620|NCT02692040|102060553|FG003|COMPLETED|Overall Study||5||
48703621|NCT02692040|102060554|FG004|COMPLETED|Overall Study||4||
48703622|NCT02692040|102060555|FG005|COMPLETED|Overall Study||5||
48703623|NCT02692040|102060556|FG006|COMPLETED|Overall Study||5||
48703624|NCT02692040|102060557|FG007|COMPLETED|Overall Study||5||
48703625|NCT02692040|102060558|FG008|COMPLETED|Overall Study||5||
48703626|NCT02692040|102060559|FG009|COMPLETED|Overall Study||4||
48703627|NCT02692040|102060560|FG010|COMPLETED|Overall Study||5||
48703628|NCT02692040|102060561|FG011|COMPLETED|Overall Study||5||
48703629|NCT02692040|102060562|FG012|COMPLETED|Overall Study||5||
48703630|NCT02692040|102060563|FG013|COMPLETED|Overall Study||3||
48703631|NCT02692040|102060564|FG014|COMPLETED|Overall Study||5||
48703632|NCT02692040|102060565|FG015|COMPLETED|Overall Study||5||
48134951|NCT01490632|100651533|FG001|NOT COMPLETED|Part C: Washout or Step-Down Period||0||
48134952|NCT01490632|100651534|FG002|NOT COMPLETED|Part C: Washout or Step-Down Period||0||
48134953|NCT01490632|100651535|FG003|NOT COMPLETED|Part C: Washout or Step-Down Period||0||
48134954|NCT01490632|100651536|FG004|NOT COMPLETED|Part C: Washout or Step-Down Period||0||
48134955|NCT01490632|100651537|FG005|NOT COMPLETED|Part C: Washout or Step-Down Period||0||
48134956|NCT01490632|100651538|FG006|NOT COMPLETED|Part C: Washout or Step-Down Period||0||
48134957|NCT01490632|100651539|FG007|NOT COMPLETED|Part C: Washout or Step-Down Period||0||
48134958|NCT01490632|100651540|FG008|NOT COMPLETED|Part C: Washout or Step-Down Period||0||
48134959|NCT01490632|100651541|FG009|NOT COMPLETED|Part C: Washout or Step-Down Period||0||
48134960|NCT01490632|100651542|FG010|NOT COMPLETED|Part C: Washout or Step-Down Period||0||
48286955|NCT02341859|101029605|FG000|STARTED|First Intervention (1 Day)||10||
48703633|NCT02692040|102060566|FG016|COMPLETED|Overall Study||4||
48703634|NCT02692040|102060550|FG000|NOT COMPLETED|Overall Study||0||
48703635|NCT02692040|102060551|FG001|NOT COMPLETED|Overall Study||0||
48703636|NCT02692040|102060552|FG002|NOT COMPLETED|Overall Study||0||
48703637|NCT02692040|102060553|FG003|NOT COMPLETED|Overall Study||0||
48703638|NCT02692040|102060554|FG004|NOT COMPLETED|Overall Study||0||
48703639|NCT02692040|102060555|FG005|NOT COMPLETED|Overall Study||0||
48703640|NCT02692040|102060556|FG006|NOT COMPLETED|Overall Study||0||
48703641|NCT02692040|102060557|FG007|NOT COMPLETED|Overall Study||0||
48703642|NCT02692040|102060558|FG008|NOT COMPLETED|Overall Study||0||
48703643|NCT02692040|102060559|FG009|NOT COMPLETED|Overall Study||0||
48703644|NCT02692040|102060560|FG010|NOT COMPLETED|Overall Study||0||
48703645|NCT02692040|102060561|FG011|NOT COMPLETED|Overall Study||0||
48703646|NCT02692040|102060562|FG012|NOT COMPLETED|Overall Study||1||
48703647|NCT02692040|102060563|FG013|NOT COMPLETED|Overall Study||3||
48703648|NCT02692040|102060564|FG014|NOT COMPLETED|Overall Study||1||
48703649|NCT02692040|102060565|FG015|NOT COMPLETED|Overall Study||1||
48703650|NCT02692040|102060566|FG016|NOT COMPLETED|Overall Study||0||
48703651|NCT03645421|102060567|FG000|STARTED|Overall Study||16||
48703652|NCT03645421|102060568|FG001|STARTED|Overall Study||15||
48703653|NCT03645421|102060569|FG002|STARTED|Overall Study||15||
48134961|NCT01490632|100651543|FG011|NOT COMPLETED|Part C: Washout or Step-Down Period||0||
48134962|NCT01490632|100651544|FG012|NOT COMPLETED|Part C: Washout or Step-Down Period||5||
48703654|NCT03645421|102060570|FG003|STARTED|Overall Study||15||
48703655|NCT03645421|102060567|FG000|Received Investigational Product (IP)|Overall Study||16||
48703656|NCT03645421|102060568|FG001|Received Investigational Product (IP)|Overall Study||15||
48703657|NCT03645421|102060569|FG002|Received Investigational Product (IP)|Overall Study||15||
48703658|NCT03645421|102060570|FG003|Received Investigational Product (IP)|Overall Study||15||
48703659|NCT03645421|102060567|FG000|COMPLETED|Overall Study||16||
48703660|NCT03645421|102060568|FG001|COMPLETED|Overall Study||15||
48703661|NCT03645421|102060569|FG002|COMPLETED|Overall Study||10||
48703662|NCT03645421|102060570|FG003|COMPLETED|Overall Study||11||
48703663|NCT03645421|102060567|FG000|NOT COMPLETED|Overall Study||0||
48703664|NCT03645421|102060568|FG001|NOT COMPLETED|Overall Study||0||
48703665|NCT03645421|102060569|FG002|NOT COMPLETED|Overall Study||5||
48703666|NCT03645421|102060570|FG003|NOT COMPLETED|Overall Study||4||
48703667|NCT04941807|102060571|FG000|STARTED|Overall Study||11||80
48703668|NCT04941807|102060572|FG001|STARTED|Overall Study||11||22
48703669|NCT04941807|102060571|FG000|COMPLETED|Overall Study||10||73
48703670|NCT04941807|102060572|FG001|COMPLETED|Overall Study||10||20
48134963|NCT01490632|100651545|FG013|NOT COMPLETED|Part C: Washout or Step-Down Period||10||
48703671|NCT04941807|102060571|FG000|NOT COMPLETED|Overall Study||1||7
48703672|NCT04941807|102060572|FG001|NOT COMPLETED|Overall Study||1||2
48703673|NCT03550170|102060573|FG000|STARTED|Overall Study||197||
48703674|NCT03550170|102060574|FG001|STARTED|Overall Study||197||
48703675|NCT03550170|102060575|FG002|STARTED|Overall Study||196||
48703676|NCT03550170|102060573|FG000|COMPLETED|Overall Study||172||
48703677|NCT03550170|102060574|FG001|COMPLETED|Overall Study||174||
48134964|NCT01490632|100651546|FG014|NOT COMPLETED|Part C: Washout or Step-Down Period||18||
48134965|NCT01490632|100651547|FG015|NOT COMPLETED|Part C: Washout or Step-Down Period||37||
48134966|NCT01490632|100651548|FG016|NOT COMPLETED|Part C: Washout or Step-Down Period||0||
48134967|NCT01490632|100651549|FG017|NOT COMPLETED|Part C: Washout or Step-Down Period||0||
48134968|NCT01490632|100651550|FG018|NOT COMPLETED|Part C: Washout or Step-Down Period||0||
48134969|NCT01490632|100651551|FG019|NOT COMPLETED|Part C: Washout or Step-Down Period||0||
48134970|NCT01490632|100651532|FG000|STARTED|Part D: Re-Treatment Period||0||
48134971|NCT01490632|100651533|FG001|STARTED|Part D: Re-Treatment Period||0||
48134972|NCT01490632|100651534|FG002|STARTED|Part D: Re-Treatment Period||0||
48134973|NCT01490632|100651535|FG003|STARTED|Part D: Re-Treatment Period||0||
48134974|NCT01490632|100651536|FG004|STARTED|Part D: Re-Treatment Period||0||
48134975|NCT01490632|100651537|FG005|STARTED|Part D: Re-Treatment Period||0||
48134976|NCT01490632|100651538|FG006|STARTED|Part D: Re-Treatment Period||0||
48134977|NCT01490632|100651539|FG007|STARTED|Part D: Re-Treatment Period||0||
48134978|NCT01490632|100651540|FG008|STARTED|Part D: Re-Treatment Period||0||
48134979|NCT01490632|100651541|FG009|STARTED|Part D: Re-Treatment Period||0||
48134980|NCT01490632|100651542|FG010|STARTED|Part D: Re-Treatment Period||0||
48134981|NCT01490632|100651543|FG011|STARTED|Part D: Re-Treatment Period||0||
48134982|NCT01490632|100651544|FG012|STARTED|Part D: Re-Treatment Period||0||
48134983|NCT01490632|100651545|FG013|STARTED|Part D: Re-Treatment Period||0||
48134984|NCT01490632|100651546|FG014|STARTED|Part D: Re-Treatment Period||0||
48134985|NCT01490632|100651547|FG015|STARTED|Part D: Re-Treatment Period||0||
48134986|NCT01490632|100651548|FG016|STARTED|Part D: Re-Treatment Period||3||
48579526|NCT01031836|101750908|FG000|COMPLETED|Stage II||1||
48579527|NCT01031836|101750909|FG001|COMPLETED|Stage II||1||
48579528|NCT01031836|101750910|FG002|COMPLETED|Stage II||2||
48579529|NCT01031836|101750911|FG003|COMPLETED|Stage II||1||
48579530|NCT01031836|101750912|FG004|COMPLETED|Stage II||3||
48579531|NCT01031836|101750913|FG005|COMPLETED|Stage II||3||
48579532|NCT01031836|101750908|FG000|NOT COMPLETED|Stage II||2||
48579533|NCT01031836|101750909|FG001|NOT COMPLETED|Stage II||0||
48579534|NCT01031836|101750910|FG002|NOT COMPLETED|Stage II||2||
48579535|NCT01031836|101750911|FG003|NOT COMPLETED|Stage II||3||
48579536|NCT01031836|101750912|FG004|NOT COMPLETED|Stage II||2||
48579537|NCT01031836|101750913|FG005|NOT COMPLETED|Stage II||1||
48579538|NCT00695292|101750914|FG000|STARTED|Overall Study||37||
48579539|NCT00695292|101750914|FG000|COMPLETED|Overall Study||37||
48579540|NCT00695292|101750914|FG000|NOT COMPLETED|Overall Study||0||
48579541|NCT01316211|101750915|FG000|STARTED|Overall Study||116||
48579542|NCT01316211|101750916|FG001|STARTED|Overall Study||123||
48579543|NCT01316211|101750915|FG000|COMPLETED|Overall Study||105||
48579544|NCT01316211|101750916|FG001|COMPLETED|Overall Study||111||
48579545|NCT01316211|101750915|FG000|NOT COMPLETED|Overall Study||11||
48579546|NCT01316211|101750916|FG001|NOT COMPLETED|Overall Study||12||
48579547|NCT04826965|101750917|FG000|STARTED|Overall Study||3||
48579548|NCT04826965|101750918|FG001|STARTED|Overall Study||2||
48579549|NCT04826965|101750917|FG000|COMPLETED|Overall Study||3||
48579550|NCT04826965|101750918|FG001|COMPLETED|Overall Study||2||
48579551|NCT04826965|101750917|FG000|NOT COMPLETED|Overall Study||0||
48579552|NCT04826965|101750918|FG001|NOT COMPLETED|Overall Study||0||
48579553|NCT01981954|101750919|FG000|STARTED|Titration Period||23||
48579554|NCT01981954|101750919|FG000|Treated|Titration Period||23||
48579555|NCT01981954|101750919|FG000|COMPLETED|Titration Period||22||
48579556|NCT01981954|101750919|FG000|NOT COMPLETED|Titration Period||1||
48579557|NCT01981954|101750919|FG000|STARTED|Fixed-Dose Assessment Period||22||
48579558|NCT01981954|101750919|FG000|Treated|Fixed-Dose Assessment Period||22||
48579559|NCT01981954|101750919|FG000|COMPLETED|Fixed-Dose Assessment Period||21||
48579560|NCT01981954|101750919|FG000|NOT COMPLETED|Fixed-Dose Assessment Period||1||
48579561|NCT01638312|101750920|FG000|STARTED|Overall Study||20||
48579562|NCT01638312|101750921|FG001|STARTED|Overall Study||30||
48579563|NCT01638312|101750920|FG000|COMPLETED|Overall Study||20||
48579564|NCT01638312|101750921|FG001|COMPLETED|Overall Study||30||
48579565|NCT01638312|101750920|FG000|NOT COMPLETED|Overall Study||0||
48579566|NCT01638312|101750921|FG001|NOT COMPLETED|Overall Study||0||
48579567|NCT00170625|101750922|FG000|STARTED|Overall Study||13||
48134987|NCT01490632|100651549|FG017|STARTED|Part D: Re-Treatment Period||13||
48134988|NCT01490632|100651550|FG018|STARTED|Part D: Re-Treatment Period||19||
48134989|NCT01490632|100651551|FG019|STARTED|Part D: Re-Treatment Period||37||
48134990|NCT01490632|100651532|FG000|COMPLETED|Part D: Re-Treatment Period||0||
48134991|NCT01490632|100651533|FG001|COMPLETED|Part D: Re-Treatment Period||0||
48134992|NCT01490632|100651534|FG002|COMPLETED|Part D: Re-Treatment Period||0||
48134993|NCT01490632|100651535|FG003|COMPLETED|Part D: Re-Treatment Period||0||
48579568|NCT00170625|101750923|FG001|STARTED|Overall Study||13||
48579569|NCT00170625|101750922|FG000|COMPLETED|Overall Study||13||
48579570|NCT00170625|101750923|FG001|COMPLETED|Overall Study||13||
48579571|NCT00170625|101750922|FG000|NOT COMPLETED|Overall Study||0||
48579572|NCT00170625|101750923|FG001|NOT COMPLETED|Overall Study||0||
48579573|NCT03033602|101750924|FG000|STARTED|Overall Study||85||
48579574|NCT03033602|101750925|FG001|STARTED|Overall Study||84||
48134994|NCT01490632|100651536|FG004|COMPLETED|Part D: Re-Treatment Period||0||
48134995|NCT01490632|100651537|FG005|COMPLETED|Part D: Re-Treatment Period||0||
48134996|NCT01490632|100651538|FG006|COMPLETED|Part D: Re-Treatment Period||0||
48134997|NCT01490632|100651539|FG007|COMPLETED|Part D: Re-Treatment Period||0||
48134998|NCT01490632|100651540|FG008|COMPLETED|Part D: Re-Treatment Period||0||
48134999|NCT01490632|100651541|FG009|COMPLETED|Part D: Re-Treatment Period||0||
48135000|NCT01490632|100651542|FG010|COMPLETED|Part D: Re-Treatment Period||0||
48135001|NCT01490632|100651543|FG011|COMPLETED|Part D: Re-Treatment Period||0||
48135002|NCT01490632|100651544|FG012|COMPLETED|Part D: Re-Treatment Period||0||
48135003|NCT01490632|100651545|FG013|COMPLETED|Part D: Re-Treatment Period||0||
48135004|NCT01490632|100651546|FG014|COMPLETED|Part D: Re-Treatment Period||0||
48286956|NCT02341859|101029606|FG001|STARTED|First Intervention (1 Day)||9||
48286957|NCT02341859|101029605|FG000|COMPLETED|First Intervention (1 Day)||10||
48286958|NCT02341859|101029606|FG001|COMPLETED|First Intervention (1 Day)||9||
48286959|NCT02341859|101029605|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48286960|NCT02341859|101029606|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48286961|NCT02341859|101029605|FG000|STARTED|Second Intervention (1 Day)||10||
48286962|NCT02341859|101029606|FG001|STARTED|Second Intervention (1 Day)||9||
48286963|NCT02341859|101029605|FG000|COMPLETED|Second Intervention (1 Day)||10||
48286964|NCT02341859|101029606|FG001|COMPLETED|Second Intervention (1 Day)||9||
48286965|NCT02341859|101029605|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48286966|NCT02341859|101029606|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48286967|NCT02447172|101029607|FG000|STARTED|Overall Study||262||
48286968|NCT02447172|101029608|FG001|STARTED|Overall Study||130||
48286969|NCT02447172|101029609|FG002|STARTED|Overall Study||132||
48286970|NCT02447172|101029607|FG000|COMPLETED|Overall Study||231||
48579575|NCT03033602|101750924|FG000|COMPLETED|Overall Study||65|completed treatment|
48579576|NCT03033602|101750925|FG001|COMPLETED|Overall Study||47|completed treatment|
48579577|NCT03033602|101750924|FG000|NOT COMPLETED|Overall Study||20||
48579578|NCT03033602|101750925|FG001|NOT COMPLETED|Overall Study||37||
48579579|NCT02294396|101750926|FG000|STARTED|Overall Study||167||
48579580|NCT02294396|101750927|FG001|STARTED|Overall Study||161||
48579581|NCT02294396|101750928|FG002|STARTED|Overall Study||161||
48579582|NCT02294396|101750929|FG003|STARTED|Overall Study||160||
48579583|NCT02294396|101750926|FG000|COMPLETED|Overall Study||127||
48579584|NCT02294396|101750927|FG001|COMPLETED|Overall Study||128||
48579585|NCT02294396|101750928|FG002|COMPLETED|Overall Study||126||
48579586|NCT02294396|101750929|FG003|COMPLETED|Overall Study||123||
48579587|NCT02294396|101750926|FG000|NOT COMPLETED|Overall Study||40||
48579588|NCT02294396|101750927|FG001|NOT COMPLETED|Overall Study||33||
48579589|NCT02294396|101750928|FG002|NOT COMPLETED|Overall Study||35||
48579590|NCT02294396|101750929|FG003|NOT COMPLETED|Overall Study||37||
48579591|NCT02208362|101750930|FG000|STARTED|Overall Study||2||
48579592|NCT02208362|101750931|FG001|STARTED|Overall Study||4||
48579593|NCT02208362|101750932|FG002|STARTED|Overall Study||4||
48579594|NCT02208362|101750933|FG003|STARTED|Overall Study||10||
48579595|NCT02208362|101750934|FG004|STARTED|Overall Study||3||
48579596|NCT02208362|101750935|FG005|STARTED|Overall Study||3||
48579597|NCT02208362|101750936|FG006|STARTED|Overall Study||5||
48579598|NCT02208362|101750937|FG007|STARTED|Overall Study||4||
48579599|NCT02208362|101750938|FG008|STARTED|Overall Study||8||
48579600|NCT02208362|101750939|FG009|STARTED|Overall Study||3||
48579601|NCT02208362|101750940|FG010|STARTED|Overall Study||8||
48579602|NCT02208362|101750941|FG011|STARTED|Overall Study||11||
48579603|NCT02208362|101750930|FG000|COMPLETED|Overall Study||2||
48579604|NCT02208362|101750931|FG001|COMPLETED|Overall Study||3||
48579605|NCT02208362|101750932|FG002|COMPLETED|Overall Study||4||
48579606|NCT02208362|101750933|FG003|COMPLETED|Overall Study||10||
48579607|NCT02208362|101750934|FG004|COMPLETED|Overall Study||3||
48579608|NCT02208362|101750935|FG005|COMPLETED|Overall Study||3||
48579609|NCT02208362|101750936|FG006|COMPLETED|Overall Study||4||
48579610|NCT02208362|101750937|FG007|COMPLETED|Overall Study||3||
48579611|NCT02208362|101750938|FG008|COMPLETED|Overall Study||5||
48579612|NCT02208362|101750939|FG009|COMPLETED|Overall Study||3||
48579613|NCT02208362|101750940|FG010|COMPLETED|Overall Study||7||
48579614|NCT02208362|101750941|FG011|COMPLETED|Overall Study||11||
48135005|NCT01490632|100651547|FG015|COMPLETED|Part D: Re-Treatment Period||0||
48135006|NCT01490632|100651548|FG016|COMPLETED|Part D: Re-Treatment Period||3||
48135007|NCT01490632|100651549|FG017|COMPLETED|Part D: Re-Treatment Period||8||
48135008|NCT01490632|100651550|FG018|COMPLETED|Part D: Re-Treatment Period||12||
48135009|NCT01490632|100651551|FG019|COMPLETED|Part D: Re-Treatment Period||30||
48286971|NCT02447172|101029608|FG001|COMPLETED|Overall Study||115||
48286972|NCT02447172|101029609|FG002|COMPLETED|Overall Study||114||
48286973|NCT02447172|101029607|FG000|NOT COMPLETED|Overall Study||31||
48286974|NCT02447172|101029608|FG001|NOT COMPLETED|Overall Study||15||
48286975|NCT02447172|101029609|FG002|NOT COMPLETED|Overall Study||18||
48579615|NCT02208362|101750930|FG000|NOT COMPLETED|Overall Study||0||
48579616|NCT02208362|101750931|FG001|NOT COMPLETED|Overall Study||1||
48579617|NCT02208362|101750932|FG002|NOT COMPLETED|Overall Study||0||
48579618|NCT02208362|101750933|FG003|NOT COMPLETED|Overall Study||0||
48579619|NCT02208362|101750934|FG004|NOT COMPLETED|Overall Study||0||
48579620|NCT02208362|101750935|FG005|NOT COMPLETED|Overall Study||0||
48579621|NCT02208362|101750936|FG006|NOT COMPLETED|Overall Study||1||
48579622|NCT02208362|101750937|FG007|NOT COMPLETED|Overall Study||1||
48579623|NCT02208362|101750938|FG008|NOT COMPLETED|Overall Study||3||
48579624|NCT02208362|101750939|FG009|NOT COMPLETED|Overall Study||0||
48579625|NCT02208362|101750940|FG010|NOT COMPLETED|Overall Study||1||
48579626|NCT02208362|101750941|FG011|NOT COMPLETED|Overall Study||0||
48579627|NCT03169881|101750942|FG000|STARTED|Overall Study||322||
48579628|NCT03169881|101750943|FG001|STARTED|Overall Study||328||
48579629|NCT03169881|101750942|FG000|Completed Assessment for Bayley Cognitive Score at Two-Year Follow-Up|Overall Study||239||
48579630|NCT03169881|101750943|FG001|Completed Assessment for Bayley Cognitive Score at Two-Year Follow-Up|Overall Study||239||
48579631|NCT03169881|101750942|FG000|Died After Hospital Discharge|Overall Study||2||
48579632|NCT03169881|101750943|FG001|Died After Hospital Discharge|Overall Study||3||
48579633|NCT03169881|101750942|FG000|Died Before Hospital Discharge|Overall Study||50||
48579634|NCT03169881|101750943|FG001|Died Before Hospital Discharge|Overall Study||50||
48579635|NCT03169881|101750942|FG000|Started Study Drug and Data Not Withdrawn Prior to Hospital Discharge|Overall Study||316||
48579636|NCT03169881|101750943|FG001|Started Study Drug and Data Not Withdrawn Prior to Hospital Discharge|Overall Study||325||
48579637|NCT03169881|101750942|FG000|Survived to Hospital Discharge (a Median of 94 Days)|Overall Study||269||
48579638|NCT03169881|101750943|FG001|Survived to Hospital Discharge (a Median of 94 Days)|Overall Study||277||
48579639|NCT03169881|101750942|FG000|COMPLETED|Overall Study||291|Complete data for Primary Outcome, Bayley Cognitive Score assessed at Two-Year Follow-up, with imputed scores for deaths occurring prior|
48579640|NCT03169881|101750943|FG001|COMPLETED|Overall Study||292|Complete data for Primary Outcome, Bayley Cognitive Score assessed at Two-Year Follow-up, with imputed scores for deaths occurring prior|
48579641|NCT03169881|101750942|FG000|NOT COMPLETED|Overall Study||31||
48579642|NCT03169881|101750943|FG001|NOT COMPLETED|Overall Study||36||
48579643|NCT01340027|101750944|FG000|STARTED|Overall Study||81||
48579644|NCT01340027|101750945|FG001|STARTED|Overall Study||78||
48579645|NCT01340027|101750946|FG002|STARTED|Overall Study||79||
48579646|NCT01340027|101750947|FG003|STARTED|Overall Study||79||
48286976|NCT00081497|101029610|FG000|STARTED|Overall Study||28||
48286977|NCT00081497|101029611|FG001|STARTED|Overall Study||39||
48286978|NCT00081497|101029610|FG000|COMPLETED|Overall Study||25||
48286979|NCT00081497|101029611|FG001|COMPLETED|Overall Study||37||
48286980|NCT00081497|101029610|FG000|NOT COMPLETED|Overall Study||3||
48579647|NCT01340027|101750948|FG004|STARTED|Overall Study||156||
48579648|NCT01340027|101750949|FG005|STARTED|Overall Study||78||
48579649|NCT01340027|101750950|FG006|STARTED|Overall Study||149||
48579650|NCT01340027|101750951|FG007|STARTED|Overall Study||149||
48579651|NCT01340027|101750952|FG008|STARTED|Overall Study||144||
48579652|NCT01340027|101750953|FG009|STARTED|Overall Study||152||
48579653|NCT01340027|101750954|FG010|STARTED|Overall Study||81||
48579654|NCT01340027|101750955|FG011|STARTED|Overall Study||81||
48579655|NCT01340027|101750944|FG000|Received Treatment|Overall Study||81||
48579656|NCT01340027|101750945|FG001|Received Treatment|Overall Study||78||
48579657|NCT01340027|101750946|FG002|Received Treatment|Overall Study||78||
48579658|NCT01340027|101750947|FG003|Received Treatment|Overall Study||79||
48579659|NCT01340027|101750948|FG004|Received Treatment|Overall Study||156||
48579660|NCT01340027|101750949|FG005|Received Treatment|Overall Study||78||
48579661|NCT01340027|101750950|FG006|Received Treatment|Overall Study||149||
48579662|NCT01340027|101750951|FG007|Received Treatment|Overall Study||149||
48579663|NCT01340027|101750952|FG008|Received Treatment|Overall Study||144||
48286981|NCT00081497|101029611|FG001|NOT COMPLETED|Overall Study||2||
48286982|NCT02257567|101029612|FG000|STARTED|Overall Study||6||
48579664|NCT01340027|101750953|FG009|Received Treatment|Overall Study||152||
48579665|NCT01340027|101750954|FG010|Received Treatment|Overall Study||81||
48579666|NCT01340027|101750955|FG011|Received Treatment|Overall Study||81||
48579667|NCT01340027|101750944|FG000|COMPLETED|Overall Study||76||
48579668|NCT01340027|101750945|FG001|COMPLETED|Overall Study||71||
48579669|NCT01340027|101750946|FG002|COMPLETED|Overall Study||75||
48579670|NCT01340027|101750947|FG003|COMPLETED|Overall Study||75||
48579671|NCT01340027|101750948|FG004|COMPLETED|Overall Study||146||
48579672|NCT01340027|101750949|FG005|COMPLETED|Overall Study||74||
48579673|NCT01340027|101750950|FG006|COMPLETED|Overall Study||142||
48579674|NCT01340027|101750951|FG007|COMPLETED|Overall Study||142||
48579675|NCT01340027|101750952|FG008|COMPLETED|Overall Study||136||
48579676|NCT01340027|101750953|FG009|COMPLETED|Overall Study||146||
48579677|NCT01340027|101750954|FG010|COMPLETED|Overall Study||79||
48579678|NCT01340027|101750955|FG011|COMPLETED|Overall Study||77||
48579679|NCT01340027|101750944|FG000|NOT COMPLETED|Overall Study||5||
48579680|NCT01340027|101750945|FG001|NOT COMPLETED|Overall Study||7||
48703678|NCT03550170|102060575|FG002|COMPLETED|Overall Study||186||
48286983|NCT02257567|101029613|FG001|STARTED|Overall Study||6||
48286984|NCT02257567|101029614|FG002|STARTED|Overall Study||6||
48286985|NCT02257567|101029615|FG003|STARTED|Overall Study||6||
48286986|NCT02257567|101029616|FG004|STARTED|Overall Study||39||
48286987|NCT02257567|101029617|FG005|STARTED|Overall Study||41||
48286988|NCT02257567|101029618|FG006|STARTED|Overall Study||40||
48286989|NCT02257567|101029619|FG007|STARTED|Overall Study||40||
48286990|NCT02257567|101029620|FG008|STARTED|Overall Study||20||
48286991|NCT02257567|101029621|FG009|STARTED|Overall Study||21||
48286992|NCT02257567|101029622|FG010|STARTED|Overall Study||106||
48135010|NCT01490632|100651532|FG000|NOT COMPLETED|Part D: Re-Treatment Period||0||
48135011|NCT01490632|100651533|FG001|NOT COMPLETED|Part D: Re-Treatment Period||0||
48135012|NCT01490632|100651534|FG002|NOT COMPLETED|Part D: Re-Treatment Period||0||
48135013|NCT01490632|100651535|FG003|NOT COMPLETED|Part D: Re-Treatment Period||0||
48135014|NCT01490632|100651536|FG004|NOT COMPLETED|Part D: Re-Treatment Period||0||
48703679|NCT03550170|102060573|FG000|NOT COMPLETED|Overall Study||25||
48703680|NCT03550170|102060574|FG001|NOT COMPLETED|Overall Study||23||
48703681|NCT03550170|102060575|FG002|NOT COMPLETED|Overall Study||10||
48135015|NCT01490632|100651537|FG005|NOT COMPLETED|Part D: Re-Treatment Period||0||
48135016|NCT01490632|100651538|FG006|NOT COMPLETED|Part D: Re-Treatment Period||0||
48135017|NCT01490632|100651539|FG007|NOT COMPLETED|Part D: Re-Treatment Period||0||
48135018|NCT01490632|100651540|FG008|NOT COMPLETED|Part D: Re-Treatment Period||0||
48135019|NCT01490632|100651541|FG009|NOT COMPLETED|Part D: Re-Treatment Period||0||
48703682|NCT00230802|102060576|FG000|STARTED|Overall Study||25||
48135020|NCT01490632|100651542|FG010|NOT COMPLETED|Part D: Re-Treatment Period||0||
48135021|NCT01490632|100651543|FG011|NOT COMPLETED|Part D: Re-Treatment Period||0||
48135022|NCT01490632|100651544|FG012|NOT COMPLETED|Part D: Re-Treatment Period||0||
48135023|NCT01490632|100651545|FG013|NOT COMPLETED|Part D: Re-Treatment Period||0||
48135024|NCT01490632|100651546|FG014|NOT COMPLETED|Part D: Re-Treatment Period||0||
48135025|NCT01490632|100651547|FG015|NOT COMPLETED|Part D: Re-Treatment Period||0||
48135026|NCT01490632|100651548|FG016|NOT COMPLETED|Part D: Re-Treatment Period||0||
48135027|NCT01490632|100651549|FG017|NOT COMPLETED|Part D: Re-Treatment Period||5||
48135028|NCT01490632|100651550|FG018|NOT COMPLETED|Part D: Re-Treatment Period||7||
48135029|NCT01490632|100651551|FG019|NOT COMPLETED|Part D: Re-Treatment Period||7||
48135030|NCT05053087|100651552|FG000|STARTED|Overall Study||21||
48135031|NCT05053087|100651553|FG001|STARTED|Overall Study||20||
48135032|NCT05053087|100651554|FG002|STARTED|Overall Study||19||
48135033|NCT05053087|100651552|FG000|COMPLETED|Overall Study||21||
48135034|NCT05053087|100651553|FG001|COMPLETED|Overall Study||20||
48135035|NCT05053087|100651554|FG002|COMPLETED|Overall Study||19||
48135036|NCT05053087|100651552|FG000|NOT COMPLETED|Overall Study||0||
48135037|NCT05053087|100651553|FG001|NOT COMPLETED|Overall Study||0||
48135038|NCT05053087|100651554|FG002|NOT COMPLETED|Overall Study||0||
48135039|NCT04088097|100651555|FG000|STARTED|Overall Study||25||
48135040|NCT04088097|100651556|FG001|STARTED|Overall Study||25||
48135041|NCT04088097|100651555|FG000|COMPLETED|Overall Study||23||
48135042|NCT04088097|100651556|FG001|COMPLETED|Overall Study||21||
48135043|NCT04088097|100651555|FG000|NOT COMPLETED|Overall Study||2||
48135044|NCT04088097|100651556|FG001|NOT COMPLETED|Overall Study||4||
48135045|NCT02508480|100651557|FG000|STARTED|Overall Study||95||
48135046|NCT02508480|100651558|FG001|STARTED|Overall Study||97||
48135047|NCT02508480|100651557|FG000|Post-Treatment Assessment|Overall Study||87|Participants who completed assessment after the 10-week photovoice intervention|
48135048|NCT02508480|100651558|FG001|Post-Treatment Assessment|Overall Study||89|Participants who completed assessment after the 10-week photovoice intervention|
48135049|NCT02508480|100651557|FG000|Three Month Follow-up|Overall Study||84|Participants who completed the 3-month post-intervention follow-up|
48135050|NCT02508480|100651558|FG001|Three Month Follow-up|Overall Study||86|Participants who completed the 3-month post-intervention follow-up|
48135051|NCT02508480|100651557|FG000|Six-Month Follow-Up|Overall Study||84|Participants who completed the 6-month post-intervention follow-up|
48135052|NCT02508480|100651558|FG001|Six-Month Follow-Up|Overall Study||86|Participants who completed the 6-month post-intervention follow-up|
48135053|NCT02508480|100651557|FG000|COMPLETED|Overall Study||90|Participants who completed at least one post-baseline assessment over the study period.|
48135054|NCT02508480|100651558|FG001|COMPLETED|Overall Study||93|Participants who completed at least one post-baseline assessment over the study period.|
48135055|NCT02508480|100651557|FG000|NOT COMPLETED|Overall Study||5||
48135056|NCT02508480|100651558|FG001|NOT COMPLETED|Overall Study||4||
48703683|NCT00230802|102060577|FG001|STARTED|Overall Study||23||
48703684|NCT00230802|102060576|FG000|COMPLETED|Overall Study||25||
48703685|NCT00230802|102060577|FG001|COMPLETED|Overall Study||23||
48703686|NCT00230802|102060576|FG000|NOT COMPLETED|Overall Study||0||
48703687|NCT00230802|102060577|FG001|NOT COMPLETED|Overall Study||0||
48703688|NCT00611442|102060578|FG000|STARTED|Overall Study||95||
48703689|NCT00611442|102060579|FG001|STARTED|Overall Study||96||
48703690|NCT00611442|102060578|FG000|COMPLETED|Overall Study||94||
48703691|NCT00611442|102060579|FG001|COMPLETED|Overall Study||94||
48703692|NCT00611442|102060578|FG000|NOT COMPLETED|Overall Study||1||
48703693|NCT00611442|102060579|FG001|NOT COMPLETED|Overall Study||2||
48703694|NCT03345160|102060580|FG000|STARTED|Overall Study||7||
48703695|NCT03345160|102060580|FG000|COMPLETED|Overall Study||7||
48703696|NCT03345160|102060580|FG000|NOT COMPLETED|Overall Study||0||
48135057|NCT04179032|100651559|FG000|STARTED|Part A (Up to Week 12)||25||
48135058|NCT04179032|100651559|FG000|COMPLETED|Part A (Up to Week 12)||25||
48703697|NCT00543803|102060581|FG000|STARTED|Overall Study||334||
48703698|NCT00543803|102060581|FG000|COMPLETED|Overall Study||192||
48135059|NCT04179032|100651559|FG000|NOT COMPLETED|Part A (Up to Week 12)||0||
48135060|NCT04179032|100651559|FG000|STARTED|Part B (Up to Week 52)||25||
48703699|NCT00543803|102060581|FG000|NOT COMPLETED|Overall Study||142||
48703700|NCT03730961|102060582|FG000|STARTED|Overall Study||12|Started = Initiated Period 1 treatment|
48703701|NCT03730961|102060583|FG001|STARTED|Overall Study||11|Started = Initiated Period 1 treatment|
48703702|NCT03730961|102060582|FG000|Period 1 Completion|Overall Study||12||
48286993|NCT02257567|101029612|FG000|Safety Population|Overall Study||6|Safety population was defined as all participants who have received at least one dose of study medication.|
48286994|NCT02257567|101029613|FG001|Safety Population|Overall Study||6|Safety population was defined as all participants who have received at least one dose of study medication.|
48703703|NCT03730961|102060583|FG001|Period 1 Completion|Overall Study||11||
48286995|NCT02257567|101029614|FG002|Safety Population|Overall Study||6|Safety population was defined as all participants who have received at least one dose of study medication.|
48286996|NCT02257567|101029615|FG003|Safety Population|Overall Study||6|Safety population was defined as all participants who have received at least one dose of study medication.|
48286997|NCT02257567|101029616|FG004|Safety Population|Overall Study||38|Safety population was defined as all participants who have received at least one dose of study medication.|
48286998|NCT02257567|101029617|FG005|Safety Population|Overall Study||41|Safety population was defined as all participants who have received at least one dose of study medication.|
48286999|NCT02257567|101029618|FG006|Safety Population|Overall Study||39|Safety population was defined as all participants who have received at least one dose of study medication.|
48287000|NCT02257567|101029619|FG007|Safety Population|Overall Study||39|Safety population was defined as all participants who have received at least one dose of study medication.|
48287001|NCT02257567|101029620|FG008|Safety Population|Overall Study||20|Safety population was defined as all participants who have received at least one dose of study medication.|
48287002|NCT02257567|101029621|FG009|Safety Population|Overall Study||20|Safety population was defined as all participants who have received at least one dose of study medication.|
48579681|NCT01340027|101750946|FG002|NOT COMPLETED|Overall Study||4||
48579682|NCT01340027|101750947|FG003|NOT COMPLETED|Overall Study||4||
48579683|NCT01340027|101750948|FG004|NOT COMPLETED|Overall Study||10||
48579684|NCT01340027|101750949|FG005|NOT COMPLETED|Overall Study||4||
48579685|NCT01340027|101750950|FG006|NOT COMPLETED|Overall Study||7||
48579686|NCT01340027|101750951|FG007|NOT COMPLETED|Overall Study||7||
48579687|NCT01340027|101750952|FG008|NOT COMPLETED|Overall Study||8||
48579688|NCT01340027|101750953|FG009|NOT COMPLETED|Overall Study||6||
48579689|NCT01340027|101750954|FG010|NOT COMPLETED|Overall Study||2||
48579690|NCT01340027|101750955|FG011|NOT COMPLETED|Overall Study||4||
48579691|NCT02805660|101750956|FG000|STARTED|Overall Study||5||
48579692|NCT02805660|101750957|FG001|STARTED|Overall Study||4||
48579693|NCT02805660|101750958|FG002|STARTED|Overall Study||11||
48579694|NCT02805660|101750959|FG003|STARTED|Overall Study||18||
48579695|NCT02805660|101750960|FG004|STARTED|Overall Study||3||
48579696|NCT02805660|101750961|FG005|STARTED|Overall Study||23||
48579697|NCT02805660|101750962|FG006|STARTED|Overall Study||19||
48579698|NCT02805660|101750956|FG000|COMPLETED|Overall Study||0||
48579699|NCT02805660|101750957|FG001|COMPLETED|Overall Study||0||
48579700|NCT02805660|101750958|FG002|COMPLETED|Overall Study||0||
48579701|NCT02805660|101750959|FG003|COMPLETED|Overall Study||0||
48703704|NCT03730961|102060582|FG000|Period 2 Completion|Overall Study||11||
48579702|NCT02805660|101750960|FG004|COMPLETED|Overall Study||0||
48579703|NCT02805660|101750961|FG005|COMPLETED|Overall Study||0||
48579704|NCT02805660|101750962|FG006|COMPLETED|Overall Study||0||
48579705|NCT02805660|101750956|FG000|NOT COMPLETED|Overall Study||5||
48579706|NCT02805660|101750957|FG001|NOT COMPLETED|Overall Study||4||
48579707|NCT02805660|101750958|FG002|NOT COMPLETED|Overall Study||11||
48579708|NCT02805660|101750959|FG003|NOT COMPLETED|Overall Study||18||
48579709|NCT02805660|101750960|FG004|NOT COMPLETED|Overall Study||3||
48579710|NCT02805660|101750961|FG005|NOT COMPLETED|Overall Study||23||
48579711|NCT02805660|101750962|FG006|NOT COMPLETED|Overall Study||19||
48703705|NCT03730961|102060583|FG001|Period 2 Completion|Overall Study||10||
48703706|NCT03730961|102060582|FG000|COMPLETED|Overall Study||12|Completed study|
48703707|NCT03730961|102060583|FG001|COMPLETED|Overall Study||10|Completed study|
48287003|NCT02257567|101029622|FG010|Safety Population|Overall Study||106|Safety population was defined as all participants who have received at least one dose of study medication.|
48287004|NCT02257567|101029612|FG000|COMPLETED|Overall Study||4||
48287005|NCT02257567|101029613|FG001|COMPLETED|Overall Study||4||
48287006|NCT02257567|101029614|FG002|COMPLETED|Overall Study||2||
48287007|NCT02257567|101029615|FG003|COMPLETED|Overall Study||1||
48287008|NCT02257567|101029616|FG004|COMPLETED|Overall Study||20||
48287009|NCT02257567|101029617|FG005|COMPLETED|Overall Study||22||
48287010|NCT02257567|101029618|FG006|COMPLETED|Overall Study||6||
48287011|NCT02257567|101029619|FG007|COMPLETED|Overall Study||2||
48287012|NCT02257567|101029620|FG008|COMPLETED|Overall Study||16||
48287013|NCT02257567|101029621|FG009|COMPLETED|Overall Study||0||
48287014|NCT02257567|101029622|FG010|COMPLETED|Overall Study||30||
48287015|NCT02257567|101029612|FG000|NOT COMPLETED|Overall Study||2||
48287016|NCT02257567|101029613|FG001|NOT COMPLETED|Overall Study||2||
48287017|NCT02257567|101029614|FG002|NOT COMPLETED|Overall Study||4||
48287018|NCT02257567|101029615|FG003|NOT COMPLETED|Overall Study||5||
48287019|NCT02257567|101029616|FG004|NOT COMPLETED|Overall Study||19||
48287020|NCT02257567|101029617|FG005|NOT COMPLETED|Overall Study||19||
48287021|NCT02257567|101029618|FG006|NOT COMPLETED|Overall Study||34||
48287022|NCT02257567|101029619|FG007|NOT COMPLETED|Overall Study||38||
48287023|NCT02257567|101029620|FG008|NOT COMPLETED|Overall Study||4||
48287024|NCT02257567|101029621|FG009|NOT COMPLETED|Overall Study||21||
48287025|NCT02257567|101029622|FG010|NOT COMPLETED|Overall Study||76||
48579712|NCT04720911|101750963|FG000|STARTED|Overall Study||15||
48579713|NCT04720911|101750964|FG001|STARTED|Overall Study||16||
48703708|NCT03730961|102060582|FG000|NOT COMPLETED|Overall Study||0||
48703709|NCT03730961|102060583|FG001|NOT COMPLETED|Overall Study||1||
48703710|NCT01713283|102060584|FG000|STARTED|Overall Study||31||
48703711|NCT01713283|102060585|FG001|STARTED|Overall Study||29||
48703712|NCT01713283|102060584|FG000|COMPLETED|Overall Study||20||
48703713|NCT01713283|102060585|FG001|COMPLETED|Overall Study||26||
48703714|NCT01713283|102060584|FG000|NOT COMPLETED|Overall Study||11||
48703715|NCT01713283|102060585|FG001|NOT COMPLETED|Overall Study||3||
48703716|NCT01461928|102060586|FG000|STARTED|Induction (up to 8 Months)||692|Induction period only|
48400257|NCT02693691|101309332|FG000|STARTED|Extended Follow-Up (Until Last pt 12M)||184||
48400258|NCT02693691|101309332|FG000|COMPLETED|Extended Follow-Up (Until Last pt 12M)||160||
48400259|NCT02693691|101309332|FG000|NOT COMPLETED|Extended Follow-Up (Until Last pt 12M)||24||
48400260|NCT00587834|101309333|FG000|STARTED|Overall Study||96||
48400261|NCT00587834|101309333|FG000|COMPLETED|Overall Study||96||
48400262|NCT00587834|101309333|FG000|NOT COMPLETED|Overall Study||0||
48400263|NCT01115517|101309334|FG000|STARTED|Overall Study||18||
48400264|NCT01115517|101309335|FG001|STARTED|Overall Study||21||
48400265|NCT01115517|101309334|FG000|COMPLETED|Overall Study||14||
48400266|NCT01115517|101309335|FG001|COMPLETED|Overall Study||16||
48400267|NCT01115517|101309334|FG000|NOT COMPLETED|Overall Study||4||
48400268|NCT01115517|101309335|FG001|NOT COMPLETED|Overall Study||5||
48400269|NCT02009930|101309336|FG000|STARTED|Overall Study||112||
48400270|NCT02009930|101309336|FG000|COMPLETED|Overall Study||107||
48400271|NCT02009930|101309336|FG000|NOT COMPLETED|Overall Study||5||
48400272|NCT01989572|101309337|FG000|STARTED|Overall Study||109||
48400273|NCT01989572|101309338|FG001|STARTED|Overall Study||111||
48400274|NCT01989572|101309339|FG002|STARTED|Overall Study||109||
48400275|NCT01989572|101309340|FG003|STARTED|Overall Study||107||
48400276|NCT01989572|101309341|FG004|STARTED|Overall Study||190||
48400277|NCT01989572|101309342|FG005|STARTED|Overall Study||189||
48400278|NCT01989572|101309337|FG000|Treated|Overall Study||104||
48400279|NCT01989572|101309338|FG001|Treated|Overall Study||110||
48400280|NCT01989572|101309339|FG002|Treated|Overall Study||107||
48400281|NCT01989572|101309340|FG003|Treated|Overall Study||104||
48400282|NCT01989572|101309341|FG004|Treated|Overall Study||186||
48400283|NCT01989572|101309342|FG005|Treated|Overall Study||171||
48400284|NCT01989572|101309337|FG000|COMPLETED|Overall Study||54||
48400285|NCT01989572|101309338|FG001|COMPLETED|Overall Study||53||
48400286|NCT01989572|101309339|FG002|COMPLETED|Overall Study||47||
48400287|NCT01989572|101309340|FG003|COMPLETED|Overall Study||56||
48400288|NCT01989572|101309341|FG004|COMPLETED|Overall Study||92||
48400289|NCT01989572|101309342|FG005|COMPLETED|Overall Study||79||
48400290|NCT01989572|101309337|FG000|NOT COMPLETED|Overall Study||55||
48703717|NCT01461928|102060587|FG001|STARTED|Induction (up to 8 Months)||0|Induction period only|
48703718|NCT01461928|102060588|FG002|STARTED|Induction (up to 8 Months)||0|Induction period only|
48400291|NCT01989572|101309338|FG001|NOT COMPLETED|Overall Study||58||
48400292|NCT01989572|101309339|FG002|NOT COMPLETED|Overall Study||62||
48703719|NCT01461928|102060586|FG000|COMPLETED|Induction (up to 8 Months)||494|Induction period only|
48703720|NCT01461928|102060587|FG001|COMPLETED|Induction (up to 8 Months)||0|Induction period only|
48703721|NCT01461928|102060588|FG002|COMPLETED|Induction (up to 8 Months)||0|Induction period only|
48400293|NCT01989572|101309340|FG003|NOT COMPLETED|Overall Study||51||
48400294|NCT01989572|101309341|FG004|NOT COMPLETED|Overall Study||98||
48400295|NCT01989572|101309342|FG005|NOT COMPLETED|Overall Study||110||
48703722|NCT01461928|102060586|FG000|NOT COMPLETED|Induction (up to 8 Months)||198||
48400296|NCT00334204|101309343|FG000|STARTED|Overall Study||58||
48400297|NCT00334204|101309343|FG000|COMPLETED|Overall Study||56||
48400298|NCT00334204|101309343|FG000|NOT COMPLETED|Overall Study||2||
48400299|NCT03862495|101309344|FG000|STARTED|Overall Study||100||
48400300|NCT03862495|101309345|FG001|STARTED|Overall Study||100||
48579714|NCT04720911|101750965|FG002|STARTED|Overall Study||16||
48579715|NCT04720911|101750963|FG000|COMPLETED|Overall Study||15||
48579716|NCT04720911|101750964|FG001|COMPLETED|Overall Study||15||
48579717|NCT04720911|101750965|FG002|COMPLETED|Overall Study||16||
48579718|NCT04720911|101750963|FG000|NOT COMPLETED|Overall Study||0||
48703723|NCT01461928|102060587|FG001|NOT COMPLETED|Induction (up to 8 Months)||0||
48135061|NCT04179032|100651559|FG000|COMPLETED|Part B (Up to Week 52)||23||
48135062|NCT04179032|100651559|FG000|NOT COMPLETED|Part B (Up to Week 52)||2||
48135063|NCT04179032|100651559|FG000|STARTED|Access Extension Phase||11||
48135064|NCT04179032|100651559|FG000|COMPLETED|Access Extension Phase||0||
48135065|NCT04179032|100651559|FG000|NOT COMPLETED|Access Extension Phase||11||
48135066|NCT02535065|100651560|FG000|STARTED|Overall Study||62||
48135067|NCT02535065|100651560|FG000|1-Month Follow-up|Overall Study||62||
48135068|NCT02535065|100651560|FG000|12-Month Follow-up|Overall Study||61||
48135069|NCT02535065|100651560|FG000|COMPLETED|Overall Study||42||
48703724|NCT01461928|102060588|FG002|NOT COMPLETED|Induction (up to 8 Months)||0||
48703725|NCT01461928|102060586|FG000|STARTED|Maintenance I (24 Months)||494|Maintenance I only|
48135070|NCT02535065|100651560|FG000|NOT COMPLETED|Overall Study||20||
48135071|NCT03985423|100655859|FG000|STARTED|Overall Study||7||
48135072|NCT03985423|100655859|FG000|COMPLETED|Overall Study||0||
48703726|NCT01461928|102060587|FG001|STARTED|Maintenance I (24 Months)||0|Maintenance I only|
48703727|NCT01461928|102060588|FG002|STARTED|Maintenance I (24 Months)||0|Maintenance I only|
48703728|NCT01461928|102060586|FG000|COMPLETED|Maintenance I (24 Months)||276|Maintenance I only|
48703729|NCT01461928|102060587|FG001|COMPLETED|Maintenance I (24 Months)||0|Maintenance I only|
48703730|NCT01461928|102060588|FG002|COMPLETED|Maintenance I (24 Months)||0|Maintenance I only|
48703731|NCT01461928|102060586|FG000|NOT COMPLETED|Maintenance I (24 Months)||218||
48703732|NCT01461928|102060587|FG001|NOT COMPLETED|Maintenance I (24 Months)||0||
48703733|NCT01461928|102060588|FG002|NOT COMPLETED|Maintenance I (24 Months)||0||
48703734|NCT01461928|102060586|FG000|STARTED|Maintenance II (15 Months)||0|Maintenance II only|
48703735|NCT01461928|102060587|FG001|STARTED|Maintenance II (15 Months)||138|Maintenance II only|
48703736|NCT01461928|102060588|FG002|STARTED|Maintenance II (15 Months)||138|Maintenance II only|
48703737|NCT01461928|102060586|FG000|COMPLETED|Maintenance II (15 Months)||0|Maintenance II only|
48135073|NCT03985423|100655859|FG000|NOT COMPLETED|Overall Study||7||
48135074|NCT03859323|100655860|FG000|STARTED|Overall Study||5||
48135075|NCT03859323|100655861|FG001|STARTED|Overall Study||5||
48579719|NCT04720911|101750964|FG001|NOT COMPLETED|Overall Study||1||
48135076|NCT03859323|100655862|FG002|STARTED|Overall Study||5||
48135077|NCT03859323|100655863|FG003|STARTED|Overall Study||5||
48135078|NCT03859323|100655864|FG004|STARTED|Overall Study||5||
48135079|NCT03859323|100655865|FG005|STARTED|Overall Study||5||
48135080|NCT03859323|100655866|FG006|STARTED|Overall Study||12||
48579720|NCT04720911|101750965|FG002|NOT COMPLETED|Overall Study||0||
48710757|NCT00168103|102078009|FG003|COMPLETED|Overall Study||1||
48135081|NCT03859323|100655867|FG007|STARTED|Overall Study||10||
48579721|NCT03485495|101750966|FG000|STARTED|Overall Study||65||
48135082|NCT03859323|100655868|FG008|STARTED|Overall Study||10||
48135083|NCT03859323|100655869|FG009|STARTED|Overall Study||10||
48135084|NCT03859323|100655870|FG010|STARTED|Overall Study||10||
48135085|NCT03859323|100655871|FG011|STARTED|Overall Study||12||
48135086|NCT03859323|100655872|FG012|STARTED|Overall Study||10||
48579722|NCT03485495|101750967|FG001|STARTED|Overall Study||59||
48579723|NCT03485495|101750966|FG000|COMPLETED|Overall Study||64||
48579724|NCT03485495|101750967|FG001|COMPLETED|Overall Study||59||
48579725|NCT03485495|101750966|FG000|NOT COMPLETED|Overall Study||1||
48579726|NCT03485495|101750967|FG001|NOT COMPLETED|Overall Study||0||
48579727|NCT02572076|101750968|FG000|STARTED|Overall Study||10||
48579728|NCT02572076|101750968|FG000|COMPLETED|Overall Study||9||
48579729|NCT02572076|101750968|FG000|NOT COMPLETED|Overall Study||1||
48579730|NCT01177293|101750969|FG000|STARTED|First Intervention Period||7||
48579731|NCT01177293|101750970|FG001|STARTED|First Intervention Period||7||
48579732|NCT01177293|101750969|FG000|COMPLETED|First Intervention Period||7||
48579733|NCT01177293|101750970|FG001|COMPLETED|First Intervention Period||7||
48579734|NCT01177293|101750969|FG000|NOT COMPLETED|First Intervention Period||0||
48579735|NCT01177293|101750970|FG001|NOT COMPLETED|First Intervention Period||0||
48135087|NCT03859323|100655860|FG000|COMPLETED|Overall Study||5||
48135088|NCT03859323|100655861|FG001|COMPLETED|Overall Study||5||
48135089|NCT03859323|100655862|FG002|COMPLETED|Overall Study||4||
48135090|NCT03859323|100655863|FG003|COMPLETED|Overall Study||5||
48135091|NCT03859323|100655864|FG004|COMPLETED|Overall Study||5||
48287026|NCT01880528|101029623|FG000|STARTED|Overall Study||12||
48287027|NCT01880528|101029624|FG001|STARTED|Overall Study||11||
48287028|NCT01880528|101029623|FG000|COMPLETED|Overall Study||11|Evaluable for primary endpoint|
48579736|NCT01177293|101750969|FG000|STARTED|Washout Period (of 14 Days)||7||
48579737|NCT01177293|101750970|FG001|STARTED|Washout Period (of 14 Days)||7||
48579738|NCT01177293|101750969|FG000|COMPLETED|Washout Period (of 14 Days)||7||
48579739|NCT01177293|101750970|FG001|COMPLETED|Washout Period (of 14 Days)||6||
48135092|NCT03859323|100655865|FG005|COMPLETED|Overall Study||4||
48135093|NCT03859323|100655866|FG006|COMPLETED|Overall Study||11||
48135094|NCT03859323|100655867|FG007|COMPLETED|Overall Study||10||
48135095|NCT03859323|100655868|FG008|COMPLETED|Overall Study||10||
48135096|NCT03859323|100655869|FG009|COMPLETED|Overall Study||8||
48135097|NCT03859323|100655870|FG010|COMPLETED|Overall Study||9||
48135098|NCT03859323|100655871|FG011|COMPLETED|Overall Study||10||
48135099|NCT03859323|100655872|FG012|COMPLETED|Overall Study||9||
48135100|NCT03859323|100655860|FG000|NOT COMPLETED|Overall Study||0||
48135101|NCT03859323|100655861|FG001|NOT COMPLETED|Overall Study||0||
48287029|NCT01880528|101029624|FG001|COMPLETED|Overall Study||10|Evaluable for primary endpoint|
48287030|NCT01880528|101029623|FG000|NOT COMPLETED|Overall Study||1||
48287031|NCT01880528|101029624|FG001|NOT COMPLETED|Overall Study||1||
48135102|NCT03859323|100655862|FG002|NOT COMPLETED|Overall Study||1||
48135103|NCT03859323|100655863|FG003|NOT COMPLETED|Overall Study||0||
48135104|NCT03859323|100655864|FG004|NOT COMPLETED|Overall Study||0||
48135105|NCT03859323|100655865|FG005|NOT COMPLETED|Overall Study||1||
48135106|NCT03859323|100655866|FG006|NOT COMPLETED|Overall Study||1||
48135107|NCT03859323|100655867|FG007|NOT COMPLETED|Overall Study||0||
48135108|NCT03859323|100655868|FG008|NOT COMPLETED|Overall Study||0||
48135109|NCT03859323|100655869|FG009|NOT COMPLETED|Overall Study||2||
48135110|NCT03859323|100655870|FG010|NOT COMPLETED|Overall Study||1||
48135111|NCT03859323|100655871|FG011|NOT COMPLETED|Overall Study||2||
48135112|NCT03859323|100655872|FG012|NOT COMPLETED|Overall Study||1||
48135113|NCT00601926|100655873|FG000|STARTED|Overall Study||5||
48135114|NCT00601926|100655873|FG000|COMPLETED|Overall Study||5||
48135115|NCT00601926|100655873|FG000|NOT COMPLETED|Overall Study||0||
48135116|NCT03674177|100655874|FG000|STARTED|Overall Study||124||
48135117|NCT03674177|100655875|FG001|STARTED|Overall Study||126||
48135118|NCT03674177|100655876|FG002|STARTED|Overall Study||126||
48135119|NCT03674177|100655877|FG003|STARTED|Overall Study||126||
48135120|NCT03674177|100655874|FG000|COMPLETED|Overall Study||122||
48135121|NCT03674177|100655875|FG001|COMPLETED|Overall Study||125||
48135122|NCT03674177|100655876|FG002|COMPLETED|Overall Study||126||
48135123|NCT03674177|100655877|FG003|COMPLETED|Overall Study||124||
48135124|NCT03674177|100655874|FG000|NOT COMPLETED|Overall Study||2||
48135125|NCT03674177|100655875|FG001|NOT COMPLETED|Overall Study||1||
48135126|NCT03674177|100655876|FG002|NOT COMPLETED|Overall Study||0||
48135127|NCT03674177|100655877|FG003|NOT COMPLETED|Overall Study||2||
48135128|NCT02460991|100655878|FG000|STARTED|Overall Study||0||
48135129|NCT02460991|100655879|FG001|STARTED|Overall Study||2||
48135130|NCT02460991|100655878|FG000|COMPLETED|Overall Study||0||
48135131|NCT02460991|100655879|FG001|COMPLETED|Overall Study||0||
48135132|NCT02460991|100655878|FG000|NOT COMPLETED|Overall Study||0||
48579740|NCT01177293|101750969|FG000|NOT COMPLETED|Washout Period (of 14 Days)||0||
48579741|NCT01177293|101750970|FG001|NOT COMPLETED|Washout Period (of 14 Days)||1||
48579742|NCT01177293|101750969|FG000|STARTED|Second Intervention Period||7||
48579743|NCT01177293|101750970|FG001|STARTED|Second Intervention Period||6||
48579744|NCT01177293|101750969|FG000|COMPLETED|Second Intervention Period||7||
48579745|NCT01177293|101750970|FG001|COMPLETED|Second Intervention Period||6||
48579746|NCT01177293|101750969|FG000|NOT COMPLETED|Second Intervention Period||0||
48579747|NCT01177293|101750970|FG001|NOT COMPLETED|Second Intervention Period||0||
48579748|NCT01475851|101750971|FG000|STARTED|Overall Study||13||
48579749|NCT01475851|101750972|FG001|STARTED|Overall Study||21||
48579750|NCT01475851|101750971|FG000|COMPLETED|Overall Study||12||
48579751|NCT01475851|101750972|FG001|COMPLETED|Overall Study||21||
48579752|NCT01475851|101750971|FG000|NOT COMPLETED|Overall Study||1||
48579753|NCT01475851|101750972|FG001|NOT COMPLETED|Overall Study||0||
48579754|NCT02693171|101750973|FG000|STARTED|Overall Study||12||
48579755|NCT02693171|101750973|FG000|COMPLETED|Overall Study||3||
48579756|NCT02693171|101750973|FG000|NOT COMPLETED|Overall Study||9||
48579757|NCT04666259|101750974|FG000|STARTED|Overall Study||26||
48579758|NCT04666259|101750975|FG001|STARTED|Overall Study||27||
48579759|NCT04666259|101750976|FG002|STARTED|Overall Study||3||
48579760|NCT04666259|101750974|FG000|Treated|Overall Study||25|Safety Set|
48579761|NCT04666259|101750975|FG001|Treated|Overall Study||27|Safety Set|
48579762|NCT04666259|101750976|FG002|Treated|Overall Study||3|Safety Set|
48579763|NCT04666259|101750974|FG000|COMPLETED|Overall Study||6||
48579764|NCT04666259|101750975|FG001|COMPLETED|Overall Study||6||
48135133|NCT02460991|100655879|FG001|NOT COMPLETED|Overall Study||2||
48135134|NCT01343082|100655880|FG000|STARTED|The run-in Period||51||
48135135|NCT01343082|100655881|FG001|STARTED|The run-in Period||49||
48135136|NCT01343082|100655882|FG002|STARTED|The run-in Period||48||
48135137|NCT01343082|100655880|FG000|COMPLETED|The run-in Period||48||
48135138|NCT01343082|100655881|FG001|COMPLETED|The run-in Period||45||
48135139|NCT01343082|100655882|FG002|COMPLETED|The run-in Period||43||
48135140|NCT01343082|100655880|FG000|NOT COMPLETED|The run-in Period||3||
48135141|NCT01343082|100655881|FG001|NOT COMPLETED|The run-in Period||4||
48135142|NCT01343082|100655882|FG002|NOT COMPLETED|The run-in Period||5||
48135143|NCT01343082|100655880|FG000|STARTED|Treatment Period , Switched to DE-111||48||
48135144|NCT01343082|100655881|FG001|STARTED|Treatment Period , Switched to DE-111||45||
48135145|NCT01343082|100655882|FG002|STARTED|Treatment Period , Switched to DE-111||43||
48135146|NCT01343082|100655880|FG000|COMPLETED|Treatment Period , Switched to DE-111||43||
48579765|NCT04666259|101750976|FG002|COMPLETED|Overall Study||0||
48579766|NCT04666259|101750974|FG000|NOT COMPLETED|Overall Study||20||
48579767|NCT04666259|101750975|FG001|NOT COMPLETED|Overall Study||21||
48579768|NCT04666259|101750976|FG002|NOT COMPLETED|Overall Study||3||
48135147|NCT01343082|100655881|FG001|COMPLETED|Treatment Period , Switched to DE-111||36||
48135148|NCT01343082|100655882|FG002|COMPLETED|Treatment Period , Switched to DE-111||31||
48135149|NCT01343082|100655880|FG000|NOT COMPLETED|Treatment Period , Switched to DE-111||5||
48135150|NCT01343082|100655881|FG001|NOT COMPLETED|Treatment Period , Switched to DE-111||9||
48135151|NCT01343082|100655882|FG002|NOT COMPLETED|Treatment Period , Switched to DE-111||12||
48135152|NCT00407537|100655883|FG000|STARTED|Overall Study||779||
48135153|NCT00407537|100655884|FG001|STARTED|Overall Study||682||
48135154|NCT00407537|100655883|FG000|Eligible for Efficacy Analysis|Overall Study||760||
48135155|NCT00407537|100655884|FG001|Eligible for Efficacy Analysis|Overall Study||657||
48579769|NCT02355821|101750977|FG000|STARTED|Overall Study||57||
48579770|NCT02355821|101750978|FG001|STARTED|Overall Study||57||
48579771|NCT02355821|101750977|FG000|COMPLETED|Overall Study||57||
48579772|NCT02355821|101750978|FG001|COMPLETED|Overall Study||57||
48579773|NCT02355821|101750977|FG000|NOT COMPLETED|Overall Study||0||
48579774|NCT02355821|101750978|FG001|NOT COMPLETED|Overall Study||0||
48579775|NCT03575793|101750979|FG000|STARTED|Overall Study||8||
48579776|NCT03575793|101750980|FG001|STARTED|Overall Study||31||
48579777|NCT03575793|101750979|FG000|COMPLETED|Overall Study||8||
48579778|NCT03575793|101750980|FG001|COMPLETED|Overall Study||28||
48579779|NCT03575793|101750979|FG000|NOT COMPLETED|Overall Study||0||
48579780|NCT03575793|101750980|FG001|NOT COMPLETED|Overall Study||3||
48579781|NCT00957268|101750981|FG000|STARTED|Overall Study||5||
48579782|NCT00957268|101750982|FG001|STARTED|Overall Study||4||
48579783|NCT00957268|101750983|FG002|STARTED|Overall Study||8||
48579784|NCT00957268|101750984|FG003|STARTED|Overall Study||7||
48579785|NCT00957268|101750985|FG004|STARTED|Overall Study||22||
48579786|NCT00957268|101750981|FG000|COMPLETED|Overall Study||5||
48579787|NCT00957268|101750982|FG001|COMPLETED|Overall Study||4||
48579788|NCT00957268|101750983|FG002|COMPLETED|Overall Study||7||
48579789|NCT00957268|101750984|FG003|COMPLETED|Overall Study||7||
48579790|NCT00957268|101750985|FG004|COMPLETED|Overall Study||22||
48579791|NCT00957268|101750981|FG000|NOT COMPLETED|Overall Study||0||
48579792|NCT00957268|101750982|FG001|NOT COMPLETED|Overall Study||0||
48579793|NCT00957268|101750983|FG002|NOT COMPLETED|Overall Study||1||
48579794|NCT00957268|101750984|FG003|NOT COMPLETED|Overall Study||0||
48579795|NCT00957268|101750985|FG004|NOT COMPLETED|Overall Study||0||
48579796|NCT00179777|101750986|FG000|STARTED|Overall Study||2613||
48579797|NCT00179777|101750987|FG001|STARTED|Overall Study||2543||
48579798|NCT00179777|101750986|FG000|COMPLETED|Overall Study||1081||
48400301|NCT03862495|101309344|FG000|COMPLETED|Overall Study||63||
48400302|NCT03862495|101309345|FG001|COMPLETED|Overall Study||65||
48400303|NCT03862495|101309344|FG000|NOT COMPLETED|Overall Study||37||
48400304|NCT03862495|101309345|FG001|NOT COMPLETED|Overall Study||35||
48400305|NCT00499460|101309346|FG000|STARTED|Intervention 1 (30 Days)||8||
48400306|NCT00499460|101309347|FG001|STARTED|Intervention 1 (30 Days)||7||
48400307|NCT00499460|101309346|FG000|COMPLETED|Intervention 1 (30 Days)||6||
48400308|NCT00499460|101309347|FG001|COMPLETED|Intervention 1 (30 Days)||7||
48400309|NCT00499460|101309346|FG000|NOT COMPLETED|Intervention 1 (30 Days)||2||
48703738|NCT01461928|102060587|FG001|COMPLETED|Maintenance II (15 Months)||115|Maintenance II only|
48703739|NCT01461928|102060588|FG002|COMPLETED|Maintenance II (15 Months)||111|Maintenance II only|
48703740|NCT01461928|102060586|FG000|NOT COMPLETED|Maintenance II (15 Months)||0||
48703741|NCT01461928|102060587|FG001|NOT COMPLETED|Maintenance II (15 Months)||23||
48703742|NCT01461928|102060588|FG002|NOT COMPLETED|Maintenance II (15 Months)||27||
48703743|NCT01328535|102060589|FG000|STARTED|Overall Study||25||
48703744|NCT01328535|102060589|FG000|COMPLETED|Overall Study||24||
48703745|NCT01328535|102060589|FG000|NOT COMPLETED|Overall Study||1||
48703746|NCT01170065|102060590|FG000|STARTED|Overall Study||37||
48703747|NCT01170065|102060591|FG001|STARTED|Overall Study||126||
48703748|NCT01170065|102060592|FG002|STARTED|Overall Study||35||
48703749|NCT01170065|102060590|FG000|COMPLETED|Overall Study||9||
48703750|NCT01170065|102060591|FG001|COMPLETED|Overall Study||34||
48703751|NCT01170065|102060592|FG002|COMPLETED|Overall Study||9||
48703752|NCT01170065|102060590|FG000|NOT COMPLETED|Overall Study||28||
48703753|NCT01170065|102060591|FG001|NOT COMPLETED|Overall Study||92||
48703754|NCT01170065|102060592|FG002|NOT COMPLETED|Overall Study||26||
48703755|NCT00986401|102060593|FG000|STARTED|Period 1||22||
48400310|NCT00499460|101309347|FG001|NOT COMPLETED|Intervention 1 (30 Days)||0||
48579799|NCT00179777|101750987|FG001|COMPLETED|Overall Study||1078||
48579800|NCT00179777|101750986|FG000|NOT COMPLETED|Overall Study||1532||
48579801|NCT00179777|101750987|FG001|NOT COMPLETED|Overall Study||1465||
48579802|NCT00981214|101750988|FG000|STARTED|Overall Study||19||
48579803|NCT00981214|101750988|FG000|COMPLETED|Overall Study||19||
48579804|NCT00981214|101750988|FG000|NOT COMPLETED|Overall Study||0||
48579805|NCT00761280|101750989|FG000|STARTED|Randomization to First Dose||14||
48579806|NCT00761280|101750990|FG001|STARTED|Randomization to First Dose||13||
48579807|NCT00761280|101750989|FG000|Catheter Surgery|Randomization to First Dose||13||
48579808|NCT00761280|101750990|FG001|Catheter Surgery|Randomization to First Dose||0||
48579809|NCT00761280|101750989|FG000|First Dose of Study Drug / Chemotherapy|Randomization to First Dose||12||
48579810|NCT00761280|101750990|FG001|First Dose of Study Drug / Chemotherapy|Randomization to First Dose||11||
48579811|NCT00761280|101750989|FG000|COMPLETED|Randomization to First Dose||12||
48579812|NCT00761280|101750990|FG001|COMPLETED|Randomization to First Dose||11||
48703756|NCT00986401|102060594|FG001|STARTED|Period 1||22||
48400311|NCT00499460|101309346|FG000|STARTED|Intervention 2 (30 Days)||6||
48400312|NCT00499460|101309347|FG001|STARTED|Intervention 2 (30 Days)||7||
48400313|NCT00499460|101309346|FG000|COMPLETED|Intervention 2 (30 Days)||6||
48400314|NCT00499460|101309347|FG001|COMPLETED|Intervention 2 (30 Days)||6||
48400315|NCT00499460|101309346|FG000|NOT COMPLETED|Intervention 2 (30 Days)||0||
48400316|NCT00499460|101309347|FG001|NOT COMPLETED|Intervention 2 (30 Days)||1||
48400317|NCT00114218|101309348|FG000|STARTED|Overall Study||28||
48400318|NCT00114218|101309348|FG000|COMPLETED|Overall Study||24||
48400319|NCT00114218|101309348|FG000|NOT COMPLETED|Overall Study||4||
48579813|NCT00761280|101750989|FG000|NOT COMPLETED|Randomization to First Dose||2||
48579814|NCT00761280|101750990|FG001|NOT COMPLETED|Randomization to First Dose||2||
48579815|NCT00761280|101750989|FG000|STARTED|First Dose to End of Study||12||
48579816|NCT00761280|101750990|FG001|STARTED|First Dose to End of Study||11||
48579817|NCT00761280|101750989|FG000|COMPLETED|First Dose to End of Study||0||
48579818|NCT00761280|101750990|FG001|COMPLETED|First Dose to End of Study||0||
48579819|NCT00761280|101750989|FG000|NOT COMPLETED|First Dose to End of Study||12||
48579820|NCT00761280|101750990|FG001|NOT COMPLETED|First Dose to End of Study||11||
48579821|NCT05831644|101750991|FG000|STARTED|First Intervention||6||
48579822|NCT05831644|101750992|FG001|STARTED|First Intervention||5||
48579823|NCT05831644|101750991|FG000|COMPLETED|First Intervention||6||
48579824|NCT05831644|101750992|FG001|COMPLETED|First Intervention||5||
48579825|NCT05831644|101750991|FG000|NOT COMPLETED|First Intervention||0||
48579826|NCT05831644|101750992|FG001|NOT COMPLETED|First Intervention||0||
48579827|NCT05831644|101750991|FG000|STARTED|Washout Between 1st and 2nd Intervention||6||
48579828|NCT05831644|101750992|FG001|STARTED|Washout Between 1st and 2nd Intervention||5||
48579829|NCT05831644|101750991|FG000|COMPLETED|Washout Between 1st and 2nd Intervention||6||
48579830|NCT05831644|101750992|FG001|COMPLETED|Washout Between 1st and 2nd Intervention||5||
48579831|NCT05831644|101750991|FG000|NOT COMPLETED|Washout Between 1st and 2nd Intervention||0||
48579832|NCT05831644|101750992|FG001|NOT COMPLETED|Washout Between 1st and 2nd Intervention||0||
48579833|NCT05831644|101750991|FG000|STARTED|Second Intervention||6||
48579834|NCT05831644|101750992|FG001|STARTED|Second Intervention||5||
48579835|NCT05831644|101750991|FG000|COMPLETED|Second Intervention||6||
48579836|NCT05831644|101750992|FG001|COMPLETED|Second Intervention||5||
48579837|NCT05831644|101750991|FG000|NOT COMPLETED|Second Intervention||0||
48579838|NCT05831644|101750992|FG001|NOT COMPLETED|Second Intervention||0||
48579839|NCT01640379|101750993|FG000|STARTED|Overall Study||149||
48579840|NCT01640379|101750994|FG001|STARTED|Overall Study||137||
48579841|NCT01640379|101750993|FG000|COMPLETED|Overall Study||135||
48579842|NCT01640379|101750994|FG001|COMPLETED|Overall Study||125||
48579843|NCT01640379|101750993|FG000|NOT COMPLETED|Overall Study||14||
48579844|NCT01640379|101750994|FG001|NOT COMPLETED|Overall Study||12||
48579845|NCT03557931|101750995|FG000|STARTED|Overall Study||100||
48579846|NCT03557931|101750996|FG001|STARTED|Overall Study||65||
48579847|NCT03557931|101750997|FG002|STARTED|Overall Study||68||
48579848|NCT03557931|101750995|FG000|COMPLETED|Overall Study||69||
48579849|NCT03557931|101750996|FG001|COMPLETED|Overall Study||46||
48579850|NCT03557931|101750997|FG002|COMPLETED|Overall Study||55||
48579851|NCT03557931|101750995|FG000|NOT COMPLETED|Overall Study||31||
48579852|NCT03557931|101750996|FG001|NOT COMPLETED|Overall Study||19||
48579853|NCT03557931|101750997|FG002|NOT COMPLETED|Overall Study||13||
48579854|NCT03961061|101750998|FG000|STARTED|Overall Study||14|Parents (7) and Children (7) per arm/group.|
48579855|NCT03961061|101750999|FG001|STARTED|Overall Study||14|Parents (7) and Children (7) per arm/group.|
48579856|NCT03961061|101750998|FG000|COMPLETED|Overall Study||4|Parents (2) and Children (2) in the Brenner FIT (standard care) arm, and Parent (1) and Child (1) in the Brenner mFIT (standard care plus mobile health components)|
48287032|NCT00910689|101029625|FG000|STARTED|Month 1: Optimal Acute Therapy Run in||55||
48287033|NCT00910689|101029626|FG001|STARTED|Month 1: Optimal Acute Therapy Run in||53||
48287034|NCT00910689|101029627|FG002|STARTED|Month 1: Optimal Acute Therapy Run in||55||
48287035|NCT00910689|101029628|FG003|STARTED|Month 1: Optimal Acute Therapy Run in||69||
48287036|NCT00910689|101029625|FG000|COMPLETED|Month 1: Optimal Acute Therapy Run in||53||
48287037|NCT00910689|101029626|FG001|COMPLETED|Month 1: Optimal Acute Therapy Run in||52||
48287038|NCT00910689|101029627|FG002|COMPLETED|Month 1: Optimal Acute Therapy Run in||50||
48287039|NCT00910689|101029628|FG003|COMPLETED|Month 1: Optimal Acute Therapy Run in||59||
48287040|NCT00910689|101029625|FG000|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||2||
48287041|NCT00910689|101029626|FG001|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||1||
48287042|NCT00910689|101029627|FG002|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||5||
48287043|NCT00910689|101029628|FG003|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||10||
48287044|NCT00910689|101029625|FG000|STARTED|Month 2- 4: Treatment Period||53||
48287045|NCT00910689|101029626|FG001|STARTED|Month 2- 4: Treatment Period||52||
48287046|NCT00910689|101029627|FG002|STARTED|Month 2- 4: Treatment Period||50||
48287047|NCT00910689|101029628|FG003|STARTED|Month 2- 4: Treatment Period||59||
48287048|NCT00910689|101029625|FG000|COMPLETED|Month 2- 4: Treatment Period||44||
48287049|NCT00910689|101029626|FG001|COMPLETED|Month 2- 4: Treatment Period||42||
48579857|NCT03961061|101750999|FG001|COMPLETED|Overall Study||2|Parents (2) and Children (2) in the Brenner FIT (standard care) arm, and Parent (1) and Child (1) in the Brenner mFIT (standard care plus mobile health components)|
48579858|NCT03961061|101750998|FG000|NOT COMPLETED|Overall Study||10||
48579859|NCT03961061|101750999|FG001|NOT COMPLETED|Overall Study||12||
48579860|NCT02669836|101751000|FG000|STARTED|Overall Study||84|Based on ITT including radio-graphic only visits|
48579861|NCT02669836|101751001|FG001|STARTED|Overall Study||78|Based on ITT including radio-graphic only visits|
48579862|NCT02669836|101751000|FG000|3-6 Month Follow up|Overall Study||60||
48579863|NCT02669836|101751001|FG001|3-6 Month Follow up|Overall Study||63||
48579864|NCT02669836|101751000|FG000|COMPLETED|Overall Study||53||
48579865|NCT02669836|101751001|FG001|COMPLETED|Overall Study||61||
48579866|NCT02669836|101751000|FG000|NOT COMPLETED|Overall Study||31||
48287050|NCT00910689|101029627|FG002|COMPLETED|Month 2- 4: Treatment Period||42||
48287051|NCT00910689|101029628|FG003|COMPLETED|Month 2- 4: Treatment Period||48||
48287052|NCT00910689|101029625|FG000|NOT COMPLETED|Month 2- 4: Treatment Period||9||
48287053|NCT00910689|101029626|FG001|NOT COMPLETED|Month 2- 4: Treatment Period||10||
48287054|NCT00910689|101029627|FG002|NOT COMPLETED|Month 2- 4: Treatment Period||8||
48703757|NCT00986401|102060593|FG000|COMPLETED|Period 1||22||
48703758|NCT00986401|102060594|FG001|COMPLETED|Period 1||21||
48703759|NCT00986401|102060593|FG000|NOT COMPLETED|Period 1||0||
48703760|NCT00986401|102060594|FG001|NOT COMPLETED|Period 1||1||
48703761|NCT00986401|102060593|FG000|STARTED|Period 2||22||
48703762|NCT00986401|102060594|FG001|STARTED|Period 2||21||
48703763|NCT00986401|102060593|FG000|COMPLETED|Period 2||22||
48703764|NCT00986401|102060594|FG001|COMPLETED|Period 2||21||
48703765|NCT00986401|102060593|FG000|NOT COMPLETED|Period 2||0||
48703766|NCT00986401|102060594|FG001|NOT COMPLETED|Period 2||0||
48703767|NCT02046226|102060595|FG000|STARTED|Overall Study||7||
48703768|NCT02046226|102060595|FG000|COMPLETED|Overall Study||0||
48703769|NCT02046226|102060595|FG000|NOT COMPLETED|Overall Study||7||
48703770|NCT03018418|102060596|FG000|STARTED|Overall Study||14||
48703771|NCT03018418|102060596|FG000|COMPLETED|Overall Study||14||
48703772|NCT03018418|102060596|FG000|NOT COMPLETED|Overall Study||0||
48703773|NCT02867813|102060597|FG000|STARTED|Overall Study||2535||
48703774|NCT02867813|102060598|FG001|STARTED|Overall Study||2500||
48703775|NCT02867813|102060597|FG000|COMPLETED|Overall Study||2084||
48703776|NCT02867813|102060598|FG001|COMPLETED|Overall Study||2090||
48703777|NCT02867813|102060597|FG000|NOT COMPLETED|Overall Study||451||
48703778|NCT02867813|102060598|FG001|NOT COMPLETED|Overall Study||410||
48703779|NCT02613117|102060599|FG000|STARTED|Overall Study||57||
48703780|NCT02613117|102060600|FG001|STARTED|Overall Study||47||
48703781|NCT02613117|102060599|FG000|COMPLETED|Overall Study||57||
48703782|NCT02613117|102060600|FG001|COMPLETED|Overall Study||47||
48703783|NCT02613117|102060599|FG000|NOT COMPLETED|Overall Study||0||
48703784|NCT02613117|102060600|FG001|NOT COMPLETED|Overall Study||0||
48703785|NCT05319899|102060601|FG000|STARTED|Overall Study||3||
48703786|NCT05319899|102060602|FG001|STARTED|Overall Study||3||
48703787|NCT05319899|102060603|FG002|STARTED|Overall Study||3||
48703788|NCT05319899|102060604|FG003|STARTED|Overall Study||3||
48287055|NCT00910689|101029628|FG003|NOT COMPLETED|Month 2- 4: Treatment Period||11||
48287056|NCT00910689|101029625|FG000|STARTED|Months 5 - 10: Evaluation Period I||44||
48287057|NCT00910689|101029626|FG001|STARTED|Months 5 - 10: Evaluation Period I||42||
48287058|NCT00910689|101029627|FG002|STARTED|Months 5 - 10: Evaluation Period I||42||
48287059|NCT00910689|101029628|FG003|STARTED|Months 5 - 10: Evaluation Period I||48||
48287060|NCT00910689|101029625|FG000|COMPLETED|Months 5 - 10: Evaluation Period I||40||
48579867|NCT02669836|101751001|FG001|NOT COMPLETED|Overall Study||17||
48579868|NCT02261948|101751002|FG000|STARTED|Overall Study||23||
48579869|NCT02261948|101751003|FG001|STARTED|Overall Study||19||
48579870|NCT02261948|101751002|FG000|COMPLETED|Overall Study||23||
48579871|NCT02261948|101751003|FG001|COMPLETED|Overall Study||19||
48579872|NCT02261948|101751002|FG000|NOT COMPLETED|Overall Study||0||
48579873|NCT02261948|101751003|FG001|NOT COMPLETED|Overall Study||0||
48579874|NCT05088603|101751004|FG000|STARTED|Overall Study||37||
48579875|NCT05088603|101751005|FG001|STARTED|Overall Study||35||
48579876|NCT05088603|101751004|FG000|COMPLETED|Overall Study||31||
48579877|NCT05088603|101751005|FG001|COMPLETED|Overall Study||34||
48579878|NCT05088603|101751004|FG000|NOT COMPLETED|Overall Study||6||
48579879|NCT05088603|101751005|FG001|NOT COMPLETED|Overall Study||1||
48579880|NCT00812981|101751006|FG000|STARTED|Overall Study||160||
48579881|NCT00812981|101751007|FG001|STARTED|Overall Study||160||
48579882|NCT00812981|101751006|FG000|COMPLETED|Overall Study||160||
48579883|NCT00812981|101751007|FG001|COMPLETED|Overall Study||159||
48579884|NCT00812981|101751006|FG000|NOT COMPLETED|Overall Study||0||
48703789|NCT05319899|102060605|FG004|STARTED|Overall Study||3||
48703790|NCT05319899|102060606|FG005|STARTED|Overall Study||3||
48703791|NCT05319899|102060601|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
48703792|NCT05319899|102060602|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3||
48703793|NCT05319899|102060603|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
48287061|NCT00910689|101029626|FG001|COMPLETED|Months 5 - 10: Evaluation Period I||35||
48579885|NCT00812981|101751007|FG001|NOT COMPLETED|Overall Study||1||
48579886|NCT05819086|101751008|FG000|STARTED|Overall Study||219||
48703794|NCT05319899|102060604|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3||
48703795|NCT05319899|102060605|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3||
48703796|NCT05319899|102060606|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3||
48703797|NCT05319899|102060601|FG000|COMPLETED|Overall Study||3||
48703798|NCT05319899|102060602|FG001|COMPLETED|Overall Study||3||
48703799|NCT05319899|102060603|FG002|COMPLETED|Overall Study||3||
48579887|NCT05819086|101751009|FG001|STARTED|Overall Study||207||
48579888|NCT05819086|101751010|FG002|STARTED|Overall Study||210||
48579889|NCT05819086|101751011|FG003|STARTED|Overall Study||203||
48579890|NCT05819086|101751008|FG000|COMPLETED|Overall Study||219||
48579891|NCT05819086|101751009|FG001|COMPLETED|Overall Study||207||
48579892|NCT05819086|101751010|FG002|COMPLETED|Overall Study||210||
48579893|NCT05819086|101751011|FG003|COMPLETED|Overall Study||203||
48579894|NCT05819086|101751008|FG000|NOT COMPLETED|Overall Study||0||
48579895|NCT05819086|101751009|FG001|NOT COMPLETED|Overall Study||0||
48579896|NCT05819086|101751010|FG002|NOT COMPLETED|Overall Study||0||
48579897|NCT05819086|101751011|FG003|NOT COMPLETED|Overall Study||0||
48579898|NCT01665950|101751012|FG000|STARTED|Overall Study||2||
48579899|NCT01665950|101751013|FG001|STARTED|Overall Study||0||
48579900|NCT01665950|101751014|FG002|STARTED|Overall Study||2||
48579901|NCT01665950|101751012|FG000|COMPLETED|Overall Study||1||
48579902|NCT01665950|101751013|FG001|COMPLETED|Overall Study||0||
48579903|NCT01665950|101751014|FG002|COMPLETED|Overall Study||1||
48579904|NCT01665950|101751012|FG000|NOT COMPLETED|Overall Study||1||
48579905|NCT01665950|101751013|FG001|NOT COMPLETED|Overall Study||0||
48579906|NCT01665950|101751014|FG002|NOT COMPLETED|Overall Study||1||
48579907|NCT02685358|101753104|FG000|STARTED|Overall Study||115||
48579908|NCT02685358|101753105|FG001|STARTED|Overall Study||119||
48579909|NCT02685358|101753104|FG000|COMPLETED|Overall Study||100||
48579910|NCT02685358|101753105|FG001|COMPLETED|Overall Study||112||
48579911|NCT02685358|101753104|FG000|NOT COMPLETED|Overall Study||15||
48579912|NCT02685358|101753105|FG001|NOT COMPLETED|Overall Study||7||
48579913|NCT02981082|101753106|FG000|STARTED|Overall Study||4||
48579914|NCT02981082|101753107|FG001|STARTED|Overall Study||2||
48579915|NCT02981082|101753106|FG000|COMPLETED|Overall Study||1||
48579916|NCT02981082|101753107|FG001|COMPLETED|Overall Study||1||
48579917|NCT02981082|101753106|FG000|NOT COMPLETED|Overall Study||3||
48579918|NCT02981082|101753107|FG001|NOT COMPLETED|Overall Study||1||
48579919|NCT00915876|101753108|FG000|STARTED|Overall Study||20||
48579920|NCT00915876|101753109|FG001|STARTED|Overall Study||21||
48579921|NCT00915876|101753108|FG000|Moving Beyond First Dose|Overall Study||20||
48579922|NCT00915876|101753109|FG001|Moving Beyond First Dose|Overall Study||20||
48579923|NCT00915876|101753108|FG000|COMPLETED|Overall Study||20||
48579924|NCT00915876|101753109|FG001|COMPLETED|Overall Study||20||
48579925|NCT00915876|101753108|FG000|NOT COMPLETED|Overall Study||0||
48579926|NCT00915876|101753109|FG001|NOT COMPLETED|Overall Study||1||
48579927|NCT01590121|101753110|FG000|STARTED|Overall Study||156||
48579928|NCT01590121|101753110|FG000|COMPLETED|Overall Study||156||
48579929|NCT01590121|101753110|FG000|NOT COMPLETED|Overall Study||0||
48579930|NCT03261674|101753111|FG000|STARTED|Overall Study||56||
48579931|NCT03261674|101753112|FG001|STARTED|Overall Study||54||
48579932|NCT03261674|101753111|FG000|COMPLETED|Overall Study||47||
48579933|NCT03261674|101753112|FG001|COMPLETED|Overall Study||39||
48579934|NCT03261674|101753111|FG000|NOT COMPLETED|Overall Study||9||
48579935|NCT03261674|101753112|FG001|NOT COMPLETED|Overall Study||15||
48579936|NCT00594100|101753113|FG000|STARTED|Procedure||245||
48579937|NCT00594100|101753113|FG000|COMPLETED|Procedure||236||
48579938|NCT00594100|101753113|FG000|NOT COMPLETED|Procedure||9||
48287062|NCT00910689|101029627|FG002|COMPLETED|Months 5 - 10: Evaluation Period I||35||
48287063|NCT00910689|101029628|FG003|COMPLETED|Months 5 - 10: Evaluation Period I||41||
48287064|NCT00910689|101029625|FG000|NOT COMPLETED|Months 5 - 10: Evaluation Period I||4||
48287065|NCT00910689|101029626|FG001|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7||
48287066|NCT00910689|101029627|FG002|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7||
48287067|NCT00910689|101029628|FG003|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7||
48287068|NCT00910689|101029625|FG000|STARTED|Months 11- 16: Evaluation Period II||40||
48287069|NCT00910689|101029626|FG001|STARTED|Months 11- 16: Evaluation Period II||35||
48287070|NCT00910689|101029627|FG002|STARTED|Months 11- 16: Evaluation Period II||35||
48287071|NCT00910689|101029628|FG003|STARTED|Months 11- 16: Evaluation Period II||41||
48287072|NCT00910689|101029625|FG000|COMPLETED|Months 11- 16: Evaluation Period II||30||
48287073|NCT00910689|101029626|FG001|COMPLETED|Months 11- 16: Evaluation Period II||25||
48287074|NCT00910689|101029627|FG002|COMPLETED|Months 11- 16: Evaluation Period II||28||
48287075|NCT00910689|101029628|FG003|COMPLETED|Months 11- 16: Evaluation Period II||35||
48287076|NCT00910689|101029625|FG000|NOT COMPLETED|Months 11- 16: Evaluation Period II||10||
48287077|NCT00910689|101029626|FG001|NOT COMPLETED|Months 11- 16: Evaluation Period II||10||
48287078|NCT00910689|101029627|FG002|NOT COMPLETED|Months 11- 16: Evaluation Period II||7||
48287079|NCT00910689|101029628|FG003|NOT COMPLETED|Months 11- 16: Evaluation Period II||6||
48579939|NCT00594100|101753113|FG000|STARTED|Follow-up Through 30 Days Post Procedure||236||
48579940|NCT00594100|101753113|FG000|COMPLETED|Follow-up Through 30 Days Post Procedure||224||
48579941|NCT00594100|101753113|FG000|NOT COMPLETED|Follow-up Through 30 Days Post Procedure||12||
48579942|NCT01080118|101753114|FG000|STARTED|Overall Study||15||
48579943|NCT01080118|101753115|FG001|STARTED|Overall Study||15||
48579944|NCT01080118|101753116|FG002|STARTED|Overall Study||30||
48579945|NCT01080118|101753117|FG003|STARTED|Overall Study||30||
48579946|NCT01080118|101753114|FG000|COMPLETED|Overall Study||15||
48579947|NCT01080118|101753115|FG001|COMPLETED|Overall Study||15||
48579948|NCT01080118|101753116|FG002|COMPLETED|Overall Study||30||
48579949|NCT01080118|101753117|FG003|COMPLETED|Overall Study||30||
48579950|NCT01080118|101753114|FG000|NOT COMPLETED|Overall Study||0||
48287080|NCT01181323|101029629|FG000|STARTED|Overall Study||124||
48287081|NCT01181323|101029630|FG001|STARTED|Overall Study||124||
48287082|NCT01181323|101029631|FG002|STARTED|Overall Study||124||
48287083|NCT01181323|101029632|FG003|STARTED|Overall Study||125||
48287084|NCT01181323|101029629|FG000|COMPLETED|Overall Study||123||
48287085|NCT01181323|101029630|FG001|COMPLETED|Overall Study||121||
48287086|NCT01181323|101029631|FG002|COMPLETED|Overall Study||123||
48287087|NCT01181323|101029632|FG003|COMPLETED|Overall Study||122||
48287088|NCT01181323|101029629|FG000|NOT COMPLETED|Overall Study||1||
48287089|NCT01181323|101029630|FG001|NOT COMPLETED|Overall Study||3||
48287090|NCT01181323|101029631|FG002|NOT COMPLETED|Overall Study||1||
48287091|NCT01181323|101029632|FG003|NOT COMPLETED|Overall Study||3||
48287092|NCT03102645|101029633|FG000|STARTED|Overall Study||8||
48287093|NCT03102645|101029634|FG001|STARTED|Overall Study||8||
48287094|NCT03102645|101029633|FG000|COMPLETED|Overall Study||8||
48287095|NCT03102645|101029634|FG001|COMPLETED|Overall Study||8||
48287096|NCT03102645|101029633|FG000|NOT COMPLETED|Overall Study||0||
48287097|NCT03102645|101029634|FG001|NOT COMPLETED|Overall Study||0||
48287098|NCT03212989|101029635|FG000|STARTED|Overall Study||17||
48287099|NCT03212989|101029635|FG000|Completed Baseline Leukapheresis|Overall Study||17||
48287100|NCT03212989|101029635|FG000|First Intervention Series VOR/HXTC Infusion|Overall Study||9||
48287101|NCT03212989|101029635|FG000|Second Intervention Series VOR/HXTC Infusion|Overall Study||9||
48287102|NCT03212989|101029635|FG000|COMPLETED|Overall Study||9||
48287103|NCT03212989|101029635|FG000|NOT COMPLETED|Overall Study||8||
48287104|NCT00618618|101029636|FG000|STARTED|Overall Study||24||
48287105|NCT00618618|101029637|FG001|STARTED|Overall Study||14||
48287106|NCT00618618|101029638|FG002|STARTED|Overall Study||21||
48287107|NCT00618618|101029639|FG003|STARTED|Overall Study||14||
48287108|NCT00618618|101029636|FG000|Received Treatment|Overall Study||24||
48287109|NCT00618618|101029637|FG001|Received Treatment|Overall Study||13||
48287110|NCT00618618|101029638|FG002|Received Treatment|Overall Study||20||
48287111|NCT00618618|101029639|FG003|Received Treatment|Overall Study||14||
48287112|NCT00618618|101029636|FG000|COMPLETED|Overall Study||20||
48287113|NCT00618618|101029637|FG001|COMPLETED|Overall Study||11||
48287114|NCT00618618|101029638|FG002|COMPLETED|Overall Study||18||
48287115|NCT00618618|101029639|FG003|COMPLETED|Overall Study||13||
48287116|NCT00618618|101029636|FG000|NOT COMPLETED|Overall Study||4||
48287117|NCT00618618|101029637|FG001|NOT COMPLETED|Overall Study||3||
48287118|NCT00618618|101029638|FG002|NOT COMPLETED|Overall Study||3||
48287119|NCT00618618|101029639|FG003|NOT COMPLETED|Overall Study||1||
48400320|NCT00712933|101309349|FG000|STARTED|Overall Study||735||
48579951|NCT01080118|101753115|FG001|NOT COMPLETED|Overall Study||0||
48579952|NCT01080118|101753116|FG002|NOT COMPLETED|Overall Study||0||
48579953|NCT01080118|101753117|FG003|NOT COMPLETED|Overall Study||0||
48579954|NCT04084561|101753118|FG000|STARTED|Overall Study||41||
48579955|NCT04084561|101753119|FG001|STARTED|Overall Study||40||
48579956|NCT04084561|101753120|FG002|STARTED|Overall Study||43||
48579957|NCT04084561|101753121|FG003|STARTED|Overall Study||42||
48579958|NCT04084561|101753118|FG000|COMPLETED|Overall Study||41||
48579959|NCT04084561|101753119|FG001|COMPLETED|Overall Study||40||
48579960|NCT04084561|101753120|FG002|COMPLETED|Overall Study||43||
48579961|NCT04084561|101753121|FG003|COMPLETED|Overall Study||42||
48579962|NCT04084561|101753118|FG000|NOT COMPLETED|Overall Study||0||
48579963|NCT04084561|101753119|FG001|NOT COMPLETED|Overall Study||0||
48579964|NCT04084561|101753120|FG002|NOT COMPLETED|Overall Study||0||
48579965|NCT04084561|101753121|FG003|NOT COMPLETED|Overall Study||0||
48579966|NCT01694069|101753122|FG000|STARTED|Overall Study||6||
48579967|NCT01694069|101753122|FG000|COMPLETED|Overall Study||6||
48579968|NCT01694069|101753122|FG000|NOT COMPLETED|Overall Study||0||
48579969|NCT02291601|101753123|FG000|STARTED|Abdomen||638||638
48579970|NCT02291601|101753124|FG001|STARTED|Abdomen||108||108
48287120|NCT00513604|101029640|FG000|STARTED|Overall Study||26||
48287121|NCT00513604|101029641|FG001|STARTED|Overall Study||39||
48287122|NCT00513604|101029642|FG002|STARTED|Overall Study||24||
48287123|NCT00513604|101029643|FG003|STARTED|Overall Study||34||
48287124|NCT00513604|101029644|FG004|STARTED|Overall Study||35||
48287125|NCT00513604|101029640|FG000|COMPLETED|Overall Study||24||
48287126|NCT00513604|101029641|FG001|COMPLETED|Overall Study||36||
48287127|NCT00513604|101029642|FG002|COMPLETED|Overall Study||21||
48579971|NCT02291601|101753125|FG002|STARTED|Abdomen||642||642
48579972|NCT02291601|101753123|FG000|COMPLETED|Abdomen||305|Completed is a lower participant number than started due to failed treatment day baselines|305
48579973|NCT02291601|101753124|FG001|COMPLETED|Abdomen||54|Completed is a lower participant number than started due to failed treatment day baselines|54
48579974|NCT02291601|101753125|FG002|COMPLETED|Abdomen||303|Completed is a lower participant number than started due to failed treatment day baselines|303
48579975|NCT02291601|101753123|FG000|NOT COMPLETED|Abdomen||333||333
48287128|NCT00513604|101029643|FG003|COMPLETED|Overall Study||34||
48400321|NCT00712933|101309349|FG000|COMPLETED|Overall Study||368||
48579976|NCT02291601|101753124|FG001|NOT COMPLETED|Abdomen||54||54
48579977|NCT02291601|101753125|FG002|NOT COMPLETED|Abdomen||339||339
48579978|NCT02291601|101753123|FG000|STARTED|Groin||520||520
48579979|NCT02291601|101753124|FG001|STARTED|Groin||93||93
48579980|NCT02291601|101753125|FG002|STARTED|Groin||515||515
48579981|NCT02291601|101753123|FG000|COMPLETED|Groin||337|Completed is a lower participant number than started due to failed treatment day baselines|337
48579982|NCT02291601|101753124|FG001|COMPLETED|Groin||63|Completed is a lower participant number than started due to failed treatment day baselines|63
48579983|NCT02291601|101753125|FG002|COMPLETED|Groin||338|Completed is a lower participant number than started due to failed treatment day baselines|338
48579984|NCT02291601|101753123|FG000|NOT COMPLETED|Groin||183||183
48579985|NCT02291601|101753124|FG001|NOT COMPLETED|Groin||30||30
48579986|NCT02291601|101753125|FG002|NOT COMPLETED|Groin||177||177
48579987|NCT01953601|101753126|FG000|STARTED|Part 1 (Base Study)||485||
48579988|NCT01953601|101753127|FG001|STARTED|Part 1 (Base Study)||484||
48579989|NCT01953601|101753128|FG002|STARTED|Part 1 (Base Study)||485||
48579990|NCT01953601|101753126|FG000|Treated|Part 1 (Base Study)||483||
48579991|NCT01953601|101753127|FG001|Treated|Part 1 (Base Study)||484||
48579992|NCT01953601|101753128|FG002|Treated|Part 1 (Base Study)||484||
48579993|NCT01953601|101753126|FG000|COMPLETED|Part 1 (Base Study)||234||
48579994|NCT01953601|101753127|FG001|COMPLETED|Part 1 (Base Study)||231||
48579995|NCT01953601|101753128|FG002|COMPLETED|Part 1 (Base Study)||239||
48579996|NCT01953601|101753126|FG000|NOT COMPLETED|Part 1 (Base Study)||251||
48579997|NCT01953601|101753127|FG001|NOT COMPLETED|Part 1 (Base Study)||253||
48579998|NCT01953601|101753128|FG002|NOT COMPLETED|Part 1 (Base Study)||246||
48579999|NCT01953601|101753126|FG000|STARTED|Part 2 (Extension Study)||198||
48580000|NCT01953601|101753127|FG001|STARTED|Part 2 (Extension Study)||191||
48580001|NCT01953601|101753128|FG002|STARTED|Part 2 (Extension Study)||204||
48580002|NCT01953601|101753126|FG000|Treated|Part 2 (Extension Study)||197||
48580003|NCT01953601|101753127|FG001|Treated|Part 2 (Extension Study)||191||
48580004|NCT01953601|101753128|FG002|Treated|Part 2 (Extension Study)||204||
48580005|NCT01953601|101753126|FG000|COMPLETED|Part 2 (Extension Study)||0||
48580006|NCT01953601|101753127|FG001|COMPLETED|Part 2 (Extension Study)||0||
48580007|NCT01953601|101753128|FG002|COMPLETED|Part 2 (Extension Study)||0||
48580008|NCT01953601|101753126|FG000|NOT COMPLETED|Part 2 (Extension Study)||198||
48580009|NCT01953601|101753127|FG001|NOT COMPLETED|Part 2 (Extension Study)||191||
48580010|NCT01953601|101753128|FG002|NOT COMPLETED|Part 2 (Extension Study)||204||
48580011|NCT02799667|101753129|FG000|STARTED|Overall Study||55||
48580012|NCT02799667|101753130|FG001|STARTED|Overall Study||55||
48580013|NCT02799667|101753129|FG000|COMPLETED|Overall Study||54||
48135156|NCT00407537|100655883|FG000|COMPLETED|Overall Study||686||
48135157|NCT00407537|100655884|FG001|COMPLETED|Overall Study||638||
48135158|NCT00407537|100655883|FG000|NOT COMPLETED|Overall Study||93||
48135159|NCT00407537|100655884|FG001|NOT COMPLETED|Overall Study||44||
48135160|NCT03836287|100655885|FG000|STARTED|Overall Study||173||
48135161|NCT03836287|100655886|FG001|STARTED|Overall Study||177||
48135162|NCT03836287|100655885|FG000|COMPLETED|Overall Study||150||
48580014|NCT02799667|101753130|FG001|COMPLETED|Overall Study||54||
48580015|NCT02799667|101753129|FG000|NOT COMPLETED|Overall Study||1||
48580016|NCT02799667|101753130|FG001|NOT COMPLETED|Overall Study||1||
48580017|NCT05338502|101753131|FG000|STARTED|Period 1 - Day 1 to Day 8||20||
48580018|NCT05338502|101753132|FG001|STARTED|Period 1 - Day 1 to Day 8||0||
48703800|NCT05319899|102060604|FG003|COMPLETED|Overall Study||3||
48135163|NCT03836287|100655886|FG001|COMPLETED|Overall Study||162||
48135164|NCT03836287|100655885|FG000|NOT COMPLETED|Overall Study||23||
48135165|NCT03836287|100655886|FG001|NOT COMPLETED|Overall Study||15||
48135166|NCT00958035|100655887|FG000|STARTED|Overall Study||46||
48135167|NCT00958035|100655888|FG001|STARTED|Overall Study||43||
48580019|NCT05338502|101753133|FG002|STARTED|Period 1 - Day 1 to Day 8||0||
48580020|NCT05338502|101753131|FG000|Received at Least One Dose of Study Drug|Period 1 - Day 1 to Day 8||20||
48580021|NCT05338502|101753132|FG001|Received at Least One Dose of Study Drug|Period 1 - Day 1 to Day 8||0||
48580022|NCT05338502|101753133|FG002|Received at Least One Dose of Study Drug|Period 1 - Day 1 to Day 8||0||
48580023|NCT05338502|101753131|FG000|COMPLETED|Period 1 - Day 1 to Day 8||20||
48580024|NCT05338502|101753132|FG001|COMPLETED|Period 1 - Day 1 to Day 8||0||
48580025|NCT05338502|101753133|FG002|COMPLETED|Period 1 - Day 1 to Day 8||0||
48580026|NCT05338502|101753131|FG000|NOT COMPLETED|Period 1 - Day 1 to Day 8||0||
48580027|NCT05338502|101753132|FG001|NOT COMPLETED|Period 1 - Day 1 to Day 8||0||
48580028|NCT05338502|101753133|FG002|NOT COMPLETED|Period 1 - Day 1 to Day 8||0||
48580029|NCT05338502|101753131|FG000|STARTED|Period 2 - Day 8 to Day 19||0||
48580030|NCT05338502|101753132|FG001|STARTED|Period 2 - Day 8 to Day 19||20||
48580031|NCT05338502|101753133|FG002|STARTED|Period 2 - Day 8 to Day 19||0||
48580032|NCT05338502|101753131|FG000|COMPLETED|Period 2 - Day 8 to Day 19||0||
48580033|NCT05338502|101753132|FG001|COMPLETED|Period 2 - Day 8 to Day 19||17||
48580034|NCT05338502|101753133|FG002|COMPLETED|Period 2 - Day 8 to Day 19||0||
48580035|NCT05338502|101753131|FG000|NOT COMPLETED|Period 2 - Day 8 to Day 19||0||
48580036|NCT05338502|101753132|FG001|NOT COMPLETED|Period 2 - Day 8 to Day 19||3||
48580037|NCT05338502|101753133|FG002|NOT COMPLETED|Period 2 - Day 8 to Day 19||0||
48703801|NCT05319899|102060605|FG004|COMPLETED|Overall Study||3||
48135168|NCT00958035|100655887|FG000|COMPLETED|Overall Study||43||
48135169|NCT00958035|100655888|FG001|COMPLETED|Overall Study||39||
48135170|NCT00958035|100655887|FG000|NOT COMPLETED|Overall Study||3||
48135171|NCT00958035|100655888|FG001|NOT COMPLETED|Overall Study||4||
48135172|NCT01218438|100655889|FG000|STARTED|Epoch 1||77||
48580038|NCT05338502|101753131|FG000|STARTED|Period 3 - Day 19 to Day 29||0||
48580039|NCT05338502|101753132|FG001|STARTED|Period 3 - Day 19 to Day 29||0||
48580040|NCT05338502|101753133|FG002|STARTED|Period 3 - Day 19 to Day 29||17||
48580041|NCT05338502|101753131|FG000|COMPLETED|Period 3 - Day 19 to Day 29||0||
48580042|NCT05338502|101753132|FG001|COMPLETED|Period 3 - Day 19 to Day 29||0||
48580043|NCT05338502|101753133|FG002|COMPLETED|Period 3 - Day 19 to Day 29||17||
48580044|NCT05338502|101753131|FG000|NOT COMPLETED|Period 3 - Day 19 to Day 29||0||
48580045|NCT05338502|101753132|FG001|NOT COMPLETED|Period 3 - Day 19 to Day 29||0||
48580046|NCT05338502|101753133|FG002|NOT COMPLETED|Period 3 - Day 19 to Day 29||0||
48580047|NCT02683928|101753134|FG000|STARTED|Overall Study||48||
48580048|NCT02683928|101753135|FG001|STARTED|Overall Study||16||
48580049|NCT02683928|101753134|FG000|COMPLETED|Overall Study||26||
48580050|NCT02683928|101753135|FG001|COMPLETED|Overall Study||8||
48580051|NCT02683928|101753134|FG000|NOT COMPLETED|Overall Study||22||
48580052|NCT02683928|101753135|FG001|NOT COMPLETED|Overall Study||8||
48580053|NCT01512446|101753136|FG000|STARTED|Overall Study||221||
48580054|NCT01512446|101753137|FG001|STARTED|Overall Study||215||
48580055|NCT01512446|101753136|FG000|Safety Analysis Set|Overall Study||197|Received at least one dose of study medication|
48580056|NCT01512446|101753137|FG001|Safety Analysis Set|Overall Study||188|Received at least one dose of study medication|
48580057|NCT01512446|101753136|FG000|COMPLETED|Overall Study||0||
48580058|NCT01512446|101753137|FG001|COMPLETED|Overall Study||0||
48580059|NCT01512446|101753136|FG000|NOT COMPLETED|Overall Study||221||
48580060|NCT01512446|101753137|FG001|NOT COMPLETED|Overall Study||215||
48580061|NCT03681678|101753138|FG000|STARTED|Overall Study||100||
48580062|NCT03681678|101753138|FG000|COMPLETED|Overall Study||80||
48580063|NCT03681678|101753138|FG000|NOT COMPLETED|Overall Study||20||
48580064|NCT00068367|101753139|FG000|STARTED|Overall Study||20||
48580065|NCT00068367|101753139|FG000|COMPLETED|Overall Study||20||
48580066|NCT00068367|101753139|FG000|NOT COMPLETED|Overall Study||0||
48580067|NCT03951064|101753140|FG000|STARTED|Overall Study||3||
48580068|NCT03951064|101753141|FG001|STARTED|Overall Study||3||
48580069|NCT03951064|101753140|FG000|COMPLETED|Overall Study||3||
48703802|NCT05319899|102060606|FG005|COMPLETED|Overall Study||3||
48703803|NCT05319899|102060601|FG000|NOT COMPLETED|Overall Study||0||
48703804|NCT05319899|102060602|FG001|NOT COMPLETED|Overall Study||0||
48703805|NCT05319899|102060603|FG002|NOT COMPLETED|Overall Study||0||
48703806|NCT05319899|102060604|FG003|NOT COMPLETED|Overall Study||0||
48703807|NCT05319899|102060605|FG004|NOT COMPLETED|Overall Study||0||
48703808|NCT05319899|102060606|FG005|NOT COMPLETED|Overall Study||0||
48703809|NCT01082874|102060607|FG000|STARTED|Overall Study||2499||
48703810|NCT01082874|102060608|FG001|STARTED|Overall Study||2510||
48703811|NCT01082874|102060609|FG002|STARTED|Overall Study||2499||
48703812|NCT01082874|102060610|FG003|STARTED|Overall Study||2502||
48703813|NCT01082874|102060607|FG000|COMPLETED|Overall Study||2488||
48703814|NCT01082874|102060608|FG001|COMPLETED|Overall Study||2498||
48703815|NCT01082874|102060609|FG002|COMPLETED|Overall Study||2488||
48703816|NCT01082874|102060610|FG003|COMPLETED|Overall Study||2489||
48287129|NCT00513604|101029644|FG004|COMPLETED|Overall Study||35||
48580070|NCT03951064|101753141|FG001|COMPLETED|Overall Study||3||
48580071|NCT03951064|101753140|FG000|NOT COMPLETED|Overall Study||0||
48580072|NCT03951064|101753141|FG001|NOT COMPLETED|Overall Study||0||
48580073|NCT03395080|101753142|FG000|STARTED|Overall Study||29|Number Started is the Safety Analysis Set defined as all subjects who received \>= 1 administration of assigned study treatment (DKN-01 or paclitaxel).Subjects with carcinosarcoma were initially enrolled in the EEC group to receive monotherapy or DKN-01+paclitaxel, but as part of a subsequent protocol amendment, carcinosarcoma subjects were enrolled \& received 600mg DKN-01 or 600mg DKN-01+paclitaxel. Results are reported by disease type and treatment received.|
48592812|NCT01764997|101783184|FG002|COMPLETED|Study Drug Treatment Period||13||
48592813|NCT01764997|101783185|FG003|COMPLETED|Study Drug Treatment Period||13||
48592814|NCT01764997|101783186|FG004|COMPLETED|Study Drug Treatment Period||286||
48703817|NCT01082874|102060607|FG000|NOT COMPLETED|Overall Study||11||
48703818|NCT01082874|102060608|FG001|NOT COMPLETED|Overall Study||12||
48703819|NCT01082874|102060609|FG002|NOT COMPLETED|Overall Study||11||
48703820|NCT01082874|102060610|FG003|NOT COMPLETED|Overall Study||13||
48703821|NCT01321216|102060611|FG000|STARTED|Overall Study||1555||
48703822|NCT01321216|102060611|FG000|COMPLETED|Overall Study||1555||
48703823|NCT01321216|102060611|FG000|NOT COMPLETED|Overall Study||0||
48703824|NCT00866034|102060612|FG000|STARTED|Overall Study||308||
48703825|NCT00866034|102060613|FG001|STARTED|Overall Study||309||
48135173|NCT01218438|100655889|FG000|COMPLETED|Epoch 1||74||
48135174|NCT01218438|100655889|FG000|NOT COMPLETED|Epoch 1||3||
48135175|NCT01218438|100655889|FG000|STARTED|Epoch 2||45||
48135176|NCT01218438|100655889|FG000|COMPLETED|Epoch 2||45||
48135177|NCT01218438|100655889|FG000|NOT COMPLETED|Epoch 2||0||
48135178|NCT01218438|100655889|FG000|STARTED|Epoch 3||74||
48135179|NCT01218438|100655889|FG000|COMPLETED|Epoch 3||70||
48135180|NCT01218438|100655889|FG000|NOT COMPLETED|Epoch 3||4||
48135181|NCT01218438|100655889|FG000|STARTED|Epoch 4||70||
48135182|NCT01218438|100655889|FG000|COMPLETED|Epoch 4||67||
48135183|NCT01218438|100655889|FG000|NOT COMPLETED|Epoch 4||3||
48135184|NCT03387852|100655890|FG000|STARTED|Overall Study||74|Randomized|
48135185|NCT03387852|100655891|FG001|STARTED|Overall Study||73|Randomized|
48135186|NCT03387852|100655892|FG002|STARTED|Overall Study||74|Randomized|
48135187|NCT03387852|100655893|FG003|STARTED|Overall Study||75|Randomized|
48287130|NCT00513604|101029640|FG000|NOT COMPLETED|Overall Study||2||
48287131|NCT00513604|101029641|FG001|NOT COMPLETED|Overall Study||3||
48580074|NCT03395080|101753143|FG001|STARTED|Overall Study||24|Number Started is the Safety Analysis Set defined as all subjects who received \>= 1 administration of assigned study treatment (DKN-01 or paclitaxel).Subjects with carcinosarcoma were initially enrolled in the EEC group to receive monotherapy or DKN-01+paclitaxel, but as part of a subsequent protocol amendment, carcinosarcoma subjects were enrolled \& received 600mg DKN-01 or 600mg DKN-01+paclitaxel. Results are reported by disease type and treatment received.|
48580075|NCT03395080|101753144|FG002|STARTED|Overall Study||14|Number Started is the Safety Analysis Set defined as all subjects who received \>= 1 administration of assigned study treatment (DKN-01 or paclitaxel).Subjects with carcinosarcoma were initially enrolled in the EEC group to receive monotherapy or DKN-01+paclitaxel, but as part of a subsequent protocol amendment, carcinosarcoma subjects were enrolled \& received 600mg DKN-01 or 600mg DKN-01+paclitaxel. Results are reported by disease type and treatment received.|
48580076|NCT03395080|101753145|FG003|STARTED|Overall Study||19|Number Started is the Safety Analysis Set defined as all subjects who received \>= 1 administration of assigned study treatment (DKN-01 or paclitaxel).Subjects with carcinosarcoma were initially enrolled in the EEC group to receive monotherapy or DKN-01+paclitaxel, but as part of a subsequent protocol amendment, carcinosarcoma subjects were enrolled \& received 600mg DKN-01 or 600mg DKN-01+paclitaxel. Results are reported by disease type and treatment received.|
48580077|NCT03395080|101753146|FG004|STARTED|Overall Study||1|Number Started is the Safety Analysis Set defined as all subjects who received \>= 1 administration of assigned study treatment (DKN-01 or paclitaxel).Subjects with carcinosarcoma were initially enrolled in the EEC group to receive monotherapy or DKN-01+paclitaxel, but as part of a subsequent protocol amendment, carcinosarcoma subjects were enrolled \& received 600mg DKN-01 or 600mg DKN-01+paclitaxel. Results are reported by disease type and treatment received.|
48592815|NCT01764997|101783182|FG000|NOT COMPLETED|Study Drug Treatment Period||0||
48592816|NCT01764997|101783183|FG001|NOT COMPLETED|Study Drug Treatment Period||1||
48592817|NCT01764997|101783184|FG002|NOT COMPLETED|Study Drug Treatment Period||0||
48592818|NCT01764997|101783185|FG003|NOT COMPLETED|Study Drug Treatment Period||0||
48592819|NCT01764997|101783186|FG004|NOT COMPLETED|Study Drug Treatment Period||36||
48135188|NCT03387852|100655890|FG000|Treated|Overall Study||74||
48135189|NCT03387852|100655891|FG001|Treated|Overall Study||73||
48135190|NCT03387852|100655892|FG002|Treated|Overall Study||74||
48135191|NCT03387852|100655893|FG003|Treated|Overall Study||74||
48135192|NCT03387852|100655890|FG000|COMPLETED|Overall Study||41||
48135193|NCT03387852|100655891|FG001|COMPLETED|Overall Study||55||
48135194|NCT03387852|100655892|FG002|COMPLETED|Overall Study||47||
48135195|NCT03387852|100655893|FG003|COMPLETED|Overall Study||56||
48135196|NCT03387852|100655890|FG000|NOT COMPLETED|Overall Study||33||
48135197|NCT03387852|100655891|FG001|NOT COMPLETED|Overall Study||18||
48135198|NCT03387852|100655892|FG002|NOT COMPLETED|Overall Study||27||
48135199|NCT03387852|100655893|FG003|NOT COMPLETED|Overall Study||19||
48135200|NCT00413153|100655894|FG000|STARTED|Overall Study||7||
48135201|NCT00413153|100655895|FG001|STARTED|Overall Study||8||
48287132|NCT00513604|101029642|FG002|NOT COMPLETED|Overall Study||3||
48287133|NCT00513604|101029643|FG003|NOT COMPLETED|Overall Study||0||
48135202|NCT00413153|100655894|FG000|COMPLETED|Overall Study||5||
48135203|NCT00413153|100655895|FG001|COMPLETED|Overall Study||7||
48135204|NCT00413153|100655894|FG000|NOT COMPLETED|Overall Study||2||
48135205|NCT00413153|100655895|FG001|NOT COMPLETED|Overall Study||1||
48135206|NCT00283504|100655896|FG000|STARTED|Overall Study||7||
48135207|NCT00283504|100655897|FG001|STARTED|Overall Study||6||
48135208|NCT00283504|100655896|FG000|COMPLETED|Overall Study||7||
48580078|NCT03395080|101753147|FG005|STARTED|Overall Study||8|Number Started is the Safety Analysis Set defined as all subjects who received \>= 1 administration of assigned study treatment (DKN-01 or paclitaxel).Subjects with carcinosarcoma were initially enrolled in the EEC group to receive monotherapy or DKN-01+paclitaxel, but as part of a subsequent protocol amendment, carcinosarcoma subjects were enrolled \& received 600mg DKN-01 or 600mg DKN-01+paclitaxel. Results are reported by disease type and treatment received.|
48580079|NCT03395080|101753148|FG006|STARTED|Overall Study||4|Number Started is the Safety Analysis Set defined as all subjects who received \>= 1 administration of assigned study treatment (DKN-01 or paclitaxel).Subjects with carcinosarcoma were initially enrolled in the EEC group to receive monotherapy or DKN-01+paclitaxel, but as part of a subsequent protocol amendment, carcinosarcoma subjects were enrolled \& received 600mg DKN-01 or 600mg DKN-01+paclitaxel. Results are reported by disease type and treatment received.|
48580080|NCT03395080|101753149|FG007|STARTED|Overall Study||12|Number Started is the Safety Analysis Set defined as all subjects who received \>= 1 administration of assigned study treatment (DKN-01 or paclitaxel).Subjects with carcinosarcoma were initially enrolled in the EEC group to receive monotherapy or DKN-01+paclitaxel, but as part of a subsequent protocol amendment, carcinosarcoma subjects were enrolled \& received 600mg DKN-01 or 600mg DKN-01+paclitaxel. Results are reported by disease type and treatment received.|
48580081|NCT03395080|101753142|FG000|COMPLETED|Overall Study||26|Number Completed is the Evaluable Analysis Set defined as all subjects who received any amount of DKN-01 and had at least 1 evaluated post-baseline RECIST assessment or were discontinued due to death.|
48580082|NCT03395080|101753143|FG001|COMPLETED|Overall Study||21|Number Completed is the Evaluable Analysis Set defined as all subjects who received any amount of DKN-01 and had at least 1 evaluated post-baseline RECIST assessment or were discontinued due to death.|
48580083|NCT03395080|101753144|FG002|COMPLETED|Overall Study||13|Number Completed is the Evaluable Analysis Set defined as all subjects who received any amount of DKN-01 and had at least 1 evaluated post-baseline RECIST assessment or were discontinued due to death.|
48580084|NCT03395080|101753145|FG003|COMPLETED|Overall Study||19|Number Completed is the Evaluable Analysis Set defined as all subjects who received any amount of DKN-01 and had at least 1 evaluated post-baseline RECIST assessment or were discontinued due to death.|
48580085|NCT03395080|101753146|FG004|COMPLETED|Overall Study||1|Number Completed is the Evaluable Analysis Set defined as all subjects who received any amount of DKN-01 and had at least 1 evaluated post-baseline RECIST assessment or were discontinued due to death.|
48135209|NCT00283504|100655897|FG001|COMPLETED|Overall Study||6||
48135210|NCT00283504|100655896|FG000|NOT COMPLETED|Overall Study||0||
48135211|NCT00283504|100655897|FG001|NOT COMPLETED|Overall Study||0||
48135212|NCT03447769|100655898|FG000|STARTED|Overall Study||693||
48135213|NCT03447769|100655899|FG001|STARTED|Overall Study||689||
48135214|NCT03447769|100655898|FG000|Treated|Overall Study||692||
48135215|NCT03447769|100655899|FG001|Treated|Overall Study||689||
48135216|NCT03447769|100655898|FG000|COMPLETED|Overall Study||414|Participants who completed treatment|
48135217|NCT03447769|100655899|FG001|COMPLETED|Overall Study||420|Participants who completed treatment|
48135218|NCT03447769|100655898|FG000|NOT COMPLETED|Overall Study||279||
48135219|NCT03447769|100655899|FG001|NOT COMPLETED|Overall Study||269||
48135220|NCT02271386|100655900|FG000|STARTED|Baseline Period- 8 Months||53||
48135221|NCT02271386|100655901|FG001|STARTED|Baseline Period- 8 Months||52||
48135222|NCT02271386|100655902|FG002|STARTED|Baseline Period- 8 Months||200||
48135223|NCT02271386|100655903|FG003|STARTED|Baseline Period- 8 Months||191||
48135224|NCT02271386|100655900|FG000|COMPLETED|Baseline Period- 8 Months||53||
48135225|NCT02271386|100655901|FG001|COMPLETED|Baseline Period- 8 Months||52||
48135226|NCT02271386|100655902|FG002|COMPLETED|Baseline Period- 8 Months||200||
48135227|NCT02271386|100655903|FG003|COMPLETED|Baseline Period- 8 Months||191||
48135228|NCT02271386|100655900|FG000|NOT COMPLETED|Baseline Period- 8 Months||0||
48135229|NCT02271386|100655901|FG001|NOT COMPLETED|Baseline Period- 8 Months||0||
48135230|NCT02271386|100655902|FG002|NOT COMPLETED|Baseline Period- 8 Months||0||
48135231|NCT02271386|100655903|FG003|NOT COMPLETED|Baseline Period- 8 Months||0||
48135232|NCT02271386|100655900|FG000|STARTED|Intervention Period- 8 Months||53||
48135233|NCT02271386|100655901|FG001|STARTED|Intervention Period- 8 Months||52||
48135234|NCT02271386|100655902|FG002|STARTED|Intervention Period- 8 Months||202||
48135235|NCT02271386|100655903|FG003|STARTED|Intervention Period- 8 Months||197||
48135236|NCT02271386|100655900|FG000|COMPLETED|Intervention Period- 8 Months||53||
48135237|NCT02271386|100655901|FG001|COMPLETED|Intervention Period- 8 Months||52||
48135238|NCT02271386|100655902|FG002|COMPLETED|Intervention Period- 8 Months||202||
48135239|NCT02271386|100655903|FG003|COMPLETED|Intervention Period- 8 Months||197||
48135240|NCT02271386|100655900|FG000|NOT COMPLETED|Intervention Period- 8 Months||0||
48135241|NCT02271386|100655901|FG001|NOT COMPLETED|Intervention Period- 8 Months||0||
48135242|NCT02271386|100655902|FG002|NOT COMPLETED|Intervention Period- 8 Months||0||
48135243|NCT02271386|100655903|FG003|NOT COMPLETED|Intervention Period- 8 Months||0||
48135244|NCT02159482|100655904|FG000|STARTED|Overall Study||11||
48135245|NCT02159482|100655904|FG000|COMPLETED|Overall Study||6||
48135246|NCT02159482|100655904|FG000|NOT COMPLETED|Overall Study||5||
48135247|NCT03879798|100655905|FG000|STARTED|Overall Study||6||
48135248|NCT03879798|100655906|FG001|STARTED|Overall Study||6||
48135249|NCT03879798|100655907|FG002|STARTED|Overall Study||0||
48135250|NCT03879798|100655908|FG003|STARTED|Overall Study||0||
48135251|NCT03879798|100655909|FG004|STARTED|Overall Study||0||
48135252|NCT03879798|100655910|FG005|STARTED|Overall Study||10||
48135253|NCT03879798|100655905|FG000|COMPLETED|Overall Study||6||
48135254|NCT03879798|100655906|FG001|COMPLETED|Overall Study||6||
48135255|NCT03879798|100655907|FG002|COMPLETED|Overall Study||0||
48580086|NCT03395080|101753147|FG005|COMPLETED|Overall Study||8|Number Completed is the Evaluable Analysis Set defined as all subjects who received any amount of DKN-01 and had at least 1 evaluated post-baseline RECIST assessment or were discontinued due to death.|
48580087|NCT03395080|101753148|FG006|COMPLETED|Overall Study||4|Number Completed is the Evaluable Analysis Set defined as all subjects who received any amount of DKN-01 and had at least 1 evaluated post-baseline RECIST assessment or were discontinued due to death.|
48580088|NCT03395080|101753149|FG007|COMPLETED|Overall Study||10|Number Completed is the Evaluable Analysis Set defined as all subjects who received any amount of DKN-01 and had at least 1 evaluated post-baseline RECIST assessment or were discontinued due to death.|
48580089|NCT03395080|101753142|FG000|NOT COMPLETED|Overall Study||3||
48703826|NCT00866034|102060612|FG000|COMPLETED|Overall Study||292||
48135256|NCT03879798|100655908|FG003|COMPLETED|Overall Study||0||
48135257|NCT03879798|100655909|FG004|COMPLETED|Overall Study||0||
48135258|NCT03879798|100655910|FG005|COMPLETED|Overall Study||7||
48135259|NCT03879798|100655905|FG000|NOT COMPLETED|Overall Study||0||
48135260|NCT03879798|100655906|FG001|NOT COMPLETED|Overall Study||0||
48135261|NCT03879798|100655907|FG002|NOT COMPLETED|Overall Study||0||
48703827|NCT00866034|102060613|FG001|COMPLETED|Overall Study||301||
48135262|NCT03879798|100655908|FG003|NOT COMPLETED|Overall Study||0||
48135263|NCT03879798|100655909|FG004|NOT COMPLETED|Overall Study||0||
48135264|NCT03879798|100655910|FG005|NOT COMPLETED|Overall Study||3||
48135265|NCT00511004|100655911|FG000|STARTED|Overall Study||13||
48135266|NCT00511004|100655912|FG001|STARTED|Overall Study||13||
48135267|NCT00511004|100655913|FG002|STARTED|Overall Study||14||
48135268|NCT00511004|100655911|FG000|COMPLETED|Overall Study||13||
48135269|NCT00511004|100655912|FG001|COMPLETED|Overall Study||13||
48135270|NCT00511004|100655913|FG002|COMPLETED|Overall Study||10||
48135271|NCT00511004|100655911|FG000|NOT COMPLETED|Overall Study||0||
48135272|NCT00511004|100655912|FG001|NOT COMPLETED|Overall Study||0||
48135273|NCT00511004|100655913|FG002|NOT COMPLETED|Overall Study||4||
48135274|NCT00744653|100655914|FG000|STARTED|Overall Study||17||
48287134|NCT00513604|101029644|FG004|NOT COMPLETED|Overall Study||0||
48287135|NCT01575028|101029645|FG000|STARTED|Overall Study||2||
48287136|NCT01575028|101029646|FG001|STARTED|Overall Study||1||
48703828|NCT00866034|102060612|FG000|NOT COMPLETED|Overall Study||16||
48703829|NCT00866034|102060613|FG001|NOT COMPLETED|Overall Study||8||
48703830|NCT02725593|102060614|FG000|STARTED|Blinded Treatment Period||39||
48703831|NCT02725593|102060615|FG001|STARTED|Blinded Treatment Period||33||
48703832|NCT02725593|102060614|FG000|Received Treatment|Blinded Treatment Period||39||
48703833|NCT02725593|102060615|FG001|Received Treatment|Blinded Treatment Period||33||
48703834|NCT02725593|102060614|FG000|COMPLETED|Blinded Treatment Period||34||
48703835|NCT02725593|102060615|FG001|COMPLETED|Blinded Treatment Period||27||
48703836|NCT02725593|102060614|FG000|NOT COMPLETED|Blinded Treatment Period||5||
48703837|NCT02725593|102060615|FG001|NOT COMPLETED|Blinded Treatment Period||6||
48703838|NCT02725593|102060614|FG000|STARTED|Long Term Extension||33||
48703839|NCT02725593|102060615|FG001|STARTED|Long Term Extension||27||
48703840|NCT02725593|102060614|FG000|COMPLETED|Long Term Extension||32||
48703841|NCT02725593|102060615|FG001|COMPLETED|Long Term Extension||24||
48703842|NCT02725593|102060614|FG000|NOT COMPLETED|Long Term Extension||1||
48703843|NCT02725593|102060615|FG001|NOT COMPLETED|Long Term Extension||3||
48703844|NCT00737711|102060616|FG000|STARTED|Overall Study||189||
48703845|NCT00737711|102060616|FG000|COMPLETED|Overall Study||158||
48703846|NCT00737711|102060616|FG000|NOT COMPLETED|Overall Study||31||
48703847|NCT01330628|102060617|FG000|STARTED|Overall Study||170||
48703848|NCT01330628|102060618|FG001|STARTED|Overall Study||82||
48703849|NCT01330628|102060617|FG000|30 Day Follow-up|Overall Study||165||
48703850|NCT01330628|102060618|FG001|30 Day Follow-up|Overall Study||73||
48703851|NCT01330628|102060617|FG000|6 Month Follow-up|Overall Study||135||
48703852|NCT01330628|102060618|FG001|6 Month Follow-up|Overall Study||60||
48703853|NCT01330628|102060617|FG000|COMPLETED|Overall Study||100||
48703854|NCT01330628|102060618|FG001|COMPLETED|Overall Study||42||
48703855|NCT01330628|102060617|FG000|NOT COMPLETED|Overall Study||70||
48135275|NCT00744653|100655914|FG000|COMPLETED|Overall Study||1||
48135276|NCT00744653|100655914|FG000|NOT COMPLETED|Overall Study||16||
48135277|NCT00360308|100655915|FG000|STARTED|Overall Study||247||
48135278|NCT00360308|100655916|FG001|STARTED|Overall Study||234||
48135279|NCT00360308|100655917|FG002|STARTED|Overall Study||242||
48135280|NCT00360308|100655915|FG000|COMPLETED|Overall Study||171||
48135281|NCT00360308|100655916|FG001|COMPLETED|Overall Study||155||
48135282|NCT00360308|100655917|FG002|COMPLETED|Overall Study||154||
48135283|NCT00360308|100655915|FG000|NOT COMPLETED|Overall Study||76||
48135284|NCT00360308|100655916|FG001|NOT COMPLETED|Overall Study||79||
48287137|NCT01575028|101029645|FG000|COMPLETED|Overall Study||2||
48287138|NCT01575028|101029646|FG001|COMPLETED|Overall Study||0||
48287139|NCT01575028|101029645|FG000|NOT COMPLETED|Overall Study||0||
48287140|NCT01575028|101029646|FG001|NOT COMPLETED|Overall Study||1||
48287141|NCT01841931|101029647|FG000|STARTED|Overall Study||4||
48287142|NCT01841931|101029647|FG000|COMPLETED|Overall Study||0||
48135285|NCT00360308|100655917|FG002|NOT COMPLETED|Overall Study||88||
48135286|NCT03894449|100655918|FG000|STARTED|Overall Study||15||
48135287|NCT03894449|100655919|FG001|STARTED|Overall Study||15||
48135288|NCT03894449|100655920|FG002|STARTED|Overall Study||15||
48135289|NCT03894449|100655921|FG003|STARTED|Overall Study||15||
48135290|NCT03894449|100655922|FG004|STARTED|Overall Study||15||
48135291|NCT03894449|100655918|FG000|COMPLETED|Overall Study||15||
48135292|NCT03894449|100655919|FG001|COMPLETED|Overall Study||15||
48135293|NCT03894449|100655920|FG002|COMPLETED|Overall Study||15||
48135294|NCT03894449|100655921|FG003|COMPLETED|Overall Study||15||
48135295|NCT03894449|100655922|FG004|COMPLETED|Overall Study||15||
48135296|NCT03894449|100655918|FG000|NOT COMPLETED|Overall Study||0||
48135297|NCT03894449|100655919|FG001|NOT COMPLETED|Overall Study||0||
48135298|NCT03894449|100655920|FG002|NOT COMPLETED|Overall Study||0||
48135299|NCT03894449|100655921|FG003|NOT COMPLETED|Overall Study||0||
48135300|NCT03894449|100655922|FG004|NOT COMPLETED|Overall Study||0||
48135301|NCT01968213|100655923|FG000|STARTED|Overall Study||375||
48135302|NCT01968213|100655924|FG001|STARTED|Overall Study||189||
48135303|NCT01968213|100655923|FG000|COMPLETED|Overall Study||375||
48135304|NCT01968213|100655924|FG001|COMPLETED|Overall Study||189||
48135305|NCT01968213|100655923|FG000|NOT COMPLETED|Overall Study||0||
48135306|NCT01968213|100655924|FG001|NOT COMPLETED|Overall Study||0||
48135307|NCT01437449|100655925|FG000|STARTED|Overall Study||27||
48135308|NCT01437449|100655925|FG000|COMPLETED|Overall Study||27||
48135309|NCT01437449|100655925|FG000|NOT COMPLETED|Overall Study||0||
48135310|NCT02103439|100655926|FG000|STARTED|Overall Study||70||
48135311|NCT02103439|100655927|FG001|STARTED|Overall Study||70||
48135312|NCT02103439|100655926|FG000|COMPLETED|Overall Study||67||
48135313|NCT02103439|100655927|FG001|COMPLETED|Overall Study||67||
48135314|NCT02103439|100655926|FG000|NOT COMPLETED|Overall Study||3||
48135315|NCT02103439|100655927|FG001|NOT COMPLETED|Overall Study||3||
48135316|NCT03478891|100655928|FG000|STARTED|Overall Study||3||
48135317|NCT03478891|100655929|FG001|STARTED|Overall Study||5||
48135318|NCT03478891|100655930|FG002|STARTED|Overall Study||11||
48135319|NCT03478891|100655928|FG000|Received MAb114|Overall Study||3||
48135320|NCT03478891|100655929|FG001|Received MAb114|Overall Study||5||
48135321|NCT03478891|100655930|FG002|Received MAb114|Overall Study||10||
48580090|NCT03395080|101753143|FG001|NOT COMPLETED|Overall Study||3||
48580091|NCT03395080|101753144|FG002|NOT COMPLETED|Overall Study||1||
48580092|NCT03395080|101753145|FG003|NOT COMPLETED|Overall Study||0||
48580093|NCT03395080|101753146|FG004|NOT COMPLETED|Overall Study||0||
48580094|NCT03395080|101753147|FG005|NOT COMPLETED|Overall Study||0||
48580095|NCT03395080|101753148|FG006|NOT COMPLETED|Overall Study||0||
48135322|NCT03478891|100655928|FG000|COMPLETED|Overall Study||2||
48135323|NCT03478891|100655929|FG001|COMPLETED|Overall Study||5||
48135324|NCT03478891|100655930|FG002|COMPLETED|Overall Study||8||
48135325|NCT03478891|100655928|FG000|NOT COMPLETED|Overall Study||1||
48135326|NCT03478891|100655929|FG001|NOT COMPLETED|Overall Study||0||
48135327|NCT03478891|100655930|FG002|NOT COMPLETED|Overall Study||3||
48135328|NCT01343368|100655931|FG000|STARTED|Overall Study||9||
48135329|NCT01343368|100655932|FG001|STARTED|Overall Study||10||
48135330|NCT01343368|100655931|FG000|COMPLETED|Overall Study||7||
48135331|NCT01343368|100655932|FG001|COMPLETED|Overall Study||10||
48135332|NCT01343368|100655931|FG000|NOT COMPLETED|Overall Study||2||
48135333|NCT01343368|100655932|FG001|NOT COMPLETED|Overall Study||0||
48135334|NCT01435577|100655933|FG000|STARTED|Overall Study||64||
48580096|NCT03395080|101753149|FG007|NOT COMPLETED|Overall Study||2||
48580097|NCT03706430|101753150|FG000|STARTED|Overall Study||63||
48580098|NCT03706430|101753150|FG000|COMPLETED|Overall Study||48||
48580099|NCT03706430|101753150|FG000|NOT COMPLETED|Overall Study||15||
48580100|NCT03105479|101753151|FG000|STARTED|Overall Study||1||
48580101|NCT03105479|101753152|FG001|STARTED|Overall Study||0||
48135335|NCT01435577|100655934|FG001|STARTED|Overall Study||65||
48135336|NCT01435577|100655933|FG000|COMPLETED|Overall Study||47||
48135337|NCT01435577|100655934|FG001|COMPLETED|Overall Study||13||
48135338|NCT01435577|100655933|FG000|NOT COMPLETED|Overall Study||17||
48135339|NCT01435577|100655934|FG001|NOT COMPLETED|Overall Study||52||
48135340|NCT04265755|100655935|FG000|STARTED|Overall Study||1406||
48135341|NCT04265755|100655935|FG000|Dose Switch From Baseline Dose|Overall Study||504||
48135342|NCT04265755|100655935|FG000|COMPLETED|Overall Study||1353|Completed study|
48135343|NCT04265755|100655935|FG000|NOT COMPLETED|Overall Study||53||
48135344|NCT02244944|100655936|FG000|STARTED|Overall Study||2||
48135345|NCT02244944|100655936|FG000|COMPLETED|Overall Study||0||
48135346|NCT02244944|100655936|FG000|NOT COMPLETED|Overall Study||2||
48135347|NCT00096135|100655937|FG000|STARTED|Overall Study||126||
48135348|NCT00096135|100655938|FG001|STARTED|Overall Study||42||
48580102|NCT03105479|101753153|FG002|STARTED|Overall Study||0||
48135349|NCT00096135|100655937|FG000|COMPLETED|Overall Study||63||
48135350|NCT00096135|100655938|FG001|COMPLETED|Overall Study||27||
48135351|NCT00096135|100655937|FG000|NOT COMPLETED|Overall Study||63||
48135352|NCT00096135|100655938|FG001|NOT COMPLETED|Overall Study||15||
48135353|NCT01660906|100655939|FG000|STARTED|Overall Study||39||
48135354|NCT01660906|100655939|FG000|COMPLETED|Overall Study||36||
48135355|NCT01660906|100655939|FG000|NOT COMPLETED|Overall Study||3||
48135356|NCT02345512|100655940|FG000|STARTED|Overall Study||11||
48135357|NCT02345512|100655940|FG000|COMPLETED|Overall Study||9||
48580103|NCT03105479|101753154|FG003|STARTED|Overall Study||0||
48135358|NCT02345512|100655940|FG000|NOT COMPLETED|Overall Study||2||
48135359|NCT02508311|100655941|FG000|STARTED|Overall Study||1||
48135360|NCT02508311|100655942|FG001|STARTED|Overall Study||0||
48703856|NCT01330628|102060618|FG001|NOT COMPLETED|Overall Study||40||
48703857|NCT01175434|102060619|FG000|STARTED|Overall Study||48||
48703858|NCT01175434|102060620|FG001|STARTED|Overall Study||51||
48703859|NCT01175434|102060619|FG000|COMPLETED|Overall Study||48||
48703860|NCT01175434|102060620|FG001|COMPLETED|Overall Study||51||
48703861|NCT01175434|102060619|FG000|NOT COMPLETED|Overall Study||0||
48703862|NCT01175434|102060620|FG001|NOT COMPLETED|Overall Study||0||
48703863|NCT04140695|102060621|FG000|STARTED|Overall Study||43||
48703864|NCT04140695|102060622|FG001|STARTED|Overall Study||44||
48703865|NCT04140695|102060621|FG000|COMPLETED|Overall Study||33||
48703866|NCT04140695|102060622|FG001|COMPLETED|Overall Study||32||
48703867|NCT04140695|102060621|FG000|NOT COMPLETED|Overall Study||10||
48703868|NCT04140695|102060622|FG001|NOT COMPLETED|Overall Study||12||
48703869|NCT02163967|102060623|FG000|STARTED|First Intervention/ Day 1||4||
48703870|NCT02163967|102060624|FG001|STARTED|First Intervention/ Day 1||4||
48703871|NCT02163967|102060625|FG002|STARTED|First Intervention/ Day 1||3||
48703872|NCT02163967|102060626|FG003|STARTED|First Intervention/ Day 1||4||
48703873|NCT02163967|102060627|FG004|STARTED|First Intervention/ Day 1||3||
48703874|NCT02163967|102060628|FG005|STARTED|First Intervention/ Day 1||3||
48703875|NCT02163967|102060623|FG000|COMPLETED|First Intervention/ Day 1||4||
48703876|NCT02163967|102060624|FG001|COMPLETED|First Intervention/ Day 1||4||
48703877|NCT02163967|102060625|FG002|COMPLETED|First Intervention/ Day 1||3||
48135361|NCT02508311|100655941|FG000|COMPLETED|Overall Study||0||
48135362|NCT02508311|100655942|FG001|COMPLETED|Overall Study||0||
48135363|NCT02508311|100655941|FG000|NOT COMPLETED|Overall Study||1||
48135364|NCT02508311|100655942|FG001|NOT COMPLETED|Overall Study||0||
48135365|NCT00659633|100655943|FG000|STARTED|Overall Study||10||
48135366|NCT00659633|100655943|FG000|COMPLETED|Overall Study||10||
48135367|NCT00659633|100655943|FG000|NOT COMPLETED|Overall Study||0||
48135368|NCT00990652|100655944|FG000|STARTED|Pre-surgical Bortezomib||10||
48135369|NCT00990652|100655944|FG000|COMPLETED|Pre-surgical Bortezomib||9||
48135370|NCT00990652|100655944|FG000|NOT COMPLETED|Pre-surgical Bortezomib||1||
48135371|NCT00990652|100655944|FG000|STARTED|Surgical Resection||9||
48135372|NCT00990652|100655944|FG000|COMPLETED|Surgical Resection||9||
48135373|NCT00990652|100655944|FG000|NOT COMPLETED|Surgical Resection||0||
48135374|NCT00990652|100655944|FG000|STARTED|Post-sugery Bortezomib + Temozolomide||9||
48135375|NCT00990652|100655944|FG000|COMPLETED|Post-sugery Bortezomib + Temozolomide||8||
48135376|NCT00990652|100655944|FG000|NOT COMPLETED|Post-sugery Bortezomib + Temozolomide||1||
48135377|NCT02777593|100655945|FG000|STARTED|Overall Study||85||
48135378|NCT02777593|100655946|FG001|STARTED|Overall Study||136||
48135379|NCT02777593|100655947|FG002|STARTED|Overall Study||10||
48135380|NCT02777593|100655948|FG003|STARTED|Overall Study||13||
48135381|NCT02777593|100655949|FG004|STARTED|Overall Study||6||
48135382|NCT02777593|100655945|FG000|COMPLETED|Overall Study||23||
48135383|NCT02777593|100655946|FG001|COMPLETED|Overall Study||24||
48135384|NCT02777593|100655947|FG002|COMPLETED|Overall Study||0||
48703878|NCT02163967|102060626|FG003|COMPLETED|First Intervention/ Day 1||4||
48703879|NCT02163967|102060627|FG004|COMPLETED|First Intervention/ Day 1||3||
48703880|NCT02163967|102060628|FG005|COMPLETED|First Intervention/ Day 1||3||
48703881|NCT02163967|102060623|FG000|NOT COMPLETED|First Intervention/ Day 1||0||
48703882|NCT02163967|102060624|FG001|NOT COMPLETED|First Intervention/ Day 1||0||
48703883|NCT02163967|102060625|FG002|NOT COMPLETED|First Intervention/ Day 1||0||
48703884|NCT02163967|102060626|FG003|NOT COMPLETED|First Intervention/ Day 1||0||
48135385|NCT02777593|100655948|FG003|COMPLETED|Overall Study||1||
48135386|NCT02777593|100655949|FG004|COMPLETED|Overall Study||0||
48135387|NCT02777593|100655945|FG000|NOT COMPLETED|Overall Study||62||
48703885|NCT02163967|102060627|FG004|NOT COMPLETED|First Intervention/ Day 1||0||
48703886|NCT02163967|102060628|FG005|NOT COMPLETED|First Intervention/ Day 1||0||
48703887|NCT02163967|102060623|FG000|STARTED|Second Intevention/Day 2||3||
48703888|NCT02163967|102060624|FG001|STARTED|Second Intevention/Day 2||4||
48703889|NCT02163967|102060625|FG002|STARTED|Second Intevention/Day 2||2||
48703890|NCT02163967|102060626|FG003|STARTED|Second Intevention/Day 2||4||
48703891|NCT02163967|102060627|FG004|STARTED|Second Intevention/Day 2||3||
48703892|NCT02163967|102060628|FG005|STARTED|Second Intevention/Day 2||3||
48703893|NCT02163967|102060623|FG000|COMPLETED|Second Intevention/Day 2||3||
48703894|NCT02163967|102060624|FG001|COMPLETED|Second Intevention/Day 2||4||
48703895|NCT02163967|102060625|FG002|COMPLETED|Second Intevention/Day 2||2||
48703896|NCT02163967|102060626|FG003|COMPLETED|Second Intevention/Day 2||4||
48703897|NCT02163967|102060627|FG004|COMPLETED|Second Intevention/Day 2||3||
48135388|NCT02777593|100655946|FG001|NOT COMPLETED|Overall Study||112||
48703898|NCT02163967|102060628|FG005|COMPLETED|Second Intevention/Day 2||3||
48135389|NCT02777593|100655947|FG002|NOT COMPLETED|Overall Study||10||
48135390|NCT02777593|100655948|FG003|NOT COMPLETED|Overall Study||12||
48135391|NCT02777593|100655949|FG004|NOT COMPLETED|Overall Study||6||
48135392|NCT02415400|100655950|FG000|STARTED|Overall Study||1153|Started = Randomized|
48135393|NCT02415400|100655951|FG001|STARTED|Overall Study||1153|Started = Randomized|
48703899|NCT02163967|102060623|FG000|NOT COMPLETED|Second Intevention/Day 2||0||
48703900|NCT02163967|102060624|FG001|NOT COMPLETED|Second Intevention/Day 2||0||
48703901|NCT02163967|102060625|FG002|NOT COMPLETED|Second Intevention/Day 2||0||
48703902|NCT02163967|102060626|FG003|NOT COMPLETED|Second Intevention/Day 2||0||
48703903|NCT02163967|102060627|FG004|NOT COMPLETED|Second Intevention/Day 2||0||
48703904|NCT02163967|102060628|FG005|NOT COMPLETED|Second Intevention/Day 2||0||
48703905|NCT02163967|102060623|FG000|STARTED|Third Intervention/Day 3||3||
48703906|NCT02163967|102060624|FG001|STARTED|Third Intervention/Day 3||3||
48703907|NCT02163967|102060625|FG002|STARTED|Third Intervention/Day 3||2||
48703908|NCT02163967|102060626|FG003|STARTED|Third Intervention/Day 3||4||
48703909|NCT02163967|102060627|FG004|STARTED|Third Intervention/Day 3||3||
48703910|NCT02163967|102060628|FG005|STARTED|Third Intervention/Day 3||3||
48703911|NCT02163967|102060623|FG000|COMPLETED|Third Intervention/Day 3||3||
48703912|NCT02163967|102060624|FG001|COMPLETED|Third Intervention/Day 3||3||
48703913|NCT02163967|102060625|FG002|COMPLETED|Third Intervention/Day 3||2||
48703914|NCT02163967|102060626|FG003|COMPLETED|Third Intervention/Day 3||4||
48703915|NCT02163967|102060627|FG004|COMPLETED|Third Intervention/Day 3||3||
48703916|NCT02163967|102060628|FG005|COMPLETED|Third Intervention/Day 3||3||
48703917|NCT02163967|102060623|FG000|NOT COMPLETED|Third Intervention/Day 3||0||
48703918|NCT02163967|102060624|FG001|NOT COMPLETED|Third Intervention/Day 3||0||
48703919|NCT02163967|102060625|FG002|NOT COMPLETED|Third Intervention/Day 3||0||
48703920|NCT02163967|102060626|FG003|NOT COMPLETED|Third Intervention/Day 3||0||
48703921|NCT02163967|102060627|FG004|NOT COMPLETED|Third Intervention/Day 3||0||
48703922|NCT02163967|102060628|FG005|NOT COMPLETED|Third Intervention/Day 3||0||
48703923|NCT00394251|102060629|FG000|STARTED|Overall Study||98||
48703924|NCT00394251|102060630|FG001|STARTED|Overall Study||99||
48703925|NCT00394251|102060629|FG000|At Least One Dose of Taxane|Overall Study||93||
48703926|NCT00394251|102060630|FG001|At Least One Dose of Taxane|Overall Study||93||
48703927|NCT00394251|102060629|FG000|COMPLETED|Overall Study||61||
48703928|NCT00394251|102060630|FG001|COMPLETED|Overall Study||61||
48703929|NCT00394251|102060629|FG000|NOT COMPLETED|Overall Study||37||
48703930|NCT00394251|102060630|FG001|NOT COMPLETED|Overall Study||38||
48703931|NCT00945529|102060631|FG000|STARTED|Overall Study||23|Data collection only - waiver of consent|
48703932|NCT00945529|102060632|FG001|STARTED|Overall Study||21|Data collection only - waiver of consent|
48703933|NCT00945529|102060631|FG000|COMPLETED|Overall Study||23||
48703934|NCT00945529|102060632|FG001|COMPLETED|Overall Study||21||
48703935|NCT00945529|102060631|FG000|NOT COMPLETED|Overall Study||0||
48703936|NCT00945529|102060632|FG001|NOT COMPLETED|Overall Study||0||
48703937|NCT04762043|102060633|FG000|STARTED|Overall Study||10||
48703938|NCT04762043|102060634|FG001|STARTED|Overall Study||20||
48703939|NCT04762043|102060633|FG000|COMPLETED|Overall Study||10||
48703940|NCT04762043|102060634|FG001|COMPLETED|Overall Study||20||
48703941|NCT04762043|102060633|FG000|NOT COMPLETED|Overall Study||0||
48703942|NCT04762043|102060634|FG001|NOT COMPLETED|Overall Study||0||
48703943|NCT01646645|102060635|FG000|STARTED|Overall Study||58||
48703944|NCT01646645|102060635|FG000|COMPLETED|Overall Study||28||
48703945|NCT01646645|102060635|FG000|NOT COMPLETED|Overall Study||30||
48703946|NCT03806556|102060636|FG000|STARTED|Overall Study||6||
48703947|NCT03806556|102060637|FG001|STARTED|Overall Study||5||
48703948|NCT03806556|102060636|FG000|COMPLETED|Overall Study||6||
48703949|NCT03806556|102060637|FG001|COMPLETED|Overall Study||5||
48703950|NCT03806556|102060636|FG000|NOT COMPLETED|Overall Study||0||
48703951|NCT03806556|102060637|FG001|NOT COMPLETED|Overall Study||0||
48703952|NCT01774253|102060638|FG000|STARTED|Overall Study||9||
48703953|NCT01774253|102060638|FG000|COMPLETED|Overall Study||0||
48703954|NCT01774253|102060638|FG000|NOT COMPLETED|Overall Study||9||
48703955|NCT01909180|102060639|FG000|STARTED|Overall Study||49||
48703956|NCT01909180|102060639|FG000|COMPLETED|Overall Study||49||
48703957|NCT01909180|102060639|FG000|NOT COMPLETED|Overall Study||0||
48703958|NCT01310179|102060640|FG000|STARTED|Overall Study||12||
48703959|NCT01310179|102060640|FG000|COMPLETED|Overall Study||12||
48703960|NCT01310179|102060640|FG000|NOT COMPLETED|Overall Study||0||
48703961|NCT01685801|102060641|FG000|STARTED|Cycle 1 Period 1 (2 Weeks)||5||
48703962|NCT01685801|102060642|FG001|STARTED|Cycle 1 Period 1 (2 Weeks)||6||
48703963|NCT01685801|102060643|FG002|STARTED|Cycle 1 Period 1 (2 Weeks)||7||
48703964|NCT01685801|102060644|FG003|STARTED|Cycle 1 Period 1 (2 Weeks)||6||
48703965|NCT01685801|102060641|FG000|COMPLETED|Cycle 1 Period 1 (2 Weeks)||5||
48703966|NCT01685801|102060642|FG001|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6||
48703967|NCT01685801|102060643|FG002|COMPLETED|Cycle 1 Period 1 (2 Weeks)||7||
48703968|NCT01685801|102060644|FG003|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6||
48400322|NCT00712933|101309349|FG000|NOT COMPLETED|Overall Study||367||
48400323|NCT02951455|101309350|FG000|STARTED|Overall Study||37||
48400324|NCT02951455|101309351|FG001|STARTED|Overall Study||37||
48400325|NCT02951455|101309352|FG002|STARTED|Overall Study||39||
48400326|NCT02951455|101309353|FG003|STARTED|Overall Study||39||
48580104|NCT03105479|101753155|FG004|STARTED|Overall Study||0||
48580105|NCT03105479|101753156|FG005|STARTED|Overall Study||0||
48580106|NCT03105479|101753157|FG006|STARTED|Overall Study||0||
48580107|NCT03105479|101753151|FG000|COMPLETED|Overall Study||1||
48580108|NCT03105479|101753152|FG001|COMPLETED|Overall Study||0||
48580109|NCT03105479|101753153|FG002|COMPLETED|Overall Study||0||
48580110|NCT03105479|101753154|FG003|COMPLETED|Overall Study||0||
48580111|NCT03105479|101753155|FG004|COMPLETED|Overall Study||0||
48580112|NCT03105479|101753156|FG005|COMPLETED|Overall Study||0||
48580113|NCT03105479|101753157|FG006|COMPLETED|Overall Study||0||
48580114|NCT03105479|101753151|FG000|NOT COMPLETED|Overall Study||0||
48580115|NCT03105479|101753152|FG001|NOT COMPLETED|Overall Study||0||
48580116|NCT03105479|101753153|FG002|NOT COMPLETED|Overall Study||0||
48580117|NCT03105479|101753154|FG003|NOT COMPLETED|Overall Study||0||
48580118|NCT03105479|101753155|FG004|NOT COMPLETED|Overall Study||0||
48580119|NCT03105479|101753156|FG005|NOT COMPLETED|Overall Study||0||
48580120|NCT03105479|101753157|FG006|NOT COMPLETED|Overall Study||0||
48580121|NCT02549287|101753158|FG000|STARTED|Overall Study||193||17
48703969|NCT01685801|102060641|FG000|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0||
48703970|NCT01685801|102060642|FG001|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0||
48703971|NCT01685801|102060643|FG002|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0||
48703972|NCT01685801|102060644|FG003|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0||
48703973|NCT01685801|102060641|FG000|STARTED|Cycle 1 Period 2 (2 Weeks)||5||
48703974|NCT01685801|102060642|FG001|STARTED|Cycle 1 Period 2 (2 Weeks)||6||
48703975|NCT01685801|102060643|FG002|STARTED|Cycle 1 Period 2 (2 Weeks)||7||
48703976|NCT01685801|102060644|FG003|STARTED|Cycle 1 Period 2 (2 Weeks)||6||
48703977|NCT01685801|102060641|FG000|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5||
48703978|NCT01685801|102060642|FG001|COMPLETED|Cycle 1 Period 2 (2 Weeks)||6||
48703979|NCT01685801|102060643|FG002|COMPLETED|Cycle 1 Period 2 (2 Weeks)||7||
48703980|NCT01685801|102060644|FG003|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5||
48703981|NCT01685801|102060641|FG000|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0||
48703982|NCT01685801|102060642|FG001|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0||
48703983|NCT01685801|102060643|FG002|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0||
48703984|NCT01685801|102060644|FG003|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||1||
48703985|NCT01685801|102060641|FG000|STARTED|Washout Period 1 (4 Weeks)||5||
48703986|NCT01685801|102060642|FG001|STARTED|Washout Period 1 (4 Weeks)||6||
48580122|NCT02549287|101753159|FG001|STARTED|Overall Study||96||15
48580123|NCT02549287|101753158|FG000|COMPLETED|Overall Study||113||17
48400327|NCT02951455|101309354|FG004|STARTED|Overall Study||36||
48580124|NCT02549287|101753159|FG001|COMPLETED|Overall Study||64||15
48580125|NCT02549287|101753158|FG000|NOT COMPLETED|Overall Study||80||0
48400328|NCT02951455|101309355|FG005|STARTED|Overall Study||37||
48400329|NCT02951455|101309356|FG006|STARTED|Overall Study||39||
48703987|NCT01685801|102060643|FG002|STARTED|Washout Period 1 (4 Weeks)||7||
48703988|NCT01685801|102060644|FG003|STARTED|Washout Period 1 (4 Weeks)||5||
48703989|NCT01685801|102060641|FG000|COMPLETED|Washout Period 1 (4 Weeks)||5||
48703990|NCT01685801|102060642|FG001|COMPLETED|Washout Period 1 (4 Weeks)||6||
48703991|NCT01685801|102060643|FG002|COMPLETED|Washout Period 1 (4 Weeks)||7||
48703992|NCT01685801|102060644|FG003|COMPLETED|Washout Period 1 (4 Weeks)||5||
48703993|NCT01685801|102060641|FG000|NOT COMPLETED|Washout Period 1 (4 Weeks)||0||
48703994|NCT01685801|102060642|FG001|NOT COMPLETED|Washout Period 1 (4 Weeks)||0||
48703995|NCT01685801|102060643|FG002|NOT COMPLETED|Washout Period 1 (4 Weeks)||0||
48703996|NCT01685801|102060644|FG003|NOT COMPLETED|Washout Period 1 (4 Weeks)||0||
48703997|NCT01685801|102060641|FG000|STARTED|Cycle 2 Period 1 (2 Weeks)||5||
48703998|NCT01685801|102060642|FG001|STARTED|Cycle 2 Period 1 (2 Weeks)||6||
48703999|NCT01685801|102060643|FG002|STARTED|Cycle 2 Period 1 (2 Weeks)||7||
48704000|NCT01685801|102060644|FG003|STARTED|Cycle 2 Period 1 (2 Weeks)||5||
48704001|NCT01685801|102060641|FG000|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5||
48704002|NCT01685801|102060642|FG001|COMPLETED|Cycle 2 Period 1 (2 Weeks)||6||
48704003|NCT01685801|102060643|FG002|COMPLETED|Cycle 2 Period 1 (2 Weeks)||7||
48287143|NCT01841931|101029647|FG000|NOT COMPLETED|Overall Study||4||
48287144|NCT00658684|101029648|FG000|STARTED|Overall Study||152||
48287145|NCT00658684|101029649|FG001|STARTED|Overall Study||99||
48287146|NCT00658684|101029650|FG002|STARTED|Overall Study||25||
48287147|NCT00658684|101029651|FG003|STARTED|Overall Study||28||
48287148|NCT00658684|101029648|FG000|COMPLETED|Overall Study||133||
48287149|NCT00658684|101029649|FG001|COMPLETED|Overall Study||84||
48287150|NCT00658684|101029650|FG002|COMPLETED|Overall Study||22||
48287151|NCT00658684|101029651|FG003|COMPLETED|Overall Study||27||
48287152|NCT00658684|101029648|FG000|NOT COMPLETED|Overall Study||19||
48287153|NCT00658684|101029649|FG001|NOT COMPLETED|Overall Study||15||
48287154|NCT00658684|101029650|FG002|NOT COMPLETED|Overall Study||3||
48287155|NCT00658684|101029651|FG003|NOT COMPLETED|Overall Study||1||
48287156|NCT03207009|101029652|FG000|STARTED|Overall Study||19||
48287157|NCT03207009|101029652|FG000|Intent-to-Treat (ITT) Population|Overall Study||19|ITT population included all 19 participants who initiated any study procedures, beginning with mobilization by G-CSF and/or plerixafor.|
48400330|NCT02951455|101309357|FG007|STARTED|Overall Study||37||
48400331|NCT02951455|101309358|FG008|STARTED|Overall Study||39||
48400332|NCT02951455|101309359|FG009|STARTED|Overall Study||37||
48400333|NCT02951455|101309360|FG010|STARTED|Overall Study||37||
48704004|NCT01685801|102060644|FG003|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5||
48704005|NCT01685801|102060641|FG000|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0||
48704006|NCT01685801|102060642|FG001|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0||
48704007|NCT01685801|102060643|FG002|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0||
48704008|NCT01685801|102060644|FG003|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0||
48704009|NCT01685801|102060641|FG000|STARTED|Cycle 2 Period 2 (2 Weeks)||5||
48287158|NCT03207009|101029652|FG000|Transplant Population (TP)|Overall Study||18|TP included all participants who received beti-cel.|
48287159|NCT03207009|101029652|FG000|COMPLETED|Overall Study||18||
48287160|NCT03207009|101029652|FG000|NOT COMPLETED|Overall Study||1||
48287161|NCT04447846|101029653|FG000|STARTED|Overall Study||10||
48287162|NCT04447846|101029653|FG000|COMPLETED|Overall Study||9||
48287163|NCT04447846|101029653|FG000|NOT COMPLETED|Overall Study||1||
48287164|NCT00968227|101029654|FG000|STARTED|Overall Study||56||
48287165|NCT00968227|101029654|FG000|COMPLETED|Overall Study||56||
48287166|NCT00968227|101029654|FG000|NOT COMPLETED|Overall Study||0||
48287167|NCT00112047|101029655|FG000|STARTED|Randomized Phase||257||
48287168|NCT00112047|101029656|FG001|STARTED|Randomized Phase||254||
48287169|NCT00112047|101029655|FG000|COMPLETED|Randomized Phase||187||
48287170|NCT00112047|101029656|FG001|COMPLETED|Randomized Phase||166||
48287171|NCT00112047|101029655|FG000|NOT COMPLETED|Randomized Phase||70||
48287172|NCT00112047|101029656|FG001|NOT COMPLETED|Randomized Phase||88||
48287173|NCT00112047|101029655|FG000|STARTED|Atripla Phase||160||
48287174|NCT00112047|101029656|FG001|STARTED|Atripla Phase||126||
48287175|NCT00112047|101029655|FG000|COMPLETED|Atripla Phase||142||
48287176|NCT00112047|101029656|FG001|COMPLETED|Atripla Phase||106||
48287177|NCT00112047|101029655|FG000|NOT COMPLETED|Atripla Phase||18||
48400334|NCT02951455|101309361|FG011|STARTED|Overall Study||39||
48400335|NCT02951455|101309362|FG012|STARTED|Overall Study||37||
48704010|NCT01685801|102060642|FG001|STARTED|Cycle 2 Period 2 (2 Weeks)||6||
48704011|NCT01685801|102060643|FG002|STARTED|Cycle 2 Period 2 (2 Weeks)||7||
48704012|NCT01685801|102060644|FG003|STARTED|Cycle 2 Period 2 (2 Weeks)||5||
48704013|NCT01685801|102060641|FG000|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5||
48704014|NCT01685801|102060642|FG001|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5||
48704015|NCT01685801|102060643|FG002|COMPLETED|Cycle 2 Period 2 (2 Weeks)||7||
48704016|NCT01685801|102060644|FG003|COMPLETED|Cycle 2 Period 2 (2 Weeks)||4||
48704017|NCT01685801|102060641|FG000|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0||
48704018|NCT01685801|102060642|FG001|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1||
48704019|NCT01685801|102060643|FG002|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0||
48287178|NCT00112047|101029656|FG001|NOT COMPLETED|Atripla Phase||20||
48287179|NCT00577356|101029657|FG000|STARTED|Overall Study||6||
48287180|NCT00577356|101029657|FG000|COMPLETED|Overall Study||6||
48704020|NCT01685801|102060644|FG003|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1||
48704021|NCT01685801|102060641|FG000|STARTED|Washout Period 2 (4 Weeks)||5||
48704022|NCT01685801|102060642|FG001|STARTED|Washout Period 2 (4 Weeks)||5||
48704023|NCT01685801|102060643|FG002|STARTED|Washout Period 2 (4 Weeks)||7||
48704024|NCT01685801|102060644|FG003|STARTED|Washout Period 2 (4 Weeks)||4||
48704025|NCT01685801|102060641|FG000|COMPLETED|Washout Period 2 (4 Weeks)||5||
48704026|NCT01685801|102060642|FG001|COMPLETED|Washout Period 2 (4 Weeks)||5||
48704027|NCT01685801|102060643|FG002|COMPLETED|Washout Period 2 (4 Weeks)||7||
48704028|NCT01685801|102060644|FG003|COMPLETED|Washout Period 2 (4 Weeks)||4||
48704029|NCT01685801|102060641|FG000|NOT COMPLETED|Washout Period 2 (4 Weeks)||0||
48704030|NCT01685801|102060642|FG001|NOT COMPLETED|Washout Period 2 (4 Weeks)||0||
48704031|NCT01685801|102060643|FG002|NOT COMPLETED|Washout Period 2 (4 Weeks)||0||
48704032|NCT01685801|102060644|FG003|NOT COMPLETED|Washout Period 2 (4 Weeks)||0||
48704033|NCT01685801|102060641|FG000|STARTED|Open-label Period (8 Weeks)||5||
48704034|NCT01685801|102060642|FG001|STARTED|Open-label Period (8 Weeks)||5||
48704035|NCT01685801|102060643|FG002|STARTED|Open-label Period (8 Weeks)||7||
48704036|NCT01685801|102060644|FG003|STARTED|Open-label Period (8 Weeks)||4||
48704037|NCT01685801|102060641|FG000|COMPLETED|Open-label Period (8 Weeks)||5||
48704038|NCT01685801|102060642|FG001|COMPLETED|Open-label Period (8 Weeks)||5||
48704039|NCT01685801|102060643|FG002|COMPLETED|Open-label Period (8 Weeks)||7||
48704040|NCT01685801|102060644|FG003|COMPLETED|Open-label Period (8 Weeks)||4||
48704041|NCT01685801|102060641|FG000|NOT COMPLETED|Open-label Period (8 Weeks)||0||
48704042|NCT01685801|102060642|FG001|NOT COMPLETED|Open-label Period (8 Weeks)||0||
48704043|NCT01685801|102060643|FG002|NOT COMPLETED|Open-label Period (8 Weeks)||0||
48704044|NCT01685801|102060644|FG003|NOT COMPLETED|Open-label Period (8 Weeks)||0||
48704045|NCT03746600|102060645|FG000|STARTED|Overall Study||26||
48704046|NCT03746600|102060646|FG001|STARTED|Overall Study||24||
48704047|NCT03746600|102060645|FG000|COMPLETED|Overall Study||21||
48704048|NCT03746600|102060646|FG001|COMPLETED|Overall Study||21||
48704049|NCT03746600|102060645|FG000|NOT COMPLETED|Overall Study||5||
48704050|NCT03746600|102060646|FG001|NOT COMPLETED|Overall Study||3||
48704051|NCT03468816|102060647|FG000|STARTED|Overall Study||2||
48704052|NCT03468816|102060648|FG001|STARTED|Overall Study||3||
48400336|NCT02951455|101309363|FG013|STARTED|Overall Study||37||
48400337|NCT02951455|101309364|FG014|STARTED|Overall Study||39||
48400338|NCT02951455|101309365|FG015|STARTED|Overall Study||36||
48400339|NCT02951455|101309350|FG000|COMPLETED|Overall Study||14||
48704053|NCT03468816|102060647|FG000|COMPLETED|Overall Study||2||
48704054|NCT03468816|102060648|FG001|COMPLETED|Overall Study||3||
48704055|NCT03468816|102060647|FG000|NOT COMPLETED|Overall Study||0||
48704056|NCT03468816|102060648|FG001|NOT COMPLETED|Overall Study||0||
48704057|NCT02974855|102060649|FG000|STARTED|Overall Study||7||
48704058|NCT02974855|102060650|FG001|STARTED|Overall Study||6||
48704059|NCT02974855|102060651|FG002|STARTED|Overall Study||6||
48704060|NCT02974855|102060652|FG003|STARTED|Overall Study||7||
48704061|NCT02974855|102060649|FG000|COMPLETED|Overall Study||7||
48704062|NCT02974855|102060650|FG001|COMPLETED|Overall Study||5||
48704063|NCT02974855|102060651|FG002|COMPLETED|Overall Study||6||
48704064|NCT02974855|102060652|FG003|COMPLETED|Overall Study||6||
48704065|NCT02974855|102060649|FG000|NOT COMPLETED|Overall Study||0||
48704066|NCT02974855|102060650|FG001|NOT COMPLETED|Overall Study||1||
48704067|NCT02974855|102060651|FG002|NOT COMPLETED|Overall Study||0||
48704068|NCT02974855|102060652|FG003|NOT COMPLETED|Overall Study||1||
48704069|NCT00405964|102060653|FG000|STARTED|Overall Study||360||
48704070|NCT00405964|102060654|FG001|STARTED|Overall Study||356||
48704071|NCT00405964|102060653|FG000|COMPLETED|Overall Study||301||
48704072|NCT00405964|102060654|FG001|COMPLETED|Overall Study||261||
48704073|NCT00405964|102060653|FG000|NOT COMPLETED|Overall Study||59||
48704074|NCT00405964|102060654|FG001|NOT COMPLETED|Overall Study||95||
48704075|NCT03727646|102060655|FG000|STARTED|Overall Study||5||
48704076|NCT03727646|102060656|FG001|STARTED|Overall Study||0||
48704077|NCT03727646|102060655|FG000|COMPLETED|Overall Study||4||
48704078|NCT03727646|102060656|FG001|COMPLETED|Overall Study||0||
48704079|NCT03727646|102060655|FG000|NOT COMPLETED|Overall Study||1||
48704080|NCT03727646|102060656|FG001|NOT COMPLETED|Overall Study||0||
48135394|NCT02415400|100655952|FG002|STARTED|Overall Study||1154|Started = Randomized|
48704081|NCT02124018|102060657|FG000|STARTED|Overall Study||371||
48704082|NCT02124018|102060658|FG001|STARTED|Overall Study||111||
48704083|NCT02124018|102060659|FG002|STARTED|Overall Study||41||
48135395|NCT02415400|100655953|FG003|STARTED|Overall Study||1154|Started = Randomized|
48135396|NCT02415400|100655950|FG000|COMPLETED|Overall Study||1087|Completed = Completing the period|
48704084|NCT02124018|102060657|FG000|COMPLETED|Overall Study||371||
48704085|NCT02124018|102060658|FG001|COMPLETED|Overall Study||111||
48141449|NCT01780922|100670424|FG001|COMPLETED|Washout (7 Days)||2||
48400340|NCT02951455|101309351|FG001|COMPLETED|Overall Study||24||
48704086|NCT02124018|102060659|FG002|COMPLETED|Overall Study||41||
48704087|NCT02124018|102060657|FG000|NOT COMPLETED|Overall Study||0||
48704088|NCT02124018|102060658|FG001|NOT COMPLETED|Overall Study||0||
48704089|NCT02124018|102060659|FG002|NOT COMPLETED|Overall Study||0||
48704090|NCT01534260|102060660|FG000|STARTED|Overall Study||17||
48704091|NCT01534260|102060661|FG001|STARTED|Overall Study||20||
48704092|NCT01534260|102060660|FG000|COMPLETED|Overall Study||1||
48287181|NCT00577356|101029657|FG000|NOT COMPLETED|Overall Study||0||
48287182|NCT01853774|101029658|FG000|STARTED|Overall Study||257||
48287183|NCT01853774|101029659|FG001|STARTED|Overall Study||162||
48287184|NCT01853774|101029658|FG000|COMPLETED|Overall Study||211||
48287185|NCT01853774|101029659|FG001|COMPLETED|Overall Study||134||
48287186|NCT01853774|101029658|FG000|NOT COMPLETED|Overall Study||46||
48287187|NCT01853774|101029659|FG001|NOT COMPLETED|Overall Study||28||
48287188|NCT01723254|101029660|FG000|STARTED|Overall Study||6||
48287189|NCT01723254|101029661|FG001|STARTED|Overall Study||21||
48287190|NCT01723254|101029662|FG002|STARTED|Overall Study||20||
48287191|NCT01723254|101029663|FG003|STARTED|Overall Study||20||
48287192|NCT01723254|101029664|FG004|STARTED|Overall Study||20||
48287193|NCT01723254|101029665|FG005|STARTED|Overall Study||20||
48287194|NCT01723254|101029666|FG006|STARTED|Overall Study||20||
48287195|NCT01723254|101029667|FG007|STARTED|Overall Study||63||
48287196|NCT01723254|101029660|FG000|COMPLETED|Overall Study||5||
48287197|NCT01723254|101029661|FG001|COMPLETED|Overall Study||18||
48287198|NCT01723254|101029662|FG002|COMPLETED|Overall Study||17||
48287199|NCT01723254|101029663|FG003|COMPLETED|Overall Study||18||
48287200|NCT01723254|101029664|FG004|COMPLETED|Overall Study||18||
48287201|NCT01723254|101029665|FG005|COMPLETED|Overall Study||18||
48287202|NCT01723254|101029666|FG006|COMPLETED|Overall Study||19||
48287203|NCT01723254|101029667|FG007|COMPLETED|Overall Study||60||
48287204|NCT01723254|101029660|FG000|NOT COMPLETED|Overall Study||1||
48287205|NCT01723254|101029661|FG001|NOT COMPLETED|Overall Study||3||
48287206|NCT01723254|101029662|FG002|NOT COMPLETED|Overall Study||3||
48287207|NCT01723254|101029663|FG003|NOT COMPLETED|Overall Study||2||
48287208|NCT01723254|101029664|FG004|NOT COMPLETED|Overall Study||2||
48287209|NCT01723254|101029665|FG005|NOT COMPLETED|Overall Study||2||
48287210|NCT01723254|101029666|FG006|NOT COMPLETED|Overall Study||1||
48287211|NCT01723254|101029667|FG007|NOT COMPLETED|Overall Study||3||
48287212|NCT01736865|101029668|FG000|STARTED|Overall Study||61||
48287213|NCT01736865|101029669|FG001|STARTED|Overall Study||66||
48287214|NCT01736865|101029668|FG000|COMPLETED|Overall Study||61||
48287215|NCT01736865|101029669|FG001|COMPLETED|Overall Study||66||
48287216|NCT01736865|101029668|FG000|NOT COMPLETED|Overall Study||0||
48287217|NCT01736865|101029669|FG001|NOT COMPLETED|Overall Study||0||
48287218|NCT00558259|101029670|FG000|STARTED|Overall Study||681||
48287219|NCT00558259|101029671|FG001|STARTED|Overall Study||662||
48287220|NCT00558259|101029670|FG000|COMPLETED|Overall Study||610||
48287221|NCT00558259|101029671|FG001|COMPLETED|Overall Study||563||
48287222|NCT00558259|101029670|FG000|NOT COMPLETED|Overall Study||71||
48287223|NCT00558259|101029671|FG001|NOT COMPLETED|Overall Study||99||
48287224|NCT01015560|101029672|FG000|STARTED|Overall Study||44||
48287225|NCT01015560|101029672|FG000|Eligible and Analyzable|Overall Study||43||
48287226|NCT01015560|101029672|FG000|COMPLETED|Overall Study||41||
48287227|NCT01015560|101029672|FG000|NOT COMPLETED|Overall Study||3||
48287228|NCT01078220|101029673|FG000|STARTED|Overall Study||189629||
48287229|NCT01078220|101029673|FG000|COMPLETED|Overall Study||189629||
48287230|NCT01078220|101029673|FG000|NOT COMPLETED|Overall Study||0||
48287231|NCT03283072|101029674|FG000|STARTED|Overall Study||7||
48287232|NCT03283072|101029675|FG001|STARTED|Overall Study||5||
48287233|NCT03283072|101029676|FG002|STARTED|Overall Study||5||
48287234|NCT03283072|101029677|FG003|STARTED|Overall Study||5||
48287235|NCT03283072|101029674|FG000|COMPLETED|Overall Study||5||
48287236|NCT03283072|101029675|FG001|COMPLETED|Overall Study||5||
48287237|NCT03283072|101029676|FG002|COMPLETED|Overall Study||5||
48287238|NCT03283072|101029677|FG003|COMPLETED|Overall Study||5||
48287239|NCT03283072|101029674|FG000|NOT COMPLETED|Overall Study||2||
48287240|NCT03283072|101029675|FG001|NOT COMPLETED|Overall Study||0||
48287241|NCT03283072|101029676|FG002|NOT COMPLETED|Overall Study||0||
48287242|NCT03283072|101029677|FG003|NOT COMPLETED|Overall Study||0||
48287243|NCT04370548|101029678|FG000|STARTED|Overall Study||204||
48287244|NCT04370548|101029679|FG001|STARTED|Overall Study||103||
48287245|NCT04370548|101029678|FG000|COMPLETED|Overall Study||190||
48287246|NCT04370548|101029679|FG001|COMPLETED|Overall Study||100||
48287247|NCT04370548|101029678|FG000|NOT COMPLETED|Overall Study||14||
48287248|NCT04370548|101029679|FG001|NOT COMPLETED|Overall Study||3||
48287249|NCT02245737|101029680|FG000|STARTED|Overall Study||740||
48287250|NCT02245737|101029681|FG001|STARTED|Overall Study||739||
48287251|NCT02245737|101029682|FG002|STARTED|Overall Study||739||
48287252|NCT02245737|101029680|FG000|Received at Least 1 Dose of Study Drug|Overall Study||738||
48287253|NCT02245737|101029681|FG001|Received at Least 1 Dose of Study Drug|Overall Study||736||
48287254|NCT02245737|101029682|FG002|Received at Least 1 Dose of Study Drug|Overall Study||735||
48287255|NCT02245737|101029680|FG000|COMPLETED|Overall Study||187||
48287256|NCT02245737|101029681|FG001|COMPLETED|Overall Study||184||
48287257|NCT02245737|101029682|FG002|COMPLETED|Overall Study||168||
48287258|NCT02245737|101029680|FG000|NOT COMPLETED|Overall Study||553||
48287259|NCT02245737|101029681|FG001|NOT COMPLETED|Overall Study||555||
48400341|NCT02951455|101309352|FG002|COMPLETED|Overall Study||27||
48287260|NCT02245737|101029682|FG002|NOT COMPLETED|Overall Study||571||
48287261|NCT00324675|101029683|FG000|STARTED|Overall Study||14||
48287262|NCT00324675|101029684|FG001|STARTED|Overall Study||14||
48287263|NCT00324675|101029683|FG000|COMPLETED|Overall Study||13||
48287264|NCT00324675|101029684|FG001|COMPLETED|Overall Study||14||
48704093|NCT01534260|102060661|FG001|COMPLETED|Overall Study||0||
48704094|NCT01534260|102060660|FG000|NOT COMPLETED|Overall Study||16||
48704095|NCT01534260|102060661|FG001|NOT COMPLETED|Overall Study||20||
48704096|NCT04606199|102060662|FG000|STARTED|Overall Study||53||
48704097|NCT04606199|102060662|FG000|COMPLETED|Overall Study||51||
48287265|NCT00324675|101029683|FG000|NOT COMPLETED|Overall Study||1||
48287266|NCT00324675|101029684|FG001|NOT COMPLETED|Overall Study||0||
48287267|NCT01226095|101029685|FG000|STARTED|Overall Study||519||
48287268|NCT01226095|101029685|FG000|COMPLETED|Overall Study||518||
48287269|NCT01226095|101029685|FG000|NOT COMPLETED|Overall Study||1||
48287270|NCT03110185|101029686|FG000|STARTED|Overall Study||27||
48580126|NCT02549287|101753159|FG001|NOT COMPLETED|Overall Study||32||0
48580127|NCT05523011|101753160|FG000|STARTED|Overall Study||10||
48287271|NCT03110185|101029687|FG001|STARTED|Overall Study||64||
48287272|NCT03110185|101029686|FG000|COMPLETED|Overall Study||17||
48287273|NCT03110185|101029687|FG001|COMPLETED|Overall Study||33||
48287274|NCT03110185|101029686|FG000|NOT COMPLETED|Overall Study||10||
48287275|NCT03110185|101029687|FG001|NOT COMPLETED|Overall Study||31||
48287276|NCT00211185|101029688|FG000|STARTED|Overall Study||49||
48580128|NCT05523011|101753160|FG000|COMPLETED|Overall Study||10||
48580129|NCT05523011|101753160|FG000|NOT COMPLETED|Overall Study||0||
48580130|NCT01252563|101753161|FG000|STARTED|Overall Study||13775||
48580131|NCT01252563|101753161|FG000|COMPLETED|Overall Study||13343||
48580132|NCT01252563|101753161|FG000|NOT COMPLETED|Overall Study||432||
48580133|NCT00090220|101753162|FG000|STARTED|Base Study Vaccination Period||1911||
48580134|NCT00090220|101753163|FG001|STARTED|Base Study Vaccination Period||1908||
48580135|NCT00090220|101753164|FG002|STARTED|Base Study Vaccination Period||0||
48580136|NCT00090220|101753165|FG003|STARTED|Base Study Vaccination Period||0||
48580137|NCT00090220|101753166|FG004|STARTED|Base Study Vaccination Period||0||
48580138|NCT00090220|101753167|FG005|STARTED|Base Study Vaccination Period||0||
48580139|NCT00090220|101753162|FG000|Vaccinated|Base Study Vaccination Period||1910||
48580140|NCT00090220|101753163|FG001|Vaccinated|Base Study Vaccination Period||1907||
48580141|NCT00090220|101753164|FG002|Vaccinated|Base Study Vaccination Period||0||
48580142|NCT00090220|101753165|FG003|Vaccinated|Base Study Vaccination Period||0||
48580143|NCT00090220|101753166|FG004|Vaccinated|Base Study Vaccination Period||0||
48580144|NCT00090220|101753167|FG005|Vaccinated|Base Study Vaccination Period||0||
48580145|NCT00090220|101753162|FG000|COMPLETED|Base Study Vaccination Period||1847||
48580146|NCT00090220|101753163|FG001|COMPLETED|Base Study Vaccination Period||1845||
48580147|NCT00090220|101753164|FG002|COMPLETED|Base Study Vaccination Period||0||
48580148|NCT00090220|101753165|FG003|COMPLETED|Base Study Vaccination Period||0||
48580149|NCT00090220|101753166|FG004|COMPLETED|Base Study Vaccination Period||0||
48287277|NCT00211185|101029688|FG000|COMPLETED|Overall Study||29||
48287278|NCT00211185|101029688|FG000|NOT COMPLETED|Overall Study||20||
48287279|NCT03699085|101029689|FG000|STARTED|Overall Study||20||
48287280|NCT03699085|101029690|FG001|STARTED|Overall Study||20||
48287281|NCT03699085|101029689|FG000|COMPLETED|Overall Study||20||
48580150|NCT00090220|101753167|FG005|COMPLETED|Base Study Vaccination Period||0||
48580151|NCT00090220|101753162|FG000|NOT COMPLETED|Base Study Vaccination Period||64||
48580152|NCT00090220|101753163|FG001|NOT COMPLETED|Base Study Vaccination Period||63||
48580153|NCT00090220|101753164|FG002|NOT COMPLETED|Base Study Vaccination Period||0||
48580154|NCT00090220|101753165|FG003|NOT COMPLETED|Base Study Vaccination Period||0||
48580155|NCT00090220|101753166|FG004|NOT COMPLETED|Base Study Vaccination Period||0||
48580156|NCT00090220|101753167|FG005|NOT COMPLETED|Base Study Vaccination Period||0||
48704098|NCT04606199|102060662|FG000|NOT COMPLETED|Overall Study||2||
48704099|NCT03576066|102060663|FG000|STARTED|Overall Study||45||
48704100|NCT03576066|102060664|FG001|STARTED|Overall Study||28||
48704101|NCT03576066|102060663|FG000|COMPLETED|Overall Study||45||
48704102|NCT03576066|102060664|FG001|COMPLETED|Overall Study||27||
48704103|NCT03576066|102060663|FG000|NOT COMPLETED|Overall Study||0||
48704104|NCT03576066|102060664|FG001|NOT COMPLETED|Overall Study||1||
48704105|NCT00515294|102060665|FG000|STARTED|Overall Study||38||
48704106|NCT00515294|102060666|FG001|STARTED|Overall Study||39||
48704107|NCT00515294|102060667|FG002|STARTED|Overall Study||38||
48704108|NCT00515294|102060668|FG003|STARTED|Overall Study||39||
48704109|NCT00515294|102060665|FG000|COMPLETED|Overall Study||29||
48287282|NCT03699085|101029690|FG001|COMPLETED|Overall Study||20||
48287283|NCT03699085|101029689|FG000|NOT COMPLETED|Overall Study||0||
48580157|NCT00090220|101753162|FG000|STARTED|Base Study Follow-up Period||1855||
48287284|NCT03699085|101029690|FG001|NOT COMPLETED|Overall Study||0||
48287285|NCT02366468|101029691|FG000|STARTED|Overall Study||68|Randomized Safety Set|
48287286|NCT02366468|101029692|FG001|STARTED|Overall Study||67|Randomized Safety Set|
48287287|NCT02366468|101029691|FG000|Full Analysis Set (FAS)|Overall Study||67|Randomized patients who received study treatment and had post-baseline primary endpoint assessments|
48294171|NCT02527343|101047539|FG003|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0||
48580158|NCT00090220|101753163|FG001|STARTED|Base Study Follow-up Period||1851||
48704110|NCT00515294|102060666|FG001|COMPLETED|Overall Study||36||
48704111|NCT00515294|102060667|FG002|COMPLETED|Overall Study||27||
48704112|NCT00515294|102060668|FG003|COMPLETED|Overall Study||35||
48704113|NCT00515294|102060665|FG000|NOT COMPLETED|Overall Study||9||
48704114|NCT00515294|102060666|FG001|NOT COMPLETED|Overall Study||3||
48704115|NCT00515294|102060667|FG002|NOT COMPLETED|Overall Study||11||
48580159|NCT00090220|101753164|FG002|STARTED|Base Study Follow-up Period||0||
48580160|NCT00090220|101753165|FG003|STARTED|Base Study Follow-up Period||0||
48580161|NCT00090220|101753166|FG004|STARTED|Base Study Follow-up Period||0||
48580162|NCT00090220|101753167|FG005|STARTED|Base Study Follow-up Period||0||
48580163|NCT00090220|101753162|FG000|COMPLETED|Base Study Follow-up Period||1695||
48580164|NCT00090220|101753163|FG001|COMPLETED|Base Study Follow-up Period||1687||
48580165|NCT00090220|101753164|FG002|COMPLETED|Base Study Follow-up Period||0||
48580166|NCT00090220|101753165|FG003|COMPLETED|Base Study Follow-up Period||0||
48135397|NCT02415400|100655951|FG001|COMPLETED|Overall Study||1091|Completed = Completing the period|
48135398|NCT02415400|100655952|FG002|COMPLETED|Overall Study||1069|Completed = Completing the period|
48580167|NCT00090220|101753166|FG004|COMPLETED|Base Study Follow-up Period||0||
48580168|NCT00090220|101753167|FG005|COMPLETED|Base Study Follow-up Period||0||
48580169|NCT00090220|101753162|FG000|NOT COMPLETED|Base Study Follow-up Period||160||
48580170|NCT00090220|101753163|FG001|NOT COMPLETED|Base Study Follow-up Period||164||
48135399|NCT02415400|100655953|FG003|COMPLETED|Overall Study||1071|Completed = Completing the period|
48580171|NCT00090220|101753164|FG002|NOT COMPLETED|Base Study Follow-up Period||0||
48580172|NCT00090220|101753165|FG003|NOT COMPLETED|Base Study Follow-up Period||0||
48580173|NCT00090220|101753166|FG004|NOT COMPLETED|Base Study Follow-up Period||0||
48580174|NCT00090220|101753167|FG005|NOT COMPLETED|Base Study Follow-up Period||0||
48580175|NCT00090220|101753162|FG000|STARTED|Extension 1 (EXT1)||0||
48580176|NCT00090220|101753163|FG001|STARTED|Extension 1 (EXT1)||0||
48135400|NCT02415400|100655950|FG000|NOT COMPLETED|Overall Study||66||
48135401|NCT02415400|100655951|FG001|NOT COMPLETED|Overall Study||62||
48135402|NCT02415400|100655952|FG002|NOT COMPLETED|Overall Study||85||
48135403|NCT02415400|100655953|FG003|NOT COMPLETED|Overall Study||83||
48135404|NCT01458574|100655954|FG000|STARTED|Overall Study||198||
48135405|NCT01458574|100655955|FG001|STARTED|Overall Study||197||
48135406|NCT01458574|100655956|FG002|STARTED|Overall Study||198||
48135407|NCT01458574|100655954|FG000|Treated|Overall Study||198||
48135408|NCT01458574|100655955|FG001|Treated|Overall Study||196||
48580177|NCT00090220|101753164|FG002|STARTED|Extension 1 (EXT1)||1322||
48580178|NCT00090220|101753165|FG003|STARTED|Extension 1 (EXT1)||7||
48580179|NCT00090220|101753166|FG004|STARTED|Extension 1 (EXT1)||0||
48580180|NCT00090220|101753167|FG005|STARTED|Extension 1 (EXT1)||0||
48580181|NCT00090220|101753162|FG000|Vaccinated|Extension 1 (EXT1)||0||
48580182|NCT00090220|101753163|FG001|Vaccinated|Extension 1 (EXT1)||0||
48580183|NCT00090220|101753164|FG002|Vaccinated|Extension 1 (EXT1)||1321||
48580184|NCT00090220|101753165|FG003|Vaccinated|Extension 1 (EXT1)||7||
48580185|NCT00090220|101753166|FG004|Vaccinated|Extension 1 (EXT1)||0||
48580186|NCT00090220|101753167|FG005|Vaccinated|Extension 1 (EXT1)||0||
48580187|NCT00090220|101753162|FG000|COMPLETED|Extension 1 (EXT1)||0||
48580188|NCT00090220|101753163|FG001|COMPLETED|Extension 1 (EXT1)||0||
48580189|NCT00090220|101753164|FG002|COMPLETED|Extension 1 (EXT1)||1267||
48580190|NCT00090220|101753165|FG003|COMPLETED|Extension 1 (EXT1)||5||
48580191|NCT00090220|101753166|FG004|COMPLETED|Extension 1 (EXT1)||0||
48580192|NCT00090220|101753167|FG005|COMPLETED|Extension 1 (EXT1)||0||
48580193|NCT00090220|101753162|FG000|NOT COMPLETED|Extension 1 (EXT1)||0||
48580194|NCT00090220|101753163|FG001|NOT COMPLETED|Extension 1 (EXT1)||0||
48580195|NCT00090220|101753164|FG002|NOT COMPLETED|Extension 1 (EXT1)||55||
48580196|NCT00090220|101753165|FG003|NOT COMPLETED|Extension 1 (EXT1)||2||
48580197|NCT00090220|101753166|FG004|NOT COMPLETED|Extension 1 (EXT1)||0||
48580198|NCT00090220|101753167|FG005|NOT COMPLETED|Extension 1 (EXT1)||0||
48135409|NCT01458574|100655956|FG002|Treated|Overall Study||198||
48135410|NCT01458574|100655954|FG000|COMPLETED|Overall Study||111||
48135411|NCT01458574|100655955|FG001|COMPLETED|Overall Study||126||
48135412|NCT01458574|100655956|FG002|COMPLETED|Overall Study||53||
48135413|NCT01458574|100655954|FG000|NOT COMPLETED|Overall Study||87||
48135414|NCT01458574|100655955|FG001|NOT COMPLETED|Overall Study||71||
48135415|NCT01458574|100655956|FG002|NOT COMPLETED|Overall Study||145||
48135416|NCT01757964|100655957|FG000|STARTED|Overall Study||9||
48135417|NCT01757964|100655958|FG001|STARTED|Overall Study||4||
48135418|NCT01757964|100655957|FG000|COMPLETED|Overall Study||9||
48135419|NCT01757964|100655958|FG001|COMPLETED|Overall Study||4||
48135420|NCT01757964|100655957|FG000|NOT COMPLETED|Overall Study||0||
48135421|NCT01757964|100655958|FG001|NOT COMPLETED|Overall Study||0||
48135422|NCT03305016|100655959|FG000|STARTED|Overall Study||146||
48135423|NCT03305016|100655959|FG000|COMPLETED|Overall Study||144||
48580199|NCT00090220|101753162|FG000|STARTED|Long-term Follow-up (EXT2)||0||
48580200|NCT00090220|101753163|FG001|STARTED|Long-term Follow-up (EXT2)||0||
48580201|NCT00090220|101753164|FG002|STARTED|Long-term Follow-up (EXT2)||0||
48580202|NCT00090220|101753165|FG003|STARTED|Long-term Follow-up (EXT2)||0||
48580203|NCT00090220|101753166|FG004|STARTED|Long-term Follow-up (EXT2)||685||
48580204|NCT00090220|101753167|FG005|STARTED|Long-term Follow-up (EXT2)||651||
48580205|NCT00090220|101753162|FG000|COMPLETED|Long-term Follow-up (EXT2)||0||
48580206|NCT00090220|101753163|FG001|COMPLETED|Long-term Follow-up (EXT2)||0||
48580207|NCT00090220|101753164|FG002|COMPLETED|Long-term Follow-up (EXT2)||0||
48135424|NCT03305016|100655959|FG000|NOT COMPLETED|Overall Study||2||
48135425|NCT03912259|100655960|FG000|STARTED|Overall Study||83||
48135426|NCT03912259|100655961|FG001|STARTED|Overall Study||82||
48580208|NCT00090220|101753165|FG003|COMPLETED|Long-term Follow-up (EXT2)||0||
48135427|NCT03912259|100655960|FG000|COMPLETED|Overall Study||66||
48135428|NCT03912259|100655961|FG001|COMPLETED|Overall Study||76||
48135429|NCT03912259|100655960|FG000|NOT COMPLETED|Overall Study||17||
48580209|NCT00090220|101753166|FG004|COMPLETED|Long-term Follow-up (EXT2)||641||
48580210|NCT00090220|101753167|FG005|COMPLETED|Long-term Follow-up (EXT2)||623||
48580211|NCT00090220|101753162|FG000|NOT COMPLETED|Long-term Follow-up (EXT2)||0||
48580212|NCT00090220|101753163|FG001|NOT COMPLETED|Long-term Follow-up (EXT2)||0||
48580213|NCT00090220|101753164|FG002|NOT COMPLETED|Long-term Follow-up (EXT2)||0||
48580214|NCT00090220|101753165|FG003|NOT COMPLETED|Long-term Follow-up (EXT2)||0||
48135430|NCT03912259|100655961|FG001|NOT COMPLETED|Overall Study||6||
48135431|NCT03725982|100655962|FG000|STARTED|First Intervention||20||
48135432|NCT03725982|100655963|FG001|STARTED|First Intervention||19||
48135433|NCT03725982|100655962|FG000|COMPLETED|First Intervention||19||
48135434|NCT03725982|100655963|FG001|COMPLETED|First Intervention||17||
48135435|NCT03725982|100655962|FG000|NOT COMPLETED|First Intervention||1||
48135436|NCT03725982|100655963|FG001|NOT COMPLETED|First Intervention||2||
48135437|NCT03725982|100655962|FG000|STARTED|Second Intervention||19||
48135438|NCT03725982|100655963|FG001|STARTED|Second Intervention||17||
48135439|NCT03725982|100655962|FG000|COMPLETED|Second Intervention||19||
48135440|NCT03725982|100655963|FG001|COMPLETED|Second Intervention||17||
48135441|NCT03725982|100655962|FG000|NOT COMPLETED|Second Intervention||0||
48135442|NCT03725982|100655963|FG001|NOT COMPLETED|Second Intervention||0||
48580215|NCT00090220|101753166|FG004|NOT COMPLETED|Long-term Follow-up (EXT2)||44||
48580216|NCT00090220|101753167|FG005|NOT COMPLETED|Long-term Follow-up (EXT2)||28||
48580217|NCT00384748|101753168|FG000|STARTED|Overall Study||25||
48580218|NCT00384748|101753169|FG001|STARTED|Overall Study||23||
48580219|NCT00384748|101753168|FG000|COMPLETED|Overall Study||25||
48580220|NCT00384748|101753169|FG001|COMPLETED|Overall Study||23||
48580221|NCT00384748|101753168|FG000|NOT COMPLETED|Overall Study||0||
48580222|NCT00384748|101753169|FG001|NOT COMPLETED|Overall Study||0||
48580223|NCT01940900|101753170|FG000|STARTED|Overall Study||311||
48704116|NCT00515294|102060668|FG003|NOT COMPLETED|Overall Study||4||
48704117|NCT05032690|102060669|FG000|STARTED|Period 1||8||
48704118|NCT05032690|102060670|FG001|STARTED|Period 1||10||
48704119|NCT05032690|102060671|FG002|STARTED|Period 1||7||
48704120|NCT05032690|102060672|FG003|STARTED|Period 1||7||
48704121|NCT05032690|102060669|FG000|COMPLETED|Period 1||7||
48704122|NCT05032690|102060670|FG001|COMPLETED|Period 1||8||
48704123|NCT05032690|102060671|FG002|COMPLETED|Period 1||7||
48704124|NCT05032690|102060672|FG003|COMPLETED|Period 1||7||
48704125|NCT05032690|102060669|FG000|NOT COMPLETED|Period 1||1||
48135443|NCT01159691|100655964|FG000|STARTED|Overall Study||76||
48135444|NCT01159691|100655964|FG000|COMPLETED|Overall Study||54||
48135445|NCT01159691|100655964|FG000|NOT COMPLETED|Overall Study||22||
48135446|NCT01369342|100655965|FG000|STARTED|Overall Study||214||
48135447|NCT01369342|100655966|FG001|STARTED|Overall Study||213||
48135448|NCT01369342|100655967|FG002|STARTED|Overall Study||213||
48135449|NCT01369342|100655965|FG000|COMPLETED|Overall Study||201||
48135450|NCT01369342|100655966|FG001|COMPLETED|Overall Study||204||
48135451|NCT01369342|100655967|FG002|COMPLETED|Overall Study||210||
48135452|NCT01369342|100655965|FG000|NOT COMPLETED|Overall Study||13||
48135453|NCT01369342|100655966|FG001|NOT COMPLETED|Overall Study||9||
48135454|NCT01369342|100655967|FG002|NOT COMPLETED|Overall Study||3||
48135455|NCT00365859|100655968|FG000|STARTED|Overall Study||86||
48135456|NCT00365859|100655969|FG001|STARTED|Overall Study||70||
48135457|NCT00365859|100655970|FG002|STARTED|Overall Study||174||
48135458|NCT00365859|100655971|FG003|STARTED|Overall Study||330||
48135459|NCT00365859|100655968|FG000|Safety Population|Overall Study||86||
48135460|NCT00365859|100655969|FG001|Safety Population|Overall Study||70||
48135461|NCT00365859|100655970|FG002|Safety Population|Overall Study||174||
48135462|NCT00365859|100655971|FG003|Safety Population|Overall Study||330||
48135463|NCT00365859|100655968|FG000|Efficacy Population|Overall Study||84||
48135464|NCT00365859|100655969|FG001|Efficacy Population|Overall Study||69||
48135465|NCT00365859|100655970|FG002|Efficacy Population|Overall Study||169||
48135466|NCT00365859|100655971|FG003|Efficacy Population|Overall Study||322||
48135467|NCT00365859|100655968|FG000|COMPLETED|Overall Study||55||
48135468|NCT00365859|100655969|FG001|COMPLETED|Overall Study||37||
48135469|NCT00365859|100655970|FG002|COMPLETED|Overall Study||107||
48135470|NCT00365859|100655971|FG003|COMPLETED|Overall Study||199||
48135471|NCT00365859|100655968|FG000|NOT COMPLETED|Overall Study||31||
48580224|NCT01940900|101753171|FG001|STARTED|Overall Study||315||
48704126|NCT05032690|102060670|FG001|NOT COMPLETED|Period 1||2||
48704127|NCT05032690|102060671|FG002|NOT COMPLETED|Period 1||0||
48704128|NCT05032690|102060672|FG003|NOT COMPLETED|Period 1||0||
48704129|NCT05032690|102060669|FG000|STARTED|Period 2||7||
48704130|NCT05032690|102060670|FG001|STARTED|Period 2||8||
48704131|NCT05032690|102060671|FG002|STARTED|Period 2||7||
48704132|NCT05032690|102060672|FG003|STARTED|Period 2||7||
48704133|NCT05032690|102060669|FG000|COMPLETED|Period 2||6||
48704134|NCT05032690|102060670|FG001|COMPLETED|Period 2||6||
48704135|NCT05032690|102060671|FG002|COMPLETED|Period 2||7||
48704136|NCT05032690|102060672|FG003|COMPLETED|Period 2||7||
48580225|NCT01940900|101753170|FG000|COMPLETED|Overall Study||282||
48580226|NCT01940900|101753171|FG001|COMPLETED|Overall Study||284||
48580227|NCT01940900|101753170|FG000|NOT COMPLETED|Overall Study||29||
48135472|NCT00365859|100655969|FG001|NOT COMPLETED|Overall Study||33||
48135473|NCT00365859|100655970|FG002|NOT COMPLETED|Overall Study||67||
48135474|NCT00365859|100655971|FG003|NOT COMPLETED|Overall Study||131||
48135475|NCT01410448|100655972|FG000|STARTED|Overall Study||193||
48135476|NCT01410448|100655973|FG001|STARTED|Overall Study||190||
48135477|NCT01410448|100655972|FG000|Intent-to Treat (ITT) Analysis Set|Overall Study||193||
48135478|NCT01410448|100655973|FG001|Intent-to Treat (ITT) Analysis Set|Overall Study||190||
48135479|NCT01410448|100655972|FG000|Modified ITT Analysis Set|Overall Study||161||
48135480|NCT01410448|100655973|FG001|Modified ITT Analysis Set|Overall Study||149||
48135481|NCT01410448|100655972|FG000|COMPLETED|Overall Study||181||
48135482|NCT01410448|100655973|FG001|COMPLETED|Overall Study||155||
48135483|NCT01410448|100655972|FG000|NOT COMPLETED|Overall Study||12||
48580228|NCT01940900|101753171|FG001|NOT COMPLETED|Overall Study||31||
48580229|NCT02423343|101753172|FG000|STARTED|Overall Study||3||
48580230|NCT02423343|101753173|FG001|STARTED|Overall Study||5||
48580231|NCT02423343|101753174|FG002|STARTED|Overall Study||3||
48580232|NCT02423343|101753175|FG003|STARTED|Overall Study||4||
48580233|NCT02423343|101753176|FG004|STARTED|Overall Study||25||
48580234|NCT02423343|101753177|FG005|STARTED|Overall Study||1||
48580235|NCT02423343|101753172|FG000|Received at Least One Dose of Study Drug|Overall Study||3||
48580236|NCT02423343|101753173|FG001|Received at Least One Dose of Study Drug|Overall Study||5||
48135484|NCT01410448|100655973|FG001|NOT COMPLETED|Overall Study||35||
48135485|NCT03538626|100655974|FG000|STARTED|Overall Study||3||
48135486|NCT03538626|100655975|FG001|STARTED|Overall Study||4||
48135487|NCT03538626|100655976|FG002|STARTED|Overall Study||3||
48135488|NCT03538626|100655977|FG003|STARTED|Overall Study||3||
48135489|NCT03538626|100655978|FG004|STARTED|Overall Study||5||
48135490|NCT03538626|100655979|FG005|STARTED|Overall Study||5||
48135491|NCT03538626|100655980|FG006|STARTED|Overall Study||5||
48135492|NCT03538626|100655981|FG007|STARTED|Overall Study||5||
48135493|NCT03538626|100655974|FG000|Received First Product Administration|Overall Study||3||
48135494|NCT03538626|100655975|FG001|Received First Product Administration|Overall Study||3||
48135495|NCT03538626|100655976|FG002|Received First Product Administration|Overall Study||3||
48135496|NCT03538626|100655977|FG003|Received First Product Administration|Overall Study||3||
48135497|NCT03538626|100655978|FG004|Received First Product Administration|Overall Study||5||
48580237|NCT02423343|101753174|FG002|Received at Least One Dose of Study Drug|Overall Study||3||
48704137|NCT05032690|102060669|FG000|NOT COMPLETED|Period 2||1||
48704138|NCT05032690|102060670|FG001|NOT COMPLETED|Period 2||2||
48704139|NCT05032690|102060671|FG002|NOT COMPLETED|Period 2||0||
48704140|NCT05032690|102060672|FG003|NOT COMPLETED|Period 2||0||
48704141|NCT05032690|102060669|FG000|STARTED|Period 3||6||
48704142|NCT05032690|102060670|FG001|STARTED|Period 3||6||
48704143|NCT05032690|102060671|FG002|STARTED|Period 3||0||
48704144|NCT05032690|102060672|FG003|STARTED|Period 3||0||
48704145|NCT05032690|102060669|FG000|COMPLETED|Period 3||6||
48704146|NCT05032690|102060670|FG001|COMPLETED|Period 3||5||
48704147|NCT05032690|102060671|FG002|COMPLETED|Period 3||0||
48704148|NCT05032690|102060672|FG003|COMPLETED|Period 3||0||
48135498|NCT03538626|100655979|FG005|Received First Product Administration|Overall Study||5||
48135499|NCT03538626|100655980|FG006|Received First Product Administration|Overall Study||5||
48135500|NCT03538626|100655981|FG007|Received First Product Administration|Overall Study||5||
48135501|NCT03538626|100655974|FG000|Received All Product Administrations|Overall Study||3||
48135502|NCT03538626|100655975|FG001|Received All Product Administrations|Overall Study||3||
48135503|NCT03538626|100655976|FG002|Received All Product Administrations|Overall Study||3||
48135504|NCT03538626|100655977|FG003|Received All Product Administrations|Overall Study||3||
48135505|NCT03538626|100655978|FG004|Received All Product Administrations|Overall Study||5||
48135506|NCT03538626|100655979|FG005|Received All Product Administrations|Overall Study||5||
48135507|NCT03538626|100655980|FG006|Received All Product Administrations|Overall Study||5||
48135508|NCT03538626|100655981|FG007|Received All Product Administrations|Overall Study||5||
48135509|NCT03538626|100655974|FG000|COMPLETED|Overall Study||3||
48135510|NCT03538626|100655975|FG001|COMPLETED|Overall Study||3||
48135511|NCT03538626|100655976|FG002|COMPLETED|Overall Study||3||
48135512|NCT03538626|100655977|FG003|COMPLETED|Overall Study||3||
48704149|NCT05032690|102060669|FG000|NOT COMPLETED|Period 3||0||
48704150|NCT05032690|102060670|FG001|NOT COMPLETED|Period 3||1||
48704151|NCT05032690|102060671|FG002|NOT COMPLETED|Period 3||0||
48135513|NCT03538626|100655978|FG004|COMPLETED|Overall Study||5||
48135514|NCT03538626|100655979|FG005|COMPLETED|Overall Study||5||
48135515|NCT03538626|100655980|FG006|COMPLETED|Overall Study||4||
48135516|NCT03538626|100655981|FG007|COMPLETED|Overall Study||5||
48704152|NCT05032690|102060672|FG003|NOT COMPLETED|Period 3||0||
48704153|NCT00837265|102060673|FG000|STARTED|Pilot Phase||11||
48580238|NCT02423343|101753175|FG003|Received at Least One Dose of Study Drug|Overall Study||4||
48592820|NCT00767039|101783187|FG000|STARTED|Overall Study||27||
48135517|NCT03538626|100655974|FG000|NOT COMPLETED|Overall Study||0||
48135518|NCT03538626|100655975|FG001|NOT COMPLETED|Overall Study||1||
48135519|NCT03538626|100655976|FG002|NOT COMPLETED|Overall Study||0||
48135520|NCT03538626|100655977|FG003|NOT COMPLETED|Overall Study||0||
48135521|NCT03538626|100655978|FG004|NOT COMPLETED|Overall Study||0||
48135522|NCT03538626|100655979|FG005|NOT COMPLETED|Overall Study||0||
48135523|NCT03538626|100655980|FG006|NOT COMPLETED|Overall Study||1||
48135524|NCT03538626|100655981|FG007|NOT COMPLETED|Overall Study||0||
48135525|NCT03165526|100655982|FG000|STARTED|Overall Study||99||
48135526|NCT03165526|100655983|FG001|STARTED|Overall Study||32||
48135527|NCT03165526|100655982|FG000|COMPLETED|Overall Study||99||
48135528|NCT03165526|100655983|FG001|COMPLETED|Overall Study||32||
48135529|NCT03165526|100655982|FG000|NOT COMPLETED|Overall Study||0||
48135530|NCT03165526|100655983|FG001|NOT COMPLETED|Overall Study||0||
48135531|NCT00784043|100655984|FG000|STARTED|Overall Study||31||
48135532|NCT00784043|100655985|FG001|STARTED|Overall Study||6||
48135533|NCT00784043|100655984|FG000|COMPLETED|Overall Study||0||
48135534|NCT00784043|100655985|FG001|COMPLETED|Overall Study||0||
48135535|NCT00784043|100655984|FG000|NOT COMPLETED|Overall Study||31||
48135536|NCT00784043|100655985|FG001|NOT COMPLETED|Overall Study||6||
48135537|NCT00936390|100655986|FG000|STARTED|Overall Study||771||
48580239|NCT02423343|101753176|FG004|Received at Least One Dose of Study Drug|Overall Study||25||
48580240|NCT02423343|101753177|FG005|Received at Least One Dose of Study Drug|Overall Study||1||
48580241|NCT02423343|101753172|FG000|COMPLETED|Overall Study||3||
48580242|NCT02423343|101753173|FG001|COMPLETED|Overall Study||4||
48580243|NCT02423343|101753174|FG002|COMPLETED|Overall Study||3||
48580244|NCT02423343|101753175|FG003|COMPLETED|Overall Study||4||
48580245|NCT02423343|101753176|FG004|COMPLETED|Overall Study||20||
48580246|NCT02423343|101753177|FG005|COMPLETED|Overall Study||1||
48580247|NCT02423343|101753172|FG000|NOT COMPLETED|Overall Study||0||
48580248|NCT02423343|101753173|FG001|NOT COMPLETED|Overall Study||1||
48580249|NCT02423343|101753174|FG002|NOT COMPLETED|Overall Study||0||
48580250|NCT02423343|101753175|FG003|NOT COMPLETED|Overall Study||0||
48580251|NCT02423343|101753176|FG004|NOT COMPLETED|Overall Study||5||
48580252|NCT02423343|101753177|FG005|NOT COMPLETED|Overall Study||0||
48580253|NCT02782065|101753178|FG000|STARTED|Overall Study||58||
48580254|NCT02782065|101753178|FG000|COMPLETED|Overall Study||58||
48580255|NCT02782065|101753178|FG000|NOT COMPLETED|Overall Study||0||
48580256|NCT03761030|101753179|FG000|STARTED|Overall Study||15||
48580257|NCT03761030|101753180|FG001|STARTED|Overall Study||16||
48580258|NCT03761030|101753179|FG000|COMPLETED|Overall Study||13||
48580259|NCT03761030|101753180|FG001|COMPLETED|Overall Study||12||
48580260|NCT03761030|101753179|FG000|NOT COMPLETED|Overall Study||2||
48135538|NCT00936390|100655987|FG001|STARTED|Overall Study||767||
48135539|NCT00936390|100655986|FG000|Eligible|Overall Study||750||
48135540|NCT00936390|100655987|FG001|Eligible|Overall Study||742||
48135541|NCT00936390|100655986|FG000|Eligible, Started Protocol Treatment, Has Adverse Event Data|Overall Study||733||
48135542|NCT00936390|100655987|FG001|Eligible, Started Protocol Treatment, Has Adverse Event Data|Overall Study||725||
48135543|NCT00936390|100655986|FG000|Eligible With Radiation Treatment Data|Overall Study||725||
48135544|NCT00936390|100655987|FG001|Eligible With Radiation Treatment Data|Overall Study||707||
48135545|NCT00936390|100655986|FG000|Eligible and Consented to Quality of Life Component|Overall Study||215||
48135546|NCT00936390|100655987|FG001|Eligible and Consented to Quality of Life Component|Overall Study||205||
48135547|NCT00936390|100655986|FG000|COMPLETED|Overall Study||750||
48135548|NCT00936390|100655987|FG001|COMPLETED|Overall Study||742||
48135549|NCT00936390|100655986|FG000|NOT COMPLETED|Overall Study||21||
48135550|NCT00936390|100655987|FG001|NOT COMPLETED|Overall Study||25||
48580261|NCT03761030|101753180|FG001|NOT COMPLETED|Overall Study||4||
48580262|NCT02255305|101753181|FG000|STARTED|Overall Study||2||
48580263|NCT02255305|101753182|FG001|STARTED|Overall Study||4||
48580264|NCT02255305|101753181|FG000|COMPLETED|Overall Study||1||
48580265|NCT02255305|101753182|FG001|COMPLETED|Overall Study||0||
48580266|NCT02255305|101753181|FG000|NOT COMPLETED|Overall Study||1||
48580267|NCT02255305|101753182|FG001|NOT COMPLETED|Overall Study||4||
48580268|NCT01482065|101753183|FG000|STARTED|Overall Study||4||
48580269|NCT01482065|101753184|FG001|STARTED|Overall Study||5||
48580270|NCT01482065|101753183|FG000|COMPLETED|Overall Study||4||
48580271|NCT01482065|101753184|FG001|COMPLETED|Overall Study||4||
48135551|NCT04667117|100655988|FG000|STARTED|Investigational Period||22||
48135552|NCT04667117|100655989|FG001|STARTED|Investigational Period||22||
48135553|NCT04667117|100655990|FG002|STARTED|Investigational Period||19||
48135554|NCT04667117|100655988|FG000|COMPLETED|Investigational Period||22||
48135555|NCT04667117|100655989|FG001|COMPLETED|Investigational Period||21||
48135556|NCT04667117|100655990|FG002|COMPLETED|Investigational Period||18||
48135557|NCT04667117|100655988|FG000|NOT COMPLETED|Investigational Period||0||
48135558|NCT04667117|100655989|FG001|NOT COMPLETED|Investigational Period||1||
48135559|NCT04667117|100655990|FG002|NOT COMPLETED|Investigational Period||1||
48135560|NCT04667117|100655988|FG000|STARTED|Extension Period||22||
48135561|NCT04667117|100655989|FG001|STARTED|Extension Period||11||
48135562|NCT04667117|100655990|FG002|STARTED|Extension Period||0||
48135563|NCT04667117|100655988|FG000|COMPLETED|Extension Period||21||
48135564|NCT04667117|100655989|FG001|COMPLETED|Extension Period||11||
48135565|NCT04667117|100655990|FG002|COMPLETED|Extension Period||0||
48135566|NCT04667117|100655988|FG000|NOT COMPLETED|Extension Period||1||
48135567|NCT04667117|100655989|FG001|NOT COMPLETED|Extension Period||0||
48135568|NCT04667117|100655990|FG002|NOT COMPLETED|Extension Period||0||
48135569|NCT01289912|100655991|FG000|STARTED|Overall Study||32||
48135570|NCT01289912|100655992|FG001|STARTED|Overall Study||15||
48135571|NCT01289912|100655991|FG000|COMPLETED|Overall Study||29||
48135572|NCT01289912|100655992|FG001|COMPLETED|Overall Study||13||
48135573|NCT01289912|100655991|FG000|NOT COMPLETED|Overall Study||3||
48135574|NCT01289912|100655992|FG001|NOT COMPLETED|Overall Study||2||
48135575|NCT01636882|100655993|FG000|STARTED|Overall Study||16||
48135576|NCT01636882|100655993|FG000|COMPLETED|Overall Study||16||
48135577|NCT01636882|100655993|FG000|NOT COMPLETED|Overall Study||0||
48135578|NCT00380068|100655994|FG000|STARTED|Overall Study||224||
48135579|NCT00380068|100655994|FG000|COMPLETED|Overall Study||155||
48135580|NCT00380068|100655994|FG000|NOT COMPLETED|Overall Study||69||
48135581|NCT00823082|100655995|FG000|STARTED|Overall Study||100||
48135582|NCT00823082|100655996|FG001|STARTED|Overall Study||100||
48135583|NCT00823082|100655995|FG000|Safety Population|Overall Study||100||
48135584|NCT00823082|100655996|FG001|Safety Population|Overall Study||99||
48135585|NCT00823082|100655995|FG000|Intent-to-Treat/Per Protocol Populations|Overall Study||100||
48135586|NCT00823082|100655996|FG001|Intent-to-Treat/Per Protocol Populations|Overall Study||94||
48135587|NCT00823082|100655995|FG000|COMPLETED|Overall Study||100||
48135588|NCT00823082|100655996|FG001|COMPLETED|Overall Study||99||
48135589|NCT00823082|100655995|FG000|NOT COMPLETED|Overall Study||0||
48135590|NCT00823082|100655996|FG001|NOT COMPLETED|Overall Study||1||
48135591|NCT02044510|100655997|FG000|STARTED|Overall Study||16||
48135592|NCT02044510|100655998|FG001|STARTED|Overall Study||16||
48135593|NCT02044510|100655997|FG000|COMPLETED|Overall Study||15||
48135594|NCT02044510|100655998|FG001|COMPLETED|Overall Study||14||
48135595|NCT02044510|100655997|FG000|NOT COMPLETED|Overall Study||1||
48135596|NCT02044510|100655998|FG001|NOT COMPLETED|Overall Study||2||
48704154|NCT00837265|102060674|FG001|STARTED|Pilot Phase||21||
48704155|NCT00837265|102060675|FG002|STARTED|Pilot Phase||20||
48704156|NCT00837265|102060676|FG003|STARTED|Pilot Phase||26||
48704157|NCT00837265|102060677|FG004|STARTED|Pilot Phase||0||
48704158|NCT00837265|102060678|FG005|STARTED|Pilot Phase||0||
48135597|NCT01953926|100655999|FG000|STARTED|Overall Study||318||
48580272|NCT01482065|101753183|FG000|NOT COMPLETED|Overall Study||0||
48580273|NCT01482065|101753184|FG001|NOT COMPLETED|Overall Study||1||
48580274|NCT01062113|101753185|FG000|STARTED|Overall Study||133||
48135598|NCT01953926|100656000|FG001|STARTED|Overall Study||45||
48135599|NCT01953926|100656001|FG002|STARTED|Overall Study||23||
48135600|NCT01953926|100656002|FG003|STARTED|Overall Study||92||
48135601|NCT01953926|100656003|FG004|STARTED|Overall Study||90||
48135602|NCT01953926|100656004|FG005|STARTED|Overall Study||7||
48135603|NCT01953926|100656005|FG006|STARTED|Overall Study||7||
48135604|NCT01953926|100655999|FG000|Treated|Overall Study||317||
48135605|NCT01953926|100656000|FG001|Treated|Overall Study||45||
48580275|NCT01062113|101753186|FG001|STARTED|Overall Study||64||
48580276|NCT01062113|101753187|FG002|STARTED|Overall Study||58||
48580277|NCT01062113|101753185|FG000|COMPLETED|Overall Study||93||
48580278|NCT01062113|101753186|FG001|COMPLETED|Overall Study||42||
48580279|NCT01062113|101753187|FG002|COMPLETED|Overall Study||27||
48580280|NCT01062113|101753185|FG000|NOT COMPLETED|Overall Study||40||
48580281|NCT01062113|101753186|FG001|NOT COMPLETED|Overall Study||22||
48580282|NCT01062113|101753187|FG002|NOT COMPLETED|Overall Study||31||
48580283|NCT02156908|101753188|FG000|STARTED|Overall Study||5||
48135606|NCT01953926|100656001|FG002|Treated|Overall Study||22||
48135607|NCT01953926|100656002|FG003|Treated|Overall Study||92||
48135608|NCT01953926|100656003|FG004|Treated|Overall Study||90||
48135609|NCT01953926|100656004|FG005|Treated|Overall Study||7||
48135610|NCT01953926|100656005|FG006|Treated|Overall Study||7||
48135611|NCT01953926|100655999|FG000|COMPLETED|Overall Study||231||
48580284|NCT02156908|101753189|FG001|STARTED|Overall Study||3||
48580285|NCT02156908|101753188|FG000|COMPLETED|Overall Study||5||
48580286|NCT02156908|101753189|FG001|COMPLETED|Overall Study||3||
48580287|NCT02156908|101753188|FG000|NOT COMPLETED|Overall Study||0||
48135612|NCT01953926|100656000|FG001|COMPLETED|Overall Study||31||
48135613|NCT01953926|100656001|FG002|COMPLETED|Overall Study||14||
48135614|NCT01953926|100656002|FG003|COMPLETED|Overall Study||70||
48135615|NCT01953926|100656003|FG004|COMPLETED|Overall Study||32||
48135616|NCT01953926|100656004|FG005|COMPLETED|Overall Study||2||
48135617|NCT01953926|100656005|FG006|COMPLETED|Overall Study||0||
48135618|NCT01953926|100655999|FG000|NOT COMPLETED|Overall Study||87||
48135619|NCT01953926|100656000|FG001|NOT COMPLETED|Overall Study||14||
48135620|NCT01953926|100656001|FG002|NOT COMPLETED|Overall Study||9||
48135621|NCT01953926|100656002|FG003|NOT COMPLETED|Overall Study||22||
48135622|NCT01953926|100656003|FG004|NOT COMPLETED|Overall Study||58||
48135623|NCT01953926|100656004|FG005|NOT COMPLETED|Overall Study||5||
48135624|NCT01953926|100656005|FG006|NOT COMPLETED|Overall Study||7||
48135625|NCT00158379|100656006|FG000|STARTED|Overall Study||105||
48135626|NCT00158379|100656006|FG000|COMPLETED|Overall Study||105||
48704159|NCT00837265|102060679|FG006|STARTED|Pilot Phase||0||
48580288|NCT02156908|101753189|FG001|NOT COMPLETED|Overall Study||0||
48580289|NCT00355147|101753190|FG000|STARTED|Overall Study||87||
48580290|NCT00355147|101753191|FG001|STARTED|Overall Study||87||
48580291|NCT00355147|101753190|FG000|COMPLETED|Overall Study||69||
48580292|NCT00355147|101753191|FG001|COMPLETED|Overall Study||67||
48580293|NCT00355147|101753190|FG000|NOT COMPLETED|Overall Study||18||
48580294|NCT00355147|101753191|FG001|NOT COMPLETED|Overall Study||20||
48580295|NCT01094301|101753192|FG000|STARTED|Trial Stage||28||
48580296|NCT01094301|101753192|FG000|Subjects Who Received Smartpatch Lead|Trial Stage||28||
48580297|NCT01094301|101753192|FG000|COMPLETED|Trial Stage||27||
48580298|NCT01094301|101753192|FG000|NOT COMPLETED|Trial Stage||1||
48580299|NCT01094301|101753192|FG000|STARTED|Implant Stage||13|Trial Stage Subjects who were successful and considered for Implant Stage phase.|
48580300|NCT01094301|101753192|FG000|Met Criteria for Implant Stage|Implant Stage||7|(Trial stage success in original design, and a return of pain in the revised design)|
48580301|NCT01094301|101753192|FG000|Subjects Who Received SPR IPG|Implant Stage||5||
48287288|NCT02366468|101029692|FG001|Full Analysis Set (FAS)|Overall Study||66|Randomized patients who received study treatment and had post-baseline primary endpoint assessments|
48287289|NCT02366468|101029691|FG000|Per Protocol Set (PPS)|Overall Study||62|All patients in the FAS who completed the trial without major protocol deviations|
48287290|NCT02366468|101029692|FG001|Per Protocol Set (PPS)|Overall Study||61|All patients in the FAS who completed the trial without major protocol deviations|
48287291|NCT02366468|101029691|FG000|COMPLETED|Overall Study||62||
48287292|NCT02366468|101029692|FG001|COMPLETED|Overall Study||58||
48287293|NCT02366468|101029691|FG000|NOT COMPLETED|Overall Study||6||
48287294|NCT02366468|101029692|FG001|NOT COMPLETED|Overall Study||9||
48287295|NCT01764685|101029693|FG000|STARTED|Overall Study||0||
48287296|NCT01764685|101029694|FG001|STARTED|Overall Study||4||
48287297|NCT01764685|101029693|FG000|COMPLETED|Overall Study||0||
48287298|NCT01764685|101029694|FG001|COMPLETED|Overall Study||3||
48287299|NCT01764685|101029693|FG000|NOT COMPLETED|Overall Study||0||
48287300|NCT01764685|101029694|FG001|NOT COMPLETED|Overall Study||1||
48287301|NCT05130047|101029695|FG000|STARTED|Overall Study||15||
48287302|NCT05130047|101029696|FG001|STARTED|Overall Study||15||
48287303|NCT05130047|101029695|FG000|COMPLETED|Overall Study||15||
48287304|NCT05130047|101029696|FG001|COMPLETED|Overall Study||15||
48287305|NCT05130047|101029695|FG000|NOT COMPLETED|Overall Study||0||
48287306|NCT05130047|101029696|FG001|NOT COMPLETED|Overall Study||0||
48287307|NCT01047293|101029697|FG000|STARTED|Overall Study||4||
48287308|NCT01047293|101029698|FG001|STARTED|Overall Study||8||
48287309|NCT01047293|101029699|FG002|STARTED|Overall Study||9||
48287310|NCT01047293|101029700|FG003|STARTED|Overall Study||26||
48287311|NCT01047293|101029697|FG000|COMPLETED|Overall Study||3||
48287312|NCT01047293|101029698|FG001|COMPLETED|Overall Study||7||
48287313|NCT01047293|101029699|FG002|COMPLETED|Overall Study||9||
48287314|NCT01047293|101029700|FG003|COMPLETED|Overall Study||26||
48287315|NCT01047293|101029697|FG000|NOT COMPLETED|Overall Study||1||
48287316|NCT01047293|101029698|FG001|NOT COMPLETED|Overall Study||1||
48287317|NCT01047293|101029699|FG002|NOT COMPLETED|Overall Study||0||
48287318|NCT01047293|101029700|FG003|NOT COMPLETED|Overall Study||0||
48287319|NCT01959334|101029701|FG000|STARTED|First Dose||26||
48287320|NCT01959334|101029702|FG001|STARTED|First Dose||49||
48287321|NCT01959334|101029701|FG000|COMPLETED|First Dose||26||
48287322|NCT01959334|101029702|FG001|COMPLETED|First Dose||49||
48287323|NCT01959334|101029701|FG000|NOT COMPLETED|First Dose||0||
48287324|NCT01959334|101029702|FG001|NOT COMPLETED|First Dose||0||
48287325|NCT01959334|101029701|FG000|STARTED|Second Dose||26||
48287326|NCT01959334|101029702|FG001|STARTED|Second Dose||49||
48287327|NCT01959334|101029701|FG000|COMPLETED|Second Dose||25||
48287328|NCT01959334|101029702|FG001|COMPLETED|Second Dose||49||
48287329|NCT01959334|101029701|FG000|NOT COMPLETED|Second Dose||1||
48287330|NCT01959334|101029702|FG001|NOT COMPLETED|Second Dose||0||
48287331|NCT01959334|101029701|FG000|STARTED|Third Dose||25||
48287332|NCT01959334|101029702|FG001|STARTED|Third Dose||49||
48287333|NCT01959334|101029701|FG000|COMPLETED|Third Dose||25||
48287334|NCT01959334|101029702|FG001|COMPLETED|Third Dose||48||
48287335|NCT01959334|101029701|FG000|NOT COMPLETED|Third Dose||0||
48287336|NCT01959334|101029702|FG001|NOT COMPLETED|Third Dose||1||
48287337|NCT00801931|101029703|FG000|STARTED|Overall Study||1||
48287338|NCT00801931|101029703|FG000|COMPLETED|Overall Study||1||
48287339|NCT00801931|101029703|FG000|NOT COMPLETED|Overall Study||0||
48287340|NCT01227382|101029704|FG000|STARTED|Overall Study||26||
48287341|NCT01227382|101029704|FG000|COMPLETED|Overall Study||26||
48287342|NCT01227382|101029704|FG000|NOT COMPLETED|Overall Study||0||
48287343|NCT00432666|101029705|FG000|STARTED|Main Period||73||
48287344|NCT00432666|101029706|FG001|STARTED|Main Period||75||
48287345|NCT00432666|101029705|FG000|COMPLETED|Main Period||71||
48287346|NCT00432666|101029706|FG001|COMPLETED|Main Period||74||
48287347|NCT00432666|101029705|FG000|NOT COMPLETED|Main Period||2||
48287348|NCT00432666|101029706|FG001|NOT COMPLETED|Main Period||1||
48287349|NCT00432666|101029705|FG000|STARTED|Open-Label Extension Period||145||
48287350|NCT00432666|101029706|FG001|STARTED|Open-Label Extension Period||0||
48287351|NCT00432666|101029705|FG000|COMPLETED|Open-Label Extension Period||120||
48580302|NCT01094301|101753192|FG000|COMPLETED|Implant Stage||5||
48287352|NCT00432666|101029706|FG001|COMPLETED|Open-Label Extension Period||0||
48287353|NCT00432666|101029705|FG000|NOT COMPLETED|Open-Label Extension Period||25||
48287354|NCT00432666|101029706|FG001|NOT COMPLETED|Open-Label Extension Period||0||
48287355|NCT02413333|101029707|FG000|STARTED|Period 1||66||
48287356|NCT02413333|101029708|FG001|STARTED|Period 1||66||
48287357|NCT02413333|101029707|FG000|Randomized and Treated|Period 1||66||
48580303|NCT01094301|101753192|FG000|NOT COMPLETED|Implant Stage||8||
48704160|NCT00837265|102060673|FG000|Modified Intent-to-treat (mITT) Population|Pilot Phase||10|All participants who were randomized into the study and received at least 1 dose of assigned study drug.|
48704161|NCT00837265|102060674|FG001|Modified Intent-to-treat (mITT) Population|Pilot Phase||21|All participants who were randomized into the study and received at least 1 dose of assigned study drug.|
48704162|NCT00837265|102060675|FG002|Modified Intent-to-treat (mITT) Population|Pilot Phase||20|All participants who were randomized into the study and received at least 1 dose of assigned study drug.|
48704163|NCT00837265|102060676|FG003|Modified Intent-to-treat (mITT) Population|Pilot Phase||25|All participants who were randomized into the study and received at least 1 dose of assigned study drug.|
48135627|NCT00158379|100656006|FG000|NOT COMPLETED|Overall Study||0||
48135628|NCT02511431|100656007|FG000|STARTED|Treatment||4||
48580304|NCT01925131|101753193|FG000|STARTED|Overall Study||5||
48580305|NCT01925131|101753194|FG001|STARTED|Overall Study||4||
48580306|NCT01925131|101753195|FG002|STARTED|Overall Study||10||
48580307|NCT01925131|101753196|FG003|STARTED|Overall Study||5||
48580308|NCT01925131|101753197|FG004|STARTED|Overall Study||11||
48580309|NCT01925131|101753198|FG005|STARTED|Overall Study||13||
48580310|NCT01925131|101753193|FG000|COMPLETED|Overall Study||0||
48580311|NCT01925131|101753194|FG001|COMPLETED|Overall Study||2||
48580312|NCT01925131|101753195|FG002|COMPLETED|Overall Study||1||
48135629|NCT02511431|100656008|FG001|STARTED|Treatment||4||
48135630|NCT02511431|100656009|FG002|STARTED|Treatment||4||
48135631|NCT02511431|100656010|FG003|STARTED|Treatment||3||
48135632|NCT02511431|100656011|FG004|STARTED|Treatment||3||
48135633|NCT02511431|100656012|FG005|STARTED|Treatment||3||
48135634|NCT02511431|100656007|FG000|COMPLETED|Treatment||4||
48135635|NCT02511431|100656008|FG001|COMPLETED|Treatment||4||
48135636|NCT02511431|100656009|FG002|COMPLETED|Treatment||3||
48135637|NCT02511431|100656010|FG003|COMPLETED|Treatment||3||
48135638|NCT02511431|100656011|FG004|COMPLETED|Treatment||3||
48135639|NCT02511431|100656012|FG005|COMPLETED|Treatment||2||
48135640|NCT02511431|100656007|FG000|NOT COMPLETED|Treatment||0||
48135641|NCT02511431|100656008|FG001|NOT COMPLETED|Treatment||0||
48135642|NCT02511431|100656009|FG002|NOT COMPLETED|Treatment||1||
48135643|NCT02511431|100656010|FG003|NOT COMPLETED|Treatment||0||
48135644|NCT02511431|100656011|FG004|NOT COMPLETED|Treatment||0||
48135645|NCT02511431|100656012|FG005|NOT COMPLETED|Treatment||1||
48135646|NCT02511431|100656007|FG000|STARTED|Post-treatment Follow-up||4||
48135647|NCT02511431|100656008|FG001|STARTED|Post-treatment Follow-up||4||
48135648|NCT02511431|100656009|FG002|STARTED|Post-treatment Follow-up||3||
48135649|NCT02511431|100656010|FG003|STARTED|Post-treatment Follow-up||3||
48135650|NCT02511431|100656011|FG004|STARTED|Post-treatment Follow-up||3||
48135651|NCT02511431|100656012|FG005|STARTED|Post-treatment Follow-up||2||
48135652|NCT02511431|100656007|FG000|COMPLETED|Post-treatment Follow-up||4||
48135653|NCT02511431|100656008|FG001|COMPLETED|Post-treatment Follow-up||4||
48135654|NCT02511431|100656009|FG002|COMPLETED|Post-treatment Follow-up||3||
48135655|NCT02511431|100656010|FG003|COMPLETED|Post-treatment Follow-up||3||
48135656|NCT02511431|100656011|FG004|COMPLETED|Post-treatment Follow-up||3||
48135657|NCT02511431|100656012|FG005|COMPLETED|Post-treatment Follow-up||2||
48135658|NCT02511431|100656007|FG000|NOT COMPLETED|Post-treatment Follow-up||0||
48135659|NCT02511431|100656008|FG001|NOT COMPLETED|Post-treatment Follow-up||0||
48135660|NCT02511431|100656009|FG002|NOT COMPLETED|Post-treatment Follow-up||0||
48135661|NCT02511431|100656010|FG003|NOT COMPLETED|Post-treatment Follow-up||0||
48135662|NCT02511431|100656011|FG004|NOT COMPLETED|Post-treatment Follow-up||0||
48135663|NCT02511431|100656012|FG005|NOT COMPLETED|Post-treatment Follow-up||0||
48135664|NCT00492349|100656013|FG000|STARTED|Overall Study||35||
48135665|NCT00492349|100656014|FG001|STARTED|Overall Study||34||
48135666|NCT00492349|100656013|FG000|Week 2|Overall Study||32||
48135667|NCT00492349|100656014|FG001|Week 2|Overall Study||33||
48135668|NCT00492349|100656013|FG000|Week 8|Overall Study||32||
48135669|NCT00492349|100656014|FG001|Week 8|Overall Study||27||
48135670|NCT00492349|100656013|FG000|COMPLETED|Overall Study||32||
48135671|NCT00492349|100656014|FG001|COMPLETED|Overall Study||27||
48135672|NCT00492349|100656013|FG000|NOT COMPLETED|Overall Study||3||
48135673|NCT00492349|100656014|FG001|NOT COMPLETED|Overall Study||7||
48135674|NCT00690521|100656015|FG000|STARTED|First Intervention (4 Days)||4||
48135675|NCT00690521|100656016|FG001|STARTED|First Intervention (4 Days)||4||
48135676|NCT00690521|100656015|FG000|COMPLETED|First Intervention (4 Days)||4||
48135677|NCT00690521|100656016|FG001|COMPLETED|First Intervention (4 Days)||4||
48135678|NCT00690521|100656015|FG000|NOT COMPLETED|First Intervention (4 Days)||0||
48287358|NCT02413333|101029708|FG001|Randomized and Treated|Period 1||66||
48287359|NCT02413333|101029707|FG000|COMPLETED|Period 1||65||
48287360|NCT02413333|101029708|FG001|COMPLETED|Period 1||65||
48580313|NCT01925131|101753196|FG003|COMPLETED|Overall Study||0||
48580314|NCT01925131|101753197|FG004|COMPLETED|Overall Study||0||
48580315|NCT01925131|101753198|FG005|COMPLETED|Overall Study||3||
48580316|NCT01925131|101753193|FG000|NOT COMPLETED|Overall Study||5||
48580317|NCT01925131|101753194|FG001|NOT COMPLETED|Overall Study||2||
48580318|NCT01925131|101753195|FG002|NOT COMPLETED|Overall Study||9||
48580319|NCT01925131|101753196|FG003|NOT COMPLETED|Overall Study||5||
48580320|NCT01925131|101753197|FG004|NOT COMPLETED|Overall Study||11||
48580321|NCT01925131|101753198|FG005|NOT COMPLETED|Overall Study||10||
48580322|NCT02448537|101753199|FG000|STARTED|Overall Study||20||
48580323|NCT02448537|101753200|FG001|STARTED|Overall Study||10||
48580324|NCT02448537|101753201|FG002|STARTED|Overall Study||12||
48580325|NCT02448537|101753199|FG000|COMPLETED|Overall Study||19||
48580326|NCT02448537|101753200|FG001|COMPLETED|Overall Study||9||
48580327|NCT02448537|101753201|FG002|COMPLETED|Overall Study||11||
48580328|NCT02448537|101753199|FG000|NOT COMPLETED|Overall Study||1||
48580329|NCT02448537|101753200|FG001|NOT COMPLETED|Overall Study||1||
48580330|NCT02448537|101753201|FG002|NOT COMPLETED|Overall Study||1||
48580331|NCT02453334|101753202|FG000|STARTED|Overall Study||122||
48580332|NCT02453334|101753203|FG001|STARTED|Overall Study||122||
48580333|NCT02453334|101753202|FG000|COMPLETED|Overall Study||81||
48580334|NCT02453334|101753203|FG001|COMPLETED|Overall Study||82||
48580335|NCT02453334|101753202|FG000|NOT COMPLETED|Overall Study||41||
48580336|NCT02453334|101753203|FG001|NOT COMPLETED|Overall Study||40||
48580337|NCT03341143|101753204|FG000|STARTED|Overall Study||20||
48580338|NCT03341143|101753204|FG000|COMPLETED|Overall Study||20||
48580339|NCT03341143|101753204|FG000|NOT COMPLETED|Overall Study||0||
48580340|NCT02195622|101753205|FG000|STARTED|Overall Study||37||
48580341|NCT02195622|101753206|FG001|STARTED|Overall Study||37||
48580342|NCT02195622|101753205|FG000|COMPLETED|Overall Study||37||
48580343|NCT02195622|101753206|FG001|COMPLETED|Overall Study||37||
48580344|NCT02195622|101753205|FG000|NOT COMPLETED|Overall Study||0||
48580345|NCT02195622|101753206|FG001|NOT COMPLETED|Overall Study||0||
48580346|NCT01421186|101753207|FG000|STARTED|Overall Study||31||
48580347|NCT01421186|101753208|FG001|STARTED|Overall Study||4||
48580348|NCT01421186|101753209|FG002|STARTED|Overall Study||18||
48580349|NCT01421186|101753210|FG003|STARTED|Overall Study||21||
48580350|NCT01421186|101753211|FG004|STARTED|Overall Study||17||
48580351|NCT01421186|101753207|FG000|COMPLETED|Overall Study||31||
48580352|NCT01421186|101753208|FG001|COMPLETED|Overall Study||4||
48580353|NCT01421186|101753209|FG002|COMPLETED|Overall Study||18||
48580354|NCT01421186|101753210|FG003|COMPLETED|Overall Study||21||
48580355|NCT01421186|101753211|FG004|COMPLETED|Overall Study||17||
48580356|NCT01421186|101753207|FG000|NOT COMPLETED|Overall Study||0||
48704164|NCT00837265|102060677|FG004|Modified Intent-to-treat (mITT) Population|Pilot Phase||0|All participants who were randomized into the study and received at least 1 dose of assigned study drug.|
48135679|NCT00690521|100656016|FG001|NOT COMPLETED|First Intervention (4 Days)||0||
48135680|NCT00690521|100656015|FG000|STARTED|Washout (7 Days)||4||
48135681|NCT00690521|100656016|FG001|STARTED|Washout (7 Days)||4||
48135682|NCT00690521|100656015|FG000|COMPLETED|Washout (7 Days)||4||
48135683|NCT00690521|100656016|FG001|COMPLETED|Washout (7 Days)||4||
48135684|NCT00690521|100656015|FG000|NOT COMPLETED|Washout (7 Days)||0||
48135685|NCT00690521|100656016|FG001|NOT COMPLETED|Washout (7 Days)||0||
48135686|NCT00690521|100656015|FG000|STARTED|Second Intervention (4 Days)||4||
48135687|NCT00690521|100656016|FG001|STARTED|Second Intervention (4 Days)||4||
48135688|NCT00690521|100656015|FG000|COMPLETED|Second Intervention (4 Days)||4||
48135689|NCT00690521|100656016|FG001|COMPLETED|Second Intervention (4 Days)||4||
48135690|NCT00690521|100656015|FG000|NOT COMPLETED|Second Intervention (4 Days)||0||
48135691|NCT00690521|100656016|FG001|NOT COMPLETED|Second Intervention (4 Days)||0||
48135692|NCT01985126|100656017|FG000|STARTED|Overall Study||18||
48135693|NCT01985126|100656018|FG001|STARTED|Overall Study||106||
48135694|NCT01985126|100656017|FG000|COMPLETED|Overall Study||0||
48135695|NCT01985126|100656018|FG001|COMPLETED|Overall Study||0||
48135696|NCT01985126|100656017|FG000|NOT COMPLETED|Overall Study||18||
48580357|NCT01421186|101753208|FG001|NOT COMPLETED|Overall Study||0||
48580358|NCT01421186|101753209|FG002|NOT COMPLETED|Overall Study||0||
48580359|NCT01421186|101753210|FG003|NOT COMPLETED|Overall Study||0||
48580360|NCT01421186|101753211|FG004|NOT COMPLETED|Overall Study||0||
48580361|NCT02036840|101753212|FG000|STARTED|Overall Study||513||
48580362|NCT02036840|101753212|FG000|COMPLETED|Overall Study||513||
48580363|NCT02036840|101753212|FG000|NOT COMPLETED|Overall Study||0||
48580364|NCT01908829|101753213|FG000|STARTED|Overall Study||727||
48580365|NCT01908829|101753214|FG001|STARTED|Overall Study||728||
48710758|NCT00168103|102078006|FG000|NOT COMPLETED|Overall Study||2||
48135697|NCT01985126|100656018|FG001|NOT COMPLETED|Overall Study||106||
48135698|NCT02979535|100656019|FG000|STARTED|Overall Study||239||
48135699|NCT02979535|100656020|FG001|STARTED|Overall Study||241||
48135700|NCT02979535|100656019|FG000|Safety Analysis Set|Overall Study||237|Safety analysis set was defined as participants who had received at least 1 dose of study vaccines.|
48135701|NCT02979535|100656020|FG001|Safety Analysis Set|Overall Study||241|Safety analysis set was defined as participants who had received at least 1 dose of study vaccines.|
48135702|NCT02979535|100656019|FG000|COMPLETED|Overall Study||144||
48135703|NCT02979535|100656020|FG001|COMPLETED|Overall Study||140||
48135704|NCT02979535|100656019|FG000|NOT COMPLETED|Overall Study||95||
48580366|NCT01908829|101753215|FG002|STARTED|Overall Study||719||
48580367|NCT01908829|101753213|FG000|Treated With Double-blind Drug|Overall Study||725||
48580368|NCT01908829|101753214|FG001|Treated With Double-blind Drug|Overall Study||728||
48580369|NCT01908829|101753215|FG002|Treated With Double-blind Drug|Overall Study||719||
48135705|NCT02979535|100656020|FG001|NOT COMPLETED|Overall Study||101||
48135706|NCT02543346|100656021|FG000|STARTED|First Priming Visit||26||
48135707|NCT02543346|100656022|FG001|STARTED|First Priming Visit||25||
48135708|NCT02543346|100656023|FG002|STARTED|First Priming Visit||24||
48135709|NCT02543346|100656024|FG003|STARTED|First Priming Visit||23||
48135710|NCT02543346|100656021|FG000|COMPLETED|First Priming Visit||26||
48135711|NCT02543346|100656022|FG001|COMPLETED|First Priming Visit||25||
48135712|NCT02543346|100656023|FG002|COMPLETED|First Priming Visit||24||
48135713|NCT02543346|100656024|FG003|COMPLETED|First Priming Visit||23||
48135714|NCT02543346|100656021|FG000|NOT COMPLETED|First Priming Visit||0||
48135715|NCT02543346|100656022|FG001|NOT COMPLETED|First Priming Visit||0||
48135716|NCT02543346|100656023|FG002|NOT COMPLETED|First Priming Visit||0||
48135717|NCT02543346|100656024|FG003|NOT COMPLETED|First Priming Visit||0||
48135718|NCT02543346|100656021|FG000|STARTED|First Treatment Visit||26||
48135719|NCT02543346|100656022|FG001|STARTED|First Treatment Visit||25||
48135720|NCT02543346|100656023|FG002|STARTED|First Treatment Visit||24||
48135721|NCT02543346|100656024|FG003|STARTED|First Treatment Visit||23||
48135722|NCT02543346|100656021|FG000|COMPLETED|First Treatment Visit||26||
48135723|NCT02543346|100656022|FG001|COMPLETED|First Treatment Visit||25||
48135724|NCT02543346|100656023|FG002|COMPLETED|First Treatment Visit||24||
48135725|NCT02543346|100656024|FG003|COMPLETED|First Treatment Visit||23||
48135726|NCT02543346|100656021|FG000|NOT COMPLETED|First Treatment Visit||0||
48135727|NCT02543346|100656022|FG001|NOT COMPLETED|First Treatment Visit||0||
48135728|NCT02543346|100656023|FG002|NOT COMPLETED|First Treatment Visit||0||
48135729|NCT02543346|100656024|FG003|NOT COMPLETED|First Treatment Visit||0||
48135730|NCT02543346|100656021|FG000|STARTED|Washout (at Least 14 Days)||26||
48135731|NCT02543346|100656022|FG001|STARTED|Washout (at Least 14 Days)||25||
48580370|NCT01908829|101753213|FG000|COMPLETED|Overall Study||678||
48580371|NCT01908829|101753214|FG001|COMPLETED|Overall Study||679||
48580372|NCT01908829|101753215|FG002|COMPLETED|Overall Study||680||
48580373|NCT01908829|101753213|FG000|NOT COMPLETED|Overall Study||49||
48580374|NCT01908829|101753214|FG001|NOT COMPLETED|Overall Study||49||
48580375|NCT01908829|101753215|FG002|NOT COMPLETED|Overall Study||39||
48580376|NCT00694473|101753216|FG000|STARTED|Overall Study||76||
48580377|NCT00694473|101753216|FG000|COMPLETED|Overall Study||69||
48580378|NCT00694473|101753216|FG000|NOT COMPLETED|Overall Study||7||
48135732|NCT02543346|100656023|FG002|STARTED|Washout (at Least 14 Days)||24||
48135733|NCT02543346|100656024|FG003|STARTED|Washout (at Least 14 Days)||23||
48287361|NCT02413333|101029707|FG000|NOT COMPLETED|Period 1||1||
48287362|NCT02413333|101029708|FG001|NOT COMPLETED|Period 1||1||
48287363|NCT02413333|101029707|FG000|STARTED|Period 2||65||
48287364|NCT02413333|101029708|FG001|STARTED|Period 2||65||
48287365|NCT02413333|101029707|FG000|COMPLETED|Period 2||64||
48287366|NCT02413333|101029708|FG001|COMPLETED|Period 2||65||
48287367|NCT02413333|101029707|FG000|NOT COMPLETED|Period 2||1||
48580379|NCT03448575|101753217|FG000|STARTED|Overall Study||385||
48580380|NCT03448575|101753218|FG001|STARTED|Overall Study||348||
48580381|NCT03448575|101753217|FG000|COMPLETED|Overall Study||385||
48580382|NCT03448575|101753218|FG001|COMPLETED|Overall Study||348||
48135734|NCT02543346|100656021|FG000|COMPLETED|Washout (at Least 14 Days)||26||
48135735|NCT02543346|100656022|FG001|COMPLETED|Washout (at Least 14 Days)||25||
48135736|NCT02543346|100656023|FG002|COMPLETED|Washout (at Least 14 Days)||24||
48135737|NCT02543346|100656024|FG003|COMPLETED|Washout (at Least 14 Days)||23||
48135738|NCT02543346|100656021|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0||
48135739|NCT02543346|100656022|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0||
48135740|NCT02543346|100656023|FG002|NOT COMPLETED|Washout (at Least 14 Days)||0||
48287368|NCT02413333|101029708|FG001|NOT COMPLETED|Period 2||0||
48287369|NCT01116102|101029709|FG000|STARTED|Overall Study||2||
48287370|NCT01116102|101029710|FG001|STARTED|Overall Study||3||
48287371|NCT01116102|101029711|FG002|STARTED|Overall Study||3||
48287372|NCT01116102|101029712|FG003|STARTED|Overall Study||3||
48287373|NCT01116102|101029713|FG004|STARTED|Overall Study||2||
48287374|NCT01116102|101029714|FG005|STARTED|Overall Study||2||
48287375|NCT01116102|101029715|FG006|STARTED|Overall Study||2||
48287376|NCT01116102|101029716|FG007|STARTED|Overall Study||3||
48287377|NCT01116102|101029709|FG000|COMPLETED|Overall Study||2||
48287378|NCT01116102|101029710|FG001|COMPLETED|Overall Study||3||
48287379|NCT01116102|101029711|FG002|COMPLETED|Overall Study||3||
48287380|NCT01116102|101029712|FG003|COMPLETED|Overall Study||3||
48287381|NCT01116102|101029713|FG004|COMPLETED|Overall Study||2||
48287382|NCT01116102|101029714|FG005|COMPLETED|Overall Study||2||
48135741|NCT02543346|100656024|FG003|NOT COMPLETED|Washout (at Least 14 Days)||0||
48135742|NCT02543346|100656021|FG000|STARTED|Second Priming Visit||26||
48287383|NCT01116102|101029715|FG006|COMPLETED|Overall Study||2||
48287384|NCT01116102|101029716|FG007|COMPLETED|Overall Study||3||
48287385|NCT01116102|101029709|FG000|NOT COMPLETED|Overall Study||0||
48287386|NCT01116102|101029710|FG001|NOT COMPLETED|Overall Study||0||
48580383|NCT03448575|101753217|FG000|NOT COMPLETED|Overall Study||0||
48135743|NCT02543346|100656022|FG001|STARTED|Second Priming Visit||25||
48287387|NCT01116102|101029711|FG002|NOT COMPLETED|Overall Study||0||
48580384|NCT03448575|101753218|FG001|NOT COMPLETED|Overall Study||0||
48580385|NCT00887783|101753219|FG000|STARTED|Overall Study||58||
48580386|NCT00887783|101753220|FG001|STARTED|Overall Study||59||
48580387|NCT00887783|101753219|FG000|COMPLETED|Overall Study||58||
48580388|NCT00887783|101753220|FG001|COMPLETED|Overall Study||59||
48580389|NCT00887783|101753219|FG000|NOT COMPLETED|Overall Study||0||
48580390|NCT00887783|101753220|FG001|NOT COMPLETED|Overall Study||0||
48580391|NCT04065451|101753221|FG000|STARTED|Overall Study||10||
48580392|NCT04065451|101753222|FG001|STARTED|Overall Study||10||
48580393|NCT04065451|101753221|FG000|COMPLETED|Overall Study||10||
48580394|NCT04065451|101753222|FG001|COMPLETED|Overall Study||10||
48580395|NCT04065451|101753221|FG000|NOT COMPLETED|Overall Study||0||
48580396|NCT04065451|101753222|FG001|NOT COMPLETED|Overall Study||0||
48580397|NCT02957968|101753223|FG000|STARTED|Overall Study||21||
48580398|NCT02957968|101753224|FG001|STARTED|Overall Study||18||
48580399|NCT02957968|101753225|FG002|STARTED|Overall Study||7||
48580400|NCT02957968|101753223|FG000|COMPLETED|Overall Study||17||
48580401|NCT02957968|101753224|FG001|COMPLETED|Overall Study||14||
48580402|NCT02957968|101753225|FG002|COMPLETED|Overall Study||6||
48580403|NCT02957968|101753223|FG000|NOT COMPLETED|Overall Study||4||
48580404|NCT02957968|101753224|FG001|NOT COMPLETED|Overall Study||4||
48580405|NCT02957968|101753225|FG002|NOT COMPLETED|Overall Study||1||
48580406|NCT02783729|101753226|FG000|STARTED|Overall Study||208||
48580407|NCT02783729|101753227|FG001|STARTED|Overall Study||263||
48580408|NCT02783729|101753228|FG002|STARTED|Overall Study||266||
48580409|NCT02783729|101753229|FG003|STARTED|Overall Study||269||
48580410|NCT02783729|101753226|FG000|COMPLETED|Overall Study||198||
48580411|NCT02783729|101753227|FG001|COMPLETED|Overall Study||246||
48580412|NCT02783729|101753228|FG002|COMPLETED|Overall Study||258||
48580413|NCT02783729|101753229|FG003|COMPLETED|Overall Study||260||
48580414|NCT02783729|101753226|FG000|NOT COMPLETED|Overall Study||10||
48580415|NCT02783729|101753227|FG001|NOT COMPLETED|Overall Study||17||
48704165|NCT00837265|102060678|FG005|Modified Intent-to-treat (mITT) Population|Pilot Phase||0|All participants who were randomized into the study and received at least 1 dose of assigned study drug.|
48704166|NCT00837265|102060679|FG006|Modified Intent-to-treat (mITT) Population|Pilot Phase||0|All participants who were randomized into the study and received at least 1 dose of assigned study drug.|
48704167|NCT00837265|102060673|FG000|COMPLETED|Pilot Phase||8||
48704168|NCT00837265|102060674|FG001|COMPLETED|Pilot Phase||18||
48704169|NCT00837265|102060675|FG002|COMPLETED|Pilot Phase||17||
48704170|NCT00837265|102060676|FG003|COMPLETED|Pilot Phase||22||
48135744|NCT02543346|100656023|FG002|STARTED|Second Priming Visit||24||
48135745|NCT02543346|100656024|FG003|STARTED|Second Priming Visit||23||
48135746|NCT02543346|100656021|FG000|COMPLETED|Second Priming Visit||25||
48135747|NCT02543346|100656022|FG001|COMPLETED|Second Priming Visit||23||
48135748|NCT02543346|100656023|FG002|COMPLETED|Second Priming Visit||22||
48135749|NCT02543346|100656024|FG003|COMPLETED|Second Priming Visit||21||
48135750|NCT02543346|100656021|FG000|NOT COMPLETED|Second Priming Visit||1||
48135751|NCT02543346|100656022|FG001|NOT COMPLETED|Second Priming Visit||2||
48135752|NCT02543346|100656023|FG002|NOT COMPLETED|Second Priming Visit||2||
48704171|NCT00837265|102060677|FG004|COMPLETED|Pilot Phase||0||
48704172|NCT00837265|102060678|FG005|COMPLETED|Pilot Phase||0||
48704173|NCT00837265|102060679|FG006|COMPLETED|Pilot Phase||0||
48704174|NCT00837265|102060673|FG000|NOT COMPLETED|Pilot Phase||3||
48135753|NCT02543346|100656024|FG003|NOT COMPLETED|Second Priming Visit||2||
48135754|NCT02543346|100656021|FG000|STARTED|Second Treatment Visit||25||
48135755|NCT02543346|100656022|FG001|STARTED|Second Treatment Visit||23||
48135756|NCT02543346|100656023|FG002|STARTED|Second Treatment Visit||22||
48135757|NCT02543346|100656024|FG003|STARTED|Second Treatment Visit||21||
48135758|NCT02543346|100656021|FG000|COMPLETED|Second Treatment Visit||25||
48580416|NCT02783729|101753228|FG002|NOT COMPLETED|Overall Study||8||
48580417|NCT02783729|101753229|FG003|NOT COMPLETED|Overall Study||9||
48580418|NCT00535782|101753230|FG000|STARTED|Part 1: 24-Week Double-blind Period||69||
48704175|NCT00837265|102060674|FG001|NOT COMPLETED|Pilot Phase||3||
48704176|NCT00837265|102060675|FG002|NOT COMPLETED|Pilot Phase||3||
48704177|NCT00837265|102060676|FG003|NOT COMPLETED|Pilot Phase||4||
48704178|NCT00837265|102060677|FG004|NOT COMPLETED|Pilot Phase||0||
48135759|NCT02543346|100656022|FG001|COMPLETED|Second Treatment Visit||23||
48135760|NCT02543346|100656023|FG002|COMPLETED|Second Treatment Visit||22||
48135761|NCT02543346|100656024|FG003|COMPLETED|Second Treatment Visit||21||
48135762|NCT02543346|100656021|FG000|NOT COMPLETED|Second Treatment Visit||0||
48135763|NCT02543346|100656022|FG001|NOT COMPLETED|Second Treatment Visit||0||
48135764|NCT02543346|100656023|FG002|NOT COMPLETED|Second Treatment Visit||0||
48704179|NCT00837265|102060678|FG005|NOT COMPLETED|Pilot Phase||0||
48704180|NCT00837265|102060679|FG006|NOT COMPLETED|Pilot Phase||0||
48704181|NCT00837265|102060673|FG000|STARTED|Main Phase||0||
48135765|NCT02543346|100656024|FG003|NOT COMPLETED|Second Treatment Visit||0||
48580419|NCT00535782|101753231|FG001|STARTED|Part 1: 24-Week Double-blind Period||63||
48580420|NCT00535782|101753232|FG002|STARTED|Part 1: 24-Week Double-blind Period||0||
48135766|NCT00288587|100656025|FG000|STARTED|Overall Study||19||
48580421|NCT00535782|101753230|FG000|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||69||
48580422|NCT00535782|101753231|FG001|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||2||
48580423|NCT00535782|101753232|FG002|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||0||
48135767|NCT00288587|100656026|FG001|STARTED|Overall Study||17||
48592821|NCT00767039|101783188|FG001|STARTED|Overall Study||25||
48135768|NCT00288587|100656025|FG000|COMPLETED|Overall Study||14||
48135769|NCT00288587|100656026|FG001|COMPLETED|Overall Study||7||
48135770|NCT00288587|100656025|FG000|NOT COMPLETED|Overall Study||5||
48135771|NCT00288587|100656026|FG001|NOT COMPLETED|Overall Study||10||
48135772|NCT03447782|100656027|FG000|STARTED|Overall Study||45||
48135773|NCT03447782|100656027|FG000|COMPLETED|Overall Study||25||
48135774|NCT03447782|100656027|FG000|NOT COMPLETED|Overall Study||20||
48135775|NCT04030416|100656028|FG000|STARTED|Overall Study||120||
48135776|NCT04030416|100656028|FG000|COMPLETED|Overall Study||119||
48135777|NCT04030416|100656028|FG000|NOT COMPLETED|Overall Study||1||
48135778|NCT04053764|100656029|FG000|STARTED|Overall Study||30||
48135779|NCT04053764|100656030|FG001|STARTED|Overall Study||28||
48135780|NCT04053764|100656029|FG000|Entered Post-treatment Follow-up, Discontinued|Overall Study||7||
48135781|NCT04053764|100656030|FG001|Entered Post-treatment Follow-up, Discontinued|Overall Study||1||
48135782|NCT04053764|100656029|FG000|Did Not Enter Post-treatment Follow-up|Overall Study||3||
48135783|NCT04053764|100656030|FG001|Did Not Enter Post-treatment Follow-up|Overall Study||2||
48135784|NCT04053764|100656029|FG000|Not Treated|Overall Study||1||
48135785|NCT04053764|100656030|FG001|Not Treated|Overall Study||0||
48135786|NCT04053764|100656029|FG000|COMPLETED|Overall Study||20|Completed = completed treatment Not Completed = discontinued treatment|
48135787|NCT04053764|100656030|FG001|COMPLETED|Overall Study||25|Completed = completed treatment Not Completed = discontinued treatment|
48135788|NCT04053764|100656029|FG000|NOT COMPLETED|Overall Study||10||
48135789|NCT04053764|100656030|FG001|NOT COMPLETED|Overall Study||3||
48135790|NCT04304833|100656031|FG000|STARTED|Overall Study||12|Participants enrolled and assessed in the study are HF patients. Caregivers were not enrolled.|
48135791|NCT04304833|100656032|FG001|STARTED|Overall Study||14|Participants enrolled and assessed in the study are HF patients. Caregivers were not enrolled.|
48135792|NCT04304833|100656031|FG000|COMPLETED|Overall Study||8||
48135793|NCT04304833|100656032|FG001|COMPLETED|Overall Study||12||
48135794|NCT04304833|100656031|FG000|NOT COMPLETED|Overall Study||4||
48135795|NCT04304833|100656032|FG001|NOT COMPLETED|Overall Study||2||
48135796|NCT01311102|100656033|FG000|STARTED|Overall Study||20||
48135797|NCT01311102|100656034|FG001|STARTED|Overall Study||20||
48135798|NCT01311102|100656033|FG000|COMPLETED|Overall Study||20||
48135799|NCT01311102|100656034|FG001|COMPLETED|Overall Study||20||
48135800|NCT01311102|100656033|FG000|NOT COMPLETED|Overall Study||0||
48135801|NCT01311102|100656034|FG001|NOT COMPLETED|Overall Study||0||
48135802|NCT04139317|100656035|FG000|STARTED|Overall Study||51||
48135803|NCT04139317|100656036|FG001|STARTED|Overall Study||25||
48135804|NCT04139317|100656035|FG000|Entered Post-treatment Follow-up|Overall Study||38|Post-treatment disease progression follow-up and survival follow-up started on day 31 after last dose of study treatment. This was applicable until the implementation of Protocol Amendment 03.|
48135805|NCT04139317|100656036|FG001|Entered Post-treatment Follow-up|Overall Study||20|Post-treatment disease progression follow-up and survival follow-up started on day 31 after last dose of study treatment. This was applicable until the implementation of Protocol Amendment 03.|
48135806|NCT04139317|100656035|FG000|COMPLETED|Overall Study||10||
48135807|NCT04139317|100656036|FG001|COMPLETED|Overall Study||7||
48135808|NCT04139317|100656035|FG000|NOT COMPLETED|Overall Study||41||
48135809|NCT04139317|100656036|FG001|NOT COMPLETED|Overall Study||18||
48135810|NCT04419493|100656037|FG000|STARTED|Period 1||6||
48135811|NCT04419493|100656038|FG001|STARTED|Period 1||6||
48135812|NCT04419493|100656039|FG002|STARTED|Period 1||9||
48135813|NCT04419493|100656040|FG003|STARTED|Period 1||9||
48135814|NCT04419493|100656037|FG000|COMPLETED|Period 1||6||
48135815|NCT04419493|100656038|FG001|COMPLETED|Period 1||6||
48135816|NCT04419493|100656039|FG002|COMPLETED|Period 1||9||
48135817|NCT04419493|100656040|FG003|COMPLETED|Period 1||9||
48135818|NCT04419493|100656037|FG000|NOT COMPLETED|Period 1||0||
48135819|NCT04419493|100656038|FG001|NOT COMPLETED|Period 1||0||
48135820|NCT04419493|100656039|FG002|NOT COMPLETED|Period 1||0||
48135821|NCT04419493|100656040|FG003|NOT COMPLETED|Period 1||0||
48135822|NCT04419493|100656037|FG000|STARTED|Wash-out After Period 1||6||
48135823|NCT04419493|100656038|FG001|STARTED|Wash-out After Period 1||6||
48135824|NCT04419493|100656039|FG002|STARTED|Wash-out After Period 1||9||
48135825|NCT04419493|100656040|FG003|STARTED|Wash-out After Period 1||9||
48135826|NCT04419493|100656037|FG000|COMPLETED|Wash-out After Period 1||5||
48135827|NCT04419493|100656038|FG001|COMPLETED|Wash-out After Period 1||4||
48135828|NCT04419493|100656039|FG002|COMPLETED|Wash-out After Period 1||8||
48135829|NCT04419493|100656040|FG003|COMPLETED|Wash-out After Period 1||9||
48135830|NCT04419493|100656037|FG000|NOT COMPLETED|Wash-out After Period 1||1||
48135831|NCT04419493|100656038|FG001|NOT COMPLETED|Wash-out After Period 1||2||
48135832|NCT04419493|100656039|FG002|NOT COMPLETED|Wash-out After Period 1||1||
48135833|NCT04419493|100656040|FG003|NOT COMPLETED|Wash-out After Period 1||0||
48135834|NCT04419493|100656037|FG000|STARTED|Period 2||5||
48135835|NCT04419493|100656038|FG001|STARTED|Period 2||4||
48135836|NCT04419493|100656039|FG002|STARTED|Period 2||8||
48135837|NCT04419493|100656040|FG003|STARTED|Period 2||9||
48135838|NCT04419493|100656037|FG000|COMPLETED|Period 2||5||
48135839|NCT04419493|100656038|FG001|COMPLETED|Period 2||4||
48135840|NCT04419493|100656039|FG002|COMPLETED|Period 2||8||
48135841|NCT04419493|100656040|FG003|COMPLETED|Period 2||9||
48135842|NCT04419493|100656037|FG000|NOT COMPLETED|Period 2||0||
48135843|NCT04419493|100656038|FG001|NOT COMPLETED|Period 2||0||
48704182|NCT00837265|102060674|FG001|STARTED|Main Phase||0||
48704183|NCT00837265|102060675|FG002|STARTED|Main Phase||0||
48704184|NCT00837265|102060676|FG003|STARTED|Main Phase||0||
48704185|NCT00837265|102060677|FG004|STARTED|Main Phase||86||
48704186|NCT00837265|102060678|FG005|STARTED|Main Phase||84||
48400342|NCT02951455|101309353|FG003|COMPLETED|Overall Study||32||
48400343|NCT02951455|101309354|FG004|COMPLETED|Overall Study||26||
48704187|NCT00837265|102060679|FG006|STARTED|Main Phase||86||
48287388|NCT01116102|101029712|FG003|NOT COMPLETED|Overall Study||0||
48287389|NCT01116102|101029713|FG004|NOT COMPLETED|Overall Study||0||
48287390|NCT01116102|101029714|FG005|NOT COMPLETED|Overall Study||0||
48287391|NCT01116102|101029715|FG006|NOT COMPLETED|Overall Study||0||
48287392|NCT01116102|101029716|FG007|NOT COMPLETED|Overall Study||0||
48287393|NCT00591370|101029717|FG000|STARTED|Overall Study||51||
48704188|NCT00837265|102060673|FG000|Received at Least 1 Dose of Study Drug|Main Phase||0||
48704189|NCT00837265|102060674|FG001|Received at Least 1 Dose of Study Drug|Main Phase||0||
48704190|NCT00837265|102060675|FG002|Received at Least 1 Dose of Study Drug|Main Phase||0||
48287394|NCT00591370|101029717|FG000|COMPLETED|Overall Study||49||
48287395|NCT00591370|101029717|FG000|NOT COMPLETED|Overall Study||2||
48287396|NCT00423930|101029718|FG000|STARTED|Overall Study||44||
48704191|NCT00837265|102060676|FG003|Received at Least 1 Dose of Study Drug|Main Phase||0||
48704192|NCT00837265|102060677|FG004|Received at Least 1 Dose of Study Drug|Main Phase||85||
48704193|NCT00837265|102060678|FG005|Received at Least 1 Dose of Study Drug|Main Phase||84||
48704194|NCT00837265|102060679|FG006|Received at Least 1 Dose of Study Drug|Main Phase||86||
48704195|NCT00837265|102060673|FG000|COMPLETED|Main Phase||0||
48704196|NCT00837265|102060674|FG001|COMPLETED|Main Phase||0||
48287397|NCT00423930|101029718|FG000|COMPLETED|Overall Study||42||
48287398|NCT00423930|101029718|FG000|NOT COMPLETED|Overall Study||2||
48287399|NCT00969709|101029719|FG000|STARTED|Overall Study||176||
48287400|NCT00969709|101029720|FG001|STARTED|Overall Study||178||
48287401|NCT00969709|101029721|FG002|STARTED|Overall Study||179||
48287402|NCT00969709|101029722|FG003|STARTED|Overall Study||180||
48287403|NCT00969709|101029719|FG000|COMPLETED|Overall Study||138||
48287404|NCT00969709|101029720|FG001|COMPLETED|Overall Study||130||
48287405|NCT00969709|101029721|FG002|COMPLETED|Overall Study||121||
48287406|NCT00969709|101029722|FG003|COMPLETED|Overall Study||117||
48287407|NCT00969709|101029719|FG000|NOT COMPLETED|Overall Study||38||
48287408|NCT00969709|101029720|FG001|NOT COMPLETED|Overall Study||48||
48400344|NCT02951455|101309355|FG005|COMPLETED|Overall Study||17||
48400345|NCT02951455|101309356|FG006|COMPLETED|Overall Study||30||
48400346|NCT02951455|101309357|FG007|COMPLETED|Overall Study||30||
48400347|NCT02951455|101309358|FG008|COMPLETED|Overall Study||26||
48400348|NCT02951455|101309359|FG009|COMPLETED|Overall Study||26||
48400349|NCT02951455|101309360|FG010|COMPLETED|Overall Study||26||
48400350|NCT02951455|101309361|FG011|COMPLETED|Overall Study||30||
48400351|NCT02951455|101309362|FG012|COMPLETED|Overall Study||25||
48400352|NCT02951455|101309363|FG013|COMPLETED|Overall Study||29||
48400353|NCT02951455|101309364|FG014|COMPLETED|Overall Study||35||
48704197|NCT00837265|102060675|FG002|COMPLETED|Main Phase||0||
48704198|NCT00837265|102060676|FG003|COMPLETED|Main Phase||0||
48704199|NCT00837265|102060677|FG004|COMPLETED|Main Phase||76||
48704200|NCT00837265|102060678|FG005|COMPLETED|Main Phase||79||
48704201|NCT00837265|102060679|FG006|COMPLETED|Main Phase||83||
48704202|NCT00837265|102060673|FG000|NOT COMPLETED|Main Phase||0||
48704203|NCT00837265|102060674|FG001|NOT COMPLETED|Main Phase||0||
48400354|NCT02951455|101309365|FG015|COMPLETED|Overall Study||28||
48400355|NCT02951455|101309350|FG000|NOT COMPLETED|Overall Study||23||
48400356|NCT02951455|101309351|FG001|NOT COMPLETED|Overall Study||13||
48400357|NCT02951455|101309352|FG002|NOT COMPLETED|Overall Study||12||
48400358|NCT02951455|101309353|FG003|NOT COMPLETED|Overall Study||7||
48287409|NCT00969709|101029721|FG002|NOT COMPLETED|Overall Study||58||
48287410|NCT00969709|101029722|FG003|NOT COMPLETED|Overall Study||63||
48287411|NCT03801915|101029723|FG000|STARTED|Overall Study||8||
48287412|NCT03801915|101029724|FG001|STARTED|Overall Study||1||
48287413|NCT03801915|101029725|FG002|STARTED|Overall Study||1||
48287414|NCT03801915|101029723|FG000|COMPLETED|Overall Study||5||
48400359|NCT02951455|101309354|FG004|NOT COMPLETED|Overall Study||10||
48704204|NCT00837265|102060675|FG002|NOT COMPLETED|Main Phase||0||
48704205|NCT00837265|102060676|FG003|NOT COMPLETED|Main Phase||0||
48704206|NCT00837265|102060677|FG004|NOT COMPLETED|Main Phase||10||
48704207|NCT00837265|102060678|FG005|NOT COMPLETED|Main Phase||5||
48704208|NCT00837265|102060679|FG006|NOT COMPLETED|Main Phase||3||
48704209|NCT00907803|102060680|FG000|STARTED|Overall Study||45||
48704210|NCT00907803|102060681|FG001|STARTED|Overall Study||46||
48704211|NCT00907803|102060682|FG002|STARTED|Overall Study||16||
48704212|NCT00907803|102060680|FG000|COMPLETED|Overall Study||42||
48704213|NCT00907803|102060681|FG001|COMPLETED|Overall Study||43||
48704214|NCT00907803|102060682|FG002|COMPLETED|Overall Study||16||
48704215|NCT00907803|102060680|FG000|NOT COMPLETED|Overall Study||3||
48704216|NCT00907803|102060681|FG001|NOT COMPLETED|Overall Study||3||
48287415|NCT03801915|101029724|FG001|COMPLETED|Overall Study||0||
48287416|NCT03801915|101029725|FG002|COMPLETED|Overall Study||0||
48287417|NCT03801915|101029723|FG000|NOT COMPLETED|Overall Study||3||
48400360|NCT02951455|101309355|FG005|NOT COMPLETED|Overall Study||20||
48135844|NCT04419493|100656039|FG002|NOT COMPLETED|Period 2||0||
48135845|NCT04419493|100656040|FG003|NOT COMPLETED|Period 2||0||
48135846|NCT03778294|100656041|FG000|STARTED|Overall Study||43||
48135847|NCT03778294|100656041|FG000|COMPLETED|Overall Study||39||
48135848|NCT03778294|100656041|FG000|NOT COMPLETED|Overall Study||4||
48135849|NCT00936858|100656042|FG000|STARTED|Overall Study||50||
48135850|NCT00936858|100656042|FG000|Participants With Medullary Thyroid Cancer|Overall Study||10||
48135851|NCT00936858|100656042|FG000|COMPLETED|Overall Study||0||
48135852|NCT00936858|100656042|FG000|NOT COMPLETED|Overall Study||50||
48400361|NCT02951455|101309356|FG006|NOT COMPLETED|Overall Study||9||
48400362|NCT02951455|101309357|FG007|NOT COMPLETED|Overall Study||7||
48400363|NCT02951455|101309358|FG008|NOT COMPLETED|Overall Study||13||
48400364|NCT02951455|101309359|FG009|NOT COMPLETED|Overall Study||11||
48400365|NCT02951455|101309360|FG010|NOT COMPLETED|Overall Study||11||
48400366|NCT02951455|101309361|FG011|NOT COMPLETED|Overall Study||9||
48400367|NCT02951455|101309362|FG012|NOT COMPLETED|Overall Study||12||
48400368|NCT02951455|101309363|FG013|NOT COMPLETED|Overall Study||8||
48400369|NCT02951455|101309364|FG014|NOT COMPLETED|Overall Study||4||
48400370|NCT02951455|101309365|FG015|NOT COMPLETED|Overall Study||8||
48400371|NCT05158179|101309366|FG000|STARTED|Overall Study||13||
48400372|NCT05158179|101309366|FG000|COMPLETED|Overall Study||13||
48135853|NCT00875836|100656043|FG000|STARTED|Overall Study||88||
48135854|NCT00875836|100656044|FG001|STARTED|Overall Study||87||
48135855|NCT00875836|100656043|FG000|COMPLETED|Overall Study||45||
48135856|NCT00875836|100656044|FG001|COMPLETED|Overall Study||47||
48135857|NCT00875836|100656043|FG000|NOT COMPLETED|Overall Study||43||
48135858|NCT00875836|100656044|FG001|NOT COMPLETED|Overall Study||40||
48135859|NCT02079805|100656045|FG000|STARTED|Overall Study||16||
48135860|NCT02079805|100656046|FG001|STARTED|Overall Study||17||
48135861|NCT02079805|100656045|FG000|COMPLETED|Overall Study||16||
48135862|NCT02079805|100656046|FG001|COMPLETED|Overall Study||15||
48135863|NCT02079805|100656045|FG000|NOT COMPLETED|Overall Study||0||
48287418|NCT03801915|101029724|FG001|NOT COMPLETED|Overall Study||1||
48287419|NCT03801915|101029725|FG002|NOT COMPLETED|Overall Study||1||
48287420|NCT00462332|101029726|FG000|STARTED|Overall Study||45||
48287421|NCT00462332|101029727|FG001|STARTED|Overall Study||41||
48287422|NCT00462332|101029726|FG000|COMPLETED|Overall Study||45||
48287423|NCT00462332|101029727|FG001|COMPLETED|Overall Study||41||
48287424|NCT00462332|101029726|FG000|NOT COMPLETED|Overall Study||0||
48287425|NCT00462332|101029727|FG001|NOT COMPLETED|Overall Study||0||
48287426|NCT00986973|101029728|FG000|STARTED|Overall Study||6||
48704217|NCT00907803|102060682|FG002|NOT COMPLETED|Overall Study||0||
48704218|NCT04420572|102060683|FG000|STARTED|Overall Study||33||
48704219|NCT04420572|102060684|FG001|STARTED|Overall Study||30||
48704220|NCT04420572|102060683|FG000|COMPLETED|Overall Study||33||
48704221|NCT04420572|102060684|FG001|COMPLETED|Overall Study||30||
48704222|NCT04420572|102060683|FG000|NOT COMPLETED|Overall Study||0||
48704223|NCT04420572|102060684|FG001|NOT COMPLETED|Overall Study||0||
48704224|NCT03224507|102060685|FG000|STARTED|Overall Study||123||
48704225|NCT03224507|102060686|FG001|STARTED|Overall Study||0||
48704226|NCT03224507|102060685|FG000|COMPLETED|Overall Study||108||
48704227|NCT03224507|102060686|FG001|COMPLETED|Overall Study||0||
48704228|NCT03224507|102060685|FG000|NOT COMPLETED|Overall Study||15||
48135864|NCT02079805|100656046|FG001|NOT COMPLETED|Overall Study||2||
48135865|NCT01316926|100656047|FG000|STARTED|Period 1||30||
48135866|NCT01316926|100656048|FG001|STARTED|Period 1||30||
48135867|NCT01316926|100656047|FG000|COMPLETED|Period 1||30||
48135868|NCT01316926|100656048|FG001|COMPLETED|Period 1||30||
48135869|NCT01316926|100656047|FG000|NOT COMPLETED|Period 1||0||
48135870|NCT01316926|100656048|FG001|NOT COMPLETED|Period 1||0||
48135871|NCT01316926|100656047|FG000|STARTED|Period 2||29||
48135872|NCT01316926|100656048|FG001|STARTED|Period 2||30||
48135873|NCT01316926|100656047|FG000|COMPLETED|Period 2||29||
48135874|NCT01316926|100656048|FG001|COMPLETED|Period 2||30||
48135875|NCT01316926|100656047|FG000|NOT COMPLETED|Period 2||0||
48135876|NCT01316926|100656048|FG001|NOT COMPLETED|Period 2||0||
48287427|NCT00986973|101029728|FG000|COMPLETED|Overall Study||5||
48287428|NCT00986973|101029728|FG000|NOT COMPLETED|Overall Study||1||
48287429|NCT02673515|101029729|FG000|STARTED|Overall Study||30||
48287430|NCT02673515|101029730|FG001|STARTED|Overall Study||30||
48287431|NCT02673515|101029729|FG000|COMPLETED|Overall Study||28||
48287432|NCT02673515|101029730|FG001|COMPLETED|Overall Study||29||
48287433|NCT02673515|101029729|FG000|NOT COMPLETED|Overall Study||2||
48287434|NCT02673515|101029730|FG001|NOT COMPLETED|Overall Study||1||
48287435|NCT02029846|101029731|FG000|STARTED|Overall Study||1||
48287436|NCT02029846|101029732|FG001|STARTED|Overall Study||1||
48287437|NCT02029846|101029731|FG000|COMPLETED|Overall Study||0||
48287438|NCT02029846|101029732|FG001|COMPLETED|Overall Study||0||
48287439|NCT02029846|101029731|FG000|NOT COMPLETED|Overall Study||1||
48287440|NCT02029846|101029732|FG001|NOT COMPLETED|Overall Study||1||
48287441|NCT03616977|101029733|FG000|STARTED|Period 1||34||
48287442|NCT03616977|101029734|FG001|STARTED|Period 1||35||
48287443|NCT03616977|101029733|FG000|Received at Least One Dose of Study Drug|Period 1||34||
48704229|NCT03224507|102060686|FG001|NOT COMPLETED|Overall Study||0||
48704230|NCT01349322|102060687|FG000|STARTED|Overall Study||1169||
48704231|NCT01349322|102060688|FG001|STARTED|Overall Study||1185||
48704232|NCT01349322|102060687|FG000|Eligible Population|Overall Study||1124||
48704233|NCT01349322|102060688|FG001|Eligible Population|Overall Study||1138||
48704234|NCT01349322|102060687|FG000|Adverse Event Population|Overall Study||1100|Eligible participants who started protocol treatment and had adverse event data|
48704235|NCT01349322|102060688|FG001|Adverse Event Population|Overall Study||1123|Eligible participants who started protocol treatment and had adverse event data|
48710759|NCT00168103|102078007|FG001|NOT COMPLETED|Overall Study||5||
48135877|NCT00823719|100656049|FG000|STARTED|Overall Study||26||
48287444|NCT03616977|101029734|FG001|Received at Least One Dose of Study Drug|Period 1||34||
48287445|NCT03616977|101029733|FG000|COMPLETED|Period 1||34||
48287446|NCT03616977|101029734|FG001|COMPLETED|Period 1||34||
48287447|NCT03616977|101029733|FG000|NOT COMPLETED|Period 1||0||
48287448|NCT03616977|101029734|FG001|NOT COMPLETED|Period 1||1||
48135878|NCT00823719|100656050|FG001|STARTED|Overall Study||35||
48135879|NCT00823719|100656049|FG000|COMPLETED|Overall Study||20||
48135880|NCT00823719|100656050|FG001|COMPLETED|Overall Study||24||
48135881|NCT00823719|100656049|FG000|NOT COMPLETED|Overall Study||6||
48135882|NCT00823719|100656050|FG001|NOT COMPLETED|Overall Study||11||
48135883|NCT05132699|100656051|FG000|STARTED|Overall Study||11||
48135884|NCT05132699|100656052|FG001|STARTED|Overall Study||10||
48135885|NCT05132699|100656051|FG000|COMPLETED|Overall Study||8||
48135886|NCT05132699|100656052|FG001|COMPLETED|Overall Study||10||
48135887|NCT05132699|100656051|FG000|NOT COMPLETED|Overall Study||3||
48135888|NCT05132699|100656052|FG001|NOT COMPLETED|Overall Study||0||
48135889|NCT00158743|100656053|FG000|STARTED|Overall Study||24||
48135890|NCT00158743|100656054|FG001|STARTED|Overall Study||27||
48135891|NCT00158743|100656053|FG000|COMPLETED|Overall Study||15||
48135892|NCT00158743|100656054|FG001|COMPLETED|Overall Study||20||
48135893|NCT00158743|100656053|FG000|NOT COMPLETED|Overall Study||9||
48135894|NCT00158743|100656054|FG001|NOT COMPLETED|Overall Study||7||
48135895|NCT02073331|100656055|FG000|STARTED|Overall Study||1420||
48135896|NCT02073331|100656055|FG000|COMPLETED|Overall Study||1420||
48135897|NCT02073331|100656055|FG000|NOT COMPLETED|Overall Study||0||
48135898|NCT03152552|100656056|FG000|STARTED|Treatment Period 1 (12 Weeks)||15|Randomized Set (RAN): all randomized patients|
48135899|NCT03152552|100656057|FG001|STARTED|Treatment Period 1 (12 Weeks)||16|Randomized Set (RAN): all randomized patients|
48135900|NCT03152552|100656058|FG002|STARTED|Treatment Period 1 (12 Weeks)||31|Randomized Set (RAN): all randomized patients|
48135901|NCT03152552|100656059|FG003|STARTED|Treatment Period 1 (12 Weeks)||30|Randomized Set (RAN): all randomized patients|
48135902|NCT03152552|100656060|FG004|STARTED|Treatment Period 1 (12 Weeks)||33|Randomized Set (RAN): all randomized patients|
48135903|NCT03152552|100656056|FG000|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||15|All patients in RAN who were not mis-randomized|
48135904|NCT03152552|100656057|FG001|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||16|All patients in RAN who were not mis-randomized|
48135905|NCT03152552|100656058|FG002|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||30|All patients in RAN who were not mis-randomized|
48135906|NCT03152552|100656059|FG003|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||30|All patients in RAN who were not mis-randomized|
48135907|NCT03152552|100656060|FG004|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||33|All patients in RAN who were not mis-randomized|
48135908|NCT03152552|100656056|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||7|Completed EPOCH 3 (double-blind period 1)|
48135909|NCT03152552|100656057|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||5|Completed EPOCH 3 (double-blind period 1)|
48135910|NCT03152552|100656058|FG002|COMPLETED|Treatment Period 1 (12 Weeks)||10|Completed EPOCH 3 (double-blind period 1)|
48135911|NCT03152552|100656059|FG003|COMPLETED|Treatment Period 1 (12 Weeks)||10|Completed EPOCH 3 (double-blind period 1)|
48135912|NCT03152552|100656060|FG004|COMPLETED|Treatment Period 1 (12 Weeks)||12|Completed EPOCH 3 (double-blind period 1)|
48400373|NCT05158179|101309366|FG000|NOT COMPLETED|Overall Study||0||
48400374|NCT00653328|101309367|FG000|STARTED|Overall Study||15||
48400375|NCT00653328|101309367|FG000|COMPLETED|Overall Study||0||
48400376|NCT00653328|101309367|FG000|NOT COMPLETED|Overall Study||15||
48400377|NCT03892707|101309368|FG000|STARTED|Overall Study||250||
48400378|NCT03892707|101309369|FG001|STARTED|Overall Study||250||
48400379|NCT03892707|101309368|FG000|Started Study Treatment at Baseline|Overall Study||244||
48400380|NCT03892707|101309369|FG001|Started Study Treatment at Baseline|Overall Study||250||
48400381|NCT03892707|101309368|FG000|COMPLETED|Overall Study||244||
48400382|NCT03892707|101309369|FG001|COMPLETED|Overall Study||244||
48400383|NCT03892707|101309368|FG000|NOT COMPLETED|Overall Study||6||
48400384|NCT03892707|101309369|FG001|NOT COMPLETED|Overall Study||6||
48400385|NCT03537092|101309370|FG000|STARTED|Overall Study||64||
48400386|NCT03537092|101309370|FG000|COMPLETED|Overall Study||64||
48135913|NCT03152552|100656056|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8||
48135914|NCT03152552|100656057|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11||
48135915|NCT03152552|100656058|FG002|NOT COMPLETED|Treatment Period 1 (12 Weeks)||21||
48135916|NCT03152552|100656059|FG003|NOT COMPLETED|Treatment Period 1 (12 Weeks)||20||
48135917|NCT03152552|100656060|FG004|NOT COMPLETED|Treatment Period 1 (12 Weeks)||21||
48400387|NCT03537092|101309370|FG000|NOT COMPLETED|Overall Study||0||
48400388|NCT02814448|101309371|FG000|STARTED|Overall Study||27||
48400389|NCT02814448|101309372|FG001|STARTED|Overall Study||24||
48400390|NCT02814448|101309373|FG002|STARTED|Overall Study||26||
48400391|NCT02814448|101309374|FG003|STARTED|Overall Study||25||
48400392|NCT02814448|101309375|FG004|STARTED|Overall Study||28||
48400393|NCT02814448|101309371|FG000|COMPLETED|Overall Study||27||
48135918|NCT03152552|100656056|FG000|STARTED|Treatment Period 2 (24 Weeks)||7||
48135919|NCT03152552|100656057|FG001|STARTED|Treatment Period 2 (24 Weeks)||5||
48135920|NCT03152552|100656058|FG002|STARTED|Treatment Period 2 (24 Weeks)||9||
48135921|NCT03152552|100656059|FG003|STARTED|Treatment Period 2 (24 Weeks)||9||
48135922|NCT03152552|100656060|FG004|STARTED|Treatment Period 2 (24 Weeks)||11||
48135923|NCT03152552|100656056|FG000|COMPLETED|Treatment Period 2 (24 Weeks)||1|Completed EPOCH 4 (double-blind period 2)|
48135924|NCT03152552|100656057|FG001|COMPLETED|Treatment Period 2 (24 Weeks)||0|Completed EPOCH 4 (double-blind period 2)|
48135925|NCT03152552|100656058|FG002|COMPLETED|Treatment Period 2 (24 Weeks)||0|Completed EPOCH 4 (double-blind period 2)|
48135926|NCT03152552|100656059|FG003|COMPLETED|Treatment Period 2 (24 Weeks)||0|Completed EPOCH 4 (double-blind period 2)|
48135927|NCT03152552|100656060|FG004|COMPLETED|Treatment Period 2 (24 Weeks)||0|Completed EPOCH 4 (double-blind period 2)|
48135928|NCT03152552|100656056|FG000|NOT COMPLETED|Treatment Period 2 (24 Weeks)||6||
48135929|NCT03152552|100656057|FG001|NOT COMPLETED|Treatment Period 2 (24 Weeks)||5||
48141450|NCT01780922|100670425|FG002|COMPLETED|Washout (7 Days)||2||
48580424|NCT00535782|101753230|FG000|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0||
48135930|NCT03152552|100656058|FG002|NOT COMPLETED|Treatment Period 2 (24 Weeks)||9||
48135931|NCT03152552|100656059|FG003|NOT COMPLETED|Treatment Period 2 (24 Weeks)||9||
48135932|NCT03152552|100656060|FG004|NOT COMPLETED|Treatment Period 2 (24 Weeks)||11||
48135933|NCT00490646|100656061|FG000|STARTED|Overall Study||25||
48135934|NCT00490646|100656062|FG001|STARTED|Overall Study||25||
48135935|NCT00490646|100656061|FG000|Treated|Overall Study||24||
48135936|NCT00490646|100656062|FG001|Treated|Overall Study||24||
48135937|NCT00490646|100656061|FG000|COMPLETED|Overall Study||23||
48135938|NCT00490646|100656062|FG001|COMPLETED|Overall Study||23||
48287449|NCT03616977|101029733|FG000|STARTED|Period 2||34||
48287450|NCT03616977|101029734|FG001|STARTED|Period 2||34||
48287451|NCT03616977|101029733|FG000|COMPLETED|Period 2||34||
48287452|NCT03616977|101029734|FG001|COMPLETED|Period 2||34||
48287453|NCT03616977|101029733|FG000|NOT COMPLETED|Period 2||0||
48287454|NCT03616977|101029734|FG001|NOT COMPLETED|Period 2||0||
48287455|NCT03616977|101029733|FG000|STARTED|Period 3||34||
48580425|NCT00535782|101753231|FG001|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||62||
48580426|NCT00535782|101753232|FG002|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0||
48580427|NCT00535782|101753230|FG000|COMPLETED|Part 1: 24-Week Double-blind Period||65||
48580428|NCT00535782|101753231|FG001|COMPLETED|Part 1: 24-Week Double-blind Period||59||
48580429|NCT00535782|101753232|FG002|COMPLETED|Part 1: 24-Week Double-blind Period||0||
48580430|NCT00535782|101753230|FG000|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4||
48580431|NCT00535782|101753231|FG001|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4||
48580432|NCT00535782|101753232|FG002|NOT COMPLETED|Part 1: 24-Week Double-blind Period||0||
48580433|NCT00535782|101753230|FG000|STARTED|Part 2: 80-Week Open-label Period||0||
48287456|NCT03616977|101029734|FG001|STARTED|Period 3||33||
48287457|NCT03616977|101029733|FG000|Received Study Drug|Period 3||33||
48287458|NCT03616977|101029734|FG001|Received Study Drug|Period 3||32||
48287459|NCT03616977|101029733|FG000|COMPLETED|Period 3||33||
48287460|NCT03616977|101029734|FG001|COMPLETED|Period 3||32||
48287461|NCT03616977|101029733|FG000|NOT COMPLETED|Period 3||1||
48287462|NCT03616977|101029734|FG001|NOT COMPLETED|Period 3||1||
48287463|NCT03616977|101029733|FG000|STARTED|Period 4||33||
48580434|NCT00535782|101753231|FG001|STARTED|Part 2: 80-Week Open-label Period||0||
48580435|NCT00535782|101753232|FG002|STARTED|Part 2: 80-Week Open-label Period||124||
48580436|NCT00535782|101753230|FG000|COMPLETED|Part 2: 80-Week Open-label Period||0||
48580437|NCT00535782|101753231|FG001|COMPLETED|Part 2: 80-Week Open-label Period||0||
48580438|NCT00535782|101753232|FG002|COMPLETED|Part 2: 80-Week Open-label Period||98||
48580439|NCT00535782|101753230|FG000|NOT COMPLETED|Part 2: 80-Week Open-label Period||0||
48580440|NCT00535782|101753231|FG001|NOT COMPLETED|Part 2: 80-Week Open-label Period||0||
48580441|NCT00535782|101753232|FG002|NOT COMPLETED|Part 2: 80-Week Open-label Period||26||
48580442|NCT01867710|101753233|FG000|STARTED|Overall Study||41||
48580443|NCT01867710|101753234|FG001|STARTED|Overall Study||41||
48287464|NCT03616977|101029734|FG001|STARTED|Period 4||32||
48287465|NCT03616977|101029733|FG000|COMPLETED|Period 4||33||
48287466|NCT03616977|101029734|FG001|COMPLETED|Period 4||32||
48287467|NCT03616977|101029733|FG000|NOT COMPLETED|Period 4||0||
48287468|NCT03616977|101029734|FG001|NOT COMPLETED|Period 4||0||
48287469|NCT00660543|101029735|FG000|STARTED|Overall Study||14||
48287470|NCT00660543|101029735|FG000|COMPLETED|Overall Study||14||
48287471|NCT00660543|101029735|FG000|NOT COMPLETED|Overall Study||0||
48287472|NCT02055781|101029736|FG000|STARTED|Overall Study||104||
48287473|NCT02055781|101029737|FG001|STARTED|Overall Study||107||
48287474|NCT02055781|101029738|FG002|STARTED|Overall Study||100||
48287475|NCT02055781|101029736|FG000|COMPLETED|Overall Study||62||
48287476|NCT02055781|101029737|FG001|COMPLETED|Overall Study||79||
48580444|NCT01867710|101753235|FG002|STARTED|Overall Study||40||
48580445|NCT01867710|101753236|FG003|STARTED|Overall Study||42||
48580446|NCT01867710|101753233|FG000|Treated|Overall Study||41||
48580447|NCT01867710|101753234|FG001|Treated|Overall Study||41||
48580448|NCT01867710|101753235|FG002|Treated|Overall Study||39||
48135939|NCT00490646|100656061|FG000|NOT COMPLETED|Overall Study||2||
48135940|NCT00490646|100656062|FG001|NOT COMPLETED|Overall Study||2||
48135941|NCT04820673|100656063|FG000|STARTED|Overall Study||300||
48141451|NCT01780922|100670426|FG003|COMPLETED|Washout (7 Days)||2||
48141452|NCT01780922|100670427|FG004|COMPLETED|Washout (7 Days)||2||
48287477|NCT02055781|101029738|FG002|COMPLETED|Overall Study||63||
48287478|NCT02055781|101029736|FG000|NOT COMPLETED|Overall Study||42||
48287479|NCT02055781|101029737|FG001|NOT COMPLETED|Overall Study||28||
48580449|NCT01867710|101753236|FG003|Treated|Overall Study||42||
48580450|NCT01867710|101753233|FG000|COMPLETED|Overall Study||0||
48287480|NCT02055781|101029738|FG002|NOT COMPLETED|Overall Study||37||
48287481|NCT01201265|101029739|FG000|STARTED|Overall Study||40||
48287482|NCT01201265|101029739|FG000|COMPLETED|Overall Study||2||
48287483|NCT01201265|101029739|FG000|NOT COMPLETED|Overall Study||38||
48287484|NCT02234687|101029740|FG000|STARTED|Overall Study||6||
48287485|NCT02234687|101029741|FG001|STARTED|Overall Study||4||
48580451|NCT01867710|101753234|FG001|COMPLETED|Overall Study||0||
48580452|NCT01867710|101753235|FG002|COMPLETED|Overall Study||0||
48580453|NCT01867710|101753236|FG003|COMPLETED|Overall Study||0||
48580454|NCT01867710|101753233|FG000|NOT COMPLETED|Overall Study||41||
48580455|NCT01867710|101753234|FG001|NOT COMPLETED|Overall Study||41||
48580456|NCT01867710|101753235|FG002|NOT COMPLETED|Overall Study||40||
48580457|NCT01867710|101753236|FG003|NOT COMPLETED|Overall Study||42||
48580458|NCT03589326|101753237|FG000|STARTED|IP (Cycles 1-3) (Cycle Length=28 Days)||164||
48580459|NCT03589326|101753238|FG001|STARTED|IP (Cycles 1-3) (Cycle Length=28 Days)||81||
48580460|NCT03589326|101753237|FG000|Efficacy Evaluable Population|IP (Cycles 1-3) (Cycle Length=28 Days)||154|Efficacy evaluable population was defined as all participants in the ITT population with BCR:ABL1 dominant variant of p190 or p210 confirmed by central lab.|
48580461|NCT03589326|101753238|FG001|Efficacy Evaluable Population|IP (Cycles 1-3) (Cycle Length=28 Days)||78|Efficacy evaluable population was defined as all participants in the ITT population with BCR:ABL1 dominant variant of p190 or p210 confirmed by central lab.|
48580462|NCT03589326|101753237|FG000|Safety Population|IP (Cycles 1-3) (Cycle Length=28 Days)||163|The safety population was defined as all participants who were randomized to the ponatinib or imatinib arm and received at least 1 dose of any study drug.|
48580463|NCT03589326|101753238|FG001|Safety Population|IP (Cycles 1-3) (Cycle Length=28 Days)||81|The safety population was defined as all participants who were randomized to the ponatinib or imatinib arm and received at least 1 dose of any study drug.|
48580464|NCT03589326|101753237|FG000|COMPLETED|IP (Cycles 1-3) (Cycle Length=28 Days)||0||
48580465|NCT03589326|101753238|FG001|COMPLETED|IP (Cycles 1-3) (Cycle Length=28 Days)||0||
48580466|NCT03589326|101753237|FG000|NOT COMPLETED|IP (Cycles 1-3) (Cycle Length=28 Days)||164||
48580467|NCT03589326|101753238|FG001|NOT COMPLETED|IP (Cycles 1-3) (Cycle Length=28 Days)||81||
48287486|NCT02234687|101029742|FG002|STARTED|Overall Study||4||
48287487|NCT02234687|101029740|FG000|COMPLETED|Overall Study||0||
48580468|NCT03589326|101753237|FG000|STARTED|CP (Cycles 4-9) (Cycle Length=28 Days)||0|Participants are still ongoing in Induction Phase.|
48580469|NCT03589326|101753238|FG001|STARTED|CP (Cycles 4-9) (Cycle Length=28 Days)||0|Participants are still ongoing in Induction Phase.|
48580470|NCT03589326|101753237|FG000|COMPLETED|CP (Cycles 4-9) (Cycle Length=28 Days)||0||
48580471|NCT03589326|101753238|FG001|COMPLETED|CP (Cycles 4-9) (Cycle Length=28 Days)||0||
48580472|NCT03589326|101753237|FG000|NOT COMPLETED|CP (Cycles 4-9) (Cycle Length=28 Days)||0||
48580473|NCT03589326|101753238|FG001|NOT COMPLETED|CP (Cycles 4-9) (Cycle Length=28 Days)||0||
48580474|NCT03589326|101753237|FG000|STARTED|MP (Cycles 10-20) (Cycle Length=28 Days)||0|Participants are still ongoing in Induction Phase.|
48580475|NCT03589326|101753238|FG001|STARTED|MP (Cycles 10-20) (Cycle Length=28 Days)||0|Participants are still ongoing in Induction Phase.|
48580476|NCT03589326|101753237|FG000|COMPLETED|MP (Cycles 10-20) (Cycle Length=28 Days)||0||
48580477|NCT03589326|101753238|FG001|COMPLETED|MP (Cycles 10-20) (Cycle Length=28 Days)||0||
48580478|NCT03589326|101753237|FG000|NOT COMPLETED|MP (Cycles 10-20) (Cycle Length=28 Days)||0||
48580479|NCT03589326|101753238|FG001|NOT COMPLETED|MP (Cycles 10-20) (Cycle Length=28 Days)||0||
48580480|NCT03518619|101753239|FG000|STARTED|Overall Study||20||
48580481|NCT03518619|101753239|FG000|COMPLETED|Overall Study||15||
48580482|NCT03518619|101753239|FG000|NOT COMPLETED|Overall Study||5||
48580483|NCT02751450|101753240|FG000|STARTED|Overall Study||117||
48580484|NCT02751450|101753241|FG001|STARTED|Overall Study||116||
48580485|NCT02751450|101753240|FG000|COMPLETED|Overall Study||116||
48580486|NCT02751450|101753241|FG001|COMPLETED|Overall Study||116||
48580487|NCT02751450|101753240|FG000|NOT COMPLETED|Overall Study||1||
48287488|NCT02234687|101029741|FG001|COMPLETED|Overall Study||0||
48580488|NCT02751450|101753241|FG001|NOT COMPLETED|Overall Study||0||
48580489|NCT00776295|101753242|FG000|STARTED|Overall Study||2||
48580490|NCT00776295|101753242|FG000|COMPLETED|Overall Study||2||
48580491|NCT00776295|101753242|FG000|NOT COMPLETED|Overall Study||0||
48580492|NCT01303406|101753243|FG000|STARTED|Overall Study||13||
48580493|NCT01303406|101753244|FG001|STARTED|Overall Study||16||
48580494|NCT01303406|101753243|FG000|COMPLETED|Overall Study||13||
48580495|NCT01303406|101753244|FG001|COMPLETED|Overall Study||15||
48580496|NCT01303406|101753243|FG000|NOT COMPLETED|Overall Study||0||
48580497|NCT01303406|101753244|FG001|NOT COMPLETED|Overall Study||1||
48580498|NCT01146379|101753245|FG000|STARTED|Overall Study||21||
48580499|NCT01146379|101753246|FG001|STARTED|Overall Study||22||
48580500|NCT01146379|101753247|FG002|STARTED|Overall Study||21||
48580501|NCT01146379|101753248|FG003|STARTED|Overall Study||21||
48580502|NCT01146379|101753245|FG000|COMPLETED|Overall Study||20||
48287489|NCT02234687|101029742|FG002|COMPLETED|Overall Study||0||
48287490|NCT02234687|101029740|FG000|NOT COMPLETED|Overall Study||6||
48287491|NCT02234687|101029741|FG001|NOT COMPLETED|Overall Study||4||
48287492|NCT02234687|101029742|FG002|NOT COMPLETED|Overall Study||4||
48287493|NCT01536015|101029743|FG000|STARTED|Overall Study||12||
48287494|NCT01536015|101029744|FG001|STARTED|Overall Study||13||
48287495|NCT01536015|101029743|FG000|COMPLETED|Overall Study||4||
48580503|NCT01146379|101753246|FG001|COMPLETED|Overall Study||21||
48580504|NCT01146379|101753247|FG002|COMPLETED|Overall Study||21||
48580505|NCT01146379|101753248|FG003|COMPLETED|Overall Study||20||
48580506|NCT01146379|101753245|FG000|NOT COMPLETED|Overall Study||1||
48580507|NCT01146379|101753246|FG001|NOT COMPLETED|Overall Study||1||
48580508|NCT01146379|101753247|FG002|NOT COMPLETED|Overall Study||0||
48135942|NCT04820673|100656063|FG000|Safety Analysis Set|Overall Study||300|Safety analysis set included all participants who started the study and received at least one dose of the sarecycline during the study observation period, as part of usual care.|
48135943|NCT04820673|100656063|FG000|Full Analysis Set (FAS)|Overall Study||253|FAS included all participants within the safety population that had at least one question answered pertaining to study primary research objective and who completed their Week-12 survey.|
48135944|NCT04820673|100656063|FG000|COMPLETED|Overall Study||262||
48135945|NCT04820673|100656063|FG000|NOT COMPLETED|Overall Study||38||
48135946|NCT01220557|100656064|FG000|STARTED|Overall Study||81||
48135947|NCT01220557|100656065|FG001|STARTED|Overall Study||79||
48135948|NCT01220557|100656064|FG000|COMPLETED|Overall Study||75||
48135949|NCT01220557|100656065|FG001|COMPLETED|Overall Study||74||
48135950|NCT01220557|100656064|FG000|NOT COMPLETED|Overall Study||6||
48135951|NCT01220557|100656065|FG001|NOT COMPLETED|Overall Study||5||
48400394|NCT02814448|101309372|FG001|COMPLETED|Overall Study||24||
48400395|NCT02814448|101309373|FG002|COMPLETED|Overall Study||25||
48400396|NCT02814448|101309374|FG003|COMPLETED|Overall Study||25||
48400397|NCT02814448|101309375|FG004|COMPLETED|Overall Study||26||
48400398|NCT02814448|101309371|FG000|NOT COMPLETED|Overall Study||0||
48400399|NCT02814448|101309372|FG001|NOT COMPLETED|Overall Study||0||
48135952|NCT01947946|100656066|FG000|STARTED|Overall Study||3||
48400400|NCT02814448|101309373|FG002|NOT COMPLETED|Overall Study||1||
48400401|NCT02814448|101309374|FG003|NOT COMPLETED|Overall Study||0||
48400402|NCT02814448|101309375|FG004|NOT COMPLETED|Overall Study||2||
48400403|NCT04685538|101309376|FG000|STARTED|Overall Study||167||
48400404|NCT04685538|101309377|FG001|STARTED|Overall Study||171||
48400405|NCT04685538|101309376|FG000|COMPLETED|Overall Study||167||
48400406|NCT04685538|101309377|FG001|COMPLETED|Overall Study||168||
48400407|NCT04685538|101309376|FG000|NOT COMPLETED|Overall Study||0||
48400408|NCT04685538|101309377|FG001|NOT COMPLETED|Overall Study||3||
48400409|NCT03054740|101309378|FG000|STARTED|Overall Study||15||
48400410|NCT03054740|101309379|FG001|STARTED|Overall Study||15||
48400411|NCT03054740|101309378|FG000|COMPLETED|Overall Study||15||
48400412|NCT03054740|101309379|FG001|COMPLETED|Overall Study||15||
48400413|NCT03054740|101309378|FG000|NOT COMPLETED|Overall Study||0||
48400414|NCT03054740|101309379|FG001|NOT COMPLETED|Overall Study||0||
48400415|NCT00225212|101313532|FG000|STARTED|Overall Study||35||
48400416|NCT00225212|101313532|FG000|COMPLETED|Overall Study||29||
48400417|NCT00225212|101313532|FG000|NOT COMPLETED|Overall Study||6||
48400418|NCT01390038|101313533|FG000|STARTED|Overall Study||157||
48400419|NCT01390038|101313533|FG000|COMPLETED|Overall Study||149||
48400420|NCT01390038|101313533|FG000|NOT COMPLETED|Overall Study||8||
48400421|NCT02451488|101313534|FG000|STARTED|Overall Study||4||
48400422|NCT02451488|101313535|FG001|STARTED|Overall Study||4||
48400423|NCT02451488|101313534|FG000|COMPLETED|Overall Study||4||
48400424|NCT02451488|101313535|FG001|COMPLETED|Overall Study||4||
48400425|NCT02451488|101313534|FG000|NOT COMPLETED|Overall Study||0||
48400426|NCT02451488|101313535|FG001|NOT COMPLETED|Overall Study||0||
48400427|NCT03674541|101313536|FG000|STARTED|Overall Study||23||
48400428|NCT03674541|101313537|FG001|STARTED|Overall Study||22||
48400429|NCT03674541|101313536|FG000|COMPLETED|Overall Study||23||
48400430|NCT03674541|101313537|FG001|COMPLETED|Overall Study||22||
48400431|NCT03674541|101313536|FG000|NOT COMPLETED|Overall Study||0||
48400432|NCT03674541|101313537|FG001|NOT COMPLETED|Overall Study||0||
48400433|NCT00441480|101313538|FG000|STARTED|Overall Study||46||
48580509|NCT01146379|101753248|FG003|NOT COMPLETED|Overall Study||1||
48580510|NCT00565643|101753249|FG000|STARTED|Overall Study||380||
48580511|NCT00565643|101753250|FG001|STARTED|Overall Study||373||
48580512|NCT00565643|101753249|FG000|Safety Data|Overall Study||380||
48580513|NCT00565643|101753250|FG001|Safety Data|Overall Study||373||
48580514|NCT00565643|101753249|FG000|Primary Outcome (Subsequent Cesarean)|Overall Study||80||
48580515|NCT00565643|101753250|FG001|Primary Outcome (Subsequent Cesarean)|Overall Study||92||
48400434|NCT00441480|101313539|FG001|STARTED|Overall Study||45||
48400435|NCT00441480|101313538|FG000|COMPLETED|Overall Study||43||
48400436|NCT00441480|101313539|FG001|COMPLETED|Overall Study||41||
48580516|NCT00565643|101753249|FG000|COMPLETED|Overall Study||380||
48135953|NCT01947946|100656067|FG001|STARTED|Overall Study||5||
48135954|NCT01947946|100656068|FG002|STARTED|Overall Study||5||
48135955|NCT01947946|100656066|FG000|COMPLETED|Overall Study||0||
48135956|NCT01947946|100656067|FG001|COMPLETED|Overall Study||0||
48135957|NCT01947946|100656068|FG002|COMPLETED|Overall Study||0||
48135958|NCT01947946|100656066|FG000|NOT COMPLETED|Overall Study||3||
48135959|NCT01947946|100656067|FG001|NOT COMPLETED|Overall Study||5||
48135960|NCT01947946|100656068|FG002|NOT COMPLETED|Overall Study||5||
48400437|NCT00441480|101313538|FG000|NOT COMPLETED|Overall Study||3||
48580517|NCT00565643|101753250|FG001|COMPLETED|Overall Study||373||
48580518|NCT00565643|101753249|FG000|NOT COMPLETED|Overall Study||0||
48580519|NCT00565643|101753250|FG001|NOT COMPLETED|Overall Study||0||
48580520|NCT02900560|101753251|FG000|STARTED|Overall Study||9||
48135961|NCT00598689|100656069|FG000|STARTED|Overall Study||40||
48135962|NCT00598689|100656070|FG001|STARTED|Overall Study||40||
48135963|NCT00598689|100656069|FG000|COMPLETED|Overall Study||40||
48135964|NCT00598689|100656070|FG001|COMPLETED|Overall Study||40||
48580521|NCT02900560|101753252|FG001|STARTED|Overall Study||10||
48580522|NCT02900560|101753253|FG002|STARTED|Overall Study||7||
48580523|NCT02900560|101753254|FG003|STARTED|Overall Study||8||
48580524|NCT02900560|101753251|FG000|COMPLETED|Overall Study||7||
48580525|NCT02900560|101753252|FG001|COMPLETED|Overall Study||10||
48580526|NCT02900560|101753253|FG002|COMPLETED|Overall Study||7||
48580527|NCT02900560|101753254|FG003|COMPLETED|Overall Study||8||
48580528|NCT02900560|101753251|FG000|NOT COMPLETED|Overall Study||2||
48580529|NCT02900560|101753252|FG001|NOT COMPLETED|Overall Study||0||
48580530|NCT02900560|101753253|FG002|NOT COMPLETED|Overall Study||0||
48580531|NCT02900560|101753254|FG003|NOT COMPLETED|Overall Study||0||
48580532|NCT04432831|101753255|FG000|STARTED|Overall Study||493||
48580533|NCT04432831|101753256|FG001|STARTED|Overall Study||506||
48580534|NCT04432831|101753257|FG002|STARTED|Overall Study||475||
48135965|NCT00598689|100656069|FG000|NOT COMPLETED|Overall Study||0||
48135966|NCT00598689|100656070|FG001|NOT COMPLETED|Overall Study||0||
48135967|NCT03579563|100656071|FG000|STARTED|Overall Study||49||
48135968|NCT03579563|100656072|FG001|STARTED|Overall Study||45||
48135969|NCT03579563|100656073|FG002|STARTED|Overall Study||52||
48135970|NCT03579563|100656074|FG003|STARTED|Overall Study||45||
48135971|NCT03579563|100656075|FG004|STARTED|Overall Study||46||
48287496|NCT01536015|101029744|FG001|COMPLETED|Overall Study||3||
48287497|NCT01536015|101029743|FG000|NOT COMPLETED|Overall Study||8||
48287498|NCT01536015|101029744|FG001|NOT COMPLETED|Overall Study||10||
48287499|NCT00691327|101029745|FG000|STARTED|Overall Study||45055||
48287500|NCT00691327|101029746|FG001|STARTED|Overall Study||39274||
48580535|NCT04432831|101753255|FG000|Received at Least One Dose of Study Drug|Overall Study||491|Safety-Evaluable Population|
48580536|NCT04432831|101753256|FG001|Received at Least One Dose of Study Drug|Overall Study||500|Safety-Evaluable Population|
48580537|NCT04432831|101753257|FG002|Received at Least One Dose of Study Drug|Overall Study||473|Safety-Evaluable Population|
48580538|NCT04432831|101753255|FG000|COMPLETED|Overall Study||405||
48580539|NCT04432831|101753256|FG001|COMPLETED|Overall Study||407||
48580540|NCT04432831|101753257|FG002|COMPLETED|Overall Study||392||
48580541|NCT04432831|101753255|FG000|NOT COMPLETED|Overall Study||88||
48580542|NCT04432831|101753256|FG001|NOT COMPLETED|Overall Study||99||
48580543|NCT04432831|101753257|FG002|NOT COMPLETED|Overall Study||83||
48580544|NCT03376256|101753258|FG000|STARTED|Overall Study||2||
48580545|NCT03376256|101753259|FG001|STARTED|Overall Study||0||
48580546|NCT03376256|101753258|FG000|COMPLETED|Overall Study||2||
48580547|NCT03376256|101753259|FG001|COMPLETED|Overall Study||0||
48580548|NCT03376256|101753258|FG000|NOT COMPLETED|Overall Study||0||
48580549|NCT03376256|101753259|FG001|NOT COMPLETED|Overall Study||0||
48287501|NCT00691327|101029745|FG000|COMPLETED|Overall Study||42214||
48287502|NCT00691327|101029746|FG001|COMPLETED|Overall Study||36766||
48287503|NCT00691327|101029745|FG000|NOT COMPLETED|Overall Study||2841||
48580550|NCT02046395|101753260|FG000|STARTED|Pre RAS Blockade Washout Period||28||
48580551|NCT02046395|101753260|FG000|COMPLETED|Pre RAS Blockade Washout Period||28||
48580552|NCT02046395|101753260|FG000|NOT COMPLETED|Pre RAS Blockade Washout Period||0||
48580553|NCT02046395|101753260|FG000|STARTED|RAS Blockade Washout Period||28||
48580554|NCT02046395|101753260|FG000|COMPLETED|RAS Blockade Washout Period||28||
48580555|NCT02046395|101753260|FG000|NOT COMPLETED|RAS Blockade Washout Period||0||
48580556|NCT02046395|101753260|FG000|STARTED|Post RAS Blockade Washout Period||28||
48580557|NCT02046395|101753260|FG000|COMPLETED|Post RAS Blockade Washout Period||27||
48580558|NCT02046395|101753260|FG000|NOT COMPLETED|Post RAS Blockade Washout Period||1||
48580559|NCT04075266|101753261|FG000|STARTED|Dose Exploration Period: 24 Week||6||
48580560|NCT04075266|101753262|FG001|STARTED|Dose Exploration Period: 24 Week||17||
48580561|NCT04075266|101753261|FG000|COMPLETED|Dose Exploration Period: 24 Week||6||
48580562|NCT04075266|101753262|FG001|COMPLETED|Dose Exploration Period: 24 Week||17||
48580563|NCT04075266|101753261|FG000|NOT COMPLETED|Dose Exploration Period: 24 Week||0||
48580564|NCT04075266|101753262|FG001|NOT COMPLETED|Dose Exploration Period: 24 Week||0||
48580565|NCT04075266|101753261|FG000|STARTED|OOE Period: 264 Week||6||
48580566|NCT04075266|101753262|FG001|STARTED|OOE Period: 264 Week||17||
48580567|NCT04075266|101753261|FG000|COMPLETED|OOE Period: 264 Week||0||
48580568|NCT04075266|101753262|FG001|COMPLETED|OOE Period: 264 Week||0||
48580569|NCT04075266|101753261|FG000|NOT COMPLETED|OOE Period: 264 Week||6||
48580570|NCT04075266|101753262|FG001|NOT COMPLETED|OOE Period: 264 Week||17||
48135972|NCT03579563|100656076|FG005|STARTED|Overall Study||53||
48135973|NCT03579563|100656071|FG000|COMPLETED|Overall Study||43||
48135974|NCT03579563|100656072|FG001|COMPLETED|Overall Study||41||
48135975|NCT03579563|100656073|FG002|COMPLETED|Overall Study||42||
48135976|NCT03579563|100656074|FG003|COMPLETED|Overall Study||40||
48135977|NCT03579563|100656075|FG004|COMPLETED|Overall Study||39||
48135978|NCT03579563|100656076|FG005|COMPLETED|Overall Study||40||
48135979|NCT03579563|100656071|FG000|NOT COMPLETED|Overall Study||6||
48135980|NCT03579563|100656072|FG001|NOT COMPLETED|Overall Study||4||
48287504|NCT00691327|101029746|FG001|NOT COMPLETED|Overall Study||2508||
48135981|NCT03579563|100656073|FG002|NOT COMPLETED|Overall Study||10||
48704236|NCT01349322|102060687|FG000|Quality of Life Population|Overall Study||429|Eligible, consented, and accrued when QOL substudy was open to enrollment|
48135982|NCT03579563|100656074|FG003|NOT COMPLETED|Overall Study||5||
48135983|NCT03579563|100656075|FG004|NOT COMPLETED|Overall Study||7||
48135984|NCT03579563|100656076|FG005|NOT COMPLETED|Overall Study||13||
48704237|NCT01349322|102060688|FG001|Quality of Life Population|Overall Study||449|Eligible, consented, and accrued when QOL substudy was open to enrollment|
48135985|NCT04495374|100656077|FG000|STARTED|Overall Study||30||
48135986|NCT04495374|100656078|FG001|STARTED|Overall Study||28||
48135987|NCT04495374|100656077|FG000|COMPLETED|Overall Study||28||
48135988|NCT04495374|100656078|FG001|COMPLETED|Overall Study||27||
48135989|NCT04495374|100656077|FG000|NOT COMPLETED|Overall Study||2||
48287505|NCT01236534|101029747|FG000|STARTED|Overall Study||11||
48287506|NCT01236534|101029748|FG001|STARTED|Overall Study||10||
48287507|NCT01236534|101029747|FG000|COMPLETED|Overall Study||8||
48287508|NCT01236534|101029748|FG001|COMPLETED|Overall Study||10||
48287509|NCT01236534|101029747|FG000|NOT COMPLETED|Overall Study||3||
48287510|NCT01236534|101029748|FG001|NOT COMPLETED|Overall Study||0||
48287511|NCT01710891|101029749|FG000|STARTED|Overall Study||95||
48287512|NCT01710891|101029750|FG001|STARTED|Overall Study||103||
48287513|NCT01710891|101029749|FG000|COMPLETED|Overall Study||95||
48287514|NCT01710891|101029750|FG001|COMPLETED|Overall Study||103||
48287515|NCT01710891|101029749|FG000|NOT COMPLETED|Overall Study||0||
48287516|NCT01710891|101029750|FG001|NOT COMPLETED|Overall Study||0||
48400438|NCT00441480|101313539|FG001|NOT COMPLETED|Overall Study||4||
48287517|NCT00704379|101029751|FG000|STARTED|Overall Study||46||
48287518|NCT00704379|101029752|FG001|STARTED|Overall Study||48||
48287519|NCT00704379|101029751|FG000|COMPLETED|Overall Study||39||
48287520|NCT00704379|101029752|FG001|COMPLETED|Overall Study||41||
48287521|NCT00704379|101029751|FG000|NOT COMPLETED|Overall Study||7||
48287522|NCT00704379|101029752|FG001|NOT COMPLETED|Overall Study||7||
48287523|NCT00996476|101029753|FG000|STARTED|Overall Study||27||
48287524|NCT00996476|101029754|FG001|STARTED|Overall Study||26||
48287525|NCT00996476|101029755|FG002|STARTED|Overall Study||13||
48287526|NCT00996476|101029756|FG003|STARTED|Overall Study||13||
48287527|NCT00996476|101029757|FG004|STARTED|Overall Study||13||
48287528|NCT00996476|101029753|FG000|COMPLETED|Overall Study||26||
48287529|NCT00996476|101029754|FG001|COMPLETED|Overall Study||23||
48287530|NCT00996476|101029755|FG002|COMPLETED|Overall Study||12||
48287531|NCT00996476|101029756|FG003|COMPLETED|Overall Study||13||
48287532|NCT00996476|101029757|FG004|COMPLETED|Overall Study||11||
48287533|NCT00996476|101029753|FG000|NOT COMPLETED|Overall Study||1||
48287534|NCT00996476|101029754|FG001|NOT COMPLETED|Overall Study||3||
48400439|NCT01024920|101313540|FG000|STARTED|Overall Study||67||
48400440|NCT01024920|101313541|FG001|STARTED|Overall Study||32||
48400441|NCT01024920|101313540|FG000|Treated|Overall Study||64||
48400442|NCT01024920|101313541|FG001|Treated|Overall Study||32||
48400443|NCT01024920|101313540|FG000|COMPLETED|Overall Study||0||
48400444|NCT01024920|101313541|FG001|COMPLETED|Overall Study||0||
48400445|NCT01024920|101313540|FG000|NOT COMPLETED|Overall Study||67||
48400446|NCT01024920|101313541|FG001|NOT COMPLETED|Overall Study||32||
48400447|NCT00814307|101313542|FG000|STARTED|Overall Study||244||
48400448|NCT00814307|101313543|FG001|STARTED|Overall Study||245||
48400449|NCT00814307|101313544|FG002|STARTED|Overall Study||61||
48400450|NCT00814307|101313545|FG003|STARTED|Overall Study||61||
48400451|NCT00814307|101313542|FG000|Treated|Overall Study||243||
48400452|NCT00814307|101313543|FG001|Treated|Overall Study||245||
48400453|NCT00814307|101313544|FG002|Treated|Overall Study||61||
48400454|NCT00814307|101313545|FG003|Treated|Overall Study||61||
48400455|NCT00814307|101313542|FG000|COMPLETED|Overall Study||232||
48400456|NCT00814307|101313543|FG001|COMPLETED|Overall Study||218||
48400457|NCT00814307|101313544|FG002|COMPLETED|Overall Study||54||
48400458|NCT00814307|101313545|FG003|COMPLETED|Overall Study||51||
48400459|NCT00814307|101313542|FG000|NOT COMPLETED|Overall Study||12||
48400460|NCT00814307|101313543|FG001|NOT COMPLETED|Overall Study||27||
48704238|NCT01349322|102060687|FG000|COMPLETED|Overall Study||1124||
48704239|NCT01349322|102060688|FG001|COMPLETED|Overall Study||1138||
48704240|NCT01349322|102060687|FG000|NOT COMPLETED|Overall Study||45||
48704241|NCT01349322|102060688|FG001|NOT COMPLETED|Overall Study||47||
48400461|NCT00814307|101313544|FG002|NOT COMPLETED|Overall Study||7||
48704242|NCT03373890|102060689|FG000|STARTED|Overall Study||6||
48135990|NCT04495374|100656078|FG001|NOT COMPLETED|Overall Study||1||
48135991|NCT03821376|100656079|FG000|STARTED|Overall Study||12||
48135992|NCT03821376|100656079|FG000|COMPLETED|Overall Study||9||
48135993|NCT03821376|100656079|FG000|NOT COMPLETED|Overall Study||3||
48135994|NCT03473886|100656080|FG000|STARTED|Overall Study||8||
48135995|NCT03473886|100656080|FG000|COMPLETED|Overall Study||7||
48135996|NCT03473886|100656080|FG000|NOT COMPLETED|Overall Study||1||
48287535|NCT00996476|101029755|FG002|NOT COMPLETED|Overall Study||1||
48287536|NCT00996476|101029756|FG003|NOT COMPLETED|Overall Study||0||
48287537|NCT00996476|101029757|FG004|NOT COMPLETED|Overall Study||2||
48287538|NCT02706899|101029758|FG000|STARTED|Overall Study||13||
48287539|NCT02706899|101029759|FG001|STARTED|Overall Study||6||
48287540|NCT02706899|101029758|FG000|COMPLETED|Overall Study||0||
48287541|NCT02706899|101029759|FG001|COMPLETED|Overall Study||0||
48400462|NCT00814307|101313545|FG003|NOT COMPLETED|Overall Study||10||
48135997|NCT00562159|100656081|FG000|STARTED|Overall Study||213||
48135998|NCT00562159|100656082|FG001|STARTED|Overall Study||225||
48135999|NCT00562159|100656081|FG000|COMPLETED|Overall Study||175||
48136000|NCT00562159|100656082|FG001|COMPLETED|Overall Study||192||
48136001|NCT00562159|100656081|FG000|NOT COMPLETED|Overall Study||38||
48136002|NCT00562159|100656082|FG001|NOT COMPLETED|Overall Study||33||
48136003|NCT02828111|100656083|FG000|STARTED|Overall Study||6||
48136004|NCT02828111|100656084|FG001|STARTED|Overall Study||6||
48136005|NCT02828111|100656085|FG002|STARTED|Overall Study||6||
48136006|NCT02828111|100656086|FG003|STARTED|Overall Study||6||
48136007|NCT02828111|100656087|FG004|STARTED|Overall Study||12||
48704243|NCT03373890|102060690|FG001|STARTED|Overall Study||6||
48704244|NCT03373890|102060689|FG000|COMPLETED|Overall Study||6||
48704245|NCT03373890|102060690|FG001|COMPLETED|Overall Study||6||
48704246|NCT03373890|102060689|FG000|NOT COMPLETED|Overall Study||0||
48704247|NCT03373890|102060690|FG001|NOT COMPLETED|Overall Study||0||
48704248|NCT02310230|102060691|FG000|STARTED|Overall Study||50||
48704249|NCT02310230|102060692|FG001|STARTED|Overall Study||50||
48704250|NCT02310230|102060691|FG000|COMPLETED|Overall Study||41||
48704251|NCT02310230|102060692|FG001|COMPLETED|Overall Study||32||
48136008|NCT02828111|100656083|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
48136009|NCT02828111|100656084|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
48704252|NCT02310230|102060691|FG000|NOT COMPLETED|Overall Study||9||
48704253|NCT02310230|102060692|FG001|NOT COMPLETED|Overall Study||18||
48704254|NCT04388319|102060693|FG000|STARTED|Enrolled in Study||26||
48704255|NCT04388319|102060693|FG000|COMPLETED|Enrolled in Study||24||
48136010|NCT02828111|100656085|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
48136011|NCT02828111|100656086|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6||
48704256|NCT04388319|102060693|FG000|NOT COMPLETED|Enrolled in Study||2||
48704257|NCT04388319|102060693|FG000|STARTED|Treatment Period||24||
48704258|NCT04388319|102060693|FG000|COMPLETED|Treatment Period||23||
48136012|NCT02828111|100656087|FG004|Received at Least 1 Dose of Study Drug|Overall Study||12||
48136013|NCT02828111|100656083|FG000|COMPLETED|Overall Study||6||
48136014|NCT02828111|100656084|FG001|COMPLETED|Overall Study||6||
48704259|NCT04388319|102060693|FG000|NOT COMPLETED|Treatment Period||1||
48136015|NCT02828111|100656085|FG002|COMPLETED|Overall Study||4||
48136016|NCT02828111|100656086|FG003|COMPLETED|Overall Study||5||
48136017|NCT02828111|100656087|FG004|COMPLETED|Overall Study||11||
48136018|NCT02828111|100656083|FG000|NOT COMPLETED|Overall Study||0||
48136019|NCT02828111|100656084|FG001|NOT COMPLETED|Overall Study||0||
48136020|NCT02828111|100656085|FG002|NOT COMPLETED|Overall Study||2||
48136021|NCT02828111|100656086|FG003|NOT COMPLETED|Overall Study||1||
48287542|NCT02706899|101029758|FG000|NOT COMPLETED|Overall Study||13||
48704260|NCT02881112|102060694|FG000|STARTED|Overall Study||180||
48704261|NCT02881112|102060694|FG000|COMPLETED|Overall Study||152||
48704262|NCT02881112|102060694|FG000|NOT COMPLETED|Overall Study||28||
48704263|NCT00420004|102060695|FG000|STARTED|Overall Study||269||
48704264|NCT00420004|102060696|FG001|STARTED|Overall Study||138||
48704265|NCT00420004|102060697|FG002|STARTED|Overall Study||62||
48704266|NCT00420004|102060695|FG000|Received at Least 1 Dose of Study Drug|Overall Study||249||
48704267|NCT00420004|102060696|FG001|Received at Least 1 Dose of Study Drug|Overall Study||122||
48704268|NCT00420004|102060697|FG002|Received at Least 1 Dose of Study Drug|Overall Study||54||
48704269|NCT00420004|102060695|FG000|COMPLETED|Overall Study||140||
48704270|NCT00420004|102060696|FG001|COMPLETED|Overall Study||67||
48704271|NCT00420004|102060697|FG002|COMPLETED|Overall Study||30||
48704272|NCT00420004|102060695|FG000|NOT COMPLETED|Overall Study||129||
48704273|NCT00420004|102060696|FG001|NOT COMPLETED|Overall Study||71||
48704274|NCT00420004|102060697|FG002|NOT COMPLETED|Overall Study||32||
48704275|NCT01070693|102060698|FG000|STARTED|Overall Study||150||
48704276|NCT01070693|102060699|FG001|STARTED|Overall Study||149||
48704277|NCT01070693|102060698|FG000|COMPLETED|Overall Study||122||
48704278|NCT01070693|102060699|FG001|COMPLETED|Overall Study||110||
48136022|NCT02828111|100656087|FG004|NOT COMPLETED|Overall Study||1||
48136023|NCT00317239|100656088|FG000|STARTED|Overall Study||147||
48136024|NCT00317239|100656089|FG001|STARTED|Overall Study||103||
48136025|NCT00317239|100656088|FG000|COMPLETED|Overall Study||134||
48136026|NCT00317239|100656089|FG001|COMPLETED|Overall Study||84||
48136027|NCT00317239|100656088|FG000|NOT COMPLETED|Overall Study||13||
48136028|NCT00317239|100656089|FG001|NOT COMPLETED|Overall Study||19||
48136029|NCT03523533|100656090|FG000|STARTED|Overall Study||5||
48136030|NCT03523533|100656090|FG000|COMPLETED|Overall Study||5||
48136031|NCT03523533|100656090|FG000|NOT COMPLETED|Overall Study||0||
48136032|NCT03726346|100656091|FG000|STARTED|Overall Study||39||
48136033|NCT03726346|100656091|FG000|COMPLETED|Overall Study||39||
48136034|NCT03726346|100656091|FG000|NOT COMPLETED|Overall Study||0||
48136035|NCT04757753|100656092|FG000|STARTED|Overall Study||77||
48136036|NCT04757753|100656093|FG001|STARTED|Overall Study||83||
48136037|NCT04757753|100656092|FG000|COMPLETED|Overall Study||66||
48136038|NCT04757753|100656093|FG001|COMPLETED|Overall Study||71||
48136039|NCT04757753|100656092|FG000|NOT COMPLETED|Overall Study||11||
48287543|NCT02706899|101029759|FG001|NOT COMPLETED|Overall Study||6||
48704279|NCT01070693|102060698|FG000|NOT COMPLETED|Overall Study||28||
48136040|NCT04757753|100656093|FG001|NOT COMPLETED|Overall Study||12||
48136041|NCT03151265|100656094|FG000|STARTED|Overall Study||20||
48136042|NCT03151265|100656095|FG001|STARTED|Overall Study||20||
48136043|NCT03151265|100656094|FG000|COMPLETED|Overall Study||20||
48136044|NCT03151265|100656095|FG001|COMPLETED|Overall Study||20||
48136045|NCT03151265|100656094|FG000|NOT COMPLETED|Overall Study||0||
48136046|NCT03151265|100656095|FG001|NOT COMPLETED|Overall Study||0||
48136047|NCT00803647|100656096|FG000|STARTED|Overall Study||20||
48136048|NCT00803647|100656096|FG000|COMPLETED|Overall Study||20||
48136049|NCT00803647|100656096|FG000|NOT COMPLETED|Overall Study||0||
48136050|NCT02075593|100656097|FG000|STARTED|Overall Study||4||
48136051|NCT02075593|100656097|FG000|Infants Born to Pregnant Women Who Received at Least One Dose of Study Treatment|Overall Study||4||
48136052|NCT02075593|100656097|FG000|COMPLETED|Overall Study||3||
48136053|NCT02075593|100656097|FG000|NOT COMPLETED|Overall Study||1||
48136054|NCT03521635|100656098|FG000|STARTED|Overall Study||49||
48136055|NCT03521635|100656099|FG001|STARTED|Overall Study||49||
48136056|NCT03521635|100656098|FG000|COMPLETED|Overall Study||45||
48136057|NCT03521635|100656099|FG001|COMPLETED|Overall Study||43||
48136058|NCT03521635|100656098|FG000|NOT COMPLETED|Overall Study||4||
48136059|NCT03521635|100656099|FG001|NOT COMPLETED|Overall Study||6||
48136060|NCT03727750|100656100|FG000|STARTED|Overall Study||51||
48136061|NCT03727750|100656100|FG000|Safety Set|Overall Study||50||
48136062|NCT03727750|100656100|FG000|COMPLETED|Overall Study||2||
48136063|NCT03727750|100656100|FG000|NOT COMPLETED|Overall Study||49||
48136064|NCT02416791|100656101|FG000|STARTED|6 Weeks||3||
48136065|NCT02416791|100656102|FG001|STARTED|6 Weeks||3||
48136066|NCT02416791|100656103|FG002|STARTED|6 Weeks||3||
48136067|NCT02416791|100656101|FG000|COMPLETED|6 Weeks||3||
48136068|NCT02416791|100656102|FG001|COMPLETED|6 Weeks||3||
48136069|NCT02416791|100656103|FG002|COMPLETED|6 Weeks||3||
48136070|NCT02416791|100656101|FG000|NOT COMPLETED|6 Weeks||0||
48136071|NCT02416791|100656102|FG001|NOT COMPLETED|6 Weeks||0||
48136072|NCT02416791|100656103|FG002|NOT COMPLETED|6 Weeks||0||
48136073|NCT02416791|100656101|FG000|STARTED|6 Months||3||
48136074|NCT02416791|100656102|FG001|STARTED|6 Months||3||
48136075|NCT02416791|100656103|FG002|STARTED|6 Months||3||
48136076|NCT02416791|100656101|FG000|COMPLETED|6 Months||3||
48287544|NCT00267631|101029760|FG000|STARTED|Overall Study||2361||
48287545|NCT00267631|101029761|FG001|STARTED|Overall Study||3031||
48287546|NCT00267631|101029760|FG000|COMPLETED|Overall Study||2361||
48287547|NCT00267631|101029761|FG001|COMPLETED|Overall Study||3031||
48287548|NCT00267631|101029760|FG000|NOT COMPLETED|Overall Study||0||
48287549|NCT00267631|101029761|FG001|NOT COMPLETED|Overall Study||0||
48287550|NCT00352911|101029762|FG000|STARTED|150mg Twice Daily (14 Days)||16||
48287551|NCT00352911|101029763|FG001|STARTED|150mg Twice Daily (14 Days)||3||
48580571|NCT05139303|101753263|FG000|STARTED|Overall Study||37||
48580572|NCT05139303|101753264|FG001|STARTED|Overall Study||59||
48580573|NCT05139303|101753263|FG000|COMPLETED|Overall Study||33||
48580574|NCT05139303|101753264|FG001|COMPLETED|Overall Study||59||
48580575|NCT05139303|101753263|FG000|NOT COMPLETED|Overall Study||4||
48580576|NCT05139303|101753264|FG001|NOT COMPLETED|Overall Study||0||
48580577|NCT02792192|101753265|FG000|STARTED|Overall Study||12||
48580578|NCT02792192|101753266|FG001|STARTED|Overall Study||12||
48580579|NCT02792192|101753267|FG002|STARTED|Overall Study||0||
48580580|NCT02792192|101753268|FG003|STARTED|Overall Study||0||
48580581|NCT02792192|101753265|FG000|COMPLETED|Overall Study||0||
48580582|NCT02792192|101753266|FG001|COMPLETED|Overall Study||1||
48580583|NCT02792192|101753267|FG002|COMPLETED|Overall Study||0||
48580584|NCT02792192|101753268|FG003|COMPLETED|Overall Study||0||
48580585|NCT02792192|101753265|FG000|NOT COMPLETED|Overall Study||12||
48580586|NCT02792192|101753266|FG001|NOT COMPLETED|Overall Study||11||
48580587|NCT02792192|101753267|FG002|NOT COMPLETED|Overall Study||0||
48580588|NCT02792192|101753268|FG003|NOT COMPLETED|Overall Study||0||
48580589|NCT03615144|101753269|FG000|STARTED|Overall Study||1||
48580590|NCT03615144|101753270|FG001|STARTED|Overall Study||0||
48580591|NCT03615144|101753269|FG000|COMPLETED|Overall Study||0||
48580592|NCT03615144|101753270|FG001|COMPLETED|Overall Study||0||
48580593|NCT03615144|101753269|FG000|NOT COMPLETED|Overall Study||1||
48580594|NCT03615144|101753270|FG001|NOT COMPLETED|Overall Study||0||
48580595|NCT01493284|101753271|FG000|STARTED|Overall Study||222||
48580596|NCT01493284|101753271|FG000|COMPLETED|Overall Study||161||
48580597|NCT01493284|101753271|FG000|NOT COMPLETED|Overall Study||61||
48580598|NCT03626363|101753272|FG000|STARTED|Overall Study||27||
48704280|NCT01070693|102060699|FG001|NOT COMPLETED|Overall Study||39||
48704281|NCT04098367|102060700|FG000|STARTED|Overall Study||63||
48704282|NCT04098367|102060701|FG001|STARTED|Overall Study||65||
48704283|NCT04098367|102060702|FG002|STARTED|Overall Study||65||
48704284|NCT04098367|102060700|FG000|First Eye Implanted|Overall Study||63||
48704285|NCT04098367|102060701|FG001|First Eye Implanted|Overall Study||65||
48136077|NCT02416791|100656102|FG001|COMPLETED|6 Months||3||
48136078|NCT02416791|100656103|FG002|COMPLETED|6 Months||2||
48136079|NCT02416791|100656101|FG000|NOT COMPLETED|6 Months||0||
48136080|NCT02416791|100656102|FG001|NOT COMPLETED|6 Months||0||
48136081|NCT02416791|100656103|FG002|NOT COMPLETED|6 Months||1||
48136082|NCT00448539|100656104|FG000|STARTED|Overall Study||134||
48136083|NCT00448539|100656105|FG001|STARTED|Overall Study||152||
48136084|NCT00448539|100656104|FG000|COMPLETED|Overall Study||0||
48136085|NCT00448539|100656105|FG001|COMPLETED|Overall Study||0||
48136086|NCT00448539|100656104|FG000|NOT COMPLETED|Overall Study||134||
48136087|NCT00448539|100656105|FG001|NOT COMPLETED|Overall Study||152||
48136088|NCT01866410|100656106|FG000|STARTED|Overall Study||37||
48136089|NCT01866410|100656106|FG000|COMPLETED|Overall Study||37||
48136090|NCT01866410|100656106|FG000|NOT COMPLETED|Overall Study||0||
48136091|NCT02864082|100656107|FG000|STARTED|Overall Study||10||
48136092|NCT02864082|100656108|FG001|STARTED|Overall Study||9||
48136093|NCT02864082|100656107|FG000|COMPLETED|Overall Study||7||
48136094|NCT02864082|100656108|FG001|COMPLETED|Overall Study||5||
48136095|NCT02864082|100656107|FG000|NOT COMPLETED|Overall Study||3||
48136096|NCT02864082|100656108|FG001|NOT COMPLETED|Overall Study||4||
48136097|NCT00116805|100656109|FG000|STARTED|Double-blind Period Through Week 48||176||
48136098|NCT00116805|100656110|FG001|STARTED|Double-blind Period Through Week 48||90||
48136099|NCT00116805|100656109|FG000|COMPLETED|Double-blind Period Through Week 48||165||
48136100|NCT00116805|100656110|FG001|COMPLETED|Double-blind Period Through Week 48||85||
48136101|NCT00116805|100656109|FG000|NOT COMPLETED|Double-blind Period Through Week 48||11||
48136102|NCT00116805|100656110|FG001|NOT COMPLETED|Double-blind Period Through Week 48||5||
48136103|NCT00116805|100656109|FG000|STARTED|Open-label Period Weeks 49 - 96||154||
48136104|NCT00116805|100656110|FG001|STARTED|Open-label Period Weeks 49 - 96||84||
48136105|NCT00116805|100656109|FG000|COMPLETED|Open-label Period Weeks 49 - 96||144||
48136106|NCT00116805|100656110|FG001|COMPLETED|Open-label Period Weeks 49 - 96||83||
48580599|NCT03626363|101753273|FG001|STARTED|Overall Study||25||
48580600|NCT03626363|101753272|FG000|COMPLETED|Overall Study||18||
48704286|NCT04098367|102060702|FG002|First Eye Implanted|Overall Study||65||
48704287|NCT04098367|102060700|FG000|Second Eye Implanted|Overall Study||63||
48704288|NCT04098367|102060701|FG001|Second Eye Implanted|Overall Study||65||
48136107|NCT00116805|100656109|FG000|NOT COMPLETED|Open-label Period Weeks 49 - 96||10||
48136108|NCT00116805|100656110|FG001|NOT COMPLETED|Open-label Period Weeks 49 - 96||1||
48287552|NCT00352911|101029762|FG000|COMPLETED|150mg Twice Daily (14 Days)||16||
48287553|NCT00352911|101029763|FG001|COMPLETED|150mg Twice Daily (14 Days)||3||
48580601|NCT03626363|101753273|FG001|COMPLETED|Overall Study||18||
48580602|NCT03626363|101753272|FG000|NOT COMPLETED|Overall Study||9||
48710760|NCT00168103|102078008|FG002|NOT COMPLETED|Overall Study||1||
48580603|NCT03626363|101753273|FG001|NOT COMPLETED|Overall Study||7||
48580604|NCT03421145|101753274|FG000|STARTED|Overall Study||50||
48580605|NCT03421145|101753275|FG001|STARTED|Overall Study||50||
48580606|NCT03421145|101753276|FG002|STARTED|Overall Study||50||
48580607|NCT03421145|101753277|FG003|STARTED|Overall Study||50||
48580608|NCT03421145|101753274|FG000|COMPLETED|Overall Study||47||
48580609|NCT03421145|101753275|FG001|COMPLETED|Overall Study||48||
48580610|NCT03421145|101753276|FG002|COMPLETED|Overall Study||45||
48580611|NCT03421145|101753277|FG003|COMPLETED|Overall Study||47||
48580612|NCT03421145|101753274|FG000|NOT COMPLETED|Overall Study||3||
48580613|NCT03421145|101753275|FG001|NOT COMPLETED|Overall Study||2||
48580614|NCT03421145|101753276|FG002|NOT COMPLETED|Overall Study||5||
48580615|NCT03421145|101753277|FG003|NOT COMPLETED|Overall Study||3||
48136109|NCT00116805|100656109|FG000|STARTED|Open-label Period Weeks 97 - 144||144||
48136110|NCT00116805|100656110|FG001|STARTED|Open-label Period Weeks 97 - 144||83||
48136111|NCT00116805|100656109|FG000|COMPLETED|Open-label Period Weeks 97 - 144||133||
48136112|NCT00116805|100656110|FG001|COMPLETED|Open-label Period Weeks 97 - 144||74||
48136113|NCT00116805|100656109|FG000|NOT COMPLETED|Open-label Period Weeks 97 - 144||11||
48136114|NCT00116805|100656110|FG001|NOT COMPLETED|Open-label Period Weeks 97 - 144||9||
48136115|NCT00116805|100656109|FG000|STARTED|Open-label Period Weeks 145 - 192||133||
48287554|NCT00352911|101029762|FG000|NOT COMPLETED|150mg Twice Daily (14 Days)||0||
48580616|NCT00569673|101753278|FG000|STARTED|Overall Study||71||
48580617|NCT00569673|101753278|FG000|COMPLETED|Overall Study||71||
48580618|NCT00569673|101753278|FG000|NOT COMPLETED|Overall Study||0||
48580619|NCT03365635|101753279|FG000|STARTED|Overall Study||3||
48400463|NCT02104141|101313546|FG000|STARTED|Overall Study||51||
48580620|NCT03365635|101753280|FG001|STARTED|Overall Study||0||
48580621|NCT03365635|101753281|FG002|STARTED|Overall Study||1||
48580622|NCT03365635|101753282|FG003|STARTED|Overall Study||0||
48580623|NCT03365635|101753283|FG004|STARTED|Overall Study||0||
48136116|NCT00116805|100656110|FG001|STARTED|Open-label Period Weeks 145 - 192||74||
48136117|NCT00116805|100656109|FG000|COMPLETED|Open-label Period Weeks 145 - 192||123||
48136118|NCT00116805|100656110|FG001|COMPLETED|Open-label Period Weeks 145 - 192||68||
48136119|NCT00116805|100656109|FG000|NOT COMPLETED|Open-label Period Weeks 145 - 192||10||
48136120|NCT00116805|100656110|FG001|NOT COMPLETED|Open-label Period Weeks 145 - 192||6||
48136121|NCT00116805|100656109|FG000|STARTED|Open-label Period Weeks 193 - 240||123||
48136122|NCT00116805|100656110|FG001|STARTED|Open-label Period Weeks 193 - 240||68||
48400464|NCT02104141|101313546|FG000|COMPLETED|Overall Study||51||
48400465|NCT02104141|101313546|FG000|NOT COMPLETED|Overall Study||0||
48136123|NCT00116805|100656109|FG000|COMPLETED|Open-label Period Weeks 193 - 240||110||
48136124|NCT00116805|100656110|FG001|COMPLETED|Open-label Period Weeks 193 - 240||64||
48136125|NCT00116805|100656109|FG000|NOT COMPLETED|Open-label Period Weeks 193 - 240||13||
48136126|NCT00116805|100656110|FG001|NOT COMPLETED|Open-label Period Weeks 193 - 240||4||
48136127|NCT00116805|100656109|FG000|STARTED|Open-label Period Weeks 241 - 288||110||
48287555|NCT00352911|101029763|FG001|NOT COMPLETED|150mg Twice Daily (14 Days)||0||
48287556|NCT00352911|101029762|FG000|STARTED|300mg Twice Daily (14 Days)||16||
48287557|NCT00352911|101029763|FG001|STARTED|300mg Twice Daily (14 Days)||3||
48287558|NCT00352911|101029762|FG000|COMPLETED|300mg Twice Daily (14 Days)||15||
48287559|NCT00352911|101029763|FG001|COMPLETED|300mg Twice Daily (14 Days)||3||
48287560|NCT00352911|101029762|FG000|NOT COMPLETED|300mg Twice Daily (14 Days)||1||
48287561|NCT00352911|101029763|FG001|NOT COMPLETED|300mg Twice Daily (14 Days)||0||
48287562|NCT00918580|101029764|FG000|STARTED|Up to 6-month Follow-up(FU)||158||
48400466|NCT01569087|101313547|FG000|STARTED|Overall Study||21||
48400467|NCT01569087|101313548|FG001|STARTED|Overall Study||20||
48287563|NCT00918580|101029764|FG000|Vaccinated Dose 1|Up to 6-month Follow-up(FU)||158||
48287564|NCT00918580|101029764|FG000|Vaccinated Dose 2|Up to 6-month Follow-up(FU)||146||
48400468|NCT01569087|101313549|FG002|STARTED|Overall Study||19||
48287565|NCT00918580|101029764|FG000|COMPLETED|Up to 6-month Follow-up(FU)||147||
48287566|NCT00918580|101029764|FG000|NOT COMPLETED|Up to 6-month Follow-up(FU)||11||
48287567|NCT00918580|101029764|FG000|STARTED|After 6-month FU to 1-year FU||147||
48287568|NCT00918580|101029764|FG000|Continued After 6-Month FU|After 6-month FU to 1-year FU||89||
48287569|NCT00918580|101029764|FG000|COMPLETED|After 6-month FU to 1-year FU||87||
48287570|NCT00918580|101029764|FG000|NOT COMPLETED|After 6-month FU to 1-year FU||60||
48287571|NCT00842985|101029765|FG000|STARTED|Screening||53||
48287572|NCT00842985|101029765|FG000|COMPLETED|Screening||26||
48287573|NCT00842985|101029765|FG000|NOT COMPLETED|Screening||27||
48287574|NCT00842985|101029765|FG000|STARTED|First Intervention||26||
48287575|NCT00842985|101029765|FG000|COMPLETED|First Intervention||20||
48287576|NCT00842985|101029765|FG000|NOT COMPLETED|First Intervention||6||
48287577|NCT00842985|101029765|FG000|STARTED|Washout Period of GE 4 Days||20||
48287578|NCT00842985|101029765|FG000|COMPLETED|Washout Period of GE 4 Days||18||
48287579|NCT00842985|101029765|FG000|NOT COMPLETED|Washout Period of GE 4 Days||2||
48287580|NCT00842985|101029765|FG000|STARTED|Second Intervention||18||
48287581|NCT00842985|101029765|FG000|COMPLETED|Second Intervention||17||
48287582|NCT00842985|101029765|FG000|NOT COMPLETED|Second Intervention||1||
48287583|NCT00842985|101029765|FG000|STARTED|Washout Period of GE 4 Days||17||
48287584|NCT00842985|101029765|FG000|COMPLETED|Washout Period of GE 4 Days||15||
48287585|NCT00842985|101029765|FG000|NOT COMPLETED|Washout Period of GE 4 Days||2||
48580624|NCT03365635|101753284|FG005|STARTED|Overall Study||0||
48580625|NCT03365635|101753279|FG000|COMPLETED|Overall Study||3||
48580626|NCT03365635|101753280|FG001|COMPLETED|Overall Study||0||
48580627|NCT03365635|101753281|FG002|COMPLETED|Overall Study||1||
48580628|NCT03365635|101753282|FG003|COMPLETED|Overall Study||0||
48580629|NCT03365635|101753283|FG004|COMPLETED|Overall Study||0||
48580630|NCT03365635|101753284|FG005|COMPLETED|Overall Study||0||
48580631|NCT03365635|101753279|FG000|NOT COMPLETED|Overall Study||0||
48580632|NCT03365635|101753280|FG001|NOT COMPLETED|Overall Study||0||
48580633|NCT03365635|101753281|FG002|NOT COMPLETED|Overall Study||0||
48580634|NCT03365635|101753282|FG003|NOT COMPLETED|Overall Study||0||
48580635|NCT03365635|101753283|FG004|NOT COMPLETED|Overall Study||0||
48580636|NCT03365635|101753284|FG005|NOT COMPLETED|Overall Study||0||
48580637|NCT01413750|101753285|FG000|STARTED|Overall Study||6||
48580638|NCT01413750|101753286|FG001|STARTED|Overall Study||6||
48580639|NCT01413750|101753287|FG002|STARTED|Overall Study||4||
48580640|NCT01413750|101753288|FG003|STARTED|Overall Study||7||
48580641|NCT01413750|101753285|FG000|COMPLETED|Overall Study||6||
48580642|NCT01413750|101753286|FG001|COMPLETED|Overall Study||6||
48580643|NCT01413750|101753287|FG002|COMPLETED|Overall Study||4||
48287586|NCT00842985|101029765|FG000|STARTED|Third Intervention||15||
48287587|NCT00842985|101029765|FG000|COMPLETED|Third Intervention||15||
48580644|NCT01413750|101753288|FG003|COMPLETED|Overall Study||7||
48580645|NCT01413750|101753285|FG000|NOT COMPLETED|Overall Study||0||
48580646|NCT01413750|101753286|FG001|NOT COMPLETED|Overall Study||0||
48580647|NCT01413750|101753287|FG002|NOT COMPLETED|Overall Study||0||
48580648|NCT01413750|101753288|FG003|NOT COMPLETED|Overall Study||0||
48580649|NCT03396315|101753289|FG000|STARTED|Overall Study||18||
48287588|NCT00842985|101029765|FG000|NOT COMPLETED|Third Intervention||0||
48287589|NCT00842985|101029765|FG000|STARTED|Washout Period of GE 4 Days||15||
48287590|NCT00842985|101029765|FG000|COMPLETED|Washout Period of GE 4 Days||15||
48287591|NCT00842985|101029765|FG000|NOT COMPLETED|Washout Period of GE 4 Days||0||
48287592|NCT00842985|101029765|FG000|STARTED|Fourth Intervention||15||
48287593|NCT00842985|101029765|FG000|COMPLETED|Fourth Intervention||15||
48287594|NCT00842985|101029765|FG000|NOT COMPLETED|Fourth Intervention||0||
48287595|NCT01480219|101029766|FG000|STARTED|Overall Study||325||
48287596|NCT01480219|101029767|FG001|STARTED|Overall Study||142||
48287597|NCT01480219|101029766|FG000|COMPLETED|Overall Study||325||
48287598|NCT01480219|101029767|FG001|COMPLETED|Overall Study||142||
48580650|NCT03396315|101753290|FG001|STARTED|Overall Study||6||
48580651|NCT03396315|101753289|FG000|COMPLETED|Overall Study||18||
48580652|NCT03396315|101753290|FG001|COMPLETED|Overall Study||6||
48580653|NCT03396315|101753289|FG000|NOT COMPLETED|Overall Study||0||
48580654|NCT03396315|101753290|FG001|NOT COMPLETED|Overall Study||0||
48580655|NCT03921840|101753291|FG000|STARTED|Overall Study||12||
48580656|NCT03921840|101753292|FG001|STARTED|Overall Study||12||
48580657|NCT03921840|101753291|FG000|COMPLETED|Overall Study||11||
48580658|NCT03921840|101753292|FG001|COMPLETED|Overall Study||12||
48580659|NCT03921840|101753291|FG000|NOT COMPLETED|Overall Study||1||
48580660|NCT03921840|101753292|FG001|NOT COMPLETED|Overall Study||0||
48136128|NCT00116805|100656110|FG001|STARTED|Open-label Period Weeks 241 - 288||64||
48580661|NCT02693106|101753293|FG000|STARTED|Overall Study||13||
48580662|NCT02693106|101753293|FG000|COMPLETED|Overall Study||10||
48580663|NCT02693106|101753293|FG000|NOT COMPLETED|Overall Study||3||
48580664|NCT00526669|101753294|FG000|STARTED|7-Day Run-in Monotherapy Treatment Phase||67||
48580665|NCT00526669|101753295|FG001|STARTED|7-Day Run-in Monotherapy Treatment Phase||0||
48580666|NCT00526669|101753294|FG000|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||67||
48580667|NCT00526669|101753295|FG001|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0||
48580668|NCT00526669|101753294|FG000|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0||
48580669|NCT00526669|101753295|FG001|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0||
48580670|NCT00526669|101753294|FG000|STARTED|Combined Treatment Phase||0||
48580671|NCT00526669|101753295|FG001|STARTED|Combined Treatment Phase||67||
48580672|NCT00526669|101753294|FG000|COMPLETED|Combined Treatment Phase||0||
48580673|NCT00526669|101753295|FG001|COMPLETED|Combined Treatment Phase||59||
48580674|NCT00526669|101753294|FG000|NOT COMPLETED|Combined Treatment Phase||0||
48580675|NCT00526669|101753295|FG001|NOT COMPLETED|Combined Treatment Phase||8||
48580676|NCT02987374|101753296|FG000|STARTED|Overall Study||10||
48580677|NCT02987374|101753296|FG000|COMPLETED|Overall Study||10||
48580678|NCT02987374|101753296|FG000|NOT COMPLETED|Overall Study||0||
48580679|NCT04871711|101753297|FG000|STARTED|Overall Study||325||
48580680|NCT04871711|101753298|FG001|STARTED|Overall Study||162||
48580681|NCT04871711|101753297|FG000|COMPLETED|Overall Study||305||
48136129|NCT00116805|100656109|FG000|COMPLETED|Open-label Period Weeks 241 - 288||104||
48580682|NCT04871711|101753298|FG001|COMPLETED|Overall Study||141||
48704289|NCT04098367|102060702|FG002|Second Eye Implanted|Overall Study||63||
48704290|NCT04098367|102060700|FG000|COMPLETED|Overall Study||61||
48704291|NCT04098367|102060701|FG001|COMPLETED|Overall Study||60||
48704292|NCT04098367|102060702|FG002|COMPLETED|Overall Study||61||
48704293|NCT04098367|102060700|FG000|NOT COMPLETED|Overall Study||2||
48704294|NCT04098367|102060701|FG001|NOT COMPLETED|Overall Study||5||
48704295|NCT04098367|102060702|FG002|NOT COMPLETED|Overall Study||4||
48704296|NCT00129701|102060703|FG000|STARTED|Overall Study||104||
48704297|NCT00129701|102060703|FG000|COMPLETED|Overall Study||71||
48704298|NCT00129701|102060703|FG000|NOT COMPLETED|Overall Study||33||
48704299|NCT02826421|102060704|FG000|STARTED|Overall Study||22||
48704300|NCT02826421|102060705|FG001|STARTED|Overall Study||29||
48704301|NCT02826421|102060706|FG002|STARTED|Overall Study||28||
48704302|NCT02826421|102060707|FG003|STARTED|Overall Study||30||
48704303|NCT02826421|102060704|FG000|Treated|Overall Study||19||
48704304|NCT02826421|102060705|FG001|Treated|Overall Study||26||
48704305|NCT02826421|102060706|FG002|Treated|Overall Study||26||
48704306|NCT02826421|102060707|FG003|Treated|Overall Study||28||
48704307|NCT02826421|102060704|FG000|COMPLETED|Overall Study||19||
48704308|NCT02826421|102060705|FG001|COMPLETED|Overall Study||26||
48704309|NCT02826421|102060706|FG002|COMPLETED|Overall Study||26||
48704310|NCT02826421|102060707|FG003|COMPLETED|Overall Study||28||
48704311|NCT02826421|102060704|FG000|NOT COMPLETED|Overall Study||3||
48704312|NCT02826421|102060705|FG001|NOT COMPLETED|Overall Study||3||
48704313|NCT02826421|102060706|FG002|NOT COMPLETED|Overall Study||2||
48704314|NCT02826421|102060707|FG003|NOT COMPLETED|Overall Study||2||
48704315|NCT01559922|102060708|FG000|STARTED|Overall Study||50||
48704316|NCT01559922|102060709|FG001|STARTED|Overall Study||97||
48704317|NCT01559922|102060708|FG000|COMPLETED|Overall Study||46||
48704318|NCT01559922|102060709|FG001|COMPLETED|Overall Study||87||
48704319|NCT01559922|102060708|FG000|NOT COMPLETED|Overall Study||4||
48287599|NCT01480219|101029766|FG000|NOT COMPLETED|Overall Study||0||
48287600|NCT01480219|101029767|FG001|NOT COMPLETED|Overall Study||0||
48287601|NCT03988920|101029768|FG000|STARTED|Overall Study||111||
48287602|NCT03988920|101029769|FG001|STARTED|Overall Study||61||
48287603|NCT03988920|101029768|FG000|COMPLETED|Overall Study||89||
48287604|NCT03988920|101029769|FG001|COMPLETED|Overall Study||35||
48287605|NCT03988920|101029768|FG000|NOT COMPLETED|Overall Study||22||
48287606|NCT03988920|101029769|FG001|NOT COMPLETED|Overall Study||26||
48287607|NCT01323647|101029770|FG000|STARTED|Overall Study||470||
48287608|NCT01323647|101029771|FG001|STARTED|Overall Study||487||
48287609|NCT01323647|101029770|FG000|COMPLETED|Overall Study||461||
48287610|NCT01323647|101029771|FG001|COMPLETED|Overall Study||487||
48287611|NCT01323647|101029770|FG000|NOT COMPLETED|Overall Study||9||
48287612|NCT01323647|101029771|FG001|NOT COMPLETED|Overall Study||0||
48287613|NCT00527592|101029772|FG000|STARTED|Overall Study||54||
48287614|NCT00527592|101029772|FG000|COMPLETED|Overall Study||54||
48287615|NCT00527592|101029772|FG000|NOT COMPLETED|Overall Study||0||
48287616|NCT02128542|101029773|FG000|STARTED|Overall Study||47||
48287617|NCT02128542|101029774|FG001|STARTED|Overall Study||19||
48287618|NCT02128542|101029773|FG000|COMPLETED|Overall Study||43||
48287619|NCT02128542|101029774|FG001|COMPLETED|Overall Study||19||
48136130|NCT00116805|100656110|FG001|COMPLETED|Open-label Period Weeks 241 - 288||64||
48287620|NCT02128542|101029773|FG000|NOT COMPLETED|Overall Study||4||
48287621|NCT02128542|101029774|FG001|NOT COMPLETED|Overall Study||0||
48287622|NCT02910739|101029775|FG000|STARTED|Overall Study||8||
48287623|NCT02910739|101029776|FG001|STARTED|Overall Study||8||
48580683|NCT04871711|101753297|FG000|NOT COMPLETED|Overall Study||20||
48580684|NCT04871711|101753298|FG001|NOT COMPLETED|Overall Study||21||
48580685|NCT02211638|101753299|FG000|STARTED|Overall Study||18113||
48580686|NCT02211638|101753299|FG000|COMPLETED|Overall Study||17130||
48580687|NCT02211638|101753299|FG000|NOT COMPLETED|Overall Study||983||
48580688|NCT02726906|101753300|FG000|STARTED|Overall Study||33||
48580689|NCT02726906|101753301|FG001|STARTED|Overall Study||33||
48580690|NCT02726906|101753300|FG000|COMPLETED|Overall Study||30||
48580691|NCT02726906|101753301|FG001|COMPLETED|Overall Study||30||
48580692|NCT02726906|101753300|FG000|NOT COMPLETED|Overall Study||3||
48580693|NCT02726906|101753301|FG001|NOT COMPLETED|Overall Study||3||
48580694|NCT01116648|101753302|FG000|STARTED|Phase 1 Dose Level 0||3||
48580695|NCT01116648|101753303|FG001|STARTED|Phase 1 Dose Level 0||0||
48580696|NCT01116648|101753304|FG002|STARTED|Phase 1 Dose Level 0||0||
48580697|NCT01116648|101753305|FG003|STARTED|Phase 1 Dose Level 0||0||
48580698|NCT01116648|101753306|FG004|STARTED|Phase 1 Dose Level 0||0||
48580699|NCT01116648|101753307|FG005|STARTED|Phase 1 Dose Level 0||0||
48580700|NCT01116648|101753308|FG006|STARTED|Phase 1 Dose Level 0||0||
48704320|NCT01559922|102060709|FG001|NOT COMPLETED|Overall Study||10||
48704321|NCT03638908|102060710|FG000|STARTED|Overall Study||8||
48704322|NCT03638908|102060710|FG000|COMPLETED|Overall Study||7||
48704323|NCT03638908|102060710|FG000|NOT COMPLETED|Overall Study||1||
48704324|NCT02023801|102060711|FG000|STARTED|Overall Study||24||
48704325|NCT02023801|102060711|FG000|Treated|Overall Study||24||
48704326|NCT02023801|102060711|FG000|COMPLETED|Overall Study||24||
48704327|NCT02023801|102060711|FG000|NOT COMPLETED|Overall Study||0||
48704328|NCT02182440|102060712|FG000|STARTED|Overall Study||116||
48704329|NCT02182440|102060713|FG001|STARTED|Overall Study||39||
48704330|NCT02182440|102060714|FG002|STARTED|Overall Study||35||
48704331|NCT02182440|102060715|FG003|STARTED|Overall Study||111||
48704332|NCT02182440|102060712|FG000|ITTcombined|Overall Study||116|Enrolled patients randomized to study drug, excl patients randomized during IA to 2 dropped doses|
48704333|NCT02182440|102060713|FG001|ITTcombined|Overall Study||31|Enrolled patients randomized to study drug, excl patients randomized during IA to 2 dropped doses|
48704334|NCT02182440|102060714|FG002|ITTcombined|Overall Study||32|Enrolled patients randomized to study drug, excl patients randomized during IA to 2 dropped doses|
48704335|NCT02182440|102060715|FG003|ITTcombined|Overall Study||111|Enrolled patients randomized to study drug, excl patients randomized during IA to 2 dropped doses|
48704336|NCT02182440|102060712|FG000|ITTinterim|Overall Study||30|All randomized patients and included in the interim analysis (IA)|
48704337|NCT02182440|102060713|FG001|ITTinterim|Overall Study||31|All randomized patients and included in the interim analysis (IA)|
48704338|NCT02182440|102060714|FG002|ITTinterim|Overall Study||32|All randomized patients and included in the interim analysis (IA)|
48704339|NCT02182440|102060715|FG003|ITTinterim|Overall Study||29|All randomized patients and included in the interim analysis (IA)|
48704340|NCT02182440|102060712|FG000|Safety Population|Overall Study||112|All randomized patients who received at least one dose of study drug|
48704341|NCT02182440|102060713|FG001|Safety Population|Overall Study||38|All randomized patients who received at least one dose of study drug|
48136131|NCT00116805|100656109|FG000|NOT COMPLETED|Open-label Period Weeks 241 - 288||6||
48136132|NCT00116805|100656110|FG001|NOT COMPLETED|Open-label Period Weeks 241 - 288||0||
48136133|NCT00116805|100656109|FG000|STARTED|Open-label Period Weeks 289 - 336||104||
48136134|NCT00116805|100656110|FG001|STARTED|Open-label Period Weeks 289 - 336||64||
48136135|NCT00116805|100656109|FG000|COMPLETED|Open-label Period Weeks 289 - 336||98||
48136136|NCT00116805|100656110|FG001|COMPLETED|Open-label Period Weeks 289 - 336||57||
48136137|NCT00116805|100656109|FG000|NOT COMPLETED|Open-label Period Weeks 289 - 336||6||
48287624|NCT02910739|101029777|FG002|STARTED|Overall Study||0||
48287625|NCT02910739|101029778|FG003|STARTED|Overall Study||0||
48287626|NCT02910739|101029775|FG000|COMPLETED|Overall Study||7||
48580701|NCT01116648|101753309|FG007|STARTED|Phase 1 Dose Level 0||0||
48580702|NCT01116648|101753310|FG008|STARTED|Phase 1 Dose Level 0||0||
48580703|NCT01116648|101753311|FG009|STARTED|Phase 1 Dose Level 0||0||
48580704|NCT01116648|101753312|FG010|STARTED|Phase 1 Dose Level 0||0||
48580705|NCT01116648|101753313|FG011|STARTED|Phase 1 Dose Level 0||0||
48580706|NCT01116648|101753314|FG012|STARTED|Phase 1 Dose Level 0||0||
48580707|NCT01116648|101753315|FG013|STARTED|Phase 1 Dose Level 0||0||
48580708|NCT01116648|101753316|FG014|STARTED|Phase 1 Dose Level 0||0||
48580709|NCT01116648|101753302|FG000|COMPLETED|Phase 1 Dose Level 0||3||
48580710|NCT01116648|101753303|FG001|COMPLETED|Phase 1 Dose Level 0||0||
48287627|NCT02910739|101029776|FG001|COMPLETED|Overall Study||8||
48287628|NCT02910739|101029777|FG002|COMPLETED|Overall Study||0||
48287629|NCT02910739|101029778|FG003|COMPLETED|Overall Study||0||
48287630|NCT02910739|101029775|FG000|NOT COMPLETED|Overall Study||1||
48287631|NCT02910739|101029776|FG001|NOT COMPLETED|Overall Study||0||
48287632|NCT02910739|101029777|FG002|NOT COMPLETED|Overall Study||0||
48287633|NCT02910739|101029778|FG003|NOT COMPLETED|Overall Study||0||
48287634|NCT01585987|101029779|FG000|STARTED|Randomized||57||
48287635|NCT01585987|101029780|FG001|STARTED|Randomized||57||
48287636|NCT01585987|101029779|FG000|COMPLETED|Randomized||57||
48287637|NCT01585987|101029780|FG001|COMPLETED|Randomized||51||
48287638|NCT01585987|101029779|FG000|NOT COMPLETED|Randomized||0||
48287639|NCT01585987|101029780|FG001|NOT COMPLETED|Randomized||6||
48580711|NCT01116648|101753304|FG002|COMPLETED|Phase 1 Dose Level 0||0||
48580712|NCT01116648|101753305|FG003|COMPLETED|Phase 1 Dose Level 0||0||
48580713|NCT01116648|101753306|FG004|COMPLETED|Phase 1 Dose Level 0||0||
48580714|NCT01116648|101753307|FG005|COMPLETED|Phase 1 Dose Level 0||0||
48580715|NCT01116648|101753308|FG006|COMPLETED|Phase 1 Dose Level 0||0||
48580716|NCT01116648|101753309|FG007|COMPLETED|Phase 1 Dose Level 0||0||
48287640|NCT01585987|101029779|FG000|STARTED|Treated||57||
48287641|NCT01585987|101029780|FG001|STARTED|Treated||51||
48287642|NCT01585987|101029779|FG000|COMPLETED|Treated||3||
48287643|NCT01585987|101029780|FG001|COMPLETED|Treated||2||
48287644|NCT01585987|101029779|FG000|NOT COMPLETED|Treated||54||
48287645|NCT01585987|101029780|FG001|NOT COMPLETED|Treated||49||
48287646|NCT03373201|101029781|FG000|STARTED|Overall Study||160||
48287647|NCT03373201|101029782|FG001|STARTED|Overall Study||160||
48580717|NCT01116648|101753310|FG008|COMPLETED|Phase 1 Dose Level 0||0||
48580718|NCT01116648|101753311|FG009|COMPLETED|Phase 1 Dose Level 0||0||
48580719|NCT01116648|101753312|FG010|COMPLETED|Phase 1 Dose Level 0||0||
48580720|NCT01116648|101753313|FG011|COMPLETED|Phase 1 Dose Level 0||0||
48580721|NCT01116648|101753314|FG012|COMPLETED|Phase 1 Dose Level 0||0||
48580722|NCT01116648|101753315|FG013|COMPLETED|Phase 1 Dose Level 0||0||
48580723|NCT01116648|101753316|FG014|COMPLETED|Phase 1 Dose Level 0||0||
48287648|NCT03373201|101029781|FG000|COMPLETED|Overall Study||159||
48400469|NCT01569087|101313547|FG000|COMPLETED|Overall Study||20||
48400470|NCT01569087|101313548|FG001|COMPLETED|Overall Study||20||
48580724|NCT01116648|101753302|FG000|NOT COMPLETED|Phase 1 Dose Level 0||0||
48580725|NCT01116648|101753303|FG001|NOT COMPLETED|Phase 1 Dose Level 0||0||
48580726|NCT01116648|101753304|FG002|NOT COMPLETED|Phase 1 Dose Level 0||0||
48580727|NCT01116648|101753305|FG003|NOT COMPLETED|Phase 1 Dose Level 0||0||
48580728|NCT01116648|101753306|FG004|NOT COMPLETED|Phase 1 Dose Level 0||0||
48400471|NCT01569087|101313549|FG002|COMPLETED|Overall Study||18||
48400472|NCT01569087|101313547|FG000|NOT COMPLETED|Overall Study||1||
48400473|NCT01569087|101313548|FG001|NOT COMPLETED|Overall Study||0||
48400474|NCT01569087|101313549|FG002|NOT COMPLETED|Overall Study||1||
48400475|NCT00845845|101313550|FG000|STARTED|Overall Study||3||
48580729|NCT01116648|101753307|FG005|NOT COMPLETED|Phase 1 Dose Level 0||0||
48580730|NCT01116648|101753308|FG006|NOT COMPLETED|Phase 1 Dose Level 0||0||
48400476|NCT00845845|101313551|FG001|STARTED|Overall Study||6||
48400477|NCT00845845|101313550|FG000|COMPLETED|Overall Study||3||
48580731|NCT01116648|101753309|FG007|NOT COMPLETED|Phase 1 Dose Level 0||0||
48136138|NCT00116805|100656110|FG001|NOT COMPLETED|Open-label Period Weeks 289 - 336||7||
48136139|NCT00116805|100656109|FG000|STARTED|Open-label Period Weeks 337 - 384||98||
48580732|NCT01116648|101753310|FG008|NOT COMPLETED|Phase 1 Dose Level 0||0||
48580733|NCT01116648|101753311|FG009|NOT COMPLETED|Phase 1 Dose Level 0||0||
48580734|NCT01116648|101753312|FG010|NOT COMPLETED|Phase 1 Dose Level 0||0||
48580735|NCT01116648|101753313|FG011|NOT COMPLETED|Phase 1 Dose Level 0||0||
48136140|NCT00116805|100656110|FG001|STARTED|Open-label Period Weeks 337 - 384||57||
48136141|NCT00116805|100656109|FG000|COMPLETED|Open-label Period Weeks 337 - 384||90||
48136142|NCT00116805|100656110|FG001|COMPLETED|Open-label Period Weeks 337 - 384||56||
48136143|NCT00116805|100656109|FG000|NOT COMPLETED|Open-label Period Weeks 337 - 384||8||
48136144|NCT00116805|100656110|FG001|NOT COMPLETED|Open-label Period Weeks 337 - 384||1||
48136145|NCT00116805|100656109|FG000|STARTED|Open-label Period Weeks 385 - 432||59||
48136146|NCT00116805|100656110|FG001|STARTED|Open-label Period Weeks 385 - 432||30||
48136147|NCT00116805|100656109|FG000|COMPLETED|Open-label Period Weeks 385 - 432||57||
48136148|NCT00116805|100656110|FG001|COMPLETED|Open-label Period Weeks 385 - 432||30||
48136149|NCT00116805|100656109|FG000|NOT COMPLETED|Open-label Period Weeks 385 - 432||2||
48136150|NCT00116805|100656110|FG001|NOT COMPLETED|Open-label Period Weeks 385 - 432||0||
48136151|NCT00116805|100656109|FG000|STARTED|Open-label Period Weeks 433 - 480||57||
48136152|NCT00116805|100656110|FG001|STARTED|Open-label Period Weeks 433 - 480||29||
48136153|NCT00116805|100656109|FG000|COMPLETED|Open-label Period Weeks 433 - 480||53||
48136154|NCT00116805|100656110|FG001|COMPLETED|Open-label Period Weeks 433 - 480||29||
48136155|NCT00116805|100656109|FG000|NOT COMPLETED|Open-label Period Weeks 433 - 480||4||
48136156|NCT00116805|100656110|FG001|NOT COMPLETED|Open-label Period Weeks 433 - 480||0||
48136157|NCT05501860|100656111|FG000|STARTED|Overall Study||166||
48136158|NCT05501860|100656112|FG001|STARTED|Overall Study||83||
48136159|NCT05501860|100656111|FG000|Specular Microscopy Population|Overall Study||13||
48136160|NCT05501860|100656112|FG001|Specular Microscopy Population|Overall Study||3||
48136161|NCT05501860|100656111|FG000|COMPLETED|Overall Study||165||
48400478|NCT00845845|101313551|FG001|COMPLETED|Overall Study||2||
48400479|NCT00845845|101313550|FG000|NOT COMPLETED|Overall Study||0||
48400480|NCT00845845|101313551|FG001|NOT COMPLETED|Overall Study||4||
48580736|NCT01116648|101753314|FG012|NOT COMPLETED|Phase 1 Dose Level 0||0||
48580737|NCT01116648|101753315|FG013|NOT COMPLETED|Phase 1 Dose Level 0||0||
48580738|NCT01116648|101753316|FG014|NOT COMPLETED|Phase 1 Dose Level 0||0||
48580739|NCT01116648|101753302|FG000|STARTED|Phase 1 Dose Level 1||0||
48580740|NCT01116648|101753303|FG001|STARTED|Phase 1 Dose Level 1||3||
48580741|NCT01116648|101753304|FG002|STARTED|Phase 1 Dose Level 1||0||
48580742|NCT01116648|101753305|FG003|STARTED|Phase 1 Dose Level 1||0||
48580743|NCT01116648|101753306|FG004|STARTED|Phase 1 Dose Level 1||0||
48580744|NCT01116648|101753307|FG005|STARTED|Phase 1 Dose Level 1||0||
48580745|NCT01116648|101753308|FG006|STARTED|Phase 1 Dose Level 1||0||
48580746|NCT01116648|101753309|FG007|STARTED|Phase 1 Dose Level 1||0||
48580747|NCT01116648|101753310|FG008|STARTED|Phase 1 Dose Level 1||0||
48580748|NCT01116648|101753311|FG009|STARTED|Phase 1 Dose Level 1||0||
48580749|NCT01116648|101753312|FG010|STARTED|Phase 1 Dose Level 1||0||
48580750|NCT01116648|101753313|FG011|STARTED|Phase 1 Dose Level 1||0||
48580751|NCT01116648|101753314|FG012|STARTED|Phase 1 Dose Level 1||0||
48580752|NCT01116648|101753315|FG013|STARTED|Phase 1 Dose Level 1||0||
48580753|NCT01116648|101753316|FG014|STARTED|Phase 1 Dose Level 1||0||
48580754|NCT01116648|101753302|FG000|COMPLETED|Phase 1 Dose Level 1||0||
48136162|NCT05501860|100656112|FG001|COMPLETED|Overall Study||82||
48136163|NCT05501860|100656111|FG000|NOT COMPLETED|Overall Study||1||
48136164|NCT05501860|100656112|FG001|NOT COMPLETED|Overall Study||1||
48136165|NCT00648908|100656113|FG000|STARTED|Overall Study||269||
48400481|NCT02911519|101313552|FG000|STARTED|Overall Study||90||
48400482|NCT02911519|101313553|FG001|STARTED|Overall Study||86||
48400483|NCT02911519|101313552|FG000|COMPLETED|Overall Study||88||
48580755|NCT01116648|101753303|FG001|COMPLETED|Phase 1 Dose Level 1||3||
48580756|NCT01116648|101753304|FG002|COMPLETED|Phase 1 Dose Level 1||0||
48136166|NCT00648908|100656113|FG000|COMPLETED|Overall Study||154||
48400484|NCT02911519|101313553|FG001|COMPLETED|Overall Study||82||
48400485|NCT02911519|101313552|FG000|NOT COMPLETED|Overall Study||2||
48400486|NCT02911519|101313553|FG001|NOT COMPLETED|Overall Study||4||
48400487|NCT01016678|101313554|FG000|STARTED|Overall Study||20||
48400488|NCT01016678|101313555|FG001|STARTED|Overall Study||17||
48400489|NCT01016678|101313556|FG002|STARTED|Overall Study||19||
48400490|NCT01016678|101313557|FG003|STARTED|Overall Study||19||
48400491|NCT01016678|101313558|FG004|STARTED|Overall Study||19||
48400492|NCT01016678|101313554|FG000|COMPLETED|Overall Study||18||
48400493|NCT01016678|101313555|FG001|COMPLETED|Overall Study||14||
48400494|NCT01016678|101313556|FG002|COMPLETED|Overall Study||15||
48400495|NCT01016678|101313557|FG003|COMPLETED|Overall Study||19||
48400496|NCT01016678|101313558|FG004|COMPLETED|Overall Study||13||
48400497|NCT01016678|101313554|FG000|NOT COMPLETED|Overall Study||2||
48400498|NCT01016678|101313555|FG001|NOT COMPLETED|Overall Study||3||
48400499|NCT01016678|101313556|FG002|NOT COMPLETED|Overall Study||4||
48580757|NCT01116648|101753305|FG003|COMPLETED|Phase 1 Dose Level 1||0||
48580758|NCT01116648|101753306|FG004|COMPLETED|Phase 1 Dose Level 1||0||
48580759|NCT01116648|101753307|FG005|COMPLETED|Phase 1 Dose Level 1||0||
48580760|NCT01116648|101753308|FG006|COMPLETED|Phase 1 Dose Level 1||0||
48580761|NCT01116648|101753309|FG007|COMPLETED|Phase 1 Dose Level 1||0||
48580762|NCT01116648|101753310|FG008|COMPLETED|Phase 1 Dose Level 1||0||
48580763|NCT01116648|101753311|FG009|COMPLETED|Phase 1 Dose Level 1||0||
48580764|NCT01116648|101753312|FG010|COMPLETED|Phase 1 Dose Level 1||0||
48580765|NCT01116648|101753313|FG011|COMPLETED|Phase 1 Dose Level 1||0||
48704342|NCT02182440|102060714|FG002|Safety Population|Overall Study||35|All randomized patients who received at least one dose of study drug|
48704343|NCT02182440|102060715|FG003|Safety Population|Overall Study||109|All randomized patients who received at least one dose of study drug|
48704344|NCT02182440|102060712|FG000|COMPLETED|Overall Study||71||
48136167|NCT00648908|100656113|FG000|NOT COMPLETED|Overall Study||115||
48136168|NCT02585895|100656114|FG000|STARTED|Primary Period||20||
48136169|NCT02585895|100656115|FG001|STARTED|Primary Period||19||
48136170|NCT02585895|100656114|FG000|COMPLETED|Primary Period||20||
48136171|NCT02585895|100656115|FG001|COMPLETED|Primary Period||19||
48136172|NCT02585895|100656114|FG000|NOT COMPLETED|Primary Period||0||
48400500|NCT01016678|101313557|FG003|NOT COMPLETED|Overall Study||0||
48400501|NCT01016678|101313558|FG004|NOT COMPLETED|Overall Study||6||
48287649|NCT03373201|101029782|FG001|COMPLETED|Overall Study||159||
48287650|NCT03373201|101029781|FG000|NOT COMPLETED|Overall Study||1||
48287651|NCT03373201|101029782|FG001|NOT COMPLETED|Overall Study||1||
48287652|NCT00359216|101029783|FG000|STARTED|Overall Study||20||
48287653|NCT00359216|101029784|FG001|STARTED|Overall Study||10||
48287654|NCT00359216|101029783|FG000|COMPLETED|Overall Study||20||
48287655|NCT00359216|101029784|FG001|COMPLETED|Overall Study||9||
48400502|NCT04238689|101313559|FG000|STARTED|Overall Study||5||
48400503|NCT04238689|101313560|FG001|STARTED|Overall Study||5||
48400504|NCT04238689|101313561|FG002|STARTED|Overall Study||5||
48400505|NCT04238689|101313562|FG003|STARTED|Overall Study||5||
48400506|NCT04238689|101313563|FG004|STARTED|Overall Study||5||
48580766|NCT01116648|101753314|FG012|COMPLETED|Phase 1 Dose Level 1||0||
48580767|NCT01116648|101753315|FG013|COMPLETED|Phase 1 Dose Level 1||0||
48580768|NCT01116648|101753316|FG014|COMPLETED|Phase 1 Dose Level 1||0||
48580769|NCT01116648|101753302|FG000|NOT COMPLETED|Phase 1 Dose Level 1||0||
48287656|NCT00359216|101029783|FG000|NOT COMPLETED|Overall Study||0||
48287657|NCT00359216|101029784|FG001|NOT COMPLETED|Overall Study||1||
48400507|NCT04238689|101313559|FG000|COMPLETED|Overall Study||5||
48400508|NCT04238689|101313560|FG001|COMPLETED|Overall Study||5||
48400509|NCT04238689|101313561|FG002|COMPLETED|Overall Study||5||
48704345|NCT02182440|102060713|FG001|COMPLETED|Overall Study||25||
48704346|NCT02182440|102060714|FG002|COMPLETED|Overall Study||24||
48704347|NCT02182440|102060715|FG003|COMPLETED|Overall Study||81||
48704348|NCT02182440|102060712|FG000|NOT COMPLETED|Overall Study||45||
48704349|NCT02182440|102060713|FG001|NOT COMPLETED|Overall Study||14||
48704350|NCT02182440|102060714|FG002|NOT COMPLETED|Overall Study||11||
48580770|NCT01116648|101753303|FG001|NOT COMPLETED|Phase 1 Dose Level 1||0||
48136173|NCT02585895|100656115|FG001|NOT COMPLETED|Primary Period||0||
48287658|NCT01065844|101029785|FG000|STARTED|Overall Study||15||
48287659|NCT01065844|101029785|FG000|COMPLETED|Overall Study||10||
48400510|NCT04238689|101313562|FG003|COMPLETED|Overall Study||5||
48400511|NCT04238689|101313563|FG004|COMPLETED|Overall Study||5||
48400512|NCT04238689|101313559|FG000|NOT COMPLETED|Overall Study||0||
48400513|NCT04238689|101313560|FG001|NOT COMPLETED|Overall Study||0||
48400514|NCT04238689|101313561|FG002|NOT COMPLETED|Overall Study||0||
48400515|NCT04238689|101313562|FG003|NOT COMPLETED|Overall Study||0||
48400516|NCT04238689|101313563|FG004|NOT COMPLETED|Overall Study||0||
48580771|NCT01116648|101753304|FG002|NOT COMPLETED|Phase 1 Dose Level 1||0||
48704351|NCT02182440|102060715|FG003|NOT COMPLETED|Overall Study||30||
48704352|NCT02214225|102060716|FG000|STARTED|Overall Study||1741||
48136174|NCT02585895|100656114|FG000|STARTED|Post-primary Period||20||
48287660|NCT01065844|101029785|FG000|NOT COMPLETED|Overall Study||5||
48400517|NCT00318370|101313564|FG000|STARTED|Period 1||28||
48287661|NCT01183260|101029786|FG000|STARTED|Overall Study||14||
48400518|NCT00318370|101313565|FG001|STARTED|Period 1||0||
48580772|NCT01116648|101753305|FG003|NOT COMPLETED|Phase 1 Dose Level 1||0||
48580773|NCT01116648|101753306|FG004|NOT COMPLETED|Phase 1 Dose Level 1||0||
48580774|NCT01116648|101753307|FG005|NOT COMPLETED|Phase 1 Dose Level 1||0||
48580775|NCT01116648|101753308|FG006|NOT COMPLETED|Phase 1 Dose Level 1||0||
48580776|NCT01116648|101753309|FG007|NOT COMPLETED|Phase 1 Dose Level 1||0||
48580777|NCT01116648|101753310|FG008|NOT COMPLETED|Phase 1 Dose Level 1||0||
48580778|NCT01116648|101753311|FG009|NOT COMPLETED|Phase 1 Dose Level 1||0||
48580779|NCT01116648|101753312|FG010|NOT COMPLETED|Phase 1 Dose Level 1||0||
48580780|NCT01116648|101753313|FG011|NOT COMPLETED|Phase 1 Dose Level 1||0||
48580781|NCT01116648|101753314|FG012|NOT COMPLETED|Phase 1 Dose Level 1||0||
48580782|NCT01116648|101753315|FG013|NOT COMPLETED|Phase 1 Dose Level 1||0||
48580783|NCT01116648|101753316|FG014|NOT COMPLETED|Phase 1 Dose Level 1||0||
48580784|NCT01116648|101753302|FG000|STARTED|Phase 1 Dose Level 2||0||
48580785|NCT01116648|101753303|FG001|STARTED|Phase 1 Dose Level 2||0||
48704353|NCT02214225|102060717|FG001|STARTED|Overall Study||871||
48704354|NCT02214225|102060718|FG002|STARTED|Overall Study||872||
48704355|NCT02214225|102060716|FG000|COMPLETED|Overall Study||1686||
48704356|NCT02214225|102060717|FG001|COMPLETED|Overall Study||852||
48704357|NCT02214225|102060718|FG002|COMPLETED|Overall Study||850||
48704358|NCT02214225|102060716|FG000|NOT COMPLETED|Overall Study||55||
48704359|NCT02214225|102060717|FG001|NOT COMPLETED|Overall Study||19||
48704360|NCT02214225|102060718|FG002|NOT COMPLETED|Overall Study||22||
48704361|NCT01118520|102060719|FG000|STARTED|Overall Study||73||
48704362|NCT01118520|102060720|FG001|STARTED|Overall Study||72||
48136175|NCT02585895|100656115|FG001|STARTED|Post-primary Period||19||
48136176|NCT02585895|100656114|FG000|COMPLETED|Post-primary Period||20||
48136177|NCT02585895|100656115|FG001|COMPLETED|Post-primary Period||19||
48136178|NCT02585895|100656114|FG000|NOT COMPLETED|Post-primary Period||0||
48136179|NCT02585895|100656115|FG001|NOT COMPLETED|Post-primary Period||0||
48136180|NCT04818346|100656116|FG000|STARTED|24-Week Placebo-controlled Period||43||
48136181|NCT04818346|100656117|FG001|STARTED|24-Week Placebo-controlled Period||43||
48136182|NCT04818346|100656118|FG002|STARTED|24-Week Placebo-controlled Period||43||
48136183|NCT04818346|100656119|FG003|STARTED|24-Week Placebo-controlled Period||42||
48136184|NCT04818346|100656116|FG000|COMPLETED|24-Week Placebo-controlled Period||35||
48136185|NCT04818346|100656117|FG001|COMPLETED|24-Week Placebo-controlled Period||38||
48287662|NCT01183260|101029787|FG001|STARTED|Overall Study||11||
48287663|NCT01183260|101029786|FG000|COMPLETED|Overall Study||10||
48287664|NCT01183260|101029787|FG001|COMPLETED|Overall Study||9||
48287665|NCT01183260|101029786|FG000|NOT COMPLETED|Overall Study||4||
48287666|NCT01183260|101029787|FG001|NOT COMPLETED|Overall Study||2||
48287667|NCT02641496|101029788|FG000|STARTED|Overall Study||41||
48287668|NCT02641496|101029789|FG001|STARTED|Overall Study||35||
48287669|NCT02641496|101029788|FG000|COMPLETED|Overall Study||27||
48287670|NCT02641496|101029789|FG001|COMPLETED|Overall Study||23||
48287671|NCT02641496|101029788|FG000|NOT COMPLETED|Overall Study||14||
48287672|NCT02641496|101029789|FG001|NOT COMPLETED|Overall Study||12||
48287673|NCT01198756|101029790|FG000|STARTED|Overall Study||932||
48287674|NCT01198756|101029791|FG001|STARTED|Overall Study||929||
48287675|NCT01198756|101029792|FG002|STARTED|Overall Study||932||
48287676|NCT01198756|101029793|FG003|STARTED|Overall Study||301||
48287677|NCT01198756|101029790|FG000|COMPLETED|Overall Study||894||
48580786|NCT01116648|101753304|FG002|STARTED|Phase 1 Dose Level 2||7||
48580787|NCT01116648|101753305|FG003|STARTED|Phase 1 Dose Level 2||0||
48287678|NCT01198756|101029791|FG001|COMPLETED|Overall Study||889||
48287679|NCT01198756|101029792|FG002|COMPLETED|Overall Study||902||
48287680|NCT01198756|101029793|FG003|COMPLETED|Overall Study||275||
48287681|NCT01198756|101029790|FG000|NOT COMPLETED|Overall Study||38||
48287682|NCT01198756|101029791|FG001|NOT COMPLETED|Overall Study||40||
48287683|NCT01198756|101029792|FG002|NOT COMPLETED|Overall Study||30||
48287684|NCT01198756|101029793|FG003|NOT COMPLETED|Overall Study||26||
48287685|NCT00196976|101029794|FG000|STARTED|Primary Study||39||
48287686|NCT00196976|101029795|FG001|STARTED|Primary Study||41||
48287687|NCT00196976|101029796|FG002|STARTED|Primary Study||41||
48580788|NCT01116648|101753306|FG004|STARTED|Phase 1 Dose Level 2||0||
48580789|NCT01116648|101753307|FG005|STARTED|Phase 1 Dose Level 2||0||
48580790|NCT01116648|101753308|FG006|STARTED|Phase 1 Dose Level 2||0||
48580791|NCT01116648|101753309|FG007|STARTED|Phase 1 Dose Level 2||0||
48580792|NCT01116648|101753310|FG008|STARTED|Phase 1 Dose Level 2||0||
48704363|NCT01118520|102060721|FG002|STARTED|Overall Study||79||
48704364|NCT01118520|102060719|FG000|COMPLETED|Overall Study||53||
48704365|NCT01118520|102060720|FG001|COMPLETED|Overall Study||49||
48136186|NCT04818346|100656118|FG002|COMPLETED|24-Week Placebo-controlled Period||32||
48136187|NCT04818346|100656119|FG003|COMPLETED|24-Week Placebo-controlled Period||34||
48136188|NCT04818346|100656116|FG000|NOT COMPLETED|24-Week Placebo-controlled Period||8||
48136189|NCT04818346|100656117|FG001|NOT COMPLETED|24-Week Placebo-controlled Period||5||
48287688|NCT00196976|101029797|FG003|STARTED|Primary Study||40||
48287689|NCT00196976|101029798|FG004|STARTED|Primary Study||40||
48287690|NCT00196976|101029799|FG005|STARTED|Primary Study||54||
48287691|NCT00196976|101029800|FG006|STARTED|Primary Study||50||
48287692|NCT00196976|101029801|FG007|STARTED|Primary Study||52||
48287693|NCT00196976|101029802|FG008|STARTED|Primary Study||52||
48287694|NCT00196976|101029803|FG009|STARTED|Primary Study||52||
48287695|NCT00196976|101029804|FG010|STARTED|Primary Study||0||
48287696|NCT00196976|101029805|FG011|STARTED|Primary Study||0||
48136190|NCT04818346|100656118|FG002|NOT COMPLETED|24-Week Placebo-controlled Period||11||
48136191|NCT04818346|100656119|FG003|NOT COMPLETED|24-Week Placebo-controlled Period||8||
48136192|NCT04818346|100656116|FG000|STARTED|28-Week Double-blind Extension Period||35||
48136193|NCT04818346|100656117|FG001|STARTED|28-Week Double-blind Extension Period||37||
48136194|NCT04818346|100656118|FG002|STARTED|28-Week Double-blind Extension Period||32||
48136195|NCT04818346|100656119|FG003|STARTED|28-Week Double-blind Extension Period||34||
48136196|NCT04818346|100656116|FG000|COMPLETED|28-Week Double-blind Extension Period||33||
48580793|NCT01116648|101753311|FG009|STARTED|Phase 1 Dose Level 2||0||
48580794|NCT01116648|101753312|FG010|STARTED|Phase 1 Dose Level 2||0||
48580795|NCT01116648|101753313|FG011|STARTED|Phase 1 Dose Level 2||0||
48580796|NCT01116648|101753314|FG012|STARTED|Phase 1 Dose Level 2||0||
48580797|NCT01116648|101753315|FG013|STARTED|Phase 1 Dose Level 2||0||
48580798|NCT01116648|101753316|FG014|STARTED|Phase 1 Dose Level 2||0||
48580799|NCT01116648|101753302|FG000|COMPLETED|Phase 1 Dose Level 2||0||
48580800|NCT01116648|101753303|FG001|COMPLETED|Phase 1 Dose Level 2||0||
48136197|NCT04818346|100656117|FG001|COMPLETED|28-Week Double-blind Extension Period||30||
48136198|NCT04818346|100656118|FG002|COMPLETED|28-Week Double-blind Extension Period||26||
48136199|NCT04818346|100656119|FG003|COMPLETED|28-Week Double-blind Extension Period||28||
48287697|NCT00196976|101029806|FG012|STARTED|Primary Study||0||
48287698|NCT00196976|101029807|FG013|STARTED|Primary Study||0||
48287699|NCT00196976|101029794|FG000|COMPLETED|Primary Study||38||
48287700|NCT00196976|101029795|FG001|COMPLETED|Primary Study||40||
48580801|NCT01116648|101753304|FG002|COMPLETED|Phase 1 Dose Level 2||7||
48580802|NCT01116648|101753305|FG003|COMPLETED|Phase 1 Dose Level 2||0||
48580803|NCT01116648|101753306|FG004|COMPLETED|Phase 1 Dose Level 2||0||
48580804|NCT01116648|101753307|FG005|COMPLETED|Phase 1 Dose Level 2||0||
48580805|NCT01116648|101753308|FG006|COMPLETED|Phase 1 Dose Level 2||0||
48580806|NCT01116648|101753309|FG007|COMPLETED|Phase 1 Dose Level 2||0||
48580807|NCT01116648|101753310|FG008|COMPLETED|Phase 1 Dose Level 2||0||
48580808|NCT01116648|101753311|FG009|COMPLETED|Phase 1 Dose Level 2||0||
48580809|NCT01116648|101753312|FG010|COMPLETED|Phase 1 Dose Level 2||0||
48580810|NCT01116648|101753313|FG011|COMPLETED|Phase 1 Dose Level 2||0||
48580811|NCT01116648|101753314|FG012|COMPLETED|Phase 1 Dose Level 2||0||
48580812|NCT01116648|101753315|FG013|COMPLETED|Phase 1 Dose Level 2||0||
48580813|NCT01116648|101753316|FG014|COMPLETED|Phase 1 Dose Level 2||0||
48580814|NCT01116648|101753302|FG000|NOT COMPLETED|Phase 1 Dose Level 2||0||
48580815|NCT01116648|101753303|FG001|NOT COMPLETED|Phase 1 Dose Level 2||0||
48580816|NCT01116648|101753304|FG002|NOT COMPLETED|Phase 1 Dose Level 2||0||
48580817|NCT01116648|101753305|FG003|NOT COMPLETED|Phase 1 Dose Level 2||0||
48580818|NCT01116648|101753306|FG004|NOT COMPLETED|Phase 1 Dose Level 2||0||
48580819|NCT01116648|101753307|FG005|NOT COMPLETED|Phase 1 Dose Level 2||0||
48580820|NCT01116648|101753308|FG006|NOT COMPLETED|Phase 1 Dose Level 2||0||
48580821|NCT01116648|101753309|FG007|NOT COMPLETED|Phase 1 Dose Level 2||0||
48580822|NCT01116648|101753310|FG008|NOT COMPLETED|Phase 1 Dose Level 2||0||
48580823|NCT01116648|101753311|FG009|NOT COMPLETED|Phase 1 Dose Level 2||0||
48580824|NCT01116648|101753312|FG010|NOT COMPLETED|Phase 1 Dose Level 2||0||
48580825|NCT01116648|101753313|FG011|NOT COMPLETED|Phase 1 Dose Level 2||0||
48580826|NCT01116648|101753314|FG012|NOT COMPLETED|Phase 1 Dose Level 2||0||
48580827|NCT01116648|101753315|FG013|NOT COMPLETED|Phase 1 Dose Level 2||0||
48580828|NCT01116648|101753316|FG014|NOT COMPLETED|Phase 1 Dose Level 2||0||
48580829|NCT01116648|101753302|FG000|STARTED|Phase 1 Dose Level 3||0||
48580830|NCT01116648|101753303|FG001|STARTED|Phase 1 Dose Level 3||0||
48580831|NCT01116648|101753304|FG002|STARTED|Phase 1 Dose Level 3||0||
48580832|NCT01116648|101753305|FG003|STARTED|Phase 1 Dose Level 3||6||
48580833|NCT01116648|101753306|FG004|STARTED|Phase 1 Dose Level 3||0||
48580834|NCT01116648|101753307|FG005|STARTED|Phase 1 Dose Level 3||0||
48580835|NCT01116648|101753308|FG006|STARTED|Phase 1 Dose Level 3||0||
48580836|NCT01116648|101753309|FG007|STARTED|Phase 1 Dose Level 3||0||
48580837|NCT01116648|101753310|FG008|STARTED|Phase 1 Dose Level 3||0||
48580838|NCT01116648|101753311|FG009|STARTED|Phase 1 Dose Level 3||0||
48580839|NCT01116648|101753312|FG010|STARTED|Phase 1 Dose Level 3||0||
48580840|NCT01116648|101753313|FG011|STARTED|Phase 1 Dose Level 3||0||
48580841|NCT01116648|101753314|FG012|STARTED|Phase 1 Dose Level 3||0||
48580842|NCT01116648|101753315|FG013|STARTED|Phase 1 Dose Level 3||0||
48580843|NCT01116648|101753316|FG014|STARTED|Phase 1 Dose Level 3||0||
48136200|NCT04818346|100656116|FG000|NOT COMPLETED|28-Week Double-blind Extension Period||2||
48136201|NCT04818346|100656117|FG001|NOT COMPLETED|28-Week Double-blind Extension Period||7||
48136202|NCT04818346|100656118|FG002|NOT COMPLETED|28-Week Double-blind Extension Period||6||
48287701|NCT00196976|101029796|FG002|COMPLETED|Primary Study||37||
48287702|NCT00196976|101029797|FG003|COMPLETED|Primary Study||39||
48580844|NCT01116648|101753302|FG000|COMPLETED|Phase 1 Dose Level 3||0||
48580845|NCT01116648|101753303|FG001|COMPLETED|Phase 1 Dose Level 3||0||
48580846|NCT01116648|101753304|FG002|COMPLETED|Phase 1 Dose Level 3||0||
48580847|NCT01116648|101753305|FG003|COMPLETED|Phase 1 Dose Level 3||4||
48287703|NCT00196976|101029798|FG004|COMPLETED|Primary Study||37||
48287704|NCT00196976|101029799|FG005|COMPLETED|Primary Study||52||
48580848|NCT01116648|101753306|FG004|COMPLETED|Phase 1 Dose Level 3||0||
48580849|NCT01116648|101753307|FG005|COMPLETED|Phase 1 Dose Level 3||0||
48287705|NCT00196976|101029800|FG006|COMPLETED|Primary Study||50||
48287706|NCT00196976|101029801|FG007|COMPLETED|Primary Study||49||
48287707|NCT00196976|101029802|FG008|COMPLETED|Primary Study||52||
48287708|NCT00196976|101029803|FG009|COMPLETED|Primary Study||51||
48287709|NCT00196976|101029804|FG010|COMPLETED|Primary Study||0||
48287710|NCT00196976|101029805|FG011|COMPLETED|Primary Study||0||
48287711|NCT00196976|101029806|FG012|COMPLETED|Primary Study||0||
48287712|NCT00196976|101029807|FG013|COMPLETED|Primary Study||0||
48287713|NCT00196976|101029794|FG000|NOT COMPLETED|Primary Study||1||
48287714|NCT00196976|101029795|FG001|NOT COMPLETED|Primary Study||1||
48287715|NCT00196976|101029796|FG002|NOT COMPLETED|Primary Study||4||
48287716|NCT00196976|101029797|FG003|NOT COMPLETED|Primary Study||1||
48287717|NCT00196976|101029798|FG004|NOT COMPLETED|Primary Study||3||
48287718|NCT00196976|101029799|FG005|NOT COMPLETED|Primary Study||2||
48400519|NCT00318370|101313566|FG002|STARTED|Period 1||0||
48400520|NCT00318370|101313564|FG000|COMPLETED|Period 1||21||
48400521|NCT00318370|101313565|FG001|COMPLETED|Period 1||0||
48400522|NCT00318370|101313566|FG002|COMPLETED|Period 1||0||
48400523|NCT00318370|101313564|FG000|NOT COMPLETED|Period 1||7||
48400524|NCT00318370|101313565|FG001|NOT COMPLETED|Period 1||0||
48580850|NCT01116648|101753308|FG006|COMPLETED|Phase 1 Dose Level 3||0||
48580851|NCT01116648|101753309|FG007|COMPLETED|Phase 1 Dose Level 3||0||
48580852|NCT01116648|101753310|FG008|COMPLETED|Phase 1 Dose Level 3||0||
48580853|NCT01116648|101753311|FG009|COMPLETED|Phase 1 Dose Level 3||0||
48580854|NCT01116648|101753312|FG010|COMPLETED|Phase 1 Dose Level 3||0||
48580855|NCT01116648|101753313|FG011|COMPLETED|Phase 1 Dose Level 3||0||
48580856|NCT01116648|101753314|FG012|COMPLETED|Phase 1 Dose Level 3||0||
48580857|NCT01116648|101753315|FG013|COMPLETED|Phase 1 Dose Level 3||0||
48580858|NCT01116648|101753316|FG014|COMPLETED|Phase 1 Dose Level 3||0||
48580859|NCT01116648|101753302|FG000|NOT COMPLETED|Phase 1 Dose Level 3||0||
48580860|NCT01116648|101753303|FG001|NOT COMPLETED|Phase 1 Dose Level 3||0||
48580861|NCT01116648|101753304|FG002|NOT COMPLETED|Phase 1 Dose Level 3||0||
48580862|NCT01116648|101753305|FG003|NOT COMPLETED|Phase 1 Dose Level 3||2||
48580863|NCT01116648|101753306|FG004|NOT COMPLETED|Phase 1 Dose Level 3||0||
48580864|NCT01116648|101753307|FG005|NOT COMPLETED|Phase 1 Dose Level 3||0||
48580865|NCT01116648|101753308|FG006|NOT COMPLETED|Phase 1 Dose Level 3||0||
48580866|NCT01116648|101753309|FG007|NOT COMPLETED|Phase 1 Dose Level 3||0||
48580867|NCT01116648|101753310|FG008|NOT COMPLETED|Phase 1 Dose Level 3||0||
48287719|NCT00196976|101029800|FG006|NOT COMPLETED|Primary Study||0||
48287720|NCT00196976|101029801|FG007|NOT COMPLETED|Primary Study||3||
48287721|NCT00196976|101029802|FG008|NOT COMPLETED|Primary Study||0||
48287722|NCT00196976|101029803|FG009|NOT COMPLETED|Primary Study||1||
48287723|NCT00196976|101029804|FG010|NOT COMPLETED|Primary Study||0||
48287724|NCT00196976|101029805|FG011|NOT COMPLETED|Primary Study||0||
48287725|NCT00196976|101029806|FG012|NOT COMPLETED|Primary Study||0||
48287726|NCT00196976|101029807|FG013|NOT COMPLETED|Primary Study||0||
48287727|NCT00196976|101029794|FG000|STARTED|Booster Study||0||
48287728|NCT00196976|101029795|FG001|STARTED|Booster Study||0||
48287729|NCT00196976|101029796|FG002|STARTED|Booster Study||0||
48287730|NCT00196976|101029797|FG003|STARTED|Booster Study||0||
48287731|NCT00196976|101029798|FG004|STARTED|Booster Study||0||
48287732|NCT00196976|101029799|FG005|STARTED|Booster Study||0||
48400525|NCT00318370|101313566|FG002|NOT COMPLETED|Period 1||0||
48400526|NCT00318370|101313564|FG000|STARTED|Period 2||0||
48400527|NCT00318370|101313565|FG001|STARTED|Period 2||47||
48400528|NCT00318370|101313566|FG002|STARTED|Period 2||0||
48400529|NCT00318370|101313564|FG000|COMPLETED|Period 2||0||
48400530|NCT00318370|101313565|FG001|COMPLETED|Period 2||36||
48400531|NCT00318370|101313566|FG002|COMPLETED|Period 2||0||
48580868|NCT01116648|101753311|FG009|NOT COMPLETED|Phase 1 Dose Level 3||0||
48580869|NCT01116648|101753312|FG010|NOT COMPLETED|Phase 1 Dose Level 3||0||
48580870|NCT01116648|101753313|FG011|NOT COMPLETED|Phase 1 Dose Level 3||0||
48580871|NCT01116648|101753314|FG012|NOT COMPLETED|Phase 1 Dose Level 3||0||
48580872|NCT01116648|101753315|FG013|NOT COMPLETED|Phase 1 Dose Level 3||0||
48580873|NCT01116648|101753316|FG014|NOT COMPLETED|Phase 1 Dose Level 3||0||
48580874|NCT01116648|101753302|FG000|STARTED|Expansion at Maximum Tolerated Dose||0||
48580875|NCT01116648|101753303|FG001|STARTED|Expansion at Maximum Tolerated Dose||0||
48580876|NCT01116648|101753304|FG002|STARTED|Expansion at Maximum Tolerated Dose||0||
48287733|NCT00196976|101029800|FG006|STARTED|Booster Study||0||
48287734|NCT00196976|101029801|FG007|STARTED|Booster Study||0||
48287735|NCT00196976|101029802|FG008|STARTED|Booster Study||0||
48287736|NCT00196976|101029803|FG009|STARTED|Booster Study||0||
48287737|NCT00196976|101029804|FG010|STARTED|Booster Study||33||
48287738|NCT00196976|101029805|FG011|STARTED|Booster Study||32||
48287739|NCT00196976|101029806|FG012|STARTED|Booster Study||45||
48287740|NCT00196976|101029807|FG013|STARTED|Booster Study||43||
48287741|NCT00196976|101029794|FG000|COMPLETED|Booster Study||0||
48287742|NCT00196976|101029795|FG001|COMPLETED|Booster Study||0||
48287743|NCT00196976|101029796|FG002|COMPLETED|Booster Study||0||
48400532|NCT00318370|101313564|FG000|NOT COMPLETED|Period 2||0||
48400533|NCT00318370|101313565|FG001|NOT COMPLETED|Period 2||11||
48400534|NCT00318370|101313566|FG002|NOT COMPLETED|Period 2||0||
48400535|NCT00318370|101313564|FG000|STARTED|Period 3||0||
48400536|NCT00318370|101313565|FG001|STARTED|Period 3||0||
48400537|NCT00318370|101313566|FG002|STARTED|Period 3||36||
48287744|NCT00196976|101029797|FG003|COMPLETED|Booster Study||0||
48287745|NCT00196976|101029798|FG004|COMPLETED|Booster Study||0||
48287746|NCT00196976|101029799|FG005|COMPLETED|Booster Study||0||
48287747|NCT00196976|101029800|FG006|COMPLETED|Booster Study||0||
48287748|NCT00196976|101029801|FG007|COMPLETED|Booster Study||0||
48287749|NCT00196976|101029802|FG008|COMPLETED|Booster Study||0||
48400538|NCT00318370|101313564|FG000|COMPLETED|Period 3||0||
48400539|NCT00318370|101313565|FG001|COMPLETED|Period 3||0||
48136203|NCT04818346|100656119|FG003|NOT COMPLETED|28-Week Double-blind Extension Period||6||
48136204|NCT01432366|100656120|FG000|STARTED|Overall Study||460||
48136205|NCT01432366|100656120|FG000|COMPLETED|Overall Study||392||
48136206|NCT01432366|100656120|FG000|NOT COMPLETED|Overall Study||68||
48136207|NCT03389802|100656121|FG000|STARTED|Overall Study||3||
48136208|NCT03389802|100656122|FG001|STARTED|Overall Study||3||
48136209|NCT03389802|100656123|FG002|STARTED|Overall Study||15||
48136210|NCT03389802|100656124|FG003|STARTED|Overall Study||6||
48136211|NCT03389802|100656125|FG004|STARTED|Overall Study||5||
48136212|NCT03389802|100656121|FG000|COMPLETED|Overall Study||0||
48136213|NCT03389802|100656122|FG001|COMPLETED|Overall Study||0||
48136214|NCT03389802|100656123|FG002|COMPLETED|Overall Study||0||
48136215|NCT03389802|100656124|FG003|COMPLETED|Overall Study||0||
48136216|NCT03389802|100656125|FG004|COMPLETED|Overall Study||0||
48287750|NCT00196976|101029803|FG009|COMPLETED|Booster Study||0||
48287751|NCT00196976|101029804|FG010|COMPLETED|Booster Study||31||
48400540|NCT00318370|101313566|FG002|COMPLETED|Period 3||3||
48400541|NCT00318370|101313564|FG000|NOT COMPLETED|Period 3||0||
48400542|NCT00318370|101313565|FG001|NOT COMPLETED|Period 3||0||
48400543|NCT00318370|101313566|FG002|NOT COMPLETED|Period 3||33||
48400544|NCT03619837|101313567|FG000|STARTED|Screening||122||
48400545|NCT03619837|101313567|FG000|COMPLETED|Screening||24||
48400546|NCT03619837|101313567|FG000|NOT COMPLETED|Screening||98||
48400547|NCT03619837|101313567|FG000|STARTED|Main Study||24||
48400548|NCT03619837|101313567|FG000|COMPLETED|Main Study||24||
48400549|NCT03619837|101313567|FG000|NOT COMPLETED|Main Study||0||
48136217|NCT03389802|100656121|FG000|NOT COMPLETED|Overall Study||3||
48136218|NCT03389802|100656122|FG001|NOT COMPLETED|Overall Study||3||
48136219|NCT03389802|100656123|FG002|NOT COMPLETED|Overall Study||15||
48136220|NCT03389802|100656124|FG003|NOT COMPLETED|Overall Study||6||
48136221|NCT03389802|100656125|FG004|NOT COMPLETED|Overall Study||5||
48136222|NCT04323436|100656126|FG000|STARTED|Overall Study||31||
48136223|NCT04323436|100656127|FG001|STARTED|Overall Study||0||
48136224|NCT04323436|100656128|FG002|STARTED|Overall Study||0||
48136225|NCT04323436|100656126|FG000|Treated With Capmatinib + Spartalizumab|Overall Study||28||
48136226|NCT04323436|100656127|FG001|Treated With Capmatinib + Spartalizumab|Overall Study||0||
48136227|NCT04323436|100656128|FG002|Treated With Capmatinib + Spartalizumab|Overall Study||0||
48141453|NCT01780922|100670428|FG005|COMPLETED|Washout (7 Days)||2||
48287752|NCT00196976|101029805|FG011|COMPLETED|Booster Study||30||
48287753|NCT00196976|101029806|FG012|COMPLETED|Booster Study||45||
48287754|NCT00196976|101029807|FG013|COMPLETED|Booster Study||43||
48287755|NCT00196976|101029794|FG000|NOT COMPLETED|Booster Study||0||
48287756|NCT00196976|101029795|FG001|NOT COMPLETED|Booster Study||0||
48287757|NCT00196976|101029796|FG002|NOT COMPLETED|Booster Study||0||
48287758|NCT00196976|101029797|FG003|NOT COMPLETED|Booster Study||0||
48287759|NCT00196976|101029798|FG004|NOT COMPLETED|Booster Study||0||
48400550|NCT01461824|101313568|FG000|STARTED|Overall Study||12||
48287760|NCT00196976|101029799|FG005|NOT COMPLETED|Booster Study||0||
48287761|NCT00196976|101029800|FG006|NOT COMPLETED|Booster Study||0||
48287762|NCT00196976|101029801|FG007|NOT COMPLETED|Booster Study||0||
48287763|NCT00196976|101029802|FG008|NOT COMPLETED|Booster Study||0||
48287764|NCT00196976|101029803|FG009|NOT COMPLETED|Booster Study||0||
48287765|NCT00196976|101029804|FG010|NOT COMPLETED|Booster Study||2||
48287766|NCT00196976|101029805|FG011|NOT COMPLETED|Booster Study||2||
48287767|NCT00196976|101029806|FG012|NOT COMPLETED|Booster Study||0||
48287768|NCT00196976|101029807|FG013|NOT COMPLETED|Booster Study||0||
48287769|NCT01074216|101029808|FG000|STARTED|Overall Study||54||
48287770|NCT01074216|101029808|FG000|COMPLETED|Overall Study||41||
48287771|NCT01074216|101029808|FG000|NOT COMPLETED|Overall Study||13||
48287772|NCT00605215|101029809|FG000|STARTED|Overall Study||450||
48287773|NCT00605215|101029810|FG001|STARTED|Overall Study||434||
48287774|NCT00605215|101029811|FG002|STARTED|Overall Study||447||
48287775|NCT00605215|101029809|FG000|Received at Least 1 Dose of Study Drug|Overall Study||449||
48287776|NCT00605215|101029810|FG001|Received at Least 1 Dose of Study Drug|Overall Study||433||
48287777|NCT00605215|101029811|FG002|Received at Least 1 Dose of Study Drug|Overall Study||442||
48287778|NCT00605215|101029809|FG000|COMPLETED|Overall Study||359||
48287779|NCT00605215|101029810|FG001|COMPLETED|Overall Study||353||
48287780|NCT00605215|101029811|FG002|COMPLETED|Overall Study||378||
48287781|NCT00605215|101029809|FG000|NOT COMPLETED|Overall Study||91||
48287782|NCT00605215|101029810|FG001|NOT COMPLETED|Overall Study||81||
48287783|NCT00605215|101029811|FG002|NOT COMPLETED|Overall Study||69||
48287784|NCT02740374|101029812|FG000|STARTED|Overall Study||55||
48287785|NCT02740374|101029813|FG001|STARTED|Overall Study||57||
48287786|NCT02740374|101029812|FG000|COMPLETED|Overall Study||55||
48287787|NCT02740374|101029813|FG001|COMPLETED|Overall Study||57||
48287788|NCT02740374|101029812|FG000|NOT COMPLETED|Overall Study||0||
48287789|NCT02740374|101029813|FG001|NOT COMPLETED|Overall Study||0||
48287790|NCT01383499|101029814|FG000|STARTED|Period 1 (4 Weeks)||27||
48287791|NCT01383499|101029815|FG001|STARTED|Period 1 (4 Weeks)||24||
48287792|NCT01383499|101029816|FG002|STARTED|Period 1 (4 Weeks)||25||
48287793|NCT01383499|101029817|FG003|STARTED|Period 1 (4 Weeks)||25||
48287794|NCT01383499|101029814|FG000|COMPLETED|Period 1 (4 Weeks)||26||
48287795|NCT01383499|101029815|FG001|COMPLETED|Period 1 (4 Weeks)||24||
48287796|NCT01383499|101029816|FG002|COMPLETED|Period 1 (4 Weeks)||25||
48287797|NCT01383499|101029817|FG003|COMPLETED|Period 1 (4 Weeks)||25||
48287798|NCT01383499|101029814|FG000|NOT COMPLETED|Period 1 (4 Weeks)||1||
48287799|NCT01383499|101029815|FG001|NOT COMPLETED|Period 1 (4 Weeks)||0||
48287800|NCT01383499|101029816|FG002|NOT COMPLETED|Period 1 (4 Weeks)||0||
48287801|NCT01383499|101029817|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0||
48287802|NCT01383499|101029814|FG000|STARTED|Period 2 (4 Weeks)||26||
48287803|NCT01383499|101029815|FG001|STARTED|Period 2 (4 Weeks)||24||
48287804|NCT01383499|101029816|FG002|STARTED|Period 2 (4 Weeks)||25||
48287805|NCT01383499|101029817|FG003|STARTED|Period 2 (4 Weeks)||25||
48287806|NCT01383499|101029814|FG000|COMPLETED|Period 2 (4 Weeks)||26||
48287807|NCT01383499|101029815|FG001|COMPLETED|Period 2 (4 Weeks)||24||
48287808|NCT01383499|101029816|FG002|COMPLETED|Period 2 (4 Weeks)||25||
48287809|NCT01383499|101029817|FG003|COMPLETED|Period 2 (4 Weeks)||25||
48287810|NCT01383499|101029814|FG000|NOT COMPLETED|Period 2 (4 Weeks)||0||
48287811|NCT01383499|101029815|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0||
48287812|NCT01383499|101029816|FG002|NOT COMPLETED|Period 2 (4 Weeks)||0||
48287813|NCT01383499|101029817|FG003|NOT COMPLETED|Period 2 (4 Weeks)||0||
48287814|NCT01383499|101029814|FG000|STARTED|Period 3 (4 Weeks)||26||
48287815|NCT01383499|101029815|FG001|STARTED|Period 3 (4 Weeks)||24||
48287816|NCT01383499|101029816|FG002|STARTED|Period 3 (4 Weeks)||25||
48287817|NCT01383499|101029817|FG003|STARTED|Period 3 (4 Weeks)||25||
48287818|NCT01383499|101029814|FG000|COMPLETED|Period 3 (4 Weeks)||26||
48287819|NCT01383499|101029815|FG001|COMPLETED|Period 3 (4 Weeks)||24||
48287820|NCT01383499|101029816|FG002|COMPLETED|Period 3 (4 Weeks)||25||
48287821|NCT01383499|101029817|FG003|COMPLETED|Period 3 (4 Weeks)||25||
48287822|NCT01383499|101029814|FG000|NOT COMPLETED|Period 3 (4 Weeks)||0||
48287823|NCT01383499|101029815|FG001|NOT COMPLETED|Period 3 (4 Weeks)||0||
48287824|NCT01383499|101029816|FG002|NOT COMPLETED|Period 3 (4 Weeks)||0||
48287825|NCT01383499|101029817|FG003|NOT COMPLETED|Period 3 (4 Weeks)||0||
48287826|NCT04375761|101029818|FG000|STARTED|Overall Study||1387||
48287827|NCT04375761|101029819|FG001|STARTED|Overall Study||2755||
48287828|NCT04375761|101029818|FG000|COMPLETED|Overall Study||1012||
48287829|NCT04375761|101029819|FG001|COMPLETED|Overall Study||2011||
48287830|NCT04375761|101029818|FG000|NOT COMPLETED|Overall Study||375||
48287831|NCT04375761|101029819|FG001|NOT COMPLETED|Overall Study||744||
48287832|NCT03143166|101029820|FG000|STARTED|Period 1||36||
48287833|NCT03143166|101029820|FG000|COMPLETED|Period 1||36||
48287834|NCT03143166|101029820|FG000|NOT COMPLETED|Period 1||0||
48287835|NCT03143166|101029820|FG000|STARTED|Period 2 (Washout of at Least 4 Days)||36||
48287836|NCT03143166|101029820|FG000|COMPLETED|Period 2 (Washout of at Least 4 Days)||35||
48287837|NCT03143166|101029820|FG000|NOT COMPLETED|Period 2 (Washout of at Least 4 Days)||1||
48287838|NCT02146326|101029821|FG000|STARTED|Overall Study||89||
48287839|NCT02146326|101029822|FG001|STARTED|Overall Study||103||
48287840|NCT02146326|101029823|FG002|STARTED|Overall Study||211||
48287841|NCT02146326|101029824|FG003|STARTED|Overall Study||258||
48287842|NCT02146326|101029821|FG000|Baseline|Overall Study||89||
48287843|NCT02146326|101029822|FG001|Baseline|Overall Study||103||
48287844|NCT02146326|101029823|FG002|Baseline|Overall Study||211||
48136228|NCT04323436|100656126|FG000|Treated With Capmatinib Only|Overall Study||3|Immediately following the discontinuation of spartalizumab (and enrollment halt), enrolled subjects who had not started study treatment received capmatinib single agent treatment from the start.|
48136229|NCT04323436|100656127|FG001|Treated With Capmatinib Only|Overall Study||0|Immediately following the discontinuation of spartalizumab (and enrollment halt), enrolled subjects who had not started study treatment received capmatinib single agent treatment from the start.|
48136230|NCT04323436|100656128|FG002|Treated With Capmatinib Only|Overall Study||0|Immediately following the discontinuation of spartalizumab (and enrollment halt), enrolled subjects who had not started study treatment received capmatinib single agent treatment from the start.|
48136231|NCT04323436|100656126|FG000|COMPLETED|Overall Study||0||
48136232|NCT04323436|100656127|FG001|COMPLETED|Overall Study||0||
48136233|NCT04323436|100656128|FG002|COMPLETED|Overall Study||0||
48136234|NCT04323436|100656126|FG000|NOT COMPLETED|Overall Study||31||
48136235|NCT04323436|100656127|FG001|NOT COMPLETED|Overall Study||0||
48136236|NCT04323436|100656128|FG002|NOT COMPLETED|Overall Study||0||
48136237|NCT03972488|100656129|FG000|STARTED|Overall Study||151||
48136238|NCT03972488|100656130|FG001|STARTED|Overall Study||75||
48136239|NCT03972488|100656129|FG000|Participants Treated in Treatment Period|Overall Study||147||
48136240|NCT03972488|100656130|FG001|Participants Treated in Treatment Period|Overall Study||73||
48136241|NCT03972488|100656129|FG000|Participants Not Treated in Treatment Period|Overall Study||4||
48136242|NCT03972488|100656130|FG001|Participants Not Treated in Treatment Period|Overall Study||2||
48136243|NCT03972488|100656129|FG000|Participants Entered Crossover Treatment Period|Overall Study||0||
48136244|NCT03972488|100656130|FG001|Participants Entered Crossover Treatment Period|Overall Study||29||
48136245|NCT03972488|100656129|FG000|Participants Entered Retreatment Period|Overall Study||8||
48136246|NCT03972488|100656130|FG001|Participants Entered Retreatment Period|Overall Study||0||
48136247|NCT03972488|100656129|FG000|COMPLETED|Overall Study||78|Completed = Treatment ongoing|
48136248|NCT03972488|100656130|FG001|COMPLETED|Overall Study||15|Completed = Treatment ongoing|
48136249|NCT03972488|100656129|FG000|NOT COMPLETED|Overall Study||73||
48136250|NCT03972488|100656130|FG001|NOT COMPLETED|Overall Study||60||
48136251|NCT00599326|100656131|FG000|STARTED|Overall Study||10||
48136252|NCT00599326|100656131|FG000|COMPLETED|Overall Study||8||
48136253|NCT00599326|100656131|FG000|NOT COMPLETED|Overall Study||2||
48136254|NCT04955639|100656132|FG000|STARTED|Overall Study||94||
48136255|NCT04955639|100656133|FG001|STARTED|Overall Study||94||
48136256|NCT04955639|100656132|FG000|Completed Week 12 Survey|Overall Study||91||
48136257|NCT04955639|100656133|FG001|Completed Week 12 Survey|Overall Study||92||
48136258|NCT04955639|100656132|FG000|COMPLETED|Overall Study||90|n = 89 fully completed the week 26 questionnaire n = 1 partially completed the week 26 questionnaire|
48136259|NCT04955639|100656133|FG001|COMPLETED|Overall Study||90|n = 89 fully completed the week 26 questionnaire n = 1 partially completed the week 26 questionnaire|
48136260|NCT04955639|100656132|FG000|NOT COMPLETED|Overall Study||4||
48136261|NCT04955639|100656133|FG001|NOT COMPLETED|Overall Study||4||
48136262|NCT00110617|100656134|FG000|STARTED|Overall Study||135||
48136263|NCT00110617|100656135|FG001|STARTED|Overall Study||68||
48136264|NCT00110617|100656134|FG000|Safety Set 1; Received Study Drug|Overall Study||135||
48136265|NCT00110617|100656135|FG001|Safety Set 1; Received Study Drug|Overall Study||56||
48136266|NCT00110617|100656134|FG000|Full Analysis 2; Received ICL670|Overall Study||135||
48136267|NCT00110617|100656135|FG001|Full Analysis 2; Received ICL670|Overall Study||53||
48136268|NCT00110617|100656134|FG000|On Going at Week 24|Overall Study||126||
48136269|NCT00110617|100656135|FG001|On Going at Week 24|Overall Study||53||
48136270|NCT00110617|100656134|FG000|COMPLETED|Overall Study||96||
48136271|NCT00110617|100656135|FG001|COMPLETED|Overall Study||39||
48136272|NCT00110617|100656134|FG000|NOT COMPLETED|Overall Study||39||
48136273|NCT00110617|100656135|FG001|NOT COMPLETED|Overall Study||29||
48136274|NCT04433767|100656136|FG000|STARTED|Overall Study||29||
48704366|NCT01118520|102060721|FG002|COMPLETED|Overall Study||59||
48704367|NCT01118520|102060719|FG000|NOT COMPLETED|Overall Study||20||
48704368|NCT01118520|102060720|FG001|NOT COMPLETED|Overall Study||23||
48704369|NCT01118520|102060721|FG002|NOT COMPLETED|Overall Study||20||
48704370|NCT04376684|102060722|FG000|STARTED|Part 1 (Up to Day 60)||403||
48704371|NCT04376684|102060723|FG001|STARTED|Part 1 (Up to Day 60)||403||
48136275|NCT04433767|100656136|FG000|COMPLETED|Overall Study||28||
48136276|NCT04433767|100656136|FG000|NOT COMPLETED|Overall Study||1||
48136277|NCT00706121|100656137|FG000|STARTED|Overall Study||2039||
48136278|NCT00706121|100656138|FG001|STARTED|Overall Study||2096||
48136279|NCT00706121|100656139|FG002|STARTED|Overall Study||2030||
48136280|NCT00706121|100656140|FG003|STARTED|Overall Study||1929||
48287845|NCT02146326|101029824|FG003|Baseline|Overall Study||258||
48287846|NCT02146326|101029821|FG000|3 Months|Overall Study||71||
48287847|NCT02146326|101029822|FG001|3 Months|Overall Study||83||
48287848|NCT02146326|101029823|FG002|3 Months|Overall Study||0||
48704372|NCT04376684|102060724|FG002|STARTED|Part 1 (Up to Day 60)||0||
48704373|NCT04376684|102060725|FG003|STARTED|Part 1 (Up to Day 60)||0||
48136281|NCT00706121|100656137|FG000|COMPLETED|Overall Study||1643||
48136282|NCT00706121|100656138|FG001|COMPLETED|Overall Study||1700||
48136283|NCT00706121|100656139|FG002|COMPLETED|Overall Study||1626||
48287849|NCT02146326|101029824|FG003|3 Months|Overall Study||0||
48704374|NCT04376684|102060722|FG000|COMPLETED|Part 1 (Up to Day 60)||388||
48704375|NCT04376684|102060723|FG001|COMPLETED|Part 1 (Up to Day 60)||379||
48704376|NCT04376684|102060724|FG002|COMPLETED|Part 1 (Up to Day 60)||0||
48287850|NCT02146326|101029821|FG000|6 Months|Overall Study||71||
48287851|NCT02146326|101029822|FG001|6 Months|Overall Study||71||
48287852|NCT02146326|101029823|FG002|6 Months|Overall Study||186||
48287853|NCT02146326|101029824|FG003|6 Months|Overall Study||235||
48287854|NCT02146326|101029821|FG000|12 Months|Overall Study||61||
48287855|NCT02146326|101029822|FG001|12 Months|Overall Study||66||
48287856|NCT02146326|101029823|FG002|12 Months|Overall Study||168||
48287857|NCT02146326|101029824|FG003|12 Months|Overall Study||210||
48287858|NCT02146326|101029821|FG000|COMPLETED|Overall Study||61||
48287859|NCT02146326|101029822|FG001|COMPLETED|Overall Study||66||
48287860|NCT02146326|101029823|FG002|COMPLETED|Overall Study||168||
48287861|NCT02146326|101029824|FG003|COMPLETED|Overall Study||210||
48287862|NCT02146326|101029821|FG000|NOT COMPLETED|Overall Study||28||
48287863|NCT02146326|101029822|FG001|NOT COMPLETED|Overall Study||37||
48287864|NCT02146326|101029823|FG002|NOT COMPLETED|Overall Study||43||
48287865|NCT02146326|101029824|FG003|NOT COMPLETED|Overall Study||48||
48287866|NCT01853644|101029825|FG000|STARTED|Registration and Treatment Start||31||
48287867|NCT01853644|101029825|FG000|Registered|Registration and Treatment Start||31||
48287868|NCT01853644|101029825|FG000|Started Treatment|Registration and Treatment Start||30||
48287869|NCT01853644|101029825|FG000|COMPLETED|Registration and Treatment Start||30||
48287870|NCT01853644|101029825|FG000|NOT COMPLETED|Registration and Treatment Start||1||
48287871|NCT01853644|101029825|FG000|STARTED|Reached First Response/Complete 2 Cycles||30||
48287872|NCT01853644|101029825|FG000|COMPLETED|Reached First Response/Complete 2 Cycles||24||
48287873|NCT01853644|101029825|FG000|NOT COMPLETED|Reached First Response/Complete 2 Cycles||6||
48287874|NCT01853644|101029825|FG000|STARTED|Continued Treatment After First Response||24||
48287875|NCT01853644|101029825|FG000|COMPLETED|Continued Treatment After First Response||12||
48287876|NCT01853644|101029825|FG000|NOT COMPLETED|Continued Treatment After First Response||12||
48287877|NCT01853644|101029825|FG000|STARTED|Follow up for 3 Years or Until Death||30||
48287878|NCT01853644|101029825|FG000|COMPLETED|Follow up for 3 Years or Until Death||30|Memo released stating that no more data to be collected after 6.10.21 for remaining patients in follow up and study is considered complete. Last follow up data collected for last patient for the study was 5.11.21.|
48287879|NCT01853644|101029825|FG000|NOT COMPLETED|Follow up for 3 Years or Until Death||0||
48287880|NCT03536143|101029826|FG000|STARTED|Overall Study||12||33
48287881|NCT03536143|101029826|FG000|B-VEC|Overall Study||12||21
48287882|NCT03536143|101029826|FG000|Placebo|Overall Study||12||12
48287883|NCT03536143|101029826|FG000|COMPLETED|Overall Study||11||31
48287884|NCT03536143|101029826|FG000|NOT COMPLETED|Overall Study||1||2
48287885|NCT00790751|101029827|FG000|STARTED|Overall Study||162||
48580877|NCT01116648|101753305|FG003|STARTED|Expansion at Maximum Tolerated Dose||0||
48580878|NCT01116648|101753306|FG004|STARTED|Expansion at Maximum Tolerated Dose||9||
48580879|NCT01116648|101753307|FG005|STARTED|Expansion at Maximum Tolerated Dose||0||
48580880|NCT01116648|101753308|FG006|STARTED|Expansion at Maximum Tolerated Dose||0||
48580881|NCT01116648|101753309|FG007|STARTED|Expansion at Maximum Tolerated Dose||0||
48580882|NCT01116648|101753310|FG008|STARTED|Expansion at Maximum Tolerated Dose||0||
48580883|NCT01116648|101753311|FG009|STARTED|Expansion at Maximum Tolerated Dose||0||
48580884|NCT01116648|101753312|FG010|STARTED|Expansion at Maximum Tolerated Dose||0||
48580885|NCT01116648|101753313|FG011|STARTED|Expansion at Maximum Tolerated Dose||0||
48580886|NCT01116648|101753314|FG012|STARTED|Expansion at Maximum Tolerated Dose||0||
48580887|NCT01116648|101753315|FG013|STARTED|Expansion at Maximum Tolerated Dose||0||
48580888|NCT01116648|101753316|FG014|STARTED|Expansion at Maximum Tolerated Dose||0||
48580889|NCT01116648|101753302|FG000|COMPLETED|Expansion at Maximum Tolerated Dose||0||
48580890|NCT01116648|101753303|FG001|COMPLETED|Expansion at Maximum Tolerated Dose||0||
48580891|NCT01116648|101753304|FG002|COMPLETED|Expansion at Maximum Tolerated Dose||0||
48580892|NCT01116648|101753305|FG003|COMPLETED|Expansion at Maximum Tolerated Dose||0||
48580893|NCT01116648|101753306|FG004|COMPLETED|Expansion at Maximum Tolerated Dose||9||
48580894|NCT01116648|101753307|FG005|COMPLETED|Expansion at Maximum Tolerated Dose||0||
48580895|NCT01116648|101753308|FG006|COMPLETED|Expansion at Maximum Tolerated Dose||0||
48580896|NCT01116648|101753309|FG007|COMPLETED|Expansion at Maximum Tolerated Dose||0||
48580897|NCT01116648|101753310|FG008|COMPLETED|Expansion at Maximum Tolerated Dose||0||
48704377|NCT04376684|102060725|FG003|COMPLETED|Part 1 (Up to Day 60)||0||
48704378|NCT04376684|102060722|FG000|NOT COMPLETED|Part 1 (Up to Day 60)||15||
48704379|NCT04376684|102060723|FG001|NOT COMPLETED|Part 1 (Up to Day 60)||24||
48704380|NCT04376684|102060724|FG002|NOT COMPLETED|Part 1 (Up to Day 60)||0||
48704381|NCT04376684|102060725|FG003|NOT COMPLETED|Part 1 (Up to Day 60)||0||
48704382|NCT04376684|102060722|FG000|STARTED|Part 2 (Up to Day 60)||0||
48704383|NCT04376684|102060723|FG001|STARTED|Part 2 (Up to Day 60)||0||
48704384|NCT04376684|102060724|FG002|STARTED|Part 2 (Up to Day 60)||175||
48704385|NCT04376684|102060725|FG003|STARTED|Part 2 (Up to Day 60)||175||
48704386|NCT04376684|102060722|FG000|COMPLETED|Part 2 (Up to Day 60)||0||
48704387|NCT04376684|102060723|FG001|COMPLETED|Part 2 (Up to Day 60)||0||
48704388|NCT04376684|102060724|FG002|COMPLETED|Part 2 (Up to Day 60)||170||
48704389|NCT04376684|102060725|FG003|COMPLETED|Part 2 (Up to Day 60)||171||
48704390|NCT04376684|102060722|FG000|NOT COMPLETED|Part 2 (Up to Day 60)||0||
48704391|NCT04376684|102060723|FG001|NOT COMPLETED|Part 2 (Up to Day 60)||0||
48704392|NCT04376684|102060724|FG002|NOT COMPLETED|Part 2 (Up to Day 60)||5||
48704393|NCT04376684|102060725|FG003|NOT COMPLETED|Part 2 (Up to Day 60)||4||
48704394|NCT00496483|102060726|FG000|STARTED|Overall Study||60||
48704395|NCT00496483|102060726|FG000|Dosed|Overall Study||51||
48704396|NCT00496483|102060726|FG000|COMPLETED|Overall Study||48||
48580898|NCT01116648|101753311|FG009|COMPLETED|Expansion at Maximum Tolerated Dose||0||
48580899|NCT01116648|101753312|FG010|COMPLETED|Expansion at Maximum Tolerated Dose||0||
48580900|NCT01116648|101753313|FG011|COMPLETED|Expansion at Maximum Tolerated Dose||0||
48580901|NCT01116648|101753314|FG012|COMPLETED|Expansion at Maximum Tolerated Dose||0||
48580902|NCT01116648|101753315|FG013|COMPLETED|Expansion at Maximum Tolerated Dose||0||
48580903|NCT01116648|101753316|FG014|COMPLETED|Expansion at Maximum Tolerated Dose||0||
48580904|NCT01116648|101753302|FG000|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0||
48580905|NCT01116648|101753303|FG001|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0||
48580906|NCT01116648|101753304|FG002|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0||
48580907|NCT01116648|101753305|FG003|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0||
48580908|NCT01116648|101753306|FG004|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0||
48580909|NCT01116648|101753307|FG005|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0||
48580910|NCT01116648|101753308|FG006|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0||
48580911|NCT01116648|101753309|FG007|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0||
48580912|NCT01116648|101753310|FG008|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0||
48580913|NCT01116648|101753311|FG009|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0||
48580914|NCT01116648|101753312|FG010|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0||
48704397|NCT00496483|102060726|FG000|NOT COMPLETED|Overall Study||12||
48704398|NCT01636063|102060727|FG000|STARTED|Overall Study||21||
48704399|NCT01636063|102060728|FG001|STARTED|Overall Study||21||
48704400|NCT01636063|102060727|FG000|COMPLETED|Overall Study||21||
48704401|NCT01636063|102060728|FG001|COMPLETED|Overall Study||21||
48704402|NCT01636063|102060727|FG000|NOT COMPLETED|Overall Study||0||
48704403|NCT01636063|102060728|FG001|NOT COMPLETED|Overall Study||0||
48704404|NCT01818258|102060729|FG000|STARTED|Overall Study||25||
48704405|NCT01818258|102060730|FG001|STARTED|Overall Study||27||
48704406|NCT01818258|102060729|FG000|COMPLETED|Overall Study||22||
48704407|NCT01818258|102060730|FG001|COMPLETED|Overall Study||24||
48704408|NCT01818258|102060729|FG000|NOT COMPLETED|Overall Study||3||
48704409|NCT01818258|102060730|FG001|NOT COMPLETED|Overall Study||3||
48704410|NCT00583414|102060731|FG000|STARTED|Overall Study||401||
48704411|NCT00583414|102060731|FG000|COMPLETED|Overall Study||401||
48704412|NCT00583414|102060731|FG000|NOT COMPLETED|Overall Study||0||
48704413|NCT00782171|102060732|FG000|STARTED|Overall Study||146||
48704414|NCT00782171|102060733|FG001|STARTED|Overall Study||134||
48704415|NCT00782171|102060732|FG000|20-23 Weeks|Overall Study||135||
48704416|NCT00782171|102060733|FG001|20-23 Weeks|Overall Study||124||
48704417|NCT00782171|102060732|FG000|1 Year|Overall Study||131||
48704418|NCT00782171|102060733|FG001|1 Year|Overall Study||120||
48704419|NCT00782171|102060732|FG000|Surgery (Baseline)|Overall Study||138|Includes patients who fulfilled all eligibility criteria and received a study implant|
48704420|NCT00782171|102060733|FG001|Surgery (Baseline)|Overall Study||128|Includes patients who fulfilled all eligibility criteria and received a study implant|
48704421|NCT00782171|102060732|FG000|COMPLETED|Overall Study||124||
48704422|NCT00782171|102060733|FG001|COMPLETED|Overall Study||115||
48136284|NCT00706121|100656140|FG003|COMPLETED|Overall Study||1577||
48136285|NCT00706121|100656137|FG000|NOT COMPLETED|Overall Study||396||
48136286|NCT00706121|100656138|FG001|NOT COMPLETED|Overall Study||396||
48580915|NCT01116648|101753313|FG011|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0||
48580916|NCT01116648|101753314|FG012|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0||
48580917|NCT01116648|101753315|FG013|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0||
48580918|NCT01116648|101753316|FG014|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0||
48580919|NCT01116648|101753302|FG000|STARTED|Phase 2||0||
48580920|NCT01116648|101753303|FG001|STARTED|Phase 2||0||
48580921|NCT01116648|101753304|FG002|STARTED|Phase 2||0||
48580922|NCT01116648|101753305|FG003|STARTED|Phase 2||0||
48580923|NCT01116648|101753306|FG004|STARTED|Phase 2||0||
48580924|NCT01116648|101753307|FG005|STARTED|Phase 2||46||
48580925|NCT01116648|101753308|FG006|STARTED|Phase 2||44||
48580926|NCT01116648|101753309|FG007|STARTED|Phase 2||0||
48580927|NCT01116648|101753310|FG008|STARTED|Phase 2||0||
48580928|NCT01116648|101753311|FG009|STARTED|Phase 2||0||
48580929|NCT01116648|101753312|FG010|STARTED|Phase 2||0||
48580930|NCT01116648|101753313|FG011|STARTED|Phase 2||0||
48580931|NCT01116648|101753314|FG012|STARTED|Phase 2||0||
48580932|NCT01116648|101753315|FG013|STARTED|Phase 2||0||
48580933|NCT01116648|101753316|FG014|STARTED|Phase 2||0||
48580934|NCT01116648|101753302|FG000|COMPLETED|Phase 2||0||
48580935|NCT01116648|101753303|FG001|COMPLETED|Phase 2||0||
48580936|NCT01116648|101753304|FG002|COMPLETED|Phase 2||0||
48580937|NCT01116648|101753305|FG003|COMPLETED|Phase 2||0||
48580938|NCT01116648|101753306|FG004|COMPLETED|Phase 2||0||
48580939|NCT01116648|101753307|FG005|COMPLETED|Phase 2||46||
48580940|NCT01116648|101753308|FG006|COMPLETED|Phase 2||44||
48580941|NCT01116648|101753309|FG007|COMPLETED|Phase 2||0||
48580942|NCT01116648|101753310|FG008|COMPLETED|Phase 2||0||
48580943|NCT01116648|101753311|FG009|COMPLETED|Phase 2||0||
48580944|NCT01116648|101753312|FG010|COMPLETED|Phase 2||0||
48580945|NCT01116648|101753313|FG011|COMPLETED|Phase 2||0||
48704423|NCT00782171|102060732|FG000|NOT COMPLETED|Overall Study||22||
48704424|NCT00782171|102060733|FG001|NOT COMPLETED|Overall Study||19||
48704425|NCT03425006|102060734|FG000|STARTED|Overall Study||23||
48704426|NCT03425006|102060734|FG000|COMPLETED|Overall Study||20||
48704427|NCT03425006|102060734|FG000|NOT COMPLETED|Overall Study||3||
48704428|NCT00396006|102060735|FG000|STARTED|Overall Study||13||
48704429|NCT00396006|102060735|FG000|COMPLETED|Overall Study||13||
48704430|NCT00396006|102060735|FG000|NOT COMPLETED|Overall Study||0||
48704431|NCT01713660|102060736|FG000|STARTED|Overall Study||37||
48580946|NCT01116648|101753314|FG012|COMPLETED|Phase 2||0||
48580947|NCT01116648|101753315|FG013|COMPLETED|Phase 2||0||
48580948|NCT01116648|101753316|FG014|COMPLETED|Phase 2||0||
48580949|NCT01116648|101753302|FG000|NOT COMPLETED|Phase 2||0||
48580950|NCT01116648|101753303|FG001|NOT COMPLETED|Phase 2||0||
48580951|NCT01116648|101753304|FG002|NOT COMPLETED|Phase 2||0||
48580952|NCT01116648|101753305|FG003|NOT COMPLETED|Phase 2||0||
48580953|NCT01116648|101753306|FG004|NOT COMPLETED|Phase 2||0||
48580954|NCT01116648|101753307|FG005|NOT COMPLETED|Phase 2||0||
48704432|NCT01713660|102060736|FG000|COMPLETED|Overall Study||37||
48136287|NCT00706121|100656139|FG002|NOT COMPLETED|Overall Study||404||
48580955|NCT01116648|101753308|FG006|NOT COMPLETED|Phase 2||0||
48580956|NCT01116648|101753309|FG007|NOT COMPLETED|Phase 2||0||
48580957|NCT01116648|101753310|FG008|NOT COMPLETED|Phase 2||0||
48580958|NCT01116648|101753311|FG009|NOT COMPLETED|Phase 2||0||
48580959|NCT01116648|101753312|FG010|NOT COMPLETED|Phase 2||0||
48580960|NCT01116648|101753313|FG011|NOT COMPLETED|Phase 2||0||
48580961|NCT01116648|101753314|FG012|NOT COMPLETED|Phase 2||0||
48580962|NCT01116648|101753315|FG013|NOT COMPLETED|Phase 2||0||
48580963|NCT01116648|101753316|FG014|NOT COMPLETED|Phase 2||0||
48580964|NCT01116648|101753302|FG000|STARTED|Phase 1-T Dose Level 0-TA||0||
48580965|NCT01116648|101753303|FG001|STARTED|Phase 1-T Dose Level 0-TA||0||
48580966|NCT01116648|101753304|FG002|STARTED|Phase 1-T Dose Level 0-TA||0||
48580967|NCT01116648|101753305|FG003|STARTED|Phase 1-T Dose Level 0-TA||0||
48580968|NCT01116648|101753306|FG004|STARTED|Phase 1-T Dose Level 0-TA||0||
48580969|NCT01116648|101753307|FG005|STARTED|Phase 1-T Dose Level 0-TA||0||
48580970|NCT01116648|101753308|FG006|STARTED|Phase 1-T Dose Level 0-TA||0||
48580971|NCT01116648|101753309|FG007|STARTED|Phase 1-T Dose Level 0-TA||3||
48580972|NCT01116648|101753310|FG008|STARTED|Phase 1-T Dose Level 0-TA||0||
48580973|NCT01116648|101753311|FG009|STARTED|Phase 1-T Dose Level 0-TA||0||
48580974|NCT01116648|101753312|FG010|STARTED|Phase 1-T Dose Level 0-TA||0||
48580975|NCT01116648|101753313|FG011|STARTED|Phase 1-T Dose Level 0-TA||0||
48580976|NCT01116648|101753314|FG012|STARTED|Phase 1-T Dose Level 0-TA||0||
48580977|NCT01116648|101753315|FG013|STARTED|Phase 1-T Dose Level 0-TA||0||
48580978|NCT01116648|101753316|FG014|STARTED|Phase 1-T Dose Level 0-TA||0||
48580979|NCT01116648|101753302|FG000|COMPLETED|Phase 1-T Dose Level 0-TA||0||
48580980|NCT01116648|101753303|FG001|COMPLETED|Phase 1-T Dose Level 0-TA||0||
48580981|NCT01116648|101753304|FG002|COMPLETED|Phase 1-T Dose Level 0-TA||0||
48580982|NCT01116648|101753305|FG003|COMPLETED|Phase 1-T Dose Level 0-TA||0||
48580983|NCT01116648|101753306|FG004|COMPLETED|Phase 1-T Dose Level 0-TA||0||
48580984|NCT01116648|101753307|FG005|COMPLETED|Phase 1-T Dose Level 0-TA||0||
48580985|NCT01116648|101753308|FG006|COMPLETED|Phase 1-T Dose Level 0-TA||0||
48136288|NCT00706121|100656140|FG003|NOT COMPLETED|Overall Study||352||
48400551|NCT01461824|101313569|FG001|STARTED|Overall Study||11||
48400552|NCT01461824|101313570|FG002|STARTED|Overall Study||11||
48400553|NCT01461824|101313568|FG000|COMPLETED|Overall Study||10||
48400554|NCT01461824|101313569|FG001|COMPLETED|Overall Study||7||
48400555|NCT01461824|101313570|FG002|COMPLETED|Overall Study||8||
48400556|NCT01461824|101313568|FG000|NOT COMPLETED|Overall Study||2||
48580986|NCT01116648|101753309|FG007|COMPLETED|Phase 1-T Dose Level 0-TA||3||
48580987|NCT01116648|101753310|FG008|COMPLETED|Phase 1-T Dose Level 0-TA||0||
48580988|NCT01116648|101753311|FG009|COMPLETED|Phase 1-T Dose Level 0-TA||0||
48580989|NCT01116648|101753312|FG010|COMPLETED|Phase 1-T Dose Level 0-TA||0||
48136289|NCT04743908|100656141|FG000|STARTED|Overall Study||661||
48136290|NCT04743908|100656142|FG001|STARTED|Overall Study||667||
48400557|NCT01461824|101313569|FG001|NOT COMPLETED|Overall Study||4||
48400558|NCT01461824|101313570|FG002|NOT COMPLETED|Overall Study||3||
48400559|NCT02384993|101313571|FG000|STARTED|Overall Study||12||
48400560|NCT02384993|101313572|FG001|STARTED|Overall Study||12||
48400561|NCT02384993|101313571|FG000|COMPLETED|Overall Study||12||
48400562|NCT02384993|101313572|FG001|COMPLETED|Overall Study||11||
48400563|NCT02384993|101313571|FG000|NOT COMPLETED|Overall Study||0||
48400564|NCT02384993|101313572|FG001|NOT COMPLETED|Overall Study||1||
48400565|NCT04366713|101313573|FG000|STARTED|Overall Study||6||
48400566|NCT04366713|101313573|FG000|Treated|Overall Study||5||
48580990|NCT01116648|101753313|FG011|COMPLETED|Phase 1-T Dose Level 0-TA||0||
48580991|NCT01116648|101753314|FG012|COMPLETED|Phase 1-T Dose Level 0-TA||0||
48580992|NCT01116648|101753315|FG013|COMPLETED|Phase 1-T Dose Level 0-TA||0||
48580993|NCT01116648|101753316|FG014|COMPLETED|Phase 1-T Dose Level 0-TA||0||
48580994|NCT01116648|101753302|FG000|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0||
48136291|NCT04743908|100656141|FG000|COMPLETED|Overall Study||478||
48580995|NCT01116648|101753303|FG001|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0||
48580996|NCT01116648|101753304|FG002|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0||
48580997|NCT01116648|101753305|FG003|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0||
48580998|NCT01116648|101753306|FG004|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0||
48580999|NCT01116648|101753307|FG005|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0||
48581000|NCT01116648|101753308|FG006|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0||
48581001|NCT01116648|101753309|FG007|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0||
48581002|NCT01116648|101753310|FG008|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0||
48581003|NCT01116648|101753311|FG009|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0||
48581004|NCT01116648|101753312|FG010|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0||
48581005|NCT01116648|101753313|FG011|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0||
48581006|NCT01116648|101753314|FG012|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0||
48581007|NCT01116648|101753315|FG013|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0||
48581008|NCT01116648|101753316|FG014|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0||
48581009|NCT01116648|101753302|FG000|STARTED|Phase 1-T Dose Level 1-TA||0||
48581010|NCT01116648|101753303|FG001|STARTED|Phase 1-T Dose Level 1-TA||0||
48581011|NCT01116648|101753304|FG002|STARTED|Phase 1-T Dose Level 1-TA||0||
48581012|NCT01116648|101753305|FG003|STARTED|Phase 1-T Dose Level 1-TA||0||
48581013|NCT01116648|101753306|FG004|STARTED|Phase 1-T Dose Level 1-TA||0||
48581014|NCT01116648|101753307|FG005|STARTED|Phase 1-T Dose Level 1-TA||0||
48581015|NCT01116648|101753308|FG006|STARTED|Phase 1-T Dose Level 1-TA||0||
48581016|NCT01116648|101753309|FG007|STARTED|Phase 1-T Dose Level 1-TA||0||
48581017|NCT01116648|101753310|FG008|STARTED|Phase 1-T Dose Level 1-TA||6||
48581018|NCT01116648|101753311|FG009|STARTED|Phase 1-T Dose Level 1-TA||0||
48581019|NCT01116648|101753312|FG010|STARTED|Phase 1-T Dose Level 1-TA||0||
48581020|NCT01116648|101753313|FG011|STARTED|Phase 1-T Dose Level 1-TA||0||
48581021|NCT01116648|101753314|FG012|STARTED|Phase 1-T Dose Level 1-TA||0||
48581022|NCT01116648|101753315|FG013|STARTED|Phase 1-T Dose Level 1-TA||0||
48581023|NCT01116648|101753316|FG014|STARTED|Phase 1-T Dose Level 1-TA||0||
48581024|NCT01116648|101753302|FG000|COMPLETED|Phase 1-T Dose Level 1-TA||0||
48581025|NCT01116648|101753303|FG001|COMPLETED|Phase 1-T Dose Level 1-TA||0||
48581026|NCT01116648|101753304|FG002|COMPLETED|Phase 1-T Dose Level 1-TA||0||
48581027|NCT01116648|101753305|FG003|COMPLETED|Phase 1-T Dose Level 1-TA||0||
48581028|NCT01116648|101753306|FG004|COMPLETED|Phase 1-T Dose Level 1-TA||0||
48581029|NCT01116648|101753307|FG005|COMPLETED|Phase 1-T Dose Level 1-TA||0||
48581030|NCT01116648|101753308|FG006|COMPLETED|Phase 1-T Dose Level 1-TA||0||
48581031|NCT01116648|101753309|FG007|COMPLETED|Phase 1-T Dose Level 1-TA||0||
48136292|NCT04743908|100656142|FG001|COMPLETED|Overall Study||485||
48136293|NCT04743908|100656141|FG000|NOT COMPLETED|Overall Study||183||
48136294|NCT04743908|100656142|FG001|NOT COMPLETED|Overall Study||182||
48287886|NCT00790751|101029828|FG001|STARTED|Overall Study||161||
48287887|NCT00790751|101029829|FG002|STARTED|Overall Study||161||
48287888|NCT00790751|101029830|FG003|STARTED|Overall Study||162||
48581032|NCT01116648|101753310|FG008|COMPLETED|Phase 1-T Dose Level 1-TA||6||
48581033|NCT01116648|101753311|FG009|COMPLETED|Phase 1-T Dose Level 1-TA||0||
48581034|NCT01116648|101753312|FG010|COMPLETED|Phase 1-T Dose Level 1-TA||0||
48581035|NCT01116648|101753313|FG011|COMPLETED|Phase 1-T Dose Level 1-TA||0||
48581036|NCT01116648|101753314|FG012|COMPLETED|Phase 1-T Dose Level 1-TA||0||
48581037|NCT01116648|101753315|FG013|COMPLETED|Phase 1-T Dose Level 1-TA||0||
48581038|NCT01116648|101753316|FG014|COMPLETED|Phase 1-T Dose Level 1-TA||0||
48704433|NCT01713660|102060736|FG000|NOT COMPLETED|Overall Study||0||
48704434|NCT03454399|102060737|FG000|STARTED|TEE Image Before Suction||47||141
48704435|NCT03454399|102060737|FG000|COMPLETED|TEE Image Before Suction||47||141
48581039|NCT01116648|101753302|FG000|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0||
48581040|NCT01116648|101753303|FG001|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0||
48581041|NCT01116648|101753304|FG002|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0||
48581042|NCT01116648|101753305|FG003|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0||
48581043|NCT01116648|101753306|FG004|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0||
48581044|NCT01116648|101753307|FG005|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0||
48581045|NCT01116648|101753308|FG006|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0||
48581046|NCT01116648|101753309|FG007|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0||
48581047|NCT01116648|101753310|FG008|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0||
48581048|NCT01116648|101753311|FG009|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0||
48581049|NCT01116648|101753312|FG010|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0||
48581050|NCT01116648|101753313|FG011|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0||
48581051|NCT01116648|101753314|FG012|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0||
48581052|NCT01116648|101753315|FG013|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0||
48581053|NCT01116648|101753316|FG014|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0||
48581054|NCT01116648|101753302|FG000|STARTED|Phase 1-T Dose Level 2-TA||0||
48581055|NCT01116648|101753303|FG001|STARTED|Phase 1-T Dose Level 2-TA||0||
48581056|NCT01116648|101753304|FG002|STARTED|Phase 1-T Dose Level 2-TA||0||
48581057|NCT01116648|101753305|FG003|STARTED|Phase 1-T Dose Level 2-TA||0||
48581058|NCT01116648|101753306|FG004|STARTED|Phase 1-T Dose Level 2-TA||0||
48581059|NCT01116648|101753307|FG005|STARTED|Phase 1-T Dose Level 2-TA||0||
48581060|NCT01116648|101753308|FG006|STARTED|Phase 1-T Dose Level 2-TA||0||
48581061|NCT01116648|101753309|FG007|STARTED|Phase 1-T Dose Level 2-TA||0||
48581062|NCT01116648|101753310|FG008|STARTED|Phase 1-T Dose Level 2-TA||0||
48581063|NCT01116648|101753311|FG009|STARTED|Phase 1-T Dose Level 2-TA||3||
48704436|NCT03454399|102060737|FG000|NOT COMPLETED|TEE Image Before Suction||0||0
48704437|NCT03454399|102060737|FG000|STARTED|TEE Image After Suction||47||141
48704438|NCT03454399|102060737|FG000|COMPLETED|TEE Image After Suction||47||141
48704439|NCT03454399|102060737|FG000|NOT COMPLETED|TEE Image After Suction||0||0
48704440|NCT00813865|102060738|FG000|STARTED|Overall Study||8||
48704441|NCT00813865|102060738|FG000|Safety Population|Overall Study||8|All participants who received at least 1 dose of study drug|
48704442|NCT00813865|102060738|FG000|Pharmacodynamic (PD) Population|Overall Study||8|Participants in the Safety Population with a baseline and at least 1 post-baseline PD measurement.|
48704443|NCT00813865|102060738|FG000|COMPLETED|Overall Study||1||
48704444|NCT00813865|102060738|FG000|NOT COMPLETED|Overall Study||7||
48704445|NCT04027803|102060739|FG000|STARTED|Overall Study||39||
48704446|NCT04027803|102060740|FG001|STARTED|Overall Study||39||
48704447|NCT04027803|102060739|FG000|COMPLETED|Overall Study||39||
48704448|NCT04027803|102060740|FG001|COMPLETED|Overall Study||39||
48704449|NCT04027803|102060739|FG000|NOT COMPLETED|Overall Study||0||
48704450|NCT04027803|102060740|FG001|NOT COMPLETED|Overall Study||0||
48704451|NCT05659719|102060741|FG000|STARTED|Overall Study||20||
48704452|NCT05659719|102060742|FG001|STARTED|Overall Study||19||
48704453|NCT05659719|102060743|FG002|STARTED|Overall Study||18||
48704454|NCT05659719|102060744|FG003|STARTED|Overall Study||191||
48704455|NCT05659719|102060741|FG000|COMPLETED|Overall Study||20||
48704456|NCT05659719|102060742|FG001|COMPLETED|Overall Study||19||
48704457|NCT05659719|102060743|FG002|COMPLETED|Overall Study||18||
48704458|NCT05659719|102060744|FG003|COMPLETED|Overall Study||2||
48704459|NCT05659719|102060741|FG000|NOT COMPLETED|Overall Study||0||
48704460|NCT05659719|102060742|FG001|NOT COMPLETED|Overall Study||0||
48704461|NCT05659719|102060743|FG002|NOT COMPLETED|Overall Study||0||
48704462|NCT05659719|102060744|FG003|NOT COMPLETED|Overall Study||189||
48704463|NCT01425359|102060745|FG000|STARTED|Overall Study||476||
48704464|NCT01425359|102060746|FG001|STARTED|Overall Study||473||
48287889|NCT00790751|101029827|FG000|COMPLETED|Overall Study||137||
48581064|NCT01116648|101753312|FG010|STARTED|Phase 1-T Dose Level 2-TA||0||
48704465|NCT01425359|102060745|FG000|COMPLETED|Overall Study||457||
48704466|NCT01425359|102060746|FG001|COMPLETED|Overall Study||451||
48287890|NCT00790751|101029828|FG001|COMPLETED|Overall Study||131||
48400567|NCT04366713|101313573|FG000|COMPLETED|Overall Study||4||
48581065|NCT01116648|101753313|FG011|STARTED|Phase 1-T Dose Level 2-TA||0||
48581066|NCT01116648|101753314|FG012|STARTED|Phase 1-T Dose Level 2-TA||0||
48581067|NCT01116648|101753315|FG013|STARTED|Phase 1-T Dose Level 2-TA||0||
48581068|NCT01116648|101753316|FG014|STARTED|Phase 1-T Dose Level 2-TA||0||
48704467|NCT01425359|102060745|FG000|NOT COMPLETED|Overall Study||19||
48704468|NCT01425359|102060746|FG001|NOT COMPLETED|Overall Study||22||
48704469|NCT04956731|102060747|FG000|STARTED|Overall Study||10||
48704470|NCT04956731|102060747|FG000|COMPLETED|Overall Study||10||
48704471|NCT04956731|102060747|FG000|NOT COMPLETED|Overall Study||0||
48704472|NCT05470842|102060748|FG000|STARTED|Overall Study||12||
48581069|NCT01116648|101753302|FG000|COMPLETED|Phase 1-T Dose Level 2-TA||0||
48581070|NCT01116648|101753303|FG001|COMPLETED|Phase 1-T Dose Level 2-TA||0||
48581071|NCT01116648|101753304|FG002|COMPLETED|Phase 1-T Dose Level 2-TA||0||
48704473|NCT05470842|102060748|FG000|COMPLETED|Overall Study||11||
48704474|NCT05470842|102060748|FG000|NOT COMPLETED|Overall Study||1||
48704475|NCT00559845|102060749|FG000|STARTED|Overall Study||56||
48704476|NCT00559845|102060749|FG000|COMPLETED|Overall Study||49||
48704477|NCT00559845|102060749|FG000|NOT COMPLETED|Overall Study||7||
48704478|NCT00405509|102060750|FG000|STARTED|Overall Study||11||
48704479|NCT00405509|102060751|FG001|STARTED|Overall Study||22||
48704480|NCT00405509|102060750|FG000|COMPLETED|Overall Study||11||
48704481|NCT00405509|102060751|FG001|COMPLETED|Overall Study||22||
48704482|NCT00405509|102060750|FG000|NOT COMPLETED|Overall Study||0||
48704483|NCT00405509|102060751|FG001|NOT COMPLETED|Overall Study||0||
48704484|NCT00790868|102060752|FG000|STARTED|Overall Study||88|98 participants were deemed ineligible at baseline and 15 others were not randomized.|
48704485|NCT00790868|102060753|FG001|STARTED|Overall Study||92|98 participants were deemed ineligible at baseline and 15 others were not randomized.|
48400568|NCT04366713|101313573|FG000|NOT COMPLETED|Overall Study||2||
48581072|NCT01116648|101753305|FG003|COMPLETED|Phase 1-T Dose Level 2-TA||0||
48581073|NCT01116648|101753306|FG004|COMPLETED|Phase 1-T Dose Level 2-TA||0||
48704486|NCT00790868|102060752|FG000|COMPLETED|Overall Study||82|All randomized participants (n = 180) were included in data analysis.|
48704487|NCT00790868|102060753|FG001|COMPLETED|Overall Study||75|All randomized participants (n = 180) were included in data analysis.|
48704488|NCT00790868|102060752|FG000|NOT COMPLETED|Overall Study||6||
48704489|NCT00790868|102060753|FG001|NOT COMPLETED|Overall Study||17||
48704490|NCT01657344|102060754|FG000|STARTED|Overall Study||421622||
48704491|NCT01657344|102060755|FG001|STARTED|Overall Study||409967||
48704492|NCT01657344|102060756|FG002|STARTED|Overall Study||196300||
48704493|NCT01657344|102060757|FG003|STARTED|Overall Study||376517||
48704494|NCT01657344|102060758|FG004|STARTED|Overall Study||157802||
48704495|NCT01657344|102060759|FG005|STARTED|Overall Study||316477||
48704496|NCT01657344|102060760|FG006|STARTED|Overall Study||140776||
48704497|NCT01657344|102060754|FG000|COMPLETED|Overall Study||421622||
48704498|NCT01657344|102060755|FG001|COMPLETED|Overall Study||409967||
48581074|NCT01116648|101753307|FG005|COMPLETED|Phase 1-T Dose Level 2-TA||0||
48581075|NCT01116648|101753308|FG006|COMPLETED|Phase 1-T Dose Level 2-TA||0||
48287891|NCT00790751|101029829|FG002|COMPLETED|Overall Study||141||
48287892|NCT00790751|101029830|FG003|COMPLETED|Overall Study||141||
48287893|NCT00790751|101029827|FG000|NOT COMPLETED|Overall Study||25||
48581076|NCT01116648|101753309|FG007|COMPLETED|Phase 1-T Dose Level 2-TA||0||
48581077|NCT01116648|101753310|FG008|COMPLETED|Phase 1-T Dose Level 2-TA||0||
48581078|NCT01116648|101753311|FG009|COMPLETED|Phase 1-T Dose Level 2-TA||3||
48581079|NCT01116648|101753312|FG010|COMPLETED|Phase 1-T Dose Level 2-TA||0||
48581080|NCT01116648|101753313|FG011|COMPLETED|Phase 1-T Dose Level 2-TA||0||
48581081|NCT01116648|101753314|FG012|COMPLETED|Phase 1-T Dose Level 2-TA||0||
48581082|NCT01116648|101753315|FG013|COMPLETED|Phase 1-T Dose Level 2-TA||0||
48581083|NCT01116648|101753316|FG014|COMPLETED|Phase 1-T Dose Level 2-TA||0||
48581084|NCT01116648|101753302|FG000|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0||
48581085|NCT01116648|101753303|FG001|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0||
48581086|NCT01116648|101753304|FG002|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0||
48581087|NCT01116648|101753305|FG003|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0||
48581088|NCT01116648|101753306|FG004|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0||
48136295|NCT02005471|100656143|FG000|STARTED|Main Study||195||
48136296|NCT02005471|100656144|FG001|STARTED|Main Study||194||
48287894|NCT00790751|101029828|FG001|NOT COMPLETED|Overall Study||30||
48287895|NCT00790751|101029829|FG002|NOT COMPLETED|Overall Study||20||
48287896|NCT00790751|101029830|FG003|NOT COMPLETED|Overall Study||21||
48136297|NCT02005471|100656145|FG002|STARTED|Main Study||0||
48136298|NCT02005471|100656146|FG003|STARTED|Main Study||0||
48136299|NCT02005471|100656143|FG000|Safety Evaluable (SE) Population|Main Study||188|SE population included all randomized participants who received at least one dose of study treatment with participants grouped according to the actual treatment received.|
48136300|NCT02005471|100656144|FG001|Safety Evaluable (SE) Population|Main Study||194|SE population included all randomized participants who received at least one dose of study treatment with participants grouped according to the actual treatment received.|
48136301|NCT02005471|100656145|FG002|Safety Evaluable (SE) Population|Main Study||0|SE population included all randomized participants who received at least one dose of study treatment with participants grouped according to the actual treatment received.|
48136302|NCT02005471|100656146|FG003|Safety Evaluable (SE) Population|Main Study||0|SE population included all randomized participants who received at least one dose of study treatment with participants grouped according to the actual treatment received.|
48136303|NCT02005471|100656143|FG000|COMPLETED|Main Study||71||
48136304|NCT02005471|100656144|FG001|COMPLETED|Main Study||118||
48287897|NCT03029351|101029831|FG000|STARTED|Overall Study||7||
48287898|NCT03029351|101029832|FG001|STARTED|Overall Study||8||
48287899|NCT03029351|101029831|FG000|COMPLETED|Overall Study||4||
48287900|NCT03029351|101029832|FG001|COMPLETED|Overall Study||5||
48287901|NCT03029351|101029831|FG000|NOT COMPLETED|Overall Study||3||
48287902|NCT03029351|101029832|FG001|NOT COMPLETED|Overall Study||3||
48287903|NCT02040584|101029833|FG000|STARTED|Overall Study||105||
48287904|NCT02040584|101029834|FG001|STARTED|Overall Study||106||
48581089|NCT01116648|101753307|FG005|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0||
48581090|NCT01116648|101753308|FG006|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0||
48581091|NCT01116648|101753309|FG007|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0||
48581092|NCT01116648|101753310|FG008|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0||
48581093|NCT01116648|101753311|FG009|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0||
48581094|NCT01116648|101753312|FG010|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0||
48581095|NCT01116648|101753313|FG011|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0||
48581096|NCT01116648|101753314|FG012|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0||
48581097|NCT01116648|101753315|FG013|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0||
48581098|NCT01116648|101753316|FG014|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0||
48581099|NCT01116648|101753302|FG000|STARTED|Phase 1-T Dose Level 0-TB||0||
48581100|NCT01116648|101753303|FG001|STARTED|Phase 1-T Dose Level 0-TB||0||
48581101|NCT01116648|101753304|FG002|STARTED|Phase 1-T Dose Level 0-TB||0||
48581102|NCT01116648|101753305|FG003|STARTED|Phase 1-T Dose Level 0-TB||0||
48136305|NCT02005471|100656145|FG002|COMPLETED|Main Study||0||
48136306|NCT02005471|100656146|FG003|COMPLETED|Main Study||0||
48136307|NCT02005471|100656143|FG000|NOT COMPLETED|Main Study||124||
48287905|NCT02040584|101029833|FG000|COMPLETED|Overall Study||70||
48287906|NCT02040584|101029834|FG001|COMPLETED|Overall Study||74||
48287907|NCT02040584|101029833|FG000|NOT COMPLETED|Overall Study||35||
48287908|NCT02040584|101029834|FG001|NOT COMPLETED|Overall Study||32||
48287909|NCT00597246|101029835|FG000|STARTED|Overall Study||30||
48581103|NCT01116648|101753306|FG004|STARTED|Phase 1-T Dose Level 0-TB||0||
48581104|NCT01116648|101753307|FG005|STARTED|Phase 1-T Dose Level 0-TB||0||
48581105|NCT01116648|101753308|FG006|STARTED|Phase 1-T Dose Level 0-TB||0||
48581106|NCT01116648|101753309|FG007|STARTED|Phase 1-T Dose Level 0-TB||0||
48581107|NCT01116648|101753310|FG008|STARTED|Phase 1-T Dose Level 0-TB||0||
48581108|NCT01116648|101753311|FG009|STARTED|Phase 1-T Dose Level 0-TB||0||
48581109|NCT01116648|101753312|FG010|STARTED|Phase 1-T Dose Level 0-TB||3||
48581110|NCT01116648|101753313|FG011|STARTED|Phase 1-T Dose Level 0-TB||0||
48581111|NCT01116648|101753314|FG012|STARTED|Phase 1-T Dose Level 0-TB||0||
48581112|NCT01116648|101753315|FG013|STARTED|Phase 1-T Dose Level 0-TB||0||
48581113|NCT01116648|101753316|FG014|STARTED|Phase 1-T Dose Level 0-TB||0||
48581114|NCT01116648|101753302|FG000|COMPLETED|Phase 1-T Dose Level 0-TB||0||
48581115|NCT01116648|101753303|FG001|COMPLETED|Phase 1-T Dose Level 0-TB||0||
48581116|NCT01116648|101753304|FG002|COMPLETED|Phase 1-T Dose Level 0-TB||0||
48581117|NCT01116648|101753305|FG003|COMPLETED|Phase 1-T Dose Level 0-TB||0||
48581118|NCT01116648|101753306|FG004|COMPLETED|Phase 1-T Dose Level 0-TB||0||
48581119|NCT01116648|101753307|FG005|COMPLETED|Phase 1-T Dose Level 0-TB||0||
48581120|NCT01116648|101753308|FG006|COMPLETED|Phase 1-T Dose Level 0-TB||0||
48581121|NCT01116648|101753309|FG007|COMPLETED|Phase 1-T Dose Level 0-TB||0||
48581122|NCT01116648|101753310|FG008|COMPLETED|Phase 1-T Dose Level 0-TB||0||
48581123|NCT01116648|101753311|FG009|COMPLETED|Phase 1-T Dose Level 0-TB||0||
48581124|NCT01116648|101753312|FG010|COMPLETED|Phase 1-T Dose Level 0-TB||3||
48581125|NCT01116648|101753313|FG011|COMPLETED|Phase 1-T Dose Level 0-TB||0||
48581126|NCT01116648|101753314|FG012|COMPLETED|Phase 1-T Dose Level 0-TB||0||
48581127|NCT01116648|101753315|FG013|COMPLETED|Phase 1-T Dose Level 0-TB||0||
48581128|NCT01116648|101753316|FG014|COMPLETED|Phase 1-T Dose Level 0-TB||0||
48581129|NCT01116648|101753302|FG000|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0||
48581130|NCT01116648|101753303|FG001|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0||
48581131|NCT01116648|101753304|FG002|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0||
48581132|NCT01116648|101753305|FG003|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0||
48581133|NCT01116648|101753306|FG004|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0||
48581134|NCT01116648|101753307|FG005|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0||
48581135|NCT01116648|101753308|FG006|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0||
48581136|NCT01116648|101753309|FG007|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0||
48581137|NCT01116648|101753310|FG008|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0||
48581138|NCT01116648|101753311|FG009|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0||
48581139|NCT01116648|101753312|FG010|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0||
48581140|NCT01116648|101753313|FG011|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0||
48581141|NCT01116648|101753314|FG012|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0||
48581142|NCT01116648|101753315|FG013|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0||
48581143|NCT01116648|101753316|FG014|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0||
48581144|NCT01116648|101753302|FG000|STARTED|Phase 1-T Dose Level 1-TB||0||
48581145|NCT01116648|101753303|FG001|STARTED|Phase 1-T Dose Level 1-TB||0||
48581146|NCT01116648|101753304|FG002|STARTED|Phase 1-T Dose Level 1-TB||0||
48581147|NCT01116648|101753305|FG003|STARTED|Phase 1-T Dose Level 1-TB||0||
48581148|NCT01116648|101753306|FG004|STARTED|Phase 1-T Dose Level 1-TB||0||
48581149|NCT01116648|101753307|FG005|STARTED|Phase 1-T Dose Level 1-TB||0||
48581150|NCT01116648|101753308|FG006|STARTED|Phase 1-T Dose Level 1-TB||0||
48581151|NCT01116648|101753309|FG007|STARTED|Phase 1-T Dose Level 1-TB||0||
48581152|NCT01116648|101753310|FG008|STARTED|Phase 1-T Dose Level 1-TB||0||
48136308|NCT02005471|100656144|FG001|NOT COMPLETED|Main Study||76||
48136309|NCT02005471|100656145|FG002|NOT COMPLETED|Main Study||0||
48136310|NCT02005471|100656146|FG003|NOT COMPLETED|Main Study||0||
48136311|NCT02005471|100656143|FG000|STARTED|Re-Treatment/Crossover (R/C) Substudy||0||
48136312|NCT02005471|100656144|FG001|STARTED|Re-Treatment/Crossover (R/C) Substudy||0||
48581153|NCT01116648|101753311|FG009|STARTED|Phase 1-T Dose Level 1-TB||0||
48581154|NCT01116648|101753312|FG010|STARTED|Phase 1-T Dose Level 1-TB||0||
48581155|NCT01116648|101753313|FG011|STARTED|Phase 1-T Dose Level 1-TB||3||
48581156|NCT01116648|101753314|FG012|STARTED|Phase 1-T Dose Level 1-TB||0||
48581157|NCT01116648|101753315|FG013|STARTED|Phase 1-T Dose Level 1-TB||0||
48581158|NCT01116648|101753316|FG014|STARTED|Phase 1-T Dose Level 1-TB||0||
48581159|NCT01116648|101753302|FG000|COMPLETED|Phase 1-T Dose Level 1-TB||0||
48581160|NCT01116648|101753303|FG001|COMPLETED|Phase 1-T Dose Level 1-TB||0||
48581161|NCT01116648|101753304|FG002|COMPLETED|Phase 1-T Dose Level 1-TB||0||
48581162|NCT01116648|101753305|FG003|COMPLETED|Phase 1-T Dose Level 1-TB||0||
48581163|NCT01116648|101753306|FG004|COMPLETED|Phase 1-T Dose Level 1-TB||0||
48136313|NCT02005471|100656145|FG002|STARTED|Re-Treatment/Crossover (R/C) Substudy||9||
48136314|NCT02005471|100656146|FG003|STARTED|Re-Treatment/Crossover (R/C) Substudy||25||
48581164|NCT01116648|101753307|FG005|COMPLETED|Phase 1-T Dose Level 1-TB||0||
48581165|NCT01116648|101753308|FG006|COMPLETED|Phase 1-T Dose Level 1-TB||0||
48581166|NCT01116648|101753309|FG007|COMPLETED|Phase 1-T Dose Level 1-TB||0||
48581167|NCT01116648|101753310|FG008|COMPLETED|Phase 1-T Dose Level 1-TB||0||
48581168|NCT01116648|101753311|FG009|COMPLETED|Phase 1-T Dose Level 1-TB||0||
48581169|NCT01116648|101753312|FG010|COMPLETED|Phase 1-T Dose Level 1-TB||0||
48581170|NCT01116648|101753313|FG011|COMPLETED|Phase 1-T Dose Level 1-TB||3||
48581171|NCT01116648|101753314|FG012|COMPLETED|Phase 1-T Dose Level 1-TB||0||
48581172|NCT01116648|101753315|FG013|COMPLETED|Phase 1-T Dose Level 1-TB||0||
48581173|NCT01116648|101753316|FG014|COMPLETED|Phase 1-T Dose Level 1-TB||0||
48581174|NCT01116648|101753302|FG000|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0||
48581175|NCT01116648|101753303|FG001|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0||
48581176|NCT01116648|101753304|FG002|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0||
48581177|NCT01116648|101753305|FG003|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0||
48581178|NCT01116648|101753306|FG004|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0||
48581179|NCT01116648|101753307|FG005|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0||
48581180|NCT01116648|101753308|FG006|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0||
48581181|NCT01116648|101753309|FG007|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0||
48581182|NCT01116648|101753310|FG008|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0||
48581183|NCT01116648|101753311|FG009|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0||
48581184|NCT01116648|101753312|FG010|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0||
48581185|NCT01116648|101753313|FG011|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0||
48581186|NCT01116648|101753314|FG012|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0||
48581187|NCT01116648|101753315|FG013|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0||
48581188|NCT01116648|101753316|FG014|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0||
48581189|NCT01116648|101753302|FG000|STARTED|Phase 1-T Dose Level 2-TB||0||
48581190|NCT01116648|101753303|FG001|STARTED|Phase 1-T Dose Level 2-TB||0||
48581191|NCT01116648|101753304|FG002|STARTED|Phase 1-T Dose Level 2-TB||0||
48581192|NCT01116648|101753305|FG003|STARTED|Phase 1-T Dose Level 2-TB||0||
48581193|NCT01116648|101753306|FG004|STARTED|Phase 1-T Dose Level 2-TB||0||
48581194|NCT01116648|101753307|FG005|STARTED|Phase 1-T Dose Level 2-TB||0||
48581195|NCT01116648|101753308|FG006|STARTED|Phase 1-T Dose Level 2-TB||0||
48581196|NCT01116648|101753309|FG007|STARTED|Phase 1-T Dose Level 2-TB||0||
48136315|NCT02005471|100656143|FG000|COMPLETED|Re-Treatment/Crossover (R/C) Substudy||0||
48136316|NCT02005471|100656144|FG001|COMPLETED|Re-Treatment/Crossover (R/C) Substudy||0||
48581197|NCT01116648|101753310|FG008|STARTED|Phase 1-T Dose Level 2-TB||0||
48581198|NCT01116648|101753311|FG009|STARTED|Phase 1-T Dose Level 2-TB||0||
48581199|NCT01116648|101753312|FG010|STARTED|Phase 1-T Dose Level 2-TB||0||
48581200|NCT01116648|101753313|FG011|STARTED|Phase 1-T Dose Level 2-TB||0||
48581201|NCT01116648|101753314|FG012|STARTED|Phase 1-T Dose Level 2-TB||6||
48581202|NCT01116648|101753315|FG013|STARTED|Phase 1-T Dose Level 2-TB||0||
48581203|NCT01116648|101753316|FG014|STARTED|Phase 1-T Dose Level 2-TB||0||
48581204|NCT01116648|101753302|FG000|COMPLETED|Phase 1-T Dose Level 2-TB||0||
48581205|NCT01116648|101753303|FG001|COMPLETED|Phase 1-T Dose Level 2-TB||0||
48581206|NCT01116648|101753304|FG002|COMPLETED|Phase 1-T Dose Level 2-TB||0||
48704499|NCT01657344|102060756|FG002|COMPLETED|Overall Study||196300||
48704500|NCT01657344|102060757|FG003|COMPLETED|Overall Study||376517||
48704501|NCT01657344|102060758|FG004|COMPLETED|Overall Study||157802||
48704502|NCT01657344|102060759|FG005|COMPLETED|Overall Study||316477||
48136317|NCT02005471|100656145|FG002|COMPLETED|Re-Treatment/Crossover (R/C) Substudy||7||
48581207|NCT01116648|101753305|FG003|COMPLETED|Phase 1-T Dose Level 2-TB||0||
48581208|NCT01116648|101753306|FG004|COMPLETED|Phase 1-T Dose Level 2-TB||0||
48581209|NCT01116648|101753307|FG005|COMPLETED|Phase 1-T Dose Level 2-TB||0||
48581210|NCT01116648|101753308|FG006|COMPLETED|Phase 1-T Dose Level 2-TB||0||
48581211|NCT01116648|101753309|FG007|COMPLETED|Phase 1-T Dose Level 2-TB||0||
48581212|NCT01116648|101753310|FG008|COMPLETED|Phase 1-T Dose Level 2-TB||0||
48581213|NCT01116648|101753311|FG009|COMPLETED|Phase 1-T Dose Level 2-TB||0||
48581214|NCT01116648|101753312|FG010|COMPLETED|Phase 1-T Dose Level 2-TB||0||
48581215|NCT01116648|101753313|FG011|COMPLETED|Phase 1-T Dose Level 2-TB||0||
48581216|NCT01116648|101753314|FG012|COMPLETED|Phase 1-T Dose Level 2-TB||6||
48581217|NCT01116648|101753315|FG013|COMPLETED|Phase 1-T Dose Level 2-TB||0||
48581218|NCT01116648|101753316|FG014|COMPLETED|Phase 1-T Dose Level 2-TB||0||
48581219|NCT01116648|101753302|FG000|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0||
48581220|NCT01116648|101753303|FG001|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0||
48581221|NCT01116648|101753304|FG002|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0||
48581222|NCT01116648|101753305|FG003|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0||
48581223|NCT01116648|101753306|FG004|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0||
48581224|NCT01116648|101753307|FG005|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0||
48581225|NCT01116648|101753308|FG006|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0||
48704503|NCT01657344|102060760|FG006|COMPLETED|Overall Study||140776||
48704504|NCT01657344|102060754|FG000|NOT COMPLETED|Overall Study||0||
48704505|NCT01657344|102060755|FG001|NOT COMPLETED|Overall Study||0||
48704506|NCT01657344|102060756|FG002|NOT COMPLETED|Overall Study||0||
48704507|NCT01657344|102060757|FG003|NOT COMPLETED|Overall Study||0||
48581226|NCT01116648|101753309|FG007|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0||
48581227|NCT01116648|101753310|FG008|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0||
48581228|NCT01116648|101753311|FG009|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0||
48581229|NCT01116648|101753312|FG010|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0||
48581230|NCT01116648|101753313|FG011|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0||
48581231|NCT01116648|101753314|FG012|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0||
48581232|NCT01116648|101753315|FG013|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0||
48704508|NCT01657344|102060758|FG004|NOT COMPLETED|Overall Study||0||
48704509|NCT01657344|102060759|FG005|NOT COMPLETED|Overall Study||0||
48704510|NCT01657344|102060760|FG006|NOT COMPLETED|Overall Study||0||
48704511|NCT03215758|102060761|FG000|STARTED|Overall Study||339||
48704512|NCT03215758|102060762|FG001|STARTED|Overall Study||336||
48581233|NCT01116648|101753316|FG014|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0||
48581234|NCT01116648|101753302|FG000|STARTED|Phase 1-T PKOlap Expansion||0||
48581235|NCT01116648|101753303|FG001|STARTED|Phase 1-T PKOlap Expansion||0||
48581236|NCT01116648|101753304|FG002|STARTED|Phase 1-T PKOlap Expansion||0||
48581237|NCT01116648|101753305|FG003|STARTED|Phase 1-T PKOlap Expansion||0||
48581238|NCT01116648|101753306|FG004|STARTED|Phase 1-T PKOlap Expansion||0||
48581239|NCT01116648|101753307|FG005|STARTED|Phase 1-T PKOlap Expansion||0||
48581240|NCT01116648|101753308|FG006|STARTED|Phase 1-T PKOlap Expansion||0||
48581241|NCT01116648|101753309|FG007|STARTED|Phase 1-T PKOlap Expansion||0||
48581242|NCT01116648|101753310|FG008|STARTED|Phase 1-T PKOlap Expansion||0||
48581243|NCT01116648|101753311|FG009|STARTED|Phase 1-T PKOlap Expansion||0||
48581244|NCT01116648|101753312|FG010|STARTED|Phase 1-T PKOlap Expansion||0||
48581245|NCT01116648|101753313|FG011|STARTED|Phase 1-T PKOlap Expansion||0||
48581246|NCT01116648|101753314|FG012|STARTED|Phase 1-T PKOlap Expansion||0||
48581247|NCT01116648|101753315|FG013|STARTED|Phase 1-T PKOlap Expansion||6||
48581248|NCT01116648|101753316|FG014|STARTED|Phase 1-T PKOlap Expansion||0||
48581249|NCT01116648|101753302|FG000|COMPLETED|Phase 1-T PKOlap Expansion||0||
48704513|NCT03215758|102060761|FG000|COMPLETED|Overall Study||334||
48704514|NCT03215758|102060762|FG001|COMPLETED|Overall Study||328||
48704515|NCT03215758|102060761|FG000|NOT COMPLETED|Overall Study||5||
48704516|NCT03215758|102060762|FG001|NOT COMPLETED|Overall Study||8||
48704517|NCT02091531|102060763|FG000|STARTED|Overall Study||9||
48704518|NCT02091531|102060763|FG000|COMPLETED|Overall Study||9||
48704519|NCT02091531|102060763|FG000|NOT COMPLETED|Overall Study||0||
48704520|NCT03372434|102060764|FG000|STARTED|Overall Study||78|Implanted with a study lens in at least one eye|78
48704521|NCT03372434|102060765|FG001|STARTED|Overall Study||73|Implanted with a study lens in at least one eye|73
48704522|NCT03372434|102060766|FG002|STARTED|Overall Study||74|Implanted with a study lens in at least one eye|74
48136318|NCT02005471|100656146|FG003|COMPLETED|Re-Treatment/Crossover (R/C) Substudy||15||
48136319|NCT02005471|100656143|FG000|NOT COMPLETED|Re-Treatment/Crossover (R/C) Substudy||0||
48136320|NCT02005471|100656144|FG001|NOT COMPLETED|Re-Treatment/Crossover (R/C) Substudy||0||
48136321|NCT02005471|100656145|FG002|NOT COMPLETED|Re-Treatment/Crossover (R/C) Substudy||2||
48136322|NCT02005471|100656146|FG003|NOT COMPLETED|Re-Treatment/Crossover (R/C) Substudy||10||
48136323|NCT02649868|100656147|FG000|STARTED|Overall Study||17||
48136324|NCT02649868|100656147|FG000|COMPLETED|Overall Study||17||
48136325|NCT02649868|100656147|FG000|NOT COMPLETED|Overall Study||0||
48136326|NCT01352598|100656148|FG000|STARTED|Overall Study||84||
48136327|NCT01352598|100656148|FG000|COMPLETED|Overall Study||72||
48136328|NCT01352598|100656148|FG000|NOT COMPLETED|Overall Study||12||
48136329|NCT03422003|100656149|FG000|STARTED|Baseline||199||
48287910|NCT00597246|101029835|FG000|COMPLETED|Overall Study||30||
48287911|NCT00597246|101029835|FG000|NOT COMPLETED|Overall Study||0||
48287912|NCT02434497|101029836|FG000|STARTED|Overall Study||9||
48287913|NCT02434497|101029836|FG000|COMPLETED|Overall Study||4||
48287914|NCT02434497|101029836|FG000|NOT COMPLETED|Overall Study||5||
48287915|NCT04850794|101029837|FG000|STARTED|Read 1st Case Study Without Tool||28||
48287916|NCT04850794|101029838|FG001|STARTED|Read 1st Case Study Without Tool||28||
48287917|NCT04850794|101029837|FG000|COMPLETED|Read 1st Case Study Without Tool||28||
48581250|NCT01116648|101753303|FG001|COMPLETED|Phase 1-T PKOlap Expansion||0||
48581251|NCT01116648|101753304|FG002|COMPLETED|Phase 1-T PKOlap Expansion||0||
48581252|NCT01116648|101753305|FG003|COMPLETED|Phase 1-T PKOlap Expansion||0||
48581253|NCT01116648|101753306|FG004|COMPLETED|Phase 1-T PKOlap Expansion||0||
48287918|NCT04850794|101029838|FG001|COMPLETED|Read 1st Case Study Without Tool||28||
48287919|NCT04850794|101029837|FG000|NOT COMPLETED|Read 1st Case Study Without Tool||0||
48287920|NCT04850794|101029838|FG001|NOT COMPLETED|Read 1st Case Study Without Tool||0||
48287921|NCT04850794|101029837|FG000|STARTED|Read 2nd Case Study With Tool||28||
48581254|NCT01116648|101753307|FG005|COMPLETED|Phase 1-T PKOlap Expansion||0||
48581255|NCT01116648|101753308|FG006|COMPLETED|Phase 1-T PKOlap Expansion||0||
48581256|NCT01116648|101753309|FG007|COMPLETED|Phase 1-T PKOlap Expansion||0||
48704523|NCT03372434|102060764|FG000|1 Month Follow-up|Overall Study||76||76
48704524|NCT03372434|102060765|FG001|1 Month Follow-up|Overall Study||72||72
48704525|NCT03372434|102060766|FG002|1 Month Follow-up|Overall Study||73||73
48704526|NCT03372434|102060764|FG000|COMPLETED|Overall Study||76|6 months follow up|76
48704527|NCT03372434|102060765|FG001|COMPLETED|Overall Study||70|6 months follow up|70
48704528|NCT03372434|102060766|FG002|COMPLETED|Overall Study||72|6 months follow up|72
48704529|NCT03372434|102060764|FG000|NOT COMPLETED|Overall Study||2||2
48704530|NCT03372434|102060765|FG001|NOT COMPLETED|Overall Study||3||3
48136330|NCT03422003|100656150|FG001|STARTED|Baseline||201||
48136331|NCT03422003|100656149|FG000|COMPLETED|Baseline||192||
48136332|NCT03422003|100656150|FG001|COMPLETED|Baseline||199||
48400569|NCT00997555|101313574|FG000|STARTED|Overall Study||13||
48400570|NCT00997555|101313575|FG001|STARTED|Overall Study||15||
48287922|NCT04850794|101029838|FG001|STARTED|Read 2nd Case Study With Tool||28||
48287923|NCT04850794|101029837|FG000|COMPLETED|Read 2nd Case Study With Tool||28||
48287924|NCT04850794|101029838|FG001|COMPLETED|Read 2nd Case Study With Tool||28||
48287925|NCT04850794|101029837|FG000|NOT COMPLETED|Read 2nd Case Study With Tool||0||
48287926|NCT04850794|101029838|FG001|NOT COMPLETED|Read 2nd Case Study With Tool||0||
48287927|NCT01078454|101029839|FG000|STARTED|Overall Study||6||
48287928|NCT01078454|101029840|FG001|STARTED|Overall Study||5||
48287929|NCT01078454|101029839|FG000|COMPLETED|Overall Study||5||
48287930|NCT01078454|101029840|FG001|COMPLETED|Overall Study||3||
48287931|NCT01078454|101029839|FG000|NOT COMPLETED|Overall Study||1||
48287932|NCT01078454|101029840|FG001|NOT COMPLETED|Overall Study||2||
48400571|NCT00997555|101313574|FG000|COMPLETED|Overall Study||13||
48581257|NCT01116648|101753310|FG008|COMPLETED|Phase 1-T PKOlap Expansion||0||
48704531|NCT03372434|102060766|FG002|NOT COMPLETED|Overall Study||2||2
48287933|NCT00249002|101029841|FG000|STARTED|Overall Study||9||
48581258|NCT01116648|101753311|FG009|COMPLETED|Phase 1-T PKOlap Expansion||0||
48581259|NCT01116648|101753312|FG010|COMPLETED|Phase 1-T PKOlap Expansion||0||
48581260|NCT01116648|101753313|FG011|COMPLETED|Phase 1-T PKOlap Expansion||0||
48581261|NCT01116648|101753314|FG012|COMPLETED|Phase 1-T PKOlap Expansion||0||
48581262|NCT01116648|101753315|FG013|COMPLETED|Phase 1-T PKOlap Expansion||6||
48581263|NCT01116648|101753316|FG014|COMPLETED|Phase 1-T PKOlap Expansion||0||
48581264|NCT01116648|101753302|FG000|NOT COMPLETED|Phase 1-T PKOlap Expansion||0||
48581265|NCT01116648|101753303|FG001|NOT COMPLETED|Phase 1-T PKOlap Expansion||0||
48581266|NCT01116648|101753304|FG002|NOT COMPLETED|Phase 1-T PKOlap Expansion||0||
48287934|NCT00249002|101029841|FG000|COMPLETED|Overall Study||2||
48287935|NCT00249002|101029841|FG000|NOT COMPLETED|Overall Study||7||
48287936|NCT04675151|101029842|FG000|STARTED|Overall Study||44||
48287937|NCT04675151|101029843|FG001|STARTED|Overall Study||30||
48287938|NCT04675151|101029844|FG002|STARTED|Overall Study||31||
48287939|NCT04675151|101029845|FG003|STARTED|Overall Study||45||
48287940|NCT04675151|101029842|FG000|COMPLETED|Overall Study||43||
48287941|NCT04675151|101029843|FG001|COMPLETED|Overall Study||30||
48287942|NCT04675151|101029844|FG002|COMPLETED|Overall Study||31||
48287943|NCT04675151|101029845|FG003|COMPLETED|Overall Study||44||
48287944|NCT04675151|101029842|FG000|NOT COMPLETED|Overall Study||1||
48287945|NCT04675151|101029843|FG001|NOT COMPLETED|Overall Study||0||
48287946|NCT04675151|101029844|FG002|NOT COMPLETED|Overall Study||0||
48287947|NCT04675151|101029845|FG003|NOT COMPLETED|Overall Study||1||
48287948|NCT01009580|101029846|FG000|STARTED|Overall Study||224||
48287949|NCT01009580|101029847|FG001|STARTED|Overall Study||223||
48287950|NCT01009580|101029846|FG000|Exposed|Overall Study||224||
48704532|NCT01215643|102060767|FG000|STARTED|Overall Study||83||
48704533|NCT01215643|102060768|FG001|STARTED|Overall Study||84||
48287951|NCT01009580|101029847|FG001|Exposed|Overall Study||222||
48287952|NCT01009580|101029846|FG000|COMPLETED|Overall Study||197||
48287953|NCT01009580|101029847|FG001|COMPLETED|Overall Study||188||
48287954|NCT01009580|101029846|FG000|NOT COMPLETED|Overall Study||27||
48287955|NCT01009580|101029847|FG001|NOT COMPLETED|Overall Study||35||
48287956|NCT00912301|101029848|FG000|STARTED|Overall Study||11||
48287957|NCT00912301|101029849|FG001|STARTED|Overall Study||12||
48287958|NCT00912301|101029850|FG002|STARTED|Overall Study||13||
48287959|NCT00912301|101029848|FG000|COMPLETED|Overall Study||11||
48287960|NCT00912301|101029849|FG001|COMPLETED|Overall Study||12||
48287961|NCT00912301|101029850|FG002|COMPLETED|Overall Study||13||
48287962|NCT00912301|101029848|FG000|NOT COMPLETED|Overall Study||0||
48287963|NCT00912301|101029849|FG001|NOT COMPLETED|Overall Study||0||
48287964|NCT00912301|101029850|FG002|NOT COMPLETED|Overall Study||0||
48287965|NCT04684394|101029851|FG000|STARTED|Overall Study||34||68
48287966|NCT04684394|101029852|FG001|STARTED|Overall Study||16||32
48287967|NCT04684394|101029851|FG000|Study Eye|Overall Study||34||34
48287968|NCT04684394|101029852|FG001|Study Eye|Overall Study||16||16
48287969|NCT04684394|101029851|FG000|Fellow Eye|Overall Study||34||34
48287970|NCT04684394|101029852|FG001|Fellow Eye|Overall Study||16||16
48287971|NCT04684394|101029851|FG000|COMPLETED|Overall Study||5||10
48287972|NCT04684394|101029852|FG001|COMPLETED|Overall Study||1||2
48287973|NCT04684394|101029851|FG000|NOT COMPLETED|Overall Study||29||58
48287974|NCT04684394|101029852|FG001|NOT COMPLETED|Overall Study||15||30
48287975|NCT02279394|101029853|FG000|STARTED|Overall Study||40||
48287976|NCT02279394|101029854|FG001|STARTED|Overall Study||11||
48400572|NCT00997555|101313575|FG001|COMPLETED|Overall Study||15||
48400573|NCT00997555|101313574|FG000|NOT COMPLETED|Overall Study||0||
48287977|NCT02279394|101029853|FG000|COMPLETED|Overall Study||40||
48287978|NCT02279394|101029854|FG001|COMPLETED|Overall Study||11||
48287979|NCT02279394|101029853|FG000|NOT COMPLETED|Overall Study||0||
48400574|NCT00997555|101313575|FG001|NOT COMPLETED|Overall Study||0||
48287980|NCT02279394|101029854|FG001|NOT COMPLETED|Overall Study||0||
48287981|NCT03439254|101029855|FG000|STARTED|Double-blind Phase (18 Months)||313||
48287982|NCT03439254|101029856|FG001|STARTED|Double-blind Phase (18 Months)||296||
48287983|NCT03439254|101029857|FG002|STARTED|Double-blind Phase (18 Months)||310||
48400575|NCT00368472|101313576|FG000|STARTED|Overall Study||138||
48581267|NCT01116648|101753305|FG003|NOT COMPLETED|Phase 1-T PKOlap Expansion||0||
48287984|NCT03439254|101029858|FG003|STARTED|Double-blind Phase (18 Months)||0||
48287985|NCT03439254|101029859|FG004|STARTED|Double-blind Phase (18 Months)||0||
48287986|NCT03439254|101029860|FG005|STARTED|Double-blind Phase (18 Months)||0||
48287987|NCT03439254|101029855|FG000|COMPLETED|Double-blind Phase (18 Months)||284||
48287988|NCT03439254|101029856|FG001|COMPLETED|Double-blind Phase (18 Months)||274||
48287989|NCT03439254|101029857|FG002|COMPLETED|Double-blind Phase (18 Months)||275||
48287990|NCT03439254|101029858|FG003|COMPLETED|Double-blind Phase (18 Months)||0||
48287991|NCT03439254|101029859|FG004|COMPLETED|Double-blind Phase (18 Months)||0||
48287992|NCT03439254|101029860|FG005|COMPLETED|Double-blind Phase (18 Months)||0||
48287993|NCT03439254|101029855|FG000|NOT COMPLETED|Double-blind Phase (18 Months)||29||
48287994|NCT03439254|101029856|FG001|NOT COMPLETED|Double-blind Phase (18 Months)||22||
48287995|NCT03439254|101029857|FG002|NOT COMPLETED|Double-blind Phase (18 Months)||35||
48287996|NCT03439254|101029858|FG003|NOT COMPLETED|Double-blind Phase (18 Months)||0||
48287997|NCT03439254|101029859|FG004|NOT COMPLETED|Double-blind Phase (18 Months)||0||
48287998|NCT03439254|101029860|FG005|NOT COMPLETED|Double-blind Phase (18 Months)||0||
48287999|NCT03439254|101029855|FG000|STARTED|Open Label Extension Phase (12 Months)||0||
48288000|NCT03439254|101029856|FG001|STARTED|Open Label Extension Phase (12 Months)||0||
48288001|NCT03439254|101029857|FG002|STARTED|Open Label Extension Phase (12 Months)||0||
48288002|NCT03439254|101029858|FG003|STARTED|Open Label Extension Phase (12 Months)||231||
48288003|NCT03439254|101029859|FG004|STARTED|Open Label Extension Phase (12 Months)||221||
48288004|NCT03439254|101029860|FG005|STARTED|Open Label Extension Phase (12 Months)||207||
48288005|NCT03439254|101029855|FG000|COMPLETED|Open Label Extension Phase (12 Months)||0||
48288006|NCT03439254|101029856|FG001|COMPLETED|Open Label Extension Phase (12 Months)||0||
48288007|NCT03439254|101029857|FG002|COMPLETED|Open Label Extension Phase (12 Months)||0||
48288008|NCT03439254|101029858|FG003|COMPLETED|Open Label Extension Phase (12 Months)||215||
48288009|NCT03439254|101029859|FG004|COMPLETED|Open Label Extension Phase (12 Months)||208||
48288010|NCT03439254|101029860|FG005|COMPLETED|Open Label Extension Phase (12 Months)||192||
48288011|NCT03439254|101029855|FG000|NOT COMPLETED|Open Label Extension Phase (12 Months)||0||
48288012|NCT03439254|101029856|FG001|NOT COMPLETED|Open Label Extension Phase (12 Months)||0||
48288013|NCT03439254|101029857|FG002|NOT COMPLETED|Open Label Extension Phase (12 Months)||0||
48288014|NCT03439254|101029858|FG003|NOT COMPLETED|Open Label Extension Phase (12 Months)||16||
48288015|NCT03439254|101029859|FG004|NOT COMPLETED|Open Label Extension Phase (12 Months)||13||
48288016|NCT03439254|101029860|FG005|NOT COMPLETED|Open Label Extension Phase (12 Months)||15||
48288017|NCT03224351|101033458|FG000|STARTED|Overall Study||10||
48288018|NCT03224351|101033459|FG001|STARTED|Overall Study||11||
48288019|NCT03224351|101033460|FG002|STARTED|Overall Study||20||
48288020|NCT03224351|101033461|FG003|STARTED|Overall Study||22||
48288021|NCT03224351|101033462|FG004|STARTED|Overall Study||11||
48288022|NCT03224351|101033463|FG005|STARTED|Overall Study||18||
48288023|NCT03224351|101033464|FG006|STARTED|Overall Study||6||
48288024|NCT03224351|101033465|FG007|STARTED|Overall Study||19||
48288025|NCT03224351|101033458|FG000|COMPLETED|Overall Study||10||
48288026|NCT03224351|101033459|FG001|COMPLETED|Overall Study||11||
48288027|NCT03224351|101033460|FG002|COMPLETED|Overall Study||20||
48288028|NCT03224351|101033461|FG003|COMPLETED|Overall Study||22||
48288029|NCT03224351|101033462|FG004|COMPLETED|Overall Study||11||
48288030|NCT03224351|101033463|FG005|COMPLETED|Overall Study||18||
48288031|NCT03224351|101033464|FG006|COMPLETED|Overall Study||6||
48581268|NCT01116648|101753306|FG004|NOT COMPLETED|Phase 1-T PKOlap Expansion||0||
48581269|NCT01116648|101753307|FG005|NOT COMPLETED|Phase 1-T PKOlap Expansion||0||
48581270|NCT01116648|101753308|FG006|NOT COMPLETED|Phase 1-T PKOlap Expansion||0||
48581271|NCT01116648|101753309|FG007|NOT COMPLETED|Phase 1-T PKOlap Expansion||0||
48581272|NCT01116648|101753310|FG008|NOT COMPLETED|Phase 1-T PKOlap Expansion||0||
48288032|NCT03224351|101033465|FG007|COMPLETED|Overall Study||19||
48288033|NCT03224351|101033458|FG000|NOT COMPLETED|Overall Study||0||
48288034|NCT03224351|101033459|FG001|NOT COMPLETED|Overall Study||0||
48288035|NCT03224351|101033460|FG002|NOT COMPLETED|Overall Study||0||
48288036|NCT03224351|101033461|FG003|NOT COMPLETED|Overall Study||0||
48288037|NCT03224351|101033462|FG004|NOT COMPLETED|Overall Study||0||
48288038|NCT03224351|101033463|FG005|NOT COMPLETED|Overall Study||0||
48288039|NCT03224351|101033464|FG006|NOT COMPLETED|Overall Study||0||
48288040|NCT03224351|101033465|FG007|NOT COMPLETED|Overall Study||0||
48288041|NCT00825916|101033466|FG000|STARTED|Overall Study||19||
48288042|NCT00825916|101033467|FG001|STARTED|Overall Study||20||
48288043|NCT00825916|101033468|FG002|STARTED|Overall Study||20||
48288044|NCT00825916|101033466|FG000|COMPLETED|Overall Study||15||
48288045|NCT00825916|101033467|FG001|COMPLETED|Overall Study||18||
48288046|NCT00825916|101033468|FG002|COMPLETED|Overall Study||19||
48288047|NCT00825916|101033466|FG000|NOT COMPLETED|Overall Study||4||
48288048|NCT00825916|101033467|FG001|NOT COMPLETED|Overall Study||2||
48288049|NCT00825916|101033468|FG002|NOT COMPLETED|Overall Study||1||
48581273|NCT01116648|101753311|FG009|NOT COMPLETED|Phase 1-T PKOlap Expansion||0||
48288050|NCT02003573|101033469|FG000|STARTED|Overall Study||3||
48288051|NCT02003573|101033470|FG001|STARTED|Overall Study||4||
48581274|NCT01116648|101753312|FG010|NOT COMPLETED|Phase 1-T PKOlap Expansion||0||
48581275|NCT01116648|101753313|FG011|NOT COMPLETED|Phase 1-T PKOlap Expansion||0||
48581276|NCT01116648|101753314|FG012|NOT COMPLETED|Phase 1-T PKOlap Expansion||0||
48581277|NCT01116648|101753315|FG013|NOT COMPLETED|Phase 1-T PKOlap Expansion||0||
48581278|NCT01116648|101753316|FG014|NOT COMPLETED|Phase 1-T PKOlap Expansion||0||
48581279|NCT01116648|101753302|FG000|STARTED|Phase 1-T PKCed Expansion||0||
48581280|NCT01116648|101753303|FG001|STARTED|Phase 1-T PKCed Expansion||0||
48581281|NCT01116648|101753304|FG002|STARTED|Phase 1-T PKCed Expansion||0||
48581282|NCT01116648|101753305|FG003|STARTED|Phase 1-T PKCed Expansion||0||
48581283|NCT01116648|101753306|FG004|STARTED|Phase 1-T PKCed Expansion||0||
48581284|NCT01116648|101753307|FG005|STARTED|Phase 1-T PKCed Expansion||0||
48704534|NCT01215643|102060769|FG002|STARTED|Overall Study||94||
48704535|NCT01215643|102060770|FG003|STARTED|Overall Study||39||
48704536|NCT01215643|102060771|FG004|STARTED|Overall Study||40||
48704537|NCT01215643|102060767|FG000|COMPLETED|Overall Study||74||
48704538|NCT01215643|102060768|FG001|COMPLETED|Overall Study||80||
48704539|NCT01215643|102060769|FG002|COMPLETED|Overall Study||82||
48704540|NCT01215643|102060770|FG003|COMPLETED|Overall Study||35||
48704541|NCT01215643|102060771|FG004|COMPLETED|Overall Study||29||
48704542|NCT01215643|102060767|FG000|NOT COMPLETED|Overall Study||9||
48704543|NCT01215643|102060768|FG001|NOT COMPLETED|Overall Study||4||
48704544|NCT01215643|102060769|FG002|NOT COMPLETED|Overall Study||12||
48704545|NCT01215643|102060770|FG003|NOT COMPLETED|Overall Study||4||
48704546|NCT01215643|102060771|FG004|NOT COMPLETED|Overall Study||11||
48704547|NCT02209545|102060772|FG000|STARTED|Overall Study||13||
48288052|NCT02003573|101033471|FG002|STARTED|Overall Study||6||
48288053|NCT02003573|101033469|FG000|COMPLETED|Overall Study||0||
48288054|NCT02003573|101033470|FG001|COMPLETED|Overall Study||0||
48288055|NCT02003573|101033471|FG002|COMPLETED|Overall Study||0||
48581285|NCT01116648|101753308|FG006|STARTED|Phase 1-T PKCed Expansion||0||
48581286|NCT01116648|101753309|FG007|STARTED|Phase 1-T PKCed Expansion||0||
48581287|NCT01116648|101753310|FG008|STARTED|Phase 1-T PKCed Expansion||0||
48704548|NCT02209545|102060773|FG001|STARTED|Overall Study||26||
48704549|NCT02209545|102060772|FG000|COMPLETED|Overall Study||13||
48704550|NCT02209545|102060773|FG001|COMPLETED|Overall Study||26||
48704551|NCT02209545|102060772|FG000|NOT COMPLETED|Overall Study||0||
48704552|NCT02209545|102060773|FG001|NOT COMPLETED|Overall Study||0||
48288056|NCT02003573|101033469|FG000|NOT COMPLETED|Overall Study||3||
48288057|NCT02003573|101033470|FG001|NOT COMPLETED|Overall Study||4||
48288058|NCT02003573|101033471|FG002|NOT COMPLETED|Overall Study||6||
48288059|NCT01178385|101033472|FG000|STARTED|Overall Study||24||
48288060|NCT01178385|101033473|FG001|STARTED|Overall Study||21||
48288061|NCT01178385|101033472|FG000|COMPLETED|Overall Study||22||
48288062|NCT01178385|101033473|FG001|COMPLETED|Overall Study||21||
48288063|NCT01178385|101033472|FG000|NOT COMPLETED|Overall Study||2||
48288064|NCT01178385|101033473|FG001|NOT COMPLETED|Overall Study||0||
48288065|NCT03725085|101033474|FG000|STARTED|Overall Study||552||
48288066|NCT03725085|101033474|FG000|COMPLETED|Overall Study||550||
48288067|NCT03725085|101033474|FG000|NOT COMPLETED|Overall Study||2||
48288068|NCT00297596|101033475|FG000|STARTED|Overall Study||25||
48288069|NCT00297596|101033475|FG000|COMPLETED|Overall Study||25||
48288070|NCT00297596|101033475|FG000|NOT COMPLETED|Overall Study||0||
48288071|NCT02775695|101033476|FG000|STARTED|Overall Study||12||
48288072|NCT02775695|101033476|FG000|COMPLETED|Overall Study||12||
48288073|NCT02775695|101033476|FG000|NOT COMPLETED|Overall Study||0||
48288074|NCT01564628|101033477|FG000|STARTED|Overall Study||185||
48288075|NCT01564628|101033478|FG001|STARTED|Overall Study||58||
48288076|NCT01564628|101033479|FG002|STARTED|Overall Study||63||
48288077|NCT01564628|101033477|FG000|COMPLETED|Overall Study||181||
48288078|NCT01564628|101033478|FG001|COMPLETED|Overall Study||56||
48288079|NCT01564628|101033479|FG002|COMPLETED|Overall Study||61||
48288080|NCT01564628|101033477|FG000|NOT COMPLETED|Overall Study||4||
48288081|NCT01564628|101033478|FG001|NOT COMPLETED|Overall Study||2||
48288082|NCT01564628|101033479|FG002|NOT COMPLETED|Overall Study||2||
48288083|NCT00585195|101033480|FG000|STARTED|Overall Study||3||
48288084|NCT00585195|101033481|FG001|STARTED|Overall Study||4||
48288085|NCT00585195|101033482|FG002|STARTED|Overall Study||9||
48288086|NCT00585195|101033483|FG003|STARTED|Overall Study||7||
48288087|NCT00585195|101033484|FG004|STARTED|Overall Study||9||
48288088|NCT00585195|101033485|FG005|STARTED|Overall Study||6||
48288089|NCT00585195|101033486|FG006|STARTED|Overall Study||7||
48288090|NCT00585195|101033487|FG007|STARTED|Overall Study||5||
48288091|NCT00585195|101033488|FG008|STARTED|Overall Study||3||
48288092|NCT00585195|101033489|FG009|STARTED|Overall Study||6||
48288093|NCT00585195|101033490|FG010|STARTED|Overall Study||11||
48288094|NCT00585195|101033491|FG011|STARTED|Overall Study||53||
48288095|NCT00585195|101033492|FG012|STARTED|Overall Study||85||
48288096|NCT00585195|101033493|FG013|STARTED|Overall Study||41||
48288097|NCT00585195|101033494|FG014|STARTED|Overall Study||48||
48288098|NCT00585195|101033495|FG015|STARTED|Overall Study||19||
48288099|NCT00585195|101033496|FG016|STARTED|Overall Study||154||
48288100|NCT00585195|101033497|FG017|STARTED|Overall Study||67||
48288101|NCT00585195|101033498|FG018|STARTED|Overall Study||21||
48288102|NCT00585195|101033499|FG019|STARTED|Overall Study||18||
48288103|NCT00585195|101033500|FG020|STARTED|Overall Study||14||
48400576|NCT00368472|101313576|FG000|COMPLETED|Overall Study||33||
48400577|NCT00368472|101313576|FG000|NOT COMPLETED|Overall Study||105||
48581288|NCT01116648|101753311|FG009|STARTED|Phase 1-T PKCed Expansion||0||
48288104|NCT00585195|101033480|FG000|Treated|Overall Study||3||
48288105|NCT00585195|101033481|FG001|Treated|Overall Study||4||
48400578|NCT01515488|101313577|FG000|STARTED|Overall Study||200||
48400579|NCT01515488|101313578|FG001|STARTED|Overall Study||200||
48581289|NCT01116648|101753312|FG010|STARTED|Phase 1-T PKCed Expansion||0||
48581290|NCT01116648|101753313|FG011|STARTED|Phase 1-T PKCed Expansion||0||
48581291|NCT01116648|101753314|FG012|STARTED|Phase 1-T PKCed Expansion||0||
48581292|NCT01116648|101753315|FG013|STARTED|Phase 1-T PKCed Expansion||0||
48581293|NCT01116648|101753316|FG014|STARTED|Phase 1-T PKCed Expansion||7||
48581294|NCT01116648|101753302|FG000|COMPLETED|Phase 1-T PKCed Expansion||0||
48581295|NCT01116648|101753303|FG001|COMPLETED|Phase 1-T PKCed Expansion||0||
48581296|NCT01116648|101753304|FG002|COMPLETED|Phase 1-T PKCed Expansion||0||
48581297|NCT01116648|101753305|FG003|COMPLETED|Phase 1-T PKCed Expansion||0||
48581298|NCT01116648|101753306|FG004|COMPLETED|Phase 1-T PKCed Expansion||0||
48581299|NCT01116648|101753307|FG005|COMPLETED|Phase 1-T PKCed Expansion||0||
48581300|NCT01116648|101753308|FG006|COMPLETED|Phase 1-T PKCed Expansion||0||
48581301|NCT01116648|101753309|FG007|COMPLETED|Phase 1-T PKCed Expansion||0||
48581302|NCT01116648|101753310|FG008|COMPLETED|Phase 1-T PKCed Expansion||0||
48581303|NCT01116648|101753311|FG009|COMPLETED|Phase 1-T PKCed Expansion||0||
48581304|NCT01116648|101753312|FG010|COMPLETED|Phase 1-T PKCed Expansion||0||
48581305|NCT01116648|101753313|FG011|COMPLETED|Phase 1-T PKCed Expansion||0||
48288106|NCT00585195|101033482|FG002|Treated|Overall Study||8||
48288107|NCT00585195|101033483|FG003|Treated|Overall Study||7||
48288108|NCT00585195|101033484|FG004|Treated|Overall Study||8||
48288109|NCT00585195|101033485|FG005|Treated|Overall Study||6||
48288110|NCT00585195|101033486|FG006|Treated|Overall Study||6||
48288111|NCT00585195|101033487|FG007|Treated|Overall Study||5||
48288112|NCT00585195|101033488|FG008|Treated|Overall Study||3||
48288113|NCT00585195|101033489|FG009|Treated|Overall Study||6||
48581306|NCT01116648|101753314|FG012|COMPLETED|Phase 1-T PKCed Expansion||0||
48288114|NCT00585195|101033490|FG010|Treated|Overall Study||9||
48288115|NCT00585195|101033491|FG011|Treated|Overall Study||53||
48288116|NCT00585195|101033492|FG012|Treated|Overall Study||85||
48288117|NCT00585195|101033493|FG013|Treated|Overall Study||41||
48288118|NCT00585195|101033494|FG014|Treated|Overall Study||48||
48581307|NCT01116648|101753315|FG013|COMPLETED|Phase 1-T PKCed Expansion||0||
48581308|NCT01116648|101753316|FG014|COMPLETED|Phase 1-T PKCed Expansion||7||
48581309|NCT01116648|101753302|FG000|NOT COMPLETED|Phase 1-T PKCed Expansion||0||
48581310|NCT01116648|101753303|FG001|NOT COMPLETED|Phase 1-T PKCed Expansion||0||
48581311|NCT01116648|101753304|FG002|NOT COMPLETED|Phase 1-T PKCed Expansion||0||
48581312|NCT01116648|101753305|FG003|NOT COMPLETED|Phase 1-T PKCed Expansion||0||
48581313|NCT01116648|101753306|FG004|NOT COMPLETED|Phase 1-T PKCed Expansion||0||
48581314|NCT01116648|101753307|FG005|NOT COMPLETED|Phase 1-T PKCed Expansion||0||
48581315|NCT01116648|101753308|FG006|NOT COMPLETED|Phase 1-T PKCed Expansion||0||
48581316|NCT01116648|101753309|FG007|NOT COMPLETED|Phase 1-T PKCed Expansion||0||
48581317|NCT01116648|101753310|FG008|NOT COMPLETED|Phase 1-T PKCed Expansion||0||
48581318|NCT01116648|101753311|FG009|NOT COMPLETED|Phase 1-T PKCed Expansion||0||
48581319|NCT01116648|101753312|FG010|NOT COMPLETED|Phase 1-T PKCed Expansion||0||
48581320|NCT01116648|101753313|FG011|NOT COMPLETED|Phase 1-T PKCed Expansion||0||
48581321|NCT01116648|101753314|FG012|NOT COMPLETED|Phase 1-T PKCed Expansion||0||
48581322|NCT01116648|101753315|FG013|NOT COMPLETED|Phase 1-T PKCed Expansion||0||
48581323|NCT01116648|101753316|FG014|NOT COMPLETED|Phase 1-T PKCed Expansion||0||
48581324|NCT02640404|101753317|FG000|STARTED|Overall Study||112||
48581325|NCT02640404|101753318|FG001|STARTED|Overall Study||112||
48581326|NCT02640404|101753317|FG000|COMPLETED|Overall Study||110||
48581327|NCT02640404|101753318|FG001|COMPLETED|Overall Study||112||
48581328|NCT02640404|101753317|FG000|NOT COMPLETED|Overall Study||2||
48581329|NCT02640404|101753318|FG001|NOT COMPLETED|Overall Study||0||
48581330|NCT03379753|101753319|FG000|STARTED|Overall Study||61||
48581331|NCT03379753|101753320|FG001|STARTED|Overall Study||71||
48581332|NCT03379753|101753319|FG000|COMPLETED|Overall Study||46||
48581333|NCT03379753|101753320|FG001|COMPLETED|Overall Study||46||
48581334|NCT03379753|101753319|FG000|NOT COMPLETED|Overall Study||15||
48581335|NCT03379753|101753320|FG001|NOT COMPLETED|Overall Study||25||
48581336|NCT00680901|101753321|FG000|STARTED|Overall Study||272||
48581337|NCT00680901|101753322|FG001|STARTED|Overall Study||273||
48581338|NCT00680901|101753321|FG000|Ongoing: On Study Treatment|Overall Study||16||
48581339|NCT00680901|101753322|FG001|Ongoing: On Study Treatment|Overall Study||13||
48581340|NCT00680901|101753321|FG000|Ongoing: In Follow Up|Overall Study||45||
48288119|NCT00585195|101033495|FG015|Treated|Overall Study||18||
48581341|NCT00680901|101753322|FG001|Ongoing: In Follow Up|Overall Study||41||
48581342|NCT00680901|101753321|FG000|COMPLETED|Overall Study||199||
48581343|NCT00680901|101753322|FG001|COMPLETED|Overall Study||197||
48581344|NCT00680901|101753321|FG000|NOT COMPLETED|Overall Study||73||
48581345|NCT00680901|101753322|FG001|NOT COMPLETED|Overall Study||76||
48581346|NCT01082211|101753323|FG000|STARTED|Overall Study||65||
48592822|NCT00767039|101783187|FG000|COMPLETED|Overall Study||22||
48581347|NCT01082211|101753323|FG000|Has Baseline PT QOL Data|Overall Study||46|Eligible patients who consented to QOL study \& have patient-reported baseline data|
48581348|NCT01082211|101753323|FG000|Has Baseline MD QOL Data|Overall Study||44|Eligible patients who consented to QOL study \& have physician-assessed baseline data|
48581349|NCT01082211|101753323|FG000|Has Baseline/12-month PT QOL Data|Overall Study||36|Eligible patients who consented to QOL study \& have patient-reported baseline/12-month data|
48581350|NCT01082211|101753323|FG000|Has Baseline/12-Month MD QOL Data|Overall Study||35|Eligible patients who consented to QOL study \& have physician-assessed baseline/12-month data|
48581351|NCT01082211|101753323|FG000|Has Baseline/36-month PT QOL Data|Overall Study||32|Eligible patients who consented to QOL study \& have patient-reported baseline/36-month data|
48581352|NCT01082211|101753323|FG000|Has Baseline/36-Month MD QOL Data|Overall Study||27|Eligible patients who consented to QOL study \& have physician-assessed baseline/36-month data|
48581353|NCT01082211|101753323|FG000|All Eligible Patients|Overall Study||58||
48581354|NCT01082211|101753323|FG000|COMPLETED|Overall Study||58||
48581355|NCT01082211|101753323|FG000|NOT COMPLETED|Overall Study||7||
48581356|NCT01704651|101753324|FG000|STARTED|Overall Study||71||
48581357|NCT01704651|101753325|FG001|STARTED|Overall Study||75||
48581358|NCT01704651|101753324|FG000|COMPLETED|Overall Study||66||
48581359|NCT01704651|101753325|FG001|COMPLETED|Overall Study||68||
48581360|NCT01704651|101753324|FG000|NOT COMPLETED|Overall Study||5||
48581361|NCT01704651|101753325|FG001|NOT COMPLETED|Overall Study||7||
48581362|NCT04060277|101753326|FG000|STARTED|Overall Study||4||
48581363|NCT04060277|101753327|FG001|STARTED|Overall Study||3||
48581364|NCT04060277|101753326|FG000|COMPLETED|Overall Study||4||
48581365|NCT04060277|101753327|FG001|COMPLETED|Overall Study||3||
48581366|NCT04060277|101753326|FG000|NOT COMPLETED|Overall Study||0||
48581367|NCT04060277|101753327|FG001|NOT COMPLETED|Overall Study||0||
48581368|NCT02640950|101753328|FG000|STARTED|Overall Study||31||
48704553|NCT02780856|102064877|FG000|STARTED|Overall Study||110|Attended Visit 1 when teeth were imaged with the Calcivis System|176
48704554|NCT02780856|102064877|FG000|COMPLETED|Overall Study||109|Attended Visit 2 - no images taken at this visit|176
48704555|NCT02780856|102064877|FG000|NOT COMPLETED|Overall Study||1||0
48704556|NCT02743949|102064878|FG000|STARTED|Overall Study||86||
48704557|NCT02743949|102064879|FG001|STARTED|Overall Study||85||
48136333|NCT03422003|100656149|FG000|NOT COMPLETED|Baseline||7||
48581369|NCT02640950|101753328|FG000|COMPLETED|Overall Study||29||
48136334|NCT03422003|100656150|FG001|NOT COMPLETED|Baseline||2||
48136335|NCT03422003|100656149|FG000|STARTED|6-month Follow-up||192||
48136336|NCT03422003|100656150|FG001|STARTED|6-month Follow-up||199||
48136337|NCT03422003|100656149|FG000|COMPLETED|6-month Follow-up||166||
48136338|NCT03422003|100656150|FG001|COMPLETED|6-month Follow-up||166||
48136339|NCT03422003|100656149|FG000|NOT COMPLETED|6-month Follow-up||26||
48136340|NCT03422003|100656150|FG001|NOT COMPLETED|6-month Follow-up||33||
48136341|NCT01073618|100656151|FG000|STARTED|Overall Study||692||
48136342|NCT01073618|100656151|FG000|COMPLETED|Overall Study||385||
48136343|NCT01073618|100656151|FG000|NOT COMPLETED|Overall Study||307||
48136344|NCT03551938|100656152|FG000|STARTED|3-Month Follow Up||160||
48136345|NCT03551938|100656153|FG001|STARTED|3-Month Follow Up||158||
48136346|NCT03551938|100656152|FG000|COMPLETED|3-Month Follow Up||121||
48136347|NCT03551938|100656153|FG001|COMPLETED|3-Month Follow Up||120||
48136348|NCT03551938|100656152|FG000|NOT COMPLETED|3-Month Follow Up||39||
48136349|NCT03551938|100656153|FG001|NOT COMPLETED|3-Month Follow Up||38||
48136350|NCT03551938|100656152|FG000|STARTED|6-Month Follow Up||160||
48136351|NCT03551938|100656153|FG001|STARTED|6-Month Follow Up||158||
48136352|NCT03551938|100656152|FG000|COMPLETED|6-Month Follow Up||114||
48136353|NCT03551938|100656153|FG001|COMPLETED|6-Month Follow Up||116||
48136354|NCT03551938|100656152|FG000|NOT COMPLETED|6-Month Follow Up||46||
48136355|NCT03551938|100656153|FG001|NOT COMPLETED|6-Month Follow Up||42||
48136356|NCT03551938|100656152|FG000|STARTED|9-Month Follow Up||160||
48136357|NCT03551938|100656153|FG001|STARTED|9-Month Follow Up||158||
48136358|NCT03551938|100656152|FG000|COMPLETED|9-Month Follow Up||116||
48704558|NCT02743949|102064880|FG002|STARTED|Overall Study||85||
48704559|NCT02743949|102064878|FG000|COMPLETED|Overall Study||82||
48704560|NCT02743949|102064879|FG001|COMPLETED|Overall Study||84||
48704561|NCT02743949|102064880|FG002|COMPLETED|Overall Study||82||
48136359|NCT03551938|100656153|FG001|COMPLETED|9-Month Follow Up||115||
48136360|NCT03551938|100656152|FG000|NOT COMPLETED|9-Month Follow Up||44||
48136361|NCT03551938|100656153|FG001|NOT COMPLETED|9-Month Follow Up||43||
48136362|NCT01093794|100656154|FG000|STARTED|Treatment Period 1||7||
48136363|NCT01093794|100656155|FG001|STARTED|Treatment Period 1||7||
48136364|NCT01093794|100656156|FG002|STARTED|Treatment Period 1||7||
48136365|NCT01093794|100656157|FG003|STARTED|Treatment Period 1||7||
48136366|NCT01093794|100656154|FG000|COMPLETED|Treatment Period 1||7||
48136367|NCT01093794|100656155|FG001|COMPLETED|Treatment Period 1||7||
48704562|NCT02743949|102064878|FG000|NOT COMPLETED|Overall Study||4||
48704563|NCT02743949|102064879|FG001|NOT COMPLETED|Overall Study||1||
48136368|NCT01093794|100656156|FG002|COMPLETED|Treatment Period 1||7||
48136369|NCT01093794|100656157|FG003|COMPLETED|Treatment Period 1||7||
48136370|NCT01093794|100656154|FG000|NOT COMPLETED|Treatment Period 1||0||
48136371|NCT01093794|100656155|FG001|NOT COMPLETED|Treatment Period 1||0||
48136372|NCT01093794|100656156|FG002|NOT COMPLETED|Treatment Period 1||0||
48136373|NCT01093794|100656157|FG003|NOT COMPLETED|Treatment Period 1||0||
48136374|NCT01093794|100656154|FG000|STARTED|Treatment Period 2||7||
48136375|NCT01093794|100656155|FG001|STARTED|Treatment Period 2||7||
48136376|NCT01093794|100656156|FG002|STARTED|Treatment Period 2||6||
48136377|NCT01093794|100656157|FG003|STARTED|Treatment Period 2||7||
48704564|NCT02743949|102064880|FG002|NOT COMPLETED|Overall Study||3||
48704565|NCT01865812|102064881|FG000|STARTED|Primary Treatment Phase||27|One participant was thought to have been incorrectly dispensed 5-mg OCA during the PTP. This participant was not included in the ITT population and this participant's data was not included in any of the analyses.|
48704566|NCT01865812|102064882|FG001|STARTED|Primary Treatment Phase||0|One participant was thought to have been incorrectly dispensed 5-mg OCA during the PTP. This participant was not included in the ITT population and this participant's data was not included in any of the analyses.|
48704567|NCT01865812|102064881|FG000|Received at Least 1 Dose of Study Drug|Primary Treatment Phase||27|One participant was thought to have been incorrectly dispensed 5-mg OCA during the PTP. This participant was not included in the ITT population and this participant's data was not included in any of the analyses.|
48704568|NCT01865812|102064882|FG001|Received at Least 1 Dose of Study Drug|Primary Treatment Phase||0|One participant was thought to have been incorrectly dispensed 5-mg OCA during the PTP. This participant was not included in the ITT population and this participant's data was not included in any of the analyses.|
48704569|NCT01865812|102064881|FG000|COMPLETED|Primary Treatment Phase||25||
48136378|NCT01093794|100656154|FG000|COMPLETED|Treatment Period 2||7||
48136379|NCT01093794|100656155|FG001|COMPLETED|Treatment Period 2||7||
48136380|NCT01093794|100656156|FG002|COMPLETED|Treatment Period 2||6||
48136381|NCT01093794|100656157|FG003|COMPLETED|Treatment Period 2||7||
48136382|NCT01093794|100656154|FG000|NOT COMPLETED|Treatment Period 2||0||
48136383|NCT01093794|100656155|FG001|NOT COMPLETED|Treatment Period 2||0||
48136384|NCT01093794|100656156|FG002|NOT COMPLETED|Treatment Period 2||0||
48136385|NCT01093794|100656157|FG003|NOT COMPLETED|Treatment Period 2||0||
48136386|NCT01093794|100656154|FG000|STARTED|Treatment Period 3||7||
48136387|NCT01093794|100656155|FG001|STARTED|Treatment Period 3||7||
48136388|NCT01093794|100656156|FG002|STARTED|Treatment Period 3||6||
48136389|NCT01093794|100656157|FG003|STARTED|Treatment Period 3||7||
48136390|NCT01093794|100656154|FG000|COMPLETED|Treatment Period 3||7||
48136391|NCT01093794|100656155|FG001|COMPLETED|Treatment Period 3||7||
48136392|NCT01093794|100656156|FG002|COMPLETED|Treatment Period 3||6||
48581370|NCT02640950|101753328|FG000|NOT COMPLETED|Overall Study||2||
48581371|NCT05127304|101753329|FG000|STARTED|Overall Study||5658|Overall post matched|
48581372|NCT05127304|101753330|FG001|STARTED|Overall Study||5658|Overall post matched|
48581373|NCT05127304|101753329|FG000|COMPLETED|Overall Study||5658||
48581374|NCT05127304|101753330|FG001|COMPLETED|Overall Study||5658||
48581375|NCT05127304|101753329|FG000|NOT COMPLETED|Overall Study||0||
48581376|NCT05127304|101753330|FG001|NOT COMPLETED|Overall Study||0||
48581377|NCT01270464|101753331|FG000|STARTED|Overall Study||105||
48581378|NCT01270464|101753332|FG001|STARTED|Overall Study||104||
48581379|NCT01270464|101753333|FG002|STARTED|Overall Study||106||
48581380|NCT01270464|101753331|FG000|Safety Analysis Set|Overall Study||105||
48581381|NCT01270464|101753332|FG001|Safety Analysis Set|Overall Study||103||
48581382|NCT01270464|101753333|FG002|Safety Analysis Set|Overall Study||103||
48581383|NCT01270464|101753331|FG000|Full Analysis Set|Overall Study||105||
48581384|NCT01270464|101753332|FG001|Full Analysis Set|Overall Study||103||
48581385|NCT01270464|101753333|FG002|Full Analysis Set|Overall Study||103||
48581386|NCT01270464|101753331|FG000|Pharmacokinetic Analysis Set|Overall Study||105||
48136393|NCT01093794|100656157|FG003|COMPLETED|Treatment Period 3||7||
48581387|NCT01270464|101753332|FG001|Pharmacokinetic Analysis Set|Overall Study||103||
48581388|NCT01270464|101753333|FG002|Pharmacokinetic Analysis Set|Overall Study||103||
48581389|NCT01270464|101753331|FG000|COMPLETED|Overall Study||85||
48581390|NCT01270464|101753332|FG001|COMPLETED|Overall Study||92||
48136394|NCT01093794|100656154|FG000|NOT COMPLETED|Treatment Period 3||0||
48136395|NCT01093794|100656155|FG001|NOT COMPLETED|Treatment Period 3||0||
48136396|NCT01093794|100656156|FG002|NOT COMPLETED|Treatment Period 3||0||
48136397|NCT01093794|100656157|FG003|NOT COMPLETED|Treatment Period 3||0||
48136398|NCT01093794|100656154|FG000|STARTED|Treatment Period 4||7||
48136399|NCT01093794|100656155|FG001|STARTED|Treatment Period 4||7||
48136400|NCT01093794|100656156|FG002|STARTED|Treatment Period 4||6||
48136401|NCT01093794|100656157|FG003|STARTED|Treatment Period 4||7||
48136402|NCT01093794|100656154|FG000|COMPLETED|Treatment Period 4||7||
48136403|NCT01093794|100656155|FG001|COMPLETED|Treatment Period 4||7||
48136404|NCT01093794|100656156|FG002|COMPLETED|Treatment Period 4||6||
48136405|NCT01093794|100656157|FG003|COMPLETED|Treatment Period 4||7||
48136406|NCT01093794|100656154|FG000|NOT COMPLETED|Treatment Period 4||0||
48136407|NCT01093794|100656155|FG001|NOT COMPLETED|Treatment Period 4||0||
48136408|NCT01093794|100656156|FG002|NOT COMPLETED|Treatment Period 4||0||
48136409|NCT01093794|100656157|FG003|NOT COMPLETED|Treatment Period 4||0||
48581391|NCT01270464|101753333|FG002|COMPLETED|Overall Study||88||
48581392|NCT01270464|101753331|FG000|NOT COMPLETED|Overall Study||20||
48136410|NCT02096900|100656158|FG000|STARTED|Overall Study||42||
48288120|NCT00585195|101033496|FG016|Treated|Overall Study||154||
48581393|NCT01270464|101753332|FG001|NOT COMPLETED|Overall Study||12||
48136411|NCT02096900|100656159|FG001|STARTED|Overall Study||44||
48136412|NCT02096900|100656158|FG000|COMPLETED|Overall Study||38||
48136413|NCT02096900|100656159|FG001|COMPLETED|Overall Study||42||
48136414|NCT02096900|100656158|FG000|NOT COMPLETED|Overall Study||4||
48136415|NCT02096900|100656159|FG001|NOT COMPLETED|Overall Study||2||
48136416|NCT01571362|100656160|FG000|STARTED|Open-Label Conversion + Titration Period||410||
48136417|NCT01571362|100656161|FG001|STARTED|Open-Label Conversion + Titration Period||0||
48136418|NCT01571362|100656162|FG002|STARTED|Open-Label Conversion + Titration Period||0||
48136419|NCT01571362|100656160|FG000|COMPLETED|Open-Label Conversion + Titration Period||281||
48136420|NCT01571362|100656161|FG001|COMPLETED|Open-Label Conversion + Titration Period||0||
48136421|NCT01571362|100656162|FG002|COMPLETED|Open-Label Conversion + Titration Period||0||
48136422|NCT01571362|100656160|FG000|NOT COMPLETED|Open-Label Conversion + Titration Period||129||
48136423|NCT01571362|100656161|FG001|NOT COMPLETED|Open-Label Conversion + Titration Period||0||
48136424|NCT01571362|100656162|FG002|NOT COMPLETED|Open-Label Conversion + Titration Period||0||
48136425|NCT01571362|100656160|FG000|STARTED|Double-Blind Treatment Period||0||
48136426|NCT01571362|100656161|FG001|STARTED|Double-Blind Treatment Period||134||
48136427|NCT01571362|100656162|FG002|STARTED|Double-Blind Treatment Period||146||
48136428|NCT01571362|100656160|FG000|COMPLETED|Double-Blind Treatment Period||0||
48136429|NCT01571362|100656161|FG001|COMPLETED|Double-Blind Treatment Period||81||
48136430|NCT01571362|100656162|FG002|COMPLETED|Double-Blind Treatment Period||107||
48136431|NCT01571362|100656160|FG000|NOT COMPLETED|Double-Blind Treatment Period||0||
48136432|NCT01571362|100656161|FG001|NOT COMPLETED|Double-Blind Treatment Period||53||
48581394|NCT01270464|101753333|FG002|NOT COMPLETED|Overall Study||18||
48581395|NCT01108341|101753334|FG000|STARTED|Overall Study||50||
48581396|NCT01108341|101753334|FG000|Safety Set (Enrolled and Treated)|Overall Study||49||
48581397|NCT01108341|101753334|FG000|COMPLETED|Overall Study||45||
48581398|NCT01108341|101753334|FG000|NOT COMPLETED|Overall Study||5||
48581399|NCT01399047|101753335|FG000|STARTED|Overall Study||10||
48581400|NCT01399047|101753336|FG001|STARTED|Overall Study||9||
48581401|NCT01399047|101753335|FG000|COMPLETED|Overall Study||10||
48581402|NCT01399047|101753336|FG001|COMPLETED|Overall Study||8||
48581403|NCT01399047|101753335|FG000|NOT COMPLETED|Overall Study||0||
48581404|NCT01399047|101753336|FG001|NOT COMPLETED|Overall Study||1||
48581405|NCT03489707|101753337|FG000|STARTED|Baseline||120||
48581406|NCT03489707|101753338|FG001|STARTED|Baseline||120||
48581407|NCT03489707|101753337|FG000|COMPLETED|Baseline||107||
48581408|NCT03489707|101753338|FG001|COMPLETED|Baseline||89||
48581409|NCT03489707|101753337|FG000|NOT COMPLETED|Baseline||13||
48581410|NCT03489707|101753338|FG001|NOT COMPLETED|Baseline||31||
48581411|NCT03489707|101753337|FG000|STARTED|12 Months||120||
48581412|NCT03489707|101753338|FG001|STARTED|12 Months||120||
48581413|NCT03489707|101753337|FG000|COMPLETED|12 Months||78||
48581414|NCT03489707|101753338|FG001|COMPLETED|12 Months||63||
48581415|NCT03489707|101753337|FG000|NOT COMPLETED|12 Months||42||
48581416|NCT03489707|101753338|FG001|NOT COMPLETED|12 Months||57||
48581417|NCT04678232|101753339|FG000|STARTED|Overall Study||45||
48581418|NCT04678232|101753339|FG000|COMPLETED|Overall Study||40||
48581419|NCT04678232|101753339|FG000|NOT COMPLETED|Overall Study||5||
48581420|NCT02115581|101753340|FG000|STARTED|Overall Study||17||
48581421|NCT02115581|101753341|FG001|STARTED|Overall Study||21||
48581422|NCT02115581|101753340|FG000|COMPLETED|Overall Study||17||
48581423|NCT02115581|101753341|FG001|COMPLETED|Overall Study||21||
48581424|NCT02115581|101753340|FG000|NOT COMPLETED|Overall Study||0||
48581425|NCT02115581|101753341|FG001|NOT COMPLETED|Overall Study||0||
48581426|NCT04687072|101753342|FG000|STARTED|Overall Study||137||
48581427|NCT04687072|101753343|FG001|STARTED|Overall Study||70||
48704570|NCT01865812|102064882|FG001|COMPLETED|Primary Treatment Phase||0||
48704571|NCT01865812|102064881|FG000|NOT COMPLETED|Primary Treatment Phase||2||
48704572|NCT01865812|102064882|FG001|NOT COMPLETED|Primary Treatment Phase||0||
48704573|NCT01865812|102064881|FG000|STARTED|Long-term Safety Extension Phase||0|Only eligible participants who completed the PTP phase enrolled in the LTSE phase.|
48136433|NCT01571362|100656162|FG002|NOT COMPLETED|Double-Blind Treatment Period||39||
48136434|NCT02132611|100656163|FG000|STARTED|Overall Study||100||
48136435|NCT02132611|100656163|FG000|COMPLETED|Overall Study||98||
48136436|NCT02132611|100656163|FG000|NOT COMPLETED|Overall Study||2||
48136437|NCT04697758|100656164|FG000|STARTED|Overall Study||3||
48581428|NCT04687072|101753342|FG000|COMPLETED|Overall Study||113||
48136438|NCT04697758|100656165|FG001|STARTED|Overall Study||3||
48581429|NCT04687072|101753343|FG001|COMPLETED|Overall Study||62||
48581430|NCT04687072|101753342|FG000|NOT COMPLETED|Overall Study||24||
48581431|NCT04687072|101753343|FG001|NOT COMPLETED|Overall Study||8||
48581432|NCT02219581|101755879|FG000|STARTED|Overall Study||0||
48581433|NCT02219581|101755880|FG001|STARTED|Overall Study||0||
48581434|NCT02219581|101755881|FG002|STARTED|Overall Study||1||
48581435|NCT02219581|101755879|FG000|COMPLETED|Overall Study||0||
48704574|NCT01865812|102064882|FG001|STARTED|Long-term Safety Extension Phase||21|Only eligible participants who completed the PTP phase enrolled in the LTSE phase.|
48581436|NCT02219581|101755880|FG001|COMPLETED|Overall Study||0||
48581437|NCT02219581|101755881|FG002|COMPLETED|Overall Study||1||
48581438|NCT02219581|101755879|FG000|NOT COMPLETED|Overall Study||0||
48581439|NCT02219581|101755880|FG001|NOT COMPLETED|Overall Study||0||
48581440|NCT02219581|101755881|FG002|NOT COMPLETED|Overall Study||0||
48581441|NCT01934517|101755882|FG000|STARTED|Overall Study||25||
48581442|NCT01934517|101755882|FG000|COMPLETED|Overall Study||25||
48581443|NCT01934517|101755882|FG000|NOT COMPLETED|Overall Study||0||
48581444|NCT01023256|101755883|FG000|STARTED|Overall Study||25||
48710761|NCT00168103|102078009|FG003|NOT COMPLETED|Overall Study||0||
48704575|NCT01865812|102064881|FG000|Received at Least 1 Dose of Study Drug|Long-term Safety Extension Phase||0||
48704576|NCT01865812|102064882|FG001|Received at Least 1 Dose of Study Drug|Long-term Safety Extension Phase||21||
48704577|NCT01865812|102064881|FG000|COMPLETED|Long-term Safety Extension Phase||0||
48704578|NCT01865812|102064882|FG001|COMPLETED|Long-term Safety Extension Phase||15||
48581445|NCT01023256|101755884|FG001|STARTED|Overall Study||22||
48581446|NCT01023256|101755885|FG002|STARTED|Overall Study||24||
48581447|NCT01023256|101755886|FG003|STARTED|Overall Study||27||
48581448|NCT01023256|101755883|FG000|COMPLETED|Overall Study||21||
48581449|NCT01023256|101755884|FG001|COMPLETED|Overall Study||19||
48581450|NCT01023256|101755885|FG002|COMPLETED|Overall Study||23||
48581451|NCT01023256|101755886|FG003|COMPLETED|Overall Study||22||
48581452|NCT01023256|101755883|FG000|NOT COMPLETED|Overall Study||4||
48581453|NCT01023256|101755884|FG001|NOT COMPLETED|Overall Study||3||
48704579|NCT01865812|102064881|FG000|NOT COMPLETED|Long-term Safety Extension Phase||0||
48704580|NCT01865812|102064882|FG001|NOT COMPLETED|Long-term Safety Extension Phase||6||
48704581|NCT01025076|102064883|FG000|STARTED|Overall Study||14||
48704582|NCT01025076|102064883|FG000|COMPLETED|Overall Study||14||
48704583|NCT01025076|102064883|FG000|NOT COMPLETED|Overall Study||0||
48704584|NCT02186652|102064884|FG000|STARTED|Overall Study||19||
48136439|NCT04697758|100656166|FG002|STARTED|Overall Study||0||
48136440|NCT04697758|100656164|FG000|COMPLETED|Overall Study||3||
48136441|NCT04697758|100656165|FG001|COMPLETED|Overall Study||3||
48136442|NCT04697758|100656166|FG002|COMPLETED|Overall Study||0||
48136443|NCT04697758|100656164|FG000|NOT COMPLETED|Overall Study||0||
48136444|NCT04697758|100656165|FG001|NOT COMPLETED|Overall Study||0||
48136445|NCT04697758|100656166|FG002|NOT COMPLETED|Overall Study||0||
48136446|NCT01627249|100656167|FG000|STARTED|Overall Study||224||
48704585|NCT02186652|102064885|FG001|STARTED|Overall Study||22||
48704586|NCT02186652|102064884|FG000|COMPLETED|Overall Study||17||
48704587|NCT02186652|102064885|FG001|COMPLETED|Overall Study||22||
48704588|NCT02186652|102064884|FG000|NOT COMPLETED|Overall Study||2||
48704589|NCT02186652|102064885|FG001|NOT COMPLETED|Overall Study||0||
48704590|NCT01528891|102064886|FG000|STARTED|Overall Study||200||
48136447|NCT01627249|100656168|FG001|STARTED|Overall Study||218||
48400580|NCT01515488|101313577|FG000|COMPLETED|Overall Study||200||
48400581|NCT01515488|101313578|FG001|COMPLETED|Overall Study||200||
48400582|NCT01515488|101313577|FG000|NOT COMPLETED|Overall Study||0||
48400583|NCT01515488|101313578|FG001|NOT COMPLETED|Overall Study||0||
48400584|NCT02786836|101313579|FG000|STARTED|Overall Study||76||
48400585|NCT02786836|101313579|FG000|Eligible Patients Enrolled Into the Stud|Overall Study||76||
48400586|NCT02786836|101313579|FG000|COMPLETED|Overall Study||62||
48581454|NCT01023256|101755885|FG002|NOT COMPLETED|Overall Study||1||
48704591|NCT01528891|102064887|FG001|STARTED|Overall Study||200||
48704592|NCT01528891|102064886|FG000|COMPLETED|Overall Study||200||
48581455|NCT01023256|101755886|FG003|NOT COMPLETED|Overall Study||5||
48704593|NCT01528891|102064887|FG001|COMPLETED|Overall Study||200||
48704594|NCT01528891|102064886|FG000|NOT COMPLETED|Overall Study||0||
48704595|NCT01528891|102064887|FG001|NOT COMPLETED|Overall Study||0||
48704596|NCT02685748|102064888|FG000|STARTED|Overall Study||28||
48704597|NCT02685748|102064889|FG001|STARTED|Overall Study||29||
48704598|NCT02685748|102064888|FG000|COMPLETED|Overall Study||25||
48704599|NCT02685748|102064889|FG001|COMPLETED|Overall Study||27||
48704600|NCT02685748|102064888|FG000|NOT COMPLETED|Overall Study||3||
48704601|NCT02685748|102064889|FG001|NOT COMPLETED|Overall Study||2||
48704602|NCT01235923|102064890|FG000|STARTED|Overall Study||10||
48704603|NCT01235923|102064891|FG001|STARTED|Overall Study||10||
48704604|NCT01235923|102064890|FG000|COMPLETED|Overall Study||10||
48704605|NCT01235923|102064891|FG001|COMPLETED|Overall Study||10||
48704606|NCT01235923|102064890|FG000|NOT COMPLETED|Overall Study||0||
48704607|NCT01235923|102064891|FG001|NOT COMPLETED|Overall Study||0||
48704608|NCT02794844|102064892|FG000|STARTED|Overall Study||28||
48136448|NCT01627249|100656169|FG002|STARTED|Overall Study||218||
48136449|NCT01627249|100656167|FG000|COMPLETED|Overall Study||208||
48136450|NCT01627249|100656168|FG001|COMPLETED|Overall Study||206||
48136451|NCT01627249|100656169|FG002|COMPLETED|Overall Study||206||
48581456|NCT00877071|101755887|FG000|STARTED|Overall Study||2||
48581457|NCT00877071|101755887|FG000|COMPLETED|Overall Study||0||
48581458|NCT00877071|101755887|FG000|NOT COMPLETED|Overall Study||2||
48136452|NCT01627249|100656167|FG000|NOT COMPLETED|Overall Study||16||
48136453|NCT01627249|100656168|FG001|NOT COMPLETED|Overall Study||12||
48400587|NCT02786836|101313579|FG000|NOT COMPLETED|Overall Study||14||
48400588|NCT01082588|101313580|FG000|STARTED|Overall Study||30||
48581459|NCT03973918|101755888|FG000|STARTED|Overall Study||2||
48581460|NCT03973918|101755889|FG001|STARTED|Overall Study||2||
48581461|NCT03973918|101755890|FG002|STARTED|Overall Study||0||
48704609|NCT02794844|102064892|FG000|COMPLETED|Overall Study||23||
48704610|NCT02794844|102064892|FG000|NOT COMPLETED|Overall Study||5||
48136454|NCT01627249|100656169|FG002|NOT COMPLETED|Overall Study||12||
48136455|NCT04837482|100656170|FG000|STARTED|Period 1||22||
48581462|NCT03973918|101755891|FG003|STARTED|Overall Study||1||
48704611|NCT00931723|102064893|FG000|STARTED|Overall Study||173||
48704612|NCT00931723|102064894|FG001|STARTED|Overall Study||183||
48704613|NCT00931723|102064893|FG000|COMPLETED|Overall Study||147||
48704614|NCT00931723|102064894|FG001|COMPLETED|Overall Study||144||
48581463|NCT03973918|101755888|FG000|COMPLETED|Overall Study||2||
48581464|NCT03973918|101755889|FG001|COMPLETED|Overall Study||1||
48581465|NCT03973918|101755890|FG002|COMPLETED|Overall Study||0||
48581466|NCT03973918|101755891|FG003|COMPLETED|Overall Study||0||
48581467|NCT03973918|101755888|FG000|NOT COMPLETED|Overall Study||0||
48581468|NCT03973918|101755889|FG001|NOT COMPLETED|Overall Study||1||
48581469|NCT03973918|101755890|FG002|NOT COMPLETED|Overall Study||0||
48581470|NCT03973918|101755891|FG003|NOT COMPLETED|Overall Study||1||
48581471|NCT01744184|101755892|FG000|STARTED|Overall Study||32||
48581472|NCT01744184|101755893|FG001|STARTED|Overall Study||30||
48581473|NCT01744184|101755892|FG000|COMPLETED|Overall Study||31||
48581474|NCT01744184|101755893|FG001|COMPLETED|Overall Study||29||
48581475|NCT01744184|101755892|FG000|NOT COMPLETED|Overall Study||1||
48581476|NCT01744184|101755893|FG001|NOT COMPLETED|Overall Study||1||
48581477|NCT02278120|101755894|FG000|STARTED|Treatment Period||335||
48581478|NCT02278120|101755895|FG001|STARTED|Treatment Period||337||
48581479|NCT02278120|101755894|FG000|Crossover Cohort|Treatment Period||0|Participants in the placebo arm who crossed over to the ribociclib arm and received at least one dose of the crossover study treatment|
48136456|NCT04837482|100656171|FG001|STARTED|Period 1||21||
48136457|NCT04837482|100656170|FG000|COMPLETED|Period 1||22||
48136458|NCT04837482|100656171|FG001|COMPLETED|Period 1||21||
48136459|NCT04837482|100656170|FG000|NOT COMPLETED|Period 1||0||
48136460|NCT04837482|100656171|FG001|NOT COMPLETED|Period 1||0||
48136461|NCT04837482|100656170|FG000|STARTED|Period 2||22||
48136462|NCT04837482|100656171|FG001|STARTED|Period 2||21||
48136463|NCT04837482|100656170|FG000|COMPLETED|Period 2||22||
48136464|NCT04837482|100656171|FG001|COMPLETED|Period 2||20||
48136465|NCT04837482|100656170|FG000|NOT COMPLETED|Period 2||0||
48136466|NCT04837482|100656171|FG001|NOT COMPLETED|Period 2||1||
48136467|NCT00765193|100656172|FG000|STARTED|Problem Area Examination||14381||
48136468|NCT00765193|100656172|FG000|COMPLETED|Problem Area Examination||14381||
48136469|NCT00765193|100656172|FG000|NOT COMPLETED|Problem Area Examination||0||
48136470|NCT00765193|100656172|FG000|STARTED|Full Body Examination||14381||
48400589|NCT01082588|101313581|FG001|STARTED|Overall Study||30||
48400590|NCT01082588|101313580|FG000|COMPLETED|Overall Study||24||
48136471|NCT00765193|100656172|FG000|COMPLETED|Full Body Examination||14381||
48136472|NCT00765193|100656172|FG000|NOT COMPLETED|Full Body Examination||0||
48136473|NCT02785406|100656173|FG000|STARTED|Overall Study||10||
48136474|NCT02785406|100656174|FG001|STARTED|Overall Study||10||
48136475|NCT02785406|100656173|FG000|Completed First Week|Overall Study||10||
48136476|NCT02785406|100656174|FG001|Completed First Week|Overall Study||10||
48136477|NCT02785406|100656173|FG000|Completed Second Week|Overall Study||10||
48136478|NCT02785406|100656174|FG001|Completed Second Week|Overall Study||10||
48136479|NCT02785406|100656173|FG000|COMPLETED|Overall Study||10||
48136480|NCT02785406|100656174|FG001|COMPLETED|Overall Study||10||
48136481|NCT02785406|100656173|FG000|NOT COMPLETED|Overall Study||0||
48136482|NCT02785406|100656174|FG001|NOT COMPLETED|Overall Study||0||
48136483|NCT04506970|100656175|FG000|STARTED|Overall Study||40||
48136484|NCT04506970|100656176|FG001|STARTED|Overall Study||20||
48400591|NCT01082588|101313581|FG001|COMPLETED|Overall Study||25||
48400592|NCT01082588|101313580|FG000|NOT COMPLETED|Overall Study||6||
48581480|NCT02278120|101755895|FG001|Crossover Cohort|Treatment Period||17|Participants in the placebo arm who crossed over to the ribociclib arm and received at least one dose of the crossover study treatment|
48581481|NCT02278120|101755894|FG000|COMPLETED|Treatment Period||0||
48581482|NCT02278120|101755895|FG001|COMPLETED|Treatment Period||0||
48581483|NCT02278120|101755894|FG000|NOT COMPLETED|Treatment Period||335||
48581484|NCT02278120|101755895|FG001|NOT COMPLETED|Treatment Period||337||
48581485|NCT02278120|101755894|FG000|STARTED|Post-treatment Efficacy Follow-up||22||
48581486|NCT02278120|101755895|FG001|STARTED|Post-treatment Efficacy Follow-up||15||
48581487|NCT02278120|101755894|FG000|COMPLETED|Post-treatment Efficacy Follow-up||0||
48581488|NCT02278120|101755895|FG001|COMPLETED|Post-treatment Efficacy Follow-up||1||
48581489|NCT02278120|101755894|FG000|NOT COMPLETED|Post-treatment Efficacy Follow-up||22||
48581490|NCT02278120|101755895|FG001|NOT COMPLETED|Post-treatment Efficacy Follow-up||14||
48581491|NCT05519228|101755896|FG000|STARTED|Overall Study||83||
48581492|NCT05519228|101755896|FG000|COMPLETED|Overall Study||83||
48136485|NCT04506970|100656175|FG000|COMPLETED|Overall Study||40|One participant was diagnosed with FGR and originally enrolled into the FGR group but was determined not to have FGR at their next clinical and research scan; therefore, this participant crossed over into the control group.|
48136486|NCT04506970|100656176|FG001|COMPLETED|Overall Study||20|One participant was diagnosed with FGR and originally enrolled into the FGR group but was determined not to have FGR at their next clinical and research scan; therefore, this participant crossed over into the control group.|
48136487|NCT04506970|100656175|FG000|NOT COMPLETED|Overall Study||0||
48136488|NCT04506970|100656176|FG001|NOT COMPLETED|Overall Study||0||
48136489|NCT02487563|100656177|FG000|STARTED|Overall Study||32||
48400593|NCT01082588|101313581|FG001|NOT COMPLETED|Overall Study||5||
48400594|NCT05097157|101313582|FG000|STARTED|Overall Study||79||
48136490|NCT02487563|100656178|FG001|STARTED|Overall Study||33||
48400595|NCT05097157|101313582|FG000|COMPLETED|Overall Study||56||
48581493|NCT05519228|101755896|FG000|NOT COMPLETED|Overall Study||0||
48136491|NCT02487563|100656179|FG002|STARTED|Overall Study||32||
48136492|NCT02487563|100656177|FG000|COMPLETED|Overall Study||30||
48136493|NCT02487563|100656178|FG001|COMPLETED|Overall Study||30||
48136494|NCT02487563|100656179|FG002|COMPLETED|Overall Study||31||
48136495|NCT02487563|100656177|FG000|NOT COMPLETED|Overall Study||2||
48136496|NCT02487563|100656178|FG001|NOT COMPLETED|Overall Study||3||
48136497|NCT02487563|100656179|FG002|NOT COMPLETED|Overall Study||1||
48136498|NCT01434602|100656180|FG000|STARTED|Phase I Dose Escalation||6||
48136499|NCT01434602|100656181|FG001|STARTED|Phase I Dose Escalation||7||
48136500|NCT01434602|100656182|FG002|STARTED|Phase I Dose Escalation||0||
48136501|NCT01434602|100656183|FG003|STARTED|Phase I Dose Escalation||0||
48136502|NCT01434602|100656184|FG004|STARTED|Phase I Dose Escalation||0||
48288121|NCT00585195|101033497|FG017|Treated|Overall Study||66||
48288122|NCT00585195|101033498|FG018|Treated|Overall Study||18||
48288123|NCT00585195|101033499|FG019|Treated|Overall Study||18||
48288124|NCT00585195|101033500|FG020|Treated|Overall Study||12||
48288125|NCT00585195|101033480|FG000|COMPLETED|Overall Study||0||
48288126|NCT00585195|101033481|FG001|COMPLETED|Overall Study||0||
48288127|NCT00585195|101033482|FG002|COMPLETED|Overall Study||0||
48288128|NCT00585195|101033483|FG003|COMPLETED|Overall Study||0||
48288129|NCT00585195|101033484|FG004|COMPLETED|Overall Study||0||
48288130|NCT00585195|101033485|FG005|COMPLETED|Overall Study||0||
48288131|NCT00585195|101033486|FG006|COMPLETED|Overall Study||0||
48288132|NCT00585195|101033487|FG007|COMPLETED|Overall Study||0||
48288133|NCT00585195|101033488|FG008|COMPLETED|Overall Study||0||
48288134|NCT00585195|101033489|FG009|COMPLETED|Overall Study||0||
48400596|NCT05097157|101313582|FG000|NOT COMPLETED|Overall Study||23||
48400597|NCT03907969|101313583|FG000|STARTED|Monotherapy Part A||1||
48400598|NCT03907969|101313584|FG001|STARTED|Monotherapy Part A||1||
48400599|NCT03907969|101313585|FG002|STARTED|Monotherapy Part A||1||
48400600|NCT03907969|101313586|FG003|STARTED|Monotherapy Part A||1||
48400601|NCT03907969|101313587|FG004|STARTED|Monotherapy Part A||3||
48400602|NCT03907969|101313588|FG005|STARTED|Monotherapy Part A||4||
48400603|NCT03907969|101313589|FG006|STARTED|Monotherapy Part A||3||
48400604|NCT03907969|101313590|FG007|STARTED|Monotherapy Part A||0||
48400605|NCT03907969|101313591|FG008|STARTED|Monotherapy Part A||0||
48400606|NCT03907969|101313592|FG009|STARTED|Monotherapy Part A||0||
48400607|NCT03907969|101313593|FG010|STARTED|Monotherapy Part A||0||
48400608|NCT03907969|101313583|FG000|COMPLETED|Monotherapy Part A||1||
48400609|NCT03907969|101313584|FG001|COMPLETED|Monotherapy Part A||0||
48400610|NCT03907969|101313585|FG002|COMPLETED|Monotherapy Part A||0||
48400611|NCT03907969|101313586|FG003|COMPLETED|Monotherapy Part A||0||
48400612|NCT03907969|101313587|FG004|COMPLETED|Monotherapy Part A||2||
48400613|NCT03907969|101313588|FG005|COMPLETED|Monotherapy Part A||1||
48400614|NCT03907969|101313589|FG006|COMPLETED|Monotherapy Part A||1||
48400615|NCT03907969|101313590|FG007|COMPLETED|Monotherapy Part A||0||
48400616|NCT03907969|101313591|FG008|COMPLETED|Monotherapy Part A||0||
48400617|NCT03907969|101313592|FG009|COMPLETED|Monotherapy Part A||0||
48400618|NCT03907969|101313593|FG010|COMPLETED|Monotherapy Part A||0||
48400619|NCT03907969|101313583|FG000|NOT COMPLETED|Monotherapy Part A||0||
48400620|NCT03907969|101313584|FG001|NOT COMPLETED|Monotherapy Part A||1||
48400621|NCT03907969|101313585|FG002|NOT COMPLETED|Monotherapy Part A||1||
48400622|NCT03907969|101313586|FG003|NOT COMPLETED|Monotherapy Part A||1||
48400623|NCT03907969|101313587|FG004|NOT COMPLETED|Monotherapy Part A||1||
48400624|NCT03907969|101313588|FG005|NOT COMPLETED|Monotherapy Part A||3||
48400625|NCT03907969|101313589|FG006|NOT COMPLETED|Monotherapy Part A||2||
48400626|NCT03907969|101313590|FG007|NOT COMPLETED|Monotherapy Part A||0||
48400627|NCT03907969|101313591|FG008|NOT COMPLETED|Monotherapy Part A||0||
48400628|NCT03907969|101313592|FG009|NOT COMPLETED|Monotherapy Part A||0||
48400629|NCT03907969|101313593|FG010|NOT COMPLETED|Monotherapy Part A||0||
48400630|NCT03907969|101313583|FG000|STARTED|Combination Therapy Part A||0||
48400631|NCT03907969|101313584|FG001|STARTED|Combination Therapy Part A||0||
48400632|NCT03907969|101313585|FG002|STARTED|Combination Therapy Part A||0||
48400633|NCT03907969|101313586|FG003|STARTED|Combination Therapy Part A||0||
48400634|NCT03907969|101313587|FG004|STARTED|Combination Therapy Part A||0||
48400635|NCT03907969|101313588|FG005|STARTED|Combination Therapy Part A||0||
48400636|NCT03907969|101313589|FG006|STARTED|Combination Therapy Part A||0||
48136503|NCT01434602|100656180|FG000|COMPLETED|Phase I Dose Escalation||6||
48136504|NCT01434602|100656181|FG001|COMPLETED|Phase I Dose Escalation||6||
48136505|NCT01434602|100656182|FG002|COMPLETED|Phase I Dose Escalation||0||
48288135|NCT00585195|101033490|FG010|COMPLETED|Overall Study||0||
48400637|NCT03907969|101313590|FG007|STARTED|Combination Therapy Part A||2||
48400638|NCT03907969|101313591|FG008|STARTED|Combination Therapy Part A||2||
48400639|NCT03907969|101313592|FG009|STARTED|Combination Therapy Part A||5||
48288136|NCT00585195|101033491|FG011|COMPLETED|Overall Study||0||
48288137|NCT00585195|101033492|FG012|COMPLETED|Overall Study||0||
48288138|NCT00585195|101033493|FG013|COMPLETED|Overall Study||0||
48400640|NCT03907969|101313593|FG010|STARTED|Combination Therapy Part A||7||
48400641|NCT03907969|101313583|FG000|COMPLETED|Combination Therapy Part A||0||
48400642|NCT03907969|101313584|FG001|COMPLETED|Combination Therapy Part A||0||
48400643|NCT03907969|101313585|FG002|COMPLETED|Combination Therapy Part A||0||
48400644|NCT03907969|101313586|FG003|COMPLETED|Combination Therapy Part A||0||
48400645|NCT03907969|101313587|FG004|COMPLETED|Combination Therapy Part A||0||
48400646|NCT03907969|101313588|FG005|COMPLETED|Combination Therapy Part A||0||
48288139|NCT00585195|101033494|FG014|COMPLETED|Overall Study||0||
48288140|NCT00585195|101033495|FG015|COMPLETED|Overall Study||0||
48288141|NCT00585195|101033496|FG016|COMPLETED|Overall Study||0||
48136506|NCT01434602|100656183|FG003|COMPLETED|Phase I Dose Escalation||0||
48288142|NCT00585195|101033497|FG017|COMPLETED|Overall Study||0||
48288143|NCT00585195|101033498|FG018|COMPLETED|Overall Study||0||
48288144|NCT00585195|101033499|FG019|COMPLETED|Overall Study||0||
48288145|NCT00585195|101033500|FG020|COMPLETED|Overall Study||0||
48400647|NCT03907969|101313589|FG006|COMPLETED|Combination Therapy Part A||0||
48400648|NCT03907969|101313590|FG007|COMPLETED|Combination Therapy Part A||0||
48400649|NCT03907969|101313591|FG008|COMPLETED|Combination Therapy Part A||0||
48400650|NCT03907969|101313592|FG009|COMPLETED|Combination Therapy Part A||1||
48400651|NCT03907969|101313593|FG010|COMPLETED|Combination Therapy Part A||1||
48400652|NCT03907969|101313583|FG000|NOT COMPLETED|Combination Therapy Part A||0||
48400653|NCT03907969|101313584|FG001|NOT COMPLETED|Combination Therapy Part A||0||
48400654|NCT03907969|101313585|FG002|NOT COMPLETED|Combination Therapy Part A||0||
48400655|NCT03907969|101313586|FG003|NOT COMPLETED|Combination Therapy Part A||0||
48400656|NCT03907969|101313587|FG004|NOT COMPLETED|Combination Therapy Part A||0||
48400657|NCT03907969|101313588|FG005|NOT COMPLETED|Combination Therapy Part A||0||
48400658|NCT03907969|101313589|FG006|NOT COMPLETED|Combination Therapy Part A||0||
48400659|NCT03907969|101313590|FG007|NOT COMPLETED|Combination Therapy Part A||2||
48400660|NCT03907969|101313591|FG008|NOT COMPLETED|Combination Therapy Part A||2||
48400661|NCT03907969|101313592|FG009|NOT COMPLETED|Combination Therapy Part A||4||
48400662|NCT03907969|101313593|FG010|NOT COMPLETED|Combination Therapy Part A||6||
48400663|NCT00383708|101313594|FG000|STARTED|Enrolment Through Start Treatment||125||
48400664|NCT00383708|101313594|FG000|COMPLETED|Enrolment Through Start Treatment||92||
48581494|NCT00896181|101755897|FG000|STARTED|Overall Study||26||
48581495|NCT00896181|101755897|FG000|COMPLETED|Overall Study||26||
48581496|NCT00896181|101755897|FG000|NOT COMPLETED|Overall Study||0||
48581497|NCT02050919|101755898|FG000|STARTED|Overall Study||20||
48581498|NCT02050919|101755898|FG000|COMPLETED|Overall Study||20||
48581499|NCT02050919|101755898|FG000|NOT COMPLETED|Overall Study||0||
48136507|NCT01434602|100656184|FG004|COMPLETED|Phase I Dose Escalation||0||
48136508|NCT01434602|100656180|FG000|NOT COMPLETED|Phase I Dose Escalation||0||
48136509|NCT01434602|100656181|FG001|NOT COMPLETED|Phase I Dose Escalation||1||
48136510|NCT01434602|100656182|FG002|NOT COMPLETED|Phase I Dose Escalation||0||
48136511|NCT01434602|100656183|FG003|NOT COMPLETED|Phase I Dose Escalation||0||
48136512|NCT01434602|100656184|FG004|NOT COMPLETED|Phase I Dose Escalation||0||
48136513|NCT01434602|100656180|FG000|STARTED|Phase II Recommended Phase 2 Dose||0||
48136514|NCT01434602|100656181|FG001|STARTED|Phase II Recommended Phase 2 Dose||0||
48136515|NCT01434602|100656182|FG002|STARTED|Phase II Recommended Phase 2 Dose||12||
48136516|NCT01434602|100656183|FG003|STARTED|Phase II Recommended Phase 2 Dose||40||
48136517|NCT01434602|100656184|FG004|STARTED|Phase II Recommended Phase 2 Dose||21||
48136518|NCT01434602|100656180|FG000|COMPLETED|Phase II Recommended Phase 2 Dose||0||
48136519|NCT01434602|100656181|FG001|COMPLETED|Phase II Recommended Phase 2 Dose||0||
48136520|NCT01434602|100656182|FG002|COMPLETED|Phase II Recommended Phase 2 Dose||12||
48136521|NCT01434602|100656183|FG003|COMPLETED|Phase II Recommended Phase 2 Dose||31||
48136522|NCT01434602|100656184|FG004|COMPLETED|Phase II Recommended Phase 2 Dose||19||
48136523|NCT01434602|100656180|FG000|NOT COMPLETED|Phase II Recommended Phase 2 Dose||0||
48288146|NCT00585195|101033480|FG000|NOT COMPLETED|Overall Study||3||
48288147|NCT00585195|101033481|FG001|NOT COMPLETED|Overall Study||4||
48288148|NCT00585195|101033482|FG002|NOT COMPLETED|Overall Study||9||
48400665|NCT00383708|101313594|FG000|NOT COMPLETED|Enrolment Through Start Treatment||33||
48400666|NCT00383708|101313594|FG000|STARTED|Run-in Period||92||
48400667|NCT00383708|101313594|FG000|COMPLETED|Run-in Period||85||
48400668|NCT00383708|101313594|FG000|NOT COMPLETED|Run-in Period||7||
48400669|NCT00383708|101313594|FG000|STARTED|Co-administration Period||57|28 subjects were not eligible for co-administration period based on IGF-1 levels and were withdrawn|
48400670|NCT00383708|101313594|FG000|COMPLETED|Co-administration Period||52||
48400671|NCT00383708|101313594|FG000|NOT COMPLETED|Co-administration Period||5||
48400672|NCT01522768|101313595|FG000|STARTED|Overall Study||42||
48400673|NCT01522768|101313595|FG000|COMPLETED|Overall Study||42||
48400674|NCT01522768|101313595|FG000|NOT COMPLETED|Overall Study||0||
48400675|NCT00422669|101313596|FG000|STARTED|Overall Study||98||
48136524|NCT01434602|100656181|FG001|NOT COMPLETED|Phase II Recommended Phase 2 Dose||0||
48136525|NCT01434602|100656182|FG002|NOT COMPLETED|Phase II Recommended Phase 2 Dose||0||
48136526|NCT01434602|100656183|FG003|NOT COMPLETED|Phase II Recommended Phase 2 Dose||9||
48136527|NCT01434602|100656184|FG004|NOT COMPLETED|Phase II Recommended Phase 2 Dose||2||
48136528|NCT01962493|100656185|FG000|STARTED|Overall Study||78||
48136529|NCT01962493|100656186|FG001|STARTED|Overall Study||82||
48288149|NCT00585195|101033483|FG003|NOT COMPLETED|Overall Study||7||
48288150|NCT00585195|101033484|FG004|NOT COMPLETED|Overall Study||9||
48400676|NCT00422669|101313597|FG001|STARTED|Overall Study||100||
48581500|NCT03854370|101755899|FG000|STARTED|Overall Study||9||
48581501|NCT03854370|101755900|FG001|STARTED|Overall Study||9||
48581502|NCT03854370|101755901|FG002|STARTED|Overall Study||7||
48581503|NCT03854370|101755902|FG003|STARTED|Overall Study||10||
48136530|NCT01962493|100656185|FG000|COMPLETED|Overall Study||73||
48136531|NCT01962493|100656186|FG001|COMPLETED|Overall Study||77||
48136532|NCT01962493|100656185|FG000|NOT COMPLETED|Overall Study||5||
48136533|NCT01962493|100656186|FG001|NOT COMPLETED|Overall Study||5||
48136534|NCT00305058|100656187|FG000|STARTED|Overall Study||97||
48136535|NCT00305058|100656188|FG001|STARTED|Overall Study||97||
48136536|NCT00305058|100656187|FG000|Inclusion/Exclusion Verification|Overall Study||96||
48288151|NCT00585195|101033485|FG005|NOT COMPLETED|Overall Study||6||
48288152|NCT00585195|101033486|FG006|NOT COMPLETED|Overall Study||7||
48288153|NCT00585195|101033487|FG007|NOT COMPLETED|Overall Study||5||
48288154|NCT00585195|101033488|FG008|NOT COMPLETED|Overall Study||3||
48288155|NCT00585195|101033489|FG009|NOT COMPLETED|Overall Study||6||
48400677|NCT00422669|101313598|FG002|STARTED|Overall Study||7||
48400678|NCT00422669|101313596|FG000|COMPLETED|Overall Study||0||
48400679|NCT00422669|101313597|FG001|COMPLETED|Overall Study||0||
48581504|NCT03854370|101755899|FG000|COMPLETED|Overall Study||8||
48581505|NCT03854370|101755900|FG001|COMPLETED|Overall Study||8||
48581506|NCT03854370|101755901|FG002|COMPLETED|Overall Study||6||
48581507|NCT03854370|101755902|FG003|COMPLETED|Overall Study||9||
48581508|NCT03854370|101755899|FG000|NOT COMPLETED|Overall Study||1||
48136537|NCT00305058|100656188|FG001|Inclusion/Exclusion Verification|Overall Study||97||
48136538|NCT00305058|100656187|FG000|All Outcome Data Collected|Overall Study||93||
48288156|NCT00585195|101033490|FG010|NOT COMPLETED|Overall Study||11||
48288157|NCT00585195|101033491|FG011|NOT COMPLETED|Overall Study||53||
48288158|NCT00585195|101033492|FG012|NOT COMPLETED|Overall Study||85||
48288159|NCT00585195|101033493|FG013|NOT COMPLETED|Overall Study||41||
48288160|NCT00585195|101033494|FG014|NOT COMPLETED|Overall Study||48||
48288161|NCT00585195|101033495|FG015|NOT COMPLETED|Overall Study||19||
48288162|NCT00585195|101033496|FG016|NOT COMPLETED|Overall Study||154||
48288163|NCT00585195|101033497|FG017|NOT COMPLETED|Overall Study||67||
48288164|NCT00585195|101033498|FG018|NOT COMPLETED|Overall Study||21||
48288165|NCT00585195|101033499|FG019|NOT COMPLETED|Overall Study||18||
48288166|NCT00585195|101033500|FG020|NOT COMPLETED|Overall Study||14||
48288167|NCT00816400|101033501|FG000|STARTED|Overall Study||3||
48288168|NCT00816400|101033502|FG001|STARTED|Overall Study||3||
48288169|NCT00816400|101033503|FG002|STARTED|Overall Study||5||
48288170|NCT00816400|101033504|FG003|STARTED|Overall Study||3||
48288171|NCT00816400|101033505|FG004|STARTED|Overall Study||3||
48288172|NCT00816400|101033506|FG005|STARTED|Overall Study||3||
48288173|NCT00816400|101033507|FG006|STARTED|Overall Study||3||
48288174|NCT00816400|101033508|FG007|STARTED|Overall Study||6||
48288175|NCT00816400|101033509|FG008|STARTED|Overall Study||6||
48136539|NCT00305058|100656188|FG001|All Outcome Data Collected|Overall Study||95||
48136540|NCT00305058|100656187|FG000|Data Collection Forms Filed for Analysis|Overall Study||90||
48288176|NCT00816400|101033501|FG000|COMPLETED|Overall Study||1||
48288177|NCT00816400|101033502|FG001|COMPLETED|Overall Study||0||
48288178|NCT00816400|101033503|FG002|COMPLETED|Overall Study||0||
48288179|NCT00816400|101033504|FG003|COMPLETED|Overall Study||0||
48288180|NCT00816400|101033505|FG004|COMPLETED|Overall Study||1||
48288181|NCT00816400|101033506|FG005|COMPLETED|Overall Study||0||
48288182|NCT00816400|101033507|FG006|COMPLETED|Overall Study||1||
48288183|NCT00816400|101033508|FG007|COMPLETED|Overall Study||1||
48288184|NCT00816400|101033509|FG008|COMPLETED|Overall Study||0||
48288185|NCT00816400|101033501|FG000|NOT COMPLETED|Overall Study||2||
48288186|NCT00816400|101033502|FG001|NOT COMPLETED|Overall Study||3||
48288187|NCT00816400|101033503|FG002|NOT COMPLETED|Overall Study||5||
48288188|NCT00816400|101033504|FG003|NOT COMPLETED|Overall Study||3||
48288189|NCT00816400|101033505|FG004|NOT COMPLETED|Overall Study||2||
48288190|NCT00816400|101033506|FG005|NOT COMPLETED|Overall Study||3||
48400680|NCT00422669|101313598|FG002|COMPLETED|Overall Study||0||
48400681|NCT00422669|101313596|FG000|NOT COMPLETED|Overall Study||98||
48400682|NCT00422669|101313597|FG001|NOT COMPLETED|Overall Study||100||
48136541|NCT00305058|100656188|FG001|Data Collection Forms Filed for Analysis|Overall Study||93||
48136542|NCT00305058|100656187|FG000|COMPLETED|Overall Study||90||
48136543|NCT00305058|100656188|FG001|COMPLETED|Overall Study||93||
48400683|NCT00422669|101313598|FG002|NOT COMPLETED|Overall Study||7||
48136544|NCT00305058|100656187|FG000|NOT COMPLETED|Overall Study||7||
48136545|NCT00305058|100656188|FG001|NOT COMPLETED|Overall Study||4||
48288191|NCT00816400|101033507|FG006|NOT COMPLETED|Overall Study||2||
48288192|NCT00816400|101033508|FG007|NOT COMPLETED|Overall Study||5||
48288193|NCT00816400|101033509|FG008|NOT COMPLETED|Overall Study||6||
48288194|NCT01489891|101033510|FG000|STARTED|Overall Study||60||
48288195|NCT01489891|101033511|FG001|STARTED|Overall Study||60||
48288196|NCT01489891|101033510|FG000|COMPLETED|Overall Study||59||
48288197|NCT01489891|101033511|FG001|COMPLETED|Overall Study||60||
48288198|NCT01489891|101033510|FG000|NOT COMPLETED|Overall Study||1||
48288199|NCT01489891|101033511|FG001|NOT COMPLETED|Overall Study||0||
48288200|NCT01022268|101033512|FG000|STARTED|Overall Study||818||
48288201|NCT01022268|101033513|FG001|STARTED|Overall Study||84||
48288202|NCT01022268|101033512|FG000|COMPLETED|Overall Study||816||
48581509|NCT03854370|101755900|FG001|NOT COMPLETED|Overall Study||1||
48581510|NCT03854370|101755901|FG002|NOT COMPLETED|Overall Study||1||
48581511|NCT03854370|101755902|FG003|NOT COMPLETED|Overall Study||1||
48288203|NCT01022268|101033513|FG001|COMPLETED|Overall Study||84||
48288204|NCT01022268|101033512|FG000|NOT COMPLETED|Overall Study||2||
48288205|NCT01022268|101033513|FG001|NOT COMPLETED|Overall Study||0||
48288206|NCT01668667|101033514|FG000|STARTED|Overall Study||126||
48288207|NCT01668667|101033515|FG001|STARTED|Overall Study||125||
48288208|NCT01668667|101033516|FG002|STARTED|Overall Study||125||
48288209|NCT01668667|101033517|FG003|STARTED|Overall Study||125||
48288210|NCT01668667|101033514|FG000|COMPLETED|Overall Study||95||
48288211|NCT01668667|101033515|FG001|COMPLETED|Overall Study||99||
48288212|NCT01668667|101033516|FG002|COMPLETED|Overall Study||94||
48288213|NCT01668667|101033517|FG003|COMPLETED|Overall Study||102||
48288214|NCT01668667|101033514|FG000|NOT COMPLETED|Overall Study||31||
48288215|NCT01668667|101033515|FG001|NOT COMPLETED|Overall Study||26||
48288216|NCT01668667|101033516|FG002|NOT COMPLETED|Overall Study||31||
48288217|NCT01668667|101033517|FG003|NOT COMPLETED|Overall Study||23||
48288218|NCT03010176|101033518|FG000|STARTED|Overall Study||32||
48288219|NCT03010176|101033519|FG001|STARTED|Overall Study||52||
48400684|NCT00928512|101313599|FG000|STARTED|Overall Study||41||
48400685|NCT00928512|101313600|FG001|STARTED|Overall Study||43||
48400686|NCT00928512|101313601|FG002|STARTED|Overall Study||49||
48400687|NCT00928512|101313602|FG003|STARTED|Overall Study||54||
48400688|NCT00928512|101313603|FG004|STARTED|Overall Study||50||
48400689|NCT00928512|101313599|FG000|Discontinued Prior to Week 16|Overall Study||3||
48400690|NCT00928512|101313600|FG001|Discontinued Prior to Week 16|Overall Study||0||
48400691|NCT00928512|101313601|FG002|Discontinued Prior to Week 16|Overall Study||2||
48400692|NCT00928512|101313602|FG003|Discontinued Prior to Week 16|Overall Study||6||
48136546|NCT00586105|100656189|FG000|STARTED|Overall Study||39||
48136547|NCT00586105|100656189|FG000|COMPLETED|Overall Study||0||
48136548|NCT00586105|100656189|FG000|NOT COMPLETED|Overall Study||39||
48136549|NCT00144339|100656190|FG000|STARTED|Overall Study||3006||
48136550|NCT00144339|100656191|FG001|STARTED|Overall Study||2986||
48136551|NCT00144339|100656190|FG000|COMPLETED|Overall Study||1648||
48136552|NCT00144339|100656191|FG001|COMPLETED|Overall Study||1887||
48136553|NCT00144339|100656190|FG000|NOT COMPLETED|Overall Study||1358||
48136554|NCT00144339|100656191|FG001|NOT COMPLETED|Overall Study||1099||
48136555|NCT02462876|100656192|FG000|STARTED|Overall Study||60||
48136556|NCT02462876|100656192|FG000|COMPLETED|Overall Study||33||
48136557|NCT02462876|100656192|FG000|NOT COMPLETED|Overall Study||27||
48136558|NCT01972516|100656193|FG000|STARTED|Overall Study||3||
48136559|NCT01972516|100656194|FG001|STARTED|Overall Study||1||
48136560|NCT01972516|100656193|FG000|COMPLETED|Overall Study||3||
48136561|NCT01972516|100656194|FG001|COMPLETED|Overall Study||1||
48136562|NCT01972516|100656193|FG000|NOT COMPLETED|Overall Study||0||
48136563|NCT01972516|100656194|FG001|NOT COMPLETED|Overall Study||0||
48136564|NCT05734846|100656195|FG000|STARTED|Period 1 (One Week)||13||
48136565|NCT05734846|100656196|FG001|STARTED|Period 1 (One Week)||12||
48136566|NCT05734846|100656195|FG000|COMPLETED|Period 1 (One Week)||13||
48136567|NCT05734846|100656196|FG001|COMPLETED|Period 1 (One Week)||12||
48136568|NCT05734846|100656195|FG000|NOT COMPLETED|Period 1 (One Week)||0||
48136569|NCT05734846|100656196|FG001|NOT COMPLETED|Period 1 (One Week)||0||
48136570|NCT05734846|100656195|FG000|STARTED|Period 2 (One Week)||13||
48136571|NCT05734846|100656196|FG001|STARTED|Period 2 (One Week)||12||
48136572|NCT05734846|100656195|FG000|COMPLETED|Period 2 (One Week)||13||
48136573|NCT05734846|100656196|FG001|COMPLETED|Period 2 (One Week)||12||
48400693|NCT00928512|101313603|FG004|Discontinued Prior to Week 16|Overall Study||5||
48136574|NCT05734846|100656195|FG000|NOT COMPLETED|Period 2 (One Week)||0||
48136575|NCT05734846|100656196|FG001|NOT COMPLETED|Period 2 (One Week)||0||
48400694|NCT00928512|101313599|FG000|Reassigned at Week 20 (Non-responders)|Overall Study||0||
48400695|NCT00928512|101313600|FG001|Reassigned at Week 20 (Non-responders)|Overall Study||23||
48400696|NCT00928512|101313601|FG002|Reassigned at Week 20 (Non-responders)|Overall Study||23||
48400697|NCT00928512|101313602|FG003|Reassigned at Week 20 (Non-responders)|Overall Study||27||
48400698|NCT00928512|101313603|FG004|Reassigned at Week 20 (Non-responders)|Overall Study||45||
48136576|NCT04773015|100656197|FG000|STARTED|Overall Study||209||
48400699|NCT00928512|101313599|FG000|Not Reassigned at Week 20 (Responders)|Overall Study||37||
48400700|NCT00928512|101313600|FG001|Not Reassigned at Week 20 (Responders)|Overall Study||20||
48400701|NCT00928512|101313601|FG002|Not Reassigned at Week 20 (Responders)|Overall Study||23||
48136577|NCT04773015|100656198|FG001|STARTED|Overall Study||18||
48288220|NCT03010176|101033520|FG002|STARTED|Overall Study||26||
48288221|NCT03010176|101033521|FG003|STARTED|Overall Study||21||
48288222|NCT03010176|101033522|FG004|STARTED|Overall Study||25||
48288223|NCT03010176|101033523|FG005|STARTED|Overall Study||0||
48136578|NCT04773015|100656197|FG000|COMPLETED|Overall Study||209||
48136579|NCT04773015|100656198|FG001|COMPLETED|Overall Study||18||
48136580|NCT04773015|100656197|FG000|NOT COMPLETED|Overall Study||0||
48400702|NCT00928512|101313602|FG003|Not Reassigned at Week 20 (Responders)|Overall Study||18||
48136581|NCT04773015|100656198|FG001|NOT COMPLETED|Overall Study||0||
48136582|NCT04331366|100656199|FG000|STARTED|Overall Study||2||
48288224|NCT03010176|101033518|FG000|Treated|Overall Study||32||
48288225|NCT03010176|101033519|FG001|Treated|Overall Study||52||
48288226|NCT03010176|101033520|FG002|Treated|Overall Study||26||
48288227|NCT03010176|101033521|FG003|Treated|Overall Study||21||
48288228|NCT03010176|101033522|FG004|Treated|Overall Study||25||
48288229|NCT03010176|101033523|FG005|Treated|Overall Study||0||
48288230|NCT03010176|101033518|FG000|Switched From Part 1 Arm 1 to Part 1 Arm 2|Overall Study||14|Switched over from Part 1 Arm 1: Ulevostinag (Cut/Subcut Lesions) to Part 1 Arm 2: Ulevostinag+Pembro (Cut/Subcut Lesions)|
48288231|NCT03010176|101033519|FG001|Switched From Part 1 Arm 1 to Part 1 Arm 2|Overall Study||0|Switched over from Part 1 Arm 1: Ulevostinag (Cut/Subcut Lesions) to Part 1 Arm 2: Ulevostinag+Pembro (Cut/Subcut Lesions)|
48288232|NCT03010176|101033520|FG002|Switched From Part 1 Arm 1 to Part 1 Arm 2|Overall Study||0|Switched over from Part 1 Arm 1: Ulevostinag (Cut/Subcut Lesions) to Part 1 Arm 2: Ulevostinag+Pembro (Cut/Subcut Lesions)|
48136583|NCT04331366|100656199|FG000|COMPLETED|Overall Study||2||
48136584|NCT04331366|100656199|FG000|NOT COMPLETED|Overall Study||0||
48136585|NCT01949480|100656200|FG000|STARTED|Overall Study||20||
48136586|NCT01949480|100656201|FG001|STARTED|Overall Study||22||
48136587|NCT01949480|100656200|FG000|COMPLETED|Overall Study||15||
48136588|NCT01949480|100656201|FG001|COMPLETED|Overall Study||14||
48136589|NCT01949480|100656200|FG000|NOT COMPLETED|Overall Study||5||
48136590|NCT01949480|100656201|FG001|NOT COMPLETED|Overall Study||8||
48136591|NCT02824913|100656202|FG000|STARTED|First Intervention (1 Day)||1||
48136592|NCT02824913|100656203|FG001|STARTED|First Intervention (1 Day)||0||
48136593|NCT02824913|100656202|FG000|COMPLETED|First Intervention (1 Day)||1||
48136594|NCT02824913|100656203|FG001|COMPLETED|First Intervention (1 Day)||0||
48704615|NCT00931723|102064893|FG000|NOT COMPLETED|Overall Study||26||
48704616|NCT00931723|102064894|FG001|NOT COMPLETED|Overall Study||39||
48704617|NCT00191724|102064895|FG000|STARTED|Overall Study||6||
48136595|NCT02824913|100656202|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48136596|NCT02824913|100656203|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48136597|NCT02824913|100656202|FG000|STARTED|Washout (7-14 Days)||1||
48136598|NCT02824913|100656203|FG001|STARTED|Washout (7-14 Days)||0||
48136599|NCT02824913|100656202|FG000|COMPLETED|Washout (7-14 Days)||1||
48136600|NCT02824913|100656203|FG001|COMPLETED|Washout (7-14 Days)||0||
48136601|NCT02824913|100656202|FG000|NOT COMPLETED|Washout (7-14 Days)||0||
48136602|NCT02824913|100656203|FG001|NOT COMPLETED|Washout (7-14 Days)||0||
48136603|NCT02824913|100656202|FG000|STARTED|Second Intervention (1 Day)||1||
48136604|NCT02824913|100656203|FG001|STARTED|Second Intervention (1 Day)||0||
48136605|NCT02824913|100656202|FG000|COMPLETED|Second Intervention (1 Day)||1||
48136606|NCT02824913|100656203|FG001|COMPLETED|Second Intervention (1 Day)||0||
48136607|NCT02824913|100656202|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48136608|NCT02824913|100656203|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48136609|NCT03421691|100656204|FG000|STARTED|Overall Study||16||
48136610|NCT03421691|100656204|FG000|COMPLETED|Overall Study||10||
48136611|NCT03421691|100656204|FG000|NOT COMPLETED|Overall Study||6||
48136612|NCT02053350|100656205|FG000|STARTED|Overall Study||7||
48136613|NCT02053350|100656205|FG000|COMPLETED|Overall Study||2||
48288233|NCT03010176|101033521|FG003|Switched From Part 1 Arm 1 to Part 1 Arm 2|Overall Study||0|Switched over from Part 1 Arm 1: Ulevostinag (Cut/Subcut Lesions) to Part 1 Arm 2: Ulevostinag+Pembro (Cut/Subcut Lesions)|
48288234|NCT03010176|101033522|FG004|Switched From Part 1 Arm 1 to Part 1 Arm 2|Overall Study||0|Switched over from Part 1 Arm 1: Ulevostinag (Cut/Subcut Lesions) to Part 1 Arm 2: Ulevostinag+Pembro (Cut/Subcut Lesions)|
48581512|NCT05238025|101755903|FG000|STARTED|Overall Study||9160|Participants vaccinated|
48581513|NCT05238025|101755904|FG001|STARTED|Overall Study||9188|Participants vaccinated|
48581514|NCT05238025|101755903|FG000|COMPLETED|Overall Study||1530|1 year follow-up|
48581515|NCT05238025|101755904|FG001|COMPLETED|Overall Study||1535|1 year follow-up|
48581516|NCT05238025|101755903|FG000|NOT COMPLETED|Overall Study||7630||
48581517|NCT05238025|101755904|FG001|NOT COMPLETED|Overall Study||7653||
48581518|NCT02023411|101755905|FG000|STARTED|Overall Study||10||
48581519|NCT02023411|101755906|FG001|STARTED|Overall Study||10||
48581520|NCT02023411|101755905|FG000|COMPLETED|Overall Study||10||
48581521|NCT02023411|101755906|FG001|COMPLETED|Overall Study||10||
48581522|NCT02023411|101755905|FG000|NOT COMPLETED|Overall Study||0||
48581523|NCT02023411|101755906|FG001|NOT COMPLETED|Overall Study||0||
48704618|NCT00191724|102064896|FG001|STARTED|Overall Study||9||
48704619|NCT00191724|102064897|FG002|STARTED|Overall Study||9||
48704620|NCT00191724|102064898|FG003|STARTED|Overall Study||8||
48704621|NCT00191724|102064899|FG004|STARTED|Overall Study||15||
48704622|NCT00191724|102064895|FG000|COMPLETED|Overall Study||5||
48704623|NCT00191724|102064896|FG001|COMPLETED|Overall Study||8||
48581524|NCT00756236|101755907|FG000|STARTED|Overall Study||20||
48704624|NCT00191724|102064897|FG002|COMPLETED|Overall Study||8||
48704625|NCT00191724|102064898|FG003|COMPLETED|Overall Study||5||
48704626|NCT00191724|102064899|FG004|COMPLETED|Overall Study||12||
48704627|NCT00191724|102064895|FG000|NOT COMPLETED|Overall Study||1||
48136614|NCT02053350|100656205|FG000|NOT COMPLETED|Overall Study||5||
48136615|NCT03077724|100661304|FG000|STARTED|Overall Study||14||
48136616|NCT03077724|100661305|FG001|STARTED|Overall Study||14||
48136617|NCT03077724|100661304|FG000|COMPLETED|Overall Study||6||
48136618|NCT03077724|100661305|FG001|COMPLETED|Overall Study||12||
48136619|NCT03077724|100661304|FG000|NOT COMPLETED|Overall Study||8||
48136620|NCT03077724|100661305|FG001|NOT COMPLETED|Overall Study||2||
48704628|NCT00191724|102064896|FG001|NOT COMPLETED|Overall Study||1||
48136621|NCT00971048|100661306|FG000|STARTED|Overall Study||30||
48136622|NCT00971048|100661307|FG001|STARTED|Overall Study||33||
48136623|NCT00971048|100661308|FG002|STARTED|Overall Study||12||
48136624|NCT00971048|100661309|FG003|STARTED|Overall Study||13||
48294172|NCT02527343|101047540|FG004|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||1||
48136625|NCT00971048|100661306|FG000|COMPLETED|Overall Study||29||
48288235|NCT03010176|101033523|FG005|Switched From Part 1 Arm 1 to Part 1 Arm 2|Overall Study||0|Switched over from Part 1 Arm 1: Ulevostinag (Cut/Subcut Lesions) to Part 1 Arm 2: Ulevostinag+Pembro (Cut/Subcut Lesions)|
48288236|NCT03010176|101033518|FG000|COMPLETED|Overall Study||0||
48288237|NCT03010176|101033519|FG001|COMPLETED|Overall Study||0||
48288238|NCT03010176|101033520|FG002|COMPLETED|Overall Study||0||
48288239|NCT03010176|101033521|FG003|COMPLETED|Overall Study||0||
48288240|NCT03010176|101033522|FG004|COMPLETED|Overall Study||0||
48288241|NCT03010176|101033523|FG005|COMPLETED|Overall Study||0||
48288242|NCT03010176|101033518|FG000|NOT COMPLETED|Overall Study||32||
48704629|NCT00191724|102064897|FG002|NOT COMPLETED|Overall Study||1||
48704630|NCT00191724|102064898|FG003|NOT COMPLETED|Overall Study||3||
48704631|NCT00191724|102064899|FG004|NOT COMPLETED|Overall Study||3||
48704632|NCT02825966|102064900|FG000|STARTED|Overall Study||35|Same 35 subjects wore the AUDICOR Ambulatory Monitoring (AM) and WCD devices sequentially.|
48704633|NCT02825966|102064900|FG000|COMPLETED|Overall Study||35|Same 35 subjects wore the AUDICOR AM and WCD devices sequentially.|
48704634|NCT02825966|102064900|FG000|NOT COMPLETED|Overall Study||0||
48704635|NCT00842946|102064901|FG000|STARTED|Overall Study||21||
48704636|NCT00842946|102064902|FG001|STARTED|Overall Study||24||
48704637|NCT00842946|102064901|FG000|COMPLETED|Overall Study||16||
48704638|NCT00842946|102064902|FG001|COMPLETED|Overall Study||19||
48704639|NCT00842946|102064901|FG000|NOT COMPLETED|Overall Study||5||
48704640|NCT00842946|102064902|FG001|NOT COMPLETED|Overall Study||5||
48704641|NCT01318278|102064903|FG000|STARTED|Overall Study||10||
48704642|NCT01318278|102064904|FG001|STARTED|Overall Study||10||
48704643|NCT01318278|102064905|FG002|STARTED|Overall Study||50||
48704644|NCT01318278|102064903|FG000|COMPLETED|Overall Study||10||
48704645|NCT01318278|102064904|FG001|COMPLETED|Overall Study||10||
48704646|NCT01318278|102064905|FG002|COMPLETED|Overall Study||50||
48704647|NCT01318278|102064903|FG000|NOT COMPLETED|Overall Study||0||
48704648|NCT01318278|102064904|FG001|NOT COMPLETED|Overall Study||0||
48704649|NCT01318278|102064905|FG002|NOT COMPLETED|Overall Study||0||
48704650|NCT01280058|102064906|FG000|STARTED|Overall Study||36||
48288243|NCT03010176|101033519|FG001|NOT COMPLETED|Overall Study||52||
48288244|NCT03010176|101033520|FG002|NOT COMPLETED|Overall Study||26||
48288245|NCT03010176|101033521|FG003|NOT COMPLETED|Overall Study||21||
48288246|NCT03010176|101033522|FG004|NOT COMPLETED|Overall Study||25||
48288247|NCT03010176|101033523|FG005|NOT COMPLETED|Overall Study||0||
48288248|NCT01954966|101033524|FG000|STARTED|Overall Study||34||
48288249|NCT01954966|101033525|FG001|STARTED|Overall Study||32||
48288250|NCT01954966|101033524|FG000|Completed Week 1 of Intervention (Drug Assigned to Receive First)|Overall Study||30||
48288251|NCT01954966|101033525|FG001|Completed Week 1 of Intervention (Drug Assigned to Receive First)|Overall Study||30||
48288252|NCT01954966|101033524|FG000|Started Phase 2 After Washout Period (1-2 Week for Males, 1-3 Month for Females)|Overall Study||30||
48288253|NCT01954966|101033525|FG001|Started Phase 2 After Washout Period (1-2 Week for Males, 1-3 Month for Females)|Overall Study||30||
48581525|NCT00756236|101755908|FG001|STARTED|Overall Study||20||
48581526|NCT00756236|101755909|FG002|STARTED|Overall Study||20||
48581527|NCT00756236|101755907|FG000|COMPLETED|Overall Study||20||
48581528|NCT00756236|101755908|FG001|COMPLETED|Overall Study||20||
48581529|NCT00756236|101755909|FG002|COMPLETED|Overall Study||20||
48581530|NCT00756236|101755907|FG000|NOT COMPLETED|Overall Study||0||
48704651|NCT01280058|102064907|FG001|STARTED|Overall Study||37||
48704652|NCT01280058|102064906|FG000|COMPLETED|Overall Study||36||
48704653|NCT01280058|102064907|FG001|COMPLETED|Overall Study||37||
48704654|NCT01280058|102064906|FG000|NOT COMPLETED|Overall Study||0||
48704655|NCT01280058|102064907|FG001|NOT COMPLETED|Overall Study||0||
48704656|NCT02109432|102064908|FG000|STARTED|Overall Study||7||
48288254|NCT01954966|101033524|FG000|Completed Week 2 of Intervention (Drug Assigned to Receive Second)|Overall Study||24||
48288255|NCT01954966|101033525|FG001|Completed Week 2 of Intervention (Drug Assigned to Receive Second)|Overall Study||28||
48288256|NCT01954966|101033524|FG000|COMPLETED|Overall Study||24||
48288257|NCT01954966|101033525|FG001|COMPLETED|Overall Study||28||
48288258|NCT01954966|101033524|FG000|NOT COMPLETED|Overall Study||10||
48288259|NCT01954966|101033525|FG001|NOT COMPLETED|Overall Study||4||
48288260|NCT02988622|101033526|FG000|STARTED|Overall Study||100||
48288261|NCT02988622|101033526|FG000|COMPLETED|Overall Study||83||
48704657|NCT02109432|102064908|FG000|COMPLETED|Overall Study||6||
48704658|NCT02109432|102064908|FG000|NOT COMPLETED|Overall Study||1||
48704659|NCT00489424|102064909|FG000|STARTED|Overall Study||267||
48704660|NCT00489424|102064910|FG001|STARTED|Overall Study||264||
48704661|NCT00489424|102064911|FG002|STARTED|Overall Study||262||
48704662|NCT00489424|102064909|FG000|COMPLETED|Overall Study||263||
48704663|NCT00489424|102064910|FG001|COMPLETED|Overall Study||259||
48704664|NCT00489424|102064911|FG002|COMPLETED|Overall Study||257||
48288262|NCT02988622|101033526|FG000|NOT COMPLETED|Overall Study||17||
48288263|NCT01236365|101033527|FG000|STARTED|Overall Study||21||
48288264|NCT01236365|101033528|FG001|STARTED|Overall Study||21||
48288265|NCT01236365|101033527|FG000|COMPLETED|Overall Study||19||
48288266|NCT01236365|101033528|FG001|COMPLETED|Overall Study||19||
48288267|NCT01236365|101033527|FG000|NOT COMPLETED|Overall Study||2||
48288268|NCT01236365|101033528|FG001|NOT COMPLETED|Overall Study||2||
48288269|NCT00252577|101033529|FG000|STARTED|Overall Study||130||
48288270|NCT00252577|101033529|FG000|COMPLETED|Overall Study||110||
48581531|NCT00756236|101755908|FG001|NOT COMPLETED|Overall Study||0||
48581532|NCT00756236|101755909|FG002|NOT COMPLETED|Overall Study||0||
48581533|NCT03831360|101755910|FG000|STARTED|Overall Study||15||
48581534|NCT03831360|101755911|FG001|STARTED|Overall Study||15||
48704665|NCT00489424|102064909|FG000|NOT COMPLETED|Overall Study||4||
48704666|NCT00489424|102064910|FG001|NOT COMPLETED|Overall Study||5||
48704667|NCT00489424|102064911|FG002|NOT COMPLETED|Overall Study||5||
48704668|NCT03828422|102064912|FG000|STARTED|Overall Study||40||
48704669|NCT03828422|102064913|FG001|STARTED|Overall Study||42||
48704670|NCT03828422|102064912|FG000|COMPLETED|Overall Study||36||
48704671|NCT03828422|102064913|FG001|COMPLETED|Overall Study||38||
48704672|NCT03828422|102064912|FG000|NOT COMPLETED|Overall Study||4||
48704673|NCT03828422|102064913|FG001|NOT COMPLETED|Overall Study||4||
48704674|NCT02918396|102064914|FG000|STARTED|Overall Study||2||
48704675|NCT02918396|102064915|FG001|STARTED|Overall Study||1||
48288271|NCT00252577|101033529|FG000|NOT COMPLETED|Overall Study||20||
48288272|NCT03241225|101033530|FG000|STARTED|Overall Study||24||
48581535|NCT03831360|101755910|FG000|COMPLETED|Overall Study||12||
48581536|NCT03831360|101755911|FG001|COMPLETED|Overall Study||14||
48704676|NCT02918396|102064916|FG002|STARTED|Overall Study||2||
48704677|NCT02918396|102064914|FG000|COMPLETED|Overall Study||2||
48704678|NCT02918396|102064915|FG001|COMPLETED|Overall Study||1||
48288273|NCT03241225|101033531|FG001|STARTED|Overall Study||16||
48288274|NCT03241225|101033530|FG000|COMPLETED|Overall Study||17||
48288275|NCT03241225|101033531|FG001|COMPLETED|Overall Study||14||
48288276|NCT03241225|101033530|FG000|NOT COMPLETED|Overall Study||7||
48581537|NCT03831360|101755910|FG000|NOT COMPLETED|Overall Study||3||
48581538|NCT03831360|101755911|FG001|NOT COMPLETED|Overall Study||1||
48581539|NCT01866657|101755912|FG000|STARTED|Overall Study||38||
48581540|NCT01866657|101755913|FG001|STARTED|Overall Study||36||
48581541|NCT01866657|101755912|FG000|COMPLETED|Overall Study||36||
48581542|NCT01866657|101755913|FG001|COMPLETED|Overall Study||36||
48581543|NCT01866657|101755912|FG000|NOT COMPLETED|Overall Study||2||
48581544|NCT01866657|101755913|FG001|NOT COMPLETED|Overall Study||0||
48581545|NCT00675428|101755914|FG000|STARTED|Overall Study||3||
48581546|NCT00675428|101755915|FG001|STARTED|Overall Study||3||
48581547|NCT00675428|101755914|FG000|COMPLETED|Overall Study||0||
48581548|NCT00675428|101755915|FG001|COMPLETED|Overall Study||0||
48581549|NCT00675428|101755914|FG000|NOT COMPLETED|Overall Study||3||
48288277|NCT03241225|101033531|FG001|NOT COMPLETED|Overall Study||2||
48288278|NCT02002650|101033532|FG000|STARTED|Overall Study||1297||
48704679|NCT02918396|102064916|FG002|COMPLETED|Overall Study||2||
48704680|NCT02918396|102064914|FG000|NOT COMPLETED|Overall Study||0||
48581550|NCT00675428|101755915|FG001|NOT COMPLETED|Overall Study||3||
48704681|NCT02918396|102064915|FG001|NOT COMPLETED|Overall Study||0||
48704682|NCT02918396|102064916|FG002|NOT COMPLETED|Overall Study||0||
48704683|NCT03457142|102064917|FG000|STARTED|Overall Study||15||
48704684|NCT03457142|102064917|FG000|COMPLETED|Overall Study||14||
48704685|NCT03457142|102064917|FG000|NOT COMPLETED|Overall Study||1||
48704686|NCT00201448|102064918|FG000|STARTED|Overall Study||42||
48704687|NCT00201448|102064919|FG001|STARTED|Overall Study||40||
48704688|NCT00201448|102064918|FG000|COMPLETED|Overall Study||42||
48704689|NCT00201448|102064919|FG001|COMPLETED|Overall Study||40||
48704690|NCT00201448|102064918|FG000|NOT COMPLETED|Overall Study||0||
48704691|NCT00201448|102064919|FG001|NOT COMPLETED|Overall Study||0||
48704692|NCT01774097|102064920|FG000|STARTED|Overall Study||40||
48288279|NCT02002650|101033533|FG001|STARTED|Overall Study||1303||
48288280|NCT02002650|101033532|FG000|COMPLETED|Overall Study||1297||
48288281|NCT02002650|101033533|FG001|COMPLETED|Overall Study||1303||
48288282|NCT02002650|101033532|FG000|NOT COMPLETED|Overall Study||0||
48288283|NCT02002650|101033533|FG001|NOT COMPLETED|Overall Study||0||
48288284|NCT01336803|101033534|FG000|STARTED|Overall Study||21||
48288285|NCT01336803|101033534|FG000|Bone Sarcoma|Overall Study||10||
48288286|NCT01336803|101033534|FG000|Osteomyelitis|Overall Study||4||
48288287|NCT01336803|101033534|FG000|Lymphoma|Overall Study||7||
48288288|NCT01336803|101033534|FG000|COMPLETED|Overall Study||21||
48288289|NCT01336803|101033534|FG000|NOT COMPLETED|Overall Study||0||
48288290|NCT01014533|101033535|FG000|STARTED|Overall Study||29||
48288291|NCT01014533|101033536|FG001|STARTED|Overall Study||30||
48288292|NCT01014533|101033535|FG000|COMPLETED|Overall Study||24||
48288293|NCT01014533|101033536|FG001|COMPLETED|Overall Study||25||
48288294|NCT01014533|101033535|FG000|NOT COMPLETED|Overall Study||5||
48581551|NCT02778074|101755916|FG000|STARTED|Overall Study||72||
48581552|NCT02778074|101755917|FG001|STARTED|Overall Study||72||
48581553|NCT02778074|101755916|FG000|COMPLETED|Overall Study||65||
48581554|NCT02778074|101755917|FG001|COMPLETED|Overall Study||62||
48581555|NCT02778074|101755916|FG000|NOT COMPLETED|Overall Study||7||
48581556|NCT02778074|101755917|FG001|NOT COMPLETED|Overall Study||10||
48581557|NCT02137850|101755918|FG000|STARTED|Main Phase: Pre-Prophylaxis||55||
48581558|NCT02137850|101755919|FG001|STARTED|Main Phase: Pre-Prophylaxis||0||
48581559|NCT02137850|101755920|FG002|STARTED|Main Phase: Pre-Prophylaxis||0||
48581560|NCT02137850|101755918|FG000|COMPLETED|Main Phase: Pre-Prophylaxis||44||
48581561|NCT02137850|101755919|FG001|COMPLETED|Main Phase: Pre-Prophylaxis||0||
48581562|NCT02137850|101755920|FG002|COMPLETED|Main Phase: Pre-Prophylaxis||0||
48581563|NCT02137850|101755918|FG000|NOT COMPLETED|Main Phase: Pre-Prophylaxis||11||
48581564|NCT02137850|101755919|FG001|NOT COMPLETED|Main Phase: Pre-Prophylaxis||0||
48581565|NCT02137850|101755920|FG002|NOT COMPLETED|Main Phase: Pre-Prophylaxis||0||
48581566|NCT02137850|101755918|FG000|STARTED|Main Phase: Prophylaxis||0||
48704693|NCT01774097|102064921|FG001|STARTED|Overall Study||42||
48704694|NCT01774097|102064920|FG000|COMPLETED|Overall Study||38||
48704695|NCT01774097|102064921|FG001|COMPLETED|Overall Study||40||
48288295|NCT01014533|101033536|FG001|NOT COMPLETED|Overall Study||5||
48288296|NCT02924064|101033537|FG000|STARTED|Overall Study||123||
48288297|NCT02924064|101033538|FG001|STARTED|Overall Study||124||
48288298|NCT02924064|101033537|FG000|FAS|Overall Study||122||
48288299|NCT02924064|101033538|FG001|FAS|Overall Study||124||
48400703|NCT00928512|101313603|FG004|Not Reassigned at Week 20 (Responders)|Overall Study||0||
48400704|NCT00928512|101313599|FG000|New Groups After Reassignment|Overall Study||60||
48400705|NCT00928512|101313600|FG001|New Groups After Reassignment|Overall Study||115||
48400706|NCT00928512|101313601|FG002|New Groups After Reassignment|Overall Study||23||
48400707|NCT00928512|101313602|FG003|New Groups After Reassignment|Overall Study||18||
48400708|NCT00928512|101313603|FG004|New Groups After Reassignment|Overall Study||0||
48400709|NCT00928512|101313599|FG000|Completed Week 16|Overall Study||38||
48400710|NCT00928512|101313600|FG001|Completed Week 16|Overall Study||43||
48400711|NCT00928512|101313601|FG002|Completed Week 16|Overall Study||47||
48400712|NCT00928512|101313602|FG003|Completed Week 16|Overall Study||48||
48400713|NCT00928512|101313603|FG004|Completed Week 16|Overall Study||45||
48400714|NCT00928512|101313599|FG000|Entered/Continued to Week 20 (All)|Overall Study||37||
48400715|NCT00928512|101313600|FG001|Entered/Continued to Week 20 (All)|Overall Study||43||
48400716|NCT00928512|101313601|FG002|Entered/Continued to Week 20 (All)|Overall Study||46||
48581567|NCT02137850|101755919|FG001|STARTED|Main Phase: Prophylaxis||69||
48581568|NCT02137850|101755920|FG002|STARTED|Main Phase: Prophylaxis||0||
48288300|NCT02924064|101033537|FG000|COMPLETED|Overall Study||99||
48288301|NCT02924064|101033538|FG001|COMPLETED|Overall Study||81||
48288302|NCT02924064|101033537|FG000|NOT COMPLETED|Overall Study||24||
48288303|NCT02924064|101033538|FG001|NOT COMPLETED|Overall Study||43||
48288304|NCT01465347|101033539|FG000|STARTED|Overall Study||3||
48288305|NCT01465347|101033540|FG001|STARTED|Overall Study||56||
48288306|NCT01465347|101033539|FG000|COMPLETED|Overall Study||2||
48288307|NCT01465347|101033540|FG001|COMPLETED|Overall Study||53||
48288308|NCT01465347|101033539|FG000|NOT COMPLETED|Overall Study||1||
48288309|NCT01465347|101033540|FG001|NOT COMPLETED|Overall Study||3||
48288310|NCT01103362|101033541|FG000|STARTED|Overall Study||596||
48400717|NCT00928512|101313602|FG003|Entered/Continued to Week 20 (All)|Overall Study||45||
48400718|NCT00928512|101313603|FG004|Entered/Continued to Week 20 (All)|Overall Study||45||
48400719|NCT00928512|101313599|FG000|COMPLETED|Overall Study||31||
48400720|NCT00928512|101313600|FG001|COMPLETED|Overall Study||37||
48400721|NCT00928512|101313601|FG002|COMPLETED|Overall Study||38||
48400722|NCT00928512|101313602|FG003|COMPLETED|Overall Study||33||
48400723|NCT00928512|101313603|FG004|COMPLETED|Overall Study||35||
48400724|NCT00928512|101313599|FG000|NOT COMPLETED|Overall Study||10||
48400725|NCT00928512|101313600|FG001|NOT COMPLETED|Overall Study||6||
48400726|NCT00928512|101313601|FG002|NOT COMPLETED|Overall Study||11||
48400727|NCT00928512|101313602|FG003|NOT COMPLETED|Overall Study||21||
48400728|NCT00928512|101313603|FG004|NOT COMPLETED|Overall Study||15||
48400729|NCT03960658|101313604|FG000|STARTED|Overall Study||12||
48400730|NCT03960658|101313604|FG000|COMPLETED|Overall Study||10||
48400731|NCT03960658|101313604|FG000|NOT COMPLETED|Overall Study||2||
48400732|NCT00323427|101313605|FG000|STARTED|Overall Study||69||
48400733|NCT00323427|101313606|FG001|STARTED|Overall Study||66||
48400734|NCT00323427|101313605|FG000|COMPLETED|Overall Study||38||
48400735|NCT00323427|101313606|FG001|COMPLETED|Overall Study||43||
48400736|NCT00323427|101313605|FG000|NOT COMPLETED|Overall Study||31||
48400737|NCT00323427|101313606|FG001|NOT COMPLETED|Overall Study||23||
48400738|NCT02421146|101313607|FG000|STARTED|Overall Study||2||
48400739|NCT02421146|101313608|FG001|STARTED|Overall Study||4||
48400740|NCT02421146|101313609|FG002|STARTED|Overall Study||3||
48400741|NCT02421146|101313610|FG003|STARTED|Overall Study||3||
48400742|NCT02421146|101313607|FG000|COMPLETED|Overall Study||2||
48400743|NCT02421146|101313608|FG001|COMPLETED|Overall Study||4||
48400744|NCT02421146|101313609|FG002|COMPLETED|Overall Study||3||
48400745|NCT02421146|101313610|FG003|COMPLETED|Overall Study||3||
48400746|NCT02421146|101313607|FG000|NOT COMPLETED|Overall Study||0||
48400747|NCT02421146|101313608|FG001|NOT COMPLETED|Overall Study||0||
48400748|NCT02421146|101313609|FG002|NOT COMPLETED|Overall Study||0||
48400749|NCT02421146|101313610|FG003|NOT COMPLETED|Overall Study||0||
48400750|NCT04716010|101313611|FG000|STARTED|Overall Study||1039||
48400751|NCT04716010|101313612|FG001|STARTED|Overall Study||1040||
48400752|NCT04716010|101313613|FG002|STARTED|Overall Study||1039||
48400753|NCT04716010|101313614|FG003|STARTED|Overall Study||1042||
48400754|NCT04716010|101313611|FG000|COMPLETED|Overall Study||887||
48400755|NCT04716010|101313612|FG001|COMPLETED|Overall Study||891||
48400756|NCT04716010|101313613|FG002|COMPLETED|Overall Study||874||
48400757|NCT04716010|101313614|FG003|COMPLETED|Overall Study||866||
48400758|NCT04716010|101313611|FG000|NOT COMPLETED|Overall Study||152||
48400759|NCT04716010|101313612|FG001|NOT COMPLETED|Overall Study||149||
48400760|NCT04716010|101313613|FG002|NOT COMPLETED|Overall Study||165||
48400761|NCT04716010|101313614|FG003|NOT COMPLETED|Overall Study||176||
48400762|NCT02820038|101313615|FG000|STARTED|Overall Study||78|Numbers are those who completed baseline data collection and given access to intervention materials|
48400763|NCT02820038|101313616|FG001|STARTED|Overall Study||77|Numbers are those who completed baseline data collection and given access to intervention materials|
48581569|NCT02137850|101755918|FG000|COMPLETED|Main Phase: Prophylaxis||0||
48581570|NCT02137850|101755919|FG001|COMPLETED|Main Phase: Prophylaxis||55||
48288311|NCT01103362|101033541|FG000|COMPLETED|Overall Study||0||
48288312|NCT01103362|101033541|FG000|NOT COMPLETED|Overall Study||596||
48288313|NCT02367820|101033542|FG000|STARTED|Overall Study||638||
48288314|NCT02367820|101033542|FG000|COMPLETED|Overall Study||402||
48581571|NCT02137850|101755920|FG002|COMPLETED|Main Phase: Prophylaxis||0||
48581572|NCT02137850|101755918|FG000|NOT COMPLETED|Main Phase: Prophylaxis||0||
48581573|NCT02137850|101755919|FG001|NOT COMPLETED|Main Phase: Prophylaxis||14||
48581574|NCT02137850|101755920|FG002|NOT COMPLETED|Main Phase: Prophylaxis||0||
48581575|NCT02137850|101755918|FG000|STARTED|Immune Tolerance Induction||0||
48581576|NCT02137850|101755919|FG001|STARTED|Immune Tolerance Induction||0||
48581577|NCT02137850|101755920|FG002|STARTED|Immune Tolerance Induction||8||
48581578|NCT02137850|101755918|FG000|COMPLETED|Immune Tolerance Induction||0||
48581579|NCT02137850|101755919|FG001|COMPLETED|Immune Tolerance Induction||0||
48581580|NCT02137850|101755920|FG002|COMPLETED|Immune Tolerance Induction||4||
48581581|NCT02137850|101755918|FG000|NOT COMPLETED|Immune Tolerance Induction||0||
48581582|NCT02137850|101755919|FG001|NOT COMPLETED|Immune Tolerance Induction||0||
48581583|NCT02137850|101755920|FG002|NOT COMPLETED|Immune Tolerance Induction||4||
48581584|NCT02137850|101755918|FG000|STARTED|Extension Phase: Prophylaxis||0||
48581585|NCT02137850|101755919|FG001|STARTED|Extension Phase: Prophylaxis||55||
48581586|NCT02137850|101755920|FG002|STARTED|Extension Phase: Prophylaxis||0||
48581587|NCT02137850|101755918|FG000|COMPLETED|Extension Phase: Prophylaxis||0||
48581588|NCT02137850|101755919|FG001|COMPLETED|Extension Phase: Prophylaxis||49||
48581589|NCT02137850|101755920|FG002|COMPLETED|Extension Phase: Prophylaxis||0||
48581590|NCT02137850|101755918|FG000|NOT COMPLETED|Extension Phase: Prophylaxis||0||
48581591|NCT02137850|101755919|FG001|NOT COMPLETED|Extension Phase: Prophylaxis||6||
48581592|NCT02137850|101755920|FG002|NOT COMPLETED|Extension Phase: Prophylaxis||0||
48581593|NCT02697890|101755921|FG000|STARTED|Overall Study||14||
48581594|NCT02697890|101755922|FG001|STARTED|Overall Study||14||
48581595|NCT02697890|101755921|FG000|COMPLETED|Overall Study||14||
48581596|NCT02697890|101755922|FG001|COMPLETED|Overall Study||14||
48581597|NCT02697890|101755921|FG000|NOT COMPLETED|Overall Study||0||
48581598|NCT02697890|101755922|FG001|NOT COMPLETED|Overall Study||0||
48581599|NCT02073448|101755923|FG000|STARTED|Overall Study||101||
48581600|NCT02073448|101755924|FG001|STARTED|Overall Study||212||
48581601|NCT02073448|101755925|FG002|STARTED|Overall Study||104||
48581602|NCT02073448|101755923|FG000|COMPLETED|Overall Study||99||
48581603|NCT02073448|101755924|FG001|COMPLETED|Overall Study||200||
48581604|NCT02073448|101755925|FG002|COMPLETED|Overall Study||99||
48288315|NCT02367820|101033542|FG000|NOT COMPLETED|Overall Study||236||
48288316|NCT01642251|101033543|FG000|STARTED|Overall Study||3||
48288317|NCT01642251|101033544|FG001|STARTED|Overall Study||6||
48288318|NCT01642251|101033545|FG002|STARTED|Overall Study||75||
48288319|NCT01642251|101033546|FG003|STARTED|Overall Study||72||
48288320|NCT01642251|101033543|FG000|Started Protocol Therapy|Overall Study||3||
48581605|NCT02073448|101755923|FG000|NOT COMPLETED|Overall Study||2||
48581606|NCT02073448|101755924|FG001|NOT COMPLETED|Overall Study||12||
48581607|NCT02073448|101755925|FG002|NOT COMPLETED|Overall Study||5||
48581608|NCT03613909|101755926|FG000|STARTED|First Take Home Use of CP950||23||
48581609|NCT03613909|101755926|FG000|COMPLETED|First Take Home Use of CP950||20||
48581610|NCT03613909|101755926|FG000|NOT COMPLETED|First Take Home Use of CP950||3||
48581611|NCT03613909|101755926|FG000|STARTED|First In Booth Testing of CP950||20||
48581612|NCT03613909|101755926|FG000|COMPLETED|First In Booth Testing of CP950||20||
48581613|NCT03613909|101755926|FG000|NOT COMPLETED|First In Booth Testing of CP950||0||
48581614|NCT03613909|101755926|FG000|STARTED|Second Take Home Use of CP950||20||
48581615|NCT03613909|101755926|FG000|COMPLETED|Second Take Home Use of CP950||20||
48581616|NCT03613909|101755926|FG000|NOT COMPLETED|Second Take Home Use of CP950||0||
48581617|NCT03613909|101755926|FG000|STARTED|Second In Booth Testing of CP950||20||
48581618|NCT03613909|101755926|FG000|COMPLETED|Second In Booth Testing of CP950||20||
48581619|NCT03613909|101755926|FG000|NOT COMPLETED|Second In Booth Testing of CP950||0||
48581620|NCT04964544|101755927|FG000|STARTED|Overall Study||1196||
48581621|NCT04964544|101755927|FG000|Had an Ask a Doctor Before Use Warning Identified by the CMOG at Final Use Visit|Overall Study||25||
48581622|NCT04964544|101755927|FG000|Had a do Not Use Warning Identified by the CMOG at Final Use Visit|Overall Study||59||
48592823|NCT00767039|101783188|FG001|COMPLETED|Overall Study||23||
48288321|NCT01642251|101033544|FG001|Started Protocol Therapy|Overall Study||6||
48581623|NCT04964544|101755927|FG000|Participants for Whom CMOG Identified a Stop Use Warning at Final Use Assessment|Overall Study||2||
48581624|NCT04964544|101755927|FG000|COMPLETED|Overall Study||1154||
48581625|NCT04964544|101755927|FG000|NOT COMPLETED|Overall Study||42||
48581626|NCT02738255|101755928|FG000|STARTED|Overall Study||11||
48581627|NCT02738255|101755929|FG001|STARTED|Overall Study||15||
48581628|NCT02738255|101755928|FG000|COMPLETED|Overall Study||11||
48288322|NCT01642251|101033545|FG002|Started Protocol Therapy|Overall Study||66||
48288323|NCT01642251|101033546|FG003|Started Protocol Therapy|Overall Study||66||
48581629|NCT02738255|101755929|FG001|COMPLETED|Overall Study||14||
48581630|NCT02738255|101755928|FG000|NOT COMPLETED|Overall Study||0||
48288324|NCT01642251|101033543|FG000|Eligible|Overall Study||3||
48288325|NCT01642251|101033544|FG001|Eligible|Overall Study||6||
48288326|NCT01642251|101033545|FG002|Eligible|Overall Study||72||
48581631|NCT02738255|101755929|FG001|NOT COMPLETED|Overall Study||1||
48581632|NCT02251106|101755930|FG000|STARTED|Overall Study||19||
48581633|NCT02251106|101755931|FG001|STARTED|Overall Study||18||
48581634|NCT02251106|101755932|FG002|STARTED|Overall Study||17||
48581635|NCT02251106|101755930|FG000|COMPLETED|Overall Study||19||
48581636|NCT02251106|101755931|FG001|COMPLETED|Overall Study||18||
48704696|NCT01774097|102064920|FG000|NOT COMPLETED|Overall Study||2||
48704697|NCT01774097|102064921|FG001|NOT COMPLETED|Overall Study||2||
48704698|NCT00570037|102064922|FG000|STARTED|Overall Study||238||
48704699|NCT00570037|102064923|FG001|STARTED|Overall Study||306||
48704700|NCT00570037|102064922|FG000|COMPLETED|Overall Study||194||
48704701|NCT00570037|102064923|FG001|COMPLETED|Overall Study||237||
48704702|NCT00570037|102064922|FG000|NOT COMPLETED|Overall Study||44||
48704703|NCT00570037|102064923|FG001|NOT COMPLETED|Overall Study||69||
48704704|NCT02596958|102064924|FG000|STARTED|Overall Study||996||
48704705|NCT02596958|102064924|FG000|COMPLETED|Overall Study||0||
48704706|NCT02596958|102064924|FG000|NOT COMPLETED|Overall Study||996||
48704707|NCT03260894|102064925|FG000|STARTED|Overall Study||64||
48704708|NCT03260894|102064926|FG001|STARTED|Overall Study||65||
48704709|NCT03260894|102064925|FG000|Intention-to-Treat (ITT)|Overall Study||64||
48704710|NCT03260894|102064926|FG001|Intention-to-Treat (ITT)|Overall Study||65||
48704711|NCT03260894|102064925|FG000|All Subjects as Treated (ASaT)|Overall Study||64||
48704712|NCT03260894|102064926|FG001|All Subjects as Treated (ASaT)|Overall Study||63||
48704713|NCT03260894|102064925|FG000|COMPLETED|Overall Study||18||
48288327|NCT01642251|101033546|FG003|Eligible|Overall Study||69||
48288328|NCT01642251|101033543|FG000|Eligible and Treated|Overall Study||3||
48288329|NCT01642251|101033544|FG001|Eligible and Treated|Overall Study||6||
48288330|NCT01642251|101033545|FG002|Eligible and Treated|Overall Study||64||
48288331|NCT01642251|101033546|FG003|Eligible and Treated|Overall Study||64||
48288332|NCT01642251|101033543|FG000|COMPLETED|Overall Study||3||
48288333|NCT01642251|101033544|FG001|COMPLETED|Overall Study||6||
48288334|NCT01642251|101033545|FG002|COMPLETED|Overall Study||53||
48288335|NCT01642251|101033546|FG003|COMPLETED|Overall Study||49||
48288336|NCT01642251|101033543|FG000|NOT COMPLETED|Overall Study||0||
48288337|NCT01642251|101033544|FG001|NOT COMPLETED|Overall Study||0||
48288338|NCT01642251|101033545|FG002|NOT COMPLETED|Overall Study||22||
48288339|NCT01642251|101033546|FG003|NOT COMPLETED|Overall Study||23||
48288340|NCT01076192|101033547|FG000|STARTED|Overall Study||547||
48288341|NCT01076192|101033547|FG000|COMPLETED|Overall Study||350||
48288342|NCT01076192|101033547|FG000|NOT COMPLETED|Overall Study||197||
48288343|NCT00978627|101033548|FG000|STARTED|Main: Week 0 to 26 (NN5401-3594)||366||
48288344|NCT00978627|101033549|FG001|STARTED|Main: Week 0 to 26 (NN5401-3594)||182||
48288345|NCT00978627|101033548|FG000|Exposed|Main: Week 0 to 26 (NN5401-3594)||362||
48288346|NCT00978627|101033549|FG001|Exposed|Main: Week 0 to 26 (NN5401-3594)||180||
48288347|NCT00978627|101033548|FG000|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||320||
48704714|NCT03260894|102064926|FG001|COMPLETED|Overall Study||15||
48704715|NCT03260894|102064925|FG000|NOT COMPLETED|Overall Study||46||
48288348|NCT00978627|101033549|FG001|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||156||
48288349|NCT00978627|101033548|FG000|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||46||
48288350|NCT00978627|101033549|FG001|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||26||
48581637|NCT02251106|101755932|FG002|COMPLETED|Overall Study||17||
48581638|NCT02251106|101755930|FG000|NOT COMPLETED|Overall Study||0||
48581639|NCT02251106|101755931|FG001|NOT COMPLETED|Overall Study||0||
48704716|NCT03260894|102064926|FG001|NOT COMPLETED|Overall Study||50||
48704717|NCT00835640|102064927|FG000|STARTED|First Intervention||12||
48581640|NCT02251106|101755932|FG002|NOT COMPLETED|Overall Study||0||
48581641|NCT00287989|101755933|FG000|STARTED|Overall Study||28||
48581642|NCT00287989|101755934|FG001|STARTED|Overall Study||29||
48581643|NCT00287989|101755935|FG002|STARTED|Overall Study||29||
48581644|NCT00287989|101755933|FG000|COMPLETED|Overall Study||28||
48581645|NCT00287989|101755934|FG001|COMPLETED|Overall Study||29||
48581646|NCT00287989|101755935|FG002|COMPLETED|Overall Study||29||
48581647|NCT00287989|101755933|FG000|NOT COMPLETED|Overall Study||0||
48581648|NCT00287989|101755934|FG001|NOT COMPLETED|Overall Study||0||
48581649|NCT00287989|101755935|FG002|NOT COMPLETED|Overall Study||0||
48581650|NCT00833482|101755936|FG000|STARTED|Days 1-3||24||
48581651|NCT00833482|101755937|FG001|STARTED|Days 1-3||0||
48136626|NCT00971048|100661307|FG001|COMPLETED|Overall Study||31||
48136627|NCT00971048|100661308|FG002|COMPLETED|Overall Study||11||
48136628|NCT00971048|100661309|FG003|COMPLETED|Overall Study||11||
48136629|NCT00971048|100661306|FG000|NOT COMPLETED|Overall Study||1||
48136630|NCT00971048|100661307|FG001|NOT COMPLETED|Overall Study||2||
48136631|NCT00971048|100661308|FG002|NOT COMPLETED|Overall Study||1||
48136632|NCT00971048|100661309|FG003|NOT COMPLETED|Overall Study||2||
48136633|NCT01917526|100661310|FG000|STARTED|Overall Study||250||
48136634|NCT01917526|100661311|FG001|STARTED|Overall Study||250||
48136635|NCT01917526|100661310|FG000|COMPLETED|Overall Study||249||
48136636|NCT01917526|100661311|FG001|COMPLETED|Overall Study||249||
48136637|NCT01917526|100661310|FG000|NOT COMPLETED|Overall Study||1||
48136638|NCT01917526|100661311|FG001|NOT COMPLETED|Overall Study||1||
48136639|NCT03712917|100661312|FG000|STARTED|Overall Study||40||
48581652|NCT00833482|101755938|FG002|STARTED|Days 1-3||0||
48581653|NCT00833482|101755939|FG003|STARTED|Days 1-3||8||
48581654|NCT00833482|101755940|FG004|STARTED|Days 1-3||0||
48581655|NCT00833482|101755941|FG005|STARTED|Days 1-3||0||
48581656|NCT00833482|101755936|FG000|COMPLETED|Days 1-3||24||
48581657|NCT00833482|101755937|FG001|COMPLETED|Days 1-3||0||
48581658|NCT00833482|101755938|FG002|COMPLETED|Days 1-3||0||
48581659|NCT00833482|101755939|FG003|COMPLETED|Days 1-3||8||
48581660|NCT00833482|101755940|FG004|COMPLETED|Days 1-3||0||
48581661|NCT00833482|101755941|FG005|COMPLETED|Days 1-3||0||
48581662|NCT00833482|101755936|FG000|NOT COMPLETED|Days 1-3||0||
48136640|NCT03712917|100661313|FG001|STARTED|Overall Study||40||
48136641|NCT03712917|100661314|FG002|STARTED|Overall Study||40||
48136642|NCT03712917|100661312|FG000|COMPLETED|Overall Study||31||
48136643|NCT03712917|100661313|FG001|COMPLETED|Overall Study||32||
48136644|NCT03712917|100661314|FG002|COMPLETED|Overall Study||31||
48136645|NCT03712917|100661312|FG000|NOT COMPLETED|Overall Study||9||
48136646|NCT03712917|100661313|FG001|NOT COMPLETED|Overall Study||8||
48136647|NCT03712917|100661314|FG002|NOT COMPLETED|Overall Study||9||
48136648|NCT02180646|100661315|FG000|STARTED|First Intervention (7 Days)||6||
48136649|NCT02180646|100661316|FG001|STARTED|First Intervention (7 Days)||6||
48136650|NCT02180646|100661315|FG000|COMPLETED|First Intervention (7 Days)||6||
48136651|NCT02180646|100661316|FG001|COMPLETED|First Intervention (7 Days)||6||
48136652|NCT02180646|100661315|FG000|NOT COMPLETED|First Intervention (7 Days)||0||
48136653|NCT02180646|100661316|FG001|NOT COMPLETED|First Intervention (7 Days)||0||
48136654|NCT02180646|100661315|FG000|STARTED|Washout (7 Days)||6||
48136655|NCT02180646|100661316|FG001|STARTED|Washout (7 Days)||6||
48581663|NCT00833482|101755937|FG001|NOT COMPLETED|Days 1-3||0||
48581664|NCT00833482|101755938|FG002|NOT COMPLETED|Days 1-3||0||
48581665|NCT00833482|101755939|FG003|NOT COMPLETED|Days 1-3||0||
48581666|NCT00833482|101755940|FG004|NOT COMPLETED|Days 1-3||0||
48581667|NCT00833482|101755941|FG005|NOT COMPLETED|Days 1-3||0||
48581668|NCT00833482|101755936|FG000|STARTED|Days 11-20||0||
48136656|NCT02180646|100661315|FG000|COMPLETED|Washout (7 Days)||6||
48581669|NCT00833482|101755937|FG001|STARTED|Days 11-20||24||
48581670|NCT00833482|101755938|FG002|STARTED|Days 11-20||0||
48581671|NCT00833482|101755939|FG003|STARTED|Days 11-20||0||
48136657|NCT02180646|100661316|FG001|COMPLETED|Washout (7 Days)||6||
48581672|NCT00833482|101755940|FG004|STARTED|Days 11-20||0||
48581673|NCT00833482|101755941|FG005|STARTED|Days 11-20||8||
48581674|NCT00833482|101755936|FG000|COMPLETED|Days 11-20||0||
48581675|NCT00833482|101755937|FG001|COMPLETED|Days 11-20||21||
48581676|NCT00833482|101755938|FG002|COMPLETED|Days 11-20||0||
48136658|NCT02180646|100661315|FG000|NOT COMPLETED|Washout (7 Days)||0||
48136659|NCT02180646|100661316|FG001|NOT COMPLETED|Washout (7 Days)||0||
48136660|NCT02180646|100661315|FG000|STARTED|Second Intervention (7 Days)||6||
48136661|NCT02180646|100661316|FG001|STARTED|Second Intervention (7 Days)||6||
48136662|NCT02180646|100661315|FG000|COMPLETED|Second Intervention (7 Days)||6||
48136663|NCT02180646|100661316|FG001|COMPLETED|Second Intervention (7 Days)||6||
48136664|NCT02180646|100661315|FG000|NOT COMPLETED|Second Intervention (7 Days)||0||
48581677|NCT00833482|101755939|FG003|COMPLETED|Days 11-20||0||
48581678|NCT00833482|101755940|FG004|COMPLETED|Days 11-20||0||
48581679|NCT00833482|101755941|FG005|COMPLETED|Days 11-20||8||
48581680|NCT00833482|101755936|FG000|NOT COMPLETED|Days 11-20||0||
48581681|NCT00833482|101755937|FG001|NOT COMPLETED|Days 11-20||3||
48581682|NCT00833482|101755938|FG002|NOT COMPLETED|Days 11-20||0||
48581683|NCT00833482|101755939|FG003|NOT COMPLETED|Days 11-20||0||
48581684|NCT00833482|101755940|FG004|NOT COMPLETED|Days 11-20||0||
48581685|NCT00833482|101755941|FG005|NOT COMPLETED|Days 11-20||0||
48581686|NCT00833482|101755936|FG000|STARTED|Days 21-30||0||
48581687|NCT00833482|101755937|FG001|STARTED|Days 21-30||0||
48581688|NCT00833482|101755938|FG002|STARTED|Days 21-30||21||
48581689|NCT00833482|101755939|FG003|STARTED|Days 21-30||0||
48581690|NCT00833482|101755940|FG004|STARTED|Days 21-30||8||
48581691|NCT00833482|101755941|FG005|STARTED|Days 21-30||0||
48581692|NCT00833482|101755936|FG000|COMPLETED|Days 21-30||0||
48581693|NCT00833482|101755937|FG001|COMPLETED|Days 21-30||0||
48581694|NCT00833482|101755938|FG002|COMPLETED|Days 21-30||20||
48581695|NCT00833482|101755939|FG003|COMPLETED|Days 21-30||0||
48581696|NCT00833482|101755940|FG004|COMPLETED|Days 21-30||7||
48581697|NCT00833482|101755941|FG005|COMPLETED|Days 21-30||0||
48581698|NCT00833482|101755936|FG000|NOT COMPLETED|Days 21-30||0||
48581699|NCT00833482|101755937|FG001|NOT COMPLETED|Days 21-30||0||
48581700|NCT00833482|101755938|FG002|NOT COMPLETED|Days 21-30||1||
48581701|NCT00833482|101755939|FG003|NOT COMPLETED|Days 21-30||0||
48581702|NCT00833482|101755940|FG004|NOT COMPLETED|Days 21-30||1||
48581703|NCT00833482|101755941|FG005|NOT COMPLETED|Days 21-30||0||
48581704|NCT00926848|101755942|FG000|STARTED|Overall Study||34||
48581705|NCT00926848|101755943|FG001|STARTED|Overall Study||34||
48581706|NCT00926848|101755942|FG000|COMPLETED|Overall Study||34||
48581707|NCT00926848|101755943|FG001|COMPLETED|Overall Study||34||
48581708|NCT00926848|101755942|FG000|NOT COMPLETED|Overall Study||0||
48581709|NCT00926848|101755943|FG001|NOT COMPLETED|Overall Study||0||
48581710|NCT05250102|101755944|FG000|STARTED|Overall Study||23||
48581711|NCT05250102|101755944|FG000|COMPLETED|Overall Study||23||
48581712|NCT05250102|101755944|FG000|NOT COMPLETED|Overall Study||0||
48581713|NCT01883817|101755945|FG000|STARTED|Overall Study||14||
48581714|NCT01883817|101755946|FG001|STARTED|Overall Study||16||
48581715|NCT01883817|101755945|FG000|COMPLETED|Overall Study||10||
48581716|NCT01883817|101755946|FG001|COMPLETED|Overall Study||9||
48581717|NCT01883817|101755945|FG000|NOT COMPLETED|Overall Study||4||
48581718|NCT01883817|101755946|FG001|NOT COMPLETED|Overall Study||7||
48581719|NCT02537431|101755947|FG000|STARTED|Open-Label Period (Week 0 to Week 48)||14||
48581720|NCT02537431|101755947|FG000|COMPLETED|Open-Label Period (Week 0 to Week 48)||13||
48581721|NCT02537431|101755947|FG000|NOT COMPLETED|Open-Label Period (Week 0 to Week 48)||1||
48581722|NCT02537431|101755947|FG000|STARTED|Treatment Extension Period I||13||
48581723|NCT02537431|101755947|FG000|COMPLETED|Treatment Extension Period I||13||
48581724|NCT02537431|101755947|FG000|NOT COMPLETED|Treatment Extension Period I||0||
48581725|NCT02537431|101755947|FG000|STARTED|Treatment Extension Period II||8||
48581726|NCT02537431|101755947|FG000|COMPLETED|Treatment Extension Period II||8||
48581727|NCT02537431|101755947|FG000|NOT COMPLETED|Treatment Extension Period II||0||
48581728|NCT04310397|101755948|FG000|STARTED|Overall Study||4||
48581729|NCT04310397|101755948|FG000|COMPLETED|Overall Study||0||
48581730|NCT04310397|101755948|FG000|NOT COMPLETED|Overall Study||4||
48581731|NCT02162719|101755949|FG000|STARTED|Overall Study||62||
48581732|NCT02162719|101755950|FG001|STARTED|Overall Study||62||
48581733|NCT02162719|101755949|FG000|COMPLETED|Overall Study||0||
48581734|NCT02162719|101755950|FG001|COMPLETED|Overall Study||0||
48581735|NCT02162719|101755949|FG000|NOT COMPLETED|Overall Study||62||
48581736|NCT02162719|101755950|FG001|NOT COMPLETED|Overall Study||62||
48581737|NCT03362190|101755951|FG000|STARTED|Overall Study||10||
48581738|NCT03362190|101755952|FG001|STARTED|Overall Study||10||
48581739|NCT03362190|101755953|FG002|STARTED|Overall Study||22||
48581740|NCT03362190|101755954|FG003|STARTED|Overall Study||22||
48581741|NCT03362190|101755951|FG000|COMPLETED|Overall Study||10||
48581742|NCT03362190|101755952|FG001|COMPLETED|Overall Study||10||
48581743|NCT03362190|101755953|FG002|COMPLETED|Overall Study||22||
48581744|NCT03362190|101755954|FG003|COMPLETED|Overall Study||20||
48581745|NCT03362190|101755951|FG000|NOT COMPLETED|Overall Study||0||
48581746|NCT03362190|101755952|FG001|NOT COMPLETED|Overall Study||0||
48581747|NCT03362190|101755953|FG002|NOT COMPLETED|Overall Study||0||
48581748|NCT03362190|101755954|FG003|NOT COMPLETED|Overall Study||2||
48581749|NCT00823043|101755955|FG000|STARTED|Overall Study||64||
48581750|NCT00823043|101755956|FG001|STARTED|Overall Study||39||
48581751|NCT00823043|101755955|FG000|COMPLETED|Overall Study||64||
48581752|NCT00823043|101755956|FG001|COMPLETED|Overall Study||39||
48581753|NCT00823043|101755955|FG000|NOT COMPLETED|Overall Study||0||
48581754|NCT00823043|101755956|FG001|NOT COMPLETED|Overall Study||0||
48581755|NCT00489086|101755957|FG000|STARTED|Overall Study||36||
48581756|NCT00489086|101755957|FG000|Completed 18 Months|Overall Study||23||
48581757|NCT00489086|101755957|FG000|COMPLETED|Overall Study||13||
48581758|NCT00489086|101755957|FG000|NOT COMPLETED|Overall Study||23||
48581759|NCT02397122|101755958|FG000|STARTED|Overall Study||20||
48581760|NCT02397122|101755959|FG001|STARTED|Overall Study||20||
48581761|NCT02397122|101755958|FG000|COMPLETED|Overall Study||20||
48581762|NCT02397122|101755959|FG001|COMPLETED|Overall Study||20||
48581763|NCT02397122|101755958|FG000|NOT COMPLETED|Overall Study||0||
48581764|NCT02397122|101755959|FG001|NOT COMPLETED|Overall Study||0||
48581765|NCT03875274|101755960|FG000|STARTED|Overall Study||35||
48581766|NCT03875274|101755961|FG001|STARTED|Overall Study||35||
48581767|NCT03875274|101755960|FG000|COMPLETED|Overall Study||35||
48581768|NCT03875274|101755961|FG001|COMPLETED|Overall Study||35||
48581769|NCT03875274|101755960|FG000|NOT COMPLETED|Overall Study||0||
48581770|NCT03875274|101755961|FG001|NOT COMPLETED|Overall Study||0||
48581771|NCT02905981|101755962|FG000|STARTED|Overall Study||1||
48581772|NCT02905981|101755962|FG000|COMPLETED|Overall Study||0||
48581773|NCT02905981|101755962|FG000|NOT COMPLETED|Overall Study||1||
48581774|NCT03457116|101755963|FG000|STARTED|Overall Study||41||
48581775|NCT03457116|101755964|FG001|STARTED|Overall Study||29||
48581776|NCT03457116|101755963|FG000|COMPLETED|Overall Study||41||
48581777|NCT03457116|101755964|FG001|COMPLETED|Overall Study||29||
48581778|NCT03457116|101755963|FG000|NOT COMPLETED|Overall Study||0||
48581779|NCT03457116|101755964|FG001|NOT COMPLETED|Overall Study||0||
48581780|NCT03386253|101755965|FG000|STARTED|Overall Study||8||
48581781|NCT03386253|101755966|FG001|STARTED|Overall Study||8||
48581782|NCT03386253|101755965|FG000|Completed tDCS / Sham Sessions|Overall Study||7||
48581783|NCT03386253|101755966|FG001|Completed tDCS / Sham Sessions|Overall Study||8||
48581784|NCT03386253|101755965|FG000|COMPLETED|Overall Study||7|Completed 4 week follow-up session|
48581785|NCT03386253|101755966|FG001|COMPLETED|Overall Study||7|Completed 4 week follow-up session|
48581786|NCT03386253|101755965|FG000|NOT COMPLETED|Overall Study||1||
48581787|NCT03386253|101755966|FG001|NOT COMPLETED|Overall Study||1||
48581788|NCT03611777|101755967|FG000|STARTED|Overall Study||432||
48581789|NCT03611777|101755968|FG001|STARTED|Overall Study||469||
48581790|NCT03611777|101755967|FG000|COMPLETED|Overall Study||432||
48581791|NCT03611777|101755968|FG001|COMPLETED|Overall Study||469||
48581792|NCT03611777|101755967|FG000|NOT COMPLETED|Overall Study||0||
48581793|NCT03611777|101755968|FG001|NOT COMPLETED|Overall Study||0||
48581794|NCT02320058|101755969|FG000|STARTED|Overall Study||101||
48581795|NCT02320058|101755970|FG001|STARTED|Overall Study||18||
48581796|NCT02320058|101755969|FG000|COMPLETED|Overall Study||59||
48581797|NCT02320058|101755970|FG001|COMPLETED|Overall Study||5||
48581798|NCT02320058|101755969|FG000|NOT COMPLETED|Overall Study||42||
48581799|NCT02320058|101755970|FG001|NOT COMPLETED|Overall Study||13||
48581800|NCT03190915|101755971|FG000|STARTED|Overall Study||10||
48581801|NCT03190915|101755971|FG000|COMPLETED|Overall Study||3||
48581802|NCT03190915|101755971|FG000|NOT COMPLETED|Overall Study||7||
48581803|NCT01758731|101755972|FG000|STARTED|Overall Study||17||
48581804|NCT01758731|101755972|FG000|COMPLETED|Overall Study||16||
48581805|NCT01758731|101755972|FG000|NOT COMPLETED|Overall Study||1||
48581806|NCT00954512|101755973|FG000|STARTED|Overall Study||2||
48581807|NCT00954512|101755974|FG001|STARTED|Overall Study||3||
48581808|NCT00954512|101755975|FG002|STARTED|Overall Study||0||
48581809|NCT00954512|101755976|FG003|STARTED|Overall Study||2||
48581810|NCT00954512|101755977|FG004|STARTED|Overall Study||4||
48581811|NCT00954512|101755978|FG005|STARTED|Overall Study||4||
48581812|NCT00954512|101755973|FG000|COMPLETED|Overall Study||0||
48581813|NCT00954512|101755974|FG001|COMPLETED|Overall Study||0||
48581814|NCT00954512|101755975|FG002|COMPLETED|Overall Study||0||
48581815|NCT00954512|101755976|FG003|COMPLETED|Overall Study||0||
48581816|NCT00954512|101755977|FG004|COMPLETED|Overall Study||0||
48581817|NCT00954512|101755978|FG005|COMPLETED|Overall Study||0||
48581818|NCT00954512|101755973|FG000|NOT COMPLETED|Overall Study||2||
48581819|NCT00954512|101755974|FG001|NOT COMPLETED|Overall Study||3||
48581820|NCT00954512|101755975|FG002|NOT COMPLETED|Overall Study||0||
48581821|NCT00954512|101755976|FG003|NOT COMPLETED|Overall Study||2||
48581822|NCT00954512|101755977|FG004|NOT COMPLETED|Overall Study||4||
48581823|NCT00954512|101755978|FG005|NOT COMPLETED|Overall Study||4||
48581824|NCT00623935|101755979|FG000|STARTED|Overall Study||56||
48581825|NCT00623935|101755979|FG000|COMPLETED|Overall Study||54||
48581826|NCT00623935|101755979|FG000|NOT COMPLETED|Overall Study||2||
48581827|NCT00089778|101755980|FG000|STARTED|Overall Study||2||
48581828|NCT00089778|101755981|FG001|STARTED|Overall Study||1||
48581829|NCT00089778|101755982|FG002|STARTED|Overall Study||8||
48581830|NCT00089778|101755980|FG000|COMPLETED|Overall Study||2||
48581831|NCT00089778|101755981|FG001|COMPLETED|Overall Study||1||
48581832|NCT00089778|101755982|FG002|COMPLETED|Overall Study||7||
48581833|NCT00089778|101755980|FG000|NOT COMPLETED|Overall Study||0||
48581834|NCT00089778|101755981|FG001|NOT COMPLETED|Overall Study||0||
48581835|NCT00089778|101755982|FG002|NOT COMPLETED|Overall Study||1||
48581836|NCT01860040|101755983|FG000|STARTED|Overall Study||1||
48581837|NCT01860040|101755984|FG001|STARTED|Overall Study||0||
48581838|NCT01860040|101755983|FG000|COMPLETED|Overall Study||0||
48581839|NCT01860040|101755984|FG001|COMPLETED|Overall Study||0||
48581840|NCT01860040|101755983|FG000|NOT COMPLETED|Overall Study||1||
48581841|NCT01860040|101755984|FG001|NOT COMPLETED|Overall Study||0||
48581842|NCT05481125|101755985|FG000|STARTED|Overall Study||89|Randomized with attempted implantation|
48581843|NCT05481125|101755986|FG001|STARTED|Overall Study||86|Randomized with attempted implantation|
48581844|NCT05481125|101755985|FG000|First Eye Implanted|Overall Study||89||
48581845|NCT05481125|101755986|FG001|First Eye Implanted|Overall Study||86||
48581846|NCT05481125|101755985|FG000|Second Eye Implanted|Overall Study||86||
48581847|NCT05481125|101755986|FG001|Second Eye Implanted|Overall Study||84||
48581848|NCT05481125|101755985|FG000|COMPLETED|Overall Study||88||
48581849|NCT05481125|101755986|FG001|COMPLETED|Overall Study||84||
48581850|NCT05481125|101755985|FG000|NOT COMPLETED|Overall Study||1||
48581851|NCT05481125|101755986|FG001|NOT COMPLETED|Overall Study||2||
48581852|NCT01769508|101755987|FG000|STARTED|Overall Study||12||
48581853|NCT01769508|101755987|FG000|COMPLETED|Overall Study||6||
48581854|NCT01769508|101755987|FG000|NOT COMPLETED|Overall Study||6||
48581855|NCT02793674|101755988|FG000|STARTED|Overall Study||9||
48581856|NCT02793674|101755989|FG001|STARTED|Overall Study||12||
48581857|NCT02793674|101755988|FG000|COMPLETED|Overall Study||9||
48581858|NCT02793674|101755989|FG001|COMPLETED|Overall Study||12||
48581859|NCT02793674|101755988|FG000|NOT COMPLETED|Overall Study||0||
48581860|NCT02793674|101755989|FG001|NOT COMPLETED|Overall Study||0||
48581861|NCT03689374|101755990|FG000|STARTED|Run-in Period (12 Weeks)||2274||
48581862|NCT03689374|101755991|FG001|STARTED|Run-in Period (12 Weeks)||0||
48581863|NCT03689374|101755992|FG002|STARTED|Run-in Period (12 Weeks)||0||
48581864|NCT03689374|101755990|FG000|COMPLETED|Run-in Period (12 Weeks)||1748||
48581865|NCT03689374|101755991|FG001|COMPLETED|Run-in Period (12 Weeks)||0||
48581866|NCT03689374|101755992|FG002|COMPLETED|Run-in Period (12 Weeks)||0||
48581867|NCT03689374|101755990|FG000|NOT COMPLETED|Run-in Period (12 Weeks)||526||
48581868|NCT03689374|101755991|FG001|NOT COMPLETED|Run-in Period (12 Weeks)||0||
48581869|NCT03689374|101755992|FG002|NOT COMPLETED|Run-in Period (12 Weeks)||0||
48581870|NCT03689374|101755990|FG000|STARTED|Treatment Period (Week 0 to 52)||0||
48581871|NCT03689374|101755991|FG001|STARTED|Treatment Period (Week 0 to 52)||874||
48581872|NCT03689374|101755992|FG002|STARTED|Treatment Period (Week 0 to 52)||874||
48581873|NCT03689374|101755990|FG000|Treated|Treatment Period (Week 0 to 52)||0||
48581874|NCT03689374|101755991|FG001|Treated|Treatment Period (Week 0 to 52)||874||
48581875|NCT03689374|101755992|FG002|Treated|Treatment Period (Week 0 to 52)||864||
48581876|NCT03689374|101755990|FG000|Full Analysis Set|Treatment Period (Week 0 to 52)||0||
48581877|NCT03689374|101755991|FG001|Full Analysis Set|Treatment Period (Week 0 to 52)||874||
48581878|NCT03689374|101755992|FG002|Full Analysis Set|Treatment Period (Week 0 to 52)||874||
48581879|NCT03689374|101755990|FG000|Safety Analysis Set|Treatment Period (Week 0 to 52)||0||
48581880|NCT03689374|101755991|FG001|Safety Analysis Set|Treatment Period (Week 0 to 52)||874||
48581881|NCT03689374|101755992|FG002|Safety Analysis Set|Treatment Period (Week 0 to 52)||864||
48581882|NCT03689374|101755990|FG000|COMPLETED|Treatment Period (Week 0 to 52)||0||
48581883|NCT03689374|101755991|FG001|COMPLETED|Treatment Period (Week 0 to 52)||850||
48581884|NCT03689374|101755992|FG002|COMPLETED|Treatment Period (Week 0 to 52)||831||
48581885|NCT03689374|101755990|FG000|NOT COMPLETED|Treatment Period (Week 0 to 52)||0||
48581886|NCT03689374|101755991|FG001|NOT COMPLETED|Treatment Period (Week 0 to 52)||24||
48581887|NCT03689374|101755992|FG002|NOT COMPLETED|Treatment Period (Week 0 to 52)||43||
48581888|NCT01177709|101755993|FG000|STARTED|Overall Study||12||
48581889|NCT01177709|101755993|FG000|COMPLETED|Overall Study||12||
48581890|NCT01177709|101755993|FG000|NOT COMPLETED|Overall Study||0||
48581891|NCT03613649|101755994|FG000|STARTED|First Treatment||6||
48288351|NCT00978627|101033548|FG000|STARTED|Extension: Week 27 to 52 (NN5401-3645)||254||
48288352|NCT00978627|101033549|FG001|STARTED|Extension: Week 27 to 52 (NN5401-3645)||122||
48288353|NCT00978627|101033548|FG000|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||233||
48581892|NCT03613649|101755995|FG001|STARTED|First Treatment||6||
48581893|NCT03613649|101755996|FG002|STARTED|First Treatment||6||
48581894|NCT03613649|101755997|FG003|STARTED|First Treatment||6||
48581895|NCT03613649|101755998|FG004|STARTED|First Treatment||6||
48581896|NCT03613649|101755999|FG005|STARTED|First Treatment||6||
48581897|NCT03613649|101756000|FG006|STARTED|First Treatment||6||
48581898|NCT03613649|101756001|FG007|STARTED|First Treatment||6||
48581899|NCT03613649|101756002|FG008|STARTED|First Treatment||6||
48581900|NCT03613649|101756003|FG009|STARTED|First Treatment||6||
48581901|NCT03613649|101756004|FG010|STARTED|First Treatment||6||
48581902|NCT03613649|101756005|FG011|STARTED|First Treatment||6||
48581903|NCT03613649|101755994|FG000|Received Treatment|First Treatment||6||
48288354|NCT00978627|101033549|FG001|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||113||
48288355|NCT00978627|101033548|FG000|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||21||
48581904|NCT03613649|101755995|FG001|Received Treatment|First Treatment||6||
48581905|NCT03613649|101755996|FG002|Received Treatment|First Treatment||6||
48581906|NCT03613649|101755997|FG003|Received Treatment|First Treatment||6||
48581907|NCT03613649|101755998|FG004|Received Treatment|First Treatment||6||
48288356|NCT00978627|101033549|FG001|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||9||
48288357|NCT00742053|101033550|FG000|STARTED|Overall Study||7||
48288358|NCT00742053|101033550|FG000|COMPLETED|Overall Study||7||
48288359|NCT00742053|101033550|FG000|NOT COMPLETED|Overall Study||0||
48288360|NCT01426867|101033551|FG000|STARTED|Overall Study||33||
48581908|NCT03613649|101755999|FG005|Received Treatment|First Treatment||6||
48581909|NCT03613649|101756000|FG006|Received Treatment|First Treatment||6||
48581910|NCT03613649|101756001|FG007|Received Treatment|First Treatment||6||
48581911|NCT03613649|101756002|FG008|Received Treatment|First Treatment||6||
48581912|NCT03613649|101756003|FG009|Received Treatment|First Treatment||6||
48581913|NCT03613649|101756004|FG010|Received Treatment|First Treatment||6||
48581914|NCT03613649|101756005|FG011|Received Treatment|First Treatment||6||
48581915|NCT03613649|101755994|FG000|COMPLETED|First Treatment||6||
48288361|NCT01426867|101033552|FG001|STARTED|Overall Study||34||
48288362|NCT01426867|101033553|FG002|STARTED|Overall Study||34||
48581916|NCT03613649|101755995|FG001|COMPLETED|First Treatment||6||
48581917|NCT03613649|101755996|FG002|COMPLETED|First Treatment||6||
48581918|NCT03613649|101755997|FG003|COMPLETED|First Treatment||6||
48581919|NCT03613649|101755998|FG004|COMPLETED|First Treatment||6||
48581920|NCT03613649|101755999|FG005|COMPLETED|First Treatment||6||
48581921|NCT03613649|101756000|FG006|COMPLETED|First Treatment||6||
48581922|NCT03613649|101756001|FG007|COMPLETED|First Treatment||6||
48581923|NCT03613649|101756002|FG008|COMPLETED|First Treatment||6||
48581924|NCT03613649|101756003|FG009|COMPLETED|First Treatment||6||
48581925|NCT03613649|101756004|FG010|COMPLETED|First Treatment||6||
48136665|NCT02180646|100661316|FG001|NOT COMPLETED|Second Intervention (7 Days)||0||
48136666|NCT01314118|100661317|FG000|STARTED|Overall Study||131||
48136667|NCT01314118|100661317|FG000|COMPLETED|Overall Study||0||
48136668|NCT01314118|100661317|FG000|NOT COMPLETED|Overall Study||131||
48136669|NCT00593372|100661318|FG000|STARTED|Overall Study||8||
48136670|NCT00593372|100661319|FG001|STARTED|Overall Study||3||
48136671|NCT00593372|100661318|FG000|COMPLETED|Overall Study||8||
48136672|NCT00593372|100661319|FG001|COMPLETED|Overall Study||3||
48136673|NCT00593372|100661318|FG000|NOT COMPLETED|Overall Study||0||
48136674|NCT00593372|100661319|FG001|NOT COMPLETED|Overall Study||0||
48136675|NCT00782340|100661320|FG000|STARTED|Open Label Titration||263||
48136676|NCT00782340|100661321|FG001|STARTED|Open Label Titration||0||
48136677|NCT00782340|100661322|FG002|STARTED|Open Label Titration||0||
48136678|NCT00782340|100661320|FG000|COMPLETED|Open Label Titration||162||
48136679|NCT00782340|100661321|FG001|COMPLETED|Open Label Titration||0||
48136680|NCT00782340|100661322|FG002|COMPLETED|Open Label Titration||0||
48136681|NCT00782340|100661320|FG000|NOT COMPLETED|Open Label Titration||101||
48136682|NCT00782340|100661321|FG001|NOT COMPLETED|Open Label Titration||0||
48136683|NCT00782340|100661322|FG002|NOT COMPLETED|Open Label Titration||0||
48136684|NCT00782340|100661320|FG000|STARTED|Randomized Double Blind||0||
48136685|NCT00782340|100661321|FG001|STARTED|Randomized Double Blind||82||
48136686|NCT00782340|100661322|FG002|STARTED|Randomized Double Blind||80||
48581926|NCT03613649|101756005|FG011|COMPLETED|First Treatment||6||
48704718|NCT00835640|102064928|FG001|STARTED|First Intervention||12||
48704719|NCT00835640|102064927|FG000|COMPLETED|First Intervention||12||
48704720|NCT00835640|102064928|FG001|COMPLETED|First Intervention||12||
48704721|NCT00835640|102064927|FG000|NOT COMPLETED|First Intervention||0||
48704722|NCT00835640|102064928|FG001|NOT COMPLETED|First Intervention||0||
48704723|NCT00835640|102064927|FG000|STARTED|Washout of 7 Days||12||
48704724|NCT00835640|102064928|FG001|STARTED|Washout of 7 Days||12||
48704725|NCT00835640|102064927|FG000|COMPLETED|Washout of 7 Days||12||
48704726|NCT00835640|102064928|FG001|COMPLETED|Washout of 7 Days||12||
48704727|NCT00835640|102064927|FG000|NOT COMPLETED|Washout of 7 Days||0||
48704728|NCT00835640|102064928|FG001|NOT COMPLETED|Washout of 7 Days||0||
48704729|NCT00835640|102064927|FG000|STARTED|Second Intervention||12||
48136687|NCT00782340|100661320|FG000|COMPLETED|Randomized Double Blind||0||
48136688|NCT00782340|100661321|FG001|COMPLETED|Randomized Double Blind||82||
48581927|NCT03613649|101755994|FG000|NOT COMPLETED|First Treatment||0||
48581928|NCT03613649|101755995|FG001|NOT COMPLETED|First Treatment||0||
48581929|NCT03613649|101755996|FG002|NOT COMPLETED|First Treatment||0||
48581930|NCT03613649|101755997|FG003|NOT COMPLETED|First Treatment||0||
48581931|NCT03613649|101755998|FG004|NOT COMPLETED|First Treatment||0||
48581932|NCT03613649|101755999|FG005|NOT COMPLETED|First Treatment||0||
48581933|NCT03613649|101756000|FG006|NOT COMPLETED|First Treatment||0||
48581934|NCT03613649|101756001|FG007|NOT COMPLETED|First Treatment||0||
48581935|NCT03613649|101756002|FG008|NOT COMPLETED|First Treatment||0||
48581936|NCT03613649|101756003|FG009|NOT COMPLETED|First Treatment||0||
48581937|NCT03613649|101756004|FG010|NOT COMPLETED|First Treatment||0||
48581938|NCT03613649|101756005|FG011|NOT COMPLETED|First Treatment||0||
48581939|NCT03613649|101755994|FG000|STARTED|Second Treatment||6||
48288363|NCT01426867|101033551|FG000|COMPLETED|Overall Study||33||
48288364|NCT01426867|101033552|FG001|COMPLETED|Overall Study||34||
48581940|NCT03613649|101755995|FG001|STARTED|Second Treatment||6||
48581941|NCT03613649|101755996|FG002|STARTED|Second Treatment||6||
48581942|NCT03613649|101755997|FG003|STARTED|Second Treatment||6||
48581943|NCT03613649|101755998|FG004|STARTED|Second Treatment||6||
48704730|NCT00835640|102064928|FG001|STARTED|Second Intervention||12||
48704731|NCT00835640|102064927|FG000|COMPLETED|Second Intervention||11||
48136689|NCT00782340|100661322|FG002|COMPLETED|Randomized Double Blind||80||
48136690|NCT00782340|100661320|FG000|NOT COMPLETED|Randomized Double Blind||0||
48288365|NCT01426867|101033553|FG002|COMPLETED|Overall Study||34||
48288366|NCT01426867|101033551|FG000|NOT COMPLETED|Overall Study||0||
48288367|NCT01426867|101033552|FG001|NOT COMPLETED|Overall Study||0||
48288368|NCT01426867|101033553|FG002|NOT COMPLETED|Overall Study||0||
48288369|NCT01153958|101033554|FG000|STARTED|Overall Study||66||
48581944|NCT03613649|101755999|FG005|STARTED|Second Treatment||6||
48581945|NCT03613649|101756000|FG006|STARTED|Second Treatment||6||
48581946|NCT03613649|101756001|FG007|STARTED|Second Treatment||6||
48581947|NCT03613649|101756002|FG008|STARTED|Second Treatment||6||
48581948|NCT03613649|101756003|FG009|STARTED|Second Treatment||6||
48581949|NCT03613649|101756004|FG010|STARTED|Second Treatment||6||
48704732|NCT00835640|102064928|FG001|COMPLETED|Second Intervention||12||
48704733|NCT00835640|102064927|FG000|NOT COMPLETED|Second Intervention||1||
48704734|NCT00835640|102064928|FG001|NOT COMPLETED|Second Intervention||0||
48704735|NCT00620425|102064929|FG000|STARTED|Overall Study||18||
48581950|NCT03613649|101756005|FG011|STARTED|Second Treatment||6||
48581951|NCT03613649|101755994|FG000|Received Treatment|Second Treatment||6||
48581952|NCT03613649|101755995|FG001|Received Treatment|Second Treatment||6||
48581953|NCT03613649|101755996|FG002|Received Treatment|Second Treatment||6||
48581954|NCT03613649|101755997|FG003|Received Treatment|Second Treatment||6||
48581955|NCT03613649|101755998|FG004|Received Treatment|Second Treatment||6||
48581956|NCT03613649|101755999|FG005|Received Treatment|Second Treatment||6||
48581957|NCT03613649|101756000|FG006|Received Treatment|Second Treatment||6||
48581958|NCT03613649|101756001|FG007|Received Treatment|Second Treatment||6||
48704736|NCT00620425|102064929|FG000|COMPLETED|Overall Study||18||
48704737|NCT00620425|102064929|FG000|NOT COMPLETED|Overall Study||0||
48704738|NCT03817463|102064930|FG000|STARTED|Overall Study||163812||
48704739|NCT03817463|102064931|FG001|STARTED|Overall Study||163812||
48704740|NCT03817463|102064930|FG000|COMPLETED|Overall Study||163812||
48704741|NCT03817463|102064931|FG001|COMPLETED|Overall Study||163812||
48704742|NCT03817463|102064930|FG000|NOT COMPLETED|Overall Study||0||
48704743|NCT03817463|102064931|FG001|NOT COMPLETED|Overall Study||0||
48704744|NCT00884039|102064932|FG000|STARTED|Overall Study||5||
48136691|NCT00782340|100661321|FG001|NOT COMPLETED|Randomized Double Blind||0||
48136692|NCT00782340|100661322|FG002|NOT COMPLETED|Randomized Double Blind||0||
48136693|NCT00321919|100661323|FG000|STARTED|Overall Study||301||
48288370|NCT01153958|101033555|FG001|STARTED|Overall Study||67||
48288371|NCT01153958|101033554|FG000|COMPLETED|Overall Study||30||
48288372|NCT01153958|101033555|FG001|COMPLETED|Overall Study||35||
48288373|NCT01153958|101033554|FG000|NOT COMPLETED|Overall Study||36||
48704745|NCT00884039|102064933|FG001|STARTED|Overall Study||2||
48704746|NCT00884039|102064932|FG000|COMPLETED|Overall Study||3||
48704747|NCT00884039|102064933|FG001|COMPLETED|Overall Study||1||
48704748|NCT00884039|102064932|FG000|NOT COMPLETED|Overall Study||2||
48136694|NCT00321919|100661324|FG001|STARTED|Overall Study||302||
48136695|NCT00321919|100661323|FG000|COMPLETED|Overall Study||226||
48136696|NCT00321919|100661324|FG001|COMPLETED|Overall Study||250||
48136697|NCT00321919|100661323|FG000|NOT COMPLETED|Overall Study||75||
48136698|NCT00321919|100661324|FG001|NOT COMPLETED|Overall Study||52||
48288374|NCT01153958|101033555|FG001|NOT COMPLETED|Overall Study||32||
48288375|NCT03929757|101033556|FG000|STARTED|Main Study: Up to Day 365||75||
48288376|NCT03929757|101033557|FG001|STARTED|Main Study: Up to Day 365||33||
48288377|NCT03929757|101033558|FG002|STARTED|Main Study: Up to Day 365||0||
48288378|NCT03929757|101033556|FG000|COMPLETED|Main Study: Up to Day 365||72||
48288379|NCT03929757|101033557|FG001|COMPLETED|Main Study: Up to Day 365||33||
48288380|NCT03929757|101033558|FG002|COMPLETED|Main Study: Up to Day 365||0||
48288381|NCT03929757|101033556|FG000|NOT COMPLETED|Main Study: Up to Day 365||3||
48581959|NCT03613649|101756002|FG008|Received Treatment|Second Treatment||6||
48581960|NCT03613649|101756003|FG009|Received Treatment|Second Treatment||6||
48581961|NCT03613649|101756004|FG010|Received Treatment|Second Treatment||6||
48581962|NCT03613649|101756005|FG011|Received Treatment|Second Treatment||6||
48581963|NCT03613649|101755994|FG000|COMPLETED|Second Treatment||6||
48581964|NCT03613649|101755995|FG001|COMPLETED|Second Treatment||6||
48581965|NCT03613649|101755996|FG002|COMPLETED|Second Treatment||5||
48581966|NCT03613649|101755997|FG003|COMPLETED|Second Treatment||6||
48581967|NCT03613649|101755998|FG004|COMPLETED|Second Treatment||5||
48581968|NCT03613649|101755999|FG005|COMPLETED|Second Treatment||6||
48704749|NCT00884039|102064933|FG001|NOT COMPLETED|Overall Study||1||
48704750|NCT00516893|102064934|FG000|STARTED|Overall Study||113||
48704751|NCT00516893|102064934|FG000|Received Study Treatment|Overall Study||112||
48704752|NCT00516893|102064934|FG000|COMPLETED|Overall Study||92||
48136699|NCT02626715|100661325|FG000|STARTED|Overall Study||6||
48136700|NCT02626715|100661326|FG001|STARTED|Overall Study||15||
48136701|NCT02626715|100661325|FG000|COMPLETED|Overall Study||6||
48136702|NCT02626715|100661326|FG001|COMPLETED|Overall Study||15||
48136703|NCT02626715|100661325|FG000|NOT COMPLETED|Overall Study||0||
48288382|NCT03929757|101033557|FG001|NOT COMPLETED|Main Study: Up to Day 365||0||
48288383|NCT03929757|101033558|FG002|NOT COMPLETED|Main Study: Up to Day 365||0||
48288384|NCT03929757|101033556|FG000|STARTED|Extension Study: Up to Extension Day 85||0||
48288385|NCT03929757|101033557|FG001|STARTED|Extension Study: Up to Extension Day 85||0||
48288386|NCT03929757|101033558|FG002|STARTED|Extension Study: Up to Extension Day 85||26||
48288387|NCT03929757|101033556|FG000|COMPLETED|Extension Study: Up to Extension Day 85||0||
48288388|NCT03929757|101033557|FG001|COMPLETED|Extension Study: Up to Extension Day 85||0||
48288389|NCT03929757|101033558|FG002|COMPLETED|Extension Study: Up to Extension Day 85||25||
48288390|NCT03929757|101033556|FG000|NOT COMPLETED|Extension Study: Up to Extension Day 85||0||
48288391|NCT03929757|101033557|FG001|NOT COMPLETED|Extension Study: Up to Extension Day 85||0||
48581969|NCT03613649|101756000|FG006|COMPLETED|Second Treatment||6||
48581970|NCT03613649|101756001|FG007|COMPLETED|Second Treatment||6||
48581971|NCT03613649|101756002|FG008|COMPLETED|Second Treatment||6||
48704753|NCT00516893|102064934|FG000|NOT COMPLETED|Overall Study||21||
48704754|NCT00284557|102064935|FG000|STARTED|Overall Study||67||
48704755|NCT00284557|102064936|FG001|STARTED|Overall Study||63||
48288392|NCT03929757|101033558|FG002|NOT COMPLETED|Extension Study: Up to Extension Day 85||1||
48288393|NCT01066520|101033559|FG000|STARTED|Overall Study||143||
48288394|NCT01066520|101033560|FG001|STARTED|Overall Study||140||
48288395|NCT01066520|101033561|FG002|STARTED|Overall Study||137||
48581972|NCT03613649|101756003|FG009|COMPLETED|Second Treatment||6||
48581973|NCT03613649|101756004|FG010|COMPLETED|Second Treatment||6||
48581974|NCT03613649|101756005|FG011|COMPLETED|Second Treatment||6||
48581975|NCT03613649|101755994|FG000|NOT COMPLETED|Second Treatment||0||
48581976|NCT03613649|101755995|FG001|NOT COMPLETED|Second Treatment||0||
48581977|NCT03613649|101755996|FG002|NOT COMPLETED|Second Treatment||1||
48581978|NCT03613649|101755997|FG003|NOT COMPLETED|Second Treatment||0||
48581979|NCT03613649|101755998|FG004|NOT COMPLETED|Second Treatment||1||
48581980|NCT03613649|101755999|FG005|NOT COMPLETED|Second Treatment||0||
48581981|NCT03613649|101756000|FG006|NOT COMPLETED|Second Treatment||0||
48581982|NCT03613649|101756001|FG007|NOT COMPLETED|Second Treatment||0||
48581983|NCT03613649|101756002|FG008|NOT COMPLETED|Second Treatment||0||
48288396|NCT01066520|101033559|FG000|COMPLETED|Overall Study||143||
48288397|NCT01066520|101033560|FG001|COMPLETED|Overall Study||140||
48288398|NCT01066520|101033561|FG002|COMPLETED|Overall Study||137||
48288399|NCT01066520|101033559|FG000|NOT COMPLETED|Overall Study||0||
48288400|NCT01066520|101033560|FG001|NOT COMPLETED|Overall Study||0||
48288401|NCT01066520|101033561|FG002|NOT COMPLETED|Overall Study||0||
48288402|NCT01588431|101033562|FG000|STARTED|Overall Study||3||
48288403|NCT01588431|101033562|FG000|COMPLETED|Overall Study||0||
48288404|NCT01588431|101033562|FG000|NOT COMPLETED|Overall Study||3||
48288405|NCT03235284|101033563|FG000|STARTED|Overall Study||15||
48288406|NCT03235284|101033564|FG001|STARTED|Overall Study||15||
48288407|NCT03235284|101033565|FG002|STARTED|Overall Study||15||
48288408|NCT03235284|101033563|FG000|COMPLETED|Overall Study||14||
48288409|NCT03235284|101033564|FG001|COMPLETED|Overall Study||13||
48288410|NCT03235284|101033565|FG002|COMPLETED|Overall Study||14||
48288411|NCT03235284|101033563|FG000|NOT COMPLETED|Overall Study||1||
48288412|NCT03235284|101033564|FG001|NOT COMPLETED|Overall Study||2||
48288413|NCT03235284|101033565|FG002|NOT COMPLETED|Overall Study||1||
48288414|NCT00306670|101033566|FG000|STARTED|Overall Study||0||
48288415|NCT00306670|101033567|FG001|STARTED|Overall Study||2||
48288416|NCT00306670|101033566|FG000|COMPLETED|Overall Study||0||
48288417|NCT00306670|101033567|FG001|COMPLETED|Overall Study||0||
48581984|NCT03613649|101756003|FG009|NOT COMPLETED|Second Treatment||0||
48581985|NCT03613649|101756004|FG010|NOT COMPLETED|Second Treatment||0||
48581986|NCT03613649|101756005|FG011|NOT COMPLETED|Second Treatment||0||
48704756|NCT00284557|102064935|FG000|COMPLETED|Overall Study||58||
48288418|NCT00306670|101033566|FG000|NOT COMPLETED|Overall Study||0||
48288419|NCT00306670|101033567|FG001|NOT COMPLETED|Overall Study||2||
48288420|NCT04822597|101033568|FG000|STARTED|Overall Study||44||
48288421|NCT04822597|101033569|FG001|STARTED|Overall Study||39||
48288422|NCT04822597|101033570|FG002|STARTED|Overall Study||44||
48288423|NCT04822597|101033571|FG003|STARTED|Overall Study||40||
48581987|NCT03613649|101755994|FG000|STARTED|Third Treatment||6||
48581988|NCT03613649|101755995|FG001|STARTED|Third Treatment||6||
48581989|NCT03613649|101755996|FG002|STARTED|Third Treatment||5||
48581990|NCT03613649|101755997|FG003|STARTED|Third Treatment||6||
48581991|NCT03613649|101755998|FG004|STARTED|Third Treatment||5||
48581992|NCT03613649|101755999|FG005|STARTED|Third Treatment||6||
48581993|NCT03613649|101756000|FG006|STARTED|Third Treatment||6||
48581994|NCT03613649|101756001|FG007|STARTED|Third Treatment||6||
48581995|NCT03613649|101756002|FG008|STARTED|Third Treatment||6||
48581996|NCT03613649|101756003|FG009|STARTED|Third Treatment||6||
48581997|NCT03613649|101756004|FG010|STARTED|Third Treatment||6||
48581998|NCT03613649|101756005|FG011|STARTED|Third Treatment||6||
48581999|NCT03613649|101755994|FG000|Received Treatment|Third Treatment||6||
48582000|NCT03613649|101755995|FG001|Received Treatment|Third Treatment||6||
48582001|NCT03613649|101755996|FG002|Received Treatment|Third Treatment||5||
48582002|NCT03613649|101755997|FG003|Received Treatment|Third Treatment||6||
48582003|NCT03613649|101755998|FG004|Received Treatment|Third Treatment||5||
48582004|NCT03613649|101755999|FG005|Received Treatment|Third Treatment||6||
48288424|NCT04822597|101033568|FG000|On Treatment As Assigned|Overall Study||44||
48288425|NCT04822597|101033569|FG001|On Treatment As Assigned|Overall Study||37||
48288426|NCT04822597|101033570|FG002|On Treatment As Assigned|Overall Study||35||
48288427|NCT04822597|101033571|FG003|On Treatment As Assigned|Overall Study||34||
48288428|NCT04822597|101033568|FG000|Off Treatment As Assigned|Overall Study||44||
48288429|NCT04822597|101033569|FG001|Off Treatment As Assigned|Overall Study||37||
48288430|NCT04822597|101033570|FG002|Off Treatment As Assigned|Overall Study||35||
48288431|NCT04822597|101033571|FG003|Off Treatment As Assigned|Overall Study||34||
48582005|NCT03613649|101756000|FG006|Received Treatment|Third Treatment||5||
48582006|NCT03613649|101756001|FG007|Received Treatment|Third Treatment||6||
48582007|NCT03613649|101756002|FG008|Received Treatment|Third Treatment||6||
48582008|NCT03613649|101756003|FG009|Received Treatment|Third Treatment||6||
48582009|NCT03613649|101756004|FG010|Received Treatment|Third Treatment||6||
48582010|NCT03613649|101756005|FG011|Received Treatment|Third Treatment||6||
48582011|NCT03613649|101755994|FG000|COMPLETED|Third Treatment||6||
48582012|NCT03613649|101755995|FG001|COMPLETED|Third Treatment||6||
48704757|NCT00284557|102064936|FG001|COMPLETED|Overall Study||50||
48704758|NCT00284557|102064935|FG000|NOT COMPLETED|Overall Study||9||
48704759|NCT00284557|102064936|FG001|NOT COMPLETED|Overall Study||13||
48704760|NCT02359045|102064937|FG000|STARTED|Overall Study||40||
48704761|NCT02359045|102064938|FG001|STARTED|Overall Study||42||
48704762|NCT02359045|102064937|FG000|COMPLETED|Overall Study||36||
48704763|NCT02359045|102064938|FG001|COMPLETED|Overall Study||39||
48704764|NCT02359045|102064937|FG000|NOT COMPLETED|Overall Study||4||
48704765|NCT02359045|102064938|FG001|NOT COMPLETED|Overall Study||3||
48704766|NCT00713349|102064939|FG000|STARTED|Overall Study||25||
48704767|NCT00713349|102064939|FG000|COMPLETED|Overall Study||24||
48704768|NCT00713349|102064939|FG000|NOT COMPLETED|Overall Study||1||
48704769|NCT04686084|102064940|FG000|STARTED|Overall Study||26||
48704770|NCT04686084|102064940|FG000|COMPLETED|Overall Study||25||
48704771|NCT04686084|102064940|FG000|NOT COMPLETED|Overall Study||1||
48704772|NCT01824823|102064941|FG000|STARTED|Overall Study||2||
48704773|NCT01824823|102064942|FG001|STARTED|Overall Study||1||
48136704|NCT02626715|100661326|FG001|NOT COMPLETED|Overall Study||0||
48136705|NCT01965834|100661327|FG000|STARTED|Overall Study||6||
48288432|NCT04822597|101033568|FG000|Analyzed With Intent to Treat|Overall Study||43||
48288433|NCT04822597|101033569|FG001|Analyzed With Intent to Treat|Overall Study||37||
48288434|NCT04822597|101033570|FG002|Analyzed With Intent to Treat|Overall Study||42||
48288435|NCT04822597|101033571|FG003|Analyzed With Intent to Treat|Overall Study||38||
48288436|NCT04822597|101033568|FG000|COMPLETED|Overall Study||43||
48288437|NCT04822597|101033569|FG001|COMPLETED|Overall Study||37||
48400764|NCT02820038|101313617|FG002|STARTED|Overall Study||65|Numbers are those who completed baseline data collection and given access to intervention materials|
48400765|NCT02820038|101313618|FG003|STARTED|Overall Study||66|Numbers are those who completed baseline data collection and given access to intervention materials|
48400766|NCT02820038|101313615|FG000|COMPLETED|Overall Study||68||
48400767|NCT02820038|101313616|FG001|COMPLETED|Overall Study||52||
48400768|NCT02820038|101313617|FG002|COMPLETED|Overall Study||60||
48400769|NCT02820038|101313618|FG003|COMPLETED|Overall Study||44||
48400770|NCT02820038|101313615|FG000|NOT COMPLETED|Overall Study||10||
48400771|NCT02820038|101313616|FG001|NOT COMPLETED|Overall Study||25||
48400772|NCT02820038|101313617|FG002|NOT COMPLETED|Overall Study||5||
48400773|NCT02820038|101313618|FG003|NOT COMPLETED|Overall Study||22||
48400774|NCT00466661|101313619|FG000|STARTED|Overall Study||16||
48400775|NCT00466661|101313620|FG001|STARTED|Overall Study||17||
48400776|NCT00466661|101313619|FG000|At Least 1 Postrandomization Visit|Overall Study||14|Defines modified Intention to Treat (mITT) sample|
48400777|NCT00466661|101313620|FG001|At Least 1 Postrandomization Visit|Overall Study||16|Defines modified Intention to Treat (mITT) sample|
48400778|NCT00466661|101313619|FG000|COMPLETED|Overall Study||12||
48400779|NCT00466661|101313620|FG001|COMPLETED|Overall Study||11||
48400780|NCT00466661|101313619|FG000|NOT COMPLETED|Overall Study||4||
48704774|NCT01824823|102064941|FG000|COMPLETED|Overall Study||0||
48704775|NCT01824823|102064942|FG001|COMPLETED|Overall Study||0||
48704776|NCT01824823|102064941|FG000|NOT COMPLETED|Overall Study||2||
48400781|NCT00466661|101313620|FG001|NOT COMPLETED|Overall Study||6||
48400782|NCT01095666|101313621|FG000|STARTED|Overall Study||145||
48400783|NCT01095666|101313622|FG001|STARTED|Overall Study||147||
48400784|NCT01095666|101313623|FG002|STARTED|Overall Study||152||
48400785|NCT01095666|101313621|FG000|COMPLETED|Overall Study||128||
48400786|NCT01095666|101313622|FG001|COMPLETED|Overall Study||136||
48400787|NCT01095666|101313623|FG002|COMPLETED|Overall Study||145||
48400788|NCT01095666|101313621|FG000|NOT COMPLETED|Overall Study||17||
48704777|NCT01824823|102064942|FG001|NOT COMPLETED|Overall Study||1||
48704778|NCT01345591|102064943|FG000|STARTED|Overall Study||20||
48704779|NCT01345591|102064943|FG000|COMPLETED|Overall Study||19||
48704780|NCT01345591|102064943|FG000|NOT COMPLETED|Overall Study||1||
48704781|NCT00241631|102064944|FG000|STARTED|Run in (2 Weeks)||25||
48704782|NCT00241631|102064945|FG001|STARTED|Run in (2 Weeks)||24||
48288438|NCT04822597|101033570|FG002|COMPLETED|Overall Study||42||
48288439|NCT04822597|101033571|FG003|COMPLETED|Overall Study||38||
48400789|NCT01095666|101313622|FG001|NOT COMPLETED|Overall Study||11||
48400790|NCT01095666|101313623|FG002|NOT COMPLETED|Overall Study||7||
48400791|NCT00390429|101313624|FG000|STARTED|Overall Study||5||
48400792|NCT00390429|101313625|FG001|STARTED|Overall Study||12||
48400793|NCT00390429|101313626|FG002|STARTED|Overall Study||25||
48400794|NCT00390429|101313627|FG003|STARTED|Overall Study||39||
48400795|NCT00390429|101313624|FG000|COMPLETED|Overall Study||5||
48704783|NCT00241631|102064944|FG000|COMPLETED|Run in (2 Weeks)||22||
48704784|NCT00241631|102064945|FG001|COMPLETED|Run in (2 Weeks)||21||
48288440|NCT04822597|101033568|FG000|NOT COMPLETED|Overall Study||1||
48288441|NCT04822597|101033569|FG001|NOT COMPLETED|Overall Study||2||
48288442|NCT04822597|101033570|FG002|NOT COMPLETED|Overall Study||2||
48400796|NCT00390429|101313625|FG001|COMPLETED|Overall Study||12||
48400797|NCT00390429|101313626|FG002|COMPLETED|Overall Study||25||
48400798|NCT00390429|101313627|FG003|COMPLETED|Overall Study||39||
48704785|NCT00241631|102064944|FG000|NOT COMPLETED|Run in (2 Weeks)||3||
48704786|NCT00241631|102064945|FG001|NOT COMPLETED|Run in (2 Weeks)||3||
48704787|NCT00241631|102064944|FG000|STARTED|Phase 1 (4 Weeks)||22||
48704788|NCT00241631|102064945|FG001|STARTED|Phase 1 (4 Weeks)||21||
48704789|NCT00241631|102064944|FG000|COMPLETED|Phase 1 (4 Weeks)||14||
48400799|NCT00390429|101313624|FG000|NOT COMPLETED|Overall Study||0||
48288443|NCT04822597|101033571|FG003|NOT COMPLETED|Overall Study||2||
48288444|NCT04275089|101033572|FG000|STARTED|Overall Study||15||
48288445|NCT04275089|101033572|FG000|COMPLETED|Overall Study||14||
48288446|NCT04275089|101033572|FG000|NOT COMPLETED|Overall Study||1||
48288447|NCT00095498|101033573|FG000|STARTED|Overall Study||76||
48288448|NCT00095498|101033574|FG001|STARTED|Overall Study||73||
48582013|NCT03613649|101755996|FG002|COMPLETED|Third Treatment||5||
48582014|NCT03613649|101755997|FG003|COMPLETED|Third Treatment||6||
48582015|NCT03613649|101755998|FG004|COMPLETED|Third Treatment||4||
48582016|NCT03613649|101755999|FG005|COMPLETED|Third Treatment||6||
48582017|NCT03613649|101756000|FG006|COMPLETED|Third Treatment||5||
48582018|NCT03613649|101756001|FG007|COMPLETED|Third Treatment||6||
48582019|NCT03613649|101756002|FG008|COMPLETED|Third Treatment||6||
48582020|NCT03613649|101756003|FG009|COMPLETED|Third Treatment||6||
48582021|NCT03613649|101756004|FG010|COMPLETED|Third Treatment||6||
48400800|NCT00390429|101313625|FG001|NOT COMPLETED|Overall Study||0||
48400801|NCT00390429|101313626|FG002|NOT COMPLETED|Overall Study||0||
48400802|NCT00390429|101313627|FG003|NOT COMPLETED|Overall Study||0||
48400803|NCT01136746|101313628|FG000|STARTED|Overall Study||9||
48400804|NCT01136746|101313629|FG001|STARTED|Overall Study||7||
48400805|NCT01136746|101313628|FG000|COMPLETED|Overall Study||6||
48400806|NCT01136746|101313629|FG001|COMPLETED|Overall Study||4||
48400807|NCT01136746|101313628|FG000|NOT COMPLETED|Overall Study||3||
48400808|NCT01136746|101313629|FG001|NOT COMPLETED|Overall Study||3||
48400809|NCT03542149|101313630|FG000|STARTED|Overall Study||2||
48400810|NCT03542149|101313631|FG001|STARTED|Overall Study||2||
48582022|NCT03613649|101756005|FG011|COMPLETED|Third Treatment||4||
48288449|NCT00095498|101033575|FG002|STARTED|Overall Study||78||
48288450|NCT00095498|101033573|FG000|Received Investigational Product|Overall Study||72||
48288451|NCT00095498|101033574|FG001|Received Investigational Product|Overall Study||71||
48288452|NCT00095498|101033575|FG002|Received Investigational Product|Overall Study||75||
48288453|NCT00095498|101033573|FG000|COMPLETED|Overall Study||39||
48288454|NCT00095498|101033574|FG001|COMPLETED|Overall Study||38||
48288455|NCT00095498|101033575|FG002|COMPLETED|Overall Study||39||
48288456|NCT00095498|101033573|FG000|NOT COMPLETED|Overall Study||37||
48288457|NCT00095498|101033574|FG001|NOT COMPLETED|Overall Study||35||
48288458|NCT00095498|101033575|FG002|NOT COMPLETED|Overall Study||39||
48288459|NCT02337751|101033576|FG000|STARTED|Overall Study||95||
48288460|NCT02337751|101033577|FG001|STARTED|Overall Study||103||
48582023|NCT03613649|101755994|FG000|NOT COMPLETED|Third Treatment||0||
48288461|NCT02337751|101033576|FG000|COMPLETED|Overall Study||84||
48288462|NCT02337751|101033577|FG001|COMPLETED|Overall Study||87||
48288463|NCT02337751|101033576|FG000|NOT COMPLETED|Overall Study||11||
48288464|NCT02337751|101033577|FG001|NOT COMPLETED|Overall Study||16||
48288465|NCT01315353|101033578|FG000|STARTED|Overall Study||145||
48288466|NCT01315353|101033579|FG001|STARTED|Overall Study||143||
48288467|NCT01315353|101033580|FG002|STARTED|Overall Study||179||
48288468|NCT01315353|101033578|FG000|COMPLETED|Overall Study||116||
48288469|NCT01315353|101033579|FG001|COMPLETED|Overall Study||120||
48288470|NCT01315353|101033580|FG002|COMPLETED|Overall Study||166||
48288471|NCT01315353|101033578|FG000|NOT COMPLETED|Overall Study||29||
48288472|NCT01315353|101033579|FG001|NOT COMPLETED|Overall Study||23||
48288473|NCT01315353|101033580|FG002|NOT COMPLETED|Overall Study||13||
48288474|NCT00700973|101033581|FG000|STARTED|Overall Study||71||
48288475|NCT00700973|101033582|FG001|STARTED|Overall Study||70||
48288476|NCT00700973|101033581|FG000|COMPLETED|Overall Study||63||
48400811|NCT03542149|101313632|FG002|STARTED|Overall Study||2||
48400812|NCT03542149|101313633|FG003|STARTED|Overall Study||6||
48400813|NCT03542149|101313634|FG004|STARTED|Overall Study||4||
48400814|NCT03542149|101313635|FG005|STARTED|Overall Study||4||
48400815|NCT03542149|101313636|FG006|STARTED|Overall Study||4||
48400816|NCT03542149|101313630|FG000|COMPLETED|Overall Study||2||
48288477|NCT00700973|101033582|FG001|COMPLETED|Overall Study||63||
48582024|NCT03613649|101755995|FG001|NOT COMPLETED|Third Treatment||0||
48582025|NCT03613649|101755996|FG002|NOT COMPLETED|Third Treatment||0||
48288478|NCT00700973|101033581|FG000|NOT COMPLETED|Overall Study||8||
48288479|NCT00700973|101033582|FG001|NOT COMPLETED|Overall Study||7||
48288480|NCT03824639|101033583|FG000|STARTED|Overall Study||29||
48288481|NCT03824639|101033584|FG001|STARTED|Overall Study||31||
48288482|NCT03824639|101033583|FG000|COMPLETED|Overall Study||29||
48288483|NCT03824639|101033584|FG001|COMPLETED|Overall Study||31||
48288484|NCT03824639|101033583|FG000|NOT COMPLETED|Overall Study||0||
48288485|NCT03824639|101033584|FG001|NOT COMPLETED|Overall Study||0||
48400817|NCT03542149|101313631|FG001|COMPLETED|Overall Study||2||
48400818|NCT03542149|101313632|FG002|COMPLETED|Overall Study||2||
48400819|NCT03542149|101313633|FG003|COMPLETED|Overall Study||5||
48400820|NCT03542149|101313634|FG004|COMPLETED|Overall Study||4||
48400821|NCT03542149|101313635|FG005|COMPLETED|Overall Study||3||
48400822|NCT03542149|101313636|FG006|COMPLETED|Overall Study||4||
48582026|NCT03613649|101755997|FG003|NOT COMPLETED|Third Treatment||0||
48288486|NCT01945060|101033585|FG000|STARTED|Overall Study||10||
48288487|NCT01945060|101033586|FG001|STARTED|Overall Study||10||
48288488|NCT01945060|101033585|FG000|COMPLETED|Overall Study||9||
48582027|NCT03613649|101755998|FG004|NOT COMPLETED|Third Treatment||1||
48400823|NCT03542149|101313630|FG000|NOT COMPLETED|Overall Study||0||
48288489|NCT01945060|101033586|FG001|COMPLETED|Overall Study||9||
48288490|NCT01945060|101033585|FG000|NOT COMPLETED|Overall Study||1||
48288491|NCT01945060|101033586|FG001|NOT COMPLETED|Overall Study||1||
48288492|NCT03045068|101033587|FG000|STARTED|Overall Study||23||
48288493|NCT03045068|101033588|FG001|STARTED|Overall Study||23||
48288494|NCT03045068|101033587|FG000|Received Intervention|Overall Study||23||
48288495|NCT03045068|101033588|FG001|Received Intervention|Overall Study||23||
48288496|NCT03045068|101033587|FG000|COMPLETED|Overall Study||21||
48288497|NCT03045068|101033588|FG001|COMPLETED|Overall Study||21||
48288498|NCT03045068|101033587|FG000|NOT COMPLETED|Overall Study||2||
48400824|NCT03542149|101313631|FG001|NOT COMPLETED|Overall Study||0||
48400825|NCT03542149|101313632|FG002|NOT COMPLETED|Overall Study||0||
48400826|NCT03542149|101313633|FG003|NOT COMPLETED|Overall Study||1||
48400827|NCT03542149|101313634|FG004|NOT COMPLETED|Overall Study||0||
48400828|NCT03542149|101313635|FG005|NOT COMPLETED|Overall Study||1||
48400829|NCT03542149|101313636|FG006|NOT COMPLETED|Overall Study||0||
48400830|NCT01391468|101313637|FG000|STARTED|Overall Study||24||
48400831|NCT01391468|101313638|FG001|STARTED|Overall Study||23||
48400832|NCT01391468|101313637|FG000|COMPLETED|Overall Study||18||
48582028|NCT03613649|101755999|FG005|NOT COMPLETED|Third Treatment||0||
48582029|NCT03613649|101756000|FG006|NOT COMPLETED|Third Treatment||1||
48582030|NCT03613649|101756001|FG007|NOT COMPLETED|Third Treatment||0||
48582031|NCT03613649|101756002|FG008|NOT COMPLETED|Third Treatment||0||
48582032|NCT03613649|101756003|FG009|NOT COMPLETED|Third Treatment||0||
48582033|NCT03613649|101756004|FG010|NOT COMPLETED|Third Treatment||0||
48582034|NCT03613649|101756005|FG011|NOT COMPLETED|Third Treatment||2||
48582035|NCT03613649|101755994|FG000|STARTED|Fourth Treatment||6||
48582036|NCT03613649|101755995|FG001|STARTED|Fourth Treatment||6||
48582037|NCT03613649|101755996|FG002|STARTED|Fourth Treatment||5||
48582038|NCT03613649|101755997|FG003|STARTED|Fourth Treatment||6||
48582039|NCT03613649|101755998|FG004|STARTED|Fourth Treatment||4||
48582040|NCT03613649|101755999|FG005|STARTED|Fourth Treatment||6||
48582041|NCT03613649|101756000|FG006|STARTED|Fourth Treatment||5||
48582042|NCT03613649|101756001|FG007|STARTED|Fourth Treatment||6||
48582043|NCT03613649|101756002|FG008|STARTED|Fourth Treatment||6||
48582044|NCT03613649|101756003|FG009|STARTED|Fourth Treatment||6||
48582045|NCT03613649|101756004|FG010|STARTED|Fourth Treatment||6||
48582046|NCT03613649|101756005|FG011|STARTED|Fourth Treatment||4||
48582047|NCT03613649|101755994|FG000|Received Treatment|Fourth Treatment||5||
48582048|NCT03613649|101755995|FG001|Received Treatment|Fourth Treatment||6||
48582049|NCT03613649|101755996|FG002|Received Treatment|Fourth Treatment||5||
48582050|NCT03613649|101755997|FG003|Received Treatment|Fourth Treatment||6||
48582051|NCT03613649|101755998|FG004|Received Treatment|Fourth Treatment||4||
48582052|NCT03613649|101755999|FG005|Received Treatment|Fourth Treatment||6||
48582053|NCT03613649|101756000|FG006|Received Treatment|Fourth Treatment||4||
48136706|NCT01965834|100661327|FG000|COMPLETED|Overall Study||2||
48136707|NCT01965834|100661327|FG000|NOT COMPLETED|Overall Study||4||
48136708|NCT03034577|100661328|FG000|STARTED|Overall Study||175||
48136709|NCT03034577|100661329|FG001|STARTED|Overall Study||175||
48136710|NCT03034577|100661328|FG000|COMPLETED|Overall Study||144||
48136711|NCT03034577|100661329|FG001|COMPLETED|Overall Study||140||
48136712|NCT03034577|100661328|FG000|NOT COMPLETED|Overall Study||31||
48136713|NCT03034577|100661329|FG001|NOT COMPLETED|Overall Study||35||
48136714|NCT02365467|100661330|FG000|STARTED|Overall Study||32||
48136715|NCT02365467|100661330|FG000|Implanted|Overall Study||30||
48136716|NCT02365467|100661330|FG000|COMPLETED|Overall Study||29||
48136717|NCT02365467|100661330|FG000|NOT COMPLETED|Overall Study||3||
48136718|NCT04023695|100661331|FG000|STARTED|Overall Study||57||
48136719|NCT04023695|100661332|FG001|STARTED|Overall Study||53||
48136720|NCT04023695|100661331|FG000|COMPLETED|Overall Study||57||
48136721|NCT04023695|100661332|FG001|COMPLETED|Overall Study||53||
48288499|NCT03045068|101033588|FG001|NOT COMPLETED|Overall Study||2||
48288500|NCT01435616|101033589|FG000|STARTED|Overall Study||1003||
48288501|NCT01435616|101033590|FG001|STARTED|Overall Study||535||
48400833|NCT01391468|101313638|FG001|COMPLETED|Overall Study||21||
48400834|NCT01391468|101313637|FG000|NOT COMPLETED|Overall Study||6||
48400835|NCT01391468|101313638|FG001|NOT COMPLETED|Overall Study||2||
48400836|NCT02017704|101313639|FG000|STARTED|Overall Study||4||
48400837|NCT02017704|101313640|FG001|STARTED|Overall Study||5||
48400838|NCT02017704|101313639|FG000|COMPLETED|Overall Study||2||
48400839|NCT02017704|101313640|FG001|COMPLETED|Overall Study||5||
48400840|NCT02017704|101313639|FG000|NOT COMPLETED|Overall Study||2||
48400841|NCT02017704|101313640|FG001|NOT COMPLETED|Overall Study||0||
48400842|NCT01634113|101313641|FG000|STARTED|Overall Study||34||
48400843|NCT01634113|101313642|FG001|STARTED|Overall Study||36||
48400844|NCT01634113|101313643|FG002|STARTED|Overall Study||32||
48400845|NCT01634113|101313641|FG000|COMPLETED|Overall Study||34||
48400846|NCT01634113|101313642|FG001|COMPLETED|Overall Study||36||
48400847|NCT01634113|101313643|FG002|COMPLETED|Overall Study||31||
48582054|NCT03613649|101756001|FG007|Received Treatment|Fourth Treatment||6||
48582055|NCT03613649|101756002|FG008|Received Treatment|Fourth Treatment||6||
48582056|NCT03613649|101756003|FG009|Received Treatment|Fourth Treatment||6||
48582057|NCT03613649|101756004|FG010|Received Treatment|Fourth Treatment||6||
48582058|NCT03613649|101756005|FG011|Received Treatment|Fourth Treatment||4||
48582059|NCT03613649|101755994|FG000|COMPLETED|Fourth Treatment||5||
48582060|NCT03613649|101755995|FG001|COMPLETED|Fourth Treatment||6||
48582061|NCT03613649|101755996|FG002|COMPLETED|Fourth Treatment||5||
48582062|NCT03613649|101755997|FG003|COMPLETED|Fourth Treatment||6||
48582063|NCT03613649|101755998|FG004|COMPLETED|Fourth Treatment||3||
48582064|NCT03613649|101755999|FG005|COMPLETED|Fourth Treatment||6||
48582065|NCT03613649|101756000|FG006|COMPLETED|Fourth Treatment||4||
48582066|NCT03613649|101756001|FG007|COMPLETED|Fourth Treatment||6||
48582067|NCT03613649|101756002|FG008|COMPLETED|Fourth Treatment||6||
48288502|NCT01435616|101033589|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1003||
48288503|NCT01435616|101033590|FG001|Received at Least 1 Dose of Study Drug|Overall Study||535||
48288504|NCT01435616|101033589|FG000|COMPLETED|Overall Study||832||
48288505|NCT01435616|101033590|FG001|COMPLETED|Overall Study||455||
48288506|NCT01435616|101033589|FG000|NOT COMPLETED|Overall Study||171||
48288507|NCT01435616|101033590|FG001|NOT COMPLETED|Overall Study||80||
48288508|NCT01992393|101033591|FG000|STARTED|Baseline||22||
48288509|NCT01992393|101033592|FG001|STARTED|Baseline||22||
48288510|NCT01992393|101033591|FG000|COMPLETED|Baseline||21||
48288511|NCT01992393|101033592|FG001|COMPLETED|Baseline||22||
48288512|NCT01992393|101033591|FG000|NOT COMPLETED|Baseline||1||
48288513|NCT01992393|101033592|FG001|NOT COMPLETED|Baseline||0||
48288514|NCT01992393|101033591|FG000|STARTED|Week 12 (3 Months)||21||
48288515|NCT01992393|101033592|FG001|STARTED|Week 12 (3 Months)||22||
48288516|NCT01992393|101033591|FG000|COMPLETED|Week 12 (3 Months)||19||
48288517|NCT01992393|101033592|FG001|COMPLETED|Week 12 (3 Months)||18||
48288518|NCT01992393|101033591|FG000|NOT COMPLETED|Week 12 (3 Months)||2||
48288519|NCT01992393|101033592|FG001|NOT COMPLETED|Week 12 (3 Months)||4||
48288520|NCT01992393|101033591|FG000|STARTED|Week 16 (4 Months)||19||
48400848|NCT01634113|101313641|FG000|NOT COMPLETED|Overall Study||0||
48582068|NCT03613649|101756003|FG009|COMPLETED|Fourth Treatment||6||
48582069|NCT03613649|101756004|FG010|COMPLETED|Fourth Treatment||6||
48582070|NCT03613649|101756005|FG011|COMPLETED|Fourth Treatment||4||
48582071|NCT03613649|101755994|FG000|NOT COMPLETED|Fourth Treatment||1||
48582072|NCT03613649|101755995|FG001|NOT COMPLETED|Fourth Treatment||0||
48582073|NCT03613649|101755996|FG002|NOT COMPLETED|Fourth Treatment||0||
48582074|NCT03613649|101755997|FG003|NOT COMPLETED|Fourth Treatment||0||
48582075|NCT03613649|101755998|FG004|NOT COMPLETED|Fourth Treatment||1||
48582076|NCT03613649|101755999|FG005|NOT COMPLETED|Fourth Treatment||0||
48582077|NCT03613649|101756000|FG006|NOT COMPLETED|Fourth Treatment||1||
48582078|NCT03613649|101756001|FG007|NOT COMPLETED|Fourth Treatment||0||
48582079|NCT03613649|101756002|FG008|NOT COMPLETED|Fourth Treatment||0||
48582080|NCT03613649|101756003|FG009|NOT COMPLETED|Fourth Treatment||0||
48582081|NCT03613649|101756004|FG010|NOT COMPLETED|Fourth Treatment||0||
48582082|NCT03613649|101756005|FG011|NOT COMPLETED|Fourth Treatment||0||
48582083|NCT02587598|101756006|FG000|STARTED|Overall Study||4||
48582084|NCT02587598|101756007|FG001|STARTED|Overall Study||11||
48582085|NCT02587598|101756008|FG002|STARTED|Overall Study||4||
48582086|NCT02587598|101756009|FG003|STARTED|Overall Study||21||
48136722|NCT04023695|100661331|FG000|NOT COMPLETED|Overall Study||0||
48136723|NCT04023695|100661332|FG001|NOT COMPLETED|Overall Study||0||
48136724|NCT01659021|100661333|FG000|STARTED|Main Study||174||
48136725|NCT01659021|100661334|FG001|STARTED|Main Study||87||
48136726|NCT01659021|100661333|FG000|Randomized and Treated|Main Study||173||
48136727|NCT01659021|100661334|FG001|Randomized and Treated|Main Study||86||
48136728|NCT01659021|100661333|FG000|COMPLETED|Main Study||100|Study completion was defined as disease progression or death.|
48136729|NCT01659021|100661334|FG001|COMPLETED|Main Study||50|Study completion was defined as disease progression or death.|
48136730|NCT01659021|100661333|FG000|NOT COMPLETED|Main Study||74||
48136731|NCT01659021|100661334|FG001|NOT COMPLETED|Main Study||37||
48136732|NCT01659021|100661333|FG000|STARTED|Long-Term Follow Up||138||
48136733|NCT01659021|100661334|FG001|STARTED|Long-Term Follow Up||69||
48136734|NCT01659021|100661333|FG000|COMPLETED|Long-Term Follow Up||133||
48288521|NCT01992393|101033592|FG001|STARTED|Week 16 (4 Months)||18||
48288522|NCT01992393|101033591|FG000|COMPLETED|Week 16 (4 Months)||19||
48288523|NCT01992393|101033592|FG001|COMPLETED|Week 16 (4 Months)||16||
48288524|NCT01992393|101033591|FG000|NOT COMPLETED|Week 16 (4 Months)||0||
48288525|NCT01992393|101033592|FG001|NOT COMPLETED|Week 16 (4 Months)||2||
48288526|NCT02199743|101033593|FG000|STARTED|Overall Study||14||
48288527|NCT02199743|101033594|FG001|STARTED|Overall Study||10||
48288528|NCT02199743|101033593|FG000|COMPLETED|Overall Study||14||
48400849|NCT01634113|101313642|FG001|NOT COMPLETED|Overall Study||0||
48582087|NCT02587598|101756010|FG004|STARTED|Overall Study||12||
48582088|NCT02587598|101756011|FG005|STARTED|Overall Study||6||
48582089|NCT02587598|101756012|FG006|STARTED|Overall Study||6||
48288529|NCT02199743|101033594|FG001|COMPLETED|Overall Study||8||
48288530|NCT02199743|101033593|FG000|NOT COMPLETED|Overall Study||0||
48288531|NCT02199743|101033594|FG001|NOT COMPLETED|Overall Study||2||
48288532|NCT02831387|101033595|FG000|STARTED|Overall Study||23||
48288533|NCT02831387|101033596|FG001|STARTED|Overall Study||24||
48288534|NCT02831387|101033595|FG000|COMPLETED|Overall Study||22||
48704790|NCT00241631|102064945|FG001|COMPLETED|Phase 1 (4 Weeks)||16||
48704791|NCT00241631|102064944|FG000|NOT COMPLETED|Phase 1 (4 Weeks)||8||
48704792|NCT00241631|102064945|FG001|NOT COMPLETED|Phase 1 (4 Weeks)||5||
48704793|NCT00241631|102064944|FG000|STARTED|Wash Out (2 Weeks)||14||
48704794|NCT00241631|102064945|FG001|STARTED|Wash Out (2 Weeks)||16||
48704795|NCT00241631|102064944|FG000|COMPLETED|Wash Out (2 Weeks)||14||
48704796|NCT00241631|102064945|FG001|COMPLETED|Wash Out (2 Weeks)||16||
48704797|NCT00241631|102064944|FG000|NOT COMPLETED|Wash Out (2 Weeks)||0||
48704798|NCT00241631|102064945|FG001|NOT COMPLETED|Wash Out (2 Weeks)||0||
48704799|NCT00241631|102064944|FG000|STARTED|Phase 2 (4 Weeks)||14||
48704800|NCT00241631|102064945|FG001|STARTED|Phase 2 (4 Weeks)||16||
48704801|NCT00241631|102064944|FG000|COMPLETED|Phase 2 (4 Weeks)||14||
48704802|NCT00241631|102064945|FG001|COMPLETED|Phase 2 (4 Weeks)||16||
48704803|NCT00241631|102064944|FG000|NOT COMPLETED|Phase 2 (4 Weeks)||0||
48704804|NCT00241631|102064945|FG001|NOT COMPLETED|Phase 2 (4 Weeks)||0||
48704805|NCT04043234|102064946|FG000|STARTED|Overall Study||4||
48704806|NCT04043234|102064946|FG000|COMPLETED|Overall Study||2||
48704807|NCT04043234|102064946|FG000|NOT COMPLETED|Overall Study||2||
48704808|NCT03416920|102064947|FG000|STARTED|Overall Study||167||
48704809|NCT03416920|102064947|FG000|COMPLETED|Overall Study||118||
48704810|NCT03416920|102064947|FG000|NOT COMPLETED|Overall Study||49||
48704811|NCT02534935|102064948|FG000|STARTED|Stage 1: 24 Months||44||
48704812|NCT02534935|102064949|FG001|STARTED|Stage 1: 24 Months||220||
48704813|NCT02534935|102064950|FG002|STARTED|Stage 1: 24 Months||132||
48704814|NCT02534935|102064948|FG000|COMPLETED|Stage 1: 24 Months||44||
48704815|NCT02534935|102064949|FG001|COMPLETED|Stage 1: 24 Months||210||
48704816|NCT02534935|102064950|FG002|COMPLETED|Stage 1: 24 Months||127||
48704817|NCT02534935|102064948|FG000|NOT COMPLETED|Stage 1: 24 Months||0||
48704818|NCT02534935|102064949|FG001|NOT COMPLETED|Stage 1: 24 Months||10||
48704819|NCT02534935|102064950|FG002|NOT COMPLETED|Stage 1: 24 Months||5||
48704820|NCT02534935|102064948|FG000|STARTED|Stage 2: 8 Months||40||
48704821|NCT02534935|102064949|FG001|STARTED|Stage 2: 8 Months||174||
48704822|NCT02534935|102064950|FG002|STARTED|Stage 2: 8 Months||0||
48704823|NCT02534935|102064948|FG000|COMPLETED|Stage 2: 8 Months||40||
48704824|NCT02534935|102064949|FG001|COMPLETED|Stage 2: 8 Months||170||
48704825|NCT02534935|102064950|FG002|COMPLETED|Stage 2: 8 Months||0||
48704826|NCT02534935|102064948|FG000|NOT COMPLETED|Stage 2: 8 Months||0||
48288535|NCT02831387|101033596|FG001|COMPLETED|Overall Study||22||
48288536|NCT02831387|101033595|FG000|NOT COMPLETED|Overall Study||1||
48288537|NCT02831387|101033596|FG001|NOT COMPLETED|Overall Study||2||
48288538|NCT03081052|101033597|FG000|STARTED|Overall Study||98|"Since these agents are standard of care at our institution for these operations, and either agent could be used outside of the study, participants were included in the analysis if they:~1. Did not die while awaiting surgery~2. Did not develop changes to enrollment criteria in the duration between consent and operation.~3. Was not withdrawn from study by physician before surgery"|
48288539|NCT03081052|101033598|FG001|STARTED|Overall Study||103|"Since these agents are standard of care at our institution for these operations, and either agent could be used outside of the study, participants were included in the analysis if they:~1. Did not die while awaiting surgery~2. Did not develop changes to enrollment criteria in the duration between consent and operation.~3. Was not withdrawn from study by physician before surgery"|
48288540|NCT03081052|101033599|FG002|STARTED|Overall Study||111|"Since these agents are standard of care at our institution for these operations, and either agent could be used outside of the study, participants were included in the analysis if they:~1. Did not die while awaiting surgery~2. Did not develop changes to enrollment criteria in the duration between consent and operation.~3. Was not withdrawn from study by physician before surgery"|
48288541|NCT03081052|101033600|FG003|STARTED|Overall Study||120|"Since these agents are standard of care at our institution for these operations, and either agent could be used outside of the study, participants were included in the analysis if they:~1. Did not die while awaiting surgery~2. Did not develop changes to enrollment criteria in the duration between consent and operation.~3. Was not withdrawn from study by physician before surgery"|
48288542|NCT03081052|101033597|FG000|COMPLETED|Overall Study||98|The number of patients who completed primary outcome follow-up|
48288543|NCT03081052|101033598|FG001|COMPLETED|Overall Study||103|The number of patients who completed primary outcome follow-up|
48288544|NCT03081052|101033599|FG002|COMPLETED|Overall Study||111|The number of patients who completed primary outcome follow-up|
48288545|NCT03081052|101033600|FG003|COMPLETED|Overall Study||120|The number of patients who completed primary outcome follow-up|
48288546|NCT03081052|101033597|FG000|NOT COMPLETED|Overall Study||0||
48288547|NCT03081052|101033598|FG001|NOT COMPLETED|Overall Study||0||
48288548|NCT03081052|101033599|FG002|NOT COMPLETED|Overall Study||0||
48288549|NCT03081052|101033600|FG003|NOT COMPLETED|Overall Study||0||
48704827|NCT02534935|102064949|FG001|NOT COMPLETED|Stage 2: 8 Months||4||
48704828|NCT02534935|102064950|FG002|NOT COMPLETED|Stage 2: 8 Months||0||
48704829|NCT02534935|102064948|FG000|STARTED|Stage 2: Booster Phase (6 Months)||0||
48704830|NCT02534935|102064949|FG001|STARTED|Stage 2: Booster Phase (6 Months)||148||
48704831|NCT02534935|102064950|FG002|STARTED|Stage 2: Booster Phase (6 Months)||0||
48704832|NCT02534935|102064948|FG000|COMPLETED|Stage 2: Booster Phase (6 Months)||0||
48710762|NCT00402714|102078010|FG000|STARTED|Overall Study||3||
48288550|NCT03002753|101033601|FG000|STARTED|First Randomization||10||
48288551|NCT03002753|101033602|FG001|STARTED|First Randomization||12||
48288552|NCT03002753|101033603|FG002|STARTED|First Randomization||21||
48288553|NCT03002753|101033601|FG000|COMPLETED|First Randomization||9||
48288554|NCT03002753|101033602|FG001|COMPLETED|First Randomization||11||
48288555|NCT03002753|101033603|FG002|COMPLETED|First Randomization||21||
48288556|NCT03002753|101033601|FG000|NOT COMPLETED|First Randomization||1||
48288557|NCT03002753|101033602|FG001|NOT COMPLETED|First Randomization||1||
48288558|NCT03002753|101033603|FG002|NOT COMPLETED|First Randomization||0||
48288559|NCT03002753|101033601|FG000|STARTED|Second Randomization (Re-randomization)||11||
48288560|NCT03002753|101033602|FG001|STARTED|Second Randomization (Re-randomization)||10||
48288561|NCT03002753|101033603|FG002|STARTED|Second Randomization (Re-randomization)||0||
48288562|NCT03002753|101033601|FG000|COMPLETED|Second Randomization (Re-randomization)||11||
48288563|NCT03002753|101033602|FG001|COMPLETED|Second Randomization (Re-randomization)||9||
48288564|NCT03002753|101033603|FG002|COMPLETED|Second Randomization (Re-randomization)||0||
48288565|NCT03002753|101033601|FG000|NOT COMPLETED|Second Randomization (Re-randomization)||0||
48288566|NCT03002753|101033602|FG001|NOT COMPLETED|Second Randomization (Re-randomization)||1||
48136735|NCT01659021|100661334|FG001|COMPLETED|Long-Term Follow Up||65||
48136736|NCT01659021|100661333|FG000|NOT COMPLETED|Long-Term Follow Up||5||
48136737|NCT01659021|100661334|FG001|NOT COMPLETED|Long-Term Follow Up||4||
48136738|NCT01404572|100661335|FG000|STARTED|Overall Study||4||
48136739|NCT01404572|100661336|FG001|STARTED|Overall Study||4||
48136740|NCT01404572|100661337|FG002|STARTED|Overall Study||4||
48136741|NCT01404572|100661335|FG000|COMPLETED|Overall Study||4||
48136742|NCT01404572|100661336|FG001|COMPLETED|Overall Study||4||
48136743|NCT01404572|100661337|FG002|COMPLETED|Overall Study||4||
48136744|NCT01404572|100661335|FG000|NOT COMPLETED|Overall Study||0||
48136745|NCT01404572|100661336|FG001|NOT COMPLETED|Overall Study||0||
48136746|NCT01404572|100661337|FG002|NOT COMPLETED|Overall Study||0||
48136747|NCT03667053|100661338|FG000|STARTED|Overall Study||21|Randomized subjects|
48136748|NCT03667053|100661339|FG001|STARTED|Overall Study||11|Randomized subjects|
48288567|NCT03002753|101033603|FG002|NOT COMPLETED|Second Randomization (Re-randomization)||0||
48582090|NCT02587598|101756013|FG007|STARTED|Overall Study||7||
48136749|NCT03667053|100661340|FG002|STARTED|Overall Study||10|Randomized subjects|
48136750|NCT03667053|100661338|FG000|Randomized and Treated|Overall Study||20||
48136751|NCT03667053|100661339|FG001|Randomized and Treated|Overall Study||11||
48136752|NCT03667053|100661340|FG002|Randomized and Treated|Overall Study||10||
48288568|NCT01280110|101033604|FG000|STARTED|Overall Study||22||
48288569|NCT01280110|101033605|FG001|STARTED|Overall Study||22||
48136753|NCT03667053|100661338|FG000|COMPLETED|Overall Study||20||
48136754|NCT03667053|100661339|FG001|COMPLETED|Overall Study||11||
48136755|NCT03667053|100661340|FG002|COMPLETED|Overall Study||10||
48136756|NCT03667053|100661338|FG000|NOT COMPLETED|Overall Study||1||
48136757|NCT03667053|100661339|FG001|NOT COMPLETED|Overall Study||0||
48288570|NCT01280110|101033604|FG000|COMPLETED|Overall Study||22||
48288571|NCT01280110|101033605|FG001|COMPLETED|Overall Study||22||
48136758|NCT03667053|100661340|FG002|NOT COMPLETED|Overall Study||0||
48136759|NCT01910129|100661341|FG000|STARTED|Run-in Period Phase 1||0||
48136760|NCT01910129|100661342|FG001|STARTED|Run-in Period Phase 1||0||
48288572|NCT01280110|101033604|FG000|NOT COMPLETED|Overall Study||0||
48288573|NCT01280110|101033605|FG001|NOT COMPLETED|Overall Study||0||
48288574|NCT00731120|101033606|FG000|STARTED|Overall Study||153||
48288575|NCT00731120|101033607|FG001|STARTED|Overall Study||152||
48288576|NCT00731120|101033608|FG002|STARTED|Overall Study||152||
48288577|NCT00731120|101033606|FG000|Treated|Overall Study||153||
48288578|NCT00731120|101033607|FG001|Treated|Overall Study||151||
48288579|NCT00731120|101033608|FG002|Treated|Overall Study||152||
48288580|NCT00731120|101033606|FG000|COMPLETED|Overall Study||111||
48288581|NCT00731120|101033607|FG001|COMPLETED|Overall Study||109||
48288582|NCT00731120|101033608|FG002|COMPLETED|Overall Study||116||
48288583|NCT00731120|101033606|FG000|NOT COMPLETED|Overall Study||42||
48288584|NCT00731120|101033607|FG001|NOT COMPLETED|Overall Study||43||
48288585|NCT00731120|101033608|FG002|NOT COMPLETED|Overall Study||36||
48288586|NCT02729753|101033609|FG000|STARTED|Overall Study||3||
48288587|NCT02729753|101033610|FG001|STARTED|Overall Study||7||
48288588|NCT02729753|101033609|FG000|COMPLETED|Overall Study||3||
48288589|NCT02729753|101033610|FG001|COMPLETED|Overall Study||6||
48288590|NCT02729753|101033609|FG000|NOT COMPLETED|Overall Study||0||
48288591|NCT02729753|101033610|FG001|NOT COMPLETED|Overall Study||1||
48288592|NCT02730598|101033611|FG000|STARTED|Overall Study||14||
48288593|NCT02730598|101033612|FG001|STARTED|Overall Study||14||
48288594|NCT02730598|101033611|FG000|COMPLETED|Overall Study||10||
48288595|NCT02730598|101033612|FG001|COMPLETED|Overall Study||10||
48582091|NCT02587598|101756014|FG008|STARTED|Overall Study||9||
48582092|NCT02587598|101756015|FG009|STARTED|Overall Study||3||
48582093|NCT02587598|101756016|FG010|STARTED|Overall Study||14||
48288596|NCT02730598|101033611|FG000|NOT COMPLETED|Overall Study||4||
48288597|NCT02730598|101033612|FG001|NOT COMPLETED|Overall Study||4||
48288598|NCT00757588|101033613|FG000|STARTED|Period 1: Short-term (24-week) Phase||304||
48288599|NCT00757588|101033614|FG001|STARTED|Period 1: Short-term (24-week) Phase||151||
48288600|NCT00757588|101033613|FG000|COMPLETED|Period 1: Short-term (24-week) Phase||268||
48288601|NCT00757588|101033614|FG001|COMPLETED|Period 1: Short-term (24-week) Phase||134||
48288602|NCT00757588|101033613|FG000|NOT COMPLETED|Period 1: Short-term (24-week) Phase||36||
48288603|NCT00757588|101033614|FG001|NOT COMPLETED|Period 1: Short-term (24-week) Phase||17||
48288604|NCT00757588|101033613|FG000|STARTED|Period 2: Long-term (52-week) Phase||268||
48288605|NCT00757588|101033614|FG001|STARTED|Period 2: Long-term (52-week) Phase||134||
48288606|NCT00757588|101033613|FG000|COMPLETED|Period 2: Long-term (52-week) Phase||246||
48582094|NCT02587598|101756006|FG000|COMPLETED|Overall Study||0|All participants in each arm discontinued study treatment and withdrew from the study.|
48582095|NCT02587598|101756007|FG001|COMPLETED|Overall Study||0|All participants in each arm discontinued study treatment and withdrew from the study.|
48582096|NCT02587598|101756008|FG002|COMPLETED|Overall Study||0|All participants in each arm discontinued study treatment and withdrew from the study.|
48582097|NCT02587598|101756009|FG003|COMPLETED|Overall Study||0|All participants in each arm discontinued study treatment and withdrew from the study.|
48582098|NCT02587598|101756010|FG004|COMPLETED|Overall Study||0|All participants in each arm discontinued study treatment and withdrew from the study.|
48288607|NCT00757588|101033614|FG001|COMPLETED|Period 2: Long-term (52-week) Phase||125||
48288608|NCT00757588|101033613|FG000|NOT COMPLETED|Period 2: Long-term (52-week) Phase||22||
48288609|NCT00757588|101033614|FG001|NOT COMPLETED|Period 2: Long-term (52-week) Phase||9||
48288610|NCT02457559|101033615|FG000|STARTED|Overall Study||2||
48288611|NCT02457559|101033616|FG001|STARTED|Overall Study||3||
48288612|NCT02457559|101033617|FG002|STARTED|Overall Study||7||
48288613|NCT02457559|101033618|FG003|STARTED|Overall Study||2||
48288614|NCT02457559|101033619|FG004|STARTED|Overall Study||1||
48288615|NCT02457559|101033620|FG005|STARTED|Overall Study||2||
48288616|NCT02457559|101033621|FG006|STARTED|Overall Study||2||
48288617|NCT02457559|101033622|FG007|STARTED|Overall Study||1||
48288618|NCT02457559|101033623|FG008|STARTED|Overall Study||3||
48288619|NCT02457559|101033624|FG009|STARTED|Overall Study||4||
48288620|NCT02457559|101033625|FG010|STARTED|Overall Study||2||
48288621|NCT02457559|101033615|FG000|COMPLETED|Overall Study||0||
48288622|NCT02457559|101033616|FG001|COMPLETED|Overall Study||0||
48288623|NCT02457559|101033617|FG002|COMPLETED|Overall Study||0||
48288624|NCT02457559|101033618|FG003|COMPLETED|Overall Study||2||
48288625|NCT02457559|101033619|FG004|COMPLETED|Overall Study||0||
48288626|NCT02457559|101033620|FG005|COMPLETED|Overall Study||0||
48288627|NCT02457559|101033621|FG006|COMPLETED|Overall Study||0||
48288628|NCT02457559|101033622|FG007|COMPLETED|Overall Study||1||
48288629|NCT02457559|101033623|FG008|COMPLETED|Overall Study||0||
48288630|NCT02457559|101033624|FG009|COMPLETED|Overall Study||0||
48288631|NCT02457559|101033625|FG010|COMPLETED|Overall Study||0||
48288632|NCT02457559|101033615|FG000|NOT COMPLETED|Overall Study||2||
48288633|NCT02457559|101033616|FG001|NOT COMPLETED|Overall Study||3||
48288634|NCT02457559|101033617|FG002|NOT COMPLETED|Overall Study||7||
48288635|NCT02457559|101033618|FG003|NOT COMPLETED|Overall Study||0||
48288636|NCT02457559|101033619|FG004|NOT COMPLETED|Overall Study||1||
48288637|NCT02457559|101033620|FG005|NOT COMPLETED|Overall Study||2||
48288638|NCT02457559|101033621|FG006|NOT COMPLETED|Overall Study||2||
48288639|NCT02457559|101033622|FG007|NOT COMPLETED|Overall Study||0||
48288640|NCT02457559|101033623|FG008|NOT COMPLETED|Overall Study||3||
48288641|NCT02457559|101033624|FG009|NOT COMPLETED|Overall Study||4||
48288642|NCT02457559|101033625|FG010|NOT COMPLETED|Overall Study||2||
48288643|NCT00926497|101033626|FG000|STARTED|Overall Study||60||
48288644|NCT00926497|101033627|FG001|STARTED|Overall Study||61||
48288645|NCT00926497|101033626|FG000|COMPLETED|Overall Study||60||
48288646|NCT00926497|101033627|FG001|COMPLETED|Overall Study||61||
48288647|NCT00926497|101033626|FG000|NOT COMPLETED|Overall Study||0||
48288648|NCT00926497|101033627|FG001|NOT COMPLETED|Overall Study||0||
48288649|NCT03737474|101033628|FG000|STARTED|Overall Study||31||
48288650|NCT03737474|101033629|FG001|STARTED|Overall Study||216||
48288651|NCT03737474|101033628|FG000|COMPLETED|Overall Study||6||
48288652|NCT03737474|101033629|FG001|COMPLETED|Overall Study||132||
48582099|NCT02587598|101756011|FG005|COMPLETED|Overall Study||0|All participants in each arm discontinued study treatment and withdrew from the study.|
48582100|NCT02587598|101756012|FG006|COMPLETED|Overall Study||0|All participants in each arm discontinued study treatment and withdrew from the study.|
48582101|NCT02587598|101756013|FG007|COMPLETED|Overall Study||0|All participants in each arm discontinued study treatment and withdrew from the study.|
48582102|NCT02587598|101756014|FG008|COMPLETED|Overall Study||0|All participants in each arm discontinued study treatment and withdrew from the study.|
48582103|NCT02587598|101756015|FG009|COMPLETED|Overall Study||0|All participants in each arm discontinued study treatment and withdrew from the study.|
48582104|NCT02587598|101756016|FG010|COMPLETED|Overall Study||0|All participants in each arm discontinued study treatment and withdrew from the study.|
48582105|NCT02587598|101756006|FG000|NOT COMPLETED|Overall Study||4||
48582106|NCT02587598|101756007|FG001|NOT COMPLETED|Overall Study||11||
48582107|NCT02587598|101756008|FG002|NOT COMPLETED|Overall Study||4||
48582108|NCT02587598|101756009|FG003|NOT COMPLETED|Overall Study||21||
48582109|NCT02587598|101756010|FG004|NOT COMPLETED|Overall Study||12||
48582110|NCT02587598|101756011|FG005|NOT COMPLETED|Overall Study||6||
48582111|NCT02587598|101756012|FG006|NOT COMPLETED|Overall Study||6||
48582112|NCT02587598|101756013|FG007|NOT COMPLETED|Overall Study||7||
48582113|NCT02587598|101756014|FG008|NOT COMPLETED|Overall Study||9||
48582114|NCT02587598|101756015|FG009|NOT COMPLETED|Overall Study||3||
48582115|NCT02587598|101756016|FG010|NOT COMPLETED|Overall Study||14||
48582116|NCT02513498|101756017|FG000|STARTED|Overall Study||50||
48582117|NCT02513498|101756017|FG000|COMPLETED|Overall Study||26||
48582118|NCT02513498|101756017|FG000|NOT COMPLETED|Overall Study||24||
48582119|NCT02336360|101756018|FG000|STARTED|Overall Study||6||
48582120|NCT02336360|101756018|FG000|COMPLETED|Overall Study||6||
48582121|NCT02336360|101756018|FG000|NOT COMPLETED|Overall Study||0||
48582122|NCT03452488|101756019|FG000|STARTED|Overall Study||81||
48582123|NCT03452488|101756020|FG001|STARTED|Overall Study||76||
48582124|NCT03452488|101756021|FG002|STARTED|Overall Study||76||
48582125|NCT03452488|101756019|FG000|COMPLETED|Overall Study||70||
48582126|NCT03452488|101756020|FG001|COMPLETED|Overall Study||64||
48582127|NCT03452488|101756021|FG002|COMPLETED|Overall Study||69||
48582128|NCT03452488|101756019|FG000|NOT COMPLETED|Overall Study||11||
48582129|NCT03452488|101756020|FG001|NOT COMPLETED|Overall Study||12||
48582130|NCT03452488|101756021|FG002|NOT COMPLETED|Overall Study||7||
48582131|NCT04713592|101756022|FG000|STARTED|Double-blind Period (Baseline - Week 16)||87||
48288653|NCT03737474|101033628|FG000|NOT COMPLETED|Overall Study||25||
48288654|NCT03737474|101033629|FG001|NOT COMPLETED|Overall Study||84||
48288655|NCT02469389|101033630|FG000|STARTED|Overall Study||53||
48288656|NCT02469389|101033631|FG001|STARTED|Overall Study||52||
48288657|NCT02469389|101033630|FG000|Completed 12-week Assessment|Overall Study||40||
48288658|NCT02469389|101033631|FG001|Completed 12-week Assessment|Overall Study||44||
48288659|NCT02469389|101033630|FG000|Completed 24-week Assessment|Overall Study||37||
48288660|NCT02469389|101033631|FG001|Completed 24-week Assessment|Overall Study||46||
48288661|NCT02469389|101033630|FG000|COMPLETED|Overall Study||37||
48288662|NCT02469389|101033631|FG001|COMPLETED|Overall Study||44||
48288663|NCT02469389|101033630|FG000|NOT COMPLETED|Overall Study||16||
48288664|NCT02469389|101033631|FG001|NOT COMPLETED|Overall Study||8||
48288665|NCT02533570|101033632|FG000|STARTED|Overall Study||4||
48288666|NCT02533570|101033633|FG001|STARTED|Overall Study||8||
48288667|NCT02533570|101033634|FG002|STARTED|Overall Study||8||
48288668|NCT02533570|101033632|FG000|COMPLETED|Overall Study||4||
48288669|NCT02533570|101033633|FG001|COMPLETED|Overall Study||7||
48288670|NCT02533570|101033634|FG002|COMPLETED|Overall Study||7||
48288671|NCT02533570|101033632|FG000|NOT COMPLETED|Overall Study||0||
48288672|NCT02533570|101033633|FG001|NOT COMPLETED|Overall Study||1||
48288673|NCT02533570|101033634|FG002|NOT COMPLETED|Overall Study||1||
48288674|NCT00158860|101033635|FG000|STARTED|Overall Study||128||
48288675|NCT00158860|101033636|FG001|STARTED|Overall Study||255||
48288676|NCT00158860|101033635|FG000|COMPLETED|Overall Study||93||
48288677|NCT00158860|101033636|FG001|COMPLETED|Overall Study||184||
48288678|NCT00158860|101033635|FG000|NOT COMPLETED|Overall Study||35||
48288679|NCT00158860|101033636|FG001|NOT COMPLETED|Overall Study||71||
48582132|NCT04713592|101756023|FG001|STARTED|Double-blind Period (Baseline - Week 16)||87||
48582133|NCT04713592|101756024|FG002|STARTED|Double-blind Period (Baseline - Week 16)||0||
48582134|NCT04713592|101756025|FG003|STARTED|Double-blind Period (Baseline - Week 16)||0||
48288680|NCT01290315|101033637|FG000|STARTED|Overall Study||14||
48288681|NCT01290315|101033638|FG001|STARTED|Overall Study||12||
48400850|NCT01634113|101313643|FG002|NOT COMPLETED|Overall Study||1||
48582135|NCT04713592|101756022|FG000|COMPLETED|Double-blind Period (Baseline - Week 16)||81||
48582136|NCT04713592|101756023|FG001|COMPLETED|Double-blind Period (Baseline - Week 16)||84||
48582137|NCT04713592|101756024|FG002|COMPLETED|Double-blind Period (Baseline - Week 16)||0||
48582138|NCT04713592|101756025|FG003|COMPLETED|Double-blind Period (Baseline - Week 16)||0||
48582139|NCT04713592|101756022|FG000|NOT COMPLETED|Double-blind Period (Baseline - Week 16)||6||
48582140|NCT04713592|101756023|FG001|NOT COMPLETED|Double-blind Period (Baseline - Week 16)||3||
48582141|NCT04713592|101756024|FG002|NOT COMPLETED|Double-blind Period (Baseline - Week 16)||0||
48582142|NCT04713592|101756025|FG003|NOT COMPLETED|Double-blind Period (Baseline - Week 16)||0||
48582143|NCT04713592|101756022|FG000|STARTED|Open-label Period (Week 16 - Week 52)||0||
48582144|NCT04713592|101756023|FG001|STARTED|Open-label Period (Week 16 - Week 52)||0||
48582145|NCT04713592|101756024|FG002|STARTED|Open-label Period (Week 16 - Week 52)||81||
48582146|NCT04713592|101756025|FG003|STARTED|Open-label Period (Week 16 - Week 52)||84||
48582147|NCT04713592|101756022|FG000|Entered Open-label Period and Received Study Drug|Open-label Period (Week 16 - Week 52)||0||
48582148|NCT04713592|101756023|FG001|Entered Open-label Period and Received Study Drug|Open-label Period (Week 16 - Week 52)||0||
48582149|NCT04713592|101756024|FG002|Entered Open-label Period and Received Study Drug|Open-label Period (Week 16 - Week 52)||81||
48582150|NCT04713592|101756025|FG003|Entered Open-label Period and Received Study Drug|Open-label Period (Week 16 - Week 52)||81||
48288682|NCT01290315|101033639|FG002|STARTED|Overall Study||10||
48288683|NCT01290315|101033640|FG003|STARTED|Overall Study||13||
48288684|NCT01290315|101033637|FG000|COMPLETED|Overall Study||11||
48288685|NCT01290315|101033638|FG001|COMPLETED|Overall Study||9||
48288686|NCT01290315|101033639|FG002|COMPLETED|Overall Study||10||
48288687|NCT01290315|101033640|FG003|COMPLETED|Overall Study||8||
48288688|NCT01290315|101033637|FG000|NOT COMPLETED|Overall Study||3||
48288689|NCT01290315|101033638|FG001|NOT COMPLETED|Overall Study||3||
48288690|NCT01290315|101033639|FG002|NOT COMPLETED|Overall Study||0||
48288691|NCT01290315|101033640|FG003|NOT COMPLETED|Overall Study||5||
48288692|NCT01090427|101033641|FG000|STARTED|Controlled Period||37||
48288693|NCT01090427|101033642|FG001|STARTED|Controlled Period||37||
48288694|NCT01090427|101033643|FG002|STARTED|Controlled Period||36||
48288695|NCT01090427|101033644|FG003|STARTED|Controlled Period||0||
48288696|NCT01090427|101033645|FG004|STARTED|Controlled Period||0||
48288697|NCT01090427|101033646|FG005|STARTED|Controlled Period||0||
48288698|NCT01090427|101033647|FG006|STARTED|Controlled Period||0||
48288699|NCT01090427|101033641|FG000|COMPLETED|Controlled Period||37||
48288700|NCT01090427|101033642|FG001|COMPLETED|Controlled Period||37||
48288701|NCT01090427|101033643|FG002|COMPLETED|Controlled Period||36||
48288702|NCT01090427|101033644|FG003|COMPLETED|Controlled Period||0||
48288703|NCT01090427|101033645|FG004|COMPLETED|Controlled Period||0||
48288704|NCT01090427|101033646|FG005|COMPLETED|Controlled Period||0||
48288705|NCT01090427|101033647|FG006|COMPLETED|Controlled Period||0||
48288706|NCT01090427|101033641|FG000|NOT COMPLETED|Controlled Period||0||
48288707|NCT01090427|101033642|FG001|NOT COMPLETED|Controlled Period||0||
48288708|NCT01090427|101033643|FG002|NOT COMPLETED|Controlled Period||0||
48288709|NCT01090427|101033644|FG003|NOT COMPLETED|Controlled Period||0||
48582151|NCT04713592|101756022|FG000|COMPLETED|Open-label Period (Week 16 - Week 52)||0||
48582152|NCT04713592|101756023|FG001|COMPLETED|Open-label Period (Week 16 - Week 52)||0||
48582153|NCT04713592|101756024|FG002|COMPLETED|Open-label Period (Week 16 - Week 52)||59||
48582154|NCT04713592|101756025|FG003|COMPLETED|Open-label Period (Week 16 - Week 52)||61||
48582155|NCT04713592|101756022|FG000|NOT COMPLETED|Open-label Period (Week 16 - Week 52)||0||
48582156|NCT04713592|101756023|FG001|NOT COMPLETED|Open-label Period (Week 16 - Week 52)||0||
48582157|NCT04713592|101756024|FG002|NOT COMPLETED|Open-label Period (Week 16 - Week 52)||22||
48582158|NCT04713592|101756025|FG003|NOT COMPLETED|Open-label Period (Week 16 - Week 52)||23||
48582159|NCT01323595|101756026|FG000|STARTED|Overall Study||39||
48582160|NCT01323595|101756027|FG001|STARTED|Overall Study||39||
48582161|NCT01323595|101756026|FG000|COMPLETED|Overall Study||16||
48582162|NCT01323595|101756027|FG001|COMPLETED|Overall Study||18||
48582163|NCT01323595|101756026|FG000|NOT COMPLETED|Overall Study||23||
48582164|NCT01323595|101756027|FG001|NOT COMPLETED|Overall Study||21||
48288710|NCT01090427|101033645|FG004|NOT COMPLETED|Controlled Period||0||
48582165|NCT03103321|101756028|FG000|STARTED|Overall Study||25||
48582166|NCT03103321|101756029|FG001|STARTED|Overall Study||39||
48704833|NCT02534935|102064949|FG001|COMPLETED|Stage 2: Booster Phase (6 Months)||147||
48704834|NCT02534935|102064950|FG002|COMPLETED|Stage 2: Booster Phase (6 Months)||0||
48288711|NCT01090427|101033646|FG005|NOT COMPLETED|Controlled Period||0||
48288712|NCT01090427|101033647|FG006|NOT COMPLETED|Controlled Period||0||
48288713|NCT01090427|101033641|FG000|STARTED|After Controlled Period||0||
48288714|NCT01090427|101033642|FG001|STARTED|After Controlled Period||0||
48582167|NCT03103321|101756030|FG002|STARTED|Overall Study||44||
48582168|NCT03103321|101756031|FG003|STARTED|Overall Study||50||
48288715|NCT01090427|101033643|FG002|STARTED|After Controlled Period||0||
48288716|NCT01090427|101033644|FG003|STARTED|After Controlled Period||19||
48288717|NCT01090427|101033645|FG004|STARTED|After Controlled Period||18||
48288718|NCT01090427|101033646|FG005|STARTED|After Controlled Period||37||
48288719|NCT01090427|101033647|FG006|STARTED|After Controlled Period||36||
48288720|NCT01090427|101033641|FG000|COMPLETED|After Controlled Period||0||
48288721|NCT01090427|101033642|FG001|COMPLETED|After Controlled Period||0||
48582169|NCT03103321|101756028|FG000|COMPLETED|Overall Study||24||
48582170|NCT03103321|101756029|FG001|COMPLETED|Overall Study||38||
48288722|NCT01090427|101033643|FG002|COMPLETED|After Controlled Period||0||
48288723|NCT01090427|101033644|FG003|COMPLETED|After Controlled Period||17||
48288724|NCT01090427|101033645|FG004|COMPLETED|After Controlled Period||18||
48582171|NCT03103321|101756030|FG002|COMPLETED|Overall Study||43||
48582172|NCT03103321|101756031|FG003|COMPLETED|Overall Study||50||
48582173|NCT03103321|101756028|FG000|NOT COMPLETED|Overall Study||1||
48582174|NCT03103321|101756029|FG001|NOT COMPLETED|Overall Study||1||
48582175|NCT03103321|101756030|FG002|NOT COMPLETED|Overall Study||1||
48582176|NCT03103321|101756031|FG003|NOT COMPLETED|Overall Study||0||
48582177|NCT03268382|101756032|FG000|STARTED|Overall Study||28||
48582178|NCT03268382|101756033|FG001|STARTED|Overall Study||3||
48582179|NCT03268382|101756034|FG002|STARTED|Overall Study||2||
48582180|NCT03268382|101756035|FG003|STARTED|Overall Study||3||
48582181|NCT03268382|101756032|FG000|COMPLETED|Overall Study||28||
48582182|NCT03268382|101756033|FG001|COMPLETED|Overall Study||3||
48288725|NCT01090427|101033646|FG005|COMPLETED|After Controlled Period||32||
48288726|NCT01090427|101033647|FG006|COMPLETED|After Controlled Period||34||
48288727|NCT01090427|101033641|FG000|NOT COMPLETED|After Controlled Period||0||
48288728|NCT01090427|101033642|FG001|NOT COMPLETED|After Controlled Period||0||
48288729|NCT01090427|101033643|FG002|NOT COMPLETED|After Controlled Period||0||
48288730|NCT01090427|101033644|FG003|NOT COMPLETED|After Controlled Period||2||
48582183|NCT03268382|101756034|FG002|COMPLETED|Overall Study||2||
48582184|NCT03268382|101756035|FG003|COMPLETED|Overall Study||3||
48582185|NCT03268382|101756032|FG000|NOT COMPLETED|Overall Study||0||
48582186|NCT03268382|101756033|FG001|NOT COMPLETED|Overall Study||0||
48582187|NCT03268382|101756034|FG002|NOT COMPLETED|Overall Study||0||
48582188|NCT03268382|101756035|FG003|NOT COMPLETED|Overall Study||0||
48582189|NCT01895270|101756036|FG000|STARTED|Study Medications Induction (W1-4)||11||
48582190|NCT01895270|101756037|FG001|STARTED|Study Medications Induction (W1-4)||14||
48582191|NCT01895270|101756036|FG000|COMPLETED|Study Medications Induction (W1-4)||5||
48582192|NCT01895270|101756037|FG001|COMPLETED|Study Medications Induction (W1-4)||8||
48582193|NCT01895270|101756036|FG000|NOT COMPLETED|Study Medications Induction (W1-4)||6||
48136761|NCT01910129|100661343|FG002|STARTED|Run-in Period Phase 1||13||
48136762|NCT01910129|100661341|FG000|COMPLETED|Run-in Period Phase 1||0||
48136763|NCT01910129|100661342|FG001|COMPLETED|Run-in Period Phase 1||0||
48136764|NCT01910129|100661343|FG002|COMPLETED|Run-in Period Phase 1||13||
48136765|NCT01910129|100661341|FG000|NOT COMPLETED|Run-in Period Phase 1||0||
48136766|NCT01910129|100661342|FG001|NOT COMPLETED|Run-in Period Phase 1||0||
48136767|NCT01910129|100661343|FG002|NOT COMPLETED|Run-in Period Phase 1||0||
48136768|NCT01910129|100661341|FG000|STARTED|Randomized Phase 2||7||
48136769|NCT01910129|100661342|FG001|STARTED|Randomized Phase 2||6||
48136770|NCT01910129|100661343|FG002|STARTED|Randomized Phase 2||0||
48136771|NCT01910129|100661341|FG000|COMPLETED|Randomized Phase 2||5||
48582194|NCT01895270|101756037|FG001|NOT COMPLETED|Study Medications Induction (W1-4)||6||
48582195|NCT01895270|101756036|FG000|STARTED|Buprenorphine Taper (W5 to W6D3)||5||
48136772|NCT01910129|100661342|FG001|COMPLETED|Randomized Phase 2||5||
48136773|NCT01910129|100661343|FG002|COMPLETED|Randomized Phase 2||0||
48582196|NCT01895270|101756037|FG001|STARTED|Buprenorphine Taper (W5 to W6D3)||7||
48582197|NCT01895270|101756036|FG000|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2||
48582198|NCT01895270|101756037|FG001|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2||
48582199|NCT01895270|101756036|FG000|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||3||
48582200|NCT01895270|101756037|FG001|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||5||
48582201|NCT01895270|101756036|FG000|STARTED|Isradipine Taper (W7-8)||2||
48582202|NCT01895270|101756037|FG001|STARTED|Isradipine Taper (W7-8)||2||
48288731|NCT01090427|101033645|FG004|NOT COMPLETED|After Controlled Period||0||
48288732|NCT01090427|101033646|FG005|NOT COMPLETED|After Controlled Period||5||
48288733|NCT01090427|101033647|FG006|NOT COMPLETED|After Controlled Period||2||
48136774|NCT01910129|100661341|FG000|NOT COMPLETED|Randomized Phase 2||2||
48136775|NCT01910129|100661342|FG001|NOT COMPLETED|Randomized Phase 2||1||
48136776|NCT01910129|100661343|FG002|NOT COMPLETED|Randomized Phase 2||0||
48136777|NCT01910129|100661341|FG000|STARTED|Randomized Phase 3||5||
48288734|NCT04161495|101033648|FG000|STARTED|Overall Study||133||
48288735|NCT04161495|101033649|FG001|STARTED|Overall Study||26||
48288736|NCT04161495|101033648|FG000|Historical Prophylaxis in OBS16221|Overall Study||82||
48288737|NCT04161495|101033649|FG001|Historical Prophylaxis in OBS16221|Overall Study||10||
48288738|NCT04161495|101033648|FG000|Arm B: On-demand|Overall Study||0||
48288739|NCT04161495|101033649|FG001|Arm B: On-demand|Overall Study||26||
48288740|NCT04161495|101033648|FG000|Arm B: Prophylaxis|Overall Study||0||
48288741|NCT04161495|101033649|FG001|Arm B: Prophylaxis|Overall Study||26||
48288742|NCT04161495|101033648|FG000|COMPLETED|Overall Study||124||
48288743|NCT04161495|101033649|FG001|COMPLETED|Overall Study||25||
48288744|NCT04161495|101033648|FG000|NOT COMPLETED|Overall Study||9||
48288745|NCT04161495|101033649|FG001|NOT COMPLETED|Overall Study||1||
48288746|NCT03525431|101033650|FG000|STARTED|Overall Study||529||
48582203|NCT01895270|101756036|FG000|COMPLETED|Isradipine Taper (W7-8)||2||
48582204|NCT01895270|101756037|FG001|COMPLETED|Isradipine Taper (W7-8)||0||
48582205|NCT01895270|101756036|FG000|NOT COMPLETED|Isradipine Taper (W7-8)||0||
48582206|NCT01895270|101756037|FG001|NOT COMPLETED|Isradipine Taper (W7-8)||2||
48582207|NCT03778931|101756038|FG000|STARTED|Overall Study||239||
48582208|NCT03778931|101756039|FG001|STARTED|Overall Study||239||
48136778|NCT01910129|100661342|FG001|STARTED|Randomized Phase 3||5||
48136779|NCT01910129|100661343|FG002|STARTED|Randomized Phase 3||0||
48136780|NCT01910129|100661341|FG000|COMPLETED|Randomized Phase 3||5||
48136781|NCT01910129|100661342|FG001|COMPLETED|Randomized Phase 3||4||
48136782|NCT01910129|100661343|FG002|COMPLETED|Randomized Phase 3||0||
48136783|NCT01910129|100661341|FG000|NOT COMPLETED|Randomized Phase 3||0||
48136784|NCT01910129|100661342|FG001|NOT COMPLETED|Randomized Phase 3||1||
48136785|NCT01910129|100661343|FG002|NOT COMPLETED|Randomized Phase 3||0||
48136786|NCT00655980|100661344|FG000|STARTED|Overall Study||276||
48136787|NCT00655980|100661345|FG001|STARTED|Overall Study||281||
48136788|NCT00655980|100661346|FG002|STARTED|Overall Study||130||
48136789|NCT00655980|100661344|FG000|COMPLETED|Overall Study||250||
48136790|NCT00655980|100661345|FG001|COMPLETED|Overall Study||250||
48136791|NCT00655980|100661346|FG002|COMPLETED|Overall Study||125||
48136792|NCT00655980|100661344|FG000|NOT COMPLETED|Overall Study||26||
48136793|NCT00655980|100661345|FG001|NOT COMPLETED|Overall Study||31||
48136794|NCT00655980|100661346|FG002|NOT COMPLETED|Overall Study||5||
48288747|NCT03525431|101033650|FG000|COMPLETED|Overall Study||529||
48288748|NCT03525431|101033650|FG000|NOT COMPLETED|Overall Study||0||
48288749|NCT00946101|101033651|FG000|STARTED|Overall Study||261||
48288750|NCT00946101|101033652|FG001|STARTED|Overall Study||65||
48288751|NCT00946101|101033651|FG000|Day 15 Post Dose 1|Overall Study||260||
48582209|NCT03778931|101756038|FG000|Intent-to-Treat Population|Overall Study||239||
48582210|NCT03778931|101756039|FG001|Intent-to-Treat Population|Overall Study||239||
48582211|NCT03778931|101756038|FG000|Safety Population|Overall Study||237||
48582212|NCT03778931|101756039|FG001|Safety Population|Overall Study||230||
48288752|NCT00946101|101033652|FG001|Day 15 Post Dose 1|Overall Study||64||
48288753|NCT00946101|101033651|FG000|Day 15 Post Dose 2|Overall Study||254||
48288754|NCT00946101|101033652|FG001|Day 15 Post Dose 2|Overall Study||63||
48288755|NCT00946101|101033651|FG000|COMPLETED|Overall Study||257||
48288756|NCT00946101|101033652|FG001|COMPLETED|Overall Study||63||
48288757|NCT00946101|101033651|FG000|NOT COMPLETED|Overall Study||4||
48400851|NCT01810380|101313644|FG000|STARTED|Overall Study||163||
48400852|NCT01810380|101313645|FG001|STARTED|Overall Study||151||
48400853|NCT01810380|101313646|FG002|STARTED|Overall Study||154||
48400854|NCT01810380|101313644|FG000|Treated|Overall Study||161||
48400855|NCT01810380|101313645|FG001|Treated|Overall Study||150||
48400856|NCT01810380|101313646|FG002|Treated|Overall Study||153||
48400857|NCT01810380|101313644|FG000|COMPLETED|Overall Study||108||
48400858|NCT01810380|101313645|FG001|COMPLETED|Overall Study||113||
48400859|NCT01810380|101313646|FG002|COMPLETED|Overall Study||122||
48400860|NCT01810380|101313644|FG000|NOT COMPLETED|Overall Study||55||
48400861|NCT01810380|101313645|FG001|NOT COMPLETED|Overall Study||38||
48400862|NCT01810380|101313646|FG002|NOT COMPLETED|Overall Study||32||
48400863|NCT03037307|101313647|FG000|STARTED|Period 1||7||
48400864|NCT03037307|101313648|FG001|STARTED|Period 1||7||
48400865|NCT03037307|101313649|FG002|STARTED|Period 1||8||
48400866|NCT03037307|101313650|FG003|STARTED|Period 1||7||
48400867|NCT03037307|101313651|FG004|STARTED|Period 1||7||
48400868|NCT03037307|101313652|FG005|STARTED|Period 1||8||
48400869|NCT03037307|101313647|FG000|COMPLETED|Period 1||7||
48400870|NCT03037307|101313648|FG001|COMPLETED|Period 1||7||
48400871|NCT03037307|101313649|FG002|COMPLETED|Period 1||8||
48400872|NCT03037307|101313650|FG003|COMPLETED|Period 1||6||
48400873|NCT03037307|101313651|FG004|COMPLETED|Period 1||7||
48400874|NCT03037307|101313652|FG005|COMPLETED|Period 1||8||
48400875|NCT03037307|101313647|FG000|NOT COMPLETED|Period 1||0||
48400876|NCT03037307|101313648|FG001|NOT COMPLETED|Period 1||0||
48136795|NCT00833989|100661347|FG000|STARTED|Overall Study||17||
48136796|NCT00833989|100661348|FG001|STARTED|Overall Study||8||
48136797|NCT00833989|100661349|FG002|STARTED|Overall Study||9||
48136798|NCT00833989|100661350|FG003|STARTED|Overall Study||8||
48136799|NCT00833989|100661347|FG000|COMPLETED|Overall Study||14||
48136800|NCT00833989|100661348|FG001|COMPLETED|Overall Study||8||
48136801|NCT00833989|100661349|FG002|COMPLETED|Overall Study||8||
48288758|NCT00946101|101033652|FG001|NOT COMPLETED|Overall Study||2||
48288759|NCT04800432|101033653|FG000|STARTED|Overall Study||47||
48288760|NCT04800432|101033654|FG001|STARTED|Overall Study||48||
48288761|NCT04800432|101033653|FG000|Parents Who Started|Overall Study||24||
48288762|NCT04800432|101033654|FG001|Parents Who Started|Overall Study||24||
48400877|NCT03037307|101313649|FG002|NOT COMPLETED|Period 1||0||
48400878|NCT03037307|101313650|FG003|NOT COMPLETED|Period 1||1||
48400879|NCT03037307|101313651|FG004|NOT COMPLETED|Period 1||0||
48400880|NCT03037307|101313652|FG005|NOT COMPLETED|Period 1||0||
48400881|NCT03037307|101313647|FG000|STARTED|Wash Out Period 1||7||
48400882|NCT03037307|101313648|FG001|STARTED|Wash Out Period 1||7||
48400883|NCT03037307|101313649|FG002|STARTED|Wash Out Period 1||8||
48400884|NCT03037307|101313650|FG003|STARTED|Wash Out Period 1||6||
48400885|NCT03037307|101313651|FG004|STARTED|Wash Out Period 1||7||
48400886|NCT03037307|101313652|FG005|STARTED|Wash Out Period 1||8||
48582213|NCT03778931|101756038|FG000|COMPLETED|Overall Study||95||
48136802|NCT00833989|100661350|FG003|COMPLETED|Overall Study||6||
48136803|NCT00833989|100661347|FG000|NOT COMPLETED|Overall Study||3||
48136804|NCT00833989|100661348|FG001|NOT COMPLETED|Overall Study||0||
48400887|NCT03037307|101313647|FG000|COMPLETED|Wash Out Period 1||7||
48400888|NCT03037307|101313648|FG001|COMPLETED|Wash Out Period 1||7||
48136805|NCT00833989|100661349|FG002|NOT COMPLETED|Overall Study||1||
48136806|NCT00833989|100661350|FG003|NOT COMPLETED|Overall Study||2||
48136807|NCT03057119|100661351|FG000|STARTED|Overall Study||17||
48136808|NCT03057119|100661352|FG001|STARTED|Overall Study||17||
48136809|NCT03057119|100661353|FG002|STARTED|Overall Study||52||
48136810|NCT03057119|100661351|FG000|Completed T1|Overall Study||17||
48136811|NCT03057119|100661352|FG001|Completed T1|Overall Study||17||
48136812|NCT03057119|100661353|FG002|Completed T1|Overall Study||45||
48136813|NCT03057119|100661351|FG000|Completed T2|Overall Study||9||
48136814|NCT03057119|100661352|FG001|Completed T2|Overall Study||5||
48288763|NCT04800432|101033653|FG000|Youth Who Started|Overall Study||23||
48288764|NCT04800432|101033654|FG001|Youth Who Started|Overall Study||24||
48288765|NCT04800432|101033653|FG000|COMPLETED|Overall Study||41||
48288766|NCT04800432|101033654|FG001|COMPLETED|Overall Study||35||
48288767|NCT04800432|101033653|FG000|NOT COMPLETED|Overall Study||6||
48288768|NCT04800432|101033654|FG001|NOT COMPLETED|Overall Study||13||
48288769|NCT02716818|101033655|FG000|STARTED|Overall Study||61||
48288770|NCT02716818|101033656|FG001|STARTED|Overall Study||61||
48288771|NCT02716818|101033655|FG000|COMPLETED|Overall Study||58||
48582214|NCT03778931|101756039|FG001|COMPLETED|Overall Study||114||
48582215|NCT03778931|101756038|FG000|NOT COMPLETED|Overall Study||144||
48582216|NCT03778931|101756039|FG001|NOT COMPLETED|Overall Study||125||
48582217|NCT01489254|101756040|FG000|STARTED|Double-blind Part||355||
48582218|NCT01489254|101756041|FG001|STARTED|Double-blind Part||357||
48582219|NCT01489254|101756042|FG002|STARTED|Double-blind Part||84||
48582220|NCT01489254|101756043|FG003|STARTED|Double-blind Part||0||
48582221|NCT01489254|101756040|FG000|COMPLETED|Double-blind Part||330||
48582222|NCT01489254|101756041|FG001|COMPLETED|Double-blind Part||324||
48582223|NCT01489254|101756042|FG002|COMPLETED|Double-blind Part||81||
48582224|NCT01489254|101756043|FG003|COMPLETED|Double-blind Part||0||
48582225|NCT01489254|101756040|FG000|NOT COMPLETED|Double-blind Part||25||
48582226|NCT01489254|101756041|FG001|NOT COMPLETED|Double-blind Part||33||
48582227|NCT01489254|101756042|FG002|NOT COMPLETED|Double-blind Part||3||
48582228|NCT01489254|101756043|FG003|NOT COMPLETED|Double-blind Part||0||
48582229|NCT01489254|101756040|FG000|STARTED|Open-label Extension Part||0||
48582230|NCT01489254|101756041|FG001|STARTED|Open-label Extension Part||0||
48582231|NCT01489254|101756042|FG002|STARTED|Open-label Extension Part||0||
48582232|NCT01489254|101756043|FG003|STARTED|Open-label Extension Part||728||
48582233|NCT01489254|101756040|FG000|COMPLETED|Open-label Extension Part||0||
48582234|NCT01489254|101756041|FG001|COMPLETED|Open-label Extension Part||0||
48582235|NCT01489254|101756042|FG002|COMPLETED|Open-label Extension Part||0||
48582236|NCT01489254|101756043|FG003|COMPLETED|Open-label Extension Part||670||
48704835|NCT02534935|102064948|FG000|NOT COMPLETED|Stage 2: Booster Phase (6 Months)||0||
48704836|NCT02534935|102064949|FG001|NOT COMPLETED|Stage 2: Booster Phase (6 Months)||1||
48136815|NCT03057119|100661353|FG002|Completed T2|Overall Study||30||
48136816|NCT03057119|100661351|FG000|Completed T3|Overall Study||4||
48136817|NCT03057119|100661352|FG001|Completed T3|Overall Study||3||
48136818|NCT03057119|100661353|FG002|Completed T3|Overall Study||35||
48136819|NCT03057119|100661351|FG000|COMPLETED|Overall Study||4|Completed all 3 assessments|
48136820|NCT03057119|100661352|FG001|COMPLETED|Overall Study||3|Completed all 3 assessments|
48136821|NCT03057119|100661353|FG002|COMPLETED|Overall Study||13|Completed all 3 assessments|
48136822|NCT03057119|100661351|FG000|NOT COMPLETED|Overall Study||13||
48136823|NCT03057119|100661352|FG001|NOT COMPLETED|Overall Study||14||
48136824|NCT03057119|100661353|FG002|NOT COMPLETED|Overall Study||39||
48582237|NCT01489254|101756040|FG000|NOT COMPLETED|Open-label Extension Part||0||
48582238|NCT01489254|101756041|FG001|NOT COMPLETED|Open-label Extension Part||0||
48582239|NCT01489254|101756042|FG002|NOT COMPLETED|Open-label Extension Part||0||
48582240|NCT01489254|101756043|FG003|NOT COMPLETED|Open-label Extension Part||58||
48704837|NCT02534935|102064950|FG002|NOT COMPLETED|Stage 2: Booster Phase (6 Months)||0||
48704838|NCT00510718|102064951|FG000|STARTED|Single Dose Period: 1 Week||15||
48136825|NCT03248739|100661354|FG000|STARTED|Overall Study||17||
48136826|NCT03248739|100661355|FG001|STARTED|Overall Study||16||
48136827|NCT03248739|100661354|FG000|COMPLETED|Overall Study||17||
48288772|NCT02716818|101033656|FG001|COMPLETED|Overall Study||59||
48288773|NCT02716818|101033655|FG000|NOT COMPLETED|Overall Study||3||
48288774|NCT02716818|101033656|FG001|NOT COMPLETED|Overall Study||2||
48288775|NCT02656823|101033657|FG000|STARTED|Overall Study||12|Implants placed at implant placement visit (IPV), Visit 3.|72
48288776|NCT02656823|101033657|FG000|Permanent Restoration (PR), Visit 8|Overall Study||11||62
48288777|NCT02656823|101033657|FG000|COMPLETED|Overall Study||7||41
48288778|NCT02656823|101033657|FG000|NOT COMPLETED|Overall Study||5||31
48288779|NCT01237587|101033658|FG000|STARTED|Double Blind Treatment (Acute Phase)||91||
48288780|NCT01237587|101033659|FG001|STARTED|Double Blind Treatment (Acute Phase)||93||
48582241|NCT02949843|101756044|FG000|STARTED|Overall Study||1||
48136828|NCT03248739|100661355|FG001|COMPLETED|Overall Study||16||
48136829|NCT03248739|100661354|FG000|NOT COMPLETED|Overall Study||0||
48400889|NCT03037307|101313649|FG002|COMPLETED|Wash Out Period 1||8||
48582242|NCT02949843|101756045|FG001|STARTED|Overall Study||2||
48582243|NCT02949843|101756046|FG002|STARTED|Overall Study||3||
48582244|NCT02949843|101756044|FG000|COMPLETED|Overall Study||1||
48582245|NCT02949843|101756045|FG001|COMPLETED|Overall Study||1||
48704839|NCT00510718|102064952|FG001|STARTED|Single Dose Period: 1 Week||12||
48704840|NCT00510718|102064951|FG000|30 mg/Day|Single Dose Period: 1 Week||3||
48400890|NCT03037307|101313650|FG003|COMPLETED|Wash Out Period 1||6||
48400891|NCT03037307|101313651|FG004|COMPLETED|Wash Out Period 1||7||
48400892|NCT03037307|101313652|FG005|COMPLETED|Wash Out Period 1||8||
48400893|NCT03037307|101313647|FG000|NOT COMPLETED|Wash Out Period 1||0||
48400894|NCT03037307|101313648|FG001|NOT COMPLETED|Wash Out Period 1||0||
48400895|NCT03037307|101313649|FG002|NOT COMPLETED|Wash Out Period 1||0||
48400896|NCT03037307|101313650|FG003|NOT COMPLETED|Wash Out Period 1||0||
48400897|NCT03037307|101313651|FG004|NOT COMPLETED|Wash Out Period 1||0||
48400898|NCT03037307|101313652|FG005|NOT COMPLETED|Wash Out Period 1||0||
48400899|NCT03037307|101313647|FG000|STARTED|Period 2||7||
48400900|NCT03037307|101313648|FG001|STARTED|Period 2||7||
48400901|NCT03037307|101313649|FG002|STARTED|Period 2||8||
48400902|NCT03037307|101313650|FG003|STARTED|Period 2||6||
48400903|NCT03037307|101313651|FG004|STARTED|Period 2||7||
48400904|NCT03037307|101313652|FG005|STARTED|Period 2||8||
48400905|NCT03037307|101313647|FG000|COMPLETED|Period 2||7||
48400906|NCT03037307|101313648|FG001|COMPLETED|Period 2||7||
48400907|NCT03037307|101313649|FG002|COMPLETED|Period 2||8||
48400908|NCT03037307|101313650|FG003|COMPLETED|Period 2||6||
48400909|NCT03037307|101313651|FG004|COMPLETED|Period 2||7||
48400910|NCT03037307|101313652|FG005|COMPLETED|Period 2||8||
48400911|NCT03037307|101313647|FG000|NOT COMPLETED|Period 2||0||
48400912|NCT03037307|101313648|FG001|NOT COMPLETED|Period 2||0||
48400913|NCT03037307|101313649|FG002|NOT COMPLETED|Period 2||0||
48400914|NCT03037307|101313650|FG003|NOT COMPLETED|Period 2||0||
48136830|NCT03248739|100661355|FG001|NOT COMPLETED|Overall Study||0||
48704841|NCT00510718|102064952|FG001|30 mg/Day|Single Dose Period: 1 Week||0||
48704842|NCT00510718|102064951|FG000|60 mg/Day|Single Dose Period: 1 Week||3||
48704843|NCT00510718|102064952|FG001|60 mg/Day|Single Dose Period: 1 Week||0||
48704844|NCT00510718|102064951|FG000|150/160 mg/Day|Single Dose Period: 1 Week||2||
48704845|NCT00510718|102064952|FG001|150/160 mg/Day|Single Dose Period: 1 Week||1||
48288781|NCT01237587|101033658|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment (Acute Phase)||91||
48288782|NCT01237587|101033659|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment (Acute Phase)||93||
48288783|NCT01237587|101033658|FG000|COMPLETED|Double Blind Treatment (Acute Phase)||74||
48288784|NCT01237587|101033659|FG001|COMPLETED|Double Blind Treatment (Acute Phase)||75||
48288785|NCT01237587|101033658|FG000|NOT COMPLETED|Double Blind Treatment (Acute Phase)||17||
48288786|NCT01237587|101033659|FG001|NOT COMPLETED|Double Blind Treatment (Acute Phase)||18||
48288787|NCT01237587|101033658|FG000|STARTED|Open Label Treatment (Extension Phase)||74||
48288788|NCT01237587|101033659|FG001|STARTED|Open Label Treatment (Extension Phase)||75||
48288789|NCT01237587|101033658|FG000|Received at Least One Dose of Study Drug|Open Label Treatment (Extension Phase)||74||
48288790|NCT01237587|101033659|FG001|Received at Least One Dose of Study Drug|Open Label Treatment (Extension Phase)||75||
48288791|NCT01237587|101033658|FG000|COMPLETED|Open Label Treatment (Extension Phase)||56||
48288792|NCT01237587|101033659|FG001|COMPLETED|Open Label Treatment (Extension Phase)||50||
48288793|NCT01237587|101033658|FG000|NOT COMPLETED|Open Label Treatment (Extension Phase)||18||
48400915|NCT03037307|101313651|FG004|NOT COMPLETED|Period 2||0||
48400916|NCT03037307|101313652|FG005|NOT COMPLETED|Period 2||0||
48400917|NCT03037307|101313647|FG000|STARTED|Wash Out Period 2||7||
48400918|NCT03037307|101313648|FG001|STARTED|Wash Out Period 2||7||
48400919|NCT03037307|101313649|FG002|STARTED|Wash Out Period 2||8||
48400920|NCT03037307|101313650|FG003|STARTED|Wash Out Period 2||6||
48400921|NCT03037307|101313651|FG004|STARTED|Wash Out Period 2||7||
48400922|NCT03037307|101313652|FG005|STARTED|Wash Out Period 2||8||
48400923|NCT03037307|101313647|FG000|COMPLETED|Wash Out Period 2||7||
48400924|NCT03037307|101313648|FG001|COMPLETED|Wash Out Period 2||7||
48400925|NCT03037307|101313649|FG002|COMPLETED|Wash Out Period 2||8||
48400926|NCT03037307|101313650|FG003|COMPLETED|Wash Out Period 2||6||
48400927|NCT03037307|101313651|FG004|COMPLETED|Wash Out Period 2||7||
48400928|NCT03037307|101313652|FG005|COMPLETED|Wash Out Period 2||8||
48400929|NCT03037307|101313647|FG000|NOT COMPLETED|Wash Out Period 2||0||
48704846|NCT00510718|102064951|FG000|240 mg/Day|Single Dose Period: 1 Week||3||
48136831|NCT00360529|100661356|FG000|STARTED|Overall Study||295||
48136832|NCT00360529|100661357|FG001|STARTED|Overall Study||295||
48136833|NCT00360529|100661358|FG002|STARTED|Overall Study||290||
48400930|NCT03037307|101313648|FG001|NOT COMPLETED|Wash Out Period 2||0||
48400931|NCT03037307|101313649|FG002|NOT COMPLETED|Wash Out Period 2||0||
48400932|NCT03037307|101313650|FG003|NOT COMPLETED|Wash Out Period 2||0||
48704847|NCT00510718|102064952|FG001|240 mg/Day|Single Dose Period: 1 Week||0||
48704848|NCT00510718|102064951|FG000|360 mg/Day|Single Dose Period: 1 Week||4||
48136834|NCT00360529|100661356|FG000|COMPLETED|Overall Study||234||
48288794|NCT01237587|101033659|FG001|NOT COMPLETED|Open Label Treatment (Extension Phase)||25||
48288795|NCT01237587|101033658|FG000|STARTED|Taper Phase||36||
48288796|NCT01237587|101033659|FG001|STARTED|Taper Phase||44||
48288797|NCT01237587|101033658|FG000|COMPLETED|Taper Phase||31||
48400933|NCT03037307|101313651|FG004|NOT COMPLETED|Wash Out Period 2||0||
48400934|NCT03037307|101313652|FG005|NOT COMPLETED|Wash Out Period 2||0||
48400935|NCT03037307|101313647|FG000|STARTED|Period 3||7||
48400936|NCT03037307|101313648|FG001|STARTED|Period 3||7||
48400937|NCT03037307|101313649|FG002|STARTED|Period 3||8||
48136835|NCT00360529|100661357|FG001|COMPLETED|Overall Study||230||
48136836|NCT00360529|100661358|FG002|COMPLETED|Overall Study||199||
48136837|NCT00360529|100661356|FG000|NOT COMPLETED|Overall Study||61||
48136838|NCT00360529|100661357|FG001|NOT COMPLETED|Overall Study||65||
48136839|NCT00360529|100661358|FG002|NOT COMPLETED|Overall Study||91||
48582246|NCT02949843|101756046|FG002|COMPLETED|Overall Study||2||
48582247|NCT02949843|101756044|FG000|NOT COMPLETED|Overall Study||0||
48582248|NCT02949843|101756045|FG001|NOT COMPLETED|Overall Study||1||
48582249|NCT02949843|101756046|FG002|NOT COMPLETED|Overall Study||1||
48582250|NCT03957473|101756047|FG000|STARTED|Overall Study||400||
48582251|NCT03957473|101756047|FG000|COMPLETED|Overall Study||370||
48704849|NCT00510718|102064952|FG001|360 mg/Day|Single Dose Period: 1 Week||2||
48136840|NCT02740127|100661359|FG000|STARTED|Overall Study||24||
48136841|NCT02740127|100661360|FG001|STARTED|Overall Study||28||
48582252|NCT03957473|101756047|FG000|NOT COMPLETED|Overall Study||30||
48136842|NCT02740127|100661359|FG000|COMPLETED|Overall Study||24||
48136843|NCT02740127|100661360|FG001|COMPLETED|Overall Study||28||
48136844|NCT02740127|100661359|FG000|NOT COMPLETED|Overall Study||0||
48400938|NCT03037307|101313650|FG003|STARTED|Period 3||6||
48400939|NCT03037307|101313651|FG004|STARTED|Period 3||7||
48400940|NCT03037307|101313652|FG005|STARTED|Period 3||8||
48400941|NCT03037307|101313647|FG000|COMPLETED|Period 3||7||
48400942|NCT03037307|101313648|FG001|COMPLETED|Period 3||7||
48400943|NCT03037307|101313649|FG002|COMPLETED|Period 3||8||
48400944|NCT03037307|101313650|FG003|COMPLETED|Period 3||6||
48400945|NCT03037307|101313651|FG004|COMPLETED|Period 3||7||
48400946|NCT03037307|101313652|FG005|COMPLETED|Period 3||8||
48400947|NCT03037307|101313647|FG000|NOT COMPLETED|Period 3||0||
48400948|NCT03037307|101313648|FG001|NOT COMPLETED|Period 3||0||
48400949|NCT03037307|101313649|FG002|NOT COMPLETED|Period 3||0||
48400950|NCT03037307|101313650|FG003|NOT COMPLETED|Period 3||0||
48400951|NCT03037307|101313651|FG004|NOT COMPLETED|Period 3||0||
48400952|NCT03037307|101313652|FG005|NOT COMPLETED|Period 3||0||
48400953|NCT00880607|101313653|FG000|STARTED|Overall Study||44||
48400954|NCT00880607|101313654|FG001|STARTED|Overall Study||37||
48400955|NCT00880607|101313653|FG000|Observation After Receiving Medication|Overall Study||42||
48582253|NCT02244463|101756048|FG000|STARTED|Period 1: PI DL1 Dose Escalation||3||
48582254|NCT02244463|101756049|FG001|STARTED|Period 1: PI DL1 Dose Escalation||0||
48582255|NCT02244463|101756050|FG002|STARTED|Period 1: PI DL1 Dose Escalation||0||
48582256|NCT02244463|101756051|FG003|STARTED|Period 1: PI DL1 Dose Escalation||0||
48704850|NCT00510718|102064951|FG000|480 mg/Day|Single Dose Period: 1 Week||0||
48136845|NCT02740127|100661360|FG001|NOT COMPLETED|Overall Study||0||
48136846|NCT04829344|100661361|FG000|STARTED|Overall Study||60||
48136847|NCT04829344|100661362|FG001|STARTED|Overall Study||60||
48136848|NCT04829344|100661361|FG000|COMPLETED|Overall Study||60||
48136849|NCT04829344|100661362|FG001|COMPLETED|Overall Study||60||
48136850|NCT04829344|100661361|FG000|NOT COMPLETED|Overall Study||0||
48136851|NCT04829344|100661362|FG001|NOT COMPLETED|Overall Study||0||
48136852|NCT03550313|100661363|FG000|STARTED|Overall Study||192||
48400956|NCT00880607|101313654|FG001|Observation After Receiving Medication|Overall Study||35||
48400957|NCT00880607|101313653|FG000|COMPLETED|Overall Study||37||
48400958|NCT00880607|101313654|FG001|COMPLETED|Overall Study||34||
48400959|NCT00880607|101313653|FG000|NOT COMPLETED|Overall Study||7||
48400960|NCT00880607|101313654|FG001|NOT COMPLETED|Overall Study||3||
48400961|NCT00212758|101313655|FG000|STARTED|First Intervention (7 Days)||8||
48400962|NCT00212758|101313656|FG001|STARTED|First Intervention (7 Days)||9||
48400963|NCT00212758|101313655|FG000|COMPLETED|First Intervention (7 Days)||8||
48400964|NCT00212758|101313656|FG001|COMPLETED|First Intervention (7 Days)||9||
48400965|NCT00212758|101313655|FG000|NOT COMPLETED|First Intervention (7 Days)||0||
48400966|NCT00212758|101313656|FG001|NOT COMPLETED|First Intervention (7 Days)||0||
48400967|NCT00212758|101313655|FG000|STARTED|Wash Out Period (2 Weeks)||8||
48400968|NCT00212758|101313656|FG001|STARTED|Wash Out Period (2 Weeks)||9||
48400969|NCT00212758|101313655|FG000|COMPLETED|Wash Out Period (2 Weeks)||8||
48400970|NCT00212758|101313656|FG001|COMPLETED|Wash Out Period (2 Weeks)||9||
48400971|NCT00212758|101313655|FG000|NOT COMPLETED|Wash Out Period (2 Weeks)||0||
48400972|NCT00212758|101313656|FG001|NOT COMPLETED|Wash Out Period (2 Weeks)||0||
48136853|NCT03550313|100661364|FG001|STARTED|Overall Study||187||
48136854|NCT03550313|100661365|FG002|STARTED|Overall Study||186||
48136855|NCT03550313|100661363|FG000|Vaccinated for Dose 1|Overall Study||171||
48400973|NCT00212758|101313655|FG000|STARTED|Second Intervention (7 Days)||8||
48400974|NCT00212758|101313656|FG001|STARTED|Second Intervention (7 Days)||9||
48400975|NCT00212758|101313655|FG000|COMPLETED|Second Intervention (7 Days)||8||
48400976|NCT00212758|101313656|FG001|COMPLETED|Second Intervention (7 Days)||9||
48400977|NCT00212758|101313655|FG000|NOT COMPLETED|Second Intervention (7 Days)||0||
48400978|NCT00212758|101313656|FG001|NOT COMPLETED|Second Intervention (7 Days)||0||
48400979|NCT00212758|101313655|FG000|STARTED|Standard Therapy of GH (12 Months)||8||
48400980|NCT00212758|101313656|FG001|STARTED|Standard Therapy of GH (12 Months)||9||
48582257|NCT02244463|101756052|FG004|STARTED|Period 1: PI DL1 Dose Escalation||0||
48582258|NCT02244463|101756053|FG005|STARTED|Period 1: PI DL1 Dose Escalation||0||
48136856|NCT03550313|100661364|FG001|Vaccinated for Dose 1|Overall Study||147||
48136857|NCT03550313|100661365|FG002|Vaccinated for Dose 1|Overall Study||166||
48582259|NCT02244463|101756048|FG000|COMPLETED|Period 1: PI DL1 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
48582260|NCT02244463|101756049|FG001|COMPLETED|Period 1: PI DL1 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
48582261|NCT02244463|101756050|FG002|COMPLETED|Period 1: PI DL1 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
48582262|NCT02244463|101756051|FG003|COMPLETED|Period 1: PI DL1 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
48400981|NCT00212758|101313655|FG000|COMPLETED|Standard Therapy of GH (12 Months)||6||
48400982|NCT00212758|101313656|FG001|COMPLETED|Standard Therapy of GH (12 Months)||8||
48400983|NCT00212758|101313655|FG000|NOT COMPLETED|Standard Therapy of GH (12 Months)||2||
48400984|NCT00212758|101313656|FG001|NOT COMPLETED|Standard Therapy of GH (12 Months)||1||
48288798|NCT01237587|101033659|FG001|COMPLETED|Taper Phase||34||
48288799|NCT01237587|101033658|FG000|NOT COMPLETED|Taper Phase||5||
48288800|NCT01237587|101033659|FG001|NOT COMPLETED|Taper Phase||10||
48288801|NCT00883051|101033660|FG000|STARTED|Overall Study||106||
48288802|NCT00883051|101033661|FG001|STARTED|Overall Study||104||
48288803|NCT00883051|101033662|FG002|STARTED|Overall Study||100||
48288804|NCT00883051|101033663|FG003|STARTED|Overall Study||99||
48288805|NCT00883051|101033664|FG004|STARTED|Overall Study||103||
48288806|NCT00883051|101033660|FG000|No Study Medication Used|Overall Study||24||
48288807|NCT00883051|101033661|FG001|No Study Medication Used|Overall Study||22||
48288808|NCT00883051|101033662|FG002|No Study Medication Used|Overall Study||29||
48288809|NCT00883051|101033663|FG003|No Study Medication Used|Overall Study||29||
48288810|NCT00883051|101033664|FG004|No Study Medication Used|Overall Study||17||
48288811|NCT00883051|101033660|FG000|Received at Least 1 Dose of Study Drug|Overall Study||82||
48288812|NCT00883051|101033661|FG001|Received at Least 1 Dose of Study Drug|Overall Study||82||
48288813|NCT00883051|101033662|FG002|Received at Least 1 Dose of Study Drug|Overall Study||71||
48288814|NCT00883051|101033663|FG003|Received at Least 1 Dose of Study Drug|Overall Study||70||
48288815|NCT00883051|101033664|FG004|Received at Least 1 Dose of Study Drug|Overall Study||86||
48288816|NCT00883051|101033660|FG000|COMPLETED|Overall Study||82||
48288817|NCT00883051|101033661|FG001|COMPLETED|Overall Study||82||
48288818|NCT00883051|101033662|FG002|COMPLETED|Overall Study||71||
48400985|NCT01831804|101313657|FG000|STARTED|Overall Study||4||
48400986|NCT01831804|101313658|FG001|STARTED|Overall Study||3||
48400987|NCT01831804|101313659|FG002|STARTED|Overall Study||9||
48288819|NCT00883051|101033663|FG003|COMPLETED|Overall Study||70||
48288820|NCT00883051|101033664|FG004|COMPLETED|Overall Study||85||
48288821|NCT00883051|101033660|FG000|NOT COMPLETED|Overall Study||24||
48288822|NCT00883051|101033661|FG001|NOT COMPLETED|Overall Study||22||
48288823|NCT00883051|101033662|FG002|NOT COMPLETED|Overall Study||29||
48288824|NCT00883051|101033663|FG003|NOT COMPLETED|Overall Study||29||
48288825|NCT00883051|101033664|FG004|NOT COMPLETED|Overall Study||18||
48288826|NCT02962960|101033665|FG000|STARTED|Overall Study||14||
48288827|NCT02962960|101033666|FG001|STARTED|Overall Study||13||
48288828|NCT02962960|101033667|FG002|STARTED|Overall Study||9||
48288829|NCT02962960|101033665|FG000|COMPLETED|Overall Study||11|Subjects who completed study up to Week 52|
48288830|NCT02962960|101033666|FG001|COMPLETED|Overall Study||11|Subjects who completed study up to Week 52|
48288831|NCT02962960|101033667|FG002|COMPLETED|Overall Study||9|Subjects who completed study up to Week 52|
48288832|NCT02962960|101033665|FG000|NOT COMPLETED|Overall Study||3||
48288833|NCT02962960|101033666|FG001|NOT COMPLETED|Overall Study||2||
48288834|NCT02962960|101033667|FG002|NOT COMPLETED|Overall Study||0||
48288835|NCT00545051|101033668|FG000|STARTED|Overall Study||68||
48288836|NCT00545051|101033669|FG001|STARTED|Overall Study||72||
48288837|NCT00545051|101033668|FG000|COMPLETED|Overall Study||59||
48288838|NCT00545051|101033669|FG001|COMPLETED|Overall Study||65||
48288839|NCT00545051|101033668|FG000|NOT COMPLETED|Overall Study||9||
48288840|NCT00545051|101033669|FG001|NOT COMPLETED|Overall Study||7||
48288841|NCT00267085|101033670|FG000|STARTED|Overall Study||10||
48288842|NCT00267085|101033670|FG000|COMPLETED|Overall Study||10||
48288843|NCT00267085|101033670|FG000|NOT COMPLETED|Overall Study||0||
48288844|NCT00424385|101033671|FG000|STARTED|Cohort 0||12||
48288845|NCT00424385|101033671|FG000|COMPLETED|Cohort 0||6||
48288846|NCT00424385|101033671|FG000|NOT COMPLETED|Cohort 0||6||
48288847|NCT00424385|101033671|FG000|STARTED|Cohort 1||5||
48288848|NCT00424385|101033671|FG000|COMPLETED|Cohort 1||4||
48288849|NCT00424385|101033671|FG000|NOT COMPLETED|Cohort 1||1||
48288850|NCT01211288|101033672|FG000|STARTED|Overall Study||21||
48288851|NCT01211288|101033673|FG001|STARTED|Overall Study||20||
48400988|NCT01831804|101313660|FG003|STARTED|Overall Study||5||
48400989|NCT01831804|101313661|FG004|STARTED|Overall Study||5||
48400990|NCT01831804|101313662|FG005|STARTED|Overall Study||3||
48400991|NCT01831804|101313663|FG006|STARTED|Overall Study||4||
48400992|NCT01831804|101313664|FG007|STARTED|Overall Study||26||
48400993|NCT01831804|101313665|FG008|STARTED|Overall Study||4||
48288852|NCT01211288|101033672|FG000|COMPLETED|Overall Study||20||
48288853|NCT01211288|101033673|FG001|COMPLETED|Overall Study||19||
48288854|NCT01211288|101033672|FG000|NOT COMPLETED|Overall Study||1||
48288855|NCT01211288|101033673|FG001|NOT COMPLETED|Overall Study||1||
48288856|NCT01522469|101033674|FG000|STARTED|Overall Study||9||
48288857|NCT01522469|101033675|FG001|STARTED|Overall Study||4||
48288858|NCT01522469|101033674|FG000|COMPLETED|Overall Study||9||
48288859|NCT01522469|101033675|FG001|COMPLETED|Overall Study||4||
48288860|NCT01522469|101033674|FG000|NOT COMPLETED|Overall Study||0||
48400994|NCT01831804|101313657|FG000|COMPLETED|Overall Study||3||
48400995|NCT01831804|101313658|FG001|COMPLETED|Overall Study||1||
48400996|NCT01831804|101313659|FG002|COMPLETED|Overall Study||3||
48704851|NCT00510718|102064952|FG001|480 mg/Day|Single Dose Period: 1 Week||6||
48704852|NCT00510718|102064951|FG000|600 mg/Day|Single Dose Period: 1 Week||0||
48704853|NCT00510718|102064952|FG001|600 mg/Day|Single Dose Period: 1 Week||3||
48704854|NCT00510718|102064951|FG000|COMPLETED|Single Dose Period: 1 Week||15||
48704855|NCT00510718|102064952|FG001|COMPLETED|Single Dose Period: 1 Week||12||
48288861|NCT01522469|101033675|FG001|NOT COMPLETED|Overall Study||0||
48288862|NCT03028220|101033676|FG000|STARTED|Overall Study||20||
48288863|NCT03028220|101033677|FG001|STARTED|Overall Study||20||
48288864|NCT03028220|101033676|FG000|COMPLETED|Overall Study||20||
48288865|NCT03028220|101033677|FG001|COMPLETED|Overall Study||20||
48704856|NCT00510718|102064951|FG000|NOT COMPLETED|Single Dose Period: 1 Week||0||
48704857|NCT00510718|102064952|FG001|NOT COMPLETED|Single Dose Period: 1 Week||0||
48704858|NCT00510718|102064951|FG000|STARTED|Multiple Dose Period: 12 Weeks||65||
48704859|NCT00510718|102064952|FG001|STARTED|Multiple Dose Period: 12 Weeks||75||
48704860|NCT00510718|102064951|FG000|30 mg/Day|Multiple Dose Period: 12 Weeks||3||
48704861|NCT00510718|102064952|FG001|30 mg/Day|Multiple Dose Period: 12 Weeks||0||
48704862|NCT00510718|102064951|FG000|60 mg/Day|Multiple Dose Period: 12 Weeks||15||
48704863|NCT00510718|102064952|FG001|60 mg/Day|Multiple Dose Period: 12 Weeks||12||
48704864|NCT00510718|102064951|FG000|150/160 mg/Day|Multiple Dose Period: 12 Weeks||15||
48704865|NCT00510718|102064952|FG001|150/160 mg/Day|Multiple Dose Period: 12 Weeks||13||
48704866|NCT00510718|102064951|FG000|240 mg/Day|Multiple Dose Period: 12 Weeks||17||
48704867|NCT00510718|102064952|FG001|240 mg/Day|Multiple Dose Period: 12 Weeks||12||
48704868|NCT00510718|102064951|FG000|360 mg/Day|Multiple Dose Period: 12 Weeks||15||
48704869|NCT00510718|102064952|FG001|360 mg/Day|Multiple Dose Period: 12 Weeks||13||
48704870|NCT00510718|102064951|FG000|480 mg/Day|Multiple Dose Period: 12 Weeks||0||
48704871|NCT00510718|102064952|FG001|480 mg/Day|Multiple Dose Period: 12 Weeks||22||
48704872|NCT00510718|102064951|FG000|600 mg/Day|Multiple Dose Period: 12 Weeks||0||
48704873|NCT00510718|102064952|FG001|600 mg/Day|Multiple Dose Period: 12 Weeks||3||
48704874|NCT00510718|102064951|FG000|COMPLETED|Multiple Dose Period: 12 Weeks||50||
48704875|NCT00510718|102064952|FG001|COMPLETED|Multiple Dose Period: 12 Weeks||43||
48704876|NCT00510718|102064951|FG000|NOT COMPLETED|Multiple Dose Period: 12 Weeks||15||
48704877|NCT00510718|102064952|FG001|NOT COMPLETED|Multiple Dose Period: 12 Weeks||32||
48704878|NCT01792817|102064953|FG000|STARTED|Phase 1 Double Blind Period||77||
48704879|NCT01792817|102064954|FG001|STARTED|Phase 1 Double Blind Period||73||
48704880|NCT01792817|102064955|FG002|STARTED|Phase 1 Double Blind Period||0||
48704881|NCT01792817|102064953|FG000|COMPLETED|Phase 1 Double Blind Period||58||
48704882|NCT01792817|102064954|FG001|COMPLETED|Phase 1 Double Blind Period||42||
48704883|NCT01792817|102064955|FG002|COMPLETED|Phase 1 Double Blind Period||0||
48704884|NCT01792817|102064953|FG000|NOT COMPLETED|Phase 1 Double Blind Period||19||
48704885|NCT01792817|102064954|FG001|NOT COMPLETED|Phase 1 Double Blind Period||31||
48704886|NCT01792817|102064955|FG002|NOT COMPLETED|Phase 1 Double Blind Period||0||
48704887|NCT01792817|102064953|FG000|STARTED|Phase 2 Open Label||0||
48704888|NCT01792817|102064954|FG001|STARTED|Phase 2 Open Label||0||
48704889|NCT01792817|102064955|FG002|STARTED|Phase 2 Open Label||100||
48704890|NCT01792817|102064953|FG000|COMPLETED|Phase 2 Open Label||0||
48704891|NCT01792817|102064954|FG001|COMPLETED|Phase 2 Open Label||0||
48704892|NCT01792817|102064955|FG002|COMPLETED|Phase 2 Open Label||74||
48704893|NCT01792817|102064953|FG000|NOT COMPLETED|Phase 2 Open Label||0||
48704894|NCT01792817|102064954|FG001|NOT COMPLETED|Phase 2 Open Label||0||
48704895|NCT01792817|102064955|FG002|NOT COMPLETED|Phase 2 Open Label||26||
48704896|NCT01460875|102064956|FG000|STARTED|Overall Study||34||
48288866|NCT03028220|101033676|FG000|NOT COMPLETED|Overall Study||0||
48704897|NCT01460875|102064956|FG000|COMPLETED|Overall Study||34||
48704898|NCT01460875|102064956|FG000|NOT COMPLETED|Overall Study||0||
48704899|NCT02300558|102064957|FG000|STARTED|Single Blind Phase (24 Weeks)||41||
48704900|NCT02300558|102064957|FG000|COMPLETED|Single Blind Phase (24 Weeks)||35||
48704901|NCT02300558|102064957|FG000|NOT COMPLETED|Single Blind Phase (24 Weeks)||6||
48704902|NCT02300558|102064957|FG000|STARTED|Open-Label (OL) Extension Phase||32|3 participants completed the single-blind phase (24 weeks) but did not continue to OL Extension.|
48288867|NCT03028220|101033677|FG001|NOT COMPLETED|Overall Study||0||
48288868|NCT01771107|101033678|FG000|STARTED|Overall Study||6||
48288869|NCT01771107|101033679|FG001|STARTED|Overall Study||35||
48288870|NCT01771107|101033678|FG000|COMPLETED|Overall Study||5||
48288871|NCT01771107|101033679|FG001|COMPLETED|Overall Study||27||
48288872|NCT01771107|101033678|FG000|NOT COMPLETED|Overall Study||1||
48288873|NCT01771107|101033679|FG001|NOT COMPLETED|Overall Study||8||
48400997|NCT01831804|101313660|FG003|COMPLETED|Overall Study||5||
48400998|NCT01831804|101313661|FG004|COMPLETED|Overall Study||3||
48704903|NCT02300558|102064957|FG000|COMPLETED|Open-Label (OL) Extension Phase||0||
48704904|NCT02300558|102064957|FG000|NOT COMPLETED|Open-Label (OL) Extension Phase||32||
48704905|NCT04752566|102064958|FG000|STARTED|Overall Study||37||
48288874|NCT01122160|101033680|FG000|STARTED|First Intervention (7 Days)||6||
48288875|NCT01122160|101033681|FG001|STARTED|First Intervention (7 Days)||5||
48288876|NCT01122160|101033680|FG000|COMPLETED|First Intervention (7 Days)||6||
48288877|NCT01122160|101033681|FG001|COMPLETED|First Intervention (7 Days)||5||
48288878|NCT01122160|101033680|FG000|NOT COMPLETED|First Intervention (7 Days)||0||
48288879|NCT01122160|101033681|FG001|NOT COMPLETED|First Intervention (7 Days)||0||
48288880|NCT01122160|101033680|FG000|STARTED|Washout (7-14 Days)||6||
48288881|NCT01122160|101033681|FG001|STARTED|Washout (7-14 Days)||5||
48288882|NCT01122160|101033680|FG000|COMPLETED|Washout (7-14 Days)||6||
48288883|NCT01122160|101033681|FG001|COMPLETED|Washout (7-14 Days)||5||
48288884|NCT01122160|101033680|FG000|NOT COMPLETED|Washout (7-14 Days)||0||
48288885|NCT01122160|101033681|FG001|NOT COMPLETED|Washout (7-14 Days)||0||
48400999|NCT01831804|101313662|FG005|COMPLETED|Overall Study||3||
48582263|NCT02244463|101756052|FG004|COMPLETED|Period 1: PI DL1 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
48582264|NCT02244463|101756053|FG005|COMPLETED|Period 1: PI DL1 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
48582265|NCT02244463|101756048|FG000|NOT COMPLETED|Period 1: PI DL1 Dose Escalation||3||
48582266|NCT02244463|101756049|FG001|NOT COMPLETED|Period 1: PI DL1 Dose Escalation||0||
48582267|NCT02244463|101756050|FG002|NOT COMPLETED|Period 1: PI DL1 Dose Escalation||0||
48582268|NCT02244463|101756051|FG003|NOT COMPLETED|Period 1: PI DL1 Dose Escalation||0||
48582269|NCT02244463|101756052|FG004|NOT COMPLETED|Period 1: PI DL1 Dose Escalation||0||
48582270|NCT02244463|101756053|FG005|NOT COMPLETED|Period 1: PI DL1 Dose Escalation||0||
48582271|NCT02244463|101756048|FG000|STARTED|Period 2: PI DL2 Dose Escalation||0|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
48136858|NCT03550313|100661363|FG000|Vaccinated for Dose 2|Overall Study||159||
48136859|NCT03550313|100661364|FG001|Vaccinated for Dose 2|Overall Study||135||
48582272|NCT02244463|101756049|FG001|STARTED|Period 2: PI DL2 Dose Escalation||3|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
48582273|NCT02244463|101756050|FG002|STARTED|Period 2: PI DL2 Dose Escalation||0|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
48582274|NCT02244463|101756051|FG003|STARTED|Period 2: PI DL2 Dose Escalation||0|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
48582275|NCT02244463|101756052|FG004|STARTED|Period 2: PI DL2 Dose Escalation||0|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
48582276|NCT02244463|101756053|FG005|STARTED|Period 2: PI DL2 Dose Escalation||0|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
48582277|NCT02244463|101756048|FG000|COMPLETED|Period 2: PI DL2 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
48582278|NCT02244463|101756049|FG001|COMPLETED|Period 2: PI DL2 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
48582279|NCT02244463|101756050|FG002|COMPLETED|Period 2: PI DL2 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
48582280|NCT02244463|101756051|FG003|COMPLETED|Period 2: PI DL2 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
48582281|NCT02244463|101756052|FG004|COMPLETED|Period 2: PI DL2 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
48582282|NCT02244463|101756053|FG005|COMPLETED|Period 2: PI DL2 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
48582283|NCT02244463|101756048|FG000|NOT COMPLETED|Period 2: PI DL2 Dose Escalation||0||
48582284|NCT02244463|101756049|FG001|NOT COMPLETED|Period 2: PI DL2 Dose Escalation||3||
48582285|NCT02244463|101756050|FG002|NOT COMPLETED|Period 2: PI DL2 Dose Escalation||0||
48582286|NCT02244463|101756051|FG003|NOT COMPLETED|Period 2: PI DL2 Dose Escalation||0||
48582287|NCT02244463|101756052|FG004|NOT COMPLETED|Period 2: PI DL2 Dose Escalation||0||
48582288|NCT02244463|101756053|FG005|NOT COMPLETED|Period 2: PI DL2 Dose Escalation||0||
48582289|NCT02244463|101756048|FG000|STARTED|Period 3: PI DL3 Dose Escalation||0|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
48582290|NCT02244463|101756049|FG001|STARTED|Period 3: PI DL3 Dose Escalation||0|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
48582291|NCT02244463|101756050|FG002|STARTED|Period 3: PI DL3 Dose Escalation||3|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
48704906|NCT04752566|102064959|FG001|STARTED|Overall Study||20||
48704907|NCT04752566|102064958|FG000|Received at Least 1 Dose of Study Drug|Overall Study||37||
48704908|NCT04752566|102064959|FG001|Received at Least 1 Dose of Study Drug|Overall Study||20||
48704909|NCT04752566|102064958|FG000|COMPLETED|Overall Study||32||
48704910|NCT04752566|102064959|FG001|COMPLETED|Overall Study||18||
48704911|NCT04752566|102064958|FG000|NOT COMPLETED|Overall Study||5||
48704912|NCT04752566|102064959|FG001|NOT COMPLETED|Overall Study||2||
48704913|NCT00529126|102064960|FG000|STARTED|Overall Study||25||
48704914|NCT00529126|102064961|FG001|STARTED|Overall Study||25||
48704915|NCT00529126|102064962|FG002|STARTED|Overall Study||24||
48704916|NCT00529126|102064963|FG003|STARTED|Overall Study||26||
48704917|NCT00529126|102064960|FG000|COMPLETED|Overall Study||25||
48704918|NCT00529126|102064961|FG001|COMPLETED|Overall Study||25||
48704919|NCT00529126|102064962|FG002|COMPLETED|Overall Study||24||
48704920|NCT00529126|102064963|FG003|COMPLETED|Overall Study||26||
48704921|NCT00529126|102064960|FG000|NOT COMPLETED|Overall Study||0||
48704922|NCT00529126|102064961|FG001|NOT COMPLETED|Overall Study||0||
48704923|NCT00529126|102064962|FG002|NOT COMPLETED|Overall Study||0||
48704924|NCT00529126|102064963|FG003|NOT COMPLETED|Overall Study||0||
48704925|NCT01574157|102064964|FG000|STARTED|Overall Study||35||
48704926|NCT01574157|102064965|FG001|STARTED|Overall Study||39||
48704927|NCT01574157|102064964|FG000|Month 3|Overall Study||31||
48136860|NCT03550313|100661365|FG002|Vaccinated for Dose 2|Overall Study||153||
48288886|NCT01122160|101033680|FG000|STARTED|Second Intervention (7 Days)||6||
48288887|NCT01122160|101033681|FG001|STARTED|Second Intervention (7 Days)||5||
48288888|NCT01122160|101033680|FG000|COMPLETED|Second Intervention (7 Days)||6||
48288889|NCT01122160|101033681|FG001|COMPLETED|Second Intervention (7 Days)||5||
48288890|NCT01122160|101033680|FG000|NOT COMPLETED|Second Intervention (7 Days)||0||
48288891|NCT01122160|101033681|FG001|NOT COMPLETED|Second Intervention (7 Days)||0||
48288892|NCT00709852|101033682|FG000|STARTED|Period 1||228||
48288893|NCT00709852|101033683|FG001|STARTED|Period 1||174||
48288894|NCT00709852|101033682|FG000|COMPLETED|Period 1||220||
48288895|NCT00709852|101033683|FG001|COMPLETED|Period 1||171||
48288896|NCT00709852|101033682|FG000|NOT COMPLETED|Period 1||8||
48288897|NCT00709852|101033683|FG001|NOT COMPLETED|Period 1||3||
48288898|NCT00709852|101033682|FG000|STARTED|Period 2||220||
48288899|NCT00709852|101033683|FG001|STARTED|Period 2||171||
48288900|NCT00709852|101033682|FG000|COMPLETED|Period 2||211||
48288901|NCT00709852|101033683|FG001|COMPLETED|Period 2||169||
48288902|NCT00709852|101033682|FG000|NOT COMPLETED|Period 2||9||
48288903|NCT00709852|101033683|FG001|NOT COMPLETED|Period 2||2||
48288904|NCT00985153|101033684|FG000|STARTED|Overall Study||985||
48288905|NCT00985153|101033685|FG001|STARTED|Overall Study||968||
48704928|NCT01574157|102064965|FG001|Month 3|Overall Study||33||
48704929|NCT01574157|102064964|FG000|COMPLETED|Overall Study||31|Month 6|
48704930|NCT01574157|102064965|FG001|COMPLETED|Overall Study||31|Month 6|
48704931|NCT01574157|102064964|FG000|NOT COMPLETED|Overall Study||4||
48704932|NCT01574157|102064965|FG001|NOT COMPLETED|Overall Study||8||
48704933|NCT00027378|102064966|FG000|STARTED|Overall Study||24||
48288906|NCT00985153|101033686|FG002|STARTED|Overall Study||962||
48288907|NCT00985153|101033687|FG003|STARTED|Overall Study||1012||
48288908|NCT00985153|101033684|FG000|Vaccinated at Visit 1|Overall Study||985||
48288909|NCT00985153|101033685|FG001|Vaccinated at Visit 1|Overall Study||968||
48288910|NCT00985153|101033686|FG002|Vaccinated at Visit 1|Overall Study||962||
48288911|NCT00985153|101033687|FG003|Vaccinated at Visit 1|Overall Study||1012||
48288912|NCT00985153|101033684|FG000|COMPLETED|Overall Study||950||
48288913|NCT00985153|101033685|FG001|COMPLETED|Overall Study||924||
48288914|NCT00985153|101033686|FG002|COMPLETED|Overall Study||918||
48288915|NCT00985153|101033687|FG003|COMPLETED|Overall Study||965||
48288916|NCT00985153|101033684|FG000|NOT COMPLETED|Overall Study||35||
48288917|NCT00985153|101033685|FG001|NOT COMPLETED|Overall Study||44||
48401000|NCT01831804|101313663|FG006|COMPLETED|Overall Study||3||
48401001|NCT01831804|101313664|FG007|COMPLETED|Overall Study||23||
48401002|NCT01831804|101313665|FG008|COMPLETED|Overall Study||2||
48401003|NCT01831804|101313657|FG000|NOT COMPLETED|Overall Study||1||
48401004|NCT01831804|101313658|FG001|NOT COMPLETED|Overall Study||2||
48401005|NCT01831804|101313659|FG002|NOT COMPLETED|Overall Study||6||
48401006|NCT01831804|101313660|FG003|NOT COMPLETED|Overall Study||0||
48704934|NCT00027378|102064967|FG001|STARTED|Overall Study||26||
48704935|NCT00027378|102064966|FG000|COMPLETED|Overall Study||24||
48704936|NCT00027378|102064967|FG001|COMPLETED|Overall Study||23||
48704937|NCT00027378|102064966|FG000|NOT COMPLETED|Overall Study||0||
48704938|NCT00027378|102064967|FG001|NOT COMPLETED|Overall Study||3||
48704939|NCT01177553|102064968|FG000|STARTED|Overall Study||3||
48704940|NCT01177553|102064969|FG001|STARTED|Overall Study||2||
48704941|NCT01177553|102064968|FG000|COMPLETED|Overall Study||2||
48704942|NCT01177553|102064969|FG001|COMPLETED|Overall Study||2||
48704943|NCT01177553|102064968|FG000|NOT COMPLETED|Overall Study||1||
48704944|NCT01177553|102064969|FG001|NOT COMPLETED|Overall Study||0||
48704945|NCT01382303|102064970|FG000|STARTED|Overall Study||87||
48704946|NCT01382303|102064971|FG001|STARTED|Overall Study||87||
48704947|NCT01382303|102064970|FG000|COMPLETED|Overall Study||52||
48704948|NCT01382303|102064971|FG001|COMPLETED|Overall Study||70||
48704949|NCT01382303|102064970|FG000|NOT COMPLETED|Overall Study||35||
48704950|NCT01382303|102064971|FG001|NOT COMPLETED|Overall Study||17||
48704951|NCT00006164|102064972|FG000|STARTED|Overall Study||517||
48704952|NCT00006164|102064973|FG001|STARTED|Overall Study||533||
48704953|NCT00006164|102064972|FG000|COMPLETED|Overall Study||447||
48704954|NCT00006164|102064973|FG001|COMPLETED|Overall Study||452||
48704955|NCT00006164|102064972|FG000|NOT COMPLETED|Overall Study||70||
48704956|NCT00006164|102064973|FG001|NOT COMPLETED|Overall Study||81||
48288918|NCT00985153|101033686|FG002|NOT COMPLETED|Overall Study||44||
48288919|NCT00985153|101033687|FG003|NOT COMPLETED|Overall Study||47||
48288920|NCT00452426|101033688|FG000|STARTED|Overall Study||496||
48288921|NCT00452426|101033689|FG001|STARTED|Overall Study||504||
48288922|NCT00452426|101033688|FG000|COMPLETED|Overall Study||489||
48288923|NCT00452426|101033689|FG001|COMPLETED|Overall Study||493||
48401007|NCT01831804|101313661|FG004|NOT COMPLETED|Overall Study||2||
48401008|NCT01831804|101313662|FG005|NOT COMPLETED|Overall Study||0||
48401009|NCT01831804|101313663|FG006|NOT COMPLETED|Overall Study||1||
48401010|NCT01831804|101313664|FG007|NOT COMPLETED|Overall Study||3||
48401011|NCT01831804|101313665|FG008|NOT COMPLETED|Overall Study||2||
48704957|NCT02320812|102064974|FG000|STARTED|Overall Study||28||
48288924|NCT00452426|101033688|FG000|NOT COMPLETED|Overall Study||7||
48288925|NCT00452426|101033689|FG001|NOT COMPLETED|Overall Study||11||
48288926|NCT01209780|101033690|FG000|STARTED|Overall Study||1042||
48288927|NCT01209780|101033691|FG001|STARTED|Overall Study||485||
48288928|NCT01209780|101033692|FG002|STARTED|Overall Study||48||
48288929|NCT01209780|101033693|FG003|STARTED|Overall Study||817||
48288930|NCT01209780|101033694|FG004|STARTED|Overall Study||412||
48288931|NCT01209780|101033690|FG000|COMPLETED|Overall Study||1016||
48288932|NCT01209780|101033691|FG001|COMPLETED|Overall Study||467||
48288933|NCT01209780|101033692|FG002|COMPLETED|Overall Study||44||
48288934|NCT01209780|101033693|FG003|COMPLETED|Overall Study||807||
48288935|NCT01209780|101033694|FG004|COMPLETED|Overall Study||407||
48288936|NCT01209780|101033690|FG000|NOT COMPLETED|Overall Study||26||
48288937|NCT01209780|101033691|FG001|NOT COMPLETED|Overall Study||18||
48288938|NCT01209780|101033692|FG002|NOT COMPLETED|Overall Study||4||
48288939|NCT01209780|101033693|FG003|NOT COMPLETED|Overall Study||10||
48288940|NCT01209780|101033694|FG004|NOT COMPLETED|Overall Study||5||
48288941|NCT00055601|101033695|FG000|STARTED|Overall Study||48||
48288942|NCT00055601|101033696|FG001|STARTED|Overall Study||49||
48288943|NCT00055601|101033695|FG000|COMPLETED|Overall Study||46||
48288944|NCT00055601|101033696|FG001|COMPLETED|Overall Study||47||
48288945|NCT00055601|101033695|FG000|NOT COMPLETED|Overall Study||2||
48582292|NCT02244463|101756051|FG003|STARTED|Period 3: PI DL3 Dose Escalation||0|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
48582293|NCT02244463|101756052|FG004|STARTED|Period 3: PI DL3 Dose Escalation||0|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
48582294|NCT02244463|101756053|FG005|STARTED|Period 3: PI DL3 Dose Escalation||0|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
48582295|NCT02244463|101756048|FG000|COMPLETED|Period 3: PI DL3 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
48582296|NCT02244463|101756049|FG001|COMPLETED|Period 3: PI DL3 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
48582297|NCT02244463|101756050|FG002|COMPLETED|Period 3: PI DL3 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
48582298|NCT02244463|101756051|FG003|COMPLETED|Period 3: PI DL3 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
48582299|NCT02244463|101756052|FG004|COMPLETED|Period 3: PI DL3 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
48592824|NCT00767039|101783187|FG000|NOT COMPLETED|Overall Study||5||
48704958|NCT02320812|102064974|FG000|COMPLETED|Overall Study||28||
48704959|NCT02320812|102064974|FG000|NOT COMPLETED|Overall Study||0||
48704960|NCT00394901|102064975|FG000|STARTED|Baseline Phase||98||
48704961|NCT00394901|102064976|FG001|STARTED|Baseline Phase||87||
48704962|NCT00394901|102064977|FG002|STARTED|Baseline Phase||90||
48704963|NCT00394901|102064978|FG003|STARTED|Baseline Phase||97||
48704964|NCT00394901|102064975|FG000|COMPLETED|Baseline Phase||98||
48704965|NCT00394901|102064976|FG001|COMPLETED|Baseline Phase||87||
48704966|NCT00394901|102064977|FG002|COMPLETED|Baseline Phase||89||
48704967|NCT00394901|102064978|FG003|COMPLETED|Baseline Phase||97||
48704968|NCT00394901|102064975|FG000|NOT COMPLETED|Baseline Phase||0||
48704969|NCT00394901|102064976|FG001|NOT COMPLETED|Baseline Phase||0||
48704970|NCT00394901|102064977|FG002|NOT COMPLETED|Baseline Phase||1||
48704971|NCT00394901|102064978|FG003|NOT COMPLETED|Baseline Phase||0||
48704972|NCT00394901|102064975|FG000|STARTED|Double-blind Phase||98||
48704973|NCT00394901|102064976|FG001|STARTED|Double-blind Phase||87||
48704974|NCT00394901|102064977|FG002|STARTED|Double-blind Phase||89||
48704975|NCT00394901|102064978|FG003|STARTED|Double-blind Phase||97||
48704976|NCT00394901|102064975|FG000|COMPLETED|Double-blind Phase||83||
48704977|NCT00394901|102064976|FG001|COMPLETED|Double-blind Phase||73||
48704978|NCT00394901|102064977|FG002|COMPLETED|Double-blind Phase||71||
48704979|NCT00394901|102064978|FG003|COMPLETED|Double-blind Phase||70||
48704980|NCT00394901|102064975|FG000|NOT COMPLETED|Double-blind Phase||15||
48704981|NCT00394901|102064976|FG001|NOT COMPLETED|Double-blind Phase||14||
48704982|NCT00394901|102064977|FG002|NOT COMPLETED|Double-blind Phase||18||
48704983|NCT00394901|102064978|FG003|NOT COMPLETED|Double-blind Phase||27||
48704984|NCT01510145|102064979|FG000|STARTED|Overall Study||191||
48704985|NCT01510145|102064979|FG000|COMPLETED|Overall Study||173||
48704986|NCT01510145|102064979|FG000|NOT COMPLETED|Overall Study||18||
48704987|NCT03842969|102064980|FG000|STARTED|Overall Study||17||
48704988|NCT03842969|102064981|FG001|STARTED|Overall Study||138||
48704989|NCT03842969|102064982|FG002|STARTED|Overall Study||81||
48704990|NCT03842969|102064980|FG000|Period 1|Overall Study||17|Period 1 has only 1 arm with 17 participants of which 15 were transferred to two Arms of Period 2 (8 and 7 participants, see below)|
48704991|NCT03842969|102064981|FG001|Period 1|Overall Study||0|Period 1 has only 1 arm with 17 participants of which 15 were transferred to two Arms of Period 2 (8 and 7 participants, see below)|
48704992|NCT03842969|102064982|FG002|Period 1|Overall Study||0|Period 1 has only 1 arm with 17 participants of which 15 were transferred to two Arms of Period 2 (8 and 7 participants, see below)|
48704993|NCT03842969|102064980|FG000|Period 2|Overall Study||0|Period 2 has 2 arms: Tominersen 120mg Q8W (8 participants from Period 1 and 138 new participants enrolled) and Tominersen 120mg Q16W (7 participants from Period 1 and 81 new enrolled). There were no participants in arm Tominersen 120mg Q4W.|
48704994|NCT03842969|102064981|FG001|Period 2|Overall Study||146|Period 2 has 2 arms: Tominersen 120mg Q8W (8 participants from Period 1 and 138 new participants enrolled) and Tominersen 120mg Q16W (7 participants from Period 1 and 81 new enrolled). There were no participants in arm Tominersen 120mg Q4W.|
48704995|NCT03842969|102064982|FG002|Period 2|Overall Study||88|Period 2 has 2 arms: Tominersen 120mg Q8W (8 participants from Period 1 and 138 new participants enrolled) and Tominersen 120mg Q16W (7 participants from Period 1 and 81 new enrolled). There were no participants in arm Tominersen 120mg Q4W.|
48704996|NCT03842969|102064980|FG000|COMPLETED|Overall Study||0|None of the participants completed the study|
48704997|NCT03842969|102064981|FG001|COMPLETED|Overall Study||0|None of the participants completed the study|
48704998|NCT03842969|102064982|FG002|COMPLETED|Overall Study||0|None of the participants completed the study|
48704999|NCT03842969|102064980|FG000|NOT COMPLETED|Overall Study||17||
48705000|NCT03842969|102064981|FG001|NOT COMPLETED|Overall Study||138||
48705001|NCT03842969|102064982|FG002|NOT COMPLETED|Overall Study||81||
48705002|NCT03549871|102064983|FG000|STARTED|Factor/BPA Prophylaxis: Day -168 to -1||30|Enrolled|
48705003|NCT03549871|102064984|FG001|STARTED|Factor/BPA Prophylaxis: Day -168 to -1||50|Enrolled|
48705004|NCT03549871|102064983|FG000|Started Directly With Fitusiran|Factor/BPA Prophylaxis: Day -168 to -1||2||
48582300|NCT02244463|101756053|FG005|COMPLETED|Period 3: PI DL3 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
48582301|NCT02244463|101756048|FG000|NOT COMPLETED|Period 3: PI DL3 Dose Escalation||0||
48582302|NCT02244463|101756049|FG001|NOT COMPLETED|Period 3: PI DL3 Dose Escalation||0||
48582303|NCT02244463|101756050|FG002|NOT COMPLETED|Period 3: PI DL3 Dose Escalation||3||
48582304|NCT02244463|101756051|FG003|NOT COMPLETED|Period 3: PI DL3 Dose Escalation||0||
48582305|NCT02244463|101756052|FG004|NOT COMPLETED|Period 3: PI DL3 Dose Escalation||0||
48582306|NCT02244463|101756053|FG005|NOT COMPLETED|Period 3: PI DL3 Dose Escalation||0||
48582307|NCT02244463|101756048|FG000|STARTED|Period 4: PI DL3 Dose Expansion||0|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
48582308|NCT02244463|101756049|FG001|STARTED|Period 4: PI DL3 Dose Expansion||0|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
48582309|NCT02244463|101756050|FG002|STARTED|Period 4: PI DL3 Dose Expansion||0|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
48582310|NCT02244463|101756051|FG003|STARTED|Period 4: PI DL3 Dose Expansion||10|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
48582311|NCT02244463|101756052|FG004|STARTED|Period 4: PI DL3 Dose Expansion||0|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
48582312|NCT02244463|101756053|FG005|STARTED|Period 4: PI DL3 Dose Expansion||0|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
48582313|NCT02244463|101756048|FG000|COMPLETED|Period 4: PI DL3 Dose Expansion||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
48582314|NCT02244463|101756049|FG001|COMPLETED|Period 4: PI DL3 Dose Expansion||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
48582315|NCT02244463|101756050|FG002|COMPLETED|Period 4: PI DL3 Dose Expansion||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
48582316|NCT02244463|101756051|FG003|COMPLETED|Period 4: PI DL3 Dose Expansion||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
48582317|NCT02244463|101756052|FG004|COMPLETED|Period 4: PI DL3 Dose Expansion||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
48582318|NCT02244463|101756053|FG005|COMPLETED|Period 4: PI DL3 Dose Expansion||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
48582319|NCT02244463|101756048|FG000|NOT COMPLETED|Period 4: PI DL3 Dose Expansion||0||
48582320|NCT02244463|101756049|FG001|NOT COMPLETED|Period 4: PI DL3 Dose Expansion||0||
48582321|NCT02244463|101756050|FG002|NOT COMPLETED|Period 4: PI DL3 Dose Expansion||0||
48582322|NCT02244463|101756051|FG003|NOT COMPLETED|Period 4: PI DL3 Dose Expansion||10||
48582323|NCT02244463|101756052|FG004|NOT COMPLETED|Period 4: PI DL3 Dose Expansion||0||
48582324|NCT02244463|101756053|FG005|NOT COMPLETED|Period 4: PI DL3 Dose Expansion||0||
48592825|NCT00767039|101783188|FG001|NOT COMPLETED|Overall Study||2||
48592826|NCT03816644|101783189|FG000|STARTED|Overall Study||599||
48592827|NCT03816644|101783190|FG001|STARTED|Overall Study||602||
48592828|NCT03816644|101783189|FG000|COMPLETED|Overall Study||592||
48592829|NCT03816644|101783190|FG001|COMPLETED|Overall Study||600||
48582325|NCT02244463|101756048|FG000|STARTED|Period 5: Phase II||0|The 'NOTE' here is an error: the PII study total sample size is unrelated to the previous PI study. Per design, all participants treated at the maximum tolerated dose would be enrolled in the PII study. In the ATC and DTC PII cohorts, there were n=6 and n=7 participants, respectively, who received the RP2D in the PI study (DL3 escalation and expansion). There were n=12 (ATC) and n=15 (DTC) participants who subsequently enrolled in the PII study.|
48582326|NCT02244463|101756049|FG001|STARTED|Period 5: Phase II||0|The 'NOTE' here is an error: the PII study total sample size is unrelated to the previous PI study. Per design, all participants treated at the maximum tolerated dose would be enrolled in the PII study. In the ATC and DTC PII cohorts, there were n=6 and n=7 participants, respectively, who received the RP2D in the PI study (DL3 escalation and expansion). There were n=12 (ATC) and n=15 (DTC) participants who subsequently enrolled in the PII study.|
48582327|NCT02244463|101756050|FG002|STARTED|Period 5: Phase II||0|The 'NOTE' here is an error: the PII study total sample size is unrelated to the previous PI study. Per design, all participants treated at the maximum tolerated dose would be enrolled in the PII study. In the ATC and DTC PII cohorts, there were n=6 and n=7 participants, respectively, who received the RP2D in the PI study (DL3 escalation and expansion). There were n=12 (ATC) and n=15 (DTC) participants who subsequently enrolled in the PII study.|
48582328|NCT02244463|101756051|FG003|STARTED|Period 5: Phase II||0|The 'NOTE' here is an error: the PII study total sample size is unrelated to the previous PI study. Per design, all participants treated at the maximum tolerated dose would be enrolled in the PII study. In the ATC and DTC PII cohorts, there were n=6 and n=7 participants, respectively, who received the RP2D in the PI study (DL3 escalation and expansion). There were n=12 (ATC) and n=15 (DTC) participants who subsequently enrolled in the PII study.|
48582329|NCT02244463|101756052|FG004|STARTED|Period 5: Phase II||18|The 'NOTE' here is an error: the PII study total sample size is unrelated to the previous PI study. Per design, all participants treated at the maximum tolerated dose would be enrolled in the PII study. In the ATC and DTC PII cohorts, there were n=6 and n=7 participants, respectively, who received the RP2D in the PI study (DL3 escalation and expansion). There were n=12 (ATC) and n=15 (DTC) participants who subsequently enrolled in the PII study.|
48582330|NCT02244463|101756053|FG005|STARTED|Period 5: Phase II||22|The 'NOTE' here is an error: the PII study total sample size is unrelated to the previous PI study. Per design, all participants treated at the maximum tolerated dose would be enrolled in the PII study. In the ATC and DTC PII cohorts, there were n=6 and n=7 participants, respectively, who received the RP2D in the PI study (DL3 escalation and expansion). There were n=12 (ATC) and n=15 (DTC) participants who subsequently enrolled in the PII study.|
48582331|NCT02244463|101756048|FG000|COMPLETED|Period 5: Phase II||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
48582332|NCT02244463|101756049|FG001|COMPLETED|Period 5: Phase II||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
48592830|NCT03816644|101783189|FG000|NOT COMPLETED|Overall Study||7||
48288946|NCT00055601|101033696|FG001|NOT COMPLETED|Overall Study||2||
48136861|NCT03550313|100661363|FG000|Vaccinated for Dose 3|Overall Study||151||
48136862|NCT03550313|100661364|FG001|Vaccinated for Dose 3|Overall Study||127||
48136863|NCT03550313|100661365|FG002|Vaccinated for Dose 3|Overall Study||146||
48136864|NCT03550313|100661363|FG000|COMPLETED|Overall Study||95||
48136865|NCT03550313|100661364|FG001|COMPLETED|Overall Study||77||
48136866|NCT03550313|100661365|FG002|COMPLETED|Overall Study||72||
48136867|NCT03550313|100661363|FG000|NOT COMPLETED|Overall Study||97||
48136868|NCT03550313|100661364|FG001|NOT COMPLETED|Overall Study||110||
48136869|NCT03550313|100661365|FG002|NOT COMPLETED|Overall Study||114||
48136870|NCT03272633|100661366|FG000|STARTED|Overall Study||0||
48582333|NCT02244463|101756050|FG002|COMPLETED|Period 5: Phase II||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
48582334|NCT02244463|101756051|FG003|COMPLETED|Period 5: Phase II||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
48582335|NCT02244463|101756052|FG004|COMPLETED|Period 5: Phase II||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
48582336|NCT02244463|101756053|FG005|COMPLETED|Period 5: Phase II||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
48582337|NCT02244463|101756048|FG000|NOT COMPLETED|Period 5: Phase II||0||
48582338|NCT02244463|101756049|FG001|NOT COMPLETED|Period 5: Phase II||0||
48582339|NCT02244463|101756050|FG002|NOT COMPLETED|Period 5: Phase II||0||
48582340|NCT02244463|101756051|FG003|NOT COMPLETED|Period 5: Phase II||0||
48582341|NCT02244463|101756052|FG004|NOT COMPLETED|Period 5: Phase II||18||
48582342|NCT02244463|101756053|FG005|NOT COMPLETED|Period 5: Phase II||22||
48582343|NCT01931956|101756054|FG000|STARTED|Overall Study||59||
48582344|NCT01931956|101756055|FG001|STARTED|Overall Study||7||
48582345|NCT01931956|101756056|FG002|STARTED|Overall Study||628||
48582346|NCT01931956|101756057|FG003|STARTED|Overall Study||271||
48582347|NCT01931956|101756054|FG000|COMPLETED|Overall Study||8||
48582348|NCT01931956|101756055|FG001|COMPLETED|Overall Study||0||
48582349|NCT01931956|101756056|FG002|COMPLETED|Overall Study||141||
48582350|NCT01931956|101756057|FG003|COMPLETED|Overall Study||138||
48582351|NCT01931956|101756054|FG000|NOT COMPLETED|Overall Study||51||
48582352|NCT01931956|101756055|FG001|NOT COMPLETED|Overall Study||7||
48582353|NCT01931956|101756056|FG002|NOT COMPLETED|Overall Study||487||
48582354|NCT01931956|101756057|FG003|NOT COMPLETED|Overall Study||133||
48582355|NCT02288091|101756058|FG000|STARTED|Overall Study||32||
48582356|NCT02288091|101756058|FG000|Randomized/Treated|Overall Study||25||
48582357|NCT02288091|101756058|FG000|COMPLETED|Overall Study||24||
48582358|NCT02288091|101756058|FG000|NOT COMPLETED|Overall Study||8||
48582359|NCT02397954|101756059|FG000|STARTED|Overall Study||4||
48582360|NCT02397954|101756059|FG000|COMPLETED|Overall Study||4||
48582361|NCT02397954|101756059|FG000|NOT COMPLETED|Overall Study||0||
48582362|NCT00435487|101756060|FG000|STARTED|Overall Study||88||
48582363|NCT00435487|101756061|FG001|STARTED|Overall Study||86||
48582364|NCT00435487|101756060|FG000|TREATED|Overall Study||88||
48582365|NCT00435487|101756061|FG001|TREATED|Overall Study||83||
48582366|NCT00435487|101756060|FG000|COMPLETED|Overall Study||76||
48582367|NCT00435487|101756061|FG001|COMPLETED|Overall Study||71||
48582368|NCT00435487|101756060|FG000|NOT COMPLETED|Overall Study||12||
48582369|NCT00435487|101756061|FG001|NOT COMPLETED|Overall Study||15||
48582370|NCT02272842|101756062|FG000|STARTED|Overall Study||300||
48582371|NCT02272842|101756063|FG001|STARTED|Overall Study||300||
48582372|NCT02272842|101756062|FG000|COMPLETED|Overall Study||284||
48582373|NCT02272842|101756063|FG001|COMPLETED|Overall Study||290||
48582374|NCT02272842|101756062|FG000|NOT COMPLETED|Overall Study||16||
48582375|NCT02272842|101756063|FG001|NOT COMPLETED|Overall Study||10||
48582376|NCT03301844|101756064|FG000|STARTED|Overall Study||19||19
48582377|NCT03301844|101756065|FG001|STARTED|Overall Study||19||19
48582378|NCT03301844|101756064|FG000|COMPLETED|Overall Study||18||18
48582379|NCT03301844|101756065|FG001|COMPLETED|Overall Study||18||18
48582380|NCT03301844|101756064|FG000|NOT COMPLETED|Overall Study||1||1
48582381|NCT03301844|101756065|FG001|NOT COMPLETED|Overall Study||1||1
48582382|NCT03766165|101756066|FG000|STARTED|Overall Study||19||
48136871|NCT03272633|100661367|FG001|STARTED|Overall Study||2||
48136872|NCT03272633|100661366|FG000|COMPLETED|Overall Study||0||
48136873|NCT03272633|100661367|FG001|COMPLETED|Overall Study||2||
48136874|NCT03272633|100661366|FG000|NOT COMPLETED|Overall Study||0||
48136875|NCT03272633|100661367|FG001|NOT COMPLETED|Overall Study||0||
48136876|NCT03230916|100661368|FG000|STARTED|Overall Study||7||
48136877|NCT03230916|100661369|FG001|STARTED|Overall Study||6||
48136878|NCT03230916|100661370|FG002|STARTED|Overall Study||6||
48136879|NCT03230916|100661371|FG003|STARTED|Overall Study||4||
48136880|NCT03230916|100661372|FG004|STARTED|Overall Study||4||
48136881|NCT03230916|100661373|FG005|STARTED|Overall Study||6||
48136882|NCT03230916|100661374|FG006|STARTED|Overall Study||3||
48136883|NCT03230916|100661375|FG007|STARTED|Overall Study||2||
48582383|NCT03766165|101756067|FG001|STARTED|Overall Study||19||
48582384|NCT03766165|101756066|FG000|COMPLETED|Overall Study||19||
48582385|NCT03766165|101756067|FG001|COMPLETED|Overall Study||19||
48582386|NCT03766165|101756066|FG000|NOT COMPLETED|Overall Study||0||
48582387|NCT03766165|101756067|FG001|NOT COMPLETED|Overall Study||0||
48582388|NCT00631410|101756068|FG000|STARTED|Overall Study||6||
48582389|NCT00631410|101756069|FG001|STARTED|Overall Study||6||
48582390|NCT00631410|101756068|FG000|COMPLETED|Overall Study||0||
48582391|NCT00631410|101756069|FG001|COMPLETED|Overall Study||0||
48582392|NCT00631410|101756068|FG000|NOT COMPLETED|Overall Study||6||
48582393|NCT00631410|101756069|FG001|NOT COMPLETED|Overall Study||6||
48582394|NCT00153543|101756070|FG000|STARTED|Overall Study||28||
48582395|NCT00153543|101756071|FG001|STARTED|Overall Study||29||
48582396|NCT00153543|101756072|FG002|STARTED|Overall Study||29||
48582397|NCT00153543|101756070|FG000|COMPLETED|Overall Study||28||
48582398|NCT00153543|101756071|FG001|COMPLETED|Overall Study||29||
48582399|NCT00153543|101756072|FG002|COMPLETED|Overall Study||27||
48582400|NCT00153543|101756070|FG000|NOT COMPLETED|Overall Study||0||
48582401|NCT00153543|101756071|FG001|NOT COMPLETED|Overall Study||0||
48582402|NCT00153543|101756072|FG002|NOT COMPLETED|Overall Study||2||
48582403|NCT03596723|101756073|FG000|STARTED|Overall Study||1||
48582404|NCT03596723|101756074|FG001|STARTED|Overall Study||1||
48136884|NCT03230916|100661376|FG008|STARTED|Overall Study||2||
48136885|NCT03230916|100661377|FG009|STARTED|Overall Study||3||
48582405|NCT03596723|101756073|FG000|COMPLETED|Overall Study||1||
48582406|NCT03596723|101756074|FG001|COMPLETED|Overall Study||1||
48136886|NCT03230916|100661378|FG010|STARTED|Overall Study||4||
48136887|NCT03230916|100661368|FG000|Treated|Overall Study||7||
48582407|NCT03596723|101756073|FG000|NOT COMPLETED|Overall Study||0||
48582408|NCT03596723|101756074|FG001|NOT COMPLETED|Overall Study||0||
48582409|NCT04807205|101756075|FG000|STARTED|Overall Study||20||
48582410|NCT04807205|101756075|FG000|COMPLETED|Overall Study||20||
48582411|NCT04807205|101756075|FG000|NOT COMPLETED|Overall Study||0||
48582412|NCT01662791|101756076|FG000|STARTED|Part 1 - Observational||8||
48582413|NCT01662791|101756077|FG001|STARTED|Part 1 - Observational||41||
48582414|NCT01662791|101756076|FG000|COMPLETED|Part 1 - Observational||8||
48582415|NCT01662791|101756077|FG001|COMPLETED|Part 1 - Observational||41||
48582416|NCT01662791|101756076|FG000|NOT COMPLETED|Part 1 - Observational||0||
48582417|NCT01662791|101756077|FG001|NOT COMPLETED|Part 1 - Observational||0||
48582418|NCT01662791|101756076|FG000|STARTED|Part 2 - Interventional||8||
48582419|NCT01662791|101756077|FG001|STARTED|Part 2 - Interventional||0||
48582420|NCT01662791|101756076|FG000|COMPLETED|Part 2 - Interventional||8||
48582421|NCT01662791|101756077|FG001|COMPLETED|Part 2 - Interventional||0||
48582422|NCT01662791|101756076|FG000|NOT COMPLETED|Part 2 - Interventional||0||
48582423|NCT01662791|101756077|FG001|NOT COMPLETED|Part 2 - Interventional||0||
48582424|NCT02807506|101756078|FG000|STARTED|Aim 1: Survey||5||
48582425|NCT02807506|101756079|FG001|STARTED|Aim 1: Survey||8||
48582426|NCT02807506|101756080|FG002|STARTED|Aim 1: Survey||6||
48582427|NCT02807506|101756081|FG003|STARTED|Aim 1: Survey||0||
48582428|NCT02807506|101756082|FG004|STARTED|Aim 1: Survey||0||
48582429|NCT02807506|101756078|FG000|COMPLETED|Aim 1: Survey||5||
48582430|NCT02807506|101756079|FG001|COMPLETED|Aim 1: Survey||8||
48582431|NCT02807506|101756080|FG002|COMPLETED|Aim 1: Survey||6||
48582432|NCT02807506|101756081|FG003|COMPLETED|Aim 1: Survey||0||
48582433|NCT02807506|101756082|FG004|COMPLETED|Aim 1: Survey||0||
48582434|NCT02807506|101756078|FG000|NOT COMPLETED|Aim 1: Survey||0||
48582435|NCT02807506|101756079|FG001|NOT COMPLETED|Aim 1: Survey||0||
48582436|NCT02807506|101756080|FG002|NOT COMPLETED|Aim 1: Survey||0||
48582437|NCT02807506|101756081|FG003|NOT COMPLETED|Aim 1: Survey||0||
48582438|NCT02807506|101756082|FG004|NOT COMPLETED|Aim 1: Survey||0||
48582439|NCT02807506|101756078|FG000|STARTED|Aim 2: Deployment 1||0||
48705005|NCT03549871|102064984|FG001|Started Directly With Fitusiran|Factor/BPA Prophylaxis: Day -168 to -1||0||
48705006|NCT03549871|102064983|FG000|Started With Factor or BPA Prophylaxis|Factor/BPA Prophylaxis: Day -168 to -1||28||
48705007|NCT03549871|102064984|FG001|Started With Factor or BPA Prophylaxis|Factor/BPA Prophylaxis: Day -168 to -1||50||
48705008|NCT03549871|102064983|FG000|COMPLETED|Factor/BPA Prophylaxis: Day -168 to -1||23||
48705009|NCT03549871|102064984|FG001|COMPLETED|Factor/BPA Prophylaxis: Day -168 to -1||46||
48705010|NCT03549871|102064983|FG000|NOT COMPLETED|Factor/BPA Prophylaxis: Day -168 to -1||7||
48705011|NCT03549871|102064984|FG001|NOT COMPLETED|Factor/BPA Prophylaxis: Day -168 to -1||4||
48705012|NCT03549871|102064983|FG000|STARTED|Fitusiran Treatment: Day 1 to Day 190||23||
48288947|NCT00848926|101033697|FG000|STARTED|Treatment Period||102||
48288948|NCT00848926|101033697|FG000|COMPLETED|Treatment Period||18||
48288949|NCT00848926|101033697|FG000|NOT COMPLETED|Treatment Period||84||
48288950|NCT00848926|101033697|FG000|STARTED|Follow-up Period||102||
48288951|NCT00848926|101033697|FG000|COMPLETED|Follow-up Period||90||
48288952|NCT00848926|101033697|FG000|NOT COMPLETED|Follow-up Period||12||
48582440|NCT02807506|101756079|FG001|STARTED|Aim 2: Deployment 1||0||
48582441|NCT02807506|101756080|FG002|STARTED|Aim 2: Deployment 1||0||
48582442|NCT02807506|101756081|FG003|STARTED|Aim 2: Deployment 1||16||
48582443|NCT02807506|101756082|FG004|STARTED|Aim 2: Deployment 1||0||
48582444|NCT02807506|101756078|FG000|COMPLETED|Aim 2: Deployment 1||0||
48582445|NCT02807506|101756079|FG001|COMPLETED|Aim 2: Deployment 1||0||
48582446|NCT02807506|101756080|FG002|COMPLETED|Aim 2: Deployment 1||0||
48582447|NCT02807506|101756081|FG003|COMPLETED|Aim 2: Deployment 1||16||
48582448|NCT02807506|101756082|FG004|COMPLETED|Aim 2: Deployment 1||0||
48582449|NCT02807506|101756078|FG000|NOT COMPLETED|Aim 2: Deployment 1||0||
48582450|NCT02807506|101756079|FG001|NOT COMPLETED|Aim 2: Deployment 1||0||
48288953|NCT03169101|101033698|FG000|STARTED|Lab Session 1 (Week 1)||41||
48582451|NCT02807506|101756080|FG002|NOT COMPLETED|Aim 2: Deployment 1||0||
48582452|NCT02807506|101756081|FG003|NOT COMPLETED|Aim 2: Deployment 1||0||
48582453|NCT02807506|101756082|FG004|NOT COMPLETED|Aim 2: Deployment 1||0||
48582454|NCT02807506|101756078|FG000|STARTED|Aim 2: Deployment 2||0||
48582455|NCT02807506|101756079|FG001|STARTED|Aim 2: Deployment 2||0||
48582456|NCT02807506|101756080|FG002|STARTED|Aim 2: Deployment 2||0||
48582457|NCT02807506|101756081|FG003|STARTED|Aim 2: Deployment 2||0||
48582458|NCT02807506|101756082|FG004|STARTED|Aim 2: Deployment 2||18||
48288954|NCT03169101|101033699|FG001|STARTED|Lab Session 1 (Week 1)||77||
48288955|NCT03169101|101033700|FG002|STARTED|Lab Session 1 (Week 1)||43||
48288956|NCT03169101|101033701|FG003|STARTED|Lab Session 1 (Week 1)||80||
48288957|NCT03169101|101033698|FG000|COMPLETED|Lab Session 1 (Week 1)||41||
48288958|NCT03169101|101033699|FG001|COMPLETED|Lab Session 1 (Week 1)||77||
48288959|NCT03169101|101033700|FG002|COMPLETED|Lab Session 1 (Week 1)||43||
48288960|NCT03169101|101033701|FG003|COMPLETED|Lab Session 1 (Week 1)||76||
48288961|NCT03169101|101033698|FG000|NOT COMPLETED|Lab Session 1 (Week 1)||0||
48288962|NCT03169101|101033699|FG001|NOT COMPLETED|Lab Session 1 (Week 1)||0||
48288963|NCT03169101|101033700|FG002|NOT COMPLETED|Lab Session 1 (Week 1)||0||
48288964|NCT03169101|101033701|FG003|NOT COMPLETED|Lab Session 1 (Week 1)||4||
48288965|NCT03169101|101033698|FG000|STARTED|Lab Session 2 (Week 2)||41||
48288966|NCT03169101|101033699|FG001|STARTED|Lab Session 2 (Week 2)||77||
48288967|NCT03169101|101033700|FG002|STARTED|Lab Session 2 (Week 2)||43||
48288968|NCT03169101|101033701|FG003|STARTED|Lab Session 2 (Week 2)||76||
48288969|NCT03169101|101033698|FG000|COMPLETED|Lab Session 2 (Week 2)||39||
48288970|NCT03169101|101033699|FG001|COMPLETED|Lab Session 2 (Week 2)||60||
48288971|NCT03169101|101033700|FG002|COMPLETED|Lab Session 2 (Week 2)||41||
48288972|NCT03169101|101033701|FG003|COMPLETED|Lab Session 2 (Week 2)||70||
48288973|NCT03169101|101033698|FG000|NOT COMPLETED|Lab Session 2 (Week 2)||2||
48288974|NCT03169101|101033699|FG001|NOT COMPLETED|Lab Session 2 (Week 2)||17||
48288975|NCT03169101|101033700|FG002|NOT COMPLETED|Lab Session 2 (Week 2)||2||
48582459|NCT02807506|101756078|FG000|COMPLETED|Aim 2: Deployment 2||0||
48582460|NCT02807506|101756079|FG001|COMPLETED|Aim 2: Deployment 2||0||
48582461|NCT02807506|101756080|FG002|COMPLETED|Aim 2: Deployment 2||0||
48288976|NCT03169101|101033701|FG003|NOT COMPLETED|Lab Session 2 (Week 2)||6||
48288977|NCT03169101|101033698|FG000|STARTED|Treatment Phase (Weeks 3-12)||39||
48582462|NCT02807506|101756081|FG003|COMPLETED|Aim 2: Deployment 2||0||
48582463|NCT02807506|101756082|FG004|COMPLETED|Aim 2: Deployment 2||18||
48288978|NCT03169101|101033699|FG001|STARTED|Treatment Phase (Weeks 3-12)||59||
48288979|NCT03169101|101033700|FG002|STARTED|Treatment Phase (Weeks 3-12)||41||
48288980|NCT03169101|101033701|FG003|STARTED|Treatment Phase (Weeks 3-12)||68||
48401012|NCT01308294|101313666|FG000|STARTED|Cycle 1||10||
48582464|NCT02807506|101756078|FG000|NOT COMPLETED|Aim 2: Deployment 2||0||
48582465|NCT02807506|101756079|FG001|NOT COMPLETED|Aim 2: Deployment 2||0||
48582466|NCT02807506|101756080|FG002|NOT COMPLETED|Aim 2: Deployment 2||0||
48582467|NCT02807506|101756081|FG003|NOT COMPLETED|Aim 2: Deployment 2||0||
48288981|NCT03169101|101033698|FG000|COMPLETED|Treatment Phase (Weeks 3-12)||38||
48705013|NCT03549871|102064984|FG001|STARTED|Fitusiran Treatment: Day 1 to Day 190||46||
48288982|NCT03169101|101033699|FG001|COMPLETED|Treatment Phase (Weeks 3-12)||48||
48288983|NCT03169101|101033700|FG002|COMPLETED|Treatment Phase (Weeks 3-12)||37||
48288984|NCT03169101|101033701|FG003|COMPLETED|Treatment Phase (Weeks 3-12)||63||
48288985|NCT03169101|101033698|FG000|NOT COMPLETED|Treatment Phase (Weeks 3-12)||1||
48288986|NCT03169101|101033699|FG001|NOT COMPLETED|Treatment Phase (Weeks 3-12)||11||
48288987|NCT03169101|101033700|FG002|NOT COMPLETED|Treatment Phase (Weeks 3-12)||4||
48288988|NCT03169101|101033701|FG003|NOT COMPLETED|Treatment Phase (Weeks 3-12)||5||
48288989|NCT01773291|101033702|FG000|STARTED|Overall Study||8||
48288990|NCT01773291|101033703|FG001|STARTED|Overall Study||9||
48288991|NCT01773291|101033704|FG002|STARTED|Overall Study||7||
48288992|NCT01773291|101033702|FG000|COMPLETED|Overall Study||7||
48288993|NCT01773291|101033703|FG001|COMPLETED|Overall Study||9||
48705014|NCT03549871|102064983|FG000|Received 80mg QM & Part of Safety Analysis Set 1 (SAS 1)|Fitusiran Treatment: Day 1 to Day 190||21||
48705015|NCT03549871|102064984|FG001|Received 80mg QM & Part of Safety Analysis Set 1 (SAS 1)|Fitusiran Treatment: Day 1 to Day 190||46||
48705016|NCT03549871|102064983|FG000|Received 50 mg Q2M & Part of Safety Analysis Set 2 (SAS 2)|Fitusiran Treatment: Day 1 to Day 190||2||
48705017|NCT03549871|102064984|FG001|Received 50 mg Q2M & Part of Safety Analysis Set 2 (SAS 2)|Fitusiran Treatment: Day 1 to Day 190||0||
48288994|NCT01773291|101033704|FG002|COMPLETED|Overall Study||6||
48288995|NCT01773291|101033702|FG000|NOT COMPLETED|Overall Study||1||
48288996|NCT01773291|101033703|FG001|NOT COMPLETED|Overall Study||0||
48288997|NCT01773291|101033704|FG002|NOT COMPLETED|Overall Study||1||
48582468|NCT02807506|101756082|FG004|NOT COMPLETED|Aim 2: Deployment 2||0||
48582469|NCT01085630|101756083|FG000|STARTED|Overall Study||26||
48582470|NCT01085630|101756084|FG001|STARTED|Overall Study||27||
48582471|NCT01085630|101756083|FG000|COMPLETED|Overall Study||22||
48582472|NCT01085630|101756084|FG001|COMPLETED|Overall Study||27||
48582473|NCT01085630|101756083|FG000|NOT COMPLETED|Overall Study||4||
48582474|NCT01085630|101756084|FG001|NOT COMPLETED|Overall Study||0||
48582475|NCT04505540|101756085|FG000|STARTED|Baseline||104||
48582476|NCT04505540|101756085|FG000|COMPLETED|Baseline||94||
48288998|NCT02292654|101033705|FG000|STARTED|Overall Study||4||
48288999|NCT02292654|101033706|FG001|STARTED|Overall Study||9||
48289000|NCT02292654|101033707|FG002|STARTED|Overall Study||7||
48289001|NCT02292654|101033705|FG000|COMPLETED|Overall Study||4||
48289002|NCT02292654|101033706|FG001|COMPLETED|Overall Study||9||
48289003|NCT02292654|101033707|FG002|COMPLETED|Overall Study||7||
48401013|NCT01308294|101313667|FG001|STARTED|Cycle 1||6||
48401014|NCT01308294|101313668|FG002|STARTED|Cycle 1||0||
48401015|NCT01308294|101313666|FG000|COMPLETED|Cycle 1||10||
48401016|NCT01308294|101313667|FG001|COMPLETED|Cycle 1||6||
48401017|NCT01308294|101313668|FG002|COMPLETED|Cycle 1||0||
48401018|NCT01308294|101313666|FG000|NOT COMPLETED|Cycle 1||0||
48582477|NCT04505540|101756085|FG000|NOT COMPLETED|Baseline||10||
48582478|NCT04505540|101756085|FG000|STARTED|1 Week Eligible to Self-report||94||
48582479|NCT04505540|101756085|FG000|COMPLETED|1 Week Eligible to Self-report||93||
48582480|NCT04505540|101756085|FG000|NOT COMPLETED|1 Week Eligible to Self-report||1||
48582481|NCT04505540|101756085|FG000|STARTED|1 Week Contacted for Self-report||93||
48582482|NCT04505540|101756085|FG000|COMPLETED|1 Week Contacted for Self-report||66||
48582483|NCT04505540|101756085|FG000|NOT COMPLETED|1 Week Contacted for Self-report||27||
48582484|NCT04505540|101756085|FG000|STARTED|1 Week Eligible for Urinanalysis||94||
48582485|NCT04505540|101756085|FG000|COMPLETED|1 Week Eligible for Urinanalysis||41||
48401019|NCT01308294|101313667|FG001|NOT COMPLETED|Cycle 1||0||
48401020|NCT01308294|101313668|FG002|NOT COMPLETED|Cycle 1||0||
48401021|NCT01308294|101313666|FG000|STARTED|Cycle 2||10||
48582486|NCT04505540|101756085|FG000|NOT COMPLETED|1 Week Eligible for Urinanalysis||53||
48705018|NCT03549871|102064983|FG000|Efficacy Analysis Set 1 (EAS 1)|Fitusiran Treatment: Day 1 to Day 190||19||
48289004|NCT02292654|101033705|FG000|NOT COMPLETED|Overall Study||0||
48401022|NCT01308294|101313667|FG001|STARTED|Cycle 2||6||
48401023|NCT01308294|101313668|FG002|STARTED|Cycle 2||0||
48401024|NCT01308294|101313666|FG000|COMPLETED|Cycle 2||10||
48401025|NCT01308294|101313667|FG001|COMPLETED|Cycle 2||5||
48401026|NCT01308294|101313668|FG002|COMPLETED|Cycle 2||0||
48401027|NCT01308294|101313666|FG000|NOT COMPLETED|Cycle 2||0||
48401028|NCT01308294|101313667|FG001|NOT COMPLETED|Cycle 2||1||
48401029|NCT01308294|101313668|FG002|NOT COMPLETED|Cycle 2||0||
48401030|NCT01308294|101313666|FG000|STARTED|Cycle 3||10||
48401031|NCT01308294|101313667|FG001|STARTED|Cycle 3||5||
48401032|NCT01308294|101313668|FG002|STARTED|Cycle 3||0||
48289005|NCT02292654|101033706|FG001|NOT COMPLETED|Overall Study||0||
48289006|NCT02292654|101033707|FG002|NOT COMPLETED|Overall Study||0||
48289007|NCT03562247|101033708|FG000|STARTED|Overall Study||10||
48289008|NCT03562247|101033709|FG001|STARTED|Overall Study||11||
48289009|NCT03562247|101033710|FG002|STARTED|Overall Study||10||
48401033|NCT01308294|101313666|FG000|COMPLETED|Cycle 3||10||
48401034|NCT01308294|101313667|FG001|COMPLETED|Cycle 3||4||
48401035|NCT01308294|101313668|FG002|COMPLETED|Cycle 3||0||
48401036|NCT01308294|101313666|FG000|NOT COMPLETED|Cycle 3||0||
48582487|NCT04505540|101756085|FG000|STARTED|1 Week Urine Sample Provided||41||
48582488|NCT04505540|101756085|FG000|COMPLETED|1 Week Urine Sample Provided||28||
48592831|NCT03816644|101783190|FG001|NOT COMPLETED|Overall Study||2||
48136888|NCT03230916|100661369|FG001|Treated|Overall Study||6||
48136889|NCT03230916|100661370|FG002|Treated|Overall Study||6||
48136890|NCT03230916|100661371|FG003|Treated|Overall Study||4||
48136891|NCT03230916|100661372|FG004|Treated|Overall Study||4||
48136892|NCT03230916|100661373|FG005|Treated|Overall Study||5||
48136893|NCT03230916|100661374|FG006|Treated|Overall Study||3||
48136894|NCT03230916|100661375|FG007|Treated|Overall Study||2||
48582489|NCT04505540|101756085|FG000|NOT COMPLETED|1 Week Urine Sample Provided||13||
48582490|NCT04505540|101756085|FG000|STARTED|3 Months Eligible to Self-report||94||
48582491|NCT04505540|101756085|FG000|COMPLETED|3 Months Eligible to Self-report||87||
48582492|NCT04505540|101756085|FG000|NOT COMPLETED|3 Months Eligible to Self-report||7||
48582493|NCT04505540|101756085|FG000|STARTED|3 Months Contacted for Self-report||87||
48582494|NCT04505540|101756085|FG000|COMPLETED|3 Months Contacted for Self-report||65||
48582495|NCT04505540|101756085|FG000|NOT COMPLETED|3 Months Contacted for Self-report||22||
48582496|NCT04505540|101756085|FG000|STARTED|3 Months Eligible for Urinanalysis||94||
48582497|NCT04505540|101756085|FG000|COMPLETED|3 Months Eligible for Urinanalysis||24||
48582498|NCT04505540|101756085|FG000|NOT COMPLETED|3 Months Eligible for Urinanalysis||70||
48582499|NCT04505540|101756085|FG000|STARTED|3 Months Urine Sample Provided||24||
48582500|NCT04505540|101756085|FG000|COMPLETED|3 Months Urine Sample Provided||11||
48582501|NCT04505540|101756085|FG000|NOT COMPLETED|3 Months Urine Sample Provided||13||
48582502|NCT04505540|101756085|FG000|STARTED|6 Months Eligible to Self-report||94||
48582503|NCT04505540|101756085|FG000|COMPLETED|6 Months Eligible to Self-report||85||
48582504|NCT04505540|101756085|FG000|NOT COMPLETED|6 Months Eligible to Self-report||9||
48582505|NCT04505540|101756085|FG000|STARTED|6 Months Contacted for Self-report||85||
48582506|NCT04505540|101756085|FG000|COMPLETED|6 Months Contacted for Self-report||68||
48582507|NCT04505540|101756085|FG000|NOT COMPLETED|6 Months Contacted for Self-report||17||
48582508|NCT04505540|101756085|FG000|STARTED|6 Months Eligible for Urinanalysis||94||
48582509|NCT04505540|101756085|FG000|COMPLETED|6 Months Eligible for Urinanalysis||3||
48582510|NCT04505540|101756085|FG000|NOT COMPLETED|6 Months Eligible for Urinanalysis||91||
48582511|NCT04505540|101756085|FG000|STARTED|6 Months Urine Sample Provided||3||
48582512|NCT04505540|101756085|FG000|COMPLETED|6 Months Urine Sample Provided||3||
48582513|NCT04505540|101756085|FG000|NOT COMPLETED|6 Months Urine Sample Provided||0||
48582514|NCT02200536|101756086|FG000|STARTED|Overall Study||32||
48582515|NCT02200536|101756087|FG001|STARTED|Overall Study||30||
48582516|NCT02200536|101756088|FG002|STARTED|Overall Study||30||
48582517|NCT02200536|101756086|FG000|COMPLETED|Overall Study||32||
48582518|NCT02200536|101756087|FG001|COMPLETED|Overall Study||30||
48582519|NCT02200536|101756088|FG002|COMPLETED|Overall Study||30||
48582520|NCT02200536|101756086|FG000|NOT COMPLETED|Overall Study||0||
48582521|NCT02200536|101756087|FG001|NOT COMPLETED|Overall Study||0||
48582522|NCT02200536|101756088|FG002|NOT COMPLETED|Overall Study||0||
48582523|NCT02345265|101756089|FG000|STARTED|Overall Study||35||
48582524|NCT02345265|101756090|FG001|STARTED|Overall Study||35||
48582525|NCT02345265|101756089|FG000|COMPLETED|Overall Study||35||
48582526|NCT02345265|101756090|FG001|COMPLETED|Overall Study||35||
48582527|NCT02345265|101756089|FG000|NOT COMPLETED|Overall Study||0||
48582528|NCT02345265|101756090|FG001|NOT COMPLETED|Overall Study||0||
48582529|NCT06137131|101756091|FG000|STARTED|Overall Study||15||
48582530|NCT06137131|101756092|FG001|STARTED|Overall Study||15||
48582531|NCT06137131|101756093|FG002|STARTED|Overall Study||14||
48582532|NCT06137131|101756094|FG003|STARTED|Overall Study||14||
48582533|NCT06137131|101756091|FG000|COMPLETED|Overall Study||14||
48582534|NCT06137131|101756092|FG001|COMPLETED|Overall Study||13||
48582535|NCT06137131|101756093|FG002|COMPLETED|Overall Study||13||
48582536|NCT06137131|101756094|FG003|COMPLETED|Overall Study||12||
48582537|NCT06137131|101756091|FG000|NOT COMPLETED|Overall Study||1||
48582538|NCT06137131|101756092|FG001|NOT COMPLETED|Overall Study||2||
48582539|NCT06137131|101756093|FG002|NOT COMPLETED|Overall Study||1||
48582540|NCT06137131|101756094|FG003|NOT COMPLETED|Overall Study||2||
48582541|NCT02497040|101756095|FG000|STARTED|Overall Study||30||
48582542|NCT02497040|101756096|FG001|STARTED|Overall Study||30||
48582543|NCT02497040|101756097|FG002|STARTED|Overall Study||30||
48136895|NCT03230916|100661376|FG008|Treated|Overall Study||2||
48136896|NCT03230916|100661377|FG009|Treated|Overall Study||3||
48136897|NCT03230916|100661378|FG010|Treated|Overall Study||4||
48136898|NCT03230916|100661368|FG000|COMPLETED|Overall Study||7||
48136899|NCT03230916|100661369|FG001|COMPLETED|Overall Study||6||
48136900|NCT03230916|100661370|FG002|COMPLETED|Overall Study||6||
48136901|NCT03230916|100661371|FG003|COMPLETED|Overall Study||4||
48136902|NCT03230916|100661372|FG004|COMPLETED|Overall Study||4||
48136903|NCT03230916|100661373|FG005|COMPLETED|Overall Study||5||
48136904|NCT03230916|100661374|FG006|COMPLETED|Overall Study||3||
48582544|NCT02497040|101756095|FG000|COMPLETED|Overall Study||30||
48582545|NCT02497040|101756096|FG001|COMPLETED|Overall Study||30||
48582546|NCT02497040|101756097|FG002|COMPLETED|Overall Study||30||
48582547|NCT02497040|101756095|FG000|NOT COMPLETED|Overall Study||0||
48582548|NCT02497040|101756096|FG001|NOT COMPLETED|Overall Study||0||
48582549|NCT02497040|101756097|FG002|NOT COMPLETED|Overall Study||0||
48582550|NCT03218826|101756098|FG000|STARTED|Overall Study||6||
48582551|NCT03218826|101756099|FG001|STARTED|Overall Study||1||
48582552|NCT03218826|101756100|FG002|STARTED|Overall Study||5||
48582553|NCT03218826|101756101|FG003|STARTED|Overall Study||4||
48582554|NCT03218826|101756102|FG004|STARTED|Overall Study||7||
48582555|NCT03218826|101756098|FG000|COMPLETED|Overall Study||5||
48582556|NCT03218826|101756099|FG001|COMPLETED|Overall Study||1||
48582557|NCT03218826|101756100|FG002|COMPLETED|Overall Study||3||
48582558|NCT03218826|101756101|FG003|COMPLETED|Overall Study||3||
48582559|NCT03218826|101756102|FG004|COMPLETED|Overall Study||6||
48582560|NCT03218826|101756098|FG000|NOT COMPLETED|Overall Study||1||
48582561|NCT03218826|101756099|FG001|NOT COMPLETED|Overall Study||0||
48582562|NCT03218826|101756100|FG002|NOT COMPLETED|Overall Study||2||
48582563|NCT03218826|101756101|FG003|NOT COMPLETED|Overall Study||1||
48582564|NCT03218826|101756102|FG004|NOT COMPLETED|Overall Study||1||
48582565|NCT03919695|101756103|FG000|STARTED|3-month Follow-up||80||
48582566|NCT03919695|101756104|FG001|STARTED|3-month Follow-up||80||
48582567|NCT03919695|101756103|FG000|COMPLETED|3-month Follow-up||79||
48582568|NCT03919695|101756104|FG001|COMPLETED|3-month Follow-up||75||
48582569|NCT03919695|101756103|FG000|NOT COMPLETED|3-month Follow-up||1||
48582570|NCT03919695|101756104|FG001|NOT COMPLETED|3-month Follow-up||5||
48582571|NCT03919695|101756103|FG000|STARTED|6-month Follow-up||79|"All participants not deceased at 3-months were attempted to be followed-up at 6 months since some at 3-months were unreachable due to being imprisoned or having traveled far away. As shown in the next flow (completed any follow-up) 2 participants in the screening and referral arm who were lost at 3 months completed the 6-month follow-up and contribute to longitudinal analyses."|
48582572|NCT03919695|101756104|FG001|STARTED|6-month Follow-up||79|"All participants not deceased at 3-months were attempted to be followed-up at 6 months since some at 3-months were unreachable due to being imprisoned or having traveled far away. As shown in the next flow (completed any follow-up) 2 participants in the screening and referral arm who were lost at 3 months completed the 6-month follow-up and contribute to longitudinal analyses."|
48582573|NCT03919695|101756103|FG000|COMPLETED|6-month Follow-up||78||
48582574|NCT03919695|101756104|FG001|COMPLETED|6-month Follow-up||74||
48582575|NCT03919695|101756103|FG000|NOT COMPLETED|6-month Follow-up||1||
48582576|NCT03919695|101756104|FG001|NOT COMPLETED|6-month Follow-up||5||
48582577|NCT03919695|101756103|FG000|STARTED|Any Follow-up (3 and/or 6 Month)||80|This flow illustrates analyses using baseline, 3 month, and 6 month data. For these analyses participants having baseline and at least one follow-up are included. Therefore, this aspect of the flow represents participants with (baseline and) 3 and/or 6 month follow-up completed.|
48582578|NCT03919695|101756104|FG001|STARTED|Any Follow-up (3 and/or 6 Month)||80|This flow illustrates analyses using baseline, 3 month, and 6 month data. For these analyses participants having baseline and at least one follow-up are included. Therefore, this aspect of the flow represents participants with (baseline and) 3 and/or 6 month follow-up completed.|
48582579|NCT03919695|101756103|FG000|COMPLETED|Any Follow-up (3 and/or 6 Month)||79||
48582580|NCT03919695|101756104|FG001|COMPLETED|Any Follow-up (3 and/or 6 Month)||77||
48582581|NCT03919695|101756103|FG000|NOT COMPLETED|Any Follow-up (3 and/or 6 Month)||1||
48582582|NCT03919695|101756104|FG001|NOT COMPLETED|Any Follow-up (3 and/or 6 Month)||3||
48582583|NCT01663285|101756105|FG000|STARTED|Overall Study||1||
48582584|NCT01663285|101756105|FG000|COMPLETED|Overall Study||1||
48582585|NCT01663285|101756105|FG000|NOT COMPLETED|Overall Study||0||
48582586|NCT01098500|101756106|FG000|STARTED|Overall Study||3800||
48582587|NCT01098500|101756106|FG000|COMPLETED|Overall Study||3800||
48582588|NCT01098500|101756106|FG000|NOT COMPLETED|Overall Study||0||
48582589|NCT00901017|101756107|FG000|STARTED|Overall Study||14||
48582590|NCT00901017|101756107|FG000|COMPLETED|Overall Study||14||
48582591|NCT00901017|101756107|FG000|NOT COMPLETED|Overall Study||0||
48582592|NCT03521115|101756108|FG000|STARTED|Time 0 Baseline Surveys||206||
48582593|NCT03521115|101756109|FG001|STARTED|Time 0 Baseline Surveys||205||
48582594|NCT03521115|101756108|FG000|COMPLETED|Time 0 Baseline Surveys||206||
48582595|NCT03521115|101756109|FG001|COMPLETED|Time 0 Baseline Surveys||205||
48582596|NCT03521115|101756108|FG000|NOT COMPLETED|Time 0 Baseline Surveys||0||
48582597|NCT03521115|101756109|FG001|NOT COMPLETED|Time 0 Baseline Surveys||0||
48582598|NCT03521115|101756108|FG000|STARTED|Time 1 Survey (6 Months Post Baseline)||206|Failure to complete program did not preclude completing surveys.|
48582599|NCT03521115|101756109|FG001|STARTED|Time 1 Survey (6 Months Post Baseline)||205|Failure to complete program did not preclude completing surveys.|
48582600|NCT03521115|101756108|FG000|COMPLETED|Time 1 Survey (6 Months Post Baseline)||150||
48582601|NCT03521115|101756109|FG001|COMPLETED|Time 1 Survey (6 Months Post Baseline)||165||
48582602|NCT03521115|101756108|FG000|NOT COMPLETED|Time 1 Survey (6 Months Post Baseline)||56||
48582603|NCT03521115|101756109|FG001|NOT COMPLETED|Time 1 Survey (6 Months Post Baseline)||40||
48582604|NCT03521115|101756108|FG000|STARTED|Time 2 Survey (12 Months Post Baseline)||150||
48582605|NCT03521115|101756109|FG001|STARTED|Time 2 Survey (12 Months Post Baseline)||165||
48582606|NCT03521115|101756108|FG000|COMPLETED|Time 2 Survey (12 Months Post Baseline)||147||
48582607|NCT03521115|101756109|FG001|COMPLETED|Time 2 Survey (12 Months Post Baseline)||164||
48582608|NCT03521115|101756108|FG000|NOT COMPLETED|Time 2 Survey (12 Months Post Baseline)||3||
48582609|NCT03521115|101756109|FG001|NOT COMPLETED|Time 2 Survey (12 Months Post Baseline)||1||
48582610|NCT03521115|101756108|FG000|STARTED|Time 3 Survey (18 Months Post Baseline)||147||
48582611|NCT03521115|101756109|FG001|STARTED|Time 3 Survey (18 Months Post Baseline)||164||
48582612|NCT03521115|101756108|FG000|COMPLETED|Time 3 Survey (18 Months Post Baseline)||145||
48710763|NCT00402714|102078011|FG001|STARTED|Overall Study||11||
48582613|NCT03521115|101756109|FG001|COMPLETED|Time 3 Survey (18 Months Post Baseline)||164||
48582614|NCT03521115|101756108|FG000|NOT COMPLETED|Time 3 Survey (18 Months Post Baseline)||2||
48582615|NCT03521115|101756109|FG001|NOT COMPLETED|Time 3 Survey (18 Months Post Baseline)||0||
48582616|NCT01852201|101756110|FG000|STARTED|Overall Study||21||
48705019|NCT03549871|102064984|FG001|Efficacy Analysis Set 1 (EAS 1)|Fitusiran Treatment: Day 1 to Day 190||46||
48705020|NCT03549871|102064983|FG000|Efficacy Analysis Set 2 (EAS 2)|Fitusiran Treatment: Day 1 to Day 190||2||
48705021|NCT03549871|102064984|FG001|Efficacy Analysis Set 2 (EAS 2)|Fitusiran Treatment: Day 1 to Day 190||0||
48705022|NCT03549871|102064983|FG000|COMPLETED|Fitusiran Treatment: Day 1 to Day 190||17||
48705023|NCT03549871|102064984|FG001|COMPLETED|Fitusiran Treatment: Day 1 to Day 190||37||
48705024|NCT03549871|102064983|FG000|NOT COMPLETED|Fitusiran Treatment: Day 1 to Day 190||6||
48705025|NCT03549871|102064984|FG001|NOT COMPLETED|Fitusiran Treatment: Day 1 to Day 190||9||
48705026|NCT04644796|102064985|FG000|STARTED|Overall Study||17||
48705027|NCT04644796|102064986|FG001|STARTED|Overall Study||17||
48705028|NCT04644796|102064985|FG000|COMPLETED|Overall Study||17||
48705029|NCT04644796|102064986|FG001|COMPLETED|Overall Study||17||
48705030|NCT04644796|102064985|FG000|NOT COMPLETED|Overall Study||0||
48705031|NCT04644796|102064986|FG001|NOT COMPLETED|Overall Study||0||
48705032|NCT04114604|102064987|FG000|STARTED|Overall Study||10||
48705033|NCT04114604|102064987|FG000|COMPLETED|Overall Study||10||
48705034|NCT04114604|102064987|FG000|NOT COMPLETED|Overall Study||0||
48705035|NCT01174004|102064988|FG000|STARTED|Overall Study||94||
48705036|NCT01174004|102064989|FG001|STARTED|Overall Study||105||
48705037|NCT01174004|102064988|FG000|COMPLETED|Overall Study||87||
48705038|NCT01174004|102064989|FG001|COMPLETED|Overall Study||89||
48705039|NCT01174004|102064988|FG000|NOT COMPLETED|Overall Study||7||
48705040|NCT01174004|102064989|FG001|NOT COMPLETED|Overall Study||16||
48705041|NCT01955434|102064990|FG000|STARTED|Overall Study||25||
48705042|NCT01955434|102064990|FG000|COMPLETED|Overall Study||25||
48705043|NCT01955434|102064990|FG000|NOT COMPLETED|Overall Study||0||
48705044|NCT02334683|102064991|FG000|STARTED|First 12 Week Period||10||
48582617|NCT01852201|101756111|FG001|STARTED|Overall Study||12||
48582618|NCT01852201|101756110|FG000|COMPLETED|Overall Study||21||
48582619|NCT01852201|101756111|FG001|COMPLETED|Overall Study||12||
48582620|NCT01852201|101756110|FG000|NOT COMPLETED|Overall Study||0||
48582621|NCT01852201|101756111|FG001|NOT COMPLETED|Overall Study||0||
48582622|NCT00941863|101756112|FG000|STARTED|Until Primary Completion Date (PCD)||7||
48582623|NCT00941863|101756113|FG001|STARTED|Until Primary Completion Date (PCD)||3||
48582624|NCT00941863|101756114|FG002|STARTED|Until Primary Completion Date (PCD)||12||
48582625|NCT00941863|101756115|FG003|STARTED|Until Primary Completion Date (PCD)||17||
48582626|NCT00941863|101756116|FG004|STARTED|Until Primary Completion Date (PCD)||119||
48582627|NCT00941863|101756112|FG000|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||7||
48582628|NCT00941863|101756113|FG001|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||3||
48582629|NCT00941863|101756114|FG002|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||12||
48582630|NCT00941863|101756115|FG003|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||17||
48582631|NCT00941863|101756116|FG004|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||94||
48582632|NCT00941863|101756112|FG000|COMPLETED|Until Primary Completion Date (PCD)||0||
48582633|NCT00941863|101756113|FG001|COMPLETED|Until Primary Completion Date (PCD)||0||
48582634|NCT00941863|101756114|FG002|COMPLETED|Until Primary Completion Date (PCD)||0||
48582635|NCT00941863|101756115|FG003|COMPLETED|Until Primary Completion Date (PCD)||0||
48582636|NCT00941863|101756116|FG004|COMPLETED|Until Primary Completion Date (PCD)||25||
48582637|NCT00941863|101756112|FG000|NOT COMPLETED|Until Primary Completion Date (PCD)||7||
48582638|NCT00941863|101756113|FG001|NOT COMPLETED|Until Primary Completion Date (PCD)||3||
48705045|NCT02334683|102064992|FG001|STARTED|First 12 Week Period||10||
48705046|NCT02334683|102064991|FG000|COMPLETED|First 12 Week Period||9||
48705047|NCT02334683|102064992|FG001|COMPLETED|First 12 Week Period||10||
48705048|NCT02334683|102064991|FG000|NOT COMPLETED|First 12 Week Period||1||
48705049|NCT02334683|102064992|FG001|NOT COMPLETED|First 12 Week Period||0||
48705050|NCT02334683|102064991|FG000|STARTED|Second 12 Week Period||9||
48705051|NCT02334683|102064992|FG001|STARTED|Second 12 Week Period||10||
48705052|NCT02334683|102064991|FG000|COMPLETED|Second 12 Week Period||9||
48705053|NCT02334683|102064992|FG001|COMPLETED|Second 12 Week Period||9||
48705054|NCT02334683|102064991|FG000|NOT COMPLETED|Second 12 Week Period||0||
48705055|NCT02334683|102064992|FG001|NOT COMPLETED|Second 12 Week Period||1||
48705056|NCT01083979|102064993|FG000|STARTED|Overall Study||1||
48705057|NCT01083979|102064993|FG000|COMPLETED|Overall Study||1||
48705058|NCT01083979|102064993|FG000|NOT COMPLETED|Overall Study||0||
48705059|NCT02230761|102064994|FG000|STARTED|Overall Study||60||
48705060|NCT02230761|102064995|FG001|STARTED|Overall Study||30||
48705061|NCT02230761|102064994|FG000|COMPLETED|Overall Study||60||
48705062|NCT02230761|102064995|FG001|COMPLETED|Overall Study||29||
48705063|NCT02230761|102064994|FG000|NOT COMPLETED|Overall Study||0||
48705064|NCT02230761|102064995|FG001|NOT COMPLETED|Overall Study||1||
48705065|NCT00803517|102064996|FG000|STARTED|Overall Study||12||
48705066|NCT00803517|102064997|FG001|STARTED|Overall Study||12||
48705067|NCT00803517|102064996|FG000|COMPLETED|Overall Study||12||
48705068|NCT00803517|102064997|FG001|COMPLETED|Overall Study||12||
48705069|NCT00803517|102064996|FG000|NOT COMPLETED|Overall Study||0||
48582639|NCT00941863|101756114|FG002|NOT COMPLETED|Until Primary Completion Date (PCD)||12||
48582640|NCT00941863|101756115|FG003|NOT COMPLETED|Until Primary Completion Date (PCD)||17||
48582641|NCT00941863|101756116|FG004|NOT COMPLETED|Until Primary Completion Date (PCD)||94||
48582642|NCT00941863|101756112|FG000|STARTED|Continued After PCD||0||
48582643|NCT00941863|101756113|FG001|STARTED|Continued After PCD||0||
48582644|NCT00941863|101756114|FG002|STARTED|Continued After PCD||0||
48582645|NCT00941863|101756115|FG003|STARTED|Continued After PCD||0||
48582646|NCT00941863|101756116|FG004|STARTED|Continued After PCD||25||
48582647|NCT00941863|101756112|FG000|COMPLETED|Continued After PCD||0||
48582648|NCT00941863|101756113|FG001|COMPLETED|Continued After PCD||0||
48582649|NCT00941863|101756114|FG002|COMPLETED|Continued After PCD||0||
48582650|NCT00941863|101756115|FG003|COMPLETED|Continued After PCD||0||
48289010|NCT03562247|101033708|FG000|COMPLETED|Overall Study||7||
48289011|NCT03562247|101033709|FG001|COMPLETED|Overall Study||10||
48289012|NCT03562247|101033710|FG002|COMPLETED|Overall Study||9||
48289013|NCT03562247|101033708|FG000|NOT COMPLETED|Overall Study||3||
48289014|NCT03562247|101033709|FG001|NOT COMPLETED|Overall Study||1||
48289015|NCT03562247|101033710|FG002|NOT COMPLETED|Overall Study||1||
48289016|NCT00636077|101033711|FG000|STARTED|Week 1||3||
48289017|NCT00636077|101033712|FG001|STARTED|Week 1||3||
48289018|NCT00636077|101033713|FG002|STARTED|Week 1||3||
48289019|NCT00636077|101033714|FG003|STARTED|Week 1||3||
48289020|NCT00636077|101033711|FG000|COMPLETED|Week 1||3||
48582651|NCT00941863|101756116|FG004|COMPLETED|Continued After PCD||6||
48582652|NCT00941863|101756112|FG000|NOT COMPLETED|Continued After PCD||0||
48582653|NCT00941863|101756113|FG001|NOT COMPLETED|Continued After PCD||0||
48582654|NCT00941863|101756114|FG002|NOT COMPLETED|Continued After PCD||0||
48582655|NCT00941863|101756115|FG003|NOT COMPLETED|Continued After PCD||0||
48582656|NCT00941863|101756116|FG004|NOT COMPLETED|Continued After PCD||19||
48582657|NCT04533412|101756117|FG000|STARTED|Overall Study||30||
48582658|NCT04533412|101756118|FG001|STARTED|Overall Study||29||
48582659|NCT04533412|101756117|FG000|COMPLETED|Overall Study||28||
48582660|NCT04533412|101756118|FG001|COMPLETED|Overall Study||24||
48582661|NCT04533412|101756117|FG000|NOT COMPLETED|Overall Study||2||
48582662|NCT04533412|101756118|FG001|NOT COMPLETED|Overall Study||5||
48582663|NCT02496091|101756119|FG000|STARTED|Overall Study||144||263
48582664|NCT02496091|101756119|FG000|COMPLETED|Overall Study||142||259
48582665|NCT02496091|101756119|FG000|NOT COMPLETED|Overall Study||2||4
48582666|NCT04321356|101756120|FG000|STARTED|Overall Study||31||
48582667|NCT04321356|101756121|FG001|STARTED|Overall Study||26||
48582668|NCT04321356|101756122|FG002|STARTED|Overall Study||29||
48582669|NCT04321356|101756123|FG003|STARTED|Overall Study||14||
48582670|NCT04321356|101756120|FG000|COMPLETED|Overall Study||31||
48582671|NCT04321356|101756121|FG001|COMPLETED|Overall Study||26||
48582672|NCT04321356|101756122|FG002|COMPLETED|Overall Study||29||
48582673|NCT04321356|101756123|FG003|COMPLETED|Overall Study||14||
48582674|NCT04321356|101756120|FG000|NOT COMPLETED|Overall Study||0||
48582675|NCT04321356|101756121|FG001|NOT COMPLETED|Overall Study||0||
48582676|NCT04321356|101756122|FG002|NOT COMPLETED|Overall Study||0||
48582677|NCT04321356|101756123|FG003|NOT COMPLETED|Overall Study||0||
48582678|NCT05225298|101756124|FG000|STARTED|Overall Study||1069||28
48582679|NCT05225298|101756125|FG001|STARTED|Overall Study||1320||29
48582680|NCT05225298|101756124|FG000|COMPLETED|Overall Study||1069||28
48582681|NCT05225298|101756125|FG001|COMPLETED|Overall Study||1320||29
48582682|NCT05225298|101756124|FG000|NOT COMPLETED|Overall Study||0||0
48582683|NCT05225298|101756125|FG001|NOT COMPLETED|Overall Study||0||0
48582684|NCT01680159|101756126|FG000|STARTED|Screening Period||46||
48582685|NCT01680159|101756126|FG000|COMPLETED|Screening Period||39||
48582686|NCT01680159|101756126|FG000|NOT COMPLETED|Screening Period||7||
48582687|NCT01680159|101756126|FG000|STARTED|Increased Dose Period||51||
48582688|NCT01680159|101756126|FG000|COMPLETED|Increased Dose Period||43||
48582689|NCT01680159|101756126|FG000|NOT COMPLETED|Increased Dose Period||8||
48582690|NCT00184717|101756127|FG000|STARTED|Main Period (GHLIQUID-1516)||39||
48582691|NCT00184717|101756128|FG001|STARTED|Main Period (GHLIQUID-1516)||38||
48289021|NCT00636077|101033712|FG001|COMPLETED|Week 1||3||
48289022|NCT00636077|101033713|FG002|COMPLETED|Week 1||3||
48289023|NCT00636077|101033714|FG003|COMPLETED|Week 1||3||
48289024|NCT00636077|101033711|FG000|NOT COMPLETED|Week 1||0||
48582692|NCT00184717|101756129|FG002|STARTED|Main Period (GHLIQUID-1516)||21||
48582693|NCT00184717|101756130|FG003|STARTED|Main Period (GHLIQUID-1516)||0||
48582694|NCT00184717|101756131|FG004|STARTED|Main Period (GHLIQUID-1516)||0||
48289025|NCT00636077|101033712|FG001|NOT COMPLETED|Week 1||0||
48289026|NCT00636077|101033713|FG002|NOT COMPLETED|Week 1||0||
48582695|NCT00184717|101756127|FG000|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38||
48582696|NCT00184717|101756128|FG001|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38||
48582697|NCT00184717|101756129|FG002|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||21||
48582698|NCT00184717|101756130|FG003|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0||
48582699|NCT00184717|101756131|FG004|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0||
48582700|NCT00184717|101756127|FG000|COMPLETED|Main Period (GHLIQUID-1516)||36||
48582701|NCT00184717|101756128|FG001|COMPLETED|Main Period (GHLIQUID-1516)||36||
48582702|NCT00184717|101756129|FG002|COMPLETED|Main Period (GHLIQUID-1516)||20||
48582703|NCT00184717|101756130|FG003|COMPLETED|Main Period (GHLIQUID-1516)||0||
48582704|NCT00184717|101756131|FG004|COMPLETED|Main Period (GHLIQUID-1516)||0||
48582705|NCT00184717|101756127|FG000|NOT COMPLETED|Main Period (GHLIQUID-1516)||3||
48582706|NCT00184717|101756128|FG001|NOT COMPLETED|Main Period (GHLIQUID-1516)||2||
48582707|NCT00184717|101756129|FG002|NOT COMPLETED|Main Period (GHLIQUID-1516)||1||
48582708|NCT00184717|101756130|FG003|NOT COMPLETED|Main Period (GHLIQUID-1516)||0||
48582709|NCT00184717|101756131|FG004|NOT COMPLETED|Main Period (GHLIQUID-1516)||0||
48582710|NCT00184717|101756127|FG000|STARTED|Extension Period (GHLIQUID-1517)||33||
48582711|NCT00184717|101756128|FG001|STARTED|Extension Period (GHLIQUID-1517)||33||
48582712|NCT00184717|101756129|FG002|STARTED|Extension Period (GHLIQUID-1517)||0||
48582713|NCT00184717|101756130|FG003|STARTED|Extension Period (GHLIQUID-1517)||10||
48582714|NCT00184717|101756131|FG004|STARTED|Extension Period (GHLIQUID-1517)||10||
48582715|NCT00184717|101756127|FG000|COMPLETED|Extension Period (GHLIQUID-1517)||23||
48582716|NCT00184717|101756128|FG001|COMPLETED|Extension Period (GHLIQUID-1517)||27||
48582717|NCT00184717|101756129|FG002|COMPLETED|Extension Period (GHLIQUID-1517)||0||
48582718|NCT00184717|101756130|FG003|COMPLETED|Extension Period (GHLIQUID-1517)||7||
48582719|NCT00184717|101756131|FG004|COMPLETED|Extension Period (GHLIQUID-1517)||5||
48582720|NCT00184717|101756127|FG000|NOT COMPLETED|Extension Period (GHLIQUID-1517)||10||
48582721|NCT00184717|101756128|FG001|NOT COMPLETED|Extension Period (GHLIQUID-1517)||6||
48582722|NCT00184717|101756129|FG002|NOT COMPLETED|Extension Period (GHLIQUID-1517)||0||
48582723|NCT00184717|101756130|FG003|NOT COMPLETED|Extension Period (GHLIQUID-1517)||3||
48582724|NCT00184717|101756131|FG004|NOT COMPLETED|Extension Period (GHLIQUID-1517)||5||
48582725|NCT03875482|101756132|FG000|STARTED|Overall Study||105||
48582726|NCT03875482|101756133|FG001|STARTED|Overall Study||52||
48582727|NCT03875482|101756132|FG000|COMPLETED|Overall Study||92||
48582728|NCT03875482|101756133|FG001|COMPLETED|Overall Study||32||
48582729|NCT03875482|101756132|FG000|NOT COMPLETED|Overall Study||13||
48582730|NCT03875482|101756133|FG001|NOT COMPLETED|Overall Study||20||
48582731|NCT01855243|101756134|FG000|STARTED|Overall Study||20||
48582732|NCT01855243|101756135|FG001|STARTED|Overall Study||21||
48582733|NCT01855243|101756136|FG002|STARTED|Overall Study||22||
48582734|NCT01855243|101756134|FG000|COMPLETED|Overall Study||19||
48582735|NCT01855243|101756135|FG001|COMPLETED|Overall Study||21||
48582736|NCT01855243|101756136|FG002|COMPLETED|Overall Study||22||
48582737|NCT01855243|101756134|FG000|NOT COMPLETED|Overall Study||1||
48582738|NCT01855243|101756135|FG001|NOT COMPLETED|Overall Study||0||
48582739|NCT01855243|101756136|FG002|NOT COMPLETED|Overall Study||0||
48582740|NCT02388815|101756137|FG000|STARTED|Overall Study||89||
48582741|NCT02388815|101756137|FG000|COMPLETED|Overall Study||85||
48582742|NCT02388815|101756137|FG000|NOT COMPLETED|Overall Study||4||
48582743|NCT02475265|101756138|FG000|STARTED|Overall Study||11||
48582744|NCT02475265|101756138|FG000|COMPLETED|Overall Study||8||
48582745|NCT02475265|101756138|FG000|NOT COMPLETED|Overall Study||3||
48582746|NCT01421225|101756139|FG000|STARTED|Overall Study||4||
48582747|NCT01421225|101756140|FG001|STARTED|Overall Study||6||
48582748|NCT01421225|101756139|FG000|COMPLETED|Overall Study||4||
48582749|NCT01421225|101756140|FG001|COMPLETED|Overall Study||5||
48582750|NCT01421225|101756139|FG000|NOT COMPLETED|Overall Study||0||
48582751|NCT01421225|101756140|FG001|NOT COMPLETED|Overall Study||1||
48582752|NCT02230696|101756141|FG000|STARTED|Overall Study||381||
48582753|NCT02230696|101756142|FG001|STARTED|Overall Study||376||
48582754|NCT02230696|101756143|FG002|STARTED|Overall Study||194||
48582755|NCT02230696|101756141|FG000|COMPLETED|Overall Study||366||
48582756|NCT02230696|101756142|FG001|COMPLETED|Overall Study||365||
48582757|NCT02230696|101756143|FG002|COMPLETED|Overall Study||190||
48582758|NCT02230696|101756141|FG000|NOT COMPLETED|Overall Study||15||
48582759|NCT02230696|101756142|FG001|NOT COMPLETED|Overall Study||11||
48582760|NCT02230696|101756143|FG002|NOT COMPLETED|Overall Study||4||
48582761|NCT03100968|101756144|FG000|STARTED|Overall Study||75||
48582762|NCT03100968|101756145|FG001|STARTED|Overall Study||75||
48582763|NCT03100968|101756144|FG000|COMPLETED|Overall Study||75||
48582764|NCT03100968|101756145|FG001|COMPLETED|Overall Study||75||
48582765|NCT03100968|101756144|FG000|NOT COMPLETED|Overall Study||0||
48582766|NCT03100968|101756145|FG001|NOT COMPLETED|Overall Study||0||
48582767|NCT00981669|101756146|FG000|STARTED|Overall Study||40||
48582768|NCT00981669|101756147|FG001|STARTED|Overall Study||40||
48582769|NCT00981669|101756146|FG000|COMPLETED|Overall Study||39||
48582770|NCT00981669|101756147|FG001|COMPLETED|Overall Study||40||
48582771|NCT00981669|101756146|FG000|NOT COMPLETED|Overall Study||1||
48582772|NCT00981669|101756147|FG001|NOT COMPLETED|Overall Study||0||
48582773|NCT04922255|101756148|FG000|STARTED|Overall Study||4||
48582774|NCT04922255|101756149|FG001|STARTED|Overall Study||6||
48582775|NCT04922255|101756150|FG002|STARTED|Overall Study||5||
48582776|NCT04922255|101756148|FG000|COMPLETED|Overall Study||4||
48582777|NCT04922255|101756149|FG001|COMPLETED|Overall Study||4||
48582778|NCT04922255|101756150|FG002|COMPLETED|Overall Study||4||
48582779|NCT04922255|101756148|FG000|NOT COMPLETED|Overall Study||0||
48582780|NCT04922255|101756149|FG001|NOT COMPLETED|Overall Study||2||
48582781|NCT04922255|101756150|FG002|NOT COMPLETED|Overall Study||1||
48582782|NCT01095978|101756151|FG000|STARTED|Overall Study||2822||
48582783|NCT01095978|101756151|FG000|COMPLETED|Overall Study||2819||
48582784|NCT01095978|101756151|FG000|NOT COMPLETED|Overall Study||3||
48582785|NCT02045862|101759050|FG000|STARTED|Overall Study||306||
48582786|NCT02045862|101759051|FG001|STARTED|Overall Study||305||
48582787|NCT02045862|101759052|FG002|STARTED|Overall Study||1218||
48582788|NCT02045862|101759050|FG000|Treated|Overall Study||306||
48582789|NCT02045862|101759051|FG001|Treated|Overall Study||303||
48582790|NCT02045862|101759052|FG002|Treated|Overall Study||1210||
48582791|NCT02045862|101759050|FG000|COMPLETED|Overall Study||267||
48582792|NCT02045862|101759051|FG001|COMPLETED|Overall Study||265||
48582793|NCT02045862|101759052|FG002|COMPLETED|Overall Study||1092||
48582794|NCT02045862|101759050|FG000|NOT COMPLETED|Overall Study||39||
48582795|NCT02045862|101759051|FG001|NOT COMPLETED|Overall Study||40||
48582796|NCT02045862|101759052|FG002|NOT COMPLETED|Overall Study||126||
48582797|NCT01302444|101759053|FG000|STARTED|Overall Study||1||
48582798|NCT01302444|101759054|FG001|STARTED|Overall Study||0||
48582799|NCT01302444|101759053|FG000|COMPLETED|Overall Study||1||
48582800|NCT01302444|101759054|FG001|COMPLETED|Overall Study||0||
48582801|NCT01302444|101759053|FG000|NOT COMPLETED|Overall Study||0||
48582802|NCT01302444|101759054|FG001|NOT COMPLETED|Overall Study||0||
48582803|NCT02029989|101759055|FG000|STARTED|Overall Study||61||
48582804|NCT02029989|101759056|FG001|STARTED|Overall Study||60||
48582805|NCT02029989|101759055|FG000|COMPLETED|Overall Study||45||
48582806|NCT02029989|101759056|FG001|COMPLETED|Overall Study||49||
48582807|NCT02029989|101759055|FG000|NOT COMPLETED|Overall Study||16||
48582808|NCT02029989|101759056|FG001|NOT COMPLETED|Overall Study||11||
48582809|NCT03190668|101759057|FG000|STARTED|Overall Study||6||
48582810|NCT03190668|101759058|FG001|STARTED|Overall Study||6||
48582811|NCT03190668|101759057|FG000|COMPLETED|Overall Study||6||
48582812|NCT03190668|101759058|FG001|COMPLETED|Overall Study||6||
48582813|NCT03190668|101759057|FG000|NOT COMPLETED|Overall Study||0||
48582814|NCT03190668|101759058|FG001|NOT COMPLETED|Overall Study||0||
48582815|NCT03834766|101759059|FG000|STARTED|Overall Study||62||
48582816|NCT03834766|101759060|FG001|STARTED|Overall Study||65||
48582817|NCT03834766|101759059|FG000|COMPLETED|Overall Study||45||
48582818|NCT03834766|101759060|FG001|COMPLETED|Overall Study||46||
48582819|NCT03834766|101759059|FG000|NOT COMPLETED|Overall Study||17||
48582820|NCT03834766|101759060|FG001|NOT COMPLETED|Overall Study||19||
48582821|NCT02419612|101759061|FG000|STARTED|Short-term Treatment Period||227||
48582822|NCT02419612|101759062|FG001|STARTED|Short-term Treatment Period||217||
48582823|NCT02419612|101759061|FG000|Recevied Treatment|Short-term Treatment Period||227||
48582824|NCT02419612|101759062|FG001|Recevied Treatment|Short-term Treatment Period||216||
48582825|NCT02419612|101759061|FG000|COMPLETED|Short-term Treatment Period||210||
48582826|NCT02419612|101759062|FG001|COMPLETED|Short-term Treatment Period||194||
48582827|NCT02419612|101759061|FG000|NOT COMPLETED|Short-term Treatment Period||17||
48582828|NCT02419612|101759062|FG001|NOT COMPLETED|Short-term Treatment Period||23||
48582829|NCT02419612|101759061|FG000|STARTED|Long-term Treatment Period||196||
48582830|NCT02419612|101759062|FG001|STARTED|Long-term Treatment Period||186||
48582831|NCT02419612|101759061|FG000|Received Treatment|Long-term Treatment Period||196||
48582832|NCT02419612|101759062|FG001|Received Treatment|Long-term Treatment Period||183||
48582833|NCT02419612|101759061|FG000|COMPLETED|Long-term Treatment Period||174||
48582834|NCT02419612|101759062|FG001|COMPLETED|Long-term Treatment Period||164||
48582835|NCT02419612|101759061|FG000|NOT COMPLETED|Long-term Treatment Period||22||
48582836|NCT02419612|101759062|FG001|NOT COMPLETED|Long-term Treatment Period||22||
48582837|NCT02730377|101759063|FG000|STARTED|Overall Study||996||
48582838|NCT02730377|101759064|FG001|STARTED|Overall Study||995||
48582839|NCT02730377|101759063|FG000|Treated|Overall Study||980||
48582840|NCT02730377|101759064|FG001|Treated|Overall Study||984||
48582841|NCT02730377|101759063|FG000|Full Analysis Set (FAS)|Overall Study||996||
48582842|NCT02730377|101759064|FG001|Full Analysis Set (FAS)|Overall Study||995||
48582843|NCT02730377|101759063|FG000|Safety Analysis Set (SAS)|Overall Study||980||
48582844|NCT02730377|101759064|FG001|Safety Analysis Set (SAS)|Overall Study||984||
48582845|NCT02730377|101759063|FG000|COMPLETED|Overall Study||446||
48705070|NCT00803517|102064997|FG001|NOT COMPLETED|Overall Study||0||
48705071|NCT03372460|102064998|FG000|STARTED|Overall Study||26||
48582846|NCT02730377|101759064|FG001|COMPLETED|Overall Study||362||
48582847|NCT02730377|101759063|FG000|NOT COMPLETED|Overall Study||550||
48582848|NCT02730377|101759064|FG001|NOT COMPLETED|Overall Study||633||
48582849|NCT02196688|101759065|FG000|STARTED|Overall Study||47||
48582850|NCT02196688|101759066|FG001|STARTED|Overall Study||24||
48582851|NCT02196688|101759065|FG000|COMPLETED|Overall Study||40||
48582852|NCT02196688|101759066|FG001|COMPLETED|Overall Study||23||
48582853|NCT02196688|101759065|FG000|NOT COMPLETED|Overall Study||7||
48582854|NCT02196688|101759066|FG001|NOT COMPLETED|Overall Study||1||
48582855|NCT03660189|101759067|FG000|STARTED|Overall Study||25||
48582856|NCT03660189|101759068|FG001|STARTED|Overall Study||32||
48582857|NCT03660189|101759067|FG000|COMPLETED|Overall Study||25||
48582858|NCT03660189|101759068|FG001|COMPLETED|Overall Study||32||
48582859|NCT03660189|101759067|FG000|NOT COMPLETED|Overall Study||0||
48582860|NCT03660189|101759068|FG001|NOT COMPLETED|Overall Study||0||
48582861|NCT00968981|101759069|FG000|STARTED|Overall Study||23||
48582862|NCT00968981|101759070|FG001|STARTED|Overall Study||22||
48582863|NCT00968981|101759071|FG002|STARTED|Overall Study||22||
48592832|NCT02938949|101786320|FG000|STARTED|Overall Study||10||
48582864|NCT00968981|101759069|FG000|Pharmacokinetic(PK) Evaluable Population|Overall Study||20||
48582865|NCT00968981|101759070|FG001|Pharmacokinetic(PK) Evaluable Population|Overall Study||21||
48582866|NCT00968981|101759071|FG002|Pharmacokinetic(PK) Evaluable Population|Overall Study||22||
48582867|NCT00968981|101759069|FG000|COMPLETED|Overall Study||1||
48582868|NCT00968981|101759070|FG001|COMPLETED|Overall Study||0||
48582869|NCT00968981|101759071|FG002|COMPLETED|Overall Study||0||
48582870|NCT00968981|101759069|FG000|NOT COMPLETED|Overall Study||22||
48582871|NCT00968981|101759070|FG001|NOT COMPLETED|Overall Study||22||
48582872|NCT00968981|101759071|FG002|NOT COMPLETED|Overall Study||22||
48582873|NCT03879525|101759072|FG000|STARTED|Overall Study||15||
48582874|NCT03879525|101759073|FG001|STARTED|Overall Study||15||
48582875|NCT03879525|101759072|FG000|COMPLETED|Overall Study||15||
48582876|NCT03879525|101759073|FG001|COMPLETED|Overall Study||15||
48582877|NCT03879525|101759072|FG000|NOT COMPLETED|Overall Study||0||
48289027|NCT00636077|101033714|FG003|NOT COMPLETED|Week 1||0||
48289028|NCT00636077|101033711|FG000|STARTED|Week 2||3||
48289029|NCT00636077|101033712|FG001|STARTED|Week 2||3||
48289030|NCT00636077|101033713|FG002|STARTED|Week 2||3||
48289031|NCT00636077|101033714|FG003|STARTED|Week 2||3||
48289032|NCT00636077|101033711|FG000|COMPLETED|Week 2||3||
48289033|NCT00636077|101033712|FG001|COMPLETED|Week 2||3||
48289034|NCT00636077|101033713|FG002|COMPLETED|Week 2||3||
48289035|NCT00636077|101033714|FG003|COMPLETED|Week 2||3||
48289036|NCT00636077|101033711|FG000|NOT COMPLETED|Week 2||0||
48289037|NCT00636077|101033712|FG001|NOT COMPLETED|Week 2||0||
48401037|NCT01308294|101313667|FG001|NOT COMPLETED|Cycle 3||1||
48401038|NCT01308294|101313668|FG002|NOT COMPLETED|Cycle 3||0||
48401039|NCT02843178|101313669|FG000|STARTED|Overall Study||86||
48401040|NCT02843178|101313670|FG001|STARTED|Overall Study||90||
48401041|NCT02843178|101313671|FG002|STARTED|Overall Study||92||
48582878|NCT03879525|101759073|FG001|NOT COMPLETED|Overall Study||0||
48582879|NCT00330343|101759074|FG000|STARTED|Overall Study||64||
48582880|NCT00330343|101759074|FG000|COMPLETED|Overall Study||59||
48582881|NCT00330343|101759074|FG000|NOT COMPLETED|Overall Study||5||
48582882|NCT05483686|101759075|FG000|STARTED|Overall Study||18||
48582883|NCT05483686|101759076|FG001|STARTED|Overall Study||20||
48582884|NCT05483686|101759075|FG000|COMPLETED|Overall Study||13||
48582885|NCT05483686|101759076|FG001|COMPLETED|Overall Study||13||
48582886|NCT05483686|101759075|FG000|NOT COMPLETED|Overall Study||5||
48582887|NCT05483686|101759076|FG001|NOT COMPLETED|Overall Study||7||
48582888|NCT04259424|101759077|FG000|STARTED|Overall Study||10||
48582889|NCT04259424|101759077|FG000|COMPLETED|Overall Study||10||
48582890|NCT04259424|101759077|FG000|NOT COMPLETED|Overall Study||0||
48582891|NCT03966924|101759078|FG000|STARTED|Overall Study||2||
48582892|NCT03966924|101759078|FG000|COMPLETED|Overall Study||2||
48582893|NCT03966924|101759078|FG000|NOT COMPLETED|Overall Study||0||
48582894|NCT00839527|101759079|FG000|STARTED|Treatment Period (TP) (156 Weeks)||115||
48582895|NCT00839527|101759080|FG001|STARTED|Treatment Period (TP) (156 Weeks)||277||
48582896|NCT00839527|101759081|FG002|STARTED|Treatment Period (TP) (156 Weeks)||271||
48582897|NCT00839527|101759079|FG000|COMPLETED|Treatment Period (TP) (156 Weeks)||55||
48582898|NCT00839527|101759080|FG001|COMPLETED|Treatment Period (TP) (156 Weeks)||159||
48582899|NCT00839527|101759081|FG002|COMPLETED|Treatment Period (TP) (156 Weeks)||152||
48582900|NCT00839527|101759079|FG000|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||60||
48289038|NCT00636077|101033713|FG002|NOT COMPLETED|Week 2||0||
48289039|NCT00636077|101033714|FG003|NOT COMPLETED|Week 2||0||
48289040|NCT00636077|101033711|FG000|STARTED|Week 3||3||
48289041|NCT00636077|101033712|FG001|STARTED|Week 3||3||
48289042|NCT00636077|101033713|FG002|STARTED|Week 3||3||
48289043|NCT00636077|101033714|FG003|STARTED|Week 3||3||
48289044|NCT00636077|101033711|FG000|COMPLETED|Week 3||3||
48289045|NCT00636077|101033712|FG001|COMPLETED|Week 3||3||
48582901|NCT00839527|101759080|FG001|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||118||
48582902|NCT00839527|101759081|FG002|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||119||
48289046|NCT00636077|101033713|FG002|COMPLETED|Week 3||3||
48289047|NCT00636077|101033714|FG003|COMPLETED|Week 3||3||
48289048|NCT00636077|101033711|FG000|NOT COMPLETED|Week 3||0||
48289049|NCT00636077|101033712|FG001|NOT COMPLETED|Week 3||0||
48289050|NCT00636077|101033713|FG002|NOT COMPLETED|Week 3||0||
48289051|NCT00636077|101033714|FG003|NOT COMPLETED|Week 3||0||
48401042|NCT02843178|101313672|FG003|STARTED|Overall Study||91||
48401043|NCT02843178|101313669|FG000|COMPLETED|Overall Study||78||
48401044|NCT02843178|101313670|FG001|COMPLETED|Overall Study||82||
48582903|NCT00839527|101759079|FG000|STARTED|Follow-up Period (FUP) (8 Weeks)||114||
48582904|NCT00839527|101759080|FG001|STARTED|Follow-up Period (FUP) (8 Weeks)||273||
48582905|NCT00839527|101759081|FG002|STARTED|Follow-up Period (FUP) (8 Weeks)||266||
48582906|NCT00839527|101759079|FG000|COMPLETED|Follow-up Period (FUP) (8 Weeks)||86||
48582907|NCT00839527|101759080|FG001|COMPLETED|Follow-up Period (FUP) (8 Weeks)||217||
48582908|NCT00839527|101759081|FG002|COMPLETED|Follow-up Period (FUP) (8 Weeks)||204||
48582909|NCT00839527|101759079|FG000|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||28||
48582910|NCT00839527|101759080|FG001|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||56||
48582911|NCT00839527|101759081|FG002|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||62||
48582912|NCT02458768|101759082|FG000|STARTED|Overall Study||57||
48582913|NCT02458768|101759083|FG001|STARTED|Overall Study||55||
48582914|NCT02458768|101759082|FG000|COMPLETED|Overall Study||50||
48582915|NCT02458768|101759083|FG001|COMPLETED|Overall Study||50||
48582916|NCT02458768|101759082|FG000|NOT COMPLETED|Overall Study||7||
48582917|NCT02458768|101759083|FG001|NOT COMPLETED|Overall Study||5||
48582918|NCT02266472|101759084|FG000|STARTED|Period 1+ Washout||15||
48582919|NCT02266472|101759085|FG001|STARTED|Period 1+ Washout||15||
48582920|NCT02266472|101759084|FG000|COMPLETED|Period 1+ Washout||15||
48582921|NCT02266472|101759085|FG001|COMPLETED|Period 1+ Washout||15||
48582922|NCT02266472|101759084|FG000|NOT COMPLETED|Period 1+ Washout||0||
48582923|NCT02266472|101759085|FG001|NOT COMPLETED|Period 1+ Washout||0||
48582924|NCT02266472|101759084|FG000|STARTED|Period 2+ Washout||15||
48582925|NCT02266472|101759085|FG001|STARTED|Period 2+ Washout||15||
48582926|NCT02266472|101759084|FG000|COMPLETED|Period 2+ Washout||15||
48582927|NCT02266472|101759085|FG001|COMPLETED|Period 2+ Washout||15||
48582928|NCT02266472|101759084|FG000|NOT COMPLETED|Period 2+ Washout||0||
48582929|NCT02266472|101759085|FG001|NOT COMPLETED|Period 2+ Washout||0||
48582930|NCT03400150|101759086|FG000|STARTED|Overall Study||143||
48582931|NCT03400150|101759087|FG001|STARTED|Overall Study||79||
48582932|NCT03400150|101759086|FG000|COMPLETED|Overall Study||139||
48582933|NCT03400150|101759087|FG001|COMPLETED|Overall Study||78||
48582934|NCT03400150|101759086|FG000|NOT COMPLETED|Overall Study||4||
48582935|NCT03400150|101759087|FG001|NOT COMPLETED|Overall Study||1||
48582936|NCT02000622|101759088|FG000|STARTED|Overall Study||205||
48582937|NCT02000622|101759089|FG001|STARTED|Overall Study||97||
48582938|NCT02000622|101759088|FG000|COMPLETED|Overall Study||36||
48582939|NCT02000622|101759089|FG001|COMPLETED|Overall Study||17||
48582940|NCT02000622|101759088|FG000|NOT COMPLETED|Overall Study||169||
48582941|NCT02000622|101759089|FG001|NOT COMPLETED|Overall Study||80||
48582942|NCT02682823|101759090|FG000|STARTED|Overall Study||17||
48582943|NCT02682823|101759091|FG001|STARTED|Overall Study||19||
48582944|NCT02682823|101759092|FG002|STARTED|Overall Study||19||
48582945|NCT02682823|101759093|FG003|STARTED|Overall Study||17||
48582946|NCT02682823|101759094|FG004|STARTED|Overall Study||19||
48582947|NCT02682823|101759090|FG000|Safety Population|Overall Study||17||
48582948|NCT02682823|101759091|FG001|Safety Population|Overall Study||19||
48705072|NCT03372460|102064999|FG001|STARTED|Overall Study||29||
48705073|NCT03372460|102064998|FG000|Included in ITT Sample|Overall Study||26||
48136905|NCT03230916|100661375|FG007|COMPLETED|Overall Study||2||
48136906|NCT03230916|100661376|FG008|COMPLETED|Overall Study||2||
48136907|NCT03230916|100661377|FG009|COMPLETED|Overall Study||3||
48136908|NCT03230916|100661378|FG010|COMPLETED|Overall Study||4||
48136909|NCT03230916|100661368|FG000|NOT COMPLETED|Overall Study||0||
48136910|NCT03230916|100661369|FG001|NOT COMPLETED|Overall Study||0||
48136911|NCT03230916|100661370|FG002|NOT COMPLETED|Overall Study||0||
48136912|NCT03230916|100661371|FG003|NOT COMPLETED|Overall Study||0||
48289052|NCT00636077|101033711|FG000|STARTED|Week 4||3||
48582949|NCT02682823|101759092|FG002|Safety Population|Overall Study||18||
48582950|NCT02682823|101759093|FG003|Safety Population|Overall Study||17||
48582951|NCT02682823|101759094|FG004|Safety Population|Overall Study||19||
48582952|NCT02682823|101759090|FG000|COMPLETED|Overall Study||17||
48582953|NCT02682823|101759091|FG001|COMPLETED|Overall Study||18||
48582954|NCT02682823|101759092|FG002|COMPLETED|Overall Study||18||
48582955|NCT02682823|101759093|FG003|COMPLETED|Overall Study||16||
48582956|NCT02682823|101759094|FG004|COMPLETED|Overall Study||18||
48582957|NCT02682823|101759090|FG000|NOT COMPLETED|Overall Study||0||
48582958|NCT02682823|101759091|FG001|NOT COMPLETED|Overall Study||1||
48582959|NCT02682823|101759092|FG002|NOT COMPLETED|Overall Study||1||
48582960|NCT02682823|101759093|FG003|NOT COMPLETED|Overall Study||1||
48582961|NCT02682823|101759094|FG004|NOT COMPLETED|Overall Study||1||
48582962|NCT04429555|101759095|FG000|STARTED|Overall Study||17||
48582963|NCT04429555|101759096|FG001|STARTED|Overall Study||17||
48582964|NCT04429555|101759095|FG000|COMPLETED|Overall Study||15||
48582965|NCT04429555|101759096|FG001|COMPLETED|Overall Study||15||
48582966|NCT04429555|101759095|FG000|NOT COMPLETED|Overall Study||2||
48582967|NCT04429555|101759096|FG001|NOT COMPLETED|Overall Study||2||
48582968|NCT00533702|101759097|FG000|STARTED|Overall Study||54||
48582969|NCT00533702|101759098|FG001|STARTED|Overall Study||52||
48582970|NCT00533702|101759097|FG000|Received Any Quantity of Study Drug|Overall Study||52||
48582971|NCT00533702|101759098|FG001|Received Any Quantity of Study Drug|Overall Study||50||
48582972|NCT00533702|101759097|FG000|COMPLETED|Overall Study||49||
48582973|NCT00533702|101759098|FG001|COMPLETED|Overall Study||50||
48582974|NCT00533702|101759097|FG000|NOT COMPLETED|Overall Study||5||
48136913|NCT03230916|100661372|FG004|NOT COMPLETED|Overall Study||0||
48289053|NCT00636077|101033712|FG001|STARTED|Week 4||3||
48582975|NCT00533702|101759098|FG001|NOT COMPLETED|Overall Study||2||
48582976|NCT02833844|101759099|FG000|STARTED|Double-Blind Period||157|Randomized|
48582977|NCT02833844|101759100|FG001|STARTED|Double-Blind Period||310|Randomized|
48582978|NCT02833844|101759099|FG000|Randomized and Treated|Double-Blind Period||157||
48582979|NCT02833844|101759100|FG001|Randomized and Treated|Double-Blind Period||307||
48582980|NCT02833844|101759099|FG000|COMPLETED|Double-Blind Period||155||
48582981|NCT02833844|101759100|FG001|COMPLETED|Double-Blind Period||303||
48582982|NCT02833844|101759099|FG000|NOT COMPLETED|Double-Blind Period||2||
48136914|NCT03230916|100661373|FG005|NOT COMPLETED|Overall Study||1||
48582983|NCT02833844|101759100|FG001|NOT COMPLETED|Double-Blind Period||7||
48582984|NCT02833844|101759099|FG000|STARTED|Open-Label Period||152||
48582985|NCT02833844|101759100|FG001|STARTED|Open-Label Period||303||
48582986|NCT02833844|101759099|FG000|Received Open-Label Study Drug|Open-Label Period||152||
48582987|NCT02833844|101759100|FG001|Received Open-Label Study Drug|Open-Label Period||299||
48582988|NCT02833844|101759099|FG000|COMPLETED|Open-Label Period||150||
48582989|NCT02833844|101759100|FG001|COMPLETED|Open-Label Period||301||
48582990|NCT02833844|101759099|FG000|NOT COMPLETED|Open-Label Period||2||
48582991|NCT02833844|101759100|FG001|NOT COMPLETED|Open-Label Period||2||
48582992|NCT01290978|101759101|FG000|STARTED|Overall Study||22||
48582993|NCT01290978|101759101|FG000|COMPLETED|Overall Study||22||
48582994|NCT01290978|101759101|FG000|NOT COMPLETED|Overall Study||0||
48582995|NCT02738879|101759102|FG000|STARTED|Overall Study||374||
48582996|NCT02738879|101759103|FG001|STARTED|Overall Study||372||
48582997|NCT02738879|101759102|FG000|Treated|Overall Study||373||
48582998|NCT02738879|101759103|FG001|Treated|Overall Study||370||
48582999|NCT02738879|101759102|FG000|COMPLETED|Overall Study||361||
48583000|NCT02738879|101759103|FG001|COMPLETED|Overall Study||347||
48583001|NCT02738879|101759102|FG000|NOT COMPLETED|Overall Study||13||
48583002|NCT02738879|101759103|FG001|NOT COMPLETED|Overall Study||25||
48583003|NCT03814720|101759104|FG000|STARTED|Overall Study||5||
48583004|NCT03814720|101759105|FG001|STARTED|Overall Study||12||
48583005|NCT03814720|101759106|FG002|STARTED|Overall Study||12||
48583006|NCT03814720|101759107|FG003|STARTED|Overall Study||12||
48583007|NCT03814720|101759108|FG004|STARTED|Overall Study||11||
48583008|NCT03814720|101759104|FG000|Received First Product Administration|Overall Study||5||
48583009|NCT03814720|101759105|FG001|Received First Product Administration|Overall Study||12||
48583010|NCT03814720|101759106|FG002|Received First Product Administration|Overall Study||12||
48583011|NCT03814720|101759107|FG003|Received First Product Administration|Overall Study||12||
48583012|NCT03814720|101759108|FG004|Received First Product Administration|Overall Study||11||
48583013|NCT03814720|101759104|FG000|Received All Product Administrations|Overall Study||5||
48583014|NCT03814720|101759105|FG001|Received All Product Administrations|Overall Study||12||
48583015|NCT03814720|101759106|FG002|Received All Product Administrations|Overall Study||7||
48583016|NCT03814720|101759107|FG003|Received All Product Administrations|Overall Study||9||
48583017|NCT03814720|101759108|FG004|Received All Product Administrations|Overall Study||7||
48583018|NCT03814720|101759104|FG000|COMPLETED|Overall Study||5||
48583019|NCT03814720|101759105|FG001|COMPLETED|Overall Study||11||
48583020|NCT03814720|101759106|FG002|COMPLETED|Overall Study||12||
48583021|NCT03814720|101759107|FG003|COMPLETED|Overall Study||12||
48583022|NCT03814720|101759108|FG004|COMPLETED|Overall Study||11||
48583023|NCT03814720|101759104|FG000|NOT COMPLETED|Overall Study||0||
48583024|NCT03814720|101759105|FG001|NOT COMPLETED|Overall Study||1||
48583025|NCT03814720|101759106|FG002|NOT COMPLETED|Overall Study||0||
48583026|NCT03814720|101759107|FG003|NOT COMPLETED|Overall Study||0||
48583027|NCT03814720|101759108|FG004|NOT COMPLETED|Overall Study||0||
48583028|NCT04466098|101759109|FG000|STARTED|Overall Study||6||
48583029|NCT04466098|101759110|FG001|STARTED|Overall Study||2||
48583030|NCT04466098|101759109|FG000|COMPLETED|Overall Study||3||
48583031|NCT04466098|101759110|FG001|COMPLETED|Overall Study||0||
48583032|NCT04466098|101759109|FG000|NOT COMPLETED|Overall Study||3||
48583033|NCT04466098|101759110|FG001|NOT COMPLETED|Overall Study||2||
48583034|NCT03315286|101759111|FG000|STARTED|Overall Study||50||
48583035|NCT03315286|101759112|FG001|STARTED|Overall Study||47||
48583036|NCT03315286|101759111|FG000|COMPLETED|Overall Study||49||
48583037|NCT03315286|101759112|FG001|COMPLETED|Overall Study||43||
48583038|NCT03315286|101759111|FG000|NOT COMPLETED|Overall Study||1||
48583039|NCT03315286|101759112|FG001|NOT COMPLETED|Overall Study||4||
48583040|NCT02669901|101759113|FG000|STARTED|Overall Study||395||
48583041|NCT02669901|101759113|FG000|COMPLETED|Overall Study||336||
48583042|NCT02669901|101759113|FG000|NOT COMPLETED|Overall Study||59||
48583043|NCT04434469|101759114|FG000|STARTED|Overall Study||3||
48583044|NCT04434469|101759115|FG001|STARTED|Overall Study||5||
48583045|NCT04434469|101759116|FG002|STARTED|Overall Study||4||
48583046|NCT04434469|101759117|FG003|STARTED|Overall Study||6||
48583047|NCT04434469|101759118|FG004|STARTED|Overall Study||6||
48583048|NCT04434469|101759119|FG005|STARTED|Overall Study||3||
48583049|NCT04434469|101759114|FG000|COMPLETED|Overall Study||0|Alive: In Follow-up|
48583050|NCT04434469|101759115|FG001|COMPLETED|Overall Study||1|Alive: In Follow-up|
48583051|NCT04434469|101759116|FG002|COMPLETED|Overall Study||0|Alive: In Follow-up|
48583052|NCT04434469|101759117|FG003|COMPLETED|Overall Study||1|Alive: In Follow-up|
48583053|NCT04434469|101759118|FG004|COMPLETED|Overall Study||0|Alive: In Follow-up|
48583054|NCT04434469|101759119|FG005|COMPLETED|Overall Study||0|Alive: In Follow-up|
48583055|NCT04434469|101759114|FG000|NOT COMPLETED|Overall Study||3||
48583056|NCT04434469|101759115|FG001|NOT COMPLETED|Overall Study||4||
48583057|NCT04434469|101759116|FG002|NOT COMPLETED|Overall Study||4||
48583058|NCT04434469|101759117|FG003|NOT COMPLETED|Overall Study||5||
48583059|NCT04434469|101759118|FG004|NOT COMPLETED|Overall Study||6||
48583060|NCT04434469|101759119|FG005|NOT COMPLETED|Overall Study||3||
48583061|NCT00076752|101759120|FG000|STARTED|Overall Study||9||
48583062|NCT00076752|101759120|FG000|COMPLETED|Overall Study||6||
48583063|NCT00076752|101759120|FG000|NOT COMPLETED|Overall Study||3||
48583064|NCT03164564|101759121|FG000|STARTED|Overall Study||1614||
48289054|NCT00636077|101033713|FG002|STARTED|Week 4||3||
48289055|NCT00636077|101033714|FG003|STARTED|Week 4||3||
48289056|NCT00636077|101033711|FG000|COMPLETED|Week 4||3||
48289057|NCT00636077|101033712|FG001|COMPLETED|Week 4||3||
48289058|NCT00636077|101033713|FG002|COMPLETED|Week 4||3||
48289059|NCT00636077|101033714|FG003|COMPLETED|Week 4||3||
48289060|NCT00636077|101033711|FG000|NOT COMPLETED|Week 4||0||
48289061|NCT00636077|101033712|FG001|NOT COMPLETED|Week 4||0||
48289062|NCT00636077|101033713|FG002|NOT COMPLETED|Week 4||0||
48289063|NCT00636077|101033714|FG003|NOT COMPLETED|Week 4||0||
48289064|NCT02217332|101033715|FG000|STARTED|Overall Study||20||
48289065|NCT02217332|101033715|FG000|COMPLETED|Overall Study||13||
48289066|NCT02217332|101033715|FG000|NOT COMPLETED|Overall Study||7||
48289067|NCT01877837|101033716|FG000|STARTED|Overall Study||30||
48289068|NCT01877837|101033716|FG000|COMPLETED|Overall Study||25||
48289069|NCT01877837|101033716|FG000|NOT COMPLETED|Overall Study||5||
48289070|NCT01813929|101033717|FG000|STARTED|Overall Study||5||
48289071|NCT01813929|101033718|FG001|STARTED|Overall Study||12||
48289072|NCT01813929|101033717|FG000|Completed Intervention 1|Overall Study||5||
48289073|NCT01813929|101033718|FG001|Completed Intervention 1|Overall Study||12||
48289074|NCT01813929|101033717|FG000|Completed Washout (2weeks up to 2 Months)|Overall Study||5||
48289075|NCT01813929|101033718|FG001|Completed Washout (2weeks up to 2 Months)|Overall Study||11||
48289076|NCT01813929|101033717|FG000|Started Intervention 2|Overall Study||5||
48289077|NCT01813929|101033718|FG001|Started Intervention 2|Overall Study||11||
48583065|NCT03164564|101759122|FG001|STARTED|Overall Study||1610||
48583066|NCT03164564|101759121|FG000|Ongoing|Overall Study||1586|Ongoing in the study indicates the participant has not terminated or completed the study.|
48583067|NCT03164564|101759122|FG001|Ongoing|Overall Study||1586|Ongoing in the study indicates the participant has not terminated or completed the study.|
48583068|NCT03164564|101759121|FG000|Terminated From the Study|Overall Study||25|Excludes participants who completed the study.|
48583069|NCT03164564|101759122|FG001|Terminated From the Study|Overall Study||17|Excludes participants who completed the study.|
48583070|NCT03164564|101759121|FG000|COMPLETED|Overall Study||3|Any seroconverters (per Site results or EAC) in Step 1 and seroconverters in Step 2 who have completed 48 weeks of follow-up.|
48583071|NCT03164564|101759122|FG001|COMPLETED|Overall Study||7|Any seroconverters (per Site results or EAC) in Step 1 and seroconverters in Step 2 who have completed 48 weeks of follow-up.|
48583072|NCT03164564|101759121|FG000|NOT COMPLETED|Overall Study||1611||
48583073|NCT03164564|101759122|FG001|NOT COMPLETED|Overall Study||1603||
48583074|NCT05033262|101759123|FG000|STARTED|Overall Study||3|After initial verbal screening and randomization, 4 dyads did not participant in the study. These dyads stopped answering calls after initial verbal consent.|
48583075|NCT05033262|101759124|FG001|STARTED|Overall Study||3|After initial verbal screening and randomization, 4 dyads did not participant in the study. These dyads stopped answering calls after initial verbal consent.|
48583076|NCT05033262|101759125|FG002|STARTED|Overall Study||4|After initial verbal screening and randomization, 4 dyads did not participant in the study. These dyads stopped answering calls after initial verbal consent.|
48583077|NCT05033262|101759126|FG003|STARTED|Overall Study||4|After initial verbal screening and randomization, 4 dyads did not participant in the study. These dyads stopped answering calls after initial verbal consent.|
48583078|NCT05033262|101759123|FG000|COMPLETED|Overall Study||2||
48583079|NCT05033262|101759124|FG001|COMPLETED|Overall Study||3||
48583080|NCT05033262|101759125|FG002|COMPLETED|Overall Study||4||
48583081|NCT05033262|101759126|FG003|COMPLETED|Overall Study||3||
48583082|NCT05033262|101759123|FG000|NOT COMPLETED|Overall Study||1||
48583083|NCT05033262|101759124|FG001|NOT COMPLETED|Overall Study||0||
48583084|NCT05033262|101759125|FG002|NOT COMPLETED|Overall Study||0||
48583085|NCT05033262|101759126|FG003|NOT COMPLETED|Overall Study||1||
48583086|NCT02135107|101759127|FG000|STARTED|Treatment Period||437||
48583087|NCT02135107|101759128|FG001|STARTED|Treatment Period||80||
48583088|NCT02135107|101759129|FG002|STARTED|Treatment Period||0||
48583089|NCT02135107|101759130|FG003|STARTED|Treatment Period||0||
48583090|NCT02135107|101759127|FG000|COMPLETED|Treatment Period||305||
48583091|NCT02135107|101759128|FG001|COMPLETED|Treatment Period||54||
48583092|NCT02135107|101759129|FG002|COMPLETED|Treatment Period||0||
48583093|NCT02135107|101759130|FG003|COMPLETED|Treatment Period||0||
48583094|NCT02135107|101759127|FG000|NOT COMPLETED|Treatment Period||132||
48583095|NCT02135107|101759128|FG001|NOT COMPLETED|Treatment Period||26||
48583096|NCT02135107|101759129|FG002|NOT COMPLETED|Treatment Period||0||
48583097|NCT02135107|101759130|FG003|NOT COMPLETED|Treatment Period||0||
48583098|NCT02135107|101759127|FG000|STARTED|Maintenance Therapy Period||0||
48583099|NCT02135107|101759128|FG001|STARTED|Maintenance Therapy Period||0||
48583100|NCT02135107|101759129|FG002|STARTED|Maintenance Therapy Period||178||
48583101|NCT02135107|101759130|FG003|STARTED|Maintenance Therapy Period||181||
48583102|NCT02135107|101759127|FG000|COMPLETED|Maintenance Therapy Period||0||
48289078|NCT01813929|101033717|FG000|COMPLETED|Overall Study||5||
48289079|NCT01813929|101033718|FG001|COMPLETED|Overall Study||11||
48289080|NCT01813929|101033717|FG000|NOT COMPLETED|Overall Study||0||
48289081|NCT01813929|101033718|FG001|NOT COMPLETED|Overall Study||1||
48289082|NCT00705679|101033719|FG000|STARTED|Overall Study||1007||
48289083|NCT00705679|101033720|FG001|STARTED|Overall Study||1003||
48289084|NCT00705679|101033721|FG002|STARTED|Overall Study||1009||
48289085|NCT00705679|101033722|FG003|STARTED|Overall Study||1007||
48289086|NCT00705679|101033723|FG004|STARTED|Overall Study||1003||
48705074|NCT03372460|102064999|FG001|Included in ITT Sample|Overall Study||28||
48705075|NCT03372460|102064998|FG000|Completed All 6 VR Sessions|Overall Study||21||
48583103|NCT02135107|101759128|FG001|COMPLETED|Maintenance Therapy Period||0||
48583104|NCT02135107|101759129|FG002|COMPLETED|Maintenance Therapy Period||163||
48583105|NCT02135107|101759130|FG003|COMPLETED|Maintenance Therapy Period||161||
48583106|NCT02135107|101759127|FG000|NOT COMPLETED|Maintenance Therapy Period||0||
48583107|NCT02135107|101759128|FG001|NOT COMPLETED|Maintenance Therapy Period||0||
48583108|NCT02135107|101759129|FG002|NOT COMPLETED|Maintenance Therapy Period||15||
48583109|NCT02135107|101759130|FG003|NOT COMPLETED|Maintenance Therapy Period||20||
48583110|NCT01033032|101759131|FG000|STARTED|Overall Study||3||
48583111|NCT01033032|101759132|FG001|STARTED|Overall Study||3||
48583112|NCT01033032|101759133|FG002|STARTED|Overall Study||3||
48583113|NCT01033032|101759134|FG003|STARTED|Overall Study||6||
48583114|NCT01033032|101759135|FG004|STARTED|Overall Study||63||
48583115|NCT01033032|101759131|FG000|COMPLETED|Overall Study||0||
48583116|NCT01033032|101759132|FG001|COMPLETED|Overall Study||0||
48583117|NCT01033032|101759133|FG002|COMPLETED|Overall Study||3||
48583118|NCT01033032|101759134|FG003|COMPLETED|Overall Study||0||
48583119|NCT01033032|101759135|FG004|COMPLETED|Overall Study||0||
48583120|NCT01033032|101759131|FG000|NOT COMPLETED|Overall Study||3||
48583121|NCT01033032|101759132|FG001|NOT COMPLETED|Overall Study||3||
48583122|NCT01033032|101759133|FG002|NOT COMPLETED|Overall Study||0||
48583123|NCT01033032|101759134|FG003|NOT COMPLETED|Overall Study||6||
48583124|NCT01033032|101759135|FG004|NOT COMPLETED|Overall Study||63||
48583125|NCT00073983|101759136|FG000|STARTED|Overall Study||54||
48583126|NCT00073983|101759136|FG000|COMPLETED|Overall Study||53||
48583127|NCT00073983|101759136|FG000|NOT COMPLETED|Overall Study||1||
48583128|NCT02655510|101759137|FG000|STARTED|Overall Study||6||
48583129|NCT02655510|101759138|FG001|STARTED|Overall Study||6||
48583130|NCT02655510|101759139|FG002|STARTED|Overall Study||6||
48583131|NCT02655510|101759137|FG000|COMPLETED|Overall Study||6||
48583132|NCT02655510|101759138|FG001|COMPLETED|Overall Study||6||
48583133|NCT02655510|101759139|FG002|COMPLETED|Overall Study||6||
48583134|NCT02655510|101759137|FG000|NOT COMPLETED|Overall Study||0||
48705076|NCT03372460|102064999|FG001|Completed All 6 VR Sessions|Overall Study||25||
48705077|NCT03372460|102064998|FG000|Completed End-of-treatment Assessments|Overall Study||24||
48705078|NCT03372460|102064999|FG001|Completed End-of-treatment Assessments|Overall Study||27||
48705079|NCT03372460|102064998|FG000|Completed 1-month Follow-up|Overall Study||19||
48705080|NCT03372460|102064999|FG001|Completed 1-month Follow-up|Overall Study||27||
48705081|NCT03372460|102064998|FG000|Completed 3-month Follow-up|Overall Study||10||
48583135|NCT02655510|101759138|FG001|NOT COMPLETED|Overall Study||0||
48583136|NCT02655510|101759139|FG002|NOT COMPLETED|Overall Study||0||
48583137|NCT00688701|101759140|FG000|STARTED|Overall Study||61||
48705082|NCT03372460|102064999|FG001|Completed 3-month Follow-up|Overall Study||19||
48705083|NCT03372460|102064998|FG000|COMPLETED|Overall Study||26|Included in primary intent-to-treat (ITT) analysis (imputed)|
48705084|NCT03372460|102064999|FG001|COMPLETED|Overall Study||28|Included in primary intent-to-treat (ITT) analysis (imputed)|
48705085|NCT03372460|102064998|FG000|NOT COMPLETED|Overall Study||0||
48705086|NCT03372460|102064999|FG001|NOT COMPLETED|Overall Study||1||
48705087|NCT03093207|102065000|FG000|STARTED|Overall Study||17||
48705088|NCT03093207|102065001|FG001|STARTED|Overall Study||17||
48705089|NCT03093207|102065000|FG000|COMPLETED|Overall Study||17||
48583138|NCT00688701|101759141|FG001|STARTED|Overall Study||61||
48583139|NCT00688701|101759142|FG002|STARTED|Overall Study||120||
48583140|NCT00688701|101759143|FG003|STARTED|Overall Study||119||
48583141|NCT00688701|101759140|FG000|Treated/Safety Population|Overall Study||61||
48583142|NCT00688701|101759141|FG001|Treated/Safety Population|Overall Study||61||
48583143|NCT00688701|101759142|FG002|Treated/Safety Population|Overall Study||120||
48583144|NCT00688701|101759143|FG003|Treated/Safety Population|Overall Study||119||
48583145|NCT00688701|101759140|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study||61||
48583146|NCT00688701|101759141|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||60||
48583147|NCT00688701|101759142|FG002|Modified Intent-to-Treat(mITT)Population|Overall Study||120||
48583148|NCT00688701|101759143|FG003|Modified Intent-to-Treat(mITT)Population|Overall Study||118||
48583149|NCT00688701|101759140|FG000|Subgroup for Standardized Meal Test|Overall Study||27||
48583150|NCT00688701|101759141|FG001|Subgroup for Standardized Meal Test|Overall Study||35||
48583151|NCT00688701|101759142|FG002|Subgroup for Standardized Meal Test|Overall Study||60||
48583152|NCT00688701|101759143|FG003|Subgroup for Standardized Meal Test|Overall Study||65||
48583153|NCT00688701|101759140|FG000|COMPLETED|Overall Study||57||
48583154|NCT00688701|101759141|FG001|COMPLETED|Overall Study||56||
48583155|NCT00688701|101759142|FG002|COMPLETED|Overall Study||110||
48705090|NCT03093207|102065001|FG001|COMPLETED|Overall Study||17||
48705091|NCT03093207|102065000|FG000|NOT COMPLETED|Overall Study||0||
48705092|NCT03093207|102065001|FG001|NOT COMPLETED|Overall Study||0||
48705093|NCT02540330|102065002|FG000|STARTED|Overall Study||2||
48705094|NCT02540330|102065003|FG001|STARTED|Overall Study||1||
48705095|NCT02540330|102065002|FG000|COMPLETED|Overall Study||2||
48705096|NCT02540330|102065003|FG001|COMPLETED|Overall Study||1||
48705097|NCT02540330|102065002|FG000|NOT COMPLETED|Overall Study||0||
48705098|NCT02540330|102065003|FG001|NOT COMPLETED|Overall Study||0||
48583156|NCT00688701|101759143|FG003|COMPLETED|Overall Study||108||
48705099|NCT01783574|102065004|FG000|STARTED|Overall Study||51||
48705100|NCT01783574|102065005|FG001|STARTED|Overall Study||50||
48705101|NCT01783574|102065004|FG000|COMPLETED|Overall Study||46||
48705102|NCT01783574|102065005|FG001|COMPLETED|Overall Study||41||
48705103|NCT01783574|102065004|FG000|NOT COMPLETED|Overall Study||5||
48705104|NCT01783574|102065005|FG001|NOT COMPLETED|Overall Study||9||
48705105|NCT02802241|102065006|FG000|STARTED|Overall Study||89|intention to treat|
48705106|NCT02802241|102065007|FG001|STARTED|Overall Study||87|intention to treat|
48705107|NCT02802241|102065008|FG002|STARTED|Overall Study||46|intention to treat|
48705108|NCT02802241|102065009|FG003|STARTED|Overall Study||86|intention to treat|
48705109|NCT02802241|102065006|FG000|Planned Analysis|Overall Study||89||
48705110|NCT02802241|102065007|FG001|Planned Analysis|Overall Study||87||
48705111|NCT02802241|102065008|FG002|Planned Analysis|Overall Study||46||
48705112|NCT02802241|102065009|FG003|Planned Analysis|Overall Study||86||
48705113|NCT02802241|102065006|FG000|COMPLETED|Overall Study||68||
48705114|NCT02802241|102065007|FG001|COMPLETED|Overall Study||71||
48705115|NCT02802241|102065008|FG002|COMPLETED|Overall Study||30||
48705116|NCT02802241|102065009|FG003|COMPLETED|Overall Study||72||
48705117|NCT02802241|102065006|FG000|NOT COMPLETED|Overall Study||21||
48705118|NCT02802241|102065007|FG001|NOT COMPLETED|Overall Study||16||
48705119|NCT02802241|102065008|FG002|NOT COMPLETED|Overall Study||16||
48705120|NCT02802241|102065009|FG003|NOT COMPLETED|Overall Study||14||
48705121|NCT03483038|102065010|FG000|STARTED|Overall Study||45||
48705122|NCT03483038|102065010|FG000|COMPLETED|Overall Study||27||
48705123|NCT03483038|102065010|FG000|NOT COMPLETED|Overall Study||18||
48705124|NCT01133405|102065011|FG000|STARTED|Period 1||3||
48705125|NCT01133405|102065012|FG001|STARTED|Period 1||6||
48705126|NCT01133405|102065013|FG002|STARTED|Period 1||5||
48705127|NCT01133405|102065014|FG003|STARTED|Period 1||5||
48705128|NCT01133405|102065015|FG004|STARTED|Period 1||3||
48705129|NCT01133405|102065016|FG005|STARTED|Period 1||5||
48705130|NCT01133405|102065017|FG006|STARTED|Period 1||5||
48705131|NCT01133405|102065018|FG007|STARTED|Period 1||2||
48705132|NCT01133405|102065019|FG008|STARTED|Period 1||4||
48705133|NCT01133405|102065020|FG009|STARTED|Period 1||2||
48705134|NCT01133405|102065011|FG000|Safety Analysis Population|Period 1||2||
48705135|NCT01133405|102065012|FG001|Safety Analysis Population|Period 1||6||
48705136|NCT01133405|102065013|FG002|Safety Analysis Population|Period 1||5||
48705137|NCT01133405|102065014|FG003|Safety Analysis Population|Period 1||5||
48705138|NCT01133405|102065015|FG004|Safety Analysis Population|Period 1||3||
48705139|NCT01133405|102065016|FG005|Safety Analysis Population|Period 1||5||
48705140|NCT01133405|102065017|FG006|Safety Analysis Population|Period 1||5||
48705141|NCT01133405|102065018|FG007|Safety Analysis Population|Period 1||2||
48705142|NCT01133405|102065019|FG008|Safety Analysis Population|Period 1||4||
48705143|NCT01133405|102065020|FG009|Safety Analysis Population|Period 1||2||
48705144|NCT01133405|102065011|FG000|Received at Least 1 Dose of Drug|Period 1||2||
48705145|NCT01133405|102065012|FG001|Received at Least 1 Dose of Drug|Period 1||4||
48705146|NCT01133405|102065013|FG002|Received at Least 1 Dose of Drug|Period 1||4||
48705147|NCT01133405|102065014|FG003|Received at Least 1 Dose of Drug|Period 1||3||
48705148|NCT01133405|102065015|FG004|Received at Least 1 Dose of Drug|Period 1||3||
48705149|NCT01133405|102065016|FG005|Received at Least 1 Dose of Drug|Period 1||4||
48705150|NCT01133405|102065017|FG006|Received at Least 1 Dose of Drug|Period 1||4||
48705151|NCT01133405|102065018|FG007|Received at Least 1 Dose of Drug|Period 1||2||
48705152|NCT01133405|102065019|FG008|Received at Least 1 Dose of Drug|Period 1||4||
48705153|NCT01133405|102065020|FG009|Received at Least 1 Dose of Drug|Period 1||2||
48705154|NCT01133405|102065011|FG000|COMPLETED|Period 1||2||
48705155|NCT01133405|102065012|FG001|COMPLETED|Period 1||3||
48705156|NCT01133405|102065013|FG002|COMPLETED|Period 1||4||
48705157|NCT01133405|102065014|FG003|COMPLETED|Period 1||1||
48705158|NCT01133405|102065015|FG004|COMPLETED|Period 1||3||
48705159|NCT01133405|102065016|FG005|COMPLETED|Period 1||3||
48705160|NCT01133405|102065017|FG006|COMPLETED|Period 1||4||
48705161|NCT01133405|102065018|FG007|COMPLETED|Period 1||2||
48289087|NCT00705679|101033719|FG000|COMPLETED|Overall Study||942||
48705162|NCT01133405|102065019|FG008|COMPLETED|Period 1||4||
48705163|NCT01133405|102065020|FG009|COMPLETED|Period 1||2||
48705164|NCT01133405|102065011|FG000|NOT COMPLETED|Period 1||1||
48705165|NCT01133405|102065012|FG001|NOT COMPLETED|Period 1||3||
48705166|NCT01133405|102065013|FG002|NOT COMPLETED|Period 1||1||
48705167|NCT01133405|102065014|FG003|NOT COMPLETED|Period 1||4||
48705168|NCT01133405|102065015|FG004|NOT COMPLETED|Period 1||0||
48705169|NCT01133405|102065016|FG005|NOT COMPLETED|Period 1||2||
48705170|NCT01133405|102065017|FG006|NOT COMPLETED|Period 1||1||
48705171|NCT01133405|102065018|FG007|NOT COMPLETED|Period 1||0||
48705172|NCT01133405|102065019|FG008|NOT COMPLETED|Period 1||0||
48705173|NCT01133405|102065020|FG009|NOT COMPLETED|Period 1||0||
48705174|NCT01133405|102065011|FG000|STARTED|Period 2||2||
48705175|NCT01133405|102065012|FG001|STARTED|Period 2||4||
48705176|NCT01133405|102065013|FG002|STARTED|Period 2||4||
48705177|NCT01133405|102065014|FG003|STARTED|Period 2||3||
48705178|NCT01133405|102065015|FG004|STARTED|Period 2||3||
48705179|NCT01133405|102065016|FG005|STARTED|Period 2||4||
48705180|NCT01133405|102065017|FG006|STARTED|Period 2||0||
48705181|NCT01133405|102065018|FG007|STARTED|Period 2||0||
48705182|NCT01133405|102065019|FG008|STARTED|Period 2||0||
48136915|NCT03230916|100661374|FG006|NOT COMPLETED|Overall Study||0||
48136916|NCT03230916|100661375|FG007|NOT COMPLETED|Overall Study||0||
48136917|NCT03230916|100661376|FG008|NOT COMPLETED|Overall Study||0||
48136918|NCT03230916|100661377|FG009|NOT COMPLETED|Overall Study||0||
48136919|NCT03230916|100661378|FG010|NOT COMPLETED|Overall Study||0||
48136920|NCT01781572|100661379|FG000|STARTED|MEK162 45mg BID+LEE011 200mg||16||
48136921|NCT01781572|100661380|FG001|STARTED|MEK162 45mg BID+LEE011 200mg||6||
48136922|NCT01781572|100661381|FG002|STARTED|MEK162 45mg BID+LEE011 200mg||41||
48136923|NCT01781572|100661379|FG000|COMPLETED|MEK162 45mg BID+LEE011 200mg||0||
48136924|NCT01781572|100661380|FG001|COMPLETED|MEK162 45mg BID+LEE011 200mg||0||
48136925|NCT01781572|100661381|FG002|COMPLETED|MEK162 45mg BID+LEE011 200mg||0||
48136926|NCT01781572|100661379|FG000|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||16||
48136927|NCT01781572|100661380|FG001|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||6||
48583157|NCT00688701|101759140|FG000|NOT COMPLETED|Overall Study||4||
48583158|NCT00688701|101759141|FG001|NOT COMPLETED|Overall Study||5||
48583159|NCT00688701|101759142|FG002|NOT COMPLETED|Overall Study||10||
48583160|NCT00688701|101759143|FG003|NOT COMPLETED|Overall Study||11||
48136928|NCT01781572|100661381|FG002|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||41||
48583161|NCT05685264|101759144|FG000|STARTED|Overall Study||9||
48583162|NCT05685264|101759145|FG001|STARTED|Overall Study||9||
48289088|NCT00705679|101033720|FG001|COMPLETED|Overall Study||864||
48289089|NCT00705679|101033721|FG002|COMPLETED|Overall Study||894||
48583163|NCT05685264|101759144|FG000|COMPLETED|Overall Study||9||
48583164|NCT05685264|101759145|FG001|COMPLETED|Overall Study||9||
48583165|NCT05685264|101759144|FG000|NOT COMPLETED|Overall Study||0||
48583166|NCT05685264|101759145|FG001|NOT COMPLETED|Overall Study||0||
48583167|NCT00679289|101759146|FG000|STARTED|Overall Study||6|Received at least 1 dose of KW2871 and initial treatment with HDI|
48583168|NCT00679289|101759147|FG001|STARTED|Overall Study||6|Received at least 1 dose of KW2871 and initial treatment with HDI|
48583169|NCT00679289|101759148|FG002|STARTED|Overall Study||24|Received at least 1 dose of KW2871 and initial treatment with HDI|
48583170|NCT00679289|101759146|FG000|COMPLETED|Overall Study||1||
48583171|NCT00679289|101759147|FG001|COMPLETED|Overall Study||0||
48583172|NCT00679289|101759148|FG002|COMPLETED|Overall Study||1||
48583173|NCT00679289|101759146|FG000|NOT COMPLETED|Overall Study||5||
48583174|NCT00679289|101759147|FG001|NOT COMPLETED|Overall Study||6||
48583175|NCT00679289|101759148|FG002|NOT COMPLETED|Overall Study||23||
48583176|NCT02986282|101759149|FG000|STARTED|Overall Study||115||
48583177|NCT02986282|101759149|FG000|COMPLETED|Overall Study||99||
48583178|NCT02986282|101759149|FG000|NOT COMPLETED|Overall Study||16||
48583179|NCT04870099|101759150|FG000|STARTED|Overall Study||141||
48583180|NCT04870099|101759150|FG000|COMPLETED|Overall Study||97||
48583181|NCT04870099|101759150|FG000|NOT COMPLETED|Overall Study||44||
48583182|NCT00880230|101759151|FG000|STARTED|Overall Study||141||
48583183|NCT00880230|101759151|FG000|COMPLETED|Overall Study||134||
48583184|NCT00880230|101759151|FG000|NOT COMPLETED|Overall Study||7||
48583185|NCT03981900|101759152|FG000|STARTED|Overall Study||314||
48583186|NCT03981900|101759152|FG000|Safety Analysis Set (SAS)|Overall Study||309||
48583187|NCT03981900|101759152|FG000|Full Analysis Set (FAS)|Overall Study||306||
48583188|NCT03981900|101759152|FG000|COMPLETED|Overall Study||227||
48583189|NCT03981900|101759152|FG000|NOT COMPLETED|Overall Study||87||
48583190|NCT00519428|101759153|FG000|STARTED|Overall Study||78||
48583191|NCT00519428|101759154|FG001|STARTED|Overall Study||84||
48583192|NCT00519428|101759155|FG002|STARTED|Overall Study||83||
48583193|NCT00519428|101759153|FG000|COMPLETED|Overall Study||57||
48583194|NCT00519428|101759154|FG001|COMPLETED|Overall Study||69||
48583195|NCT00519428|101759155|FG002|COMPLETED|Overall Study||58||
48583196|NCT00519428|101759153|FG000|NOT COMPLETED|Overall Study||21||
48583197|NCT00519428|101759154|FG001|NOT COMPLETED|Overall Study||15||
48583198|NCT00519428|101759155|FG002|NOT COMPLETED|Overall Study||25||
48583199|NCT00960986|101759156|FG000|STARTED|Period 1 (Screening and Washout)||59||
48583200|NCT00960986|101759157|FG001|STARTED|Period 1 (Screening and Washout)||63||
48583201|NCT00960986|101759158|FG002|STARTED|Period 1 (Screening and Washout)||63||
48583202|NCT00960986|101759159|FG003|STARTED|Period 1 (Screening and Washout)||64||
48583203|NCT00960986|101759156|FG000|COMPLETED|Period 1 (Screening and Washout)||56||
48583204|NCT00960986|101759157|FG001|COMPLETED|Period 1 (Screening and Washout)||59||
48583205|NCT00960986|101759158|FG002|COMPLETED|Period 1 (Screening and Washout)||59||
48583206|NCT00960986|101759159|FG003|COMPLETED|Period 1 (Screening and Washout)||61||
48583207|NCT00960986|101759156|FG000|NOT COMPLETED|Period 1 (Screening and Washout)||3||
48136929|NCT01781572|100661379|FG000|STARTED|MEK162 45mg BID+LEE011 250mg||3||
48136930|NCT01781572|100661380|FG001|STARTED|MEK162 45mg BID+LEE011 250mg||0||
48136931|NCT01781572|100661381|FG002|STARTED|MEK162 45mg BID+LEE011 250mg||0||
48136932|NCT01781572|100661379|FG000|COMPLETED|MEK162 45mg BID+LEE011 250mg||0||
48136933|NCT01781572|100661380|FG001|COMPLETED|MEK162 45mg BID+LEE011 250mg||0||
48136934|NCT01781572|100661381|FG002|COMPLETED|MEK162 45mg BID+LEE011 250mg||0||
48136935|NCT01781572|100661379|FG000|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||3||
48136936|NCT01781572|100661380|FG001|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||0||
48583208|NCT00960986|101759157|FG001|NOT COMPLETED|Period 1 (Screening and Washout)||4||
48705183|NCT01133405|102065020|FG009|STARTED|Period 2||0||
48705184|NCT01133405|102065011|FG000|Received at Least 1 Dose of Study Drug|Period 2||2||
48705185|NCT01133405|102065012|FG001|Received at Least 1 Dose of Study Drug|Period 2||4||
48705186|NCT01133405|102065013|FG002|Received at Least 1 Dose of Study Drug|Period 2||4||
48705187|NCT01133405|102065014|FG003|Received at Least 1 Dose of Study Drug|Period 2||3||
48705188|NCT01133405|102065015|FG004|Received at Least 1 Dose of Study Drug|Period 2||3||
48705189|NCT01133405|102065016|FG005|Received at Least 1 Dose of Study Drug|Period 2||4||
48705190|NCT01133405|102065017|FG006|Received at Least 1 Dose of Study Drug|Period 2||0||
48705191|NCT01133405|102065018|FG007|Received at Least 1 Dose of Study Drug|Period 2||0||
48705192|NCT01133405|102065019|FG008|Received at Least 1 Dose of Study Drug|Period 2||0||
48705193|NCT01133405|102065020|FG009|Received at Least 1 Dose of Study Drug|Period 2||0||
48705194|NCT01133405|102065011|FG000|COMPLETED|Period 2||2||
48705195|NCT01133405|102065012|FG001|COMPLETED|Period 2||3||
48705196|NCT01133405|102065013|FG002|COMPLETED|Period 2||3||
48705197|NCT01133405|102065014|FG003|COMPLETED|Period 2||2||
48705198|NCT01133405|102065015|FG004|COMPLETED|Period 2||3||
48705199|NCT01133405|102065016|FG005|COMPLETED|Period 2||2||
48705200|NCT01133405|102065017|FG006|COMPLETED|Period 2||0||
48705201|NCT01133405|102065018|FG007|COMPLETED|Period 2||0||
48705202|NCT01133405|102065019|FG008|COMPLETED|Period 2||0||
48705203|NCT01133405|102065020|FG009|COMPLETED|Period 2||0||
48705204|NCT01133405|102065011|FG000|NOT COMPLETED|Period 2||0||
48705205|NCT01133405|102065012|FG001|NOT COMPLETED|Period 2||1||
48705206|NCT01133405|102065013|FG002|NOT COMPLETED|Period 2||1||
48705207|NCT01133405|102065014|FG003|NOT COMPLETED|Period 2||1||
48705208|NCT01133405|102065015|FG004|NOT COMPLETED|Period 2||0||
48705209|NCT01133405|102065016|FG005|NOT COMPLETED|Period 2||2||
48705210|NCT01133405|102065017|FG006|NOT COMPLETED|Period 2||0||
48705211|NCT01133405|102065018|FG007|NOT COMPLETED|Period 2||0||
48705212|NCT01133405|102065019|FG008|NOT COMPLETED|Period 2||0||
48705213|NCT01133405|102065020|FG009|NOT COMPLETED|Period 2||0||
48705214|NCT01133405|102065011|FG000|STARTED|Period 3||2||
48705215|NCT01133405|102065012|FG001|STARTED|Period 3||4||
48705216|NCT01133405|102065013|FG002|STARTED|Period 3||4||
48705217|NCT01133405|102065014|FG003|STARTED|Period 3||2||
48705218|NCT01133405|102065015|FG004|STARTED|Period 3||3||
48705219|NCT01133405|102065016|FG005|STARTED|Period 3||2||
48705220|NCT01133405|102065017|FG006|STARTED|Period 3||0||
48705221|NCT01133405|102065018|FG007|STARTED|Period 3||0||
48705222|NCT01133405|102065019|FG008|STARTED|Period 3||0||
48705223|NCT01133405|102065020|FG009|STARTED|Period 3||0||
48705224|NCT01133405|102065011|FG000|Received at Least 1 Dose of Study Drug|Period 3||2||
48705225|NCT01133405|102065012|FG001|Received at Least 1 Dose of Study Drug|Period 3||4||
48705226|NCT01133405|102065013|FG002|Received at Least 1 Dose of Study Drug|Period 3||4||
48705227|NCT01133405|102065014|FG003|Received at Least 1 Dose of Study Drug|Period 3||2||
48705228|NCT01133405|102065015|FG004|Received at Least 1 Dose of Study Drug|Period 3||3||
48705229|NCT01133405|102065016|FG005|Received at Least 1 Dose of Study Drug|Period 3||2||
48705230|NCT01133405|102065017|FG006|Received at Least 1 Dose of Study Drug|Period 3||0||
48705231|NCT01133405|102065018|FG007|Received at Least 1 Dose of Study Drug|Period 3||0||
48705232|NCT01133405|102065019|FG008|Received at Least 1 Dose of Study Drug|Period 3||0||
48705233|NCT01133405|102065020|FG009|Received at Least 1 Dose of Study Drug|Period 3||0||
48705234|NCT01133405|102065011|FG000|COMPLETED|Period 3||2||
48705235|NCT01133405|102065012|FG001|COMPLETED|Period 3||4||
48705236|NCT01133405|102065013|FG002|COMPLETED|Period 3||4||
48705237|NCT01133405|102065014|FG003|COMPLETED|Period 3||2||
48705238|NCT01133405|102065015|FG004|COMPLETED|Period 3||3||
48705239|NCT01133405|102065016|FG005|COMPLETED|Period 3||2||
48705240|NCT01133405|102065017|FG006|COMPLETED|Period 3||0||
48705241|NCT01133405|102065018|FG007|COMPLETED|Period 3||0||
48705242|NCT01133405|102065019|FG008|COMPLETED|Period 3||0||
48705243|NCT01133405|102065020|FG009|COMPLETED|Period 3||0||
48705244|NCT01133405|102065011|FG000|NOT COMPLETED|Period 3||0||
48705245|NCT01133405|102065012|FG001|NOT COMPLETED|Period 3||0||
48705246|NCT01133405|102065013|FG002|NOT COMPLETED|Period 3||0||
48705247|NCT01133405|102065014|FG003|NOT COMPLETED|Period 3||0||
48705248|NCT01133405|102065015|FG004|NOT COMPLETED|Period 3||0||
48705249|NCT01133405|102065016|FG005|NOT COMPLETED|Period 3||0||
48705250|NCT01133405|102065017|FG006|NOT COMPLETED|Period 3||0||
48705251|NCT01133405|102065018|FG007|NOT COMPLETED|Period 3||0||
48705252|NCT01133405|102065019|FG008|NOT COMPLETED|Period 3||0||
48705253|NCT01133405|102065020|FG009|NOT COMPLETED|Period 3||0||
48705254|NCT01973387|102065021|FG000|STARTED|Overall Study||106||
48705255|NCT01973387|102065022|FG001|STARTED|Overall Study||54||
48705256|NCT01973387|102065021|FG000|Treated|Overall Study||104||
48705257|NCT01973387|102065022|FG001|Treated|Overall Study||52||
48705258|NCT01973387|102065021|FG000|COMPLETED|Overall Study||0||
48705259|NCT01973387|102065022|FG001|COMPLETED|Overall Study||36||
48705260|NCT01973387|102065021|FG000|NOT COMPLETED|Overall Study||106||
48705261|NCT01973387|102065022|FG001|NOT COMPLETED|Overall Study||18||
48705262|NCT04417218|102065023|FG000|STARTED|First Intervention (1 Week))||25||
48705263|NCT04417218|102065024|FG001|STARTED|First Intervention (1 Week))||22||
48705264|NCT04417218|102065023|FG000|COMPLETED|First Intervention (1 Week))||24||
48583209|NCT00960986|101759158|FG002|NOT COMPLETED|Period 1 (Screening and Washout)||4||
48583210|NCT00960986|101759159|FG003|NOT COMPLETED|Period 1 (Screening and Washout)||3||
48583211|NCT00960986|101759156|FG000|STARTED|Period 2 (1-week Initial Dosing Period)||56||
48583212|NCT00960986|101759157|FG001|STARTED|Period 2 (1-week Initial Dosing Period)||59||
48583213|NCT00960986|101759158|FG002|STARTED|Period 2 (1-week Initial Dosing Period)||59||
48583214|NCT00960986|101759159|FG003|STARTED|Period 2 (1-week Initial Dosing Period)||61||
48583215|NCT00960986|101759156|FG000|COMPLETED|Period 2 (1-week Initial Dosing Period)||56||
48583216|NCT00960986|101759157|FG001|COMPLETED|Period 2 (1-week Initial Dosing Period)||59||
48583217|NCT00960986|101759158|FG002|COMPLETED|Period 2 (1-week Initial Dosing Period)||59||
48583218|NCT00960986|101759159|FG003|COMPLETED|Period 2 (1-week Initial Dosing Period)||61||
48583219|NCT00960986|101759156|FG000|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0||
48583220|NCT00960986|101759157|FG001|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0||
48583221|NCT00960986|101759158|FG002|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0||
48583222|NCT00960986|101759159|FG003|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0||
48583223|NCT00960986|101759156|FG000|STARTED|Period 3 (7-week Therapy Period)||56||
48583224|NCT00960986|101759157|FG001|STARTED|Period 3 (7-week Therapy Period)||59||
48583225|NCT00960986|101759158|FG002|STARTED|Period 3 (7-week Therapy Period)||59||
48583226|NCT00960986|101759159|FG003|STARTED|Period 3 (7-week Therapy Period)||61||
48583227|NCT00960986|101759156|FG000|COMPLETED|Period 3 (7-week Therapy Period)||26||
48583228|NCT00960986|101759157|FG001|COMPLETED|Period 3 (7-week Therapy Period)||36||
48583229|NCT00960986|101759158|FG002|COMPLETED|Period 3 (7-week Therapy Period)||39||
48583230|NCT00960986|101759159|FG003|COMPLETED|Period 3 (7-week Therapy Period)||36||
48583231|NCT00960986|101759156|FG000|NOT COMPLETED|Period 3 (7-week Therapy Period)||30||
48583232|NCT00960986|101759157|FG001|NOT COMPLETED|Period 3 (7-week Therapy Period)||23||
48583233|NCT00960986|101759158|FG002|NOT COMPLETED|Period 3 (7-week Therapy Period)||20||
48583234|NCT00960986|101759159|FG003|NOT COMPLETED|Period 3 (7-week Therapy Period)||25||
48583235|NCT02759055|101759160|FG000|STARTED|Overall Study||12702||
48583236|NCT02759055|101759161|FG001|STARTED|Overall Study||8962||
48583237|NCT02759055|101759160|FG000|COMPLETED|Overall Study||10775||
48583238|NCT02759055|101759161|FG001|COMPLETED|Overall Study||7454||
48583239|NCT02759055|101759160|FG000|NOT COMPLETED|Overall Study||1927||
48583240|NCT02759055|101759161|FG001|NOT COMPLETED|Overall Study||1508||
48583241|NCT02353442|101759162|FG000|STARTED|Overall Study||28||
48583242|NCT02353442|101759163|FG001|STARTED|Overall Study||31||
48583243|NCT02353442|101759162|FG000|COMPLETED|Overall Study||25||
48583244|NCT02353442|101759163|FG001|COMPLETED|Overall Study||27||
48583245|NCT02353442|101759162|FG000|NOT COMPLETED|Overall Study||3||
48583246|NCT02353442|101759163|FG001|NOT COMPLETED|Overall Study||4||
48583247|NCT02798289|101759164|FG000|STARTED|Overall Study||55||
48583248|NCT02798289|101759164|FG000|COMPLETED|Overall Study||55||
48583249|NCT02798289|101759164|FG000|NOT COMPLETED|Overall Study||0||
48583250|NCT01707108|101759165|FG000|STARTED|Overall Study||60||117
48583251|NCT01707108|101759165|FG000|1 Year|Overall Study||60||117
48583252|NCT01707108|101759165|FG000|COMPLETED|Overall Study||60||117
48583253|NCT01707108|101759165|FG000|NOT COMPLETED|Overall Study||0||0
48583254|NCT01945970|101759166|FG000|STARTED|Overall Study||5||
48583255|NCT01945970|101759167|FG001|STARTED|Overall Study||5||
48583256|NCT01945970|101759168|FG002|STARTED|Overall Study||5||
48583257|NCT01945970|101759169|FG003|STARTED|Overall Study||5||
48583258|NCT01945970|101759170|FG004|STARTED|Overall Study||5||
48583259|NCT01945970|101759171|FG005|STARTED|Overall Study||5||
48583260|NCT01945970|101759166|FG000|COMPLETED|Overall Study||5||
48583261|NCT01945970|101759167|FG001|COMPLETED|Overall Study||5||
48583262|NCT01945970|101759168|FG002|COMPLETED|Overall Study||5||
48583263|NCT01945970|101759169|FG003|COMPLETED|Overall Study||5||
48583264|NCT01945970|101759170|FG004|COMPLETED|Overall Study||5||
48583265|NCT01945970|101759171|FG005|COMPLETED|Overall Study||5||
48583266|NCT01945970|101759166|FG000|NOT COMPLETED|Overall Study||0||
48583267|NCT01945970|101759167|FG001|NOT COMPLETED|Overall Study||0||
48583268|NCT01945970|101759168|FG002|NOT COMPLETED|Overall Study||0||
48583269|NCT01945970|101759169|FG003|NOT COMPLETED|Overall Study||0||
48583270|NCT01945970|101759170|FG004|NOT COMPLETED|Overall Study||0||
48583271|NCT01945970|101759171|FG005|NOT COMPLETED|Overall Study||0||
48583272|NCT05413369|101759172|FG000|STARTED|Overall Study||291|Randomized|
48583273|NCT05413369|101759173|FG001|STARTED|Overall Study||291|Randomized|
48583274|NCT05413369|101759172|FG000|Randomized and Treated|Overall Study||290||
48583275|NCT05413369|101759173|FG001|Randomized and Treated|Overall Study||291||
48583276|NCT05413369|101759172|FG000|Completed 24-week Treatment Period|Overall Study||272||
48583277|NCT05413369|101759173|FG001|Completed 24-week Treatment Period|Overall Study||284||
48583278|NCT05413369|101759172|FG000|COMPLETED|Overall Study||274|Completed the study per protocol|
48583279|NCT05413369|101759173|FG001|COMPLETED|Overall Study||284|Completed the study per protocol|
48583280|NCT05413369|101759172|FG000|NOT COMPLETED|Overall Study||17||
48583281|NCT05413369|101759173|FG001|NOT COMPLETED|Overall Study||7||
48583282|NCT04016779|101759174|FG000|STARTED|Overall Study||184|"Number of subjects started is based on the Randomized Population (defined as number of subjects who were randomized). Two subjects who were randomized, however, were not treated. Reason Not Completed section is summarized by Randomized Population."|
48592833|NCT02938949|101786321|FG001|STARTED|Overall Study||10||
48592834|NCT02938949|101786320|FG000|COMPLETED|Overall Study||10||
48136937|NCT01781572|100661381|FG002|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||0||
48136938|NCT01781572|100661379|FG000|STARTED|MEK162 30mg BID+LEE011 300mg||4||
48136939|NCT01781572|100661380|FG001|STARTED|MEK162 30mg BID+LEE011 300mg||2||
48136940|NCT01781572|100661381|FG002|STARTED|MEK162 30mg BID+LEE011 300mg||0||
48136941|NCT01781572|100661379|FG000|COMPLETED|MEK162 30mg BID+LEE011 300mg||0||
48136942|NCT01781572|100661380|FG001|COMPLETED|MEK162 30mg BID+LEE011 300mg||0||
48136943|NCT01781572|100661381|FG002|COMPLETED|MEK162 30mg BID+LEE011 300mg||0||
48136944|NCT01781572|100661379|FG000|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||4||
48136945|NCT01781572|100661380|FG001|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||2||
48136946|NCT01781572|100661381|FG002|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||0||
48136947|NCT01781572|100661379|FG000|STARTED|MEK162 45mg BID+LEE011 300mg||6||
48136948|NCT01781572|100661380|FG001|STARTED|MEK162 45mg BID+LEE011 300mg||4||
48136949|NCT01781572|100661381|FG002|STARTED|MEK162 45mg BID+LEE011 300mg||0||
48136950|NCT01781572|100661379|FG000|COMPLETED|MEK162 45mg BID+LEE011 300mg||0||
48583283|NCT04016779|101759175|FG001|STARTED|Overall Study||190|"Number of subjects started is based on the Randomized Population (defined as number of subjects who were randomized). Two subjects who were randomized, however, were not treated. Reason Not Completed section is summarized by Randomized Population."|
48583284|NCT04016779|101759174|FG000|Treated|Overall Study||183|Number of subjects treated is based on the Safety Population (defined as number of subjects who were randomized and took at least one dose of study medication)|
48583285|NCT04016779|101759175|FG001|Treated|Overall Study||189|Number of subjects treated is based on the Safety Population (defined as number of subjects who were randomized and took at least one dose of study medication)|
48583286|NCT04016779|101759174|FG000|COMPLETED|Overall Study||140|Number of subjects completed is based on the Randomized Population.|
48583287|NCT04016779|101759175|FG001|COMPLETED|Overall Study||127|Number of subjects completed is based on the Randomized Population.|
48583288|NCT04016779|101759174|FG000|NOT COMPLETED|Overall Study||44||
48583289|NCT04016779|101759175|FG001|NOT COMPLETED|Overall Study||63||
48583290|NCT02344251|101759176|FG000|STARTED|Overall Study||20||
48583291|NCT02344251|101759177|FG001|STARTED|Overall Study||20||
48583292|NCT02344251|101759176|FG000|COMPLETED|Overall Study||20||
48583293|NCT02344251|101759177|FG001|COMPLETED|Overall Study||20||
48583294|NCT02344251|101759176|FG000|NOT COMPLETED|Overall Study||0||
48583295|NCT02344251|101759177|FG001|NOT COMPLETED|Overall Study||0||
48583296|NCT02663102|101759178|FG000|STARTED|Overall Study||687||
48583297|NCT02663102|101759179|FG001|STARTED|Overall Study||701||
48583298|NCT02663102|101759178|FG000|COMPLETED|Overall Study||687||
48583299|NCT02663102|101759179|FG001|COMPLETED|Overall Study||701||
48583300|NCT02663102|101759178|FG000|NOT COMPLETED|Overall Study||0||
48583301|NCT02663102|101759179|FG001|NOT COMPLETED|Overall Study||0||
48583302|NCT04257032|101759180|FG000|STARTED|Period 1 (+ Washout Period)||7||
48583303|NCT04257032|101759181|FG001|STARTED|Period 1 (+ Washout Period)||7||
48583304|NCT04257032|101759182|FG002|STARTED|Period 1 (+ Washout Period)||7||
48583305|NCT04257032|101759183|FG003|STARTED|Period 1 (+ Washout Period)||7||
48583306|NCT04257032|101759180|FG000|COMPLETED|Period 1 (+ Washout Period)||7||
48583307|NCT04257032|101759181|FG001|COMPLETED|Period 1 (+ Washout Period)||7||
48583308|NCT04257032|101759182|FG002|COMPLETED|Period 1 (+ Washout Period)||7||
48583309|NCT04257032|101759183|FG003|COMPLETED|Period 1 (+ Washout Period)||7||
48583310|NCT04257032|101759180|FG000|NOT COMPLETED|Period 1 (+ Washout Period)||0||
48583311|NCT04257032|101759181|FG001|NOT COMPLETED|Period 1 (+ Washout Period)||0||
48583312|NCT04257032|101759182|FG002|NOT COMPLETED|Period 1 (+ Washout Period)||0||
48583313|NCT04257032|101759183|FG003|NOT COMPLETED|Period 1 (+ Washout Period)||0||
48583314|NCT04257032|101759180|FG000|STARTED|Period 2||7||
48583315|NCT04257032|101759181|FG001|STARTED|Period 2||7||
48583316|NCT04257032|101759182|FG002|STARTED|Period 2||7||
48583317|NCT04257032|101759183|FG003|STARTED|Period 2||7||
48583318|NCT04257032|101759180|FG000|COMPLETED|Period 2||7||
48583319|NCT04257032|101759181|FG001|COMPLETED|Period 2||7||
48583320|NCT04257032|101759182|FG002|COMPLETED|Period 2||7||
48583321|NCT04257032|101759183|FG003|COMPLETED|Period 2||7||
48583322|NCT04257032|101759180|FG000|NOT COMPLETED|Period 2||0||
48583323|NCT04257032|101759181|FG001|NOT COMPLETED|Period 2||0||
48583324|NCT04257032|101759182|FG002|NOT COMPLETED|Period 2||0||
48583325|NCT04257032|101759183|FG003|NOT COMPLETED|Period 2||0||
48583326|NCT03788434|101759184|FG000|STARTED|Overall Study||30||
48583327|NCT03788434|101759185|FG001|STARTED|Overall Study||27||
48583328|NCT03788434|101759186|FG002|STARTED|Overall Study||22||
48583329|NCT03788434|101759184|FG000|COMPLETED|Overall Study||29||
48583330|NCT03788434|101759185|FG001|COMPLETED|Overall Study||27||
48583331|NCT03788434|101759186|FG002|COMPLETED|Overall Study||22||
48583332|NCT03788434|101759184|FG000|NOT COMPLETED|Overall Study||1||
48583333|NCT03788434|101759185|FG001|NOT COMPLETED|Overall Study||0||
48136951|NCT01781572|100661380|FG001|COMPLETED|MEK162 45mg BID+LEE011 300mg||0||
48583334|NCT03788434|101759186|FG002|NOT COMPLETED|Overall Study||0||
48583335|NCT01343277|101759187|FG000|STARTED|Overall Study||384||
48136952|NCT01781572|100661381|FG002|COMPLETED|MEK162 45mg BID+LEE011 300mg||0||
48136953|NCT01781572|100661379|FG000|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||6||
48583336|NCT01343277|101759188|FG001|STARTED|Overall Study||193||
48583337|NCT01343277|101759187|FG000|Treated|Overall Study||378||
48583338|NCT01343277|101759188|FG001|Treated|Overall Study||172||
48583339|NCT01343277|101759187|FG000|COMPLETED|Overall Study||0||
48583340|NCT01343277|101759188|FG001|COMPLETED|Overall Study||0||
48583341|NCT01343277|101759187|FG000|NOT COMPLETED|Overall Study||384||
48583342|NCT01343277|101759188|FG001|NOT COMPLETED|Overall Study||193||
48583343|NCT02233296|101759189|FG000|STARTED|Overall Study||16||
48583344|NCT02233296|101759190|FG001|STARTED|Overall Study||14||
48583345|NCT02233296|101759189|FG000|COMPLETED|Overall Study||16||
48583346|NCT02233296|101759190|FG001|COMPLETED|Overall Study||14||
48583347|NCT02233296|101759189|FG000|NOT COMPLETED|Overall Study||0||
48583348|NCT02233296|101759190|FG001|NOT COMPLETED|Overall Study||0||
48583349|NCT02111785|101759191|FG000|STARTED|Overall Study||3||
48583350|NCT02111785|101759192|FG001|STARTED|Overall Study||5||
48583351|NCT02111785|101759193|FG002|STARTED|Overall Study||1||
48583352|NCT02111785|101759194|FG003|STARTED|Overall Study||1||
48583353|NCT02111785|101759191|FG000|COMPLETED|Overall Study||3||
48583354|NCT02111785|101759192|FG001|COMPLETED|Overall Study||4||
48583355|NCT02111785|101759193|FG002|COMPLETED|Overall Study||1||
48583356|NCT02111785|101759194|FG003|COMPLETED|Overall Study||1||
48583357|NCT02111785|101759191|FG000|NOT COMPLETED|Overall Study||0||
48583358|NCT02111785|101759192|FG001|NOT COMPLETED|Overall Study||1||
48583359|NCT02111785|101759193|FG002|NOT COMPLETED|Overall Study||0||
48583360|NCT02111785|101759194|FG003|NOT COMPLETED|Overall Study||0||
48583361|NCT05318092|101759195|FG000|STARTED|Overall Study||122||
48583362|NCT05318092|101759195|FG000|COMPLETED|Overall Study||118||
48583363|NCT05318092|101759195|FG000|NOT COMPLETED|Overall Study||4||
48583364|NCT01598090|101759196|FG000|STARTED|Treatment Period||27||
48583365|NCT01598090|101759197|FG001|STARTED|Treatment Period||411||
48583366|NCT01598090|101759198|FG002|STARTED|Treatment Period||206||
48583367|NCT01598090|101759196|FG000|COMPLETED|Treatment Period||16||
48583368|NCT01598090|101759197|FG001|COMPLETED|Treatment Period||339||
48583369|NCT01598090|101759198|FG002|COMPLETED|Treatment Period||171||
48583370|NCT01598090|101759196|FG000|NOT COMPLETED|Treatment Period||11||
48583371|NCT01598090|101759197|FG001|NOT COMPLETED|Treatment Period||72||
48583372|NCT01598090|101759198|FG002|NOT COMPLETED|Treatment Period||35||
48583373|NCT01598090|101759196|FG000|STARTED|Follow-up Period||26||
48583374|NCT01598090|101759197|FG001|STARTED|Follow-up Period||399||
48583375|NCT01598090|101759198|FG002|STARTED|Follow-up Period||199||
48583376|NCT01598090|101759196|FG000|COMPLETED|Follow-up Period||21||
48583377|NCT01598090|101759197|FG001|COMPLETED|Follow-up Period||364||
48583378|NCT01598090|101759198|FG002|COMPLETED|Follow-up Period||171||
48583379|NCT01598090|101759196|FG000|NOT COMPLETED|Follow-up Period||5||
48583380|NCT01598090|101759197|FG001|NOT COMPLETED|Follow-up Period||35||
48583381|NCT01598090|101759198|FG002|NOT COMPLETED|Follow-up Period||28||
48583382|NCT04709692|101759199|FG000|STARTED|Overall Study||10||
48583383|NCT04709692|101759200|FG001|STARTED|Overall Study||12||
48583384|NCT04709692|101759199|FG000|COMPLETED|Overall Study||10||
48583385|NCT04709692|101759200|FG001|COMPLETED|Overall Study||11||
48583386|NCT04709692|101759199|FG000|NOT COMPLETED|Overall Study||0||
48583387|NCT04709692|101759200|FG001|NOT COMPLETED|Overall Study||1||
48583388|NCT04286581|101759201|FG000|STARTED|Overall Study||74||
48583389|NCT04286581|101759202|FG001|STARTED|Overall Study||74||
48705265|NCT04417218|102065024|FG001|COMPLETED|First Intervention (1 Week))||22||
48705266|NCT04417218|102065023|FG000|NOT COMPLETED|First Intervention (1 Week))||1||
48705267|NCT04417218|102065024|FG001|NOT COMPLETED|First Intervention (1 Week))||0||
48705268|NCT04417218|102065023|FG000|STARTED|Washout (2 Weeks)||24||
48705269|NCT04417218|102065024|FG001|STARTED|Washout (2 Weeks)||22||
48705270|NCT04417218|102065023|FG000|COMPLETED|Washout (2 Weeks)||24||
48705271|NCT04417218|102065024|FG001|COMPLETED|Washout (2 Weeks)||22||
48583390|NCT04286581|101759201|FG000|COMPLETED|Overall Study||70||
48583391|NCT04286581|101759202|FG001|COMPLETED|Overall Study||70||
48583392|NCT04286581|101759201|FG000|NOT COMPLETED|Overall Study||4||
48583393|NCT04286581|101759202|FG001|NOT COMPLETED|Overall Study||4||
48583394|NCT01471340|101759203|FG000|STARTED|Overall Study||5868||
48583395|NCT01471340|101759204|FG001|STARTED|Overall Study||5861||
48583396|NCT01471340|101759203|FG000|COMPLETED|Overall Study||5862||
48583397|NCT01471340|101759204|FG001|COMPLETED|Overall Study||5855||
48583398|NCT01471340|101759203|FG000|NOT COMPLETED|Overall Study||6||
48583399|NCT01471340|101759204|FG001|NOT COMPLETED|Overall Study||6||
48705272|NCT04417218|102065023|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
48705273|NCT04417218|102065024|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
48705274|NCT04417218|102065023|FG000|STARTED|Second Intervention (1 Week)||24||
48705275|NCT04417218|102065024|FG001|STARTED|Second Intervention (1 Week)||22||
48705276|NCT04417218|102065023|FG000|COMPLETED|Second Intervention (1 Week)||24||
48705277|NCT04417218|102065024|FG001|COMPLETED|Second Intervention (1 Week)||22||
48705278|NCT04417218|102065023|FG000|NOT COMPLETED|Second Intervention (1 Week)||0||
48705279|NCT04417218|102065024|FG001|NOT COMPLETED|Second Intervention (1 Week)||0||
48705280|NCT02959827|102065025|FG000|STARTED|Overall Study||2320||
48583400|NCT02357706|101759205|FG000|STARTED|Overall Study||10||
48583401|NCT02357706|101759206|FG001|STARTED|Overall Study||10||
48583402|NCT02357706|101759205|FG000|COMPLETED|Overall Study||10||
48583403|NCT02357706|101759206|FG001|COMPLETED|Overall Study||10||
48583404|NCT02357706|101759205|FG000|NOT COMPLETED|Overall Study||0||
48583405|NCT02357706|101759206|FG001|NOT COMPLETED|Overall Study||0||
48583406|NCT02256982|101759207|FG000|STARTED|Overall Study||1||
48583407|NCT02256982|101759208|FG001|STARTED|Overall Study||2||
48583408|NCT02256982|101759207|FG000|COMPLETED|Overall Study||1||
48583409|NCT02256982|101759208|FG001|COMPLETED|Overall Study||1||
48583410|NCT02256982|101759207|FG000|NOT COMPLETED|Overall Study||0||
48583411|NCT02256982|101759208|FG001|NOT COMPLETED|Overall Study||1||
48583412|NCT00965341|101759209|FG000|STARTED|Overall Study||19||
48583413|NCT00965341|101759210|FG001|STARTED|Overall Study||24||
48583414|NCT00965341|101759209|FG000|COMPLETED|Overall Study||13||
48583415|NCT00965341|101759210|FG001|COMPLETED|Overall Study||16||
48583416|NCT00965341|101759209|FG000|NOT COMPLETED|Overall Study||6||
48583417|NCT00965341|101759210|FG001|NOT COMPLETED|Overall Study||8||
48583418|NCT01676896|101759211|FG000|STARTED|Overall Study||96||
48583419|NCT01676896|101759212|FG001|STARTED|Overall Study||96||
48583420|NCT01676896|101759213|FG002|STARTED|Overall Study||100||
48136954|NCT01781572|100661380|FG001|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||4||
48136955|NCT01781572|100661381|FG002|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||0||
48583421|NCT01676896|101759211|FG000|COMPLETED|Overall Study||84||
48583422|NCT01676896|101759212|FG001|COMPLETED|Overall Study||89||
48583423|NCT01676896|101759213|FG002|COMPLETED|Overall Study||81||
48583424|NCT01676896|101759211|FG000|NOT COMPLETED|Overall Study||12||
48583425|NCT01676896|101759212|FG001|NOT COMPLETED|Overall Study||7||
48583426|NCT01676896|101759213|FG002|NOT COMPLETED|Overall Study||19||
48583427|NCT00808639|101759214|FG000|STARTED|Overall Study||39||
48583428|NCT00808639|101759214|FG000|COMPLETED|Overall Study||38||
48583429|NCT00808639|101759214|FG000|NOT COMPLETED|Overall Study||1||
48583430|NCT00723255|101759215|FG000|STARTED|Overall Study||53||
48583431|NCT00723255|101759215|FG000|COMPLETED|Overall Study||49||
48583432|NCT00723255|101759215|FG000|NOT COMPLETED|Overall Study||4||
48583433|NCT01187771|101759216|FG000|STARTED|Overall Study||28||
48583434|NCT01187771|101759217|FG001|STARTED|Overall Study||21||
48583435|NCT01187771|101759216|FG000|COMPLETED|Overall Study||25||
48583436|NCT01187771|101759217|FG001|COMPLETED|Overall Study||18||
48583437|NCT01187771|101759216|FG000|NOT COMPLETED|Overall Study||3||
48583438|NCT01187771|101759217|FG001|NOT COMPLETED|Overall Study||3||
48583439|NCT00150800|101759218|FG000|STARTED|Overall Study||667||
48583440|NCT00150800|101759218|FG000|COMPLETED|Overall Study||171||
48583441|NCT00150800|101759218|FG000|NOT COMPLETED|Overall Study||496||
48583442|NCT01290679|101759219|FG000|STARTED|Overall Study||257||
48583443|NCT01290679|101759220|FG001|STARTED|Overall Study||134||
48583444|NCT01290679|101759219|FG000|COMPLETED|Overall Study||241||
48583445|NCT01290679|101759220|FG001|COMPLETED|Overall Study||113||
48583446|NCT01290679|101759219|FG000|NOT COMPLETED|Overall Study||16||
48583447|NCT01290679|101759220|FG001|NOT COMPLETED|Overall Study||21||
48583448|NCT00836888|101759221|FG000|STARTED|Overall Study||3||
48583449|NCT00836888|101759222|FG001|STARTED|Overall Study||5||
48583450|NCT00836888|101759223|FG002|STARTED|Overall Study||6||
48583451|NCT00836888|101759224|FG003|STARTED|Overall Study||3||
48583452|NCT00836888|101759221|FG000|COMPLETED|Overall Study||0||
48583453|NCT00836888|101759222|FG001|COMPLETED|Overall Study||2||
48583454|NCT00836888|101759223|FG002|COMPLETED|Overall Study||0||
48583455|NCT00836888|101759224|FG003|COMPLETED|Overall Study||0||
48583456|NCT00836888|101759221|FG000|NOT COMPLETED|Overall Study||3||
48583457|NCT00836888|101759222|FG001|NOT COMPLETED|Overall Study||3||
48583458|NCT00836888|101759223|FG002|NOT COMPLETED|Overall Study||6||
48583459|NCT00836888|101759224|FG003|NOT COMPLETED|Overall Study||3||
48136956|NCT01781572|100661379|FG000|STARTED|MEK162 30mg LEE011 200mg||0||
48583460|NCT02805179|101759225|FG000|STARTED|Overall Study||26||
48583461|NCT02805179|101759225|FG000|Eligible Patients That Started Dose-intensified Chemo-radiation|Overall Study||23||
48583462|NCT02805179|101759225|FG000|Subset of Participants, Boosted to Both High B-value Diffusion and Perfusion|Overall Study||13|Protocol amended to include perfusion|
48583463|NCT02805179|101759225|FG000|COMPLETED|Overall Study||23||
48583464|NCT02805179|101759225|FG000|NOT COMPLETED|Overall Study||3||
48583465|NCT00832871|101759226|FG000|STARTED|Overall Study||4||
48583466|NCT00832871|101759226|FG000|COMPLETED|Overall Study||4||
48583467|NCT00832871|101759226|FG000|NOT COMPLETED|Overall Study||0||
48583468|NCT00102531|101759227|FG000|STARTED|Overall Study||7||
48583469|NCT00102531|101759228|FG001|STARTED|Overall Study||12||
48583470|NCT00102531|101759227|FG000|COMPLETED|Overall Study||2||
48583471|NCT00102531|101759228|FG001|COMPLETED|Overall Study||1||
48583472|NCT00102531|101759227|FG000|NOT COMPLETED|Overall Study||5||
48583473|NCT00102531|101759228|FG001|NOT COMPLETED|Overall Study||11||
48583474|NCT00890084|101759229|FG000|STARTED|Overall Study||2913||
48583475|NCT00890084|101759229|FG000|COMPLETED|Overall Study||2771||
48583476|NCT00890084|101759229|FG000|NOT COMPLETED|Overall Study||142||
48583477|NCT03388645|101759230|FG000|STARTED|Low Dose RSV A2||4||
48583478|NCT03388645|101759231|FG001|STARTED|Low Dose RSV A2||0||
48583479|NCT03388645|101759230|FG000|COMPLETED|Low Dose RSV A2||4||
48705281|NCT02959827|102065025|FG000|COMPLETED|Overall Study||2320||
48583480|NCT03388645|101759231|FG001|COMPLETED|Low Dose RSV A2||0||
48583481|NCT03388645|101759230|FG000|NOT COMPLETED|Low Dose RSV A2||0||
48583482|NCT03388645|101759231|FG001|NOT COMPLETED|Low Dose RSV A2||0||
48583483|NCT03388645|101759230|FG000|STARTED|High Dose RSV A2||0||
48583484|NCT03388645|101759231|FG001|STARTED|High Dose RSV A2||8||
48583485|NCT03388645|101759230|FG000|COMPLETED|High Dose RSV A2||0||
48583486|NCT03388645|101759231|FG001|COMPLETED|High Dose RSV A2||7||
48583487|NCT03388645|101759230|FG000|NOT COMPLETED|High Dose RSV A2||0||
48583488|NCT03388645|101759231|FG001|NOT COMPLETED|High Dose RSV A2||1||
48583489|NCT03057054|101759232|FG000|STARTED|Overall Study||85||
48583490|NCT03057054|101759233|FG001|STARTED|Overall Study||88||
48583491|NCT03057054|101759232|FG000|Prior to Initial Stem Cell Infusion|Overall Study||83|Patients who started protocol therapy (either placebo or LBP, depending on randomization) after enrollment and prior to receiving their initial stem cell infusion.|
48583492|NCT03057054|101759233|FG001|Prior to Initial Stem Cell Infusion|Overall Study||86|Patients who started protocol therapy (either placebo or LBP, depending on randomization) after enrollment and prior to receiving their initial stem cell infusion.|
48705282|NCT02959827|102065025|FG000|NOT COMPLETED|Overall Study||0||
48705283|NCT01566695|102065026|FG000|STARTED|Overall Study||107||
48705284|NCT01566695|102065027|FG001|STARTED|Overall Study||109||
48705285|NCT01566695|102065026|FG000|COMPLETED|Overall Study||12|Completed = participants on treatment as of data cut off date of 25 Jan 2019|
48705286|NCT01566695|102065027|FG001|COMPLETED|Overall Study||10|Completed = participants on treatment as of data cut off date of 25 Jan 2019|
48401045|NCT02843178|101313671|FG002|COMPLETED|Overall Study||85||
48401046|NCT02843178|101313672|FG003|COMPLETED|Overall Study||87||
48705287|NCT01566695|102065026|FG000|NOT COMPLETED|Overall Study||95||
48705288|NCT01566695|102065027|FG001|NOT COMPLETED|Overall Study||99||
48705289|NCT03392883|102065028|FG000|STARTED|Overall Study||1264||
48705290|NCT03392883|102065029|FG001|STARTED|Overall Study||45||
48705291|NCT03392883|102065030|FG002|STARTED|Overall Study||39||
48705292|NCT03392883|102065028|FG000|COMPLETED|Overall Study||928||
48705293|NCT03392883|102065029|FG001|COMPLETED|Overall Study||32||
48705294|NCT03392883|102065030|FG002|COMPLETED|Overall Study||30||
48705295|NCT03392883|102065028|FG000|NOT COMPLETED|Overall Study||336||
48705296|NCT03392883|102065029|FG001|NOT COMPLETED|Overall Study||13||
48705297|NCT03392883|102065030|FG002|NOT COMPLETED|Overall Study||9||
48705298|NCT01032291|102065031|FG000|STARTED|Safety Lead-in||8||
48705299|NCT01032291|102065032|FG001|STARTED|Safety Lead-in||0||
48401047|NCT02843178|101313669|FG000|NOT COMPLETED|Overall Study||8||
48401048|NCT02843178|101313670|FG001|NOT COMPLETED|Overall Study||8||
48401049|NCT02843178|101313671|FG002|NOT COMPLETED|Overall Study||7||
48401050|NCT02843178|101313672|FG003|NOT COMPLETED|Overall Study||4||
48401051|NCT01001572|101313673|FG000|STARTED|Single-Blind Valsartan 160 mg||932||
48401052|NCT01001572|101313674|FG001|STARTED|Single-Blind Valsartan 160 mg||0||
48401053|NCT01001572|101313675|FG002|STARTED|Single-Blind Valsartan 160 mg||0||
48401054|NCT01001572|101313673|FG000|COMPLETED|Single-Blind Valsartan 160 mg||654||
48401055|NCT01001572|101313674|FG001|COMPLETED|Single-Blind Valsartan 160 mg||0||
48401056|NCT01001572|101313675|FG002|COMPLETED|Single-Blind Valsartan 160 mg||0||
48401057|NCT01001572|101313673|FG000|NOT COMPLETED|Single-Blind Valsartan 160 mg||278||
48401058|NCT01001572|101313674|FG001|NOT COMPLETED|Single-Blind Valsartan 160 mg||0||
48401059|NCT01001572|101313675|FG002|NOT COMPLETED|Single-Blind Valsartan 160 mg||0||
48401060|NCT01001572|101313673|FG000|STARTED|Double-Blind Treatment Phase||0||
48401061|NCT01001572|101313674|FG001|STARTED|Double-Blind Treatment Phase||329||
48401062|NCT01001572|101313675|FG002|STARTED|Double-Blind Treatment Phase||325||
48401063|NCT01001572|101313673|FG000|Full Analysis Set (FAS)|Double-Blind Treatment Phase||0||
48401064|NCT01001572|101313674|FG001|Full Analysis Set (FAS)|Double-Blind Treatment Phase||328||
48401065|NCT01001572|101313675|FG002|Full Analysis Set (FAS)|Double-Blind Treatment Phase||323||
48401066|NCT01001572|101313673|FG000|COMPLETED|Double-Blind Treatment Phase||0||
48401067|NCT01001572|101313674|FG001|COMPLETED|Double-Blind Treatment Phase||319||
48401068|NCT01001572|101313675|FG002|COMPLETED|Double-Blind Treatment Phase||306||
48401069|NCT01001572|101313673|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0||
48401070|NCT01001572|101313674|FG001|NOT COMPLETED|Double-Blind Treatment Phase||10||
48401071|NCT01001572|101313675|FG002|NOT COMPLETED|Double-Blind Treatment Phase||19||
48401072|NCT01197794|101313676|FG000|STARTED|Overall Study||164||
48401073|NCT01197794|101313677|FG001|STARTED|Overall Study||161||
48401074|NCT01197794|101313678|FG002|STARTED|Overall Study||166||
48401075|NCT01197794|101313679|FG003|STARTED|Overall Study||164||
48401076|NCT01197794|101313680|FG004|STARTED|Overall Study||163||
48401077|NCT01197794|101313681|FG005|STARTED|Overall Study||163||
48401078|NCT01197794|101313682|FG006|STARTED|Overall Study||163||
48401079|NCT01197794|101313676|FG000|COMPLETED|Overall Study||148||
48401080|NCT01197794|101313677|FG001|COMPLETED|Overall Study||146||
48401081|NCT01197794|101313678|FG002|COMPLETED|Overall Study||153||
48401082|NCT01197794|101313679|FG003|COMPLETED|Overall Study||152||
48401083|NCT01197794|101313680|FG004|COMPLETED|Overall Study||149||
48401084|NCT01197794|101313681|FG005|COMPLETED|Overall Study||144||
48401085|NCT01197794|101313682|FG006|COMPLETED|Overall Study||142||
48401086|NCT01197794|101313676|FG000|NOT COMPLETED|Overall Study||16||
48401087|NCT01197794|101313677|FG001|NOT COMPLETED|Overall Study||15||
48705300|NCT01032291|102065033|FG002|STARTED|Safety Lead-in||0||
48583493|NCT03057054|101759232|FG000|Initial Stem Cell Infusion|Overall Study||78|Patients who received initial stem cell infusion within 6-months of study enrollment after initiating protocol therapy (LBP or placebo).|
48583494|NCT03057054|101759233|FG001|Initial Stem Cell Infusion|Overall Study||81|Patients who received initial stem cell infusion within 6-months of study enrollment after initiating protocol therapy (LBP or placebo).|
48583495|NCT03057054|101759232|FG000|COMPLETED|Overall Study||74||
48583496|NCT03057054|101759233|FG001|COMPLETED|Overall Study||80||
48583497|NCT03057054|101759232|FG000|NOT COMPLETED|Overall Study||11||
48583498|NCT03057054|101759233|FG001|NOT COMPLETED|Overall Study||8||
48583499|NCT00537316|101759234|FG000|STARTED|Part 1||79||
48583500|NCT00537316|101759235|FG001|STARTED|Part 1||80||
48583501|NCT00537316|101759236|FG002|STARTED|Part 1||80||
48583502|NCT00537316|101759237|FG003|STARTED|Part 1||0||
48583503|NCT00537316|101759238|FG004|STARTED|Part 1||0||
48583504|NCT00537316|101759239|FG005|STARTED|Part 1||0||
48583505|NCT00537316|101759240|FG006|STARTED|Part 1||0||
48583506|NCT00537316|101759234|FG000|COMPLETED|Part 1||65||
48583507|NCT00537316|101759235|FG001|COMPLETED|Part 1||53||
48583508|NCT00537316|101759236|FG002|COMPLETED|Part 1||63||
48583509|NCT00537316|101759237|FG003|COMPLETED|Part 1||0||
48583510|NCT00537316|101759238|FG004|COMPLETED|Part 1||0||
48583511|NCT00537316|101759239|FG005|COMPLETED|Part 1||0||
48583512|NCT00537316|101759240|FG006|COMPLETED|Part 1||0||
48583513|NCT00537316|101759234|FG000|NOT COMPLETED|Part 1||14||
48583514|NCT00537316|101759235|FG001|NOT COMPLETED|Part 1||27||
48583515|NCT00537316|101759236|FG002|NOT COMPLETED|Part 1||17||
48583516|NCT00537316|101759237|FG003|NOT COMPLETED|Part 1||0||
48583517|NCT00537316|101759238|FG004|NOT COMPLETED|Part 1||0||
48583518|NCT00537316|101759239|FG005|NOT COMPLETED|Part 1||0||
48583519|NCT00537316|101759240|FG006|NOT COMPLETED|Part 1||0||
48583520|NCT00537316|101759234|FG000|STARTED|Part 2||37||
48583521|NCT00537316|101759235|FG001|STARTED|Part 2||10||
48583522|NCT00537316|101759236|FG002|STARTED|Part 2||48||
48583523|NCT00537316|101759237|FG003|STARTED|Part 2||5||
48583524|NCT00537316|101759238|FG004|STARTED|Part 2||2||
48583525|NCT00537316|101759239|FG005|STARTED|Part 2||4||
48583526|NCT00537316|101759240|FG006|STARTED|Part 2||2||
48583527|NCT00537316|101759234|FG000|COMPLETED|Part 2||11||
48583528|NCT00537316|101759235|FG001|COMPLETED|Part 2||1||
48583529|NCT00537316|101759236|FG002|COMPLETED|Part 2||16||
48583530|NCT00537316|101759237|FG003|COMPLETED|Part 2||2||
48583531|NCT00537316|101759238|FG004|COMPLETED|Part 2||1||
48583532|NCT00537316|101759239|FG005|COMPLETED|Part 2||0||
48583533|NCT00537316|101759240|FG006|COMPLETED|Part 2||0||
48583534|NCT00537316|101759234|FG000|NOT COMPLETED|Part 2||26||
48583535|NCT00537316|101759235|FG001|NOT COMPLETED|Part 2||9||
48583536|NCT00537316|101759236|FG002|NOT COMPLETED|Part 2||32||
48583537|NCT00537316|101759237|FG003|NOT COMPLETED|Part 2||3||
48583538|NCT00537316|101759238|FG004|NOT COMPLETED|Part 2||1||
48583539|NCT00537316|101759239|FG005|NOT COMPLETED|Part 2||4||
48583540|NCT00537316|101759240|FG006|NOT COMPLETED|Part 2||2||
48583541|NCT03429244|101759241|FG000|STARTED|Overall Study||16||
48583542|NCT03429244|101759242|FG001|STARTED|Overall Study||11||
48583543|NCT03429244|101759243|FG002|STARTED|Overall Study||9||
48583544|NCT03429244|101759241|FG000|COMPLETED|Overall Study||14||
48583545|NCT03429244|101759242|FG001|COMPLETED|Overall Study||10||
48583546|NCT03429244|101759243|FG002|COMPLETED|Overall Study||8||
48583547|NCT03429244|101759241|FG000|NOT COMPLETED|Overall Study||2||
48583548|NCT03429244|101759242|FG001|NOT COMPLETED|Overall Study||1||
48583549|NCT03429244|101759243|FG002|NOT COMPLETED|Overall Study||1||
48583550|NCT03528369|101759244|FG000|STARTED|Overall Study||40||
48583551|NCT03528369|101759245|FG001|STARTED|Overall Study||42||
48583552|NCT03528369|101759246|FG002|STARTED|Overall Study||40||
48583553|NCT03528369|101759244|FG000|COMPLETED|Overall Study||37||
48583554|NCT03528369|101759245|FG001|COMPLETED|Overall Study||41||
48583555|NCT03528369|101759246|FG002|COMPLETED|Overall Study||40||
48583556|NCT03528369|101759244|FG000|NOT COMPLETED|Overall Study||3||
48583557|NCT03528369|101759245|FG001|NOT COMPLETED|Overall Study||1||
48583558|NCT03528369|101759246|FG002|NOT COMPLETED|Overall Study||0||
48583559|NCT04535531|101759247|FG000|STARTED|Overall Study||444||
48583560|NCT04535531|101759248|FG001|STARTED|Overall Study||447||
48583561|NCT04535531|101759247|FG000|COMPLETED|Overall Study||363||
48583562|NCT04535531|101759248|FG001|COMPLETED|Overall Study||390||
48583563|NCT04535531|101759247|FG000|NOT COMPLETED|Overall Study||81||
48583564|NCT04535531|101759248|FG001|NOT COMPLETED|Overall Study||57||
48583565|NCT00784303|101759249|FG000|STARTED|Overall Study||58||
48583566|NCT00784303|101759250|FG001|STARTED|Overall Study||59||
48583567|NCT00784303|101759249|FG000|COMPLETED|Overall Study||58||
48583568|NCT00784303|101759250|FG001|COMPLETED|Overall Study||59||
48583569|NCT00784303|101759249|FG000|NOT COMPLETED|Overall Study||0||
48583570|NCT00784303|101759250|FG001|NOT COMPLETED|Overall Study||0||
48583571|NCT01629290|101759251|FG000|STARTED|Overall Study||15||
48583572|NCT01629290|101759251|FG000|COMPLETED|Overall Study||15||
48583573|NCT01629290|101759251|FG000|NOT COMPLETED|Overall Study||0||
48583574|NCT03514485|101759252|FG000|STARTED|Overall Study||121||
48583575|NCT03514485|101759253|FG001|STARTED|Overall Study||112||
48583576|NCT03514485|101759254|FG002|STARTED|Overall Study||110||
48583577|NCT03514485|101759255|FG003|STARTED|Overall Study||112||
48583578|NCT03514485|101759256|FG004|STARTED|Overall Study||82||
48583579|NCT03514485|101759257|FG005|STARTED|Overall Study||89||
48583580|NCT03514485|101759252|FG000|COMPLETED|Overall Study||116||
48583581|NCT03514485|101759253|FG001|COMPLETED|Overall Study||108||
48583582|NCT03514485|101759254|FG002|COMPLETED|Overall Study||105||
48583583|NCT03514485|101759255|FG003|COMPLETED|Overall Study||111||
48583584|NCT03514485|101759256|FG004|COMPLETED|Overall Study||79||
48583585|NCT03514485|101759257|FG005|COMPLETED|Overall Study||84||
48583586|NCT03514485|101759252|FG000|NOT COMPLETED|Overall Study||5||
48583587|NCT03514485|101759253|FG001|NOT COMPLETED|Overall Study||4||
48583588|NCT03514485|101759254|FG002|NOT COMPLETED|Overall Study||5||
48583589|NCT03514485|101759255|FG003|NOT COMPLETED|Overall Study||1||
48583590|NCT03514485|101759256|FG004|NOT COMPLETED|Overall Study||3||
48583591|NCT03514485|101759257|FG005|NOT COMPLETED|Overall Study||5||
48583592|NCT04696354|101759258|FG000|STARTED|Overall Study||6||
48583593|NCT04696354|101759259|FG001|STARTED|Overall Study||6||
48583594|NCT04696354|101759258|FG000|COMPLETED|Overall Study||0||
48583595|NCT04696354|101759259|FG001|COMPLETED|Overall Study||0||
48583596|NCT04696354|101759258|FG000|NOT COMPLETED|Overall Study||6||
48583597|NCT04696354|101759259|FG001|NOT COMPLETED|Overall Study||6||
48583598|NCT03724877|101759260|FG000|STARTED|Overall Study||6921|Started are Initiators|
48583599|NCT03724877|101759261|FG001|STARTED|Overall Study||1932|Started are Initiators|
48583600|NCT03724877|101759260|FG000|COMPLETED|Overall Study||6921||
48583601|NCT03724877|101759261|FG001|COMPLETED|Overall Study||1932||
48583602|NCT03724877|101759260|FG000|NOT COMPLETED|Overall Study||0||
48583603|NCT03724877|101759261|FG001|NOT COMPLETED|Overall Study||0||
48583604|NCT00068393|101759262|FG000|STARTED|Overall Study||39||
48583605|NCT00068393|101759262|FG000|Eligible and Treated|Overall Study||38||
48583606|NCT00068393|101759262|FG000|COMPLETED|Overall Study||29||
48583607|NCT00068393|101759262|FG000|NOT COMPLETED|Overall Study||10||
48583608|NCT03124407|101759263|FG000|STARTED|Overall Study||40||
48583609|NCT03124407|101759264|FG001|STARTED|Overall Study||20||
48583610|NCT03124407|101759265|FG002|STARTED|Overall Study||40||
48583611|NCT03124407|101759266|FG003|STARTED|Overall Study||20||
48583612|NCT03124407|101759263|FG000|COMPLETED|Overall Study||39||
48583613|NCT03124407|101759264|FG001|COMPLETED|Overall Study||20||
48583614|NCT03124407|101759265|FG002|COMPLETED|Overall Study||39||
48583615|NCT03124407|101759266|FG003|COMPLETED|Overall Study||20||
48583616|NCT03124407|101759263|FG000|NOT COMPLETED|Overall Study||1||
48583617|NCT03124407|101759264|FG001|NOT COMPLETED|Overall Study||0||
48583618|NCT03124407|101759265|FG002|NOT COMPLETED|Overall Study||1||
48583619|NCT03124407|101759266|FG003|NOT COMPLETED|Overall Study||0||
48583620|NCT03395184|101759267|FG000|STARTED|Induction Period (Up to 12 Weeks)||79||
48583621|NCT03395184|101759268|FG001|STARTED|Induction Period (Up to 12 Weeks)||93||
48583622|NCT03395184|101759269|FG002|STARTED|Induction Period (Up to 12 Weeks)||72||
48583623|NCT03395184|101759270|FG003|STARTED|Induction Period (Up to 12 Weeks)||0||
48583624|NCT03395184|101759271|FG004|STARTED|Induction Period (Up to 12 Weeks)||0||
48583625|NCT03395184|101759272|FG005|STARTED|Induction Period (Up to 12 Weeks)||0||
48583626|NCT03395184|101759273|FG006|STARTED|Induction Period (Up to 12 Weeks)||0||
48583627|NCT03395184|101759267|FG000|COMPLETED|Induction Period (Up to 12 Weeks)||68||
48583628|NCT03395184|101759268|FG001|COMPLETED|Induction Period (Up to 12 Weeks)||84||
48583629|NCT03395184|101759269|FG002|COMPLETED|Induction Period (Up to 12 Weeks)||65||
48583630|NCT03395184|101759270|FG003|COMPLETED|Induction Period (Up to 12 Weeks)||0||
48583631|NCT03395184|101759271|FG004|COMPLETED|Induction Period (Up to 12 Weeks)||0||
48583632|NCT03395184|101759272|FG005|COMPLETED|Induction Period (Up to 12 Weeks)||0||
48583633|NCT03395184|101759273|FG006|COMPLETED|Induction Period (Up to 12 Weeks)||0||
48583634|NCT03395184|101759267|FG000|NOT COMPLETED|Induction Period (Up to 12 Weeks)||11||
48583635|NCT03395184|101759268|FG001|NOT COMPLETED|Induction Period (Up to 12 Weeks)||9||
48583636|NCT03395184|101759269|FG002|NOT COMPLETED|Induction Period (Up to 12 Weeks)||7||
48583637|NCT03395184|101759270|FG003|NOT COMPLETED|Induction Period (Up to 12 Weeks)||0||
48583638|NCT03395184|101759271|FG004|NOT COMPLETED|Induction Period (Up to 12 Weeks)||0||
48583639|NCT03395184|101759272|FG005|NOT COMPLETED|Induction Period (Up to 12 Weeks)||0||
48583640|NCT03395184|101759273|FG006|NOT COMPLETED|Induction Period (Up to 12 Weeks)||0||
48583641|NCT03395184|101759267|FG000|STARTED|OLE Period (Up to 52 Weeks)||0||
48583642|NCT03395184|101759268|FG001|STARTED|OLE Period (Up to 52 Weeks)||0||
48583643|NCT03395184|101759269|FG002|STARTED|OLE Period (Up to 52 Weeks)||0||
48583644|NCT03395184|101759270|FG003|STARTED|OLE Period (Up to 52 Weeks)||36||
48583645|NCT03395184|101759271|FG004|STARTED|OLE Period (Up to 52 Weeks)||84||
48583646|NCT03395184|101759272|FG005|STARTED|OLE Period (Up to 52 Weeks)||32||
48583647|NCT03395184|101759273|FG006|STARTED|OLE Period (Up to 52 Weeks)||64||
48583648|NCT03395184|101759267|FG000|COMPLETED|OLE Period (Up to 52 Weeks)||0||
48583649|NCT03395184|101759268|FG001|COMPLETED|OLE Period (Up to 52 Weeks)||0||
48583650|NCT03395184|101759269|FG002|COMPLETED|OLE Period (Up to 52 Weeks)||0||
48583651|NCT03395184|101759270|FG003|COMPLETED|OLE Period (Up to 52 Weeks)||20||
48583652|NCT03395184|101759271|FG004|COMPLETED|OLE Period (Up to 52 Weeks)||45||
48583653|NCT03395184|101759272|FG005|COMPLETED|OLE Period (Up to 52 Weeks)||21||
48583654|NCT03395184|101759273|FG006|COMPLETED|OLE Period (Up to 52 Weeks)||34||
48583655|NCT03395184|101759267|FG000|NOT COMPLETED|OLE Period (Up to 52 Weeks)||0||
48583656|NCT03395184|101759268|FG001|NOT COMPLETED|OLE Period (Up to 52 Weeks)||0||
48592835|NCT02938949|101786321|FG001|COMPLETED|Overall Study||10||
48583657|NCT03395184|101759269|FG002|NOT COMPLETED|OLE Period (Up to 52 Weeks)||0||
48583658|NCT03395184|101759270|FG003|NOT COMPLETED|OLE Period (Up to 52 Weeks)||16||
48583659|NCT03395184|101759271|FG004|NOT COMPLETED|OLE Period (Up to 52 Weeks)||39||
48583660|NCT03395184|101759272|FG005|NOT COMPLETED|OLE Period (Up to 52 Weeks)||11||
48583661|NCT03395184|101759273|FG006|NOT COMPLETED|OLE Period (Up to 52 Weeks)||30||
48583662|NCT03339726|101759274|FG000|STARTED|Overall Study||64||
48583663|NCT03339726|101759275|FG001|STARTED|Overall Study||66||
48583664|NCT03339726|101759276|FG002|STARTED|Overall Study||63||
48583665|NCT03339726|101759274|FG000|COMPLETED|Overall Study||63||
48583666|NCT03339726|101759275|FG001|COMPLETED|Overall Study||65||
48583667|NCT03339726|101759276|FG002|COMPLETED|Overall Study||63||
48583668|NCT03339726|101759274|FG000|NOT COMPLETED|Overall Study||1||
48583669|NCT03339726|101759275|FG001|NOT COMPLETED|Overall Study||1||
48583670|NCT03339726|101759276|FG002|NOT COMPLETED|Overall Study||0||
48583671|NCT00729157|101759277|FG000|STARTED|Overall Study||41||
48401088|NCT01197794|101313678|FG002|NOT COMPLETED|Overall Study||13||
48401089|NCT01197794|101313679|FG003|NOT COMPLETED|Overall Study||12||
48401090|NCT01197794|101313680|FG004|NOT COMPLETED|Overall Study||14||
48401091|NCT01197794|101313681|FG005|NOT COMPLETED|Overall Study||19||
48401092|NCT01197794|101313682|FG006|NOT COMPLETED|Overall Study||21||
48401093|NCT01415908|101313683|FG000|STARTED|Overall Study||11||
48583672|NCT00729157|101759277|FG000|COMPLETED|Overall Study||40||
48401094|NCT01415908|101313684|FG001|STARTED|Overall Study||4||
48401095|NCT01415908|101313683|FG000|COMPLETED|Overall Study||10||
48583673|NCT00729157|101759277|FG000|NOT COMPLETED|Overall Study||1||
48583674|NCT01663779|101759278|FG000|STARTED|Overall Study||27||
48583675|NCT01663779|101759279|FG001|STARTED|Overall Study||23||
48401096|NCT01415908|101313684|FG001|COMPLETED|Overall Study||4||
48583676|NCT01663779|101759278|FG000|COMPLETED|Overall Study||27||
48401097|NCT01415908|101313683|FG000|NOT COMPLETED|Overall Study||1||
48401098|NCT01415908|101313684|FG001|NOT COMPLETED|Overall Study||0||
48401099|NCT00591240|101313685|FG000|STARTED|Overall Study||116||
48401100|NCT00591240|101313686|FG001|STARTED|Overall Study||222||
48401101|NCT00591240|101313685|FG000|COMPLETED|Overall Study||116||
48401102|NCT00591240|101313686|FG001|COMPLETED|Overall Study||222||
48401103|NCT00591240|101313685|FG000|NOT COMPLETED|Overall Study||0||
48401104|NCT00591240|101313686|FG001|NOT COMPLETED|Overall Study||0||
48401105|NCT00278863|101313687|FG000|STARTED|Overall Study||49||
48401106|NCT00278863|101313688|FG001|STARTED|Overall Study||47||
48401107|NCT00278863|101313687|FG000|COMPLETED|Overall Study||44||
48401108|NCT00278863|101313688|FG001|COMPLETED|Overall Study||45||
48401109|NCT00278863|101313687|FG000|NOT COMPLETED|Overall Study||5||
48401110|NCT00278863|101313688|FG001|NOT COMPLETED|Overall Study||2||
48401111|NCT01750840|101313689|FG000|STARTED|Overall Study||8||
48401112|NCT01750840|101313689|FG000|COMPLETED|Overall Study||4||
48401113|NCT01750840|101313689|FG000|NOT COMPLETED|Overall Study||4||
48401114|NCT03150199|101313690|FG000|STARTED|Overall Study||30||
48401115|NCT03150199|101313691|FG001|STARTED|Overall Study||30||
48401116|NCT03150199|101313690|FG000|COMPLETED|Overall Study||30||
48401117|NCT03150199|101313691|FG001|COMPLETED|Overall Study||30||
48401118|NCT03150199|101313690|FG000|NOT COMPLETED|Overall Study||0||
48401119|NCT03150199|101313691|FG001|NOT COMPLETED|Overall Study||0||
48401120|NCT01544478|101313692|FG000|STARTED|Overall Study||1030||
48401121|NCT01544478|101313692|FG000|Vaccination 1|Overall Study||1030||
48401122|NCT01544478|101313692|FG000|Vaccination 2|Overall Study||1026||
48401123|NCT01544478|101313692|FG000|Vaccination 3|Overall Study||1019||
48401124|NCT01544478|101313692|FG000|COMPLETED|Overall Study||912||
48401125|NCT01544478|101313692|FG000|NOT COMPLETED|Overall Study||118||
48401126|NCT01202760|101313693|FG000|STARTED|Overall Study||379||
48583677|NCT01663779|101759279|FG001|COMPLETED|Overall Study||23||
48583678|NCT01663779|101759278|FG000|NOT COMPLETED|Overall Study||0||
48401127|NCT01202760|101313694|FG001|STARTED|Overall Study||374||
48401128|NCT01202760|101313695|FG002|STARTED|Overall Study||251||
48401129|NCT01202760|101313693|FG000|Received at Least One Dose of Study Drug|Overall Study||379||
48401130|NCT01202760|101313694|FG001|Received at Least One Dose of Study Drug|Overall Study||371||
48401131|NCT01202760|101313695|FG002|Received at Least One Dose of Study Drug|Overall Study||250||
48401132|NCT01202760|101313693|FG000|COMPLETED|Overall Study||332||
48401133|NCT01202760|101313694|FG001|COMPLETED|Overall Study||322||
48401134|NCT01202760|101313695|FG002|COMPLETED|Overall Study||216||
48401135|NCT01202760|101313693|FG000|NOT COMPLETED|Overall Study||47||
48401136|NCT01202760|101313694|FG001|NOT COMPLETED|Overall Study||52||
48401137|NCT01202760|101313695|FG002|NOT COMPLETED|Overall Study||35||
48401138|NCT01149772|101313696|FG000|STARTED|Overall Study||180||
48401139|NCT01149772|101313697|FG001|STARTED|Overall Study||122||
48401140|NCT01149772|101313696|FG000|COMPLETED|Overall Study||132||
48401141|NCT01149772|101313697|FG001|COMPLETED|Overall Study||101||
48401142|NCT01149772|101313696|FG000|NOT COMPLETED|Overall Study||48||
48401143|NCT01149772|101313697|FG001|NOT COMPLETED|Overall Study||21||
48401144|NCT00770224|101313698|FG000|STARTED|Step 1: Induction||87||
48401145|NCT00770224|101313699|FG001|STARTED|Step 1: Induction||0||
48401146|NCT00770224|101313698|FG000|Eligible and Evaluable|Step 1: Induction||84||
48401147|NCT00770224|101313699|FG001|Eligible and Evaluable|Step 1: Induction||0||
48401148|NCT00770224|101313698|FG000|COMPLETED|Step 1: Induction||73||
48401149|NCT00770224|101313699|FG001|COMPLETED|Step 1: Induction||0||
48401150|NCT00770224|101313698|FG000|NOT COMPLETED|Step 1: Induction||14||
48401151|NCT00770224|101313699|FG001|NOT COMPLETED|Step 1: Induction||0||
48401152|NCT00770224|101313698|FG000|STARTED|Step 2: Maintenance||0||
48401153|NCT00770224|101313699|FG001|STARTED|Step 2: Maintenance||71||
48401154|NCT00770224|101313698|FG000|Eligible and Evaluable|Step 2: Maintenance||0||
48401155|NCT00770224|101313699|FG001|Eligible and Evaluable|Step 2: Maintenance||69||
48401156|NCT00770224|101313698|FG000|COMPLETED|Step 2: Maintenance||0||
48705301|NCT01032291|102065031|FG000|COMPLETED|Safety Lead-in||6||
48705302|NCT01032291|102065032|FG001|COMPLETED|Safety Lead-in||0||
48705303|NCT01032291|102065033|FG002|COMPLETED|Safety Lead-in||0||
48705304|NCT01032291|102065031|FG000|NOT COMPLETED|Safety Lead-in||2||
48705305|NCT01032291|102065032|FG001|NOT COMPLETED|Safety Lead-in||0||
48705306|NCT01032291|102065033|FG002|NOT COMPLETED|Safety Lead-in||0||
48705307|NCT01032291|102065031|FG000|STARTED|Proof of Concept||0||
48705308|NCT01032291|102065032|FG001|STARTED|Proof of Concept||22||
48705309|NCT01032291|102065033|FG002|STARTED|Proof of Concept||21||
48705310|NCT01032291|102065031|FG000|Intent to Treat and Safety Populations|Proof of Concept||0||
48705311|NCT01032291|102065032|FG001|Intent to Treat and Safety Populations|Proof of Concept||21||
48705312|NCT01032291|102065033|FG002|Intent to Treat and Safety Populations|Proof of Concept||21||
48705313|NCT01032291|102065031|FG000|COMPLETED|Proof of Concept||0||
48705314|NCT01032291|102065032|FG001|COMPLETED|Proof of Concept||14||
48705315|NCT01032291|102065033|FG002|COMPLETED|Proof of Concept||18||
48705316|NCT01032291|102065031|FG000|NOT COMPLETED|Proof of Concept||0||
48705317|NCT01032291|102065032|FG001|NOT COMPLETED|Proof of Concept||8||
48705318|NCT01032291|102065033|FG002|NOT COMPLETED|Proof of Concept||3||
48705319|NCT04151628|102065034|FG000|STARTED|Overall Study||8||
48705320|NCT04151628|102065035|FG001|STARTED|Overall Study||64||
48705321|NCT04151628|102065034|FG000|COMPLETED|Overall Study||8||
48705322|NCT04151628|102065035|FG001|COMPLETED|Overall Study||64||
48705323|NCT04151628|102065034|FG000|NOT COMPLETED|Overall Study||0||
48705324|NCT04151628|102065035|FG001|NOT COMPLETED|Overall Study||0||
48705325|NCT03158012|102065036|FG000|STARTED|Overall Study||8||
48705326|NCT03158012|102065037|FG001|STARTED|Overall Study||7||
48705327|NCT03158012|102065036|FG000|COMPLETED|Overall Study||8||
48705328|NCT03158012|102065037|FG001|COMPLETED|Overall Study||6||
48705329|NCT03158012|102065036|FG000|NOT COMPLETED|Overall Study||0||
48705330|NCT03158012|102065037|FG001|NOT COMPLETED|Overall Study||1||
48705331|NCT01360398|102065038|FG000|STARTED|Overall Study||127||
48705332|NCT01360398|102065038|FG000|COMPLETED|Overall Study||105||
48705333|NCT01360398|102065038|FG000|NOT COMPLETED|Overall Study||22||
48705334|NCT00985907|102065039|FG000|STARTED|Overall Study||13||
48705335|NCT00985907|102065039|FG000|COMPLETED|Overall Study||0||
48705336|NCT00985907|102065039|FG000|NOT COMPLETED|Overall Study||13||
48705337|NCT04385238|102065040|FG000|STARTED|Overall Study||5712||
48705338|NCT04385238|102065041|FG001|STARTED|Overall Study||1182||
48705339|NCT04385238|102065040|FG000|COMPLETED|Overall Study||5712||
48705340|NCT04385238|102065041|FG001|COMPLETED|Overall Study||1182||
48705341|NCT04385238|102065040|FG000|NOT COMPLETED|Overall Study||0||
48705342|NCT04385238|102065041|FG001|NOT COMPLETED|Overall Study||0||
48401157|NCT00770224|101313699|FG001|COMPLETED|Step 2: Maintenance||41||
48401158|NCT00770224|101313698|FG000|NOT COMPLETED|Step 2: Maintenance||0||
48401159|NCT00770224|101313699|FG001|NOT COMPLETED|Step 2: Maintenance||30||
48401160|NCT00520299|101313700|FG000|STARTED|Overall Study||6||
48401161|NCT00520299|101313701|FG001|STARTED|Overall Study||6||
48401162|NCT00520299|101313702|FG002|STARTED|Overall Study||19||
48401163|NCT00520299|101313700|FG000|COMPLETED|Overall Study||6||
48401164|NCT00520299|101313701|FG001|COMPLETED|Overall Study||3||
48705343|NCT03263923|102065042|FG000|STARTED|Overall Study||174|Enrolled, consented, Participants who were sent the baseline questionnaire.|
48705344|NCT03263923|102065043|FG001|STARTED|Overall Study||172|Enrolled, consented, Participants who were sent the baseline questionnaire.|
48705345|NCT03263923|102065042|FG000|Completed Enrolled Participants Who Completed the Baseline Questionnaire|Overall Study||173||
48705346|NCT03263923|102065043|FG001|Completed Enrolled Participants Who Completed the Baseline Questionnaire|Overall Study||169||
48705347|NCT03263923|102065042|FG000|Completed Intervention and T2 Questionnaire|Overall Study||149||
48705348|NCT03263923|102065043|FG001|Completed Intervention and T2 Questionnaire|Overall Study||151||
48401165|NCT00520299|101313702|FG002|COMPLETED|Overall Study||13||
48401166|NCT00520299|101313700|FG000|NOT COMPLETED|Overall Study||0||
48401167|NCT00520299|101313701|FG001|NOT COMPLETED|Overall Study||3||
48136957|NCT01781572|100661380|FG001|STARTED|MEK162 30mg LEE011 200mg||5||
48136958|NCT01781572|100661381|FG002|STARTED|MEK162 30mg LEE011 200mg||0||
48136959|NCT01781572|100661379|FG000|COMPLETED|MEK162 30mg LEE011 200mg||0||
48136960|NCT01781572|100661380|FG001|COMPLETED|MEK162 30mg LEE011 200mg||0||
48401168|NCT00520299|101313702|FG002|NOT COMPLETED|Overall Study||6||
48401169|NCT00432562|101313703|FG000|STARTED|Overall Study||16||
48401170|NCT00432562|101313704|FG001|STARTED|Overall Study||15||
48401171|NCT00432562|101313703|FG000|COMPLETED|Overall Study||13||
48401172|NCT00432562|101313704|FG001|COMPLETED|Overall Study||15||
48583679|NCT01663779|101759279|FG001|NOT COMPLETED|Overall Study||0||
48583680|NCT02980341|101759280|FG000|STARTED|Dose Escalation||3||
48583681|NCT02980341|101759281|FG001|STARTED|Dose Escalation||3||
48583682|NCT02980341|101759282|FG002|STARTED|Dose Escalation||15||
48583683|NCT02980341|101759283|FG003|STARTED|Dose Escalation||15||
48583684|NCT02980341|101759284|FG004|STARTED|Dose Escalation||6||
48583685|NCT02980341|101759285|FG005|STARTED|Dose Escalation||0||
48583686|NCT02980341|101759286|FG006|STARTED|Dose Escalation||0||
48583687|NCT02980341|101759287|FG007|STARTED|Dose Escalation||0||
48583688|NCT02980341|101759288|FG008|STARTED|Dose Escalation||0||
48583689|NCT02980341|101759289|FG009|STARTED|Dose Escalation||0||
48583690|NCT02980341|101759290|FG010|STARTED|Dose Escalation||0||
48583691|NCT02980341|101759280|FG000|COMPLETED|Dose Escalation||0||
48583692|NCT02980341|101759281|FG001|COMPLETED|Dose Escalation||0||
48583693|NCT02980341|101759282|FG002|COMPLETED|Dose Escalation||0||
48583694|NCT02980341|101759283|FG003|COMPLETED|Dose Escalation||0||
48583695|NCT02980341|101759284|FG004|COMPLETED|Dose Escalation||0||
48136961|NCT01781572|100661381|FG002|COMPLETED|MEK162 30mg LEE011 200mg||0||
48136962|NCT01781572|100661379|FG000|NOT COMPLETED|MEK162 30mg LEE011 200mg||0||
48136963|NCT01781572|100661380|FG001|NOT COMPLETED|MEK162 30mg LEE011 200mg||5||
48136964|NCT01781572|100661381|FG002|NOT COMPLETED|MEK162 30mg LEE011 200mg||0||
48136965|NCT01781572|100661379|FG000|STARTED|MEK162 45mg LEE011 450mg||0||
48136966|NCT01781572|100661380|FG001|STARTED|MEK162 45mg LEE011 450mg||9||
48136967|NCT01781572|100661381|FG002|STARTED|MEK162 45mg LEE011 450mg||0||
48136968|NCT01781572|100661379|FG000|COMPLETED|MEK162 45mg LEE011 450mg||0||
48136969|NCT01781572|100661380|FG001|COMPLETED|MEK162 45mg LEE011 450mg||0||
48136970|NCT01781572|100661381|FG002|COMPLETED|MEK162 45mg LEE011 450mg||0||
48136971|NCT01781572|100661379|FG000|NOT COMPLETED|MEK162 45mg LEE011 450mg||0||
48136972|NCT01781572|100661380|FG001|NOT COMPLETED|MEK162 45mg LEE011 450mg||9||
48136973|NCT01781572|100661381|FG002|NOT COMPLETED|MEK162 45mg LEE011 450mg||0||
48136974|NCT01781572|100661379|FG000|STARTED|MEK162 45mg LEE011 600mg||0||
48136975|NCT01781572|100661380|FG001|STARTED|MEK162 45mg LEE011 600mg||6||
48136976|NCT01781572|100661381|FG002|STARTED|MEK162 45mg LEE011 600mg||0||
48136977|NCT01781572|100661379|FG000|COMPLETED|MEK162 45mg LEE011 600mg||0||
48136978|NCT01781572|100661380|FG001|COMPLETED|MEK162 45mg LEE011 600mg||0||
48136979|NCT01781572|100661381|FG002|COMPLETED|MEK162 45mg LEE011 600mg||0||
48136980|NCT01781572|100661379|FG000|NOT COMPLETED|MEK162 45mg LEE011 600mg||0||
48136981|NCT01781572|100661380|FG001|NOT COMPLETED|MEK162 45mg LEE011 600mg||6||
48136982|NCT01781572|100661381|FG002|NOT COMPLETED|MEK162 45mg LEE011 600mg||0||
48401173|NCT00432562|101313703|FG000|NOT COMPLETED|Overall Study||3||
48401174|NCT00432562|101313704|FG001|NOT COMPLETED|Overall Study||0||
48401175|NCT02177812|101313705|FG000|STARTED|Part 1 (Median of 4 Weeks)||1||
48401176|NCT02177812|101313706|FG001|STARTED|Part 1 (Median of 4 Weeks)||2||
48401177|NCT02177812|101313707|FG002|STARTED|Part 1 (Median of 4 Weeks)||7||
48401178|NCT02177812|101313708|FG003|STARTED|Part 1 (Median of 4 Weeks)||5||
48401179|NCT02177812|101313709|FG004|STARTED|Part 1 (Median of 4 Weeks)||6||
48401180|NCT02177812|101313710|FG005|STARTED|Part 1 (Median of 4 Weeks)||4||
48583696|NCT02980341|101759285|FG005|COMPLETED|Dose Escalation||0||
48583697|NCT02980341|101759286|FG006|COMPLETED|Dose Escalation||0||
48583698|NCT02980341|101759287|FG007|COMPLETED|Dose Escalation||0||
48583699|NCT02980341|101759288|FG008|COMPLETED|Dose Escalation||0||
48583700|NCT02980341|101759289|FG009|COMPLETED|Dose Escalation||0||
48583701|NCT02980341|101759290|FG010|COMPLETED|Dose Escalation||0||
48583702|NCT02980341|101759280|FG000|NOT COMPLETED|Dose Escalation||3||
48583703|NCT02980341|101759281|FG001|NOT COMPLETED|Dose Escalation||3||
48583704|NCT02980341|101759282|FG002|NOT COMPLETED|Dose Escalation||15||
48401181|NCT02177812|101313711|FG006|STARTED|Part 1 (Median of 4 Weeks)||10||
48401182|NCT02177812|101313712|FG007|STARTED|Part 1 (Median of 4 Weeks)||6||
48583705|NCT02980341|101759283|FG003|NOT COMPLETED|Dose Escalation||15||
48136983|NCT00321854|100661382|FG000|STARTED|Overall Study||261||
48136984|NCT00321854|100661383|FG001|STARTED|Overall Study||274||
48136985|NCT00321854|100661382|FG000|COMPLETED|Overall Study||198||
48136986|NCT00321854|100661383|FG001|COMPLETED|Overall Study||192||
48136987|NCT00321854|100661382|FG000|NOT COMPLETED|Overall Study||63||
48136988|NCT00321854|100661383|FG001|NOT COMPLETED|Overall Study||82||
48136989|NCT03690869|100661384|FG000|STARTED|Overall Study||3||
48401183|NCT02177812|101313713|FG008|STARTED|Part 1 (Median of 4 Weeks)||0||
48401184|NCT02177812|101313705|FG000|COMPLETED|Part 1 (Median of 4 Weeks)||1||
48583706|NCT02980341|101759284|FG004|NOT COMPLETED|Dose Escalation||6||
48583707|NCT02980341|101759285|FG005|NOT COMPLETED|Dose Escalation||0||
48136990|NCT03690869|100661385|FG001|STARTED|Overall Study||5||
48136991|NCT03690869|100661386|FG002|STARTED|Overall Study||3||
48136992|NCT03690869|100661387|FG003|STARTED|Overall Study||9||
48583708|NCT02980341|101759286|FG006|NOT COMPLETED|Dose Escalation||0||
48583709|NCT02980341|101759287|FG007|NOT COMPLETED|Dose Escalation||0||
48583710|NCT02980341|101759288|FG008|NOT COMPLETED|Dose Escalation||0||
48583711|NCT02980341|101759289|FG009|NOT COMPLETED|Dose Escalation||0||
48583712|NCT02980341|101759290|FG010|NOT COMPLETED|Dose Escalation||0||
48583713|NCT02980341|101759280|FG000|STARTED|Dose Finding||0||
48583714|NCT02980341|101759281|FG001|STARTED|Dose Finding||0||
48583715|NCT02980341|101759282|FG002|STARTED|Dose Finding||0||
48583716|NCT02980341|101759283|FG003|STARTED|Dose Finding||0||
48583717|NCT02980341|101759284|FG004|STARTED|Dose Finding||0||
48583718|NCT02980341|101759285|FG005|STARTED|Dose Finding||12||
48583719|NCT02980341|101759286|FG006|STARTED|Dose Finding||12||
48583720|NCT02980341|101759287|FG007|STARTED|Dose Finding||0||
48583721|NCT02980341|101759288|FG008|STARTED|Dose Finding||0||
48583722|NCT02980341|101759289|FG009|STARTED|Dose Finding||0||
48583723|NCT02980341|101759290|FG010|STARTED|Dose Finding||0||
48583724|NCT02980341|101759280|FG000|COMPLETED|Dose Finding||0||
48583725|NCT02980341|101759281|FG001|COMPLETED|Dose Finding||0||
48583726|NCT02980341|101759282|FG002|COMPLETED|Dose Finding||0||
48583727|NCT02980341|101759283|FG003|COMPLETED|Dose Finding||0||
48583728|NCT02980341|101759284|FG004|COMPLETED|Dose Finding||0||
48583729|NCT02980341|101759285|FG005|COMPLETED|Dose Finding||0||
48583730|NCT02980341|101759286|FG006|COMPLETED|Dose Finding||0||
48583731|NCT02980341|101759287|FG007|COMPLETED|Dose Finding||0||
48583732|NCT02980341|101759288|FG008|COMPLETED|Dose Finding||0||
48583733|NCT02980341|101759289|FG009|COMPLETED|Dose Finding||0||
48583734|NCT02980341|101759290|FG010|COMPLETED|Dose Finding||0||
48136993|NCT03690869|100661388|FG004|STARTED|Overall Study||5||
48136994|NCT03690869|100661389|FG005|STARTED|Overall Study||6||
48136995|NCT03690869|100661390|FG006|STARTED|Overall Study||5||
48289090|NCT00705679|101033722|FG003|COMPLETED|Overall Study||927||
48583735|NCT02980341|101759280|FG000|NOT COMPLETED|Dose Finding||0||
48583736|NCT02980341|101759281|FG001|NOT COMPLETED|Dose Finding||0||
48583737|NCT02980341|101759282|FG002|NOT COMPLETED|Dose Finding||0||
48583738|NCT02980341|101759283|FG003|NOT COMPLETED|Dose Finding||0||
48583739|NCT02980341|101759284|FG004|NOT COMPLETED|Dose Finding||0||
48583740|NCT02980341|101759285|FG005|NOT COMPLETED|Dose Finding||12||
48583741|NCT02980341|101759286|FG006|NOT COMPLETED|Dose Finding||12||
48583742|NCT02980341|101759287|FG007|NOT COMPLETED|Dose Finding||0||
48583743|NCT02980341|101759288|FG008|NOT COMPLETED|Dose Finding||0||
48583744|NCT02980341|101759289|FG009|NOT COMPLETED|Dose Finding||0||
48583745|NCT02980341|101759290|FG010|NOT COMPLETED|Dose Finding||0||
48583746|NCT02980341|101759280|FG000|STARTED|Dose Expansion||0||
48583747|NCT02980341|101759281|FG001|STARTED|Dose Expansion||0||
48583748|NCT02980341|101759282|FG002|STARTED|Dose Expansion||0||
48583749|NCT02980341|101759283|FG003|STARTED|Dose Expansion||0||
48583750|NCT02980341|101759284|FG004|STARTED|Dose Expansion||0||
48583751|NCT02980341|101759285|FG005|STARTED|Dose Expansion||0||
48583752|NCT02980341|101759286|FG006|STARTED|Dose Expansion||0||
48583753|NCT02980341|101759287|FG007|STARTED|Dose Expansion||33||
48583754|NCT02980341|101759288|FG008|STARTED|Dose Expansion||31||
48583755|NCT02980341|101759289|FG009|STARTED|Dose Expansion||21||
48583756|NCT02980341|101759290|FG010|STARTED|Dose Expansion||31||
48583757|NCT02980341|101759280|FG000|COMPLETED|Dose Expansion||0||
48583758|NCT02980341|101759281|FG001|COMPLETED|Dose Expansion||0||
48583759|NCT02980341|101759282|FG002|COMPLETED|Dose Expansion||0||
48583760|NCT02980341|101759283|FG003|COMPLETED|Dose Expansion||0||
48583761|NCT02980341|101759284|FG004|COMPLETED|Dose Expansion||0||
48583762|NCT02980341|101759285|FG005|COMPLETED|Dose Expansion||0||
48583763|NCT02980341|101759286|FG006|COMPLETED|Dose Expansion||0||
48583764|NCT02980341|101759287|FG007|COMPLETED|Dose Expansion||0||
48583765|NCT02980341|101759288|FG008|COMPLETED|Dose Expansion||0||
48583766|NCT02980341|101759289|FG009|COMPLETED|Dose Expansion||0||
48583767|NCT02980341|101759290|FG010|COMPLETED|Dose Expansion||0||
48583768|NCT02980341|101759280|FG000|NOT COMPLETED|Dose Expansion||0||
48583769|NCT02980341|101759281|FG001|NOT COMPLETED|Dose Expansion||0||
48583770|NCT02980341|101759282|FG002|NOT COMPLETED|Dose Expansion||0||
48583771|NCT02980341|101759283|FG003|NOT COMPLETED|Dose Expansion||0||
48583772|NCT02980341|101759284|FG004|NOT COMPLETED|Dose Expansion||0||
48583773|NCT02980341|101759285|FG005|NOT COMPLETED|Dose Expansion||0||
48583774|NCT02980341|101759286|FG006|NOT COMPLETED|Dose Expansion||0||
48583775|NCT02980341|101759287|FG007|NOT COMPLETED|Dose Expansion||33||
48583776|NCT02980341|101759288|FG008|NOT COMPLETED|Dose Expansion||31||
48583777|NCT02980341|101759289|FG009|NOT COMPLETED|Dose Expansion||21||
48583778|NCT02980341|101759290|FG010|NOT COMPLETED|Dose Expansion||31||
48583779|NCT02295020|101759291|FG000|STARTED|Overall Study||20||
48583780|NCT02295020|101759292|FG001|STARTED|Overall Study||20||
48583781|NCT02295020|101759291|FG000|COMPLETED|Overall Study||17||
48583782|NCT02295020|101759292|FG001|COMPLETED|Overall Study||17||
48583783|NCT02295020|101759291|FG000|NOT COMPLETED|Overall Study||3||
48583784|NCT02295020|101759292|FG001|NOT COMPLETED|Overall Study||3||
48583785|NCT00979875|101759293|FG000|STARTED|Intervention 1||2||
48583786|NCT00979875|101759294|FG001|STARTED|Intervention 1||2||
48583787|NCT00979875|101759295|FG002|STARTED|Intervention 1||3||
48583788|NCT00979875|101759296|FG003|STARTED|Intervention 1||2||
48583789|NCT00979875|101759297|FG004|STARTED|Intervention 1||3||
48583790|NCT00979875|101759298|FG005|STARTED|Intervention 1||2||
48705349|NCT03263923|102065042|FG000|COMPLETED|Overall Study||149||
48705350|NCT03263923|102065043|FG001|COMPLETED|Overall Study||151||
48705351|NCT03263923|102065042|FG000|NOT COMPLETED|Overall Study||25||
48705352|NCT03263923|102065043|FG001|NOT COMPLETED|Overall Study||21||
48705353|NCT02439450|102065044|FG000|STARTED|Overall Study||47||
48705354|NCT02439450|102065045|FG001|STARTED|Overall Study||68||
48583791|NCT00979875|101759293|FG000|Received at Least 1 Dose of Study Drug|Intervention 1||2||
48583792|NCT00979875|101759294|FG001|Received at Least 1 Dose of Study Drug|Intervention 1||2||
48583793|NCT00979875|101759295|FG002|Received at Least 1 Dose of Study Drug|Intervention 1||3||
48583794|NCT00979875|101759296|FG003|Received at Least 1 Dose of Study Drug|Intervention 1||2||
48583795|NCT00979875|101759297|FG004|Received at Least 1 Dose of Study Drug|Intervention 1||3||
48583796|NCT00979875|101759298|FG005|Received at Least 1 Dose of Study Drug|Intervention 1||2||
48583797|NCT00979875|101759293|FG000|COMPLETED|Intervention 1||2||
48583798|NCT00979875|101759294|FG001|COMPLETED|Intervention 1||2||
48583799|NCT00979875|101759295|FG002|COMPLETED|Intervention 1||3||
48705355|NCT02439450|102065046|FG002|STARTED|Overall Study||2||
48705356|NCT02439450|102065047|FG003|STARTED|Overall Study||4||
48583800|NCT00979875|101759296|FG003|COMPLETED|Intervention 1||2||
48705357|NCT02439450|102065044|FG000|COMPLETED|Overall Study||21||
48705358|NCT02439450|102065045|FG001|COMPLETED|Overall Study||24||
48705359|NCT02439450|102065046|FG002|COMPLETED|Overall Study||0||
48583801|NCT00979875|101759297|FG004|COMPLETED|Intervention 1||3||
48583802|NCT00979875|101759298|FG005|COMPLETED|Intervention 1||2||
48136996|NCT03690869|100661391|FG007|STARTED|Overall Study||12||
48583803|NCT00979875|101759293|FG000|NOT COMPLETED|Intervention 1||0||
48583804|NCT00979875|101759294|FG001|NOT COMPLETED|Intervention 1||0||
48705360|NCT02439450|102065047|FG003|COMPLETED|Overall Study||0||
48705361|NCT02439450|102065044|FG000|NOT COMPLETED|Overall Study||26||
48705362|NCT02439450|102065045|FG001|NOT COMPLETED|Overall Study||44||
48583805|NCT00979875|101759295|FG002|NOT COMPLETED|Intervention 1||0||
48583806|NCT00979875|101759296|FG003|NOT COMPLETED|Intervention 1||0||
48583807|NCT00979875|101759297|FG004|NOT COMPLETED|Intervention 1||0||
48583808|NCT00979875|101759298|FG005|NOT COMPLETED|Intervention 1||0||
48583809|NCT00979875|101759293|FG000|STARTED|Washout 1 (3 to 14 Days)||2||
48583810|NCT00979875|101759294|FG001|STARTED|Washout 1 (3 to 14 Days)||2||
48583811|NCT00979875|101759295|FG002|STARTED|Washout 1 (3 to 14 Days)||3||
48583812|NCT00979875|101759296|FG003|STARTED|Washout 1 (3 to 14 Days)||2||
48583813|NCT00979875|101759297|FG004|STARTED|Washout 1 (3 to 14 Days)||3||
48583814|NCT00979875|101759298|FG005|STARTED|Washout 1 (3 to 14 Days)||2||
48583815|NCT00979875|101759293|FG000|COMPLETED|Washout 1 (3 to 14 Days)||2||
48583816|NCT00979875|101759294|FG001|COMPLETED|Washout 1 (3 to 14 Days)||2||
48583817|NCT00979875|101759295|FG002|COMPLETED|Washout 1 (3 to 14 Days)||3||
48583818|NCT00979875|101759296|FG003|COMPLETED|Washout 1 (3 to 14 Days)||2||
48583819|NCT00979875|101759297|FG004|COMPLETED|Washout 1 (3 to 14 Days)||3||
48583820|NCT00979875|101759298|FG005|COMPLETED|Washout 1 (3 to 14 Days)||2||
48583821|NCT00979875|101759293|FG000|NOT COMPLETED|Washout 1 (3 to 14 Days)||0||
48583822|NCT00979875|101759294|FG001|NOT COMPLETED|Washout 1 (3 to 14 Days)||0||
48583823|NCT00979875|101759295|FG002|NOT COMPLETED|Washout 1 (3 to 14 Days)||0||
48705363|NCT02439450|102065046|FG002|NOT COMPLETED|Overall Study||2||
48705364|NCT02439450|102065047|FG003|NOT COMPLETED|Overall Study||4||
48705365|NCT03651856|102065048|FG000|STARTED|Overall Study||10||
48705366|NCT03651856|102065048|FG000|COMPLETED|Overall Study||10||
48705367|NCT03651856|102065048|FG000|NOT COMPLETED|Overall Study||0||
48705368|NCT02701777|102065049|FG000|STARTED|Overall Study||17||
48705369|NCT02701777|102065050|FG001|STARTED|Overall Study||16||
48705370|NCT02701777|102065051|FG002|STARTED|Overall Study||16||
48705371|NCT02701777|102065052|FG003|STARTED|Overall Study||13||
48705372|NCT02701777|102065049|FG000|COMPLETED|Overall Study||13||
48705373|NCT02701777|102065050|FG001|COMPLETED|Overall Study||13||
48705374|NCT02701777|102065051|FG002|COMPLETED|Overall Study||12||
48705375|NCT02701777|102065052|FG003|COMPLETED|Overall Study||11||
48705376|NCT02701777|102065049|FG000|NOT COMPLETED|Overall Study||4||
48705377|NCT02701777|102065050|FG001|NOT COMPLETED|Overall Study||3||
48705378|NCT02701777|102065051|FG002|NOT COMPLETED|Overall Study||4||
48705379|NCT02701777|102065052|FG003|NOT COMPLETED|Overall Study||2||
48705380|NCT03440918|102065053|FG000|STARTED|Overall Study||133||
48705381|NCT03440918|102065054|FG001|STARTED|Overall Study||138||
48705382|NCT03440918|102065053|FG000|COMPLETED|Overall Study||133||
48705383|NCT03440918|102065054|FG001|COMPLETED|Overall Study||122||
48705384|NCT03440918|102065053|FG000|NOT COMPLETED|Overall Study||0||
48705385|NCT03440918|102065054|FG001|NOT COMPLETED|Overall Study||16||
48705386|NCT01559259|102065055|FG000|STARTED|Overall Study||30||
48705387|NCT01559259|102065056|FG001|STARTED|Overall Study||90||
48705388|NCT01559259|102065057|FG002|STARTED|Overall Study||93||
48705389|NCT01559259|102065058|FG003|STARTED|Overall Study||89||
48705390|NCT01559259|102065059|FG004|STARTED|Overall Study||92||
48705391|NCT01559259|102065055|FG000|COMPLETED|Overall Study||30||
48705392|NCT01559259|102065056|FG001|COMPLETED|Overall Study||89||
48705393|NCT01559259|102065057|FG002|COMPLETED|Overall Study||92||
48583824|NCT00979875|101759296|FG003|NOT COMPLETED|Washout 1 (3 to 14 Days)||0||
48583825|NCT00979875|101759297|FG004|NOT COMPLETED|Washout 1 (3 to 14 Days)||0||
48583826|NCT00979875|101759298|FG005|NOT COMPLETED|Washout 1 (3 to 14 Days)||0||
48583827|NCT00979875|101759293|FG000|STARTED|Intervention 2||2||
48705394|NCT01559259|102065058|FG003|COMPLETED|Overall Study||88||
48705395|NCT01559259|102065059|FG004|COMPLETED|Overall Study||92||
48705396|NCT01559259|102065055|FG000|NOT COMPLETED|Overall Study||0||
48705397|NCT01559259|102065056|FG001|NOT COMPLETED|Overall Study||1||
48705398|NCT01559259|102065057|FG002|NOT COMPLETED|Overall Study||1||
48705399|NCT01559259|102065058|FG003|NOT COMPLETED|Overall Study||1||
48705400|NCT01559259|102065059|FG004|NOT COMPLETED|Overall Study||0||
48705401|NCT03284333|102065060|FG000|STARTED|Overall Study||43||
48705402|NCT03284333|102065060|FG000|COMPLETED|Overall Study||38||
48705403|NCT03284333|102065060|FG000|NOT COMPLETED|Overall Study||5||
48705404|NCT02099344|102065061|FG000|STARTED|Overall Study||1||
48705405|NCT02099344|102065062|FG001|STARTED|Overall Study||0||
48705406|NCT02099344|102065061|FG000|COMPLETED|Overall Study||0||
48705407|NCT02099344|102065062|FG001|COMPLETED|Overall Study||0||
48705408|NCT02099344|102065061|FG000|NOT COMPLETED|Overall Study||1||
48705409|NCT02099344|102065062|FG001|NOT COMPLETED|Overall Study||0||
48705410|NCT00923975|102065063|FG000|STARTED|Overall Study||51||
48705411|NCT00923975|102065063|FG000|COMPLETED|Overall Study||50||
48705412|NCT00923975|102065063|FG000|NOT COMPLETED|Overall Study||1||
48705413|NCT02493257|102065064|FG000|STARTED|Overall Study||11||
48705414|NCT02493257|102065065|FG001|STARTED|Overall Study||11||
48705415|NCT02493257|102065064|FG000|4 Week Follow up|Overall Study||11||
48705416|NCT02493257|102065065|FG001|4 Week Follow up|Overall Study||11||
48289091|NCT00705679|101033723|FG004|COMPLETED|Overall Study||934||
48705417|NCT02493257|102065064|FG000|12 Week Follow up|Overall Study||10||
48705418|NCT02493257|102065065|FG001|12 Week Follow up|Overall Study||10||
48705419|NCT02493257|102065064|FG000|COMPLETED|Overall Study||10||
48705420|NCT02493257|102065065|FG001|COMPLETED|Overall Study||10||
48705421|NCT02493257|102065064|FG000|NOT COMPLETED|Overall Study||1||
48705422|NCT02493257|102065065|FG001|NOT COMPLETED|Overall Study||1||
48705423|NCT01166958|102065066|FG000|STARTED|Overall Study||13||
48705424|NCT01166958|102065067|FG001|STARTED|Overall Study||13||
48583828|NCT00979875|101759294|FG001|STARTED|Intervention 2||2||
48583829|NCT00979875|101759295|FG002|STARTED|Intervention 2||3||
48583830|NCT00979875|101759296|FG003|STARTED|Intervention 2||2||
48705425|NCT01166958|102065066|FG000|COMPLETED|Overall Study||12||
48705426|NCT01166958|102065067|FG001|COMPLETED|Overall Study||13||
48705427|NCT01166958|102065066|FG000|NOT COMPLETED|Overall Study||1||
48705428|NCT01166958|102065067|FG001|NOT COMPLETED|Overall Study||0||
48705429|NCT03640052|102065068|FG000|STARTED|Overall Study||2||
48705430|NCT03640052|102065069|FG001|STARTED|Overall Study||1||
48705431|NCT03640052|102065070|FG002|STARTED|Overall Study||1||
48705432|NCT03640052|102065071|FG003|STARTED|Overall Study||1||
48705433|NCT03640052|102065072|FG004|STARTED|Overall Study||1||
48583831|NCT00979875|101759297|FG004|STARTED|Intervention 2||3||
48583832|NCT00979875|101759298|FG005|STARTED|Intervention 2||2||
48136997|NCT03690869|100661392|FG008|STARTED|Overall Study||1||
48136998|NCT03690869|100661393|FG009|STARTED|Overall Study||8||
48136999|NCT03690869|100661384|FG000|COMPLETED|Overall Study||0||
48137000|NCT03690869|100661385|FG001|COMPLETED|Overall Study||0||
48137001|NCT03690869|100661386|FG002|COMPLETED|Overall Study||0||
48137002|NCT03690869|100661387|FG003|COMPLETED|Overall Study||0||
48137003|NCT03690869|100661388|FG004|COMPLETED|Overall Study||0||
48583833|NCT00979875|101759293|FG000|COMPLETED|Intervention 2||2||
48583834|NCT00979875|101759294|FG001|COMPLETED|Intervention 2||2||
48583835|NCT00979875|101759295|FG002|COMPLETED|Intervention 2||3||
48583836|NCT00979875|101759296|FG003|COMPLETED|Intervention 2||2||
48583837|NCT00979875|101759297|FG004|COMPLETED|Intervention 2||3||
48583838|NCT00979875|101759298|FG005|COMPLETED|Intervention 2||2||
48583839|NCT00979875|101759293|FG000|NOT COMPLETED|Intervention 2||0||
48583840|NCT00979875|101759294|FG001|NOT COMPLETED|Intervention 2||0||
48583841|NCT00979875|101759295|FG002|NOT COMPLETED|Intervention 2||0||
48583842|NCT00979875|101759296|FG003|NOT COMPLETED|Intervention 2||0||
48583843|NCT00979875|101759297|FG004|NOT COMPLETED|Intervention 2||0||
48583844|NCT00979875|101759298|FG005|NOT COMPLETED|Intervention 2||0||
48137004|NCT03690869|100661389|FG005|COMPLETED|Overall Study||0||
48137005|NCT03690869|100661390|FG006|COMPLETED|Overall Study||0||
48137006|NCT03690869|100661391|FG007|COMPLETED|Overall Study||1||
48137007|NCT03690869|100661392|FG008|COMPLETED|Overall Study||0||
48137008|NCT03690869|100661393|FG009|COMPLETED|Overall Study||0||
48137009|NCT03690869|100661384|FG000|NOT COMPLETED|Overall Study||3||
48137010|NCT03690869|100661385|FG001|NOT COMPLETED|Overall Study||5||
48137011|NCT03690869|100661386|FG002|NOT COMPLETED|Overall Study||3||
48137012|NCT03690869|100661387|FG003|NOT COMPLETED|Overall Study||9||
48137013|NCT03690869|100661388|FG004|NOT COMPLETED|Overall Study||5||
48137014|NCT03690869|100661389|FG005|NOT COMPLETED|Overall Study||6||
48137015|NCT03690869|100661390|FG006|NOT COMPLETED|Overall Study||5||
48137016|NCT03690869|100661391|FG007|NOT COMPLETED|Overall Study||11||
48137017|NCT03690869|100661392|FG008|NOT COMPLETED|Overall Study||1||
48583845|NCT00979875|101759293|FG000|STARTED|Washout 2 (3 to 14 Days)||2||
48583846|NCT00979875|101759294|FG001|STARTED|Washout 2 (3 to 14 Days)||2||
48583847|NCT00979875|101759295|FG002|STARTED|Washout 2 (3 to 14 Days)||3||
48583848|NCT00979875|101759296|FG003|STARTED|Washout 2 (3 to 14 Days)||2||
48583849|NCT00979875|101759297|FG004|STARTED|Washout 2 (3 to 14 Days)||3||
48583850|NCT00979875|101759298|FG005|STARTED|Washout 2 (3 to 14 Days)||2||
48583851|NCT00979875|101759293|FG000|COMPLETED|Washout 2 (3 to 14 Days)||2||
48583852|NCT00979875|101759294|FG001|COMPLETED|Washout 2 (3 to 14 Days)||2||
48583853|NCT00979875|101759295|FG002|COMPLETED|Washout 2 (3 to 14 Days)||3||
48583854|NCT00979875|101759296|FG003|COMPLETED|Washout 2 (3 to 14 Days)||2||
48583855|NCT00979875|101759297|FG004|COMPLETED|Washout 2 (3 to 14 Days)||3||
48583856|NCT00979875|101759298|FG005|COMPLETED|Washout 2 (3 to 14 Days)||2||
48705434|NCT03640052|102065068|FG000|COMPLETED|Overall Study||2||
48705435|NCT03640052|102065069|FG001|COMPLETED|Overall Study||0||
48705436|NCT03640052|102065070|FG002|COMPLETED|Overall Study||1||
48705437|NCT03640052|102065071|FG003|COMPLETED|Overall Study||1||
48137018|NCT03690869|100661393|FG009|NOT COMPLETED|Overall Study||8||
48137019|NCT02291614|100661394|FG000|STARTED|Overall Study||3||
48137020|NCT02291614|100661395|FG001|STARTED|Overall Study||3||
48137021|NCT02291614|100661396|FG002|STARTED|Overall Study||3||
48137022|NCT02291614|100661397|FG003|STARTED|Overall Study||5||
48137023|NCT02291614|100661398|FG004|STARTED|Overall Study||3||
48583857|NCT00979875|101759293|FG000|NOT COMPLETED|Washout 2 (3 to 14 Days)||0||
48583858|NCT00979875|101759294|FG001|NOT COMPLETED|Washout 2 (3 to 14 Days)||0||
48583859|NCT00979875|101759295|FG002|NOT COMPLETED|Washout 2 (3 to 14 Days)||0||
48583860|NCT00979875|101759296|FG003|NOT COMPLETED|Washout 2 (3 to 14 Days)||0||
48705438|NCT03640052|102065072|FG004|COMPLETED|Overall Study||1||
48137024|NCT02291614|100661399|FG005|STARTED|Overall Study||3||
48137025|NCT02291614|100661400|FG006|STARTED|Overall Study||6||
48137026|NCT02291614|100661401|FG007|STARTED|Overall Study||3||
48137027|NCT02291614|100661402|FG008|STARTED|Overall Study||3||
48137028|NCT02291614|100661403|FG009|STARTED|Overall Study||11||
48137029|NCT02291614|100661404|FG010|STARTED|Overall Study||2||
48137030|NCT02291614|100661394|FG000|Received AMG 211|Overall Study||3||
48137031|NCT02291614|100661395|FG001|Received AMG 211|Overall Study||3||
48137032|NCT02291614|100661396|FG002|Received AMG 211|Overall Study||3||
48137033|NCT02291614|100661397|FG003|Received AMG 211|Overall Study||5||
48137034|NCT02291614|100661398|FG004|Received AMG 211|Overall Study||3||
48583861|NCT00979875|101759297|FG004|NOT COMPLETED|Washout 2 (3 to 14 Days)||0||
48583862|NCT00979875|101759298|FG005|NOT COMPLETED|Washout 2 (3 to 14 Days)||0||
48583863|NCT00979875|101759293|FG000|STARTED|Intervention 3||2||
48583864|NCT00979875|101759294|FG001|STARTED|Intervention 3||2||
48583865|NCT00979875|101759295|FG002|STARTED|Intervention 3||3||
48583866|NCT00979875|101759296|FG003|STARTED|Intervention 3||2||
48583867|NCT00979875|101759297|FG004|STARTED|Intervention 3||3||
48137035|NCT02291614|100661399|FG005|Received AMG 211|Overall Study||3||
48137036|NCT02291614|100661400|FG006|Received AMG 211|Overall Study||6||
48137037|NCT02291614|100661401|FG007|Received AMG 211|Overall Study||3||
48137038|NCT02291614|100661402|FG008|Received AMG 211|Overall Study||3||
48137039|NCT02291614|100661403|FG009|Received AMG 211|Overall Study||10||
48137040|NCT02291614|100661404|FG010|Received AMG 211|Overall Study||2||
48137041|NCT02291614|100661394|FG000|COMPLETED|Overall Study||3||
48137042|NCT02291614|100661395|FG001|COMPLETED|Overall Study||2||
48137043|NCT02291614|100661396|FG002|COMPLETED|Overall Study||2||
48137044|NCT02291614|100661397|FG003|COMPLETED|Overall Study||4||
48137045|NCT02291614|100661398|FG004|COMPLETED|Overall Study||2||
48137046|NCT02291614|100661399|FG005|COMPLETED|Overall Study||2||
48137047|NCT02291614|100661400|FG006|COMPLETED|Overall Study||5||
48137048|NCT02291614|100661401|FG007|COMPLETED|Overall Study||2||
48137049|NCT02291614|100661402|FG008|COMPLETED|Overall Study||3||
48137050|NCT02291614|100661403|FG009|COMPLETED|Overall Study||9||
48137051|NCT02291614|100661404|FG010|COMPLETED|Overall Study||0||
48137052|NCT02291614|100661394|FG000|NOT COMPLETED|Overall Study||0||
48137053|NCT02291614|100661395|FG001|NOT COMPLETED|Overall Study||1||
48137054|NCT02291614|100661396|FG002|NOT COMPLETED|Overall Study||1||
48137055|NCT02291614|100661397|FG003|NOT COMPLETED|Overall Study||1||
48137056|NCT02291614|100661398|FG004|NOT COMPLETED|Overall Study||1||
48137057|NCT02291614|100661399|FG005|NOT COMPLETED|Overall Study||1||
48137058|NCT02291614|100661400|FG006|NOT COMPLETED|Overall Study||1||
48137059|NCT02291614|100661401|FG007|NOT COMPLETED|Overall Study||1||
48137060|NCT02291614|100661402|FG008|NOT COMPLETED|Overall Study||0||
48137061|NCT02291614|100661403|FG009|NOT COMPLETED|Overall Study||2||
48137062|NCT02291614|100661404|FG010|NOT COMPLETED|Overall Study||2||
48137063|NCT00838110|100661405|FG000|STARTED|Overall Study||127||
48137064|NCT00838110|100661406|FG001|STARTED|Overall Study||128||
48137065|NCT00838110|100661407|FG002|STARTED|Overall Study||243||
48137066|NCT00838110|100661408|FG003|STARTED|Overall Study||244||
48137067|NCT00838110|100661405|FG000|Treated|Overall Study||127||
48137068|NCT00838110|100661406|FG001|Treated|Overall Study||127||
48137069|NCT00838110|100661407|FG002|Treated|Overall Study||243||
48137070|NCT00838110|100661408|FG003|Treated|Overall Study||244||
48137071|NCT00838110|100661405|FG000|COMPLETED|Overall Study||105||
48137072|NCT00838110|100661406|FG001|COMPLETED|Overall Study||106||
48137073|NCT00838110|100661407|FG002|COMPLETED|Overall Study||226||
48137074|NCT00838110|100661408|FG003|COMPLETED|Overall Study||226||
48137075|NCT00838110|100661405|FG000|NOT COMPLETED|Overall Study||22||
48137076|NCT00838110|100661406|FG001|NOT COMPLETED|Overall Study||22||
48137077|NCT00838110|100661407|FG002|NOT COMPLETED|Overall Study||17||
48137078|NCT00838110|100661408|FG003|NOT COMPLETED|Overall Study||18||
48137079|NCT02935062|100661409|FG000|STARTED|Overall Study||8||
48137080|NCT02935062|100661410|FG001|STARTED|Overall Study||8||
48583868|NCT00979875|101759298|FG005|STARTED|Intervention 3||2||
48583869|NCT00979875|101759293|FG000|COMPLETED|Intervention 3||2||
48137081|NCT02935062|100661411|FG002|STARTED|Overall Study||8||
48137082|NCT02935062|100661409|FG000|COMPLETED|Overall Study||8||
48137083|NCT02935062|100661410|FG001|COMPLETED|Overall Study||8||
48137084|NCT02935062|100661411|FG002|COMPLETED|Overall Study||8||
48137085|NCT02935062|100661409|FG000|NOT COMPLETED|Overall Study||0||
48137086|NCT02935062|100661410|FG001|NOT COMPLETED|Overall Study||0||
48137087|NCT02935062|100661411|FG002|NOT COMPLETED|Overall Study||0||
48137088|NCT01308749|100661412|FG000|STARTED|Period 1: Double Blind Treatment||12||
48137089|NCT01308749|100661413|FG001|STARTED|Period 1: Double Blind Treatment||13||
48137090|NCT01308749|100661412|FG000|COMPLETED|Period 1: Double Blind Treatment||11||
48583870|NCT00979875|101759294|FG001|COMPLETED|Intervention 3||2||
48583871|NCT00979875|101759295|FG002|COMPLETED|Intervention 3||3||
48137091|NCT01308749|100661413|FG001|COMPLETED|Period 1: Double Blind Treatment||13||
48137092|NCT01308749|100661412|FG000|NOT COMPLETED|Period 1: Double Blind Treatment||1||
48137093|NCT01308749|100661413|FG001|NOT COMPLETED|Period 1: Double Blind Treatment||0||
48137094|NCT01308749|100661412|FG000|STARTED|Period 2: Open Label Treatment||11||
48137095|NCT01308749|100661413|FG001|STARTED|Period 2: Open Label Treatment||13||
48583872|NCT00979875|101759296|FG003|COMPLETED|Intervention 3||2||
48401185|NCT02177812|101313706|FG001|COMPLETED|Part 1 (Median of 4 Weeks)||2||
48401186|NCT02177812|101313707|FG002|COMPLETED|Part 1 (Median of 4 Weeks)||7||
48401187|NCT02177812|101313708|FG003|COMPLETED|Part 1 (Median of 4 Weeks)||4||
48401188|NCT02177812|101313709|FG004|COMPLETED|Part 1 (Median of 4 Weeks)||5||
48401189|NCT02177812|101313710|FG005|COMPLETED|Part 1 (Median of 4 Weeks)||1||
48401190|NCT02177812|101313711|FG006|COMPLETED|Part 1 (Median of 4 Weeks)||1||
48401191|NCT02177812|101313712|FG007|COMPLETED|Part 1 (Median of 4 Weeks)||4||
48401192|NCT02177812|101313713|FG008|COMPLETED|Part 1 (Median of 4 Weeks)||0||
48401193|NCT02177812|101313705|FG000|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0||
48401194|NCT02177812|101313706|FG001|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0||
48401195|NCT02177812|101313707|FG002|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0||
48401196|NCT02177812|101313708|FG003|NOT COMPLETED|Part 1 (Median of 4 Weeks)||1||
48401197|NCT02177812|101313709|FG004|NOT COMPLETED|Part 1 (Median of 4 Weeks)||1||
48401198|NCT02177812|101313710|FG005|NOT COMPLETED|Part 1 (Median of 4 Weeks)||3||
48583873|NCT00979875|101759297|FG004|COMPLETED|Intervention 3||3||
48583874|NCT00979875|101759298|FG005|COMPLETED|Intervention 3||2||
48583875|NCT00979875|101759293|FG000|NOT COMPLETED|Intervention 3||0||
48583876|NCT00979875|101759294|FG001|NOT COMPLETED|Intervention 3||0||
48583877|NCT00979875|101759295|FG002|NOT COMPLETED|Intervention 3||0||
48401199|NCT02177812|101313711|FG006|NOT COMPLETED|Part 1 (Median of 4 Weeks)||9||
48401200|NCT02177812|101313712|FG007|NOT COMPLETED|Part 1 (Median of 4 Weeks)||2||
48401201|NCT02177812|101313713|FG008|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0||
48401202|NCT02177812|101313705|FG000|STARTED|Part 2 (Up to 14 Months)||0||
48401203|NCT02177812|101313706|FG001|STARTED|Part 2 (Up to 14 Months)||0||
48401204|NCT02177812|101313707|FG002|STARTED|Part 2 (Up to 14 Months)||0||
48401205|NCT02177812|101313708|FG003|STARTED|Part 2 (Up to 14 Months)||0||
48401206|NCT02177812|101313709|FG004|STARTED|Part 2 (Up to 14 Months)||0||
48401207|NCT02177812|101313710|FG005|STARTED|Part 2 (Up to 14 Months)||0||
48401208|NCT02177812|101313711|FG006|STARTED|Part 2 (Up to 14 Months)||0||
48401209|NCT02177812|101313712|FG007|STARTED|Part 2 (Up to 14 Months)||0||
48401210|NCT02177812|101313713|FG008|STARTED|Part 2 (Up to 14 Months)||0||
48401211|NCT02177812|101313705|FG000|COMPLETED|Part 2 (Up to 14 Months)||0||
48583878|NCT00979875|101759296|FG003|NOT COMPLETED|Intervention 3||0||
48583879|NCT00979875|101759297|FG004|NOT COMPLETED|Intervention 3||0||
48137096|NCT01308749|100661412|FG000|COMPLETED|Period 2: Open Label Treatment||11||
48137097|NCT01308749|100661413|FG001|COMPLETED|Period 2: Open Label Treatment||11||
48137098|NCT01308749|100661412|FG000|NOT COMPLETED|Period 2: Open Label Treatment||0||
48137099|NCT01308749|100661413|FG001|NOT COMPLETED|Period 2: Open Label Treatment||2||
48137100|NCT01664078|100661414|FG000|STARTED|Overall Study||190||
48137101|NCT01664078|100661414|FG000|COMPLETED|Overall Study||121||
48137102|NCT01664078|100661414|FG000|NOT COMPLETED|Overall Study||69||
48137103|NCT02037347|100661415|FG000|STARTED|Overall Study||1||
48137104|NCT02037347|100661415|FG000|COMPLETED|Overall Study||1||
48583880|NCT00979875|101759298|FG005|NOT COMPLETED|Intervention 3||0||
48583881|NCT03699280|101759299|FG000|STARTED|Overall Study||20||
48583882|NCT03699280|101759300|FG001|STARTED|Overall Study||20||
48583883|NCT03699280|101759299|FG000|COMPLETED|Overall Study||20||
48583884|NCT03699280|101759300|FG001|COMPLETED|Overall Study||20||
48583885|NCT03699280|101759299|FG000|NOT COMPLETED|Overall Study||0||
48583886|NCT03699280|101759300|FG001|NOT COMPLETED|Overall Study||0||
48583887|NCT01273623|101759301|FG000|STARTED|Overall Study||55||
48583888|NCT01273623|101759301|FG000|COMPLETED|Overall Study||26||
48583889|NCT01273623|101759301|FG000|NOT COMPLETED|Overall Study||29||
48583890|NCT01923298|101759302|FG000|STARTED|Overall Study||14||
48705439|NCT03640052|102065068|FG000|NOT COMPLETED|Overall Study||0||
48137105|NCT02037347|100661415|FG000|NOT COMPLETED|Overall Study||0||
48137106|NCT02076152|100661416|FG000|STARTED|Overall Study||2||
48137107|NCT02076152|100661417|FG001|STARTED|Overall Study||9||
48137108|NCT02076152|100661416|FG000|COMPLETED|Overall Study||2||
48137109|NCT02076152|100661417|FG001|COMPLETED|Overall Study||9||
48137110|NCT02076152|100661416|FG000|NOT COMPLETED|Overall Study||0||
48137111|NCT02076152|100661417|FG001|NOT COMPLETED|Overall Study||0||
48137112|NCT01810588|100661418|FG000|STARTED|Cohort 1 - Minimum Cell Dose 2 x 10^7 TN||15||
48137113|NCT01810588|100661419|FG001|STARTED|Cohort 1 - Minimum Cell Dose 2 x 10^7 TN||0||
48137114|NCT01810588|100661420|FG002|STARTED|Cohort 1 - Minimum Cell Dose 2 x 10^7 TN||0||
48137115|NCT01810588|100661421|FG003|STARTED|Cohort 1 - Minimum Cell Dose 2 x 10^7 TN||0||
48137116|NCT01810588|100661418|FG000|COMPLETED|Cohort 1 - Minimum Cell Dose 2 x 10^7 TN||15||
48137117|NCT01810588|100661419|FG001|COMPLETED|Cohort 1 - Minimum Cell Dose 2 x 10^7 TN||0||
48137118|NCT01810588|100661420|FG002|COMPLETED|Cohort 1 - Minimum Cell Dose 2 x 10^7 TN||0||
48137119|NCT01810588|100661421|FG003|COMPLETED|Cohort 1 - Minimum Cell Dose 2 x 10^7 TN||0||
48137120|NCT01810588|100661418|FG000|NOT COMPLETED|Cohort 1 - Minimum Cell Dose 2 x 10^7 TN||0||
48137121|NCT01810588|100661419|FG001|NOT COMPLETED|Cohort 1 - Minimum Cell Dose 2 x 10^7 TN||0||
48137122|NCT01810588|100661420|FG002|NOT COMPLETED|Cohort 1 - Minimum Cell Dose 2 x 10^7 TN||0||
48137123|NCT01810588|100661421|FG003|NOT COMPLETED|Cohort 1 - Minimum Cell Dose 2 x 10^7 TN||0||
48137124|NCT01810588|100661418|FG000|STARTED|Cohort 2 - Minimum Cell Dose 1 x 10^7 TN||0||
48137125|NCT01810588|100661419|FG001|STARTED|Cohort 2 - Minimum Cell Dose 1 x 10^7 TN||20||
48137126|NCT01810588|100661420|FG002|STARTED|Cohort 2 - Minimum Cell Dose 1 x 10^7 TN||0||
48137127|NCT01810588|100661421|FG003|STARTED|Cohort 2 - Minimum Cell Dose 1 x 10^7 TN||0||
48137128|NCT01810588|100661418|FG000|COMPLETED|Cohort 2 - Minimum Cell Dose 1 x 10^7 TN||0||
48137129|NCT01810588|100661419|FG001|COMPLETED|Cohort 2 - Minimum Cell Dose 1 x 10^7 TN||20||
48137130|NCT01810588|100661420|FG002|COMPLETED|Cohort 2 - Minimum Cell Dose 1 x 10^7 TN||0||
48289092|NCT00705679|101033719|FG000|NOT COMPLETED|Overall Study||65||
48289093|NCT00705679|101033720|FG001|NOT COMPLETED|Overall Study||139||
48583891|NCT01923298|101759302|FG000|COMPLETED|Overall Study||14||
48583892|NCT01923298|101759302|FG000|NOT COMPLETED|Overall Study||0||
48583893|NCT01913535|101759303|FG000|STARTED|Phase 1 (Days 0-2)||2||
48583894|NCT01913535|101759304|FG001|STARTED|Phase 1 (Days 0-2)||2||
48583895|NCT01913535|101759305|FG002|STARTED|Phase 1 (Days 0-2)||1||
48583896|NCT01913535|101759306|FG003|STARTED|Phase 1 (Days 0-2)||2||
48137131|NCT01810588|100661421|FG003|COMPLETED|Cohort 2 - Minimum Cell Dose 1 x 10^7 TN||0||
48137132|NCT01810588|100661418|FG000|NOT COMPLETED|Cohort 2 - Minimum Cell Dose 1 x 10^7 TN||0||
48137133|NCT01810588|100661419|FG001|NOT COMPLETED|Cohort 2 - Minimum Cell Dose 1 x 10^7 TN||0||
48137134|NCT01810588|100661420|FG002|NOT COMPLETED|Cohort 2 - Minimum Cell Dose 1 x 10^7 TN||0||
48137135|NCT01810588|100661421|FG003|NOT COMPLETED|Cohort 2 - Minimum Cell Dose 1 x 10^7 TN||0||
48137136|NCT01810588|100661418|FG000|STARTED|Cohort 3 - Minimum Cell Dose 0.5 x 10^7||0||
48137137|NCT01810588|100661419|FG001|STARTED|Cohort 3 - Minimum Cell Dose 0.5 x 10^7||0||
48137138|NCT01810588|100661420|FG002|STARTED|Cohort 3 - Minimum Cell Dose 0.5 x 10^7||25||
48137139|NCT01810588|100661421|FG003|STARTED|Cohort 3 - Minimum Cell Dose 0.5 x 10^7||0||
48705440|NCT03640052|102065069|FG001|NOT COMPLETED|Overall Study||1||
48705441|NCT03640052|102065070|FG002|NOT COMPLETED|Overall Study||0||
48137140|NCT01810588|100661418|FG000|COMPLETED|Cohort 3 - Minimum Cell Dose 0.5 x 10^7||0||
48137141|NCT01810588|100661419|FG001|COMPLETED|Cohort 3 - Minimum Cell Dose 0.5 x 10^7||0||
48137142|NCT01810588|100661420|FG002|COMPLETED|Cohort 3 - Minimum Cell Dose 0.5 x 10^7||25||
48141454|NCT01780922|100670423|FG000|NOT COMPLETED|Washout (7 Days)||0||
48141455|NCT01780922|100670424|FG001|NOT COMPLETED|Washout (7 Days)||0||
48141456|NCT01780922|100670425|FG002|NOT COMPLETED|Washout (7 Days)||0||
48141457|NCT01780922|100670426|FG003|NOT COMPLETED|Washout (7 Days)||0||
48141458|NCT01780922|100670427|FG004|NOT COMPLETED|Washout (7 Days)||0||
48141459|NCT01780922|100670428|FG005|NOT COMPLETED|Washout (7 Days)||0||
48141460|NCT01780922|100670423|FG000|STARTED|Second Intervention (1 Day)||2||
48137143|NCT01810588|100661421|FG003|COMPLETED|Cohort 3 - Minimum Cell Dose 0.5 x 10^7||0||
48137144|NCT01810588|100661418|FG000|NOT COMPLETED|Cohort 3 - Minimum Cell Dose 0.5 x 10^7||0||
48137145|NCT01810588|100661419|FG001|NOT COMPLETED|Cohort 3 - Minimum Cell Dose 0.5 x 10^7||0||
48137146|NCT01810588|100661420|FG002|NOT COMPLETED|Cohort 3 - Minimum Cell Dose 0.5 x 10^7||0||
48137147|NCT01810588|100661421|FG003|NOT COMPLETED|Cohort 3 - Minimum Cell Dose 0.5 x 10^7||0||
48137148|NCT01810588|100661418|FG000|STARTED|Cohort 4||0||
48137149|NCT01810588|100661419|FG001|STARTED|Cohort 4||0||
48137150|NCT01810588|100661420|FG002|STARTED|Cohort 4||0||
48137151|NCT01810588|100661421|FG003|STARTED|Cohort 4||210||
48137152|NCT01810588|100661418|FG000|COMPLETED|Cohort 4||0||
48137153|NCT01810588|100661419|FG001|COMPLETED|Cohort 4||0||
48137154|NCT01810588|100661420|FG002|COMPLETED|Cohort 4||0||
48137155|NCT01810588|100661421|FG003|COMPLETED|Cohort 4||210||
48137156|NCT01810588|100661418|FG000|NOT COMPLETED|Cohort 4||0||
48289094|NCT00705679|101033721|FG002|NOT COMPLETED|Overall Study||115||
48289095|NCT00705679|101033722|FG003|NOT COMPLETED|Overall Study||80||
48289096|NCT00705679|101033723|FG004|NOT COMPLETED|Overall Study||69||
48583897|NCT01913535|101759307|FG004|STARTED|Phase 1 (Days 0-2)||1||
48583898|NCT01913535|101759303|FG000|COMPLETED|Phase 1 (Days 0-2)||2||
48583899|NCT01913535|101759304|FG001|COMPLETED|Phase 1 (Days 0-2)||2||
48583900|NCT01913535|101759305|FG002|COMPLETED|Phase 1 (Days 0-2)||1||
48583901|NCT01913535|101759306|FG003|COMPLETED|Phase 1 (Days 0-2)||2||
48583902|NCT01913535|101759307|FG004|COMPLETED|Phase 1 (Days 0-2)||1||
48583903|NCT01913535|101759303|FG000|NOT COMPLETED|Phase 1 (Days 0-2)||0||
48583904|NCT01913535|101759304|FG001|NOT COMPLETED|Phase 1 (Days 0-2)||0||
48583905|NCT01913535|101759305|FG002|NOT COMPLETED|Phase 1 (Days 0-2)||0||
48705442|NCT03640052|102065071|FG003|NOT COMPLETED|Overall Study||0||
48705443|NCT03640052|102065072|FG004|NOT COMPLETED|Overall Study||0||
48705444|NCT02210221|102065073|FG000|STARTED|Overall Study||4559||
48583906|NCT01913535|101759306|FG003|NOT COMPLETED|Phase 1 (Days 0-2)||0||
48583907|NCT01913535|101759307|FG004|NOT COMPLETED|Phase 1 (Days 0-2)||0||
48583908|NCT01913535|101759303|FG000|STARTED|Phase 2 (Days 3-5)||2||
48705445|NCT02210221|102065073|FG000|COMPLETED|Overall Study||4509||
48705446|NCT02210221|102065073|FG000|NOT COMPLETED|Overall Study||50||
48705447|NCT01459653|102065074|FG000|STARTED|Overall Study||1496||
48137157|NCT01810588|100661419|FG001|NOT COMPLETED|Cohort 4||0||
48137158|NCT01810588|100661420|FG002|NOT COMPLETED|Cohort 4||0||
48583909|NCT01913535|101759304|FG001|STARTED|Phase 2 (Days 3-5)||2||
48583910|NCT01913535|101759305|FG002|STARTED|Phase 2 (Days 3-5)||1||
48583911|NCT01913535|101759306|FG003|STARTED|Phase 2 (Days 3-5)||2||
48583912|NCT01913535|101759307|FG004|STARTED|Phase 2 (Days 3-5)||1||
48583913|NCT01913535|101759303|FG000|COMPLETED|Phase 2 (Days 3-5)||2||
48583914|NCT01913535|101759304|FG001|COMPLETED|Phase 2 (Days 3-5)||2||
48583915|NCT01913535|101759305|FG002|COMPLETED|Phase 2 (Days 3-5)||1||
48583916|NCT01913535|101759306|FG003|COMPLETED|Phase 2 (Days 3-5)||2||
48583917|NCT01913535|101759307|FG004|COMPLETED|Phase 2 (Days 3-5)||1||
48583918|NCT01913535|101759303|FG000|NOT COMPLETED|Phase 2 (Days 3-5)||0||
48583919|NCT01913535|101759304|FG001|NOT COMPLETED|Phase 2 (Days 3-5)||0||
48583920|NCT01913535|101759305|FG002|NOT COMPLETED|Phase 2 (Days 3-5)||0||
48583921|NCT01913535|101759306|FG003|NOT COMPLETED|Phase 2 (Days 3-5)||0||
48583922|NCT01913535|101759307|FG004|NOT COMPLETED|Phase 2 (Days 3-5)||0||
48583923|NCT00160706|101759308|FG000|STARTED|Overall Study||310||
48583924|NCT00160706|101759308|FG000|COMPLETED|Overall Study||24||
48583925|NCT00160706|101759308|FG000|NOT COMPLETED|Overall Study||286||
48705448|NCT01459653|102065074|FG000|COMPLETED|Overall Study||828||
48705449|NCT01459653|102065074|FG000|NOT COMPLETED|Overall Study||668||
48705450|NCT02242435|102065075|FG000|STARTED|Overall Study||172||
48705451|NCT02242435|102065076|FG001|STARTED|Overall Study||170||
48137159|NCT01810588|100661421|FG003|NOT COMPLETED|Cohort 4||0||
48137160|NCT03776136|100661422|FG000|STARTED|Overall Study||103||
48137161|NCT03776136|100661422|FG000|Treated|Overall Study||103||
48583926|NCT02274870|101759309|FG000|STARTED|Overall Study||32||
48583927|NCT02274870|101759310|FG001|STARTED|Overall Study||33||
48583928|NCT02274870|101759309|FG000|COMPLETED|Overall Study||32||
48583929|NCT02274870|101759310|FG001|COMPLETED|Overall Study||33||
48705452|NCT02242435|102065075|FG000|COMPLETED|Overall Study||152||
48137162|NCT03776136|100661422|FG000|COMPLETED|Overall Study||0||
48137163|NCT03776136|100661422|FG000|NOT COMPLETED|Overall Study||103||
48137164|NCT01026974|100661423|FG000|STARTED|Overall Study||16||
48137165|NCT01026974|100661424|FG001|STARTED|Overall Study||14||
48137166|NCT01026974|100661425|FG002|STARTED|Overall Study||41||
48137167|NCT01026974|100661426|FG003|STARTED|Overall Study||49||
48137168|NCT01026974|100661423|FG000|COMPLETED|Overall Study||15||
48289097|NCT02407990|101033724|FG000|STARTED|Overall Study||3||
48289098|NCT02407990|101033725|FG001|STARTED|Overall Study||26||
48289099|NCT02407990|101033726|FG002|STARTED|Overall Study||26||
48289100|NCT02407990|101033727|FG003|STARTED|Overall Study||7||
48583930|NCT02274870|101759309|FG000|NOT COMPLETED|Overall Study||0||
48583931|NCT02274870|101759310|FG001|NOT COMPLETED|Overall Study||0||
48583932|NCT01813214|101759311|FG000|STARTED|Overall Study||3||
48583933|NCT01813214|101759312|FG001|STARTED|Overall Study||2||
48583934|NCT01813214|101759311|FG000|COMPLETED|Overall Study||3||
48583935|NCT01813214|101759312|FG001|COMPLETED|Overall Study||2||
48583936|NCT01813214|101759311|FG000|NOT COMPLETED|Overall Study||0||
48289101|NCT02407990|101033728|FG004|STARTED|Overall Study||21||
48289102|NCT02407990|101033729|FG005|STARTED|Overall Study||20||
48289103|NCT02407990|101033730|FG006|STARTED|Overall Study||13||
48289104|NCT02407990|101033731|FG007|STARTED|Overall Study||335||
48289105|NCT02407990|101033724|FG000|COMPLETED|Overall Study||0||
48289106|NCT02407990|101033725|FG001|COMPLETED|Overall Study||0||
48289107|NCT02407990|101033726|FG002|COMPLETED|Overall Study||0||
48401212|NCT02177812|101313706|FG001|COMPLETED|Part 2 (Up to 14 Months)||0||
48583937|NCT01813214|101759312|FG001|NOT COMPLETED|Overall Study||0||
48583938|NCT06586788|101759313|FG000|STARTED|Overall Study||154||
48137169|NCT01026974|100661424|FG001|COMPLETED|Overall Study||12||
48137170|NCT01026974|100661425|FG002|COMPLETED|Overall Study||29||
48137171|NCT01026974|100661426|FG003|COMPLETED|Overall Study||46||
48137172|NCT01026974|100661423|FG000|NOT COMPLETED|Overall Study||1||
48137173|NCT01026974|100661424|FG001|NOT COMPLETED|Overall Study||2||
48137174|NCT01026974|100661425|FG002|NOT COMPLETED|Overall Study||12||
48137175|NCT01026974|100661426|FG003|NOT COMPLETED|Overall Study||3||
48137176|NCT04479618|100661427|FG000|STARTED|Overall Study||18||
48137177|NCT04479618|100661428|FG001|STARTED|Overall Study||14||
48137178|NCT04479618|100661429|FG002|STARTED|Overall Study||16||
48137179|NCT04479618|100661427|FG000|COMPLETED|Overall Study||16||
48137180|NCT04479618|100661428|FG001|COMPLETED|Overall Study||13||
48137181|NCT04479618|100661429|FG002|COMPLETED|Overall Study||11||
48137182|NCT04479618|100661427|FG000|NOT COMPLETED|Overall Study||2||
48137183|NCT04479618|100661428|FG001|NOT COMPLETED|Overall Study||1||
48137184|NCT04479618|100661429|FG002|NOT COMPLETED|Overall Study||5||
48137185|NCT04831736|100661430|FG000|STARTED|Overall Study||15||
48137186|NCT04831736|100661431|FG001|STARTED|Overall Study||16||
48137187|NCT04831736|100661430|FG000|COMPLETED|Overall Study||15||
48137188|NCT04831736|100661431|FG001|COMPLETED|Overall Study||15||
48137189|NCT04831736|100661430|FG000|NOT COMPLETED|Overall Study||0||
48137190|NCT04831736|100661431|FG001|NOT COMPLETED|Overall Study||1||
48705453|NCT02242435|102065076|FG001|COMPLETED|Overall Study||154||
48705454|NCT02242435|102065075|FG000|NOT COMPLETED|Overall Study||20||
48705455|NCT02242435|102065076|FG001|NOT COMPLETED|Overall Study||16||
48137191|NCT02156674|100661432|FG000|STARTED|Overall Study||1||
48137192|NCT02156674|100661432|FG000|COMPLETED|Overall Study||1||
48137193|NCT02156674|100661432|FG000|NOT COMPLETED|Overall Study||0||
48289108|NCT02407990|101033727|FG003|COMPLETED|Overall Study||0||
48401213|NCT02177812|101313707|FG002|COMPLETED|Part 2 (Up to 14 Months)||0||
48583939|NCT06586788|101759313|FG000|COMPLETED|Overall Study||146||
48583940|NCT06586788|101759313|FG000|NOT COMPLETED|Overall Study||8||
48583941|NCT01817582|101759314|FG000|STARTED|Overall Study||33||
48583942|NCT01817582|101759315|FG001|STARTED|Overall Study||36||
48583943|NCT01817582|101759316|FG002|STARTED|Overall Study||33||
48583944|NCT01817582|101759314|FG000|Received at Least 1 Dose of Study Drug|Overall Study||33||
48583945|NCT01817582|101759315|FG001|Received at Least 1 Dose of Study Drug|Overall Study||36||
48583946|NCT01817582|101759316|FG002|Received at Least 1 Dose of Study Drug|Overall Study||33||
48583947|NCT01817582|101759314|FG000|COMPLETED|Overall Study||31||
48583948|NCT01817582|101759315|FG001|COMPLETED|Overall Study||35||
48583949|NCT01817582|101759316|FG002|COMPLETED|Overall Study||33||
48583950|NCT01817582|101759314|FG000|NOT COMPLETED|Overall Study||2||
48583951|NCT01817582|101759315|FG001|NOT COMPLETED|Overall Study||1||
48583952|NCT01817582|101759316|FG002|NOT COMPLETED|Overall Study||0||
48583953|NCT02247440|101759317|FG000|STARTED|Overall Study||18||
48583954|NCT02247440|101759317|FG000|COMPLETED|Overall Study||14||
48583955|NCT02247440|101759317|FG000|NOT COMPLETED|Overall Study||4||
48705456|NCT00457821|102065077|FG000|STARTED|Part 1||4||
48289109|NCT02407990|101033728|FG004|COMPLETED|Overall Study||0||
48137194|NCT01562756|100661433|FG000|STARTED|Overall Study||6||
48137195|NCT01562756|100661433|FG000|COMPLETED|Overall Study||6||
48137196|NCT01562756|100661433|FG000|NOT COMPLETED|Overall Study||0||
48137197|NCT01126593|100661434|FG000|STARTED|Overall Study||33||
48137198|NCT01126593|100661435|FG001|STARTED|Overall Study||29||
48137199|NCT01126593|100661436|FG002|STARTED|Overall Study||34||
48137200|NCT01126593|100661434|FG000|COMPLETED|Overall Study||29||
48137201|NCT01126593|100661435|FG001|COMPLETED|Overall Study||27||
48137202|NCT01126593|100661436|FG002|COMPLETED|Overall Study||32||
48137203|NCT01126593|100661434|FG000|NOT COMPLETED|Overall Study||4||
48137204|NCT01126593|100661435|FG001|NOT COMPLETED|Overall Study||2||
48137205|NCT01126593|100661436|FG002|NOT COMPLETED|Overall Study||2||
48137206|NCT04348604|100661437|FG000|STARTED|Baseline (Randomized)||17||
48137207|NCT04348604|100661438|FG001|STARTED|Baseline (Randomized)||19||
48137208|NCT04348604|100661437|FG000|COMPLETED|Baseline (Randomized)||17||
48583956|NCT00256854|101759318|FG000|STARTED|Overall Study||26||
48583957|NCT00256854|101759319|FG001|STARTED|Overall Study||26||
48583958|NCT00256854|101759320|FG002|STARTED|Overall Study||26||
48583959|NCT00256854|101759321|FG003|STARTED|Overall Study||27||
48289110|NCT02407990|101033729|FG005|COMPLETED|Overall Study||0||
48289111|NCT02407990|101033730|FG006|COMPLETED|Overall Study||0||
48289112|NCT02407990|101033731|FG007|COMPLETED|Overall Study||0||
48289113|NCT02407990|101033724|FG000|NOT COMPLETED|Overall Study||3||
48401214|NCT02177812|101313708|FG003|COMPLETED|Part 2 (Up to 14 Months)||0||
48401215|NCT02177812|101313709|FG004|COMPLETED|Part 2 (Up to 14 Months)||0||
48401216|NCT02177812|101313710|FG005|COMPLETED|Part 2 (Up to 14 Months)||0||
48401217|NCT02177812|101313711|FG006|COMPLETED|Part 2 (Up to 14 Months)||0||
48401218|NCT02177812|101313712|FG007|COMPLETED|Part 2 (Up to 14 Months)||0||
48401219|NCT02177812|101313713|FG008|COMPLETED|Part 2 (Up to 14 Months)||0||
48401220|NCT02177812|101313705|FG000|NOT COMPLETED|Part 2 (Up to 14 Months)||0||
48401221|NCT02177812|101313706|FG001|NOT COMPLETED|Part 2 (Up to 14 Months)||0||
48401222|NCT02177812|101313707|FG002|NOT COMPLETED|Part 2 (Up to 14 Months)||0||
48401223|NCT02177812|101313708|FG003|NOT COMPLETED|Part 2 (Up to 14 Months)||0||
48401224|NCT02177812|101313709|FG004|NOT COMPLETED|Part 2 (Up to 14 Months)||0||
48401225|NCT02177812|101313710|FG005|NOT COMPLETED|Part 2 (Up to 14 Months)||0||
48401226|NCT02177812|101313711|FG006|NOT COMPLETED|Part 2 (Up to 14 Months)||0||
48401227|NCT02177812|101313712|FG007|NOT COMPLETED|Part 2 (Up to 14 Months)||0||
48583960|NCT00256854|101759322|FG004|STARTED|Overall Study||16||
48583961|NCT00256854|101759323|FG005|STARTED|Overall Study||14||
48583962|NCT00256854|101759318|FG000|COMPLETED|Overall Study||23||
48583963|NCT00256854|101759319|FG001|COMPLETED|Overall Study||22||
48583964|NCT00256854|101759320|FG002|COMPLETED|Overall Study||23||
48583965|NCT00256854|101759321|FG003|COMPLETED|Overall Study||24||
48583966|NCT00256854|101759322|FG004|COMPLETED|Overall Study||15||
48705457|NCT00457821|102065078|FG001|STARTED|Part 1||4||
48705458|NCT00457821|102065079|FG002|STARTED|Part 1||5||
48705459|NCT00457821|102065080|FG003|STARTED|Part 1||4||
48705460|NCT00457821|102065081|FG004|STARTED|Part 1||4||
48705461|NCT00457821|102065082|FG005|STARTED|Part 1||0||
48705462|NCT00457821|102065083|FG006|STARTED|Part 1||0||
48705463|NCT00457821|102065084|FG007|STARTED|Part 1||0||
48705464|NCT00457821|102065077|FG000|COMPLETED|Part 1||4||
48705465|NCT00457821|102065078|FG001|COMPLETED|Part 1||4||
48137209|NCT04348604|100661438|FG001|COMPLETED|Baseline (Randomized)||19||
48137210|NCT04348604|100661437|FG000|NOT COMPLETED|Baseline (Randomized)||0||
48137211|NCT04348604|100661438|FG001|NOT COMPLETED|Baseline (Randomized)||0||
48137212|NCT04348604|100661437|FG000|STARTED|Week 8||17||
48137213|NCT04348604|100661438|FG001|STARTED|Week 8||19||
48137214|NCT04348604|100661437|FG000|COMPLETED|Week 8||15||
48137215|NCT04348604|100661438|FG001|COMPLETED|Week 8||15||
48137216|NCT04348604|100661437|FG000|NOT COMPLETED|Week 8||2||
48137217|NCT04348604|100661438|FG001|NOT COMPLETED|Week 8||4||
48137218|NCT04348604|100661437|FG000|STARTED|Week 12||15||
48137219|NCT04348604|100661438|FG001|STARTED|Week 12||15||
48137220|NCT04348604|100661437|FG000|COMPLETED|Week 12||13||
48137221|NCT04348604|100661438|FG001|COMPLETED|Week 12||13||
48137222|NCT04348604|100661437|FG000|NOT COMPLETED|Week 12||2||
48137223|NCT04348604|100661438|FG001|NOT COMPLETED|Week 12||2||
48137224|NCT04348604|100661437|FG000|STARTED|Week 24||13||
48137225|NCT04348604|100661438|FG001|STARTED|Week 24||13||
48137226|NCT04348604|100661437|FG000|COMPLETED|Week 24||11||
48137227|NCT04348604|100661438|FG001|COMPLETED|Week 24||12||
48137228|NCT04348604|100661437|FG000|NOT COMPLETED|Week 24||2||
48137229|NCT04348604|100661438|FG001|NOT COMPLETED|Week 24||1||
48137230|NCT00546728|100661439|FG000|STARTED|Overall Study||25||
48137231|NCT00546728|100661440|FG001|STARTED|Overall Study||25||
48137232|NCT00546728|100661439|FG000|COMPLETED|Overall Study||25||
48137233|NCT00546728|100661440|FG001|COMPLETED|Overall Study||25||
48137234|NCT00546728|100661439|FG000|NOT COMPLETED|Overall Study||0||
48137235|NCT00546728|100661440|FG001|NOT COMPLETED|Overall Study||0||
48137236|NCT02352948|100661441|FG000|STARTED|Overall Study||62||
48137237|NCT02352948|100661442|FG001|STARTED|Overall Study||64||
48137238|NCT02352948|100661443|FG002|STARTED|Overall Study||174||
48137239|NCT02352948|100661444|FG003|STARTED|Overall Study||118||
48137240|NCT02352948|100661445|FG004|STARTED|Overall Study||117||
48289114|NCT02407990|101033725|FG001|NOT COMPLETED|Overall Study||26||
48401228|NCT02177812|101313713|FG008|NOT COMPLETED|Part 2 (Up to 14 Months)||0||
48583967|NCT00256854|101759323|FG005|COMPLETED|Overall Study||13||
48583968|NCT00256854|101759318|FG000|NOT COMPLETED|Overall Study||3||
48705466|NCT00457821|102065079|FG002|COMPLETED|Part 1||4||
48705467|NCT00457821|102065080|FG003|COMPLETED|Part 1||4||
48401229|NCT02512276|101313714|FG000|STARTED|Overall Study||2038||
48401230|NCT02512276|101313715|FG001|STARTED|Overall Study||2040||
48583969|NCT00256854|101759319|FG001|NOT COMPLETED|Overall Study||4||
48583970|NCT00256854|101759320|FG002|NOT COMPLETED|Overall Study||3||
48705468|NCT00457821|102065081|FG004|COMPLETED|Part 1||4||
48705469|NCT00457821|102065082|FG005|COMPLETED|Part 1||0||
48705470|NCT00457821|102065083|FG006|COMPLETED|Part 1||0||
48705471|NCT00457821|102065084|FG007|COMPLETED|Part 1||0||
48705472|NCT00457821|102065077|FG000|NOT COMPLETED|Part 1||0||
48583971|NCT00256854|101759321|FG003|NOT COMPLETED|Overall Study||3||
48583972|NCT00256854|101759322|FG004|NOT COMPLETED|Overall Study||1||
48583973|NCT00256854|101759323|FG005|NOT COMPLETED|Overall Study||1||
48583974|NCT05600270|101759324|FG000|STARTED|Overall Study||33||
48583975|NCT05600270|101759325|FG001|STARTED|Overall Study||33||
48583976|NCT05600270|101759324|FG000|COMPLETED|Overall Study||33||
48583977|NCT05600270|101759325|FG001|COMPLETED|Overall Study||33||
48583978|NCT05600270|101759324|FG000|NOT COMPLETED|Overall Study||0||
48583979|NCT05600270|101759325|FG001|NOT COMPLETED|Overall Study||0||
48583980|NCT01430403|101759326|FG000|STARTED|Overall Study||259||
48583981|NCT01430403|101759327|FG001|STARTED|Overall Study||130||
48583982|NCT01430403|101759328|FG002|STARTED|Overall Study||89||
48583983|NCT01430403|101759326|FG000|COMPLETED|Overall Study||242||
48705473|NCT00457821|102065078|FG001|NOT COMPLETED|Part 1||0||
48705474|NCT00457821|102065079|FG002|NOT COMPLETED|Part 1||1||
48705475|NCT00457821|102065080|FG003|NOT COMPLETED|Part 1||0||
48705476|NCT00457821|102065081|FG004|NOT COMPLETED|Part 1||0||
48705477|NCT00457821|102065082|FG005|NOT COMPLETED|Part 1||0||
48401231|NCT02512276|101313714|FG000|COMPLETED|Overall Study||2030||
48401232|NCT02512276|101313715|FG001|COMPLETED|Overall Study||2029||
48705478|NCT00457821|102065083|FG006|NOT COMPLETED|Part 1||0||
48705479|NCT00457821|102065084|FG007|NOT COMPLETED|Part 1||0||
48705480|NCT00457821|102065077|FG000|STARTED|Part 2||0||
48705481|NCT00457821|102065078|FG001|STARTED|Part 2||0||
48705482|NCT00457821|102065079|FG002|STARTED|Part 2||0||
48705483|NCT00457821|102065080|FG003|STARTED|Part 2||0||
48705484|NCT00457821|102065081|FG004|STARTED|Part 2||0||
48705485|NCT00457821|102065082|FG005|STARTED|Part 2||8||
48705486|NCT00457821|102065083|FG006|STARTED|Part 2||7||
48705487|NCT00457821|102065084|FG007|STARTED|Part 2||5||
48583984|NCT01430403|101759327|FG001|COMPLETED|Overall Study||121||
48583985|NCT01430403|101759328|FG002|COMPLETED|Overall Study||81||
48705488|NCT00457821|102065077|FG000|Completed Study Drug Treatment|Part 2||0||
48705489|NCT00457821|102065078|FG001|Completed Study Drug Treatment|Part 2||0||
48705490|NCT00457821|102065079|FG002|Completed Study Drug Treatment|Part 2||0||
48705491|NCT00457821|102065080|FG003|Completed Study Drug Treatment|Part 2||0||
48705492|NCT00457821|102065081|FG004|Completed Study Drug Treatment|Part 2||0||
48705493|NCT00457821|102065082|FG005|Completed Study Drug Treatment|Part 2||8||
48705494|NCT00457821|102065083|FG006|Completed Study Drug Treatment|Part 2||7||
48705495|NCT00457821|102065084|FG007|Completed Study Drug Treatment|Part 2||4||
48705496|NCT00457821|102065077|FG000|COMPLETED|Part 2||0||
48583986|NCT01430403|101759326|FG000|NOT COMPLETED|Overall Study||17||
48583987|NCT01430403|101759327|FG001|NOT COMPLETED|Overall Study||9||
48583988|NCT01430403|101759328|FG002|NOT COMPLETED|Overall Study||8||
48583989|NCT00750139|101759329|FG000|STARTED|Overall Study||234||
48583990|NCT00750139|101759330|FG001|STARTED|Overall Study||118||
48583991|NCT00750139|101759331|FG002|STARTED|Overall Study||236||
48583992|NCT00750139|101759332|FG003|STARTED|Overall Study||119||
48583993|NCT00750139|101759329|FG000|COMPLETED|Overall Study||145||
48705497|NCT00457821|102065078|FG001|COMPLETED|Part 2||0||
48705498|NCT00457821|102065079|FG002|COMPLETED|Part 2||0||
48289115|NCT02407990|101033726|FG002|NOT COMPLETED|Overall Study||26||
48289116|NCT02407990|101033727|FG003|NOT COMPLETED|Overall Study||7||
48289117|NCT02407990|101033728|FG004|NOT COMPLETED|Overall Study||21||
48289118|NCT02407990|101033729|FG005|NOT COMPLETED|Overall Study||20||
48289119|NCT02407990|101033730|FG006|NOT COMPLETED|Overall Study||13||
48289120|NCT02407990|101033731|FG007|NOT COMPLETED|Overall Study||335||
48289121|NCT00661479|101033732|FG000|STARTED|Overall Study||12||
48401233|NCT02512276|101313714|FG000|NOT COMPLETED|Overall Study||8||
48401234|NCT02512276|101313715|FG001|NOT COMPLETED|Overall Study||11||
48705499|NCT00457821|102065080|FG003|COMPLETED|Part 2||0||
48705500|NCT00457821|102065081|FG004|COMPLETED|Part 2||0||
48705501|NCT00457821|102065082|FG005|COMPLETED|Part 2||8||
48705502|NCT00457821|102065083|FG006|COMPLETED|Part 2||7||
48705503|NCT00457821|102065084|FG007|COMPLETED|Part 2||4||
48705504|NCT00457821|102065077|FG000|NOT COMPLETED|Part 2||0||
48705505|NCT00457821|102065078|FG001|NOT COMPLETED|Part 2||0||
48705506|NCT00457821|102065079|FG002|NOT COMPLETED|Part 2||0||
48705507|NCT00457821|102065080|FG003|NOT COMPLETED|Part 2||0||
48705508|NCT00457821|102065081|FG004|NOT COMPLETED|Part 2||0||
48705509|NCT00457821|102065082|FG005|NOT COMPLETED|Part 2||0||
48583994|NCT00750139|101759330|FG001|COMPLETED|Overall Study||59||
48705510|NCT00457821|102065083|FG006|NOT COMPLETED|Part 2||0||
48705511|NCT00457821|102065084|FG007|NOT COMPLETED|Part 2||1||
48705512|NCT02788773|102065085|FG000|STARTED|Overall Study||39||
48705513|NCT02788773|102065086|FG001|STARTED|Overall Study||13||
48705514|NCT02788773|102065085|FG000|COMPLETED|Overall Study||39||
48289122|NCT00661479|101033733|FG001|STARTED|Overall Study||3||
48289123|NCT00661479|101033734|FG002|STARTED|Overall Study||3||
48289124|NCT00661479|101033735|FG003|STARTED|Overall Study||3||
48289125|NCT00661479|101033732|FG000|COMPLETED|Overall Study||12||
48289126|NCT00661479|101033733|FG001|COMPLETED|Overall Study||3||
48289127|NCT00661479|101033734|FG002|COMPLETED|Overall Study||3||
48401235|NCT02351739|101313716|FG000|STARTED|Overall Study||38||
48401236|NCT02351739|101313717|FG001|STARTED|Overall Study||40||
48705515|NCT02788773|102065086|FG001|COMPLETED|Overall Study||13||
48401237|NCT02351739|101313716|FG000|Enrolled|Overall Study||38||
48401238|NCT02351739|101313717|FG001|Enrolled|Overall Study||40||
48401239|NCT02351739|101313716|FG000|Received Study Medication|Overall Study||35||
48583995|NCT00750139|101759331|FG002|COMPLETED|Overall Study||135||
48583996|NCT00750139|101759332|FG003|COMPLETED|Overall Study||73||
48583997|NCT00750139|101759329|FG000|NOT COMPLETED|Overall Study||89||
48583998|NCT00750139|101759330|FG001|NOT COMPLETED|Overall Study||59||
48705516|NCT02788773|102065085|FG000|NOT COMPLETED|Overall Study||0||
48705517|NCT02788773|102065086|FG001|NOT COMPLETED|Overall Study||0||
48705518|NCT02763254|102065087|FG000|STARTED|Overall Study||1||
48705519|NCT02763254|102065087|FG000|COMPLETED|Overall Study||0||
48705520|NCT02763254|102065087|FG000|NOT COMPLETED|Overall Study||1||
48705521|NCT00549900|102065088|FG000|STARTED|Overall Study||30||
48705522|NCT00549900|102065088|FG000|COMPLETED|Overall Study||29||
48705523|NCT00549900|102065088|FG000|NOT COMPLETED|Overall Study||1||
48705524|NCT00746239|102065089|FG000|STARTED|Overall Study||11||
48705525|NCT00746239|102065089|FG000|COMPLETED|Overall Study||5||
48705526|NCT00746239|102065089|FG000|NOT COMPLETED|Overall Study||6||
48705527|NCT02264665|102065090|FG000|STARTED|Overall Study||35||
48705528|NCT02264665|102065091|FG001|STARTED|Overall Study||23||
48705529|NCT02264665|102065092|FG002|STARTED|Overall Study||52||
48705530|NCT02264665|102065093|FG003|STARTED|Overall Study||30||
48705531|NCT02264665|102065094|FG004|STARTED|Overall Study||1||
48705532|NCT02264665|102065095|FG005|STARTED|Overall Study||0||
48401240|NCT02351739|101313717|FG001|Received Study Medication|Overall Study||40||
48401241|NCT02351739|101313716|FG000|Discontinued Study|Overall Study||38||
48401242|NCT02351739|101313717|FG001|Discontinued Study|Overall Study||40||
48583999|NCT00750139|101759331|FG002|NOT COMPLETED|Overall Study||101||
48584000|NCT00750139|101759332|FG003|NOT COMPLETED|Overall Study||46||
48584001|NCT04223635|101759333|FG000|STARTED|Overall Study||8||
48584002|NCT04223635|101759334|FG001|STARTED|Overall Study||8||
48584003|NCT04223635|101759333|FG000|COMPLETED|Overall Study||8||
48401243|NCT02351739|101313716|FG000|COMPLETED|Overall Study||0||
48401244|NCT02351739|101313717|FG001|COMPLETED|Overall Study||0||
48401245|NCT02351739|101313716|FG000|NOT COMPLETED|Overall Study||38||
48401246|NCT02351739|101313717|FG001|NOT COMPLETED|Overall Study||40||
48401247|NCT02699125|101313718|FG000|STARTED|Placebo||21||
48401248|NCT02699125|101313719|FG001|STARTED|Placebo||20||
48401249|NCT02699125|101313718|FG000|COMPLETED|Placebo||18||
48137241|NCT02352948|100661446|FG005|STARTED|Overall Study||60||
48137242|NCT02352948|100661441|FG000|Received Treatment|Overall Study||62||
48137243|NCT02352948|100661442|FG001|Received Treatment|Overall Study||63||
48137244|NCT02352948|100661443|FG002|Received Treatment|Overall Study||173||
48137245|NCT02352948|100661444|FG003|Received Treatment|Overall Study||110||
48137246|NCT02352948|100661445|FG004|Received Treatment|Overall Study||117||
48137247|NCT02352948|100661446|FG005|Received Treatment|Overall Study||60||
48289128|NCT00661479|101033735|FG003|COMPLETED|Overall Study||3||
48289129|NCT00661479|101033732|FG000|NOT COMPLETED|Overall Study||0||
48289130|NCT00661479|101033733|FG001|NOT COMPLETED|Overall Study||0||
48289131|NCT00661479|101033734|FG002|NOT COMPLETED|Overall Study||0||
48289132|NCT00661479|101033735|FG003|NOT COMPLETED|Overall Study||0||
48289133|NCT02288247|101033736|FG000|STARTED|Period 1: OL Treatment (Max: 315 Weeks)||688||
48289134|NCT02288247|101033737|FG001|STARTED|Period 1: OL Treatment (Max: 315 Weeks)||0||
48289135|NCT02288247|101033736|FG000|Treated|Period 1: OL Treatment (Max: 315 Weeks)||687||
48289136|NCT02288247|101033737|FG001|Treated|Period 1: OL Treatment (Max: 315 Weeks)||0||
48289137|NCT02288247|101033736|FG000|COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||41|Completed participants are those who did not have a treatment discontinuation.|
48289138|NCT02288247|101033737|FG001|COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||0|Completed participants are those who did not have a treatment discontinuation.|
48401250|NCT02699125|101313719|FG001|COMPLETED|Placebo||16||
48401251|NCT02699125|101313718|FG000|NOT COMPLETED|Placebo||3||
48401252|NCT02699125|101313719|FG001|NOT COMPLETED|Placebo||4||
48401253|NCT02699125|101313718|FG000|STARTED|First Intervention (6 Weeks).||18||
48584004|NCT04223635|101759334|FG001|COMPLETED|Overall Study||8||
48584005|NCT04223635|101759333|FG000|NOT COMPLETED|Overall Study||0||
48289139|NCT02288247|101033736|FG000|NOT COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||647||
48289140|NCT02288247|101033737|FG001|NOT COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||0||
48584006|NCT04223635|101759334|FG001|NOT COMPLETED|Overall Study||0||
48584007|NCT01075646|101759335|FG000|STARTED|Overall Study||33||
48584008|NCT01075646|101759336|FG001|STARTED|Overall Study||34||
48584009|NCT01075646|101759337|FG002|STARTED|Overall Study||53||
48584010|NCT01075646|101759338|FG003|STARTED|Overall Study||46||
48584011|NCT01075646|101759335|FG000|COMPLETED|Overall Study||29||
48584012|NCT01075646|101759336|FG001|COMPLETED|Overall Study||31||
48584013|NCT01075646|101759337|FG002|COMPLETED|Overall Study||52||
48584014|NCT01075646|101759338|FG003|COMPLETED|Overall Study||44||
48705533|NCT02264665|102065096|FG006|STARTED|Overall Study||3||
48584015|NCT01075646|101759335|FG000|NOT COMPLETED|Overall Study||4||
48584016|NCT01075646|101759336|FG001|NOT COMPLETED|Overall Study||3||
48584017|NCT01075646|101759337|FG002|NOT COMPLETED|Overall Study||1||
48584018|NCT01075646|101759338|FG003|NOT COMPLETED|Overall Study||2||
48584019|NCT00656851|101762045|FG000|STARTED|Overall Study||12||
48705534|NCT02264665|102065090|FG000|Reference Set (Full Analysis Set)|Overall Study||32||
48705535|NCT02264665|102065091|FG001|Reference Set (Full Analysis Set)|Overall Study||23||
48705536|NCT02264665|102065092|FG002|Reference Set (Full Analysis Set)|Overall Study||50||
48705537|NCT02264665|102065093|FG003|Reference Set (Full Analysis Set)|Overall Study||28||
48705538|NCT02264665|102065094|FG004|Reference Set (Full Analysis Set)|Overall Study||1||
48705539|NCT02264665|102065095|FG005|Reference Set (Full Analysis Set)|Overall Study||0||
48705540|NCT02264665|102065096|FG006|Reference Set (Full Analysis Set)|Overall Study||0||
48137248|NCT02352948|100661441|FG000|Completed Study Treatment|Overall Study||15||
48137249|NCT02352948|100661442|FG001|Completed Study Treatment|Overall Study||0||
48137250|NCT02352948|100661443|FG002|Completed Study Treatment|Overall Study||36||
48137251|NCT02352948|100661444|FG003|Completed Study Treatment|Overall Study||0||
48289141|NCT02288247|101033736|FG000|STARTED|Period 2: DB Treatment (Max: 180 Weeks)||137||
48401254|NCT02699125|101313719|FG001|STARTED|First Intervention (6 Weeks).||16||
48401255|NCT02699125|101313718|FG000|COMPLETED|First Intervention (6 Weeks).||18||
48401256|NCT02699125|101313719|FG001|COMPLETED|First Intervention (6 Weeks).||16||
48401257|NCT02699125|101313718|FG000|NOT COMPLETED|First Intervention (6 Weeks).||0||
48401258|NCT02699125|101313719|FG001|NOT COMPLETED|First Intervention (6 Weeks).||0||
48401259|NCT02699125|101313718|FG000|STARTED|Second Intervention (6 Weeks).||18||
48401260|NCT02699125|101313719|FG001|STARTED|Second Intervention (6 Weeks).||16||
48401261|NCT02699125|101313718|FG000|COMPLETED|Second Intervention (6 Weeks).||11||
48401262|NCT02699125|101313719|FG001|COMPLETED|Second Intervention (6 Weeks).||14||
48401263|NCT02699125|101313718|FG000|NOT COMPLETED|Second Intervention (6 Weeks).||7||
48401264|NCT02699125|101313719|FG001|NOT COMPLETED|Second Intervention (6 Weeks).||2||
48401265|NCT02079519|101313720|FG000|STARTED|Overall Study||10||
48401266|NCT02079519|101313720|FG000|COMPLETED|Overall Study||0||
48584020|NCT00656851|101762046|FG001|STARTED|Overall Study||12||
48584021|NCT00656851|101762045|FG000|COMPLETED|Overall Study||12||
48584022|NCT00656851|101762046|FG001|COMPLETED|Overall Study||8||
48584023|NCT00656851|101762045|FG000|NOT COMPLETED|Overall Study||0||
48584024|NCT00656851|101762046|FG001|NOT COMPLETED|Overall Study||4||
48584025|NCT00438100|101762047|FG000|STARTED|Overall Study||73||
48584026|NCT00438100|101762048|FG001|STARTED|Overall Study||69||
48584027|NCT00438100|101762047|FG000|COMPLETED|Overall Study||71||
48584028|NCT00438100|101762048|FG001|COMPLETED|Overall Study||65||
48584029|NCT00438100|101762047|FG000|NOT COMPLETED|Overall Study||2||
48584030|NCT00438100|101762048|FG001|NOT COMPLETED|Overall Study||4||
48584031|NCT03089697|101762049|FG000|STARTED|Overall Study||13||
48289142|NCT02288247|101033737|FG001|STARTED|Period 2: DB Treatment (Max: 180 Weeks)||136||
48289143|NCT02288247|101033736|FG000|Treated|Period 2: DB Treatment (Max: 180 Weeks)||136||
48289144|NCT02288247|101033737|FG001|Treated|Period 2: DB Treatment (Max: 180 Weeks)||135||
48289145|NCT02288247|101033736|FG000|COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||1|Completed participants are those who did not have a treatment discontinuation. Not completed participants discontinued treatment but are still ongoing the study.|
48289146|NCT02288247|101033737|FG001|COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||1|Completed participants are those who did not have a treatment discontinuation. Not completed participants discontinued treatment but are still ongoing the study.|
48289147|NCT02288247|101033736|FG000|NOT COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||136||
48289148|NCT02288247|101033737|FG001|NOT COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||135||
48289149|NCT03730480|101033738|FG000|STARTED|Overall Study||372||
48289150|NCT03730480|101033738|FG000|COMPLETED|Overall Study||371||
48289151|NCT03730480|101033738|FG000|NOT COMPLETED|Overall Study||1||
48289152|NCT01296347|101033739|FG000|STARTED|Allocation||38||
48289153|NCT01296347|101033740|FG001|STARTED|Allocation||39||
48289154|NCT01296347|101033739|FG000|COMPLETED|Allocation||35||
48289155|NCT01296347|101033740|FG001|COMPLETED|Allocation||35||
48584032|NCT03089697|101762050|FG001|STARTED|Overall Study||12||
48289156|NCT01296347|101033739|FG000|NOT COMPLETED|Allocation||3||
48289157|NCT01296347|101033740|FG001|NOT COMPLETED|Allocation||4||
48289158|NCT01296347|101033739|FG000|STARTED|6 Week Follow up||35||
48289159|NCT01296347|101033740|FG001|STARTED|6 Week Follow up||35||
48289160|NCT01296347|101033739|FG000|COMPLETED|6 Week Follow up||35||
48289161|NCT01296347|101033740|FG001|COMPLETED|6 Week Follow up||34||
48289162|NCT01296347|101033739|FG000|NOT COMPLETED|6 Week Follow up||0||
48289163|NCT01296347|101033740|FG001|NOT COMPLETED|6 Week Follow up||1||
48289164|NCT01296347|101033739|FG000|STARTED|3 Month Follow up||35||
48289165|NCT01296347|101033740|FG001|STARTED|3 Month Follow up||34||
48289166|NCT01296347|101033739|FG000|COMPLETED|3 Month Follow up||34||
48289167|NCT01296347|101033740|FG001|COMPLETED|3 Month Follow up||33||
48289168|NCT01296347|101033739|FG000|NOT COMPLETED|3 Month Follow up||1||
48289169|NCT01296347|101033740|FG001|NOT COMPLETED|3 Month Follow up||1||
48289170|NCT01296347|101033739|FG000|STARTED|6 Month Follow up||34||
48584033|NCT03089697|101762049|FG000|COMPLETED|Overall Study||11||
48584034|NCT03089697|101762050|FG001|COMPLETED|Overall Study||10||
48584035|NCT03089697|101762049|FG000|NOT COMPLETED|Overall Study||2||
48705541|NCT02264665|102065090|FG000|Safety Set|Overall Study||35||
48705542|NCT02264665|102065091|FG001|Safety Set|Overall Study||23||
48705543|NCT02264665|102065092|FG002|Safety Set|Overall Study||52||
48705544|NCT02264665|102065093|FG003|Safety Set|Overall Study||30||
48705545|NCT02264665|102065094|FG004|Safety Set|Overall Study||1||
48705546|NCT02264665|102065095|FG005|Safety Set|Overall Study||0||
48705547|NCT02264665|102065096|FG006|Safety Set|Overall Study||0||
48705548|NCT02264665|102065090|FG000|COMPLETED|Overall Study||22||
48705549|NCT02264665|102065091|FG001|COMPLETED|Overall Study||15||
48705550|NCT02264665|102065092|FG002|COMPLETED|Overall Study||31||
48705551|NCT02264665|102065093|FG003|COMPLETED|Overall Study||21||
48705552|NCT02264665|102065094|FG004|COMPLETED|Overall Study||1||
48705553|NCT02264665|102065095|FG005|COMPLETED|Overall Study||0||
48705554|NCT02264665|102065096|FG006|COMPLETED|Overall Study||0||
48705555|NCT02264665|102065090|FG000|NOT COMPLETED|Overall Study||13||
48705556|NCT02264665|102065091|FG001|NOT COMPLETED|Overall Study||8||
48705557|NCT02264665|102065092|FG002|NOT COMPLETED|Overall Study||21||
48705558|NCT02264665|102065093|FG003|NOT COMPLETED|Overall Study||9||
48289171|NCT01296347|101033740|FG001|STARTED|6 Month Follow up||33||
48289172|NCT01296347|101033739|FG000|COMPLETED|6 Month Follow up||32||
48289173|NCT01296347|101033740|FG001|COMPLETED|6 Month Follow up||31||
48289174|NCT01296347|101033739|FG000|NOT COMPLETED|6 Month Follow up||2||
48289175|NCT01296347|101033740|FG001|NOT COMPLETED|6 Month Follow up||2||
48289176|NCT01296347|101033739|FG000|STARTED|12 Month Follow up||32||
48289177|NCT01296347|101033740|FG001|STARTED|12 Month Follow up||31||
48705559|NCT02264665|102065094|FG004|NOT COMPLETED|Overall Study||0||
48705560|NCT02264665|102065095|FG005|NOT COMPLETED|Overall Study||0||
48289178|NCT01296347|101033739|FG000|COMPLETED|12 Month Follow up||28||
48289179|NCT01296347|101033740|FG001|COMPLETED|12 Month Follow up||28||
48289180|NCT01296347|101033739|FG000|NOT COMPLETED|12 Month Follow up||4||
48289181|NCT01296347|101033740|FG001|NOT COMPLETED|12 Month Follow up||3||
48584036|NCT03089697|101762050|FG001|NOT COMPLETED|Overall Study||2||
48584037|NCT03881696|101762051|FG000|STARTED|Overall Study||120||
48584038|NCT03881696|101762052|FG001|STARTED|Overall Study||60||
48584039|NCT03881696|101762051|FG000|COMPLETED|Overall Study||114||
48584040|NCT03881696|101762052|FG001|COMPLETED|Overall Study||60||
48584041|NCT03881696|101762051|FG000|NOT COMPLETED|Overall Study||6||
48584042|NCT03881696|101762052|FG001|NOT COMPLETED|Overall Study||0||
48584043|NCT03200704|101762053|FG000|STARTED|Overall Study||152||
48584044|NCT03200704|101762053|FG000|COMPLETED|Overall Study||151||
48137252|NCT02352948|100661445|FG004|Completed Study Treatment|Overall Study||23||
48401267|NCT02079519|101313720|FG000|NOT COMPLETED|Overall Study||10||
48584045|NCT03200704|101762053|FG000|NOT COMPLETED|Overall Study||1||
48584046|NCT01106677|101762054|FG000|STARTED|Core Period: Baseline to Week 26||183||
48584047|NCT01106677|101762055|FG001|STARTED|Core Period: Baseline to Week 26||368||
48584048|NCT01106677|101762056|FG002|STARTED|Core Period: Baseline to Week 26||367||
48584049|NCT01106677|101762057|FG003|STARTED|Core Period: Baseline to Week 26||366||
48705561|NCT02264665|102065096|FG006|NOT COMPLETED|Overall Study||3||
48705562|NCT04051710|102065097|FG000|STARTED|Overall Study||620||
48705563|NCT04051710|102065098|FG001|STARTED|Overall Study||620||
48705564|NCT04051710|102065099|FG002|STARTED|Overall Study||310||
48705565|NCT04051710|102065097|FG000|COMPLETED|Overall Study||616||
48137253|NCT02352948|100661446|FG005|Completed Study Treatment|Overall Study||4||
48705566|NCT04051710|102065098|FG001|COMPLETED|Overall Study||612||
48705567|NCT04051710|102065099|FG002|COMPLETED|Overall Study||306||
48705568|NCT04051710|102065097|FG000|NOT COMPLETED|Overall Study||4||
48705569|NCT04051710|102065098|FG001|NOT COMPLETED|Overall Study||8||
48137254|NCT02352948|100661441|FG000|COMPLETED|Overall Study||13|Completed the Study|
48137255|NCT02352948|100661442|FG001|COMPLETED|Overall Study||5|Completed the Study|
48705570|NCT04051710|102065099|FG002|NOT COMPLETED|Overall Study||4||
48705571|NCT03804021|102065100|FG000|STARTED|Overall Study||2||
48705572|NCT03804021|102065101|FG001|STARTED|Overall Study||2||
48705573|NCT03804021|102065102|FG002|STARTED|Overall Study||2||
48705574|NCT03804021|102065100|FG000|COMPLETED|Overall Study||2||
48137256|NCT02352948|100661443|FG002|COMPLETED|Overall Study||45|Completed the Study|
48137257|NCT02352948|100661444|FG003|COMPLETED|Overall Study||19|Completed the Study|
48137258|NCT02352948|100661445|FG004|COMPLETED|Overall Study||29|Completed the Study|
48137259|NCT02352948|100661446|FG005|COMPLETED|Overall Study||11|Completed the Study|
48137260|NCT02352948|100661441|FG000|NOT COMPLETED|Overall Study||49||
48137261|NCT02352948|100661442|FG001|NOT COMPLETED|Overall Study||59||
48137262|NCT02352948|100661443|FG002|NOT COMPLETED|Overall Study||129||
48137263|NCT02352948|100661444|FG003|NOT COMPLETED|Overall Study||99||
48137264|NCT02352948|100661445|FG004|NOT COMPLETED|Overall Study||88||
48137265|NCT02352948|100661446|FG005|NOT COMPLETED|Overall Study||49||
48137266|NCT00626522|100661447|FG000|STARTED|Overall Study||121||
48137267|NCT00626522|100661448|FG001|STARTED|Overall Study||120||
48137268|NCT00626522|100661449|FG002|STARTED|Overall Study||125||
48137269|NCT00626522|100661450|FG003|STARTED|Overall Study||76||
48137270|NCT00626522|100661451|FG004|STARTED|Overall Study||65||
48137271|NCT00626522|100661452|FG005|STARTED|Overall Study||59||
48137272|NCT00626522|100661447|FG000|COMPLETED|Overall Study||115||
48289182|NCT03625895|101033741|FG000|STARTED|Overall Study||1826||
48289183|NCT03625895|101033741|FG000|COMPLETED|Overall Study||1241||
48289184|NCT03625895|101033741|FG000|NOT COMPLETED|Overall Study||585||
48289185|NCT00591721|101033742|FG000|STARTED|Overall Study||89||
48289186|NCT00591721|101033743|FG001|STARTED|Overall Study||92||
48289187|NCT00591721|101033742|FG000|COMPLETED|Overall Study||68||
48289188|NCT00591721|101033743|FG001|COMPLETED|Overall Study||70||
48289189|NCT00591721|101033742|FG000|NOT COMPLETED|Overall Study||21||
48289190|NCT00591721|101033743|FG001|NOT COMPLETED|Overall Study||22||
48289191|NCT00836095|101033744|FG000|STARTED|Overall Study||22||
48289192|NCT00836095|101033745|FG001|STARTED|Overall Study||30||
48289193|NCT00836095|101033744|FG000|COMPLETED|Overall Study||22||
48289194|NCT00836095|101033745|FG001|COMPLETED|Overall Study||27||
48289195|NCT00836095|101033744|FG000|NOT COMPLETED|Overall Study||0||
48289196|NCT00836095|101033745|FG001|NOT COMPLETED|Overall Study||3||
48289197|NCT04555031|101033746|FG000|STARTED|Overall Study||10||
48289198|NCT04555031|101033746|FG000|COMPLETED|Overall Study||10||
48289199|NCT04555031|101033746|FG000|NOT COMPLETED|Overall Study||0||
48289200|NCT03567434|101033747|FG000|STARTED|Overall Study||16||
48289201|NCT03567434|101033748|FG001|STARTED|Overall Study||22||
48289202|NCT03567434|101033747|FG000|Completed Test 1|Overall Study||16||
48289203|NCT03567434|101033748|FG001|Completed Test 1|Overall Study||22||
48705575|NCT03804021|102065101|FG001|COMPLETED|Overall Study||2||
48289204|NCT03567434|101033747|FG000|Completed Test 2|Overall Study||15||
48289205|NCT03567434|101033748|FG001|Completed Test 2|Overall Study||19||
48289206|NCT03567434|101033747|FG000|COMPLETED|Overall Study||15||
48289207|NCT03567434|101033748|FG001|COMPLETED|Overall Study||19||
48401268|NCT00910728|101313721|FG000|STARTED|Overall Study||6||
48584050|NCT01106677|101762054|FG000|COMPLETED|Core Period: Baseline to Week 26||155||
48584051|NCT01106677|101762055|FG001|COMPLETED|Core Period: Baseline to Week 26||322||
48584052|NCT01106677|101762056|FG002|COMPLETED|Core Period: Baseline to Week 26||323||
48584053|NCT01106677|101762057|FG003|COMPLETED|Core Period: Baseline to Week 26||319||
48137273|NCT00626522|100661448|FG001|COMPLETED|Overall Study||113||
48137274|NCT00626522|100661449|FG002|COMPLETED|Overall Study||117||
48137275|NCT00626522|100661450|FG003|COMPLETED|Overall Study||74||
48137276|NCT00626522|100661451|FG004|COMPLETED|Overall Study||58||
48137277|NCT00626522|100661452|FG005|COMPLETED|Overall Study||57||
48137278|NCT00626522|100661447|FG000|NOT COMPLETED|Overall Study||6||
48137279|NCT00626522|100661448|FG001|NOT COMPLETED|Overall Study||7||
48137280|NCT00626522|100661449|FG002|NOT COMPLETED|Overall Study||8||
48137281|NCT00626522|100661450|FG003|NOT COMPLETED|Overall Study||2||
48137282|NCT00626522|100661451|FG004|NOT COMPLETED|Overall Study||7||
48137283|NCT00626522|100661452|FG005|NOT COMPLETED|Overall Study||2||
48137284|NCT01310036|100661453|FG000|STARTED|Overall Study||208||
48137285|NCT01310036|100661453|FG000|COMPLETED|Overall Study||6||
48137286|NCT01310036|100661453|FG000|NOT COMPLETED|Overall Study||202||
48137287|NCT03082963|100661454|FG000|STARTED|Overall Study||10||
48137288|NCT03082963|100661454|FG000|COMPLETED|Overall Study||10||
48137289|NCT03082963|100661454|FG000|NOT COMPLETED|Overall Study||0||
48137290|NCT02599194|100661455|FG000|STARTED|Overall Study||7||
48401269|NCT00910728|101313722|FG001|STARTED|Overall Study||3||
48401270|NCT00910728|101313723|FG002|STARTED|Overall Study||3||
48401271|NCT00910728|101313724|FG003|STARTED|Overall Study||3||
48401272|NCT00910728|101313725|FG004|STARTED|Overall Study||6||
48401273|NCT00910728|101313726|FG005|STARTED|Overall Study||1||
48401274|NCT00910728|101313727|FG006|STARTED|Overall Study||6||
48401275|NCT00910728|101313728|FG007|STARTED|Overall Study||4||
48401276|NCT00910728|101313729|FG008|STARTED|Overall Study||3||
48401277|NCT00910728|101313721|FG000|COMPLETED|Overall Study||0||
48137291|NCT02599194|100661455|FG000|COMPLETED|Overall Study||7||
48137292|NCT02599194|100661455|FG000|NOT COMPLETED|Overall Study||0||
48137293|NCT02370602|100661456|FG000|STARTED|Overall Study||1||
48137294|NCT02370602|100661457|FG001|STARTED|Overall Study||2||
48137295|NCT02370602|100661458|FG002|STARTED|Overall Study||2||
48137296|NCT02370602|100661459|FG003|STARTED|Overall Study||3||
48137297|NCT02370602|100661460|FG004|STARTED|Overall Study||3||
48137298|NCT02370602|100661461|FG005|STARTED|Overall Study||2||
48137299|NCT02370602|100661456|FG000|COMPLETED|Overall Study||0||
48137300|NCT02370602|100661457|FG001|COMPLETED|Overall Study||2||
48137301|NCT02370602|100661458|FG002|COMPLETED|Overall Study||2||
48401278|NCT00910728|101313722|FG001|COMPLETED|Overall Study||0||
48401279|NCT00910728|101313723|FG002|COMPLETED|Overall Study||0||
48401280|NCT00910728|101313724|FG003|COMPLETED|Overall Study||0||
48401281|NCT00910728|101313725|FG004|COMPLETED|Overall Study||1||
48401282|NCT00910728|101313726|FG005|COMPLETED|Overall Study||0||
48401283|NCT00910728|101313727|FG006|COMPLETED|Overall Study||0||
48401284|NCT00910728|101313728|FG007|COMPLETED|Overall Study||1||
48137302|NCT02370602|100661459|FG003|COMPLETED|Overall Study||3||
48137303|NCT02370602|100661460|FG004|COMPLETED|Overall Study||3||
48137304|NCT02370602|100661461|FG005|COMPLETED|Overall Study||2||
48137305|NCT02370602|100661456|FG000|NOT COMPLETED|Overall Study||1||
48137306|NCT02370602|100661457|FG001|NOT COMPLETED|Overall Study||0||
48137307|NCT02370602|100661458|FG002|NOT COMPLETED|Overall Study||0||
48137308|NCT02370602|100661459|FG003|NOT COMPLETED|Overall Study||0||
48137309|NCT02370602|100661460|FG004|NOT COMPLETED|Overall Study||0||
48137310|NCT02370602|100661461|FG005|NOT COMPLETED|Overall Study||0||
48401285|NCT00910728|101313729|FG008|COMPLETED|Overall Study||0||
48401286|NCT00910728|101313721|FG000|NOT COMPLETED|Overall Study||6||
48401287|NCT00910728|101313722|FG001|NOT COMPLETED|Overall Study||3||
48401288|NCT00910728|101313723|FG002|NOT COMPLETED|Overall Study||3||
48401289|NCT00910728|101313724|FG003|NOT COMPLETED|Overall Study||3||
48401290|NCT00910728|101313725|FG004|NOT COMPLETED|Overall Study||5||
48401291|NCT00910728|101313726|FG005|NOT COMPLETED|Overall Study||1||
48401292|NCT00910728|101313727|FG006|NOT COMPLETED|Overall Study||6||
48401293|NCT00910728|101313728|FG007|NOT COMPLETED|Overall Study||3||
48401294|NCT00910728|101313729|FG008|NOT COMPLETED|Overall Study||3||
48401295|NCT02658968|101313730|FG000|STARTED|Received Rituximab||3||
48401296|NCT02658968|101313731|FG001|STARTED|Received Rituximab||3||
48401297|NCT02658968|101313732|FG002|STARTED|Received Rituximab||3||
48401298|NCT02658968|101313733|FG003|STARTED|Received Rituximab||7||
48401299|NCT02658968|101313734|FG004|STARTED|Received Rituximab||2||
48401300|NCT02658968|101313730|FG000|COMPLETED|Received Rituximab||3||
48401301|NCT02658968|101313731|FG001|COMPLETED|Received Rituximab||3||
48401302|NCT02658968|101313732|FG002|COMPLETED|Received Rituximab||3||
48401303|NCT02658968|101313733|FG003|COMPLETED|Received Rituximab||7||
48401304|NCT02658968|101313734|FG004|COMPLETED|Received Rituximab||0||
48401305|NCT02658968|101313730|FG000|NOT COMPLETED|Received Rituximab||0||
48401306|NCT02658968|101313731|FG001|NOT COMPLETED|Received Rituximab||0||
48401307|NCT02658968|101313732|FG002|NOT COMPLETED|Received Rituximab||0||
48137311|NCT00071487|100661462|FG000|STARTED|52-Week Double-Blind Period||113||
48584054|NCT01106677|101762054|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||28||
48584055|NCT01106677|101762055|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||46||
48705576|NCT03804021|102065102|FG002|COMPLETED|Overall Study||2||
48705577|NCT03804021|102065100|FG000|NOT COMPLETED|Overall Study||0||
48705578|NCT03804021|102065101|FG001|NOT COMPLETED|Overall Study||0||
48705579|NCT03804021|102065102|FG002|NOT COMPLETED|Overall Study||0||
48137312|NCT00071487|100661463|FG001|STARTED|52-Week Double-Blind Period||114||
48137313|NCT00071487|100661464|FG002|STARTED|52-Week Double-Blind Period||111||
48137314|NCT00071487|100661465|FG003|STARTED|52-Week Double-Blind Period||111||
48584056|NCT01106677|101762056|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||44||
48584057|NCT01106677|101762057|FG003|NOT COMPLETED|Core Period: Baseline to Week 26||47||
48584058|NCT01106677|101762054|FG000|STARTED|Extension Period: Week 26 to Week 52||153||
48584059|NCT01106677|101762055|FG001|STARTED|Extension Period: Week 26 to Week 52||316||
48584060|NCT01106677|101762056|FG002|STARTED|Extension Period: Week 26 to Week 52||321||
48584061|NCT01106677|101762057|FG003|STARTED|Extension Period: Week 26 to Week 52||313||
48584062|NCT01106677|101762054|FG000|COMPLETED|Extension Period: Week 26 to Week 52||138||
48584063|NCT01106677|101762055|FG001|COMPLETED|Extension Period: Week 26 to Week 52||298||
48584064|NCT01106677|101762056|FG002|COMPLETED|Extension Period: Week 26 to Week 52||299||
48584065|NCT01106677|101762057|FG003|COMPLETED|Extension Period: Week 26 to Week 52||285||
48584066|NCT01106677|101762054|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||15||
48584067|NCT01106677|101762055|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||18||
48584068|NCT01106677|101762056|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||22||
48584069|NCT01106677|101762057|FG003|NOT COMPLETED|Extension Period: Week 26 to Week 52||28||
48584070|NCT06207149|101762058|FG000|STARTED|Overall Study||24||
48584071|NCT06207149|101762059|FG001|STARTED|Overall Study||24||
48584072|NCT06207149|101762058|FG000|COMPLETED|Overall Study||17||
48584073|NCT06207149|101762059|FG001|COMPLETED|Overall Study||13||
48584074|NCT06207149|101762058|FG000|NOT COMPLETED|Overall Study||7||
48584075|NCT06207149|101762059|FG001|NOT COMPLETED|Overall Study||11||
48584076|NCT04798989|101762060|FG000|STARTED|Overall Study||6||
48584077|NCT04798989|101762061|FG001|STARTED|Overall Study||6||
48584078|NCT04798989|101762060|FG000|COMPLETED|Overall Study||6||
48584079|NCT04798989|101762061|FG001|COMPLETED|Overall Study||6||
48584080|NCT04798989|101762060|FG000|NOT COMPLETED|Overall Study||0||
48584081|NCT04798989|101762061|FG001|NOT COMPLETED|Overall Study||0||
48584082|NCT00474201|101762062|FG000|STARTED|Overall Study||15||
48584083|NCT00474201|101762062|FG000|COMPLETED|Overall Study||15||
48584084|NCT00474201|101762062|FG000|NOT COMPLETED|Overall Study||0||
48584085|NCT02764801|101762063|FG000|STARTED|Overall Study||131||
48584086|NCT02764801|101762063|FG000|COMPLETED|Overall Study||103||
48584087|NCT02764801|101762063|FG000|NOT COMPLETED|Overall Study||28||
48584088|NCT02004886|101762064|FG000|STARTED|Overall Study||19||
48584089|NCT02004886|101762065|FG001|STARTED|Overall Study||18||
48584090|NCT02004886|101762066|FG002|STARTED|Overall Study||18||
48584091|NCT02004886|101762067|FG003|STARTED|Overall Study||19||
48584092|NCT02004886|101762064|FG000|COMPLETED|Overall Study||18||
48584093|NCT02004886|101762065|FG001|COMPLETED|Overall Study||17||
48584094|NCT02004886|101762066|FG002|COMPLETED|Overall Study||18||
48584095|NCT02004886|101762067|FG003|COMPLETED|Overall Study||19||
48584096|NCT02004886|101762064|FG000|NOT COMPLETED|Overall Study||1||
48584097|NCT02004886|101762065|FG001|NOT COMPLETED|Overall Study||1||
48705580|NCT01740089|102065103|FG000|STARTED|First 12 Weeks of Treatment||50||
48705581|NCT01740089|102065104|FG001|STARTED|First 12 Weeks of Treatment||50||
48705582|NCT01740089|102065105|FG002|STARTED|First 12 Weeks of Treatment||50||
48705583|NCT01740089|102065103|FG000|COMPLETED|First 12 Weeks of Treatment||50||
48705584|NCT01740089|102065104|FG001|COMPLETED|First 12 Weeks of Treatment||48||
48137315|NCT00071487|100661462|FG000|COMPLETED|52-Week Double-Blind Period||93||
48137316|NCT00071487|100661463|FG001|COMPLETED|52-Week Double-Blind Period||87||
48584098|NCT02004886|101762066|FG002|NOT COMPLETED|Overall Study||0||
48584099|NCT02004886|101762067|FG003|NOT COMPLETED|Overall Study||0||
48584100|NCT01188876|101762068|FG000|STARTED|Overall Study||50||
48584101|NCT01188876|101762068|FG000|COMPLETED|Overall Study||50||
48584102|NCT01188876|101762068|FG000|NOT COMPLETED|Overall Study||0||
48584103|NCT03153982|101762069|FG000|STARTED|Overall Study||16||
48584104|NCT03153982|101762069|FG000|COMPLETED|Overall Study||16||
48584105|NCT03153982|101762069|FG000|NOT COMPLETED|Overall Study||0||
48584106|NCT02410798|101762070|FG000|STARTED|Overall Study||12||
48584107|NCT02410798|101762070|FG000|COMPLETED|Overall Study||12||
48584108|NCT02410798|101762070|FG000|NOT COMPLETED|Overall Study||0||
48584109|NCT01880086|101762071|FG000|STARTED|Overall Study||6||
48584110|NCT01880086|101762072|FG001|STARTED|Overall Study||7||
48584111|NCT01880086|101762071|FG000|COMPLETED|Overall Study||5||
48584112|NCT01880086|101762072|FG001|COMPLETED|Overall Study||6||
48584113|NCT01880086|101762071|FG000|NOT COMPLETED|Overall Study||1||
48584114|NCT01880086|101762072|FG001|NOT COMPLETED|Overall Study||1||
48584115|NCT04934189|101762073|FG000|STARTED|Overall Study||60||
48584116|NCT04934189|101762073|FG000|COMPLETED|Overall Study||39||
48584117|NCT04934189|101762073|FG000|NOT COMPLETED|Overall Study||21||
48584118|NCT02901275|101762074|FG000|STARTED|Overall Study||29||
48584119|NCT02901275|101762074|FG000|Placebo + Placebo|Overall Study||29||
48584120|NCT02901275|101762074|FG000|Hydromorphone (Oral) 4mg + Placebo|Overall Study||29||
48584121|NCT02901275|101762074|FG000|Hydromorphone (Oral) 4mg + Dronabinol (Oral) 2.5mg|Overall Study||29||
48584122|NCT02901275|101762074|FG000|Hydromorphone (Oral) 4mg + Dronabinol (Oral) 5mg|Overall Study||29||
48584123|NCT02901275|101762074|FG000|Hydromorphone (Oral) 4mg + Dronabinol (Oral) 10mg|Overall Study||29||
48584124|NCT02901275|101762074|FG000|COMPLETED|Overall Study||29||
48584125|NCT02901275|101762074|FG000|NOT COMPLETED|Overall Study||0||
48584126|NCT03098498|101762075|FG000|STARTED|Overall Study||22||
48584127|NCT03098498|101762076|FG001|STARTED|Overall Study||22||
48584128|NCT03098498|101762075|FG000|COMPLETED|Overall Study||22||
48137317|NCT00071487|100661464|FG002|COMPLETED|52-Week Double-Blind Period||94||
48137318|NCT00071487|100661465|FG003|COMPLETED|52-Week Double-Blind Period||90||
48137319|NCT00071487|100661462|FG000|NOT COMPLETED|52-Week Double-Blind Period||20||
48137320|NCT00071487|100661463|FG001|NOT COMPLETED|52-Week Double-Blind Period||27||
48137321|NCT00071487|100661464|FG002|NOT COMPLETED|52-Week Double-Blind Period||17||
48137322|NCT00071487|100661465|FG003|NOT COMPLETED|52-Week Double-Blind Period||21||
48137323|NCT00071487|100661462|FG000|STARTED|24-Week Open-Label Extension Period||0||
48137324|NCT00071487|100661463|FG001|STARTED|24-Week Open-Label Extension Period||19||
48137325|NCT00071487|100661464|FG002|STARTED|24-Week Open-Label Extension Period||24||
48137326|NCT00071487|100661465|FG003|STARTED|24-Week Open-Label Extension Period||302||
48137327|NCT00071487|100661462|FG000|COMPLETED|24-Week Open-Label Extension Period||0||
48137328|NCT00071487|100661463|FG001|COMPLETED|24-Week Open-Label Extension Period||19||
48137329|NCT00071487|100661464|FG002|COMPLETED|24-Week Open-Label Extension Period||23||
48137330|NCT00071487|100661465|FG003|COMPLETED|24-Week Open-Label Extension Period||279||
48137331|NCT00071487|100661462|FG000|NOT COMPLETED|24-Week Open-Label Extension Period||0||
48137332|NCT00071487|100661463|FG001|NOT COMPLETED|24-Week Open-Label Extension Period||0||
48137333|NCT00071487|100661464|FG002|NOT COMPLETED|24-Week Open-Label Extension Period||1||
48137334|NCT00071487|100661465|FG003|NOT COMPLETED|24-Week Open-Label Extension Period||23||
48137335|NCT00295750|100661466|FG000|STARTED|Overall Study||206||
48137336|NCT00295750|100661467|FG001|STARTED|Overall Study||210||
48137337|NCT00295750|100661468|FG002|STARTED|Overall Study||204||
48137338|NCT00295750|100661466|FG000|Intent-to-treat (ITT) Population|Overall Study||202||
48137339|NCT00295750|100661467|FG001|Intent-to-treat (ITT) Population|Overall Study||207||
48137340|NCT00295750|100661468|FG002|Intent-to-treat (ITT) Population|Overall Study||201||
48137341|NCT00295750|100661466|FG000|COMPLETED|Overall Study||163||
48137342|NCT00295750|100661467|FG001|COMPLETED|Overall Study||169||
48137343|NCT00295750|100661468|FG002|COMPLETED|Overall Study||172||
48584129|NCT03098498|101762076|FG001|COMPLETED|Overall Study||22||
48584130|NCT03098498|101762075|FG000|NOT COMPLETED|Overall Study||0||
48584131|NCT03098498|101762076|FG001|NOT COMPLETED|Overall Study||0||
48137344|NCT00295750|100661466|FG000|NOT COMPLETED|Overall Study||43||
48137345|NCT00295750|100661467|FG001|NOT COMPLETED|Overall Study||41||
48137346|NCT00295750|100661468|FG002|NOT COMPLETED|Overall Study||32||
48137347|NCT03105362|100661469|FG000|STARTED|Overall Study||4||
48137348|NCT03105362|100661469|FG000|Completed 1 Week of Study|Overall Study||4||
48137349|NCT03105362|100661469|FG000|Completed 2 Weeks of Study|Overall Study||3||
48137350|NCT03105362|100661469|FG000|Completed 2 Week Questionaire|Overall Study||2||
48137351|NCT03105362|100661469|FG000|COMPLETED|Overall Study||2||
48137352|NCT03105362|100661469|FG000|NOT COMPLETED|Overall Study||2||
48584132|NCT02161484|101762077|FG000|STARTED|Overall Study||5||
48584133|NCT02161484|101762078|FG001|STARTED|Overall Study||5||
48584134|NCT02161484|101762077|FG000|COMPLETED|Overall Study||1||
48584135|NCT02161484|101762078|FG001|COMPLETED|Overall Study||2||
48584136|NCT02161484|101762077|FG000|NOT COMPLETED|Overall Study||4||
48584137|NCT02161484|101762078|FG001|NOT COMPLETED|Overall Study||3||
48584138|NCT00828074|101762079|FG000|STARTED|Overall Study||6||
48584139|NCT00828074|101762080|FG001|STARTED|Overall Study||5||
48584140|NCT00828074|101762081|FG002|STARTED|Overall Study||35||
48584141|NCT00828074|101762079|FG000|COMPLETED|Overall Study||6||
48137353|NCT01109992|100661470|FG000|STARTED|Overall Study||11|Subjects screened|
48137354|NCT01109992|100661471|FG001|STARTED|Overall Study||32|Subjects screened|
48137355|NCT01109992|100661470|FG000|Subjects Enrolled|Overall Study||11||
48137356|NCT01109992|100661471|FG001|Subjects Enrolled|Overall Study||32||
48137357|NCT01109992|100661470|FG000|COMPLETED|Overall Study||11||
48137358|NCT01109992|100661471|FG001|COMPLETED|Overall Study||30||
48137359|NCT01109992|100661470|FG000|NOT COMPLETED|Overall Study||0||
48137360|NCT01109992|100661471|FG001|NOT COMPLETED|Overall Study||2||
48137361|NCT03449030|100661472|FG000|STARTED|Overall Study||1||
48137362|NCT03449030|100661473|FG001|STARTED|Overall Study||1||
48137363|NCT03449030|100661474|FG002|STARTED|Overall Study||1||
48137364|NCT03449030|100661475|FG003|STARTED|Overall Study||5||
48137365|NCT03449030|100661476|FG004|STARTED|Overall Study||7||
48137366|NCT03449030|100661477|FG005|STARTED|Overall Study||7||
48137367|NCT03449030|100661478|FG006|STARTED|Overall Study||2||
48137368|NCT03449030|100661479|FG007|STARTED|Overall Study||3||
48137369|NCT03449030|100661480|FG008|STARTED|Overall Study||3||
48137370|NCT03449030|100661481|FG009|STARTED|Overall Study||1||
48137371|NCT03449030|100661472|FG000|COMPLETED|Overall Study||0||
48137372|NCT03449030|100661473|FG001|COMPLETED|Overall Study||0||
48137373|NCT03449030|100661474|FG002|COMPLETED|Overall Study||0||
48137374|NCT03449030|100661475|FG003|COMPLETED|Overall Study||0||
48137375|NCT03449030|100661476|FG004|COMPLETED|Overall Study||0||
48137376|NCT03449030|100661477|FG005|COMPLETED|Overall Study||0||
48137377|NCT03449030|100661478|FG006|COMPLETED|Overall Study||0||
48137378|NCT03449030|100661479|FG007|COMPLETED|Overall Study||0||
48137379|NCT03449030|100661480|FG008|COMPLETED|Overall Study||0||
48137380|NCT03449030|100661481|FG009|COMPLETED|Overall Study||0||
48137381|NCT03449030|100661472|FG000|NOT COMPLETED|Overall Study||1||
48137382|NCT03449030|100661473|FG001|NOT COMPLETED|Overall Study||1||
48137383|NCT03449030|100661474|FG002|NOT COMPLETED|Overall Study||1||
48137384|NCT03449030|100661475|FG003|NOT COMPLETED|Overall Study||5||
48137385|NCT03449030|100661476|FG004|NOT COMPLETED|Overall Study||7||
48137386|NCT03449030|100661477|FG005|NOT COMPLETED|Overall Study||7||
48137387|NCT03449030|100661478|FG006|NOT COMPLETED|Overall Study||2||
48137388|NCT03449030|100661479|FG007|NOT COMPLETED|Overall Study||3||
48137389|NCT03449030|100661480|FG008|NOT COMPLETED|Overall Study||3||
48137390|NCT03449030|100661481|FG009|NOT COMPLETED|Overall Study||1||
48137391|NCT02334800|100661482|FG000|STARTED|Overall Study||7||
48137392|NCT02334800|100661483|FG001|STARTED|Overall Study||7||
48137393|NCT02334800|100661484|FG002|STARTED|Overall Study||7||
48137394|NCT02334800|100661485|FG003|STARTED|Overall Study||7||
48137395|NCT02334800|100661482|FG000|Received Treatment|Overall Study||7||
48137396|NCT02334800|100661483|FG001|Received Treatment|Overall Study||7||
48137397|NCT02334800|100661484|FG002|Received Treatment|Overall Study||7||
48137398|NCT02334800|100661485|FG003|Received Treatment|Overall Study||7||
48137399|NCT02334800|100661482|FG000|COMPLETED|Overall Study||7||
48137400|NCT02334800|100661483|FG001|COMPLETED|Overall Study||7||
48137401|NCT02334800|100661484|FG002|COMPLETED|Overall Study||7||
48137402|NCT02334800|100661485|FG003|COMPLETED|Overall Study||7||
48137403|NCT02334800|100661482|FG000|NOT COMPLETED|Overall Study||0||
48137404|NCT02334800|100661483|FG001|NOT COMPLETED|Overall Study||0||
48137405|NCT02334800|100661484|FG002|NOT COMPLETED|Overall Study||0||
48137406|NCT02334800|100661485|FG003|NOT COMPLETED|Overall Study||0||
48137407|NCT03743038|100661486|FG000|STARTED|Overall Study||12|Test Article A and Test Article B|24
48137408|NCT03743038|100661486|FG000|Test Article A|Overall Study||12||12
48137409|NCT03743038|100661486|FG000|Test Article B|Overall Study||12||12
48137410|NCT03743038|100661486|FG000|COMPLETED|Overall Study||11|Test Article A and Test Article B|22
48137411|NCT03743038|100661486|FG000|NOT COMPLETED|Overall Study||1||2
48137412|NCT00553267|100661487|FG000|STARTED|Overall Study||315||
48137413|NCT00553267|100661488|FG001|STARTED|Overall Study||315||
48137414|NCT00553267|100661489|FG002|STARTED|Overall Study||317||
48137415|NCT00553267|100661487|FG000|COMPLETED|Overall Study||301||
48137416|NCT00553267|100661488|FG001|COMPLETED|Overall Study||297||
48137417|NCT00553267|100661489|FG002|COMPLETED|Overall Study||307||
48137418|NCT00553267|100661487|FG000|NOT COMPLETED|Overall Study||14||
48137419|NCT00553267|100661488|FG001|NOT COMPLETED|Overall Study||18||
48137420|NCT00553267|100661489|FG002|NOT COMPLETED|Overall Study||10||
48137421|NCT04320069|100661490|FG000|STARTED|Phase 1: Omnipod Horizon™ Without CGM||25||
48137422|NCT04320069|100661490|FG000|COMPLETED|Phase 1: Omnipod Horizon™ Without CGM||25||
48137423|NCT04320069|100661490|FG000|NOT COMPLETED|Phase 1: Omnipod Horizon™ Without CGM||0||
48137424|NCT04320069|100661490|FG000|STARTED|Phase 2: Omnipod Horizon™ With CGM||25||
48137425|NCT04320069|100661490|FG000|COMPLETED|Phase 2: Omnipod Horizon™ With CGM||25||
48137426|NCT04320069|100661490|FG000|NOT COMPLETED|Phase 2: Omnipod Horizon™ With CGM||0||
48137427|NCT00485485|100661491|FG000|STARTED|Overall Study||7||
48137428|NCT00485485|100661491|FG000|COMPLETED|Overall Study||7||
48137429|NCT00485485|100661491|FG000|NOT COMPLETED|Overall Study||0||
48137430|NCT03266588|100661492|FG000|STARTED|Observational Period||1605|Number includes participants who entered the Observation Period.|
48137431|NCT03266588|100661493|FG001|STARTED|Observational Period||786|Number includes participants who entered the Observation Period.|
48137432|NCT03266588|100661494|FG002|STARTED|Observational Period||476|Number includes participants who entered the Observation Period.|
48137433|NCT03266588|100661492|FG000|COMPLETED|Observational Period||1089||
48137434|NCT03266588|100661493|FG001|COMPLETED|Observational Period||511||
48137435|NCT03266588|100661494|FG002|COMPLETED|Observational Period||308||
48137436|NCT03266588|100661492|FG000|NOT COMPLETED|Observational Period||516||
48137437|NCT03266588|100661493|FG001|NOT COMPLETED|Observational Period||275||
48137438|NCT03266588|100661494|FG002|NOT COMPLETED|Observational Period||168||
48137439|NCT03266588|100661492|FG000|STARTED|Long-term Treatment Period||1089||
48137440|NCT03266588|100661493|FG001|STARTED|Long-term Treatment Period||511||
48137441|NCT03266588|100661494|FG002|STARTED|Long-term Treatment Period||308||
48137442|NCT03266588|100661492|FG000|Treated|Long-term Treatment Period||1033||
48137443|NCT03266588|100661493|FG001|Treated|Long-term Treatment Period||481||
48137444|NCT03266588|100661494|FG002|Treated|Long-term Treatment Period||286||
48137445|NCT03266588|100661492|FG000|COMPLETED|Long-term Treatment Period||683||
48137446|NCT03266588|100661493|FG001|COMPLETED|Long-term Treatment Period||271||
48137447|NCT03266588|100661494|FG002|COMPLETED|Long-term Treatment Period||243||
48137448|NCT03266588|100661492|FG000|NOT COMPLETED|Long-term Treatment Period||406||
48137449|NCT03266588|100661493|FG001|NOT COMPLETED|Long-term Treatment Period||240||
48137450|NCT03266588|100661494|FG002|NOT COMPLETED|Long-term Treatment Period||65||
48137451|NCT01763567|100661495|FG000|STARTED|Overall Study||19||
48137452|NCT01763567|100661495|FG000|COMPLETED|Overall Study||19||
48137453|NCT01763567|100661495|FG000|NOT COMPLETED|Overall Study||0||
48137454|NCT02007577|100661496|FG000|STARTED|Overall Study||27||
48137455|NCT02007577|100661497|FG001|STARTED|Overall Study||14||
48137456|NCT02007577|100661496|FG000|COMPLETED|Overall Study||26||
48137457|NCT02007577|100661497|FG001|COMPLETED|Overall Study||13||
48137458|NCT02007577|100661496|FG000|NOT COMPLETED|Overall Study||1||
48137459|NCT02007577|100661497|FG001|NOT COMPLETED|Overall Study||1||
48137460|NCT02221934|100661498|FG000|STARTED|Screening||0||
48137461|NCT02221934|100661499|FG001|STARTED|Screening||0||
48137462|NCT02221934|100661500|FG002|STARTED|Screening||607||
48137463|NCT02221934|100661498|FG000|COMPLETED|Screening||0||
48137464|NCT02221934|100661499|FG001|COMPLETED|Screening||0||
48137465|NCT02221934|100661500|FG002|COMPLETED|Screening||183||
48705585|NCT01740089|102065105|FG002|COMPLETED|First 12 Weeks of Treatment||48||
48705586|NCT01740089|102065103|FG000|NOT COMPLETED|First 12 Weeks of Treatment||0||
48705587|NCT01740089|102065104|FG001|NOT COMPLETED|First 12 Weeks of Treatment||2||
48137466|NCT02221934|100661498|FG000|NOT COMPLETED|Screening||0||
48137467|NCT02221934|100661499|FG001|NOT COMPLETED|Screening||0||
48137468|NCT02221934|100661500|FG002|NOT COMPLETED|Screening||424||
48137469|NCT02221934|100661498|FG000|STARTED|Device Activation||0||
48137470|NCT02221934|100661499|FG001|STARTED|Device Activation||0||
48137471|NCT02221934|100661500|FG002|STARTED|Device Activation||183||
48137472|NCT02221934|100661498|FG000|Primary Safety Analysis Cohort|Device Activation||0||
48137473|NCT02221934|100661499|FG001|Primary Safety Analysis Cohort|Device Activation||0||
48137474|NCT02221934|100661500|FG002|Primary Safety Analysis Cohort|Device Activation||183||
48137475|NCT02221934|100661498|FG000|Successful Implant|Device Activation||0||
48137476|NCT02221934|100661499|FG001|Successful Implant|Device Activation||0||
48137477|NCT02221934|100661500|FG002|Successful Implant|Device Activation||180||
48137478|NCT02221934|100661498|FG000|COMPLETED|Device Activation||0||
48137479|NCT02221934|100661499|FG001|COMPLETED|Device Activation||0||
48137480|NCT02221934|100661500|FG002|COMPLETED|Device Activation||178||
48137481|NCT02221934|100661498|FG000|NOT COMPLETED|Device Activation||0||
48137482|NCT02221934|100661499|FG001|NOT COMPLETED|Device Activation||0||
48137483|NCT02221934|100661500|FG002|NOT COMPLETED|Device Activation||5||
48137484|NCT02221934|100661498|FG000|STARTED|Randomized Testing (Month 1 to Month 3)||87||
48137485|NCT02221934|100661499|FG001|STARTED|Randomized Testing (Month 1 to Month 3)||91||
48137486|NCT02221934|100661500|FG002|STARTED|Randomized Testing (Month 1 to Month 3)||0||
48401308|NCT02658968|101313733|FG003|NOT COMPLETED|Received Rituximab||0||
48584142|NCT00828074|101762080|FG001|COMPLETED|Overall Study||5||
48584143|NCT00828074|101762081|FG002|COMPLETED|Overall Study||35||
48584144|NCT00828074|101762079|FG000|NOT COMPLETED|Overall Study||0||
48584145|NCT00828074|101762080|FG001|NOT COMPLETED|Overall Study||0||
48137487|NCT02221934|100661498|FG000|Successful Randomization|Randomized Testing (Month 1 to Month 3)||87||
48137488|NCT02221934|100661499|FG001|Successful Randomization|Randomized Testing (Month 1 to Month 3)||91||
48137489|NCT02221934|100661500|FG002|Successful Randomization|Randomized Testing (Month 1 to Month 3)||0||
48289208|NCT03567434|101033747|FG000|NOT COMPLETED|Overall Study||1||
48289209|NCT03567434|101033748|FG001|NOT COMPLETED|Overall Study||3||
48584146|NCT00828074|101762081|FG002|NOT COMPLETED|Overall Study||0||
48137490|NCT02221934|100661498|FG000|Successful Device Use (Primary Effectiveness Analysis Cohort)|Randomized Testing (Month 1 to Month 3)||85||
48137491|NCT02221934|100661499|FG001|Successful Device Use (Primary Effectiveness Analysis Cohort)|Randomized Testing (Month 1 to Month 3)||85||
48137492|NCT02221934|100661500|FG002|Successful Device Use (Primary Effectiveness Analysis Cohort)|Randomized Testing (Month 1 to Month 3)||0||
48137493|NCT02221934|100661498|FG000|COMPLETED|Randomized Testing (Month 1 to Month 3)||82||
48584147|NCT03083561|101762082|FG000|STARTED|Overall Study||6||
48584148|NCT03083561|101762083|FG001|STARTED|Overall Study||6||
48584149|NCT03083561|101762084|FG002|STARTED|Overall Study||6||
48584150|NCT03083561|101762085|FG003|STARTED|Overall Study||6||
48584151|NCT03083561|101762086|FG004|STARTED|Overall Study||3||
48137494|NCT02221934|100661499|FG001|COMPLETED|Randomized Testing (Month 1 to Month 3)||83||
48137495|NCT02221934|100661500|FG002|COMPLETED|Randomized Testing (Month 1 to Month 3)||0||
48137496|NCT02221934|100661498|FG000|NOT COMPLETED|Randomized Testing (Month 1 to Month 3)||5||
48137497|NCT02221934|100661499|FG001|NOT COMPLETED|Randomized Testing (Month 1 to Month 3)||8||
48137498|NCT02221934|100661500|FG002|NOT COMPLETED|Randomized Testing (Month 1 to Month 3)||0||
48137499|NCT02221934|100661498|FG000|STARTED|Follow-up (Month 3 to Month 12)||82||
48137500|NCT02221934|100661499|FG001|STARTED|Follow-up (Month 3 to Month 12)||83||
48137501|NCT02221934|100661500|FG002|STARTED|Follow-up (Month 3 to Month 12)||0||
48137502|NCT02221934|100661498|FG000|COMPLETED|Follow-up (Month 3 to Month 12)||74||
48137503|NCT02221934|100661499|FG001|COMPLETED|Follow-up (Month 3 to Month 12)||75||
48137504|NCT02221934|100661500|FG002|COMPLETED|Follow-up (Month 3 to Month 12)||0||
48137505|NCT02221934|100661498|FG000|NOT COMPLETED|Follow-up (Month 3 to Month 12)||8||
48137506|NCT02221934|100661499|FG001|NOT COMPLETED|Follow-up (Month 3 to Month 12)||8||
48137507|NCT02221934|100661500|FG002|NOT COMPLETED|Follow-up (Month 3 to Month 12)||0||
48137508|NCT02367911|100661501|FG000|STARTED|Overall Study||71||
48137509|NCT02367911|100661502|FG001|STARTED|Overall Study||73||
48137510|NCT02367911|100661501|FG000|COMPLETED|Overall Study||66||
48137511|NCT02367911|100661502|FG001|COMPLETED|Overall Study||69||
48137512|NCT02367911|100661501|FG000|NOT COMPLETED|Overall Study||5||
48137513|NCT02367911|100661502|FG001|NOT COMPLETED|Overall Study||4||
48137514|NCT01730937|100661503|FG000|STARTED|Overall Study||97||
48137515|NCT01730937|100661504|FG001|STARTED|Overall Study||96||
48137516|NCT01730937|100661503|FG000|Eligible Population|Overall Study||92||
48137517|NCT01730937|100661504|FG001|Eligible Population|Overall Study||85||
48137518|NCT01730937|100661503|FG000|Adverse Event Population|Overall Study||88|Eligible, started treatment, and were assessed for adverse events.|
48137519|NCT01730937|100661504|FG001|Adverse Event Population|Overall Study||83|Eligible, started treatment, and were assessed for adverse events.|
48137520|NCT01730937|100661503|FG000|Quality of Life Population|Overall Study||46|Eligible with consent for quality of life study component|
48137521|NCT01730937|100661504|FG001|Quality of Life Population|Overall Study||37|Eligible with consent for quality of life study component|
48137522|NCT01730937|100661503|FG000|COMPLETED|Overall Study||92|Participants contributing data to results are considered to have completed the study.|
48137523|NCT01730937|100661504|FG001|COMPLETED|Overall Study||85|Participants contributing data to results are considered to have completed the study.|
48137524|NCT01730937|100661503|FG000|NOT COMPLETED|Overall Study||5||
48137525|NCT01730937|100661504|FG001|NOT COMPLETED|Overall Study||11||
48137526|NCT03832010|100661505|FG000|STARTED|Overall Study||8||
48137527|NCT03832010|100661506|FG001|STARTED|Overall Study||7||
48137528|NCT03832010|100661507|FG002|STARTED|Overall Study||9||
48137529|NCT03832010|100661505|FG000|COMPLETED|Overall Study||4||
48137530|NCT03832010|100661506|FG001|COMPLETED|Overall Study||5||
48137531|NCT03832010|100661507|FG002|COMPLETED|Overall Study||8||
48137532|NCT03832010|100661505|FG000|NOT COMPLETED|Overall Study||4||
48137533|NCT03832010|100661506|FG001|NOT COMPLETED|Overall Study||2||
48137534|NCT03832010|100661507|FG002|NOT COMPLETED|Overall Study||1||
48137535|NCT02091726|100661508|FG000|STARTED|Overall Study||110||
48137536|NCT02091726|100661508|FG000|1 Week Followup|Overall Study||110||
48137537|NCT02091726|100661508|FG000|4 Week Followup|Overall Study||104||
48137538|NCT02091726|100661508|FG000|COMPLETED|Overall Study||104||
48137539|NCT02091726|100661508|FG000|NOT COMPLETED|Overall Study||6||
48137540|NCT02653482|100661509|FG000|STARTED|Overall Study||131||
48137541|NCT02653482|100661510|FG001|STARTED|Overall Study||132||
48137542|NCT02653482|100661509|FG000|COMPLETED|Overall Study||130||
48137543|NCT02653482|100661510|FG001|COMPLETED|Overall Study||131||
48137544|NCT02653482|100661509|FG000|NOT COMPLETED|Overall Study||1||
48137545|NCT02653482|100661510|FG001|NOT COMPLETED|Overall Study||1||
48137546|NCT03812146|100661511|FG000|STARTED|Overall Study||33||
48137547|NCT03812146|100661512|FG001|STARTED|Overall Study||30||
48137548|NCT03812146|100661511|FG000|COMPLETED|Overall Study||26||
48137549|NCT03812146|100661512|FG001|COMPLETED|Overall Study||29||
48137550|NCT03812146|100661511|FG000|NOT COMPLETED|Overall Study||7||
48137551|NCT03812146|100661512|FG001|NOT COMPLETED|Overall Study||1||
48137552|NCT01494051|100661513|FG000|STARTED|Overall Study||6||
48137553|NCT01494051|100661514|FG001|STARTED|Overall Study||7||
48137554|NCT01494051|100661513|FG000|COMPLETED|Overall Study||6||
48137555|NCT01494051|100661514|FG001|COMPLETED|Overall Study||7||
48137556|NCT01494051|100661513|FG000|NOT COMPLETED|Overall Study||0||
48137557|NCT01494051|100661514|FG001|NOT COMPLETED|Overall Study||0||
48137558|NCT02647658|100661515|FG000|STARTED|Overall Study||1207||39
48137559|NCT02647658|100661516|FG001|STARTED|Overall Study||1093||37
48137560|NCT02647658|100661515|FG000|6 Month Assessment|Overall Study||658||38
48289210|NCT02192879|101033749|FG000|STARTED|Overall Study||3||
48137561|NCT02647658|100661516|FG001|6 Month Assessment|Overall Study||635||35
48137562|NCT02647658|100661515|FG000|COMPLETED|Overall Study||1192||39
48137563|NCT02647658|100661516|FG001|COMPLETED|Overall Study||1069||37
48137564|NCT02647658|100661515|FG000|NOT COMPLETED|Overall Study||15||0
48137565|NCT02647658|100661516|FG001|NOT COMPLETED|Overall Study||24||0
48137566|NCT04401579|100661517|FG000|STARTED|Overall Study||515||
48137567|NCT04401579|100661518|FG001|STARTED|Overall Study||518||
48137568|NCT04401579|100661517|FG000|Treated|Overall Study||507||
48289211|NCT02192879|101033750|FG001|STARTED|Overall Study||4||
48137569|NCT04401579|100661518|FG001|Treated|Overall Study||509||
48137570|NCT04401579|100661517|FG000|COMPLETED|Overall Study||431||
48137571|NCT04401579|100661518|FG001|COMPLETED|Overall Study||408||
48137572|NCT04401579|100661517|FG000|NOT COMPLETED|Overall Study||84||
48137573|NCT04401579|100661518|FG001|NOT COMPLETED|Overall Study||110||
48137574|NCT03301051|100661519|FG000|STARTED|Overall Study||5077||
48137575|NCT03301051|100661520|FG001|STARTED|Overall Study||5083||
48137576|NCT03301051|100661519|FG000|Safety Analysis Set|Overall Study||5064||
48137577|NCT03301051|100661520|FG001|Safety Analysis Set|Overall Study||5072||
48137578|NCT03301051|100661519|FG000|Vaccinated|Overall Study||5065||
48137579|NCT03301051|100661520|FG001|Vaccinated|Overall Study||5072||
48137580|NCT03301051|100661519|FG000|COMPLETED|Overall Study||4731||
48137581|NCT03301051|100661520|FG001|COMPLETED|Overall Study||4711||
48137582|NCT03301051|100661519|FG000|NOT COMPLETED|Overall Study||346||
48137583|NCT03301051|100661520|FG001|NOT COMPLETED|Overall Study||372||
48137584|NCT01914926|100661521|FG000|STARTED|Overall Study||29||
48137585|NCT01914926|100661522|FG001|STARTED|Overall Study||25||
48137586|NCT01914926|100661521|FG000|COMPLETED|Overall Study||28||
48137587|NCT01914926|100661522|FG001|COMPLETED|Overall Study||24||
48137588|NCT01914926|100661521|FG000|NOT COMPLETED|Overall Study||1||
48584152|NCT03083561|101762087|FG005|STARTED|Overall Study||9||
48584153|NCT03083561|101762082|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
48584154|NCT03083561|101762083|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
48584155|NCT03083561|101762084|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
48584156|NCT03083561|101762085|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6||
48584157|NCT03083561|101762086|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3||
48584158|NCT03083561|101762087|FG005|Received at Least 1 Dose of Study Drug|Overall Study||9||
48705588|NCT01740089|102065105|FG002|NOT COMPLETED|First 12 Weeks of Treatment||2||
48705589|NCT01740089|102065103|FG000|STARTED|After 12 Weeks||50||
48705590|NCT01740089|102065104|FG001|STARTED|After 12 Weeks||48||
48705591|NCT01740089|102065105|FG002|STARTED|After 12 Weeks||48||
48705592|NCT01740089|102065103|FG000|COMPLETED|After 12 Weeks||43||
48705593|NCT01740089|102065104|FG001|COMPLETED|After 12 Weeks||45||
48705594|NCT01740089|102065105|FG002|COMPLETED|After 12 Weeks||37||
48705595|NCT01740089|102065103|FG000|NOT COMPLETED|After 12 Weeks||7||
48705596|NCT01740089|102065104|FG001|NOT COMPLETED|After 12 Weeks||3||
48705597|NCT01740089|102065105|FG002|NOT COMPLETED|After 12 Weeks||11||
48705598|NCT03447314|102065106|FG000|STARTED|Part 1 (Up to 47 Months and 13 Days)||9||
48705599|NCT03447314|102065107|FG001|STARTED|Part 1 (Up to 47 Months and 13 Days)||6||
48705600|NCT03447314|102065108|FG002|STARTED|Part 1 (Up to 47 Months and 13 Days)||9||
48705601|NCT03447314|102065109|FG003|STARTED|Part 1 (Up to 47 Months and 13 Days)||4||
48137589|NCT01914926|100661522|FG001|NOT COMPLETED|Overall Study||1||
48137590|NCT01178853|100661523|FG000|STARTED|Period 1 (Warfarin Titration)||24||
48137591|NCT01178853|100661524|FG001|STARTED|Period 1 (Warfarin Titration)||24||
48137592|NCT01178853|100661523|FG000|COMPLETED|Period 1 (Warfarin Titration)||23||
48137593|NCT01178853|100661524|FG001|COMPLETED|Period 1 (Warfarin Titration)||22||
48289212|NCT02192879|101033751|FG002|STARTED|Overall Study||3||
48289213|NCT02192879|101033749|FG000|COMPLETED|Overall Study||3||
48289214|NCT02192879|101033750|FG001|COMPLETED|Overall Study||4||
48584159|NCT03083561|101762082|FG000|COMPLETED|Overall Study||6||
48584160|NCT03083561|101762083|FG001|COMPLETED|Overall Study||6||
48584161|NCT03083561|101762084|FG002|COMPLETED|Overall Study||6||
48584162|NCT03083561|101762085|FG003|COMPLETED|Overall Study||6||
48584163|NCT03083561|101762086|FG004|COMPLETED|Overall Study||3||
48584164|NCT03083561|101762087|FG005|COMPLETED|Overall Study||9||
48584165|NCT03083561|101762082|FG000|NOT COMPLETED|Overall Study||0||
48584166|NCT03083561|101762083|FG001|NOT COMPLETED|Overall Study||0||
48584167|NCT03083561|101762084|FG002|NOT COMPLETED|Overall Study||0||
48584168|NCT03083561|101762085|FG003|NOT COMPLETED|Overall Study||0||
48584169|NCT03083561|101762086|FG004|NOT COMPLETED|Overall Study||0||
48584170|NCT03083561|101762087|FG005|NOT COMPLETED|Overall Study||0||
48584171|NCT00381043|101762088|FG000|STARTED|Overall Study||51||
48584172|NCT00381043|101762089|FG001|STARTED|Overall Study||49||
48584173|NCT00381043|101762088|FG000|COMPLETED|Overall Study||39||
48584174|NCT00381043|101762089|FG001|COMPLETED|Overall Study||41||
48584175|NCT00381043|101762088|FG000|NOT COMPLETED|Overall Study||12||
48584176|NCT00381043|101762089|FG001|NOT COMPLETED|Overall Study||8||
48705602|NCT03447314|102065110|FG004|STARTED|Part 1 (Up to 47 Months and 13 Days)||2||
48137594|NCT01178853|100661523|FG000|NOT COMPLETED|Period 1 (Warfarin Titration)||1||
48137595|NCT01178853|100661524|FG001|NOT COMPLETED|Period 1 (Warfarin Titration)||2||
48289215|NCT02192879|101033751|FG002|COMPLETED|Overall Study||3||
48584177|NCT00655707|101762090|FG000|STARTED|Overall Study||5||
48584178|NCT00655707|101762090|FG000|COMPLETED|Overall Study||5||
48584179|NCT00655707|101762090|FG000|NOT COMPLETED|Overall Study||0||
48584180|NCT00737204|101762091|FG000|STARTED|Overall Study||36||
48584181|NCT00737204|101762092|FG001|STARTED|Overall Study||34||
48584182|NCT00737204|101762091|FG000|COMPLETED|Overall Study||36||
48584183|NCT00737204|101762092|FG001|COMPLETED|Overall Study||28||
48584184|NCT00737204|101762091|FG000|NOT COMPLETED|Overall Study||0||
48584185|NCT00737204|101762092|FG001|NOT COMPLETED|Overall Study||6||
48584186|NCT01369030|101762093|FG000|STARTED|Overall Study||594||
48584187|NCT01369030|101762093|FG000|COMPLETED|Overall Study||554||
48584188|NCT01369030|101762093|FG000|NOT COMPLETED|Overall Study||40||
48705603|NCT03447314|102065111|FG005|STARTED|Part 1 (Up to 47 Months and 13 Days)||6||
48705604|NCT03447314|102065112|FG006|STARTED|Part 1 (Up to 47 Months and 13 Days)||5||
48705605|NCT03447314|102065113|FG007|STARTED|Part 1 (Up to 47 Months and 13 Days)||0||
48584189|NCT02105246|101762094|FG000|STARTED|Overall Study||557||
48584190|NCT02105246|101762095|FG001|STARTED|Overall Study||597||
48584191|NCT02105246|101762094|FG000|COMPLETED|Overall Study||557||
48584192|NCT02105246|101762095|FG001|COMPLETED|Overall Study||597||
48584193|NCT02105246|101762094|FG000|NOT COMPLETED|Overall Study||0||
48584194|NCT02105246|101762095|FG001|NOT COMPLETED|Overall Study||0||
48705606|NCT03447314|102065114|FG008|STARTED|Part 1 (Up to 47 Months and 13 Days)||0||
48705607|NCT03447314|102065115|FG009|STARTED|Part 1 (Up to 47 Months and 13 Days)||0||
48705608|NCT03447314|102065116|FG010|STARTED|Part 1 (Up to 47 Months and 13 Days)||7||
48705609|NCT03447314|102065117|FG011|STARTED|Part 1 (Up to 47 Months and 13 Days)||6||
48705610|NCT03447314|102065118|FG012|STARTED|Part 1 (Up to 47 Months and 13 Days)||0||
48401309|NCT02658968|101313734|FG004|NOT COMPLETED|Received Rituximab||2||
48401310|NCT02658968|101313730|FG000|STARTED|Received Lilotomab and Betalutin||3||
48584195|NCT00840307|101762096|FG000|STARTED|Overall Study||20||
48584196|NCT00840307|101762096|FG000|COMPLETED|Overall Study||16||
48584197|NCT00840307|101762096|FG000|NOT COMPLETED|Overall Study||4||
48584198|NCT02989649|101762097|FG000|STARTED|Overall Study||593||
48705611|NCT03447314|102065119|FG013|STARTED|Part 1 (Up to 47 Months and 13 Days)||0||
48137596|NCT01178853|100661523|FG000|STARTED|Period 2 (Warfarin + Study Drug)||23||
48137597|NCT01178853|100661524|FG001|STARTED|Period 2 (Warfarin + Study Drug)||22||
48137598|NCT01178853|100661523|FG000|COMPLETED|Period 2 (Warfarin + Study Drug)||22||
48137599|NCT01178853|100661524|FG001|COMPLETED|Period 2 (Warfarin + Study Drug)||22||
48137600|NCT01178853|100661523|FG000|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||1||
48137601|NCT01178853|100661524|FG001|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||0||
48137602|NCT01178853|100661523|FG000|STARTED|Period 3 (Warfarin Titration)||22||
48137603|NCT01178853|100661524|FG001|STARTED|Period 3 (Warfarin Titration)||22||
48137604|NCT01178853|100661523|FG000|COMPLETED|Period 3 (Warfarin Titration)||21||
48137605|NCT01178853|100661524|FG001|COMPLETED|Period 3 (Warfarin Titration)||22||
48137606|NCT01178853|100661523|FG000|NOT COMPLETED|Period 3 (Warfarin Titration)||1||
48137607|NCT01178853|100661524|FG001|NOT COMPLETED|Period 3 (Warfarin Titration)||0||
48137608|NCT01178853|100661523|FG000|STARTED|Period 4 (Warfarin + Study Drug)||21||
48137609|NCT01178853|100661524|FG001|STARTED|Period 4 (Warfarin + Study Drug)||22||
48137610|NCT01178853|100661523|FG000|COMPLETED|Period 4 (Warfarin + Study Drug)||21||
48137611|NCT01178853|100661524|FG001|COMPLETED|Period 4 (Warfarin + Study Drug)||19||
48137612|NCT01178853|100661523|FG000|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||0||
48137613|NCT01178853|100661524|FG001|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||3||
48137614|NCT02105948|100661525|FG000|STARTED|Overall Study||229||
48137615|NCT02105948|100661526|FG001|STARTED|Overall Study||233||
48584199|NCT02989649|101762097|FG000|Started But Not Treated|Overall Study||84||
48137616|NCT02105948|100661527|FG002|STARTED|Overall Study||190||
48137617|NCT02105948|100661528|FG003|STARTED|Overall Study||184||
48137618|NCT02105948|100661525|FG000|Completed Investigational Product (IP)|Overall Study||185||
48137619|NCT02105948|100661526|FG001|Completed Investigational Product (IP)|Overall Study||203||
48137620|NCT02105948|100661527|FG002|Completed Investigational Product (IP)|Overall Study||148||
48137621|NCT02105948|100661528|FG003|Completed Investigational Product (IP)|Overall Study||149||
48137622|NCT02105948|100661525|FG000|Not Completed IP|Overall Study||44||
48289216|NCT02192879|101033749|FG000|NOT COMPLETED|Overall Study||0||
48289217|NCT02192879|101033750|FG001|NOT COMPLETED|Overall Study||0||
48289218|NCT02192879|101033751|FG002|NOT COMPLETED|Overall Study||0||
48289219|NCT00986674|101033752|FG000|STARTED|Overall Study||47||
48289220|NCT00986674|101033753|FG001|STARTED|Overall Study||45||
48289221|NCT00986674|101033754|FG002|STARTED|Overall Study||48||
48289222|NCT00986674|101033752|FG000|Treated|Overall Study||43||
48289223|NCT00986674|101033753|FG001|Treated|Overall Study||42||
48137623|NCT02105948|100661526|FG001|Not Completed IP|Overall Study||30||
48137624|NCT02105948|100661527|FG002|Not Completed IP|Overall Study||42||
48137625|NCT02105948|100661528|FG003|Not Completed IP|Overall Study||35||
48401311|NCT02658968|101313731|FG001|STARTED|Received Lilotomab and Betalutin||3||
48401312|NCT02658968|101313732|FG002|STARTED|Received Lilotomab and Betalutin||3||
48401313|NCT02658968|101313733|FG003|STARTED|Received Lilotomab and Betalutin||7||
48401314|NCT02658968|101313734|FG004|STARTED|Received Lilotomab and Betalutin||0||
48584200|NCT02989649|101762097|FG000|Eligible to Enter Into Treatment Period|Overall Study||509||
48584201|NCT02989649|101762097|FG000|COMPLETED|Overall Study||173||
48584202|NCT02989649|101762097|FG000|NOT COMPLETED|Overall Study||420||
48584203|NCT03214380|101762098|FG000|STARTED|Lead-in||750||
48584204|NCT03214380|101762099|FG001|STARTED|Lead-in||0||
48584205|NCT03214380|101762100|FG002|STARTED|Lead-in||0||
48584206|NCT03214380|101762101|FG003|STARTED|Lead-in||183||
48584207|NCT03214380|101762102|FG004|STARTED|Lead-in||0||
48584208|NCT03214380|101762103|FG005|STARTED|Lead-in||0||
48705612|NCT03447314|102065120|FG014|STARTED|Part 1 (Up to 47 Months and 13 Days)||0||
48705613|NCT03447314|102065121|FG015|STARTED|Part 1 (Up to 47 Months and 13 Days)||0||
48705614|NCT03447314|102065122|FG016|STARTED|Part 1 (Up to 47 Months and 13 Days)||0||
48705615|NCT03447314|102065123|FG017|STARTED|Part 1 (Up to 47 Months and 13 Days)||0||
48705616|NCT03447314|102065106|FG000|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||2||
48705617|NCT03447314|102065107|FG001|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||1||
48584209|NCT03214380|101762098|FG000|Received at Least 1 Dose Lead-in Insulin|Lead-in||750||
48584210|NCT03214380|101762099|FG001|Received at Least 1 Dose Lead-in Insulin|Lead-in||0||
48584211|NCT03214380|101762100|FG002|Received at Least 1 Dose Lead-in Insulin|Lead-in||0||
48705618|NCT03447314|102065108|FG002|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||2||
48705619|NCT03447314|102065109|FG003|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
48705620|NCT03447314|102065110|FG004|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||1||
48705621|NCT03447314|102065111|FG005|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
48705622|NCT03447314|102065112|FG006|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||2||
48705623|NCT03447314|102065113|FG007|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
48705624|NCT03447314|102065114|FG008|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
48705625|NCT03447314|102065115|FG009|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
48705626|NCT03447314|102065116|FG010|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||2||
48705627|NCT03447314|102065117|FG011|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||3||
48705628|NCT03447314|102065118|FG012|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
48705629|NCT03447314|102065119|FG013|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
48289224|NCT00986674|101033754|FG002|Treated|Overall Study||47||
48289225|NCT00986674|101033752|FG000|Eligible and Treated|Overall Study||39||
48289226|NCT00986674|101033753|FG001|Eligible and Treated|Overall Study||41||
48584212|NCT03214380|101762101|FG003|Received at Least 1 Dose Lead-in Insulin|Lead-in||183||
48584213|NCT03214380|101762102|FG004|Received at Least 1 Dose Lead-in Insulin|Lead-in||0||
48584214|NCT03214380|101762103|FG005|Received at Least 1 Dose Lead-in Insulin|Lead-in||0||
48584215|NCT03214380|101762098|FG000|COMPLETED|Lead-in||673||
48584216|NCT03214380|101762099|FG001|COMPLETED|Lead-in||0||
48584217|NCT03214380|101762100|FG002|COMPLETED|Lead-in||0||
48584218|NCT03214380|101762101|FG003|COMPLETED|Lead-in||164||
48584219|NCT03214380|101762102|FG004|COMPLETED|Lead-in||0||
48584220|NCT03214380|101762103|FG005|COMPLETED|Lead-in||0||
48584221|NCT03214380|101762098|FG000|NOT COMPLETED|Lead-in||77||
48584222|NCT03214380|101762099|FG001|NOT COMPLETED|Lead-in||0||
48584223|NCT03214380|101762100|FG002|NOT COMPLETED|Lead-in||0||
48584224|NCT03214380|101762101|FG003|NOT COMPLETED|Lead-in||19||
48584225|NCT03214380|101762102|FG004|NOT COMPLETED|Lead-in||0||
48584226|NCT03214380|101762103|FG005|NOT COMPLETED|Lead-in||0||
48705630|NCT03447314|102065120|FG014|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
48710764|NCT00402714|102078010|FG000|COMPLETED|Overall Study||3||
48289227|NCT00986674|101033754|FG002|Eligible and Treated|Overall Study||47||
48289228|NCT00986674|101033752|FG000|COMPLETED|Overall Study||0||
48289229|NCT00986674|101033753|FG001|COMPLETED|Overall Study||0||
48289230|NCT00986674|101033754|FG002|COMPLETED|Overall Study||0||
48289231|NCT00986674|101033752|FG000|NOT COMPLETED|Overall Study||47||
48289232|NCT00986674|101033753|FG001|NOT COMPLETED|Overall Study||45||
48289233|NCT00986674|101033754|FG002|NOT COMPLETED|Overall Study||48||
48289234|NCT01485055|101033755|FG000|STARTED|Overall Study||11||
48289235|NCT01485055|101033755|FG000|COMPLETED|Overall Study||11||
48289236|NCT01485055|101033755|FG000|NOT COMPLETED|Overall Study||0||
48289237|NCT02684851|101033756|FG000|STARTED|Overall Study||42||
48289238|NCT02684851|101033757|FG001|STARTED|Overall Study||45||
48289239|NCT02684851|101033756|FG000|COMPLETED|Overall Study||42||
48289240|NCT02684851|101033757|FG001|COMPLETED|Overall Study||45||
48401315|NCT02658968|101313730|FG000|COMPLETED|Received Lilotomab and Betalutin||0||
48401316|NCT02658968|101313731|FG001|COMPLETED|Received Lilotomab and Betalutin||0||
48289241|NCT02684851|101033756|FG000|NOT COMPLETED|Overall Study||0||
48289242|NCT02684851|101033757|FG001|NOT COMPLETED|Overall Study||0||
48289243|NCT02181387|101037327|FG000|STARTED|Overall Study||14||
48289244|NCT02181387|101037328|FG001|STARTED|Overall Study||19||
48289245|NCT02181387|101037327|FG000|COMPLETED|Overall Study||12||
48289246|NCT02181387|101037328|FG001|COMPLETED|Overall Study||15||
48289247|NCT02181387|101037327|FG000|NOT COMPLETED|Overall Study||2||
48289248|NCT02181387|101037328|FG001|NOT COMPLETED|Overall Study||4||
48289249|NCT02572882|101037329|FG000|STARTED|Overall Study||13||
48289250|NCT02572882|101037329|FG000|COMPLETED|Overall Study||11||
48401317|NCT02658968|101313732|FG002|COMPLETED|Received Lilotomab and Betalutin||0||
48401318|NCT02658968|101313733|FG003|COMPLETED|Received Lilotomab and Betalutin||1||
48584227|NCT03214380|101762098|FG000|STARTED|Treatment Period||0||
48584228|NCT03214380|101762099|FG001|STARTED|Treatment Period||337||
48584229|NCT03214380|101762100|FG002|STARTED|Treatment Period||336||
48584230|NCT03214380|101762101|FG003|STARTED|Treatment Period||0||
48584231|NCT03214380|101762102|FG004|STARTED|Treatment Period||82||
48584232|NCT03214380|101762103|FG005|STARTED|Treatment Period||82||
48584233|NCT03214380|101762098|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||0||
48584234|NCT03214380|101762099|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||337||
48584235|NCT03214380|101762100|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||336||
48289251|NCT02572882|101037329|FG000|NOT COMPLETED|Overall Study||2||
48289252|NCT02315352|101037330|FG000|STARTED|First Intervention (Day 1)||24||
48289253|NCT02315352|101037331|FG001|STARTED|First Intervention (Day 1)||24||
48289254|NCT02315352|101037332|FG002|STARTED|First Intervention (Day 1)||0||
48289255|NCT02315352|101037333|FG003|STARTED|First Intervention (Day 1)||0||
48289256|NCT02315352|101037334|FG004|STARTED|First Intervention (Day 1)||0||
48289257|NCT02315352|101037335|FG005|STARTED|First Intervention (Day 1)||0||
48289258|NCT02315352|101037336|FG006|STARTED|First Intervention (Day 1)||0||
48289259|NCT02315352|101037337|FG007|STARTED|First Intervention (Day 1)||0||
48401319|NCT02658968|101313734|FG004|COMPLETED|Received Lilotomab and Betalutin||0||
48584236|NCT03214380|101762101|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||0||
48584237|NCT03214380|101762102|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||82||
48584238|NCT03214380|101762103|FG005|Received at Least 1 Dose of Study Drug|Treatment Period||82||
48584239|NCT03214380|101762098|FG000|COMPLETED|Treatment Period||0||
48584240|NCT03214380|101762099|FG001|COMPLETED|Treatment Period||319||
48584241|NCT03214380|101762100|FG002|COMPLETED|Treatment Period||320||
48584242|NCT03214380|101762101|FG003|COMPLETED|Treatment Period||0||
48584243|NCT03214380|101762102|FG004|COMPLETED|Treatment Period||73||
48584244|NCT03214380|101762103|FG005|COMPLETED|Treatment Period||71||
48584245|NCT03214380|101762098|FG000|NOT COMPLETED|Treatment Period||0||
48584246|NCT03214380|101762099|FG001|NOT COMPLETED|Treatment Period||18||
48289260|NCT02315352|101037330|FG000|COMPLETED|First Intervention (Day 1)||24||
48289261|NCT02315352|101037331|FG001|COMPLETED|First Intervention (Day 1)||24||
48584247|NCT03214380|101762100|FG002|NOT COMPLETED|Treatment Period||16||
48584248|NCT03214380|101762101|FG003|NOT COMPLETED|Treatment Period||0||
48584249|NCT03214380|101762102|FG004|NOT COMPLETED|Treatment Period||9||
48584250|NCT03214380|101762103|FG005|NOT COMPLETED|Treatment Period||11||
48584251|NCT01646021|101762104|FG000|STARTED|Overall Study||139||
48705631|NCT03447314|102065121|FG015|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
48705632|NCT03447314|102065122|FG016|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
48705633|NCT03447314|102065123|FG017|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
48705634|NCT03447314|102065106|FG000|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||7||
48705635|NCT03447314|102065107|FG001|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||5||
48705636|NCT03447314|102065108|FG002|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||7||
48705637|NCT03447314|102065109|FG003|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||4||
48705638|NCT03447314|102065110|FG004|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||1||
48705639|NCT03447314|102065111|FG005|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||6||
48705640|NCT03447314|102065112|FG006|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||3||
48705641|NCT03447314|102065113|FG007|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
48705642|NCT03447314|102065114|FG008|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
48705643|NCT03447314|102065115|FG009|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
48705644|NCT03447314|102065116|FG010|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||5||
48705645|NCT03447314|102065117|FG011|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||3||
48705646|NCT03447314|102065118|FG012|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
48705647|NCT03447314|102065119|FG013|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
48705648|NCT03447314|102065120|FG014|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
48705649|NCT03447314|102065121|FG015|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
48289262|NCT02315352|101037332|FG002|COMPLETED|First Intervention (Day 1)||0||
48289263|NCT02315352|101037333|FG003|COMPLETED|First Intervention (Day 1)||0||
48289264|NCT02315352|101037334|FG004|COMPLETED|First Intervention (Day 1)||0||
48289265|NCT02315352|101037335|FG005|COMPLETED|First Intervention (Day 1)||0||
48289266|NCT02315352|101037336|FG006|COMPLETED|First Intervention (Day 1)||0||
48289267|NCT02315352|101037337|FG007|COMPLETED|First Intervention (Day 1)||0||
48584252|NCT01646021|101762105|FG001|STARTED|Overall Study||141||
48584253|NCT01646021|101762104|FG000|Treated|Overall Study||139||
48584254|NCT01646021|101762105|FG001|Treated|Overall Study||139||
48584255|NCT01646021|101762104|FG000|COMPLETED|Overall Study||0||
48584256|NCT01646021|101762105|FG001|COMPLETED|Overall Study||0||
48584257|NCT01646021|101762104|FG000|NOT COMPLETED|Overall Study||139||
48584258|NCT01646021|101762105|FG001|NOT COMPLETED|Overall Study||141||
48137626|NCT02105948|100661525|FG000|Withdrew IP Due to: Adverse Event|Overall Study||20||
48137627|NCT02105948|100661526|FG001|Withdrew IP Due to: Adverse Event|Overall Study||16||
48137628|NCT02105948|100661527|FG002|Withdrew IP Due to: Adverse Event|Overall Study||15||
48401320|NCT02658968|101313730|FG000|NOT COMPLETED|Received Lilotomab and Betalutin||3||
48401321|NCT02658968|101313731|FG001|NOT COMPLETED|Received Lilotomab and Betalutin||3||
48401322|NCT02658968|101313732|FG002|NOT COMPLETED|Received Lilotomab and Betalutin||3||
48401323|NCT02658968|101313733|FG003|NOT COMPLETED|Received Lilotomab and Betalutin||6||
48401324|NCT02658968|101313734|FG004|NOT COMPLETED|Received Lilotomab and Betalutin||0||
48401325|NCT01000818|101313735|FG000|STARTED|Raltegravir||18||
48401326|NCT01000818|101313735|FG000|COMPLETED|Raltegravir||18||
48401327|NCT01000818|101313735|FG000|NOT COMPLETED|Raltegravir||0||
48401328|NCT01000818|101313735|FG000|STARTED|Famotidine + Raltegravir||18||
48401329|NCT01000818|101313735|FG000|COMPLETED|Famotidine + Raltegravir||18||
48401330|NCT01000818|101313735|FG000|NOT COMPLETED|Famotidine + Raltegravir||0||
48705650|NCT03447314|102065122|FG016|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
48705651|NCT03447314|102065123|FG017|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
48705652|NCT03447314|102065106|FG000|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
48705653|NCT03447314|102065107|FG001|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
48401331|NCT01000818|101313735|FG000|STARTED|Omeprazole + Raltegravir||18||
48401332|NCT01000818|101313735|FG000|COMPLETED|Omeprazole + Raltegravir||18||
48401333|NCT01000818|101313735|FG000|NOT COMPLETED|Omeprazole + Raltegravir||0||
48401334|NCT00778310|101313736|FG000|STARTED|Overall Study||17||
48401335|NCT00778310|101313737|FG001|STARTED|Overall Study||26||
48401336|NCT00778310|101313736|FG000|Usable Data|Overall Study||14||
48401337|NCT00778310|101313737|FG001|Usable Data|Overall Study||21||
48401338|NCT00778310|101313736|FG000|COMPLETED|Overall Study||17||
48401339|NCT00778310|101313737|FG001|COMPLETED|Overall Study||26||
48401340|NCT00778310|101313736|FG000|NOT COMPLETED|Overall Study||0||
48401341|NCT00778310|101313737|FG001|NOT COMPLETED|Overall Study||0||
48401342|NCT02575300|101313738|FG000|STARTED|Overall Study||20||
48401343|NCT02575300|101313738|FG000|COMPLETED|Overall Study||20||
48401344|NCT02575300|101313738|FG000|NOT COMPLETED|Overall Study||0||
48401345|NCT01052831|101313739|FG000|STARTED|Overall Study||26||
48705654|NCT03447314|102065108|FG002|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
48705655|NCT03447314|102065109|FG003|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
48705656|NCT03447314|102065110|FG004|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
48705657|NCT03447314|102065111|FG005|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
48705658|NCT03447314|102065112|FG006|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
48705659|NCT03447314|102065113|FG007|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
48705660|NCT03447314|102065114|FG008|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
48705661|NCT03447314|102065115|FG009|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
48705662|NCT03447314|102065116|FG010|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
48705663|NCT03447314|102065117|FG011|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
48705664|NCT03447314|102065118|FG012|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
48401346|NCT01052831|101313740|FG001|STARTED|Overall Study||24||
48401347|NCT01052831|101313739|FG000|COMPLETED|Overall Study||22||
48401348|NCT01052831|101313740|FG001|COMPLETED|Overall Study||23||
48401349|NCT01052831|101313739|FG000|NOT COMPLETED|Overall Study||4||
48401350|NCT01052831|101313740|FG001|NOT COMPLETED|Overall Study||1||
48401351|NCT01170949|101313741|FG000|STARTED|Overall Study||50||
48401352|NCT01170949|101313742|FG001|STARTED|Overall Study||26||
48401353|NCT01170949|101313741|FG000|COMPLETED|Overall Study||43||
48401354|NCT01170949|101313742|FG001|COMPLETED|Overall Study||22||
48401355|NCT01170949|101313741|FG000|NOT COMPLETED|Overall Study||7||
48401356|NCT01170949|101313742|FG001|NOT COMPLETED|Overall Study||4||
48401357|NCT02762708|101313743|FG000|STARTED|Study 1 - RYGB vs Caloric Restriction||3||
48401358|NCT02762708|101313744|FG001|STARTED|Study 1 - RYGB vs Caloric Restriction||9||
48401359|NCT02762708|101313745|FG002|STARTED|Study 1 - RYGB vs Caloric Restriction||0||
48401360|NCT02762708|101313746|FG003|STARTED|Study 1 - RYGB vs Caloric Restriction||0||
48401361|NCT02762708|101313743|FG000|COMPLETED|Study 1 - RYGB vs Caloric Restriction||3||
48401362|NCT02762708|101313744|FG001|COMPLETED|Study 1 - RYGB vs Caloric Restriction||7||
48401363|NCT02762708|101313745|FG002|COMPLETED|Study 1 - RYGB vs Caloric Restriction||0||
48401364|NCT02762708|101313746|FG003|COMPLETED|Study 1 - RYGB vs Caloric Restriction||0||
48401365|NCT02762708|101313743|FG000|NOT COMPLETED|Study 1 - RYGB vs Caloric Restriction||0||
48401366|NCT02762708|101313744|FG001|NOT COMPLETED|Study 1 - RYGB vs Caloric Restriction||2||
48401367|NCT02762708|101313745|FG002|NOT COMPLETED|Study 1 - RYGB vs Caloric Restriction||0||
48401368|NCT02762708|101313746|FG003|NOT COMPLETED|Study 1 - RYGB vs Caloric Restriction||0||
48401369|NCT02762708|101313743|FG000|STARTED|Study 2 - Exendin (9,39) Amide Study||0||
48401370|NCT02762708|101313744|FG001|STARTED|Study 2 - Exendin (9,39) Amide Study||0||
48401371|NCT02762708|101313745|FG002|STARTED|Study 2 - Exendin (9,39) Amide Study||1||
48401372|NCT02762708|101313746|FG003|STARTED|Study 2 - Exendin (9,39) Amide Study||0||
48584259|NCT00482677|101762106|FG000|STARTED|Overall Study||281||
48584260|NCT00482677|101762107|FG001|STARTED|Overall Study||281||
48584261|NCT00482677|101762106|FG000|COMPLETED|Overall Study||281||
48584262|NCT00482677|101762107|FG001|COMPLETED|Overall Study||281||
48584263|NCT00482677|101762106|FG000|NOT COMPLETED|Overall Study||0||
48584264|NCT00482677|101762107|FG001|NOT COMPLETED|Overall Study||0||
48584265|NCT00288067|101762108|FG000|STARTED|Overall Study||32||
48584266|NCT00288067|101762108|FG000|COMPLETED|Overall Study||32||
48584267|NCT00288067|101762108|FG000|NOT COMPLETED|Overall Study||0||
48584268|NCT05500274|101762109|FG000|STARTED|Overall Study||403||
48584269|NCT05500274|101762110|FG001|STARTED|Overall Study||407||
48584270|NCT05500274|101762109|FG000|COMPLETED|Overall Study||315||
48584271|NCT05500274|101762110|FG001|COMPLETED|Overall Study||314||
48584272|NCT05500274|101762109|FG000|NOT COMPLETED|Overall Study||88||
48584273|NCT05500274|101762110|FG001|NOT COMPLETED|Overall Study||93||
48584274|NCT01869699|101762111|FG000|STARTED|Overall Study||21||
48584275|NCT01869699|101762112|FG001|STARTED|Overall Study||20||
48584276|NCT01869699|101762111|FG000|COMPLETED|Overall Study||20||
48584277|NCT01869699|101762112|FG001|COMPLETED|Overall Study||20||
48584278|NCT01869699|101762111|FG000|NOT COMPLETED|Overall Study||1||
48401373|NCT02762708|101313743|FG000|COMPLETED|Study 2 - Exendin (9,39) Amide Study||0||
48401374|NCT02762708|101313744|FG001|COMPLETED|Study 2 - Exendin (9,39) Amide Study||0||
48401375|NCT02762708|101313745|FG002|COMPLETED|Study 2 - Exendin (9,39) Amide Study||1||
48401376|NCT02762708|101313746|FG003|COMPLETED|Study 2 - Exendin (9,39) Amide Study||0||
48401377|NCT02762708|101313743|FG000|NOT COMPLETED|Study 2 - Exendin (9,39) Amide Study||0||
48401378|NCT02762708|101313744|FG001|NOT COMPLETED|Study 2 - Exendin (9,39) Amide Study||0||
48401379|NCT02762708|101313745|FG002|NOT COMPLETED|Study 2 - Exendin (9,39) Amide Study||0||
48401380|NCT02762708|101313746|FG003|NOT COMPLETED|Study 2 - Exendin (9,39) Amide Study||0||
48401381|NCT02157168|101313747|FG000|STARTED|Overall Study||746||
48401382|NCT02157168|101313748|FG001|STARTED|Overall Study||159||
48401383|NCT02157168|101313749|FG002|STARTED|Overall Study||1362||
48401384|NCT02157168|101313747|FG000|COMPLETED|Overall Study||746||
48401385|NCT02157168|101313748|FG001|COMPLETED|Overall Study||159||
48401386|NCT02157168|101313749|FG002|COMPLETED|Overall Study||1362||
48401387|NCT02157168|101313747|FG000|NOT COMPLETED|Overall Study||0||
48401388|NCT02157168|101313748|FG001|NOT COMPLETED|Overall Study||0||
48401389|NCT02157168|101313749|FG002|NOT COMPLETED|Overall Study||0||
48401390|NCT01628393|101313750|FG000|STARTED|Placebo-controlled Treatment Period||88||
48401391|NCT01628393|101313751|FG001|STARTED|Placebo-controlled Treatment Period||87||
48401392|NCT01628393|101313752|FG002|STARTED|Placebo-controlled Treatment Period||83||
48401393|NCT01628393|101313753|FG003|STARTED|Placebo-controlled Treatment Period||0||
48401394|NCT01628393|101313754|FG004|STARTED|Placebo-controlled Treatment Period||0||
48401395|NCT01628393|101313750|FG000|COMPLETED|Placebo-controlled Treatment Period||85||
48401396|NCT01628393|101313751|FG001|COMPLETED|Placebo-controlled Treatment Period||85||
48401397|NCT01628393|101313752|FG002|COMPLETED|Placebo-controlled Treatment Period||82||
48401398|NCT01628393|101313753|FG003|COMPLETED|Placebo-controlled Treatment Period||0||
48401399|NCT01628393|101313754|FG004|COMPLETED|Placebo-controlled Treatment Period||0||
48401400|NCT01628393|101313750|FG000|NOT COMPLETED|Placebo-controlled Treatment Period||3||
48401401|NCT01628393|101313751|FG001|NOT COMPLETED|Placebo-controlled Treatment Period||2||
48584279|NCT01869699|101762112|FG001|NOT COMPLETED|Overall Study||0||
48584280|NCT01597375|101762113|FG000|STARTED|First Intervention (4 Weeks)||23||
48584281|NCT01597375|101762114|FG001|STARTED|First Intervention (4 Weeks)||23||
48584282|NCT01597375|101762113|FG000|COMPLETED|First Intervention (4 Weeks)||21||
48584283|NCT01597375|101762114|FG001|COMPLETED|First Intervention (4 Weeks)||22||
48584284|NCT01597375|101762113|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2||
48584285|NCT01597375|101762114|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1||
48584286|NCT01597375|101762113|FG000|STARTED|Washout (2 Weeks)||21||
48584287|NCT01597375|101762114|FG001|STARTED|Washout (2 Weeks)||22||
48584288|NCT01597375|101762113|FG000|COMPLETED|Washout (2 Weeks)||20||
48584289|NCT01597375|101762114|FG001|COMPLETED|Washout (2 Weeks)||22||
48584290|NCT01597375|101762113|FG000|NOT COMPLETED|Washout (2 Weeks)||1||
48584291|NCT01597375|101762114|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
48584292|NCT01597375|101762113|FG000|STARTED|Second Intervention||20||
48401402|NCT01628393|101313752|FG002|NOT COMPLETED|Placebo-controlled Treatment Period||1||
48401403|NCT01628393|101313753|FG003|NOT COMPLETED|Placebo-controlled Treatment Period||0||
48401404|NCT01628393|101313754|FG004|NOT COMPLETED|Placebo-controlled Treatment Period||0||
48401405|NCT01628393|101313750|FG000|STARTED|Blinded Active Extension Period||0|Three participants who completed the placebo-controlled treatment period declined to enter the blinded extension period.|
48401406|NCT01628393|101313751|FG001|STARTED|Blinded Active Extension Period||85|Three participants who completed the placebo-controlled treatment period declined to enter the blinded extension period.|
48401407|NCT01628393|101313752|FG002|STARTED|Blinded Active Extension Period||81|Three participants who completed the placebo-controlled treatment period declined to enter the blinded extension period.|
48401408|NCT01628393|101313753|FG003|STARTED|Blinded Active Extension Period||41|Three participants who completed the placebo-controlled treatment period declined to enter the blinded extension period.|
48401409|NCT01628393|101313754|FG004|STARTED|Blinded Active Extension Period||42|Three participants who completed the placebo-controlled treatment period declined to enter the blinded extension period.|
48401410|NCT01628393|101313750|FG000|COMPLETED|Blinded Active Extension Period||0||
48401411|NCT01628393|101313751|FG001|COMPLETED|Blinded Active Extension Period||75||
48401412|NCT01628393|101313752|FG002|COMPLETED|Blinded Active Extension Period||75||
48705665|NCT03447314|102065119|FG013|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
48705666|NCT03447314|102065120|FG014|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
48705667|NCT03447314|102065121|FG015|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
48705668|NCT03447314|102065122|FG016|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
48705669|NCT03447314|102065123|FG017|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
48705670|NCT03447314|102065106|FG000|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48705671|NCT03447314|102065107|FG001|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48705672|NCT03447314|102065108|FG002|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48705673|NCT03447314|102065109|FG003|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48705674|NCT03447314|102065110|FG004|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48705675|NCT03447314|102065111|FG005|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48705676|NCT03447314|102065112|FG006|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48705677|NCT03447314|102065113|FG007|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48705678|NCT03447314|102065114|FG008|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48705679|NCT03447314|102065115|FG009|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48705680|NCT03447314|102065116|FG010|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48705681|NCT03447314|102065117|FG011|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48705682|NCT03447314|102065118|FG012|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48705683|NCT03447314|102065119|FG013|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48705684|NCT03447314|102065120|FG014|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48705685|NCT03447314|102065121|FG015|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48705686|NCT03447314|102065122|FG016|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48705687|NCT03447314|102065123|FG017|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48705688|NCT03447314|102065106|FG000|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48705689|NCT03447314|102065107|FG001|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48705690|NCT03447314|102065108|FG002|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48137629|NCT02105948|100661528|FG003|Withdrew IP Due to: Adverse Event|Overall Study||13||
48137630|NCT02105948|100661525|FG000|Withdrew IP Due to: Lack of Efficacy|Overall Study||5||
48137631|NCT02105948|100661526|FG001|Withdrew IP Due to: Lack of Efficacy|Overall Study||2||
48289268|NCT02315352|101037330|FG000|NOT COMPLETED|First Intervention (Day 1)||0||
48137632|NCT02105948|100661527|FG002|Withdrew IP Due to: Lack of Efficacy|Overall Study||8||
48137633|NCT02105948|100661528|FG003|Withdrew IP Due to: Lack of Efficacy|Overall Study||2||
48137634|NCT02105948|100661525|FG000|Withdrew IP Due to: Protocol Deviation|Overall Study||1||
48137635|NCT02105948|100661526|FG001|Withdrew IP Due to: Protocol Deviation|Overall Study||3||
48137636|NCT02105948|100661527|FG002|Withdrew IP Due to: Protocol Deviation|Overall Study||3||
48289269|NCT02315352|101037331|FG001|NOT COMPLETED|First Intervention (Day 1)||0||
48289270|NCT02315352|101037332|FG002|NOT COMPLETED|First Intervention (Day 1)||0||
48289271|NCT02315352|101037333|FG003|NOT COMPLETED|First Intervention (Day 1)||0||
48289272|NCT02315352|101037334|FG004|NOT COMPLETED|First Intervention (Day 1)||0||
48289273|NCT02315352|101037335|FG005|NOT COMPLETED|First Intervention (Day 1)||0||
48289274|NCT02315352|101037336|FG006|NOT COMPLETED|First Intervention (Day 1)||0||
48289275|NCT02315352|101037337|FG007|NOT COMPLETED|First Intervention (Day 1)||0||
48401413|NCT01628393|101313753|FG003|COMPLETED|Blinded Active Extension Period||37||
48401414|NCT01628393|101313754|FG004|COMPLETED|Blinded Active Extension Period||36||
48401415|NCT01628393|101313750|FG000|NOT COMPLETED|Blinded Active Extension Period||0||
48401416|NCT01628393|101313751|FG001|NOT COMPLETED|Blinded Active Extension Period||10||
48401417|NCT01628393|101313752|FG002|NOT COMPLETED|Blinded Active Extension Period||6||
48401418|NCT01628393|101313753|FG003|NOT COMPLETED|Blinded Active Extension Period||4||
48401419|NCT01628393|101313754|FG004|NOT COMPLETED|Blinded Active Extension Period||6||
48401420|NCT01607073|101313755|FG000|STARTED|Overall Study||2||
48401421|NCT01607073|101313755|FG000|COMPLETED|Overall Study||1||
48401422|NCT01607073|101313755|FG000|NOT COMPLETED|Overall Study||1||
48401423|NCT00437203|101313756|FG000|STARTED|Overall Study||6||
48137637|NCT02105948|100661528|FG003|Withdrew IP Due to: Protocol Deviation|Overall Study||0||
48401424|NCT00437203|101313757|FG001|STARTED|Overall Study||8||
48401425|NCT00437203|101313758|FG002|STARTED|Overall Study||3||
48401426|NCT00437203|101313759|FG003|STARTED|Overall Study||3||
48401427|NCT00437203|101313760|FG004|STARTED|Overall Study||3||
48401428|NCT00437203|101313761|FG005|STARTED|Overall Study||3||
48401429|NCT00437203|101313762|FG006|STARTED|Overall Study||7||
48401430|NCT00437203|101313763|FG007|STARTED|Overall Study||3||
48401431|NCT00437203|101313764|FG008|STARTED|Overall Study||3||
48401432|NCT00437203|101313765|FG009|STARTED|Overall Study||4||
48401433|NCT00437203|101313756|FG000|COMPLETED|Overall Study||0||
48401434|NCT00437203|101313757|FG001|COMPLETED|Overall Study||0||
48401435|NCT00437203|101313758|FG002|COMPLETED|Overall Study||0||
48401436|NCT00437203|101313759|FG003|COMPLETED|Overall Study||0||
48584293|NCT01597375|101762114|FG001|STARTED|Second Intervention||22||
48584294|NCT01597375|101762113|FG000|COMPLETED|Second Intervention||19||
48584295|NCT01597375|101762114|FG001|COMPLETED|Second Intervention||21||
48584296|NCT01597375|101762113|FG000|NOT COMPLETED|Second Intervention||1||
48137638|NCT02105948|100661525|FG000|Withdrew IP Due to: Lost to Follow-up|Overall Study||0||
48137639|NCT02105948|100661526|FG001|Withdrew IP Due to: Lost to Follow-up|Overall Study||0||
48289276|NCT02315352|101037330|FG000|STARTED|Second Intervention (Day 1)||24||
48289277|NCT02315352|101037331|FG001|STARTED|Second Intervention (Day 1)||24||
48289278|NCT02315352|101037332|FG002|STARTED|Second Intervention (Day 1)||0||
48289279|NCT02315352|101037333|FG003|STARTED|Second Intervention (Day 1)||0||
48289280|NCT02315352|101037334|FG004|STARTED|Second Intervention (Day 1)||0||
48289281|NCT02315352|101037335|FG005|STARTED|Second Intervention (Day 1)||0||
48289282|NCT02315352|101037336|FG006|STARTED|Second Intervention (Day 1)||0||
48289283|NCT02315352|101037337|FG007|STARTED|Second Intervention (Day 1)||0||
48289284|NCT02315352|101037330|FG000|COMPLETED|Second Intervention (Day 1)||24||
48289285|NCT02315352|101037331|FG001|COMPLETED|Second Intervention (Day 1)||24||
48289286|NCT02315352|101037332|FG002|COMPLETED|Second Intervention (Day 1)||0||
48289287|NCT02315352|101037333|FG003|COMPLETED|Second Intervention (Day 1)||0||
48289288|NCT02315352|101037334|FG004|COMPLETED|Second Intervention (Day 1)||0||
48289289|NCT02315352|101037335|FG005|COMPLETED|Second Intervention (Day 1)||0||
48289290|NCT02315352|101037336|FG006|COMPLETED|Second Intervention (Day 1)||0||
48289291|NCT02315352|101037337|FG007|COMPLETED|Second Intervention (Day 1)||0||
48289292|NCT02315352|101037330|FG000|NOT COMPLETED|Second Intervention (Day 1)||0||
48289293|NCT02315352|101037331|FG001|NOT COMPLETED|Second Intervention (Day 1)||0||
48289294|NCT02315352|101037332|FG002|NOT COMPLETED|Second Intervention (Day 1)||0||
48289295|NCT02315352|101037333|FG003|NOT COMPLETED|Second Intervention (Day 1)||0||
48289296|NCT02315352|101037334|FG004|NOT COMPLETED|Second Intervention (Day 1)||0||
48289297|NCT02315352|101037335|FG005|NOT COMPLETED|Second Intervention (Day 1)||0||
48289298|NCT02315352|101037336|FG006|NOT COMPLETED|Second Intervention (Day 1)||0||
48289299|NCT02315352|101037337|FG007|NOT COMPLETED|Second Intervention (Day 1)||0||
48289300|NCT02315352|101037330|FG000|STARTED|Third Intervention (Day 2)||0||
48289301|NCT02315352|101037331|FG001|STARTED|Third Intervention (Day 2)||0||
48289302|NCT02315352|101037332|FG002|STARTED|Third Intervention (Day 2)||7||
48289303|NCT02315352|101037333|FG003|STARTED|Third Intervention (Day 2)||8||
48289304|NCT02315352|101037334|FG004|STARTED|Third Intervention (Day 2)||8||
48289305|NCT02315352|101037335|FG005|STARTED|Third Intervention (Day 2)||7||
48289306|NCT02315352|101037336|FG006|STARTED|Third Intervention (Day 2)||9||
48289307|NCT02315352|101037337|FG007|STARTED|Third Intervention (Day 2)||8||
48289308|NCT02315352|101037330|FG000|COMPLETED|Third Intervention (Day 2)||0||
48289309|NCT02315352|101037331|FG001|COMPLETED|Third Intervention (Day 2)||0||
48289310|NCT02315352|101037332|FG002|COMPLETED|Third Intervention (Day 2)||7||
48289311|NCT02315352|101037333|FG003|COMPLETED|Third Intervention (Day 2)||8||
48289312|NCT02315352|101037334|FG004|COMPLETED|Third Intervention (Day 2)||8||
48289313|NCT02315352|101037335|FG005|COMPLETED|Third Intervention (Day 2)||7||
48289314|NCT02315352|101037336|FG006|COMPLETED|Third Intervention (Day 2)||9||
48289315|NCT02315352|101037337|FG007|COMPLETED|Third Intervention (Day 2)||8||
48401437|NCT00437203|101313760|FG004|COMPLETED|Overall Study||0||
48401438|NCT00437203|101313761|FG005|COMPLETED|Overall Study||0||
48401439|NCT00437203|101313762|FG006|COMPLETED|Overall Study||0||
48401440|NCT00437203|101313763|FG007|COMPLETED|Overall Study||0||
48401441|NCT00437203|101313764|FG008|COMPLETED|Overall Study||0||
48401442|NCT00437203|101313765|FG009|COMPLETED|Overall Study||0||
48401443|NCT00437203|101313756|FG000|NOT COMPLETED|Overall Study||6||
48401444|NCT00437203|101313757|FG001|NOT COMPLETED|Overall Study||8||
48401445|NCT00437203|101313758|FG002|NOT COMPLETED|Overall Study||3||
48401446|NCT00437203|101313759|FG003|NOT COMPLETED|Overall Study||3||
48137640|NCT02105948|100661527|FG002|Withdrew IP Due to: Lost to Follow-up|Overall Study||1||
48137641|NCT02105948|100661528|FG003|Withdrew IP Due to: Lost to Follow-up|Overall Study||2||
48401447|NCT00437203|101313760|FG004|NOT COMPLETED|Overall Study||3||
48401448|NCT00437203|101313761|FG005|NOT COMPLETED|Overall Study||3||
48401449|NCT00437203|101313762|FG006|NOT COMPLETED|Overall Study||7||
48401450|NCT00437203|101313763|FG007|NOT COMPLETED|Overall Study||3||
48584297|NCT01597375|101762114|FG001|NOT COMPLETED|Second Intervention||1||
48137642|NCT02105948|100661525|FG000|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16||
48584298|NCT02314260|101762115|FG000|STARTED|Overall Study||80||
48401451|NCT00437203|101313764|FG008|NOT COMPLETED|Overall Study||3||
48401452|NCT00437203|101313765|FG009|NOT COMPLETED|Overall Study||4||
48401453|NCT00527072|101313766|FG000|STARTED|Overall Study||215||
48401454|NCT00527072|101313766|FG000|COMPLETED|Overall Study||179||
48584299|NCT02314260|101762115|FG000|COMPLETED|Overall Study||80||
48137643|NCT02105948|100661526|FG001|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||8||
48137644|NCT02105948|100661527|FG002|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11||
48137645|NCT02105948|100661528|FG003|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||15||
48137646|NCT02105948|100661525|FG000|Withdrew IP Due to: Physician Decision|Overall Study||2||
48137647|NCT02105948|100661526|FG001|Withdrew IP Due to: Physician Decision|Overall Study||1||
48137648|NCT02105948|100661527|FG002|Withdrew IP Due to: Physician Decision|Overall Study||4||
48137649|NCT02105948|100661528|FG003|Withdrew IP Due to: Physician Decision|Overall Study||2||
48137650|NCT02105948|100661525|FG000|Withdrew IP Due to: Stopping Criteria|Overall Study||0||
48137651|NCT02105948|100661526|FG001|Withdrew IP Due to: Stopping Criteria|Overall Study||0||
48137652|NCT02105948|100661527|FG002|Withdrew IP Due to: Stopping Criteria|Overall Study||0||
48137653|NCT02105948|100661528|FG003|Withdrew IP Due to: Stopping Criteria|Overall Study||1||
48137654|NCT02105948|100661525|FG000|COMPLETED|Overall Study||202||
48137655|NCT02105948|100661526|FG001|COMPLETED|Overall Study||213||
48137656|NCT02105948|100661527|FG002|COMPLETED|Overall Study||162||
48137657|NCT02105948|100661528|FG003|COMPLETED|Overall Study||157||
48137658|NCT02105948|100661525|FG000|NOT COMPLETED|Overall Study||27||
48137659|NCT02105948|100661526|FG001|NOT COMPLETED|Overall Study||20||
48137660|NCT02105948|100661527|FG002|NOT COMPLETED|Overall Study||28||
48137661|NCT02105948|100661528|FG003|NOT COMPLETED|Overall Study||27||
48137662|NCT02682264|100661529|FG000|STARTED|Overall Study||317||
48289316|NCT02315352|101037330|FG000|NOT COMPLETED|Third Intervention (Day 2)||0||
48289317|NCT02315352|101037331|FG001|NOT COMPLETED|Third Intervention (Day 2)||0||
48289318|NCT02315352|101037332|FG002|NOT COMPLETED|Third Intervention (Day 2)||0||
48289319|NCT02315352|101037333|FG003|NOT COMPLETED|Third Intervention (Day 2)||0||
48289320|NCT02315352|101037334|FG004|NOT COMPLETED|Third Intervention (Day 2)||0||
48289321|NCT02315352|101037335|FG005|NOT COMPLETED|Third Intervention (Day 2)||0||
48289322|NCT02315352|101037336|FG006|NOT COMPLETED|Third Intervention (Day 2)||0||
48289323|NCT02315352|101037337|FG007|NOT COMPLETED|Third Intervention (Day 2)||0||
48289324|NCT02315352|101037330|FG000|STARTED|Fourth Intervention (Day 2)||0||
48289325|NCT02315352|101037331|FG001|STARTED|Fourth Intervention (Day 2)||0||
48289326|NCT02315352|101037332|FG002|STARTED|Fourth Intervention (Day 2)||7||
48289327|NCT02315352|101037333|FG003|STARTED|Fourth Intervention (Day 2)||8||
48289328|NCT02315352|101037334|FG004|STARTED|Fourth Intervention (Day 2)||8||
48289329|NCT02315352|101037335|FG005|STARTED|Fourth Intervention (Day 2)||7||
48289330|NCT02315352|101037336|FG006|STARTED|Fourth Intervention (Day 2)||9||
48289331|NCT02315352|101037337|FG007|STARTED|Fourth Intervention (Day 2)||8||
48289332|NCT02315352|101037330|FG000|COMPLETED|Fourth Intervention (Day 2)||0||
48289333|NCT02315352|101037331|FG001|COMPLETED|Fourth Intervention (Day 2)||0||
48289334|NCT02315352|101037332|FG002|COMPLETED|Fourth Intervention (Day 2)||7||
48289335|NCT02315352|101037333|FG003|COMPLETED|Fourth Intervention (Day 2)||8||
48289336|NCT02315352|101037334|FG004|COMPLETED|Fourth Intervention (Day 2)||8||
48289337|NCT02315352|101037335|FG005|COMPLETED|Fourth Intervention (Day 2)||7||
48289338|NCT02315352|101037336|FG006|COMPLETED|Fourth Intervention (Day 2)||9||
48289339|NCT02315352|101037337|FG007|COMPLETED|Fourth Intervention (Day 2)||8||
48289340|NCT02315352|101037330|FG000|NOT COMPLETED|Fourth Intervention (Day 2)||0||
48289341|NCT02315352|101037331|FG001|NOT COMPLETED|Fourth Intervention (Day 2)||0||
48289342|NCT02315352|101037332|FG002|NOT COMPLETED|Fourth Intervention (Day 2)||0||
48289343|NCT02315352|101037333|FG003|NOT COMPLETED|Fourth Intervention (Day 2)||0||
48289344|NCT02315352|101037334|FG004|NOT COMPLETED|Fourth Intervention (Day 2)||0||
48289345|NCT02315352|101037335|FG005|NOT COMPLETED|Fourth Intervention (Day 2)||0||
48289346|NCT02315352|101037336|FG006|NOT COMPLETED|Fourth Intervention (Day 2)||0||
48289347|NCT02315352|101037337|FG007|NOT COMPLETED|Fourth Intervention (Day 2)||0||
48401455|NCT00527072|101313766|FG000|NOT COMPLETED|Overall Study||36||
48401456|NCT00614991|101313767|FG000|STARTED|Overall Study||8||
48401457|NCT00614991|101313768|FG001|STARTED|Overall Study||9||
48401458|NCT00614991|101313769|FG002|STARTED|Overall Study||7||
48401459|NCT00614991|101313770|FG003|STARTED|Overall Study||7||
48401460|NCT00614991|101313771|FG004|STARTED|Overall Study||7||
48584300|NCT02314260|101762115|FG000|NOT COMPLETED|Overall Study||0||
48584301|NCT01729338|101762116|FG000|STARTED|Overall Study||16||
48584302|NCT01729338|101762116|FG000|COMPLETED|Overall Study||14||
48584303|NCT01729338|101762116|FG000|NOT COMPLETED|Overall Study||2||
48584304|NCT00978250|101762117|FG000|STARTED|Overall Study||25||
48584305|NCT00978250|101762118|FG001|STARTED|Overall Study||30||
48401461|NCT00614991|101313772|FG005|STARTED|Overall Study||6||
48401462|NCT00614991|101313767|FG000|COMPLETED|Overall Study||5||
48289348|NCT02315352|101037330|FG000|STARTED|Fifth Intervention (Day 2)||0||
48289349|NCT02315352|101037331|FG001|STARTED|Fifth Intervention (Day 2)||0||
48401463|NCT00614991|101313768|FG001|COMPLETED|Overall Study||6||
48401464|NCT00614991|101313769|FG002|COMPLETED|Overall Study||7||
48401465|NCT00614991|101313770|FG003|COMPLETED|Overall Study||7||
48584306|NCT00978250|101762119|FG002|STARTED|Overall Study||18||
48584307|NCT00978250|101762120|FG003|STARTED|Overall Study||22||
48289350|NCT02315352|101037332|FG002|STARTED|Fifth Intervention (Day 2)||7||
48289351|NCT02315352|101037333|FG003|STARTED|Fifth Intervention (Day 2)||8||
48289352|NCT02315352|101037334|FG004|STARTED|Fifth Intervention (Day 2)||8||
48289353|NCT02315352|101037335|FG005|STARTED|Fifth Intervention (Day 2)||7||
48289354|NCT02315352|101037336|FG006|STARTED|Fifth Intervention (Day 2)||9||
48289355|NCT02315352|101037337|FG007|STARTED|Fifth Intervention (Day 2)||8||
48289356|NCT02315352|101037330|FG000|COMPLETED|Fifth Intervention (Day 2)||0||
48289357|NCT02315352|101037331|FG001|COMPLETED|Fifth Intervention (Day 2)||0||
48289358|NCT02315352|101037332|FG002|COMPLETED|Fifth Intervention (Day 2)||7||
48289359|NCT02315352|101037333|FG003|COMPLETED|Fifth Intervention (Day 2)||8||
48289360|NCT02315352|101037334|FG004|COMPLETED|Fifth Intervention (Day 2)||8||
48289361|NCT02315352|101037335|FG005|COMPLETED|Fifth Intervention (Day 2)||7||
48289362|NCT02315352|101037336|FG006|COMPLETED|Fifth Intervention (Day 2)||9||
48289363|NCT02315352|101037337|FG007|COMPLETED|Fifth Intervention (Day 2)||8||
48289364|NCT02315352|101037330|FG000|NOT COMPLETED|Fifth Intervention (Day 2)||0||
48289365|NCT02315352|101037331|FG001|NOT COMPLETED|Fifth Intervention (Day 2)||0||
48289366|NCT02315352|101037332|FG002|NOT COMPLETED|Fifth Intervention (Day 2)||0||
48289367|NCT02315352|101037333|FG003|NOT COMPLETED|Fifth Intervention (Day 2)||0||
48584308|NCT00978250|101762117|FG000|COMPLETED|Overall Study||25||
48584309|NCT00978250|101762118|FG001|COMPLETED|Overall Study||29||
48584310|NCT00978250|101762119|FG002|COMPLETED|Overall Study||18||
48584311|NCT00978250|101762120|FG003|COMPLETED|Overall Study||21||
48584312|NCT00978250|101762117|FG000|NOT COMPLETED|Overall Study||0||
48584313|NCT00978250|101762118|FG001|NOT COMPLETED|Overall Study||1||
48584314|NCT00978250|101762119|FG002|NOT COMPLETED|Overall Study||0||
48584315|NCT00978250|101762120|FG003|NOT COMPLETED|Overall Study||1||
48584316|NCT02225366|101762121|FG000|STARTED|Overall Study||2||
48584317|NCT02225366|101762122|FG001|STARTED|Overall Study||1||
48584318|NCT02225366|101762121|FG000|COMPLETED|Overall Study||1||
48584319|NCT02225366|101762122|FG001|COMPLETED|Overall Study||1||
48584320|NCT02225366|101762121|FG000|NOT COMPLETED|Overall Study||1||
48584321|NCT02225366|101762122|FG001|NOT COMPLETED|Overall Study||0||
48584322|NCT00976820|101762123|FG000|STARTED|Overall Study||67||
48584323|NCT00976820|101762124|FG001|STARTED|Overall Study||128||
48584324|NCT00976820|101762125|FG002|STARTED|Overall Study||64||
48584325|NCT00976820|101762126|FG003|STARTED|Overall Study||63||
48584326|NCT00976820|101762123|FG000|COMPLETED|Overall Study||59||
48289368|NCT02315352|101037334|FG004|NOT COMPLETED|Fifth Intervention (Day 2)||0||
48289369|NCT02315352|101037335|FG005|NOT COMPLETED|Fifth Intervention (Day 2)||0||
48289370|NCT02315352|101037336|FG006|NOT COMPLETED|Fifth Intervention (Day 2)||0||
48289371|NCT02315352|101037337|FG007|NOT COMPLETED|Fifth Intervention (Day 2)||0||
48289372|NCT03541174|101037338|FG000|STARTED|Part 1 Double-Blind||243||
48289373|NCT03541174|101037339|FG001|STARTED|Part 1 Double-Blind||243||
48289374|NCT03541174|101037340|FG002|STARTED|Part 1 Double-Blind||244||
48289375|NCT03541174|101037341|FG003|STARTED|Part 1 Double-Blind||0||
48289376|NCT03541174|101037342|FG004|STARTED|Part 1 Double-Blind||0||
48289377|NCT03541174|101037343|FG005|STARTED|Part 1 Double-Blind||0||
48289378|NCT03541174|101037338|FG000|Safety Set|Part 1 Double-Blind||243|Two participants randomized to placebo received at least one dose of aprocitentan 25 mg during double-blind part 1.|
48289379|NCT03541174|101037339|FG001|Safety Set|Part 1 Double-Blind||245|Two participants randomized to placebo received at least one dose of aprocitentan 25 mg during double-blind part 1.|
48289380|NCT03541174|101037340|FG002|Safety Set|Part 1 Double-Blind||242|Two participants randomized to placebo received at least one dose of aprocitentan 25 mg during double-blind part 1.|
48584327|NCT00976820|101762124|FG001|COMPLETED|Overall Study||108||
48584328|NCT00976820|101762125|FG002|COMPLETED|Overall Study||60||
48584329|NCT00976820|101762126|FG003|COMPLETED|Overall Study||56||
48584330|NCT00976820|101762123|FG000|NOT COMPLETED|Overall Study||8||
48584331|NCT00976820|101762124|FG001|NOT COMPLETED|Overall Study||20||
48584332|NCT00976820|101762125|FG002|NOT COMPLETED|Overall Study||4||
48584333|NCT00976820|101762126|FG003|NOT COMPLETED|Overall Study||7||
48584334|NCT01996410|101762127|FG000|STARTED|Overall Study||3||
48584335|NCT01996410|101762128|FG001|STARTED|Overall Study||3||
48584336|NCT01996410|101762129|FG002|STARTED|Overall Study||0||
48584337|NCT01996410|101762130|FG003|STARTED|Overall Study||0||
48289381|NCT03541174|101037341|FG003|Safety Set|Part 1 Double-Blind||0|Two participants randomized to placebo received at least one dose of aprocitentan 25 mg during double-blind part 1.|
48289382|NCT03541174|101037342|FG004|Safety Set|Part 1 Double-Blind||0|Two participants randomized to placebo received at least one dose of aprocitentan 25 mg during double-blind part 1.|
48289383|NCT03541174|101037343|FG005|Safety Set|Part 1 Double-Blind||0|Two participants randomized to placebo received at least one dose of aprocitentan 25 mg during double-blind part 1.|
48289384|NCT03541174|101037338|FG000|COMPLETED|Part 1 Double-Blind||232||
48289385|NCT03541174|101037339|FG001|COMPLETED|Part 1 Double-Blind||234||
48289386|NCT03541174|101037340|FG002|COMPLETED|Part 1 Double-Blind||238||
48584338|NCT01996410|101762131|FG004|STARTED|Overall Study||2||
48584339|NCT01996410|101762132|FG005|STARTED|Overall Study||2||
48584340|NCT01996410|101762133|FG006|STARTED|Overall Study||0||
48584341|NCT01996410|101762134|FG007|STARTED|Overall Study||0||
48584342|NCT01996410|101762127|FG000|COMPLETED|Overall Study||3||
48584343|NCT01996410|101762128|FG001|COMPLETED|Overall Study||3||
48289387|NCT03541174|101037341|FG003|COMPLETED|Part 1 Double-Blind||0||
48401466|NCT00614991|101313771|FG004|COMPLETED|Overall Study||6||
48584344|NCT01996410|101762129|FG002|COMPLETED|Overall Study||0||
48584345|NCT01996410|101762130|FG003|COMPLETED|Overall Study||0||
48584346|NCT01996410|101762131|FG004|COMPLETED|Overall Study||2||
48584347|NCT01996410|101762132|FG005|COMPLETED|Overall Study||2||
48584348|NCT01996410|101762133|FG006|COMPLETED|Overall Study||0||
48584349|NCT01996410|101762134|FG007|COMPLETED|Overall Study||0||
48584350|NCT01996410|101762127|FG000|NOT COMPLETED|Overall Study||0||
48584351|NCT01996410|101762128|FG001|NOT COMPLETED|Overall Study||0||
48584352|NCT01996410|101762129|FG002|NOT COMPLETED|Overall Study||0||
48584353|NCT01996410|101762130|FG003|NOT COMPLETED|Overall Study||0||
48584354|NCT01996410|101762131|FG004|NOT COMPLETED|Overall Study||0||
48584355|NCT01996410|101762132|FG005|NOT COMPLETED|Overall Study||0||
48584356|NCT01996410|101762133|FG006|NOT COMPLETED|Overall Study||0||
48584357|NCT01996410|101762134|FG007|NOT COMPLETED|Overall Study||0||
48584358|NCT01876784|101762135|FG000|STARTED|Randomized Treatment Period (40 Months)||119||
48584359|NCT01876784|101762136|FG001|STARTED|Randomized Treatment Period (40 Months)||119||
48584360|NCT01876784|101762135|FG000|Treated|Randomized Treatment Period (40 Months)||117||
48584361|NCT01876784|101762136|FG001|Treated|Randomized Treatment Period (40 Months)||118||
48584362|NCT01876784|101762135|FG000|COMPLETED|Randomized Treatment Period (40 Months)||0||
48584363|NCT01876784|101762136|FG001|COMPLETED|Randomized Treatment Period (40 Months)||0||
48584364|NCT01876784|101762135|FG000|NOT COMPLETED|Randomized Treatment Period (40 Months)||119||
48584365|NCT01876784|101762136|FG001|NOT COMPLETED|Randomized Treatment Period (40 Months)||119||
48584366|NCT01876784|101762135|FG000|STARTED|Open-label Period (31 Months)||23|Post completion of randomized treatment period, only eligible participants entered Open label period.|
48584367|NCT01876784|101762136|FG001|STARTED|Open-label Period (31 Months)||74|Post completion of randomized treatment period, only eligible participants entered Open label period.|
48584368|NCT01876784|101762135|FG000|COMPLETED|Open-label Period (31 Months)||0||
48289388|NCT03541174|101037342|FG004|COMPLETED|Part 1 Double-Blind||0||
48289389|NCT03541174|101037343|FG005|COMPLETED|Part 1 Double-Blind||0||
48289390|NCT03541174|101037338|FG000|NOT COMPLETED|Part 1 Double-Blind||11||
48289391|NCT03541174|101037339|FG001|NOT COMPLETED|Part 1 Double-Blind||9||
48289392|NCT03541174|101037340|FG002|NOT COMPLETED|Part 1 Double-Blind||6||
48289393|NCT03541174|101037341|FG003|NOT COMPLETED|Part 1 Double-Blind||0||
48289394|NCT03541174|101037342|FG004|NOT COMPLETED|Part 1 Double-Blind||0||
48289395|NCT03541174|101037343|FG005|NOT COMPLETED|Part 1 Double-Blind||0||
48401467|NCT00614991|101313772|FG005|COMPLETED|Overall Study||6||
48401468|NCT00614991|101313767|FG000|NOT COMPLETED|Overall Study||3||
48401469|NCT00614991|101313768|FG001|NOT COMPLETED|Overall Study||3||
48584369|NCT01876784|101762136|FG001|COMPLETED|Open-label Period (31 Months)||0||
48584370|NCT01876784|101762135|FG000|NOT COMPLETED|Open-label Period (31 Months)||23||
48584371|NCT01876784|101762136|FG001|NOT COMPLETED|Open-label Period (31 Months)||74||
48584372|NCT03533114|101762137|FG000|STARTED|Overall||88||
48584373|NCT03533114|101762138|FG001|STARTED|Overall||66||
48584374|NCT03533114|101762137|FG000|COMPLETED|Overall||57||
48584375|NCT03533114|101762138|FG001|COMPLETED|Overall||38||
48584376|NCT03533114|101762137|FG000|NOT COMPLETED|Overall||31||
48584377|NCT03533114|101762138|FG001|NOT COMPLETED|Overall||28||
48584378|NCT03533114|101762137|FG000|STARTED|Open Label Titration and Optimization||88||
48584379|NCT03533114|101762138|FG001|STARTED|Open Label Titration and Optimization||66||
48584380|NCT03533114|101762137|FG000|COMPLETED|Open Label Titration and Optimization||72||
48584381|NCT03533114|101762138|FG001|COMPLETED|Open Label Titration and Optimization||53||
48592836|NCT02938949|101786320|FG000|NOT COMPLETED|Overall Study||0||
48137663|NCT02682264|100661530|FG001|STARTED|Overall Study||290||
48137664|NCT02682264|100661529|FG000|COMPLETED|Overall Study||179||
48137665|NCT02682264|100661530|FG001|COMPLETED|Overall Study||168||
48137666|NCT02682264|100661529|FG000|NOT COMPLETED|Overall Study||138||
48137667|NCT02682264|100661530|FG001|NOT COMPLETED|Overall Study||122||
48137668|NCT03720704|100661531|FG000|STARTED|Overall Study||280||
48137669|NCT03720704|100661531|FG000|COMPLETED|Overall Study||210||
48137670|NCT03720704|100661531|FG000|NOT COMPLETED|Overall Study||70||
48137671|NCT02459574|100661532|FG000|STARTED|Overall Study||108||
48137672|NCT02459574|100661533|FG001|STARTED|Overall Study||103||
48137673|NCT02459574|100661534|FG002|STARTED|Overall Study||110||
48137674|NCT02459574|100661532|FG000|COMPLETED|Overall Study||101||
48137675|NCT02459574|100661533|FG001|COMPLETED|Overall Study||95||
48137676|NCT02459574|100661534|FG002|COMPLETED|Overall Study||108||
48137677|NCT02459574|100661532|FG000|NOT COMPLETED|Overall Study||7||
48137678|NCT02459574|100661533|FG001|NOT COMPLETED|Overall Study||8||
48137679|NCT02459574|100661534|FG002|NOT COMPLETED|Overall Study||2||
48137680|NCT00866840|100661535|FG000|STARTED|Overall Study||13||
48137681|NCT00866840|100661535|FG000|COMPLETED|Overall Study||13||
48137682|NCT00866840|100661535|FG000|NOT COMPLETED|Overall Study||0||
48137683|NCT01201629|100661536|FG000|STARTED|Overall Study||8|Study started in 9/16/2010|
48137684|NCT01201629|100661537|FG001|STARTED|Overall Study||8|Study started in 9/16/2010|
48137685|NCT01201629|100661536|FG000|COMPLETED|Overall Study||8|Study terminated in 12/2015|
48137686|NCT01201629|100661537|FG001|COMPLETED|Overall Study||8|Study terminated in 12/2015|
48137687|NCT01201629|100661536|FG000|NOT COMPLETED|Overall Study||0||
48137688|NCT01201629|100661537|FG001|NOT COMPLETED|Overall Study||0||
48137689|NCT01786967|100661538|FG000|STARTED|Overall Study||61||
48137690|NCT01786967|100661538|FG000|Extensive Metabolizers|Overall Study||54||
48137691|NCT01786967|100661538|FG000|Poor Metabolizers|Overall Study||4||
48137692|NCT01786967|100661538|FG000|Metabolizer Status Undetermined|Overall Study||3||
48137693|NCT01786967|100661538|FG000|COMPLETED|Overall Study||61||
48137694|NCT01786967|100661538|FG000|NOT COMPLETED|Overall Study||0||
48137695|NCT02012491|100661539|FG000|STARTED|Overall Study||151||
48137696|NCT02012491|100661540|FG001|STARTED|Overall Study||149||
48137697|NCT02012491|100661539|FG000|COMPLETED|Overall Study||149||
48137698|NCT02012491|100661540|FG001|COMPLETED|Overall Study||148||
48137699|NCT02012491|100661539|FG000|NOT COMPLETED|Overall Study||2||
48137700|NCT02012491|100661540|FG001|NOT COMPLETED|Overall Study||1||
48137701|NCT01360606|100661541|FG000|STARTED|50 Gy||3||
48137702|NCT01360606|100661542|FG001|STARTED|50 Gy||0||
48137703|NCT01360606|100661541|FG000|COMPLETED|50 Gy||3||
48137704|NCT01360606|100661542|FG001|COMPLETED|50 Gy||0||
48137705|NCT01360606|100661541|FG000|NOT COMPLETED|50 Gy||0||
48137706|NCT01360606|100661542|FG001|NOT COMPLETED|50 Gy||0||
48137707|NCT01360606|100661541|FG000|STARTED|60 Gy||0||
48137708|NCT01360606|100661542|FG001|STARTED|60 Gy||6||
48137709|NCT01360606|100661541|FG000|COMPLETED|60 Gy||0||
48137710|NCT01360606|100661542|FG001|COMPLETED|60 Gy||6||
48137711|NCT01360606|100661541|FG000|NOT COMPLETED|60 Gy||0||
48584382|NCT03533114|101762137|FG000|NOT COMPLETED|Open Label Titration and Optimization||16||
48584383|NCT03533114|101762138|FG001|NOT COMPLETED|Open Label Titration and Optimization||13||
48584384|NCT03533114|101762137|FG000|STARTED|Stable Dose||71||
48584385|NCT03533114|101762138|FG001|STARTED|Stable Dose||52||
48584386|NCT03533114|101762137|FG000|COMPLETED|Stable Dose||69||
48584387|NCT03533114|101762138|FG001|COMPLETED|Stable Dose||50||
48584388|NCT03533114|101762137|FG000|NOT COMPLETED|Stable Dose||2||
48584389|NCT03533114|101762138|FG001|NOT COMPLETED|Stable Dose||2||
48584390|NCT03533114|101762137|FG000|STARTED|Double Blind Randomized-Withdrawal||69||
48137712|NCT01360606|100661542|FG001|NOT COMPLETED|60 Gy||0||
48137713|NCT02252211|100661543|FG000|STARTED|Overall Study||5||
48137714|NCT02252211|100661544|FG001|STARTED|Overall Study||3||
48137715|NCT02252211|100661545|FG002|STARTED|Overall Study||1||
48137716|NCT02252211|100661543|FG000|Received Dose 1 (Day 1)|Overall Study||4||
48584391|NCT03533114|101762138|FG001|STARTED|Double Blind Randomized-Withdrawal||47||
48137717|NCT02252211|100661544|FG001|Received Dose 1 (Day 1)|Overall Study||3||
48137718|NCT02252211|100661545|FG002|Received Dose 1 (Day 1)|Overall Study||0||
48137719|NCT02252211|100661543|FG000|Received Dose 2 (Day 8)|Overall Study||4||
48137720|NCT02252211|100661544|FG001|Received Dose 2 (Day 8)|Overall Study||3||
48137721|NCT02252211|100661545|FG002|Received Dose 2 (Day 8)|Overall Study||0||
48137722|NCT02252211|100661543|FG000|Received Dose 3 (Day 22)|Overall Study||3||
48137723|NCT02252211|100661544|FG001|Received Dose 3 (Day 22)|Overall Study||3||
48137724|NCT02252211|100661545|FG002|Received Dose 3 (Day 22)|Overall Study||0||
48137725|NCT02252211|100661543|FG000|Received Dose 4 (Day 36)|Overall Study||1||
48137726|NCT02252211|100661544|FG001|Received Dose 4 (Day 36)|Overall Study||1||
48137727|NCT02252211|100661545|FG002|Received Dose 4 (Day 36)|Overall Study||0||
48137728|NCT02252211|100661543|FG000|Received Further Doses (Through Dose 24)|Overall Study||1||
48137729|NCT02252211|100661544|FG001|Received Further Doses (Through Dose 24)|Overall Study||0||
48137730|NCT02252211|100661545|FG002|Received Further Doses (Through Dose 24)|Overall Study||0||
48137731|NCT02252211|100661543|FG000|COMPLETED|Overall Study||0|Completed the study as planned per protocol|
48137732|NCT02252211|100661544|FG001|COMPLETED|Overall Study||0|Completed the study as planned per protocol|
48584392|NCT03533114|101762137|FG000|JZP-258|Double Blind Randomized-Withdrawal||57||
48137733|NCT02252211|100661545|FG002|COMPLETED|Overall Study||0|Completed the study as planned per protocol|
48137734|NCT02252211|100661543|FG000|NOT COMPLETED|Overall Study||5||
48137735|NCT02252211|100661544|FG001|NOT COMPLETED|Overall Study||3||
48137736|NCT02252211|100661545|FG002|NOT COMPLETED|Overall Study||1||
48137737|NCT01007591|100661546|FG000|STARTED|Overall Study||27||
48137738|NCT01007591|100661547|FG001|STARTED|Overall Study||13||
48137739|NCT01007591|100661546|FG000|COMPLETED|Overall Study||26||
48584393|NCT03533114|101762138|FG001|JZP-258|Double Blind Randomized-Withdrawal||0||
48584394|NCT03533114|101762137|FG000|Placebo|Double Blind Randomized-Withdrawal||0||
48584395|NCT03533114|101762138|FG001|Placebo|Double Blind Randomized-Withdrawal||59||
48137740|NCT01007591|100661547|FG001|COMPLETED|Overall Study||12||
48137741|NCT01007591|100661546|FG000|NOT COMPLETED|Overall Study||1||
48137742|NCT01007591|100661547|FG001|NOT COMPLETED|Overall Study||1||
48137743|NCT00201006|100661548|FG000|STARTED|Overall Study||83||
48137744|NCT00201006|100661549|FG001|STARTED|Overall Study||72||
48584396|NCT03533114|101762137|FG000|COMPLETED|Double Blind Randomized-Withdrawal||67||
48584397|NCT03533114|101762138|FG001|COMPLETED|Double Blind Randomized-Withdrawal||46||
48584398|NCT03533114|101762137|FG000|NOT COMPLETED|Double Blind Randomized-Withdrawal||2||
48584399|NCT03533114|101762138|FG001|NOT COMPLETED|Double Blind Randomized-Withdrawal||1||
48584400|NCT03533114|101762137|FG000|STARTED|Open-Label Safety Extension||65||
48584401|NCT03533114|101762138|FG001|STARTED|Open-Label Safety Extension||41||
48584402|NCT03533114|101762137|FG000|COMPLETED|Open-Label Safety Extension||57||
48584403|NCT03533114|101762138|FG001|COMPLETED|Open-Label Safety Extension||38||
48584404|NCT03533114|101762137|FG000|NOT COMPLETED|Open-Label Safety Extension||8||
48584405|NCT03533114|101762138|FG001|NOT COMPLETED|Open-Label Safety Extension||3||
48584406|NCT01669174|101762139|FG000|STARTED|Overall Study||33||
48584407|NCT01669174|101762140|FG001|STARTED|Overall Study||34||
48584408|NCT01669174|101762139|FG000|COMPLETED|Overall Study||27||
48584409|NCT01669174|101762140|FG001|COMPLETED|Overall Study||28||
48584410|NCT01669174|101762139|FG000|NOT COMPLETED|Overall Study||6||
48584411|NCT01669174|101762140|FG001|NOT COMPLETED|Overall Study||6||
48584412|NCT00191282|101762141|FG000|STARTED|Overall Study||558||
48584413|NCT00191282|101762142|FG001|STARTED|Overall Study||558||
48584414|NCT00191282|101762141|FG000|COMPLETED|Overall Study||338||
48584415|NCT00191282|101762142|FG001|COMPLETED|Overall Study||346||
48584416|NCT00191282|101762141|FG000|NOT COMPLETED|Overall Study||220||
48584417|NCT00191282|101762142|FG001|NOT COMPLETED|Overall Study||212||
48584418|NCT03782298|101762143|FG000|STARTED|Overall Study||140||142
48584419|NCT03782298|101762143|FG000|DYNOMITE™ 2.0 PK Suture Anchor With Needles|Overall Study||17|Type of suture anchor received at start|17
48584420|NCT03782298|101762143|FG000|RAPTORMITE™ 3.0 Suture Anchor With Needles|Overall Study||71|Type of suture anchor received at start|71
48584421|NCT03782298|101762143|FG000|FOOTPRINT™ Ultra PK SL Suture Anchor|Overall Study||57|Type of suture anchor received at start|59
48584422|NCT03782298|101762143|FG000|COMPLETED|Overall Study||136||136
48584423|NCT03782298|101762143|FG000|NOT COMPLETED|Overall Study||4||6
48584424|NCT03834974|101762144|FG000|STARTED|Overall Study||34||
48137745|NCT00201006|100661550|FG002|STARTED|Overall Study||79||
48137746|NCT00201006|100661548|FG000|COMPLETED|Overall Study||75||
48137747|NCT00201006|100661549|FG001|COMPLETED|Overall Study||70||
48137748|NCT00201006|100661550|FG002|COMPLETED|Overall Study||75||
48137749|NCT00201006|100661548|FG000|NOT COMPLETED|Overall Study||8||
48289396|NCT03541174|101037338|FG000|STARTED|Part 2 Single-Blind||0||
48289397|NCT03541174|101037339|FG001|STARTED|Part 2 Single-Blind||0||
48584425|NCT03834974|101762145|FG001|STARTED|Overall Study||32||
48137750|NCT00201006|100661549|FG001|NOT COMPLETED|Overall Study||2||
48137751|NCT00201006|100661550|FG002|NOT COMPLETED|Overall Study||4||
48137752|NCT00896168|100661551|FG000|STARTED|Overall Study||104||
48137753|NCT00896168|100661552|FG001|STARTED|Overall Study||130||
48137754|NCT00896168|100661551|FG000|COMPLETED|Overall Study||90||
48137755|NCT00896168|100661552|FG001|COMPLETED|Overall Study||111||
48584426|NCT03834974|101762144|FG000|COMPLETED|Overall Study||34||
48584427|NCT03834974|101762145|FG001|COMPLETED|Overall Study||32||
48584428|NCT03834974|101762144|FG000|NOT COMPLETED|Overall Study||0||
48705691|NCT03447314|102065109|FG003|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48705692|NCT03447314|102065110|FG004|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48705693|NCT03447314|102065111|FG005|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48705694|NCT03447314|102065112|FG006|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48705695|NCT03447314|102065113|FG007|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48705696|NCT03447314|102065114|FG008|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48137756|NCT00896168|100661551|FG000|NOT COMPLETED|Overall Study||14||
48137757|NCT00896168|100661552|FG001|NOT COMPLETED|Overall Study||19||
48137758|NCT03998618|100661553|FG000|STARTED|Overall Study||116||
48137759|NCT03998618|100661554|FG001|STARTED|Overall Study||120||
48137760|NCT03998618|100661553|FG000|COMPLETED|Overall Study||97||
48137761|NCT03998618|100661554|FG001|COMPLETED|Overall Study||91||
48137762|NCT03998618|100661553|FG000|NOT COMPLETED|Overall Study||19||
48584429|NCT03834974|101762145|FG001|NOT COMPLETED|Overall Study||0||
48584430|NCT01137110|101762146|FG000|STARTED|Overall Study||35||
48705697|NCT03447314|102065115|FG009|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48705698|NCT03447314|102065116|FG010|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48137763|NCT03998618|100661554|FG001|NOT COMPLETED|Overall Study||29||
48137764|NCT00121238|100661555|FG000|STARTED|Overall Study||16||
48137765|NCT00121238|100661555|FG000|COMPLETED|Overall Study||13||
48137766|NCT00121238|100661555|FG000|NOT COMPLETED|Overall Study||3||
48137767|NCT00987467|100661556|FG000|STARTED|Overall Study||12||
48137768|NCT00987467|100661556|FG000|COMPLETED|Overall Study||10||
48137769|NCT00987467|100661556|FG000|NOT COMPLETED|Overall Study||2||
48137770|NCT01585103|100661557|FG000|STARTED|Overall Study||86||
48289398|NCT03541174|101037340|FG002|STARTED|Part 2 Single-Blind||0||
48289399|NCT03541174|101037341|FG003|STARTED|Part 2 Single-Blind||704||
48584431|NCT01137110|101762147|FG001|STARTED|Overall Study||49||
48584432|NCT01137110|101762146|FG000|COMPLETED|Overall Study||34||
48584433|NCT01137110|101762147|FG001|COMPLETED|Overall Study||49||
48584434|NCT01137110|101762146|FG000|NOT COMPLETED|Overall Study||1||
48584435|NCT01137110|101762147|FG001|NOT COMPLETED|Overall Study||0||
48584436|NCT01323010|101762148|FG000|STARTED|Overall Study||60||
48137771|NCT01585103|100661557|FG000|COMPLETED|Overall Study||80||
48137772|NCT01585103|100661557|FG000|NOT COMPLETED|Overall Study||6||
48137773|NCT02504294|100661558|FG000|STARTED|Overall Study||212||
48137774|NCT02504294|100661559|FG001|STARTED|Overall Study||206||
48137775|NCT02504294|100661558|FG000|COMPLETED|Overall Study||156||
48137776|NCT02504294|100661559|FG001|COMPLETED|Overall Study||158||
48137777|NCT02504294|100661558|FG000|NOT COMPLETED|Overall Study||56||
48137778|NCT02504294|100661559|FG001|NOT COMPLETED|Overall Study||48||
48289400|NCT03541174|101037342|FG004|STARTED|Part 2 Single-Blind||0||
48289401|NCT03541174|101037343|FG005|STARTED|Part 2 Single-Blind||0||
48137779|NCT03019536|100661560|FG000|STARTED|Overall Study||6||
48137780|NCT03019536|100661561|FG001|STARTED|Overall Study||7||
48289402|NCT03541174|101037338|FG000|COMPLETED|Part 2 Single-Blind||0||
48584437|NCT01323010|101762149|FG001|STARTED|Overall Study||59||
48584438|NCT01323010|101762148|FG000|COMPLETED|Overall Study||60||
48584439|NCT01323010|101762149|FG001|COMPLETED|Overall Study||59||
48584440|NCT01323010|101762148|FG000|NOT COMPLETED|Overall Study||0||
48137781|NCT03019536|100661562|FG002|STARTED|Overall Study||9||
48137782|NCT03019536|100661560|FG000|Received at Least One Dose of Study Drug|Overall Study||6||
48137783|NCT03019536|100661561|FG001|Received at Least One Dose of Study Drug|Overall Study||7||
48137784|NCT03019536|100661562|FG002|Received at Least One Dose of Study Drug|Overall Study||9||
48137785|NCT03019536|100661560|FG000|COMPLETED|Overall Study||5||
48137786|NCT03019536|100661561|FG001|COMPLETED|Overall Study||6||
48137787|NCT03019536|100661562|FG002|COMPLETED|Overall Study||7||
48137788|NCT03019536|100661560|FG000|NOT COMPLETED|Overall Study||1||
48137789|NCT03019536|100661561|FG001|NOT COMPLETED|Overall Study||1||
48137790|NCT03019536|100661562|FG002|NOT COMPLETED|Overall Study||2||
48137791|NCT05553808|100661563|FG000|STARTED|Overall Study||35||
48137792|NCT05553808|100661564|FG001|STARTED|Overall Study||70||
48137793|NCT05553808|100661563|FG000|COMPLETED|Overall Study||0||
48137794|NCT05553808|100661564|FG001|COMPLETED|Overall Study||0||
48137795|NCT05553808|100661563|FG000|NOT COMPLETED|Overall Study||35||
48137796|NCT05553808|100661564|FG001|NOT COMPLETED|Overall Study||70||
48137797|NCT04969250|100661565|FG000|STARTED|Overall Study||16||
48137798|NCT04969250|100661566|FG001|STARTED|Overall Study||18||
48137799|NCT04969250|100661567|FG002|STARTED|Overall Study||16||
48137800|NCT04969250|100661568|FG003|STARTED|Overall Study||16||
48137801|NCT04969250|100661565|FG000|COMPLETED|Overall Study||16||
48137802|NCT04969250|100661566|FG001|COMPLETED|Overall Study||15||
48137803|NCT04969250|100661567|FG002|COMPLETED|Overall Study||13||
48137804|NCT04969250|100661568|FG003|COMPLETED|Overall Study||8||
48137805|NCT04969250|100661565|FG000|NOT COMPLETED|Overall Study||0||
48137806|NCT04969250|100661566|FG001|NOT COMPLETED|Overall Study||3||
48137807|NCT04969250|100661567|FG002|NOT COMPLETED|Overall Study||3||
48137808|NCT04969250|100661568|FG003|NOT COMPLETED|Overall Study||8||
48137809|NCT01098006|100661569|FG000|STARTED|Overall Study||7||
48137810|NCT01098006|100661570|FG001|STARTED|Overall Study||11||
48137811|NCT01098006|100661571|FG002|STARTED|Overall Study||60||
48137812|NCT01098006|100661572|FG003|STARTED|Overall Study||21||
48137813|NCT01098006|100661569|FG000|COMPLETED|Overall Study||7||
48137814|NCT01098006|100661570|FG001|COMPLETED|Overall Study||11||
48137815|NCT01098006|100661571|FG002|COMPLETED|Overall Study||60||
48137816|NCT01098006|100661572|FG003|COMPLETED|Overall Study||21||
48137817|NCT01098006|100661569|FG000|NOT COMPLETED|Overall Study||0||
48137818|NCT01098006|100661570|FG001|NOT COMPLETED|Overall Study||0||
48584441|NCT01323010|101762149|FG001|NOT COMPLETED|Overall Study||0||
48584442|NCT05113979|101762150|FG000|STARTED|Overall Study||10||
48584443|NCT05113979|101762150|FG000|COMPLETED|Overall Study||7||
48137819|NCT01098006|100661571|FG002|NOT COMPLETED|Overall Study||0||
48137820|NCT01098006|100661572|FG003|NOT COMPLETED|Overall Study||0||
48137821|NCT01666002|100661573|FG000|STARTED|Overall Study||17||
48137822|NCT01666002|100661574|FG001|STARTED|Overall Study||10||
48137823|NCT01666002|100661573|FG000|COMPLETED|Overall Study||12||
48137824|NCT01666002|100661574|FG001|COMPLETED|Overall Study||10||
48137825|NCT01666002|100661573|FG000|NOT COMPLETED|Overall Study||5||
48584444|NCT05113979|101762150|FG000|NOT COMPLETED|Overall Study||3||
48137826|NCT01666002|100661574|FG001|NOT COMPLETED|Overall Study||0||
48137827|NCT01597687|100661575|FG000|STARTED|Overall Study||76||
48137828|NCT01597687|100661576|FG001|STARTED|Overall Study||89||
48137829|NCT01597687|100661577|FG002|STARTED|Overall Study||147||
48137830|NCT01597687|100661575|FG000|COMPLETED|Overall Study||76||
48137831|NCT01597687|100661576|FG001|COMPLETED|Overall Study||89||
48137832|NCT01597687|100661577|FG002|COMPLETED|Overall Study||147||
48137833|NCT01597687|100661575|FG000|NOT COMPLETED|Overall Study||0||
48137834|NCT01597687|100661576|FG001|NOT COMPLETED|Overall Study||0||
48137835|NCT01597687|100661577|FG002|NOT COMPLETED|Overall Study||0||
48137836|NCT01669122|100661578|FG000|STARTED|Period I||40||
48137837|NCT01669122|100661578|FG000|Safety Population|Period I||39||
48137838|NCT01669122|100661578|FG000|COMPLETED|Period I||39||
48584445|NCT04874233|101762151|FG000|STARTED|Overall Study||20||
48137839|NCT01669122|100661578|FG000|NOT COMPLETED|Period I||1||
48137840|NCT01669122|100661578|FG000|STARTED|Washout Period I||39||
48137841|NCT01669122|100661578|FG000|COMPLETED|Washout Period I||39||
48137842|NCT01669122|100661578|FG000|NOT COMPLETED|Washout Period I||0||
48137843|NCT01669122|100661578|FG000|STARTED|Period II||39||
48137844|NCT01669122|100661578|FG000|COMPLETED|Period II||39||
48137845|NCT01669122|100661578|FG000|NOT COMPLETED|Period II||0||
48137846|NCT01669122|100661578|FG000|STARTED|Washout Period II||39||
48137847|NCT01669122|100661578|FG000|COMPLETED|Washout Period II||37||
48137848|NCT01669122|100661578|FG000|NOT COMPLETED|Washout Period II||2||
48137849|NCT01669122|100661578|FG000|STARTED|Washout Period III||37||
48137850|NCT01669122|100661578|FG000|COMPLETED|Washout Period III||37||
48137851|NCT01669122|100661578|FG000|NOT COMPLETED|Washout Period III||0||
48584446|NCT04874233|101762152|FG001|STARTED|Overall Study||21||
48584447|NCT04874233|101762153|FG002|STARTED|Overall Study||19||
48137852|NCT01669122|100661578|FG000|STARTED|Period III||37||
48137853|NCT01669122|100661578|FG000|COMPLETED|Period III||37||
48137854|NCT01669122|100661578|FG000|NOT COMPLETED|Period III||0||
48137855|NCT01669122|100661578|FG000|STARTED|Period IV||37||
48137856|NCT01669122|100661578|FG000|COMPLETED|Period IV||37||
48137857|NCT01669122|100661578|FG000|NOT COMPLETED|Period IV||0||
48137858|NCT01059760|100661579|FG000|STARTED|Overall Study||16||
48137859|NCT01059760|100661580|FG001|STARTED|Overall Study||14||
48137860|NCT01059760|100661579|FG000|COMPLETED|Overall Study||16||
48137861|NCT01059760|100661580|FG001|COMPLETED|Overall Study||14||
48137862|NCT01059760|100661579|FG000|NOT COMPLETED|Overall Study||0||
48584448|NCT04874233|101762154|FG003|STARTED|Overall Study||20||
48584449|NCT04874233|101762151|FG000|COMPLETED|Overall Study||18||
48584450|NCT04874233|101762152|FG001|COMPLETED|Overall Study||20||
48584451|NCT04874233|101762153|FG002|COMPLETED|Overall Study||19||
48584452|NCT04874233|101762154|FG003|COMPLETED|Overall Study||17||
48584453|NCT04874233|101762151|FG000|NOT COMPLETED|Overall Study||2||
48584454|NCT04874233|101762152|FG001|NOT COMPLETED|Overall Study||1||
48584455|NCT04874233|101762153|FG002|NOT COMPLETED|Overall Study||0||
48584456|NCT04874233|101762154|FG003|NOT COMPLETED|Overall Study||3||
48584457|NCT02548351|101762155|FG000|STARTED|Overall Study||825||
48584458|NCT02548351|101762156|FG001|STARTED|Overall Study||827||
48584459|NCT02548351|101762157|FG002|STARTED|Overall Study||825||
48584460|NCT02548351|101762155|FG000|COMPLETED|Overall Study||0||
48584461|NCT02548351|101762156|FG001|COMPLETED|Overall Study||0||
48584462|NCT02548351|101762157|FG002|COMPLETED|Overall Study||0||
48584463|NCT02548351|101762155|FG000|NOT COMPLETED|Overall Study||825||
48584464|NCT02548351|101762156|FG001|NOT COMPLETED|Overall Study||827||
48584465|NCT02548351|101762157|FG002|NOT COMPLETED|Overall Study||825||
48705699|NCT03447314|102065117|FG011|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48705700|NCT03447314|102065118|FG012|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48705701|NCT03447314|102065119|FG013|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48705702|NCT03447314|102065120|FG014|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48289403|NCT03541174|101037339|FG001|COMPLETED|Part 2 Single-Blind||0||
48289404|NCT03541174|101037340|FG002|COMPLETED|Part 2 Single-Blind||0||
48289405|NCT03541174|101037341|FG003|COMPLETED|Part 2 Single-Blind||613||
48289406|NCT03541174|101037342|FG004|COMPLETED|Part 2 Single-Blind||0||
48289407|NCT03541174|101037343|FG005|COMPLETED|Part 2 Single-Blind||0||
48289408|NCT03541174|101037338|FG000|NOT COMPLETED|Part 2 Single-Blind||0||
48289409|NCT03541174|101037339|FG001|NOT COMPLETED|Part 2 Single-Blind||0||
48584466|NCT01083186|101762158|FG000|STARTED|Overall Study||500||
48584467|NCT01083186|101762158|FG000|COMPLETED|Overall Study||406||
48289410|NCT03541174|101037340|FG002|NOT COMPLETED|Part 2 Single-Blind||0||
48289411|NCT03541174|101037341|FG003|NOT COMPLETED|Part 2 Single-Blind||91||
48289412|NCT03541174|101037342|FG004|NOT COMPLETED|Part 2 Single-Blind||0||
48289413|NCT03541174|101037343|FG005|NOT COMPLETED|Part 2 Single-Blind||0||
48584468|NCT01083186|101762158|FG000|NOT COMPLETED|Overall Study||94||
48705703|NCT03447314|102065121|FG015|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48705704|NCT03447314|102065122|FG016|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48705705|NCT03447314|102065123|FG017|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
48137863|NCT01059760|100661580|FG001|NOT COMPLETED|Overall Study||0||
48137864|NCT05608629|100661581|FG000|STARTED|Overall Study||17||
48137865|NCT05608629|100661581|FG000|COMPLETED|Overall Study||15||
48289414|NCT03541174|101037338|FG000|STARTED|Part 3 Double-Blind Withdrawal||0||
48289415|NCT03541174|101037339|FG001|STARTED|Part 3 Double-Blind Withdrawal||0||
48289416|NCT03541174|101037340|FG002|STARTED|Part 3 Double-Blind Withdrawal||0||
48289417|NCT03541174|101037341|FG003|STARTED|Part 3 Double-Blind Withdrawal||0||
48289418|NCT03541174|101037342|FG004|STARTED|Part 3 Double-Blind Withdrawal||307||
48401470|NCT00614991|101313769|FG002|NOT COMPLETED|Overall Study||0||
48137866|NCT05608629|100661581|FG000|NOT COMPLETED|Overall Study||2||
48137867|NCT00715429|100661582|FG000|STARTED|Overall Study||7||
48137868|NCT00715429|100661583|FG001|STARTED|Overall Study||7||
48584469|NCT02847494|101762159|FG000|STARTED|Overall Study||109||
48584470|NCT02847494|101762160|FG001|STARTED|Overall Study||111||
48584471|NCT02847494|101762159|FG000|COMPLETED|Overall Study||101||
48584472|NCT02847494|101762160|FG001|COMPLETED|Overall Study||106||
48705706|NCT03754582|102065124|FG000|STARTED|Pretreatment Phase||21||
48137869|NCT00715429|100661582|FG000|COMPLETED|Overall Study||7||
48137870|NCT00715429|100661583|FG001|COMPLETED|Overall Study||6||
48137871|NCT00715429|100661582|FG000|NOT COMPLETED|Overall Study||0||
48137872|NCT00715429|100661583|FG001|NOT COMPLETED|Overall Study||1||
48289419|NCT03541174|101037343|FG005|STARTED|Part 3 Double-Blind Withdrawal||307||
48289420|NCT03541174|101037338|FG000|Safety Set|Part 3 Double-Blind Withdrawal||0|613 participants started study treatment in Part 3. Four participants re-randomised to placebo received at least one dose of aprocitentan 25 mg during part 3.|
48584473|NCT02847494|101762159|FG000|NOT COMPLETED|Overall Study||8||
48584474|NCT02847494|101762160|FG001|NOT COMPLETED|Overall Study||5||
48584475|NCT01322594|101762161|FG000|STARTED|Overall Study||6||
48584476|NCT01322594|101762162|FG001|STARTED|Overall Study||3||
48584477|NCT01322594|101762163|FG002|STARTED|Overall Study||3||
48584478|NCT01322594|101762164|FG003|STARTED|Overall Study||6||
48584479|NCT01322594|101762165|FG004|STARTED|Overall Study||7||
48584480|NCT01322594|101762166|FG005|STARTED|Overall Study||6||
48584481|NCT01322594|101762161|FG000|COMPLETED|Overall Study||6||
48584482|NCT01322594|101762162|FG001|COMPLETED|Overall Study||3||
48137873|NCT05457608|100661584|FG000|STARTED|Period 1: Lens A (15 Minutes)||42||
48137874|NCT05457608|100661585|FG001|STARTED|Period 1: Lens A (15 Minutes)||0||
48137875|NCT05457608|100661584|FG000|COMPLETED|Period 1: Lens A (15 Minutes)||42||
48137876|NCT05457608|100661585|FG001|COMPLETED|Period 1: Lens A (15 Minutes)||0||
48137877|NCT05457608|100661584|FG000|NOT COMPLETED|Period 1: Lens A (15 Minutes)||0||
48137878|NCT05457608|100661585|FG001|NOT COMPLETED|Period 1: Lens A (15 Minutes)||0||
48137879|NCT05457608|100661584|FG000|STARTED|Period 2: Lens B (15 Minutes)||0||
48137880|NCT05457608|100661585|FG001|STARTED|Period 2: Lens B (15 Minutes)||42||
48137881|NCT05457608|100661584|FG000|COMPLETED|Period 2: Lens B (15 Minutes)||0||
48137882|NCT05457608|100661585|FG001|COMPLETED|Period 2: Lens B (15 Minutes)||42||
48137883|NCT05457608|100661584|FG000|NOT COMPLETED|Period 2: Lens B (15 Minutes)||0||
48137884|NCT05457608|100661585|FG001|NOT COMPLETED|Period 2: Lens B (15 Minutes)||0||
48137885|NCT01054820|100661586|FG000|STARTED|Overall Study||123||
48137886|NCT01054820|100661586|FG000|COMPLETED|Overall Study||121||
48137887|NCT01054820|100661586|FG000|NOT COMPLETED|Overall Study||2||
48584483|NCT01322594|101762163|FG002|COMPLETED|Overall Study||3||
48584484|NCT01322594|101762164|FG003|COMPLETED|Overall Study||6||
48584485|NCT01322594|101762165|FG004|COMPLETED|Overall Study||7||
48584486|NCT01322594|101762166|FG005|COMPLETED|Overall Study||6||
48584487|NCT01322594|101762161|FG000|NOT COMPLETED|Overall Study||0||
48584488|NCT01322594|101762162|FG001|NOT COMPLETED|Overall Study||0||
48584489|NCT01322594|101762163|FG002|NOT COMPLETED|Overall Study||0||
48584490|NCT01322594|101762164|FG003|NOT COMPLETED|Overall Study||0||
48584491|NCT01322594|101762165|FG004|NOT COMPLETED|Overall Study||0||
48584492|NCT01322594|101762166|FG005|NOT COMPLETED|Overall Study||0||
48705707|NCT03754582|102065125|FG001|STARTED|Pretreatment Phase||0||
48705708|NCT03754582|102065126|FG002|STARTED|Pretreatment Phase||0||
48705709|NCT03754582|102065124|FG000|COMPLETED|Pretreatment Phase||21||
48705710|NCT03754582|102065125|FG001|COMPLETED|Pretreatment Phase||0||
48705711|NCT03754582|102065126|FG002|COMPLETED|Pretreatment Phase||0||
48705712|NCT03754582|102065124|FG000|NOT COMPLETED|Pretreatment Phase||0||
48705713|NCT03754582|102065125|FG001|NOT COMPLETED|Pretreatment Phase||0||
48705714|NCT03754582|102065126|FG002|NOT COMPLETED|Pretreatment Phase||0||
48705715|NCT03754582|102065124|FG000|STARTED|Treatment Phase||0||
48705716|NCT03754582|102065125|FG001|STARTED|Treatment Phase||21||
48705717|NCT03754582|102065126|FG002|STARTED|Treatment Phase||0||
48705718|NCT03754582|102065124|FG000|COMPLETED|Treatment Phase||0||
48705719|NCT03754582|102065125|FG001|COMPLETED|Treatment Phase||20||
48705720|NCT03754582|102065126|FG002|COMPLETED|Treatment Phase||0||
48705721|NCT03754582|102065124|FG000|NOT COMPLETED|Treatment Phase||0||
48705722|NCT03754582|102065125|FG001|NOT COMPLETED|Treatment Phase||1||
48705723|NCT03754582|102065126|FG002|NOT COMPLETED|Treatment Phase||0||
48705724|NCT03754582|102065124|FG000|STARTED|Follow-up Phase||0||
48705725|NCT03754582|102065125|FG001|STARTED|Follow-up Phase||0||
48705726|NCT03754582|102065126|FG002|STARTED|Follow-up Phase||21||
48705727|NCT03754582|102065124|FG000|COMPLETED|Follow-up Phase||0||
48137888|NCT04564833|100661587|FG000|STARTED|Overall Study||46||
48137889|NCT04564833|100661588|FG001|STARTED|Overall Study||45||
48137890|NCT04564833|100661589|FG002|STARTED|Overall Study||44||
48137891|NCT04564833|100661587|FG000|COMPLETED|Overall Study||46||
48137892|NCT04564833|100661588|FG001|COMPLETED|Overall Study||45||
48137893|NCT04564833|100661589|FG002|COMPLETED|Overall Study||44||
48137894|NCT04564833|100661587|FG000|NOT COMPLETED|Overall Study||0||
48137895|NCT04564833|100661588|FG001|NOT COMPLETED|Overall Study||0||
48137896|NCT04564833|100661589|FG002|NOT COMPLETED|Overall Study||0||
48137897|NCT02937545|100661590|FG000|STARTED|Overall Study||69||
48137898|NCT02937545|100661591|FG001|STARTED|Overall Study||85||
48137899|NCT02937545|100661592|FG002|STARTED|Overall Study||15||
48137900|NCT02937545|100661593|FG003|STARTED|Overall Study||21||
48137901|NCT02937545|100661590|FG000|COMPLETED|Overall Study||67||
48705728|NCT03754582|102065125|FG001|COMPLETED|Follow-up Phase||0||
48705729|NCT03754582|102065126|FG002|COMPLETED|Follow-up Phase||20||
48705730|NCT03754582|102065124|FG000|NOT COMPLETED|Follow-up Phase||0||
48137902|NCT02937545|100661591|FG001|COMPLETED|Overall Study||83||
48137903|NCT02937545|100661592|FG002|COMPLETED|Overall Study||9||
48137904|NCT02937545|100661593|FG003|COMPLETED|Overall Study||14||
48137905|NCT02937545|100661590|FG000|NOT COMPLETED|Overall Study||2||
48137906|NCT02937545|100661591|FG001|NOT COMPLETED|Overall Study||2||
48137907|NCT02937545|100661592|FG002|NOT COMPLETED|Overall Study||6||
48584493|NCT05087966|101762167|FG000|STARTED|Overall Study||31||
48584494|NCT05087966|101762167|FG000|COMPLETED|Overall Study||25||
48584495|NCT05087966|101762167|FG000|NOT COMPLETED|Overall Study||6||
48584496|NCT04351373|101762168|FG000|STARTED|Overall Study||12||
48584497|NCT04351373|101762168|FG000|COMPLETED|Overall Study||11||
48584498|NCT04351373|101762168|FG000|NOT COMPLETED|Overall Study||1||
48584499|NCT04034251|101762169|FG000|STARTED|Overall Study||5||
48584500|NCT04034251|101762170|FG001|STARTED|Overall Study||7||
48584501|NCT04034251|101762171|FG002|STARTED|Overall Study||0||
48584502|NCT04034251|101762169|FG000|COMPLETED|Overall Study||4||
48584503|NCT04034251|101762170|FG001|COMPLETED|Overall Study||7||
48584504|NCT04034251|101762171|FG002|COMPLETED|Overall Study||0||
48584505|NCT04034251|101762169|FG000|NOT COMPLETED|Overall Study||1||
48584506|NCT04034251|101762170|FG001|NOT COMPLETED|Overall Study||0||
48584507|NCT04034251|101762171|FG002|NOT COMPLETED|Overall Study||0||
48584508|NCT05870956|101762172|FG000|STARTED|Overall Study||781||
48584509|NCT05870956|101762173|FG001|STARTED|Overall Study||202||
48584510|NCT05870956|101762174|FG002|STARTED|Overall Study||190||
48584511|NCT05870956|101762175|FG003|STARTED|Overall Study||255||
48584512|NCT05870956|101762176|FG004|STARTED|Overall Study||370||
48584513|NCT05870956|101762172|FG000|COMPLETED|Overall Study||781||
48584514|NCT05870956|101762173|FG001|COMPLETED|Overall Study||202||
48401471|NCT00614991|101313770|FG003|NOT COMPLETED|Overall Study||0||
48401472|NCT00614991|101313771|FG004|NOT COMPLETED|Overall Study||1||
48401473|NCT00614991|101313772|FG005|NOT COMPLETED|Overall Study||0||
48401474|NCT00201760|101313773|FG000|STARTED|Overall Study||5||
48401475|NCT00201760|101313774|FG001|STARTED|Overall Study||5||
48401476|NCT00201760|101313773|FG000|COMPLETED|Overall Study||5||
48584515|NCT05870956|101762174|FG002|COMPLETED|Overall Study||190||
48584516|NCT05870956|101762175|FG003|COMPLETED|Overall Study||255||
48584517|NCT05870956|101762176|FG004|COMPLETED|Overall Study||370||
48584518|NCT05870956|101762172|FG000|NOT COMPLETED|Overall Study||0||
48584519|NCT05870956|101762173|FG001|NOT COMPLETED|Overall Study||0||
48584520|NCT05870956|101762174|FG002|NOT COMPLETED|Overall Study||0||
48584521|NCT05870956|101762175|FG003|NOT COMPLETED|Overall Study||0||
48584522|NCT05870956|101762176|FG004|NOT COMPLETED|Overall Study||0||
48584523|NCT03348930|101762177|FG000|STARTED|First Intervention (2 Weeks)||10||
48137908|NCT02937545|100661593|FG003|NOT COMPLETED|Overall Study||7||
48137909|NCT03166618|100661594|FG000|STARTED|Overall Study||0||
48137910|NCT03166618|100661595|FG001|STARTED|Overall Study||1||
48584524|NCT03348930|101762178|FG001|STARTED|First Intervention (2 Weeks)||10||
48584525|NCT03348930|101762177|FG000|COMPLETED|First Intervention (2 Weeks)||10||
48584526|NCT03348930|101762178|FG001|COMPLETED|First Intervention (2 Weeks)||10||
48584527|NCT03348930|101762177|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0||
48584528|NCT03348930|101762178|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0||
48584529|NCT03348930|101762177|FG000|STARTED|Washout (1 Week)||10||
48584530|NCT03348930|101762178|FG001|STARTED|Washout (1 Week)||10||
48584531|NCT03348930|101762177|FG000|COMPLETED|Washout (1 Week)||9||
48584532|NCT03348930|101762178|FG001|COMPLETED|Washout (1 Week)||9||
48584533|NCT03348930|101762177|FG000|NOT COMPLETED|Washout (1 Week)||1||
48137911|NCT03166618|100661594|FG000|COMPLETED|Overall Study||0||
48137912|NCT03166618|100661595|FG001|COMPLETED|Overall Study||0||
48137913|NCT03166618|100661594|FG000|NOT COMPLETED|Overall Study||0||
48137914|NCT03166618|100661595|FG001|NOT COMPLETED|Overall Study||1||
48137915|NCT02898974|100661596|FG000|STARTED|Overall Study||13||
48137916|NCT02898974|100661597|FG001|STARTED|Overall Study||9||
48137917|NCT02898974|100661596|FG000|COMPLETED|Overall Study||13||
48137918|NCT02898974|100661597|FG001|COMPLETED|Overall Study||9||
48137919|NCT02898974|100661596|FG000|NOT COMPLETED|Overall Study||0||
48137920|NCT02898974|100661597|FG001|NOT COMPLETED|Overall Study||0||
48137921|NCT03643952|100661598|FG000|STARTED|Overall Study||18||
48401477|NCT00201760|101313774|FG001|COMPLETED|Overall Study||5||
48401478|NCT00201760|101313773|FG000|NOT COMPLETED|Overall Study||0||
48401479|NCT00201760|101313774|FG001|NOT COMPLETED|Overall Study||0||
48401480|NCT01963780|101313775|FG000|STARTED|Overall Study||79||
48401481|NCT01963780|101313775|FG000|COMPLETED|Overall Study||72|Subjects completed 12-month follow-up|
48401482|NCT01963780|101313775|FG000|NOT COMPLETED|Overall Study||7||
48401483|NCT02738580|101313776|FG000|STARTED|Overall Study||56||
48401484|NCT02738580|101313777|FG001|STARTED|Overall Study||56||
48401485|NCT02738580|101313776|FG000|COMPLETED|Overall Study||52||
48401486|NCT02738580|101313777|FG001|COMPLETED|Overall Study||52||
48584534|NCT03348930|101762178|FG001|NOT COMPLETED|Washout (1 Week)||1||
48584535|NCT03348930|101762177|FG000|STARTED|Second Intervention (2 Weeks)||9||
48584536|NCT03348930|101762178|FG001|STARTED|Second Intervention (2 Weeks)||9||
48584537|NCT03348930|101762177|FG000|COMPLETED|Second Intervention (2 Weeks)||9||
48584538|NCT03348930|101762178|FG001|COMPLETED|Second Intervention (2 Weeks)||9||
48705731|NCT03754582|102065125|FG001|NOT COMPLETED|Follow-up Phase||0||
48137922|NCT03643952|100661598|FG000|COMPLETED|Overall Study||17||
48137923|NCT03643952|100661598|FG000|NOT COMPLETED|Overall Study||1||
48137924|NCT05554237|100661599|FG000|STARTED|Part 1: Period 1 Treatment (1 Day)||2||
48137925|NCT05554237|100661600|FG001|STARTED|Part 1: Period 1 Treatment (1 Day)||2||
48401487|NCT02738580|101313776|FG000|NOT COMPLETED|Overall Study||4||
48401488|NCT02738580|101313777|FG001|NOT COMPLETED|Overall Study||4||
48584539|NCT03348930|101762177|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48584540|NCT03348930|101762178|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48584541|NCT02754674|101762179|FG000|STARTED|Overall Study||34||
48584542|NCT02754674|101762180|FG001|STARTED|Overall Study||33||
48584543|NCT02754674|101762179|FG000|COMPLETED|Overall Study||28||
48584544|NCT02754674|101762180|FG001|COMPLETED|Overall Study||26||
48584545|NCT02754674|101762179|FG000|NOT COMPLETED|Overall Study||6||
48584546|NCT02754674|101762180|FG001|NOT COMPLETED|Overall Study||7||
48584547|NCT04064411|101762181|FG000|STARTED|Overall Study||255|Intent-to-Treat (ITT) Population: Includes all participants randomized into this study.|
48289421|NCT03541174|101037339|FG001|Safety Set|Part 3 Double-Blind Withdrawal||0|613 participants started study treatment in Part 3. Four participants re-randomised to placebo received at least one dose of aprocitentan 25 mg during part 3.|
48289422|NCT03541174|101037340|FG002|Safety Set|Part 3 Double-Blind Withdrawal||0|613 participants started study treatment in Part 3. Four participants re-randomised to placebo received at least one dose of aprocitentan 25 mg during part 3.|
48289423|NCT03541174|101037341|FG003|Safety Set|Part 3 Double-Blind Withdrawal||0|613 participants started study treatment in Part 3. Four participants re-randomised to placebo received at least one dose of aprocitentan 25 mg during part 3.|
48289424|NCT03541174|101037342|FG004|Safety Set|Part 3 Double-Blind Withdrawal||310|613 participants started study treatment in Part 3. Four participants re-randomised to placebo received at least one dose of aprocitentan 25 mg during part 3.|
48289425|NCT03541174|101037343|FG005|Safety Set|Part 3 Double-Blind Withdrawal||303|613 participants started study treatment in Part 3. Four participants re-randomised to placebo received at least one dose of aprocitentan 25 mg during part 3.|
48289426|NCT03541174|101037338|FG000|COMPLETED|Part 3 Double-Blind Withdrawal||0||
48289427|NCT03541174|101037339|FG001|COMPLETED|Part 3 Double-Blind Withdrawal||0||
48289428|NCT03541174|101037340|FG002|COMPLETED|Part 3 Double-Blind Withdrawal||0||
48289429|NCT03541174|101037341|FG003|COMPLETED|Part 3 Double-Blind Withdrawal||0||
48289430|NCT03541174|101037342|FG004|COMPLETED|Part 3 Double-Blind Withdrawal||288||
48289431|NCT03541174|101037343|FG005|COMPLETED|Part 3 Double-Blind Withdrawal||289||
48289432|NCT03541174|101037338|FG000|NOT COMPLETED|Part 3 Double-Blind Withdrawal||0||
48289433|NCT03541174|101037339|FG001|NOT COMPLETED|Part 3 Double-Blind Withdrawal||0||
48289434|NCT03541174|101037340|FG002|NOT COMPLETED|Part 3 Double-Blind Withdrawal||0||
48584548|NCT04064411|101762182|FG001|STARTED|Overall Study||256|Intent-to-Treat (ITT) Population: Includes all participants randomized into this study.|
48584549|NCT04064411|101762181|FG000|Received at Least 1 Dose of Study Drug|Overall Study||254|Safety Population: Includes all participants who received at least 1 dose of study drug.|
48584550|NCT04064411|101762182|FG001|Received at Least 1 Dose of Study Drug|Overall Study||252|Safety Population: Includes all participants who received at least 1 dose of study drug.|
48401489|NCT01057862|101313778|FG000|STARTED|Overall Study||5||
48401490|NCT01057862|101313779|FG001|STARTED|Overall Study||4||
48401491|NCT01057862|101313778|FG000|COMPLETED|Overall Study||4||
48401492|NCT01057862|101313779|FG001|COMPLETED|Overall Study||2||
48401493|NCT01057862|101313778|FG000|NOT COMPLETED|Overall Study||1||
48401494|NCT01057862|101313779|FG001|NOT COMPLETED|Overall Study||2||
48401495|NCT00294684|101313780|FG000|STARTED|Overall Study||70||
48401496|NCT00294684|101313781|FG001|STARTED|Overall Study||70||
48584551|NCT04064411|101762181|FG000|COMPLETED|Overall Study||191||
48584552|NCT04064411|101762182|FG001|COMPLETED|Overall Study||201||
48401497|NCT00294684|101313780|FG000|COMPLETED|Overall Study||65||
48401498|NCT00294684|101313781|FG001|COMPLETED|Overall Study||62||
48401499|NCT00294684|101313780|FG000|NOT COMPLETED|Overall Study||5||
48401500|NCT00294684|101313781|FG001|NOT COMPLETED|Overall Study||8||
48289435|NCT03541174|101037341|FG003|NOT COMPLETED|Part 3 Double-Blind Withdrawal||0||
48289436|NCT03541174|101037342|FG004|NOT COMPLETED|Part 3 Double-Blind Withdrawal||19||
48289437|NCT03541174|101037343|FG005|NOT COMPLETED|Part 3 Double-Blind Withdrawal||18||
48289438|NCT00549783|101037344|FG000|STARTED|Overall Study||139||
48289439|NCT00549783|101037345|FG001|STARTED|Overall Study||135||
48289440|NCT00549783|101037344|FG000|COMPLETED|Overall Study||131||
48289441|NCT00549783|101037345|FG001|COMPLETED|Overall Study||122||
48289442|NCT00549783|101037344|FG000|NOT COMPLETED|Overall Study||8||
48289443|NCT00549783|101037345|FG001|NOT COMPLETED|Overall Study||13||
48289444|NCT01321151|101037346|FG000|STARTED|Overall Study||6||
48289445|NCT01321151|101037347|FG001|STARTED|Overall Study||6||
48289446|NCT01321151|101037346|FG000|COMPLETED|Overall Study||6||
48401501|NCT04134728|101313782|FG000|STARTED|Overall Study||156||
48401502|NCT04134728|101313783|FG001|STARTED|Overall Study||158||
48401503|NCT04134728|101313784|FG002|STARTED|Overall Study||156||
48401504|NCT04134728|101313785|FG003|STARTED|Overall Study||26||
48584553|NCT04064411|101762181|FG000|NOT COMPLETED|Overall Study||64||
48584554|NCT04064411|101762182|FG001|NOT COMPLETED|Overall Study||55||
48584555|NCT02345460|101762183|FG000|STARTED|Overall Study||1||
48584556|NCT02345460|101762183|FG000|COMPLETED|Overall Study||1||
48584557|NCT02345460|101762183|FG000|NOT COMPLETED|Overall Study||0||
48584558|NCT03990571|101762184|FG000|STARTED|Overall Study||34||
48584559|NCT03990571|101762184|FG000|COMPLETED|Overall Study||28||
48584560|NCT03990571|101762184|FG000|NOT COMPLETED|Overall Study||6||
48584561|NCT03829618|101762185|FG000|STARTED|Overall Study||15||
48584562|NCT03829618|101762186|FG001|STARTED|Overall Study||7||
48584563|NCT03829618|101762187|FG002|STARTED|Overall Study||7||
48584564|NCT03829618|101762185|FG000|COMPLETED|Overall Study||15||
48584565|NCT03829618|101762186|FG001|COMPLETED|Overall Study||7||
48584566|NCT03829618|101762187|FG002|COMPLETED|Overall Study||7||
48584567|NCT03829618|101762185|FG000|NOT COMPLETED|Overall Study||0||
48584568|NCT03829618|101762186|FG001|NOT COMPLETED|Overall Study||0||
48584569|NCT03829618|101762187|FG002|NOT COMPLETED|Overall Study||0||
48584570|NCT00231114|101762188|FG000|STARTED|Randomized||196||
48289447|NCT01321151|101037347|FG001|COMPLETED|Overall Study||6||
48289448|NCT01321151|101037346|FG000|NOT COMPLETED|Overall Study||0||
48289449|NCT01321151|101037347|FG001|NOT COMPLETED|Overall Study||0||
48289450|NCT02679573|101037348|FG000|STARTED|Overall Study||431||
48289451|NCT02679573|101037349|FG001|STARTED|Overall Study||428||
48289452|NCT02679573|101037348|FG000|COMPLETED|Overall Study||394||
48289453|NCT02679573|101037349|FG001|COMPLETED|Overall Study||389||
48289454|NCT02679573|101037348|FG000|NOT COMPLETED|Overall Study||37||
48289455|NCT02679573|101037349|FG001|NOT COMPLETED|Overall Study||39||
48289456|NCT00321373|101037350|FG000|STARTED|Overall Study||407||
48584571|NCT00231114|101762189|FG001|STARTED|Randomized||101||
48584572|NCT00231114|101762188|FG000|COMPLETED|Randomized||190||
48584573|NCT00231114|101762189|FG001|COMPLETED|Randomized||98||
48584574|NCT00231114|101762188|FG000|NOT COMPLETED|Randomized||6||
48584575|NCT00231114|101762189|FG001|NOT COMPLETED|Randomized||3||
48584576|NCT00231114|101762188|FG000|STARTED|Treatment Period||190||
48584577|NCT00231114|101762189|FG001|STARTED|Treatment Period||98||
48584578|NCT00231114|101762188|FG000|COMPLETED|Treatment Period||189||
48584579|NCT00231114|101762189|FG001|COMPLETED|Treatment Period||98||
48584580|NCT00231114|101762188|FG000|NOT COMPLETED|Treatment Period||1||
48584581|NCT00231114|101762189|FG001|NOT COMPLETED|Treatment Period||0||
48584582|NCT00231114|101762188|FG000|STARTED|Post-Treatment Period||189||
48584583|NCT00231114|101762189|FG001|STARTED|Post-Treatment Period||98||
48584584|NCT00231114|101762188|FG000|COMPLETED|Post-Treatment Period||181||
48584585|NCT00231114|101762189|FG001|COMPLETED|Post-Treatment Period||97||
48584586|NCT00231114|101762188|FG000|NOT COMPLETED|Post-Treatment Period||8||
48584587|NCT00231114|101762189|FG001|NOT COMPLETED|Post-Treatment Period||1||
48584588|NCT00581347|101762190|FG000|STARTED|Overall Study||3839||
48584589|NCT00581347|101762191|FG001|STARTED|Overall Study||3707||
48584590|NCT00581347|101762190|FG000|COMPLETED|Overall Study||3839||
48584591|NCT00581347|101762191|FG001|COMPLETED|Overall Study||3707||
48584592|NCT00581347|101762190|FG000|NOT COMPLETED|Overall Study||0||
48584593|NCT00581347|101762191|FG001|NOT COMPLETED|Overall Study||0||
48584594|NCT01899742|101762192|FG000|STARTED|Overall Study||247||
48584595|NCT01899742|101762193|FG001|STARTED|Overall Study||247||
48584596|NCT01899742|101762192|FG000|COMPLETED|Overall Study||230||
48584597|NCT01899742|101762193|FG001|COMPLETED|Overall Study||231||
48584598|NCT01899742|101762192|FG000|NOT COMPLETED|Overall Study||17||
48584599|NCT01899742|101762193|FG001|NOT COMPLETED|Overall Study||16||
48584600|NCT01966068|101762194|FG000|STARTED|Overall Study||294||
48584601|NCT01966068|101762194|FG000|Used the MyAsthma Portal at Least Once|Overall Study||237||
48584602|NCT01966068|101762194|FG000|Use the MyAsthma Portal More Than Once|Overall Study||156||
48584603|NCT01966068|101762194|FG000|COMPLETED|Overall Study||156||
48584604|NCT01966068|101762194|FG000|NOT COMPLETED|Overall Study||138||
48584605|NCT05633992|101762195|FG000|STARTED|Overall Study||225||
48584606|NCT05633992|101762196|FG001|STARTED|Overall Study||225||
48584607|NCT05633992|101762195|FG000|COMPLETED|Overall Study||225||
48584608|NCT05633992|101762196|FG001|COMPLETED|Overall Study||225||
48584609|NCT05633992|101762195|FG000|NOT COMPLETED|Overall Study||0||
48137926|NCT05554237|100661601|FG002|STARTED|Part 1: Period 1 Treatment (1 Day)||2||
48584610|NCT05633992|101762196|FG001|NOT COMPLETED|Overall Study||0||
48584611|NCT04021121|101762197|FG000|STARTED|Overall Study||9||
48584612|NCT04021121|101762198|FG001|STARTED|Overall Study||11||
48584613|NCT04021121|101762199|FG002|STARTED|Overall Study||10||
48584614|NCT04021121|101762200|FG003|STARTED|Overall Study||10||
48584615|NCT04021121|101762197|FG000|COMPLETED|Overall Study||6||
48584616|NCT04021121|101762198|FG001|COMPLETED|Overall Study||8||
48584617|NCT04021121|101762199|FG002|COMPLETED|Overall Study||5||
48584618|NCT04021121|101762200|FG003|COMPLETED|Overall Study||6||
48584619|NCT04021121|101762197|FG000|NOT COMPLETED|Overall Study||3||
48584620|NCT04021121|101762198|FG001|NOT COMPLETED|Overall Study||3||
48584621|NCT04021121|101762199|FG002|NOT COMPLETED|Overall Study||5||
48584622|NCT04021121|101762200|FG003|NOT COMPLETED|Overall Study||4||
48584623|NCT03702010|101762201|FG000|STARTED|First Stimulation (5 Days)||13||
48289457|NCT00321373|101037351|FG001|STARTED|Overall Study||406||
48289458|NCT00321373|101037352|FG002|STARTED|Overall Study||407||
48289459|NCT00321373|101037350|FG000|COMPLETED|Overall Study||405||
48289460|NCT00321373|101037351|FG001|COMPLETED|Overall Study||406||
48289461|NCT00321373|101037352|FG002|COMPLETED|Overall Study||404||
48289462|NCT00321373|101037350|FG000|NOT COMPLETED|Overall Study||2||
48289463|NCT00321373|101037351|FG001|NOT COMPLETED|Overall Study||0||
48289464|NCT00321373|101037352|FG002|NOT COMPLETED|Overall Study||3||
48289465|NCT01762501|101037353|FG000|STARTED|Overall Study||359||
48289466|NCT01762501|101037354|FG001|STARTED|Overall Study||359||
48584624|NCT03702010|101762202|FG001|STARTED|First Stimulation (5 Days)||14||
48705732|NCT03754582|102065126|FG002|NOT COMPLETED|Follow-up Phase||1||
48705733|NCT03895086|102065127|FG000|STARTED|Overall Study||1||
48705734|NCT03895086|102065128|FG001|STARTED|Overall Study||0||
48705735|NCT03895086|102065127|FG000|COMPLETED|Overall Study||0||
48705736|NCT03895086|102065128|FG001|COMPLETED|Overall Study||0||
48289467|NCT01762501|101037353|FG000|COMPLETED|Overall Study||332||
48289468|NCT01762501|101037354|FG001|COMPLETED|Overall Study||336||
48289469|NCT01762501|101037353|FG000|NOT COMPLETED|Overall Study||27||
48289470|NCT01762501|101037354|FG001|NOT COMPLETED|Overall Study||23||
48289471|NCT02729831|101037355|FG000|STARTED|Baseline (Post Decision Aid, Pre-visit)||320||
48705737|NCT03895086|102065127|FG000|NOT COMPLETED|Overall Study||1||
48705738|NCT03895086|102065128|FG001|NOT COMPLETED|Overall Study||0||
48705739|NCT03832114|102065129|FG000|STARTED|Run-in Phase||16||
48705740|NCT03832114|102065130|FG001|STARTED|Run-in Phase||11||
48401505|NCT04134728|101313786|FG004|STARTED|Overall Study||26||
48401506|NCT04134728|101313787|FG005|STARTED|Overall Study||27||
48401507|NCT04134728|101313782|FG000|COMPLETED|Overall Study||143||
48401508|NCT04134728|101313783|FG001|COMPLETED|Overall Study||144||
48401509|NCT04134728|101313784|FG002|COMPLETED|Overall Study||133||
48401510|NCT04134728|101313785|FG003|COMPLETED|Overall Study||23||
48401511|NCT04134728|101313786|FG004|COMPLETED|Overall Study||25||
48401512|NCT04134728|101313787|FG005|COMPLETED|Overall Study||26||
48401513|NCT04134728|101313782|FG000|NOT COMPLETED|Overall Study||13||
48705741|NCT03832114|102065131|FG002|STARTED|Run-in Phase||0||
48289472|NCT02729831|101037356|FG001|STARTED|Baseline (Post Decision Aid, Pre-visit)||315||
48401514|NCT04134728|101313783|FG001|NOT COMPLETED|Overall Study||14||
48401515|NCT04134728|101313784|FG002|NOT COMPLETED|Overall Study||23||
48401516|NCT04134728|101313785|FG003|NOT COMPLETED|Overall Study||3||
48401517|NCT04134728|101313786|FG004|NOT COMPLETED|Overall Study||1||
48401518|NCT04134728|101313787|FG005|NOT COMPLETED|Overall Study||1||
48401519|NCT03706040|101313788|FG000|STARTED|Period A (Week 0 to Week 16)||34|Randomized|
48401520|NCT03706040|101313789|FG001|STARTED|Period A (Week 0 to Week 16)||69|Randomized|
48401521|NCT03706040|101313790|FG002|STARTED|Period A (Week 0 to Week 16)||69|Randomized|
48401522|NCT03706040|101313791|FG003|STARTED|Period A (Week 0 to Week 16)||0|Randomized|
48401523|NCT03706040|101313792|FG004|STARTED|Period A (Week 0 to Week 16)||0|Randomized|
48401524|NCT03706040|101313793|FG005|STARTED|Period A (Week 0 to Week 16)||0|Randomized|
48401525|NCT03706040|101313794|FG006|STARTED|Period A (Week 0 to Week 16)||0|Randomized|
48401526|NCT03706040|101313788|FG000|Received Study Drug|Period A (Week 0 to Week 16)||34||
48584625|NCT03702010|101762201|FG000|COMPLETED|First Stimulation (5 Days)||13||
48584626|NCT03702010|101762202|FG001|COMPLETED|First Stimulation (5 Days)||14||
48584627|NCT03702010|101762201|FG000|NOT COMPLETED|First Stimulation (5 Days)||0||
48584628|NCT03702010|101762202|FG001|NOT COMPLETED|First Stimulation (5 Days)||0||
48584629|NCT03702010|101762201|FG000|STARTED|Washout + Second Stimulation (2+5days)||13||
48584630|NCT03702010|101762202|FG001|STARTED|Washout + Second Stimulation (2+5days)||14||
48705742|NCT03832114|102065132|FG003|STARTED|Run-in Phase||0||
48705743|NCT03832114|102065129|FG000|COMPLETED|Run-in Phase||16||
48705744|NCT03832114|102065130|FG001|COMPLETED|Run-in Phase||11||
48584631|NCT03702010|101762201|FG000|COMPLETED|Washout + Second Stimulation (2+5days)||13||
48584632|NCT03702010|101762202|FG001|COMPLETED|Washout + Second Stimulation (2+5days)||14||
48584633|NCT03702010|101762201|FG000|NOT COMPLETED|Washout + Second Stimulation (2+5days)||0||
48584634|NCT03702010|101762202|FG001|NOT COMPLETED|Washout + Second Stimulation (2+5days)||0||
48584635|NCT03702010|101762201|FG000|STARTED|Follow-up (30days)||13||
48584636|NCT03702010|101762202|FG001|STARTED|Follow-up (30days)||14||
48584637|NCT03702010|101762201|FG000|COMPLETED|Follow-up (30days)||11||
48584638|NCT03702010|101762202|FG001|COMPLETED|Follow-up (30days)||12||
48584639|NCT03702010|101762201|FG000|NOT COMPLETED|Follow-up (30days)||2||
48584640|NCT03702010|101762202|FG001|NOT COMPLETED|Follow-up (30days)||2||
48584641|NCT02655016|101762203|FG000|STARTED|Overall Study||246||
48584642|NCT02655016|101762204|FG001|STARTED|Overall Study||487||
48584643|NCT02655016|101762203|FG000|Received Study Treatment|Overall Study||244||
48584644|NCT02655016|101762204|FG001|Received Study Treatment|Overall Study||484||
48584645|NCT02655016|101762203|FG000|Ongoing With Treatment in the Study|Overall Study||69||
48584646|NCT02655016|101762204|FG001|Ongoing With Treatment in the Study|Overall Study||177||
48584647|NCT02655016|101762203|FG000|COMPLETED|Overall Study||191||
48584648|NCT02655016|101762204|FG001|COMPLETED|Overall Study||397||
48584649|NCT02655016|101762203|FG000|NOT COMPLETED|Overall Study||55||
48584650|NCT02655016|101762204|FG001|NOT COMPLETED|Overall Study||90||
48584651|NCT01168908|101762205|FG000|STARTED|Double Blind, Placebo Controlled||10||
48584652|NCT01168908|101762206|FG001|STARTED|Double Blind, Placebo Controlled||10||
48584653|NCT01168908|101762205|FG000|COMPLETED|Double Blind, Placebo Controlled||7||
48584654|NCT01168908|101762206|FG001|COMPLETED|Double Blind, Placebo Controlled||8||
48584655|NCT01168908|101762205|FG000|NOT COMPLETED|Double Blind, Placebo Controlled||3||
48584656|NCT01168908|101762206|FG001|NOT COMPLETED|Double Blind, Placebo Controlled||2||
48584657|NCT01168908|101762205|FG000|STARTED|Open Label||7||
48584658|NCT01168908|101762206|FG001|STARTED|Open Label||8||
48584659|NCT01168908|101762205|FG000|COMPLETED|Open Label||6||
48584660|NCT01168908|101762206|FG001|COMPLETED|Open Label||7||
48584661|NCT01168908|101762205|FG000|NOT COMPLETED|Open Label||1||
48584662|NCT01168908|101762206|FG001|NOT COMPLETED|Open Label||1||
48584663|NCT03886519|101762207|FG000|STARTED|Overall Study||351||446
48584664|NCT03886519|101762208|FG001|STARTED|Overall Study||349||446
48584665|NCT03886519|101762207|FG000|3-6 Month Visit|Overall Study||264||317
48584666|NCT03886519|101762208|FG001|3-6 Month Visit|Overall Study||252||337
48584667|NCT03886519|101762207|FG000|12 Month Visit|Overall Study||312||399
48705745|NCT03832114|102065131|FG002|COMPLETED|Run-in Phase||0||
48705746|NCT03832114|102065132|FG003|COMPLETED|Run-in Phase||0||
48705747|NCT03832114|102065129|FG000|NOT COMPLETED|Run-in Phase||0||
48705748|NCT03832114|102065130|FG001|NOT COMPLETED|Run-in Phase||0||
48705749|NCT03832114|102065131|FG002|NOT COMPLETED|Run-in Phase||0||
48705750|NCT03832114|102065132|FG003|NOT COMPLETED|Run-in Phase||0||
48705751|NCT03832114|102065129|FG000|STARTED|Dose Escalation/200mg b.i.d Treatment||0||
48705752|NCT03832114|102065130|FG001|STARTED|Dose Escalation/200mg b.i.d Treatment||0||
48705753|NCT03832114|102065131|FG002|STARTED|Dose Escalation/200mg b.i.d Treatment||16||
48705754|NCT03832114|102065132|FG003|STARTED|Dose Escalation/200mg b.i.d Treatment||11||
48705755|NCT03832114|102065129|FG000|COMPLETED|Dose Escalation/200mg b.i.d Treatment||0||
48705756|NCT03832114|102065130|FG001|COMPLETED|Dose Escalation/200mg b.i.d Treatment||0||
48705757|NCT03832114|102065131|FG002|COMPLETED|Dose Escalation/200mg b.i.d Treatment||16||
48705758|NCT03832114|102065132|FG003|COMPLETED|Dose Escalation/200mg b.i.d Treatment||11||
48705759|NCT03832114|102065129|FG000|NOT COMPLETED|Dose Escalation/200mg b.i.d Treatment||0||
48705760|NCT03832114|102065130|FG001|NOT COMPLETED|Dose Escalation/200mg b.i.d Treatment||0||
48705761|NCT03832114|102065131|FG002|NOT COMPLETED|Dose Escalation/200mg b.i.d Treatment||0||
48705762|NCT03832114|102065132|FG003|NOT COMPLETED|Dose Escalation/200mg b.i.d Treatment||0||
48705763|NCT02578680|102065133|FG000|STARTED|Overall Study||410||
48705764|NCT02578680|102065134|FG001|STARTED|Overall Study||206||
48705765|NCT02578680|102065133|FG000|Treated|Overall Study||405||
48705766|NCT02578680|102065134|FG001|Treated|Overall Study||202||
48705767|NCT02578680|102065133|FG000|Switched to Pembrolizumab|Overall Study||0||
48705768|NCT02578680|102065134|FG001|Switched to Pembrolizumab|Overall Study||84||
48705769|NCT02578680|102065133|FG000|COMPLETED|Overall Study||0||
48705770|NCT02578680|102065134|FG001|COMPLETED|Overall Study||0||
48705771|NCT02578680|102065133|FG000|NOT COMPLETED|Overall Study||410||
48705772|NCT02578680|102065134|FG001|NOT COMPLETED|Overall Study||206||
48289473|NCT02729831|101037357|FG002|STARTED|Baseline (Post Decision Aid, Pre-visit)||293||
48289474|NCT02729831|101037358|FG003|STARTED|Baseline (Post Decision Aid, Pre-visit)||292||
48289475|NCT02729831|101037355|FG000|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||282||
48289476|NCT02729831|101037356|FG001|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||292||
48289477|NCT02729831|101037357|FG002|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||275||
48289478|NCT02729831|101037358|FG003|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||275||
48289479|NCT02729831|101037355|FG000|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||38||
48289480|NCT02729831|101037356|FG001|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||23||
48289481|NCT02729831|101037357|FG002|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||18||
48289482|NCT02729831|101037358|FG003|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||17||
48289483|NCT02729831|101037355|FG000|STARTED|1 Week Post-visit||282||
48289484|NCT02729831|101037356|FG001|STARTED|1 Week Post-visit||292||
48705773|NCT03703817|102065135|FG000|STARTED|Overall Study||288||
48705774|NCT03703817|102065136|FG001|STARTED|Overall Study||133||
48705775|NCT03703817|102065135|FG000|COMPLETED|Overall Study||281||
48705776|NCT03703817|102065136|FG001|COMPLETED|Overall Study||129||
48705777|NCT03703817|102065135|FG000|NOT COMPLETED|Overall Study||7||
48289485|NCT02729831|101037357|FG002|STARTED|1 Week Post-visit||275||
48289486|NCT02729831|101037358|FG003|STARTED|1 Week Post-visit||275||
48289487|NCT02729831|101037355|FG000|COMPLETED|1 Week Post-visit||239||
48289488|NCT02729831|101037356|FG001|COMPLETED|1 Week Post-visit||252||
48289489|NCT02729831|101037357|FG002|COMPLETED|1 Week Post-visit||237||
48289490|NCT02729831|101037358|FG003|COMPLETED|1 Week Post-visit||239||
48289491|NCT02729831|101037355|FG000|NOT COMPLETED|1 Week Post-visit||43||
48289492|NCT02729831|101037356|FG001|NOT COMPLETED|1 Week Post-visit||40||
48289493|NCT02729831|101037357|FG002|NOT COMPLETED|1 Week Post-visit||38||
48584668|NCT03886519|101762208|FG001|12 Month Visit|Overall Study||316||399
48584669|NCT03886519|101762207|FG000|COMPLETED|Overall Study||335|Primary outcomes based on completing either the 3-6 month visit and/or the 12 month visit. Therefore, number completed is greater than the number of individuals seen at either visit.|425
48584670|NCT03886519|101762208|FG001|COMPLETED|Overall Study||328|Primary outcomes based on completing either the 3-6 month visit and/or the 12 month visit. Therefore, number completed is greater than the number of individuals seen at either visit.|420
48584671|NCT03886519|101762207|FG000|NOT COMPLETED|Overall Study||16||21
48584672|NCT03886519|101762208|FG001|NOT COMPLETED|Overall Study||21||26
48584673|NCT02523924|101762209|FG000|STARTED|Overall Study||31||
48584674|NCT02523924|101762209|FG000|COMPLETED|Overall Study||31||
48584675|NCT02523924|101762209|FG000|NOT COMPLETED|Overall Study||0||
48584676|NCT01746420|101762210|FG000|STARTED|Overall Study||20||
48584677|NCT01746420|101762211|FG001|STARTED|Overall Study||20||
48584678|NCT01746420|101762212|FG002|STARTED|Overall Study||20||
48584679|NCT01746420|101762213|FG003|STARTED|Overall Study||20||
48584680|NCT01746420|101762214|FG004|STARTED|Overall Study||20||
48584681|NCT01746420|101762210|FG000|COMPLETED|Overall Study||17||
48705778|NCT03703817|102065136|FG001|NOT COMPLETED|Overall Study||4||
48705779|NCT02150057|102065137|FG000|STARTED|Overall Study||25||
48705780|NCT02150057|102065138|FG001|STARTED|Overall Study||26||
48584682|NCT01746420|101762211|FG001|COMPLETED|Overall Study||18||
48584683|NCT01746420|101762212|FG002|COMPLETED|Overall Study||17||
48584684|NCT01746420|101762213|FG003|COMPLETED|Overall Study||20||
48584685|NCT01746420|101762214|FG004|COMPLETED|Overall Study||20||
48289494|NCT02729831|101037358|FG003|NOT COMPLETED|1 Week Post-visit||36||
48289495|NCT02729831|101037355|FG000|STARTED|6 Month Follow-up||282|Follow-up survey (Period 3) was sent to all those who completed the Baseline (Period 1) survey.|
48289496|NCT02729831|101037356|FG001|STARTED|6 Month Follow-up||292|Follow-up survey (Period 3) was sent to all those who completed the Baseline (Period 1) survey.|
48289497|NCT02729831|101037357|FG002|STARTED|6 Month Follow-up||275|Follow-up survey (Period 3) was sent to all those who completed the Baseline (Period 1) survey.|
48289498|NCT02729831|101037358|FG003|STARTED|6 Month Follow-up||275|Follow-up survey (Period 3) was sent to all those who completed the Baseline (Period 1) survey.|
48289499|NCT02729831|101037355|FG000|COMPLETED|6 Month Follow-up||227||
48584686|NCT01746420|101762210|FG000|NOT COMPLETED|Overall Study||3||
48584687|NCT01746420|101762211|FG001|NOT COMPLETED|Overall Study||2||
48584688|NCT01746420|101762212|FG002|NOT COMPLETED|Overall Study||3||
48584689|NCT01746420|101762213|FG003|NOT COMPLETED|Overall Study||0||
48584690|NCT01746420|101762214|FG004|NOT COMPLETED|Overall Study||0||
48705781|NCT02150057|102065137|FG000|COMPLETED|Overall Study||19||
48705782|NCT02150057|102065138|FG001|COMPLETED|Overall Study||22||
48705783|NCT02150057|102065137|FG000|NOT COMPLETED|Overall Study||6||
48705784|NCT02150057|102065138|FG001|NOT COMPLETED|Overall Study||4||
48705785|NCT00664560|102065139|FG000|STARTED|Overall Study||247||
48705786|NCT00664560|102065140|FG001|STARTED|Overall Study||243||
48705787|NCT00664560|102065141|FG002|STARTED|Overall Study||124||
48401527|NCT03706040|101313789|FG001|Received Study Drug|Period A (Week 0 to Week 16)||69||
48401528|NCT03706040|101313790|FG002|Received Study Drug|Period A (Week 0 to Week 16)||69||
48401529|NCT03706040|101313791|FG003|Received Study Drug|Period A (Week 0 to Week 16)||0||
48401530|NCT03706040|101313792|FG004|Received Study Drug|Period A (Week 0 to Week 16)||0||
48401531|NCT03706040|101313793|FG005|Received Study Drug|Period A (Week 0 to Week 16)||0||
48401532|NCT03706040|101313794|FG006|Received Study Drug|Period A (Week 0 to Week 16)||0||
48401533|NCT03706040|101313788|FG000|COMPLETED|Period A (Week 0 to Week 16)||25|Competed Period A|
48401534|NCT03706040|101313789|FG001|COMPLETED|Period A (Week 0 to Week 16)||61|Competed Period A|
48401535|NCT03706040|101313790|FG002|COMPLETED|Period A (Week 0 to Week 16)||58|Competed Period A|
48401536|NCT03706040|101313791|FG003|COMPLETED|Period A (Week 0 to Week 16)||0|Competed Period A|
48401537|NCT03706040|101313792|FG004|COMPLETED|Period A (Week 0 to Week 16)||0|Competed Period A|
48401538|NCT03706040|101313793|FG005|COMPLETED|Period A (Week 0 to Week 16)||0|Competed Period A|
48289500|NCT02729831|101037356|FG001|COMPLETED|6 Month Follow-up||238||
48289501|NCT02729831|101037357|FG002|COMPLETED|6 Month Follow-up||227||
48289502|NCT02729831|101037358|FG003|COMPLETED|6 Month Follow-up||232||
48289503|NCT02729831|101037355|FG000|NOT COMPLETED|6 Month Follow-up||55||
48289504|NCT02729831|101037356|FG001|NOT COMPLETED|6 Month Follow-up||54||
48289505|NCT02729831|101037357|FG002|NOT COMPLETED|6 Month Follow-up||48||
48289506|NCT02729831|101037358|FG003|NOT COMPLETED|6 Month Follow-up||43||
48289507|NCT00640133|101037359|FG000|STARTED|Randomization Phase (Baseline-Month 3)||15||
48289508|NCT00640133|101037360|FG001|STARTED|Randomization Phase (Baseline-Month 3)||12||
48289509|NCT00640133|101037359|FG000|COMPLETED|Randomization Phase (Baseline-Month 3)||15||
48289510|NCT00640133|101037360|FG001|COMPLETED|Randomization Phase (Baseline-Month 3)||12||
48401539|NCT03706040|101313794|FG006|COMPLETED|Period A (Week 0 to Week 16)||0|Competed Period A|
48401540|NCT03706040|101313788|FG000|NOT COMPLETED|Period A (Week 0 to Week 16)||9||
48401541|NCT03706040|101313789|FG001|NOT COMPLETED|Period A (Week 0 to Week 16)||8||
48401542|NCT03706040|101313790|FG002|NOT COMPLETED|Period A (Week 0 to Week 16)||11||
48401543|NCT03706040|101313791|FG003|NOT COMPLETED|Period A (Week 0 to Week 16)||0||
48401544|NCT03706040|101313792|FG004|NOT COMPLETED|Period A (Week 0 to Week 16)||0||
48401545|NCT03706040|101313793|FG005|NOT COMPLETED|Period A (Week 0 to Week 16)||0||
48401546|NCT03706040|101313794|FG006|NOT COMPLETED|Period A (Week 0 to Week 16)||0||
48401547|NCT03706040|101313788|FG000|STARTED|Period B (Week 16 to Week 52)||0||
48401548|NCT03706040|101313789|FG001|STARTED|Period B (Week 16 to Week 52)||0||
48401549|NCT03706040|101313790|FG002|STARTED|Period B (Week 16 to Week 52)||0||
48401550|NCT03706040|101313791|FG003|STARTED|Period B (Week 16 to Week 52)||13||
48401551|NCT03706040|101313792|FG004|STARTED|Period B (Week 16 to Week 52)||12||
48401552|NCT03706040|101313793|FG005|STARTED|Period B (Week 16 to Week 52)||61||
48401553|NCT03706040|101313794|FG006|STARTED|Period B (Week 16 to Week 52)||58||
48401554|NCT03706040|101313788|FG000|Received Study Drug|Period B (Week 16 to Week 52)||0||
48401555|NCT03706040|101313789|FG001|Received Study Drug|Period B (Week 16 to Week 52)||0||
48401556|NCT03706040|101313790|FG002|Received Study Drug|Period B (Week 16 to Week 52)||0||
48401557|NCT03706040|101313791|FG003|Received Study Drug|Period B (Week 16 to Week 52)||13||
48401558|NCT03706040|101313792|FG004|Received Study Drug|Period B (Week 16 to Week 52)||11||
48401559|NCT03706040|101313793|FG005|Received Study Drug|Period B (Week 16 to Week 52)||61||
48401560|NCT03706040|101313794|FG006|Received Study Drug|Period B (Week 16 to Week 52)||57||
48401561|NCT03706040|101313788|FG000|COMPLETED|Period B (Week 16 to Week 52)||0|Completed study|
48401562|NCT03706040|101313789|FG001|COMPLETED|Period B (Week 16 to Week 52)||0|Completed study|
48401563|NCT03706040|101313790|FG002|COMPLETED|Period B (Week 16 to Week 52)||0|Completed study|
48401564|NCT03706040|101313791|FG003|COMPLETED|Period B (Week 16 to Week 52)||5|Completed study|
48401565|NCT03706040|101313792|FG004|COMPLETED|Period B (Week 16 to Week 52)||3|Completed study|
48401566|NCT03706040|101313793|FG005|COMPLETED|Period B (Week 16 to Week 52)||33|Completed study|
48705788|NCT00664560|102065139|FG000|COMPLETED|Overall Study||208||
48705789|NCT00664560|102065140|FG001|COMPLETED|Overall Study||208||
48705790|NCT00664560|102065141|FG002|COMPLETED|Overall Study||105||
48705791|NCT00664560|102065139|FG000|NOT COMPLETED|Overall Study||39||
48401567|NCT03706040|101313794|FG006|COMPLETED|Period B (Week 16 to Week 52)||30|Completed study|
48401568|NCT03706040|101313788|FG000|NOT COMPLETED|Period B (Week 16 to Week 52)||0||
48401569|NCT03706040|101313789|FG001|NOT COMPLETED|Period B (Week 16 to Week 52)||0||
48401570|NCT03706040|101313790|FG002|NOT COMPLETED|Period B (Week 16 to Week 52)||0||
48705792|NCT00664560|102065140|FG001|NOT COMPLETED|Overall Study||35||
48705793|NCT00664560|102065141|FG002|NOT COMPLETED|Overall Study||19||
48401571|NCT03706040|101313791|FG003|NOT COMPLETED|Period B (Week 16 to Week 52)||8||
48401572|NCT03706040|101313792|FG004|NOT COMPLETED|Period B (Week 16 to Week 52)||9||
48401573|NCT03706040|101313793|FG005|NOT COMPLETED|Period B (Week 16 to Week 52)||28||
48401574|NCT03706040|101313794|FG006|NOT COMPLETED|Period B (Week 16 to Week 52)||28||
48401575|NCT00655811|101313795|FG000|STARTED|Overall Study||40||
48401576|NCT00655811|101313795|FG000|COMPLETED|Overall Study||40||
48705794|NCT00856206|102065142|FG000|STARTED|Overall Study||330||
48705795|NCT00856206|102065143|FG001|STARTED|Overall Study||985||
48705796|NCT00856206|102065142|FG000|COMPLETED|Overall Study||276||
48705797|NCT00856206|102065143|FG001|COMPLETED|Overall Study||824||
48705798|NCT00856206|102065142|FG000|NOT COMPLETED|Overall Study||54||
48584691|NCT00956592|101762215|FG000|STARTED|Overall Study||150||
48584692|NCT00956592|101762216|FG001|STARTED|Overall Study||150||
48584693|NCT00956592|101762215|FG000|COMPLETED|Overall Study||149||
48584694|NCT00956592|101762216|FG001|COMPLETED|Overall Study||147||
48584695|NCT00956592|101762215|FG000|NOT COMPLETED|Overall Study||1||
48584696|NCT00956592|101762216|FG001|NOT COMPLETED|Overall Study||3||
48584697|NCT01931995|101762217|FG000|STARTED|First Intervention (1 Day)||23||
48289511|NCT00640133|101037359|FG000|NOT COMPLETED|Randomization Phase (Baseline-Month 3)||0||
48289512|NCT00640133|101037360|FG001|NOT COMPLETED|Randomization Phase (Baseline-Month 3)||0||
48289513|NCT00640133|101037359|FG000|STARTED|Open Label Phase (Month 4-12)||27||
48584698|NCT01931995|101762218|FG001|STARTED|First Intervention (1 Day)||22||
48584699|NCT01931995|101762217|FG000|COMPLETED|First Intervention (1 Day)||19||
48584700|NCT01931995|101762218|FG001|COMPLETED|First Intervention (1 Day)||18||
48584701|NCT01931995|101762217|FG000|NOT COMPLETED|First Intervention (1 Day)||4||
48584702|NCT01931995|101762218|FG001|NOT COMPLETED|First Intervention (1 Day)||4||
48584703|NCT01931995|101762217|FG000|STARTED|Washout (at Least 6 Days)||19||
48584704|NCT01931995|101762218|FG001|STARTED|Washout (at Least 6 Days)||18||
48705799|NCT00856206|102065143|FG001|NOT COMPLETED|Overall Study||161||
48705800|NCT01057225|102065144|FG000|STARTED|Overall Study||3||
48705801|NCT01057225|102065145|FG001|STARTED|Overall Study||3||
48705802|NCT01057225|102065146|FG002|STARTED|Overall Study||6||
48705803|NCT01057225|102065147|FG003|STARTED|Overall Study||7||
48705804|NCT01057225|102065148|FG004|STARTED|Overall Study||22||
48289514|NCT00640133|101037360|FG001|STARTED|Open Label Phase (Month 4-12)||0||
48289515|NCT00640133|101037359|FG000|COMPLETED|Open Label Phase (Month 4-12)||24||
48289516|NCT00640133|101037360|FG001|COMPLETED|Open Label Phase (Month 4-12)||0||
48289517|NCT00640133|101037359|FG000|NOT COMPLETED|Open Label Phase (Month 4-12)||3||
48289518|NCT00640133|101037360|FG001|NOT COMPLETED|Open Label Phase (Month 4-12)||0||
48289519|NCT01000285|101037361|FG000|STARTED|Overall Study||18||
48289520|NCT01000285|101037361|FG000|COMPLETED|Overall Study||18||
48289521|NCT01000285|101037361|FG000|NOT COMPLETED|Overall Study||0||
48289522|NCT01036763|101037362|FG000|STARTED|Overall Study||1264||
48289523|NCT01036763|101037362|FG000|COMPLETED|Overall Study||1171||
48289524|NCT01036763|101037362|FG000|NOT COMPLETED|Overall Study||93||
48584705|NCT01931995|101762217|FG000|COMPLETED|Washout (at Least 6 Days)||19||
48584706|NCT01931995|101762218|FG001|COMPLETED|Washout (at Least 6 Days)||18||
48584707|NCT01931995|101762217|FG000|NOT COMPLETED|Washout (at Least 6 Days)||0||
48584708|NCT01931995|101762218|FG001|NOT COMPLETED|Washout (at Least 6 Days)||0||
48705805|NCT01057225|102065149|FG005|STARTED|Overall Study||23||
48705806|NCT01057225|102065144|FG000|COMPLETED|Overall Study||3||
48289525|NCT03607422|101037363|FG000|STARTED|Overall Study||242|Randomized into study|
48289526|NCT03607422|101037364|FG001|STARTED|Overall Study||243|Randomized into study|
48289527|NCT03607422|101037365|FG002|STARTED|Overall Study||247|Randomized into study|
48289528|NCT03607422|101037366|FG003|STARTED|Overall Study||60|Randomized into study|
48584709|NCT01931995|101762217|FG000|STARTED|Second Intervention (1 Day)||18||
48584710|NCT01931995|101762218|FG001|STARTED|Second Intervention (1 Day)||19||
48584711|NCT01931995|101762217|FG000|COMPLETED|Second Intervention (1 Day)||18||
48584712|NCT01931995|101762218|FG001|COMPLETED|Second Intervention (1 Day)||19||
48584713|NCT01931995|101762217|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48584714|NCT01931995|101762218|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48705807|NCT01057225|102065145|FG001|COMPLETED|Overall Study||3||
48705808|NCT01057225|102065146|FG002|COMPLETED|Overall Study||6||
48705809|NCT01057225|102065147|FG003|COMPLETED|Overall Study||7||
48705810|NCT01057225|102065148|FG004|COMPLETED|Overall Study||22||
48705811|NCT01057225|102065149|FG005|COMPLETED|Overall Study||23||
48584715|NCT01520558|101762219|FG000|STARTED|Overall Study||3||
48584716|NCT01520558|101762220|FG001|STARTED|Overall Study||3||
48705812|NCT01057225|102065144|FG000|NOT COMPLETED|Overall Study||0||
48705813|NCT01057225|102065145|FG001|NOT COMPLETED|Overall Study||0||
48584717|NCT01520558|101762221|FG002|STARTED|Overall Study||6||
48584718|NCT01520558|101762219|FG000|COMPLETED|Overall Study||1||
48584719|NCT01520558|101762220|FG001|COMPLETED|Overall Study||1||
48584720|NCT01520558|101762221|FG002|COMPLETED|Overall Study||3||
48584721|NCT01520558|101762219|FG000|NOT COMPLETED|Overall Study||2||
48584722|NCT01520558|101762220|FG001|NOT COMPLETED|Overall Study||2||
48584723|NCT01520558|101762221|FG002|NOT COMPLETED|Overall Study||3||
48584724|NCT02651155|101762222|FG000|STARTED|Overall Study||99||
48584725|NCT02651155|101762223|FG001|STARTED|Overall Study||105||
48584726|NCT02651155|101762222|FG000|COMPLETED|Overall Study||93||
48584727|NCT02651155|101762223|FG001|COMPLETED|Overall Study||103||
48584728|NCT02651155|101762222|FG000|NOT COMPLETED|Overall Study||6||
48584729|NCT02651155|101762223|FG001|NOT COMPLETED|Overall Study||2||
48584730|NCT01878084|101762224|FG000|STARTED|Overall Study||9||18
48705814|NCT01057225|102065146|FG002|NOT COMPLETED|Overall Study||0||
48705815|NCT01057225|102065147|FG003|NOT COMPLETED|Overall Study||0||
48705816|NCT01057225|102065148|FG004|NOT COMPLETED|Overall Study||0||
48705817|NCT01057225|102065149|FG005|NOT COMPLETED|Overall Study||0||
48705818|NCT02583230|102065150|FG000|STARTED|Overall Study||11||
48705819|NCT02583230|102065150|FG000|COMPLETED|Overall Study||11||
48705820|NCT02583230|102065150|FG000|NOT COMPLETED|Overall Study||0||
48584731|NCT01878084|101762224|FG000|Test(Received TAMP Bioglass) s|Overall Study||7||7
48584732|NCT01878084|101762224|FG000|Control (Sockets Were Left Empty)|Overall Study||7||7
48584733|NCT01878084|101762224|FG000|COMPLETED|Overall Study||7||14
48584734|NCT01878084|101762224|FG000|NOT COMPLETED|Overall Study||2||4
48584735|NCT01820572|101762225|FG000|STARTED|Randomization||223|= Participants Randomized|
48584736|NCT01820572|101762226|FG001|STARTED|Randomization||223|= Participants Randomized|
48705821|NCT01474772|102065151|FG000|STARTED|Period 1||101||
48705822|NCT01474772|102065152|FG001|STARTED|Period 1||102||
48705823|NCT01474772|102065151|FG000|COMPLETED|Period 1||89||
48584737|NCT01820572|101762225|FG000|COMPLETED|Randomization||221|= Participants Treated|
48584738|NCT01820572|101762226|FG001|COMPLETED|Randomization||222|= Participants Treated|
48584739|NCT01820572|101762225|FG000|NOT COMPLETED|Randomization||2||
48584740|NCT01820572|101762226|FG001|NOT COMPLETED|Randomization||1||
48584741|NCT01820572|101762225|FG000|STARTED|Treatment Period||221|= participants treated|
48584742|NCT01820572|101762226|FG001|STARTED|Treatment Period||222|= participants treated|
48584743|NCT01820572|101762225|FG000|COMPLETED|Treatment Period||195|= participants completing treatment|
48705824|NCT01474772|102065152|FG001|COMPLETED|Period 1||99||
48705825|NCT01474772|102065151|FG000|NOT COMPLETED|Period 1||12||
48705826|NCT01474772|102065152|FG001|NOT COMPLETED|Period 1||3||
48705827|NCT01474772|102065151|FG000|STARTED|Washout||89||
48584744|NCT01820572|101762226|FG001|COMPLETED|Treatment Period||186|= participants completing treatment|
48584745|NCT01820572|101762225|FG000|NOT COMPLETED|Treatment Period||26||
48584746|NCT01820572|101762226|FG001|NOT COMPLETED|Treatment Period||36||
48705828|NCT01474772|102065152|FG001|STARTED|Washout||99||
48705829|NCT01474772|102065151|FG000|COMPLETED|Washout||86||
48584747|NCT01070095|101762227|FG000|STARTED|Baseline Period||19||
48584748|NCT01070095|101762228|FG001|STARTED|Baseline Period||830||
48584749|NCT01070095|101762227|FG000|COMPLETED|Baseline Period||18||
48584750|NCT01070095|101762228|FG001|COMPLETED|Baseline Period||830||
48705830|NCT01474772|102065152|FG001|COMPLETED|Washout||97||
48705831|NCT01474772|102065151|FG000|NOT COMPLETED|Washout||3||
48705832|NCT01474772|102065152|FG001|NOT COMPLETED|Washout||2||
48289529|NCT03607422|101037367|FG004|STARTED|Overall Study||58|Randomized into study|
48289530|NCT03607422|101037368|FG005|STARTED|Overall Study||62|Randomized into study|
48289531|NCT03607422|101037363|FG000|COMPLETED|Overall Study||204|Completed Week 16|
48401577|NCT00655811|101313795|FG000|NOT COMPLETED|Overall Study||0||
48584751|NCT01070095|101762227|FG000|NOT COMPLETED|Baseline Period||1||
48584752|NCT01070095|101762228|FG001|NOT COMPLETED|Baseline Period||0||
48584753|NCT01070095|101762227|FG000|STARTED|Intervention Period||18||
48584754|NCT01070095|101762228|FG001|STARTED|Intervention Period||890||
48584755|NCT01070095|101762227|FG000|COMPLETED|Intervention Period||18||
48584756|NCT01070095|101762228|FG001|COMPLETED|Intervention Period||890||
48584757|NCT01070095|101762227|FG000|NOT COMPLETED|Intervention Period||0||
48584758|NCT01070095|101762228|FG001|NOT COMPLETED|Intervention Period||0||
48584759|NCT00562302|101762229|FG000|STARTED|Overall Study||170||
48584760|NCT00562302|101762230|FG001|STARTED|Overall Study||169||
48584761|NCT00562302|101762229|FG000|COMPLETED|Overall Study||150||
48584762|NCT00562302|101762230|FG001|COMPLETED|Overall Study||137||
48584763|NCT00562302|101762229|FG000|NOT COMPLETED|Overall Study||20||
48584764|NCT00562302|101762230|FG001|NOT COMPLETED|Overall Study||32||
48584765|NCT03483961|101762231|FG000|STARTED|Overall Study||53||
48584766|NCT03483961|101762232|FG001|STARTED|Overall Study||52||
48584767|NCT03483961|101762233|FG002|STARTED|Overall Study||51||
48584768|NCT03483961|101762234|FG003|STARTED|Overall Study||50||
48584769|NCT03483961|101762235|FG004|STARTED|Overall Study||53||
48584770|NCT03483961|101762236|FG005|STARTED|Overall Study||53||
48584771|NCT03483961|101762237|FG006|STARTED|Overall Study||51||
48584772|NCT03483961|101762238|FG007|STARTED|Overall Study||52||
48584773|NCT03483961|101762239|FG008|STARTED|Overall Study||20||
48584774|NCT03483961|101762240|FG009|STARTED|Overall Study||10||
48584775|NCT03483961|101762231|FG000|Exposed / Safety|Overall Study||53||
48584776|NCT03483961|101762232|FG001|Exposed / Safety|Overall Study||52||
48584777|NCT03483961|101762233|FG002|Exposed / Safety|Overall Study||50||
48584778|NCT03483961|101762234|FG003|Exposed / Safety|Overall Study||51||
48584779|NCT03483961|101762235|FG004|Exposed / Safety|Overall Study||53||
48584780|NCT03483961|101762236|FG005|Exposed / Safety|Overall Study||53||
48584781|NCT03483961|101762237|FG006|Exposed / Safety|Overall Study||51||
48584782|NCT03483961|101762238|FG007|Exposed / Safety|Overall Study||52||
48584783|NCT03483961|101762239|FG008|Exposed / Safety|Overall Study||20||
48584784|NCT03483961|101762240|FG009|Exposed / Safety|Overall Study||10||
48584785|NCT03483961|101762231|FG000|Immunogenicity-evaluable|Overall Study||47||
48584786|NCT03483961|101762232|FG001|Immunogenicity-evaluable|Overall Study||44||
48584787|NCT03483961|101762233|FG002|Immunogenicity-evaluable|Overall Study||44||
48584788|NCT03483961|101762234|FG003|Immunogenicity-evaluable|Overall Study||45||
48584789|NCT03483961|101762235|FG004|Immunogenicity-evaluable|Overall Study||48||
48584790|NCT03483961|101762236|FG005|Immunogenicity-evaluable|Overall Study||48||
48584791|NCT03483961|101762237|FG006|Immunogenicity-evaluable|Overall Study||47||
48584792|NCT03483961|101762238|FG007|Immunogenicity-evaluable|Overall Study||50||
48584793|NCT03483961|101762239|FG008|Immunogenicity-evaluable|Overall Study||20||
48584794|NCT03483961|101762240|FG009|Immunogenicity-evaluable|Overall Study||10||
48584795|NCT03483961|101762231|FG000|COMPLETED|Overall Study||42||
48584796|NCT03483961|101762232|FG001|COMPLETED|Overall Study||42||
48584797|NCT03483961|101762233|FG002|COMPLETED|Overall Study||39||
48584798|NCT03483961|101762234|FG003|COMPLETED|Overall Study||41||
48289532|NCT03607422|101037364|FG001|COMPLETED|Overall Study||233|Completed Week 16|
48289533|NCT03607422|101037365|FG002|COMPLETED|Overall Study||235|Completed Week 16|
48289534|NCT03607422|101037366|FG003|COMPLETED|Overall Study||55|Completed Week 16|
48289535|NCT03607422|101037367|FG004|COMPLETED|Overall Study||55|Completed Week 16|
48289536|NCT03607422|101037368|FG005|COMPLETED|Overall Study||59|Completed Week 16|
48289537|NCT03607422|101037363|FG000|NOT COMPLETED|Overall Study||38||
48289538|NCT03607422|101037364|FG001|NOT COMPLETED|Overall Study||10||
48289539|NCT03607422|101037365|FG002|NOT COMPLETED|Overall Study||12||
48401578|NCT01614795|101313796|FG000|STARTED|Overall Study||11||
48401579|NCT01614795|101313797|FG001|STARTED|Overall Study||12||
48401580|NCT01614795|101313798|FG002|STARTED|Overall Study||11||
48401581|NCT01614795|101313799|FG003|STARTED|Overall Study||12||
48584799|NCT03483961|101762235|FG004|COMPLETED|Overall Study||43||
48584800|NCT03483961|101762236|FG005|COMPLETED|Overall Study||47||
48584801|NCT03483961|101762237|FG006|COMPLETED|Overall Study||46||
48584802|NCT03483961|101762238|FG007|COMPLETED|Overall Study||39||
48289540|NCT03607422|101037366|FG003|NOT COMPLETED|Overall Study||5||
48584803|NCT03483961|101762239|FG008|COMPLETED|Overall Study||18||
48584804|NCT03483961|101762240|FG009|COMPLETED|Overall Study||10||
48584805|NCT03483961|101762231|FG000|NOT COMPLETED|Overall Study||11||
48584806|NCT03483961|101762232|FG001|NOT COMPLETED|Overall Study||10||
48584807|NCT03483961|101762233|FG002|NOT COMPLETED|Overall Study||12||
48289541|NCT03607422|101037367|FG004|NOT COMPLETED|Overall Study||3||
48584808|NCT03483961|101762234|FG003|NOT COMPLETED|Overall Study||9||
48584809|NCT03483961|101762235|FG004|NOT COMPLETED|Overall Study||10||
48584810|NCT03483961|101762236|FG005|NOT COMPLETED|Overall Study||6||
48584811|NCT03483961|101762237|FG006|NOT COMPLETED|Overall Study||5||
48584812|NCT03483961|101762238|FG007|NOT COMPLETED|Overall Study||13||
48584813|NCT03483961|101762239|FG008|NOT COMPLETED|Overall Study||2||
48137927|NCT05554237|100661602|FG003|STARTED|Part 1: Period 1 Treatment (1 Day)||2||
48137928|NCT05554237|100661603|FG004|STARTED|Part 1: Period 1 Treatment (1 Day)||0||
48137929|NCT05554237|100661604|FG005|STARTED|Part 1: Period 1 Treatment (1 Day)||0||
48584814|NCT03483961|101762240|FG009|NOT COMPLETED|Overall Study||0||
48584815|NCT00637000|101762241|FG000|STARTED|Overall Study||20||
48584816|NCT00637000|101762242|FG001|STARTED|Overall Study||18||
48584817|NCT00637000|101762241|FG000|Evaluable|Overall Study||18||
48584818|NCT00637000|101762242|FG001|Evaluable|Overall Study||16||
48584819|NCT00637000|101762241|FG000|COMPLETED|Overall Study||16||
48137930|NCT05554237|100661605|FG006|STARTED|Part 1: Period 1 Treatment (1 Day)||0||
48137931|NCT05554237|100661606|FG007|STARTED|Part 1: Period 1 Treatment (1 Day)||0||
48137932|NCT05554237|100661607|FG008|STARTED|Part 1: Period 1 Treatment (1 Day)||0||
48137933|NCT05554237|100661608|FG009|STARTED|Part 1: Period 1 Treatment (1 Day)||0||
48137934|NCT05554237|100661609|FG010|STARTED|Part 1: Period 1 Treatment (1 Day)||0||
48289542|NCT03607422|101037368|FG005|NOT COMPLETED|Overall Study||3||
48289543|NCT01598311|101037369|FG000|STARTED|Overall Study||303|Randomized|
48584820|NCT00637000|101762242|FG001|COMPLETED|Overall Study||15||
48584821|NCT00637000|101762241|FG000|NOT COMPLETED|Overall Study||4||
48584822|NCT00637000|101762242|FG001|NOT COMPLETED|Overall Study||3||
48584823|NCT01975571|101762243|FG000|STARTED|Overall Study||15||
48584824|NCT01975571|101762244|FG001|STARTED|Overall Study||5||
48584825|NCT01975571|101762245|FG002|STARTED|Overall Study||0||
48584826|NCT01975571|101762243|FG000|COMPLETED|Overall Study||14||
48584827|NCT01975571|101762244|FG001|COMPLETED|Overall Study||3||
48584828|NCT01975571|101762245|FG002|COMPLETED|Overall Study||0||
48584829|NCT01975571|101762243|FG000|NOT COMPLETED|Overall Study||1||
48584830|NCT01975571|101762244|FG001|NOT COMPLETED|Overall Study||2||
48584831|NCT01975571|101762245|FG002|NOT COMPLETED|Overall Study||0||
48584832|NCT02091986|101762246|FG000|STARTED|Overall Study||92||
48584833|NCT02091986|101762247|FG001|STARTED|Overall Study||95||
48584834|NCT02091986|101762248|FG002|STARTED|Overall Study||92||
48584835|NCT02091986|101762246|FG000|COMPLETED|Overall Study||85||
48584836|NCT02091986|101762247|FG001|COMPLETED|Overall Study||84||
48584837|NCT02091986|101762248|FG002|COMPLETED|Overall Study||84||
48584838|NCT02091986|101762246|FG000|NOT COMPLETED|Overall Study||7||
48584839|NCT02091986|101762247|FG001|NOT COMPLETED|Overall Study||11||
48584840|NCT02091986|101762248|FG002|NOT COMPLETED|Overall Study||8||
48584841|NCT01717482|101762249|FG000|STARTED|Overall Study||4||
48584842|NCT01717482|101762250|FG001|STARTED|Overall Study||2||
48584843|NCT01717482|101762249|FG000|COMPLETED|Overall Study||0||
48584844|NCT01717482|101762250|FG001|COMPLETED|Overall Study||2||
48584845|NCT01717482|101762249|FG000|NOT COMPLETED|Overall Study||4||
48584846|NCT01717482|101762250|FG001|NOT COMPLETED|Overall Study||0||
48584847|NCT03681990|101762251|FG000|STARTED|Overall Study||28||84
48584848|NCT03681990|101762251|FG000|COMPLETED|Overall Study||28||84
48584849|NCT03681990|101762251|FG000|NOT COMPLETED|Overall Study||0||0
48584850|NCT02892422|101762252|FG000|STARTED|Overall Study||528||
48584851|NCT02892422|101762252|FG000|COMPLETED|Overall Study||318||
48584852|NCT02892422|101762252|FG000|NOT COMPLETED|Overall Study||210||
48584853|NCT00796705|101762253|FG000|STARTED|Overall Study||3||
48584854|NCT00796705|101762254|FG001|STARTED|Overall Study||4||
48584855|NCT00796705|101762255|FG002|STARTED|Overall Study||4||
48584856|NCT00796705|101762256|FG003|STARTED|Overall Study||2||
48584857|NCT00796705|101762253|FG000|COMPLETED|Overall Study||3||
48584858|NCT00796705|101762254|FG001|COMPLETED|Overall Study||4||
48584859|NCT00796705|101762255|FG002|COMPLETED|Overall Study||4||
48137935|NCT05554237|100661610|FG011|STARTED|Part 1: Period 1 Treatment (1 Day)||0||
48137936|NCT05554237|100661611|FG012|STARTED|Part 1: Period 1 Treatment (1 Day)||0||
48584860|NCT00796705|101762256|FG003|COMPLETED|Overall Study||2||
48584861|NCT00796705|101762253|FG000|NOT COMPLETED|Overall Study||0||
48584862|NCT00796705|101762254|FG001|NOT COMPLETED|Overall Study||0||
48584863|NCT00796705|101762255|FG002|NOT COMPLETED|Overall Study||0||
48584864|NCT00796705|101762256|FG003|NOT COMPLETED|Overall Study||0||
48584865|NCT02319174|101762257|FG000|STARTED|Overall Study||43||
48584866|NCT02319174|101762257|FG000|COMPLETED|Overall Study||42||
48584867|NCT02319174|101762257|FG000|NOT COMPLETED|Overall Study||1||
48584868|NCT01893281|101762258|FG000|STARTED|Overall Study||78||
48584869|NCT01893281|101762258|FG000|Received at Least 1 Dose of Study Drug|Overall Study||78||
48584870|NCT01893281|101762258|FG000|COMPLETED|Overall Study||75||
48584871|NCT01893281|101762258|FG000|NOT COMPLETED|Overall Study||3||
48584872|NCT00624195|101762259|FG000|STARTED|Overall Study||29||
48584873|NCT00624195|101762260|FG001|STARTED|Overall Study||30||
48137937|NCT05554237|100661612|FG013|STARTED|Part 1: Period 1 Treatment (1 Day)||0||
48137938|NCT05554237|100661599|FG000|COMPLETED|Part 1: Period 1 Treatment (1 Day)||2||
48137939|NCT05554237|100661600|FG001|COMPLETED|Part 1: Period 1 Treatment (1 Day)||2||
48584874|NCT00624195|101762259|FG000|COMPLETED|Overall Study||26||
48584875|NCT00624195|101762260|FG001|COMPLETED|Overall Study||23||
48584876|NCT00624195|101762259|FG000|NOT COMPLETED|Overall Study||3||
48584877|NCT00624195|101762260|FG001|NOT COMPLETED|Overall Study||7||
48584878|NCT00205868|101762261|FG000|STARTED|Overall Study||304||
48584879|NCT00205868|101762261|FG000|COMPLETED|Overall Study||304||
48584880|NCT00205868|101762261|FG000|NOT COMPLETED|Overall Study||0||
48584881|NCT02752165|101762262|FG000|STARTED|Overall Study||191||
48584882|NCT02752165|101762263|FG001|STARTED|Overall Study||193||
48584883|NCT02752165|101762262|FG000|COMPLETED|Overall Study||146||
48584884|NCT02752165|101762263|FG001|COMPLETED|Overall Study||144||
48584885|NCT02752165|101762262|FG000|NOT COMPLETED|Overall Study||45||
48137940|NCT05554237|100661601|FG002|COMPLETED|Part 1: Period 1 Treatment (1 Day)||2||
48289544|NCT01598311|101037370|FG001|STARTED|Overall Study||305|Randomized|
48289545|NCT01598311|101037369|FG000|Treated|Overall Study||294|Safety Population|
48584886|NCT02752165|101762263|FG001|NOT COMPLETED|Overall Study||49||
48584887|NCT05036668|101762264|FG000|STARTED|Overall Study||10||
48584888|NCT05036668|101762265|FG001|STARTED|Overall Study||10||
48584889|NCT05036668|101762266|FG002|STARTED|Overall Study||10||
48584890|NCT05036668|101762264|FG000|COMPLETED|Overall Study||10||
48584891|NCT05036668|101762265|FG001|COMPLETED|Overall Study||10||
48584892|NCT05036668|101762266|FG002|COMPLETED|Overall Study||9||
48584893|NCT05036668|101762264|FG000|NOT COMPLETED|Overall Study||0||
48584894|NCT05036668|101762265|FG001|NOT COMPLETED|Overall Study||0||
48584895|NCT05036668|101762266|FG002|NOT COMPLETED|Overall Study||1||
48584896|NCT03330262|101762267|FG000|STARTED|First Six Weeks||7||
48137941|NCT05554237|100661602|FG003|COMPLETED|Part 1: Period 1 Treatment (1 Day)||2||
48137942|NCT05554237|100661603|FG004|COMPLETED|Part 1: Period 1 Treatment (1 Day)||0||
48137943|NCT05554237|100661604|FG005|COMPLETED|Part 1: Period 1 Treatment (1 Day)||0||
48137944|NCT05554237|100661605|FG006|COMPLETED|Part 1: Period 1 Treatment (1 Day)||0||
48137945|NCT05554237|100661606|FG007|COMPLETED|Part 1: Period 1 Treatment (1 Day)||0||
48137946|NCT05554237|100661607|FG008|COMPLETED|Part 1: Period 1 Treatment (1 Day)||0||
48137947|NCT05554237|100661608|FG009|COMPLETED|Part 1: Period 1 Treatment (1 Day)||0||
48137948|NCT05554237|100661609|FG010|COMPLETED|Part 1: Period 1 Treatment (1 Day)||0||
48137949|NCT05554237|100661610|FG011|COMPLETED|Part 1: Period 1 Treatment (1 Day)||0||
48137950|NCT05554237|100661611|FG012|COMPLETED|Part 1: Period 1 Treatment (1 Day)||0||
48137951|NCT05554237|100661612|FG013|COMPLETED|Part 1: Period 1 Treatment (1 Day)||0||
48137952|NCT05554237|100661599|FG000|NOT COMPLETED|Part 1: Period 1 Treatment (1 Day)||0||
48137953|NCT05554237|100661600|FG001|NOT COMPLETED|Part 1: Period 1 Treatment (1 Day)||0||
48137954|NCT05554237|100661601|FG002|NOT COMPLETED|Part 1: Period 1 Treatment (1 Day)||0||
48584897|NCT03330262|101762268|FG001|STARTED|First Six Weeks||6||
48584898|NCT03330262|101762267|FG000|COMPLETED|First Six Weeks||7||
48584899|NCT03330262|101762268|FG001|COMPLETED|First Six Weeks||6||
48137955|NCT05554237|100661602|FG003|NOT COMPLETED|Part 1: Period 1 Treatment (1 Day)||0||
48137956|NCT05554237|100661603|FG004|NOT COMPLETED|Part 1: Period 1 Treatment (1 Day)||0||
48137957|NCT05554237|100661604|FG005|NOT COMPLETED|Part 1: Period 1 Treatment (1 Day)||0||
48137958|NCT05554237|100661605|FG006|NOT COMPLETED|Part 1: Period 1 Treatment (1 Day)||0||
48137959|NCT05554237|100661606|FG007|NOT COMPLETED|Part 1: Period 1 Treatment (1 Day)||0||
48289546|NCT01598311|101037370|FG001|Treated|Overall Study||301|Safety Population|
48584900|NCT03330262|101762267|FG000|NOT COMPLETED|First Six Weeks||0||
48584901|NCT03330262|101762268|FG001|NOT COMPLETED|First Six Weeks||0||
48584902|NCT03330262|101762267|FG000|STARTED|Second Six Weeks||7||
48584903|NCT03330262|101762268|FG001|STARTED|Second Six Weeks||6||
48584904|NCT03330262|101762267|FG000|COMPLETED|Second Six Weeks||5||
48137960|NCT05554237|100661607|FG008|NOT COMPLETED|Part 1: Period 1 Treatment (1 Day)||0||
48137961|NCT05554237|100661608|FG009|NOT COMPLETED|Part 1: Period 1 Treatment (1 Day)||0||
48137962|NCT05554237|100661609|FG010|NOT COMPLETED|Part 1: Period 1 Treatment (1 Day)||0||
48137963|NCT05554237|100661610|FG011|NOT COMPLETED|Part 1: Period 1 Treatment (1 Day)||0||
48137964|NCT05554237|100661611|FG012|NOT COMPLETED|Part 1: Period 1 Treatment (1 Day)||0||
48137965|NCT05554237|100661612|FG013|NOT COMPLETED|Part 1: Period 1 Treatment (1 Day)||0||
48137966|NCT05554237|100661599|FG000|STARTED|Part 1: Period 1 Washout (3 Days)||2||
48137967|NCT05554237|100661600|FG001|STARTED|Part 1: Period 1 Washout (3 Days)||2||
48137968|NCT05554237|100661601|FG002|STARTED|Part 1: Period 1 Washout (3 Days)||2||
48289547|NCT01598311|101037369|FG000|Treated and Confirmed CDAD|Overall Study||285|mMITT Population|
48584905|NCT03330262|101762268|FG001|COMPLETED|Second Six Weeks||5||
48584906|NCT03330262|101762267|FG000|NOT COMPLETED|Second Six Weeks||2||
48584907|NCT03330262|101762268|FG001|NOT COMPLETED|Second Six Weeks||1||
48584908|NCT00908791|101762269|FG000|STARTED|Overall Study||24||
48584909|NCT00908791|101762269|FG000|COMPLETED|Overall Study||24||
48137969|NCT05554237|100661602|FG003|STARTED|Part 1: Period 1 Washout (3 Days)||2||
48137970|NCT05554237|100661603|FG004|STARTED|Part 1: Period 1 Washout (3 Days)||0||
48137971|NCT05554237|100661604|FG005|STARTED|Part 1: Period 1 Washout (3 Days)||0||
48137972|NCT05554237|100661605|FG006|STARTED|Part 1: Period 1 Washout (3 Days)||0||
48137973|NCT05554237|100661606|FG007|STARTED|Part 1: Period 1 Washout (3 Days)||0||
48289548|NCT01598311|101037370|FG001|Treated and Confirmed CDAD|Overall Study||292|mMITT Population|
48289549|NCT01598311|101037369|FG000|COMPLETED|Overall Study||256||
48289550|NCT01598311|101037370|FG001|COMPLETED|Overall Study||244||
48289551|NCT01598311|101037369|FG000|NOT COMPLETED|Overall Study||47||
48289552|NCT01598311|101037370|FG001|NOT COMPLETED|Overall Study||61||
48289553|NCT01874431|101037371|FG000|STARTED|Overall Study||96||
48289554|NCT01874431|101037372|FG001|STARTED|Overall Study||92||
48289555|NCT01874431|101037373|FG002|STARTED|Overall Study||100||
48289556|NCT01874431|101037374|FG003|STARTED|Overall Study||98||
48289557|NCT01874431|101037375|FG004|STARTED|Overall Study||98||
48289558|NCT01874431|101037376|FG005|STARTED|Overall Study||125||
48289559|NCT01874431|101037377|FG006|STARTED|Overall Study||120||
48289560|NCT01874431|101037378|FG007|STARTED|Overall Study||94||
48289561|NCT01874431|101037371|FG000|Participants Received Treatment|Overall Study||96||
48289562|NCT01874431|101037372|FG001|Participants Received Treatment|Overall Study||92||
48584910|NCT00908791|101762269|FG000|NOT COMPLETED|Overall Study||0||
48584911|NCT01190410|101762270|FG000|STARTED|Overall Study||4|16|
48584912|NCT01190410|101762271|FG001|STARTED|Overall Study||12|16|
48584913|NCT01190410|101762270|FG000|Re-Induction|Overall Study||0||
48584914|NCT01190410|101762271|FG001|Re-Induction|Overall Study||2||
48584915|NCT01190410|101762270|FG000|COMPLETED|Overall Study||3|6|
48584916|NCT01190410|101762271|FG001|COMPLETED|Overall Study||3|6|
48584917|NCT01190410|101762270|FG000|NOT COMPLETED|Overall Study||1||
48584918|NCT01190410|101762271|FG001|NOT COMPLETED|Overall Study||9||
48584919|NCT02729038|101762272|FG000|STARTED|Part 1 (Up to 44 Days)||8||
48584920|NCT02729038|101762273|FG001|STARTED|Part 1 (Up to 44 Days)||8||
48705833|NCT01474772|102065151|FG000|STARTED|Period 2||86||
48705834|NCT01474772|102065152|FG001|STARTED|Period 2||97||
48705835|NCT01474772|102065151|FG000|COMPLETED|Period 2||77||
48705836|NCT01474772|102065152|FG001|COMPLETED|Period 2||87||
48705837|NCT01474772|102065151|FG000|NOT COMPLETED|Period 2||9||
48705838|NCT01474772|102065152|FG001|NOT COMPLETED|Period 2||10||
48705839|NCT01474772|102065151|FG000|STARTED|Follow-up||77||
48705840|NCT01474772|102065152|FG001|STARTED|Follow-up||87||
48705841|NCT01474772|102065151|FG000|COMPLETED|Follow-up||77||
48705842|NCT01474772|102065152|FG001|COMPLETED|Follow-up||86||
48289563|NCT01874431|101037373|FG002|Participants Received Treatment|Overall Study||100||
48289564|NCT01874431|101037374|FG003|Participants Received Treatment|Overall Study||97||
48289565|NCT01874431|101037375|FG004|Participants Received Treatment|Overall Study||98||
48137974|NCT05554237|100661607|FG008|STARTED|Part 1: Period 1 Washout (3 Days)||0||
48289566|NCT01874431|101037376|FG005|Participants Received Treatment|Overall Study||125||
48289567|NCT01874431|101037377|FG006|Participants Received Treatment|Overall Study||119||
48584921|NCT02729038|101762274|FG002|STARTED|Part 1 (Up to 44 Days)||8||
48584922|NCT02729038|101762275|FG003|STARTED|Part 1 (Up to 44 Days)||0||
48584923|NCT02729038|101762272|FG000|COMPLETED|Part 1 (Up to 44 Days)||8||
48584924|NCT02729038|101762273|FG001|COMPLETED|Part 1 (Up to 44 Days)||8||
48584925|NCT02729038|101762274|FG002|COMPLETED|Part 1 (Up to 44 Days)||8||
48584926|NCT02729038|101762275|FG003|COMPLETED|Part 1 (Up to 44 Days)||0||
48584927|NCT02729038|101762272|FG000|NOT COMPLETED|Part 1 (Up to 44 Days)||0||
48584928|NCT02729038|101762273|FG001|NOT COMPLETED|Part 1 (Up to 44 Days)||0||
48584929|NCT02729038|101762274|FG002|NOT COMPLETED|Part 1 (Up to 44 Days)||0||
48584930|NCT02729038|101762275|FG003|NOT COMPLETED|Part 1 (Up to 44 Days)||0||
48584931|NCT02729038|101762272|FG000|STARTED|Part 2 (Up to 50 Days)||0||
48705843|NCT01474772|102065151|FG000|NOT COMPLETED|Follow-up||0||
48705844|NCT01474772|102065152|FG001|NOT COMPLETED|Follow-up||1||
48289568|NCT01874431|101037378|FG007|Participants Received Treatment|Overall Study||94||
48289569|NCT01874431|101037371|FG000|COMPLETED|Overall Study||90||
48289570|NCT01874431|101037372|FG001|COMPLETED|Overall Study||87||
48584932|NCT02729038|101762273|FG001|STARTED|Part 2 (Up to 50 Days)||0||
48705845|NCT02135029|102065153|FG000|STARTED|Overall Study||73||
48584933|NCT02729038|101762274|FG002|STARTED|Part 2 (Up to 50 Days)||0||
48584934|NCT02729038|101762275|FG003|STARTED|Part 2 (Up to 50 Days)||8||
48705846|NCT02135029|102065154|FG001|STARTED|Overall Study||74||
48705847|NCT02135029|102065155|FG002|STARTED|Overall Study||37||
48705848|NCT02135029|102065153|FG000|Treated|Overall Study||73||
48705849|NCT02135029|102065154|FG001|Treated|Overall Study||74||
48705850|NCT02135029|102065155|FG002|Treated|Overall Study||36||
48705851|NCT02135029|102065153|FG000|COMPLETED|Overall Study||69||
48705852|NCT02135029|102065154|FG001|COMPLETED|Overall Study||69||
48705853|NCT02135029|102065155|FG002|COMPLETED|Overall Study||34||
48705854|NCT02135029|102065153|FG000|NOT COMPLETED|Overall Study||4||
48705855|NCT02135029|102065154|FG001|NOT COMPLETED|Overall Study||5||
48705856|NCT02135029|102065155|FG002|NOT COMPLETED|Overall Study||3||
48705857|NCT04523454|102065156|FG000|STARTED|Overall Study||96||
48705858|NCT04523454|102065156|FG000|COMPLETED|Overall Study||96||
48705859|NCT04523454|102065156|FG000|NOT COMPLETED|Overall Study||0||
48705860|NCT03555981|102065157|FG000|STARTED|Overall Study||138||
48705861|NCT03555981|102065158|FG001|STARTED|Overall Study||141||
48584935|NCT02729038|101762272|FG000|COMPLETED|Part 2 (Up to 50 Days)||0||
48584936|NCT02729038|101762273|FG001|COMPLETED|Part 2 (Up to 50 Days)||0||
48584937|NCT02729038|101762274|FG002|COMPLETED|Part 2 (Up to 50 Days)||0||
48584938|NCT02729038|101762275|FG003|COMPLETED|Part 2 (Up to 50 Days)||8||
48584939|NCT02729038|101762272|FG000|NOT COMPLETED|Part 2 (Up to 50 Days)||0||
48584940|NCT02729038|101762273|FG001|NOT COMPLETED|Part 2 (Up to 50 Days)||0||
48584941|NCT02729038|101762274|FG002|NOT COMPLETED|Part 2 (Up to 50 Days)||0||
48584942|NCT02729038|101762275|FG003|NOT COMPLETED|Part 2 (Up to 50 Days)||0||
48584943|NCT00319592|101762276|FG000|STARTED|Overall Study||30||
48584944|NCT00319592|101762277|FG001|STARTED|Overall Study||30||
48584945|NCT00319592|101762276|FG000|COMPLETED|Overall Study||29||
48584946|NCT00319592|101762277|FG001|COMPLETED|Overall Study||29||
48584947|NCT00319592|101762276|FG000|NOT COMPLETED|Overall Study||1||
48584948|NCT00319592|101762277|FG001|NOT COMPLETED|Overall Study||1||
48584949|NCT00747474|101762278|FG000|STARTED|Cohort 1 (1.5 mg/m^2) Period||3||
48584950|NCT00747474|101762279|FG001|STARTED|Cohort 1 (1.5 mg/m^2) Period||0||
48584951|NCT00747474|101762280|FG002|STARTED|Cohort 1 (1.5 mg/m^2) Period||0||
48584952|NCT00747474|101762281|FG003|STARTED|Cohort 1 (1.5 mg/m^2) Period||0||
48584953|NCT00747474|101762282|FG004|STARTED|Cohort 1 (1.5 mg/m^2) Period||0||
48584954|NCT00747474|101762283|FG005|STARTED|Cohort 1 (1.5 mg/m^2) Period||0||
48584955|NCT00747474|101762284|FG006|STARTED|Cohort 1 (1.5 mg/m^2) Period||0||
48137975|NCT05554237|100661608|FG009|STARTED|Part 1: Period 1 Washout (3 Days)||0||
48137976|NCT05554237|100661609|FG010|STARTED|Part 1: Period 1 Washout (3 Days)||0||
48705862|NCT03555981|102065157|FG000|COMPLETED|Overall Study||138||
48705863|NCT03555981|102065158|FG001|COMPLETED|Overall Study||139||
48705864|NCT03555981|102065157|FG000|NOT COMPLETED|Overall Study||0||
48705865|NCT03555981|102065158|FG001|NOT COMPLETED|Overall Study||2||
48705866|NCT04392141|102065159|FG000|STARTED|Overall Study||60||
48705867|NCT04392141|102065160|FG001|STARTED|Overall Study||60||
48705868|NCT04392141|102065159|FG000|COMPLETED|Overall Study||60||
48705869|NCT04392141|102065160|FG001|COMPLETED|Overall Study||60||
48705870|NCT04392141|102065159|FG000|NOT COMPLETED|Overall Study||0||
48137977|NCT05554237|100661610|FG011|STARTED|Part 1: Period 1 Washout (3 Days)||0||
48137978|NCT05554237|100661611|FG012|STARTED|Part 1: Period 1 Washout (3 Days)||0||
48137979|NCT05554237|100661612|FG013|STARTED|Part 1: Period 1 Washout (3 Days)||0||
48289571|NCT01874431|101037373|FG002|COMPLETED|Overall Study||90||
48584956|NCT00747474|101762285|FG007|STARTED|Cohort 1 (1.5 mg/m^2) Period||0||
48584957|NCT00747474|101762286|FG008|STARTED|Cohort 1 (1.5 mg/m^2) Period||0||
48584958|NCT00747474|101762287|FG009|STARTED|Cohort 1 (1.5 mg/m^2) Period||0||
48584959|NCT00747474|101762288|FG010|STARTED|Cohort 1 (1.5 mg/m^2) Period||0||
48584960|NCT00747474|101762289|FG011|STARTED|Cohort 1 (1.5 mg/m^2) Period||0||
48584961|NCT00747474|101762278|FG000|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||3||
48584962|NCT00747474|101762279|FG001|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
48584963|NCT00747474|101762280|FG002|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
48584964|NCT00747474|101762281|FG003|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
48584965|NCT00747474|101762282|FG004|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
48584966|NCT00747474|101762283|FG005|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
48584967|NCT00747474|101762284|FG006|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
48584968|NCT00747474|101762285|FG007|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
48584969|NCT00747474|101762286|FG008|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
48584970|NCT00747474|101762287|FG009|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
48584971|NCT00747474|101762288|FG010|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
48584972|NCT00747474|101762289|FG011|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
48584973|NCT00747474|101762278|FG000|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
48584974|NCT00747474|101762279|FG001|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
48584975|NCT00747474|101762280|FG002|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
48584976|NCT00747474|101762281|FG003|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
48705871|NCT04392141|102065160|FG001|NOT COMPLETED|Overall Study||0||
48705872|NCT00075946|102065161|FG000|STARTED|Overall Study||148||
48705873|NCT00075946|102065162|FG001|STARTED|Overall Study||151||
48705874|NCT00075946|102065163|FG002|STARTED|Overall Study||28||
48705875|NCT00075946|102065164|FG003|STARTED|Overall Study||30||
48705876|NCT00075946|102065165|FG004|STARTED|Overall Study||188||
48584977|NCT00747474|101762282|FG004|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
48584978|NCT00747474|101762283|FG005|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
48584979|NCT00747474|101762284|FG006|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
48137980|NCT05554237|100661599|FG000|COMPLETED|Part 1: Period 1 Washout (3 Days)||2||
48137981|NCT05554237|100661600|FG001|COMPLETED|Part 1: Period 1 Washout (3 Days)||2||
48137982|NCT05554237|100661601|FG002|COMPLETED|Part 1: Period 1 Washout (3 Days)||2||
48137983|NCT05554237|100661602|FG003|COMPLETED|Part 1: Period 1 Washout (3 Days)||2||
48137984|NCT05554237|100661603|FG004|COMPLETED|Part 1: Period 1 Washout (3 Days)||0||
48137985|NCT05554237|100661604|FG005|COMPLETED|Part 1: Period 1 Washout (3 Days)||0||
48137986|NCT05554237|100661605|FG006|COMPLETED|Part 1: Period 1 Washout (3 Days)||0||
48137987|NCT05554237|100661606|FG007|COMPLETED|Part 1: Period 1 Washout (3 Days)||0||
48137988|NCT05554237|100661607|FG008|COMPLETED|Part 1: Period 1 Washout (3 Days)||0||
48137989|NCT05554237|100661608|FG009|COMPLETED|Part 1: Period 1 Washout (3 Days)||0||
48137990|NCT05554237|100661609|FG010|COMPLETED|Part 1: Period 1 Washout (3 Days)||0||
48137991|NCT05554237|100661610|FG011|COMPLETED|Part 1: Period 1 Washout (3 Days)||0||
48137992|NCT05554237|100661611|FG012|COMPLETED|Part 1: Period 1 Washout (3 Days)||0||
48137993|NCT05554237|100661612|FG013|COMPLETED|Part 1: Period 1 Washout (3 Days)||0||
48137994|NCT05554237|100661599|FG000|NOT COMPLETED|Part 1: Period 1 Washout (3 Days)||0||
48137995|NCT05554237|100661600|FG001|NOT COMPLETED|Part 1: Period 1 Washout (3 Days)||0||
48137996|NCT05554237|100661601|FG002|NOT COMPLETED|Part 1: Period 1 Washout (3 Days)||0||
48137997|NCT05554237|100661602|FG003|NOT COMPLETED|Part 1: Period 1 Washout (3 Days)||0||
48137998|NCT05554237|100661603|FG004|NOT COMPLETED|Part 1: Period 1 Washout (3 Days)||0||
48137999|NCT05554237|100661604|FG005|NOT COMPLETED|Part 1: Period 1 Washout (3 Days)||0||
48138000|NCT05554237|100661605|FG006|NOT COMPLETED|Part 1: Period 1 Washout (3 Days)||0||
48138001|NCT05554237|100661606|FG007|NOT COMPLETED|Part 1: Period 1 Washout (3 Days)||0||
48138002|NCT05554237|100661607|FG008|NOT COMPLETED|Part 1: Period 1 Washout (3 Days)||0||
48138003|NCT05554237|100661608|FG009|NOT COMPLETED|Part 1: Period 1 Washout (3 Days)||0||
48138004|NCT05554237|100661609|FG010|NOT COMPLETED|Part 1: Period 1 Washout (3 Days)||0||
48138005|NCT05554237|100661610|FG011|NOT COMPLETED|Part 1: Period 1 Washout (3 Days)||0||
48138006|NCT05554237|100661611|FG012|NOT COMPLETED|Part 1: Period 1 Washout (3 Days)||0||
48138007|NCT05554237|100661612|FG013|NOT COMPLETED|Part 1: Period 1 Washout (3 Days)||0||
48138008|NCT05554237|100661599|FG000|STARTED|Part 1: Period 2 Treatment (1 Day)||2||
48138009|NCT05554237|100661600|FG001|STARTED|Part 1: Period 2 Treatment (1 Day)||2||
48138010|NCT05554237|100661601|FG002|STARTED|Part 1: Period 2 Treatment (1 Day)||2||
48138011|NCT05554237|100661602|FG003|STARTED|Part 1: Period 2 Treatment (1 Day)||2||
48138012|NCT05554237|100661603|FG004|STARTED|Part 1: Period 2 Treatment (1 Day)||0||
48138013|NCT05554237|100661604|FG005|STARTED|Part 1: Period 2 Treatment (1 Day)||0||
48584980|NCT00747474|101762285|FG007|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
48584981|NCT00747474|101762286|FG008|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
48584982|NCT00747474|101762287|FG009|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
48705877|NCT00075946|102065161|FG000|Treated and With Toxicity Data Available|Overall Study||142||
48705878|NCT00075946|102065162|FG001|Treated and With Toxicity Data Available|Overall Study||148||
48705879|NCT00075946|102065163|FG002|Treated and With Toxicity Data Available|Overall Study||27||
48705880|NCT00075946|102065164|FG003|Treated and With Toxicity Data Available|Overall Study||29||
48705881|NCT00075946|102065165|FG004|Treated and With Toxicity Data Available|Overall Study||154||
48705882|NCT00075946|102065161|FG000|Included in Primary Analysis|Overall Study||143||
48705883|NCT00075946|102065162|FG001|Included in Primary Analysis|Overall Study||146||
48705884|NCT00075946|102065163|FG002|Included in Primary Analysis|Overall Study||23||
48705885|NCT00075946|102065164|FG003|Included in Primary Analysis|Overall Study||29||
48138014|NCT05554237|100661605|FG006|STARTED|Part 1: Period 2 Treatment (1 Day)||0||
48138015|NCT05554237|100661606|FG007|STARTED|Part 1: Period 2 Treatment (1 Day)||0||
48138016|NCT05554237|100661607|FG008|STARTED|Part 1: Period 2 Treatment (1 Day)||0||
48584983|NCT00747474|101762288|FG010|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
48584984|NCT00747474|101762289|FG011|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
48584985|NCT00747474|101762278|FG000|STARTED|Cohort 2 (3 mg/m^2) Period||0||
48584986|NCT00747474|101762279|FG001|STARTED|Cohort 2 (3 mg/m^2) Period||4||
48584987|NCT00747474|101762280|FG002|STARTED|Cohort 2 (3 mg/m^2) Period||0||
48584988|NCT00747474|101762281|FG003|STARTED|Cohort 2 (3 mg/m^2) Period||0||
48705886|NCT00075946|102065165|FG004|Included in Primary Analysis|Overall Study||0||
48138017|NCT05554237|100661608|FG009|STARTED|Part 1: Period 2 Treatment (1 Day)||0||
48138018|NCT05554237|100661609|FG010|STARTED|Part 1: Period 2 Treatment (1 Day)||0||
48138019|NCT05554237|100661610|FG011|STARTED|Part 1: Period 2 Treatment (1 Day)||0||
48138020|NCT05554237|100661611|FG012|STARTED|Part 1: Period 2 Treatment (1 Day)||0||
48138021|NCT05554237|100661612|FG013|STARTED|Part 1: Period 2 Treatment (1 Day)||0||
48138022|NCT05554237|100661599|FG000|COMPLETED|Part 1: Period 2 Treatment (1 Day)||2||
48138023|NCT05554237|100661600|FG001|COMPLETED|Part 1: Period 2 Treatment (1 Day)||2||
48138024|NCT05554237|100661601|FG002|COMPLETED|Part 1: Period 2 Treatment (1 Day)||2||
48705887|NCT00075946|102065161|FG000|COMPLETED|Overall Study||0||
48705888|NCT00075946|102065162|FG001|COMPLETED|Overall Study||0||
48705889|NCT00075946|102065163|FG002|COMPLETED|Overall Study||0||
48584989|NCT00747474|101762282|FG004|STARTED|Cohort 2 (3 mg/m^2) Period||0||
48584990|NCT00747474|101762283|FG005|STARTED|Cohort 2 (3 mg/m^2) Period||0||
48584991|NCT00747474|101762284|FG006|STARTED|Cohort 2 (3 mg/m^2) Period||0||
48584992|NCT00747474|101762285|FG007|STARTED|Cohort 2 (3 mg/m^2) Period||0||
48584993|NCT00747474|101762286|FG008|STARTED|Cohort 2 (3 mg/m^2) Period||0||
48584994|NCT00747474|101762287|FG009|STARTED|Cohort 2 (3 mg/m^2) Period||0||
48584995|NCT00747474|101762288|FG010|STARTED|Cohort 2 (3 mg/m^2) Period||0||
48584996|NCT00747474|101762289|FG011|STARTED|Cohort 2 (3 mg/m^2) Period||0||
48705890|NCT00075946|102065164|FG003|COMPLETED|Overall Study||0||
48138025|NCT05554237|100661602|FG003|COMPLETED|Part 1: Period 2 Treatment (1 Day)||2||
48289572|NCT01874431|101037374|FG003|COMPLETED|Overall Study||91||
48289573|NCT01874431|101037375|FG004|COMPLETED|Overall Study||90||
48289574|NCT01874431|101037376|FG005|COMPLETED|Overall Study||114||
48138026|NCT05554237|100661603|FG004|COMPLETED|Part 1: Period 2 Treatment (1 Day)||0||
48138027|NCT05554237|100661604|FG005|COMPLETED|Part 1: Period 2 Treatment (1 Day)||0||
48138028|NCT05554237|100661605|FG006|COMPLETED|Part 1: Period 2 Treatment (1 Day)||0||
48705891|NCT00075946|102065165|FG004|COMPLETED|Overall Study||0||
48138029|NCT05554237|100661606|FG007|COMPLETED|Part 1: Period 2 Treatment (1 Day)||0||
48138030|NCT05554237|100661607|FG008|COMPLETED|Part 1: Period 2 Treatment (1 Day)||0||
48138031|NCT05554237|100661608|FG009|COMPLETED|Part 1: Period 2 Treatment (1 Day)||0||
48138032|NCT05554237|100661609|FG010|COMPLETED|Part 1: Period 2 Treatment (1 Day)||0||
48138033|NCT05554237|100661610|FG011|COMPLETED|Part 1: Period 2 Treatment (1 Day)||0||
48138034|NCT05554237|100661611|FG012|COMPLETED|Part 1: Period 2 Treatment (1 Day)||0||
48138035|NCT05554237|100661612|FG013|COMPLETED|Part 1: Period 2 Treatment (1 Day)||0||
48138036|NCT05554237|100661599|FG000|NOT COMPLETED|Part 1: Period 2 Treatment (1 Day)||0||
48138037|NCT05554237|100661600|FG001|NOT COMPLETED|Part 1: Period 2 Treatment (1 Day)||0||
48138038|NCT05554237|100661601|FG002|NOT COMPLETED|Part 1: Period 2 Treatment (1 Day)||0||
48138039|NCT05554237|100661602|FG003|NOT COMPLETED|Part 1: Period 2 Treatment (1 Day)||0||
48289575|NCT01874431|101037377|FG006|COMPLETED|Overall Study||112||
48289576|NCT01874431|101037378|FG007|COMPLETED|Overall Study||90||
48289577|NCT01874431|101037371|FG000|NOT COMPLETED|Overall Study||6||
48289578|NCT01874431|101037372|FG001|NOT COMPLETED|Overall Study||5||
48289579|NCT01874431|101037373|FG002|NOT COMPLETED|Overall Study||10||
48289580|NCT01874431|101037374|FG003|NOT COMPLETED|Overall Study||7||
48289581|NCT01874431|101037375|FG004|NOT COMPLETED|Overall Study||8||
48289582|NCT01874431|101037376|FG005|NOT COMPLETED|Overall Study||11||
48289583|NCT01874431|101037377|FG006|NOT COMPLETED|Overall Study||8||
48289584|NCT01874431|101037378|FG007|NOT COMPLETED|Overall Study||4||
48289585|NCT01970345|101037379|FG000|STARTED|First Treatment Phase 12 Weeks||1||
48289586|NCT01970345|101037380|FG001|STARTED|First Treatment Phase 12 Weeks||2||
48289587|NCT01970345|101037379|FG000|COMPLETED|First Treatment Phase 12 Weeks||0||
48289588|NCT01970345|101037380|FG001|COMPLETED|First Treatment Phase 12 Weeks||1||
48289589|NCT01970345|101037379|FG000|NOT COMPLETED|First Treatment Phase 12 Weeks||1||
48289590|NCT01970345|101037380|FG001|NOT COMPLETED|First Treatment Phase 12 Weeks||1||
48289591|NCT01970345|101037379|FG000|STARTED|Crossover Washout Period 4 Weeks||0||
48289592|NCT01970345|101037380|FG001|STARTED|Crossover Washout Period 4 Weeks||1||
48289593|NCT01970345|101037379|FG000|COMPLETED|Crossover Washout Period 4 Weeks||0||
48289594|NCT01970345|101037380|FG001|COMPLETED|Crossover Washout Period 4 Weeks||1||
48289595|NCT01970345|101037379|FG000|NOT COMPLETED|Crossover Washout Period 4 Weeks||0||
48289596|NCT01970345|101037380|FG001|NOT COMPLETED|Crossover Washout Period 4 Weeks||0||
48289597|NCT01970345|101037379|FG000|STARTED|Second Treatment Phase 12 Weeks||0||
48138040|NCT05554237|100661603|FG004|NOT COMPLETED|Part 1: Period 2 Treatment (1 Day)||0||
48138041|NCT05554237|100661604|FG005|NOT COMPLETED|Part 1: Period 2 Treatment (1 Day)||0||
48289598|NCT01970345|101037380|FG001|STARTED|Second Treatment Phase 12 Weeks||1||
48289599|NCT01970345|101037379|FG000|COMPLETED|Second Treatment Phase 12 Weeks||0||
48289600|NCT01970345|101037380|FG001|COMPLETED|Second Treatment Phase 12 Weeks||0||
48289601|NCT01970345|101037379|FG000|NOT COMPLETED|Second Treatment Phase 12 Weeks||0||
48289602|NCT01970345|101037380|FG001|NOT COMPLETED|Second Treatment Phase 12 Weeks||1||
48401582|NCT01614795|101313796|FG000|COMPLETED|Overall Study||0||
48401583|NCT01614795|101313797|FG001|COMPLETED|Overall Study||0||
48401584|NCT01614795|101313798|FG002|COMPLETED|Overall Study||0||
48584997|NCT00747474|101762278|FG000|COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
48584998|NCT00747474|101762279|FG001|COMPLETED|Cohort 2 (3 mg/m^2) Period||4||
48584999|NCT00747474|101762280|FG002|COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
48585000|NCT00747474|101762281|FG003|COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
48585001|NCT00747474|101762282|FG004|COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
48585002|NCT00747474|101762283|FG005|COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
48585003|NCT00747474|101762284|FG006|COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
48705892|NCT00075946|102065161|FG000|NOT COMPLETED|Overall Study||148||
48705893|NCT00075946|102065162|FG001|NOT COMPLETED|Overall Study||151||
48138042|NCT05554237|100661605|FG006|NOT COMPLETED|Part 1: Period 2 Treatment (1 Day)||0||
48289603|NCT00372229|101037381|FG000|STARTED|Study Phase||148||
48401585|NCT01614795|101313799|FG003|COMPLETED|Overall Study||0||
48401586|NCT01614795|101313796|FG000|NOT COMPLETED|Overall Study||11||
48585004|NCT00747474|101762285|FG007|COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
48705894|NCT00075946|102065163|FG002|NOT COMPLETED|Overall Study||28||
48289604|NCT00372229|101037382|FG001|STARTED|Study Phase||151||
48289605|NCT00372229|101037381|FG000|COMPLETED|Study Phase||117||
48289606|NCT00372229|101037382|FG001|COMPLETED|Study Phase||122||
48289607|NCT00372229|101037381|FG000|NOT COMPLETED|Study Phase||31||
48289608|NCT00372229|101037382|FG001|NOT COMPLETED|Study Phase||29||
48289609|NCT00372229|101037381|FG000|STARTED|Follow-Up Phase||117||
48289610|NCT00372229|101037382|FG001|STARTED|Follow-Up Phase||122||
48289611|NCT00372229|101037381|FG000|COMPLETED|Follow-Up Phase||71||
48289612|NCT00372229|101037382|FG001|COMPLETED|Follow-Up Phase||70||
48289613|NCT00372229|101037381|FG000|NOT COMPLETED|Follow-Up Phase||46||
48289614|NCT00372229|101037382|FG001|NOT COMPLETED|Follow-Up Phase||52||
48289615|NCT02390050|101037383|FG000|STARTED|Overall Study||72||
48289616|NCT02390050|101037384|FG001|STARTED|Overall Study||72||
48289617|NCT02390050|101037385|FG002|STARTED|Overall Study||72||
48289618|NCT02390050|101037386|FG003|STARTED|Overall Study||76||
48289619|NCT02390050|101037383|FG000|COMPLETED|Overall Study||65||
48289620|NCT02390050|101037384|FG001|COMPLETED|Overall Study||67||
48289621|NCT02390050|101037385|FG002|COMPLETED|Overall Study||68||
48289622|NCT02390050|101037386|FG003|COMPLETED|Overall Study||69||
48289623|NCT02390050|101037383|FG000|NOT COMPLETED|Overall Study||7||
48289624|NCT02390050|101037384|FG001|NOT COMPLETED|Overall Study||5||
48289625|NCT02390050|101037385|FG002|NOT COMPLETED|Overall Study||4||
48289626|NCT02390050|101037386|FG003|NOT COMPLETED|Overall Study||7||
48289627|NCT02269332|101037387|FG000|STARTED|Overall Study||298||
48289628|NCT02269332|101037387|FG000|COMPLETED|Overall Study||228||
48289629|NCT02269332|101037387|FG000|NOT COMPLETED|Overall Study||70||
48289630|NCT04196101|101037388|FG000|STARTED|Overall Study||41||
48289631|NCT04196101|101037389|FG001|STARTED|Overall Study||41||
48289632|NCT04196101|101037388|FG000|COMPLETED|Overall Study||31||
48289633|NCT04196101|101037389|FG001|COMPLETED|Overall Study||30||
48289634|NCT04196101|101037388|FG000|NOT COMPLETED|Overall Study||10||
48289635|NCT04196101|101037389|FG001|NOT COMPLETED|Overall Study||11||
48289636|NCT00504660|101037390|FG000|STARTED|Overall Study||31||
48289637|NCT00504660|101037391|FG001|STARTED|Overall Study||43||
48289638|NCT00504660|101037390|FG000|COMPLETED|Overall Study||31||
48289639|NCT00504660|101037391|FG001|COMPLETED|Overall Study||43||
48289640|NCT00504660|101037390|FG000|NOT COMPLETED|Overall Study||0||
48289641|NCT00504660|101037391|FG001|NOT COMPLETED|Overall Study||0||
48289642|NCT01783847|101037392|FG000|STARTED|Overall Study||85||
48289643|NCT01783847|101037393|FG001|STARTED|Overall Study||16||
48289644|NCT01783847|101037394|FG002|STARTED|Overall Study||16||
48289645|NCT01783847|101037392|FG000|COMPLETED|Overall Study||69||
48289646|NCT01783847|101037393|FG001|COMPLETED|Overall Study||15||
48289647|NCT01783847|101037394|FG002|COMPLETED|Overall Study||16||
48289648|NCT01783847|101037392|FG000|NOT COMPLETED|Overall Study||16||
48289649|NCT01783847|101037393|FG001|NOT COMPLETED|Overall Study||1||
48289650|NCT01783847|101037394|FG002|NOT COMPLETED|Overall Study||0||
48289651|NCT02630693|101037395|FG000|STARTED|Overall Study||90||
48289652|NCT02630693|101037396|FG001|STARTED|Overall Study||90||
48289653|NCT02630693|101037395|FG000|COMPLETED|Overall Study||90||
48585005|NCT00747474|101762286|FG008|COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
48585006|NCT00747474|101762287|FG009|COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
48585007|NCT00747474|101762288|FG010|COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
48585008|NCT00747474|101762289|FG011|COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
48585009|NCT00747474|101762278|FG000|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
48585010|NCT00747474|101762279|FG001|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
48585011|NCT00747474|101762280|FG002|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
48585012|NCT00747474|101762281|FG003|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
48585013|NCT00747474|101762282|FG004|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
48585014|NCT00747474|101762283|FG005|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
48289654|NCT02630693|101037396|FG001|COMPLETED|Overall Study||89||
48289655|NCT02630693|101037395|FG000|NOT COMPLETED|Overall Study||0||
48401587|NCT01614795|101313797|FG001|NOT COMPLETED|Overall Study||12||
48585015|NCT00747474|101762284|FG006|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
48585016|NCT00747474|101762285|FG007|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
48585017|NCT00747474|101762286|FG008|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
48585018|NCT00747474|101762287|FG009|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
48585019|NCT00747474|101762288|FG010|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
48585020|NCT00747474|101762289|FG011|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
48585021|NCT00747474|101762278|FG000|STARTED|Cohort 3 (6 mg/m^2) Period||0||
48289656|NCT02630693|101037396|FG001|NOT COMPLETED|Overall Study||1||
48289657|NCT03265938|101037397|FG000|STARTED|Overall Study||100||
48585022|NCT00747474|101762279|FG001|STARTED|Cohort 3 (6 mg/m^2) Period||0||
48289658|NCT03265938|101037397|FG000|COMPLETED|Overall Study||92||
48289659|NCT03265938|101037397|FG000|NOT COMPLETED|Overall Study||8||
48289660|NCT00538915|101037398|FG000|STARTED|Overall Study||63||
48289661|NCT00538915|101037398|FG000|COMPLETED|Overall Study||52||
48289662|NCT00538915|101037398|FG000|NOT COMPLETED|Overall Study||11||
48289663|NCT01011387|101037399|FG000|STARTED|Overall Study||16||
48289664|NCT01011387|101037399|FG000|COMPLETED|Overall Study||10||
48289665|NCT01011387|101037399|FG000|NOT COMPLETED|Overall Study||6||
48289666|NCT01377753|101037400|FG000|STARTED|Overall Study||15||
48585023|NCT00747474|101762280|FG002|STARTED|Cohort 3 (6 mg/m^2) Period||3||
48585024|NCT00747474|101762281|FG003|STARTED|Cohort 3 (6 mg/m^2) Period||0||
48585025|NCT00747474|101762282|FG004|STARTED|Cohort 3 (6 mg/m^2) Period||0||
48585026|NCT00747474|101762283|FG005|STARTED|Cohort 3 (6 mg/m^2) Period||0||
48585027|NCT00747474|101762284|FG006|STARTED|Cohort 3 (6 mg/m^2) Period||0||
48585028|NCT00747474|101762285|FG007|STARTED|Cohort 3 (6 mg/m^2) Period||0||
48585029|NCT00747474|101762286|FG008|STARTED|Cohort 3 (6 mg/m^2) Period||0||
48585030|NCT00747474|101762287|FG009|STARTED|Cohort 3 (6 mg/m^2) Period||0||
48585031|NCT00747474|101762288|FG010|STARTED|Cohort 3 (6 mg/m^2) Period||0||
48585032|NCT00747474|101762289|FG011|STARTED|Cohort 3 (6 mg/m^2) Period||0||
48585033|NCT00747474|101762278|FG000|COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
48585034|NCT00747474|101762279|FG001|COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
48592837|NCT02938949|101786321|FG001|NOT COMPLETED|Overall Study||0||
48289667|NCT01377753|101037400|FG000|COMPLETED|Overall Study||15||
48289668|NCT01377753|101037400|FG000|NOT COMPLETED|Overall Study||0||
48289669|NCT02667587|101037401|FG000|STARTED|Pre-Treatment||358||
48289670|NCT02667587|101037402|FG001|STARTED|Pre-Treatment||358||
48289671|NCT02667587|101037401|FG000|COMPLETED|Pre-Treatment||354||
48289672|NCT02667587|101037402|FG001|COMPLETED|Pre-Treatment||355||
48289673|NCT02667587|101037401|FG000|NOT COMPLETED|Pre-Treatment||4||
48289674|NCT02667587|101037402|FG001|NOT COMPLETED|Pre-Treatment||3||
48705895|NCT00075946|102065164|FG003|NOT COMPLETED|Overall Study||30||
48705896|NCT00075946|102065165|FG004|NOT COMPLETED|Overall Study||188||
48705897|NCT00758264|102065166|FG000|STARTED|Active Phase||182||
48705898|NCT00758264|102065167|FG001|STARTED|Active Phase||91||
48705899|NCT00758264|102065168|FG002|STARTED|Active Phase||90||
48705900|NCT00758264|102065166|FG000|COMPLETED|Active Phase||181||
48705901|NCT00758264|102065167|FG001|COMPLETED|Active Phase||91||
48705902|NCT00758264|102065168|FG002|COMPLETED|Active Phase||85||
48705903|NCT00758264|102065166|FG000|NOT COMPLETED|Active Phase||1||
48705904|NCT00758264|102065167|FG001|NOT COMPLETED|Active Phase||0||
48289675|NCT02667587|101037401|FG000|STARTED|End of Treatment||355||
48289676|NCT02667587|101037402|FG001|STARTED|End of Treatment||354||
48289677|NCT02667587|101037401|FG000|COMPLETED|End of Treatment||37|CONTINUING IN THE TREATMENT PERIOD|
48289678|NCT02667587|101037402|FG001|COMPLETED|End of Treatment||44|CONTINUING IN THE TREATMENT PERIOD|
48289679|NCT02667587|101037401|FG000|NOT COMPLETED|End of Treatment||318||
48289680|NCT02667587|101037402|FG001|NOT COMPLETED|End of Treatment||310||
48289681|NCT00153062|101037403|FG000|STARTED|Overall Study||5086||
48289682|NCT00153062|101037404|FG001|STARTED|Overall Study||5095||
48289683|NCT00153062|101037405|FG002|STARTED|Overall Study||5060||
48289684|NCT00153062|101037406|FG003|STARTED|Overall Study||5091||
48401588|NCT01614795|101313798|FG002|NOT COMPLETED|Overall Study||11||
48401589|NCT01614795|101313799|FG003|NOT COMPLETED|Overall Study||12||
48401590|NCT02475629|101313800|FG000|STARTED|Overall Study||40||
48401591|NCT02475629|101313800|FG000|COMPLETED|Overall Study||31||
48401592|NCT02475629|101313800|FG000|NOT COMPLETED|Overall Study||9||
48401593|NCT00701441|101313801|FG000|STARTED|Overall Study||9||
48401594|NCT00701441|101313802|FG001|STARTED|Overall Study||16||
48401595|NCT00701441|101313801|FG000|COMPLETED|Overall Study||9||
48401596|NCT00701441|101313802|FG001|COMPLETED|Overall Study||12||
48401597|NCT00701441|101313801|FG000|NOT COMPLETED|Overall Study||0||
48401598|NCT00701441|101313802|FG001|NOT COMPLETED|Overall Study||4||
48401599|NCT02754661|101313803|FG000|STARTED|Overall Study||160||
48401600|NCT02754661|101313804|FG001|STARTED|Overall Study||160||
48705905|NCT00758264|102065168|FG002|NOT COMPLETED|Active Phase||5||
48705906|NCT00758264|102065166|FG000|STARTED|Extended Safety Follow Up (ESFU) Phase||181||
48289685|NCT00153062|101037403|FG000|COMPLETED|Overall Study||4699||
48401601|NCT02754661|101313803|FG000|COMPLETED|Overall Study||145||
48401602|NCT02754661|101313804|FG001|COMPLETED|Overall Study||141||
48705907|NCT00758264|102065167|FG001|STARTED|Extended Safety Follow Up (ESFU) Phase||90||
48705908|NCT00758264|102065168|FG002|STARTED|Extended Safety Follow Up (ESFU) Phase||89||
48705909|NCT00758264|102065166|FG000|COMPLETED|Extended Safety Follow Up (ESFU) Phase||181||
48401603|NCT02754661|101313803|FG000|NOT COMPLETED|Overall Study||15||
48401604|NCT02754661|101313804|FG001|NOT COMPLETED|Overall Study||19||
48401605|NCT02255760|101313805|FG000|STARTED|Overall Study||14||
48401606|NCT02255760|101313806|FG001|STARTED|Overall Study||3||
48401607|NCT02255760|101313807|FG002|STARTED|Overall Study||15||
48401608|NCT02255760|101313808|FG003|STARTED|Overall Study||15||
48401609|NCT02255760|101313809|FG004|STARTED|Overall Study||9||
48401610|NCT02255760|101313805|FG000|COMPLETED|Overall Study||14||
48401611|NCT02255760|101313806|FG001|COMPLETED|Overall Study||2||
48401612|NCT02255760|101313807|FG002|COMPLETED|Overall Study||15||
48401613|NCT02255760|101313808|FG003|COMPLETED|Overall Study||15||
48401614|NCT02255760|101313809|FG004|COMPLETED|Overall Study||9||
48401615|NCT02255760|101313805|FG000|NOT COMPLETED|Overall Study||0||
48401616|NCT02255760|101313806|FG001|NOT COMPLETED|Overall Study||1||
48401617|NCT02255760|101313807|FG002|NOT COMPLETED|Overall Study||0||
48401618|NCT02255760|101313808|FG003|NOT COMPLETED|Overall Study||0||
48401619|NCT02255760|101313809|FG004|NOT COMPLETED|Overall Study||0||
48401620|NCT03690674|101313810|FG000|STARTED|Overall Study||35||
48401621|NCT03690674|101313811|FG001|STARTED|Overall Study||35||
48705910|NCT00758264|102065167|FG001|COMPLETED|Extended Safety Follow Up (ESFU) Phase||90||
48705911|NCT00758264|102065168|FG002|COMPLETED|Extended Safety Follow Up (ESFU) Phase||89||
48705912|NCT00758264|102065166|FG000|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0||
48705913|NCT00758264|102065167|FG001|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0||
48705914|NCT00758264|102065168|FG002|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0||
48289686|NCT00153062|101037404|FG001|COMPLETED|Overall Study||4689||
48289687|NCT00153062|101037405|FG002|COMPLETED|Overall Study||4645||
48401622|NCT03690674|101313810|FG000|COMPLETED|Overall Study||32||
48401623|NCT03690674|101313811|FG001|COMPLETED|Overall Study||32||
48401624|NCT03690674|101313810|FG000|NOT COMPLETED|Overall Study||3||
48401625|NCT03690674|101313811|FG001|NOT COMPLETED|Overall Study||3||
48401626|NCT00841672|101313812|FG000|STARTED|Overall Study||244||
48401627|NCT00841672|101313813|FG001|STARTED|Overall Study||241||
48401628|NCT00841672|101313812|FG000|COMPLETED|Overall Study||224||
48401629|NCT00841672|101313813|FG001|COMPLETED|Overall Study||209||
48401630|NCT00841672|101313812|FG000|NOT COMPLETED|Overall Study||20||
48401631|NCT00841672|101313813|FG001|NOT COMPLETED|Overall Study||32||
48401632|NCT03457636|101313814|FG000|STARTED|Overall Study||22||
48401633|NCT03457636|101313814|FG000|COMPLETED|Overall Study||20||
48585035|NCT00747474|101762280|FG002|COMPLETED|Cohort 3 (6 mg/m^2) Period||3||
48585036|NCT00747474|101762281|FG003|COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
48585037|NCT00747474|101762282|FG004|COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
48585038|NCT00747474|101762283|FG005|COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
48585039|NCT00747474|101762284|FG006|COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
48585040|NCT00747474|101762285|FG007|COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
48585041|NCT00747474|101762286|FG008|COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
48585042|NCT00747474|101762287|FG009|COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
48585043|NCT00747474|101762288|FG010|COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
48585044|NCT00747474|101762289|FG011|COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
48585045|NCT00747474|101762278|FG000|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
48585046|NCT00747474|101762279|FG001|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
48585047|NCT00747474|101762280|FG002|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
48585048|NCT00747474|101762281|FG003|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
48585049|NCT00747474|101762282|FG004|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
48585050|NCT00747474|101762283|FG005|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
48585051|NCT00747474|101762284|FG006|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
48585052|NCT00747474|101762285|FG007|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
48585053|NCT00747474|101762286|FG008|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
48585054|NCT00747474|101762287|FG009|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
48585055|NCT00747474|101762288|FG010|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
48585056|NCT00747474|101762289|FG011|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
48585057|NCT00747474|101762278|FG000|STARTED|Cohort 4 (9 mg/m^2) Period||0||
48585058|NCT00747474|101762279|FG001|STARTED|Cohort 4 (9 mg/m^2) Period||0||
48585059|NCT00747474|101762280|FG002|STARTED|Cohort 4 (9 mg/m^2) Period||0||
48585060|NCT00747474|101762281|FG003|STARTED|Cohort 4 (9 mg/m^2) Period||4||
48585061|NCT00747474|101762282|FG004|STARTED|Cohort 4 (9 mg/m^2) Period||0||
48585062|NCT00747474|101762283|FG005|STARTED|Cohort 4 (9 mg/m^2) Period||0||
48585063|NCT00747474|101762284|FG006|STARTED|Cohort 4 (9 mg/m^2) Period||0||
48585064|NCT00747474|101762285|FG007|STARTED|Cohort 4 (9 mg/m^2) Period||0||
48585065|NCT00747474|101762286|FG008|STARTED|Cohort 4 (9 mg/m^2) Period||0||
48585066|NCT00747474|101762287|FG009|STARTED|Cohort 4 (9 mg/m^2) Period||0||
48585067|NCT00747474|101762288|FG010|STARTED|Cohort 4 (9 mg/m^2) Period||0||
48705915|NCT02370004|102065169|FG000|STARTED|Overall Study||11||
48289688|NCT00153062|101037406|FG003|COMPLETED|Overall Study||4680||
48289689|NCT00153062|101037403|FG000|NOT COMPLETED|Overall Study||387||
48289690|NCT00153062|101037404|FG001|NOT COMPLETED|Overall Study||406||
48289691|NCT00153062|101037405|FG002|NOT COMPLETED|Overall Study||415||
48289692|NCT00153062|101037406|FG003|NOT COMPLETED|Overall Study||411||
48289693|NCT00505284|101037407|FG000|STARTED|Overall Study||73||
48289694|NCT00505284|101037408|FG001|STARTED|Overall Study||72||
48289695|NCT00505284|101037409|FG002|STARTED|Overall Study||69||
48289696|NCT00505284|101037410|FG003|STARTED|Overall Study||68||
48289697|NCT00505284|101037411|FG004|STARTED|Overall Study||70||
48289698|NCT00505284|101037407|FG000|COMPLETED|Overall Study||63||
48289699|NCT00505284|101037408|FG001|COMPLETED|Overall Study||56||
48289700|NCT00505284|101037409|FG002|COMPLETED|Overall Study||57||
48289701|NCT00505284|101037410|FG003|COMPLETED|Overall Study||49||
48289702|NCT00505284|101037411|FG004|COMPLETED|Overall Study||37||
48289703|NCT00505284|101037407|FG000|NOT COMPLETED|Overall Study||10||
48289704|NCT00505284|101037408|FG001|NOT COMPLETED|Overall Study||16||
48289705|NCT00505284|101037409|FG002|NOT COMPLETED|Overall Study||12||
48289706|NCT00505284|101037410|FG003|NOT COMPLETED|Overall Study||19||
48289707|NCT00505284|101037411|FG004|NOT COMPLETED|Overall Study||33||
48289708|NCT02335710|101037412|FG000|STARTED|Overall Study||40||
48289709|NCT02335710|101037413|FG001|STARTED|Overall Study||10||
48289710|NCT02335710|101037412|FG000|COMPLETED|Overall Study||40||
48289711|NCT02335710|101037413|FG001|COMPLETED|Overall Study||10||
48585068|NCT00747474|101762289|FG011|STARTED|Cohort 4 (9 mg/m^2) Period||0||
48585069|NCT00747474|101762278|FG000|COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
48585070|NCT00747474|101762279|FG001|COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
48585071|NCT00747474|101762280|FG002|COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
48585072|NCT00747474|101762281|FG003|COMPLETED|Cohort 4 (9 mg/m^2) Period||4||
48585073|NCT00747474|101762282|FG004|COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
48585074|NCT00747474|101762283|FG005|COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
48585075|NCT00747474|101762284|FG006|COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
48585076|NCT00747474|101762285|FG007|COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
48585077|NCT00747474|101762286|FG008|COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
48585078|NCT00747474|101762287|FG009|COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
48289712|NCT02335710|101037412|FG000|NOT COMPLETED|Overall Study||0||
48289713|NCT02335710|101037413|FG001|NOT COMPLETED|Overall Study||0||
48289714|NCT01248780|101037414|FG000|STARTED|Overall Study||132||
48585079|NCT00747474|101762288|FG010|COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
48585080|NCT00747474|101762289|FG011|COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
48289715|NCT01248780|101037415|FG001|STARTED|Overall Study||132||
48289716|NCT01248780|101037414|FG000|COMPLETED|Overall Study||123||
48289717|NCT01248780|101037415|FG001|COMPLETED|Overall Study||117||
48289718|NCT01248780|101037414|FG000|NOT COMPLETED|Overall Study||9||
48289719|NCT01248780|101037415|FG001|NOT COMPLETED|Overall Study||15||
48289720|NCT02112838|101037416|FG000|STARTED|Overall Study||25||
48289721|NCT02112838|101037417|FG001|STARTED|Overall Study||26||
48289722|NCT02112838|101037418|FG002|STARTED|Overall Study||25||
48138043|NCT05554237|100661606|FG007|NOT COMPLETED|Part 1: Period 2 Treatment (1 Day)||0||
48289723|NCT02112838|101037416|FG000|COMPLETED|Overall Study||20||
48289724|NCT02112838|101037417|FG001|COMPLETED|Overall Study||24||
48289725|NCT02112838|101037418|FG002|COMPLETED|Overall Study||24||
48289726|NCT02112838|101037416|FG000|NOT COMPLETED|Overall Study||5||
48289727|NCT02112838|101037417|FG001|NOT COMPLETED|Overall Study||2||
48289728|NCT02112838|101037418|FG002|NOT COMPLETED|Overall Study||1||
48289729|NCT00901186|101037419|FG000|STARTED|Overall Study||40||
48289730|NCT00901186|101037420|FG001|STARTED|Overall Study||43||
48585081|NCT00747474|101762278|FG000|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
48585082|NCT00747474|101762279|FG001|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
48138044|NCT05554237|100661607|FG008|NOT COMPLETED|Part 1: Period 2 Treatment (1 Day)||0||
48138045|NCT05554237|100661608|FG009|NOT COMPLETED|Part 1: Period 2 Treatment (1 Day)||0||
48138046|NCT05554237|100661609|FG010|NOT COMPLETED|Part 1: Period 2 Treatment (1 Day)||0||
48138047|NCT05554237|100661610|FG011|NOT COMPLETED|Part 1: Period 2 Treatment (1 Day)||0||
48138048|NCT05554237|100661611|FG012|NOT COMPLETED|Part 1: Period 2 Treatment (1 Day)||0||
48138049|NCT05554237|100661612|FG013|NOT COMPLETED|Part 1: Period 2 Treatment (1 Day)||0||
48138050|NCT05554237|100661599|FG000|STARTED|Part 1: Period 2 Washout (3 Days)||2||
48289731|NCT00901186|101037419|FG000|Safety Set|Overall Study||39||
48289732|NCT00901186|101037420|FG001|Safety Set|Overall Study||43||
48289733|NCT00901186|101037419|FG000|Intent to Treat|Overall Study||35||
48289734|NCT00901186|101037420|FG001|Intent to Treat|Overall Study||38||
48401634|NCT03457636|101313814|FG000|NOT COMPLETED|Overall Study||2||
48401635|NCT02792049|101313815|FG000|STARTED|Overall Study||35||
48401636|NCT02792049|101313816|FG001|STARTED|Overall Study||35||
48401637|NCT02792049|101313815|FG000|COMPLETED|Overall Study||35||
48401638|NCT02792049|101313816|FG001|COMPLETED|Overall Study||35||
48401639|NCT02792049|101313815|FG000|NOT COMPLETED|Overall Study||0||
48401640|NCT02792049|101313816|FG001|NOT COMPLETED|Overall Study||0||
48401641|NCT04348435|101313817|FG000|STARTED|Overall Study||19||
48401642|NCT04348435|101313818|FG001|STARTED|Overall Study||9||
48401643|NCT04348435|101313819|FG002|STARTED|Overall Study||12||
48401644|NCT04348435|101313820|FG003|STARTED|Overall Study||13||
48401645|NCT04348435|101313817|FG000|COMPLETED|Overall Study||11||
48401646|NCT04348435|101313818|FG001|COMPLETED|Overall Study||5||
48401647|NCT04348435|101313819|FG002|COMPLETED|Overall Study||9||
48401648|NCT04348435|101313820|FG003|COMPLETED|Overall Study||10||
48401649|NCT04348435|101313817|FG000|NOT COMPLETED|Overall Study||8||
48289735|NCT00901186|101037419|FG000|COMPLETED|Overall Study||31||
48289736|NCT00901186|101037420|FG001|COMPLETED|Overall Study||32||
48289737|NCT00901186|101037419|FG000|NOT COMPLETED|Overall Study||9||
48289738|NCT00901186|101037420|FG001|NOT COMPLETED|Overall Study||11||
48289739|NCT01506609|101037421|FG000|STARTED|Overall Study||2||
48289740|NCT01506609|101037422|FG001|STARTED|Overall Study||1||
48289741|NCT01506609|101037423|FG002|STARTED|Overall Study||1||
48289742|NCT01506609|101037424|FG003|STARTED|Overall Study||99||
48289743|NCT01506609|101037425|FG004|STARTED|Overall Study||97||
48289744|NCT01506609|101037426|FG005|STARTED|Overall Study||94||
48289745|NCT01506609|101037421|FG000|COMPLETED|Overall Study||0||
48289746|NCT01506609|101037422|FG001|COMPLETED|Overall Study||0||
48289747|NCT01506609|101037423|FG002|COMPLETED|Overall Study||0||
48289748|NCT01506609|101037424|FG003|COMPLETED|Overall Study||0||
48289749|NCT01506609|101037425|FG004|COMPLETED|Overall Study||1||
48289750|NCT01506609|101037426|FG005|COMPLETED|Overall Study||0||
48289751|NCT01506609|101037421|FG000|NOT COMPLETED|Overall Study||2||
48289752|NCT01506609|101037422|FG001|NOT COMPLETED|Overall Study||1||
48289753|NCT01506609|101037423|FG002|NOT COMPLETED|Overall Study||1||
48289754|NCT01506609|101037424|FG003|NOT COMPLETED|Overall Study||99||
48289755|NCT01506609|101037425|FG004|NOT COMPLETED|Overall Study||96||
48289756|NCT01506609|101037426|FG005|NOT COMPLETED|Overall Study||94||
48289757|NCT02550470|101037427|FG000|STARTED|Overall Study||0||58
48289758|NCT02550470|101037428|FG001|STARTED|Overall Study||0||65
48289759|NCT02550470|101037429|FG002|STARTED|Overall Study||0||63
48289760|NCT02550470|101037427|FG000|COMPLETED|Overall Study||0||58
48289761|NCT02550470|101037428|FG001|COMPLETED|Overall Study||0||65
48289762|NCT02550470|101037429|FG002|COMPLETED|Overall Study||0||63
48289763|NCT02550470|101037427|FG000|NOT COMPLETED|Overall Study||0||0
48289764|NCT02550470|101037428|FG001|NOT COMPLETED|Overall Study||0||0
48289765|NCT02550470|101037429|FG002|NOT COMPLETED|Overall Study||0||0
48289766|NCT00528645|101037430|FG000|STARTED|Overall Study||23||
48289767|NCT00528645|101037430|FG000|COMPLETED|Overall Study||20||
48289768|NCT00528645|101037430|FG000|NOT COMPLETED|Overall Study||3||
48289769|NCT00435591|101037431|FG000|STARTED|Overall Study||30||
48289770|NCT00435591|101037432|FG001|STARTED|Overall Study||31||
48289771|NCT00435591|101037433|FG002|STARTED|Overall Study||30||
48289772|NCT00435591|101037434|FG003|STARTED|Overall Study||30||
48289773|NCT00435591|101037431|FG000|Safety Analysis Set|Overall Study||28||
48289774|NCT00435591|101037432|FG001|Safety Analysis Set|Overall Study||30||
48289775|NCT00435591|101037433|FG002|Safety Analysis Set|Overall Study||30||
48289776|NCT00435591|101037434|FG003|Safety Analysis Set|Overall Study||29||
48289777|NCT00435591|101037431|FG000|Full Analysis Set|Overall Study||28||
48289778|NCT00435591|101037432|FG001|Full Analysis Set|Overall Study||29||
48289779|NCT00435591|101037433|FG002|Full Analysis Set|Overall Study||30||
48401650|NCT04348435|101313818|FG001|NOT COMPLETED|Overall Study||4||
48401651|NCT04348435|101313819|FG002|NOT COMPLETED|Overall Study||3||
48401652|NCT04348435|101313820|FG003|NOT COMPLETED|Overall Study||3||
48401653|NCT00618813|101313821|FG000|STARTED|Overall Study||35||
48401654|NCT00618813|101313821|FG000|Completed Enrollment - Week 12 Treatment|Overall Study||35||
48289780|NCT00435591|101037434|FG003|Full Analysis Set|Overall Study||29||
48289781|NCT00435591|101037431|FG000|End of Treatment|Overall Study||25||
48289782|NCT00435591|101037432|FG001|End of Treatment|Overall Study||27||
48289783|NCT00435591|101037433|FG002|End of Treatment|Overall Study||27||
48289784|NCT00435591|101037434|FG003|End of Treatment|Overall Study||23||
48289785|NCT00435591|101037431|FG000|COMPLETED|Overall Study||23||
48289786|NCT00435591|101037432|FG001|COMPLETED|Overall Study||27||
48401655|NCT00618813|101313821|FG000|Completed Week 13 to Week 22 Treatment|Overall Study||34||
48401656|NCT00618813|101313821|FG000|Completed Week 23 to Week 28 Therapy|Overall Study||34||
48401657|NCT00618813|101313821|FG000|Completed Week 29 to Week 37 Therapy|Overall Study||33||
48401658|NCT00618813|101313821|FG000|COMPLETED|Overall Study||31||
48401659|NCT00618813|101313821|FG000|NOT COMPLETED|Overall Study||4||
48401660|NCT00064077|101313822|FG000|STARTED|Overall Study||118||
48401661|NCT00064077|101313823|FG001|STARTED|Overall Study||117||
48401662|NCT00064077|101313824|FG002|STARTED|Overall Study||119||
48401663|NCT00064077|101313825|FG003|STARTED|Overall Study||118||
48401664|NCT00064077|101313822|FG000|COMPLETED|Overall Study||103||
48401665|NCT00064077|101313823|FG001|COMPLETED|Overall Study||108||
48401666|NCT00064077|101313824|FG002|COMPLETED|Overall Study||112||
48401667|NCT00064077|101313825|FG003|COMPLETED|Overall Study||111||
48401668|NCT00064077|101313822|FG000|NOT COMPLETED|Overall Study||15||
48401669|NCT00064077|101313823|FG001|NOT COMPLETED|Overall Study||9||
48401670|NCT00064077|101313824|FG002|NOT COMPLETED|Overall Study||7||
48401671|NCT00064077|101313825|FG003|NOT COMPLETED|Overall Study||7||
48401672|NCT03979872|101313826|FG000|STARTED|Overall Study||22||
48401673|NCT03979872|101313827|FG001|STARTED|Overall Study||23||
48401674|NCT03979872|101313828|FG002|STARTED|Overall Study||24||
48289787|NCT00435591|101037433|FG002|COMPLETED|Overall Study||25||
48289788|NCT00435591|101037434|FG003|COMPLETED|Overall Study||19||
48289789|NCT00435591|101037431|FG000|NOT COMPLETED|Overall Study||7||
48289790|NCT00435591|101037432|FG001|NOT COMPLETED|Overall Study||4||
48289791|NCT00435591|101037433|FG002|NOT COMPLETED|Overall Study||5||
48289792|NCT00435591|101037434|FG003|NOT COMPLETED|Overall Study||11||
48289793|NCT02561754|101037435|FG000|STARTED|Overall Study||36||
48289794|NCT02561754|101037436|FG001|STARTED|Overall Study||39||
48401675|NCT03979872|101313829|FG003|STARTED|Overall Study||23||
48401676|NCT03979872|101313826|FG000|COMPLETED|Overall Study||19||
48401677|NCT03979872|101313827|FG001|COMPLETED|Overall Study||15||
48401678|NCT03979872|101313828|FG002|COMPLETED|Overall Study||18||
48401679|NCT03979872|101313829|FG003|COMPLETED|Overall Study||19||
48401680|NCT03979872|101313826|FG000|NOT COMPLETED|Overall Study||3||
48401681|NCT03979872|101313827|FG001|NOT COMPLETED|Overall Study||8||
48401682|NCT03979872|101313828|FG002|NOT COMPLETED|Overall Study||6||
48401683|NCT03979872|101313829|FG003|NOT COMPLETED|Overall Study||4||
48401684|NCT01589263|101313830|FG000|STARTED|Overall Study||9||
48401685|NCT01589263|101313831|FG001|STARTED|Overall Study||12||
48401686|NCT01589263|101313830|FG000|COMPLETED|Overall Study||9||
48401687|NCT01589263|101313831|FG001|COMPLETED|Overall Study||12||
48401688|NCT01589263|101313830|FG000|NOT COMPLETED|Overall Study||0||
48585083|NCT00747474|101762280|FG002|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
48585084|NCT00747474|101762281|FG003|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
48585085|NCT00747474|101762282|FG004|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
48585086|NCT00747474|101762283|FG005|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
48585087|NCT00747474|101762284|FG006|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
48585088|NCT00747474|101762285|FG007|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
48585089|NCT00747474|101762286|FG008|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
48585090|NCT00747474|101762287|FG009|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
48705916|NCT02370004|102065169|FG000|COMPLETED|Overall Study||10||
48705917|NCT02370004|102065169|FG000|NOT COMPLETED|Overall Study||1||
48705918|NCT02437305|102065170|FG000|STARTED|Overall Study||50||
48705919|NCT02437305|102065171|FG001|STARTED|Overall Study||50||
48705920|NCT02437305|102065170|FG000|COMPLETED|Overall Study||32||
48401689|NCT01589263|101313831|FG001|NOT COMPLETED|Overall Study||0||
48401690|NCT03436147|101313832|FG000|STARTED|Overall Study||19||
48401691|NCT03436147|101313833|FG001|STARTED|Overall Study||30||
48401692|NCT03436147|101313832|FG000|COMPLETED|Overall Study||15||
48401693|NCT03436147|101313833|FG001|COMPLETED|Overall Study||19||
48401694|NCT03436147|101313832|FG000|NOT COMPLETED|Overall Study||4||
48401695|NCT03436147|101313833|FG001|NOT COMPLETED|Overall Study||11||
48401696|NCT01150760|101313834|FG000|STARTED|Overall Study||3525||
48401697|NCT01150760|101313835|FG001|STARTED|Overall Study||3525||
48401698|NCT01150760|101313834|FG000|COMPLETED|Overall Study||3525||
48585091|NCT00747474|101762288|FG010|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
48585092|NCT00747474|101762289|FG011|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
48585093|NCT00747474|101762278|FG000|STARTED|Cohort 5 (13.5 mg/m^2) Period||0||
48585094|NCT00747474|101762279|FG001|STARTED|Cohort 5 (13.5 mg/m^2) Period||0||
48705921|NCT02437305|102065171|FG001|COMPLETED|Overall Study||38||
48705922|NCT02437305|102065170|FG000|NOT COMPLETED|Overall Study||18||
48705923|NCT02437305|102065171|FG001|NOT COMPLETED|Overall Study||12||
48705924|NCT03569748|102065172|FG000|STARTED|Overall Study||110||
48705925|NCT03569748|102065173|FG001|STARTED|Overall Study||110||
48705926|NCT03569748|102065172|FG000|COMPLETED|Overall Study||110||
48705927|NCT03569748|102065173|FG001|COMPLETED|Overall Study||101||
48705928|NCT03569748|102065172|FG000|NOT COMPLETED|Overall Study||0||
48289795|NCT02561754|101037437|FG002|STARTED|Overall Study||35||
48585095|NCT00747474|101762280|FG002|STARTED|Cohort 5 (13.5 mg/m^2) Period||0||
48401699|NCT01150760|101313835|FG001|COMPLETED|Overall Study||3525||
48401700|NCT01150760|101313834|FG000|NOT COMPLETED|Overall Study||0||
48585096|NCT00747474|101762281|FG003|STARTED|Cohort 5 (13.5 mg/m^2) Period||0||
48585097|NCT00747474|101762282|FG004|STARTED|Cohort 5 (13.5 mg/m^2) Period||4||
48705929|NCT03569748|102065173|FG001|NOT COMPLETED|Overall Study||9||
48705930|NCT01730833|102065174|FG000|STARTED|Overall Study||18||
48705931|NCT01730833|102065175|FG001|STARTED|Overall Study||45||
48289796|NCT02561754|101037435|FG000|6 Months|Overall Study||35||
48289797|NCT02561754|101037436|FG001|6 Months|Overall Study||39||
48289798|NCT02561754|101037437|FG002|6 Months|Overall Study||30||
48401701|NCT01150760|101313835|FG001|NOT COMPLETED|Overall Study||0||
48401702|NCT04153929|101313836|FG000|STARTED|Overall Study||60|Entered/Randomized|
48401703|NCT04153929|101313837|FG001|STARTED|Overall Study||50|Entered/Randomized|
48401704|NCT04153929|101313838|FG002|STARTED|Overall Study||50|Entered/Randomized|
48401705|NCT04153929|101313839|FG003|STARTED|Overall Study||52|Entered/Randomized|
48401706|NCT04153929|101313840|FG004|STARTED|Overall Study||50|Entered/Randomized|
48401707|NCT04153929|101313841|FG005|STARTED|Overall Study||51|Entered/Randomized|
48401708|NCT04153929|101313842|FG006|STARTED|Overall Study||50|Entered/Randomized|
48401709|NCT04153929|101313843|FG007|STARTED|Overall Study||50|Entered/Randomized|
48401710|NCT04153929|101313836|FG000|Treated|Overall Study||59||
48401711|NCT04153929|101313837|FG001|Treated|Overall Study||50||
48401712|NCT04153929|101313838|FG002|Treated|Overall Study||50||
48401713|NCT04153929|101313839|FG003|Treated|Overall Study||52||
48401714|NCT04153929|101313840|FG004|Treated|Overall Study||50||
48401715|NCT04153929|101313841|FG005|Treated|Overall Study||51||
48289799|NCT02561754|101037435|FG000|12 Months|Overall Study||32||
48289800|NCT02561754|101037436|FG001|12 Months|Overall Study||34||
48289801|NCT02561754|101037437|FG002|12 Months|Overall Study||26||
48289802|NCT02561754|101037435|FG000|COMPLETED|Overall Study||30||
48401716|NCT04153929|101313842|FG006|Treated|Overall Study||49||
48401717|NCT04153929|101313843|FG007|Treated|Overall Study||50||
48401718|NCT04153929|101313836|FG000|COMPLETED|Overall Study||49|Completed planned treatment|
48401719|NCT04153929|101313837|FG001|COMPLETED|Overall Study||41|Completed planned treatment|
48401720|NCT04153929|101313838|FG002|COMPLETED|Overall Study||45|Completed planned treatment|
48401721|NCT04153929|101313839|FG003|COMPLETED|Overall Study||36|Completed planned treatment|
48401722|NCT04153929|101313840|FG004|COMPLETED|Overall Study||33|Completed planned treatment|
48585098|NCT00747474|101762283|FG005|STARTED|Cohort 5 (13.5 mg/m^2) Period||0||
48705932|NCT01730833|102065174|FG000|COMPLETED|Overall Study||18||
48289803|NCT02561754|101037436|FG001|COMPLETED|Overall Study||33||
48289804|NCT02561754|101037437|FG002|COMPLETED|Overall Study||26||
48289805|NCT02561754|101037435|FG000|NOT COMPLETED|Overall Study||6||
48289806|NCT02561754|101037436|FG001|NOT COMPLETED|Overall Study||6||
48289807|NCT02561754|101037437|FG002|NOT COMPLETED|Overall Study||9||
48289808|NCT02951767|101037438|FG000|STARTED|Overall Study||119||
48289809|NCT02951767|101037438|FG000|COMPLETED|Overall Study||0||
48289810|NCT02951767|101037438|FG000|NOT COMPLETED|Overall Study||119||
48289811|NCT02075541|101037439|FG000|STARTED|Overall Study||73||
48289812|NCT02075541|101037440|FG001|STARTED|Overall Study||72||
48401723|NCT04153929|101313841|FG005|COMPLETED|Overall Study||45|Completed planned treatment|
48401724|NCT04153929|101313842|FG006|COMPLETED|Overall Study||37|Completed planned treatment|
48585099|NCT00747474|101762284|FG006|STARTED|Cohort 5 (13.5 mg/m^2) Period||0||
48585100|NCT00747474|101762285|FG007|STARTED|Cohort 5 (13.5 mg/m^2) Period||0||
48585101|NCT00747474|101762286|FG008|STARTED|Cohort 5 (13.5 mg/m^2) Period||0||
48585102|NCT00747474|101762287|FG009|STARTED|Cohort 5 (13.5 mg/m^2) Period||0||
48585103|NCT00747474|101762288|FG010|STARTED|Cohort 5 (13.5 mg/m^2) Period||0||
48585104|NCT00747474|101762289|FG011|STARTED|Cohort 5 (13.5 mg/m^2) Period||0||
48585105|NCT00747474|101762278|FG000|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
48585106|NCT00747474|101762279|FG001|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
48585107|NCT00747474|101762280|FG002|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
48585108|NCT00747474|101762281|FG003|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
48585109|NCT00747474|101762282|FG004|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||4||
48585110|NCT00747474|101762283|FG005|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
48585111|NCT00747474|101762284|FG006|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
48585112|NCT00747474|101762285|FG007|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
48585113|NCT00747474|101762286|FG008|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
48585114|NCT00747474|101762287|FG009|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
48585115|NCT00747474|101762288|FG010|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
48585116|NCT00747474|101762289|FG011|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
48585117|NCT00747474|101762278|FG000|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
48585118|NCT00747474|101762279|FG001|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
48585119|NCT00747474|101762280|FG002|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
48585120|NCT00747474|101762281|FG003|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
48585121|NCT00747474|101762282|FG004|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
48585122|NCT00747474|101762283|FG005|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
48585123|NCT00747474|101762284|FG006|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
48585124|NCT00747474|101762285|FG007|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
48585125|NCT00747474|101762286|FG008|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
48585126|NCT00747474|101762287|FG009|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
48585127|NCT00747474|101762288|FG010|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
48585128|NCT00747474|101762289|FG011|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
48585129|NCT00747474|101762278|FG000|STARTED|Cohort 6 (20 mg/m^2) Period||0||
48585130|NCT00747474|101762279|FG001|STARTED|Cohort 6 (20 mg/m^2) Period||0||
48705933|NCT01730833|102065175|FG001|COMPLETED|Overall Study||45||
48289813|NCT02075541|101037439|FG000|COMPLETED|Overall Study||69||
48289814|NCT02075541|101037440|FG001|COMPLETED|Overall Study||64||
48289815|NCT02075541|101037439|FG000|NOT COMPLETED|Overall Study||4||
48585131|NCT00747474|101762280|FG002|STARTED|Cohort 6 (20 mg/m^2) Period||0||
48585132|NCT00747474|101762281|FG003|STARTED|Cohort 6 (20 mg/m^2) Period||0||
48585133|NCT00747474|101762282|FG004|STARTED|Cohort 6 (20 mg/m^2) Period||0||
48585134|NCT00747474|101762283|FG005|STARTED|Cohort 6 (20 mg/m^2) Period||4||
48585135|NCT00747474|101762284|FG006|STARTED|Cohort 6 (20 mg/m^2) Period||0||
48585136|NCT00747474|101762285|FG007|STARTED|Cohort 6 (20 mg/m^2) Period||0||
48289816|NCT02075541|101037440|FG001|NOT COMPLETED|Overall Study||8||
48289817|NCT01650246|101037441|FG000|STARTED|Overall Study||143||
48289818|NCT01650246|101037441|FG000|COMPLETED|Overall Study||0||
48705934|NCT01730833|102065174|FG000|NOT COMPLETED|Overall Study||0||
48705935|NCT01730833|102065175|FG001|NOT COMPLETED|Overall Study||0||
48705936|NCT04600076|102065176|FG000|STARTED|Overall Study||22||
48705937|NCT04600076|102065176|FG000|COMPLETED|Overall Study||19||
48705938|NCT04600076|102065176|FG000|NOT COMPLETED|Overall Study||3||
48705939|NCT01874275|102065177|FG000|STARTED|Overall Study||4||
48705940|NCT01874275|102065178|FG001|STARTED|Overall Study||2||
48705941|NCT01874275|102065177|FG000|COMPLETED|Overall Study||3||
48705942|NCT01874275|102065178|FG001|COMPLETED|Overall Study||2||
48705943|NCT01874275|102065177|FG000|NOT COMPLETED|Overall Study||1||
48705944|NCT01874275|102065178|FG001|NOT COMPLETED|Overall Study||0||
48705945|NCT04092907|102065179|FG000|STARTED|Overall Study||50||
48705946|NCT04092907|102065180|FG001|STARTED|Overall Study||50||
48705947|NCT04092907|102065179|FG000|COMPLETED|Overall Study||48||
48705948|NCT04092907|102065180|FG001|COMPLETED|Overall Study||50||
48705949|NCT04092907|102065179|FG000|NOT COMPLETED|Overall Study||2||
48705950|NCT04092907|102065180|FG001|NOT COMPLETED|Overall Study||0||
48705951|NCT03280303|102065181|FG000|STARTED|Overall Study||1250||
48705952|NCT03280303|102065181|FG000|COMPLETED|Overall Study||54||
48705953|NCT03280303|102065181|FG000|NOT COMPLETED|Overall Study||1196||
48705954|NCT00683917|102065182|FG000|STARTED|Overall Study||10||
48705955|NCT00683917|102065182|FG000|COMPLETED|Overall Study||0||
48705956|NCT00683917|102065182|FG000|NOT COMPLETED|Overall Study||10||
48705957|NCT04899440|102065183|FG000|STARTED|Overall Study||15||
48705958|NCT04899440|102065184|FG001|STARTED|Overall Study||15||
48705959|NCT04899440|102065183|FG000|COMPLETED|Overall Study||15||
48705960|NCT04899440|102065184|FG001|COMPLETED|Overall Study||15||
48705961|NCT04899440|102065183|FG000|NOT COMPLETED|Overall Study||0||
48705962|NCT04899440|102065184|FG001|NOT COMPLETED|Overall Study||0||
48705963|NCT03764631|102065185|FG000|STARTED|Overall Study||751||
48289819|NCT01650246|101037441|FG000|NOT COMPLETED|Overall Study||143||
48289820|NCT00857272|101037442|FG000|STARTED|Overall Study||154||
48289821|NCT00857272|101037443|FG001|STARTED|Overall Study||154||
48289822|NCT00857272|101037442|FG000|COMPLETED|Overall Study||145||
48289823|NCT00857272|101037443|FG001|COMPLETED|Overall Study||145||
48289824|NCT00857272|101037442|FG000|NOT COMPLETED|Overall Study||9||
48289825|NCT00857272|101037443|FG001|NOT COMPLETED|Overall Study||9||
48289826|NCT01013597|101037444|FG000|STARTED|Overall Study||13||
48289827|NCT01013597|101037444|FG000|COMPLETED|Overall Study||12||
48289828|NCT01013597|101037444|FG000|NOT COMPLETED|Overall Study||1||
48289829|NCT01822301|101037445|FG000|STARTED|Overall Study||5||
48289830|NCT01822301|101037445|FG000|COMPLETED|Overall Study||5||
48289831|NCT01822301|101037445|FG000|NOT COMPLETED|Overall Study||0||
48289832|NCT01012713|101037446|FG000|STARTED|Overall Study||30||
48289833|NCT01012713|101037446|FG000|COMPLETED|Overall Study||27||
48289834|NCT01012713|101037446|FG000|NOT COMPLETED|Overall Study||3||
48289835|NCT02768870|101037447|FG000|STARTED|Overall Study||26|Enrolled in Study|
48289836|NCT02768870|101037447|FG000|Implanted With Device|Overall Study||24||
48289837|NCT02768870|101037447|FG000|Discharge|Overall Study||26||
48289838|NCT02768870|101037447|FG000|30 Days|Overall Study||26||
48289839|NCT02768870|101037447|FG000|6 Months|Overall Study||25||
48289840|NCT02768870|101037447|FG000|12 Months|Overall Study||23||
48401725|NCT04153929|101313843|FG007|COMPLETED|Overall Study||45|Completed planned treatment|
48401726|NCT04153929|101313836|FG000|NOT COMPLETED|Overall Study||11||
48289841|NCT02768870|101037447|FG000|18 Months|Overall Study||23||
48289842|NCT02768870|101037447|FG000|24 Months|Overall Study||21||
48289843|NCT02768870|101037447|FG000|30 Months|Overall Study||19||
48289844|NCT02768870|101037447|FG000|36 Months|Overall Study||17||
48289845|NCT02768870|101037447|FG000|48 Months|Overall Study||15||
48289846|NCT02768870|101037447|FG000|60 Months|Overall Study||14||
48289847|NCT02768870|101037447|FG000|COMPLETED|Overall Study||14||
48289848|NCT02768870|101037447|FG000|NOT COMPLETED|Overall Study||12||
48289849|NCT00903630|101037448|FG000|STARTED|Phase l||6||
48705964|NCT03764631|102065186|FG001|STARTED|Overall Study||751||
48705965|NCT03764631|102065185|FG000|COMPLETED|Overall Study||710||
48705966|NCT03764631|102065186|FG001|COMPLETED|Overall Study||698||
48705967|NCT03764631|102065185|FG000|NOT COMPLETED|Overall Study||41||
48705968|NCT03764631|102065186|FG001|NOT COMPLETED|Overall Study||53||
48705969|NCT01498575|102065187|FG000|STARTED|Overall Sample||610||
48705970|NCT01498575|102065188|FG001|STARTED|Overall Sample||414||
48705971|NCT01498575|102065187|FG000|COMPLETED|Overall Sample||550||
48705972|NCT01498575|102065188|FG001|COMPLETED|Overall Sample||400||
48705973|NCT01498575|102065187|FG000|NOT COMPLETED|Overall Sample||60||
48705974|NCT01498575|102065188|FG001|NOT COMPLETED|Overall Sample||14||
48705975|NCT01498575|102065187|FG000|STARTED|On the Road Driving Assessment (ODA)||128||
48710765|NCT00402714|102078011|FG001|COMPLETED|Overall Study||11||
48289850|NCT00903630|101037449|FG001|STARTED|Phase l||5||
48289851|NCT00903630|101037450|FG002|STARTED|Phase l||0||
48289852|NCT00903630|101037448|FG000|COMPLETED|Phase l||6||
48289853|NCT00903630|101037449|FG001|COMPLETED|Phase l||5||
48289854|NCT00903630|101037450|FG002|COMPLETED|Phase l||0||
48289855|NCT00903630|101037448|FG000|NOT COMPLETED|Phase l||0||
48289856|NCT00903630|101037449|FG001|NOT COMPLETED|Phase l||0||
48705976|NCT01498575|102065188|FG001|STARTED|On the Road Driving Assessment (ODA)||89||
48138051|NCT05554237|100661600|FG001|STARTED|Part 1: Period 2 Washout (3 Days)||2||
48138052|NCT05554237|100661601|FG002|STARTED|Part 1: Period 2 Washout (3 Days)||2||
48138053|NCT05554237|100661602|FG003|STARTED|Part 1: Period 2 Washout (3 Days)||2||
48585137|NCT00747474|101762286|FG008|STARTED|Cohort 6 (20 mg/m^2) Period||0||
48585138|NCT00747474|101762287|FG009|STARTED|Cohort 6 (20 mg/m^2) Period||0||
48585139|NCT00747474|101762288|FG010|STARTED|Cohort 6 (20 mg/m^2) Period||0||
48585140|NCT00747474|101762289|FG011|STARTED|Cohort 6 (20 mg/m^2) Period||0||
48585141|NCT00747474|101762278|FG000|COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
48585142|NCT00747474|101762279|FG001|COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
48585143|NCT00747474|101762280|FG002|COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
48585144|NCT00747474|101762281|FG003|COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
48585145|NCT00747474|101762282|FG004|COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
48138054|NCT05554237|100661603|FG004|STARTED|Part 1: Period 2 Washout (3 Days)||0||
48138055|NCT05554237|100661604|FG005|STARTED|Part 1: Period 2 Washout (3 Days)||0||
48138056|NCT05554237|100661605|FG006|STARTED|Part 1: Period 2 Washout (3 Days)||0||
48138057|NCT05554237|100661606|FG007|STARTED|Part 1: Period 2 Washout (3 Days)||0||
48138058|NCT05554237|100661607|FG008|STARTED|Part 1: Period 2 Washout (3 Days)||0||
48138059|NCT05554237|100661608|FG009|STARTED|Part 1: Period 2 Washout (3 Days)||0||
48289857|NCT00903630|101037450|FG002|NOT COMPLETED|Phase l||0||
48585146|NCT00747474|101762283|FG005|COMPLETED|Cohort 6 (20 mg/m^2) Period||4||
48585147|NCT00747474|101762284|FG006|COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
48585148|NCT00747474|101762285|FG007|COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
48585149|NCT00747474|101762286|FG008|COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
48585150|NCT00747474|101762287|FG009|COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
48585151|NCT00747474|101762288|FG010|COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
48585152|NCT00747474|101762289|FG011|COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
48585153|NCT00747474|101762278|FG000|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
48585154|NCT00747474|101762279|FG001|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
48585155|NCT00747474|101762280|FG002|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
48585156|NCT00747474|101762281|FG003|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
48585157|NCT00747474|101762282|FG004|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
48585158|NCT00747474|101762283|FG005|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
48585159|NCT00747474|101762284|FG006|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
48585160|NCT00747474|101762285|FG007|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
48585161|NCT00747474|101762286|FG008|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
48585162|NCT00747474|101762287|FG009|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
48585163|NCT00747474|101762288|FG010|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
48585164|NCT00747474|101762289|FG011|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
48585165|NCT00747474|101762278|FG000|STARTED|Cohort 7 (30 mg/m^2) Period||0||
48585166|NCT00747474|101762279|FG001|STARTED|Cohort 7 (30 mg/m^2) Period||0||
48585167|NCT00747474|101762280|FG002|STARTED|Cohort 7 (30 mg/m^2) Period||0||
48585168|NCT00747474|101762281|FG003|STARTED|Cohort 7 (30 mg/m^2) Period||0||
48585169|NCT00747474|101762282|FG004|STARTED|Cohort 7 (30 mg/m^2) Period||0||
48585170|NCT00747474|101762283|FG005|STARTED|Cohort 7 (30 mg/m^2) Period||0||
48585171|NCT00747474|101762284|FG006|STARTED|Cohort 7 (30 mg/m^2) Period||4||
48585172|NCT00747474|101762285|FG007|STARTED|Cohort 7 (30 mg/m^2) Period||0||
48585173|NCT00747474|101762286|FG008|STARTED|Cohort 7 (30 mg/m^2) Period||0||
48585174|NCT00747474|101762287|FG009|STARTED|Cohort 7 (30 mg/m^2) Period||0||
48585175|NCT00747474|101762288|FG010|STARTED|Cohort 7 (30 mg/m^2) Period||0||
48585176|NCT00747474|101762289|FG011|STARTED|Cohort 7 (30 mg/m^2) Period||0||
48585177|NCT00747474|101762278|FG000|COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
48289858|NCT00903630|101037448|FG000|STARTED|Phase 2||6||
48289859|NCT00903630|101037449|FG001|STARTED|Phase 2||0||
48289860|NCT00903630|101037450|FG002|STARTED|Phase 2||4||
48289861|NCT00903630|101037448|FG000|COMPLETED|Phase 2||6||
48289862|NCT00903630|101037449|FG001|COMPLETED|Phase 2||0||
48289863|NCT00903630|101037450|FG002|COMPLETED|Phase 2||3||
48289864|NCT00903630|101037448|FG000|NOT COMPLETED|Phase 2||0||
48289865|NCT00903630|101037449|FG001|NOT COMPLETED|Phase 2||0||
48289866|NCT00903630|101037450|FG002|NOT COMPLETED|Phase 2||1||
48289867|NCT01670760|101037451|FG000|STARTED|Overall Study||20||
48289868|NCT01670760|101037451|FG000|COMPLETED|Overall Study||20||
48289869|NCT01670760|101037451|FG000|NOT COMPLETED|Overall Study||0||
48289870|NCT00784693|101037452|FG000|STARTED|Overall Study||23||
48289871|NCT00784693|101037453|FG001|STARTED|Overall Study||25||
48289872|NCT00784693|101037452|FG000|Treated|Overall Study||22||
48289873|NCT00784693|101037453|FG001|Treated|Overall Study||25||
48289874|NCT00784693|101037452|FG000|COMPLETED|Overall Study||20||
48585178|NCT00747474|101762279|FG001|COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
48138060|NCT05554237|100661609|FG010|STARTED|Part 1: Period 2 Washout (3 Days)||0||
48289875|NCT00784693|101037453|FG001|COMPLETED|Overall Study||19||
48585179|NCT00747474|101762280|FG002|COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
48585180|NCT00747474|101762281|FG003|COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
48289876|NCT00784693|101037452|FG000|NOT COMPLETED|Overall Study||3||
48289877|NCT00784693|101037453|FG001|NOT COMPLETED|Overall Study||6||
48289878|NCT02502799|101037454|FG000|STARTED|Phase 1: Brief Intervention Sessions||0||
48138061|NCT05554237|100661610|FG011|STARTED|Part 1: Period 2 Washout (3 Days)||0||
48138062|NCT05554237|100661611|FG012|STARTED|Part 1: Period 2 Washout (3 Days)||0||
48138063|NCT05554237|100661612|FG013|STARTED|Part 1: Period 2 Washout (3 Days)||0||
48138064|NCT05554237|100661599|FG000|COMPLETED|Part 1: Period 2 Washout (3 Days)||2||
48138065|NCT05554237|100661600|FG001|COMPLETED|Part 1: Period 2 Washout (3 Days)||2||
48138066|NCT05554237|100661601|FG002|COMPLETED|Part 1: Period 2 Washout (3 Days)||2||
48138067|NCT05554237|100661602|FG003|COMPLETED|Part 1: Period 2 Washout (3 Days)||2||
48138068|NCT05554237|100661603|FG004|COMPLETED|Part 1: Period 2 Washout (3 Days)||0||
48138069|NCT05554237|100661604|FG005|COMPLETED|Part 1: Period 2 Washout (3 Days)||0||
48138070|NCT05554237|100661605|FG006|COMPLETED|Part 1: Period 2 Washout (3 Days)||0||
48138071|NCT05554237|100661606|FG007|COMPLETED|Part 1: Period 2 Washout (3 Days)||0||
48138072|NCT05554237|100661607|FG008|COMPLETED|Part 1: Period 2 Washout (3 Days)||0||
48138073|NCT05554237|100661608|FG009|COMPLETED|Part 1: Period 2 Washout (3 Days)||0||
48138074|NCT05554237|100661609|FG010|COMPLETED|Part 1: Period 2 Washout (3 Days)||0||
48138075|NCT05554237|100661610|FG011|COMPLETED|Part 1: Period 2 Washout (3 Days)||0||
48138076|NCT05554237|100661611|FG012|COMPLETED|Part 1: Period 2 Washout (3 Days)||0||
48585181|NCT00747474|101762282|FG004|COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
48138077|NCT05554237|100661612|FG013|COMPLETED|Part 1: Period 2 Washout (3 Days)||0||
48138078|NCT05554237|100661599|FG000|NOT COMPLETED|Part 1: Period 2 Washout (3 Days)||0||
48138079|NCT05554237|100661600|FG001|NOT COMPLETED|Part 1: Period 2 Washout (3 Days)||0||
48138080|NCT05554237|100661601|FG002|NOT COMPLETED|Part 1: Period 2 Washout (3 Days)||0||
48138081|NCT05554237|100661602|FG003|NOT COMPLETED|Part 1: Period 2 Washout (3 Days)||0||
48138082|NCT05554237|100661603|FG004|NOT COMPLETED|Part 1: Period 2 Washout (3 Days)||0||
48138083|NCT05554237|100661604|FG005|NOT COMPLETED|Part 1: Period 2 Washout (3 Days)||0||
48138084|NCT05554237|100661605|FG006|NOT COMPLETED|Part 1: Period 2 Washout (3 Days)||0||
48138085|NCT05554237|100661606|FG007|NOT COMPLETED|Part 1: Period 2 Washout (3 Days)||0||
48138086|NCT05554237|100661607|FG008|NOT COMPLETED|Part 1: Period 2 Washout (3 Days)||0||
48138087|NCT05554237|100661608|FG009|NOT COMPLETED|Part 1: Period 2 Washout (3 Days)||0||
48138088|NCT05554237|100661609|FG010|NOT COMPLETED|Part 1: Period 2 Washout (3 Days)||0||
48138089|NCT05554237|100661610|FG011|NOT COMPLETED|Part 1: Period 2 Washout (3 Days)||0||
48138090|NCT05554237|100661611|FG012|NOT COMPLETED|Part 1: Period 2 Washout (3 Days)||0||
48138091|NCT05554237|100661612|FG013|NOT COMPLETED|Part 1: Period 2 Washout (3 Days)||0||
48138092|NCT05554237|100661599|FG000|STARTED|Part 1: Period 3 Treatment (1 Day)||2||
48138093|NCT05554237|100661600|FG001|STARTED|Part 1: Period 3 Treatment (1 Day)||2||
48138094|NCT05554237|100661601|FG002|STARTED|Part 1: Period 3 Treatment (1 Day)||2||
48138095|NCT05554237|100661602|FG003|STARTED|Part 1: Period 3 Treatment (1 Day)||2||
48138096|NCT05554237|100661603|FG004|STARTED|Part 1: Period 3 Treatment (1 Day)||0||
48138097|NCT05554237|100661604|FG005|STARTED|Part 1: Period 3 Treatment (1 Day)||0||
48585182|NCT00747474|101762283|FG005|COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
48585183|NCT00747474|101762284|FG006|COMPLETED|Cohort 7 (30 mg/m^2) Period||4||
48585184|NCT00747474|101762285|FG007|COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
48585185|NCT00747474|101762286|FG008|COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
48705977|NCT01498575|102065187|FG000|COMPLETED|On the Road Driving Assessment (ODA)||86||
48705978|NCT01498575|102065188|FG001|COMPLETED|On the Road Driving Assessment (ODA)||65||
48705979|NCT01498575|102065187|FG000|NOT COMPLETED|On the Road Driving Assessment (ODA)||42||
48705980|NCT01498575|102065188|FG001|NOT COMPLETED|On the Road Driving Assessment (ODA)||24||
48705981|NCT00534118|102065189|FG000|STARTED|Overall Study||17||
48705982|NCT00534118|102065190|FG001|STARTED|Overall Study||22||
48705983|NCT00534118|102065189|FG000|COMPLETED|Overall Study||17||
48138098|NCT05554237|100661605|FG006|STARTED|Part 1: Period 3 Treatment (1 Day)||0||
48138099|NCT05554237|100661606|FG007|STARTED|Part 1: Period 3 Treatment (1 Day)||0||
48289879|NCT02502799|101037455|FG001|STARTED|Phase 1: Brief Intervention Sessions||0||
48585186|NCT00747474|101762287|FG009|COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
48585187|NCT00747474|101762288|FG010|COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
48585188|NCT00747474|101762289|FG011|COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
48705984|NCT00534118|102065190|FG001|COMPLETED|Overall Study||22||
48705985|NCT00534118|102065189|FG000|NOT COMPLETED|Overall Study||0||
48138100|NCT05554237|100661607|FG008|STARTED|Part 1: Period 3 Treatment (1 Day)||0||
48138101|NCT05554237|100661608|FG009|STARTED|Part 1: Period 3 Treatment (1 Day)||0||
48138102|NCT05554237|100661609|FG010|STARTED|Part 1: Period 3 Treatment (1 Day)||0||
48138103|NCT05554237|100661610|FG011|STARTED|Part 1: Period 3 Treatment (1 Day)||0||
48138104|NCT05554237|100661611|FG012|STARTED|Part 1: Period 3 Treatment (1 Day)||0||
48138105|NCT05554237|100661612|FG013|STARTED|Part 1: Period 3 Treatment (1 Day)||0||
48138106|NCT05554237|100661599|FG000|COMPLETED|Part 1: Period 3 Treatment (1 Day)||2||
48705986|NCT00534118|102065190|FG001|NOT COMPLETED|Overall Study||0||
48705987|NCT01159171|102065191|FG000|STARTED|Overall Study||50||
48705988|NCT01159171|102065191|FG000|COMPLETED|Overall Study||0||
48705989|NCT01159171|102065191|FG000|NOT COMPLETED|Overall Study||50||
48138107|NCT05554237|100661600|FG001|COMPLETED|Part 1: Period 3 Treatment (1 Day)||2||
48138108|NCT05554237|100661601|FG002|COMPLETED|Part 1: Period 3 Treatment (1 Day)||2||
48138109|NCT05554237|100661602|FG003|COMPLETED|Part 1: Period 3 Treatment (1 Day)||2||
48138110|NCT05554237|100661603|FG004|COMPLETED|Part 1: Period 3 Treatment (1 Day)||0||
48138111|NCT05554237|100661604|FG005|COMPLETED|Part 1: Period 3 Treatment (1 Day)||0||
48138112|NCT05554237|100661605|FG006|COMPLETED|Part 1: Period 3 Treatment (1 Day)||0||
48138113|NCT05554237|100661606|FG007|COMPLETED|Part 1: Period 3 Treatment (1 Day)||0||
48138114|NCT05554237|100661607|FG008|COMPLETED|Part 1: Period 3 Treatment (1 Day)||0||
48138115|NCT05554237|100661608|FG009|COMPLETED|Part 1: Period 3 Treatment (1 Day)||0||
48138116|NCT05554237|100661609|FG010|COMPLETED|Part 1: Period 3 Treatment (1 Day)||0||
48138117|NCT05554237|100661610|FG011|COMPLETED|Part 1: Period 3 Treatment (1 Day)||0||
48138118|NCT05554237|100661611|FG012|COMPLETED|Part 1: Period 3 Treatment (1 Day)||0||
48138119|NCT05554237|100661612|FG013|COMPLETED|Part 1: Period 3 Treatment (1 Day)||0||
48138120|NCT05554237|100661599|FG000|NOT COMPLETED|Part 1: Period 3 Treatment (1 Day)||0||
48138121|NCT05554237|100661600|FG001|NOT COMPLETED|Part 1: Period 3 Treatment (1 Day)||0||
48138122|NCT05554237|100661601|FG002|NOT COMPLETED|Part 1: Period 3 Treatment (1 Day)||0||
48138123|NCT05554237|100661602|FG003|NOT COMPLETED|Part 1: Period 3 Treatment (1 Day)||0||
48705990|NCT00624819|102065192|FG000|STARTED|Follow-up Period: Year 1||391||
48705991|NCT00624819|102065193|FG001|STARTED|Follow-up Period: Year 1||31||
48705992|NCT00624819|102065194|FG002|STARTED|Follow-up Period: Year 1||102||
48705993|NCT00624819|102065195|FG003|STARTED|Follow-up Period: Year 1||0||
48705994|NCT00624819|102065192|FG000|COMPLETED|Follow-up Period: Year 1||391||
48705995|NCT00624819|102065193|FG001|COMPLETED|Follow-up Period: Year 1||31||
48705996|NCT00624819|102065194|FG002|COMPLETED|Follow-up Period: Year 1||102||
48705997|NCT00624819|102065195|FG003|COMPLETED|Follow-up Period: Year 1||0||
48138124|NCT05554237|100661603|FG004|NOT COMPLETED|Part 1: Period 3 Treatment (1 Day)||0||
48138125|NCT05554237|100661604|FG005|NOT COMPLETED|Part 1: Period 3 Treatment (1 Day)||0||
48138126|NCT05554237|100661605|FG006|NOT COMPLETED|Part 1: Period 3 Treatment (1 Day)||0||
48138127|NCT05554237|100661606|FG007|NOT COMPLETED|Part 1: Period 3 Treatment (1 Day)||0||
48138128|NCT05554237|100661607|FG008|NOT COMPLETED|Part 1: Period 3 Treatment (1 Day)||0||
48138129|NCT05554237|100661608|FG009|NOT COMPLETED|Part 1: Period 3 Treatment (1 Day)||0||
48138130|NCT05554237|100661609|FG010|NOT COMPLETED|Part 1: Period 3 Treatment (1 Day)||0||
48138131|NCT05554237|100661610|FG011|NOT COMPLETED|Part 1: Period 3 Treatment (1 Day)||0||
48138132|NCT05554237|100661611|FG012|NOT COMPLETED|Part 1: Period 3 Treatment (1 Day)||0||
48138133|NCT05554237|100661612|FG013|NOT COMPLETED|Part 1: Period 3 Treatment (1 Day)||0||
48705998|NCT00624819|102065192|FG000|NOT COMPLETED|Follow-up Period: Year 1||0||
48705999|NCT00624819|102065193|FG001|NOT COMPLETED|Follow-up Period: Year 1||0||
48289880|NCT02502799|101037456|FG002|STARTED|Phase 1: Brief Intervention Sessions||0||
48289881|NCT02502799|101037457|FG003|STARTED|Phase 1: Brief Intervention Sessions||158||
48289882|NCT02502799|101037454|FG000|COMPLETED|Phase 1: Brief Intervention Sessions||0||
48289883|NCT02502799|101037455|FG001|COMPLETED|Phase 1: Brief Intervention Sessions||0||
48585189|NCT00747474|101762278|FG000|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
48585190|NCT00747474|101762279|FG001|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
48585191|NCT00747474|101762280|FG002|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
48585192|NCT00747474|101762281|FG003|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
48585193|NCT00747474|101762282|FG004|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
48585194|NCT00747474|101762283|FG005|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
48585195|NCT00747474|101762284|FG006|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
48585196|NCT00747474|101762285|FG007|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
48585197|NCT00747474|101762286|FG008|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
48585198|NCT00747474|101762287|FG009|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
48585199|NCT00747474|101762288|FG010|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
48585200|NCT00747474|101762289|FG011|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
48585201|NCT00747474|101762278|FG000|STARTED|Cohort 8 (40 mg/m^2) Period||0||
48706000|NCT00624819|102065194|FG002|NOT COMPLETED|Follow-up Period: Year 1||0||
48706001|NCT00624819|102065195|FG003|NOT COMPLETED|Follow-up Period: Year 1||0||
48706002|NCT00624819|102065192|FG000|STARTED|Follow-up Period: Year 2||370||
48706003|NCT00624819|102065193|FG001|STARTED|Follow-up Period: Year 2||31||
48706004|NCT00624819|102065194|FG002|STARTED|Follow-up Period: Year 2||96||
48706005|NCT00624819|102065195|FG003|STARTED|Follow-up Period: Year 2||0||
48138134|NCT05554237|100661599|FG000|STARTED|Part 1: Period 3 Washout (3 Days)||2||
48138135|NCT05554237|100661600|FG001|STARTED|Part 1: Period 3 Washout (3 Days)||2||
48138136|NCT05554237|100661601|FG002|STARTED|Part 1: Period 3 Washout (3 Days)||2||
48138137|NCT05554237|100661602|FG003|STARTED|Part 1: Period 3 Washout (3 Days)||2||
48138138|NCT05554237|100661603|FG004|STARTED|Part 1: Period 3 Washout (3 Days)||0||
48138139|NCT05554237|100661604|FG005|STARTED|Part 1: Period 3 Washout (3 Days)||0||
48138140|NCT05554237|100661605|FG006|STARTED|Part 1: Period 3 Washout (3 Days)||0||
48138141|NCT05554237|100661606|FG007|STARTED|Part 1: Period 3 Washout (3 Days)||0||
48138142|NCT05554237|100661607|FG008|STARTED|Part 1: Period 3 Washout (3 Days)||0||
48138143|NCT05554237|100661608|FG009|STARTED|Part 1: Period 3 Washout (3 Days)||0||
48138144|NCT05554237|100661609|FG010|STARTED|Part 1: Period 3 Washout (3 Days)||0||
48706006|NCT00624819|102065192|FG000|COMPLETED|Follow-up Period: Year 2||370||
48706007|NCT00624819|102065193|FG001|COMPLETED|Follow-up Period: Year 2||31||
48706008|NCT00624819|102065194|FG002|COMPLETED|Follow-up Period: Year 2||96||
48706009|NCT00624819|102065195|FG003|COMPLETED|Follow-up Period: Year 2||0||
48706010|NCT00624819|102065192|FG000|NOT COMPLETED|Follow-up Period: Year 2||0||
48706011|NCT00624819|102065193|FG001|NOT COMPLETED|Follow-up Period: Year 2||0||
48706012|NCT00624819|102065194|FG002|NOT COMPLETED|Follow-up Period: Year 2||0||
48706013|NCT00624819|102065195|FG003|NOT COMPLETED|Follow-up Period: Year 2||0||
48706014|NCT00624819|102065192|FG000|STARTED|Follow-up Period: Year 4||264||
48706015|NCT00624819|102065193|FG001|STARTED|Follow-up Period: Year 4||20||
48706016|NCT00624819|102065194|FG002|STARTED|Follow-up Period: Year 4||65||
48706017|NCT00624819|102065195|FG003|STARTED|Follow-up Period: Year 4||100||
48706018|NCT00624819|102065192|FG000|COMPLETED|Follow-up Period: Year 4||263||
48706019|NCT00624819|102065193|FG001|COMPLETED|Follow-up Period: Year 4||19||
48289884|NCT02502799|101037456|FG002|COMPLETED|Phase 1: Brief Intervention Sessions||0||
48585202|NCT00747474|101762279|FG001|STARTED|Cohort 8 (40 mg/m^2) Period||0||
48585203|NCT00747474|101762280|FG002|STARTED|Cohort 8 (40 mg/m^2) Period||0||
48706020|NCT00624819|102065194|FG002|COMPLETED|Follow-up Period: Year 4||64||
48706021|NCT00624819|102065195|FG003|COMPLETED|Follow-up Period: Year 4||100||
48706022|NCT00624819|102065192|FG000|NOT COMPLETED|Follow-up Period: Year 4||1||
48706023|NCT00624819|102065193|FG001|NOT COMPLETED|Follow-up Period: Year 4||1||
48706024|NCT00624819|102065194|FG002|NOT COMPLETED|Follow-up Period: Year 4||1||
48138145|NCT05554237|100661610|FG011|STARTED|Part 1: Period 3 Washout (3 Days)||0||
48138146|NCT05554237|100661611|FG012|STARTED|Part 1: Period 3 Washout (3 Days)||0||
48138147|NCT05554237|100661612|FG013|STARTED|Part 1: Period 3 Washout (3 Days)||0||
48138148|NCT05554237|100661599|FG000|COMPLETED|Part 1: Period 3 Washout (3 Days)||2||
48138149|NCT05554237|100661600|FG001|COMPLETED|Part 1: Period 3 Washout (3 Days)||2||
48138150|NCT05554237|100661601|FG002|COMPLETED|Part 1: Period 3 Washout (3 Days)||2||
48138151|NCT05554237|100661602|FG003|COMPLETED|Part 1: Period 3 Washout (3 Days)||2||
48138152|NCT05554237|100661603|FG004|COMPLETED|Part 1: Period 3 Washout (3 Days)||0||
48138153|NCT05554237|100661604|FG005|COMPLETED|Part 1: Period 3 Washout (3 Days)||0||
48138154|NCT05554237|100661605|FG006|COMPLETED|Part 1: Period 3 Washout (3 Days)||0||
48138155|NCT05554237|100661606|FG007|COMPLETED|Part 1: Period 3 Washout (3 Days)||0||
48138156|NCT05554237|100661607|FG008|COMPLETED|Part 1: Period 3 Washout (3 Days)||0||
48138157|NCT05554237|100661608|FG009|COMPLETED|Part 1: Period 3 Washout (3 Days)||0||
48138158|NCT05554237|100661609|FG010|COMPLETED|Part 1: Period 3 Washout (3 Days)||0||
48138159|NCT05554237|100661610|FG011|COMPLETED|Part 1: Period 3 Washout (3 Days)||0||
48138160|NCT05554237|100661611|FG012|COMPLETED|Part 1: Period 3 Washout (3 Days)||0||
48585204|NCT00747474|101762281|FG003|STARTED|Cohort 8 (40 mg/m^2) Period||0||
48138161|NCT05554237|100661612|FG013|COMPLETED|Part 1: Period 3 Washout (3 Days)||0||
48706025|NCT00624819|102065195|FG003|NOT COMPLETED|Follow-up Period: Year 4||0||
48706026|NCT02526524|102065196|FG000|STARTED|Overall Study||94||
48706027|NCT02526524|102065197|FG001|STARTED|Overall Study||95||
48138162|NCT05554237|100661599|FG000|NOT COMPLETED|Part 1: Period 3 Washout (3 Days)||0||
48138163|NCT05554237|100661600|FG001|NOT COMPLETED|Part 1: Period 3 Washout (3 Days)||0||
48138164|NCT05554237|100661601|FG002|NOT COMPLETED|Part 1: Period 3 Washout (3 Days)||0||
48138165|NCT05554237|100661602|FG003|NOT COMPLETED|Part 1: Period 3 Washout (3 Days)||0||
48138166|NCT05554237|100661603|FG004|NOT COMPLETED|Part 1: Period 3 Washout (3 Days)||0||
48138167|NCT05554237|100661604|FG005|NOT COMPLETED|Part 1: Period 3 Washout (3 Days)||0||
48138168|NCT05554237|100661605|FG006|NOT COMPLETED|Part 1: Period 3 Washout (3 Days)||0||
48401727|NCT04153929|101313837|FG001|NOT COMPLETED|Overall Study||9||
48401728|NCT04153929|101313838|FG002|NOT COMPLETED|Overall Study||5||
48401729|NCT04153929|101313839|FG003|NOT COMPLETED|Overall Study||16||
48401730|NCT04153929|101313840|FG004|NOT COMPLETED|Overall Study||17||
48401731|NCT04153929|101313841|FG005|NOT COMPLETED|Overall Study||6||
48401732|NCT04153929|101313842|FG006|NOT COMPLETED|Overall Study||13||
48401733|NCT04153929|101313843|FG007|NOT COMPLETED|Overall Study||5||
48585205|NCT00747474|101762282|FG004|STARTED|Cohort 8 (40 mg/m^2) Period||0||
48585206|NCT00747474|101762283|FG005|STARTED|Cohort 8 (40 mg/m^2) Period||0||
48585207|NCT00747474|101762284|FG006|STARTED|Cohort 8 (40 mg/m^2) Period||0||
48585208|NCT00747474|101762285|FG007|STARTED|Cohort 8 (40 mg/m^2) Period||6||
48585209|NCT00747474|101762286|FG008|STARTED|Cohort 8 (40 mg/m^2) Period||0||
48585210|NCT00747474|101762287|FG009|STARTED|Cohort 8 (40 mg/m^2) Period||0||
48585211|NCT00747474|101762288|FG010|STARTED|Cohort 8 (40 mg/m^2) Period||0||
48585212|NCT00747474|101762289|FG011|STARTED|Cohort 8 (40 mg/m^2) Period||0||
48585213|NCT00747474|101762278|FG000|COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
48585214|NCT00747474|101762279|FG001|COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
48585215|NCT00747474|101762280|FG002|COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
48585216|NCT00747474|101762281|FG003|COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
48585217|NCT00747474|101762282|FG004|COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
48585218|NCT00747474|101762283|FG005|COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
48585219|NCT00747474|101762284|FG006|COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
48138169|NCT05554237|100661606|FG007|NOT COMPLETED|Part 1: Period 3 Washout (3 Days)||0||
48138170|NCT05554237|100661607|FG008|NOT COMPLETED|Part 1: Period 3 Washout (3 Days)||0||
48138171|NCT05554237|100661608|FG009|NOT COMPLETED|Part 1: Period 3 Washout (3 Days)||0||
48138172|NCT05554237|100661609|FG010|NOT COMPLETED|Part 1: Period 3 Washout (3 Days)||0||
48138173|NCT05554237|100661610|FG011|NOT COMPLETED|Part 1: Period 3 Washout (3 Days)||0||
48138174|NCT05554237|100661611|FG012|NOT COMPLETED|Part 1: Period 3 Washout (3 Days)||0||
48138175|NCT05554237|100661612|FG013|NOT COMPLETED|Part 1: Period 3 Washout (3 Days)||0||
48138176|NCT05554237|100661599|FG000|STARTED|Part 1: Period 4 Treatment (1 Day)||2||
48138177|NCT05554237|100661600|FG001|STARTED|Part 1: Period 4 Treatment (1 Day)||2||
48138178|NCT05554237|100661601|FG002|STARTED|Part 1: Period 4 Treatment (1 Day)||2||
48138179|NCT05554237|100661602|FG003|STARTED|Part 1: Period 4 Treatment (1 Day)||2||
48138180|NCT05554237|100661603|FG004|STARTED|Part 1: Period 4 Treatment (1 Day)||0||
48138181|NCT05554237|100661604|FG005|STARTED|Part 1: Period 4 Treatment (1 Day)||0||
48138182|NCT05554237|100661605|FG006|STARTED|Part 1: Period 4 Treatment (1 Day)||0||
48138183|NCT05554237|100661606|FG007|STARTED|Part 1: Period 4 Treatment (1 Day)||0||
48138184|NCT05554237|100661607|FG008|STARTED|Part 1: Period 4 Treatment (1 Day)||0||
48138185|NCT05554237|100661608|FG009|STARTED|Part 1: Period 4 Treatment (1 Day)||0||
48138186|NCT05554237|100661609|FG010|STARTED|Part 1: Period 4 Treatment (1 Day)||0||
48706028|NCT02526524|102065198|FG002|STARTED|Overall Study||96||
48706029|NCT02526524|102065199|FG003|STARTED|Overall Study||96||
48138187|NCT05554237|100661610|FG011|STARTED|Part 1: Period 4 Treatment (1 Day)||0||
48138188|NCT05554237|100661611|FG012|STARTED|Part 1: Period 4 Treatment (1 Day)||0||
48138189|NCT05554237|100661612|FG013|STARTED|Part 1: Period 4 Treatment (1 Day)||0||
48138190|NCT05554237|100661599|FG000|COMPLETED|Part 1: Period 4 Treatment (1 Day)||2||
48401734|NCT02266004|101313844|FG000|STARTED|Overall Study||9||
48401735|NCT02266004|101313844|FG000|COMPLETED|Overall Study||7||
48585220|NCT00747474|101762285|FG007|COMPLETED|Cohort 8 (40 mg/m^2) Period||5||
48585221|NCT00747474|101762286|FG008|COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
48585222|NCT00747474|101762287|FG009|COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
48585223|NCT00747474|101762288|FG010|COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
48585224|NCT00747474|101762289|FG011|COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
48585225|NCT00747474|101762278|FG000|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
48706030|NCT02526524|102065200|FG004|STARTED|Overall Study||96||
48706031|NCT02526524|102065201|FG005|STARTED|Overall Study||94||
48706032|NCT02526524|102065196|FG000|COMPLETED|Overall Study||82||
48706033|NCT02526524|102065197|FG001|COMPLETED|Overall Study||86||
48585226|NCT00747474|101762279|FG001|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
48585227|NCT00747474|101762280|FG002|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
48585228|NCT00747474|101762281|FG003|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
48706034|NCT02526524|102065198|FG002|COMPLETED|Overall Study||70||
48585229|NCT00747474|101762282|FG004|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
48138191|NCT05554237|100661600|FG001|COMPLETED|Part 1: Period 4 Treatment (1 Day)||2||
48138192|NCT05554237|100661601|FG002|COMPLETED|Part 1: Period 4 Treatment (1 Day)||2||
48138193|NCT05554237|100661602|FG003|COMPLETED|Part 1: Period 4 Treatment (1 Day)||2||
48138194|NCT05554237|100661603|FG004|COMPLETED|Part 1: Period 4 Treatment (1 Day)||0||
48138195|NCT05554237|100661604|FG005|COMPLETED|Part 1: Period 4 Treatment (1 Day)||0||
48138196|NCT05554237|100661605|FG006|COMPLETED|Part 1: Period 4 Treatment (1 Day)||0||
48138197|NCT05554237|100661606|FG007|COMPLETED|Part 1: Period 4 Treatment (1 Day)||0||
48138198|NCT05554237|100661607|FG008|COMPLETED|Part 1: Period 4 Treatment (1 Day)||0||
48138199|NCT05554237|100661608|FG009|COMPLETED|Part 1: Period 4 Treatment (1 Day)||0||
48138200|NCT05554237|100661609|FG010|COMPLETED|Part 1: Period 4 Treatment (1 Day)||0||
48138201|NCT05554237|100661610|FG011|COMPLETED|Part 1: Period 4 Treatment (1 Day)||0||
48138202|NCT05554237|100661611|FG012|COMPLETED|Part 1: Period 4 Treatment (1 Day)||0||
48138203|NCT05554237|100661612|FG013|COMPLETED|Part 1: Period 4 Treatment (1 Day)||0||
48138204|NCT05554237|100661599|FG000|NOT COMPLETED|Part 1: Period 4 Treatment (1 Day)||0||
48138205|NCT05554237|100661600|FG001|NOT COMPLETED|Part 1: Period 4 Treatment (1 Day)||0||
48138206|NCT05554237|100661601|FG002|NOT COMPLETED|Part 1: Period 4 Treatment (1 Day)||0||
48138207|NCT05554237|100661602|FG003|NOT COMPLETED|Part 1: Period 4 Treatment (1 Day)||0||
48138208|NCT05554237|100661603|FG004|NOT COMPLETED|Part 1: Period 4 Treatment (1 Day)||0||
48138209|NCT05554237|100661604|FG005|NOT COMPLETED|Part 1: Period 4 Treatment (1 Day)||0||
48138210|NCT05554237|100661605|FG006|NOT COMPLETED|Part 1: Period 4 Treatment (1 Day)||0||
48138211|NCT05554237|100661606|FG007|NOT COMPLETED|Part 1: Period 4 Treatment (1 Day)||0||
48138212|NCT05554237|100661607|FG008|NOT COMPLETED|Part 1: Period 4 Treatment (1 Day)||0||
48138213|NCT05554237|100661608|FG009|NOT COMPLETED|Part 1: Period 4 Treatment (1 Day)||0||
48138214|NCT05554237|100661609|FG010|NOT COMPLETED|Part 1: Period 4 Treatment (1 Day)||0||
48138215|NCT05554237|100661610|FG011|NOT COMPLETED|Part 1: Period 4 Treatment (1 Day)||0||
48138216|NCT05554237|100661611|FG012|NOT COMPLETED|Part 1: Period 4 Treatment (1 Day)||0||
48138217|NCT05554237|100661612|FG013|NOT COMPLETED|Part 1: Period 4 Treatment (1 Day)||0||
48138218|NCT05554237|100661599|FG000|STARTED|Part 1: Period 4 Washout (3 Days)||2||
48138219|NCT05554237|100661600|FG001|STARTED|Part 1: Period 4 Washout (3 Days)||2||
48138220|NCT05554237|100661601|FG002|STARTED|Part 1: Period 4 Washout (3 Days)||2||
48138221|NCT05554237|100661602|FG003|STARTED|Part 1: Period 4 Washout (3 Days)||2||
48138222|NCT05554237|100661603|FG004|STARTED|Part 1: Period 4 Washout (3 Days)||0||
48138223|NCT05554237|100661604|FG005|STARTED|Part 1: Period 4 Washout (3 Days)||0||
48585230|NCT00747474|101762283|FG005|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
48585231|NCT00747474|101762284|FG006|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
48585232|NCT00747474|101762285|FG007|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||1||
48585233|NCT00747474|101762286|FG008|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
48585234|NCT00747474|101762287|FG009|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
48585235|NCT00747474|101762288|FG010|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
48585236|NCT00747474|101762289|FG011|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
48585237|NCT00747474|101762278|FG000|STARTED|Cohort 9 (35 mg/m^2) Period||0||
48585238|NCT00747474|101762279|FG001|STARTED|Cohort 9 (35 mg/m^2) Period||0||
48585239|NCT00747474|101762280|FG002|STARTED|Cohort 9 (35 mg/m^2) Period||0||
48585240|NCT00747474|101762281|FG003|STARTED|Cohort 9 (35 mg/m^2) Period||0||
48585241|NCT00747474|101762282|FG004|STARTED|Cohort 9 (35 mg/m^2) Period||0||
48585242|NCT00747474|101762283|FG005|STARTED|Cohort 9 (35 mg/m^2) Period||0||
48585243|NCT00747474|101762284|FG006|STARTED|Cohort 9 (35 mg/m^2) Period||0||
48585244|NCT00747474|101762285|FG007|STARTED|Cohort 9 (35 mg/m^2) Period||0||
48585245|NCT00747474|101762286|FG008|STARTED|Cohort 9 (35 mg/m^2) Period||4||
48585246|NCT00747474|101762287|FG009|STARTED|Cohort 9 (35 mg/m^2) Period||0||
48585247|NCT00747474|101762288|FG010|STARTED|Cohort 9 (35 mg/m^2) Period||0||
48585248|NCT00747474|101762289|FG011|STARTED|Cohort 9 (35 mg/m^2) Period||0||
48585249|NCT00747474|101762278|FG000|COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
48585250|NCT00747474|101762279|FG001|COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
48585251|NCT00747474|101762280|FG002|COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
48585252|NCT00747474|101762281|FG003|COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
48585253|NCT00747474|101762282|FG004|COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
48585254|NCT00747474|101762283|FG005|COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
48585255|NCT00747474|101762284|FG006|COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
48585256|NCT00747474|101762285|FG007|COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
48585257|NCT00747474|101762286|FG008|COMPLETED|Cohort 9 (35 mg/m^2) Period||4||
48585258|NCT00747474|101762287|FG009|COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
48585259|NCT00747474|101762288|FG010|COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
48585260|NCT00747474|101762289|FG011|COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
48585261|NCT00747474|101762278|FG000|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
48138224|NCT05554237|100661605|FG006|STARTED|Part 1: Period 4 Washout (3 Days)||0||
48138225|NCT05554237|100661606|FG007|STARTED|Part 1: Period 4 Washout (3 Days)||0||
48138226|NCT05554237|100661607|FG008|STARTED|Part 1: Period 4 Washout (3 Days)||0||
48585262|NCT00747474|101762279|FG001|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
48585263|NCT00747474|101762280|FG002|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
48585264|NCT00747474|101762281|FG003|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
48585265|NCT00747474|101762282|FG004|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
48585266|NCT00747474|101762283|FG005|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
48585267|NCT00747474|101762284|FG006|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
48585268|NCT00747474|101762285|FG007|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
48585269|NCT00747474|101762286|FG008|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
48585270|NCT00747474|101762287|FG009|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
48585271|NCT00747474|101762288|FG010|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
48585272|NCT00747474|101762289|FG011|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
48585273|NCT00747474|101762278|FG000|STARTED|Cohort 10 (40 mg/m^2) Period||0||
48585274|NCT00747474|101762279|FG001|STARTED|Cohort 10 (40 mg/m^2) Period||0||
48585275|NCT00747474|101762280|FG002|STARTED|Cohort 10 (40 mg/m^2) Period||0||
48585276|NCT00747474|101762281|FG003|STARTED|Cohort 10 (40 mg/m^2) Period||0||
48585277|NCT00747474|101762282|FG004|STARTED|Cohort 10 (40 mg/m^2) Period||0||
48585278|NCT00747474|101762283|FG005|STARTED|Cohort 10 (40 mg/m^2) Period||0||
48585279|NCT00747474|101762284|FG006|STARTED|Cohort 10 (40 mg/m^2) Period||0||
48585280|NCT00747474|101762285|FG007|STARTED|Cohort 10 (40 mg/m^2) Period||0||
48585281|NCT00747474|101762286|FG008|STARTED|Cohort 10 (40 mg/m^2) Period||0||
48585282|NCT00747474|101762287|FG009|STARTED|Cohort 10 (40 mg/m^2) Period||7||
48585283|NCT00747474|101762288|FG010|STARTED|Cohort 10 (40 mg/m^2) Period||0||
48585284|NCT00747474|101762289|FG011|STARTED|Cohort 10 (40 mg/m^2) Period||0||
48585285|NCT00747474|101762278|FG000|COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
48585286|NCT00747474|101762279|FG001|COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
48585287|NCT00747474|101762280|FG002|COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
48585288|NCT00747474|101762281|FG003|COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
48585289|NCT00747474|101762282|FG004|COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
48585290|NCT00747474|101762283|FG005|COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
48585291|NCT00747474|101762284|FG006|COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
48585292|NCT00747474|101762285|FG007|COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
48585293|NCT00747474|101762286|FG008|COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
48585294|NCT00747474|101762287|FG009|COMPLETED|Cohort 10 (40 mg/m^2) Period||7||
48585295|NCT00747474|101762288|FG010|COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
48585296|NCT00747474|101762289|FG011|COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
48585297|NCT00747474|101762278|FG000|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
48585298|NCT00747474|101762279|FG001|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
48585299|NCT00747474|101762280|FG002|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
48585300|NCT00747474|101762281|FG003|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
48585301|NCT00747474|101762282|FG004|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
48585302|NCT00747474|101762283|FG005|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
48585303|NCT00747474|101762284|FG006|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
48585304|NCT00747474|101762285|FG007|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
48585305|NCT00747474|101762286|FG008|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
48585306|NCT00747474|101762287|FG009|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
48585307|NCT00747474|101762288|FG010|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
48585308|NCT00747474|101762289|FG011|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
48585309|NCT00747474|101762278|FG000|STARTED|Cohort 11 (50 mg/m^2) Period||0||
48585310|NCT00747474|101762279|FG001|STARTED|Cohort 11 (50 mg/m^2) Period||0||
48585311|NCT00747474|101762280|FG002|STARTED|Cohort 11 (50 mg/m^2) Period||0||
48585312|NCT00747474|101762281|FG003|STARTED|Cohort 11 (50 mg/m^2) Period||0||
48585313|NCT00747474|101762282|FG004|STARTED|Cohort 11 (50 mg/m^2) Period||0||
48585314|NCT00747474|101762283|FG005|STARTED|Cohort 11 (50 mg/m^2) Period||0||
48585315|NCT00747474|101762284|FG006|STARTED|Cohort 11 (50 mg/m^2) Period||0||
48585316|NCT00747474|101762285|FG007|STARTED|Cohort 11 (50 mg/m^2) Period||0||
48585317|NCT00747474|101762286|FG008|STARTED|Cohort 11 (50 mg/m^2) Period||0||
48585318|NCT00747474|101762287|FG009|STARTED|Cohort 11 (50 mg/m^2) Period||0||
48585319|NCT00747474|101762288|FG010|STARTED|Cohort 11 (50 mg/m^2) Period||5||
48585320|NCT00747474|101762289|FG011|STARTED|Cohort 11 (50 mg/m^2) Period||0||
48585321|NCT00747474|101762278|FG000|COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
48585322|NCT00747474|101762279|FG001|COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
48585323|NCT00747474|101762280|FG002|COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
48585324|NCT00747474|101762281|FG003|COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
48585325|NCT00747474|101762282|FG004|COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
48585326|NCT00747474|101762283|FG005|COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
48585327|NCT00747474|101762284|FG006|COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
48585328|NCT00747474|101762285|FG007|COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
48585329|NCT00747474|101762286|FG008|COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
48585330|NCT00747474|101762287|FG009|COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
48585331|NCT00747474|101762288|FG010|COMPLETED|Cohort 11 (50 mg/m^2) Period||5||
48585332|NCT00747474|101762289|FG011|COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
48585333|NCT00747474|101762278|FG000|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
48585334|NCT00747474|101762279|FG001|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
48585335|NCT00747474|101762280|FG002|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
48585336|NCT00747474|101762281|FG003|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
48585337|NCT00747474|101762282|FG004|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
48585338|NCT00747474|101762283|FG005|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
48585339|NCT00747474|101762284|FG006|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
48585340|NCT00747474|101762285|FG007|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
48585341|NCT00747474|101762286|FG008|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
48585342|NCT00747474|101762287|FG009|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
48585343|NCT00747474|101762288|FG010|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
48585344|NCT00747474|101762289|FG011|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
48585345|NCT00747474|101762278|FG000|STARTED|Cohort 12 (60 mg/m^2) Period||0||
48585346|NCT00747474|101762279|FG001|STARTED|Cohort 12 (60 mg/m^2) Period||0||
48585347|NCT00747474|101762280|FG002|STARTED|Cohort 12 (60 mg/m^2) Period||0||
48585348|NCT00747474|101762281|FG003|STARTED|Cohort 12 (60 mg/m^2) Period||0||
48585349|NCT00747474|101762282|FG004|STARTED|Cohort 12 (60 mg/m^2) Period||0||
48585350|NCT00747474|101762283|FG005|STARTED|Cohort 12 (60 mg/m^2) Period||0||
48585351|NCT00747474|101762284|FG006|STARTED|Cohort 12 (60 mg/m^2) Period||0||
48585352|NCT00747474|101762285|FG007|STARTED|Cohort 12 (60 mg/m^2) Period||0||
48585353|NCT00747474|101762286|FG008|STARTED|Cohort 12 (60 mg/m^2) Period||0||
48585354|NCT00747474|101762287|FG009|STARTED|Cohort 12 (60 mg/m^2) Period||0||
48585355|NCT00747474|101762288|FG010|STARTED|Cohort 12 (60 mg/m^2) Period||0||
48585356|NCT00747474|101762289|FG011|STARTED|Cohort 12 (60 mg/m^2) Period||6||
48585357|NCT00747474|101762278|FG000|COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
48585358|NCT00747474|101762279|FG001|COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
48585359|NCT00747474|101762280|FG002|COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
48585360|NCT00747474|101762281|FG003|COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
48585361|NCT00747474|101762282|FG004|COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
48585362|NCT00747474|101762283|FG005|COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
48585363|NCT00747474|101762284|FG006|COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
48585364|NCT00747474|101762285|FG007|COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
48585365|NCT00747474|101762286|FG008|COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
48585366|NCT00747474|101762287|FG009|COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
48585367|NCT00747474|101762288|FG010|COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
48585368|NCT00747474|101762289|FG011|COMPLETED|Cohort 12 (60 mg/m^2) Period||6||
48585369|NCT00747474|101762278|FG000|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
48585370|NCT00747474|101762279|FG001|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
48585371|NCT00747474|101762280|FG002|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
48585372|NCT00747474|101762281|FG003|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
48585373|NCT00747474|101762282|FG004|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
48585374|NCT00747474|101762283|FG005|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
48585375|NCT00747474|101762284|FG006|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
48585376|NCT00747474|101762285|FG007|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
48585377|NCT00747474|101762286|FG008|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
48585378|NCT00747474|101762287|FG009|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
48585379|NCT00747474|101762288|FG010|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
48585380|NCT00747474|101762289|FG011|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
48585381|NCT02233101|101762290|FG000|STARTED|Overall Study||86||
48585382|NCT02233101|101762291|FG001|STARTED|Overall Study||81||
48585383|NCT02233101|101762290|FG000|COMPLETED|Overall Study||74||
48585384|NCT02233101|101762291|FG001|COMPLETED|Overall Study||80||
48585385|NCT02233101|101762290|FG000|NOT COMPLETED|Overall Study||12||
48585386|NCT02233101|101762291|FG001|NOT COMPLETED|Overall Study||1||
48585387|NCT00422695|101762292|FG000|STARTED|Overall Study||105||
48138227|NCT05554237|100661608|FG009|STARTED|Part 1: Period 4 Washout (3 Days)||0||
48138228|NCT05554237|100661609|FG010|STARTED|Part 1: Period 4 Washout (3 Days)||0||
48138229|NCT05554237|100661610|FG011|STARTED|Part 1: Period 4 Washout (3 Days)||0||
48138230|NCT05554237|100661611|FG012|STARTED|Part 1: Period 4 Washout (3 Days)||0||
48138231|NCT05554237|100661612|FG013|STARTED|Part 1: Period 4 Washout (3 Days)||0||
48138232|NCT05554237|100661599|FG000|COMPLETED|Part 1: Period 4 Washout (3 Days)||2||
48138233|NCT05554237|100661600|FG001|COMPLETED|Part 1: Period 4 Washout (3 Days)||2||
48138234|NCT05554237|100661601|FG002|COMPLETED|Part 1: Period 4 Washout (3 Days)||2||
48138235|NCT05554237|100661602|FG003|COMPLETED|Part 1: Period 4 Washout (3 Days)||2||
48138236|NCT05554237|100661603|FG004|COMPLETED|Part 1: Period 4 Washout (3 Days)||0||
48138237|NCT05554237|100661604|FG005|COMPLETED|Part 1: Period 4 Washout (3 Days)||0||
48138238|NCT05554237|100661605|FG006|COMPLETED|Part 1: Period 4 Washout (3 Days)||0||
48138239|NCT05554237|100661606|FG007|COMPLETED|Part 1: Period 4 Washout (3 Days)||0||
48138240|NCT05554237|100661607|FG008|COMPLETED|Part 1: Period 4 Washout (3 Days)||0||
48138241|NCT05554237|100661608|FG009|COMPLETED|Part 1: Period 4 Washout (3 Days)||0||
48138242|NCT05554237|100661609|FG010|COMPLETED|Part 1: Period 4 Washout (3 Days)||0||
48138243|NCT05554237|100661610|FG011|COMPLETED|Part 1: Period 4 Washout (3 Days)||0||
48289885|NCT02502799|101037457|FG003|COMPLETED|Phase 1: Brief Intervention Sessions||141||
48138244|NCT05554237|100661611|FG012|COMPLETED|Part 1: Period 4 Washout (3 Days)||0||
48138245|NCT05554237|100661612|FG013|COMPLETED|Part 1: Period 4 Washout (3 Days)||0||
48289886|NCT02502799|101037454|FG000|NOT COMPLETED|Phase 1: Brief Intervention Sessions||0||
48289887|NCT02502799|101037455|FG001|NOT COMPLETED|Phase 1: Brief Intervention Sessions||0||
48289888|NCT02502799|101037456|FG002|NOT COMPLETED|Phase 1: Brief Intervention Sessions||0||
48138246|NCT05554237|100661599|FG000|NOT COMPLETED|Part 1: Period 4 Washout (3 Days)||0||
48289889|NCT02502799|101037457|FG003|NOT COMPLETED|Phase 1: Brief Intervention Sessions||17||
48585388|NCT00422695|101762293|FG001|STARTED|Overall Study||38||
48585389|NCT00422695|101762292|FG000|COMPLETED|Overall Study||105||
48585390|NCT00422695|101762293|FG001|COMPLETED|Overall Study||38||
48585391|NCT00422695|101762292|FG000|NOT COMPLETED|Overall Study||0||
48585392|NCT00422695|101762293|FG001|NOT COMPLETED|Overall Study||0||
48585393|NCT03843541|101762294|FG000|STARTED|Overall Study||111||
48585394|NCT03843541|101762295|FG001|STARTED|Overall Study||111||
48585395|NCT03843541|101762296|FG002|STARTED|Overall Study||111||
48585396|NCT03843541|101762294|FG000|Modified ITT|Overall Study||108||
48585397|NCT03843541|101762295|FG001|Modified ITT|Overall Study||110||
48585398|NCT03843541|101762296|FG002|Modified ITT|Overall Study||110||
48585399|NCT03843541|101762294|FG000|COMPLETED|Overall Study||96||
48585400|NCT03843541|101762295|FG001|COMPLETED|Overall Study||95||
48585401|NCT03843541|101762296|FG002|COMPLETED|Overall Study||97||
48585402|NCT03843541|101762294|FG000|NOT COMPLETED|Overall Study||15||
48585403|NCT03843541|101762295|FG001|NOT COMPLETED|Overall Study||16||
48585404|NCT03843541|101762296|FG002|NOT COMPLETED|Overall Study||14||
48585405|NCT03030989|101762297|FG000|STARTED|Overall Study||21||
48585406|NCT03030989|101762298|FG001|STARTED|Overall Study||29||
48585407|NCT03030989|101762297|FG000|COMPLETED|Overall Study||9|Dropout due to fatigue at using wipes was high; compliance is enhanced with monitoring in hospital.|
48585408|NCT03030989|101762298|FG001|COMPLETED|Overall Study||15|Dropout due to fatigue at using wipes was high; compliance is enhanced with monitoring in hospital.|
48585409|NCT03030989|101762297|FG000|NOT COMPLETED|Overall Study||12||
48585410|NCT03030989|101762298|FG001|NOT COMPLETED|Overall Study||14||
48585411|NCT02593526|101762299|FG000|STARTED|Overall Study||0||
48585412|NCT02593526|101762300|FG001|STARTED|Overall Study||0||
48585413|NCT02593526|101762301|FG002|STARTED|Overall Study||0||
48585414|NCT02593526|101762302|FG003|STARTED|Overall Study||1||
48585415|NCT02593526|101762299|FG000|COMPLETED|Overall Study||0||
48585416|NCT02593526|101762300|FG001|COMPLETED|Overall Study||0||
48585417|NCT02593526|101762301|FG002|COMPLETED|Overall Study||0||
48585418|NCT02593526|101762302|FG003|COMPLETED|Overall Study||1||
48585419|NCT02593526|101762299|FG000|NOT COMPLETED|Overall Study||0||
48585420|NCT02593526|101762300|FG001|NOT COMPLETED|Overall Study||0||
48585421|NCT02593526|101762301|FG002|NOT COMPLETED|Overall Study||0||
48585422|NCT02593526|101762302|FG003|NOT COMPLETED|Overall Study||0||
48289890|NCT02502799|101037454|FG000|STARTED|Phase 2: Intervention Phase||16||
48289891|NCT02502799|101037455|FG001|STARTED|Phase 2: Intervention Phase||17||
48289892|NCT02502799|101037456|FG002|STARTED|Phase 2: Intervention Phase||16||
48289893|NCT02502799|101037457|FG003|STARTED|Phase 2: Intervention Phase||0||
48289894|NCT02502799|101037454|FG000|COMPLETED|Phase 2: Intervention Phase||6||
48289895|NCT02502799|101037455|FG001|COMPLETED|Phase 2: Intervention Phase||6||
48289896|NCT02502799|101037456|FG002|COMPLETED|Phase 2: Intervention Phase||7||
48289897|NCT02502799|101037457|FG003|COMPLETED|Phase 2: Intervention Phase||0||
48585423|NCT02327403|101762303|FG000|STARTED|Overall Study||15||
48585424|NCT02327403|101762303|FG000|COMPLETED|Overall Study||13||
48585425|NCT02327403|101762303|FG000|NOT COMPLETED|Overall Study||2||
48585426|NCT01167881|101762304|FG000|STARTED|Overall Study||769||
48585427|NCT01167881|101762305|FG001|STARTED|Overall Study||780||
48585428|NCT01167881|101762304|FG000|Completed After 2 Years Treatment|Overall Study||95||
48585429|NCT01167881|101762305|FG001|Completed After 2 Years Treatment|Overall Study||127||
48585430|NCT01167881|101762304|FG000|Completed After 4 Years Treatment|Overall Study||515||
48585431|NCT01167881|101762305|FG001|Completed After 4 Years Treatment|Overall Study||462||
48585432|NCT01167881|101762304|FG000|COMPLETED|Overall Study||610||
48585433|NCT01167881|101762305|FG001|COMPLETED|Overall Study||589||
48585434|NCT01167881|101762304|FG000|NOT COMPLETED|Overall Study||159||
48585435|NCT01167881|101762305|FG001|NOT COMPLETED|Overall Study||191||
48585436|NCT00281632|101762306|FG000|STARTED|Overall Study||36||
48585437|NCT00281632|101762306|FG000|COMPLETED|Overall Study||0||
48585438|NCT00281632|101762306|FG000|NOT COMPLETED|Overall Study||36||
48585439|NCT02005692|101762307|FG000|STARTED|Overall Study||70||
48585440|NCT02005692|101762307|FG000|COMPLETED|Overall Study||63||
48585441|NCT02005692|101762307|FG000|NOT COMPLETED|Overall Study||7||
48585442|NCT03197324|101762308|FG000|STARTED|Overall Study||10||
48585443|NCT03197324|101762309|FG001|STARTED|Overall Study||10||
48585444|NCT03197324|101762308|FG000|COMPLETED|Overall Study||10||
48585445|NCT03197324|101762309|FG001|COMPLETED|Overall Study||9||
48585446|NCT03197324|101762308|FG000|NOT COMPLETED|Overall Study||0||
48585447|NCT03197324|101762309|FG001|NOT COMPLETED|Overall Study||1||
48585448|NCT01032239|101762310|FG000|STARTED|Overall Study||31||
48289898|NCT02502799|101037454|FG000|NOT COMPLETED|Phase 2: Intervention Phase||10||
48289899|NCT02502799|101037455|FG001|NOT COMPLETED|Phase 2: Intervention Phase||11||
48289900|NCT02502799|101037456|FG002|NOT COMPLETED|Phase 2: Intervention Phase||9||
48585449|NCT01032239|101762311|FG001|STARTED|Overall Study||29||
48585450|NCT01032239|101762310|FG000|Implant|Overall Study||25||
48585451|NCT01032239|101762311|FG001|Implant|Overall Study||0||
48585452|NCT01032239|101762310|FG000|COMPLETED|Overall Study||24||
48585453|NCT01032239|101762311|FG001|COMPLETED|Overall Study||24||
48585454|NCT01032239|101762310|FG000|NOT COMPLETED|Overall Study||7||
48585455|NCT01032239|101762311|FG001|NOT COMPLETED|Overall Study||5||
48585456|NCT02691013|101762312|FG000|STARTED|Overall Study||61||
48585457|NCT02691013|101762313|FG001|STARTED|Overall Study||59||
48138247|NCT05554237|100661600|FG001|NOT COMPLETED|Part 1: Period 4 Washout (3 Days)||0||
48138248|NCT05554237|100661601|FG002|NOT COMPLETED|Part 1: Period 4 Washout (3 Days)||0||
48138249|NCT05554237|100661602|FG003|NOT COMPLETED|Part 1: Period 4 Washout (3 Days)||0||
48138250|NCT05554237|100661603|FG004|NOT COMPLETED|Part 1: Period 4 Washout (3 Days)||0||
48138251|NCT05554237|100661604|FG005|NOT COMPLETED|Part 1: Period 4 Washout (3 Days)||0||
48138252|NCT05554237|100661605|FG006|NOT COMPLETED|Part 1: Period 4 Washout (3 Days)||0||
48138253|NCT05554237|100661606|FG007|NOT COMPLETED|Part 1: Period 4 Washout (3 Days)||0||
48138254|NCT05554237|100661607|FG008|NOT COMPLETED|Part 1: Period 4 Washout (3 Days)||0||
48138255|NCT05554237|100661608|FG009|NOT COMPLETED|Part 1: Period 4 Washout (3 Days)||0||
48138256|NCT05554237|100661609|FG010|NOT COMPLETED|Part 1: Period 4 Washout (3 Days)||0||
48138257|NCT05554237|100661610|FG011|NOT COMPLETED|Part 1: Period 4 Washout (3 Days)||0||
48138258|NCT05554237|100661611|FG012|NOT COMPLETED|Part 1: Period 4 Washout (3 Days)||0||
48138259|NCT05554237|100661612|FG013|NOT COMPLETED|Part 1: Period 4 Washout (3 Days)||0||
48138260|NCT05554237|100661599|FG000|STARTED|Part 1: Period 5 Treatment (1 Day)||2||
48138261|NCT05554237|100661600|FG001|STARTED|Part 1: Period 5 Treatment (1 Day)||2||
48138262|NCT05554237|100661601|FG002|STARTED|Part 1: Period 5 Treatment (1 Day)||2||
48138263|NCT05554237|100661602|FG003|STARTED|Part 1: Period 5 Treatment (1 Day)||2||
48138264|NCT05554237|100661603|FG004|STARTED|Part 1: Period 5 Treatment (1 Day)||0||
48138265|NCT05554237|100661604|FG005|STARTED|Part 1: Period 5 Treatment (1 Day)||0||
48138266|NCT05554237|100661605|FG006|STARTED|Part 1: Period 5 Treatment (1 Day)||0||
48138267|NCT05554237|100661606|FG007|STARTED|Part 1: Period 5 Treatment (1 Day)||0||
48585458|NCT02691013|101762312|FG000|COMPLETED|Overall Study||58||
48585459|NCT02691013|101762313|FG001|COMPLETED|Overall Study||59||
48585460|NCT02691013|101762312|FG000|NOT COMPLETED|Overall Study||3||
48585461|NCT02691013|101762313|FG001|NOT COMPLETED|Overall Study||0||
48585462|NCT05835011|101762314|FG000|STARTED|Overall Study||2||
48585463|NCT05835011|101762314|FG000|COMPLETED|Overall Study||0||
48585464|NCT05835011|101762314|FG000|NOT COMPLETED|Overall Study||2||
48585465|NCT01608087|101762315|FG000|STARTED|Overall Study||30||
48706035|NCT02526524|102065199|FG003|COMPLETED|Overall Study||89||
48706036|NCT02526524|102065200|FG004|COMPLETED|Overall Study||72||
48706037|NCT02526524|102065201|FG005|COMPLETED|Overall Study||73||
48706038|NCT02526524|102065196|FG000|NOT COMPLETED|Overall Study||12||
48706039|NCT02526524|102065197|FG001|NOT COMPLETED|Overall Study||9||
48706040|NCT02526524|102065198|FG002|NOT COMPLETED|Overall Study||26||
48706041|NCT02526524|102065199|FG003|NOT COMPLETED|Overall Study||7||
48706042|NCT02526524|102065200|FG004|NOT COMPLETED|Overall Study||24||
48706043|NCT02526524|102065201|FG005|NOT COMPLETED|Overall Study||21||
48706044|NCT04239222|102069623|FG000|STARTED|Baseline||6||
48706045|NCT04239222|102069624|FG001|STARTED|Baseline||8||
48706046|NCT04239222|102069625|FG002|STARTED|Baseline||4||
48706047|NCT04239222|102069626|FG003|STARTED|Baseline||8||
48706048|NCT04239222|102069623|FG000|COMPLETED|Baseline||6||
48706049|NCT04239222|102069624|FG001|COMPLETED|Baseline||8||
48706050|NCT04239222|102069625|FG002|COMPLETED|Baseline||3||
48706051|NCT04239222|102069626|FG003|COMPLETED|Baseline||7||
48706052|NCT04239222|102069623|FG000|NOT COMPLETED|Baseline||0||
48706053|NCT04239222|102069624|FG001|NOT COMPLETED|Baseline||0||
48706054|NCT04239222|102069625|FG002|NOT COMPLETED|Baseline||1||
48706055|NCT04239222|102069626|FG003|NOT COMPLETED|Baseline||1||
48138268|NCT05554237|100661607|FG008|STARTED|Part 1: Period 5 Treatment (1 Day)||0||
48289901|NCT02502799|101037457|FG003|NOT COMPLETED|Phase 2: Intervention Phase||0||
48585466|NCT01608087|101762316|FG001|STARTED|Overall Study||30||
48585467|NCT01608087|101762317|FG002|STARTED|Overall Study||31||
48706056|NCT04239222|102069623|FG000|STARTED|First Foot Assignment||6||
48706057|NCT04239222|102069624|FG001|STARTED|First Foot Assignment||8||
48706058|NCT04239222|102069625|FG002|STARTED|First Foot Assignment||3||
48706059|NCT04239222|102069626|FG003|STARTED|First Foot Assignment||7||
48706060|NCT04239222|102069623|FG000|COMPLETED|First Foot Assignment||6||
48706061|NCT04239222|102069624|FG001|COMPLETED|First Foot Assignment||8||
48585468|NCT01608087|101762315|FG000|COMPLETED|Overall Study||30||
48585469|NCT01608087|101762316|FG001|COMPLETED|Overall Study||28||
48706062|NCT04239222|102069625|FG002|COMPLETED|First Foot Assignment||2||
48706063|NCT04239222|102069626|FG003|COMPLETED|First Foot Assignment||7||
48706064|NCT04239222|102069623|FG000|NOT COMPLETED|First Foot Assignment||0||
48706065|NCT04239222|102069624|FG001|NOT COMPLETED|First Foot Assignment||0||
48706066|NCT04239222|102069625|FG002|NOT COMPLETED|First Foot Assignment||1||
48706067|NCT04239222|102069626|FG003|NOT COMPLETED|First Foot Assignment||0||
48706068|NCT04239222|102069623|FG000|STARTED|Crossover to Alternate Foot Assignment||6||
48706069|NCT04239222|102069624|FG001|STARTED|Crossover to Alternate Foot Assignment||8||
48706070|NCT04239222|102069625|FG002|STARTED|Crossover to Alternate Foot Assignment||2||
48138269|NCT05554237|100661608|FG009|STARTED|Part 1: Period 5 Treatment (1 Day)||0||
48138270|NCT05554237|100661609|FG010|STARTED|Part 1: Period 5 Treatment (1 Day)||0||
48138271|NCT05554237|100661610|FG011|STARTED|Part 1: Period 5 Treatment (1 Day)||0||
48585470|NCT01608087|101762317|FG002|COMPLETED|Overall Study||31||
48585471|NCT01608087|101762315|FG000|NOT COMPLETED|Overall Study||0||
48706071|NCT04239222|102069626|FG003|STARTED|Crossover to Alternate Foot Assignment||7||
48706072|NCT04239222|102069623|FG000|COMPLETED|Crossover to Alternate Foot Assignment||6||
48138272|NCT05554237|100661611|FG012|STARTED|Part 1: Period 5 Treatment (1 Day)||0||
48138273|NCT05554237|100661612|FG013|STARTED|Part 1: Period 5 Treatment (1 Day)||0||
48138274|NCT05554237|100661599|FG000|COMPLETED|Part 1: Period 5 Treatment (1 Day)||2||
48138275|NCT05554237|100661600|FG001|COMPLETED|Part 1: Period 5 Treatment (1 Day)||2||
48138276|NCT05554237|100661601|FG002|COMPLETED|Part 1: Period 5 Treatment (1 Day)||2||
48138277|NCT05554237|100661602|FG003|COMPLETED|Part 1: Period 5 Treatment (1 Day)||2||
48138278|NCT05554237|100661603|FG004|COMPLETED|Part 1: Period 5 Treatment (1 Day)||0||
48138279|NCT05554237|100661604|FG005|COMPLETED|Part 1: Period 5 Treatment (1 Day)||0||
48138280|NCT05554237|100661605|FG006|COMPLETED|Part 1: Period 5 Treatment (1 Day)||0||
48138281|NCT05554237|100661606|FG007|COMPLETED|Part 1: Period 5 Treatment (1 Day)||0||
48138282|NCT05554237|100661607|FG008|COMPLETED|Part 1: Period 5 Treatment (1 Day)||0||
48138283|NCT05554237|100661608|FG009|COMPLETED|Part 1: Period 5 Treatment (1 Day)||0||
48138284|NCT05554237|100661609|FG010|COMPLETED|Part 1: Period 5 Treatment (1 Day)||0||
48138285|NCT05554237|100661610|FG011|COMPLETED|Part 1: Period 5 Treatment (1 Day)||0||
48138286|NCT05554237|100661611|FG012|COMPLETED|Part 1: Period 5 Treatment (1 Day)||0||
48585472|NCT01608087|101762316|FG001|NOT COMPLETED|Overall Study||2||
48585473|NCT01608087|101762317|FG002|NOT COMPLETED|Overall Study||0||
48585474|NCT01767506|101762318|FG000|STARTED|Overall Study||0||26
48138287|NCT05554237|100661612|FG013|COMPLETED|Part 1: Period 5 Treatment (1 Day)||0||
48138288|NCT05554237|100661599|FG000|NOT COMPLETED|Part 1: Period 5 Treatment (1 Day)||0||
48289902|NCT02725801|101037458|FG000|STARTED|Overall Study||8||
48289903|NCT02725801|101037459|FG001|STARTED|Overall Study||12||
48289904|NCT02725801|101037458|FG000|COMPLETED|Overall Study||8||
48289905|NCT02725801|101037459|FG001|COMPLETED|Overall Study||12||
48289906|NCT02725801|101037458|FG000|NOT COMPLETED|Overall Study||0||
48289907|NCT02725801|101037459|FG001|NOT COMPLETED|Overall Study||0||
48289908|NCT02111187|101037460|FG000|STARTED|Overall Study||7||
48289909|NCT02111187|101037461|FG001|STARTED|Overall Study||7||
48289910|NCT02111187|101037460|FG000|COMPLETED|Overall Study||7||
48289911|NCT02111187|101037461|FG001|COMPLETED|Overall Study||7||
48289912|NCT02111187|101037460|FG000|NOT COMPLETED|Overall Study||0||
48289913|NCT02111187|101037461|FG001|NOT COMPLETED|Overall Study||0||
48289914|NCT01248065|101037462|FG000|STARTED|Overall Study||207||
48289915|NCT01248065|101037463|FG001|STARTED|Overall Study||201||
48289916|NCT01248065|101037462|FG000|COMPLETED|Overall Study||181||
48289917|NCT01248065|101037463|FG001|COMPLETED|Overall Study||179||
48585475|NCT01767506|101762319|FG001|STARTED|Overall Study||0||26
48585476|NCT01767506|101762318|FG000|COMPLETED|Overall Study||0||26
48585477|NCT01767506|101762319|FG001|COMPLETED|Overall Study||0||26
48585478|NCT01767506|101762318|FG000|NOT COMPLETED|Overall Study||0||0
48585479|NCT01767506|101762319|FG001|NOT COMPLETED|Overall Study||0||0
48585480|NCT03960866|101762320|FG000|STARTED|Overall Study||19||
48289918|NCT01248065|101037462|FG000|NOT COMPLETED|Overall Study||26||
48289919|NCT01248065|101037463|FG001|NOT COMPLETED|Overall Study||22||
48289920|NCT00511901|101037464|FG000|STARTED|Overall Study||11||
48289921|NCT00511901|101037465|FG001|STARTED|Overall Study||11||
48289922|NCT00511901|101037464|FG000|COMPLETED|Overall Study||10||
48289923|NCT00511901|101037465|FG001|COMPLETED|Overall Study||8||
48289924|NCT00511901|101037464|FG000|NOT COMPLETED|Overall Study||1||
48289925|NCT00511901|101037465|FG001|NOT COMPLETED|Overall Study||3||
48585481|NCT03960866|101762321|FG001|STARTED|Overall Study||20||
48585482|NCT03960866|101762320|FG000|COMPLETED|Overall Study||19||
48585483|NCT03960866|101762321|FG001|COMPLETED|Overall Study||20||
48585484|NCT03960866|101762320|FG000|NOT COMPLETED|Overall Study||0||
48585485|NCT03960866|101762321|FG001|NOT COMPLETED|Overall Study||0||
48585486|NCT02009397|101762322|FG000|STARTED|Overall Study||26||
48585487|NCT02009397|101762322|FG000|COMPLETED|Overall Study||6||
48585488|NCT02009397|101762322|FG000|NOT COMPLETED|Overall Study||20||
48585489|NCT02396420|101762323|FG000|STARTED|Overall Study||2||
48585490|NCT02396420|101762323|FG000|1 Month Post PAE|Overall Study||2||
48289926|NCT01323634|101037466|FG000|STARTED|2-week Run-in Period||733||
48289927|NCT01323634|101037467|FG001|STARTED|2-week Run-in Period||0||
48289928|NCT01323634|101037468|FG002|STARTED|2-week Run-in Period||0||
48289929|NCT01323634|101037466|FG000|COMPLETED|2-week Run-in Period||521||
48289930|NCT01323634|101037467|FG001|COMPLETED|2-week Run-in Period||0||
48289931|NCT01323634|101037468|FG002|COMPLETED|2-week Run-in Period||0||
48289932|NCT01323634|101037466|FG000|NOT COMPLETED|2-week Run-in Period||212||
48289933|NCT01323634|101037467|FG001|NOT COMPLETED|2-week Run-in Period||0||
48289934|NCT01323634|101037468|FG002|NOT COMPLETED|2-week Run-in Period||0||
48585491|NCT02396420|101762323|FG000|3 Months Post PAE|Overall Study||2||
48138289|NCT05554237|100661600|FG001|NOT COMPLETED|Part 1: Period 5 Treatment (1 Day)||0||
48138290|NCT05554237|100661601|FG002|NOT COMPLETED|Part 1: Period 5 Treatment (1 Day)||0||
48289935|NCT01323634|101037466|FG000|STARTED|Double-Blind (DB) Treatment Period||0||
48289936|NCT01323634|101037467|FG001|STARTED|Double-Blind (DB) Treatment Period||260||
48289937|NCT01323634|101037468|FG002|STARTED|Double-Blind (DB) Treatment Period||261||
48585492|NCT02396420|101762323|FG000|6 Months Post PAE|Overall Study||2||
48585493|NCT02396420|101762323|FG000|COMPLETED|Overall Study||1|12 Months Post PAE|
48585494|NCT02396420|101762323|FG000|NOT COMPLETED|Overall Study||1||
48289938|NCT01323634|101037466|FG000|COMPLETED|Double-Blind (DB) Treatment Period||0||
48289939|NCT01323634|101037467|FG001|COMPLETED|Double-Blind (DB) Treatment Period||235||
48289940|NCT01323634|101037468|FG002|COMPLETED|Double-Blind (DB) Treatment Period||239||
48289941|NCT01323634|101037466|FG000|NOT COMPLETED|Double-Blind (DB) Treatment Period||0||
48289942|NCT01323634|101037467|FG001|NOT COMPLETED|Double-Blind (DB) Treatment Period||25||
48289943|NCT01323634|101037468|FG002|NOT COMPLETED|Double-Blind (DB) Treatment Period||22||
48289944|NCT04788511|101037469|FG000|STARTED|Overall Study||263||
48289945|NCT04788511|101037470|FG001|STARTED|Overall Study||266||
48289946|NCT04788511|101037469|FG000|Full Analysis Set (FAS)|Overall Study||263||
48289947|NCT04788511|101037470|FG001|Full Analysis Set (FAS)|Overall Study||266||
48289948|NCT04788511|101037469|FG000|Safety Analysis Set (SAS)|Overall Study||263||
48289949|NCT04788511|101037470|FG001|Safety Analysis Set (SAS)|Overall Study||266||
48289950|NCT04788511|101037469|FG000|COMPLETED|Overall Study||256||
48289951|NCT04788511|101037470|FG001|COMPLETED|Overall Study||254||
48289952|NCT04788511|101037469|FG000|NOT COMPLETED|Overall Study||7||
48289953|NCT04788511|101037470|FG001|NOT COMPLETED|Overall Study||12||
48289954|NCT00346632|101037471|FG000|STARTED|Overall Study||3||
48289955|NCT00346632|101037472|FG001|STARTED|Overall Study||3||
48289956|NCT00346632|101037473|FG002|STARTED|Overall Study||6||
48289957|NCT00346632|101037474|FG003|STARTED|Overall Study||3||
48289958|NCT00346632|101037475|FG004|STARTED|Overall Study||4||
48289959|NCT00346632|101037476|FG005|STARTED|Overall Study||2||
48289960|NCT00346632|101037477|FG006|STARTED|Overall Study||5||
48289961|NCT00346632|101037478|FG007|STARTED|Overall Study||4||
48289962|NCT00346632|101037479|FG008|STARTED|Overall Study||4||
48706073|NCT04239222|102069624|FG001|COMPLETED|Crossover to Alternate Foot Assignment||8||
48706074|NCT04239222|102069625|FG002|COMPLETED|Crossover to Alternate Foot Assignment||1||
48706075|NCT04239222|102069626|FG003|COMPLETED|Crossover to Alternate Foot Assignment||7||
48706076|NCT04239222|102069623|FG000|NOT COMPLETED|Crossover to Alternate Foot Assignment||0||
48706077|NCT04239222|102069624|FG001|NOT COMPLETED|Crossover to Alternate Foot Assignment||0||
48706078|NCT04239222|102069625|FG002|NOT COMPLETED|Crossover to Alternate Foot Assignment||1||
48289963|NCT00346632|101037480|FG009|STARTED|Overall Study||3||
48289964|NCT00346632|101037471|FG000|COMPLETED|Overall Study||0||
48289965|NCT00346632|101037472|FG001|COMPLETED|Overall Study||0||
48289966|NCT00346632|101037473|FG002|COMPLETED|Overall Study||0||
48289967|NCT00346632|101037474|FG003|COMPLETED|Overall Study||0||
48289968|NCT00346632|101037475|FG004|COMPLETED|Overall Study||0||
48289969|NCT00346632|101037476|FG005|COMPLETED|Overall Study||0||
48289970|NCT00346632|101037477|FG006|COMPLETED|Overall Study||0||
48289971|NCT00346632|101037478|FG007|COMPLETED|Overall Study||0||
48289972|NCT00346632|101037479|FG008|COMPLETED|Overall Study||0||
48289973|NCT00346632|101037480|FG009|COMPLETED|Overall Study||0||
48289974|NCT00346632|101037471|FG000|NOT COMPLETED|Overall Study||3||
48289975|NCT00346632|101037472|FG001|NOT COMPLETED|Overall Study||3||
48289976|NCT00346632|101037473|FG002|NOT COMPLETED|Overall Study||6||
48289977|NCT00346632|101037474|FG003|NOT COMPLETED|Overall Study||3||
48289978|NCT00346632|101037475|FG004|NOT COMPLETED|Overall Study||4||
48289979|NCT00346632|101037476|FG005|NOT COMPLETED|Overall Study||2||
48289980|NCT00346632|101037477|FG006|NOT COMPLETED|Overall Study||5||
48289981|NCT00346632|101037478|FG007|NOT COMPLETED|Overall Study||4||
48289982|NCT00346632|101037479|FG008|NOT COMPLETED|Overall Study||4||
48289983|NCT00346632|101037480|FG009|NOT COMPLETED|Overall Study||3||
48289984|NCT01054170|101037481|FG000|STARTED|Overall Study||25||
48706079|NCT04239222|102069626|FG003|NOT COMPLETED|Crossover to Alternate Foot Assignment||0||
48706080|NCT04239222|102069623|FG000|STARTED|Return to Baseline Foot||6||
48706081|NCT04239222|102069624|FG001|STARTED|Return to Baseline Foot||8||
48706082|NCT04239222|102069625|FG002|STARTED|Return to Baseline Foot||2||
48706083|NCT04239222|102069626|FG003|STARTED|Return to Baseline Foot||7||
48289985|NCT01054170|101037482|FG001|STARTED|Overall Study||27||
48289986|NCT01054170|101037481|FG000|COMPLETED|Overall Study||21||
48289987|NCT01054170|101037482|FG001|COMPLETED|Overall Study||21||
48289988|NCT01054170|101037481|FG000|NOT COMPLETED|Overall Study||4||
48289989|NCT01054170|101037482|FG001|NOT COMPLETED|Overall Study||6||
48289990|NCT00757783|101037483|FG000|STARTED|Overall Study||34||
48289991|NCT00757783|101037484|FG001|STARTED|Overall Study||31||
48289992|NCT00757783|101037483|FG000|COMPLETED|Overall Study||29||
48289993|NCT00757783|101037484|FG001|COMPLETED|Overall Study||25||
48289994|NCT00757783|101037483|FG000|NOT COMPLETED|Overall Study||5||
48289995|NCT00757783|101037484|FG001|NOT COMPLETED|Overall Study||6||
48289996|NCT02953860|101037485|FG000|STARTED|Overall Study||32||
48706084|NCT04239222|102069623|FG000|COMPLETED|Return to Baseline Foot||6||
48706085|NCT04239222|102069624|FG001|COMPLETED|Return to Baseline Foot||8||
48706086|NCT04239222|102069625|FG002|COMPLETED|Return to Baseline Foot||2||
48706087|NCT04239222|102069626|FG003|COMPLETED|Return to Baseline Foot||7||
48706088|NCT04239222|102069623|FG000|NOT COMPLETED|Return to Baseline Foot||0||
48706089|NCT04239222|102069624|FG001|NOT COMPLETED|Return to Baseline Foot||0||
48706090|NCT04239222|102069625|FG002|NOT COMPLETED|Return to Baseline Foot||0||
48706091|NCT04239222|102069626|FG003|NOT COMPLETED|Return to Baseline Foot||0||
48706092|NCT01813721|102069627|FG000|STARTED|Overall Study||1007||
48289997|NCT02953860|101037485|FG000|COMPLETED|Overall Study||32||
48289998|NCT02953860|101037485|FG000|NOT COMPLETED|Overall Study||0||
48289999|NCT01688830|101037486|FG000|STARTED|Overall Study||21||
48706093|NCT01813721|102069627|FG000|COMPLETED|Overall Study||943||
48706094|NCT01813721|102069627|FG000|NOT COMPLETED|Overall Study||64||
48585495|NCT00405522|101764548|FG000|STARTED|Overall Study||17||
48585496|NCT00405522|101764549|FG001|STARTED|Overall Study||17||
48585497|NCT00405522|101764548|FG000|COMPLETED|Overall Study||17||
48585498|NCT00405522|101764549|FG001|COMPLETED|Overall Study||17||
48585499|NCT00405522|101764548|FG000|NOT COMPLETED|Overall Study||0||
48585500|NCT00405522|101764549|FG001|NOT COMPLETED|Overall Study||0||
48290000|NCT01688830|101037487|FG001|STARTED|Overall Study||6||
48706095|NCT01626118|102069628|FG000|STARTED|Overall Study||94||
48706096|NCT01626118|102069629|FG001|STARTED|Overall Study||93||
48706097|NCT01626118|102069630|FG002|STARTED|Overall Study||92||
48706098|NCT01626118|102069631|FG003|STARTED|Overall Study||94||
48706099|NCT01626118|102069628|FG000|COMPLETED|Overall Study||92||
48706100|NCT01626118|102069629|FG001|COMPLETED|Overall Study||91||
48706101|NCT01626118|102069630|FG002|COMPLETED|Overall Study||90||
48706102|NCT01626118|102069631|FG003|COMPLETED|Overall Study||91||
48706103|NCT01626118|102069628|FG000|NOT COMPLETED|Overall Study||2||
48706104|NCT01626118|102069629|FG001|NOT COMPLETED|Overall Study||2||
48706105|NCT01626118|102069630|FG002|NOT COMPLETED|Overall Study||2||
48290001|NCT01688830|101037488|FG002|STARTED|Overall Study||6||
48290002|NCT01688830|101037489|FG003|STARTED|Overall Study||6||
48290003|NCT01688830|101037490|FG004|STARTED|Overall Study||5||
48290004|NCT01688830|101037491|FG005|STARTED|Overall Study||6||
48585501|NCT04009668|101764550|FG000|STARTED|Overall Study||7||
48585502|NCT04009668|101764550|FG000|COMPLETED|Overall Study||7||
48585503|NCT04009668|101764550|FG000|NOT COMPLETED|Overall Study||0||
48585504|NCT00342563|101764551|FG000|STARTED|Overall Study||41||
48585505|NCT00342563|101764552|FG001|STARTED|Overall Study||27||
48290005|NCT01688830|101037492|FG006|STARTED|Overall Study||12||
48290006|NCT01688830|101037493|FG007|STARTED|Overall Study||6||
48290007|NCT01688830|101037494|FG008|STARTED|Overall Study||6||
48290008|NCT01688830|101037495|FG009|STARTED|Overall Study||6||
48290009|NCT01688830|101037496|FG010|STARTED|Overall Study||6||
48290010|NCT01688830|101037497|FG011|STARTED|Overall Study||6||
48290011|NCT01688830|101037498|FG012|STARTED|Overall Study||6||
48290012|NCT01688830|101037499|FG013|STARTED|Overall Study||6||
48290013|NCT01688830|101037500|FG014|STARTED|Overall Study||6||
48290014|NCT01688830|101037501|FG015|STARTED|Overall Study||9||
48290015|NCT01688830|101037502|FG016|STARTED|Overall Study||9||
48290016|NCT01688830|101037503|FG017|STARTED|Overall Study||9||
48290017|NCT01688830|101037504|FG018|STARTED|Overall Study||8||
48290018|NCT01688830|101037505|FG019|STARTED|Overall Study||3||
48290019|NCT01688830|101037506|FG020|STARTED|Overall Study||9||
48290020|NCT01688830|101037486|FG000|COMPLETED|Overall Study||21||
48585506|NCT00342563|101764553|FG002|STARTED|Overall Study||40||
48585507|NCT00342563|101764554|FG003|STARTED|Overall Study||28||
48585508|NCT00342563|101764551|FG000|COMPLETED|Overall Study||35||
48585509|NCT00342563|101764552|FG001|COMPLETED|Overall Study||19||
48585510|NCT00342563|101764553|FG002|COMPLETED|Overall Study||26||
48706106|NCT01626118|102069631|FG003|NOT COMPLETED|Overall Study||3||
48706107|NCT01691885|102069632|FG000|STARTED|Treatment Period 1(7-14 Days)||22||
48706108|NCT01691885|102069633|FG001|STARTED|Treatment Period 1(7-14 Days)||23||
48706109|NCT01691885|102069632|FG000|COMPLETED|Treatment Period 1(7-14 Days)||21||
48706110|NCT01691885|102069633|FG001|COMPLETED|Treatment Period 1(7-14 Days)||22||
48706111|NCT01691885|102069632|FG000|NOT COMPLETED|Treatment Period 1(7-14 Days)||1||
48706112|NCT01691885|102069633|FG001|NOT COMPLETED|Treatment Period 1(7-14 Days)||1||
48706113|NCT01691885|102069632|FG000|STARTED|Washout Period (7-9 Days)||21||
48706114|NCT01691885|102069633|FG001|STARTED|Washout Period (7-9 Days)||22||
48706115|NCT01691885|102069632|FG000|COMPLETED|Washout Period (7-9 Days)||21||
48706116|NCT01691885|102069633|FG001|COMPLETED|Washout Period (7-9 Days)||21||
48706117|NCT01691885|102069632|FG000|NOT COMPLETED|Washout Period (7-9 Days)||0||
48706118|NCT01691885|102069633|FG001|NOT COMPLETED|Washout Period (7-9 Days)||1||
48706119|NCT01691885|102069632|FG000|STARTED|Treatment Period 2 (7-14 Days)||21||
48706120|NCT01691885|102069633|FG001|STARTED|Treatment Period 2 (7-14 Days)||21||
48706121|NCT01691885|102069632|FG000|COMPLETED|Treatment Period 2 (7-14 Days)||21||
48585511|NCT00342563|101764554|FG003|COMPLETED|Overall Study||22||
48585512|NCT00342563|101764551|FG000|NOT COMPLETED|Overall Study||6||
48585513|NCT00342563|101764552|FG001|NOT COMPLETED|Overall Study||8||
48585514|NCT00342563|101764553|FG002|NOT COMPLETED|Overall Study||14||
48290021|NCT01688830|101037487|FG001|COMPLETED|Overall Study||6||
48290022|NCT01688830|101037488|FG002|COMPLETED|Overall Study||6||
48585515|NCT00342563|101764554|FG003|NOT COMPLETED|Overall Study||6||
48585516|NCT02796352|101764555|FG000|STARTED|Overall Study||1||
48585517|NCT02796352|101764555|FG000|COMPLETED|Overall Study||1||
48401736|NCT02266004|101313844|FG000|NOT COMPLETED|Overall Study||2||
48401737|NCT01999348|101313845|FG000|STARTED|Overall Study||1553||
48401738|NCT01999348|101313845|FG000|COMPLETED|Overall Study||1433||
48401739|NCT01999348|101313845|FG000|NOT COMPLETED|Overall Study||120||
48401740|NCT01927887|101313846|FG000|STARTED|Overall Study||12||
48585518|NCT02796352|101764555|FG000|NOT COMPLETED|Overall Study||0||
48585519|NCT05174949|101764556|FG000|STARTED|Overall Study||1||
48585520|NCT05174949|101764557|FG001|STARTED|Overall Study||4||
48401741|NCT01927887|101313846|FG000|COMPLETED|Overall Study||12||
48401742|NCT01927887|101313846|FG000|NOT COMPLETED|Overall Study||0||
48401743|NCT00588523|101313847|FG000|STARTED|Overall Study||60||
48585521|NCT05174949|101764558|FG002|STARTED|Overall Study||1||
48585522|NCT05174949|101764559|FG003|STARTED|Overall Study||5||
48585523|NCT05174949|101764560|FG004|STARTED|Overall Study||2||
48585524|NCT05174949|101764561|FG005|STARTED|Overall Study||1||
48585525|NCT05174949|101764556|FG000|Per-protocol (PP) Population|Overall Study||1||
48585526|NCT05174949|101764557|FG001|Per-protocol (PP) Population|Overall Study||4||
48585527|NCT05174949|101764558|FG002|Per-protocol (PP) Population|Overall Study||1||
48585528|NCT05174949|101764559|FG003|Per-protocol (PP) Population|Overall Study||4||
48585529|NCT05174949|101764560|FG004|Per-protocol (PP) Population|Overall Study||2||
48585530|NCT05174949|101764561|FG005|Per-protocol (PP) Population|Overall Study||1||
48585531|NCT05174949|101764556|FG000|COMPLETED|Overall Study||0||
48585532|NCT05174949|101764557|FG001|COMPLETED|Overall Study||1||
48585533|NCT05174949|101764558|FG002|COMPLETED|Overall Study||1||
48585534|NCT05174949|101764559|FG003|COMPLETED|Overall Study||3||
48585535|NCT05174949|101764560|FG004|COMPLETED|Overall Study||2||
48585536|NCT05174949|101764561|FG005|COMPLETED|Overall Study||1||
48585537|NCT05174949|101764556|FG000|NOT COMPLETED|Overall Study||1||
48585538|NCT05174949|101764557|FG001|NOT COMPLETED|Overall Study||3||
48585539|NCT05174949|101764558|FG002|NOT COMPLETED|Overall Study||0||
48585540|NCT05174949|101764559|FG003|NOT COMPLETED|Overall Study||2||
48585541|NCT05174949|101764560|FG004|NOT COMPLETED|Overall Study||0||
48585542|NCT05174949|101764561|FG005|NOT COMPLETED|Overall Study||0||
48585543|NCT01579045|101764562|FG000|STARTED|Overall Study||24||
48585544|NCT01579045|101764562|FG000|COMPLETED|Overall Study||24||
48585545|NCT01579045|101764562|FG000|NOT COMPLETED|Overall Study||0||
48585546|NCT06017752|101764563|FG000|STARTED|Overall Study||18||
48585547|NCT06017752|101764563|FG000|COMPLETED|Overall Study||17||
48585548|NCT06017752|101764563|FG000|NOT COMPLETED|Overall Study||1||
48585549|NCT03155178|101764564|FG000|STARTED|Overall Study||69||69
48585550|NCT03155178|101764565|FG001|STARTED|Overall Study||69||69
48585551|NCT03155178|101764566|FG002|STARTED|Overall Study||69||69
48585552|NCT03155178|101764567|FG003|STARTED|Overall Study||69||69
48585553|NCT03155178|101764564|FG000|COMPLETED|Overall Study||62||62
48585554|NCT03155178|101764565|FG001|COMPLETED|Overall Study||62||62
48585555|NCT03155178|101764566|FG002|COMPLETED|Overall Study||62||62
48585556|NCT03155178|101764567|FG003|COMPLETED|Overall Study||62||62
48585557|NCT03155178|101764564|FG000|NOT COMPLETED|Overall Study||7||7
48585558|NCT03155178|101764565|FG001|NOT COMPLETED|Overall Study||7||7
48585559|NCT03155178|101764566|FG002|NOT COMPLETED|Overall Study||7||7
48585560|NCT03155178|101764567|FG003|NOT COMPLETED|Overall Study||7||7
48585561|NCT01895608|101764568|FG000|STARTED|Overall Study||10||
48585562|NCT01895608|101764569|FG001|STARTED|Overall Study||7||
48585563|NCT01895608|101764570|FG002|STARTED|Overall Study||11||
48585564|NCT01895608|101764571|FG003|STARTED|Overall Study||6||
48585565|NCT01895608|101764568|FG000|COMPLETED|Overall Study||10||
48585566|NCT01895608|101764569|FG001|COMPLETED|Overall Study||6||
48585567|NCT01895608|101764570|FG002|COMPLETED|Overall Study||8||
48585568|NCT01895608|101764571|FG003|COMPLETED|Overall Study||6||
48585569|NCT01895608|101764568|FG000|NOT COMPLETED|Overall Study||0||
48585570|NCT01895608|101764569|FG001|NOT COMPLETED|Overall Study||1||
48585571|NCT01895608|101764570|FG002|NOT COMPLETED|Overall Study||3||
48585572|NCT01895608|101764571|FG003|NOT COMPLETED|Overall Study||0||
48585573|NCT01967706|101764572|FG000|STARTED|Washout Period of 1 Day (Day 0)||22||
48585574|NCT01967706|101764573|FG001|STARTED|Washout Period of 1 Day (Day 0)||22||
48585575|NCT01967706|101764574|FG002|STARTED|Washout Period of 1 Day (Day 0)||9||
48585576|NCT01967706|101764575|FG003|STARTED|Washout Period of 1 Day (Day 0)||9||
48585577|NCT01967706|101764572|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22||
48585578|NCT01967706|101764573|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||22||
48585579|NCT01967706|101764574|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9||
48585580|NCT01967706|101764575|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9||
48585581|NCT01967706|101764572|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0||
48585582|NCT01967706|101764573|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0||
48585583|NCT01967706|101764574|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0||
48401744|NCT00588523|101313847|FG000|COMPLETED|Overall Study||57||
48401745|NCT00588523|101313847|FG000|NOT COMPLETED|Overall Study||3||
48585584|NCT01967706|101764575|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0||
48585585|NCT01967706|101764572|FG000|STARTED|First Intervention (Day 1)||22||
48585586|NCT01967706|101764573|FG001|STARTED|First Intervention (Day 1)||22||
48585587|NCT01967706|101764574|FG002|STARTED|First Intervention (Day 1)||9||
48585588|NCT01967706|101764575|FG003|STARTED|First Intervention (Day 1)||9||
48706122|NCT01691885|102069633|FG001|COMPLETED|Treatment Period 2 (7-14 Days)||21||
48706123|NCT01691885|102069632|FG000|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0||
48138291|NCT05554237|100661602|FG003|NOT COMPLETED|Part 1: Period 5 Treatment (1 Day)||0||
48138292|NCT05554237|100661603|FG004|NOT COMPLETED|Part 1: Period 5 Treatment (1 Day)||0||
48138293|NCT05554237|100661604|FG005|NOT COMPLETED|Part 1: Period 5 Treatment (1 Day)||0||
48138294|NCT05554237|100661605|FG006|NOT COMPLETED|Part 1: Period 5 Treatment (1 Day)||0||
48138295|NCT05554237|100661606|FG007|NOT COMPLETED|Part 1: Period 5 Treatment (1 Day)||0||
48401746|NCT02499575|101313848|FG000|STARTED|Overall Study||1||
48401747|NCT02499575|101313849|FG001|STARTED|Overall Study||1||
48401748|NCT02499575|101313848|FG000|COMPLETED|Overall Study||1||
48401749|NCT02499575|101313849|FG001|COMPLETED|Overall Study||0||
48401750|NCT02499575|101313848|FG000|NOT COMPLETED|Overall Study||0||
48401751|NCT02499575|101313849|FG001|NOT COMPLETED|Overall Study||1||
48401752|NCT00365768|101313850|FG000|STARTED|Overall Study||24||
48401753|NCT00365768|101313851|FG001|STARTED|Overall Study||25||
48401754|NCT00365768|101313850|FG000|COMPLETED|Overall Study||24||
48401755|NCT00365768|101313851|FG001|COMPLETED|Overall Study||25||
48401756|NCT00365768|101313850|FG000|NOT COMPLETED|Overall Study||0||
48401757|NCT00365768|101313851|FG001|NOT COMPLETED|Overall Study||0||
48401758|NCT00126672|101313852|FG000|STARTED|Overall Study||36||
48585589|NCT01967706|101764572|FG000|COMPLETED|First Intervention (Day 1)||21||
48585590|NCT01967706|101764573|FG001|COMPLETED|First Intervention (Day 1)||22||
48585591|NCT01967706|101764574|FG002|COMPLETED|First Intervention (Day 1)||9||
48585592|NCT01967706|101764575|FG003|COMPLETED|First Intervention (Day 1)||9||
48585593|NCT01967706|101764572|FG000|NOT COMPLETED|First Intervention (Day 1)||1||
48585594|NCT01967706|101764573|FG001|NOT COMPLETED|First Intervention (Day 1)||0||
48585595|NCT01967706|101764574|FG002|NOT COMPLETED|First Intervention (Day 1)||0||
48585596|NCT01967706|101764575|FG003|NOT COMPLETED|First Intervention (Day 1)||0||
48585597|NCT01967706|101764572|FG000|STARTED|Washout Period of 1 Day (Day 2)||21||
48585598|NCT01967706|101764573|FG001|STARTED|Washout Period of 1 Day (Day 2)||22||
48585599|NCT01967706|101764574|FG002|STARTED|Washout Period of 1 Day (Day 2)||9||
48585600|NCT01967706|101764575|FG003|STARTED|Washout Period of 1 Day (Day 2)||9||
48585601|NCT01967706|101764572|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||21||
48585602|NCT01967706|101764573|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||22||
48706124|NCT01691885|102069633|FG001|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0||
48706125|NCT00932620|102069634|FG000|STARTED|Overall Study||50||
48706126|NCT00932620|102069635|FG001|STARTED|Overall Study||50||
48706127|NCT00932620|102069634|FG000|COMPLETED|Overall Study||50||
48706128|NCT00932620|102069635|FG001|COMPLETED|Overall Study||50||
48706129|NCT00932620|102069634|FG000|NOT COMPLETED|Overall Study||0||
48706130|NCT00932620|102069635|FG001|NOT COMPLETED|Overall Study||0||
48706131|NCT02118766|102069636|FG000|STARTED|Overall Study||507||
48706132|NCT02118766|102069637|FG001|STARTED|Overall Study||256||
48706133|NCT02118766|102069636|FG000|Treated|Overall Study||503||
48706134|NCT02118766|102069637|FG001|Treated|Overall Study||256||
48706135|NCT02118766|102069636|FG000|COMPLETED|Overall Study||477||
48706136|NCT02118766|102069637|FG001|COMPLETED|Overall Study||225||
48706137|NCT02118766|102069636|FG000|NOT COMPLETED|Overall Study||30||
48706138|NCT02118766|102069637|FG001|NOT COMPLETED|Overall Study||31||
48706139|NCT01432145|102069638|FG000|STARTED|Overall Study||74||
48706140|NCT01432145|102069638|FG000|COMPLETED|Overall Study||67||
48706141|NCT01432145|102069638|FG000|NOT COMPLETED|Overall Study||7||
48706142|NCT01842035|102069639|FG000|STARTED|Overall Study||90||
48706143|NCT01842035|102069639|FG000|COMPLETED|Overall Study||90||
48706144|NCT01842035|102069639|FG000|NOT COMPLETED|Overall Study||0||
48706145|NCT04484649|102069640|FG000|STARTED|Overall Study||30||
48706146|NCT04484649|102069641|FG001|STARTED|Overall Study||31||
48706147|NCT04484649|102069640|FG000|COMPLETED|Overall Study||22|Completed at least 1 day of actigraphy post intervention|
48706148|NCT04484649|102069641|FG001|COMPLETED|Overall Study||26|Completed at least 1 day of actigraphy post intervention|
48138296|NCT05554237|100661607|FG008|NOT COMPLETED|Part 1: Period 5 Treatment (1 Day)||0||
48401759|NCT00126672|101313852|FG000|COMPLETED|Overall Study||28||
48401760|NCT00126672|101313852|FG000|NOT COMPLETED|Overall Study||8||
48401761|NCT01143714|101313853|FG000|STARTED|Overall Study||29||
48401762|NCT01143714|101313854|FG001|STARTED|Overall Study||28||
48401763|NCT01143714|101313853|FG000|COMPLETED|Overall Study||22||
48585603|NCT01967706|101764574|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9||
48585604|NCT01967706|101764575|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||9||
48706149|NCT04484649|102069640|FG000|NOT COMPLETED|Overall Study||8||
48706150|NCT04484649|102069641|FG001|NOT COMPLETED|Overall Study||5||
48706151|NCT03389555|102069642|FG000|STARTED|Overall Study||103||
48401764|NCT01143714|101313854|FG001|COMPLETED|Overall Study||25||
48706152|NCT03389555|102069643|FG001|STARTED|Overall Study||102||
48401765|NCT01143714|101313853|FG000|NOT COMPLETED|Overall Study||7||
48585605|NCT01967706|101764572|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
48585606|NCT01967706|101764573|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
48585607|NCT01967706|101764574|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
48585608|NCT01967706|101764575|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
48585609|NCT01967706|101764572|FG000|STARTED|Second Intervention (Day 3)||21||
48585610|NCT01967706|101764573|FG001|STARTED|Second Intervention (Day 3)||22||
48585611|NCT01967706|101764574|FG002|STARTED|Second Intervention (Day 3)||9||
48585612|NCT01967706|101764575|FG003|STARTED|Second Intervention (Day 3)||9||
48585613|NCT01967706|101764572|FG000|COMPLETED|Second Intervention (Day 3)||21||
48585614|NCT01967706|101764573|FG001|COMPLETED|Second Intervention (Day 3)||22||
48585615|NCT01967706|101764574|FG002|COMPLETED|Second Intervention (Day 3)||9||
48585616|NCT01967706|101764575|FG003|COMPLETED|Second Intervention (Day 3)||9||
48585617|NCT01967706|101764572|FG000|NOT COMPLETED|Second Intervention (Day 3)||0||
48585618|NCT01967706|101764573|FG001|NOT COMPLETED|Second Intervention (Day 3)||0||
48585619|NCT01967706|101764574|FG002|NOT COMPLETED|Second Intervention (Day 3)||0||
48585620|NCT01967706|101764575|FG003|NOT COMPLETED|Second Intervention (Day 3)||0||
48585621|NCT01246349|101764576|FG000|STARTED|Overall Study||20||
48585622|NCT01246349|101764577|FG001|STARTED|Overall Study||20||
48585623|NCT01246349|101764576|FG000|COMPLETED|Overall Study||20||
48585624|NCT01246349|101764577|FG001|COMPLETED|Overall Study||20||
48585625|NCT01246349|101764576|FG000|NOT COMPLETED|Overall Study||0||
48585626|NCT01246349|101764577|FG001|NOT COMPLETED|Overall Study||0||
48585627|NCT03499899|101764578|FG000|STARTED|Overall Study||20||
48585628|NCT03499899|101764579|FG001|STARTED|Overall Study||34||
48585629|NCT03499899|101764580|FG002|STARTED|Overall Study||34||
48290023|NCT01688830|101037489|FG003|COMPLETED|Overall Study||6||
48290024|NCT01688830|101037490|FG004|COMPLETED|Overall Study||5||
48290025|NCT01688830|101037491|FG005|COMPLETED|Overall Study||6||
48290026|NCT01688830|101037492|FG006|COMPLETED|Overall Study||12||
48290027|NCT01688830|101037493|FG007|COMPLETED|Overall Study||6||
48290028|NCT01688830|101037494|FG008|COMPLETED|Overall Study||6||
48290029|NCT01688830|101037495|FG009|COMPLETED|Overall Study||6||
48290030|NCT01688830|101037496|FG010|COMPLETED|Overall Study||5||
48290031|NCT01688830|101037497|FG011|COMPLETED|Overall Study||6||
48290032|NCT01688830|101037498|FG012|COMPLETED|Overall Study||6||
48290033|NCT01688830|101037499|FG013|COMPLETED|Overall Study||6||
48290034|NCT01688830|101037500|FG014|COMPLETED|Overall Study||6||
48290035|NCT01688830|101037501|FG015|COMPLETED|Overall Study||9||
48290036|NCT01688830|101037502|FG016|COMPLETED|Overall Study||9||
48290037|NCT01688830|101037503|FG017|COMPLETED|Overall Study||9||
48290038|NCT01688830|101037504|FG018|COMPLETED|Overall Study||8||
48290039|NCT01688830|101037505|FG019|COMPLETED|Overall Study||3||
48290040|NCT01688830|101037506|FG020|COMPLETED|Overall Study||9||
48290041|NCT01688830|101037486|FG000|NOT COMPLETED|Overall Study||0||
48290042|NCT01688830|101037487|FG001|NOT COMPLETED|Overall Study||0||
48290043|NCT01688830|101037488|FG002|NOT COMPLETED|Overall Study||0||
48290044|NCT01688830|101037489|FG003|NOT COMPLETED|Overall Study||0||
48290045|NCT01688830|101037490|FG004|NOT COMPLETED|Overall Study||0||
48585630|NCT03499899|101764578|FG000|Treated|Overall Study||19||
48585631|NCT03499899|101764579|FG001|Treated|Overall Study||34||
48585632|NCT03499899|101764580|FG002|Treated|Overall Study||34||
48585633|NCT03499899|101764578|FG000|COMPLETED|Overall Study||0||
48585634|NCT03499899|101764579|FG001|COMPLETED|Overall Study||0||
48585635|NCT03499899|101764580|FG002|COMPLETED|Overall Study||0||
48585636|NCT03499899|101764578|FG000|NOT COMPLETED|Overall Study||20||
48585637|NCT03499899|101764579|FG001|NOT COMPLETED|Overall Study||34||
48585638|NCT03499899|101764580|FG002|NOT COMPLETED|Overall Study||34||
48585639|NCT01190267|101764581|FG000|STARTED|Overall Study||196||
48585640|NCT01190267|101764582|FG001|STARTED|Overall Study||8||
48706153|NCT03389555|102069642|FG000|COMPLETED|Overall Study||101||
48585641|NCT01190267|101764581|FG000|COMPLETED|Overall Study||155||
48585642|NCT01190267|101764582|FG001|COMPLETED|Overall Study||4||
48585643|NCT01190267|101764581|FG000|NOT COMPLETED|Overall Study||41||
48585644|NCT01190267|101764582|FG001|NOT COMPLETED|Overall Study||4||
48585645|NCT01450826|101764583|FG000|STARTED|Overall Study||70||
48706154|NCT03389555|102069643|FG001|COMPLETED|Overall Study||99||
48706155|NCT03389555|102069642|FG000|NOT COMPLETED|Overall Study||2||
48706156|NCT03389555|102069643|FG001|NOT COMPLETED|Overall Study||3||
48706157|NCT05438602|102069644|FG000|STARTED|Treatment (15 Days)||54||
48706158|NCT05438602|102069645|FG001|STARTED|Treatment (15 Days)||52||
48706159|NCT05438602|102069646|FG002|STARTED|Treatment (15 Days)||51||
48706160|NCT05438602|102069644|FG000|COMPLETED|Treatment (15 Days)||50||
48706161|NCT05438602|102069645|FG001|COMPLETED|Treatment (15 Days)||49||
48290046|NCT01688830|101037491|FG005|NOT COMPLETED|Overall Study||0||
48290047|NCT01688830|101037492|FG006|NOT COMPLETED|Overall Study||0||
48290048|NCT01688830|101037493|FG007|NOT COMPLETED|Overall Study||0||
48585646|NCT01450826|101764584|FG001|STARTED|Overall Study||66||
48585647|NCT01450826|101764583|FG000|COMPLETED|Overall Study||70||
48585648|NCT01450826|101764584|FG001|COMPLETED|Overall Study||66||
48585649|NCT01450826|101764583|FG000|NOT COMPLETED|Overall Study||0||
48585650|NCT01450826|101764584|FG001|NOT COMPLETED|Overall Study||0||
48585651|NCT02380261|101764585|FG000|STARTED|Overall Study||35||
48290049|NCT01688830|101037494|FG008|NOT COMPLETED|Overall Study||0||
48290050|NCT01688830|101037495|FG009|NOT COMPLETED|Overall Study||0||
48290051|NCT01688830|101037496|FG010|NOT COMPLETED|Overall Study||1||
48290052|NCT01688830|101037497|FG011|NOT COMPLETED|Overall Study||0||
48290053|NCT01688830|101037498|FG012|NOT COMPLETED|Overall Study||0||
48290054|NCT01688830|101037499|FG013|NOT COMPLETED|Overall Study||0||
48290055|NCT01688830|101037500|FG014|NOT COMPLETED|Overall Study||0||
48290056|NCT01688830|101037501|FG015|NOT COMPLETED|Overall Study||0||
48290057|NCT01688830|101037502|FG016|NOT COMPLETED|Overall Study||0||
48290058|NCT01688830|101037503|FG017|NOT COMPLETED|Overall Study||0||
48290059|NCT01688830|101037504|FG018|NOT COMPLETED|Overall Study||0||
48290060|NCT01688830|101037505|FG019|NOT COMPLETED|Overall Study||0||
48290061|NCT01688830|101037506|FG020|NOT COMPLETED|Overall Study||0||
48290062|NCT00818649|101037507|FG000|STARTED|Overall Study||16||
48401766|NCT01143714|101313854|FG001|NOT COMPLETED|Overall Study||3||
48401767|NCT00899678|101313855|FG000|STARTED|Induction Period (Weeks 0 to 6)||27||
48401768|NCT00899678|101313856|FG001|STARTED|Induction Period (Weeks 0 to 6)||37||
48290063|NCT00818649|101037507|FG000|COMPLETED|Overall Study||12||
48290064|NCT00818649|101037507|FG000|NOT COMPLETED|Overall Study||4||
48290065|NCT01948908|101037508|FG000|STARTED|Overall Study||33||
48290066|NCT01948908|101037509|FG001|STARTED|Overall Study||33||
48290067|NCT01948908|101037510|FG002|STARTED|Overall Study||33||
48401769|NCT00899678|101313857|FG002|STARTED|Induction Period (Weeks 0 to 6)||35||
48401770|NCT00899678|101313855|FG000|COMPLETED|Induction Period (Weeks 0 to 6)||2||
48401771|NCT00899678|101313856|FG001|COMPLETED|Induction Period (Weeks 0 to 6)||37||
48401772|NCT00899678|101313857|FG002|COMPLETED|Induction Period (Weeks 0 to 6)||35||
48401773|NCT00899678|101313855|FG000|NOT COMPLETED|Induction Period (Weeks 0 to 6)||25||
48401774|NCT00899678|101313856|FG001|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0||
48290068|NCT01948908|101037508|FG000|COMPLETED|Overall Study||32||
48290069|NCT01948908|101037509|FG001|COMPLETED|Overall Study||33||
48290070|NCT01948908|101037510|FG002|COMPLETED|Overall Study||31||
48401775|NCT00899678|101313857|FG002|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0||
48401776|NCT00899678|101313855|FG000|STARTED|Maintenance Period (Weeks 8 to 62)||0||
48401777|NCT00899678|101313856|FG001|STARTED|Maintenance Period (Weeks 8 to 62)||37||
48401778|NCT00899678|101313857|FG002|STARTED|Maintenance Period (Weeks 8 to 62)||35||
48401779|NCT00899678|101313855|FG000|COMPLETED|Maintenance Period (Weeks 8 to 62)||0||
48401780|NCT00899678|101313856|FG001|COMPLETED|Maintenance Period (Weeks 8 to 62)||12||
48401781|NCT00899678|101313857|FG002|COMPLETED|Maintenance Period (Weeks 8 to 62)||7||
48401782|NCT00899678|101313855|FG000|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||0||
48401783|NCT00899678|101313856|FG001|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||25||
48401784|NCT00899678|101313857|FG002|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||28||
48401785|NCT03087708|101313858|FG000|STARTED|Overall Study||17||
48401786|NCT03087708|101313859|FG001|STARTED|Overall Study||16||
48401787|NCT03087708|101313860|FG002|STARTED|Overall Study||17||
48401788|NCT03087708|101313858|FG000|COMPLETED|Overall Study||15||
48401789|NCT03087708|101313859|FG001|COMPLETED|Overall Study||15||
48401790|NCT03087708|101313860|FG002|COMPLETED|Overall Study||13||
48401791|NCT03087708|101313858|FG000|NOT COMPLETED|Overall Study||2||
48401792|NCT03087708|101313859|FG001|NOT COMPLETED|Overall Study||1||
48401793|NCT03087708|101313860|FG002|NOT COMPLETED|Overall Study||4||
48401794|NCT02999191|101313861|FG000|STARTED|Treatment Period 1 [1 Day]||6||
48401795|NCT02999191|101313862|FG001|STARTED|Treatment Period 1 [1 Day]||6||
48401796|NCT02999191|101313863|FG002|STARTED|Treatment Period 1 [1 Day]||6||
48401797|NCT02999191|101313861|FG000|COMPLETED|Treatment Period 1 [1 Day]||6||
48401798|NCT02999191|101313862|FG001|COMPLETED|Treatment Period 1 [1 Day]||6||
48401799|NCT02999191|101313863|FG002|COMPLETED|Treatment Period 1 [1 Day]||6||
48401800|NCT02999191|101313861|FG000|NOT COMPLETED|Treatment Period 1 [1 Day]||0||
48401801|NCT02999191|101313862|FG001|NOT COMPLETED|Treatment Period 1 [1 Day]||0||
48401802|NCT02999191|101313863|FG002|NOT COMPLETED|Treatment Period 1 [1 Day]||0||
48401803|NCT02999191|101313861|FG000|STARTED|Wash-out Period 1 [21 Days]||6||
48401804|NCT02999191|101313862|FG001|STARTED|Wash-out Period 1 [21 Days]||6||
48401805|NCT02999191|101313863|FG002|STARTED|Wash-out Period 1 [21 Days]||6||
48401806|NCT02999191|101313861|FG000|COMPLETED|Wash-out Period 1 [21 Days]||6||
48585652|NCT02380261|101764585|FG000|COMPLETED|Overall Study||35||
48585653|NCT02380261|101764585|FG000|NOT COMPLETED|Overall Study||0||
48585654|NCT01346189|101764586|FG000|STARTED|Overall Study||433||
48585655|NCT01346189|101764587|FG001|STARTED|Overall Study||358||
48585656|NCT01346189|101764588|FG002|STARTED|Overall Study||346||
48585657|NCT01346189|101764589|FG003|STARTED|Overall Study||366||
48585658|NCT01346189|101764586|FG000|COMPLETED|Overall Study||417||
48290071|NCT01948908|101037508|FG000|NOT COMPLETED|Overall Study||1||
48290072|NCT01948908|101037509|FG001|NOT COMPLETED|Overall Study||0||
48290073|NCT01948908|101037510|FG002|NOT COMPLETED|Overall Study||2||
48401807|NCT02999191|101313862|FG001|COMPLETED|Wash-out Period 1 [21 Days]||5||
48401808|NCT02999191|101313863|FG002|COMPLETED|Wash-out Period 1 [21 Days]||6||
48401809|NCT02999191|101313861|FG000|NOT COMPLETED|Wash-out Period 1 [21 Days]||0||
48401810|NCT02999191|101313862|FG001|NOT COMPLETED|Wash-out Period 1 [21 Days]||1||
48585659|NCT01346189|101764587|FG001|COMPLETED|Overall Study||341||
48585660|NCT01346189|101764588|FG002|COMPLETED|Overall Study||332||
48401811|NCT02999191|101313863|FG002|NOT COMPLETED|Wash-out Period 1 [21 Days]||0||
48401812|NCT02999191|101313861|FG000|STARTED|Treatment Period 2 [1 Day]||6||
48401813|NCT02999191|101313862|FG001|STARTED|Treatment Period 2 [1 Day]||5||
48401814|NCT02999191|101313863|FG002|STARTED|Treatment Period 2 [1 Day]||6||
48401815|NCT02999191|101313861|FG000|COMPLETED|Treatment Period 2 [1 Day]||6||
48401816|NCT02999191|101313862|FG001|COMPLETED|Treatment Period 2 [1 Day]||5||
48401817|NCT02999191|101313863|FG002|COMPLETED|Treatment Period 2 [1 Day]||6||
48401818|NCT02999191|101313861|FG000|NOT COMPLETED|Treatment Period 2 [1 Day]||0||
48401819|NCT02999191|101313862|FG001|NOT COMPLETED|Treatment Period 2 [1 Day]||0||
48401820|NCT02999191|101313863|FG002|NOT COMPLETED|Treatment Period 2 [1 Day]||0||
48401821|NCT02999191|101313861|FG000|STARTED|Wash-out Period 2 [21 Days]||6||
48585661|NCT01346189|101764589|FG003|COMPLETED|Overall Study||355||
48585662|NCT01346189|101764586|FG000|NOT COMPLETED|Overall Study||16||
48585663|NCT01346189|101764587|FG001|NOT COMPLETED|Overall Study||17||
48585664|NCT01346189|101764588|FG002|NOT COMPLETED|Overall Study||14||
48585665|NCT01346189|101764589|FG003|NOT COMPLETED|Overall Study||11||
48585666|NCT00135798|101764590|FG000|STARTED|Overall Study||16||
48585667|NCT00135798|101764591|FG001|STARTED|Overall Study||31||
48585668|NCT00135798|101764592|FG002|STARTED|Overall Study||32||
48585669|NCT00135798|101764590|FG000|COMPLETED|Overall Study||16||
48585670|NCT00135798|101764591|FG001|COMPLETED|Overall Study||31||
48585671|NCT00135798|101764592|FG002|COMPLETED|Overall Study||32||
48585672|NCT00135798|101764590|FG000|NOT COMPLETED|Overall Study||0||
48585673|NCT00135798|101764591|FG001|NOT COMPLETED|Overall Study||0||
48585674|NCT00135798|101764592|FG002|NOT COMPLETED|Overall Study||0||
48585675|NCT01970475|101764593|FG000|STARTED|Overall Study||264||
48585676|NCT01970475|101764594|FG001|STARTED|Overall Study||262||
48585677|NCT01970475|101764593|FG000|COMPLETED|Overall Study||243||
48585678|NCT01970475|101764594|FG001|COMPLETED|Overall Study||251||
48585679|NCT01970475|101764593|FG000|NOT COMPLETED|Overall Study||21||
48585680|NCT01970475|101764594|FG001|NOT COMPLETED|Overall Study||11||
48585681|NCT00351741|101764595|FG000|STARTED|Overall Study||31||
48585682|NCT00351741|101764596|FG001|STARTED|Overall Study||31||
48585683|NCT00351741|101764595|FG000|COMPLETED|Overall Study||31||
48585684|NCT00351741|101764596|FG001|COMPLETED|Overall Study||31||
48585685|NCT00351741|101764595|FG000|NOT COMPLETED|Overall Study||0||
48585686|NCT00351741|101764596|FG001|NOT COMPLETED|Overall Study||0||
48585687|NCT00471718|101764597|FG000|STARTED|Overall Study||27||
48585688|NCT00471718|101764597|FG000|COMPLETED|Overall Study||0||
48585689|NCT00471718|101764597|FG000|NOT COMPLETED|Overall Study||27||
48585690|NCT00214149|101764598|FG000|STARTED|Overall Study||127||
48585691|NCT00214149|101764598|FG000|COMPLETED|Overall Study||0||
48585692|NCT00214149|101764598|FG000|NOT COMPLETED|Overall Study||127||
48585693|NCT02659514|101764599|FG000|STARTED|Overall Study||33||
48585694|NCT02659514|101764600|FG001|STARTED|Overall Study||34||
48585695|NCT02659514|101764599|FG000|Safety Population|Overall Study||33|Safety Population included all participants who received at least one dose of poziotinib.|
48585696|NCT02659514|101764600|FG001|Safety Population|Overall Study||34|Safety Population included all participants who received at least one dose of poziotinib.|
48585697|NCT02659514|101764599|FG000|Evaluable Population|Overall Study||30|Evaluable Population included all participants who had received at least one cycle of poziotinib and had at least one evaluable post-baseline tumor response evaluation using response Evaluation Criteria in Solid Tumors, version 1.1 (RECIST, v1.1).|
48585698|NCT02659514|101764600|FG001|Evaluable Population|Overall Study||27|Evaluable Population included all participants who had received at least one cycle of poziotinib and had at least one evaluable post-baseline tumor response evaluation using response Evaluation Criteria in Solid Tumors, version 1.1 (RECIST, v1.1).|
48585699|NCT02659514|101764599|FG000|COMPLETED|Overall Study||1||
48585700|NCT02659514|101764600|FG001|COMPLETED|Overall Study||0||
48585701|NCT02659514|101764599|FG000|NOT COMPLETED|Overall Study||32||
48585702|NCT02659514|101764600|FG001|NOT COMPLETED|Overall Study||34||
48585703|NCT01470651|101764601|FG000|STARTED|Overall Study||13||
48585704|NCT01470651|101764602|FG001|STARTED|Overall Study||13||
48585705|NCT01470651|101764601|FG000|COMPLETED|Overall Study||6||
48585706|NCT01470651|101764602|FG001|COMPLETED|Overall Study||10||
48585707|NCT01470651|101764601|FG000|NOT COMPLETED|Overall Study||7||
48585708|NCT01470651|101764602|FG001|NOT COMPLETED|Overall Study||3||
48585709|NCT00638443|101764603|FG000|STARTED|First Intervention||14||
48585710|NCT00638443|101764604|FG001|STARTED|First Intervention||15||
48585711|NCT00638443|101764603|FG000|COMPLETED|First Intervention||12||
48585712|NCT00638443|101764604|FG001|COMPLETED|First Intervention||14||
48585713|NCT00638443|101764603|FG000|NOT COMPLETED|First Intervention||2||
48585714|NCT00638443|101764604|FG001|NOT COMPLETED|First Intervention||1||
48585715|NCT00638443|101764603|FG000|STARTED|Washout||12||
48585716|NCT00638443|101764604|FG001|STARTED|Washout||14||
48585717|NCT00638443|101764603|FG000|COMPLETED|Washout||12||
48585718|NCT00638443|101764604|FG001|COMPLETED|Washout||14||
48585719|NCT00638443|101764603|FG000|NOT COMPLETED|Washout||0||
48401822|NCT02999191|101313862|FG001|STARTED|Wash-out Period 2 [21 Days]||5||
48585720|NCT00638443|101764604|FG001|NOT COMPLETED|Washout||0||
48585721|NCT00638443|101764603|FG000|STARTED|Second Intervention||12||
48585722|NCT00638443|101764604|FG001|STARTED|Second Intervention||14||
48585723|NCT00638443|101764603|FG000|COMPLETED|Second Intervention||12||
48585724|NCT00638443|101764604|FG001|COMPLETED|Second Intervention||14||
48585725|NCT00638443|101764603|FG000|NOT COMPLETED|Second Intervention||0||
48585726|NCT00638443|101764604|FG001|NOT COMPLETED|Second Intervention||0||
48585727|NCT03505593|101764605|FG000|STARTED|Overall Study||48||
48585728|NCT03505593|101764605|FG000|COMPLETED|Overall Study||43||
48585729|NCT03505593|101764605|FG000|NOT COMPLETED|Overall Study||5||
48585730|NCT00749684|101764606|FG000|STARTED|Overall Study||138||
48585731|NCT00749684|101764606|FG000|COMPLETED|Overall Study||56||
48585732|NCT00749684|101764606|FG000|NOT COMPLETED|Overall Study||82||
48585733|NCT02828124|101764607|FG000|STARTED|Overall Study||1||
48585734|NCT02828124|101764608|FG001|STARTED|Overall Study||2||
48585735|NCT02828124|101764609|FG002|STARTED|Overall Study||1||
48585736|NCT02828124|101764610|FG003|STARTED|Overall Study||6||
48585737|NCT02828124|101764607|FG000|COMPLETED|Overall Study||0||
48585738|NCT02828124|101764608|FG001|COMPLETED|Overall Study||0||
48585739|NCT02828124|101764609|FG002|COMPLETED|Overall Study||0||
48585740|NCT02828124|101764610|FG003|COMPLETED|Overall Study||0||
48585741|NCT02828124|101764607|FG000|NOT COMPLETED|Overall Study||1||
48585742|NCT02828124|101764608|FG001|NOT COMPLETED|Overall Study||2||
48585743|NCT02828124|101764609|FG002|NOT COMPLETED|Overall Study||1||
48585744|NCT02828124|101764610|FG003|NOT COMPLETED|Overall Study||6||
48585745|NCT01330394|101764611|FG000|STARTED|Overall Study||17||
48585746|NCT01330394|101764612|FG001|STARTED|Overall Study||16||
48585747|NCT01330394|101764611|FG000|COMPLETED|Overall Study||17||
48585748|NCT01330394|101764612|FG001|COMPLETED|Overall Study||16||
48585749|NCT01330394|101764611|FG000|NOT COMPLETED|Overall Study||0||
48585750|NCT01330394|101764612|FG001|NOT COMPLETED|Overall Study||0||
48585751|NCT04507256|101764613|FG000|STARTED|Overall Study||10||
48585752|NCT04507256|101764614|FG001|STARTED|Overall Study||10||
48585753|NCT04507256|101764615|FG002|STARTED|Overall Study||10||
48585754|NCT04507256|101764616|FG003|STARTED|Overall Study||10||
48585755|NCT04507256|101764617|FG004|STARTED|Overall Study||10||
48585756|NCT04507256|101764618|FG005|STARTED|Overall Study||10||
48585757|NCT04507256|101764613|FG000|COMPLETED|Overall Study||9||
48585758|NCT04507256|101764614|FG001|COMPLETED|Overall Study||10||
48290074|NCT00850603|101037511|FG000|STARTED|Overall Study||34||
48290075|NCT00850603|101037512|FG001|STARTED|Overall Study||34||
48290076|NCT00850603|101037513|FG002|STARTED|Overall Study||34||
48290077|NCT00850603|101037514|FG003|STARTED|Overall Study||34||
48290078|NCT00850603|101037515|FG004|STARTED|Overall Study||34||
48290079|NCT00850603|101037511|FG000|COMPLETED|Overall Study||34||
48290080|NCT00850603|101037512|FG001|COMPLETED|Overall Study||34||
48290081|NCT00850603|101037513|FG002|COMPLETED|Overall Study||34||
48290082|NCT00850603|101037514|FG003|COMPLETED|Overall Study||34||
48290083|NCT00850603|101037515|FG004|COMPLETED|Overall Study||34||
48290084|NCT00850603|101037511|FG000|NOT COMPLETED|Overall Study||0||
48290085|NCT00850603|101037512|FG001|NOT COMPLETED|Overall Study||0||
48290086|NCT00850603|101037513|FG002|NOT COMPLETED|Overall Study||0||
48290087|NCT00850603|101037514|FG003|NOT COMPLETED|Overall Study||0||
48290088|NCT00850603|101037515|FG004|NOT COMPLETED|Overall Study||0||
48290089|NCT02796625|101037516|FG000|STARTED|Overall Study||80||
48290090|NCT02796625|101037516|FG000|COMPLETED|Overall Study||61||
48290091|NCT02796625|101037516|FG000|NOT COMPLETED|Overall Study||19||
48290092|NCT01721460|101037517|FG000|STARTED|Overall Study||6||
48290093|NCT01721460|101037517|FG000|COMPLETED|Overall Study||5||
48290094|NCT01721460|101037517|FG000|NOT COMPLETED|Overall Study||1||
48290095|NCT01651442|101037518|FG000|STARTED|Phase I Treatment||104||
48290096|NCT01651442|101037519|FG001|STARTED|Phase I Treatment||107||
48290097|NCT01651442|101037520|FG002|STARTED|Phase I Treatment||0||
48290098|NCT01651442|101037521|FG003|STARTED|Phase I Treatment||0||
48290099|NCT01651442|101037522|FG004|STARTED|Phase I Treatment||0||
48585759|NCT04507256|101764615|FG002|COMPLETED|Overall Study||10||
48706162|NCT05438602|102069646|FG002|COMPLETED|Treatment (15 Days)||43||
48290100|NCT01651442|101037523|FG005|STARTED|Phase I Treatment||0||
48290101|NCT01651442|101037518|FG000|COMPLETED|Phase I Treatment||88||
48290102|NCT01651442|101037519|FG001|COMPLETED|Phase I Treatment||80||
48290103|NCT01651442|101037520|FG002|COMPLETED|Phase I Treatment||0||
48290104|NCT01651442|101037521|FG003|COMPLETED|Phase I Treatment||0||
48290105|NCT01651442|101037522|FG004|COMPLETED|Phase I Treatment||0||
48290106|NCT01651442|101037523|FG005|COMPLETED|Phase I Treatment||0||
48290107|NCT01651442|101037518|FG000|NOT COMPLETED|Phase I Treatment||16||
48290108|NCT01651442|101037519|FG001|NOT COMPLETED|Phase I Treatment||27||
48290109|NCT01651442|101037520|FG002|NOT COMPLETED|Phase I Treatment||0||
48585760|NCT04507256|101764616|FG003|COMPLETED|Overall Study||9||
48585761|NCT04507256|101764617|FG004|COMPLETED|Overall Study||10||
48585762|NCT04507256|101764618|FG005|COMPLETED|Overall Study||10||
48585763|NCT04507256|101764613|FG000|NOT COMPLETED|Overall Study||1||
48585764|NCT04507256|101764614|FG001|NOT COMPLETED|Overall Study||0||
48585765|NCT04507256|101764615|FG002|NOT COMPLETED|Overall Study||0||
48585766|NCT04507256|101764616|FG003|NOT COMPLETED|Overall Study||1||
48585767|NCT04507256|101764617|FG004|NOT COMPLETED|Overall Study||0||
48585768|NCT04507256|101764618|FG005|NOT COMPLETED|Overall Study||0||
48585769|NCT02163226|101764619|FG000|STARTED|Overall Study||79||
48585770|NCT02163226|101764620|FG001|STARTED|Overall Study||81||
48585771|NCT02163226|101764619|FG000|COMPLETED|Overall Study||63||
48585772|NCT02163226|101764620|FG001|COMPLETED|Overall Study||70||
48585773|NCT02163226|101764619|FG000|NOT COMPLETED|Overall Study||16||
48585774|NCT02163226|101764620|FG001|NOT COMPLETED|Overall Study||11||
48585775|NCT01056198|101764621|FG000|STARTED|Overall Study||24||
48585776|NCT01056198|101764622|FG001|STARTED|Overall Study||24||
48585777|NCT01056198|101764621|FG000|COMPLETED|Overall Study||24||
48585778|NCT01056198|101764622|FG001|COMPLETED|Overall Study||24||
48585779|NCT01056198|101764621|FG000|NOT COMPLETED|Overall Study||0||
48585780|NCT01056198|101764622|FG001|NOT COMPLETED|Overall Study||0||
48585781|NCT01194531|101764623|FG000|STARTED|Overall Study||29||
48585782|NCT01194531|101764624|FG001|STARTED|Overall Study||30||
48585783|NCT01194531|101764623|FG000|COMPLETED|Overall Study||24||
48585784|NCT01194531|101764624|FG001|COMPLETED|Overall Study||27||
48585785|NCT01194531|101764623|FG000|NOT COMPLETED|Overall Study||5||
48585786|NCT01194531|101764624|FG001|NOT COMPLETED|Overall Study||3||
48585787|NCT02360631|101764625|FG000|STARTED|Overall Study||300||
48585788|NCT02360631|101764626|FG001|STARTED|Overall Study||200||
48585789|NCT02360631|101764625|FG000|Week 12|Overall Study||249||
48585790|NCT02360631|101764626|FG001|Week 12|Overall Study||165||
48585791|NCT02360631|101764625|FG000|COMPLETED|Overall Study||267||
48585792|NCT02360631|101764626|FG001|COMPLETED|Overall Study||174||
48585793|NCT02360631|101764625|FG000|NOT COMPLETED|Overall Study||33||
48585794|NCT02360631|101764626|FG001|NOT COMPLETED|Overall Study||26||
48585795|NCT05167370|101764627|FG000|STARTED|Overall Study||2||
48585796|NCT05167370|101764627|FG000|COMPLETED|Overall Study||2||
48585797|NCT05167370|101764627|FG000|NOT COMPLETED|Overall Study||0||
48585798|NCT00721279|101764628|FG000|STARTED|Overall Study||452||
48585799|NCT00721279|101764629|FG001|STARTED|Overall Study||97||
48585800|NCT00721279|101764628|FG000|COMPLETED|Overall Study||416||
48585801|NCT00721279|101764629|FG001|COMPLETED|Overall Study||73||
48585802|NCT00721279|101764628|FG000|NOT COMPLETED|Overall Study||36||
48585803|NCT00721279|101764629|FG001|NOT COMPLETED|Overall Study||24||
48585804|NCT03826628|101764630|FG000|STARTED|Overall Study||36||
48585805|NCT03826628|101764631|FG001|STARTED|Overall Study||33||
48585806|NCT03826628|101764632|FG002|STARTED|Overall Study||38||
48585807|NCT03826628|101764630|FG000|COMPLETED|Overall Study||32||
48585808|NCT03826628|101764631|FG001|COMPLETED|Overall Study||31||
48585809|NCT03826628|101764632|FG002|COMPLETED|Overall Study||35||
48585810|NCT03826628|101764630|FG000|NOT COMPLETED|Overall Study||4||
48585811|NCT03826628|101764631|FG001|NOT COMPLETED|Overall Study||2||
48585812|NCT03826628|101764632|FG002|NOT COMPLETED|Overall Study||3||
48585813|NCT02776644|101764633|FG000|STARTED|Overall Study||1223||
48585814|NCT02776644|101764634|FG001|STARTED|Overall Study||126||
48585815|NCT02776644|101764633|FG000|COMPLETED|Overall Study||1223||
48585816|NCT02776644|101764634|FG001|COMPLETED|Overall Study||126||
48585817|NCT02776644|101764633|FG000|NOT COMPLETED|Overall Study||0||
48585818|NCT02776644|101764634|FG001|NOT COMPLETED|Overall Study||0||
48585819|NCT04197869|101764635|FG000|STARTED|Overall Study||34||
48585820|NCT04197869|101764636|FG001|STARTED|Overall Study||37||
48585821|NCT04197869|101764635|FG000|COMPLETED|Overall Study||24||
48585822|NCT04197869|101764636|FG001|COMPLETED|Overall Study||25||
48585823|NCT04197869|101764635|FG000|NOT COMPLETED|Overall Study||10||
48585824|NCT04197869|101764636|FG001|NOT COMPLETED|Overall Study||12||
48585825|NCT05239494|101764637|FG000|STARTED|Overall Study||60||
48585826|NCT05239494|101764637|FG000|COMPLETED|Overall Study||59||
48585827|NCT05239494|101764637|FG000|NOT COMPLETED|Overall Study||1||
48585828|NCT02751879|101764638|FG000|STARTED|Overall Study||157||
48585829|NCT02751879|101764639|FG001|STARTED|Overall Study||71||
48585830|NCT02751879|101764638|FG000|On Treatment at Study Completion|Overall Study||81||
48585831|NCT02751879|101764639|FG001|On Treatment at Study Completion|Overall Study||41||
48585832|NCT02751879|101764638|FG000|COMPLETED|Overall Study||157||
48585833|NCT02751879|101764639|FG001|COMPLETED|Overall Study||71||
48585834|NCT02751879|101764638|FG000|NOT COMPLETED|Overall Study||0||
48585835|NCT02751879|101764639|FG001|NOT COMPLETED|Overall Study||0||
48585836|NCT01698879|101764640|FG000|STARTED|Overall Study||6||
48585837|NCT01698879|101764641|FG001|STARTED|Overall Study||20||
48585838|NCT01698879|101764642|FG002|STARTED|Overall Study||20||
48585839|NCT01698879|101764640|FG000|COMPLETED|Overall Study||5||
48585840|NCT01698879|101764641|FG001|COMPLETED|Overall Study||20||
48585841|NCT01698879|101764642|FG002|COMPLETED|Overall Study||20||
48585842|NCT01698879|101764640|FG000|NOT COMPLETED|Overall Study||1||
48585843|NCT01698879|101764641|FG001|NOT COMPLETED|Overall Study||0||
48585844|NCT01698879|101764642|FG002|NOT COMPLETED|Overall Study||0||
48585845|NCT02877095|101764643|FG000|STARTED|Overall Study||20||
48585846|NCT02877095|101764644|FG001|STARTED|Overall Study||20||
48585847|NCT02877095|101764643|FG000|COMPLETED|Overall Study||20||
48585848|NCT02877095|101764644|FG001|COMPLETED|Overall Study||20||
48585849|NCT02877095|101764643|FG000|NOT COMPLETED|Overall Study||0||
48585850|NCT02877095|101764644|FG001|NOT COMPLETED|Overall Study||0||
48585851|NCT00287872|101764645|FG000|STARTED|Overall Study||30||
48585852|NCT00287872|101764645|FG000|COMPLETED|Overall Study||30||
48585853|NCT00287872|101764645|FG000|NOT COMPLETED|Overall Study||0||
48585854|NCT05148234|101764646|FG000|STARTED|Phase I||0||
48585855|NCT05148234|101764647|FG001|STARTED|Phase I||1||
48585856|NCT05148234|101764648|FG002|STARTED|Phase I||0||
48585857|NCT05148234|101764649|FG003|STARTED|Phase I||0||
48585858|NCT05148234|101764650|FG004|STARTED|Phase I||0||
48585859|NCT05148234|101764651|FG005|STARTED|Phase I||0||
48585860|NCT05148234|101764652|FG006|STARTED|Phase I||0||
48585861|NCT05148234|101764653|FG007|STARTED|Phase I||1||
48585862|NCT05148234|101764646|FG000|COMPLETED|Phase I||0||
48585863|NCT05148234|101764647|FG001|COMPLETED|Phase I||0||
48585864|NCT05148234|101764648|FG002|COMPLETED|Phase I||0||
48585865|NCT05148234|101764649|FG003|COMPLETED|Phase I||0||
48585866|NCT05148234|101764650|FG004|COMPLETED|Phase I||0||
48585867|NCT05148234|101764651|FG005|COMPLETED|Phase I||0||
48585868|NCT05148234|101764652|FG006|COMPLETED|Phase I||0||
48585869|NCT05148234|101764653|FG007|COMPLETED|Phase I||0||
48585870|NCT05148234|101764646|FG000|NOT COMPLETED|Phase I||0||
48585871|NCT05148234|101764647|FG001|NOT COMPLETED|Phase I||1||
48585872|NCT05148234|101764648|FG002|NOT COMPLETED|Phase I||0||
48585873|NCT05148234|101764649|FG003|NOT COMPLETED|Phase I||0||
48585874|NCT05148234|101764650|FG004|NOT COMPLETED|Phase I||0||
48585875|NCT05148234|101764651|FG005|NOT COMPLETED|Phase I||0||
48585876|NCT05148234|101764652|FG006|NOT COMPLETED|Phase I||0||
48585877|NCT05148234|101764653|FG007|NOT COMPLETED|Phase I||1||
48585878|NCT05148234|101764646|FG000|STARTED|Phase II||0||
48585879|NCT05148234|101764647|FG001|STARTED|Phase II||0||
48585880|NCT05148234|101764648|FG002|STARTED|Phase II||0||
48585881|NCT05148234|101764649|FG003|STARTED|Phase II||0||
48585882|NCT05148234|101764650|FG004|STARTED|Phase II||0||
48585883|NCT05148234|101764651|FG005|STARTED|Phase II||0||
48585884|NCT05148234|101764652|FG006|STARTED|Phase II||0||
48585885|NCT05148234|101764653|FG007|STARTED|Phase II||0||
48585886|NCT05148234|101764646|FG000|COMPLETED|Phase II||0||
48585887|NCT05148234|101764647|FG001|COMPLETED|Phase II||0||
48585888|NCT05148234|101764648|FG002|COMPLETED|Phase II||0||
48585889|NCT05148234|101764649|FG003|COMPLETED|Phase II||0||
48585890|NCT05148234|101764650|FG004|COMPLETED|Phase II||0||
48585891|NCT05148234|101764651|FG005|COMPLETED|Phase II||0||
48585892|NCT05148234|101764652|FG006|COMPLETED|Phase II||0||
48585893|NCT05148234|101764653|FG007|COMPLETED|Phase II||0||
48585894|NCT05148234|101764646|FG000|NOT COMPLETED|Phase II||0||
48585895|NCT05148234|101764647|FG001|NOT COMPLETED|Phase II||0||
48585896|NCT05148234|101764648|FG002|NOT COMPLETED|Phase II||0||
48585897|NCT05148234|101764649|FG003|NOT COMPLETED|Phase II||0||
48585898|NCT05148234|101764650|FG004|NOT COMPLETED|Phase II||0||
48585899|NCT05148234|101764651|FG005|NOT COMPLETED|Phase II||0||
48585900|NCT05148234|101764652|FG006|NOT COMPLETED|Phase II||0||
48585901|NCT05148234|101764653|FG007|NOT COMPLETED|Phase II||0||
48585902|NCT01901653|101764654|FG000|STARTED|Overall Study||3||
48585903|NCT01901653|101764655|FG001|STARTED|Overall Study||1||
48585904|NCT01901653|101764656|FG002|STARTED|Overall Study||11||
48585905|NCT01901653|101764657|FG003|STARTED|Overall Study||3||
48585906|NCT01901653|101764658|FG004|STARTED|Overall Study||2||
48290110|NCT01651442|101037521|FG003|NOT COMPLETED|Phase I Treatment||0||
48290111|NCT01651442|101037522|FG004|NOT COMPLETED|Phase I Treatment||0||
48290112|NCT01651442|101037523|FG005|NOT COMPLETED|Phase I Treatment||0||
48290113|NCT01651442|101037518|FG000|STARTED|Phase II Treatment||0||
48290114|NCT01651442|101037519|FG001|STARTED|Phase II Treatment||0||
48290115|NCT01651442|101037520|FG002|STARTED|Phase II Treatment||27||
48290116|NCT01651442|101037521|FG003|STARTED|Phase II Treatment||27||
48290117|NCT01651442|101037522|FG004|STARTED|Phase II Treatment||27||
48290118|NCT01651442|101037523|FG005|STARTED|Phase II Treatment||27||
48290119|NCT01651442|101037518|FG000|COMPLETED|Phase II Treatment||0||
48290120|NCT01651442|101037519|FG001|COMPLETED|Phase II Treatment||0||
48290121|NCT01651442|101037520|FG002|COMPLETED|Phase II Treatment||25||
48290122|NCT01651442|101037521|FG003|COMPLETED|Phase II Treatment||15||
48290123|NCT01651442|101037522|FG004|COMPLETED|Phase II Treatment||21||
48290124|NCT01651442|101037523|FG005|COMPLETED|Phase II Treatment||17||
48585907|NCT01901653|101764659|FG005|STARTED|Overall Study||3||
48585908|NCT01901653|101764660|FG006|STARTED|Overall Study||7||
48585909|NCT01901653|101764661|FG007|STARTED|Overall Study||10||
48585910|NCT01901653|101764662|FG008|STARTED|Overall Study||1||
48585911|NCT01901653|101764663|FG009|STARTED|Overall Study||18||
48585912|NCT01901653|101764664|FG010|STARTED|Overall Study||2||
48585913|NCT01901653|101764665|FG011|STARTED|Overall Study||16||
48290125|NCT01651442|101037518|FG000|NOT COMPLETED|Phase II Treatment||0||
48585914|NCT01901653|101764666|FG012|STARTED|Overall Study||5||
48585915|NCT01901653|101764654|FG000|COMPLETED|Overall Study||0||
48585916|NCT01901653|101764655|FG001|COMPLETED|Overall Study||0||
48290126|NCT01651442|101037519|FG001|NOT COMPLETED|Phase II Treatment||0||
48585917|NCT01901653|101764656|FG002|COMPLETED|Overall Study||0||
48585918|NCT01901653|101764657|FG003|COMPLETED|Overall Study||0||
48585919|NCT01901653|101764658|FG004|COMPLETED|Overall Study||0||
48585920|NCT01901653|101764659|FG005|COMPLETED|Overall Study||0||
48585921|NCT01901653|101764660|FG006|COMPLETED|Overall Study||0||
48585922|NCT01901653|101764661|FG007|COMPLETED|Overall Study||0||
48585923|NCT01901653|101764662|FG008|COMPLETED|Overall Study||0||
48585924|NCT01901653|101764663|FG009|COMPLETED|Overall Study||0||
48290127|NCT01651442|101037520|FG002|NOT COMPLETED|Phase II Treatment||2||
48290128|NCT01651442|101037521|FG003|NOT COMPLETED|Phase II Treatment||12||
48290129|NCT01651442|101037522|FG004|NOT COMPLETED|Phase II Treatment||6||
48290130|NCT01651442|101037523|FG005|NOT COMPLETED|Phase II Treatment||10||
48290131|NCT02197767|101037524|FG000|STARTED|Overall Study||11||
48290132|NCT02197767|101037524|FG000|COMPLETED|Overall Study||11||
48290133|NCT02197767|101037524|FG000|NOT COMPLETED|Overall Study||0||
48290134|NCT02571049|101037525|FG000|STARTED|Screening||10||
48290135|NCT02571049|101037526|FG001|STARTED|Screening||14||
48585925|NCT01901653|101764664|FG010|COMPLETED|Overall Study||0||
48585926|NCT01901653|101764665|FG011|COMPLETED|Overall Study||0||
48585927|NCT01901653|101764666|FG012|COMPLETED|Overall Study||0||
48585928|NCT01901653|101764654|FG000|NOT COMPLETED|Overall Study||3||
48585929|NCT01901653|101764655|FG001|NOT COMPLETED|Overall Study||1||
48585930|NCT01901653|101764656|FG002|NOT COMPLETED|Overall Study||11||
48585931|NCT01901653|101764657|FG003|NOT COMPLETED|Overall Study||3||
48585932|NCT01901653|101764658|FG004|NOT COMPLETED|Overall Study||2||
48585933|NCT01901653|101764659|FG005|NOT COMPLETED|Overall Study||3||
48290136|NCT02571049|101037525|FG000|COMPLETED|Screening||8||
48290137|NCT02571049|101037526|FG001|COMPLETED|Screening||12||
48290138|NCT02571049|101037525|FG000|NOT COMPLETED|Screening||2||
48290139|NCT02571049|101037526|FG001|NOT COMPLETED|Screening||2||
48290140|NCT02571049|101037525|FG000|STARTED|Randomization||8||
48290141|NCT02571049|101037526|FG001|STARTED|Randomization||12||
48290142|NCT02571049|101037525|FG000|COMPLETED|Randomization||8||
48290143|NCT02571049|101037526|FG001|COMPLETED|Randomization||10||
48585934|NCT01901653|101764660|FG006|NOT COMPLETED|Overall Study||7||
48585935|NCT01901653|101764661|FG007|NOT COMPLETED|Overall Study||10||
48585936|NCT01901653|101764662|FG008|NOT COMPLETED|Overall Study||1||
48585937|NCT01901653|101764663|FG009|NOT COMPLETED|Overall Study||18||
48585938|NCT01901653|101764664|FG010|NOT COMPLETED|Overall Study||2||
48585939|NCT01901653|101764665|FG011|NOT COMPLETED|Overall Study||16||
48706163|NCT05438602|102069644|FG000|NOT COMPLETED|Treatment (15 Days)||4||
48706164|NCT05438602|102069645|FG001|NOT COMPLETED|Treatment (15 Days)||3||
48706165|NCT05438602|102069646|FG002|NOT COMPLETED|Treatment (15 Days)||8||
48706166|NCT05438602|102069644|FG000|STARTED|Follow-up (Through Day 44)||54||
48706167|NCT05438602|102069645|FG001|STARTED|Follow-up (Through Day 44)||52||
48706168|NCT05438602|102069646|FG002|STARTED|Follow-up (Through Day 44)||51||
48706169|NCT05438602|102069644|FG000|COMPLETED|Follow-up (Through Day 44)||50||
48706170|NCT05438602|102069645|FG001|COMPLETED|Follow-up (Through Day 44)||50||
48706171|NCT05438602|102069646|FG002|COMPLETED|Follow-up (Through Day 44)||45||
48706172|NCT05438602|102069644|FG000|NOT COMPLETED|Follow-up (Through Day 44)||4||
48706173|NCT05438602|102069645|FG001|NOT COMPLETED|Follow-up (Through Day 44)||2||
48706174|NCT05438602|102069646|FG002|NOT COMPLETED|Follow-up (Through Day 44)||6||
48706175|NCT05438602|102069644|FG000|STARTED|Long-term Follow-up (Through Week 24)||54||
48706176|NCT05438602|102069645|FG001|STARTED|Long-term Follow-up (Through Week 24)||52||
48706177|NCT05438602|102069646|FG002|STARTED|Long-term Follow-up (Through Week 24)||51||
48290144|NCT02571049|101037525|FG000|NOT COMPLETED|Randomization||0||
48290145|NCT02571049|101037526|FG001|NOT COMPLETED|Randomization||2||
48290146|NCT01304238|101037527|FG000|STARTED|Overall Study||32||
48290147|NCT01304238|101037528|FG001|STARTED|Overall Study||4||
48290148|NCT01304238|101037529|FG002|STARTED|Overall Study||46||
48290149|NCT01304238|101037530|FG003|STARTED|Overall Study||78||
48585940|NCT01901653|101764666|FG012|NOT COMPLETED|Overall Study||5||
48585941|NCT02680834|101764667|FG000|STARTED|Overall Study||26||
48585942|NCT02680834|101764668|FG001|STARTED|Overall Study||30||
48585943|NCT02680834|101764667|FG000|COMPLETED|Overall Study||15||
48585944|NCT02680834|101764668|FG001|COMPLETED|Overall Study||27||
48585945|NCT02680834|101764667|FG000|NOT COMPLETED|Overall Study||11||
48585946|NCT02680834|101764668|FG001|NOT COMPLETED|Overall Study||3||
48585947|NCT02951533|101764669|FG000|STARTED|Part I (Week 0 Through Week 24)||60||
48585948|NCT02951533|101764670|FG001|STARTED|Part I (Week 0 Through Week 24)||59||
48585949|NCT02951533|101764671|FG002|STARTED|Part I (Week 0 Through Week 24)||0||
48585950|NCT02951533|101764669|FG000|Treated|Part I (Week 0 Through Week 24)||60||
48585951|NCT02951533|101764670|FG001|Treated|Part I (Week 0 Through Week 24)||58||
48706178|NCT05438602|102069644|FG000|COMPLETED|Long-term Follow-up (Through Week 24)||47||
48706179|NCT05438602|102069645|FG001|COMPLETED|Long-term Follow-up (Through Week 24)||47||
48706180|NCT05438602|102069646|FG002|COMPLETED|Long-term Follow-up (Through Week 24)||44||
48706181|NCT05438602|102069644|FG000|NOT COMPLETED|Long-term Follow-up (Through Week 24)||7||
48706182|NCT05438602|102069645|FG001|NOT COMPLETED|Long-term Follow-up (Through Week 24)||5||
48706183|NCT05438602|102069646|FG002|NOT COMPLETED|Long-term Follow-up (Through Week 24)||7||
48706184|NCT00909545|102069647|FG000|STARTED|Overall Study||26||
48706185|NCT00909545|102069648|FG001|STARTED|Overall Study||23||
48290150|NCT01304238|101037531|FG004|STARTED|Overall Study||11||
48585952|NCT02951533|101764671|FG002|Treated|Part I (Week 0 Through Week 24)||0||
48585953|NCT02951533|101764669|FG000|COMPLETED|Part I (Week 0 Through Week 24)||56||
48290151|NCT01304238|101037532|FG005|STARTED|Overall Study||11||
48290152|NCT01304238|101037533|FG006|STARTED|Overall Study||5||
48290153|NCT01304238|101037534|FG007|STARTED|Overall Study||4||
48290154|NCT01304238|101037535|FG008|STARTED|Overall Study||1||
48290155|NCT01304238|101037536|FG009|STARTED|Overall Study||3||
48585954|NCT02951533|101764670|FG001|COMPLETED|Part I (Week 0 Through Week 24)||36||
48585955|NCT02951533|101764671|FG002|COMPLETED|Part I (Week 0 Through Week 24)||0||
48585956|NCT02951533|101764669|FG000|NOT COMPLETED|Part I (Week 0 Through Week 24)||4||
48585957|NCT02951533|101764670|FG001|NOT COMPLETED|Part I (Week 0 Through Week 24)||23||
48585958|NCT02951533|101764671|FG002|NOT COMPLETED|Part I (Week 0 Through Week 24)||0||
48585959|NCT02951533|101764669|FG000|STARTED|Part IIa (Week 24 Through Week 32)||56||
48585960|NCT02951533|101764670|FG001|STARTED|Part IIa (Week 24 Through Week 32)||35||
48585961|NCT02951533|101764671|FG002|STARTED|Part IIa (Week 24 Through Week 32)||0||
48585962|NCT02951533|101764669|FG000|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||54||
48585963|NCT02951533|101764670|FG001|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||14||
48585964|NCT02951533|101764671|FG002|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||0||
48585965|NCT02951533|101764669|FG000|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||1||
48585966|NCT02951533|101764670|FG001|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||20||
48585967|NCT02951533|101764671|FG002|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||0||
48585968|NCT02951533|101764669|FG000|COMPLETED|Part IIa (Week 24 Through Week 32)||55||
48585969|NCT02951533|101764670|FG001|COMPLETED|Part IIa (Week 24 Through Week 32)||34||
48585970|NCT02951533|101764671|FG002|COMPLETED|Part IIa (Week 24 Through Week 32)||0||
48585971|NCT02951533|101764669|FG000|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||1||
48706186|NCT00909545|102069649|FG002|STARTED|Overall Study||26||
48706187|NCT00909545|102069650|FG003|STARTED|Overall Study||24||
48706188|NCT00909545|102069647|FG000|COMPLETED|Overall Study||25||
48706189|NCT00909545|102069648|FG001|COMPLETED|Overall Study||22||
48706190|NCT00909545|102069649|FG002|COMPLETED|Overall Study||25||
48706191|NCT00909545|102069650|FG003|COMPLETED|Overall Study||19||
48706192|NCT00909545|102069647|FG000|NOT COMPLETED|Overall Study||1||
48706193|NCT00909545|102069648|FG001|NOT COMPLETED|Overall Study||1||
48706194|NCT00909545|102069649|FG002|NOT COMPLETED|Overall Study||1||
48706195|NCT00909545|102069650|FG003|NOT COMPLETED|Overall Study||5||
48706196|NCT02599649|102069651|FG000|STARTED|Overall Study||2||
48706197|NCT02599649|102069652|FG001|STARTED|Overall Study||0||
48706198|NCT02599649|102069653|FG002|STARTED|Overall Study||8||
48706199|NCT02599649|102069654|FG003|STARTED|Overall Study||0||
48706200|NCT02599649|102069651|FG000|COMPLETED|Overall Study||2||
48585972|NCT02951533|101764670|FG001|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||1||
48585973|NCT02951533|101764671|FG002|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||0||
48585974|NCT02951533|101764669|FG000|STARTED|Part IIb (Week 32 Through Week 56)||55||
48585975|NCT02951533|101764670|FG001|STARTED|Part IIb (Week 32 Through Week 56)||14||
48585976|NCT02951533|101764671|FG002|STARTED|Part IIb (Week 32 Through Week 56)||20||
48585977|NCT02951533|101764669|FG000|COMPLETED|Part IIb (Week 32 Through Week 56)||54||
48585978|NCT02951533|101764670|FG001|COMPLETED|Part IIb (Week 32 Through Week 56)||10||
48585979|NCT02951533|101764671|FG002|COMPLETED|Part IIb (Week 32 Through Week 56)||20||
48585980|NCT02951533|101764669|FG000|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||1||
48585981|NCT02951533|101764670|FG001|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||4||
48585982|NCT02951533|101764671|FG002|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||0||
48585983|NCT02951533|101764669|FG000|STARTED|Part III (Week 64 Through Week 100)||36||
48585984|NCT02951533|101764670|FG001|STARTED|Part III (Week 64 Through Week 100)||0||
48585985|NCT02951533|101764671|FG002|STARTED|Part III (Week 64 Through Week 100)||12||
48585986|NCT02951533|101764669|FG000|COMPLETED|Part III (Week 64 Through Week 100)||32||
48585987|NCT02951533|101764670|FG001|COMPLETED|Part III (Week 64 Through Week 100)||0||
48585988|NCT02951533|101764671|FG002|COMPLETED|Part III (Week 64 Through Week 100)||10||
48706201|NCT02599649|102069652|FG001|COMPLETED|Overall Study||0||
48706202|NCT02599649|102069653|FG002|COMPLETED|Overall Study||8||
48706203|NCT02599649|102069654|FG003|COMPLETED|Overall Study||0||
48706204|NCT02599649|102069651|FG000|NOT COMPLETED|Overall Study||0||
48706205|NCT02599649|102069652|FG001|NOT COMPLETED|Overall Study||0||
48706206|NCT02599649|102069653|FG002|NOT COMPLETED|Overall Study||0||
48706207|NCT02599649|102069654|FG003|NOT COMPLETED|Overall Study||0||
48706208|NCT05275010|102069655|FG000|STARTED|Overall Study||76||
48706209|NCT05275010|102069656|FG001|STARTED|Overall Study||75||
48706210|NCT05275010|102069655|FG000|Received the Single Dose of Study Treatment|Overall Study||72|Safety Population|
48706211|NCT05275010|102069656|FG001|Received the Single Dose of Study Treatment|Overall Study||74|Safety Population|
48585989|NCT02951533|101764669|FG000|NOT COMPLETED|Part III (Week 64 Through Week 100)||4||
48585990|NCT02951533|101764670|FG001|NOT COMPLETED|Part III (Week 64 Through Week 100)||0||
48706212|NCT05275010|102069655|FG000|Entered Follow-Up|Overall Study||71||
48585991|NCT02951533|101764671|FG002|NOT COMPLETED|Part III (Week 64 Through Week 100)||2||
48585992|NCT04712019|101764672|FG000|STARTED|Overall Study||10||10
48585993|NCT04712019|101764673|FG001|STARTED|Overall Study||10||10
48585994|NCT04712019|101764672|FG000|COMPLETED|Overall Study||7||7
48585995|NCT04712019|101764673|FG001|COMPLETED|Overall Study||7||7
48706213|NCT05275010|102069656|FG001|Entered Follow-Up|Overall Study||74||
48706214|NCT05275010|102069655|FG000|COMPLETED|Overall Study||71||
48706215|NCT05275010|102069656|FG001|COMPLETED|Overall Study||73||
48706216|NCT05275010|102069655|FG000|NOT COMPLETED|Overall Study||5||
48706217|NCT05275010|102069656|FG001|NOT COMPLETED|Overall Study||2||
48706218|NCT01886690|102069657|FG000|STARTED|Overall Study||75||
48585996|NCT04712019|101764672|FG000|NOT COMPLETED|Overall Study||3||3
48585997|NCT04712019|101764673|FG001|NOT COMPLETED|Overall Study||3||3
48585998|NCT02784613|101764674|FG000|STARTED|Overall Study||10||
48585999|NCT02784613|101764674|FG000|COMPLETED|Overall Study||8||
48586000|NCT02784613|101764674|FG000|NOT COMPLETED|Overall Study||2||
48586001|NCT01154296|101764675|FG000|STARTED|Randomization and Intervention||2505||
48586002|NCT01154296|101764676|FG001|STARTED|Randomization and Intervention||2507||
48586003|NCT01154296|101764675|FG000|COMPLETED|Randomization and Intervention||2500||
48586004|NCT01154296|101764676|FG001|COMPLETED|Randomization and Intervention||2505||
48586005|NCT01154296|101764675|FG000|NOT COMPLETED|Randomization and Intervention||5||
48586006|NCT01154296|101764676|FG001|NOT COMPLETED|Randomization and Intervention||2||
48586007|NCT01154296|101764675|FG000|STARTED|6-month Follow-up||2505||
48586008|NCT01154296|101764676|FG001|STARTED|6-month Follow-up||2507||
48586009|NCT01154296|101764675|FG000|COMPLETED|6-month Follow-up||2177||
48586010|NCT01154296|101764676|FG001|COMPLETED|6-month Follow-up||2179||
48586011|NCT01154296|101764675|FG000|NOT COMPLETED|6-month Follow-up||328||
48586012|NCT01154296|101764676|FG001|NOT COMPLETED|6-month Follow-up||328||
48586013|NCT00654992|101764677|FG000|STARTED|Overall Study||36||
48586014|NCT00654992|101764678|FG001|STARTED|Overall Study||35||
48401823|NCT02999191|101313863|FG002|STARTED|Wash-out Period 2 [21 Days]||6||
48401824|NCT02999191|101313861|FG000|COMPLETED|Wash-out Period 2 [21 Days]||6||
48401825|NCT02999191|101313862|FG001|COMPLETED|Wash-out Period 2 [21 Days]||5||
48290156|NCT01304238|101037527|FG000|COMPLETED|Overall Study||32||
48290157|NCT01304238|101037528|FG001|COMPLETED|Overall Study||4||
48290158|NCT01304238|101037529|FG002|COMPLETED|Overall Study||46||
48401826|NCT02999191|101313863|FG002|COMPLETED|Wash-out Period 2 [21 Days]||6||
48586015|NCT00654992|101764677|FG000|COMPLETED|Overall Study||36||
48586016|NCT00654992|101764678|FG001|COMPLETED|Overall Study||35||
48586017|NCT00654992|101764677|FG000|NOT COMPLETED|Overall Study||0||
48586018|NCT00654992|101764678|FG001|NOT COMPLETED|Overall Study||0||
48586019|NCT03430895|101764679|FG000|STARTED|Overall Study||15||
48586020|NCT03430895|101764679|FG000|COMPLETED|Overall Study||13||
48586021|NCT03430895|101764679|FG000|NOT COMPLETED|Overall Study||2||
48586022|NCT00981045|101764680|FG000|STARTED|Overall Study||1290||
48586023|NCT00981045|101764681|FG001|STARTED|Overall Study||1294||
48586024|NCT00981045|101764680|FG000|COMPLETED|Overall Study||1276||
48586025|NCT00981045|101764681|FG001|COMPLETED|Overall Study||1285||
48586026|NCT00981045|101764680|FG000|NOT COMPLETED|Overall Study||14||
48586027|NCT00981045|101764681|FG001|NOT COMPLETED|Overall Study||9||
48586028|NCT00824382|101764682|FG000|STARTED|Overall Study||79||
48586029|NCT00824382|101764683|FG001|STARTED|Overall Study||84||
48586030|NCT00824382|101764684|FG002|STARTED|Overall Study||79||
48290159|NCT01304238|101037530|FG003|COMPLETED|Overall Study||78||
48586031|NCT00824382|101764685|FG003|STARTED|Overall Study||86||
48586032|NCT00824382|101764682|FG000|COMPLETED|Overall Study||74||
48586033|NCT00824382|101764683|FG001|COMPLETED|Overall Study||82||
48586034|NCT00824382|101764684|FG002|COMPLETED|Overall Study||76||
48586035|NCT00824382|101764685|FG003|COMPLETED|Overall Study||81||
48586036|NCT00824382|101764682|FG000|NOT COMPLETED|Overall Study||5||
48586037|NCT00824382|101764683|FG001|NOT COMPLETED|Overall Study||2||
48586038|NCT00824382|101764684|FG002|NOT COMPLETED|Overall Study||3||
48586039|NCT00824382|101764685|FG003|NOT COMPLETED|Overall Study||5||
48586040|NCT04537910|101764686|FG000|STARTED|Overall Study||6||
48586041|NCT04537910|101764687|FG001|STARTED|Overall Study||5||
48586042|NCT04537910|101764688|FG002|STARTED|Overall Study||7||
48586043|NCT04537910|101764689|FG003|STARTED|Overall Study||7||
48586044|NCT04537910|101764686|FG000|Received at Least One Dose of Study Drug|Overall Study||6||
48586045|NCT04537910|101764687|FG001|Received at Least One Dose of Study Drug|Overall Study||5||
48586046|NCT04537910|101764688|FG002|Received at Least One Dose of Study Drug|Overall Study||7||
48586047|NCT04537910|101764689|FG003|Received at Least One Dose of Study Drug|Overall Study||7||
48586048|NCT04537910|101764686|FG000|COMPLETED|Overall Study||6||
48586049|NCT04537910|101764687|FG001|COMPLETED|Overall Study||5||
48586050|NCT04537910|101764688|FG002|COMPLETED|Overall Study||7||
48586051|NCT04537910|101764689|FG003|COMPLETED|Overall Study||7||
48586052|NCT04537910|101764686|FG000|NOT COMPLETED|Overall Study||0||
48586053|NCT04537910|101764687|FG001|NOT COMPLETED|Overall Study||0||
48586054|NCT04537910|101764688|FG002|NOT COMPLETED|Overall Study||0||
48586055|NCT04537910|101764689|FG003|NOT COMPLETED|Overall Study||0||
48586056|NCT01905553|101764690|FG000|STARTED|Period 1||5||
48586057|NCT01905553|101764691|FG001|STARTED|Period 1||4||
48586058|NCT01905553|101764690|FG000|COMPLETED|Period 1||5||
48586059|NCT01905553|101764691|FG001|COMPLETED|Period 1||4||
48586060|NCT01905553|101764690|FG000|NOT COMPLETED|Period 1||0||
48586061|NCT01905553|101764691|FG001|NOT COMPLETED|Period 1||0||
48586062|NCT01905553|101764690|FG000|STARTED|Period 2||5||
48586063|NCT01905553|101764691|FG001|STARTED|Period 2||4||
48586064|NCT01905553|101764690|FG000|COMPLETED|Period 2||4||
48586065|NCT01905553|101764691|FG001|COMPLETED|Period 2||4||
48586066|NCT01905553|101764690|FG000|NOT COMPLETED|Period 2||1||
48586067|NCT01905553|101764691|FG001|NOT COMPLETED|Period 2||0||
48586068|NCT00614120|101764692|FG000|STARTED|Overall Study||231||
48586069|NCT00614120|101764693|FG001|STARTED|Overall Study||233||
48586070|NCT00614120|101764694|FG002|STARTED|Overall Study||234||
48586071|NCT00614120|101764695|FG003|STARTED|Overall Study||231||
48586072|NCT00614120|101764692|FG000|Exposed to Study Drug|Overall Study||231||
48586073|NCT00614120|101764693|FG001|Exposed to Study Drug|Overall Study||233||
48586074|NCT00614120|101764694|FG002|Exposed to Study Drug|Overall Study||233||
48586075|NCT00614120|101764695|FG003|Exposed to Study Drug|Overall Study||231||
48586076|NCT00614120|101764692|FG000|COMPLETED|Overall Study||202||
48586077|NCT00614120|101764693|FG001|COMPLETED|Overall Study||187||
48586078|NCT00614120|101764694|FG002|COMPLETED|Overall Study||175||
48586079|NCT00614120|101764695|FG003|COMPLETED|Overall Study||215||
48586080|NCT00614120|101764692|FG000|NOT COMPLETED|Overall Study||29||
48586081|NCT00614120|101764693|FG001|NOT COMPLETED|Overall Study||46||
48586082|NCT00614120|101764694|FG002|NOT COMPLETED|Overall Study||59||
48586083|NCT00614120|101764695|FG003|NOT COMPLETED|Overall Study||16||
48586084|NCT01296542|101764696|FG000|STARTED|Overall Study||30||
48586085|NCT01296542|101764697|FG001|STARTED|Overall Study||30||
48586086|NCT01296542|101764696|FG000|COMPLETED|Overall Study||30||
48586087|NCT01296542|101764697|FG001|COMPLETED|Overall Study||28||
48586088|NCT01296542|101764696|FG000|NOT COMPLETED|Overall Study||0||
48586089|NCT01296542|101764697|FG001|NOT COMPLETED|Overall Study||2||
48586090|NCT05537441|101764698|FG000|STARTED|Overall Study||224959||
48586091|NCT05537441|101764699|FG001|STARTED|Overall Study||3872||
48586092|NCT05537441|101764698|FG000|COMPLETED|Overall Study||224959||
48586093|NCT05537441|101764699|FG001|COMPLETED|Overall Study||3872||
48586094|NCT05537441|101764698|FG000|NOT COMPLETED|Overall Study||0||
48586095|NCT05537441|101764699|FG001|NOT COMPLETED|Overall Study||0||
48586096|NCT00754208|101764700|FG000|STARTED|Overall Study||7||
48586097|NCT00754208|101764700|FG000|COMPLETED|Overall Study||7||
48586098|NCT00754208|101764700|FG000|NOT COMPLETED|Overall Study||0||
48586099|NCT03385304|101764701|FG000|STARTED|Overall Study||828|Total Study Duration|7
48586100|NCT03385304|101764702|FG001|STARTED|Overall Study||810|Total Study Duration|7
48586101|NCT03385304|101764701|FG000|Months 1-2|Overall Study||114||7
48586102|NCT03385304|101764702|FG001|Months 1-2|Overall Study||108||7
48586103|NCT03385304|101764701|FG000|Months 3-4|Overall Study||102||7
48586104|NCT03385304|101764702|FG001|Months 3-4|Overall Study||104||7
48586105|NCT03385304|101764701|FG000|Months 5-6|Overall Study||98||7
48586106|NCT03385304|101764702|FG001|Months 5-6|Overall Study||53||5
48586107|NCT03385304|101764701|FG000|Months 7-8|Overall Study||50||5
48586108|NCT03385304|101764702|FG001|Months 7-8|Overall Study||68||7
48586109|NCT03385304|101764701|FG000|Months 9-10|Overall Study||91||6
48586110|NCT03385304|101764702|FG001|Months 9-10|Overall Study||63||5
48586111|NCT03385304|101764701|FG000|Months 11-12|Overall Study||72||5
48586112|NCT03385304|101764702|FG001|Months 11-12|Overall Study||75||5
48586113|NCT03385304|101764701|FG000|Months 13-14|Overall Study||62||5
48586114|NCT03385304|101764702|FG001|Months 13-14|Overall Study||50||4
48586115|NCT03385304|101764701|FG000|Months 15-16|Overall Study||38||4
48586116|NCT03385304|101764702|FG001|Months 15-16|Overall Study||55||5
48586117|NCT03385304|101764701|FG000|Months 17-18|Overall Study||38||5
48586118|NCT03385304|101764702|FG001|Months 17-18|Overall Study||44||5
48586119|NCT03385304|101764701|FG000|Months 19-20|Overall Study||32||5
48586120|NCT03385304|101764702|FG001|Months 19-20|Overall Study||46||3
48586121|NCT03385304|101764701|FG000|Months 21-22|Overall Study||50||4
48586122|NCT03385304|101764702|FG001|Months 21-22|Overall Study||40||5
48586123|NCT03385304|101764701|FG000|Months 23-24|Overall Study||30||4
48586124|NCT03385304|101764702|FG001|Months 23-24|Overall Study||64||5
48586125|NCT03385304|101764701|FG000|Months 25-26|Overall Study||22||1
48586126|NCT03385304|101764702|FG001|Months 25-26|Overall Study||14||1
48586127|NCT03385304|101764701|FG000|Months 27-28|Overall Study||21||1
48586128|NCT03385304|101764702|FG001|Months 27-28|Overall Study||18||1
48586129|NCT03385304|101764701|FG000|Months 29-30|Overall Study||0||0
48586130|NCT03385304|101764702|FG001|Months 29-30|Overall Study||8||1
48586131|NCT03385304|101764701|FG000|Months 31-32|Overall Study||8||1
48586132|NCT03385304|101764702|FG001|Months 31-32|Overall Study||0||0
48586133|NCT03385304|101764701|FG000|COMPLETED|Overall Study||787|Total Study Duration|7
48586134|NCT03385304|101764702|FG001|COMPLETED|Overall Study||784|Total Study Duration|7
48586135|NCT03385304|101764701|FG000|NOT COMPLETED|Overall Study||41||0
48586136|NCT03385304|101764702|FG001|NOT COMPLETED|Overall Study||26||0
48586137|NCT01597388|101764703|FG000|STARTED|Overall Study||6||
48586138|NCT01597388|101764704|FG001|STARTED|Overall Study||13||
48586139|NCT01597388|101764705|FG002|STARTED|Overall Study||14||
48586140|NCT01597388|101764706|FG003|STARTED|Overall Study||10||
48586141|NCT01597388|101764707|FG004|STARTED|Overall Study||37||
48586142|NCT01597388|101764708|FG005|STARTED|Overall Study||4||
48586143|NCT01597388|101764709|FG006|STARTED|Overall Study||8||
48586144|NCT01597388|101764710|FG007|STARTED|Overall Study||5||
48586145|NCT01597388|101764711|FG008|STARTED|Overall Study||2||
48586146|NCT01597388|101764703|FG000|COMPLETED|Overall Study||6||
48586147|NCT01597388|101764704|FG001|COMPLETED|Overall Study||13||
48586148|NCT01597388|101764705|FG002|COMPLETED|Overall Study||14||
48586149|NCT01597388|101764706|FG003|COMPLETED|Overall Study||10||
48586150|NCT01597388|101764707|FG004|COMPLETED|Overall Study||37||
48586151|NCT01597388|101764708|FG005|COMPLETED|Overall Study||4||
48586152|NCT01597388|101764709|FG006|COMPLETED|Overall Study||8||
48586153|NCT01597388|101764710|FG007|COMPLETED|Overall Study||5||
48586154|NCT01597388|101764711|FG008|COMPLETED|Overall Study||2||
48586155|NCT01597388|101764703|FG000|NOT COMPLETED|Overall Study||0||
48586156|NCT01597388|101764704|FG001|NOT COMPLETED|Overall Study||0||
48586157|NCT01597388|101764705|FG002|NOT COMPLETED|Overall Study||0||
48586158|NCT01597388|101764706|FG003|NOT COMPLETED|Overall Study||0||
48586159|NCT01597388|101764707|FG004|NOT COMPLETED|Overall Study||0||
48586160|NCT01597388|101764708|FG005|NOT COMPLETED|Overall Study||0||
48586161|NCT01597388|101764709|FG006|NOT COMPLETED|Overall Study||0||
48586162|NCT01597388|101764710|FG007|NOT COMPLETED|Overall Study||0||
48586163|NCT01597388|101764711|FG008|NOT COMPLETED|Overall Study||0||
48586164|NCT04739722|101764712|FG000|STARTED|Overall Study||14263||
48586165|NCT04739722|101764712|FG000|COMPLETED|Overall Study||7763||
48586166|NCT04739722|101764712|FG000|NOT COMPLETED|Overall Study||6500||
48586167|NCT03843632|101764713|FG000|STARTED|Overall Study||50||
48586168|NCT03843632|101764714|FG001|STARTED|Overall Study||30||
48586169|NCT03843632|101764715|FG002|STARTED|Overall Study||33||
48586170|NCT03843632|101764716|FG003|STARTED|Overall Study||37||
48586171|NCT03843632|101764713|FG000|Vaccination 1|Overall Study||50||
48586172|NCT03843632|101764714|FG001|Vaccination 1|Overall Study||30||
48586173|NCT03843632|101764715|FG002|Vaccination 1|Overall Study||33||
48586174|NCT03843632|101764716|FG003|Vaccination 1|Overall Study||37||
48586175|NCT03843632|101764713|FG000|Vaccination 2|Overall Study||49||
48586176|NCT03843632|101764714|FG001|Vaccination 2|Overall Study||30||
48586177|NCT03843632|101764715|FG002|Vaccination 2|Overall Study||0||
48586178|NCT03843632|101764716|FG003|Vaccination 2|Overall Study||0||
48586179|NCT03843632|101764713|FG000|COMPLETED|Overall Study||49||
48586180|NCT03843632|101764714|FG001|COMPLETED|Overall Study||30||
48586181|NCT03843632|101764715|FG002|COMPLETED|Overall Study||33||
48586182|NCT03843632|101764716|FG003|COMPLETED|Overall Study||37||
48586183|NCT03843632|101764713|FG000|NOT COMPLETED|Overall Study||1||
48586184|NCT03843632|101764714|FG001|NOT COMPLETED|Overall Study||0||
48586185|NCT03843632|101764715|FG002|NOT COMPLETED|Overall Study||0||
48586186|NCT03843632|101764716|FG003|NOT COMPLETED|Overall Study||0||
48586187|NCT01123941|101764717|FG000|STARTED|Overall Study||25||
48586188|NCT01123941|101764718|FG001|STARTED|Overall Study||25||
48586189|NCT01123941|101764717|FG000|COMPLETED|Overall Study||23||
48586190|NCT01123941|101764718|FG001|COMPLETED|Overall Study||24||
48586191|NCT01123941|101764717|FG000|NOT COMPLETED|Overall Study||2||
48586192|NCT01123941|101764718|FG001|NOT COMPLETED|Overall Study||1||
48586193|NCT02231879|101764719|FG000|STARTED|Overall Study||10||
48586194|NCT02231879|101764720|FG001|STARTED|Overall Study||9||
48586195|NCT02231879|101764719|FG000|COMPLETED|Overall Study||8||
48586196|NCT02231879|101764720|FG001|COMPLETED|Overall Study||7||
48586197|NCT02231879|101764719|FG000|NOT COMPLETED|Overall Study||2||
48586198|NCT02231879|101764720|FG001|NOT COMPLETED|Overall Study||2||
48586199|NCT00452673|101764721|FG000|STARTED|Dose Escalation Period||7||
48586200|NCT00452673|101764722|FG001|STARTED|Dose Escalation Period||9||
48586201|NCT00452673|101764723|FG002|STARTED|Dose Escalation Period||6||
48586202|NCT00452673|101764724|FG003|STARTED|Dose Escalation Period||9||
48586203|NCT00452673|101764725|FG004|STARTED|Dose Escalation Period||0||
48586204|NCT00452673|101764721|FG000|COMPLETED|Dose Escalation Period||0||
48586205|NCT00452673|101764722|FG001|COMPLETED|Dose Escalation Period||0||
48586206|NCT00452673|101764723|FG002|COMPLETED|Dose Escalation Period||0||
48586207|NCT00452673|101764724|FG003|COMPLETED|Dose Escalation Period||0||
48586208|NCT00452673|101764725|FG004|COMPLETED|Dose Escalation Period||0||
48586209|NCT00452673|101764721|FG000|NOT COMPLETED|Dose Escalation Period||7||
48586210|NCT00452673|101764722|FG001|NOT COMPLETED|Dose Escalation Period||9||
48586211|NCT00452673|101764723|FG002|NOT COMPLETED|Dose Escalation Period||6||
48592838|NCT00371644|101786322|FG000|STARTED|Overall Study||72||
48586212|NCT00452673|101764724|FG003|NOT COMPLETED|Dose Escalation Period||9||
48586213|NCT00452673|101764725|FG004|NOT COMPLETED|Dose Escalation Period||0||
48586214|NCT00452673|101764721|FG000|STARTED|Dose Expansion Period||0||
48586215|NCT00452673|101764722|FG001|STARTED|Dose Expansion Period||0||
48586216|NCT00452673|101764723|FG002|STARTED|Dose Expansion Period||0||
48586217|NCT00452673|101764724|FG003|STARTED|Dose Expansion Period||0||
48586218|NCT00452673|101764725|FG004|STARTED|Dose Expansion Period||21||
48586219|NCT00452673|101764721|FG000|COMPLETED|Dose Expansion Period||0||
48586220|NCT00452673|101764722|FG001|COMPLETED|Dose Expansion Period||0||
48586221|NCT00452673|101764723|FG002|COMPLETED|Dose Expansion Period||0||
48586222|NCT00452673|101764724|FG003|COMPLETED|Dose Expansion Period||0||
48586223|NCT00452673|101764725|FG004|COMPLETED|Dose Expansion Period||0||
48586224|NCT00452673|101764721|FG000|NOT COMPLETED|Dose Expansion Period||0||
48586225|NCT00452673|101764722|FG001|NOT COMPLETED|Dose Expansion Period||0||
48586226|NCT00452673|101764723|FG002|NOT COMPLETED|Dose Expansion Period||0||
48586227|NCT00452673|101764724|FG003|NOT COMPLETED|Dose Expansion Period||0||
48586228|NCT00452673|101764725|FG004|NOT COMPLETED|Dose Expansion Period||21||
48586229|NCT03020199|101764726|FG000|STARTED|Treatment Period||116|All the subjects in the study were included in the Randomized Set and the Full Analysis Set (FAS).|
48586230|NCT03020199|101764727|FG001|STARTED|Treatment Period||80|All the subjects in the study were included in the Randomized Set and the Full Analysis Set (FAS).|
48586231|NCT03020199|101764726|FG000|Modified Full Analysis Set (mFAS)|Treatment Period||77|All randomized subjects who received at least one dose of study treatment during the Treatment Period|
48586232|NCT03020199|101764727|FG001|Modified Full Analysis Set (mFAS)|Treatment Period||76|All randomized subjects who received at least one dose of study treatment during the Treatment Period|
48586233|NCT03020199|101764726|FG000|Subjects Not Treated|Treatment Period||3||
48586234|NCT03020199|101764727|FG001|Subjects Not Treated|Treatment Period||4||
48586235|NCT03020199|101764726|FG000|Main Study|Treatment Period||80||
48586236|NCT03020199|101764727|FG001|Main Study|Treatment Period||80||
48586237|NCT03020199|101764726|FG000|Mechanistic Sub-study|Treatment Period||36||
48586238|NCT03020199|101764727|FG001|Mechanistic Sub-study|Treatment Period||0||
48586239|NCT03020199|101764726|FG000|COMPLETED|Treatment Period||103|Completed treatment|
48586240|NCT03020199|101764727|FG001|COMPLETED|Treatment Period||46|Completed treatment|
48586241|NCT03020199|101764726|FG000|NOT COMPLETED|Treatment Period||13||
48586242|NCT03020199|101764727|FG001|NOT COMPLETED|Treatment Period||34||
48586243|NCT03020199|101764726|FG000|STARTED|Follow-up Period||73||
48586244|NCT03020199|101764727|FG001|STARTED|Follow-up Period||39||
48586245|NCT03020199|101764726|FG000|Main Study|Follow-up Period||67||
48586246|NCT03020199|101764727|FG001|Main Study|Follow-up Period||39||
48586247|NCT03020199|101764726|FG000|Mechanistic Sub-study|Follow-up Period||6||
48586248|NCT03020199|101764727|FG001|Mechanistic Sub-study|Follow-up Period||0||
48586249|NCT03020199|101764726|FG000|COMPLETED|Follow-up Period||13|Subjects in the Main Study who completed Week 104/208|
48586250|NCT03020199|101764727|FG001|COMPLETED|Follow-up Period||8|Subjects in the Main Study who completed Week 104/208|
48586251|NCT03020199|101764726|FG000|NOT COMPLETED|Follow-up Period||60||
48586252|NCT03020199|101764727|FG001|NOT COMPLETED|Follow-up Period||31||
48586253|NCT03555565|101764728|FG000|STARTED|Overall Study||1026||
48586254|NCT03555565|101764728|FG000|COMPLETED|Overall Study||1011||
48586255|NCT03555565|101764728|FG000|NOT COMPLETED|Overall Study||15||
48586256|NCT04178824|101764729|FG000|STARTED|Overall Study||57||
48586257|NCT04178824|101764730|FG001|STARTED|Overall Study||57||
48586258|NCT04178824|101764731|FG002|STARTED|Overall Study||53||
48586259|NCT04178824|101764729|FG000|COMPLETED|Overall Study||38||
48586260|NCT04178824|101764730|FG001|COMPLETED|Overall Study||33||
48586261|NCT04178824|101764731|FG002|COMPLETED|Overall Study||36||
48586262|NCT04178824|101764729|FG000|NOT COMPLETED|Overall Study||19||
48586263|NCT04178824|101764730|FG001|NOT COMPLETED|Overall Study||24||
48586264|NCT04178824|101764731|FG002|NOT COMPLETED|Overall Study||17||
48586265|NCT01565668|101764732|FG000|STARTED|Overall Study||38||
48586266|NCT01565668|101764733|FG001|STARTED|Overall Study||38||
48586267|NCT01565668|101764732|FG000|Completed Treatment Per Protocol|Overall Study||0||
48586268|NCT01565668|101764733|FG001|Completed Treatment Per Protocol|Overall Study||0||
48586269|NCT01565668|101764732|FG000|Started 30-day Follow-up|Overall Study||37||
48586270|NCT01565668|101764733|FG001|Started 30-day Follow-up|Overall Study||37||
48586271|NCT01565668|101764732|FG000|Completed 30-day Follow-up|Overall Study||11||
48586272|NCT01565668|101764733|FG001|Completed 30-day Follow-up|Overall Study||5||
48586273|NCT01565668|101764732|FG000|Started Long-term Follow-up|Overall Study||36||
48586274|NCT01565668|101764733|FG001|Started Long-term Follow-up|Overall Study||33||
48586275|NCT01565668|101764732|FG000|Completed Long-term Follow-up|Overall Study||0||
48586276|NCT01565668|101764733|FG001|Completed Long-term Follow-up|Overall Study||0||
48586277|NCT01565668|101764732|FG000|COMPLETED|Overall Study||0||
48586278|NCT01565668|101764733|FG001|COMPLETED|Overall Study||0||
48586279|NCT01565668|101764732|FG000|NOT COMPLETED|Overall Study||38||
48586280|NCT01565668|101764733|FG001|NOT COMPLETED|Overall Study||38||
48586281|NCT04464720|101764734|FG000|STARTED|Pre-Intervention||19||
48586282|NCT04464720|101764734|FG000|COMPLETED|Pre-Intervention||18||
48586283|NCT04464720|101764734|FG000|NOT COMPLETED|Pre-Intervention||1||
48586284|NCT04464720|101764734|FG000|STARTED|Post-Intervention||18||
48586285|NCT04464720|101764734|FG000|COMPLETED|Post-Intervention||18||
48586286|NCT04464720|101764734|FG000|NOT COMPLETED|Post-Intervention||0||
48586287|NCT02416193|101764735|FG000|STARTED|Overall Study||15||
48586288|NCT02416193|101764736|FG001|STARTED|Overall Study||15||
48586289|NCT02416193|101764735|FG000|COMPLETED|Overall Study||15||
48586290|NCT02416193|101764736|FG001|COMPLETED|Overall Study||15||
48586291|NCT02416193|101764735|FG000|NOT COMPLETED|Overall Study||0||
48586292|NCT02416193|101764736|FG001|NOT COMPLETED|Overall Study||0||
48586293|NCT04281901|101764737|FG000|STARTED|Overall Study||12|Baseline evaluation (i.e., first check-up)|12
48586294|NCT04281901|101764738|FG001|STARTED|Overall Study||12|Baseline evaluation (i.e., first check-up)|14
48586295|NCT04281901|101764737|FG000|2. Check-up|Overall Study||11|1 month after the baseline evaluation|11
48586296|NCT04281901|101764738|FG001|2. Check-up|Overall Study||11|1 month after the baseline evaluation|13
48586297|NCT04281901|101764737|FG000|3. Check-up|Overall Study||11|2 months after baseline evaluation|11
48586298|NCT04281901|101764738|FG001|3. Check-up|Overall Study||11|2 months after baseline evaluation|13
48586299|NCT04281901|101764737|FG000|COMPLETED|Overall Study||11|4. check-up (i.e., 3. months after the baseline evaluation)|11
48586300|NCT04281901|101764738|FG001|COMPLETED|Overall Study||11|4. check-up (i.e., 3. months after the baseline evaluation)|13
48586301|NCT04281901|101764737|FG000|NOT COMPLETED|Overall Study||1||1
48586302|NCT04281901|101764738|FG001|NOT COMPLETED|Overall Study||1||1
48586303|NCT03614078|101764739|FG000|STARTED|Overall Study||31||
48586304|NCT03614078|101764740|FG001|STARTED|Overall Study||30||
48586305|NCT03614078|101764741|FG002|STARTED|Overall Study||31||
48586306|NCT03614078|101764739|FG000|COMPLETED|Overall Study||28||
48586307|NCT03614078|101764740|FG001|COMPLETED|Overall Study||23||
48586308|NCT03614078|101764741|FG002|COMPLETED|Overall Study||26||
48586309|NCT03614078|101764739|FG000|NOT COMPLETED|Overall Study||3||
48586310|NCT03614078|101764740|FG001|NOT COMPLETED|Overall Study||7||
48586311|NCT03614078|101764741|FG002|NOT COMPLETED|Overall Study||5||
48586312|NCT03467217|101764742|FG000|STARTED|Overall Study||43||
48586313|NCT03467217|101764743|FG001|STARTED|Overall Study||40||
48586314|NCT03467217|101764742|FG000|COMPLETED|Overall Study||33||
48586315|NCT03467217|101764743|FG001|COMPLETED|Overall Study||34||
48586316|NCT03467217|101764742|FG000|NOT COMPLETED|Overall Study||10||
48586317|NCT03467217|101764743|FG001|NOT COMPLETED|Overall Study||6||
48586318|NCT02253316|101764744|FG000|STARTED|Consolidation||236||
48586319|NCT02253316|101764745|FG001|STARTED|Consolidation||0||
48586320|NCT02253316|101764746|FG002|STARTED|Consolidation||0||
48586321|NCT02253316|101764744|FG000|COMPLETED|Consolidation||220||
48586322|NCT02253316|101764745|FG001|COMPLETED|Consolidation||0||
48586323|NCT02253316|101764746|FG002|COMPLETED|Consolidation||0||
48706219|NCT01886690|102069658|FG001|STARTED|Overall Study||73||
48706220|NCT01886690|102069657|FG000|COMPLETED|Overall Study||75||
48706221|NCT01886690|102069658|FG001|COMPLETED|Overall Study||71||
48586324|NCT02253316|101764744|FG000|NOT COMPLETED|Consolidation||16||
48586325|NCT02253316|101764745|FG001|NOT COMPLETED|Consolidation||0||
48586326|NCT02253316|101764746|FG002|NOT COMPLETED|Consolidation||0||
48586327|NCT02253316|101764744|FG000|STARTED|Maintenance||0||
48586328|NCT02253316|101764745|FG001|STARTED|Maintenance||99||
48586329|NCT02253316|101764746|FG002|STARTED|Maintenance||116||
48586330|NCT02253316|101764744|FG000|COMPLETED|Maintenance||0||
48586331|NCT02253316|101764745|FG001|COMPLETED|Maintenance||69||
48586332|NCT02253316|101764746|FG002|COMPLETED|Maintenance||74||
48586333|NCT02253316|101764744|FG000|NOT COMPLETED|Maintenance||0||
48586334|NCT02253316|101764745|FG001|NOT COMPLETED|Maintenance||30||
48586335|NCT02253316|101764746|FG002|NOT COMPLETED|Maintenance||42||
48586336|NCT00792688|101764747|FG000|STARTED|Overall Study||9||
48586337|NCT00792688|101764748|FG001|STARTED|Overall Study||8||
48586338|NCT00792688|101764749|FG002|STARTED|Overall Study||9||
48586339|NCT00792688|101764747|FG000|COMPLETED|Overall Study||9||
48586340|NCT00792688|101764748|FG001|COMPLETED|Overall Study||8||
48586341|NCT00792688|101764749|FG002|COMPLETED|Overall Study||9||
48706222|NCT01886690|102069657|FG000|NOT COMPLETED|Overall Study||0||
48706223|NCT01886690|102069658|FG001|NOT COMPLETED|Overall Study||2||
48706224|NCT00395291|102069659|FG000|STARTED|First Intervention||17||
48706225|NCT00395291|102069660|FG001|STARTED|First Intervention||9||
48586342|NCT00792688|101764747|FG000|NOT COMPLETED|Overall Study||0||
48586343|NCT00792688|101764748|FG001|NOT COMPLETED|Overall Study||0||
48586344|NCT00792688|101764749|FG002|NOT COMPLETED|Overall Study||0||
48586345|NCT05803096|101764750|FG000|STARTED|Overall Study||66||
48586346|NCT05803096|101764751|FG001|STARTED|Overall Study||67||
48586347|NCT05803096|101764750|FG000|COMPLETED|Overall Study||61||
48586348|NCT05803096|101764751|FG001|COMPLETED|Overall Study||67||
48586349|NCT05803096|101764750|FG000|NOT COMPLETED|Overall Study||5||
48586350|NCT05803096|101764751|FG001|NOT COMPLETED|Overall Study||0||
48586351|NCT02720744|101764752|FG000|STARTED|Overall Study||107||
48586352|NCT02720744|101764753|FG001|STARTED|Overall Study||105||
48586353|NCT02720744|101764752|FG000|COMPLETED|Overall Study||69||
48586354|NCT02720744|101764753|FG001|COMPLETED|Overall Study||79||
48586355|NCT02720744|101764752|FG000|NOT COMPLETED|Overall Study||38||
48586356|NCT02720744|101764753|FG001|NOT COMPLETED|Overall Study||26||
48586357|NCT00885742|101764754|FG000|STARTED|Overall Study||41||
48706226|NCT00395291|102069659|FG000|COMPLETED|First Intervention||15||
48706227|NCT00395291|102069660|FG001|COMPLETED|First Intervention||9||
48706228|NCT00395291|102069659|FG000|NOT COMPLETED|First Intervention||2||
48586358|NCT00885742|101764754|FG000|COMPLETED|Overall Study||41||
48586359|NCT00885742|101764754|FG000|NOT COMPLETED|Overall Study||0||
48586360|NCT03605862|101764755|FG000|STARTED|Overall Study||872||
48586361|NCT03605862|101764756|FG001|STARTED|Overall Study||884||
48586362|NCT03605862|101764755|FG000|COMPLETED|Overall Study||844||
48586363|NCT03605862|101764756|FG001|COMPLETED|Overall Study||858||
48586364|NCT03605862|101764755|FG000|NOT COMPLETED|Overall Study||28||
48586365|NCT03605862|101764756|FG001|NOT COMPLETED|Overall Study||26||
48586366|NCT03955081|101764757|FG000|STARTED|Overall Study||302||
48586367|NCT03955081|101764757|FG000|COMPLETED|Overall Study||302||
48586368|NCT03955081|101764757|FG000|NOT COMPLETED|Overall Study||0||
48586369|NCT02341495|101764758|FG000|STARTED|Overall Study||4||
48586370|NCT02341495|101764758|FG000|COMPLETED|Overall Study||4||
48586371|NCT02341495|101764758|FG000|NOT COMPLETED|Overall Study||0||
48586372|NCT03937908|101764759|FG000|STARTED|Overall Study||2||
48586373|NCT03937908|101764760|FG001|STARTED|Overall Study||3||
48586374|NCT03937908|101764759|FG000|COMPLETED|Overall Study||2||
48586375|NCT03937908|101764760|FG001|COMPLETED|Overall Study||2||
48586376|NCT03937908|101764759|FG000|NOT COMPLETED|Overall Study||0||
48586377|NCT03937908|101764760|FG001|NOT COMPLETED|Overall Study||1||
48586378|NCT00308087|101764761|FG000|STARTED|Overall Study||37||
48586379|NCT00308087|101764762|FG001|STARTED|Overall Study||38||
48586380|NCT00308087|101764761|FG000|COMPLETED|Overall Study||1||
48586381|NCT00308087|101764762|FG001|COMPLETED|Overall Study||1||
48586382|NCT00308087|101764761|FG000|NOT COMPLETED|Overall Study||36||
48586383|NCT00308087|101764762|FG001|NOT COMPLETED|Overall Study||37||
48586384|NCT05343364|101764763|FG000|STARTED|Overall Study||12||
48586385|NCT05343364|101764764|FG001|STARTED|Overall Study||12||
48586386|NCT05343364|101764763|FG000|COMPLETED|Overall Study||12||
48586387|NCT05343364|101764764|FG001|COMPLETED|Overall Study||11||
48586388|NCT05343364|101764763|FG000|NOT COMPLETED|Overall Study||0||
48586389|NCT05343364|101764764|FG001|NOT COMPLETED|Overall Study||1||
48586390|NCT03852628|101764765|FG000|STARTED|Overall Study||35||
48586391|NCT03852628|101764766|FG001|STARTED|Overall Study||34||
48586392|NCT03852628|101764765|FG000|COMPLETED|Overall Study||22||
48586393|NCT03852628|101764766|FG001|COMPLETED|Overall Study||22||
48586394|NCT03852628|101764765|FG000|NOT COMPLETED|Overall Study||13||
48586395|NCT03852628|101764766|FG001|NOT COMPLETED|Overall Study||12||
48586396|NCT01053962|101764767|FG000|STARTED|Pretreatment Period||14||
48586397|NCT01053962|101764768|FG001|STARTED|Pretreatment Period||15||
48586398|NCT01053962|101764769|FG002|STARTED|Pretreatment Period||16||
48586399|NCT01053962|101764770|FG003|STARTED|Pretreatment Period||17||
48586400|NCT01053962|101764771|FG004|STARTED|Pretreatment Period||22||
48586401|NCT01053962|101764767|FG000|COMPLETED|Pretreatment Period||14||
48586402|NCT01053962|101764768|FG001|COMPLETED|Pretreatment Period||14||
48586403|NCT01053962|101764769|FG002|COMPLETED|Pretreatment Period||15||
48586404|NCT01053962|101764770|FG003|COMPLETED|Pretreatment Period||15||
48586405|NCT01053962|101764771|FG004|COMPLETED|Pretreatment Period||20||
48586406|NCT01053962|101764767|FG000|NOT COMPLETED|Pretreatment Period||0||
48586407|NCT01053962|101764768|FG001|NOT COMPLETED|Pretreatment Period||1||
48586408|NCT01053962|101764769|FG002|NOT COMPLETED|Pretreatment Period||1||
48586409|NCT01053962|101764770|FG003|NOT COMPLETED|Pretreatment Period||2||
48586410|NCT01053962|101764771|FG004|NOT COMPLETED|Pretreatment Period||2||
48586411|NCT01053962|101764767|FG000|STARTED|Treatment Period||14||
48586412|NCT01053962|101764768|FG001|STARTED|Treatment Period||14||
48586413|NCT01053962|101764769|FG002|STARTED|Treatment Period||15||
48586414|NCT01053962|101764770|FG003|STARTED|Treatment Period||15||
48586415|NCT01053962|101764771|FG004|STARTED|Treatment Period||20||
48586416|NCT01053962|101764767|FG000|COMPLETED|Treatment Period||13||
48586417|NCT01053962|101764768|FG001|COMPLETED|Treatment Period||14||
48586418|NCT01053962|101764769|FG002|COMPLETED|Treatment Period||15||
48586419|NCT01053962|101764770|FG003|COMPLETED|Treatment Period||15||
48586420|NCT01053962|101764771|FG004|COMPLETED|Treatment Period||17||
48586421|NCT01053962|101764767|FG000|NOT COMPLETED|Treatment Period||1||
48586422|NCT01053962|101764768|FG001|NOT COMPLETED|Treatment Period||0||
48586423|NCT01053962|101764769|FG002|NOT COMPLETED|Treatment Period||0||
48586424|NCT01053962|101764770|FG003|NOT COMPLETED|Treatment Period||0||
48586425|NCT01053962|101764771|FG004|NOT COMPLETED|Treatment Period||3||
48586426|NCT01053962|101764767|FG000|STARTED|Follow-up Period||13||
48586427|NCT01053962|101764768|FG001|STARTED|Follow-up Period||14||
48586428|NCT01053962|101764769|FG002|STARTED|Follow-up Period||15||
48586429|NCT01053962|101764770|FG003|STARTED|Follow-up Period||15||
48586430|NCT01053962|101764771|FG004|STARTED|Follow-up Period||17||
48586431|NCT01053962|101764767|FG000|COMPLETED|Follow-up Period||13||
48586432|NCT01053962|101764768|FG001|COMPLETED|Follow-up Period||14||
48586433|NCT01053962|101764769|FG002|COMPLETED|Follow-up Period||15||
48586434|NCT01053962|101764770|FG003|COMPLETED|Follow-up Period||15||
48586435|NCT01053962|101764771|FG004|COMPLETED|Follow-up Period||17||
48586436|NCT01053962|101764767|FG000|NOT COMPLETED|Follow-up Period||0||
48586437|NCT01053962|101764768|FG001|NOT COMPLETED|Follow-up Period||0||
48586438|NCT01053962|101764769|FG002|NOT COMPLETED|Follow-up Period||0||
48586439|NCT01053962|101764770|FG003|NOT COMPLETED|Follow-up Period||0||
48586440|NCT01053962|101764771|FG004|NOT COMPLETED|Follow-up Period||0||
48586441|NCT01351480|101764772|FG000|STARTED|Overall Study||34||
48586442|NCT01351480|101764772|FG000|COMPLETED|Overall Study||26||
48586443|NCT01351480|101764772|FG000|NOT COMPLETED|Overall Study||8||
48586444|NCT03075891|101764773|FG000|STARTED|Overall Study||135||
48586445|NCT03075891|101764774|FG001|STARTED|Overall Study||138||
48586446|NCT03075891|101764773|FG000|COMPLETED|Overall Study||126||
48586447|NCT03075891|101764774|FG001|COMPLETED|Overall Study||125||
48586448|NCT03075891|101764773|FG000|NOT COMPLETED|Overall Study||9||
48586449|NCT03075891|101764774|FG001|NOT COMPLETED|Overall Study||13||
48586450|NCT02991729|101764775|FG000|STARTED|Overall Study||105||
48586451|NCT02991729|101764776|FG001|STARTED|Overall Study||92||
48586452|NCT02991729|101764775|FG000|COMPLETED|Overall Study||105||
48586453|NCT02991729|101764776|FG001|COMPLETED|Overall Study||92||
48586454|NCT02991729|101764775|FG000|NOT COMPLETED|Overall Study||0||
48586455|NCT02991729|101764776|FG001|NOT COMPLETED|Overall Study||0||
48586456|NCT05010512|101764777|FG000|STARTED|Period 1, 8 (-0/+3) Days||55||
48586457|NCT05010512|101764778|FG001|STARTED|Period 1, 8 (-0/+3) Days||56||
48586458|NCT05010512|101764777|FG000|COMPLETED|Period 1, 8 (-0/+3) Days||55||
48586459|NCT05010512|101764778|FG001|COMPLETED|Period 1, 8 (-0/+3) Days||56||
48586460|NCT05010512|101764777|FG000|NOT COMPLETED|Period 1, 8 (-0/+3) Days||0||
48586461|NCT05010512|101764778|FG001|NOT COMPLETED|Period 1, 8 (-0/+3) Days||0||
48586462|NCT05010512|101764777|FG000|STARTED|Period 2, 8 (-0/+3) Days||55||
48586463|NCT05010512|101764778|FG001|STARTED|Period 2, 8 (-0/+3) Days||56||
48586464|NCT05010512|101764777|FG000|COMPLETED|Period 2, 8 (-0/+3) Days||55||
48586465|NCT05010512|101764778|FG001|COMPLETED|Period 2, 8 (-0/+3) Days||56||
48586466|NCT05010512|101764777|FG000|NOT COMPLETED|Period 2, 8 (-0/+3) Days||0||
48706229|NCT00395291|102069660|FG001|NOT COMPLETED|First Intervention||0||
48706230|NCT00395291|102069659|FG000|STARTED|Washout Period for 30 Days||15||
48706231|NCT00395291|102069660|FG001|STARTED|Washout Period for 30 Days||9||
48706232|NCT00395291|102069659|FG000|COMPLETED|Washout Period for 30 Days||13||
48706233|NCT00395291|102069660|FG001|COMPLETED|Washout Period for 30 Days||9||
48706234|NCT00395291|102069659|FG000|NOT COMPLETED|Washout Period for 30 Days||2||
48706235|NCT00395291|102069660|FG001|NOT COMPLETED|Washout Period for 30 Days||0||
48706236|NCT00395291|102069659|FG000|STARTED|Second Intervention||13||
48706237|NCT00395291|102069660|FG001|STARTED|Second Intervention||9||
48706238|NCT00395291|102069659|FG000|COMPLETED|Second Intervention||13||
48706239|NCT00395291|102069660|FG001|COMPLETED|Second Intervention||9||
48706240|NCT00395291|102069659|FG000|NOT COMPLETED|Second Intervention||0||
48706241|NCT00395291|102069660|FG001|NOT COMPLETED|Second Intervention||0||
48706242|NCT03515551|102069661|FG000|STARTED|Overall Study||4||
48706243|NCT03515551|102069662|FG001|STARTED|Overall Study||3||
48706244|NCT03515551|102069663|FG002|STARTED|Overall Study||5||
48706245|NCT03515551|102069664|FG003|STARTED|Overall Study||3||
48706246|NCT03515551|102069665|FG004|STARTED|Overall Study||5||
48138297|NCT05554237|100661608|FG009|NOT COMPLETED|Part 1: Period 5 Treatment (1 Day)||0||
48138298|NCT05554237|100661609|FG010|NOT COMPLETED|Part 1: Period 5 Treatment (1 Day)||0||
48138299|NCT05554237|100661610|FG011|NOT COMPLETED|Part 1: Period 5 Treatment (1 Day)||0||
48138300|NCT05554237|100661611|FG012|NOT COMPLETED|Part 1: Period 5 Treatment (1 Day)||0||
48706247|NCT03515551|102069666|FG005|STARTED|Overall Study||4||
48706248|NCT03515551|102069667|FG006|STARTED|Overall Study||5||
48706249|NCT03515551|102069661|FG000|COMPLETED|Overall Study||0||
48706250|NCT03515551|102069662|FG001|COMPLETED|Overall Study||0||
48706251|NCT03515551|102069663|FG002|COMPLETED|Overall Study||0||
48138301|NCT05554237|100661612|FG013|NOT COMPLETED|Part 1: Period 5 Treatment (1 Day)||0||
48138302|NCT05554237|100661599|FG000|STARTED|Part 2 (7 Days)||0||
48138303|NCT05554237|100661600|FG001|STARTED|Part 2 (7 Days)||0||
48586467|NCT05010512|101764778|FG001|NOT COMPLETED|Period 2, 8 (-0/+3) Days||0||
48586468|NCT01275755|101764779|FG000|STARTED|Run-in Placebo Period||41||
48586469|NCT01275755|101764780|FG001|STARTED|Run-in Placebo Period||40||
48586470|NCT01275755|101764779|FG000|COMPLETED|Run-in Placebo Period||41||
48586471|NCT01275755|101764780|FG001|COMPLETED|Run-in Placebo Period||40||
48586472|NCT01275755|101764779|FG000|NOT COMPLETED|Run-in Placebo Period||0||
48586473|NCT01275755|101764780|FG001|NOT COMPLETED|Run-in Placebo Period||0||
48586474|NCT01275755|101764779|FG000|STARTED|Double-blind Treatment Period||41||
48586475|NCT01275755|101764780|FG001|STARTED|Double-blind Treatment Period||40||
48586476|NCT01275755|101764779|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||41||
48586477|NCT01275755|101764780|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||40||
48586478|NCT01275755|101764779|FG000|COMPLETED|Double-blind Treatment Period||39||
48586479|NCT01275755|101764780|FG001|COMPLETED|Double-blind Treatment Period||37||
48586480|NCT01275755|101764779|FG000|NOT COMPLETED|Double-blind Treatment Period||2||
48586481|NCT01275755|101764780|FG001|NOT COMPLETED|Double-blind Treatment Period||3||
48706252|NCT03515551|102069664|FG003|COMPLETED|Overall Study||0||
48138304|NCT05554237|100661601|FG002|STARTED|Part 2 (7 Days)||0||
48586482|NCT01275755|101764779|FG000|STARTED|Run-out Placebo Period||39||
48586483|NCT01275755|101764780|FG001|STARTED|Run-out Placebo Period||37||
48586484|NCT01275755|101764779|FG000|COMPLETED|Run-out Placebo Period||38||
48706253|NCT03515551|102069665|FG004|COMPLETED|Overall Study||0||
48706254|NCT03515551|102069666|FG005|COMPLETED|Overall Study||0||
48706255|NCT03515551|102069667|FG006|COMPLETED|Overall Study||0||
48586485|NCT01275755|101764780|FG001|COMPLETED|Run-out Placebo Period||37||
48706256|NCT03515551|102069661|FG000|NOT COMPLETED|Overall Study||4||
48138305|NCT05554237|100661602|FG003|STARTED|Part 2 (7 Days)||0||
48138306|NCT05554237|100661603|FG004|STARTED|Part 2 (7 Days)||6||
48138307|NCT05554237|100661604|FG005|STARTED|Part 2 (7 Days)||2||
48138308|NCT05554237|100661605|FG006|STARTED|Part 2 (7 Days)||6||
48138309|NCT05554237|100661606|FG007|STARTED|Part 2 (7 Days)||2||
48138310|NCT05554237|100661607|FG008|STARTED|Part 2 (7 Days)||6||
48138311|NCT05554237|100661608|FG009|STARTED|Part 2 (7 Days)||2||
48138312|NCT05554237|100661609|FG010|STARTED|Part 2 (7 Days)||5||
48586486|NCT01275755|101764779|FG000|NOT COMPLETED|Run-out Placebo Period||1||
48586487|NCT01275755|101764780|FG001|NOT COMPLETED|Run-out Placebo Period||0||
48586488|NCT01790828|101764781|FG000|STARTED|Overall Study||42||
48586489|NCT01790828|101764781|FG000|COMPLETED|Overall Study||8||
48586490|NCT01790828|101764781|FG000|NOT COMPLETED|Overall Study||34||
48586491|NCT02394340|101764782|FG000|STARTED|Overall Study||20||
48138313|NCT05554237|100661610|FG011|STARTED|Part 2 (7 Days)||1||
48138314|NCT05554237|100661611|FG012|STARTED|Part 2 (7 Days)||3||
48138315|NCT05554237|100661612|FG013|STARTED|Part 2 (7 Days)||1||
48586492|NCT02394340|101764782|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20||
48586493|NCT02394340|101764782|FG000|COMPLETED|Overall Study||18||
48586494|NCT02394340|101764782|FG000|NOT COMPLETED|Overall Study||2||
48138316|NCT05554237|100661599|FG000|COMPLETED|Part 2 (7 Days)||0||
48138317|NCT05554237|100661600|FG001|COMPLETED|Part 2 (7 Days)||0||
48138318|NCT05554237|100661601|FG002|COMPLETED|Part 2 (7 Days)||0||
48138319|NCT05554237|100661602|FG003|COMPLETED|Part 2 (7 Days)||0||
48138320|NCT05554237|100661603|FG004|COMPLETED|Part 2 (7 Days)||4||
48138321|NCT05554237|100661604|FG005|COMPLETED|Part 2 (7 Days)||2||
48706257|NCT03515551|102069662|FG001|NOT COMPLETED|Overall Study||3||
48706258|NCT03515551|102069663|FG002|NOT COMPLETED|Overall Study||5||
48706259|NCT03515551|102069664|FG003|NOT COMPLETED|Overall Study||3||
48706260|NCT03515551|102069665|FG004|NOT COMPLETED|Overall Study||5||
48706261|NCT03515551|102069666|FG005|NOT COMPLETED|Overall Study||4||
48706262|NCT03515551|102069667|FG006|NOT COMPLETED|Overall Study||5||
48706263|NCT02925078|102069668|FG000|STARTED|Overall Study||14||
48706264|NCT02925078|102069669|FG001|STARTED|Overall Study||16||
48706265|NCT02925078|102069668|FG000|COMPLETED|Overall Study||13||
48706266|NCT02925078|102069669|FG001|COMPLETED|Overall Study||13||
48706267|NCT02925078|102069668|FG000|NOT COMPLETED|Overall Study||1||
48706268|NCT02925078|102069669|FG001|NOT COMPLETED|Overall Study||3||
48706269|NCT03334851|102069670|FG000|STARTED|Overall Study||8||
48706270|NCT03334851|102069671|FG001|STARTED|Overall Study||3||
48706271|NCT03334851|102069672|FG002|STARTED|Overall Study||3||
48706272|NCT03334851|102069673|FG003|STARTED|Overall Study||3||
48706273|NCT03334851|102069674|FG004|STARTED|Overall Study||3||
48706274|NCT03334851|102069675|FG005|STARTED|Overall Study||6||
48706275|NCT03334851|102069676|FG006|STARTED|Overall Study||5||
48706276|NCT03334851|102069677|FG007|STARTED|Overall Study||11||
48138322|NCT05554237|100661605|FG006|COMPLETED|Part 2 (7 Days)||6||
48138323|NCT05554237|100661606|FG007|COMPLETED|Part 2 (7 Days)||2||
48586495|NCT00688935|101770204|FG000|STARTED|Overall Study||0||
48586496|NCT00688935|101770204|FG000|COMPLETED|Overall Study||0||
48706277|NCT03334851|102069678|FG008|STARTED|Overall Study||6||
48706278|NCT03334851|102069679|FG009|STARTED|Overall Study||6||
48706279|NCT03334851|102069680|FG010|STARTED|Overall Study||7||
48706280|NCT03334851|102069681|FG011|STARTED|Overall Study||6||
48706281|NCT03334851|102069682|FG012|STARTED|Overall Study||6||
48706282|NCT03334851|102069670|FG000|COMPLETED|Overall Study||8||
48706283|NCT03334851|102069671|FG001|COMPLETED|Overall Study||3||
48706284|NCT03334851|102069672|FG002|COMPLETED|Overall Study||3||
48706285|NCT03334851|102069673|FG003|COMPLETED|Overall Study||3||
48706286|NCT03334851|102069674|FG004|COMPLETED|Overall Study||3||
48706287|NCT03334851|102069675|FG005|COMPLETED|Overall Study||6||
48706288|NCT03334851|102069676|FG006|COMPLETED|Overall Study||5||
48706289|NCT03334851|102069677|FG007|COMPLETED|Overall Study||9||
48706290|NCT03334851|102069678|FG008|COMPLETED|Overall Study||6||
48706291|NCT03334851|102069679|FG009|COMPLETED|Overall Study||6||
48706292|NCT03334851|102069680|FG010|COMPLETED|Overall Study||4||
48138324|NCT05554237|100661607|FG008|COMPLETED|Part 2 (7 Days)||6||
48138325|NCT05554237|100661608|FG009|COMPLETED|Part 2 (7 Days)||1||
48138326|NCT05554237|100661609|FG010|COMPLETED|Part 2 (7 Days)||5||
48138327|NCT05554237|100661610|FG011|COMPLETED|Part 2 (7 Days)||1||
48138328|NCT05554237|100661611|FG012|COMPLETED|Part 2 (7 Days)||2||
48586497|NCT00688935|101770204|FG000|NOT COMPLETED|Overall Study||0||
48586498|NCT01369108|101770205|FG000|STARTED|Overall Study||60||
48586499|NCT01369108|101770205|FG000|COMPLETED|Overall Study||49||
48586500|NCT01369108|101770205|FG000|NOT COMPLETED|Overall Study||11||
48586501|NCT01936181|101770206|FG000|STARTED|Randomised, Double-blind||291||
48586502|NCT01936181|101770207|FG001|STARTED|Randomised, Double-blind||293||
48586503|NCT01936181|101770208|FG002|STARTED|Randomised, Double-blind||0||
48586504|NCT01936181|101770209|FG003|STARTED|Randomised, Double-blind||0||
48586505|NCT01936181|101770206|FG000|COMPLETED|Randomised, Double-blind||227||
48706293|NCT03334851|102069681|FG011|COMPLETED|Overall Study||5||
48706294|NCT03334851|102069682|FG012|COMPLETED|Overall Study||5||
48706295|NCT03334851|102069670|FG000|NOT COMPLETED|Overall Study||0||
48706296|NCT03334851|102069671|FG001|NOT COMPLETED|Overall Study||0||
48706297|NCT03334851|102069672|FG002|NOT COMPLETED|Overall Study||0||
48706298|NCT03334851|102069673|FG003|NOT COMPLETED|Overall Study||0||
48290160|NCT01304238|101037531|FG004|COMPLETED|Overall Study||11||
48290161|NCT01304238|101037532|FG005|COMPLETED|Overall Study||11||
48586506|NCT01936181|101770207|FG001|COMPLETED|Randomised, Double-blind||225||
48586507|NCT01936181|101770208|FG002|COMPLETED|Randomised, Double-blind||0||
48586508|NCT01936181|101770209|FG003|COMPLETED|Randomised, Double-blind||0||
48586509|NCT01936181|101770206|FG000|NOT COMPLETED|Randomised, Double-blind||64||
48586510|NCT01936181|101770207|FG001|NOT COMPLETED|Randomised, Double-blind||68||
48586511|NCT01936181|101770208|FG002|NOT COMPLETED|Randomised, Double-blind||0||
48586512|NCT01936181|101770209|FG003|NOT COMPLETED|Randomised, Double-blind||0||
48586513|NCT01936181|101770206|FG000|STARTED|Transition-extension||201||
48706299|NCT03334851|102069674|FG004|NOT COMPLETED|Overall Study||0||
48706300|NCT03334851|102069675|FG005|NOT COMPLETED|Overall Study||0||
48706301|NCT03334851|102069676|FG006|NOT COMPLETED|Overall Study||0||
48706302|NCT03334851|102069677|FG007|NOT COMPLETED|Overall Study||2||
48706303|NCT03334851|102069678|FG008|NOT COMPLETED|Overall Study||0||
48706304|NCT03334851|102069679|FG009|NOT COMPLETED|Overall Study||0||
48706305|NCT03334851|102069680|FG010|NOT COMPLETED|Overall Study||3||
48706306|NCT03334851|102069681|FG011|NOT COMPLETED|Overall Study||1||
48706307|NCT03334851|102069682|FG012|NOT COMPLETED|Overall Study||1||
48706308|NCT01456195|102069683|FG000|STARTED|Overall Study||143||
48706309|NCT01456195|102069684|FG001|STARTED|Overall Study||137||
48706310|NCT01456195|102069685|FG002|STARTED|Overall Study||141||
48706311|NCT01456195|102069683|FG000|COMPLETED|Overall Study||132||
48706312|NCT01456195|102069684|FG001|COMPLETED|Overall Study||127||
48706313|NCT01456195|102069685|FG002|COMPLETED|Overall Study||127||
48706314|NCT01456195|102069683|FG000|NOT COMPLETED|Overall Study||11||
48706315|NCT01456195|102069684|FG001|NOT COMPLETED|Overall Study||10||
48706316|NCT01456195|102069685|FG002|NOT COMPLETED|Overall Study||14||
48706317|NCT02737553|102069686|FG000|STARTED|Overall Study||49||
48706318|NCT02737553|102069687|FG001|STARTED|Overall Study||48||
48706319|NCT02737553|102069686|FG000|COMPLETED|Overall Study||49||
48706320|NCT02737553|102069687|FG001|COMPLETED|Overall Study||48||
48706321|NCT02737553|102069686|FG000|NOT COMPLETED|Overall Study||0||
48706322|NCT02737553|102069687|FG001|NOT COMPLETED|Overall Study||0||
48706323|NCT01062841|102069688|FG000|STARTED|Overall Study||203||
48706324|NCT01062841|102069689|FG001|STARTED|Overall Study||215||
48706325|NCT01062841|102069688|FG000|COMPLETED|Overall Study||154||
48706326|NCT01062841|102069689|FG001|COMPLETED|Overall Study||162||
48706327|NCT01062841|102069688|FG000|NOT COMPLETED|Overall Study||49||
48706328|NCT01062841|102069689|FG001|NOT COMPLETED|Overall Study||53||
48706329|NCT01789138|102069690|FG000|STARTED|Overall Study||254||
48706330|NCT01789138|102069691|FG001|STARTED|Overall Study||258||
48706331|NCT01789138|102069690|FG000|COMPLETED|Overall Study||213||
48706332|NCT01789138|102069691|FG001|COMPLETED|Overall Study||206||
48706333|NCT01789138|102069690|FG000|NOT COMPLETED|Overall Study||41||
48706334|NCT01789138|102069691|FG001|NOT COMPLETED|Overall Study||52||
48706335|NCT04753658|102069692|FG000|STARTED|Overall Study||15||
48706336|NCT04753658|102069692|FG000|COMPLETED|Overall Study||0||
48706337|NCT04753658|102069692|FG000|NOT COMPLETED|Overall Study||15||
48706338|NCT02388490|102069693|FG000|STARTED|Overall Study||25||
48706339|NCT02388490|102069693|FG000|COMPLETED|Overall Study||25||
48706340|NCT02388490|102069693|FG000|NOT COMPLETED|Overall Study||0||
48706341|NCT02136680|102069694|FG000|STARTED|Overall Study||112||
48706342|NCT02136680|102069695|FG001|STARTED|Overall Study||85||
48706343|NCT02136680|102069694|FG000|Interview 1|Overall Study||112||
48706344|NCT02136680|102069695|FG001|Interview 1|Overall Study||85||
48706345|NCT02136680|102069694|FG000|Interview 2|Overall Study||97||
48706346|NCT02136680|102069695|FG001|Interview 2|Overall Study||70||
48706347|NCT02136680|102069694|FG000|Interview 3|Overall Study||80||
48706348|NCT02136680|102069695|FG001|Interview 3|Overall Study||56||
48706349|NCT02136680|102069694|FG000|COMPLETED|Overall Study||80||
48706350|NCT02136680|102069695|FG001|COMPLETED|Overall Study||56||
48706351|NCT02136680|102069694|FG000|NOT COMPLETED|Overall Study||32||
48706352|NCT02136680|102069695|FG001|NOT COMPLETED|Overall Study||29||
48290162|NCT01304238|101037533|FG006|COMPLETED|Overall Study||5||
48290163|NCT01304238|101037534|FG007|COMPLETED|Overall Study||4||
48290164|NCT01304238|101037535|FG008|COMPLETED|Overall Study||1||
48290165|NCT01304238|101037536|FG009|COMPLETED|Overall Study||3||
48586514|NCT01936181|101770207|FG001|STARTED|Transition-extension||0||
48586515|NCT01936181|101770208|FG002|STARTED|Transition-extension||94||
48586516|NCT01936181|101770209|FG003|STARTED|Transition-extension||101||
48586517|NCT01936181|101770206|FG000|COMPLETED|Transition-extension||186||
48586518|NCT01936181|101770207|FG001|COMPLETED|Transition-extension||0||
48586519|NCT01936181|101770208|FG002|COMPLETED|Transition-extension||88||
48586520|NCT01936181|101770209|FG003|COMPLETED|Transition-extension||96||
48706353|NCT01010568|102069696|FG000|STARTED|Overall Study||10||
48706354|NCT01010568|102069696|FG000|COMPLETED|Overall Study||5||
48706355|NCT01010568|102069696|FG000|NOT COMPLETED|Overall Study||5||
48706356|NCT02068846|102069697|FG000|STARTED|Overall Study||9||
48706357|NCT02068846|102069698|FG001|STARTED|Overall Study||8||
48706358|NCT02068846|102069697|FG000|COMPLETED|Overall Study||8||
48706359|NCT02068846|102069698|FG001|COMPLETED|Overall Study||7||
48706360|NCT02068846|102069697|FG000|NOT COMPLETED|Overall Study||1||
48706361|NCT02068846|102069698|FG001|NOT COMPLETED|Overall Study||1||
48290166|NCT01304238|101037527|FG000|NOT COMPLETED|Overall Study||0||
48290167|NCT01304238|101037528|FG001|NOT COMPLETED|Overall Study||0||
48290168|NCT01304238|101037529|FG002|NOT COMPLETED|Overall Study||0||
48290169|NCT01304238|101037530|FG003|NOT COMPLETED|Overall Study||0||
48290170|NCT01304238|101037531|FG004|NOT COMPLETED|Overall Study||0||
48290171|NCT01304238|101037532|FG005|NOT COMPLETED|Overall Study||0||
48290172|NCT01304238|101037533|FG006|NOT COMPLETED|Overall Study||0||
48290173|NCT01304238|101037534|FG007|NOT COMPLETED|Overall Study||0||
48290174|NCT01304238|101037535|FG008|NOT COMPLETED|Overall Study||0||
48290175|NCT01304238|101037536|FG009|NOT COMPLETED|Overall Study||0||
48290176|NCT00370331|101037537|FG000|STARTED|Overall Study||62||
48290177|NCT00370331|101037538|FG001|STARTED|Overall Study||135||
48290178|NCT00370331|101037537|FG000|COMPLETED|Overall Study||55||
48290179|NCT00370331|101037538|FG001|COMPLETED|Overall Study||112||
48290180|NCT00370331|101037537|FG000|NOT COMPLETED|Overall Study||7||
48586521|NCT01936181|101770206|FG000|NOT COMPLETED|Transition-extension||15||
48586522|NCT01936181|101770207|FG001|NOT COMPLETED|Transition-extension||0||
48586523|NCT01936181|101770208|FG002|NOT COMPLETED|Transition-extension||6||
48586524|NCT01936181|101770209|FG003|NOT COMPLETED|Transition-extension||5||
48586525|NCT05129137|101770210|FG000|STARTED|First Period||8||
48586526|NCT05129137|101770211|FG001|STARTED|First Period||8||
48586527|NCT05129137|101770212|FG002|STARTED|First Period||8||
48586528|NCT05129137|101770213|FG003|STARTED|First Period||8||
48586529|NCT05129137|101770210|FG000|COMPLETED|First Period||8||
48290181|NCT00370331|101037538|FG001|NOT COMPLETED|Overall Study||23||
48290182|NCT02041520|101037539|FG000|STARTED|Overall Study||35||
48290183|NCT02041520|101037540|FG001|STARTED|Overall Study||35||
48290184|NCT02041520|101037539|FG000|COMPLETED|Overall Study||29||
48290185|NCT02041520|101037540|FG001|COMPLETED|Overall Study||28||
48290186|NCT02041520|101037539|FG000|NOT COMPLETED|Overall Study||6||
48290187|NCT02041520|101037540|FG001|NOT COMPLETED|Overall Study||7||
48290188|NCT01639495|101037541|FG000|STARTED|Overall Study||148||
48290189|NCT01639495|101037541|FG000|Safety Cohort|Overall Study||144|Safety population includes those enrolled subjects who underwent insertion of the study catheter.|
48290190|NCT01639495|101037541|FG000|Primary Effectiveness Cohort|Overall Study||138|Safety cohort subjects meeting eligibility criteria \& receiving radiofrequency (RF) ablation for AF|
48290191|NCT01639495|101037541|FG000|COMPLETED|Overall Study||132||
48290192|NCT01639495|101037541|FG000|NOT COMPLETED|Overall Study||16||
48290193|NCT01664598|101037542|FG000|STARTED|Overall Study||49||
48290194|NCT01664598|101037542|FG000|COMPLETED|Overall Study||43||
48138329|NCT05554237|100661612|FG013|COMPLETED|Part 2 (7 Days)||1||
48138330|NCT05554237|100661599|FG000|NOT COMPLETED|Part 2 (7 Days)||0||
48138331|NCT05554237|100661600|FG001|NOT COMPLETED|Part 2 (7 Days)||0||
48290195|NCT01664598|101037542|FG000|NOT COMPLETED|Overall Study||6||
48290196|NCT05323396|101037543|FG000|STARTED|Overall Study||29||
48290197|NCT05323396|101037544|FG001|STARTED|Overall Study||71||
48290198|NCT05323396|101037543|FG000|Laboratory Evaluation Performed|Overall Study||29||
48290199|NCT05323396|101037544|FG001|Laboratory Evaluation Performed|Overall Study||71||
48290200|NCT05323396|101037543|FG000|Received Intervention|Overall Study||28||
48290201|NCT05323396|101037544|FG001|Received Intervention|Overall Study||0||
48290202|NCT05323396|101037543|FG000|COMPLETED|Overall Study||27||
48290203|NCT05323396|101037544|FG001|COMPLETED|Overall Study||40||
48290204|NCT05323396|101037543|FG000|NOT COMPLETED|Overall Study||2||
48290205|NCT05323396|101037544|FG001|NOT COMPLETED|Overall Study||31||
48290206|NCT01941719|101037545|FG000|STARTED|Overall Study||48||
48290207|NCT01941719|101037546|FG001|STARTED|Overall Study||51||
48586530|NCT05129137|101770211|FG001|COMPLETED|First Period||8||
48586531|NCT05129137|101770212|FG002|COMPLETED|First Period||7||
48586532|NCT05129137|101770213|FG003|COMPLETED|First Period||8||
48586533|NCT05129137|101770210|FG000|NOT COMPLETED|First Period||0||
48586534|NCT05129137|101770211|FG001|NOT COMPLETED|First Period||0||
48586535|NCT05129137|101770212|FG002|NOT COMPLETED|First Period||1||
48586536|NCT05129137|101770213|FG003|NOT COMPLETED|First Period||0||
48586537|NCT05129137|101770210|FG000|STARTED|Second Period||8||
48290208|NCT01941719|101037545|FG000|Month 1|Overall Study||43||
48290209|NCT01941719|101037546|FG001|Month 1|Overall Study||48||
48290210|NCT01941719|101037545|FG000|Month 3|Overall Study||38||
48290211|NCT01941719|101037546|FG001|Month 3|Overall Study||44||
48586538|NCT05129137|101770211|FG001|STARTED|Second Period||8||
48290212|NCT01941719|101037545|FG000|Month 6|Overall Study||34||
48290213|NCT01941719|101037546|FG001|Month 6|Overall Study||42||
48290214|NCT01941719|101037545|FG000|Month 9|Overall Study||29||
48290215|NCT01941719|101037546|FG001|Month 9|Overall Study||37||
48290216|NCT01941719|101037545|FG000|Month 12|Overall Study||28||
48290217|NCT01941719|101037546|FG001|Month 12|Overall Study||32||
48290218|NCT01941719|101037545|FG000|COMPLETED|Overall Study||28||
48290219|NCT01941719|101037546|FG001|COMPLETED|Overall Study||32||
48290220|NCT01941719|101037545|FG000|NOT COMPLETED|Overall Study||20||
48290221|NCT01941719|101037546|FG001|NOT COMPLETED|Overall Study||19||
48290222|NCT00477334|101037547|FG000|STARTED|Overall Study||312||
48290223|NCT00477334|101037548|FG001|STARTED|Overall Study||151||
48290224|NCT00477334|101037547|FG000|Randomized and Took Study Drug|Overall Study||206||
48290225|NCT00477334|101037548|FG001|Randomized and Took Study Drug|Overall Study||98||
48290226|NCT00477334|101037547|FG000|Intent to Treat Population|Overall Study||201||
48290227|NCT00477334|101037548|FG001|Intent to Treat Population|Overall Study||98||
48290228|NCT00477334|101037547|FG000|Participants Completing First Recurrence|Overall Study||187||
48290229|NCT00477334|101037548|FG001|Participants Completing First Recurrence|Overall Study||92||
48290230|NCT00477334|101037547|FG000|Modified Intent to Treat Population|Overall Study||152||
48290231|NCT00477334|101037548|FG001|Modified Intent to Treat Population|Overall Study||78||
48290232|NCT00477334|101037547|FG000|COMPLETED|Overall Study||142||
48290233|NCT00477334|101037548|FG001|COMPLETED|Overall Study||75||
48290234|NCT00477334|101037547|FG000|NOT COMPLETED|Overall Study||170||
48290235|NCT00477334|101037548|FG001|NOT COMPLETED|Overall Study||76||
48290236|NCT03019796|101037549|FG000|STARTED|First Intervention Drug Tests||20||
48290237|NCT03019796|101037550|FG001|STARTED|First Intervention Drug Tests||20||
48290238|NCT03019796|101037549|FG000|COMPLETED|First Intervention Drug Tests||20||
48290239|NCT03019796|101037550|FG001|COMPLETED|First Intervention Drug Tests||20||
48290240|NCT03019796|101037549|FG000|NOT COMPLETED|First Intervention Drug Tests||0||
48290241|NCT03019796|101037550|FG001|NOT COMPLETED|First Intervention Drug Tests||0||
48290242|NCT03019796|101037549|FG000|STARTED|Second Intervention Training (4 Months)||20||
48290243|NCT03019796|101037550|FG001|STARTED|Second Intervention Training (4 Months)||20||
48290244|NCT03019796|101037549|FG000|COMPLETED|Second Intervention Training (4 Months)||19||
48290245|NCT03019796|101037550|FG001|COMPLETED|Second Intervention Training (4 Months)||19||
48290246|NCT03019796|101037549|FG000|NOT COMPLETED|Second Intervention Training (4 Months)||1||
48290247|NCT03019796|101037550|FG001|NOT COMPLETED|Second Intervention Training (4 Months)||1||
48290248|NCT03019796|101037549|FG000|STARTED|Third Intervention Drug Test||19||
48290249|NCT03019796|101037550|FG001|STARTED|Third Intervention Drug Test||19||
48290250|NCT03019796|101037549|FG000|COMPLETED|Third Intervention Drug Test||19||
48290251|NCT03019796|101037550|FG001|COMPLETED|Third Intervention Drug Test||19||
48290252|NCT03019796|101037549|FG000|NOT COMPLETED|Third Intervention Drug Test||0||
48290253|NCT03019796|101037550|FG001|NOT COMPLETED|Third Intervention Drug Test||0||
48290254|NCT00777946|101037551|FG000|STARTED|Overall Study||283||
48290255|NCT00777946|101037552|FG001|STARTED|Overall Study||277||
48290256|NCT00777946|101037553|FG002|STARTED|Overall Study||260||
48290257|NCT00777946|101037551|FG000|Safety & Full Analysis Sets|Overall Study||282||
48290258|NCT00777946|101037552|FG001|Safety & Full Analysis Sets|Overall Study||276||
48290259|NCT00777946|101037553|FG002|Safety & Full Analysis Sets|Overall Study||260||
48290260|NCT00777946|101037551|FG000|COMPLETED|Overall Study||262||
48290261|NCT00777946|101037552|FG001|COMPLETED|Overall Study||271||
48290262|NCT00777946|101037553|FG002|COMPLETED|Overall Study||244||
48290263|NCT00777946|101037551|FG000|NOT COMPLETED|Overall Study||21||
48290264|NCT00777946|101037552|FG001|NOT COMPLETED|Overall Study||6||
48290265|NCT00777946|101037553|FG002|NOT COMPLETED|Overall Study||16||
48290266|NCT03221192|101037554|FG000|STARTED|Overall Study||27||
48290267|NCT03221192|101037554|FG000|COMPLETED|Overall Study||27||
48290268|NCT03221192|101037554|FG000|NOT COMPLETED|Overall Study||0||
48290269|NCT03087019|101037555|FG000|STARTED|Overall Study||11||
48290270|NCT03087019|101037556|FG001|STARTED|Overall Study||10||
48290271|NCT03087019|101037555|FG000|COMPLETED|Overall Study||10||
48290272|NCT03087019|101037556|FG001|COMPLETED|Overall Study||10||
48290273|NCT03087019|101037555|FG000|NOT COMPLETED|Overall Study||1||
48401827|NCT02999191|101313861|FG000|NOT COMPLETED|Wash-out Period 2 [21 Days]||0||
48401828|NCT02999191|101313862|FG001|NOT COMPLETED|Wash-out Period 2 [21 Days]||0||
48401829|NCT02999191|101313863|FG002|NOT COMPLETED|Wash-out Period 2 [21 Days]||0||
48401830|NCT02999191|101313861|FG000|STARTED|Treatment Period 3 [1 Day]||6||
48290274|NCT03087019|101037556|FG001|NOT COMPLETED|Overall Study||0||
48290275|NCT00983931|101037557|FG000|STARTED|Colchicine Alone||24||
48290276|NCT00983931|101037557|FG000|COMPLETED|Colchicine Alone||24||
48290277|NCT00983931|101037557|FG000|NOT COMPLETED|Colchicine Alone||0||
48290278|NCT00983931|101037557|FG000|STARTED|14 Day Washout Period||24||
48290279|NCT00983931|101037557|FG000|COMPLETED|14 Day Washout Period||23||
48290280|NCT00983931|101037557|FG000|NOT COMPLETED|14 Day Washout Period||1||
48290281|NCT00983931|101037557|FG000|STARTED|Colchicine With Cyclosporine||23||
48290282|NCT00983931|101037557|FG000|COMPLETED|Colchicine With Cyclosporine||23||
48290283|NCT00983931|101037557|FG000|NOT COMPLETED|Colchicine With Cyclosporine||0||
48290284|NCT02518490|101037558|FG000|STARTED|Overall Study||18||18
48290285|NCT02518490|101037559|FG001|STARTED|Overall Study||18||18
48290286|NCT02518490|101037558|FG000|COMPLETED|Overall Study||17||17
48290287|NCT02518490|101037559|FG001|COMPLETED|Overall Study||17||17
48290288|NCT02518490|101037558|FG000|NOT COMPLETED|Overall Study||1||1
48290289|NCT02518490|101037559|FG001|NOT COMPLETED|Overall Study||1||1
48290290|NCT00394082|101037560|FG000|STARTED|Overall Study||50||
48290291|NCT00394082|101037560|FG000|At Least One Response Assessment|Overall Study||43||
48290292|NCT00394082|101037560|FG000|COMPLETED|Overall Study||24||
48290293|NCT00394082|101037560|FG000|NOT COMPLETED|Overall Study||26||
48290294|NCT01411839|101037561|FG000|STARTED|Overall Study||20||
48290295|NCT01411839|101037562|FG001|STARTED|Overall Study||20||
48290296|NCT01411839|101037561|FG000|COMPLETED|Overall Study||16||
48290297|NCT01411839|101037562|FG001|COMPLETED|Overall Study||17||
48290298|NCT01411839|101037561|FG000|NOT COMPLETED|Overall Study||4||
48290299|NCT01411839|101037562|FG001|NOT COMPLETED|Overall Study||3||
48290300|NCT02783768|101037563|FG000|STARTED|Overall Study||6||
48290301|NCT02783768|101037564|FG001|STARTED|Overall Study||5||
48290302|NCT02783768|101037563|FG000|COMPLETED|Overall Study||5||
48290303|NCT02783768|101037564|FG001|COMPLETED|Overall Study||5||
48290304|NCT02783768|101037563|FG000|NOT COMPLETED|Overall Study||1||
48290305|NCT02783768|101037564|FG001|NOT COMPLETED|Overall Study||0||
48290306|NCT03840915|101037565|FG000|STARTED|Overall Study||40||
48290307|NCT03840915|101037566|FG001|STARTED|Overall Study||9||
48290308|NCT03840915|101037567|FG002|STARTED|Overall Study||9||
48290309|NCT03840915|101037568|FG003|STARTED|Overall Study||12||
48290310|NCT03840915|101037565|FG000|Safety Analysis Set|Overall Study||40|All participants who were administered any dose of any study intervention (bintrafusp alfa or one of the chemotherapies).|
48290311|NCT03840915|101037566|FG001|Safety Analysis Set|Overall Study||9|All participants who were administered any dose of any study intervention (bintrafusp alfa or one of the chemotherapies).|
48290312|NCT03840915|101037567|FG002|Safety Analysis Set|Overall Study||9|All participants who were administered any dose of any study intervention (bintrafusp alfa or one of the chemotherapies).|
48290313|NCT03840915|101037568|FG003|Safety Analysis Set|Overall Study||12|All participants who were administered any dose of any study intervention (bintrafusp alfa or one of the chemotherapies).|
48290314|NCT03840915|101037565|FG000|Full Analysis Set|Overall Study||40|All participants who were administered any dose of any study intervention (bintrafusp alfa or one of the chemotherapies).|
48290315|NCT03840915|101037566|FG001|Full Analysis Set|Overall Study||9|All participants who were administered any dose of any study intervention (bintrafusp alfa or one of the chemotherapies).|
48290316|NCT03840915|101037567|FG002|Full Analysis Set|Overall Study||9|All participants who were administered any dose of any study intervention (bintrafusp alfa or one of the chemotherapies).|
48290317|NCT03840915|101037568|FG003|Full Analysis Set|Overall Study||12|All participants who were administered any dose of any study intervention (bintrafusp alfa or one of the chemotherapies).|
48290318|NCT03840915|101037565|FG000|Dose-Limiting Toxicity Analysis Set|Overall Study||8|All participants who received at least 90% of the bintrafusp alfa infusion and all other planned study administrations during the DLT observation period of 3 weeks and who did not discontinue the study for other reasons than DLT during the first cycle, or who experienced at least one DLT.|
48290319|NCT03840915|101037566|FG001|Dose-Limiting Toxicity Analysis Set|Overall Study||8|All participants who received at least 90% of the bintrafusp alfa infusion and all other planned study administrations during the DLT observation period of 3 weeks and who did not discontinue the study for other reasons than DLT during the first cycle, or who experienced at least one DLT.|
48290320|NCT03840915|101037567|FG002|Dose-Limiting Toxicity Analysis Set|Overall Study||8|All participants who received at least 90% of the bintrafusp alfa infusion and all other planned study administrations during the DLT observation period of 3 weeks and who did not discontinue the study for other reasons than DLT during the first cycle, or who experienced at least one DLT.|
48290321|NCT03840915|101037568|FG003|Dose-Limiting Toxicity Analysis Set|Overall Study||11|All participants who received at least 90% of the bintrafusp alfa infusion and all other planned study administrations during the DLT observation period of 3 weeks and who did not discontinue the study for other reasons than DLT during the first cycle, or who experienced at least one DLT.|
48290322|NCT03840915|101037565|FG000|COMPLETED|Overall Study||40||
48290323|NCT03840915|101037566|FG001|COMPLETED|Overall Study||9||
48290324|NCT03840915|101037567|FG002|COMPLETED|Overall Study||9||
48290325|NCT03840915|101037568|FG003|COMPLETED|Overall Study||12||
48290326|NCT03840915|101037565|FG000|NOT COMPLETED|Overall Study||0||
48290327|NCT03840915|101037566|FG001|NOT COMPLETED|Overall Study||0||
48290328|NCT03840915|101037567|FG002|NOT COMPLETED|Overall Study||0||
48290329|NCT03840915|101037568|FG003|NOT COMPLETED|Overall Study||0||
48290330|NCT01288521|101037569|FG000|STARTED|Overall Study||3||
48290331|NCT01288521|101037570|FG001|STARTED|Overall Study||5||
48290332|NCT01288521|101037569|FG000|COMPLETED|Overall Study||3||
48290333|NCT01288521|101037570|FG001|COMPLETED|Overall Study||5||
48290334|NCT01288521|101037569|FG000|NOT COMPLETED|Overall Study||0||
48290335|NCT01288521|101037570|FG001|NOT COMPLETED|Overall Study||0||
48290336|NCT03128008|101037571|FG000|STARTED|Overall Study||10||
48290337|NCT03128008|101037571|FG000|COMPLETED|Overall Study||1||
48290338|NCT03128008|101037571|FG000|NOT COMPLETED|Overall Study||9||
48290339|NCT02009761|101037572|FG000|STARTED|Overall Study||6||
48290340|NCT02009761|101037572|FG000|COMPLETED|Overall Study||2||
48290341|NCT02009761|101037572|FG000|NOT COMPLETED|Overall Study||4||
48290342|NCT01878214|101037573|FG000|STARTED|Overall Study||223||
48290343|NCT01878214|101037574|FG001|STARTED|Overall Study||219||
48290344|NCT01878214|101037573|FG000|COMPLETED|Overall Study||170||
48290345|NCT01878214|101037574|FG001|COMPLETED|Overall Study||175||
48290346|NCT01878214|101037573|FG000|NOT COMPLETED|Overall Study||53||
48290347|NCT01878214|101037574|FG001|NOT COMPLETED|Overall Study||44||
48290348|NCT00580645|101037575|FG000|STARTED|Overall Study||20||
48138332|NCT05554237|100661601|FG002|NOT COMPLETED|Part 2 (7 Days)||0||
48138333|NCT05554237|100661602|FG003|NOT COMPLETED|Part 2 (7 Days)||0||
48138334|NCT05554237|100661603|FG004|NOT COMPLETED|Part 2 (7 Days)||2||
48138335|NCT05554237|100661604|FG005|NOT COMPLETED|Part 2 (7 Days)||0||
48138336|NCT05554237|100661605|FG006|NOT COMPLETED|Part 2 (7 Days)||0||
48138337|NCT05554237|100661606|FG007|NOT COMPLETED|Part 2 (7 Days)||0||
48586539|NCT05129137|101770212|FG002|STARTED|Second Period||7||
48586540|NCT05129137|101770213|FG003|STARTED|Second Period||8||
48586541|NCT05129137|101770210|FG000|COMPLETED|Second Period||7||
48586542|NCT05129137|101770211|FG001|COMPLETED|Second Period||8||
48586543|NCT05129137|101770212|FG002|COMPLETED|Second Period||7||
48586544|NCT05129137|101770213|FG003|COMPLETED|Second Period||7||
48138338|NCT05554237|100661607|FG008|NOT COMPLETED|Part 2 (7 Days)||0||
48138339|NCT05554237|100661608|FG009|NOT COMPLETED|Part 2 (7 Days)||1||
48138340|NCT05554237|100661609|FG010|NOT COMPLETED|Part 2 (7 Days)||0||
48138341|NCT05554237|100661610|FG011|NOT COMPLETED|Part 2 (7 Days)||0||
48138342|NCT05554237|100661611|FG012|NOT COMPLETED|Part 2 (7 Days)||1||
48138343|NCT05554237|100661612|FG013|NOT COMPLETED|Part 2 (7 Days)||0||
48586545|NCT05129137|101770210|FG000|NOT COMPLETED|Second Period||1||
48586546|NCT05129137|101770211|FG001|NOT COMPLETED|Second Period||0||
48138344|NCT02388386|100661613|FG000|STARTED|Overall Study||10||
48138345|NCT02388386|100661613|FG000|COMPLETED|Overall Study||10||
48138346|NCT02388386|100661613|FG000|NOT COMPLETED|Overall Study||0||
48138347|NCT02479412|100661614|FG000|STARTED|Overall Study||6||
48138348|NCT02479412|100661615|FG001|STARTED|Overall Study||6||
48138349|NCT02479412|100661616|FG002|STARTED|Overall Study||6||
48138350|NCT02479412|100661617|FG003|STARTED|Overall Study||7||
48290349|NCT00580645|101037576|FG001|STARTED|Overall Study||20||
48290350|NCT00580645|101037577|FG002|STARTED|Overall Study||20||
48138351|NCT02479412|100661618|FG004|STARTED|Overall Study||6||
48138352|NCT02479412|100661619|FG005|STARTED|Overall Study||5||
48138353|NCT02479412|100661620|FG006|STARTED|Overall Study||6||
48138354|NCT02479412|100661621|FG007|STARTED|Overall Study||5||
48138355|NCT02479412|100661622|FG008|STARTED|Overall Study||7||
48138356|NCT02479412|100661614|FG000|COMPLETED|Overall Study||6||
48138357|NCT02479412|100661615|FG001|COMPLETED|Overall Study||6||
48138358|NCT02479412|100661616|FG002|COMPLETED|Overall Study||4||
48138359|NCT02479412|100661617|FG003|COMPLETED|Overall Study||6||
48138360|NCT02479412|100661618|FG004|COMPLETED|Overall Study||5||
48290351|NCT00580645|101037575|FG000|COMPLETED|Overall Study||20||
48290352|NCT00580645|101037576|FG001|COMPLETED|Overall Study||20||
48290353|NCT00580645|101037577|FG002|COMPLETED|Overall Study||20||
48290354|NCT00580645|101037575|FG000|NOT COMPLETED|Overall Study||0||
48138361|NCT02479412|100661619|FG005|COMPLETED|Overall Study||5||
48138362|NCT02479412|100661620|FG006|COMPLETED|Overall Study||6||
48138363|NCT02479412|100661621|FG007|COMPLETED|Overall Study||4||
48138364|NCT02479412|100661622|FG008|COMPLETED|Overall Study||6||
48138365|NCT02479412|100661614|FG000|NOT COMPLETED|Overall Study||0||
48138366|NCT02479412|100661615|FG001|NOT COMPLETED|Overall Study||0||
48138367|NCT02479412|100661616|FG002|NOT COMPLETED|Overall Study||2||
48138368|NCT02479412|100661617|FG003|NOT COMPLETED|Overall Study||1||
48138369|NCT02479412|100661618|FG004|NOT COMPLETED|Overall Study||1||
48138370|NCT02479412|100661619|FG005|NOT COMPLETED|Overall Study||0||
48138371|NCT02479412|100661620|FG006|NOT COMPLETED|Overall Study||0||
48138372|NCT02479412|100661621|FG007|NOT COMPLETED|Overall Study||1||
48138373|NCT02479412|100661622|FG008|NOT COMPLETED|Overall Study||1||
48138374|NCT02921997|100661623|FG000|STARTED|Overall Study||10||
48138375|NCT02921997|100661624|FG001|STARTED|Overall Study||10||
48586547|NCT05129137|101770212|FG002|NOT COMPLETED|Second Period||0||
48586548|NCT05129137|101770213|FG003|NOT COMPLETED|Second Period||1||
48586549|NCT05129137|101770210|FG000|STARTED|Third Period||7||
48586550|NCT05129137|101770211|FG001|STARTED|Third Period||8||
48586551|NCT05129137|101770212|FG002|STARTED|Third Period||7||
48586552|NCT05129137|101770213|FG003|STARTED|Third Period||7||
48586553|NCT05129137|101770210|FG000|COMPLETED|Third Period||7||
48138376|NCT02921997|100661625|FG002|STARTED|Overall Study||10||
48138377|NCT02921997|100661623|FG000|COMPLETED|Overall Study||10||
48138378|NCT02921997|100661624|FG001|COMPLETED|Overall Study||10||
48138379|NCT02921997|100661625|FG002|COMPLETED|Overall Study||10||
48138380|NCT02921997|100661623|FG000|NOT COMPLETED|Overall Study||0||
48138381|NCT02921997|100661624|FG001|NOT COMPLETED|Overall Study||0||
48138382|NCT02921997|100661625|FG002|NOT COMPLETED|Overall Study||0||
48138383|NCT04913363|100661626|FG000|STARTED|Overall Study||12||
48138384|NCT04913363|100661627|FG001|STARTED|Overall Study||1||
48138385|NCT04913363|100661628|FG002|STARTED|Overall Study||1||
48138386|NCT04913363|100661629|FG003|STARTED|Overall Study||3||
48290355|NCT00580645|101037576|FG001|NOT COMPLETED|Overall Study||0||
48290356|NCT00580645|101037577|FG002|NOT COMPLETED|Overall Study||0||
48586554|NCT05129137|101770211|FG001|COMPLETED|Third Period||8||
48586555|NCT05129137|101770212|FG002|COMPLETED|Third Period||7||
48586556|NCT05129137|101770213|FG003|COMPLETED|Third Period||6||
48586557|NCT05129137|101770210|FG000|NOT COMPLETED|Third Period||0||
48586558|NCT05129137|101770211|FG001|NOT COMPLETED|Third Period||0||
48586559|NCT05129137|101770212|FG002|NOT COMPLETED|Third Period||0||
48586560|NCT05129137|101770213|FG003|NOT COMPLETED|Third Period||1||
48586561|NCT05129137|101770210|FG000|STARTED|Forth Period||7||
48586562|NCT05129137|101770211|FG001|STARTED|Forth Period||8||
48586563|NCT05129137|101770212|FG002|STARTED|Forth Period||7||
48586564|NCT05129137|101770213|FG003|STARTED|Forth Period||6||
48586565|NCT05129137|101770210|FG000|COMPLETED|Forth Period||7||
48586566|NCT05129137|101770211|FG001|COMPLETED|Forth Period||7||
48586567|NCT05129137|101770212|FG002|COMPLETED|Forth Period||6||
48586568|NCT05129137|101770213|FG003|COMPLETED|Forth Period||6||
48586569|NCT05129137|101770210|FG000|NOT COMPLETED|Forth Period||0||
48586570|NCT05129137|101770211|FG001|NOT COMPLETED|Forth Period||1||
48586571|NCT05129137|101770212|FG002|NOT COMPLETED|Forth Period||1||
48586572|NCT05129137|101770213|FG003|NOT COMPLETED|Forth Period||0||
48586573|NCT01253174|101770214|FG000|STARTED|Period 1||6||
48586574|NCT01253174|101770215|FG001|STARTED|Period 1||10||
48586575|NCT01253174|101770216|FG002|STARTED|Period 1||9||
48586576|NCT01253174|101770217|FG003|STARTED|Period 1||7||
48586577|NCT01253174|101770218|FG004|STARTED|Period 1||9||
48586578|NCT01253174|101770219|FG005|STARTED|Period 1||7||
48586579|NCT01253174|101770214|FG000|COMPLETED|Period 1||6||
48586580|NCT01253174|101770215|FG001|COMPLETED|Period 1||9||
48586581|NCT01253174|101770216|FG002|COMPLETED|Period 1||8||
48586582|NCT01253174|101770217|FG003|COMPLETED|Period 1||7||
48586583|NCT01253174|101770218|FG004|COMPLETED|Period 1||8||
48586584|NCT01253174|101770219|FG005|COMPLETED|Period 1||7||
48586585|NCT01253174|101770214|FG000|NOT COMPLETED|Period 1||0||
48586586|NCT01253174|101770215|FG001|NOT COMPLETED|Period 1||1||
48586587|NCT01253174|101770216|FG002|NOT COMPLETED|Period 1||1||
48586588|NCT01253174|101770217|FG003|NOT COMPLETED|Period 1||0||
48586589|NCT01253174|101770218|FG004|NOT COMPLETED|Period 1||1||
48586590|NCT01253174|101770219|FG005|NOT COMPLETED|Period 1||0||
48586591|NCT01253174|101770214|FG000|STARTED|Period 2||6||
48586592|NCT01253174|101770215|FG001|STARTED|Period 2||9||
48586593|NCT01253174|101770216|FG002|STARTED|Period 2||8||
48586594|NCT01253174|101770217|FG003|STARTED|Period 2||7||
48586595|NCT01253174|101770218|FG004|STARTED|Period 2||8||
48586596|NCT01253174|101770219|FG005|STARTED|Period 2||7||
48586597|NCT01253174|101770214|FG000|COMPLETED|Period 2||6||
48586598|NCT01253174|101770215|FG001|COMPLETED|Period 2||9||
48586599|NCT01253174|101770216|FG002|COMPLETED|Period 2||7||
48586600|NCT01253174|101770217|FG003|COMPLETED|Period 2||7||
48586601|NCT01253174|101770218|FG004|COMPLETED|Period 2||8||
48586602|NCT01253174|101770219|FG005|COMPLETED|Period 2||7||
48586603|NCT01253174|101770214|FG000|NOT COMPLETED|Period 2||0||
48586604|NCT01253174|101770215|FG001|NOT COMPLETED|Period 2||0||
48586605|NCT01253174|101770216|FG002|NOT COMPLETED|Period 2||1||
48586606|NCT01253174|101770217|FG003|NOT COMPLETED|Period 2||0||
48586607|NCT01253174|101770218|FG004|NOT COMPLETED|Period 2||0||
48586608|NCT01253174|101770219|FG005|NOT COMPLETED|Period 2||0||
48586609|NCT01253174|101770214|FG000|STARTED|Period 3||6||
48586610|NCT01253174|101770215|FG001|STARTED|Period 3||9||
48586611|NCT01253174|101770216|FG002|STARTED|Period 3||7||
48586612|NCT01253174|101770217|FG003|STARTED|Period 3||7||
48586613|NCT01253174|101770218|FG004|STARTED|Period 3||8||
48586614|NCT01253174|101770219|FG005|STARTED|Period 3||7||
48706362|NCT02913430|102069699|FG000|STARTED|Overall Study||5||
48706363|NCT02913430|102069700|FG001|STARTED|Overall Study||2||
48138387|NCT04913363|100661630|FG004|STARTED|Overall Study||5||
48138388|NCT04913363|100661631|FG005|STARTED|Overall Study||2||
48138389|NCT04913363|100661626|FG000|COMPLETED|Overall Study||12||
48138390|NCT04913363|100661627|FG001|COMPLETED|Overall Study||1||
48586615|NCT01253174|101770214|FG000|COMPLETED|Period 3||6||
48586616|NCT01253174|101770215|FG001|COMPLETED|Period 3||8||
48586617|NCT01253174|101770216|FG002|COMPLETED|Period 3||6||
48586618|NCT01253174|101770217|FG003|COMPLETED|Period 3||7||
48586619|NCT01253174|101770218|FG004|COMPLETED|Period 3||7||
48586620|NCT01253174|101770219|FG005|COMPLETED|Period 3||7||
48586621|NCT01253174|101770214|FG000|NOT COMPLETED|Period 3||0||
48586622|NCT01253174|101770215|FG001|NOT COMPLETED|Period 3||1||
48586623|NCT01253174|101770216|FG002|NOT COMPLETED|Period 3||1||
48586624|NCT01253174|101770217|FG003|NOT COMPLETED|Period 3||0||
48138391|NCT04913363|100661628|FG002|COMPLETED|Overall Study||1||
48586625|NCT01253174|101770218|FG004|NOT COMPLETED|Period 3||1||
48586626|NCT01253174|101770219|FG005|NOT COMPLETED|Period 3||0||
48586627|NCT00425061|101770220|FG000|STARTED|Overall Study||16||
48586628|NCT00425061|101770221|FG001|STARTED|Overall Study||17||
48586629|NCT00425061|101770222|FG002|STARTED|Overall Study||16||
48586630|NCT00425061|101770223|FG003|STARTED|Overall Study||16||
48586631|NCT00425061|101770224|FG004|STARTED|Overall Study||45||
48586632|NCT00425061|101770225|FG005|STARTED|Overall Study||4||
48586633|NCT00425061|101770226|FG006|STARTED|Overall Study||45||
48586634|NCT00425061|101770220|FG000|COMPLETED|Overall Study||14||
48586635|NCT00425061|101770221|FG001|COMPLETED|Overall Study||15||
48586636|NCT00425061|101770222|FG002|COMPLETED|Overall Study||16||
48586637|NCT00425061|101770223|FG003|COMPLETED|Overall Study||14||
48586638|NCT00425061|101770224|FG004|COMPLETED|Overall Study||19||
48586639|NCT00425061|101770225|FG005|COMPLETED|Overall Study||0||
48586640|NCT00425061|101770226|FG006|COMPLETED|Overall Study||26||
48586641|NCT00425061|101770220|FG000|NOT COMPLETED|Overall Study||2||
48138392|NCT04913363|100661629|FG003|COMPLETED|Overall Study||3||
48138393|NCT04913363|100661630|FG004|COMPLETED|Overall Study||5||
48138394|NCT04913363|100661631|FG005|COMPLETED|Overall Study||2||
48138395|NCT04913363|100661626|FG000|NOT COMPLETED|Overall Study||0||
48138396|NCT04913363|100661627|FG001|NOT COMPLETED|Overall Study||0||
48138397|NCT04913363|100661628|FG002|NOT COMPLETED|Overall Study||0||
48138398|NCT04913363|100661629|FG003|NOT COMPLETED|Overall Study||0||
48138399|NCT04913363|100661630|FG004|NOT COMPLETED|Overall Study||0||
48138400|NCT04913363|100661631|FG005|NOT COMPLETED|Overall Study||0||
48138401|NCT04137380|100661632|FG000|STARTED|Overall Study||6||
48138402|NCT04137380|100661633|FG001|STARTED|Overall Study||10||
48138403|NCT04137380|100661634|FG002|STARTED|Overall Study||10||
48138404|NCT04137380|100661635|FG003|STARTED|Overall Study||10||
48138405|NCT04137380|100661636|FG004|STARTED|Overall Study||4||
48138406|NCT04137380|100661637|FG005|STARTED|Overall Study||10||
48138407|NCT04137380|100661638|FG006|STARTED|Overall Study||10||
48138408|NCT04137380|100661632|FG000|Received at Least One Dose of Study Drug|Overall Study||6||
48138409|NCT04137380|100661633|FG001|Received at Least One Dose of Study Drug|Overall Study||10||
48138410|NCT04137380|100661634|FG002|Received at Least One Dose of Study Drug|Overall Study||10||
48138411|NCT04137380|100661635|FG003|Received at Least One Dose of Study Drug|Overall Study||10||
48138412|NCT04137380|100661636|FG004|Received at Least One Dose of Study Drug|Overall Study||4||
48138413|NCT04137380|100661637|FG005|Received at Least One Dose of Study Drug|Overall Study||10||
48138414|NCT04137380|100661638|FG006|Received at Least One Dose of Study Drug|Overall Study||10||
48138415|NCT04137380|100661632|FG000|COMPLETED|Overall Study||6||
48138416|NCT04137380|100661633|FG001|COMPLETED|Overall Study||10||
48138417|NCT04137380|100661634|FG002|COMPLETED|Overall Study||10||
48138418|NCT04137380|100661635|FG003|COMPLETED|Overall Study||9||
48138419|NCT04137380|100661636|FG004|COMPLETED|Overall Study||4||
48138420|NCT04137380|100661637|FG005|COMPLETED|Overall Study||10||
48138421|NCT04137380|100661638|FG006|COMPLETED|Overall Study||10||
48138422|NCT04137380|100661632|FG000|NOT COMPLETED|Overall Study||0||
48138423|NCT04137380|100661633|FG001|NOT COMPLETED|Overall Study||0||
48138424|NCT04137380|100661634|FG002|NOT COMPLETED|Overall Study||0||
48138425|NCT04137380|100661635|FG003|NOT COMPLETED|Overall Study||1||
48138426|NCT04137380|100661636|FG004|NOT COMPLETED|Overall Study||0||
48138427|NCT04137380|100661637|FG005|NOT COMPLETED|Overall Study||0||
48138428|NCT04137380|100661638|FG006|NOT COMPLETED|Overall Study||0||
48138429|NCT01939028|100661639|FG000|STARTED|Overall Study||58||
48138430|NCT01939028|100661639|FG000|COMPLETED|Overall Study||46||
48138431|NCT01939028|100661639|FG000|NOT COMPLETED|Overall Study||12||
48138432|NCT01613248|100661640|FG000|STARTED|Overall Study||139||
48138433|NCT01613248|100661641|FG001|STARTED|Overall Study||138||
48138434|NCT01613248|100661642|FG002|STARTED|Overall Study||139||
48138435|NCT01613248|100661643|FG003|STARTED|Overall Study||139||
48138436|NCT01613248|100661644|FG004|STARTED|Overall Study||139||
48138437|NCT01613248|100661645|FG005|STARTED|Overall Study||140||
48138438|NCT01613248|100661640|FG000|COMPLETED|Overall Study||110||
48138439|NCT01613248|100661641|FG001|COMPLETED|Overall Study||104||
48138440|NCT01613248|100661642|FG002|COMPLETED|Overall Study||106||
48138441|NCT01613248|100661643|FG003|COMPLETED|Overall Study||101||
48138442|NCT01613248|100661644|FG004|COMPLETED|Overall Study||104||
48586642|NCT00425061|101770221|FG001|NOT COMPLETED|Overall Study||2||
48586643|NCT00425061|101770222|FG002|NOT COMPLETED|Overall Study||0||
48586644|NCT00425061|101770223|FG003|NOT COMPLETED|Overall Study||2||
48586645|NCT00425061|101770224|FG004|NOT COMPLETED|Overall Study||26||
48586646|NCT00425061|101770225|FG005|NOT COMPLETED|Overall Study||4||
48586647|NCT00425061|101770226|FG006|NOT COMPLETED|Overall Study||19||
48586648|NCT04776018|101770227|FG000|STARTED|Overall Study||3||
48138443|NCT01613248|100661645|FG005|COMPLETED|Overall Study||102||
48138444|NCT01613248|100661640|FG000|NOT COMPLETED|Overall Study||29||
48138445|NCT01613248|100661641|FG001|NOT COMPLETED|Overall Study||34||
48138446|NCT01613248|100661642|FG002|NOT COMPLETED|Overall Study||33||
48138447|NCT01613248|100661643|FG003|NOT COMPLETED|Overall Study||38||
48138448|NCT01613248|100661644|FG004|NOT COMPLETED|Overall Study||35||
48138449|NCT01613248|100661645|FG005|NOT COMPLETED|Overall Study||38||
48138450|NCT01169467|100661646|FG000|STARTED|Overall Study||44||
48138451|NCT01169467|100661647|FG001|STARTED|Overall Study||40||
48138452|NCT01169467|100661646|FG000|COMPLETED|Overall Study||37||
48138453|NCT01169467|100661647|FG001|COMPLETED|Overall Study||36||
48138454|NCT01169467|100661646|FG000|NOT COMPLETED|Overall Study||7||
48138455|NCT01169467|100661647|FG001|NOT COMPLETED|Overall Study||4||
48586649|NCT04776018|101770228|FG001|STARTED|Overall Study||3||
48138456|NCT00074035|100661648|FG000|STARTED|Overall Study||38||
48138457|NCT00074035|100661648|FG000|COMPLETED|Overall Study||38||
48138458|NCT00074035|100661648|FG000|NOT COMPLETED|Overall Study||0||
48138459|NCT02310750|100661649|FG000|STARTED|HP Period 1||7||
48138460|NCT02310750|100661650|FG001|STARTED|HP Period 1||6||
48138461|NCT02310750|100661651|FG002|STARTED|HP Period 1||6||
48138462|NCT02310750|100661652|FG003|STARTED|HP Period 1||6||
48138463|NCT02310750|100661653|FG004|STARTED|HP Period 1||8||
48138464|NCT02310750|100661654|FG005|STARTED|HP Period 1||8||
48138465|NCT02310750|100661655|FG006|STARTED|HP Period 1||13||
48586650|NCT04776018|101770229|FG002|STARTED|Overall Study||10||
48586651|NCT04776018|101770230|FG003|STARTED|Overall Study||3||
48586652|NCT04776018|101770231|FG004|STARTED|Overall Study||8||
48586653|NCT04776018|101770232|FG005|STARTED|Overall Study||0||
48586654|NCT04776018|101770233|FG006|STARTED|Overall Study||0||
48586655|NCT04776018|101770227|FG000|COMPLETED|Overall Study||0||
48138466|NCT02310750|100661656|FG007|STARTED|HP Period 1||0||
48138467|NCT02310750|100661657|FG008|STARTED|HP Period 1||0||
48138468|NCT02310750|100661658|FG009|STARTED|HP Period 1||0||
48138469|NCT02310750|100661659|FG010|STARTED|HP Period 1||2||
48138470|NCT02310750|100661660|FG011|STARTED|HP Period 1||2||
48138471|NCT02310750|100661661|FG012|STARTED|HP Period 1||2||
48586656|NCT04776018|101770228|FG001|COMPLETED|Overall Study||0||
48586657|NCT04776018|101770229|FG002|COMPLETED|Overall Study||0||
48586658|NCT04776018|101770230|FG003|COMPLETED|Overall Study||0||
48586659|NCT04776018|101770231|FG004|COMPLETED|Overall Study||0||
48586660|NCT04776018|101770232|FG005|COMPLETED|Overall Study||0||
48586661|NCT04776018|101770233|FG006|COMPLETED|Overall Study||0||
48586662|NCT04776018|101770227|FG000|NOT COMPLETED|Overall Study||3||
48586663|NCT04776018|101770228|FG001|NOT COMPLETED|Overall Study||3||
48586664|NCT04776018|101770229|FG002|NOT COMPLETED|Overall Study||10||
48586665|NCT04776018|101770230|FG003|NOT COMPLETED|Overall Study||3||
48586666|NCT04776018|101770231|FG004|NOT COMPLETED|Overall Study||8||
48586667|NCT04776018|101770232|FG005|NOT COMPLETED|Overall Study||0||
48586668|NCT04776018|101770233|FG006|NOT COMPLETED|Overall Study||0||
48586669|NCT01084668|101770234|FG000|STARTED|Overall Study||42||
48586670|NCT01084668|101770234|FG000|COMPLETED|Overall Study||33||
48586671|NCT01084668|101770234|FG000|NOT COMPLETED|Overall Study||9||
48586672|NCT00343785|101770235|FG000|STARTED|Overall Study||21||
48138472|NCT02310750|100661662|FG013|STARTED|HP Period 1||2||
48138473|NCT02310750|100661663|FG014|STARTED|HP Period 1||2||
48138474|NCT02310750|100661664|FG015|STARTED|HP Period 1||2||
48138475|NCT02310750|100661649|FG000|COMPLETED|HP Period 1||6||
48138476|NCT02310750|100661650|FG001|COMPLETED|HP Period 1||6||
48138477|NCT02310750|100661651|FG002|COMPLETED|HP Period 1||6||
48138478|NCT02310750|100661652|FG003|COMPLETED|HP Period 1||5||
48138479|NCT02310750|100661653|FG004|COMPLETED|HP Period 1||8||
48138480|NCT02310750|100661654|FG005|COMPLETED|HP Period 1||8||
48138481|NCT02310750|100661655|FG006|COMPLETED|HP Period 1||12||
48138482|NCT02310750|100661656|FG007|COMPLETED|HP Period 1||0||
48138483|NCT02310750|100661657|FG008|COMPLETED|HP Period 1||0||
48138484|NCT02310750|100661658|FG009|COMPLETED|HP Period 1||0||
48290357|NCT01340651|101037578|FG000|STARTED|Overall Study||41||
48290358|NCT01340651|101037578|FG000|COMPLETED|Overall Study||24||
48290359|NCT01340651|101037578|FG000|NOT COMPLETED|Overall Study||17||
48290360|NCT01401582|101037579|FG000|STARTED|Overall Study||226||
48401831|NCT02999191|101313862|FG001|STARTED|Treatment Period 3 [1 Day]||6||
48586673|NCT00343785|101770235|FG000|COMPLETED|Overall Study||21||
48586674|NCT00343785|101770235|FG000|NOT COMPLETED|Overall Study||0||
48586675|NCT04778059|101770236|FG000|STARTED|Overall Study||3||
48586676|NCT04778059|101770237|FG001|STARTED|Overall Study||3||
48586677|NCT04778059|101770238|FG002|STARTED|Overall Study||3||
48586678|NCT04778059|101770239|FG003|STARTED|Overall Study||2||
48586679|NCT04778059|101770240|FG004|STARTED|Overall Study||10||
48586680|NCT04778059|101770236|FG000|COMPLETED|Overall Study||1||
48586681|NCT04778059|101770237|FG001|COMPLETED|Overall Study||1||
48138485|NCT02310750|100661659|FG010|COMPLETED|HP Period 1||2||
48138486|NCT02310750|100661660|FG011|COMPLETED|HP Period 1||2||
48138487|NCT02310750|100661661|FG012|COMPLETED|HP Period 1||2||
48138488|NCT02310750|100661662|FG013|COMPLETED|HP Period 1||2||
48138489|NCT02310750|100661663|FG014|COMPLETED|HP Period 1||2||
48138490|NCT02310750|100661664|FG015|COMPLETED|HP Period 1||2||
48138491|NCT02310750|100661649|FG000|NOT COMPLETED|HP Period 1||1||
48290361|NCT01401582|101037580|FG001|STARTED|Overall Study||408||
48290362|NCT01401582|101037579|FG000|Baseline Completed|Overall Study||168||
48290363|NCT01401582|101037580|FG001|Baseline Completed|Overall Study||348||
48290364|NCT01401582|101037579|FG000|COMPLETED|Overall Study||116||
48290365|NCT01401582|101037580|FG001|COMPLETED|Overall Study||291||
48290366|NCT01401582|101037579|FG000|NOT COMPLETED|Overall Study||110||
48290367|NCT01401582|101037580|FG001|NOT COMPLETED|Overall Study||117||
48290368|NCT01285609|101037581|FG000|STARTED|Randomized||479|Started = Randomized|
48290369|NCT01285609|101037582|FG001|STARTED|Randomized||477|Started = Randomized|
48290370|NCT01285609|101037581|FG000|Treated With Chemotherapy (1st Dose)|Randomized||475||
48290371|NCT01285609|101037582|FG001|Treated With Chemotherapy (1st Dose)|Randomized||473||
48290372|NCT01285609|101037581|FG000|COMPLETED|Randomized||388|Completed = Continued to Blinded Therapy|
48138492|NCT02310750|100661650|FG001|NOT COMPLETED|HP Period 1||0||
48138493|NCT02310750|100661651|FG002|NOT COMPLETED|HP Period 1||0||
48138494|NCT02310750|100661652|FG003|NOT COMPLETED|HP Period 1||1||
48138495|NCT02310750|100661653|FG004|NOT COMPLETED|HP Period 1||0||
48138496|NCT02310750|100661654|FG005|NOT COMPLETED|HP Period 1||0||
48138497|NCT02310750|100661655|FG006|NOT COMPLETED|HP Period 1||1||
48290373|NCT01285609|101037582|FG001|COMPLETED|Randomized||361|Completed = Continued to Blinded Therapy|
48290374|NCT01285609|101037581|FG000|NOT COMPLETED|Randomized||91||
48290375|NCT01285609|101037582|FG001|NOT COMPLETED|Randomized||116||
48290376|NCT01285609|101037581|FG000|STARTED|Treated With Blinded Therapy||388|Started = Received at least one dose of Blinded Therapy|
48290377|NCT01285609|101037582|FG001|STARTED|Treated With Blinded Therapy||361|Started = Received at least one dose of Blinded Therapy|
48290378|NCT01285609|101037581|FG000|COMPLETED|Treated With Blinded Therapy||1|Completed = Completed the Blinded Therapy treatment phase|
48290379|NCT01285609|101037582|FG001|COMPLETED|Treated With Blinded Therapy||2|Completed = Completed the Blinded Therapy treatment phase|
48290380|NCT01285609|101037581|FG000|NOT COMPLETED|Treated With Blinded Therapy||387||
48290381|NCT01285609|101037582|FG001|NOT COMPLETED|Treated With Blinded Therapy||359||
48401832|NCT02999191|101313863|FG002|STARTED|Treatment Period 3 [1 Day]||6||
48586682|NCT04778059|101770238|FG002|COMPLETED|Overall Study||2||
48586683|NCT04778059|101770239|FG003|COMPLETED|Overall Study||1||
48586684|NCT04778059|101770240|FG004|COMPLETED|Overall Study||7||
48586685|NCT04778059|101770236|FG000|NOT COMPLETED|Overall Study||2||
48586686|NCT04778059|101770237|FG001|NOT COMPLETED|Overall Study||2||
48586687|NCT04778059|101770238|FG002|NOT COMPLETED|Overall Study||1||
48586688|NCT04778059|101770239|FG003|NOT COMPLETED|Overall Study||1||
48586689|NCT04778059|101770240|FG004|NOT COMPLETED|Overall Study||3||
48586690|NCT01645891|101770241|FG000|STARTED|Overall Study||74||
48138498|NCT02310750|100661656|FG007|NOT COMPLETED|HP Period 1||0||
48138499|NCT02310750|100661657|FG008|NOT COMPLETED|HP Period 1||0||
48138500|NCT02310750|100661658|FG009|NOT COMPLETED|HP Period 1||0||
48138501|NCT02310750|100661659|FG010|NOT COMPLETED|HP Period 1||0||
48138502|NCT02310750|100661660|FG011|NOT COMPLETED|HP Period 1||0||
48138503|NCT02310750|100661661|FG012|NOT COMPLETED|HP Period 1||0||
48138504|NCT02310750|100661662|FG013|NOT COMPLETED|HP Period 1||0||
48138505|NCT02310750|100661663|FG014|NOT COMPLETED|HP Period 1||0||
48138506|NCT02310750|100661664|FG015|NOT COMPLETED|HP Period 1||0||
48138507|NCT02310750|100661649|FG000|STARTED|HP Washout 1||0||
48138508|NCT02310750|100661650|FG001|STARTED|HP Washout 1||0||
48138509|NCT02310750|100661651|FG002|STARTED|HP Washout 1||6||
48138510|NCT02310750|100661652|FG003|STARTED|HP Washout 1||5||
48138511|NCT02310750|100661653|FG004|STARTED|HP Washout 1||8||
48138512|NCT02310750|100661654|FG005|STARTED|HP Washout 1||8||
48586691|NCT01645891|101770242|FG001|STARTED|Overall Study||72||
48586692|NCT01645891|101770241|FG000|COMPLETED|Overall Study||52||
48586693|NCT01645891|101770242|FG001|COMPLETED|Overall Study||53||
48586694|NCT01645891|101770241|FG000|NOT COMPLETED|Overall Study||22||
48586695|NCT01645891|101770242|FG001|NOT COMPLETED|Overall Study||19||
48586696|NCT01613222|101770243|FG000|STARTED|Overall Study||63||
48138513|NCT02310750|100661655|FG006|STARTED|HP Washout 1||12||
48138514|NCT02310750|100661656|FG007|STARTED|HP Washout 1||0||
48138515|NCT02310750|100661657|FG008|STARTED|HP Washout 1||0||
48290382|NCT03814187|101037583|FG000|STARTED|Overall Study||1513|All enrolled participants|
48290383|NCT03814187|101037584|FG001|STARTED|Overall Study||1478|All enrolled participants|
48290384|NCT03814187|101037585|FG002|STARTED|Overall Study||284|All enrolled participants|
48294173|NCT02527343|101047541|FG005|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||2||
48401833|NCT02999191|101313861|FG000|COMPLETED|Treatment Period 3 [1 Day]||6||
48401834|NCT02999191|101313862|FG001|COMPLETED|Treatment Period 3 [1 Day]||6||
48586697|NCT01613222|101770243|FG000|COMPLETED|Overall Study||51||
48586698|NCT01613222|101770243|FG000|NOT COMPLETED|Overall Study||12||
48138516|NCT02310750|100661658|FG009|STARTED|HP Washout 1||0||
48138517|NCT02310750|100661659|FG010|STARTED|HP Washout 1||2||
48138518|NCT02310750|100661660|FG011|STARTED|HP Washout 1||2||
48138519|NCT02310750|100661661|FG012|STARTED|HP Washout 1||2||
48138520|NCT02310750|100661662|FG013|STARTED|HP Washout 1||2||
48138521|NCT02310750|100661663|FG014|STARTED|HP Washout 1||2||
48138522|NCT02310750|100661664|FG015|STARTED|HP Washout 1||2||
48138523|NCT02310750|100661649|FG000|COMPLETED|HP Washout 1||0||
48138524|NCT02310750|100661650|FG001|COMPLETED|HP Washout 1||0||
48138525|NCT02310750|100661651|FG002|COMPLETED|HP Washout 1||5||
48138526|NCT02310750|100661652|FG003|COMPLETED|HP Washout 1||4||
48138527|NCT02310750|100661653|FG004|COMPLETED|HP Washout 1||6||
48138528|NCT02310750|100661654|FG005|COMPLETED|HP Washout 1||6||
48138529|NCT02310750|100661655|FG006|COMPLETED|HP Washout 1||9||
48138530|NCT02310750|100661656|FG007|COMPLETED|HP Washout 1||0||
48138531|NCT02310750|100661657|FG008|COMPLETED|HP Washout 1||0||
48138532|NCT02310750|100661658|FG009|COMPLETED|HP Washout 1||0||
48138533|NCT02310750|100661659|FG010|COMPLETED|HP Washout 1||2||
48586699|NCT02832375|101770244|FG000|STARTED|Overall Study||121||
48586700|NCT02832375|101770245|FG001|STARTED|Overall Study||121||
48586701|NCT02832375|101770244|FG000|COMPLETED|Overall Study||119||
48586702|NCT02832375|101770245|FG001|COMPLETED|Overall Study||121||
48586703|NCT02832375|101770244|FG000|NOT COMPLETED|Overall Study||2||
48586704|NCT02832375|101770245|FG001|NOT COMPLETED|Overall Study||0||
48586705|NCT02031640|101770246|FG000|STARTED|Screening Period||1113||
48586706|NCT02031640|101770247|FG001|STARTED|Screening Period||0||
48586707|NCT02031640|101770248|FG002|STARTED|Screening Period||0||
48586708|NCT02031640|101770249|FG003|STARTED|Screening Period||0||
48586709|NCT02031640|101770250|FG004|STARTED|Screening Period||0||
48586710|NCT02031640|101770251|FG005|STARTED|Screening Period||0||
48586711|NCT02031640|101770246|FG000|COMPLETED|Screening Period||701||
48586712|NCT02031640|101770247|FG001|COMPLETED|Screening Period||0||
48586713|NCT02031640|101770248|FG002|COMPLETED|Screening Period||0||
48138534|NCT02310750|100661660|FG011|COMPLETED|HP Washout 1||2||
48138535|NCT02310750|100661661|FG012|COMPLETED|HP Washout 1||2||
48138536|NCT02310750|100661662|FG013|COMPLETED|HP Washout 1||2||
48138537|NCT02310750|100661663|FG014|COMPLETED|HP Washout 1||2||
48138538|NCT02310750|100661664|FG015|COMPLETED|HP Washout 1||2||
48706364|NCT02913430|102069699|FG000|COMPLETED|Overall Study||5||
48706365|NCT02913430|102069700|FG001|COMPLETED|Overall Study||2||
48706366|NCT02913430|102069699|FG000|NOT COMPLETED|Overall Study||0||
48706367|NCT02913430|102069700|FG001|NOT COMPLETED|Overall Study||0||
48586714|NCT02031640|101770249|FG003|COMPLETED|Screening Period||0||
48586715|NCT02031640|101770250|FG004|COMPLETED|Screening Period||0||
48586716|NCT02031640|101770251|FG005|COMPLETED|Screening Period||0||
48586717|NCT02031640|101770246|FG000|NOT COMPLETED|Screening Period||412||
48586718|NCT02031640|101770247|FG001|NOT COMPLETED|Screening Period||0||
48586719|NCT02031640|101770248|FG002|NOT COMPLETED|Screening Period||0||
48586720|NCT02031640|101770249|FG003|NOT COMPLETED|Screening Period||0||
48586721|NCT02031640|101770250|FG004|NOT COMPLETED|Screening Period||0||
48586722|NCT02031640|101770251|FG005|NOT COMPLETED|Screening Period||0||
48586723|NCT02031640|101770246|FG000|STARTED|Run-In Period||701||
48586724|NCT02031640|101770247|FG001|STARTED|Run-In Period||0||
48586725|NCT02031640|101770248|FG002|STARTED|Run-In Period||0||
48586726|NCT02031640|101770249|FG003|STARTED|Run-In Period||0||
48586727|NCT02031640|101770250|FG004|STARTED|Run-In Period||0||
48586728|NCT02031640|101770251|FG005|STARTED|Run-In Period||0||
48586729|NCT02031640|101770246|FG000|COMPLETED|Run-In Period||532||
48586730|NCT02031640|101770247|FG001|COMPLETED|Run-In Period||0||
48586731|NCT02031640|101770248|FG002|COMPLETED|Run-In Period||0||
48586732|NCT02031640|101770249|FG003|COMPLETED|Run-In Period||0||
48586733|NCT02031640|101770250|FG004|COMPLETED|Run-In Period||0||
48586734|NCT02031640|101770251|FG005|COMPLETED|Run-In Period||0||
48586735|NCT02031640|101770246|FG000|NOT COMPLETED|Run-In Period||169||
48586736|NCT02031640|101770247|FG001|NOT COMPLETED|Run-In Period||0||
48586737|NCT02031640|101770248|FG002|NOT COMPLETED|Run-In Period||0||
48586738|NCT02031640|101770249|FG003|NOT COMPLETED|Run-In Period||0||
48586739|NCT02031640|101770250|FG004|NOT COMPLETED|Run-In Period||0||
48586740|NCT02031640|101770251|FG005|NOT COMPLETED|Run-In Period||0||
48706368|NCT00814697|102069701|FG000|STARTED|Overall Study||12||
48706369|NCT00814697|102069701|FG000|COMPLETED|Overall Study||12||
48706370|NCT00814697|102069701|FG000|NOT COMPLETED|Overall Study||0||
48706371|NCT01790178|102069702|FG000|STARTED|Overall Study||16||
48706372|NCT01790178|102069703|FG001|STARTED|Overall Study||24||
48706373|NCT01790178|102069702|FG000|COMPLETED|Overall Study||16||
48706374|NCT01790178|102069703|FG001|COMPLETED|Overall Study||24||
48706375|NCT01790178|102069702|FG000|NOT COMPLETED|Overall Study||0||
48706376|NCT01790178|102069703|FG001|NOT COMPLETED|Overall Study||0||
48706377|NCT03848208|102069704|FG000|STARTED|Overall Study||18|randomized and treated|
48706378|NCT03848208|102069705|FG001|STARTED|Overall Study||6|randomized and treated|
48706379|NCT03848208|102069706|FG002|STARTED|Overall Study||6|randomized and treated|
48706380|NCT03848208|102069707|FG003|STARTED|Overall Study||6|randomized and treated|
48138539|NCT02310750|100661649|FG000|NOT COMPLETED|HP Washout 1||0||
48138540|NCT02310750|100661650|FG001|NOT COMPLETED|HP Washout 1||0||
48138541|NCT02310750|100661651|FG002|NOT COMPLETED|HP Washout 1||1||
48138542|NCT02310750|100661652|FG003|NOT COMPLETED|HP Washout 1||1||
48138543|NCT02310750|100661653|FG004|NOT COMPLETED|HP Washout 1||2||
48138544|NCT02310750|100661654|FG005|NOT COMPLETED|HP Washout 1||2||
48138545|NCT02310750|100661655|FG006|NOT COMPLETED|HP Washout 1||3||
48138546|NCT02310750|100661656|FG007|NOT COMPLETED|HP Washout 1||0||
48138547|NCT02310750|100661657|FG008|NOT COMPLETED|HP Washout 1||0||
48138548|NCT02310750|100661658|FG009|NOT COMPLETED|HP Washout 1||0||
48138549|NCT02310750|100661659|FG010|NOT COMPLETED|HP Washout 1||0||
48138550|NCT02310750|100661660|FG011|NOT COMPLETED|HP Washout 1||0||
48138551|NCT02310750|100661661|FG012|NOT COMPLETED|HP Washout 1||0||
48138552|NCT02310750|100661662|FG013|NOT COMPLETED|HP Washout 1||0||
48138553|NCT02310750|100661663|FG014|NOT COMPLETED|HP Washout 1||0||
48138554|NCT02310750|100661664|FG015|NOT COMPLETED|HP Washout 1||0||
48290385|NCT03814187|101037583|FG000|Safety Population|Overall Study||1512|All ORION-3 rollover subjects who signed the informed consent to Study ORION-8, and all ORION-9/ORION-10/ORION-11 rollover subjects with at least one study drug administration in Study ORION-8|
48138555|NCT02310750|100661649|FG000|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0||
48586741|NCT02031640|101770246|FG000|STARTED|Double-blind Treatment Period||0||
48586742|NCT02031640|101770247|FG001|STARTED|Double-blind Treatment Period||106||
48586743|NCT02031640|101770248|FG002|STARTED|Double-blind Treatment Period||106||
48586744|NCT02031640|101770249|FG003|STARTED|Double-blind Treatment Period||106||
48586745|NCT02031640|101770250|FG004|STARTED|Double-blind Treatment Period||107||
48586746|NCT02031640|101770251|FG005|STARTED|Double-blind Treatment Period||107||
48586747|NCT02031640|101770246|FG000|Full Analysis Set|Double-blind Treatment Period||0|Randomized patients with at least 1 dose of drug and 1 postbaseline trough am FEV1|
48592839|NCT00371644|101786323|FG001|STARTED|Overall Study||57||
48706381|NCT03848208|102069708|FG004|STARTED|Overall Study||6|randomized and treated|
48706382|NCT03848208|102069709|FG005|STARTED|Overall Study||6|randomized and treated|
48706383|NCT03848208|102069710|FG006|STARTED|Overall Study||6|randomized and treated|
48586748|NCT02031640|101770247|FG001|Full Analysis Set|Double-blind Treatment Period||106|Randomized patients with at least 1 dose of drug and 1 postbaseline trough am FEV1|
48586749|NCT02031640|101770248|FG002|Full Analysis Set|Double-blind Treatment Period||104|Randomized patients with at least 1 dose of drug and 1 postbaseline trough am FEV1|
48586750|NCT02031640|101770249|FG003|Full Analysis Set|Double-blind Treatment Period||106|Randomized patients with at least 1 dose of drug and 1 postbaseline trough am FEV1|
48586751|NCT02031640|101770250|FG004|Full Analysis Set|Double-blind Treatment Period||106|Randomized patients with at least 1 dose of drug and 1 postbaseline trough am FEV1|
48586752|NCT02031640|101770251|FG005|Full Analysis Set|Double-blind Treatment Period||107|Randomized patients with at least 1 dose of drug and 1 postbaseline trough am FEV1|
48586753|NCT02031640|101770246|FG000|COMPLETED|Double-blind Treatment Period||0||
48138556|NCT02310750|100661650|FG001|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0||
48706384|NCT03848208|102069711|FG007|STARTED|Overall Study||6|randomized and treated|
48706385|NCT03848208|102069712|FG008|STARTED|Overall Study||6|randomized and treated|
48706386|NCT03848208|102069713|FG009|STARTED|Overall Study||6|randomized and treated|
48138557|NCT02310750|100661651|FG002|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||5||
48138558|NCT02310750|100661652|FG003|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||4||
48290386|NCT03814187|101037584|FG001|Safety Population|Overall Study||1478|All ORION-3 rollover subjects who signed the informed consent to Study ORION-8, and all ORION-9/ORION-10/ORION-11 rollover subjects with at least one study drug administration in Study ORION-8|
48290387|NCT03814187|101037585|FG002|Safety Population|Overall Study||284|All ORION-3 rollover subjects who signed the informed consent to Study ORION-8, and all ORION-9/ORION-10/ORION-11 rollover subjects with at least one study drug administration in Study ORION-8|
48290388|NCT03814187|101037583|FG000|COMPLETED|Overall Study||1246||
48586754|NCT02031640|101770247|FG001|COMPLETED|Double-blind Treatment Period||84||
48586755|NCT02031640|101770248|FG002|COMPLETED|Double-blind Treatment Period||100||
48586756|NCT02031640|101770249|FG003|COMPLETED|Double-blind Treatment Period||99||
48586757|NCT02031640|101770250|FG004|COMPLETED|Double-blind Treatment Period||96||
48586758|NCT02031640|101770251|FG005|COMPLETED|Double-blind Treatment Period||104||
48586759|NCT02031640|101770246|FG000|NOT COMPLETED|Double-blind Treatment Period||0||
48290389|NCT03814187|101037584|FG001|COMPLETED|Overall Study||1200||
48586760|NCT02031640|101770247|FG001|NOT COMPLETED|Double-blind Treatment Period||22||
48586761|NCT02031640|101770248|FG002|NOT COMPLETED|Double-blind Treatment Period||6||
48586762|NCT02031640|101770249|FG003|NOT COMPLETED|Double-blind Treatment Period||7||
48586763|NCT02031640|101770250|FG004|NOT COMPLETED|Double-blind Treatment Period||11||
48586764|NCT02031640|101770251|FG005|NOT COMPLETED|Double-blind Treatment Period||3||
48586765|NCT02487771|101770252|FG000|STARTED|Overall Study||91||
48586766|NCT02487771|101770253|FG001|STARTED|Overall Study||99||
48586767|NCT02487771|101770252|FG000|COMPLETED|Overall Study||81||
48586768|NCT02487771|101770253|FG001|COMPLETED|Overall Study||85||
48586769|NCT02487771|101770252|FG000|NOT COMPLETED|Overall Study||10||
48586770|NCT02487771|101770253|FG001|NOT COMPLETED|Overall Study||14||
48586771|NCT03800836|101770254|FG000|STARTED|Overall Study||71||
48586772|NCT03800836|101770255|FG001|STARTED|Overall Study||20||
48586773|NCT03800836|101770256|FG002|STARTED|Overall Study||13||
48586774|NCT03800836|101770257|FG003|STARTED|Overall Study||12||
48586775|NCT03800836|101770258|FG004|STARTED|Overall Study||17||
48586776|NCT03800836|101770259|FG005|STARTED|Overall Study||6||
48586777|NCT03800836|101770254|FG000|Safety Population|Overall Study||70|Safety population included all participants who received any study treatment.|
48586778|NCT03800836|101770255|FG001|Safety Population|Overall Study||20|Safety population included all participants who received any study treatment.|
48586779|NCT03800836|101770256|FG002|Safety Population|Overall Study||12|Safety population included all participants who received any study treatment.|
48586780|NCT03800836|101770257|FG003|Safety Population|Overall Study||12|Safety population included all participants who received any study treatment.|
48586781|NCT03800836|101770258|FG004|Safety Population|Overall Study||17|Safety population included all participants who received any study treatment.|
48586782|NCT03800836|101770259|FG005|Safety Population|Overall Study||6|Safety population included all participants who received any study treatment.|
48586783|NCT03800836|101770254|FG000|COMPLETED|Overall Study||0||
48586784|NCT03800836|101770255|FG001|COMPLETED|Overall Study||0||
48706387|NCT03848208|102069704|FG000|COMPLETED|Overall Study||18||
48706388|NCT03848208|102069705|FG001|COMPLETED|Overall Study||6||
48706389|NCT03848208|102069706|FG002|COMPLETED|Overall Study||6||
48138559|NCT02310750|100661653|FG004|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6||
48138560|NCT02310750|100661654|FG005|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6||
48138561|NCT02310750|100661655|FG006|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9||
48138562|NCT02310750|100661656|FG007|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9||
48138563|NCT02310750|100661657|FG008|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||14||
48138564|NCT02310750|100661658|FG009|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||7||
48138565|NCT02310750|100661659|FG010|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2||
48138566|NCT02310750|100661660|FG011|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2||
48138567|NCT02310750|100661661|FG012|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2||
48138568|NCT02310750|100661662|FG013|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2||
48138569|NCT02310750|100661663|FG014|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2||
48138570|NCT02310750|100661664|FG015|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2||
48138571|NCT02310750|100661649|FG000|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0||
48138572|NCT02310750|100661650|FG001|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0||
48706390|NCT03848208|102069707|FG003|COMPLETED|Overall Study||6||
48706391|NCT03848208|102069708|FG004|COMPLETED|Overall Study||6||
48706392|NCT03848208|102069709|FG005|COMPLETED|Overall Study||6||
48706393|NCT03848208|102069710|FG006|COMPLETED|Overall Study||6||
48706394|NCT03848208|102069711|FG007|COMPLETED|Overall Study||6||
48138573|NCT02310750|100661651|FG002|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||5||
48138574|NCT02310750|100661652|FG003|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3||
48138575|NCT02310750|100661653|FG004|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6||
48138576|NCT02310750|100661654|FG005|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4||
48586785|NCT03800836|101770256|FG002|COMPLETED|Overall Study||0||
48586786|NCT03800836|101770257|FG003|COMPLETED|Overall Study||0||
48586787|NCT03800836|101770258|FG004|COMPLETED|Overall Study||0||
48586788|NCT03800836|101770259|FG005|COMPLETED|Overall Study||0||
48586789|NCT03800836|101770254|FG000|NOT COMPLETED|Overall Study||71||
48586790|NCT03800836|101770255|FG001|NOT COMPLETED|Overall Study||20||
48586791|NCT03800836|101770256|FG002|NOT COMPLETED|Overall Study||13||
48586792|NCT03800836|101770257|FG003|NOT COMPLETED|Overall Study||12||
48586793|NCT03800836|101770258|FG004|NOT COMPLETED|Overall Study||17||
48586794|NCT03800836|101770259|FG005|NOT COMPLETED|Overall Study||6||
48586795|NCT04748458|101770260|FG000|STARTED|Overall Study||85||100
48586796|NCT04748458|101770260|FG000|COMPLETED|Overall Study||85||100
48586797|NCT04748458|101770260|FG000|NOT COMPLETED|Overall Study||0||0
48586798|NCT03891862|101770261|FG000|STARTED|Open-label Period||135||
48586799|NCT03891862|101770262|FG001|STARTED|Open-label Period||0||
48586800|NCT03891862|101770263|FG002|STARTED|Open-label Period||0||
48586801|NCT03891862|101770261|FG000|Safety Analysis Set|Open-label Period||132|The safety analysis set for the open-label valbenazine group in this period includes all participants who received at least one dose of study drug and have any post-baseline safety data collected.|
48586802|NCT03891862|101770262|FG001|Safety Analysis Set|Open-label Period||0|The safety analysis set for the open-label valbenazine group in this period includes all participants who received at least one dose of study drug and have any post-baseline safety data collected.|
48586803|NCT03891862|101770263|FG002|Safety Analysis Set|Open-label Period||0|The safety analysis set for the open-label valbenazine group in this period includes all participants who received at least one dose of study drug and have any post-baseline safety data collected.|
48586804|NCT03891862|101770261|FG000|COMPLETED|Open-label Period||119||
48586805|NCT03891862|101770262|FG001|COMPLETED|Open-label Period||0||
48586806|NCT03891862|101770263|FG002|COMPLETED|Open-label Period||0||
48586807|NCT03891862|101770261|FG000|NOT COMPLETED|Open-label Period||16||
48586808|NCT03891862|101770262|FG001|NOT COMPLETED|Open-label Period||0||
48586809|NCT03891862|101770263|FG002|NOT COMPLETED|Open-label Period||0||
48586810|NCT03891862|101770261|FG000|STARTED|Placebo-controlled Period and Follow-up||0|One participant who completed the open-label period was not randomized.|
48586811|NCT03891862|101770262|FG001|STARTED|Placebo-controlled Period and Follow-up||59|One participant who completed the open-label period was not randomized.|
48586812|NCT03891862|101770263|FG002|STARTED|Placebo-controlled Period and Follow-up||59|One participant who completed the open-label period was not randomized.|
48586813|NCT03891862|101770261|FG000|Persistence of Effect Analysis Set|Placebo-controlled Period and Follow-up||0|Persistence of Effect analysis set included all randomized participants who received at least one dose of randomized study drug and have at least one AIMS assessment during the placebo-controlled period.|
48586814|NCT03891862|101770262|FG001|Persistence of Effect Analysis Set|Placebo-controlled Period and Follow-up||58|Persistence of Effect analysis set included all randomized participants who received at least one dose of randomized study drug and have at least one AIMS assessment during the placebo-controlled period.|
48586815|NCT03891862|101770263|FG002|Persistence of Effect Analysis Set|Placebo-controlled Period and Follow-up||59|Persistence of Effect analysis set included all randomized participants who received at least one dose of randomized study drug and have at least one AIMS assessment during the placebo-controlled period.|
48586816|NCT03891862|101770261|FG000|Completed Placebo-controlled Period|Placebo-controlled Period and Follow-up||0||
48586817|NCT03891862|101770262|FG001|Completed Placebo-controlled Period|Placebo-controlled Period and Follow-up||53||
48586818|NCT03891862|101770263|FG002|Completed Placebo-controlled Period|Placebo-controlled Period and Follow-up||56||
48586819|NCT03891862|101770261|FG000|COMPLETED|Placebo-controlled Period and Follow-up||0||
48586820|NCT03891862|101770262|FG001|COMPLETED|Placebo-controlled Period and Follow-up||53||
48586821|NCT03891862|101770263|FG002|COMPLETED|Placebo-controlled Period and Follow-up||55||
48586822|NCT03891862|101770261|FG000|NOT COMPLETED|Placebo-controlled Period and Follow-up||0||
48586823|NCT03891862|101770262|FG001|NOT COMPLETED|Placebo-controlled Period and Follow-up||6||
48586824|NCT03891862|101770263|FG002|NOT COMPLETED|Placebo-controlled Period and Follow-up||4||
48586825|NCT02210247|101770264|FG000|STARTED|Overall Study||12||
48586826|NCT02210247|101770265|FG001|STARTED|Overall Study||12||
48586827|NCT02210247|101770266|FG002|STARTED|Overall Study||12||
48586828|NCT02210247|101770267|FG003|STARTED|Overall Study||12||
48706395|NCT03848208|102069712|FG008|COMPLETED|Overall Study||6||
48706396|NCT03848208|102069713|FG009|COMPLETED|Overall Study||6||
48706397|NCT03848208|102069704|FG000|NOT COMPLETED|Overall Study||0||
48706398|NCT03848208|102069705|FG001|NOT COMPLETED|Overall Study||0||
48138577|NCT02310750|100661655|FG006|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||9||
48138578|NCT02310750|100661656|FG007|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||7||
48138579|NCT02310750|100661657|FG008|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6||
48138580|NCT02310750|100661658|FG009|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4||
48138581|NCT02310750|100661659|FG010|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2||
48586829|NCT02210247|101770268|FG004|STARTED|Overall Study||12||
48586830|NCT02210247|101770264|FG000|COMPLETED|Overall Study||12||
48586831|NCT02210247|101770265|FG001|COMPLETED|Overall Study||12||
48586832|NCT02210247|101770266|FG002|COMPLETED|Overall Study||12||
48586833|NCT02210247|101770267|FG003|COMPLETED|Overall Study||12||
48586834|NCT02210247|101770268|FG004|COMPLETED|Overall Study||12||
48586835|NCT02210247|101770264|FG000|NOT COMPLETED|Overall Study||0||
48586836|NCT02210247|101770265|FG001|NOT COMPLETED|Overall Study||0||
48586837|NCT02210247|101770266|FG002|NOT COMPLETED|Overall Study||0||
48586838|NCT02210247|101770267|FG003|NOT COMPLETED|Overall Study||0||
48586839|NCT02210247|101770268|FG004|NOT COMPLETED|Overall Study||0||
48706399|NCT03848208|102069706|FG002|NOT COMPLETED|Overall Study||0||
48706400|NCT03848208|102069707|FG003|NOT COMPLETED|Overall Study||0||
48706401|NCT03848208|102069708|FG004|NOT COMPLETED|Overall Study||0||
48586840|NCT03403751|101770269|FG000|STARTED|Overall Study||28||
48586841|NCT03403751|101770270|FG001|STARTED|Overall Study||30||
48586842|NCT03403751|101770269|FG000|COMPLETED|Overall Study||21||
48586843|NCT03403751|101770270|FG001|COMPLETED|Overall Study||22||
48586844|NCT03403751|101770269|FG000|NOT COMPLETED|Overall Study||7||
48586845|NCT03403751|101770270|FG001|NOT COMPLETED|Overall Study||8||
48586846|NCT00129727|101770271|FG000|STARTED|Overall Study||62||
48586847|NCT00129727|101770271|FG000|COMPLETED|Overall Study||57||
48586848|NCT00129727|101770271|FG000|NOT COMPLETED|Overall Study||5||
48586849|NCT01647516|101770272|FG000|STARTED|Induction Period (IP)||66||
48586850|NCT01647516|101770273|FG001|STARTED|Induction Period (IP)||66||
48586851|NCT01647516|101770274|FG002|STARTED|Induction Period (IP)||67||
48586852|NCT01647516|101770275|FG003|STARTED|Induction Period (IP)||0||
48586853|NCT01647516|101770276|FG004|STARTED|Induction Period (IP)||0||
48586854|NCT01647516|101770277|FG005|STARTED|Induction Period (IP)||0||
48586855|NCT01647516|101770272|FG000|Received Study Drug|Induction Period (IP)||65||
48586856|NCT01647516|101770273|FG001|Received Study Drug|Induction Period (IP)||65||
48586857|NCT01647516|101770274|FG002|Received Study Drug|Induction Period (IP)||67||
48138582|NCT02310750|100661660|FG011|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2||
48138583|NCT02310750|100661661|FG012|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2||
48138584|NCT02310750|100661662|FG013|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2||
48586858|NCT01647516|101770275|FG003|Received Study Drug|Induction Period (IP)||0||
48586859|NCT01647516|101770276|FG004|Received Study Drug|Induction Period (IP)||0||
48586860|NCT01647516|101770277|FG005|Received Study Drug|Induction Period (IP)||0||
48586861|NCT01647516|101770272|FG000|COMPLETED|Induction Period (IP)||60||
48586862|NCT01647516|101770273|FG001|COMPLETED|Induction Period (IP)||63||
48586863|NCT01647516|101770274|FG002|COMPLETED|Induction Period (IP)||63||
48586864|NCT01647516|101770275|FG003|COMPLETED|Induction Period (IP)||0||
48586865|NCT01647516|101770276|FG004|COMPLETED|Induction Period (IP)||0||
48706402|NCT03848208|102069709|FG005|NOT COMPLETED|Overall Study||0||
48706403|NCT03848208|102069710|FG006|NOT COMPLETED|Overall Study||0||
48706404|NCT03848208|102069711|FG007|NOT COMPLETED|Overall Study||0||
48706405|NCT03848208|102069712|FG008|NOT COMPLETED|Overall Study||0||
48706406|NCT03848208|102069713|FG009|NOT COMPLETED|Overall Study||0||
48706407|NCT01505673|102069714|FG000|STARTED|Overall Study||35||
48706408|NCT01505673|102069715|FG001|STARTED|Overall Study||36||
48706409|NCT01505673|102069714|FG000|COMPLETED|Overall Study||32||
48138585|NCT02310750|100661663|FG014|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2||
48706410|NCT01505673|102069715|FG001|COMPLETED|Overall Study||34||
48706411|NCT01505673|102069714|FG000|NOT COMPLETED|Overall Study||3||
48706412|NCT01505673|102069715|FG001|NOT COMPLETED|Overall Study||2||
48706413|NCT04105738|102069716|FG000|STARTED|Overall Study||13||
48138586|NCT02310750|100661664|FG015|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2||
48138587|NCT02310750|100661649|FG000|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0||
48138588|NCT02310750|100661650|FG001|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0||
48138589|NCT02310750|100661651|FG002|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0||
48138590|NCT02310750|100661652|FG003|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||1||
48138591|NCT02310750|100661653|FG004|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0||
48138592|NCT02310750|100661654|FG005|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2||
48138593|NCT02310750|100661655|FG006|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0||
48586866|NCT01647516|101770277|FG005|COMPLETED|Induction Period (IP)||0||
48586867|NCT01647516|101770272|FG000|NOT COMPLETED|Induction Period (IP)||6||
48586868|NCT01647516|101770273|FG001|NOT COMPLETED|Induction Period (IP)||3||
48586869|NCT01647516|101770274|FG002|NOT COMPLETED|Induction Period (IP)||4||
48586870|NCT01647516|101770275|FG003|NOT COMPLETED|Induction Period (IP)||0||
48586871|NCT01647516|101770276|FG004|NOT COMPLETED|Induction Period (IP)||0||
48706414|NCT04105738|102069717|FG001|STARTED|Overall Study||0||
48706415|NCT04105738|102069716|FG000|COMPLETED|Overall Study||13||
48706416|NCT04105738|102069717|FG001|COMPLETED|Overall Study||0||
48706417|NCT04105738|102069716|FG000|NOT COMPLETED|Overall Study||0||
48706418|NCT04105738|102069717|FG001|NOT COMPLETED|Overall Study||0||
48706419|NCT03305419|102069718|FG000|STARTED|Part A Period 1 (1Day) + Washout (7days)||3|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48706420|NCT03305419|102069719|FG001|STARTED|Part A Period 1 (1Day) + Washout (7days)||3|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48710766|NCT00402714|102078010|FG000|NOT COMPLETED|Overall Study||0||
48706421|NCT03305419|102069720|FG002|STARTED|Part A Period 1 (1Day) + Washout (7days)||3|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48706422|NCT03305419|102069721|FG003|STARTED|Part A Period 1 (1Day) + Washout (7days)||3|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48586872|NCT01647516|101770277|FG005|NOT COMPLETED|Induction Period (IP)||0||
48586873|NCT01647516|101770272|FG000|STARTED|Maintenance Period (MP)||25||
48586874|NCT01647516|101770273|FG001|STARTED|Maintenance Period (MP)||36||
48706423|NCT03305419|102069722|FG004|STARTED|Part A Period 1 (1Day) + Washout (7days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48706424|NCT03305419|102069723|FG005|STARTED|Part A Period 1 (1Day) + Washout (7days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48706425|NCT03305419|102069724|FG006|STARTED|Part A Period 1 (1Day) + Washout (7days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48706426|NCT03305419|102069725|FG007|STARTED|Part A Period 1 (1Day) + Washout (7days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48706427|NCT03305419|102069718|FG000|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48706428|NCT03305419|102069719|FG001|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||2|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48706429|NCT03305419|102069720|FG002|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48706430|NCT03305419|102069721|FG003|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48706431|NCT03305419|102069722|FG004|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48706432|NCT03305419|102069723|FG005|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48706433|NCT03305419|102069724|FG006|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48706434|NCT03305419|102069725|FG007|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48586875|NCT01647516|101770274|FG002|STARTED|Maintenance Period (MP)||42||
48586876|NCT01647516|101770275|FG003|STARTED|Maintenance Period (MP)||0||
48586877|NCT01647516|101770276|FG004|STARTED|Maintenance Period (MP)||0||
48586878|NCT01647516|101770277|FG005|STARTED|Maintenance Period (MP)||0||
48586879|NCT01647516|101770272|FG000|COMPLETED|Maintenance Period (MP)||21||
48586880|NCT01647516|101770273|FG001|COMPLETED|Maintenance Period (MP)||30||
48586881|NCT01647516|101770274|FG002|COMPLETED|Maintenance Period (MP)||40||
48586882|NCT01647516|101770275|FG003|COMPLETED|Maintenance Period (MP)||0||
48586883|NCT01647516|101770276|FG004|COMPLETED|Maintenance Period (MP)||0||
48586884|NCT01647516|101770277|FG005|COMPLETED|Maintenance Period (MP)||0||
48586885|NCT01647516|101770272|FG000|NOT COMPLETED|Maintenance Period (MP)||4||
48586886|NCT01647516|101770273|FG001|NOT COMPLETED|Maintenance Period (MP)||6||
48586887|NCT01647516|101770274|FG002|NOT COMPLETED|Maintenance Period (MP)||2||
48586888|NCT01647516|101770275|FG003|NOT COMPLETED|Maintenance Period (MP)||0||
48586889|NCT01647516|101770276|FG004|NOT COMPLETED|Maintenance Period (MP)||0||
48586890|NCT01647516|101770277|FG005|NOT COMPLETED|Maintenance Period (MP)||0||
48586891|NCT01647516|101770272|FG000|STARTED|Open-Label Period||0||
48586892|NCT01647516|101770273|FG001|STARTED|Open-Label Period||0||
48586893|NCT01647516|101770274|FG002|STARTED|Open-Label Period||0||
48586894|NCT01647516|101770275|FG003|STARTED|Open-Label Period||55||
48586895|NCT01647516|101770276|FG004|STARTED|Open-Label Period||56||
48586896|NCT01647516|101770277|FG005|STARTED|Open-Label Period||59||
48706435|NCT03305419|102069718|FG000|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0||
48706436|NCT03305419|102069719|FG001|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||1||
48706437|NCT03305419|102069720|FG002|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0||
48706438|NCT03305419|102069721|FG003|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0||
48706439|NCT03305419|102069722|FG004|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0||
48706440|NCT03305419|102069723|FG005|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0||
48706441|NCT03305419|102069724|FG006|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0||
48138594|NCT02310750|100661656|FG007|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2||
48706442|NCT03305419|102069725|FG007|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0||
48138595|NCT02310750|100661657|FG008|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||8||
48138596|NCT02310750|100661658|FG009|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3||
48138597|NCT02310750|100661659|FG010|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0||
48138598|NCT02310750|100661660|FG011|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0||
48586897|NCT01647516|101770272|FG000|COMPLETED|Open-Label Period||0||
48586898|NCT01647516|101770273|FG001|COMPLETED|Open-Label Period||0||
48586899|NCT01647516|101770274|FG002|COMPLETED|Open-Label Period||0||
48138599|NCT02310750|100661661|FG012|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0||
48586900|NCT01647516|101770275|FG003|COMPLETED|Open-Label Period||6||
48586901|NCT01647516|101770276|FG004|COMPLETED|Open-Label Period||5||
48586902|NCT01647516|101770277|FG005|COMPLETED|Open-Label Period||3||
48586903|NCT01647516|101770272|FG000|NOT COMPLETED|Open-Label Period||0||
48586904|NCT01647516|101770273|FG001|NOT COMPLETED|Open-Label Period||0||
48586905|NCT01647516|101770274|FG002|NOT COMPLETED|Open-Label Period||0||
48586906|NCT01647516|101770275|FG003|NOT COMPLETED|Open-Label Period||49||
48586907|NCT01647516|101770276|FG004|NOT COMPLETED|Open-Label Period||51||
48586908|NCT01647516|101770277|FG005|NOT COMPLETED|Open-Label Period||56||
48586909|NCT01953874|101770278|FG000|STARTED|Overall Study||65||
48586910|NCT01953874|101770279|FG001|STARTED|Overall Study||61||
48586911|NCT01953874|101770278|FG000|COMPLETED|Overall Study||65||
48586912|NCT01953874|101770279|FG001|COMPLETED|Overall Study||61||
48586913|NCT01953874|101770278|FG000|NOT COMPLETED|Overall Study||0||
48586914|NCT01953874|101770279|FG001|NOT COMPLETED|Overall Study||0||
48586915|NCT02963558|101770280|FG000|STARTED|Overall Study||14||
48138600|NCT02310750|100661662|FG013|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0||
48138601|NCT02310750|100661663|FG014|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0||
48138602|NCT02310750|100661664|FG015|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0||
48586916|NCT02963558|101770281|FG001|STARTED|Overall Study||10||
48586917|NCT02963558|101770280|FG000|COMPLETED|Overall Study||13||
48706443|NCT03305419|102069718|FG000|STARTED|Part A Period 2 (1Day) + Washout (7days)||3|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48706444|NCT03305419|102069719|FG001|STARTED|Part A Period 2 (1Day) + Washout (7days)||3|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48706445|NCT03305419|102069720|FG002|STARTED|Part A Period 2 (1Day) + Washout (7days)||3|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48706446|NCT03305419|102069721|FG003|STARTED|Part A Period 2 (1Day) + Washout (7days)||3|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48706447|NCT03305419|102069722|FG004|STARTED|Part A Period 2 (1Day) + Washout (7days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48706448|NCT03305419|102069723|FG005|STARTED|Part A Period 2 (1Day) + Washout (7days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48706449|NCT03305419|102069724|FG006|STARTED|Part A Period 2 (1Day) + Washout (7days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48138603|NCT02310750|100661649|FG000|STARTED|HP Washout 2||0||
48138604|NCT02310750|100661650|FG001|STARTED|HP Washout 2||0||
48138605|NCT02310750|100661651|FG002|STARTED|HP Washout 2||0||
48138606|NCT02310750|100661652|FG003|STARTED|HP Washout 2||0||
48138607|NCT02310750|100661653|FG004|STARTED|HP Washout 2||6||
48706450|NCT03305419|102069725|FG007|STARTED|Part A Period 2 (1Day) + Washout (7days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48706451|NCT03305419|102069718|FG000|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||1|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48706452|NCT03305419|102069719|FG001|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48710767|NCT00402714|102078011|FG001|NOT COMPLETED|Overall Study||0||
48138608|NCT02310750|100661654|FG005|STARTED|HP Washout 2||0||
48138609|NCT02310750|100661655|FG006|STARTED|HP Washout 2||9||
48138610|NCT02310750|100661656|FG007|STARTED|HP Washout 2||0||
48138611|NCT02310750|100661657|FG008|STARTED|HP Washout 2||0||
48138612|NCT02310750|100661658|FG009|STARTED|HP Washout 2||0||
48138613|NCT02310750|100661659|FG010|STARTED|HP Washout 2||2||
48138614|NCT02310750|100661660|FG011|STARTED|HP Washout 2||2||
48138615|NCT02310750|100661661|FG012|STARTED|HP Washout 2||2||
48138616|NCT02310750|100661662|FG013|STARTED|HP Washout 2||2||
48138617|NCT02310750|100661663|FG014|STARTED|HP Washout 2||2||
48138618|NCT02310750|100661664|FG015|STARTED|HP Washout 2||2||
48586918|NCT02963558|101770281|FG001|COMPLETED|Overall Study||9||
48586919|NCT02963558|101770280|FG000|NOT COMPLETED|Overall Study||1||
48586920|NCT02963558|101770281|FG001|NOT COMPLETED|Overall Study||1||
48586921|NCT01968707|101770282|FG000|STARTED|Overall Study||247||247
48586922|NCT01968707|101770283|FG001|STARTED|Overall Study||74||74
48586923|NCT01968707|101770284|FG002|STARTED|Overall Study||246||246
48586924|NCT01968707|101770285|FG003|STARTED|Overall Study||245||245
48586925|NCT01968707|101770286|FG004|STARTED|Overall Study||236||236
48586926|NCT01968707|101770287|FG005|STARTED|Overall Study||70||70
48586927|NCT01968707|101770288|FG006|STARTED|Overall Study||238||238
48586928|NCT01968707|101770289|FG007|STARTED|Overall Study||238||238
48586929|NCT01968707|101770282|FG000|COMPLETED|Overall Study||198||198
48586930|NCT01968707|101770283|FG001|COMPLETED|Overall Study||62||62
48586931|NCT01968707|101770284|FG002|COMPLETED|Overall Study||205||205
48586932|NCT01968707|101770285|FG003|COMPLETED|Overall Study||201||201
48586933|NCT01968707|101770286|FG004|COMPLETED|Overall Study||200||200
48586934|NCT01968707|101770287|FG005|COMPLETED|Overall Study||59||59
48586935|NCT01968707|101770288|FG006|COMPLETED|Overall Study||204||204
48586936|NCT01968707|101770289|FG007|COMPLETED|Overall Study||203||203
48138619|NCT02310750|100661649|FG000|COMPLETED|HP Washout 2||0||
48138620|NCT02310750|100661650|FG001|COMPLETED|HP Washout 2||0||
48138621|NCT02310750|100661651|FG002|COMPLETED|HP Washout 2||0||
48138622|NCT02310750|100661652|FG003|COMPLETED|HP Washout 2||0||
48138623|NCT02310750|100661653|FG004|COMPLETED|HP Washout 2||5||
48138624|NCT02310750|100661654|FG005|COMPLETED|HP Washout 2||0||
48138625|NCT02310750|100661655|FG006|COMPLETED|HP Washout 2||2||
48290390|NCT03814187|101037585|FG002|COMPLETED|Overall Study||0||
48290391|NCT03814187|101037583|FG000|NOT COMPLETED|Overall Study||267||
48290392|NCT03814187|101037584|FG001|NOT COMPLETED|Overall Study||278||
48290393|NCT03814187|101037585|FG002|NOT COMPLETED|Overall Study||284||
48290394|NCT04585776|101037586|FG000|STARTED|Overall Study||31||
48706453|NCT03305419|102069720|FG002|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48290395|NCT04585776|101037586|FG000|Received Atleast 1 Dose of Study Drug|Overall Study||31||
48290396|NCT04585776|101037586|FG000|COMPLETED|Overall Study||31||
48290397|NCT04585776|101037586|FG000|NOT COMPLETED|Overall Study||0||
48290398|NCT03717129|101037587|FG000|STARTED|Genvoya Oral Dose (1 Week)||12||
48706454|NCT03305419|102069721|FG003|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48706455|NCT03305419|102069722|FG004|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48706456|NCT03305419|102069723|FG005|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48706457|NCT03305419|102069724|FG006|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48706458|NCT03305419|102069725|FG007|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48706459|NCT03305419|102069718|FG000|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||2||
48706460|NCT03305419|102069719|FG001|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0||
48706461|NCT03305419|102069720|FG002|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0||
48706462|NCT03305419|102069721|FG003|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0||
48706463|NCT03305419|102069722|FG004|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0||
48706464|NCT03305419|102069723|FG005|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0||
48706465|NCT03305419|102069724|FG006|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0||
48706466|NCT03305419|102069725|FG007|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0||
48706467|NCT03305419|102069718|FG000|STARTED|Part A Period 3 (1Day) + Washout (7days)||3||
48706468|NCT03305419|102069719|FG001|STARTED|Part A Period 3 (1Day) + Washout (7days)||3||
48706469|NCT03305419|102069720|FG002|STARTED|Part A Period 3 (1Day) + Washout (7days)||3||
48706470|NCT03305419|102069721|FG003|STARTED|Part A Period 3 (1Day) + Washout (7days)||3||
48706471|NCT03305419|102069722|FG004|STARTED|Part A Period 3 (1Day) + Washout (7days)||0||
48706472|NCT03305419|102069723|FG005|STARTED|Part A Period 3 (1Day) + Washout (7days)||0||
48706473|NCT03305419|102069724|FG006|STARTED|Part A Period 3 (1Day) + Washout (7days)||0||
48706474|NCT03305419|102069725|FG007|STARTED|Part A Period 3 (1Day) + Washout (7days)||0||
48706475|NCT03305419|102069718|FG000|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3||
48706476|NCT03305419|102069719|FG001|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3||
48706477|NCT03305419|102069720|FG002|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3||
48706478|NCT03305419|102069721|FG003|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3||
48706479|NCT03305419|102069722|FG004|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0||
48706480|NCT03305419|102069723|FG005|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0||
48706481|NCT03305419|102069724|FG006|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0||
48706482|NCT03305419|102069725|FG007|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0||
48706483|NCT03305419|102069718|FG000|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0||
48706484|NCT03305419|102069719|FG001|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0||
48706485|NCT03305419|102069720|FG002|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0||
48706486|NCT03305419|102069721|FG003|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0||
48710768|NCT01924442|102078012|FG000|STARTED|Overall Study||1099||
48138626|NCT02310750|100661656|FG007|COMPLETED|HP Washout 2||0||
48138627|NCT02310750|100661657|FG008|COMPLETED|HP Washout 2||0||
48138628|NCT02310750|100661658|FG009|COMPLETED|HP Washout 2||0||
48138629|NCT02310750|100661659|FG010|COMPLETED|HP Washout 2||2||
48138630|NCT02310750|100661660|FG011|COMPLETED|HP Washout 2||2||
48138631|NCT02310750|100661661|FG012|COMPLETED|HP Washout 2||2||
48138632|NCT02310750|100661662|FG013|COMPLETED|HP Washout 2||2||
48138633|NCT02310750|100661663|FG014|COMPLETED|HP Washout 2||2||
48138634|NCT02310750|100661664|FG015|COMPLETED|HP Washout 2||2||
48138635|NCT02310750|100661649|FG000|NOT COMPLETED|HP Washout 2||0||
48138636|NCT02310750|100661650|FG001|NOT COMPLETED|HP Washout 2||0||
48138637|NCT02310750|100661651|FG002|NOT COMPLETED|HP Washout 2||0||
48138638|NCT02310750|100661652|FG003|NOT COMPLETED|HP Washout 2||0||
48138639|NCT02310750|100661653|FG004|NOT COMPLETED|HP Washout 2||1||
48138640|NCT02310750|100661654|FG005|NOT COMPLETED|HP Washout 2||0||
48138641|NCT02310750|100661655|FG006|NOT COMPLETED|HP Washout 2||7||
48138642|NCT02310750|100661656|FG007|NOT COMPLETED|HP Washout 2||0||
48706487|NCT03305419|102069722|FG004|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0||
48706488|NCT03305419|102069723|FG005|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0||
48706489|NCT03305419|102069724|FG006|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0||
48706490|NCT03305419|102069725|FG007|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0||
48706491|NCT03305419|102069718|FG000|STARTED|Part B (14 Days)||0||
48706492|NCT03305419|102069719|FG001|STARTED|Part B (14 Days)||0||
48706493|NCT03305419|102069720|FG002|STARTED|Part B (14 Days)||0||
48706494|NCT03305419|102069721|FG003|STARTED|Part B (14 Days)||0||
48706495|NCT03305419|102069722|FG004|STARTED|Part B (14 Days)||14||
48706496|NCT03305419|102069723|FG005|STARTED|Part B (14 Days)||20||
48706497|NCT03305419|102069724|FG006|STARTED|Part B (14 Days)||13||
48706498|NCT03305419|102069725|FG007|STARTED|Part B (14 Days)||0||
48706499|NCT03305419|102069718|FG000|COMPLETED|Part B (14 Days)||0||
48706500|NCT03305419|102069719|FG001|COMPLETED|Part B (14 Days)||0||
48706501|NCT03305419|102069720|FG002|COMPLETED|Part B (14 Days)||0||
48706502|NCT03305419|102069721|FG003|COMPLETED|Part B (14 Days)||0||
48706503|NCT03305419|102069722|FG004|COMPLETED|Part B (14 Days)||11||
48706504|NCT03305419|102069723|FG005|COMPLETED|Part B (14 Days)||10||
48706505|NCT03305419|102069724|FG006|COMPLETED|Part B (14 Days)||8||
48138643|NCT02310750|100661657|FG008|NOT COMPLETED|HP Washout 2||0||
48138644|NCT02310750|100661658|FG009|NOT COMPLETED|HP Washout 2||0||
48138645|NCT02310750|100661659|FG010|NOT COMPLETED|HP Washout 2||0||
48138646|NCT02310750|100661660|FG011|NOT COMPLETED|HP Washout 2||0||
48138647|NCT02310750|100661661|FG012|NOT COMPLETED|HP Washout 2||0||
48706506|NCT03305419|102069725|FG007|COMPLETED|Part B (14 Days)||0||
48706507|NCT03305419|102069718|FG000|NOT COMPLETED|Part B (14 Days)||0||
48706508|NCT03305419|102069719|FG001|NOT COMPLETED|Part B (14 Days)||0||
48706509|NCT03305419|102069720|FG002|NOT COMPLETED|Part B (14 Days)||0||
48706510|NCT03305419|102069721|FG003|NOT COMPLETED|Part B (14 Days)||0||
48706511|NCT03305419|102069722|FG004|NOT COMPLETED|Part B (14 Days)||3||
48706512|NCT03305419|102069723|FG005|NOT COMPLETED|Part B (14 Days)||10||
48706513|NCT03305419|102069724|FG006|NOT COMPLETED|Part B (14 Days)||5||
48706514|NCT03305419|102069725|FG007|NOT COMPLETED|Part B (14 Days)||0||
48586937|NCT01968707|101770282|FG000|NOT COMPLETED|Overall Study||49||49
48586938|NCT01968707|101770283|FG001|NOT COMPLETED|Overall Study||12||12
48586939|NCT01968707|101770284|FG002|NOT COMPLETED|Overall Study||41||41
48586940|NCT01968707|101770285|FG003|NOT COMPLETED|Overall Study||44||44
48586941|NCT01968707|101770286|FG004|NOT COMPLETED|Overall Study||36||36
48586942|NCT01968707|101770287|FG005|NOT COMPLETED|Overall Study||11||11
48586943|NCT01968707|101770288|FG006|NOT COMPLETED|Overall Study||34||34
48586944|NCT01968707|101770289|FG007|NOT COMPLETED|Overall Study||35||35
48586945|NCT02637895|101770290|FG000|STARTED|Overall Study||21||
48706515|NCT02358031|102069726|FG000|STARTED|Overall Study||301||
48706516|NCT02358031|102069727|FG001|STARTED|Overall Study||281||
48706517|NCT02358031|102069728|FG002|STARTED|Overall Study||300||
48706518|NCT02358031|102069726|FG000|Treated|Overall Study||300||
48706519|NCT02358031|102069727|FG001|Treated|Overall Study||276||
48706520|NCT02358031|102069728|FG002|Treated|Overall Study||287||
48290399|NCT03717129|101037587|FG000|COMPLETED|Genvoya Oral Dose (1 Week)||12||
48586946|NCT02637895|101770291|FG001|STARTED|Overall Study||20||
48586947|NCT02637895|101770290|FG000|COMPLETED|Overall Study||15||
48586948|NCT02637895|101770291|FG001|COMPLETED|Overall Study||17||
48586949|NCT02637895|101770290|FG000|NOT COMPLETED|Overall Study||6||
48586950|NCT02637895|101770291|FG001|NOT COMPLETED|Overall Study||3||
48586951|NCT03589976|101770292|FG000|STARTED|Overall Study||35||
48586952|NCT03589976|101770293|FG001|STARTED|Overall Study||12||
48586953|NCT03589976|101770292|FG000|COMPLETED|Overall Study||16||
48586954|NCT03589976|101770293|FG001|COMPLETED|Overall Study||6||
48586955|NCT03589976|101770292|FG000|NOT COMPLETED|Overall Study||19||
48586956|NCT03589976|101770293|FG001|NOT COMPLETED|Overall Study||6||
48586957|NCT01054300|101770294|FG000|STARTED|Period 1||13||
48586958|NCT01054300|101770295|FG001|STARTED|Period 1||13||
48586959|NCT01054300|101770296|FG002|STARTED|Period 1||13||
48586960|NCT01054300|101770297|FG003|STARTED|Period 1||13||
48586961|NCT01054300|101770294|FG000|COMPLETED|Period 1||12||
48586962|NCT01054300|101770295|FG001|COMPLETED|Period 1||13||
48586963|NCT01054300|101770296|FG002|COMPLETED|Period 1||13||
48586964|NCT01054300|101770297|FG003|COMPLETED|Period 1||13||
48586965|NCT01054300|101770294|FG000|NOT COMPLETED|Period 1||1||
48586966|NCT01054300|101770295|FG001|NOT COMPLETED|Period 1||0||
48586967|NCT01054300|101770296|FG002|NOT COMPLETED|Period 1||0||
48586968|NCT01054300|101770297|FG003|NOT COMPLETED|Period 1||0||
48586969|NCT01054300|101770294|FG000|STARTED|Period 2||12||
48586970|NCT01054300|101770295|FG001|STARTED|Period 2||13||
48586971|NCT01054300|101770296|FG002|STARTED|Period 2||13||
48586972|NCT01054300|101770297|FG003|STARTED|Period 2||13||
48586973|NCT01054300|101770294|FG000|COMPLETED|Period 2||12||
48586974|NCT01054300|101770295|FG001|COMPLETED|Period 2||13||
48586975|NCT01054300|101770296|FG002|COMPLETED|Period 2||12||
48586976|NCT01054300|101770297|FG003|COMPLETED|Period 2||13||
48586977|NCT01054300|101770294|FG000|NOT COMPLETED|Period 2||0||
48586978|NCT01054300|101770295|FG001|NOT COMPLETED|Period 2||0||
48586979|NCT01054300|101770296|FG002|NOT COMPLETED|Period 2||1||
48706521|NCT02358031|102069726|FG000|Pembro Mono v Control Efficacy Analyses|Overall Study||301||
48706522|NCT02358031|102069727|FG001|Pembro Mono v Control Efficacy Analyses|Overall Study||0||
48706523|NCT02358031|102069728|FG002|Pembro Mono v Control Efficacy Analyses|Overall Study||300||
48706524|NCT02358031|102069726|FG000|Pembro Combo v Control Efficacy Analyses|Overall Study||0||
48706525|NCT02358031|102069727|FG001|Pembro Combo v Control Efficacy Analyses|Overall Study||281||
48706526|NCT02358031|102069728|FG002|Pembro Combo v Control Efficacy Analyses|Overall Study||278||
48706527|NCT02358031|102069726|FG000|Received Second Course of Pembrolizumab|Overall Study||8||
48290400|NCT03717129|101037587|FG000|NOT COMPLETED|Genvoya Oral Dose (1 Week)||0||
48290401|NCT03717129|101037587|FG000|STARTED|Washout (2 Weeks)||12||
48290402|NCT03717129|101037587|FG000|COMPLETED|Washout (2 Weeks)||12||
48290403|NCT03717129|101037587|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
48290404|NCT03717129|101037587|FG000|STARTED|Genvoya Crushed Dose (1 Week)||12||
48290405|NCT03717129|101037587|FG000|COMPLETED|Genvoya Crushed Dose (1 Week)||12||
48290406|NCT03717129|101037587|FG000|NOT COMPLETED|Genvoya Crushed Dose (1 Week)||0||
48290407|NCT01116882|101037588|FG000|STARTED|30-day||2774||
48290408|NCT01116882|101037589|FG001|STARTED|30-day||917||
48290409|NCT01116882|101037588|FG000|COMPLETED|30-day||2706||
48290410|NCT01116882|101037589|FG001|COMPLETED|30-day||886||
48290411|NCT01116882|101037588|FG000|NOT COMPLETED|30-day||68||
48290412|NCT01116882|101037589|FG001|NOT COMPLETED|30-day||31||
48290413|NCT01116882|101037588|FG000|STARTED|12-month||2706||
48290414|NCT01116882|101037589|FG001|STARTED|12-month||886||
48290415|NCT01116882|101037588|FG000|COMPLETED|12-month||2439||
48290416|NCT01116882|101037589|FG001|COMPLETED|12-month||787||
48290417|NCT01116882|101037588|FG000|NOT COMPLETED|12-month||267||
48290418|NCT01116882|101037589|FG001|NOT COMPLETED|12-month||99||
48290419|NCT00715962|101037590|FG000|STARTED|Overall Study||50||
48290420|NCT00715962|101037591|FG001|STARTED|Overall Study||50||
48290421|NCT00715962|101037590|FG000|COMPLETED|Overall Study||44||
48586980|NCT01054300|101770297|FG003|NOT COMPLETED|Period 2||0||
48586981|NCT03138252|101770298|FG000|STARTED|Overall Study||90||
48586982|NCT03138252|101770299|FG001|STARTED|Overall Study||90||
48290422|NCT00715962|101037591|FG001|COMPLETED|Overall Study||48||
48586983|NCT03138252|101770298|FG000|COMPLETED|Overall Study||90||
48586984|NCT03138252|101770299|FG001|COMPLETED|Overall Study||90||
48586985|NCT03138252|101770298|FG000|NOT COMPLETED|Overall Study||0||
48586986|NCT03138252|101770299|FG001|NOT COMPLETED|Overall Study||0||
48586987|NCT00380081|101770300|FG000|STARTED|Overall Study||14||
48586988|NCT00380081|101770301|FG001|STARTED|Overall Study||13||
48706528|NCT02358031|102069727|FG001|Received Second Course of Pembrolizumab|Overall Study||6||
48290423|NCT00715962|101037590|FG000|NOT COMPLETED|Overall Study||6||
48290424|NCT00715962|101037591|FG001|NOT COMPLETED|Overall Study||2||
48290425|NCT00687973|101037592|FG000|STARTED|Overall Study||193||
48290426|NCT00687973|101037593|FG001|STARTED|Overall Study||200||
48290427|NCT00687973|101037592|FG000|COMPLETED|Overall Study||169||
48586989|NCT00380081|101770302|FG002|STARTED|Overall Study||13||
48290428|NCT00687973|101037593|FG001|COMPLETED|Overall Study||162||
48586990|NCT00380081|101770303|FG003|STARTED|Overall Study||15||
48586991|NCT00380081|101770304|FG004|STARTED|Overall Study||13||
48586992|NCT00380081|101770305|FG005|STARTED|Overall Study||14||
48586993|NCT00380081|101770300|FG000|COMPLETED|Overall Study||14||
48586994|NCT00380081|101770301|FG001|COMPLETED|Overall Study||13||
48586995|NCT00380081|101770302|FG002|COMPLETED|Overall Study||13||
48586996|NCT00380081|101770303|FG003|COMPLETED|Overall Study||15||
48586997|NCT00380081|101770304|FG004|COMPLETED|Overall Study||12||
48586998|NCT00380081|101770305|FG005|COMPLETED|Overall Study||13||
48586999|NCT00380081|101770300|FG000|NOT COMPLETED|Overall Study||0||
48587000|NCT00380081|101770301|FG001|NOT COMPLETED|Overall Study||0||
48587001|NCT00380081|101770302|FG002|NOT COMPLETED|Overall Study||0||
48587002|NCT00380081|101770303|FG003|NOT COMPLETED|Overall Study||0||
48587003|NCT00380081|101770304|FG004|NOT COMPLETED|Overall Study||1||
48587004|NCT00380081|101770305|FG005|NOT COMPLETED|Overall Study||1||
48587005|NCT00658775|101770306|FG000|STARTED|Overall Study||537||
48587006|NCT00658775|101770307|FG001|STARTED|Overall Study||528||
48587007|NCT00658775|101770306|FG000|COMPLETED|Overall Study||495||
48587008|NCT00658775|101770307|FG001|COMPLETED|Overall Study||485||
48587009|NCT00658775|101770306|FG000|NOT COMPLETED|Overall Study||42||
48587010|NCT00658775|101770307|FG001|NOT COMPLETED|Overall Study||43||
48587011|NCT02836236|101770308|FG000|STARTED|Double-Blind Treatment Phase||105||
48587012|NCT02836236|101770309|FG001|STARTED|Double-Blind Treatment Phase||50||
48587013|NCT02836236|101770310|FG002|STARTED|Double-Blind Treatment Phase||0||
48587014|NCT02836236|101770311|FG003|STARTED|Double-Blind Treatment Phase||0||
48587015|NCT02836236|101770308|FG000|COMPLETED|Double-Blind Treatment Phase||99||
48587016|NCT02836236|101770309|FG001|COMPLETED|Double-Blind Treatment Phase||47||
48587017|NCT02836236|101770310|FG002|COMPLETED|Double-Blind Treatment Phase||0||
48587018|NCT02836236|101770311|FG003|COMPLETED|Double-Blind Treatment Phase||0||
48587019|NCT02836236|101770308|FG000|NOT COMPLETED|Double-Blind Treatment Phase||6||
48587020|NCT02836236|101770309|FG001|NOT COMPLETED|Double-Blind Treatment Phase||3||
48587021|NCT02836236|101770310|FG002|NOT COMPLETED|Double-Blind Treatment Phase||0||
48587022|NCT02836236|101770311|FG003|NOT COMPLETED|Double-Blind Treatment Phase||0||
48587023|NCT02836236|101770308|FG000|STARTED|Open-Label TAF Treatment Phase||0|At the end of Double-blind Phase, participants were given the option to receive TAF in an OL TAF Extension Phase for additional 240 weeks.|
48587024|NCT02836236|101770309|FG001|STARTED|Open-Label TAF Treatment Phase||0|At the end of Double-blind Phase, participants were given the option to receive TAF in an OL TAF Extension Phase for additional 240 weeks.|
48587025|NCT02836236|101770310|FG002|STARTED|Open-Label TAF Treatment Phase||99|At the end of Double-blind Phase, participants were given the option to receive TAF in an OL TAF Extension Phase for additional 240 weeks.|
48706529|NCT02358031|102069728|FG002|Received Second Course of Pembrolizumab|Overall Study||0||
48706530|NCT02358031|102069726|FG000|COMPLETED|Overall Study||2||
48706531|NCT02358031|102069727|FG001|COMPLETED|Overall Study||1||
48706532|NCT02358031|102069728|FG002|COMPLETED|Overall Study||0||
48706533|NCT02358031|102069726|FG000|NOT COMPLETED|Overall Study||299||
48706534|NCT02358031|102069727|FG001|NOT COMPLETED|Overall Study||280||
48706535|NCT02358031|102069728|FG002|NOT COMPLETED|Overall Study||300||
48706536|NCT03088748|102069729|FG000|STARTED|Overall Study||40||
48706537|NCT03088748|102069730|FG001|STARTED|Overall Study||10||
48706538|NCT03088748|102069729|FG000|COMPLETED|Overall Study||40||
48706539|NCT03088748|102069730|FG001|COMPLETED|Overall Study||10||
48706540|NCT03088748|102069729|FG000|NOT COMPLETED|Overall Study||0||
48706541|NCT03088748|102069730|FG001|NOT COMPLETED|Overall Study||0||
48706542|NCT04319380|102069731|FG000|STARTED|Overall Study||1683||
48706543|NCT04319380|102069732|FG001|STARTED|Overall Study||1705||
48706544|NCT04319380|102069733|FG002|STARTED|Overall Study||1710||
48706545|NCT04319380|102069731|FG000|COMPLETED|Overall Study||1644||
48706546|NCT04319380|102069732|FG001|COMPLETED|Overall Study||1650||
48706547|NCT04319380|102069733|FG002|COMPLETED|Overall Study||1661||
48706548|NCT04319380|102069731|FG000|NOT COMPLETED|Overall Study||39||
48706549|NCT04319380|102069732|FG001|NOT COMPLETED|Overall Study||55||
48706550|NCT04319380|102069733|FG002|NOT COMPLETED|Overall Study||49||
48706551|NCT03349645|102069734|FG000|STARTED|Overall Study||94||
48706552|NCT03349645|102069734|FG000|COMPLETED|Overall Study||12||
48706553|NCT03349645|102069734|FG000|NOT COMPLETED|Overall Study||82||
48706554|NCT04979897|102069735|FG000|STARTED|Overall Study||149||
48706555|NCT04979897|102069736|FG001|STARTED|Overall Study||103||
48706556|NCT04979897|102069735|FG000|3-month Follow-up|Overall Study||55||
48706557|NCT04979897|102069736|FG001|3-month Follow-up|Overall Study||50||
48706558|NCT04979897|102069735|FG000|COMPLETED|Overall Study||30||
48706559|NCT04979897|102069736|FG001|COMPLETED|Overall Study||37||
48706560|NCT04979897|102069735|FG000|NOT COMPLETED|Overall Study||119||
48706561|NCT04979897|102069736|FG001|NOT COMPLETED|Overall Study||66||
48706562|NCT01018134|102069737|FG000|STARTED|Overall Study||30||
48706563|NCT01018134|102069738|FG001|STARTED|Overall Study||31||
48592840|NCT00371644|101786322|FG000|COMPLETED|Overall Study||44||
48706564|NCT01018134|102069739|FG002|STARTED|Overall Study||30||
48706565|NCT01018134|102069740|FG003|STARTED|Overall Study||29||
48706566|NCT01018134|102069741|FG004|STARTED|Overall Study||15||
48706567|NCT01018134|102069742|FG005|STARTED|Overall Study||15||
48706568|NCT01018134|102069737|FG000|COMPLETED|Overall Study||30||
48706569|NCT01018134|102069738|FG001|COMPLETED|Overall Study||30||
48706570|NCT01018134|102069739|FG002|COMPLETED|Overall Study||29||
48706571|NCT01018134|102069740|FG003|COMPLETED|Overall Study||29||
48587026|NCT02836236|101770311|FG003|STARTED|Open-Label TAF Treatment Phase||47|At the end of Double-blind Phase, participants were given the option to receive TAF in an OL TAF Extension Phase for additional 240 weeks.|
48587027|NCT02836236|101770308|FG000|COMPLETED|Open-Label TAF Treatment Phase||0||
48587028|NCT02836236|101770309|FG001|COMPLETED|Open-Label TAF Treatment Phase||0||
48587029|NCT02836236|101770310|FG002|COMPLETED|Open-Label TAF Treatment Phase||92||
48587030|NCT02836236|101770311|FG003|COMPLETED|Open-Label TAF Treatment Phase||43||
48587031|NCT02836236|101770308|FG000|NOT COMPLETED|Open-Label TAF Treatment Phase||0||
48587032|NCT02836236|101770309|FG001|NOT COMPLETED|Open-Label TAF Treatment Phase||0||
48706572|NCT01018134|102069741|FG004|COMPLETED|Overall Study||15||
48706573|NCT01018134|102069742|FG005|COMPLETED|Overall Study||15||
48706574|NCT01018134|102069737|FG000|NOT COMPLETED|Overall Study||0||
48706575|NCT01018134|102069738|FG001|NOT COMPLETED|Overall Study||1||
48706576|NCT01018134|102069739|FG002|NOT COMPLETED|Overall Study||1||
48706577|NCT01018134|102069740|FG003|NOT COMPLETED|Overall Study||0||
48706578|NCT01018134|102069741|FG004|NOT COMPLETED|Overall Study||0||
48706579|NCT01018134|102069742|FG005|NOT COMPLETED|Overall Study||0||
48706580|NCT03272828|102069743|FG000|STARTED|Overall Study||24||
48706581|NCT03272828|102069744|FG001|STARTED|Overall Study||23||
48706582|NCT03272828|102069743|FG000|COMPLETED|Overall Study||13||
48706583|NCT03272828|102069744|FG001|COMPLETED|Overall Study||13||
48706584|NCT03272828|102069743|FG000|NOT COMPLETED|Overall Study||11||
48706585|NCT03272828|102069744|FG001|NOT COMPLETED|Overall Study||10||
48587033|NCT02836236|101770310|FG002|NOT COMPLETED|Open-Label TAF Treatment Phase||7||
48587034|NCT02836236|101770311|FG003|NOT COMPLETED|Open-Label TAF Treatment Phase||4||
48587035|NCT04360174|101770312|FG000|STARTED|Overall Study||5||
48587036|NCT04360174|101770313|FG001|STARTED|Overall Study||4||
48587037|NCT04360174|101770314|FG002|STARTED|Overall Study||5||
48587038|NCT04360174|101770315|FG003|STARTED|Overall Study||5||
48587039|NCT04360174|101770312|FG000|COMPLETED|Overall Study||5||
48587040|NCT04360174|101770313|FG001|COMPLETED|Overall Study||4||
48587041|NCT04360174|101770314|FG002|COMPLETED|Overall Study||5||
48587042|NCT04360174|101770315|FG003|COMPLETED|Overall Study||5||
48587043|NCT04360174|101770312|FG000|NOT COMPLETED|Overall Study||0||
48587044|NCT04360174|101770313|FG001|NOT COMPLETED|Overall Study||0||
48587045|NCT04360174|101770314|FG002|NOT COMPLETED|Overall Study||0||
48587046|NCT04360174|101770315|FG003|NOT COMPLETED|Overall Study||0||
48587047|NCT00725608|101770316|FG000|STARTED|Overall Study||307||
48587048|NCT00725608|101770316|FG000|COMPLETED|Overall Study||140||
48587049|NCT00725608|101770316|FG000|NOT COMPLETED|Overall Study||167||
48587050|NCT02541669|101770317|FG000|STARTED|Open Label Treatment Period||8||
48587051|NCT02541669|101770318|FG001|STARTED|Open Label Treatment Period||8||
48587052|NCT02541669|101770319|FG002|STARTED|Open Label Treatment Period||0||
48587053|NCT02541669|101770320|FG003|STARTED|Open Label Treatment Period||0||
48587054|NCT02541669|101770321|FG004|STARTED|Open Label Treatment Period||0||
48587055|NCT02541669|101770317|FG000|COMPLETED|Open Label Treatment Period||8||
48587056|NCT02541669|101770318|FG001|COMPLETED|Open Label Treatment Period||8||
48587057|NCT02541669|101770319|FG002|COMPLETED|Open Label Treatment Period||0||
48587058|NCT02541669|101770320|FG003|COMPLETED|Open Label Treatment Period||0||
48587059|NCT02541669|101770321|FG004|COMPLETED|Open Label Treatment Period||0||
48587060|NCT02541669|101770317|FG000|NOT COMPLETED|Open Label Treatment Period||0||
48587061|NCT02541669|101770318|FG001|NOT COMPLETED|Open Label Treatment Period||0||
48587062|NCT02541669|101770319|FG002|NOT COMPLETED|Open Label Treatment Period||0||
48706586|NCT02927925|102069745|FG000|STARTED|Overall Study||32||
48706587|NCT02927925|102069745|FG000|COMPLETED|Overall Study||0||
48706588|NCT02927925|102069745|FG000|NOT COMPLETED|Overall Study||32||
48706589|NCT01071200|102069746|FG000|STARTED|Overall Study||67||
48587063|NCT02541669|101770320|FG003|NOT COMPLETED|Open Label Treatment Period||0||
48587064|NCT02541669|101770321|FG004|NOT COMPLETED|Open Label Treatment Period||0||
48587065|NCT02541669|101770317|FG000|STARTED|Double-Blinded Treatment Period||0||
48587066|NCT02541669|101770318|FG001|STARTED|Double-Blinded Treatment Period||0||
48587067|NCT02541669|101770319|FG002|STARTED|Double-Blinded Treatment Period||16||
48587068|NCT02541669|101770320|FG003|STARTED|Double-Blinded Treatment Period||16||
48706590|NCT01071200|102069747|FG001|STARTED|Overall Study||66||
48706591|NCT01071200|102069746|FG000|COMPLETED|Overall Study||60||
48706592|NCT01071200|102069747|FG001|COMPLETED|Overall Study||63||
48587069|NCT02541669|101770321|FG004|STARTED|Double-Blinded Treatment Period||16||
48587070|NCT02541669|101770317|FG000|COMPLETED|Double-Blinded Treatment Period||0||
48587071|NCT02541669|101770318|FG001|COMPLETED|Double-Blinded Treatment Period||0||
48587072|NCT02541669|101770319|FG002|COMPLETED|Double-Blinded Treatment Period||15||
48587073|NCT02541669|101770320|FG003|COMPLETED|Double-Blinded Treatment Period||16||
48587074|NCT02541669|101770321|FG004|COMPLETED|Double-Blinded Treatment Period||15||
48587075|NCT02541669|101770317|FG000|NOT COMPLETED|Double-Blinded Treatment Period||0||
48587076|NCT02541669|101770318|FG001|NOT COMPLETED|Double-Blinded Treatment Period||0||
48587077|NCT02541669|101770319|FG002|NOT COMPLETED|Double-Blinded Treatment Period||1||
48587078|NCT02541669|101770320|FG003|NOT COMPLETED|Double-Blinded Treatment Period||0||
48587079|NCT02541669|101770321|FG004|NOT COMPLETED|Double-Blinded Treatment Period||1||
48587080|NCT02111746|101770322|FG000|STARTED|Overall Study||172||
48138648|NCT02310750|100661662|FG013|NOT COMPLETED|HP Washout 2||0||
48138649|NCT02310750|100661663|FG014|NOT COMPLETED|HP Washout 2||0||
48587081|NCT02111746|101770323|FG001|STARTED|Overall Study||171||
48587082|NCT02111746|101770322|FG000|COMPLETED|Overall Study||169||
48587083|NCT02111746|101770323|FG001|COMPLETED|Overall Study||169||
48587084|NCT02111746|101770322|FG000|NOT COMPLETED|Overall Study||3||
48587085|NCT02111746|101770323|FG001|NOT COMPLETED|Overall Study||2||
48587086|NCT03361865|101770324|FG000|STARTED|Overall Study||44||
48587087|NCT03361865|101770325|FG001|STARTED|Overall Study||49||
48587088|NCT03361865|101770324|FG000|Intention-to-Treat (ITT)|Overall Study||44||
48587089|NCT03361865|101770325|FG001|Intention-to-Treat (ITT)|Overall Study||49||
48587090|NCT03361865|101770324|FG000|All Participants as Treated (APaT)|Overall Study||43||
48587091|NCT03361865|101770325|FG001|All Participants as Treated (APaT)|Overall Study||49||
48587092|NCT03361865|101770324|FG000|COMPLETED|Overall Study||25|Refers to participants that discontinued study with amendment 4, and didn't require follow-up.|
48587093|NCT03361865|101770325|FG001|COMPLETED|Overall Study||22|Refers to participants that discontinued study with amendment 4, and didn't require follow-up.|
48587094|NCT03361865|101770324|FG000|NOT COMPLETED|Overall Study||19||
48587095|NCT03361865|101770325|FG001|NOT COMPLETED|Overall Study||27||
48587096|NCT03045276|101770326|FG000|STARTED|Intervention Phase||77||
48587097|NCT03045276|101770327|FG001|STARTED|Intervention Phase||78||
48587098|NCT03045276|101770328|FG002|STARTED|Intervention Phase||52||
48587099|NCT03045276|101770329|FG003|STARTED|Intervention Phase||51||
48587100|NCT03045276|101770326|FG000|COMPLETED|Intervention Phase||67||
48587101|NCT03045276|101770327|FG001|COMPLETED|Intervention Phase||73||
48587102|NCT03045276|101770328|FG002|COMPLETED|Intervention Phase||49||
48587103|NCT03045276|101770329|FG003|COMPLETED|Intervention Phase||44||
48587104|NCT03045276|101770326|FG000|NOT COMPLETED|Intervention Phase||10||
48587105|NCT03045276|101770327|FG001|NOT COMPLETED|Intervention Phase||5||
48587106|NCT03045276|101770328|FG002|NOT COMPLETED|Intervention Phase||3||
48587107|NCT03045276|101770329|FG003|NOT COMPLETED|Intervention Phase||7||
48587108|NCT03045276|101770326|FG000|STARTED|Follow-Up Phase||67||
48587109|NCT03045276|101770327|FG001|STARTED|Follow-Up Phase||73||
48587110|NCT03045276|101770328|FG002|STARTED|Follow-Up Phase||49||
48587111|NCT03045276|101770329|FG003|STARTED|Follow-Up Phase||44||
48587112|NCT03045276|101770326|FG000|COMPLETED|Follow-Up Phase||66||
48587113|NCT03045276|101770327|FG001|COMPLETED|Follow-Up Phase||68||
48587114|NCT03045276|101770328|FG002|COMPLETED|Follow-Up Phase||45||
48587115|NCT03045276|101770329|FG003|COMPLETED|Follow-Up Phase||39||
48587116|NCT03045276|101770326|FG000|NOT COMPLETED|Follow-Up Phase||1||
48587117|NCT03045276|101770327|FG001|NOT COMPLETED|Follow-Up Phase||5||
48587118|NCT03045276|101770328|FG002|NOT COMPLETED|Follow-Up Phase||4||
48587119|NCT03045276|101770329|FG003|NOT COMPLETED|Follow-Up Phase||5||
48587120|NCT04323306|101770330|FG000|STARTED|Overall Study||6||
48587121|NCT04323306|101770331|FG001|STARTED|Overall Study||6||
48587122|NCT04323306|101770332|FG002|STARTED|Overall Study||6||
48587123|NCT04323306|101770333|FG003|STARTED|Overall Study||6||
48587124|NCT04323306|101770334|FG004|STARTED|Overall Study||6||
48587125|NCT04323306|101770335|FG005|STARTED|Overall Study||8||
48587126|NCT04323306|101770336|FG006|STARTED|Overall Study||12||
48587127|NCT04323306|101770337|FG007|STARTED|Overall Study||4||
48587128|NCT04323306|101770338|FG008|STARTED|Overall Study||5||
48587129|NCT04323306|101770330|FG000|COMPLETED|Overall Study||5||
48587130|NCT04323306|101770331|FG001|COMPLETED|Overall Study||6||
48587131|NCT04323306|101770332|FG002|COMPLETED|Overall Study||6||
48587132|NCT04323306|101770333|FG003|COMPLETED|Overall Study||6||
48587133|NCT04323306|101770334|FG004|COMPLETED|Overall Study||6||
48587134|NCT04323306|101770335|FG005|COMPLETED|Overall Study||7||
48587135|NCT04323306|101770336|FG006|COMPLETED|Overall Study||9||
48587136|NCT04323306|101770337|FG007|COMPLETED|Overall Study||4||
48587137|NCT04323306|101770338|FG008|COMPLETED|Overall Study||4||
48587138|NCT04323306|101770330|FG000|NOT COMPLETED|Overall Study||1||
48587139|NCT04323306|101770331|FG001|NOT COMPLETED|Overall Study||0||
48587140|NCT04323306|101770332|FG002|NOT COMPLETED|Overall Study||0||
48587141|NCT04323306|101770333|FG003|NOT COMPLETED|Overall Study||0||
48587142|NCT04323306|101770334|FG004|NOT COMPLETED|Overall Study||0||
48587143|NCT04323306|101770335|FG005|NOT COMPLETED|Overall Study||1||
48587144|NCT04323306|101770336|FG006|NOT COMPLETED|Overall Study||3||
48587145|NCT04323306|101770337|FG007|NOT COMPLETED|Overall Study||0||
48587146|NCT04323306|101770338|FG008|NOT COMPLETED|Overall Study||1||
48587147|NCT03917472|101770339|FG000|STARTED|Overall Study||346||
48587148|NCT03917472|101770340|FG001|STARTED|Overall Study||171||
48587149|NCT03917472|101770339|FG000|COMPLETED|Overall Study||311||
48587150|NCT03917472|101770340|FG001|COMPLETED|Overall Study||156||
48587151|NCT03917472|101770339|FG000|NOT COMPLETED|Overall Study||35||
48587152|NCT03917472|101770340|FG001|NOT COMPLETED|Overall Study||15||
48587153|NCT04050124|101770341|FG000|STARTED|Overall Study||8||
48587154|NCT04050124|101770342|FG001|STARTED|Overall Study||9||
48587155|NCT04050124|101770341|FG000|COMPLETED|Overall Study||7||
48587156|NCT04050124|101770342|FG001|COMPLETED|Overall Study||9||
48587157|NCT04050124|101770341|FG000|NOT COMPLETED|Overall Study||1||
48587158|NCT04050124|101770342|FG001|NOT COMPLETED|Overall Study||0||
48587159|NCT00791661|101770343|FG000|STARTED|Period 1||8||
48587160|NCT00791661|101770344|FG001|STARTED|Period 1||8||
48587161|NCT00791661|101770345|FG002|STARTED|Period 1||8||
48587162|NCT00791661|101770343|FG000|Received MK-1006|Period 1||6||
48587163|NCT00791661|101770344|FG001|Received MK-1006|Period 1||6||
48587164|NCT00791661|101770345|FG002|Received MK-1006|Period 1||6||
48587165|NCT00791661|101770343|FG000|Received Matching Placebo to MK-1006|Period 1||2||
48587166|NCT00791661|101770344|FG001|Received Matching Placebo to MK-1006|Period 1||2||
48587167|NCT00791661|101770345|FG002|Received Matching Placebo to MK-1006|Period 1||2||
48587168|NCT00791661|101770343|FG000|COMPLETED|Period 1||8||
48587169|NCT00791661|101770344|FG001|COMPLETED|Period 1||8||
48587170|NCT00791661|101770345|FG002|COMPLETED|Period 1||8||
48587171|NCT00791661|101770343|FG000|NOT COMPLETED|Period 1||0||
48587172|NCT00791661|101770344|FG001|NOT COMPLETED|Period 1||0||
48587173|NCT00791661|101770345|FG002|NOT COMPLETED|Period 1||0||
48587174|NCT00791661|101770343|FG000|STARTED|7 Day Wash-out||8||
48587175|NCT00791661|101770344|FG001|STARTED|7 Day Wash-out||8||
48587176|NCT00791661|101770345|FG002|STARTED|7 Day Wash-out||8||
48587177|NCT00791661|101770343|FG000|COMPLETED|7 Day Wash-out||8||
48587178|NCT00791661|101770344|FG001|COMPLETED|7 Day Wash-out||8||
48706593|NCT01071200|102069746|FG000|NOT COMPLETED|Overall Study||7||
48587179|NCT00791661|101770345|FG002|COMPLETED|7 Day Wash-out||6||
48587180|NCT00791661|101770343|FG000|NOT COMPLETED|7 Day Wash-out||0||
48587181|NCT00791661|101770344|FG001|NOT COMPLETED|7 Day Wash-out||0||
48587182|NCT00791661|101770345|FG002|NOT COMPLETED|7 Day Wash-out||2||
48587183|NCT00791661|101770343|FG000|STARTED|Period 2||8||
48587184|NCT00791661|101770344|FG001|STARTED|Period 2||8||
48587185|NCT00791661|101770345|FG002|STARTED|Period 2||6||
48587186|NCT00791661|101770343|FG000|Received MK-1006|Period 2||6||
48587187|NCT00791661|101770344|FG001|Received MK-1006|Period 2||6||
48587188|NCT00791661|101770345|FG002|Received MK-1006|Period 2||4||
48587189|NCT00791661|101770343|FG000|Received Matching Placebo to MK-1006|Period 2||2||
48587190|NCT00791661|101770344|FG001|Received Matching Placebo to MK-1006|Period 2||2||
48587191|NCT00791661|101770345|FG002|Received Matching Placebo to MK-1006|Period 2||2||
48587192|NCT00791661|101770343|FG000|COMPLETED|Period 2||8||
48587193|NCT00791661|101770344|FG001|COMPLETED|Period 2||8||
48587194|NCT00791661|101770345|FG002|COMPLETED|Period 2||6||
48587195|NCT00791661|101770343|FG000|NOT COMPLETED|Period 2||0||
48587196|NCT00791661|101770344|FG001|NOT COMPLETED|Period 2||0||
48587197|NCT00791661|101770345|FG002|NOT COMPLETED|Period 2||0||
48587198|NCT00791661|101770343|FG000|STARTED|7 Day Wash-out||8||
48587199|NCT00791661|101770344|FG001|STARTED|7 Day Wash-out||8||
48587200|NCT00791661|101770345|FG002|STARTED|7 Day Wash-out||6||
48587201|NCT00791661|101770343|FG000|COMPLETED|7 Day Wash-out||8||
48587202|NCT00791661|101770344|FG001|COMPLETED|7 Day Wash-out||8||
48587203|NCT00791661|101770345|FG002|COMPLETED|7 Day Wash-out||6||
48587204|NCT00791661|101770343|FG000|NOT COMPLETED|7 Day Wash-out||0||
48587205|NCT00791661|101770344|FG001|NOT COMPLETED|7 Day Wash-out||0||
48587206|NCT00791661|101770345|FG002|NOT COMPLETED|7 Day Wash-out||0||
48587207|NCT00791661|101770343|FG000|STARTED|Period 3||8||
48587208|NCT00791661|101770344|FG001|STARTED|Period 3||8||
48587209|NCT00791661|101770345|FG002|STARTED|Period 3||6||
48587210|NCT00791661|101770343|FG000|Received MK-1006|Period 3||6||
48587211|NCT00791661|101770344|FG001|Received MK-1006|Period 3||6||
48587212|NCT00791661|101770345|FG002|Received MK-1006|Period 3||5||
48587213|NCT00791661|101770343|FG000|Received Matching Placebo to MK-1006|Period 3||2||
48587214|NCT00791661|101770344|FG001|Received Matching Placebo to MK-1006|Period 3||2||
48587215|NCT00791661|101770345|FG002|Received Matching Placebo to MK-1006|Period 3||1||
48587216|NCT00791661|101770343|FG000|COMPLETED|Period 3||8||
48587217|NCT00791661|101770344|FG001|COMPLETED|Period 3||8||
48587218|NCT00791661|101770345|FG002|COMPLETED|Period 3||6||
48587219|NCT00791661|101770343|FG000|NOT COMPLETED|Period 3||0||
48587220|NCT00791661|101770344|FG001|NOT COMPLETED|Period 3||0||
48587221|NCT00791661|101770345|FG002|NOT COMPLETED|Period 3||0||
48587222|NCT04725812|101770346|FG000|STARTED|Overall Study||2||
48587223|NCT04725812|101770346|FG000|COMPLETED|Overall Study||1||
48587224|NCT04725812|101770346|FG000|NOT COMPLETED|Overall Study||1||
48138650|NCT02310750|100661664|FG015|NOT COMPLETED|HP Washout 2||0||
48138651|NCT02310750|100661649|FG000|STARTED|HP MAD and Fasted/Fed||0||
48138652|NCT02310750|100661650|FG001|STARTED|HP MAD and Fasted/Fed||0||
48138653|NCT02310750|100661651|FG002|STARTED|HP MAD and Fasted/Fed||0||
48138654|NCT02310750|100661652|FG003|STARTED|HP MAD and Fasted/Fed||0||
48138655|NCT02310750|100661653|FG004|STARTED|HP MAD and Fasted/Fed||5||
48290429|NCT00687973|101037592|FG000|NOT COMPLETED|Overall Study||24||
48290430|NCT00687973|101037593|FG001|NOT COMPLETED|Overall Study||38||
48138656|NCT02310750|100661654|FG005|STARTED|HP MAD and Fasted/Fed||0||
48138657|NCT02310750|100661655|FG006|STARTED|HP MAD and Fasted/Fed||2||
48138658|NCT02310750|100661656|FG007|STARTED|HP MAD and Fasted/Fed||0||
48138659|NCT02310750|100661657|FG008|STARTED|HP MAD and Fasted/Fed||0||
48138660|NCT02310750|100661658|FG009|STARTED|HP MAD and Fasted/Fed||0||
48290431|NCT05007808|101037594|FG000|STARTED|Overall Study||105||
48290432|NCT05007808|101037595|FG001|STARTED|Overall Study||105||
48290433|NCT05007808|101037594|FG000|COMPLETED|Overall Study||99||
48290434|NCT05007808|101037595|FG001|COMPLETED|Overall Study||100||
48290435|NCT05007808|101037594|FG000|NOT COMPLETED|Overall Study||6||
48290436|NCT05007808|101037595|FG001|NOT COMPLETED|Overall Study||5||
48587225|NCT00567489|101770347|FG000|STARTED|Overall Study||127||
48138661|NCT02310750|100661659|FG010|STARTED|HP MAD and Fasted/Fed||2||
48138662|NCT02310750|100661660|FG011|STARTED|HP MAD and Fasted/Fed||2||
48138663|NCT02310750|100661661|FG012|STARTED|HP MAD and Fasted/Fed||2||
48138664|NCT02310750|100661662|FG013|STARTED|HP MAD and Fasted/Fed||2||
48138665|NCT02310750|100661663|FG014|STARTED|HP MAD and Fasted/Fed||2||
48138666|NCT02310750|100661664|FG015|STARTED|HP MAD and Fasted/Fed||2||
48138667|NCT02310750|100661649|FG000|COMPLETED|HP MAD and Fasted/Fed||0||
48138668|NCT02310750|100661650|FG001|COMPLETED|HP MAD and Fasted/Fed||0||
48138669|NCT02310750|100661651|FG002|COMPLETED|HP MAD and Fasted/Fed||0||
48138670|NCT02310750|100661652|FG003|COMPLETED|HP MAD and Fasted/Fed||0||
48138671|NCT02310750|100661653|FG004|COMPLETED|HP MAD and Fasted/Fed||4||
48138672|NCT02310750|100661654|FG005|COMPLETED|HP MAD and Fasted/Fed||0||
48138673|NCT02310750|100661655|FG006|COMPLETED|HP MAD and Fasted/Fed||2||
48138674|NCT02310750|100661656|FG007|COMPLETED|HP MAD and Fasted/Fed||0||
48587226|NCT00567489|101770348|FG001|STARTED|Overall Study||124||
48587227|NCT00567489|101770347|FG000|COMPLETED|Overall Study||120||
48587228|NCT00567489|101770348|FG001|COMPLETED|Overall Study||101||
48138675|NCT02310750|100661657|FG008|COMPLETED|HP MAD and Fasted/Fed||0||
48138676|NCT02310750|100661658|FG009|COMPLETED|HP MAD and Fasted/Fed||0||
48587229|NCT00567489|101770347|FG000|NOT COMPLETED|Overall Study||7||
48587230|NCT00567489|101770348|FG001|NOT COMPLETED|Overall Study||23||
48587231|NCT03696108|101770349|FG000|STARTED|Overall Study||84||
48587232|NCT03696108|101770350|FG001|STARTED|Overall Study||85||
48587233|NCT03696108|101770349|FG000|COMPLETED|Overall Study||80||
48587234|NCT03696108|101770350|FG001|COMPLETED|Overall Study||79||
48401835|NCT02999191|101313863|FG002|COMPLETED|Treatment Period 3 [1 Day]||6||
48401836|NCT02999191|101313861|FG000|NOT COMPLETED|Treatment Period 3 [1 Day]||0||
48401837|NCT02999191|101313862|FG001|NOT COMPLETED|Treatment Period 3 [1 Day]||0||
48401838|NCT02999191|101313863|FG002|NOT COMPLETED|Treatment Period 3 [1 Day]||0||
48401839|NCT01921452|101313864|FG000|STARTED|Overall Study||283||
48401840|NCT01921452|101313864|FG000|COMPLETED|Overall Study||283||
48401841|NCT01921452|101313864|FG000|NOT COMPLETED|Overall Study||0||
48401842|NCT00081939|101313865|FG000|STARTED|Overall Study||303||
48401843|NCT00081939|101313865|FG000|COMPLETED|Overall Study||303||
48401844|NCT00081939|101313865|FG000|NOT COMPLETED|Overall Study||0||
48401845|NCT00251589|101313866|FG000|STARTED|Overall Study||16||
48587235|NCT03696108|101770349|FG000|NOT COMPLETED|Overall Study||4||
48587236|NCT03696108|101770350|FG001|NOT COMPLETED|Overall Study||6||
48587237|NCT04017832|101770351|FG000|STARTED|Overall Study||361||
48587238|NCT04017832|101770352|FG001|STARTED|Overall Study||360||
48587239|NCT04017832|101770353|FG002|STARTED|Overall Study||361||
48587240|NCT04017832|101770354|FG003|STARTED|Overall Study||359||
48401846|NCT00251589|101313867|FG001|STARTED|Overall Study||3||
48401847|NCT00251589|101313868|FG002|STARTED|Overall Study||2||
48401848|NCT00251589|101313869|FG003|STARTED|Overall Study||2||
48401849|NCT00251589|101313866|FG000|COMPLETED|Overall Study||1||
48401850|NCT00251589|101313867|FG001|COMPLETED|Overall Study||0||
48587241|NCT04017832|101770351|FG000|Full Analysis Set|Overall Study||361||
48587242|NCT04017832|101770352|FG001|Full Analysis Set|Overall Study||360||
48401851|NCT00251589|101313868|FG002|COMPLETED|Overall Study||0||
48401852|NCT00251589|101313869|FG003|COMPLETED|Overall Study||0||
48401853|NCT00251589|101313866|FG000|NOT COMPLETED|Overall Study||15||
48401854|NCT00251589|101313867|FG001|NOT COMPLETED|Overall Study||3||
48401855|NCT00251589|101313868|FG002|NOT COMPLETED|Overall Study||2||
48401856|NCT00251589|101313869|FG003|NOT COMPLETED|Overall Study||2||
48401857|NCT03370913|101313870|FG000|STARTED|Overall Study||134||
48401858|NCT03370913|101313870|FG000|COMPLETED|Overall Study||132|Participants completed Week 104 Visit|
48401859|NCT03370913|101313870|FG000|NOT COMPLETED|Overall Study||2||
48401860|NCT02420990|101313871|FG000|STARTED|Baseline||53||
48401861|NCT02420990|101313872|FG001|STARTED|Baseline||92||
48401862|NCT02420990|101313871|FG000|COMPLETED|Baseline||53||
48401863|NCT02420990|101313872|FG001|COMPLETED|Baseline||92||
48401864|NCT02420990|101313871|FG000|NOT COMPLETED|Baseline||0||
48401865|NCT02420990|101313872|FG001|NOT COMPLETED|Baseline||0||
48401866|NCT02420990|101313871|FG000|STARTED|3-Month Follow-up||53||
48401867|NCT02420990|101313872|FG001|STARTED|3-Month Follow-up||92||
48401868|NCT02420990|101313871|FG000|COMPLETED|3-Month Follow-up||53||
48401869|NCT02420990|101313872|FG001|COMPLETED|3-Month Follow-up||92||
48401870|NCT02420990|101313871|FG000|NOT COMPLETED|3-Month Follow-up||0||
48401871|NCT02420990|101313872|FG001|NOT COMPLETED|3-Month Follow-up||0||
48401872|NCT02420990|101313871|FG000|STARTED|6-Month Follow-up||53||
48401873|NCT02420990|101313872|FG001|STARTED|6-Month Follow-up||92||
48401874|NCT02420990|101313871|FG000|COMPLETED|6-Month Follow-up||53||
48401875|NCT02420990|101313872|FG001|COMPLETED|6-Month Follow-up||92||
48401876|NCT02420990|101313871|FG000|NOT COMPLETED|6-Month Follow-up||0||
48401877|NCT02420990|101313872|FG001|NOT COMPLETED|6-Month Follow-up||0||
48401878|NCT02420990|101313871|FG000|STARTED|12-Month Follow-up||53||
48401879|NCT02420990|101313872|FG001|STARTED|12-Month Follow-up||92||
48401880|NCT02420990|101313871|FG000|COMPLETED|12-Month Follow-up||53||
48401881|NCT02420990|101313872|FG001|COMPLETED|12-Month Follow-up||92||
48401882|NCT02420990|101313871|FG000|NOT COMPLETED|12-Month Follow-up||0||
48401883|NCT02420990|101313872|FG001|NOT COMPLETED|12-Month Follow-up||0||
48401884|NCT01498588|101313873|FG000|STARTED|Overall Study||7||
48401885|NCT01498588|101313873|FG000|COMPLETED|Overall Study||7||
48401886|NCT01498588|101313873|FG000|NOT COMPLETED|Overall Study||0||
48401887|NCT01112982|101313874|FG000|STARTED|Overall Study||74||
48401888|NCT01112982|101313874|FG000|COMPLETED|Overall Study||72||
48401889|NCT01112982|101313874|FG000|NOT COMPLETED|Overall Study||2||
48401890|NCT04857892|101313875|FG000|STARTED|Part 1: Period 1 (Day 1)||9||
48401891|NCT04857892|101313876|FG001|STARTED|Part 1: Period 1 (Day 1)||7||
48401892|NCT04857892|101313877|FG002|STARTED|Part 1: Period 1 (Day 1)||7||
48401893|NCT04857892|101313878|FG003|STARTED|Part 1: Period 1 (Day 1)||0||
48401894|NCT04857892|101313879|FG004|STARTED|Part 1: Period 1 (Day 1)||0||
48401895|NCT04857892|101313875|FG000|COMPLETED|Part 1: Period 1 (Day 1)||8||
48401896|NCT04857892|101313876|FG001|COMPLETED|Part 1: Period 1 (Day 1)||7||
48401897|NCT04857892|101313877|FG002|COMPLETED|Part 1: Period 1 (Day 1)||7||
48401898|NCT04857892|101313878|FG003|COMPLETED|Part 1: Period 1 (Day 1)||0||
48401899|NCT04857892|101313879|FG004|COMPLETED|Part 1: Period 1 (Day 1)||0||
48401900|NCT04857892|101313875|FG000|NOT COMPLETED|Part 1: Period 1 (Day 1)||1||
48401901|NCT04857892|101313876|FG001|NOT COMPLETED|Part 1: Period 1 (Day 1)||0||
48401902|NCT04857892|101313877|FG002|NOT COMPLETED|Part 1: Period 1 (Day 1)||0||
48587243|NCT04017832|101770353|FG002|Full Analysis Set|Overall Study||361||
48587244|NCT04017832|101770354|FG003|Full Analysis Set|Overall Study||359||
48587245|NCT04017832|101770351|FG000|Safety Analysis Set|Overall Study||361||
48401903|NCT04857892|101313878|FG003|NOT COMPLETED|Part 1: Period 1 (Day 1)||0||
48401904|NCT04857892|101313879|FG004|NOT COMPLETED|Part 1: Period 1 (Day 1)||0||
48401905|NCT04857892|101313875|FG000|STARTED|Part 1: Washout Period 1 (Up to 7 Days)||8||
48401906|NCT04857892|101313876|FG001|STARTED|Part 1: Washout Period 1 (Up to 7 Days)||7||
48401907|NCT04857892|101313877|FG002|STARTED|Part 1: Washout Period 1 (Up to 7 Days)||7||
48401908|NCT04857892|101313878|FG003|STARTED|Part 1: Washout Period 1 (Up to 7 Days)||0||
48587246|NCT04017832|101770352|FG001|Safety Analysis Set|Overall Study||358||
48587247|NCT04017832|101770353|FG002|Safety Analysis Set|Overall Study||361||
48587248|NCT04017832|101770354|FG003|Safety Analysis Set|Overall Study||358||
48587249|NCT04017832|101770351|FG000|COMPLETED|Overall Study||345||
48587250|NCT04017832|101770352|FG001|COMPLETED|Overall Study||342||
48587251|NCT04017832|101770353|FG002|COMPLETED|Overall Study||335||
48587252|NCT04017832|101770354|FG003|COMPLETED|Overall Study||350||
48587253|NCT04017832|101770351|FG000|NOT COMPLETED|Overall Study||16||
48587254|NCT04017832|101770352|FG001|NOT COMPLETED|Overall Study||18||
48587255|NCT04017832|101770353|FG002|NOT COMPLETED|Overall Study||26||
48587256|NCT04017832|101770354|FG003|NOT COMPLETED|Overall Study||9||
48587257|NCT02234596|101770355|FG000|STARTED|Overall Study||34||
48587258|NCT02234596|101770355|FG000|COMPLETED|Overall Study||32||
48587259|NCT02234596|101770355|FG000|NOT COMPLETED|Overall Study||2||
48587260|NCT03409107|101770356|FG000|STARTED|Overall Study||307||
48587261|NCT03409107|101770357|FG001|STARTED|Overall Study||307||
48587262|NCT03409107|101770356|FG000|COMPLETED|Overall Study||290||
48587263|NCT03409107|101770357|FG001|COMPLETED|Overall Study||300||
48587264|NCT03409107|101770356|FG000|NOT COMPLETED|Overall Study||17||
48587265|NCT03409107|101770357|FG001|NOT COMPLETED|Overall Study||7||
48587266|NCT01701193|101770358|FG000|STARTED|Overall Study||18||
48587267|NCT01701193|101770359|FG001|STARTED|Overall Study||19||
48587268|NCT01701193|101770360|FG002|STARTED|Overall Study||5||
48587269|NCT01701193|101770361|FG003|STARTED|Overall Study||5||
48587270|NCT01701193|101770358|FG000|COMPLETED|Overall Study||15||
48587271|NCT01701193|101770359|FG001|COMPLETED|Overall Study||17||
48587272|NCT01701193|101770360|FG002|COMPLETED|Overall Study||4||
48587273|NCT01701193|101770361|FG003|COMPLETED|Overall Study||3||
48587274|NCT01701193|101770358|FG000|NOT COMPLETED|Overall Study||3||
48587275|NCT01701193|101770359|FG001|NOT COMPLETED|Overall Study||2||
48587276|NCT01701193|101770360|FG002|NOT COMPLETED|Overall Study||1||
48587277|NCT01701193|101770361|FG003|NOT COMPLETED|Overall Study||2||
48587278|NCT02100670|101770362|FG000|STARTED|Overall Study||118||
48587279|NCT02100670|101770363|FG001|STARTED|Overall Study||113||
48587280|NCT02100670|101770364|FG002|STARTED|Overall Study||78||
48587281|NCT02100670|101770365|FG003|STARTED|Overall Study||76||
48587282|NCT02100670|101770362|FG000|COMPLETED|Overall Study||105||
48587283|NCT02100670|101770363|FG001|COMPLETED|Overall Study||106||
48587284|NCT02100670|101770364|FG002|COMPLETED|Overall Study||74||
48587285|NCT02100670|101770365|FG003|COMPLETED|Overall Study||75||
48587286|NCT02100670|101770362|FG000|NOT COMPLETED|Overall Study||13||
48587287|NCT02100670|101770363|FG001|NOT COMPLETED|Overall Study||7||
48587288|NCT02100670|101770364|FG002|NOT COMPLETED|Overall Study||4||
48587289|NCT02100670|101770365|FG003|NOT COMPLETED|Overall Study||1||
48587290|NCT01378377|101770366|FG000|STARTED|Overall Study||4||
48587291|NCT01378377|101770367|FG001|STARTED|Overall Study||23||
48587292|NCT01378377|101770368|FG002|STARTED|Overall Study||6||
48587293|NCT01378377|101770366|FG000|COMPLETED|Overall Study||4||
48587294|NCT01378377|101770367|FG001|COMPLETED|Overall Study||23||
48587295|NCT01378377|101770368|FG002|COMPLETED|Overall Study||6||
48587296|NCT01378377|101770366|FG000|NOT COMPLETED|Overall Study||0||
48587297|NCT01378377|101770367|FG001|NOT COMPLETED|Overall Study||0||
48587298|NCT01378377|101770368|FG002|NOT COMPLETED|Overall Study||0||
48587299|NCT03671564|101770369|FG000|STARTED|Overall Study||4||
48587300|NCT03671564|101770370|FG001|STARTED|Overall Study||6||
48587301|NCT03671564|101770371|FG002|STARTED|Overall Study||4||
48587302|NCT03671564|101770369|FG000|COMPLETED|Overall Study||0||
48587303|NCT03671564|101770370|FG001|COMPLETED|Overall Study||0||
48587304|NCT03671564|101770371|FG002|COMPLETED|Overall Study||0||
48587305|NCT03671564|101770369|FG000|NOT COMPLETED|Overall Study||4||
48587306|NCT03671564|101770370|FG001|NOT COMPLETED|Overall Study||6||
48587307|NCT03671564|101770371|FG002|NOT COMPLETED|Overall Study||4||
48587308|NCT02279745|101770372|FG000|STARTED|Overall Study||45||
48587309|NCT02279745|101770372|FG000|COMPLETED|Overall Study||25||
48587310|NCT02279745|101770372|FG000|NOT COMPLETED|Overall Study||20||
48587311|NCT00251303|101770373|FG000|STARTED|Overall Study||30||
48587312|NCT00251303|101770374|FG001|STARTED|Overall Study||30||
48587313|NCT00251303|101770373|FG000|COMPLETED|Overall Study||22||
48587314|NCT00251303|101770374|FG001|COMPLETED|Overall Study||29||
48401909|NCT04857892|101313879|FG004|STARTED|Part 1: Washout Period 1 (Up to 7 Days)||0||
48587315|NCT00251303|101770373|FG000|NOT COMPLETED|Overall Study||8||
48587316|NCT00251303|101770374|FG001|NOT COMPLETED|Overall Study||1||
48587317|NCT02677038|101770375|FG000|STARTED|Overall Study||24||
48587318|NCT02677038|101770375|FG000|COMPLETED|Overall Study||22||
48587319|NCT02677038|101770375|FG000|NOT COMPLETED|Overall Study||2||
48587320|NCT00743730|101770376|FG000|STARTED|Overall Study||27||
48587321|NCT00743730|101770377|FG001|STARTED|Overall Study||34||
48587322|NCT00743730|101770378|FG002|STARTED|Overall Study||33||
48587323|NCT00743730|101770376|FG000|COMPLETED|Overall Study||22||
48587324|NCT00743730|101770377|FG001|COMPLETED|Overall Study||30||
48587325|NCT00743730|101770378|FG002|COMPLETED|Overall Study||28||
48587326|NCT00743730|101770376|FG000|NOT COMPLETED|Overall Study||5||
48587327|NCT00743730|101770377|FG001|NOT COMPLETED|Overall Study||4||
48587328|NCT00743730|101770378|FG002|NOT COMPLETED|Overall Study||5||
48587329|NCT02822573|101770379|FG000|STARTED|Overall Study||140||
48587330|NCT02822573|101770380|FG001|STARTED|Overall Study||136||
48587331|NCT02822573|101770379|FG000|COMPLETED|Overall Study||110||
48587332|NCT02822573|101770380|FG001|COMPLETED|Overall Study||117||
48587333|NCT02822573|101770379|FG000|NOT COMPLETED|Overall Study||30||
48587334|NCT02822573|101770380|FG001|NOT COMPLETED|Overall Study||19||
48587335|NCT00614523|101770381|FG000|STARTED|Overall Study||83||
48587336|NCT00614523|101770382|FG001|STARTED|Overall Study||167||
48587337|NCT00614523|101770381|FG000|COMPLETED|Overall Study||20||
48587338|NCT00614523|101770382|FG001|COMPLETED|Overall Study||36||
48587339|NCT00614523|101770381|FG000|NOT COMPLETED|Overall Study||63||
48587340|NCT00614523|101770382|FG001|NOT COMPLETED|Overall Study||131||
48587341|NCT05723328|101770383|FG000|STARTED|Overall Study||5||
48587342|NCT05723328|101770384|FG001|STARTED|Overall Study||2||
48587343|NCT05723328|101770383|FG000|Received Music Therapy|Overall Study||0||
48587344|NCT05723328|101770384|FG001|Received Music Therapy|Overall Study||0||
48587345|NCT05723328|101770383|FG000|COMPLETED|Overall Study||0||
48587346|NCT05723328|101770384|FG001|COMPLETED|Overall Study||0||
48587347|NCT05723328|101770383|FG000|NOT COMPLETED|Overall Study||5||
48587348|NCT05723328|101770384|FG001|NOT COMPLETED|Overall Study||2||
48587349|NCT00348790|101770385|FG000|STARTED|Began Treatment||25||
48587350|NCT00348790|101770385|FG000|COMPLETED|Began Treatment||25||
48587351|NCT00348790|101770385|FG000|NOT COMPLETED|Began Treatment||0||
48587352|NCT00348790|101770385|FG000|STARTED|Completed Treatment||25||
48587353|NCT00348790|101770385|FG000|COMPLETED|Completed Treatment||0||
48587354|NCT00348790|101770385|FG000|NOT COMPLETED|Completed Treatment||25||
48587355|NCT02656290|101770386|FG000|STARTED|Overall Study||26||
48587356|NCT02656290|101770386|FG000|Discharge|Overall Study||26||
48587357|NCT02656290|101770386|FG000|30 Days|Overall Study||26||
48587358|NCT02656290|101770386|FG000|3-6 Months|Overall Study||25||
48587359|NCT02656290|101770386|FG000|1 Year|Overall Study||25||
48587360|NCT02656290|101770386|FG000|2 Years|Overall Study||24||
48587361|NCT02656290|101770386|FG000|3 Years|Overall Study||24||
48587362|NCT02656290|101770386|FG000|4 Years|Overall Study||19||
48587363|NCT02656290|101770386|FG000|5 Years|Overall Study||22||
48587364|NCT02656290|101770386|FG000|COMPLETED|Overall Study||22||
48587365|NCT02656290|101770386|FG000|NOT COMPLETED|Overall Study||4||
48587366|NCT00782184|101770387|FG000|STARTED|Overall Study||120||
48587367|NCT00782184|101770388|FG001|STARTED|Overall Study||130||
48587368|NCT00782184|101770387|FG000|COMPLETED|Overall Study||116||
48587369|NCT00782184|101770388|FG001|COMPLETED|Overall Study||125||
48587370|NCT00782184|101770387|FG000|NOT COMPLETED|Overall Study||4||
48587371|NCT00782184|101770388|FG001|NOT COMPLETED|Overall Study||5||
48587372|NCT05845567|101770389|FG000|STARTED|Overall Study||20||
48587373|NCT05845567|101770389|FG000|Safety Analysis Population|Overall Study||20||
48587374|NCT05845567|101770389|FG000|PK Analysis Population|Overall Study||20||
48587375|NCT05845567|101770389|FG000|Drug-Drug Interaction Comparable Bioavailability|Overall Study||19||
48587376|NCT05845567|101770389|FG000|COMPLETED|Overall Study||19||
48587377|NCT05845567|101770389|FG000|NOT COMPLETED|Overall Study||1||
48587378|NCT01128218|101770390|FG000|STARTED|Overall Study||3||
48587379|NCT01128218|101770391|FG001|STARTED|Overall Study||3||
48587380|NCT01128218|101770392|FG002|STARTED|Overall Study||3||
48587381|NCT01128218|101770393|FG003|STARTED|Overall Study||4||
48587382|NCT01128218|101770394|FG004|STARTED|Overall Study||6||
48587383|NCT01128218|101770395|FG005|STARTED|Overall Study||14||
48587384|NCT01128218|101770390|FG000|COMPLETED|Overall Study||3||
48587385|NCT01128218|101770391|FG001|COMPLETED|Overall Study||3||
48706594|NCT01071200|102069747|FG001|NOT COMPLETED|Overall Study||3||
48290437|NCT04058366|101037596|FG000|STARTED|Overall Study||251||
48290438|NCT04058366|101037596|FG000|COMPLETED|Overall Study||215||
48290439|NCT04058366|101037596|FG000|NOT COMPLETED|Overall Study||36||
48290440|NCT01007643|101037597|FG000|STARTED|Overall Study||8||
48290441|NCT01007643|101037598|FG001|STARTED|Overall Study||14||
48587386|NCT01128218|101770392|FG002|COMPLETED|Overall Study||3||
48587387|NCT01128218|101770393|FG003|COMPLETED|Overall Study||4||
48587388|NCT01128218|101770394|FG004|COMPLETED|Overall Study||6||
48587389|NCT01128218|101770395|FG005|COMPLETED|Overall Study||14||
48587390|NCT01128218|101770390|FG000|NOT COMPLETED|Overall Study||0||
48587391|NCT01128218|101770391|FG001|NOT COMPLETED|Overall Study||0||
48587392|NCT01128218|101770392|FG002|NOT COMPLETED|Overall Study||0||
48587393|NCT01128218|101770393|FG003|NOT COMPLETED|Overall Study||0||
48587394|NCT01128218|101770394|FG004|NOT COMPLETED|Overall Study||0||
48587395|NCT01128218|101770395|FG005|NOT COMPLETED|Overall Study||0||
48587396|NCT01500187|101770396|FG000|STARTED|Overall Study||23||106
48587397|NCT01500187|101770397|FG001|STARTED|Overall Study||15||74
48587398|NCT01500187|101770396|FG000|COMPLETED|Overall Study||17||76
48587399|NCT01500187|101770397|FG001|COMPLETED|Overall Study||15||72
48587400|NCT01500187|101770396|FG000|NOT COMPLETED|Overall Study||6||30
48587401|NCT01500187|101770397|FG001|NOT COMPLETED|Overall Study||0||2
48587402|NCT02643849|101770398|FG000|STARTED|Overall Study||107||
48587403|NCT02643849|101770398|FG000|COMPLETED|Overall Study||82||
48587404|NCT02643849|101770398|FG000|NOT COMPLETED|Overall Study||25||
48587405|NCT05363072|101770399|FG000|STARTED|Overall Study||1112|All RCC participants|
48587406|NCT05363072|101770399|FG000|Treated Metastatic RCC Participants (mRCC)|Overall Study||191||
48587407|NCT05363072|101770399|FG000|Not Treated Metastatic RCC Participants|Overall Study||145||
48587408|NCT05363072|101770399|FG000|COMPLETED|Overall Study||1112||
48587409|NCT05363072|101770399|FG000|NOT COMPLETED|Overall Study||0||
48587410|NCT02153671|101770400|FG000|STARTED|Overall Study||19||
48587411|NCT02153671|101770401|FG001|STARTED|Overall Study||24||
48587412|NCT02153671|101770400|FG000|COMPLETED|Overall Study||19||
48587413|NCT02153671|101770401|FG001|COMPLETED|Overall Study||24||
48587414|NCT02153671|101770400|FG000|NOT COMPLETED|Overall Study||0||
48587415|NCT02153671|101770401|FG001|NOT COMPLETED|Overall Study||0||
48587416|NCT04216589|101770402|FG000|STARTED|Overall Study||51||
48587417|NCT04216589|101770402|FG000|Completed Study Treatment|Overall Study||48||
48587418|NCT04216589|101770402|FG000|COMPLETED|Overall Study||47||
48587419|NCT04216589|101770402|FG000|NOT COMPLETED|Overall Study||4||
48587420|NCT00382590|101770403|FG000|STARTED|Overall Study||4||
48587421|NCT00382590|101770404|FG001|STARTED|Overall Study||6||
48587422|NCT00382590|101770403|FG000|COMPLETED|Overall Study||4||
48587423|NCT00382590|101770404|FG001|COMPLETED|Overall Study||6||
48587424|NCT00382590|101770403|FG000|NOT COMPLETED|Overall Study||0||
48587425|NCT00382590|101770404|FG001|NOT COMPLETED|Overall Study||0||
48587426|NCT04616573|101770405|FG000|STARTED|Overall Study||1||
48587427|NCT04616573|101770406|FG001|STARTED|Overall Study||0||
48587428|NCT04616573|101770407|FG002|STARTED|Overall Study||0||
48587429|NCT04616573|101770405|FG000|COMPLETED|Overall Study||0||
48587430|NCT04616573|101770406|FG001|COMPLETED|Overall Study||0||
48587431|NCT04616573|101770407|FG002|COMPLETED|Overall Study||0||
48587432|NCT04616573|101770405|FG000|NOT COMPLETED|Overall Study||1||
48587433|NCT04616573|101770406|FG001|NOT COMPLETED|Overall Study||0||
48587434|NCT04616573|101770407|FG002|NOT COMPLETED|Overall Study||0||
48587435|NCT04184362|101770408|FG000|STARTED|Overall Study||5||
48587436|NCT04184362|101770409|FG001|STARTED|Overall Study||5||
48587437|NCT04184362|101770408|FG000|COMPLETED|Overall Study||5||
48587438|NCT04184362|101770409|FG001|COMPLETED|Overall Study||5||
48587439|NCT04184362|101770408|FG000|NOT COMPLETED|Overall Study||0||
48587440|NCT04184362|101770409|FG001|NOT COMPLETED|Overall Study||0||
48587441|NCT04284930|101770410|FG000|STARTED|Overall Study||8||
48587442|NCT04284930|101770411|FG001|STARTED|Overall Study||5||
48587443|NCT04284930|101770412|FG002|STARTED|Overall Study||8||
48706595|NCT01244633|102069748|FG000|STARTED|Overall Study||18||
48706596|NCT01244633|102069748|FG000|COMPLETED|Overall Study||15||
48706597|NCT01244633|102069748|FG000|NOT COMPLETED|Overall Study||3||
48706598|NCT00711347|102069749|FG000|STARTED|Overall Study||14||
48706599|NCT00711347|102069750|FG001|STARTED|Overall Study||14||
48706600|NCT00711347|102069749|FG000|COMPLETED|Overall Study||14||
48706601|NCT00711347|102069750|FG001|COMPLETED|Overall Study||14||
48706602|NCT00711347|102069749|FG000|NOT COMPLETED|Overall Study||0||
48706603|NCT00711347|102069750|FG001|NOT COMPLETED|Overall Study||0||
48706604|NCT02076399|102069751|FG000|STARTED|Overall Study||51||
48587444|NCT04284930|101770410|FG000|COMPLETED|Overall Study||8||
48587445|NCT04284930|101770411|FG001|COMPLETED|Overall Study||5||
48587446|NCT04284930|101770412|FG002|COMPLETED|Overall Study||8||
48587447|NCT04284930|101770410|FG000|NOT COMPLETED|Overall Study||0||
48587448|NCT04284930|101770411|FG001|NOT COMPLETED|Overall Study||0||
48587449|NCT04284930|101770412|FG002|NOT COMPLETED|Overall Study||0||
48587450|NCT01878812|101770413|FG000|STARTED|Overall Study||60||
48587451|NCT01878812|101770414|FG001|STARTED|Overall Study||57||
48587452|NCT01878812|101770413|FG000|COMPLETED|Overall Study||60||
48587453|NCT01878812|101770414|FG001|COMPLETED|Overall Study||57||
48587454|NCT01878812|101770413|FG000|NOT COMPLETED|Overall Study||0||
48587455|NCT01878812|101770414|FG001|NOT COMPLETED|Overall Study||0||
48587456|NCT02968433|101770415|FG000|STARTED|Overall Study||16||
48706605|NCT02076399|102069752|FG001|STARTED|Overall Study||25||
48706606|NCT02076399|102069751|FG000|COMPLETED|Overall Study||12||
48706607|NCT02076399|102069752|FG001|COMPLETED|Overall Study||1||
48587457|NCT02968433|101770415|FG000|COMPLETED|Overall Study||15||
48587458|NCT02968433|101770415|FG000|NOT COMPLETED|Overall Study||1||
48706608|NCT02076399|102069751|FG000|NOT COMPLETED|Overall Study||39||
48706609|NCT02076399|102069752|FG001|NOT COMPLETED|Overall Study||24||
48706610|NCT02279719|102069753|FG000|STARTED|Overall Study||5||
48587459|NCT04654754|101770416|FG000|STARTED|LVN With T-piece and a Filter||12||
48587460|NCT04654754|101770416|FG000|COMPLETED|LVN With T-piece and a Filter||12||
48587461|NCT04654754|101770416|FG000|NOT COMPLETED|LVN With T-piece and a Filter||0||
48587462|NCT04654754|101770416|FG000|STARTED|High-flow High-humidity With Adapter||12||
48587463|NCT04654754|101770416|FG000|COMPLETED|High-flow High-humidity With Adapter||12||
48587464|NCT04654754|101770416|FG000|NOT COMPLETED|High-flow High-humidity With Adapter||0||
48587465|NCT04654754|101770416|FG000|STARTED|LVN With Trach Collar||12||
48706611|NCT02279719|102069754|FG001|STARTED|Overall Study||10||
48706612|NCT02279719|102069755|FG002|STARTED|Overall Study||4||
48587466|NCT04654754|101770416|FG000|COMPLETED|LVN With Trach Collar||12||
48587467|NCT04654754|101770416|FG000|NOT COMPLETED|LVN With Trach Collar||0||
48587468|NCT04654754|101770416|FG000|STARTED|Venturi With Trach Collar||12||
48587469|NCT04654754|101770416|FG000|COMPLETED|Venturi With Trach Collar||12||
48587470|NCT04654754|101770416|FG000|NOT COMPLETED|Venturi With Trach Collar||0||
48587471|NCT04654754|101770416|FG000|STARTED|High-flow High-humidity With Scavenger||12||
48587472|NCT04654754|101770416|FG000|COMPLETED|High-flow High-humidity With Scavenger||12||
48587473|NCT04654754|101770416|FG000|NOT COMPLETED|High-flow High-humidity With Scavenger||0||
48587474|NCT04064242|101770417|FG000|STARTED|Overall Study||31||
48587475|NCT04064242|101770418|FG001|STARTED|Overall Study||31||
48587476|NCT04064242|101770417|FG000|COMPLETED|Overall Study||31||
48587477|NCT04064242|101770418|FG001|COMPLETED|Overall Study||31||
48587478|NCT04064242|101770417|FG000|NOT COMPLETED|Overall Study||0||
48587479|NCT04064242|101770418|FG001|NOT COMPLETED|Overall Study||0||
48587480|NCT05356533|101770419|FG000|STARTED|Overall Study||60||
48587481|NCT05356533|101770420|FG001|STARTED|Overall Study||60||
48587482|NCT05356533|101770419|FG000|COMPLETED|Overall Study||49||
48587483|NCT05356533|101770420|FG001|COMPLETED|Overall Study||57||
48587484|NCT05356533|101770419|FG000|NOT COMPLETED|Overall Study||11||
48587485|NCT05356533|101770420|FG001|NOT COMPLETED|Overall Study||3||
48587486|NCT02218736|101770421|FG000|STARTED|Overall Study||45||
48587487|NCT02218736|101770422|FG001|STARTED|Overall Study||44||
48587488|NCT02218736|101770421|FG000|COMPLETED|Overall Study||33||
48587489|NCT02218736|101770422|FG001|COMPLETED|Overall Study||35||
48587490|NCT02218736|101770421|FG000|NOT COMPLETED|Overall Study||12||
48587491|NCT02218736|101770422|FG001|NOT COMPLETED|Overall Study||9||
48587492|NCT01254318|101770423|FG000|STARTED|Overall Study||130||
48587493|NCT01254318|101770423|FG000|COMPLETED|Overall Study||78||
48587494|NCT01254318|101770423|FG000|NOT COMPLETED|Overall Study||52||
48587495|NCT02347891|101770424|FG000|STARTED|Week 0 - Week 40 (Randomized Phase)||10||
48587496|NCT02347891|101770425|FG001|STARTED|Week 0 - Week 40 (Randomized Phase)||7||
48587497|NCT02347891|101770424|FG000|Received 5 Doses and Included in Included in the Final Intention-to-treat Analysis|Week 0 - Week 40 (Randomized Phase)||9||
48587498|NCT02347891|101770425|FG001|Received 5 Doses and Included in Included in the Final Intention-to-treat Analysis|Week 0 - Week 40 (Randomized Phase)||6||
48587499|NCT02347891|101770424|FG000|COMPLETED|Week 0 - Week 40 (Randomized Phase)||8|9 patients that completed week 16 and were included in 40 week ITT analysis|
48587500|NCT02347891|101770425|FG001|COMPLETED|Week 0 - Week 40 (Randomized Phase)||6|9 patients that completed week 16 and were included in 40 week ITT analysis|
48587501|NCT02347891|101770424|FG000|NOT COMPLETED|Week 0 - Week 40 (Randomized Phase)||2||
48587502|NCT02347891|101770425|FG001|NOT COMPLETED|Week 0 - Week 40 (Randomized Phase)||1||
48587503|NCT02347891|101770424|FG000|STARTED|Week 40 - Week 64 (Open Lable Phase)||8||
48587504|NCT02347891|101770425|FG001|STARTED|Week 40 - Week 64 (Open Lable Phase)||6||
48587505|NCT02347891|101770424|FG000|COMPLETED|Week 40 - Week 64 (Open Lable Phase)||7|all 9 patients that completed week 16 were included in final 64 week ITT analysis.|
48587506|NCT02347891|101770425|FG001|COMPLETED|Week 40 - Week 64 (Open Lable Phase)||5|all 9 patients that completed week 16 were included in final 64 week ITT analysis.|
48587507|NCT02347891|101770424|FG000|NOT COMPLETED|Week 40 - Week 64 (Open Lable Phase)||1||
48587508|NCT02347891|101770425|FG001|NOT COMPLETED|Week 40 - Week 64 (Open Lable Phase)||1||
48587509|NCT02276053|101770426|FG000|STARTED|Overall Study||93||
48587510|NCT02276053|101770426|FG000|COMPLETED|Overall Study||79||
48587511|NCT02276053|101770426|FG000|NOT COMPLETED|Overall Study||14||
48587512|NCT00174967|101770427|FG000|STARTED|Overall Study||37||
48587513|NCT00174967|101770428|FG001|STARTED|Overall Study||40||
48587514|NCT00174967|101770429|FG002|STARTED|Overall Study||38||
48587515|NCT00174967|101770430|FG003|STARTED|Overall Study||38||
48587516|NCT00174967|101770427|FG000|COMPLETED|Overall Study||36||
48587517|NCT00174967|101770428|FG001|COMPLETED|Overall Study||37||
48290442|NCT01007643|101037597|FG000|COMPLETED|Overall Study||8||
48290443|NCT01007643|101037598|FG001|COMPLETED|Overall Study||14||
48290444|NCT01007643|101037597|FG000|NOT COMPLETED|Overall Study||0||
48290445|NCT01007643|101037598|FG001|NOT COMPLETED|Overall Study||0||
48587518|NCT00174967|101770429|FG002|COMPLETED|Overall Study||36||
48587519|NCT00174967|101770430|FG003|COMPLETED|Overall Study||36||
48587520|NCT00174967|101770427|FG000|NOT COMPLETED|Overall Study||1||
48587521|NCT00174967|101770428|FG001|NOT COMPLETED|Overall Study||3||
48587522|NCT00174967|101770429|FG002|NOT COMPLETED|Overall Study||2||
48587523|NCT00174967|101770430|FG003|NOT COMPLETED|Overall Study||2||
48587524|NCT01460654|101770431|FG000|STARTED|Overall Study||19||
48587525|NCT01460654|101770432|FG001|STARTED|Overall Study||10||
48587526|NCT01460654|101770433|FG002|STARTED|Overall Study||15||
48587527|NCT01460654|101770431|FG000|COMPLETED|Overall Study||14||
48587528|NCT01460654|101770432|FG001|COMPLETED|Overall Study||9||
48587529|NCT01460654|101770433|FG002|COMPLETED|Overall Study||13||
48587530|NCT01460654|101770431|FG000|NOT COMPLETED|Overall Study||5||
48587531|NCT01460654|101770432|FG001|NOT COMPLETED|Overall Study||1||
48587532|NCT01460654|101770433|FG002|NOT COMPLETED|Overall Study||2||
48587533|NCT04852679|101770434|FG000|STARTED|Main Intervention Period||43|Treated participants.|
48587534|NCT04852679|101770434|FG000|Study Intervention Completion at Week 24|Main Intervention Period||28||
48587535|NCT04852679|101770434|FG000|COMPLETED|Main Intervention Period||22|Study intervention completion at Week 48.|
48587536|NCT04852679|101770434|FG000|NOT COMPLETED|Main Intervention Period||21||
48587537|NCT04852679|101770434|FG000|STARTED|Independent Injection Period||5||
48587538|NCT04852679|101770434|FG000|COMPLETED|Independent Injection Period||4|Study intervention completion at Week 72.|
48587539|NCT04852679|101770434|FG000|NOT COMPLETED|Independent Injection Period||1||
48587540|NCT02855359|101770435|FG000|STARTED|Overall Study||11||
48587541|NCT02855359|101770436|FG001|STARTED|Overall Study||13||
48587542|NCT02855359|101770437|FG002|STARTED|Overall Study||0||
48290446|NCT01210664|101037599|FG000|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3||
48290447|NCT01210664|101037600|FG001|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0||
48290448|NCT01210664|101037601|FG002|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0||
48290449|NCT01210664|101037602|FG003|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0||
48290450|NCT01210664|101037599|FG000|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3||
48290451|NCT01210664|101037600|FG001|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0||
48290452|NCT01210664|101037601|FG002|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0||
48290453|NCT01210664|101037602|FG003|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0||
48290454|NCT01210664|101037599|FG000|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3||
48290455|NCT01210664|101037600|FG001|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0||
48290456|NCT01210664|101037601|FG002|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0||
48290457|NCT01210664|101037602|FG003|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0||
48587543|NCT02855359|101770438|FG003|STARTED|Overall Study||0||
48587544|NCT02855359|101770435|FG000|COMPLETED|Overall Study||0||
48587545|NCT02855359|101770436|FG001|COMPLETED|Overall Study||0||
48587546|NCT02855359|101770437|FG002|COMPLETED|Overall Study||0||
48587547|NCT02855359|101770438|FG003|COMPLETED|Overall Study||0||
48587548|NCT02855359|101770435|FG000|NOT COMPLETED|Overall Study||11||
48587549|NCT02855359|101770436|FG001|NOT COMPLETED|Overall Study||13||
48587550|NCT02855359|101770437|FG002|NOT COMPLETED|Overall Study||0||
48587551|NCT02855359|101770438|FG003|NOT COMPLETED|Overall Study||0||
48587552|NCT04032106|101770439|FG000|STARTED|Overall Study||412||
48587553|NCT04032106|101770440|FG001|STARTED|Overall Study||407||
48587554|NCT04032106|101770441|FG002|STARTED|Overall Study||408||
48587555|NCT04032106|101770439|FG000|COMPLETED|Overall Study||295||
48587556|NCT04032106|101770440|FG001|COMPLETED|Overall Study||271||
48587557|NCT04032106|101770441|FG002|COMPLETED|Overall Study||276||
48587558|NCT04032106|101770439|FG000|NOT COMPLETED|Overall Study||117||
48587559|NCT04032106|101770440|FG001|NOT COMPLETED|Overall Study||136||
48587560|NCT04032106|101770441|FG002|NOT COMPLETED|Overall Study||132||
48587561|NCT01943851|101770442|FG000|STARTED|Part 1 (Up to 86.9 Weeks)||1||
48587562|NCT01943851|101770443|FG001|STARTED|Part 1 (Up to 86.9 Weeks)||1||
48587563|NCT01943851|101770444|FG002|STARTED|Part 1 (Up to 86.9 Weeks)||1||
48587564|NCT01943851|101770445|FG003|STARTED|Part 1 (Up to 86.9 Weeks)||5||
48587565|NCT01943851|101770446|FG004|STARTED|Part 1 (Up to 86.9 Weeks)||1||
48587566|NCT01943851|101770447|FG005|STARTED|Part 1 (Up to 86.9 Weeks)||4||
48587567|NCT01943851|101770448|FG006|STARTED|Part 1 (Up to 86.9 Weeks)||8||
48587568|NCT01943851|101770449|FG007|STARTED|Part 1 (Up to 86.9 Weeks)||18||
48587569|NCT01943851|101770450|FG008|STARTED|Part 1 (Up to 86.9 Weeks)||3||
48290458|NCT01210664|101037599|FG000|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0||
48587570|NCT01943851|101770451|FG009|STARTED|Part 1 (Up to 86.9 Weeks)||8||
48587571|NCT01943851|101770452|FG010|STARTED|Part 1 (Up to 86.9 Weeks)||1||
48587572|NCT01943851|101770453|FG011|STARTED|Part 1 (Up to 86.9 Weeks)||7||
48587573|NCT01943851|101770454|FG012|STARTED|Part 1 (Up to 86.9 Weeks)||7||
48587574|NCT01943851|101770455|FG013|STARTED|Part 1 (Up to 86.9 Weeks)||16||
48587575|NCT01943851|101770456|FG014|STARTED|Part 1 (Up to 86.9 Weeks)||6||
48587576|NCT01943851|101770457|FG015|STARTED|Part 1 (Up to 86.9 Weeks)||0||
48587577|NCT01943851|101770458|FG016|STARTED|Part 1 (Up to 86.9 Weeks)||0||
48587578|NCT01943851|101770459|FG017|STARTED|Part 1 (Up to 86.9 Weeks)||0||
48587579|NCT01943851|101770442|FG000|COMPLETED|Part 1 (Up to 86.9 Weeks)||1||
48587580|NCT01943851|101770443|FG001|COMPLETED|Part 1 (Up to 86.9 Weeks)||1||
48587581|NCT01943851|101770444|FG002|COMPLETED|Part 1 (Up to 86.9 Weeks)||1||
48587582|NCT01943851|101770445|FG003|COMPLETED|Part 1 (Up to 86.9 Weeks)||4||
48587583|NCT01943851|101770446|FG004|COMPLETED|Part 1 (Up to 86.9 Weeks)||0||
48587584|NCT01943851|101770447|FG005|COMPLETED|Part 1 (Up to 86.9 Weeks)||4||
48587585|NCT01943851|101770448|FG006|COMPLETED|Part 1 (Up to 86.9 Weeks)||7||
48587586|NCT01943851|101770449|FG007|COMPLETED|Part 1 (Up to 86.9 Weeks)||16||
48587587|NCT01943851|101770450|FG008|COMPLETED|Part 1 (Up to 86.9 Weeks)||2||
48587588|NCT01943851|101770451|FG009|COMPLETED|Part 1 (Up to 86.9 Weeks)||8||
48587589|NCT01943851|101770452|FG010|COMPLETED|Part 1 (Up to 86.9 Weeks)||1||
48587590|NCT01943851|101770453|FG011|COMPLETED|Part 1 (Up to 86.9 Weeks)||7||
48587591|NCT01943851|101770454|FG012|COMPLETED|Part 1 (Up to 86.9 Weeks)||7||
48587592|NCT01943851|101770455|FG013|COMPLETED|Part 1 (Up to 86.9 Weeks)||15||
48587593|NCT01943851|101770456|FG014|COMPLETED|Part 1 (Up to 86.9 Weeks)||6||
48587594|NCT01943851|101770457|FG015|COMPLETED|Part 1 (Up to 86.9 Weeks)||0||
48587595|NCT01943851|101770458|FG016|COMPLETED|Part 1 (Up to 86.9 Weeks)||0||
48587596|NCT01943851|101770459|FG017|COMPLETED|Part 1 (Up to 86.9 Weeks)||0||
48587597|NCT01943851|101770442|FG000|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0||
48587598|NCT01943851|101770443|FG001|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0||
48587599|NCT01943851|101770444|FG002|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0||
48587600|NCT01943851|101770445|FG003|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1||
48138677|NCT02310750|100661659|FG010|COMPLETED|HP MAD and Fasted/Fed||2||
48587601|NCT01943851|101770446|FG004|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1||
48587602|NCT01943851|101770447|FG005|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0||
48587603|NCT01943851|101770448|FG006|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1||
48587604|NCT01943851|101770449|FG007|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||2||
48587605|NCT01943851|101770450|FG008|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1||
48587606|NCT01943851|101770451|FG009|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0||
48587607|NCT01943851|101770452|FG010|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0||
48587608|NCT01943851|101770453|FG011|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0||
48587609|NCT01943851|101770454|FG012|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0||
48138678|NCT02310750|100661660|FG011|COMPLETED|HP MAD and Fasted/Fed||2||
48587610|NCT01943851|101770455|FG013|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1||
48587611|NCT01943851|101770456|FG014|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0||
48587612|NCT01943851|101770457|FG015|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0||
48587613|NCT01943851|101770458|FG016|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0||
48587614|NCT01943851|101770459|FG017|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0||
48587615|NCT01943851|101770442|FG000|STARTED|Part 2 (Up to 36.4 Weeks)||0||
48587616|NCT01943851|101770443|FG001|STARTED|Part 2 (Up to 36.4 Weeks)||0||
48587617|NCT01943851|101770444|FG002|STARTED|Part 2 (Up to 36.4 Weeks)||0||
48587618|NCT01943851|101770445|FG003|STARTED|Part 2 (Up to 36.4 Weeks)||0||
48587619|NCT01943851|101770446|FG004|STARTED|Part 2 (Up to 36.4 Weeks)||0||
48587620|NCT01943851|101770447|FG005|STARTED|Part 2 (Up to 36.4 Weeks)||0||
48587621|NCT01943851|101770448|FG006|STARTED|Part 2 (Up to 36.4 Weeks)||0||
48587622|NCT01943851|101770449|FG007|STARTED|Part 2 (Up to 36.4 Weeks)||0||
48587623|NCT01943851|101770450|FG008|STARTED|Part 2 (Up to 36.4 Weeks)||0||
48587624|NCT01943851|101770451|FG009|STARTED|Part 2 (Up to 36.4 Weeks)||0||
48587625|NCT01943851|101770452|FG010|STARTED|Part 2 (Up to 36.4 Weeks)||0||
48587626|NCT01943851|101770453|FG011|STARTED|Part 2 (Up to 36.4 Weeks)||0||
48587627|NCT01943851|101770454|FG012|STARTED|Part 2 (Up to 36.4 Weeks)||0||
48587628|NCT01943851|101770455|FG013|STARTED|Part 2 (Up to 36.4 Weeks)||0||
48587629|NCT01943851|101770456|FG014|STARTED|Part 2 (Up to 36.4 Weeks)||0||
48587630|NCT01943851|101770457|FG015|STARTED|Part 2 (Up to 36.4 Weeks)||7||
48587631|NCT01943851|101770458|FG016|STARTED|Part 2 (Up to 36.4 Weeks)||16||
48587632|NCT01943851|101770459|FG017|STARTED|Part 2 (Up to 36.4 Weeks)||1||
48587633|NCT01943851|101770442|FG000|COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
48587634|NCT01943851|101770443|FG001|COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
48587635|NCT01943851|101770444|FG002|COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
48587636|NCT01943851|101770445|FG003|COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
48587637|NCT01943851|101770446|FG004|COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
48587638|NCT01943851|101770447|FG005|COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
48587639|NCT01943851|101770448|FG006|COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
48587640|NCT01943851|101770449|FG007|COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
48587641|NCT01943851|101770450|FG008|COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
48587642|NCT01943851|101770451|FG009|COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
48587643|NCT01943851|101770452|FG010|COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
48587644|NCT01943851|101770453|FG011|COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
48587645|NCT01943851|101770454|FG012|COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
48587646|NCT01943851|101770455|FG013|COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
48706613|NCT02279719|102069756|FG003|STARTED|Overall Study||9||
48706614|NCT02279719|102069757|FG004|STARTED|Overall Study||28||
48706615|NCT02279719|102069758|FG005|STARTED|Overall Study||10||
48706616|NCT02279719|102069759|FG006|STARTED|Overall Study||31||
48706617|NCT02279719|102069753|FG000|COMPLETED|Overall Study||5||
48706618|NCT02279719|102069754|FG001|COMPLETED|Overall Study||10||
48706619|NCT02279719|102069755|FG002|COMPLETED|Overall Study||4||
48706620|NCT02279719|102069756|FG003|COMPLETED|Overall Study||9||
48706621|NCT02279719|102069757|FG004|COMPLETED|Overall Study||25||
48706622|NCT02279719|102069758|FG005|COMPLETED|Overall Study||10||
48706623|NCT02279719|102069759|FG006|COMPLETED|Overall Study||28||
48706624|NCT02279719|102069753|FG000|NOT COMPLETED|Overall Study||0||
48706625|NCT02279719|102069754|FG001|NOT COMPLETED|Overall Study||0||
48706626|NCT02279719|102069755|FG002|NOT COMPLETED|Overall Study||0||
48706627|NCT02279719|102069756|FG003|NOT COMPLETED|Overall Study||0||
48706628|NCT02279719|102069757|FG004|NOT COMPLETED|Overall Study||3||
48706629|NCT02279719|102069758|FG005|NOT COMPLETED|Overall Study||0||
48706630|NCT02279719|102069759|FG006|NOT COMPLETED|Overall Study||3||
48706631|NCT04432493|102069760|FG000|STARTED|Overall Study||16||
48706632|NCT04432493|102069761|FG001|STARTED|Overall Study||18||
48706633|NCT04432493|102069762|FG002|STARTED|Overall Study||22||
48706634|NCT04432493|102069763|FG003|STARTED|Overall Study||25||
48706635|NCT04432493|102069760|FG000|COMPLETED|Overall Study||16||
48706636|NCT04432493|102069761|FG001|COMPLETED|Overall Study||18||
48706637|NCT04432493|102069762|FG002|COMPLETED|Overall Study||22||
48706638|NCT04432493|102069763|FG003|COMPLETED|Overall Study||25||
48706639|NCT04432493|102069760|FG000|NOT COMPLETED|Overall Study||0||
48138679|NCT02310750|100661661|FG012|COMPLETED|HP MAD and Fasted/Fed||2||
48587647|NCT01943851|101770456|FG014|COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
48587648|NCT01943851|101770457|FG015|COMPLETED|Part 2 (Up to 36.4 Weeks)||1||
48587649|NCT01943851|101770458|FG016|COMPLETED|Part 2 (Up to 36.4 Weeks)||13||
48587650|NCT01943851|101770459|FG017|COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
48587651|NCT01943851|101770442|FG000|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
48706640|NCT04432493|102069761|FG001|NOT COMPLETED|Overall Study||0||
48706641|NCT04432493|102069762|FG002|NOT COMPLETED|Overall Study||0||
48706642|NCT04432493|102069763|FG003|NOT COMPLETED|Overall Study||0||
48706643|NCT00100230|102069764|FG000|STARTED|Overall Study||41||
48706644|NCT00100230|102069765|FG001|STARTED|Overall Study||37||
48706645|NCT00100230|102069764|FG000|COMPLETED|Overall Study||29||
48706646|NCT00100230|102069765|FG001|COMPLETED|Overall Study||22||
48706647|NCT00100230|102069764|FG000|NOT COMPLETED|Overall Study||12||
48706648|NCT00100230|102069765|FG001|NOT COMPLETED|Overall Study||15||
48706649|NCT01089023|102069766|FG000|STARTED|Overall Study||95||
48706650|NCT01089023|102069766|FG000|COMPLETED|Overall Study||88||
48706651|NCT01089023|102069766|FG000|NOT COMPLETED|Overall Study||7||
48706652|NCT01672658|102069767|FG000|STARTED|Overall Study||16||
48706653|NCT01672658|102069768|FG001|STARTED|Overall Study||15||
48706654|NCT01672658|102069767|FG000|COMPLETED|Overall Study||16||
48706655|NCT01672658|102069768|FG001|COMPLETED|Overall Study||14||
48706656|NCT01672658|102069767|FG000|NOT COMPLETED|Overall Study||0||
48706657|NCT01672658|102069768|FG001|NOT COMPLETED|Overall Study||1||
48138680|NCT02310750|100661662|FG013|COMPLETED|HP MAD and Fasted/Fed||2||
48138681|NCT02310750|100661663|FG014|COMPLETED|HP MAD and Fasted/Fed||2||
48138682|NCT02310750|100661664|FG015|COMPLETED|HP MAD and Fasted/Fed||2||
48138683|NCT02310750|100661649|FG000|NOT COMPLETED|HP MAD and Fasted/Fed||0||
48138684|NCT02310750|100661650|FG001|NOT COMPLETED|HP MAD and Fasted/Fed||0||
48138685|NCT02310750|100661651|FG002|NOT COMPLETED|HP MAD and Fasted/Fed||0||
48138686|NCT02310750|100661652|FG003|NOT COMPLETED|HP MAD and Fasted/Fed||0||
48138687|NCT02310750|100661653|FG004|NOT COMPLETED|HP MAD and Fasted/Fed||1||
48138688|NCT02310750|100661654|FG005|NOT COMPLETED|HP MAD and Fasted/Fed||0||
48138689|NCT02310750|100661655|FG006|NOT COMPLETED|HP MAD and Fasted/Fed||0||
48138690|NCT02310750|100661656|FG007|NOT COMPLETED|HP MAD and Fasted/Fed||0||
48138691|NCT02310750|100661657|FG008|NOT COMPLETED|HP MAD and Fasted/Fed||0||
48138692|NCT02310750|100661658|FG009|NOT COMPLETED|HP MAD and Fasted/Fed||0||
48138693|NCT02310750|100661659|FG010|NOT COMPLETED|HP MAD and Fasted/Fed||0||
48138694|NCT02310750|100661660|FG011|NOT COMPLETED|HP MAD and Fasted/Fed||0||
48587652|NCT01943851|101770443|FG001|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
48587653|NCT01943851|101770444|FG002|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
48587654|NCT01943851|101770445|FG003|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
48587655|NCT01943851|101770446|FG004|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
48587656|NCT01943851|101770447|FG005|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
48587657|NCT01943851|101770448|FG006|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
48138695|NCT02310750|100661661|FG012|NOT COMPLETED|HP MAD and Fasted/Fed||0||
48138696|NCT02310750|100661662|FG013|NOT COMPLETED|HP MAD and Fasted/Fed||0||
48138697|NCT02310750|100661663|FG014|NOT COMPLETED|HP MAD and Fasted/Fed||0||
48138698|NCT02310750|100661664|FG015|NOT COMPLETED|HP MAD and Fasted/Fed||0||
48138699|NCT04786444|100661665|FG000|STARTED|Overall Study||136||
48138700|NCT04786444|100661666|FG001|STARTED|Overall Study||137||
48138701|NCT04786444|100661667|FG002|STARTED|Overall Study||135||
48138702|NCT04786444|100661665|FG000|COMPLETED|Overall Study||121||
48138703|NCT04786444|100661666|FG001|COMPLETED|Overall Study||120||
48138704|NCT04786444|100661667|FG002|COMPLETED|Overall Study||123||
48138705|NCT04786444|100661665|FG000|NOT COMPLETED|Overall Study||15||
48138706|NCT04786444|100661666|FG001|NOT COMPLETED|Overall Study||17||
48138707|NCT04786444|100661667|FG002|NOT COMPLETED|Overall Study||12||
48138708|NCT01572727|100661668|FG000|STARTED|Overall Study||207||
48138709|NCT01572727|100661669|FG001|STARTED|Overall Study||209||
48138710|NCT01572727|100661668|FG000|Pts With Treatment + Safety Assessment|Overall Study||202||
48138711|NCT01572727|100661669|FG001|Pts With Treatment + Safety Assessment|Overall Study||201||
48138712|NCT01572727|100661668|FG000|COMPLETED|Overall Study||0||
48138713|NCT01572727|100661669|FG001|COMPLETED|Overall Study||0||
48138714|NCT01572727|100661668|FG000|NOT COMPLETED|Overall Study||207||
48138715|NCT01572727|100661669|FG001|NOT COMPLETED|Overall Study||209||
48138716|NCT02590354|100661670|FG000|STARTED|Phase 1||114||
48138717|NCT02590354|100661670|FG000|COMPLETED|Phase 1||16||
48138718|NCT02590354|100661670|FG000|NOT COMPLETED|Phase 1||98||
48138719|NCT02590354|100661670|FG000|STARTED|Phase 2 - Treatment Interruption||16||
48138720|NCT02590354|100661670|FG000|COMPLETED|Phase 2 - Treatment Interruption||14||
48138721|NCT02590354|100661670|FG000|NOT COMPLETED|Phase 2 - Treatment Interruption||2||
48138722|NCT03759873|100661671|FG000|STARTED|Overall Study||57||
48138723|NCT03759873|100661672|FG001|STARTED|Overall Study||57||
48587658|NCT01943851|101770449|FG007|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
48587659|NCT01943851|101770450|FG008|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
48706658|NCT04070326|102069769|FG000|STARTED|Baseline Observation-12 Weeks Before TP||4||
48138724|NCT03759873|100661673|FG002|STARTED|Overall Study||57||
48138725|NCT03759873|100661674|FG003|STARTED|Overall Study||38||
48138726|NCT03759873|100661671|FG000|COMPLETED|Overall Study||53||
48138727|NCT03759873|100661672|FG001|COMPLETED|Overall Study||51||
48138728|NCT03759873|100661673|FG002|COMPLETED|Overall Study||52||
48138729|NCT03759873|100661674|FG003|COMPLETED|Overall Study||36||
48138730|NCT03759873|100661671|FG000|NOT COMPLETED|Overall Study||4||
48138731|NCT03759873|100661672|FG001|NOT COMPLETED|Overall Study||6||
48138732|NCT03759873|100661673|FG002|NOT COMPLETED|Overall Study||5||
48587660|NCT01943851|101770451|FG009|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
48587661|NCT01943851|101770452|FG010|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
48592841|NCT00371644|101786323|FG001|COMPLETED|Overall Study||44||
48706659|NCT04070326|102069770|FG001|STARTED|Baseline Observation-12 Weeks Before TP||17||
48706660|NCT04070326|102069769|FG000|COMPLETED|Baseline Observation-12 Weeks Before TP||4||
48706661|NCT04070326|102069770|FG001|COMPLETED|Baseline Observation-12 Weeks Before TP||17||
48138733|NCT03759873|100661674|FG003|NOT COMPLETED|Overall Study||2||
48138734|NCT01764945|100661675|FG000|STARTED|Overall Study||5||
48138735|NCT01764945|100661676|FG001|STARTED|Overall Study||5||
48138736|NCT01764945|100661677|FG002|STARTED|Overall Study||5||
48138737|NCT01764945|100661678|FG003|STARTED|Overall Study||5||
48138738|NCT01764945|100661679|FG004|STARTED|Overall Study||10||
48138739|NCT01764945|100661680|FG005|STARTED|Overall Study||8||
48138740|NCT01764945|100661681|FG006|STARTED|Overall Study||9||
48138741|NCT01764945|100661682|FG007|STARTED|Overall Study||9||
48138742|NCT01764945|100661675|FG000|COMPLETED|Overall Study||5||
48138743|NCT01764945|100661676|FG001|COMPLETED|Overall Study||4||
48587662|NCT01943851|101770453|FG011|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
48587663|NCT01943851|101770454|FG012|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
48587664|NCT01943851|101770455|FG013|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
48587665|NCT01943851|101770456|FG014|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
48587666|NCT01943851|101770457|FG015|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||6||
48587667|NCT01943851|101770458|FG016|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||3||
48587668|NCT01943851|101770459|FG017|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||1||
48587669|NCT02662764|101770460|FG000|STARTED|Overall Study||320||
48587670|NCT02662764|101770460|FG000|COMPLETED|Overall Study||290||
48587671|NCT02662764|101770460|FG000|NOT COMPLETED|Overall Study||30||
48587672|NCT04756154|101770461|FG000|STARTED|Overall Study||135||135
48587673|NCT04756154|101770462|FG001|STARTED|Overall Study||135||135
48587674|NCT04756154|101770463|FG002|STARTED|Overall Study||38||38
48706662|NCT04070326|102069769|FG000|NOT COMPLETED|Baseline Observation-12 Weeks Before TP||0||
48706663|NCT04070326|102069770|FG001|NOT COMPLETED|Baseline Observation-12 Weeks Before TP||0||
48706664|NCT04070326|102069769|FG000|STARTED|Treatment Period A (Weeks 1 to 26)||4||
48706665|NCT04070326|102069770|FG001|STARTED|Treatment Period A (Weeks 1 to 26)||17||
48706666|NCT04070326|102069769|FG000|COMPLETED|Treatment Period A (Weeks 1 to 26)||3||
48706667|NCT04070326|102069770|FG001|COMPLETED|Treatment Period A (Weeks 1 to 26)||17||
48706668|NCT04070326|102069769|FG000|NOT COMPLETED|Treatment Period A (Weeks 1 to 26)||1||
48706669|NCT04070326|102069770|FG001|NOT COMPLETED|Treatment Period A (Weeks 1 to 26)||0||
48706670|NCT04070326|102069769|FG000|STARTED|Treatment Period B (Weeks 27 to 52)||3||
48706671|NCT04070326|102069770|FG001|STARTED|Treatment Period B (Weeks 27 to 52)||17||
48706672|NCT04070326|102069769|FG000|COMPLETED|Treatment Period B (Weeks 27 to 52)||3||
48706673|NCT04070326|102069770|FG001|COMPLETED|Treatment Period B (Weeks 27 to 52)||17||
48706674|NCT04070326|102069769|FG000|NOT COMPLETED|Treatment Period B (Weeks 27 to 52)||0||
48587675|NCT04756154|101770461|FG000|COMPLETED|Overall Study||104||104
48587676|NCT04756154|101770462|FG001|COMPLETED|Overall Study||106||106
48706675|NCT04070326|102069770|FG001|NOT COMPLETED|Treatment Period B (Weeks 27 to 52)||0||
48706676|NCT02754141|102069771|FG000|STARTED|Overall Study||14||
48706677|NCT02754141|102069772|FG001|STARTED|Overall Study||12||
48706678|NCT02754141|102069773|FG002|STARTED|Overall Study||12||
48706679|NCT02754141|102069774|FG003|STARTED|Overall Study||9||
48706680|NCT02754141|102069775|FG004|STARTED|Overall Study||12||
48706681|NCT02754141|102069776|FG005|STARTED|Overall Study||9||
48706682|NCT02754141|102069777|FG006|STARTED|Overall Study||8||
48138744|NCT01764945|100661677|FG002|COMPLETED|Overall Study||5||
48587677|NCT04756154|101770463|FG002|COMPLETED|Overall Study||31||31
48138745|NCT01764945|100661678|FG003|COMPLETED|Overall Study||5||
48138746|NCT01764945|100661679|FG004|COMPLETED|Overall Study||10||
48138747|NCT01764945|100661680|FG005|COMPLETED|Overall Study||8||
48138748|NCT01764945|100661681|FG006|COMPLETED|Overall Study||8||
48138749|NCT01764945|100661682|FG007|COMPLETED|Overall Study||9||
48138750|NCT01764945|100661675|FG000|NOT COMPLETED|Overall Study||0||
48138751|NCT01764945|100661676|FG001|NOT COMPLETED|Overall Study||1||
48138752|NCT01764945|100661677|FG002|NOT COMPLETED|Overall Study||0||
48138753|NCT01764945|100661678|FG003|NOT COMPLETED|Overall Study||0||
48138754|NCT01764945|100661679|FG004|NOT COMPLETED|Overall Study||0||
48290459|NCT01210664|101037600|FG001|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0||
48290460|NCT01210664|101037601|FG002|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0||
48290461|NCT01210664|101037602|FG003|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0||
48290462|NCT01210664|101037599|FG000|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0||
48290463|NCT01210664|101037600|FG001|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3||
48290464|NCT01210664|101037601|FG002|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0||
48290465|NCT01210664|101037602|FG003|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0||
48290466|NCT01210664|101037599|FG000|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0||
48290467|NCT01210664|101037600|FG001|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3||
48290468|NCT01210664|101037601|FG002|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0||
48587678|NCT04756154|101770461|FG000|NOT COMPLETED|Overall Study||31||31
48587679|NCT04756154|101770462|FG001|NOT COMPLETED|Overall Study||29||29
48290469|NCT01210664|101037602|FG003|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0||
48290470|NCT01210664|101037599|FG000|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0||
48401910|NCT04857892|101313875|FG000|COMPLETED|Part 1: Washout Period 1 (Up to 7 Days)||8||
48401911|NCT04857892|101313876|FG001|COMPLETED|Part 1: Washout Period 1 (Up to 7 Days)||7||
48401912|NCT04857892|101313877|FG002|COMPLETED|Part 1: Washout Period 1 (Up to 7 Days)||7||
48401913|NCT04857892|101313878|FG003|COMPLETED|Part 1: Washout Period 1 (Up to 7 Days)||0||
48401914|NCT04857892|101313879|FG004|COMPLETED|Part 1: Washout Period 1 (Up to 7 Days)||0||
48401915|NCT04857892|101313875|FG000|NOT COMPLETED|Part 1: Washout Period 1 (Up to 7 Days)||0||
48401916|NCT04857892|101313876|FG001|NOT COMPLETED|Part 1: Washout Period 1 (Up to 7 Days)||0||
48401917|NCT04857892|101313877|FG002|NOT COMPLETED|Part 1: Washout Period 1 (Up to 7 Days)||0||
48401918|NCT04857892|101313878|FG003|NOT COMPLETED|Part 1: Washout Period 1 (Up to 7 Days)||0||
48401919|NCT04857892|101313879|FG004|NOT COMPLETED|Part 1: Washout Period 1 (Up to 7 Days)||0||
48587680|NCT04756154|101770463|FG002|NOT COMPLETED|Overall Study||7||7
48587681|NCT02648477|101770464|FG000|STARTED|Overall Study||10||
48587682|NCT02648477|101770465|FG001|STARTED|Overall Study||20||
48587683|NCT02648477|101770464|FG000|COMPLETED|Overall Study||10||
48587684|NCT02648477|101770465|FG001|COMPLETED|Overall Study||20||
48587685|NCT02648477|101770464|FG000|NOT COMPLETED|Overall Study||0||
48587686|NCT02648477|101770465|FG001|NOT COMPLETED|Overall Study||0||
48587687|NCT01508052|101770466|FG000|STARTED|Overall Study||20||
48587688|NCT01508052|101770467|FG001|STARTED|Overall Study||20||
48587689|NCT01508052|101770466|FG000|COMPLETED|Overall Study||20||
48587690|NCT01508052|101770467|FG001|COMPLETED|Overall Study||20||
48587691|NCT01508052|101770466|FG000|NOT COMPLETED|Overall Study||0||
48587692|NCT01508052|101770467|FG001|NOT COMPLETED|Overall Study||0||
48587693|NCT02829723|101770468|FG000|STARTED|Overall Study||5|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
48587694|NCT02829723|101770469|FG001|STARTED|Overall Study||7|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
48587695|NCT02829723|101770470|FG002|STARTED|Overall Study||5|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
48592842|NCT00371644|101786322|FG000|NOT COMPLETED|Overall Study||28||
48138755|NCT01764945|100661680|FG005|NOT COMPLETED|Overall Study||0||
48138756|NCT01764945|100661681|FG006|NOT COMPLETED|Overall Study||1||
48138757|NCT01764945|100661682|FG007|NOT COMPLETED|Overall Study||0||
48138758|NCT00352365|100661683|FG000|STARTED|Induction Therapy||41||
48138759|NCT00352365|100661683|FG000|Eligible|Induction Therapy||38||
48138760|NCT00352365|100661683|FG000|Eligible and Began Protocol Therapy|Induction Therapy||37||
48138761|NCT00352365|100661683|FG000|COMPLETED|Induction Therapy||14||
48290471|NCT01210664|101037600|FG001|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3||
48290472|NCT01210664|101037601|FG002|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0||
48290473|NCT01210664|101037602|FG003|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0||
48290474|NCT01210664|101037599|FG000|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0||
48290475|NCT01210664|101037600|FG001|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0||
48290476|NCT01210664|101037601|FG002|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0||
48290477|NCT01210664|101037602|FG003|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0||
48290478|NCT01210664|101037599|FG000|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0||
48290479|NCT01210664|101037600|FG001|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0||
48290480|NCT01210664|101037601|FG002|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||5||
48290481|NCT01210664|101037602|FG003|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0||
48290482|NCT01210664|101037599|FG000|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0||
48290483|NCT01210664|101037600|FG001|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0||
48290484|NCT01210664|101037601|FG002|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||4||
48290485|NCT01210664|101037602|FG003|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0||
48290486|NCT01210664|101037599|FG000|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0||
48290487|NCT01210664|101037600|FG001|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0||
48290488|NCT01210664|101037601|FG002|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||3||
48290489|NCT01210664|101037602|FG003|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0||
48290490|NCT01210664|101037599|FG000|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0||
48290491|NCT01210664|101037600|FG001|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0||
48290492|NCT01210664|101037601|FG002|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||2||
48290493|NCT01210664|101037602|FG003|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0||
48290494|NCT01210664|101037599|FG000|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0||
48290495|NCT01210664|101037600|FG001|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0||
48290496|NCT01210664|101037601|FG002|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0||
48290497|NCT01210664|101037602|FG003|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||5||
48290498|NCT01210664|101037599|FG000|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0||
48290499|NCT01210664|101037600|FG001|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0||
48290500|NCT01210664|101037601|FG002|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0||
48290501|NCT01210664|101037602|FG003|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||4||
48290502|NCT01210664|101037599|FG000|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0||
48290503|NCT01210664|101037600|FG001|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0||
48290504|NCT01210664|101037601|FG002|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0||
48290505|NCT01210664|101037602|FG003|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||4||
48290506|NCT01210664|101037599|FG000|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0||
48290507|NCT01210664|101037600|FG001|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0||
48290508|NCT01210664|101037601|FG002|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0||
48290509|NCT01210664|101037602|FG003|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||1||
48290510|NCT01227577|101037603|FG000|STARTED|Overall Study||128||
48290511|NCT01227577|101037603|FG000|COMPLETED|Overall Study||93||
48290512|NCT01227577|101037603|FG000|NOT COMPLETED|Overall Study||35||
48290513|NCT03271021|101037604|FG000|STARTED|Overall Study||738||
48290514|NCT03271021|101037605|FG001|STARTED|Overall Study||750||
48290515|NCT03271021|101037604|FG000|COMPLETED|Overall Study||649||
48290516|NCT03271021|101037605|FG001|COMPLETED|Overall Study||644||
48290517|NCT03271021|101037604|FG000|NOT COMPLETED|Overall Study||89||
48290518|NCT03271021|101037605|FG001|NOT COMPLETED|Overall Study||106||
48290519|NCT01105754|101037606|FG000|STARTED|Overall Study||319||
48290520|NCT01105754|101037607|FG001|STARTED|Overall Study||319||
48290521|NCT01105754|101037606|FG000|COMPLETED|Overall Study||304||
48290522|NCT01105754|101037607|FG001|COMPLETED|Overall Study||307||
48290523|NCT01105754|101037606|FG000|NOT COMPLETED|Overall Study||15||
48290524|NCT01105754|101037607|FG001|NOT COMPLETED|Overall Study||12||
48290525|NCT01952054|101037608|FG000|STARTED|Overall Study||6||
48290526|NCT01952054|101037608|FG000|COMPLETED|Overall Study||5||
48290527|NCT01952054|101037608|FG000|NOT COMPLETED|Overall Study||1||
48290528|NCT00760006|101037609|FG000|STARTED|Overall Study||86||
48290529|NCT00760006|101037610|FG001|STARTED|Overall Study||138||
48290530|NCT00760006|101037609|FG000|COMPLETED|Overall Study||86||
48290531|NCT00760006|101037610|FG001|COMPLETED|Overall Study||138||
48401920|NCT04857892|101313875|FG000|STARTED|Part 1: Period 2 (Day 1)||8||
48401921|NCT04857892|101313876|FG001|STARTED|Part 1: Period 2 (Day 1)||7||
48401922|NCT04857892|101313877|FG002|STARTED|Part 1: Period 2 (Day 1)||7||
48401923|NCT04857892|101313878|FG003|STARTED|Part 1: Period 2 (Day 1)||0||
48290532|NCT00760006|101037609|FG000|NOT COMPLETED|Overall Study||0||
48290533|NCT00760006|101037610|FG001|NOT COMPLETED|Overall Study||0||
48290534|NCT01944371|101037611|FG000|STARTED|Overall Study||10||
48290535|NCT01944371|101037612|FG001|STARTED|Overall Study||10||
48290536|NCT01944371|101037613|FG002|STARTED|Overall Study||10||
48290537|NCT01944371|101037611|FG000|COMPLETED|Overall Study||10||
48290538|NCT01944371|101037612|FG001|COMPLETED|Overall Study||10||
48290539|NCT01944371|101037613|FG002|COMPLETED|Overall Study||10||
48290540|NCT01944371|101037611|FG000|NOT COMPLETED|Overall Study||0||
48290541|NCT01944371|101037612|FG001|NOT COMPLETED|Overall Study||0||
48290542|NCT01944371|101037613|FG002|NOT COMPLETED|Overall Study||0||
48290543|NCT02649946|101037614|FG000|STARTED|Overall Study||142||
48290544|NCT02649946|101037615|FG001|STARTED|Overall Study||138||
48290545|NCT02649946|101037614|FG000|COMPLETED|Overall Study||130||
48290546|NCT02649946|101037615|FG001|COMPLETED|Overall Study||123||
48290547|NCT02649946|101037614|FG000|NOT COMPLETED|Overall Study||12||
48290548|NCT02649946|101037615|FG001|NOT COMPLETED|Overall Study||15||
48401924|NCT04857892|101313879|FG004|STARTED|Part 1: Period 2 (Day 1)||0||
48290549|NCT03536754|101037616|FG000|STARTED|Double Blind Period 1||12||
48290550|NCT03536754|101037617|FG001|STARTED|Double Blind Period 1||11||
48290551|NCT03536754|101037618|FG002|STARTED|Double Blind Period 1||12||
48290552|NCT03536754|101037619|FG003|STARTED|Double Blind Period 1||11||
48290553|NCT03536754|101037620|FG004|STARTED|Double Blind Period 1||0||
48138762|NCT00352365|100661683|FG000|NOT COMPLETED|Induction Therapy||27||
48138763|NCT00352365|100661683|FG000|STARTED|Maintenance Therapy||12||
48138764|NCT00352365|100661683|FG000|Eligible and Began Protocol Therapy|Maintenance Therapy||8||
48138765|NCT00352365|100661683|FG000|COMPLETED|Maintenance Therapy||0||
48138766|NCT00352365|100661683|FG000|NOT COMPLETED|Maintenance Therapy||12||
48138767|NCT02345031|100661684|FG000|STARTED|Overall Study||38||
48138768|NCT02345031|100661685|FG001|STARTED|Overall Study||40||
48138769|NCT02345031|100661684|FG000|COMPLETED|Overall Study||37||
48138770|NCT02345031|100661685|FG001|COMPLETED|Overall Study||39||
48138771|NCT02345031|100661684|FG000|NOT COMPLETED|Overall Study||1||
48138772|NCT02345031|100661685|FG001|NOT COMPLETED|Overall Study||1||
48138773|NCT02034578|100661686|FG000|STARTED|Overall Study||4||
48138774|NCT02034578|100661687|FG001|STARTED|Overall Study||3||
48138775|NCT02034578|100661688|FG002|STARTED|Overall Study||4||
48138776|NCT02034578|100661689|FG003|STARTED|Overall Study||3||
48138777|NCT02034578|100661690|FG004|STARTED|Overall Study||4||
48138778|NCT02034578|100661691|FG005|STARTED|Overall Study||3||
48138779|NCT02034578|100661686|FG000|COMPLETED|Overall Study||4||
48138780|NCT02034578|100661687|FG001|COMPLETED|Overall Study||3||
48138781|NCT02034578|100661688|FG002|COMPLETED|Overall Study||4||
48138782|NCT02034578|100661689|FG003|COMPLETED|Overall Study||3||
48138783|NCT02034578|100661690|FG004|COMPLETED|Overall Study||4||
48138784|NCT02034578|100661691|FG005|COMPLETED|Overall Study||3||
48138785|NCT02034578|100661686|FG000|NOT COMPLETED|Overall Study||0||
48138786|NCT02034578|100661687|FG001|NOT COMPLETED|Overall Study||0||
48138787|NCT02034578|100661688|FG002|NOT COMPLETED|Overall Study||0||
48138788|NCT02034578|100661689|FG003|NOT COMPLETED|Overall Study||0||
48138789|NCT02034578|100661690|FG004|NOT COMPLETED|Overall Study||0||
48138790|NCT02034578|100661691|FG005|NOT COMPLETED|Overall Study||0||
48138791|NCT05003791|100661692|FG000|STARTED|Overall Study||48||
48138792|NCT05003791|100661692|FG000|COMPLETED|Overall Study||45||
48138793|NCT05003791|100661692|FG000|NOT COMPLETED|Overall Study||3||
48138794|NCT01221597|100661693|FG000|STARTED|Overall Study||277||
48138795|NCT01221597|100661694|FG001|STARTED|Overall Study||140||
48138796|NCT01221597|100661693|FG000|COMPLETED|Overall Study||241||
48138797|NCT01221597|100661694|FG001|COMPLETED|Overall Study||124||
48138798|NCT01221597|100661693|FG000|NOT COMPLETED|Overall Study||36||
48138799|NCT01221597|100661694|FG001|NOT COMPLETED|Overall Study||16||
48138800|NCT04729803|100661695|FG000|STARTED|Overall Study||13||
48138801|NCT04729803|100661696|FG001|STARTED|Overall Study||18||
48138802|NCT04729803|100661697|FG002|STARTED|Overall Study||22||
48138803|NCT04729803|100661695|FG000|Post-treatment|Overall Study||7||
48138804|NCT04729803|100661696|FG001|Post-treatment|Overall Study||15||
48138805|NCT04729803|100661697|FG002|Post-treatment|Overall Study||12||
48138806|NCT04729803|100661695|FG000|COMPLETED|Overall Study||6||
48138807|NCT04729803|100661696|FG001|COMPLETED|Overall Study||12||
48138808|NCT04729803|100661697|FG002|COMPLETED|Overall Study||9||
48138809|NCT04729803|100661695|FG000|NOT COMPLETED|Overall Study||7||
48138810|NCT04729803|100661696|FG001|NOT COMPLETED|Overall Study||6||
48138811|NCT04729803|100661697|FG002|NOT COMPLETED|Overall Study||13||
48138812|NCT04747977|100665439|FG000|STARTED|Overall Study||57||
48138813|NCT04747977|100665440|FG001|STARTED|Overall Study||57||
48138814|NCT04747977|100665441|FG002|STARTED|Overall Study||58||
48138815|NCT04747977|100665439|FG000|COMPLETED|Overall Study||54||
48138816|NCT04747977|100665440|FG001|COMPLETED|Overall Study||56||
48138817|NCT04747977|100665441|FG002|COMPLETED|Overall Study||55||
48138818|NCT04747977|100665439|FG000|NOT COMPLETED|Overall Study||3||
48138819|NCT04747977|100665440|FG001|NOT COMPLETED|Overall Study||1||
48138820|NCT04747977|100665441|FG002|NOT COMPLETED|Overall Study||3||
48138821|NCT03923959|100665442|FG000|STARTED|Overall Study||146||
48138822|NCT03923959|100665443|FG001|STARTED|Overall Study||138||
48138823|NCT03923959|100665442|FG000|COMPLETED|Overall Study||73||
48138824|NCT03923959|100665443|FG001|COMPLETED|Overall Study||68||
48138825|NCT03923959|100665442|FG000|NOT COMPLETED|Overall Study||73||
48138826|NCT03923959|100665443|FG001|NOT COMPLETED|Overall Study||70||
48290554|NCT03536754|101037616|FG000|COMPLETED|Double Blind Period 1||12||
48290555|NCT03536754|101037617|FG001|COMPLETED|Double Blind Period 1||11||
48290556|NCT03536754|101037618|FG002|COMPLETED|Double Blind Period 1||11||
48138827|NCT00377819|100665444|FG000|STARTED|Overall Study||251||
48138828|NCT00377819|100665445|FG001|STARTED|Overall Study||253||
48138829|NCT00377819|100665444|FG000|Received Study Medication|Overall Study||249||
48138830|NCT00377819|100665445|FG001|Received Study Medication|Overall Study||253||
48138831|NCT00377819|100665444|FG000|COMPLETED|Overall Study||238||
48138832|NCT00377819|100665445|FG001|COMPLETED|Overall Study||243||
48138833|NCT00377819|100665444|FG000|NOT COMPLETED|Overall Study||13||
48138834|NCT00377819|100665445|FG001|NOT COMPLETED|Overall Study||10||
48138835|NCT01750268|100665446|FG000|STARTED|Overall Study||15||
48138836|NCT01750268|100665447|FG001|STARTED|Overall Study||17||
48290557|NCT03536754|101037619|FG003|COMPLETED|Double Blind Period 1||11||
48138837|NCT01750268|100665446|FG000|COMPLETED|Overall Study||13||
48138838|NCT01750268|100665447|FG001|COMPLETED|Overall Study||12||
48138839|NCT01750268|100665446|FG000|NOT COMPLETED|Overall Study||2||
48138840|NCT01750268|100665447|FG001|NOT COMPLETED|Overall Study||5||
48138841|NCT02363738|100665448|FG000|STARTED|Overall Study||29||
48138842|NCT02363738|100665449|FG001|STARTED|Overall Study||31||
48138843|NCT02363738|100665448|FG000|COMPLETED|Overall Study||21||
48138844|NCT02363738|100665449|FG001|COMPLETED|Overall Study||26||
48138845|NCT02363738|100665448|FG000|NOT COMPLETED|Overall Study||8||
48138846|NCT02363738|100665449|FG001|NOT COMPLETED|Overall Study||5||
48138847|NCT00572234|100665450|FG000|STARTED|Overall Study||19||
48138848|NCT00572234|100665451|FG001|STARTED|Overall Study||21||
48138849|NCT00572234|100665450|FG000|COMPLETED|Overall Study||18||
48138850|NCT00572234|100665451|FG001|COMPLETED|Overall Study||16||
48138851|NCT00572234|100665450|FG000|NOT COMPLETED|Overall Study||1||
48138852|NCT00572234|100665451|FG001|NOT COMPLETED|Overall Study||5||
48138853|NCT01605617|100665452|FG000|STARTED|First Intervention||2||
48138854|NCT01605617|100665453|FG001|STARTED|First Intervention||2||
48138855|NCT01605617|100665452|FG000|COMPLETED|First Intervention||2||
48138856|NCT01605617|100665453|FG001|COMPLETED|First Intervention||1||
48138857|NCT01605617|100665452|FG000|NOT COMPLETED|First Intervention||0||
48138858|NCT01605617|100665453|FG001|NOT COMPLETED|First Intervention||1||
48138859|NCT01605617|100665452|FG000|STARTED|Washout Period of 4 Weeks||2||
48138860|NCT01605617|100665453|FG001|STARTED|Washout Period of 4 Weeks||1||
48138861|NCT01605617|100665452|FG000|COMPLETED|Washout Period of 4 Weeks||0||
48138862|NCT01605617|100665453|FG001|COMPLETED|Washout Period of 4 Weeks||0||
48138863|NCT01605617|100665452|FG000|NOT COMPLETED|Washout Period of 4 Weeks||2||
48138864|NCT01605617|100665453|FG001|NOT COMPLETED|Washout Period of 4 Weeks||1||
48138865|NCT01605617|100665452|FG000|STARTED|Second Intervention||0||
48138866|NCT01605617|100665453|FG001|STARTED|Second Intervention||0||
48138867|NCT01605617|100665452|FG000|COMPLETED|Second Intervention||0||
48138868|NCT01605617|100665453|FG001|COMPLETED|Second Intervention||0||
48138869|NCT01605617|100665452|FG000|NOT COMPLETED|Second Intervention||0||
48138870|NCT01605617|100665453|FG001|NOT COMPLETED|Second Intervention||0||
48138871|NCT04447404|100665454|FG000|STARTED|Overall Study||2||
48138872|NCT04447404|100665455|FG001|STARTED|Overall Study||0||
48138873|NCT04447404|100665454|FG000|COMPLETED|Overall Study||0||
48138874|NCT04447404|100665455|FG001|COMPLETED|Overall Study||0||
48138875|NCT04447404|100665454|FG000|NOT COMPLETED|Overall Study||2||
48138876|NCT04447404|100665455|FG001|NOT COMPLETED|Overall Study||0||
48138877|NCT04154787|100665456|FG000|STARTED|Overall Study||3||
48138878|NCT04154787|100665457|FG001|STARTED|Overall Study||19||
48587696|NCT02829723|101770471|FG003|STARTED|Overall Study||6|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
48587697|NCT02829723|101770472|FG004|STARTED|Overall Study||3|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
48587698|NCT02829723|101770473|FG005|STARTED|Overall Study||5|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
48587699|NCT02829723|101770474|FG006|STARTED|Overall Study||6|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
48587700|NCT02829723|101770475|FG007|STARTED|Overall Study||8|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
48138879|NCT04154787|100665458|FG002|STARTED|Overall Study||15||
48138880|NCT04154787|100665456|FG000|COMPLETED|Overall Study||3||
48138881|NCT04154787|100665457|FG001|COMPLETED|Overall Study||9||
48138882|NCT04154787|100665458|FG002|COMPLETED|Overall Study||14||
48138883|NCT04154787|100665456|FG000|NOT COMPLETED|Overall Study||0||
48138884|NCT04154787|100665457|FG001|NOT COMPLETED|Overall Study||10||
48138885|NCT04154787|100665458|FG002|NOT COMPLETED|Overall Study||1||
48138886|NCT01715805|100665459|FG000|STARTED|Placebo + ADT Lead-in Period||1022||
48138887|NCT01715805|100665460|FG001|STARTED|Placebo + ADT Lead-in Period||0||
48138888|NCT01715805|100665461|FG002|STARTED|Placebo + ADT Lead-in Period||0||
48138889|NCT01715805|100665462|FG003|STARTED|Placebo + ADT Lead-in Period||0||
48138890|NCT01715805|100665459|FG000|COMPLETED|Placebo + ADT Lead-in Period||807||
48138891|NCT01715805|100665460|FG001|COMPLETED|Placebo + ADT Lead-in Period||0||
48138892|NCT01715805|100665461|FG002|COMPLETED|Placebo + ADT Lead-in Period||0||
48138893|NCT01715805|100665462|FG003|COMPLETED|Placebo + ADT Lead-in Period||0||
48138894|NCT01715805|100665459|FG000|NOT COMPLETED|Placebo + ADT Lead-in Period||215||
48138895|NCT01715805|100665460|FG001|NOT COMPLETED|Placebo + ADT Lead-in Period||0||
48138896|NCT01715805|100665461|FG002|NOT COMPLETED|Placebo + ADT Lead-in Period||0||
48138897|NCT01715805|100665462|FG003|NOT COMPLETED|Placebo + ADT Lead-in Period||0||
48138898|NCT01715805|100665459|FG000|STARTED|Double-Blind or Continued Treatment||0||
48138899|NCT01715805|100665460|FG001|STARTED|Double-Blind or Continued Treatment||261||
48138900|NCT01715805|100665461|FG002|STARTED|Double-Blind or Continued Treatment||269||
48138901|NCT01715805|100665462|FG003|STARTED|Double-Blind or Continued Treatment||270||
48138902|NCT01715805|100665459|FG000|Double-Blind Safety Population|Double-Blind or Continued Treatment||0||
48138903|NCT01715805|100665460|FG001|Double-Blind Safety Population|Double-Blind or Continued Treatment||258||
48138904|NCT01715805|100665461|FG002|Double-Blind Safety Population|Double-Blind or Continued Treatment||269||
48138905|NCT01715805|100665462|FG003|Double-Blind Safety Population|Double-Blind or Continued Treatment||0||
48138906|NCT01715805|100665459|FG000|COMPLETED|Double-Blind or Continued Treatment||0||
48138907|NCT01715805|100665460|FG001|COMPLETED|Double-Blind or Continued Treatment||222||
48138908|NCT01715805|100665461|FG002|COMPLETED|Double-Blind or Continued Treatment||213||
48290558|NCT03536754|101037620|FG004|COMPLETED|Double Blind Period 1||0||
48290559|NCT03536754|101037616|FG000|NOT COMPLETED|Double Blind Period 1||0||
48290560|NCT03536754|101037617|FG001|NOT COMPLETED|Double Blind Period 1||0||
48290561|NCT03536754|101037618|FG002|NOT COMPLETED|Double Blind Period 1||1||
48290562|NCT03536754|101037619|FG003|NOT COMPLETED|Double Blind Period 1||0||
48290563|NCT03536754|101037620|FG004|NOT COMPLETED|Double Blind Period 1||0||
48401925|NCT04857892|101313875|FG000|COMPLETED|Part 1: Period 2 (Day 1)||8||
48401926|NCT04857892|101313876|FG001|COMPLETED|Part 1: Period 2 (Day 1)||7||
48401927|NCT04857892|101313877|FG002|COMPLETED|Part 1: Period 2 (Day 1)||7||
48401928|NCT04857892|101313878|FG003|COMPLETED|Part 1: Period 2 (Day 1)||0||
48401929|NCT04857892|101313879|FG004|COMPLETED|Part 1: Period 2 (Day 1)||0||
48401930|NCT04857892|101313875|FG000|NOT COMPLETED|Part 1: Period 2 (Day 1)||0||
48401931|NCT04857892|101313876|FG001|NOT COMPLETED|Part 1: Period 2 (Day 1)||0||
48401932|NCT04857892|101313877|FG002|NOT COMPLETED|Part 1: Period 2 (Day 1)||0||
48401933|NCT04857892|101313878|FG003|NOT COMPLETED|Part 1: Period 2 (Day 1)||0||
48401934|NCT04857892|101313879|FG004|NOT COMPLETED|Part 1: Period 2 (Day 1)||0||
48401935|NCT04857892|101313875|FG000|STARTED|Part 1: Washout Period 2 (Up to 7 Days)||8||
48401936|NCT04857892|101313876|FG001|STARTED|Part 1: Washout Period 2 (Up to 7 Days)||7||
48401937|NCT04857892|101313877|FG002|STARTED|Part 1: Washout Period 2 (Up to 7 Days)||7||
48401938|NCT04857892|101313878|FG003|STARTED|Part 1: Washout Period 2 (Up to 7 Days)||0||
48401939|NCT04857892|101313879|FG004|STARTED|Part 1: Washout Period 2 (Up to 7 Days)||0||
48401940|NCT04857892|101313875|FG000|COMPLETED|Part 1: Washout Period 2 (Up to 7 Days)||6||
48401941|NCT04857892|101313876|FG001|COMPLETED|Part 1: Washout Period 2 (Up to 7 Days)||6||
48401942|NCT04857892|101313877|FG002|COMPLETED|Part 1: Washout Period 2 (Up to 7 Days)||6||
48401943|NCT04857892|101313878|FG003|COMPLETED|Part 1: Washout Period 2 (Up to 7 Days)||0||
48401944|NCT04857892|101313879|FG004|COMPLETED|Part 1: Washout Period 2 (Up to 7 Days)||0||
48401945|NCT04857892|101313875|FG000|NOT COMPLETED|Part 1: Washout Period 2 (Up to 7 Days)||2||
48401946|NCT04857892|101313876|FG001|NOT COMPLETED|Part 1: Washout Period 2 (Up to 7 Days)||1||
48401947|NCT04857892|101313877|FG002|NOT COMPLETED|Part 1: Washout Period 2 (Up to 7 Days)||1||
48401948|NCT04857892|101313878|FG003|NOT COMPLETED|Part 1: Washout Period 2 (Up to 7 Days)||0||
48401949|NCT04857892|101313879|FG004|NOT COMPLETED|Part 1: Washout Period 2 (Up to 7 Days)||0||
48401950|NCT04857892|101313875|FG000|STARTED|Part 1: Period 3 (Day 1)||6||
48401951|NCT04857892|101313876|FG001|STARTED|Part 1: Period 3 (Day 1)||6||
48401952|NCT04857892|101313877|FG002|STARTED|Part 1: Period 3 (Day 1)||6||
48401953|NCT04857892|101313878|FG003|STARTED|Part 1: Period 3 (Day 1)||0||
48401954|NCT04857892|101313879|FG004|STARTED|Part 1: Period 3 (Day 1)||0||
48401955|NCT04857892|101313875|FG000|COMPLETED|Part 1: Period 3 (Day 1)||6||
48401956|NCT04857892|101313876|FG001|COMPLETED|Part 1: Period 3 (Day 1)||6||
48401957|NCT04857892|101313877|FG002|COMPLETED|Part 1: Period 3 (Day 1)||6||
48401958|NCT04857892|101313878|FG003|COMPLETED|Part 1: Period 3 (Day 1)||0||
48401959|NCT04857892|101313879|FG004|COMPLETED|Part 1: Period 3 (Day 1)||0||
48401960|NCT04857892|101313875|FG000|NOT COMPLETED|Part 1: Period 3 (Day 1)||0||
48401961|NCT04857892|101313876|FG001|NOT COMPLETED|Part 1: Period 3 (Day 1)||0||
48401962|NCT04857892|101313877|FG002|NOT COMPLETED|Part 1: Period 3 (Day 1)||0||
48401963|NCT04857892|101313878|FG003|NOT COMPLETED|Part 1: Period 3 (Day 1)||0||
48401964|NCT04857892|101313879|FG004|NOT COMPLETED|Part 1: Period 3 (Day 1)||0||
48401965|NCT04857892|101313875|FG000|STARTED|Part 2: Period 1 (Day 1)||0||
48401966|NCT04857892|101313876|FG001|STARTED|Part 2: Period 1 (Day 1)||0||
48401967|NCT04857892|101313877|FG002|STARTED|Part 2: Period 1 (Day 1)||0||
48401968|NCT04857892|101313878|FG003|STARTED|Part 2: Period 1 (Day 1)||9||
48401969|NCT04857892|101313879|FG004|STARTED|Part 2: Period 1 (Day 1)||9||
48401970|NCT04857892|101313875|FG000|COMPLETED|Part 2: Period 1 (Day 1)||0||
48401971|NCT04857892|101313876|FG001|COMPLETED|Part 2: Period 1 (Day 1)||0||
48290564|NCT03536754|101037616|FG000|STARTED|Open Label Extension||0||
48290565|NCT03536754|101037617|FG001|STARTED|Open Label Extension||0||
48290566|NCT03536754|101037618|FG002|STARTED|Open Label Extension||0||
48401972|NCT04857892|101313877|FG002|COMPLETED|Part 2: Period 1 (Day 1)||0||
48401973|NCT04857892|101313878|FG003|COMPLETED|Part 2: Period 1 (Day 1)||9||
48401974|NCT04857892|101313879|FG004|COMPLETED|Part 2: Period 1 (Day 1)||9||
48138909|NCT01715805|100665462|FG003|COMPLETED|Double-Blind or Continued Treatment||222||
48138910|NCT01715805|100665459|FG000|NOT COMPLETED|Double-Blind or Continued Treatment||0||
48138911|NCT01715805|100665460|FG001|NOT COMPLETED|Double-Blind or Continued Treatment||39||
48138912|NCT01715805|100665461|FG002|NOT COMPLETED|Double-Blind or Continued Treatment||56||
48138913|NCT01715805|100665462|FG003|NOT COMPLETED|Double-Blind or Continued Treatment||48||
48138914|NCT02952924|100665463|FG000|STARTED|Overall Study||11||
48138915|NCT02952924|100665464|FG001|STARTED|Overall Study||10||
48290567|NCT03536754|101037619|FG003|STARTED|Open Label Extension||0||
48290568|NCT03536754|101037620|FG004|STARTED|Open Label Extension||43||
48138916|NCT02952924|100665465|FG002|STARTED|Overall Study||6||
48138917|NCT02952924|100665466|FG003|STARTED|Overall Study||3||
48290569|NCT03536754|101037616|FG000|COMPLETED|Open Label Extension||0||
48290570|NCT03536754|101037617|FG001|COMPLETED|Open Label Extension||0||
48290571|NCT03536754|101037618|FG002|COMPLETED|Open Label Extension||0||
48290572|NCT03536754|101037619|FG003|COMPLETED|Open Label Extension||0||
48290573|NCT03536754|101037620|FG004|COMPLETED|Open Label Extension||42||
48290574|NCT03536754|101037616|FG000|NOT COMPLETED|Open Label Extension||0||
48290575|NCT03536754|101037617|FG001|NOT COMPLETED|Open Label Extension||0||
48290576|NCT03536754|101037618|FG002|NOT COMPLETED|Open Label Extension||0||
48401975|NCT04857892|101313875|FG000|NOT COMPLETED|Part 2: Period 1 (Day 1)||0||
48587701|NCT02829723|101770476|FG008|STARTED|Overall Study||9|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
48587702|NCT02829723|101770477|FG009|STARTED|Overall Study||5|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
48587703|NCT02829723|101770478|FG010|STARTED|Overall Study||10|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
48587704|NCT02829723|101770479|FG011|STARTED|Overall Study||0|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
48587705|NCT02829723|101770480|FG012|STARTED|Overall Study||5|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
48587706|NCT02829723|101770481|FG013|STARTED|Overall Study||6|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
48587707|NCT02829723|101770482|FG014|STARTED|Overall Study||4|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
48138918|NCT02952924|100665467|FG004|STARTED|Overall Study||6||
48138919|NCT02952924|100665468|FG005|STARTED|Overall Study||3||
48138920|NCT02952924|100665469|FG006|STARTED|Overall Study||6||
48138921|NCT02952924|100665470|FG007|STARTED|Overall Study||6||
48138922|NCT02952924|100665471|FG008|STARTED|Overall Study||6||
48138923|NCT02952924|100665472|FG009|STARTED|Overall Study||6||
48138924|NCT02952924|100665473|FG010|STARTED|Overall Study||7||
48138925|NCT02952924|100665474|FG011|STARTED|Overall Study||7||
48138926|NCT02952924|100665475|FG012|STARTED|Overall Study||6||
48290577|NCT03536754|101037619|FG003|NOT COMPLETED|Open Label Extension||0||
48290578|NCT03536754|101037620|FG004|NOT COMPLETED|Open Label Extension||1||
48290579|NCT00413972|101037621|FG000|STARTED|Overall Study||98||
48290580|NCT00413972|101037622|FG001|STARTED|Overall Study||98||
48138927|NCT02952924|100665476|FG013|STARTED|Overall Study||6||
48138928|NCT02952924|100665477|FG014|STARTED|Overall Study||6||
48138929|NCT02952924|100665478|FG015|STARTED|Overall Study||6||
48587708|NCT02829723|101770483|FG015|STARTED|Overall Study||5|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
48587709|NCT02829723|101770484|FG016|STARTED|Overall Study||9|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
48587710|NCT02829723|101770485|FG017|STARTED|Overall Study||5|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
48587711|NCT02829723|101770486|FG018|STARTED|Overall Study||6|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
48587712|NCT02829723|101770487|FG019|STARTED|Overall Study||5|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
48587713|NCT02829723|101770488|FG020|STARTED|Overall Study||11|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
48587714|NCT02829723|101770489|FG021|STARTED|Overall Study||9|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
48587715|NCT02829723|101770490|FG022|STARTED|Overall Study||4|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
48706683|NCT02754141|102069778|FG007|STARTED|Overall Study||7||
48706684|NCT02754141|102069779|FG008|STARTED|Overall Study||18||
48706685|NCT02754141|102069780|FG009|STARTED|Overall Study||19||
48706686|NCT02754141|102069781|FG010|STARTED|Overall Study||31||
48706687|NCT02754141|102069782|FG011|STARTED|Overall Study||15||
48706688|NCT02754141|102069783|FG012|STARTED|Overall Study||15||
48706689|NCT02754141|102069784|FG013|STARTED|Overall Study||19||
48706690|NCT02754141|102069785|FG014|STARTED|Overall Study||18||
48706691|NCT02754141|102069786|FG015|STARTED|Overall Study||14||
48706692|NCT02754141|102069787|FG016|STARTED|Overall Study||2||
48706693|NCT02754141|102069788|FG017|STARTED|Overall Study||1||
48706694|NCT02754141|102069771|FG000|Continuing to Combo Therapy|Overall Study||12||
48706695|NCT02754141|102069772|FG001|Continuing to Combo Therapy|Overall Study||11||
48706696|NCT02754141|102069773|FG002|Continuing to Combo Therapy|Overall Study||12||
48706697|NCT02754141|102069774|FG003|Continuing to Combo Therapy|Overall Study||7||
48706698|NCT02754141|102069775|FG004|Continuing to Combo Therapy|Overall Study||10||
48706699|NCT02754141|102069776|FG005|Continuing to Combo Therapy|Overall Study||0||
48706700|NCT02754141|102069777|FG006|Continuing to Combo Therapy|Overall Study||0||
48706701|NCT02754141|102069778|FG007|Continuing to Combo Therapy|Overall Study||0||
48706702|NCT02754141|102069779|FG008|Continuing to Combo Therapy|Overall Study||0||
48706703|NCT02754141|102069780|FG009|Continuing to Combo Therapy|Overall Study||0||
48706704|NCT02754141|102069781|FG010|Continuing to Combo Therapy|Overall Study||0||
48706705|NCT02754141|102069782|FG011|Continuing to Combo Therapy|Overall Study||0||
48706706|NCT02754141|102069783|FG012|Continuing to Combo Therapy|Overall Study||0||
48706707|NCT02754141|102069784|FG013|Continuing to Combo Therapy|Overall Study||0||
48706708|NCT02754141|102069785|FG014|Continuing to Combo Therapy|Overall Study||0||
48706709|NCT02754141|102069786|FG015|Continuing to Combo Therapy|Overall Study||0||
48706710|NCT02754141|102069787|FG016|Continuing to Combo Therapy|Overall Study||0||
48706711|NCT02754141|102069788|FG017|Continuing to Combo Therapy|Overall Study||0||
48706712|NCT02754141|102069771|FG000|Crossing Over to RCC Combo Therapy|Overall Study||0||
48706713|NCT02754141|102069772|FG001|Crossing Over to RCC Combo Therapy|Overall Study||0||
48706714|NCT02754141|102069773|FG002|Crossing Over to RCC Combo Therapy|Overall Study||0||
48706715|NCT02754141|102069774|FG003|Crossing Over to RCC Combo Therapy|Overall Study||0||
48706716|NCT02754141|102069775|FG004|Crossing Over to RCC Combo Therapy|Overall Study||0||
48706717|NCT02754141|102069776|FG005|Crossing Over to RCC Combo Therapy|Overall Study||0||
48706718|NCT02754141|102069777|FG006|Crossing Over to RCC Combo Therapy|Overall Study||0||
48706719|NCT02754141|102069778|FG007|Crossing Over to RCC Combo Therapy|Overall Study||0||
48706720|NCT02754141|102069779|FG008|Crossing Over to RCC Combo Therapy|Overall Study||0||
48706721|NCT02754141|102069780|FG009|Crossing Over to RCC Combo Therapy|Overall Study||0||
48706722|NCT02754141|102069781|FG010|Crossing Over to RCC Combo Therapy|Overall Study||0||
48706723|NCT02754141|102069782|FG011|Crossing Over to RCC Combo Therapy|Overall Study||0||
48706724|NCT02754141|102069783|FG012|Crossing Over to RCC Combo Therapy|Overall Study||0||
48706725|NCT02754141|102069784|FG013|Crossing Over to RCC Combo Therapy|Overall Study||3||
48706726|NCT02754141|102069785|FG014|Crossing Over to RCC Combo Therapy|Overall Study||0||
48706727|NCT02754141|102069786|FG015|Crossing Over to RCC Combo Therapy|Overall Study||0||
48710769|NCT01924442|102078013|FG001|STARTED|Overall Study||1104||
48587716|NCT02829723|101770491|FG023|STARTED|Overall Study||6|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
48587717|NCT02829723|101770492|FG024|STARTED|Overall Study||5|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
48587718|NCT02829723|101770493|FG025|STARTED|Overall Study||22|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
48592843|NCT00371644|101786323|FG001|NOT COMPLETED|Overall Study||13||
48138930|NCT02952924|100665479|FG016|STARTED|Overall Study||6||
48138931|NCT02952924|100665480|FG017|STARTED|Overall Study||7||
48138932|NCT02952924|100665481|FG018|STARTED|Overall Study||6||
48138933|NCT02952924|100665482|FG019|STARTED|Overall Study||32||
48138934|NCT02952924|100665483|FG020|STARTED|Overall Study||10||
48138935|NCT02952924|100665484|FG021|STARTED|Overall Study||30||
48138936|NCT02952924|100665463|FG000|COMPLETED|Overall Study||11||
48138937|NCT02952924|100665464|FG001|COMPLETED|Overall Study||10||
48138938|NCT02952924|100665465|FG002|COMPLETED|Overall Study||6||
48138939|NCT02952924|100665466|FG003|COMPLETED|Overall Study||3||
48138940|NCT02952924|100665467|FG004|COMPLETED|Overall Study||6||
48138941|NCT02952924|100665468|FG005|COMPLETED|Overall Study||3||
48138942|NCT02952924|100665469|FG006|COMPLETED|Overall Study||6||
48138943|NCT02952924|100665470|FG007|COMPLETED|Overall Study||6||
48138944|NCT02952924|100665471|FG008|COMPLETED|Overall Study||6||
48138945|NCT02952924|100665472|FG009|COMPLETED|Overall Study||6||
48138946|NCT02952924|100665473|FG010|COMPLETED|Overall Study||7||
48138947|NCT02952924|100665474|FG011|COMPLETED|Overall Study||7||
48587719|NCT02829723|101770494|FG026|STARTED|Overall Study||21|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
48587720|NCT02829723|101770468|FG000|Safety Set|Overall Study||5|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
48587721|NCT02829723|101770469|FG001|Safety Set|Overall Study||7|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
48587722|NCT02829723|101770470|FG002|Safety Set|Overall Study||5|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
48587723|NCT02829723|101770471|FG003|Safety Set|Overall Study||6|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
48587724|NCT02829723|101770472|FG004|Safety Set|Overall Study||3|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
48587725|NCT02829723|101770473|FG005|Safety Set|Overall Study||5|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
48587726|NCT02829723|101770474|FG006|Safety Set|Overall Study||6|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
48587727|NCT02829723|101770475|FG007|Safety Set|Overall Study||8|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
48138948|NCT02952924|100665475|FG012|COMPLETED|Overall Study||6||
48401976|NCT04857892|101313876|FG001|NOT COMPLETED|Part 2: Period 1 (Day 1)||0||
48587728|NCT02829723|101770476|FG008|Safety Set|Overall Study||9|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
48587729|NCT02829723|101770477|FG009|Safety Set|Overall Study||5|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
48587730|NCT02829723|101770478|FG010|Safety Set|Overall Study||10|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
48587731|NCT02829723|101770479|FG011|Safety Set|Overall Study||1|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
48587732|NCT02829723|101770480|FG012|Safety Set|Overall Study||4|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
48592844|NCT01455181|101786324|FG000|STARTED|Overall Study||24||
48592845|NCT01455181|101786324|FG000|COMPLETED|Overall Study||24||
48706728|NCT02754141|102069787|FG016|Crossing Over to RCC Combo Therapy|Overall Study||0||
48706729|NCT02754141|102069788|FG017|Crossing Over to RCC Combo Therapy|Overall Study||0||
48706730|NCT02754141|102069771|FG000|COMPLETED|Overall Study||1||
48706731|NCT02754141|102069772|FG001|COMPLETED|Overall Study||2||
48401977|NCT04857892|101313877|FG002|NOT COMPLETED|Part 2: Period 1 (Day 1)||0||
48401978|NCT04857892|101313878|FG003|NOT COMPLETED|Part 2: Period 1 (Day 1)||0||
48706732|NCT02754141|102069773|FG002|COMPLETED|Overall Study||4||
48706733|NCT02754141|102069774|FG003|COMPLETED|Overall Study||1||
48706734|NCT02754141|102069775|FG004|COMPLETED|Overall Study||2||
48706735|NCT02754141|102069776|FG005|COMPLETED|Overall Study||0||
48706736|NCT02754141|102069777|FG006|COMPLETED|Overall Study||0||
48706737|NCT02754141|102069778|FG007|COMPLETED|Overall Study||0||
48706738|NCT02754141|102069779|FG008|COMPLETED|Overall Study||6||
48706739|NCT02754141|102069780|FG009|COMPLETED|Overall Study||2||
48706740|NCT02754141|102069781|FG010|COMPLETED|Overall Study||11||
48706741|NCT02754141|102069782|FG011|COMPLETED|Overall Study||1||
48706742|NCT02754141|102069783|FG012|COMPLETED|Overall Study||1||
48706743|NCT02754141|102069784|FG013|COMPLETED|Overall Study||5||
48706744|NCT02754141|102069785|FG014|COMPLETED|Overall Study||5||
48706745|NCT02754141|102069786|FG015|COMPLETED|Overall Study||0||
48706746|NCT02754141|102069787|FG016|COMPLETED|Overall Study||2||
48706747|NCT02754141|102069788|FG017|COMPLETED|Overall Study||0||
48706748|NCT02754141|102069771|FG000|NOT COMPLETED|Overall Study||13||
48706749|NCT02754141|102069772|FG001|NOT COMPLETED|Overall Study||10||
48706750|NCT02754141|102069773|FG002|NOT COMPLETED|Overall Study||8||
48706751|NCT02754141|102069774|FG003|NOT COMPLETED|Overall Study||8||
48706752|NCT02754141|102069775|FG004|NOT COMPLETED|Overall Study||10||
48706753|NCT02754141|102069776|FG005|NOT COMPLETED|Overall Study||9||
48706754|NCT02754141|102069777|FG006|NOT COMPLETED|Overall Study||8||
48706755|NCT02754141|102069778|FG007|NOT COMPLETED|Overall Study||7||
48706756|NCT02754141|102069779|FG008|NOT COMPLETED|Overall Study||12||
48706757|NCT02754141|102069780|FG009|NOT COMPLETED|Overall Study||17||
48706758|NCT02754141|102069781|FG010|NOT COMPLETED|Overall Study||20||
48706759|NCT02754141|102069782|FG011|NOT COMPLETED|Overall Study||14||
48706760|NCT02754141|102069783|FG012|NOT COMPLETED|Overall Study||14||
48706761|NCT02754141|102069784|FG013|NOT COMPLETED|Overall Study||14||
48706762|NCT02754141|102069785|FG014|NOT COMPLETED|Overall Study||13||
48706763|NCT02754141|102069786|FG015|NOT COMPLETED|Overall Study||14||
48706764|NCT02754141|102069787|FG016|NOT COMPLETED|Overall Study||0||
48706765|NCT02754141|102069788|FG017|NOT COMPLETED|Overall Study||1||
48706766|NCT00610441|102069789|FG000|STARTED|Treatment Period 1 - 3 Weeks||15||
48706767|NCT00610441|102069790|FG001|STARTED|Treatment Period 1 - 3 Weeks||16||
48706768|NCT00610441|102069791|FG002|STARTED|Treatment Period 1 - 3 Weeks||18||
48706769|NCT00610441|102069792|FG003|STARTED|Treatment Period 1 - 3 Weeks||18||
48706770|NCT00610441|102069789|FG000|COMPLETED|Treatment Period 1 - 3 Weeks||12||
48706771|NCT00610441|102069790|FG001|COMPLETED|Treatment Period 1 - 3 Weeks||14||
48706772|NCT00610441|102069791|FG002|COMPLETED|Treatment Period 1 - 3 Weeks||11||
48706773|NCT00610441|102069792|FG003|COMPLETED|Treatment Period 1 - 3 Weeks||16||
48706774|NCT00610441|102069789|FG000|NOT COMPLETED|Treatment Period 1 - 3 Weeks||3||
48706775|NCT00610441|102069790|FG001|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2||
48706776|NCT00610441|102069791|FG002|NOT COMPLETED|Treatment Period 1 - 3 Weeks||7||
48706777|NCT00610441|102069792|FG003|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2||
48138949|NCT02952924|100665476|FG013|COMPLETED|Overall Study||6||
48290581|NCT00413972|101037623|FG002|STARTED|Overall Study||98||
48290582|NCT00413972|101037624|FG003|STARTED|Overall Study||98||
48290583|NCT00413972|101037621|FG000|COMPLETED|Overall Study||91||
48290584|NCT00413972|101037622|FG001|COMPLETED|Overall Study||90||
48290585|NCT00413972|101037623|FG002|COMPLETED|Overall Study||88||
48290586|NCT00413972|101037624|FG003|COMPLETED|Overall Study||95||
48290587|NCT00413972|101037621|FG000|NOT COMPLETED|Overall Study||7||
48290588|NCT00413972|101037622|FG001|NOT COMPLETED|Overall Study||8||
48290589|NCT00413972|101037623|FG002|NOT COMPLETED|Overall Study||10||
48706778|NCT00610441|102069789|FG000|STARTED|Placebo Washout Period - 2 Weeks||12||
48706779|NCT00610441|102069790|FG001|STARTED|Placebo Washout Period - 2 Weeks||14||
48706780|NCT00610441|102069791|FG002|STARTED|Placebo Washout Period - 2 Weeks||11||
48290590|NCT00413972|101037624|FG003|NOT COMPLETED|Overall Study||3||
48706781|NCT00610441|102069792|FG003|STARTED|Placebo Washout Period - 2 Weeks||16||
48706782|NCT00610441|102069789|FG000|COMPLETED|Placebo Washout Period - 2 Weeks||12||
48706783|NCT00610441|102069790|FG001|COMPLETED|Placebo Washout Period - 2 Weeks||13||
48706784|NCT00610441|102069791|FG002|COMPLETED|Placebo Washout Period - 2 Weeks||9||
48706785|NCT00610441|102069792|FG003|COMPLETED|Placebo Washout Period - 2 Weeks||16||
48706786|NCT00610441|102069789|FG000|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0||
48706787|NCT00610441|102069790|FG001|NOT COMPLETED|Placebo Washout Period - 2 Weeks||1||
48706788|NCT00610441|102069791|FG002|NOT COMPLETED|Placebo Washout Period - 2 Weeks||2||
48706789|NCT00610441|102069792|FG003|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0||
48706790|NCT00610441|102069789|FG000|STARTED|Treatment Period 2 - 3 Weeks||12||
48706791|NCT00610441|102069790|FG001|STARTED|Treatment Period 2 - 3 Weeks||13||
48706792|NCT00610441|102069791|FG002|STARTED|Treatment Period 2 - 3 Weeks||9||
48706793|NCT00610441|102069792|FG003|STARTED|Treatment Period 2 - 3 Weeks||16||
48706794|NCT00610441|102069789|FG000|COMPLETED|Treatment Period 2 - 3 Weeks||10||
48706795|NCT00610441|102069790|FG001|COMPLETED|Treatment Period 2 - 3 Weeks||12||
48706796|NCT00610441|102069791|FG002|COMPLETED|Treatment Period 2 - 3 Weeks||9||
48706797|NCT00610441|102069792|FG003|COMPLETED|Treatment Period 2 - 3 Weeks||14||
48706798|NCT00610441|102069789|FG000|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2||
48138950|NCT02952924|100665477|FG014|COMPLETED|Overall Study||6||
48587733|NCT02829723|101770481|FG013|Safety Set|Overall Study||6|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
48587734|NCT02829723|101770482|FG014|Safety Set|Overall Study||4|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
48587735|NCT02829723|101770483|FG015|Safety Set|Overall Study||5|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
48138951|NCT02952924|100665478|FG015|COMPLETED|Overall Study||6||
48138952|NCT02952924|100665479|FG016|COMPLETED|Overall Study||6||
48401979|NCT04857892|101313879|FG004|NOT COMPLETED|Part 2: Period 1 (Day 1)||0||
48401980|NCT04857892|101313875|FG000|STARTED|Part 2: Washout Period 1 (Up to 7 Days)||0||
48401981|NCT04857892|101313876|FG001|STARTED|Part 2: Washout Period 1 (Up to 7 Days)||0||
48401982|NCT04857892|101313877|FG002|STARTED|Part 2: Washout Period 1 (Up to 7 Days)||0||
48401983|NCT04857892|101313878|FG003|STARTED|Part 2: Washout Period 1 (Up to 7 Days)||9||
48401984|NCT04857892|101313879|FG004|STARTED|Part 2: Washout Period 1 (Up to 7 Days)||9||
48401985|NCT04857892|101313875|FG000|COMPLETED|Part 2: Washout Period 1 (Up to 7 Days)||0||
48401986|NCT04857892|101313876|FG001|COMPLETED|Part 2: Washout Period 1 (Up to 7 Days)||0||
48401987|NCT04857892|101313877|FG002|COMPLETED|Part 2: Washout Period 1 (Up to 7 Days)||0||
48401988|NCT04857892|101313878|FG003|COMPLETED|Part 2: Washout Period 1 (Up to 7 Days)||9||
48401989|NCT04857892|101313879|FG004|COMPLETED|Part 2: Washout Period 1 (Up to 7 Days)||8||
48401990|NCT04857892|101313875|FG000|NOT COMPLETED|Part 2: Washout Period 1 (Up to 7 Days)||0||
48401991|NCT04857892|101313876|FG001|NOT COMPLETED|Part 2: Washout Period 1 (Up to 7 Days)||0||
48401992|NCT04857892|101313877|FG002|NOT COMPLETED|Part 2: Washout Period 1 (Up to 7 Days)||0||
48401993|NCT04857892|101313878|FG003|NOT COMPLETED|Part 2: Washout Period 1 (Up to 7 Days)||0||
48587736|NCT02829723|101770484|FG016|Safety Set|Overall Study||9|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
48587737|NCT02829723|101770485|FG017|Safety Set|Overall Study||5|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
48706799|NCT00610441|102069790|FG001|NOT COMPLETED|Treatment Period 2 - 3 Weeks||1||
48706800|NCT00610441|102069791|FG002|NOT COMPLETED|Treatment Period 2 - 3 Weeks||0||
48706801|NCT00610441|102069792|FG003|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2||
48706802|NCT03089944|102069793|FG000|STARTED|Overall Study||343||
48706803|NCT03089944|102069793|FG000|COMPLETED|Overall Study||331||
48706804|NCT03089944|102069793|FG000|NOT COMPLETED|Overall Study||12||
48706805|NCT02640625|102069794|FG000|STARTED|Overall Study||20||
48706806|NCT02640625|102069794|FG000|COMPLETED|Overall Study||19||
48706807|NCT02640625|102069794|FG000|NOT COMPLETED|Overall Study||1||
48706808|NCT02210689|102069795|FG000|STARTED|Overall Study||242||
48706809|NCT02210689|102069796|FG001|STARTED|Overall Study||240||
48706810|NCT02210689|102069797|FG002|STARTED|Overall Study||122||
48706811|NCT02210689|102069795|FG000|Safety Population|Overall Study||233|Randomized participants who received the investigational product.|
48706812|NCT02210689|102069796|FG001|Safety Population|Overall Study||236|Randomized participants who received the investigational product.|
48706813|NCT02210689|102069797|FG002|Safety Population|Overall Study||122|Randomized participants who received the investigational product.|
48710770|NCT01924442|102078012|FG000|COMPLETED|Overall Study||1059||
48290591|NCT03430531|101037625|FG000|STARTED|Overall Study||6||
48290592|NCT03430531|101037625|FG000|COMPLETED|Overall Study||6||
48290593|NCT03430531|101037625|FG000|NOT COMPLETED|Overall Study||0||
48290594|NCT02684253|101037626|FG000|STARTED|Overall Study||32||
48138953|NCT02952924|100665480|FG017|COMPLETED|Overall Study||6||
48290595|NCT02684253|101037627|FG001|STARTED|Overall Study||33||
48138954|NCT02952924|100665481|FG018|COMPLETED|Overall Study||6||
48290596|NCT02684253|101037626|FG000|COMPLETED|Overall Study||32||
48290597|NCT02684253|101037627|FG001|COMPLETED|Overall Study||33||
48587738|NCT02829723|101770486|FG018|Safety Set|Overall Study||6|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
48587739|NCT02829723|101770487|FG019|Safety Set|Overall Study||5|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
48587740|NCT02829723|101770488|FG020|Safety Set|Overall Study||11|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
48587741|NCT02829723|101770489|FG021|Safety Set|Overall Study||9|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
48587742|NCT02829723|101770490|FG022|Safety Set|Overall Study||4|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
48587743|NCT02829723|101770491|FG023|Safety Set|Overall Study||6|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
48587744|NCT02829723|101770492|FG024|Safety Set|Overall Study||5|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
48587745|NCT02829723|101770493|FG025|Safety Set|Overall Study||22|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
48587746|NCT02829723|101770494|FG026|Safety Set|Overall Study||21|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
48587747|NCT02829723|101770468|FG000|Japanese Cohort|Overall Study||0||
48587748|NCT02829723|101770469|FG001|Japanese Cohort|Overall Study||0||
48290598|NCT02684253|101037626|FG000|NOT COMPLETED|Overall Study||0||
48587749|NCT02829723|101770470|FG002|Japanese Cohort|Overall Study||0||
48587750|NCT02829723|101770471|FG003|Japanese Cohort|Overall Study||0||
48587751|NCT02829723|101770472|FG004|Japanese Cohort|Overall Study||0||
48587752|NCT02829723|101770473|FG005|Japanese Cohort|Overall Study||0||
48587753|NCT02829723|101770474|FG006|Japanese Cohort|Overall Study||0||
48290599|NCT02684253|101037627|FG001|NOT COMPLETED|Overall Study||0||
48290600|NCT02450799|101037628|FG000|STARTED|Overall Study||31||
48290601|NCT02450799|101037629|FG001|STARTED|Overall Study||37||
48290602|NCT02450799|101037630|FG002|STARTED|Overall Study||30||
48401994|NCT04857892|101313879|FG004|NOT COMPLETED|Part 2: Washout Period 1 (Up to 7 Days)||1||
48401995|NCT04857892|101313875|FG000|STARTED|Part 2: Period 2 (Day 1)||0||
48401996|NCT04857892|101313876|FG001|STARTED|Part 2: Period 2 (Day 1)||0||
48401997|NCT04857892|101313877|FG002|STARTED|Part 2: Period 2 (Day 1)||0||
48587754|NCT02829723|101770475|FG007|Japanese Cohort|Overall Study||3||
48587755|NCT02829723|101770476|FG008|Japanese Cohort|Overall Study||5||
48587756|NCT02829723|101770477|FG009|Japanese Cohort|Overall Study||0||
48587757|NCT02829723|101770478|FG010|Japanese Cohort|Overall Study||0||
48587758|NCT02829723|101770479|FG011|Japanese Cohort|Overall Study||0||
48587759|NCT02829723|101770480|FG012|Japanese Cohort|Overall Study||0||
48587760|NCT02829723|101770481|FG013|Japanese Cohort|Overall Study||0||
48587761|NCT02829723|101770482|FG014|Japanese Cohort|Overall Study||0||
48138955|NCT02952924|100665482|FG019|COMPLETED|Overall Study||31||
48138956|NCT02952924|100665483|FG020|COMPLETED|Overall Study||10||
48138957|NCT02952924|100665484|FG021|COMPLETED|Overall Study||28||
48138958|NCT02952924|100665463|FG000|NOT COMPLETED|Overall Study||0||
48138959|NCT02952924|100665464|FG001|NOT COMPLETED|Overall Study||0||
48587762|NCT02829723|101770483|FG015|Japanese Cohort|Overall Study||0||
48587763|NCT02829723|101770484|FG016|Japanese Cohort|Overall Study||0||
48138960|NCT02952924|100665465|FG002|NOT COMPLETED|Overall Study||0||
48138961|NCT02952924|100665466|FG003|NOT COMPLETED|Overall Study||0||
48138962|NCT02952924|100665467|FG004|NOT COMPLETED|Overall Study||0||
48138963|NCT02952924|100665468|FG005|NOT COMPLETED|Overall Study||0||
48587764|NCT02829723|101770485|FG017|Japanese Cohort|Overall Study||0||
48138964|NCT02952924|100665469|FG006|NOT COMPLETED|Overall Study||0||
48138965|NCT02952924|100665470|FG007|NOT COMPLETED|Overall Study||0||
48290603|NCT02450799|101037628|FG000|COMPLETED|Overall Study||31||
48290604|NCT02450799|101037629|FG001|COMPLETED|Overall Study||37||
48290605|NCT02450799|101037630|FG002|COMPLETED|Overall Study||30||
48290606|NCT02450799|101037628|FG000|NOT COMPLETED|Overall Study||0||
48290607|NCT02450799|101037629|FG001|NOT COMPLETED|Overall Study||0||
48290608|NCT02450799|101037630|FG002|NOT COMPLETED|Overall Study||0||
48290609|NCT00427895|101037631|FG000|STARTED|Between 6-Month Follow-up - Year 1||411||
48290610|NCT00427895|101037632|FG001|STARTED|Between 6-Month Follow-up - Year 1||411||
48290611|NCT00427895|101037633|FG002|STARTED|Between 6-Month Follow-up - Year 1||392||
48290612|NCT00427895|101037634|FG003|STARTED|Between 6-Month Follow-up - Year 1||854||
48290613|NCT00427895|101037635|FG004|STARTED|Between 6-Month Follow-up - Year 1||0||
48290614|NCT00427895|101037636|FG005|STARTED|Between 6-Month Follow-up - Year 1||0||
48290615|NCT00427895|101037637|FG006|STARTED|Between 6-Month Follow-up - Year 1||0||
48587765|NCT02829723|101770486|FG018|Japanese Cohort|Overall Study||0||
48587766|NCT02829723|101770487|FG019|Japanese Cohort|Overall Study||0||
48587767|NCT02829723|101770488|FG020|Japanese Cohort|Overall Study||0||
48587768|NCT02829723|101770489|FG021|Japanese Cohort|Overall Study||0||
48587769|NCT02829723|101770490|FG022|Japanese Cohort|Overall Study||0||
48587770|NCT02829723|101770491|FG023|Japanese Cohort|Overall Study||0||
48587771|NCT02829723|101770492|FG024|Japanese Cohort|Overall Study||0||
48587772|NCT02829723|101770493|FG025|Japanese Cohort|Overall Study||0||
48587773|NCT02829723|101770494|FG026|Japanese Cohort|Overall Study||0||
48587774|NCT02829723|101770468|FG000|COMPLETED|Overall Study||0||
48587775|NCT02829723|101770469|FG001|COMPLETED|Overall Study||0||
48587776|NCT02829723|101770470|FG002|COMPLETED|Overall Study||0||
48587777|NCT02829723|101770471|FG003|COMPLETED|Overall Study||0||
48587778|NCT02829723|101770472|FG004|COMPLETED|Overall Study||0||
48587779|NCT02829723|101770473|FG005|COMPLETED|Overall Study||0||
48587780|NCT02829723|101770474|FG006|COMPLETED|Overall Study||0||
48587781|NCT02829723|101770475|FG007|COMPLETED|Overall Study||0||
48587782|NCT02829723|101770476|FG008|COMPLETED|Overall Study||0||
48587783|NCT02829723|101770477|FG009|COMPLETED|Overall Study||0||
48587784|NCT02829723|101770478|FG010|COMPLETED|Overall Study||0||
48587785|NCT02829723|101770479|FG011|COMPLETED|Overall Study||0||
48706814|NCT02210689|102069795|FG000|mITT Population|Overall Study||199|Randomized participants that applied the study dose, and returned for post-baseline evaluation visit|
48706815|NCT02210689|102069796|FG001|mITT Population|Overall Study||207|Randomized participants that applied the study dose, and returned for post-baseline evaluation visit|
48706816|NCT02210689|102069797|FG002|mITT Population|Overall Study||107|Randomized participants that applied the study dose, and returned for post-baseline evaluation visit|
48706817|NCT02210689|102069795|FG000|PP Population|Overall Study||164|Randomized subjects that were compliant with study treatment, and completed the study.|
48706818|NCT02210689|102069796|FG001|PP Population|Overall Study||169|Randomized subjects that were compliant with study treatment, and completed the study.|
48706819|NCT02210689|102069797|FG002|PP Population|Overall Study||84|Randomized subjects that were compliant with study treatment, and completed the study.|
48706820|NCT02210689|102069795|FG000|COMPLETED|Overall Study||190||
48706821|NCT02210689|102069796|FG001|COMPLETED|Overall Study||193||
48706822|NCT02210689|102069797|FG002|COMPLETED|Overall Study||99||
48706823|NCT02210689|102069795|FG000|NOT COMPLETED|Overall Study||52||
48706824|NCT02210689|102069796|FG001|NOT COMPLETED|Overall Study||47||
48706825|NCT02210689|102069797|FG002|NOT COMPLETED|Overall Study||23||
48706826|NCT02226562|102069798|FG000|STARTED|Overall Study||95||
48706827|NCT02226562|102069799|FG001|STARTED|Overall Study||96||
48706828|NCT02226562|102069798|FG000|COMPLETED|Overall Study||95||
48706829|NCT02226562|102069799|FG001|COMPLETED|Overall Study||95||
48706830|NCT02226562|102069798|FG000|NOT COMPLETED|Overall Study||0||
48706831|NCT02226562|102069799|FG001|NOT COMPLETED|Overall Study||1||
48706832|NCT02994953|102069800|FG000|STARTED|Overall Study||9||
48290616|NCT00427895|101037638|FG007|STARTED|Between 6-Month Follow-up - Year 1||0||
48290617|NCT00427895|101037631|FG000|COMPLETED|Between 6-Month Follow-up - Year 1||411||
48290618|NCT00427895|101037632|FG001|COMPLETED|Between 6-Month Follow-up - Year 1||411||
48290619|NCT00427895|101037633|FG002|COMPLETED|Between 6-Month Follow-up - Year 1||392||
48290620|NCT00427895|101037634|FG003|COMPLETED|Between 6-Month Follow-up - Year 1||502||
48290621|NCT00427895|101037635|FG004|COMPLETED|Between 6-Month Follow-up - Year 1||0||
48290622|NCT00427895|101037636|FG005|COMPLETED|Between 6-Month Follow-up - Year 1||0||
48587786|NCT02829723|101770480|FG012|COMPLETED|Overall Study||0||
48587787|NCT02829723|101770481|FG013|COMPLETED|Overall Study||0||
48587788|NCT02829723|101770482|FG014|COMPLETED|Overall Study||0||
48587789|NCT02829723|101770483|FG015|COMPLETED|Overall Study||0||
48587790|NCT02829723|101770484|FG016|COMPLETED|Overall Study||0||
48587791|NCT02829723|101770485|FG017|COMPLETED|Overall Study||0||
48587792|NCT02829723|101770486|FG018|COMPLETED|Overall Study||0||
48587793|NCT02829723|101770487|FG019|COMPLETED|Overall Study||0||
48587794|NCT02829723|101770488|FG020|COMPLETED|Overall Study||0||
48587795|NCT02829723|101770489|FG021|COMPLETED|Overall Study||0||
48587796|NCT02829723|101770490|FG022|COMPLETED|Overall Study||0||
48290623|NCT00427895|101037637|FG006|COMPLETED|Between 6-Month Follow-up - Year 1||0||
48587797|NCT02829723|101770491|FG023|COMPLETED|Overall Study||0||
48587798|NCT02829723|101770492|FG024|COMPLETED|Overall Study||0||
48587799|NCT02829723|101770493|FG025|COMPLETED|Overall Study||0||
48587800|NCT02829723|101770494|FG026|COMPLETED|Overall Study||0||
48587801|NCT02829723|101770468|FG000|NOT COMPLETED|Overall Study||5||
48587802|NCT02829723|101770469|FG001|NOT COMPLETED|Overall Study||7||
48587803|NCT02829723|101770470|FG002|NOT COMPLETED|Overall Study||5||
48401998|NCT04857892|101313878|FG003|STARTED|Part 2: Period 2 (Day 1)||9||
48290624|NCT00427895|101037638|FG007|COMPLETED|Between 6-Month Follow-up - Year 1||0||
48290625|NCT00427895|101037631|FG000|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0||
48290626|NCT00427895|101037632|FG001|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0||
48290627|NCT00427895|101037633|FG002|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0||
48290628|NCT00427895|101037634|FG003|NOT COMPLETED|Between 6-Month Follow-up - Year 1||352||
48290629|NCT00427895|101037635|FG004|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0||
48290630|NCT00427895|101037636|FG005|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0||
48290631|NCT00427895|101037637|FG006|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0||
48290632|NCT00427895|101037638|FG007|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0||
48290633|NCT00427895|101037631|FG000|STARTED|Vax 2/Year 3 to 4||0||
48401999|NCT04857892|101313879|FG004|STARTED|Part 2: Period 2 (Day 1)||8||
48290634|NCT00427895|101037632|FG001|STARTED|Vax 2/Year 3 to 4||0||
48402000|NCT04857892|101313875|FG000|COMPLETED|Part 2: Period 2 (Day 1)||0||
48402001|NCT04857892|101313876|FG001|COMPLETED|Part 2: Period 2 (Day 1)||0||
48402002|NCT04857892|101313877|FG002|COMPLETED|Part 2: Period 2 (Day 1)||0||
48587804|NCT02829723|101770471|FG003|NOT COMPLETED|Overall Study||6||
48587805|NCT02829723|101770472|FG004|NOT COMPLETED|Overall Study||3||
48587806|NCT02829723|101770473|FG005|NOT COMPLETED|Overall Study||5||
48587807|NCT02829723|101770474|FG006|NOT COMPLETED|Overall Study||6||
48587808|NCT02829723|101770475|FG007|NOT COMPLETED|Overall Study||8||
48587809|NCT02829723|101770476|FG008|NOT COMPLETED|Overall Study||9||
48587810|NCT02829723|101770477|FG009|NOT COMPLETED|Overall Study||5||
48587811|NCT02829723|101770478|FG010|NOT COMPLETED|Overall Study||10||
48587812|NCT02829723|101770479|FG011|NOT COMPLETED|Overall Study||0||
48587813|NCT02829723|101770480|FG012|NOT COMPLETED|Overall Study||5||
48587814|NCT02829723|101770481|FG013|NOT COMPLETED|Overall Study||6||
48587815|NCT02829723|101770482|FG014|NOT COMPLETED|Overall Study||4||
48587816|NCT02829723|101770483|FG015|NOT COMPLETED|Overall Study||5||
48587817|NCT02829723|101770484|FG016|NOT COMPLETED|Overall Study||9||
48587818|NCT02829723|101770485|FG017|NOT COMPLETED|Overall Study||5||
48587819|NCT02829723|101770486|FG018|NOT COMPLETED|Overall Study||6||
48587820|NCT02829723|101770487|FG019|NOT COMPLETED|Overall Study||5||
48587821|NCT02829723|101770488|FG020|NOT COMPLETED|Overall Study||11||
48587822|NCT02829723|101770489|FG021|NOT COMPLETED|Overall Study||9||
48587823|NCT02829723|101770490|FG022|NOT COMPLETED|Overall Study||4||
48587824|NCT02829723|101770491|FG023|NOT COMPLETED|Overall Study||6||
48587825|NCT02829723|101770492|FG024|NOT COMPLETED|Overall Study||5||
48587826|NCT02829723|101770493|FG025|NOT COMPLETED|Overall Study||22||
48587827|NCT02829723|101770494|FG026|NOT COMPLETED|Overall Study||21||
48587828|NCT02062944|101770495|FG000|STARTED|Overall Study||21||
48587829|NCT02062944|101770495|FG000|COMPLETED|Overall Study||15||
48587830|NCT02062944|101770495|FG000|NOT COMPLETED|Overall Study||6||
48587831|NCT03053063|101770496|FG000|STARTED|Randomized Phase||355||
48587832|NCT03053063|101770497|FG001|STARTED|Randomized Phase||354||
48587833|NCT03053063|101770498|FG002|STARTED|Randomized Phase||174||
48587834|NCT03053063|101770499|FG003|STARTED|Randomized Phase||0||
48587835|NCT03053063|101770496|FG000|COMPLETED|Randomized Phase||0||
48587836|NCT03053063|101770497|FG001|COMPLETED|Randomized Phase||0||
48587837|NCT03053063|101770498|FG002|COMPLETED|Randomized Phase||0||
48587838|NCT03053063|101770499|FG003|COMPLETED|Randomized Phase||0||
48587839|NCT03053063|101770496|FG000|NOT COMPLETED|Randomized Phase||355||
48587840|NCT03053063|101770497|FG001|NOT COMPLETED|Randomized Phase||354||
48587841|NCT03053063|101770498|FG002|NOT COMPLETED|Randomized Phase||174||
48290635|NCT00427895|101037633|FG002|STARTED|Vax 2/Year 3 to 4||0||
48587842|NCT03053063|101770499|FG003|NOT COMPLETED|Randomized Phase||0||
48587843|NCT03053063|101770496|FG000|STARTED|Open-Label Phase||0||
48587844|NCT03053063|101770497|FG001|STARTED|Open-Label Phase||0||
48587845|NCT03053063|101770498|FG002|STARTED|Open-Label Phase||0||
48587846|NCT03053063|101770499|FG003|STARTED|Open-Label Phase||23||
48587847|NCT03053063|101770496|FG000|COMPLETED|Open-Label Phase||0||
48587848|NCT03053063|101770497|FG001|COMPLETED|Open-Label Phase||0||
48587849|NCT03053063|101770498|FG002|COMPLETED|Open-Label Phase||0||
48587850|NCT03053063|101770499|FG003|COMPLETED|Open-Label Phase||0||
48587851|NCT03053063|101770496|FG000|NOT COMPLETED|Open-Label Phase||0||
48587852|NCT03053063|101770497|FG001|NOT COMPLETED|Open-Label Phase||0||
48290636|NCT00427895|101037634|FG003|STARTED|Vax 2/Year 3 to 4||0||
48290637|NCT00427895|101037635|FG004|STARTED|Vax 2/Year 3 to 4||108||
48290638|NCT00427895|101037636|FG005|STARTED|Vax 2/Year 3 to 4||108||
48290639|NCT00427895|101037637|FG006|STARTED|Vax 2/Year 3 to 4||189||
48587853|NCT03053063|101770498|FG002|NOT COMPLETED|Open-Label Phase||0||
48587854|NCT03053063|101770499|FG003|NOT COMPLETED|Open-Label Phase||23||
48587855|NCT03962790|101770500|FG000|STARTED|Period 1||48||
48587856|NCT03962790|101770501|FG001|STARTED|Period 1||46||
48587857|NCT03962790|101770500|FG000|COMPLETED|Period 1||45||
48706833|NCT02994953|102069801|FG001|STARTED|Overall Study||7||
48706834|NCT02994953|102069802|FG002|STARTED|Overall Study||7||
48706835|NCT02994953|102069803|FG003|STARTED|Overall Study||6||
48402003|NCT04857892|101313878|FG003|COMPLETED|Part 2: Period 2 (Day 1)||9||
48402004|NCT04857892|101313879|FG004|COMPLETED|Part 2: Period 2 (Day 1)||8||
48402005|NCT04857892|101313875|FG000|NOT COMPLETED|Part 2: Period 2 (Day 1)||0||
48402006|NCT04857892|101313876|FG001|NOT COMPLETED|Part 2: Period 2 (Day 1)||0||
48402007|NCT04857892|101313877|FG002|NOT COMPLETED|Part 2: Period 2 (Day 1)||0||
48402008|NCT04857892|101313878|FG003|NOT COMPLETED|Part 2: Period 2 (Day 1)||0||
48402009|NCT04857892|101313879|FG004|NOT COMPLETED|Part 2: Period 2 (Day 1)||0||
48402010|NCT00643448|101313880|FG000|STARTED|Overall Study||21||
48402011|NCT00643448|101313881|FG001|STARTED|Overall Study||22||
48402012|NCT00643448|101313882|FG002|STARTED|Overall Study||22||
48402013|NCT00643448|101313880|FG000|COMPLETED|Overall Study||17||
48402014|NCT00643448|101313881|FG001|COMPLETED|Overall Study||17||
48402015|NCT00643448|101313882|FG002|COMPLETED|Overall Study||16||
48402016|NCT00643448|101313880|FG000|NOT COMPLETED|Overall Study||4||
48402017|NCT00643448|101313881|FG001|NOT COMPLETED|Overall Study||5||
48402018|NCT00643448|101313882|FG002|NOT COMPLETED|Overall Study||6||
48402019|NCT02671760|101313883|FG000|STARTED|Overall Study||13||
48402020|NCT02671760|101313884|FG001|STARTED|Overall Study||13||
48402021|NCT02671760|101313885|FG002|STARTED|Overall Study||13||
48402022|NCT02671760|101313883|FG000|COMPLETED|Overall Study||13||
48402023|NCT02671760|101313884|FG001|COMPLETED|Overall Study||12||
48402024|NCT02671760|101313885|FG002|COMPLETED|Overall Study||13||
48402025|NCT02671760|101313883|FG000|NOT COMPLETED|Overall Study||0||
48402026|NCT02671760|101313884|FG001|NOT COMPLETED|Overall Study||1||
48402027|NCT02671760|101313885|FG002|NOT COMPLETED|Overall Study||0||
48402028|NCT03489850|101313886|FG000|STARTED|Overall Study||24||
48402029|NCT03489850|101313887|FG001|STARTED|Overall Study||28||
48402030|NCT03489850|101313886|FG000|COMPLETED|Overall Study||23||
48402031|NCT03489850|101313887|FG001|COMPLETED|Overall Study||27||
48402032|NCT03489850|101313886|FG000|NOT COMPLETED|Overall Study||1||
48402033|NCT03489850|101313887|FG001|NOT COMPLETED|Overall Study||1||
48402034|NCT00255034|101317566|FG000|STARTED|Overall Study||79||
48402035|NCT00255034|101317567|FG001|STARTED|Overall Study||64||
48402036|NCT00255034|101317566|FG000|COMPLETED|Overall Study||64||
48402037|NCT00255034|101317567|FG001|COMPLETED|Overall Study||26||
48402038|NCT00255034|101317566|FG000|NOT COMPLETED|Overall Study||15||
48402039|NCT00255034|101317567|FG001|NOT COMPLETED|Overall Study||38||
48402040|NCT01628042|101317568|FG000|STARTED|Overall Study||8||
48402041|NCT01628042|101317569|FG001|STARTED|Overall Study||8||
48402042|NCT01628042|101317570|FG002|STARTED|Overall Study||8||
48402043|NCT01628042|101317571|FG003|STARTED|Overall Study||8||
48402044|NCT01628042|101317568|FG000|COMPLETED|Overall Study||8||
48402045|NCT01628042|101317569|FG001|COMPLETED|Overall Study||8||
48402046|NCT01628042|101317570|FG002|COMPLETED|Overall Study||8||
48402047|NCT01628042|101317571|FG003|COMPLETED|Overall Study||8||
48402048|NCT01628042|101317568|FG000|NOT COMPLETED|Overall Study||0||
48402049|NCT01628042|101317569|FG001|NOT COMPLETED|Overall Study||0||
48402050|NCT01628042|101317570|FG002|NOT COMPLETED|Overall Study||0||
48402051|NCT01628042|101317571|FG003|NOT COMPLETED|Overall Study||0||
48402052|NCT00643097|101317572|FG000|STARTED|Overall Study||18||
48402053|NCT00643097|101317573|FG001|STARTED|Overall Study||12||
48402054|NCT00643097|101317574|FG002|STARTED|Overall Study||10||
48402055|NCT00643097|101317572|FG000|COMPLETED|Overall Study||18||
48402056|NCT00643097|101317573|FG001|COMPLETED|Overall Study||12||
48402057|NCT00643097|101317574|FG002|COMPLETED|Overall Study||10||
48402058|NCT00643097|101317572|FG000|NOT COMPLETED|Overall Study||0||
48402059|NCT00643097|101317573|FG001|NOT COMPLETED|Overall Study||0||
48402060|NCT00643097|101317574|FG002|NOT COMPLETED|Overall Study||0||
48402061|NCT00464711|101317575|FG000|STARTED|Overall Study||40||
48706836|NCT02994953|102069804|FG004|STARTED|Overall Study||7||
48706837|NCT02994953|102069805|FG005|STARTED|Overall Study||16||
48706838|NCT02994953|102069800|FG000|COMPLETED|Overall Study||9||
48706839|NCT02994953|102069801|FG001|COMPLETED|Overall Study||7||
48402062|NCT00464711|101317575|FG000|COMPLETED|Overall Study||25||
48402063|NCT00464711|101317575|FG000|NOT COMPLETED|Overall Study||15||
48402064|NCT03788616|101317576|FG000|STARTED|Overall Study||35||35
48402065|NCT03788616|101317577|FG001|STARTED|Overall Study||35||35
48587858|NCT03962790|101770501|FG001|COMPLETED|Period 1||44||
48587859|NCT03962790|101770500|FG000|NOT COMPLETED|Period 1||3||
48587860|NCT03962790|101770501|FG001|NOT COMPLETED|Period 1||2||
48587861|NCT03962790|101770500|FG000|STARTED|Period 2||45||
48290640|NCT00427895|101037638|FG007|STARTED|Vax 2/Year 3 to 4||214||
48290641|NCT00427895|101037631|FG000|COMPLETED|Vax 2/Year 3 to 4||0||
48290642|NCT00427895|101037632|FG001|COMPLETED|Vax 2/Year 3 to 4||0||
48587862|NCT03962790|101770501|FG001|STARTED|Period 2||44||
48587863|NCT03962790|101770500|FG000|COMPLETED|Period 2||45||
48587864|NCT03962790|101770501|FG001|COMPLETED|Period 2||44||
48587865|NCT03962790|101770500|FG000|NOT COMPLETED|Period 2||0||
48290643|NCT00427895|101037633|FG002|COMPLETED|Vax 2/Year 3 to 4||0||
48290644|NCT00427895|101037634|FG003|COMPLETED|Vax 2/Year 3 to 4||0||
48290645|NCT00427895|101037635|FG004|COMPLETED|Vax 2/Year 3 to 4||107||
48290646|NCT00427895|101037636|FG005|COMPLETED|Vax 2/Year 3 to 4||108||
48290647|NCT00427895|101037637|FG006|COMPLETED|Vax 2/Year 3 to 4||189||
48290648|NCT00427895|101037638|FG007|COMPLETED|Vax 2/Year 3 to 4||212||
48290649|NCT00427895|101037631|FG000|NOT COMPLETED|Vax 2/Year 3 to 4||0||
48290650|NCT00427895|101037632|FG001|NOT COMPLETED|Vax 2/Year 3 to 4||0||
48290651|NCT00427895|101037633|FG002|NOT COMPLETED|Vax 2/Year 3 to 4||0||
48290652|NCT00427895|101037634|FG003|NOT COMPLETED|Vax 2/Year 3 to 4||0||
48290653|NCT00427895|101037635|FG004|NOT COMPLETED|Vax 2/Year 3 to 4||1||
48290654|NCT00427895|101037636|FG005|NOT COMPLETED|Vax 2/Year 3 to 4||0||
48290655|NCT00427895|101037637|FG006|NOT COMPLETED|Vax 2/Year 3 to 4||0||
48290656|NCT00427895|101037638|FG007|NOT COMPLETED|Vax 2/Year 3 to 4||2||
48290657|NCT00427895|101037631|FG000|STARTED|Vax 1 Baseline/6-Month Follow-up||418||
48706840|NCT02994953|102069802|FG002|COMPLETED|Overall Study||7||
48706841|NCT02994953|102069803|FG003|COMPLETED|Overall Study||6||
48706842|NCT02994953|102069804|FG004|COMPLETED|Overall Study||7||
48706843|NCT02994953|102069805|FG005|COMPLETED|Overall Study||16||
48706844|NCT02994953|102069800|FG000|NOT COMPLETED|Overall Study||0||
48706845|NCT02994953|102069801|FG001|NOT COMPLETED|Overall Study||0||
48290658|NCT00427895|101037632|FG001|STARTED|Vax 1 Baseline/6-Month Follow-up||417||
48290659|NCT00427895|101037633|FG002|STARTED|Vax 1 Baseline/6-Month Follow-up||406||
48290660|NCT00427895|101037634|FG003|STARTED|Vax 1 Baseline/6-Month Follow-up||900||
48290661|NCT00427895|101037635|FG004|STARTED|Vax 1 Baseline/6-Month Follow-up||0||
48290662|NCT00427895|101037636|FG005|STARTED|Vax 1 Baseline/6-Month Follow-up||0||
48290663|NCT00427895|101037637|FG006|STARTED|Vax 1 Baseline/6-Month Follow-up||0||
48290664|NCT00427895|101037638|FG007|STARTED|Vax 1 Baseline/6-Month Follow-up||0||
48290665|NCT00427895|101037631|FG000|Vaccinated|Vax 1 Baseline/6-Month Follow-up||417||
48290666|NCT00427895|101037632|FG001|Vaccinated|Vax 1 Baseline/6-Month Follow-up||414||
48290667|NCT00427895|101037633|FG002|Vaccinated|Vax 1 Baseline/6-Month Follow-up||404||
48290668|NCT00427895|101037634|FG003|Vaccinated|Vax 1 Baseline/6-Month Follow-up||899||
48290669|NCT00427895|101037635|FG004|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0||
48290670|NCT00427895|101037636|FG005|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0||
48402066|NCT03788616|101317576|FG000|COMPLETED|Overall Study||30||30
48402067|NCT03788616|101317577|FG001|COMPLETED|Overall Study||32||32
48402068|NCT03788616|101317576|FG000|NOT COMPLETED|Overall Study||5||5
48402069|NCT03788616|101317577|FG001|NOT COMPLETED|Overall Study||3||3
48402070|NCT01709708|101317578|FG000|STARTED|Overall Study||27||
48402071|NCT01709708|101317579|FG001|STARTED|Overall Study||14||
48402072|NCT01709708|101317578|FG000|COMPLETED|Overall Study||26||
48587866|NCT03962790|101770501|FG001|NOT COMPLETED|Period 2||0||
48587867|NCT01992653|101770502|FG000|STARTED|Overall Study||3||
48587868|NCT01992653|101770503|FG001|STARTED|Overall Study||3||
48587869|NCT01992653|101770504|FG002|STARTED|Overall Study||6||
48706846|NCT02994953|102069802|FG002|NOT COMPLETED|Overall Study||0||
48706847|NCT02994953|102069803|FG003|NOT COMPLETED|Overall Study||0||
48706848|NCT02994953|102069804|FG004|NOT COMPLETED|Overall Study||0||
48706849|NCT02994953|102069805|FG005|NOT COMPLETED|Overall Study||0||
48706850|NCT03352453|102069806|FG000|STARTED|Overall Study||66||
48706851|NCT03352453|102069807|FG001|STARTED|Overall Study||72||
48706852|NCT03352453|102069806|FG000|COMPLETED|Overall Study||44||
48706853|NCT03352453|102069807|FG001|COMPLETED|Overall Study||40||
48706854|NCT03352453|102069806|FG000|NOT COMPLETED|Overall Study||22||
48706855|NCT03352453|102069807|FG001|NOT COMPLETED|Overall Study||32||
48706856|NCT01804582|102069808|FG000|STARTED|Overall Study||177||
48706857|NCT01804582|102069809|FG001|STARTED|Overall Study||173||
48706858|NCT01804582|102069808|FG000|COMPLETED|Overall Study||128||
48706859|NCT01804582|102069809|FG001|COMPLETED|Overall Study||117||
48706860|NCT01804582|102069808|FG000|NOT COMPLETED|Overall Study||49||
48138966|NCT02952924|100665471|FG008|NOT COMPLETED|Overall Study||0||
48138967|NCT02952924|100665472|FG009|NOT COMPLETED|Overall Study||0||
48138968|NCT02952924|100665473|FG010|NOT COMPLETED|Overall Study||0||
48138969|NCT02952924|100665474|FG011|NOT COMPLETED|Overall Study||0||
48138970|NCT02952924|100665475|FG012|NOT COMPLETED|Overall Study||0||
48402073|NCT01709708|101317579|FG001|COMPLETED|Overall Study||12||
48587870|NCT01992653|101770505|FG003|STARTED|Overall Study||1||
48587871|NCT01992653|101770506|FG004|STARTED|Overall Study||6||
48587872|NCT01992653|101770507|FG005|STARTED|Overall Study||6||
48587873|NCT01992653|101770508|FG006|STARTED|Overall Study||40||
48587874|NCT01992653|101770509|FG007|STARTED|Overall Study||17||
48587875|NCT01992653|101770502|FG000|COMPLETED|Overall Study||3||
48587876|NCT01992653|101770503|FG001|COMPLETED|Overall Study||3||
48587877|NCT01992653|101770504|FG002|COMPLETED|Overall Study||5||
48587878|NCT01992653|101770505|FG003|COMPLETED|Overall Study||1||
48587879|NCT01992653|101770506|FG004|COMPLETED|Overall Study||5||
48587880|NCT01992653|101770507|FG005|COMPLETED|Overall Study||6||
48587881|NCT01992653|101770508|FG006|COMPLETED|Overall Study||32||
48587882|NCT01992653|101770509|FG007|COMPLETED|Overall Study||13||
48587883|NCT01992653|101770502|FG000|NOT COMPLETED|Overall Study||0||
48587884|NCT01992653|101770503|FG001|NOT COMPLETED|Overall Study||0||
48587885|NCT01992653|101770504|FG002|NOT COMPLETED|Overall Study||1||
48587886|NCT01992653|101770505|FG003|NOT COMPLETED|Overall Study||0||
48587887|NCT01992653|101770506|FG004|NOT COMPLETED|Overall Study||1||
48587888|NCT01992653|101770507|FG005|NOT COMPLETED|Overall Study||0||
48587889|NCT01992653|101770508|FG006|NOT COMPLETED|Overall Study||8||
48587890|NCT01992653|101770509|FG007|NOT COMPLETED|Overall Study||4||
48587891|NCT04413552|101770510|FG000|STARTED|Overall Study||6||
48587892|NCT04413552|101770511|FG001|STARTED|Overall Study||6||
48587893|NCT04413552|101770512|FG002|STARTED|Overall Study||6||
48587894|NCT04413552|101770513|FG003|STARTED|Overall Study||6||
48587895|NCT04413552|101770514|FG004|STARTED|Overall Study||6||
48587896|NCT04413552|101770515|FG005|STARTED|Overall Study||6||
48587897|NCT04413552|101770516|FG006|STARTED|Overall Study||7||
48587898|NCT04413552|101770517|FG007|STARTED|Overall Study||6||
48706861|NCT01804582|102069809|FG001|NOT COMPLETED|Overall Study||56||
48706862|NCT01866423|102069810|FG000|STARTED|Overall Study||4||
48706863|NCT01866423|102069810|FG000|COMPLETED|Overall Study||0||
48138971|NCT02952924|100665476|FG013|NOT COMPLETED|Overall Study||0||
48138972|NCT02952924|100665477|FG014|NOT COMPLETED|Overall Study||0||
48138973|NCT02952924|100665478|FG015|NOT COMPLETED|Overall Study||0||
48138974|NCT02952924|100665479|FG016|NOT COMPLETED|Overall Study||0||
48290671|NCT00427895|101037637|FG006|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0||
48587899|NCT04413552|101770518|FG008|STARTED|Overall Study||16||
48587900|NCT04413552|101770519|FG009|STARTED|Overall Study||8||
48587901|NCT04413552|101770510|FG000|Received Study Drug|Overall Study||6||
48587902|NCT04413552|101770511|FG001|Received Study Drug|Overall Study||6||
48587903|NCT04413552|101770512|FG002|Received Study Drug|Overall Study||6||
48587904|NCT04413552|101770513|FG003|Received Study Drug|Overall Study||6||
48587905|NCT04413552|101770514|FG004|Received Study Drug|Overall Study||6||
48138975|NCT02952924|100665480|FG017|NOT COMPLETED|Overall Study||1||
48138976|NCT02952924|100665481|FG018|NOT COMPLETED|Overall Study||0||
48138977|NCT02952924|100665482|FG019|NOT COMPLETED|Overall Study||1||
48138978|NCT02952924|100665483|FG020|NOT COMPLETED|Overall Study||0||
48138979|NCT02952924|100665484|FG021|NOT COMPLETED|Overall Study||2||
48138980|NCT01227681|100665485|FG000|STARTED|Overall Study||4||
48138981|NCT01227681|100665486|FG001|STARTED|Overall Study||0||
48138982|NCT01227681|100665487|FG002|STARTED|Overall Study||0||
48138983|NCT01227681|100665485|FG000|COMPLETED|Overall Study||4||
48138984|NCT01227681|100665486|FG001|COMPLETED|Overall Study||0||
48138985|NCT01227681|100665487|FG002|COMPLETED|Overall Study||0||
48138986|NCT01227681|100665485|FG000|NOT COMPLETED|Overall Study||0||
48138987|NCT01227681|100665486|FG001|NOT COMPLETED|Overall Study||0||
48138988|NCT01227681|100665487|FG002|NOT COMPLETED|Overall Study||0||
48138989|NCT04066114|100665488|FG000|STARTED|Overall Study||8||
48587906|NCT04413552|101770515|FG005|Received Study Drug|Overall Study||6||
48587907|NCT04413552|101770516|FG006|Received Study Drug|Overall Study||6||
48587908|NCT04413552|101770517|FG007|Received Study Drug|Overall Study||6||
48587909|NCT04413552|101770518|FG008|Received Study Drug|Overall Study||16||
48587910|NCT04413552|101770519|FG009|Received Study Drug|Overall Study||8||
48587911|NCT04413552|101770510|FG000|COMPLETED|Overall Study||6||
48587912|NCT04413552|101770511|FG001|COMPLETED|Overall Study||6||
48587913|NCT04413552|101770512|FG002|COMPLETED|Overall Study||6||
48587914|NCT04413552|101770513|FG003|COMPLETED|Overall Study||6||
48587915|NCT04413552|101770514|FG004|COMPLETED|Overall Study||6||
48587916|NCT04413552|101770515|FG005|COMPLETED|Overall Study||6||
48587917|NCT04413552|101770516|FG006|COMPLETED|Overall Study||6||
48706864|NCT01866423|102069810|FG000|NOT COMPLETED|Overall Study||4||
48706865|NCT03618628|102069811|FG000|STARTED|Overall Study||3||
48706866|NCT03618628|102069811|FG000|COMPLETED|Overall Study||1||
48402074|NCT01709708|101317578|FG000|NOT COMPLETED|Overall Study||1||
48402075|NCT01709708|101317579|FG001|NOT COMPLETED|Overall Study||2||
48402076|NCT04511338|101317580|FG000|STARTED|Period 1||8||
48402077|NCT04511338|101317581|FG001|STARTED|Period 1||8||
48402078|NCT04511338|101317580|FG000|COMPLETED|Period 1||7||
48402079|NCT04511338|101317581|FG001|COMPLETED|Period 1||8||
48402080|NCT04511338|101317580|FG000|NOT COMPLETED|Period 1||1||
48402081|NCT04511338|101317581|FG001|NOT COMPLETED|Period 1||0||
48402082|NCT04511338|101317580|FG000|STARTED|Washout||8||
48402083|NCT04511338|101317581|FG001|STARTED|Washout||8||
48402084|NCT04511338|101317580|FG000|COMPLETED|Washout||8||
48402085|NCT04511338|101317581|FG001|COMPLETED|Washout||8||
48402086|NCT04511338|101317580|FG000|NOT COMPLETED|Washout||0||
48402087|NCT04511338|101317581|FG001|NOT COMPLETED|Washout||0||
48402088|NCT04511338|101317580|FG000|STARTED|Period 2||8||
48402089|NCT04511338|101317581|FG001|STARTED|Period 2||8||
48402090|NCT04511338|101317580|FG000|COMPLETED|Period 2||8||
48587918|NCT04413552|101770517|FG007|COMPLETED|Overall Study||6||
48587919|NCT04413552|101770518|FG008|COMPLETED|Overall Study||16||
48587920|NCT04413552|101770519|FG009|COMPLETED|Overall Study||8||
48587921|NCT04413552|101770510|FG000|NOT COMPLETED|Overall Study||0||
48587922|NCT04413552|101770511|FG001|NOT COMPLETED|Overall Study||0||
48587923|NCT04413552|101770512|FG002|NOT COMPLETED|Overall Study||0||
48587924|NCT04413552|101770513|FG003|NOT COMPLETED|Overall Study||0||
48587925|NCT04413552|101770514|FG004|NOT COMPLETED|Overall Study||0||
48587926|NCT04413552|101770515|FG005|NOT COMPLETED|Overall Study||0||
48402091|NCT04511338|101317581|FG001|COMPLETED|Period 2||5||
48402092|NCT04511338|101317580|FG000|NOT COMPLETED|Period 2||0||
48402093|NCT04511338|101317581|FG001|NOT COMPLETED|Period 2||3||
48402094|NCT01947647|101317582|FG000|STARTED|Treatment Phase||46||
48402095|NCT01947647|101317583|FG001|STARTED|Treatment Phase||47||
48402096|NCT01947647|101317582|FG000|COMPLETED|Treatment Phase||29||
48402097|NCT01947647|101317583|FG001|COMPLETED|Treatment Phase||21||
48402098|NCT01947647|101317582|FG000|NOT COMPLETED|Treatment Phase||17||
48402099|NCT01947647|101317583|FG001|NOT COMPLETED|Treatment Phase||26||
48402100|NCT01947647|101317582|FG000|STARTED|6-month Followup Phase||29||
48402101|NCT01947647|101317583|FG001|STARTED|6-month Followup Phase||21||
48402102|NCT01947647|101317582|FG000|COMPLETED|6-month Followup Phase||20||
48402103|NCT01947647|101317583|FG001|COMPLETED|6-month Followup Phase||13||
48402104|NCT01947647|101317582|FG000|NOT COMPLETED|6-month Followup Phase||9||
48402105|NCT01947647|101317583|FG001|NOT COMPLETED|6-month Followup Phase||8||
48402106|NCT01927068|101317584|FG000|STARTED|Overall Study||370||
48402107|NCT01927068|101317585|FG001|STARTED|Overall Study||129||
48402108|NCT01927068|101317584|FG000|COMPLETED|Overall Study||262||
48402109|NCT01927068|101317585|FG001|COMPLETED|Overall Study||121||
48402110|NCT01927068|101317584|FG000|NOT COMPLETED|Overall Study||108||
48402111|NCT01927068|101317585|FG001|NOT COMPLETED|Overall Study||8||
48402112|NCT00748865|101317586|FG000|STARTED|Overall Study||10||
48402113|NCT00748865|101317587|FG001|STARTED|Overall Study||10||
48402114|NCT00748865|101317586|FG000|COMPLETED|Overall Study||10||
48402115|NCT00748865|101317587|FG001|COMPLETED|Overall Study||10||
48402116|NCT00748865|101317586|FG000|NOT COMPLETED|Overall Study||0||
48402117|NCT00748865|101317587|FG001|NOT COMPLETED|Overall Study||0||
48402118|NCT01801189|101317588|FG000|STARTED|Overall Study||28||
48402119|NCT01801189|101317589|FG001|STARTED|Overall Study||33||
48402120|NCT01801189|101317588|FG000|COMPLETED|Overall Study||28||
48402121|NCT01801189|101317589|FG001|COMPLETED|Overall Study||33||
48402122|NCT01801189|101317588|FG000|NOT COMPLETED|Overall Study||0||
48402123|NCT01801189|101317589|FG001|NOT COMPLETED|Overall Study||0||
48402124|NCT01190020|101317590|FG000|STARTED|Overall Study||29||
48402125|NCT01190020|101317591|FG001|STARTED|Overall Study||12||
48402126|NCT01190020|101317590|FG000|COMPLETED|Overall Study||22||
48402127|NCT01190020|101317591|FG001|COMPLETED|Overall Study||12||
48402128|NCT01190020|101317590|FG000|NOT COMPLETED|Overall Study||7||
48402129|NCT01190020|101317591|FG001|NOT COMPLETED|Overall Study||0||
48402130|NCT00056550|101317592|FG000|STARTED|Overall Study||14||
48587927|NCT04413552|101770516|FG006|NOT COMPLETED|Overall Study||1||
48587928|NCT04413552|101770517|FG007|NOT COMPLETED|Overall Study||0||
48587929|NCT04413552|101770518|FG008|NOT COMPLETED|Overall Study||0||
48587930|NCT04413552|101770519|FG009|NOT COMPLETED|Overall Study||0||
48587931|NCT00271011|101770520|FG000|STARTED|Overall Study||13||
48587932|NCT00271011|101770520|FG000|COMPLETED|Overall Study||13||
48402131|NCT00056550|101317592|FG000|COMPLETED|Overall Study||14||
48402132|NCT00056550|101317592|FG000|NOT COMPLETED|Overall Study||0||
48402133|NCT00093470|101317593|FG000|STARTED|Overall Study||73||
48402134|NCT00093470|101317594|FG001|STARTED|Overall Study||71||
48587933|NCT00271011|101770520|FG000|NOT COMPLETED|Overall Study||0||
48587934|NCT02777970|101770521|FG000|STARTED|Overall Study||261||
48587935|NCT02777970|101770522|FG001|STARTED|Overall Study||262||
48587936|NCT02777970|101770523|FG002|STARTED|Overall Study||131||
48402135|NCT00093470|101317593|FG000|Treated|Overall Study||72||
48402136|NCT00093470|101317594|FG001|Treated|Overall Study||71||
48402137|NCT00093470|101317593|FG000|Patients With Toxicity Assessment|Overall Study||72||
48402138|NCT00093470|101317594|FG001|Patients With Toxicity Assessment|Overall Study||69||
48402139|NCT00093470|101317593|FG000|COMPLETED|Overall Study||0||
48706867|NCT03618628|102069811|FG000|NOT COMPLETED|Overall Study||2||
48706868|NCT02299570|102069812|FG000|STARTED|Overall Study||45||
48706869|NCT02299570|102069813|FG001|STARTED|Overall Study||44||
48706870|NCT02299570|102069814|FG002|STARTED|Overall Study||44||
48706871|NCT02299570|102069812|FG000|COMPLETED|Overall Study||31||
48706872|NCT02299570|102069813|FG001|COMPLETED|Overall Study||35||
48402140|NCT00093470|101317594|FG001|COMPLETED|Overall Study||71||
48402141|NCT00093470|101317593|FG000|NOT COMPLETED|Overall Study||73||
48402142|NCT00093470|101317594|FG001|NOT COMPLETED|Overall Study||0||
48402143|NCT01105936|101317595|FG000|STARTED|Period 1||8||
48706873|NCT02299570|102069814|FG002|COMPLETED|Overall Study||25||
48706874|NCT02299570|102069812|FG000|NOT COMPLETED|Overall Study||14||
48706875|NCT02299570|102069813|FG001|NOT COMPLETED|Overall Study||9||
48706876|NCT02299570|102069814|FG002|NOT COMPLETED|Overall Study||19||
48706877|NCT03664674|102069815|FG000|STARTED|Overall Study||73||
48706878|NCT03664674|102069816|FG001|STARTED|Overall Study||75||
48706879|NCT03664674|102069815|FG000|COMPLETED|Overall Study||70||
48706880|NCT03664674|102069816|FG001|COMPLETED|Overall Study||73||
48706881|NCT03664674|102069815|FG000|NOT COMPLETED|Overall Study||3||
48706882|NCT03664674|102069816|FG001|NOT COMPLETED|Overall Study||2||
48706883|NCT02956044|102069817|FG000|STARTED|Overall Study||18||
48706884|NCT02956044|102069818|FG001|STARTED|Overall Study||18||
48706885|NCT02956044|102069819|FG002|STARTED|Overall Study||18||
48706886|NCT02956044|102069817|FG000|COMPLETED|Overall Study||18||
48706887|NCT02956044|102069818|FG001|COMPLETED|Overall Study||18||
48706888|NCT02956044|102069819|FG002|COMPLETED|Overall Study||18||
48706889|NCT02956044|102069817|FG000|NOT COMPLETED|Overall Study||0||
48706890|NCT02956044|102069818|FG001|NOT COMPLETED|Overall Study||0||
48706891|NCT02956044|102069819|FG002|NOT COMPLETED|Overall Study||0||
48402144|NCT01105936|101317596|FG001|STARTED|Period 1||8||
48402145|NCT01105936|101317597|FG002|STARTED|Period 1||7||
48402146|NCT01105936|101317598|FG003|STARTED|Period 1||8||
48402147|NCT01105936|101317595|FG000|COMPLETED|Period 1||8||
48402148|NCT01105936|101317596|FG001|COMPLETED|Period 1||8||
48402149|NCT01105936|101317597|FG002|COMPLETED|Period 1||7||
48402150|NCT01105936|101317598|FG003|COMPLETED|Period 1||7||
48402151|NCT01105936|101317595|FG000|NOT COMPLETED|Period 1||0||
48402152|NCT01105936|101317596|FG001|NOT COMPLETED|Period 1||0||
48402153|NCT01105936|101317597|FG002|NOT COMPLETED|Period 1||0||
48402154|NCT01105936|101317598|FG003|NOT COMPLETED|Period 1||1||
48402155|NCT01105936|101317595|FG000|STARTED|Wash-out Period 1||8||
48402156|NCT01105936|101317596|FG001|STARTED|Wash-out Period 1||8||
48402157|NCT01105936|101317597|FG002|STARTED|Wash-out Period 1||7||
48402158|NCT01105936|101317598|FG003|STARTED|Wash-out Period 1||7||
48402159|NCT01105936|101317595|FG000|COMPLETED|Wash-out Period 1||8||
48706892|NCT00525824|102069820|FG000|STARTED|Overall Study||214||
48706893|NCT00525824|102069821|FG001|STARTED|Overall Study||214||
48587937|NCT02777970|101770521|FG000|COMPLETED|Overall Study||260||
48587938|NCT02777970|101770522|FG001|COMPLETED|Overall Study||261||
48587939|NCT02777970|101770523|FG002|COMPLETED|Overall Study||131||
48587940|NCT02777970|101770521|FG000|NOT COMPLETED|Overall Study||1||
48587941|NCT02777970|101770522|FG001|NOT COMPLETED|Overall Study||1||
48587942|NCT02777970|101770523|FG002|NOT COMPLETED|Overall Study||0||
48587943|NCT00793624|101770524|FG000|STARTED|Overall Study||225||
48587944|NCT00793624|101770525|FG001|STARTED|Overall Study||227||
48587945|NCT00793624|101770526|FG002|STARTED|Overall Study||225||
48587946|NCT00793624|101770527|FG003|STARTED|Overall Study||227||
48587947|NCT00793624|101770524|FG000|COMPLETED|Overall Study||168||
48587948|NCT00793624|101770525|FG001|COMPLETED|Overall Study||191||
48587949|NCT00793624|101770526|FG002|COMPLETED|Overall Study||186||
48706894|NCT00525824|102069822|FG002|STARTED|Overall Study||202||
48706895|NCT00525824|102069823|FG003|STARTED|Overall Study||203||
48706896|NCT00525824|102069820|FG000|COMPLETED|Overall Study||195||
48706897|NCT00525824|102069821|FG001|COMPLETED|Overall Study||186||
48706898|NCT00525824|102069822|FG002|COMPLETED|Overall Study||183||
48706899|NCT00525824|102069823|FG003|COMPLETED|Overall Study||188||
48706900|NCT00525824|102069820|FG000|NOT COMPLETED|Overall Study||19||
48706901|NCT00525824|102069821|FG001|NOT COMPLETED|Overall Study||28||
48587950|NCT00793624|101770527|FG003|COMPLETED|Overall Study||184||
48587951|NCT00793624|101770524|FG000|NOT COMPLETED|Overall Study||57||
48587952|NCT00793624|101770525|FG001|NOT COMPLETED|Overall Study||36||
48587953|NCT00793624|101770526|FG002|NOT COMPLETED|Overall Study||39||
48587954|NCT00793624|101770527|FG003|NOT COMPLETED|Overall Study||43||
48587955|NCT01077739|101770528|FG000|STARTED|Overall Study||25||
48587956|NCT01077739|101770529|FG001|STARTED|Overall Study||50||
48587957|NCT01077739|101770528|FG000|COMPLETED|Overall Study||20||
48587958|NCT01077739|101770529|FG001|COMPLETED|Overall Study||40||
48290672|NCT00427895|101037638|FG007|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0||
48290673|NCT00427895|101037631|FG000|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411||
48290674|NCT00427895|101037632|FG001|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411||
48290675|NCT00427895|101037633|FG002|COMPLETED|Vax 1 Baseline/6-Month Follow-up||392||
48290676|NCT00427895|101037634|FG003|COMPLETED|Vax 1 Baseline/6-Month Follow-up||854||
48587959|NCT01077739|101770528|FG000|NOT COMPLETED|Overall Study||5||
48587960|NCT01077739|101770529|FG001|NOT COMPLETED|Overall Study||10||
48587961|NCT02468154|101770530|FG000|STARTED|Overall Study||29||
48587962|NCT02468154|101770531|FG001|STARTED|Overall Study||28||
48706902|NCT00525824|102069822|FG002|NOT COMPLETED|Overall Study||19||
48290677|NCT00427895|101037635|FG004|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0||
48290678|NCT00427895|101037636|FG005|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0||
48290679|NCT00427895|101037637|FG006|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0||
48290680|NCT00427895|101037638|FG007|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0||
48587963|NCT02468154|101770530|FG000|COMPLETED|Overall Study||29||
48587964|NCT02468154|101770531|FG001|COMPLETED|Overall Study||28||
48587965|NCT02468154|101770530|FG000|NOT COMPLETED|Overall Study||0||
48587966|NCT02468154|101770531|FG001|NOT COMPLETED|Overall Study||0||
48587967|NCT03290547|101770532|FG000|STARTED|Overall Study||22||
48587968|NCT03290547|101770532|FG000|COMPLETED|Overall Study||6||
48587969|NCT03290547|101770532|FG000|NOT COMPLETED|Overall Study||16||
48706903|NCT00525824|102069823|FG003|NOT COMPLETED|Overall Study||15||
48706904|NCT00772369|102069824|FG000|STARTED|Overall Study||3214||
48706905|NCT00772369|102069824|FG000|COMPLETED|Overall Study||3213||
48290681|NCT00427895|101037631|FG000|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||7||
48290682|NCT00427895|101037632|FG001|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||6||
48290683|NCT00427895|101037633|FG002|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||14||
48290684|NCT00427895|101037634|FG003|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||46||
48290685|NCT00427895|101037635|FG004|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0||
48290686|NCT00427895|101037636|FG005|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0||
48290687|NCT00427895|101037637|FG006|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0||
48587970|NCT02267772|101770533|FG000|STARTED|Overall Study||50||
48587971|NCT02267772|101770534|FG001|STARTED|Overall Study||52||
48587972|NCT02267772|101770533|FG000|Randomized|Overall Study||50||
48587973|NCT02267772|101770534|FG001|Randomized|Overall Study||52||
48587974|NCT02267772|101770533|FG000|Received Study Drug|Overall Study||48||
48290688|NCT00427895|101037638|FG007|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0||
48290689|NCT00427895|101037631|FG000|STARTED|Vax 1/Year 1 Follow-up||411||
48290690|NCT00427895|101037632|FG001|STARTED|Vax 1/Year 1 Follow-up||411||
48290691|NCT00427895|101037633|FG002|STARTED|Vax 1/Year 1 Follow-up||392||
48290692|NCT00427895|101037634|FG003|STARTED|Vax 1/Year 1 Follow-up||502||
48290693|NCT00427895|101037635|FG004|STARTED|Vax 1/Year 1 Follow-up||0||
48290694|NCT00427895|101037636|FG005|STARTED|Vax 1/Year 1 Follow-up||0||
48290695|NCT00427895|101037637|FG006|STARTED|Vax 1/Year 1 Follow-up||0||
48290696|NCT00427895|101037638|FG007|STARTED|Vax 1/Year 1 Follow-up||0||
48290697|NCT00427895|101037631|FG000|COMPLETED|Vax 1/Year 1 Follow-up||404||
48290698|NCT00427895|101037632|FG001|COMPLETED|Vax 1/Year 1 Follow-up||396||
48290699|NCT00427895|101037633|FG002|COMPLETED|Vax 1/Year 1 Follow-up||373||
48290700|NCT00427895|101037634|FG003|COMPLETED|Vax 1/Year 1 Follow-up||469||
48290701|NCT00427895|101037635|FG004|COMPLETED|Vax 1/Year 1 Follow-up||0||
48290702|NCT00427895|101037636|FG005|COMPLETED|Vax 1/Year 1 Follow-up||0||
48290703|NCT00427895|101037637|FG006|COMPLETED|Vax 1/Year 1 Follow-up||0||
48587975|NCT02267772|101770534|FG001|Received Study Drug|Overall Study||52||
48587976|NCT02267772|101770533|FG000|COMPLETED|Overall Study||48||
48587977|NCT02267772|101770534|FG001|COMPLETED|Overall Study||52||
48587978|NCT02267772|101770533|FG000|NOT COMPLETED|Overall Study||2||
48587979|NCT02267772|101770534|FG001|NOT COMPLETED|Overall Study||0||
48587980|NCT02773212|101770535|FG000|STARTED|Overall Study||21||
48587981|NCT02773212|101770536|FG001|STARTED|Overall Study||15||
48587982|NCT02773212|101770537|FG002|STARTED|Overall Study||19||
48587983|NCT02773212|101770535|FG000|COMPLETED|Overall Study||6||
48587984|NCT02773212|101770536|FG001|COMPLETED|Overall Study||9||
48587985|NCT02773212|101770537|FG002|COMPLETED|Overall Study||16||
48587986|NCT02773212|101770535|FG000|NOT COMPLETED|Overall Study||15||
48587987|NCT02773212|101770536|FG001|NOT COMPLETED|Overall Study||6||
48290704|NCT00427895|101037638|FG007|COMPLETED|Vax 1/Year 1 Follow-up||0||
48290705|NCT00427895|101037631|FG000|NOT COMPLETED|Vax 1/Year 1 Follow-up||7||
48290706|NCT00427895|101037632|FG001|NOT COMPLETED|Vax 1/Year 1 Follow-up||15||
48587988|NCT02773212|101770537|FG002|NOT COMPLETED|Overall Study||3||
48587989|NCT04791319|101770538|FG000|STARTED|Placebo Controlled Period (Week 0-15)||33||
48587990|NCT04791319|101770539|FG001|STARTED|Placebo Controlled Period (Week 0-15)||33||
48587991|NCT04791319|101770540|FG002|STARTED|Placebo Controlled Period (Week 0-15)||67||
48587992|NCT04791319|101770541|FG003|STARTED|Placebo Controlled Period (Week 0-15)||66||
48587993|NCT04791319|101770542|FG004|STARTED|Placebo Controlled Period (Week 0-15)||0||
48587994|NCT04791319|101770543|FG005|STARTED|Placebo Controlled Period (Week 0-15)||0||
48138990|NCT04066114|100665489|FG001|STARTED|Overall Study||7||
48138991|NCT04066114|100665490|FG002|STARTED|Overall Study||9||
48138992|NCT04066114|100665488|FG000|COMPLETED|Overall Study||6||
48138993|NCT04066114|100665489|FG001|COMPLETED|Overall Study||0||
48138994|NCT04066114|100665490|FG002|COMPLETED|Overall Study||9||
48138995|NCT04066114|100665488|FG000|NOT COMPLETED|Overall Study||2||
48138996|NCT04066114|100665489|FG001|NOT COMPLETED|Overall Study||7||
48138997|NCT04066114|100665490|FG002|NOT COMPLETED|Overall Study||0||
48138998|NCT00728819|100665491|FG000|STARTED|Overall Study||171||
48138999|NCT00728819|100665492|FG001|STARTED|Overall Study||168||
48139000|NCT00728819|100665491|FG000|COMPLETED|Overall Study||135||
48139001|NCT00728819|100665492|FG001|COMPLETED|Overall Study||139||
48139002|NCT00728819|100665491|FG000|NOT COMPLETED|Overall Study||36||
48139003|NCT00728819|100665492|FG001|NOT COMPLETED|Overall Study||29||
48139004|NCT02273141|100665493|FG000|STARTED|Overall Study||257||
48139005|NCT02273141|100665494|FG001|STARTED|Overall Study||258||
48139006|NCT02273141|100665493|FG000|COMPLETED|Overall Study||240||
48139007|NCT02273141|100665494|FG001|COMPLETED|Overall Study||233||
48139008|NCT02273141|100665493|FG000|NOT COMPLETED|Overall Study||17||
48139009|NCT02273141|100665494|FG001|NOT COMPLETED|Overall Study||25||
48139010|NCT01602536|100665495|FG000|STARTED|Overall Study||80||
48139011|NCT01602536|100665496|FG001|STARTED|Overall Study||80||
48139012|NCT01602536|100665495|FG000|COMPLETED|Overall Study||65||
48139013|NCT01602536|100665496|FG001|COMPLETED|Overall Study||70||
48139014|NCT01602536|100665495|FG000|NOT COMPLETED|Overall Study||15||
48587995|NCT04791319|101770544|FG006|STARTED|Placebo Controlled Period (Week 0-15)||0||
48587996|NCT04791319|101770545|FG007|STARTED|Placebo Controlled Period (Week 0-15)||0||
48587997|NCT04791319|101770546|FG008|STARTED|Placebo Controlled Period (Week 0-15)||0||
48587998|NCT04791319|101770547|FG009|STARTED|Placebo Controlled Period (Week 0-15)||0||
48587999|NCT04791319|101770548|FG010|STARTED|Placebo Controlled Period (Week 0-15)||0||
48588000|NCT04791319|101770538|FG000|Treated|Placebo Controlled Period (Week 0-15)||33||
48588001|NCT04791319|101770539|FG001|Treated|Placebo Controlled Period (Week 0-15)||33||
48588002|NCT04791319|101770540|FG002|Treated|Placebo Controlled Period (Week 0-15)||67||
48588003|NCT04791319|101770541|FG003|Treated|Placebo Controlled Period (Week 0-15)||65||
48588004|NCT04791319|101770542|FG004|Treated|Placebo Controlled Period (Week 0-15)||0||
48588005|NCT04791319|101770543|FG005|Treated|Placebo Controlled Period (Week 0-15)||0||
48588006|NCT04791319|101770544|FG006|Treated|Placebo Controlled Period (Week 0-15)||0||
48588007|NCT04791319|101770545|FG007|Treated|Placebo Controlled Period (Week 0-15)||0||
48588008|NCT04791319|101770546|FG008|Treated|Placebo Controlled Period (Week 0-15)||0||
48588009|NCT04791319|101770547|FG009|Treated|Placebo Controlled Period (Week 0-15)||0||
48592846|NCT01455181|101786324|FG000|NOT COMPLETED|Overall Study||0||
48706906|NCT00772369|102069824|FG000|NOT COMPLETED|Overall Study||1||
48706907|NCT03440723|102069825|FG000|STARTED|Overall Study||21||
48706908|NCT03440723|102069826|FG001|STARTED|Overall Study||21||
48706909|NCT03440723|102069825|FG000|COMPLETED|Overall Study||21||
48706910|NCT03440723|102069826|FG001|COMPLETED|Overall Study||21||
48706911|NCT03440723|102069825|FG000|NOT COMPLETED|Overall Study||0||
48706912|NCT03440723|102069826|FG001|NOT COMPLETED|Overall Study||0||
48706913|NCT02576535|102069827|FG000|STARTED|Overall Study||18||
48706914|NCT02576535|102069827|FG000|COMPLETED|Overall Study||16||
48706915|NCT02576535|102069827|FG000|NOT COMPLETED|Overall Study||2||
48706916|NCT00350272|102069828|FG000|STARTED|Blinded 12-Week Treatment||39||
48706917|NCT00350272|102069829|FG001|STARTED|Blinded 12-Week Treatment||37||
48706918|NCT00350272|102069828|FG000|COMPLETED|Blinded 12-Week Treatment||30||
48706919|NCT00350272|102069829|FG001|COMPLETED|Blinded 12-Week Treatment||35||
48706920|NCT00350272|102069828|FG000|NOT COMPLETED|Blinded 12-Week Treatment||9||
48706921|NCT00350272|102069829|FG001|NOT COMPLETED|Blinded 12-Week Treatment||2||
48706922|NCT00350272|102069828|FG000|STARTED|Open-Label 84 Week Treatment||30||
48706923|NCT00350272|102069829|FG001|STARTED|Open-Label 84 Week Treatment||35||
48706924|NCT00350272|102069828|FG000|COMPLETED|Open-Label 84 Week Treatment||21||
48706925|NCT00350272|102069829|FG001|COMPLETED|Open-Label 84 Week Treatment||27||
48706926|NCT00350272|102069828|FG000|NOT COMPLETED|Open-Label 84 Week Treatment||9||
48706927|NCT00350272|102069829|FG001|NOT COMPLETED|Open-Label 84 Week Treatment||8||
48706928|NCT02981407|102069830|FG000|STARTED|Overall Study||1757||
48139015|NCT01602536|100665496|FG001|NOT COMPLETED|Overall Study||10||
48139016|NCT05073133|100665497|FG000|STARTED|Overall Study||16||
48139017|NCT05073133|100665497|FG000|COMPLETED|Overall Study||14||
48139018|NCT05073133|100665497|FG000|NOT COMPLETED|Overall Study||2||
48139019|NCT02010060|100665498|FG000|STARTED|Overall Study||15||
48139020|NCT02010060|100665499|FG001|STARTED|Overall Study||15||
48139021|NCT02010060|100665500|FG002|STARTED|Overall Study||15||
48139022|NCT02010060|100665498|FG000|COMPLETED|Overall Study||14||
48139023|NCT02010060|100665499|FG001|COMPLETED|Overall Study||12||
48139024|NCT02010060|100665500|FG002|COMPLETED|Overall Study||13||
48139025|NCT02010060|100665498|FG000|NOT COMPLETED|Overall Study||1||
48139026|NCT02010060|100665499|FG001|NOT COMPLETED|Overall Study||3||
48139027|NCT02010060|100665500|FG002|NOT COMPLETED|Overall Study||2||
48139028|NCT04717596|100665501|FG000|STARTED|Overall Study||455||
48139029|NCT04717596|100665501|FG000|COMPLETED|Overall Study||451||
48139030|NCT04717596|100665501|FG000|NOT COMPLETED|Overall Study||4||
48139031|NCT02241967|100665502|FG000|STARTED|Overall Study||30||
48139032|NCT02241967|100665503|FG001|STARTED|Overall Study||30||
48139033|NCT02241967|100665504|FG002|STARTED|Overall Study||30||
48139034|NCT02241967|100665505|FG003|STARTED|Overall Study||29||
48139035|NCT02241967|100665502|FG000|COMPLETED|Overall Study||30||
48139036|NCT02241967|100665503|FG001|COMPLETED|Overall Study||30||
48139037|NCT02241967|100665504|FG002|COMPLETED|Overall Study||30||
48139038|NCT02241967|100665505|FG003|COMPLETED|Overall Study||29||
48139039|NCT02241967|100665502|FG000|NOT COMPLETED|Overall Study||0||
48139040|NCT02241967|100665503|FG001|NOT COMPLETED|Overall Study||0||
48139041|NCT02241967|100665504|FG002|NOT COMPLETED|Overall Study||0||
48139042|NCT02241967|100665505|FG003|NOT COMPLETED|Overall Study||0||
48139043|NCT02562755|100665506|FG000|STARTED|Overall Study||234|Randomized|
48139044|NCT02562755|100665507|FG001|STARTED|Overall Study||225|Randomized|
48139045|NCT02562755|100665506|FG000|Safety Population|Overall Study||218|Patients who received at least one dose of study treatment|
48139046|NCT02562755|100665507|FG001|Safety Population|Overall Study||217|Patients who received at least one dose of study treatment|
48139047|NCT02562755|100665506|FG000|COMPLETED|Overall Study||161||
48139048|NCT02562755|100665507|FG001|COMPLETED|Overall Study||153||
48139049|NCT02562755|100665506|FG000|NOT COMPLETED|Overall Study||73||
48139050|NCT02562755|100665507|FG001|NOT COMPLETED|Overall Study||72||
48139051|NCT01328574|100665508|FG000|STARTED|Overall Study||13||
48588010|NCT04791319|101770548|FG010|Treated|Placebo Controlled Period (Week 0-15)||0||
48588011|NCT04791319|101770538|FG000|COMPLETED|Placebo Controlled Period (Week 0-15)||19||
48139052|NCT01328574|100665508|FG000|COMPLETED|Overall Study||12||
48139053|NCT01328574|100665508|FG000|NOT COMPLETED|Overall Study||1||
48139054|NCT01662882|100665509|FG000|STARTED|Overall Study||15||
48139055|NCT01662882|100665510|FG001|STARTED|Overall Study||18||
48139056|NCT01662882|100665511|FG002|STARTED|Overall Study||15||
48139057|NCT01662882|100665509|FG000|COMPLETED|Overall Study||15||
48139058|NCT01662882|100665510|FG001|COMPLETED|Overall Study||18||
48139059|NCT01662882|100665511|FG002|COMPLETED|Overall Study||15||
48139060|NCT01662882|100665509|FG000|NOT COMPLETED|Overall Study||0||
48139061|NCT01662882|100665510|FG001|NOT COMPLETED|Overall Study||0||
48139062|NCT01662882|100665511|FG002|NOT COMPLETED|Overall Study||0||
48139063|NCT02267382|100665512|FG000|STARTED|Overall Study||42||
48139064|NCT02267382|100665513|FG001|STARTED|Overall Study||43||
48139065|NCT02267382|100665514|FG002|STARTED|Overall Study||43||
48139066|NCT02267382|100665515|FG003|STARTED|Overall Study||41||
48139067|NCT02267382|100665516|FG004|STARTED|Overall Study||46||
48139068|NCT02267382|100665512|FG000|COMPLETED|Overall Study||35||
48139069|NCT02267382|100665513|FG001|COMPLETED|Overall Study||33||
48139070|NCT02267382|100665514|FG002|COMPLETED|Overall Study||34||
48588012|NCT04791319|101770539|FG001|COMPLETED|Placebo Controlled Period (Week 0-15)||21||
48139071|NCT02267382|100665515|FG003|COMPLETED|Overall Study||35||
48139072|NCT02267382|100665516|FG004|COMPLETED|Overall Study||39||
48139073|NCT02267382|100665512|FG000|NOT COMPLETED|Overall Study||7||
48139074|NCT02267382|100665513|FG001|NOT COMPLETED|Overall Study||10||
48588013|NCT04791319|101770540|FG002|COMPLETED|Placebo Controlled Period (Week 0-15)||30||
48588014|NCT04791319|101770541|FG003|COMPLETED|Placebo Controlled Period (Week 0-15)||38||
48139075|NCT02267382|100665514|FG002|NOT COMPLETED|Overall Study||9||
48139076|NCT02267382|100665515|FG003|NOT COMPLETED|Overall Study||6||
48139077|NCT02267382|100665516|FG004|NOT COMPLETED|Overall Study||7||
48139078|NCT00920426|100665517|FG000|STARTED|ITZ111451||8||
48139079|NCT00920426|100665518|FG001|STARTED|ITZ111451||0||
48139080|NCT00920426|100665519|FG002|STARTED|ITZ111451||0||
48139081|NCT00920426|100665520|FG003|STARTED|ITZ111451||0||
48139082|NCT00920426|100665517|FG000|COMPLETED|ITZ111451||7||
48139083|NCT00920426|100665518|FG001|COMPLETED|ITZ111451||0||
48139084|NCT00920426|100665519|FG002|COMPLETED|ITZ111451||0||
48139085|NCT00920426|100665520|FG003|COMPLETED|ITZ111451||0||
48139086|NCT00920426|100665517|FG000|NOT COMPLETED|ITZ111451||1||
48139087|NCT00920426|100665518|FG001|NOT COMPLETED|ITZ111451||0||
48139088|NCT00920426|100665519|FG002|NOT COMPLETED|ITZ111451||0||
48139089|NCT00920426|100665520|FG003|NOT COMPLETED|ITZ111451||0||
48139090|NCT00920426|100665517|FG000|STARTED|ITZ112929: Randomized Regimen||0||
48139091|NCT00920426|100665518|FG001|STARTED|ITZ112929: Randomized Regimen||7||
48139092|NCT00920426|100665519|FG002|STARTED|ITZ112929: Randomized Regimen||2||
48588015|NCT04791319|101770542|FG004|COMPLETED|Placebo Controlled Period (Week 0-15)||0||
48588016|NCT04791319|101770543|FG005|COMPLETED|Placebo Controlled Period (Week 0-15)||0||
48588017|NCT04791319|101770544|FG006|COMPLETED|Placebo Controlled Period (Week 0-15)||0||
48706929|NCT02981407|102069831|FG001|STARTED|Overall Study||1749||
48139093|NCT00920426|100665520|FG003|STARTED|ITZ112929: Randomized Regimen||0||
48139094|NCT00920426|100665517|FG000|COMPLETED|ITZ112929: Randomized Regimen||0||
48139095|NCT00920426|100665518|FG001|COMPLETED|ITZ112929: Randomized Regimen||7||
48139096|NCT00920426|100665519|FG002|COMPLETED|ITZ112929: Randomized Regimen||2||
48139097|NCT00920426|100665520|FG003|COMPLETED|ITZ112929: Randomized Regimen||0||
48139098|NCT00920426|100665517|FG000|NOT COMPLETED|ITZ112929: Randomized Regimen||0||
48139099|NCT00920426|100665518|FG001|NOT COMPLETED|ITZ112929: Randomized Regimen||0||
48139100|NCT00920426|100665519|FG002|NOT COMPLETED|ITZ112929: Randomized Regimen||0||
48139101|NCT00920426|100665520|FG003|NOT COMPLETED|ITZ112929: Randomized Regimen||0||
48139102|NCT00920426|100665517|FG000|STARTED|ITZ112929: Optimized Therapy (OT)||0||
48139103|NCT00920426|100665518|FG001|STARTED|ITZ112929: Optimized Therapy (OT)||0||
48139104|NCT00920426|100665519|FG002|STARTED|ITZ112929: Optimized Therapy (OT)||0||
48139105|NCT00920426|100665520|FG003|STARTED|ITZ112929: Optimized Therapy (OT)||8||
48139106|NCT00920426|100665517|FG000|COMPLETED|ITZ112929: Optimized Therapy (OT)||0||
48139107|NCT00920426|100665518|FG001|COMPLETED|ITZ112929: Optimized Therapy (OT)||0||
48139108|NCT00920426|100665519|FG002|COMPLETED|ITZ112929: Optimized Therapy (OT)||0||
48139109|NCT00920426|100665520|FG003|COMPLETED|ITZ112929: Optimized Therapy (OT)||8||
48139110|NCT00920426|100665517|FG000|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0||
48139111|NCT00920426|100665518|FG001|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0||
48139112|NCT00920426|100665519|FG002|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0||
48139113|NCT00920426|100665520|FG003|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0||
48139114|NCT02534909|100665521|FG000|STARTED|Treatment Period 1 to 3 (up to Week 312)||10|All enrolled patients were included in the Safety and Pharmacokinetic (PK) analysis sets|
48139115|NCT02534909|100665521|FG000|COMPLETED|Treatment Period 1 to 3 (up to Week 312)||9||
48139116|NCT02534909|100665521|FG000|NOT COMPLETED|Treatment Period 1 to 3 (up to Week 312)||1||
48139117|NCT02534909|100665521|FG000|STARTED|Treatment Period 4 (20 Weeks)||9||
48139118|NCT02534909|100665521|FG000|COMPLETED|Treatment Period 4 (20 Weeks)||9||
48139119|NCT02534909|100665521|FG000|NOT COMPLETED|Treatment Period 4 (20 Weeks)||0||
48139120|NCT00233493|100665522|FG000|STARTED|Overall Study||32||32
48139121|NCT00233493|100665523|FG001|STARTED|Overall Study||18||18
48139122|NCT00233493|100665522|FG000|COMPLETED|Overall Study||32||32
48139123|NCT00233493|100665523|FG001|COMPLETED|Overall Study||18||18
48139124|NCT00233493|100665522|FG000|NOT COMPLETED|Overall Study||0||0
48139125|NCT00233493|100665523|FG001|NOT COMPLETED|Overall Study||0||0
48402160|NCT01105936|101317596|FG001|COMPLETED|Wash-out Period 1||8||
48402161|NCT01105936|101317597|FG002|COMPLETED|Wash-out Period 1||7||
48402162|NCT01105936|101317598|FG003|COMPLETED|Wash-out Period 1||7||
48402163|NCT01105936|101317595|FG000|NOT COMPLETED|Wash-out Period 1||0||
48402164|NCT01105936|101317596|FG001|NOT COMPLETED|Wash-out Period 1||0||
48402165|NCT01105936|101317597|FG002|NOT COMPLETED|Wash-out Period 1||0||
48402166|NCT01105936|101317598|FG003|NOT COMPLETED|Wash-out Period 1||0||
48588018|NCT04791319|101770545|FG007|COMPLETED|Placebo Controlled Period (Week 0-15)||0||
48588019|NCT04791319|101770546|FG008|COMPLETED|Placebo Controlled Period (Week 0-15)||0||
48706930|NCT02981407|102069830|FG000|Data at 30 Days Post Randomization|Overall Study||1755||
48139126|NCT01380327|100665524|FG000|STARTED|Overall Study||30||
48139127|NCT01380327|100665525|FG001|STARTED|Overall Study||31||
48139128|NCT01380327|100665526|FG002|STARTED|Overall Study||28||
48139129|NCT01380327|100665524|FG000|COMPLETED|Overall Study||27||
48139130|NCT01380327|100665525|FG001|COMPLETED|Overall Study||28||
48139131|NCT01380327|100665526|FG002|COMPLETED|Overall Study||21||
48402167|NCT01105936|101317595|FG000|STARTED|Period 2||8||
48402168|NCT01105936|101317596|FG001|STARTED|Period 2||8||
48402169|NCT01105936|101317597|FG002|STARTED|Period 2||7||
48402170|NCT01105936|101317598|FG003|STARTED|Period 2||7||
48402171|NCT01105936|101317595|FG000|COMPLETED|Period 2||7||
48402172|NCT01105936|101317596|FG001|COMPLETED|Period 2||8||
48402173|NCT01105936|101317597|FG002|COMPLETED|Period 2||7||
48402174|NCT01105936|101317598|FG003|COMPLETED|Period 2||7||
48402175|NCT01105936|101317595|FG000|NOT COMPLETED|Period 2||1||
48402176|NCT01105936|101317596|FG001|NOT COMPLETED|Period 2||0||
48588020|NCT04791319|101770547|FG009|COMPLETED|Placebo Controlled Period (Week 0-15)||0||
48588021|NCT04791319|101770548|FG010|COMPLETED|Placebo Controlled Period (Week 0-15)||0||
48588022|NCT04791319|101770538|FG000|NOT COMPLETED|Placebo Controlled Period (Week 0-15)||14||
48588023|NCT04791319|101770539|FG001|NOT COMPLETED|Placebo Controlled Period (Week 0-15)||12||
48588024|NCT04791319|101770540|FG002|NOT COMPLETED|Placebo Controlled Period (Week 0-15)||37||
48402177|NCT01105936|101317597|FG002|NOT COMPLETED|Period 2||0||
48402178|NCT01105936|101317598|FG003|NOT COMPLETED|Period 2||0||
48402179|NCT01105936|101317595|FG000|STARTED|Wash-out Period 2||7||
48588025|NCT04791319|101770541|FG003|NOT COMPLETED|Placebo Controlled Period (Week 0-15)||28||
48588026|NCT04791319|101770542|FG004|NOT COMPLETED|Placebo Controlled Period (Week 0-15)||0||
48588027|NCT04791319|101770543|FG005|NOT COMPLETED|Placebo Controlled Period (Week 0-15)||0||
48588028|NCT04791319|101770544|FG006|NOT COMPLETED|Placebo Controlled Period (Week 0-15)||0||
48588029|NCT04791319|101770545|FG007|NOT COMPLETED|Placebo Controlled Period (Week 0-15)||0||
48588030|NCT04791319|101770546|FG008|NOT COMPLETED|Placebo Controlled Period (Week 0-15)||0||
48588031|NCT04791319|101770547|FG009|NOT COMPLETED|Placebo Controlled Period (Week 0-15)||0||
48588032|NCT04791319|101770548|FG010|NOT COMPLETED|Placebo Controlled Period (Week 0-15)||0||
48588033|NCT04791319|101770538|FG000|STARTED|Active Treatment Period (Week 16-31)||0||
48588034|NCT04791319|101770539|FG001|STARTED|Active Treatment Period (Week 16-31)||0||
48588035|NCT04791319|101770540|FG002|STARTED|Active Treatment Period (Week 16-31)||0||
48588036|NCT04791319|101770541|FG003|STARTED|Active Treatment Period (Week 16-31)||0||
48588037|NCT04791319|101770542|FG004|STARTED|Active Treatment Period (Week 16-31)||19||
48588038|NCT04791319|101770543|FG005|STARTED|Active Treatment Period (Week 16-31)||21||
48588039|NCT04791319|101770544|FG006|STARTED|Active Treatment Period (Week 16-31)||22||
48588040|NCT04791319|101770545|FG007|STARTED|Active Treatment Period (Week 16-31)||3||
48588041|NCT04791319|101770546|FG008|STARTED|Active Treatment Period (Week 16-31)||5||
48588042|NCT04791319|101770547|FG009|STARTED|Active Treatment Period (Week 16-31)||27||
48588043|NCT04791319|101770548|FG010|STARTED|Active Treatment Period (Week 16-31)||11||
48588044|NCT04791319|101770538|FG000|COMPLETED|Active Treatment Period (Week 16-31)||0||
48588045|NCT04791319|101770539|FG001|COMPLETED|Active Treatment Period (Week 16-31)||0||
48588046|NCT04791319|101770540|FG002|COMPLETED|Active Treatment Period (Week 16-31)||0||
48588047|NCT04791319|101770541|FG003|COMPLETED|Active Treatment Period (Week 16-31)||0||
48588048|NCT04791319|101770542|FG004|COMPLETED|Active Treatment Period (Week 16-31)||1||
48402180|NCT01105936|101317596|FG001|STARTED|Wash-out Period 2||8||
48402181|NCT01105936|101317597|FG002|STARTED|Wash-out Period 2||7||
48588049|NCT04791319|101770543|FG005|COMPLETED|Active Treatment Period (Week 16-31)||6||
48588050|NCT04791319|101770544|FG006|COMPLETED|Active Treatment Period (Week 16-31)||3||
48588051|NCT04791319|101770545|FG007|COMPLETED|Active Treatment Period (Week 16-31)||1||
48588052|NCT04791319|101770546|FG008|COMPLETED|Active Treatment Period (Week 16-31)||1||
48588053|NCT04791319|101770547|FG009|COMPLETED|Active Treatment Period (Week 16-31)||6||
48588054|NCT04791319|101770548|FG010|COMPLETED|Active Treatment Period (Week 16-31)||2||
48588055|NCT04791319|101770538|FG000|NOT COMPLETED|Active Treatment Period (Week 16-31)||0||
48588056|NCT04791319|101770539|FG001|NOT COMPLETED|Active Treatment Period (Week 16-31)||0||
48588057|NCT04791319|101770540|FG002|NOT COMPLETED|Active Treatment Period (Week 16-31)||0||
48588058|NCT04791319|101770541|FG003|NOT COMPLETED|Active Treatment Period (Week 16-31)||0||
48588059|NCT04791319|101770542|FG004|NOT COMPLETED|Active Treatment Period (Week 16-31)||18||
48588060|NCT04791319|101770543|FG005|NOT COMPLETED|Active Treatment Period (Week 16-31)||15||
48588061|NCT04791319|101770544|FG006|NOT COMPLETED|Active Treatment Period (Week 16-31)||19||
48588062|NCT04791319|101770545|FG007|NOT COMPLETED|Active Treatment Period (Week 16-31)||2||
48588063|NCT04791319|101770546|FG008|NOT COMPLETED|Active Treatment Period (Week 16-31)||4||
48588064|NCT04791319|101770547|FG009|NOT COMPLETED|Active Treatment Period (Week 16-31)||21||
48588065|NCT04791319|101770548|FG010|NOT COMPLETED|Active Treatment Period (Week 16-31)||9||
48588066|NCT04143594|101770549|FG000|STARTED|Overall Study||52||
48588067|NCT04143594|101770550|FG001|STARTED|Overall Study||53||
48588068|NCT04143594|101770551|FG002|STARTED|Overall Study||52||
48588069|NCT04143594|101770552|FG003|STARTED|Overall Study||26||
48588070|NCT04143594|101770549|FG000|COMPLETED|Overall Study||41||
48588071|NCT04143594|101770550|FG001|COMPLETED|Overall Study||35||
48588072|NCT04143594|101770551|FG002|COMPLETED|Overall Study||36||
48588073|NCT04143594|101770552|FG003|COMPLETED|Overall Study||24||
48588074|NCT04143594|101770549|FG000|NOT COMPLETED|Overall Study||11||
48588075|NCT04143594|101770550|FG001|NOT COMPLETED|Overall Study||18||
48588076|NCT04143594|101770551|FG002|NOT COMPLETED|Overall Study||16||
48588077|NCT04143594|101770552|FG003|NOT COMPLETED|Overall Study||2||
48588078|NCT00387751|101770553|FG000|STARTED|Overall Study||14||
48402182|NCT01105936|101317598|FG003|STARTED|Wash-out Period 2||7||
48588079|NCT00387751|101770553|FG000|COMPLETED|Overall Study||14||
48588080|NCT00387751|101770553|FG000|NOT COMPLETED|Overall Study||0||
48588081|NCT02520427|101770554|FG000|STARTED|Overall Study||1||
48588082|NCT02520427|101770555|FG001|STARTED|Overall Study||1||
48588083|NCT02520427|101770556|FG002|STARTED|Overall Study||3||
48588084|NCT02520427|101770557|FG003|STARTED|Overall Study||3||
48588085|NCT02520427|101770558|FG004|STARTED|Overall Study||3||
48588086|NCT02520427|101770559|FG005|STARTED|Overall Study||3||
48588087|NCT02520427|101770560|FG006|STARTED|Overall Study||4||
48588088|NCT02520427|101770561|FG007|STARTED|Overall Study||4||
48588089|NCT02520427|101770562|FG008|STARTED|Overall Study||4||
48588090|NCT02520427|101770563|FG009|STARTED|Overall Study||3||
48588091|NCT02520427|101770564|FG010|STARTED|Overall Study||4||
48588092|NCT02520427|101770565|FG011|STARTED|Overall Study||7||
48588093|NCT02520427|101770566|FG012|STARTED|Overall Study||3||
48588094|NCT02520427|101770567|FG013|STARTED|Overall Study||3||
48588095|NCT02520427|101770568|FG014|STARTED|Overall Study||6||
48402183|NCT01105936|101317595|FG000|COMPLETED|Wash-out Period 2||7||
48402184|NCT01105936|101317596|FG001|COMPLETED|Wash-out Period 2||8||
48402185|NCT01105936|101317597|FG002|COMPLETED|Wash-out Period 2||7||
48402186|NCT01105936|101317598|FG003|COMPLETED|Wash-out Period 2||7||
48402187|NCT01105936|101317595|FG000|NOT COMPLETED|Wash-out Period 2||0||
48402188|NCT01105936|101317596|FG001|NOT COMPLETED|Wash-out Period 2||0||
48402189|NCT01105936|101317597|FG002|NOT COMPLETED|Wash-out Period 2||0||
48402190|NCT01105936|101317598|FG003|NOT COMPLETED|Wash-out Period 2||0||
48402191|NCT01105936|101317595|FG000|STARTED|Period 3||7||
48402192|NCT01105936|101317596|FG001|STARTED|Period 3||8||
48402193|NCT01105936|101317597|FG002|STARTED|Period 3||7||
48402194|NCT01105936|101317598|FG003|STARTED|Period 3||7||
48402195|NCT01105936|101317595|FG000|COMPLETED|Period 3||7||
48402196|NCT01105936|101317596|FG001|COMPLETED|Period 3||6||
48402197|NCT01105936|101317597|FG002|COMPLETED|Period 3||7||
48402198|NCT01105936|101317598|FG003|COMPLETED|Period 3||7||
48588096|NCT02520427|101770569|FG015|STARTED|Overall Study||3||
48588097|NCT02520427|101770570|FG016|STARTED|Overall Study||5||
48588098|NCT02520427|101770571|FG017|STARTED|Overall Study||4||
48588099|NCT02520427|101770572|FG018|STARTED|Overall Study||5||
48588100|NCT02520427|101770573|FG019|STARTED|Overall Study||8||
48588101|NCT02520427|101770574|FG020|STARTED|Overall Study||4||
48588102|NCT02520427|101770575|FG021|STARTED|Overall Study||2||
48588103|NCT02520427|101770576|FG022|STARTED|Overall Study||4||
48588104|NCT02520427|101770577|FG023|STARTED|Overall Study||3||
48588105|NCT02520427|101770578|FG024|STARTED|Overall Study||4||
48588106|NCT02520427|101770579|FG025|STARTED|Overall Study||1||
48588107|NCT02520427|101770554|FG000|COMPLETED|Overall Study||0||
48588108|NCT02520427|101770555|FG001|COMPLETED|Overall Study||1||
48588109|NCT02520427|101770556|FG002|COMPLETED|Overall Study||2||
48588110|NCT02520427|101770557|FG003|COMPLETED|Overall Study||3||
48588111|NCT02520427|101770558|FG004|COMPLETED|Overall Study||3||
48588112|NCT02520427|101770559|FG005|COMPLETED|Overall Study||3||
48706931|NCT02981407|102069831|FG001|Data at 30 Days Post Randomization|Overall Study||1749||
48706932|NCT02981407|102069830|FG000|COMPLETED|Overall Study||1755||
48706933|NCT02981407|102069831|FG001|COMPLETED|Overall Study||1749||
48706934|NCT02981407|102069830|FG000|NOT COMPLETED|Overall Study||2||
48706935|NCT02981407|102069831|FG001|NOT COMPLETED|Overall Study||0||
48706936|NCT00223977|102069832|FG000|STARTED|Overall Study||46||
48706937|NCT00223977|102069833|FG001|STARTED|Overall Study||58||
48706938|NCT00223977|102069834|FG002|STARTED|Overall Study||42||
48706939|NCT00223977|102069832|FG000|COMPLETED|Overall Study||37||
48706940|NCT00223977|102069833|FG001|COMPLETED|Overall Study||47||
48706941|NCT00223977|102069834|FG002|COMPLETED|Overall Study||39||
48706942|NCT00223977|102069832|FG000|NOT COMPLETED|Overall Study||9||
48706943|NCT00223977|102069833|FG001|NOT COMPLETED|Overall Study||11||
48706944|NCT00223977|102069834|FG002|NOT COMPLETED|Overall Study||3||
48706945|NCT02563860|102069835|FG000|STARTED|Overall Study||20||
48706946|NCT02563860|102069835|FG000|COMPLETED|Overall Study||19||
48706947|NCT02563860|102069835|FG000|NOT COMPLETED|Overall Study||1||
48706948|NCT00744978|102069836|FG000|STARTED|Period 1||32||
48706949|NCT00744978|102069837|FG001|STARTED|Period 1||34||
48402199|NCT01105936|101317595|FG000|NOT COMPLETED|Period 3||0||
48402200|NCT01105936|101317596|FG001|NOT COMPLETED|Period 3||2||
48402201|NCT01105936|101317597|FG002|NOT COMPLETED|Period 3||0||
48402202|NCT01105936|101317598|FG003|NOT COMPLETED|Period 3||0||
48402203|NCT03997760|101317599|FG000|STARTED|Overall Study||5||
48402204|NCT03997760|101317600|FG001|STARTED|Overall Study||4||
48402205|NCT03997760|101317601|FG002|STARTED|Overall Study||6||
48402206|NCT03997760|101317602|FG003|STARTED|Overall Study||4||
48402207|NCT03997760|101317599|FG000|COMPLETED|Overall Study||5||
48402208|NCT03997760|101317600|FG001|COMPLETED|Overall Study||3||
48402209|NCT03997760|101317601|FG002|COMPLETED|Overall Study||6||
48402210|NCT03997760|101317602|FG003|COMPLETED|Overall Study||4||
48402211|NCT03997760|101317599|FG000|NOT COMPLETED|Overall Study||0||
48402212|NCT03997760|101317600|FG001|NOT COMPLETED|Overall Study||1||
48402213|NCT03997760|101317601|FG002|NOT COMPLETED|Overall Study||0||
48402214|NCT03997760|101317602|FG003|NOT COMPLETED|Overall Study||0||
48402215|NCT04914819|101317603|FG000|STARTED|Overall Study||40||
48588113|NCT02520427|101770560|FG006|COMPLETED|Overall Study||4||
48588114|NCT02520427|101770561|FG007|COMPLETED|Overall Study||4||
48402216|NCT04914819|101317604|FG001|STARTED|Overall Study||20||
48588115|NCT02520427|101770562|FG008|COMPLETED|Overall Study||3||
48588116|NCT02520427|101770563|FG009|COMPLETED|Overall Study||2||
48588117|NCT02520427|101770564|FG010|COMPLETED|Overall Study||4||
48588118|NCT02520427|101770565|FG011|COMPLETED|Overall Study||7||
48402217|NCT04914819|101317603|FG000|COMPLETED|Overall Study||26||
48402218|NCT04914819|101317604|FG001|COMPLETED|Overall Study||18||
48402219|NCT04914819|101317603|FG000|NOT COMPLETED|Overall Study||14||
48402220|NCT04914819|101317604|FG001|NOT COMPLETED|Overall Study||2||
48588119|NCT02520427|101770566|FG012|COMPLETED|Overall Study||2||
48706950|NCT00744978|102069836|FG000|Treated|Period 1||31||
48402221|NCT01783470|101317605|FG000|STARTED|Overall Study||6||
48402222|NCT01783470|101317606|FG001|STARTED|Overall Study||6||
48402223|NCT01783470|101317605|FG000|COMPLETED|Overall Study||6||
48588120|NCT02520427|101770567|FG013|COMPLETED|Overall Study||2||
48706951|NCT00744978|102069837|FG001|Treated|Period 1||33||
48706952|NCT00744978|102069836|FG000|COMPLETED|Period 1||26||
48706953|NCT00744978|102069837|FG001|COMPLETED|Period 1||29||
48706954|NCT00744978|102069836|FG000|NOT COMPLETED|Period 1||6||
48706955|NCT00744978|102069837|FG001|NOT COMPLETED|Period 1||5||
48706956|NCT00744978|102069836|FG000|STARTED|Placebo Washout||26||
48706957|NCT00744978|102069837|FG001|STARTED|Placebo Washout||29||
48706958|NCT00744978|102069836|FG000|COMPLETED|Placebo Washout||26||
48706959|NCT00744978|102069837|FG001|COMPLETED|Placebo Washout||29||
48706960|NCT00744978|102069836|FG000|NOT COMPLETED|Placebo Washout||0||
48706961|NCT00744978|102069837|FG001|NOT COMPLETED|Placebo Washout||0||
48706962|NCT00744978|102069836|FG000|STARTED|Period 2||26||
48706963|NCT00744978|102069837|FG001|STARTED|Period 2||29||
48706964|NCT00744978|102069836|FG000|COMPLETED|Period 2||26||
48706965|NCT00744978|102069837|FG001|COMPLETED|Period 2||28||
48706966|NCT00744978|102069836|FG000|NOT COMPLETED|Period 2||0||
48706967|NCT00744978|102069837|FG001|NOT COMPLETED|Period 2||1||
48706968|NCT01846663|102069838|FG000|STARTED|Overall Study||3||
48706969|NCT01846663|102069839|FG001|STARTED|Overall Study||3||
48706970|NCT01846663|102069838|FG000|COMPLETED|Overall Study||0||
48706971|NCT01846663|102069839|FG001|COMPLETED|Overall Study||1||
48706972|NCT01846663|102069838|FG000|NOT COMPLETED|Overall Study||3||
48706973|NCT01846663|102069839|FG001|NOT COMPLETED|Overall Study||2||
48706974|NCT03407053|102069840|FG000|STARTED|Overall Study||10||
48706975|NCT03407053|102069841|FG001|STARTED|Overall Study||10||
48706976|NCT03407053|102069840|FG000|COMPLETED|Overall Study||10||
48706977|NCT03407053|102069841|FG001|COMPLETED|Overall Study||10||
48706978|NCT03407053|102069840|FG000|NOT COMPLETED|Overall Study||0||
48706979|NCT03407053|102069841|FG001|NOT COMPLETED|Overall Study||0||
48706980|NCT01241344|102069842|FG000|STARTED|Overall Study||14||
48706981|NCT01241344|102069843|FG001|STARTED|Overall Study||16||
48706982|NCT01241344|102069844|FG002|STARTED|Overall Study||18||
48706983|NCT01241344|102069845|FG003|STARTED|Overall Study||4||
48706984|NCT01241344|102069842|FG000|Randomized to Open-label|Overall Study||3|The number of previously randomized subjects who were considered treatment failures were offered open-label BCV therapy.|
48706985|NCT01241344|102069843|FG001|Randomized to Open-label|Overall Study||4|The number of previously randomized subjects who were considered treatment failures were offered open-label BCV therapy.|
48706986|NCT01241344|102069844|FG002|Randomized to Open-label|Overall Study||5|The number of previously randomized subjects who were considered treatment failures were offered open-label BCV therapy.|
48706987|NCT01241344|102069845|FG003|Randomized to Open-label|Overall Study||0|The number of previously randomized subjects who were considered treatment failures were offered open-label BCV therapy.|
48706988|NCT01241344|102069842|FG000|COMPLETED|Overall Study||9||
48706989|NCT01241344|102069843|FG001|COMPLETED|Overall Study||7||
48706990|NCT01241344|102069844|FG002|COMPLETED|Overall Study||9||
48706991|NCT01241344|102069845|FG003|COMPLETED|Overall Study||2||
48706992|NCT01241344|102069842|FG000|NOT COMPLETED|Overall Study||5||
48706993|NCT01241344|102069843|FG001|NOT COMPLETED|Overall Study||9||
48706994|NCT01241344|102069844|FG002|NOT COMPLETED|Overall Study||9||
48706995|NCT01241344|102069845|FG003|NOT COMPLETED|Overall Study||2||
48706996|NCT03920293|102069846|FG000|STARTED|Randomized-Controlled Period||86||
48706997|NCT03920293|102069847|FG001|STARTED|Randomized-Controlled Period||89||
48706998|NCT03920293|102069846|FG000|Received at Least 1 Dose of Study Drug|Randomized-Controlled Period||86||
48706999|NCT03920293|102069847|FG001|Received at Least 1 Dose of Study Drug|Randomized-Controlled Period||89||
48707000|NCT03920293|102069846|FG000|COMPLETED|Randomized-Controlled Period||79||
48707001|NCT03920293|102069847|FG001|COMPLETED|Randomized-Controlled Period||83||
48707002|NCT03920293|102069846|FG000|NOT COMPLETED|Randomized-Controlled Period||7||
48707003|NCT03920293|102069847|FG001|NOT COMPLETED|Randomized-Controlled Period||6||
48707004|NCT03920293|102069846|FG000|STARTED|Open- Label Extension Period||78||
48707005|NCT03920293|102069847|FG001|STARTED|Open- Label Extension Period||83||
48707006|NCT03920293|102069846|FG000|COMPLETED|Open- Label Extension Period||60||
48707007|NCT03920293|102069847|FG001|COMPLETED|Open- Label Extension Period||63||
48707008|NCT03920293|102069846|FG000|NOT COMPLETED|Open- Label Extension Period||18||
48707009|NCT03920293|102069847|FG001|NOT COMPLETED|Open- Label Extension Period||20||
48707010|NCT00837824|102069848|FG000|STARTED|Overall Study||11||
48707011|NCT00837824|102069849|FG001|STARTED|Overall Study||9||
48707012|NCT00837824|102069848|FG000|COMPLETED|Overall Study||11||
48707013|NCT00837824|102069849|FG001|COMPLETED|Overall Study||9||
48707014|NCT00837824|102069848|FG000|NOT COMPLETED|Overall Study||0||
48707015|NCT00837824|102069849|FG001|NOT COMPLETED|Overall Study||0||
48707016|NCT03960580|102069850|FG000|STARTED|Overall Study||75||
48707017|NCT03960580|102069851|FG001|STARTED|Overall Study||74||
48707018|NCT03960580|102069852|FG002|STARTED|Overall Study||74||
48707019|NCT03960580|102069850|FG000|COMPLETED|Overall Study||69||
48707020|NCT03960580|102069851|FG001|COMPLETED|Overall Study||70||
48707021|NCT03960580|102069852|FG002|COMPLETED|Overall Study||71||
48707022|NCT03960580|102069850|FG000|NOT COMPLETED|Overall Study||6||
48707023|NCT03960580|102069851|FG001|NOT COMPLETED|Overall Study||4||
48707024|NCT03960580|102069852|FG002|NOT COMPLETED|Overall Study||3||
48707025|NCT02456636|102069853|FG000|STARTED|Overall Study||478||
48707026|NCT02456636|102069854|FG001|STARTED|Overall Study||479||
48707027|NCT02456636|102069855|FG002|STARTED|Overall Study||475||
48707028|NCT02456636|102069853|FG000|6 Month|Overall Study||474||
48707029|NCT02456636|102069854|FG001|6 Month|Overall Study||474||
48707030|NCT02456636|102069855|FG002|6 Month|Overall Study||468||
48707031|NCT02456636|102069853|FG000|18 Month|Overall Study||467||
48707032|NCT02456636|102069854|FG001|18 Month|Overall Study||463||
48707033|NCT02456636|102069855|FG002|18 Month|Overall Study||461||
48707034|NCT02456636|102069853|FG000|COMPLETED|Overall Study||410||
48707035|NCT02456636|102069854|FG001|COMPLETED|Overall Study||410||
48707036|NCT02456636|102069855|FG002|COMPLETED|Overall Study||400||
48707037|NCT02456636|102069853|FG000|NOT COMPLETED|Overall Study||68||
48707038|NCT02456636|102069854|FG001|NOT COMPLETED|Overall Study||69||
48707039|NCT02456636|102069855|FG002|NOT COMPLETED|Overall Study||75||
48707040|NCT00834990|102069856|FG000|STARTED|First Intervention||12||
48707041|NCT00834990|102069857|FG001|STARTED|First Intervention||11||
48707042|NCT00834990|102069856|FG000|COMPLETED|First Intervention||12||
48290707|NCT00427895|101037633|FG002|NOT COMPLETED|Vax 1/Year 1 Follow-up||19||
48290708|NCT00427895|101037634|FG003|NOT COMPLETED|Vax 1/Year 1 Follow-up||33||
48290709|NCT00427895|101037635|FG004|NOT COMPLETED|Vax 1/Year 1 Follow-up||0||
48290710|NCT00427895|101037636|FG005|NOT COMPLETED|Vax 1/Year 1 Follow-up||0||
48290711|NCT00427895|101037637|FG006|NOT COMPLETED|Vax 1/Year 1 Follow-up||0||
48290712|NCT00427895|101037638|FG007|NOT COMPLETED|Vax 1/Year 1 Follow-up||0||
48290713|NCT00427895|101037631|FG000|STARTED|Between Year 1 - Vax 2/Year 3 to 4||404||
48402224|NCT01783470|101317606|FG001|COMPLETED|Overall Study||6||
48402225|NCT01783470|101317605|FG000|NOT COMPLETED|Overall Study||0||
48402226|NCT01783470|101317606|FG001|NOT COMPLETED|Overall Study||0||
48402227|NCT01316380|101317607|FG000|STARTED|Overall Study||156||
48402228|NCT01316380|101317608|FG001|STARTED|Overall Study||154||
48402229|NCT01316380|101317609|FG002|STARTED|Overall Study||155||
48402230|NCT01316380|101317607|FG000|COMPLETED|Overall Study||154||
48402231|NCT01316380|101317608|FG001|COMPLETED|Overall Study||149||
48402232|NCT01316380|101317609|FG002|COMPLETED|Overall Study||152||
48402233|NCT01316380|101317607|FG000|NOT COMPLETED|Overall Study||2||
48588121|NCT02520427|101770568|FG014|COMPLETED|Overall Study||5||
48588122|NCT02520427|101770569|FG015|COMPLETED|Overall Study||3||
48588123|NCT02520427|101770570|FG016|COMPLETED|Overall Study||2||
48588124|NCT02520427|101770571|FG017|COMPLETED|Overall Study||3||
48588125|NCT02520427|101770572|FG018|COMPLETED|Overall Study||2||
48588126|NCT02520427|101770573|FG019|COMPLETED|Overall Study||3||
48588127|NCT02520427|101770574|FG020|COMPLETED|Overall Study||2||
48588128|NCT02520427|101770575|FG021|COMPLETED|Overall Study||2||
48707043|NCT00834990|102069857|FG001|COMPLETED|First Intervention||11||
48707044|NCT00834990|102069856|FG000|NOT COMPLETED|First Intervention||0||
48707045|NCT00834990|102069857|FG001|NOT COMPLETED|First Intervention||0||
48707046|NCT00834990|102069856|FG000|STARTED|Washout of 7 Days||12||
48707047|NCT00834990|102069857|FG001|STARTED|Washout of 7 Days||11||
48707048|NCT00834990|102069856|FG000|COMPLETED|Washout of 7 Days||12||
48707049|NCT00834990|102069857|FG001|COMPLETED|Washout of 7 Days||11||
48707050|NCT00834990|102069856|FG000|NOT COMPLETED|Washout of 7 Days||0||
48707051|NCT00834990|102069857|FG001|NOT COMPLETED|Washout of 7 Days||0||
48707052|NCT00834990|102069856|FG000|STARTED|Second Intervention||12||
48707053|NCT00834990|102069857|FG001|STARTED|Second Intervention||11||
48707054|NCT00834990|102069856|FG000|COMPLETED|Second Intervention||12||
48707055|NCT00834990|102069857|FG001|COMPLETED|Second Intervention||11||
48707056|NCT00834990|102069856|FG000|NOT COMPLETED|Second Intervention||0||
48290714|NCT00427895|101037632|FG001|STARTED|Between Year 1 - Vax 2/Year 3 to 4||396||
48290715|NCT00427895|101037633|FG002|STARTED|Between Year 1 - Vax 2/Year 3 to 4||373||
48290716|NCT00427895|101037634|FG003|STARTED|Between Year 1 - Vax 2/Year 3 to 4||469||
48402234|NCT01316380|101317608|FG001|NOT COMPLETED|Overall Study||5||
48402235|NCT01316380|101317609|FG002|NOT COMPLETED|Overall Study||3||
48402236|NCT00662389|101317610|FG000|STARTED|Overall Study||4||
48588129|NCT02520427|101770576|FG022|COMPLETED|Overall Study||3||
48588130|NCT02520427|101770577|FG023|COMPLETED|Overall Study||3||
48588131|NCT02520427|101770578|FG024|COMPLETED|Overall Study||3||
48588132|NCT02520427|101770579|FG025|COMPLETED|Overall Study||1||
48588133|NCT02520427|101770554|FG000|NOT COMPLETED|Overall Study||1||
48588134|NCT02520427|101770555|FG001|NOT COMPLETED|Overall Study||0||
48588135|NCT02520427|101770556|FG002|NOT COMPLETED|Overall Study||1||
48707057|NCT00834990|102069857|FG001|NOT COMPLETED|Second Intervention||0||
48707058|NCT02791191|102069858|FG000|STARTED|Overall Study||55||
48707059|NCT02791191|102069859|FG001|STARTED|Overall Study||128||
48707060|NCT02791191|102069860|FG002|STARTED|Overall Study||133||
48707061|NCT02791191|102069858|FG000|Received One Dose of Study Drug|Overall Study||55||
48707062|NCT02791191|102069859|FG001|Received One Dose of Study Drug|Overall Study||127||
48707063|NCT02791191|102069860|FG002|Received One Dose of Study Drug|Overall Study||133||
48707064|NCT02791191|102069858|FG000|COMPLETED|Overall Study||17||
48707065|NCT02791191|102069859|FG001|COMPLETED|Overall Study||17||
48707066|NCT02791191|102069860|FG002|COMPLETED|Overall Study||13||
48707067|NCT02791191|102069858|FG000|NOT COMPLETED|Overall Study||38||
48707068|NCT02791191|102069859|FG001|NOT COMPLETED|Overall Study||111||
48707069|NCT02791191|102069860|FG002|NOT COMPLETED|Overall Study||120||
48707070|NCT00760461|102069861|FG000|STARTED|Overall Study||44||
48707071|NCT00760461|102069861|FG000|COMPLETED|Overall Study||0||
48707072|NCT00760461|102069861|FG000|NOT COMPLETED|Overall Study||44||
48402237|NCT00662389|101317610|FG000|COMPLETED|Overall Study||4||
48402238|NCT00662389|101317610|FG000|NOT COMPLETED|Overall Study||0||
48402239|NCT01188460|101317611|FG000|STARTED|Overall Study||25||
48588136|NCT02520427|101770557|FG003|NOT COMPLETED|Overall Study||0||
48402240|NCT01188460|101317612|FG001|STARTED|Overall Study||23||
48402241|NCT01188460|101317611|FG000|COMPLETED|Overall Study||25||
48402242|NCT01188460|101317612|FG001|COMPLETED|Overall Study||23||
48402243|NCT01188460|101317611|FG000|NOT COMPLETED|Overall Study||0||
48588137|NCT02520427|101770558|FG004|NOT COMPLETED|Overall Study||0||
48588138|NCT02520427|101770559|FG005|NOT COMPLETED|Overall Study||0||
48588139|NCT02520427|101770560|FG006|NOT COMPLETED|Overall Study||0||
48588140|NCT02520427|101770561|FG007|NOT COMPLETED|Overall Study||0||
48588141|NCT02520427|101770562|FG008|NOT COMPLETED|Overall Study||1||
48588142|NCT02520427|101770563|FG009|NOT COMPLETED|Overall Study||1||
48588143|NCT02520427|101770564|FG010|NOT COMPLETED|Overall Study||0||
48139132|NCT01380327|100665524|FG000|NOT COMPLETED|Overall Study||3||
48139133|NCT01380327|100665525|FG001|NOT COMPLETED|Overall Study||3||
48588144|NCT02520427|101770565|FG011|NOT COMPLETED|Overall Study||0||
48588145|NCT02520427|101770566|FG012|NOT COMPLETED|Overall Study||1||
48588146|NCT02520427|101770567|FG013|NOT COMPLETED|Overall Study||1||
48588147|NCT02520427|101770568|FG014|NOT COMPLETED|Overall Study||1||
48588148|NCT02520427|101770569|FG015|NOT COMPLETED|Overall Study||0||
48588149|NCT02520427|101770570|FG016|NOT COMPLETED|Overall Study||3||
48588150|NCT02520427|101770571|FG017|NOT COMPLETED|Overall Study||1||
48588151|NCT02520427|101770572|FG018|NOT COMPLETED|Overall Study||3||
48588152|NCT02520427|101770573|FG019|NOT COMPLETED|Overall Study||5||
48588153|NCT02520427|101770574|FG020|NOT COMPLETED|Overall Study||2||
48139134|NCT01380327|100665526|FG002|NOT COMPLETED|Overall Study||7||
48139135|NCT04482647|100665527|FG000|STARTED|Overall Study||100||
48139136|NCT04482647|100665527|FG000|COMPLETED|Overall Study||88||
48588154|NCT02520427|101770575|FG021|NOT COMPLETED|Overall Study||0||
48588155|NCT02520427|101770576|FG022|NOT COMPLETED|Overall Study||1||
48588156|NCT02520427|101770577|FG023|NOT COMPLETED|Overall Study||0||
48588157|NCT02520427|101770578|FG024|NOT COMPLETED|Overall Study||1||
48588158|NCT02520427|101770579|FG025|NOT COMPLETED|Overall Study||0||
48588159|NCT03492398|101770580|FG000|STARTED|Overall Study||8||
48588160|NCT03492398|101770581|FG001|STARTED|Overall Study||6||
48588161|NCT03492398|101770582|FG002|STARTED|Overall Study||6||
48588162|NCT03492398|101770583|FG003|STARTED|Overall Study||6||
48588163|NCT03492398|101770584|FG004|STARTED|Overall Study||6||
48588164|NCT03492398|101770585|FG005|STARTED|Overall Study||6||
48588165|NCT03492398|101770586|FG006|STARTED|Overall Study||6||
48588166|NCT03492398|101770587|FG007|STARTED|Overall Study||6||
48588167|NCT03492398|101770588|FG008|STARTED|Overall Study||6||
48588168|NCT03492398|101770580|FG000|COMPLETED|Overall Study||8||
48588169|NCT03492398|101770581|FG001|COMPLETED|Overall Study||6||
48588170|NCT03492398|101770582|FG002|COMPLETED|Overall Study||6||
48588171|NCT03492398|101770583|FG003|COMPLETED|Overall Study||6||
48588172|NCT03492398|101770584|FG004|COMPLETED|Overall Study||6||
48139137|NCT04482647|100665527|FG000|NOT COMPLETED|Overall Study||12||
48588173|NCT03492398|101770585|FG005|COMPLETED|Overall Study||6||
48588174|NCT03492398|101770586|FG006|COMPLETED|Overall Study||5||
48588175|NCT03492398|101770587|FG007|COMPLETED|Overall Study||5||
48588176|NCT03492398|101770588|FG008|COMPLETED|Overall Study||6||
48402244|NCT01188460|101317612|FG001|NOT COMPLETED|Overall Study||0||
48402245|NCT03250624|101317613|FG000|STARTED|Overall Study||32||
48402246|NCT03250624|101317614|FG001|STARTED|Overall Study||31||
48402247|NCT03250624|101317613|FG000|COMPLETED|Overall Study||30||
48402248|NCT03250624|101317614|FG001|COMPLETED|Overall Study||24||
48402249|NCT03250624|101317613|FG000|NOT COMPLETED|Overall Study||2||
48402250|NCT03250624|101317614|FG001|NOT COMPLETED|Overall Study||7||
48402251|NCT01480232|101317615|FG000|STARTED|Overall Study||40||
48402252|NCT01480232|101317616|FG001|STARTED|Overall Study||41||
48402253|NCT01480232|101317617|FG002|STARTED|Overall Study||38||
48402254|NCT01480232|101317618|FG003|STARTED|Overall Study||41||
48402255|NCT01480232|101317615|FG000|COMPLETED|Overall Study||22||
48402256|NCT01480232|101317616|FG001|COMPLETED|Overall Study||19||
48402257|NCT01480232|101317617|FG002|COMPLETED|Overall Study||21||
48402258|NCT01480232|101317618|FG003|COMPLETED|Overall Study||22||
48402259|NCT01480232|101317615|FG000|NOT COMPLETED|Overall Study||18||
48402260|NCT01480232|101317616|FG001|NOT COMPLETED|Overall Study||22||
48402261|NCT01480232|101317617|FG002|NOT COMPLETED|Overall Study||17||
48402262|NCT01480232|101317618|FG003|NOT COMPLETED|Overall Study||19||
48402263|NCT00044655|101317619|FG000|STARTED|Overall Study||102||
48402264|NCT00044655|101317620|FG001|STARTED|Overall Study||117||
48402265|NCT00044655|101317619|FG000|COMPLETED|Overall Study||82||
48402266|NCT00044655|101317620|FG001|COMPLETED|Overall Study||79||
48402267|NCT00044655|101317619|FG000|NOT COMPLETED|Overall Study||20||
48402268|NCT00044655|101317620|FG001|NOT COMPLETED|Overall Study||38||
48402269|NCT02848313|101317621|FG000|STARTED|Overall Study||21||
48139138|NCT00414700|100665528|FG000|STARTED|Overall Study||57||
48139139|NCT00414700|100665529|FG001|STARTED|Overall Study||61||
48139140|NCT00414700|100665528|FG000|COMPLETED|Overall Study||51||
48139141|NCT00414700|100665529|FG001|COMPLETED|Overall Study||58||
48139142|NCT00414700|100665528|FG000|NOT COMPLETED|Overall Study||6||
48139143|NCT00414700|100665529|FG001|NOT COMPLETED|Overall Study||3||
48139144|NCT01650259|100665530|FG000|STARTED|Overall Study||2513||
48139145|NCT01650259|100665531|FG001|STARTED|Overall Study||2363||
48139146|NCT01650259|100665530|FG000|COMPLETED|Overall Study||1470||
48139147|NCT01650259|100665531|FG001|COMPLETED|Overall Study||2128||
48290717|NCT00427895|101037635|FG004|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0||
48290718|NCT00427895|101037636|FG005|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0||
48290719|NCT00427895|101037637|FG006|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0||
48290720|NCT00427895|101037638|FG007|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0||
48290721|NCT00427895|101037631|FG000|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||216||
48290722|NCT00427895|101037632|FG001|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||189||
48290723|NCT00427895|101037633|FG002|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||214||
48290724|NCT00427895|101037634|FG003|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0||
48290725|NCT00427895|101037635|FG004|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0||
48290726|NCT00427895|101037636|FG005|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0||
48290727|NCT00427895|101037637|FG006|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0||
48290728|NCT00427895|101037638|FG007|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0||
48290729|NCT00427895|101037631|FG000|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||188||
48402270|NCT02848313|101317622|FG001|STARTED|Overall Study||19||
48402271|NCT02848313|101317621|FG000|COMPLETED|Overall Study||18||
48402272|NCT02848313|101317622|FG001|COMPLETED|Overall Study||15||
48402273|NCT02848313|101317621|FG000|NOT COMPLETED|Overall Study||3||
48402274|NCT02848313|101317622|FG001|NOT COMPLETED|Overall Study||4||
48402275|NCT02578992|101317623|FG000|STARTED|Overall Study||65||
48402276|NCT02578992|101317624|FG001|STARTED|Overall Study||65||
48402277|NCT02578992|101317623|FG000|COMPLETED|Overall Study||62||
48402278|NCT02578992|101317624|FG001|COMPLETED|Overall Study||62||
48402279|NCT02578992|101317623|FG000|NOT COMPLETED|Overall Study||3||
48402280|NCT02578992|101317624|FG001|NOT COMPLETED|Overall Study||3||
48402281|NCT00611767|101317625|FG000|STARTED|Overall Study||49||
48402282|NCT00611767|101317626|FG001|STARTED|Overall Study||24||
48402283|NCT00611767|101317625|FG000|Thiopental Test Day|Overall Study||3||
48402284|NCT00611767|101317626|FG001|Thiopental Test Day|Overall Study||1||
48402285|NCT00611767|101317625|FG000|Placebo Test Day|Overall Study||6||
48402286|NCT00611767|101317626|FG001|Placebo Test Day|Overall Study||1||
48402287|NCT00611767|101317625|FG000|COMPLETED|Overall Study||40||
48402288|NCT00611767|101317626|FG001|COMPLETED|Overall Study||22||
48402289|NCT00611767|101317625|FG000|NOT COMPLETED|Overall Study||9||
48402290|NCT00611767|101317626|FG001|NOT COMPLETED|Overall Study||2||
48402291|NCT00262314|101317627|FG000|STARTED|Overall Study||509||
48402292|NCT00262314|101317627|FG000|COMPLETED|Overall Study||172||
48402293|NCT00262314|101317627|FG000|NOT COMPLETED|Overall Study||337||
48402294|NCT00224003|101317628|FG000|STARTED|Overall Study||23||
48402295|NCT00224003|101317628|FG000|COMPLETED|Overall Study||16||
48402296|NCT00224003|101317628|FG000|NOT COMPLETED|Overall Study||7||
48402297|NCT01119963|101317629|FG000|STARTED|Overall Study||74||
48402298|NCT01119963|101317630|FG001|STARTED|Overall Study||78||
48290730|NCT00427895|101037632|FG001|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||207||
48290731|NCT00427895|101037633|FG002|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||159||
48290732|NCT00427895|101037634|FG003|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||469||
48402299|NCT01119963|101317629|FG000|COMPLETED|Overall Study||73||
48402300|NCT01119963|101317630|FG001|COMPLETED|Overall Study||77||
48290733|NCT00427895|101037635|FG004|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0||
48290734|NCT00427895|101037636|FG005|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0||
48290735|NCT00427895|101037637|FG006|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0||
48290736|NCT00427895|101037638|FG007|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0||
48290737|NCT04097301|101037639|FG000|STARTED|Overall Study||8||
48290738|NCT04097301|101037639|FG000|Treated Patients|Overall Study||2||
48402301|NCT01119963|101317629|FG000|NOT COMPLETED|Overall Study||1||
48402302|NCT01119963|101317630|FG001|NOT COMPLETED|Overall Study||1||
48402303|NCT03682055|101317631|FG000|STARTED|Overall Study||1||
48402304|NCT03682055|101317632|FG001|STARTED|Overall Study||2||
48402305|NCT03682055|101317633|FG002|STARTED|Overall Study||1||
48402306|NCT03682055|101317634|FG003|STARTED|Overall Study||2||
48402307|NCT03682055|101317635|FG004|STARTED|Overall Study||1||
48402308|NCT03682055|101317636|FG005|STARTED|Overall Study||7||
48402309|NCT03682055|101317631|FG000|COMPLETED|Overall Study||0||
48402310|NCT03682055|101317632|FG001|COMPLETED|Overall Study||0||
48402311|NCT03682055|101317633|FG002|COMPLETED|Overall Study||0||
48402312|NCT03682055|101317634|FG003|COMPLETED|Overall Study||0||
48402313|NCT03682055|101317635|FG004|COMPLETED|Overall Study||0||
48402314|NCT03682055|101317636|FG005|COMPLETED|Overall Study||0||
48402315|NCT03682055|101317631|FG000|NOT COMPLETED|Overall Study||1||
48402316|NCT03682055|101317632|FG001|NOT COMPLETED|Overall Study||2||
48402317|NCT03682055|101317633|FG002|NOT COMPLETED|Overall Study||1||
48402318|NCT03682055|101317634|FG003|NOT COMPLETED|Overall Study||2||
48402319|NCT03682055|101317635|FG004|NOT COMPLETED|Overall Study||1||
48402320|NCT03682055|101317636|FG005|NOT COMPLETED|Overall Study||7||
48402321|NCT02637804|101317637|FG000|STARTED|First Intervention (1 Week)||27||
48402322|NCT02637804|101317638|FG001|STARTED|First Intervention (1 Week)||28||
48402323|NCT02637804|101317639|FG002|STARTED|First Intervention (1 Week)||25||
48402324|NCT02637804|101317640|FG003|STARTED|First Intervention (1 Week)||26||
48402325|NCT02637804|101317637|FG000|COMPLETED|First Intervention (1 Week)||27||
48402326|NCT02637804|101317638|FG001|COMPLETED|First Intervention (1 Week)||28||
48402327|NCT02637804|101317639|FG002|COMPLETED|First Intervention (1 Week)||25||
48402328|NCT02637804|101317640|FG003|COMPLETED|First Intervention (1 Week)||26||
48402329|NCT02637804|101317637|FG000|NOT COMPLETED|First Intervention (1 Week)||0||
48402330|NCT02637804|101317638|FG001|NOT COMPLETED|First Intervention (1 Week)||0||
48402331|NCT02637804|101317639|FG002|NOT COMPLETED|First Intervention (1 Week)||0||
48588177|NCT03492398|101770580|FG000|NOT COMPLETED|Overall Study||0||
48588178|NCT03492398|101770581|FG001|NOT COMPLETED|Overall Study||0||
48588179|NCT03492398|101770582|FG002|NOT COMPLETED|Overall Study||0||
48588180|NCT03492398|101770583|FG003|NOT COMPLETED|Overall Study||0||
48588181|NCT03492398|101770584|FG004|NOT COMPLETED|Overall Study||0||
48588182|NCT03492398|101770585|FG005|NOT COMPLETED|Overall Study||0||
48588183|NCT03492398|101770586|FG006|NOT COMPLETED|Overall Study||1||
48707073|NCT01310400|102069862|FG000|STARTED|Overall Study||452||
48707074|NCT01310400|102069863|FG001|STARTED|Overall Study||452||
48707075|NCT01310400|102069864|FG002|STARTED|Overall Study||452||
48707076|NCT01310400|102069862|FG000|COMPLETED|Overall Study||424||
48707077|NCT01310400|102069863|FG001|COMPLETED|Overall Study||420||
48707078|NCT01310400|102069864|FG002|COMPLETED|Overall Study||422||
48402332|NCT02637804|101317640|FG003|NOT COMPLETED|First Intervention (1 Week)||0||
48588184|NCT03492398|101770587|FG007|NOT COMPLETED|Overall Study||1||
48707079|NCT01310400|102069862|FG000|NOT COMPLETED|Overall Study||28||
48707080|NCT01310400|102069863|FG001|NOT COMPLETED|Overall Study||32||
48402333|NCT02637804|101317637|FG000|STARTED|Second Intervention (1 Week)||27||
48402334|NCT02637804|101317638|FG001|STARTED|Second Intervention (1 Week)||28||
48402335|NCT02637804|101317639|FG002|STARTED|Second Intervention (1 Week)||25||
48402336|NCT02637804|101317640|FG003|STARTED|Second Intervention (1 Week)||26||
48402337|NCT02637804|101317637|FG000|COMPLETED|Second Intervention (1 Week)||27||
48402338|NCT02637804|101317638|FG001|COMPLETED|Second Intervention (1 Week)||28||
48402339|NCT02637804|101317639|FG002|COMPLETED|Second Intervention (1 Week)||25||
48402340|NCT02637804|101317640|FG003|COMPLETED|Second Intervention (1 Week)||26||
48402341|NCT02637804|101317637|FG000|NOT COMPLETED|Second Intervention (1 Week)||0||
48402342|NCT02637804|101317638|FG001|NOT COMPLETED|Second Intervention (1 Week)||0||
48588185|NCT03492398|101770588|FG008|NOT COMPLETED|Overall Study||0||
48588186|NCT00754520|101773437|FG000|STARTED|Overall Study||111||
48707081|NCT01310400|102069864|FG002|NOT COMPLETED|Overall Study||30||
48707082|NCT02813668|102069865|FG000|STARTED|Overall Study||2108||
48707083|NCT02813668|102069865|FG000|COMPLETED|Overall Study||1358||
48707084|NCT02813668|102069865|FG000|NOT COMPLETED|Overall Study||750||
48707085|NCT00945061|102069866|FG000|STARTED|Overall Study||12||
48402343|NCT02637804|101317639|FG002|NOT COMPLETED|Second Intervention (1 Week)||0||
48402344|NCT02637804|101317640|FG003|NOT COMPLETED|Second Intervention (1 Week)||0||
48402345|NCT04058158|101317641|FG000|STARTED|Period 1||25||
48402346|NCT04058158|101317642|FG001|STARTED|Period 1||25||
48402347|NCT04058158|101317641|FG000|COMPLETED|Period 1||23||
48402348|NCT04058158|101317642|FG001|COMPLETED|Period 1||23||
48402349|NCT04058158|101317641|FG000|NOT COMPLETED|Period 1||2||
48402350|NCT04058158|101317642|FG001|NOT COMPLETED|Period 1||2||
48290739|NCT04097301|101037639|FG000|COMPLETED|Overall Study||1||
48402351|NCT04058158|101317641|FG000|STARTED|Period 2||23||
48402352|NCT04058158|101317642|FG001|STARTED|Period 2||23||
48402353|NCT04058158|101317641|FG000|COMPLETED|Period 2||23||
48402354|NCT04058158|101317642|FG001|COMPLETED|Period 2||23||
48402355|NCT04058158|101317641|FG000|NOT COMPLETED|Period 2||0||
48402356|NCT04058158|101317642|FG001|NOT COMPLETED|Period 2||0||
48402357|NCT02829775|101317643|FG000|STARTED|Overall Study||9||
48290740|NCT04097301|101037639|FG000|NOT COMPLETED|Overall Study||7||
48290741|NCT02996565|101037640|FG000|STARTED|Overall Study||1648|Patients|9
48290742|NCT02996565|101037641|FG001|STARTED|Overall Study||1423|Patients|10
48290743|NCT02996565|101037640|FG000|Referred to Intended Provider for Hypertension Follow-up|Overall Study||1480|Intended provider: Medical Assistant for BP check (Best Practice) or MTM Pharmacist (Telehealth Care)|9
48290744|NCT02996565|101037641|FG001|Referred to Intended Provider for Hypertension Follow-up|Overall Study||1060|Intended provider: Medical Assistant for BP check (Best Practice) or MTM Pharmacist (Telehealth Care)|10
48290745|NCT02996565|101037640|FG000|Attended Follow-up Within 6 Weeks (With Any Provider Type)|Overall Study||890||9
48290746|NCT02996565|101037641|FG001|Attended Follow-up Within 6 Weeks (With Any Provider Type)|Overall Study||887||10
48290747|NCT02996565|101037640|FG000|Attended Follow-up Within 6 Weeks (With Intended Provider)|Overall Study||532|Intended provider: Medical Assistant for BP check (Best Practice) or MTM Pharmacist (Telehealth Care)|9
48290748|NCT02996565|101037641|FG001|Attended Follow-up Within 6 Weeks (With Intended Provider)|Overall Study||385|Intended provider: Medical Assistant for BP check (Best Practice) or MTM Pharmacist (Telehealth Care)|10
48290749|NCT02996565|101037640|FG000|COMPLETED|Overall Study||532|"Met per protocol definition for treatment adherence"|9
48290750|NCT02996565|101037641|FG001|COMPLETED|Overall Study||275|"Met per protocol definition for treatment adherence"|10
48290751|NCT02996565|101037640|FG000|NOT COMPLETED|Overall Study||1116||0
48290752|NCT02996565|101037641|FG001|NOT COMPLETED|Overall Study||1148||0
48290753|NCT01043393|101037642|FG000|STARTED|Overall Study||12||
48290754|NCT01043393|101037643|FG001|STARTED|Overall Study||12||
48290755|NCT01043393|101037642|FG000|COMPLETED|Overall Study||12||
48290756|NCT01043393|101037643|FG001|COMPLETED|Overall Study||12||
48402358|NCT02829775|101317643|FG000|COMPLETED|Overall Study||4||
48402359|NCT02829775|101317643|FG000|NOT COMPLETED|Overall Study||5||
48402360|NCT02021071|101317644|FG000|STARTED|Overall Study||12||
48290757|NCT01043393|101037642|FG000|NOT COMPLETED|Overall Study||0||
48290758|NCT01043393|101037643|FG001|NOT COMPLETED|Overall Study||0||
48290759|NCT03305731|101037644|FG000|STARTED|Overall Study||21|Baseline|
48290760|NCT03305731|101037644|FG000|Week 6|Overall Study||20||
48402361|NCT02021071|101317645|FG001|STARTED|Overall Study||12||
48402362|NCT02021071|101317644|FG000|COMPLETED|Overall Study||12||
48402363|NCT02021071|101317645|FG001|COMPLETED|Overall Study||12||
48402364|NCT02021071|101317644|FG000|NOT COMPLETED|Overall Study||0||
48588187|NCT00754520|101773438|FG001|STARTED|Overall Study||102||
48588188|NCT00754520|101773437|FG000|COMPLETED|Overall Study||56||
48588189|NCT00754520|101773438|FG001|COMPLETED|Overall Study||53||
48588190|NCT00754520|101773437|FG000|NOT COMPLETED|Overall Study||55||
48588191|NCT00754520|101773438|FG001|NOT COMPLETED|Overall Study||49||
48588192|NCT00727844|101773439|FG000|STARTED|Initial Randomization||21||
48588193|NCT00727844|101773440|FG001|STARTED|Initial Randomization||20||
48588194|NCT00727844|101773441|FG002|STARTED|Initial Randomization||0||
48588195|NCT00727844|101773442|FG003|STARTED|Initial Randomization||0||
48588196|NCT00727844|101773439|FG000|Included in MITT Analysis|Initial Randomization||19||
48588197|NCT00727844|101773440|FG001|Included in MITT Analysis|Initial Randomization||20||
48588198|NCT00727844|101773441|FG002|Included in MITT Analysis|Initial Randomization||0||
48588199|NCT00727844|101773442|FG003|Included in MITT Analysis|Initial Randomization||0||
48588200|NCT00727844|101773439|FG000|COMPLETED|Initial Randomization||19||
48588201|NCT00727844|101773440|FG001|COMPLETED|Initial Randomization||20||
48588202|NCT00727844|101773441|FG002|COMPLETED|Initial Randomization||0||
48588203|NCT00727844|101773442|FG003|COMPLETED|Initial Randomization||0||
48588204|NCT00727844|101773439|FG000|NOT COMPLETED|Initial Randomization||2||
48588205|NCT00727844|101773440|FG001|NOT COMPLETED|Initial Randomization||0||
48588206|NCT00727844|101773441|FG002|NOT COMPLETED|Initial Randomization||0||
48588207|NCT00727844|101773442|FG003|NOT COMPLETED|Initial Randomization||0||
48588208|NCT00727844|101773439|FG000|STARTED|Second Randomization||0||
48588209|NCT00727844|101773440|FG001|STARTED|Second Randomization||0||
48588210|NCT00727844|101773441|FG002|STARTED|Second Randomization||17||
48588211|NCT00727844|101773442|FG003|STARTED|Second Randomization||16||
48588212|NCT00727844|101773439|FG000|COMPLETED|Second Randomization||0||
48588213|NCT00727844|101773440|FG001|COMPLETED|Second Randomization||0||
48588214|NCT00727844|101773441|FG002|COMPLETED|Second Randomization||17||
48588215|NCT00727844|101773442|FG003|COMPLETED|Second Randomization||16||
48588216|NCT00727844|101773439|FG000|NOT COMPLETED|Second Randomization||0||
48588217|NCT00727844|101773440|FG001|NOT COMPLETED|Second Randomization||0||
48588218|NCT00727844|101773441|FG002|NOT COMPLETED|Second Randomization||0||
48588219|NCT00727844|101773442|FG003|NOT COMPLETED|Second Randomization||0||
48588220|NCT03309657|101773443|FG000|STARTED|Overall Study||10||
48588221|NCT03309657|101773443|FG000|COMPLETED|Overall Study||10||
48588222|NCT03309657|101773443|FG000|NOT COMPLETED|Overall Study||0||
48588223|NCT04521621|101773444|FG000|STARTED|Overall Study||22||
48588224|NCT04521621|101773445|FG001|STARTED|Overall Study||14||
48588225|NCT04521621|101773446|FG002|STARTED|Overall Study||17||
48588226|NCT04521621|101773447|FG003|STARTED|Overall Study||6||
48588227|NCT04521621|101773448|FG004|STARTED|Overall Study||3||
48588228|NCT04521621|101773449|FG005|STARTED|Overall Study||14||
48588229|NCT04521621|101773450|FG006|STARTED|Overall Study||0||
48588230|NCT04521621|101773451|FG007|STARTED|Overall Study||0||
48588231|NCT04521621|101773444|FG000|Treated|Overall Study||21||
48588232|NCT04521621|101773445|FG001|Treated|Overall Study||14||
48588233|NCT04521621|101773446|FG002|Treated|Overall Study||17||
48588234|NCT04521621|101773447|FG003|Treated|Overall Study||6||
48588235|NCT04521621|101773448|FG004|Treated|Overall Study||3||
48588236|NCT04521621|101773449|FG005|Treated|Overall Study||14||
48588237|NCT04521621|101773450|FG006|Treated|Overall Study||0||
48588238|NCT04521621|101773451|FG007|Treated|Overall Study||0||
48588239|NCT04521621|101773444|FG000|COMPLETED|Overall Study||0||
48588240|NCT04521621|101773445|FG001|COMPLETED|Overall Study||0||
48588241|NCT04521621|101773446|FG002|COMPLETED|Overall Study||0||
48588242|NCT04521621|101773447|FG003|COMPLETED|Overall Study||0||
48588243|NCT04521621|101773448|FG004|COMPLETED|Overall Study||0||
48588244|NCT04521621|101773449|FG005|COMPLETED|Overall Study||0||
48588245|NCT04521621|101773450|FG006|COMPLETED|Overall Study||0||
48588246|NCT04521621|101773451|FG007|COMPLETED|Overall Study||0||
48588247|NCT04521621|101773444|FG000|NOT COMPLETED|Overall Study||22||
48588248|NCT04521621|101773445|FG001|NOT COMPLETED|Overall Study||14||
48588249|NCT04521621|101773446|FG002|NOT COMPLETED|Overall Study||17||
48588250|NCT04521621|101773447|FG003|NOT COMPLETED|Overall Study||6||
48588251|NCT04521621|101773448|FG004|NOT COMPLETED|Overall Study||3||
48588252|NCT04521621|101773449|FG005|NOT COMPLETED|Overall Study||14||
48588253|NCT04521621|101773450|FG006|NOT COMPLETED|Overall Study||0||
48588254|NCT04521621|101773451|FG007|NOT COMPLETED|Overall Study||0||
48588255|NCT05178641|101773452|FG000|STARTED|First 3 Weeks of Study (Week 1-3)||16||
48588256|NCT05178641|101773453|FG001|STARTED|First 3 Weeks of Study (Week 1-3)||16||
48588257|NCT05178641|101773452|FG000|COMPLETED|First 3 Weeks of Study (Week 1-3)||12||
48588258|NCT05178641|101773453|FG001|COMPLETED|First 3 Weeks of Study (Week 1-3)||14||
48588259|NCT05178641|101773452|FG000|NOT COMPLETED|First 3 Weeks of Study (Week 1-3)||4||
48588260|NCT05178641|101773453|FG001|NOT COMPLETED|First 3 Weeks of Study (Week 1-3)||2||
48588261|NCT05178641|101773452|FG000|STARTED|Last 3 Weeks of Study (Week 3-6)||12||
48588262|NCT05178641|101773453|FG001|STARTED|Last 3 Weeks of Study (Week 3-6)||14||
48588263|NCT05178641|101773452|FG000|COMPLETED|Last 3 Weeks of Study (Week 3-6)||12||
48588264|NCT05178641|101773453|FG001|COMPLETED|Last 3 Weeks of Study (Week 3-6)||14||
48588265|NCT05178641|101773452|FG000|NOT COMPLETED|Last 3 Weeks of Study (Week 3-6)||0||
48588266|NCT05178641|101773453|FG001|NOT COMPLETED|Last 3 Weeks of Study (Week 3-6)||0||
48588267|NCT03201874|101773454|FG000|STARTED|Baseline||54|Parents started Education Control: 54, Adolescents started Education Control: 54, Parents started Pain Self-Management Intervention: 56, Adolescents started Pain Self-Management Intervention: 57|
48588268|NCT03201874|101773455|FG001|STARTED|Baseline||57|Parents started Education Control: 54, Adolescents started Education Control: 54, Parents started Pain Self-Management Intervention: 56, Adolescents started Pain Self-Management Intervention: 57|
48588269|NCT03201874|101773454|FG000|COMPLETED|Baseline||54|Parents completed Education Control: 50, Adolescents completed Education Control: 54, Parents completed Pain Self-Management Intervention: 55, Adolescents completed Pain Self-Management Intervention: 57|
48588270|NCT03201874|101773455|FG001|COMPLETED|Baseline||57|Parents completed Education Control: 50, Adolescents completed Education Control: 54, Parents completed Pain Self-Management Intervention: 55, Adolescents completed Pain Self-Management Intervention: 57|
48588271|NCT03201874|101773454|FG000|NOT COMPLETED|Baseline||0||
48588272|NCT03201874|101773455|FG001|NOT COMPLETED|Baseline||0||
48588273|NCT03201874|101773454|FG000|STARTED|Post-Treatment (12 Weeks)||54|Parents started Education Control: 51, Adolescents started Education Control: 54, Parents started Pain Self-Management Intervention: 56, Adolescents started Pain Self-Management Intervention: 57|
48592847|NCT02059434|101786325|FG000|STARTED|Period 1 (After Screening/run-in Period)||2||
48592848|NCT02059434|101786326|FG001|STARTED|Period 1 (After Screening/run-in Period)||2||
48139148|NCT01650259|100665530|FG000|NOT COMPLETED|Overall Study||1043||
48139149|NCT01650259|100665531|FG001|NOT COMPLETED|Overall Study||235||
48139150|NCT02625623|100665532|FG000|STARTED|Overall Study||186||
48139151|NCT02625623|100665533|FG001|STARTED|Overall Study||185||
48139152|NCT02625623|100665532|FG000|Treated|Overall Study||177||
48139153|NCT02625623|100665533|FG001|Treated|Overall Study||184||
48402365|NCT02021071|101317645|FG001|NOT COMPLETED|Overall Study||0||
48402366|NCT01597440|101317646|FG000|STARTED|Overall Study||1||
48402367|NCT01597440|101317647|FG001|STARTED|Overall Study||0||
48402368|NCT01597440|101317646|FG000|COMPLETED|Overall Study||1||
48139154|NCT02625623|100665532|FG000|COMPLETED|Overall Study||177||
48139155|NCT02625623|100665533|FG001|COMPLETED|Overall Study||184||
48139156|NCT02625623|100665532|FG000|NOT COMPLETED|Overall Study||9||
48139157|NCT02625623|100665533|FG001|NOT COMPLETED|Overall Study||1||
48402369|NCT01597440|101317647|FG001|COMPLETED|Overall Study||0||
48402370|NCT01597440|101317646|FG000|NOT COMPLETED|Overall Study||0||
48402371|NCT01597440|101317647|FG001|NOT COMPLETED|Overall Study||0||
48402372|NCT00899600|101317648|FG000|STARTED|Overall Study||50||
48402373|NCT00899600|101317649|FG001|STARTED|Overall Study||52||
48402374|NCT00899600|101317648|FG000|COMPLETED|Overall Study||50||
48402375|NCT00899600|101317649|FG001|COMPLETED|Overall Study||52||
48402376|NCT00899600|101317648|FG000|NOT COMPLETED|Overall Study||0||
48588274|NCT03201874|101773455|FG001|STARTED|Post-Treatment (12 Weeks)||57|Parents started Education Control: 51, Adolescents started Education Control: 54, Parents started Pain Self-Management Intervention: 56, Adolescents started Pain Self-Management Intervention: 57|
48588275|NCT03201874|101773454|FG000|COMPLETED|Post-Treatment (12 Weeks)||50|Parents completed Education Control: 43, Adolescents completed Education Control: 50, Parents completed Pain Self-Management Intervention: 43, Adolescents completed Pain Self-Management Intervention: 52|
48588276|NCT03201874|101773455|FG001|COMPLETED|Post-Treatment (12 Weeks)||52|Parents completed Education Control: 43, Adolescents completed Education Control: 50, Parents completed Pain Self-Management Intervention: 43, Adolescents completed Pain Self-Management Intervention: 52|
48588277|NCT03201874|101773454|FG000|NOT COMPLETED|Post-Treatment (12 Weeks)||4||
48588278|NCT03201874|101773455|FG001|NOT COMPLETED|Post-Treatment (12 Weeks)||5||
48588279|NCT03201874|101773454|FG000|STARTED|Follow-up (26 Weeks)||54|Parents started Education Control: 51, Adolescents started Education Control: 54, Parents started Pain Self-Management Intervention: 56, Adolescents started Pain Self-Management Intervention: 57|
48588280|NCT03201874|101773455|FG001|STARTED|Follow-up (26 Weeks)||57|Parents started Education Control: 51, Adolescents started Education Control: 54, Parents started Pain Self-Management Intervention: 56, Adolescents started Pain Self-Management Intervention: 57|
48707086|NCT00945061|102069867|FG001|STARTED|Overall Study||1||
48707087|NCT00945061|102069866|FG000|COMPLETED|Overall Study||12||
48707088|NCT00945061|102069867|FG001|COMPLETED|Overall Study||1||
48707089|NCT00945061|102069866|FG000|NOT COMPLETED|Overall Study||0||
48707090|NCT00945061|102069867|FG001|NOT COMPLETED|Overall Study||0||
48707091|NCT00468676|102069868|FG000|STARTED|Overall Study||108||
48707092|NCT00468676|102069869|FG001|STARTED|Overall Study||106||
48707093|NCT00468676|102069868|FG000|COMPLETED|Overall Study||92||
48707094|NCT00468676|102069869|FG001|COMPLETED|Overall Study||94||
48707095|NCT00468676|102069868|FG000|NOT COMPLETED|Overall Study||16||
48707096|NCT00468676|102069869|FG001|NOT COMPLETED|Overall Study||12||
48707097|NCT02298179|102069870|FG000|STARTED|Overall Study||24||
48707098|NCT02298179|102069871|FG001|STARTED|Overall Study||24||
48707099|NCT02298179|102069872|FG002|STARTED|Overall Study||24||
48707100|NCT02298179|102069873|FG003|STARTED|Overall Study||24||
48707101|NCT02298179|102069874|FG004|STARTED|Overall Study||24||
48707102|NCT02298179|102069875|FG005|STARTED|Overall Study||24||
48707103|NCT02298179|102069876|FG006|STARTED|Overall Study||24||
48707104|NCT02298179|102069877|FG007|STARTED|Overall Study||24||
48707105|NCT02298179|102069878|FG008|STARTED|Overall Study||24||
48707106|NCT02298179|102069879|FG009|STARTED|Overall Study||24||
48707107|NCT02298179|102069880|FG010|STARTED|Overall Study||24||
48707108|NCT02298179|102069881|FG011|STARTED|Overall Study||24||
48707109|NCT02298179|102069870|FG000|COMPLETED|Overall Study||24||
48707110|NCT02298179|102069871|FG001|COMPLETED|Overall Study||24||
48707111|NCT02298179|102069872|FG002|COMPLETED|Overall Study||23||
48707112|NCT02298179|102069873|FG003|COMPLETED|Overall Study||24||
48707113|NCT02298179|102069874|FG004|COMPLETED|Overall Study||24||
48707114|NCT02298179|102069875|FG005|COMPLETED|Overall Study||24||
48707115|NCT02298179|102069876|FG006|COMPLETED|Overall Study||24||
48707116|NCT02298179|102069877|FG007|COMPLETED|Overall Study||23||
48707117|NCT02298179|102069878|FG008|COMPLETED|Overall Study||24||
48707118|NCT02298179|102069879|FG009|COMPLETED|Overall Study||24||
48707119|NCT02298179|102069880|FG010|COMPLETED|Overall Study||24||
48707120|NCT02298179|102069881|FG011|COMPLETED|Overall Study||24||
48707121|NCT02298179|102069870|FG000|NOT COMPLETED|Overall Study||0||
48707122|NCT02298179|102069871|FG001|NOT COMPLETED|Overall Study||0||
48707123|NCT02298179|102069872|FG002|NOT COMPLETED|Overall Study||1||
48707124|NCT02298179|102069873|FG003|NOT COMPLETED|Overall Study||0||
48707125|NCT02298179|102069874|FG004|NOT COMPLETED|Overall Study||0||
48707126|NCT02298179|102069875|FG005|NOT COMPLETED|Overall Study||0||
48707127|NCT02298179|102069876|FG006|NOT COMPLETED|Overall Study||0||
48707128|NCT02298179|102069877|FG007|NOT COMPLETED|Overall Study||1||
48707129|NCT02298179|102069878|FG008|NOT COMPLETED|Overall Study||0||
48588281|NCT03201874|101773454|FG000|COMPLETED|Follow-up (26 Weeks)||49|Parents completed Education Control: 44, Adolescents completed Education Control: 49, Parents completed Pain Self-Management Intervention: 41, Adolescents completed Pain Self-Management Intervention: 49|
48588282|NCT03201874|101773455|FG001|COMPLETED|Follow-up (26 Weeks)||49|Parents completed Education Control: 44, Adolescents completed Education Control: 49, Parents completed Pain Self-Management Intervention: 41, Adolescents completed Pain Self-Management Intervention: 49|
48588283|NCT03201874|101773454|FG000|NOT COMPLETED|Follow-up (26 Weeks)||5||
48588284|NCT03201874|101773455|FG001|NOT COMPLETED|Follow-up (26 Weeks)||8||
48588285|NCT01582178|101773456|FG000|STARTED|Overall Study||106||
48588286|NCT01582178|101773457|FG001|STARTED|Overall Study||106||
48588287|NCT01582178|101773456|FG000|COMPLETED|Overall Study||100||
48588288|NCT01582178|101773457|FG001|COMPLETED|Overall Study||101||
48588289|NCT01582178|101773456|FG000|NOT COMPLETED|Overall Study||6||
48588290|NCT01582178|101773457|FG001|NOT COMPLETED|Overall Study||5||
48588291|NCT01021761|101773458|FG000|STARTED|Overall Study||42||
48588292|NCT01021761|101773459|FG001|STARTED|Overall Study||42||
48588293|NCT01021761|101773460|FG002|STARTED|Overall Study||42||
48588294|NCT01021761|101773458|FG000|COMPLETED|Overall Study||41||
48588295|NCT01021761|101773459|FG001|COMPLETED|Overall Study||38||
48588296|NCT01021761|101773460|FG002|COMPLETED|Overall Study||42||
48139158|NCT01517802|100665534|FG000|STARTED|Overall Study||31||
48139159|NCT01517802|100665534|FG000|COMPLETED|Overall Study||30||
48139160|NCT01517802|100665534|FG000|NOT COMPLETED|Overall Study||1||
48139161|NCT02046980|100665535|FG000|STARTED|Overall Study||72||
48139162|NCT02046980|100665536|FG001|STARTED|Overall Study||72||
48139163|NCT02046980|100665537|FG002|STARTED|Overall Study||73||
48139164|NCT02046980|100665535|FG000|COMPLETED|Overall Study||70||
48139165|NCT02046980|100665536|FG001|COMPLETED|Overall Study||67||
48139166|NCT02046980|100665537|FG002|COMPLETED|Overall Study||72||
48139167|NCT02046980|100665535|FG000|NOT COMPLETED|Overall Study||2||
48139168|NCT02046980|100665536|FG001|NOT COMPLETED|Overall Study||5||
48139169|NCT02046980|100665537|FG002|NOT COMPLETED|Overall Study||1||
48139170|NCT03336619|100665538|FG000|STARTED|Overall Study||515||
48139171|NCT03336619|100665539|FG001|STARTED|Overall Study||515||
48139172|NCT03336619|100665538|FG000|Positive for Influenza by RT-PCR at Baseline (Intent-to-treat Infected [ITTI] Population)|Overall Study||314||
48139173|NCT03336619|100665539|FG001|Positive for Influenza by RT-PCR at Baseline (Intent-to-treat Infected [ITTI] Population)|Overall Study||306||
48139174|NCT03336619|100665538|FG000|COMPLETED|Overall Study||301||
48139175|NCT03336619|100665539|FG001|COMPLETED|Overall Study||290||
48139176|NCT03336619|100665538|FG000|NOT COMPLETED|Overall Study||214||
48139177|NCT03336619|100665539|FG001|NOT COMPLETED|Overall Study||225||
48139178|NCT00383448|100665540|FG000|STARTED|Overall Study||38||
48139179|NCT00383448|100665540|FG000|COMPLETED|Overall Study||38||
48139180|NCT00383448|100665540|FG000|NOT COMPLETED|Overall Study||0||
48139181|NCT01556438|100665541|FG000|STARTED|Overall Study||4||
48139182|NCT01556438|100665542|FG001|STARTED|Overall Study||12||
48588297|NCT01021761|101773458|FG000|NOT COMPLETED|Overall Study||1||
48588298|NCT01021761|101773459|FG001|NOT COMPLETED|Overall Study||4||
48588299|NCT01021761|101773460|FG002|NOT COMPLETED|Overall Study||0||
48588300|NCT00893997|101773461|FG000|STARTED|Overall Study||10||
48588301|NCT00893997|101773461|FG000|COMPLETED|Overall Study||10||
48588302|NCT00893997|101773461|FG000|NOT COMPLETED|Overall Study||0||
48588303|NCT04638881|101773462|FG000|STARTED|Overall Study||46||
48588304|NCT04638881|101773463|FG001|STARTED|Overall Study||46||
48588305|NCT04638881|101773462|FG000|COMPLETED|Overall Study||46||
48588306|NCT04638881|101773463|FG001|COMPLETED|Overall Study||46||
48588307|NCT04638881|101773462|FG000|NOT COMPLETED|Overall Study||0||
48588308|NCT04638881|101773463|FG001|NOT COMPLETED|Overall Study||0||
48588309|NCT02733185|101773464|FG000|STARTED|Overall Study||250||
48588310|NCT02733185|101773465|FG001|STARTED|Overall Study||249||
48588311|NCT02733185|101773466|FG002|STARTED|Overall Study||250||
48588312|NCT02733185|101773467|FG003|STARTED|Overall Study||251||
48588313|NCT02733185|101773464|FG000|COMPLETED|Overall Study||175||
48588314|NCT02733185|101773465|FG001|COMPLETED|Overall Study||187||
48588315|NCT02733185|101773466|FG002|COMPLETED|Overall Study||182||
48588316|NCT02733185|101773467|FG003|COMPLETED|Overall Study||176||
48588317|NCT02733185|101773464|FG000|NOT COMPLETED|Overall Study||75||
48588318|NCT02733185|101773465|FG001|NOT COMPLETED|Overall Study||62||
48588319|NCT02733185|101773466|FG002|NOT COMPLETED|Overall Study||68||
48588320|NCT02733185|101773467|FG003|NOT COMPLETED|Overall Study||75||
48588321|NCT00748189|101773468|FG000|STARTED|Overall Study||226||
48588322|NCT00748189|101773469|FG001|STARTED|Overall Study||221||
48588323|NCT00748189|101773468|FG000|COMPLETED|Overall Study||10||
48588324|NCT00748189|101773469|FG001|COMPLETED|Overall Study||9||
48139183|NCT01556438|100665541|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4||
48139184|NCT01556438|100665542|FG001|Received at Least 1 Dose of Study Drug|Overall Study||12||
48139185|NCT01556438|100665541|FG000|Received BTZ IV|Overall Study||4||
48139186|NCT01556438|100665542|FG001|Received BTZ IV|Overall Study||4||
48139187|NCT01556438|100665541|FG000|Received BTZ SC|Overall Study||0||
48139188|NCT01556438|100665542|FG001|Received BTZ SC|Overall Study||8||
48139189|NCT01556438|100665541|FG000|COMPLETED|Overall Study||0||
48139190|NCT01556438|100665542|FG001|COMPLETED|Overall Study||1||
48139191|NCT01556438|100665541|FG000|NOT COMPLETED|Overall Study||4||
48588325|NCT00748189|101773468|FG000|NOT COMPLETED|Overall Study||216||
48139192|NCT01556438|100665542|FG001|NOT COMPLETED|Overall Study||11||
48139193|NCT00263666|100665543|FG000|STARTED|Overall Study||50||
48139194|NCT00263666|100665544|FG001|STARTED|Overall Study||50||
48139195|NCT00263666|100665543|FG000|COMPLETED|Overall Study||43||
48588326|NCT00748189|101773469|FG001|NOT COMPLETED|Overall Study||212||
48588327|NCT00742872|101773470|FG000|STARTED|Overall Study||21||
48588328|NCT00742872|101773471|FG001|STARTED|Overall Study||20||
48588329|NCT00742872|101773470|FG000|COMPLETED|Overall Study||9||
48588330|NCT00742872|101773471|FG001|COMPLETED|Overall Study||12||
48588331|NCT00742872|101773470|FG000|NOT COMPLETED|Overall Study||12||
48588332|NCT00742872|101773471|FG001|NOT COMPLETED|Overall Study||8||
48588333|NCT05129475|101773472|FG000|STARTED|Period 1||6||
48588334|NCT05129475|101773473|FG001|STARTED|Period 1||6||
48588335|NCT05129475|101773472|FG000|COMPLETED|Period 1||6||
48588336|NCT05129475|101773473|FG001|COMPLETED|Period 1||6||
48588337|NCT05129475|101773472|FG000|NOT COMPLETED|Period 1||0||
48588338|NCT05129475|101773473|FG001|NOT COMPLETED|Period 1||0||
48588339|NCT05129475|101773472|FG000|STARTED|Washout Period||6||
48588340|NCT05129475|101773473|FG001|STARTED|Washout Period||6||
48588341|NCT05129475|101773472|FG000|COMPLETED|Washout Period||6||
48588342|NCT05129475|101773473|FG001|COMPLETED|Washout Period||6||
48588343|NCT05129475|101773472|FG000|NOT COMPLETED|Washout Period||0||
48588344|NCT05129475|101773473|FG001|NOT COMPLETED|Washout Period||0||
48588345|NCT05129475|101773472|FG000|STARTED|Period 2||6||
48588346|NCT05129475|101773473|FG001|STARTED|Period 2||6||
48139196|NCT00263666|100665544|FG001|COMPLETED|Overall Study||39||
48139197|NCT00263666|100665543|FG000|NOT COMPLETED|Overall Study||7||
48139198|NCT00263666|100665544|FG001|NOT COMPLETED|Overall Study||11||
48139199|NCT02979262|100665545|FG000|STARTED|Overall Study||33||
48139200|NCT02979262|100665546|FG001|STARTED|Overall Study||29||
48139201|NCT02979262|100665545|FG000|Received Allocated Intervention|Overall Study||30||
48139202|NCT02979262|100665546|FG001|Received Allocated Intervention|Overall Study||27||
48139203|NCT02979262|100665545|FG000|COMPLETED|Overall Study||21||
48139204|NCT02979262|100665546|FG001|COMPLETED|Overall Study||20||
48139205|NCT02979262|100665545|FG000|NOT COMPLETED|Overall Study||12||
48139206|NCT02979262|100665546|FG001|NOT COMPLETED|Overall Study||9||
48139207|NCT02384954|100665547|FG000|STARTED|Phase 1||3||
48588347|NCT05129475|101773472|FG000|COMPLETED|Period 2||6||
48588348|NCT05129475|101773473|FG001|COMPLETED|Period 2||6||
48588349|NCT05129475|101773472|FG000|NOT COMPLETED|Period 2||0||
48588350|NCT05129475|101773473|FG001|NOT COMPLETED|Period 2||0||
48707130|NCT02298179|102069879|FG009|NOT COMPLETED|Overall Study||0||
48707131|NCT02298179|102069880|FG010|NOT COMPLETED|Overall Study||0||
48707132|NCT02298179|102069881|FG011|NOT COMPLETED|Overall Study||0||
48707133|NCT02337530|102069882|FG000|STARTED|Overall Study||20||
48707134|NCT02337530|102069883|FG001|STARTED|Overall Study||21||
48707135|NCT02337530|102069884|FG002|STARTED|Overall Study||21||
48707136|NCT02337530|102069882|FG000|COMPLETED|Overall Study||20||
48707137|NCT02337530|102069883|FG001|COMPLETED|Overall Study||21||
48707138|NCT02337530|102069884|FG002|COMPLETED|Overall Study||21||
48707139|NCT02337530|102069882|FG000|NOT COMPLETED|Overall Study||0||
48588351|NCT00394836|101773474|FG000|STARTED|Teatment or Follow-up Phase||30||
48588352|NCT00394836|101773475|FG001|STARTED|Teatment or Follow-up Phase||86||
48588353|NCT00394836|101773474|FG000|Early Follow-up Entry|Teatment or Follow-up Phase||4||
48707140|NCT02337530|102069883|FG001|NOT COMPLETED|Overall Study||0||
48707141|NCT02337530|102069884|FG002|NOT COMPLETED|Overall Study||0||
48707142|NCT04195438|102069885|FG000|STARTED|Overall Study||25||
48139208|NCT02384954|100665548|FG001|STARTED|Phase 1||3||
48139209|NCT02384954|100665549|FG002|STARTED|Phase 1||3||
48139210|NCT02384954|100665550|FG003|STARTED|Phase 1||3||
48139211|NCT02384954|100665551|FG004|STARTED|Phase 1||3||
48139212|NCT02384954|100665552|FG005|STARTED|Phase 1||3||
48139213|NCT02384954|100665553|FG006|STARTED|Phase 1||3||
48139214|NCT02384954|100665554|FG007|STARTED|Phase 1||0||
48139215|NCT02384954|100665555|FG008|STARTED|Phase 1||0||
48139216|NCT02384954|100665547|FG000|COMPLETED|Phase 1||1||
48139217|NCT02384954|100665548|FG001|COMPLETED|Phase 1||3||
48139218|NCT02384954|100665549|FG002|COMPLETED|Phase 1||1||
48588354|NCT00394836|101773475|FG001|Early Follow-up Entry|Teatment or Follow-up Phase||8||
48588355|NCT00394836|101773474|FG000|COMPLETED|Teatment or Follow-up Phase||2||
48588356|NCT00394836|101773475|FG001|COMPLETED|Teatment or Follow-up Phase||8||
48588357|NCT00394836|101773474|FG000|NOT COMPLETED|Teatment or Follow-up Phase||28||
48707143|NCT04195438|102069885|FG000|COMPLETED|Overall Study||24||
48588358|NCT00394836|101773475|FG001|NOT COMPLETED|Teatment or Follow-up Phase||78||
48588359|NCT00394836|101773474|FG000|STARTED|Extended Follow-up Phase (2-5 Years)||20||
48588360|NCT00394836|101773475|FG001|STARTED|Extended Follow-up Phase (2-5 Years)||58||
48588361|NCT00394836|101773474|FG000|COMPLETED|Extended Follow-up Phase (2-5 Years)||0||
48588362|NCT00394836|101773475|FG001|COMPLETED|Extended Follow-up Phase (2-5 Years)||5||
48139219|NCT02384954|100665550|FG003|COMPLETED|Phase 1||2||
48588363|NCT00394836|101773474|FG000|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||20||
48588364|NCT00394836|101773475|FG001|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||53||
48707144|NCT04195438|102069885|FG000|NOT COMPLETED|Overall Study||1||
48139220|NCT02384954|100665551|FG004|COMPLETED|Phase 1||3||
48139221|NCT02384954|100665552|FG005|COMPLETED|Phase 1||3||
48139222|NCT02384954|100665553|FG006|COMPLETED|Phase 1||3||
48707145|NCT01688921|102069886|FG000|STARTED|Overall Study||627||
48139223|NCT02384954|100665554|FG007|COMPLETED|Phase 1||0||
48402377|NCT00899600|101317649|FG001|NOT COMPLETED|Overall Study||0||
48402378|NCT01316939|101317650|FG000|STARTED|Overall Study||76||
48402379|NCT01316939|101317651|FG001|STARTED|Overall Study||77||
48402380|NCT01316939|101317652|FG002|STARTED|Overall Study||76||
48402381|NCT01316939|101317650|FG000|COMPLETED|Overall Study||13||
48402382|NCT01316939|101317651|FG001|COMPLETED|Overall Study||9||
48402383|NCT01316939|101317652|FG002|COMPLETED|Overall Study||7||
48402384|NCT01316939|101317650|FG000|NOT COMPLETED|Overall Study||63||
48402385|NCT01316939|101317651|FG001|NOT COMPLETED|Overall Study||68||
48402386|NCT01316939|101317652|FG002|NOT COMPLETED|Overall Study||69||
48402387|NCT03146403|101317653|FG000|STARTED|Overall Study||16||
48402388|NCT03146403|101317654|FG001|STARTED|Overall Study||17||
48402389|NCT03146403|101317653|FG000|COMPLETED|Overall Study||14||
48402390|NCT03146403|101317654|FG001|COMPLETED|Overall Study||14||
48707146|NCT01688921|102069887|FG001|STARTED|Overall Study||623||
48707147|NCT01688921|102069886|FG000|COMPLETED|Overall Study||611||
48707148|NCT01688921|102069887|FG001|COMPLETED|Overall Study||608||
48707149|NCT01688921|102069886|FG000|NOT COMPLETED|Overall Study||16||
48707150|NCT01688921|102069887|FG001|NOT COMPLETED|Overall Study||15||
48707151|NCT03593681|102069888|FG000|STARTED|Overall Study||150||
48402391|NCT03146403|101317653|FG000|NOT COMPLETED|Overall Study||2||
48402392|NCT03146403|101317654|FG001|NOT COMPLETED|Overall Study||3||
48402393|NCT03148795|101317655|FG000|STARTED|Overall Study||128||
48402394|NCT03148795|101317655|FG000|COMPLETED|Overall Study||127||
48588365|NCT04161079|101773476|FG000|STARTED|Clinical Investigation 2010-040||12||
48588366|NCT04161079|101773476|FG000|COMPLETED|Clinical Investigation 2010-040||11||
48588367|NCT04161079|101773476|FG000|NOT COMPLETED|Clinical Investigation 2010-040||1||
48588368|NCT04161079|101773476|FG000|STARTED|2010-040FU5 >5 Years Follow-up||7|It is follow-up group from the clinical investigation 2010-040.|
48588369|NCT04161079|101773476|FG000|COMPLETED|2010-040FU5 >5 Years Follow-up||7||
48588370|NCT04161079|101773476|FG000|NOT COMPLETED|2010-040FU5 >5 Years Follow-up||0||
48588371|NCT02600845|101773477|FG000|STARTED|Overall Study||122||
48588372|NCT02600845|101773477|FG000|COMPLETED|Overall Study||104||
48588373|NCT02600845|101773477|FG000|NOT COMPLETED|Overall Study||18||
48707152|NCT03593681|102069888|FG000|COMPLETED|Overall Study||115||
48707153|NCT03593681|102069888|FG000|NOT COMPLETED|Overall Study||35||
48707154|NCT03866538|102069889|FG000|STARTED|Overall Study||0||
48707155|NCT03866538|102069890|FG001|STARTED|Overall Study||1||
48707156|NCT03866538|102069889|FG000|COMPLETED|Overall Study||0||
48707157|NCT03866538|102069890|FG001|COMPLETED|Overall Study||1||
48707158|NCT03866538|102069889|FG000|NOT COMPLETED|Overall Study||0||
48707159|NCT03866538|102069890|FG001|NOT COMPLETED|Overall Study||0||
48707160|NCT01904149|102069891|FG000|STARTED|Overall Study||152||
48707161|NCT01904149|102069892|FG001|STARTED|Overall Study||151||
48707162|NCT01904149|102069893|FG002|STARTED|Overall Study||150||
48707163|NCT01904149|102069894|FG003|STARTED|Overall Study||51||
48707164|NCT01904149|102069895|FG004|STARTED|Overall Study||51||
48707165|NCT01904149|102069896|FG005|STARTED|Overall Study||51||
48707166|NCT01904149|102069891|FG000|Single-dose Phase|Overall Study||152||
48707167|NCT01904149|102069892|FG001|Single-dose Phase|Overall Study||151||
48707168|NCT01904149|102069893|FG002|Single-dose Phase|Overall Study||150||
48707169|NCT01904149|102069894|FG003|Single-dose Phase|Overall Study||51||
48707170|NCT01904149|102069895|FG004|Single-dose Phase|Overall Study||51||
48707171|NCT01904149|102069896|FG005|Single-dose Phase|Overall Study||51||
48707172|NCT01904149|102069891|FG000|Multiple-dose Phase|Overall Study||150||
48707173|NCT01904149|102069892|FG001|Multiple-dose Phase|Overall Study||146||
48707174|NCT01904149|102069893|FG002|Multiple-dose Phase|Overall Study||149||
48707175|NCT01904149|102069894|FG003|Multiple-dose Phase|Overall Study||48||
48707176|NCT01904149|102069895|FG004|Multiple-dose Phase|Overall Study||48||
48707177|NCT01904149|102069896|FG005|Multiple-dose Phase|Overall Study||49||
48707178|NCT01904149|102069891|FG000|COMPLETED|Overall Study||147||
48707179|NCT01904149|102069892|FG001|COMPLETED|Overall Study||140||
48707180|NCT01904149|102069893|FG002|COMPLETED|Overall Study||148||
48707181|NCT01904149|102069894|FG003|COMPLETED|Overall Study||47||
48707182|NCT01904149|102069895|FG004|COMPLETED|Overall Study||46||
48707183|NCT01904149|102069896|FG005|COMPLETED|Overall Study||48||
48707184|NCT01904149|102069891|FG000|NOT COMPLETED|Overall Study||5||
48707185|NCT01904149|102069892|FG001|NOT COMPLETED|Overall Study||11||
48139224|NCT02384954|100665555|FG008|COMPLETED|Phase 1||0||
48402395|NCT03148795|101317655|FG000|NOT COMPLETED|Overall Study||1||
48402396|NCT04445688|101317656|FG000|STARTED|First Intervention||62||
48707186|NCT01904149|102069893|FG002|NOT COMPLETED|Overall Study||2||
48402397|NCT04445688|101317656|FG000|Treatment A|First Intervention||21||
48402398|NCT04445688|101317656|FG000|Treatment B|First Intervention||21||
48402399|NCT04445688|101317656|FG000|Treatment C|First Intervention||20||
48402400|NCT04445688|101317656|FG000|COMPLETED|First Intervention||62||
48402401|NCT04445688|101317656|FG000|NOT COMPLETED|First Intervention||0||
48707187|NCT01904149|102069894|FG003|NOT COMPLETED|Overall Study||4||
48707188|NCT01904149|102069895|FG004|NOT COMPLETED|Overall Study||5||
48707189|NCT01904149|102069896|FG005|NOT COMPLETED|Overall Study||3||
48707190|NCT03106844|102069897|FG000|STARTED|Overall Study||50||
48707191|NCT03106844|102069897|FG000|COMPLETED|Overall Study||49||
48707192|NCT03106844|102069897|FG000|NOT COMPLETED|Overall Study||1||
48707193|NCT00969761|102069898|FG000|STARTED|Discont. Before Start of Treat. Cycle 2||3||
48707194|NCT00969761|102069899|FG001|STARTED|Discont. Before Start of Treat. Cycle 2||3||
48707195|NCT00969761|102069900|FG002|STARTED|Discont. Before Start of Treat. Cycle 2||12||
48707196|NCT00969761|102069901|FG003|STARTED|Discont. Before Start of Treat. Cycle 2||6||
48707197|NCT00969761|102069902|FG004|STARTED|Discont. Before Start of Treat. Cycle 2||3||
48707198|NCT00969761|102069903|FG005|STARTED|Discont. Before Start of Treat. Cycle 2||3||
48707199|NCT00969761|102069904|FG006|STARTED|Discont. Before Start of Treat. Cycle 2||3||
48707200|NCT00969761|102069905|FG007|STARTED|Discont. Before Start of Treat. Cycle 2||6||
48707201|NCT00969761|102069906|FG008|STARTED|Discont. Before Start of Treat. Cycle 2||13||
48707202|NCT00969761|102069907|FG009|STARTED|Discont. Before Start of Treat. Cycle 2||3||
48707203|NCT00969761|102069908|FG010|STARTED|Discont. Before Start of Treat. Cycle 2||3||
48707204|NCT00969761|102069909|FG011|STARTED|Discont. Before Start of Treat. Cycle 2||3||
48707205|NCT00969761|102069898|FG000|COMPLETED|Discont. Before Start of Treat. Cycle 2||2||
48707206|NCT00969761|102069899|FG001|COMPLETED|Discont. Before Start of Treat. Cycle 2||3||
48707207|NCT00969761|102069900|FG002|COMPLETED|Discont. Before Start of Treat. Cycle 2||10||
48707208|NCT00969761|102069901|FG003|COMPLETED|Discont. Before Start of Treat. Cycle 2||5||
48707209|NCT00969761|102069902|FG004|COMPLETED|Discont. Before Start of Treat. Cycle 2||3||
48707210|NCT00969761|102069903|FG005|COMPLETED|Discont. Before Start of Treat. Cycle 2||3||
48707211|NCT00969761|102069904|FG006|COMPLETED|Discont. Before Start of Treat. Cycle 2||3||
48139225|NCT02384954|100665547|FG000|NOT COMPLETED|Phase 1||2||
48139226|NCT02384954|100665548|FG001|NOT COMPLETED|Phase 1||0||
48139227|NCT02384954|100665549|FG002|NOT COMPLETED|Phase 1||2||
48139228|NCT02384954|100665550|FG003|NOT COMPLETED|Phase 1||1||
48588374|NCT01223469|101773478|FG000|STARTED|Overall Study||34||
48588375|NCT01223469|101773479|FG001|STARTED|Overall Study||43||
48588376|NCT01223469|101773478|FG000|COMPLETED|Overall Study||34||
48588377|NCT01223469|101773479|FG001|COMPLETED|Overall Study||43||
48588378|NCT01223469|101773478|FG000|NOT COMPLETED|Overall Study||0||
48588379|NCT01223469|101773479|FG001|NOT COMPLETED|Overall Study||0||
48588380|NCT03719287|101773480|FG000|STARTED|Overall Study||100||
48588381|NCT03719287|101773481|FG001|STARTED|Overall Study||99||
48588382|NCT03719287|101773482|FG002|STARTED|Overall Study||96||
48588383|NCT03719287|101773480|FG000|COMPLETED|Overall Study||100||
48588384|NCT03719287|101773481|FG001|COMPLETED|Overall Study||99||
48588385|NCT03719287|101773482|FG002|COMPLETED|Overall Study||96||
48588386|NCT03719287|101773480|FG000|NOT COMPLETED|Overall Study||0||
48588387|NCT03719287|101773481|FG001|NOT COMPLETED|Overall Study||0||
48588388|NCT03719287|101773482|FG002|NOT COMPLETED|Overall Study||0||
48588389|NCT02584998|101773483|FG000|STARTED|Overall Study||260||
48588390|NCT02584998|101773484|FG001|STARTED|Overall Study||261||
48588391|NCT02584998|101773485|FG002|STARTED|Overall Study||261||
48588392|NCT02584998|101773483|FG000|COMPLETED|Overall Study||260||
48588393|NCT02584998|101773484|FG001|COMPLETED|Overall Study||261||
48588394|NCT02584998|101773485|FG002|COMPLETED|Overall Study||261||
48588395|NCT02584998|101773483|FG000|NOT COMPLETED|Overall Study||0||
48588396|NCT02584998|101773484|FG001|NOT COMPLETED|Overall Study||0||
48588397|NCT02584998|101773485|FG002|NOT COMPLETED|Overall Study||0||
48588398|NCT00432276|101773486|FG000|STARTED|Overall Study||404||
48588399|NCT00432276|101773487|FG001|STARTED|Overall Study||399||
48588400|NCT00432276|101773486|FG000|Per Protocol Set|Overall Study||303||
48588401|NCT00432276|101773487|FG001|Per Protocol Set|Overall Study||306||
48588402|NCT00432276|101773486|FG000|COMPLETED|Overall Study||283||
48588403|NCT00432276|101773487|FG001|COMPLETED|Overall Study||243||
48588404|NCT00432276|101773486|FG000|NOT COMPLETED|Overall Study||121||
48588405|NCT00432276|101773487|FG001|NOT COMPLETED|Overall Study||156||
48588406|NCT02484651|101773488|FG000|STARTED|Overall Study||35||
48588407|NCT02484651|101773489|FG001|STARTED|Overall Study||35||
48588408|NCT02484651|101773488|FG000|End of Clinical Study|Overall Study||35|Patients that followed the protocol and finished the clinical study.|
48588409|NCT02484651|101773489|FG001|End of Clinical Study|Overall Study||35|Patients that followed the protocol and finished the clinical study.|
48588410|NCT02484651|101773488|FG000|Data Analysis|Overall Study||32|Patients with valid recorded data included in the data analysis|
48588411|NCT02484651|101773489|FG001|Data Analysis|Overall Study||31|Patients with valid recorded data included in the data analysis|
48588412|NCT02484651|101773488|FG000|COMPLETED|Overall Study||32||
48588413|NCT02484651|101773489|FG001|COMPLETED|Overall Study||31||
48588414|NCT02484651|101773488|FG000|NOT COMPLETED|Overall Study||3||
48139229|NCT02384954|100665551|FG004|NOT COMPLETED|Phase 1||0||
48139230|NCT02384954|100665552|FG005|NOT COMPLETED|Phase 1||0||
48139231|NCT02384954|100665553|FG006|NOT COMPLETED|Phase 1||0||
48139232|NCT02384954|100665554|FG007|NOT COMPLETED|Phase 1||0||
48139233|NCT02384954|100665555|FG008|NOT COMPLETED|Phase 1||0||
48139234|NCT02384954|100665547|FG000|STARTED|Phase 2||0||
48588415|NCT02484651|101773489|FG001|NOT COMPLETED|Overall Study||4||
48588416|NCT03597009|101773490|FG000|STARTED|Overall Study||1||
48588417|NCT03597009|101773490|FG000|COMPLETED|Overall Study||1||
48139235|NCT02384954|100665548|FG001|STARTED|Phase 2||0||
48588418|NCT03597009|101773490|FG000|NOT COMPLETED|Overall Study||0||
48139236|NCT02384954|100665549|FG002|STARTED|Phase 2||0||
48139237|NCT02384954|100665550|FG003|STARTED|Phase 2||0||
48588419|NCT00970632|101773491|FG000|STARTED|Overall Study||172||
48588420|NCT00970632|101773492|FG001|STARTED|Overall Study||171||
48588421|NCT00970632|101773493|FG002|STARTED|Overall Study||168||
48588422|NCT00970632|101773491|FG000|COMPLETED|Overall Study||148||
48588423|NCT00970632|101773492|FG001|COMPLETED|Overall Study||156||
48588424|NCT00970632|101773493|FG002|COMPLETED|Overall Study||150||
48588425|NCT00970632|101773491|FG000|NOT COMPLETED|Overall Study||24||
48588426|NCT00970632|101773492|FG001|NOT COMPLETED|Overall Study||15||
48588427|NCT00970632|101773493|FG002|NOT COMPLETED|Overall Study||18||
48588428|NCT02275780|101773494|FG000|STARTED|Base Study: 96 Weeks||385||
48588429|NCT02275780|101773495|FG001|STARTED|Base Study: 96 Weeks||384||
48588430|NCT02275780|101773494|FG000|Treated|Base Study: 96 Weeks||383||
48588431|NCT02275780|101773495|FG001|Treated|Base Study: 96 Weeks||383||
48588432|NCT02275780|101773494|FG000|COMPLETED|Base Study: 96 Weeks||292||
48588433|NCT02275780|101773495|FG001|COMPLETED|Base Study: 96 Weeks||273||
48588434|NCT02275780|101773494|FG000|NOT COMPLETED|Base Study: 96 Weeks||93||
48588435|NCT02275780|101773495|FG001|NOT COMPLETED|Base Study: 96 Weeks||111||
48588436|NCT02275780|101773494|FG000|STARTED|Study Extension 1: Week 96 to Week 192||259||
48588437|NCT02275780|101773495|FG001|STARTED|Study Extension 1: Week 96 to Week 192||233||
48588438|NCT02275780|101773494|FG000|COMPLETED|Study Extension 1: Week 96 to Week 192||210||
48588439|NCT02275780|101773495|FG001|COMPLETED|Study Extension 1: Week 96 to Week 192||190||
48588440|NCT02275780|101773494|FG000|NOT COMPLETED|Study Extension 1: Week 96 to Week 192||49||
48588441|NCT02275780|101773495|FG001|NOT COMPLETED|Study Extension 1: Week 96 to Week 192||43||
48588442|NCT02275780|101773494|FG000|STARTED|Study Extension 2: Week 192 to Week 288||148||
48588443|NCT02275780|101773495|FG001|STARTED|Study Extension 2: Week 192 to Week 288||129||
48588444|NCT02275780|101773494|FG000|COMPLETED|Study Extension 2: Week 192 to Week 288||101||
48588445|NCT02275780|101773495|FG001|COMPLETED|Study Extension 2: Week 192 to Week 288||91||
48588446|NCT02275780|101773494|FG000|NOT COMPLETED|Study Extension 2: Week 192 to Week 288||47||
48588447|NCT02275780|101773495|FG001|NOT COMPLETED|Study Extension 2: Week 192 to Week 288||38||
48588448|NCT02275780|101773494|FG000|STARTED|Study Extension 3: Week 288 to Week 384||50||
48588449|NCT02275780|101773495|FG001|STARTED|Study Extension 3: Week 288 to Week 384||36||
48588450|NCT02275780|101773494|FG000|COMPLETED|Study Extension 3: Week 288 to Week 384||36||
48588451|NCT02275780|101773495|FG001|COMPLETED|Study Extension 3: Week 288 to Week 384||23||
48588452|NCT02275780|101773494|FG000|NOT COMPLETED|Study Extension 3: Week 288 to Week 384||14||
48588453|NCT02275780|101773495|FG001|NOT COMPLETED|Study Extension 3: Week 288 to Week 384||13||
48588454|NCT00157248|101773496|FG000|STARTED|Overall Study||98||
48588455|NCT00157248|101773497|FG001|STARTED|Overall Study||89||
48588456|NCT00157248|101773498|FG002|STARTED|Overall Study||50||
48588457|NCT00157248|101773499|FG003|STARTED|Overall Study||124||
48588458|NCT00157248|101773496|FG000|COMPLETED|Overall Study||50||
48139238|NCT02384954|100665551|FG004|STARTED|Phase 2||0||
48139239|NCT02384954|100665552|FG005|STARTED|Phase 2||0||
48139240|NCT02384954|100665553|FG006|STARTED|Phase 2||0||
48139241|NCT02384954|100665554|FG007|STARTED|Phase 2||16||
48139242|NCT02384954|100665555|FG008|STARTED|Phase 2||9||
48139243|NCT02384954|100665547|FG000|COMPLETED|Phase 2||0||
48588459|NCT00157248|101773497|FG001|COMPLETED|Overall Study||52||
48588460|NCT00157248|101773498|FG002|COMPLETED|Overall Study||29||
48588461|NCT00157248|101773499|FG003|COMPLETED|Overall Study||77||
48139244|NCT02384954|100665548|FG001|COMPLETED|Phase 2||0||
48139245|NCT02384954|100665549|FG002|COMPLETED|Phase 2||0||
48139246|NCT02384954|100665550|FG003|COMPLETED|Phase 2||0||
48139247|NCT02384954|100665551|FG004|COMPLETED|Phase 2||0||
48139248|NCT02384954|100665552|FG005|COMPLETED|Phase 2||0||
48139249|NCT02384954|100665553|FG006|COMPLETED|Phase 2||0||
48139250|NCT02384954|100665554|FG007|COMPLETED|Phase 2||13||
48139251|NCT02384954|100665555|FG008|COMPLETED|Phase 2||6||
48139252|NCT02384954|100665547|FG000|NOT COMPLETED|Phase 2||0||
48139253|NCT02384954|100665548|FG001|NOT COMPLETED|Phase 2||0||
48402402|NCT04445688|101317656|FG000|STARTED|Washout (One Week)||62||
48402403|NCT04445688|101317656|FG000|COMPLETED|Washout (One Week)||59||
48402404|NCT04445688|101317656|FG000|NOT COMPLETED|Washout (One Week)||3||
48402405|NCT04445688|101317656|FG000|STARTED|Second Intervention||59||
48402406|NCT04445688|101317656|FG000|Treatment A|Second Intervention||18||
48402407|NCT04445688|101317656|FG000|Treatment B|Second Intervention||21||
48402408|NCT04445688|101317656|FG000|Treatment C|Second Intervention||20||
48402409|NCT04445688|101317656|FG000|COMPLETED|Second Intervention||59||
48402410|NCT04445688|101317656|FG000|NOT COMPLETED|Second Intervention||0||
48402411|NCT04445688|101317656|FG000|STARTED|Washout (One Week)||59||
48402412|NCT04445688|101317656|FG000|COMPLETED|Washout (One Week)||59||
48402413|NCT04445688|101317656|FG000|NOT COMPLETED|Washout (One Week)||0||
48402414|NCT04445688|101317656|FG000|STARTED|Third Intervention||59||
48402415|NCT04445688|101317656|FG000|Treatment A|Third Intervention||20||
48139254|NCT02384954|100665549|FG002|NOT COMPLETED|Phase 2||0||
48139255|NCT02384954|100665550|FG003|NOT COMPLETED|Phase 2||0||
48139256|NCT02384954|100665551|FG004|NOT COMPLETED|Phase 2||0||
48139257|NCT02384954|100665552|FG005|NOT COMPLETED|Phase 2||0||
48402416|NCT04445688|101317656|FG000|Treatment B|Third Intervention||20||
48588462|NCT00157248|101773496|FG000|NOT COMPLETED|Overall Study||48||
48588463|NCT00157248|101773497|FG001|NOT COMPLETED|Overall Study||37||
48588464|NCT00157248|101773498|FG002|NOT COMPLETED|Overall Study||21||
48139258|NCT02384954|100665553|FG006|NOT COMPLETED|Phase 2||0||
48588465|NCT00157248|101773499|FG003|NOT COMPLETED|Overall Study||47||
48588466|NCT00759785|101773500|FG000|STARTED|Overall Study||26||
48139259|NCT02384954|100665554|FG007|NOT COMPLETED|Phase 2||3||
48139260|NCT02384954|100665555|FG008|NOT COMPLETED|Phase 2||3||
48139261|NCT03826667|100665556|FG000|STARTED|Overall Study||464||467
48139262|NCT03826667|100665556|FG000|HEALICOIL™ PK Preloaded Suture Anchors|Overall Study||193|Type of suture anchor received at start|193
48139263|NCT03826667|100665556|FG000|BIORAPTOR™ 2.3 PK Suture Anchors/BIORAPTOR™ Curved 2.3 PK Suture Anchors|Overall Study||41|Type of suture anchor received at start|41
48139264|NCT03826667|100665556|FG000|MULTIFIX™ S Ultra Knotless Fixation System|Overall Study||78|Type of suture anchor received at start|78
48139265|NCT03826667|100665556|FG000|FOOTPRINT™ Ultra PK Suture Anchors|Overall Study||136|Type of suture anchor received at start|138
48139266|NCT03826667|100665556|FG000|TWINFIX™ Ultra PK Suture Anchors/TWINFIX™ Ultra Preloaded and With Needles|Overall Study||57|Type of suture anchor received at start|57
48139267|NCT03826667|100665556|FG000|SPEEDSCREW™ Knotless Fixation System|Overall Study||59|Type of suture anchor received at start|59
48139268|NCT03826667|100665556|FG000|SpeedLock Knotless Fixation Device|Overall Study||18|Type of suture anchor received at start|18
48139269|NCT03826667|100665556|FG000|COMPLETED|Overall Study||443||446
48139270|NCT03826667|100665556|FG000|NOT COMPLETED|Overall Study||21||21
48139271|NCT03335033|100665557|FG000|STARTED|Overall Study||17||
48290761|NCT03305731|101037644|FG000|Week 11|Overall Study||20||
48290762|NCT03305731|101037644|FG000|COMPLETED|Overall Study||20|Week 18|
48290763|NCT03305731|101037644|FG000|NOT COMPLETED|Overall Study||1||
48290764|NCT02084056|101037645|FG000|STARTED|Treatment Period 1 (4 Days)||28||
48290765|NCT02084056|101037646|FG001|STARTED|Treatment Period 1 (4 Days)||30||
48290766|NCT02084056|101037647|FG002|STARTED|Treatment Period 1 (4 Days)||8||
48290767|NCT02084056|101037648|FG003|STARTED|Treatment Period 1 (4 Days)||8||
48290768|NCT02084056|101037645|FG000|COMPLETED|Treatment Period 1 (4 Days)||27||
48290769|NCT02084056|101037646|FG001|COMPLETED|Treatment Period 1 (4 Days)||30||
48290770|NCT02084056|101037647|FG002|COMPLETED|Treatment Period 1 (4 Days)||8||
48290771|NCT02084056|101037648|FG003|COMPLETED|Treatment Period 1 (4 Days)||8||
48290772|NCT02084056|101037645|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||1||
48290773|NCT02084056|101037646|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
48290774|NCT02084056|101037647|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
48588467|NCT00759785|101773501|FG001|STARTED|Overall Study||22||
48588468|NCT00759785|101773500|FG000|Treated|Overall Study||25||
48588469|NCT00759785|101773501|FG001|Treated|Overall Study||20||
48290775|NCT02084056|101037648|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
48290776|NCT02084056|101037645|FG000|STARTED|Washout Period 1 (35 Days)||27||
48290777|NCT02084056|101037646|FG001|STARTED|Washout Period 1 (35 Days)||30||
48290778|NCT02084056|101037647|FG002|STARTED|Washout Period 1 (35 Days)||8||
48290779|NCT02084056|101037648|FG003|STARTED|Washout Period 1 (35 Days)||8||
48290780|NCT02084056|101037645|FG000|COMPLETED|Washout Period 1 (35 Days)||26||
48402417|NCT04445688|101317656|FG000|Treatment C|Third Intervention||19||
48402418|NCT04445688|101317656|FG000|COMPLETED|Third Intervention||59||
48402419|NCT04445688|101317656|FG000|NOT COMPLETED|Third Intervention||0||
48402420|NCT02901080|101317657|FG000|STARTED|Overall Study||161||
48402421|NCT02901080|101317657|FG000|COMPLETED|Overall Study||112||
48402422|NCT02901080|101317657|FG000|NOT COMPLETED|Overall Study||49||
48402423|NCT01711658|101317658|FG000|STARTED|Overall Study||64||
48402424|NCT01711658|101317659|FG001|STARTED|Overall Study||63||
48402425|NCT01711658|101317658|FG000|Participants Who Started Protocol Treatment|Overall Study||59||
48402426|NCT01711658|101317659|FG001|Participants Who Started Protocol Treatment|Overall Study||60||
48402427|NCT01711658|101317658|FG000|COMPLETED|Overall Study||64|Participants contributing data to results are considered to have completed the study.|
48402428|NCT01711658|101317659|FG001|COMPLETED|Overall Study||63|Participants contributing data to results are considered to have completed the study.|
48402429|NCT01711658|101317658|FG000|NOT COMPLETED|Overall Study||0||
48402430|NCT01711658|101317659|FG001|NOT COMPLETED|Overall Study||0||
48402431|NCT04731922|101317660|FG000|STARTED|Overall Study||23||
48402432|NCT04731922|101317661|FG001|STARTED|Overall Study||6||
48588470|NCT00759785|101773500|FG000|COMPLETED|Overall Study||14||
48139272|NCT03335033|100665558|FG001|STARTED|Overall Study||37||
48139273|NCT03335033|100665557|FG000|COMPLETED|Overall Study||17||
48139274|NCT03335033|100665558|FG001|COMPLETED|Overall Study||37||
48139275|NCT03335033|100665557|FG000|NOT COMPLETED|Overall Study||0||
48139276|NCT03335033|100665558|FG001|NOT COMPLETED|Overall Study||0||
48290781|NCT02084056|101037646|FG001|COMPLETED|Washout Period 1 (35 Days)||30||
48290782|NCT02084056|101037647|FG002|COMPLETED|Washout Period 1 (35 Days)||8||
48290783|NCT02084056|101037648|FG003|COMPLETED|Washout Period 1 (35 Days)||8||
48290784|NCT02084056|101037645|FG000|NOT COMPLETED|Washout Period 1 (35 Days)||1||
48290785|NCT02084056|101037646|FG001|NOT COMPLETED|Washout Period 1 (35 Days)||0||
48290786|NCT02084056|101037647|FG002|NOT COMPLETED|Washout Period 1 (35 Days)||0||
48588471|NCT00759785|101773501|FG001|COMPLETED|Overall Study||17||
48588472|NCT00759785|101773500|FG000|NOT COMPLETED|Overall Study||12||
48588473|NCT00759785|101773501|FG001|NOT COMPLETED|Overall Study||5||
48588474|NCT04258254|101773502|FG000|STARTED|Overall Study||15||
48290787|NCT02084056|101037648|FG003|NOT COMPLETED|Washout Period 1 (35 Days)||0||
48588475|NCT04258254|101773503|FG001|STARTED|Overall Study||16||
48588476|NCT04258254|101773504|FG002|STARTED|Overall Study||15||
48588477|NCT04258254|101773502|FG000|COMPLETED|Overall Study||15||
48290788|NCT02084056|101037645|FG000|STARTED|Treatment Period 2 (4 Days)||26||
48290789|NCT02084056|101037646|FG001|STARTED|Treatment Period 2 (4 Days)||30||
48290790|NCT02084056|101037647|FG002|STARTED|Treatment Period 2 (4 Days)||8||
48290791|NCT02084056|101037648|FG003|STARTED|Treatment Period 2 (4 Days)||8||
48290792|NCT02084056|101037645|FG000|COMPLETED|Treatment Period 2 (4 Days)||26||
48290793|NCT02084056|101037646|FG001|COMPLETED|Treatment Period 2 (4 Days)||30||
48290794|NCT02084056|101037647|FG002|COMPLETED|Treatment Period 2 (4 Days)||8||
48290795|NCT02084056|101037648|FG003|COMPLETED|Treatment Period 2 (4 Days)||8||
48290796|NCT02084056|101037645|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
48290797|NCT02084056|101037646|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
48290798|NCT02084056|101037647|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
48290799|NCT02084056|101037648|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
48707212|NCT00969761|102069905|FG007|COMPLETED|Discont. Before Start of Treat. Cycle 2||6||
48707213|NCT00969761|102069906|FG008|COMPLETED|Discont. Before Start of Treat. Cycle 2||11||
48707214|NCT00969761|102069907|FG009|COMPLETED|Discont. Before Start of Treat. Cycle 2||2||
48290800|NCT02483585|101037649|FG000|STARTED|Double-blind Treatment Phase||291||
48290801|NCT02483585|101037650|FG001|STARTED|Double-blind Treatment Phase||286||
48290802|NCT02483585|101037649|FG000|Received Treatment|Double-blind Treatment Phase||289||
48290803|NCT02483585|101037650|FG001|Received Treatment|Double-blind Treatment Phase||283||
48290804|NCT02483585|101037649|FG000|COMPLETED|Double-blind Treatment Phase||275||
48290805|NCT02483585|101037650|FG001|COMPLETED|Double-blind Treatment Phase||271||
48588478|NCT04258254|101773503|FG001|COMPLETED|Overall Study||15||
48588479|NCT04258254|101773504|FG002|COMPLETED|Overall Study||15||
48588480|NCT04258254|101773502|FG000|NOT COMPLETED|Overall Study||0||
48588481|NCT04258254|101773503|FG001|NOT COMPLETED|Overall Study||1||
48588482|NCT04258254|101773504|FG002|NOT COMPLETED|Overall Study||0||
48588483|NCT06350461|101773505|FG000|STARTED|Overall Study||184||
48588484|NCT06350461|101773506|FG001|STARTED|Overall Study||186||
48588485|NCT06350461|101773505|FG000|COMPLETED|Overall Study||181||
48588486|NCT06350461|101773506|FG001|COMPLETED|Overall Study||183||
48588487|NCT06350461|101773505|FG000|NOT COMPLETED|Overall Study||3||
48588488|NCT06350461|101773506|FG001|NOT COMPLETED|Overall Study||3||
48588489|NCT02908672|101773507|FG000|STARTED|Overall Study||258||
48588490|NCT02908672|101773508|FG001|STARTED|Overall Study||256||
48588491|NCT02908672|101773507|FG000|COMPLETED|Overall Study||0||
48588492|NCT02908672|101773508|FG001|COMPLETED|Overall Study||0||
48588493|NCT02908672|101773507|FG000|NOT COMPLETED|Overall Study||258||
48290806|NCT02483585|101037649|FG000|NOT COMPLETED|Double-blind Treatment Phase||16||
48290807|NCT02483585|101037650|FG001|NOT COMPLETED|Double-blind Treatment Phase||15||
48290808|NCT02483585|101037649|FG000|STARTED|Open-label Treatment Phase||270||
48290809|NCT02483585|101037650|FG001|STARTED|Open-label Treatment Phase||268||
48290810|NCT02483585|101037649|FG000|COMPLETED|Open-label Treatment Phase||243||
48290811|NCT02483585|101037650|FG001|COMPLETED|Open-label Treatment Phase||243||
48290812|NCT02483585|101037649|FG000|NOT COMPLETED|Open-label Treatment Phase||27||
48290813|NCT02483585|101037650|FG001|NOT COMPLETED|Open-label Treatment Phase||25||
48290814|NCT03938545|101037651|FG000|STARTED|Overall Study||18||
48290815|NCT03938545|101037652|FG001|STARTED|Overall Study||19||
48290816|NCT03938545|101037653|FG002|STARTED|Overall Study||10||
48290817|NCT03938545|101037654|FG003|STARTED|Overall Study||18||
48290818|NCT03938545|101037651|FG000|COMPLETED|Overall Study||10||
48402433|NCT04731922|101317662|FG002|STARTED|Overall Study||6||
48402434|NCT04731922|101317663|FG003|STARTED|Overall Study||6||
48588494|NCT02908672|101773508|FG001|NOT COMPLETED|Overall Study||256||
48588495|NCT00712881|101773509|FG000|STARTED|Overall Study||63||
48588496|NCT00712881|101773510|FG001|STARTED|Overall Study||63||
48588497|NCT00712881|101773509|FG000|Received at Least 1 Dose of Study Drug|Overall Study||62||
48588498|NCT00712881|101773510|FG001|Received at Least 1 Dose of Study Drug|Overall Study||63||
48588499|NCT00712881|101773509|FG000|Completed 8 Cycles of Treatment|Overall Study||55||
48707215|NCT00969761|102069908|FG010|COMPLETED|Discont. Before Start of Treat. Cycle 2||3||
48707216|NCT00969761|102069909|FG011|COMPLETED|Discont. Before Start of Treat. Cycle 2||3||
48710771|NCT01924442|102078013|FG001|COMPLETED|Overall Study||967||
48290819|NCT03938545|101037652|FG001|COMPLETED|Overall Study||14||
48290820|NCT03938545|101037653|FG002|COMPLETED|Overall Study||7||
48290821|NCT03938545|101037654|FG003|COMPLETED|Overall Study||13||
48290822|NCT03938545|101037651|FG000|NOT COMPLETED|Overall Study||8||
48290823|NCT03938545|101037652|FG001|NOT COMPLETED|Overall Study||5||
48290824|NCT03938545|101037653|FG002|NOT COMPLETED|Overall Study||3||
48290825|NCT03938545|101037654|FG003|NOT COMPLETED|Overall Study||5||
48290826|NCT02924428|101037655|FG000|STARTED|Overall Study||20||
48290827|NCT02924428|101037656|FG001|STARTED|Overall Study||19||
48290828|NCT02924428|101037655|FG000|COMPLETED|Overall Study||16||
48588500|NCT00712881|101773510|FG001|Completed 8 Cycles of Treatment|Overall Study||56||
48588501|NCT00712881|101773509|FG000|COMPLETED|Overall Study||53||
48290829|NCT02924428|101037656|FG001|COMPLETED|Overall Study||14||
48290830|NCT02924428|101037655|FG000|NOT COMPLETED|Overall Study||4||
48290831|NCT02924428|101037656|FG001|NOT COMPLETED|Overall Study||5||
48290832|NCT01347762|101037657|FG000|STARTED|Overall Study||10||
48402435|NCT04731922|101317664|FG004|STARTED|Overall Study||7||
48588502|NCT00712881|101773510|FG001|COMPLETED|Overall Study||56||
48290833|NCT01347762|101037658|FG001|STARTED|Overall Study||8||
48290834|NCT01347762|101037659|FG002|STARTED|Overall Study||16||
48290835|NCT01347762|101037660|FG003|STARTED|Overall Study||18||
48290836|NCT01347762|101037657|FG000|COMPLETED|Overall Study||6||
48290837|NCT01347762|101037658|FG001|COMPLETED|Overall Study||6||
48290838|NCT01347762|101037659|FG002|COMPLETED|Overall Study||7||
48290839|NCT01347762|101037660|FG003|COMPLETED|Overall Study||10||
48290840|NCT01347762|101037657|FG000|NOT COMPLETED|Overall Study||4||
48290841|NCT01347762|101037658|FG001|NOT COMPLETED|Overall Study||2||
48290842|NCT01347762|101037659|FG002|NOT COMPLETED|Overall Study||9||
48290843|NCT01347762|101037660|FG003|NOT COMPLETED|Overall Study||8||
48290844|NCT02090959|101037661|FG000|STARTED|Overall Study||219||
48290845|NCT02090959|101037661|FG000|As-treated Population|Overall Study||218|All participants who received at least 1 dose of study drug.|
48290846|NCT02090959|101037661|FG000|COMPLETED|Overall Study||68||
48290847|NCT02090959|101037661|FG000|NOT COMPLETED|Overall Study||151||
48290848|NCT00950950|101037662|FG000|STARTED|Overall Study||12||
48290849|NCT00950950|101037663|FG001|STARTED|Overall Study||12||
48290850|NCT00950950|101037662|FG000|COMPLETED|Overall Study||11||
48290851|NCT00950950|101037663|FG001|COMPLETED|Overall Study||11||
48290852|NCT00950950|101037662|FG000|NOT COMPLETED|Overall Study||1||
48290853|NCT00950950|101037663|FG001|NOT COMPLETED|Overall Study||1||
48290854|NCT01990560|101037664|FG000|STARTED|Overall Study||8||
48290855|NCT01990560|101037664|FG000|COMPLETED|Overall Study||7||
48290856|NCT01990560|101037664|FG000|NOT COMPLETED|Overall Study||1||
48290857|NCT01154010|101037665|FG000|STARTED|Overall Study||9||
48290858|NCT01154010|101037666|FG001|STARTED|Overall Study||9||
48290859|NCT01154010|101037665|FG000|COMPLETED|Overall Study||9||
48290860|NCT01154010|101037666|FG001|COMPLETED|Overall Study||8||
48290861|NCT01154010|101037665|FG000|NOT COMPLETED|Overall Study||0||
48290862|NCT01154010|101037666|FG001|NOT COMPLETED|Overall Study||1||
48290863|NCT02292927|101037667|FG000|STARTED|Overall Study||13||
48290864|NCT02292927|101037668|FG001|STARTED|Overall Study||12||
48290865|NCT02292927|101037667|FG000|COMPLETED|Overall Study||0||
48290866|NCT02292927|101037668|FG001|COMPLETED|Overall Study||5||
48290867|NCT02292927|101037667|FG000|NOT COMPLETED|Overall Study||13||
48290868|NCT02292927|101037668|FG001|NOT COMPLETED|Overall Study||7||
48290869|NCT03622619|101037669|FG000|STARTED|Overall Study||23||
48402436|NCT04731922|101317665|FG005|STARTED|Overall Study||6||
48290870|NCT03622619|101037670|FG001|STARTED|Overall Study||23||
48290871|NCT03622619|101037669|FG000|COMPLETED|Overall Study||21||
48290872|NCT03622619|101037670|FG001|COMPLETED|Overall Study||21||
48290873|NCT03622619|101037669|FG000|NOT COMPLETED|Overall Study||2||
48290874|NCT03622619|101037670|FG001|NOT COMPLETED|Overall Study||2||
48290875|NCT00642772|101037671|FG000|STARTED|Overall Study||24||
48290876|NCT00642772|101037671|FG000|COMPLETED|Overall Study||14||
48290877|NCT00642772|101037671|FG000|NOT COMPLETED|Overall Study||10||
48290878|NCT03834051|101037672|FG000|STARTED|Overall Study||33||
48290879|NCT03834051|101037672|FG000|COMPLETED|Overall Study||21||
48290880|NCT03834051|101037672|FG000|NOT COMPLETED|Overall Study||12||
48290881|NCT01401907|101037673|FG000|STARTED|Overall Study||175||
48290882|NCT01401907|101037674|FG001|STARTED|Overall Study||175||
48290883|NCT01401907|101037673|FG000|12 Week Outcomes|Overall Study||148||
48290884|NCT01401907|101037674|FG001|12 Week Outcomes|Overall Study||153||
48290885|NCT01401907|101037673|FG000|COMPLETED|Overall Study||118|24 week outcomes|
48290886|NCT01401907|101037674|FG001|COMPLETED|Overall Study||124|24 week outcomes|
48290887|NCT01401907|101037673|FG000|NOT COMPLETED|Overall Study||57||
48290888|NCT01401907|101037674|FG001|NOT COMPLETED|Overall Study||51||
48290889|NCT00928447|101037675|FG000|STARTED|Overall Study||22||176
48290890|NCT00928447|101037675|FG000|Received at Least 1 Dose of rHuPH20|Overall Study||21|One half of the participant's back received rHuPH20|168
48290891|NCT00928447|101037675|FG000|Received at Least 1 Dose of Placebo|Overall Study||21|One half of the participant's back received placebo|168
48402437|NCT04731922|101317666|FG006|STARTED|Overall Study||6||
48588503|NCT00712881|101773509|FG000|NOT COMPLETED|Overall Study||10||
48588504|NCT00712881|101773510|FG001|NOT COMPLETED|Overall Study||7||
48588505|NCT02809859|101773511|FG000|STARTED|Overall Study||139||
48588506|NCT02809859|101773511|FG000|COMPLETED|Overall Study||125||
48588507|NCT02809859|101773511|FG000|NOT COMPLETED|Overall Study||14||
48588508|NCT05177354|101773512|FG000|STARTED|Implant to 30-day Visit||60||
48588509|NCT05177354|101773512|FG000|COMPLETED|Implant to 30-day Visit||57||
48588510|NCT05177354|101773512|FG000|NOT COMPLETED|Implant to 30-day Visit||3||
48588511|NCT05177354|101773512|FG000|STARTED|30-day Visit to 3-Month Visit||57||
48588512|NCT05177354|101773512|FG000|COMPLETED|30-day Visit to 3-Month Visit||56||
48588513|NCT05177354|101773512|FG000|NOT COMPLETED|30-day Visit to 3-Month Visit||1||
48588514|NCT00656487|101773513|FG000|STARTED|Overall Study||23||
48588515|NCT00656487|101773514|FG001|STARTED|Overall Study||23||
48588516|NCT00656487|101773515|FG002|STARTED|Overall Study||20||
48588517|NCT00656487|101773513|FG000|COMPLETED|Overall Study||21||
48588518|NCT00656487|101773514|FG001|COMPLETED|Overall Study||19||
48588519|NCT00656487|101773515|FG002|COMPLETED|Overall Study||20||
48588520|NCT00656487|101773513|FG000|NOT COMPLETED|Overall Study||2||
48588521|NCT00656487|101773514|FG001|NOT COMPLETED|Overall Study||4||
48402438|NCT04731922|101317667|FG007|STARTED|Overall Study||6||
48402439|NCT04731922|101317668|FG008|STARTED|Overall Study||6||
48402440|NCT04731922|101317669|FG009|STARTED|Overall Study||6||
48402441|NCT04731922|101317670|FG010|STARTED|Overall Study||6||
48588522|NCT00656487|101773515|FG002|NOT COMPLETED|Overall Study||0||
48707217|NCT00969761|102069898|FG000|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1||
48707218|NCT00969761|102069899|FG001|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0||
48707219|NCT00969761|102069900|FG002|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||2||
48707220|NCT00969761|102069901|FG003|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1||
48707221|NCT00969761|102069902|FG004|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0||
48707222|NCT00969761|102069903|FG005|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0||
48707223|NCT00969761|102069904|FG006|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0||
48707224|NCT00969761|102069905|FG007|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0||
48707225|NCT00969761|102069906|FG008|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||2||
48707226|NCT00969761|102069907|FG009|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1||
48707227|NCT00969761|102069908|FG010|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0||
48707228|NCT00969761|102069909|FG011|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0||
48707229|NCT00969761|102069898|FG000|STARTED|Treated in and Beyond Treat. Cycle 2||2||
48290892|NCT00928447|101037675|FG000|COMPLETED|Overall Study||20||160
48290893|NCT00928447|101037675|FG000|NOT COMPLETED|Overall Study||2||16
48290894|NCT02875977|101037676|FG000|STARTED|Overall Study||100||
48290895|NCT02875977|101037677|FG001|STARTED|Overall Study||100||
48290896|NCT02875977|101037676|FG000|COMPLETED|Overall Study||58||
48290897|NCT02875977|101037677|FG001|COMPLETED|Overall Study||71||
48290898|NCT02875977|101037676|FG000|NOT COMPLETED|Overall Study||42||
48290899|NCT02875977|101037677|FG001|NOT COMPLETED|Overall Study||29||
48290900|NCT01439360|101037678|FG000|STARTED|Overall Study||6006||
48290901|NCT01439360|101037679|FG001|STARTED|Overall Study||6012||
48290902|NCT01439360|101037678|FG000|COMPLETED|Overall Study||5808||
48290903|NCT01439360|101037679|FG001|COMPLETED|Overall Study||5804||
48290904|NCT01439360|101037678|FG000|NOT COMPLETED|Overall Study||198||
48402442|NCT04731922|101317671|FG011|STARTED|Overall Study||6||
48588523|NCT01806961|101773516|FG000|STARTED|Overall Study||16||
48588524|NCT01806961|101773516|FG000|COMPLETED|Overall Study||0||
48588525|NCT01806961|101773516|FG000|NOT COMPLETED|Overall Study||16||
48588526|NCT02767492|101773517|FG000|STARTED|Overall Study||45||
48588527|NCT02767492|101773518|FG001|STARTED|Overall Study||45||
48588528|NCT02767492|101773517|FG000|COMPLETED|Overall Study||35||
48588529|NCT02767492|101773518|FG001|COMPLETED|Overall Study||35||
48588530|NCT02767492|101773517|FG000|NOT COMPLETED|Overall Study||10||
48588531|NCT02767492|101773518|FG001|NOT COMPLETED|Overall Study||10||
48588532|NCT02946073|101773519|FG000|STARTED|Titration Phase||811|Subjects were not randomized at this time, so all were receiving open-label CAM2038.|
48588533|NCT02946073|101773520|FG001|STARTED|Titration Phase||0|Subjects were not randomized at this time, so all were receiving open-label CAM2038.|
48588534|NCT02946073|101773521|FG002|STARTED|Titration Phase||98|Subjects were not randomized at this time, so all were receiving open-label CAM2038.|
48588535|NCT02946073|101773522|FG003|STARTED|Titration Phase||0|Subjects were not randomized at this time, so all were receiving open-label CAM2038.|
48588536|NCT02946073|101773519|FG000|COMPLETED|Titration Phase||222|Subjects were not randomized at this time, so all were receiving open-label CAM2038.|
48588537|NCT02946073|101773520|FG001|COMPLETED|Titration Phase||0|Subjects were not randomized at this time, so all were receiving open-label CAM2038.|
48588538|NCT02946073|101773521|FG002|COMPLETED|Titration Phase||75|Subjects were not randomized at this time, so all were receiving open-label CAM2038.|
48588539|NCT02946073|101773522|FG003|COMPLETED|Titration Phase||0|Subjects were not randomized at this time, so all were receiving open-label CAM2038.|
48588540|NCT02946073|101773519|FG000|NOT COMPLETED|Titration Phase||589||
48588541|NCT02946073|101773520|FG001|NOT COMPLETED|Titration Phase||0||
48588542|NCT02946073|101773521|FG002|NOT COMPLETED|Titration Phase||23||
48588543|NCT02946073|101773522|FG003|NOT COMPLETED|Titration Phase||0||
48588544|NCT02946073|101773519|FG000|STARTED|Double Blind Phase||112||
48290905|NCT01439360|101037679|FG001|NOT COMPLETED|Overall Study||208||
48290906|NCT02394951|101037680|FG000|STARTED|Period I||12||
48290907|NCT02394951|101037681|FG001|STARTED|Period I||14||
48290908|NCT02394951|101037680|FG000|COMPLETED|Period I||11||
48290909|NCT02394951|101037681|FG001|COMPLETED|Period I||13||
48290910|NCT02394951|101037680|FG000|NOT COMPLETED|Period I||1||
48290911|NCT02394951|101037681|FG001|NOT COMPLETED|Period I||1||
48290912|NCT02394951|101037680|FG000|STARTED|Period II||11||
48290913|NCT02394951|101037681|FG001|STARTED|Period II||13||
48290914|NCT02394951|101037680|FG000|COMPLETED|Period II||11||
48290915|NCT02394951|101037681|FG001|COMPLETED|Period II||9||
48290916|NCT02394951|101037680|FG000|NOT COMPLETED|Period II||0||
48402443|NCT04731922|101317672|FG012|STARTED|Overall Study||8||
48588545|NCT02946073|101773520|FG001|STARTED|Double Blind Phase||110||
48588546|NCT02946073|101773521|FG002|STARTED|Double Blind Phase||0||
48588547|NCT02946073|101773522|FG003|STARTED|Double Blind Phase||0||
48588548|NCT02946073|101773519|FG000|COMPLETED|Double Blind Phase||88||
48588549|NCT02946073|101773520|FG001|COMPLETED|Double Blind Phase||70||
48588550|NCT02946073|101773521|FG002|COMPLETED|Double Blind Phase||0||
48588551|NCT02946073|101773522|FG003|COMPLETED|Double Blind Phase||0||
48588552|NCT02946073|101773519|FG000|NOT COMPLETED|Double Blind Phase||24||
48588553|NCT02946073|101773520|FG001|NOT COMPLETED|Double Blind Phase||40||
48588554|NCT02946073|101773521|FG002|NOT COMPLETED|Double Blind Phase||0||
48588555|NCT02946073|101773522|FG003|NOT COMPLETED|Double Blind Phase||0||
48588556|NCT02946073|101773519|FG000|STARTED|Open Label Phase||0||
48588557|NCT02946073|101773520|FG001|STARTED|Open Label Phase||0||
48588558|NCT02946073|101773521|FG002|STARTED|Open Label Phase||75||
48588559|NCT02946073|101773522|FG003|STARTED|Open Label Phase||57||
48588560|NCT02946073|101773519|FG000|COMPLETED|Open Label Phase||0||
48139277|NCT03713593|100665559|FG000|STARTED|Overall Study||395||
48139278|NCT03713593|100665560|FG001|STARTED|Overall Study||399||
48139279|NCT03713593|100665559|FG000|COMPLETED|Overall Study||0||
48139280|NCT03713593|100665560|FG001|COMPLETED|Overall Study||0||
48139281|NCT03713593|100665559|FG000|NOT COMPLETED|Overall Study||395||
48139282|NCT03713593|100665560|FG001|NOT COMPLETED|Overall Study||399||
48139283|NCT02959437|100665561|FG000|STARTED|Overall Study||62||
48139284|NCT02959437|100665562|FG001|STARTED|Overall Study||8||
48290917|NCT02394951|101037681|FG001|NOT COMPLETED|Period II||4||
48290918|NCT03343301|101037682|FG000|STARTED|Overall Study||3||
48290919|NCT03343301|101037683|FG001|STARTED|Overall Study||9||
48290920|NCT03343301|101037682|FG000|Received Any Study Treatment|Overall Study||3||
48290921|NCT03343301|101037683|FG001|Received Any Study Treatment|Overall Study||9||
48290922|NCT03343301|101037682|FG000|COMPLETED|Overall Study||0||
48290923|NCT03343301|101037683|FG001|COMPLETED|Overall Study||0||
48290924|NCT03343301|101037682|FG000|NOT COMPLETED|Overall Study||3||
48290925|NCT03343301|101037683|FG001|NOT COMPLETED|Overall Study||9||
48588561|NCT02946073|101773520|FG001|COMPLETED|Open Label Phase||0||
48588562|NCT02946073|101773521|FG002|COMPLETED|Open Label Phase||54||
48588563|NCT02946073|101773522|FG003|COMPLETED|Open Label Phase||44||
48588564|NCT02946073|101773519|FG000|NOT COMPLETED|Open Label Phase||0||
48588565|NCT02946073|101773520|FG001|NOT COMPLETED|Open Label Phase||0||
48139285|NCT02959437|100665563|FG002|STARTED|Overall Study||0||
48139286|NCT02959437|100665564|FG003|STARTED|Overall Study||0||
48290926|NCT00812331|101037684|FG000|STARTED|Overall Study||6||
48290927|NCT00812331|101037685|FG001|STARTED|Overall Study||8||
48290928|NCT00812331|101037686|FG002|STARTED|Overall Study||8||
48290929|NCT00812331|101037687|FG003|STARTED|Overall Study||7||
48290930|NCT00812331|101037688|FG004|STARTED|Overall Study||8||
48290931|NCT00812331|101037684|FG000|COMPLETED|Overall Study||5||
48290932|NCT00812331|101037685|FG001|COMPLETED|Overall Study||8||
48290933|NCT00812331|101037686|FG002|COMPLETED|Overall Study||8||
48290934|NCT00812331|101037687|FG003|COMPLETED|Overall Study||7||
48290935|NCT00812331|101037688|FG004|COMPLETED|Overall Study||8||
48290936|NCT00812331|101037684|FG000|NOT COMPLETED|Overall Study||1||
48290937|NCT00812331|101037685|FG001|NOT COMPLETED|Overall Study||0||
48290938|NCT00812331|101037686|FG002|NOT COMPLETED|Overall Study||0||
48290939|NCT00812331|101037687|FG003|NOT COMPLETED|Overall Study||0||
48290940|NCT00812331|101037688|FG004|NOT COMPLETED|Overall Study||0||
48290941|NCT03430206|101037689|FG000|STARTED|Overall Study||40||
48588566|NCT02946073|101773521|FG002|NOT COMPLETED|Open Label Phase||21||
48588567|NCT02946073|101773522|FG003|NOT COMPLETED|Open Label Phase||13||
48588568|NCT05249127|101773523|FG000|STARTED|Overall Study||52||
48588569|NCT05249127|101773523|FG000|COMPLETED|Overall Study||32||
48588570|NCT05249127|101773523|FG000|NOT COMPLETED|Overall Study||20||
48588571|NCT00477750|101773524|FG000|STARTED|Overall Study||26||
48588572|NCT00477750|101773524|FG000|COMPLETED|Overall Study||15||
48588573|NCT00477750|101773524|FG000|NOT COMPLETED|Overall Study||11||
48588574|NCT01447446|101773525|FG000|STARTED|Overall Study||2312||
48588575|NCT01447446|101773526|FG001|STARTED|Overall Study||496||
48588576|NCT01447446|101773527|FG002|STARTED|Overall Study||292||
48139287|NCT02959437|100665561|FG000|COMPLETED|Overall Study||0||
48139288|NCT02959437|100665562|FG001|COMPLETED|Overall Study||0||
48290942|NCT03430206|101037690|FG001|STARTED|Overall Study||38||
48290943|NCT03430206|101037689|FG000|COMPLETED|Overall Study||18||
48290944|NCT03430206|101037690|FG001|COMPLETED|Overall Study||21||
48290945|NCT03430206|101037689|FG000|NOT COMPLETED|Overall Study||22||
48290946|NCT03430206|101037690|FG001|NOT COMPLETED|Overall Study||17||
48290947|NCT01162317|101037691|FG000|STARTED|Overall Study||30||
48290948|NCT01162317|101037692|FG001|STARTED|Overall Study||30||
48290949|NCT01162317|101037691|FG000|COMPLETED|Overall Study||27||
48139289|NCT02959437|100665563|FG002|COMPLETED|Overall Study||0||
48139290|NCT02959437|100665564|FG003|COMPLETED|Overall Study||0||
48290950|NCT01162317|101037692|FG001|COMPLETED|Overall Study||28||
48290951|NCT01162317|101037691|FG000|NOT COMPLETED|Overall Study||3||
48290952|NCT01162317|101037692|FG001|NOT COMPLETED|Overall Study||2||
48588577|NCT01447446|101773528|FG003|STARTED|Overall Study||93||
48588578|NCT01447446|101773529|FG004|STARTED|Overall Study||821||
48588579|NCT01447446|101773530|FG005|STARTED|Overall Study||86||
48707230|NCT00969761|102069899|FG001|STARTED|Treated in and Beyond Treat. Cycle 2||3||
48707231|NCT00969761|102069900|FG002|STARTED|Treated in and Beyond Treat. Cycle 2||10||
48707232|NCT00969761|102069901|FG003|STARTED|Treated in and Beyond Treat. Cycle 2||5||
48707233|NCT00969761|102069902|FG004|STARTED|Treated in and Beyond Treat. Cycle 2||3||
48707234|NCT00969761|102069903|FG005|STARTED|Treated in and Beyond Treat. Cycle 2||3||
48707235|NCT00969761|102069904|FG006|STARTED|Treated in and Beyond Treat. Cycle 2||3||
48707236|NCT00969761|102069905|FG007|STARTED|Treated in and Beyond Treat. Cycle 2||6||
48707237|NCT00969761|102069906|FG008|STARTED|Treated in and Beyond Treat. Cycle 2||11||
48707238|NCT00969761|102069907|FG009|STARTED|Treated in and Beyond Treat. Cycle 2||2||
48707239|NCT00969761|102069908|FG010|STARTED|Treated in and Beyond Treat. Cycle 2||3||
48707240|NCT00969761|102069909|FG011|STARTED|Treated in and Beyond Treat. Cycle 2||3||
48707241|NCT00969761|102069898|FG000|COMPLETED|Treated in and Beyond Treat. Cycle 2||0||
48707242|NCT00969761|102069899|FG001|COMPLETED|Treated in and Beyond Treat. Cycle 2||0||
48707243|NCT00969761|102069900|FG002|COMPLETED|Treated in and Beyond Treat. Cycle 2||0||
48707244|NCT00969761|102069901|FG003|COMPLETED|Treated in and Beyond Treat. Cycle 2||0||
48707245|NCT00969761|102069902|FG004|COMPLETED|Treated in and Beyond Treat. Cycle 2||0||
48707246|NCT00969761|102069903|FG005|COMPLETED|Treated in and Beyond Treat. Cycle 2||0||
48707247|NCT00969761|102069904|FG006|COMPLETED|Treated in and Beyond Treat. Cycle 2||0||
48402444|NCT04731922|101317673|FG013|STARTED|Overall Study||8||
48402445|NCT04731922|101317674|FG014|STARTED|Overall Study||6||
48402446|NCT04731922|101317675|FG015|STARTED|Overall Study||6||
48402447|NCT04731922|101317676|FG016|STARTED|Overall Study||6||
48402448|NCT04731922|101317660|FG000|COMPLETED|Overall Study||22||
48402449|NCT04731922|101317661|FG001|COMPLETED|Overall Study||6||
48402450|NCT04731922|101317662|FG002|COMPLETED|Overall Study||6||
48402451|NCT04731922|101317663|FG003|COMPLETED|Overall Study||5||
48402452|NCT04731922|101317664|FG004|COMPLETED|Overall Study||6||
48402453|NCT04731922|101317665|FG005|COMPLETED|Overall Study||5||
48402454|NCT04731922|101317666|FG006|COMPLETED|Overall Study||4||
48402455|NCT04731922|101317667|FG007|COMPLETED|Overall Study||6||
48402456|NCT04731922|101317668|FG008|COMPLETED|Overall Study||6||
48588580|NCT01447446|101773525|FG000|COMPLETED|Overall Study||1590||
48402457|NCT04731922|101317669|FG009|COMPLETED|Overall Study||6||
48402458|NCT04731922|101317670|FG010|COMPLETED|Overall Study||5||
48402459|NCT04731922|101317671|FG011|COMPLETED|Overall Study||6||
48402460|NCT04731922|101317672|FG012|COMPLETED|Overall Study||8||
48402461|NCT04731922|101317673|FG013|COMPLETED|Overall Study||7||
48402462|NCT04731922|101317674|FG014|COMPLETED|Overall Study||6||
48402463|NCT04731922|101317675|FG015|COMPLETED|Overall Study||6||
48402464|NCT04731922|101317676|FG016|COMPLETED|Overall Study||6||
48402465|NCT04731922|101317660|FG000|NOT COMPLETED|Overall Study||1||
48402466|NCT04731922|101317661|FG001|NOT COMPLETED|Overall Study||0||
48402467|NCT04731922|101317662|FG002|NOT COMPLETED|Overall Study||0||
48402468|NCT04731922|101317663|FG003|NOT COMPLETED|Overall Study||1||
48402469|NCT04731922|101317664|FG004|NOT COMPLETED|Overall Study||1||
48402470|NCT04731922|101317665|FG005|NOT COMPLETED|Overall Study||1||
48402471|NCT04731922|101317666|FG006|NOT COMPLETED|Overall Study||2||
48402472|NCT04731922|101317667|FG007|NOT COMPLETED|Overall Study||0||
48402473|NCT04731922|101317668|FG008|NOT COMPLETED|Overall Study||0||
48402474|NCT04731922|101317669|FG009|NOT COMPLETED|Overall Study||0||
48402475|NCT04731922|101317670|FG010|NOT COMPLETED|Overall Study||1||
48402476|NCT04731922|101317671|FG011|NOT COMPLETED|Overall Study||0||
48402477|NCT04731922|101317672|FG012|NOT COMPLETED|Overall Study||0||
48402478|NCT04731922|101317673|FG013|NOT COMPLETED|Overall Study||1||
48402479|NCT04731922|101317674|FG014|NOT COMPLETED|Overall Study||0||
48402480|NCT04731922|101317675|FG015|NOT COMPLETED|Overall Study||0||
48402481|NCT04731922|101317676|FG016|NOT COMPLETED|Overall Study||0||
48402482|NCT00607919|101317677|FG000|STARTED|Acute Phase||120||
48402483|NCT00607919|101317678|FG001|STARTED|Acute Phase||89||
48402484|NCT00607919|101317677|FG000|COMPLETED|Acute Phase||86||
48402485|NCT00607919|101317678|FG001|COMPLETED|Acute Phase||73||
48402486|NCT00607919|101317677|FG000|NOT COMPLETED|Acute Phase||34||
48402487|NCT00607919|101317678|FG001|NOT COMPLETED|Acute Phase||16||
48402488|NCT00607919|101317677|FG000|STARTED|Open-Label Phase||84||
48588581|NCT01447446|101773526|FG001|COMPLETED|Overall Study||331||
48588582|NCT01447446|101773527|FG002|COMPLETED|Overall Study||192||
48588583|NCT01447446|101773528|FG003|COMPLETED|Overall Study||60||
48588584|NCT01447446|101773529|FG004|COMPLETED|Overall Study||610||
48588585|NCT01447446|101773530|FG005|COMPLETED|Overall Study||54||
48588586|NCT01447446|101773525|FG000|NOT COMPLETED|Overall Study||722||
48588587|NCT01447446|101773526|FG001|NOT COMPLETED|Overall Study||165||
48588588|NCT01447446|101773527|FG002|NOT COMPLETED|Overall Study||100||
48402489|NCT00607919|101317678|FG001|STARTED|Open-Label Phase||71||
48402490|NCT00607919|101317677|FG000|COMPLETED|Open-Label Phase||74||
48588589|NCT01447446|101773528|FG003|NOT COMPLETED|Overall Study||33||
48707248|NCT00969761|102069905|FG007|COMPLETED|Treated in and Beyond Treat. Cycle 2||0||
48402491|NCT00607919|101317678|FG001|COMPLETED|Open-Label Phase||59||
48402492|NCT00607919|101317677|FG000|NOT COMPLETED|Open-Label Phase||10||
48402493|NCT00607919|101317678|FG001|NOT COMPLETED|Open-Label Phase||12||
48588590|NCT01447446|101773529|FG004|NOT COMPLETED|Overall Study||211||
48707249|NCT00969761|102069906|FG008|COMPLETED|Treated in and Beyond Treat. Cycle 2||0||
48707250|NCT00969761|102069907|FG009|COMPLETED|Treated in and Beyond Treat. Cycle 2||0||
48707251|NCT00969761|102069908|FG010|COMPLETED|Treated in and Beyond Treat. Cycle 2||0||
48707252|NCT00969761|102069909|FG011|COMPLETED|Treated in and Beyond Treat. Cycle 2||0||
48710772|NCT01924442|102078012|FG000|NOT COMPLETED|Overall Study||40||
48139291|NCT02959437|100665561|FG000|NOT COMPLETED|Overall Study||62||
48139292|NCT02959437|100665562|FG001|NOT COMPLETED|Overall Study||8||
48139293|NCT02959437|100665563|FG002|NOT COMPLETED|Overall Study||0||
48139294|NCT02959437|100665564|FG003|NOT COMPLETED|Overall Study||0||
48139295|NCT01452269|100665565|FG000|STARTED|Overall Study||48||
48139296|NCT01452269|100665566|FG001|STARTED|Overall Study||56||
48139297|NCT01452269|100665565|FG000|COMPLETED|Overall Study||47||
48139298|NCT01452269|100665566|FG001|COMPLETED|Overall Study||51||
48139299|NCT01452269|100665565|FG000|NOT COMPLETED|Overall Study||1||
48139300|NCT01452269|100665566|FG001|NOT COMPLETED|Overall Study||5||
48139301|NCT00688636|100665567|FG000|STARTED|Overall Study||11||
48139302|NCT00688636|100665568|FG001|STARTED|Overall Study||13||
48139303|NCT00688636|100665567|FG000|COMPLETED|Overall Study||9||
48139304|NCT00688636|100665568|FG001|COMPLETED|Overall Study||12||
48139305|NCT00688636|100665567|FG000|NOT COMPLETED|Overall Study||2||
48139306|NCT00688636|100665568|FG001|NOT COMPLETED|Overall Study||1||
48139307|NCT00182754|100665569|FG000|STARTED|Overall Study||16||
48290953|NCT02915302|101040616|FG000|STARTED|Overall Study||955||
48290954|NCT02915302|101040617|FG001|STARTED|Overall Study||995||
48290955|NCT02915302|101040616|FG000|Vaccinated (Safety Analysis Set)|Overall Study||949||
48290956|NCT02915302|101040617|FG001|Vaccinated (Safety Analysis Set)|Overall Study||992||
48290957|NCT02915302|101040616|FG000|COMPLETED|Overall Study||890||
48290958|NCT02915302|101040617|FG001|COMPLETED|Overall Study||917||
48290959|NCT02915302|101040616|FG000|NOT COMPLETED|Overall Study||65||
48290960|NCT02915302|101040617|FG001|NOT COMPLETED|Overall Study||78||
48290961|NCT02481947|101040618|FG000|STARTED|Overall Study||230||
48290962|NCT02481947|101040619|FG001|STARTED|Overall Study||229||
48588591|NCT01447446|101773530|FG005|NOT COMPLETED|Overall Study||32||
48588592|NCT04325698|101773531|FG000|STARTED|Overall Study||4||
48139308|NCT00182754|100665570|FG001|STARTED|Overall Study||17||
48139309|NCT00182754|100665569|FG000|COMPLETED|Overall Study||16||
48139310|NCT00182754|100665570|FG001|COMPLETED|Overall Study||17||
48139311|NCT00182754|100665569|FG000|NOT COMPLETED|Overall Study||0||
48139312|NCT00182754|100665570|FG001|NOT COMPLETED|Overall Study||0||
48139313|NCT02486328|100665571|FG000|STARTED|Overall Study||52||
48139314|NCT02486328|100665572|FG001|STARTED|Overall Study||51||
48139315|NCT02486328|100665571|FG000|COMPLETED|Overall Study||50||
48139316|NCT02486328|100665572|FG001|COMPLETED|Overall Study||50||
48139317|NCT02486328|100665571|FG000|NOT COMPLETED|Overall Study||2||
48139318|NCT02486328|100665572|FG001|NOT COMPLETED|Overall Study||1||
48139319|NCT02958969|100665573|FG000|STARTED|Overall Study||50||
48139320|NCT02958969|100665573|FG000|COMPLETED|Overall Study||50||
48290963|NCT02481947|101040618|FG000|COMPLETED|Overall Study||184||
48290964|NCT02481947|101040619|FG001|COMPLETED|Overall Study||193||
48290965|NCT02481947|101040618|FG000|NOT COMPLETED|Overall Study||46||
48290966|NCT02481947|101040619|FG001|NOT COMPLETED|Overall Study||36||
48290967|NCT01028937|101040620|FG000|STARTED|Overall Study||6||
48290968|NCT01028937|101040620|FG000|COMPLETED|Overall Study||6||
48290969|NCT01028937|101040620|FG000|NOT COMPLETED|Overall Study||0||
48290970|NCT02666846|101040621|FG000|STARTED|Overall Study||20||
48290971|NCT02666846|101040622|FG001|STARTED|Overall Study||20||
48290972|NCT02666846|101040623|FG002|STARTED|Overall Study||20||
48588593|NCT04325698|101773532|FG001|STARTED|Overall Study||4||
48588594|NCT04325698|101773531|FG000|COMPLETED|Overall Study||3||
48588595|NCT04325698|101773532|FG001|COMPLETED|Overall Study||1||
48588596|NCT04325698|101773531|FG000|NOT COMPLETED|Overall Study||1||
48588597|NCT04325698|101773532|FG001|NOT COMPLETED|Overall Study||3||
48588598|NCT01154088|101773533|FG000|STARTED|Overall Study||390||
48588599|NCT01154088|101773534|FG001|STARTED|Overall Study||390||
48588600|NCT01154088|101773535|FG002|STARTED|Overall Study||390||
48588601|NCT01154088|101773533|FG000|COMPLETED|Overall Study||386||
48588602|NCT01154088|101773534|FG001|COMPLETED|Overall Study||384||
48588603|NCT01154088|101773535|FG002|COMPLETED|Overall Study||383||
48588604|NCT01154088|101773533|FG000|NOT COMPLETED|Overall Study||4||
48588605|NCT01154088|101773534|FG001|NOT COMPLETED|Overall Study||6||
48588606|NCT01154088|101773535|FG002|NOT COMPLETED|Overall Study||7||
48588607|NCT03535740|101773536|FG000|STARTED|Overall Study||103||
48588608|NCT03535740|101773536|FG000|Participants Who Received Escalated Dose of Brigatinib 240 mg|Overall Study||13||
48588609|NCT03535740|101773536|FG000|COMPLETED|Overall Study||0||
48588610|NCT03535740|101773536|FG000|NOT COMPLETED|Overall Study||103||
48588611|NCT04506905|101773537|FG000|STARTED|Overall Study||6||
48588612|NCT04506905|101773538|FG001|STARTED|Overall Study||14||
48588613|NCT04506905|101773539|FG002|STARTED|Overall Study||0||
48588614|NCT04506905|101773540|FG003|STARTED|Overall Study||12||
48588615|NCT04506905|101773541|FG004|STARTED|Overall Study||0||
48588616|NCT04506905|101773542|FG005|STARTED|Overall Study||5||
48588617|NCT04506905|101773543|FG006|STARTED|Overall Study||13||
48588618|NCT04506905|101773544|FG007|STARTED|Overall Study||6||
48588619|NCT04506905|101773545|FG008|STARTED|Overall Study||7||
48588620|NCT04506905|101773537|FG000|COMPLETED|Overall Study||5||
48588621|NCT04506905|101773538|FG001|COMPLETED|Overall Study||14||
48588622|NCT04506905|101773539|FG002|COMPLETED|Overall Study||0||
48588623|NCT04506905|101773540|FG003|COMPLETED|Overall Study||9||
48588624|NCT04506905|101773541|FG004|COMPLETED|Overall Study||0||
48588625|NCT04506905|101773542|FG005|COMPLETED|Overall Study||5||
48588626|NCT04506905|101773543|FG006|COMPLETED|Overall Study||13||
48588627|NCT04506905|101773544|FG007|COMPLETED|Overall Study||6||
48588628|NCT04506905|101773545|FG008|COMPLETED|Overall Study||7||
48588629|NCT04506905|101773537|FG000|NOT COMPLETED|Overall Study||1||
48588630|NCT04506905|101773538|FG001|NOT COMPLETED|Overall Study||0||
48588631|NCT04506905|101773539|FG002|NOT COMPLETED|Overall Study||0||
48588632|NCT04506905|101773540|FG003|NOT COMPLETED|Overall Study||3||
48588633|NCT04506905|101773541|FG004|NOT COMPLETED|Overall Study||0||
48588634|NCT04506905|101773542|FG005|NOT COMPLETED|Overall Study||0||
48588635|NCT04506905|101773543|FG006|NOT COMPLETED|Overall Study||0||
48588636|NCT04506905|101773544|FG007|NOT COMPLETED|Overall Study||0||
48588637|NCT04506905|101773545|FG008|NOT COMPLETED|Overall Study||0||
48588638|NCT00984139|101773546|FG000|STARTED|Overall Study||306||
48588639|NCT00984139|101773546|FG000|COMPLETED|Overall Study||306||
48588640|NCT00984139|101773546|FG000|NOT COMPLETED|Overall Study||0||
48588641|NCT02658734|101773547|FG000|STARTED|Overall Study||70||
48588642|NCT02658734|101773547|FG000|COMPLETED|Overall Study||13||
48588643|NCT02658734|101773547|FG000|NOT COMPLETED|Overall Study||57||
48588644|NCT01867294|101773548|FG000|STARTED|Overall Study||9||
48588645|NCT01867294|101773549|FG001|STARTED|Overall Study||10||
48588646|NCT01867294|101773550|FG002|STARTED|Overall Study||0||
48588647|NCT01867294|101773551|FG003|STARTED|Overall Study||0||
48588648|NCT01867294|101773548|FG000|COMPLETED|Overall Study||8||
48588649|NCT01867294|101773549|FG001|COMPLETED|Overall Study||9||
48707253|NCT00969761|102069898|FG000|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||2||
48707254|NCT00969761|102069899|FG001|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3||
48707255|NCT00969761|102069900|FG002|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||10||
48707256|NCT00969761|102069901|FG003|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||5||
48707257|NCT00969761|102069902|FG004|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3||
48588650|NCT01867294|101773550|FG002|COMPLETED|Overall Study||0||
48588651|NCT01867294|101773551|FG003|COMPLETED|Overall Study||0||
48588652|NCT01867294|101773548|FG000|NOT COMPLETED|Overall Study||1||
48588653|NCT01867294|101773549|FG001|NOT COMPLETED|Overall Study||1||
48588654|NCT01867294|101773550|FG002|NOT COMPLETED|Overall Study||0||
48588655|NCT01867294|101773551|FG003|NOT COMPLETED|Overall Study||0||
48588656|NCT00654875|101773552|FG000|STARTED|Overall Study||164||
48588657|NCT00654875|101773553|FG001|STARTED|Overall Study||164||
48588658|NCT00654875|101773552|FG000|COMPLETED|Overall Study||147||
48588659|NCT00654875|101773553|FG001|COMPLETED|Overall Study||147||
48588660|NCT00654875|101773552|FG000|NOT COMPLETED|Overall Study||17||
48588661|NCT00654875|101773553|FG001|NOT COMPLETED|Overall Study||17||
48588662|NCT03692325|101773554|FG000|STARTED|Overall Study||33||
48588663|NCT03692325|101773554|FG000|COMPLETED|Overall Study||29||
48588664|NCT03692325|101773554|FG000|NOT COMPLETED|Overall Study||4||
48588665|NCT03721835|101773555|FG000|STARTED|Overall Study||15||
48588666|NCT03721835|101773555|FG000|COMPLETED|Overall Study||3||
48588667|NCT03721835|101773555|FG000|NOT COMPLETED|Overall Study||12||
48588668|NCT01438294|101773556|FG000|STARTED|Overall Study||16||
48588669|NCT01438294|101773557|FG001|STARTED|Overall Study||20||
48588670|NCT01438294|101773556|FG000|COMPLETED|Overall Study||13||
48588671|NCT01438294|101773557|FG001|COMPLETED|Overall Study||13||
48588672|NCT01438294|101773556|FG000|NOT COMPLETED|Overall Study||3||
48588673|NCT01438294|101773557|FG001|NOT COMPLETED|Overall Study||7||
48588674|NCT00546117|101773558|FG000|STARTED|Overall Study||9||
48588675|NCT00546117|101773559|FG001|STARTED|Overall Study||7||
48588676|NCT00546117|101773558|FG000|COMPLETED|Overall Study||5||
48588677|NCT00546117|101773559|FG001|COMPLETED|Overall Study||7||
48588678|NCT00546117|101773558|FG000|NOT COMPLETED|Overall Study||4||
48588679|NCT00546117|101773559|FG001|NOT COMPLETED|Overall Study||0||
48588680|NCT00474786|101773560|FG000|STARTED|Overall Study||259||
48588681|NCT00474786|101773561|FG001|STARTED|Overall Study||253||
48588682|NCT00474786|101773560|FG000|COMPLETED|Overall Study||0||
48588683|NCT00474786|101773561|FG001|COMPLETED|Overall Study||0||
48588684|NCT00474786|101773560|FG000|NOT COMPLETED|Overall Study||259||
48588685|NCT00474786|101773561|FG001|NOT COMPLETED|Overall Study||253||
48588686|NCT05028075|101773562|FG000|STARTED|Overall Study||633||
48588687|NCT05028075|101773563|FG001|STARTED|Overall Study||642||
48588688|NCT05028075|101773562|FG000|COMPLETED|Overall Study||509||
48588689|NCT05028075|101773563|FG001|COMPLETED|Overall Study||462||
48588690|NCT05028075|101773562|FG000|NOT COMPLETED|Overall Study||124||
48707258|NCT00969761|102069903|FG005|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3||
48139321|NCT02958969|100665573|FG000|NOT COMPLETED|Overall Study||0||
48588691|NCT05028075|101773563|FG001|NOT COMPLETED|Overall Study||180||
48588692|NCT02860000|101773564|FG000|STARTED|Initial Treatment||47||
48588693|NCT02860000|101773565|FG001|STARTED|Initial Treatment||49||
48588694|NCT02860000|101773564|FG000|COMPLETED|Initial Treatment||46||
48588695|NCT02860000|101773565|FG001|COMPLETED|Initial Treatment||45||
48588696|NCT02860000|101773564|FG000|NOT COMPLETED|Initial Treatment||1||
48588697|NCT02860000|101773565|FG001|NOT COMPLETED|Initial Treatment||4||
48588698|NCT02860000|101773564|FG000|STARTED|Optional Cross-over||17||
48588699|NCT02860000|101773565|FG001|STARTED|Optional Cross-over||0||
48588700|NCT02860000|101773564|FG000|COMPLETED|Optional Cross-over||17||
48588701|NCT02860000|101773565|FG001|COMPLETED|Optional Cross-over||0||
48588702|NCT02860000|101773564|FG000|NOT COMPLETED|Optional Cross-over||0||
48588703|NCT02860000|101773565|FG001|NOT COMPLETED|Optional Cross-over||0||
48588704|NCT04114357|101773566|FG000|STARTED|Baseline-Randomization||6||
48588705|NCT04114357|101773567|FG001|STARTED|Baseline-Randomization||6||
48588706|NCT04114357|101773566|FG000|COMPLETED|Baseline-Randomization||3||
48588707|NCT04114357|101773567|FG001|COMPLETED|Baseline-Randomization||4||
48588708|NCT04114357|101773566|FG000|NOT COMPLETED|Baseline-Randomization||3||
48588709|NCT04114357|101773567|FG001|NOT COMPLETED|Baseline-Randomization||2||
48588710|NCT04114357|101773566|FG000|STARTED|Cross-over||3||
48588711|NCT04114357|101773567|FG001|STARTED|Cross-over||4||
48588712|NCT04114357|101773566|FG000|COMPLETED|Cross-over||3||
48588713|NCT04114357|101773567|FG001|COMPLETED|Cross-over||3||
48588714|NCT04114357|101773566|FG000|NOT COMPLETED|Cross-over||0||
48588715|NCT04114357|101773567|FG001|NOT COMPLETED|Cross-over||1||
48588716|NCT04972968|101773568|FG000|STARTED|Overall Study||50||
48588717|NCT04972968|101773569|FG001|STARTED|Overall Study||42||
48588718|NCT04972968|101773570|FG002|STARTED|Overall Study||45||
48588719|NCT04972968|101773571|FG003|STARTED|Overall Study||44||
48588720|NCT04972968|101773568|FG000|COMPLETED|Overall Study||12||
48588721|NCT04972968|101773569|FG001|COMPLETED|Overall Study||8||
48588722|NCT04972968|101773570|FG002|COMPLETED|Overall Study||8||
48588723|NCT04972968|101773571|FG003|COMPLETED|Overall Study||7||
48588724|NCT04972968|101773568|FG000|NOT COMPLETED|Overall Study||38||
48588725|NCT04972968|101773569|FG001|NOT COMPLETED|Overall Study||34||
48588726|NCT04972968|101773570|FG002|NOT COMPLETED|Overall Study||37||
48588727|NCT04972968|101773571|FG003|NOT COMPLETED|Overall Study||37||
48588728|NCT02589522|101773572|FG000|STARTED|Overall Study||11||
48588729|NCT02589522|101773573|FG001|STARTED|Overall Study||4||
48588730|NCT02589522|101773574|FG002|STARTED|Overall Study||0||
48588731|NCT02589522|101773572|FG000|COMPLETED|Overall Study||9||
48588732|NCT02589522|101773573|FG001|COMPLETED|Overall Study||2||
48588733|NCT02589522|101773574|FG002|COMPLETED|Overall Study||0||
48588734|NCT02589522|101773572|FG000|NOT COMPLETED|Overall Study||2||
48588735|NCT02589522|101773573|FG001|NOT COMPLETED|Overall Study||2||
48588736|NCT02589522|101773574|FG002|NOT COMPLETED|Overall Study||0||
48707259|NCT00969761|102069904|FG006|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3||
48707260|NCT00969761|102069905|FG007|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||6||
48707261|NCT00969761|102069906|FG008|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||11||
48707262|NCT00969761|102069907|FG009|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||2||
48707263|NCT00969761|102069908|FG010|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3||
48707264|NCT00969761|102069909|FG011|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3||
48707265|NCT01323270|102069910|FG000|STARTED|Overall Study||373||
48707266|NCT01323270|102069911|FG001|STARTED|Overall Study||376||
48707267|NCT01323270|102069910|FG000|COMPLETED|Overall Study||330||
48707268|NCT01323270|102069911|FG001|COMPLETED|Overall Study||347||
48707269|NCT01323270|102069910|FG000|NOT COMPLETED|Overall Study||43||
48707270|NCT01323270|102069911|FG001|NOT COMPLETED|Overall Study||29||
48707271|NCT01819129|102069912|FG000|STARTED|Overall Study||345||
48707272|NCT01819129|102069913|FG001|STARTED|Overall Study||344||
48139322|NCT03317977|100665574|FG000|STARTED|Overall Study||36||
48588737|NCT03602391|101773575|FG000|STARTED|Overall Study||11||
48588738|NCT03602391|101773576|FG001|STARTED|Overall Study||9||
48588739|NCT03602391|101773575|FG000|COMPLETED|Overall Study||4||
48588740|NCT03602391|101773576|FG001|COMPLETED|Overall Study||3||
48588741|NCT03602391|101773575|FG000|NOT COMPLETED|Overall Study||7||
48588742|NCT03602391|101773576|FG001|NOT COMPLETED|Overall Study||6||
48588743|NCT01730534|101773577|FG000|STARTED|Overall Study||8582||
48588744|NCT01730534|101773578|FG001|STARTED|Overall Study||8578||
48588745|NCT01730534|101773577|FG000|COMPLETED|Overall Study||8473||
48588746|NCT01730534|101773578|FG001|COMPLETED|Overall Study||8433||
48707273|NCT01819129|102069912|FG000|Exposed|Overall Study||341||
48588747|NCT01730534|101773577|FG000|NOT COMPLETED|Overall Study||109||
48707274|NCT01819129|102069913|FG001|Exposed|Overall Study||341||
48707275|NCT01819129|102069912|FG000|COMPLETED|Overall Study||301||
48588748|NCT01730534|101773578|FG001|NOT COMPLETED|Overall Study||145||
48707276|NCT01819129|102069913|FG001|COMPLETED|Overall Study||305||
48707277|NCT01819129|102069912|FG000|NOT COMPLETED|Overall Study||44||
48588749|NCT00602290|101773579|FG000|STARTED|Overall Study||48||
48707278|NCT01819129|102069913|FG001|NOT COMPLETED|Overall Study||39||
48139323|NCT03317977|100665575|FG001|STARTED|Overall Study||39||
48588750|NCT00602290|101773580|FG001|STARTED|Overall Study||48||
48588751|NCT00602290|101773581|FG002|STARTED|Overall Study||47||
48588752|NCT00602290|101773579|FG000|COMPLETED|Overall Study||46||
48588753|NCT00602290|101773580|FG001|COMPLETED|Overall Study||46||
48588754|NCT00602290|101773581|FG002|COMPLETED|Overall Study||46||
48588755|NCT00602290|101773579|FG000|NOT COMPLETED|Overall Study||2||
48588756|NCT00602290|101773580|FG001|NOT COMPLETED|Overall Study||2||
48588757|NCT00602290|101773581|FG002|NOT COMPLETED|Overall Study||1||
48588758|NCT03998163|101773582|FG000|STARTED|Overall Study||222||
48588759|NCT03998163|101773582|FG000|COMPLETED|Overall Study||197||
48588760|NCT03998163|101773582|FG000|NOT COMPLETED|Overall Study||25||
48588761|NCT01104246|101773583|FG000|STARTED|Overall Study||40||
48588762|NCT01104246|101773583|FG000|Baseline Characteristics Measured|Overall Study||35||
48588763|NCT01104246|101773583|FG000|COMPLETED|Overall Study||35||
48588764|NCT01104246|101773583|FG000|NOT COMPLETED|Overall Study||5||
48588765|NCT01550705|101773584|FG000|STARTED|Overall Study||11||
48588766|NCT01550705|101773584|FG000|COMPLETED|Overall Study||10||
48588767|NCT01550705|101773584|FG000|NOT COMPLETED|Overall Study||1||
48588768|NCT05397171|101773585|FG000|STARTED|Overall Study||3||
48588769|NCT05397171|101773586|FG001|STARTED|Overall Study||6||
48588770|NCT05397171|101773587|FG002|STARTED|Overall Study||7||
48588771|NCT05397171|101773585|FG000|COMPLETED|Overall Study||0||
48588772|NCT05397171|101773586|FG001|COMPLETED|Overall Study||0||
48290973|NCT02666846|101040621|FG000|COMPLETED|Overall Study||20||
48290974|NCT02666846|101040622|FG001|COMPLETED|Overall Study||20||
48290975|NCT02666846|101040623|FG002|COMPLETED|Overall Study||20||
48290976|NCT02666846|101040621|FG000|NOT COMPLETED|Overall Study||0||
48290977|NCT02666846|101040622|FG001|NOT COMPLETED|Overall Study||0||
48290978|NCT02666846|101040623|FG002|NOT COMPLETED|Overall Study||0||
48290979|NCT01774487|101040624|FG000|STARTED|Overall Study||12||
48290980|NCT01774487|101040625|FG001|STARTED|Overall Study||5||
48290981|NCT01774487|101040624|FG000|COMPLETED|Overall Study||8||
48290982|NCT01774487|101040625|FG001|COMPLETED|Overall Study||1||
48290983|NCT01774487|101040624|FG000|NOT COMPLETED|Overall Study||4||
48290984|NCT01774487|101040625|FG001|NOT COMPLETED|Overall Study||4||
48290985|NCT04262817|101040626|FG000|STARTED|Overall Study||16||
48588773|NCT05397171|101773587|FG002|COMPLETED|Overall Study||0||
48588774|NCT05397171|101773585|FG000|NOT COMPLETED|Overall Study||3||
48588775|NCT05397171|101773586|FG001|NOT COMPLETED|Overall Study||6||
48588776|NCT05397171|101773587|FG002|NOT COMPLETED|Overall Study||7||
48588777|NCT02499146|101773588|FG000|STARTED|Overall Study||26||
48588778|NCT02499146|101773588|FG000|COMPLETED|Overall Study||0||
48588779|NCT02499146|101773588|FG000|NOT COMPLETED|Overall Study||26||
48588780|NCT02375555|101773589|FG000|STARTED|Induction Period||40||
48588781|NCT02375555|101773589|FG000|Induction Therapy Cycles 1-4|Induction Period||34||
48588782|NCT02375555|101773589|FG000|Induction Therapy Cycles 5-8|Induction Period||12||
48588783|NCT02375555|101773589|FG000|Autologous Stem Cell Transplant|Induction Period||19||
48588784|NCT02375555|101773589|FG000|COMPLETED|Induction Period||29||
48588785|NCT02375555|101773589|FG000|NOT COMPLETED|Induction Period||11||
48588786|NCT02375555|101773589|FG000|STARTED|Maintenance Period||29||
48588787|NCT02375555|101773589|FG000|COMPLETED|Maintenance Period||0||
48588788|NCT02375555|101773589|FG000|NOT COMPLETED|Maintenance Period||29||
48588789|NCT02407457|101773590|FG000|STARTED|Baseline||235||
48588790|NCT02407457|101773591|FG001|STARTED|Baseline||220||
48588791|NCT02407457|101773590|FG000|COMPLETED|Baseline||235||
48588792|NCT02407457|101773591|FG001|COMPLETED|Baseline||220||
48588793|NCT02407457|101773590|FG000|NOT COMPLETED|Baseline||0||
48588794|NCT02407457|101773591|FG001|NOT COMPLETED|Baseline||0||
48290986|NCT04262817|101040626|FG000|Freebase Tobacco Flavor Completed|Overall Study||16||
48290987|NCT04262817|101040626|FG000|Freebase Menthol Flavor Completed|Overall Study||16||
48290988|NCT04262817|101040626|FG000|Nicotine Salt Tobacco Flavor Completed|Overall Study||16||
48290989|NCT04262817|101040626|FG000|Nicotine Salt Menthol Flavor Completed|Overall Study||16||
48588795|NCT02407457|101773590|FG000|STARTED|1 Month||235||
48588796|NCT02407457|101773591|FG001|STARTED|1 Month||220||
48588797|NCT02407457|101773590|FG000|COMPLETED|1 Month||229||
48588798|NCT02407457|101773591|FG001|COMPLETED|1 Month||214||
48290990|NCT04262817|101040626|FG000|COMPLETED|Overall Study||16||
48290991|NCT04262817|101040626|FG000|NOT COMPLETED|Overall Study||0||
48290992|NCT02344004|101040627|FG000|STARTED|Overall Study||224||
48588799|NCT02407457|101773590|FG000|NOT COMPLETED|1 Month||6||
48588800|NCT02407457|101773591|FG001|NOT COMPLETED|1 Month||6||
48402494|NCT04498468|101317679|FG000|STARTED|Overall Study||77||154
48402495|NCT04498468|101317679|FG000|COMPLETED|Overall Study||74||148
48402496|NCT04498468|101317679|FG000|NOT COMPLETED|Overall Study||3||6
48402497|NCT03289052|101317680|FG000|STARTED|Overall Study||20||
48402498|NCT03289052|101317681|FG001|STARTED|Overall Study||111||
48402499|NCT03289052|101317682|FG002|STARTED|Overall Study||37||
48402500|NCT03289052|101317680|FG000|COMPLETED|Overall Study||20||
48402501|NCT03289052|101317681|FG001|COMPLETED|Overall Study||108||
48402502|NCT03289052|101317682|FG002|COMPLETED|Overall Study||32||
48402503|NCT03289052|101317680|FG000|NOT COMPLETED|Overall Study||0||
48402504|NCT03289052|101317681|FG001|NOT COMPLETED|Overall Study||3||
48402505|NCT03289052|101317682|FG002|NOT COMPLETED|Overall Study||5||
48402506|NCT02725268|101317683|FG000|STARTED|Overall Study||90||
48402507|NCT02725268|101317684|FG001|STARTED|Overall Study||90||
48402508|NCT02725268|101317685|FG002|STARTED|Overall Study||41||
48707279|NCT01686750|102069914|FG000|STARTED|Overall Study||11001||11
48707280|NCT01686750|102069915|FG001|STARTED|Overall Study||10725||11
48707281|NCT01686750|102069914|FG000|COMPLETED|Overall Study||11001||11
48707282|NCT01686750|102069915|FG001|COMPLETED|Overall Study||10725||11
48707283|NCT01686750|102069914|FG000|NOT COMPLETED|Overall Study||0||0
48707284|NCT01686750|102069915|FG001|NOT COMPLETED|Overall Study||0||0
48707285|NCT00645528|102069916|FG000|STARTED|Overall Study||39||
48402509|NCT02725268|101317686|FG003|STARTED|Overall Study||20||
48402510|NCT02725268|101317683|FG000|Started|Overall Study||90||
48402511|NCT02725268|101317684|FG001|Started|Overall Study||90||
48402512|NCT02725268|101317685|FG002|Started|Overall Study||41||
48402513|NCT02725268|101317686|FG003|Started|Overall Study||20||
48402514|NCT02725268|101317683|FG000|Completed|Overall Study||18||
48402515|NCT02725268|101317684|FG001|Completed|Overall Study||20||
48402516|NCT02725268|101317685|FG002|Completed|Overall Study||3||
48707286|NCT00645528|102069916|FG000|COMPLETED|Overall Study||32||
48707287|NCT00645528|102069916|FG000|NOT COMPLETED|Overall Study||7||
48707288|NCT02323204|102069917|FG000|STARTED|Baseline Survey Completion||155||
48707289|NCT02323204|102069918|FG001|STARTED|Baseline Survey Completion||155||
48139324|NCT03317977|100665574|FG000|COMPLETED|Overall Study||31||
48139325|NCT03317977|100665575|FG001|COMPLETED|Overall Study||35||
48139326|NCT03317977|100665574|FG000|NOT COMPLETED|Overall Study||5||
48402517|NCT02725268|101317686|FG003|Completed|Overall Study||2||
48402518|NCT02725268|101317683|FG000|COMPLETED|Overall Study||18||
48402519|NCT02725268|101317684|FG001|COMPLETED|Overall Study||20||
48402520|NCT02725268|101317685|FG002|COMPLETED|Overall Study||3||
48402521|NCT02725268|101317686|FG003|COMPLETED|Overall Study||2||
48402522|NCT02725268|101317683|FG000|NOT COMPLETED|Overall Study||72||
48402523|NCT02725268|101317684|FG001|NOT COMPLETED|Overall Study||70||
48402524|NCT02725268|101317685|FG002|NOT COMPLETED|Overall Study||38||
48402525|NCT02725268|101317686|FG003|NOT COMPLETED|Overall Study||18||
48402526|NCT00136357|101317687|FG000|STARTED|Overall Study||41||
48402527|NCT00136357|101317688|FG001|STARTED|Overall Study||41||
48402528|NCT00136357|101317687|FG000|COMPLETED|Overall Study||38||
48402529|NCT00136357|101317688|FG001|COMPLETED|Overall Study||39||
48402530|NCT00136357|101317687|FG000|NOT COMPLETED|Overall Study||3||
48402531|NCT00136357|101317688|FG001|NOT COMPLETED|Overall Study||2||
48402532|NCT03654560|101317689|FG000|STARTED|Overall Study||118||
48402533|NCT03654560|101317690|FG001|STARTED|Overall Study||118||
48402534|NCT03654560|101317689|FG000|COMPLETED|Overall Study||114||
48402535|NCT03654560|101317690|FG001|COMPLETED|Overall Study||117||
48402536|NCT03654560|101317689|FG000|NOT COMPLETED|Overall Study||4||
48402537|NCT03654560|101317690|FG001|NOT COMPLETED|Overall Study||1||
48402538|NCT00425945|101317691|FG000|STARTED|Overall Study||64||
48707290|NCT02323204|102069919|FG002|STARTED|Baseline Survey Completion||159||
48139327|NCT03317977|100665575|FG001|NOT COMPLETED|Overall Study||4||
48139328|NCT01064739|100665576|FG000|STARTED|Fixed Sodium Study Diet||14||
48402539|NCT00425945|101317692|FG001|STARTED|Overall Study||66||
48707291|NCT02323204|102069920|FG003|STARTED|Baseline Survey Completion||159||
48707292|NCT02323204|102069917|FG000|COMPLETED|Baseline Survey Completion||145||
48707293|NCT02323204|102069918|FG001|COMPLETED|Baseline Survey Completion||146||
48707294|NCT02323204|102069919|FG002|COMPLETED|Baseline Survey Completion||154||
48707295|NCT02323204|102069920|FG003|COMPLETED|Baseline Survey Completion||156||
48707296|NCT02323204|102069917|FG000|NOT COMPLETED|Baseline Survey Completion||10||
48707297|NCT02323204|102069918|FG001|NOT COMPLETED|Baseline Survey Completion||9||
48707298|NCT02323204|102069919|FG002|NOT COMPLETED|Baseline Survey Completion||5||
48707299|NCT02323204|102069920|FG003|NOT COMPLETED|Baseline Survey Completion||3||
48707300|NCT02323204|102069917|FG000|STARTED|6-week Follow-up Survey Completion||145||
48707301|NCT02323204|102069918|FG001|STARTED|6-week Follow-up Survey Completion||146||
48588801|NCT02407457|101773590|FG000|STARTED|6-Month||231||
48588802|NCT02407457|101773591|FG001|STARTED|6-Month||219||
48588803|NCT02407457|101773590|FG000|COMPLETED|6-Month||211||
48588804|NCT02407457|101773591|FG001|COMPLETED|6-Month||194||
48588805|NCT02407457|101773590|FG000|NOT COMPLETED|6-Month||20||
48588806|NCT02407457|101773591|FG001|NOT COMPLETED|6-Month||25||
48139329|NCT01064739|100665576|FG000|COMPLETED|Fixed Sodium Study Diet||14||
48139330|NCT01064739|100665576|FG000|NOT COMPLETED|Fixed Sodium Study Diet||0||
48139331|NCT01064739|100665576|FG000|STARTED|Fixed Sodium Diet + Fava Beans||14||
48139332|NCT01064739|100665576|FG000|COMPLETED|Fixed Sodium Diet + Fava Beans||13||
48139333|NCT01064739|100665576|FG000|NOT COMPLETED|Fixed Sodium Diet + Fava Beans||1||
48139334|NCT02142049|100665577|FG000|STARTED|Overall Study||3||
48139335|NCT02142049|100665578|FG001|STARTED|Overall Study||3||
48139336|NCT02142049|100665579|FG002|STARTED|Overall Study||3||
48139337|NCT02142049|100665580|FG003|STARTED|Overall Study||6||
48139338|NCT02142049|100665581|FG004|STARTED|Overall Study||20||
48139339|NCT02142049|100665577|FG000|COMPLETED|Overall Study||3||
48588807|NCT02407457|101773590|FG000|STARTED|1 Year||227||
48588808|NCT02407457|101773591|FG001|STARTED|1 Year||208||
48588809|NCT02407457|101773590|FG000|COMPLETED|1 Year||194||
48588810|NCT02407457|101773591|FG001|COMPLETED|1 Year||180||
48588811|NCT02407457|101773590|FG000|NOT COMPLETED|1 Year||33||
48588812|NCT02407457|101773591|FG001|NOT COMPLETED|1 Year||28||
48588813|NCT02407457|101773590|FG000|STARTED|2-year||218||
48588814|NCT02407457|101773591|FG001|STARTED|2-year||194||
48588815|NCT02407457|101773590|FG000|COMPLETED|2-year||184||
48588816|NCT02407457|101773591|FG001|COMPLETED|2-year||159||
48588817|NCT02407457|101773590|FG000|NOT COMPLETED|2-year||34||
48588818|NCT02407457|101773591|FG001|NOT COMPLETED|2-year||35||
48588819|NCT02407457|101773590|FG000|STARTED|3-year||197||
48588820|NCT02407457|101773591|FG001|STARTED|3-year||174||
48588821|NCT02407457|101773590|FG000|COMPLETED|3-year||158||
48588822|NCT02407457|101773591|FG001|COMPLETED|3-year||138||
48588823|NCT02407457|101773590|FG000|NOT COMPLETED|3-year||39||
48588824|NCT02407457|101773591|FG001|NOT COMPLETED|3-year||36||
48588825|NCT02407457|101773590|FG000|STARTED|4-year||177||
48588826|NCT02407457|101773591|FG001|STARTED|4-year||133||
48588827|NCT02407457|101773590|FG000|COMPLETED|4-year||131||
48588828|NCT02407457|101773591|FG001|COMPLETED|4-year||95||
48588829|NCT02407457|101773590|FG000|NOT COMPLETED|4-year||46||
48588830|NCT02407457|101773591|FG001|NOT COMPLETED|4-year||38||
48707302|NCT02323204|102069919|FG002|STARTED|6-week Follow-up Survey Completion||154||
48707303|NCT02323204|102069920|FG003|STARTED|6-week Follow-up Survey Completion||156||
48707304|NCT02323204|102069917|FG000|COMPLETED|6-week Follow-up Survey Completion||104||
48707305|NCT02323204|102069918|FG001|COMPLETED|6-week Follow-up Survey Completion||110||
48707306|NCT02323204|102069919|FG002|COMPLETED|6-week Follow-up Survey Completion||112||
48707307|NCT02323204|102069920|FG003|COMPLETED|6-week Follow-up Survey Completion||119||
48139340|NCT02142049|100665578|FG001|COMPLETED|Overall Study||3||
48139341|NCT02142049|100665579|FG002|COMPLETED|Overall Study||3||
48139342|NCT02142049|100665580|FG003|COMPLETED|Overall Study||6||
48139343|NCT02142049|100665581|FG004|COMPLETED|Overall Study||20||
48139344|NCT02142049|100665577|FG000|NOT COMPLETED|Overall Study||0||
48139345|NCT02142049|100665578|FG001|NOT COMPLETED|Overall Study||0||
48139346|NCT02142049|100665579|FG002|NOT COMPLETED|Overall Study||0||
48139347|NCT02142049|100665580|FG003|NOT COMPLETED|Overall Study||0||
48139348|NCT02142049|100665581|FG004|NOT COMPLETED|Overall Study||0||
48139349|NCT03058679|100665582|FG000|STARTED|Baseline to Week 6||99||
48588831|NCT02407457|101773590|FG000|STARTED|5-year||148||
48588832|NCT02407457|101773591|FG001|STARTED|5-year||131||
48588833|NCT02407457|101773590|FG000|COMPLETED|5-year||107||
48588834|NCT02407457|101773591|FG001|COMPLETED|5-year||114||
48588835|NCT02407457|101773590|FG000|NOT COMPLETED|5-year||41||
48588836|NCT02407457|101773591|FG001|NOT COMPLETED|5-year||17||
48588837|NCT04598451|101773592|FG000|STARTED|Overall Study||147||
48588838|NCT04598451|101773593|FG001|STARTED|Overall Study||75||
48139350|NCT03058679|100665583|FG001|STARTED|Baseline to Week 6||92||
48139351|NCT03058679|100665582|FG000|COMPLETED|Baseline to Week 6||81||
48139352|NCT03058679|100665583|FG001|COMPLETED|Baseline to Week 6||77||
48588839|NCT04598451|101773592|FG000|COMPLETED|Overall Study||104||
48588840|NCT04598451|101773593|FG001|COMPLETED|Overall Study||46||
48588841|NCT04598451|101773592|FG000|NOT COMPLETED|Overall Study||43||
48588842|NCT04598451|101773593|FG001|NOT COMPLETED|Overall Study||29||
48588843|NCT03783130|101773594|FG000|STARTED|Overall Study||3||
48588844|NCT03783130|101773595|FG001|STARTED|Overall Study||3||
48139353|NCT03058679|100665582|FG000|NOT COMPLETED|Baseline to Week 6||18||
48139354|NCT03058679|100665583|FG001|NOT COMPLETED|Baseline to Week 6||15||
48139355|NCT03058679|100665582|FG000|STARTED|Week 6 to Week 12||81||
48139356|NCT03058679|100665583|FG001|STARTED|Week 6 to Week 12||77||
48139357|NCT03058679|100665582|FG000|COMPLETED|Week 6 to Week 12||61||
48139358|NCT03058679|100665583|FG001|COMPLETED|Week 6 to Week 12||60||
48139359|NCT03058679|100665582|FG000|NOT COMPLETED|Week 6 to Week 12||20||
48139360|NCT03058679|100665583|FG001|NOT COMPLETED|Week 6 to Week 12||17||
48139361|NCT03046212|100665584|FG000|STARTED|Overall Study||15||
48139362|NCT03046212|100665585|FG001|STARTED|Overall Study||15||
48139363|NCT03046212|100665584|FG000|COMPLETED|Overall Study||15||
48139364|NCT03046212|100665585|FG001|COMPLETED|Overall Study||15||
48588845|NCT03783130|101773596|FG002|STARTED|Overall Study||5||
48588846|NCT03783130|101773597|FG003|STARTED|Overall Study||5||
48588847|NCT03783130|101773594|FG000|Received All Product Administrations|Overall Study||3||
48588848|NCT03783130|101773595|FG001|Received All Product Administrations|Overall Study||3||
48588849|NCT03783130|101773596|FG002|Received All Product Administrations|Overall Study||5||
48588850|NCT03783130|101773597|FG003|Received All Product Administrations|Overall Study||5||
48588851|NCT03783130|101773594|FG000|COMPLETED|Overall Study||3||
48588852|NCT03783130|101773595|FG001|COMPLETED|Overall Study||3||
48588853|NCT03783130|101773596|FG002|COMPLETED|Overall Study||5||
48588854|NCT03783130|101773597|FG003|COMPLETED|Overall Study||5||
48588855|NCT03783130|101773594|FG000|NOT COMPLETED|Overall Study||0||
48588856|NCT03783130|101773595|FG001|NOT COMPLETED|Overall Study||0||
48588857|NCT03783130|101773596|FG002|NOT COMPLETED|Overall Study||0||
48588858|NCT03783130|101773597|FG003|NOT COMPLETED|Overall Study||0||
48588859|NCT00514904|101773598|FG000|STARTED|Overall Study||1125||
48588860|NCT00514904|101773599|FG001|STARTED|Overall Study||376||
48588861|NCT00514904|101773598|FG000|COMPLETED|Overall Study||1101||
48588862|NCT00514904|101773599|FG001|COMPLETED|Overall Study||371||
48588863|NCT00514904|101773598|FG000|NOT COMPLETED|Overall Study||24||
48588864|NCT00514904|101773599|FG001|NOT COMPLETED|Overall Study||5||
48707308|NCT02323204|102069917|FG000|NOT COMPLETED|6-week Follow-up Survey Completion||41||
48707309|NCT02323204|102069918|FG001|NOT COMPLETED|6-week Follow-up Survey Completion||36||
48707310|NCT02323204|102069919|FG002|NOT COMPLETED|6-week Follow-up Survey Completion||42||
48707311|NCT02323204|102069920|FG003|NOT COMPLETED|6-week Follow-up Survey Completion||37||
48139365|NCT03046212|100665584|FG000|NOT COMPLETED|Overall Study||0||
48139366|NCT03046212|100665585|FG001|NOT COMPLETED|Overall Study||0||
48139367|NCT03150056|100665586|FG000|STARTED|Overall Study||10||
48588865|NCT01917812|101773600|FG000|STARTED|Overall Study||16||
48588866|NCT01917812|101773601|FG001|STARTED|Overall Study||16||
48588867|NCT01917812|101773602|FG002|STARTED|Overall Study||16||
48588868|NCT01917812|101773600|FG000|COMPLETED|Overall Study||15||
48588869|NCT01917812|101773601|FG001|COMPLETED|Overall Study||16||
48588870|NCT01917812|101773602|FG002|COMPLETED|Overall Study||16||
48588871|NCT01917812|101773600|FG000|NOT COMPLETED|Overall Study||1||
48588872|NCT01917812|101773601|FG001|NOT COMPLETED|Overall Study||0||
48588873|NCT01917812|101773602|FG002|NOT COMPLETED|Overall Study||0||
48707312|NCT02323204|102069917|FG000|STARTED|6-week Follow-up Intervention Booster||0||
48707313|NCT02323204|102069918|FG001|STARTED|6-week Follow-up Intervention Booster||146||
48707314|NCT02323204|102069919|FG002|STARTED|6-week Follow-up Intervention Booster||0||
48139368|NCT03150056|100665587|FG001|STARTED|Overall Study||6||
48139369|NCT03150056|100665588|FG002|STARTED|Overall Study||4||
48139370|NCT03150056|100665589|FG003|STARTED|Overall Study||10||
48139371|NCT03150056|100665590|FG004|STARTED|Overall Study||22||
48139372|NCT03150056|100665591|FG005|STARTED|Overall Study||21||
48139373|NCT03150056|100665586|FG000|COMPLETED|Overall Study||0||
48290993|NCT02344004|101040628|FG001|STARTED|Overall Study||112||
48290994|NCT02344004|101040627|FG000|COMPLETED|Overall Study||163||
48290995|NCT02344004|101040628|FG001|COMPLETED|Overall Study||98||
48290996|NCT02344004|101040627|FG000|NOT COMPLETED|Overall Study||61||
48588874|NCT02703272|101773603|FG000|STARTED|Overall Study||11||
48707315|NCT02323204|102069920|FG003|STARTED|6-week Follow-up Intervention Booster||156||
48139374|NCT03150056|100665587|FG001|COMPLETED|Overall Study||1||
48139375|NCT03150056|100665588|FG002|COMPLETED|Overall Study||1||
48139376|NCT03150056|100665589|FG003|COMPLETED|Overall Study||2||
48139377|NCT03150056|100665590|FG004|COMPLETED|Overall Study||9||
48139378|NCT03150056|100665591|FG005|COMPLETED|Overall Study||3||
48139379|NCT03150056|100665586|FG000|NOT COMPLETED|Overall Study||10||
48139380|NCT03150056|100665587|FG001|NOT COMPLETED|Overall Study||5||
48139381|NCT03150056|100665588|FG002|NOT COMPLETED|Overall Study||3||
48139382|NCT03150056|100665589|FG003|NOT COMPLETED|Overall Study||8||
48588875|NCT02703272|101773604|FG001|STARTED|Overall Study||10||
48588876|NCT02703272|101773605|FG002|STARTED|Overall Study||35||
48588877|NCT02703272|101773606|FG003|STARTED|Overall Study||16||
48588878|NCT02703272|101773603|FG000|COMPLETED|Overall Study||0||
48588879|NCT02703272|101773604|FG001|COMPLETED|Overall Study||0||
48588880|NCT02703272|101773605|FG002|COMPLETED|Overall Study||0||
48588881|NCT02703272|101773606|FG003|COMPLETED|Overall Study||0||
48588882|NCT02703272|101773603|FG000|NOT COMPLETED|Overall Study||11||
48588883|NCT02703272|101773604|FG001|NOT COMPLETED|Overall Study||10||
48588884|NCT02703272|101773605|FG002|NOT COMPLETED|Overall Study||35||
48588885|NCT02703272|101773606|FG003|NOT COMPLETED|Overall Study||16||
48588886|NCT00199797|101773607|FG000|STARTED|Overall Study||20||
48588887|NCT00199797|101773607|FG000|COMPLETED|Overall Study||17||
48588888|NCT00199797|101773607|FG000|NOT COMPLETED|Overall Study||3||
48588889|NCT04889157|101773608|FG000|STARTED|BLINDED TREATMENT||5||
48588890|NCT04889157|101773609|FG001|STARTED|BLINDED TREATMENT||15||
48588891|NCT04889157|101773608|FG000|Discontinued|BLINDED TREATMENT||0||
48588892|NCT04889157|101773609|FG001|Discontinued|BLINDED TREATMENT||0||
48588893|NCT04889157|101773608|FG000|COMPLETED|BLINDED TREATMENT||5||
48588894|NCT04889157|101773609|FG001|COMPLETED|BLINDED TREATMENT||15||
48588895|NCT04889157|101773608|FG000|NOT COMPLETED|BLINDED TREATMENT||0||
48707316|NCT02323204|102069917|FG000|COMPLETED|6-week Follow-up Intervention Booster||0||
48707317|NCT02323204|102069918|FG001|COMPLETED|6-week Follow-up Intervention Booster||103||
48707318|NCT02323204|102069919|FG002|COMPLETED|6-week Follow-up Intervention Booster||0||
48707319|NCT02323204|102069920|FG003|COMPLETED|6-week Follow-up Intervention Booster||120||
48707320|NCT02323204|102069917|FG000|NOT COMPLETED|6-week Follow-up Intervention Booster||0||
48707321|NCT02323204|102069918|FG001|NOT COMPLETED|6-week Follow-up Intervention Booster||43||
48707322|NCT02323204|102069919|FG002|NOT COMPLETED|6-week Follow-up Intervention Booster||0||
48707323|NCT02323204|102069920|FG003|NOT COMPLETED|6-week Follow-up Intervention Booster||36||
48707324|NCT02323204|102069917|FG000|STARTED|3-month Follow-up Survey Completion||145||
48707325|NCT02323204|102069918|FG001|STARTED|3-month Follow-up Survey Completion||146||
48707326|NCT02323204|102069919|FG002|STARTED|3-month Follow-up Survey Completion||154||
48139383|NCT03150056|100665590|FG004|NOT COMPLETED|Overall Study||13||
48139384|NCT03150056|100665591|FG005|NOT COMPLETED|Overall Study||18||
48139385|NCT00868439|100665592|FG000|STARTED|Overall Study||56||
48139386|NCT00868439|100665593|FG001|STARTED|Overall Study||49||
48139387|NCT00868439|100665592|FG000|COMPLETED|Overall Study||48||
48139388|NCT00868439|100665593|FG001|COMPLETED|Overall Study||40||
48139389|NCT00868439|100665592|FG000|NOT COMPLETED|Overall Study||8||
48139390|NCT00868439|100665593|FG001|NOT COMPLETED|Overall Study||9||
48139391|NCT01552213|100665594|FG000|STARTED|Overall Study||50|Number of subjects randomized|
48139392|NCT01552213|100665595|FG001|STARTED|Overall Study||45|Number of subjects randomized|
48139393|NCT01552213|100665594|FG000|Analyzed|Overall Study||42|Subjects who completed the OGTT or were started on insulin prior to the OGTT|
48139394|NCT01552213|100665595|FG001|Analyzed|Overall Study||41|Subjects who completed the OGTT or were started on insulin prior to the OGTT|
48139395|NCT01552213|100665594|FG000|COMPLETED|Overall Study||37|Pregnancy outcome data available|
48139396|NCT01552213|100665595|FG001|COMPLETED|Overall Study||37|Pregnancy outcome data available|
48139397|NCT01552213|100665594|FG000|NOT COMPLETED|Overall Study||13||
48139398|NCT01552213|100665595|FG001|NOT COMPLETED|Overall Study||8||
48290997|NCT02344004|101040628|FG001|NOT COMPLETED|Overall Study||14||
48290998|NCT01636960|101040629|FG000|STARTED|Induction Phase||9||
48290999|NCT01636960|101040629|FG000|COMPLETED|Induction Phase||7||
48291000|NCT01636960|101040629|FG000|NOT COMPLETED|Induction Phase||2||
48291001|NCT01636960|101040629|FG000|STARTED|Maintenance Phase||7||
48588896|NCT04889157|101773609|FG001|NOT COMPLETED|BLINDED TREATMENT||0||
48588897|NCT04889157|101773608|FG000|STARTED|Follow-Up||5||
48588898|NCT04889157|101773609|FG001|STARTED|Follow-Up||15||
48588899|NCT04889157|101773608|FG000|Received Treatment|Follow-Up||5||
48588900|NCT04889157|101773609|FG001|Received Treatment|Follow-Up||15||
48707327|NCT02323204|102069920|FG003|STARTED|3-month Follow-up Survey Completion||156||
48707328|NCT02323204|102069917|FG000|COMPLETED|3-month Follow-up Survey Completion||91||
48707329|NCT02323204|102069918|FG001|COMPLETED|3-month Follow-up Survey Completion||99||
48707330|NCT02323204|102069919|FG002|COMPLETED|3-month Follow-up Survey Completion||113||
48707331|NCT02323204|102069920|FG003|COMPLETED|3-month Follow-up Survey Completion||112||
48707332|NCT02323204|102069917|FG000|NOT COMPLETED|3-month Follow-up Survey Completion||54||
48707333|NCT02323204|102069918|FG001|NOT COMPLETED|3-month Follow-up Survey Completion||47||
48707334|NCT02323204|102069919|FG002|NOT COMPLETED|3-month Follow-up Survey Completion||41||
48707335|NCT02323204|102069920|FG003|NOT COMPLETED|3-month Follow-up Survey Completion||44||
48707336|NCT02323204|102069917|FG000|STARTED|6-month Follow-up Survey Completion||145||
48291002|NCT01636960|101040629|FG000|COMPLETED|Maintenance Phase||0||
48291003|NCT01636960|101040629|FG000|NOT COMPLETED|Maintenance Phase||7||
48139399|NCT03708198|100665596|FG000|STARTED|Overall Study||15||
48139400|NCT03708198|100665596|FG000|COMPLETED|Overall Study||15||
48139401|NCT03708198|100665596|FG000|NOT COMPLETED|Overall Study||0||
48139402|NCT01682460|100665597|FG000|STARTED|Overall Study||15||
48139403|NCT01682460|100665597|FG000|COMPLETED|Overall Study||11||
48139404|NCT01682460|100665597|FG000|NOT COMPLETED|Overall Study||4||
48291004|NCT02618915|101040630|FG000|STARTED|Overall Study||3||
48588901|NCT04889157|101773608|FG000|COMPLETED|Follow-Up||5||
48588902|NCT04889157|101773609|FG001|COMPLETED|Follow-Up||15||
48588903|NCT04889157|101773608|FG000|NOT COMPLETED|Follow-Up||0||
48588904|NCT04889157|101773609|FG001|NOT COMPLETED|Follow-Up||0||
48707337|NCT02323204|102069918|FG001|STARTED|6-month Follow-up Survey Completion||146||
48707338|NCT02323204|102069919|FG002|STARTED|6-month Follow-up Survey Completion||154||
48707339|NCT02323204|102069920|FG003|STARTED|6-month Follow-up Survey Completion||156||
48707340|NCT02323204|102069917|FG000|COMPLETED|6-month Follow-up Survey Completion||96||
48402540|NCT00425945|101317691|FG000|COMPLETED|Overall Study||60||
48588905|NCT04505722|101773610|FG000|STARTED|DB Phase (Day 1 up to 6 Months)||22174||
48588906|NCT04505722|101773611|FG001|STARTED|DB Phase (Day 1 up to 6 Months)||22150||
48588907|NCT04505722|101773612|FG002|STARTED|DB Phase (Day 1 up to 6 Months)||0||
48588908|NCT04505722|101773610|FG000|Vaccinated|DB Phase (Day 1 up to 6 Months)||21898||
48588909|NCT04505722|101773611|FG001|Vaccinated|DB Phase (Day 1 up to 6 Months)||21890||
48588910|NCT04505722|101773612|FG002|Vaccinated|DB Phase (Day 1 up to 6 Months)||0||
48588911|NCT04505722|101773610|FG000|COMPLETED|DB Phase (Day 1 up to 6 Months)||21138||
48588912|NCT04505722|101773611|FG001|COMPLETED|DB Phase (Day 1 up to 6 Months)||20662||
48588913|NCT04505722|101773612|FG002|COMPLETED|DB Phase (Day 1 up to 6 Months)||0||
48588914|NCT04505722|101773610|FG000|NOT COMPLETED|DB Phase (Day 1 up to 6 Months)||1036||
48588915|NCT04505722|101773611|FG001|NOT COMPLETED|DB Phase (Day 1 up to 6 Months)||1488||
48588916|NCT04505722|101773612|FG002|NOT COMPLETED|DB Phase (Day 1 up to 6 Months)||0||
48588917|NCT04505722|101773610|FG000|STARTED|DB + OL Phase (2 Years 6.5 Months)||0||
48588918|NCT04505722|101773611|FG001|STARTED|DB + OL Phase (2 Years 6.5 Months)||0||
48588919|NCT04505722|101773612|FG002|STARTED|DB + OL Phase (2 Years 6.5 Months)||43788||
48588920|NCT04505722|101773610|FG000|COMPLETED|DB + OL Phase (2 Years 6.5 Months)||0||
48588921|NCT04505722|101773611|FG001|COMPLETED|DB + OL Phase (2 Years 6.5 Months)||0||
48588922|NCT04505722|101773612|FG002|COMPLETED|DB + OL Phase (2 Years 6.5 Months)||31593||
48588923|NCT04505722|101773610|FG000|NOT COMPLETED|DB + OL Phase (2 Years 6.5 Months)||0||
48588924|NCT04505722|101773611|FG001|NOT COMPLETED|DB + OL Phase (2 Years 6.5 Months)||0||
48588925|NCT04505722|101773612|FG002|NOT COMPLETED|DB + OL Phase (2 Years 6.5 Months)||12195||
48588926|NCT02202044|101773613|FG000|STARTED|Overall Study||0||
48588927|NCT02202044|101773613|FG000|COMPLETED|Overall Study||0||
48588928|NCT02202044|101773613|FG000|NOT COMPLETED|Overall Study||0||
48588929|NCT01362244|101773614|FG000|STARTED|Overall Study||54||
48588930|NCT01362244|101773615|FG001|STARTED|Overall Study||51||
48588931|NCT01362244|101773614|FG000|COMPLETED|Overall Study||22||
48588932|NCT01362244|101773615|FG001|COMPLETED|Overall Study||19||
48588933|NCT01362244|101773614|FG000|NOT COMPLETED|Overall Study||32||
48588934|NCT01362244|101773615|FG001|NOT COMPLETED|Overall Study||32||
48588935|NCT00336024|101773616|FG000|STARTED|Overall Study||46||
48588936|NCT00336024|101773617|FG001|STARTED|Overall Study||45||
48588937|NCT00336024|101773616|FG000|COMPLETED|Overall Study||26||
48588938|NCT00336024|101773617|FG001|COMPLETED|Overall Study||26||
48588939|NCT00336024|101773616|FG000|NOT COMPLETED|Overall Study||20||
48588940|NCT00336024|101773617|FG001|NOT COMPLETED|Overall Study||19||
48588941|NCT04852276|101773618|FG000|STARTED|Overall Study||235||
48588942|NCT04852276|101773619|FG001|STARTED|Overall Study||73||
48588943|NCT04852276|101773618|FG000|COMPLETED|Overall Study||192||
48588944|NCT04852276|101773619|FG001|COMPLETED|Overall Study||58||
48588945|NCT04852276|101773618|FG000|NOT COMPLETED|Overall Study||43||
48588946|NCT04852276|101773619|FG001|NOT COMPLETED|Overall Study||15||
48588947|NCT03091192|101773620|FG000|STARTED|Overall Study||33||
48588948|NCT03091192|101773621|FG001|STARTED|Overall Study||27||
48588949|NCT03091192|101773620|FG000|COMPLETED|Overall Study||0||
48588950|NCT03091192|101773621|FG001|COMPLETED|Overall Study||0||
48588951|NCT03091192|101773620|FG000|NOT COMPLETED|Overall Study||33||
48588952|NCT03091192|101773621|FG001|NOT COMPLETED|Overall Study||27||
48588953|NCT02553499|101773622|FG000|STARTED|Overall Study||2||
48588954|NCT02553499|101773623|FG001|STARTED|Overall Study||2||
48588955|NCT02553499|101773624|FG002|STARTED|Overall Study||2||
48588956|NCT02553499|101773625|FG003|STARTED|Overall Study||2||
48588957|NCT02553499|101773626|FG004|STARTED|Overall Study||3||
48588958|NCT02553499|101773627|FG005|STARTED|Overall Study||3||
48588959|NCT02553499|101773628|FG006|STARTED|Overall Study||3||
48707341|NCT02323204|102069918|FG001|COMPLETED|6-month Follow-up Survey Completion||96||
48707342|NCT02323204|102069919|FG002|COMPLETED|6-month Follow-up Survey Completion||113||
48707343|NCT02323204|102069920|FG003|COMPLETED|6-month Follow-up Survey Completion||112||
48707344|NCT02323204|102069917|FG000|NOT COMPLETED|6-month Follow-up Survey Completion||49||
48707345|NCT02323204|102069918|FG001|NOT COMPLETED|6-month Follow-up Survey Completion||50||
48588960|NCT02553499|101773629|FG007|STARTED|Overall Study||3||
48707346|NCT02323204|102069919|FG002|NOT COMPLETED|6-month Follow-up Survey Completion||41||
48707347|NCT02323204|102069920|FG003|NOT COMPLETED|6-month Follow-up Survey Completion||44||
48707348|NCT00717522|102069921|FG000|STARTED|Overall Study||7||
48588961|NCT02553499|101773630|FG008|STARTED|Overall Study||3||
48588962|NCT02553499|101773631|FG009|STARTED|Overall Study||3||
48707349|NCT00717522|102069921|FG000|COMPLETED|Overall Study||0||
48707350|NCT00717522|102069921|FG000|NOT COMPLETED|Overall Study||7||
48588963|NCT02553499|101773632|FG010|STARTED|Overall Study||3||
48588964|NCT02553499|101773633|FG011|STARTED|Overall Study||3||
48588965|NCT02553499|101773634|FG012|STARTED|Overall Study||3||
48588966|NCT02553499|101773635|FG013|STARTED|Overall Study||2||
48588967|NCT02553499|101773622|FG000|COMPLETED|Overall Study||0||
48588968|NCT02553499|101773623|FG001|COMPLETED|Overall Study||0||
48588969|NCT02553499|101773624|FG002|COMPLETED|Overall Study||0||
48588970|NCT02553499|101773625|FG003|COMPLETED|Overall Study||0||
48588971|NCT02553499|101773626|FG004|COMPLETED|Overall Study||0||
48588972|NCT02553499|101773627|FG005|COMPLETED|Overall Study||0||
48588973|NCT02553499|101773628|FG006|COMPLETED|Overall Study||0||
48588974|NCT02553499|101773629|FG007|COMPLETED|Overall Study||0||
48588975|NCT02553499|101773630|FG008|COMPLETED|Overall Study||0||
48291005|NCT02618915|101040631|FG001|STARTED|Overall Study||3||
48291006|NCT02618915|101040630|FG000|COMPLETED|Overall Study||3||
48291007|NCT02618915|101040631|FG001|COMPLETED|Overall Study||3||
48291008|NCT02618915|101040630|FG000|NOT COMPLETED|Overall Study||0||
48291009|NCT02618915|101040631|FG001|NOT COMPLETED|Overall Study||0||
48291010|NCT03291587|101040632|FG000|STARTED|Overall Study||523||
48291011|NCT03291587|101040633|FG001|STARTED|Overall Study||571||
48291012|NCT03291587|101040632|FG000|14 Day Follow-up|Overall Study||483||
48291013|NCT03291587|101040633|FG001|14 Day Follow-up|Overall Study||547||
48291014|NCT03291587|101040632|FG000|3 Month Follow-up|Overall Study||445||
48291015|NCT03291587|101040633|FG001|3 Month Follow-up|Overall Study||538||
48291016|NCT03291587|101040632|FG000|COMPLETED|Overall Study||442||
48291017|NCT03291587|101040633|FG001|COMPLETED|Overall Study||514||
48291018|NCT03291587|101040632|FG000|NOT COMPLETED|Overall Study||81||
48291019|NCT03291587|101040633|FG001|NOT COMPLETED|Overall Study||57||
48291020|NCT03038438|101040634|FG000|STARTED|Overall Study||200||
48291021|NCT03038438|101040634|FG000|30-Day Follow-Up|Overall Study||198||
48291022|NCT03038438|101040634|FG000|6-Month Follow-up|Overall Study||193||
48291023|NCT03038438|101040634|FG000|12-Month Follow-up|Overall Study||191||
48291024|NCT03038438|101040634|FG000|24-Month Follow-up|Overall Study||148||
48291025|NCT03038438|101040634|FG000|36-Month Follow-up|Overall Study||162||
48291026|NCT03038438|101040634|FG000|COMPLETED|Overall Study||162||
48291027|NCT03038438|101040634|FG000|NOT COMPLETED|Overall Study||38||
48291028|NCT05056987|101040635|FG000|STARTED|First Wear Period, Day 14 or Day 28||18||36
48291029|NCT05056987|101040636|FG001|STARTED|First Wear Period, Day 14 or Day 28||18||36
48291030|NCT05056987|101040635|FG000|COMPLETED|First Wear Period, Day 14 or Day 28||17||34
48291031|NCT05056987|101040636|FG001|COMPLETED|First Wear Period, Day 14 or Day 28||16||32
48291032|NCT05056987|101040635|FG000|NOT COMPLETED|First Wear Period, Day 14 or Day 28||1||2
48291033|NCT05056987|101040636|FG001|NOT COMPLETED|First Wear Period, Day 14 or Day 28||2||4
48291034|NCT05056987|101040635|FG000|STARTED|Second Wear Period, Day 14 or Day 28||17||34
48291035|NCT05056987|101040636|FG001|STARTED|Second Wear Period, Day 14 or Day 28||16||32
48291036|NCT05056987|101040635|FG000|COMPLETED|Second Wear Period, Day 14 or Day 28||17||34
48291037|NCT05056987|101040636|FG001|COMPLETED|Second Wear Period, Day 14 or Day 28||16||32
48291038|NCT05056987|101040635|FG000|NOT COMPLETED|Second Wear Period, Day 14 or Day 28||0||0
48291039|NCT05056987|101040636|FG001|NOT COMPLETED|Second Wear Period, Day 14 or Day 28||0||0
48291040|NCT01853137|101040637|FG000|STARTED|Overall Study||25||
48291041|NCT01853137|101040638|FG001|STARTED|Overall Study||18||
48291042|NCT01853137|101040637|FG000|COMPLETED|Overall Study||21||
48291043|NCT01853137|101040638|FG001|COMPLETED|Overall Study||17||
48291044|NCT01853137|101040637|FG000|NOT COMPLETED|Overall Study||4||
48291045|NCT01853137|101040638|FG001|NOT COMPLETED|Overall Study||1||
48291046|NCT00744523|101040639|FG000|STARTED|Procedure||37||
48291047|NCT00744523|101040640|FG001|STARTED|Procedure||225||
48291048|NCT00744523|101040639|FG000|COMPLETED|Procedure||37||
48291049|NCT00744523|101040640|FG001|COMPLETED|Procedure||225||
48291050|NCT00744523|101040639|FG000|NOT COMPLETED|Procedure||0||
48291051|NCT00744523|101040640|FG001|NOT COMPLETED|Procedure||0||
48291052|NCT00744523|101040639|FG000|STARTED|30 Days After the Procedure||37||
48291053|NCT00744523|101040640|FG001|STARTED|30 Days After the Procedure||225||
48291054|NCT00744523|101040639|FG000|COMPLETED|30 Days After the Procedure||37||
48291055|NCT00744523|101040640|FG001|COMPLETED|30 Days After the Procedure||220||
48291056|NCT00744523|101040639|FG000|NOT COMPLETED|30 Days After the Procedure||0||
48291057|NCT00744523|101040640|FG001|NOT COMPLETED|30 Days After the Procedure||5||
48291058|NCT01783041|101040641|FG000|STARTED|First 2 Weeks of Life||72||
48291059|NCT01783041|101040642|FG001|STARTED|First 2 Weeks of Life||72||
48291060|NCT01783041|101040641|FG000|COMPLETED|First 2 Weeks of Life||69||
48291061|NCT01783041|101040642|FG001|COMPLETED|First 2 Weeks of Life||71||
48291062|NCT01783041|101040641|FG000|NOT COMPLETED|First 2 Weeks of Life||3||
48291063|NCT01783041|101040642|FG001|NOT COMPLETED|First 2 Weeks of Life||1||
48291064|NCT01783041|101040641|FG000|STARTED|NNNS Examination at Term Equivalent Age||69||
48588976|NCT02553499|101773631|FG009|COMPLETED|Overall Study||0||
48291065|NCT01783041|101040642|FG001|STARTED|NNNS Examination at Term Equivalent Age||71||
48588977|NCT02553499|101773632|FG010|COMPLETED|Overall Study||0||
48291066|NCT01783041|101040641|FG000|COMPLETED|NNNS Examination at Term Equivalent Age||60||
48291067|NCT01783041|101040642|FG001|COMPLETED|NNNS Examination at Term Equivalent Age||59||
48291068|NCT01783041|101040641|FG000|NOT COMPLETED|NNNS Examination at Term Equivalent Age||9||
48291069|NCT01783041|101040642|FG001|NOT COMPLETED|NNNS Examination at Term Equivalent Age||12||
48291070|NCT04882995|101040643|FG000|STARTED|Overall Study||41||
48291071|NCT04882995|101040644|FG001|STARTED|Overall Study||43||
48291072|NCT04882995|101040643|FG000|COMPLETED|Overall Study||35||
48291073|NCT04882995|101040644|FG001|COMPLETED|Overall Study||36||
48588978|NCT02553499|101773633|FG011|COMPLETED|Overall Study||0||
48291074|NCT04882995|101040643|FG000|NOT COMPLETED|Overall Study||6||
48402541|NCT00425945|101317692|FG001|COMPLETED|Overall Study||61||
48402542|NCT00425945|101317691|FG000|NOT COMPLETED|Overall Study||4||
48402543|NCT00425945|101317692|FG001|NOT COMPLETED|Overall Study||5||
48402544|NCT04757376|101317693|FG000|STARTED|TP I - Week 0, Day 1 to Week 52 Predose||240||
48402545|NCT04757376|101317694|FG001|STARTED|TP I - Week 0, Day 1 to Week 52 Predose||239||
48402546|NCT04757376|101317695|FG002|STARTED|TP I - Week 0, Day 1 to Week 52 Predose||0||
48588979|NCT02553499|101773634|FG012|COMPLETED|Overall Study||0||
48588980|NCT02553499|101773635|FG013|COMPLETED|Overall Study||0||
48588981|NCT02553499|101773622|FG000|NOT COMPLETED|Overall Study||2||
48588982|NCT02553499|101773623|FG001|NOT COMPLETED|Overall Study||2||
48588983|NCT02553499|101773624|FG002|NOT COMPLETED|Overall Study||2||
48588984|NCT02553499|101773625|FG003|NOT COMPLETED|Overall Study||2||
48402547|NCT04757376|101317696|FG003|STARTED|TP I - Week 0, Day 1 to Week 52 Predose||0||
48402548|NCT04757376|101317697|FG004|STARTED|TP I - Week 0, Day 1 to Week 52 Predose||0||
48402549|NCT04757376|101317693|FG000|COMPLETED|TP I - Week 0, Day 1 to Week 52 Predose||221|completed the study treatment in TP I|
48402550|NCT04757376|101317694|FG001|COMPLETED|TP I - Week 0, Day 1 to Week 52 Predose||201|completed the study treatment in TP I|
48402551|NCT04757376|101317695|FG002|COMPLETED|TP I - Week 0, Day 1 to Week 52 Predose||0|completed the study treatment in TP I|
48402552|NCT04757376|101317696|FG003|COMPLETED|TP I - Week 0, Day 1 to Week 52 Predose||0|completed the study treatment in TP I|
48402553|NCT04757376|101317697|FG004|COMPLETED|TP I - Week 0, Day 1 to Week 52 Predose||0|completed the study treatment in TP I|
48402554|NCT04757376|101317693|FG000|NOT COMPLETED|TP I - Week 0, Day 1 to Week 52 Predose||19||
48402555|NCT04757376|101317694|FG001|NOT COMPLETED|TP I - Week 0, Day 1 to Week 52 Predose||38||
48402556|NCT04757376|101317695|FG002|NOT COMPLETED|TP I - Week 0, Day 1 to Week 52 Predose||0||
48402557|NCT04757376|101317696|FG003|NOT COMPLETED|TP I - Week 0, Day 1 to Week 52 Predose||0||
48402558|NCT04757376|101317697|FG004|NOT COMPLETED|TP I - Week 0, Day 1 to Week 52 Predose||0||
48588985|NCT02553499|101773626|FG004|NOT COMPLETED|Overall Study||3||
48588986|NCT02553499|101773627|FG005|NOT COMPLETED|Overall Study||3||
48402559|NCT04757376|101317693|FG000|STARTED|TP II - Week 52 to Week 78||0||
48402560|NCT04757376|101317694|FG001|STARTED|TP II - Week 52 to Week 78||0||
48402561|NCT04757376|101317695|FG002|STARTED|TP II - Week 52 to Week 78||221||
48402562|NCT04757376|101317696|FG003|STARTED|TP II - Week 52 to Week 78||100||
48402563|NCT04757376|101317697|FG004|STARTED|TP II - Week 52 to Week 78||101||
48402564|NCT04757376|101317693|FG000|COMPLETED|TP II - Week 52 to Week 78||0|completed the study treatment in TP II|
48402565|NCT04757376|101317694|FG001|COMPLETED|TP II - Week 52 to Week 78||0|completed the study treatment in TP II|
48402566|NCT04757376|101317695|FG002|COMPLETED|TP II - Week 52 to Week 78||220|completed the study treatment in TP II|
48402567|NCT04757376|101317696|FG003|COMPLETED|TP II - Week 52 to Week 78||100|completed the study treatment in TP II|
48402568|NCT04757376|101317697|FG004|COMPLETED|TP II - Week 52 to Week 78||101|completed the study treatment in TP II|
48402569|NCT04757376|101317693|FG000|NOT COMPLETED|TP II - Week 52 to Week 78||0||
48402570|NCT04757376|101317694|FG001|NOT COMPLETED|TP II - Week 52 to Week 78||0||
48402571|NCT04757376|101317695|FG002|NOT COMPLETED|TP II - Week 52 to Week 78||1||
48402572|NCT04757376|101317696|FG003|NOT COMPLETED|TP II - Week 52 to Week 78||0||
48402573|NCT04757376|101317697|FG004|NOT COMPLETED|TP II - Week 52 to Week 78||0||
48402574|NCT01240304|101317698|FG000|STARTED|Overall Study||10||
48402575|NCT01240304|101317698|FG000|COMPLETED|Overall Study||0||
48402576|NCT01240304|101317698|FG000|NOT COMPLETED|Overall Study||10||
48402577|NCT04038385|101317699|FG000|STARTED|Overall Study||160||
48402578|NCT04038385|101317700|FG001|STARTED|Overall Study||137||
48402579|NCT04038385|101317699|FG000|COMPLETED|Overall Study||143|143 (intervention) and 130 (control) provided self-report data; 137 (intervention) and 124 (control) provided biometric data. For biometric data,13 (intervention) and 10 (control) competed the baseline assessment only.|
48402580|NCT04038385|101317700|FG001|COMPLETED|Overall Study||130|143 (intervention) and 130 (control) provided self-report data; 137 (intervention) and 124 (control) provided biometric data. For biometric data,13 (intervention) and 10 (control) competed the baseline assessment only.|
48588987|NCT02553499|101773628|FG006|NOT COMPLETED|Overall Study||3||
48588988|NCT02553499|101773629|FG007|NOT COMPLETED|Overall Study||3||
48588989|NCT02553499|101773630|FG008|NOT COMPLETED|Overall Study||3||
48588990|NCT02553499|101773631|FG009|NOT COMPLETED|Overall Study||3||
48588991|NCT02553499|101773632|FG010|NOT COMPLETED|Overall Study||3||
48588992|NCT02553499|101773633|FG011|NOT COMPLETED|Overall Study||3||
48588993|NCT02553499|101773634|FG012|NOT COMPLETED|Overall Study||3||
48588994|NCT02553499|101773635|FG013|NOT COMPLETED|Overall Study||2||
48588995|NCT03991013|101773636|FG000|STARTED|Overall Study||65||
48402581|NCT04038385|101317699|FG000|NOT COMPLETED|Overall Study||17||
48402582|NCT04038385|101317700|FG001|NOT COMPLETED|Overall Study||7||
48402583|NCT00905268|101317701|FG000|STARTED|Overall Study||57||
48402584|NCT00905268|101317702|FG001|STARTED|Overall Study||57||
48402585|NCT00905268|101317703|FG002|STARTED|Overall Study||59||
48588996|NCT03991013|101773637|FG001|STARTED|Overall Study||65||
48588997|NCT03991013|101773638|FG002|STARTED|Overall Study||62||
48588998|NCT03991013|101773636|FG000|COMPLETED|Overall Study||64||
48588999|NCT03991013|101773637|FG001|COMPLETED|Overall Study||63||
48589000|NCT03991013|101773638|FG002|COMPLETED|Overall Study||62||
48589001|NCT03991013|101773636|FG000|NOT COMPLETED|Overall Study||1||
48589002|NCT03991013|101773637|FG001|NOT COMPLETED|Overall Study||2||
48589003|NCT03991013|101773638|FG002|NOT COMPLETED|Overall Study||0||
48402586|NCT00905268|101317704|FG003|STARTED|Overall Study||59||
48402587|NCT00905268|101317701|FG000|COMPLETED|Overall Study||53||
48402588|NCT00905268|101317702|FG001|COMPLETED|Overall Study||56||
48402589|NCT00905268|101317703|FG002|COMPLETED|Overall Study||59||
48402590|NCT00905268|101317704|FG003|COMPLETED|Overall Study||57||
48402591|NCT00905268|101317701|FG000|NOT COMPLETED|Overall Study||4||
48402592|NCT00905268|101317702|FG001|NOT COMPLETED|Overall Study||1||
48402593|NCT00905268|101317703|FG002|NOT COMPLETED|Overall Study||0||
48402594|NCT00905268|101317704|FG003|NOT COMPLETED|Overall Study||2||
48402595|NCT01376388|101317705|FG000|STARTED|Overall Study||130||
48402596|NCT01376388|101317705|FG000|COMPLETED|Overall Study||112||
48402597|NCT01376388|101317705|FG000|NOT COMPLETED|Overall Study||18||
48402598|NCT01448707|101317706|FG000|STARTED|Overall Study||137||
48402599|NCT01448707|101317707|FG001|STARTED|Overall Study||136||
48402600|NCT01448707|101317706|FG000|COMPLETED|Overall Study||119||
48402601|NCT01448707|101317707|FG001|COMPLETED|Overall Study||118||
48291075|NCT04882995|101040644|FG001|NOT COMPLETED|Overall Study||7||
48291076|NCT00759915|101040645|FG000|STARTED|Overall Study||18||
48707351|NCT03344549|102069922|FG000|STARTED|Overall Study||26||
48707352|NCT03344549|102069923|FG001|STARTED|Overall Study||27||
48291077|NCT00759915|101040646|FG001|STARTED|Overall Study||18||
48291078|NCT00759915|101040645|FG000|COMPLETED|Overall Study||17||
48291079|NCT00759915|101040646|FG001|COMPLETED|Overall Study||17||
48291080|NCT00759915|101040645|FG000|NOT COMPLETED|Overall Study||1||
48291081|NCT00759915|101040646|FG001|NOT COMPLETED|Overall Study||1||
48291082|NCT01257425|101040647|FG000|STARTED|Overall Study||52||
48291083|NCT01257425|101040648|FG001|STARTED|Overall Study||51||
48291084|NCT01257425|101040647|FG000|COMPLETED|Overall Study||46||
48291085|NCT01257425|101040648|FG001|COMPLETED|Overall Study||45||
48291086|NCT01257425|101040647|FG000|NOT COMPLETED|Overall Study||6||
48291087|NCT01257425|101040648|FG001|NOT COMPLETED|Overall Study||6||
48291088|NCT03339570|101040649|FG000|STARTED|Overall Study||20||
48291089|NCT03339570|101040649|FG000|COMPLETED|Overall Study||16||
48291090|NCT03339570|101040649|FG000|NOT COMPLETED|Overall Study||4||
48291091|NCT01590017|101040650|FG000|STARTED|Overall Study||41||
48291092|NCT01590017|101040650|FG000|COMPLETED|Overall Study||37||
48291093|NCT01590017|101040650|FG000|NOT COMPLETED|Overall Study||4||
48291094|NCT00732225|101040651|FG000|STARTED|Overall Study||71||
48291095|NCT00732225|101040652|FG001|STARTED|Overall Study||40||
48402602|NCT01448707|101317706|FG000|NOT COMPLETED|Overall Study||18||
48707353|NCT03344549|102069922|FG000|COMPLETED|Overall Study||19||
48707354|NCT03344549|102069923|FG001|COMPLETED|Overall Study||12||
48139405|NCT03624504|100665598|FG000|STARTED|Overall Study||82||
48139406|NCT03624504|100665598|FG000|COMPLETED|Overall Study||81||
48139407|NCT03624504|100665598|FG000|NOT COMPLETED|Overall Study||1||
48139408|NCT00317772|100665599|FG000|STARTED|Overall Study||3||
48139409|NCT00317772|100665600|FG001|STARTED|Overall Study||3||
48139410|NCT00317772|100665601|FG002|STARTED|Overall Study||3||
48139411|NCT00317772|100665602|FG003|STARTED|Overall Study||10||
48139412|NCT00317772|100665599|FG000|COMPLETED|Overall Study||1||
48139413|NCT00317772|100665600|FG001|COMPLETED|Overall Study||1||
48139414|NCT00317772|100665601|FG002|COMPLETED|Overall Study||2||
48139415|NCT00317772|100665602|FG003|COMPLETED|Overall Study||1||
48139416|NCT00317772|100665599|FG000|NOT COMPLETED|Overall Study||2||
48139417|NCT00317772|100665600|FG001|NOT COMPLETED|Overall Study||2||
48139418|NCT00317772|100665601|FG002|NOT COMPLETED|Overall Study||1||
48139419|NCT00317772|100665602|FG003|NOT COMPLETED|Overall Study||9||
48139420|NCT01426191|100665603|FG000|STARTED|Overall Study||2032||
48139421|NCT01426191|100665603|FG000|COMPLETED|Overall Study||2032||
48139422|NCT01426191|100665603|FG000|NOT COMPLETED|Overall Study||0||
48139423|NCT01672801|100665604|FG000|STARTED|Overall Study||9||
48139424|NCT01672801|100665605|FG001|STARTED|Overall Study||9||
48139425|NCT01672801|100665604|FG000|COMPLETED|Overall Study||9||
48139426|NCT01672801|100665605|FG001|COMPLETED|Overall Study||8||
48139427|NCT01672801|100665604|FG000|NOT COMPLETED|Overall Study||0||
48139428|NCT01672801|100665605|FG001|NOT COMPLETED|Overall Study||1||
48139429|NCT01206738|100665606|FG000|STARTED|Overall Study||63||
48139430|NCT01206738|100665607|FG001|STARTED|Overall Study||74||
48139431|NCT01206738|100665608|FG002|STARTED|Overall Study||61||
48139432|NCT01206738|100665606|FG000|COMPLETED|Overall Study||40||
48139433|NCT01206738|100665607|FG001|COMPLETED|Overall Study||49||
48139434|NCT01206738|100665608|FG002|COMPLETED|Overall Study||42||
48139435|NCT01206738|100665606|FG000|NOT COMPLETED|Overall Study||23||
48139436|NCT01206738|100665607|FG001|NOT COMPLETED|Overall Study||25||
48291096|NCT00732225|101040653|FG002|STARTED|Overall Study||26||
48291097|NCT00732225|101040654|FG003|STARTED|Overall Study||33||
48139437|NCT01206738|100665608|FG002|NOT COMPLETED|Overall Study||19||
48139438|NCT01592643|100665609|FG000|STARTED|Overall Study||30||45
48139439|NCT01592643|100665609|FG000|COMPLETED|Overall Study||30||45
48291098|NCT00732225|101040655|FG004|STARTED|Overall Study||54||
48291099|NCT00732225|101040651|FG000|COMPLETED|Overall Study||60||
48707355|NCT03344549|102069922|FG000|NOT COMPLETED|Overall Study||7||
48707356|NCT03344549|102069923|FG001|NOT COMPLETED|Overall Study||15||
48139440|NCT01592643|100665609|FG000|NOT COMPLETED|Overall Study||0||0
48291100|NCT00732225|101040652|FG001|COMPLETED|Overall Study||32||
48402603|NCT01448707|101317707|FG001|NOT COMPLETED|Overall Study||18||
48291101|NCT00732225|101040653|FG002|COMPLETED|Overall Study||23||
48291102|NCT00732225|101040654|FG003|COMPLETED|Overall Study||29||
48291103|NCT00732225|101040655|FG004|COMPLETED|Overall Study||48||
48291104|NCT00732225|101040651|FG000|NOT COMPLETED|Overall Study||11||
48291105|NCT00732225|101040652|FG001|NOT COMPLETED|Overall Study||8||
48291106|NCT00732225|101040653|FG002|NOT COMPLETED|Overall Study||3||
48291107|NCT00732225|101040654|FG003|NOT COMPLETED|Overall Study||4||
48291108|NCT00732225|101040655|FG004|NOT COMPLETED|Overall Study||6||
48291109|NCT00932113|101040656|FG000|STARTED|Overall Study||15||
48291110|NCT00932113|101040657|FG001|STARTED|Overall Study||15||
48291111|NCT00932113|101040656|FG000|COMPLETED|Overall Study||14||
48291112|NCT00932113|101040657|FG001|COMPLETED|Overall Study||15||
48291113|NCT00932113|101040656|FG000|NOT COMPLETED|Overall Study||1||
48291114|NCT00932113|101040657|FG001|NOT COMPLETED|Overall Study||0||
48291115|NCT00390910|101040658|FG000|STARTED|Overall Study||50||
48291116|NCT00390910|101040659|FG001|STARTED|Overall Study||87||
48291117|NCT00390910|101040660|FG002|STARTED|Overall Study||149||
48291118|NCT00390910|101040658|FG000|COMPLETED|Overall Study||48||
48291119|NCT00390910|101040659|FG001|COMPLETED|Overall Study||83||
48291120|NCT00390910|101040660|FG002|COMPLETED|Overall Study||139||
48291121|NCT00390910|101040658|FG000|NOT COMPLETED|Overall Study||2||
48291122|NCT00390910|101040659|FG001|NOT COMPLETED|Overall Study||4||
48291123|NCT00390910|101040660|FG002|NOT COMPLETED|Overall Study||10||
48291124|NCT01270971|101040661|FG000|STARTED|Overall Study||400||
48291125|NCT01270971|101040662|FG001|STARTED|Overall Study||194||
48291126|NCT01270971|101040661|FG000|COMPLETED|Overall Study||348||
48291127|NCT01270971|101040662|FG001|COMPLETED|Overall Study||171||
48291128|NCT01270971|101040661|FG000|NOT COMPLETED|Overall Study||52||
48291129|NCT01270971|101040662|FG001|NOT COMPLETED|Overall Study||23||
48291130|NCT01802567|101040663|FG000|STARTED|Overall Study||52||
48291131|NCT01802567|101040663|FG000|COMPLETED|Overall Study||34||
48291132|NCT01802567|101040663|FG000|NOT COMPLETED|Overall Study||18||
48291133|NCT02134977|101040664|FG000|STARTED|Overall Study||2816||
48291134|NCT02134977|101040664|FG000|COMPLETED|Overall Study||2714||
48291135|NCT02134977|101040664|FG000|NOT COMPLETED|Overall Study||102||
48291136|NCT00122460|101040665|FG000|STARTED|Overall Study||222||
48291137|NCT00122460|101040666|FG001|STARTED|Overall Study||220||
48291138|NCT00122460|101040665|FG000|COMPLETED|Overall Study||215||
48291139|NCT00122460|101040666|FG001|COMPLETED|Overall Study||219||
48707357|NCT00916058|102069924|FG000|STARTED|Phase 1||3||
48707358|NCT00916058|102069925|FG001|STARTED|Phase 1||6||
48707359|NCT00916058|102069926|FG002|STARTED|Phase 1||3||
48707360|NCT00916058|102069927|FG003|STARTED|Phase 1||3||
48707361|NCT00916058|102069928|FG004|STARTED|Phase 1||3||
48707362|NCT00916058|102069929|FG005|STARTED|Phase 1||8||
48707363|NCT00916058|102069930|FG006|STARTED|Phase 1||0||
48707364|NCT00916058|102069924|FG000|COMPLETED|Phase 1||3||
48707365|NCT00916058|102069925|FG001|COMPLETED|Phase 1||6||
48707366|NCT00916058|102069926|FG002|COMPLETED|Phase 1||3||
48707367|NCT00916058|102069927|FG003|COMPLETED|Phase 1||3||
48707368|NCT00916058|102069928|FG004|COMPLETED|Phase 1||3||
48707369|NCT00916058|102069929|FG005|COMPLETED|Phase 1||7||
48707370|NCT00916058|102069930|FG006|COMPLETED|Phase 1||0||
48707371|NCT00916058|102069924|FG000|NOT COMPLETED|Phase 1||0||
48707372|NCT00916058|102069925|FG001|NOT COMPLETED|Phase 1||0||
48707373|NCT00916058|102069926|FG002|NOT COMPLETED|Phase 1||0||
48707374|NCT00916058|102069927|FG003|NOT COMPLETED|Phase 1||0||
48707375|NCT00916058|102069928|FG004|NOT COMPLETED|Phase 1||0||
48707376|NCT00916058|102069929|FG005|NOT COMPLETED|Phase 1||1||
48707377|NCT00916058|102069930|FG006|NOT COMPLETED|Phase 1||0||
48707378|NCT00916058|102069924|FG000|STARTED|Phase 2||0||
48707379|NCT00916058|102069925|FG001|STARTED|Phase 2||0||
48707380|NCT00916058|102069926|FG002|STARTED|Phase 2||0||
48707381|NCT00916058|102069927|FG003|STARTED|Phase 2||0||
48707382|NCT00916058|102069928|FG004|STARTED|Phase 2||0||
48707383|NCT00916058|102069929|FG005|STARTED|Phase 2||0||
48707384|NCT00916058|102069930|FG006|STARTED|Phase 2||31||
48707385|NCT00916058|102069924|FG000|COMPLETED|Phase 2||0||
48139441|NCT00395876|100665610|FG000|STARTED|Overall Study||50||
48139442|NCT00395876|100665611|FG001|STARTED|Overall Study||50||
48139443|NCT00395876|100665610|FG000|COMPLETED|Overall Study||47||
48139444|NCT00395876|100665611|FG001|COMPLETED|Overall Study||50||
48139445|NCT00395876|100665610|FG000|NOT COMPLETED|Overall Study||3||
48139446|NCT00395876|100665611|FG001|NOT COMPLETED|Overall Study||0||
48139447|NCT02395120|100665612|FG000|STARTED|Overall Study||400|Caregivers and Children|
48139448|NCT02395120|100665613|FG001|STARTED|Overall Study||398|Caregivers and Children|
48139449|NCT02395120|100665614|FG002|STARTED|Overall Study||43|Caregivers and Children|
48139450|NCT02395120|100665615|FG003|STARTED|Overall Study||63|Caregivers and Children|
48139451|NCT02395120|100665616|FG004|STARTED|Overall Study||401|Caregivers and Children|
48402604|NCT01784614|101317708|FG000|STARTED|Period 1||3||
48402605|NCT01784614|101317709|FG001|STARTED|Period 1||3||
48402606|NCT01784614|101317710|FG002|STARTED|Period 1||3||
48402607|NCT01784614|101317711|FG003|STARTED|Period 1||3||
48402608|NCT01784614|101317712|FG004|STARTED|Period 1||3||
48402609|NCT01784614|101317713|FG005|STARTED|Period 1||3||
48402610|NCT01784614|101317714|FG006|STARTED|Period 1||3||
48402611|NCT01784614|101317715|FG007|STARTED|Period 1||3||
48402612|NCT01784614|101317708|FG000|Received at Least 1 Dose of Study Drug|Period 1||3||
48402613|NCT01784614|101317709|FG001|Received at Least 1 Dose of Study Drug|Period 1||3||
48402614|NCT01784614|101317710|FG002|Received at Least 1 Dose of Study Drug|Period 1||3||
48402615|NCT01784614|101317711|FG003|Received at Least 1 Dose of Study Drug|Period 1||3||
48402616|NCT01784614|101317712|FG004|Received at Least 1 Dose of Study Drug|Period 1||3||
48402617|NCT01784614|101317713|FG005|Received at Least 1 Dose of Study Drug|Period 1||3||
48402618|NCT01784614|101317714|FG006|Received at Least 1 Dose of Study Drug|Period 1||3||
48402619|NCT01784614|101317715|FG007|Received at Least 1 Dose of Study Drug|Period 1||3||
48402620|NCT01784614|101317708|FG000|COMPLETED|Period 1||3||
48402621|NCT01784614|101317709|FG001|COMPLETED|Period 1||3||
48402622|NCT01784614|101317710|FG002|COMPLETED|Period 1||3||
48402623|NCT01784614|101317711|FG003|COMPLETED|Period 1||3||
48402624|NCT01784614|101317712|FG004|COMPLETED|Period 1||3||
48402625|NCT01784614|101317713|FG005|COMPLETED|Period 1||3||
48402626|NCT01784614|101317714|FG006|COMPLETED|Period 1||3||
48402627|NCT01784614|101317715|FG007|COMPLETED|Period 1||3||
48402628|NCT01784614|101317708|FG000|NOT COMPLETED|Period 1||0||
48402629|NCT01784614|101317709|FG001|NOT COMPLETED|Period 1||0||
48402630|NCT01784614|101317710|FG002|NOT COMPLETED|Period 1||0||
48402631|NCT01784614|101317711|FG003|NOT COMPLETED|Period 1||0||
48402632|NCT01784614|101317712|FG004|NOT COMPLETED|Period 1||0||
48402633|NCT01784614|101317713|FG005|NOT COMPLETED|Period 1||0||
48402634|NCT01784614|101317714|FG006|NOT COMPLETED|Period 1||0||
48402635|NCT01784614|101317715|FG007|NOT COMPLETED|Period 1||0||
48402636|NCT01784614|101317708|FG000|STARTED|Period 2||3||
48402637|NCT01784614|101317709|FG001|STARTED|Period 2||3||
48402638|NCT01784614|101317710|FG002|STARTED|Period 2||3||
48402639|NCT01784614|101317711|FG003|STARTED|Period 2||3||
48707386|NCT00916058|102069925|FG001|COMPLETED|Phase 2||0||
48707387|NCT00916058|102069926|FG002|COMPLETED|Phase 2||0||
48707388|NCT00916058|102069927|FG003|COMPLETED|Phase 2||0||
48707389|NCT00916058|102069928|FG004|COMPLETED|Phase 2||0||
48707390|NCT00916058|102069929|FG005|COMPLETED|Phase 2||0||
48707391|NCT00916058|102069930|FG006|COMPLETED|Phase 2||28||
48707392|NCT00916058|102069924|FG000|NOT COMPLETED|Phase 2||0||
48402640|NCT01784614|101317712|FG004|STARTED|Period 2||3||
48402641|NCT01784614|101317713|FG005|STARTED|Period 2||3||
48402642|NCT01784614|101317714|FG006|STARTED|Period 2||3||
48402643|NCT01784614|101317715|FG007|STARTED|Period 2||2||
48589004|NCT03369067|101773639|FG000|STARTED|Overall Study||24||
48589005|NCT03369067|101773640|FG001|STARTED|Overall Study||24||
48589006|NCT03369067|101773639|FG000|COMPLETED|Overall Study||24||
48589007|NCT03369067|101773640|FG001|COMPLETED|Overall Study||24||
48589008|NCT03369067|101773639|FG000|NOT COMPLETED|Overall Study||0||
48589009|NCT03369067|101773640|FG001|NOT COMPLETED|Overall Study||0||
48589010|NCT04696861|101773641|FG000|STARTED|Overall Study||30||
48589011|NCT04696861|101773642|FG001|STARTED|Overall Study||30||
48589012|NCT04696861|101773641|FG000|COMPLETED|Overall Study||26||
48589013|NCT04696861|101773642|FG001|COMPLETED|Overall Study||30||
48589014|NCT04696861|101773641|FG000|NOT COMPLETED|Overall Study||4||
48589015|NCT04696861|101773642|FG001|NOT COMPLETED|Overall Study||0||
48589016|NCT01953432|101773643|FG000|STARTED|Overall Study||22||
48589017|NCT01953432|101773644|FG001|STARTED|Overall Study||21||
48402644|NCT01784614|101317708|FG000|COMPLETED|Period 2||3||
48402645|NCT01784614|101317709|FG001|COMPLETED|Period 2||3||
48402646|NCT01784614|101317710|FG002|COMPLETED|Period 2||3||
48402647|NCT01784614|101317711|FG003|COMPLETED|Period 2||3||
48402648|NCT01784614|101317712|FG004|COMPLETED|Period 2||3||
48402649|NCT01784614|101317713|FG005|COMPLETED|Period 2||3||
48402650|NCT01784614|101317714|FG006|COMPLETED|Period 2||3||
48402651|NCT01784614|101317715|FG007|COMPLETED|Period 2||2||
48402652|NCT01784614|101317708|FG000|NOT COMPLETED|Period 2||0||
48402653|NCT01784614|101317709|FG001|NOT COMPLETED|Period 2||0||
48402654|NCT01784614|101317710|FG002|NOT COMPLETED|Period 2||0||
48402655|NCT01784614|101317711|FG003|NOT COMPLETED|Period 2||0||
48402656|NCT01784614|101317712|FG004|NOT COMPLETED|Period 2||0||
48707393|NCT00916058|102069925|FG001|NOT COMPLETED|Phase 2||0||
48707394|NCT00916058|102069926|FG002|NOT COMPLETED|Phase 2||0||
48707395|NCT00916058|102069927|FG003|NOT COMPLETED|Phase 2||0||
48707396|NCT00916058|102069928|FG004|NOT COMPLETED|Phase 2||0||
48707397|NCT00916058|102069929|FG005|NOT COMPLETED|Phase 2||0||
48707398|NCT00916058|102069930|FG006|NOT COMPLETED|Phase 2||3||
48707399|NCT01140568|102069931|FG000|STARTED|Overall Study||38|Patients who signed study consent|
48707400|NCT01140568|102069931|FG000|Screen Fail|Overall Study||4||
48707401|NCT01140568|102069931|FG000|Treated With Study Drug|Overall Study||34||
48707402|NCT01140568|102069931|FG000|COMPLETED|Overall Study||2|Patients who were still on study at the time of closure|
48707403|NCT01140568|102069931|FG000|NOT COMPLETED|Overall Study||36||
48291140|NCT00122460|101040665|FG000|NOT COMPLETED|Overall Study||7||
48291141|NCT00122460|101040666|FG001|NOT COMPLETED|Overall Study||1||
48291142|NCT00156819|101040667|FG000|STARTED|Overall Study||169||
48291143|NCT00156819|101040668|FG001|STARTED|Overall Study||166||
48291144|NCT00156819|101040669|FG002|STARTED|Overall Study||165||
48291145|NCT00156819|101040667|FG000|COMPLETED|Overall Study||168||
48291146|NCT00156819|101040668|FG001|COMPLETED|Overall Study||165||
48402657|NCT01784614|101317713|FG005|NOT COMPLETED|Period 2||0||
48402658|NCT01784614|101317714|FG006|NOT COMPLETED|Period 2||0||
48402659|NCT01784614|101317715|FG007|NOT COMPLETED|Period 2||0||
48707404|NCT02708849|102069932|FG000|STARTED|Overall Study||2||
48707405|NCT02708849|102069933|FG001|STARTED|Overall Study||1||
48707406|NCT02708849|102069932|FG000|COMPLETED|Overall Study||1||
48707407|NCT02708849|102069933|FG001|COMPLETED|Overall Study||1||
48707408|NCT02708849|102069932|FG000|NOT COMPLETED|Overall Study||1||
48707409|NCT02708849|102069933|FG001|NOT COMPLETED|Overall Study||0||
48707410|NCT00145418|102069934|FG000|STARTED|Overall Study||15||
48707411|NCT00145418|102069934|FG000|COMPLETED|Overall Study||15||
48707412|NCT00145418|102069934|FG000|NOT COMPLETED|Overall Study||0||
48707413|NCT00435162|102069935|FG000|STARTED|Period 1 (6 Weeks)||15||
48707414|NCT00435162|102069936|FG001|STARTED|Period 1 (6 Weeks)||15||
48707415|NCT00435162|102069937|FG002|STARTED|Period 1 (6 Weeks)||6||
48707416|NCT00435162|102069938|FG003|STARTED|Period 1 (6 Weeks)||8||
48707417|NCT00435162|102069939|FG004|STARTED|Period 1 (6 Weeks)||15||
48707418|NCT00435162|102069940|FG005|STARTED|Period 1 (6 Weeks)||15||
48707419|NCT00435162|102069935|FG000|COMPLETED|Period 1 (6 Weeks)||15||
48707420|NCT00435162|102069936|FG001|COMPLETED|Period 1 (6 Weeks)||15||
48707421|NCT00435162|102069937|FG002|COMPLETED|Period 1 (6 Weeks)||6||
48707422|NCT00435162|102069938|FG003|COMPLETED|Period 1 (6 Weeks)||8||
48707423|NCT00435162|102069939|FG004|COMPLETED|Period 1 (6 Weeks)||15||
48707424|NCT00435162|102069940|FG005|COMPLETED|Period 1 (6 Weeks)||15||
48707425|NCT00435162|102069935|FG000|NOT COMPLETED|Period 1 (6 Weeks)||0||
48707426|NCT00435162|102069936|FG001|NOT COMPLETED|Period 1 (6 Weeks)||0||
48707427|NCT00435162|102069937|FG002|NOT COMPLETED|Period 1 (6 Weeks)||0||
48707428|NCT00435162|102069938|FG003|NOT COMPLETED|Period 1 (6 Weeks)||0||
48707429|NCT00435162|102069939|FG004|NOT COMPLETED|Period 1 (6 Weeks)||0||
48707430|NCT00435162|102069940|FG005|NOT COMPLETED|Period 1 (6 Weeks)||0||
48707431|NCT00435162|102069935|FG000|STARTED|Period 2 (2 Weeks)||15||
48707432|NCT00435162|102069936|FG001|STARTED|Period 2 (2 Weeks)||15||
48707433|NCT00435162|102069937|FG002|STARTED|Period 2 (2 Weeks)||6||
48707434|NCT00435162|102069938|FG003|STARTED|Period 2 (2 Weeks)||8||
48707435|NCT00435162|102069939|FG004|STARTED|Period 2 (2 Weeks)||15||
48707436|NCT00435162|102069940|FG005|STARTED|Period 2 (2 Weeks)||15||
48707437|NCT00435162|102069935|FG000|COMPLETED|Period 2 (2 Weeks)||15||
48707438|NCT00435162|102069936|FG001|COMPLETED|Period 2 (2 Weeks)||14||
48291147|NCT00156819|101040669|FG002|COMPLETED|Overall Study||162||
48291148|NCT00156819|101040667|FG000|NOT COMPLETED|Overall Study||1||
48291149|NCT00156819|101040668|FG001|NOT COMPLETED|Overall Study||1||
48291150|NCT00156819|101040669|FG002|NOT COMPLETED|Overall Study||3||
48291151|NCT00723021|101040670|FG000|STARTED|Intervention Period 1||3||
48291152|NCT00723021|101040671|FG001|STARTED|Intervention Period 1||3||
48291153|NCT00723021|101040672|FG002|STARTED|Intervention Period 1||3||
48402660|NCT01784614|101317708|FG000|STARTED|Period 3||3||
48291154|NCT00723021|101040673|FG003|STARTED|Intervention Period 1||3||
48402661|NCT01784614|101317709|FG001|STARTED|Period 3||2||
48291155|NCT00723021|101040674|FG004|STARTED|Intervention Period 1||3||
48402662|NCT01784614|101317710|FG002|STARTED|Period 3||3||
48291156|NCT00723021|101040670|FG000|COMPLETED|Intervention Period 1||3||
48402663|NCT01784614|101317711|FG003|STARTED|Period 3||3||
48707439|NCT00435162|102069937|FG002|COMPLETED|Period 2 (2 Weeks)||6||
48707440|NCT00435162|102069938|FG003|COMPLETED|Period 2 (2 Weeks)||8||
48707441|NCT00435162|102069939|FG004|COMPLETED|Period 2 (2 Weeks)||15||
48707442|NCT00435162|102069940|FG005|COMPLETED|Period 2 (2 Weeks)||15||
48707443|NCT00435162|102069935|FG000|NOT COMPLETED|Period 2 (2 Weeks)||0||
48707444|NCT00435162|102069936|FG001|NOT COMPLETED|Period 2 (2 Weeks)||1||
48707445|NCT00435162|102069937|FG002|NOT COMPLETED|Period 2 (2 Weeks)||0||
48291157|NCT00723021|101040671|FG001|COMPLETED|Intervention Period 1||3||
48291158|NCT00723021|101040672|FG002|COMPLETED|Intervention Period 1||3||
48291159|NCT00723021|101040673|FG003|COMPLETED|Intervention Period 1||3||
48291160|NCT00723021|101040674|FG004|COMPLETED|Intervention Period 1||3||
48291161|NCT00723021|101040670|FG000|NOT COMPLETED|Intervention Period 1||0||
48291162|NCT00723021|101040671|FG001|NOT COMPLETED|Intervention Period 1||0||
48291163|NCT00723021|101040672|FG002|NOT COMPLETED|Intervention Period 1||0||
48291164|NCT00723021|101040673|FG003|NOT COMPLETED|Intervention Period 1||0||
48291165|NCT00723021|101040674|FG004|NOT COMPLETED|Intervention Period 1||0||
48291166|NCT00723021|101040670|FG000|STARTED|Intervention Period 2||3||
48291167|NCT00723021|101040671|FG001|STARTED|Intervention Period 2||3||
48291168|NCT00723021|101040672|FG002|STARTED|Intervention Period 2||3||
48291169|NCT00723021|101040673|FG003|STARTED|Intervention Period 2||3||
48291170|NCT00723021|101040674|FG004|STARTED|Intervention Period 2||3||
48291171|NCT00723021|101040670|FG000|COMPLETED|Intervention Period 2||3||
48291172|NCT00723021|101040671|FG001|COMPLETED|Intervention Period 2||3||
48291173|NCT00723021|101040672|FG002|COMPLETED|Intervention Period 2||3||
48291174|NCT00723021|101040673|FG003|COMPLETED|Intervention Period 2||3||
48291175|NCT00723021|101040674|FG004|COMPLETED|Intervention Period 2||3||
48291176|NCT00723021|101040670|FG000|NOT COMPLETED|Intervention Period 2||0||
48291177|NCT00723021|101040671|FG001|NOT COMPLETED|Intervention Period 2||0||
48291178|NCT00723021|101040672|FG002|NOT COMPLETED|Intervention Period 2||0||
48291179|NCT00723021|101040673|FG003|NOT COMPLETED|Intervention Period 2||0||
48291180|NCT00723021|101040674|FG004|NOT COMPLETED|Intervention Period 2||0||
48291181|NCT00723021|101040670|FG000|STARTED|Intervention Period 3||3||
48291182|NCT00723021|101040671|FG001|STARTED|Intervention Period 3||3||
48291183|NCT00723021|101040672|FG002|STARTED|Intervention Period 3||3||
48291184|NCT00723021|101040673|FG003|STARTED|Intervention Period 3||3||
48291185|NCT00723021|101040674|FG004|STARTED|Intervention Period 3||3||
48291186|NCT00723021|101040670|FG000|COMPLETED|Intervention Period 3||3||
48291187|NCT00723021|101040671|FG001|COMPLETED|Intervention Period 3||3||
48291188|NCT00723021|101040672|FG002|COMPLETED|Intervention Period 3||3||
48291189|NCT00723021|101040673|FG003|COMPLETED|Intervention Period 3||3||
48291190|NCT00723021|101040674|FG004|COMPLETED|Intervention Period 3||3||
48291191|NCT00723021|101040670|FG000|NOT COMPLETED|Intervention Period 3||0||
48291192|NCT00723021|101040671|FG001|NOT COMPLETED|Intervention Period 3||0||
48291193|NCT00723021|101040672|FG002|NOT COMPLETED|Intervention Period 3||0||
48291194|NCT00723021|101040673|FG003|NOT COMPLETED|Intervention Period 3||0||
48291195|NCT00723021|101040674|FG004|NOT COMPLETED|Intervention Period 3||0||
48291196|NCT00723021|101040670|FG000|STARTED|Intervention Period 4||3||
48291197|NCT00723021|101040671|FG001|STARTED|Intervention Period 4||3||
48291198|NCT00723021|101040672|FG002|STARTED|Intervention Period 4||3||
48291199|NCT00723021|101040673|FG003|STARTED|Intervention Period 4||3||
48291200|NCT00723021|101040674|FG004|STARTED|Intervention Period 4||3||
48291201|NCT00723021|101040670|FG000|COMPLETED|Intervention Period 4||3||
48291202|NCT00723021|101040671|FG001|COMPLETED|Intervention Period 4||3||
48291203|NCT00723021|101040672|FG002|COMPLETED|Intervention Period 4||3||
48291204|NCT00723021|101040673|FG003|COMPLETED|Intervention Period 4||3||
48291205|NCT00723021|101040674|FG004|COMPLETED|Intervention Period 4||2||
48291206|NCT00723021|101040670|FG000|NOT COMPLETED|Intervention Period 4||0||
48291207|NCT00723021|101040671|FG001|NOT COMPLETED|Intervention Period 4||0||
48291208|NCT00723021|101040672|FG002|NOT COMPLETED|Intervention Period 4||0||
48291209|NCT00723021|101040673|FG003|NOT COMPLETED|Intervention Period 4||0||
48291210|NCT00723021|101040674|FG004|NOT COMPLETED|Intervention Period 4||1||
48291211|NCT00723021|101040670|FG000|STARTED|Intervention Period 5||3||
48291212|NCT00723021|101040671|FG001|STARTED|Intervention Period 5||3||
48291213|NCT00723021|101040672|FG002|STARTED|Intervention Period 5||3||
48291214|NCT00723021|101040673|FG003|STARTED|Intervention Period 5||3||
48291215|NCT00723021|101040674|FG004|STARTED|Intervention Period 5||2||
48291216|NCT00723021|101040670|FG000|COMPLETED|Intervention Period 5||3||
48291217|NCT00723021|101040671|FG001|COMPLETED|Intervention Period 5||3||
48291218|NCT00723021|101040672|FG002|COMPLETED|Intervention Period 5||3||
48291219|NCT00723021|101040673|FG003|COMPLETED|Intervention Period 5||3||
48291220|NCT00723021|101040674|FG004|COMPLETED|Intervention Period 5||2||
48291221|NCT00723021|101040670|FG000|NOT COMPLETED|Intervention Period 5||0||
48291222|NCT00723021|101040671|FG001|NOT COMPLETED|Intervention Period 5||0||
48291223|NCT00723021|101040672|FG002|NOT COMPLETED|Intervention Period 5||0||
48291224|NCT00723021|101040673|FG003|NOT COMPLETED|Intervention Period 5||0||
48291225|NCT00723021|101040674|FG004|NOT COMPLETED|Intervention Period 5||0||
48291226|NCT03995667|101040675|FG000|STARTED|Overall Study||3||
48291227|NCT03995667|101040675|FG000|COMPLETED|Overall Study||1||
48291228|NCT03995667|101040675|FG000|NOT COMPLETED|Overall Study||2||
48291229|NCT02963610|101040676|FG000|STARTED|Overall Study||3||
48291230|NCT02963610|101040676|FG000|COMPLETED|Overall Study||0||
48291231|NCT02963610|101040676|FG000|NOT COMPLETED|Overall Study||3||
48291232|NCT01776541|101040677|FG000|STARTED|Overall Study||488||
48291233|NCT01776541|101040678|FG001|STARTED|Overall Study||491||
48291234|NCT01776541|101040677|FG000|COMPLETED|Overall Study||432||
48291235|NCT01776541|101040678|FG001|COMPLETED|Overall Study||416||
48291236|NCT01776541|101040677|FG000|NOT COMPLETED|Overall Study||56||
48291237|NCT01776541|101040678|FG001|NOT COMPLETED|Overall Study||75||
48291238|NCT02349646|101040679|FG000|STARTED|Overall Study||33||
48291239|NCT02349646|101040679|FG000|Received Trial System|Overall Study||24||
48291240|NCT02349646|101040679|FG000|Receive Permanent System|Overall Study||27||
48291241|NCT02349646|101040679|FG000|COMPLETED|Overall Study||16||
48589018|NCT01953432|101773643|FG000|COMPLETED|Overall Study||8||
48589019|NCT01953432|101773644|FG001|COMPLETED|Overall Study||6||
48589020|NCT01953432|101773643|FG000|NOT COMPLETED|Overall Study||14||
48589021|NCT01953432|101773644|FG001|NOT COMPLETED|Overall Study||15||
48589022|NCT03627416|101773645|FG000|STARTED|Overall Study||8||
48589023|NCT03627416|101773646|FG001|STARTED|Overall Study||7||
48589024|NCT03627416|101773645|FG000|COMPLETED|Overall Study||8||
48291242|NCT02349646|101040679|FG000|NOT COMPLETED|Overall Study||17||
48291243|NCT02401867|101040680|FG000|STARTED|Enrolled||150||
48291244|NCT02401867|101040680|FG000|COMPLETED|Enrolled||150||
48291245|NCT02401867|101040680|FG000|NOT COMPLETED|Enrolled||0||
48291246|NCT02401867|101040680|FG000|STARTED|Specimen Collection||150||
48291247|NCT02401867|101040680|FG000|COMPLETED|Specimen Collection||140||
48291248|NCT02401867|101040680|FG000|NOT COMPLETED|Specimen Collection||10||
48291249|NCT02401867|101040680|FG000|STARTED|Analysis||140||
48291250|NCT02401867|101040680|FG000|COMPLETED|Analysis||131||
48291251|NCT02401867|101040680|FG000|NOT COMPLETED|Analysis||9||
48291252|NCT02684357|101040681|FG000|STARTED|Part A||98||
48291253|NCT02684357|101040682|FG001|STARTED|Part A||99||
48291254|NCT02684357|101040683|FG002|STARTED|Part A||294||
48291255|NCT02684357|101040684|FG003|STARTED|Part A||0||
48589025|NCT03627416|101773646|FG001|COMPLETED|Overall Study||6||
48589026|NCT03627416|101773645|FG000|NOT COMPLETED|Overall Study||0||
48589027|NCT03627416|101773646|FG001|NOT COMPLETED|Overall Study||1||
48589028|NCT02609100|101773647|FG000|STARTED|Overall Study||2||
48589029|NCT02609100|101773648|FG001|STARTED|Overall Study||2||
48589030|NCT02609100|101773647|FG000|COMPLETED|Overall Study||2||
48589031|NCT02609100|101773648|FG001|COMPLETED|Overall Study||2||
48589032|NCT02609100|101773647|FG000|NOT COMPLETED|Overall Study||0||
48589033|NCT02609100|101773648|FG001|NOT COMPLETED|Overall Study||0||
48589034|NCT01187498|101773649|FG000|STARTED|Overall Study||73||
48589035|NCT01187498|101773650|FG001|STARTED|Overall Study||70||
48589036|NCT01187498|101773649|FG000|COMPLETED|Overall Study||64||
48589037|NCT01187498|101773650|FG001|COMPLETED|Overall Study||60||
48589038|NCT01187498|101773649|FG000|NOT COMPLETED|Overall Study||9||
48589039|NCT01187498|101773650|FG001|NOT COMPLETED|Overall Study||10||
48589040|NCT01044290|101773651|FG000|STARTED|Randomization||75||
48589041|NCT01044290|101773652|FG001|STARTED|Randomization||74||
48589042|NCT01044290|101773653|FG002|STARTED|Randomization||72||
48589043|NCT01044290|101773651|FG000|Randomized|Randomization||75||
48589044|NCT01044290|101773652|FG001|Randomized|Randomization||74||
48589045|NCT01044290|101773653|FG002|Randomized|Randomization||72||
48589046|NCT01044290|101773651|FG000|COMPLETED|Randomization||75||
48589047|NCT01044290|101773652|FG001|COMPLETED|Randomization||74||
48291256|NCT02684357|101040685|FG004|STARTED|Part A||0||
48291257|NCT02684357|101040686|FG005|STARTED|Part A||0||
48589048|NCT01044290|101773653|FG002|COMPLETED|Randomization||72||
48589049|NCT01044290|101773651|FG000|NOT COMPLETED|Randomization||0||
48589050|NCT01044290|101773652|FG001|NOT COMPLETED|Randomization||0||
48589051|NCT01044290|101773653|FG002|NOT COMPLETED|Randomization||0||
48291258|NCT02684357|101040681|FG000|COMPLETED|Part A||94||
48291259|NCT02684357|101040682|FG001|COMPLETED|Part A||96||
48291260|NCT02684357|101040683|FG002|COMPLETED|Part A||292||
48291261|NCT02684357|101040684|FG003|COMPLETED|Part A||0||
48291262|NCT02684357|101040685|FG004|COMPLETED|Part A||0||
48291263|NCT02684357|101040686|FG005|COMPLETED|Part A||0||
48291264|NCT02684357|101040681|FG000|NOT COMPLETED|Part A||4||
48291265|NCT02684357|101040682|FG001|NOT COMPLETED|Part A||3||
48589052|NCT01044290|101773651|FG000|STARTED|Follow-up 1||75||
48589053|NCT01044290|101773652|FG001|STARTED|Follow-up 1||74||
48589054|NCT01044290|101773653|FG002|STARTED|Follow-up 1||72||
48589055|NCT01044290|101773651|FG000|Completed F1 Interview|Follow-up 1||61||
48589056|NCT01044290|101773652|FG001|Completed F1 Interview|Follow-up 1||60||
48589057|NCT01044290|101773653|FG002|Completed F1 Interview|Follow-up 1||61||
48589058|NCT01044290|101773651|FG000|COMPLETED|Follow-up 1||70||
48589059|NCT01044290|101773652|FG001|COMPLETED|Follow-up 1||69||
48589060|NCT01044290|101773653|FG002|COMPLETED|Follow-up 1||71||
48589061|NCT01044290|101773651|FG000|NOT COMPLETED|Follow-up 1||5||
48589062|NCT01044290|101773652|FG001|NOT COMPLETED|Follow-up 1||5||
48589063|NCT01044290|101773653|FG002|NOT COMPLETED|Follow-up 1||1||
48589064|NCT01044290|101773651|FG000|STARTED|Follow-Up 2||70||
48291266|NCT02684357|101040683|FG002|NOT COMPLETED|Part A||2||
48291267|NCT02684357|101040684|FG003|NOT COMPLETED|Part A||0||
48291268|NCT02684357|101040685|FG004|NOT COMPLETED|Part A||0||
48589065|NCT01044290|101773652|FG001|STARTED|Follow-Up 2||69||
48589066|NCT01044290|101773653|FG002|STARTED|Follow-Up 2||71||
48589067|NCT01044290|101773651|FG000|Completed F2 Interview|Follow-Up 2||64||
48402664|NCT01784614|101317712|FG004|STARTED|Period 3||3||
48402665|NCT01784614|101317713|FG005|STARTED|Period 3||3||
48402666|NCT01784614|101317714|FG006|STARTED|Period 3||3||
48402667|NCT01784614|101317715|FG007|STARTED|Period 3||2||
48402668|NCT01784614|101317708|FG000|COMPLETED|Period 3||3||
48402669|NCT01784614|101317709|FG001|COMPLETED|Period 3||2||
48402670|NCT01784614|101317710|FG002|COMPLETED|Period 3||3||
48402671|NCT01784614|101317711|FG003|COMPLETED|Period 3||3||
48402672|NCT01784614|101317712|FG004|COMPLETED|Period 3||3||
48402673|NCT01784614|101317713|FG005|COMPLETED|Period 3||3||
48402674|NCT01784614|101317714|FG006|COMPLETED|Period 3||3||
48402675|NCT01784614|101317715|FG007|COMPLETED|Period 3||2||
48402676|NCT01784614|101317708|FG000|NOT COMPLETED|Period 3||0||
48402677|NCT01784614|101317709|FG001|NOT COMPLETED|Period 3||0||
48402678|NCT01784614|101317710|FG002|NOT COMPLETED|Period 3||0||
48402679|NCT01784614|101317711|FG003|NOT COMPLETED|Period 3||0||
48402680|NCT01784614|101317712|FG004|NOT COMPLETED|Period 3||0||
48402681|NCT01784614|101317713|FG005|NOT COMPLETED|Period 3||0||
48402682|NCT01784614|101317714|FG006|NOT COMPLETED|Period 3||0||
48402683|NCT01784614|101317715|FG007|NOT COMPLETED|Period 3||0||
48402684|NCT01784614|101317708|FG000|STARTED|Period 4||3||
48402685|NCT01784614|101317709|FG001|STARTED|Period 4||2||
48402686|NCT01784614|101317710|FG002|STARTED|Period 4||3||
48402687|NCT01784614|101317711|FG003|STARTED|Period 4||3||
48402688|NCT01784614|101317712|FG004|STARTED|Period 4||3||
48402689|NCT01784614|101317713|FG005|STARTED|Period 4||3||
48402690|NCT01784614|101317714|FG006|STARTED|Period 4||3||
48402691|NCT01784614|101317715|FG007|STARTED|Period 4||2||
48402692|NCT01784614|101317708|FG000|COMPLETED|Period 4||3||
48402693|NCT01784614|101317709|FG001|COMPLETED|Period 4||2||
48402694|NCT01784614|101317710|FG002|COMPLETED|Period 4||3||
48402695|NCT01784614|101317711|FG003|COMPLETED|Period 4||3||
48707446|NCT00435162|102069938|FG003|NOT COMPLETED|Period 2 (2 Weeks)||0||
48707447|NCT00435162|102069939|FG004|NOT COMPLETED|Period 2 (2 Weeks)||0||
48707448|NCT00435162|102069940|FG005|NOT COMPLETED|Period 2 (2 Weeks)||0||
48707449|NCT01550341|102069941|FG000|STARTED|Overall Study||32||
48707450|NCT01550341|102069942|FG001|STARTED|Overall Study||18||
48707451|NCT01550341|102069941|FG000|COMPLETED|Overall Study||32||
48707452|NCT01550341|102069942|FG001|COMPLETED|Overall Study||18||
48707453|NCT01550341|102069941|FG000|NOT COMPLETED|Overall Study||0||
48707454|NCT01550341|102069942|FG001|NOT COMPLETED|Overall Study||0||
48707455|NCT00596154|102069943|FG000|STARTED|Overall Study||33||
48707456|NCT00596154|102069943|FG000|COMPLETED|Overall Study||31||
48707457|NCT00596154|102069943|FG000|NOT COMPLETED|Overall Study||2||
48707458|NCT03691844|102069944|FG000|STARTED|Overall Study||121||
48402696|NCT01784614|101317712|FG004|COMPLETED|Period 4||3||
48402697|NCT01784614|101317713|FG005|COMPLETED|Period 4||3||
48402698|NCT01784614|101317714|FG006|COMPLETED|Period 4||3||
48402699|NCT01784614|101317715|FG007|COMPLETED|Period 4||2||
48402700|NCT01784614|101317708|FG000|NOT COMPLETED|Period 4||0||
48402701|NCT01784614|101317709|FG001|NOT COMPLETED|Period 4||0||
48402702|NCT01784614|101317710|FG002|NOT COMPLETED|Period 4||0||
48402703|NCT01784614|101317711|FG003|NOT COMPLETED|Period 4||0||
48402704|NCT01784614|101317712|FG004|NOT COMPLETED|Period 4||0||
48707459|NCT03691844|102069945|FG001|STARTED|Overall Study||121||
48707460|NCT03691844|102069946|FG002|STARTED|Overall Study||121||
48707461|NCT03691844|102069947|FG003|STARTED|Overall Study||81||
48707462|NCT03691844|102069944|FG000|COMPLETED|Overall Study||114||
48707463|NCT03691844|102069945|FG001|COMPLETED|Overall Study||109||
48707464|NCT03691844|102069946|FG002|COMPLETED|Overall Study||108||
48707465|NCT03691844|102069947|FG003|COMPLETED|Overall Study||70||
48402705|NCT01784614|101317713|FG005|NOT COMPLETED|Period 4||0||
48402706|NCT01784614|101317714|FG006|NOT COMPLETED|Period 4||0||
48402707|NCT01784614|101317715|FG007|NOT COMPLETED|Period 4||0||
48402708|NCT01300949|101317716|FG000|STARTED|Overall Study||154||
48402709|NCT01300949|101317717|FG001|STARTED|Overall Study||125||
48402710|NCT01300949|101317718|FG002|STARTED|Overall Study||35||
48402711|NCT01300949|101317716|FG000|COMPLETED|Overall Study||154||
48402712|NCT01300949|101317717|FG001|COMPLETED|Overall Study||125||
48402713|NCT01300949|101317718|FG002|COMPLETED|Overall Study||35||
48402714|NCT01300949|101317716|FG000|NOT COMPLETED|Overall Study||0||
48402715|NCT01300949|101317717|FG001|NOT COMPLETED|Overall Study||0||
48402716|NCT01300949|101317718|FG002|NOT COMPLETED|Overall Study||0||
48402717|NCT02069704|101317719|FG000|STARTED|Overall Study||69||
48402718|NCT02069704|101317720|FG001|STARTED|Overall Study||71||
48402719|NCT02069704|101317719|FG000|COMPLETED|Overall Study||69||
48402720|NCT02069704|101317720|FG001|COMPLETED|Overall Study||71||
48402721|NCT02069704|101317719|FG000|NOT COMPLETED|Overall Study||0||
48402722|NCT02069704|101317720|FG001|NOT COMPLETED|Overall Study||0||
48402723|NCT01770145|101317721|FG000|STARTED|Baseline||127||
48402724|NCT01770145|101317721|FG000|COMPLETED|Baseline||101||
48707466|NCT03691844|102069944|FG000|NOT COMPLETED|Overall Study||7||
48707467|NCT03691844|102069945|FG001|NOT COMPLETED|Overall Study||12||
48707468|NCT03691844|102069946|FG002|NOT COMPLETED|Overall Study||13||
48707469|NCT03691844|102069947|FG003|NOT COMPLETED|Overall Study||11||
48707470|NCT01643850|102069948|FG000|STARTED|Overall Study||5||
48707471|NCT01643850|102069949|FG001|STARTED|Overall Study||2||
48589068|NCT01044290|101773652|FG001|Completed F2 Interview|Follow-Up 2||57||
48589069|NCT01044290|101773653|FG002|Completed F2 Interview|Follow-Up 2||64||
48589070|NCT01044290|101773651|FG000|COMPLETED|Follow-Up 2||70||
48589071|NCT01044290|101773652|FG001|COMPLETED|Follow-Up 2||67||
48589072|NCT01044290|101773653|FG002|COMPLETED|Follow-Up 2||69||
48589073|NCT01044290|101773651|FG000|NOT COMPLETED|Follow-Up 2||0||
48589074|NCT01044290|101773652|FG001|NOT COMPLETED|Follow-Up 2||2||
48589075|NCT01044290|101773653|FG002|NOT COMPLETED|Follow-Up 2||2||
48291269|NCT02684357|101040686|FG005|NOT COMPLETED|Part A||0||
48291270|NCT02684357|101040681|FG000|STARTED|Part B||0||
48291271|NCT02684357|101040682|FG001|STARTED|Part B||0||
48291272|NCT02684357|101040683|FG002|STARTED|Part B||0||
48291273|NCT02684357|101040684|FG003|STARTED|Part B||94||
48291274|NCT02684357|101040685|FG004|STARTED|Part B||94||
48291275|NCT02684357|101040686|FG005|STARTED|Part B||291||
48291276|NCT02684357|101040681|FG000|COMPLETED|Part B||0||
48291277|NCT02684357|101040682|FG001|COMPLETED|Part B||0||
48291278|NCT02684357|101040683|FG002|COMPLETED|Part B||0||
48291279|NCT02684357|101040684|FG003|COMPLETED|Part B||91||
48291280|NCT02684357|101040685|FG004|COMPLETED|Part B||90||
48291281|NCT02684357|101040686|FG005|COMPLETED|Part B||278||
48291282|NCT02684357|101040681|FG000|NOT COMPLETED|Part B||0||
48291283|NCT02684357|101040682|FG001|NOT COMPLETED|Part B||0||
48291284|NCT02684357|101040683|FG002|NOT COMPLETED|Part B||0||
48291285|NCT02684357|101040684|FG003|NOT COMPLETED|Part B||3||
48291286|NCT02684357|101040685|FG004|NOT COMPLETED|Part B||4||
48291287|NCT02684357|101040686|FG005|NOT COMPLETED|Part B||13||
48291288|NCT03975595|101040687|FG000|STARTED|Overall Study||21||
48291289|NCT03975595|101040688|FG001|STARTED|Overall Study||23||
48291290|NCT03975595|101040687|FG000|COMPLETED|Overall Study||15||
48291291|NCT03975595|101040688|FG001|COMPLETED|Overall Study||14||
48291292|NCT03975595|101040687|FG000|NOT COMPLETED|Overall Study||6||
48291293|NCT03975595|101040688|FG001|NOT COMPLETED|Overall Study||9||
48291294|NCT02354508|101040689|FG000|STARTED|Period 1: Core Phase||41||
48291295|NCT02354508|101040690|FG001|STARTED|Period 1: Core Phase||29||
48291296|NCT02354508|101040691|FG002|STARTED|Period 1: Core Phase||53||
48291297|NCT02354508|101040689|FG000|COMPLETED|Period 1: Core Phase||39|Completed 36 week (wk) Core phase|
48291298|NCT02354508|101040690|FG001|COMPLETED|Period 1: Core Phase||27|Completed 36 week (wk) Core phase|
48589076|NCT02345889|101773654|FG000|STARTED|Overall Study||316||
48589077|NCT02345889|101773655|FG001|STARTED|Overall Study||316||
48589078|NCT02345889|101773656|FG002|STARTED|Overall Study||315||
48589079|NCT02345889|101773657|FG003|STARTED|Overall Study||315||
48589080|NCT02345889|101773654|FG000|COMPLETED|Overall Study||295||
48589081|NCT02345889|101773655|FG001|COMPLETED|Overall Study||299||
48589082|NCT02345889|101773656|FG002|COMPLETED|Overall Study||295||
48589083|NCT02345889|101773657|FG003|COMPLETED|Overall Study||299||
48589084|NCT02345889|101773654|FG000|NOT COMPLETED|Overall Study||21||
48589085|NCT02345889|101773655|FG001|NOT COMPLETED|Overall Study||17||
48589086|NCT02345889|101773656|FG002|NOT COMPLETED|Overall Study||20||
48589087|NCT02345889|101773657|FG003|NOT COMPLETED|Overall Study||16||
48589088|NCT01217385|101773658|FG000|STARTED|Overall Study||60||
48589089|NCT01217385|101773658|FG000|COMPLETED|Overall Study||34||
48589090|NCT01217385|101773658|FG000|NOT COMPLETED|Overall Study||26||
48589091|NCT02814227|101773659|FG000|STARTED|Overall Study||52||
48589092|NCT02814227|101773659|FG000|COMPLETED|Overall Study||52||
48589093|NCT02814227|101773659|FG000|NOT COMPLETED|Overall Study||0||
48589094|NCT00288600|101773660|FG000|STARTED|Overall Study||46||
48589095|NCT00288600|101773661|FG001|STARTED|Overall Study||46||
48589096|NCT00288600|101773660|FG000|COMPLETED|Overall Study||46||
48589097|NCT00288600|101773661|FG001|COMPLETED|Overall Study||46||
48589098|NCT00288600|101773660|FG000|NOT COMPLETED|Overall Study||0||
48589099|NCT00288600|101773661|FG001|NOT COMPLETED|Overall Study||0||
48589100|NCT01239212|101773662|FG000|STARTED|Overall Study||7||
48589101|NCT01239212|101773662|FG000|COMPLETED|Overall Study||7||
48589102|NCT01239212|101773662|FG000|NOT COMPLETED|Overall Study||0||
48589103|NCT03729570|101773663|FG000|STARTED|Overall Study||108||
48589104|NCT03729570|101773664|FG001|STARTED|Overall Study||109||
48589105|NCT03729570|101773663|FG000|COMPLETED|Overall Study||80||
48589106|NCT03729570|101773664|FG001|COMPLETED|Overall Study||84||
48589107|NCT03729570|101773663|FG000|NOT COMPLETED|Overall Study||28||
48589108|NCT03729570|101773664|FG001|NOT COMPLETED|Overall Study||25||
48707472|NCT01643850|102069950|FG002|STARTED|Overall Study||8||
48707473|NCT01643850|102069951|FG003|STARTED|Overall Study||3||
48291299|NCT02354508|101040691|FG002|COMPLETED|Period 1: Core Phase||47|Completed 36 week (wk) Core phase|
48707474|NCT01643850|102069952|FG004|STARTED|Overall Study||3||
48291300|NCT02354508|101040689|FG000|NOT COMPLETED|Period 1: Core Phase||2||
48291301|NCT02354508|101040690|FG001|NOT COMPLETED|Period 1: Core Phase||2||
48589109|NCT01118624|101773665|FG000|STARTED|Overall Study||22||
48589110|NCT01118624|101773665|FG000|COMPLETED|Overall Study||0||
48589111|NCT01118624|101773665|FG000|NOT COMPLETED|Overall Study||22||
48589112|NCT02086682|101773666|FG000|STARTED|Overall Study||156||
48589113|NCT02086682|101773667|FG001|STARTED|Overall Study||182||
48589114|NCT02086682|101773666|FG000|COMPLETED|Overall Study||156||
48589115|NCT02086682|101773667|FG001|COMPLETED|Overall Study||182||
48707475|NCT01643850|102069953|FG005|STARTED|Overall Study||3||
48589116|NCT02086682|101773666|FG000|NOT COMPLETED|Overall Study||0||
48589117|NCT02086682|101773667|FG001|NOT COMPLETED|Overall Study||0||
48589118|NCT03205761|101773668|FG000|STARTED|Overall Study||11||
48589119|NCT03205761|101773668|FG000|COMPLETED|Overall Study||0||
48589120|NCT03205761|101773668|FG000|NOT COMPLETED|Overall Study||11||
48589121|NCT00810446|101773669|FG000|STARTED|Overall Study||72||
48589122|NCT00810446|101773669|FG000|COMPLETED|Overall Study||72||
48589123|NCT00810446|101773669|FG000|NOT COMPLETED|Overall Study||0||
48589124|NCT01424514|101776534|FG000|STARTED|Period 1:Intervention Period 1 (14 Days)||20||
48589125|NCT01424514|101776535|FG001|STARTED|Period 1:Intervention Period 1 (14 Days)||20||
48589126|NCT01424514|101776534|FG000|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19||
48589127|NCT01424514|101776535|FG001|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19||
48589128|NCT01424514|101776534|FG000|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1||
48589129|NCT01424514|101776535|FG001|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1||
48589130|NCT01424514|101776534|FG000|STARTED|Period 2:Washout Period (4 Weeks)||19||
48589131|NCT01424514|101776535|FG001|STARTED|Period 2:Washout Period (4 Weeks)||19||
48589132|NCT01424514|101776534|FG000|COMPLETED|Period 2:Washout Period (4 Weeks)||19||
48589133|NCT01424514|101776535|FG001|COMPLETED|Period 2:Washout Period (4 Weeks)||19||
48589134|NCT01424514|101776534|FG000|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0||
48707476|NCT01643850|102069954|FG006|STARTED|Overall Study||4||
48707477|NCT01643850|102069955|FG007|STARTED|Overall Study||4||
48707478|NCT01643850|102069956|FG008|STARTED|Overall Study||4||
48291302|NCT02354508|101040691|FG002|NOT COMPLETED|Period 1: Core Phase||6||
48291303|NCT02354508|101040689|FG000|STARTED|Period 2: Extension Phase||26||
48291304|NCT02354508|101040690|FG001|STARTED|Period 2: Extension Phase||23||
48291305|NCT02354508|101040691|FG002|STARTED|Period 2: Extension Phase||39||
48291306|NCT02354508|101040689|FG000|COMPLETED|Period 2: Extension Phase||20|Completed 72 week extension phase|
48291307|NCT02354508|101040690|FG001|COMPLETED|Period 2: Extension Phase||19|Completed 72 week extension phase|
48291308|NCT02354508|101040691|FG002|COMPLETED|Period 2: Extension Phase||36|Completed 72 week extension phase|
48291309|NCT02354508|101040689|FG000|NOT COMPLETED|Period 2: Extension Phase||6||
48291310|NCT02354508|101040690|FG001|NOT COMPLETED|Period 2: Extension Phase||4||
48291311|NCT02354508|101040691|FG002|NOT COMPLETED|Period 2: Extension Phase||3||
48707479|NCT01643850|102069948|FG000|COMPLETED|Overall Study||5||
48707480|NCT01643850|102069949|FG001|COMPLETED|Overall Study||2||
48707481|NCT01643850|102069950|FG002|COMPLETED|Overall Study||7||
48707482|NCT01643850|102069951|FG003|COMPLETED|Overall Study||3||
48707483|NCT01643850|102069952|FG004|COMPLETED|Overall Study||0||
48707484|NCT01643850|102069953|FG005|COMPLETED|Overall Study||3||
48707485|NCT01643850|102069954|FG006|COMPLETED|Overall Study||3||
48707486|NCT01643850|102069955|FG007|COMPLETED|Overall Study||4||
48291312|NCT02354508|101040689|FG000|STARTED|Period 3: Post-treatment Follow up Phase||26|Entered post-treatment follow up|
48291313|NCT02354508|101040690|FG001|STARTED|Period 3: Post-treatment Follow up Phase||23|Entered post-treatment follow up|
48291314|NCT02354508|101040691|FG002|STARTED|Period 3: Post-treatment Follow up Phase||39|Entered post-treatment follow up|
48291315|NCT02354508|101040689|FG000|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase||4||
48291316|NCT02354508|101040690|FG001|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase||3||
48291317|NCT02354508|101040691|FG002|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase||3||
48707487|NCT01643850|102069956|FG008|COMPLETED|Overall Study||3||
48707488|NCT01643850|102069948|FG000|NOT COMPLETED|Overall Study||0||
48707489|NCT01643850|102069949|FG001|NOT COMPLETED|Overall Study||0||
48707490|NCT01643850|102069950|FG002|NOT COMPLETED|Overall Study||1||
48707491|NCT01643850|102069951|FG003|NOT COMPLETED|Overall Study||0||
48707492|NCT01643850|102069952|FG004|NOT COMPLETED|Overall Study||3||
48707493|NCT01643850|102069953|FG005|NOT COMPLETED|Overall Study||0||
48707494|NCT01643850|102069954|FG006|NOT COMPLETED|Overall Study||1||
48707495|NCT01643850|102069955|FG007|NOT COMPLETED|Overall Study||0||
48707496|NCT01643850|102069956|FG008|NOT COMPLETED|Overall Study||1||
48589135|NCT01424514|101776535|FG001|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0||
48589136|NCT01424514|101776534|FG000|STARTED|Period 3:Intervention Period 2 (14 Days)||19||
48589137|NCT01424514|101776535|FG001|STARTED|Period 3:Intervention Period 2 (14 Days)||19||
48589138|NCT01424514|101776534|FG000|COMPLETED|Period 3:Intervention Period 2 (14 Days)||18||
48589139|NCT01424514|101776535|FG001|COMPLETED|Period 3:Intervention Period 2 (14 Days)||19||
48589140|NCT01424514|101776534|FG000|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||1||
48589141|NCT01424514|101776535|FG001|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||0||
48589142|NCT02889835|101776536|FG000|STARTED|Overall Study||53|A total of 53 patients were enrolled. Each patient received in different teeth, one restoration of each intervention except for 3 patients who received two restorations of each intervention for a total of 56 teeth per intervention.|56
48592849|NCT02059434|101786327|FG002|STARTED|Period 1 (After Screening/run-in Period)||2||
48707497|NCT00635739|102069957|FG000|STARTED|Overall Study||42||
48707498|NCT00635739|102069958|FG001|STARTED|Overall Study||38||
48707499|NCT00635739|102069957|FG000|COMPLETED|Overall Study||39||
48707500|NCT00635739|102069958|FG001|COMPLETED|Overall Study||36||
48589143|NCT02889835|101776537|FG001|STARTED|Overall Study||53|A total of 53 patients were enrolled. Each patient received in different teeth, one restoration of each intervention except for 3 patients who received two restorations of each intervention for a total of 56 teeth per intervention.|56
48589144|NCT02889835|101776538|FG002|STARTED|Overall Study||53|A total of 53 patients were enrolled. Each patient received in different teeth, one restoration of each intervention except for 3 patients who received two restorations of each intervention for a total of 56 teeth per intervention.|56
48589145|NCT02889835|101776536|FG000|COMPLETED|Overall Study||35||37
48589146|NCT02889835|101776537|FG001|COMPLETED|Overall Study||35||37
48589147|NCT02889835|101776538|FG002|COMPLETED|Overall Study||35||37
48589148|NCT02889835|101776536|FG000|NOT COMPLETED|Overall Study||18||19
48589149|NCT02889835|101776537|FG001|NOT COMPLETED|Overall Study||18||19
48589150|NCT02889835|101776538|FG002|NOT COMPLETED|Overall Study||18||19
48589151|NCT01984892|101776539|FG000|STARTED|Overall Study||8||
48589152|NCT01984892|101776539|FG000|COMPLETED|Overall Study||1||
48589153|NCT01984892|101776539|FG000|NOT COMPLETED|Overall Study||7||
48589154|NCT02893553|101776540|FG000|STARTED|Study 1||21||
48589155|NCT02893553|101776540|FG000|Midodrine (Low)|Study 1||19||
48589156|NCT02893553|101776540|FG000|Midodrine (Medium)|Study 1||6||
48589157|NCT02893553|101776540|FG000|Midodrine (High)|Study 1||0||
48589158|NCT02893553|101776540|FG000|Mirabegron (Low)|Study 1||19||
48589159|NCT02893553|101776540|FG000|Mirabegron (Medium)|Study 1||15||
48589160|NCT02893553|101776540|FG000|Mirabegron (High)|Study 1||8||
48707501|NCT00635739|102069957|FG000|NOT COMPLETED|Overall Study||3||
48707502|NCT00635739|102069958|FG001|NOT COMPLETED|Overall Study||2||
48707503|NCT04610489|102069959|FG000|STARTED|Overall Study||117||
48707504|NCT04610489|102069959|FG000|COMPLETED|Overall Study||117||
48707505|NCT04610489|102069959|FG000|NOT COMPLETED|Overall Study||0||
48291318|NCT02354508|101040689|FG000|COMPLETED|Period 3: Post-treatment Follow up Phase||22|Entered post-treatment follow-up, completed|
48291319|NCT02354508|101040690|FG001|COMPLETED|Period 3: Post-treatment Follow up Phase||20|Entered post-treatment follow-up, completed|
48291320|NCT02354508|101040691|FG002|COMPLETED|Period 3: Post-treatment Follow up Phase||36|Entered post-treatment follow-up, completed|
48291321|NCT02354508|101040689|FG000|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||4||
48291322|NCT02354508|101040690|FG001|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||3||
48291323|NCT02354508|101040691|FG002|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||3||
48291324|NCT02350777|101040692|FG000|STARTED|Overall Study||2||
48291325|NCT02350777|101040693|FG001|STARTED|Overall Study||2||
48291326|NCT02350777|101040692|FG000|COMPLETED|Overall Study||2||
48291327|NCT02350777|101040693|FG001|COMPLETED|Overall Study||2||
48291328|NCT02350777|101040692|FG000|NOT COMPLETED|Overall Study||0||
48291329|NCT02350777|101040693|FG001|NOT COMPLETED|Overall Study||0||
48291330|NCT01060540|101040694|FG000|STARTED|Overall Study||303||
48291331|NCT01060540|101040695|FG001|STARTED|Overall Study||298||
48291332|NCT01060540|101040694|FG000|COMPLETED|Overall Study||239||
48291333|NCT01060540|101040695|FG001|COMPLETED|Overall Study||233||
48291334|NCT01060540|101040694|FG000|NOT COMPLETED|Overall Study||64||
48291335|NCT01060540|101040695|FG001|NOT COMPLETED|Overall Study||65||
48291336|NCT01506453|101040696|FG000|STARTED|Overall Study||25||
48291337|NCT01506453|101040697|FG001|STARTED|Overall Study||26||
48291338|NCT01506453|101040696|FG000|COMPLETED|Overall Study||25||
48291339|NCT01506453|101040697|FG001|COMPLETED|Overall Study||24||
48707506|NCT04795167|102069960|FG000|STARTED|Overall Study||53||
48707507|NCT04795167|102069961|FG001|STARTED|Overall Study||61||
48707508|NCT04795167|102069962|FG002|STARTED|Overall Study||1||
48707509|NCT04795167|102069960|FG000|COMPLETED|Overall Study||48||
48291340|NCT01506453|101040696|FG000|NOT COMPLETED|Overall Study||0||
48589161|NCT02893553|101776540|FG000|Pyridostigmine (Low)|Study 1||19||
48589162|NCT02893553|101776540|FG000|Pyridostigmine (Medium)|Study 1||10||
48589163|NCT02893553|101776540|FG000|Pyridostigmine (High)|Study 1||5||
48589164|NCT02893553|101776540|FG000|Placebo|Study 1||0||
48707510|NCT04795167|102069961|FG001|COMPLETED|Overall Study||43||
48707511|NCT04795167|102069962|FG002|COMPLETED|Overall Study||0||
48707512|NCT04795167|102069960|FG000|NOT COMPLETED|Overall Study||5||
48589165|NCT02893553|101776540|FG000|COMPLETED|Study 1||19||
48589166|NCT02893553|101776540|FG000|NOT COMPLETED|Study 1||2||
48589167|NCT02893553|101776540|FG000|STARTED|Study 2||18||
48589168|NCT02893553|101776540|FG000|Midodrine (Low)|Study 2||11||
48589169|NCT02893553|101776540|FG000|Midodrine (Medium)|Study 2||5||
48589170|NCT02893553|101776540|FG000|Midodrine (High)|Study 2||0||
48589171|NCT02893553|101776540|FG000|Mirabegron (Low)|Study 2||3||
48589172|NCT02893553|101776540|FG000|Mirabegron (Medium)|Study 2||7||
48589173|NCT02893553|101776540|FG000|Mirabegron (High)|Study 2||7||
48589174|NCT02893553|101776540|FG000|Pyridostigmine (Low)|Study 2||7||
48589175|NCT02893553|101776540|FG000|Pyridostigmine (Medium)|Study 2||5||
48707513|NCT04795167|102069961|FG001|NOT COMPLETED|Overall Study||18||
48707514|NCT04795167|102069962|FG002|NOT COMPLETED|Overall Study||1||
48707515|NCT01301521|102069963|FG000|STARTED|Overall Study||116||
48707516|NCT01301521|102069964|FG001|STARTED|Overall Study||113||
48707517|NCT01301521|102069963|FG000|COMPLETED|Overall Study||47||
48589176|NCT02893553|101776540|FG000|Pyridostigmine (High)|Study 2||5||
48589177|NCT02893553|101776540|FG000|Placebo|Study 2||16||
48589178|NCT02893553|101776540|FG000|COMPLETED|Study 2||16||
48589179|NCT02893553|101776540|FG000|NOT COMPLETED|Study 2||2||
48707518|NCT01301521|102069964|FG001|COMPLETED|Overall Study||43||
48707519|NCT01301521|102069963|FG000|NOT COMPLETED|Overall Study||69||
48707520|NCT01301521|102069964|FG001|NOT COMPLETED|Overall Study||70||
48707521|NCT00536874|102069965|FG000|STARTED|Overall Study||39||
48707522|NCT00536874|102069965|FG000|COMPLETED|Overall Study||35||
48707523|NCT00536874|102069965|FG000|NOT COMPLETED|Overall Study||4||
48707524|NCT00867087|102069966|FG000|STARTED|Overall Study||63||
48707525|NCT00867087|102069966|FG000|COMPLETED|Overall Study||21||
48707526|NCT00867087|102069966|FG000|NOT COMPLETED|Overall Study||42||
48707527|NCT00107315|102069967|FG000|STARTED|Overall Study||16||
48707528|NCT00107315|102069967|FG000|COMPLETED|Overall Study||1||
48707529|NCT00107315|102069967|FG000|NOT COMPLETED|Overall Study||15||
48707530|NCT03660228|102069968|FG000|STARTED|Overall Study||62||
48707531|NCT03660228|102069968|FG000|COMPLETED|Overall Study||38||
48707532|NCT03660228|102069968|FG000|NOT COMPLETED|Overall Study||24||
48707533|NCT02723006|102069969|FG000|STARTED|Overall Study||1||
48707534|NCT02723006|102069970|FG001|STARTED|Overall Study||9||
48707535|NCT02723006|102069971|FG002|STARTED|Overall Study||12||
48707536|NCT02723006|102069969|FG000|COMPLETED|Overall Study||0||
48707537|NCT02723006|102069970|FG001|COMPLETED|Overall Study||2||
48707538|NCT02723006|102069971|FG002|COMPLETED|Overall Study||5||
48707539|NCT02723006|102069969|FG000|NOT COMPLETED|Overall Study||1||
48707540|NCT02723006|102069970|FG001|NOT COMPLETED|Overall Study||7||
48707541|NCT02723006|102069971|FG002|NOT COMPLETED|Overall Study||7||
48707542|NCT02002936|102073140|FG000|STARTED|Overall Study||1||
48707543|NCT02002936|102073140|FG000|COMPLETED|Overall Study||1||
48707544|NCT02002936|102073140|FG000|NOT COMPLETED|Overall Study||0||
48707545|NCT02928029|102073141|FG000|STARTED|Overall Study||3||
48707546|NCT02928029|102073142|FG001|STARTED|Overall Study||4||
48707547|NCT02928029|102073141|FG000|COMPLETED|Overall Study||0||
48707548|NCT02928029|102073142|FG001|COMPLETED|Overall Study||0||
48707549|NCT02928029|102073141|FG000|NOT COMPLETED|Overall Study||3||
48589180|NCT00664859|101776541|FG000|STARTED|Overall Study||51||
48589181|NCT00664859|101776542|FG001|STARTED|Overall Study||45||
48589182|NCT00664859|101776543|FG002|STARTED|Overall Study||44||
48589183|NCT00664859|101776541|FG000|COMPLETED|Overall Study||34||
48589184|NCT00664859|101776542|FG001|COMPLETED|Overall Study||35||
48589185|NCT00664859|101776543|FG002|COMPLETED|Overall Study||23||
48589186|NCT00664859|101776541|FG000|NOT COMPLETED|Overall Study||17||
48589187|NCT00664859|101776542|FG001|NOT COMPLETED|Overall Study||10||
48589188|NCT00664859|101776543|FG002|NOT COMPLETED|Overall Study||21||
48589189|NCT03687372|101776544|FG000|STARTED|Overall Study||254||
48589190|NCT03687372|101776545|FG001|STARTED|Overall Study||249||
48589191|NCT03687372|101776544|FG000|COMPLETED|Overall Study||237||
48589192|NCT03687372|101776545|FG001|COMPLETED|Overall Study||210||
48589193|NCT03687372|101776544|FG000|NOT COMPLETED|Overall Study||17||
48589194|NCT03687372|101776545|FG001|NOT COMPLETED|Overall Study||39||
48589195|NCT02715700|101776546|FG000|STARTED|Overall Study||14||
48589196|NCT02715700|101776546|FG000|COMPLETED|Overall Study||14||
48589197|NCT02715700|101776546|FG000|NOT COMPLETED|Overall Study||0||
48589198|NCT03476174|101776547|FG000|STARTED|Overall Study||1||
48589199|NCT03476174|101776547|FG000|COMPLETED|Overall Study||1||
48707550|NCT02928029|102073142|FG001|NOT COMPLETED|Overall Study||4||
48707551|NCT00607113|102073143|FG000|STARTED|Overall Study||19||
48707552|NCT00607113|102073144|FG001|STARTED|Overall Study||20||
48707553|NCT00607113|102073143|FG000|COMPLETED|Overall Study||19||
48707554|NCT00607113|102073144|FG001|COMPLETED|Overall Study||20||
48707555|NCT00607113|102073143|FG000|NOT COMPLETED|Overall Study||0||
48707556|NCT00607113|102073144|FG001|NOT COMPLETED|Overall Study||0||
48707557|NCT05894538|102073145|FG000|STARTED|Overall Study||718||
48707558|NCT05894538|102073146|FG001|STARTED|Overall Study||741||
48707559|NCT05894538|102073145|FG000|COMPLETED|Overall Study||708||
48707560|NCT05894538|102073146|FG001|COMPLETED|Overall Study||724||
48707561|NCT05894538|102073145|FG000|NOT COMPLETED|Overall Study||10||
48589200|NCT03476174|101776547|FG000|NOT COMPLETED|Overall Study||0||
48589201|NCT02581475|101776548|FG000|STARTED|Overall Study||193||
48589202|NCT02581475|101776549|FG001|STARTED|Overall Study||193||
48589203|NCT02581475|101776548|FG000|COMPLETED|Overall Study||182||
48589204|NCT02581475|101776549|FG001|COMPLETED|Overall Study||178||
48589205|NCT02581475|101776548|FG000|NOT COMPLETED|Overall Study||11||
48589206|NCT02581475|101776549|FG001|NOT COMPLETED|Overall Study||15||
48589207|NCT01007136|101776550|FG000|STARTED|Overall Study||19||
48589208|NCT01007136|101776551|FG001|STARTED|Overall Study||17||
48589209|NCT01007136|101776552|FG002|STARTED|Overall Study||15||
48589210|NCT01007136|101776553|FG003|STARTED|Overall Study||6||
48589211|NCT01007136|101776554|FG004|STARTED|Overall Study||4||
48589212|NCT01007136|101776550|FG000|COMPLETED|Overall Study||15||
48589213|NCT01007136|101776551|FG001|COMPLETED|Overall Study||13||
48589214|NCT01007136|101776552|FG002|COMPLETED|Overall Study||15||
48589215|NCT01007136|101776553|FG003|COMPLETED|Overall Study||6||
48589216|NCT01007136|101776554|FG004|COMPLETED|Overall Study||4||
48589217|NCT01007136|101776550|FG000|NOT COMPLETED|Overall Study||4||
48589218|NCT01007136|101776551|FG001|NOT COMPLETED|Overall Study||4||
48589219|NCT01007136|101776552|FG002|NOT COMPLETED|Overall Study||0||
48589220|NCT01007136|101776553|FG003|NOT COMPLETED|Overall Study||0||
48589221|NCT01007136|101776554|FG004|NOT COMPLETED|Overall Study||0||
48589222|NCT02620384|101776555|FG000|STARTED|Overall Study||70||
48589223|NCT02620384|101776556|FG001|STARTED|Overall Study||73||
48589224|NCT02620384|101776555|FG000|COMPLETED|Overall Study||66||
48589225|NCT02620384|101776556|FG001|COMPLETED|Overall Study||66||
48589226|NCT02620384|101776555|FG000|NOT COMPLETED|Overall Study||4||
48589227|NCT02620384|101776556|FG001|NOT COMPLETED|Overall Study||7||
48589228|NCT02224820|101776557|FG000|STARTED|Overall Study||8||
48589229|NCT02224820|101776557|FG000|COMPLETED|Overall Study||8||
48589230|NCT02224820|101776557|FG000|NOT COMPLETED|Overall Study||0||
48589231|NCT03813147|101776558|FG000|STARTED|Overall Study||6||
48589232|NCT03813147|101776559|FG001|STARTED|Overall Study||6||
48589233|NCT03813147|101776558|FG000|COMPLETED|Overall Study||0||
48589234|NCT03813147|101776559|FG001|COMPLETED|Overall Study||1||
48589235|NCT03813147|101776558|FG000|NOT COMPLETED|Overall Study||6||
48589236|NCT03813147|101776559|FG001|NOT COMPLETED|Overall Study||5||
48589237|NCT00138073|101776560|FG000|STARTED|Overall Study||55||
48707562|NCT05894538|102073146|FG001|NOT COMPLETED|Overall Study||17||
48707563|NCT04677660|102073147|FG000|STARTED|Overall Study||50||
48707564|NCT04677660|102073148|FG001|STARTED|Overall Study||150||
48707565|NCT04677660|102073147|FG000|COMPLETED|Overall Study||7||
48707566|NCT04677660|102073148|FG001|COMPLETED|Overall Study||137||
48707567|NCT04677660|102073147|FG000|NOT COMPLETED|Overall Study||43||
48707568|NCT04677660|102073148|FG001|NOT COMPLETED|Overall Study||13||
48707569|NCT02383420|102073149|FG000|STARTED|Overall Study||10||
48707570|NCT02383420|102073150|FG001|STARTED|Overall Study||10||
48707571|NCT02383420|102073151|FG002|STARTED|Overall Study||3||
48707572|NCT02383420|102073149|FG000|COMPLETED|Overall Study||8||
48707573|NCT02383420|102073150|FG001|COMPLETED|Overall Study||10||
48589238|NCT00138073|101776560|FG000|Pre-intervention Testing|Overall Study||55||
48589239|NCT00138073|101776560|FG000|COMPLETED|Overall Study||0||
48589240|NCT00138073|101776560|FG000|NOT COMPLETED|Overall Study||55||
48589241|NCT01013844|101776561|FG000|STARTED|Overall Study||65||
48589242|NCT01013844|101776562|FG001|STARTED|Overall Study||65||
48589243|NCT01013844|101776561|FG000|COMPLETED|Overall Study||65||
48589244|NCT01013844|101776562|FG001|COMPLETED|Overall Study||65||
48589245|NCT01013844|101776561|FG000|NOT COMPLETED|Overall Study||0||
48589246|NCT01013844|101776562|FG001|NOT COMPLETED|Overall Study||0||
48589247|NCT03698994|101776563|FG000|STARTED|Overall Study||20||
48589248|NCT03698994|101776563|FG000|COMPLETED|Overall Study||1||
48589249|NCT03698994|101776563|FG000|NOT COMPLETED|Overall Study||19||
48589250|NCT01294007|101776564|FG000|STARTED|Overall Study||1||
48589251|NCT01294007|101776564|FG000|COMPLETED|Overall Study||1||
48589252|NCT01294007|101776564|FG000|NOT COMPLETED|Overall Study||0||
48589253|NCT01740128|101776565|FG000|STARTED|Overall Study||10||
48589254|NCT01740128|101776566|FG001|STARTED|Overall Study||11||
48589255|NCT01740128|101776565|FG000|COMPLETED|Overall Study||4||
48589256|NCT01740128|101776566|FG001|COMPLETED|Overall Study||4||
48707574|NCT02383420|102073151|FG002|COMPLETED|Overall Study||3||
48707575|NCT02383420|102073149|FG000|NOT COMPLETED|Overall Study||2||
48707576|NCT02383420|102073150|FG001|NOT COMPLETED|Overall Study||0||
48707577|NCT02383420|102073151|FG002|NOT COMPLETED|Overall Study||0||
48707578|NCT04857437|102073152|FG000|STARTED|Part 1 Period 1||2||
48707579|NCT04857437|102073153|FG001|STARTED|Part 1 Period 1||1||
48707580|NCT04857437|102073154|FG002|STARTED|Part 1 Period 1||2||
48707581|NCT04857437|102073155|FG003|STARTED|Part 1 Period 1||1||
48707582|NCT04857437|102073156|FG004|STARTED|Part 1 Period 1||2||
48707583|NCT04857437|102073157|FG005|STARTED|Part 1 Period 1||1||
48707584|NCT04857437|102073158|FG006|STARTED|Part 1 Period 1||1||
48707585|NCT04857437|102073159|FG007|STARTED|Part 1 Period 1||2||
48707586|NCT04857437|102073152|FG000|COMPLETED|Part 1 Period 1||2||
48707587|NCT04857437|102073153|FG001|COMPLETED|Part 1 Period 1||1||
48707588|NCT04857437|102073154|FG002|COMPLETED|Part 1 Period 1||2||
48707589|NCT04857437|102073155|FG003|COMPLETED|Part 1 Period 1||1||
48707590|NCT04857437|102073156|FG004|COMPLETED|Part 1 Period 1||2||
48402725|NCT01770145|101317721|FG000|NOT COMPLETED|Baseline||26||
48402726|NCT01770145|101317721|FG000|STARTED|Treatment||101||
48402727|NCT01770145|101317721|FG000|COMPLETED|Treatment||97||
48402728|NCT01770145|101317721|FG000|NOT COMPLETED|Treatment||4||
48589257|NCT01740128|101776565|FG000|NOT COMPLETED|Overall Study||6||
48707591|NCT04857437|102073157|FG005|COMPLETED|Part 1 Period 1||1||
48139452|NCT02395120|100665612|FG000|Started-Caregivers|Overall Study||188|Caregivers (primary caregiver of family)|
48291341|NCT01506453|101040697|FG001|NOT COMPLETED|Overall Study||2||
48291342|NCT00250926|101040698|FG000|STARTED|Overall Study||23||
48291343|NCT00250926|101040698|FG000|COMPLETED|Overall Study||23||
48291344|NCT00250926|101040698|FG000|NOT COMPLETED|Overall Study||0||
48291345|NCT01477320|101040699|FG000|STARTED|Overall Study||62||
48291346|NCT01477320|101040700|FG001|STARTED|Overall Study||62||
48291347|NCT01477320|101040699|FG000|COMPLETED|Overall Study||55||
48291348|NCT01477320|101040700|FG001|COMPLETED|Overall Study||47||
48291349|NCT01477320|101040699|FG000|NOT COMPLETED|Overall Study||7||
48291350|NCT01477320|101040700|FG001|NOT COMPLETED|Overall Study||15||
48291351|NCT01115660|101040701|FG000|STARTED|Overall Study||20||
48291352|NCT01115660|101040702|FG001|STARTED|Overall Study||10||
48291353|NCT01115660|101040701|FG000|COMPLETED|Overall Study||19||
48402729|NCT01993667|101317722|FG000|STARTED|Overall Study||64||
48402730|NCT01993667|101317723|FG001|STARTED|Overall Study||66||
48589258|NCT01740128|101776566|FG001|NOT COMPLETED|Overall Study||7||
48589259|NCT04630249|101776567|FG000|STARTED|Overall Study||224||
48589260|NCT04630249|101776568|FG001|STARTED|Overall Study||191||
48589261|NCT04630249|101776567|FG000|COMPLETED|Overall Study||224|Follow-up data was extracted from the EHR and may not capture all participants that did not continue prenatal care in the study healthcare system.|
48589262|NCT04630249|101776568|FG001|COMPLETED|Overall Study||191|Follow-up data was extracted from the EHR and may not capture all participants that did not continue prenatal care in the study healthcare system.|
48589263|NCT04630249|101776567|FG000|NOT COMPLETED|Overall Study||0||
48589264|NCT04630249|101776568|FG001|NOT COMPLETED|Overall Study||0||
48589265|NCT03470012|101776569|FG000|STARTED|Overall Study||24||
48589266|NCT03470012|101776569|FG000|COMPLETED|Overall Study||24||
48589267|NCT03470012|101776569|FG000|NOT COMPLETED|Overall Study||0||
48589268|NCT02344290|101776570|FG000|STARTED|Overall Study||3888||
48589269|NCT02344290|101776571|FG001|STARTED|Overall Study||3881||
48589270|NCT02344290|101776570|FG000|Enrolled in Mechanistic Substudy|Overall Study||402||
48291354|NCT01115660|101040702|FG001|COMPLETED|Overall Study||10||
48291355|NCT01115660|101040701|FG000|NOT COMPLETED|Overall Study||1||
48291356|NCT01115660|101040702|FG001|NOT COMPLETED|Overall Study||0||
48291357|NCT02470910|101040703|FG000|STARTED|Overall Study||15||
48291358|NCT02470910|101040703|FG000|COMPLETED|Overall Study||15||
48291359|NCT02470910|101040703|FG000|NOT COMPLETED|Overall Study||0||
48291360|NCT01048671|101040704|FG000|STARTED|Overall Study||66||
48291361|NCT01048671|101040705|FG001|STARTED|Overall Study||264||
48291362|NCT01048671|101040706|FG002|STARTED|Overall Study||152||
48291363|NCT01048671|101040704|FG000|COMPLETED|Overall Study||66||
48291364|NCT01048671|101040705|FG001|COMPLETED|Overall Study||263||
48291365|NCT01048671|101040706|FG002|COMPLETED|Overall Study||151||
48291366|NCT01048671|101040704|FG000|NOT COMPLETED|Overall Study||0||
48291367|NCT01048671|101040705|FG001|NOT COMPLETED|Overall Study||1||
48291368|NCT01048671|101040706|FG002|NOT COMPLETED|Overall Study||1||
48291369|NCT00682890|101040707|FG000|STARTED|Overall Study||12||
48291370|NCT00682890|101040708|FG001|STARTED|Overall Study||11||
48291371|NCT00682890|101040707|FG000|COMPLETED|Overall Study||10||
48291372|NCT00682890|101040708|FG001|COMPLETED|Overall Study||9||
48291373|NCT00682890|101040707|FG000|NOT COMPLETED|Overall Study||2||
48291374|NCT00682890|101040708|FG001|NOT COMPLETED|Overall Study||2||
48291375|NCT03037931|101040709|FG000|STARTED|Overall Study||1532||
48291376|NCT03037931|101040710|FG001|STARTED|Overall Study||1533||
48291377|NCT03037931|101040709|FG000|COMPLETED|Overall Study||1123||
48291378|NCT03037931|101040710|FG001|COMPLETED|Overall Study||1121||
48291379|NCT03037931|101040709|FG000|NOT COMPLETED|Overall Study||409||
48291380|NCT03037931|101040710|FG001|NOT COMPLETED|Overall Study||412||
48291381|NCT01328717|101040711|FG000|STARTED|Overall Study||78||
48291382|NCT01328717|101040711|FG000|COMPLETED|Overall Study||77||
48291383|NCT01328717|101040711|FG000|NOT COMPLETED|Overall Study||1||
48291384|NCT00906945|101040712|FG000|STARTED|Overall Study||3||
48291385|NCT00906945|101040713|FG001|STARTED|Overall Study||3||
48291386|NCT00906945|101040714|FG002|STARTED|Overall Study||3||
48291387|NCT00906945|101040715|FG003|STARTED|Overall Study||7||
48291388|NCT00906945|101040716|FG004|STARTED|Overall Study||7||
48291389|NCT00906945|101040717|FG005|STARTED|Overall Study||16||
48291390|NCT00906945|101040712|FG000|COMPLETED|Overall Study||3||
48291391|NCT00906945|101040713|FG001|COMPLETED|Overall Study||3||
48291392|NCT00906945|101040714|FG002|COMPLETED|Overall Study||3||
48291393|NCT00906945|101040715|FG003|COMPLETED|Overall Study||6||
48291394|NCT00906945|101040716|FG004|COMPLETED|Overall Study||6||
48291395|NCT00906945|101040717|FG005|COMPLETED|Overall Study||14||
48291396|NCT00906945|101040712|FG000|NOT COMPLETED|Overall Study||0||
48291397|NCT00906945|101040713|FG001|NOT COMPLETED|Overall Study||0||
48291398|NCT00906945|101040714|FG002|NOT COMPLETED|Overall Study||0||
48291399|NCT00906945|101040715|FG003|NOT COMPLETED|Overall Study||1||
48291400|NCT00906945|101040716|FG004|NOT COMPLETED|Overall Study||1||
48291401|NCT00906945|101040717|FG005|NOT COMPLETED|Overall Study||2||
48291402|NCT01786187|101040718|FG000|STARTED|Overall Study||40||
48291403|NCT01786187|101040719|FG001|STARTED|Overall Study||47||
48291404|NCT01786187|101040718|FG000|COMPLETED|Overall Study||35||
48291405|NCT01786187|101040719|FG001|COMPLETED|Overall Study||37||
48291406|NCT01786187|101040718|FG000|NOT COMPLETED|Overall Study||5||
48291407|NCT01786187|101040719|FG001|NOT COMPLETED|Overall Study||10||
48291408|NCT00596427|101040720|FG000|STARTED|Overall Study||30||
48291409|NCT00596427|101040721|FG001|STARTED|Overall Study||30||
48291410|NCT00596427|101040720|FG000|COMPLETED|Overall Study||26||
48291411|NCT00596427|101040721|FG001|COMPLETED|Overall Study||28||
48291412|NCT00596427|101040720|FG000|NOT COMPLETED|Overall Study||4||
48291413|NCT00596427|101040721|FG001|NOT COMPLETED|Overall Study||2||
48291414|NCT01696942|101040722|FG000|STARTED|Overall Study||5||
48291415|NCT01696942|101040723|FG001|STARTED|Overall Study||5||
48291416|NCT01696942|101040722|FG000|COMPLETED|Overall Study||3||
48291417|NCT01696942|101040723|FG001|COMPLETED|Overall Study||2||
48291418|NCT01696942|101040722|FG000|NOT COMPLETED|Overall Study||2||
48291419|NCT01696942|101040723|FG001|NOT COMPLETED|Overall Study||3||
48291420|NCT04262947|101040724|FG000|STARTED|Overall Study||13||
48291421|NCT04262947|101040725|FG001|STARTED|Overall Study||13||
48291422|NCT04262947|101040726|FG002|STARTED|Overall Study||12||
48291423|NCT04262947|101040724|FG000|COMPLETED|Overall Study||13||
48291424|NCT04262947|101040725|FG001|COMPLETED|Overall Study||13||
48589271|NCT02344290|101776571|FG001|Enrolled in Mechanistic Substudy|Overall Study||402||
48589272|NCT02344290|101776570|FG000|Completed Mechanistic Substudy|Overall Study||349||
48589273|NCT02344290|101776571|FG001|Completed Mechanistic Substudy|Overall Study||350||
48589274|NCT02344290|101776570|FG000|COMPLETED|Overall Study||3201||
48589275|NCT02344290|101776571|FG001|COMPLETED|Overall Study||3201||
48589276|NCT02344290|101776570|FG000|NOT COMPLETED|Overall Study||687||
48589277|NCT02344290|101776571|FG001|NOT COMPLETED|Overall Study||680||
48589278|NCT00834639|101776572|FG000|STARTED|First Intervention||12||
48589279|NCT00834639|101776573|FG001|STARTED|First Intervention||12||
48589280|NCT00834639|101776572|FG000|COMPLETED|First Intervention||12||
48589281|NCT00834639|101776573|FG001|COMPLETED|First Intervention||12||
48589282|NCT00834639|101776572|FG000|NOT COMPLETED|First Intervention||0||
48589283|NCT00834639|101776573|FG001|NOT COMPLETED|First Intervention||0||
48589284|NCT00834639|101776572|FG000|STARTED|Washout of 7 Days||12||
48589285|NCT00834639|101776573|FG001|STARTED|Washout of 7 Days||12||
48589286|NCT00834639|101776572|FG000|COMPLETED|Washout of 7 Days||12||
48589287|NCT00834639|101776573|FG001|COMPLETED|Washout of 7 Days||12||
48589288|NCT00834639|101776572|FG000|NOT COMPLETED|Washout of 7 Days||0||
48589289|NCT00834639|101776573|FG001|NOT COMPLETED|Washout of 7 Days||0||
48589290|NCT00834639|101776572|FG000|STARTED|Second Intervention||12||
48589291|NCT00834639|101776573|FG001|STARTED|Second Intervention||12||
48589292|NCT00834639|101776572|FG000|COMPLETED|Second Intervention||12||
48589293|NCT00834639|101776573|FG001|COMPLETED|Second Intervention||10||
48589294|NCT00834639|101776572|FG000|NOT COMPLETED|Second Intervention||0||
48589295|NCT00834639|101776573|FG001|NOT COMPLETED|Second Intervention||2||
48589296|NCT01093326|101776574|FG000|STARTED|Overall Study||115||
48707592|NCT04857437|102073158|FG006|COMPLETED|Part 1 Period 1||1||
48707593|NCT04857437|102073159|FG007|COMPLETED|Part 1 Period 1||2||
48707594|NCT04857437|102073152|FG000|NOT COMPLETED|Part 1 Period 1||0||
48707595|NCT04857437|102073153|FG001|NOT COMPLETED|Part 1 Period 1||0||
48707596|NCT04857437|102073154|FG002|NOT COMPLETED|Part 1 Period 1||0||
48707597|NCT04857437|102073155|FG003|NOT COMPLETED|Part 1 Period 1||0||
48707598|NCT04857437|102073156|FG004|NOT COMPLETED|Part 1 Period 1||0||
48707599|NCT04857437|102073157|FG005|NOT COMPLETED|Part 1 Period 1||0||
48707600|NCT04857437|102073158|FG006|NOT COMPLETED|Part 1 Period 1||0||
48707601|NCT04857437|102073159|FG007|NOT COMPLETED|Part 1 Period 1||0||
48291425|NCT04262947|101040726|FG002|COMPLETED|Overall Study||12||
48291426|NCT04262947|101040724|FG000|NOT COMPLETED|Overall Study||0||
48291427|NCT04262947|101040725|FG001|NOT COMPLETED|Overall Study||0||
48291428|NCT04262947|101040726|FG002|NOT COMPLETED|Overall Study||0||
48589297|NCT01093326|101776575|FG001|STARTED|Overall Study||121||
48589298|NCT01093326|101776576|FG002|STARTED|Overall Study||117||
48589299|NCT01093326|101776574|FG000|COMPLETED|Overall Study||71||
48589300|NCT01093326|101776575|FG001|COMPLETED|Overall Study||80||
48589301|NCT01093326|101776576|FG002|COMPLETED|Overall Study||76||
48589302|NCT01093326|101776574|FG000|NOT COMPLETED|Overall Study||44||
48589303|NCT01093326|101776575|FG001|NOT COMPLETED|Overall Study||41||
48589304|NCT01093326|101776576|FG002|NOT COMPLETED|Overall Study||41||
48589305|NCT01037127|101776577|FG000|STARTED|Overall Study||40||
48589306|NCT01037127|101776578|FG001|STARTED|Overall Study||57||
48589307|NCT01037127|101776577|FG000|COMPLETED|Overall Study||35||
48589308|NCT01037127|101776578|FG001|COMPLETED|Overall Study||36||
48707602|NCT04857437|102073152|FG000|STARTED|Part 1 Period 2||2||
48707603|NCT04857437|102073153|FG001|STARTED|Part 1 Period 2||1||
48707604|NCT04857437|102073154|FG002|STARTED|Part 1 Period 2||2||
48707605|NCT04857437|102073155|FG003|STARTED|Part 1 Period 2||1||
48707606|NCT04857437|102073156|FG004|STARTED|Part 1 Period 2||2||
48707607|NCT04857437|102073157|FG005|STARTED|Part 1 Period 2||1||
48707608|NCT04857437|102073158|FG006|STARTED|Part 1 Period 2||1||
48707609|NCT04857437|102073159|FG007|STARTED|Part 1 Period 2||2||
48707610|NCT04857437|102073152|FG000|COMPLETED|Part 1 Period 2||2||
48707611|NCT04857437|102073153|FG001|COMPLETED|Part 1 Period 2||1||
48707612|NCT04857437|102073154|FG002|COMPLETED|Part 1 Period 2||2||
48707613|NCT04857437|102073155|FG003|COMPLETED|Part 1 Period 2||1||
48707614|NCT04857437|102073156|FG004|COMPLETED|Part 1 Period 2||2||
48707615|NCT04857437|102073157|FG005|COMPLETED|Part 1 Period 2||1||
48707616|NCT04857437|102073158|FG006|COMPLETED|Part 1 Period 2||1||
48707617|NCT04857437|102073159|FG007|COMPLETED|Part 1 Period 2||2||
48707618|NCT04857437|102073152|FG000|NOT COMPLETED|Part 1 Period 2||0||
48707619|NCT04857437|102073153|FG001|NOT COMPLETED|Part 1 Period 2||0||
48707620|NCT04857437|102073154|FG002|NOT COMPLETED|Part 1 Period 2||0||
48707621|NCT04857437|102073155|FG003|NOT COMPLETED|Part 1 Period 2||0||
48707622|NCT04857437|102073156|FG004|NOT COMPLETED|Part 1 Period 2||0||
48707623|NCT04857437|102073157|FG005|NOT COMPLETED|Part 1 Period 2||0||
48707624|NCT04857437|102073158|FG006|NOT COMPLETED|Part 1 Period 2||0||
48589309|NCT01037127|101776577|FG000|NOT COMPLETED|Overall Study||5||
48589310|NCT01037127|101776578|FG001|NOT COMPLETED|Overall Study||21||
48589311|NCT02691936|101776579|FG000|STARTED|Overall Study||35||
48589312|NCT02691936|101776580|FG001|STARTED|Overall Study||34||
48589313|NCT02691936|101776579|FG000|COMPLETED|Overall Study||33||
48589314|NCT02691936|101776580|FG001|COMPLETED|Overall Study||29||
48589315|NCT02691936|101776579|FG000|NOT COMPLETED|Overall Study||2||
48589316|NCT02691936|101776580|FG001|NOT COMPLETED|Overall Study||5||
48589317|NCT02447497|101776581|FG000|STARTED|Overall Study||25||25
48589318|NCT02447497|101776582|FG001|STARTED|Overall Study||25||25
48589319|NCT02447497|101776583|FG002|STARTED|Overall Study||23||23
48589320|NCT02447497|101776584|FG003|STARTED|Overall Study||23||23
48589321|NCT02447497|101776581|FG000|COMPLETED|Overall Study||19||19
48589322|NCT02447497|101776582|FG001|COMPLETED|Overall Study||19||19
48589323|NCT02447497|101776583|FG002|COMPLETED|Overall Study||21||21
48589324|NCT02447497|101776584|FG003|COMPLETED|Overall Study||21||21
48589325|NCT02447497|101776581|FG000|NOT COMPLETED|Overall Study||6||6
48589326|NCT02447497|101776582|FG001|NOT COMPLETED|Overall Study||6||6
48589327|NCT02447497|101776583|FG002|NOT COMPLETED|Overall Study||2||2
48589328|NCT02447497|101776584|FG003|NOT COMPLETED|Overall Study||2||2
48589329|NCT04525079|101776585|FG000|STARTED|Overall Study||6||
48589330|NCT04525079|101776586|FG001|STARTED|Overall Study||6||
48589331|NCT04525079|101776587|FG002|STARTED|Overall Study||6||
48589332|NCT04525079|101776588|FG003|STARTED|Overall Study||6||
48589333|NCT04525079|101776589|FG004|STARTED|Overall Study||8||
48589334|NCT04525079|101776585|FG000|COMPLETED|Overall Study||6||
48589335|NCT04525079|101776586|FG001|COMPLETED|Overall Study||6||
48589336|NCT04525079|101776587|FG002|COMPLETED|Overall Study||6||
48589337|NCT04525079|101776588|FG003|COMPLETED|Overall Study||6||
48589338|NCT04525079|101776589|FG004|COMPLETED|Overall Study||8||
48589339|NCT04525079|101776585|FG000|NOT COMPLETED|Overall Study||0||
48589340|NCT04525079|101776586|FG001|NOT COMPLETED|Overall Study||0||
48589341|NCT04525079|101776587|FG002|NOT COMPLETED|Overall Study||0||
48589342|NCT04525079|101776588|FG003|NOT COMPLETED|Overall Study||0||
48589343|NCT04525079|101776589|FG004|NOT COMPLETED|Overall Study||0||
48589344|NCT03673345|101776590|FG000|STARTED|Overall Study||5||
48589345|NCT03673345|101776591|FG001|STARTED|Overall Study||3||
48589346|NCT03673345|101776592|FG002|STARTED|Overall Study||57||
48589347|NCT03673345|101776593|FG003|STARTED|Overall Study||12||
48589348|NCT03673345|101776594|FG004|STARTED|Overall Study||21||
48589349|NCT03673345|101776595|FG005|STARTED|Overall Study||7||
48589350|NCT03673345|101776596|FG006|STARTED|Overall Study||20||
48589351|NCT03673345|101776597|FG007|STARTED|Overall Study||0||
48589352|NCT03673345|101776590|FG000|COMPLETED|Overall Study||3||
48589353|NCT03673345|101776591|FG001|COMPLETED|Overall Study||3||
48707625|NCT04857437|102073159|FG007|NOT COMPLETED|Part 1 Period 2||0||
48707626|NCT04857437|102073152|FG000|STARTED|Part 1 Period 3||2||
48707627|NCT04857437|102073153|FG001|STARTED|Part 1 Period 3||1||
48707628|NCT04857437|102073154|FG002|STARTED|Part 1 Period 3||2||
48707629|NCT04857437|102073155|FG003|STARTED|Part 1 Period 3||1||
48707630|NCT04857437|102073156|FG004|STARTED|Part 1 Period 3||2||
48707631|NCT04857437|102073157|FG005|STARTED|Part 1 Period 3||1||
48707632|NCT04857437|102073158|FG006|STARTED|Part 1 Period 3||1||
48707633|NCT04857437|102073159|FG007|STARTED|Part 1 Period 3||1||
48707634|NCT04857437|102073152|FG000|COMPLETED|Part 1 Period 3||2||
48707635|NCT04857437|102073153|FG001|COMPLETED|Part 1 Period 3||1||
48707636|NCT04857437|102073154|FG002|COMPLETED|Part 1 Period 3||2||
48707637|NCT04857437|102073155|FG003|COMPLETED|Part 1 Period 3||1||
48707638|NCT04857437|102073156|FG004|COMPLETED|Part 1 Period 3||2||
48707639|NCT04857437|102073157|FG005|COMPLETED|Part 1 Period 3||1||
48707640|NCT04857437|102073158|FG006|COMPLETED|Part 1 Period 3||1||
48707641|NCT04857437|102073159|FG007|COMPLETED|Part 1 Period 3||1||
48707642|NCT04857437|102073152|FG000|NOT COMPLETED|Part 1 Period 3||0||
48707643|NCT04857437|102073153|FG001|NOT COMPLETED|Part 1 Period 3||0||
48707644|NCT04857437|102073154|FG002|NOT COMPLETED|Part 1 Period 3||0||
48707645|NCT04857437|102073155|FG003|NOT COMPLETED|Part 1 Period 3||0||
48707646|NCT04857437|102073156|FG004|NOT COMPLETED|Part 1 Period 3||0||
48707647|NCT04857437|102073157|FG005|NOT COMPLETED|Part 1 Period 3||0||
48707648|NCT04857437|102073158|FG006|NOT COMPLETED|Part 1 Period 3||0||
48707649|NCT04857437|102073159|FG007|NOT COMPLETED|Part 1 Period 3||0||
48707650|NCT04857437|102073152|FG000|STARTED|Part 1 Period 4||2||
48707651|NCT04857437|102073153|FG001|STARTED|Part 1 Period 4||1||
48707652|NCT04857437|102073154|FG002|STARTED|Part 1 Period 4||2||
48707653|NCT04857437|102073155|FG003|STARTED|Part 1 Period 4||1||
48291429|NCT03296033|101040727|FG000|STARTED|Overall Study||60||
48291430|NCT03296033|101040728|FG001|STARTED|Overall Study||62||
48291431|NCT03296033|101040727|FG000|COMPLETED|Overall Study||51||
48291432|NCT03296033|101040728|FG001|COMPLETED|Overall Study||52||
48291433|NCT03296033|101040727|FG000|NOT COMPLETED|Overall Study||9||
48291434|NCT03296033|101040728|FG001|NOT COMPLETED|Overall Study||10||
48291435|NCT00966277|101040729|FG000|STARTED|Overall Study||38||
48291436|NCT00966277|101040730|FG001|STARTED|Overall Study||37||
48291437|NCT00966277|101040729|FG000|COMPLETED|Overall Study||34||
48291438|NCT00966277|101040730|FG001|COMPLETED|Overall Study||33||
48291439|NCT00966277|101040729|FG000|NOT COMPLETED|Overall Study||4||
48291440|NCT00966277|101040730|FG001|NOT COMPLETED|Overall Study||4||
48291441|NCT00603720|101040731|FG000|STARTED|Overall Study||10||
48291442|NCT00603720|101040732|FG001|STARTED|Overall Study||10||
48291443|NCT00603720|101040733|FG002|STARTED|Overall Study||12||
48291444|NCT00603720|101040734|FG003|STARTED|Overall Study||10||
48291445|NCT00603720|101040735|FG004|STARTED|Overall Study||12||
48291446|NCT00603720|101040731|FG000|COMPLETED|Overall Study||10||
48291447|NCT00603720|101040732|FG001|COMPLETED|Overall Study||10||
48589354|NCT03673345|101776592|FG002|COMPLETED|Overall Study||48||
48589355|NCT03673345|101776593|FG003|COMPLETED|Overall Study||7||
48589356|NCT03673345|101776594|FG004|COMPLETED|Overall Study||19||
48589357|NCT03673345|101776595|FG005|COMPLETED|Overall Study||6||
48589358|NCT03673345|101776596|FG006|COMPLETED|Overall Study||20||
48707654|NCT04857437|102073156|FG004|STARTED|Part 1 Period 4||2||
48291448|NCT00603720|101040733|FG002|COMPLETED|Overall Study||12||
48291449|NCT00603720|101040734|FG003|COMPLETED|Overall Study||10||
48291450|NCT00603720|101040735|FG004|COMPLETED|Overall Study||12||
48291451|NCT00603720|101040731|FG000|NOT COMPLETED|Overall Study||0||
48291452|NCT00603720|101040732|FG001|NOT COMPLETED|Overall Study||0||
48291453|NCT00603720|101040733|FG002|NOT COMPLETED|Overall Study||0||
48291454|NCT00603720|101040734|FG003|NOT COMPLETED|Overall Study||0||
48589359|NCT03673345|101776597|FG007|COMPLETED|Overall Study||0||
48589360|NCT03673345|101776590|FG000|NOT COMPLETED|Overall Study||2||
48589361|NCT03673345|101776591|FG001|NOT COMPLETED|Overall Study||0||
48291455|NCT00603720|101040735|FG004|NOT COMPLETED|Overall Study||0||
48291456|NCT03214094|101040736|FG000|STARTED|Overall Study||1119||
48291457|NCT03214094|101040736|FG000|COMPLETED|Overall Study||1059||
48291458|NCT03214094|101040736|FG000|NOT COMPLETED|Overall Study||60||
48291459|NCT03796260|101040737|FG000|STARTED|Period 1||7||
48291460|NCT03796260|101040738|FG001|STARTED|Period 1||7||
48291461|NCT03796260|101040737|FG000|COMPLETED|Period 1||7||
48291462|NCT03796260|101040738|FG001|COMPLETED|Period 1||7||
48291463|NCT03796260|101040737|FG000|NOT COMPLETED|Period 1||0||
48291464|NCT03796260|101040738|FG001|NOT COMPLETED|Period 1||0||
48291465|NCT03796260|101040737|FG000|STARTED|Period 2||7||
48589362|NCT03673345|101776592|FG002|NOT COMPLETED|Overall Study||9||
48589363|NCT03673345|101776593|FG003|NOT COMPLETED|Overall Study||5||
48291466|NCT03796260|101040738|FG001|STARTED|Period 2||7||
48291467|NCT03796260|101040737|FG000|COMPLETED|Period 2||7||
48291468|NCT03796260|101040738|FG001|COMPLETED|Period 2||7||
48291469|NCT03796260|101040737|FG000|NOT COMPLETED|Period 2||0||
48291470|NCT03796260|101040738|FG001|NOT COMPLETED|Period 2||0||
48291471|NCT00118755|101040739|FG000|STARTED|Overall Study||217||
48291472|NCT00118755|101040740|FG001|STARTED|Overall Study||218||
48291473|NCT00118755|101040739|FG000|Safety Population|Overall Study||208||
48291474|NCT00118755|101040740|FG001|Safety Population|Overall Study||211||
48291475|NCT00118755|101040739|FG000|COMPLETED|Overall Study||7||
48291476|NCT00118755|101040740|FG001|COMPLETED|Overall Study||3||
48291477|NCT00118755|101040739|FG000|NOT COMPLETED|Overall Study||210||
48291478|NCT00118755|101040740|FG001|NOT COMPLETED|Overall Study||215||
48291479|NCT01853982|101040741|FG000|STARTED|Overall Study||2||
48139453|NCT02395120|100665613|FG001|Started-Caregivers|Overall Study||188|Caregivers (primary caregiver of family)|
48139454|NCT02395120|100665614|FG002|Started-Caregivers|Overall Study||20|Caregivers (primary caregiver of family)|
48139455|NCT02395120|100665615|FG003|Started-Caregivers|Overall Study||28|Caregivers (primary caregiver of family)|
48139456|NCT02395120|100665616|FG004|Started-Caregivers|Overall Study||187|Caregivers (primary caregiver of family)|
48139457|NCT02395120|100665612|FG000|Started-Children|Overall Study||212|Children (can be multiple children of caregiver)|
48139458|NCT02395120|100665613|FG001|Started-Children|Overall Study||210|Children (can be multiple children of caregiver)|
48139459|NCT02395120|100665614|FG002|Started-Children|Overall Study||23|Children (can be multiple children of caregiver)|
48139460|NCT02395120|100665615|FG003|Started-Children|Overall Study||35|Children (can be multiple children of caregiver)|
48139461|NCT02395120|100665616|FG004|Started-Children|Overall Study||214|Children (can be multiple children of caregiver)|
48139462|NCT02395120|100665612|FG000|Completed-Caregivers|Overall Study||161|Caregivers (primary caregiver of family)|
48139463|NCT02395120|100665613|FG001|Completed-Caregivers|Overall Study||159|Caregivers (primary caregiver of family)|
48139464|NCT02395120|100665614|FG002|Completed-Caregivers|Overall Study||17|Caregivers (primary caregiver of family)|
48139465|NCT02395120|100665615|FG003|Completed-Caregivers|Overall Study||25|Caregivers (primary caregiver of family)|
48139466|NCT02395120|100665616|FG004|Completed-Caregivers|Overall Study||164|Caregivers (primary caregiver of family)|
48139467|NCT02395120|100665612|FG000|Completed-Children|Overall Study||182|Children (can be multiple children of caregiver)|
48139468|NCT02395120|100665613|FG001|Completed-Children|Overall Study||177|Children (can be multiple children of caregiver)|
48139469|NCT02395120|100665614|FG002|Completed-Children|Overall Study||20|Children (can be multiple children of caregiver)|
48139470|NCT02395120|100665615|FG003|Completed-Children|Overall Study||32|Children (can be multiple children of caregiver)|
48139471|NCT02395120|100665616|FG004|Completed-Children|Overall Study||186|Children (can be multiple children of caregiver)|
48139472|NCT02395120|100665612|FG000|COMPLETED|Overall Study||343|Caregivers and Children|
48139473|NCT02395120|100665613|FG001|COMPLETED|Overall Study||336|Caregivers and Children|
48139474|NCT02395120|100665614|FG002|COMPLETED|Overall Study||37|Caregivers and Children|
48139475|NCT02395120|100665615|FG003|COMPLETED|Overall Study||57|Caregivers and Children|
48139476|NCT02395120|100665616|FG004|COMPLETED|Overall Study||350|Caregivers and Children|
48139477|NCT02395120|100665612|FG000|NOT COMPLETED|Overall Study||57||
48139478|NCT02395120|100665613|FG001|NOT COMPLETED|Overall Study||62||
48139479|NCT02395120|100665614|FG002|NOT COMPLETED|Overall Study||6||
48139480|NCT02395120|100665615|FG003|NOT COMPLETED|Overall Study||6||
48139481|NCT02395120|100665616|FG004|NOT COMPLETED|Overall Study||51||
48139482|NCT02827877|100665617|FG000|STARTED|Overall Study||18||
48139483|NCT02827877|100665617|FG000|COMPLETED|Overall Study||17||
48139484|NCT02827877|100665617|FG000|NOT COMPLETED|Overall Study||1||
48139485|NCT03704376|100665618|FG000|STARTED|Overall Study||42||
48139486|NCT03704376|100665619|FG001|STARTED|Overall Study||44||
48139487|NCT03704376|100665618|FG000|COMPLETED|Overall Study||38||
48139488|NCT03704376|100665619|FG001|COMPLETED|Overall Study||40||
48139489|NCT03704376|100665618|FG000|NOT COMPLETED|Overall Study||4||
48139490|NCT03704376|100665619|FG001|NOT COMPLETED|Overall Study||4||
48139491|NCT02041195|100665620|FG000|STARTED|Overall Study||10||
48291480|NCT01853982|101040742|FG001|STARTED|Overall Study||2||
48139492|NCT02041195|100665621|FG001|STARTED|Overall Study||9||
48291481|NCT01853982|101040741|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2||
48291482|NCT01853982|101040742|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2||
48291483|NCT01853982|101040741|FG000|COMPLETED|Overall Study||0||
48291484|NCT01853982|101040742|FG001|COMPLETED|Overall Study||1||
48291485|NCT01853982|101040741|FG000|NOT COMPLETED|Overall Study||2||
48291486|NCT01853982|101040742|FG001|NOT COMPLETED|Overall Study||1||
48291487|NCT00343252|101040743|FG000|STARTED|All Randomized Participants||361||
48291488|NCT00343252|101040744|FG001|STARTED|All Randomized Participants||351||
48291489|NCT00343252|101040743|FG000|COMPLETED|All Randomized Participants||259||
48291490|NCT00343252|101040744|FG001|COMPLETED|All Randomized Participants||269||
48291491|NCT00343252|101040743|FG000|NOT COMPLETED|All Randomized Participants||102||
48291492|NCT00343252|101040744|FG001|NOT COMPLETED|All Randomized Participants||82||
48291493|NCT00343252|101040743|FG000|STARTED|6 Months (All Treated Participants)||360||
48291494|NCT00343252|101040744|FG001|STARTED|6 Months (All Treated Participants)||350||
48707655|NCT04857437|102073157|FG005|STARTED|Part 1 Period 4||0||
48707656|NCT04857437|102073158|FG006|STARTED|Part 1 Period 4||0||
48707657|NCT04857437|102073159|FG007|STARTED|Part 1 Period 4||1||
48707658|NCT04857437|102073152|FG000|COMPLETED|Part 1 Period 4||2||
48707659|NCT04857437|102073153|FG001|COMPLETED|Part 1 Period 4||1||
48707660|NCT04857437|102073154|FG002|COMPLETED|Part 1 Period 4||2||
48707661|NCT04857437|102073155|FG003|COMPLETED|Part 1 Period 4||1||
48707662|NCT04857437|102073156|FG004|COMPLETED|Part 1 Period 4||2||
48707663|NCT04857437|102073157|FG005|COMPLETED|Part 1 Period 4||0||
48707664|NCT04857437|102073158|FG006|COMPLETED|Part 1 Period 4||0||
48139493|NCT02041195|100665622|FG002|STARTED|Overall Study||3||
48139494|NCT02041195|100665623|FG003|STARTED|Overall Study||3||
48139495|NCT02041195|100665624|FG004|STARTED|Overall Study||11||
48291495|NCT00343252|101040743|FG000|COMPLETED|6 Months (All Treated Participants)||304||
48291496|NCT00343252|101040744|FG001|COMPLETED|6 Months (All Treated Participants)||306||
48291497|NCT00343252|101040743|FG000|NOT COMPLETED|6 Months (All Treated Participants)||56||
48291498|NCT00343252|101040744|FG001|NOT COMPLETED|6 Months (All Treated Participants)||44||
48707665|NCT04857437|102073159|FG007|COMPLETED|Part 1 Period 4||1||
48707666|NCT04857437|102073152|FG000|NOT COMPLETED|Part 1 Period 4||0||
48707667|NCT04857437|102073153|FG001|NOT COMPLETED|Part 1 Period 4||0||
48707668|NCT04857437|102073154|FG002|NOT COMPLETED|Part 1 Period 4||0||
48707669|NCT04857437|102073155|FG003|NOT COMPLETED|Part 1 Period 4||0||
48707670|NCT04857437|102073156|FG004|NOT COMPLETED|Part 1 Period 4||0||
48707671|NCT04857437|102073157|FG005|NOT COMPLETED|Part 1 Period 4||0||
48707672|NCT04857437|102073158|FG006|NOT COMPLETED|Part 1 Period 4||0||
48707673|NCT04857437|102073159|FG007|NOT COMPLETED|Part 1 Period 4||0||
48707674|NCT00043108|102073160|FG000|STARTED|Overall Study||19||
48707675|NCT00043108|102073160|FG000|COMPLETED|Overall Study||19||
48707676|NCT00043108|102073160|FG000|NOT COMPLETED|Overall Study||0||
48707677|NCT03040414|102073161|FG000|STARTED|Overall Study||57|Started Period 1|
48707678|NCT03040414|102073162|FG001|STARTED|Overall Study||56|Started Period 1|
48707679|NCT03040414|102073161|FG000|Completed Period 1|Overall Study||56||
48402731|NCT01993667|101317722|FG000|COMPLETED|Overall Study||43||
48707680|NCT03040414|102073162|FG001|Completed Period 1|Overall Study||55||
48707681|NCT03040414|102073161|FG000|Started Period 2|Overall Study||56||
48139496|NCT02041195|100665625|FG005|STARTED|Overall Study||6||
48139497|NCT02041195|100665626|FG006|STARTED|Overall Study||29||
48139498|NCT02041195|100665627|FG007|STARTED|Overall Study||28||
48139499|NCT02041195|100665620|FG000|COMPLETED|Overall Study||8||
48139500|NCT02041195|100665621|FG001|COMPLETED|Overall Study||6||
48707682|NCT03040414|102073162|FG001|Started Period 2|Overall Study||55||
48707683|NCT03040414|102073161|FG000|COMPLETED|Overall Study||56|Completed Period 2|
48707684|NCT03040414|102073162|FG001|COMPLETED|Overall Study||55|Completed Period 2|
48707685|NCT03040414|102073161|FG000|NOT COMPLETED|Overall Study||1||
48291499|NCT00343252|101040743|FG000|STARTED|12 Months (All Treated Participants)||360||
48291500|NCT00343252|101040744|FG001|STARTED|12 Months (All Treated Participants)||350||
48291501|NCT00343252|101040743|FG000|COMPLETED|12 Months (All Treated Participants)||274||
48291502|NCT00343252|101040744|FG001|COMPLETED|12 Months (All Treated Participants)||281||
48291503|NCT00343252|101040743|FG000|NOT COMPLETED|12 Months (All Treated Participants)||86||
48291504|NCT00343252|101040744|FG001|NOT COMPLETED|12 Months (All Treated Participants)||69||
48291505|NCT00343252|101040743|FG000|STARTED|18 Months (All Treated Participants)||360||
48291506|NCT00343252|101040744|FG001|STARTED|18 Months (All Treated Participants)||350||
48291507|NCT00343252|101040743|FG000|COMPLETED|18 Months (All Treated Participants)||259||
48291508|NCT00343252|101040744|FG001|COMPLETED|18 Months (All Treated Participants)||269||
48291509|NCT00343252|101040743|FG000|NOT COMPLETED|18 Months (All Treated Participants)||101||
48589364|NCT03673345|101776594|FG004|NOT COMPLETED|Overall Study||2||
48589365|NCT03673345|101776595|FG005|NOT COMPLETED|Overall Study||1||
48589366|NCT03673345|101776596|FG006|NOT COMPLETED|Overall Study||0||
48589367|NCT03673345|101776597|FG007|NOT COMPLETED|Overall Study||0||
48589368|NCT00636194|101776598|FG000|STARTED|Overall Study||175||
48589369|NCT00636194|101776599|FG001|STARTED|Overall Study||175||
48589370|NCT00636194|101776598|FG000|COMPLETED|Overall Study||172||
48589371|NCT00636194|101776599|FG001|COMPLETED|Overall Study||175||
48589372|NCT00636194|101776598|FG000|NOT COMPLETED|Overall Study||3||
48589373|NCT00636194|101776599|FG001|NOT COMPLETED|Overall Study||0||
48707686|NCT03040414|102073162|FG001|NOT COMPLETED|Overall Study||1||
48707687|NCT01690546|102073163|FG000|STARTED|Overall Study||35||
48707688|NCT01690546|102073163|FG000|Extended Release Injectable NTX|Overall Study||27||
48707689|NCT01690546|102073163|FG000|COMPLETED|Overall Study||26||
48707690|NCT01690546|102073163|FG000|NOT COMPLETED|Overall Study||9||
48589374|NCT01088243|101776600|FG000|STARTED|Overall Study||13||
48589375|NCT01088243|101776601|FG001|STARTED|Overall Study||5||
48589376|NCT01088243|101776600|FG000|COMPLETED|Overall Study||12||
48589377|NCT01088243|101776601|FG001|COMPLETED|Overall Study||5||
48589378|NCT01088243|101776600|FG000|NOT COMPLETED|Overall Study||1||
48589379|NCT01088243|101776601|FG001|NOT COMPLETED|Overall Study||0||
48589380|NCT03338803|101776602|FG000|STARTED|Overall Study||11001||
48589381|NCT03338803|101776602|FG000|COMPLETED|Overall Study||11001||
48589382|NCT03338803|101776602|FG000|NOT COMPLETED|Overall Study||0||
48589383|NCT02156895|101776603|FG000|STARTED|Overall Study||111||
48589384|NCT02156895|101776603|FG000|COMPLETED|Overall Study||111||
48589385|NCT02156895|101776603|FG000|NOT COMPLETED|Overall Study||0||
48589386|NCT01608815|101776604|FG000|STARTED|Overall Study||188||
48589387|NCT01608815|101776605|FG001|STARTED|Overall Study||7||
48589388|NCT01608815|101776606|FG002|STARTED|Overall Study||5||
48589389|NCT01608815|101776604|FG000|COMPLETED|Overall Study||188||
48589390|NCT01608815|101776605|FG001|COMPLETED|Overall Study||7||
48589391|NCT01608815|101776606|FG002|COMPLETED|Overall Study||5||
48589392|NCT01608815|101776604|FG000|NOT COMPLETED|Overall Study||0||
48589393|NCT01608815|101776605|FG001|NOT COMPLETED|Overall Study||0||
48589394|NCT01608815|101776606|FG002|NOT COMPLETED|Overall Study||0||
48589395|NCT00359736|101776607|FG000|STARTED|Overall Study||14||
48589396|NCT00359736|101776608|FG001|STARTED|Overall Study||15||
48589397|NCT00359736|101776607|FG000|COMPLETED|Overall Study||14||
48589398|NCT00359736|101776608|FG001|COMPLETED|Overall Study||15||
48589399|NCT00359736|101776607|FG000|NOT COMPLETED|Overall Study||0||
48707691|NCT00693017|102073164|FG000|STARTED|Overall Study||2||
48707692|NCT00693017|102073165|FG001|STARTED|Overall Study||2||
48707693|NCT00693017|102073164|FG000|COMPLETED|Overall Study||0||
48707694|NCT00693017|102073165|FG001|COMPLETED|Overall Study||0||
48707695|NCT00693017|102073164|FG000|NOT COMPLETED|Overall Study||2||
48291510|NCT00343252|101040744|FG001|NOT COMPLETED|18 Months (All Treated Participants)||81||
48291511|NCT01468831|101040745|FG000|STARTED|Overall Study||4||4
48291512|NCT01468831|101040746|FG001|STARTED|Overall Study||5||5
48291513|NCT01468831|101040745|FG000|Month 12 (Primary Outcome)|Overall Study||4||4
48291514|NCT01468831|101040746|FG001|Month 12 (Primary Outcome)|Overall Study||4||4
48291515|NCT01468831|101040745|FG000|COMPLETED|Overall Study||4||4
48291516|NCT01468831|101040746|FG001|COMPLETED|Overall Study||4||4
48291517|NCT01468831|101040745|FG000|NOT COMPLETED|Overall Study||0||0
48291518|NCT01468831|101040746|FG001|NOT COMPLETED|Overall Study||1||1
48291519|NCT00601419|101040747|FG000|STARTED|Overall Study||230||
48291520|NCT00601419|101040747|FG000|COMPLETED|Overall Study||226||
48589400|NCT00359736|101776608|FG001|NOT COMPLETED|Overall Study||0||
48589401|NCT04432090|101776609|FG000|STARTED|Overall Study||32|Enrolled|
48589402|NCT04432090|101776610|FG001|STARTED|Overall Study||32|Enrolled|
48589403|NCT04432090|101776611|FG002|STARTED|Overall Study||46|Enrolled|
48589404|NCT04432090|101776609|FG000|Randomized|Overall Study||13||
48589405|NCT04432090|101776610|FG001|Randomized|Overall Study||14||
48589406|NCT04432090|101776611|FG002|Randomized|Overall Study||9||
48589407|NCT04432090|101776609|FG000|COMPLETED|Overall Study||9||
48589408|NCT04432090|101776610|FG001|COMPLETED|Overall Study||9||
48589409|NCT04432090|101776611|FG002|COMPLETED|Overall Study||9||
48589410|NCT04432090|101776609|FG000|NOT COMPLETED|Overall Study||23||
48589411|NCT04432090|101776610|FG001|NOT COMPLETED|Overall Study||23||
48589412|NCT04432090|101776611|FG002|NOT COMPLETED|Overall Study||37||
48707696|NCT00693017|102073165|FG001|NOT COMPLETED|Overall Study||2||
48707697|NCT00765882|102073166|FG000|STARTED|Overall Study||215||
48707698|NCT00765882|102073167|FG001|STARTED|Overall Study||213||
48707699|NCT00765882|102073168|FG002|STARTED|Overall Study||205||
48707700|NCT00765882|102073166|FG000|COMPLETED|Overall Study||191||
48707701|NCT00765882|102073167|FG001|COMPLETED|Overall Study||173||
48707702|NCT00765882|102073168|FG002|COMPLETED|Overall Study||169||
48707703|NCT00765882|102073166|FG000|NOT COMPLETED|Overall Study||24||
48402732|NCT01993667|101317723|FG001|COMPLETED|Overall Study||47||
48402733|NCT01993667|101317722|FG000|NOT COMPLETED|Overall Study||21||
48402734|NCT01993667|101317723|FG001|NOT COMPLETED|Overall Study||19||
48402735|NCT02283333|101317724|FG000|STARTED|Overall Study||77||
48402736|NCT02283333|101317725|FG001|STARTED|Overall Study||78||
48402737|NCT02283333|101317724|FG000|COMPLETED|Overall Study||63||
48402738|NCT02283333|101317725|FG001|COMPLETED|Overall Study||64||
48402739|NCT02283333|101317724|FG000|NOT COMPLETED|Overall Study||14||
48402740|NCT02283333|101317725|FG001|NOT COMPLETED|Overall Study||14||
48402741|NCT03595449|101317726|FG000|STARTED|Overall Study||118||
48402742|NCT03595449|101317727|FG001|STARTED|Overall Study||115||
48402743|NCT03595449|101317726|FG000|COMPLETED|Overall Study||118||
48402744|NCT03595449|101317727|FG001|COMPLETED|Overall Study||115||
48402745|NCT03595449|101317726|FG000|NOT COMPLETED|Overall Study||0||
48402746|NCT03595449|101317727|FG001|NOT COMPLETED|Overall Study||0||
48402747|NCT01451983|101317728|FG000|STARTED|Overall Study||26||
48402748|NCT01451983|101317729|FG001|STARTED|Overall Study||27||
48402749|NCT01451983|101317730|FG002|STARTED|Overall Study||61||
48402750|NCT01451983|101317731|FG003|STARTED|Overall Study||24||
48402751|NCT01451983|101317728|FG000|COMPLETED|Overall Study||26||
48402752|NCT01451983|101317729|FG001|COMPLETED|Overall Study||27||
48402753|NCT01451983|101317730|FG002|COMPLETED|Overall Study||61||
48402754|NCT01451983|101317731|FG003|COMPLETED|Overall Study||24||
48402755|NCT01451983|101317728|FG000|NOT COMPLETED|Overall Study||0||
48402756|NCT01451983|101317729|FG001|NOT COMPLETED|Overall Study||0||
48402757|NCT01451983|101317730|FG002|NOT COMPLETED|Overall Study||0||
48402758|NCT01451983|101317731|FG003|NOT COMPLETED|Overall Study||0||
48402759|NCT01868594|101317732|FG000|STARTED|Overall Study||76||
48589413|NCT05093530|101776612|FG000|STARTED|Overall Study||12||
48589414|NCT05093530|101776613|FG001|STARTED|Overall Study||4||
48589415|NCT05093530|101776614|FG002|STARTED|Overall Study||4||
48291521|NCT00601419|101040747|FG000|NOT COMPLETED|Overall Study||4||
48291522|NCT01580969|101040748|FG000|STARTED|Overall Study||6||
48291523|NCT01580969|101040749|FG001|STARTED|Overall Study||3||
48291524|NCT01580969|101040750|FG002|STARTED|Overall Study||13||
48291525|NCT01580969|101040748|FG000|COMPLETED|Overall Study||3||
48291526|NCT01580969|101040749|FG001|COMPLETED|Overall Study||3||
48291527|NCT01580969|101040750|FG002|COMPLETED|Overall Study||13||
48291528|NCT01580969|101040748|FG000|NOT COMPLETED|Overall Study||3||
48291529|NCT01580969|101040749|FG001|NOT COMPLETED|Overall Study||0||
48291530|NCT01580969|101040750|FG002|NOT COMPLETED|Overall Study||0||
48291531|NCT01635920|101040751|FG000|STARTED|Overall Study||125||
48291532|NCT01635920|101040752|FG001|STARTED|Overall Study||126||
48291533|NCT01635920|101040751|FG000|COMPLETED|Overall Study||122||
48291534|NCT01635920|101040752|FG001|COMPLETED|Overall Study||125||
48589416|NCT05093530|101776615|FG003|STARTED|Overall Study||4||
48589417|NCT05093530|101776616|FG004|STARTED|Overall Study||6||
48589418|NCT05093530|101776617|FG005|STARTED|Overall Study||6||
48589419|NCT05093530|101776618|FG006|STARTED|Overall Study||6||
48589420|NCT05093530|101776619|FG007|STARTED|Overall Study||6||
48589421|NCT05093530|101776620|FG008|STARTED|Overall Study||6||
48291535|NCT01635920|101040751|FG000|NOT COMPLETED|Overall Study||3||
48589422|NCT05093530|101776621|FG009|STARTED|Overall Study||6||
48589423|NCT05093530|101776612|FG000|COMPLETED|Overall Study||12||
48707704|NCT00765882|102073167|FG001|NOT COMPLETED|Overall Study||40||
48707705|NCT00765882|102073168|FG002|NOT COMPLETED|Overall Study||36||
48707706|NCT02759107|102073169|FG000|STARTED|Overall Study||14||
48707707|NCT02759107|102073170|FG001|STARTED|Overall Study||6||
48291536|NCT01635920|101040752|FG001|NOT COMPLETED|Overall Study||1||
48291537|NCT01104116|101040753|FG000|STARTED|Overall Study||1||
48291538|NCT01104116|101040753|FG000|COMPLETED|Overall Study||1||
48291539|NCT01104116|101040753|FG000|NOT COMPLETED|Overall Study||0||
48291540|NCT01580423|101040754|FG000|STARTED|First Intervention||8||
48291541|NCT01580423|101040755|FG001|STARTED|First Intervention||8||
48291542|NCT01580423|101040754|FG000|COMPLETED|First Intervention||8||
48402760|NCT01868594|101317733|FG001|STARTED|Overall Study||75||
48402761|NCT01868594|101317732|FG000|COMPLETED|Overall Study||72||
48402762|NCT01868594|101317733|FG001|COMPLETED|Overall Study||72||
48402763|NCT01868594|101317732|FG000|NOT COMPLETED|Overall Study||4||
48402764|NCT01868594|101317733|FG001|NOT COMPLETED|Overall Study||3||
48402765|NCT02580591|101317734|FG000|STARTED|Overall Study||242||
48402766|NCT02580591|101317735|FG001|STARTED|Overall Study||242||
48402767|NCT02580591|101317736|FG002|STARTED|Overall Study||248||
48589424|NCT05093530|101776613|FG001|COMPLETED|Overall Study||4||
48707708|NCT02759107|102073171|FG002|STARTED|Overall Study||12||
48589425|NCT05093530|101776614|FG002|COMPLETED|Overall Study||4||
48291543|NCT01580423|101040755|FG001|COMPLETED|First Intervention||8||
48291544|NCT01580423|101040754|FG000|NOT COMPLETED|First Intervention||0||
48291545|NCT01580423|101040755|FG001|NOT COMPLETED|First Intervention||0||
48291546|NCT01580423|101040754|FG000|STARTED|Second Intervention||8||
48291547|NCT01580423|101040755|FG001|STARTED|Second Intervention||8||
48291548|NCT01580423|101040754|FG000|COMPLETED|Second Intervention||8||
48291549|NCT01580423|101040755|FG001|COMPLETED|Second Intervention||8||
48291550|NCT01580423|101040754|FG000|NOT COMPLETED|Second Intervention||0||
48291551|NCT01580423|101040755|FG001|NOT COMPLETED|Second Intervention||0||
48291552|NCT01236339|101040756|FG000|STARTED|Overall Study||13||
48291553|NCT01236339|101040757|FG001|STARTED|Overall Study||13||
48291554|NCT01236339|101040756|FG000|LVP Crossover to TIPS|Overall Study||0||
48291555|NCT01236339|101040757|FG001|LVP Crossover to TIPS|Overall Study||4||
48291556|NCT01236339|101040756|FG000|COMPLETED|Overall Study||2||
48291557|NCT01236339|101040757|FG001|COMPLETED|Overall Study||0||
48291558|NCT01236339|101040756|FG000|NOT COMPLETED|Overall Study||11||
48291559|NCT01236339|101040757|FG001|NOT COMPLETED|Overall Study||13||
48291560|NCT00336895|101040758|FG000|STARTED|Overall Study||30||
48291561|NCT00336895|101040758|FG000|COMPLETED|Overall Study||26||
48291562|NCT00336895|101040758|FG000|NOT COMPLETED|Overall Study||4||
48291563|NCT00568802|101040759|FG000|STARTED|Overall Study||27||
48291564|NCT00568802|101040759|FG000|COMPLETED|Overall Study||24||
48291565|NCT00568802|101040759|FG000|NOT COMPLETED|Overall Study||3||
48291566|NCT00753272|101040760|FG000|STARTED|Overall Study||21893||
48291567|NCT00753272|101040761|FG001|STARTED|Overall Study||21802||
48291568|NCT00753272|101040760|FG000|COMPLETED|Overall Study||16911||
48291569|NCT00753272|101040761|FG001|COMPLETED|Overall Study||16895||
48291570|NCT00753272|101040760|FG000|NOT COMPLETED|Overall Study||4982||
48291571|NCT00753272|101040761|FG001|NOT COMPLETED|Overall Study||4907||
48291572|NCT01411215|101040762|FG000|STARTED|Overall Study||69||
48291573|NCT01411215|101040763|FG001|STARTED|Overall Study||91||
48291574|NCT01411215|101040762|FG000|Treated|Overall Study||69||
48291575|NCT01411215|101040763|FG001|Treated|Overall Study||90||
48291576|NCT01411215|101040762|FG000|COMPLETED|Overall Study||3||
48291577|NCT01411215|101040763|FG001|COMPLETED|Overall Study||7||
48291578|NCT01411215|101040762|FG000|NOT COMPLETED|Overall Study||66||
48291579|NCT01411215|101040763|FG001|NOT COMPLETED|Overall Study||84||
48291580|NCT00971243|101040764|FG000|STARTED|Double Blind Period||87||
48291581|NCT00971243|101040765|FG001|STARTED|Double Blind Period||93||
48291582|NCT00971243|101040766|FG002|STARTED|Double Blind Period||91||
48291583|NCT00971243|101040767|FG003|STARTED|Double Blind Period||88||
48291584|NCT00971243|101040768|FG004|STARTED|Double Blind Period||88||
48291585|NCT00971243|101040764|FG000|COMPLETED|Double Blind Period||68||
48291586|NCT00971243|101040765|FG001|COMPLETED|Double Blind Period||82||
48291587|NCT00971243|101040766|FG002|COMPLETED|Double Blind Period||72||
48291588|NCT00971243|101040767|FG003|COMPLETED|Double Blind Period||74||
48291589|NCT00971243|101040768|FG004|COMPLETED|Double Blind Period||70||
48291590|NCT00971243|101040764|FG000|NOT COMPLETED|Double Blind Period||19||
48291591|NCT00971243|101040765|FG001|NOT COMPLETED|Double Blind Period||11||
48291592|NCT00971243|101040766|FG002|NOT COMPLETED|Double Blind Period||19||
48291593|NCT00971243|101040767|FG003|NOT COMPLETED|Double Blind Period||14||
48291594|NCT00971243|101040768|FG004|NOT COMPLETED|Double Blind Period||18||
48291595|NCT00971243|101040764|FG000|STARTED|Open-label Period||68||
48291596|NCT00971243|101040765|FG001|STARTED|Open-label Period||81||
48291597|NCT00971243|101040766|FG002|STARTED|Open-label Period||71||
48291598|NCT00971243|101040767|FG003|STARTED|Open-label Period||74||
48291599|NCT00971243|101040768|FG004|STARTED|Open-label Period||70||
48291600|NCT00971243|101040764|FG000|COMPLETED|Open-label Period||60||
48291601|NCT00971243|101040765|FG001|COMPLETED|Open-label Period||71||
48291602|NCT00971243|101040766|FG002|COMPLETED|Open-label Period||66||
48291603|NCT00971243|101040767|FG003|COMPLETED|Open-label Period||64||
48291604|NCT00971243|101040768|FG004|COMPLETED|Open-label Period||64||
48291605|NCT00971243|101040764|FG000|NOT COMPLETED|Open-label Period||8||
48291606|NCT00971243|101040765|FG001|NOT COMPLETED|Open-label Period||10||
48291607|NCT00971243|101040766|FG002|NOT COMPLETED|Open-label Period||5||
48291608|NCT00971243|101040767|FG003|NOT COMPLETED|Open-label Period||10||
48291609|NCT00971243|101040768|FG004|NOT COMPLETED|Open-label Period||6||
48291610|NCT02752074|101040769|FG000|STARTED|Overall Study||354||
48291611|NCT02752074|101040770|FG001|STARTED|Overall Study||352||
48291612|NCT02752074|101040769|FG000|Treated|Overall Study||353||
48291613|NCT02752074|101040770|FG001|Treated|Overall Study||352||
48291614|NCT02752074|101040769|FG000|COMPLETED|Overall Study||198||
48291615|NCT02752074|101040770|FG001|COMPLETED|Overall Study||209||
48291616|NCT02752074|101040769|FG000|NOT COMPLETED|Overall Study||156||
48291617|NCT02752074|101040770|FG001|NOT COMPLETED|Overall Study||143||
48291618|NCT00971932|101040771|FG000|STARTED|Overall Study||33||
48291619|NCT00971932|101040771|FG000|COMPLETED|Overall Study||26||
48291620|NCT00971932|101040771|FG000|NOT COMPLETED|Overall Study||7||
48291621|NCT01589237|101040772|FG000|STARTED|Part A (52 Weeks)||11||
48291622|NCT01589237|101040773|FG001|STARTED|Part A (52 Weeks)||12||
48291623|NCT01589237|101040774|FG002|STARTED|Part A (52 Weeks)||10||
48291624|NCT01589237|101040775|FG003|STARTED|Part A (52 Weeks)||5||
48291625|NCT01589237|101040772|FG000|COMPLETED|Part A (52 Weeks)||9||
48291626|NCT01589237|101040773|FG001|COMPLETED|Part A (52 Weeks)||9||
48291627|NCT01589237|101040774|FG002|COMPLETED|Part A (52 Weeks)||8||
48291628|NCT01589237|101040775|FG003|COMPLETED|Part A (52 Weeks)||5||
48291629|NCT01589237|101040772|FG000|NOT COMPLETED|Part A (52 Weeks)||2||
48291630|NCT01589237|101040773|FG001|NOT COMPLETED|Part A (52 Weeks)||3||
48291631|NCT01589237|101040774|FG002|NOT COMPLETED|Part A (52 Weeks)||2||
48291632|NCT01589237|101040775|FG003|NOT COMPLETED|Part A (52 Weeks)||0||
48291633|NCT01589237|101040772|FG000|STARTED|Part B (Planned for 78 Week-terminated)||5||
48291634|NCT01589237|101040773|FG001|STARTED|Part B (Planned for 78 Week-terminated)||6||
48291635|NCT01589237|101040774|FG002|STARTED|Part B (Planned for 78 Week-terminated)||4||
48291636|NCT01589237|101040775|FG003|STARTED|Part B (Planned for 78 Week-terminated)||4||
48291637|NCT01589237|101040772|FG000|COMPLETED|Part B (Planned for 78 Week-terminated)||0||
48589426|NCT05093530|101776615|FG003|COMPLETED|Overall Study||4||
48589427|NCT05093530|101776616|FG004|COMPLETED|Overall Study||6||
48589428|NCT05093530|101776617|FG005|COMPLETED|Overall Study||6||
48589429|NCT05093530|101776618|FG006|COMPLETED|Overall Study||5||
48291638|NCT01589237|101040773|FG001|COMPLETED|Part B (Planned for 78 Week-terminated)||0||
48291639|NCT01589237|101040774|FG002|COMPLETED|Part B (Planned for 78 Week-terminated)||0||
48291640|NCT01589237|101040775|FG003|COMPLETED|Part B (Planned for 78 Week-terminated)||0||
48291641|NCT01589237|101040772|FG000|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||5||
48291642|NCT01589237|101040773|FG001|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||6||
48291643|NCT01589237|101040774|FG002|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4||
48291644|NCT01589237|101040775|FG003|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4||
48291645|NCT00770341|101040776|FG000|STARTED|Overall Study||89||
48291646|NCT00770341|101040777|FG001|STARTED|Overall Study||22||
48291647|NCT00770341|101040778|FG002|STARTED|Overall Study||11||
48291648|NCT00770341|101040776|FG000|COMPLETED|Overall Study||77||
48291649|NCT00770341|101040777|FG001|COMPLETED|Overall Study||17||
48291650|NCT00770341|101040778|FG002|COMPLETED|Overall Study||8||
48291651|NCT00770341|101040776|FG000|NOT COMPLETED|Overall Study||12||
48291652|NCT00770341|101040777|FG001|NOT COMPLETED|Overall Study||5||
48291653|NCT00770341|101040778|FG002|NOT COMPLETED|Overall Study||3||
48291654|NCT04390022|101040779|FG000|STARTED|Overall Study||12||
48291655|NCT04390022|101040780|FG001|STARTED|Overall Study||12||
48291656|NCT04390022|101040779|FG000|COMPLETED|Overall Study||12||
48291657|NCT04390022|101040780|FG001|COMPLETED|Overall Study||12||
48291658|NCT04390022|101040779|FG000|NOT COMPLETED|Overall Study||0||
48291659|NCT04390022|101040780|FG001|NOT COMPLETED|Overall Study||0||
48291660|NCT03371381|101040781|FG000|STARTED|Overall Study||12||
48589430|NCT05093530|101776619|FG007|COMPLETED|Overall Study||6||
48291661|NCT03371381|101040781|FG000|COMPLETED|Overall Study||0||
48291662|NCT03371381|101040781|FG000|NOT COMPLETED|Overall Study||12||
48291663|NCT01919814|101040782|FG000|STARTED|Overall Study||30||
48291664|NCT01919814|101040783|FG001|STARTED|Overall Study||30||
48291665|NCT01919814|101040782|FG000|COMPLETED|Overall Study||27||
48291666|NCT01919814|101040783|FG001|COMPLETED|Overall Study||30||
48291667|NCT01919814|101040782|FG000|NOT COMPLETED|Overall Study||3||
48291668|NCT01919814|101040783|FG001|NOT COMPLETED|Overall Study||0||
48291669|NCT00810394|101040784|FG000|STARTED|Overall Study||50||
48291670|NCT00810394|101040784|FG000|Cycle 2 600mg Twice Daily|Overall Study||13||
48291671|NCT00810394|101040784|FG000|Cycle 2 400mg Once Daily|Overall Study||22||
48291672|NCT00810394|101040784|FG000|Cycle 3 800 mg Twice Daily|Overall Study||4||
48291673|NCT00810394|101040784|FG000|Cycle 3 400mg Twice Daily|Overall Study||5||
48291674|NCT00810394|101040784|FG000|COMPLETED|Overall Study||47||
48291675|NCT00810394|101040784|FG000|NOT COMPLETED|Overall Study||3||
48291676|NCT00552240|101040785|FG000|STARTED|Overall Study||75||
48291677|NCT00552240|101040786|FG001|STARTED|Overall Study||77||
48291678|NCT00552240|101040785|FG000|COMPLETED|Overall Study||51||
48291679|NCT00552240|101040786|FG001|COMPLETED|Overall Study||59||
48291680|NCT00552240|101040785|FG000|NOT COMPLETED|Overall Study||24||
48589431|NCT05093530|101776620|FG008|COMPLETED|Overall Study||6||
48291681|NCT00552240|101040786|FG001|NOT COMPLETED|Overall Study||18||
48291682|NCT00815685|101040787|FG000|STARTED|Overall Study||36||
48291683|NCT00815685|101040787|FG000|COMPLETED|Overall Study||14||
48291684|NCT00815685|101040787|FG000|NOT COMPLETED|Overall Study||22||
48291685|NCT03945825|101040788|FG000|STARTED|Overall Study||41||
48589432|NCT05093530|101776621|FG009|COMPLETED|Overall Study||6||
48291686|NCT03945825|101040789|FG001|STARTED|Overall Study||37||
48291687|NCT03945825|101040790|FG002|STARTED|Overall Study||40||
48291688|NCT03945825|101040791|FG003|STARTED|Overall Study||41||
48291689|NCT03945825|101040792|FG004|STARTED|Overall Study||39||
48291690|NCT03945825|101040793|FG005|STARTED|Overall Study||43||
48291691|NCT03945825|101040788|FG000|COMPLETED|Overall Study||39||
48291692|NCT03945825|101040789|FG001|COMPLETED|Overall Study||32||
48291693|NCT03945825|101040790|FG002|COMPLETED|Overall Study||39||
48291694|NCT03945825|101040791|FG003|COMPLETED|Overall Study||39||
48291695|NCT03945825|101040792|FG004|COMPLETED|Overall Study||36||
48291696|NCT03945825|101040793|FG005|COMPLETED|Overall Study||40||
48291697|NCT03945825|101040788|FG000|NOT COMPLETED|Overall Study||2||
48291698|NCT03945825|101040789|FG001|NOT COMPLETED|Overall Study||5||
48291699|NCT03945825|101040790|FG002|NOT COMPLETED|Overall Study||1||
48291700|NCT03945825|101040791|FG003|NOT COMPLETED|Overall Study||2||
48291701|NCT03945825|101040792|FG004|NOT COMPLETED|Overall Study||3||
48291702|NCT03945825|101040793|FG005|NOT COMPLETED|Overall Study||3||
48291703|NCT02268474|101040794|FG000|STARTED|Overall Study||22||44
48291704|NCT02268474|101040794|FG000|Treatment With the 532nm KTP Laser|Overall Study||22||22
48291705|NCT02268474|101040794|FG000|Treatment With the 595nm Pulse Dye Laser|Overall Study||22||22
48291706|NCT02268474|101040794|FG000|COMPLETED|Overall Study||19||38
48291707|NCT02268474|101040794|FG000|NOT COMPLETED|Overall Study||3||6
48291708|NCT00775463|101040795|FG000|STARTED|Overall Study||76||
48291709|NCT00775463|101040796|FG001|STARTED|Overall Study||72||
48291710|NCT00775463|101040795|FG000|COMPLETED|Overall Study||65||
48291711|NCT00775463|101040796|FG001|COMPLETED|Overall Study||59||
48291712|NCT00775463|101040795|FG000|NOT COMPLETED|Overall Study||11||
48291713|NCT00775463|101040796|FG001|NOT COMPLETED|Overall Study||13||
48291714|NCT01707225|101040797|FG000|STARTED|Overall Study||10||
48291715|NCT01707225|101040797|FG000|COMPLETED|Overall Study||10||
48291716|NCT01707225|101040797|FG000|NOT COMPLETED|Overall Study||0||
48291717|NCT01210118|101040798|FG000|STARTED|Overall Study||45||
48291718|NCT01210118|101040799|FG001|STARTED|Overall Study||47||
48291719|NCT01210118|101040798|FG000|COMPLETED|Overall Study||42||
48291720|NCT01210118|101040799|FG001|COMPLETED|Overall Study||42||
48291721|NCT01210118|101040798|FG000|NOT COMPLETED|Overall Study||3||
48291722|NCT01210118|101040799|FG001|NOT COMPLETED|Overall Study||5||
48291723|NCT00738582|101040800|FG000|STARTED|Combination Therapy||89||
48291724|NCT00738582|101040801|FG001|STARTED|Combination Therapy||0||
48291725|NCT00738582|101040800|FG000|COMPLETED|Combination Therapy||56||
48291726|NCT00738582|101040801|FG001|COMPLETED|Combination Therapy||0||
48291727|NCT00738582|101040800|FG000|NOT COMPLETED|Combination Therapy||33||
48291728|NCT00738582|101040801|FG001|NOT COMPLETED|Combination Therapy||0||
48291729|NCT00738582|101040800|FG000|STARTED|Maintenance Therapy||0||
48291730|NCT00738582|101040801|FG001|STARTED|Maintenance Therapy||56||
48291731|NCT00738582|101040800|FG000|COMPLETED|Maintenance Therapy||0||
48291732|NCT00738582|101040801|FG001|COMPLETED|Maintenance Therapy||0||
48291733|NCT00738582|101040800|FG000|NOT COMPLETED|Maintenance Therapy||0||
48291734|NCT00738582|101040801|FG001|NOT COMPLETED|Maintenance Therapy||56||
48291735|NCT01990209|101040802|FG000|STARTED|Overall Study||27||
48291736|NCT01990209|101040803|FG001|STARTED|Overall Study||44||
48291737|NCT01990209|101040802|FG000|COMPLETED|Overall Study||0||
48291738|NCT01990209|101040803|FG001|COMPLETED|Overall Study||0||
48291739|NCT01990209|101040802|FG000|NOT COMPLETED|Overall Study||27||
48291740|NCT01990209|101040803|FG001|NOT COMPLETED|Overall Study||44||
48291741|NCT05249829|101040804|FG000|STARTED|Overall Study||367||
48291742|NCT05249829|101040805|FG001|STARTED|Overall Study||357||
48291743|NCT05249829|101040806|FG002|STARTED|Overall Study||1422||
48291744|NCT05249829|101040807|FG003|STARTED|Overall Study||1402||
48291745|NCT05249829|101040804|FG000|Received at Least 1 Dose of Study Drug|Overall Study||367||
48291746|NCT05249829|101040805|FG001|Received at Least 1 Dose of Study Drug|Overall Study||357||
48291747|NCT05249829|101040806|FG002|Received at Least 1 Dose of Study Drug|Overall Study||1422||
48291748|NCT05249829|101040807|FG003|Received at Least 1 Dose of Study Drug|Overall Study||1402||
48291749|NCT05249829|101040804|FG000|COMPLETED|Overall Study||337||
48291750|NCT05249829|101040805|FG001|COMPLETED|Overall Study||320||
48291751|NCT05249829|101040806|FG002|COMPLETED|Overall Study||1314||
48291752|NCT05249829|101040807|FG003|COMPLETED|Overall Study||1295||
48291753|NCT05249829|101040804|FG000|NOT COMPLETED|Overall Study||30||
48291754|NCT05249829|101040805|FG001|NOT COMPLETED|Overall Study||37||
48291755|NCT05249829|101040806|FG002|NOT COMPLETED|Overall Study||108||
48291756|NCT05249829|101040807|FG003|NOT COMPLETED|Overall Study||107||
48291757|NCT01768117|101040808|FG000|STARTED|Overall Study||13||
48291758|NCT01768117|101040808|FG000|COMPLETED|Overall Study||7||
48291759|NCT01768117|101040808|FG000|NOT COMPLETED|Overall Study||6||
48291760|NCT01007448|101040809|FG000|STARTED|Overall Study||30||
48291761|NCT01007448|101040810|FG001|STARTED|Overall Study||29||
48291762|NCT01007448|101040809|FG000|Full Analysis Population|Overall Study||30|Received at Least 1 Dose of Study Drug|
48291763|NCT01007448|101040810|FG001|Full Analysis Population|Overall Study||29|Received at Least 1 Dose of Study Drug|
48291764|NCT01007448|101040809|FG000|Safety Population|Overall Study||30|Received at Least 1 Dose of Study Drug and had at least 1 safety assessment after treatment.|
48291765|NCT01007448|101040810|FG001|Safety Population|Overall Study||29|Received at Least 1 Dose of Study Drug and had at least 1 safety assessment after treatment.|
48291766|NCT01007448|101040809|FG000|COMPLETED|Overall Study||20||
48291767|NCT01007448|101040810|FG001|COMPLETED|Overall Study||20||
48291768|NCT01007448|101040809|FG000|NOT COMPLETED|Overall Study||10||
48291769|NCT01007448|101040810|FG001|NOT COMPLETED|Overall Study||9||
48291770|NCT02520284|101040811|FG000|STARTED|Blinded Induction Phase: Up to Week 8||54||
48291771|NCT02520284|101040812|FG001|STARTED|Blinded Induction Phase: Up to Week 8||56||
48291772|NCT02520284|101040813|FG002|STARTED|Blinded Induction Phase: Up to Week 8||55||
48291773|NCT02520284|101040811|FG000|COMPLETED|Blinded Induction Phase: Up to Week 8||52||
48291774|NCT02520284|101040812|FG001|COMPLETED|Blinded Induction Phase: Up to Week 8||52||
48291775|NCT02520284|101040813|FG002|COMPLETED|Blinded Induction Phase: Up to Week 8||53||
48291776|NCT02520284|101040811|FG000|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||2||
48291777|NCT02520284|101040812|FG001|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||4||
48291778|NCT02520284|101040813|FG002|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||2||
48291779|NCT02520284|101040811|FG000|STARTED|Blinded Maintenance Phase: Up to Week 51||20||
48291780|NCT02520284|101040812|FG001|STARTED|Blinded Maintenance Phase: Up to Week 51||16||
48291781|NCT02520284|101040813|FG002|STARTED|Blinded Maintenance Phase: Up to Week 51||18||
48291782|NCT02520284|101040811|FG000|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0||
48291783|NCT02520284|101040812|FG001|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0||
48291784|NCT02520284|101040813|FG002|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0||
48291785|NCT02520284|101040811|FG000|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||20||
48291786|NCT02520284|101040812|FG001|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||16||
48291787|NCT02520284|101040813|FG002|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||18||
48291788|NCT02520284|101040811|FG000|STARTED|Open-Label MaintenancePhase: Upto Week51||32||
48291789|NCT02520284|101040812|FG001|STARTED|Open-Label MaintenancePhase: Upto Week51||35||
48291790|NCT02520284|101040813|FG002|STARTED|Open-Label MaintenancePhase: Upto Week51||34||
48291791|NCT02520284|101040811|FG000|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0||
48291792|NCT02520284|101040812|FG001|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0||
48291793|NCT02520284|101040813|FG002|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0||
48291794|NCT02520284|101040811|FG000|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||32||
48291795|NCT02520284|101040812|FG001|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||35||
48291796|NCT02520284|101040813|FG002|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||34||
48291797|NCT01847469|101040814|FG000|STARTED|Overall Study||18||
48291798|NCT01847469|101040815|FG001|STARTED|Overall Study||6||
48291799|NCT01847469|101040814|FG000|COMPLETED|Overall Study||9||
48291800|NCT01847469|101040815|FG001|COMPLETED|Overall Study||3||
48291801|NCT01847469|101040814|FG000|NOT COMPLETED|Overall Study||9||
48291802|NCT01847469|101040815|FG001|NOT COMPLETED|Overall Study||3||
48291803|NCT01597141|101040816|FG000|STARTED|Overall Study||50||
48291804|NCT01597141|101040817|FG001|STARTED|Overall Study||50||
48291805|NCT01597141|101040816|FG000|COMPLETED|Overall Study||50||
48291806|NCT01597141|101040817|FG001|COMPLETED|Overall Study||50||
48291807|NCT01597141|101040816|FG000|NOT COMPLETED|Overall Study||0||
48707709|NCT02759107|102073172|FG003|STARTED|Overall Study||5||
48707710|NCT02759107|102073173|FG004|STARTED|Overall Study||6||
48707711|NCT02759107|102073174|FG005|STARTED|Overall Study||6||
48291808|NCT01597141|101040817|FG001|NOT COMPLETED|Overall Study||0||
48291809|NCT01605292|101040818|FG000|STARTED|Overall Study||351||
48291810|NCT01605292|101040819|FG001|STARTED|Overall Study||347||
48291811|NCT01605292|101040818|FG000|COMPLETED|Overall Study||351||
48291812|NCT01605292|101040819|FG001|COMPLETED|Overall Study||347||
48291813|NCT01605292|101040818|FG000|NOT COMPLETED|Overall Study||0||
48291814|NCT01605292|101040819|FG001|NOT COMPLETED|Overall Study||0||
48291815|NCT02939170|101040820|FG000|STARTED|Overall Study||40||
48291816|NCT02939170|101040821|FG001|STARTED|Overall Study||40||
48291817|NCT02939170|101040820|FG000|COMPLETED|Overall Study||40||
48291818|NCT02939170|101040821|FG001|COMPLETED|Overall Study||40||
48707712|NCT02759107|102073175|FG006|STARTED|Overall Study||7||
48291819|NCT02939170|101040820|FG000|NOT COMPLETED|Overall Study||0||
48291820|NCT02939170|101040821|FG001|NOT COMPLETED|Overall Study||0||
48291821|NCT02680002|101040822|FG000|STARTED|Overall Study||71||
48291822|NCT02680002|101040823|FG001|STARTED|Overall Study||70||
48291823|NCT02680002|101040824|FG002|STARTED|Overall Study||70||
48291824|NCT02680002|101040825|FG003|STARTED|Overall Study||71||
48291825|NCT02680002|101040826|FG004|STARTED|Overall Study||70||
48291826|NCT02680002|101040827|FG005|STARTED|Overall Study||70||
48291827|NCT02680002|101040822|FG000|Day 0 (Dose 1)|Overall Study||70||
48291828|NCT02680002|101040823|FG001|Day 0 (Dose 1)|Overall Study||70||
48291829|NCT02680002|101040824|FG002|Day 0 (Dose 1)|Overall Study||70||
48291830|NCT02680002|101040825|FG003|Day 0 (Dose 1)|Overall Study||71||
48291831|NCT02680002|101040826|FG004|Day 0 (Dose 1)|Overall Study||70||
48291832|NCT02680002|101040827|FG005|Day 0 (Dose 1)|Overall Study||68||
48291833|NCT02680002|101040822|FG000|Day 21 (Dose 2)|Overall Study||63||
48707713|NCT02759107|102073176|FG007|STARTED|Overall Study||4||
48707714|NCT02759107|102073177|FG008|STARTED|Overall Study||4||
48291834|NCT02680002|101040823|FG001|Day 21 (Dose 2)|Overall Study||68||
48291835|NCT02680002|101040824|FG002|Day 21 (Dose 2)|Overall Study||65||
48291836|NCT02680002|101040825|FG003|Day 21 (Dose 2)|Overall Study||69||
48291837|NCT02680002|101040826|FG004|Day 21 (Dose 2)|Overall Study||65||
48291838|NCT02680002|101040827|FG005|Day 21 (Dose 2)|Overall Study||63||
48291839|NCT02680002|101040822|FG000|Day 201|Overall Study||58||
48291840|NCT02680002|101040823|FG001|Day 201|Overall Study||66||
48291841|NCT02680002|101040824|FG002|Day 201|Overall Study||60||
48291842|NCT02680002|101040825|FG003|Day 201|Overall Study||67||
48707715|NCT02759107|102073178|FG009|STARTED|Overall Study||6||
48291843|NCT02680002|101040826|FG004|Day 201|Overall Study||59||
48291844|NCT02680002|101040827|FG005|Day 201|Overall Study||61||
48402768|NCT02580591|101317737|FG003|STARTED|Overall Study||245||
48402769|NCT02580591|101317734|FG000|Treated|Overall Study||241||
48402770|NCT02580591|101317735|FG001|Treated|Overall Study||241||
48402771|NCT02580591|101317736|FG002|Treated|Overall Study||248||
48707716|NCT02759107|102073179|FG010|STARTED|Overall Study||6||
48707717|NCT02759107|102073180|FG011|STARTED|Overall Study||6||
48707718|NCT02759107|102073181|FG012|STARTED|Overall Study||7||
48707719|NCT02759107|102073182|FG013|STARTED|Overall Study||11||
48707720|NCT02759107|102073183|FG014|STARTED|Overall Study||9||
48707721|NCT02759107|102073184|FG015|STARTED|Overall Study||9||
48707722|NCT02759107|102073185|FG016|STARTED|Overall Study||12||
48707723|NCT02759107|102073186|FG017|STARTED|Overall Study||12||
48291845|NCT02680002|101040822|FG000|COMPLETED|Overall Study||58||
48589433|NCT05093530|101776612|FG000|NOT COMPLETED|Overall Study||0||
48589434|NCT05093530|101776613|FG001|NOT COMPLETED|Overall Study||0||
48589435|NCT05093530|101776614|FG002|NOT COMPLETED|Overall Study||0||
48589436|NCT05093530|101776615|FG003|NOT COMPLETED|Overall Study||0||
48589437|NCT05093530|101776616|FG004|NOT COMPLETED|Overall Study||0||
48589438|NCT05093530|101776617|FG005|NOT COMPLETED|Overall Study||0||
48589439|NCT05093530|101776618|FG006|NOT COMPLETED|Overall Study||1||
48589440|NCT05093530|101776619|FG007|NOT COMPLETED|Overall Study||0||
48589441|NCT05093530|101776620|FG008|NOT COMPLETED|Overall Study||0||
48589442|NCT05093530|101776621|FG009|NOT COMPLETED|Overall Study||0||
48589443|NCT02223650|101776622|FG000|STARTED|Overall Study||27||
48589444|NCT02223650|101776623|FG001|STARTED|Overall Study||31||
48589445|NCT02223650|101776622|FG000|COMPLETED|Overall Study||27||
48589446|NCT02223650|101776623|FG001|COMPLETED|Overall Study||31||
48589447|NCT02223650|101776622|FG000|NOT COMPLETED|Overall Study||0||
48589448|NCT02223650|101776623|FG001|NOT COMPLETED|Overall Study||0||
48589449|NCT03126019|101776624|FG000|STARTED|Overall Study||23||
48589450|NCT03126019|101776625|FG001|STARTED|Overall Study||103||
48589451|NCT03126019|101776624|FG000|COMPLETED|Overall Study||0||
48589452|NCT03126019|101776625|FG001|COMPLETED|Overall Study||0||
48589453|NCT03126019|101776624|FG000|NOT COMPLETED|Overall Study||23||
48589454|NCT03126019|101776625|FG001|NOT COMPLETED|Overall Study||103||
48589455|NCT01230424|101776626|FG000|STARTED|Overall Study||70||
48589456|NCT01230424|101776627|FG001|STARTED|Overall Study||70||
48589457|NCT01230424|101776626|FG000|COMPLETED|Overall Study||70||
48589458|NCT01230424|101776627|FG001|COMPLETED|Overall Study||70||
48589459|NCT01230424|101776626|FG000|NOT COMPLETED|Overall Study||0||
48589460|NCT01230424|101776627|FG001|NOT COMPLETED|Overall Study||0||
48589461|NCT00520481|101776628|FG000|STARTED|Overall Study||31||
48589462|NCT00520481|101776629|FG001|STARTED|Overall Study||10||
48589463|NCT00520481|101776628|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31||
48589464|NCT00520481|101776629|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10||
48589465|NCT00520481|101776628|FG000|COMPLETED|Overall Study||24||
48589466|NCT00520481|101776629|FG001|COMPLETED|Overall Study||9||
48589467|NCT00520481|101776628|FG000|NOT COMPLETED|Overall Study||7||
48589468|NCT00520481|101776629|FG001|NOT COMPLETED|Overall Study||1||
48589469|NCT01783639|101776630|FG000|STARTED|Overall Study||120||
48589470|NCT01783639|101776630|FG000|COMPLETED|Overall Study||120||
48589471|NCT01783639|101776630|FG000|NOT COMPLETED|Overall Study||0||
48589472|NCT01770366|101776631|FG000|STARTED|Overall Study||4||
48707724|NCT02759107|102073169|FG000|Received at Least One Dose of Study Drug|Overall Study||14||
48291846|NCT02680002|101040823|FG001|COMPLETED|Overall Study||66||
48402772|NCT02580591|101317737|FG003|Treated|Overall Study||245||
48402773|NCT02580591|101317734|FG000|COMPLETED|Overall Study||224||
48402774|NCT02580591|101317735|FG001|COMPLETED|Overall Study||232||
48402775|NCT02580591|101317736|FG002|COMPLETED|Overall Study||235||
48589473|NCT01770366|101776632|FG001|STARTED|Overall Study||6||
48589474|NCT01770366|101776631|FG000|COMPLETED|Overall Study||2||
48589475|NCT01770366|101776632|FG001|COMPLETED|Overall Study||4||
48589476|NCT01770366|101776631|FG000|NOT COMPLETED|Overall Study||2||
48707725|NCT02759107|102073170|FG001|Received at Least One Dose of Study Drug|Overall Study||6||
48291847|NCT02680002|101040824|FG002|COMPLETED|Overall Study||60||
48589477|NCT01770366|101776632|FG001|NOT COMPLETED|Overall Study||2||
48589478|NCT01968356|101776633|FG000|STARTED|Overall Study||101||101
48707726|NCT02759107|102073171|FG002|Received at Least One Dose of Study Drug|Overall Study||12||
48707727|NCT02759107|102073172|FG003|Received at Least One Dose of Study Drug|Overall Study||5||
48402776|NCT02580591|101317737|FG003|COMPLETED|Overall Study||233||
48402777|NCT02580591|101317734|FG000|NOT COMPLETED|Overall Study||18||
48291848|NCT02680002|101040825|FG003|COMPLETED|Overall Study||67||
48291849|NCT02680002|101040826|FG004|COMPLETED|Overall Study||59||
48589479|NCT01968356|101776634|FG001|STARTED|Overall Study||93||93
48589480|NCT01968356|101776635|FG002|STARTED|Overall Study||96||96
48589481|NCT01968356|101776636|FG003|STARTED|Overall Study||32||32
48291850|NCT02680002|101040827|FG005|COMPLETED|Overall Study||61||
48291851|NCT02680002|101040822|FG000|NOT COMPLETED|Overall Study||13||
48291852|NCT02680002|101040823|FG001|NOT COMPLETED|Overall Study||4||
48291853|NCT02680002|101040824|FG002|NOT COMPLETED|Overall Study||10||
48291854|NCT02680002|101040825|FG003|NOT COMPLETED|Overall Study||4||
48291855|NCT02680002|101040826|FG004|NOT COMPLETED|Overall Study||11||
48291856|NCT02680002|101040827|FG005|NOT COMPLETED|Overall Study||9||
48291857|NCT00645047|101040828|FG000|STARTED|Overall Study||103||
48291858|NCT00645047|101040829|FG001|STARTED|Overall Study||104||
48589482|NCT01968356|101776637|FG004|STARTED|Overall Study||97||97
48589483|NCT01968356|101776638|FG005|STARTED|Overall Study||99||99
48589484|NCT01968356|101776639|FG006|STARTED|Overall Study||97||97
48589485|NCT01968356|101776640|FG007|STARTED|Overall Study||31||31
48589486|NCT01968356|101776633|FG000|COMPLETED|Overall Study||101||101
48589487|NCT01968356|101776634|FG001|COMPLETED|Overall Study||93||93
48589488|NCT01968356|101776635|FG002|COMPLETED|Overall Study||96||96
48589489|NCT01968356|101776636|FG003|COMPLETED|Overall Study||32||32
48589490|NCT01968356|101776637|FG004|COMPLETED|Overall Study||97||97
48589491|NCT01968356|101776638|FG005|COMPLETED|Overall Study||99||99
48589492|NCT01968356|101776639|FG006|COMPLETED|Overall Study||97||97
48589493|NCT01968356|101776640|FG007|COMPLETED|Overall Study||31||31
48589494|NCT01968356|101776633|FG000|NOT COMPLETED|Overall Study||0||0
48589495|NCT01968356|101776634|FG001|NOT COMPLETED|Overall Study||0||0
48589496|NCT01968356|101776635|FG002|NOT COMPLETED|Overall Study||0||0
48707728|NCT02759107|102073173|FG004|Received at Least One Dose of Study Drug|Overall Study||6||
48707729|NCT02759107|102073174|FG005|Received at Least One Dose of Study Drug|Overall Study||6||
48291859|NCT00645047|101040828|FG000|Post|Overall Study||74||
48291860|NCT00645047|101040829|FG001|Post|Overall Study||80||
48291861|NCT00645047|101040828|FG000|COMPLETED|Overall Study||60||
48291862|NCT00645047|101040829|FG001|COMPLETED|Overall Study||65||
48589497|NCT01968356|101776636|FG003|NOT COMPLETED|Overall Study||0||0
48707730|NCT02759107|102073175|FG006|Received at Least One Dose of Study Drug|Overall Study||7||
48707731|NCT02759107|102073176|FG007|Received at Least One Dose of Study Drug|Overall Study||4||
48707732|NCT02759107|102073177|FG008|Received at Least One Dose of Study Drug|Overall Study||4||
48707733|NCT02759107|102073178|FG009|Received at Least One Dose of Study Drug|Overall Study||6||
48707734|NCT02759107|102073179|FG010|Received at Least One Dose of Study Drug|Overall Study||6||
48707735|NCT02759107|102073180|FG011|Received at Least One Dose of Study Drug|Overall Study||6||
48707736|NCT02759107|102073181|FG012|Received at Least One Dose of Study Drug|Overall Study||7||
48707737|NCT02759107|102073182|FG013|Received at Least One Dose of Study Drug|Overall Study||11||
48707738|NCT02759107|102073183|FG014|Received at Least One Dose of Study Drug|Overall Study||9||
48707739|NCT02759107|102073184|FG015|Received at Least One Dose of Study Drug|Overall Study||9||
48707740|NCT02759107|102073185|FG016|Received at Least One Dose of Study Drug|Overall Study||12||
48707741|NCT02759107|102073186|FG017|Received at Least One Dose of Study Drug|Overall Study||12||
48707742|NCT02759107|102073169|FG000|COMPLETED|Overall Study||14||
48707743|NCT02759107|102073170|FG001|COMPLETED|Overall Study||6||
48707744|NCT02759107|102073171|FG002|COMPLETED|Overall Study||12||
48707745|NCT02759107|102073172|FG003|COMPLETED|Overall Study||5||
48707746|NCT02759107|102073173|FG004|COMPLETED|Overall Study||6||
48707747|NCT02759107|102073174|FG005|COMPLETED|Overall Study||6||
48291863|NCT00645047|101040828|FG000|NOT COMPLETED|Overall Study||43||
48402778|NCT02580591|101317735|FG001|NOT COMPLETED|Overall Study||10||
48589498|NCT01968356|101776637|FG004|NOT COMPLETED|Overall Study||0||0
48589499|NCT01968356|101776638|FG005|NOT COMPLETED|Overall Study||0||0
48589500|NCT01968356|101776639|FG006|NOT COMPLETED|Overall Study||0||0
48291864|NCT00645047|101040829|FG001|NOT COMPLETED|Overall Study||39||
48291865|NCT01275131|101040830|FG000|STARTED|Period 1||11||
48291866|NCT01275131|101040831|FG001|STARTED|Period 1||9||
48589501|NCT01968356|101776640|FG007|NOT COMPLETED|Overall Study||0||0
48589502|NCT02017912|101776641|FG000|STARTED|Overall Study||36||
48589503|NCT02017912|101776642|FG001|STARTED|Overall Study||12||
48589504|NCT02017912|101776641|FG000|COMPLETED|Overall Study||33||
48589505|NCT02017912|101776642|FG001|COMPLETED|Overall Study||10||
48589506|NCT02017912|101776641|FG000|NOT COMPLETED|Overall Study||3||
48589507|NCT02017912|101776642|FG001|NOT COMPLETED|Overall Study||2||
48589508|NCT01317797|101776643|FG000|STARTED|Overall Study||8||
48589509|NCT01317797|101776644|FG001|STARTED|Overall Study||7||
48589510|NCT01317797|101776645|FG002|STARTED|Overall Study||9||
48589511|NCT01317797|101776643|FG000|COMPLETED|Overall Study||8||
48589512|NCT01317797|101776644|FG001|COMPLETED|Overall Study||6||
48589513|NCT01317797|101776645|FG002|COMPLETED|Overall Study||8||
48589514|NCT01317797|101776643|FG000|NOT COMPLETED|Overall Study||0||
48589515|NCT01317797|101776644|FG001|NOT COMPLETED|Overall Study||1||
48589516|NCT01317797|101776645|FG002|NOT COMPLETED|Overall Study||1||
48589517|NCT04891406|101776646|FG000|STARTED|Overall Study||5||
48589518|NCT04891406|101776647|FG001|STARTED|Overall Study||5||
48589519|NCT04891406|101776648|FG002|STARTED|Overall Study||5||
48589520|NCT04891406|101776649|FG003|STARTED|Overall Study||5||
48589521|NCT04891406|101776650|FG004|STARTED|Overall Study||4||
48589522|NCT04891406|101776646|FG000|COMPLETED|Overall Study||5||
48589523|NCT04891406|101776647|FG001|COMPLETED|Overall Study||4||
48589524|NCT04891406|101776648|FG002|COMPLETED|Overall Study||5||
48589525|NCT04891406|101776649|FG003|COMPLETED|Overall Study||5||
48589526|NCT04891406|101776650|FG004|COMPLETED|Overall Study||3||
48589527|NCT04891406|101776646|FG000|NOT COMPLETED|Overall Study||0||
48589528|NCT04891406|101776647|FG001|NOT COMPLETED|Overall Study||1||
48589529|NCT04891406|101776648|FG002|NOT COMPLETED|Overall Study||0||
48589530|NCT04891406|101776649|FG003|NOT COMPLETED|Overall Study||0||
48589531|NCT04891406|101776650|FG004|NOT COMPLETED|Overall Study||1||
48589532|NCT01849068|101776651|FG000|STARTED|Overall Study||10||
48589533|NCT01849068|101776652|FG001|STARTED|Overall Study||10||
48589534|NCT01849068|101776651|FG000|COMPLETED|Overall Study||10||
48589535|NCT01849068|101776652|FG001|COMPLETED|Overall Study||10||
48589536|NCT01849068|101776651|FG000|NOT COMPLETED|Overall Study||0||
48589537|NCT01849068|101776652|FG001|NOT COMPLETED|Overall Study||0||
48589538|NCT00230022|101776653|FG000|STARTED|Overall Study||15||
48589539|NCT00230022|101776654|FG001|STARTED|Overall Study||15||
48589540|NCT00230022|101776653|FG000|COMPLETED|Overall Study||15||
48589541|NCT00230022|101776654|FG001|COMPLETED|Overall Study||15||
48589542|NCT00230022|101776653|FG000|NOT COMPLETED|Overall Study||0||
48589543|NCT00230022|101776654|FG001|NOT COMPLETED|Overall Study||0||
48589544|NCT00595517|101776655|FG000|STARTED|Overall Study||130||
48589545|NCT00595517|101776655|FG000|COMPLETED|Overall Study||111||
48589546|NCT00595517|101776655|FG000|NOT COMPLETED|Overall Study||19||
48589547|NCT02892513|101776656|FG000|STARTED|Overall Study||28||
48589548|NCT02892513|101776657|FG001|STARTED|Overall Study||25||
48589549|NCT02892513|101776656|FG000|COMPLETED|Overall Study||28||
48589550|NCT02892513|101776657|FG001|COMPLETED|Overall Study||24||
48589551|NCT02892513|101776656|FG000|NOT COMPLETED|Overall Study||0||
48589552|NCT02892513|101776657|FG001|NOT COMPLETED|Overall Study||1||
48589553|NCT00334633|101776658|FG000|STARTED|Overall Study||197||
48589554|NCT00334633|101776659|FG001|STARTED|Overall Study||200||
48589555|NCT00334633|101776660|FG002|STARTED|Overall Study||196||
48589556|NCT00334633|101776658|FG000|COMPLETED|Overall Study||117||
48589557|NCT00334633|101776659|FG001|COMPLETED|Overall Study||118||
48589558|NCT00334633|101776660|FG002|COMPLETED|Overall Study||114||
48589559|NCT00334633|101776658|FG000|NOT COMPLETED|Overall Study||80||
48707748|NCT02759107|102073175|FG006|COMPLETED|Overall Study||7||
48707749|NCT02759107|102073176|FG007|COMPLETED|Overall Study||4||
48707750|NCT02759107|102073177|FG008|COMPLETED|Overall Study||4||
48707751|NCT02759107|102073178|FG009|COMPLETED|Overall Study||5||
48707752|NCT02759107|102073179|FG010|COMPLETED|Overall Study||6||
48402779|NCT02580591|101317736|FG002|NOT COMPLETED|Overall Study||13||
48402780|NCT02580591|101317737|FG003|NOT COMPLETED|Overall Study||12||
48402781|NCT00693693|101317738|FG000|STARTED|Overall Study||7||
48402782|NCT00693693|101317739|FG001|STARTED|Overall Study||9||
48589560|NCT00334633|101776659|FG001|NOT COMPLETED|Overall Study||82||
48589561|NCT00334633|101776660|FG002|NOT COMPLETED|Overall Study||82||
48589562|NCT04364802|101776661|FG000|STARTED|Overall Study||11||
48402783|NCT00693693|101317740|FG002|STARTED|Overall Study||9||
48402784|NCT00693693|101317738|FG000|COMPLETED|Overall Study||6||
48589563|NCT04364802|101776662|FG001|STARTED|Overall Study||38||
48589564|NCT04364802|101776663|FG002|STARTED|Overall Study||17||
48589565|NCT04364802|101776664|FG003|STARTED|Overall Study||14||
48589566|NCT04364802|101776665|FG004|STARTED|Overall Study||2||
48589567|NCT04364802|101776666|FG005|STARTED|Overall Study||16||
48589568|NCT04364802|101776661|FG000|COMPLETED|Overall Study||11||
48707753|NCT02759107|102073180|FG011|COMPLETED|Overall Study||6||
48707754|NCT02759107|102073181|FG012|COMPLETED|Overall Study||5||
48707755|NCT02759107|102073182|FG013|COMPLETED|Overall Study||11||
48707756|NCT02759107|102073183|FG014|COMPLETED|Overall Study||9||
48707757|NCT02759107|102073184|FG015|COMPLETED|Overall Study||8||
48707758|NCT02759107|102073185|FG016|COMPLETED|Overall Study||12||
48139501|NCT02041195|100665622|FG002|COMPLETED|Overall Study||3||
48139502|NCT02041195|100665623|FG003|COMPLETED|Overall Study||3||
48139503|NCT02041195|100665624|FG004|COMPLETED|Overall Study||10||
48139504|NCT02041195|100665625|FG005|COMPLETED|Overall Study||6||
48139505|NCT02041195|100665626|FG006|COMPLETED|Overall Study||22||
48139506|NCT02041195|100665627|FG007|COMPLETED|Overall Study||25||
48139507|NCT02041195|100665620|FG000|NOT COMPLETED|Overall Study||2||
48139508|NCT02041195|100665621|FG001|NOT COMPLETED|Overall Study||3||
48139509|NCT02041195|100665622|FG002|NOT COMPLETED|Overall Study||0||
48139510|NCT02041195|100665623|FG003|NOT COMPLETED|Overall Study||0||
48139511|NCT02041195|100665624|FG004|NOT COMPLETED|Overall Study||1||
48139512|NCT02041195|100665625|FG005|NOT COMPLETED|Overall Study||0||
48139513|NCT02041195|100665626|FG006|NOT COMPLETED|Overall Study||7||
48139514|NCT02041195|100665627|FG007|NOT COMPLETED|Overall Study||3||
48139515|NCT01349569|100665628|FG000|STARTED|Overall Study||16||
48139516|NCT01349569|100665628|FG000|COMPLETED|Overall Study||12||
48139517|NCT01349569|100665628|FG000|NOT COMPLETED|Overall Study||4||
48139518|NCT03108924|100665629|FG000|STARTED|Overall Study||6||
48139519|NCT03108924|100665630|FG001|STARTED|Overall Study||6||
48139520|NCT03108924|100665631|FG002|STARTED|Overall Study||6||
48139521|NCT03108924|100665632|FG003|STARTED|Overall Study||6||
48139522|NCT03108924|100665629|FG000|COMPLETED|Overall Study||6||
48139523|NCT03108924|100665630|FG001|COMPLETED|Overall Study||6||
48139524|NCT03108924|100665631|FG002|COMPLETED|Overall Study||6||
48139525|NCT03108924|100665632|FG003|COMPLETED|Overall Study||6||
48139526|NCT03108924|100665629|FG000|NOT COMPLETED|Overall Study||0||
48139527|NCT03108924|100665630|FG001|NOT COMPLETED|Overall Study||0||
48139528|NCT03108924|100665631|FG002|NOT COMPLETED|Overall Study||0||
48139529|NCT03108924|100665632|FG003|NOT COMPLETED|Overall Study||0||
48139530|NCT01047839|100665633|FG000|STARTED|Overall Study||12||
48139531|NCT01047839|100665634|FG001|STARTED|Overall Study||29||
48139532|NCT01047839|100665635|FG002|STARTED|Overall Study||59||
48139533|NCT01047839|100665633|FG000|COMPLETED|Overall Study||10||
48139534|NCT01047839|100665634|FG001|COMPLETED|Overall Study||29||
48139535|NCT01047839|100665635|FG002|COMPLETED|Overall Study||53||
48291867|NCT01275131|101040832|FG002|STARTED|Period 1||13||
48291868|NCT01275131|101040833|FG003|STARTED|Period 1||12||
48291869|NCT01275131|101040830|FG000|Received at Least One Dose of Study Drug|Period 1||11||
48291870|NCT01275131|101040831|FG001|Received at Least One Dose of Study Drug|Period 1||9||
48291871|NCT01275131|101040832|FG002|Received at Least One Dose of Study Drug|Period 1||13||
48291872|NCT01275131|101040833|FG003|Received at Least One Dose of Study Drug|Period 1||12||
48291873|NCT01275131|101040830|FG000|COMPLETED|Period 1||9||
48291874|NCT01275131|101040831|FG001|COMPLETED|Period 1||9||
48291875|NCT01275131|101040832|FG002|COMPLETED|Period 1||10||
48291876|NCT01275131|101040833|FG003|COMPLETED|Period 1||10||
48291877|NCT01275131|101040830|FG000|NOT COMPLETED|Period 1||2||
48291878|NCT01275131|101040831|FG001|NOT COMPLETED|Period 1||0||
48291879|NCT01275131|101040832|FG002|NOT COMPLETED|Period 1||3||
48291880|NCT01275131|101040833|FG003|NOT COMPLETED|Period 1||2||
48291881|NCT01275131|101040830|FG000|STARTED|5- to 14-Day Washout Period||9||
48291882|NCT01275131|101040831|FG001|STARTED|5- to 14-Day Washout Period||9||
48291883|NCT01275131|101040832|FG002|STARTED|5- to 14-Day Washout Period||10||
48291884|NCT01275131|101040833|FG003|STARTED|5- to 14-Day Washout Period||10||
48291885|NCT01275131|101040830|FG000|COMPLETED|5- to 14-Day Washout Period||9||
48291886|NCT01275131|101040831|FG001|COMPLETED|5- to 14-Day Washout Period||9||
48291887|NCT01275131|101040832|FG002|COMPLETED|5- to 14-Day Washout Period||10||
48589569|NCT04364802|101776662|FG001|COMPLETED|Overall Study||38||
48589570|NCT04364802|101776663|FG002|COMPLETED|Overall Study||17||
48291888|NCT01275131|101040833|FG003|COMPLETED|5- to 14-Day Washout Period||10||
48291889|NCT01275131|101040830|FG000|NOT COMPLETED|5- to 14-Day Washout Period||0||
48291890|NCT01275131|101040831|FG001|NOT COMPLETED|5- to 14-Day Washout Period||0||
48291891|NCT01275131|101040832|FG002|NOT COMPLETED|5- to 14-Day Washout Period||0||
48291892|NCT01275131|101040833|FG003|NOT COMPLETED|5- to 14-Day Washout Period||0||
48291893|NCT01275131|101040830|FG000|STARTED|Period 2 (Crossover)||9||
48291894|NCT01275131|101040831|FG001|STARTED|Period 2 (Crossover)||9||
48291895|NCT01275131|101040832|FG002|STARTED|Period 2 (Crossover)||10||
48589571|NCT04364802|101776664|FG003|COMPLETED|Overall Study||14||
48589572|NCT04364802|101776665|FG004|COMPLETED|Overall Study||2||
48589573|NCT04364802|101776666|FG005|COMPLETED|Overall Study||16||
48589574|NCT04364802|101776661|FG000|NOT COMPLETED|Overall Study||0||
48589575|NCT04364802|101776662|FG001|NOT COMPLETED|Overall Study||0||
48589576|NCT04364802|101776663|FG002|NOT COMPLETED|Overall Study||0||
48589577|NCT04364802|101776664|FG003|NOT COMPLETED|Overall Study||0||
48291896|NCT01275131|101040833|FG003|STARTED|Period 2 (Crossover)||10||
48291897|NCT01275131|101040830|FG000|COMPLETED|Period 2 (Crossover)||8||
48291898|NCT01275131|101040831|FG001|COMPLETED|Period 2 (Crossover)||8||
48291899|NCT01275131|101040832|FG002|COMPLETED|Period 2 (Crossover)||9||
48291900|NCT01275131|101040833|FG003|COMPLETED|Period 2 (Crossover)||8||
48291901|NCT01275131|101040830|FG000|NOT COMPLETED|Period 2 (Crossover)||1||
48291902|NCT01275131|101040831|FG001|NOT COMPLETED|Period 2 (Crossover)||1||
48291903|NCT01275131|101040832|FG002|NOT COMPLETED|Period 2 (Crossover)||1||
48291904|NCT01275131|101040833|FG003|NOT COMPLETED|Period 2 (Crossover)||2||
48291905|NCT00865969|101040834|FG000|STARTED|Overall Study||129||
48291906|NCT00865969|101040834|FG000|COMPLETED|Overall Study||129||
48291907|NCT00865969|101040834|FG000|NOT COMPLETED|Overall Study||0||
48291908|NCT01596621|101040835|FG000|STARTED|Overall Study||102||
48291909|NCT01596621|101040835|FG000|Received at Least 1 Dose of Study Drug|Overall Study||102||
48291910|NCT01596621|101040835|FG000|COMPLETED|Overall Study||24||
48291911|NCT01596621|101040835|FG000|NOT COMPLETED|Overall Study||78||
48291912|NCT00495586|101040836|FG000|STARTED|Overall Study||156||
48589578|NCT04364802|101776665|FG004|NOT COMPLETED|Overall Study||0||
48589579|NCT04364802|101776666|FG005|NOT COMPLETED|Overall Study||0||
48589580|NCT02609724|101776667|FG000|STARTED|Overall Study||65||
48589581|NCT02609724|101776668|FG001|STARTED|Overall Study||64||
48589582|NCT02609724|101776669|FG002|STARTED|Overall Study||65||
48589583|NCT02609724|101776667|FG000|Post Intensive Treatment Phase (= Primary Endpoint)|Overall Study||63||
48589584|NCT02609724|101776668|FG001|Post Intensive Treatment Phase (= Primary Endpoint)|Overall Study||63||
48589585|NCT02609724|101776669|FG002|Post Intensive Treatment Phase (= Primary Endpoint)|Overall Study||64||
48589586|NCT02609724|101776667|FG000|COMPLETED|Overall Study||60||
48291913|NCT00495586|101040837|FG001|STARTED|Overall Study||162||
48291914|NCT00495586|101040836|FG000|COMPLETED|Overall Study||152||
48291915|NCT00495586|101040837|FG001|COMPLETED|Overall Study||158||
48291916|NCT00495586|101040836|FG000|NOT COMPLETED|Overall Study||4||
48291917|NCT00495586|101040837|FG001|NOT COMPLETED|Overall Study||4||
48589587|NCT02609724|101776668|FG001|COMPLETED|Overall Study||61||
48589588|NCT02609724|101776669|FG002|COMPLETED|Overall Study||61||
48589589|NCT02609724|101776667|FG000|NOT COMPLETED|Overall Study||5||
48589590|NCT02609724|101776668|FG001|NOT COMPLETED|Overall Study||3||
48589591|NCT02609724|101776669|FG002|NOT COMPLETED|Overall Study||4||
48291918|NCT04634825|101040838|FG000|STARTED|Overall Study||48||
48291919|NCT04634825|101040839|FG001|STARTED|Overall Study||14||
48291920|NCT04634825|101040838|FG000|COMPLETED|Overall Study||0||
48291921|NCT04634825|101040839|FG001|COMPLETED|Overall Study||0||
48291922|NCT04634825|101040838|FG000|NOT COMPLETED|Overall Study||48||
48291923|NCT04634825|101040839|FG001|NOT COMPLETED|Overall Study||14||
48291924|NCT03076333|101040840|FG000|STARTED|Overall Study||3||
48402785|NCT00693693|101317739|FG001|COMPLETED|Overall Study||8||
48402786|NCT00693693|101317740|FG002|COMPLETED|Overall Study||7||
48402787|NCT00693693|101317738|FG000|NOT COMPLETED|Overall Study||1||
48402788|NCT00693693|101317739|FG001|NOT COMPLETED|Overall Study||1||
48402789|NCT00693693|101317740|FG002|NOT COMPLETED|Overall Study||2||
48402790|NCT02443155|101317741|FG000|STARTED|Overall Study||77||
48402791|NCT02443155|101317742|FG001|STARTED|Overall Study||77||
48402792|NCT02443155|101317743|FG002|STARTED|Overall Study||76||
48402793|NCT02443155|101317744|FG003|STARTED|Overall Study||77||
48402794|NCT02443155|101317741|FG000|Full Analysis Set|Overall Study||77||
48402795|NCT02443155|101317742|FG001|Full Analysis Set|Overall Study||77||
48402796|NCT02443155|101317743|FG002|Full Analysis Set|Overall Study||76||
48589592|NCT02543892|101776670|FG000|STARTED|Received Vaccination 1||12||
48589593|NCT02543892|101776671|FG001|STARTED|Received Vaccination 1||12||
48589594|NCT02543892|101776672|FG002|STARTED|Received Vaccination 1||12||
48589595|NCT02543892|101776673|FG003|STARTED|Received Vaccination 1||12||
48589596|NCT02543892|101776674|FG004|STARTED|Received Vaccination 1||50||
48589597|NCT02543892|101776675|FG005|STARTED|Received Vaccination 1||50||
48589598|NCT02543892|101776676|FG006|STARTED|Received Vaccination 1||50||
48589599|NCT02543892|101776677|FG007|STARTED|Received Vaccination 1||50||
48589600|NCT02543892|101776670|FG000|COMPLETED|Received Vaccination 1||12||
48589601|NCT02543892|101776671|FG001|COMPLETED|Received Vaccination 1||12||
48589602|NCT02543892|101776672|FG002|COMPLETED|Received Vaccination 1||12||
48707759|NCT02759107|102073186|FG017|COMPLETED|Overall Study||10||
48707760|NCT02759107|102073169|FG000|NOT COMPLETED|Overall Study||0||
48707761|NCT02759107|102073170|FG001|NOT COMPLETED|Overall Study||0||
48707762|NCT02759107|102073171|FG002|NOT COMPLETED|Overall Study||0||
48707763|NCT02759107|102073172|FG003|NOT COMPLETED|Overall Study||0||
48707764|NCT02759107|102073173|FG004|NOT COMPLETED|Overall Study||0||
48707765|NCT02759107|102073174|FG005|NOT COMPLETED|Overall Study||0||
48707766|NCT02759107|102073175|FG006|NOT COMPLETED|Overall Study||0||
48707767|NCT02759107|102073176|FG007|NOT COMPLETED|Overall Study||0||
48707768|NCT02759107|102073177|FG008|NOT COMPLETED|Overall Study||0||
48707769|NCT02759107|102073178|FG009|NOT COMPLETED|Overall Study||1||
48707770|NCT02759107|102073179|FG010|NOT COMPLETED|Overall Study||0||
48707771|NCT02759107|102073180|FG011|NOT COMPLETED|Overall Study||0||
48707772|NCT02759107|102073181|FG012|NOT COMPLETED|Overall Study||2||
48139536|NCT01047839|100665633|FG000|NOT COMPLETED|Overall Study||2||
48589603|NCT02543892|101776673|FG003|COMPLETED|Received Vaccination 1||12||
48589604|NCT02543892|101776674|FG004|COMPLETED|Received Vaccination 1||50||
48707773|NCT02759107|102073182|FG013|NOT COMPLETED|Overall Study||0||
48139537|NCT01047839|100665634|FG001|NOT COMPLETED|Overall Study||0||
48402797|NCT02443155|101317744|FG003|Full Analysis Set|Overall Study||77||
48402798|NCT02443155|101317741|FG000|PK Analysis Set|Overall Study||21||
48402799|NCT02443155|101317742|FG001|PK Analysis Set|Overall Study||21||
48589605|NCT02543892|101776675|FG005|COMPLETED|Received Vaccination 1||50||
48139538|NCT01047839|100665635|FG002|NOT COMPLETED|Overall Study||6||
48139539|NCT02727894|100665636|FG000|STARTED|Overall Study||73||
48402800|NCT02443155|101317743|FG002|PK Analysis Set|Overall Study||22||
48402801|NCT02443155|101317744|FG003|PK Analysis Set|Overall Study||20||
48402802|NCT02443155|101317741|FG000|Safety Analysis Set|Overall Study||77||
48402803|NCT02443155|101317742|FG001|Safety Analysis Set|Overall Study||77||
48402804|NCT02443155|101317743|FG002|Safety Analysis Set|Overall Study||76||
48402805|NCT02443155|101317744|FG003|Safety Analysis Set|Overall Study||77||
48402806|NCT02443155|101317741|FG000|COMPLETED|Overall Study||65||
48402807|NCT02443155|101317742|FG001|COMPLETED|Overall Study||63||
48402808|NCT02443155|101317743|FG002|COMPLETED|Overall Study||67||
48402809|NCT02443155|101317744|FG003|COMPLETED|Overall Study||61||
48402810|NCT02443155|101317741|FG000|NOT COMPLETED|Overall Study||12||
48402811|NCT02443155|101317742|FG001|NOT COMPLETED|Overall Study||14||
48402812|NCT02443155|101317743|FG002|NOT COMPLETED|Overall Study||9||
48402813|NCT02443155|101317744|FG003|NOT COMPLETED|Overall Study||16||
48402814|NCT05041062|101317745|FG000|STARTED|Overall Study||2||
48402815|NCT05041062|101317745|FG000|COMPLETED|Overall Study||0||
48402816|NCT05041062|101317745|FG000|NOT COMPLETED|Overall Study||2||
48402817|NCT01858597|101317746|FG000|STARTED|Overall Study||30||
48402818|NCT01858597|101317747|FG001|STARTED|Overall Study||60||
48402819|NCT01858597|101317746|FG000|COMPLETED|Overall Study||30||
48402820|NCT01858597|101317747|FG001|COMPLETED|Overall Study||60||
48402821|NCT01858597|101317746|FG000|NOT COMPLETED|Overall Study||0||
48402822|NCT01858597|101317747|FG001|NOT COMPLETED|Overall Study||0||
48402823|NCT01192100|101317748|FG000|STARTED|Overall Study||6||
48402824|NCT01192100|101317749|FG001|STARTED|Overall Study||4||
48402825|NCT01192100|101317750|FG002|STARTED|Overall Study||3||
48402826|NCT01192100|101317751|FG003|STARTED|Overall Study||4||
48402827|NCT01192100|101317752|FG004|STARTED|Overall Study||3||
48402828|NCT01192100|101317753|FG005|STARTED|Overall Study||2||
48402829|NCT01192100|101317748|FG000|Began 1st Intervention Week|Overall Study||6||
48402830|NCT01192100|101317749|FG001|Began 1st Intervention Week|Overall Study||4||
48402831|NCT01192100|101317750|FG002|Began 1st Intervention Week|Overall Study||3||
48402832|NCT01192100|101317751|FG003|Began 1st Intervention Week|Overall Study||4||
48402833|NCT01192100|101317752|FG004|Began 1st Intervention Week|Overall Study||3||
48402834|NCT01192100|101317753|FG005|Began 1st Intervention Week|Overall Study||2||
48402835|NCT01192100|101317748|FG000|Began 2nd Intervention Week|Overall Study||6||
48402836|NCT01192100|101317749|FG001|Began 2nd Intervention Week|Overall Study||4||
48402837|NCT01192100|101317750|FG002|Began 2nd Intervention Week|Overall Study||3||
48402838|NCT01192100|101317751|FG003|Began 2nd Intervention Week|Overall Study||3||
48402839|NCT01192100|101317752|FG004|Began 2nd Intervention Week|Overall Study||2||
48402840|NCT01192100|101317753|FG005|Began 2nd Intervention Week|Overall Study||2||
48402841|NCT01192100|101317748|FG000|Began 3rd Intervention Week|Overall Study||6||
48402842|NCT01192100|101317749|FG001|Began 3rd Intervention Week|Overall Study||4||
48402843|NCT01192100|101317750|FG002|Began 3rd Intervention Week|Overall Study||3||
48402844|NCT01192100|101317751|FG003|Began 3rd Intervention Week|Overall Study||3||
48589606|NCT02543892|101776676|FG006|COMPLETED|Received Vaccination 1||50||
48589607|NCT02543892|101776677|FG007|COMPLETED|Received Vaccination 1||50||
48589608|NCT02543892|101776670|FG000|NOT COMPLETED|Received Vaccination 1||0||
48589609|NCT02543892|101776671|FG001|NOT COMPLETED|Received Vaccination 1||0||
48589610|NCT02543892|101776672|FG002|NOT COMPLETED|Received Vaccination 1||0||
48589611|NCT02543892|101776673|FG003|NOT COMPLETED|Received Vaccination 1||0||
48589612|NCT02543892|101776674|FG004|NOT COMPLETED|Received Vaccination 1||0||
48589613|NCT02543892|101776675|FG005|NOT COMPLETED|Received Vaccination 1||0||
48589614|NCT02543892|101776676|FG006|NOT COMPLETED|Received Vaccination 1||0||
48589615|NCT02543892|101776677|FG007|NOT COMPLETED|Received Vaccination 1||0||
48589616|NCT02543892|101776670|FG000|STARTED|Received Vaccination 2||12||
48589617|NCT02543892|101776671|FG001|STARTED|Received Vaccination 2||12||
48402845|NCT01192100|101317752|FG004|Began 3rd Intervention Week|Overall Study||2||
48402846|NCT01192100|101317753|FG005|Began 3rd Intervention Week|Overall Study||2||
48402847|NCT01192100|101317748|FG000|COMPLETED|Overall Study||6||
48402848|NCT01192100|101317749|FG001|COMPLETED|Overall Study||4||
48589618|NCT02543892|101776672|FG002|STARTED|Received Vaccination 2||12||
48589619|NCT02543892|101776673|FG003|STARTED|Received Vaccination 2||12||
48589620|NCT02543892|101776674|FG004|STARTED|Received Vaccination 2||50||
48589621|NCT02543892|101776675|FG005|STARTED|Received Vaccination 2||50||
48589622|NCT02543892|101776676|FG006|STARTED|Received Vaccination 2||50||
48589623|NCT02543892|101776677|FG007|STARTED|Received Vaccination 2||50||
48589624|NCT02543892|101776670|FG000|COMPLETED|Received Vaccination 2||11||
48589625|NCT02543892|101776671|FG001|COMPLETED|Received Vaccination 2||11||
48139540|NCT02727894|100665637|FG001|STARTED|Overall Study||192||
48139541|NCT02727894|100665636|FG000|COMPLETED|Overall Study||73||
48402849|NCT01192100|101317750|FG002|COMPLETED|Overall Study||3||
48402850|NCT01192100|101317751|FG003|COMPLETED|Overall Study||3||
48402851|NCT01192100|101317752|FG004|COMPLETED|Overall Study||2||
48402852|NCT01192100|101317753|FG005|COMPLETED|Overall Study||2||
48402853|NCT01192100|101317748|FG000|NOT COMPLETED|Overall Study||0||
48402854|NCT01192100|101317749|FG001|NOT COMPLETED|Overall Study||0||
48402855|NCT01192100|101317750|FG002|NOT COMPLETED|Overall Study||0||
48402856|NCT01192100|101317751|FG003|NOT COMPLETED|Overall Study||1||
48589626|NCT02543892|101776672|FG002|COMPLETED|Received Vaccination 2||12||
48589627|NCT02543892|101776673|FG003|COMPLETED|Received Vaccination 2||12||
48589628|NCT02543892|101776674|FG004|COMPLETED|Received Vaccination 2||50||
48589629|NCT02543892|101776675|FG005|COMPLETED|Received Vaccination 2||49||
48589630|NCT02543892|101776676|FG006|COMPLETED|Received Vaccination 2||50||
48589631|NCT02543892|101776677|FG007|COMPLETED|Received Vaccination 2||49||
48589632|NCT02543892|101776670|FG000|NOT COMPLETED|Received Vaccination 2||1||
48589633|NCT02543892|101776671|FG001|NOT COMPLETED|Received Vaccination 2||1||
48589634|NCT02543892|101776672|FG002|NOT COMPLETED|Received Vaccination 2||0||
48589635|NCT02543892|101776673|FG003|NOT COMPLETED|Received Vaccination 2||0||
48589636|NCT02543892|101776674|FG004|NOT COMPLETED|Received Vaccination 2||0||
48589637|NCT02543892|101776675|FG005|NOT COMPLETED|Received Vaccination 2||1||
48589638|NCT02543892|101776676|FG006|NOT COMPLETED|Received Vaccination 2||0||
48589639|NCT02543892|101776677|FG007|NOT COMPLETED|Received Vaccination 2||1||
48707774|NCT02759107|102073183|FG014|NOT COMPLETED|Overall Study||0||
48707775|NCT02759107|102073184|FG015|NOT COMPLETED|Overall Study||1||
48139542|NCT02727894|100665637|FG001|COMPLETED|Overall Study||192||
48139543|NCT02727894|100665636|FG000|NOT COMPLETED|Overall Study||0||
48139544|NCT02727894|100665637|FG001|NOT COMPLETED|Overall Study||0||
48139545|NCT00808808|100665638|FG000|STARTED|Overall Study||4078||
48139546|NCT00808808|100665639|FG001|STARTED|Overall Study||3757||
48139547|NCT00808808|100665640|FG002|STARTED|Overall Study||4387||
48139548|NCT00808808|100665638|FG000|Vaccinated|Overall Study||1392||
48139549|NCT00808808|100665639|FG001|Vaccinated|Overall Study||1489||
48139550|NCT00808808|100665640|FG002|Vaccinated|Overall Study||2132||
48139551|NCT00808808|100665638|FG000|COMPLETED|Overall Study||1261||
48139552|NCT00808808|100665639|FG001|COMPLETED|Overall Study||1320||
48139553|NCT00808808|100665640|FG002|COMPLETED|Overall Study||1830||
48139554|NCT00808808|100665638|FG000|NOT COMPLETED|Overall Study||2817||
48139555|NCT00808808|100665639|FG001|NOT COMPLETED|Overall Study||2437||
48139556|NCT00808808|100665640|FG002|NOT COMPLETED|Overall Study||2557||
48139557|NCT00574080|100665641|FG000|STARTED|Overall Study||10||
48139558|NCT00574080|100665642|FG001|STARTED|Overall Study||10||
48139559|NCT00574080|100665641|FG000|COMPLETED|Overall Study||0||
48139560|NCT00574080|100665642|FG001|COMPLETED|Overall Study||0||
48139561|NCT00574080|100665641|FG000|NOT COMPLETED|Overall Study||10||
48139562|NCT00574080|100665642|FG001|NOT COMPLETED|Overall Study||10||
48139563|NCT01615731|100665643|FG000|STARTED|Overall Study||24||
48139564|NCT01615731|100665644|FG001|STARTED|Overall Study||26||
48139565|NCT01615731|100665643|FG000|COMPLETED|Overall Study||21||
48139566|NCT01615731|100665644|FG001|COMPLETED|Overall Study||24||
48139567|NCT01615731|100665643|FG000|NOT COMPLETED|Overall Study||3||
48139568|NCT01615731|100665644|FG001|NOT COMPLETED|Overall Study||2||
48139569|NCT00843167|100665645|FG000|STARTED|Treatment Period||27||
48589640|NCT02543892|101776670|FG000|STARTED|Had Immunology Data||11||
48707776|NCT02759107|102073185|FG016|NOT COMPLETED|Overall Study||0||
48707777|NCT02759107|102073186|FG017|NOT COMPLETED|Overall Study||2||
48707778|NCT03553498|102073187|FG000|STARTED|Overall Study||81||
48707779|NCT03553498|102073188|FG001|STARTED|Overall Study||81||
48707780|NCT03553498|102073187|FG000|COMPLETED|Overall Study||80||
48707781|NCT03553498|102073188|FG001|COMPLETED|Overall Study||79||
48139570|NCT00843167|100665646|FG001|STARTED|Treatment Period||27||
48139571|NCT00843167|100665645|FG000|COMPLETED|Treatment Period||24||
48139572|NCT00843167|100665646|FG001|COMPLETED|Treatment Period||19||
48139573|NCT00843167|100665645|FG000|NOT COMPLETED|Treatment Period||3||
48139574|NCT00843167|100665646|FG001|NOT COMPLETED|Treatment Period||8||
48139575|NCT00843167|100665645|FG000|STARTED|Follow-up||24||
48139576|NCT00843167|100665646|FG001|STARTED|Follow-up||24||
48139577|NCT00843167|100665645|FG000|Completed Final Visit|Follow-up||24||
48139578|NCT00843167|100665646|FG001|Completed Final Visit|Follow-up||24||
48139579|NCT00843167|100665645|FG000|COMPLETED|Follow-up||24||
48139580|NCT00843167|100665646|FG001|COMPLETED|Follow-up||24||
48139581|NCT00843167|100665645|FG000|NOT COMPLETED|Follow-up||0||
48139582|NCT00843167|100665646|FG001|NOT COMPLETED|Follow-up||0||
48139583|NCT03147248|100665647|FG000|STARTED|Overall Study||13||
48139584|NCT03147248|100665648|FG001|STARTED|Overall Study||11||
48139585|NCT03147248|100665649|FG002|STARTED|Overall Study||12||
48589641|NCT02543892|101776671|FG001|STARTED|Had Immunology Data||11||
48589642|NCT02543892|101776672|FG002|STARTED|Had Immunology Data||12||
48589643|NCT02543892|101776673|FG003|STARTED|Had Immunology Data||12||
48707782|NCT03553498|102073187|FG000|NOT COMPLETED|Overall Study||1||
48707783|NCT03553498|102073188|FG001|NOT COMPLETED|Overall Study||2||
48291925|NCT03076333|101040840|FG000|COMPLETED|Overall Study||3||
48291926|NCT03076333|101040840|FG000|NOT COMPLETED|Overall Study||0||
48291927|NCT03513588|101040841|FG000|STARTED|Overall Study||16||
48589644|NCT02543892|101776674|FG004|STARTED|Had Immunology Data||50||
48589645|NCT02543892|101776675|FG005|STARTED|Had Immunology Data||49||
48589646|NCT02543892|101776676|FG006|STARTED|Had Immunology Data||50||
48589647|NCT02543892|101776677|FG007|STARTED|Had Immunology Data||49||
48589648|NCT02543892|101776670|FG000|COMPLETED|Had Immunology Data||11||
48589649|NCT02543892|101776671|FG001|COMPLETED|Had Immunology Data||11||
48589650|NCT02543892|101776672|FG002|COMPLETED|Had Immunology Data||12||
48589651|NCT02543892|101776673|FG003|COMPLETED|Had Immunology Data||12||
48589652|NCT02543892|101776674|FG004|COMPLETED|Had Immunology Data||50||
48589653|NCT02543892|101776675|FG005|COMPLETED|Had Immunology Data||49||
48589654|NCT02543892|101776676|FG006|COMPLETED|Had Immunology Data||49||
48589655|NCT02543892|101776677|FG007|COMPLETED|Had Immunology Data||49||
48589656|NCT02543892|101776670|FG000|NOT COMPLETED|Had Immunology Data||0||
48589657|NCT02543892|101776671|FG001|NOT COMPLETED|Had Immunology Data||0||
48589658|NCT02543892|101776672|FG002|NOT COMPLETED|Had Immunology Data||0||
48589659|NCT02543892|101776673|FG003|NOT COMPLETED|Had Immunology Data||0||
48589660|NCT02543892|101776674|FG004|NOT COMPLETED|Had Immunology Data||0||
48589661|NCT02543892|101776675|FG005|NOT COMPLETED|Had Immunology Data||0||
48589662|NCT02543892|101776676|FG006|NOT COMPLETED|Had Immunology Data||1||
48589663|NCT02543892|101776677|FG007|NOT COMPLETED|Had Immunology Data||0||
48589664|NCT00937040|101776678|FG000|STARTED|Overall Study||179||
48589665|NCT00937040|101776679|FG001|STARTED|Overall Study||178||
48589666|NCT00937040|101776678|FG000|COMPLETED|Overall Study||138||
48589667|NCT00937040|101776679|FG001|COMPLETED|Overall Study||141||
48589668|NCT00937040|101776678|FG000|NOT COMPLETED|Overall Study||41||
48589669|NCT00937040|101776679|FG001|NOT COMPLETED|Overall Study||37||
48589670|NCT04450407|101776680|FG000|STARTED|Overall Study||124||
48589671|NCT04450407|101776681|FG001|STARTED|Overall Study||16||
48589672|NCT04450407|101776682|FG002|STARTED|Overall Study||126||
48589673|NCT04450407|101776680|FG000|Received at Least One Dose of Study Drug|Overall Study||123||
48589674|NCT04450407|101776681|FG001|Received at Least One Dose of Study Drug|Overall Study||16||
48589675|NCT04450407|101776682|FG002|Received at Least One Dose of Study Drug|Overall Study||126||
48589676|NCT04450407|101776680|FG000|COMPLETED|Overall Study||107||
48589677|NCT04450407|101776681|FG001|COMPLETED|Overall Study||15||
48589678|NCT04450407|101776682|FG002|COMPLETED|Overall Study||118||
48589679|NCT04450407|101776680|FG000|NOT COMPLETED|Overall Study||17||
48589680|NCT04450407|101776681|FG001|NOT COMPLETED|Overall Study||1||
48589681|NCT04450407|101776682|FG002|NOT COMPLETED|Overall Study||8||
48589682|NCT03192995|101776683|FG000|STARTED|Overall Study||16||
48589683|NCT03192995|101776684|FG001|STARTED|Overall Study||6||
48589684|NCT03192995|101776683|FG000|COMPLETED|Overall Study||16||
48589685|NCT03192995|101776684|FG001|COMPLETED|Overall Study||6||
48589686|NCT03192995|101776683|FG000|NOT COMPLETED|Overall Study||0||
48589687|NCT03192995|101776684|FG001|NOT COMPLETED|Overall Study||0||
48589688|NCT00201240|101776685|FG000|STARTED|Overall Study||47||
48589689|NCT00201240|101776685|FG000|COMPLETED|Overall Study||44||
48589690|NCT00201240|101776685|FG000|NOT COMPLETED|Overall Study||3||
48589691|NCT04743804|101776686|FG000|STARTED|Overall Study||9||
48589692|NCT04743804|101776687|FG001|STARTED|Overall Study||7||
48589693|NCT04743804|101776686|FG000|Received at Least 1 Dose of Study Drug|Overall Study||9||
48291928|NCT03513588|101040842|FG001|STARTED|Overall Study||17||
48291929|NCT03513588|101040843|FG002|STARTED|Overall Study||15||
48291930|NCT03513588|101040841|FG000|COMPLETED|Overall Study||15||
48291931|NCT03513588|101040842|FG001|COMPLETED|Overall Study||15||
48589694|NCT04743804|101776687|FG001|Received at Least 1 Dose of Study Drug|Overall Study||7||
48589695|NCT04743804|101776686|FG000|COMPLETED|Overall Study||4||
48589696|NCT04743804|101776687|FG001|COMPLETED|Overall Study||1||
48589697|NCT04743804|101776686|FG000|NOT COMPLETED|Overall Study||5||
48589698|NCT04743804|101776687|FG001|NOT COMPLETED|Overall Study||6||
48589699|NCT01854879|101776688|FG000|STARTED|Overall Study||97||
48589700|NCT01854879|101776688|FG000|COMPLETED|Overall Study||92||
48589701|NCT01854879|101776688|FG000|NOT COMPLETED|Overall Study||5||
48291932|NCT03513588|101040843|FG002|COMPLETED|Overall Study||13||
48589702|NCT03652636|101776689|FG000|STARTED|Overall Study||47||
48589703|NCT03652636|101776689|FG000|COMPLETED|Overall Study||40||
48707784|NCT00101816|102073189|FG000|STARTED|Overall Study||10||
48707785|NCT00101816|102073190|FG001|STARTED|Overall Study||99||
48707786|NCT00101816|102073189|FG000|COMPLETED|Overall Study||10||
48707787|NCT00101816|102073190|FG001|COMPLETED|Overall Study||99||
48707788|NCT00101816|102073189|FG000|NOT COMPLETED|Overall Study||0||
48589704|NCT03652636|101776689|FG000|NOT COMPLETED|Overall Study||7||
48589705|NCT00258349|101776690|FG000|STARTED|Overall Study||16||
48589706|NCT00258349|101776690|FG000|HER2-positive by Central Review|Overall Study||10||
48589707|NCT00258349|101776690|FG000|COMPLETED|Overall Study||16||
48589708|NCT00258349|101776690|FG000|NOT COMPLETED|Overall Study||0||
48589709|NCT01130519|101776691|FG000|STARTED|Overall Study||20||
48589710|NCT01130519|101776692|FG001|STARTED|Overall Study||21||
48589711|NCT01130519|101776693|FG002|STARTED|Overall Study||23||
48589712|NCT01130519|101776694|FG003|STARTED|Overall Study||19||
48589713|NCT01130519|101776691|FG000|COMPLETED|Overall Study||20||
48589714|NCT01130519|101776692|FG001|COMPLETED|Overall Study||21||
48589715|NCT01130519|101776693|FG002|COMPLETED|Overall Study||23||
48589716|NCT01130519|101776694|FG003|COMPLETED|Overall Study||19||
48589717|NCT01130519|101776691|FG000|NOT COMPLETED|Overall Study||0||
48589718|NCT01130519|101776692|FG001|NOT COMPLETED|Overall Study||0||
48589719|NCT01130519|101776693|FG002|NOT COMPLETED|Overall Study||0||
48589720|NCT01130519|101776694|FG003|NOT COMPLETED|Overall Study||0||
48589721|NCT04569968|101776695|FG000|STARTED|Overall Study||86||
48589722|NCT04569968|101776696|FG001|STARTED|Overall Study||60||
48589723|NCT04569968|101776695|FG000|COMPLETED|Overall Study||15||
48589724|NCT04569968|101776696|FG001|COMPLETED|Overall Study||16||
48589725|NCT04569968|101776695|FG000|NOT COMPLETED|Overall Study||71||
48589726|NCT04569968|101776696|FG001|NOT COMPLETED|Overall Study||44||
48589727|NCT02614222|101776697|FG000|STARTED|Overall Study||13||
48589728|NCT02614222|101776698|FG001|STARTED|Overall Study||14||
48589729|NCT02614222|101776697|FG000|COMPLETED|Overall Study||13||
48589730|NCT02614222|101776698|FG001|COMPLETED|Overall Study||14||
48589731|NCT02614222|101776697|FG000|NOT COMPLETED|Overall Study||0||
48589732|NCT02614222|101776698|FG001|NOT COMPLETED|Overall Study||0||
48589733|NCT00585013|101776699|FG000|STARTED|Overall Study||8||
48589734|NCT00585013|101776700|FG001|STARTED|Overall Study||8||
48589735|NCT00585013|101776699|FG000|COMPLETED|Overall Study||8||
48589736|NCT00585013|101776700|FG001|COMPLETED|Overall Study||8||
48589737|NCT00585013|101776699|FG000|NOT COMPLETED|Overall Study||0||
48589738|NCT00585013|101776700|FG001|NOT COMPLETED|Overall Study||0||
48589739|NCT02071706|101776701|FG000|STARTED|Overall Study||62||
48589740|NCT02071706|101776701|FG000|COMPLETED|Overall Study||59||
48589741|NCT02071706|101776701|FG000|NOT COMPLETED|Overall Study||3||
48589742|NCT00738881|101776702|FG000|STARTED|Overall Study||11||
48589743|NCT00738881|101776703|FG001|STARTED|Overall Study||12||
48589744|NCT00738881|101776702|FG000|COMPLETED|Overall Study||11||
48589745|NCT00738881|101776703|FG001|COMPLETED|Overall Study||10||
48589746|NCT00738881|101776702|FG000|NOT COMPLETED|Overall Study||0||
48589747|NCT00738881|101776703|FG001|NOT COMPLETED|Overall Study||2||
48589748|NCT00916344|101776704|FG000|STARTED|Overall Study||175||
48589749|NCT00916344|101776704|FG000|COMPLETED|Overall Study||167||
48589750|NCT00916344|101776704|FG000|NOT COMPLETED|Overall Study||8||
48589751|NCT00765895|101776705|FG000|STARTED|Overall Study||65||
48589752|NCT00765895|101776706|FG001|STARTED|Overall Study||65||
48589753|NCT00765895|101776705|FG000|COMPLETED|Overall Study||65||
48589754|NCT00765895|101776706|FG001|COMPLETED|Overall Study||65||
48707789|NCT00101816|102073190|FG001|NOT COMPLETED|Overall Study||0||
48707790|NCT05599451|102073191|FG000|STARTED|Overall Study||11||
48707791|NCT05599451|102073192|FG001|STARTED|Overall Study||19||
48707792|NCT05599451|102073193|FG002|STARTED|Overall Study||20||
48707793|NCT05599451|102073194|FG003|STARTED|Overall Study||21||
48707794|NCT05599451|102073195|FG004|STARTED|Overall Study||20||
48707795|NCT05599451|102073191|FG000|COMPLETED|Overall Study||0||
48589755|NCT00765895|101776705|FG000|NOT COMPLETED|Overall Study||0||
48589756|NCT00765895|101776706|FG001|NOT COMPLETED|Overall Study||0||
48589757|NCT03193801|101776707|FG000|STARTED|Overall Study||53||
48589758|NCT03193801|101776707|FG000|COMPLETED|Overall Study||50||
48589759|NCT03193801|101776707|FG000|NOT COMPLETED|Overall Study||3||
48707796|NCT05599451|102073192|FG001|COMPLETED|Overall Study||19||
48589760|NCT00705718|101776708|FG000|STARTED|Overall Study||44||
48589761|NCT00705718|101776709|FG001|STARTED|Overall Study||150||
48589762|NCT00705718|101776708|FG000|1 Month Follow up|Overall Study||43||
48589763|NCT00705718|101776709|FG001|1 Month Follow up|Overall Study||149||
48589764|NCT00705718|101776708|FG000|6 Month Follow up|Overall Study||40||
48707797|NCT05599451|102073193|FG002|COMPLETED|Overall Study||20||
48589765|NCT00705718|101776709|FG001|6 Month Follow up|Overall Study||143||
48589766|NCT00705718|101776708|FG000|12 Month Follow up|Overall Study||37||
48589767|NCT00705718|101776709|FG001|12 Month Follow up|Overall Study||128||
48707798|NCT05599451|102073194|FG003|COMPLETED|Overall Study||20||
48589768|NCT00705718|101776708|FG000|COMPLETED|Overall Study||37||
48589769|NCT00705718|101776709|FG001|COMPLETED|Overall Study||128||
48707799|NCT05599451|102073195|FG004|COMPLETED|Overall Study||20||
48707800|NCT05599451|102073191|FG000|NOT COMPLETED|Overall Study||11||
48707801|NCT05599451|102073192|FG001|NOT COMPLETED|Overall Study||0||
48707802|NCT05599451|102073193|FG002|NOT COMPLETED|Overall Study||0||
48707803|NCT05599451|102073194|FG003|NOT COMPLETED|Overall Study||1||
48589770|NCT00705718|101776708|FG000|NOT COMPLETED|Overall Study||7||
48589771|NCT00705718|101776709|FG001|NOT COMPLETED|Overall Study||22||
48589772|NCT00029536|101776710|FG000|STARTED|Overall Study||85||
48402857|NCT01192100|101317752|FG004|NOT COMPLETED|Overall Study||1||
48402858|NCT01192100|101317753|FG005|NOT COMPLETED|Overall Study||0||
48402859|NCT02116361|101317754|FG000|STARTED|Overall Study||69||
48589773|NCT00029536|101776711|FG001|STARTED|Overall Study||45||
48589774|NCT00029536|101776712|FG002|STARTED|Overall Study||105||
48589775|NCT00029536|101776713|FG003|STARTED|Overall Study||59||
48589776|NCT00029536|101776710|FG000|COMPLETED|Overall Study||85||
48589777|NCT00029536|101776711|FG001|COMPLETED|Overall Study||45||
48589778|NCT00029536|101776712|FG002|COMPLETED|Overall Study||105||
48589779|NCT00029536|101776713|FG003|COMPLETED|Overall Study||59||
48589780|NCT00029536|101776710|FG000|NOT COMPLETED|Overall Study||0||
48707804|NCT05599451|102073195|FG004|NOT COMPLETED|Overall Study||0||
48707805|NCT01370837|102073196|FG000|STARTED|Overall Study||12||
48707806|NCT01370837|102073197|FG001|STARTED|Overall Study||12||
48707807|NCT01370837|102073198|FG002|STARTED|Overall Study||17||
48707808|NCT01370837|102073196|FG000|COMPLETED|Overall Study||12||
48707809|NCT01370837|102073197|FG001|COMPLETED|Overall Study||12||
48707810|NCT01370837|102073198|FG002|COMPLETED|Overall Study||17||
48707811|NCT01370837|102073196|FG000|NOT COMPLETED|Overall Study||0||
48707812|NCT01370837|102073197|FG001|NOT COMPLETED|Overall Study||0||
48139586|NCT03147248|100665650|FG003|STARTED|Overall Study||12||
48139587|NCT03147248|100665651|FG004|STARTED|Overall Study||167||
48139588|NCT03147248|100665652|FG005|STARTED|Overall Study||176||
48139589|NCT03147248|100665647|FG000|COMPLETED|Overall Study||12||
48139590|NCT03147248|100665648|FG001|COMPLETED|Overall Study||9||
48139591|NCT03147248|100665649|FG002|COMPLETED|Overall Study||10||
48139592|NCT03147248|100665650|FG003|COMPLETED|Overall Study||10||
48291933|NCT03513588|101040841|FG000|NOT COMPLETED|Overall Study||1||
48291934|NCT03513588|101040842|FG001|NOT COMPLETED|Overall Study||2||
48291935|NCT03513588|101040843|FG002|NOT COMPLETED|Overall Study||2||
48291936|NCT03568331|101040844|FG000|STARTED|Overall Study||188||
48291937|NCT03568331|101040845|FG001|STARTED|Overall Study||187||
48291938|NCT03568331|101040844|FG000|COMPLETED|Overall Study||142||
48291939|NCT03568331|101040845|FG001|COMPLETED|Overall Study||144||
48291940|NCT03568331|101040844|FG000|NOT COMPLETED|Overall Study||46||
48291941|NCT03568331|101040845|FG001|NOT COMPLETED|Overall Study||43||
48291942|NCT02678247|101040846|FG000|STARTED|First Intervention (7 Weeks)||15||
48291943|NCT02678247|101040847|FG001|STARTED|First Intervention (7 Weeks)||15||
48291944|NCT02678247|101040846|FG000|COMPLETED|First Intervention (7 Weeks)||13||
48291945|NCT02678247|101040847|FG001|COMPLETED|First Intervention (7 Weeks)||11||
48291946|NCT02678247|101040846|FG000|NOT COMPLETED|First Intervention (7 Weeks)||2||
48291947|NCT02678247|101040847|FG001|NOT COMPLETED|First Intervention (7 Weeks)||4||
48402860|NCT02116361|101317755|FG001|STARTED|Overall Study||65||
48402861|NCT02116361|101317756|FG002|STARTED|Overall Study||59||
48402862|NCT02116361|101317757|FG003|STARTED|Overall Study||65||
48589781|NCT00029536|101776711|FG001|NOT COMPLETED|Overall Study||0||
48589782|NCT00029536|101776712|FG002|NOT COMPLETED|Overall Study||0||
48589783|NCT00029536|101776713|FG003|NOT COMPLETED|Overall Study||0||
48707813|NCT01370837|102073198|FG002|NOT COMPLETED|Overall Study||0||
48707814|NCT06276881|102073199|FG000|STARTED|Overall Study||75||
48707815|NCT06276881|102073199|FG000|Generating and Validating the Stimuli|Overall Study||10||
48707816|NCT06276881|102073199|FG000|Testing Medoc, Validating Thermal Responses|Overall Study||18||
48707817|NCT06276881|102073199|FG000|Testing Pain Relief (Analysis Group)|Overall Study||47||
48139593|NCT03147248|100665651|FG004|COMPLETED|Overall Study||141||
48139594|NCT03147248|100665652|FG005|COMPLETED|Overall Study||145||
48402863|NCT02116361|101317754|FG000|COMPLETED|Overall Study||38||
48402864|NCT02116361|101317755|FG001|COMPLETED|Overall Study||34||
48589784|NCT02737631|101776714|FG000|STARTED|Overall Study||222||
48589785|NCT02737631|101776714|FG000|COMPLETED|Overall Study||222||
48589786|NCT02737631|101776714|FG000|NOT COMPLETED|Overall Study||0||
48707818|NCT06276881|102073199|FG000|COMPLETED|Overall Study||75||
48139595|NCT03147248|100665647|FG000|NOT COMPLETED|Overall Study||1||
48139596|NCT03147248|100665648|FG001|NOT COMPLETED|Overall Study||2||
48139597|NCT03147248|100665649|FG002|NOT COMPLETED|Overall Study||2||
48139598|NCT03147248|100665650|FG003|NOT COMPLETED|Overall Study||2||
48139599|NCT03147248|100665651|FG004|NOT COMPLETED|Overall Study||26||
48139600|NCT03147248|100665652|FG005|NOT COMPLETED|Overall Study||31||
48139601|NCT02605954|100665653|FG000|STARTED|Overall Study||183||
48139602|NCT02605954|100665654|FG001|STARTED|Overall Study||92||
48139603|NCT02605954|100665653|FG000|COMPLETED|Overall Study||171||
48291948|NCT02678247|101040846|FG000|STARTED|Second Intervention (7 Weeks)||14||
48291949|NCT02678247|101040847|FG001|STARTED|Second Intervention (7 Weeks)||11||
48707819|NCT06276881|102073199|FG000|NOT COMPLETED|Overall Study||0||
48139604|NCT02605954|100665654|FG001|COMPLETED|Overall Study||88||
48402865|NCT02116361|101317756|FG002|COMPLETED|Overall Study||33||
48402866|NCT02116361|101317757|FG003|COMPLETED|Overall Study||34||
48402867|NCT02116361|101317754|FG000|NOT COMPLETED|Overall Study||31||
48402868|NCT02116361|101317755|FG001|NOT COMPLETED|Overall Study||31||
48402869|NCT02116361|101317756|FG002|NOT COMPLETED|Overall Study||26||
48402870|NCT02116361|101317757|FG003|NOT COMPLETED|Overall Study||31||
48402871|NCT00329784|101317758|FG000|STARTED|Overall Study||270||
48589787|NCT03660475|101776715|FG000|STARTED|Overall Study||30||
48139605|NCT02605954|100665653|FG000|NOT COMPLETED|Overall Study||12||
48139606|NCT02605954|100665654|FG001|NOT COMPLETED|Overall Study||4||
48139607|NCT03736434|100665655|FG000|STARTED|Overall Study||13||
48139608|NCT03736434|100665656|FG001|STARTED|Overall Study||13||
48589788|NCT03660475|101776716|FG001|STARTED|Overall Study||30||
48139609|NCT03736434|100665657|FG002|STARTED|Overall Study||12||
48139610|NCT03736434|100665655|FG000|COMPLETED|Overall Study||12||
48139611|NCT03736434|100665656|FG001|COMPLETED|Overall Study||13||
48139612|NCT03736434|100665657|FG002|COMPLETED|Overall Study||6||
48139613|NCT03736434|100665655|FG000|NOT COMPLETED|Overall Study||1||
48139614|NCT03736434|100665656|FG001|NOT COMPLETED|Overall Study||0||
48139615|NCT03736434|100665657|FG002|NOT COMPLETED|Overall Study||6||
48139616|NCT03069482|100665658|FG000|STARTED|Overall Study||34||
48139617|NCT03069482|100665659|FG001|STARTED|Overall Study||29||
48139618|NCT03069482|100665658|FG000|COMPLETED|Overall Study||33||
48139619|NCT03069482|100665659|FG001|COMPLETED|Overall Study||28||
48139620|NCT03069482|100665658|FG000|NOT COMPLETED|Overall Study||1||
48139621|NCT03069482|100665659|FG001|NOT COMPLETED|Overall Study||1||
48139622|NCT04323852|100665660|FG000|STARTED|Overall Study||35||
48139623|NCT04323852|100665661|FG001|STARTED|Overall Study||35||
48139624|NCT04323852|100665660|FG000|COMPLETED|Overall Study||35||
48139625|NCT04323852|100665661|FG001|COMPLETED|Overall Study||35||
48139626|NCT04323852|100665660|FG000|NOT COMPLETED|Overall Study||0||
48139627|NCT04323852|100665661|FG001|NOT COMPLETED|Overall Study||0||
48139628|NCT04899349|100665662|FG000|STARTED|Overall Study||2||
48139629|NCT04899349|100665663|FG001|STARTED|Overall Study||0||
48139630|NCT04899349|100665662|FG000|COMPLETED|Overall Study||0||
48139631|NCT04899349|100665663|FG001|COMPLETED|Overall Study||0||
48402872|NCT00329784|101317759|FG001|STARTED|Overall Study||272||
48402873|NCT00329784|101317760|FG002|STARTED|Overall Study||51||
48402874|NCT00329784|101317761|FG003|STARTED|Overall Study||47||
48589789|NCT03660475|101776715|FG000|COMPLETED|Overall Study||30||
48589790|NCT03660475|101776716|FG001|COMPLETED|Overall Study||30||
48589791|NCT03660475|101776715|FG000|NOT COMPLETED|Overall Study||0||
48402875|NCT00329784|101317758|FG000|COMPLETED|Overall Study||265||
48402876|NCT00329784|101317759|FG001|COMPLETED|Overall Study||267||
48589792|NCT03660475|101776716|FG001|NOT COMPLETED|Overall Study||0||
48139632|NCT04899349|100665662|FG000|NOT COMPLETED|Overall Study||2||
48139633|NCT04899349|100665663|FG001|NOT COMPLETED|Overall Study||0||
48139634|NCT00167544|100665664|FG000|STARTED|Overall Study||31||
48139635|NCT00167544|100665665|FG001|STARTED|Overall Study||33||
48139636|NCT00167544|100665664|FG000|COMPLETED|Overall Study||30||
48139637|NCT00167544|100665665|FG001|COMPLETED|Overall Study||33||
48139638|NCT00167544|100665664|FG000|NOT COMPLETED|Overall Study||1||
48291950|NCT02678247|101040846|FG000|COMPLETED|Second Intervention (7 Weeks)||10||
48291951|NCT02678247|101040847|FG001|COMPLETED|Second Intervention (7 Weeks)||9||
48402877|NCT00329784|101317760|FG002|COMPLETED|Overall Study||51||
48402878|NCT00329784|101317761|FG003|COMPLETED|Overall Study||47||
48402879|NCT00329784|101317758|FG000|NOT COMPLETED|Overall Study||5||
48402880|NCT00329784|101317759|FG001|NOT COMPLETED|Overall Study||5||
48402881|NCT00329784|101317760|FG002|NOT COMPLETED|Overall Study||0||
48402882|NCT00329784|101317761|FG003|NOT COMPLETED|Overall Study||0||
48402883|NCT00398138|101317762|FG000|STARTED|Overall Study||12||
48589793|NCT00381238|101776717|FG000|STARTED|Overall Study||33||
48139639|NCT00167544|100665665|FG001|NOT COMPLETED|Overall Study||0||
48139640|NCT01763931|100665666|FG000|STARTED|Overall Study||2||
48139641|NCT01763931|100665667|FG001|STARTED|Overall Study||4||
48139642|NCT01763931|100665666|FG000|COMPLETED|Overall Study||2||
48139643|NCT01763931|100665667|FG001|COMPLETED|Overall Study||3||
48139644|NCT01763931|100665666|FG000|NOT COMPLETED|Overall Study||0||
48139645|NCT01763931|100665667|FG001|NOT COMPLETED|Overall Study||1||
48139646|NCT02576067|100665668|FG000|STARTED|Overall Study||60||
48139647|NCT02576067|100665669|FG001|STARTED|Overall Study||63||
48139648|NCT02576067|100665668|FG000|COMPLETED|Overall Study||26||
48139649|NCT02576067|100665669|FG001|COMPLETED|Overall Study||27||
48139650|NCT02576067|100665668|FG000|NOT COMPLETED|Overall Study||34||
48139651|NCT02576067|100665669|FG001|NOT COMPLETED|Overall Study||36||
48139652|NCT02734212|100665670|FG000|STARTED|Overall Study||29||
48139653|NCT02734212|100665671|FG001|STARTED|Overall Study||28||
48139654|NCT02734212|100665670|FG000|COMPLETED|Overall Study||24||
48589794|NCT00381238|101776717|FG000|COMPLETED|Overall Study||21||
48139655|NCT02734212|100665671|FG001|COMPLETED|Overall Study||18||
48139656|NCT02734212|100665670|FG000|NOT COMPLETED|Overall Study||5||
48139657|NCT02734212|100665671|FG001|NOT COMPLETED|Overall Study||10||
48139658|NCT01134900|100665672|FG000|STARTED|Overall Study||200||
48589795|NCT00381238|101776717|FG000|NOT COMPLETED|Overall Study||12||
48589796|NCT01253668|101776718|FG000|STARTED|Overall Study||0|The study was terminated, and the PI has left the institution. Despite all possible efforts to contact the PI/study team members, no data are available to be reported.|
48589797|NCT01253668|101776718|FG000|COMPLETED|Overall Study||0|The study was terminated, and the PI has left the institution. Despite all possible efforts to contact the PI/study team members, no data are available to be reported|
48589798|NCT01253668|101776718|FG000|NOT COMPLETED|Overall Study||0||
48589799|NCT00811317|101776719|FG000|STARTED|Overall Study||11||
48589800|NCT00811317|101776719|FG000|COMPLETED|Overall Study||11||
48589801|NCT00811317|101776719|FG000|NOT COMPLETED|Overall Study||0||
48589802|NCT01173055|101776720|FG000|STARTED|Period 1 - Day 1 to 49||10||
48589803|NCT01173055|101776721|FG001|STARTED|Period 1 - Day 1 to 49||12||
48589804|NCT01173055|101776720|FG000|COMPLETED|Period 1 - Day 1 to 49||8||
48707820|NCT03258281|102073200|FG000|STARTED|Overall Study||3||
48707821|NCT03258281|102073201|FG001|STARTED|Overall Study||1||
48707822|NCT03258281|102073200|FG000|COMPLETED|Overall Study||3||
48707823|NCT03258281|102073201|FG001|COMPLETED|Overall Study||1||
48707824|NCT03258281|102073200|FG000|NOT COMPLETED|Overall Study||0||
48707825|NCT03258281|102073201|FG001|NOT COMPLETED|Overall Study||0||
48707826|NCT03315104|102073202|FG000|STARTED|Overall Study||21||
48707827|NCT03315104|102073203|FG001|STARTED|Overall Study||20||
48707828|NCT03315104|102073204|FG002|STARTED|Overall Study||24||
48707829|NCT03315104|102073202|FG000|Dosed (Safety Population)|Overall Study||19||
48707830|NCT03315104|102073203|FG001|Dosed (Safety Population)|Overall Study||19||
48707831|NCT03315104|102073204|FG002|Dosed (Safety Population)|Overall Study||22||
48707832|NCT03315104|102073202|FG000|COMPLETED|Overall Study||18||
48139659|NCT01134900|100665673|FG001|STARTED|Overall Study||196||
48139660|NCT01134900|100665672|FG000|COMPLETED|Overall Study||200||
48139661|NCT01134900|100665673|FG001|COMPLETED|Overall Study||196||
48139662|NCT01134900|100665672|FG000|NOT COMPLETED|Overall Study||0||
48139663|NCT01134900|100665673|FG001|NOT COMPLETED|Overall Study||0||
48139664|NCT02587351|100665674|FG000|STARTED|Overall Study||268||
48707833|NCT03315104|102073203|FG001|COMPLETED|Overall Study||16||
48139665|NCT02587351|100665675|FG001|STARTED|Overall Study||264||
48139666|NCT02587351|100665674|FG000|COMPLETED|Overall Study||268||
48402884|NCT00398138|101317762|FG000|COMPLETED|Overall Study||10||
48402885|NCT00398138|101317762|FG000|NOT COMPLETED|Overall Study||2||
48402886|NCT00937326|101317763|FG000|STARTED|Overall Study||46||
48402887|NCT00937326|101317764|FG001|STARTED|Overall Study||45||
48402888|NCT00937326|101317765|FG002|STARTED|Overall Study||46||
48589805|NCT01173055|101776721|FG001|COMPLETED|Period 1 - Day 1 to 49||10||
48589806|NCT01173055|101776720|FG000|NOT COMPLETED|Period 1 - Day 1 to 49||2||
48589807|NCT01173055|101776721|FG001|NOT COMPLETED|Period 1 - Day 1 to 49||2||
48139667|NCT02587351|100665675|FG001|COMPLETED|Overall Study||264||
48139668|NCT02587351|100665674|FG000|NOT COMPLETED|Overall Study||0||
48139669|NCT02587351|100665675|FG001|NOT COMPLETED|Overall Study||0||
48139670|NCT02477618|100665676|FG000|STARTED|Overall Study||65||
48139671|NCT02477618|100665677|FG001|STARTED|Overall Study||67||
48139672|NCT02477618|100665676|FG000|Intent-to-Treat Analysis Set|Overall Study||66||
48139673|NCT02477618|100665677|FG001|Intent-to-Treat Analysis Set|Overall Study||66||
48139674|NCT02477618|100665676|FG000|COMPLETED|Overall Study||50|Participants who completed both study drug and study visits.|
48139675|NCT02477618|100665677|FG001|COMPLETED|Overall Study||53|Participants who completed both study drug and study visits.|
48139676|NCT02477618|100665676|FG000|NOT COMPLETED|Overall Study||15||
48139677|NCT02477618|100665677|FG001|NOT COMPLETED|Overall Study||14||
48139678|NCT06281548|100665678|FG000|STARTED|Overall Study||30||
48139679|NCT06281548|100665678|FG000|COMPLETED|Overall Study||27||
48139680|NCT06281548|100665678|FG000|NOT COMPLETED|Overall Study||3||
48402889|NCT00937326|101317766|FG003|STARTED|Overall Study||45||
48402890|NCT00937326|101317767|FG004|STARTED|Overall Study||45||
48402891|NCT00937326|101317763|FG000|COMPLETED|Overall Study||43||
48589808|NCT01173055|101776720|FG000|STARTED|Placebo Washout Period - Day 50 to 63||8||
48139681|NCT00996996|100665679|FG000|STARTED|Overall Study||77||
48139682|NCT00996996|100665679|FG000|COMPLETED|Overall Study||44||
48139683|NCT00996996|100665679|FG000|NOT COMPLETED|Overall Study||33||
48139684|NCT01507220|100665680|FG000|STARTED|Overall Study||2||
48139685|NCT01507220|100665681|FG001|STARTED|Overall Study||0||
48139686|NCT01507220|100665680|FG000|COMPLETED|Overall Study||2||
48139687|NCT01507220|100665681|FG001|COMPLETED|Overall Study||0||
48139688|NCT01507220|100665680|FG000|NOT COMPLETED|Overall Study||0||
48139689|NCT01507220|100665681|FG001|NOT COMPLETED|Overall Study||0||
48139690|NCT02235493|100665682|FG000|STARTED|Overall Study||6||
48139691|NCT02235493|100665682|FG000|COMPLETED|Overall Study||6||
48139692|NCT02235493|100665682|FG000|NOT COMPLETED|Overall Study||0||
48139693|NCT03732209|100665683|FG000|STARTED|Overall Study||20||
48139694|NCT03732209|100665684|FG001|STARTED|Overall Study||23||
48139695|NCT03732209|100665683|FG000|COMPLETED|Overall Study||8||
48139696|NCT03732209|100665684|FG001|COMPLETED|Overall Study||10||
48139697|NCT03732209|100665683|FG000|NOT COMPLETED|Overall Study||12||
48139698|NCT03732209|100665684|FG001|NOT COMPLETED|Overall Study||13||
48139699|NCT02672111|100665685|FG000|STARTED|Overall Study||190||
48139700|NCT02672111|100665686|FG001|STARTED|Overall Study||37||
48139701|NCT02672111|100665685|FG000|Completed Treatment|Overall Study||138||
48139702|NCT02672111|100665686|FG001|Completed Treatment|Overall Study||29||
48139703|NCT02672111|100665685|FG000|COMPLETED|Overall Study||132||
48139704|NCT02672111|100665686|FG001|COMPLETED|Overall Study||25||
48139705|NCT02672111|100665685|FG000|NOT COMPLETED|Overall Study||58||
48139706|NCT02672111|100665686|FG001|NOT COMPLETED|Overall Study||12||
48139707|NCT01618838|100665687|FG000|STARTED|Overall Study||4||
48139708|NCT01618838|100665687|FG000|COMPLETED|Overall Study||0||
48402892|NCT00937326|101317764|FG001|COMPLETED|Overall Study||38||
48402893|NCT00937326|101317765|FG002|COMPLETED|Overall Study||42||
48402894|NCT00937326|101317766|FG003|COMPLETED|Overall Study||40||
48402895|NCT00937326|101317767|FG004|COMPLETED|Overall Study||40||
48402896|NCT00937326|101317763|FG000|NOT COMPLETED|Overall Study||3||
48139709|NCT01618838|100665687|FG000|NOT COMPLETED|Overall Study||4||
48139710|NCT01292603|100665688|FG000|STARTED|Part 1: Pilot Dose Selection Period||16||
48139711|NCT01292603|100665689|FG001|STARTED|Part 1: Pilot Dose Selection Period||17||
48139712|NCT01292603|100665690|FG002|STARTED|Part 1: Pilot Dose Selection Period||23||
48139713|NCT01292603|100665691|FG003|STARTED|Part 1: Pilot Dose Selection Period||8||
48139714|NCT01292603|100665692|FG004|STARTED|Part 1: Pilot Dose Selection Period||0||
48139715|NCT01292603|100665693|FG005|STARTED|Part 1: Pilot Dose Selection Period||0||
48139716|NCT01292603|100665688|FG000|COMPLETED|Part 1: Pilot Dose Selection Period||16||
48139717|NCT01292603|100665689|FG001|COMPLETED|Part 1: Pilot Dose Selection Period||17||
48139718|NCT01292603|100665690|FG002|COMPLETED|Part 1: Pilot Dose Selection Period||23||
48139719|NCT01292603|100665691|FG003|COMPLETED|Part 1: Pilot Dose Selection Period||0||
48139720|NCT01292603|100665692|FG004|COMPLETED|Part 1: Pilot Dose Selection Period||0||
48139721|NCT01292603|100665693|FG005|COMPLETED|Part 1: Pilot Dose Selection Period||0||
48139722|NCT01292603|100665688|FG000|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0||
48139723|NCT01292603|100665689|FG001|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0||
48139724|NCT01292603|100665690|FG002|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0||
48139725|NCT01292603|100665691|FG003|NOT COMPLETED|Part 1: Pilot Dose Selection Period||8||
48139726|NCT01292603|100665692|FG004|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0||
48139727|NCT01292603|100665693|FG005|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0||
48139728|NCT01292603|100665688|FG000|STARTED|Part 1: Regular Follow-Up Period||16||
48291952|NCT02678247|101040846|FG000|NOT COMPLETED|Second Intervention (7 Weeks)||4||
48291953|NCT02678247|101040847|FG001|NOT COMPLETED|Second Intervention (7 Weeks)||2||
48291954|NCT02270515|101040848|FG000|STARTED|Intervention Period 1: 0-6 Months||175||
48291955|NCT02270515|101040848|FG000|COMPLETED|Intervention Period 1: 0-6 Months||159||
48291956|NCT02270515|101040848|FG000|NOT COMPLETED|Intervention Period 1: 0-6 Months||16||
48291957|NCT02270515|101040848|FG000|STARTED|Intervention Period 2: 6-12 Months||159||
48402897|NCT00937326|101317764|FG001|NOT COMPLETED|Overall Study||7||
48402898|NCT00937326|101317765|FG002|NOT COMPLETED|Overall Study||4||
48291958|NCT02270515|101040848|FG000|COMPLETED|Intervention Period 2: 6-12 Months||127||
48291959|NCT02270515|101040848|FG000|NOT COMPLETED|Intervention Period 2: 6-12 Months||32||
48291960|NCT02270515|101040848|FG000|STARTED|Intervention Period 3: 12-18 Months||127||
48291961|NCT02270515|101040848|FG000|COMPLETED|Intervention Period 3: 12-18 Months||103||
48291962|NCT02270515|101040848|FG000|NOT COMPLETED|Intervention Period 3: 12-18 Months||24||
48291963|NCT01689337|101040849|FG000|STARTED|Overall Study||1||
48291964|NCT01689337|101040849|FG000|COMPLETED|Overall Study||0||
48291965|NCT01689337|101040849|FG000|NOT COMPLETED|Overall Study||1||
48291966|NCT04256629|101040850|FG000|STARTED|Overall Study||4||
48291967|NCT04256629|101040851|FG001|STARTED|Overall Study||4||
48291968|NCT04256629|101040852|FG002|STARTED|Overall Study||4||
48291969|NCT04256629|101040853|FG003|STARTED|Overall Study||4||
48291970|NCT04256629|101040854|FG004|STARTED|Overall Study||4||
48291971|NCT04256629|101040855|FG005|STARTED|Overall Study||4||
48291972|NCT04256629|101040850|FG000|COMPLETED|Overall Study||4||
48291973|NCT04256629|101040851|FG001|COMPLETED|Overall Study||3||
48291974|NCT04256629|101040852|FG002|COMPLETED|Overall Study||4||
48291975|NCT04256629|101040853|FG003|COMPLETED|Overall Study||4||
48402899|NCT00937326|101317766|FG003|NOT COMPLETED|Overall Study||5||
48402900|NCT00937326|101317767|FG004|NOT COMPLETED|Overall Study||5||
48402901|NCT00845507|101317768|FG000|STARTED|Overall Study||24||
48402902|NCT00845507|101317769|FG001|STARTED|Overall Study||30||
48291976|NCT04256629|101040854|FG004|COMPLETED|Overall Study||4||
48291977|NCT04256629|101040855|FG005|COMPLETED|Overall Study||3||
48291978|NCT04256629|101040850|FG000|NOT COMPLETED|Overall Study||0||
48291979|NCT04256629|101040851|FG001|NOT COMPLETED|Overall Study||1||
48291980|NCT04256629|101040852|FG002|NOT COMPLETED|Overall Study||0||
48291981|NCT04256629|101040853|FG003|NOT COMPLETED|Overall Study||0||
48291982|NCT04256629|101040854|FG004|NOT COMPLETED|Overall Study||0||
48291983|NCT04256629|101040855|FG005|NOT COMPLETED|Overall Study||1||
48291984|NCT01614197|101040856|FG000|STARTED|Overall Study||3||
48291985|NCT01614197|101040857|FG001|STARTED|Overall Study||4||
48402903|NCT00845507|101317768|FG000|COMPLETED|Overall Study||22||
48402904|NCT00845507|101317769|FG001|COMPLETED|Overall Study||29||
48402905|NCT00845507|101317768|FG000|NOT COMPLETED|Overall Study||2||
48402906|NCT00845507|101317769|FG001|NOT COMPLETED|Overall Study||1||
48291986|NCT01614197|101040858|FG002|STARTED|Overall Study||6||
48291987|NCT01614197|101040859|FG003|STARTED|Overall Study||3||
48291988|NCT01614197|101040856|FG000|COMPLETED|Overall Study||3||
48291989|NCT01614197|101040857|FG001|COMPLETED|Overall Study||3||
48291990|NCT01614197|101040858|FG002|COMPLETED|Overall Study||6||
48291991|NCT01614197|101040859|FG003|COMPLETED|Overall Study||3||
48291992|NCT01614197|101040856|FG000|NOT COMPLETED|Overall Study||0||
48291993|NCT01614197|101040857|FG001|NOT COMPLETED|Overall Study||1||
48291994|NCT01614197|101040858|FG002|NOT COMPLETED|Overall Study||0||
48589809|NCT01173055|101776721|FG001|STARTED|Placebo Washout Period - Day 50 to 63||10||
48589810|NCT01173055|101776720|FG000|COMPLETED|Placebo Washout Period - Day 50 to 63||8||
48589811|NCT01173055|101776721|FG001|COMPLETED|Placebo Washout Period - Day 50 to 63||10||
48589812|NCT01173055|101776720|FG000|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0||
48589813|NCT01173055|101776721|FG001|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0||
48589814|NCT01173055|101776720|FG000|STARTED|Period 2 - Day 64 to 112||8||
48589815|NCT01173055|101776721|FG001|STARTED|Period 2 - Day 64 to 112||10||
48589816|NCT01173055|101776720|FG000|COMPLETED|Period 2 - Day 64 to 112||8||
48589817|NCT01173055|101776721|FG001|COMPLETED|Period 2 - Day 64 to 112||9||
48589818|NCT01173055|101776720|FG000|NOT COMPLETED|Period 2 - Day 64 to 112||0||
48707834|NCT03315104|102073204|FG002|COMPLETED|Overall Study||19||
48707835|NCT03315104|102073202|FG000|NOT COMPLETED|Overall Study||3||
48707836|NCT03315104|102073203|FG001|NOT COMPLETED|Overall Study||4||
48707837|NCT03315104|102073204|FG002|NOT COMPLETED|Overall Study||5||
48707838|NCT00521599|102073205|FG000|STARTED|Overall Study||268||
48707839|NCT00521599|102073206|FG001|STARTED|Overall Study||268||
48707840|NCT00521599|102073207|FG002|STARTED|Overall Study||136||
48707841|NCT00521599|102073205|FG000|COMPLETED|Overall Study||243||
48707842|NCT00521599|102073206|FG001|COMPLETED|Overall Study||239||
48707843|NCT00521599|102073207|FG002|COMPLETED|Overall Study||100||
48707844|NCT00521599|102073205|FG000|NOT COMPLETED|Overall Study||25||
48707845|NCT00521599|102073206|FG001|NOT COMPLETED|Overall Study||29||
48707846|NCT00521599|102073207|FG002|NOT COMPLETED|Overall Study||36||
48707847|NCT01757561|102073208|FG000|STARTED|Overall Study||38||
48707848|NCT01757561|102073209|FG001|STARTED|Overall Study||34||
48707849|NCT01757561|102073210|FG002|STARTED|Overall Study||38||
48707850|NCT01757561|102073211|FG003|STARTED|Overall Study||34||
48707851|NCT01757561|102073208|FG000|COMPLETED|Overall Study||32||
48707852|NCT01757561|102073209|FG001|COMPLETED|Overall Study||28||
48707853|NCT01757561|102073210|FG002|COMPLETED|Overall Study||31||
48707854|NCT01757561|102073211|FG003|COMPLETED|Overall Study||25||
48707855|NCT01757561|102073208|FG000|NOT COMPLETED|Overall Study||6||
48707856|NCT01757561|102073209|FG001|NOT COMPLETED|Overall Study||6||
48707857|NCT01757561|102073210|FG002|NOT COMPLETED|Overall Study||7||
48707858|NCT01757561|102073211|FG003|NOT COMPLETED|Overall Study||9||
48707859|NCT00230282|102073212|FG000|STARTED|Fludarabine + Cyclophosphamide||25||
48707860|NCT00230282|102073212|FG000|COMPLETED|Fludarabine + Cyclophosphamide||17||
48707861|NCT00230282|102073212|FG000|NOT COMPLETED|Fludarabine + Cyclophosphamide||8||
48707862|NCT00230282|102073212|FG000|STARTED|Maintanence Therapy With Alemtuzumab||17||
48707863|NCT00230282|102073212|FG000|COMPLETED|Maintanence Therapy With Alemtuzumab||17||
48707864|NCT00230282|102073212|FG000|NOT COMPLETED|Maintanence Therapy With Alemtuzumab||0||
48707865|NCT02083705|102073213|FG000|STARTED|Overall Study||5||
48707866|NCT02083705|102073214|FG001|STARTED|Overall Study||4||
48707867|NCT02083705|102073213|FG000|COMPLETED|Overall Study||5||
48707868|NCT02083705|102073214|FG001|COMPLETED|Overall Study||4||
48707869|NCT02083705|102073213|FG000|NOT COMPLETED|Overall Study||0||
48707870|NCT02083705|102073214|FG001|NOT COMPLETED|Overall Study||0||
48707871|NCT03826173|102073215|FG000|STARTED|Overall Study||13||
48707872|NCT03826173|102073216|FG001|STARTED|Overall Study||30||
48707873|NCT03826173|102073217|FG002|STARTED|Overall Study||11||
48707874|NCT03826173|102073215|FG000|COMPLETED|Overall Study||12||
48707875|NCT03826173|102073216|FG001|COMPLETED|Overall Study||27||
48707876|NCT03826173|102073217|FG002|COMPLETED|Overall Study||6||
48707877|NCT03826173|102073215|FG000|NOT COMPLETED|Overall Study||1||
48589819|NCT01173055|101776721|FG001|NOT COMPLETED|Period 2 - Day 64 to 112||1||
48707878|NCT03826173|102073216|FG001|NOT COMPLETED|Overall Study||3||
48707879|NCT03826173|102073217|FG002|NOT COMPLETED|Overall Study||5||
48707880|NCT03304054|102073218|FG000|STARTED|Overall Study||27||
48707881|NCT03304054|102073219|FG001|STARTED|Overall Study||7||
48707882|NCT03304054|102073220|FG002|STARTED|Overall Study||28||
48589820|NCT00710684|101776722|FG000|STARTED|Overall Study||225||
48707883|NCT03304054|102073221|FG003|STARTED|Overall Study||8||
48707884|NCT03304054|102073222|FG004|STARTED|Overall Study||17||
48707885|NCT03304054|102073223|FG005|STARTED|Overall Study||6||
48707886|NCT03304054|102073218|FG000|COMPLETED|Overall Study||27||
48707887|NCT03304054|102073219|FG001|COMPLETED|Overall Study||7||
48707888|NCT03304054|102073220|FG002|COMPLETED|Overall Study||27||
48707889|NCT03304054|102073221|FG003|COMPLETED|Overall Study||8||
48707890|NCT03304054|102073222|FG004|COMPLETED|Overall Study||0||
48291995|NCT01614197|101040859|FG003|NOT COMPLETED|Overall Study||0||
48291996|NCT01809002|101040860|FG000|STARTED|Overall Study||112||
48291997|NCT01809002|101040861|FG001|STARTED|Overall Study||108||
48291998|NCT01809002|101040860|FG000|COMPLETED|Overall Study||91||
48291999|NCT01809002|101040861|FG001|COMPLETED|Overall Study||92||
48292000|NCT01809002|101040860|FG000|NOT COMPLETED|Overall Study||21||
48292001|NCT01809002|101040861|FG001|NOT COMPLETED|Overall Study||16||
48292002|NCT00116337|101040862|FG000|STARTED|Overall Study||17||
48292003|NCT00116337|101040862|FG000|COMPLETED|Overall Study||17||
48292004|NCT00116337|101040862|FG000|NOT COMPLETED|Overall Study||0||
48402907|NCT00809055|101317770|FG000|STARTED|Overall Study||37||
48402908|NCT00809055|101317771|FG001|STARTED|Overall Study||37||
48402909|NCT00809055|101317770|FG000|COMPLETED|Overall Study||28||
48402910|NCT00809055|101317771|FG001|COMPLETED|Overall Study||30||
48402911|NCT00809055|101317770|FG000|NOT COMPLETED|Overall Study||9||
48402912|NCT00809055|101317771|FG001|NOT COMPLETED|Overall Study||7||
48402913|NCT00047853|101317772|FG000|STARTED|Overall Study Participants||921||
48292005|NCT02076178|101040863|FG000|STARTED|Oral Phase||21||
48292006|NCT02076178|101040864|FG001|STARTED|Oral Phase||106||
48402914|NCT00047853|101317773|FG001|STARTED|Overall Study Participants||142||
48402915|NCT00047853|101317772|FG000|COMPLETED|Overall Study Participants||921||
48402916|NCT00047853|101317773|FG001|COMPLETED|Overall Study Participants||142||
48402917|NCT00047853|101317772|FG000|NOT COMPLETED|Overall Study Participants||0||
48402918|NCT00047853|101317773|FG001|NOT COMPLETED|Overall Study Participants||0||
48402919|NCT00047853|101317772|FG000|STARTED|Perception Study||396||
48402920|NCT00047853|101317773|FG001|STARTED|Perception Study||4||
48402921|NCT00047853|101317772|FG000|COMPLETED|Perception Study||396||
48402922|NCT00047853|101317773|FG001|COMPLETED|Perception Study||4||
48402923|NCT00047853|101317772|FG000|NOT COMPLETED|Perception Study||0||
48402924|NCT00047853|101317773|FG001|NOT COMPLETED|Perception Study||0||
48402925|NCT00047853|101317772|FG000|STARTED|Memory Study||165||
48402926|NCT00047853|101317773|FG001|STARTED|Memory Study||50||
48292007|NCT02076178|101040863|FG000|COMPLETED|Oral Phase||21||
48292008|NCT02076178|101040864|FG001|COMPLETED|Oral Phase||94||
48292009|NCT02076178|101040863|FG000|NOT COMPLETED|Oral Phase||0||
48292010|NCT02076178|101040864|FG001|NOT COMPLETED|Oral Phase||12||
48292011|NCT02076178|101040863|FG000|STARTED|Injection Phase||21||
48292012|NCT02076178|101040864|FG001|STARTED|Injection Phase||94||
48292013|NCT02076178|101040863|FG000|COMPLETED|Injection Phase||20||
48292014|NCT02076178|101040864|FG001|COMPLETED|Injection Phase||87||
48292015|NCT02076178|101040863|FG000|NOT COMPLETED|Injection Phase||1||
48402927|NCT00047853|101317772|FG000|COMPLETED|Memory Study||165||
48402928|NCT00047853|101317773|FG001|COMPLETED|Memory Study||50||
48402929|NCT00047853|101317772|FG000|NOT COMPLETED|Memory Study||0||
48402930|NCT00047853|101317773|FG001|NOT COMPLETED|Memory Study||0||
48402931|NCT00047853|101317772|FG000|STARTED|Resting State Study||218||
48402932|NCT00047853|101317773|FG001|STARTED|Resting State Study||57||
48402933|NCT00047853|101317772|FG000|COMPLETED|Resting State Study||218||
48402934|NCT00047853|101317773|FG001|COMPLETED|Resting State Study||57||
48402935|NCT00047853|101317772|FG000|NOT COMPLETED|Resting State Study||0||
48402936|NCT00047853|101317773|FG001|NOT COMPLETED|Resting State Study||0||
48402937|NCT00047853|101317772|FG000|STARTED|Passive Presentation Study||57||
48402938|NCT00047853|101317773|FG001|STARTED|Passive Presentation Study||0||
48402939|NCT00047853|101317772|FG000|COMPLETED|Passive Presentation Study||57||
48402940|NCT00047853|101317773|FG001|COMPLETED|Passive Presentation Study||0||
48402941|NCT00047853|101317772|FG000|NOT COMPLETED|Passive Presentation Study||0||
48402942|NCT00047853|101317773|FG001|NOT COMPLETED|Passive Presentation Study||0||
48402943|NCT00047853|101317772|FG000|STARTED|Loss Aversion Task||14||
48402944|NCT00047853|101317773|FG001|STARTED|Loss Aversion Task||22||
48292016|NCT02076178|101040864|FG001|NOT COMPLETED|Injection Phase||7||
48292017|NCT01839487|101040865|FG000|STARTED|Run-in Phase (Maximum Exposure:295 Days)||16||
48292018|NCT01839487|101040866|FG001|STARTED|Run-in Phase (Maximum Exposure:295 Days)||7||
48402945|NCT00047853|101317772|FG000|COMPLETED|Loss Aversion Task||14||
48402946|NCT00047853|101317773|FG001|COMPLETED|Loss Aversion Task||22||
48402947|NCT00047853|101317772|FG000|NOT COMPLETED|Loss Aversion Task||0||
48292019|NCT01839487|101040867|FG002|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0||
48292020|NCT01839487|101040868|FG003|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0||
48292021|NCT01839487|101040869|FG004|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0||
48292022|NCT01839487|101040870|FG005|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0||
48402948|NCT00047853|101317773|FG001|NOT COMPLETED|Loss Aversion Task||0||
48402949|NCT00047853|101317772|FG000|STARTED|Motivation Task||264||
48402950|NCT00047853|101317773|FG001|STARTED|Motivation Task||37||
48402951|NCT00047853|101317772|FG000|COMPLETED|Motivation Task||264||
48402952|NCT00047853|101317773|FG001|COMPLETED|Motivation Task||37||
48402953|NCT00047853|101317772|FG000|NOT COMPLETED|Motivation Task||0||
48402954|NCT00047853|101317773|FG001|NOT COMPLETED|Motivation Task||0||
48402955|NCT00047853|101317772|FG000|STARTED|Valence/Salience Study (ValSal Task)||118||
48402956|NCT00047853|101317773|FG001|STARTED|Valence/Salience Study (ValSal Task)||32||
48402957|NCT00047853|101317772|FG000|COMPLETED|Valence/Salience Study (ValSal Task)||118||
48402958|NCT00047853|101317773|FG001|COMPLETED|Valence/Salience Study (ValSal Task)||32||
48402959|NCT00047853|101317772|FG000|NOT COMPLETED|Valence/Salience Study (ValSal Task)||0||
48402960|NCT00047853|101317773|FG001|NOT COMPLETED|Valence/Salience Study (ValSal Task)||0||
48402961|NCT00047853|101317772|FG000|STARTED|Active Avoidance and Sustained Attention||162||
48402962|NCT00047853|101317773|FG001|STARTED|Active Avoidance and Sustained Attention||58||
48402963|NCT00047853|101317772|FG000|COMPLETED|Active Avoidance and Sustained Attention||162||
48402964|NCT00047853|101317773|FG001|COMPLETED|Active Avoidance and Sustained Attention||58||
48402965|NCT00047853|101317772|FG000|NOT COMPLETED|Active Avoidance and Sustained Attention||0||
48402966|NCT00047853|101317773|FG001|NOT COMPLETED|Active Avoidance and Sustained Attention||0||
48402967|NCT00420342|101317774|FG000|STARTED|Overall Study||30||
48402968|NCT00420342|101317775|FG001|STARTED|Overall Study||33||
48402969|NCT00420342|101317776|FG002|STARTED|Overall Study||29||
48402970|NCT00420342|101317774|FG000|Received Treatment|Overall Study||29||
48402971|NCT00420342|101317775|FG001|Received Treatment|Overall Study||32||
48402972|NCT00420342|101317776|FG002|Received Treatment|Overall Study||29||
48402973|NCT00420342|101317774|FG000|COMPLETED|Overall Study||29||
48402974|NCT00420342|101317775|FG001|COMPLETED|Overall Study||31||
48402975|NCT00420342|101317776|FG002|COMPLETED|Overall Study||28||
48292023|NCT01839487|101040865|FG000|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0||
48707891|NCT03304054|102073223|FG005|COMPLETED|Overall Study||0||
48707892|NCT03304054|102073218|FG000|NOT COMPLETED|Overall Study||0||
48707893|NCT03304054|102073219|FG001|NOT COMPLETED|Overall Study||0||
48707894|NCT03304054|102073220|FG002|NOT COMPLETED|Overall Study||1||
48707895|NCT03304054|102073221|FG003|NOT COMPLETED|Overall Study||0||
48707896|NCT03304054|102073222|FG004|NOT COMPLETED|Overall Study||17||
48707897|NCT03304054|102073223|FG005|NOT COMPLETED|Overall Study||6||
48707898|NCT01921218|102073224|FG000|STARTED|Overall Study||6||
48707899|NCT01921218|102073225|FG001|STARTED|Overall Study||7||
48707900|NCT01921218|102073224|FG000|COMPLETED|Overall Study||3||
48707901|NCT01921218|102073225|FG001|COMPLETED|Overall Study||3||
48707902|NCT01921218|102073224|FG000|NOT COMPLETED|Overall Study||3||
48707903|NCT01921218|102073225|FG001|NOT COMPLETED|Overall Study||4||
48707904|NCT01352741|102073226|FG000|STARTED|Open-label Tapentadol Titration Period||445||
48707905|NCT01352741|102073227|FG001|STARTED|Open-label Tapentadol Titration Period||0||
48292024|NCT01839487|101040866|FG001|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0||
48292025|NCT01839487|101040867|FG002|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0||
48292026|NCT01839487|101040868|FG003|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0||
48292027|NCT01839487|101040869|FG004|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0||
48292028|NCT01839487|101040870|FG005|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0||
48292029|NCT01839487|101040865|FG000|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||16||
48292030|NCT01839487|101040866|FG001|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||7||
48292031|NCT01839487|101040867|FG002|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0||
48292032|NCT01839487|101040868|FG003|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0||
48292033|NCT01839487|101040869|FG004|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0||
48292034|NCT01839487|101040870|FG005|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0||
48707906|NCT01352741|102073226|FG000|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||59||
48707907|NCT01352741|102073227|FG001|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||0||
48707908|NCT01352741|102073226|FG000|Full Analysis Set|Open-label Tapentadol Titration Period||436||
48707909|NCT01352741|102073227|FG001|Full Analysis Set|Open-label Tapentadol Titration Period||0||
48292035|NCT01839487|101040865|FG000|STARTED|Phase 2 (Maximum Exposure:935 Days)||0||
48292036|NCT01839487|101040866|FG001|STARTED|Phase 2 (Maximum Exposure:935 Days)||0||
48292037|NCT01839487|101040867|FG002|STARTED|Phase 2 (Maximum Exposure:935 Days)||61||
48292038|NCT01839487|101040868|FG003|STARTED|Phase 2 (Maximum Exposure:935 Days)||62||
48292039|NCT01839487|101040869|FG004|STARTED|Phase 2 (Maximum Exposure:935 Days)||89||
48292040|NCT01839487|101040870|FG005|STARTED|Phase 2 (Maximum Exposure:935 Days)||44||
48292041|NCT01839487|101040865|FG000|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0||
48292042|NCT01839487|101040866|FG001|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0||
48292043|NCT01839487|101040867|FG002|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0||
48292044|NCT01839487|101040868|FG003|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0||
48292045|NCT01839487|101040869|FG004|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||1||
48292046|NCT01839487|101040870|FG005|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0||
48292047|NCT01839487|101040865|FG000|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0||
48707910|NCT01352741|102073226|FG000|COMPLETED|Open-label Tapentadol Titration Period||372||
48292048|NCT01839487|101040866|FG001|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0||
48292049|NCT01839487|101040867|FG002|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||61||
48292050|NCT01839487|101040868|FG003|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||62||
48292051|NCT01839487|101040869|FG004|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||88||
48707911|NCT01352741|102073227|FG001|COMPLETED|Open-label Tapentadol Titration Period||0||
48707912|NCT01352741|102073226|FG000|NOT COMPLETED|Open-label Tapentadol Titration Period||73||
48707913|NCT01352741|102073227|FG001|NOT COMPLETED|Open-label Tapentadol Titration Period||0||
48707914|NCT01352741|102073226|FG000|STARTED|Double-blind Comparative Period||154||
48707915|NCT01352741|102073227|FG001|STARTED|Double-blind Comparative Period||159||
48707916|NCT01352741|102073226|FG000|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||19||
48707917|NCT01352741|102073227|FG001|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||18||
48707918|NCT01352741|102073226|FG000|No Pain Assessments Available|Double-blind Comparative Period||2||
48707919|NCT01352741|102073227|FG001|No Pain Assessments Available|Double-blind Comparative Period||2||
48707920|NCT01352741|102073226|FG000|Full Analysis Set|Double-blind Comparative Period||152||
48707921|NCT01352741|102073227|FG001|Full Analysis Set|Double-blind Comparative Period||157||
48707922|NCT01352741|102073226|FG000|Major Protocol Deviations|Double-blind Comparative Period||13||
48707923|NCT01352741|102073227|FG001|Major Protocol Deviations|Double-blind Comparative Period||8||
48707924|NCT01352741|102073226|FG000|Per Protocol Set|Double-blind Comparative Period||139||
48292052|NCT01839487|101040870|FG005|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||44||
48292053|NCT04175626|101040871|FG000|STARTED|Overall Study||556||
48707925|NCT01352741|102073227|FG001|Per Protocol Set|Double-blind Comparative Period||149||
48707926|NCT01352741|102073226|FG000|painDetect Per Protocol Set|Double-blind Comparative Period||109||
48707927|NCT01352741|102073227|FG001|painDetect Per Protocol Set|Double-blind Comparative Period||127||
48707928|NCT01352741|102073226|FG000|SF-12 Per Protocol Set|Double-blind Comparative Period||131||
48707929|NCT01352741|102073227|FG001|SF-12 Per Protocol Set|Double-blind Comparative Period||143||
48707930|NCT01352741|102073226|FG000|EQ-5D Per Protocol Set|Double-blind Comparative Period||131||
48707931|NCT01352741|102073227|FG001|EQ-5D Per Protocol Set|Double-blind Comparative Period||143||
48707932|NCT01352741|102073226|FG000|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||123||
48707933|NCT01352741|102073227|FG001|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||137||
48707934|NCT01352741|102073226|FG000|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||123||
48707935|NCT01352741|102073227|FG001|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||137||
48707936|NCT01352741|102073226|FG000|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||123||
48707937|NCT01352741|102073227|FG001|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||137||
48292054|NCT04175626|101040871|FG000|COMPLETED|Overall Study||531|All subjects included in analysis through 360 days post index procedure.|
48292055|NCT04175626|101040871|FG000|NOT COMPLETED|Overall Study||25||
48402976|NCT00420342|101317774|FG000|NOT COMPLETED|Overall Study||1||
48707938|NCT01352741|102073226|FG000|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||123||
48707939|NCT01352741|102073227|FG001|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||137||
48707940|NCT01352741|102073226|FG000|COMPLETED|Double-blind Comparative Period||126||
48707941|NCT01352741|102073227|FG001|COMPLETED|Double-blind Comparative Period||133||
48707942|NCT01352741|102073226|FG000|NOT COMPLETED|Double-blind Comparative Period||28||
48707943|NCT01352741|102073227|FG001|NOT COMPLETED|Double-blind Comparative Period||26||
48707944|NCT01352741|102073226|FG000|STARTED|Open-Label Tapentadol Continuation Arm||59||
48707945|NCT01352741|102073227|FG001|STARTED|Open-Label Tapentadol Continuation Arm||0||
48707946|NCT01352741|102073226|FG000|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||2||
48707947|NCT01352741|102073227|FG001|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||0||
48707948|NCT01352741|102073226|FG000|Full Analysis Set|Open-Label Tapentadol Continuation Arm||57||
48707949|NCT01352741|102073227|FG001|Full Analysis Set|Open-Label Tapentadol Continuation Arm||0||
48707950|NCT01352741|102073226|FG000|COMPLETED|Open-Label Tapentadol Continuation Arm||51||
48707951|NCT01352741|102073227|FG001|COMPLETED|Open-Label Tapentadol Continuation Arm||0||
48707952|NCT01352741|102073226|FG000|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||8||
48707953|NCT01352741|102073227|FG001|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||0||
48707954|NCT01352741|102073226|FG000|STARTED|Open-Label Tapentadol Pick-Up Arm||37||
48707955|NCT01352741|102073227|FG001|STARTED|Open-Label Tapentadol Pick-Up Arm||0||
48707956|NCT01352741|102073226|FG000|COMPLETED|Open-Label Tapentadol Pick-Up Arm||37||
48707957|NCT01352741|102073227|FG001|COMPLETED|Open-Label Tapentadol Pick-Up Arm||0||
48707958|NCT01352741|102073226|FG000|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0||
48707959|NCT01352741|102073227|FG001|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0||
48707960|NCT00866047|102073228|FG000|STARTED|Treatment Period||58||
48292056|NCT02240693|101044222|FG000|STARTED|Overall Study||22||
48292057|NCT02240693|101044223|FG001|STARTED|Overall Study||21||
48292058|NCT02240693|101044224|FG002|STARTED|Overall Study||21||
48707961|NCT00866047|102073228|FG000|COMPLETED|Treatment Period||10||
48707962|NCT00866047|102073228|FG000|NOT COMPLETED|Treatment Period||48||
48707963|NCT00866047|102073228|FG000|STARTED|Follow-up Period||58||
48292059|NCT02240693|101044225|FG003|STARTED|Overall Study||21||
48292060|NCT02240693|101044226|FG004|STARTED|Overall Study||43||
48292061|NCT02240693|101044222|FG000|COMPLETED|Overall Study||22||
48292062|NCT02240693|101044223|FG001|COMPLETED|Overall Study||21||
48292063|NCT02240693|101044224|FG002|COMPLETED|Overall Study||17||
48292064|NCT02240693|101044225|FG003|COMPLETED|Overall Study||20||
48292065|NCT02240693|101044226|FG004|COMPLETED|Overall Study||42||
48292066|NCT02240693|101044222|FG000|NOT COMPLETED|Overall Study||0||
48292067|NCT02240693|101044223|FG001|NOT COMPLETED|Overall Study||0||
48292068|NCT02240693|101044224|FG002|NOT COMPLETED|Overall Study||4||
48292069|NCT02240693|101044225|FG003|NOT COMPLETED|Overall Study||1||
48292070|NCT02240693|101044226|FG004|NOT COMPLETED|Overall Study||1||
48292071|NCT03482583|101044227|FG000|STARTED|Overall Study||37||
48292072|NCT03482583|101044228|FG001|STARTED|Overall Study||14||
48292073|NCT03482583|101044229|FG002|STARTED|Overall Study||39||
48292074|NCT03482583|101044227|FG000|COMPLETED|Overall Study||12||
48292075|NCT03482583|101044228|FG001|COMPLETED|Overall Study||5||
48292076|NCT03482583|101044229|FG002|COMPLETED|Overall Study||18||
48292077|NCT03482583|101044227|FG000|NOT COMPLETED|Overall Study||25||
48292078|NCT03482583|101044228|FG001|NOT COMPLETED|Overall Study||9||
48292079|NCT03482583|101044229|FG002|NOT COMPLETED|Overall Study||21||
48292080|NCT02943226|101044230|FG000|STARTED|Overall Study||31||
48292081|NCT02943226|101044231|FG001|STARTED|Overall Study||30||
48292082|NCT02943226|101044230|FG000|COMPLETED|Overall Study||31||
48292083|NCT02943226|101044231|FG001|COMPLETED|Overall Study||30||
48292084|NCT02943226|101044230|FG000|NOT COMPLETED|Overall Study||0||
48292085|NCT02943226|101044231|FG001|NOT COMPLETED|Overall Study||0||
48292086|NCT03809429|101044232|FG000|STARTED|Overall Study||220|The number covers the number of randomized participants.|
48292087|NCT03809429|101044233|FG001|STARTED|Overall Study||215|The number covers the number of randomized participants.|
48292088|NCT03809429|101044232|FG000|COMPLETED|Overall Study||192||
48292089|NCT03809429|101044233|FG001|COMPLETED|Overall Study||195||
48292090|NCT03809429|101044232|FG000|NOT COMPLETED|Overall Study||28||
48292091|NCT03809429|101044233|FG001|NOT COMPLETED|Overall Study||20||
48292092|NCT03008707|101044234|FG000|STARTED|Overall Study||28||
48292093|NCT03008707|101044235|FG001|STARTED|Overall Study||38||
48292094|NCT03008707|101044234|FG000|COMPLETED|Overall Study||28||
48292095|NCT03008707|101044235|FG001|COMPLETED|Overall Study||38||
48292096|NCT03008707|101044234|FG000|NOT COMPLETED|Overall Study||0||
48292097|NCT03008707|101044235|FG001|NOT COMPLETED|Overall Study||0||
48292098|NCT04461483|101044236|FG000|STARTED|Part 1 (Day 1)||6||
48292099|NCT04461483|101044237|FG001|STARTED|Part 1 (Day 1)||6||
48292100|NCT04461483|101044238|FG002|STARTED|Part 1 (Day 1)||6||
48292101|NCT04461483|101044239|FG003|STARTED|Part 1 (Day 1)||6||
48292102|NCT04461483|101044240|FG004|STARTED|Part 1 (Day 1)||0||
48292103|NCT04461483|101044241|FG005|STARTED|Part 1 (Day 1)||0||
48292104|NCT04461483|101044236|FG000|COMPLETED|Part 1 (Day 1)||6||
48292105|NCT04461483|101044237|FG001|COMPLETED|Part 1 (Day 1)||6||
48292106|NCT04461483|101044238|FG002|COMPLETED|Part 1 (Day 1)||6||
48292107|NCT04461483|101044239|FG003|COMPLETED|Part 1 (Day 1)||6||
48292108|NCT04461483|101044240|FG004|COMPLETED|Part 1 (Day 1)||0||
48292109|NCT04461483|101044241|FG005|COMPLETED|Part 1 (Day 1)||0||
48292110|NCT04461483|101044236|FG000|NOT COMPLETED|Part 1 (Day 1)||0||
48292111|NCT04461483|101044237|FG001|NOT COMPLETED|Part 1 (Day 1)||0||
48292112|NCT04461483|101044238|FG002|NOT COMPLETED|Part 1 (Day 1)||0||
48292113|NCT04461483|101044239|FG003|NOT COMPLETED|Part 1 (Day 1)||0||
48292114|NCT04461483|101044240|FG004|NOT COMPLETED|Part 1 (Day 1)||0||
48707964|NCT00866047|102073228|FG000|COMPLETED|Follow-up Period||53||
48707965|NCT00866047|102073228|FG000|NOT COMPLETED|Follow-up Period||5||
48707966|NCT01571284|102073229|FG000|STARTED|Overall Study||781||
48707967|NCT01571284|102073229|FG000|Safety Population|Overall Study||779|Participants who signed informed consent form and received at least part of one dose of treatment.|
48707968|NCT01571284|102073229|FG000|COMPLETED|Overall Study||612||
48292115|NCT04461483|101044241|FG005|NOT COMPLETED|Part 1 (Day 1)||0||
48292116|NCT04461483|101044236|FG000|STARTED|Part 2 (Day 1 to 21)||0||
48292117|NCT04461483|101044237|FG001|STARTED|Part 2 (Day 1 to 21)||0||
48292118|NCT04461483|101044238|FG002|STARTED|Part 2 (Day 1 to 21)||0||
48707969|NCT01571284|102073229|FG000|NOT COMPLETED|Overall Study||169||
48707970|NCT00896363|102073230|FG000|STARTED|Overall Study||31||
48292119|NCT04461483|101044239|FG003|STARTED|Part 2 (Day 1 to 21)||0||
48292120|NCT04461483|101044240|FG004|STARTED|Part 2 (Day 1 to 21)||3||
48292121|NCT04461483|101044241|FG005|STARTED|Part 2 (Day 1 to 21)||6||
48292122|NCT04461483|101044236|FG000|COMPLETED|Part 2 (Day 1 to 21)||0||
48292123|NCT04461483|101044237|FG001|COMPLETED|Part 2 (Day 1 to 21)||0||
48292124|NCT04461483|101044238|FG002|COMPLETED|Part 2 (Day 1 to 21)||0||
48292125|NCT04461483|101044239|FG003|COMPLETED|Part 2 (Day 1 to 21)||0||
48292126|NCT04461483|101044240|FG004|COMPLETED|Part 2 (Day 1 to 21)||3||
48292127|NCT04461483|101044241|FG005|COMPLETED|Part 2 (Day 1 to 21)||6||
48292128|NCT04461483|101044236|FG000|NOT COMPLETED|Part 2 (Day 1 to 21)||0||
48292129|NCT04461483|101044237|FG001|NOT COMPLETED|Part 2 (Day 1 to 21)||0||
48292130|NCT04461483|101044238|FG002|NOT COMPLETED|Part 2 (Day 1 to 21)||0||
48292131|NCT04461483|101044239|FG003|NOT COMPLETED|Part 2 (Day 1 to 21)||0||
48292132|NCT04461483|101044240|FG004|NOT COMPLETED|Part 2 (Day 1 to 21)||0||
48292133|NCT04461483|101044241|FG005|NOT COMPLETED|Part 2 (Day 1 to 21)||0||
48292134|NCT04464954|101044242|FG000|STARTED|Overall Study||10||
48292135|NCT04464954|101044243|FG001|STARTED|Overall Study||10||
48292136|NCT04464954|101044244|FG002|STARTED|Overall Study||10||
48292137|NCT04464954|101044242|FG000|COMPLETED|Overall Study||10||
48292138|NCT04464954|101044243|FG001|COMPLETED|Overall Study||10||
48292139|NCT04464954|101044244|FG002|COMPLETED|Overall Study||10||
48292140|NCT04464954|101044242|FG000|NOT COMPLETED|Overall Study||0||
48292141|NCT04464954|101044243|FG001|NOT COMPLETED|Overall Study||0||
48292142|NCT04464954|101044244|FG002|NOT COMPLETED|Overall Study||0||
48292143|NCT02057523|101044245|FG000|STARTED|Overall Study||2||
48292144|NCT02057523|101044245|FG000|COMPLETED|Overall Study||0||
48292145|NCT02057523|101044245|FG000|NOT COMPLETED|Overall Study||2||
48292146|NCT00235547|101044246|FG000|STARTED|2 Month Follow-up Survey||154||
48589821|NCT00710684|101776723|FG001|STARTED|Overall Study||221||
48589822|NCT00710684|101776724|FG002|STARTED|Overall Study||236||
48707971|NCT00896363|102073231|FG001|STARTED|Overall Study||36||
48707972|NCT00896363|102073232|FG002|STARTED|Overall Study||32||
48707973|NCT00896363|102073230|FG000|COMPLETED|Overall Study||25||
48589823|NCT00710684|101776722|FG000|COMPLETED|Overall Study||151||
48589824|NCT00710684|101776723|FG001|COMPLETED|Overall Study||147||
48589825|NCT00710684|101776724|FG002|COMPLETED|Overall Study||172||
48589826|NCT00710684|101776722|FG000|NOT COMPLETED|Overall Study||74||
48589827|NCT00710684|101776723|FG001|NOT COMPLETED|Overall Study||74||
48589828|NCT00710684|101776724|FG002|NOT COMPLETED|Overall Study||64||
48707974|NCT00896363|102073231|FG001|COMPLETED|Overall Study||25||
48707975|NCT00896363|102073232|FG002|COMPLETED|Overall Study||24||
48707976|NCT00896363|102073230|FG000|NOT COMPLETED|Overall Study||6||
48707977|NCT00896363|102073231|FG001|NOT COMPLETED|Overall Study||11||
48707978|NCT00896363|102073232|FG002|NOT COMPLETED|Overall Study||8||
48589829|NCT00278148|101776725|FG000|STARTED|Phase I - Dose Escalation||4||
48292147|NCT00235547|101044247|FG001|STARTED|2 Month Follow-up Survey||144||
48707979|NCT01779869|102073233|FG000|STARTED|Overall Study||16||
48589830|NCT00278148|101776726|FG001|STARTED|Phase I - Dose Escalation||2||
48707980|NCT01779869|102073233|FG000|COMPLETED|Overall Study||14||
48707981|NCT01779869|102073233|FG000|NOT COMPLETED|Overall Study||2||
48707982|NCT01327053|102073234|FG000|STARTED|Overall Study||79||
48402977|NCT00420342|101317775|FG001|NOT COMPLETED|Overall Study||2||
48589831|NCT00278148|101776727|FG002|STARTED|Phase I - Dose Escalation||3||
48707983|NCT01327053|102073235|FG001|STARTED|Overall Study||151||
48707984|NCT01327053|102073234|FG000|Untreated|Overall Study||0||
48589832|NCT00278148|101776725|FG000|COMPLETED|Phase I - Dose Escalation||4||
48589833|NCT00278148|101776726|FG001|COMPLETED|Phase I - Dose Escalation||2||
48589834|NCT00278148|101776727|FG002|COMPLETED|Phase I - Dose Escalation||3||
48589835|NCT00278148|101776725|FG000|NOT COMPLETED|Phase I - Dose Escalation||0||
48589836|NCT00278148|101776726|FG001|NOT COMPLETED|Phase I - Dose Escalation||0||
48589837|NCT00278148|101776727|FG002|NOT COMPLETED|Phase I - Dose Escalation||0||
48589838|NCT00278148|101776725|FG000|STARTED|Phase II - Expansion Phase||0||
48589839|NCT00278148|101776726|FG001|STARTED|Phase II - Expansion Phase||0||
48589840|NCT00278148|101776727|FG002|STARTED|Phase II - Expansion Phase||26||
48589841|NCT00278148|101776725|FG000|COMPLETED|Phase II - Expansion Phase||0||
48589842|NCT00278148|101776726|FG001|COMPLETED|Phase II - Expansion Phase||0||
48589843|NCT00278148|101776727|FG002|COMPLETED|Phase II - Expansion Phase||20||
48589844|NCT00278148|101776725|FG000|NOT COMPLETED|Phase II - Expansion Phase||0||
48589845|NCT00278148|101776726|FG001|NOT COMPLETED|Phase II - Expansion Phase||0||
48589846|NCT00278148|101776727|FG002|NOT COMPLETED|Phase II - Expansion Phase||6||
48589847|NCT03634033|101776728|FG000|STARTED|Overall Study||3497||9
48589848|NCT03634033|101776729|FG001|STARTED|Overall Study||3533||9
48589849|NCT03634033|101776730|FG002|STARTED|Overall Study||282||9
48589850|NCT03634033|101776731|FG003|STARTED|Overall Study||257||9
48589851|NCT03634033|101776732|FG004|STARTED|Overall Study||106||3
48589852|NCT03634033|101776733|FG005|STARTED|Overall Study||50||3
48589853|NCT03634033|101776734|FG006|STARTED|Overall Study||52||3
48589854|NCT03634033|101776728|FG000|COMPLETED|Overall Study||3113||9
48589855|NCT03634033|101776729|FG001|COMPLETED|Overall Study||3242||9
48402978|NCT00420342|101317776|FG002|NOT COMPLETED|Overall Study||1||
48402979|NCT02001688|101317777|FG000|STARTED|Overall Study||12||
48402980|NCT02001688|101317778|FG001|STARTED|Overall Study||12||
48402981|NCT02001688|101317779|FG002|STARTED|Overall Study||12||
48402982|NCT02001688|101317777|FG000|COMPLETED|Overall Study||12||
48402983|NCT02001688|101317778|FG001|COMPLETED|Overall Study||11||
48402984|NCT02001688|101317779|FG002|COMPLETED|Overall Study||11||
48402985|NCT02001688|101317777|FG000|NOT COMPLETED|Overall Study||0||
48402986|NCT02001688|101317778|FG001|NOT COMPLETED|Overall Study||1||
48589856|NCT03634033|101776730|FG002|COMPLETED|Overall Study||168||9
48589857|NCT03634033|101776731|FG003|COMPLETED|Overall Study||96||9
48589858|NCT03634033|101776732|FG004|COMPLETED|Overall Study||101||3
48589859|NCT03634033|101776733|FG005|COMPLETED|Overall Study||37||3
48589860|NCT03634033|101776734|FG006|COMPLETED|Overall Study||37||3
48589861|NCT03634033|101776728|FG000|NOT COMPLETED|Overall Study||384||0
48589862|NCT03634033|101776729|FG001|NOT COMPLETED|Overall Study||291||0
48589863|NCT03634033|101776730|FG002|NOT COMPLETED|Overall Study||114||0
48589864|NCT03634033|101776731|FG003|NOT COMPLETED|Overall Study||161||0
48589865|NCT03634033|101776732|FG004|NOT COMPLETED|Overall Study||5||0
48589866|NCT03634033|101776733|FG005|NOT COMPLETED|Overall Study||13||0
48589867|NCT03634033|101776734|FG006|NOT COMPLETED|Overall Study||15||0
48589868|NCT00972816|101776735|FG000|STARTED|Overall Study||173||
48589869|NCT00972816|101776736|FG001|STARTED|Overall Study||169||
48589870|NCT00972816|101776737|FG002|STARTED|Overall Study||169||
48589871|NCT00972816|101776738|FG003|STARTED|Overall Study||169||
48589872|NCT00972816|101776739|FG004|STARTED|Overall Study||169||
48589873|NCT00972816|101776740|FG005|STARTED|Overall Study||169||
48589874|NCT00972816|101776741|FG006|STARTED|Overall Study||169||
48589875|NCT00972816|101776742|FG007|STARTED|Overall Study||170||
48589876|NCT00972816|101776735|FG000|COMPLETED|Overall Study||156||
48589877|NCT00972816|101776736|FG001|COMPLETED|Overall Study||158||
48589878|NCT00972816|101776737|FG002|COMPLETED|Overall Study||160||
48589879|NCT00972816|101776738|FG003|COMPLETED|Overall Study||161||
48589880|NCT00972816|101776739|FG004|COMPLETED|Overall Study||157||
48589881|NCT00972816|101776740|FG005|COMPLETED|Overall Study||158||
48589882|NCT00972816|101776741|FG006|COMPLETED|Overall Study||159||
48589883|NCT00972816|101776742|FG007|COMPLETED|Overall Study||161||
48589884|NCT00972816|101776735|FG000|NOT COMPLETED|Overall Study||17||
48589885|NCT00972816|101776736|FG001|NOT COMPLETED|Overall Study||11||
48589886|NCT00972816|101776737|FG002|NOT COMPLETED|Overall Study||9||
48589887|NCT00972816|101776738|FG003|NOT COMPLETED|Overall Study||8||
48589888|NCT00972816|101776739|FG004|NOT COMPLETED|Overall Study||12||
48589889|NCT00972816|101776740|FG005|NOT COMPLETED|Overall Study||11||
48589890|NCT00972816|101776741|FG006|NOT COMPLETED|Overall Study||10||
48589891|NCT00972816|101776742|FG007|NOT COMPLETED|Overall Study||9||
48589892|NCT03320850|101776743|FG000|STARTED|Overall Study||18||
48707985|NCT01327053|102073235|FG001|Untreated|Overall Study||1||
48707986|NCT01327053|102073234|FG000|Patients Cont. to Next Phase of Trial|Overall Study||52||
48707987|NCT01327053|102073235|FG001|Patients Cont. to Next Phase of Trial|Overall Study||89||
48707988|NCT01327053|102073234|FG000|Survival Follow-up|Overall Study||33||
48707989|NCT01327053|102073235|FG001|Survival Follow-up|Overall Study||49||
48707990|NCT01327053|102073234|FG000|Post-treatment Follow-up|Overall Study||19||
48707991|NCT01327053|102073235|FG001|Post-treatment Follow-up|Overall Study||40||
48707992|NCT01327053|102073234|FG000|COMPLETED|Overall Study||0||
48707993|NCT01327053|102073235|FG001|COMPLETED|Overall Study||0||
48707994|NCT01327053|102073234|FG000|NOT COMPLETED|Overall Study||79||
48707995|NCT01327053|102073235|FG001|NOT COMPLETED|Overall Study||151||
48707996|NCT01080768|102073236|FG000|STARTED|Overall Study||14||
48707997|NCT01080768|102073237|FG001|STARTED|Overall Study||17||
48707998|NCT01080768|102073236|FG000|COMPLETED|Overall Study||12||
48707999|NCT01080768|102073237|FG001|COMPLETED|Overall Study||16||
48708000|NCT01080768|102073236|FG000|NOT COMPLETED|Overall Study||2||
48708001|NCT01080768|102073237|FG001|NOT COMPLETED|Overall Study||1||
48708002|NCT02229214|102073238|FG000|STARTED|Overall Study||41||
48708003|NCT02229214|102073239|FG001|STARTED|Overall Study||10||
48708004|NCT02229214|102073238|FG000|COMPLETED|Overall Study||35||
48708005|NCT02229214|102073239|FG001|COMPLETED|Overall Study||10||
48708006|NCT02229214|102073238|FG000|NOT COMPLETED|Overall Study||6||
48708007|NCT02229214|102073239|FG001|NOT COMPLETED|Overall Study||0||
48708008|NCT02509039|102073240|FG000|STARTED|Overall Study||3||
48708009|NCT02509039|102073241|FG001|STARTED|Overall Study||3||
48708010|NCT02509039|102073242|FG002|STARTED|Overall Study||3||
48708011|NCT02509039|102073243|FG003|STARTED|Overall Study||6||
48708012|NCT02509039|102073240|FG000|COMPLETED|Overall Study||0||
48708013|NCT02509039|102073241|FG001|COMPLETED|Overall Study||0||
48708014|NCT02509039|102073242|FG002|COMPLETED|Overall Study||0||
48708015|NCT02509039|102073243|FG003|COMPLETED|Overall Study||0||
48708016|NCT02509039|102073240|FG000|NOT COMPLETED|Overall Study||3||
48708017|NCT02509039|102073241|FG001|NOT COMPLETED|Overall Study||3||
48708018|NCT02509039|102073242|FG002|NOT COMPLETED|Overall Study||3||
48708019|NCT02509039|102073243|FG003|NOT COMPLETED|Overall Study||6||
48708020|NCT04508751|102073244|FG000|STARTED|Overall Study||10||
48708021|NCT04508751|102073245|FG001|STARTED|Overall Study||5||
48708022|NCT04508751|102073246|FG002|STARTED|Overall Study||7||
48589893|NCT03320850|101776744|FG001|STARTED|Overall Study||12||
48589894|NCT03320850|101776745|FG002|STARTED|Overall Study||18||
48589895|NCT03320850|101776746|FG003|STARTED|Overall Study||22||
48589896|NCT03320850|101776747|FG004|STARTED|Overall Study||19||
48589897|NCT03320850|101776748|FG005|STARTED|Overall Study||58||
48589898|NCT03320850|101776749|FG006|STARTED|Overall Study||57||
48589899|NCT03320850|101776750|FG007|STARTED|Overall Study||60||
48589900|NCT03320850|101776751|FG008|STARTED|Overall Study||60||
48589901|NCT03320850|101776752|FG009|STARTED|Overall Study||59||
48589902|NCT03320850|101776743|FG000|Safety Population|Overall Study||18|Safety Population included all participants enrolled in this study who received the study treatment in Stage 1 and Stage 2.|
48589903|NCT03320850|101776744|FG001|Safety Population|Overall Study||12|Safety Population included all participants enrolled in this study who received the study treatment in Stage 1 and Stage 2.|
48589904|NCT03320850|101776745|FG002|Safety Population|Overall Study||18|Safety Population included all participants enrolled in this study who received the study treatment in Stage 1 and Stage 2.|
48592850|NCT02059434|101786328|FG003|STARTED|Period 1 (After Screening/run-in Period)||2||
48589905|NCT03320850|101776746|FG003|Safety Population|Overall Study||22|Safety Population included all participants enrolled in this study who received the study treatment in Stage 1 and Stage 2.|
48589906|NCT03320850|101776747|FG004|Safety Population|Overall Study||19|Safety Population included all participants enrolled in this study who received the study treatment in Stage 1 and Stage 2.|
48589907|NCT03320850|101776748|FG005|Safety Population|Overall Study||57|Safety Population included all participants enrolled in this study who received the study treatment in Stage 1 and Stage 2.|
48589908|NCT03320850|101776749|FG006|Safety Population|Overall Study||57|Safety Population included all participants enrolled in this study who received the study treatment in Stage 1 and Stage 2.|
48589909|NCT03320850|101776750|FG007|Safety Population|Overall Study||60|Safety Population included all participants enrolled in this study who received the study treatment in Stage 1 and Stage 2.|
48589910|NCT03320850|101776751|FG008|Safety Population|Overall Study||60|Safety Population included all participants enrolled in this study who received the study treatment in Stage 1 and Stage 2.|
48589911|NCT03320850|101776752|FG009|Safety Population|Overall Study||58|Safety Population included all participants enrolled in this study who received the study treatment in Stage 1 and Stage 2.|
48589912|NCT03320850|101776743|FG000|COMPLETED|Overall Study||18||
48589913|NCT03320850|101776744|FG001|COMPLETED|Overall Study||12||
48589914|NCT03320850|101776745|FG002|COMPLETED|Overall Study||18||
48708023|NCT04508751|102073244|FG000|COMPLETED|Overall Study||10||
48708024|NCT04508751|102073245|FG001|COMPLETED|Overall Study||5||
48589915|NCT03320850|101776746|FG003|COMPLETED|Overall Study||21||
48589916|NCT03320850|101776747|FG004|COMPLETED|Overall Study||17||
48589917|NCT03320850|101776748|FG005|COMPLETED|Overall Study||49||
48589918|NCT03320850|101776749|FG006|COMPLETED|Overall Study||50||
48589919|NCT03320850|101776750|FG007|COMPLETED|Overall Study||53||
48589920|NCT03320850|101776751|FG008|COMPLETED|Overall Study||50||
48589921|NCT03320850|101776752|FG009|COMPLETED|Overall Study||50||
48589922|NCT03320850|101776743|FG000|NOT COMPLETED|Overall Study||0||
48589923|NCT03320850|101776744|FG001|NOT COMPLETED|Overall Study||0||
48708025|NCT04508751|102073246|FG002|COMPLETED|Overall Study||5||
48708026|NCT04508751|102073244|FG000|NOT COMPLETED|Overall Study||0||
48708027|NCT04508751|102073245|FG001|NOT COMPLETED|Overall Study||0||
48708028|NCT04508751|102073246|FG002|NOT COMPLETED|Overall Study||2||
48708029|NCT02240368|102073247|FG000|STARTED|Overall Study||9||
48708030|NCT02240368|102073248|FG001|STARTED|Overall Study||22||
48708031|NCT02240368|102073249|FG002|STARTED|Overall Study||19||
48708032|NCT02240368|102073247|FG000|COMPLETED|Overall Study||8||
48708033|NCT02240368|102073248|FG001|COMPLETED|Overall Study||22||
48708034|NCT02240368|102073249|FG002|COMPLETED|Overall Study||18||
48708035|NCT02240368|102073247|FG000|NOT COMPLETED|Overall Study||1||
48708036|NCT02240368|102073248|FG001|NOT COMPLETED|Overall Study||0||
48708037|NCT02240368|102073249|FG002|NOT COMPLETED|Overall Study||1||
48708038|NCT01799239|102073250|FG000|STARTED|Period 1 (7 Days)||15||
48708039|NCT01799239|102073251|FG001|STARTED|Period 1 (7 Days)||16||
48708040|NCT01799239|102073250|FG000|COMPLETED|Period 1 (7 Days)||12||
48708041|NCT01799239|102073251|FG001|COMPLETED|Period 1 (7 Days)||15||
48708042|NCT01799239|102073250|FG000|NOT COMPLETED|Period 1 (7 Days)||3||
48708043|NCT01799239|102073251|FG001|NOT COMPLETED|Period 1 (7 Days)||1||
48708044|NCT01799239|102073250|FG000|STARTED|Period 2 (7 Days)||13||
48708045|NCT01799239|102073251|FG001|STARTED|Period 2 (7 Days)||15||
48708046|NCT01799239|102073250|FG000|COMPLETED|Period 2 (7 Days)||11||
48708047|NCT01799239|102073251|FG001|COMPLETED|Period 2 (7 Days)||14||
48708048|NCT01799239|102073250|FG000|NOT COMPLETED|Period 2 (7 Days)||2||
48708049|NCT01799239|102073251|FG001|NOT COMPLETED|Period 2 (7 Days)||1||
48708050|NCT03054350|102073252|FG000|STARTED|Primary Efficacy Period (6 Weeks)||15||
48708051|NCT03054350|102073253|FG001|STARTED|Primary Efficacy Period (6 Weeks)||15||
48708052|NCT03054350|102073254|FG002|STARTED|Primary Efficacy Period (6 Weeks)||15||
48708053|NCT03054350|102073255|FG003|STARTED|Primary Efficacy Period (6 Weeks)||5||
48708054|NCT03054350|102073256|FG004|STARTED|Primary Efficacy Period (6 Weeks)||5||
48708055|NCT03054350|102073257|FG005|STARTED|Primary Efficacy Period (6 Weeks)||5||
48708056|NCT03054350|102073252|FG000|COMPLETED|Primary Efficacy Period (6 Weeks)||11||
48708057|NCT03054350|102073253|FG001|COMPLETED|Primary Efficacy Period (6 Weeks)||13||
48708058|NCT03054350|102073254|FG002|COMPLETED|Primary Efficacy Period (6 Weeks)||13||
48708059|NCT03054350|102073255|FG003|COMPLETED|Primary Efficacy Period (6 Weeks)||3||
48708060|NCT03054350|102073256|FG004|COMPLETED|Primary Efficacy Period (6 Weeks)||1||
48710773|NCT01924442|102078013|FG001|NOT COMPLETED|Overall Study||137||
48708061|NCT03054350|102073257|FG005|COMPLETED|Primary Efficacy Period (6 Weeks)||2||
48708062|NCT03054350|102073252|FG000|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||4||
48708063|NCT03054350|102073253|FG001|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||2||
48708064|NCT03054350|102073254|FG002|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||2||
48708065|NCT03054350|102073255|FG003|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||2||
48708066|NCT03054350|102073256|FG004|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||4||
48708067|NCT03054350|102073257|FG005|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||3||
48708068|NCT03054350|102073252|FG000|STARTED|Dose Adjustment and Maintenance Period||11||
48708069|NCT03054350|102073253|FG001|STARTED|Dose Adjustment and Maintenance Period||13||
48708070|NCT03054350|102073254|FG002|STARTED|Dose Adjustment and Maintenance Period||13||
48708071|NCT03054350|102073255|FG003|STARTED|Dose Adjustment and Maintenance Period||3||
48139729|NCT01292603|100665689|FG001|STARTED|Part 1: Regular Follow-Up Period||17||
48139730|NCT01292603|100665690|FG002|STARTED|Part 1: Regular Follow-Up Period||23||
48139731|NCT01292603|100665691|FG003|STARTED|Part 1: Regular Follow-Up Period||8||
48139732|NCT01292603|100665692|FG004|STARTED|Part 1: Regular Follow-Up Period||0||
48139733|NCT01292603|100665693|FG005|STARTED|Part 1: Regular Follow-Up Period||0||
48139734|NCT01292603|100665688|FG000|COMPLETED|Part 1: Regular Follow-Up Period||10||
48139735|NCT01292603|100665689|FG001|COMPLETED|Part 1: Regular Follow-Up Period||10||
48139736|NCT01292603|100665690|FG002|COMPLETED|Part 1: Regular Follow-Up Period||17||
48139737|NCT01292603|100665691|FG003|COMPLETED|Part 1: Regular Follow-Up Period||7||
48139738|NCT01292603|100665692|FG004|COMPLETED|Part 1: Regular Follow-Up Period||0||
48139739|NCT01292603|100665693|FG005|COMPLETED|Part 1: Regular Follow-Up Period||0||
48139740|NCT01292603|100665688|FG000|NOT COMPLETED|Part 1: Regular Follow-Up Period||6||
48139741|NCT01292603|100665689|FG001|NOT COMPLETED|Part 1: Regular Follow-Up Period||7||
48139742|NCT01292603|100665690|FG002|NOT COMPLETED|Part 1: Regular Follow-Up Period||6||
48139743|NCT01292603|100665691|FG003|NOT COMPLETED|Part 1: Regular Follow-Up Period||1||
48708072|NCT03054350|102073256|FG004|STARTED|Dose Adjustment and Maintenance Period||1||
48708073|NCT03054350|102073257|FG005|STARTED|Dose Adjustment and Maintenance Period||2||
48708074|NCT03054350|102073252|FG000|COMPLETED|Dose Adjustment and Maintenance Period||10||
48708075|NCT03054350|102073253|FG001|COMPLETED|Dose Adjustment and Maintenance Period||13||
48708076|NCT03054350|102073254|FG002|COMPLETED|Dose Adjustment and Maintenance Period||12||
48708077|NCT03054350|102073255|FG003|COMPLETED|Dose Adjustment and Maintenance Period||2||
48708078|NCT03054350|102073256|FG004|COMPLETED|Dose Adjustment and Maintenance Period||1||
48708079|NCT03054350|102073257|FG005|COMPLETED|Dose Adjustment and Maintenance Period||2||
48708080|NCT03054350|102073252|FG000|NOT COMPLETED|Dose Adjustment and Maintenance Period||1||
48708081|NCT03054350|102073253|FG001|NOT COMPLETED|Dose Adjustment and Maintenance Period||0||
48708082|NCT03054350|102073254|FG002|NOT COMPLETED|Dose Adjustment and Maintenance Period||1||
48708083|NCT03054350|102073255|FG003|NOT COMPLETED|Dose Adjustment and Maintenance Period||1||
48708084|NCT03054350|102073256|FG004|NOT COMPLETED|Dose Adjustment and Maintenance Period||0||
48708085|NCT03054350|102073257|FG005|NOT COMPLETED|Dose Adjustment and Maintenance Period||0||
48139744|NCT01292603|100665692|FG004|NOT COMPLETED|Part 1: Regular Follow-Up Period||0||
48139745|NCT01292603|100665693|FG005|NOT COMPLETED|Part 1: Regular Follow-Up Period||0||
48139746|NCT01292603|100665688|FG000|STARTED|Part 2: Dose Confirmation Period||0||
48139747|NCT01292603|100665689|FG001|STARTED|Part 2: Dose Confirmation Period||0||
48139748|NCT01292603|100665690|FG002|STARTED|Part 2: Dose Confirmation Period||0||
48139749|NCT01292603|100665691|FG003|STARTED|Part 2: Dose Confirmation Period||0||
48139750|NCT01292603|100665692|FG004|STARTED|Part 2: Dose Confirmation Period||88||
48139751|NCT01292603|100665693|FG005|STARTED|Part 2: Dose Confirmation Period||88||
48139752|NCT01292603|100665688|FG000|COMPLETED|Part 2: Dose Confirmation Period||0||
48139753|NCT01292603|100665689|FG001|COMPLETED|Part 2: Dose Confirmation Period||0||
48139754|NCT01292603|100665690|FG002|COMPLETED|Part 2: Dose Confirmation Period||0||
48139755|NCT01292603|100665691|FG003|COMPLETED|Part 2: Dose Confirmation Period||0||
48139756|NCT01292603|100665692|FG004|COMPLETED|Part 2: Dose Confirmation Period||72||
48139757|NCT01292603|100665693|FG005|COMPLETED|Part 2: Dose Confirmation Period||73||
48139758|NCT01292603|100665688|FG000|NOT COMPLETED|Part 2: Dose Confirmation Period||0||
48139759|NCT01292603|100665689|FG001|NOT COMPLETED|Part 2: Dose Confirmation Period||0||
48139760|NCT01292603|100665690|FG002|NOT COMPLETED|Part 2: Dose Confirmation Period||0||
48139761|NCT01292603|100665691|FG003|NOT COMPLETED|Part 2: Dose Confirmation Period||0||
48139762|NCT01292603|100665692|FG004|NOT COMPLETED|Part 2: Dose Confirmation Period||16||
48139763|NCT01292603|100665693|FG005|NOT COMPLETED|Part 2: Dose Confirmation Period||15||
48139764|NCT01292603|100665688|FG000|STARTED|Part 2: Regular Follow-Up||0||
48139765|NCT01292603|100665689|FG001|STARTED|Part 2: Regular Follow-Up||0||
48708086|NCT01527513|102073258|FG000|STARTED|Double Blind Period (DB) - Part I||40||
48708087|NCT01527513|102073259|FG001|STARTED|Double Blind Period (DB) - Part I||83||
48139766|NCT01292603|100665690|FG002|STARTED|Part 2: Regular Follow-Up||0||
48139767|NCT01292603|100665691|FG003|STARTED|Part 2: Regular Follow-Up||0||
48139768|NCT01292603|100665692|FG004|STARTED|Part 2: Regular Follow-Up||87||
48139769|NCT01292603|100665693|FG005|STARTED|Part 2: Regular Follow-Up||87||
48139770|NCT01292603|100665688|FG000|COMPLETED|Part 2: Regular Follow-Up||0||
48139771|NCT01292603|100665689|FG001|COMPLETED|Part 2: Regular Follow-Up||0||
48139772|NCT01292603|100665690|FG002|COMPLETED|Part 2: Regular Follow-Up||0||
48139773|NCT01292603|100665691|FG003|COMPLETED|Part 2: Regular Follow-Up||0||
48139774|NCT01292603|100665692|FG004|COMPLETED|Part 2: Regular Follow-Up||68||
48139775|NCT01292603|100665693|FG005|COMPLETED|Part 2: Regular Follow-Up||75||
48139776|NCT01292603|100665688|FG000|NOT COMPLETED|Part 2: Regular Follow-Up||0||
48139777|NCT01292603|100665689|FG001|NOT COMPLETED|Part 2: Regular Follow-Up||0||
48139778|NCT01292603|100665690|FG002|NOT COMPLETED|Part 2: Regular Follow-Up||0||
48139779|NCT01292603|100665691|FG003|NOT COMPLETED|Part 2: Regular Follow-Up||0||
48139780|NCT01292603|100665692|FG004|NOT COMPLETED|Part 2: Regular Follow-Up||19||
48139781|NCT01292603|100665693|FG005|NOT COMPLETED|Part 2: Regular Follow-Up||12||
48141461|NCT01780922|100670424|FG001|STARTED|Second Intervention (1 Day)||2||
48708088|NCT01527513|102073258|FG000|Randomized|Double Blind Period (DB) - Part I||40||
48139782|NCT01292603|100665688|FG000|STARTED|Overall Survival Status||16|Patients could enter survival follow-up directly after premature treatment withdrawal,|
48139783|NCT01292603|100665689|FG001|STARTED|Overall Survival Status||17|Patients could enter survival follow-up directly after premature treatment withdrawal,|
48139784|NCT01292603|100665690|FG002|STARTED|Overall Survival Status||23|Patients could enter survival follow-up directly after premature treatment withdrawal,|
48139785|NCT01292603|100665691|FG003|STARTED|Overall Survival Status||8|Patients could enter survival follow-up directly after premature treatment withdrawal,|
48139786|NCT01292603|100665692|FG004|STARTED|Overall Survival Status||88|Patients could enter survival follow-up directly after premature treatment withdrawal,|
48139787|NCT01292603|100665693|FG005|STARTED|Overall Survival Status||88|Patients could enter survival follow-up directly after premature treatment withdrawal,|
48139788|NCT01292603|100665688|FG000|COMPLETED|Overall Survival Status||13|Overall survival.|
48139789|NCT01292603|100665689|FG001|COMPLETED|Overall Survival Status||16|Overall survival.|
48139790|NCT01292603|100665690|FG002|COMPLETED|Overall Survival Status||20|Overall survival.|
48139791|NCT01292603|100665691|FG003|COMPLETED|Overall Survival Status||7|Overall survival.|
48139792|NCT01292603|100665692|FG004|COMPLETED|Overall Survival Status||72|Overall survival.|
48139793|NCT01292603|100665693|FG005|COMPLETED|Overall Survival Status||78|Overall survival.|
48139794|NCT01292603|100665688|FG000|NOT COMPLETED|Overall Survival Status||3||
48139795|NCT01292603|100665689|FG001|NOT COMPLETED|Overall Survival Status||1||
48139796|NCT01292603|100665690|FG002|NOT COMPLETED|Overall Survival Status||3||
48139797|NCT01292603|100665691|FG003|NOT COMPLETED|Overall Survival Status||1||
48139798|NCT01292603|100665692|FG004|NOT COMPLETED|Overall Survival Status||16||
48139799|NCT01292603|100665693|FG005|NOT COMPLETED|Overall Survival Status||10||
48139800|NCT02127164|100665694|FG000|STARTED|Overall Study||18||
48139801|NCT02127164|100665694|FG000|COMPLETED|Overall Study||18||
48139802|NCT02127164|100665694|FG000|NOT COMPLETED|Overall Study||0||
48139803|NCT02097472|100665695|FG000|STARTED|Received Vaccination 1||18||
48139804|NCT02097472|100665696|FG001|STARTED|Received Vaccination 1||18||
48139805|NCT02097472|100665697|FG002|STARTED|Received Vaccination 1||18||
48139806|NCT02097472|100665698|FG003|STARTED|Received Vaccination 1||50||
48139807|NCT02097472|100665699|FG004|STARTED|Received Vaccination 1||50||
48139808|NCT02097472|100665700|FG005|STARTED|Received Vaccination 1||50||
48139809|NCT02097472|100665701|FG006|STARTED|Received Vaccination 1||50||
48139810|NCT02097472|100665702|FG007|STARTED|Received Vaccination 1||50||
48139811|NCT02097472|100665695|FG000|COMPLETED|Received Vaccination 1||18||
48139812|NCT02097472|100665696|FG001|COMPLETED|Received Vaccination 1||18||
48139813|NCT02097472|100665697|FG002|COMPLETED|Received Vaccination 1||18||
48139814|NCT02097472|100665698|FG003|COMPLETED|Received Vaccination 1||50||
48139815|NCT02097472|100665699|FG004|COMPLETED|Received Vaccination 1||50||
48292148|NCT00235547|101044246|FG000|COMPLETED|2 Month Follow-up Survey||108||
48292149|NCT00235547|101044247|FG001|COMPLETED|2 Month Follow-up Survey||104||
48292150|NCT00235547|101044246|FG000|NOT COMPLETED|2 Month Follow-up Survey||46||
48292151|NCT00235547|101044247|FG001|NOT COMPLETED|2 Month Follow-up Survey||40||
48292152|NCT00235547|101044246|FG000|STARTED|6 Month Follow-up Survey||154||
48589924|NCT03320850|101776745|FG002|NOT COMPLETED|Overall Study||0||
48589925|NCT03320850|101776746|FG003|NOT COMPLETED|Overall Study||1||
48589926|NCT03320850|101776747|FG004|NOT COMPLETED|Overall Study||2||
48589927|NCT03320850|101776748|FG005|NOT COMPLETED|Overall Study||9||
48589928|NCT03320850|101776749|FG006|NOT COMPLETED|Overall Study||7||
48589929|NCT03320850|101776750|FG007|NOT COMPLETED|Overall Study||7||
48589930|NCT03320850|101776751|FG008|NOT COMPLETED|Overall Study||10||
48708089|NCT01527513|102073259|FG001|Randomized|Double Blind Period (DB) - Part I||83||
48708090|NCT01527513|102073258|FG000|Safety Population|Double Blind Period (DB) - Part I||40||
48708091|NCT01527513|102073259|FG001|Safety Population|Double Blind Period (DB) - Part I||83||
48708092|NCT01527513|102073258|FG000|Entered Maintenance Period|Double Blind Period (DB) - Part I||40||
48708093|NCT01527513|102073259|FG001|Entered Maintenance Period|Double Blind Period (DB) - Part I||76||
48708094|NCT01527513|102073258|FG000|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||37||
48708095|NCT01527513|102073259|FG001|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||75||
48708096|NCT01527513|102073258|FG000|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||37||
48708097|NCT01527513|102073259|FG001|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||75||
48292153|NCT00235547|101044247|FG001|STARTED|6 Month Follow-up Survey||144||
48292154|NCT00235547|101044246|FG000|COMPLETED|6 Month Follow-up Survey||83||
48292155|NCT00235547|101044247|FG001|COMPLETED|6 Month Follow-up Survey||76||
48292156|NCT00235547|101044246|FG000|NOT COMPLETED|6 Month Follow-up Survey||71||
48402987|NCT02001688|101317779|FG002|NOT COMPLETED|Overall Study||1||
48708098|NCT01527513|102073258|FG000|Efficacy PP Population|Double Blind Period (DB) - Part I||37||
48139816|NCT02097472|100665700|FG005|COMPLETED|Received Vaccination 1||50||
48139817|NCT02097472|100665701|FG006|COMPLETED|Received Vaccination 1||50||
48139818|NCT02097472|100665702|FG007|COMPLETED|Received Vaccination 1||50||
48139819|NCT02097472|100665695|FG000|NOT COMPLETED|Received Vaccination 1||0||
48139820|NCT02097472|100665696|FG001|NOT COMPLETED|Received Vaccination 1||0||
48139821|NCT02097472|100665697|FG002|NOT COMPLETED|Received Vaccination 1||0||
48292157|NCT00235547|101044247|FG001|NOT COMPLETED|6 Month Follow-up Survey||68||
48589931|NCT03320850|101776752|FG009|NOT COMPLETED|Overall Study||9||
48589932|NCT06137703|101776753|FG000|STARTED|Overall Study||13||
48589933|NCT06137703|101776754|FG001|STARTED|Overall Study||13||
48139822|NCT02097472|100665698|FG003|NOT COMPLETED|Received Vaccination 1||0||
48139823|NCT02097472|100665699|FG004|NOT COMPLETED|Received Vaccination 1||0||
48139824|NCT02097472|100665700|FG005|NOT COMPLETED|Received Vaccination 1||0||
48139825|NCT02097472|100665701|FG006|NOT COMPLETED|Received Vaccination 1||0||
48139826|NCT02097472|100665702|FG007|NOT COMPLETED|Received Vaccination 1||0||
48139827|NCT02097472|100665695|FG000|STARTED|Received Vaccination 2||18||
48139828|NCT02097472|100665696|FG001|STARTED|Received Vaccination 2||18||
48139829|NCT02097472|100665697|FG002|STARTED|Received Vaccination 2||18||
48139830|NCT02097472|100665698|FG003|STARTED|Received Vaccination 2||50||
48589934|NCT06137703|101776755|FG002|STARTED|Overall Study||13||
48589935|NCT06137703|101776756|FG003|STARTED|Overall Study||13||
48589936|NCT06137703|101776753|FG000|COMPLETED|Overall Study||13||
48589937|NCT06137703|101776754|FG001|COMPLETED|Overall Study||12||
48589938|NCT06137703|101776755|FG002|COMPLETED|Overall Study||12||
48589939|NCT06137703|101776756|FG003|COMPLETED|Overall Study||13||
48589940|NCT06137703|101776753|FG000|NOT COMPLETED|Overall Study||0||
48589941|NCT06137703|101776754|FG001|NOT COMPLETED|Overall Study||1||
48589942|NCT06137703|101776755|FG002|NOT COMPLETED|Overall Study||1||
48589943|NCT06137703|101776756|FG003|NOT COMPLETED|Overall Study||0||
48589944|NCT01552915|101776757|FG000|STARTED|Overall Study||91||
48589945|NCT01552915|101776758|FG001|STARTED|Overall Study||184||
48139831|NCT02097472|100665699|FG004|STARTED|Received Vaccination 2||50||
48139832|NCT02097472|100665700|FG005|STARTED|Received Vaccination 2||50||
48139833|NCT02097472|100665701|FG006|STARTED|Received Vaccination 2||50||
48139834|NCT02097472|100665702|FG007|STARTED|Received Vaccination 2||50||
48139835|NCT02097472|100665695|FG000|COMPLETED|Received Vaccination 2||18||
48139836|NCT02097472|100665696|FG001|COMPLETED|Received Vaccination 2||18||
48589946|NCT01552915|101776759|FG002|STARTED|Overall Study||184||
48589947|NCT01552915|101776757|FG000|COMPLETED|Overall Study||68||
48589948|NCT01552915|101776758|FG001|COMPLETED|Overall Study||155||
48292158|NCT00887432|101044248|FG000|STARTED|Overall Study||58||
48292159|NCT00887432|101044249|FG001|STARTED|Overall Study||74||
48292160|NCT00887432|101044248|FG000|COMPLETED|Overall Study||43||
48292161|NCT00887432|101044249|FG001|COMPLETED|Overall Study||60||
48292162|NCT00887432|101044248|FG000|NOT COMPLETED|Overall Study||15||
48292163|NCT00887432|101044249|FG001|NOT COMPLETED|Overall Study||14||
48589949|NCT01552915|101776759|FG002|COMPLETED|Overall Study||157||
48292164|NCT01209143|101044250|FG000|STARTED|Overall Study||24||
48292165|NCT01209143|101044251|FG001|STARTED|Overall Study||28||
48292166|NCT01209143|101044250|FG000|COMPLETED|Overall Study||5||
48292167|NCT01209143|101044251|FG001|COMPLETED|Overall Study||8||
48589950|NCT01552915|101776757|FG000|NOT COMPLETED|Overall Study||23||
48589951|NCT01552915|101776758|FG001|NOT COMPLETED|Overall Study||29||
48589952|NCT01552915|101776759|FG002|NOT COMPLETED|Overall Study||27||
48589953|NCT03875092|101776760|FG000|STARTED|Overall Study||65||
48589954|NCT03875092|101776761|FG001|STARTED|Overall Study||60||
48589955|NCT03875092|101776760|FG000|Treated|Overall Study||65||
48589956|NCT03875092|101776761|FG001|Treated|Overall Study||60||
48139837|NCT02097472|100665697|FG002|COMPLETED|Received Vaccination 2||18||
48139838|NCT02097472|100665698|FG003|COMPLETED|Received Vaccination 2||50||
48139839|NCT02097472|100665699|FG004|COMPLETED|Received Vaccination 2||50||
48139840|NCT02097472|100665700|FG005|COMPLETED|Received Vaccination 2||50||
48139841|NCT02097472|100665701|FG006|COMPLETED|Received Vaccination 2||49||
48139842|NCT02097472|100665702|FG007|COMPLETED|Received Vaccination 2||50||
48139843|NCT02097472|100665695|FG000|NOT COMPLETED|Received Vaccination 2||0||
48139844|NCT02097472|100665696|FG001|NOT COMPLETED|Received Vaccination 2||0||
48139845|NCT02097472|100665697|FG002|NOT COMPLETED|Received Vaccination 2||0||
48139846|NCT02097472|100665698|FG003|NOT COMPLETED|Received Vaccination 2||0||
48139847|NCT02097472|100665699|FG004|NOT COMPLETED|Received Vaccination 2||0||
48139848|NCT02097472|100665700|FG005|NOT COMPLETED|Received Vaccination 2||0||
48139849|NCT02097472|100665701|FG006|NOT COMPLETED|Received Vaccination 2||1||
48139850|NCT02097472|100665702|FG007|NOT COMPLETED|Received Vaccination 2||0||
48139851|NCT02097472|100665695|FG000|STARTED|Assessed for Immunogenicity||18||
48139852|NCT02097472|100665696|FG001|STARTED|Assessed for Immunogenicity||18||
48139853|NCT02097472|100665697|FG002|STARTED|Assessed for Immunogenicity||18||
48139854|NCT02097472|100665698|FG003|STARTED|Assessed for Immunogenicity||50||
48139855|NCT02097472|100665699|FG004|STARTED|Assessed for Immunogenicity||50||
48139856|NCT02097472|100665700|FG005|STARTED|Assessed for Immunogenicity||50||
48139857|NCT02097472|100665701|FG006|STARTED|Assessed for Immunogenicity||49||
48139858|NCT02097472|100665702|FG007|STARTED|Assessed for Immunogenicity||50||
48292168|NCT01209143|101044250|FG000|NOT COMPLETED|Overall Study||19||
48292169|NCT01209143|101044251|FG001|NOT COMPLETED|Overall Study||20||
48292170|NCT01079741|101044252|FG000|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||3||
48589957|NCT03875092|101776760|FG000|Switched to Pembrolizumab+Chemotherapy|Overall Study||0||
48589958|NCT03875092|101776761|FG001|Switched to Pembrolizumab+Chemotherapy|Overall Study||38||
48589959|NCT03875092|101776760|FG000|Received Second Course of Pembrolizumab|Overall Study||6||
48589960|NCT03875092|101776761|FG001|Received Second Course of Pembrolizumab|Overall Study||0||
48589961|NCT03875092|101776760|FG000|COMPLETED|Overall Study||0||
48589962|NCT03875092|101776761|FG001|COMPLETED|Overall Study||0||
48589963|NCT03875092|101776760|FG000|NOT COMPLETED|Overall Study||65||
48139859|NCT02097472|100665695|FG000|COMPLETED|Assessed for Immunogenicity||18||
48139860|NCT02097472|100665696|FG001|COMPLETED|Assessed for Immunogenicity||18||
48139861|NCT02097472|100665697|FG002|COMPLETED|Assessed for Immunogenicity||17||
48139862|NCT02097472|100665698|FG003|COMPLETED|Assessed for Immunogenicity||48||
48139863|NCT02097472|100665699|FG004|COMPLETED|Assessed for Immunogenicity||50||
48139864|NCT02097472|100665700|FG005|COMPLETED|Assessed for Immunogenicity||48||
48139865|NCT02097472|100665701|FG006|COMPLETED|Assessed for Immunogenicity||47||
48589964|NCT03875092|101776761|FG001|NOT COMPLETED|Overall Study||60||
48589965|NCT04789291|101776762|FG000|STARTED|Period 1||7||
48589966|NCT04789291|101776763|FG001|STARTED|Period 1||6||
48589967|NCT04789291|101776762|FG000|COMPLETED|Period 1||7||
48589968|NCT04789291|101776763|FG001|COMPLETED|Period 1||6||
48589969|NCT04789291|101776762|FG000|NOT COMPLETED|Period 1||0||
48589970|NCT04789291|101776763|FG001|NOT COMPLETED|Period 1||0||
48589971|NCT04789291|101776762|FG000|STARTED|Wash-out||7||
48589972|NCT04789291|101776763|FG001|STARTED|Wash-out||6||
48589973|NCT04789291|101776762|FG000|COMPLETED|Wash-out||7||
48589974|NCT04789291|101776763|FG001|COMPLETED|Wash-out||6||
48589975|NCT04789291|101776762|FG000|NOT COMPLETED|Wash-out||0||
48139866|NCT02097472|100665702|FG007|COMPLETED|Assessed for Immunogenicity||49||
48139867|NCT02097472|100665695|FG000|NOT COMPLETED|Assessed for Immunogenicity||0||
48139868|NCT02097472|100665696|FG001|NOT COMPLETED|Assessed for Immunogenicity||0||
48139869|NCT02097472|100665697|FG002|NOT COMPLETED|Assessed for Immunogenicity||1||
48139870|NCT02097472|100665698|FG003|NOT COMPLETED|Assessed for Immunogenicity||2||
48139871|NCT02097472|100665699|FG004|NOT COMPLETED|Assessed for Immunogenicity||0||
48139872|NCT02097472|100665700|FG005|NOT COMPLETED|Assessed for Immunogenicity||2||
48139873|NCT02097472|100665701|FG006|NOT COMPLETED|Assessed for Immunogenicity||2||
48139874|NCT02097472|100665702|FG007|NOT COMPLETED|Assessed for Immunogenicity||1||
48139875|NCT01680328|100665703|FG000|STARTED|Overall Study||82||
48139876|NCT01680328|100665703|FG000|Subjects Missing Injections|Overall Study||2||
48139877|NCT01680328|100665703|FG000|COMPLETED|Overall Study||80||
48139878|NCT01680328|100665703|FG000|NOT COMPLETED|Overall Study||2||
48139879|NCT03151434|100665704|FG000|STARTED|Overall Study||53||
48139880|NCT03151434|100665705|FG001|STARTED|Overall Study||47||
48139881|NCT03151434|100665706|FG002|STARTED|Overall Study||47||
48139882|NCT03151434|100665704|FG000|COMPLETED|Overall Study||40||
48139883|NCT03151434|100665705|FG001|COMPLETED|Overall Study||40||
48139884|NCT03151434|100665706|FG002|COMPLETED|Overall Study||40||
48139885|NCT03151434|100665704|FG000|NOT COMPLETED|Overall Study||13||
48139886|NCT03151434|100665705|FG001|NOT COMPLETED|Overall Study||7||
48139887|NCT03151434|100665706|FG002|NOT COMPLETED|Overall Study||7||
48139888|NCT02680054|100665707|FG000|STARTED|Overall Study||38||
48139889|NCT02680054|100665707|FG000|COMPLETED|Overall Study||27||
48139890|NCT02680054|100665707|FG000|NOT COMPLETED|Overall Study||11||
48139891|NCT00622167|100665708|FG000|STARTED|Overall Study||24||
48139892|NCT00622167|100665708|FG000|COMPLETED|Overall Study||4||
48139893|NCT00622167|100665708|FG000|NOT COMPLETED|Overall Study||20||
48139894|NCT02566031|100665709|FG000|STARTED|Overall Study||189||
48589976|NCT04789291|101776763|FG001|NOT COMPLETED|Wash-out||0||
48589977|NCT04789291|101776762|FG000|STARTED|Period 2||7||
48589978|NCT04789291|101776763|FG001|STARTED|Period 2||6||
48589979|NCT04789291|101776762|FG000|COMPLETED|Period 2||7||
48589980|NCT04789291|101776763|FG001|COMPLETED|Period 2||6||
48589981|NCT04789291|101776762|FG000|NOT COMPLETED|Period 2||0||
48589982|NCT04789291|101776763|FG001|NOT COMPLETED|Period 2||0||
48589983|NCT00635453|101776764|FG000|STARTED|Overall Study||360|Pregnant woman|
48589984|NCT00635453|101776765|FG001|STARTED|Overall Study||355|Pregnant woman|
48139895|NCT02566031|100665710|FG001|STARTED|Overall Study||190||
48139896|NCT02566031|100665709|FG000|COMPLETED|Overall Study||169||
48139897|NCT02566031|100665710|FG001|COMPLETED|Overall Study||178||
48139898|NCT02566031|100665709|FG000|NOT COMPLETED|Overall Study||20||
48139899|NCT02566031|100665710|FG001|NOT COMPLETED|Overall Study||12||
48139900|NCT02911948|100665711|FG000|STARTED|Overall Study||105||
48139901|NCT02911948|100665712|FG001|STARTED|Overall Study||105||
48139902|NCT02911948|100665711|FG000|COMPLETED|Overall Study||105||
48139903|NCT02911948|100665712|FG001|COMPLETED|Overall Study||98||
48139904|NCT02911948|100665711|FG000|NOT COMPLETED|Overall Study||0||
48139905|NCT02911948|100665712|FG001|NOT COMPLETED|Overall Study||7||
48139906|NCT01972841|100665713|FG000|STARTED|Overall Study||447||
48139907|NCT01972841|100665714|FG001|STARTED|Overall Study||441||
48139908|NCT01972841|100665715|FG002|STARTED|Overall Study||437||
48589985|NCT00635453|101776764|FG000|6 Months Assessment|Overall Study||322|Mother-Child Pairs|
48589986|NCT00635453|101776765|FG001|6 Months Assessment|Overall Study||311|Mother-Child Pairs|
48589987|NCT00635453|101776764|FG000|12 Months Assessment|Overall Study||285|Mother-Child Pairs|
48589988|NCT00635453|101776765|FG001|12 Months Assessment|Overall Study||260|Mother-Child Pairs|
48139909|NCT01972841|100665716|FG003|STARTED|Overall Study||434||
48139910|NCT01972841|100665717|FG004|STARTED|Overall Study||885||
48139911|NCT01972841|100665718|FG005|STARTED|Overall Study||883||
48589989|NCT00635453|101776764|FG000|3 Years Assessment|Overall Study||246||
48589990|NCT00635453|101776765|FG001|3 Years Assessment|Overall Study||204||
48589991|NCT00635453|101776764|FG000|COMPLETED|Overall Study||206|6 years assessment Mother-Child Pairs|
48589992|NCT00635453|101776765|FG001|COMPLETED|Overall Study||181|6 years assessment Mother-Child Pairs|
48139912|NCT01972841|100665713|FG000|COMPLETED|Overall Study||404||
48139913|NCT01972841|100665714|FG001|COMPLETED|Overall Study||397||
48139914|NCT01972841|100665715|FG002|COMPLETED|Overall Study||387||
48139915|NCT01972841|100665716|FG003|COMPLETED|Overall Study||397||
48139916|NCT01972841|100665717|FG004|COMPLETED|Overall Study||802||
48139917|NCT01972841|100665718|FG005|COMPLETED|Overall Study||798||
48139918|NCT01972841|100665713|FG000|NOT COMPLETED|Overall Study||43||
48139919|NCT01972841|100665714|FG001|NOT COMPLETED|Overall Study||44||
48139920|NCT01972841|100665715|FG002|NOT COMPLETED|Overall Study||50||
48139921|NCT01972841|100665716|FG003|NOT COMPLETED|Overall Study||37||
48139922|NCT01972841|100665717|FG004|NOT COMPLETED|Overall Study||83||
48139923|NCT01972841|100665718|FG005|NOT COMPLETED|Overall Study||85||
48139924|NCT02732366|100665719|FG000|STARTED|Overall Study||23||
48139925|NCT02732366|100665720|FG001|STARTED|Overall Study||23||
48139926|NCT02732366|100665719|FG000|Withdrawal by Participant|Overall Study||5||
48139927|NCT02732366|100665720|FG001|Withdrawal by Participant|Overall Study||2||
48139928|NCT02732366|100665719|FG000|COMPLETED|Overall Study||18||
48139929|NCT02732366|100665720|FG001|COMPLETED|Overall Study||21||
48589993|NCT00635453|101776764|FG000|NOT COMPLETED|Overall Study||154||
48589994|NCT00635453|101776765|FG001|NOT COMPLETED|Overall Study||174||
48589995|NCT01892085|101776766|FG000|STARTED|Overall Study||58||
48589996|NCT01892085|101776767|FG001|STARTED|Overall Study||62||
48589997|NCT01892085|101776768|FG002|STARTED|Overall Study||60||
48589998|NCT01892085|101776766|FG000|COMPLETED|Overall Study||52||
48589999|NCT01892085|101776767|FG001|COMPLETED|Overall Study||61||
48590000|NCT01892085|101776768|FG002|COMPLETED|Overall Study||55||
48590001|NCT01892085|101776766|FG000|NOT COMPLETED|Overall Study||6||
48590002|NCT01892085|101776767|FG001|NOT COMPLETED|Overall Study||1||
48590003|NCT01892085|101776768|FG002|NOT COMPLETED|Overall Study||5||
48590004|NCT00875433|101776769|FG000|STARTED|Overall Study||60||
48292171|NCT01079741|101044253|FG001|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0||
48292172|NCT01079741|101044254|FG002|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0||
48292173|NCT01079741|101044255|FG003|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0||
48292174|NCT01079741|101044256|FG004|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0||
48139930|NCT02732366|100665719|FG000|NOT COMPLETED|Overall Study||5||
48139931|NCT02732366|100665720|FG001|NOT COMPLETED|Overall Study||2||
48139932|NCT02372409|100665721|FG000|STARTED|Overall Study||5||
48139933|NCT02372409|100665722|FG001|STARTED|Overall Study||1||
48139934|NCT02372409|100665721|FG000|COMPLETED|Overall Study||3||
48139935|NCT02372409|100665722|FG001|COMPLETED|Overall Study||0||
48139936|NCT02372409|100665721|FG000|NOT COMPLETED|Overall Study||2||
48139937|NCT02372409|100665722|FG001|NOT COMPLETED|Overall Study||1||
48139938|NCT03160027|100665723|FG000|STARTED|Overall Study||6||
48139939|NCT03160027|100665724|FG001|STARTED|Overall Study||4||
48139940|NCT03160027|100665725|FG002|STARTED|Overall Study||6||
48139941|NCT03160027|100665726|FG003|STARTED|Overall Study||4||
48590005|NCT00875433|101776769|FG000|COMPLETED|Overall Study||0||
48590006|NCT00875433|101776769|FG000|NOT COMPLETED|Overall Study||60||
48590007|NCT01312233|101776770|FG000|STARTED|Overall Study||44||
48590008|NCT01312233|101776771|FG001|STARTED|Overall Study||44||
48590009|NCT01312233|101776772|FG002|STARTED|Overall Study||43||
48590010|NCT01312233|101776770|FG000|COMPLETED|Overall Study||42||
48590011|NCT01312233|101776771|FG001|COMPLETED|Overall Study||44||
48590012|NCT01312233|101776772|FG002|COMPLETED|Overall Study||36||
48292175|NCT01079741|101044252|FG000|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||3||
48292176|NCT01079741|101044253|FG001|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0||
48139942|NCT03160027|100665723|FG000|COMPLETED|Overall Study||6||
48139943|NCT03160027|100665724|FG001|COMPLETED|Overall Study||4||
48139944|NCT03160027|100665725|FG002|COMPLETED|Overall Study||6||
48139945|NCT03160027|100665726|FG003|COMPLETED|Overall Study||4||
48139946|NCT03160027|100665723|FG000|NOT COMPLETED|Overall Study||0||
48139947|NCT03160027|100665724|FG001|NOT COMPLETED|Overall Study||0||
48139948|NCT03160027|100665725|FG002|NOT COMPLETED|Overall Study||0||
48590013|NCT01312233|101776770|FG000|NOT COMPLETED|Overall Study||2||
48590014|NCT01312233|101776771|FG001|NOT COMPLETED|Overall Study||0||
48590015|NCT01312233|101776772|FG002|NOT COMPLETED|Overall Study||7||
48590016|NCT05537792|101776773|FG000|STARTED|Overall Study||10||
48590017|NCT05537792|101776773|FG000|COMPLETED|Overall Study||10||
48139949|NCT03160027|100665726|FG003|NOT COMPLETED|Overall Study||0||
48590018|NCT05537792|101776773|FG000|NOT COMPLETED|Overall Study||0||
48139950|NCT00476476|100665727|FG000|STARTED|Overall Study||17||
48139951|NCT00476476|100665728|FG001|STARTED|Overall Study||24||
48139952|NCT00476476|100665727|FG000|Response Evaluable|Overall Study||17||
48139953|NCT00476476|100665728|FG001|Response Evaluable|Overall Study||23||
48139954|NCT00476476|100665727|FG000|COMPLETED|Overall Study||15||
48139955|NCT00476476|100665728|FG001|COMPLETED|Overall Study||0||
48139956|NCT00476476|100665727|FG000|NOT COMPLETED|Overall Study||2||
48139957|NCT00476476|100665728|FG001|NOT COMPLETED|Overall Study||24||
48590019|NCT04112160|101776774|FG000|STARTED|Overall Study||63||
48590020|NCT04112160|101776775|FG001|STARTED|Overall Study||62||
48590021|NCT04112160|101776774|FG000|COMPLETED|Overall Study||62||
48590022|NCT04112160|101776775|FG001|COMPLETED|Overall Study||62||
48590023|NCT04112160|101776774|FG000|NOT COMPLETED|Overall Study||1||
48590024|NCT04112160|101776775|FG001|NOT COMPLETED|Overall Study||0||
48139958|NCT00477191|100665729|FG000|STARTED|Overall Study||18||
48139959|NCT00477191|100665729|FG000|COMPLETED|Overall Study||13||
48139960|NCT00477191|100665729|FG000|NOT COMPLETED|Overall Study||5||
48139961|NCT01343407|100665730|FG000|STARTED|First Treatment Period (Part 2)||2|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
48139962|NCT01343407|100665731|FG001|STARTED|First Treatment Period (Part 2)||2|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
48139963|NCT01343407|100665732|FG002|STARTED|First Treatment Period (Part 2)||3|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
48139964|NCT01343407|100665733|FG003|STARTED|First Treatment Period (Part 2)||3|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
48292177|NCT01079741|101044254|FG002|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0||
48292178|NCT01079741|101044255|FG003|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0||
48292179|NCT01079741|101044256|FG004|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0||
48292180|NCT01079741|101044252|FG000|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0||
48292181|NCT01079741|101044253|FG001|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0||
48292182|NCT01079741|101044254|FG002|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0||
48292183|NCT01079741|101044255|FG003|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0||
48292184|NCT01079741|101044256|FG004|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0||
48292185|NCT01079741|101044252|FG000|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0||
48292186|NCT01079741|101044253|FG001|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||4||
48292187|NCT01079741|101044254|FG002|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0||
48292188|NCT01079741|101044255|FG003|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0||
48292189|NCT01079741|101044256|FG004|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0||
48292190|NCT01079741|101044252|FG000|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0||
48292191|NCT01079741|101044253|FG001|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||3||
48292192|NCT01079741|101044254|FG002|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0||
48292193|NCT01079741|101044255|FG003|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0||
48292194|NCT01079741|101044256|FG004|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0||
48292195|NCT01079741|101044252|FG000|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0||
48292196|NCT01079741|101044253|FG001|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||1||
48292197|NCT01079741|101044254|FG002|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0||
48292198|NCT01079741|101044255|FG003|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0||
48292199|NCT01079741|101044256|FG004|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0||
48292200|NCT01079741|101044252|FG000|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0||
48292201|NCT01079741|101044253|FG001|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0||
48292202|NCT01079741|101044254|FG002|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||3||
48292203|NCT01079741|101044255|FG003|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0||
48292204|NCT01079741|101044256|FG004|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0||
48292205|NCT01079741|101044252|FG000|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0||
48292206|NCT01079741|101044253|FG001|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0||
48292207|NCT01079741|101044254|FG002|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0||
48292208|NCT01079741|101044255|FG003|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0||
48292209|NCT01079741|101044256|FG004|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0||
48292210|NCT01079741|101044252|FG000|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0||
48708099|NCT01527513|102073259|FG001|Efficacy PP Population|Double Blind Period (DB) - Part I||67||
48708100|NCT01527513|102073258|FG000|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||36||
48708101|NCT01527513|102073259|FG001|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||66||
48708102|NCT01527513|102073258|FG000|COMPLETED|Double Blind Period (DB) - Part I||37||
48708103|NCT01527513|102073259|FG001|COMPLETED|Double Blind Period (DB) - Part I||75||
48708104|NCT01527513|102073258|FG000|NOT COMPLETED|Double Blind Period (DB) - Part I||3||
48708105|NCT01527513|102073259|FG001|NOT COMPLETED|Double Blind Period (DB) - Part I||8||
48708106|NCT01527513|102073258|FG000|STARTED|Eligible for 1-Year Open Label Period||0||
48708107|NCT01527513|102073259|FG001|STARTED|Eligible for 1-Year Open Label Period||112||
48708108|NCT01527513|102073258|FG000|COMPLETED|Eligible for 1-Year Open Label Period||0||
48708109|NCT01527513|102073259|FG001|COMPLETED|Eligible for 1-Year Open Label Period||95||
48708110|NCT01527513|102073258|FG000|NOT COMPLETED|Eligible for 1-Year Open Label Period||0||
48708111|NCT01527513|102073259|FG001|NOT COMPLETED|Eligible for 1-Year Open Label Period||17||
48708112|NCT00613925|102073260|FG000|STARTED|Overall Study||37||
48708113|NCT00613925|102073261|FG001|STARTED|Overall Study||33||
48708114|NCT00613925|102073260|FG000|COMPLETED|Overall Study||37||
48708115|NCT00613925|102073261|FG001|COMPLETED|Overall Study||32||
48708116|NCT00613925|102073260|FG000|NOT COMPLETED|Overall Study||0||
48708117|NCT00613925|102073261|FG001|NOT COMPLETED|Overall Study||1||
48708118|NCT03115853|102073262|FG000|STARTED|Overall Study||31||
48708119|NCT03115853|102073262|FG000|COMPLETED|Overall Study||31||
48708120|NCT03115853|102073262|FG000|NOT COMPLETED|Overall Study||0||
48708121|NCT02427568|102073263|FG000|STARTED|Overall Study||5||
48708122|NCT02427568|102073264|FG001|STARTED|Overall Study||13||
48708123|NCT02427568|102073263|FG000|COMPLETED|Overall Study||5||
48708124|NCT02427568|102073264|FG001|COMPLETED|Overall Study||13||
48708125|NCT02427568|102073263|FG000|NOT COMPLETED|Overall Study||0||
48708126|NCT02427568|102073264|FG001|NOT COMPLETED|Overall Study||0||
48708127|NCT03989427|102073265|FG000|STARTED|First Intervention (2 Weeks)||15||
48292211|NCT01079741|101044253|FG001|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0||
48292212|NCT01079741|101044254|FG002|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||3||
48292213|NCT01079741|101044255|FG003|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0||
48292214|NCT01079741|101044256|FG004|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0||
48292215|NCT01079741|101044252|FG000|STARTED|Phase 2 (Weeks 37-48)||0||
48292216|NCT01079741|101044253|FG001|STARTED|Phase 2 (Weeks 37-48)||0||
48292217|NCT01079741|101044254|FG002|STARTED|Phase 2 (Weeks 37-48)||0||
48292218|NCT01079741|101044255|FG003|STARTED|Phase 2 (Weeks 37-48)||12||
48292219|NCT01079741|101044256|FG004|STARTED|Phase 2 (Weeks 37-48)||12||
48292220|NCT01079741|101044252|FG000|COMPLETED|Phase 2 (Weeks 37-48)||0||
48292221|NCT01079741|101044253|FG001|COMPLETED|Phase 2 (Weeks 37-48)||0||
48292222|NCT01079741|101044254|FG002|COMPLETED|Phase 2 (Weeks 37-48)||0||
48292223|NCT01079741|101044255|FG003|COMPLETED|Phase 2 (Weeks 37-48)||12||
48292224|NCT01079741|101044256|FG004|COMPLETED|Phase 2 (Weeks 37-48)||9||
48292225|NCT01079741|101044252|FG000|NOT COMPLETED|Phase 2 (Weeks 37-48)||0||
48292226|NCT01079741|101044253|FG001|NOT COMPLETED|Phase 2 (Weeks 37-48)||0||
48292227|NCT01079741|101044254|FG002|NOT COMPLETED|Phase 2 (Weeks 37-48)||0||
48292228|NCT01079741|101044255|FG003|NOT COMPLETED|Phase 2 (Weeks 37-48)||0||
48292229|NCT01079741|101044256|FG004|NOT COMPLETED|Phase 2 (Weeks 37-48)||3||
48292230|NCT01676909|101044257|FG000|STARTED|Overall Study||124||
48292231|NCT01676909|101044258|FG001|STARTED|Overall Study||118||
48292232|NCT01676909|101044257|FG000|Post-Treatment Assessment|Overall Study||105||
48590025|NCT00504725|101776776|FG000|STARTED|Overall Study||21||
48590026|NCT00504725|101776777|FG001|STARTED|Overall Study||20||
48590027|NCT00504725|101776776|FG000|COMPLETED|Overall Study||20||
48590028|NCT00504725|101776777|FG001|COMPLETED|Overall Study||20||
48590029|NCT00504725|101776776|FG000|NOT COMPLETED|Overall Study||1||
48590030|NCT00504725|101776777|FG001|NOT COMPLETED|Overall Study||0||
48590031|NCT02052596|101776778|FG000|STARTED|Active Phase||412||
48590032|NCT02052596|101776779|FG001|STARTED|Active Phase||418||
48590033|NCT02052596|101776778|FG000|COMPLETED|Active Phase||396||
48590034|NCT02052596|101776779|FG001|COMPLETED|Active Phase||398||
48590035|NCT02052596|101776778|FG000|NOT COMPLETED|Active Phase||16||
48590036|NCT02052596|101776779|FG001|NOT COMPLETED|Active Phase||20||
48590037|NCT02052596|101776778|FG000|STARTED|Safety Phase||412||
48590038|NCT02052596|101776779|FG001|STARTED|Safety Phase||418||
48590039|NCT02052596|101776778|FG000|COMPLETED|Safety Phase||385||
48590040|NCT02052596|101776779|FG001|COMPLETED|Safety Phase||383||
48590041|NCT02052596|101776778|FG000|NOT COMPLETED|Safety Phase||27||
48590042|NCT02052596|101776779|FG001|NOT COMPLETED|Safety Phase||35||
48590043|NCT01797081|101776780|FG000|STARTED|Overall Study||104||
48590044|NCT01797081|101776781|FG001|STARTED|Overall Study||99||
48590045|NCT01797081|101776782|FG002|STARTED|Overall Study||48||
48590046|NCT01797081|101776783|FG003|STARTED|Overall Study||49||
48590047|NCT01797081|101776780|FG000|COMPLETED|Overall Study||90||
48590048|NCT01797081|101776781|FG001|COMPLETED|Overall Study||95||
48590049|NCT01797081|101776782|FG002|COMPLETED|Overall Study||43||
48590050|NCT01797081|101776783|FG003|COMPLETED|Overall Study||40||
48590051|NCT01797081|101776780|FG000|NOT COMPLETED|Overall Study||14||
48590052|NCT01797081|101776781|FG001|NOT COMPLETED|Overall Study||4||
48590053|NCT01797081|101776782|FG002|NOT COMPLETED|Overall Study||5||
48590054|NCT01797081|101776783|FG003|NOT COMPLETED|Overall Study||9||
48590055|NCT00182728|101776784|FG000|STARTED|Overall Study||71||
48590056|NCT00182728|101776784|FG000|COMPLETED|Overall Study||71||
48590057|NCT00182728|101776784|FG000|NOT COMPLETED|Overall Study||0||
48590058|NCT01796197|101776785|FG000|STARTED|Overall Study||23||
48590059|NCT01796197|101776785|FG000|COMPLETED|Overall Study||21||
48590060|NCT01796197|101776785|FG000|NOT COMPLETED|Overall Study||2||
48590061|NCT02651415|101776786|FG000|STARTED|Overall Study||12||
48590062|NCT02651415|101776786|FG000|COMPLETED|Overall Study||10||
48590063|NCT02651415|101776786|FG000|NOT COMPLETED|Overall Study||2||
48590064|NCT00348595|101776787|FG000|STARTED|Overall Study||26||
48590065|NCT00348595|101776788|FG001|STARTED|Overall Study||34||
48590066|NCT00348595|101776787|FG000|COMPLETED|Overall Study||21||
48590067|NCT00348595|101776788|FG001|COMPLETED|Overall Study||26||
48590068|NCT00348595|101776787|FG000|NOT COMPLETED|Overall Study||5||
48590069|NCT00348595|101776788|FG001|NOT COMPLETED|Overall Study||8||
48590070|NCT00189306|101776789|FG000|STARTED|Treatment Period||169||
48590071|NCT00189306|101776789|FG000|COMPLETED|Treatment Period||164||
48292233|NCT01676909|101044258|FG001|Post-Treatment Assessment|Overall Study||107||
48292234|NCT01676909|101044257|FG000|COMPLETED|Overall Study||106||
48292235|NCT01676909|101044258|FG001|COMPLETED|Overall Study||104||
48292236|NCT01676909|101044257|FG000|NOT COMPLETED|Overall Study||18||
48590072|NCT00189306|101776789|FG000|NOT COMPLETED|Treatment Period||5||
48590073|NCT00189306|101776789|FG000|STARTED|Posttreatment Period||169||
48590074|NCT00189306|101776789|FG000|COMPLETED|Posttreatment Period||157||
48590075|NCT00189306|101776789|FG000|NOT COMPLETED|Posttreatment Period||12||
48590076|NCT00189306|101776789|FG000|STARTED|Long-Term Follow-up||157||
48590077|NCT00189306|101776789|FG000|COMPLETED|Long-Term Follow-up||119||
48590078|NCT00189306|101776789|FG000|NOT COMPLETED|Long-Term Follow-up||38||
48590079|NCT01553240|101776790|FG000|STARTED|Overall Study||0||
48590080|NCT01553240|101776790|FG000|COMPLETED|Overall Study||0||
48590081|NCT01553240|101776790|FG000|NOT COMPLETED|Overall Study||0||
48292237|NCT01676909|101044258|FG001|NOT COMPLETED|Overall Study||14||
48292238|NCT02480153|101044259|FG000|STARTED|Period 1: First Dose to Week 26 Pre-dose||297||
48292239|NCT02480153|101044260|FG001|STARTED|Period 1: First Dose to Week 26 Pre-dose||300||
48292240|NCT02480153|101044261|FG002|STARTED|Period 1: First Dose to Week 26 Pre-dose||0||
48292241|NCT02480153|101044259|FG000|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||297||
48292242|NCT02480153|101044260|FG001|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||299||
48292243|NCT02480153|101044261|FG002|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||0||
48292244|NCT02480153|101044259|FG000|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||293||
48292245|NCT02480153|101044260|FG001|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||284||
48292246|NCT02480153|101044261|FG002|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||0||
48139965|NCT01343407|100665734|FG004|STARTED|First Treatment Period (Part 2)||3|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
48139966|NCT01343407|100665735|FG005|STARTED|First Treatment Period (Part 2)||3|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
48139967|NCT01343407|100665730|FG000|COMPLETED|First Treatment Period (Part 2)||2||
48139968|NCT01343407|100665731|FG001|COMPLETED|First Treatment Period (Part 2)||2||
48139969|NCT01343407|100665732|FG002|COMPLETED|First Treatment Period (Part 2)||3||
48139970|NCT01343407|100665733|FG003|COMPLETED|First Treatment Period (Part 2)||3||
48139971|NCT01343407|100665734|FG004|COMPLETED|First Treatment Period (Part 2)||3||
48139972|NCT01343407|100665735|FG005|COMPLETED|First Treatment Period (Part 2)||3||
48139973|NCT01343407|100665730|FG000|NOT COMPLETED|First Treatment Period (Part 2)||0||
48139974|NCT01343407|100665731|FG001|NOT COMPLETED|First Treatment Period (Part 2)||0||
48139975|NCT01343407|100665732|FG002|NOT COMPLETED|First Treatment Period (Part 2)||0||
48139976|NCT01343407|100665733|FG003|NOT COMPLETED|First Treatment Period (Part 2)||0||
48139977|NCT01343407|100665734|FG004|NOT COMPLETED|First Treatment Period (Part 2)||0||
48292247|NCT02480153|101044259|FG000|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||4||
48292248|NCT02480153|101044260|FG001|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||16||
48292249|NCT02480153|101044261|FG002|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||0||
48292250|NCT02480153|101044259|FG000|STARTED|Period 2: Week 26 to Week 52 Pre-dose||283||
48292251|NCT02480153|101044260|FG001|STARTED|Period 2: Week 26 to Week 52 Pre-dose||135||
48139978|NCT01343407|100665735|FG005|NOT COMPLETED|First Treatment Period (Part 2)||0||
48139979|NCT01343407|100665730|FG000|STARTED|First Washout (Part 2)||2||
48139980|NCT01343407|100665731|FG001|STARTED|First Washout (Part 2)||2||
48292252|NCT02480153|101044261|FG002|STARTED|Period 2: Week 26 to Week 52 Pre-dose||134||
48292253|NCT02480153|101044259|FG000|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||283||
48292254|NCT02480153|101044260|FG001|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||135||
48292255|NCT02480153|101044261|FG002|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||133||
48292256|NCT02480153|101044259|FG000|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||263||
48139981|NCT01343407|100665732|FG002|STARTED|First Washout (Part 2)||3||
48139982|NCT01343407|100665733|FG003|STARTED|First Washout (Part 2)||3||
48139983|NCT01343407|100665734|FG004|STARTED|First Washout (Part 2)||3||
48139984|NCT01343407|100665735|FG005|STARTED|First Washout (Part 2)||3||
48139985|NCT01343407|100665730|FG000|COMPLETED|First Washout (Part 2)||2||
48139986|NCT01343407|100665731|FG001|COMPLETED|First Washout (Part 2)||2||
48139987|NCT01343407|100665732|FG002|COMPLETED|First Washout (Part 2)||3||
48139988|NCT01343407|100665733|FG003|COMPLETED|First Washout (Part 2)||3||
48292257|NCT02480153|101044260|FG001|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||122||
48292258|NCT02480153|101044261|FG002|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||127||
48292259|NCT02480153|101044259|FG000|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||20||
48292260|NCT02480153|101044260|FG001|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||13||
48292261|NCT02480153|101044261|FG002|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||7||
48292262|NCT02480153|101044259|FG000|STARTED|Period 3: Week 52 Dosing to Week 78||259||
48292263|NCT02480153|101044260|FG001|STARTED|Period 3: Week 52 Dosing to Week 78||121||
48292264|NCT02480153|101044261|FG002|STARTED|Period 3: Week 52 Dosing to Week 78||127||
48292265|NCT02480153|101044259|FG000|Received Treatment|Period 3: Week 52 Dosing to Week 78||258||
48292266|NCT02480153|101044260|FG001|Received Treatment|Period 3: Week 52 Dosing to Week 78||120||
48292267|NCT02480153|101044261|FG002|Received Treatment|Period 3: Week 52 Dosing to Week 78||127||
48292268|NCT02480153|101044259|FG000|COMPLETED|Period 3: Week 52 Dosing to Week 78||252||
48292269|NCT02480153|101044260|FG001|COMPLETED|Period 3: Week 52 Dosing to Week 78||118||
48708128|NCT03989427|102073266|FG001|STARTED|First Intervention (2 Weeks)||15||
48708129|NCT03989427|102073265|FG000|COMPLETED|First Intervention (2 Weeks)||15||
48708130|NCT03989427|102073266|FG001|COMPLETED|First Intervention (2 Weeks)||15||
48139989|NCT01343407|100665734|FG004|COMPLETED|First Washout (Part 2)||3||
48139990|NCT01343407|100665735|FG005|COMPLETED|First Washout (Part 2)||3||
48139991|NCT01343407|100665730|FG000|NOT COMPLETED|First Washout (Part 2)||0||
48139992|NCT01343407|100665731|FG001|NOT COMPLETED|First Washout (Part 2)||0||
48139993|NCT01343407|100665732|FG002|NOT COMPLETED|First Washout (Part 2)||0||
48139994|NCT01343407|100665733|FG003|NOT COMPLETED|First Washout (Part 2)||0||
48139995|NCT01343407|100665734|FG004|NOT COMPLETED|First Washout (Part 2)||0||
48139996|NCT01343407|100665735|FG005|NOT COMPLETED|First Washout (Part 2)||0||
48139997|NCT01343407|100665730|FG000|STARTED|Second Treatment Period (Part 2)||2|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
48708131|NCT03989427|102073265|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0||
48292270|NCT02480153|101044261|FG002|COMPLETED|Period 3: Week 52 Dosing to Week 78||123||
48292271|NCT02480153|101044259|FG000|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||7||
48292272|NCT02480153|101044260|FG001|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||3||
48292273|NCT02480153|101044261|FG002|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||4||
48292274|NCT00252733|101044262|FG000|STARTED|Overall Study||711||
48708132|NCT03989427|102073266|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0||
48708133|NCT03989427|102073265|FG000|STARTED|Washout (1 Week)||15||
48708134|NCT03989427|102073266|FG001|STARTED|Washout (1 Week)||15||
48708135|NCT03989427|102073265|FG000|COMPLETED|Washout (1 Week)||15||
48708136|NCT03989427|102073266|FG001|COMPLETED|Washout (1 Week)||15||
48708137|NCT03989427|102073265|FG000|NOT COMPLETED|Washout (1 Week)||0||
48708138|NCT03989427|102073266|FG001|NOT COMPLETED|Washout (1 Week)||0||
48708139|NCT03989427|102073265|FG000|STARTED|Second Intervention (2 Weeks)||15||
48708140|NCT03989427|102073266|FG001|STARTED|Second Intervention (2 Weeks)||15||
48710774|NCT00899717|102078014|FG000|STARTED|Overall Study||10||
48292275|NCT00252733|101044263|FG001|STARTED|Overall Study||710||
48292276|NCT00252733|101044262|FG000|COMPLETED|Overall Study||605||
48292277|NCT00252733|101044263|FG001|COMPLETED|Overall Study||618||
48292278|NCT00252733|101044262|FG000|NOT COMPLETED|Overall Study||106||
48292279|NCT00252733|101044263|FG001|NOT COMPLETED|Overall Study||92||
48402988|NCT00810043|101317780|FG000|STARTED|Overall Study||57||
48402989|NCT00810043|101317781|FG001|STARTED|Overall Study||55||
48402990|NCT00810043|101317782|FG002|STARTED|Overall Study||8||
48402991|NCT00810043|101317780|FG000|COMPLETED|Overall Study||53||
48402992|NCT00810043|101317781|FG001|COMPLETED|Overall Study||54||
48402993|NCT00810043|101317782|FG002|COMPLETED|Overall Study||0||
48708141|NCT03989427|102073265|FG000|COMPLETED|Second Intervention (2 Weeks)||15||
48708142|NCT03989427|102073266|FG001|COMPLETED|Second Intervention (2 Weeks)||15||
48708143|NCT03989427|102073265|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48708144|NCT03989427|102073266|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48708145|NCT03362931|102073267|FG000|STARTED|Overall Study||62||
48708146|NCT03362931|102073267|FG000|COMPLETED|Overall Study||59||
48708147|NCT03362931|102073267|FG000|NOT COMPLETED|Overall Study||3||
48708148|NCT00462735|102073268|FG000|STARTED|Overall Study||33||
48708149|NCT00462735|102073268|FG000|COMPLETED|Overall Study||33||
48708150|NCT00462735|102073268|FG000|NOT COMPLETED|Overall Study||0||
48708151|NCT04854031|102073269|FG000|STARTED|Overall Study||8||
48708152|NCT04854031|102073269|FG000|COMPLETED|Overall Study||8||
48708153|NCT04854031|102073269|FG000|NOT COMPLETED|Overall Study||0||
48708154|NCT01396265|102073270|FG000|STARTED|Afatinib||22||
48708155|NCT01396265|102073270|FG000|COMPLETED|Afatinib||22||
48708156|NCT01396265|102073270|FG000|NOT COMPLETED|Afatinib||0||
48708157|NCT01396265|102073270|FG000|STARTED|Washout||22||
48708158|NCT01396265|102073270|FG000|COMPLETED|Washout||22||
48708159|NCT01396265|102073270|FG000|NOT COMPLETED|Washout||0||
48708160|NCT01396265|102073270|FG000|STARTED|Rifa+Afatinib||22||
48708161|NCT01396265|102073270|FG000|COMPLETED|Rifa+Afatinib||21||
48708162|NCT01396265|102073270|FG000|NOT COMPLETED|Rifa+Afatinib||1||
48708163|NCT03831880|102073271|FG000|STARTED|Period 1 (12 Weeks)||43||
48708164|NCT03831880|102073272|FG001|STARTED|Period 1 (12 Weeks)||44||
48708165|NCT03831880|102073271|FG000|COMPLETED|Period 1 (12 Weeks)||43||
48708166|NCT03831880|102073272|FG001|COMPLETED|Period 1 (12 Weeks)||43||
48139998|NCT01343407|100665731|FG001|STARTED|Second Treatment Period (Part 2)||2|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
48139999|NCT01343407|100665732|FG002|STARTED|Second Treatment Period (Part 2)||3|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
48292280|NCT01718353|101044264|FG000|STARTED|Overall Study||41||
48292281|NCT01718353|101044265|FG001|STARTED|Overall Study||22||
48292282|NCT01718353|101044264|FG000|Treated|Overall Study||39||
48292283|NCT01718353|101044265|FG001|Treated|Overall Study||22||
48292284|NCT01718353|101044264|FG000|Treated up to End of Cycle 4|Overall Study||32||
48292285|NCT01718353|101044265|FG001|Treated up to End of Cycle 4|Overall Study||16||
48292286|NCT01718353|101044264|FG000|Treated From Cycle 5|Overall Study||23||
48292287|NCT01718353|101044265|FG001|Treated From Cycle 5|Overall Study||25||
48292288|NCT01718353|101044264|FG000|COMPLETED|Overall Study||29||
48292289|NCT01718353|101044265|FG001|COMPLETED|Overall Study||17||
48292290|NCT01718353|101044264|FG000|NOT COMPLETED|Overall Study||12||
48292291|NCT01718353|101044265|FG001|NOT COMPLETED|Overall Study||5||
48292292|NCT02409368|101044266|FG000|STARTED|Original Classification||173||
48292293|NCT02409368|101044267|FG001|STARTED|Original Classification||534||
48292294|NCT02409368|101044268|FG002|STARTED|Original Classification||103||
48292295|NCT02409368|101044269|FG003|STARTED|Original Classification||1||
48292296|NCT02409368|101044266|FG000|COMPLETED|Original Classification||173||
48292297|NCT02409368|101044267|FG001|COMPLETED|Original Classification||534||
48292298|NCT02409368|101044268|FG002|COMPLETED|Original Classification||103||
48292299|NCT02409368|101044269|FG003|COMPLETED|Original Classification||1||
48292300|NCT02409368|101044266|FG000|NOT COMPLETED|Original Classification||0||
48292301|NCT02409368|101044267|FG001|NOT COMPLETED|Original Classification||0||
48292302|NCT02409368|101044268|FG002|NOT COMPLETED|Original Classification||0||
48402994|NCT00810043|101317780|FG000|NOT COMPLETED|Overall Study||4||
48402995|NCT00810043|101317781|FG001|NOT COMPLETED|Overall Study||1||
48402996|NCT00810043|101317782|FG002|NOT COMPLETED|Overall Study||8||
48402997|NCT03796195|101317783|FG000|STARTED|Overall Study||1||
48402998|NCT03796195|101317783|FG000|COMPLETED|Overall Study||0||
48402999|NCT03796195|101317783|FG000|NOT COMPLETED|Overall Study||1||
48403000|NCT01673490|101317784|FG000|STARTED|Overall Study||59||
48403001|NCT01673490|101317784|FG000|COMPLETED|Overall Study||52||
48708167|NCT03831880|102073271|FG000|NOT COMPLETED|Period 1 (12 Weeks)||0||
48708168|NCT03831880|102073272|FG001|NOT COMPLETED|Period 1 (12 Weeks)||1||
48708169|NCT03831880|102073271|FG000|STARTED|Period 2 (12 Weeks)||43||
48708170|NCT03831880|102073272|FG001|STARTED|Period 2 (12 Weeks)||43||
48708171|NCT03831880|102073271|FG000|COMPLETED|Period 2 (12 Weeks)||43||
48708172|NCT03831880|102073272|FG001|COMPLETED|Period 2 (12 Weeks)||42||
48708173|NCT03831880|102073271|FG000|NOT COMPLETED|Period 2 (12 Weeks)||0||
48708174|NCT03831880|102073272|FG001|NOT COMPLETED|Period 2 (12 Weeks)||1||
48708175|NCT03831880|102073271|FG000|STARTED|Follow-up (5 Weeks)||43||
48708176|NCT03831880|102073272|FG001|STARTED|Follow-up (5 Weeks)||43||
48708177|NCT03831880|102073271|FG000|COMPLETED|Follow-up (5 Weeks)||43||
48140000|NCT01343407|100665733|FG003|STARTED|Second Treatment Period (Part 2)||3|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
48141462|NCT01780922|100670425|FG002|STARTED|Second Intervention (1 Day)||2||
48292303|NCT02409368|101044269|FG003|NOT COMPLETED|Original Classification||0||
48292304|NCT02409368|101044266|FG000|STARTED|ECOG Reclassification||172||
48590082|NCT02262000|101776791|FG000|STARTED|Overall Study||3||
48590083|NCT02262000|101776792|FG001|STARTED|Overall Study||0||
48590084|NCT02262000|101776791|FG000|COMPLETED|Overall Study||3||
48590085|NCT02262000|101776792|FG001|COMPLETED|Overall Study||0||
48590086|NCT02262000|101776791|FG000|NOT COMPLETED|Overall Study||0||
48590087|NCT02262000|101776792|FG001|NOT COMPLETED|Overall Study||0||
48590088|NCT01300338|101776793|FG000|STARTED|Overall Study||25||
48590089|NCT01300338|101776794|FG001|STARTED|Overall Study||25||
48708178|NCT03831880|102073272|FG001|COMPLETED|Follow-up (5 Weeks)||43||
48708179|NCT03831880|102073271|FG000|NOT COMPLETED|Follow-up (5 Weeks)||0||
48708180|NCT03831880|102073272|FG001|NOT COMPLETED|Follow-up (5 Weeks)||0||
48708181|NCT00773786|102073273|FG000|STARTED|First Intervention (1 Week)||10||
48708182|NCT00773786|102073274|FG001|STARTED|First Intervention (1 Week)||10||
48708183|NCT00773786|102073273|FG000|COMPLETED|First Intervention (1 Week)||10||
48708184|NCT00773786|102073274|FG001|COMPLETED|First Intervention (1 Week)||10||
48708185|NCT00773786|102073273|FG000|NOT COMPLETED|First Intervention (1 Week)||0||
48708186|NCT00773786|102073274|FG001|NOT COMPLETED|First Intervention (1 Week)||0||
48708187|NCT00773786|102073273|FG000|STARTED|Washout (1 Week)||10||
48708188|NCT00773786|102073274|FG001|STARTED|Washout (1 Week)||10||
48708189|NCT00773786|102073273|FG000|COMPLETED|Washout (1 Week)||10||
48708190|NCT00773786|102073274|FG001|COMPLETED|Washout (1 Week)||10||
48708191|NCT00773786|102073273|FG000|NOT COMPLETED|Washout (1 Week)||0||
48708192|NCT00773786|102073274|FG001|NOT COMPLETED|Washout (1 Week)||0||
48708193|NCT00773786|102073273|FG000|STARTED|Second Intervention (1 Week)||10||
48708194|NCT00773786|102073274|FG001|STARTED|Second Intervention (1 Week)||10||
48708195|NCT00773786|102073273|FG000|COMPLETED|Second Intervention (1 Week)||10||
48708196|NCT00773786|102073274|FG001|COMPLETED|Second Intervention (1 Week)||10||
48708197|NCT00773786|102073273|FG000|NOT COMPLETED|Second Intervention (1 Week)||0||
48292305|NCT02409368|101044267|FG001|STARTED|ECOG Reclassification||537||
48292306|NCT02409368|101044268|FG002|STARTED|ECOG Reclassification||102||
48292307|NCT02409368|101044269|FG003|STARTED|ECOG Reclassification||1||
48292308|NCT02409368|101044266|FG000|COMPLETED|ECOG Reclassification||0||
48590090|NCT01300338|101776793|FG000|COMPLETED|Overall Study||20||
48590091|NCT01300338|101776794|FG001|COMPLETED|Overall Study||25||
48590092|NCT01300338|101776793|FG000|NOT COMPLETED|Overall Study||5||
48590093|NCT01300338|101776794|FG001|NOT COMPLETED|Overall Study||0||
48590094|NCT01282164|101776795|FG000|STARTED|Overall Study||29||
48590095|NCT01282164|101776796|FG001|STARTED|Overall Study||14||
48590096|NCT01282164|101776795|FG000|COMPLETED|Overall Study||28||
48708198|NCT00773786|102073274|FG001|NOT COMPLETED|Second Intervention (1 Week)||0||
48708199|NCT02256267|102073275|FG000|STARTED|Period 1 (Day 1; Day 2 to Day 9 Washout)||24||
48708200|NCT02256267|102073275|FG000|Received at Least 1 Dose of LY2835219|Period 1 (Day 1; Day 2 to Day 9 Washout)||24||
48708201|NCT02256267|102073275|FG000|COMPLETED|Period 1 (Day 1; Day 2 to Day 9 Washout)||23||
48708202|NCT02256267|102073275|FG000|NOT COMPLETED|Period 1 (Day 1; Day 2 to Day 9 Washout)||1||
48708203|NCT02256267|102073275|FG000|STARTED|Period 2 (Day 1 to Day 6)||23||
48708204|NCT02256267|102073275|FG000|Received at Least 1 Dose of Rifampin|Period 2 (Day 1 to Day 6)||23||
48708205|NCT02256267|102073275|FG000|COMPLETED|Period 2 (Day 1 to Day 6)||23||
48140001|NCT01343407|100665734|FG004|STARTED|Second Treatment Period (Part 2)||3|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
48708206|NCT02256267|102073275|FG000|NOT COMPLETED|Period 2 (Day 1 to Day 6)||0||
48708207|NCT02256267|102073275|FG000|STARTED|Period 2 (Day 7 to Day 14)||23||
48708208|NCT02256267|102073275|FG000|Received LY2835219 + Rifampin|Period 2 (Day 7 to Day 14)||23||
48708209|NCT02256267|102073275|FG000|COMPLETED|Period 2 (Day 7 to Day 14)||22||
48708210|NCT02256267|102073275|FG000|NOT COMPLETED|Period 2 (Day 7 to Day 14)||1||
48140002|NCT01343407|100665735|FG005|STARTED|Second Treatment Period (Part 2)||3|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
48140003|NCT01343407|100665730|FG000|COMPLETED|Second Treatment Period (Part 2)||2||
48140004|NCT01343407|100665731|FG001|COMPLETED|Second Treatment Period (Part 2)||2||
48140005|NCT01343407|100665732|FG002|COMPLETED|Second Treatment Period (Part 2)||2||
48140006|NCT01343407|100665733|FG003|COMPLETED|Second Treatment Period (Part 2)||3||
48708211|NCT00585546|102073276|FG000|STARTED|LVAD Implantation Required for 4 Months||18||
48708212|NCT00585546|102073276|FG000|COMPLETED|LVAD Implantation Required for 4 Months||13||
48708213|NCT00585546|102073276|FG000|NOT COMPLETED|LVAD Implantation Required for 4 Months||5||
48708214|NCT00585546|102073276|FG000|STARTED|Clenbuterol Treatment - up to 12 Months||13||
48708215|NCT00585546|102073276|FG000|COMPLETED|Clenbuterol Treatment - up to 12 Months||9||
48708216|NCT00585546|102073276|FG000|NOT COMPLETED|Clenbuterol Treatment - up to 12 Months||4||
48708217|NCT01065051|102073277|FG000|STARTED|Overall Study||1||
48708218|NCT01065051|102073278|FG001|STARTED|Overall Study||0||
48403002|NCT01673490|101317784|FG000|NOT COMPLETED|Overall Study||7||
48403003|NCT01520688|101317785|FG000|STARTED|Overall Study||4||
48403004|NCT01520688|101317786|FG001|STARTED|Overall Study||4||
48403005|NCT01520688|101317787|FG002|STARTED|Overall Study||4||
48403006|NCT01520688|101317788|FG003|STARTED|Overall Study||5||
48403007|NCT01520688|101317789|FG004|STARTED|Overall Study||5||
48403008|NCT01520688|101317790|FG005|STARTED|Overall Study||5||
48403009|NCT01520688|101317791|FG006|STARTED|Overall Study||5||
48403010|NCT01520688|101317785|FG000|COMPLETED|Overall Study||4||
48403011|NCT01520688|101317786|FG001|COMPLETED|Overall Study||2||
48403012|NCT01520688|101317787|FG002|COMPLETED|Overall Study||4||
48403013|NCT01520688|101317788|FG003|COMPLETED|Overall Study||4||
48590097|NCT01282164|101776796|FG001|COMPLETED|Overall Study||14||
48590098|NCT01282164|101776795|FG000|NOT COMPLETED|Overall Study||1||
48590099|NCT01282164|101776796|FG001|NOT COMPLETED|Overall Study||0||
48590100|NCT02319967|101776797|FG000|STARTED|Overall Study||126||
48590101|NCT02319967|101776798|FG001|STARTED|Overall Study||126||
48590102|NCT02319967|101776799|FG002|STARTED|Overall Study||121||
48590103|NCT02319967|101776797|FG000|COMPLETED|Overall Study||78||
48590104|NCT02319967|101776798|FG001|COMPLETED|Overall Study||82||
48590105|NCT02319967|101776799|FG002|COMPLETED|Overall Study||76||
48590106|NCT02319967|101776797|FG000|NOT COMPLETED|Overall Study||48||
48590107|NCT02319967|101776798|FG001|NOT COMPLETED|Overall Study||44||
48590108|NCT02319967|101776799|FG002|NOT COMPLETED|Overall Study||45||
48590109|NCT04186806|101776800|FG000|STARTED|Period 1: 7 Days||20||
48590110|NCT04186806|101776801|FG001|STARTED|Period 1: 7 Days||20||
48590111|NCT04186806|101776800|FG000|COMPLETED|Period 1: 7 Days||19||
48590112|NCT04186806|101776801|FG001|COMPLETED|Period 1: 7 Days||20||
48590113|NCT04186806|101776800|FG000|NOT COMPLETED|Period 1: 7 Days||1||
48590114|NCT04186806|101776801|FG001|NOT COMPLETED|Period 1: 7 Days||0||
48590115|NCT04186806|101776800|FG000|STARTED|Washout Period: at Least 2 Days||19||
48590116|NCT04186806|101776801|FG001|STARTED|Washout Period: at Least 2 Days||20||
48590117|NCT04186806|101776800|FG000|COMPLETED|Washout Period: at Least 2 Days||19||
48590118|NCT04186806|101776801|FG001|COMPLETED|Washout Period: at Least 2 Days||20||
48590119|NCT04186806|101776800|FG000|NOT COMPLETED|Washout Period: at Least 2 Days||0||
48590120|NCT04186806|101776801|FG001|NOT COMPLETED|Washout Period: at Least 2 Days||0||
48590121|NCT04186806|101776800|FG000|STARTED|Period 2: 7 Days||19||
48590122|NCT04186806|101776801|FG001|STARTED|Period 2: 7 Days||20||
48590123|NCT04186806|101776800|FG000|COMPLETED|Period 2: 7 Days||19||
48590124|NCT04186806|101776801|FG001|COMPLETED|Period 2: 7 Days||20||
48590125|NCT04186806|101776800|FG000|NOT COMPLETED|Period 2: 7 Days||0||
48403014|NCT01520688|101317789|FG004|COMPLETED|Overall Study||4||
48403015|NCT01520688|101317790|FG005|COMPLETED|Overall Study||5||
48590126|NCT04186806|101776801|FG001|NOT COMPLETED|Period 2: 7 Days||0||
48590127|NCT00090987|101776802|FG000|STARTED|Overall Study||30||
48590128|NCT00090987|101776802|FG000|COMPLETED|Overall Study||9||
48590129|NCT00090987|101776802|FG000|NOT COMPLETED|Overall Study||21||
48590130|NCT00176644|101776803|FG000|STARTED|Overall Study||23||
48708219|NCT01065051|102073277|FG000|COMPLETED|Overall Study||1||
48708220|NCT01065051|102073278|FG001|COMPLETED|Overall Study||0||
48708221|NCT01065051|102073277|FG000|NOT COMPLETED|Overall Study||0||
48292309|NCT02409368|101044267|FG001|COMPLETED|ECOG Reclassification||0||
48292310|NCT02409368|101044268|FG002|COMPLETED|ECOG Reclassification||0||
48292311|NCT02409368|101044269|FG003|COMPLETED|ECOG Reclassification||0||
48403016|NCT01520688|101317791|FG006|COMPLETED|Overall Study||0||
48403017|NCT01520688|101317785|FG000|NOT COMPLETED|Overall Study||0||
48403018|NCT01520688|101317786|FG001|NOT COMPLETED|Overall Study||2||
48403019|NCT01520688|101317787|FG002|NOT COMPLETED|Overall Study||0||
48403020|NCT01520688|101317788|FG003|NOT COMPLETED|Overall Study||1||
48403021|NCT01520688|101317789|FG004|NOT COMPLETED|Overall Study||1||
48403022|NCT01520688|101317790|FG005|NOT COMPLETED|Overall Study||0||
48403023|NCT01520688|101317791|FG006|NOT COMPLETED|Overall Study||5||
48403024|NCT00429572|101317792|FG000|STARTED|Overall Study||19||
48403025|NCT00429572|101317792|FG000|COMPLETED|Overall Study||18||
48403026|NCT00429572|101317792|FG000|NOT COMPLETED|Overall Study||1||
48403027|NCT02996994|101317793|FG000|STARTED|Overall Study||364||
48403028|NCT02996994|101317793|FG000|COMPLETED|Overall Study||364||
48708222|NCT01065051|102073278|FG001|NOT COMPLETED|Overall Study||0||
48708223|NCT02460783|102073279|FG000|STARTED|Overall Study||22||
48708224|NCT02460783|102073280|FG001|STARTED|Overall Study||24||
48403029|NCT02996994|101317793|FG000|NOT COMPLETED|Overall Study||0||
48403030|NCT02348840|101317794|FG000|STARTED|Overall Study||23||
48403031|NCT02348840|101317795|FG001|STARTED|Overall Study||21||
48292312|NCT02409368|101044266|FG000|NOT COMPLETED|ECOG Reclassification||172||
48292313|NCT02409368|101044267|FG001|NOT COMPLETED|ECOG Reclassification||537||
48292314|NCT02409368|101044268|FG002|NOT COMPLETED|ECOG Reclassification||102||
48292315|NCT02409368|101044269|FG003|NOT COMPLETED|ECOG Reclassification||1||
48292316|NCT01907360|101044270|FG000|STARTED|Overall Study||18||
48292317|NCT01907360|101044271|FG001|STARTED|Overall Study||11||
48292318|NCT01907360|101044270|FG000|COMPLETED|Overall Study||18||
48292319|NCT01907360|101044271|FG001|COMPLETED|Overall Study||11||
48292320|NCT01907360|101044270|FG000|NOT COMPLETED|Overall Study||0||
48292321|NCT01907360|101044271|FG001|NOT COMPLETED|Overall Study||0||
48292322|NCT00605644|101044272|FG000|STARTED|Overall Study||29||
48292323|NCT00605644|101044273|FG001|STARTED|Overall Study||19||
48292324|NCT00605644|101044274|FG002|STARTED|Overall Study||20||
48292325|NCT00605644|101044275|FG003|STARTED|Overall Study||30||
48292326|NCT00605644|101044276|FG004|STARTED|Overall Study||30||
48292327|NCT00605644|101044272|FG000|COMPLETED|Overall Study||28||
48292328|NCT00605644|101044273|FG001|COMPLETED|Overall Study||18||
48292329|NCT00605644|101044274|FG002|COMPLETED|Overall Study||18||
48292330|NCT00605644|101044275|FG003|COMPLETED|Overall Study||25||
48292331|NCT00605644|101044276|FG004|COMPLETED|Overall Study||22||
48292332|NCT00605644|101044272|FG000|NOT COMPLETED|Overall Study||1||
48292333|NCT00605644|101044273|FG001|NOT COMPLETED|Overall Study||1||
48292334|NCT00605644|101044274|FG002|NOT COMPLETED|Overall Study||2||
48292335|NCT00605644|101044275|FG003|NOT COMPLETED|Overall Study||5||
48292336|NCT00605644|101044276|FG004|NOT COMPLETED|Overall Study||8||
48292337|NCT03215810|101044277|FG000|STARTED|Overall Study||20||
48292338|NCT03215810|101044277|FG000|COMPLETED|Overall Study||16||
48292339|NCT03215810|101044277|FG000|NOT COMPLETED|Overall Study||4||
48292340|NCT01911065|101044278|FG000|STARTED|Overall Study||45||
48292341|NCT01911065|101044279|FG001|STARTED|Overall Study||9||
48292342|NCT01911065|101044278|FG000|COMPLETED|Overall Study||45||
48292343|NCT01911065|101044279|FG001|COMPLETED|Overall Study||9||
48292344|NCT01911065|101044278|FG000|NOT COMPLETED|Overall Study||0||
48292345|NCT01911065|101044279|FG001|NOT COMPLETED|Overall Study||0||
48292346|NCT01313689|101044280|FG000|STARTED|24-Week Randomization 1||79||
48292347|NCT01313689|101044281|FG001|STARTED|24-Week Randomization 1||43||
48292348|NCT01313689|101044282|FG002|STARTED|24-Week Randomization 1||0||
48292349|NCT01313689|101044283|FG003|STARTED|24-Week Randomization 1||0||
48292350|NCT01313689|101044284|FG004|STARTED|24-Week Randomization 1||0||
48292351|NCT01313689|101044280|FG000|COMPLETED|24-Week Randomization 1||60||
48292352|NCT01313689|101044281|FG001|COMPLETED|24-Week Randomization 1||33||
48292353|NCT01313689|101044282|FG002|COMPLETED|24-Week Randomization 1||0||
48292354|NCT01313689|101044283|FG003|COMPLETED|24-Week Randomization 1||0||
48292355|NCT01313689|101044284|FG004|COMPLETED|24-Week Randomization 1||0||
48292356|NCT01313689|101044280|FG000|NOT COMPLETED|24-Week Randomization 1||19||
48292357|NCT01313689|101044281|FG001|NOT COMPLETED|24-Week Randomization 1||10||
48292358|NCT01313689|101044282|FG002|NOT COMPLETED|24-Week Randomization 1||0||
48292359|NCT01313689|101044283|FG003|NOT COMPLETED|24-Week Randomization 1||0||
48292360|NCT01313689|101044284|FG004|NOT COMPLETED|24-Week Randomization 1||0||
48292361|NCT01313689|101044280|FG000|STARTED|24-Week Randomization 2||0||
48292362|NCT01313689|101044281|FG001|STARTED|24-Week Randomization 2||0||
48292363|NCT01313689|101044282|FG002|STARTED|24-Week Randomization 2||24||
48292364|NCT01313689|101044283|FG003|STARTED|24-Week Randomization 2||13||
48292365|NCT01313689|101044284|FG004|STARTED|24-Week Randomization 2||42||
48292366|NCT01313689|101044280|FG000|COMPLETED|24-Week Randomization 2||0||
48292367|NCT01313689|101044281|FG001|COMPLETED|24-Week Randomization 2||0||
48292368|NCT01313689|101044282|FG002|COMPLETED|24-Week Randomization 2||21||
48292369|NCT01313689|101044283|FG003|COMPLETED|24-Week Randomization 2||12||
48292370|NCT01313689|101044284|FG004|COMPLETED|24-Week Randomization 2||27||
48292371|NCT01313689|101044280|FG000|NOT COMPLETED|24-Week Randomization 2||0||
48292372|NCT01313689|101044281|FG001|NOT COMPLETED|24-Week Randomization 2||0||
48292373|NCT01313689|101044282|FG002|NOT COMPLETED|24-Week Randomization 2||3||
48292374|NCT01313689|101044283|FG003|NOT COMPLETED|24-Week Randomization 2||1||
48292375|NCT01313689|101044284|FG004|NOT COMPLETED|24-Week Randomization 2||15||
48292376|NCT00323856|101044285|FG000|STARTED|Overall Study||50||
48292377|NCT00323856|101044285|FG000|COMPLETED|Overall Study||45||
48292378|NCT00323856|101044285|FG000|NOT COMPLETED|Overall Study||5||
48292379|NCT00319839|101044286|FG000|STARTED|Overall Study||7||
48292380|NCT00319839|101044286|FG000|COMPLETED|Overall Study||1||
48292381|NCT00319839|101044286|FG000|NOT COMPLETED|Overall Study||6||
48292382|NCT02121834|101044287|FG000|STARTED|Overall Study||12||
48292383|NCT02121834|101044288|FG001|STARTED|Overall Study||11||
48292384|NCT02121834|101044289|FG002|STARTED|Overall Study||9||
48292385|NCT02121834|101044290|FG003|STARTED|Overall Study||10||
48292386|NCT02121834|101044291|FG004|STARTED|Overall Study||9||
48292387|NCT02121834|101044292|FG005|STARTED|Overall Study||9||
48292388|NCT02121834|101044293|FG006|STARTED|Overall Study||3||
48292389|NCT02121834|101044287|FG000|Received at Least One Dose of Study Drug|Overall Study||12||
48292390|NCT02121834|101044288|FG001|Received at Least One Dose of Study Drug|Overall Study||11||
48292391|NCT02121834|101044289|FG002|Received at Least One Dose of Study Drug|Overall Study||9||
48292392|NCT02121834|101044290|FG003|Received at Least One Dose of Study Drug|Overall Study||10||
48292393|NCT02121834|101044291|FG004|Received at Least One Dose of Study Drug|Overall Study||9||
48292394|NCT02121834|101044292|FG005|Received at Least One Dose of Study Drug|Overall Study||9||
48292395|NCT02121834|101044293|FG006|Received at Least One Dose of Study Drug|Overall Study||3||
48292396|NCT02121834|101044287|FG000|COMPLETED|Overall Study||12||
48292397|NCT02121834|101044288|FG001|COMPLETED|Overall Study||9||
48292398|NCT02121834|101044289|FG002|COMPLETED|Overall Study||7||
48292399|NCT02121834|101044290|FG003|COMPLETED|Overall Study||10||
48292400|NCT02121834|101044291|FG004|COMPLETED|Overall Study||9||
48292401|NCT02121834|101044292|FG005|COMPLETED|Overall Study||9||
48292402|NCT02121834|101044293|FG006|COMPLETED|Overall Study||3||
48403032|NCT02348840|101317796|FG002|STARTED|Overall Study||425||
48403033|NCT02348840|101317797|FG003|STARTED|Overall Study||374||
48403034|NCT02348840|101317794|FG000|COMPLETED|Overall Study||21||
48403035|NCT02348840|101317795|FG001|COMPLETED|Overall Study||20||
48403036|NCT02348840|101317796|FG002|COMPLETED|Overall Study||425||
48403037|NCT02348840|101317797|FG003|COMPLETED|Overall Study||374||
48403038|NCT02348840|101317794|FG000|NOT COMPLETED|Overall Study||2||
48403039|NCT02348840|101317795|FG001|NOT COMPLETED|Overall Study||1||
48403040|NCT02348840|101317796|FG002|NOT COMPLETED|Overall Study||0||
48403041|NCT02348840|101317797|FG003|NOT COMPLETED|Overall Study||0||
48403042|NCT03639987|101317798|FG000|STARTED|Overall Study||26||
48140007|NCT01343407|100665734|FG004|COMPLETED|Second Treatment Period (Part 2)||3||
48292403|NCT02121834|101044287|FG000|NOT COMPLETED|Overall Study||0||
48292404|NCT02121834|101044288|FG001|NOT COMPLETED|Overall Study||2||
48292405|NCT02121834|101044289|FG002|NOT COMPLETED|Overall Study||2||
48292406|NCT02121834|101044290|FG003|NOT COMPLETED|Overall Study||0||
48292407|NCT02121834|101044291|FG004|NOT COMPLETED|Overall Study||0||
48292408|NCT02121834|101044292|FG005|NOT COMPLETED|Overall Study||0||
48292409|NCT02121834|101044293|FG006|NOT COMPLETED|Overall Study||0||
48292410|NCT01672723|101044294|FG000|STARTED|First Intervention||19||
48292411|NCT01672723|101044295|FG001|STARTED|First Intervention||15||
48403043|NCT03639987|101317799|FG001|STARTED|Overall Study||26||
48403044|NCT03639987|101317798|FG000|COMPLETED|Overall Study||0||
48403045|NCT03639987|101317799|FG001|COMPLETED|Overall Study||0||
48403046|NCT03639987|101317798|FG000|NOT COMPLETED|Overall Study||26||
48403047|NCT03639987|101317799|FG001|NOT COMPLETED|Overall Study||26||
48403048|NCT00641706|101317800|FG000|STARTED|Overall Study||37||
48403049|NCT00641706|101317801|FG001|STARTED|Overall Study||7||
48403050|NCT00641706|101317800|FG000|COMPLETED|Overall Study||28||
48403051|NCT00641706|101317801|FG001|COMPLETED|Overall Study||4||
48403052|NCT00641706|101317800|FG000|NOT COMPLETED|Overall Study||9||
48403053|NCT00641706|101317801|FG001|NOT COMPLETED|Overall Study||3||
48403054|NCT05406440|101317802|FG000|STARTED|Overall Study||8||
48403055|NCT05406440|101317803|FG001|STARTED|Overall Study||3||
48403056|NCT05406440|101317804|FG002|STARTED|Overall Study||8||
48403057|NCT05406440|101317805|FG003|STARTED|Overall Study||2||
48403058|NCT05406440|101317806|FG004|STARTED|Overall Study||18||
48403059|NCT05406440|101317807|FG005|STARTED|Overall Study||2||
48403060|NCT05406440|101317808|FG006|STARTED|Overall Study||12||
48403061|NCT05406440|101317802|FG000|COMPLETED|Overall Study||8||
48403062|NCT05406440|101317803|FG001|COMPLETED|Overall Study||3||
48403063|NCT05406440|101317804|FG002|COMPLETED|Overall Study||8||
48403064|NCT05406440|101317805|FG003|COMPLETED|Overall Study||2||
48590131|NCT00176644|101776803|FG000|COMPLETED|Overall Study||22||
48140008|NCT01343407|100665735|FG005|COMPLETED|Second Treatment Period (Part 2)||3||
48140009|NCT01343407|100665730|FG000|NOT COMPLETED|Second Treatment Period (Part 2)||0||
48140010|NCT01343407|100665731|FG001|NOT COMPLETED|Second Treatment Period (Part 2)||0||
48140011|NCT01343407|100665732|FG002|NOT COMPLETED|Second Treatment Period (Part 2)||1||
48140012|NCT01343407|100665733|FG003|NOT COMPLETED|Second Treatment Period (Part 2)||0||
48140013|NCT01343407|100665734|FG004|NOT COMPLETED|Second Treatment Period (Part 2)||0||
48140014|NCT01343407|100665735|FG005|NOT COMPLETED|Second Treatment Period (Part 2)||0||
48140015|NCT01343407|100665730|FG000|STARTED|Second Washout (Part 2)||2||
48292412|NCT01672723|101044294|FG000|COMPLETED|First Intervention||16||
48403065|NCT05406440|101317806|FG004|COMPLETED|Overall Study||15||
48403066|NCT05406440|101317807|FG005|COMPLETED|Overall Study||0||
48403067|NCT05406440|101317808|FG006|COMPLETED|Overall Study||12||
48403068|NCT05406440|101317802|FG000|NOT COMPLETED|Overall Study||0||
48403069|NCT05406440|101317803|FG001|NOT COMPLETED|Overall Study||0||
48403070|NCT05406440|101317804|FG002|NOT COMPLETED|Overall Study||0||
48403071|NCT05406440|101317805|FG003|NOT COMPLETED|Overall Study||0||
48403072|NCT05406440|101317806|FG004|NOT COMPLETED|Overall Study||3||
48403073|NCT05406440|101317807|FG005|NOT COMPLETED|Overall Study||2||
48403074|NCT05406440|101317808|FG006|NOT COMPLETED|Overall Study||0||
48590132|NCT00176644|101776803|FG000|NOT COMPLETED|Overall Study||1||
48590133|NCT03558152|101776804|FG000|STARTED|Overall Study||22||
48590134|NCT03558152|101776805|FG001|STARTED|Overall Study||21||
48590135|NCT03558152|101776806|FG002|STARTED|Overall Study||21||
48590136|NCT03558152|101776807|FG003|STARTED|Overall Study||23||
48708225|NCT02460783|102073279|FG000|COMPLETED|Overall Study||20||
48708226|NCT02460783|102073280|FG001|COMPLETED|Overall Study||20||
48708227|NCT02460783|102073279|FG000|NOT COMPLETED|Overall Study||2||
48708228|NCT02460783|102073280|FG001|NOT COMPLETED|Overall Study||4||
48708229|NCT05427539|102073281|FG000|STARTED|Period 1||31||
48403075|NCT03472040|101317809|FG000|STARTED|Overall Study||100||
48403076|NCT03472040|101317810|FG001|STARTED|Overall Study||287||
48403077|NCT03472040|101317809|FG000|COMPLETED|Overall Study||0||
48403078|NCT03472040|101317810|FG001|COMPLETED|Overall Study||1||
48403079|NCT03472040|101317809|FG000|NOT COMPLETED|Overall Study||100||
48403080|NCT03472040|101317810|FG001|NOT COMPLETED|Overall Study||286||
48403081|NCT04623255|101317811|FG000|STARTED|Overall Study||11||
48403082|NCT04623255|101317812|FG001|STARTED|Overall Study||12||
48403083|NCT04623255|101317811|FG000|COMPLETED|Overall Study||11||
48590137|NCT03558152|101776808|FG004|STARTED|Overall Study||22||
48590138|NCT03558152|101776809|FG005|STARTED|Overall Study||21||
48590139|NCT03558152|101776810|FG006|STARTED|Overall Study||43||
48590140|NCT03558152|101776811|FG007|STARTED|Overall Study||22||
48590141|NCT03558152|101776804|FG000|COMPLETED|Overall Study||7||
48590142|NCT03558152|101776805|FG001|COMPLETED|Overall Study||6||
48590143|NCT03558152|101776806|FG002|COMPLETED|Overall Study||8||
48590144|NCT03558152|101776807|FG003|COMPLETED|Overall Study||8||
48590145|NCT03558152|101776808|FG004|COMPLETED|Overall Study||3||
48708230|NCT05427539|102073282|FG001|STARTED|Period 1||34||
48708231|NCT05427539|102073281|FG000|COMPLETED|Period 1||29||
48708232|NCT05427539|102073282|FG001|COMPLETED|Period 1||33||
48708233|NCT05427539|102073281|FG000|NOT COMPLETED|Period 1||2||
48708234|NCT05427539|102073282|FG001|NOT COMPLETED|Period 1||1||
48708235|NCT05427539|102073281|FG000|STARTED|Period 2||29||
48708236|NCT05427539|102073282|FG001|STARTED|Period 2||33||
48403084|NCT04623255|101317812|FG001|COMPLETED|Overall Study||11||
48403085|NCT04623255|101317811|FG000|NOT COMPLETED|Overall Study||0||
48403086|NCT04623255|101317812|FG001|NOT COMPLETED|Overall Study||1||
48403087|NCT03062267|101317813|FG000|STARTED|Overall Study||12||
48403088|NCT03062267|101317814|FG001|STARTED|Overall Study||37||
48403089|NCT03062267|101317813|FG000|COMPLETED|Overall Study||10||
48403090|NCT03062267|101317814|FG001|COMPLETED|Overall Study||32||
48403091|NCT03062267|101317813|FG000|NOT COMPLETED|Overall Study||2||
48590146|NCT03558152|101776809|FG005|COMPLETED|Overall Study||7||
48708237|NCT05427539|102073281|FG000|COMPLETED|Period 2||29||
48708238|NCT05427539|102073282|FG001|COMPLETED|Period 2||33||
48708239|NCT05427539|102073281|FG000|NOT COMPLETED|Period 2||0||
48590147|NCT03558152|101776810|FG006|COMPLETED|Overall Study||21||
48590148|NCT03558152|101776811|FG007|COMPLETED|Overall Study||6||
48708240|NCT05427539|102073282|FG001|NOT COMPLETED|Period 2||0||
48708241|NCT01218100|102073283|FG000|STARTED|Overall Study||95||
48708242|NCT01218100|102073284|FG001|STARTED|Overall Study||190||
48708243|NCT01218100|102073285|FG002|STARTED|Overall Study||189||
48708244|NCT01218100|102073286|FG003|STARTED|Overall Study||190||
48708245|NCT01218100|102073283|FG000|COMPLETED|Overall Study||71||
48708246|NCT01218100|102073284|FG001|COMPLETED|Overall Study||165||
48708247|NCT01218100|102073285|FG002|COMPLETED|Overall Study||162||
48708248|NCT01218100|102073286|FG003|COMPLETED|Overall Study||156||
48708249|NCT01218100|102073283|FG000|NOT COMPLETED|Overall Study||24||
48708250|NCT01218100|102073284|FG001|NOT COMPLETED|Overall Study||25||
48708251|NCT01218100|102073285|FG002|NOT COMPLETED|Overall Study||27||
48708252|NCT01218100|102073286|FG003|NOT COMPLETED|Overall Study||34||
48708253|NCT02141490|102073287|FG000|STARTED|Overall Study||34||
48708254|NCT02141490|102073288|FG001|STARTED|Overall Study||6||
48708255|NCT02141490|102073289|FG002|STARTED|Overall Study||3||
48708256|NCT02141490|102073287|FG000|COMPLETED|Overall Study||30||
48708257|NCT02141490|102073288|FG001|COMPLETED|Overall Study||6||
48708258|NCT02141490|102073289|FG002|COMPLETED|Overall Study||3||
48708259|NCT02141490|102073287|FG000|NOT COMPLETED|Overall Study||4||
48708260|NCT02141490|102073288|FG001|NOT COMPLETED|Overall Study||0||
48708261|NCT02141490|102073289|FG002|NOT COMPLETED|Overall Study||0||
48708262|NCT02868034|102073290|FG000|STARTED|Overall Study||30||
48708263|NCT02868034|102073291|FG001|STARTED|Overall Study||29||
48708264|NCT02868034|102073292|FG002|STARTED|Overall Study||30||
48708265|NCT02868034|102073293|FG003|STARTED|Overall Study||31||
48708266|NCT02868034|102073294|FG004|STARTED|Overall Study||30||
48708267|NCT02868034|102073295|FG005|STARTED|Overall Study||29||
48708268|NCT02868034|102073296|FG006|STARTED|Overall Study||30||
48708269|NCT02868034|102073297|FG007|STARTED|Overall Study||32||
48708270|NCT02868034|102073290|FG000|COMPLETED|Overall Study||22||
48708271|NCT02868034|102073291|FG001|COMPLETED|Overall Study||23||
48708272|NCT02868034|102073292|FG002|COMPLETED|Overall Study||26||
48708273|NCT02868034|102073293|FG003|COMPLETED|Overall Study||27||
48708274|NCT02868034|102073294|FG004|COMPLETED|Overall Study||24||
48708275|NCT02868034|102073295|FG005|COMPLETED|Overall Study||26||
48708276|NCT02868034|102073296|FG006|COMPLETED|Overall Study||24||
48708277|NCT02868034|102073297|FG007|COMPLETED|Overall Study||26||
48708278|NCT02868034|102073290|FG000|NOT COMPLETED|Overall Study||8||
48708279|NCT02868034|102073291|FG001|NOT COMPLETED|Overall Study||6||
48708280|NCT02868034|102073292|FG002|NOT COMPLETED|Overall Study||4||
48708281|NCT02868034|102073293|FG003|NOT COMPLETED|Overall Study||4||
48708282|NCT02868034|102073294|FG004|NOT COMPLETED|Overall Study||6||
48708283|NCT02868034|102073295|FG005|NOT COMPLETED|Overall Study||3||
48708284|NCT02868034|102073296|FG006|NOT COMPLETED|Overall Study||6||
48708285|NCT02868034|102073297|FG007|NOT COMPLETED|Overall Study||6||
48708286|NCT00937404|102073298|FG000|STARTED|Overall Study||25||
48708287|NCT00937404|102073298|FG000|COMPLETED|Overall Study||23||
48708288|NCT00937404|102073298|FG000|NOT COMPLETED|Overall Study||2||
48708289|NCT02098369|102073299|FG000|STARTED|Overall Study||142||
48708290|NCT02098369|102073300|FG001|STARTED|Overall Study||154||
48708291|NCT02098369|102073301|FG002|STARTED|Overall Study||148||
48708292|NCT02098369|102073299|FG000|COMPLETED|Overall Study||135||
48708293|NCT02098369|102073300|FG001|COMPLETED|Overall Study||145||
48708294|NCT02098369|102073301|FG002|COMPLETED|Overall Study||143||
48708295|NCT02098369|102073299|FG000|NOT COMPLETED|Overall Study||7||
48708296|NCT02098369|102073300|FG001|NOT COMPLETED|Overall Study||9||
48708297|NCT02098369|102073301|FG002|NOT COMPLETED|Overall Study||5||
48708298|NCT01665430|102073302|FG000|STARTED|Overall Study||38||
48708299|NCT01665430|102073302|FG000|COMPLETED|Overall Study||29||
48708300|NCT01665430|102073302|FG000|NOT COMPLETED|Overall Study||9||
48708301|NCT03100539|102073303|FG000|STARTED|Overall Study||145||
48708302|NCT03100539|102073304|FG001|STARTED|Overall Study||145||
48708303|NCT03100539|102073305|FG002|STARTED|Overall Study||102||
48708304|NCT03100539|102073303|FG000|1 Month|Overall Study||109||
48708305|NCT03100539|102073304|FG001|1 Month|Overall Study||114||
48708306|NCT03100539|102073305|FG002|1 Month|Overall Study||43||
48708307|NCT03100539|102073303|FG000|3 Month|Overall Study||87||
48708308|NCT03100539|102073304|FG001|3 Month|Overall Study||109||
48708309|NCT03100539|102073305|FG002|3 Month|Overall Study||34||
48708310|NCT03100539|102073303|FG000|6 Month|Overall Study||77||
48708311|NCT03100539|102073304|FG001|6 Month|Overall Study||83||
48708312|NCT03100539|102073305|FG002|6 Month|Overall Study||39||
48140016|NCT01343407|100665731|FG001|STARTED|Second Washout (Part 2)||2||
48140017|NCT01343407|100665732|FG002|STARTED|Second Washout (Part 2)||2||
48140018|NCT01343407|100665733|FG003|STARTED|Second Washout (Part 2)||3||
48140019|NCT01343407|100665734|FG004|STARTED|Second Washout (Part 2)||3||
48140020|NCT01343407|100665735|FG005|STARTED|Second Washout (Part 2)||3||
48140021|NCT01343407|100665730|FG000|COMPLETED|Second Washout (Part 2)||2||
48140022|NCT01343407|100665731|FG001|COMPLETED|Second Washout (Part 2)||2||
48140023|NCT01343407|100665732|FG002|COMPLETED|Second Washout (Part 2)||1||
48403092|NCT03062267|101317814|FG001|NOT COMPLETED|Overall Study||5||
48590149|NCT03558152|101776804|FG000|NOT COMPLETED|Overall Study||15||
48590150|NCT03558152|101776805|FG001|NOT COMPLETED|Overall Study||15||
48590151|NCT03558152|101776806|FG002|NOT COMPLETED|Overall Study||13||
48590152|NCT03558152|101776807|FG003|NOT COMPLETED|Overall Study||15||
48590153|NCT03558152|101776808|FG004|NOT COMPLETED|Overall Study||19||
48590154|NCT03558152|101776809|FG005|NOT COMPLETED|Overall Study||14||
48590155|NCT03558152|101776810|FG006|NOT COMPLETED|Overall Study||22||
48590156|NCT03558152|101776811|FG007|NOT COMPLETED|Overall Study||16||
48590157|NCT00784238|101776812|FG000|STARTED|Overall Study||289||
48590158|NCT00784238|101776812|FG000|COMPLETED|Overall Study||170||
48590159|NCT00784238|101776812|FG000|NOT COMPLETED|Overall Study||119||
48590160|NCT05821296|101776813|FG000|STARTED|Overall Study||33||
48590161|NCT05821296|101776813|FG000|COMPLETED|Overall Study||33||
48590162|NCT05821296|101776813|FG000|NOT COMPLETED|Overall Study||0||
48590163|NCT03384784|101776814|FG000|STARTED|First Intervention (12 Weeks)||28||
48590164|NCT03384784|101776815|FG001|STARTED|First Intervention (12 Weeks)||30||
48590165|NCT03384784|101776814|FG000|COMPLETED|First Intervention (12 Weeks)||25||
48590166|NCT03384784|101776815|FG001|COMPLETED|First Intervention (12 Weeks)||25||
48590167|NCT03384784|101776814|FG000|NOT COMPLETED|First Intervention (12 Weeks)||3||
48708313|NCT03100539|102073303|FG000|COMPLETED|Overall Study||77||
48708314|NCT03100539|102073304|FG001|COMPLETED|Overall Study||83||
48708315|NCT03100539|102073305|FG002|COMPLETED|Overall Study||39||
48708316|NCT03100539|102073303|FG000|NOT COMPLETED|Overall Study||68||
48708317|NCT03100539|102073304|FG001|NOT COMPLETED|Overall Study||62||
48708318|NCT03100539|102073305|FG002|NOT COMPLETED|Overall Study||63||
48708319|NCT00787930|102073306|FG000|STARTED|Acute Treatment -- 3 Weeks||19||
48708320|NCT00787930|102073306|FG000|COMPLETED|Acute Treatment -- 3 Weeks||19||
48708321|NCT00787930|102073306|FG000|NOT COMPLETED|Acute Treatment -- 3 Weeks||0||
48708322|NCT00787930|102073306|FG000|STARTED|Continuation Treatment -- up to 12 Month||19||
48708323|NCT00787930|102073306|FG000|COMPLETED|Continuation Treatment -- up to 12 Month||16||
48708324|NCT00787930|102073306|FG000|NOT COMPLETED|Continuation Treatment -- up to 12 Month||3||
48708325|NCT04569136|102073307|FG000|STARTED|Overall Study||12||
48708326|NCT04569136|102073308|FG001|STARTED|Overall Study||12||
48708327|NCT04569136|102073309|FG002|STARTED|Overall Study||13||
48708328|NCT04569136|102073307|FG000|COMPLETED|Overall Study||10||
48140024|NCT01343407|100665733|FG003|COMPLETED|Second Washout (Part 2)||3||
48708329|NCT04569136|102073308|FG001|COMPLETED|Overall Study||12||
48708330|NCT04569136|102073309|FG002|COMPLETED|Overall Study||12||
48708331|NCT04569136|102073307|FG000|NOT COMPLETED|Overall Study||2||
48708332|NCT04569136|102073308|FG001|NOT COMPLETED|Overall Study||0||
48708333|NCT04569136|102073309|FG002|NOT COMPLETED|Overall Study||1||
48140025|NCT01343407|100665734|FG004|COMPLETED|Second Washout (Part 2)||3||
48590168|NCT03384784|101776815|FG001|NOT COMPLETED|First Intervention (12 Weeks)||5||
48708334|NCT02370641|102073310|FG000|STARTED|Overall Study||18||
48708335|NCT02370641|102073311|FG001|STARTED|Overall Study||8||
48590169|NCT03384784|101776814|FG000|STARTED|Washout (4 Weeks)||25||
48590170|NCT03384784|101776815|FG001|STARTED|Washout (4 Weeks)||25||
48708336|NCT02370641|102073310|FG000|COMPLETED|Overall Study||14||
48708337|NCT02370641|102073311|FG001|COMPLETED|Overall Study||6||
48708338|NCT02370641|102073310|FG000|NOT COMPLETED|Overall Study||4||
48708339|NCT02370641|102073311|FG001|NOT COMPLETED|Overall Study||2||
48708340|NCT00888329|102073312|FG000|STARTED|Overall Study||125||
48708341|NCT00888329|102073313|FG001|STARTED|Overall Study||131||
48708342|NCT00888329|102073312|FG000|COMPLETED|Overall Study||119||
48708343|NCT00888329|102073313|FG001|COMPLETED|Overall Study||122||
48403093|NCT02204410|101317815|FG000|STARTED|Overall Study||21||
48403094|NCT02204410|101317815|FG000|COMPLETED|Overall Study||10||
48403095|NCT02204410|101317815|FG000|NOT COMPLETED|Overall Study||11||
48403096|NCT01685203|101317816|FG000|STARTED|Overall Study||44||
48403097|NCT01685203|101317817|FG001|STARTED|Overall Study||42||
48403098|NCT01685203|101317818|FG002|STARTED|Overall Study||40||
48403099|NCT01685203|101317819|FG003|STARTED|Overall Study||42||
48403100|NCT01685203|101317820|FG004|STARTED|Overall Study||49||
48403101|NCT01685203|101317821|FG005|STARTED|Overall Study||47||
48403102|NCT01685203|101317822|FG006|STARTED|Overall Study||52||
48403103|NCT01685203|101317816|FG000|Completed Study Drug|Overall Study||42||
48403104|NCT01685203|101317817|FG001|Completed Study Drug|Overall Study||40||
48403105|NCT01685203|101317818|FG002|Completed Study Drug|Overall Study||39||
48403106|NCT01685203|101317819|FG003|Completed Study Drug|Overall Study||42||
48403107|NCT01685203|101317820|FG004|Completed Study Drug|Overall Study||49||
48403108|NCT01685203|101317821|FG005|Completed Study Drug|Overall Study||43||
48403109|NCT01685203|101317822|FG006|Completed Study Drug|Overall Study||52||
48403110|NCT01685203|101317816|FG000|COMPLETED|Overall Study||40||
48403111|NCT01685203|101317817|FG001|COMPLETED|Overall Study||39||
48403112|NCT01685203|101317818|FG002|COMPLETED|Overall Study||40||
48403113|NCT01685203|101317819|FG003|COMPLETED|Overall Study||41||
48403114|NCT01685203|101317820|FG004|COMPLETED|Overall Study||49||
48403115|NCT01685203|101317821|FG005|COMPLETED|Overall Study||44||
48403116|NCT01685203|101317822|FG006|COMPLETED|Overall Study||52||
48403117|NCT01685203|101317816|FG000|NOT COMPLETED|Overall Study||4||
48403118|NCT01685203|101317817|FG001|NOT COMPLETED|Overall Study||3||
48403119|NCT01685203|101317818|FG002|NOT COMPLETED|Overall Study||0||
48403120|NCT01685203|101317819|FG003|NOT COMPLETED|Overall Study||1||
48403121|NCT01685203|101317820|FG004|NOT COMPLETED|Overall Study||0||
48403122|NCT01685203|101317821|FG005|NOT COMPLETED|Overall Study||3||
48403123|NCT01685203|101317822|FG006|NOT COMPLETED|Overall Study||0||
48403124|NCT01094808|101317823|FG000|STARTED|Overall Study||21||
48403125|NCT01094808|101317824|FG001|STARTED|Overall Study||20||
48403126|NCT01094808|101317825|FG002|STARTED|Overall Study||21||
48403127|NCT01094808|101317823|FG000|COMPLETED|Overall Study||20||
48403128|NCT01094808|101317824|FG001|COMPLETED|Overall Study||19||
48708344|NCT00888329|102073312|FG000|NOT COMPLETED|Overall Study||6||
48708345|NCT00888329|102073313|FG001|NOT COMPLETED|Overall Study||9||
48708346|NCT01466660|102073314|FG000|STARTED|Overall Study||160||
48708347|NCT01466660|102073315|FG001|STARTED|Overall Study||159||
48708348|NCT01466660|102073314|FG000|COMPLETED|Overall Study||0||
48708349|NCT01466660|102073315|FG001|COMPLETED|Overall Study||0||
48708350|NCT01466660|102073314|FG000|NOT COMPLETED|Overall Study||160||
48708351|NCT01466660|102073315|FG001|NOT COMPLETED|Overall Study||159||
48708352|NCT03500172|102073316|FG000|STARTED|Period 1: Baseline Randomization||0||
48403129|NCT01094808|101317825|FG002|COMPLETED|Overall Study||21||
48403130|NCT01094808|101317823|FG000|NOT COMPLETED|Overall Study||1||
48403131|NCT01094808|101317824|FG001|NOT COMPLETED|Overall Study||1||
48710775|NCT00899717|102078015|FG001|STARTED|Overall Study||11||
48403132|NCT01094808|101317825|FG002|NOT COMPLETED|Overall Study||0||
48403133|NCT03630016|101317826|FG000|STARTED|Overall Study||11||
48403134|NCT03630016|101317826|FG000|COMPLETED|Overall Study||10||
48403135|NCT03630016|101317826|FG000|NOT COMPLETED|Overall Study||1||
48403136|NCT03882723|101317827|FG000|STARTED|Overall Study||8||
48403137|NCT03882723|101317827|FG000|BiTrac Max Shield|Overall Study||8||
48590171|NCT03384784|101776814|FG000|COMPLETED|Washout (4 Weeks)||17||
48590172|NCT03384784|101776815|FG001|COMPLETED|Washout (4 Weeks)||24||
48590173|NCT03384784|101776814|FG000|NOT COMPLETED|Washout (4 Weeks)||8||
48590174|NCT03384784|101776815|FG001|NOT COMPLETED|Washout (4 Weeks)||1||
48590175|NCT03384784|101776814|FG000|STARTED|Second Intervention (12 Weeks)||17||
48590176|NCT03384784|101776815|FG001|STARTED|Second Intervention (12 Weeks)||24||
48403138|NCT03882723|101317827|FG000|BiTrac™ Full Face|Overall Study||8||
48403139|NCT03882723|101317827|FG000|Respironics PerforMax|Overall Study||8||
48590177|NCT03384784|101776814|FG000|COMPLETED|Second Intervention (12 Weeks)||16||
48590178|NCT03384784|101776815|FG001|COMPLETED|Second Intervention (12 Weeks)||21||
48590179|NCT03384784|101776814|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||1||
48590180|NCT03384784|101776815|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||3||
48590181|NCT03653351|101776816|FG000|STARTED|Overall Study||14||
48590182|NCT03653351|101776817|FG001|STARTED|Overall Study||12||
48590183|NCT03653351|101776816|FG000|COMPLETED|Overall Study||13||
48590184|NCT03653351|101776817|FG001|COMPLETED|Overall Study||10||
48590185|NCT03653351|101776816|FG000|NOT COMPLETED|Overall Study||1||
48590186|NCT03653351|101776817|FG001|NOT COMPLETED|Overall Study||2||
48590187|NCT01668966|101776818|FG000|STARTED|Overall Study||23||
48590188|NCT01668966|101776818|FG000|Treated|Overall Study||21||
48590189|NCT01668966|101776818|FG000|COMPLETED|Overall Study||19||
48590190|NCT01668966|101776818|FG000|NOT COMPLETED|Overall Study||4||
48590191|NCT05028413|101776819|FG000|STARTED|Overall Study||10||
48590192|NCT05028413|101776820|FG001|STARTED|Overall Study||10||
48590193|NCT05028413|101776819|FG000|COMPLETED|Overall Study||10||
48590194|NCT05028413|101776820|FG001|COMPLETED|Overall Study||10||
48590195|NCT05028413|101776819|FG000|NOT COMPLETED|Overall Study||0||
48590196|NCT05028413|101776820|FG001|NOT COMPLETED|Overall Study||0||
48590197|NCT05153148|101776821|FG000|STARTED|Overall Study||75||
48590198|NCT05153148|101776822|FG001|STARTED|Overall Study||76||
48590199|NCT05153148|101776823|FG002|STARTED|Overall Study||78||
48590200|NCT05153148|101776824|FG003|STARTED|Overall Study||76||
48590201|NCT05153148|101776821|FG000|COMPLETED|Overall Study||66||
48590202|NCT05153148|101776822|FG001|COMPLETED|Overall Study||66||
48590203|NCT05153148|101776823|FG002|COMPLETED|Overall Study||65||
48590204|NCT05153148|101776824|FG003|COMPLETED|Overall Study||60||
48590205|NCT05153148|101776821|FG000|NOT COMPLETED|Overall Study||9||
48590206|NCT05153148|101776822|FG001|NOT COMPLETED|Overall Study||10||
48590207|NCT05153148|101776823|FG002|NOT COMPLETED|Overall Study||13||
48590208|NCT05153148|101776824|FG003|NOT COMPLETED|Overall Study||16||
48590209|NCT00459706|101776825|FG000|STARTED|Overall Study||325||
48292413|NCT01672723|101044295|FG001|COMPLETED|First Intervention||15||
48292414|NCT01672723|101044294|FG000|NOT COMPLETED|First Intervention||3||
48292415|NCT01672723|101044295|FG001|NOT COMPLETED|First Intervention||0||
48292416|NCT01672723|101044294|FG000|STARTED|Washout Period of 10 Days||16||
48292417|NCT01672723|101044295|FG001|STARTED|Washout Period of 10 Days||15||
48292418|NCT01672723|101044294|FG000|COMPLETED|Washout Period of 10 Days||16||
48292419|NCT01672723|101044295|FG001|COMPLETED|Washout Period of 10 Days||15||
48292420|NCT01672723|101044294|FG000|NOT COMPLETED|Washout Period of 10 Days||0||
48292421|NCT01672723|101044295|FG001|NOT COMPLETED|Washout Period of 10 Days||0||
48292422|NCT01672723|101044294|FG000|STARTED|Second Intervention||16||
48292423|NCT01672723|101044295|FG001|STARTED|Second Intervention||15||
48292424|NCT01672723|101044294|FG000|COMPLETED|Second Intervention||16||
48292425|NCT01672723|101044295|FG001|COMPLETED|Second Intervention||15||
48292426|NCT01672723|101044294|FG000|NOT COMPLETED|Second Intervention||0||
48292427|NCT01672723|101044295|FG001|NOT COMPLETED|Second Intervention||0||
48403140|NCT03882723|101317827|FG000|Respironics AF531|Overall Study||8||
48590210|NCT00459706|101776826|FG001|STARTED|Overall Study||315||
48292428|NCT03706313|101044296|FG000|STARTED|Overall Study||20||
48292429|NCT03706313|101044297|FG001|STARTED|Overall Study||20||
48292430|NCT03706313|101044296|FG000|COMPLETED|Overall Study||20||
48292431|NCT03706313|101044297|FG001|COMPLETED|Overall Study||20||
48292432|NCT03706313|101044296|FG000|NOT COMPLETED|Overall Study||0||
48590211|NCT00459706|101776825|FG000|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study||324||
48590212|NCT00459706|101776826|FG001|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study||313||
48590213|NCT00459706|101776825|FG000|COMPLETED|Overall Study||299||
48590214|NCT00459706|101776826|FG001|COMPLETED|Overall Study||294||
48590215|NCT00459706|101776825|FG000|NOT COMPLETED|Overall Study||26||
48590216|NCT00459706|101776826|FG001|NOT COMPLETED|Overall Study||21||
48590217|NCT00732758|101776827|FG000|STARTED|Overall Study||78||
48590218|NCT00732758|101776828|FG001|STARTED|Overall Study||79||
48590219|NCT00732758|101776827|FG000|COMPLETED|Overall Study||70||
48590220|NCT00732758|101776828|FG001|COMPLETED|Overall Study||63||
48590221|NCT00732758|101776827|FG000|NOT COMPLETED|Overall Study||8||
48292433|NCT03706313|101044297|FG001|NOT COMPLETED|Overall Study||0||
48292434|NCT00390182|101044298|FG000|STARTED|Overall Study||38||
48590222|NCT00732758|101776828|FG001|NOT COMPLETED|Overall Study||16||
48590223|NCT01995175|101776829|FG000|STARTED|Period 1 - From 0 up to 2 Years of Age||2401||
48590224|NCT01995175|101776829|FG000|COMPLETED|Period 1 - From 0 up to 2 Years of Age||2148|Completed=Number of subjects that completed the primary study|
48590225|NCT01995175|101776829|FG000|NOT COMPLETED|Period 1 - From 0 up to 2 Years of Age||253||
48590226|NCT01995175|101776829|FG000|STARTED|Period 2 - From 2 up to 6 Years of Age||1395||
48590227|NCT01995175|101776829|FG000|COMPLETED|Period 2 - From 2 up to 6 Years of Age||1338||
48590228|NCT01995175|101776829|FG000|NOT COMPLETED|Period 2 - From 2 up to 6 Years of Age||57||
48590229|NCT02461524|101779655|FG000|STARTED|Overall Study||69||
48590230|NCT02461524|101779655|FG000|COMPLETED|Overall Study||38||
48590231|NCT02461524|101779655|FG000|NOT COMPLETED|Overall Study||31||
48590232|NCT03047720|101779656|FG000|STARTED|First Intervention (6weeks)||12||
48590233|NCT03047720|101779657|FG001|STARTED|First Intervention (6weeks)||0||
48590234|NCT03047720|101779656|FG000|COMPLETED|First Intervention (6weeks)||5||
48403141|NCT03882723|101317827|FG000|COMPLETED|Overall Study||8||
48590235|NCT03047720|101779657|FG001|COMPLETED|First Intervention (6weeks)||0||
48590236|NCT03047720|101779656|FG000|NOT COMPLETED|First Intervention (6weeks)||7||
48590237|NCT03047720|101779657|FG001|NOT COMPLETED|First Intervention (6weeks)||0||
48590238|NCT03047720|101779656|FG000|STARTED|Second Intervention (6weeks)||0||
48590239|NCT03047720|101779657|FG001|STARTED|Second Intervention (6weeks)||0||
48590240|NCT03047720|101779656|FG000|COMPLETED|Second Intervention (6weeks)||0||
48590241|NCT03047720|101779657|FG001|COMPLETED|Second Intervention (6weeks)||0||
48590242|NCT03047720|101779656|FG000|NOT COMPLETED|Second Intervention (6weeks)||0||
48590243|NCT03047720|101779657|FG001|NOT COMPLETED|Second Intervention (6weeks)||0||
48590244|NCT01203826|101779658|FG000|STARTED|Overall Study||6||
48590245|NCT01203826|101779659|FG001|STARTED|Overall Study||6||
48590246|NCT01203826|101779658|FG000|COMPLETED|Overall Study||6||
48590247|NCT01203826|101779659|FG001|COMPLETED|Overall Study||6||
48590248|NCT01203826|101779658|FG000|NOT COMPLETED|Overall Study||0||
48590249|NCT01203826|101779659|FG001|NOT COMPLETED|Overall Study||0||
48590250|NCT02089334|101779660|FG000|STARTED|Overall Study||3||
48590251|NCT02089334|101779661|FG001|STARTED|Overall Study||4||
48590252|NCT02089334|101779662|FG002|STARTED|Overall Study||4||
48590253|NCT02089334|101779663|FG003|STARTED|Overall Study||13||
48590254|NCT02089334|101779660|FG000|Received Study Drug|Overall Study||3||
48590255|NCT02089334|101779661|FG001|Received Study Drug|Overall Study||4||
48590256|NCT02089334|101779662|FG002|Received Study Drug|Overall Study||3||
48590257|NCT02089334|101779663|FG003|Received Study Drug|Overall Study||11||
48590258|NCT02089334|101779660|FG000|COMPLETED|Overall Study||3||
48590259|NCT02089334|101779661|FG001|COMPLETED|Overall Study||4||
48590260|NCT02089334|101779662|FG002|COMPLETED|Overall Study||3||
48590261|NCT02089334|101779663|FG003|COMPLETED|Overall Study||6||
48590262|NCT02089334|101779660|FG000|NOT COMPLETED|Overall Study||0||
48590263|NCT02089334|101779661|FG001|NOT COMPLETED|Overall Study||0||
48590264|NCT02089334|101779662|FG002|NOT COMPLETED|Overall Study||1||
48590265|NCT02089334|101779663|FG003|NOT COMPLETED|Overall Study||7||
48292435|NCT00390182|101044298|FG000|COMPLETED|Overall Study||33||
48292436|NCT00390182|101044298|FG000|NOT COMPLETED|Overall Study||5||
48292437|NCT00063154|101044299|FG000|STARTED|Overall Study||51||
48292438|NCT00063154|101044299|FG000|COMPLETED|Overall Study||0||
48292439|NCT00063154|101044299|FG000|NOT COMPLETED|Overall Study||51||
48292440|NCT01193920|101044300|FG000|STARTED|Overall Study||40||
48292441|NCT01193920|101044301|FG001|STARTED|Overall Study||20||
48292442|NCT01193920|101044302|FG002|STARTED|Overall Study||80||
48292443|NCT01193920|101044303|FG003|STARTED|Overall Study||80||
48292444|NCT01193920|101044304|FG004|STARTED|Overall Study||80||
48292445|NCT01193920|101044305|FG005|STARTED|Overall Study||80||
48292446|NCT01193920|101044306|FG006|STARTED|Overall Study||80||
48292447|NCT01193920|101044307|FG007|STARTED|Overall Study||80||
48292448|NCT01193920|101044308|FG008|STARTED|Overall Study||76||
48403142|NCT03882723|101317827|FG000|NOT COMPLETED|Overall Study||0||
48590266|NCT02817516|101779664|FG000|STARTED|Overall Study||6||
48403143|NCT00561340|101317828|FG000|STARTED|Overall Study||13||
48590267|NCT02817516|101779665|FG001|STARTED|Overall Study||6||
48590268|NCT02817516|101779666|FG002|STARTED|Overall Study||6||
48590269|NCT02817516|101779667|FG003|STARTED|Overall Study||6||
48590270|NCT02817516|101779664|FG000|COMPLETED|Overall Study||6||
48590271|NCT02817516|101779665|FG001|COMPLETED|Overall Study||6||
48590272|NCT02817516|101779666|FG002|COMPLETED|Overall Study||5||
48590273|NCT02817516|101779667|FG003|COMPLETED|Overall Study||6||
48292449|NCT01193920|101044309|FG009|STARTED|Overall Study||81||
48292450|NCT01193920|101044300|FG000|COMPLETED|Overall Study||37||
48292451|NCT01193920|101044301|FG001|COMPLETED|Overall Study||20||
48292452|NCT01193920|101044302|FG002|COMPLETED|Overall Study||74||
48590274|NCT02817516|101779664|FG000|NOT COMPLETED|Overall Study||0||
48292453|NCT01193920|101044303|FG003|COMPLETED|Overall Study||76||
48403144|NCT00561340|101317829|FG001|STARTED|Overall Study||16||
48590275|NCT02817516|101779665|FG001|NOT COMPLETED|Overall Study||0||
48590276|NCT02817516|101779666|FG002|NOT COMPLETED|Overall Study||1||
48590277|NCT02817516|101779667|FG003|NOT COMPLETED|Overall Study||0||
48590278|NCT05072964|101779668|FG000|STARTED|Overall Study||180||
48590279|NCT05072964|101779668|FG000|COMPLETED|Overall Study||175||
48590280|NCT05072964|101779668|FG000|NOT COMPLETED|Overall Study||5||
48708353|NCT03500172|102073317|FG001|STARTED|Period 1: Baseline Randomization||0||
48708354|NCT03500172|102073318|FG002|STARTED|Period 1: Baseline Randomization||0||
48708355|NCT03500172|102073319|FG003|STARTED|Period 1: Baseline Randomization||0||
48590281|NCT02987972|101779669|FG000|STARTED|Overall Study||351||
48590282|NCT02987972|101779670|FG001|STARTED|Overall Study||350||
48708356|NCT03500172|102073320|FG004|STARTED|Period 1: Baseline Randomization||0||
48708357|NCT03500172|102073321|FG005|STARTED|Period 1: Baseline Randomization||0||
48708358|NCT03500172|102073322|FG006|STARTED|Period 1: Baseline Randomization||0||
48708359|NCT03500172|102073323|FG007|STARTED|Period 1: Baseline Randomization||0||
48708360|NCT03500172|102073324|FG008|STARTED|Period 1: Baseline Randomization||614||
48708361|NCT03500172|102073325|FG009|STARTED|Period 1: Baseline Randomization||390||
48140026|NCT01343407|100665735|FG005|COMPLETED|Second Washout (Part 2)||3||
48140027|NCT01343407|100665730|FG000|NOT COMPLETED|Second Washout (Part 2)||0||
48140028|NCT01343407|100665731|FG001|NOT COMPLETED|Second Washout (Part 2)||0||
48140029|NCT01343407|100665732|FG002|NOT COMPLETED|Second Washout (Part 2)||1||
48140030|NCT01343407|100665733|FG003|NOT COMPLETED|Second Washout (Part 2)||0||
48292454|NCT01193920|101044304|FG004|COMPLETED|Overall Study||74||
48292455|NCT01193920|101044305|FG005|COMPLETED|Overall Study||76||
48292456|NCT01193920|101044306|FG006|COMPLETED|Overall Study||74||
48292457|NCT01193920|101044307|FG007|COMPLETED|Overall Study||76||
48292458|NCT01193920|101044308|FG008|COMPLETED|Overall Study||71||
48292459|NCT01193920|101044309|FG009|COMPLETED|Overall Study||74||
48292460|NCT01193920|101044300|FG000|NOT COMPLETED|Overall Study||3||
48292461|NCT01193920|101044301|FG001|NOT COMPLETED|Overall Study||0||
48292462|NCT01193920|101044302|FG002|NOT COMPLETED|Overall Study||6||
48292463|NCT01193920|101044303|FG003|NOT COMPLETED|Overall Study||4||
48292464|NCT01193920|101044304|FG004|NOT COMPLETED|Overall Study||6||
48292465|NCT01193920|101044305|FG005|NOT COMPLETED|Overall Study||4||
48292466|NCT01193920|101044306|FG006|NOT COMPLETED|Overall Study||6||
48292467|NCT01193920|101044307|FG007|NOT COMPLETED|Overall Study||4||
48292468|NCT01193920|101044308|FG008|NOT COMPLETED|Overall Study||5||
48292469|NCT01193920|101044309|FG009|NOT COMPLETED|Overall Study||7||
48292470|NCT02960854|101044310|FG000|STARTED|Overall Study||15||
48292471|NCT02960854|101044311|FG001|STARTED|Overall Study||16||
48292472|NCT02960854|101044310|FG000|COMPLETED|Overall Study||8||
48292473|NCT02960854|101044311|FG001|COMPLETED|Overall Study||7||
48292474|NCT02960854|101044310|FG000|NOT COMPLETED|Overall Study||7||
48292475|NCT02960854|101044311|FG001|NOT COMPLETED|Overall Study||9||
48292476|NCT01588496|101044312|FG000|STARTED|Overall Study||8||
48292477|NCT01588496|101044313|FG001|STARTED|Overall Study||17||
48292478|NCT01588496|101044314|FG002|STARTED|Overall Study||33||
48292479|NCT01588496|101044312|FG000|Received Treatment|Overall Study||8||
48292480|NCT01588496|101044313|FG001|Received Treatment|Overall Study||16||
48292481|NCT01588496|101044314|FG002|Received Treatment|Overall Study||33||
48292482|NCT01588496|101044312|FG000|COMPLETED|Overall Study||8||
48292483|NCT01588496|101044313|FG001|COMPLETED|Overall Study||16||
48292484|NCT01588496|101044314|FG002|COMPLETED|Overall Study||33||
48292485|NCT01588496|101044312|FG000|NOT COMPLETED|Overall Study||0||
48292486|NCT01588496|101044313|FG001|NOT COMPLETED|Overall Study||1||
48292487|NCT01588496|101044314|FG002|NOT COMPLETED|Overall Study||0||
48292488|NCT00645801|101044315|FG000|STARTED|Overall Study||77||
48292489|NCT00645801|101044316|FG001|STARTED|Overall Study||81||
48292490|NCT00645801|101044315|FG000|COMPLETED|Overall Study||57||
48292491|NCT00645801|101044316|FG001|COMPLETED|Overall Study||66||
48590283|NCT02987972|101779671|FG002|STARTED|Overall Study||350||
48590284|NCT02987972|101779669|FG000|Vaccination 1|Overall Study||350||
48590285|NCT02987972|101779670|FG001|Vaccination 1|Overall Study||347||
48708362|NCT03500172|102073326|FG010|STARTED|Period 1: Baseline Randomization||387||
48140031|NCT01343407|100665734|FG004|NOT COMPLETED|Second Washout (Part 2)||0||
48140032|NCT01343407|100665735|FG005|NOT COMPLETED|Second Washout (Part 2)||0||
48292492|NCT00645801|101044315|FG000|NOT COMPLETED|Overall Study||20||
48292493|NCT00645801|101044316|FG001|NOT COMPLETED|Overall Study||15||
48292494|NCT01768520|101044317|FG000|STARTED|Overall Study||152||
48292495|NCT01768520|101044318|FG001|STARTED|Overall Study||147||
48292496|NCT01768520|101044319|FG002|STARTED|Overall Study||39||
48292497|NCT01768520|101044317|FG000|COMPLETED|Overall Study||120||
48292498|NCT01768520|101044318|FG001|COMPLETED|Overall Study||121||
48292499|NCT01768520|101044319|FG002|COMPLETED|Overall Study||30||
48708363|NCT03500172|102073316|FG000|COMPLETED|Period 1: Baseline Randomization||0||
48708364|NCT03500172|102073317|FG001|COMPLETED|Period 1: Baseline Randomization||0||
48140033|NCT01343407|100665730|FG000|STARTED|Third Treatment Period (Part 2)||2|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
48140034|NCT01343407|100665731|FG001|STARTED|Third Treatment Period (Part 2)||2|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
48292500|NCT01768520|101044317|FG000|NOT COMPLETED|Overall Study||32||
48590286|NCT02987972|101779671|FG002|Vaccination 1|Overall Study||347||
48292501|NCT01768520|101044318|FG001|NOT COMPLETED|Overall Study||26||
48292502|NCT01768520|101044319|FG002|NOT COMPLETED|Overall Study||9||
48292503|NCT00852540|101044320|FG000|STARTED|Overall Study||270||
48140035|NCT01343407|100665732|FG002|STARTED|Third Treatment Period (Part 2)||1|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
48140036|NCT01343407|100665733|FG003|STARTED|Third Treatment Period (Part 2)||3|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
48140037|NCT01343407|100665734|FG004|STARTED|Third Treatment Period (Part 2)||3|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
48292504|NCT00852540|101044321|FG001|STARTED|Overall Study||140||
48292505|NCT00852540|101044320|FG000|COMPLETED|Overall Study||234||
48292506|NCT00852540|101044321|FG001|COMPLETED|Overall Study||122||
48292507|NCT00852540|101044320|FG000|NOT COMPLETED|Overall Study||36||
48292508|NCT00852540|101044321|FG001|NOT COMPLETED|Overall Study||18||
48292509|NCT02856828|101044322|FG000|STARTED|Overall Study||2||
48292510|NCT02856828|101044323|FG001|STARTED|Overall Study||3||
48292511|NCT02856828|101044322|FG000|COMPLETED|Overall Study||2||
48292512|NCT02856828|101044323|FG001|COMPLETED|Overall Study||3||
48292513|NCT02856828|101044322|FG000|NOT COMPLETED|Overall Study||0||
48292514|NCT02856828|101044323|FG001|NOT COMPLETED|Overall Study||0||
48292515|NCT01001832|101044324|FG000|STARTED|Short-term Period||59||
48292516|NCT01001832|101044325|FG001|STARTED|Short-term Period||59||
48590287|NCT02987972|101779669|FG000|Vaccination 2|Overall Study||333||
48590288|NCT02987972|101779670|FG001|Vaccination 2|Overall Study||335||
48590289|NCT02987972|101779671|FG002|Vaccination 2|Overall Study||335||
48590290|NCT02987972|101779669|FG000|Vaccination 3|Overall Study||330||
48590291|NCT02987972|101779670|FG001|Vaccination 3|Overall Study||331||
48590292|NCT02987972|101779671|FG002|Vaccination 3|Overall Study||332||
48590293|NCT02987972|101779669|FG000|Vaccination 4|Overall Study||310||
48590294|NCT02987972|101779670|FG001|Vaccination 4|Overall Study||306||
48140038|NCT01343407|100665735|FG005|STARTED|Third Treatment Period (Part 2)||3|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
48140039|NCT01343407|100665730|FG000|COMPLETED|Third Treatment Period (Part 2)||2||
48140040|NCT01343407|100665731|FG001|COMPLETED|Third Treatment Period (Part 2)||2||
48140041|NCT01343407|100665732|FG002|COMPLETED|Third Treatment Period (Part 2)||1||
48140042|NCT01343407|100665733|FG003|COMPLETED|Third Treatment Period (Part 2)||3||
48140043|NCT01343407|100665734|FG004|COMPLETED|Third Treatment Period (Part 2)||3||
48140044|NCT01343407|100665735|FG005|COMPLETED|Third Treatment Period (Part 2)||3||
48140045|NCT01343407|100665730|FG000|NOT COMPLETED|Third Treatment Period (Part 2)||0||
48140046|NCT01343407|100665731|FG001|NOT COMPLETED|Third Treatment Period (Part 2)||0||
48140047|NCT01343407|100665732|FG002|NOT COMPLETED|Third Treatment Period (Part 2)||0||
48140048|NCT01343407|100665733|FG003|NOT COMPLETED|Third Treatment Period (Part 2)||0||
48140049|NCT01343407|100665734|FG004|NOT COMPLETED|Third Treatment Period (Part 2)||0||
48140050|NCT01343407|100665735|FG005|NOT COMPLETED|Third Treatment Period (Part 2)||0||
48140051|NCT03370887|100665736|FG000|STARTED|Overall Study||7||
48140052|NCT03370887|100665737|FG001|STARTED|Overall Study||4||
48140053|NCT03370887|100665736|FG000|COMPLETED|Overall Study||7||
48140054|NCT03370887|100665737|FG001|COMPLETED|Overall Study||4||
48140055|NCT03370887|100665736|FG000|NOT COMPLETED|Overall Study||0||
48140056|NCT03370887|100665737|FG001|NOT COMPLETED|Overall Study||0||
48140057|NCT01519713|100665738|FG000|STARTED|Overall Study||194||
48140058|NCT01519713|100665739|FG001|STARTED|Overall Study||2||
48140059|NCT01519713|100665740|FG002|STARTED|Overall Study||4||
48140060|NCT01519713|100665738|FG000|COMPLETED|Overall Study||194||
48140061|NCT01519713|100665739|FG001|COMPLETED|Overall Study||2||
48140062|NCT01519713|100665740|FG002|COMPLETED|Overall Study||4||
48140063|NCT01519713|100665738|FG000|NOT COMPLETED|Overall Study||0||
48140064|NCT01519713|100665739|FG001|NOT COMPLETED|Overall Study||0||
48140065|NCT01519713|100665740|FG002|NOT COMPLETED|Overall Study||0||
48140066|NCT01358968|100665741|FG000|STARTED|Period 1||20||
48140067|NCT01358968|100665742|FG001|STARTED|Period 1||0||
48140068|NCT01358968|100665743|FG002|STARTED|Period 1||0||
48140069|NCT01358968|100665744|FG003|STARTED|Period 1||0||
48140070|NCT01358968|100665741|FG000|Received at Least 1 Dose of Study Drug|Period 1||20||
48140071|NCT01358968|100665742|FG001|Received at Least 1 Dose of Study Drug|Period 1||0||
48140072|NCT01358968|100665743|FG002|Received at Least 1 Dose of Study Drug|Period 1||0||
48292517|NCT01001832|101044324|FG000|COMPLETED|Short-term Period||57||
48590295|NCT02987972|101779671|FG002|Vaccination 4|Overall Study||311||
48590296|NCT02987972|101779669|FG000|COMPLETED|Overall Study||308||
48590297|NCT02987972|101779670|FG001|COMPLETED|Overall Study||305||
48590298|NCT02987972|101779671|FG002|COMPLETED|Overall Study||308||
48590299|NCT02987972|101779669|FG000|NOT COMPLETED|Overall Study||43||
48590300|NCT02987972|101779670|FG001|NOT COMPLETED|Overall Study||45||
48590301|NCT02987972|101779671|FG002|NOT COMPLETED|Overall Study||42||
48590302|NCT02706886|101779672|FG000|STARTED|Part A: SAD Period||8||
48590303|NCT02706886|101779673|FG001|STARTED|Part A: SAD Period||6||
48590304|NCT02706886|101779674|FG002|STARTED|Part A: SAD Period||6||
48590305|NCT02706886|101779675|FG003|STARTED|Part A: SAD Period||6||
48590306|NCT02706886|101779676|FG004|STARTED|Part A: SAD Period||6||
48590307|NCT02706886|101779677|FG005|STARTED|Part A: SAD Period||0||
48590308|NCT02706886|101779678|FG006|STARTED|Part A: SAD Period||0||
48590309|NCT02706886|101779679|FG007|STARTED|Part A: SAD Period||0||
48590310|NCT02706886|101779680|FG008|STARTED|Part A: SAD Period||0||
48590311|NCT02706886|101779672|FG000|COMPLETED|Part A: SAD Period||8||
48590312|NCT02706886|101779673|FG001|COMPLETED|Part A: SAD Period||6||
48590313|NCT02706886|101779674|FG002|COMPLETED|Part A: SAD Period||6||
48590314|NCT02706886|101779675|FG003|COMPLETED|Part A: SAD Period||4||
48590315|NCT02706886|101779676|FG004|COMPLETED|Part A: SAD Period||6||
48590316|NCT02706886|101779677|FG005|COMPLETED|Part A: SAD Period||0||
48140073|NCT01358968|100665744|FG003|Received at Least 1 Dose of Study Drug|Period 1||0||
48140074|NCT01358968|100665741|FG000|COMPLETED|Period 1||20||
48140075|NCT01358968|100665742|FG001|COMPLETED|Period 1||0||
48140076|NCT01358968|100665743|FG002|COMPLETED|Period 1||0||
48140077|NCT01358968|100665744|FG003|COMPLETED|Period 1||0||
48140078|NCT01358968|100665741|FG000|NOT COMPLETED|Period 1||0||
48140079|NCT01358968|100665742|FG001|NOT COMPLETED|Period 1||0||
48140080|NCT01358968|100665743|FG002|NOT COMPLETED|Period 1||0||
48140081|NCT01358968|100665744|FG003|NOT COMPLETED|Period 1||0||
48140082|NCT01358968|100665741|FG000|STARTED|Period 2||0||
48140083|NCT01358968|100665742|FG001|STARTED|Period 2||20||
48140084|NCT01358968|100665743|FG002|STARTED|Period 2||0||
48140085|NCT01358968|100665744|FG003|STARTED|Period 2||0||
48140086|NCT01358968|100665741|FG000|Received at Least 1 Dose of Study Drug|Period 2||0||
48140087|NCT01358968|100665742|FG001|Received at Least 1 Dose of Study Drug|Period 2||19||
48140088|NCT01358968|100665743|FG002|Received at Least 1 Dose of Study Drug|Period 2||0||
48140089|NCT01358968|100665744|FG003|Received at Least 1 Dose of Study Drug|Period 2||0||
48140090|NCT01358968|100665741|FG000|COMPLETED|Period 2||0||
48140091|NCT01358968|100665742|FG001|COMPLETED|Period 2||19||
48140092|NCT01358968|100665743|FG002|COMPLETED|Period 2||0||
48140093|NCT01358968|100665744|FG003|COMPLETED|Period 2||0||
48140094|NCT01358968|100665741|FG000|NOT COMPLETED|Period 2||0||
48590317|NCT02706886|101779678|FG006|COMPLETED|Part A: SAD Period||0||
48140095|NCT01358968|100665742|FG001|NOT COMPLETED|Period 2||1||
48590318|NCT02706886|101779679|FG007|COMPLETED|Part A: SAD Period||0||
48140096|NCT01358968|100665743|FG002|NOT COMPLETED|Period 2||0||
48140097|NCT01358968|100665744|FG003|NOT COMPLETED|Period 2||0||
48140098|NCT01358968|100665741|FG000|STARTED|Continued Access Phase||0||
48140099|NCT01358968|100665742|FG001|STARTED|Continued Access Phase||0||
48140100|NCT01358968|100665743|FG002|STARTED|Continued Access Phase||12||
48590319|NCT02706886|101779680|FG008|COMPLETED|Part A: SAD Period||0||
48590320|NCT02706886|101779672|FG000|NOT COMPLETED|Part A: SAD Period||0||
48590321|NCT02706886|101779673|FG001|NOT COMPLETED|Part A: SAD Period||0||
48590322|NCT02706886|101779674|FG002|NOT COMPLETED|Part A: SAD Period||0||
48590323|NCT02706886|101779675|FG003|NOT COMPLETED|Part A: SAD Period||2||
48140101|NCT01358968|100665744|FG003|STARTED|Continued Access Phase||7||
48140102|NCT01358968|100665741|FG000|Received at Least 1 Dose of Study Drug|Continued Access Phase||0||
48590324|NCT02706886|101779676|FG004|NOT COMPLETED|Part A: SAD Period||0||
48140103|NCT01358968|100665742|FG001|Received at Least 1 Dose of Study Drug|Continued Access Phase||0||
48140104|NCT01358968|100665743|FG002|Received at Least 1 Dose of Study Drug|Continued Access Phase||12||
48292518|NCT01001832|101044325|FG001|COMPLETED|Short-term Period||56||
48590325|NCT02706886|101779677|FG005|NOT COMPLETED|Part A: SAD Period||0||
48590326|NCT02706886|101779678|FG006|NOT COMPLETED|Part A: SAD Period||0||
48590327|NCT02706886|101779679|FG007|NOT COMPLETED|Part A: SAD Period||0||
48590328|NCT02706886|101779680|FG008|NOT COMPLETED|Part A: SAD Period||0||
48590329|NCT02706886|101779672|FG000|STARTED|Part B: MAD Study Days 1-85||0||
48590330|NCT02706886|101779673|FG001|STARTED|Part B: MAD Study Days 1-85||0||
48590331|NCT02706886|101779674|FG002|STARTED|Part B: MAD Study Days 1-85||0||
48590332|NCT02706886|101779675|FG003|STARTED|Part B: MAD Study Days 1-85||0||
48590333|NCT02706886|101779676|FG004|STARTED|Part B: MAD Study Days 1-85||0||
48590334|NCT02706886|101779677|FG005|STARTED|Part B: MAD Study Days 1-85||3||
48590335|NCT02706886|101779678|FG006|STARTED|Part B: MAD Study Days 1-85||7||
48590336|NCT02706886|101779679|FG007|STARTED|Part B: MAD Study Days 1-85||7||
48590337|NCT02706886|101779680|FG008|STARTED|Part B: MAD Study Days 1-85||3||
48590338|NCT02706886|101779672|FG000|COMPLETED|Part B: MAD Study Days 1-85||0||
48590339|NCT02706886|101779673|FG001|COMPLETED|Part B: MAD Study Days 1-85||0||
48590340|NCT02706886|101779674|FG002|COMPLETED|Part B: MAD Study Days 1-85||0||
48590341|NCT02706886|101779675|FG003|COMPLETED|Part B: MAD Study Days 1-85||0||
48590342|NCT02706886|101779676|FG004|COMPLETED|Part B: MAD Study Days 1-85||0||
48590343|NCT02706886|101779677|FG005|COMPLETED|Part B: MAD Study Days 1-85||3||
48590344|NCT02706886|101779678|FG006|COMPLETED|Part B: MAD Study Days 1-85||7||
48590345|NCT02706886|101779679|FG007|COMPLETED|Part B: MAD Study Days 1-85||7||
48590346|NCT02706886|101779680|FG008|COMPLETED|Part B: MAD Study Days 1-85||3||
48590347|NCT02706886|101779672|FG000|NOT COMPLETED|Part B: MAD Study Days 1-85||0||
48590348|NCT02706886|101779673|FG001|NOT COMPLETED|Part B: MAD Study Days 1-85||0||
48590349|NCT02706886|101779674|FG002|NOT COMPLETED|Part B: MAD Study Days 1-85||0||
48590350|NCT02706886|101779675|FG003|NOT COMPLETED|Part B: MAD Study Days 1-85||0||
48590351|NCT02706886|101779676|FG004|NOT COMPLETED|Part B: MAD Study Days 1-85||0||
48590352|NCT02706886|101779677|FG005|NOT COMPLETED|Part B: MAD Study Days 1-85||0||
48590353|NCT02706886|101779678|FG006|NOT COMPLETED|Part B: MAD Study Days 1-85||0||
48590354|NCT02706886|101779679|FG007|NOT COMPLETED|Part B: MAD Study Days 1-85||0||
48590355|NCT02706886|101779680|FG008|NOT COMPLETED|Part B: MAD Study Days 1-85||0||
48590356|NCT02706886|101779672|FG000|STARTED|Part B: MAD Study Day 85-End of Study||0||
48590357|NCT02706886|101779673|FG001|STARTED|Part B: MAD Study Day 85-End of Study||0||
48590358|NCT02706886|101779674|FG002|STARTED|Part B: MAD Study Day 85-End of Study||0||
48140105|NCT01358968|100665744|FG003|Received at Least 1 Dose of Study Drug|Continued Access Phase||7||
48590359|NCT02706886|101779675|FG003|STARTED|Part B: MAD Study Day 85-End of Study||0||
48590360|NCT02706886|101779676|FG004|STARTED|Part B: MAD Study Day 85-End of Study||0||
48590361|NCT02706886|101779677|FG005|STARTED|Part B: MAD Study Day 85-End of Study||0||
48590362|NCT02706886|101779678|FG006|STARTED|Part B: MAD Study Day 85-End of Study||8||
48140106|NCT01358968|100665741|FG000|COMPLETED|Continued Access Phase||0||
48590363|NCT02706886|101779679|FG007|STARTED|Part B: MAD Study Day 85-End of Study||8||
48140107|NCT01358968|100665742|FG001|COMPLETED|Continued Access Phase||0||
48292519|NCT01001832|101044324|FG000|NOT COMPLETED|Short-term Period||2||
48292520|NCT01001832|101044325|FG001|NOT COMPLETED|Short-term Period||3||
48292521|NCT01001832|101044324|FG000|STARTED|Long-term Period||56||
48292522|NCT01001832|101044325|FG001|STARTED|Long-term Period||56||
48292523|NCT01001832|101044324|FG000|COMPLETED|Long-term Period||52||
48292524|NCT01001832|101044325|FG001|COMPLETED|Long-term Period||51||
48292525|NCT01001832|101044324|FG000|NOT COMPLETED|Long-term Period||4||
48292526|NCT01001832|101044325|FG001|NOT COMPLETED|Long-term Period||5||
48292527|NCT01001832|101044324|FG000|STARTED|Follow-up Period||52||
48292528|NCT01001832|101044325|FG001|STARTED|Follow-up Period||51||
48292529|NCT01001832|101044324|FG000|COMPLETED|Follow-up Period||34||
48292530|NCT01001832|101044325|FG001|COMPLETED|Follow-up Period||30||
48292531|NCT01001832|101044324|FG000|NOT COMPLETED|Follow-up Period||18||
48292532|NCT01001832|101044325|FG001|NOT COMPLETED|Follow-up Period||21||
48292533|NCT04025580|101044326|FG000|STARTED|Overall Study||24||
48292534|NCT04025580|101044327|FG001|STARTED|Overall Study||34||
48292535|NCT04025580|101044328|FG002|STARTED|Overall Study||40||
48292536|NCT04025580|101044326|FG000|COMPLETED|Overall Study||13||
48292537|NCT04025580|101044327|FG001|COMPLETED|Overall Study||34||
48403145|NCT00561340|101317828|FG000|COMPLETED|Overall Study||7||
48403146|NCT00561340|101317829|FG001|COMPLETED|Overall Study||16||
48708365|NCT03500172|102073318|FG002|COMPLETED|Period 1: Baseline Randomization||0||
48708366|NCT03500172|102073319|FG003|COMPLETED|Period 1: Baseline Randomization||0||
48708367|NCT03500172|102073320|FG004|COMPLETED|Period 1: Baseline Randomization||0||
48708368|NCT03500172|102073321|FG005|COMPLETED|Period 1: Baseline Randomization||0||
48708369|NCT03500172|102073322|FG006|COMPLETED|Period 1: Baseline Randomization||0||
48708370|NCT03500172|102073323|FG007|COMPLETED|Period 1: Baseline Randomization||0||
48708371|NCT03500172|102073324|FG008|COMPLETED|Period 1: Baseline Randomization||614||
48708372|NCT03500172|102073325|FG009|COMPLETED|Period 1: Baseline Randomization||387||
48708373|NCT03500172|102073326|FG010|COMPLETED|Period 1: Baseline Randomization||387||
48708374|NCT03500172|102073316|FG000|NOT COMPLETED|Period 1: Baseline Randomization||0||
48708375|NCT03500172|102073317|FG001|NOT COMPLETED|Period 1: Baseline Randomization||0||
48708376|NCT03500172|102073318|FG002|NOT COMPLETED|Period 1: Baseline Randomization||0||
48708377|NCT03500172|102073319|FG003|NOT COMPLETED|Period 1: Baseline Randomization||0||
48708378|NCT03500172|102073320|FG004|NOT COMPLETED|Period 1: Baseline Randomization||0||
48708379|NCT03500172|102073321|FG005|NOT COMPLETED|Period 1: Baseline Randomization||0||
48708380|NCT03500172|102073322|FG006|NOT COMPLETED|Period 1: Baseline Randomization||0||
48708381|NCT03500172|102073323|FG007|NOT COMPLETED|Period 1: Baseline Randomization||0||
48708382|NCT03500172|102073324|FG008|NOT COMPLETED|Period 1: Baseline Randomization||0||
48708383|NCT03500172|102073325|FG009|NOT COMPLETED|Period 1: Baseline Randomization||3||
48708384|NCT03500172|102073326|FG010|NOT COMPLETED|Period 1: Baseline Randomization||0||
48708385|NCT03500172|102073316|FG000|STARTED|Period 2: Re-Randomization||27||
48708386|NCT03500172|102073317|FG001|STARTED|Period 2: Re-Randomization||24||
48708387|NCT03500172|102073318|FG002|STARTED|Period 2: Re-Randomization||171||
48708388|NCT03500172|102073319|FG003|STARTED|Period 2: Re-Randomization||165||
48708389|NCT03500172|102073320|FG004|STARTED|Period 2: Re-Randomization||20||
48708390|NCT03500172|102073321|FG005|STARTED|Period 2: Re-Randomization||27||
48708391|NCT03500172|102073322|FG006|STARTED|Period 2: Re-Randomization||177||
48708392|NCT03500172|102073323|FG007|STARTED|Period 2: Re-Randomization||163||
48708393|NCT03500172|102073324|FG008|STARTED|Period 2: Re-Randomization||614||
48708394|NCT03500172|102073325|FG009|STARTED|Period 2: Re-Randomization||0||
48708395|NCT03500172|102073326|FG010|STARTED|Period 2: Re-Randomization||0||
48708396|NCT03500172|102073316|FG000|COMPLETED|Period 2: Re-Randomization||19||
48708397|NCT03500172|102073317|FG001|COMPLETED|Period 2: Re-Randomization||18||
48708398|NCT03500172|102073318|FG002|COMPLETED|Period 2: Re-Randomization||84||
48708399|NCT03500172|102073319|FG003|COMPLETED|Period 2: Re-Randomization||93||
48708400|NCT03500172|102073320|FG004|COMPLETED|Period 2: Re-Randomization||14||
48708401|NCT03500172|102073321|FG005|COMPLETED|Period 2: Re-Randomization||21||
48708402|NCT03500172|102073322|FG006|COMPLETED|Period 2: Re-Randomization||109||
48708403|NCT03500172|102073323|FG007|COMPLETED|Period 2: Re-Randomization||87||
48708404|NCT03500172|102073324|FG008|COMPLETED|Period 2: Re-Randomization||614||
48708405|NCT03500172|102073325|FG009|COMPLETED|Period 2: Re-Randomization||0||
48708406|NCT03500172|102073326|FG010|COMPLETED|Period 2: Re-Randomization||0||
48708407|NCT03500172|102073316|FG000|NOT COMPLETED|Period 2: Re-Randomization||8||
48292538|NCT04025580|101044328|FG002|COMPLETED|Overall Study||40||
48292539|NCT04025580|101044326|FG000|NOT COMPLETED|Overall Study||11||
48292540|NCT04025580|101044327|FG001|NOT COMPLETED|Overall Study||0||
48292541|NCT04025580|101044328|FG002|NOT COMPLETED|Overall Study||0||
48292542|NCT01217957|101044329|FG000|STARTED|Phase 1||3||
48292543|NCT01217957|101044330|FG001|STARTED|Phase 1||3||
48292544|NCT01217957|101044331|FG002|STARTED|Phase 1||6||
48292545|NCT01217957|101044332|FG003|STARTED|Phase 1||3||
48292546|NCT01217957|101044333|FG004|STARTED|Phase 1||0||
48292547|NCT01217957|101044329|FG000|COMPLETED|Phase 1||2||
48292548|NCT01217957|101044330|FG001|COMPLETED|Phase 1||3||
48708408|NCT03500172|102073317|FG001|NOT COMPLETED|Period 2: Re-Randomization||6||
48708409|NCT03500172|102073318|FG002|NOT COMPLETED|Period 2: Re-Randomization||87||
48708410|NCT03500172|102073319|FG003|NOT COMPLETED|Period 2: Re-Randomization||72||
48708411|NCT03500172|102073320|FG004|NOT COMPLETED|Period 2: Re-Randomization||6||
48708412|NCT03500172|102073321|FG005|NOT COMPLETED|Period 2: Re-Randomization||6||
48708413|NCT03500172|102073322|FG006|NOT COMPLETED|Period 2: Re-Randomization||68||
48708414|NCT03500172|102073323|FG007|NOT COMPLETED|Period 2: Re-Randomization||76||
48708415|NCT03500172|102073324|FG008|NOT COMPLETED|Period 2: Re-Randomization||0||
48708416|NCT03500172|102073325|FG009|NOT COMPLETED|Period 2: Re-Randomization||0||
48708417|NCT03500172|102073326|FG010|NOT COMPLETED|Period 2: Re-Randomization||0||
48708418|NCT02637427|102073327|FG000|STARTED|Overall Study||27||
48708419|NCT02637427|102073328|FG001|STARTED|Overall Study||30||
48292549|NCT01217957|101044331|FG002|COMPLETED|Phase 1||5||
48292550|NCT01217957|101044332|FG003|COMPLETED|Phase 1||2||
48292551|NCT01217957|101044333|FG004|COMPLETED|Phase 1||0||
48292552|NCT01217957|101044329|FG000|NOT COMPLETED|Phase 1||1||
48292553|NCT01217957|101044330|FG001|NOT COMPLETED|Phase 1||0||
48292554|NCT01217957|101044331|FG002|NOT COMPLETED|Phase 1||1||
48292555|NCT01217957|101044332|FG003|NOT COMPLETED|Phase 1||1||
48292556|NCT01217957|101044333|FG004|NOT COMPLETED|Phase 1||0||
48292557|NCT01217957|101044329|FG000|STARTED|Phase 2||0||
48292558|NCT01217957|101044330|FG001|STARTED|Phase 2||0||
48292559|NCT01217957|101044331|FG002|STARTED|Phase 2||0||
48292560|NCT01217957|101044332|FG003|STARTED|Phase 2||0||
48292561|NCT01217957|101044333|FG004|STARTED|Phase 2||50||
48292562|NCT01217957|101044329|FG000|COMPLETED|Phase 2||0||
48292563|NCT01217957|101044330|FG001|COMPLETED|Phase 2||0||
48292564|NCT01217957|101044331|FG002|COMPLETED|Phase 2||0||
48292565|NCT01217957|101044332|FG003|COMPLETED|Phase 2||0||
48292566|NCT01217957|101044333|FG004|COMPLETED|Phase 2||49||
48292567|NCT01217957|101044329|FG000|NOT COMPLETED|Phase 2||0||
48708420|NCT02637427|102073327|FG000|COMPLETED|Overall Study||27||
48708421|NCT02637427|102073328|FG001|COMPLETED|Overall Study||30||
48708422|NCT02637427|102073327|FG000|NOT COMPLETED|Overall Study||0||
48708423|NCT02637427|102073328|FG001|NOT COMPLETED|Overall Study||0||
48708424|NCT00731653|102073329|FG000|STARTED|Overall Study||81||
48708425|NCT00731653|102073329|FG000|COMPLETED|Overall Study||72||
48292568|NCT01217957|101044330|FG001|NOT COMPLETED|Phase 2||0||
48292569|NCT01217957|101044331|FG002|NOT COMPLETED|Phase 2||0||
48292570|NCT01217957|101044332|FG003|NOT COMPLETED|Phase 2||0||
48292571|NCT01217957|101044333|FG004|NOT COMPLETED|Phase 2||1||
48708426|NCT00731653|102073329|FG000|NOT COMPLETED|Overall Study||9||
48708427|NCT01453946|102073330|FG000|STARTED|Overall Study||50||
48708428|NCT01453946|102073330|FG000|COMPLETED|Overall Study||41||
48708429|NCT01453946|102073330|FG000|NOT COMPLETED|Overall Study||9||
48708430|NCT01028716|102073331|FG000|STARTED|Overall Study||46||
48140108|NCT01358968|100665743|FG002|COMPLETED|Continued Access Phase||0||
48140109|NCT01358968|100665744|FG003|COMPLETED|Continued Access Phase||0||
48140110|NCT01358968|100665741|FG000|NOT COMPLETED|Continued Access Phase||0||
48140111|NCT01358968|100665742|FG001|NOT COMPLETED|Continued Access Phase||0||
48140112|NCT01358968|100665743|FG002|NOT COMPLETED|Continued Access Phase||12||
48140113|NCT01358968|100665744|FG003|NOT COMPLETED|Continued Access Phase||7||
48140114|NCT01302119|100665745|FG000|STARTED|Overall Study||399||
48140115|NCT01302119|100665746|FG001|STARTED|Overall Study||205||
48140116|NCT01302119|100665745|FG000|COMPLETED|Overall Study||349||
48140117|NCT01302119|100665746|FG001|COMPLETED|Overall Study||177||
48140118|NCT01302119|100665745|FG000|NOT COMPLETED|Overall Study||50||
48140119|NCT01302119|100665746|FG001|NOT COMPLETED|Overall Study||28||
48140120|NCT05239039|100665747|FG000|STARTED|Overall Study||24||
48140121|NCT05239039|100665748|FG001|STARTED|Overall Study||15||
48140122|NCT05239039|100665747|FG000|COMPLETED|Overall Study||24||
48140123|NCT05239039|100665748|FG001|COMPLETED|Overall Study||14||
48140124|NCT05239039|100665747|FG000|NOT COMPLETED|Overall Study||0||
48140125|NCT05239039|100665748|FG001|NOT COMPLETED|Overall Study||1||
48140126|NCT03586648|100665749|FG000|STARTED|Period 1||36||
48140127|NCT03586648|100665750|FG001|STARTED|Period 1||34||
48140128|NCT03586648|100665749|FG000|COMPLETED|Period 1||32||
48140129|NCT03586648|100665750|FG001|COMPLETED|Period 1||30||
48140130|NCT03586648|100665749|FG000|NOT COMPLETED|Period 1||4||
48140131|NCT03586648|100665750|FG001|NOT COMPLETED|Period 1||4||
48140132|NCT03586648|100665749|FG000|STARTED|Period 2||32||
48140133|NCT03586648|100665750|FG001|STARTED|Period 2||30||
48140134|NCT03586648|100665749|FG000|COMPLETED|Period 2||31||
48140135|NCT03586648|100665750|FG001|COMPLETED|Period 2||30||
48140136|NCT03586648|100665749|FG000|NOT COMPLETED|Period 2||1||
48140137|NCT03586648|100665750|FG001|NOT COMPLETED|Period 2||0||
48140138|NCT02474927|100670096|FG000|STARTED|Overall Study||22||
48140139|NCT02474927|100670096|FG000|COMPLETED|Overall Study||22||
48140140|NCT02474927|100670096|FG000|NOT COMPLETED|Overall Study||0||
48140141|NCT05046795|100670097|FG000|STARTED|Overall Study||129|Subjects who received at least one dose of study treatment|
48140142|NCT05046795|100670098|FG001|STARTED|Overall Study||128|Subjects who received at least one dose of study treatment|
48140143|NCT05046795|100670097|FG000|COMPLETED|Overall Study||107||
48140144|NCT05046795|100670098|FG001|COMPLETED|Overall Study||99||
48140145|NCT05046795|100670097|FG000|NOT COMPLETED|Overall Study||22||
48140146|NCT05046795|100670098|FG001|NOT COMPLETED|Overall Study||29||
48140147|NCT00670774|100670099|FG000|STARTED|Overall Study||26||
48140148|NCT00670774|100670099|FG000|COMPLETED|Overall Study||26||
48140149|NCT00670774|100670099|FG000|NOT COMPLETED|Overall Study||0||
48140150|NCT01693120|100670100|FG000|STARTED|Enrollment||199||
48140151|NCT01693120|100670100|FG000|COMPLETED|Enrollment||129||
48140152|NCT01693120|100670100|FG000|NOT COMPLETED|Enrollment||70||
48292572|NCT01111474|101044334|FG000|STARTED|Overall Study||74||
48292573|NCT01111474|101044334|FG000|COMPLETED|Overall Study||62||
48292574|NCT01111474|101044334|FG000|NOT COMPLETED|Overall Study||12||
48292575|NCT01801735|101044335|FG000|STARTED|Overall Study||600||
48292576|NCT01801735|101044335|FG000|COMPLETED|Overall Study||390||
48292577|NCT01801735|101044335|FG000|NOT COMPLETED|Overall Study||210||
48292578|NCT04080908|101044336|FG000|STARTED|Overall Study||1||
48708431|NCT01028716|102073331|FG000|COMPLETED|Overall Study||45||
48708432|NCT01028716|102073331|FG000|NOT COMPLETED|Overall Study||1||
48708433|NCT03995680|102073332|FG000|STARTED|Overall Study||199||
48708434|NCT03995680|102073333|FG001|STARTED|Overall Study||198||
48708435|NCT03995680|102073332|FG000|COMPLETED|Overall Study||197||
48708436|NCT03995680|102073333|FG001|COMPLETED|Overall Study||196||
48708437|NCT03995680|102073332|FG000|NOT COMPLETED|Overall Study||2||
48708438|NCT03995680|102073333|FG001|NOT COMPLETED|Overall Study||2||
48708439|NCT02233738|102073334|FG000|STARTED|Overall Study||93||
48708440|NCT02233738|102073335|FG001|STARTED|Overall Study||91||
48708441|NCT02233738|102073334|FG000|1 Month Follow-Up|Overall Study||89||
48708442|NCT02233738|102073335|FG001|1 Month Follow-Up|Overall Study||82||
48708443|NCT02233738|102073334|FG000|3 Month Follow-Up|Overall Study||87||
48708444|NCT02233738|102073335|FG001|3 Month Follow-Up|Overall Study||77||
48708445|NCT02233738|102073334|FG000|6 Month Follow-Up|Overall Study||85||
48708446|NCT02233738|102073335|FG001|6 Month Follow-Up|Overall Study||75||
48708447|NCT02233738|102073334|FG000|COMPLETED|Overall Study||85||
48708448|NCT02233738|102073335|FG001|COMPLETED|Overall Study||75||
48708449|NCT02233738|102073334|FG000|NOT COMPLETED|Overall Study||8||
48708450|NCT02233738|102073335|FG001|NOT COMPLETED|Overall Study||16||
48708451|NCT03770728|102073336|FG000|STARTED|Overall Study||79||
48292579|NCT04080908|101044336|FG000|COMPLETED|Overall Study||1||
48708452|NCT03770728|102073337|FG001|STARTED|Overall Study||78||
48708453|NCT03770728|102073338|FG002|STARTED|Overall Study||77||
48708454|NCT03770728|102073339|FG003|STARTED|Overall Study||78||
48708455|NCT03770728|102073336|FG000|Safety Population|Overall Study||79|Participants who received at least 1 dose or part of a dose of the Investigational Medicinal Product (IMP), analyzed according to the treatment actually received.|
48708456|NCT03770728|102073337|FG001|Safety Population|Overall Study||78|Participants who received at least 1 dose or part of a dose of the Investigational Medicinal Product (IMP), analyzed according to the treatment actually received.|
48708457|NCT03770728|102073338|FG002|Safety Population|Overall Study||80|Participants who received at least 1 dose or part of a dose of the Investigational Medicinal Product (IMP), analyzed according to the treatment actually received.|
48708458|NCT03770728|102073339|FG003|Safety Population|Overall Study||75|Participants who received at least 1 dose or part of a dose of the Investigational Medicinal Product (IMP), analyzed according to the treatment actually received.|
48708459|NCT03770728|102073336|FG000|COMPLETED|Overall Study||41||
48708460|NCT03770728|102073337|FG001|COMPLETED|Overall Study||47||
48708461|NCT03770728|102073338|FG002|COMPLETED|Overall Study||45||
48708462|NCT03770728|102073339|FG003|COMPLETED|Overall Study||43||
48708463|NCT03770728|102073336|FG000|NOT COMPLETED|Overall Study||38||
48708464|NCT03770728|102073337|FG001|NOT COMPLETED|Overall Study||31||
48708465|NCT03770728|102073338|FG002|NOT COMPLETED|Overall Study||32||
48708466|NCT03770728|102073339|FG003|NOT COMPLETED|Overall Study||35||
48708467|NCT03724981|102073340|FG000|STARTED|First Device||156||
48292580|NCT04080908|101044336|FG000|NOT COMPLETED|Overall Study||0||
48292581|NCT01491672|101044337|FG000|STARTED|Overall Study||58||
48292582|NCT01491672|101044338|FG001|STARTED|Overall Study||62||
48292583|NCT01491672|101044339|FG002|STARTED|Overall Study||14||
48292584|NCT01491672|101044337|FG000|Safety Set|Overall Study||58||
48292585|NCT01491672|101044338|FG001|Safety Set|Overall Study||61||
48292586|NCT01491672|101044339|FG002|Safety Set|Overall Study||14||
48708468|NCT03724981|102073341|FG001|STARTED|First Device||156||
48708469|NCT03724981|102073340|FG000|COMPLETED|First Device||155||
48708470|NCT03724981|102073341|FG001|COMPLETED|First Device||155||
48708471|NCT03724981|102073340|FG000|NOT COMPLETED|First Device||1||
48708472|NCT03724981|102073341|FG001|NOT COMPLETED|First Device||1||
48708473|NCT03724981|102073340|FG000|STARTED|Second Device||155||
48708474|NCT03724981|102073341|FG001|STARTED|Second Device||155||
48708475|NCT03724981|102073340|FG000|COMPLETED|Second Device||155||
48708476|NCT03724981|102073341|FG001|COMPLETED|Second Device||155||
48708477|NCT03724981|102073340|FG000|NOT COMPLETED|Second Device||0||
48708478|NCT03724981|102073341|FG001|NOT COMPLETED|Second Device||0||
48708479|NCT01135914|102073342|FG000|STARTED|Overall Study||78||
48708480|NCT01135914|102073343|FG001|STARTED|Overall Study||80||
48708481|NCT01135914|102073344|FG002|STARTED|Overall Study||81||
48708482|NCT01135914|102073342|FG000|Intent to Treat (ITT) Population|Overall Study||73||
48708483|NCT01135914|102073343|FG001|Intent to Treat (ITT) Population|Overall Study||75||
48708484|NCT01135914|102073344|FG002|Intent to Treat (ITT) Population|Overall Study||72||
48708485|NCT01135914|102073342|FG000|Safety Population|Overall Study||73||
48708486|NCT01135914|102073343|FG001|Safety Population|Overall Study||75||
48708487|NCT01135914|102073344|FG002|Safety Population|Overall Study||74||
48708488|NCT01135914|102073342|FG000|COMPLETED|Overall Study||74||
48708489|NCT01135914|102073343|FG001|COMPLETED|Overall Study||75||
48708490|NCT01135914|102073344|FG002|COMPLETED|Overall Study||59||
48708491|NCT01135914|102073342|FG000|NOT COMPLETED|Overall Study||4||
48708492|NCT01135914|102073343|FG001|NOT COMPLETED|Overall Study||5||
48708493|NCT01135914|102073344|FG002|NOT COMPLETED|Overall Study||22||
48708494|NCT00712530|102073345|FG000|STARTED|Overall Study||3||
48708495|NCT00712530|102073346|FG001|STARTED|Overall Study||3||
48140153|NCT01693120|100670100|FG000|STARTED|Phased RF Study Procedure and Follow-up||129||
48140154|NCT01693120|100670100|FG000|COMPLETED|Phased RF Study Procedure and Follow-up||112||
48140155|NCT01693120|100670100|FG000|NOT COMPLETED|Phased RF Study Procedure and Follow-up||17||
48403147|NCT00561340|101317828|FG000|NOT COMPLETED|Overall Study||6||
48403148|NCT00561340|101317829|FG001|NOT COMPLETED|Overall Study||0||
48403149|NCT01412151|101317830|FG000|STARTED|Week 0 - 306 - Treatment Period||10||
48403150|NCT01412151|101317830|FG000|COMPLETED|Week 0 - 306 - Treatment Period||5||
48403151|NCT01412151|101317830|FG000|NOT COMPLETED|Week 0 - 306 - Treatment Period||5||
48403152|NCT01412151|101317830|FG000|STARTED|Week 306 - 310 - Washout Period||5||
48403153|NCT01412151|101317830|FG000|COMPLETED|Week 306 - 310 - Washout Period||3||
48403154|NCT01412151|101317830|FG000|NOT COMPLETED|Week 306 - 310 - Washout Period||2||
48403155|NCT02215616|101317831|FG000|STARTED|Overall Study||108||
48403156|NCT02215616|101317832|FG001|STARTED|Overall Study||107||
48403157|NCT02215616|101317833|FG002|STARTED|Overall Study||107||
48403158|NCT02215616|101317834|FG003|STARTED|Overall Study||30||
48403159|NCT02215616|101317831|FG000|Received at Least 1 Dose of Study Drug|Overall Study||108||
48403160|NCT02215616|101317832|FG001|Received at Least 1 Dose of Study Drug|Overall Study||107||
48403161|NCT02215616|101317833|FG002|Received at Least 1 Dose of Study Drug|Overall Study||106||
48403162|NCT02215616|101317834|FG003|Received at Least 1 Dose of Study Drug|Overall Study||29||
48403163|NCT02215616|101317831|FG000|COMPLETED|Overall Study||97||
48140156|NCT02358603|100670101|FG000|STARTED|Overall Study||40||
48140157|NCT02358603|100670102|FG001|STARTED|Overall Study||8||
48140158|NCT02358603|100670101|FG000|COMPLETED|Overall Study||40||
48140159|NCT02358603|100670102|FG001|COMPLETED|Overall Study||8||
48292587|NCT01491672|101044337|FG000|COMPLETED|Overall Study||2||
48292588|NCT01491672|101044338|FG001|COMPLETED|Overall Study||2||
48292589|NCT01491672|101044339|FG002|COMPLETED|Overall Study||3||
48403164|NCT02215616|101317832|FG001|COMPLETED|Overall Study||90||
48403165|NCT02215616|101317833|FG002|COMPLETED|Overall Study||93||
48403166|NCT02215616|101317834|FG003|COMPLETED|Overall Study||17||
48403167|NCT02215616|101317831|FG000|NOT COMPLETED|Overall Study||11||
48403168|NCT02215616|101317832|FG001|NOT COMPLETED|Overall Study||17||
48403169|NCT02215616|101317833|FG002|NOT COMPLETED|Overall Study||14||
48403170|NCT02215616|101317834|FG003|NOT COMPLETED|Overall Study||13||
48403171|NCT03039790|101317835|FG000|STARTED|Overall Study||25||
48403172|NCT03039790|101317836|FG001|STARTED|Overall Study||19||
48403173|NCT03039790|101317837|FG002|STARTED|Overall Study||27||
48708496|NCT00712530|102073347|FG002|STARTED|Overall Study||3||
48708497|NCT00712530|102073345|FG000|COMPLETED|Overall Study||3||
48708498|NCT00712530|102073346|FG001|COMPLETED|Overall Study||3||
48140160|NCT02358603|100670101|FG000|NOT COMPLETED|Overall Study||0||
48292590|NCT01491672|101044337|FG000|NOT COMPLETED|Overall Study||56||
48292591|NCT01491672|101044338|FG001|NOT COMPLETED|Overall Study||60||
48292592|NCT01491672|101044339|FG002|NOT COMPLETED|Overall Study||11||
48403174|NCT03039790|101317838|FG003|STARTED|Overall Study||27||
48403175|NCT03039790|101317839|FG004|STARTED|Overall Study||23||
48403176|NCT03039790|101317840|FG005|STARTED|Overall Study||27||
48403177|NCT03039790|101317841|FG006|STARTED|Overall Study||25||
48403178|NCT03039790|101317842|FG007|STARTED|Overall Study||28||
48403179|NCT03039790|101317843|FG008|STARTED|Overall Study||22||
48140161|NCT02358603|100670102|FG001|NOT COMPLETED|Overall Study||0||
48140162|NCT04302350|100670103|FG000|STARTED|Overall Study||26||
48140163|NCT04302350|100670104|FG001|STARTED|Overall Study||26||
48292593|NCT00960531|101044340|FG000|STARTED|Overall Study||21||
48292594|NCT00960531|101044341|FG001|STARTED|Overall Study||6||
48292595|NCT00960531|101044342|FG002|STARTED|Overall Study||41||
48403180|NCT03039790|101317844|FG009|STARTED|Overall Study||28||
48403181|NCT03039790|101317845|FG010|STARTED|Overall Study||21||
48403182|NCT03039790|101317846|FG011|STARTED|Overall Study||25||
48403183|NCT03039790|101317847|FG012|STARTED|Overall Study||24||
48708499|NCT00712530|102073347|FG002|COMPLETED|Overall Study||3||
48292596|NCT00960531|101044343|FG003|STARTED|Overall Study||25||
48292597|NCT00960531|101044344|FG004|STARTED|Overall Study||5||
48292598|NCT00960531|101044345|FG005|STARTED|Overall Study||9||
48708500|NCT00712530|102073345|FG000|NOT COMPLETED|Overall Study||0||
48292599|NCT00960531|101044346|FG006|STARTED|Overall Study||27||
48292600|NCT00960531|101044347|FG007|STARTED|Overall Study||6||
48292601|NCT00960531|101044348|FG008|STARTED|Overall Study||16||
48292602|NCT00960531|101044349|FG009|STARTED|Overall Study||4||
48292603|NCT00960531|101044340|FG000|Treated|Overall Study||21||
48292604|NCT00960531|101044341|FG001|Treated|Overall Study||6||
48292605|NCT00960531|101044342|FG002|Treated|Overall Study||41||
48292606|NCT00960531|101044343|FG003|Treated|Overall Study||24||
48292607|NCT00960531|101044344|FG004|Treated|Overall Study||5||
48292608|NCT00960531|101044345|FG005|Treated|Overall Study||9||
48292609|NCT00960531|101044346|FG006|Treated|Overall Study||27||
48292610|NCT00960531|101044347|FG007|Treated|Overall Study||6||
48292611|NCT00960531|101044348|FG008|Treated|Overall Study||16||
48292612|NCT00960531|101044349|FG009|Treated|Overall Study||4||
48292613|NCT00960531|101044340|FG000|Completed Treatment|Overall Study||12||
48292614|NCT00960531|101044341|FG001|Completed Treatment|Overall Study||5||
48708501|NCT00712530|102073346|FG001|NOT COMPLETED|Overall Study||0||
48708502|NCT00712530|102073347|FG002|NOT COMPLETED|Overall Study||0||
48292615|NCT00960531|101044342|FG002|Completed Treatment|Overall Study||15||
48292616|NCT00960531|101044343|FG003|Completed Treatment|Overall Study||17||
48292617|NCT00960531|101044344|FG004|Completed Treatment|Overall Study||3||
48292618|NCT00960531|101044345|FG005|Completed Treatment|Overall Study||7||
48292619|NCT00960531|101044346|FG006|Completed Treatment|Overall Study||4||
48403184|NCT03039790|101317848|FG013|STARTED|Overall Study||24||
48403185|NCT03039790|101317849|FG014|STARTED|Overall Study||24||
48403186|NCT03039790|101317850|FG015|STARTED|Overall Study||29||
48708503|NCT03610581|102073348|FG000|STARTED|Overall Study||5||
48708504|NCT03610581|102073349|FG001|STARTED|Overall Study||4||
48708505|NCT03610581|102073348|FG000|Vaccinated|Overall Study||4||
48708506|NCT03610581|102073349|FG001|Vaccinated|Overall Study||4||
48708507|NCT03610581|102073348|FG000|COMPLETED|Overall Study||2||
48708508|NCT03610581|102073349|FG001|COMPLETED|Overall Study||3||
48708509|NCT03610581|102073348|FG000|NOT COMPLETED|Overall Study||3||
48708510|NCT03610581|102073349|FG001|NOT COMPLETED|Overall Study||1||
48708511|NCT03858335|102073350|FG000|STARTED|Overall Study||16||
48708512|NCT03858335|102073351|FG001|STARTED|Overall Study||16||
48708513|NCT03858335|102073350|FG000|COMPLETED|Overall Study||12||
48708514|NCT03858335|102073351|FG001|COMPLETED|Overall Study||12||
48292620|NCT00960531|101044347|FG007|Completed Treatment|Overall Study||3||
48292621|NCT00960531|101044348|FG008|Completed Treatment|Overall Study||2||
48292622|NCT00960531|101044349|FG009|Completed Treatment|Overall Study||4||
48292623|NCT00960531|101044340|FG000|COMPLETED|Overall Study||11||
48292624|NCT00960531|101044341|FG001|COMPLETED|Overall Study||5||
48292625|NCT00960531|101044342|FG002|COMPLETED|Overall Study||15||
48292626|NCT00960531|101044343|FG003|COMPLETED|Overall Study||17||
48292627|NCT00960531|101044344|FG004|COMPLETED|Overall Study||3||
48292628|NCT00960531|101044345|FG005|COMPLETED|Overall Study||6||
48292629|NCT00960531|101044346|FG006|COMPLETED|Overall Study||3||
48292630|NCT00960531|101044347|FG007|COMPLETED|Overall Study||2||
48292631|NCT00960531|101044348|FG008|COMPLETED|Overall Study||2||
48292632|NCT00960531|101044349|FG009|COMPLETED|Overall Study||3||
48292633|NCT00960531|101044340|FG000|NOT COMPLETED|Overall Study||10||
48292634|NCT00960531|101044341|FG001|NOT COMPLETED|Overall Study||1||
48292635|NCT00960531|101044342|FG002|NOT COMPLETED|Overall Study||26||
48708515|NCT03858335|102073350|FG000|NOT COMPLETED|Overall Study||4||
48708516|NCT03858335|102073351|FG001|NOT COMPLETED|Overall Study||4||
48708517|NCT01101971|102073352|FG000|STARTED|Overall Study||45||
48708518|NCT01101971|102073352|FG000|COMPLETED|Overall Study||45||
48292636|NCT00960531|101044343|FG003|NOT COMPLETED|Overall Study||8||
48292637|NCT00960531|101044344|FG004|NOT COMPLETED|Overall Study||2||
48292638|NCT00960531|101044345|FG005|NOT COMPLETED|Overall Study||3||
48292639|NCT00960531|101044346|FG006|NOT COMPLETED|Overall Study||24||
48292640|NCT00960531|101044347|FG007|NOT COMPLETED|Overall Study||4||
48292641|NCT00960531|101044348|FG008|NOT COMPLETED|Overall Study||14||
48292642|NCT00960531|101044349|FG009|NOT COMPLETED|Overall Study||1||
48292643|NCT00610467|101044350|FG000|STARTED|Overall Study||1||
48292644|NCT00610467|101044351|FG001|STARTED|Overall Study||1||
48292645|NCT00610467|101044350|FG000|COMPLETED|Overall Study||1||
48292646|NCT00610467|101044351|FG001|COMPLETED|Overall Study||1||
48403187|NCT03039790|101317851|FG016|STARTED|Overall Study||39||
48708519|NCT01101971|102073352|FG000|NOT COMPLETED|Overall Study||0||
48708520|NCT00006046|102073353|FG000|STARTED|Overall Study||7||
48708521|NCT00006046|102073354|FG001|STARTED|Overall Study||0||
48708522|NCT00006046|102073355|FG002|STARTED|Overall Study||0||
48708523|NCT00006046|102073356|FG003|STARTED|Overall Study||0||
48708524|NCT00006046|102073357|FG004|STARTED|Overall Study||0||
48708525|NCT00006046|102073353|FG000|COMPLETED|Overall Study||2||
48292647|NCT00610467|101044350|FG000|NOT COMPLETED|Overall Study||0||
48292648|NCT00610467|101044351|FG001|NOT COMPLETED|Overall Study||0||
48403188|NCT03039790|101317852|FG017|STARTED|Overall Study||14||
48403189|NCT03039790|101317853|FG018|STARTED|Overall Study||35||
48292649|NCT02054741|101044352|FG000|STARTED|Overall Study||362||16
48292650|NCT02054741|101044353|FG001|STARTED|Overall Study||371||24
48292651|NCT02054741|101044352|FG000|COMPLETED|Overall Study||210||16
48403190|NCT03039790|101317854|FG019|STARTED|Overall Study||42||
48403191|NCT03039790|101317835|FG000|Per Protocol Set (PPS)|Overall Study||25|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
48403192|NCT03039790|101317836|FG001|Per Protocol Set (PPS)|Overall Study||19|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
48403193|NCT03039790|101317837|FG002|Per Protocol Set (PPS)|Overall Study||27|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
48403194|NCT03039790|101317838|FG003|Per Protocol Set (PPS)|Overall Study||26|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
48403195|NCT03039790|101317839|FG004|Per Protocol Set (PPS)|Overall Study||23|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
48403196|NCT03039790|101317840|FG005|Per Protocol Set (PPS)|Overall Study||27|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
48403197|NCT03039790|101317841|FG006|Per Protocol Set (PPS)|Overall Study||25|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
48403198|NCT03039790|101317842|FG007|Per Protocol Set (PPS)|Overall Study||28|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
48403199|NCT03039790|101317843|FG008|Per Protocol Set (PPS)|Overall Study||22|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
48403200|NCT03039790|101317844|FG009|Per Protocol Set (PPS)|Overall Study||28|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
48403201|NCT03039790|101317845|FG010|Per Protocol Set (PPS)|Overall Study||19|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
48403202|NCT03039790|101317846|FG011|Per Protocol Set (PPS)|Overall Study||25|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
48403203|NCT03039790|101317847|FG012|Per Protocol Set (PPS)|Overall Study||24|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
48403204|NCT03039790|101317848|FG013|Per Protocol Set (PPS)|Overall Study||24|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
48403205|NCT03039790|101317849|FG014|Per Protocol Set (PPS)|Overall Study||24|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
48403206|NCT03039790|101317850|FG015|Per Protocol Set (PPS)|Overall Study||29|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
48403207|NCT03039790|101317851|FG016|Per Protocol Set (PPS)|Overall Study||39|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
48403208|NCT03039790|101317852|FG017|Per Protocol Set (PPS)|Overall Study||14|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
48403209|NCT03039790|101317853|FG018|Per Protocol Set (PPS)|Overall Study||35|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
48708526|NCT00006046|102073354|FG001|COMPLETED|Overall Study||0||
48708527|NCT00006046|102073355|FG002|COMPLETED|Overall Study||0||
48708528|NCT00006046|102073356|FG003|COMPLETED|Overall Study||0||
48292652|NCT02054741|101044353|FG001|COMPLETED|Overall Study||242||24
48292653|NCT02054741|101044352|FG000|NOT COMPLETED|Overall Study||152||0
48403210|NCT03039790|101317854|FG019|Per Protocol Set (PPS)|Overall Study||42|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
48403211|NCT03039790|101317835|FG000|COMPLETED|Overall Study||21||
48403212|NCT03039790|101317836|FG001|COMPLETED|Overall Study||19||
48403213|NCT03039790|101317837|FG002|COMPLETED|Overall Study||26||
48403214|NCT03039790|101317838|FG003|COMPLETED|Overall Study||25||
48403215|NCT03039790|101317839|FG004|COMPLETED|Overall Study||23||
48403216|NCT03039790|101317840|FG005|COMPLETED|Overall Study||26||
48708529|NCT00006046|102073357|FG004|COMPLETED|Overall Study||0||
48708530|NCT00006046|102073353|FG000|NOT COMPLETED|Overall Study||5||
48292654|NCT02054741|101044353|FG001|NOT COMPLETED|Overall Study||129||0
48292655|NCT02966301|101044354|FG000|STARTED|Overall Study||21||
48292656|NCT02966301|101044354|FG000|Full Analysis Set (FAS)|Overall Study||20||
48708531|NCT00006046|102073354|FG001|NOT COMPLETED|Overall Study||0||
48708532|NCT00006046|102073355|FG002|NOT COMPLETED|Overall Study||0||
48708533|NCT00006046|102073356|FG003|NOT COMPLETED|Overall Study||0||
48708534|NCT00006046|102073357|FG004|NOT COMPLETED|Overall Study||0||
48708535|NCT00493636|102073358|FG000|STARTED|Overall Study||81||
48708536|NCT00493636|102073359|FG001|STARTED|Overall Study||79||
48708537|NCT00493636|102073358|FG000|COMPLETED|Overall Study||79||
48708538|NCT00493636|102073359|FG001|COMPLETED|Overall Study||77||
48292657|NCT02966301|101044354|FG000|Safety Analysis (SA)|Overall Study||21||
48292658|NCT02966301|101044354|FG000|COMPLETED|Overall Study||18||
48292659|NCT02966301|101044354|FG000|NOT COMPLETED|Overall Study||3||
48292660|NCT00346268|101044355|FG000|STARTED|Overall Study||52||
48292661|NCT00346268|101044356|FG001|STARTED|Overall Study||53||
48292662|NCT00346268|101044355|FG000|COMPLETED|Overall Study||50||
48292663|NCT00346268|101044356|FG001|COMPLETED|Overall Study||50||
48292664|NCT00346268|101044355|FG000|NOT COMPLETED|Overall Study||2||
48292665|NCT00346268|101044356|FG001|NOT COMPLETED|Overall Study||3||
48292666|NCT03527173|101044357|FG000|STARTED|Overall Study||36||
48292667|NCT03527173|101044358|FG001|STARTED|Overall Study||35||
48292668|NCT03527173|101044357|FG000|COMPLETED|Overall Study||29||
48292669|NCT03527173|101044358|FG001|COMPLETED|Overall Study||28||
48292670|NCT03527173|101044357|FG000|NOT COMPLETED|Overall Study||7||
48292671|NCT03527173|101044358|FG001|NOT COMPLETED|Overall Study||7||
48292672|NCT02499770|101044359|FG000|STARTED|Overall Study||19||
48292673|NCT02499770|101044360|FG001|STARTED|Overall Study||77||
48292674|NCT02499770|101044359|FG000|COMPLETED|Overall Study||0||
48292675|NCT02499770|101044360|FG001|COMPLETED|Overall Study||0||
48292676|NCT02499770|101044359|FG000|NOT COMPLETED|Overall Study||19||
48403217|NCT03039790|101317841|FG006|COMPLETED|Overall Study||24||
48403218|NCT03039790|101317842|FG007|COMPLETED|Overall Study||27||
48403219|NCT03039790|101317843|FG008|COMPLETED|Overall Study||22||
48403220|NCT03039790|101317844|FG009|COMPLETED|Overall Study||26||
48403221|NCT03039790|101317845|FG010|COMPLETED|Overall Study||20||
48403222|NCT03039790|101317846|FG011|COMPLETED|Overall Study||25||
48403223|NCT03039790|101317847|FG012|COMPLETED|Overall Study||21||
48403224|NCT03039790|101317848|FG013|COMPLETED|Overall Study||24||
48403225|NCT03039790|101317849|FG014|COMPLETED|Overall Study||20||
48708539|NCT00493636|102073358|FG000|NOT COMPLETED|Overall Study||2||
48708540|NCT00493636|102073359|FG001|NOT COMPLETED|Overall Study||2||
48708541|NCT03158272|102073360|FG000|STARTED|Overall Study||3|Started = Entered treatment period|
48708542|NCT03158272|102073361|FG001|STARTED|Overall Study||4|Started = Entered treatment period|
48710776|NCT00899717|102078014|FG000|COMPLETED|Overall Study||10||
48292677|NCT02499770|101044360|FG001|NOT COMPLETED|Overall Study||77||
48292678|NCT02094755|101044361|FG000|STARTED|Overall Study||100||
48292679|NCT02094755|101044361|FG000|COMPLETED|Overall Study||100||
48292680|NCT02094755|101044361|FG000|NOT COMPLETED|Overall Study||0||
48292681|NCT01122862|101044362|FG000|STARTED|Period 1||8||
48292682|NCT01122862|101044363|FG001|STARTED|Period 1||8||
48292683|NCT01122862|101044364|FG002|STARTED|Period 1||7||
48292684|NCT01122862|101044362|FG000|COMPLETED|Period 1||8||
48292685|NCT01122862|101044363|FG001|COMPLETED|Period 1||7||
48292686|NCT01122862|101044364|FG002|COMPLETED|Period 1||7||
48292687|NCT01122862|101044362|FG000|NOT COMPLETED|Period 1||0||
48292688|NCT01122862|101044363|FG001|NOT COMPLETED|Period 1||1||
48292689|NCT01122862|101044364|FG002|NOT COMPLETED|Period 1||0||
48292690|NCT01122862|101044362|FG000|STARTED|Period 2||8||
48292691|NCT01122862|101044363|FG001|STARTED|Period 2||7||
48403226|NCT03039790|101317850|FG015|COMPLETED|Overall Study||22||
48403227|NCT03039790|101317851|FG016|COMPLETED|Overall Study||29||
48403228|NCT03039790|101317852|FG017|COMPLETED|Overall Study||12||
48403229|NCT03039790|101317853|FG018|COMPLETED|Overall Study||29||
48403230|NCT03039790|101317854|FG019|COMPLETED|Overall Study||34||
48403231|NCT03039790|101317835|FG000|NOT COMPLETED|Overall Study||4||
48403232|NCT03039790|101317836|FG001|NOT COMPLETED|Overall Study||0||
48403233|NCT03039790|101317837|FG002|NOT COMPLETED|Overall Study||1||
48403234|NCT03039790|101317838|FG003|NOT COMPLETED|Overall Study||2||
48403235|NCT03039790|101317839|FG004|NOT COMPLETED|Overall Study||0||
48403236|NCT03039790|101317840|FG005|NOT COMPLETED|Overall Study||1||
48403237|NCT03039790|101317841|FG006|NOT COMPLETED|Overall Study||1||
48403238|NCT03039790|101317842|FG007|NOT COMPLETED|Overall Study||1||
48403239|NCT03039790|101317843|FG008|NOT COMPLETED|Overall Study||0||
48403240|NCT03039790|101317844|FG009|NOT COMPLETED|Overall Study||2||
48403241|NCT03039790|101317845|FG010|NOT COMPLETED|Overall Study||1||
48403242|NCT03039790|101317846|FG011|NOT COMPLETED|Overall Study||0||
48403243|NCT03039790|101317847|FG012|NOT COMPLETED|Overall Study||3||
48292692|NCT01122862|101044364|FG002|STARTED|Period 2||7||
48292693|NCT01122862|101044362|FG000|COMPLETED|Period 2||8||
48292694|NCT01122862|101044363|FG001|COMPLETED|Period 2||7||
48292695|NCT01122862|101044364|FG002|COMPLETED|Period 2||6||
48292696|NCT01122862|101044362|FG000|NOT COMPLETED|Period 2||0||
48292697|NCT01122862|101044363|FG001|NOT COMPLETED|Period 2||0||
48292698|NCT01122862|101044364|FG002|NOT COMPLETED|Period 2||1||
48292699|NCT01122862|101044362|FG000|STARTED|Period 3||6||
48292700|NCT01122862|101044363|FG001|STARTED|Period 3||7||
48292701|NCT01122862|101044364|FG002|STARTED|Period 3||8||
48292702|NCT01122862|101044362|FG000|COMPLETED|Period 3||6||
48292703|NCT01122862|101044363|FG001|COMPLETED|Period 3||7||
48403244|NCT03039790|101317848|FG013|NOT COMPLETED|Overall Study||0||
48403245|NCT03039790|101317849|FG014|NOT COMPLETED|Overall Study||4||
48403246|NCT03039790|101317850|FG015|NOT COMPLETED|Overall Study||7||
48403247|NCT03039790|101317851|FG016|NOT COMPLETED|Overall Study||10||
48403248|NCT03039790|101317852|FG017|NOT COMPLETED|Overall Study||2||
48403249|NCT03039790|101317853|FG018|NOT COMPLETED|Overall Study||6||
48403250|NCT03039790|101317854|FG019|NOT COMPLETED|Overall Study||8||
48403251|NCT01193049|101317855|FG000|STARTED|Period 1: Placebo Run-In||5||
48403252|NCT01193049|101317856|FG001|STARTED|Period 1: Placebo Run-In||6||
48403253|NCT01193049|101317855|FG000|COMPLETED|Period 1: Placebo Run-In||5||
48403254|NCT01193049|101317856|FG001|COMPLETED|Period 1: Placebo Run-In||6||
48403255|NCT01193049|101317855|FG000|NOT COMPLETED|Period 1: Placebo Run-In||0||
48403256|NCT01193049|101317856|FG001|NOT COMPLETED|Period 1: Placebo Run-In||0||
48403257|NCT01193049|101317855|FG000|STARTED|Washout 1 : 21 Day Washout||5||
48403258|NCT01193049|101317856|FG001|STARTED|Washout 1 : 21 Day Washout||6||
48403259|NCT01193049|101317855|FG000|COMPLETED|Washout 1 : 21 Day Washout||5||
48403260|NCT01193049|101317856|FG001|COMPLETED|Washout 1 : 21 Day Washout||6||
48403261|NCT01193049|101317855|FG000|NOT COMPLETED|Washout 1 : 21 Day Washout||0||
48403262|NCT01193049|101317856|FG001|NOT COMPLETED|Washout 1 : 21 Day Washout||0||
48403263|NCT01193049|101317855|FG000|STARTED|Period 2 : Double Blind Crossover||5||
48403264|NCT01193049|101317856|FG001|STARTED|Period 2 : Double Blind Crossover||6||
48292704|NCT01122862|101044364|FG002|COMPLETED|Period 3||8||
48292705|NCT01122862|101044362|FG000|NOT COMPLETED|Period 3||0||
48292706|NCT01122862|101044363|FG001|NOT COMPLETED|Period 3||0||
48292707|NCT01122862|101044364|FG002|NOT COMPLETED|Period 3||0||
48292708|NCT02434939|101044365|FG000|STARTED|Overall Study||120||
48292709|NCT02434939|101044366|FG001|STARTED|Overall Study||120||
48292710|NCT02434939|101044365|FG000|COMPLETED|Overall Study||83||
48292711|NCT02434939|101044366|FG001|COMPLETED|Overall Study||71||
48292712|NCT02434939|101044365|FG000|NOT COMPLETED|Overall Study||37||
48292713|NCT02434939|101044366|FG001|NOT COMPLETED|Overall Study||49||
48292714|NCT00355199|101044367|FG000|STARTED|Overall Study||120||
48292715|NCT00355199|101044368|FG001|STARTED|Overall Study||126||
48292716|NCT00355199|101044367|FG000|COMPLETED|Overall Study||113||
48292717|NCT00355199|101044368|FG001|COMPLETED|Overall Study||122||
48292718|NCT00355199|101044367|FG000|NOT COMPLETED|Overall Study||7||
48403265|NCT01193049|101317855|FG000|COMPLETED|Period 2 : Double Blind Crossover||5||
48403266|NCT01193049|101317856|FG001|COMPLETED|Period 2 : Double Blind Crossover||6||
48403267|NCT01193049|101317855|FG000|NOT COMPLETED|Period 2 : Double Blind Crossover||0||
48403268|NCT01193049|101317856|FG001|NOT COMPLETED|Period 2 : Double Blind Crossover||0||
48403269|NCT01193049|101317855|FG000|STARTED|Washout 2 : 21 Day Washout||5||
48403270|NCT01193049|101317856|FG001|STARTED|Washout 2 : 21 Day Washout||6||
48403271|NCT01193049|101317855|FG000|COMPLETED|Washout 2 : 21 Day Washout||5||
48403272|NCT01193049|101317856|FG001|COMPLETED|Washout 2 : 21 Day Washout||6||
48403273|NCT01193049|101317855|FG000|NOT COMPLETED|Washout 2 : 21 Day Washout||0||
48403274|NCT01193049|101317856|FG001|NOT COMPLETED|Washout 2 : 21 Day Washout||0||
48403275|NCT01193049|101317855|FG000|STARTED|Period 3 : Double Blind Crossover||5||
48403276|NCT01193049|101317856|FG001|STARTED|Period 3 : Double Blind Crossover||6||
48403277|NCT01193049|101317855|FG000|COMPLETED|Period 3 : Double Blind Crossover||5||
48403278|NCT01193049|101317856|FG001|COMPLETED|Period 3 : Double Blind Crossover||6||
48403279|NCT01193049|101317855|FG000|NOT COMPLETED|Period 3 : Double Blind Crossover||0||
48403280|NCT01193049|101317856|FG001|NOT COMPLETED|Period 3 : Double Blind Crossover||0||
48403281|NCT01749800|101317857|FG000|STARTED|Overall Study||6||
48403282|NCT01749800|101317858|FG001|STARTED|Overall Study||1||
48403283|NCT01749800|101317859|FG002|STARTED|Overall Study||0||
48403284|NCT01749800|101317857|FG000|COMPLETED|Overall Study||3||
48292719|NCT00355199|101044368|FG001|NOT COMPLETED|Overall Study||4||
48292720|NCT03714425|101044369|FG000|STARTED|Overall Study||62||
48292721|NCT03714425|101044370|FG001|STARTED|Overall Study||57||
48292722|NCT03714425|101044369|FG000|COMPLETED|Overall Study||55||
48292723|NCT03714425|101044370|FG001|COMPLETED|Overall Study||46||
48292724|NCT03714425|101044369|FG000|NOT COMPLETED|Overall Study||7||
48292725|NCT03714425|101044370|FG001|NOT COMPLETED|Overall Study||11||
48292726|NCT03324451|101044371|FG000|STARTED|Overall Study||97||
48292727|NCT03324451|101044372|FG001|STARTED|Overall Study||54||
48292728|NCT03324451|101044371|FG000|COMPLETED|Overall Study||65||
48292729|NCT03324451|101044372|FG001|COMPLETED|Overall Study||41||
48292730|NCT03324451|101044371|FG000|NOT COMPLETED|Overall Study||32||
48403285|NCT01749800|101317858|FG001|COMPLETED|Overall Study||0||
48403286|NCT01749800|101317859|FG002|COMPLETED|Overall Study||0||
48403287|NCT01749800|101317857|FG000|NOT COMPLETED|Overall Study||3||
48403288|NCT01749800|101317858|FG001|NOT COMPLETED|Overall Study||1||
48403289|NCT01749800|101317859|FG002|NOT COMPLETED|Overall Study||0||
48292731|NCT03324451|101044372|FG001|NOT COMPLETED|Overall Study||13||
48292732|NCT00512317|101044373|FG000|STARTED|Overall Study||123||
48292733|NCT00512317|101044373|FG000|COMPLETED|Overall Study||6||
48292734|NCT00512317|101044373|FG000|NOT COMPLETED|Overall Study||117||
48292735|NCT00655863|101044374|FG000|STARTED|Overall Study||24||
48292736|NCT00655863|101044375|FG001|STARTED|Overall Study||25||
48292737|NCT00655863|101044376|FG002|STARTED|Overall Study||22||
48708543|NCT03158272|102073362|FG002|STARTED|Overall Study||6|Started = Entered treatment period|
48708544|NCT03158272|102073363|FG003|STARTED|Overall Study||6|Started = Entered treatment period|
48708545|NCT03158272|102073360|FG000|COMPLETED|Overall Study||0||
48708546|NCT03158272|102073361|FG001|COMPLETED|Overall Study||0||
48708547|NCT03158272|102073362|FG002|COMPLETED|Overall Study||0||
48708548|NCT03158272|102073363|FG003|COMPLETED|Overall Study||0||
48708549|NCT03158272|102073360|FG000|NOT COMPLETED|Overall Study||3||
48292738|NCT00655863|101044374|FG000|COMPLETED|Overall Study||24||
48403290|NCT00324740|101317860|FG000|STARTED|Overall Study||7||
48403291|NCT00324740|101317861|FG001|STARTED|Overall Study||3||
48403292|NCT00324740|101317862|FG002|STARTED|Overall Study||4||
48403293|NCT00324740|101317860|FG000|COMPLETED|Overall Study||6||
48403294|NCT00324740|101317861|FG001|COMPLETED|Overall Study||3||
48403295|NCT00324740|101317862|FG002|COMPLETED|Overall Study||3||
48403296|NCT00324740|101317860|FG000|NOT COMPLETED|Overall Study||1||
48403297|NCT00324740|101317861|FG001|NOT COMPLETED|Overall Study||0||
48708550|NCT03158272|102073361|FG001|NOT COMPLETED|Overall Study||4||
48292739|NCT00655863|101044375|FG001|COMPLETED|Overall Study||25||
48292740|NCT00655863|101044376|FG002|COMPLETED|Overall Study||21||
48292741|NCT00655863|101044374|FG000|NOT COMPLETED|Overall Study||0||
48292742|NCT00655863|101044375|FG001|NOT COMPLETED|Overall Study||0||
48292743|NCT00655863|101044376|FG002|NOT COMPLETED|Overall Study||1||
48292744|NCT02791945|101044377|FG000|STARTED|Overall Study||14||
48292745|NCT02791945|101044378|FG001|STARTED|Overall Study||16||
48292746|NCT02791945|101044377|FG000|COMPLETED|Overall Study||12||
48292747|NCT02791945|101044378|FG001|COMPLETED|Overall Study||14||
48292748|NCT02791945|101044377|FG000|NOT COMPLETED|Overall Study||2||
48292749|NCT02791945|101044378|FG001|NOT COMPLETED|Overall Study||2||
48292750|NCT02937454|101044379|FG000|STARTED|Overall Study||567|All Randomised Set|
48292751|NCT02937454|101044380|FG001|STARTED|Overall Study||565|All Randomised Set|
48292752|NCT02937454|101044379|FG000|Started Treatment|Overall Study||559||
48292753|NCT02937454|101044380|FG001|Started Treatment|Overall Study||551||
48292754|NCT02937454|101044379|FG000|COMPLETED|Overall Study||427||
48292755|NCT02937454|101044380|FG001|COMPLETED|Overall Study||437||
48292756|NCT02937454|101044379|FG000|NOT COMPLETED|Overall Study||140||
48292757|NCT02937454|101044380|FG001|NOT COMPLETED|Overall Study||128||
48292758|NCT01614743|101044381|FG000|STARTED|Overall Study||4||
48292759|NCT01614743|101044382|FG001|STARTED|Overall Study||5||
48292760|NCT01614743|101044381|FG000|COMPLETED|Overall Study||3||
48292761|NCT01614743|101044382|FG001|COMPLETED|Overall Study||5||
48292762|NCT01614743|101044381|FG000|NOT COMPLETED|Overall Study||1||
48292763|NCT01614743|101044382|FG001|NOT COMPLETED|Overall Study||0||
48292764|NCT00577473|101044383|FG000|STARTED|Overall Study||154||
48292765|NCT00577473|101044384|FG001|STARTED|Overall Study||147||
48292766|NCT00577473|101044383|FG000|ITT Population|Overall Study||150||
48292767|NCT00577473|101044384|FG001|ITT Population|Overall Study||136||
48292768|NCT00577473|101044383|FG000|COMPLETED|Overall Study||133||
48292769|NCT00577473|101044384|FG001|COMPLETED|Overall Study||123||
48292770|NCT00577473|101044383|FG000|NOT COMPLETED|Overall Study||21||
48403298|NCT00324740|101317862|FG002|NOT COMPLETED|Overall Study||1||
48403299|NCT00156013|101317863|FG000|STARTED|Overall Study||33||
48403300|NCT00156013|101317863|FG000|COMPLETED|Overall Study||31||
48403301|NCT00156013|101317863|FG000|NOT COMPLETED|Overall Study||2||
48403302|NCT03518034|101317864|FG000|STARTED|Overall Study||2601|Participants in Full Analysis Set (randomized, and no duplicate/triplicate participant IDs)|
48708551|NCT03158272|102073362|FG002|NOT COMPLETED|Overall Study||6||
48708552|NCT03158272|102073363|FG003|NOT COMPLETED|Overall Study||6||
48708553|NCT02367391|102073364|FG000|STARTED|Overall Study||76||
48292771|NCT00577473|101044384|FG001|NOT COMPLETED|Overall Study||24||
48292772|NCT00763867|101044385|FG000|STARTED|Overall Study||103||
48292773|NCT00763867|101044386|FG001|STARTED|Overall Study||113||
48292774|NCT00763867|101044385|FG000|COMPLETED|Overall Study||98||
48292775|NCT00763867|101044386|FG001|COMPLETED|Overall Study||101||
48292776|NCT00763867|101044385|FG000|NOT COMPLETED|Overall Study||5||
48292777|NCT00763867|101044386|FG001|NOT COMPLETED|Overall Study||12||
48292778|NCT00292162|101044387|FG000|STARTED|Overall Study||19||
48292779|NCT00292162|101044388|FG001|STARTED|Overall Study||22||
48292780|NCT00292162|101044387|FG000|COMPLETED|Overall Study||18||
48403303|NCT03518034|101317865|FG001|STARTED|Overall Study||2603|Participants in Full Analysis Set (randomized, and no duplicate/triplicate participant IDs)|
48404082|NCT03689972|101321769|FG003|STARTED|Part 2:Run-in Period (Week73uptoWeek107)||0||
48708554|NCT02367391|102073365|FG001|STARTED|Overall Study||76||
48292781|NCT00292162|101044388|FG001|COMPLETED|Overall Study||20||
48292782|NCT00292162|101044387|FG000|NOT COMPLETED|Overall Study||1||
48292783|NCT00292162|101044388|FG001|NOT COMPLETED|Overall Study||2||
48292784|NCT02097641|101044389|FG000|STARTED|Overall Study||40||
48292785|NCT02097641|101044390|FG001|STARTED|Overall Study||20||
48292786|NCT02097641|101044389|FG000|COMPLETED|Overall Study||40||
48292787|NCT02097641|101044390|FG001|COMPLETED|Overall Study||20||
48292788|NCT02097641|101044389|FG000|NOT COMPLETED|Overall Study||0||
48292789|NCT02097641|101044390|FG001|NOT COMPLETED|Overall Study||0||
48292790|NCT03401229|101044391|FG000|STARTED|Overall Study||207||
48292791|NCT03401229|101044392|FG001|STARTED|Overall Study||203||
48292792|NCT03401229|101044391|FG000|COMPLETED|Overall Study||167||
48292793|NCT03401229|101044392|FG001|COMPLETED|Overall Study||166||
48292794|NCT03401229|101044391|FG000|NOT COMPLETED|Overall Study||40||
48292795|NCT03401229|101044392|FG001|NOT COMPLETED|Overall Study||37||
48292796|NCT01313637|101044393|FG000|STARTED|Overall Study||275||
48292797|NCT01313637|101044394|FG001|STARTED|Overall Study||407||
48292798|NCT01313637|101044395|FG002|STARTED|Overall Study||404||
48292799|NCT01313637|101044396|FG003|STARTED|Overall Study||403||
48292800|NCT01313637|101044393|FG000|COMPLETED|Overall Study||183||
48292801|NCT01313637|101044394|FG001|COMPLETED|Overall Study||312||
48404083|NCT03689972|101321770|FG004|STARTED|Part 2:Run-in Period (Week73uptoWeek107)||0||
48708555|NCT02367391|102073364|FG000|COMPLETED|Overall Study||74||
48708556|NCT02367391|102073365|FG001|COMPLETED|Overall Study||76||
48708557|NCT02367391|102073364|FG000|NOT COMPLETED|Overall Study||2||
48708558|NCT02367391|102073365|FG001|NOT COMPLETED|Overall Study||0||
48708559|NCT03510468|102073366|FG000|STARTED|Overall Study||28||
48708560|NCT03510468|102073366|FG000|COMPLETED|Overall Study||18||
48708561|NCT03510468|102073366|FG000|NOT COMPLETED|Overall Study||10||
48708562|NCT03176472|102073367|FG000|STARTED|Double Blind Treatment Period||142||
48708563|NCT03176472|102073368|FG001|STARTED|Double Blind Treatment Period||140||
48708564|NCT03176472|102073367|FG000|COMPLETED|Double Blind Treatment Period||132||
48708565|NCT03176472|102073368|FG001|COMPLETED|Double Blind Treatment Period||124||
48708566|NCT03176472|102073367|FG000|NOT COMPLETED|Double Blind Treatment Period||10||
48708567|NCT03176472|102073368|FG001|NOT COMPLETED|Double Blind Treatment Period||16||
48708568|NCT03176472|102073367|FG000|STARTED|Open Label Extension||131||
48708569|NCT03176472|102073368|FG001|STARTED|Open Label Extension||121||
48708570|NCT03176472|102073367|FG000|COMPLETED|Open Label Extension||123||
48708571|NCT03176472|102073368|FG001|COMPLETED|Open Label Extension||109||
48708572|NCT03176472|102073367|FG000|NOT COMPLETED|Open Label Extension||8||
48708573|NCT03176472|102073368|FG001|NOT COMPLETED|Open Label Extension||12||
48708574|NCT00902018|102073369|FG000|STARTED|Overall Study||7||
48708575|NCT00902018|102073370|FG001|STARTED|Overall Study||3||
48708576|NCT00902018|102073371|FG002|STARTED|Overall Study||10||
48708577|NCT00902018|102073369|FG000|COMPLETED|Overall Study||7||
48708578|NCT00902018|102073370|FG001|COMPLETED|Overall Study||3||
48708579|NCT00902018|102073371|FG002|COMPLETED|Overall Study||10||
48708580|NCT00902018|102073369|FG000|NOT COMPLETED|Overall Study||0||
48708581|NCT00902018|102073370|FG001|NOT COMPLETED|Overall Study||0||
48708582|NCT00902018|102073371|FG002|NOT COMPLETED|Overall Study||0||
48708583|NCT03054805|102073372|FG000|STARTED|Overall Study||58||
48708584|NCT03054805|102073373|FG001|STARTED|Overall Study||51||
48708585|NCT03054805|102073374|FG002|STARTED|Overall Study||44||
48708586|NCT03054805|102073372|FG000|COMPLETED|Overall Study||42||
48708587|NCT03054805|102073373|FG001|COMPLETED|Overall Study||41||
48708588|NCT03054805|102073374|FG002|COMPLETED|Overall Study||42||
48708589|NCT03054805|102073372|FG000|NOT COMPLETED|Overall Study||16||
48708590|NCT03054805|102073373|FG001|NOT COMPLETED|Overall Study||10||
48292802|NCT01313637|101044395|FG002|COMPLETED|Overall Study||298||
48292803|NCT01313637|101044396|FG003|COMPLETED|Overall Study||325||
48292804|NCT01313637|101044393|FG000|NOT COMPLETED|Overall Study||92||
48292805|NCT01313637|101044394|FG001|NOT COMPLETED|Overall Study||95||
48292806|NCT01313637|101044395|FG002|NOT COMPLETED|Overall Study||106||
48292807|NCT01313637|101044396|FG003|NOT COMPLETED|Overall Study||78||
48708591|NCT03054805|102073374|FG002|NOT COMPLETED|Overall Study||2||
48708592|NCT01598753|102073375|FG000|STARTED|Overall Study||37||
48708593|NCT01598753|102073376|FG001|STARTED|Overall Study||31||
48708594|NCT01598753|102073377|FG002|STARTED|Overall Study||32||
48708595|NCT01598753|102073378|FG003|STARTED|Overall Study||34||
48292808|NCT01098097|101044397|FG000|STARTED|Overall Study||963||
48292809|NCT01098097|101044397|FG000|COMPLETED|Overall Study||881||
48292810|NCT01098097|101044397|FG000|NOT COMPLETED|Overall Study||82||
48140164|NCT04302350|100670105|FG002|STARTED|Overall Study||26||
48292811|NCT01777269|101044398|FG000|STARTED|Overall Study||246||
48292812|NCT01777269|101044399|FG001|STARTED|Overall Study||243||
48292813|NCT01777269|101044398|FG000|COMPLETED|Overall Study||191||
48292814|NCT01777269|101044399|FG001|COMPLETED|Overall Study||184||
48292815|NCT01777269|101044398|FG000|NOT COMPLETED|Overall Study||55||
48292816|NCT01777269|101044399|FG001|NOT COMPLETED|Overall Study||59||
48292817|NCT00585377|101044400|FG000|STARTED|Overall Study||50||
48292818|NCT00585377|101044400|FG000|COMPLETED|Overall Study||50||
48292819|NCT00585377|101044400|FG000|NOT COMPLETED|Overall Study||0||
48292820|NCT00816348|101044401|FG000|STARTED|Overall Study||15||
48292821|NCT00816348|101044401|FG000|COMPLETED|Overall Study||15||
48292822|NCT00816348|101044401|FG000|NOT COMPLETED|Overall Study||0||
48292823|NCT01577745|101044402|FG000|STARTED|Overall Study||3||
48292824|NCT01577745|101044403|FG001|STARTED|Overall Study||3||
48292825|NCT01577745|101044404|FG002|STARTED|Overall Study||3||
48292826|NCT01577745|101044405|FG003|STARTED|Overall Study||6||
48292827|NCT01577745|101044406|FG004|STARTED|Overall Study||5||
48140165|NCT04302350|100670103|FG000|COMPLETED|Overall Study||24||
48140166|NCT04302350|100670104|FG001|COMPLETED|Overall Study||23||
48140167|NCT04302350|100670105|FG002|COMPLETED|Overall Study||18||
48140168|NCT04302350|100670103|FG000|NOT COMPLETED|Overall Study||2||
48140169|NCT04302350|100670104|FG001|NOT COMPLETED|Overall Study||3||
48140170|NCT04302350|100670105|FG002|NOT COMPLETED|Overall Study||8||
48140171|NCT00492284|100670106|FG000|STARTED|Overall Study||39||
48140172|NCT00492284|100670107|FG001|STARTED|Overall Study||39||
48140173|NCT00492284|100670108|FG002|STARTED|Overall Study||43||
48140174|NCT00492284|100670109|FG003|STARTED|Overall Study||41||
48140175|NCT00492284|100670106|FG000|COMPLETED|Overall Study||38||
48140176|NCT00492284|100670107|FG001|COMPLETED|Overall Study||35||
48140177|NCT00492284|100670108|FG002|COMPLETED|Overall Study||37||
48140178|NCT00492284|100670109|FG003|COMPLETED|Overall Study||31||
48140179|NCT00492284|100670106|FG000|NOT COMPLETED|Overall Study||1||
48140180|NCT00492284|100670107|FG001|NOT COMPLETED|Overall Study||4||
48140181|NCT00492284|100670108|FG002|NOT COMPLETED|Overall Study||6||
48140182|NCT00492284|100670109|FG003|NOT COMPLETED|Overall Study||10||
48140183|NCT01275625|100670110|FG000|STARTED|Overall Study||77||
48140184|NCT01275625|100670110|FG000|Treated|Overall Study||77||
48140185|NCT01275625|100670110|FG000|COMPLETED|Overall Study||64||
48140186|NCT01275625|100670110|FG000|NOT COMPLETED|Overall Study||13||
48140187|NCT02062632|100670111|FG000|STARTED|Overall Study||3||
48140188|NCT02062632|100670111|FG000|COMPLETED|Overall Study||2||
48140189|NCT02062632|100670111|FG000|NOT COMPLETED|Overall Study||1||
48140190|NCT00639717|100670112|FG000|STARTED|Overall Study||48||
48140191|NCT00639717|100670112|FG000|COMPLETED|Overall Study||48||
48140192|NCT00639717|100670112|FG000|NOT COMPLETED|Overall Study||0||
48140193|NCT04542343|100670113|FG000|STARTED|Overall Study||17||
48140194|NCT04542343|100670114|FG001|STARTED|Overall Study||46||
48140195|NCT04542343|100670115|FG002|STARTED|Overall Study||152||
48140196|NCT04542343|100670113|FG000|COMPLETED|Overall Study||10||
48140197|NCT04542343|100670114|FG001|COMPLETED|Overall Study||19||
48140198|NCT04542343|100670115|FG002|COMPLETED|Overall Study||110||
48140199|NCT04542343|100670113|FG000|NOT COMPLETED|Overall Study||7||
48140200|NCT04542343|100670114|FG001|NOT COMPLETED|Overall Study||27||
48140201|NCT04542343|100670115|FG002|NOT COMPLETED|Overall Study||42||
48140202|NCT03397264|100670116|FG000|STARTED|Overall Study||3||
48140203|NCT03397264|100670117|FG001|STARTED|Overall Study||3||
48140204|NCT03397264|100670118|FG002|STARTED|Overall Study||3||
48140205|NCT03397264|100670119|FG003|STARTED|Overall Study||96||
48140206|NCT03397264|100670120|FG004|STARTED|Overall Study||48||
48292828|NCT01577745|101044407|FG005|STARTED|Overall Study||5||
48292829|NCT01577745|101044402|FG000|COMPLETED|Overall Study||0||
48292830|NCT01577745|101044403|FG001|COMPLETED|Overall Study||0||
48292831|NCT01577745|101044404|FG002|COMPLETED|Overall Study||1||
48292832|NCT01577745|101044405|FG003|COMPLETED|Overall Study||0||
48292833|NCT01577745|101044406|FG004|COMPLETED|Overall Study||0||
48292834|NCT01577745|101044407|FG005|COMPLETED|Overall Study||1||
48140207|NCT03397264|100670116|FG000|COMPLETED|Overall Study||3|Completed the Treatment Phase to Week 12|
48292835|NCT01577745|101044402|FG000|NOT COMPLETED|Overall Study||3||
48140208|NCT03397264|100670117|FG001|COMPLETED|Overall Study||3|Completed the Treatment Phase to Week 12|
48140209|NCT03397264|100670118|FG002|COMPLETED|Overall Study||3|Completed the Treatment Phase to Week 12|
48292836|NCT01577745|101044403|FG001|NOT COMPLETED|Overall Study||3||
48292837|NCT01577745|101044404|FG002|NOT COMPLETED|Overall Study||2||
48708596|NCT01598753|102073375|FG000|COMPLETED|Overall Study||25||
48708597|NCT01598753|102073376|FG001|COMPLETED|Overall Study||16||
48708598|NCT01598753|102073377|FG002|COMPLETED|Overall Study||24||
48708599|NCT01598753|102073378|FG003|COMPLETED|Overall Study||19||
48708600|NCT01598753|102073375|FG000|NOT COMPLETED|Overall Study||12||
48708601|NCT01598753|102073376|FG001|NOT COMPLETED|Overall Study||15||
48140210|NCT03397264|100670119|FG003|COMPLETED|Overall Study||89|Completed the Treatment Phase to Week 12|
48140211|NCT03397264|100670120|FG004|COMPLETED|Overall Study||47|Completed the Treatment Phase to Week 12|
48140212|NCT03397264|100670116|FG000|NOT COMPLETED|Overall Study||0||
48140213|NCT03397264|100670117|FG001|NOT COMPLETED|Overall Study||0||
48140214|NCT03397264|100670118|FG002|NOT COMPLETED|Overall Study||0||
48590364|NCT02706886|101779680|FG008|STARTED|Part B: MAD Study Day 85-End of Study||4||
48590365|NCT02706886|101779672|FG000|COMPLETED|Part B: MAD Study Day 85-End of Study||0||
48590366|NCT02706886|101779673|FG001|COMPLETED|Part B: MAD Study Day 85-End of Study||0||
48708602|NCT01598753|102073377|FG002|NOT COMPLETED|Overall Study||8||
48140215|NCT03397264|100670119|FG003|NOT COMPLETED|Overall Study||7||
48140216|NCT03397264|100670120|FG004|NOT COMPLETED|Overall Study||1||
48140217|NCT04383496|100670121|FG000|STARTED|Overall Study||21||
48140218|NCT04383496|100670121|FG000|COMPLETED|Overall Study||19||
48140219|NCT04383496|100670121|FG000|NOT COMPLETED|Overall Study||2||
48140220|NCT05557942|100670122|FG000|STARTED|Overall Study||18||
48140221|NCT05557942|100670123|FG001|STARTED|Overall Study||18||
48590367|NCT02706886|101779674|FG002|COMPLETED|Part B: MAD Study Day 85-End of Study||0||
48590368|NCT02706886|101779675|FG003|COMPLETED|Part B: MAD Study Day 85-End of Study||0||
48590369|NCT02706886|101779676|FG004|COMPLETED|Part B: MAD Study Day 85-End of Study||0||
48590370|NCT02706886|101779677|FG005|COMPLETED|Part B: MAD Study Day 85-End of Study||0||
48590371|NCT02706886|101779678|FG006|COMPLETED|Part B: MAD Study Day 85-End of Study||8||
48590372|NCT02706886|101779679|FG007|COMPLETED|Part B: MAD Study Day 85-End of Study||8||
48590373|NCT02706886|101779680|FG008|COMPLETED|Part B: MAD Study Day 85-End of Study||4||
48590374|NCT02706886|101779672|FG000|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0||
48590375|NCT02706886|101779673|FG001|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0||
48590376|NCT02706886|101779674|FG002|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0||
48708603|NCT01598753|102073378|FG003|NOT COMPLETED|Overall Study||15||
48708604|NCT01173029|102073379|FG000|STARTED|Overall Study||61||
48708605|NCT01173029|102073380|FG001|STARTED|Overall Study||31||
48140222|NCT05557942|100670124|FG002|STARTED|Overall Study||16||
48140223|NCT05557942|100670125|FG003|STARTED|Overall Study||45||
48140224|NCT05557942|100670126|FG004|STARTED|Overall Study||48||
48140225|NCT05557942|100670127|FG005|STARTED|Overall Study||41||
48140226|NCT05557942|100670122|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18||
48140227|NCT05557942|100670123|FG001|Received at Least 1 Dose of Study Drug|Overall Study||18||
48140228|NCT05557942|100670124|FG002|Received at Least 1 Dose of Study Drug|Overall Study||16||
48140229|NCT05557942|100670125|FG003|Received at Least 1 Dose of Study Drug|Overall Study||45||
48140230|NCT05557942|100670126|FG004|Received at Least 1 Dose of Study Drug|Overall Study||48||
48140231|NCT05557942|100670127|FG005|Received at Least 1 Dose of Study Drug|Overall Study||41||
48140232|NCT05557942|100670122|FG000|COMPLETED|Overall Study||0|"Completed refers to participants who completed the study"|
48140233|NCT05557942|100670123|FG001|COMPLETED|Overall Study||0|"Completed refers to participants who completed the study"|
48140234|NCT05557942|100670124|FG002|COMPLETED|Overall Study||0|"Completed refers to participants who completed the study"|
48140235|NCT05557942|100670125|FG003|COMPLETED|Overall Study||0|"Completed refers to participants who completed the study"|
48140236|NCT05557942|100670126|FG004|COMPLETED|Overall Study||0|"Completed refers to participants who completed the study"|
48140237|NCT05557942|100670127|FG005|COMPLETED|Overall Study||0|"Completed refers to participants who completed the study"|
48140238|NCT05557942|100670122|FG000|NOT COMPLETED|Overall Study||18||
48140239|NCT05557942|100670123|FG001|NOT COMPLETED|Overall Study||18||
48140240|NCT05557942|100670124|FG002|NOT COMPLETED|Overall Study||16||
48140241|NCT05557942|100670125|FG003|NOT COMPLETED|Overall Study||45||
48140242|NCT05557942|100670126|FG004|NOT COMPLETED|Overall Study||48||
48140243|NCT05557942|100670127|FG005|NOT COMPLETED|Overall Study||41||
48708606|NCT01173029|102073379|FG000|COMPLETED|Overall Study||61||
48708607|NCT01173029|102073380|FG001|COMPLETED|Overall Study||31||
48708608|NCT01173029|102073379|FG000|NOT COMPLETED|Overall Study||0||
48140244|NCT02148250|100670128|FG000|STARTED|Screening||17||
48140245|NCT02148250|100670129|FG001|STARTED|Screening||0||
48140246|NCT02148250|100670128|FG000|COMPLETED|Screening||12||
48140247|NCT02148250|100670129|FG001|COMPLETED|Screening||0||
48140248|NCT02148250|100670128|FG000|NOT COMPLETED|Screening||5||
48140249|NCT02148250|100670129|FG001|NOT COMPLETED|Screening||0||
48140250|NCT02148250|100670128|FG000|STARTED|Period 1||6||
48140251|NCT02148250|100670129|FG001|STARTED|Period 1||6||
48708609|NCT01173029|102073380|FG001|NOT COMPLETED|Overall Study||0||
48708610|NCT00246025|102073381|FG000|STARTED|Overall Study||124||
48708611|NCT00246025|102073382|FG001|STARTED|Overall Study||133||
48708612|NCT00246025|102073383|FG002|STARTED|Overall Study||126||
48292838|NCT01577745|101044405|FG003|NOT COMPLETED|Overall Study||6||
48292839|NCT01577745|101044406|FG004|NOT COMPLETED|Overall Study||5||
48292840|NCT01577745|101044407|FG005|NOT COMPLETED|Overall Study||4||
48708613|NCT00246025|102073384|FG003|STARTED|Overall Study||129||
48708614|NCT00246025|102073381|FG000|COMPLETED|Overall Study||114||
48708615|NCT00246025|102073382|FG001|COMPLETED|Overall Study||124||
48708616|NCT00246025|102073383|FG002|COMPLETED|Overall Study||116||
48708617|NCT00246025|102073384|FG003|COMPLETED|Overall Study||116||
48708618|NCT00246025|102073381|FG000|NOT COMPLETED|Overall Study||10||
48292841|NCT02893930|101044408|FG000|STARTED|Overall Study||13||
48292842|NCT02893930|101044408|FG000|Eligible and Treated|Overall Study||12||
48292843|NCT02893930|101044408|FG000|COMPLETED|Overall Study||0||
48292844|NCT02893930|101044408|FG000|NOT COMPLETED|Overall Study||13||
48292845|NCT01759368|101044409|FG000|STARTED|Overall Study||47||
48292846|NCT01759368|101044410|FG001|STARTED|Overall Study||47||
48292847|NCT01759368|101044409|FG000|COMPLETED|Overall Study||46||
48292848|NCT01759368|101044410|FG001|COMPLETED|Overall Study||47||
48292849|NCT01759368|101044409|FG000|NOT COMPLETED|Overall Study||1||
48292850|NCT01759368|101044410|FG001|NOT COMPLETED|Overall Study||0||
48292851|NCT02175004|101044411|FG000|STARTED|Overall Study||50||
48292852|NCT02175004|101044412|FG001|STARTED|Overall Study||85||
48708619|NCT00246025|102073382|FG001|NOT COMPLETED|Overall Study||9||
48708620|NCT00246025|102073383|FG002|NOT COMPLETED|Overall Study||10||
48708621|NCT00246025|102073384|FG003|NOT COMPLETED|Overall Study||13||
48708622|NCT00966849|102073385|FG000|STARTED|Overall Study||3660||1319
48708623|NCT00966849|102073386|FG001|STARTED|Overall Study||3976||1525
48708624|NCT00966849|102073387|FG002|STARTED|Overall Study||3169||1199
48708625|NCT00966849|102073385|FG000|COMPLETED|Overall Study||2119||1248
48708626|NCT00966849|102073386|FG001|COMPLETED|Overall Study||2498||1452
48708627|NCT00966849|102073387|FG002|COMPLETED|Overall Study||1876||1118
48292853|NCT02175004|101044411|FG000|COMPLETED|Overall Study||9||
48708628|NCT00966849|102073385|FG000|NOT COMPLETED|Overall Study||1541||71
48708629|NCT00966849|102073386|FG001|NOT COMPLETED|Overall Study||1478||73
48708630|NCT00966849|102073387|FG002|NOT COMPLETED|Overall Study||1293||81
48708631|NCT00559468|102073388|FG000|STARTED|Overall Study||26||
48708632|NCT00559468|102073389|FG001|STARTED|Overall Study||26||
48708633|NCT00559468|102073388|FG000|Treated|Overall Study||26||
48292854|NCT02175004|101044412|FG001|COMPLETED|Overall Study||9||
48292855|NCT02175004|101044411|FG000|NOT COMPLETED|Overall Study||41||
48292856|NCT02175004|101044412|FG001|NOT COMPLETED|Overall Study||76||
48292857|NCT02973048|101044413|FG000|STARTED|Overall Study||20||
48292858|NCT02973048|101044414|FG001|STARTED|Overall Study||20||
48292859|NCT02973048|101044413|FG000|COMPLETED|Overall Study||19||
48292860|NCT02973048|101044414|FG001|COMPLETED|Overall Study||17||
48292861|NCT02973048|101044413|FG000|NOT COMPLETED|Overall Study||1||
48292862|NCT02973048|101044414|FG001|NOT COMPLETED|Overall Study||3||
48708634|NCT00559468|102073389|FG001|Treated|Overall Study||25||
48708635|NCT00559468|102073388|FG000|COMPLETED|Overall Study||26||
48708636|NCT00559468|102073389|FG001|COMPLETED|Overall Study||25||
48708637|NCT00559468|102073388|FG000|NOT COMPLETED|Overall Study||0||
48708638|NCT00559468|102073389|FG001|NOT COMPLETED|Overall Study||1||
48708639|NCT00076336|102073390|FG000|STARTED|Overall Study||116||
48292863|NCT02958267|101044415|FG000|STARTED|Enrollment||17||
48292864|NCT02958267|101044416|FG001|STARTED|Enrollment||15||
48292865|NCT02958267|101044415|FG000|COMPLETED|Enrollment||17||
48292866|NCT02958267|101044416|FG001|COMPLETED|Enrollment||15||
48292867|NCT02958267|101044415|FG000|NOT COMPLETED|Enrollment||0||
48292868|NCT02958267|101044416|FG001|NOT COMPLETED|Enrollment||0||
48292869|NCT02958267|101044415|FG000|STARTED|Enrollment to Actual Treatment Complete||17||
48708640|NCT00076336|102073391|FG001|STARTED|Overall Study||116||
48708641|NCT00076336|102073390|FG000|Safety Population|Overall Study||115||
48708642|NCT00076336|102073391|FG001|Safety Population|Overall Study||116||
48708643|NCT00076336|102073390|FG000|Intent to Treat (ITT) Population|Overall Study||114||
48708644|NCT00076336|102073391|FG001|Intent to Treat (ITT) Population|Overall Study||114||
48708645|NCT00076336|102073390|FG000|Completed Week 52|Overall Study||97||
48708646|NCT00076336|102073391|FG001|Completed Week 52|Overall Study||94||
48708647|NCT00076336|102073390|FG000|Completed Week 104|Overall Study||70||
48292870|NCT02958267|101044416|FG001|STARTED|Enrollment to Actual Treatment Complete||15||
48292871|NCT02958267|101044415|FG000|COMPLETED|Enrollment to Actual Treatment Complete||15||
48292872|NCT02958267|101044416|FG001|COMPLETED|Enrollment to Actual Treatment Complete||15||
48292873|NCT02958267|101044415|FG000|NOT COMPLETED|Enrollment to Actual Treatment Complete||2||
48292874|NCT02958267|101044416|FG001|NOT COMPLETED|Enrollment to Actual Treatment Complete||0||
48292875|NCT02958267|101044415|FG000|STARTED|Follow-up Visits||15||
48292876|NCT02958267|101044416|FG001|STARTED|Follow-up Visits||15||
48292877|NCT02958267|101044415|FG000|3 Month Follow-up|Follow-up Visits||15||
48292878|NCT02958267|101044416|FG001|3 Month Follow-up|Follow-up Visits||15||
48708648|NCT00076336|102073391|FG001|Completed Week 104|Overall Study||62||
48708649|NCT00076336|102073390|FG000|COMPLETED|Overall Study||64||
48708650|NCT00076336|102073391|FG001|COMPLETED|Overall Study||60||
48708651|NCT00076336|102073390|FG000|NOT COMPLETED|Overall Study||52||
48708652|NCT00076336|102073391|FG001|NOT COMPLETED|Overall Study||56||
48708653|NCT01238835|102073392|FG000|STARTED|Overall Study||218||
48708654|NCT01238835|102073392|FG000|COMPLETED|Overall Study||82||
48708655|NCT01238835|102073392|FG000|NOT COMPLETED|Overall Study||136||
48708656|NCT04346108|102073393|FG000|STARTED|Epoch 1 (13 Weeks)||17||
48708657|NCT04346108|102073394|FG001|STARTED|Epoch 1 (13 Weeks)||0||
48708658|NCT04346108|102073395|FG002|STARTED|Epoch 1 (13 Weeks)||0||
48708659|NCT04346108|102073393|FG000|COMPLETED|Epoch 1 (13 Weeks)||17||
48708660|NCT04346108|102073394|FG001|COMPLETED|Epoch 1 (13 Weeks)||0||
48708661|NCT04346108|102073395|FG002|COMPLETED|Epoch 1 (13 Weeks)||0||
48708662|NCT04346108|102073393|FG000|NOT COMPLETED|Epoch 1 (13 Weeks)||0||
48708663|NCT04346108|102073394|FG001|NOT COMPLETED|Epoch 1 (13 Weeks)||0||
48708664|NCT04346108|102073395|FG002|NOT COMPLETED|Epoch 1 (13 Weeks)||0||
48708665|NCT04346108|102073393|FG000|STARTED|Epoch 2 (24 Weeks After Epoch 1)||0||
48708666|NCT04346108|102073394|FG001|STARTED|Epoch 2 (24 Weeks After Epoch 1)||17||
48708667|NCT04346108|102073395|FG002|STARTED|Epoch 2 (24 Weeks After Epoch 1)||0||
48708668|NCT04346108|102073393|FG000|COMPLETED|Epoch 2 (24 Weeks After Epoch 1)||0||
48708669|NCT04346108|102073394|FG001|COMPLETED|Epoch 2 (24 Weeks After Epoch 1)||15||
48708670|NCT04346108|102073395|FG002|COMPLETED|Epoch 2 (24 Weeks After Epoch 1)||0||
48708671|NCT04346108|102073393|FG000|NOT COMPLETED|Epoch 2 (24 Weeks After Epoch 1)||0||
48708672|NCT04346108|102073394|FG001|NOT COMPLETED|Epoch 2 (24 Weeks After Epoch 1)||2||
48708673|NCT04346108|102073395|FG002|NOT COMPLETED|Epoch 2 (24 Weeks After Epoch 1)||0||
48708674|NCT04346108|102073393|FG000|STARTED|Epoch 3 (12 Weeks After Epoch 2)||0||
48708675|NCT04346108|102073394|FG001|STARTED|Epoch 3 (12 Weeks After Epoch 2)||0||
48708676|NCT04346108|102073395|FG002|STARTED|Epoch 3 (12 Weeks After Epoch 2)||7||
48708677|NCT04346108|102073393|FG000|COMPLETED|Epoch 3 (12 Weeks After Epoch 2)||0||
48708678|NCT04346108|102073394|FG001|COMPLETED|Epoch 3 (12 Weeks After Epoch 2)||0||
48708679|NCT04346108|102073395|FG002|COMPLETED|Epoch 3 (12 Weeks After Epoch 2)||7||
48708680|NCT04346108|102073393|FG000|NOT COMPLETED|Epoch 3 (12 Weeks After Epoch 2)||0||
48708681|NCT04346108|102073394|FG001|NOT COMPLETED|Epoch 3 (12 Weeks After Epoch 2)||0||
48708682|NCT04346108|102073395|FG002|NOT COMPLETED|Epoch 3 (12 Weeks After Epoch 2)||0||
48708683|NCT05357664|102073396|FG000|STARTED|Overall Study||11|11|11
48708684|NCT05357664|102073396|FG000|COMPLETED|Overall Study||0|0|0
48708685|NCT05357664|102073396|FG000|NOT COMPLETED|Overall Study||11||11
48708686|NCT01327274|102073397|FG000|STARTED|Overall Study||15||
48708687|NCT01327274|102073397|FG000|COMPLETED|Overall Study||15||
48708688|NCT01327274|102073397|FG000|NOT COMPLETED|Overall Study||0||
48708689|NCT02129478|102073398|FG000|STARTED|Overall Study||15||
48708690|NCT02129478|102073398|FG000|COMPLETED|Overall Study||15||
48708691|NCT02129478|102073398|FG000|NOT COMPLETED|Overall Study||0||
48708692|NCT02390414|102073399|FG000|STARTED|Overall Study||113||
48708693|NCT02390414|102073400|FG001|STARTED|Overall Study||177||
48708694|NCT02390414|102073399|FG000|COMPLETED|Overall Study||113||
48708695|NCT02390414|102073400|FG001|COMPLETED|Overall Study||177||
48708696|NCT02390414|102073399|FG000|NOT COMPLETED|Overall Study||0||
48708697|NCT02390414|102073400|FG001|NOT COMPLETED|Overall Study||0||
48708698|NCT00929773|102073401|FG000|STARTED|Overall Study||50||
48708699|NCT00929773|102073402|FG001|STARTED|Overall Study||50||
48140252|NCT02148250|100670128|FG000|COMPLETED|Period 1||6||
48140253|NCT02148250|100670129|FG001|COMPLETED|Period 1||6||
48140254|NCT02148250|100670128|FG000|NOT COMPLETED|Period 1||0||
48140255|NCT02148250|100670129|FG001|NOT COMPLETED|Period 1||0||
48140256|NCT02148250|100670128|FG000|STARTED|Period 2||6||
48140257|NCT02148250|100670129|FG001|STARTED|Period 2||6||
48140258|NCT02148250|100670128|FG000|COMPLETED|Period 2||6||
48708700|NCT00929773|102073401|FG000|COMPLETED|Overall Study||50||
48708701|NCT00929773|102073402|FG001|COMPLETED|Overall Study||50||
48708702|NCT00929773|102073401|FG000|NOT COMPLETED|Overall Study||0||
48708703|NCT00929773|102073402|FG001|NOT COMPLETED|Overall Study||0||
48708704|NCT00445848|102073403|FG000|STARTED|Overall Study||85||
48708705|NCT00445848|102073403|FG000|COMPLETED|Overall Study||0||
48140259|NCT02148250|100670129|FG001|COMPLETED|Period 2||6||
48140260|NCT02148250|100670128|FG000|NOT COMPLETED|Period 2||0||
48708706|NCT00445848|102073403|FG000|NOT COMPLETED|Overall Study||85||
48708707|NCT02088073|102073404|FG000|STARTED|Acute Phase||258||
48708708|NCT02088073|102073405|FG001|STARTED|Acute Phase||0||
48708709|NCT02088073|102073406|FG002|STARTED|Acute Phase||0||
48708710|NCT02088073|102073407|FG003|STARTED|Acute Phase||0||
48708711|NCT02088073|102073408|FG004|STARTED|Acute Phase||0||
48708712|NCT02088073|102073404|FG000|COMPLETED|Acute Phase||251||
48708713|NCT02088073|102073405|FG001|COMPLETED|Acute Phase||0||
48708714|NCT02088073|102073406|FG002|COMPLETED|Acute Phase||0||
48708715|NCT02088073|102073407|FG003|COMPLETED|Acute Phase||0||
48708716|NCT02088073|102073408|FG004|COMPLETED|Acute Phase||0||
48708717|NCT02088073|102073404|FG000|NOT COMPLETED|Acute Phase||7||
48708718|NCT02088073|102073405|FG001|NOT COMPLETED|Acute Phase||0||
48708719|NCT02088073|102073406|FG002|NOT COMPLETED|Acute Phase||0||
48708720|NCT02088073|102073407|FG003|NOT COMPLETED|Acute Phase||0||
48708721|NCT02088073|102073408|FG004|NOT COMPLETED|Acute Phase||0||
48708722|NCT02088073|102073404|FG000|STARTED|Maintanance Phase||0||
48708723|NCT02088073|102073405|FG001|STARTED|Maintanance Phase||85||
48708724|NCT02088073|102073406|FG002|STARTED|Maintanance Phase||45||
48708725|NCT02088073|102073407|FG003|STARTED|Maintanance Phase||51||
48708726|NCT02088073|102073408|FG004|STARTED|Maintanance Phase||56||
48708727|NCT02088073|102073404|FG000|COMPLETED|Maintanance Phase||0||
48708728|NCT02088073|102073405|FG001|COMPLETED|Maintanance Phase||75||
48708729|NCT02088073|102073406|FG002|COMPLETED|Maintanance Phase||40||
48708730|NCT02088073|102073407|FG003|COMPLETED|Maintanance Phase||44||
48708731|NCT02088073|102073408|FG004|COMPLETED|Maintanance Phase||49||
48590377|NCT02706886|101779675|FG003|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0||
48590378|NCT02706886|101779676|FG004|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0||
48590379|NCT02706886|101779677|FG005|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0||
48590380|NCT02706886|101779678|FG006|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0||
48590381|NCT02706886|101779679|FG007|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0||
48590382|NCT02706886|101779680|FG008|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0||
48590383|NCT03584464|101779681|FG000|STARTED|Overall Study||205||
48590384|NCT03584464|101779681|FG000|COMPLETED|Overall Study||204||
48590385|NCT03584464|101779681|FG000|NOT COMPLETED|Overall Study||1||
48590386|NCT01328548|101779682|FG000|STARTED|Overall Study||191||
48590387|NCT01328548|101779683|FG001|STARTED|Overall Study||50||
48590388|NCT01328548|101779682|FG000|COMPLETED|Overall Study||187||
48590389|NCT01328548|101779683|FG001|COMPLETED|Overall Study||50||
48590390|NCT01328548|101779682|FG000|NOT COMPLETED|Overall Study||4||
48590391|NCT01328548|101779683|FG001|NOT COMPLETED|Overall Study||0||
48590392|NCT00805870|101779684|FG000|STARTED|Overall Study||10||
48590393|NCT00805870|101779685|FG001|STARTED|Overall Study||10||
48590394|NCT00805870|101779684|FG000|COMPLETED|Overall Study||10||
48590395|NCT00805870|101779685|FG001|COMPLETED|Overall Study||10||
48590396|NCT00805870|101779684|FG000|NOT COMPLETED|Overall Study||0||
48590397|NCT00805870|101779685|FG001|NOT COMPLETED|Overall Study||0||
48590398|NCT03104400|101779686|FG000|STARTED|Overall Study||211||
48708732|NCT02088073|102073404|FG000|NOT COMPLETED|Maintanance Phase||0||
48708733|NCT02088073|102073405|FG001|NOT COMPLETED|Maintanance Phase||10||
48708734|NCT02088073|102073406|FG002|NOT COMPLETED|Maintanance Phase||5||
48708735|NCT02088073|102073407|FG003|NOT COMPLETED|Maintanance Phase||7||
48708736|NCT02088073|102073408|FG004|NOT COMPLETED|Maintanance Phase||7||
48708737|NCT00996281|102073409|FG000|STARTED|Overall Study||418||
48708738|NCT00996281|102073410|FG001|STARTED|Overall Study||419||
48708739|NCT00996281|102073409|FG000|COMPLETED|Overall Study||287||
48708740|NCT00996281|102073410|FG001|COMPLETED|Overall Study||330||
48708741|NCT00996281|102073409|FG000|NOT COMPLETED|Overall Study||131||
48590399|NCT03104400|101779687|FG001|STARTED|Overall Study||212||
48590400|NCT03104400|101779688|FG002|STARTED|Overall Study||429||
48708742|NCT00996281|102073410|FG001|NOT COMPLETED|Overall Study||89||
48708743|NCT00068250|102073411|FG000|STARTED|Phase I: Dose Level 1||6||
48708744|NCT00068250|102073412|FG001|STARTED|Phase I: Dose Level 1||0||
48708745|NCT00068250|102073413|FG002|STARTED|Phase I: Dose Level 1||0||
48708746|NCT00068250|102073414|FG003|STARTED|Phase I: Dose Level 1||0||
48708747|NCT00068250|102073411|FG000|COMPLETED|Phase I: Dose Level 1||6||
48708748|NCT00068250|102073412|FG001|COMPLETED|Phase I: Dose Level 1||0||
48590401|NCT03104400|101779689|FG003|STARTED|Overall Study||430||
48590402|NCT03104400|101779690|FG004|STARTED|Overall Study||423||
48140261|NCT02148250|100670129|FG001|NOT COMPLETED|Period 2||0||
48140262|NCT02232893|100670130|FG000|STARTED|Overall Study||35||
48140263|NCT02232893|100670131|FG001|STARTED|Overall Study||34||
48140264|NCT02232893|100670130|FG000|Safety Population|Overall Study||34||
48140265|NCT02232893|100670131|FG001|Safety Population|Overall Study||32||
48590403|NCT03104400|101779686|FG000|Received Study Drug|Overall Study||211||
48708749|NCT00068250|102073413|FG002|COMPLETED|Phase I: Dose Level 1||0||
48708750|NCT00068250|102073414|FG003|COMPLETED|Phase I: Dose Level 1||0||
48708751|NCT00068250|102073411|FG000|NOT COMPLETED|Phase I: Dose Level 1||0||
48140266|NCT02232893|100670130|FG000|Primary Endpoint Population|Overall Study||24||
48140267|NCT02232893|100670131|FG001|Primary Endpoint Population|Overall Study||19||
48140268|NCT02232893|100670130|FG000|COMPLETED|Overall Study||31||
48140269|NCT02232893|100670131|FG001|COMPLETED|Overall Study||27||
48590404|NCT03104400|101779687|FG001|Received Study Drug|Overall Study||212||
48590405|NCT03104400|101779688|FG002|Received Study Drug|Overall Study||429||
48708752|NCT00068250|102073412|FG001|NOT COMPLETED|Phase I: Dose Level 1||0||
48708753|NCT00068250|102073413|FG002|NOT COMPLETED|Phase I: Dose Level 1||0||
48708754|NCT00068250|102073414|FG003|NOT COMPLETED|Phase I: Dose Level 1||0||
48708755|NCT00068250|102073411|FG000|STARTED|Phase I: Dose Level 2||0||
48708756|NCT00068250|102073412|FG001|STARTED|Phase I: Dose Level 2||7||
48708757|NCT00068250|102073413|FG002|STARTED|Phase I: Dose Level 2||0||
48708758|NCT00068250|102073414|FG003|STARTED|Phase I: Dose Level 2||0||
48708759|NCT00068250|102073411|FG000|COMPLETED|Phase I: Dose Level 2||0||
48708760|NCT00068250|102073412|FG001|COMPLETED|Phase I: Dose Level 2||6||
48708761|NCT00068250|102073413|FG002|COMPLETED|Phase I: Dose Level 2||0||
48708762|NCT00068250|102073414|FG003|COMPLETED|Phase I: Dose Level 2||0||
48708763|NCT00068250|102073411|FG000|NOT COMPLETED|Phase I: Dose Level 2||0||
48708764|NCT00068250|102073412|FG001|NOT COMPLETED|Phase I: Dose Level 2||1||
48708765|NCT00068250|102073413|FG002|NOT COMPLETED|Phase I: Dose Level 2||0||
48708766|NCT00068250|102073414|FG003|NOT COMPLETED|Phase I: Dose Level 2||0||
48708767|NCT00068250|102073411|FG000|STARTED|Phase II: Dose Level 2||0||
48708768|NCT00068250|102073412|FG001|STARTED|Phase II: Dose Level 2||0||
48708769|NCT00068250|102073413|FG002|STARTED|Phase II: Dose Level 2||0||
48708770|NCT00068250|102073414|FG003|STARTED|Phase II: Dose Level 2||47||
48708771|NCT00068250|102073411|FG000|COMPLETED|Phase II: Dose Level 2||0||
48708772|NCT00068250|102073412|FG001|COMPLETED|Phase II: Dose Level 2||0||
48708773|NCT00068250|102073413|FG002|COMPLETED|Phase II: Dose Level 2||0||
48708774|NCT00068250|102073414|FG003|COMPLETED|Phase II: Dose Level 2||47||
48708775|NCT00068250|102073411|FG000|NOT COMPLETED|Phase II: Dose Level 2||0||
48708776|NCT00068250|102073412|FG001|NOT COMPLETED|Phase II: Dose Level 2||0||
48708777|NCT00068250|102073413|FG002|NOT COMPLETED|Phase II: Dose Level 2||0||
48708778|NCT00068250|102073414|FG003|NOT COMPLETED|Phase II: Dose Level 2||0||
48708779|NCT01185964|102073415|FG000|STARTED|Phase 1b and Phase 2||15||
48708780|NCT01185964|102073416|FG001|STARTED|Phase 1b and Phase 2||66||
48708781|NCT01185964|102073417|FG002|STARTED|Phase 1b and Phase 2||67||
48708782|NCT01185964|102073418|FG003|STARTED|Phase 1b and Phase 2||0||
48708783|NCT01185964|102073415|FG000|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||15||
48708784|NCT01185964|102073416|FG001|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||64||
48708785|NCT01185964|102073417|FG002|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||65||
48708786|NCT01185964|102073418|FG003|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||0||
48708787|NCT01185964|102073415|FG000|COMPLETED|Phase 1b and Phase 2||13||
48708788|NCT01185964|102073416|FG001|COMPLETED|Phase 1b and Phase 2||56||
48708789|NCT01185964|102073417|FG002|COMPLETED|Phase 1b and Phase 2||58||
48708790|NCT01185964|102073418|FG003|COMPLETED|Phase 1b and Phase 2||0||
48708791|NCT01185964|102073415|FG000|NOT COMPLETED|Phase 1b and Phase 2||2||
48708792|NCT01185964|102073416|FG001|NOT COMPLETED|Phase 1b and Phase 2||10||
48708793|NCT01185964|102073417|FG002|NOT COMPLETED|Phase 1b and Phase 2||9||
48140270|NCT02232893|100670130|FG000|NOT COMPLETED|Overall Study||4||
48590406|NCT03104400|101779689|FG003|Received Study Drug|Overall Study||429||
48590407|NCT03104400|101779690|FG004|Received Study Drug|Overall Study||423||
48590408|NCT03104400|101779686|FG000|Completed Week 24|Overall Study||190||
48590409|NCT03104400|101779687|FG001|Completed Week 24|Overall Study||193||
48590410|NCT03104400|101779688|FG002|Completed Week 24|Overall Study||404||
48708794|NCT01185964|102073418|FG003|NOT COMPLETED|Phase 1b and Phase 2||0||
48708795|NCT01185964|102073415|FG000|STARTED|Optional Olaratumab Monotherapy on Dox||0||
48708796|NCT01185964|102073416|FG001|STARTED|Optional Olaratumab Monotherapy on Dox||0||
48140271|NCT02232893|100670131|FG001|NOT COMPLETED|Overall Study||7||
48140272|NCT04537923|100670132|FG000|STARTED|Overall Study||243||
48140273|NCT04537923|100670133|FG001|STARTED|Overall Study||238||
48140274|NCT04537923|100670134|FG002|STARTED|Overall Study||236||
48590411|NCT03104400|101779689|FG003|Completed Week 24|Overall Study||408||
48590412|NCT03104400|101779690|FG004|Completed Week 24|Overall Study||394||
48708797|NCT01185964|102073417|FG002|STARTED|Optional Olaratumab Monotherapy on Dox||0||
48708798|NCT01185964|102073418|FG003|STARTED|Optional Olaratumab Monotherapy on Dox||30||
48590413|NCT03104400|101779686|FG000|COMPLETED|Overall Study||177|Completed Week 56 (Period 1)|
48590414|NCT03104400|101779687|FG001|COMPLETED|Overall Study||178|Completed Week 56 (Period 1)|
48590415|NCT03104400|101779688|FG002|COMPLETED|Overall Study||370|Completed Week 56 (Period 1)|
48590416|NCT03104400|101779689|FG003|COMPLETED|Overall Study||379|Completed Week 56 (Period 1)|
48590417|NCT03104400|101779690|FG004|COMPLETED|Overall Study||366|Completed Week 56 (Period 1)|
48590418|NCT03104400|101779686|FG000|NOT COMPLETED|Overall Study||34||
48590419|NCT03104400|101779687|FG001|NOT COMPLETED|Overall Study||34||
48590420|NCT03104400|101779688|FG002|NOT COMPLETED|Overall Study||59||
48590421|NCT03104400|101779689|FG003|NOT COMPLETED|Overall Study||51||
48708799|NCT01185964|102073415|FG000|COMPLETED|Optional Olaratumab Monotherapy on Dox||0||
48708800|NCT01185964|102073416|FG001|COMPLETED|Optional Olaratumab Monotherapy on Dox||0||
48708801|NCT01185964|102073417|FG002|COMPLETED|Optional Olaratumab Monotherapy on Dox||0||
48708802|NCT01185964|102073418|FG003|COMPLETED|Optional Olaratumab Monotherapy on Dox||25||
48708803|NCT01185964|102073415|FG000|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0||
48708804|NCT01185964|102073416|FG001|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0||
48708805|NCT01185964|102073417|FG002|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0||
48140275|NCT04537923|100670135|FG003|STARTED|Overall Study||711||
48140276|NCT04537923|100670132|FG000|Received at Least One Dose of Study Drug|Overall Study||243||
48140277|NCT04537923|100670133|FG001|Received at Least One Dose of Study Drug|Overall Study||238||
48140278|NCT04537923|100670134|FG002|Received at Least One Dose of Study Drug|Overall Study||236||
48708806|NCT01185964|102073418|FG003|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||5||
48708807|NCT02089464|102073419|FG000|STARTED|Overall Study||132||
48140279|NCT04537923|100670135|FG003|Received at Least One Dose of Study Drug|Overall Study||708||
48708808|NCT02089464|102073420|FG001|STARTED|Overall Study||67||
48708809|NCT02089464|102073419|FG000|COMPLETED|Overall Study||104||
48708810|NCT02089464|102073420|FG001|COMPLETED|Overall Study||51||
48708811|NCT02089464|102073419|FG000|NOT COMPLETED|Overall Study||28||
48708812|NCT02089464|102073420|FG001|NOT COMPLETED|Overall Study||16||
48708813|NCT03964246|102073421|FG000|STARTED|Overall Study||22||
48708814|NCT03964246|102073422|FG001|STARTED|Overall Study||0||
48708815|NCT03964246|102073421|FG000|COMPLETED|Overall Study||13||
48708816|NCT03964246|102073422|FG001|COMPLETED|Overall Study||0||
48708817|NCT03964246|102073421|FG000|NOT COMPLETED|Overall Study||9||
48708818|NCT03964246|102073422|FG001|NOT COMPLETED|Overall Study||0||
48140280|NCT04537923|100670132|FG000|COMPLETED|Overall Study||228||
48590422|NCT03104400|101779690|FG004|NOT COMPLETED|Overall Study||57||
48590423|NCT01443494|101779691|FG000|STARTED|Overall Study||19||
48590424|NCT01443494|101779691|FG000|COMPLETED|Overall Study||19||
48590425|NCT01443494|101779691|FG000|NOT COMPLETED|Overall Study||0||
48590426|NCT06011161|101779692|FG000|STARTED|Overall Study||40||
48590427|NCT06011161|101779692|FG000|COMPLETED|Overall Study||33||
48140281|NCT04537923|100670133|FG001|COMPLETED|Overall Study||228||
48140282|NCT04537923|100670134|FG002|COMPLETED|Overall Study||225||
48140283|NCT04537923|100670135|FG003|COMPLETED|Overall Study||623||
48590428|NCT06011161|101779692|FG000|NOT COMPLETED|Overall Study||7||
48708819|NCT01967823|102073423|FG000|STARTED|Overall Study||11||
48708820|NCT01967823|102073423|FG000|COMPLETED|Overall Study||10||
48708821|NCT01967823|102073423|FG000|NOT COMPLETED|Overall Study||1||
48708822|NCT00832130|102073424|FG000|STARTED|Overall Study||69||
48708823|NCT00832130|102073425|FG001|STARTED|Overall Study||70||
48708824|NCT00832130|102073424|FG000|COMPLETED|Overall Study||69||
48708825|NCT00832130|102073425|FG001|COMPLETED|Overall Study||70||
48708826|NCT00832130|102073424|FG000|NOT COMPLETED|Overall Study||0||
48708827|NCT00832130|102073425|FG001|NOT COMPLETED|Overall Study||0||
48708828|NCT01778049|102073426|FG000|STARTED|Open Label Treatment Period||354||
48708829|NCT01778049|102073427|FG001|STARTED|Open Label Treatment Period||355||
48708830|NCT01778049|102073428|FG002|STARTED|Open Label Treatment Period||0||
48708831|NCT01778049|102073429|FG003|STARTED|Open Label Treatment Period||0||
48140284|NCT04537923|100670132|FG000|NOT COMPLETED|Overall Study||15||
48140285|NCT04537923|100670133|FG001|NOT COMPLETED|Overall Study||10||
48140286|NCT04537923|100670134|FG002|NOT COMPLETED|Overall Study||11||
48140287|NCT04537923|100670135|FG003|NOT COMPLETED|Overall Study||88||
48140288|NCT00596440|100670136|FG000|STARTED|Overall Study||113||
48140289|NCT00596440|100670137|FG001|STARTED|Overall Study||121||
48140290|NCT00596440|100670136|FG000|Showed to Eligibility Visit|Overall Study||85||
48140291|NCT00596440|100670137|FG001|Showed to Eligibility Visit|Overall Study||72||
48140292|NCT00596440|100670136|FG000|Showed to First Treatment Session|Overall Study||61||
48292879|NCT02958267|101044415|FG000|6 Month Follow-up|Follow-up Visits||14||
48292880|NCT02958267|101044416|FG001|6 Month Follow-up|Follow-up Visits||14||
48292881|NCT02958267|101044415|FG000|12 Month Follow-up|Follow-up Visits||13||
48292882|NCT02958267|101044416|FG001|12 Month Follow-up|Follow-up Visits||14||
48292883|NCT02958267|101044415|FG000|COMPLETED|Follow-up Visits||13||
48292884|NCT02958267|101044416|FG001|COMPLETED|Follow-up Visits||14||
48292885|NCT02958267|101044415|FG000|NOT COMPLETED|Follow-up Visits||2||
48292886|NCT02958267|101044416|FG001|NOT COMPLETED|Follow-up Visits||1||
48708832|NCT01778049|102073430|FG004|STARTED|Open Label Treatment Period||0||
48708833|NCT01778049|102073431|FG005|STARTED|Open Label Treatment Period||0||
48708834|NCT01778049|102073426|FG000|COMPLETED|Open Label Treatment Period||256||
48140293|NCT00596440|100670137|FG001|Showed to First Treatment Session|Overall Study||52||
48140294|NCT00596440|100670136|FG000|COMPLETED|Overall Study||48||
48140295|NCT00596440|100670137|FG001|COMPLETED|Overall Study||41||
48140296|NCT00596440|100670136|FG000|NOT COMPLETED|Overall Study||65||
48140297|NCT00596440|100670137|FG001|NOT COMPLETED|Overall Study||80||
48292887|NCT02464033|101044417|FG000|STARTED|Overall Study||20||
48708835|NCT01778049|102073427|FG001|COMPLETED|Open Label Treatment Period||226||
48140298|NCT00725296|100670138|FG000|STARTED|Overall Study||163||
48590429|NCT00793546|101779693|FG000|STARTED|Overall Study||14||
48590430|NCT00793546|101779694|FG001|STARTED|Overall Study||28||
48590431|NCT00793546|101779693|FG000|COMPLETED|Overall Study||0||
48590432|NCT00793546|101779694|FG001|COMPLETED|Overall Study||0||
48590433|NCT00793546|101779693|FG000|NOT COMPLETED|Overall Study||14||
48590434|NCT00793546|101779694|FG001|NOT COMPLETED|Overall Study||28||
48590435|NCT02474589|101779695|FG000|STARTED|Overall Study||359||
48590436|NCT02474589|101779696|FG001|STARTED|Overall Study||90||
48590437|NCT02474589|101779695|FG000|COMPLETED|Overall Study||334||
48140299|NCT00725296|100670138|FG000|COMPLETED|Overall Study||101||
48140300|NCT00725296|100670138|FG000|NOT COMPLETED|Overall Study||62||
48140301|NCT00047879|100670139|FG000|STARTED|Overall Study||4||
48140302|NCT00047879|100670140|FG001|STARTED|Overall Study||3||
48140303|NCT00047879|100670139|FG000|COMPLETED|Overall Study||0||
48590438|NCT02474589|101779696|FG001|COMPLETED|Overall Study||85||
48590439|NCT02474589|101779695|FG000|NOT COMPLETED|Overall Study||25||
48590440|NCT02474589|101779696|FG001|NOT COMPLETED|Overall Study||5||
48590441|NCT04299048|101779697|FG000|STARTED|Overall Study||11||
48708836|NCT01778049|102073428|FG002|COMPLETED|Open Label Treatment Period||0||
48708837|NCT01778049|102073429|FG003|COMPLETED|Open Label Treatment Period||0||
48708838|NCT01778049|102073430|FG004|COMPLETED|Open Label Treatment Period||0||
48708839|NCT01778049|102073431|FG005|COMPLETED|Open Label Treatment Period||0||
48140304|NCT00047879|100670140|FG001|COMPLETED|Overall Study||0||
48590442|NCT04299048|101779697|FG000|Treated|Overall Study||10||
48590443|NCT04299048|101779697|FG000|COMPLETED|Overall Study||7||
48590444|NCT04299048|101779697|FG000|NOT COMPLETED|Overall Study||4||
48590445|NCT04683939|101779698|FG000|STARTED|Overall Study||3||
48590446|NCT04683939|101779699|FG001|STARTED|Overall Study||3||
48590447|NCT04683939|101779700|FG002|STARTED|Overall Study||4||
48590448|NCT04683939|101779701|FG003|STARTED|Overall Study||3||
48590449|NCT04683939|101779698|FG000|COMPLETED|Overall Study||0||
48590450|NCT04683939|101779699|FG001|COMPLETED|Overall Study||0||
48590451|NCT04683939|101779700|FG002|COMPLETED|Overall Study||0||
48590452|NCT04683939|101779701|FG003|COMPLETED|Overall Study||0||
48590453|NCT04683939|101779698|FG000|NOT COMPLETED|Overall Study||3||
48590454|NCT04683939|101779699|FG001|NOT COMPLETED|Overall Study||3||
48590455|NCT04683939|101779700|FG002|NOT COMPLETED|Overall Study||4||
48590456|NCT04683939|101779701|FG003|NOT COMPLETED|Overall Study||3||
48590457|NCT01097421|101779702|FG000|STARTED|Overall Study||328||
48590458|NCT01097421|101779702|FG000|COMPLETED|Overall Study||314||
48590459|NCT01097421|101779702|FG000|NOT COMPLETED|Overall Study||14||
48590460|NCT02046005|101779703|FG000|STARTED|Overall Study||80||
48590461|NCT02046005|101779704|FG001|STARTED|Overall Study||78||
48590462|NCT02046005|101779705|FG002|STARTED|Overall Study||80||
48590463|NCT02046005|101779703|FG000|COMPLETED|Overall Study||72||
48590464|NCT02046005|101779704|FG001|COMPLETED|Overall Study||71||
48590465|NCT02046005|101779705|FG002|COMPLETED|Overall Study||70||
48590466|NCT02046005|101779703|FG000|NOT COMPLETED|Overall Study||8||
48590467|NCT02046005|101779704|FG001|NOT COMPLETED|Overall Study||7||
48590468|NCT02046005|101779705|FG002|NOT COMPLETED|Overall Study||10||
48708840|NCT01778049|102073426|FG000|NOT COMPLETED|Open Label Treatment Period||98||
48708841|NCT01778049|102073427|FG001|NOT COMPLETED|Open Label Treatment Period||129||
48708842|NCT01778049|102073428|FG002|NOT COMPLETED|Open Label Treatment Period||0||
48708843|NCT01778049|102073429|FG003|NOT COMPLETED|Open Label Treatment Period||0||
48708844|NCT01778049|102073430|FG004|NOT COMPLETED|Open Label Treatment Period||0||
48708845|NCT01778049|102073431|FG005|NOT COMPLETED|Open Label Treatment Period||0||
48708846|NCT01778049|102073426|FG000|STARTED|Double Blind Treatment Period||0||
48708847|NCT01778049|102073427|FG001|STARTED|Double Blind Treatment Period||0||
48708848|NCT01778049|102073428|FG002|STARTED|Double Blind Treatment Period||126||
48708849|NCT01778049|102073429|FG003|STARTED|Double Blind Treatment Period||130||
48708850|NCT01778049|102073430|FG004|STARTED|Double Blind Treatment Period||114||
48140305|NCT00047879|100670139|FG000|NOT COMPLETED|Overall Study||4||
48708851|NCT01778049|102073431|FG005|STARTED|Double Blind Treatment Period||112||
48708852|NCT01778049|102073426|FG000|COMPLETED|Double Blind Treatment Period||0||
48708853|NCT01778049|102073427|FG001|COMPLETED|Double Blind Treatment Period||0||
48140306|NCT00047879|100670140|FG001|NOT COMPLETED|Overall Study||3||
48140307|NCT02216123|100670141|FG000|STARTED|Overall Study||166||
48140308|NCT02216123|100670142|FG001|STARTED|Overall Study||85||
48140309|NCT02216123|100670141|FG000|COMPLETED|Overall Study||160||
48140310|NCT02216123|100670142|FG001|COMPLETED|Overall Study||83||
48140311|NCT02216123|100670141|FG000|NOT COMPLETED|Overall Study||6||
48140312|NCT02216123|100670142|FG001|NOT COMPLETED|Overall Study||2||
48140313|NCT03969654|100670143|FG000|STARTED|Overall Study||133||133
48140314|NCT03969654|100670144|FG001|STARTED|Overall Study||48||48
48140315|NCT03969654|100670143|FG000|COMPLETED|Overall Study||133||133
48590469|NCT01446237|101779706|FG000|STARTED|Overall Study||125||
48590470|NCT01446237|101779706|FG000|COMPLETED|Overall Study||115||
48590471|NCT01446237|101779706|FG000|NOT COMPLETED|Overall Study||10||
48590472|NCT01661933|101779707|FG000|STARTED|Gluten Micro-challenge||12||
48590473|NCT01661933|101779707|FG000|COMPLETED|Gluten Micro-challenge||12||
48590474|NCT01661933|101779707|FG000|NOT COMPLETED|Gluten Micro-challenge||0||
48590475|NCT01661933|101779707|FG000|STARTED|Low-dose Gluten Challenge||12||
48590476|NCT01661933|101779707|FG000|COMPLETED|Low-dose Gluten Challenge||10||
48590477|NCT01661933|101779707|FG000|NOT COMPLETED|Low-dose Gluten Challenge||2||
48590478|NCT01661933|101779707|FG000|STARTED|High-dose Gluten Challenge||10||
48590479|NCT01661933|101779707|FG000|COMPLETED|High-dose Gluten Challenge||8||
48590480|NCT01661933|101779707|FG000|NOT COMPLETED|High-dose Gluten Challenge||2||
48590481|NCT01632904|101779708|FG000|STARTED|Overall Study||54||
48590482|NCT01632904|101779709|FG001|STARTED|Overall Study||56||
48590483|NCT01632904|101779708|FG000|COMPLETED|Overall Study||47||
48590484|NCT01632904|101779709|FG001|COMPLETED|Overall Study||50||
48590485|NCT01632904|101779708|FG000|NOT COMPLETED|Overall Study||7||
48590486|NCT01632904|101779709|FG001|NOT COMPLETED|Overall Study||6||
48590487|NCT00412217|101779710|FG000|STARTED|Overall Study||46||
48590488|NCT00412217|101779711|FG001|STARTED|Overall Study||48||
48590489|NCT00412217|101779710|FG000|COMPLETED|Overall Study||0||
48590490|NCT00412217|101779711|FG001|COMPLETED|Overall Study||0||
48590491|NCT00412217|101779710|FG000|NOT COMPLETED|Overall Study||46||
48590492|NCT00412217|101779711|FG001|NOT COMPLETED|Overall Study||48||
48292888|NCT02464033|101044417|FG000|COMPLETED|Overall Study||20||
48292889|NCT02464033|101044417|FG000|NOT COMPLETED|Overall Study||0||
48292890|NCT03572478|101044418|FG000|STARTED|Overall Study||12||
48292891|NCT03572478|101044418|FG000|COMPLETED|Overall Study||12||
48292892|NCT03572478|101044418|FG000|NOT COMPLETED|Overall Study||0||
48292893|NCT01201317|101044419|FG000|STARTED|Overall Study||48||
48292894|NCT01201317|101044420|FG001|STARTED|Overall Study||45||
48590493|NCT02195310|101779712|FG000|STARTED|Overall Study||173||
48590494|NCT02195310|101779713|FG001|STARTED|Overall Study||169||
48590495|NCT02195310|101779712|FG000|COMPLETED|Overall Study||153||
48590496|NCT02195310|101779713|FG001|COMPLETED|Overall Study||153||
48590497|NCT02195310|101779712|FG000|NOT COMPLETED|Overall Study||20||
48590498|NCT02195310|101779713|FG001|NOT COMPLETED|Overall Study||16||
48590499|NCT05619536|101779714|FG000|STARTED|Overall Study||7||
48590500|NCT05619536|101779715|FG001|STARTED|Overall Study||8||
48590501|NCT05619536|101779716|FG002|STARTED|Overall Study||7||
48590502|NCT05619536|101779717|FG003|STARTED|Overall Study||6||
48590503|NCT05619536|101779714|FG000|COMPLETED|Overall Study||7||
48590504|NCT05619536|101779715|FG001|COMPLETED|Overall Study||6||
48590505|NCT05619536|101779716|FG002|COMPLETED|Overall Study||6||
48590506|NCT05619536|101779717|FG003|COMPLETED|Overall Study||5||
48590507|NCT05619536|101779714|FG000|NOT COMPLETED|Overall Study||0||
48590508|NCT05619536|101779715|FG001|NOT COMPLETED|Overall Study||2||
48590509|NCT05619536|101779716|FG002|NOT COMPLETED|Overall Study||1||
48590510|NCT05619536|101779717|FG003|NOT COMPLETED|Overall Study||1||
48590511|NCT03467763|101779718|FG000|STARTED|Overall Study||13||
48590512|NCT03467763|101779718|FG000|Weeks 1-2|Overall Study||13||
48590513|NCT03467763|101779718|FG000|Weeks 3-4|Overall Study||10||
48590514|NCT03467763|101779718|FG000|Weeks 5-6|Overall Study||8||
48590515|NCT03467763|101779718|FG000|Weeks 7-8|Overall Study||7||
48590516|NCT03467763|101779718|FG000|Weeks 9 - 10|Overall Study||6||
48590517|NCT03467763|101779718|FG000|Week 11-12|Overall Study||6||
48590518|NCT03467763|101779718|FG000|Weeks 13-14|Overall Study||2||
48590519|NCT03467763|101779718|FG000|Weeks 15-16|Overall Study||2||
48590520|NCT03467763|101779718|FG000|COMPLETED|Overall Study||10|Subjects who stopped medication after completing a period are considered to have completed the study|
48590521|NCT03467763|101779718|FG000|NOT COMPLETED|Overall Study||3||
48708854|NCT01778049|102073428|FG002|COMPLETED|Double Blind Treatment Period||111||
48708855|NCT01778049|102073429|FG003|COMPLETED|Double Blind Treatment Period||118||
48708856|NCT01778049|102073430|FG004|COMPLETED|Double Blind Treatment Period||102||
48590522|NCT00640653|101779719|FG000|STARTED|Overall Study||131||
48708857|NCT01778049|102073431|FG005|COMPLETED|Double Blind Treatment Period||105||
48708858|NCT01778049|102073426|FG000|NOT COMPLETED|Double Blind Treatment Period||0||
48708859|NCT01778049|102073427|FG001|NOT COMPLETED|Double Blind Treatment Period||0||
48590523|NCT00640653|101779720|FG001|STARTED|Overall Study||134||
48590524|NCT00640653|101779721|FG002|STARTED|Overall Study||129||
48590525|NCT00640653|101779722|FG003|STARTED|Overall Study||134||
48590526|NCT00640653|101779723|FG004|STARTED|Overall Study||134||
48708860|NCT01778049|102073428|FG002|NOT COMPLETED|Double Blind Treatment Period||15||
48590527|NCT00640653|101779719|FG000|Followed-up at 3 mo|Overall Study||126||
48590528|NCT00640653|101779720|FG001|Followed-up at 3 mo|Overall Study||127||
48590529|NCT00640653|101779721|FG002|Followed-up at 3 mo|Overall Study||125||
48590530|NCT00640653|101779722|FG003|Followed-up at 3 mo|Overall Study||129||
48590531|NCT00640653|101779723|FG004|Followed-up at 3 mo|Overall Study||126||
48590532|NCT00640653|101779719|FG000|Followed-up at 6 mo|Overall Study||127||
48590533|NCT00640653|101779720|FG001|Followed-up at 6 mo|Overall Study||130||
48590534|NCT00640653|101779721|FG002|Followed-up at 6 mo|Overall Study||124||
48590535|NCT00640653|101779722|FG003|Followed-up at 6 mo|Overall Study||130||
48590536|NCT00640653|101779723|FG004|Followed-up at 6 mo|Overall Study||125||
48590537|NCT00640653|101779719|FG000|Followed-up at 12 mo|Overall Study||124||
48590538|NCT00640653|101779720|FG001|Followed-up at 12 mo|Overall Study||121||
48590539|NCT00640653|101779721|FG002|Followed-up at 12 mo|Overall Study||115||
48590540|NCT00640653|101779722|FG003|Followed-up at 12 mo|Overall Study||122||
48590541|NCT00640653|101779723|FG004|Followed-up at 12 mo|Overall Study||116||
48590542|NCT00640653|101779719|FG000|Followed-up at 18 mo|Overall Study||118||
48590543|NCT00640653|101779720|FG001|Followed-up at 18 mo|Overall Study||112||
48590544|NCT00640653|101779721|FG002|Followed-up at 18 mo|Overall Study||113||
48590545|NCT00640653|101779722|FG003|Followed-up at 18 mo|Overall Study||117||
48590546|NCT00640653|101779723|FG004|Followed-up at 18 mo|Overall Study||117||
48590547|NCT00640653|101779719|FG000|Followed-up at 24 mo|Overall Study||114||
48590548|NCT00640653|101779720|FG001|Followed-up at 24 mo|Overall Study||116||
48590549|NCT00640653|101779721|FG002|Followed-up at 24 mo|Overall Study||105||
48590550|NCT00640653|101779722|FG003|Followed-up at 24 mo|Overall Study||112||
48590551|NCT00640653|101779723|FG004|Followed-up at 24 mo|Overall Study||112||
48590552|NCT00640653|101779719|FG000|COMPLETED|Overall Study||128||
48590553|NCT00640653|101779720|FG001|COMPLETED|Overall Study||131||
48590554|NCT00640653|101779721|FG002|COMPLETED|Overall Study||129||
48590555|NCT00640653|101779722|FG003|COMPLETED|Overall Study||132||
48590556|NCT00640653|101779723|FG004|COMPLETED|Overall Study||129||
48590557|NCT00640653|101779719|FG000|NOT COMPLETED|Overall Study||3||
48590558|NCT00640653|101779720|FG001|NOT COMPLETED|Overall Study||3||
48590559|NCT00640653|101779721|FG002|NOT COMPLETED|Overall Study||0||
48590560|NCT00640653|101779722|FG003|NOT COMPLETED|Overall Study||2||
48590561|NCT00640653|101779723|FG004|NOT COMPLETED|Overall Study||5||
48590562|NCT00355706|101779724|FG000|STARTED|Overall Study||50||
48590563|NCT00355706|101779725|FG001|STARTED|Overall Study||50||
48590564|NCT00355706|101779724|FG000|COMPLETED|Overall Study||50||
48590565|NCT00355706|101779725|FG001|COMPLETED|Overall Study||50||
48590566|NCT00355706|101779724|FG000|NOT COMPLETED|Overall Study||0||
48590567|NCT00355706|101779725|FG001|NOT COMPLETED|Overall Study||0||
48590568|NCT00878969|101779726|FG000|STARTED|Overall Study||25||
48590569|NCT00878969|101779727|FG001|STARTED|Overall Study||27||
48590570|NCT00878969|101779728|FG002|STARTED|Overall Study||26||
48590571|NCT00878969|101779726|FG000|COMPLETED|Overall Study||10||
48590572|NCT00878969|101779727|FG001|COMPLETED|Overall Study||12||
48590573|NCT00878969|101779728|FG002|COMPLETED|Overall Study||15||
48590574|NCT00878969|101779726|FG000|NOT COMPLETED|Overall Study||15||
48590575|NCT00878969|101779727|FG001|NOT COMPLETED|Overall Study||15||
48590576|NCT00878969|101779728|FG002|NOT COMPLETED|Overall Study||11||
48590577|NCT00177307|101779729|FG000|STARTED|Overall Study||40||
48590578|NCT00177307|101779729|FG000|COMPLETED|Overall Study||39||
48590579|NCT00177307|101779729|FG000|NOT COMPLETED|Overall Study||1||
48590580|NCT01575275|101779730|FG000|STARTED|Overall Study||8||
48140316|NCT03969654|100670144|FG001|COMPLETED|Overall Study||48||48
48140317|NCT03969654|100670143|FG000|NOT COMPLETED|Overall Study||0||0
48140318|NCT03969654|100670144|FG001|NOT COMPLETED|Overall Study||0||0
48140319|NCT02130193|100670145|FG000|STARTED|Part A: 4-week Open-label Period||9||
48140320|NCT02130193|100670146|FG001|STARTED|Part A: 4-week Open-label Period||0||
48140321|NCT02130193|100670147|FG002|STARTED|Part A: 4-week Open-label Period||0||
48140322|NCT02130193|100670145|FG000|COMPLETED|Part A: 4-week Open-label Period||9||
48140323|NCT02130193|100670146|FG001|COMPLETED|Part A: 4-week Open-label Period||0||
48140324|NCT02130193|100670147|FG002|COMPLETED|Part A: 4-week Open-label Period||0||
48140325|NCT02130193|100670145|FG000|NOT COMPLETED|Part A: 4-week Open-label Period||0||
48140326|NCT02130193|100670146|FG001|NOT COMPLETED|Part A: 4-week Open-label Period||0||
48140327|NCT02130193|100670147|FG002|NOT COMPLETED|Part A: 4-week Open-label Period||0||
48140328|NCT02130193|100670145|FG000|STARTED|Part B: 52-week Double-blind Period||0||
48140329|NCT02130193|100670146|FG001|STARTED|Part B: 52-week Double-blind Period||48||
48140330|NCT02130193|100670147|FG002|STARTED|Part B: 52-week Double-blind Period||45||
48140331|NCT02130193|100670145|FG000|COMPLETED|Part B: 52-week Double-blind Period||0||
48140332|NCT02130193|100670146|FG001|COMPLETED|Part B: 52-week Double-blind Period||38||
48140333|NCT02130193|100670147|FG002|COMPLETED|Part B: 52-week Double-blind Period||37||
48140334|NCT02130193|100670145|FG000|NOT COMPLETED|Part B: 52-week Double-blind Period||0||
48140335|NCT02130193|100670146|FG001|NOT COMPLETED|Part B: 52-week Double-blind Period||10||
48140336|NCT02130193|100670147|FG002|NOT COMPLETED|Part B: 52-week Double-blind Period||8||
48140337|NCT01681589|100670148|FG000|STARTED|Overall Study||0||
48140338|NCT01681589|100670149|FG001|STARTED|Overall Study||0||
48140339|NCT01681589|100670150|FG002|STARTED|Overall Study||0||
48140340|NCT01681589|100670148|FG000|COMPLETED|Overall Study||0||
48140341|NCT01681589|100670149|FG001|COMPLETED|Overall Study||0||
48140342|NCT01681589|100670150|FG002|COMPLETED|Overall Study||0||
48140343|NCT01681589|100670148|FG000|NOT COMPLETED|Overall Study||0||
48140344|NCT01681589|100670149|FG001|NOT COMPLETED|Overall Study||0||
48140345|NCT01681589|100670150|FG002|NOT COMPLETED|Overall Study||0||
48140346|NCT03814889|100670151|FG000|STARTED|Acute Testing||14||
48140347|NCT03814889|100670152|FG001|STARTED|Acute Testing||0||
48140348|NCT03814889|100670151|FG000|COMPLETED|Acute Testing||14||
48140349|NCT03814889|100670152|FG001|COMPLETED|Acute Testing||0||
48140350|NCT03814889|100670151|FG000|NOT COMPLETED|Acute Testing||0||
48140351|NCT03814889|100670152|FG001|NOT COMPLETED|Acute Testing||0||
48140352|NCT03814889|100670151|FG000|STARTED|Longitudinal Testing||0||
48140353|NCT03814889|100670152|FG001|STARTED|Longitudinal Testing||21||
48140354|NCT03814889|100670151|FG000|COMPLETED|Longitudinal Testing||0||
48140355|NCT03814889|100670152|FG001|COMPLETED|Longitudinal Testing||20||
48140356|NCT03814889|100670151|FG000|NOT COMPLETED|Longitudinal Testing||0||
48140357|NCT03814889|100670152|FG001|NOT COMPLETED|Longitudinal Testing||1||
48140358|NCT02363946|100670153|FG000|STARTED|Overall Study||4||
48590581|NCT01575275|101779730|FG000|COMPLETED|Overall Study||8||
48590582|NCT01575275|101779730|FG000|NOT COMPLETED|Overall Study||0||
48590583|NCT03200847|101779731|FG000|STARTED|Overall Study||26||
48590584|NCT03200847|101779731|FG000|COMPLETED|Overall Study||25||
48590585|NCT03200847|101779731|FG000|NOT COMPLETED|Overall Study||1||
48590586|NCT00655733|101779732|FG000|STARTED|Overall Study||51||
48590587|NCT00655733|101779733|FG001|STARTED|Overall Study||50||
48590588|NCT00655733|101779732|FG000|COMPLETED|Overall Study||44||
48590589|NCT00655733|101779733|FG001|COMPLETED|Overall Study||42||
48140359|NCT02363946|100670154|FG001|STARTED|Overall Study||4||
48140360|NCT02363946|100670155|FG002|STARTED|Overall Study||4||
48140361|NCT02363946|100670156|FG003|STARTED|Overall Study||4||
48590590|NCT00655733|101779732|FG000|NOT COMPLETED|Overall Study||7||
48590591|NCT00655733|101779733|FG001|NOT COMPLETED|Overall Study||8||
48590592|NCT01741792|101779734|FG000|STARTED|Overall Study||9||
48590593|NCT01741792|101779735|FG001|STARTED|Overall Study||2||
48590594|NCT01741792|101779736|FG002|STARTED|Overall Study||14||
48590595|NCT01741792|101779734|FG000|Efficacy Set|Overall Study||7||
48590596|NCT01741792|101779735|FG001|Efficacy Set|Overall Study||1||
48140362|NCT02363946|100670157|FG004|STARTED|Overall Study||4||
48140363|NCT02363946|100670158|FG005|STARTED|Overall Study||4||
48140364|NCT02363946|100670159|FG006|STARTED|Overall Study||4||
48140365|NCT02363946|100670160|FG007|STARTED|Overall Study||4||
48140366|NCT02363946|100670161|FG008|STARTED|Overall Study||4||
48140367|NCT02363946|100670162|FG009|STARTED|Overall Study||18||
48140368|NCT02363946|100670163|FG010|STARTED|Overall Study||4||
48140369|NCT02363946|100670164|FG011|STARTED|Overall Study||3||
48140370|NCT02363946|100670165|FG012|STARTED|Overall Study||4||
48140371|NCT02363946|100670153|FG000|COMPLETED|Overall Study||4||
48140372|NCT02363946|100670154|FG001|COMPLETED|Overall Study||4||
48590597|NCT01741792|101779736|FG002|Efficacy Set|Overall Study||13||
48140373|NCT02363946|100670155|FG002|COMPLETED|Overall Study||4||
48140374|NCT02363946|100670156|FG003|COMPLETED|Overall Study||4||
48140375|NCT02363946|100670157|FG004|COMPLETED|Overall Study||4||
48403304|NCT03518034|101317864|FG000|Participants in Safety Analysis Set (Randomized, Treated, no Duplicate/Triplicate Participant IDs)|Overall Study||2596||
48403305|NCT03518034|101317865|FG001|Participants in Safety Analysis Set (Randomized, Treated, no Duplicate/Triplicate Participant IDs)|Overall Study||2602||
48140376|NCT02363946|100670158|FG005|COMPLETED|Overall Study||4||
48140377|NCT02363946|100670159|FG006|COMPLETED|Overall Study||4||
48140378|NCT02363946|100670160|FG007|COMPLETED|Overall Study||3||
48140379|NCT02363946|100670161|FG008|COMPLETED|Overall Study||4||
48140380|NCT02363946|100670162|FG009|COMPLETED|Overall Study||18||
48140381|NCT02363946|100670163|FG010|COMPLETED|Overall Study||4||
48140382|NCT02363946|100670164|FG011|COMPLETED|Overall Study||3||
48140383|NCT02363946|100670165|FG012|COMPLETED|Overall Study||4||
48140384|NCT02363946|100670153|FG000|NOT COMPLETED|Overall Study||0||
48140385|NCT02363946|100670154|FG001|NOT COMPLETED|Overall Study||0||
48140386|NCT02363946|100670155|FG002|NOT COMPLETED|Overall Study||0||
48140387|NCT02363946|100670156|FG003|NOT COMPLETED|Overall Study||0||
48140388|NCT02363946|100670157|FG004|NOT COMPLETED|Overall Study||0||
48140389|NCT02363946|100670158|FG005|NOT COMPLETED|Overall Study||0||
48140390|NCT02363946|100670159|FG006|NOT COMPLETED|Overall Study||0||
48403306|NCT03518034|101317864|FG000|COMPLETED|Overall Study||1594||
48403307|NCT03518034|101317865|FG001|COMPLETED|Overall Study||1581||
48403308|NCT03518034|101317864|FG000|NOT COMPLETED|Overall Study||1007||
48403309|NCT03518034|101317865|FG001|NOT COMPLETED|Overall Study||1022||
48403310|NCT03039569|101317866|FG000|STARTED|Overall Study||40||
48403311|NCT03039569|101317867|FG001|STARTED|Overall Study||39||
48140391|NCT02363946|100670160|FG007|NOT COMPLETED|Overall Study||1||
48403312|NCT03039569|101317866|FG000|COMPLETED|Overall Study||35||
48403313|NCT03039569|101317867|FG001|COMPLETED|Overall Study||35||
48403314|NCT03039569|101317866|FG000|NOT COMPLETED|Overall Study||5||
48403315|NCT03039569|101317867|FG001|NOT COMPLETED|Overall Study||4||
48403316|NCT00322387|101317868|FG000|STARTED|Treatment Period||14||
48403317|NCT00322387|101317869|FG001|STARTED|Treatment Period||26||
48403318|NCT00322387|101317868|FG000|COMPLETED|Treatment Period||14||
48140392|NCT02363946|100670161|FG008|NOT COMPLETED|Overall Study||0||
48140393|NCT02363946|100670162|FG009|NOT COMPLETED|Overall Study||0||
48140394|NCT02363946|100670163|FG010|NOT COMPLETED|Overall Study||0||
48140395|NCT02363946|100670164|FG011|NOT COMPLETED|Overall Study||0||
48140396|NCT02363946|100670165|FG012|NOT COMPLETED|Overall Study||0||
48140397|NCT01983293|100670166|FG000|STARTED|Overall Study||161||
48140398|NCT01983293|100670167|FG001|STARTED|Overall Study||81||
48140399|NCT01983293|100670166|FG000|COMPLETED|Overall Study||128||
48140400|NCT01983293|100670167|FG001|COMPLETED|Overall Study||62||
48140401|NCT01983293|100670166|FG000|NOT COMPLETED|Overall Study||33||
48140402|NCT01983293|100670167|FG001|NOT COMPLETED|Overall Study||19||
48140403|NCT02836418|100670168|FG000|STARTED|Overall Study||8||
48140404|NCT02836418|100670168|FG000|Received at Least One Dose of Study Drug|Overall Study||8||
48140405|NCT02836418|100670168|FG000|COMPLETED|Overall Study||8||
48140406|NCT02836418|100670168|FG000|NOT COMPLETED|Overall Study||0||
48140407|NCT03585244|100670169|FG000|STARTED|Overall Study||180||
48140408|NCT03585244|100670169|FG000|COMPLETED|Overall Study||165||
48403319|NCT00322387|101317869|FG001|COMPLETED|Treatment Period||25||
48403320|NCT00322387|101317868|FG000|NOT COMPLETED|Treatment Period||0||
48403321|NCT00322387|101317869|FG001|NOT COMPLETED|Treatment Period||1||
48403322|NCT00322387|101317868|FG000|STARTED|Follow-up Period||14||
48403323|NCT00322387|101317869|FG001|STARTED|Follow-up Period||26||
48403324|NCT00322387|101317868|FG000|COMPLETED|Follow-up Period||12||
48403325|NCT00322387|101317869|FG001|COMPLETED|Follow-up Period||23||
48403326|NCT00322387|101317868|FG000|NOT COMPLETED|Follow-up Period||2||
48403327|NCT00322387|101317869|FG001|NOT COMPLETED|Follow-up Period||3||
48403328|NCT03510910|101317870|FG000|STARTED|Overall Study||42||
48403329|NCT03510910|101317871|FG001|STARTED|Overall Study||43||
48403330|NCT03510910|101317870|FG000|COMPLETED|Overall Study||40||
48403331|NCT03510910|101317871|FG001|COMPLETED|Overall Study||40||
48403332|NCT03510910|101317870|FG000|NOT COMPLETED|Overall Study||2||
48403333|NCT03510910|101317871|FG001|NOT COMPLETED|Overall Study||3||
48403334|NCT02975349|101317872|FG000|STARTED|Active Treatment Period (24 Weeks)||54||
48403335|NCT02975349|101317873|FG001|STARTED|Active Treatment Period (24 Weeks)||0||
48403336|NCT02975349|101317874|FG002|STARTED|Active Treatment Period (24 Weeks)||52||
48140409|NCT03585244|100670169|FG000|NOT COMPLETED|Overall Study||15||
48403337|NCT02975349|101317875|FG003|STARTED|Active Treatment Period (24 Weeks)||53||
48403338|NCT02975349|101317876|FG004|STARTED|Active Treatment Period (24 Weeks)||54||
48403339|NCT02975349|101317877|FG005|STARTED|Active Treatment Period (24 Weeks)||54||
48403340|NCT02975349|101317872|FG000|COMPLETED|Active Treatment Period (24 Weeks)||49||
48403341|NCT02975349|101317873|FG001|COMPLETED|Active Treatment Period (24 Weeks)||0||
48403342|NCT02975349|101317874|FG002|COMPLETED|Active Treatment Period (24 Weeks)||47||
48403343|NCT02975349|101317875|FG003|COMPLETED|Active Treatment Period (24 Weeks)||48||
48403344|NCT02975349|101317876|FG004|COMPLETED|Active Treatment Period (24 Weeks)||48||
48403345|NCT02975349|101317877|FG005|COMPLETED|Active Treatment Period (24 Weeks)||52||
48403346|NCT02975349|101317872|FG000|NOT COMPLETED|Active Treatment Period (24 Weeks)||5||
48140410|NCT02412137|100670170|FG000|STARTED|Overall Study||144||
48140411|NCT02412137|100670171|FG001|STARTED|Overall Study||101||
48140412|NCT02412137|100670170|FG000|COMPLETED|Overall Study||93||
48140413|NCT02412137|100670171|FG001|COMPLETED|Overall Study||78||
48140414|NCT02412137|100670170|FG000|NOT COMPLETED|Overall Study||51||
48140415|NCT02412137|100670171|FG001|NOT COMPLETED|Overall Study||23||
48140416|NCT00489970|100670172|FG000|STARTED|Persistence Year 1||1069||
48140417|NCT00489970|100670173|FG001|STARTED|Persistence Year 1||523||
48140418|NCT00489970|100670174|FG002|STARTED|Persistence Year 1||0||
48140419|NCT00489970|100670172|FG000|COMPLETED|Persistence Year 1||1069||
48140420|NCT00489970|100670173|FG001|COMPLETED|Persistence Year 1||523||
48140421|NCT00489970|100670174|FG002|COMPLETED|Persistence Year 1||0||
48292895|NCT01201317|101044421|FG002|STARTED|Overall Study||41||
48292896|NCT01201317|101044419|FG000|COMPLETED|Overall Study||39||
48292897|NCT01201317|101044420|FG001|COMPLETED|Overall Study||38||
48292898|NCT01201317|101044421|FG002|COMPLETED|Overall Study||33||
48292899|NCT01201317|101044419|FG000|NOT COMPLETED|Overall Study||9||
48292900|NCT01201317|101044420|FG001|NOT COMPLETED|Overall Study||7||
48292901|NCT01201317|101044421|FG002|NOT COMPLETED|Overall Study||8||
48292902|NCT00959647|101044422|FG000|STARTED|Overall Study||19||
48292903|NCT00959647|101044422|FG000|COMPLETED|Overall Study||0||
48292904|NCT00959647|101044422|FG000|NOT COMPLETED|Overall Study||19||
48292905|NCT01759407|101044423|FG000|STARTED|Overall Study||10||
48292906|NCT01759407|101044424|FG001|STARTED|Overall Study||9||
48292907|NCT01759407|101044423|FG000|COMPLETED|Overall Study||10||
48292908|NCT01759407|101044424|FG001|COMPLETED|Overall Study||7||
48292909|NCT01759407|101044423|FG000|NOT COMPLETED|Overall Study||0||
48292910|NCT01759407|101044424|FG001|NOT COMPLETED|Overall Study||2||
48292911|NCT02709096|101044425|FG000|STARTED|Overall Study||22||
48292912|NCT02709096|101044426|FG001|STARTED|Overall Study||11||
48292913|NCT02709096|101044425|FG000|COMPLETED|Overall Study||21||
48292914|NCT02709096|101044426|FG001|COMPLETED|Overall Study||10||
48403347|NCT02975349|101317873|FG001|NOT COMPLETED|Active Treatment Period (24 Weeks)||0||
48403348|NCT02975349|101317874|FG002|NOT COMPLETED|Active Treatment Period (24 Weeks)||5||
48403349|NCT02975349|101317875|FG003|NOT COMPLETED|Active Treatment Period (24 Weeks)||5||
48590598|NCT01741792|101779734|FG000|COMPLETED|Overall Study||3||
48590599|NCT01741792|101779735|FG001|COMPLETED|Overall Study||1||
48590600|NCT01741792|101779736|FG002|COMPLETED|Overall Study||2||
48590601|NCT01741792|101779734|FG000|NOT COMPLETED|Overall Study||6||
48590602|NCT01741792|101779735|FG001|NOT COMPLETED|Overall Study||1||
48590603|NCT01741792|101779736|FG002|NOT COMPLETED|Overall Study||12||
48708861|NCT01778049|102073429|FG003|NOT COMPLETED|Double Blind Treatment Period||12||
48708862|NCT01778049|102073430|FG004|NOT COMPLETED|Double Blind Treatment Period||12||
48708863|NCT01778049|102073431|FG005|NOT COMPLETED|Double Blind Treatment Period||7||
48708864|NCT01981863|102073432|FG000|STARTED|Overall Study||20||
48708865|NCT01981863|102073433|FG001|STARTED|Overall Study||20||
48590604|NCT00723190|101779737|FG000|STARTED|Overall Study||303||
48590605|NCT00723190|101779737|FG000|SAFETY POPULATION|Overall Study||301||
48590606|NCT00723190|101779737|FG000|COMPLETED|Overall Study||161||
48590607|NCT00723190|101779737|FG000|NOT COMPLETED|Overall Study||142||
48590608|NCT02083185|101779738|FG000|STARTED|Overall Study||56||
48708866|NCT01981863|102073432|FG000|COMPLETED|Overall Study||20||
48140422|NCT00489970|100670172|FG000|NOT COMPLETED|Persistence Year 1||0||
48140423|NCT00489970|100670173|FG001|NOT COMPLETED|Persistence Year 1||0||
48140424|NCT00489970|100670174|FG002|NOT COMPLETED|Persistence Year 1||0||
48140425|NCT00489970|100670172|FG000|STARTED|Persistence Year 3||1019||
48140426|NCT00489970|100670173|FG001|STARTED|Persistence Year 3||486||
48140427|NCT00489970|100670174|FG002|STARTED|Persistence Year 3||0||
48140428|NCT00489970|100670172|FG000|COMPLETED|Persistence Year 3||1019||
48140429|NCT00489970|100670173|FG001|COMPLETED|Persistence Year 3||486||
48140430|NCT00489970|100670174|FG002|COMPLETED|Persistence Year 3||0||
48140431|NCT00489970|100670172|FG000|NOT COMPLETED|Persistence Year 3||0||
48292915|NCT02709096|101044425|FG000|NOT COMPLETED|Overall Study||1||
48292916|NCT02709096|101044426|FG001|NOT COMPLETED|Overall Study||1||
48292917|NCT01163916|101044427|FG000|STARTED|Overall Study||126||
48292918|NCT01163916|101044428|FG001|STARTED|Overall Study||35||
48292919|NCT01163916|101044429|FG002|STARTED|Overall Study||91||
48292920|NCT01163916|101044427|FG000|Safety Population|Overall Study||125||
48292921|NCT01163916|101044428|FG001|Safety Population|Overall Study||35||
48292922|NCT01163916|101044429|FG002|Safety Population|Overall Study||91||
48292923|NCT01163916|101044427|FG000|COMPLETED|Overall Study||96||
48292924|NCT01163916|101044428|FG001|COMPLETED|Overall Study||31||
48590609|NCT02083185|101779739|FG001|STARTED|Overall Study||56||
48292925|NCT01163916|101044429|FG002|COMPLETED|Overall Study||71||
48292926|NCT01163916|101044427|FG000|NOT COMPLETED|Overall Study||30||
48403350|NCT02975349|101317876|FG004|NOT COMPLETED|Active Treatment Period (24 Weeks)||6||
48590610|NCT02083185|101779740|FG002|STARTED|Overall Study||24||
48708867|NCT01981863|102073433|FG001|COMPLETED|Overall Study||20||
48140432|NCT00489970|100670173|FG001|NOT COMPLETED|Persistence Year 3||0||
48140433|NCT00489970|100670174|FG002|NOT COMPLETED|Persistence Year 3||0||
48140434|NCT00489970|100670172|FG000|STARTED|Persistence Year 5||856||
48140435|NCT00489970|100670173|FG001|STARTED|Persistence Year 5||401||
48292927|NCT01163916|101044428|FG001|NOT COMPLETED|Overall Study||4||
48590611|NCT02083185|101779738|FG000|Safety Population|Overall Study||56||
48292928|NCT01163916|101044429|FG002|NOT COMPLETED|Overall Study||20||
48292929|NCT01592500|101044430|FG000|STARTED|Overall Study||14||
48292930|NCT01592500|101044431|FG001|STARTED|Overall Study||15||
48292931|NCT01592500|101044432|FG002|STARTED|Overall Study||14||
48292932|NCT01592500|101044433|FG003|STARTED|Overall Study||13||
48292933|NCT01592500|101044430|FG000|COMPLETED|Overall Study||13||
48292934|NCT01592500|101044431|FG001|COMPLETED|Overall Study||15||
48292935|NCT01592500|101044432|FG002|COMPLETED|Overall Study||14||
48292936|NCT01592500|101044433|FG003|COMPLETED|Overall Study||11||
48292937|NCT01592500|101044430|FG000|NOT COMPLETED|Overall Study||1||
48292938|NCT01592500|101044431|FG001|NOT COMPLETED|Overall Study||0||
48292939|NCT01592500|101044432|FG002|NOT COMPLETED|Overall Study||0||
48292940|NCT01592500|101044433|FG003|NOT COMPLETED|Overall Study||2||
48292941|NCT02683876|101044434|FG000|STARTED|Overall Study||17||
48292942|NCT02683876|101044435|FG001|STARTED|Overall Study||22||
48292943|NCT02683876|101044434|FG000|COMPLETED|Overall Study||15||
48292944|NCT02683876|101044435|FG001|COMPLETED|Overall Study||22||
48292945|NCT02683876|101044434|FG000|NOT COMPLETED|Overall Study||2||
48292946|NCT02683876|101044435|FG001|NOT COMPLETED|Overall Study||0||
48292947|NCT02534038|101044436|FG000|STARTED|Period 1 (6 Weeks)||1||
48292948|NCT02534038|101044437|FG001|STARTED|Period 1 (6 Weeks)||0||
48292949|NCT02534038|101044436|FG000|COMPLETED|Period 1 (6 Weeks)||1||
48292950|NCT02534038|101044437|FG001|COMPLETED|Period 1 (6 Weeks)||0||
48292951|NCT02534038|101044436|FG000|NOT COMPLETED|Period 1 (6 Weeks)||0||
48292952|NCT02534038|101044437|FG001|NOT COMPLETED|Period 1 (6 Weeks)||0||
48292953|NCT02534038|101044436|FG000|STARTED|Period 2 (6 Weeks)||1||
48292954|NCT02534038|101044437|FG001|STARTED|Period 2 (6 Weeks)||0||
48292955|NCT02534038|101044436|FG000|COMPLETED|Period 2 (6 Weeks)||1||
48292956|NCT02534038|101044437|FG001|COMPLETED|Period 2 (6 Weeks)||0||
48292957|NCT02534038|101044436|FG000|NOT COMPLETED|Period 2 (6 Weeks)||0||
48292958|NCT02534038|101044437|FG001|NOT COMPLETED|Period 2 (6 Weeks)||0||
48292959|NCT01966471|101044438|FG000|STARTED|Overall Study||918||
48292960|NCT01966471|101044439|FG001|STARTED|Overall Study||928||
48292961|NCT01966471|101044438|FG000|COMPLETED|Overall Study||0||
48292962|NCT01966471|101044439|FG001|COMPLETED|Overall Study||0||
48292963|NCT01966471|101044438|FG000|NOT COMPLETED|Overall Study||918||
48292964|NCT01966471|101044439|FG001|NOT COMPLETED|Overall Study||928||
48292965|NCT01442779|101044440|FG000|STARTED|Overall Study||18||
48292966|NCT01442779|101044440|FG000|COMPLETED|Overall Study||11||
48292967|NCT01442779|101044440|FG000|NOT COMPLETED|Overall Study||7||
48292968|NCT02145247|101044441|FG000|STARTED|Overall Study||20||
48292969|NCT02145247|101044442|FG001|STARTED|Overall Study||19||
48292970|NCT02145247|101044441|FG000|COMPLETED|Overall Study||20||
48590612|NCT02083185|101779739|FG001|Safety Population|Overall Study||54||
48590613|NCT02083185|101779740|FG002|Safety Population|Overall Study||24||
48590614|NCT02083185|101779738|FG000|COMPLETED|Overall Study||36||
48590615|NCT02083185|101779739|FG001|COMPLETED|Overall Study||27||
48590616|NCT02083185|101779740|FG002|COMPLETED|Overall Study||17||
48590617|NCT02083185|101779738|FG000|NOT COMPLETED|Overall Study||20||
48590618|NCT02083185|101779739|FG001|NOT COMPLETED|Overall Study||29||
48590619|NCT02083185|101779740|FG002|NOT COMPLETED|Overall Study||7||
48708868|NCT01981863|102073432|FG000|NOT COMPLETED|Overall Study||0||
48708869|NCT01981863|102073433|FG001|NOT COMPLETED|Overall Study||0||
48708870|NCT00983515|102073434|FG000|STARTED|Colchicine Alone||24||
48708871|NCT00983515|102073434|FG000|COMPLETED|Colchicine Alone||24||
48292971|NCT02145247|101044442|FG001|COMPLETED|Overall Study||19||
48292972|NCT02145247|101044441|FG000|NOT COMPLETED|Overall Study||0||
48292973|NCT02145247|101044442|FG001|NOT COMPLETED|Overall Study||0||
48292974|NCT01145755|101044443|FG000|STARTED|Overall Study||40||
48292975|NCT01145755|101044444|FG001|STARTED|Overall Study||47||
48292976|NCT01145755|101044445|FG002|STARTED|Overall Study||44||
48292977|NCT01145755|101044443|FG000|COMPLETED|Overall Study||20||
48590620|NCT02426749|101779741|FG000|STARTED|Overall Study||12||
48590621|NCT02426749|101779742|FG001|STARTED|Overall Study||10||
48708872|NCT00983515|102073434|FG000|NOT COMPLETED|Colchicine Alone||0||
48708873|NCT00983515|102073434|FG000|STARTED|14 Day Washout Period||24||
48708874|NCT00983515|102073434|FG000|COMPLETED|14 Day Washout Period||24||
48708875|NCT00983515|102073434|FG000|NOT COMPLETED|14 Day Washout Period||0||
48292978|NCT01145755|101044444|FG001|COMPLETED|Overall Study||19||
48292979|NCT01145755|101044445|FG002|COMPLETED|Overall Study||19||
48292980|NCT01145755|101044443|FG000|NOT COMPLETED|Overall Study||20||
48292981|NCT01145755|101044444|FG001|NOT COMPLETED|Overall Study||28||
48292982|NCT01145755|101044445|FG002|NOT COMPLETED|Overall Study||25||
48292983|NCT03426267|101044446|FG000|STARTED|Overall Study||163||
48292984|NCT03426267|101044447|FG001|STARTED|Overall Study||162||
48292985|NCT03426267|101044446|FG000|Modified Intent-to-Treat Population|Overall Study||154||
48292986|NCT03426267|101044447|FG001|Modified Intent-to-Treat Population|Overall Study||144||
48292987|NCT03426267|101044446|FG000|COMPLETED|Overall Study||142||
48708876|NCT00983515|102073434|FG000|STARTED|Ritonavir Alone||24||
48708877|NCT00983515|102073434|FG000|COMPLETED|Ritonavir Alone||18||
48708878|NCT00983515|102073434|FG000|NOT COMPLETED|Ritonavir Alone||6||
48708879|NCT00983515|102073434|FG000|STARTED|Colchicine With Ritonavir||18||
48140436|NCT00489970|100670174|FG002|STARTED|Persistence Year 5||0||
48140437|NCT00489970|100670172|FG000|COMPLETED|Persistence Year 5||856||
48140438|NCT00489970|100670173|FG001|COMPLETED|Persistence Year 5||401||
48140439|NCT00489970|100670174|FG002|COMPLETED|Persistence Year 5||0||
48140440|NCT00489970|100670172|FG000|NOT COMPLETED|Persistence Year 5||0||
48140441|NCT00489970|100670173|FG001|NOT COMPLETED|Persistence Year 5||0||
48140442|NCT00489970|100670174|FG002|NOT COMPLETED|Persistence Year 5||0||
48140443|NCT00489970|100670172|FG000|STARTED|Persistence Year 9||309||
48140444|NCT00489970|100670173|FG001|STARTED|Persistence Year 9||138||
48140445|NCT00489970|100670174|FG002|STARTED|Persistence Year 9||362||
48140446|NCT00489970|100670172|FG000|COMPLETED|Persistence Year 9||306||
48140447|NCT00489970|100670173|FG001|COMPLETED|Persistence Year 9||136||
48140448|NCT00489970|100670174|FG002|COMPLETED|Persistence Year 9||357||
48140449|NCT00489970|100670172|FG000|NOT COMPLETED|Persistence Year 9||3||
48140450|NCT00489970|100670173|FG001|NOT COMPLETED|Persistence Year 9||2||
48403351|NCT02975349|101317877|FG005|NOT COMPLETED|Active Treatment Period (24 Weeks)||2||
48403352|NCT02975349|101317872|FG000|STARTED|Blinded Extension Period (24 Weeks)||0||
48403353|NCT02975349|101317873|FG001|STARTED|Blinded Extension Period (24 Weeks)||49||
48403354|NCT02975349|101317874|FG002|STARTED|Blinded Extension Period (24 Weeks)||47||
48403355|NCT02975349|101317875|FG003|STARTED|Blinded Extension Period (24 Weeks)||48||
48403356|NCT02975349|101317876|FG004|STARTED|Blinded Extension Period (24 Weeks)||48||
48403357|NCT02975349|101317877|FG005|STARTED|Blinded Extension Period (24 Weeks)||52||
48403358|NCT02975349|101317872|FG000|COMPLETED|Blinded Extension Period (24 Weeks)||0||
48403359|NCT02975349|101317873|FG001|COMPLETED|Blinded Extension Period (24 Weeks)||42||
48403360|NCT02975349|101317874|FG002|COMPLETED|Blinded Extension Period (24 Weeks)||43||
48140451|NCT00489970|100670174|FG002|NOT COMPLETED|Persistence Year 9||5||
48140452|NCT03252587|100670175|FG000|STARTED|Overall Study||90|Started = Randomized and treated|
48140453|NCT03252587|100670176|FG001|STARTED|Overall Study||91|Started = Randomized and treated|
48140454|NCT03252587|100670177|FG002|STARTED|Overall Study||93|Started = Randomized and treated|
48140455|NCT03252587|100670178|FG003|STARTED|Overall Study||89|Started = Randomized and treated|
48403361|NCT02975349|101317875|FG003|COMPLETED|Blinded Extension Period (24 Weeks)||44||
48403362|NCT02975349|101317876|FG004|COMPLETED|Blinded Extension Period (24 Weeks)||46||
48403363|NCT02975349|101317877|FG005|COMPLETED|Blinded Extension Period (24 Weeks)||52||
48403364|NCT02975349|101317872|FG000|NOT COMPLETED|Blinded Extension Period (24 Weeks)||0||
48403365|NCT02975349|101317873|FG001|NOT COMPLETED|Blinded Extension Period (24 Weeks)||7||
48403366|NCT02975349|101317874|FG002|NOT COMPLETED|Blinded Extension Period (24 Weeks)||4||
48403367|NCT02975349|101317875|FG003|NOT COMPLETED|Blinded Extension Period (24 Weeks)||4||
48403368|NCT02975349|101317876|FG004|NOT COMPLETED|Blinded Extension Period (24 Weeks)||2||
48403369|NCT02975349|101317877|FG005|NOT COMPLETED|Blinded Extension Period (24 Weeks)||0||
48403370|NCT00445341|101317878|FG000|STARTED|Overall Study||28||
48403371|NCT00445341|101317878|FG000|COMPLETED|Overall Study||26||
48403372|NCT00445341|101317878|FG000|NOT COMPLETED|Overall Study||2||
48403373|NCT00739960|101317879|FG000|STARTED|Overall Study||1||
48403374|NCT00739960|101317879|FG000|COMPLETED|Overall Study||1||
48403375|NCT00739960|101317879|FG000|NOT COMPLETED|Overall Study||0||
48590622|NCT02426749|101779741|FG000|COMPLETED|Overall Study||9||
48590623|NCT02426749|101779742|FG001|COMPLETED|Overall Study||9||
48590624|NCT02426749|101779741|FG000|NOT COMPLETED|Overall Study||3||
48590625|NCT02426749|101779742|FG001|NOT COMPLETED|Overall Study||1||
48590626|NCT01565369|101779743|FG000|STARTED|Overall Study||35||
48590627|NCT01565369|101779743|FG000|COMPLETED|Overall Study||35||
48590628|NCT01565369|101779743|FG000|NOT COMPLETED|Overall Study||0||
48590629|NCT02619396|101779744|FG000|STARTED|Overall Study||20||
48590630|NCT02619396|101779745|FG001|STARTED|Overall Study||20||
48590631|NCT02619396|101779746|FG002|STARTED|Overall Study||20||
48590632|NCT02619396|101779747|FG003|STARTED|Overall Study||20||
48590633|NCT02619396|101779744|FG000|COMPLETED|Overall Study||20||
48590634|NCT02619396|101779745|FG001|COMPLETED|Overall Study||20||
48590635|NCT02619396|101779746|FG002|COMPLETED|Overall Study||20||
48590636|NCT02619396|101779747|FG003|COMPLETED|Overall Study||20||
48708880|NCT00983515|102073434|FG000|COMPLETED|Colchicine With Ritonavir||17||
48708881|NCT00983515|102073434|FG000|NOT COMPLETED|Colchicine With Ritonavir||1||
48292988|NCT03426267|101044447|FG001|COMPLETED|Overall Study||90||
48403376|NCT00110591|101317880|FG000|STARTED|Overall Study||4||
48403377|NCT00110591|101317881|FG001|STARTED|Overall Study||4||
48403378|NCT00110591|101317882|FG002|STARTED|Overall Study||4||
48403379|NCT00110591|101317883|FG003|STARTED|Overall Study||4||
48403380|NCT00110591|101317884|FG004|STARTED|Overall Study||4||
48403381|NCT00110591|101317880|FG000|COMPLETED|Overall Study||4||
48403382|NCT00110591|101317881|FG001|COMPLETED|Overall Study||4||
48403383|NCT00110591|101317882|FG002|COMPLETED|Overall Study||4||
48403384|NCT00110591|101317883|FG003|COMPLETED|Overall Study||4||
48590637|NCT02619396|101779744|FG000|NOT COMPLETED|Overall Study||0||
48590638|NCT02619396|101779745|FG001|NOT COMPLETED|Overall Study||0||
48708882|NCT01069861|102073435|FG000|STARTED|Overall Study||4||
48292989|NCT03426267|101044446|FG000|NOT COMPLETED|Overall Study||21||
48292990|NCT03426267|101044447|FG001|NOT COMPLETED|Overall Study||72||
48292991|NCT01249274|101044448|FG000|STARTED|Overall Study||25||
48292992|NCT01249274|101044449|FG001|STARTED|Overall Study||25||
48292993|NCT01249274|101044448|FG000|Completed Treatment|Overall Study||21||
48292994|NCT01249274|101044449|FG001|Completed Treatment|Overall Study||19||
48292995|NCT01249274|101044448|FG000|Completed Treatment & Post Trial Visit|Overall Study||20||
48292996|NCT01249274|101044449|FG001|Completed Treatment & Post Trial Visit|Overall Study||17||
48292997|NCT01249274|101044448|FG000|Completed Post Trial Visit But Not tx|Overall Study||1||
48292998|NCT01249274|101044449|FG001|Completed Post Trial Visit But Not tx|Overall Study||2||
48292999|NCT01249274|101044448|FG000|COMPLETED|Overall Study||21||
48590639|NCT02619396|101779746|FG002|NOT COMPLETED|Overall Study||0||
48590640|NCT02619396|101779747|FG003|NOT COMPLETED|Overall Study||0||
48590641|NCT02634268|101779748|FG000|STARTED|Overall Study||346||
48590642|NCT02634268|101779749|FG001|STARTED|Overall Study||338||
48590643|NCT02634268|101779748|FG000|COMPLETED|Overall Study||287||
48590644|NCT02634268|101779749|FG001|COMPLETED|Overall Study||291||
48590645|NCT02634268|101779748|FG000|NOT COMPLETED|Overall Study||59||
48590646|NCT02634268|101779749|FG001|NOT COMPLETED|Overall Study||47||
48708883|NCT01069861|102073435|FG000|COMPLETED|Overall Study||1||
48293000|NCT01249274|101044449|FG001|COMPLETED|Overall Study||19||
48293001|NCT01249274|101044448|FG000|NOT COMPLETED|Overall Study||4||
48403385|NCT00110591|101317884|FG004|COMPLETED|Overall Study||4||
48403386|NCT00110591|101317880|FG000|NOT COMPLETED|Overall Study||0||
48403387|NCT00110591|101317881|FG001|NOT COMPLETED|Overall Study||0||
48403388|NCT00110591|101317882|FG002|NOT COMPLETED|Overall Study||0||
48590647|NCT01152359|101779750|FG000|STARTED|Overall Study||105||
48590648|NCT01152359|101779751|FG001|STARTED|Overall Study||102||
48590649|NCT01152359|101779750|FG000|COMPLETED|Overall Study||81||
48708884|NCT01069861|102073435|FG000|NOT COMPLETED|Overall Study||3||
48708885|NCT05039671|102073436|FG000|STARTED|Overall Study||13||
48140456|NCT03252587|100670175|FG000|COMPLETED|Overall Study||66|Completed = Completed treatment|
48140457|NCT03252587|100670176|FG001|COMPLETED|Overall Study||71|Completed = Completed treatment|
48140458|NCT03252587|100670177|FG002|COMPLETED|Overall Study||76|Completed = Completed treatment|
48140459|NCT03252587|100670178|FG003|COMPLETED|Overall Study||62|Completed = Completed treatment|
48140460|NCT03252587|100670175|FG000|NOT COMPLETED|Overall Study||24||
48140461|NCT03252587|100670176|FG001|NOT COMPLETED|Overall Study||20||
48140462|NCT03252587|100670177|FG002|NOT COMPLETED|Overall Study||17||
48140463|NCT03252587|100670178|FG003|NOT COMPLETED|Overall Study||27||
48140464|NCT02657226|100670179|FG000|STARTED|Overall Study||15724||
48140465|NCT02657226|100670179|FG000|COMPLETED|Overall Study||15724|Total study population 15724.Patients were observed using different criteria of monitoring.|
48140466|NCT02657226|100670179|FG000|NOT COMPLETED|Overall Study||0||
48140467|NCT02671435|100670180|FG000|STARTED|Overall Study||3||
48140468|NCT02671435|100670181|FG001|STARTED|Overall Study||3||
48140469|NCT02671435|100670182|FG002|STARTED|Overall Study||3||
48140470|NCT02671435|100670183|FG003|STARTED|Overall Study||18||
48140471|NCT02671435|100670184|FG004|STARTED|Overall Study||18||
48140472|NCT02671435|100670185|FG005|STARTED|Overall Study||40||
48140473|NCT02671435|100670186|FG006|STARTED|Overall Study||40||
48140474|NCT02671435|100670187|FG007|STARTED|Overall Study||40||
48140475|NCT02671435|100670188|FG008|STARTED|Overall Study||20||
48140476|NCT02671435|100670189|FG009|STARTED|Overall Study||18||
48140477|NCT02671435|100670190|FG010|STARTED|Overall Study||18||
48140478|NCT02671435|100670191|FG011|STARTED|Overall Study||40||
48140479|NCT02671435|100670192|FG012|STARTED|Overall Study||41||
48140480|NCT02671435|100670193|FG013|STARTED|Overall Study||44||
48140481|NCT02671435|100670194|FG014|STARTED|Overall Study||37||
48140482|NCT02671435|100670180|FG000|Treated|Overall Study||3||
48140483|NCT02671435|100670181|FG001|Treated|Overall Study||3||
48140484|NCT02671435|100670182|FG002|Treated|Overall Study||3||
48140485|NCT02671435|100670183|FG003|Treated|Overall Study||18||
48140486|NCT02671435|100670184|FG004|Treated|Overall Study||18||
48140487|NCT02671435|100670185|FG005|Treated|Overall Study||40||
48140488|NCT02671435|100670186|FG006|Treated|Overall Study||40||
48140489|NCT02671435|100670187|FG007|Treated|Overall Study||40||
48140490|NCT02671435|100670188|FG008|Treated|Overall Study||20||
48293002|NCT01249274|101044449|FG001|NOT COMPLETED|Overall Study||6||
48590650|NCT01152359|101779751|FG001|COMPLETED|Overall Study||80||
48708886|NCT05039671|102073437|FG001|STARTED|Overall Study||79||
48293003|NCT01498679|101044450|FG000|STARTED|Overall Study||154||
48293004|NCT01498679|101044451|FG001|STARTED|Overall Study||153||
48293005|NCT01498679|101044450|FG000|COMPLETED|Overall Study||65||
48293006|NCT01498679|101044451|FG001|COMPLETED|Overall Study||131||
48708887|NCT05039671|102073436|FG000|COMPLETED|Overall Study||12||
48293007|NCT01498679|101044450|FG000|NOT COMPLETED|Overall Study||89||
48590651|NCT01152359|101779750|FG000|NOT COMPLETED|Overall Study||24||
48708888|NCT05039671|102073437|FG001|COMPLETED|Overall Study||57||
48708889|NCT05039671|102073436|FG000|NOT COMPLETED|Overall Study||1||
48293008|NCT01498679|101044451|FG001|NOT COMPLETED|Overall Study||22||
48293009|NCT00690443|101044452|FG000|STARTED|Overall Study||23||
48293010|NCT00690443|101044453|FG001|STARTED|Overall Study||21||
48293011|NCT00690443|101044452|FG000|COMPLETED|Overall Study||22||
48293012|NCT00690443|101044453|FG001|COMPLETED|Overall Study||19||
48293013|NCT00690443|101044452|FG000|NOT COMPLETED|Overall Study||1||
48293014|NCT00690443|101044453|FG001|NOT COMPLETED|Overall Study||2||
48293015|NCT02054520|101044454|FG000|STARTED|Overall Study||11||
48293016|NCT02054520|101044455|FG001|STARTED|Overall Study||16||
48293017|NCT02054520|101044456|FG002|STARTED|Overall Study||6||
48293018|NCT02054520|101044457|FG003|STARTED|Overall Study||6||
48293019|NCT02054520|101044458|FG004|STARTED|Overall Study||5||
48293020|NCT02054520|101044459|FG005|STARTED|Overall Study||3||
48293021|NCT02054520|101044454|FG000|COMPLETED|Overall Study||2||
48293022|NCT02054520|101044455|FG001|COMPLETED|Overall Study||11||
48293023|NCT02054520|101044456|FG002|COMPLETED|Overall Study||0||
48293024|NCT02054520|101044457|FG003|COMPLETED|Overall Study||0||
48293025|NCT02054520|101044458|FG004|COMPLETED|Overall Study||0||
48293026|NCT02054520|101044459|FG005|COMPLETED|Overall Study||0||
48293027|NCT02054520|101044454|FG000|NOT COMPLETED|Overall Study||9||
48293028|NCT02054520|101044455|FG001|NOT COMPLETED|Overall Study||5||
48293029|NCT02054520|101044456|FG002|NOT COMPLETED|Overall Study||6||
48293030|NCT02054520|101044457|FG003|NOT COMPLETED|Overall Study||6||
48293031|NCT02054520|101044458|FG004|NOT COMPLETED|Overall Study||5||
48293032|NCT02054520|101044459|FG005|NOT COMPLETED|Overall Study||3||
48293033|NCT01313117|101044460|FG000|STARTED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2||
48590652|NCT01152359|101779751|FG001|NOT COMPLETED|Overall Study||22||
48590653|NCT00131365|101779752|FG000|STARTED|Overall Study||9||
48590654|NCT00131365|101779752|FG000|COMPLETED|Overall Study||5|5 out of 9 enrolled participants were followed through the month 36 visit.|
48590655|NCT00131365|101779752|FG000|NOT COMPLETED|Overall Study||4||
48590656|NCT00347919|101779753|FG000|STARTED|Overall Study||73||
48590657|NCT00347919|101779754|FG001|STARTED|Overall Study||76||
48590658|NCT00347919|101779755|FG002|STARTED|Overall Study||40||
48590659|NCT00347919|101779753|FG000|COMPLETED|Overall Study||2||
48590660|NCT00347919|101779754|FG001|COMPLETED|Overall Study||0||
48590661|NCT00347919|101779755|FG002|COMPLETED|Overall Study||2||
48590662|NCT00347919|101779753|FG000|NOT COMPLETED|Overall Study||71||
48590663|NCT00347919|101779754|FG001|NOT COMPLETED|Overall Study||76||
48590664|NCT00347919|101779755|FG002|NOT COMPLETED|Overall Study||38||
48590665|NCT02560324|101779756|FG000|STARTED|Period 1 (2 Weeks)||35||
48590666|NCT02560324|101779757|FG001|STARTED|Period 1 (2 Weeks)||34||
48590667|NCT02560324|101779756|FG000|COMPLETED|Period 1 (2 Weeks)||23||
48590668|NCT02560324|101779757|FG001|COMPLETED|Period 1 (2 Weeks)||25||
48590669|NCT02560324|101779756|FG000|NOT COMPLETED|Period 1 (2 Weeks)||12||
48590670|NCT02560324|101779757|FG001|NOT COMPLETED|Period 1 (2 Weeks)||9||
48590671|NCT02560324|101779756|FG000|STARTED|Washout (2 Weeks)||23||
48293034|NCT01313117|101044460|FG000|COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2||
48293035|NCT01313117|101044460|FG000|NOT COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||0||
48293036|NCT01313117|101044460|FG000|STARTED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||2||
48293037|NCT01313117|101044460|FG000|COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1||
48293038|NCT01313117|101044460|FG000|NOT COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1||
48293039|NCT01313117|101044460|FG000|STARTED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2||
48403389|NCT00110591|101317883|FG003|NOT COMPLETED|Overall Study||0||
48590672|NCT02560324|101779757|FG001|STARTED|Washout (2 Weeks)||25||
48590673|NCT02560324|101779756|FG000|COMPLETED|Washout (2 Weeks)||23||
48590674|NCT02560324|101779757|FG001|COMPLETED|Washout (2 Weeks)||23||
48590675|NCT02560324|101779756|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
48590676|NCT02560324|101779757|FG001|NOT COMPLETED|Washout (2 Weeks)||2||
48590677|NCT02560324|101779756|FG000|STARTED|Period 2 (2 Weeks)||23||
48590678|NCT02560324|101779757|FG001|STARTED|Period 2 (2 Weeks)||23||
48590679|NCT02560324|101779756|FG000|COMPLETED|Period 2 (2 Weeks)||22||
48590680|NCT02560324|101779757|FG001|COMPLETED|Period 2 (2 Weeks)||21||
48590681|NCT02560324|101779756|FG000|NOT COMPLETED|Period 2 (2 Weeks)||1||
48590682|NCT02560324|101779757|FG001|NOT COMPLETED|Period 2 (2 Weeks)||2||
48590683|NCT00819780|101779758|FG000|STARTED|Overall Study||142||
48590684|NCT00819780|101779759|FG001|STARTED|Overall Study||143||
48590685|NCT00819780|101779758|FG000|Received Study Treatment|Overall Study||139||
48590686|NCT00819780|101779759|FG001|Received Study Treatment|Overall Study||139||
48403390|NCT00110591|101317884|FG004|NOT COMPLETED|Overall Study||0||
48590687|NCT00819780|101779758|FG000|COMPLETED|Overall Study||114||
48590688|NCT00819780|101779759|FG001|COMPLETED|Overall Study||122||
48590689|NCT00819780|101779758|FG000|NOT COMPLETED|Overall Study||28||
48590690|NCT00819780|101779759|FG001|NOT COMPLETED|Overall Study||21||
48590691|NCT01447927|101779760|FG000|STARTED|Overall Study||38||
48590692|NCT01447927|101779761|FG001|STARTED|Overall Study||36||
48293040|NCT01313117|101044460|FG000|COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2||
48293041|NCT01313117|101044460|FG000|NOT COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||0||
48293042|NCT01313117|101044460|FG000|STARTED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2||
48293043|NCT01313117|101044460|FG000|COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2||
48293044|NCT01313117|101044460|FG000|NOT COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||0||
48140491|NCT02671435|100670189|FG009|Treated|Overall Study||18||
48140492|NCT02671435|100670190|FG010|Treated|Overall Study||18||
48140493|NCT02671435|100670191|FG011|Treated|Overall Study||39||
48140494|NCT02671435|100670192|FG012|Treated|Overall Study||41||
48140495|NCT02671435|100670193|FG013|Treated|Overall Study||44||
48140496|NCT02671435|100670194|FG014|Treated|Overall Study||37||
48140497|NCT02671435|100670180|FG000|COMPLETED|Overall Study||0||
48140498|NCT02671435|100670181|FG001|COMPLETED|Overall Study||0||
48140499|NCT02671435|100670182|FG002|COMPLETED|Overall Study||0||
48140500|NCT02671435|100670183|FG003|COMPLETED|Overall Study||0||
48140501|NCT02671435|100670184|FG004|COMPLETED|Overall Study||0||
48140502|NCT02671435|100670185|FG005|COMPLETED|Overall Study||0||
48140503|NCT02671435|100670186|FG006|COMPLETED|Overall Study||0||
48140504|NCT02671435|100670187|FG007|COMPLETED|Overall Study||0||
48140505|NCT02671435|100670188|FG008|COMPLETED|Overall Study||0||
48140506|NCT02671435|100670189|FG009|COMPLETED|Overall Study||0||
48293045|NCT01313117|101044460|FG000|STARTED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1||
48293046|NCT01313117|101044460|FG000|COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||0||
48590693|NCT01447927|101779760|FG000|COMPLETED|Overall Study||33||
48590694|NCT01447927|101779761|FG001|COMPLETED|Overall Study||33||
48590695|NCT01447927|101779760|FG000|NOT COMPLETED|Overall Study||5||
48590696|NCT01447927|101779761|FG001|NOT COMPLETED|Overall Study||3||
48590697|NCT01459718|101779762|FG000|STARTED|Overall Study||13||
48293047|NCT01313117|101044460|FG000|NOT COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1||
48590698|NCT01459718|101779762|FG000|Safety Analysis Set|Overall Study||13||
48590699|NCT01459718|101779762|FG000|COMPLETED|Overall Study||10||
48590700|NCT01459718|101779762|FG000|NOT COMPLETED|Overall Study||3||
48590701|NCT00093847|101779763|FG000|STARTED|Overall Study||39||
48590702|NCT00093847|101779764|FG001|STARTED|Overall Study||34||
48590703|NCT00093847|101779763|FG000|COMPLETED|Overall Study||31||
48590704|NCT00093847|101779764|FG001|COMPLETED|Overall Study||24||
48590705|NCT00093847|101779763|FG000|NOT COMPLETED|Overall Study||8||
48590706|NCT00093847|101779764|FG001|NOT COMPLETED|Overall Study||10||
48140507|NCT02671435|100670190|FG010|COMPLETED|Overall Study||0||
48140508|NCT02671435|100670191|FG011|COMPLETED|Overall Study||0||
48140509|NCT02671435|100670192|FG012|COMPLETED|Overall Study||0||
48140510|NCT02671435|100670193|FG013|COMPLETED|Overall Study||0||
48140511|NCT02671435|100670194|FG014|COMPLETED|Overall Study||0||
48140512|NCT02671435|100670180|FG000|NOT COMPLETED|Overall Study||3||
48140513|NCT02671435|100670181|FG001|NOT COMPLETED|Overall Study||3||
48140514|NCT02671435|100670182|FG002|NOT COMPLETED|Overall Study||3||
48140515|NCT02671435|100670183|FG003|NOT COMPLETED|Overall Study||18||
48140516|NCT02671435|100670184|FG004|NOT COMPLETED|Overall Study||18||
48140517|NCT02671435|100670185|FG005|NOT COMPLETED|Overall Study||40||
48293048|NCT01190514|101044461|FG000|STARTED|First Intervention (Period 1)||11||
48293049|NCT01190514|101044462|FG001|STARTED|First Intervention (Period 1)||10||
48590707|NCT04007107|101779765|FG000|STARTED|Treatment Period 1 (Day 1)||26||
48590708|NCT04007107|101779766|FG001|STARTED|Treatment Period 1 (Day 1)||26||
48140518|NCT02671435|100670186|FG006|NOT COMPLETED|Overall Study||40||
48140519|NCT02671435|100670187|FG007|NOT COMPLETED|Overall Study||40||
48590709|NCT04007107|101779767|FG002|STARTED|Treatment Period 1 (Day 1)||25||
48590710|NCT04007107|101779768|FG003|STARTED|Treatment Period 1 (Day 1)||26||
48140520|NCT02671435|100670188|FG008|NOT COMPLETED|Overall Study||20||
48140521|NCT02671435|100670189|FG009|NOT COMPLETED|Overall Study||18||
48140522|NCT02671435|100670190|FG010|NOT COMPLETED|Overall Study||18||
48590711|NCT04007107|101779765|FG000|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26||
48590712|NCT04007107|101779766|FG001|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26||
48590713|NCT04007107|101779767|FG002|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||25||
48590714|NCT04007107|101779768|FG003|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26||
48590715|NCT04007107|101779765|FG000|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26||
48590716|NCT04007107|101779766|FG001|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26||
48590717|NCT04007107|101779767|FG002|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||25||
48590718|NCT04007107|101779768|FG003|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26||
48590719|NCT04007107|101779765|FG000|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||26||
48140523|NCT02671435|100670191|FG011|NOT COMPLETED|Overall Study||40||
48140524|NCT02671435|100670192|FG012|NOT COMPLETED|Overall Study||41||
48140525|NCT02671435|100670193|FG013|NOT COMPLETED|Overall Study||44||
48140526|NCT02671435|100670194|FG014|NOT COMPLETED|Overall Study||37||
48140527|NCT00272168|100670195|FG000|STARTED|Overall Study||47||
48140528|NCT00272168|100670196|FG001|STARTED|Overall Study||41||
48590720|NCT04007107|101779766|FG001|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||25||
48590721|NCT04007107|101779767|FG002|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||25||
48590722|NCT04007107|101779768|FG003|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||26||
48590723|NCT04007107|101779765|FG000|COMPLETED|Treatment Period 1 (Day 1)||26||
48590724|NCT04007107|101779766|FG001|COMPLETED|Treatment Period 1 (Day 1)||26||
48590725|NCT04007107|101779767|FG002|COMPLETED|Treatment Period 1 (Day 1)||25||
48590726|NCT04007107|101779768|FG003|COMPLETED|Treatment Period 1 (Day 1)||26||
48590727|NCT04007107|101779765|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48590728|NCT04007107|101779766|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48590729|NCT04007107|101779767|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48140529|NCT00272168|100670195|FG000|COMPLETED|Overall Study||37||
48140530|NCT00272168|100670196|FG001|COMPLETED|Overall Study||31||
48140531|NCT00272168|100670195|FG000|NOT COMPLETED|Overall Study||10||
48140532|NCT00272168|100670196|FG001|NOT COMPLETED|Overall Study||10||
48708890|NCT05039671|102073437|FG001|NOT COMPLETED|Overall Study||22||
48708891|NCT05028517|102073438|FG000|STARTED|Overall Study||43||
48708892|NCT05028517|102073439|FG001|STARTED|Overall Study||43||
48140533|NCT05525494|100670197|FG000|STARTED|Overall Study||43682||
48140534|NCT05525494|100670198|FG001|STARTED|Overall Study||43668||
48590730|NCT04007107|101779768|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48590731|NCT04007107|101779765|FG000|STARTED|Treatment Period 2 (Day 1)||26||
48293050|NCT01190514|101044463|FG002|STARTED|First Intervention (Period 1)||10||
48293051|NCT01190514|101044464|FG003|STARTED|First Intervention (Period 1)||10||
48293052|NCT01190514|101044461|FG000|COMPLETED|First Intervention (Period 1)||10||
48590732|NCT04007107|101779766|FG001|STARTED|Treatment Period 2 (Day 1)||26||
48590733|NCT04007107|101779767|FG002|STARTED|Treatment Period 2 (Day 1)||25||
48590734|NCT04007107|101779768|FG003|STARTED|Treatment Period 2 (Day 1)||26||
48590735|NCT04007107|101779765|FG000|COMPLETED|Treatment Period 2 (Day 1)||26||
48590736|NCT04007107|101779766|FG001|COMPLETED|Treatment Period 2 (Day 1)||25||
48590737|NCT04007107|101779767|FG002|COMPLETED|Treatment Period 2 (Day 1)||25||
48590738|NCT04007107|101779768|FG003|COMPLETED|Treatment Period 2 (Day 1)||26||
48590739|NCT04007107|101779765|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
48590740|NCT04007107|101779766|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||1||
48708893|NCT05028517|102073440|FG002|STARTED|Overall Study||43||
48708894|NCT05028517|102073438|FG000|Completed Baseline Surveys|Overall Study||41||
48708895|NCT05028517|102073439|FG001|Completed Baseline Surveys|Overall Study||39||
48140535|NCT05525494|100670199|FG002|STARTED|Overall Study||21881||
48140536|NCT05525494|100670200|FG003|STARTED|Overall Study||21876||
48590741|NCT04007107|101779767|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
48708896|NCT05028517|102073440|FG002|Completed Baseline Surveys|Overall Study||39||
48708897|NCT05028517|102073438|FG000|Completed 6-week Follow-up Surveys|Overall Study||30||
48708898|NCT05028517|102073439|FG001|Completed 6-week Follow-up Surveys|Overall Study||28||
48708899|NCT05028517|102073440|FG002|Completed 6-week Follow-up Surveys|Overall Study||32||
48403391|NCT00572728|101317885|FG000|STARTED|Overall Study||90||
48403392|NCT00572728|101317885|FG000|Eligible|Overall Study||87||
48403393|NCT00572728|101317885|FG000|Enrolled Under Amendment 5 or Later|Overall Study||82||
48403394|NCT00572728|101317885|FG000|Did Not Withdraw|Overall Study||72||
48403395|NCT00572728|101317885|FG000|On Study|Overall Study||71||
48708900|NCT05028517|102073438|FG000|COMPLETED|Overall Study||30|12-week Follow-up Surveys|
48708901|NCT05028517|102073439|FG001|COMPLETED|Overall Study||23|12-week Follow-up Surveys|
48708902|NCT05028517|102073440|FG002|COMPLETED|Overall Study||30|12-week Follow-up Surveys|
48708903|NCT05028517|102073438|FG000|NOT COMPLETED|Overall Study||13||
48708904|NCT05028517|102073439|FG001|NOT COMPLETED|Overall Study||20||
48708905|NCT05028517|102073440|FG002|NOT COMPLETED|Overall Study||13||
48708906|NCT01846195|102073441|FG000|STARTED|Overall Study||5||
48708907|NCT01846195|102073442|FG001|STARTED|Overall Study||45||
48708908|NCT01846195|102073441|FG000|COMPLETED|Overall Study||5||
48708909|NCT01846195|102073442|FG001|COMPLETED|Overall Study||45||
48708910|NCT01846195|102073441|FG000|NOT COMPLETED|Overall Study||0||
48708911|NCT01846195|102073442|FG001|NOT COMPLETED|Overall Study||0||
48708912|NCT03385265|102073443|FG000|STARTED|Overall Study||20||
48708913|NCT03385265|102073444|FG001|STARTED|Overall Study||11||
48708914|NCT03385265|102073445|FG002|STARTED|Overall Study||20||
48708915|NCT03385265|102073446|FG003|STARTED|Overall Study||11||
48708916|NCT03385265|102073443|FG000|COMPLETED|Overall Study||15||
48708917|NCT03385265|102073444|FG001|COMPLETED|Overall Study||9||
48708918|NCT03385265|102073445|FG002|COMPLETED|Overall Study||15||
48403396|NCT00572728|101317885|FG000|Completed FLT1 Scan|Overall Study||67||
48403397|NCT00572728|101317885|FG000|First Therapy Initiated|Overall Study||65||
48403398|NCT00572728|101317885|FG000|Completed FLT2 Scan|Overall Study||60||
48403399|NCT00572728|101317885|FG000|Second Chemotherapy Initiated|Overall Study||59||
48403400|NCT00572728|101317885|FG000|Second Chemotherapy Initiated After FLT2|Overall Study||52||
48403401|NCT00572728|101317885|FG000|Pathology Complete|Overall Study||51||
48403402|NCT00572728|101317885|FG000|Completed FLT3 Scan|Overall Study||43||
48403403|NCT00572728|101317885|FG000|LN Evaluation After NAC|Overall Study||38||
48403404|NCT00572728|101317885|FG000|RCB Evaluation|Overall Study||35||
48403405|NCT00572728|101317885|FG000|COMPLETED|Overall Study||51||
48403406|NCT00572728|101317885|FG000|NOT COMPLETED|Overall Study||39||
48403407|NCT00571519|101317886|FG000|STARTED|Overall Study||3||
48403408|NCT00571519|101317887|FG001|STARTED|Overall Study||9||
48403409|NCT00571519|101317888|FG002|STARTED|Overall Study||12||
48403410|NCT00571519|101317889|FG003|STARTED|Overall Study||27||
48403411|NCT00571519|101317890|FG004|STARTED|Overall Study||9||
48403412|NCT00571519|101317891|FG005|STARTED|Overall Study||10||
48403413|NCT00571519|101317892|FG006|STARTED|Overall Study||24||
48403414|NCT00571519|101317886|FG000|COMPLETED|Overall Study||0||
48708919|NCT03385265|102073446|FG003|COMPLETED|Overall Study||9||
48708920|NCT03385265|102073443|FG000|NOT COMPLETED|Overall Study||5||
48708921|NCT03385265|102073444|FG001|NOT COMPLETED|Overall Study||2||
48708922|NCT03385265|102073445|FG002|NOT COMPLETED|Overall Study||5||
48708923|NCT03385265|102073446|FG003|NOT COMPLETED|Overall Study||2||
48708924|NCT02115750|102073447|FG000|STARTED|Part 1||323||
48708925|NCT02115750|102073448|FG001|STARTED|Part 1||324||
48708926|NCT02115750|102073447|FG000|COMPLETED|Part 1||301||
48708927|NCT02115750|102073448|FG001|COMPLETED|Part 1||312||
48708928|NCT02115750|102073447|FG000|NOT COMPLETED|Part 1||22||
48708929|NCT02115750|102073448|FG001|NOT COMPLETED|Part 1||12||
48708930|NCT02115750|102073447|FG000|STARTED|Part 2: All Subjects Receive CHS-0214||280||
48708931|NCT02115750|102073448|FG001|STARTED|Part 2: All Subjects Receive CHS-0214||284||
48708932|NCT02115750|102073447|FG000|COMPLETED|Part 2: All Subjects Receive CHS-0214||269||
48708933|NCT02115750|102073448|FG001|COMPLETED|Part 2: All Subjects Receive CHS-0214||272||
48708934|NCT02115750|102073447|FG000|NOT COMPLETED|Part 2: All Subjects Receive CHS-0214||11||
48708935|NCT02115750|102073448|FG001|NOT COMPLETED|Part 2: All Subjects Receive CHS-0214||12||
48708936|NCT00328653|102073449|FG000|STARTED|Period I||40||
48403415|NCT00571519|101317887|FG001|COMPLETED|Overall Study||0||
48403416|NCT00571519|101317888|FG002|COMPLETED|Overall Study||0||
48403417|NCT00571519|101317889|FG003|COMPLETED|Overall Study||0||
48708937|NCT00328653|102073450|FG001|STARTED|Period I||39||
48708938|NCT00328653|102073451|FG002|STARTED|Period I||39||
48403418|NCT00571519|101317890|FG004|COMPLETED|Overall Study||0||
48403419|NCT00571519|101317891|FG005|COMPLETED|Overall Study||0||
48403420|NCT00571519|101317892|FG006|COMPLETED|Overall Study||0||
48590742|NCT04007107|101779768|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
48590743|NCT02260869|101779769|FG000|STARTED|Overall Study||38||
48590744|NCT02260869|101779770|FG001|STARTED|Overall Study||37||
48590745|NCT02260869|101779769|FG000|COMPLETED|Overall Study||31||
48590746|NCT02260869|101779770|FG001|COMPLETED|Overall Study||29||
48590747|NCT02260869|101779769|FG000|NOT COMPLETED|Overall Study||7||
48590748|NCT02260869|101779770|FG001|NOT COMPLETED|Overall Study||8||
48590749|NCT00769067|101779771|FG000|STARTED|Overall Study||94||
48590750|NCT00769067|101779772|FG001|STARTED|Overall Study||94||
48590751|NCT00769067|101779771|FG000|Treated|Overall Study||94||
48590752|NCT00769067|101779772|FG001|Treated|Overall Study||93||
48590753|NCT00769067|101779771|FG000|COMPLETED|Overall Study||0||
48590754|NCT00769067|101779772|FG001|COMPLETED|Overall Study||0||
48590755|NCT00769067|101779771|FG000|NOT COMPLETED|Overall Study||94||
48590756|NCT00769067|101779772|FG001|NOT COMPLETED|Overall Study||94||
48590757|NCT00108485|101779773|FG000|STARTED|Overall Study||5||
48590758|NCT00108485|101779774|FG001|STARTED|Overall Study||4||
48590759|NCT00108485|101779773|FG000|COMPLETED|Overall Study||2||
48590760|NCT00108485|101779774|FG001|COMPLETED|Overall Study||2||
48590761|NCT00108485|101779773|FG000|NOT COMPLETED|Overall Study||3||
48590762|NCT00108485|101779774|FG001|NOT COMPLETED|Overall Study||2||
48590763|NCT02879994|101779775|FG000|STARTED|Overall Study||11||
48590764|NCT02879994|101779775|FG000|COMPLETED|Overall Study||0||
48590765|NCT02879994|101779775|FG000|NOT COMPLETED|Overall Study||11||
48590766|NCT01283334|101779776|FG000|STARTED|Overall Study||20||
48590767|NCT01283334|101779776|FG000|COMPLETED|Overall Study||13||
48590768|NCT01283334|101779776|FG000|NOT COMPLETED|Overall Study||7||
48590769|NCT02407054|101779777|FG000|STARTED|Overall Study||13||
48590770|NCT02407054|101779778|FG001|STARTED|Overall Study||65||
48590771|NCT02407054|101779779|FG002|STARTED|Overall Study||64||
48590772|NCT02407054|101779777|FG000|Received at Least One Dose of Study Drug|Overall Study||13||
48590773|NCT02407054|101779778|FG001|Received at Least One Dose of Study Drug|Overall Study||65||
48590774|NCT02407054|101779779|FG002|Received at Least One Dose of Study Drug|Overall Study||64||
48590775|NCT02407054|101779777|FG000|COMPLETED|Overall Study||6||
48590776|NCT02407054|101779778|FG001|COMPLETED|Overall Study||47||
48590777|NCT02407054|101779779|FG002|COMPLETED|Overall Study||57||
48590778|NCT02407054|101779777|FG000|NOT COMPLETED|Overall Study||7||
48590779|NCT02407054|101779778|FG001|NOT COMPLETED|Overall Study||18||
48590780|NCT02407054|101779779|FG002|NOT COMPLETED|Overall Study||7||
48590781|NCT01004406|101779780|FG000|STARTED|Overall Study||21||
48590782|NCT01004406|101779781|FG001|STARTED|Overall Study||10||
48590783|NCT01004406|101779780|FG000|COMPLETED|Overall Study||18||
48590784|NCT01004406|101779781|FG001|COMPLETED|Overall Study||10||
48590785|NCT01004406|101779780|FG000|NOT COMPLETED|Overall Study||3||
48590786|NCT01004406|101779781|FG001|NOT COMPLETED|Overall Study||0||
48590787|NCT01588457|101779782|FG000|STARTED|Randomization 1||53|Not all subjects were eligible to progress to from Randomization 1 to 2 based on depression symptoms|
48590788|NCT01588457|101779783|FG001|STARTED|Randomization 1||59|Not all subjects were eligible to progress to from Randomization 1 to 2 based on depression symptoms|
48590789|NCT01588457|101779784|FG002|STARTED|Randomization 1||0|Not all subjects were eligible to progress to from Randomization 1 to 2 based on depression symptoms|
48590790|NCT01588457|101779785|FG003|STARTED|Randomization 1||0|Not all subjects were eligible to progress to from Randomization 1 to 2 based on depression symptoms|
48590791|NCT01588457|101779782|FG000|COMPLETED|Randomization 1||30||
48708939|NCT00328653|102073449|FG000|COMPLETED|Period I||36||
48708940|NCT00328653|102073450|FG001|COMPLETED|Period I||39||
48708941|NCT00328653|102073451|FG002|COMPLETED|Period I||36||
48708942|NCT00328653|102073449|FG000|NOT COMPLETED|Period I||4||
48708943|NCT00328653|102073450|FG001|NOT COMPLETED|Period I||0||
48708944|NCT00328653|102073451|FG002|NOT COMPLETED|Period I||3||
48708945|NCT00328653|102073449|FG000|STARTED|Period II||0||
48708946|NCT00328653|102073450|FG001|STARTED|Period II||58||
48708947|NCT00328653|102073451|FG002|STARTED|Period II||53||
48708948|NCT00328653|102073449|FG000|COMPLETED|Period II||0||
48403421|NCT00571519|101317886|FG000|NOT COMPLETED|Overall Study||3||
48403422|NCT00571519|101317887|FG001|NOT COMPLETED|Overall Study||9||
48590792|NCT01588457|101779783|FG001|COMPLETED|Randomization 1||43||
48590793|NCT01588457|101779784|FG002|COMPLETED|Randomization 1||0||
48590794|NCT01588457|101779785|FG003|COMPLETED|Randomization 1||0||
48590795|NCT01588457|101779782|FG000|NOT COMPLETED|Randomization 1||23||
48590796|NCT01588457|101779783|FG001|NOT COMPLETED|Randomization 1||16||
48590797|NCT01588457|101779784|FG002|NOT COMPLETED|Randomization 1||0||
48590798|NCT01588457|101779785|FG003|NOT COMPLETED|Randomization 1||0||
48708949|NCT00328653|102073450|FG001|COMPLETED|Period II||50||
48708950|NCT00328653|102073451|FG002|COMPLETED|Period II||49||
48708951|NCT00328653|102073449|FG000|NOT COMPLETED|Period II||0||
48708952|NCT00328653|102073450|FG001|NOT COMPLETED|Period II||8||
48293053|NCT01190514|101044462|FG001|COMPLETED|First Intervention (Period 1)||10||
48293054|NCT01190514|101044463|FG002|COMPLETED|First Intervention (Period 1)||10||
48708953|NCT00328653|102073451|FG002|NOT COMPLETED|Period II||4||
48708954|NCT03114124|102073452|FG000|STARTED|Overall Study||15||
48708955|NCT03114124|102073453|FG001|STARTED|Overall Study||15||
48708956|NCT03114124|102073452|FG000|COMPLETED|Overall Study||15||
48708957|NCT03114124|102073453|FG001|COMPLETED|Overall Study||15||
48708958|NCT03114124|102073452|FG000|NOT COMPLETED|Overall Study||0||
48708959|NCT03114124|102073453|FG001|NOT COMPLETED|Overall Study||0||
48708960|NCT00871117|102073454|FG000|STARTED|Overall Study||239||
48708961|NCT00871117|102073455|FG001|STARTED|Overall Study||237||
48708962|NCT00871117|102073454|FG000|COMPLETED|Overall Study||234||
48708963|NCT00871117|102073455|FG001|COMPLETED|Overall Study||227||
48708964|NCT00871117|102073454|FG000|NOT COMPLETED|Overall Study||5||
48708965|NCT00871117|102073455|FG001|NOT COMPLETED|Overall Study||10||
48708966|NCT03249935|102077705|FG000|STARTED|Overall Study||100||
48708967|NCT03249935|102077705|FG000|COMPLETED|Overall Study||55||
48708968|NCT03249935|102077705|FG000|NOT COMPLETED|Overall Study||45||
48708969|NCT02242981|102077706|FG000|STARTED|Overall Study||6||
48708970|NCT02242981|102077706|FG000|Received Study Drug|Overall Study||6||
48708971|NCT02242981|102077706|FG000|COMPLETED|Overall Study||5||
48708972|NCT02242981|102077706|FG000|NOT COMPLETED|Overall Study||1||
48708973|NCT02970006|102077707|FG000|STARTED|Overall Study||15||
48708974|NCT02970006|102077707|FG000|COMPLETED|Overall Study||14||
48708975|NCT02970006|102077707|FG000|NOT COMPLETED|Overall Study||1||
48708976|NCT01335750|102077708|FG000|STARTED|Overall Study||32||
48708977|NCT01335750|102077708|FG000|COMPLETED|Overall Study||32||
48708978|NCT01335750|102077708|FG000|NOT COMPLETED|Overall Study||0||
48708979|NCT00539513|102077709|FG000|STARTED|Overall Study||5||
48708980|NCT00539513|102077710|FG001|STARTED|Overall Study||5||
48708981|NCT00539513|102077709|FG000|Received Allocated Intervention|Overall Study||3||
48708982|NCT00539513|102077710|FG001|Received Allocated Intervention|Overall Study||4||
48708983|NCT00539513|102077709|FG000|COMPLETED|Overall Study||3||
48708984|NCT00539513|102077710|FG001|COMPLETED|Overall Study||3||
48708985|NCT00539513|102077709|FG000|NOT COMPLETED|Overall Study||2||
48708986|NCT00539513|102077710|FG001|NOT COMPLETED|Overall Study||2||
48708987|NCT01129882|102077711|FG000|STARTED|Overall Study||709||
48708988|NCT01129882|102077711|FG000|Received at Least 1 Dose of Study Drug|Overall Study||709||
48708989|NCT01129882|102077711|FG000|COMPLETED|Overall Study||431||
48708990|NCT01129882|102077711|FG000|NOT COMPLETED|Overall Study||278||
48708991|NCT00589056|102077712|FG000|STARTED|Overall Study||55||
48708992|NCT00589056|102077712|FG000|COMPLETED|Overall Study||52||
48140537|NCT05525494|100670201|FG004|STARTED|Overall Study||21864||
48708993|NCT00589056|102077712|FG000|NOT COMPLETED|Overall Study||3||
48708994|NCT01338610|102077713|FG000|STARTED|Overall Study||39||
48708995|NCT01338610|102077714|FG001|STARTED|Overall Study||56||
48708996|NCT01338610|102077715|FG002|STARTED|Overall Study||29||
48708997|NCT01338610|102077713|FG000|COMPLETED|Overall Study||34||
48708998|NCT01338610|102077714|FG001|COMPLETED|Overall Study||55||
48708999|NCT01338610|102077715|FG002|COMPLETED|Overall Study||28||
48709000|NCT01338610|102077713|FG000|NOT COMPLETED|Overall Study||5||
48709001|NCT01338610|102077714|FG001|NOT COMPLETED|Overall Study||1||
48709002|NCT01338610|102077715|FG002|NOT COMPLETED|Overall Study||1||
48709003|NCT01245738|102077716|FG000|STARTED|Overall Study||514||
48709004|NCT01245738|102077716|FG000|COMPLETED|Overall Study||474||
48709005|NCT01245738|102077716|FG000|NOT COMPLETED|Overall Study||40||
48709006|NCT02838901|102077717|FG000|STARTED|Overall Study||9||
48709007|NCT02838901|102077718|FG001|STARTED|Overall Study||9||
48709008|NCT02838901|102077717|FG000|COMPLETED|Overall Study||7||
48140538|NCT05525494|100670202|FG005|STARTED|Overall Study||21857||
48140539|NCT05525494|100670203|FG006|STARTED|Overall Study||87257||
48140540|NCT05525494|100670197|FG000|COMPLETED|Overall Study||43682||
48140541|NCT05525494|100670198|FG001|COMPLETED|Overall Study||43668||
48140542|NCT05525494|100670199|FG002|COMPLETED|Overall Study||21881||
48140543|NCT05525494|100670200|FG003|COMPLETED|Overall Study||21876||
48140544|NCT05525494|100670201|FG004|COMPLETED|Overall Study||21864||
48140545|NCT05525494|100670202|FG005|COMPLETED|Overall Study||21857||
48140546|NCT05525494|100670203|FG006|COMPLETED|Overall Study||87257||
48140547|NCT05525494|100670197|FG000|NOT COMPLETED|Overall Study||0||
48140548|NCT05525494|100670198|FG001|NOT COMPLETED|Overall Study||0||
48140549|NCT05525494|100670199|FG002|NOT COMPLETED|Overall Study||0||
48293055|NCT01190514|101044464|FG003|COMPLETED|First Intervention (Period 1)||10||
48293056|NCT01190514|101044461|FG000|NOT COMPLETED|First Intervention (Period 1)||1||
48140550|NCT05525494|100670200|FG003|NOT COMPLETED|Overall Study||0||
48140551|NCT05525494|100670201|FG004|NOT COMPLETED|Overall Study||0||
48709009|NCT02838901|102077718|FG001|COMPLETED|Overall Study||7||
48709010|NCT02838901|102077717|FG000|NOT COMPLETED|Overall Study||2||
48709011|NCT02838901|102077718|FG001|NOT COMPLETED|Overall Study||2||
48709012|NCT01133275|102077719|FG000|STARTED|Overall Study||28||
48709013|NCT01133275|102077719|FG000|COMPLETED|Overall Study||26||
48709014|NCT01133275|102077719|FG000|NOT COMPLETED|Overall Study||2||
48709015|NCT00504504|102077720|FG000|STARTED|Overall Study||82||
48709016|NCT00504504|102077720|FG000|COMPLETED|Overall Study||82||
48709017|NCT00504504|102077720|FG000|NOT COMPLETED|Overall Study||0||
48709018|NCT00953680|102077721|FG000|STARTED|Period 1||38||
48709019|NCT00953680|102077722|FG001|STARTED|Period 1||39||
48709020|NCT00953680|102077721|FG000|COMPLETED|Period 1||38||
48709021|NCT00953680|102077722|FG001|COMPLETED|Period 1||38||
48709022|NCT00953680|102077721|FG000|NOT COMPLETED|Period 1||0||
48709023|NCT00953680|102077722|FG001|NOT COMPLETED|Period 1||1||
48709024|NCT00953680|102077721|FG000|STARTED|Period 2||38||
48709025|NCT00953680|102077722|FG001|STARTED|Period 2||38||
48709026|NCT00953680|102077721|FG000|COMPLETED|Period 2||38||
48709027|NCT00953680|102077722|FG001|COMPLETED|Period 2||38||
48709028|NCT00953680|102077721|FG000|NOT COMPLETED|Period 2||0||
48709029|NCT00953680|102077722|FG001|NOT COMPLETED|Period 2||0||
48709030|NCT01605227|102077723|FG000|STARTED|Overall Study||682|Randomized|
48709031|NCT01605227|102077724|FG001|STARTED|Overall Study||346|Randomized|
48709032|NCT01605227|102077723|FG000|COMPLETED|Overall Study||61|Subjects still on study treatment at data cut-off date|
48709033|NCT01605227|102077724|FG001|COMPLETED|Overall Study||17|Subjects still on study treatment at data cut-off date|
48709034|NCT01605227|102077723|FG000|NOT COMPLETED|Overall Study||621||
48709035|NCT01605227|102077724|FG001|NOT COMPLETED|Overall Study||329||
48709036|NCT02436668|102077725|FG000|STARTED|Overall Study||213||
48709037|NCT02436668|102077726|FG001|STARTED|Overall Study||211||
48709038|NCT02436668|102077725|FG000|COMPLETED|Overall Study||212||
48709039|NCT02436668|102077726|FG001|COMPLETED|Overall Study||207||
48709040|NCT02436668|102077725|FG000|NOT COMPLETED|Overall Study||1||
48709041|NCT02436668|102077726|FG001|NOT COMPLETED|Overall Study||4||
48709042|NCT01287221|102077727|FG000|STARTED|Overall Study||50||
48709043|NCT01287221|102077728|FG001|STARTED|Overall Study||50||
48140552|NCT05525494|100670202|FG005|NOT COMPLETED|Overall Study||0||
48140553|NCT05525494|100670203|FG006|NOT COMPLETED|Overall Study||0||
48140554|NCT02167074|100670204|FG000|STARTED|Overall Study||306||
48403423|NCT00571519|101317888|FG002|NOT COMPLETED|Overall Study||12||
48403424|NCT00571519|101317889|FG003|NOT COMPLETED|Overall Study||27||
48403425|NCT00571519|101317890|FG004|NOT COMPLETED|Overall Study||9||
48403426|NCT00571519|101317891|FG005|NOT COMPLETED|Overall Study||10||
48403427|NCT00571519|101317892|FG006|NOT COMPLETED|Overall Study||24||
48403428|NCT00247273|101317893|FG000|STARTED|Overall Study||644||
48403429|NCT00247273|101317894|FG001|STARTED|Overall Study||650||
48403430|NCT00247273|101317893|FG000|Intent to Treat Population|Overall Study||642||
48403431|NCT00247273|101317894|FG001|Intent to Treat Population|Overall Study||650||
48403432|NCT00247273|101317893|FG000|COMPLETED|Overall Study||498||
48403433|NCT00247273|101317894|FG001|COMPLETED|Overall Study||513||
48403434|NCT00247273|101317893|FG000|NOT COMPLETED|Overall Study||146||
48403435|NCT00247273|101317894|FG001|NOT COMPLETED|Overall Study||137||
48403436|NCT01807091|101317895|FG000|STARTED|Overall Study||17||
48403437|NCT01807091|101317895|FG000|COMPLETED|Overall Study||17||
48403438|NCT01807091|101317895|FG000|NOT COMPLETED|Overall Study||0||
48403439|NCT03787095|101317896|FG000|STARTED|Overall Study||4||
48403440|NCT03787095|101317897|FG001|STARTED|Overall Study||1||
48403441|NCT03787095|101317896|FG000|COMPLETED|Overall Study||4||
48403442|NCT03787095|101317897|FG001|COMPLETED|Overall Study||1||
48403443|NCT03787095|101317896|FG000|NOT COMPLETED|Overall Study||0||
48403444|NCT03787095|101317897|FG001|NOT COMPLETED|Overall Study||0||
48403445|NCT02668952|101317898|FG000|STARTED|Overall Study||16||
48403446|NCT02668952|101317899|FG001|STARTED|Overall Study||14||
48403447|NCT02668952|101317898|FG000|COMPLETED|Overall Study||16||
48403448|NCT02668952|101317899|FG001|COMPLETED|Overall Study||14||
48403449|NCT02668952|101317898|FG000|NOT COMPLETED|Overall Study||0||
48403450|NCT02668952|101317899|FG001|NOT COMPLETED|Overall Study||0||
48403451|NCT01975675|101317900|FG000|STARTED|Overall Study||83||
48709044|NCT01287221|102077727|FG000|Completed 3 Months Follow-up|Overall Study||49||
48709045|NCT01287221|102077728|FG001|Completed 3 Months Follow-up|Overall Study||50||
48709046|NCT01287221|102077727|FG000|Completed 6 Months Follow-up|Overall Study||47||
48709047|NCT01287221|102077728|FG001|Completed 6 Months Follow-up|Overall Study||43||
48709048|NCT01287221|102077727|FG000|Completed 9 Months Follow-up|Overall Study||42||
48709049|NCT01287221|102077728|FG001|Completed 9 Months Follow-up|Overall Study||40||
48709050|NCT01287221|102077727|FG000|Completed 12 Months Follow-up|Overall Study||40||
48709051|NCT01287221|102077728|FG001|Completed 12 Months Follow-up|Overall Study||39||
48709052|NCT01287221|102077727|FG000|COMPLETED|Overall Study||46||
48709053|NCT01287221|102077728|FG001|COMPLETED|Overall Study||45||
48709054|NCT01287221|102077727|FG000|NOT COMPLETED|Overall Study||4||
48709055|NCT01287221|102077728|FG001|NOT COMPLETED|Overall Study||5||
48709056|NCT00642174|102077729|FG000|STARTED|Period 1 - Initial Drug||18||
48709057|NCT00642174|102077730|FG001|STARTED|Period 1 - Initial Drug||17||
48709058|NCT00642174|102077729|FG000|COMPLETED|Period 1 - Initial Drug||18||
48709059|NCT00642174|102077730|FG001|COMPLETED|Period 1 - Initial Drug||16||
48403452|NCT01975675|101317901|FG001|STARTED|Overall Study||83||
48403453|NCT01975675|101317902|FG002|STARTED|Overall Study||88||
48403454|NCT01975675|101317903|FG003|STARTED|Overall Study||87||
48709060|NCT00642174|102077729|FG000|NOT COMPLETED|Period 1 - Initial Drug||0||
48709061|NCT00642174|102077730|FG001|NOT COMPLETED|Period 1 - Initial Drug||1||
48709062|NCT00642174|102077729|FG000|STARTED|Period 2 - Crossover Drug||18||
48709063|NCT00642174|102077730|FG001|STARTED|Period 2 - Crossover Drug||16||
48709064|NCT00642174|102077729|FG000|COMPLETED|Period 2 - Crossover Drug||18||
48709065|NCT00642174|102077730|FG001|COMPLETED|Period 2 - Crossover Drug||16||
48709066|NCT00642174|102077729|FG000|NOT COMPLETED|Period 2 - Crossover Drug||0||
48709067|NCT00642174|102077730|FG001|NOT COMPLETED|Period 2 - Crossover Drug||0||
48709068|NCT02825420|102077731|FG000|STARTED|Overall Study||131||
48709069|NCT02825420|102077732|FG001|STARTED|Overall Study||89||
48709070|NCT02825420|102077731|FG000|COMPLETED|Overall Study||88||
48709071|NCT02825420|102077732|FG001|COMPLETED|Overall Study||72||
48709072|NCT02825420|102077731|FG000|NOT COMPLETED|Overall Study||43||
48709073|NCT02825420|102077732|FG001|NOT COMPLETED|Overall Study||17||
48709074|NCT01286987|102077733|FG000|STARTED|Part 1: Dose Escalation||3||
48709075|NCT01286987|102077734|FG001|STARTED|Part 1: Dose Escalation||3||
48709076|NCT01286987|102077735|FG002|STARTED|Part 1: Dose Escalation||3||
48709077|NCT01286987|102077736|FG003|STARTED|Part 1: Dose Escalation||3||
48709078|NCT01286987|102077737|FG004|STARTED|Part 1: Dose Escalation||3||
48709079|NCT01286987|102077738|FG005|STARTED|Part 1: Dose Escalation||6||
48709080|NCT01286987|102077739|FG006|STARTED|Part 1: Dose Escalation||6||
48709081|NCT01286987|102077740|FG007|STARTED|Part 1: Dose Escalation||6||
48709082|NCT01286987|102077741|FG008|STARTED|Part 1: Dose Escalation||6||
48709083|NCT01286987|102077742|FG009|STARTED|Part 1: Dose Escalation||0||
48709084|NCT01286987|102077743|FG010|STARTED|Part 1: Dose Escalation||0||
48709085|NCT01286987|102077744|FG011|STARTED|Part 1: Dose Escalation||0||
48709086|NCT01286987|102077745|FG012|STARTED|Part 1: Dose Escalation||0||
48709087|NCT01286987|102077746|FG013|STARTED|Part 1: Dose Escalation||0||
48709088|NCT01286987|102077747|FG014|STARTED|Part 1: Dose Escalation||0||
48709089|NCT01286987|102077733|FG000|Colorectal Cancer|Part 1: Dose Escalation||1||
48709090|NCT01286987|102077734|FG001|Colorectal Cancer|Part 1: Dose Escalation||0||
48709091|NCT01286987|102077735|FG002|Colorectal Cancer|Part 1: Dose Escalation||1||
48709092|NCT01286987|102077736|FG003|Colorectal Cancer|Part 1: Dose Escalation||0||
48709093|NCT01286987|102077737|FG004|Colorectal Cancer|Part 1: Dose Escalation||0||
48709094|NCT01286987|102077738|FG005|Colorectal Cancer|Part 1: Dose Escalation||0||
48709095|NCT01286987|102077739|FG006|Colorectal Cancer|Part 1: Dose Escalation||0||
48709096|NCT01286987|102077740|FG007|Colorectal Cancer|Part 1: Dose Escalation||0||
48709097|NCT01286987|102077741|FG008|Colorectal Cancer|Part 1: Dose Escalation||0||
48709098|NCT01286987|102077742|FG009|Colorectal Cancer|Part 1: Dose Escalation||0||
48709099|NCT01286987|102077743|FG010|Colorectal Cancer|Part 1: Dose Escalation||0||
48709100|NCT01286987|102077744|FG011|Colorectal Cancer|Part 1: Dose Escalation||0||
48709101|NCT01286987|102077745|FG012|Colorectal Cancer|Part 1: Dose Escalation||0||
48709102|NCT01286987|102077746|FG013|Colorectal Cancer|Part 1: Dose Escalation||0||
48709103|NCT01286987|102077747|FG014|Colorectal Cancer|Part 1: Dose Escalation||0||
48709104|NCT01286987|102077733|FG000|Prostate Cancer|Part 1: Dose Escalation||0||
48709105|NCT01286987|102077734|FG001|Prostate Cancer|Part 1: Dose Escalation||0||
48293057|NCT01190514|101044462|FG001|NOT COMPLETED|First Intervention (Period 1)||0||
48709106|NCT01286987|102077735|FG002|Prostate Cancer|Part 1: Dose Escalation||0||
48709107|NCT01286987|102077736|FG003|Prostate Cancer|Part 1: Dose Escalation||0||
48709108|NCT01286987|102077737|FG004|Prostate Cancer|Part 1: Dose Escalation||0||
48709109|NCT01286987|102077738|FG005|Prostate Cancer|Part 1: Dose Escalation||1||
48709110|NCT01286987|102077739|FG006|Prostate Cancer|Part 1: Dose Escalation||0||
48709111|NCT01286987|102077740|FG007|Prostate Cancer|Part 1: Dose Escalation||0||
48709112|NCT01286987|102077741|FG008|Prostate Cancer|Part 1: Dose Escalation||0||
48709113|NCT01286987|102077742|FG009|Prostate Cancer|Part 1: Dose Escalation||0||
48709114|NCT01286987|102077743|FG010|Prostate Cancer|Part 1: Dose Escalation||0||
48709115|NCT01286987|102077744|FG011|Prostate Cancer|Part 1: Dose Escalation||0||
48709116|NCT01286987|102077745|FG012|Prostate Cancer|Part 1: Dose Escalation||0||
48709117|NCT01286987|102077746|FG013|Prostate Cancer|Part 1: Dose Escalation||0||
48709118|NCT01286987|102077747|FG014|Prostate Cancer|Part 1: Dose Escalation||0||
48709119|NCT01286987|102077733|FG000|Ewing Cancer|Part 1: Dose Escalation||0||
48709120|NCT01286987|102077734|FG001|Ewing Cancer|Part 1: Dose Escalation||0||
48709121|NCT01286987|102077735|FG002|Ewing Cancer|Part 1: Dose Escalation||0||
48709122|NCT01286987|102077736|FG003|Ewing Cancer|Part 1: Dose Escalation||0||
48709123|NCT01286987|102077737|FG004|Ewing Cancer|Part 1: Dose Escalation||0||
48709124|NCT01286987|102077738|FG005|Ewing Cancer|Part 1: Dose Escalation||0||
48709125|NCT01286987|102077739|FG006|Ewing Cancer|Part 1: Dose Escalation||0||
48709126|NCT01286987|102077740|FG007|Ewing Cancer|Part 1: Dose Escalation||1||
48709127|NCT01286987|102077741|FG008|Ewing Cancer|Part 1: Dose Escalation||1||
48709128|NCT01286987|102077742|FG009|Ewing Cancer|Part 1: Dose Escalation||0||
48709129|NCT01286987|102077743|FG010|Ewing Cancer|Part 1: Dose Escalation||0||
48709130|NCT01286987|102077744|FG011|Ewing Cancer|Part 1: Dose Escalation||0||
48709131|NCT01286987|102077745|FG012|Ewing Cancer|Part 1: Dose Escalation||0||
48709132|NCT01286987|102077746|FG013|Ewing Cancer|Part 1: Dose Escalation||0||
48709133|NCT01286987|102077747|FG014|Ewing Cancer|Part 1: Dose Escalation||0||
48709134|NCT01286987|102077733|FG000|Pancreatic Cancer|Part 1: Dose Escalation||1||
48709135|NCT01286987|102077734|FG001|Pancreatic Cancer|Part 1: Dose Escalation||2||
48709136|NCT01286987|102077735|FG002|Pancreatic Cancer|Part 1: Dose Escalation||0||
48709137|NCT01286987|102077736|FG003|Pancreatic Cancer|Part 1: Dose Escalation||0||
48709138|NCT01286987|102077737|FG004|Pancreatic Cancer|Part 1: Dose Escalation||0||
48709139|NCT01286987|102077738|FG005|Pancreatic Cancer|Part 1: Dose Escalation||0||
48709140|NCT01286987|102077739|FG006|Pancreatic Cancer|Part 1: Dose Escalation||0||
48709141|NCT01286987|102077740|FG007|Pancreatic Cancer|Part 1: Dose Escalation||0||
48709142|NCT01286987|102077741|FG008|Pancreatic Cancer|Part 1: Dose Escalation||0||
48709143|NCT01286987|102077742|FG009|Pancreatic Cancer|Part 1: Dose Escalation||0||
48709144|NCT01286987|102077743|FG010|Pancreatic Cancer|Part 1: Dose Escalation||0||
48709145|NCT01286987|102077744|FG011|Pancreatic Cancer|Part 1: Dose Escalation||0||
48709146|NCT01286987|102077745|FG012|Pancreatic Cancer|Part 1: Dose Escalation||0||
48709147|NCT01286987|102077746|FG013|Pancreatic Cancer|Part 1: Dose Escalation||0||
48709148|NCT01286987|102077747|FG014|Pancreatic Cancer|Part 1: Dose Escalation||0||
48709149|NCT01286987|102077733|FG000|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||1||
48709150|NCT01286987|102077734|FG001|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||1||
48709151|NCT01286987|102077735|FG002|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||2||
48709152|NCT01286987|102077736|FG003|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3||
48709153|NCT01286987|102077737|FG004|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3||
48709154|NCT01286987|102077738|FG005|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||4||
48709155|NCT01286987|102077739|FG006|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||4||
48709156|NCT01286987|102077740|FG007|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3||
48709157|NCT01286987|102077741|FG008|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||2||
48709158|NCT01286987|102077742|FG009|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0||
48709159|NCT01286987|102077743|FG010|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0||
48709160|NCT01286987|102077744|FG011|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0||
48709161|NCT01286987|102077745|FG012|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0||
48709162|NCT01286987|102077746|FG013|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0||
48709163|NCT01286987|102077747|FG014|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0||
48709164|NCT01286987|102077733|FG000|Breast Cancer|Part 1: Dose Escalation||0||
48709165|NCT01286987|102077734|FG001|Breast Cancer|Part 1: Dose Escalation||0||
48709166|NCT01286987|102077735|FG002|Breast Cancer|Part 1: Dose Escalation||0||
48709167|NCT01286987|102077736|FG003|Breast Cancer|Part 1: Dose Escalation||0||
48709168|NCT01286987|102077737|FG004|Breast Cancer|Part 1: Dose Escalation||0||
48709169|NCT01286987|102077738|FG005|Breast Cancer|Part 1: Dose Escalation||1||
48709170|NCT01286987|102077739|FG006|Breast Cancer|Part 1: Dose Escalation||2||
48709171|NCT01286987|102077740|FG007|Breast Cancer|Part 1: Dose Escalation||2||
48709172|NCT01286987|102077741|FG008|Breast Cancer|Part 1: Dose Escalation||3||
48709173|NCT01286987|102077742|FG009|Breast Cancer|Part 1: Dose Escalation||0||
48709174|NCT01286987|102077743|FG010|Breast Cancer|Part 1: Dose Escalation||0||
48709175|NCT01286987|102077744|FG011|Breast Cancer|Part 1: Dose Escalation||0||
48709176|NCT01286987|102077745|FG012|Breast Cancer|Part 1: Dose Escalation||0||
48709177|NCT01286987|102077746|FG013|Breast Cancer|Part 1: Dose Escalation||0||
48709178|NCT01286987|102077747|FG014|Breast Cancer|Part 1: Dose Escalation||0||
48709179|NCT01286987|102077733|FG000|COMPLETED|Part 1: Dose Escalation||0||
48709180|NCT01286987|102077734|FG001|COMPLETED|Part 1: Dose Escalation||0||
48709181|NCT01286987|102077735|FG002|COMPLETED|Part 1: Dose Escalation||0||
48709182|NCT01286987|102077736|FG003|COMPLETED|Part 1: Dose Escalation||0||
48709183|NCT01286987|102077737|FG004|COMPLETED|Part 1: Dose Escalation||0||
48709184|NCT01286987|102077738|FG005|COMPLETED|Part 1: Dose Escalation||0||
48709185|NCT01286987|102077739|FG006|COMPLETED|Part 1: Dose Escalation||1||
48709186|NCT01286987|102077740|FG007|COMPLETED|Part 1: Dose Escalation||1||
48709187|NCT01286987|102077741|FG008|COMPLETED|Part 1: Dose Escalation||0||
48709188|NCT01286987|102077742|FG009|COMPLETED|Part 1: Dose Escalation||0||
48709189|NCT01286987|102077743|FG010|COMPLETED|Part 1: Dose Escalation||0||
48709190|NCT01286987|102077744|FG011|COMPLETED|Part 1: Dose Escalation||0||
48709191|NCT01286987|102077745|FG012|COMPLETED|Part 1: Dose Escalation||0||
48709192|NCT01286987|102077746|FG013|COMPLETED|Part 1: Dose Escalation||0||
48709193|NCT01286987|102077747|FG014|COMPLETED|Part 1: Dose Escalation||0||
48709194|NCT01286987|102077733|FG000|NOT COMPLETED|Part 1: Dose Escalation||3||
48709195|NCT01286987|102077734|FG001|NOT COMPLETED|Part 1: Dose Escalation||3||
48709196|NCT01286987|102077735|FG002|NOT COMPLETED|Part 1: Dose Escalation||3||
48709197|NCT01286987|102077736|FG003|NOT COMPLETED|Part 1: Dose Escalation||3||
48709198|NCT01286987|102077737|FG004|NOT COMPLETED|Part 1: Dose Escalation||3||
48709199|NCT01286987|102077738|FG005|NOT COMPLETED|Part 1: Dose Escalation||6||
48709200|NCT01286987|102077739|FG006|NOT COMPLETED|Part 1: Dose Escalation||5||
48709201|NCT01286987|102077740|FG007|NOT COMPLETED|Part 1: Dose Escalation||5||
48709202|NCT01286987|102077741|FG008|NOT COMPLETED|Part 1: Dose Escalation||6||
48709203|NCT01286987|102077742|FG009|NOT COMPLETED|Part 1: Dose Escalation||0||
48709204|NCT01286987|102077743|FG010|NOT COMPLETED|Part 1: Dose Escalation||0||
48709205|NCT01286987|102077744|FG011|NOT COMPLETED|Part 1: Dose Escalation||0||
48709206|NCT01286987|102077745|FG012|NOT COMPLETED|Part 1: Dose Escalation||0||
48709207|NCT01286987|102077746|FG013|NOT COMPLETED|Part 1: Dose Escalation||0||
48709208|NCT01286987|102077747|FG014|NOT COMPLETED|Part 1: Dose Escalation||0||
48709209|NCT01286987|102077733|FG000|STARTED|Part 2: Dose Expansion||0||
48709210|NCT01286987|102077734|FG001|STARTED|Part 2: Dose Expansion||0||
48709211|NCT01286987|102077735|FG002|STARTED|Part 2: Dose Expansion||0||
48709212|NCT01286987|102077736|FG003|STARTED|Part 2: Dose Expansion||0||
48709213|NCT01286987|102077737|FG004|STARTED|Part 2: Dose Expansion||0||
48709214|NCT01286987|102077738|FG005|STARTED|Part 2: Dose Expansion||0||
48709215|NCT01286987|102077739|FG006|STARTED|Part 2: Dose Expansion||0||
48709216|NCT01286987|102077740|FG007|STARTED|Part 2: Dose Expansion||0||
48709217|NCT01286987|102077741|FG008|STARTED|Part 2: Dose Expansion||0||
48709218|NCT01286987|102077742|FG009|STARTED|Part 2: Dose Expansion||12||
48709219|NCT01286987|102077743|FG010|STARTED|Part 2: Dose Expansion||12||
48709220|NCT01286987|102077744|FG011|STARTED|Part 2: Dose Expansion||11||
48709221|NCT01286987|102077745|FG012|STARTED|Part 2: Dose Expansion||12||
48709222|NCT01286987|102077746|FG013|STARTED|Part 2: Dose Expansion||24||
48709223|NCT01286987|102077747|FG014|STARTED|Part 2: Dose Expansion||3||
48709224|NCT01286987|102077733|FG000|Treated|Part 2: Dose Expansion||0||
48709225|NCT01286987|102077734|FG001|Treated|Part 2: Dose Expansion||0||
48709226|NCT01286987|102077735|FG002|Treated|Part 2: Dose Expansion||0||
48709227|NCT01286987|102077736|FG003|Treated|Part 2: Dose Expansion||0||
48709228|NCT01286987|102077737|FG004|Treated|Part 2: Dose Expansion||0||
48709229|NCT01286987|102077738|FG005|Treated|Part 2: Dose Expansion||0||
48709230|NCT01286987|102077739|FG006|Treated|Part 2: Dose Expansion||0||
48709231|NCT01286987|102077740|FG007|Treated|Part 2: Dose Expansion||0||
48709232|NCT01286987|102077741|FG008|Treated|Part 2: Dose Expansion||0||
48709233|NCT01286987|102077742|FG009|Treated|Part 2: Dose Expansion||12||
48709234|NCT01286987|102077743|FG010|Treated|Part 2: Dose Expansion||11||
48709235|NCT01286987|102077744|FG011|Treated|Part 2: Dose Expansion||10||
48709236|NCT01286987|102077745|FG012|Treated|Part 2: Dose Expansion||12||
48403455|NCT01975675|101317900|FG000|COMPLETED|Overall Study||83||
48403456|NCT01975675|101317901|FG001|COMPLETED|Overall Study||82||
48403457|NCT01975675|101317902|FG002|COMPLETED|Overall Study||88||
48403458|NCT01975675|101317903|FG003|COMPLETED|Overall Study||87||
48403459|NCT01975675|101317900|FG000|NOT COMPLETED|Overall Study||0||
48403460|NCT01975675|101317901|FG001|NOT COMPLETED|Overall Study||1||
48403461|NCT01975675|101317902|FG002|NOT COMPLETED|Overall Study||0||
48403462|NCT01975675|101317903|FG003|NOT COMPLETED|Overall Study||0||
48403463|NCT02939651|101317904|FG000|STARTED|Overall Study||21||
48403464|NCT02939651|101317904|FG000|COMPLETED|Overall Study||21||
48403465|NCT02939651|101317904|FG000|NOT COMPLETED|Overall Study||0||
48403466|NCT00838383|101317905|FG000|STARTED|Overall Study||9||
48403467|NCT00838383|101317906|FG001|STARTED|Overall Study||10||
48403468|NCT00838383|101317907|FG002|STARTED|Overall Study||10||
48403469|NCT00838383|101317905|FG000|COMPLETED|Overall Study||9||
48403470|NCT00838383|101317906|FG001|COMPLETED|Overall Study||10||
48403471|NCT00838383|101317907|FG002|COMPLETED|Overall Study||10||
48403472|NCT00838383|101317905|FG000|NOT COMPLETED|Overall Study||0||
48403473|NCT00838383|101317906|FG001|NOT COMPLETED|Overall Study||0||
48403474|NCT00838383|101317907|FG002|NOT COMPLETED|Overall Study||0||
48403475|NCT00756093|101321611|FG000|STARTED|First Intervention||5||
48403476|NCT00756093|101321612|FG001|STARTED|First Intervention||5||
48403477|NCT00756093|101321613|FG002|STARTED|First Intervention||5||
48403478|NCT00756093|101321614|FG003|STARTED|First Intervention||5||
48403479|NCT00756093|101321611|FG000|COMPLETED|First Intervention||5||
48403480|NCT00756093|101321612|FG001|COMPLETED|First Intervention||5||
48403481|NCT00756093|101321613|FG002|COMPLETED|First Intervention||5||
48403482|NCT00756093|101321614|FG003|COMPLETED|First Intervention||5||
48403483|NCT00756093|101321611|FG000|NOT COMPLETED|First Intervention||0||
48403484|NCT00756093|101321612|FG001|NOT COMPLETED|First Intervention||0||
48403485|NCT00756093|101321613|FG002|NOT COMPLETED|First Intervention||0||
48403486|NCT00756093|101321614|FG003|NOT COMPLETED|First Intervention||0||
48403487|NCT00756093|101321611|FG000|STARTED|Second Intervention||5||
48403488|NCT00756093|101321612|FG001|STARTED|Second Intervention||5||
48403489|NCT00756093|101321613|FG002|STARTED|Second Intervention||5||
48403490|NCT00756093|101321614|FG003|STARTED|Second Intervention||5||
48403491|NCT00756093|101321611|FG000|COMPLETED|Second Intervention||5||
48403492|NCT00756093|101321612|FG001|COMPLETED|Second Intervention||5||
48403493|NCT00756093|101321613|FG002|COMPLETED|Second Intervention||5||
48403494|NCT00756093|101321614|FG003|COMPLETED|Second Intervention||5||
48403495|NCT00756093|101321611|FG000|NOT COMPLETED|Second Intervention||0||
48403496|NCT00756093|101321612|FG001|NOT COMPLETED|Second Intervention||0||
48403497|NCT00756093|101321613|FG002|NOT COMPLETED|Second Intervention||0||
48403498|NCT00756093|101321614|FG003|NOT COMPLETED|Second Intervention||0||
48403499|NCT00756093|101321611|FG000|STARTED|Third Intervention||5||
48403500|NCT00756093|101321612|FG001|STARTED|Third Intervention||5||
48403501|NCT00756093|101321613|FG002|STARTED|Third Intervention||5||
48403502|NCT00756093|101321614|FG003|STARTED|Third Intervention||5||
48403503|NCT00756093|101321611|FG000|COMPLETED|Third Intervention||5||
48403504|NCT00756093|101321612|FG001|COMPLETED|Third Intervention||5||
48403505|NCT00756093|101321613|FG002|COMPLETED|Third Intervention||5||
48403506|NCT00756093|101321614|FG003|COMPLETED|Third Intervention||5||
48403507|NCT00756093|101321611|FG000|NOT COMPLETED|Third Intervention||0||
48403508|NCT00756093|101321612|FG001|NOT COMPLETED|Third Intervention||0||
48403509|NCT00756093|101321613|FG002|NOT COMPLETED|Third Intervention||0||
48403510|NCT00756093|101321614|FG003|NOT COMPLETED|Third Intervention||0||
48403511|NCT00756093|101321611|FG000|STARTED|Fourth Intervention||5||
48403512|NCT00756093|101321612|FG001|STARTED|Fourth Intervention||5||
48403513|NCT00756093|101321613|FG002|STARTED|Fourth Intervention||5||
48403514|NCT00756093|101321614|FG003|STARTED|Fourth Intervention||5||
48403515|NCT00756093|101321611|FG000|COMPLETED|Fourth Intervention||5||
48403516|NCT00756093|101321612|FG001|COMPLETED|Fourth Intervention||5||
48403517|NCT00756093|101321613|FG002|COMPLETED|Fourth Intervention||5||
48403518|NCT00756093|101321614|FG003|COMPLETED|Fourth Intervention||5||
48403519|NCT00756093|101321611|FG000|NOT COMPLETED|Fourth Intervention||0||
48709237|NCT01286987|102077746|FG013|Treated|Part 2: Dose Expansion||23||
48403520|NCT00756093|101321612|FG001|NOT COMPLETED|Fourth Intervention||0||
48403521|NCT00756093|101321613|FG002|NOT COMPLETED|Fourth Intervention||0||
48709238|NCT01286987|102077747|FG014|Treated|Part 2: Dose Expansion||3||
48709239|NCT01286987|102077733|FG000|COMPLETED|Part 2: Dose Expansion||0||
48403522|NCT00756093|101321614|FG003|NOT COMPLETED|Fourth Intervention||0||
48403523|NCT00369746|101321615|FG000|STARTED|Overall Study||138||
48403524|NCT00369746|101321616|FG001|STARTED|Overall Study||536||
48403525|NCT00369746|101321615|FG000|COMPLETED|Overall Study||138||
48403526|NCT00369746|101321616|FG001|COMPLETED|Overall Study||536||
48709240|NCT01286987|102077734|FG001|COMPLETED|Part 2: Dose Expansion||0||
48293058|NCT01190514|101044463|FG002|NOT COMPLETED|First Intervention (Period 1)||0||
48293059|NCT01190514|101044464|FG003|NOT COMPLETED|First Intervention (Period 1)||0||
48293060|NCT01190514|101044461|FG000|STARTED|Second Intervention (Period 2)||10||
48293061|NCT01190514|101044462|FG001|STARTED|Second Intervention (Period 2)||10||
48293062|NCT01190514|101044463|FG002|STARTED|Second Intervention (Period 2)||10||
48293063|NCT01190514|101044464|FG003|STARTED|Second Intervention (Period 2)||10||
48293064|NCT01190514|101044461|FG000|COMPLETED|Second Intervention (Period 2)||10||
48293065|NCT01190514|101044462|FG001|COMPLETED|Second Intervention (Period 2)||10||
48293066|NCT01190514|101044463|FG002|COMPLETED|Second Intervention (Period 2)||10||
48293067|NCT01190514|101044464|FG003|COMPLETED|Second Intervention (Period 2)||10||
48293068|NCT01190514|101044461|FG000|NOT COMPLETED|Second Intervention (Period 2)||0||
48293069|NCT01190514|101044462|FG001|NOT COMPLETED|Second Intervention (Period 2)||0||
48293070|NCT01190514|101044463|FG002|NOT COMPLETED|Second Intervention (Period 2)||0||
48293071|NCT01190514|101044464|FG003|NOT COMPLETED|Second Intervention (Period 2)||0||
48293072|NCT01190514|101044461|FG000|STARTED|Third Intervention (Period 3)||10||
48293073|NCT01190514|101044462|FG001|STARTED|Third Intervention (Period 3)||10||
48293074|NCT01190514|101044463|FG002|STARTED|Third Intervention (Period 3)||10||
48293075|NCT01190514|101044464|FG003|STARTED|Third Intervention (Period 3)||10||
48293076|NCT01190514|101044461|FG000|COMPLETED|Third Intervention (Period 3)||9||
48293077|NCT01190514|101044462|FG001|COMPLETED|Third Intervention (Period 3)||10||
48293078|NCT01190514|101044463|FG002|COMPLETED|Third Intervention (Period 3)||10||
48293079|NCT01190514|101044464|FG003|COMPLETED|Third Intervention (Period 3)||10||
48293080|NCT01190514|101044461|FG000|NOT COMPLETED|Third Intervention (Period 3)||1||
48293081|NCT01190514|101044462|FG001|NOT COMPLETED|Third Intervention (Period 3)||0||
48293082|NCT01190514|101044463|FG002|NOT COMPLETED|Third Intervention (Period 3)||0||
48293083|NCT01190514|101044464|FG003|NOT COMPLETED|Third Intervention (Period 3)||0||
48293084|NCT01190514|101044461|FG000|STARTED|Fourth Intervention (Period 4)||9||
48293085|NCT01190514|101044462|FG001|STARTED|Fourth Intervention (Period 4)||10||
48293086|NCT01190514|101044463|FG002|STARTED|Fourth Intervention (Period 4)||10||
48293087|NCT01190514|101044464|FG003|STARTED|Fourth Intervention (Period 4)||10||
48293088|NCT01190514|101044461|FG000|COMPLETED|Fourth Intervention (Period 4)||9||
48293089|NCT01190514|101044462|FG001|COMPLETED|Fourth Intervention (Period 4)||10||
48293090|NCT01190514|101044463|FG002|COMPLETED|Fourth Intervention (Period 4)||10||
48293091|NCT01190514|101044464|FG003|COMPLETED|Fourth Intervention (Period 4)||10||
48293092|NCT01190514|101044461|FG000|NOT COMPLETED|Fourth Intervention (Period 4)||0||
48403527|NCT00369746|101321615|FG000|NOT COMPLETED|Overall Study||0||
48403528|NCT00369746|101321616|FG001|NOT COMPLETED|Overall Study||0||
48403529|NCT03441594|101321617|FG000|STARTED|Overall Study||56||
48403530|NCT03441594|101321617|FG000|COMPLETED|Overall Study||56||
48403531|NCT03441594|101321617|FG000|NOT COMPLETED|Overall Study||0||
48403532|NCT02959970|101321618|FG000|STARTED|Overall Study||17||
48403533|NCT02959970|101321619|FG001|STARTED|Overall Study||83||
48403534|NCT02959970|101321618|FG000|COMPLETED|Overall Study||15||
48403535|NCT02959970|101321619|FG001|COMPLETED|Overall Study||76||
48403536|NCT02959970|101321618|FG000|NOT COMPLETED|Overall Study||2||
48590799|NCT01588457|101779782|FG000|STARTED|Randomization 2||21|Some subjects completed at the end of Randomization 1 and did not progress to randomization 2|
48590800|NCT01588457|101779783|FG001|STARTED|Randomization 2||31|Some subjects completed at the end of Randomization 1 and did not progress to randomization 2|
48590801|NCT01588457|101779784|FG002|STARTED|Randomization 2||17|Some subjects completed at the end of Randomization 1 and did not progress to randomization 2|
48590802|NCT01588457|101779785|FG003|STARTED|Randomization 2||18|Some subjects completed at the end of Randomization 1 and did not progress to randomization 2|
48590803|NCT01588457|101779782|FG000|COMPLETED|Randomization 2||1||
48403537|NCT02959970|101321619|FG001|NOT COMPLETED|Overall Study||7||
48403538|NCT03338036|101321620|FG000|STARTED|Overall Study||0||
48403539|NCT03338036|101321621|FG001|STARTED|Overall Study||11||
48403540|NCT03338036|101321622|FG002|STARTED|Overall Study||12||
48403541|NCT03338036|101321623|FG003|STARTED|Overall Study||8||
48403542|NCT03338036|101321620|FG000|COMPLETED|Overall Study||0||
48403543|NCT03338036|101321621|FG001|COMPLETED|Overall Study||7||
48403544|NCT03338036|101321622|FG002|COMPLETED|Overall Study||9||
48403545|NCT03338036|101321623|FG003|COMPLETED|Overall Study||8||
48403546|NCT03338036|101321620|FG000|NOT COMPLETED|Overall Study||0||
48403547|NCT03338036|101321621|FG001|NOT COMPLETED|Overall Study||4||
48403548|NCT03338036|101321622|FG002|NOT COMPLETED|Overall Study||3||
48403549|NCT03338036|101321623|FG003|NOT COMPLETED|Overall Study||0||
48403550|NCT01689324|101321624|FG000|STARTED|Overall Study||43||
48403551|NCT01689324|101321624|FG000|COMPLETED|Overall Study||43||
48403552|NCT01689324|101321624|FG000|NOT COMPLETED|Overall Study||0||
48590804|NCT01588457|101779783|FG001|COMPLETED|Randomization 2||3||
48403553|NCT04445051|101321625|FG000|STARTED|Overall Study||5||
48403554|NCT04445051|101321626|FG001|STARTED|Overall Study||4||
48403555|NCT04445051|101321627|FG002|STARTED|Overall Study||5||
48403556|NCT04445051|101321628|FG003|STARTED|Overall Study||6||
48403557|NCT04445051|101321629|FG004|STARTED|Overall Study||5||
48403558|NCT04445051|101321630|FG005|STARTED|Overall Study||5||
48403559|NCT04445051|101321625|FG000|COMPLETED|Overall Study||5||
48140555|NCT02167074|100670205|FG001|STARTED|Overall Study||302||
48140556|NCT02167074|100670204|FG000|COMPLETED|Overall Study||306||
48140557|NCT02167074|100670205|FG001|COMPLETED|Overall Study||302||
48140558|NCT02167074|100670204|FG000|NOT COMPLETED|Overall Study||0||
48140559|NCT02167074|100670205|FG001|NOT COMPLETED|Overall Study||0||
48140560|NCT00700401|100670206|FG000|STARTED|Overall Study||262||
48140561|NCT00700401|100670206|FG000|COMPLETED|Overall Study||168||
48140562|NCT00700401|100670206|FG000|NOT COMPLETED|Overall Study||94||
48140563|NCT00113568|100670207|FG000|STARTED|Overall Study||784||
48140564|NCT00113568|100670207|FG000|Intent to Treat Population|Overall Study||723||
48140565|NCT00113568|100670207|FG000|COMPLETED|Overall Study||239||
48140566|NCT00113568|100670207|FG000|NOT COMPLETED|Overall Study||545||
48140567|NCT02239679|100670208|FG000|STARTED|Overall Study||53||
48140568|NCT02239679|100670209|FG001|STARTED|Overall Study||59||
48140569|NCT02239679|100670210|FG002|STARTED|Overall Study||54||
48590805|NCT01588457|101779784|FG002|COMPLETED|Randomization 2||12||
48709241|NCT01286987|102077735|FG002|COMPLETED|Part 2: Dose Expansion||0||
48709242|NCT01286987|102077736|FG003|COMPLETED|Part 2: Dose Expansion||0||
48709243|NCT01286987|102077737|FG004|COMPLETED|Part 2: Dose Expansion||0||
48590806|NCT01588457|101779785|FG003|COMPLETED|Randomization 2||13||
48590807|NCT01588457|101779782|FG000|NOT COMPLETED|Randomization 2||20||
48590808|NCT01588457|101779783|FG001|NOT COMPLETED|Randomization 2||28||
48590809|NCT01588457|101779784|FG002|NOT COMPLETED|Randomization 2||5||
48590810|NCT01588457|101779785|FG003|NOT COMPLETED|Randomization 2||5||
48590811|NCT05168878|101779786|FG000|STARTED|Overall Study||95||
48590812|NCT05168878|101779787|FG001|STARTED|Overall Study||62||
48590813|NCT05168878|101779788|FG002|STARTED|Overall Study||127||
48590814|NCT05168878|101779789|FG003|STARTED|Overall Study||123||
48590815|NCT05168878|101779786|FG000|COMPLETED|Overall Study||51||
48590816|NCT05168878|101779787|FG001|COMPLETED|Overall Study||23||
48590817|NCT05168878|101779788|FG002|COMPLETED|Overall Study||45||
48590818|NCT05168878|101779789|FG003|COMPLETED|Overall Study||46||
48590819|NCT05168878|101779786|FG000|NOT COMPLETED|Overall Study||44||
48590820|NCT05168878|101779787|FG001|NOT COMPLETED|Overall Study||39||
48590821|NCT05168878|101779788|FG002|NOT COMPLETED|Overall Study||82||
48709244|NCT01286987|102077738|FG005|COMPLETED|Part 2: Dose Expansion||0||
48709245|NCT01286987|102077739|FG006|COMPLETED|Part 2: Dose Expansion||0||
48709246|NCT01286987|102077740|FG007|COMPLETED|Part 2: Dose Expansion||0||
48709247|NCT01286987|102077741|FG008|COMPLETED|Part 2: Dose Expansion||0||
48709248|NCT01286987|102077742|FG009|COMPLETED|Part 2: Dose Expansion||1||
48709249|NCT01286987|102077743|FG010|COMPLETED|Part 2: Dose Expansion||2||
48709250|NCT01286987|102077744|FG011|COMPLETED|Part 2: Dose Expansion||1||
48709251|NCT01286987|102077745|FG012|COMPLETED|Part 2: Dose Expansion||0||
48709252|NCT01286987|102077746|FG013|COMPLETED|Part 2: Dose Expansion||0||
48709253|NCT01286987|102077747|FG014|COMPLETED|Part 2: Dose Expansion||1||
48709254|NCT01286987|102077733|FG000|NOT COMPLETED|Part 2: Dose Expansion||0||
48709255|NCT01286987|102077734|FG001|NOT COMPLETED|Part 2: Dose Expansion||0||
48709256|NCT01286987|102077735|FG002|NOT COMPLETED|Part 2: Dose Expansion||0||
48709257|NCT01286987|102077736|FG003|NOT COMPLETED|Part 2: Dose Expansion||0||
48709258|NCT01286987|102077737|FG004|NOT COMPLETED|Part 2: Dose Expansion||0||
48709259|NCT01286987|102077738|FG005|NOT COMPLETED|Part 2: Dose Expansion||0||
48709260|NCT01286987|102077739|FG006|NOT COMPLETED|Part 2: Dose Expansion||0||
48709261|NCT01286987|102077740|FG007|NOT COMPLETED|Part 2: Dose Expansion||0||
48709262|NCT01286987|102077741|FG008|NOT COMPLETED|Part 2: Dose Expansion||0||
48709263|NCT01286987|102077742|FG009|NOT COMPLETED|Part 2: Dose Expansion||11||
48709264|NCT01286987|102077743|FG010|NOT COMPLETED|Part 2: Dose Expansion||10||
48709265|NCT01286987|102077744|FG011|NOT COMPLETED|Part 2: Dose Expansion||10||
48590822|NCT05168878|101779789|FG003|NOT COMPLETED|Overall Study||77||
48590823|NCT03506568|101779790|FG000|STARTED|Stage 1||0||
48590824|NCT03506568|101779791|FG001|STARTED|Stage 1||0||
48590825|NCT03506568|101779792|FG002|STARTED|Stage 1||50||
48590826|NCT03506568|101779790|FG000|COMPLETED|Stage 1||0||
48590827|NCT03506568|101779791|FG001|COMPLETED|Stage 1||0||
48590828|NCT03506568|101779792|FG002|COMPLETED|Stage 1||5||
48709266|NCT01286987|102077745|FG012|NOT COMPLETED|Part 2: Dose Expansion||12||
48709267|NCT01286987|102077746|FG013|NOT COMPLETED|Part 2: Dose Expansion||24||
48709268|NCT01286987|102077747|FG014|NOT COMPLETED|Part 2: Dose Expansion||2||
48709269|NCT03552536|102077748|FG000|STARTED|Overall Study||5||
48709270|NCT03552536|102077749|FG001|STARTED|Overall Study||0||
48709271|NCT03552536|102077750|FG002|STARTED|Overall Study||0||
48709272|NCT03552536|102077748|FG000|COMPLETED|Overall Study||5||
48709273|NCT03552536|102077749|FG001|COMPLETED|Overall Study||0||
48709274|NCT03552536|102077750|FG002|COMPLETED|Overall Study||0||
48140570|NCT02239679|100670208|FG000|COMPLETED|Overall Study||50||
48140571|NCT02239679|100670209|FG001|COMPLETED|Overall Study||56||
48140572|NCT02239679|100670210|FG002|COMPLETED|Overall Study||53||
48140573|NCT02239679|100670208|FG000|NOT COMPLETED|Overall Study||3||
48140574|NCT02239679|100670209|FG001|NOT COMPLETED|Overall Study||3||
48140575|NCT02239679|100670210|FG002|NOT COMPLETED|Overall Study||1||
48140576|NCT03057795|100670211|FG000|STARTED|Overall Study||59||
48140577|NCT03057795|100670211|FG000|COMPLETED|Overall Study||59||
48590829|NCT03506568|101779790|FG000|NOT COMPLETED|Stage 1||0||
48590830|NCT03506568|101779791|FG001|NOT COMPLETED|Stage 1||0||
48293093|NCT01190514|101044462|FG001|NOT COMPLETED|Fourth Intervention (Period 4)||0||
48293094|NCT01190514|101044463|FG002|NOT COMPLETED|Fourth Intervention (Period 4)||0||
48293095|NCT01190514|101044464|FG003|NOT COMPLETED|Fourth Intervention (Period 4)||0||
48293096|NCT00448123|101044465|FG000|STARTED|Overall Study||62||
48293097|NCT00448123|101044466|FG001|STARTED|Overall Study||65||
48293098|NCT00448123|101044465|FG000|COMPLETED|Overall Study||47||
48293099|NCT00448123|101044466|FG001|COMPLETED|Overall Study||53||
48293100|NCT00448123|101044465|FG000|NOT COMPLETED|Overall Study||15||
48293101|NCT00448123|101044466|FG001|NOT COMPLETED|Overall Study||12||
48293102|NCT00690820|101044467|FG000|STARTED|Period 1||8||
48293103|NCT00690820|101044468|FG001|STARTED|Period 1||9||
48293104|NCT00690820|101044467|FG000|COMPLETED|Period 1||8||
48293105|NCT00690820|101044468|FG001|COMPLETED|Period 1||8||
48293106|NCT00690820|101044467|FG000|NOT COMPLETED|Period 1||0||
48293107|NCT00690820|101044468|FG001|NOT COMPLETED|Period 1||1||
48590831|NCT03506568|101779792|FG002|NOT COMPLETED|Stage 1||45||
48590832|NCT03506568|101779790|FG000|STARTED|Stage 2||2||
48590833|NCT03506568|101779791|FG001|STARTED|Stage 2||3||
48590834|NCT03506568|101779792|FG002|STARTED|Stage 2||0||
48590835|NCT03506568|101779790|FG000|COMPLETED|Stage 2||1||
48293108|NCT00690820|101044467|FG000|STARTED|Period 2||8||
48293109|NCT00690820|101044468|FG001|STARTED|Period 2||8||
48293110|NCT00690820|101044467|FG000|COMPLETED|Period 2||8||
48293111|NCT00690820|101044468|FG001|COMPLETED|Period 2||8||
48293112|NCT00690820|101044467|FG000|NOT COMPLETED|Period 2||0||
48590836|NCT03506568|101779791|FG001|COMPLETED|Stage 2||2||
48590837|NCT03506568|101779792|FG002|COMPLETED|Stage 2||0||
48590838|NCT03506568|101779790|FG000|NOT COMPLETED|Stage 2||1||
48590839|NCT03506568|101779791|FG001|NOT COMPLETED|Stage 2||1||
48590840|NCT03506568|101779792|FG002|NOT COMPLETED|Stage 2||0||
48590841|NCT03435224|101779793|FG000|STARTED|Overall Study||29||
48590842|NCT03435224|101779793|FG000|COMPLETED|Overall Study||25||
48590843|NCT03435224|101779793|FG000|NOT COMPLETED|Overall Study||4||
48590844|NCT00082017|101779794|FG000|STARTED|Overall Study||11||
48293113|NCT00690820|101044468|FG001|NOT COMPLETED|Period 2||0||
48293114|NCT02697292|101044469|FG000|STARTED|Overall Study||9||
48293115|NCT02697292|101044470|FG001|STARTED|Overall Study||8||
48293116|NCT02697292|101044469|FG000|COMPLETED|Overall Study||9||
48293117|NCT02697292|101044470|FG001|COMPLETED|Overall Study||8||
48293118|NCT02697292|101044469|FG000|NOT COMPLETED|Overall Study||0||
48590845|NCT00082017|101779795|FG001|STARTED|Overall Study||9||
48590846|NCT00082017|101779794|FG000|COMPLETED|Overall Study||11||
48590847|NCT00082017|101779795|FG001|COMPLETED|Overall Study||9||
48590848|NCT00082017|101779794|FG000|NOT COMPLETED|Overall Study||0||
48590849|NCT00082017|101779795|FG001|NOT COMPLETED|Overall Study||0||
48590850|NCT01279070|101779796|FG000|STARTED|Overall Study||34||
48590851|NCT01279070|101779797|FG001|STARTED|Overall Study||28||
48590852|NCT01279070|101779796|FG000|COMPLETED|Overall Study||29||
48590853|NCT01279070|101779797|FG001|COMPLETED|Overall Study||24||
48590854|NCT01279070|101779796|FG000|NOT COMPLETED|Overall Study||5||
48590855|NCT01279070|101779797|FG001|NOT COMPLETED|Overall Study||4||
48293119|NCT02697292|101044470|FG001|NOT COMPLETED|Overall Study||0||
48293120|NCT01324440|101044471|FG000|STARTED|Overall Study||32||
48590856|NCT01470781|101779798|FG000|STARTED|Overall Study||39||
48590857|NCT01470781|101779799|FG001|STARTED|Overall Study||33||
48590858|NCT01470781|101779798|FG000|Midpoint Assessment|Overall Study||30||
48590859|NCT01470781|101779799|FG001|Midpoint Assessment|Overall Study||30||
48293121|NCT01324440|101044472|FG001|STARTED|Overall Study||32||
48293122|NCT01324440|101044471|FG000|COMPLETED|Overall Study||32||
48293123|NCT01324440|101044472|FG001|COMPLETED|Overall Study||31||
48293124|NCT01324440|101044471|FG000|NOT COMPLETED|Overall Study||0||
48293125|NCT01324440|101044472|FG001|NOT COMPLETED|Overall Study||1||
48293126|NCT00007345|101044473|FG000|STARTED|Overall Study||47||
48293127|NCT00007345|101044474|FG001|STARTED|Overall Study||84||
48293128|NCT00007345|101044473|FG000|COMPLETED|Overall Study||45||
48293129|NCT00007345|101044474|FG001|COMPLETED|Overall Study||73||
48590860|NCT01470781|101779798|FG000|Post-Treatment Assessment|Overall Study||22||
48590861|NCT01470781|101779799|FG001|Post-Treatment Assessment|Overall Study||23||
48590862|NCT01470781|101779798|FG000|COMPLETED|Overall Study||21||
48590863|NCT01470781|101779799|FG001|COMPLETED|Overall Study||21||
48590864|NCT01470781|101779798|FG000|NOT COMPLETED|Overall Study||18||
48590865|NCT01470781|101779799|FG001|NOT COMPLETED|Overall Study||12||
48590866|NCT04250350|101779800|FG000|STARTED|Overall Study||206||
48590867|NCT04250350|101779800|FG000|COMPLETED|Overall Study||172||
48590868|NCT04250350|101779800|FG000|NOT COMPLETED|Overall Study||34||
48590869|NCT00373958|101779801|FG000|STARTED|Infant Series||334||
48590870|NCT00373958|101779802|FG001|STARTED|Infant Series||332||
48590871|NCT00373958|101779801|FG000|Vaccinated Dose 1|Infant Series||332||
48590872|NCT00373958|101779802|FG001|Vaccinated Dose 1|Infant Series||331||
48590873|NCT00373958|101779801|FG000|Vaccinated Dose 2|Infant Series||309||
48590874|NCT00373958|101779802|FG001|Vaccinated Dose 2|Infant Series||305||
48590875|NCT00373958|101779801|FG000|Vaccinated Dose 3|Infant Series||298||
48590876|NCT00373958|101779802|FG001|Vaccinated Dose 3|Infant Series||300||
48590877|NCT00373958|101779801|FG000|COMPLETED|Infant Series||294||
48590878|NCT00373958|101779802|FG001|COMPLETED|Infant Series||290||
48590879|NCT00373958|101779801|FG000|NOT COMPLETED|Infant Series||40||
48590880|NCT00373958|101779802|FG001|NOT COMPLETED|Infant Series||42||
48590881|NCT00373958|101779801|FG000|STARTED|Toddler Dose||294||
48590882|NCT00373958|101779802|FG001|STARTED|Toddler Dose||290||
48293130|NCT00007345|101044473|FG000|NOT COMPLETED|Overall Study||2||
48293131|NCT00007345|101044474|FG001|NOT COMPLETED|Overall Study||11||
48293132|NCT03554954|101044475|FG000|STARTED|Overall Study||108||
48293133|NCT03554954|101044475|FG000|COMPLETED|Overall Study||108||
48293134|NCT03554954|101044475|FG000|NOT COMPLETED|Overall Study||0||
48293135|NCT01959516|101044476|FG000|STARTED|Epoch 1||63||
48293136|NCT01959516|101044477|FG001|STARTED|Epoch 1||63||
48293137|NCT01959516|101044476|FG000|Safety Population|Epoch 1||62||
48293138|NCT01959516|101044477|FG001|Safety Population|Epoch 1||62||
48293139|NCT01959516|101044476|FG000|ITT Population|Epoch 1||62||
48293140|NCT01959516|101044477|FG001|ITT Population|Epoch 1||62||
48293141|NCT01959516|101044476|FG000|COMPLETED|Epoch 1||53||
48293142|NCT01959516|101044477|FG001|COMPLETED|Epoch 1||58||
48590883|NCT00373958|101779801|FG000|Withdrawn After Infant Series|Toddler Dose||22||
48590884|NCT00373958|101779802|FG001|Withdrawn After Infant Series|Toddler Dose||25||
48590885|NCT00373958|101779801|FG000|Vaccinated Toddler Dose|Toddler Dose||272||
48590886|NCT00373958|101779802|FG001|Vaccinated Toddler Dose|Toddler Dose||265||
48590887|NCT00373958|101779801|FG000|COMPLETED|Toddler Dose||264||
48590888|NCT00373958|101779802|FG001|COMPLETED|Toddler Dose||252||
48590889|NCT00373958|101779801|FG000|NOT COMPLETED|Toddler Dose||30||
48590890|NCT00373958|101779802|FG001|NOT COMPLETED|Toddler Dose||38||
48590891|NCT01650545|101779803|FG000|STARTED|Overall Study||11||
48590892|NCT01650545|101779804|FG001|STARTED|Overall Study||10||
48590893|NCT01650545|101779803|FG000|COMPLETED|Overall Study||11||
48590894|NCT01650545|101779804|FG001|COMPLETED|Overall Study||10||
48293143|NCT01959516|101044476|FG000|NOT COMPLETED|Epoch 1||10||
48293144|NCT01959516|101044477|FG001|NOT COMPLETED|Epoch 1||5||
48293145|NCT01959516|101044476|FG000|STARTED|Epoch 2||63||
48293146|NCT01959516|101044477|FG001|STARTED|Epoch 2||63||
48293147|NCT01959516|101044476|FG000|COMPLETED|Epoch 2||61||
48293148|NCT01959516|101044477|FG001|COMPLETED|Epoch 2||62||
48293149|NCT01959516|101044476|FG000|NOT COMPLETED|Epoch 2||2||
48293150|NCT01959516|101044477|FG001|NOT COMPLETED|Epoch 2||1||
48293151|NCT00406653|101044478|FG000|STARTED|Induction Period||65||
48293152|NCT00406653|101044479|FG001|STARTED|Induction Period||128||
48293153|NCT00406653|101044480|FG002|STARTED|Induction Period||130||
48590895|NCT01650545|101779803|FG000|NOT COMPLETED|Overall Study||0||
48590896|NCT01650545|101779804|FG001|NOT COMPLETED|Overall Study||0||
48590897|NCT01871402|101779805|FG000|STARTED|Overall Study||110||
48590898|NCT01871402|101779806|FG001|STARTED|Overall Study||111||
48590899|NCT01871402|101779805|FG000|COMPLETED|Overall Study||109||
48590900|NCT01871402|101779806|FG001|COMPLETED|Overall Study||108||
48590901|NCT01871402|101779805|FG000|NOT COMPLETED|Overall Study||1||
48590902|NCT01871402|101779806|FG001|NOT COMPLETED|Overall Study||3||
48590903|NCT01482962|101779807|FG000|STARTED|Overall Study||138||
48590904|NCT01482962|101779808|FG001|STARTED|Overall Study||133||
48590905|NCT01482962|101779807|FG000|Safety Population: Received Study Drug|Overall Study||137||
48590906|NCT01482962|101779808|FG001|Safety Population: Received Study Drug|Overall Study||127||
48590907|NCT01482962|101779807|FG000|COMPLETED|Overall Study||0||
48590908|NCT01482962|101779808|FG001|COMPLETED|Overall Study||0||
48590909|NCT01482962|101779807|FG000|NOT COMPLETED|Overall Study||138||
48590910|NCT01482962|101779808|FG001|NOT COMPLETED|Overall Study||133||
48590911|NCT00003910|101779809|FG000|STARTED|Step 1||55||
48590912|NCT00003910|101779810|FG001|STARTED|Step 1||0||
48590913|NCT00003910|101779809|FG000|COMPLETED|Step 1||55||
48590914|NCT00003910|101779810|FG001|COMPLETED|Step 1||0||
48590915|NCT00003910|101779809|FG000|NOT COMPLETED|Step 1||0||
48590916|NCT00003910|101779810|FG001|NOT COMPLETED|Step 1||0||
48590917|NCT00003910|101779809|FG000|STARTED|Step 2||0||
48590918|NCT00003910|101779810|FG001|STARTED|Step 2||16||
48590919|NCT00003910|101779809|FG000|COMPLETED|Step 2||0||
48590920|NCT00003910|101779810|FG001|COMPLETED|Step 2||16||
48590921|NCT00003910|101779809|FG000|NOT COMPLETED|Step 2||0||
48590922|NCT00003910|101779810|FG001|NOT COMPLETED|Step 2||0||
48590923|NCT03796442|101779811|FG000|STARTED|Overall Study||70||
48590924|NCT03796442|101779812|FG001|STARTED|Overall Study||70||
48590925|NCT03796442|101779811|FG000|COMPLETED|Overall Study||66||
48590926|NCT03796442|101779812|FG001|COMPLETED|Overall Study||63||
48590927|NCT03796442|101779811|FG000|NOT COMPLETED|Overall Study||4||
48590928|NCT03796442|101779812|FG001|NOT COMPLETED|Overall Study||7||
48590929|NCT03419598|101779813|FG000|STARTED|Overall Study||30|Since this is a virtual trial, the virtual patients were duplicated and enrolled into both arms|
48590930|NCT03419598|101779813|FG000|Subject Specific Tibia Models Created and Virtual Osteotomy Performed|Overall Study||28||
48293154|NCT00406653|101044481|FG003|STARTED|Induction Period||128||
48293155|NCT00406653|101044482|FG004|STARTED|Induction Period||0||
48293156|NCT00406653|101044483|FG005|STARTED|Induction Period||0||
48293157|NCT00406653|101044484|FG006|STARTED|Induction Period||0||
48590931|NCT03419598|101779813|FG000|Virtual Cohort Duplicated Into A. Personalised and B. Generic Copies|Overall Study||28||
48590932|NCT03419598|101779813|FG000|Finite Element (FE) Model Created for Cohort Copy Stabilised by Personalised HTO Plate|Overall Study||28||
48590933|NCT03419598|101779813|FG000|FE Models Created for Cohort Copy Stabilised by Generic HTO Plate|Overall Study||28||
48590934|NCT03419598|101779813|FG000|FE Models Solved for Personalised HTO Plate Stabilised Cohort Copy|Overall Study||28||
48590935|NCT03419598|101779813|FG000|FE Models Solved for Generic HTO Plate Stabilised Cohort Copy|Overall Study||28||
48590936|NCT03419598|101779813|FG000|COMPLETED|Overall Study||28||
48590937|NCT03419598|101779813|FG000|NOT COMPLETED|Overall Study||2||
48590938|NCT01573767|101779814|FG000|STARTED|Overall Study||115||
48590939|NCT01573767|101779815|FG001|STARTED|Overall Study||114||
48590940|NCT01573767|101779816|FG002|STARTED|Overall Study||113||
48590941|NCT01573767|101779817|FG003|STARTED|Overall Study||114||
48590942|NCT01573767|101779814|FG000|COMPLETED|Overall Study||93||
48590943|NCT01573767|101779815|FG001|COMPLETED|Overall Study||93||
48590944|NCT01573767|101779816|FG002|COMPLETED|Overall Study||99||
48590945|NCT01573767|101779817|FG003|COMPLETED|Overall Study||90||
48590946|NCT01573767|101779814|FG000|NOT COMPLETED|Overall Study||22||
48590947|NCT01573767|101779815|FG001|NOT COMPLETED|Overall Study||21||
48140578|NCT03057795|100670211|FG000|NOT COMPLETED|Overall Study||0||
48140579|NCT01128413|100670212|FG000|STARTED|Overall Study||11||
48140580|NCT01128413|100670213|FG001|STARTED|Overall Study||11||
48590948|NCT01573767|101779816|FG002|NOT COMPLETED|Overall Study||14||
48590949|NCT01573767|101779817|FG003|NOT COMPLETED|Overall Study||24||
48590950|NCT03794661|101779818|FG000|STARTED|Overall Study||8||
48590951|NCT03794661|101779818|FG000|COMPLETED|Overall Study||8||
48590952|NCT03794661|101779818|FG000|NOT COMPLETED|Overall Study||0||
48590953|NCT02142361|101779819|FG000|STARTED|Overall Study||20||
48590954|NCT02142361|101779820|FG001|STARTED|Overall Study||20||
48590955|NCT02142361|101779821|FG002|STARTED|Overall Study||20||
48590956|NCT02142361|101779819|FG000|COMPLETED|Overall Study||20||
48590957|NCT02142361|101779820|FG001|COMPLETED|Overall Study||20||
48590958|NCT02142361|101779821|FG002|COMPLETED|Overall Study||20||
48590959|NCT02142361|101779819|FG000|NOT COMPLETED|Overall Study||0||
48590960|NCT02142361|101779820|FG001|NOT COMPLETED|Overall Study||0||
48140581|NCT01128413|100670212|FG000|COMPLETED|Overall Study||7||
48140582|NCT01128413|100670213|FG001|COMPLETED|Overall Study||10||
48140583|NCT01128413|100670212|FG000|NOT COMPLETED|Overall Study||4||
48590961|NCT02142361|101779821|FG002|NOT COMPLETED|Overall Study||0||
48590962|NCT00565916|101779822|FG000|STARTED|Overall Study||11||
48590963|NCT00565916|101779823|FG001|STARTED|Overall Study||11||
48590964|NCT00565916|101779822|FG000|COMPLETED|Overall Study||11||
48590965|NCT00565916|101779823|FG001|COMPLETED|Overall Study||11||
48590966|NCT00565916|101779822|FG000|NOT COMPLETED|Overall Study||0||
48590967|NCT00565916|101779823|FG001|NOT COMPLETED|Overall Study||0||
48590968|NCT03912818|101779824|FG000|STARTED|Overall Study||3||
48293158|NCT00406653|101044478|FG000|COMPLETED|Induction Period||50||
48293159|NCT00406653|101044479|FG001|COMPLETED|Induction Period||94||
48590969|NCT03912818|101779825|FG001|STARTED|Overall Study||0||
48590970|NCT03912818|101779826|FG002|STARTED|Overall Study||3||
48590971|NCT03912818|101779824|FG000|COMPLETED|Overall Study||3||
48590972|NCT03912818|101779825|FG001|COMPLETED|Overall Study||0||
48590973|NCT03912818|101779826|FG002|COMPLETED|Overall Study||3||
48590974|NCT03912818|101779824|FG000|NOT COMPLETED|Overall Study||0||
48293160|NCT00406653|101044480|FG002|COMPLETED|Induction Period||112||
48590975|NCT03912818|101779825|FG001|NOT COMPLETED|Overall Study||0||
48590976|NCT03912818|101779826|FG002|NOT COMPLETED|Overall Study||0||
48590977|NCT02044874|101779827|FG000|STARTED|Overall Study||201||
48590978|NCT02044874|101779828|FG001|STARTED|Overall Study||202||
48590979|NCT02044874|101779829|FG002|STARTED|Overall Study||200||
48590980|NCT02044874|101779827|FG000|COMPLETED|Overall Study||171||
48140584|NCT01128413|100670213|FG001|NOT COMPLETED|Overall Study||1||
48140585|NCT03819660|100670214|FG000|STARTED|Overall Study||13||
48140586|NCT03819660|100670214|FG000|COMPLETED|Overall Study||13||
48140587|NCT03819660|100670214|FG000|NOT COMPLETED|Overall Study||0||
48140588|NCT01298128|100670215|FG000|STARTED|Overall Study||35||
48140589|NCT01298128|100670216|FG001|STARTED|Overall Study||35||
48140590|NCT01298128|100670215|FG000|COMPLETED|Overall Study||26||
48590981|NCT02044874|101779828|FG001|COMPLETED|Overall Study||147||
48590982|NCT02044874|101779829|FG002|COMPLETED|Overall Study||140||
48590983|NCT02044874|101779827|FG000|NOT COMPLETED|Overall Study||30||
48590984|NCT02044874|101779828|FG001|NOT COMPLETED|Overall Study||55||
48709275|NCT03552536|102077748|FG000|NOT COMPLETED|Overall Study||0||
48709276|NCT03552536|102077749|FG001|NOT COMPLETED|Overall Study||0||
48709277|NCT03552536|102077750|FG002|NOT COMPLETED|Overall Study||0||
48709278|NCT04709484|102077751|FG000|STARTED|Overall Study||34||
48709279|NCT04709484|102077752|FG001|STARTED|Overall Study||32||
48709280|NCT04709484|102077751|FG000|COMPLETED|Overall Study||34||
48709281|NCT04709484|102077752|FG001|COMPLETED|Overall Study||32||
48709282|NCT04709484|102077751|FG000|NOT COMPLETED|Overall Study||0||
48709283|NCT04709484|102077752|FG001|NOT COMPLETED|Overall Study||0||
48709284|NCT01367704|102077753|FG000|STARTED|Overall Study||998||
48709285|NCT01367704|102077754|FG001|STARTED|Overall Study||1008||
48709286|NCT01367704|102077753|FG000|COMPLETED|Overall Study||951||
48709287|NCT01367704|102077754|FG001|COMPLETED|Overall Study||847||
48709288|NCT01367704|102077753|FG000|NOT COMPLETED|Overall Study||47||
48709289|NCT01367704|102077754|FG001|NOT COMPLETED|Overall Study||161||
48709290|NCT00858897|102077755|FG000|STARTED|First Intervention (1 Day)||4||
48709291|NCT00858897|102077756|FG001|STARTED|First Intervention (1 Day)||6||
48709292|NCT00858897|102077755|FG000|COMPLETED|First Intervention (1 Day)||4||
48709293|NCT00858897|102077756|FG001|COMPLETED|First Intervention (1 Day)||6||
48709294|NCT00858897|102077755|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48709295|NCT00858897|102077756|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48709296|NCT00858897|102077755|FG000|STARTED|Washout (~9 Days)||4||
48709297|NCT00858897|102077756|FG001|STARTED|Washout (~9 Days)||6||
48709298|NCT00858897|102077755|FG000|COMPLETED|Washout (~9 Days)||4||
48709299|NCT00858897|102077756|FG001|COMPLETED|Washout (~9 Days)||6||
48709300|NCT00858897|102077755|FG000|NOT COMPLETED|Washout (~9 Days)||0||
48709301|NCT00858897|102077756|FG001|NOT COMPLETED|Washout (~9 Days)||0||
48709302|NCT00858897|102077755|FG000|STARTED|2nd Intervention (1 Day)||4||
48709303|NCT00858897|102077756|FG001|STARTED|2nd Intervention (1 Day)||6||
48709304|NCT00858897|102077755|FG000|COMPLETED|2nd Intervention (1 Day)||4||
48709305|NCT00858897|102077756|FG001|COMPLETED|2nd Intervention (1 Day)||6||
48709306|NCT00858897|102077755|FG000|NOT COMPLETED|2nd Intervention (1 Day)||0||
48709307|NCT00858897|102077756|FG001|NOT COMPLETED|2nd Intervention (1 Day)||0||
48709308|NCT03095027|102077757|FG000|STARTED|Period 1, First Week of Wear||27|As Treated; 1 subject randomized to stenfilcon A/FID122819 exposed to FID122819/stenfilcon A instead|
48709309|NCT03095027|102077758|FG001|STARTED|Period 1, First Week of Wear||24|As Treated; 1 subject randomized to stenfilcon A/FID122819 exposed to FID122819/stenfilcon A instead|
48709310|NCT03095027|102077757|FG000|COMPLETED|Period 1, First Week of Wear||27||
48709311|NCT03095027|102077758|FG001|COMPLETED|Period 1, First Week of Wear||24||
48709312|NCT03095027|102077757|FG000|NOT COMPLETED|Period 1, First Week of Wear||0||
48140591|NCT01298128|100670216|FG001|COMPLETED|Overall Study||27||
48140592|NCT01298128|100670215|FG000|NOT COMPLETED|Overall Study||9||
48140593|NCT01298128|100670216|FG001|NOT COMPLETED|Overall Study||8||
48140594|NCT03555396|100670217|FG000|STARTED|Overall Study||64||
48140595|NCT03555396|100670218|FG001|STARTED|Overall Study||68||
48140596|NCT03555396|100670217|FG000|Index Case|Overall Study||32||
48140597|NCT03555396|100670218|FG001|Index Case|Overall Study||34||
48590985|NCT02044874|101779829|FG002|NOT COMPLETED|Overall Study||60||
48590986|NCT02267135|101779830|FG000|STARTED|Period 1 (Randomized Set)||51||
48590987|NCT02267135|101779831|FG001|STARTED|Period 1 (Randomized Set)||51||
48590988|NCT02267135|101779830|FG000|COMPLETED|Period 1 (Randomized Set)||50||
48590989|NCT02267135|101779831|FG001|COMPLETED|Period 1 (Randomized Set)||47||
48590990|NCT02267135|101779830|FG000|NOT COMPLETED|Period 1 (Randomized Set)||1||
48590991|NCT02267135|101779831|FG001|NOT COMPLETED|Period 1 (Randomized Set)||4||
48590992|NCT02267135|101779830|FG000|STARTED|Period 2 (Randomized Set)||50||
48590993|NCT02267135|101779831|FG001|STARTED|Period 2 (Randomized Set)||47||
48590994|NCT02267135|101779830|FG000|COMPLETED|Period 2 (Randomized Set)||46||
48709313|NCT03095027|102077758|FG001|NOT COMPLETED|Period 1, First Week of Wear||0||
48709314|NCT03095027|102077757|FG000|STARTED|Period 2, Second Week of Wear||27||
48709315|NCT03095027|102077758|FG001|STARTED|Period 2, Second Week of Wear||24||
48709316|NCT03095027|102077757|FG000|COMPLETED|Period 2, Second Week of Wear||26||
48709317|NCT03095027|102077758|FG001|COMPLETED|Period 2, Second Week of Wear||24||
48709318|NCT03095027|102077757|FG000|NOT COMPLETED|Period 2, Second Week of Wear||1||
48709319|NCT03095027|102077758|FG001|NOT COMPLETED|Period 2, Second Week of Wear||0||
48140598|NCT03555396|100670217|FG000|Treatment Support Partner|Overall Study||32||
48140599|NCT03555396|100670218|FG001|Treatment Support Partner|Overall Study||34||
48140600|NCT03555396|100670217|FG000|COMPLETED|Overall Study||61||
48140601|NCT03555396|100670218|FG001|COMPLETED|Overall Study||65||
48140602|NCT03555396|100670217|FG000|NOT COMPLETED|Overall Study||3||
48140603|NCT03555396|100670218|FG001|NOT COMPLETED|Overall Study||3||
48140604|NCT02300220|100670219|FG000|STARTED|Overall Study||72||
48140605|NCT02300220|100670220|FG001|STARTED|Overall Study||72||
48403560|NCT04445051|101321626|FG001|COMPLETED|Overall Study||4||
48403561|NCT04445051|101321627|FG002|COMPLETED|Overall Study||4||
48403562|NCT04445051|101321628|FG003|COMPLETED|Overall Study||6||
48403563|NCT04445051|101321629|FG004|COMPLETED|Overall Study||5||
48403564|NCT04445051|101321630|FG005|COMPLETED|Overall Study||5||
48403565|NCT04445051|101321625|FG000|NOT COMPLETED|Overall Study||0||
48403566|NCT04445051|101321626|FG001|NOT COMPLETED|Overall Study||0||
48403567|NCT04445051|101321627|FG002|NOT COMPLETED|Overall Study||1||
48140606|NCT02300220|100670219|FG000|COMPLETED|Overall Study||68||
48140607|NCT02300220|100670220|FG001|COMPLETED|Overall Study||65||
48140608|NCT02300220|100670219|FG000|NOT COMPLETED|Overall Study||4||
48140609|NCT02300220|100670220|FG001|NOT COMPLETED|Overall Study||7||
48140610|NCT03282227|100670221|FG000|STARTED|Overall Study||342||
48403568|NCT04445051|101321628|FG003|NOT COMPLETED|Overall Study||0||
48403569|NCT04445051|101321629|FG004|NOT COMPLETED|Overall Study||0||
48403570|NCT04445051|101321630|FG005|NOT COMPLETED|Overall Study||0||
48403571|NCT01352845|101321631|FG000|STARTED|Overall Study||2471||
48590995|NCT02267135|101779831|FG001|COMPLETED|Period 2 (Randomized Set)||46||
48590996|NCT02267135|101779830|FG000|NOT COMPLETED|Period 2 (Randomized Set)||4||
48590997|NCT02267135|101779831|FG001|NOT COMPLETED|Period 2 (Randomized Set)||1||
48590998|NCT01432561|101779832|FG000|STARTED|Overall Study||8||
48590999|NCT01432561|101779832|FG000|COMPLETED|Overall Study||8||
48591000|NCT01432561|101779832|FG000|NOT COMPLETED|Overall Study||0||
48591001|NCT00084318|101779833|FG000|STARTED|Overall Study||119||
48591002|NCT00084318|101779834|FG001|STARTED|Overall Study||119||
48591003|NCT00084318|101779833|FG000|COMPLETED|Overall Study||97||
48591004|NCT00084318|101779834|FG001|COMPLETED|Overall Study||106||
48591005|NCT00084318|101779833|FG000|NOT COMPLETED|Overall Study||22||
48591006|NCT00084318|101779834|FG001|NOT COMPLETED|Overall Study||13||
48591007|NCT00497770|101779835|FG000|STARTED|Overall Study||304||
48591008|NCT00497770|101779836|FG001|STARTED|Overall Study||65||
48591009|NCT00497770|101779837|FG002|STARTED|Overall Study||37||
48591010|NCT00497770|101779838|FG003|STARTED|Overall Study||28||
48591011|NCT00497770|101779835|FG000|COMPLETED|Overall Study||304||
48591012|NCT00497770|101779836|FG001|COMPLETED|Overall Study||65||
48591013|NCT00497770|101779837|FG002|COMPLETED|Overall Study||37||
48591014|NCT00497770|101779838|FG003|COMPLETED|Overall Study||28||
48591015|NCT00497770|101779835|FG000|NOT COMPLETED|Overall Study||0||
48591016|NCT00497770|101779836|FG001|NOT COMPLETED|Overall Study||0||
48140611|NCT03282227|100670221|FG000|Completed at Least 6 Months|Overall Study||257||
48403572|NCT01352845|101321632|FG001|STARTED|Overall Study||822||
48403573|NCT01352845|101321631|FG000|COMPLETED|Overall Study||1800||
48403574|NCT01352845|101321632|FG001|COMPLETED|Overall Study||619||
48403575|NCT01352845|101321631|FG000|NOT COMPLETED|Overall Study||671||
48403576|NCT01352845|101321632|FG001|NOT COMPLETED|Overall Study||203||
48403577|NCT02025530|101321633|FG000|STARTED|Overall Study||296||
48403578|NCT02025530|101321634|FG001|STARTED|Overall Study||734||
48403579|NCT02025530|101321633|FG000|COMPLETED|Overall Study||291||
48591017|NCT00497770|101779837|FG002|NOT COMPLETED|Overall Study||0||
48591018|NCT00497770|101779838|FG003|NOT COMPLETED|Overall Study||0||
48591019|NCT04416737|101779839|FG000|STARTED|Week 1 (First Injection)||10||
48591020|NCT04416737|101779840|FG001|STARTED|Week 1 (First Injection)||6||
48591021|NCT04416737|101779839|FG000|Received Injection|Week 1 (First Injection)||10||
48591022|NCT04416737|101779840|FG001|Received Injection|Week 1 (First Injection)||6||
48591023|NCT04416737|101779839|FG000|Received Disallowed Medication Prior to Injection|Week 1 (First Injection)||0||
48140612|NCT03282227|100670221|FG000|COMPLETED|Overall Study||127|Completed 12 Months|
48140613|NCT03282227|100670221|FG000|NOT COMPLETED|Overall Study||215||
48140614|NCT01027000|100670222|FG000|STARTED|Overall Study||68||
48140615|NCT01027000|100670222|FG000|COMPLETED|Overall Study||68||
48403580|NCT02025530|101321634|FG001|COMPLETED|Overall Study||733||
48591024|NCT04416737|101779840|FG001|Received Disallowed Medication Prior to Injection|Week 1 (First Injection)||1||
48591025|NCT04416737|101779839|FG000|Suspension of Basal Insulin > 2 Hours Prior to Injection|Week 1 (First Injection)||1||
48403581|NCT02025530|101321633|FG000|NOT COMPLETED|Overall Study||5||
48403582|NCT02025530|101321634|FG001|NOT COMPLETED|Overall Study||1||
48403583|NCT01712490|101321635|FG000|STARTED|Overall Study||664||
48591026|NCT04416737|101779840|FG001|Suspension of Basal Insulin > 2 Hours Prior to Injection|Week 1 (First Injection)||1||
48591027|NCT04416737|101779839|FG000|Achieved Induced Hypoglycemia|Week 1 (First Injection)||4||
48591028|NCT04416737|101779840|FG001|Achieved Induced Hypoglycemia|Week 1 (First Injection)||4||
48591029|NCT04416737|101779839|FG000|COMPLETED|Week 1 (First Injection)||10||
48591030|NCT04416737|101779840|FG001|COMPLETED|Week 1 (First Injection)||5||
48591031|NCT04416737|101779839|FG000|NOT COMPLETED|Week 1 (First Injection)||0||
48591032|NCT04416737|101779840|FG001|NOT COMPLETED|Week 1 (First Injection)||1||
48591033|NCT04416737|101779839|FG000|STARTED|Week 2 (Second Injection)||10||
48591034|NCT04416737|101779840|FG001|STARTED|Week 2 (Second Injection)||5||
48591035|NCT04416737|101779839|FG000|Suspension of Basal Insulin > 2 Hours Prior to Injection|Week 2 (Second Injection)||1||
48591036|NCT04416737|101779840|FG001|Suspension of Basal Insulin > 2 Hours Prior to Injection|Week 2 (Second Injection)||1||
48591037|NCT04416737|101779839|FG000|Achieved Induced Hypoglycemia|Week 2 (Second Injection)||7||
48591038|NCT04416737|101779840|FG001|Achieved Induced Hypoglycemia|Week 2 (Second Injection)||4||
48591039|NCT04416737|101779839|FG000|COMPLETED|Week 2 (Second Injection)||10||
48591040|NCT04416737|101779840|FG001|COMPLETED|Week 2 (Second Injection)||5||
48591041|NCT04416737|101779839|FG000|NOT COMPLETED|Week 2 (Second Injection)||0||
48591042|NCT04416737|101779840|FG001|NOT COMPLETED|Week 2 (Second Injection)||0||
48591043|NCT04416737|101779839|FG000|STARTED|Week 3 (Third Injection)||10||
48591044|NCT04416737|101779840|FG001|STARTED|Week 3 (Third Injection)||5||
48591045|NCT04416737|101779839|FG000|Suspension of Basal Insulin > 2 Hours Prior to Injection|Week 3 (Third Injection)||1||
48591046|NCT04416737|101779840|FG001|Suspension of Basal Insulin > 2 Hours Prior to Injection|Week 3 (Third Injection)||1||
48591047|NCT04416737|101779839|FG000|Achieved Induced Hypoglycemia|Week 3 (Third Injection)||9||
48591048|NCT04416737|101779840|FG001|Achieved Induced Hypoglycemia|Week 3 (Third Injection)||4||
48591049|NCT04416737|101779839|FG000|COMPLETED|Week 3 (Third Injection)||10||
48591050|NCT04416737|101779840|FG001|COMPLETED|Week 3 (Third Injection)||5||
48591051|NCT04416737|101779839|FG000|NOT COMPLETED|Week 3 (Third Injection)||0||
48591052|NCT04416737|101779840|FG001|NOT COMPLETED|Week 3 (Third Injection)||0||
48591053|NCT01322035|101779841|FG000|STARTED|Overall Study||16||
48591054|NCT01322035|101779842|FG001|STARTED|Overall Study||11||
48591055|NCT01322035|101779841|FG000|COMPLETED|Overall Study||8||
48591056|NCT01322035|101779842|FG001|COMPLETED|Overall Study||8||
48591057|NCT01322035|101779841|FG000|NOT COMPLETED|Overall Study||8||
48591058|NCT01322035|101779842|FG001|NOT COMPLETED|Overall Study||3||
48591059|NCT01892709|101779843|FG000|STARTED|Overall Study||215||
48591060|NCT01892709|101779843|FG000|COMPLETED|Overall Study||215||
48591061|NCT01892709|101779843|FG000|NOT COMPLETED|Overall Study||0||
48591062|NCT03191864|101779844|FG000|STARTED|Baseline Symptom Assessment||0|Due to the high placebo response rates, the study utilized a 4-week single-blind placebo run-in period to not only establish the baseline symptoms for the study, but also to ensure that all subjects enrolled had sufficient severity of EoE to warrant inclusion in the study.|
48591063|NCT03191864|101779845|FG001|STARTED|Baseline Symptom Assessment||0|Due to the high placebo response rates, the study utilized a 4-week single-blind placebo run-in period to not only establish the baseline symptoms for the study, but also to ensure that all subjects enrolled had sufficient severity of EoE to warrant inclusion in the study.|
48591064|NCT03191864|101779846|FG002|STARTED|Baseline Symptom Assessment||0|Due to the high placebo response rates, the study utilized a 4-week single-blind placebo run-in period to not only establish the baseline symptoms for the study, but also to ensure that all subjects enrolled had sufficient severity of EoE to warrant inclusion in the study.|
48591065|NCT03191864|101779847|FG003|STARTED|Baseline Symptom Assessment||0|Due to the high placebo response rates, the study utilized a 4-week single-blind placebo run-in period to not only establish the baseline symptoms for the study, but also to ensure that all subjects enrolled had sufficient severity of EoE to warrant inclusion in the study.|
48591066|NCT03191864|101779848|FG004|STARTED|Baseline Symptom Assessment||0|Due to the high placebo response rates, the study utilized a 4-week single-blind placebo run-in period to not only establish the baseline symptoms for the study, but also to ensure that all subjects enrolled had sufficient severity of EoE to warrant inclusion in the study.|
48591067|NCT03191864|101779849|FG005|STARTED|Baseline Symptom Assessment||308|Due to the high placebo response rates, the study utilized a 4-week single-blind placebo run-in period to not only establish the baseline symptoms for the study, but also to ensure that all subjects enrolled had sufficient severity of EoE to warrant inclusion in the study.|
48591068|NCT03191864|101779844|FG000|COMPLETED|Baseline Symptom Assessment||0||
48140616|NCT01027000|100670222|FG000|NOT COMPLETED|Overall Study||0||
48140617|NCT05224050|100670223|FG000|STARTED|Overall Study||28||
48140618|NCT05224050|100670223|FG000|Treatment Completed|Overall Study||19||
48140619|NCT05224050|100670223|FG000|Follow-up Completed|Overall Study||16||
48140620|NCT05224050|100670223|FG000|COMPLETED|Overall Study||16||
48293161|NCT00406653|101044481|FG003|COMPLETED|Induction Period||102||
48293162|NCT00406653|101044482|FG004|COMPLETED|Induction Period||0||
48293163|NCT00406653|101044483|FG005|COMPLETED|Induction Period||0||
48140621|NCT05224050|100670223|FG000|NOT COMPLETED|Overall Study||12||
48140622|NCT01518868|100670224|FG000|STARTED|Overall Study||63||
48140623|NCT01518868|100670225|FG001|STARTED|Overall Study||63||
48140624|NCT01518868|100670224|FG000|COMPLETED|Overall Study||59||
48140625|NCT01518868|100670225|FG001|COMPLETED|Overall Study||59||
48140626|NCT01518868|100670224|FG000|NOT COMPLETED|Overall Study||4||
48140627|NCT01518868|100670225|FG001|NOT COMPLETED|Overall Study||4||
48140628|NCT01217073|100670226|FG000|STARTED|Base Period||113||
48140629|NCT01217073|100670227|FG001|STARTED|Base Period||115||
48140630|NCT01217073|100670228|FG002|STARTED|Base Period||114||
48140631|NCT01217073|100670229|FG003|STARTED|Base Period||115||
48140632|NCT01217073|100670230|FG004|STARTED|Base Period||114||
48140633|NCT01217073|100670231|FG005|STARTED|Base Period||114||
48140634|NCT01217073|100670232|FG006|STARTED|Base Period||0||
48140635|NCT01217073|100670233|FG007|STARTED|Base Period||0||
48140636|NCT01217073|100670226|FG000|COMPLETED|Base Period||106||
48140637|NCT01217073|100670227|FG001|COMPLETED|Base Period||110||
48140638|NCT01217073|100670228|FG002|COMPLETED|Base Period||107||
48140639|NCT01217073|100670229|FG003|COMPLETED|Base Period||113||
48293164|NCT00406653|101044484|FG006|COMPLETED|Induction Period||0||
48293165|NCT00406653|101044478|FG000|NOT COMPLETED|Induction Period||15||
48293166|NCT00406653|101044479|FG001|NOT COMPLETED|Induction Period||34||
48293167|NCT00406653|101044480|FG002|NOT COMPLETED|Induction Period||18||
48293168|NCT00406653|101044481|FG003|NOT COMPLETED|Induction Period||26||
48709320|NCT03711929|102077759|FG000|STARTED|Double Masked Treatment Period (DMTP)||57||65
48709321|NCT03711929|102077760|FG001|STARTED|Double Masked Treatment Period (DMTP)||59||68
48709322|NCT03711929|102077761|FG002|STARTED|Double Masked Treatment Period (DMTP)||29||32
48709323|NCT03711929|102077759|FG000|COMPLETED|Double Masked Treatment Period (DMTP)||51||59
48709324|NCT03711929|102077760|FG001|COMPLETED|Double Masked Treatment Period (DMTP)||48||55
48709325|NCT03711929|102077761|FG002|COMPLETED|Double Masked Treatment Period (DMTP)||24||27
48709326|NCT03711929|102077759|FG000|NOT COMPLETED|Double Masked Treatment Period (DMTP)||6||6
48709327|NCT03711929|102077760|FG001|NOT COMPLETED|Double Masked Treatment Period (DMTP)||11||13
48709328|NCT03711929|102077761|FG002|NOT COMPLETED|Double Masked Treatment Period (DMTP)||5||5
48709329|NCT03711929|102077759|FG000|STARTED|Open Label Treatment Period (OLTP)||42||49
48709330|NCT03711929|102077760|FG001|STARTED|Open Label Treatment Period (OLTP)||40||47
48709331|NCT03711929|102077761|FG002|STARTED|Open Label Treatment Period (OLTP)||21||24
48709332|NCT03711929|102077759|FG000|COMPLETED|Open Label Treatment Period (OLTP)||34||40
48709333|NCT03711929|102077760|FG001|COMPLETED|Open Label Treatment Period (OLTP)||35||41
48709334|NCT03711929|102077761|FG002|COMPLETED|Open Label Treatment Period (OLTP)||15||16
48709335|NCT03711929|102077759|FG000|NOT COMPLETED|Open Label Treatment Period (OLTP)||8||9
48709336|NCT03711929|102077760|FG001|NOT COMPLETED|Open Label Treatment Period (OLTP)||5||6
48709337|NCT03711929|102077761|FG002|NOT COMPLETED|Open Label Treatment Period (OLTP)||6||8
48709338|NCT00085254|102077762|FG000|STARTED|Overall Study||18||
48709339|NCT00085254|102077763|FG001|STARTED|Overall Study||46||
48709340|NCT00085254|102077764|FG002|STARTED|Overall Study||48||
48709341|NCT00085254|102077762|FG000|COMPLETED|Overall Study||18||
48709342|NCT00085254|102077763|FG001|COMPLETED|Overall Study||46||
48709343|NCT00085254|102077764|FG002|COMPLETED|Overall Study||48||
48709344|NCT00085254|102077762|FG000|NOT COMPLETED|Overall Study||0||
48709345|NCT00085254|102077763|FG001|NOT COMPLETED|Overall Study||0||
48709346|NCT00085254|102077764|FG002|NOT COMPLETED|Overall Study||0||
48709347|NCT00694096|102077765|FG000|STARTED|Overall Study||25||
48709348|NCT00694096|102077765|FG000|COMPLETED|Overall Study||20||
48709349|NCT00694096|102077765|FG000|NOT COMPLETED|Overall Study||5||
48709350|NCT05082428|102077766|FG000|STARTED|Overall Study||252||
48709351|NCT05082428|102077766|FG000|COMPLETED|Overall Study||252||
48709352|NCT05082428|102077766|FG000|NOT COMPLETED|Overall Study||0||
48709353|NCT00355342|102077767|FG000|STARTED|Overall Study||94||
48709354|NCT00355342|102077768|FG001|STARTED|Overall Study||92||
48709355|NCT00355342|102077767|FG000|COMPLETED|Overall Study||55||
48709356|NCT00355342|102077768|FG001|COMPLETED|Overall Study||56||
48140640|NCT01217073|100670230|FG004|COMPLETED|Base Period||99||
48140641|NCT01217073|100670231|FG005|COMPLETED|Base Period||105||
48140642|NCT01217073|100670232|FG006|COMPLETED|Base Period||0||
48293169|NCT00406653|101044482|FG004|NOT COMPLETED|Induction Period||0||
48293170|NCT00406653|101044483|FG005|NOT COMPLETED|Induction Period||0||
48293171|NCT00406653|101044484|FG006|NOT COMPLETED|Induction Period||0||
48293172|NCT00406653|101044478|FG000|STARTED|Maintenance Period||0||
48293173|NCT00406653|101044479|FG001|STARTED|Maintenance Period||0||
48140643|NCT01217073|100670233|FG007|COMPLETED|Base Period||0||
48140644|NCT01217073|100670226|FG000|NOT COMPLETED|Base Period||7||
48140645|NCT01217073|100670227|FG001|NOT COMPLETED|Base Period||5||
48709357|NCT00355342|102077767|FG000|NOT COMPLETED|Overall Study||39||
48709358|NCT00355342|102077768|FG001|NOT COMPLETED|Overall Study||36||
48709359|NCT02969590|102077769|FG000|STARTED|Screening Period||5||
48709360|NCT02969590|102077770|FG001|STARTED|Screening Period||0||
48709361|NCT02969590|102077771|FG002|STARTED|Screening Period||0||
48709362|NCT02969590|102077769|FG000|COMPLETED|Screening Period||4||
48709363|NCT02969590|102077770|FG001|COMPLETED|Screening Period||0||
48709364|NCT02969590|102077771|FG002|COMPLETED|Screening Period||0||
48709365|NCT02969590|102077769|FG000|NOT COMPLETED|Screening Period||1||
48709366|NCT02969590|102077770|FG001|NOT COMPLETED|Screening Period||0||
48709367|NCT02969590|102077771|FG002|NOT COMPLETED|Screening Period||0||
48709368|NCT02969590|102077769|FG000|STARTED|Treatment Period 1||0||
48709369|NCT02969590|102077770|FG001|STARTED|Treatment Period 1||2||
48709370|NCT02969590|102077771|FG002|STARTED|Treatment Period 1||2||
48709371|NCT02969590|102077769|FG000|COMPLETED|Treatment Period 1||0||
48709372|NCT02969590|102077770|FG001|COMPLETED|Treatment Period 1||2||
48709373|NCT02969590|102077771|FG002|COMPLETED|Treatment Period 1||2||
48709374|NCT02969590|102077769|FG000|NOT COMPLETED|Treatment Period 1||0||
48293174|NCT00406653|101044480|FG002|STARTED|Maintenance Period||0||
48293175|NCT00406653|101044481|FG003|STARTED|Maintenance Period||0||
48293176|NCT00406653|101044482|FG004|STARTED|Maintenance Period||44||
48293177|NCT00406653|101044483|FG005|STARTED|Maintenance Period||46||
48591069|NCT03191864|101779845|FG001|COMPLETED|Baseline Symptom Assessment||0||
48591070|NCT03191864|101779846|FG002|COMPLETED|Baseline Symptom Assessment||0||
48591071|NCT03191864|101779847|FG003|COMPLETED|Baseline Symptom Assessment||0||
48591072|NCT03191864|101779848|FG004|COMPLETED|Baseline Symptom Assessment||0||
48591073|NCT03191864|101779849|FG005|COMPLETED|Baseline Symptom Assessment||106||
48709375|NCT02969590|102077770|FG001|NOT COMPLETED|Treatment Period 1||0||
48591074|NCT03191864|101779844|FG000|NOT COMPLETED|Baseline Symptom Assessment||0||
48591075|NCT03191864|101779845|FG001|NOT COMPLETED|Baseline Symptom Assessment||0||
48591076|NCT03191864|101779846|FG002|NOT COMPLETED|Baseline Symptom Assessment||0||
48591077|NCT03191864|101779847|FG003|NOT COMPLETED|Baseline Symptom Assessment||0||
48591078|NCT03191864|101779848|FG004|NOT COMPLETED|Baseline Symptom Assessment||0||
48591079|NCT03191864|101779849|FG005|NOT COMPLETED|Baseline Symptom Assessment||202||
48591080|NCT03191864|101779844|FG000|STARTED|Part 1 - Induction||21||
48591081|NCT03191864|101779845|FG001|STARTED|Part 1 - Induction||22||
48591082|NCT03191864|101779846|FG002|STARTED|Part 1 - Induction||22||
48591083|NCT03191864|101779847|FG003|STARTED|Part 1 - Induction||20||
48709376|NCT02969590|102077771|FG002|NOT COMPLETED|Treatment Period 1||0||
48709377|NCT02969590|102077769|FG000|STARTED|Treatment Period 2||0||
48140646|NCT01217073|100670228|FG002|NOT COMPLETED|Base Period||7||
48293178|NCT00406653|101044484|FG006|STARTED|Maintenance Period||0||
48293179|NCT00406653|101044478|FG000|COMPLETED|Maintenance Period||0||
48293180|NCT00406653|101044479|FG001|COMPLETED|Maintenance Period||0||
48293181|NCT00406653|101044480|FG002|COMPLETED|Maintenance Period||0||
48293182|NCT00406653|101044481|FG003|COMPLETED|Maintenance Period||0||
48293183|NCT00406653|101044482|FG004|COMPLETED|Maintenance Period||14||
48293184|NCT00406653|101044483|FG005|COMPLETED|Maintenance Period||10||
48293185|NCT00406653|101044484|FG006|COMPLETED|Maintenance Period||0||
48293186|NCT00406653|101044478|FG000|NOT COMPLETED|Maintenance Period||0||
48293187|NCT00406653|101044479|FG001|NOT COMPLETED|Maintenance Period||0||
48293188|NCT00406653|101044480|FG002|NOT COMPLETED|Maintenance Period||0||
48403584|NCT01712490|101321636|FG001|STARTED|Overall Study||670||
48403585|NCT01712490|101321635|FG000|Treated|Overall Study||662||
48403586|NCT01712490|101321636|FG001|Treated|Overall Study||659||
48591084|NCT03191864|101779848|FG004|STARTED|Part 1 - Induction||0||
48591085|NCT03191864|101779849|FG005|STARTED|Part 1 - Induction||21||
48709378|NCT02969590|102077770|FG001|STARTED|Treatment Period 2||2||
48709379|NCT02969590|102077771|FG002|STARTED|Treatment Period 2||2||
48140647|NCT01217073|100670229|FG003|NOT COMPLETED|Base Period||2||
48140648|NCT01217073|100670230|FG004|NOT COMPLETED|Base Period||15||
48140649|NCT01217073|100670231|FG005|NOT COMPLETED|Base Period||9||
48140650|NCT01217073|100670232|FG006|NOT COMPLETED|Base Period||0||
48140651|NCT01217073|100670233|FG007|NOT COMPLETED|Base Period||0||
48140652|NCT01217073|100670226|FG000|STARTED|Extension Period||0||
48140653|NCT01217073|100670227|FG001|STARTED|Extension Period||0||
48140654|NCT01217073|100670228|FG002|STARTED|Extension Period||0||
48140655|NCT01217073|100670229|FG003|STARTED|Extension Period||0||
48140656|NCT01217073|100670230|FG004|STARTED|Extension Period||0||
48140657|NCT01217073|100670231|FG005|STARTED|Extension Period||0||
48140658|NCT01217073|100670232|FG006|STARTED|Extension Period||405||
48140659|NCT01217073|100670233|FG007|STARTED|Extension Period||80||
48140660|NCT01217073|100670226|FG000|COMPLETED|Extension Period||0||
48140661|NCT01217073|100670227|FG001|COMPLETED|Extension Period||0||
48140662|NCT01217073|100670228|FG002|COMPLETED|Extension Period||0||
48140663|NCT01217073|100670229|FG003|COMPLETED|Extension Period||0||
48140664|NCT01217073|100670230|FG004|COMPLETED|Extension Period||0||
48293189|NCT00406653|101044481|FG003|NOT COMPLETED|Maintenance Period||0||
48293190|NCT00406653|101044482|FG004|NOT COMPLETED|Maintenance Period||30||
48591086|NCT03191864|101779844|FG000|COMPLETED|Part 1 - Induction||18||
48709380|NCT02969590|102077769|FG000|COMPLETED|Treatment Period 2||0||
48709381|NCT02969590|102077770|FG001|COMPLETED|Treatment Period 2||2||
48709382|NCT02969590|102077771|FG002|COMPLETED|Treatment Period 2||2||
48709383|NCT02969590|102077769|FG000|NOT COMPLETED|Treatment Period 2||0||
48709384|NCT02969590|102077770|FG001|NOT COMPLETED|Treatment Period 2||0||
48293191|NCT00406653|101044483|FG005|NOT COMPLETED|Maintenance Period||36||
48293192|NCT00406653|101044484|FG006|NOT COMPLETED|Maintenance Period||0||
48293193|NCT00406653|101044478|FG000|STARTED|Open-Label Period||0||
48293194|NCT00406653|101044479|FG001|STARTED|Open-Label Period||0||
48293195|NCT00406653|101044480|FG002|STARTED|Open-Label Period||0||
48293196|NCT00406653|101044481|FG003|STARTED|Open-Label Period||0||
48293197|NCT00406653|101044482|FG004|STARTED|Open-Label Period||0||
48293198|NCT00406653|101044483|FG005|STARTED|Open-Label Period||0||
48293199|NCT00406653|101044484|FG006|STARTED|Open-Label Period||324||
48293200|NCT00406653|101044478|FG000|COMPLETED|Open-Label Period||0||
48293201|NCT00406653|101044479|FG001|COMPLETED|Open-Label Period||0||
48293202|NCT00406653|101044480|FG002|COMPLETED|Open-Label Period||0||
48293203|NCT00406653|101044481|FG003|COMPLETED|Open-Label Period||0||
48293204|NCT00406653|101044482|FG004|COMPLETED|Open-Label Period||0||
48293205|NCT00406653|101044483|FG005|COMPLETED|Open-Label Period||0||
48293206|NCT00406653|101044484|FG006|COMPLETED|Open-Label Period||0||
48293207|NCT00406653|101044478|FG000|NOT COMPLETED|Open-Label Period||0||
48293208|NCT00406653|101044479|FG001|NOT COMPLETED|Open-Label Period||0||
48293209|NCT00406653|101044480|FG002|NOT COMPLETED|Open-Label Period||0||
48293210|NCT00406653|101044481|FG003|NOT COMPLETED|Open-Label Period||0||
48293211|NCT00406653|101044482|FG004|NOT COMPLETED|Open-Label Period||0||
48293212|NCT00406653|101044483|FG005|NOT COMPLETED|Open-Label Period||0||
48293213|NCT00406653|101044484|FG006|NOT COMPLETED|Open-Label Period||324||
48293214|NCT02578862|101044485|FG000|STARTED|Overall Study||37||
48293215|NCT02578862|101044486|FG001|STARTED|Overall Study||35||
48293216|NCT02578862|101044485|FG000|COMPLETED|Overall Study||37||
48293217|NCT02578862|101044486|FG001|COMPLETED|Overall Study||33||
48293218|NCT02578862|101044485|FG000|NOT COMPLETED|Overall Study||0||
48293219|NCT02578862|101044486|FG001|NOT COMPLETED|Overall Study||2||
48293220|NCT00091169|101044487|FG000|STARTED|Overall Study||189||
48293221|NCT00091169|101044488|FG001|STARTED|Overall Study||187||
48293222|NCT00091169|101044487|FG000|Treated|Overall Study||163||
48293223|NCT00091169|101044488|FG001|Treated|Overall Study||170||
48293224|NCT00091169|101044487|FG000|COMPLETED|Overall Study||132||
48293225|NCT00091169|101044488|FG001|COMPLETED|Overall Study||134||
48293226|NCT00091169|101044487|FG000|NOT COMPLETED|Overall Study||57||
48293227|NCT00091169|101044488|FG001|NOT COMPLETED|Overall Study||53||
48293228|NCT02070588|101044489|FG000|STARTED|Overall Study||86||
48293229|NCT02070588|101044490|FG001|STARTED|Overall Study||26||
48293230|NCT02070588|101044491|FG002|STARTED|Overall Study||0||
48293231|NCT02070588|101044489|FG000|COMPLETED|Overall Study||47||
48293232|NCT02070588|101044490|FG001|COMPLETED|Overall Study||25||
48293233|NCT02070588|101044491|FG002|COMPLETED|Overall Study||0||
48293234|NCT02070588|101044489|FG000|NOT COMPLETED|Overall Study||39||
48293235|NCT02070588|101044490|FG001|NOT COMPLETED|Overall Study||1||
48293236|NCT02070588|101044491|FG002|NOT COMPLETED|Overall Study||0||
48293237|NCT04465760|101044492|FG000|STARTED|Overall Study||9||
48293238|NCT04465760|101044492|FG000|COMPLETED|Overall Study||9||
48293239|NCT04465760|101044492|FG000|NOT COMPLETED|Overall Study||0||
48293240|NCT02743377|101044493|FG000|STARTED|Overall Study||9||
48293241|NCT02743377|101044494|FG001|STARTED|Overall Study||6||
48293242|NCT02743377|101044493|FG000|Brain PET With 11C Rolipram|Overall Study||8||
48403587|NCT01712490|101321635|FG000|COMPLETED|Overall Study||0||
48403588|NCT01712490|101321636|FG001|COMPLETED|Overall Study||0||
48709385|NCT02969590|102077771|FG002|NOT COMPLETED|Treatment Period 2||0||
48709386|NCT01638052|102077772|FG000|STARTED|Overall Study||28||
48709387|NCT01638052|102077773|FG001|STARTED|Overall Study||28||
48709388|NCT01638052|102077772|FG000|COMPLETED|Overall Study||28||
48709389|NCT01638052|102077773|FG001|COMPLETED|Overall Study||28||
48709390|NCT01638052|102077772|FG000|NOT COMPLETED|Overall Study||0||
48293243|NCT02743377|101044494|FG001|Brain PET With 11C Rolipram|Overall Study||3||
48293244|NCT02743377|101044493|FG000|Whole Body PET Baseline With 11C Rolipra|Overall Study||5||
48293245|NCT02743377|101044494|FG001|Whole Body PET Baseline With 11C Rolipra|Overall Study||4||
48293246|NCT02743377|101044493|FG000|Whole Body PET Baseline & Blocked|Overall Study||0||
48293247|NCT02743377|101044494|FG001|Whole Body PET Baseline & Blocked|Overall Study||2||
48403589|NCT01712490|101321635|FG000|NOT COMPLETED|Overall Study||664||
48293248|NCT02743377|101044493|FG000|COMPLETED|Overall Study||7||
48293249|NCT02743377|101044494|FG001|COMPLETED|Overall Study||6||
48293250|NCT02743377|101044493|FG000|NOT COMPLETED|Overall Study||2||
48293251|NCT02743377|101044494|FG001|NOT COMPLETED|Overall Study||0||
48709391|NCT01638052|102077773|FG001|NOT COMPLETED|Overall Study||0||
48709392|NCT00789581|102077774|FG000|STARTED|AC Therapy||306|All randomized patients.|
48709393|NCT00789581|102077775|FG001|STARTED|AC Therapy||308|All randomized patients.|
48709394|NCT00789581|102077774|FG000|COMPLETED|AC Therapy||295|5 patients were randomized but never treated.|
48709395|NCT00789581|102077775|FG001|COMPLETED|AC Therapy||291|5 patients were randomized but never treated.|
48293252|NCT01491893|101044495|FG000|STARTED|Overall Study||1||
48293253|NCT01491893|101044496|FG001|STARTED|Overall Study||1||
48403590|NCT01712490|101321636|FG001|NOT COMPLETED|Overall Study||670||
48293254|NCT01491893|101044497|FG002|STARTED|Overall Study||1||
48140665|NCT01217073|100670231|FG005|COMPLETED|Extension Period||0||
48140666|NCT01217073|100670232|FG006|COMPLETED|Extension Period||314||
48140667|NCT01217073|100670233|FG007|COMPLETED|Extension Period||60||
48140668|NCT01217073|100670226|FG000|NOT COMPLETED|Extension Period||0||
48140669|NCT01217073|100670227|FG001|NOT COMPLETED|Extension Period||0||
48140670|NCT01217073|100670228|FG002|NOT COMPLETED|Extension Period||0||
48140671|NCT01217073|100670229|FG003|NOT COMPLETED|Extension Period||0||
48140672|NCT01217073|100670230|FG004|NOT COMPLETED|Extension Period||0||
48140673|NCT01217073|100670231|FG005|NOT COMPLETED|Extension Period||0||
48140674|NCT01217073|100670232|FG006|NOT COMPLETED|Extension Period||91||
48140675|NCT01217073|100670233|FG007|NOT COMPLETED|Extension Period||20||
48140676|NCT00695903|100670234|FG000|STARTED|Had End of Therapy (EOT) Assessment||19||
48140677|NCT00695903|100670235|FG001|STARTED|Had End of Therapy (EOT) Assessment||19||
48140678|NCT00695903|100670234|FG000|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||9||
48140679|NCT00695903|100670235|FG001|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||6||
48140680|NCT00695903|100670234|FG000|COMPLETED|Had End of Therapy (EOT) Assessment||7||
48140681|NCT00695903|100670235|FG001|COMPLETED|Had End of Therapy (EOT) Assessment||4||
48140682|NCT00695903|100670234|FG000|NOT COMPLETED|Had End of Therapy (EOT) Assessment||12||
48140683|NCT00695903|100670235|FG001|NOT COMPLETED|Had End of Therapy (EOT) Assessment||15||
48140684|NCT00695903|100670234|FG000|STARTED|Had Test of Cure (TOC) Assessment||7||
48140685|NCT00695903|100670235|FG001|STARTED|Had Test of Cure (TOC) Assessment||4||
48140686|NCT00695903|100670234|FG000|COMPLETED|Had Test of Cure (TOC) Assessment||5||
48140687|NCT00695903|100670235|FG001|COMPLETED|Had Test of Cure (TOC) Assessment||3||
48140688|NCT00695903|100670234|FG000|NOT COMPLETED|Had Test of Cure (TOC) Assessment||2||
48140689|NCT00695903|100670235|FG001|NOT COMPLETED|Had Test of Cure (TOC) Assessment||1||
48140690|NCT02512575|100670236|FG000|STARTED|Overall Study||6||
48140691|NCT02512575|100670237|FG001|STARTED|Overall Study||6||
48140692|NCT02512575|100670238|FG002|STARTED|Overall Study||6||
48140693|NCT02512575|100670239|FG003|STARTED|Overall Study||6||
48140694|NCT02512575|100670240|FG004|STARTED|Overall Study||6||
48140695|NCT02512575|100670241|FG005|STARTED|Overall Study||6||
48140696|NCT02512575|100670242|FG006|STARTED|Overall Study||6||
48140697|NCT02512575|100670243|FG007|STARTED|Overall Study||6||
48140698|NCT02512575|100670244|FG008|STARTED|Overall Study||6||
48140699|NCT02512575|100670245|FG009|STARTED|Overall Study||18||
48140700|NCT02512575|100670236|FG000|COMPLETED|Overall Study||6||
48140701|NCT02512575|100670237|FG001|COMPLETED|Overall Study||6||
48140702|NCT02512575|100670238|FG002|COMPLETED|Overall Study||6||
48140703|NCT02512575|100670239|FG003|COMPLETED|Overall Study||6||
48140704|NCT02512575|100670240|FG004|COMPLETED|Overall Study||6||
48140705|NCT02512575|100670241|FG005|COMPLETED|Overall Study||6||
48140706|NCT02512575|100670242|FG006|COMPLETED|Overall Study||6||
48140707|NCT02512575|100670243|FG007|COMPLETED|Overall Study||6||
48140708|NCT02512575|100670244|FG008|COMPLETED|Overall Study||6||
48140709|NCT02512575|100670245|FG009|COMPLETED|Overall Study||18||
48140710|NCT02512575|100670236|FG000|NOT COMPLETED|Overall Study||0||
48140711|NCT02512575|100670237|FG001|NOT COMPLETED|Overall Study||0||
48140712|NCT02512575|100670238|FG002|NOT COMPLETED|Overall Study||0||
48140713|NCT02512575|100670239|FG003|NOT COMPLETED|Overall Study||0||
48140714|NCT02512575|100670240|FG004|NOT COMPLETED|Overall Study||0||
48140715|NCT02512575|100670241|FG005|NOT COMPLETED|Overall Study||0||
48140716|NCT02512575|100670242|FG006|NOT COMPLETED|Overall Study||0||
48140717|NCT02512575|100670243|FG007|NOT COMPLETED|Overall Study||0||
48140718|NCT02512575|100670244|FG008|NOT COMPLETED|Overall Study||0||
48140719|NCT02512575|100670245|FG009|NOT COMPLETED|Overall Study||0||
48140720|NCT00784810|100670246|FG000|STARTED|Overall Study||124||
48140721|NCT00784810|100670247|FG001|STARTED|Overall Study||123||
48140722|NCT00784810|100670246|FG000|COMPLETED|Overall Study||61||
48140723|NCT00784810|100670247|FG001|COMPLETED|Overall Study||74||
48140724|NCT00784810|100670246|FG000|NOT COMPLETED|Overall Study||63||
48140725|NCT00784810|100670247|FG001|NOT COMPLETED|Overall Study||49||
48140726|NCT02097108|100670248|FG000|STARTED|Overall Study||11||
48140727|NCT02097108|100670248|FG000|COMPLETED|Overall Study||9||
48293255|NCT01491893|101044498|FG003|STARTED|Overall Study||1||
48140728|NCT02097108|100670248|FG000|NOT COMPLETED|Overall Study||2||
48140729|NCT00679939|100670249|FG000|STARTED|52-Week Double-Blind (DB) Period||114||
48140730|NCT00679939|100670250|FG001|STARTED|52-Week Double-Blind (DB) Period||112||
48140731|NCT00679939|100670249|FG000|COMPLETED|52-Week Double-Blind (DB) Period||77||
48140732|NCT00679939|100670250|FG001|COMPLETED|52-Week Double-Blind (DB) Period||85||
48140733|NCT00679939|100670249|FG000|NOT COMPLETED|52-Week Double-Blind (DB) Period||37||
48140734|NCT00679939|100670250|FG001|NOT COMPLETED|52-Week Double-Blind (DB) Period||27||
48140735|NCT00679939|100670249|FG000|STARTED|24-Week Open-Label (OL) Period||76||
48140736|NCT00679939|100670250|FG001|STARTED|24-Week Open-Label (OL) Period||84||
48140737|NCT00679939|100670249|FG000|COMPLETED|24-Week Open-Label (OL) Period||69||
48293256|NCT01491893|101044499|FG004|STARTED|Overall Study||4||
48293257|NCT01491893|101044500|FG005|STARTED|Overall Study||1||
48293258|NCT01491893|101044501|FG006|STARTED|Overall Study||6||
48293259|NCT01491893|101044502|FG007|STARTED|Overall Study||24||
48140738|NCT00679939|100670250|FG001|COMPLETED|24-Week Open-Label (OL) Period||80||
48293260|NCT01491893|101044503|FG008|STARTED|Overall Study||15||
48293261|NCT01491893|101044504|FG009|STARTED|Overall Study||7||
48293262|NCT01491893|101044495|FG000|COMPLETED|Overall Study||1||
48293263|NCT01491893|101044496|FG001|COMPLETED|Overall Study||1||
48293264|NCT01491893|101044497|FG002|COMPLETED|Overall Study||1||
48403591|NCT00653068|101321637|FG000|STARTED|Overall Study||70||
48403592|NCT00653068|101321637|FG000|COMPLETED|Overall Study||20||
48403593|NCT00653068|101321637|FG000|NOT COMPLETED|Overall Study||50||
48403594|NCT01502761|101321638|FG000|STARTED|Overall Study||4||
48591087|NCT03191864|101779845|FG001|COMPLETED|Part 1 - Induction||19||
48591088|NCT03191864|101779846|FG002|COMPLETED|Part 1 - Induction||20||
48591089|NCT03191864|101779847|FG003|COMPLETED|Part 1 - Induction||19||
48591090|NCT03191864|101779848|FG004|COMPLETED|Part 1 - Induction||0||
48591091|NCT03191864|101779849|FG005|COMPLETED|Part 1 - Induction||16||
48591092|NCT03191864|101779844|FG000|NOT COMPLETED|Part 1 - Induction||3||
48591093|NCT03191864|101779845|FG001|NOT COMPLETED|Part 1 - Induction||3||
48591094|NCT03191864|101779846|FG002|NOT COMPLETED|Part 1 - Induction||2||
48591095|NCT03191864|101779847|FG003|NOT COMPLETED|Part 1 - Induction||1||
48591096|NCT03191864|101779848|FG004|NOT COMPLETED|Part 1 - Induction||0||
48591097|NCT03191864|101779849|FG005|NOT COMPLETED|Part 1 - Induction||5||
48591098|NCT03191864|101779844|FG000|STARTED|Part 2 - Maintenance||10|Note that those subjects that were non-responders at Week 12 were switched from another arm to the Single-blind APT-1011 3 mg BID arm. This arm was a single-blinded arm for the subjects only.|
48591099|NCT03191864|101779845|FG001|STARTED|Part 2 - Maintenance||19|Note that those subjects that were non-responders at Week 12 were switched from another arm to the Single-blind APT-1011 3 mg BID arm. This arm was a single-blinded arm for the subjects only.|
48591100|NCT03191864|101779846|FG002|STARTED|Part 2 - Maintenance||14|Note that those subjects that were non-responders at Week 12 were switched from another arm to the Single-blind APT-1011 3 mg BID arm. This arm was a single-blinded arm for the subjects only.|
48591101|NCT03191864|101779847|FG003|STARTED|Part 2 - Maintenance||16|Note that those subjects that were non-responders at Week 12 were switched from another arm to the Single-blind APT-1011 3 mg BID arm. This arm was a single-blinded arm for the subjects only.|
48592851|NCT02059434|101786329|FG004|STARTED|Period 1 (After Screening/run-in Period)||2||
48709396|NCT00789581|102077774|FG000|NOT COMPLETED|AC Therapy||11||
48709397|NCT00789581|102077775|FG001|NOT COMPLETED|AC Therapy||17||
48709398|NCT00789581|102077774|FG000|STARTED|Adjuvant Therapy||295||
48709399|NCT00789581|102077775|FG001|STARTED|Adjuvant Therapy||291||
48709400|NCT00789581|102077774|FG000|COMPLETED|Adjuvant Therapy||255|4 patients completed AC therapy but did not initiate adjuvant treatment.|
48709401|NCT00789581|102077775|FG001|COMPLETED|Adjuvant Therapy||234|4 patients completed AC therapy but did not initiate adjuvant treatment.|
48709402|NCT00789581|102077774|FG000|NOT COMPLETED|Adjuvant Therapy||40||
48709403|NCT00789581|102077775|FG001|NOT COMPLETED|Adjuvant Therapy||57||
48293265|NCT01491893|101044498|FG003|COMPLETED|Overall Study||1||
48403595|NCT01502761|101321639|FG001|STARTED|Overall Study||0||
48403596|NCT01502761|101321640|FG002|STARTED|Overall Study||0||
48403597|NCT01502761|101321641|FG003|STARTED|Overall Study||0||
48403598|NCT01502761|101321638|FG000|COMPLETED|Overall Study||4||
48403599|NCT01502761|101321639|FG001|COMPLETED|Overall Study||0||
48403600|NCT01502761|101321640|FG002|COMPLETED|Overall Study||0||
48403601|NCT01502761|101321641|FG003|COMPLETED|Overall Study||0||
48403602|NCT01502761|101321638|FG000|NOT COMPLETED|Overall Study||0||
48403603|NCT01502761|101321639|FG001|NOT COMPLETED|Overall Study||0||
48403604|NCT01502761|101321640|FG002|NOT COMPLETED|Overall Study||0||
48709404|NCT03245736|102077776|FG000|STARTED|Overall Study||5||
48709405|NCT03245736|102077776|FG000|COMPLETED|Overall Study||0||
48709406|NCT03245736|102077776|FG000|NOT COMPLETED|Overall Study||5||
48709407|NCT04685707|102077777|FG000|STARTED|HFFS Session||11||
48709408|NCT04685707|102077778|FG001|STARTED|HFFS Session||9||
48293266|NCT01491893|101044499|FG004|COMPLETED|Overall Study||4||
48293267|NCT01491893|101044500|FG005|COMPLETED|Overall Study||1||
48293268|NCT01491893|101044501|FG006|COMPLETED|Overall Study||6||
48293269|NCT01491893|101044502|FG007|COMPLETED|Overall Study||24||
48293270|NCT01491893|101044503|FG008|COMPLETED|Overall Study||15||
48293271|NCT01491893|101044504|FG009|COMPLETED|Overall Study||7||
48293272|NCT01491893|101044495|FG000|NOT COMPLETED|Overall Study||0||
48293273|NCT01491893|101044496|FG001|NOT COMPLETED|Overall Study||0||
48293274|NCT01491893|101044497|FG002|NOT COMPLETED|Overall Study||0||
48293275|NCT01491893|101044498|FG003|NOT COMPLETED|Overall Study||0||
48293276|NCT01491893|101044499|FG004|NOT COMPLETED|Overall Study||0||
48293277|NCT01491893|101044500|FG005|NOT COMPLETED|Overall Study||0||
48293278|NCT01491893|101044501|FG006|NOT COMPLETED|Overall Study||0||
48293279|NCT01491893|101044502|FG007|NOT COMPLETED|Overall Study||0||
48293280|NCT01491893|101044503|FG008|NOT COMPLETED|Overall Study||0||
48293281|NCT01491893|101044504|FG009|NOT COMPLETED|Overall Study||0||
48293282|NCT02618031|101044505|FG000|STARTED|Overall Study||46||
48293283|NCT02618031|101044506|FG001|STARTED|Overall Study||11||
48293284|NCT02618031|101044505|FG000|COMPLETED|Overall Study||45||
48293285|NCT02618031|101044506|FG001|COMPLETED|Overall Study||11||
48403605|NCT01502761|101321641|FG003|NOT COMPLETED|Overall Study||0||
48403606|NCT00077922|101321642|FG000|STARTED|Overall Study||15||
48403607|NCT00077922|101321642|FG000|COMPLETED|Overall Study||15||
48403608|NCT00077922|101321642|FG000|NOT COMPLETED|Overall Study||0||
48140739|NCT00679939|100670249|FG000|NOT COMPLETED|24-Week Open-Label (OL) Period||7||
48140740|NCT00679939|100670250|FG001|NOT COMPLETED|24-Week Open-Label (OL) Period||4||
48140741|NCT01381692|100670251|FG000|STARTED|Overall Study||7||
48140742|NCT01381692|100670252|FG001|STARTED|Overall Study||2||
48403609|NCT06022224|101321643|FG000|STARTED|Overall Study||17||
48403610|NCT06022224|101321644|FG001|STARTED|Overall Study||18||
48403611|NCT06022224|101321643|FG000|COMPLETED|Overall Study||17||
48403612|NCT06022224|101321644|FG001|COMPLETED|Overall Study||18||
48403613|NCT06022224|101321643|FG000|NOT COMPLETED|Overall Study||0||
48591102|NCT03191864|101779848|FG004|STARTED|Part 2 - Maintenance||34|Note that those subjects that were non-responders at Week 12 were switched from another arm to the Single-blind APT-1011 3 mg BID arm. This arm was a single-blinded arm for the subjects only.|
48591103|NCT03191864|101779849|FG005|STARTED|Part 2 - Maintenance||0|Note that those subjects that were non-responders at Week 12 were switched from another arm to the Single-blind APT-1011 3 mg BID arm. This arm was a single-blinded arm for the subjects only.|
48591104|NCT03191864|101779844|FG000|COMPLETED|Part 2 - Maintenance||5||
48591105|NCT03191864|101779845|FG001|COMPLETED|Part 2 - Maintenance||17||
48591106|NCT03191864|101779846|FG002|COMPLETED|Part 2 - Maintenance||11||
48591107|NCT03191864|101779847|FG003|COMPLETED|Part 2 - Maintenance||14||
48709409|NCT04685707|102077777|FG000|COMPLETED|HFFS Session||11||
48709410|NCT04685707|102077778|FG001|COMPLETED|HFFS Session||9||
48709411|NCT04685707|102077777|FG000|NOT COMPLETED|HFFS Session||0||
48709412|NCT04685707|102077778|FG001|NOT COMPLETED|HFFS Session||0||
48709413|NCT04685707|102077777|FG000|STARTED|Washout||11||
48709414|NCT04685707|102077778|FG001|STARTED|Washout||9||
48709415|NCT04685707|102077777|FG000|COMPLETED|Washout||11||
48709416|NCT04685707|102077778|FG001|COMPLETED|Washout||9||
48709417|NCT04685707|102077777|FG000|NOT COMPLETED|Washout||0||
48709418|NCT04685707|102077778|FG001|NOT COMPLETED|Washout||0||
48709419|NCT04685707|102077777|FG000|STARTED|Control Session||11||
48140743|NCT01381692|100670253|FG002|STARTED|Overall Study||0||
48140744|NCT01381692|100670254|FG003|STARTED|Overall Study||0||
48140745|NCT01381692|100670255|FG004|STARTED|Overall Study||0||
48140746|NCT01381692|100670256|FG005|STARTED|Overall Study||0||
48140747|NCT01381692|100670251|FG000|COMPLETED|Overall Study||6||
48293286|NCT02618031|101044505|FG000|NOT COMPLETED|Overall Study||1||
48293287|NCT02618031|101044506|FG001|NOT COMPLETED|Overall Study||0||
48293288|NCT00332189|101044507|FG000|STARTED|Overall Study||111||
48293289|NCT00332189|101044507|FG000|COMPLETED|Overall Study||90||
48293290|NCT00332189|101044507|FG000|NOT COMPLETED|Overall Study||21||
48293291|NCT00938860|101044508|FG000|STARTED|Overall Study||50||
48293292|NCT00938860|101044509|FG001|STARTED|Overall Study||42||
48293293|NCT00938860|101044508|FG000|Efficacy Population|Overall Study||40||
48293294|NCT00938860|101044509|FG001|Efficacy Population|Overall Study||41||
48293295|NCT00938860|101044508|FG000|COMPLETED|Overall Study||25||
48293296|NCT00938860|101044509|FG001|COMPLETED|Overall Study||25||
48293297|NCT00938860|101044508|FG000|NOT COMPLETED|Overall Study||25||
48293298|NCT00938860|101044509|FG001|NOT COMPLETED|Overall Study||17||
48293299|NCT04187989|101044510|FG000|STARTED|Overall Study - 3-Month Follow-Up||76||
48293300|NCT04187989|101044511|FG001|STARTED|Overall Study - 3-Month Follow-Up||73||
48293301|NCT04187989|101044510|FG000|COMPLETED|Overall Study - 3-Month Follow-Up||70|Completed 3-Month Follow-Up|
48293302|NCT04187989|101044511|FG001|COMPLETED|Overall Study - 3-Month Follow-Up||65|Completed 3-Month Follow-Up|
48293303|NCT04187989|101044510|FG000|NOT COMPLETED|Overall Study - 3-Month Follow-Up||6||
48293304|NCT04187989|101044511|FG001|NOT COMPLETED|Overall Study - 3-Month Follow-Up||8||
48293305|NCT04187989|101044510|FG000|STARTED|Overall Study - 6-Month Follow-Up||76||
48293306|NCT04187989|101044511|FG001|STARTED|Overall Study - 6-Month Follow-Up||73||
48293307|NCT04187989|101044510|FG000|COMPLETED|Overall Study - 6-Month Follow-Up||68|Completed 6-Month Follow-Up|
48293308|NCT04187989|101044511|FG001|COMPLETED|Overall Study - 6-Month Follow-Up||65|Completed 6-Month Follow-Up|
48293309|NCT04187989|101044510|FG000|NOT COMPLETED|Overall Study - 6-Month Follow-Up||8||
48403614|NCT06022224|101321644|FG001|NOT COMPLETED|Overall Study||0||
48403615|NCT02480998|101321645|FG000|STARTED|Overall Study||56||
48403616|NCT02480998|101321646|FG001|STARTED|Overall Study||28||
48591108|NCT03191864|101779848|FG004|COMPLETED|Part 2 - Maintenance||19||
48591109|NCT03191864|101779849|FG005|COMPLETED|Part 2 - Maintenance||0||
48591110|NCT03191864|101779844|FG000|NOT COMPLETED|Part 2 - Maintenance||5||
48591111|NCT03191864|101779845|FG001|NOT COMPLETED|Part 2 - Maintenance||2||
48591112|NCT03191864|101779846|FG002|NOT COMPLETED|Part 2 - Maintenance||3||
48591113|NCT03191864|101779847|FG003|NOT COMPLETED|Part 2 - Maintenance||2||
48709420|NCT04685707|102077778|FG001|STARTED|Control Session||9||
48709421|NCT04685707|102077777|FG000|COMPLETED|Control Session||11||
48709422|NCT04685707|102077778|FG001|COMPLETED|Control Session||9||
48403617|NCT02480998|101321645|FG000|COMPLETED|Overall Study||56||
48403618|NCT02480998|101321646|FG001|COMPLETED|Overall Study||28||
48403619|NCT02480998|101321645|FG000|NOT COMPLETED|Overall Study||0||
48403620|NCT02480998|101321646|FG001|NOT COMPLETED|Overall Study||0||
48403621|NCT03799627|101321647|FG000|STARTED|Overall Study||35||
48403622|NCT03799627|101321648|FG001|STARTED|Overall Study||34||
48403623|NCT03799627|101321649|FG002|STARTED|Overall Study||23||
48403624|NCT03799627|101321650|FG003|STARTED|Overall Study||18||
48403625|NCT03799627|101321651|FG004|STARTED|Overall Study||21||
48591114|NCT03191864|101779848|FG004|NOT COMPLETED|Part 2 - Maintenance||15||
48591115|NCT03191864|101779849|FG005|NOT COMPLETED|Part 2 - Maintenance||0||
48591116|NCT04481035|101779850|FG000|STARTED|Period 1||3||
48591117|NCT04481035|101779851|FG001|STARTED|Period 1||2||
48591118|NCT04481035|101779850|FG000|COMPLETED|Period 1||3||
48591119|NCT04481035|101779851|FG001|COMPLETED|Period 1||2||
48591120|NCT04481035|101779850|FG000|NOT COMPLETED|Period 1||0||
48591121|NCT04481035|101779851|FG001|NOT COMPLETED|Period 1||0||
48591122|NCT04481035|101779850|FG000|STARTED|Period 2||3||
48591123|NCT04481035|101779851|FG001|STARTED|Period 2||2||
48591124|NCT04481035|101779850|FG000|COMPLETED|Period 2||3||
48591125|NCT04481035|101779851|FG001|COMPLETED|Period 2||2||
48591126|NCT04481035|101779850|FG000|NOT COMPLETED|Period 2||0||
48591127|NCT04481035|101779851|FG001|NOT COMPLETED|Period 2||0||
48591128|NCT04395391|101779852|FG000|STARTED|Overall Study||30||
48591129|NCT04395391|101779852|FG000|COMPLETED|Overall Study||30||
48591130|NCT04395391|101779852|FG000|NOT COMPLETED|Overall Study||0||
48591131|NCT00894790|101779853|FG000|STARTED|Overall Study||4||
48591132|NCT00894790|101779854|FG001|STARTED|Overall Study||4||
48591133|NCT00894790|101779853|FG000|COMPLETED|Overall Study||3||
48591134|NCT00894790|101779854|FG001|COMPLETED|Overall Study||2||
48591135|NCT00894790|101779853|FG000|NOT COMPLETED|Overall Study||1||
48591136|NCT00894790|101779854|FG001|NOT COMPLETED|Overall Study||2||
48591137|NCT01793688|101779855|FG000|STARTED|Overall Study||982||
48591138|NCT01793688|101779855|FG000|COMPLETED|Overall Study||980||
48591139|NCT01793688|101779855|FG000|NOT COMPLETED|Overall Study||2||
48591140|NCT01306045|101779856|FG000|STARTED|Met General Eligibility Criteria||481|647met eligibility criteria/underwent molecular profiling, 257 had 1 of the core mutations\&45 enrolled in 1 of the treatment arms. 602 enrolled in Not Otherwise Specified Arm\&received standard of care treatment or enrolled in other clinical trials\&followed prospectively until death(312 with tumors-wild type or unknown for the mutation of interest, 212positive for 1 of the core mutations of interest but failed to enroll in treatment arms (screen failures)\&78 with unsuccessful molecular profiling.|
48591141|NCT01306045|101779857|FG001|STARTED|Met General Eligibility Criteria||68|647met eligibility criteria/underwent molecular profiling, 257 had 1 of the core mutations\&45 enrolled in 1 of the treatment arms. 602 enrolled in Not Otherwise Specified Arm\&received standard of care treatment or enrolled in other clinical trials\&followed prospectively until death(312 with tumors-wild type or unknown for the mutation of interest, 212positive for 1 of the core mutations of interest but failed to enroll in treatment arms (screen failures)\&78 with unsuccessful molecular profiling.|
48591142|NCT01306045|101779858|FG002|STARTED|Met General Eligibility Criteria||98|647met eligibility criteria/underwent molecular profiling, 257 had 1 of the core mutations\&45 enrolled in 1 of the treatment arms. 602 enrolled in Not Otherwise Specified Arm\&received standard of care treatment or enrolled in other clinical trials\&followed prospectively until death(312 with tumors-wild type or unknown for the mutation of interest, 212positive for 1 of the core mutations of interest but failed to enroll in treatment arms (screen failures)\&78 with unsuccessful molecular profiling.|
48591143|NCT01306045|101779856|FG000|Had EGFR Mutations|Met General Eligibility Criteria||88||
48591144|NCT01306045|101779857|FG001|Had EGFR Mutations|Met General Eligibility Criteria||1||
48403626|NCT03799627|101321652|FG005|STARTED|Overall Study||21||
48403627|NCT03799627|101321653|FG006|STARTED|Overall Study||13||
48403628|NCT03799627|101321654|FG007|STARTED|Overall Study||5||
48403629|NCT03799627|101321655|FG008|STARTED|Overall Study||5||
48403630|NCT03799627|101321647|FG000|COMPLETED|Overall Study||27||
48403631|NCT03799627|101321648|FG001|COMPLETED|Overall Study||23||
48403632|NCT03799627|101321649|FG002|COMPLETED|Overall Study||22||
48403633|NCT03799627|101321650|FG003|COMPLETED|Overall Study||8||
48403634|NCT03799627|101321651|FG004|COMPLETED|Overall Study||12||
48403635|NCT03799627|101321652|FG005|COMPLETED|Overall Study||8||
48403636|NCT03799627|101321653|FG006|COMPLETED|Overall Study||10||
48403637|NCT03799627|101321654|FG007|COMPLETED|Overall Study||3||
48403638|NCT03799627|101321655|FG008|COMPLETED|Overall Study||2||
48403639|NCT03799627|101321647|FG000|NOT COMPLETED|Overall Study||8||
48403640|NCT03799627|101321648|FG001|NOT COMPLETED|Overall Study||11||
48403641|NCT03799627|101321649|FG002|NOT COMPLETED|Overall Study||1||
48403642|NCT03799627|101321650|FG003|NOT COMPLETED|Overall Study||10||
48403643|NCT03799627|101321651|FG004|NOT COMPLETED|Overall Study||9||
48403644|NCT03799627|101321652|FG005|NOT COMPLETED|Overall Study||13||
48403645|NCT03799627|101321653|FG006|NOT COMPLETED|Overall Study||3||
48403646|NCT03799627|101321654|FG007|NOT COMPLETED|Overall Study||2||
48403647|NCT03799627|101321655|FG008|NOT COMPLETED|Overall Study||3||
48403648|NCT01039428|101321656|FG000|STARTED|Overall Study||35||
48403649|NCT01039428|101321657|FG001|STARTED|Overall Study||28||
48403650|NCT01039428|101321656|FG000|COMPLETED|Overall Study||33||
48403651|NCT01039428|101321657|FG001|COMPLETED|Overall Study||28||
48403652|NCT01039428|101321656|FG000|NOT COMPLETED|Overall Study||2||
48403653|NCT01039428|101321657|FG001|NOT COMPLETED|Overall Study||0||
48709423|NCT04685707|102077777|FG000|NOT COMPLETED|Control Session||0||
48709424|NCT04685707|102077778|FG001|NOT COMPLETED|Control Session||0||
48591145|NCT01306045|101779858|FG002|Had EGFR Mutations|Met General Eligibility Criteria||1||
48591146|NCT01306045|101779856|FG000|Had KRAS, HRAS, NRAS, or BRAF Mutations|Met General Eligibility Criteria||103||
48709425|NCT02403635|102077779|FG000|STARTED|Overall Study||27||
48709426|NCT02403635|102077779|FG000|Screening (28 Days)|Overall Study||27||
48709427|NCT02403635|102077779|FG000|Received the First Dose|Overall Study||18||
48709428|NCT02403635|102077779|FG000|COMPLETED|Overall Study||18||
48709429|NCT02403635|102077779|FG000|NOT COMPLETED|Overall Study||9||
48709430|NCT04209114|102077780|FG000|STARTED|Pre-Treatment Phase||37|Randomized|
48709431|NCT04209114|102077781|FG001|STARTED|Pre-Treatment Phase||37|Randomized|
48709432|NCT04209114|102077782|FG002|STARTED|Pre-Treatment Phase||40|Randomized|
48709433|NCT04209114|102077780|FG000|COMPLETED|Pre-Treatment Phase||37|Treated|
48709434|NCT04209114|102077781|FG001|COMPLETED|Pre-Treatment Phase||37|Treated|
48293310|NCT04187989|101044511|FG001|NOT COMPLETED|Overall Study - 6-Month Follow-Up||8||
48293311|NCT02788903|101044512|FG000|STARTED|Overall Study||567908||
48293312|NCT02788903|101044513|FG001|STARTED|Overall Study||2054256||
48403654|NCT00106249|101321658|FG000|STARTED|Overall Study||14||
48403655|NCT00106249|101321659|FG001|STARTED|Overall Study||13||
48591147|NCT01306045|101779857|FG001|Had KRAS, HRAS, NRAS, or BRAF Mutations|Met General Eligibility Criteria||5||
48591148|NCT01306045|101779858|FG002|Had KRAS, HRAS, NRAS, or BRAF Mutations|Met General Eligibility Criteria||2||
48591149|NCT01306045|101779856|FG000|Had PTEN, Akt1, or PIK3CA Abnormalities|Met General Eligibility Criteria||22||
48591150|NCT01306045|101779857|FG001|Had PTEN, Akt1, or PIK3CA Abnormalities|Met General Eligibility Criteria||7||
48591151|NCT01306045|101779858|FG002|Had PTEN, Akt1, or PIK3CA Abnormalities|Met General Eligibility Criteria||2||
48591152|NCT01306045|101779856|FG000|Had ERBB2 Mutations or Amplifications|Met General Eligibility Criteria||13||
48591153|NCT01306045|101779857|FG001|Had ERBB2 Mutations or Amplifications|Met General Eligibility Criteria||1||
48591154|NCT01306045|101779858|FG002|Had ERBB2 Mutations or Amplifications|Met General Eligibility Criteria||1||
48591155|NCT01306045|101779856|FG000|Had KIT or PDGFRA Mutations or Amplifications|Met General Eligibility Criteria||5||
48591156|NCT01306045|101779857|FG001|Had KIT or PDGFRA Mutations or Amplifications|Met General Eligibility Criteria||1||
48591157|NCT01306045|101779858|FG002|Had KIT or PDGFRA Mutations or Amplifications|Met General Eligibility Criteria||5||
48709435|NCT04209114|102077782|FG002|COMPLETED|Pre-Treatment Phase||32|Treated|
48709436|NCT04209114|102077780|FG000|NOT COMPLETED|Pre-Treatment Phase||0||
48709437|NCT04209114|102077781|FG001|NOT COMPLETED|Pre-Treatment Phase||0||
48709438|NCT04209114|102077782|FG002|NOT COMPLETED|Pre-Treatment Phase||8||
48709439|NCT04209114|102077780|FG000|STARTED|Treatment Phase||37|Treated|
48709440|NCT04209114|102077781|FG001|STARTED|Treatment Phase||37|Treated|
48709441|NCT04209114|102077782|FG002|STARTED|Treatment Phase||32|Treated|
48709442|NCT04209114|102077780|FG000|COMPLETED|Treatment Phase||15||
48709443|NCT04209114|102077781|FG001|COMPLETED|Treatment Phase||13||
48709444|NCT04209114|102077782|FG002|COMPLETED|Treatment Phase||32||
48709445|NCT04209114|102077780|FG000|NOT COMPLETED|Treatment Phase||22||
48709446|NCT04209114|102077781|FG001|NOT COMPLETED|Treatment Phase||24||
48709447|NCT04209114|102077782|FG002|NOT COMPLETED|Treatment Phase||0||
48709448|NCT02387801|102077783|FG000|STARTED|Induction Dosing Period||6||
48709449|NCT02387801|102077784|FG001|STARTED|Induction Dosing Period||6||
48709450|NCT02387801|102077783|FG000|COMPLETED|Induction Dosing Period||6||
48709451|NCT02387801|102077784|FG001|COMPLETED|Induction Dosing Period||6||
48710777|NCT00899717|102078015|FG001|COMPLETED|Overall Study||11||
48140748|NCT01381692|100670252|FG001|COMPLETED|Overall Study||2||
48140749|NCT01381692|100670253|FG002|COMPLETED|Overall Study||0||
48140750|NCT01381692|100670254|FG003|COMPLETED|Overall Study||0||
48140751|NCT01381692|100670255|FG004|COMPLETED|Overall Study||0||
48140752|NCT01381692|100670256|FG005|COMPLETED|Overall Study||0||
48140753|NCT01381692|100670251|FG000|NOT COMPLETED|Overall Study||1||
48140754|NCT01381692|100670252|FG001|NOT COMPLETED|Overall Study||0||
48140755|NCT01381692|100670253|FG002|NOT COMPLETED|Overall Study||0||
48140756|NCT01381692|100670254|FG003|NOT COMPLETED|Overall Study||0||
48140757|NCT01381692|100670255|FG004|NOT COMPLETED|Overall Study||0||
48140758|NCT01381692|100670256|FG005|NOT COMPLETED|Overall Study||0||
48140759|NCT02564523|100670257|FG000|STARTED|Overall Study||225||
48140760|NCT02564523|100670258|FG001|STARTED|Overall Study||43||
48140761|NCT02564523|100670259|FG002|STARTED|Overall Study||224||
48140762|NCT02564523|100670260|FG003|STARTED|Overall Study||44||
48140763|NCT02564523|100670261|FG004|STARTED|Overall Study||110||
48140764|NCT02564523|100670262|FG005|STARTED|Overall Study||22||
48140765|NCT02564523|100670263|FG006|STARTED|Overall Study||59||
48140766|NCT02564523|100670264|FG007|STARTED|Overall Study||12||
48140767|NCT02564523|100670265|FG008|STARTED|Overall Study||59||
48140768|NCT02564523|100670266|FG009|STARTED|Overall Study||12||
48140769|NCT02564523|100670267|FG010|STARTED|Overall Study||55||
48140770|NCT02564523|100670268|FG011|STARTED|Overall Study||11||
48140771|NCT02564523|100670269|FG012|STARTED|Overall Study||55||
48140772|NCT02564523|100670270|FG013|STARTED|Overall Study||10||
48140773|NCT02564523|100670271|FG014|STARTED|Overall Study||54||
48140774|NCT02564523|100670272|FG015|STARTED|Overall Study||12||
48403656|NCT00106249|101321658|FG000|COMPLETED|Overall Study||11||
48403657|NCT00106249|101321659|FG001|COMPLETED|Overall Study||11||
48709452|NCT02387801|102077783|FG000|NOT COMPLETED|Induction Dosing Period||0||
48709453|NCT02387801|102077784|FG001|NOT COMPLETED|Induction Dosing Period||0||
48709454|NCT02387801|102077783|FG000|STARTED|Maintenance Dosing Period||0||
48709455|NCT02387801|102077784|FG001|STARTED|Maintenance Dosing Period||12||
48709456|NCT02387801|102077783|FG000|COMPLETED|Maintenance Dosing Period||0||
48709457|NCT02387801|102077784|FG001|COMPLETED|Maintenance Dosing Period||12||
48709458|NCT02387801|102077783|FG000|NOT COMPLETED|Maintenance Dosing Period||0||
48709459|NCT02387801|102077784|FG001|NOT COMPLETED|Maintenance Dosing Period||0||
48709460|NCT02387801|102077783|FG000|STARTED|Post-Treatment Follow-up||0||
48709461|NCT02387801|102077784|FG001|STARTED|Post-Treatment Follow-up||12||
48709462|NCT02387801|102077783|FG000|COMPLETED|Post-Treatment Follow-up||0||
48709463|NCT02387801|102077784|FG001|COMPLETED|Post-Treatment Follow-up||12||
48709464|NCT02387801|102077783|FG000|NOT COMPLETED|Post-Treatment Follow-up||0||
48709465|NCT02387801|102077784|FG001|NOT COMPLETED|Post-Treatment Follow-up||0||
48709466|NCT03894969|102077785|FG000|STARTED|Overall Study||134||
48709467|NCT03894969|102077786|FG001|STARTED|Overall Study||134||
48709468|NCT03894969|102077787|FG002|STARTED|Overall Study||122||
48709469|NCT03894969|102077788|FG003|STARTED|Overall Study||135||
48709470|NCT03894969|102077789|FG004|STARTED|Overall Study||16||
48709471|NCT03894969|102077785|FG000|COMPLETED|Overall Study||129||
48709472|NCT03894969|102077786|FG001|COMPLETED|Overall Study||129||
48709473|NCT03894969|102077787|FG002|COMPLETED|Overall Study||118||
48709474|NCT03894969|102077788|FG003|COMPLETED|Overall Study||128||
48591158|NCT01306045|101779856|FG000|Enrolled Onto Treatment Arm|Met General Eligibility Criteria||38||
48591159|NCT01306045|101779857|FG001|Enrolled Onto Treatment Arm|Met General Eligibility Criteria||4||
48591160|NCT01306045|101779858|FG002|Enrolled Onto Treatment Arm|Met General Eligibility Criteria||3||
48591161|NCT01306045|101779856|FG000|COMPLETED|Met General Eligibility Criteria||288||
48591162|NCT01306045|101779857|FG001|COMPLETED|Met General Eligibility Criteria||57||
48591163|NCT01306045|101779858|FG002|COMPLETED|Met General Eligibility Criteria||90||
48591164|NCT01306045|101779856|FG000|NOT COMPLETED|Met General Eligibility Criteria||193||
48591165|NCT01306045|101779857|FG001|NOT COMPLETED|Met General Eligibility Criteria||11||
48591166|NCT01306045|101779858|FG002|NOT COMPLETED|Met General Eligibility Criteria||8||
48591167|NCT01306045|101779856|FG000|STARTED|Treatments Received||38||
48591168|NCT01306045|101779857|FG001|STARTED|Treatments Received||4||
48591169|NCT01306045|101779858|FG002|STARTED|Treatments Received||3||
48591170|NCT01306045|101779856|FG000|Received Erlotinib: Arm 1, Arm 2, and Arm 3 Respectively.|Treatments Received||15||
48591171|NCT01306045|101779857|FG001|Received Erlotinib: Arm 1, Arm 2, and Arm 3 Respectively.|Treatments Received||0||
48591172|NCT01306045|101779858|FG002|Received Erlotinib: Arm 1, Arm 2, and Arm 3 Respectively.|Treatments Received||1||
48591173|NCT01306045|101779856|FG000|Received Selumetinib: Arm 4, Arm 5, and Arm 6 Respectively.|Treatments Received||9||
48591174|NCT01306045|101779857|FG001|Received Selumetinib: Arm 4, Arm 5, and Arm 6 Respectively.|Treatments Received||1||
48591175|NCT01306045|101779858|FG002|Received Selumetinib: Arm 4, Arm 5, and Arm 6 Respectively.|Treatments Received||0||
48591176|NCT01306045|101779856|FG000|Received MK2206: Arm 7, Arm 8, and Arm 9 Respectively.|Treatments Received||4||
48591177|NCT01306045|101779857|FG001|Received MK2206: Arm 7, Arm 8, and Arm 9 Respectively.|Treatments Received||2||
48591178|NCT01306045|101779858|FG002|Received MK2206: Arm 7, Arm 8, and Arm 9 Respectively.|Treatments Received||1||
48591179|NCT01306045|101779856|FG000|Received Lapatinib: Arm 10, Arm 11, and Arm 12 Respectively.|Treatments Received||6||
48591180|NCT01306045|101779857|FG001|Received Lapatinib: Arm 10, Arm 11, and Arm 12 Respectively.|Treatments Received||1||
48591181|NCT01306045|101779858|FG002|Received Lapatinib: Arm 10, Arm 11, and Arm 12 Respectively.|Treatments Received||0||
48591182|NCT01306045|101779856|FG000|Received Sunitinib: Arm 13, Arm 14, and Arm 15 Respectively.|Treatments Received||2||
48591183|NCT01306045|101779857|FG001|Received Sunitinib: Arm 13, Arm 14, and Arm 15 Respectively.|Treatments Received||0||
48591184|NCT01306045|101779858|FG002|Received Sunitinib: Arm 13, Arm 14, and Arm 15 Respectively.|Treatments Received||1||
48591185|NCT01306045|101779856|FG000|COMPLETED|Treatments Received||36||
48591186|NCT01306045|101779857|FG001|COMPLETED|Treatments Received||4||
48591187|NCT01306045|101779858|FG002|COMPLETED|Treatments Received||3||
48591188|NCT01306045|101779856|FG000|NOT COMPLETED|Treatments Received||2||
48591189|NCT01306045|101779857|FG001|NOT COMPLETED|Treatments Received||0||
48591190|NCT01306045|101779858|FG002|NOT COMPLETED|Treatments Received||0||
48591191|NCT01570634|101779859|FG000|STARTED|Overall Study||2||
48591192|NCT01570634|101779859|FG000|COMPLETED|Overall Study||2||
48591193|NCT01570634|101779859|FG000|NOT COMPLETED|Overall Study||0||
48591194|NCT00094536|101779860|FG000|STARTED|Inclusion Exclusion Evaluation||106||
48591195|NCT00094536|101779860|FG000|COMPLETED|Inclusion Exclusion Evaluation||82||
48591196|NCT00094536|101779860|FG000|NOT COMPLETED|Inclusion Exclusion Evaluation||24||
48709475|NCT03894969|102077789|FG004|COMPLETED|Overall Study||2||
48709476|NCT03894969|102077785|FG000|NOT COMPLETED|Overall Study||5||
48709477|NCT03894969|102077786|FG001|NOT COMPLETED|Overall Study||5||
48709478|NCT03894969|102077787|FG002|NOT COMPLETED|Overall Study||4||
48709479|NCT03894969|102077788|FG003|NOT COMPLETED|Overall Study||7||
48709480|NCT03894969|102077789|FG004|NOT COMPLETED|Overall Study||14||
48709481|NCT01154283|102077790|FG000|STARTED|0-6 Weeks||14||
48709482|NCT01154283|102077791|FG001|STARTED|0-6 Weeks||14||
48709483|NCT01154283|102077790|FG000|COMPLETED|0-6 Weeks||7||
48709484|NCT01154283|102077791|FG001|COMPLETED|0-6 Weeks||11||
48591197|NCT00094536|101779860|FG000|STARTED|Treatment and Follow-up||82||
48293313|NCT02788903|101044512|FG000|COMPLETED|Overall Study||567908||
48293314|NCT02788903|101044513|FG001|COMPLETED|Overall Study||2054256||
48293315|NCT02788903|101044512|FG000|NOT COMPLETED|Overall Study||0||
48293316|NCT02788903|101044513|FG001|NOT COMPLETED|Overall Study||0||
48293317|NCT00953407|101044514|FG000|STARTED|Overall Study||26||
48293318|NCT00953407|101044515|FG001|STARTED|Overall Study||25||
48293319|NCT00953407|101044516|FG002|STARTED|Overall Study||26||
48293320|NCT00953407|101044517|FG003|STARTED|Overall Study||25||
48293321|NCT00953407|101044518|FG004|STARTED|Overall Study||24||
48293322|NCT00953407|101044514|FG000|COMPLETED|Overall Study||25||
48293323|NCT00953407|101044515|FG001|COMPLETED|Overall Study||24||
48293324|NCT00953407|101044516|FG002|COMPLETED|Overall Study||25||
48293325|NCT00953407|101044517|FG003|COMPLETED|Overall Study||23||
48293326|NCT00953407|101044518|FG004|COMPLETED|Overall Study||23||
48293327|NCT00953407|101044514|FG000|NOT COMPLETED|Overall Study||1||
48293328|NCT00953407|101044515|FG001|NOT COMPLETED|Overall Study||1||
48293329|NCT00953407|101044516|FG002|NOT COMPLETED|Overall Study||1||
48293330|NCT00953407|101044517|FG003|NOT COMPLETED|Overall Study||2||
48293331|NCT00953407|101044518|FG004|NOT COMPLETED|Overall Study||1||
48293332|NCT04259645|101044519|FG000|STARTED|Overall Study||29||
48293333|NCT04259645|101044520|FG001|STARTED|Overall Study||31||
48293334|NCT04259645|101044519|FG000|COMPLETED|Overall Study||29||
48293335|NCT04259645|101044520|FG001|COMPLETED|Overall Study||31||
48293336|NCT04259645|101044519|FG000|NOT COMPLETED|Overall Study||0||
48293337|NCT04259645|101044520|FG001|NOT COMPLETED|Overall Study||0||
48293338|NCT00282282|101044521|FG000|STARTED|Overall Study||29||
48293339|NCT00282282|101044521|FG000|COMPLETED|Overall Study||29||
48293340|NCT00282282|101044521|FG000|NOT COMPLETED|Overall Study||0||
48293341|NCT01403610|101044522|FG000|STARTED|Overall Study||5||
48293342|NCT01403610|101044523|FG001|STARTED|Overall Study||6||
48293343|NCT01403610|101044524|FG002|STARTED|Overall Study||4||
48293344|NCT01403610|101044525|FG003|STARTED|Overall Study||13||
48293345|NCT01403610|101044522|FG000|COMPLETED|Overall Study||3||
48293346|NCT01403610|101044523|FG001|COMPLETED|Overall Study||3||
48293347|NCT01403610|101044524|FG002|COMPLETED|Overall Study||4||
48293348|NCT01403610|101044525|FG003|COMPLETED|Overall Study||13||
48293349|NCT01403610|101044522|FG000|NOT COMPLETED|Overall Study||2||
48293350|NCT01403610|101044523|FG001|NOT COMPLETED|Overall Study||3||
48293351|NCT01403610|101044524|FG002|NOT COMPLETED|Overall Study||0||
48293352|NCT01403610|101044525|FG003|NOT COMPLETED|Overall Study||0||
48293353|NCT03435497|101044526|FG000|STARTED|Overall Study||51||
48293354|NCT03435497|101044527|FG001|STARTED|Overall Study||47||
48293355|NCT03435497|101044526|FG000|COMPLETED|Overall Study||49||
48293356|NCT03435497|101044527|FG001|COMPLETED|Overall Study||41||
48293357|NCT03435497|101044526|FG000|NOT COMPLETED|Overall Study||2||
48293358|NCT03435497|101044527|FG001|NOT COMPLETED|Overall Study||6||
48293359|NCT00547365|101044528|FG000|STARTED|Overall Study||10||
48293360|NCT00547365|101044528|FG000|COMPLETED|Overall Study||2||
48293361|NCT00547365|101044528|FG000|NOT COMPLETED|Overall Study||8||
48293362|NCT01222273|101044529|FG000|STARTED|Overall Study||7||
48293363|NCT01222273|101044529|FG000|COMPLETED|Overall Study||7||
48293364|NCT01222273|101044529|FG000|NOT COMPLETED|Overall Study||0||
48293365|NCT02668185|101044530|FG000|STARTED|Baseline Period (2 Weeks)||20||
48293366|NCT02668185|101044531|FG001|STARTED|Baseline Period (2 Weeks)||17||
48293367|NCT02668185|101044530|FG000|COMPLETED|Baseline Period (2 Weeks)||20||
48293368|NCT02668185|101044531|FG001|COMPLETED|Baseline Period (2 Weeks)||17||
48293369|NCT02668185|101044530|FG000|NOT COMPLETED|Baseline Period (2 Weeks)||0||
48293370|NCT02668185|101044531|FG001|NOT COMPLETED|Baseline Period (2 Weeks)||0||
48293371|NCT02668185|101044530|FG000|STARTED|First Intervention (4 Weeks)||20||
48293372|NCT02668185|101044531|FG001|STARTED|First Intervention (4 Weeks)||17||
48293373|NCT02668185|101044530|FG000|COMPLETED|First Intervention (4 Weeks)||18||
48293374|NCT02668185|101044531|FG001|COMPLETED|First Intervention (4 Weeks)||17||
48293375|NCT02668185|101044530|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2||
48293376|NCT02668185|101044531|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0||
48293377|NCT02668185|101044530|FG000|STARTED|Washout Period (2 Weeks)||18||
48293378|NCT02668185|101044531|FG001|STARTED|Washout Period (2 Weeks)||17||
48293379|NCT02668185|101044530|FG000|COMPLETED|Washout Period (2 Weeks)||17||
48293380|NCT02668185|101044531|FG001|COMPLETED|Washout Period (2 Weeks)||15||
48293381|NCT02668185|101044530|FG000|NOT COMPLETED|Washout Period (2 Weeks)||1||
48293382|NCT02668185|101044531|FG001|NOT COMPLETED|Washout Period (2 Weeks)||2||
48293383|NCT02668185|101044530|FG000|STARTED|Second Intervention (4 Weeks)||17||
48293384|NCT02668185|101044531|FG001|STARTED|Second Intervention (4 Weeks)||15||
48293385|NCT02668185|101044530|FG000|COMPLETED|Second Intervention (4 Weeks)||16||
48293386|NCT02668185|101044531|FG001|COMPLETED|Second Intervention (4 Weeks)||12||
48293387|NCT02668185|101044530|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1||
48293388|NCT02668185|101044531|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||3||
48293389|NCT02668185|101044530|FG000|STARTED|Moitoring Period (2 Weeks)||16||
48293390|NCT02668185|101044531|FG001|STARTED|Moitoring Period (2 Weeks)||12||
48293391|NCT02668185|101044530|FG000|COMPLETED|Moitoring Period (2 Weeks)||16||
48293392|NCT02668185|101044531|FG001|COMPLETED|Moitoring Period (2 Weeks)||12||
48403658|NCT00106249|101321658|FG000|NOT COMPLETED|Overall Study||3||
48293393|NCT02668185|101044530|FG000|NOT COMPLETED|Moitoring Period (2 Weeks)||0||
48293394|NCT02668185|101044531|FG001|NOT COMPLETED|Moitoring Period (2 Weeks)||0||
48293395|NCT02935452|101044532|FG000|STARTED|Overall Study||30||
48293396|NCT02935452|101044533|FG001|STARTED|Overall Study||30||
48293397|NCT02935452|101044532|FG000|COMPLETED|Overall Study||27||
48293398|NCT02935452|101044533|FG001|COMPLETED|Overall Study||29||
48293399|NCT02935452|101044532|FG000|NOT COMPLETED|Overall Study||3||
48293400|NCT02935452|101044533|FG001|NOT COMPLETED|Overall Study||1||
48293401|NCT01898923|101044534|FG000|STARTED|Overall Study||122||
48293402|NCT01898923|101044535|FG001|STARTED|Overall Study||114||
48293403|NCT01898923|101044534|FG000|COMPLETED|Overall Study||106||
48293404|NCT01898923|101044535|FG001|COMPLETED|Overall Study||93||
48293405|NCT01898923|101044534|FG000|NOT COMPLETED|Overall Study||16||
48293406|NCT01898923|101044535|FG001|NOT COMPLETED|Overall Study||21||
48293407|NCT02411357|101044536|FG000|STARTED|Overall Study||48||
48293408|NCT02411357|101044537|FG001|STARTED|Overall Study||48||
48293409|NCT02411357|101044538|FG002|STARTED|Overall Study||42||
48293410|NCT02411357|101044536|FG000|COMPLETED|Overall Study||48||
48293411|NCT02411357|101044537|FG001|COMPLETED|Overall Study||48||
48293412|NCT02411357|101044538|FG002|COMPLETED|Overall Study||42||
48293413|NCT02411357|101044536|FG000|NOT COMPLETED|Overall Study||0||
48293414|NCT02411357|101044537|FG001|NOT COMPLETED|Overall Study||0||
48293415|NCT02411357|101044538|FG002|NOT COMPLETED|Overall Study||0||
48293416|NCT01012739|101044539|FG000|STARTED|Treatment Period 1||9||
48293417|NCT01012739|101044540|FG001|STARTED|Treatment Period 1||8||
48293418|NCT01012739|101044541|FG002|STARTED|Treatment Period 1||9||
48293419|NCT01012739|101044542|FG003|STARTED|Treatment Period 1||9||
48293420|NCT01012739|101044539|FG000|COMPLETED|Treatment Period 1||9||
48293421|NCT01012739|101044540|FG001|COMPLETED|Treatment Period 1||8||
48293422|NCT01012739|101044541|FG002|COMPLETED|Treatment Period 1||9||
48293423|NCT01012739|101044542|FG003|COMPLETED|Treatment Period 1||8||
48293424|NCT01012739|101044539|FG000|NOT COMPLETED|Treatment Period 1||0||
48293425|NCT01012739|101044540|FG001|NOT COMPLETED|Treatment Period 1||0||
48293426|NCT01012739|101044541|FG002|NOT COMPLETED|Treatment Period 1||0||
48293427|NCT01012739|101044542|FG003|NOT COMPLETED|Treatment Period 1||1||
48293428|NCT01012739|101044539|FG000|STARTED|Treatment Period 2||9||
48293429|NCT01012739|101044540|FG001|STARTED|Treatment Period 2||8||
48293430|NCT01012739|101044541|FG002|STARTED|Treatment Period 2||9||
48293431|NCT01012739|101044542|FG003|STARTED|Treatment Period 2||8||
48293432|NCT01012739|101044539|FG000|COMPLETED|Treatment Period 2||9||
48293433|NCT01012739|101044540|FG001|COMPLETED|Treatment Period 2||8||
48293434|NCT01012739|101044541|FG002|COMPLETED|Treatment Period 2||9||
48293435|NCT01012739|101044542|FG003|COMPLETED|Treatment Period 2||7||
48293436|NCT01012739|101044539|FG000|NOT COMPLETED|Treatment Period 2||0||
48293437|NCT01012739|101044540|FG001|NOT COMPLETED|Treatment Period 2||0||
48293438|NCT01012739|101044541|FG002|NOT COMPLETED|Treatment Period 2||0||
48293439|NCT01012739|101044542|FG003|NOT COMPLETED|Treatment Period 2||1||
48293440|NCT01012739|101044539|FG000|STARTED|Treatment Period 3||9||
48293441|NCT01012739|101044540|FG001|STARTED|Treatment Period 3||8||
48293442|NCT01012739|101044541|FG002|STARTED|Treatment Period 3||9||
48293443|NCT01012739|101044542|FG003|STARTED|Treatment Period 3||7||
48293444|NCT01012739|101044539|FG000|COMPLETED|Treatment Period 3||9||
48293445|NCT01012739|101044540|FG001|COMPLETED|Treatment Period 3||8||
48293446|NCT01012739|101044541|FG002|COMPLETED|Treatment Period 3||9||
48293447|NCT01012739|101044542|FG003|COMPLETED|Treatment Period 3||7||
48293448|NCT01012739|101044539|FG000|NOT COMPLETED|Treatment Period 3||0||
48293449|NCT01012739|101044540|FG001|NOT COMPLETED|Treatment Period 3||0||
48293450|NCT01012739|101044541|FG002|NOT COMPLETED|Treatment Period 3||0||
48293451|NCT01012739|101044542|FG003|NOT COMPLETED|Treatment Period 3||0||
48293452|NCT01012739|101044539|FG000|STARTED|Treatment Period 4||9||
48293453|NCT01012739|101044540|FG001|STARTED|Treatment Period 4||8||
48293454|NCT01012739|101044541|FG002|STARTED|Treatment Period 4||9||
48293455|NCT01012739|101044542|FG003|STARTED|Treatment Period 4||7||
48293456|NCT01012739|101044539|FG000|COMPLETED|Treatment Period 4||9||
48293457|NCT01012739|101044540|FG001|COMPLETED|Treatment Period 4||8||
48293458|NCT01012739|101044541|FG002|COMPLETED|Treatment Period 4||9||
48293459|NCT01012739|101044542|FG003|COMPLETED|Treatment Period 4||7||
48293460|NCT01012739|101044539|FG000|NOT COMPLETED|Treatment Period 4||0||
48293461|NCT01012739|101044540|FG001|NOT COMPLETED|Treatment Period 4||0||
48293462|NCT01012739|101044541|FG002|NOT COMPLETED|Treatment Period 4||0||
48293463|NCT01012739|101044542|FG003|NOT COMPLETED|Treatment Period 4||0||
48293464|NCT00368992|101044543|FG000|STARTED|Overall Study||110||
48293465|NCT00368992|101044543|FG000|COMPLETED|Overall Study||0||
48293466|NCT00368992|101044543|FG000|NOT COMPLETED|Overall Study||110||
48293467|NCT01426763|101044544|FG000|STARTED|Overall Study||6||
48293468|NCT01426763|101044545|FG001|STARTED|Overall Study||6||
48293469|NCT01426763|101044544|FG000|COMPLETED|Overall Study||6||
48293470|NCT01426763|101044545|FG001|COMPLETED|Overall Study||6||
48293471|NCT01426763|101044544|FG000|NOT COMPLETED|Overall Study||0||
48293472|NCT01426763|101044545|FG001|NOT COMPLETED|Overall Study||0||
48293473|NCT02074553|101044546|FG000|STARTED|Intervention Period 1||12||
48293474|NCT02074553|101044547|FG001|STARTED|Intervention Period 1||12||
48293475|NCT02074553|101044548|FG002|STARTED|Intervention Period 1||12||
48293476|NCT02074553|101044549|FG003|STARTED|Intervention Period 1||13||
48293477|NCT02074553|101044550|FG004|STARTED|Intervention Period 1||12||
48293478|NCT02074553|101044551|FG005|STARTED|Intervention Period 1||12||
48293479|NCT02074553|101044552|FG006|STARTED|Intervention Period 1||12||
48293480|NCT02074553|101044553|FG007|STARTED|Intervention Period 1||12||
48293481|NCT02074553|101044546|FG000|COMPLETED|Intervention Period 1||12||
48293482|NCT02074553|101044547|FG001|COMPLETED|Intervention Period 1||12||
48293483|NCT02074553|101044548|FG002|COMPLETED|Intervention Period 1||12||
48293484|NCT02074553|101044549|FG003|COMPLETED|Intervention Period 1||12||
48293485|NCT02074553|101044550|FG004|COMPLETED|Intervention Period 1||12||
48293486|NCT02074553|101044551|FG005|COMPLETED|Intervention Period 1||12||
48293487|NCT02074553|101044552|FG006|COMPLETED|Intervention Period 1||12||
48293488|NCT02074553|101044553|FG007|COMPLETED|Intervention Period 1||12||
48293489|NCT02074553|101044546|FG000|NOT COMPLETED|Intervention Period 1||0||
48293490|NCT02074553|101044547|FG001|NOT COMPLETED|Intervention Period 1||0||
48293491|NCT02074553|101044548|FG002|NOT COMPLETED|Intervention Period 1||0||
48293492|NCT02074553|101044549|FG003|NOT COMPLETED|Intervention Period 1||1||
48293493|NCT02074553|101044550|FG004|NOT COMPLETED|Intervention Period 1||0||
48293494|NCT02074553|101044551|FG005|NOT COMPLETED|Intervention Period 1||0||
48293495|NCT02074553|101044552|FG006|NOT COMPLETED|Intervention Period 1||0||
48293496|NCT02074553|101044553|FG007|NOT COMPLETED|Intervention Period 1||0||
48293497|NCT02074553|101044546|FG000|STARTED|Washout Period 1||12||
48293498|NCT02074553|101044547|FG001|STARTED|Washout Period 1||12||
48293499|NCT02074553|101044548|FG002|STARTED|Washout Period 1||12||
48293500|NCT02074553|101044549|FG003|STARTED|Washout Period 1||12||
48293501|NCT02074553|101044550|FG004|STARTED|Washout Period 1||12||
48293502|NCT02074553|101044551|FG005|STARTED|Washout Period 1||12||
48293503|NCT02074553|101044552|FG006|STARTED|Washout Period 1||12||
48293504|NCT02074553|101044553|FG007|STARTED|Washout Period 1||12||
48293505|NCT02074553|101044546|FG000|COMPLETED|Washout Period 1||11||
48293506|NCT02074553|101044547|FG001|COMPLETED|Washout Period 1||12||
48293507|NCT02074553|101044548|FG002|COMPLETED|Washout Period 1||12||
48293508|NCT02074553|101044549|FG003|COMPLETED|Washout Period 1||11||
48293509|NCT02074553|101044550|FG004|COMPLETED|Washout Period 1||12||
48293510|NCT02074553|101044551|FG005|COMPLETED|Washout Period 1||11||
48293511|NCT02074553|101044552|FG006|COMPLETED|Washout Period 1||12||
48293512|NCT02074553|101044553|FG007|COMPLETED|Washout Period 1||12||
48293513|NCT02074553|101044546|FG000|NOT COMPLETED|Washout Period 1||1||
48293514|NCT02074553|101044547|FG001|NOT COMPLETED|Washout Period 1||0||
48293515|NCT02074553|101044548|FG002|NOT COMPLETED|Washout Period 1||0||
48293516|NCT02074553|101044549|FG003|NOT COMPLETED|Washout Period 1||1||
48591198|NCT00094536|101779860|FG000|12 Month Follow-up|Treatment and Follow-up||69||
48591199|NCT00094536|101779860|FG000|24 Month Follow-up|Treatment and Follow-up||53||
48591200|NCT00094536|101779860|FG000|36 Month Follow-up|Treatment and Follow-up||51||
48591201|NCT00094536|101779860|FG000|COMPLETED|Treatment and Follow-up||51||
48591202|NCT00094536|101779860|FG000|NOT COMPLETED|Treatment and Follow-up||31||
48591203|NCT05323994|101779861|FG000|STARTED|Overall Study||104||
48591204|NCT05323994|101779861|FG000|COMPLETED|Overall Study||103||
48591205|NCT05323994|101779861|FG000|NOT COMPLETED|Overall Study||1||
48591206|NCT00985517|101779862|FG000|STARTED|Overall Study||3||
48591207|NCT00985517|101779863|FG001|STARTED|Overall Study||3||
48591208|NCT00985517|101779864|FG002|STARTED|Overall Study||24||
48591209|NCT00985517|101779865|FG003|STARTED|Overall Study||27||
48591210|NCT00985517|101779862|FG000|COMPLETED|Overall Study||3||
48591211|NCT00985517|101779863|FG001|COMPLETED|Overall Study||3||
48591212|NCT00985517|101779864|FG002|COMPLETED|Overall Study||23||
48591213|NCT00985517|101779865|FG003|COMPLETED|Overall Study||24||
48591214|NCT00985517|101779862|FG000|NOT COMPLETED|Overall Study||0||
48591215|NCT00985517|101779863|FG001|NOT COMPLETED|Overall Study||0||
48591216|NCT00985517|101779864|FG002|NOT COMPLETED|Overall Study||1||
48293517|NCT02074553|101044550|FG004|NOT COMPLETED|Washout Period 1||0||
48293518|NCT02074553|101044551|FG005|NOT COMPLETED|Washout Period 1||1||
48293519|NCT02074553|101044552|FG006|NOT COMPLETED|Washout Period 1||0||
48293520|NCT02074553|101044553|FG007|NOT COMPLETED|Washout Period 1||0||
48293521|NCT02074553|101044546|FG000|STARTED|Intervention Period 2||11||
48293522|NCT02074553|101044547|FG001|STARTED|Intervention Period 2||12||
48293523|NCT02074553|101044548|FG002|STARTED|Intervention Period 2||12||
48293524|NCT02074553|101044549|FG003|STARTED|Intervention Period 2||11||
48293525|NCT02074553|101044550|FG004|STARTED|Intervention Period 2||12||
48293526|NCT02074553|101044551|FG005|STARTED|Intervention Period 2||11||
48591217|NCT00985517|101779865|FG003|NOT COMPLETED|Overall Study||3||
48591218|NCT01286168|101779866|FG000|STARTED|Overall Study||104||
48591219|NCT01286168|101779866|FG000|COMPLETED|Overall Study||101||
48591220|NCT01286168|101779866|FG000|NOT COMPLETED|Overall Study||3||
48591221|NCT00880581|101779867|FG000|STARTED|Cycle 1||30||
48591222|NCT00880581|101779867|FG000|COMPLETED|Cycle 1||30||
48591223|NCT00880581|101779867|FG000|NOT COMPLETED|Cycle 1||0||
48591224|NCT00880581|101779867|FG000|STARTED|Cycle 2 Re-treatment||24||
48591225|NCT00880581|101779867|FG000|COMPLETED|Cycle 2 Re-treatment||24||
48591226|NCT00880581|101779867|FG000|NOT COMPLETED|Cycle 2 Re-treatment||0||
48591227|NCT00570349|101779868|FG000|STARTED|Overall Study||6||
48591228|NCT00570349|101779869|FG001|STARTED|Overall Study||6||
48591229|NCT00570349|101779870|FG002|STARTED|Overall Study||6||
48591230|NCT00570349|101779868|FG000|COMPLETED|Overall Study||6||
48591231|NCT00570349|101779869|FG001|COMPLETED|Overall Study||6||
48591232|NCT00570349|101779870|FG002|COMPLETED|Overall Study||6||
48591233|NCT00570349|101779868|FG000|NOT COMPLETED|Overall Study||0||
48591234|NCT00570349|101779869|FG001|NOT COMPLETED|Overall Study||0||
48591235|NCT00570349|101779870|FG002|NOT COMPLETED|Overall Study||0||
48591236|NCT02210286|101779871|FG000|STARTED|Overall Study||17||
48591237|NCT02210286|101779871|FG000|COMPLETED|Overall Study||15||
48591238|NCT02210286|101779871|FG000|NOT COMPLETED|Overall Study||2||
48591239|NCT00232596|101779872|FG000|STARTED|6-Week Titration Phase||152||
48591240|NCT00232596|101779873|FG001|STARTED|6-Week Titration Phase||154||
48591241|NCT00232596|101779872|FG000|COMPLETED|6-Week Titration Phase||138||
48591242|NCT00232596|101779873|FG001|COMPLETED|6-Week Titration Phase||125||
48709485|NCT01154283|102077790|FG000|NOT COMPLETED|0-6 Weeks||7||
48709486|NCT01154283|102077791|FG001|NOT COMPLETED|0-6 Weeks||3||
48709487|NCT01154283|102077790|FG000|STARTED|7-12 Weeks||7||
48709488|NCT01154283|102077791|FG001|STARTED|7-12 Weeks||11||
48709489|NCT01154283|102077790|FG000|COMPLETED|7-12 Weeks||6||
48709490|NCT01154283|102077791|FG001|COMPLETED|7-12 Weeks||10||
48709491|NCT01154283|102077790|FG000|NOT COMPLETED|7-12 Weeks||1||
48709492|NCT01154283|102077791|FG001|NOT COMPLETED|7-12 Weeks||1||
48709493|NCT01952665|102077792|FG000|STARTED|Overall Study||37||
48709494|NCT01952665|102077793|FG001|STARTED|Overall Study||26||
48293527|NCT02074553|101044552|FG006|STARTED|Intervention Period 2||12||
48591243|NCT00232596|101779872|FG000|NOT COMPLETED|6-Week Titration Phase||14||
48591244|NCT00232596|101779873|FG001|NOT COMPLETED|6-Week Titration Phase||29||
48591245|NCT00232596|101779872|FG000|STARTED|12-Week Maintenance Phase||138||
48293528|NCT02074553|101044553|FG007|STARTED|Intervention Period 2||12||
48293529|NCT02074553|101044546|FG000|COMPLETED|Intervention Period 2||11||
48293530|NCT02074553|101044547|FG001|COMPLETED|Intervention Period 2||12||
48293531|NCT02074553|101044548|FG002|COMPLETED|Intervention Period 2||12||
48293532|NCT02074553|101044549|FG003|COMPLETED|Intervention Period 2||11||
48293533|NCT02074553|101044550|FG004|COMPLETED|Intervention Period 2||12||
48293534|NCT02074553|101044551|FG005|COMPLETED|Intervention Period 2||11||
48293535|NCT02074553|101044552|FG006|COMPLETED|Intervention Period 2||12||
48403659|NCT00106249|101321659|FG001|NOT COMPLETED|Overall Study||2||
48403660|NCT00918346|101321660|FG000|STARTED|First Treatment Period (4 Weeks)||21||
48403661|NCT00918346|101321661|FG001|STARTED|First Treatment Period (4 Weeks)||22||
48403662|NCT00918346|101321660|FG000|COMPLETED|First Treatment Period (4 Weeks)||21||
48403663|NCT00918346|101321661|FG001|COMPLETED|First Treatment Period (4 Weeks)||21||
48403664|NCT00918346|101321660|FG000|NOT COMPLETED|First Treatment Period (4 Weeks)||0||
48403665|NCT00918346|101321661|FG001|NOT COMPLETED|First Treatment Period (4 Weeks)||1||
48403666|NCT00918346|101321660|FG000|STARTED|Washout (at Least 4 Weeks)||21||
48403667|NCT00918346|101321661|FG001|STARTED|Washout (at Least 4 Weeks)||21||
48403668|NCT00918346|101321660|FG000|COMPLETED|Washout (at Least 4 Weeks)||21||
48403669|NCT00918346|101321661|FG001|COMPLETED|Washout (at Least 4 Weeks)||21||
48403670|NCT00918346|101321660|FG000|NOT COMPLETED|Washout (at Least 4 Weeks)||0||
48403671|NCT00918346|101321661|FG001|NOT COMPLETED|Washout (at Least 4 Weeks)||0||
48403672|NCT00918346|101321660|FG000|STARTED|Second Treatment Period (4 Weeks)||21||
48403673|NCT00918346|101321661|FG001|STARTED|Second Treatment Period (4 Weeks)||21||
48403674|NCT00918346|101321660|FG000|COMPLETED|Second Treatment Period (4 Weeks)||21||
48403675|NCT00918346|101321661|FG001|COMPLETED|Second Treatment Period (4 Weeks)||21||
48403676|NCT00918346|101321660|FG000|NOT COMPLETED|Second Treatment Period (4 Weeks)||0||
48403677|NCT00918346|101321661|FG001|NOT COMPLETED|Second Treatment Period (4 Weeks)||0||
48403678|NCT00918346|101321660|FG000|STARTED|Post Study Period||21||
48403679|NCT00918346|101321661|FG001|STARTED|Post Study Period||21||
48403680|NCT00918346|101321660|FG000|COMPLETED|Post Study Period||21||
48403681|NCT00918346|101321661|FG001|COMPLETED|Post Study Period||21||
48403682|NCT00918346|101321660|FG000|NOT COMPLETED|Post Study Period||0||
48403683|NCT00918346|101321661|FG001|NOT COMPLETED|Post Study Period||0||
48403684|NCT01855945|101321662|FG000|STARTED|Overall Study||54||
48403685|NCT01855945|101321663|FG001|STARTED|Overall Study||55||
48591246|NCT00232596|101779873|FG001|STARTED|12-Week Maintenance Phase||125||
48591247|NCT00232596|101779872|FG000|COMPLETED|12-Week Maintenance Phase||126||
48591248|NCT00232596|101779873|FG001|COMPLETED|12-Week Maintenance Phase||97||
48591249|NCT00232596|101779872|FG000|NOT COMPLETED|12-Week Maintenance Phase||12||
48709495|NCT01952665|102077792|FG000|COMPLETED|Overall Study||31||
48709496|NCT01952665|102077793|FG001|COMPLETED|Overall Study||20||
48709497|NCT01952665|102077792|FG000|NOT COMPLETED|Overall Study||6||
48403686|NCT01855945|101321664|FG002|STARTED|Overall Study||51||
48403687|NCT01855945|101321665|FG003|STARTED|Overall Study||53||
48403688|NCT01855945|101321666|FG004|STARTED|Overall Study||51||
48591250|NCT00232596|101779873|FG001|NOT COMPLETED|12-Week Maintenance Phase||28||
48591251|NCT04420585|101779874|FG000|STARTED|Overall Study||8||
48591252|NCT04420585|101779874|FG000|COMPLETED|Overall Study||5||
48591253|NCT04420585|101779874|FG000|NOT COMPLETED|Overall Study||3||
48591254|NCT02174913|101779875|FG000|STARTED|Overall Study||17||
48591255|NCT02174913|101779876|FG001|STARTED|Overall Study||17||
48591256|NCT02174913|101779875|FG000|COMPLETED|Overall Study||17||
48591257|NCT02174913|101779876|FG001|COMPLETED|Overall Study||17||
48140775|NCT02564523|100670273|FG016|STARTED|Overall Study||54||
48591258|NCT02174913|101779875|FG000|NOT COMPLETED|Overall Study||0||
48591259|NCT02174913|101779876|FG001|NOT COMPLETED|Overall Study||0||
48591260|NCT02035748|101779877|FG000|STARTED|Overall Study||468||
48591261|NCT02035748|101779877|FG000|COMPLETED|Overall Study||448||
48591262|NCT02035748|101779877|FG000|NOT COMPLETED|Overall Study||20||
48591263|NCT04612777|101779878|FG000|STARTED|Overall Study||117||
48591264|NCT04612777|101779879|FG001|STARTED|Overall Study||123||
48591265|NCT04612777|101779878|FG000|4 Months|Overall Study||109||
48591266|NCT04612777|101779879|FG001|4 Months|Overall Study||109||
48591267|NCT04612777|101779878|FG000|8 Months|Overall Study||106||
48591268|NCT04612777|101779879|FG001|8 Months|Overall Study||106||
48591269|NCT04612777|101779878|FG000|COMPLETED|Overall Study||100||
48591270|NCT04612777|101779879|FG001|COMPLETED|Overall Study||100||
48591271|NCT04612777|101779878|FG000|NOT COMPLETED|Overall Study||17||
48591272|NCT04612777|101779879|FG001|NOT COMPLETED|Overall Study||23||
48591273|NCT02079636|101779880|FG000|STARTED|Overall Study||8||
48591274|NCT02079636|101779881|FG001|STARTED|Overall Study||15||
48591275|NCT02079636|101779882|FG002|STARTED|Overall Study||3||
48591276|NCT02079636|101779883|FG003|STARTED|Overall Study||21||
48591277|NCT02079636|101779884|FG004|STARTED|Overall Study||4||
48591278|NCT02079636|101779885|FG005|STARTED|Overall Study||19||
48591279|NCT02079636|101779886|FG006|STARTED|Overall Study||12||
48591280|NCT02079636|101779887|FG007|STARTED|Overall Study||4||
48591281|NCT02079636|101779888|FG008|STARTED|Overall Study||3||
48591282|NCT02079636|101779889|FG009|STARTED|Overall Study||9||
48591283|NCT02079636|101779890|FG010|STARTED|Overall Study||10||
48591284|NCT02079636|101779891|FG011|STARTED|Overall Study||6||
48591285|NCT02079636|101779892|FG012|STARTED|Overall Study||8||
48591286|NCT02079636|101779893|FG013|STARTED|Overall Study||3||
48591287|NCT02079636|101779894|FG014|STARTED|Overall Study||17||
48591288|NCT02079636|101779880|FG000|Received at Least One Dose of Study Drug|Overall Study||8||
48591289|NCT02079636|101779881|FG001|Received at Least One Dose of Study Drug|Overall Study||15||
48591290|NCT02079636|101779882|FG002|Received at Least One Dose of Study Drug|Overall Study||3||
48591291|NCT02079636|101779883|FG003|Received at Least One Dose of Study Drug|Overall Study||21||
48591292|NCT02079636|101779884|FG004|Received at Least One Dose of Study Drug|Overall Study||4||
48591293|NCT02079636|101779885|FG005|Received at Least One Dose of Study Drug|Overall Study||19||
48591294|NCT02079636|101779886|FG006|Received at Least One Dose of Study Drug|Overall Study||12||
48709498|NCT01952665|102077793|FG001|NOT COMPLETED|Overall Study||6||
48709499|NCT03777917|102077794|FG000|STARTED|Overall Study||43||
48709500|NCT03777917|102077795|FG001|STARTED|Overall Study||23||
48709501|NCT03777917|102077794|FG000|Safety Population|Overall Study||43|1 participant randomized into treatment group did not receive any treatment and was excluded from the safety population, and 1 participant randomized into the untreated group received Belotero Balance®.|
48709502|NCT03777917|102077795|FG001|Safety Population|Overall Study||22|1 participant randomized into treatment group did not receive any treatment and was excluded from the safety population, and 1 participant randomized into the untreated group received Belotero Balance®.|
48709503|NCT03777917|102077794|FG000|COMPLETED|Overall Study||34||
48709504|NCT03777917|102077795|FG001|COMPLETED|Overall Study||21||
48709505|NCT03777917|102077794|FG000|NOT COMPLETED|Overall Study||9||
48709506|NCT03777917|102077795|FG001|NOT COMPLETED|Overall Study||2||
48140776|NCT02564523|100670274|FG017|STARTED|Overall Study||12||
48591295|NCT02079636|101779887|FG007|Received at Least One Dose of Study Drug|Overall Study||4||
48591296|NCT02079636|101779888|FG008|Received at Least One Dose of Study Drug|Overall Study||3||
48591297|NCT02079636|101779889|FG009|Received at Least One Dose of Study Drug|Overall Study||9||
48591298|NCT02079636|101779890|FG010|Received at Least One Dose of Study Drug|Overall Study||10||
48591299|NCT02079636|101779891|FG011|Received at Least One Dose of Study Drug|Overall Study||6||
48591300|NCT02079636|101779892|FG012|Received at Least One Dose of Study Drug|Overall Study||8||
48591301|NCT02079636|101779893|FG013|Received at Least One Dose of Study Drug|Overall Study||3||
48591302|NCT02079636|101779894|FG014|Received at Least One Dose of Study Drug|Overall Study||17||
48591303|NCT02079636|101779880|FG000|COMPLETED|Overall Study||5||
48591304|NCT02079636|101779881|FG001|COMPLETED|Overall Study||13||
48591305|NCT02079636|101779882|FG002|COMPLETED|Overall Study||3||
48591306|NCT02079636|101779883|FG003|COMPLETED|Overall Study||9||
48591307|NCT02079636|101779884|FG004|COMPLETED|Overall Study||2||
48591308|NCT02079636|101779885|FG005|COMPLETED|Overall Study||13||
48709507|NCT01952444|102077796|FG000|STARTED|Overall Study||20||
48709508|NCT01952444|102077797|FG001|STARTED|Overall Study||20||
48709509|NCT01952444|102077796|FG000|COMPLETED|Overall Study||20||
48709510|NCT01952444|102077797|FG001|COMPLETED|Overall Study||19||
48709511|NCT01952444|102077796|FG000|NOT COMPLETED|Overall Study||0||
48709512|NCT01952444|102077797|FG001|NOT COMPLETED|Overall Study||1||
48709513|NCT03403231|102077798|FG000|STARTED|Overall Study||9||
48709514|NCT03403231|102077799|FG001|STARTED|Overall Study||9||
48709515|NCT03403231|102077800|FG002|STARTED|Overall Study||9||
48709516|NCT03403231|102077801|FG003|STARTED|Overall Study||9||
48709517|NCT03403231|102077802|FG004|STARTED|Overall Study||9||
48709518|NCT03403231|102077803|FG005|STARTED|Overall Study||9||
48591309|NCT02079636|101779886|FG006|COMPLETED|Overall Study||11||
48591310|NCT02079636|101779887|FG007|COMPLETED|Overall Study||3||
48591311|NCT02079636|101779888|FG008|COMPLETED|Overall Study||3||
48591312|NCT02079636|101779889|FG009|COMPLETED|Overall Study||6||
48591313|NCT02079636|101779890|FG010|COMPLETED|Overall Study||8||
48591314|NCT02079636|101779891|FG011|COMPLETED|Overall Study||4||
48591315|NCT02079636|101779892|FG012|COMPLETED|Overall Study||5||
48591316|NCT02079636|101779893|FG013|COMPLETED|Overall Study||3||
48591317|NCT02079636|101779894|FG014|COMPLETED|Overall Study||12||
48591318|NCT02079636|101779880|FG000|NOT COMPLETED|Overall Study||3||
48591319|NCT02079636|101779881|FG001|NOT COMPLETED|Overall Study||2||
48591320|NCT02079636|101779882|FG002|NOT COMPLETED|Overall Study||0||
48293536|NCT02074553|101044553|FG007|COMPLETED|Intervention Period 2||12||
48293537|NCT02074553|101044546|FG000|NOT COMPLETED|Intervention Period 2||0||
48293538|NCT02074553|101044547|FG001|NOT COMPLETED|Intervention Period 2||0||
48293539|NCT02074553|101044548|FG002|NOT COMPLETED|Intervention Period 2||0||
48591321|NCT02079636|101779883|FG003|NOT COMPLETED|Overall Study||12||
48591322|NCT02079636|101779884|FG004|NOT COMPLETED|Overall Study||2||
48591323|NCT02079636|101779885|FG005|NOT COMPLETED|Overall Study||6||
48591324|NCT02079636|101779886|FG006|NOT COMPLETED|Overall Study||1||
48591325|NCT02079636|101779887|FG007|NOT COMPLETED|Overall Study||1||
48591326|NCT02079636|101779888|FG008|NOT COMPLETED|Overall Study||0||
48591327|NCT02079636|101779889|FG009|NOT COMPLETED|Overall Study||3||
48591328|NCT02079636|101779890|FG010|NOT COMPLETED|Overall Study||2||
48591329|NCT02079636|101779891|FG011|NOT COMPLETED|Overall Study||2||
48591330|NCT02079636|101779892|FG012|NOT COMPLETED|Overall Study||3||
48591331|NCT02079636|101779893|FG013|NOT COMPLETED|Overall Study||0||
48591332|NCT02079636|101779894|FG014|NOT COMPLETED|Overall Study||5||
48591333|NCT01115556|101779895|FG000|STARTED|Overall Study||7||
48709519|NCT03403231|102077804|FG006|STARTED|Overall Study||9||
48709520|NCT03403231|102077805|FG007|STARTED|Overall Study||9||
48709521|NCT03403231|102077806|FG008|STARTED|Overall Study||9||
48709522|NCT03403231|102077807|FG009|STARTED|Overall Study||9||
48293540|NCT02074553|101044549|FG003|NOT COMPLETED|Intervention Period 2||0||
48293541|NCT02074553|101044550|FG004|NOT COMPLETED|Intervention Period 2||0||
48591334|NCT01115556|101779896|FG001|STARTED|Overall Study||2||
48591335|NCT01115556|101779895|FG000|COMPLETED|Overall Study||7||
48709523|NCT03403231|102077808|FG010|STARTED|Overall Study||9||
48591336|NCT01115556|101779896|FG001|COMPLETED|Overall Study||2||
48709524|NCT03403231|102077809|FG011|STARTED|Overall Study||9||
48709525|NCT03403231|102077810|FG012|STARTED|Overall Study||9||
48709526|NCT03403231|102077811|FG013|STARTED|Overall Study||9||
48709527|NCT03403231|102077812|FG014|STARTED|Overall Study||9||
48709528|NCT03403231|102077813|FG015|STARTED|Overall Study||9||
48709529|NCT03403231|102077798|FG000|COMPLETED|Overall Study||9||
48709530|NCT03403231|102077799|FG001|COMPLETED|Overall Study||9||
48709531|NCT03403231|102077800|FG002|COMPLETED|Overall Study||9||
48293542|NCT02074553|101044551|FG005|NOT COMPLETED|Intervention Period 2||0||
48293543|NCT02074553|101044552|FG006|NOT COMPLETED|Intervention Period 2||0||
48591337|NCT01115556|101779895|FG000|NOT COMPLETED|Overall Study||0||
48591338|NCT01115556|101779896|FG001|NOT COMPLETED|Overall Study||0||
48591339|NCT01576276|101779897|FG000|STARTED|Overall Study||22||
48591340|NCT01576276|101779898|FG001|STARTED|Overall Study||29||
48591341|NCT01576276|101779897|FG000|COMPLETED|Overall Study||14||
48591342|NCT01576276|101779898|FG001|COMPLETED|Overall Study||18||
48591343|NCT01576276|101779897|FG000|NOT COMPLETED|Overall Study||8||
48591344|NCT01576276|101779898|FG001|NOT COMPLETED|Overall Study||11||
48709532|NCT03403231|102077801|FG003|COMPLETED|Overall Study||9||
48709533|NCT03403231|102077802|FG004|COMPLETED|Overall Study||9||
48591345|NCT02719938|101779899|FG000|STARTED|Overall Study||30||
48591346|NCT02719938|101779900|FG001|STARTED|Overall Study||32||
48403689|NCT01855945|101321667|FG005|STARTED|Overall Study||53||
48403690|NCT01855945|101321668|FG006|STARTED|Overall Study||53||
48591347|NCT02719938|101779899|FG000|COMPLETED|Overall Study||26||
48591348|NCT02719938|101779900|FG001|COMPLETED|Overall Study||31||
48591349|NCT02719938|101779899|FG000|NOT COMPLETED|Overall Study||4||
48591350|NCT02719938|101779900|FG001|NOT COMPLETED|Overall Study||1||
48591351|NCT04329091|101779901|FG000|STARTED|Overall Study||9||
48591352|NCT04329091|101779901|FG000|COMPLETED|Overall Study||4||
48591353|NCT04329091|101779901|FG000|NOT COMPLETED|Overall Study||5||
48591354|NCT02062710|101779902|FG000|STARTED|Overall Study||3||
48140777|NCT02564523|100670257|FG000|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||34||
48403691|NCT01855945|101321669|FG007|STARTED|Overall Study||55||
48403692|NCT01855945|101321670|FG008|STARTED|Overall Study||48||
48403693|NCT01855945|101321671|FG009|STARTED|Overall Study||51||
48403694|NCT01855945|101321672|FG010|STARTED|Overall Study||51||
48403695|NCT01855945|101321673|FG011|STARTED|Overall Study||52||
48591355|NCT02062710|101779903|FG001|STARTED|Overall Study||4||
48591356|NCT02062710|101779904|FG002|STARTED|Overall Study||5||
48591357|NCT02062710|101779905|FG003|STARTED|Overall Study||3||
48591358|NCT02062710|101779906|FG004|STARTED|Overall Study||3||
48591359|NCT02062710|101779907|FG005|STARTED|Overall Study||4||
48591360|NCT02062710|101779902|FG000|COMPLETED|Overall Study||3||
48591361|NCT02062710|101779903|FG001|COMPLETED|Overall Study||4||
48591362|NCT02062710|101779904|FG002|COMPLETED|Overall Study||5||
48591363|NCT02062710|101779905|FG003|COMPLETED|Overall Study||3||
48591364|NCT02062710|101779906|FG004|COMPLETED|Overall Study||3||
48591365|NCT02062710|101779907|FG005|COMPLETED|Overall Study||4||
48591366|NCT02062710|101779902|FG000|NOT COMPLETED|Overall Study||0||
48591367|NCT02062710|101779903|FG001|NOT COMPLETED|Overall Study||0||
48591368|NCT02062710|101779904|FG002|NOT COMPLETED|Overall Study||0||
48591369|NCT02062710|101779905|FG003|NOT COMPLETED|Overall Study||0||
48591370|NCT02062710|101779906|FG004|NOT COMPLETED|Overall Study||0||
48709534|NCT03403231|102077803|FG005|COMPLETED|Overall Study||9||
48709535|NCT03403231|102077804|FG006|COMPLETED|Overall Study||9||
48709536|NCT03403231|102077805|FG007|COMPLETED|Overall Study||9||
48709537|NCT03403231|102077806|FG008|COMPLETED|Overall Study||9||
48709538|NCT03403231|102077807|FG009|COMPLETED|Overall Study||9||
48709539|NCT03403231|102077808|FG010|COMPLETED|Overall Study||9||
48709540|NCT03403231|102077809|FG011|COMPLETED|Overall Study||9||
48709541|NCT03403231|102077810|FG012|COMPLETED|Overall Study||9||
48709542|NCT03403231|102077811|FG013|COMPLETED|Overall Study||9||
48709543|NCT03403231|102077812|FG014|COMPLETED|Overall Study||9||
48709544|NCT03403231|102077813|FG015|COMPLETED|Overall Study||9||
48709545|NCT03403231|102077798|FG000|NOT COMPLETED|Overall Study||0||
48709546|NCT03403231|102077799|FG001|NOT COMPLETED|Overall Study||0||
48709547|NCT03403231|102077800|FG002|NOT COMPLETED|Overall Study||0||
48709548|NCT03403231|102077801|FG003|NOT COMPLETED|Overall Study||0||
48709549|NCT03403231|102077802|FG004|NOT COMPLETED|Overall Study||0||
48709550|NCT03403231|102077803|FG005|NOT COMPLETED|Overall Study||0||
48709551|NCT03403231|102077804|FG006|NOT COMPLETED|Overall Study||0||
48709552|NCT03403231|102077805|FG007|NOT COMPLETED|Overall Study||0||
48709553|NCT03403231|102077806|FG008|NOT COMPLETED|Overall Study||0||
48709554|NCT03403231|102077807|FG009|NOT COMPLETED|Overall Study||0||
48709555|NCT03403231|102077808|FG010|NOT COMPLETED|Overall Study||0||
48709556|NCT03403231|102077809|FG011|NOT COMPLETED|Overall Study||0||
48709557|NCT03403231|102077810|FG012|NOT COMPLETED|Overall Study||0||
48709558|NCT03403231|102077811|FG013|NOT COMPLETED|Overall Study||0||
48709559|NCT03403231|102077812|FG014|NOT COMPLETED|Overall Study||0||
48709560|NCT03403231|102077813|FG015|NOT COMPLETED|Overall Study||0||
48709561|NCT03220581|102077814|FG000|STARTED|Overall Study||28||
48709562|NCT03220581|102077815|FG001|STARTED|Overall Study||32||
48709563|NCT03220581|102077814|FG000|COMPLETED|Overall Study||25||
48709564|NCT03220581|102077815|FG001|COMPLETED|Overall Study||25||
48709565|NCT03220581|102077814|FG000|NOT COMPLETED|Overall Study||3||
48709566|NCT03220581|102077815|FG001|NOT COMPLETED|Overall Study||7||
48709567|NCT02255565|102077816|FG000|STARTED|Overall Study||9||
48709568|NCT02255565|102077817|FG001|STARTED|Overall Study||9||
48709569|NCT02255565|102077818|FG002|STARTED|Overall Study||9||
48709570|NCT02255565|102077816|FG000|COMPLETED|Overall Study||9||
48709571|NCT02255565|102077817|FG001|COMPLETED|Overall Study||8||
48709572|NCT02255565|102077818|FG002|COMPLETED|Overall Study||9||
48709573|NCT02255565|102077816|FG000|NOT COMPLETED|Overall Study||0||
48709574|NCT02255565|102077817|FG001|NOT COMPLETED|Overall Study||1||
48709575|NCT02255565|102077818|FG002|NOT COMPLETED|Overall Study||0||
48709576|NCT03614416|102077819|FG000|STARTED|Overall Study||13||
48709577|NCT03614416|102077819|FG000|COMPLETED|Overall Study||13||
48709578|NCT03614416|102077819|FG000|NOT COMPLETED|Overall Study||0||
48709579|NCT00853125|102077820|FG000|STARTED|Overall Study||10||
48709580|NCT00853125|102077820|FG000|COMPLETED|Overall Study||9||
48709581|NCT00853125|102077820|FG000|NOT COMPLETED|Overall Study||1||
48709582|NCT03080883|102077821|FG000|STARTED|Overall Study||179||
48709583|NCT03080883|102077822|FG001|STARTED|Overall Study||181||
48709584|NCT03080883|102077821|FG000|COMPLETED|Overall Study||111||
48709585|NCT03080883|102077822|FG001|COMPLETED|Overall Study||109||
48709586|NCT03080883|102077821|FG000|NOT COMPLETED|Overall Study||68||
48709587|NCT03080883|102077822|FG001|NOT COMPLETED|Overall Study||72||
48709588|NCT00477269|102077823|FG000|STARTED|Core Study||28||
48709589|NCT00477269|102077824|FG001|STARTED|Core Study||31||
48709590|NCT00477269|102077825|FG002|STARTED|Core Study||0||
48709591|NCT00477269|102077823|FG000|COMPLETED|Core Study||19||
48709592|NCT00477269|102077824|FG001|COMPLETED|Core Study||23||
48709593|NCT00477269|102077825|FG002|COMPLETED|Core Study||0||
48709594|NCT00477269|102077823|FG000|NOT COMPLETED|Core Study||9||
48709595|NCT00477269|102077824|FG001|NOT COMPLETED|Core Study||8||
48709596|NCT00477269|102077825|FG002|NOT COMPLETED|Core Study||0||
48709597|NCT00477269|102077823|FG000|STARTED|Open Label Extension||0||
48709598|NCT00477269|102077824|FG001|STARTED|Open Label Extension||0||
48709599|NCT00477269|102077825|FG002|STARTED|Open Label Extension||22||
48709600|NCT00477269|102077823|FG000|COMPLETED|Open Label Extension||0||
48709601|NCT00477269|102077824|FG001|COMPLETED|Open Label Extension||0||
48709602|NCT00477269|102077825|FG002|COMPLETED|Open Label Extension||9||
48709603|NCT00477269|102077823|FG000|NOT COMPLETED|Open Label Extension||0||
48709604|NCT00477269|102077824|FG001|NOT COMPLETED|Open Label Extension||0||
48709605|NCT00477269|102077825|FG002|NOT COMPLETED|Open Label Extension||13||
48709606|NCT00970814|102077826|FG000|STARTED|Overall Study||66||
48709607|NCT00970814|102077827|FG001|STARTED|Overall Study||64||
48709608|NCT00970814|102077826|FG000|COMPLETED|Overall Study||58||
48709609|NCT00970814|102077827|FG001|COMPLETED|Overall Study||50||
48709610|NCT00970814|102077826|FG000|NOT COMPLETED|Overall Study||8||
48709611|NCT00970814|102077827|FG001|NOT COMPLETED|Overall Study||14||
48709612|NCT00159913|102077828|FG000|STARTED|Overall Study||42||
48709613|NCT00159913|102077829|FG001|STARTED|Overall Study||55||
48709614|NCT00159913|102077830|FG002|STARTED|Overall Study||77||
48709615|NCT00159913|102077831|FG003|STARTED|Overall Study||60||
48709616|NCT00159913|102077828|FG000|COMPLETED|Overall Study||40||
48709617|NCT00159913|102077829|FG001|COMPLETED|Overall Study||55||
48709618|NCT00159913|102077830|FG002|COMPLETED|Overall Study||75||
48293544|NCT02074553|101044553|FG007|NOT COMPLETED|Intervention Period 2||0||
48293545|NCT02074553|101044546|FG000|STARTED|Washout Period 2||11||
48293546|NCT02074553|101044547|FG001|STARTED|Washout Period 2||12||
48293547|NCT02074553|101044548|FG002|STARTED|Washout Period 2||12||
48293548|NCT02074553|101044549|FG003|STARTED|Washout Period 2||11||
48293549|NCT02074553|101044550|FG004|STARTED|Washout Period 2||12||
48293550|NCT02074553|101044551|FG005|STARTED|Washout Period 2||11||
48293551|NCT02074553|101044552|FG006|STARTED|Washout Period 2||12||
48293552|NCT02074553|101044553|FG007|STARTED|Washout Period 2||12||
48293553|NCT02074553|101044546|FG000|COMPLETED|Washout Period 2||11||
48293554|NCT02074553|101044547|FG001|COMPLETED|Washout Period 2||12||
48293555|NCT02074553|101044548|FG002|COMPLETED|Washout Period 2||11||
48293556|NCT02074553|101044549|FG003|COMPLETED|Washout Period 2||11||
48293557|NCT02074553|101044550|FG004|COMPLETED|Washout Period 2||12||
48293558|NCT02074553|101044551|FG005|COMPLETED|Washout Period 2||10||
48293559|NCT02074553|101044552|FG006|COMPLETED|Washout Period 2||11||
48293560|NCT02074553|101044553|FG007|COMPLETED|Washout Period 2||12||
48293561|NCT02074553|101044546|FG000|NOT COMPLETED|Washout Period 2||0||
48591371|NCT02062710|101779907|FG005|NOT COMPLETED|Overall Study||0||
48591372|NCT01605032|101779908|FG000|STARTED|Overall Study||19||
48709619|NCT00159913|102077831|FG003|COMPLETED|Overall Study||58||
48591373|NCT01605032|101779908|FG000|COMPLETED|Overall Study||18||
48591374|NCT01605032|101779908|FG000|NOT COMPLETED|Overall Study||1||
48591375|NCT02850016|101779909|FG000|STARTED|Overall Study||11||
48591376|NCT02850016|101779910|FG001|STARTED|Overall Study||9||
48591377|NCT02850016|101779909|FG000|COMPLETED|Overall Study||10||
48591378|NCT02850016|101779910|FG001|COMPLETED|Overall Study||7||
48591379|NCT02850016|101779909|FG000|NOT COMPLETED|Overall Study||1||
48591380|NCT02850016|101779910|FG001|NOT COMPLETED|Overall Study||2||
48591381|NCT00467961|101779911|FG000|STARTED|Overall Study||31||
48591382|NCT00467961|101779911|FG000|COMPLETED|Overall Study||24||
48591383|NCT00467961|101779911|FG000|NOT COMPLETED|Overall Study||7||
48591384|NCT00955968|101779912|FG000|STARTED|Overall Study||828||
48591385|NCT00955968|101779913|FG001|STARTED|Overall Study||825||
48709620|NCT00159913|102077828|FG000|NOT COMPLETED|Overall Study||2||
48709621|NCT00159913|102077829|FG001|NOT COMPLETED|Overall Study||0||
48709622|NCT00159913|102077830|FG002|NOT COMPLETED|Overall Study||2||
48709623|NCT00159913|102077831|FG003|NOT COMPLETED|Overall Study||2||
48591386|NCT00955968|101779912|FG000|COMPLETED|Overall Study||691||
48591387|NCT00955968|101779913|FG001|COMPLETED|Overall Study||699||
48709624|NCT02014480|102077832|FG000|STARTED|Treatment Period 1 (14 Days)||35||
48709625|NCT02014480|102077833|FG001|STARTED|Treatment Period 1 (14 Days)||35||
48293562|NCT02074553|101044547|FG001|NOT COMPLETED|Washout Period 2||0||
48293563|NCT02074553|101044548|FG002|NOT COMPLETED|Washout Period 2||1||
48293564|NCT02074553|101044549|FG003|NOT COMPLETED|Washout Period 2||0||
48293565|NCT02074553|101044550|FG004|NOT COMPLETED|Washout Period 2||0||
48293566|NCT02074553|101044551|FG005|NOT COMPLETED|Washout Period 2||1||
48591388|NCT00955968|101779912|FG000|NOT COMPLETED|Overall Study||137||
48591389|NCT00955968|101779913|FG001|NOT COMPLETED|Overall Study||126||
48709626|NCT02014480|102077834|FG002|STARTED|Treatment Period 1 (14 Days)||34||
48709627|NCT02014480|102077835|FG003|STARTED|Treatment Period 1 (14 Days)||34||
48591390|NCT00900757|101779914|FG000|STARTED|Overall Study||57||
48591391|NCT00900757|101779914|FG000|COMPLETED|Overall Study||38||
48591392|NCT00900757|101779914|FG000|NOT COMPLETED|Overall Study||19||
48591393|NCT02284568|101779915|FG000|STARTED|Overall Study||140||
48591394|NCT02284568|101779916|FG001|STARTED|Overall Study||139||
48591395|NCT02284568|101779917|FG002|STARTED|Overall Study||95||
48591396|NCT02284568|101779915|FG000|Safety Population|Overall Study||140||
48591397|NCT02284568|101779916|FG001|Safety Population|Overall Study||138||
48591398|NCT02284568|101779917|FG002|Safety Population|Overall Study||95||
48591399|NCT02284568|101779915|FG000|Completed Week 48 MRI - on Treatment|Overall Study||113||
48591400|NCT02284568|101779916|FG001|Completed Week 48 MRI - on Treatment|Overall Study||107||
48591401|NCT02284568|101779917|FG002|Completed Week 48 MRI - on Treatment|Overall Study||0||
48591402|NCT02284568|101779915|FG000|COMPLETED|Overall Study||109||
48591403|NCT02284568|101779916|FG001|COMPLETED|Overall Study||93||
48591404|NCT02284568|101779917|FG002|COMPLETED|Overall Study||0||
48591405|NCT02284568|101779915|FG000|NOT COMPLETED|Overall Study||31||
48591406|NCT02284568|101779916|FG001|NOT COMPLETED|Overall Study||46||
48591407|NCT02284568|101779917|FG002|NOT COMPLETED|Overall Study||95||
48591408|NCT04253782|101779918|FG000|STARTED|Overall Study||36||
48591409|NCT04253782|101779919|FG001|STARTED|Overall Study||45||
48591410|NCT04253782|101779918|FG000|COMPLETED|Overall Study||34||
48591411|NCT04253782|101779919|FG001|COMPLETED|Overall Study||45||
48591412|NCT04253782|101779918|FG000|NOT COMPLETED|Overall Study||2||
48591413|NCT04253782|101779919|FG001|NOT COMPLETED|Overall Study||0||
48591414|NCT00197002|101779920|FG000|STARTED|Overall Study||147||
48591415|NCT00197002|101779921|FG001|STARTED|Overall Study||137||
48140778|NCT02564523|100670258|FG001|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||8||
48140779|NCT02564523|100670259|FG002|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||39||
48140780|NCT02564523|100670260|FG003|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||9||
48140781|NCT02564523|100670261|FG004|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0||
48140782|NCT02564523|100670262|FG005|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0||
48140783|NCT02564523|100670263|FG006|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0||
48140784|NCT02564523|100670264|FG007|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0||
48140785|NCT02564523|100670265|FG008|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0||
48140786|NCT02564523|100670266|FG009|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0||
48140787|NCT02564523|100670267|FG010|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0||
48591416|NCT00197002|101779922|FG002|STARTED|Overall Study||149||
48591417|NCT00197002|101779920|FG000|COMPLETED|Overall Study||125||
48591418|NCT00197002|101779921|FG001|COMPLETED|Overall Study||119||
48591419|NCT00197002|101779922|FG002|COMPLETED|Overall Study||132||
48591420|NCT00197002|101779920|FG000|NOT COMPLETED|Overall Study||22||
48591421|NCT00197002|101779921|FG001|NOT COMPLETED|Overall Study||18||
48591422|NCT00197002|101779922|FG002|NOT COMPLETED|Overall Study||17||
48591423|NCT05129293|101779923|FG000|STARTED|Overall Study||17||
48591424|NCT05129293|101779924|FG001|STARTED|Overall Study||18||
48591425|NCT05129293|101779923|FG000|COMPLETED|Overall Study||15||
48591426|NCT05129293|101779924|FG001|COMPLETED|Overall Study||16||
48591427|NCT05129293|101779923|FG000|NOT COMPLETED|Overall Study||2||
48591428|NCT05129293|101779924|FG001|NOT COMPLETED|Overall Study||2||
48591429|NCT02054910|101779925|FG000|STARTED|Overall Study||4||
48591430|NCT02054910|101779926|FG001|STARTED|Overall Study||1||
48591431|NCT02054910|101779925|FG000|COMPLETED|Overall Study||0||
48591432|NCT02054910|101779926|FG001|COMPLETED|Overall Study||0||
48591433|NCT02054910|101779925|FG000|NOT COMPLETED|Overall Study||4||
48591434|NCT02054910|101779926|FG001|NOT COMPLETED|Overall Study||1||
48591435|NCT00932698|101779927|FG000|STARTED|Part 1 (Dose Escalation)||3||
48591436|NCT00932698|101779928|FG001|STARTED|Part 1 (Dose Escalation)||3||
48591437|NCT00932698|101779929|FG002|STARTED|Part 1 (Dose Escalation)||3||
48591438|NCT00932698|101779930|FG003|STARTED|Part 1 (Dose Escalation)||3||
48591439|NCT00932698|101779931|FG004|STARTED|Part 1 (Dose Escalation)||3||
48591440|NCT00932698|101779932|FG005|STARTED|Part 1 (Dose Escalation)||7||
48591441|NCT00932698|101779933|FG006|STARTED|Part 1 (Dose Escalation)||4||
48591442|NCT00932698|101779934|FG007|STARTED|Part 1 (Dose Escalation)||0||
48591443|NCT00932698|101779935|FG008|STARTED|Part 1 (Dose Escalation)||0||
48591444|NCT00932698|101779936|FG009|STARTED|Part 1 (Dose Escalation)||0||
48591445|NCT00932698|101779937|FG010|STARTED|Part 1 (Dose Escalation)||0||
48591446|NCT00932698|101779927|FG000|COMPLETED|Part 1 (Dose Escalation)||0||
48591447|NCT00932698|101779928|FG001|COMPLETED|Part 1 (Dose Escalation)||0||
48591448|NCT00932698|101779929|FG002|COMPLETED|Part 1 (Dose Escalation)||0||
48591449|NCT00932698|101779930|FG003|COMPLETED|Part 1 (Dose Escalation)||0||
48591450|NCT00932698|101779931|FG004|COMPLETED|Part 1 (Dose Escalation)||0||
48591451|NCT00932698|101779932|FG005|COMPLETED|Part 1 (Dose Escalation)||0||
48591452|NCT00932698|101779933|FG006|COMPLETED|Part 1 (Dose Escalation)||0||
48709628|NCT02014480|102077836|FG004|STARTED|Treatment Period 1 (14 Days)||35||
48709629|NCT02014480|102077837|FG005|STARTED|Treatment Period 1 (14 Days)||34||
48709630|NCT02014480|102077832|FG000|COMPLETED|Treatment Period 1 (14 Days)||35||
48709631|NCT02014480|102077833|FG001|COMPLETED|Treatment Period 1 (14 Days)||34||
48709632|NCT02014480|102077834|FG002|COMPLETED|Treatment Period 1 (14 Days)||33||
48709633|NCT02014480|102077835|FG003|COMPLETED|Treatment Period 1 (14 Days)||32||
48709634|NCT02014480|102077836|FG004|COMPLETED|Treatment Period 1 (14 Days)||34||
48140788|NCT02564523|100670268|FG011|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0||
48140789|NCT02564523|100670269|FG012|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0||
48140790|NCT02564523|100670270|FG013|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0||
48140791|NCT02564523|100670271|FG014|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0||
48140792|NCT02564523|100670272|FG015|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0||
48140793|NCT02564523|100670273|FG016|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0||
48140794|NCT02564523|100670274|FG017|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0||
48140795|NCT02564523|100670257|FG000|COMPLETED|Overall Study||215||
48140796|NCT02564523|100670258|FG001|COMPLETED|Overall Study||40||
48140797|NCT02564523|100670259|FG002|COMPLETED|Overall Study||214||
48140798|NCT02564523|100670260|FG003|COMPLETED|Overall Study||43||
48140799|NCT02564523|100670261|FG004|COMPLETED|Overall Study||106||
48591453|NCT00932698|101779934|FG007|COMPLETED|Part 1 (Dose Escalation)||0||
48591454|NCT00932698|101779935|FG008|COMPLETED|Part 1 (Dose Escalation)||0||
48591455|NCT00932698|101779936|FG009|COMPLETED|Part 1 (Dose Escalation)||0||
48591456|NCT00932698|101779937|FG010|COMPLETED|Part 1 (Dose Escalation)||0||
48709635|NCT02014480|102077837|FG005|COMPLETED|Treatment Period 1 (14 Days)||34||
48710778|NCT00899717|102078014|FG000|NOT COMPLETED|Overall Study||0||
48140800|NCT02564523|100670262|FG005|COMPLETED|Overall Study||22||
48140801|NCT02564523|100670263|FG006|COMPLETED|Overall Study||56||
48591457|NCT00932698|101779927|FG000|NOT COMPLETED|Part 1 (Dose Escalation)||3||
48591458|NCT00932698|101779928|FG001|NOT COMPLETED|Part 1 (Dose Escalation)||3||
48591459|NCT00932698|101779929|FG002|NOT COMPLETED|Part 1 (Dose Escalation)||3||
48591460|NCT00932698|101779930|FG003|NOT COMPLETED|Part 1 (Dose Escalation)||3||
48591461|NCT00932698|101779931|FG004|NOT COMPLETED|Part 1 (Dose Escalation)||3||
48591462|NCT00932698|101779932|FG005|NOT COMPLETED|Part 1 (Dose Escalation)||7||
48591463|NCT00932698|101779933|FG006|NOT COMPLETED|Part 1 (Dose Escalation)||4||
48591464|NCT00932698|101779934|FG007|NOT COMPLETED|Part 1 (Dose Escalation)||0||
48591465|NCT00932698|101779935|FG008|NOT COMPLETED|Part 1 (Dose Escalation)||0||
48591466|NCT00932698|101779936|FG009|NOT COMPLETED|Part 1 (Dose Escalation)||0||
48709636|NCT02014480|102077832|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||0||
48709637|NCT02014480|102077833|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1||
48709638|NCT02014480|102077834|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||1||
48709639|NCT02014480|102077835|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||2||
48709640|NCT02014480|102077836|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||1||
48709641|NCT02014480|102077837|FG005|NOT COMPLETED|Treatment Period 1 (14 Days)||0||
48709642|NCT02014480|102077832|FG000|STARTED|Washout Period 1 (10 to 14 Days)||35||
48709643|NCT02014480|102077833|FG001|STARTED|Washout Period 1 (10 to 14 Days)||34||
48709644|NCT02014480|102077834|FG002|STARTED|Washout Period 1 (10 to 14 Days)||33||
48709645|NCT02014480|102077835|FG003|STARTED|Washout Period 1 (10 to 14 Days)||32||
48709646|NCT02014480|102077836|FG004|STARTED|Washout Period 1 (10 to 14 Days)||34||
48709647|NCT02014480|102077837|FG005|STARTED|Washout Period 1 (10 to 14 Days)||34||
48709648|NCT02014480|102077832|FG000|COMPLETED|Washout Period 1 (10 to 14 Days)||35||
48709649|NCT02014480|102077833|FG001|COMPLETED|Washout Period 1 (10 to 14 Days)||34||
48709650|NCT02014480|102077834|FG002|COMPLETED|Washout Period 1 (10 to 14 Days)||32||
48709651|NCT02014480|102077835|FG003|COMPLETED|Washout Period 1 (10 to 14 Days)||32||
48709652|NCT02014480|102077836|FG004|COMPLETED|Washout Period 1 (10 to 14 Days)||34||
48709653|NCT02014480|102077837|FG005|COMPLETED|Washout Period 1 (10 to 14 Days)||34||
48709654|NCT02014480|102077832|FG000|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0||
48709655|NCT02014480|102077833|FG001|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0||
48709656|NCT02014480|102077834|FG002|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1||
48709657|NCT02014480|102077835|FG003|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0||
48709658|NCT02014480|102077836|FG004|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0||
48709659|NCT02014480|102077837|FG005|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0||
48709660|NCT02014480|102077832|FG000|STARTED|Treatment Period 2 (14 Days)||35||
48709661|NCT02014480|102077833|FG001|STARTED|Treatment Period 2 (14 Days)||34||
48591467|NCT00932698|101779937|FG010|NOT COMPLETED|Part 1 (Dose Escalation)||0||
48591468|NCT00932698|101779927|FG000|STARTED|Part 2 (Dose Expansion)||0||
48709662|NCT02014480|102077834|FG002|STARTED|Treatment Period 2 (14 Days)||32||
48709663|NCT02014480|102077835|FG003|STARTED|Treatment Period 2 (14 Days)||32||
48709664|NCT02014480|102077836|FG004|STARTED|Treatment Period 2 (14 Days)||34||
48709665|NCT02014480|102077837|FG005|STARTED|Treatment Period 2 (14 Days)||34||
48709666|NCT02014480|102077832|FG000|COMPLETED|Treatment Period 2 (14 Days)||34||
48709667|NCT02014480|102077833|FG001|COMPLETED|Treatment Period 2 (14 Days)||33||
48709668|NCT02014480|102077834|FG002|COMPLETED|Treatment Period 2 (14 Days)||30||
48709669|NCT02014480|102077835|FG003|COMPLETED|Treatment Period 2 (14 Days)||31||
48709670|NCT02014480|102077836|FG004|COMPLETED|Treatment Period 2 (14 Days)||34||
48709671|NCT02014480|102077837|FG005|COMPLETED|Treatment Period 2 (14 Days)||34||
48709672|NCT02014480|102077832|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||1||
48709673|NCT02014480|102077833|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||1||
48709674|NCT02014480|102077834|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||2||
48709675|NCT02014480|102077835|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||1||
48709676|NCT02014480|102077836|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
48709677|NCT02014480|102077837|FG005|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
48709678|NCT02014480|102077832|FG000|STARTED|Washout Period 2 (10 to 14 Days)||34||
48709679|NCT02014480|102077833|FG001|STARTED|Washout Period 2 (10 to 14 Days)||33||
48709680|NCT02014480|102077834|FG002|STARTED|Washout Period 2 (10 to 14 Days)||30||
48709681|NCT02014480|102077835|FG003|STARTED|Washout Period 2 (10 to 14 Days)||31||
48709682|NCT02014480|102077836|FG004|STARTED|Washout Period 2 (10 to 14 Days)||34||
48709683|NCT02014480|102077837|FG005|STARTED|Washout Period 2 (10 to 14 Days)||34||
48709684|NCT02014480|102077832|FG000|COMPLETED|Washout Period 2 (10 to 14 Days)||34||
48709685|NCT02014480|102077833|FG001|COMPLETED|Washout Period 2 (10 to 14 Days)||33||
48140802|NCT02564523|100670264|FG007|COMPLETED|Overall Study||12||
48140803|NCT02564523|100670265|FG008|COMPLETED|Overall Study||59||
48140804|NCT02564523|100670266|FG009|COMPLETED|Overall Study||12||
48591469|NCT00932698|101779928|FG001|STARTED|Part 2 (Dose Expansion)||0||
48591470|NCT00932698|101779929|FG002|STARTED|Part 2 (Dose Expansion)||0||
48709686|NCT02014480|102077834|FG002|COMPLETED|Washout Period 2 (10 to 14 Days)||30||
48709687|NCT02014480|102077835|FG003|COMPLETED|Washout Period 2 (10 to 14 Days)||31||
48709688|NCT02014480|102077836|FG004|COMPLETED|Washout Period 2 (10 to 14 Days)||34||
48709689|NCT02014480|102077837|FG005|COMPLETED|Washout Period 2 (10 to 14 Days)||34||
48591471|NCT00932698|101779930|FG003|STARTED|Part 2 (Dose Expansion)||0||
48140805|NCT02564523|100670267|FG010|COMPLETED|Overall Study||52||
48140806|NCT02564523|100670268|FG011|COMPLETED|Overall Study||10||
48140807|NCT02564523|100670269|FG012|COMPLETED|Overall Study||53||
48140808|NCT02564523|100670270|FG013|COMPLETED|Overall Study||10||
48591472|NCT00932698|101779931|FG004|STARTED|Part 2 (Dose Expansion)||0||
48591473|NCT00932698|101779932|FG005|STARTED|Part 2 (Dose Expansion)||0||
48591474|NCT00932698|101779933|FG006|STARTED|Part 2 (Dose Expansion)||0||
48591475|NCT00932698|101779934|FG007|STARTED|Part 2 (Dose Expansion)||20||
48591476|NCT00932698|101779935|FG008|STARTED|Part 2 (Dose Expansion)||12||
48591477|NCT00932698|101779936|FG009|STARTED|Part 2 (Dose Expansion)||6||
48591478|NCT00932698|101779937|FG010|STARTED|Part 2 (Dose Expansion)||2||
48591479|NCT00932698|101779927|FG000|COMPLETED|Part 2 (Dose Expansion)||0||
48591480|NCT00932698|101779928|FG001|COMPLETED|Part 2 (Dose Expansion)||0||
48591481|NCT00932698|101779929|FG002|COMPLETED|Part 2 (Dose Expansion)||0||
48591482|NCT00932698|101779930|FG003|COMPLETED|Part 2 (Dose Expansion)||0||
48591483|NCT00932698|101779931|FG004|COMPLETED|Part 2 (Dose Expansion)||0||
48591484|NCT00932698|101779932|FG005|COMPLETED|Part 2 (Dose Expansion)||0||
48591485|NCT00932698|101779933|FG006|COMPLETED|Part 2 (Dose Expansion)||0||
48591486|NCT00932698|101779934|FG007|COMPLETED|Part 2 (Dose Expansion)||0||
48591487|NCT00932698|101779935|FG008|COMPLETED|Part 2 (Dose Expansion)||0||
48591488|NCT00932698|101779936|FG009|COMPLETED|Part 2 (Dose Expansion)||0||
48591489|NCT00932698|101779937|FG010|COMPLETED|Part 2 (Dose Expansion)||0||
48591490|NCT00932698|101779927|FG000|NOT COMPLETED|Part 2 (Dose Expansion)||0||
48591491|NCT00932698|101779928|FG001|NOT COMPLETED|Part 2 (Dose Expansion)||0||
48591492|NCT00932698|101779929|FG002|NOT COMPLETED|Part 2 (Dose Expansion)||0||
48591493|NCT00932698|101779930|FG003|NOT COMPLETED|Part 2 (Dose Expansion)||0||
48591494|NCT00932698|101779931|FG004|NOT COMPLETED|Part 2 (Dose Expansion)||0||
48591495|NCT00932698|101779932|FG005|NOT COMPLETED|Part 2 (Dose Expansion)||0||
48591496|NCT00932698|101779933|FG006|NOT COMPLETED|Part 2 (Dose Expansion)||0||
48591497|NCT00932698|101779934|FG007|NOT COMPLETED|Part 2 (Dose Expansion)||20||
48591498|NCT00932698|101779935|FG008|NOT COMPLETED|Part 2 (Dose Expansion)||12||
48591499|NCT00932698|101779936|FG009|NOT COMPLETED|Part 2 (Dose Expansion)||6||
48591500|NCT00932698|101779937|FG010|NOT COMPLETED|Part 2 (Dose Expansion)||2||
48591501|NCT01096589|101779938|FG000|STARTED|Overall Study||22||
48591502|NCT01096589|101779939|FG001|STARTED|Overall Study||20||
48591503|NCT01096589|101779940|FG002|STARTED|Overall Study||22||
48591504|NCT01096589|101779941|FG003|STARTED|Overall Study||18||
48591505|NCT01096589|101779938|FG000|COMPLETED|Overall Study||18||
48591506|NCT01096589|101779939|FG001|COMPLETED|Overall Study||18||
48591507|NCT01096589|101779940|FG002|COMPLETED|Overall Study||18||
48591508|NCT01096589|101779941|FG003|COMPLETED|Overall Study||15||
48591509|NCT01096589|101779938|FG000|NOT COMPLETED|Overall Study||4||
48591510|NCT01096589|101779939|FG001|NOT COMPLETED|Overall Study||2||
48591511|NCT01096589|101779940|FG002|NOT COMPLETED|Overall Study||4||
48591512|NCT01096589|101779941|FG003|NOT COMPLETED|Overall Study||3||
48591513|NCT00460265|101779942|FG000|STARTED|Overall Study||328||
48591514|NCT00460265|101779943|FG001|STARTED|Overall Study||330||
48591515|NCT00460265|101779942|FG000|Randomized While Alive|Overall Study||327||
48709690|NCT02014480|102077832|FG000|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0||
48709691|NCT02014480|102077833|FG001|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0||
48709692|NCT02014480|102077834|FG002|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0||
48709693|NCT02014480|102077835|FG003|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0||
48709694|NCT02014480|102077836|FG004|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0||
48709695|NCT02014480|102077837|FG005|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0||
48709696|NCT02014480|102077832|FG000|STARTED|Treatment Period 3 (14 Days)||34||
48709697|NCT02014480|102077833|FG001|STARTED|Treatment Period 3 (14 Days)||33||
48140809|NCT02564523|100670271|FG014|COMPLETED|Overall Study||54||
48140810|NCT02564523|100670272|FG015|COMPLETED|Overall Study||12||
48140811|NCT02564523|100670273|FG016|COMPLETED|Overall Study||54||
48140812|NCT02564523|100670274|FG017|COMPLETED|Overall Study||11||
48140813|NCT02564523|100670257|FG000|NOT COMPLETED|Overall Study||10||
48140814|NCT02564523|100670258|FG001|NOT COMPLETED|Overall Study||3||
48591516|NCT00460265|101779943|FG001|Randomized While Alive|Overall Study||330||
48591517|NCT00460265|101779942|FG000|Received Study Medication|Overall Study||325||
48293567|NCT02074553|101044552|FG006|NOT COMPLETED|Washout Period 2||1||
48591518|NCT00460265|101779943|FG001|Received Study Medication|Overall Study||325||
48591519|NCT00460265|101779942|FG000|COMPLETED|Overall Study||243||
48591520|NCT00460265|101779943|FG001|COMPLETED|Overall Study||241||
48591521|NCT00460265|101779942|FG000|NOT COMPLETED|Overall Study||85||
48591522|NCT00460265|101779943|FG001|NOT COMPLETED|Overall Study||89||
48591523|NCT00535847|101779944|FG000|STARTED|Overall Study||81||
48140815|NCT02564523|100670259|FG002|NOT COMPLETED|Overall Study||10||
48591524|NCT00535847|101779945|FG001|STARTED|Overall Study||34||
48591525|NCT00535847|101779946|FG002|STARTED|Overall Study||2||
48591526|NCT00535847|101779944|FG000|COMPLETED|Overall Study||59||
48591527|NCT00535847|101779945|FG001|COMPLETED|Overall Study||20||
48591528|NCT00535847|101779946|FG002|COMPLETED|Overall Study||0||
48591529|NCT00535847|101779944|FG000|NOT COMPLETED|Overall Study||22||
48709698|NCT02014480|102077834|FG002|STARTED|Treatment Period 3 (14 Days)||30||
48709699|NCT02014480|102077835|FG003|STARTED|Treatment Period 3 (14 Days)||31||
48709700|NCT02014480|102077836|FG004|STARTED|Treatment Period 3 (14 Days)||34||
48709701|NCT02014480|102077837|FG005|STARTED|Treatment Period 3 (14 Days)||34||
48709702|NCT02014480|102077832|FG000|COMPLETED|Treatment Period 3 (14 Days)||34||
48709703|NCT02014480|102077833|FG001|COMPLETED|Treatment Period 3 (14 Days)||32||
48591530|NCT00535847|101779945|FG001|NOT COMPLETED|Overall Study||14||
48591531|NCT00535847|101779946|FG002|NOT COMPLETED|Overall Study||2||
48591532|NCT00108342|101779947|FG000|STARTED|Overall Study||8||
48591533|NCT00108342|101779948|FG001|STARTED|Overall Study||9||
48591534|NCT00108342|101779947|FG000|COMPLETED|Overall Study||7||
48591535|NCT00108342|101779948|FG001|COMPLETED|Overall Study||9||
48591536|NCT00108342|101779947|FG000|NOT COMPLETED|Overall Study||1||
48591537|NCT00108342|101779948|FG001|NOT COMPLETED|Overall Study||0||
48591538|NCT00358956|101779949|FG000|STARTED|Overall Study||19||
48591539|NCT00358956|101779949|FG000|COMPLETED|Overall Study||11||
48591540|NCT00358956|101779949|FG000|NOT COMPLETED|Overall Study||8||
48591541|NCT02523235|101779950|FG000|STARTED|Overall Study||56||
48591542|NCT02523235|101779951|FG001|STARTED|Overall Study||58||
48591543|NCT02523235|101779950|FG000|COMPLETED|Overall Study||56||
48591544|NCT02523235|101779951|FG001|COMPLETED|Overall Study||58||
48591545|NCT02523235|101779950|FG000|NOT COMPLETED|Overall Study||0||
48591546|NCT02523235|101779951|FG001|NOT COMPLETED|Overall Study||0||
48709704|NCT02014480|102077834|FG002|COMPLETED|Treatment Period 3 (14 Days)||29||
48709705|NCT02014480|102077835|FG003|COMPLETED|Treatment Period 3 (14 Days)||31||
48709706|NCT02014480|102077836|FG004|COMPLETED|Treatment Period 3 (14 Days)||34||
48709707|NCT02014480|102077837|FG005|COMPLETED|Treatment Period 3 (14 Days)||32||
48709708|NCT02014480|102077832|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0||
48709709|NCT02014480|102077833|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||1||
48709710|NCT02014480|102077834|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||1||
48709711|NCT02014480|102077835|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0||
48709712|NCT02014480|102077836|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||0||
48709713|NCT02014480|102077837|FG005|NOT COMPLETED|Treatment Period 3 (14 Days)||2||
48709714|NCT02370537|102077838|FG000|STARTED|Part A (Open-label Recruitment)||16||
48709715|NCT02370537|102077839|FG001|STARTED|Part A (Open-label Recruitment)||16||
48709716|NCT02370537|102077840|FG002|STARTED|Part A (Open-label Recruitment)||283||
48709717|NCT02370537|102077838|FG000|COMPLETED|Part A (Open-label Recruitment)||16||
48709718|NCT02370537|102077839|FG001|COMPLETED|Part A (Open-label Recruitment)||15||
48709719|NCT02370537|102077840|FG002|COMPLETED|Part A (Open-label Recruitment)||282||
48709720|NCT02370537|102077838|FG000|NOT COMPLETED|Part A (Open-label Recruitment)||0||
48709721|NCT02370537|102077839|FG001|NOT COMPLETED|Part A (Open-label Recruitment)||1||
48709722|NCT02370537|102077840|FG002|NOT COMPLETED|Part A (Open-label Recruitment)||1||
48709723|NCT02370537|102077838|FG000|STARTED|Part B||16||
48709724|NCT02370537|102077839|FG001|STARTED|Part B||15||
48709725|NCT02370537|102077840|FG002|STARTED|Part B||282||
48709726|NCT02370537|102077838|FG000|Eligible for Randomisation|Part B||15||
48709727|NCT02370537|102077839|FG001|Eligible for Randomisation|Part B||13||
48709728|NCT02370537|102077840|FG002|Eligible for Randomisation|Part B||23||
48709729|NCT02370537|102077838|FG000|Period 1 Sequence AB|Part B||8||
48709730|NCT02370537|102077839|FG001|Period 1 Sequence AB|Part B||6||
48709731|NCT02370537|102077840|FG002|Period 1 Sequence AB|Part B||11||
48709732|NCT02370537|102077838|FG000|Period 1 Sequence BA|Part B||7||
48709733|NCT02370537|102077839|FG001|Period 1 Sequence BA|Part B||7||
48709734|NCT02370537|102077840|FG002|Period 1 Sequence BA|Part B||12||
48709735|NCT02370537|102077838|FG000|Period 2 Sequence AB|Part B||8||
48709736|NCT02370537|102077839|FG001|Period 2 Sequence AB|Part B||5||
48709737|NCT02370537|102077840|FG002|Period 2 Sequence AB|Part B||11||
48709738|NCT02370537|102077838|FG000|Period 2 Sequence BA|Part B||7||
48709739|NCT02370537|102077839|FG001|Period 2 Sequence BA|Part B||7||
48709740|NCT02370537|102077840|FG002|Period 2 Sequence BA|Part B||12||
48403696|NCT01855945|101321662|FG000|COMPLETED|Overall Study||38||
48403697|NCT01855945|101321663|FG001|COMPLETED|Overall Study||44||
48403698|NCT01855945|101321664|FG002|COMPLETED|Overall Study||39||
48403699|NCT01855945|101321665|FG003|COMPLETED|Overall Study||49||
48403700|NCT01855945|101321666|FG004|COMPLETED|Overall Study||50||
48403701|NCT01855945|101321667|FG005|COMPLETED|Overall Study||50||
48403702|NCT01855945|101321668|FG006|COMPLETED|Overall Study||43||
48403703|NCT01855945|101321669|FG007|COMPLETED|Overall Study||47||
48591547|NCT03181503|101779952|FG000|STARTED|Overall Study||36||
48591548|NCT03181503|101779953|FG001|STARTED|Overall Study||34||
48591549|NCT03181503|101779952|FG000|Treated|Overall Study||36||
48591550|NCT03181503|101779953|FG001|Treated|Overall Study||34||
48591551|NCT03181503|101779952|FG000|COMPLETED|Overall Study||29||
48709741|NCT02370537|102077838|FG000|COMPLETED|Part B||15||
48709742|NCT02370537|102077839|FG001|COMPLETED|Part B||12||
48709743|NCT02370537|102077840|FG002|COMPLETED|Part B||23||
48709744|NCT02370537|102077838|FG000|NOT COMPLETED|Part B||1||
48709745|NCT02370537|102077839|FG001|NOT COMPLETED|Part B||3||
48709746|NCT02370537|102077840|FG002|NOT COMPLETED|Part B||259||
48140816|NCT02564523|100670260|FG003|NOT COMPLETED|Overall Study||1||
48293568|NCT02074553|101044553|FG007|NOT COMPLETED|Washout Period 2||0||
48293569|NCT02074553|101044546|FG000|STARTED|Intervention Period 3||11||
48293570|NCT02074553|101044547|FG001|STARTED|Intervention Period 3||12||
48293571|NCT02074553|101044548|FG002|STARTED|Intervention Period 3||11||
48293572|NCT02074553|101044549|FG003|STARTED|Intervention Period 3||11||
48293573|NCT02074553|101044550|FG004|STARTED|Intervention Period 3||12||
48293574|NCT02074553|101044551|FG005|STARTED|Intervention Period 3||10||
48293575|NCT02074553|101044552|FG006|STARTED|Intervention Period 3||11||
48293576|NCT02074553|101044553|FG007|STARTED|Intervention Period 3||12||
48293577|NCT02074553|101044546|FG000|COMPLETED|Intervention Period 3||11||
48293578|NCT02074553|101044547|FG001|COMPLETED|Intervention Period 3||12||
48293579|NCT02074553|101044548|FG002|COMPLETED|Intervention Period 3||11||
48293580|NCT02074553|101044549|FG003|COMPLETED|Intervention Period 3||11||
48293581|NCT02074553|101044550|FG004|COMPLETED|Intervention Period 3||12||
48293582|NCT02074553|101044551|FG005|COMPLETED|Intervention Period 3||10||
48293583|NCT02074553|101044552|FG006|COMPLETED|Intervention Period 3||11||
48591552|NCT03181503|101779953|FG001|COMPLETED|Overall Study||31||
48591553|NCT03181503|101779952|FG000|NOT COMPLETED|Overall Study||7||
48591554|NCT03181503|101779953|FG001|NOT COMPLETED|Overall Study||3||
48591555|NCT04106089|101779954|FG000|STARTED|Overall Study||29||
48591556|NCT04106089|101779955|FG001|STARTED|Overall Study||21||
48140817|NCT02564523|100670261|FG004|NOT COMPLETED|Overall Study||4||
48140818|NCT02564523|100670262|FG005|NOT COMPLETED|Overall Study||0||
48140819|NCT02564523|100670263|FG006|NOT COMPLETED|Overall Study||3||
48140820|NCT02564523|100670264|FG007|NOT COMPLETED|Overall Study||0||
48140821|NCT02564523|100670265|FG008|NOT COMPLETED|Overall Study||0||
48140822|NCT02564523|100670266|FG009|NOT COMPLETED|Overall Study||0||
48140823|NCT02564523|100670267|FG010|NOT COMPLETED|Overall Study||3||
48140824|NCT02564523|100670268|FG011|NOT COMPLETED|Overall Study||1||
48140825|NCT02564523|100670269|FG012|NOT COMPLETED|Overall Study||2||
48140826|NCT02564523|100670270|FG013|NOT COMPLETED|Overall Study||0||
48140827|NCT02564523|100670271|FG014|NOT COMPLETED|Overall Study||0||
48140828|NCT02564523|100670272|FG015|NOT COMPLETED|Overall Study||0||
48140829|NCT02564523|100670273|FG016|NOT COMPLETED|Overall Study||0||
48140830|NCT02564523|100670274|FG017|NOT COMPLETED|Overall Study||1||
48140831|NCT03568318|100670275|FG000|STARTED|Overall Study||264|Randomized into study|
48140832|NCT03568318|100670276|FG001|STARTED|Overall Study||261|Randomized into study|
48140833|NCT03568318|100670277|FG002|STARTED|Overall Study||260|Randomized into study|
48140834|NCT03568318|100670278|FG003|STARTED|Overall Study||63|Randomized into study|
48140835|NCT03568318|100670279|FG004|STARTED|Overall Study||60|Randomized into study|
48140836|NCT03568318|100670280|FG005|STARTED|Overall Study||60|Randomized into study|
48140837|NCT03568318|100670275|FG000|Received Study Drug|Overall Study||264||
48140838|NCT03568318|100670276|FG001|Received Study Drug|Overall Study||261||
48140839|NCT03568318|100670277|FG002|Received Study Drug|Overall Study||260||
48140840|NCT03568318|100670278|FG003|Received Study Drug|Overall Study||62||
48293584|NCT02074553|101044553|FG007|COMPLETED|Intervention Period 3||12||
48293585|NCT02074553|101044546|FG000|NOT COMPLETED|Intervention Period 3||0||
48293586|NCT02074553|101044547|FG001|NOT COMPLETED|Intervention Period 3||0||
48293587|NCT02074553|101044548|FG002|NOT COMPLETED|Intervention Period 3||0||
48293588|NCT02074553|101044549|FG003|NOT COMPLETED|Intervention Period 3||0||
48293589|NCT02074553|101044550|FG004|NOT COMPLETED|Intervention Period 3||0||
48140841|NCT03568318|100670279|FG004|Received Study Drug|Overall Study||60||
48293590|NCT02074553|101044551|FG005|NOT COMPLETED|Intervention Period 3||0||
48293591|NCT02074553|101044552|FG006|NOT COMPLETED|Intervention Period 3||0||
48293592|NCT02074553|101044553|FG007|NOT COMPLETED|Intervention Period 3||0||
48591557|NCT04106089|101779954|FG000|COMPLETED|Overall Study||21||
48591558|NCT04106089|101779955|FG001|COMPLETED|Overall Study||19||
48591559|NCT04106089|101779954|FG000|NOT COMPLETED|Overall Study||8||
48403704|NCT01855945|101321670|FG008|COMPLETED|Overall Study||46||
48403705|NCT01855945|101321671|FG009|COMPLETED|Overall Study||49||
48403706|NCT01855945|101321672|FG010|COMPLETED|Overall Study||46||
48403707|NCT01855945|101321673|FG011|COMPLETED|Overall Study||49||
48403708|NCT01855945|101321662|FG000|NOT COMPLETED|Overall Study||16||
48403709|NCT01855945|101321663|FG001|NOT COMPLETED|Overall Study||11||
48591560|NCT04106089|101779955|FG001|NOT COMPLETED|Overall Study||2||
48591561|NCT01179737|101782891|FG000|STARTED|Cohort 1 & Cohort 2||12||
48591562|NCT01179737|101782892|FG001|STARTED|Cohort 1 & Cohort 2||3||
48709747|NCT02811913|102077841|FG000|STARTED|Overall Study||20||
48709748|NCT02811913|102077841|FG000|COMPLETED|Overall Study||16||
48709749|NCT02811913|102077841|FG000|NOT COMPLETED|Overall Study||4||
48709750|NCT01437098|102077842|FG000|STARTED|Overall Study||55||
48709751|NCT01437098|102077842|FG000|30 Days|Overall Study||51||
48709752|NCT01437098|102077842|FG000|6 Months|Overall Study||47||
48709753|NCT01437098|102077842|FG000|12 Months|Overall Study||45||
48709754|NCT01437098|102077842|FG000|24 Months|Overall Study||42||
48709755|NCT01437098|102077842|FG000|36 Months|Overall Study||36||
48709756|NCT01437098|102077842|FG000|COMPLETED|Overall Study||42||
48709757|NCT01437098|102077842|FG000|NOT COMPLETED|Overall Study||13||
48709758|NCT02743780|102077843|FG000|STARTED|Part 1 (3 Days)||6||
48709759|NCT02743780|102077844|FG001|STARTED|Part 1 (3 Days)||6||
48403710|NCT01855945|101321664|FG002|NOT COMPLETED|Overall Study||12||
48403711|NCT01855945|101321665|FG003|NOT COMPLETED|Overall Study||4||
48709760|NCT02743780|102077845|FG002|STARTED|Part 1 (3 Days)||6||
48709761|NCT02743780|102077846|FG003|STARTED|Part 1 (3 Days)||6||
48403712|NCT01855945|101321666|FG004|NOT COMPLETED|Overall Study||1||
48709762|NCT02743780|102077847|FG004|STARTED|Part 1 (3 Days)||8||
48709763|NCT02743780|102077843|FG000|COMPLETED|Part 1 (3 Days)||6||
48403713|NCT01855945|101321667|FG005|NOT COMPLETED|Overall Study||3||
48591563|NCT01179737|101782893|FG002|STARTED|Cohort 1 & Cohort 2||4||
48591564|NCT01179737|101782894|FG003|STARTED|Cohort 1 & Cohort 2||4||
48591565|NCT01179737|101782891|FG000|COMPLETED|Cohort 1 & Cohort 2||7||
48591566|NCT01179737|101782892|FG001|COMPLETED|Cohort 1 & Cohort 2||1||
48591567|NCT01179737|101782893|FG002|COMPLETED|Cohort 1 & Cohort 2||0||
48591568|NCT01179737|101782894|FG003|COMPLETED|Cohort 1 & Cohort 2||0||
48591569|NCT01179737|101782891|FG000|NOT COMPLETED|Cohort 1 & Cohort 2||5||
48591570|NCT01179737|101782892|FG001|NOT COMPLETED|Cohort 1 & Cohort 2||2||
48591571|NCT01179737|101782893|FG002|NOT COMPLETED|Cohort 1 & Cohort 2||4||
48591572|NCT01179737|101782894|FG003|NOT COMPLETED|Cohort 1 & Cohort 2||4||
48591573|NCT01179737|101782891|FG000|STARTED|Cohort 1 & Cohort 2 Expansion||5||
48709764|NCT02743780|102077844|FG001|COMPLETED|Part 1 (3 Days)||6||
48709765|NCT02743780|102077845|FG002|COMPLETED|Part 1 (3 Days)||6||
48293593|NCT02074553|101044546|FG000|STARTED|Washout Period 3||11||
48293594|NCT02074553|101044547|FG001|STARTED|Washout Period 3||12||
48293595|NCT02074553|101044548|FG002|STARTED|Washout Period 3||11||
48293596|NCT02074553|101044549|FG003|STARTED|Washout Period 3||11||
48293597|NCT02074553|101044550|FG004|STARTED|Washout Period 3||12||
48293598|NCT02074553|101044551|FG005|STARTED|Washout Period 3||10||
48403714|NCT01855945|101321668|FG006|NOT COMPLETED|Overall Study||10||
48403715|NCT01855945|101321669|FG007|NOT COMPLETED|Overall Study||8||
48403716|NCT01855945|101321670|FG008|NOT COMPLETED|Overall Study||2||
48403717|NCT01855945|101321671|FG009|NOT COMPLETED|Overall Study||2||
48403718|NCT01855945|101321672|FG010|NOT COMPLETED|Overall Study||5||
48403719|NCT01855945|101321673|FG011|NOT COMPLETED|Overall Study||3||
48403720|NCT05083949|101321674|FG000|STARTED|Period 1||16||
48403721|NCT05083949|101321675|FG001|STARTED|Period 1||16||
48403722|NCT05083949|101321674|FG000|COMPLETED|Period 1||13||
48403723|NCT05083949|101321675|FG001|COMPLETED|Period 1||14||
48403724|NCT05083949|101321674|FG000|NOT COMPLETED|Period 1||3||
48403725|NCT05083949|101321675|FG001|NOT COMPLETED|Period 1||2||
48403726|NCT05083949|101321674|FG000|STARTED|Wash-out||13||
48293599|NCT02074553|101044552|FG006|STARTED|Washout Period 3||11||
48293600|NCT02074553|101044553|FG007|STARTED|Washout Period 3||12||
48293601|NCT02074553|101044546|FG000|COMPLETED|Washout Period 3||11||
48293602|NCT02074553|101044547|FG001|COMPLETED|Washout Period 3||12||
48293603|NCT02074553|101044548|FG002|COMPLETED|Washout Period 3||11||
48293604|NCT02074553|101044549|FG003|COMPLETED|Washout Period 3||11||
48293605|NCT02074553|101044550|FG004|COMPLETED|Washout Period 3||12||
48293606|NCT02074553|101044551|FG005|COMPLETED|Washout Period 3||10||
48293607|NCT02074553|101044552|FG006|COMPLETED|Washout Period 3||11||
48293608|NCT02074553|101044553|FG007|COMPLETED|Washout Period 3||11||
48293609|NCT02074553|101044546|FG000|NOT COMPLETED|Washout Period 3||0||
48293610|NCT02074553|101044547|FG001|NOT COMPLETED|Washout Period 3||0||
48293611|NCT02074553|101044548|FG002|NOT COMPLETED|Washout Period 3||0||
48293612|NCT02074553|101044549|FG003|NOT COMPLETED|Washout Period 3||0||
48293613|NCT02074553|101044550|FG004|NOT COMPLETED|Washout Period 3||0||
48293614|NCT02074553|101044551|FG005|NOT COMPLETED|Washout Period 3||0||
48293615|NCT02074553|101044552|FG006|NOT COMPLETED|Washout Period 3||0||
48293616|NCT02074553|101044553|FG007|NOT COMPLETED|Washout Period 3||1||
48293617|NCT02074553|101044546|FG000|STARTED|Intervention Period 4||11||
48293618|NCT02074553|101044547|FG001|STARTED|Intervention Period 4||12||
48293619|NCT02074553|101044548|FG002|STARTED|Intervention Period 4||11||
48293620|NCT02074553|101044549|FG003|STARTED|Intervention Period 4||11||
48293621|NCT02074553|101044550|FG004|STARTED|Intervention Period 4||12||
48293622|NCT02074553|101044551|FG005|STARTED|Intervention Period 4||10||
48293623|NCT02074553|101044552|FG006|STARTED|Intervention Period 4||11||
48293624|NCT02074553|101044553|FG007|STARTED|Intervention Period 4||11||
48403727|NCT05083949|101321675|FG001|STARTED|Wash-out||14||
48403728|NCT05083949|101321674|FG000|COMPLETED|Wash-out||13||
48403729|NCT05083949|101321675|FG001|COMPLETED|Wash-out||14||
48403730|NCT05083949|101321674|FG000|NOT COMPLETED|Wash-out||0||
48403731|NCT05083949|101321675|FG001|NOT COMPLETED|Wash-out||0||
48403732|NCT05083949|101321674|FG000|STARTED|Period 2||13||
48403733|NCT05083949|101321675|FG001|STARTED|Period 2||14||
48403734|NCT05083949|101321674|FG000|COMPLETED|Period 2||12||
48403735|NCT05083949|101321675|FG001|COMPLETED|Period 2||12||
48403736|NCT05083949|101321674|FG000|NOT COMPLETED|Period 2||1||
48403737|NCT05083949|101321675|FG001|NOT COMPLETED|Period 2||2||
48403738|NCT00010803|101321676|FG000|STARTED|Overall Study||1545||
48403739|NCT00010803|101321677|FG001|STARTED|Overall Study||1524||
48403740|NCT00010803|101321676|FG000|COMPLETED|Overall Study||1448||
48403741|NCT00010803|101321677|FG001|COMPLETED|Overall Study||1426||
48403742|NCT00010803|101321676|FG000|NOT COMPLETED|Overall Study||97||
48403743|NCT00010803|101321677|FG001|NOT COMPLETED|Overall Study||98||
48403744|NCT02687711|101321678|FG000|STARTED|Overall Study||544||
48403745|NCT02687711|101321678|FG000|COMPLETED|Overall Study||332||
48403746|NCT02687711|101321678|FG000|NOT COMPLETED|Overall Study||212||
48591574|NCT01179737|101782892|FG001|STARTED|Cohort 1 & Cohort 2 Expansion||1||
48591575|NCT01179737|101782893|FG002|STARTED|Cohort 1 & Cohort 2 Expansion||0||
48591576|NCT01179737|101782894|FG003|STARTED|Cohort 1 & Cohort 2 Expansion||0||
48591577|NCT01179737|101782891|FG000|COMPLETED|Cohort 1 & Cohort 2 Expansion||4||
48293625|NCT02074553|101044546|FG000|COMPLETED|Intervention Period 4||11||
48293626|NCT02074553|101044547|FG001|COMPLETED|Intervention Period 4||12||
48293627|NCT02074553|101044548|FG002|COMPLETED|Intervention Period 4||11||
48293628|NCT02074553|101044549|FG003|COMPLETED|Intervention Period 4||11||
48293629|NCT02074553|101044550|FG004|COMPLETED|Intervention Period 4||12||
48293630|NCT02074553|101044551|FG005|COMPLETED|Intervention Period 4||10||
48403747|NCT03168841|101321679|FG000|STARTED|Overall Study||40||
48293631|NCT02074553|101044552|FG006|COMPLETED|Intervention Period 4||11||
48293632|NCT02074553|101044553|FG007|COMPLETED|Intervention Period 4||11||
48403748|NCT03168841|101321679|FG000|COMPLETED|Overall Study||36||
48403749|NCT03168841|101321679|FG000|NOT COMPLETED|Overall Study||4||
48403750|NCT00481988|101321680|FG000|STARTED|Overall Study||12||
48403751|NCT00481988|101321681|FG001|STARTED|Overall Study||9||
48591578|NCT01179737|101782892|FG001|COMPLETED|Cohort 1 & Cohort 2 Expansion||1||
48591579|NCT01179737|101782893|FG002|COMPLETED|Cohort 1 & Cohort 2 Expansion||0||
48293633|NCT02074553|101044546|FG000|NOT COMPLETED|Intervention Period 4||0||
48293634|NCT02074553|101044547|FG001|NOT COMPLETED|Intervention Period 4||0||
48293635|NCT02074553|101044548|FG002|NOT COMPLETED|Intervention Period 4||0||
48293636|NCT02074553|101044549|FG003|NOT COMPLETED|Intervention Period 4||0||
48293637|NCT02074553|101044550|FG004|NOT COMPLETED|Intervention Period 4||0||
48293638|NCT02074553|101044551|FG005|NOT COMPLETED|Intervention Period 4||0||
48293639|NCT02074553|101044552|FG006|NOT COMPLETED|Intervention Period 4||0||
48293640|NCT02074553|101044553|FG007|NOT COMPLETED|Intervention Period 4||0||
48293641|NCT00448279|101044554|FG000|STARTED|Overall Study||29||
48293642|NCT00448279|101044555|FG001|STARTED|Overall Study||29||
48293643|NCT00448279|101044554|FG000|COMPLETED|Overall Study||0||
48293644|NCT00448279|101044555|FG001|COMPLETED|Overall Study||0||
48140842|NCT03568318|100670280|FG005|Received Study Drug|Overall Study||60||
48140843|NCT03568318|100670275|FG000|COMPLETED|Overall Study||244|Completed Week 16|
48140844|NCT03568318|100670276|FG001|COMPLETED|Overall Study||249|Completed Week 16|
48140845|NCT03568318|100670277|FG002|COMPLETED|Overall Study||250|Completed Week 16|
48140846|NCT03568318|100670278|FG003|COMPLETED|Overall Study||59|Completed Week 16|
48140847|NCT03568318|100670279|FG004|COMPLETED|Overall Study||58|Completed Week 16|
48140848|NCT03568318|100670280|FG005|COMPLETED|Overall Study||60|Completed Week 16|
48140849|NCT03568318|100670275|FG000|NOT COMPLETED|Overall Study||20||
48140850|NCT03568318|100670276|FG001|NOT COMPLETED|Overall Study||12||
48140851|NCT03568318|100670277|FG002|NOT COMPLETED|Overall Study||10||
48140852|NCT03568318|100670278|FG003|NOT COMPLETED|Overall Study||4||
48140853|NCT03568318|100670279|FG004|NOT COMPLETED|Overall Study||2||
48140854|NCT03568318|100670280|FG005|NOT COMPLETED|Overall Study||0||
48140855|NCT01864564|100670281|FG000|STARTED|Overall Study||480||
48140856|NCT01864564|100670282|FG001|STARTED|Overall Study||482||
48140857|NCT01864564|100670281|FG000|COMPLETED|Overall Study||443||
48140858|NCT01864564|100670282|FG001|COMPLETED|Overall Study||387||
48140859|NCT01864564|100670281|FG000|NOT COMPLETED|Overall Study||37||
48140860|NCT01864564|100670282|FG001|NOT COMPLETED|Overall Study||95||
48140861|NCT03053050|100670283|FG000|STARTED|Randomized Phase||324||
48140862|NCT03053050|100670284|FG001|STARTED|Randomized Phase||323||
48140863|NCT03053050|100670285|FG002|STARTED|Randomized Phase||161||
48140864|NCT03053050|100670286|FG003|STARTED|Randomized Phase||0||
48140865|NCT03053050|100670283|FG000|COMPLETED|Randomized Phase||0||
48140866|NCT03053050|100670284|FG001|COMPLETED|Randomized Phase||0||
48140867|NCT03053050|100670285|FG002|COMPLETED|Randomized Phase||0||
48140868|NCT03053050|100670286|FG003|COMPLETED|Randomized Phase||0||
48140869|NCT03053050|100670283|FG000|NOT COMPLETED|Randomized Phase||324||
48140870|NCT03053050|100670284|FG001|NOT COMPLETED|Randomized Phase||323||
48140871|NCT03053050|100670285|FG002|NOT COMPLETED|Randomized Phase||161||
48140872|NCT03053050|100670286|FG003|NOT COMPLETED|Randomized Phase||0||
48140873|NCT03053050|100670283|FG000|STARTED|Open-label Phase||0||
48140874|NCT03053050|100670284|FG001|STARTED|Open-label Phase||0||
48293645|NCT00448279|101044554|FG000|NOT COMPLETED|Overall Study||29||
48293646|NCT00448279|101044555|FG001|NOT COMPLETED|Overall Study||29||
48293647|NCT02767128|101044556|FG000|STARTED|Overall Study||14||
48293648|NCT02767128|101044556|FG000|Baseline|Overall Study||14||
48293649|NCT02767128|101044556|FG000|Fer-In-Sol|Overall Study||14||
48293650|NCT02767128|101044556|FG000|Shohl's + Fer-In-Sol|Overall Study||14||
48293651|NCT02767128|101044556|FG000|Triferic|Overall Study||14||
48293652|NCT02767128|101044556|FG000|Shohl's + Triferic After 10 Min|Overall Study||14||
48293653|NCT02767128|101044556|FG000|Shohl's + Triferic Immediately|Overall Study||14||
48293654|NCT02767128|101044556|FG000|COMPLETED|Overall Study||14||
48293655|NCT02767128|101044556|FG000|NOT COMPLETED|Overall Study||0||
48293656|NCT02294227|101044557|FG000|STARTED|Overall Study||114||
48293657|NCT02294227|101044558|FG001|STARTED|Overall Study||113||
48293658|NCT02294227|101044559|FG002|STARTED|Overall Study||114||
48293659|NCT02294227|101044557|FG000|COMPLETED|Overall Study||89|Completed Week 104|
48293660|NCT02294227|101044558|FG001|COMPLETED|Overall Study||88|Completed Week 104|
48293661|NCT02294227|101044559|FG002|COMPLETED|Overall Study||95|Completed Week 104|
48293662|NCT02294227|101044557|FG000|NOT COMPLETED|Overall Study||25||
48293663|NCT02294227|101044558|FG001|NOT COMPLETED|Overall Study||25||
48293664|NCT02294227|101044559|FG002|NOT COMPLETED|Overall Study||19||
48293665|NCT02325557|101044560|FG000|STARTED|Overall Study||10||
48293666|NCT02325557|101044561|FG001|STARTED|Overall Study||1||
48293667|NCT02325557|101044562|FG002|STARTED|Overall Study||2||
48293668|NCT02325557|101044563|FG003|STARTED|Overall Study||37||
48293669|NCT02325557|101044560|FG000|COMPLETED|Overall Study||0||
48293670|NCT02325557|101044561|FG001|COMPLETED|Overall Study||0||
48293671|NCT02325557|101044562|FG002|COMPLETED|Overall Study||0||
48293672|NCT02325557|101044563|FG003|COMPLETED|Overall Study||0||
48293673|NCT02325557|101044560|FG000|NOT COMPLETED|Overall Study||10||
48293674|NCT02325557|101044561|FG001|NOT COMPLETED|Overall Study||1||
48293675|NCT02325557|101044562|FG002|NOT COMPLETED|Overall Study||2||
48293676|NCT02325557|101044563|FG003|NOT COMPLETED|Overall Study||37||
48293677|NCT04281004|101044564|FG000|STARTED|Overall Study||29||58
48293678|NCT04281004|101044565|FG001|STARTED|Overall Study||32||64
48293679|NCT04281004|101044564|FG000|COMPLETED|Overall Study||28||56
48293680|NCT04281004|101044565|FG001|COMPLETED|Overall Study||32||64
48293681|NCT04281004|101044564|FG000|NOT COMPLETED|Overall Study||1||2
48293682|NCT04281004|101044565|FG001|NOT COMPLETED|Overall Study||0||0
48293683|NCT01824160|101047416|FG000|STARTED|Overall Study||50||
48293684|NCT01824160|101047416|FG000|COMPLETED|Overall Study||50||
48293685|NCT01824160|101047416|FG000|NOT COMPLETED|Overall Study||0||
48293686|NCT00561951|101047417|FG000|STARTED|Overall Study||318||
48293687|NCT00561951|101047418|FG001|STARTED|Overall Study||320||
48293688|NCT00561951|101047419|FG002|STARTED|Overall Study||313||
48293689|NCT00561951|101047417|FG000|COMPLETED|Overall Study||285||
48293690|NCT00561951|101047418|FG001|COMPLETED|Overall Study||286||
48293691|NCT00561951|101047419|FG002|COMPLETED|Overall Study||281||
48293692|NCT00561951|101047417|FG000|NOT COMPLETED|Overall Study||33||
48293693|NCT00561951|101047418|FG001|NOT COMPLETED|Overall Study||34||
48293694|NCT00561951|101047419|FG002|NOT COMPLETED|Overall Study||32||
48591580|NCT01179737|101782894|FG003|COMPLETED|Cohort 1 & Cohort 2 Expansion||0||
48591581|NCT01179737|101782891|FG000|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||1||
48591582|NCT01179737|101782892|FG001|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0||
48591583|NCT01179737|101782893|FG002|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0||
48591584|NCT01179737|101782894|FG003|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0||
48591585|NCT01179737|101782891|FG000|STARTED|Extension||3||
48591586|NCT01179737|101782892|FG001|STARTED|Extension||0||
48591587|NCT01179737|101782893|FG002|STARTED|Extension||0||
48293695|NCT02832154|101047420|FG000|STARTED|Overall Study||43||
48293696|NCT02832154|101047420|FG000|COMPLETED|Overall Study||43||
48591588|NCT01179737|101782894|FG003|STARTED|Extension||0||
48591589|NCT01179737|101782891|FG000|COMPLETED|Extension||0||
48591590|NCT01179737|101782892|FG001|COMPLETED|Extension||0||
48293697|NCT02832154|101047420|FG000|NOT COMPLETED|Overall Study||0||
48293698|NCT01551212|101047421|FG000|STARTED|Overall Study||171|Randomized|
48293699|NCT01551212|101047422|FG001|STARTED|Overall Study||168|Randomized|
48293700|NCT01551212|101047421|FG000|Full Anylsis Set (FAS)|Overall Study||169|Randomized and received at least 1 dose of study drug|
48293701|NCT01551212|101047422|FG001|Full Anylsis Set (FAS)|Overall Study||164|Randomized and received at least 1 dose of study drug|
48591591|NCT01179737|101782893|FG002|COMPLETED|Extension||0||
48591592|NCT01179737|101782894|FG003|COMPLETED|Extension||0||
48591593|NCT01179737|101782891|FG000|NOT COMPLETED|Extension||3||
48709766|NCT02743780|102077846|FG003|COMPLETED|Part 1 (3 Days)||6||
48709767|NCT02743780|102077847|FG004|COMPLETED|Part 1 (3 Days)||8||
48709768|NCT02743780|102077843|FG000|NOT COMPLETED|Part 1 (3 Days)||0||
48709769|NCT02743780|102077844|FG001|NOT COMPLETED|Part 1 (3 Days)||0||
48709770|NCT02743780|102077845|FG002|NOT COMPLETED|Part 1 (3 Days)||0||
48709771|NCT02743780|102077846|FG003|NOT COMPLETED|Part 1 (3 Days)||0||
48591594|NCT01179737|101782892|FG001|NOT COMPLETED|Extension||0||
48591595|NCT01179737|101782893|FG002|NOT COMPLETED|Extension||0||
48591596|NCT01179737|101782894|FG003|NOT COMPLETED|Extension||0||
48709772|NCT02743780|102077847|FG004|NOT COMPLETED|Part 1 (3 Days)||0||
48591597|NCT01794793|101782895|FG000|STARTED|Treatment Period||337||
48591598|NCT01794793|101782895|FG000|COMPLETED|Treatment Period||239||
48591599|NCT01794793|101782895|FG000|NOT COMPLETED|Treatment Period||98||
48591600|NCT01794793|101782895|FG000|STARTED|Post-treatment Follow-up||149||
48591601|NCT01794793|101782895|FG000|COMPLETED|Post-treatment Follow-up||110||
48591602|NCT01794793|101782895|FG000|NOT COMPLETED|Post-treatment Follow-up||39||
48591603|NCT01917344|101782896|FG000|STARTED|Overall Study||10||
48591604|NCT01917344|101782896|FG000|COMPLETED|Overall Study||9||
48591605|NCT01917344|101782896|FG000|NOT COMPLETED|Overall Study||1||
48591606|NCT02954653|101782897|FG000|STARTED|Overall Study||4||
48709773|NCT02743780|102077843|FG000|STARTED|Part 2 (8 Days)||0||
48709774|NCT02743780|102077844|FG001|STARTED|Part 2 (8 Days)||6||
48709775|NCT02743780|102077845|FG002|STARTED|Part 2 (8 Days)||6||
48709776|NCT02743780|102077846|FG003|STARTED|Part 2 (8 Days)||0||
48709777|NCT02743780|102077847|FG004|STARTED|Part 2 (8 Days)||4||
48709778|NCT02743780|102077843|FG000|COMPLETED|Part 2 (8 Days)||0||
48709779|NCT02743780|102077844|FG001|COMPLETED|Part 2 (8 Days)||6||
48140875|NCT03053050|100670285|FG002|STARTED|Open-label Phase||0||
48140876|NCT03053050|100670286|FG003|STARTED|Open-label Phase||99||
48709780|NCT02743780|102077845|FG002|COMPLETED|Part 2 (8 Days)||6||
48709781|NCT02743780|102077846|FG003|COMPLETED|Part 2 (8 Days)||0||
48709782|NCT02743780|102077847|FG004|COMPLETED|Part 2 (8 Days)||4||
48709783|NCT02743780|102077843|FG000|NOT COMPLETED|Part 2 (8 Days)||0||
48709784|NCT02743780|102077844|FG001|NOT COMPLETED|Part 2 (8 Days)||0||
48709785|NCT02743780|102077845|FG002|NOT COMPLETED|Part 2 (8 Days)||0||
48709786|NCT02743780|102077846|FG003|NOT COMPLETED|Part 2 (8 Days)||0||
48709787|NCT02743780|102077847|FG004|NOT COMPLETED|Part 2 (8 Days)||0||
48140877|NCT03053050|100670283|FG000|COMPLETED|Open-label Phase||0||
48591607|NCT02954653|101782898|FG001|STARTED|Overall Study||4||
48591608|NCT02954653|101782899|FG002|STARTED|Overall Study||0||
48591609|NCT02954653|101782900|FG003|STARTED|Overall Study||0||
48591610|NCT02954653|101782901|FG004|STARTED|Overall Study||0||
48591611|NCT02954653|101782902|FG005|STARTED|Overall Study||0||
48591612|NCT02954653|101782903|FG006|STARTED|Overall Study||0||
48591613|NCT02954653|101782904|FG007|STARTED|Overall Study||0||
48591614|NCT02954653|101782905|FG008|STARTED|Overall Study||0||
48709788|NCT02743780|102077843|FG000|STARTED|Part 3 (7 Days)||0||
48709789|NCT02743780|102077844|FG001|STARTED|Part 3 (7 Days)||0||
48709790|NCT02743780|102077845|FG002|STARTED|Part 3 (7 Days)||25||
48709791|NCT02743780|102077846|FG003|STARTED|Part 3 (7 Days)||0||
48709792|NCT02743780|102077847|FG004|STARTED|Part 3 (7 Days)||25||
48709793|NCT02743780|102077843|FG000|COMPLETED|Part 3 (7 Days)||0||
48591615|NCT02954653|101782897|FG000|Received Treatment|Overall Study||3||
48591616|NCT02954653|101782898|FG001|Received Treatment|Overall Study||4||
48591617|NCT02954653|101782899|FG002|Received Treatment|Overall Study||0||
48591618|NCT02954653|101782900|FG003|Received Treatment|Overall Study||0||
48591619|NCT02954653|101782901|FG004|Received Treatment|Overall Study||0||
48591620|NCT02954653|101782902|FG005|Received Treatment|Overall Study||0||
48591621|NCT02954653|101782903|FG006|Received Treatment|Overall Study||0||
48591622|NCT02954653|101782904|FG007|Received Treatment|Overall Study||0||
48591623|NCT02954653|101782905|FG008|Received Treatment|Overall Study||0||
48591624|NCT02954653|101782897|FG000|COMPLETED|Overall Study||0||
48591625|NCT02954653|101782898|FG001|COMPLETED|Overall Study||1||
48591626|NCT02954653|101782899|FG002|COMPLETED|Overall Study||0||
48591627|NCT02954653|101782900|FG003|COMPLETED|Overall Study||0||
48591628|NCT02954653|101782901|FG004|COMPLETED|Overall Study||0||
48591629|NCT02954653|101782902|FG005|COMPLETED|Overall Study||0||
48591630|NCT02954653|101782903|FG006|COMPLETED|Overall Study||0||
48591631|NCT02954653|101782904|FG007|COMPLETED|Overall Study||0||
48591632|NCT02954653|101782905|FG008|COMPLETED|Overall Study||0||
48591633|NCT02954653|101782897|FG000|NOT COMPLETED|Overall Study||4||
48591634|NCT02954653|101782898|FG001|NOT COMPLETED|Overall Study||3||
48591635|NCT02954653|101782899|FG002|NOT COMPLETED|Overall Study||0||
48591636|NCT02954653|101782900|FG003|NOT COMPLETED|Overall Study||0||
48591637|NCT02954653|101782901|FG004|NOT COMPLETED|Overall Study||0||
48591638|NCT02954653|101782902|FG005|NOT COMPLETED|Overall Study||0||
48591639|NCT02954653|101782903|FG006|NOT COMPLETED|Overall Study||0||
48591640|NCT02954653|101782904|FG007|NOT COMPLETED|Overall Study||0||
48591641|NCT02954653|101782905|FG008|NOT COMPLETED|Overall Study||0||
48591642|NCT02681757|101782906|FG000|STARTED|Overall Study||47||
48591643|NCT02681757|101782907|FG001|STARTED|Overall Study||49||
48591644|NCT02681757|101782906|FG000|COMPLETED|Overall Study||47||
48591645|NCT02681757|101782907|FG001|COMPLETED|Overall Study||49||
48591646|NCT02681757|101782906|FG000|NOT COMPLETED|Overall Study||0||
48591647|NCT02681757|101782907|FG001|NOT COMPLETED|Overall Study||0||
48591648|NCT01967641|101782908|FG000|STARTED|Randomized||51||
48591649|NCT01967641|101782908|FG000|COMPLETED|Randomized||43||
48591650|NCT01967641|101782908|FG000|NOT COMPLETED|Randomized||8||
48591651|NCT01967641|101782908|FG000|STARTED|Admission to Inpatient Phase||43||
48591652|NCT01967641|101782908|FG000|COMPLETED|Admission to Inpatient Phase||31||
48591653|NCT01967641|101782908|FG000|NOT COMPLETED|Admission to Inpatient Phase||12||
48591654|NCT01967641|101782908|FG000|STARTED|12-week Outpatient Phase||31||
48591655|NCT01967641|101782908|FG000|COMPLETED|12-week Outpatient Phase||18||
48591656|NCT01967641|101782908|FG000|NOT COMPLETED|12-week Outpatient Phase||13||
48591657|NCT00984061|101782909|FG000|STARTED|Colchicine Alone||24||
48591658|NCT00984061|101782909|FG000|COMPLETED|Colchicine Alone||24||
48709794|NCT02743780|102077844|FG001|COMPLETED|Part 3 (7 Days)||0||
48709795|NCT02743780|102077845|FG002|COMPLETED|Part 3 (7 Days)||24||
48709796|NCT02743780|102077846|FG003|COMPLETED|Part 3 (7 Days)||0||
48709797|NCT02743780|102077847|FG004|COMPLETED|Part 3 (7 Days)||25||
48709798|NCT02743780|102077843|FG000|NOT COMPLETED|Part 3 (7 Days)||0||
48709799|NCT02743780|102077844|FG001|NOT COMPLETED|Part 3 (7 Days)||0||
48709800|NCT02743780|102077845|FG002|NOT COMPLETED|Part 3 (7 Days)||1||
48709801|NCT02743780|102077846|FG003|NOT COMPLETED|Part 3 (7 Days)||0||
48709802|NCT02743780|102077847|FG004|NOT COMPLETED|Part 3 (7 Days)||0||
48709803|NCT01187004|102077848|FG000|STARTED|Overall Study||20||
48709804|NCT01187004|102077849|FG001|STARTED|Overall Study||144||
48709805|NCT01187004|102077848|FG000|COMPLETED|Overall Study||20||
48709806|NCT01187004|102077849|FG001|COMPLETED|Overall Study||144||
48709807|NCT01187004|102077848|FG000|NOT COMPLETED|Overall Study||0||
48709808|NCT01187004|102077849|FG001|NOT COMPLETED|Overall Study||0||
48709809|NCT02785458|102077850|FG000|STARTED|Baseline||526||
48709810|NCT02785458|102077851|FG001|STARTED|Baseline||479||
48709811|NCT02785458|102077850|FG000|COMPLETED|Baseline||526||
48709812|NCT02785458|102077851|FG001|COMPLETED|Baseline||479||
48709813|NCT02785458|102077850|FG000|NOT COMPLETED|Baseline||0||
48709814|NCT02785458|102077851|FG001|NOT COMPLETED|Baseline||0||
48709815|NCT02785458|102077850|FG000|STARTED|1 Month||526||
48709816|NCT02785458|102077851|FG001|STARTED|1 Month||479||
48709817|NCT02785458|102077850|FG000|COMPLETED|1 Month||443||
48591659|NCT00984061|101782909|FG000|NOT COMPLETED|Colchicine Alone||0||
48591660|NCT00984061|101782909|FG000|STARTED|21 Day Washout Period||24||
48591661|NCT00984061|101782909|FG000|COMPLETED|21 Day Washout Period||24||
48591662|NCT00984061|101782909|FG000|NOT COMPLETED|21 Day Washout Period||0||
48591663|NCT00984061|101782909|FG000|STARTED|Clarithromycin Alone||24||
48591664|NCT00984061|101782909|FG000|COMPLETED|Clarithromycin Alone||23||
48591665|NCT00984061|101782909|FG000|NOT COMPLETED|Clarithromycin Alone||1||
48591666|NCT00984061|101782909|FG000|STARTED|Colchicine With Clarithromycin||23||
48591667|NCT00984061|101782909|FG000|COMPLETED|Colchicine With Clarithromycin||23||
48709818|NCT02785458|102077851|FG001|COMPLETED|1 Month||404||
48709819|NCT02785458|102077850|FG000|NOT COMPLETED|1 Month||83||
48709820|NCT02785458|102077851|FG001|NOT COMPLETED|1 Month||75||
48709821|NCT02785458|102077850|FG000|STARTED|3 Months||443||
48709822|NCT02785458|102077851|FG001|STARTED|3 Months||404||
48591668|NCT00984061|101782909|FG000|NOT COMPLETED|Colchicine With Clarithromycin||0||
48709823|NCT02785458|102077850|FG000|COMPLETED|3 Months||315||
48591669|NCT00713661|101782910|FG000|STARTED|Overall Study||7||
48591670|NCT00713661|101782911|FG001|STARTED|Overall Study||9||
48591671|NCT00713661|101782912|FG002|STARTED|Overall Study||4||
48591672|NCT00713661|101782913|FG003|STARTED|Overall Study||5||
48591673|NCT00713661|101782910|FG000|COMPLETED|Overall Study||7||
48591674|NCT00713661|101782911|FG001|COMPLETED|Overall Study||9||
48591675|NCT00713661|101782912|FG002|COMPLETED|Overall Study||4||
48591676|NCT00713661|101782913|FG003|COMPLETED|Overall Study||5||
48591677|NCT00713661|101782910|FG000|NOT COMPLETED|Overall Study||0||
48591678|NCT00713661|101782911|FG001|NOT COMPLETED|Overall Study||0||
48293702|NCT01551212|101047421|FG000|Safety Set|Overall Study||169|Received at least 1 dose of study drug and had a post-baseline safety assessment|
48591679|NCT00713661|101782912|FG002|NOT COMPLETED|Overall Study||0||
48591680|NCT00713661|101782913|FG003|NOT COMPLETED|Overall Study||0||
48591681|NCT00387010|101782914|FG000|STARTED|Dose Titration Period||218||
48591682|NCT00387010|101782914|FG000|COMPLETED|Dose Titration Period||180||
48591683|NCT00387010|101782914|FG000|NOT COMPLETED|Dose Titration Period||38||
48591684|NCT00387010|101782914|FG000|STARTED|Treatment Period||180||
48591685|NCT00387010|101782914|FG000|Full Analysis Set|Treatment Period||175||
48591686|NCT00387010|101782914|FG000|COMPLETED|Treatment Period||169||
48591687|NCT00387010|101782914|FG000|NOT COMPLETED|Treatment Period||11||
48591688|NCT02928770|101782915|FG000|STARTED|Overall Study||32||
48591689|NCT02928770|101782915|FG000|COMPLETED|Overall Study||30||
48591690|NCT02928770|101782915|FG000|NOT COMPLETED|Overall Study||2||
48293703|NCT01551212|101047422|FG001|Safety Set|Overall Study||164|Received at least 1 dose of study drug and had a post-baseline safety assessment|
48293704|NCT01551212|101047421|FG000|Per Protocol Set (PP)|Overall Study||110|In FAS without a major protocol deviation|
48293705|NCT01551212|101047422|FG001|Per Protocol Set (PP)|Overall Study||101|In FAS without a major protocol deviation|
48293706|NCT01551212|101047421|FG000|COMPLETED|Overall Study||166||
48293707|NCT01551212|101047422|FG001|COMPLETED|Overall Study||148||
48293708|NCT01551212|101047421|FG000|NOT COMPLETED|Overall Study||5||
48293709|NCT01551212|101047422|FG001|NOT COMPLETED|Overall Study||20||
48293710|NCT00899548|101047423|FG000|STARTED|Overall Study||182||
48293711|NCT00899548|101047423|FG000|COMPLETED|Overall Study||179||
48293712|NCT00899548|101047423|FG000|NOT COMPLETED|Overall Study||3||
48293713|NCT00504881|101047424|FG000|STARTED|Overall Study||121||
48293714|NCT00504881|101047425|FG001|STARTED|Overall Study||359||
48293715|NCT00504881|101047424|FG000|COMPLETED|Overall Study||111||
48293716|NCT00504881|101047425|FG001|COMPLETED|Overall Study||323||
48293717|NCT00504881|101047424|FG000|NOT COMPLETED|Overall Study||10||
48293718|NCT00504881|101047425|FG001|NOT COMPLETED|Overall Study||36||
48293719|NCT01966380|101047426|FG000|STARTED|Overall Study||3||
48293720|NCT01966380|101047427|FG001|STARTED|Overall Study||3||
48293721|NCT01966380|101047426|FG000|COMPLETED|Overall Study||3||
48293722|NCT01966380|101047427|FG001|COMPLETED|Overall Study||2||
48293723|NCT01966380|101047426|FG000|NOT COMPLETED|Overall Study||0||
48293724|NCT01966380|101047427|FG001|NOT COMPLETED|Overall Study||1||
48293725|NCT02318797|101047428|FG000|STARTED|Overall Study||516|# of individuals enrolled in each study arm|
48293726|NCT02318797|101047429|FG001|STARTED|Overall Study||713|# of individuals enrolled in each study arm|
48293727|NCT02318797|101047428|FG000|COMPLETED|Overall Study||428|# of individuals for whom we have at least one data element at the final data collection time point|
48293728|NCT02318797|101047429|FG001|COMPLETED|Overall Study||611|# of individuals for whom we have at least one data element at the final data collection time point|
48293729|NCT02318797|101047428|FG000|NOT COMPLETED|Overall Study||88||
48293730|NCT02318797|101047429|FG001|NOT COMPLETED|Overall Study||102||
48293731|NCT01097785|101047430|FG000|STARTED|Cycle 1 (30 Days)||6||
48293732|NCT01097785|101047431|FG001|STARTED|Cycle 1 (30 Days)||6||
48293733|NCT01097785|101047430|FG000|COMPLETED|Cycle 1 (30 Days)||6||
48293734|NCT01097785|101047431|FG001|COMPLETED|Cycle 1 (30 Days)||6||
48293735|NCT01097785|101047430|FG000|NOT COMPLETED|Cycle 1 (30 Days)||0||
48293736|NCT01097785|101047431|FG001|NOT COMPLETED|Cycle 1 (30 Days)||0||
48293737|NCT01097785|101047430|FG000|STARTED|Washout (2 Weeks)||6||
48293738|NCT01097785|101047431|FG001|STARTED|Washout (2 Weeks)||6||
48293739|NCT01097785|101047430|FG000|COMPLETED|Washout (2 Weeks)||6||
48591691|NCT02122770|101782916|FG000|STARTED|Part A: Drug-drug Interaction 2||13||
48591692|NCT02122770|101782917|FG001|STARTED|Part A: Drug-drug Interaction 2||13||
48591693|NCT02122770|101782918|FG002|STARTED|Part A: Drug-drug Interaction 2||6||
48591694|NCT02122770|101782919|FG003|STARTED|Part A: Drug-drug Interaction 2||19||
48591695|NCT02122770|101782920|FG004|STARTED|Part A: Drug-drug Interaction 2||0||
48293740|NCT01097785|101047431|FG001|COMPLETED|Washout (2 Weeks)||6||
48293741|NCT01097785|101047430|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
48293742|NCT01097785|101047431|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
48293743|NCT01097785|101047430|FG000|STARTED|Cycle 3 (30 Days)||6||
48293744|NCT01097785|101047431|FG001|STARTED|Cycle 3 (30 Days)||6||
48293745|NCT01097785|101047430|FG000|COMPLETED|Cycle 3 (30 Days)||6||
48293746|NCT01097785|101047431|FG001|COMPLETED|Cycle 3 (30 Days)||6||
48591696|NCT02122770|101782921|FG005|STARTED|Part A: Drug-drug Interaction 2||0||
48592852|NCT02059434|101786330|FG005|STARTED|Period 1 (After Screening/run-in Period)||2||
48293747|NCT01097785|101047430|FG000|NOT COMPLETED|Cycle 3 (30 Days)||0||
48591697|NCT02122770|101782916|FG000|COMPLETED|Part A: Drug-drug Interaction 2||9|Completed Part A, ongoing to Part B|
48591698|NCT02122770|101782917|FG001|COMPLETED|Part A: Drug-drug Interaction 2||7|Completed Part A, ongoing to Part B|
48591699|NCT02122770|101782918|FG002|COMPLETED|Part A: Drug-drug Interaction 2||4|Completed Part A, ongoing to Part B|
48591700|NCT02122770|101782919|FG003|COMPLETED|Part A: Drug-drug Interaction 2||16|Completed Part A, ongoing to Part B|
48591701|NCT02122770|101782920|FG004|COMPLETED|Part A: Drug-drug Interaction 2||0|Completed Part A, ongoing to Part B|
48591702|NCT02122770|101782921|FG005|COMPLETED|Part A: Drug-drug Interaction 2||0|Completed Part A, ongoing to Part B|
48591703|NCT02122770|101782916|FG000|NOT COMPLETED|Part A: Drug-drug Interaction 2||4||
48591704|NCT02122770|101782917|FG001|NOT COMPLETED|Part A: Drug-drug Interaction 2||6||
48591705|NCT02122770|101782918|FG002|NOT COMPLETED|Part A: Drug-drug Interaction 2||2||
48591706|NCT02122770|101782919|FG003|NOT COMPLETED|Part A: Drug-drug Interaction 2||3||
48591707|NCT02122770|101782920|FG004|NOT COMPLETED|Part A: Drug-drug Interaction 2||0||
48591708|NCT02122770|101782921|FG005|NOT COMPLETED|Part A: Drug-drug Interaction 2||0||
48591709|NCT02122770|101782916|FG000|STARTED|Part B: Standard of Care||0||
48591710|NCT02122770|101782917|FG001|STARTED|Part B: Standard of Care||0||
48591711|NCT02122770|101782918|FG002|STARTED|Part B: Standard of Care||0||
48591712|NCT02122770|101782919|FG003|STARTED|Part B: Standard of Care||0||
48591713|NCT02122770|101782920|FG004|STARTED|Part B: Standard of Care||23||
48591714|NCT02122770|101782921|FG005|STARTED|Part B: Standard of Care||13||
48591715|NCT02122770|101782916|FG000|COMPLETED|Part B: Standard of Care||0||
48709824|NCT02785458|102077851|FG001|COMPLETED|3 Months||293||
48709825|NCT02785458|102077850|FG000|NOT COMPLETED|3 Months||128||
48709826|NCT02785458|102077851|FG001|NOT COMPLETED|3 Months||111||
48709827|NCT04706273|102077852|FG000|STARTED|Overall Study||321||324
48709828|NCT04706273|102077852|FG000|COMPLETED|Overall Study||136||136
48709829|NCT04706273|102077852|FG000|NOT COMPLETED|Overall Study||185||188
48709830|NCT03023826|102077853|FG000|STARTED|Period 1||4||
48709831|NCT03023826|102077854|FG001|STARTED|Period 1||4||
48709832|NCT03023826|102077855|FG002|STARTED|Period 1||5||
48709833|NCT03023826|102077856|FG003|STARTED|Period 1||4||
48709834|NCT03023826|102077857|FG004|STARTED|Period 1||4||
48709835|NCT03023826|102077858|FG005|STARTED|Period 1||5||
48709836|NCT03023826|102077853|FG000|Received at Least One Dose of Study Drug|Period 1||4||
48709837|NCT03023826|102077854|FG001|Received at Least One Dose of Study Drug|Period 1||4||
48709838|NCT03023826|102077855|FG002|Received at Least One Dose of Study Drug|Period 1||5||
48709839|NCT03023826|102077856|FG003|Received at Least One Dose of Study Drug|Period 1||4||
48709840|NCT03023826|102077857|FG004|Received at Least One Dose of Study Drug|Period 1||4||
48709841|NCT03023826|102077858|FG005|Received at Least One Dose of Study Drug|Period 1||5||
48709842|NCT03023826|102077853|FG000|COMPLETED|Period 1||4||
48709843|NCT03023826|102077854|FG001|COMPLETED|Period 1||4||
48709844|NCT03023826|102077855|FG002|COMPLETED|Period 1||5||
48709845|NCT03023826|102077856|FG003|COMPLETED|Period 1||4||
48709846|NCT03023826|102077857|FG004|COMPLETED|Period 1||3||
48709847|NCT03023826|102077858|FG005|COMPLETED|Period 1||5||
48709848|NCT03023826|102077853|FG000|NOT COMPLETED|Period 1||0||
48709849|NCT03023826|102077854|FG001|NOT COMPLETED|Period 1||0||
48709850|NCT03023826|102077855|FG002|NOT COMPLETED|Period 1||0||
48709851|NCT03023826|102077856|FG003|NOT COMPLETED|Period 1||0||
48709852|NCT03023826|102077857|FG004|NOT COMPLETED|Period 1||1||
48709853|NCT03023826|102077858|FG005|NOT COMPLETED|Period 1||0||
48709854|NCT03023826|102077853|FG000|STARTED|Period 2||4||
48709855|NCT03023826|102077854|FG001|STARTED|Period 2||4||
48709856|NCT03023826|102077855|FG002|STARTED|Period 2||5||
48709857|NCT03023826|102077856|FG003|STARTED|Period 2||4||
48709858|NCT03023826|102077857|FG004|STARTED|Period 2||3||
48709859|NCT03023826|102077858|FG005|STARTED|Period 2||5||
48709860|NCT03023826|102077853|FG000|COMPLETED|Period 2||4||
48709861|NCT03023826|102077854|FG001|COMPLETED|Period 2||4||
48709862|NCT03023826|102077855|FG002|COMPLETED|Period 2||5||
48709863|NCT03023826|102077856|FG003|COMPLETED|Period 2||4||
48709864|NCT03023826|102077857|FG004|COMPLETED|Period 2||3||
48709865|NCT03023826|102077858|FG005|COMPLETED|Period 2||5||
48709866|NCT03023826|102077853|FG000|NOT COMPLETED|Period 2||0||
48709867|NCT03023826|102077854|FG001|NOT COMPLETED|Period 2||0||
48709868|NCT03023826|102077855|FG002|NOT COMPLETED|Period 2||0||
48709869|NCT03023826|102077856|FG003|NOT COMPLETED|Period 2||0||
48709870|NCT03023826|102077857|FG004|NOT COMPLETED|Period 2||0||
48709871|NCT03023826|102077858|FG005|NOT COMPLETED|Period 2||0||
48709872|NCT03023826|102077853|FG000|STARTED|Period 3||4||
48709873|NCT03023826|102077854|FG001|STARTED|Period 3||4||
48709874|NCT03023826|102077855|FG002|STARTED|Period 3||5||
48709875|NCT03023826|102077856|FG003|STARTED|Period 3||4||
48709876|NCT03023826|102077857|FG004|STARTED|Period 3||3||
48709877|NCT03023826|102077858|FG005|STARTED|Period 3||5||
48709878|NCT03023826|102077853|FG000|COMPLETED|Period 3||4||
48140878|NCT03053050|100670284|FG001|COMPLETED|Open-label Phase||0||
48709879|NCT03023826|102077854|FG001|COMPLETED|Period 3||4||
48709880|NCT03023826|102077855|FG002|COMPLETED|Period 3||5||
48709881|NCT03023826|102077856|FG003|COMPLETED|Period 3||4||
48709882|NCT03023826|102077857|FG004|COMPLETED|Period 3||3||
48140879|NCT03053050|100670285|FG002|COMPLETED|Open-label Phase||0||
48709883|NCT03023826|102077858|FG005|COMPLETED|Period 3||5||
48591716|NCT02122770|101782917|FG001|COMPLETED|Part B: Standard of Care||0||
48591717|NCT02122770|101782918|FG002|COMPLETED|Part B: Standard of Care||0||
48591718|NCT02122770|101782919|FG003|COMPLETED|Part B: Standard of Care||0||
48591719|NCT02122770|101782920|FG004|COMPLETED|Part B: Standard of Care||0||
48591720|NCT02122770|101782921|FG005|COMPLETED|Part B: Standard of Care||0||
48591721|NCT02122770|101782916|FG000|NOT COMPLETED|Part B: Standard of Care||0||
48591722|NCT02122770|101782917|FG001|NOT COMPLETED|Part B: Standard of Care||0||
48591723|NCT02122770|101782918|FG002|NOT COMPLETED|Part B: Standard of Care||0||
48591724|NCT02122770|101782919|FG003|NOT COMPLETED|Part B: Standard of Care||0||
48591725|NCT02122770|101782920|FG004|NOT COMPLETED|Part B: Standard of Care||23||
48591726|NCT02122770|101782921|FG005|NOT COMPLETED|Part B: Standard of Care||13||
48591727|NCT01382225|101782922|FG000|STARTED|Overall Study||725||
48591728|NCT01382225|101782923|FG001|STARTED|Overall Study||729||
48591729|NCT01382225|101782922|FG000|COMPLETED|Overall Study||711||
48591730|NCT01382225|101782923|FG001|COMPLETED|Overall Study||722||
48591731|NCT01382225|101782922|FG000|NOT COMPLETED|Overall Study||14||
48591732|NCT01382225|101782923|FG001|NOT COMPLETED|Overall Study||7||
48591733|NCT00386425|101782924|FG000|STARTED|Overall Study||227||
48591734|NCT00386425|101782925|FG001|STARTED|Overall Study||206||
48591735|NCT00386425|101782926|FG002|STARTED|Overall Study||53||
48591736|NCT00386425|101782924|FG000|Received Study Drug|Overall Study||227||
48591737|NCT00386425|101782925|FG001|Received Study Drug|Overall Study||206||
48591738|NCT00386425|101782926|FG002|Received Study Drug|Overall Study||53||
48591739|NCT00386425|101782924|FG000|COMPLETED|Overall Study||224||
48591740|NCT00386425|101782925|FG001|COMPLETED|Overall Study||205||
48591741|NCT00386425|101782926|FG002|COMPLETED|Overall Study||53||
48591742|NCT00386425|101782924|FG000|NOT COMPLETED|Overall Study||3||
48591743|NCT00386425|101782925|FG001|NOT COMPLETED|Overall Study||1||
48591744|NCT00386425|101782926|FG002|NOT COMPLETED|Overall Study||0||
48591745|NCT00900731|101782927|FG000|STARTED|Overall Study||797||
48591746|NCT00900731|101782928|FG001|STARTED|Overall Study||801||
48591747|NCT00900731|101782927|FG000|Safety Set: Received Study Drug|Overall Study||794||
48293748|NCT01097785|101047431|FG001|NOT COMPLETED|Cycle 3 (30 Days)||0||
48293749|NCT01975974|101047432|FG000|STARTED|Overall Study||100||
48709884|NCT03023826|102077853|FG000|NOT COMPLETED|Period 3||0||
48709885|NCT03023826|102077854|FG001|NOT COMPLETED|Period 3||0||
48709886|NCT03023826|102077855|FG002|NOT COMPLETED|Period 3||0||
48709887|NCT03023826|102077856|FG003|NOT COMPLETED|Period 3||0||
48709888|NCT03023826|102077857|FG004|NOT COMPLETED|Period 3||0||
48709889|NCT03023826|102077858|FG005|NOT COMPLETED|Period 3||0||
48709890|NCT00824005|102077859|FG000|STARTED|Overall Study||31||
48709891|NCT00824005|102077860|FG001|STARTED|Overall Study||61||
48709892|NCT00824005|102077859|FG000|COMPLETED|Overall Study||31||
48709893|NCT00824005|102077860|FG001|COMPLETED|Overall Study||59||
48709894|NCT00824005|102077859|FG000|NOT COMPLETED|Overall Study||0||
48709895|NCT00824005|102077860|FG001|NOT COMPLETED|Overall Study||2||
48709896|NCT04283942|102077861|FG000|STARTED|Overall Study||30||
48709897|NCT04283942|102077862|FG001|STARTED|Overall Study||30||
48709898|NCT04283942|102077861|FG000|COMPLETED|Overall Study||28||
48709899|NCT04283942|102077862|FG001|COMPLETED|Overall Study||28||
48293750|NCT01975974|101047432|FG000|COMPLETED|Overall Study||100||
48709900|NCT04283942|102077861|FG000|NOT COMPLETED|Overall Study||2||
48709901|NCT04283942|102077862|FG001|NOT COMPLETED|Overall Study||2||
48709902|NCT03733028|102077863|FG000|STARTED|Overall Study||19||
48709903|NCT03733028|102077864|FG001|STARTED|Overall Study||17||
48709904|NCT03733028|102077863|FG000|COMPLETED|Overall Study||18||
48709905|NCT03733028|102077864|FG001|COMPLETED|Overall Study||15||
48709906|NCT03733028|102077863|FG000|NOT COMPLETED|Overall Study||1||
48709907|NCT03733028|102077864|FG001|NOT COMPLETED|Overall Study||2||
48709908|NCT03028480|102077865|FG000|STARTED|Overall Study||1061|Enrolled Set|
48709909|NCT03028480|102077865|FG000|Safety Population|Overall Study||1027||
48709910|NCT03028480|102077865|FG000|COMPLETED|Overall Study||1027||
48709911|NCT03028480|102077865|FG000|NOT COMPLETED|Overall Study||34||
48709912|NCT03630198|102077866|FG000|STARTED|Overall Study||13||
48403752|NCT00481988|101321680|FG000|Crossover|Overall Study||11||
48403753|NCT00481988|101321681|FG001|Crossover|Overall Study||8||
48403754|NCT00481988|101321680|FG000|COMPLETED|Overall Study||11||
48403755|NCT00481988|101321681|FG001|COMPLETED|Overall Study||8||
48403756|NCT00481988|101321680|FG000|NOT COMPLETED|Overall Study||1||
48403757|NCT00481988|101321681|FG001|NOT COMPLETED|Overall Study||1||
48403758|NCT03077243|101321682|FG000|STARTED|Overall Study||18||
48403759|NCT03077243|101321683|FG001|STARTED|Overall Study||105||
48403760|NCT03077243|101321684|FG002|STARTED|Overall Study||3||
48403761|NCT03077243|101321685|FG003|STARTED|Overall Study||69||
48403762|NCT03077243|101321682|FG000|Assessment and Biopsy Was Done if Required at 2 Years After Treatment|Overall Study||11||
48403763|NCT03077243|101321683|FG001|Assessment and Biopsy Was Done if Required at 2 Years After Treatment|Overall Study||51||
48403764|NCT03077243|101321684|FG002|Assessment and Biopsy Was Done if Required at 2 Years After Treatment|Overall Study||2||
48403765|NCT03077243|101321685|FG003|Assessment and Biopsy Was Done if Required at 2 Years After Treatment|Overall Study||0||
48403766|NCT03077243|101321682|FG000|COMPLETED|Overall Study||15||
48403767|NCT03077243|101321683|FG001|COMPLETED|Overall Study||100||
48403768|NCT03077243|101321684|FG002|COMPLETED|Overall Study||3||
48403769|NCT03077243|101321685|FG003|COMPLETED|Overall Study||0||
48403770|NCT03077243|101321682|FG000|NOT COMPLETED|Overall Study||3||
48591748|NCT00900731|101782928|FG001|Safety Set: Received Study Drug|Overall Study||799||
48591749|NCT00900731|101782927|FG000|COMPLETED|Overall Study||737||
48591750|NCT00900731|101782928|FG001|COMPLETED|Overall Study||740||
48591751|NCT00900731|101782927|FG000|NOT COMPLETED|Overall Study||60||
48591752|NCT00900731|101782928|FG001|NOT COMPLETED|Overall Study||61||
48591753|NCT02063178|101782929|FG000|STARTED|Overall Study||124||
48591754|NCT02063178|101782930|FG001|STARTED|Overall Study||124||
48591755|NCT02063178|101782929|FG000|COMPLETED|Overall Study||95||
48591756|NCT02063178|101782930|FG001|COMPLETED|Overall Study||77||
48591757|NCT02063178|101782929|FG000|NOT COMPLETED|Overall Study||29||
48591758|NCT02063178|101782930|FG001|NOT COMPLETED|Overall Study||47||
48591759|NCT03559868|101782931|FG000|STARTED|Overall Study||14||
48591760|NCT03559868|101782932|FG001|STARTED|Overall Study||14||
48709913|NCT03630198|102077867|FG001|STARTED|Overall Study||18||
48709914|NCT03630198|102077866|FG000|COMPLETED|Overall Study||13||
48709915|NCT03630198|102077867|FG001|COMPLETED|Overall Study||18||
48709916|NCT03630198|102077866|FG000|NOT COMPLETED|Overall Study||0||
48709917|NCT03630198|102077867|FG001|NOT COMPLETED|Overall Study||0||
48709918|NCT03294135|102077868|FG000|STARTED|Overall Study||50||
48709919|NCT03294135|102077869|FG001|STARTED|Overall Study||43||
48709920|NCT03294135|102077870|FG002|STARTED|Overall Study||101||
48709921|NCT03294135|102077868|FG000|COMPLETED|Overall Study||46||
48709922|NCT03294135|102077869|FG001|COMPLETED|Overall Study||43||
48709923|NCT03294135|102077870|FG002|COMPLETED|Overall Study||99||
48709924|NCT03294135|102077868|FG000|NOT COMPLETED|Overall Study||4||
48709925|NCT03294135|102077869|FG001|NOT COMPLETED|Overall Study||0||
48709926|NCT03294135|102077870|FG002|NOT COMPLETED|Overall Study||2||
48709927|NCT03404804|102077871|FG000|STARTED|Overall Study||116||
48709928|NCT03404804|102077871|FG000|COMPLETED|Overall Study||116||
48709929|NCT03404804|102077871|FG000|NOT COMPLETED|Overall Study||0||
48709930|NCT01312389|102077872|FG000|STARTED|Phase 1||3||
48709931|NCT01312389|102077873|FG001|STARTED|Phase 1||0||
48709932|NCT01312389|102077874|FG002|STARTED|Phase 1||0||
48709933|NCT01312389|102077872|FG000|COMPLETED|Phase 1||3||
48709934|NCT01312389|102077873|FG001|COMPLETED|Phase 1||0||
48709935|NCT01312389|102077874|FG002|COMPLETED|Phase 1||0||
48709936|NCT01312389|102077872|FG000|NOT COMPLETED|Phase 1||0||
48709937|NCT01312389|102077873|FG001|NOT COMPLETED|Phase 1||0||
48709938|NCT01312389|102077874|FG002|NOT COMPLETED|Phase 1||0||
48709939|NCT01312389|102077872|FG000|STARTED|Phase 2||0||
48709940|NCT01312389|102077873|FG001|STARTED|Phase 2||0||
48709941|NCT01312389|102077874|FG002|STARTED|Phase 2||0||
48403771|NCT03077243|101321683|FG001|NOT COMPLETED|Overall Study||5||
48709942|NCT01312389|102077872|FG000|COMPLETED|Phase 2||0||
48709943|NCT01312389|102077873|FG001|COMPLETED|Phase 2||0||
48709944|NCT01312389|102077874|FG002|COMPLETED|Phase 2||0||
48709945|NCT01312389|102077872|FG000|NOT COMPLETED|Phase 2||0||
48709946|NCT01312389|102077873|FG001|NOT COMPLETED|Phase 2||0||
48591761|NCT03559868|101782933|FG002|STARTED|Overall Study||14||
48591762|NCT03559868|101782931|FG000|COMPLETED|Overall Study||6||
48709947|NCT01312389|102077874|FG002|NOT COMPLETED|Phase 2||0||
48709948|NCT02446418|102077875|FG000|STARTED|Overall Study||210||
48403772|NCT03077243|101321684|FG002|NOT COMPLETED|Overall Study||0||
48403773|NCT03077243|101321685|FG003|NOT COMPLETED|Overall Study||69||
48403774|NCT01802515|101321686|FG000|STARTED|Overall Study||5||
48709949|NCT02446418|102077876|FG001|STARTED|Overall Study||210||
48403775|NCT01802515|101321687|FG001|STARTED|Overall Study||5||
48709950|NCT02446418|102077875|FG000|COMPLETED|Overall Study||192||
48709951|NCT02446418|102077876|FG001|COMPLETED|Overall Study||194||
48709952|NCT02446418|102077875|FG000|NOT COMPLETED|Overall Study||18||
48709953|NCT02446418|102077876|FG001|NOT COMPLETED|Overall Study||16||
48709954|NCT02839902|102077877|FG000|STARTED|Overall Study||24||
48709955|NCT02839902|102077878|FG001|STARTED|Overall Study||29||
48709956|NCT02839902|102077877|FG000|COMPLETED|Overall Study||24||
48709957|NCT02839902|102077878|FG001|COMPLETED|Overall Study||29||
48709958|NCT02839902|102077877|FG000|NOT COMPLETED|Overall Study||0||
48709959|NCT02839902|102077878|FG001|NOT COMPLETED|Overall Study||0||
48709960|NCT03503292|102077879|FG000|STARTED|Overall Study||2||
48709961|NCT03503292|102077880|FG001|STARTED|Overall Study||90||
48709962|NCT03503292|102077879|FG000|COMPLETED|Overall Study||2||
48709963|NCT03503292|102077880|FG001|COMPLETED|Overall Study||90||
48709964|NCT03503292|102077879|FG000|NOT COMPLETED|Overall Study||0||
48709965|NCT03503292|102077880|FG001|NOT COMPLETED|Overall Study||0||
48709966|NCT03773133|102077881|FG000|STARTED|Overall Study||8||
48709967|NCT03773133|102077881|FG000|Received the Screening IIP|Overall Study||8||
48709968|NCT03773133|102077881|FG000|Received the Therapeutic IRPP|Overall Study||0||
48709969|NCT03773133|102077881|FG000|COMPLETED|Overall Study||0||
48709970|NCT03773133|102077881|FG000|NOT COMPLETED|Overall Study||8||
48709971|NCT01390779|102077882|FG000|STARTED|Overall Study||33||
48709972|NCT01390779|102077882|FG000|COMPLETED|Overall Study||32||
48709973|NCT01390779|102077882|FG000|NOT COMPLETED|Overall Study||1||
48709974|NCT02435680|102077883|FG000|STARTED|Overall Study||21||
48709975|NCT02435680|102077884|FG001|STARTED|Overall Study||13||
48709976|NCT02435680|102077885|FG002|STARTED|Overall Study||16||
48709977|NCT02435680|102077883|FG000|COMPLETED|Overall Study||0||
48709978|NCT02435680|102077884|FG001|COMPLETED|Overall Study||0||
48709979|NCT02435680|102077885|FG002|COMPLETED|Overall Study||0||
48709980|NCT02435680|102077883|FG000|NOT COMPLETED|Overall Study||21||
48709981|NCT02435680|102077884|FG001|NOT COMPLETED|Overall Study||13||
48709982|NCT02435680|102077885|FG002|NOT COMPLETED|Overall Study||16||
48709983|NCT00591149|102077886|FG000|STARTED|Overall Study||16||
48709984|NCT00591149|102077886|FG000|COMPLETED|Overall Study||11||
48709985|NCT00591149|102077886|FG000|NOT COMPLETED|Overall Study||5||
48709986|NCT01655043|102077887|FG000|STARTED|Overall Study||20||
48709987|NCT01655043|102077887|FG000|COMPLETED|Overall Study||20||
48709988|NCT01655043|102077887|FG000|NOT COMPLETED|Overall Study||0||
48709989|NCT04662073|102077888|FG000|STARTED|Overall Study||2||
48709990|NCT04662073|102077889|FG001|STARTED|Overall Study||0||
48709991|NCT04662073|102077888|FG000|COMPLETED|Overall Study||1||
48709992|NCT04662073|102077889|FG001|COMPLETED|Overall Study||0||
48709993|NCT04662073|102077888|FG000|NOT COMPLETED|Overall Study||1||
48709994|NCT04662073|102077889|FG001|NOT COMPLETED|Overall Study||0||
48709995|NCT00495521|102077890|FG000|STARTED|Overall Study||1||
48709996|NCT00495521|102077891|FG001|STARTED|Overall Study||1||
48709997|NCT00495521|102077890|FG000|COMPLETED|Overall Study||1||
48709998|NCT00495521|102077891|FG001|COMPLETED|Overall Study||0||
48709999|NCT00495521|102077890|FG000|NOT COMPLETED|Overall Study||0||
48710000|NCT00495521|102077891|FG001|NOT COMPLETED|Overall Study||1||
48710001|NCT02880514|102077892|FG000|STARTED|Overall Study||50||50
48710002|NCT02880514|102077893|FG001|STARTED|Overall Study||50||50
48710003|NCT02880514|102077892|FG000|COMPLETED|Overall Study||50||50
48710004|NCT02880514|102077893|FG001|COMPLETED|Overall Study||50||50
48710005|NCT02880514|102077892|FG000|NOT COMPLETED|Overall Study||0||0
48710006|NCT02880514|102077893|FG001|NOT COMPLETED|Overall Study||0||0
48710007|NCT03035773|102077894|FG000|STARTED|Overall Study||126||
48710008|NCT03035773|102077895|FG001|STARTED|Overall Study||125||
48710009|NCT03035773|102077896|FG002|STARTED|Overall Study||127||
48710010|NCT03035773|102077894|FG000|COMPLETED|Overall Study||107||
48710011|NCT03035773|102077895|FG001|COMPLETED|Overall Study||105||
48710012|NCT03035773|102077896|FG002|COMPLETED|Overall Study||104||
48710013|NCT03035773|102077894|FG000|NOT COMPLETED|Overall Study||19||
48710014|NCT03035773|102077895|FG001|NOT COMPLETED|Overall Study||20||
48710015|NCT03035773|102077896|FG002|NOT COMPLETED|Overall Study||23||
48710016|NCT01741532|102077897|FG000|STARTED|Overall Study||59||
48710017|NCT01741532|102077898|FG001|STARTED|Overall Study||30||
48710018|NCT01741532|102077897|FG000|Exposed|Overall Study||58||
48710019|NCT01741532|102077898|FG001|Exposed|Overall Study||30||
48710020|NCT01741532|102077897|FG000|Provided Post-baseline Efficacy Data|Overall Study||58||
48710021|NCT01741532|102077898|FG001|Provided Post-baseline Efficacy Data|Overall Study||28||
48710022|NCT01741532|102077897|FG000|COMPLETED|Overall Study||49||
48710023|NCT01741532|102077898|FG001|COMPLETED|Overall Study||27||
48710024|NCT01741532|102077897|FG000|NOT COMPLETED|Overall Study||10||
48710025|NCT01741532|102077898|FG001|NOT COMPLETED|Overall Study||3||
48710026|NCT03834506|102077899|FG000|STARTED|Overall Study||515||
48710027|NCT03834506|102077900|FG001|STARTED|Overall Study||515||
48710028|NCT03834506|102077899|FG000|Treated|Overall Study||514||
48710029|NCT03834506|102077900|FG001|Treated|Overall Study||514||
48710030|NCT03834506|102077899|FG000|COMPLETED|Overall Study||0||
48710031|NCT03834506|102077900|FG001|COMPLETED|Overall Study||0||
48710032|NCT03834506|102077899|FG000|NOT COMPLETED|Overall Study||515||
48710033|NCT03834506|102077900|FG001|NOT COMPLETED|Overall Study||515||
48710034|NCT01510184|102077901|FG000|STARTED|Overall Study||36||
48710035|NCT01510184|102077902|FG001|STARTED|Overall Study||43||
48710036|NCT01510184|102077901|FG000|COMPLETED|Overall Study||6||
48710037|NCT01510184|102077902|FG001|COMPLETED|Overall Study||8||
48710038|NCT01510184|102077901|FG000|NOT COMPLETED|Overall Study||30||
48710039|NCT01510184|102077902|FG001|NOT COMPLETED|Overall Study||35||
48710040|NCT04422561|102077903|FG000|STARTED|Overall Study||228||
48710041|NCT04422561|102077904|FG001|STARTED|Overall Study||112||
48710042|NCT04422561|102077903|FG000|COMPLETED|Overall Study||203||
48710043|NCT04422561|102077904|FG001|COMPLETED|Overall Study||101||
48140880|NCT03053050|100670286|FG003|COMPLETED|Open-label Phase||0||
48591763|NCT03559868|101782932|FG001|COMPLETED|Overall Study||6||
48591764|NCT03559868|101782933|FG002|COMPLETED|Overall Study||7||
48591765|NCT03559868|101782931|FG000|NOT COMPLETED|Overall Study||8||
48591766|NCT03559868|101782932|FG001|NOT COMPLETED|Overall Study||8||
48591767|NCT03559868|101782933|FG002|NOT COMPLETED|Overall Study||7||
48591768|NCT02718248|101782934|FG000|STARTED|Overall Study||7||
48591769|NCT02718248|101782934|FG000|COMPLETED|Overall Study||7||
48591770|NCT02718248|101782934|FG000|NOT COMPLETED|Overall Study||0||
48591771|NCT00697541|101782935|FG000|STARTED|Overall Study||10||
48591772|NCT00697541|101782936|FG001|STARTED|Overall Study||10||
48591773|NCT00697541|101782935|FG000|COMPLETED|Overall Study||8||
48591774|NCT00697541|101782936|FG001|COMPLETED|Overall Study||9||
48591775|NCT00697541|101782935|FG000|NOT COMPLETED|Overall Study||2||
48591776|NCT00697541|101782936|FG001|NOT COMPLETED|Overall Study||1||
48591777|NCT00976209|101782937|FG000|STARTED|Treatment Period 1||165||
48591778|NCT00976209|101782938|FG001|STARTED|Treatment Period 1||166||
48710044|NCT04422561|102077903|FG000|NOT COMPLETED|Overall Study||25||
48710045|NCT04422561|102077904|FG001|NOT COMPLETED|Overall Study||11||
48710046|NCT02498067|102077905|FG000|STARTED|Overall Study||104||
48710047|NCT02498067|102077905|FG000|COMPLETED|Overall Study||71||
48710048|NCT02498067|102077905|FG000|NOT COMPLETED|Overall Study||33||
48710049|NCT00167102|102077906|FG000|STARTED|Overall Study||23||
48710050|NCT00167102|102077907|FG001|STARTED|Overall Study||22||
48710051|NCT00167102|102077906|FG000|COMPLETED|Overall Study||23||
48710052|NCT00167102|102077907|FG001|COMPLETED|Overall Study||22||
48710053|NCT00167102|102077906|FG000|NOT COMPLETED|Overall Study||0||
48710054|NCT00167102|102077907|FG001|NOT COMPLETED|Overall Study||0||
48710055|NCT03532932|102077908|FG000|STARTED|Overall Study||1214||
48710056|NCT03532932|102077909|FG001|STARTED|Overall Study||687||
48140881|NCT03053050|100670283|FG000|NOT COMPLETED|Open-label Phase||0||
48591779|NCT00976209|101782937|FG000|COMPLETED|Treatment Period 1||162||
48710057|NCT03532932|102077908|FG000|COMPLETED|Overall Study||1140||
48710058|NCT03532932|102077909|FG001|COMPLETED|Overall Study||615||
48710059|NCT03532932|102077908|FG000|NOT COMPLETED|Overall Study||74||
48710060|NCT03532932|102077909|FG001|NOT COMPLETED|Overall Study||72||
48710061|NCT00359944|102077910|FG000|STARTED|Overall Study||50||
48591780|NCT00976209|101782938|FG001|COMPLETED|Treatment Period 1||165||
48591781|NCT00976209|101782937|FG000|NOT COMPLETED|Treatment Period 1||3||
48591782|NCT00976209|101782938|FG001|NOT COMPLETED|Treatment Period 1||1||
48710062|NCT00359944|102077911|FG001|STARTED|Overall Study||47||
48710063|NCT00359944|102077912|FG002|STARTED|Overall Study||57||
48403776|NCT01802515|101321688|FG002|STARTED|Overall Study||4||
48710064|NCT00359944|102077910|FG000|COMPLETED|Overall Study||34||
48710065|NCT00359944|102077911|FG001|COMPLETED|Overall Study||28||
48710066|NCT00359944|102077912|FG002|COMPLETED|Overall Study||38||
48710067|NCT00359944|102077910|FG000|NOT COMPLETED|Overall Study||16||
48710068|NCT00359944|102077911|FG001|NOT COMPLETED|Overall Study||19||
48710069|NCT00359944|102077912|FG002|NOT COMPLETED|Overall Study||19||
48710070|NCT00445939|102077913|FG000|STARTED|Period A - Week 0 - Week 4||33||
48710071|NCT00445939|102077914|FG001|STARTED|Period A - Week 0 - Week 4||34||
48710072|NCT00445939|102077915|FG002|STARTED|Period A - Week 0 - Week 4||23||
48710073|NCT00445939|102077916|FG003|STARTED|Period A - Week 0 - Week 4||0||
48710074|NCT00445939|102077913|FG000|COMPLETED|Period A - Week 0 - Week 4||32||
48710075|NCT00445939|102077914|FG001|COMPLETED|Period A - Week 0 - Week 4||32||
48710076|NCT00445939|102077915|FG002|COMPLETED|Period A - Week 0 - Week 4||23||
48710077|NCT00445939|102077916|FG003|COMPLETED|Period A - Week 0 - Week 4||0||
48710078|NCT00445939|102077913|FG000|NOT COMPLETED|Period A - Week 0 - Week 4||1||
48140882|NCT03053050|100670284|FG001|NOT COMPLETED|Open-label Phase||0||
48403777|NCT01802515|101321686|FG000|COMPLETED|Overall Study||2||
48403778|NCT01802515|101321687|FG001|COMPLETED|Overall Study||5||
48403779|NCT01802515|101321688|FG002|COMPLETED|Overall Study||4||
48403780|NCT01802515|101321686|FG000|NOT COMPLETED|Overall Study||3||
48403781|NCT01802515|101321687|FG001|NOT COMPLETED|Overall Study||0||
48403782|NCT01802515|101321688|FG002|NOT COMPLETED|Overall Study||0||
48403783|NCT00550290|101321689|FG000|STARTED|Overall Study||10||
48403784|NCT00550290|101321690|FG001|STARTED|Overall Study||8||
48403785|NCT00550290|101321689|FG000|COMPLETED|Overall Study||10||
48403786|NCT00550290|101321690|FG001|COMPLETED|Overall Study||8||
48403787|NCT00550290|101321689|FG000|NOT COMPLETED|Overall Study||0||
48403788|NCT00550290|101321690|FG001|NOT COMPLETED|Overall Study||0||
48403789|NCT01678313|101321691|FG000|STARTED|Completed the 3-month Therapy||70||
48403790|NCT01678313|101321692|FG001|STARTED|Completed the 3-month Therapy||70||
48403791|NCT01678313|101321691|FG000|COMPLETED|Completed the 3-month Therapy||64||
48403792|NCT01678313|101321692|FG001|COMPLETED|Completed the 3-month Therapy||58||
48403793|NCT01678313|101321691|FG000|NOT COMPLETED|Completed the 3-month Therapy||6||
48403794|NCT01678313|101321692|FG001|NOT COMPLETED|Completed the 3-month Therapy||12||
48403795|NCT01678313|101321691|FG000|STARTED|PSA >4 ng/dL at 3 Months||64||
48403796|NCT01678313|101321692|FG001|STARTED|PSA >4 ng/dL at 3 Months||58||
48403797|NCT01678313|101321691|FG000|COMPLETED|PSA >4 ng/dL at 3 Months||56||
48403798|NCT01678313|101321692|FG001|COMPLETED|PSA >4 ng/dL at 3 Months||49||
48403799|NCT01678313|101321691|FG000|NOT COMPLETED|PSA >4 ng/dL at 3 Months||8||
48403800|NCT01678313|101321692|FG001|NOT COMPLETED|PSA >4 ng/dL at 3 Months||9||
48403801|NCT01678313|101321691|FG000|STARTED|Prostate Biopsy at 3 Months||56||
48403802|NCT01678313|101321692|FG001|STARTED|Prostate Biopsy at 3 Months||49||
48403803|NCT01678313|101321691|FG000|COMPLETED|Prostate Biopsy at 3 Months||45||
48403804|NCT01678313|101321692|FG001|COMPLETED|Prostate Biopsy at 3 Months||37||
48591783|NCT00976209|101782937|FG000|STARTED|Wash-out Period||162||
48591784|NCT00976209|101782938|FG001|STARTED|Wash-out Period||165||
48591785|NCT00976209|101782937|FG000|COMPLETED|Wash-out Period||158||
48591786|NCT00976209|101782938|FG001|COMPLETED|Wash-out Period||163||
48591787|NCT00976209|101782937|FG000|NOT COMPLETED|Wash-out Period||4||
48591788|NCT00976209|101782938|FG001|NOT COMPLETED|Wash-out Period||2||
48591789|NCT00976209|101782937|FG000|STARTED|Treatment Period 2||158||
48591790|NCT00976209|101782938|FG001|STARTED|Treatment Period 2||163||
48591791|NCT00976209|101782937|FG000|COMPLETED|Treatment Period 2||158||
48710079|NCT00445939|102077914|FG001|NOT COMPLETED|Period A - Week 0 - Week 4||2||
48710080|NCT00445939|102077915|FG002|NOT COMPLETED|Period A - Week 0 - Week 4||0||
48710081|NCT00445939|102077916|FG003|NOT COMPLETED|Period A - Week 0 - Week 4||0||
48710082|NCT00445939|102077913|FG000|STARTED|Period B - Week 4 - Week 8||16||
48710083|NCT00445939|102077914|FG001|STARTED|Period B - Week 4 - Week 8||0||
48710084|NCT00445939|102077915|FG002|STARTED|Period B - Week 4 - Week 8||0||
48591792|NCT00976209|101782938|FG001|COMPLETED|Treatment Period 2||161||
48591793|NCT00976209|101782937|FG000|NOT COMPLETED|Treatment Period 2||0||
48403805|NCT01678313|101321691|FG000|NOT COMPLETED|Prostate Biopsy at 3 Months||11||
48403806|NCT01678313|101321692|FG001|NOT COMPLETED|Prostate Biopsy at 3 Months||12||
48293751|NCT01975974|101047432|FG000|NOT COMPLETED|Overall Study||0||
48710085|NCT00445939|102077916|FG003|STARTED|Period B - Week 4 - Week 8||21||
48710086|NCT00445939|102077913|FG000|COMPLETED|Period B - Week 4 - Week 8||14||
48710087|NCT00445939|102077914|FG001|COMPLETED|Period B - Week 4 - Week 8||0||
48710088|NCT00445939|102077915|FG002|COMPLETED|Period B - Week 4 - Week 8||0||
48710089|NCT00445939|102077916|FG003|COMPLETED|Period B - Week 4 - Week 8||20||
48710090|NCT00445939|102077913|FG000|NOT COMPLETED|Period B - Week 4 - Week 8||2||
48710091|NCT00445939|102077914|FG001|NOT COMPLETED|Period B - Week 4 - Week 8||0||
48710092|NCT00445939|102077915|FG002|NOT COMPLETED|Period B - Week 4 - Week 8||0||
48710093|NCT00445939|102077916|FG003|NOT COMPLETED|Period B - Week 4 - Week 8||1||
48710094|NCT00750191|102077917|FG000|STARTED|Overall Study||27||
48710095|NCT00750191|102077918|FG001|STARTED|Overall Study||30||
48710096|NCT00750191|102077917|FG000|COMPLETED|Overall Study||22||
48710097|NCT00750191|102077918|FG001|COMPLETED|Overall Study||20||
48710098|NCT00750191|102077917|FG000|NOT COMPLETED|Overall Study||5||
48710099|NCT00750191|102077918|FG001|NOT COMPLETED|Overall Study||10||
48710100|NCT02638207|102077919|FG000|STARTED|Overall Study||35||
48710101|NCT02638207|102077920|FG001|STARTED|Overall Study||69||
48710102|NCT02638207|102077921|FG002|STARTED|Overall Study||38||
48710103|NCT02638207|102077919|FG000|COMPLETED|Overall Study||28||
48710104|NCT02638207|102077920|FG001|COMPLETED|Overall Study||61||
48710105|NCT02638207|102077921|FG002|COMPLETED|Overall Study||34||
48710106|NCT02638207|102077919|FG000|NOT COMPLETED|Overall Study||7||
48293752|NCT00494481|101047433|FG000|STARTED|Overall Study||35||
48293753|NCT00494481|101047434|FG001|STARTED|Overall Study||29||
48293754|NCT00494481|101047433|FG000|COMPLETED|Overall Study||6||
48293755|NCT00494481|101047434|FG001|COMPLETED|Overall Study||5||
48293756|NCT00494481|101047433|FG000|NOT COMPLETED|Overall Study||29||
48293757|NCT00494481|101047434|FG001|NOT COMPLETED|Overall Study||24||
48293758|NCT00824161|101047435|FG000|STARTED|Overall Study||28||
48293759|NCT00824161|101047435|FG000|COMPLETED|Overall Study||26||
48293760|NCT00824161|101047435|FG000|NOT COMPLETED|Overall Study||2||
48293761|NCT01502631|101047436|FG000|STARTED|Overall Study||30||
48293762|NCT01502631|101047437|FG001|STARTED|Overall Study||31||
48293763|NCT01502631|101047436|FG000|COMPLETED|Overall Study||10||
48293764|NCT01502631|101047437|FG001|COMPLETED|Overall Study||11||
48293765|NCT01502631|101047436|FG000|NOT COMPLETED|Overall Study||20||
48293766|NCT01502631|101047437|FG001|NOT COMPLETED|Overall Study||20||
48293767|NCT00940108|101047438|FG000|STARTED|Overall Study||82||
48293768|NCT00940108|101047439|FG001|STARTED|Overall Study||80||
48293769|NCT00940108|101047440|FG002|STARTED|Overall Study||103||
48293770|NCT00940108|101047441|FG003|STARTED|Overall Study||104||
48293771|NCT00940108|101047438|FG000|COMPLETED|Overall Study||77||
48293772|NCT00940108|101047439|FG001|COMPLETED|Overall Study||71||
48293773|NCT00940108|101047440|FG002|COMPLETED|Overall Study||100||
48293774|NCT00940108|101047441|FG003|COMPLETED|Overall Study||99||
48293775|NCT00940108|101047438|FG000|NOT COMPLETED|Overall Study||5||
48293776|NCT00940108|101047439|FG001|NOT COMPLETED|Overall Study||9||
48293777|NCT00940108|101047440|FG002|NOT COMPLETED|Overall Study||3||
48293778|NCT00940108|101047441|FG003|NOT COMPLETED|Overall Study||5||
48293779|NCT05057923|101047442|FG000|STARTED|Overall Study||6||
48293780|NCT05057923|101047442|FG000|COMPLETED|Overall Study||6||
48293781|NCT05057923|101047442|FG000|NOT COMPLETED|Overall Study||0||
48293782|NCT00959166|101047443|FG000|STARTED|Overall Study||24||
48293783|NCT00959166|101047444|FG001|STARTED|Overall Study||57||
48293784|NCT00959166|101047443|FG000|COMPLETED|Overall Study||24||
48293785|NCT00959166|101047444|FG001|COMPLETED|Overall Study||57||
48293786|NCT00959166|101047443|FG000|NOT COMPLETED|Overall Study||0||
48293787|NCT00959166|101047444|FG001|NOT COMPLETED|Overall Study||0||
48293788|NCT02019927|101047445|FG000|STARTED|Overall Study||46||
48293789|NCT02019927|101047446|FG001|STARTED|Overall Study||23||
48293790|NCT02019927|101047447|FG002|STARTED|Overall Study||9||
48293791|NCT02019927|101047448|FG003|STARTED|Overall Study||5||
48293792|NCT02019927|101047449|FG004|STARTED|Overall Study||10||
48293793|NCT02019927|101047450|FG005|STARTED|Overall Study||4||
48293794|NCT02019927|101047445|FG000|COMPLETED|Overall Study||44||
48293795|NCT02019927|101047446|FG001|COMPLETED|Overall Study||19||
48293796|NCT02019927|101047447|FG002|COMPLETED|Overall Study||8||
48293797|NCT02019927|101047448|FG003|COMPLETED|Overall Study||3||
48710107|NCT02638207|102077920|FG001|NOT COMPLETED|Overall Study||8||
48710108|NCT02638207|102077921|FG002|NOT COMPLETED|Overall Study||4||
48710109|NCT02818036|102077922|FG000|STARTED|Overall Study||42||
48710110|NCT02818036|102077923|FG001|STARTED|Overall Study||40||
48710111|NCT02818036|102077922|FG000|COMPLETED|Overall Study||40||
48710112|NCT02818036|102077923|FG001|COMPLETED|Overall Study||40||
48710113|NCT02818036|102077922|FG000|NOT COMPLETED|Overall Study||2||
48710114|NCT02818036|102077923|FG001|NOT COMPLETED|Overall Study||0||
48710115|NCT00793572|102077924|FG000|STARTED|Overall Study||32||
48710116|NCT00793572|102077924|FG000|COMPLETED|Overall Study||32||
48710117|NCT00793572|102077924|FG000|NOT COMPLETED|Overall Study||0||
48710118|NCT05074888|102077925|FG000|STARTED|Overall Study||330||
48710119|NCT05074888|102077926|FG001|STARTED|Overall Study||346||
48710120|NCT05074888|102077925|FG000|COMPLETED|Overall Study||330||
48710121|NCT05074888|102077926|FG001|COMPLETED|Overall Study||346||
48710122|NCT05074888|102077925|FG000|NOT COMPLETED|Overall Study||0||
48591794|NCT00976209|101782938|FG001|NOT COMPLETED|Treatment Period 2||2||
48591795|NCT00270231|101782939|FG000|STARTED|First Intervention||32||
48591796|NCT00270231|101782940|FG001|STARTED|First Intervention||32||
48591797|NCT00270231|101782939|FG000|COMPLETED|First Intervention||31||
48591798|NCT00270231|101782940|FG001|COMPLETED|First Intervention||31||
48591799|NCT00270231|101782939|FG000|NOT COMPLETED|First Intervention||1||
48591800|NCT00270231|101782940|FG001|NOT COMPLETED|First Intervention||1||
48591801|NCT00270231|101782939|FG000|STARTED|Washout Period||31||
48591802|NCT00270231|101782940|FG001|STARTED|Washout Period||31||
48591803|NCT00270231|101782939|FG000|COMPLETED|Washout Period||30||
48591804|NCT00270231|101782940|FG001|COMPLETED|Washout Period||31||
48591805|NCT00270231|101782939|FG000|NOT COMPLETED|Washout Period||1||
48591806|NCT00270231|101782940|FG001|NOT COMPLETED|Washout Period||0||
48591807|NCT00270231|101782939|FG000|STARTED|Second Intervention||30||
48591808|NCT00270231|101782940|FG001|STARTED|Second Intervention||31||
48591809|NCT00270231|101782939|FG000|COMPLETED|Second Intervention||30||
48591810|NCT00270231|101782940|FG001|COMPLETED|Second Intervention||30||
48591811|NCT00270231|101782939|FG000|NOT COMPLETED|Second Intervention||0||
48591812|NCT00270231|101782940|FG001|NOT COMPLETED|Second Intervention||1||
48591813|NCT02978859|101782941|FG000|STARTED|Overall Study||29||
48591814|NCT02978859|101782941|FG000|COMPLETED|Overall Study||29||
48591815|NCT02978859|101782941|FG000|NOT COMPLETED|Overall Study||0||
48591816|NCT02998476|101782942|FG000|STARTED|Overall Study||55|60|
48591817|NCT02998476|101782943|FG001|STARTED|Overall Study||5|60|
48591818|NCT02998476|101782942|FG000|COMPLETED|Overall Study||0|0|
48591819|NCT02998476|101782943|FG001|COMPLETED|Overall Study||0|0|
48591820|NCT02998476|101782942|FG000|NOT COMPLETED|Overall Study||55||
48591821|NCT02998476|101782943|FG001|NOT COMPLETED|Overall Study||5||
48591822|NCT02002533|101782944|FG000|STARTED|Overall Study||34||
48591823|NCT02002533|101782945|FG001|STARTED|Overall Study||37||
48591824|NCT02002533|101782944|FG000|COMPLETED|Overall Study||28||
48591825|NCT02002533|101782945|FG001|COMPLETED|Overall Study||19||
48710123|NCT05074888|102077926|FG001|NOT COMPLETED|Overall Study||0||
48710124|NCT00642369|102077927|FG000|STARTED|Overall Study||30||
48710125|NCT00642369|102077928|FG001|STARTED|Overall Study||30||
48710126|NCT00642369|102077927|FG000|COMPLETED|Overall Study||25||
48710127|NCT00642369|102077928|FG001|COMPLETED|Overall Study||24||
48710128|NCT00642369|102077927|FG000|NOT COMPLETED|Overall Study||5||
48710129|NCT00642369|102077928|FG001|NOT COMPLETED|Overall Study||6||
48710130|NCT00293709|102077929|FG000|STARTED|Overall Study||149||
48710131|NCT00293709|102077929|FG000|COMPLETED|Overall Study||102||
48710132|NCT00293709|102077929|FG000|NOT COMPLETED|Overall Study||47||
48710133|NCT01893372|102077930|FG000|STARTED|Overall Study||7||
48710134|NCT01893372|102077931|FG001|STARTED|Overall Study||22||
48710135|NCT01893372|102077930|FG000|COMPLETED|Overall Study||7||
48710136|NCT01893372|102077931|FG001|COMPLETED|Overall Study||22||
48710137|NCT01893372|102077930|FG000|NOT COMPLETED|Overall Study||0||
48710138|NCT01893372|102077931|FG001|NOT COMPLETED|Overall Study||0||
48710139|NCT03622112|102077932|FG000|STARTED|Overall Study||110|One patient in the AZD7594 50 μg treatment arm did not receive any treatment and was randomised in error (protocol deviation).|
48710140|NCT03622112|102077933|FG001|STARTED|Overall Study||112|One patient in the AZD7594 50 μg treatment arm did not receive any treatment and was randomised in error (protocol deviation).|
48710141|NCT03622112|102077934|FG002|STARTED|Overall Study||111|One patient in the AZD7594 50 μg treatment arm did not receive any treatment and was randomised in error (protocol deviation).|
48710142|NCT03622112|102077935|FG003|STARTED|Overall Study||113|One patient in the AZD7594 50 μg treatment arm did not receive any treatment and was randomised in error (protocol deviation).|
48710143|NCT03622112|102077936|FG004|STARTED|Overall Study||134|One patient in the AZD7594 50 μg treatment arm did not receive any treatment and was randomised in error (protocol deviation).|
48710144|NCT03622112|102077937|FG005|STARTED|Overall Study||113|One patient in the AZD7594 50 μg treatment arm did not receive any treatment and was randomised in error (protocol deviation).|
48710145|NCT03622112|102077938|FG006|STARTED|Overall Study||112|One patient in the AZD7594 50 μg treatment arm did not receive any treatment and was randomised in error (protocol deviation).|
48710146|NCT03622112|102077932|FG000|COMPLETED|Overall Study||85||
48710147|NCT03622112|102077933|FG001|COMPLETED|Overall Study||92||
48710148|NCT03622112|102077934|FG002|COMPLETED|Overall Study||95||
48710149|NCT03622112|102077935|FG003|COMPLETED|Overall Study||91||
48710150|NCT03622112|102077936|FG004|COMPLETED|Overall Study||124||
48710151|NCT03622112|102077937|FG005|COMPLETED|Overall Study||71||
48710152|NCT03622112|102077938|FG006|COMPLETED|Overall Study||103||
48710153|NCT03622112|102077932|FG000|NOT COMPLETED|Overall Study||25||
48710154|NCT03622112|102077933|FG001|NOT COMPLETED|Overall Study||20||
48591826|NCT02002533|101782944|FG000|NOT COMPLETED|Overall Study||6||
48591827|NCT02002533|101782945|FG001|NOT COMPLETED|Overall Study||18||
48591828|NCT04045132|101782946|FG000|STARTED|Overall Study||37|These numbers represent the participants who completed a baseline visit and were randomized.|
48591829|NCT04045132|101782947|FG001|STARTED|Overall Study||38|These numbers represent the participants who completed a baseline visit and were randomized.|
48591830|NCT04045132|101782946|FG000|COMPLETED|Overall Study||34|These numbers represent the participants who at the 3-month follow up completed all secondary measures as well as the Parent Child Early Relational Assessment (PCERA). Those who did not complete the PCERA and/or who did not complete all the follow up measures were not considered to have completed their study participation.|
48592853|NCT02059434|101786331|FG006|STARTED|Period 1 (After Screening/run-in Period)||2||
48710155|NCT03622112|102077934|FG002|NOT COMPLETED|Overall Study||16||
48710156|NCT03622112|102077935|FG003|NOT COMPLETED|Overall Study||22||
48710157|NCT03622112|102077936|FG004|NOT COMPLETED|Overall Study||10||
48710158|NCT03622112|102077937|FG005|NOT COMPLETED|Overall Study||42||
48293798|NCT02019927|101047449|FG004|COMPLETED|Overall Study||7||
48293799|NCT02019927|101047450|FG005|COMPLETED|Overall Study||3||
48293800|NCT02019927|101047445|FG000|NOT COMPLETED|Overall Study||2||
48293801|NCT02019927|101047446|FG001|NOT COMPLETED|Overall Study||4||
48293802|NCT02019927|101047447|FG002|NOT COMPLETED|Overall Study||1||
48293803|NCT02019927|101047448|FG003|NOT COMPLETED|Overall Study||2||
48403807|NCT00608881|101321693|FG000|STARTED|Overall Study||303||
48403808|NCT00608881|101321694|FG001|STARTED|Overall Study||306||
48403809|NCT00608881|101321693|FG000|COMPLETED|Overall Study||224||
48403810|NCT00608881|101321694|FG001|COMPLETED|Overall Study||240||
48403811|NCT00608881|101321693|FG000|NOT COMPLETED|Overall Study||79||
48403812|NCT00608881|101321694|FG001|NOT COMPLETED|Overall Study||66||
48403813|NCT00688623|101321695|FG000|STARTED|Overall Study||73||
48403814|NCT00688623|101321695|FG000|Safety Analysis Set|Overall Study||73||
48293804|NCT02019927|101047449|FG004|NOT COMPLETED|Overall Study||3||
48293805|NCT02019927|101047450|FG005|NOT COMPLETED|Overall Study||1||
48293806|NCT03587974|101047451|FG000|STARTED|Overall Study||30||
48293807|NCT03587974|101047452|FG001|STARTED|Overall Study||30||
48293808|NCT03587974|101047451|FG000|COMPLETED|Overall Study||25||
48293809|NCT03587974|101047452|FG001|COMPLETED|Overall Study||26||
48293810|NCT03587974|101047451|FG000|NOT COMPLETED|Overall Study||5||
48293811|NCT03587974|101047452|FG001|NOT COMPLETED|Overall Study||4||
48293812|NCT01745848|101047453|FG000|STARTED|Overall Study||26||
48293813|NCT01745848|101047453|FG000|COMPLETED|Overall Study||20||
48293814|NCT01745848|101047453|FG000|NOT COMPLETED|Overall Study||6||
48293815|NCT01030198|101047454|FG000|STARTED|Overall Study||0||
48293816|NCT01030198|101047455|FG001|STARTED|Overall Study||7||
48293817|NCT01030198|101047454|FG000|COMPLETED|Overall Study||0||
48293818|NCT01030198|101047455|FG001|COMPLETED|Overall Study||0||
48293819|NCT01030198|101047454|FG000|NOT COMPLETED|Overall Study||0||
48293820|NCT01030198|101047455|FG001|NOT COMPLETED|Overall Study||7||
48293821|NCT03346161|101047456|FG000|STARTED|Overall Study||60||
48403815|NCT00688623|101321695|FG000|Per Protocol (PP)|Overall Study||60||
48403816|NCT00688623|101321695|FG000|COMPLETED|Overall Study||18||
48403817|NCT00688623|101321695|FG000|NOT COMPLETED|Overall Study||55||
48403818|NCT05166603|101321696|FG000|STARTED|Overall Study||73||
48403819|NCT05166603|101321697|FG001|STARTED|Overall Study||38||
48403820|NCT05166603|101321696|FG000|COMPLETED|Overall Study||5||
48403821|NCT05166603|101321697|FG001|COMPLETED|Overall Study||38||
48403822|NCT05166603|101321696|FG000|NOT COMPLETED|Overall Study||68||
48293822|NCT03346161|101047457|FG001|STARTED|Overall Study||60||
48293823|NCT03346161|101047456|FG000|COMPLETED|Overall Study||60||
48403823|NCT05166603|101321697|FG001|NOT COMPLETED|Overall Study||0||
48710159|NCT03622112|102077938|FG006|NOT COMPLETED|Overall Study||9||
48710160|NCT01448824|102077939|FG000|STARTED|Part 1 Period 1: Multiple Ascending Dose||12||
48710161|NCT01448824|102077940|FG001|STARTED|Part 1 Period 1: Multiple Ascending Dose||4||
48710162|NCT01448824|102077941|FG002|STARTED|Part 1 Period 1: Multiple Ascending Dose||4||
48710163|NCT01448824|102077942|FG003|STARTED|Part 1 Period 1: Multiple Ascending Dose||10||
48710164|NCT01448824|102077943|FG004|STARTED|Part 1 Period 1: Multiple Ascending Dose||16||
48710165|NCT01448824|102077944|FG005|STARTED|Part 1 Period 1: Multiple Ascending Dose||12||
48403824|NCT00646581|101321698|FG000|STARTED|Overall Study||15||
48710166|NCT01448824|102077945|FG006|STARTED|Part 1 Period 1: Multiple Ascending Dose||12||
48710167|NCT01448824|102077946|FG007|STARTED|Part 1 Period 1: Multiple Ascending Dose||0||
48710168|NCT01448824|102077939|FG000|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12||
48710169|NCT01448824|102077940|FG001|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||4||
48710170|NCT01448824|102077941|FG002|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||4||
48710171|NCT01448824|102077942|FG003|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||10||
48710172|NCT01448824|102077943|FG004|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||16||
48710173|NCT01448824|102077944|FG005|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12||
48710174|NCT01448824|102077945|FG006|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12||
48403825|NCT00646581|101321699|FG001|STARTED|Overall Study||15||
48403826|NCT00646581|101321698|FG000|COMPLETED|Overall Study||15||
48403827|NCT00646581|101321699|FG001|COMPLETED|Overall Study||15||
48403828|NCT00646581|101321698|FG000|NOT COMPLETED|Overall Study||0||
48403829|NCT00646581|101321699|FG001|NOT COMPLETED|Overall Study||0||
48403830|NCT03383614|101321700|FG000|STARTED|Overall Study||6||
48403831|NCT03383614|101321701|FG001|STARTED|Overall Study||6||
48403832|NCT03383614|101321702|FG002|STARTED|Overall Study||6||
48403833|NCT03383614|101321703|FG003|STARTED|Overall Study||6||
48403834|NCT03383614|101321700|FG000|COMPLETED|Overall Study||6||
48403835|NCT03383614|101321701|FG001|COMPLETED|Overall Study||5||
48403836|NCT03383614|101321702|FG002|COMPLETED|Overall Study||6||
48403837|NCT03383614|101321703|FG003|COMPLETED|Overall Study||6||
48403838|NCT03383614|101321700|FG000|NOT COMPLETED|Overall Study||0||
48403839|NCT03383614|101321701|FG001|NOT COMPLETED|Overall Study||1||
48403840|NCT03383614|101321702|FG002|NOT COMPLETED|Overall Study||0||
48403841|NCT03383614|101321703|FG003|NOT COMPLETED|Overall Study||0||
48591831|NCT04045132|101782947|FG001|COMPLETED|Overall Study||32|These numbers represent the participants who at the 3-month follow up completed all secondary measures as well as the Parent Child Early Relational Assessment (PCERA). Those who did not complete the PCERA and/or who did not complete all the follow up measures were not considered to have completed their study participation.|
48591832|NCT04045132|101782946|FG000|NOT COMPLETED|Overall Study||3||
48591833|NCT04045132|101782947|FG001|NOT COMPLETED|Overall Study||6||
48591834|NCT03085238|101782948|FG000|STARTED|Overall Study||23||
48591835|NCT03085238|101782948|FG000|1 Month|Overall Study||23||
48591836|NCT03085238|101782948|FG000|3 Months|Overall Study||22||
48591837|NCT03085238|101782948|FG000|6 Months|Overall Study||19||
48591838|NCT03085238|101782948|FG000|9 Months|Overall Study||16||
48591839|NCT03085238|101782948|FG000|12 Months|Overall Study||14||
48591840|NCT03085238|101782948|FG000|15 Months|Overall Study||11||
48591841|NCT03085238|101782948|FG000|18 Months|Overall Study||7||
48591842|NCT03085238|101782948|FG000|COMPLETED|Overall Study||19||
48710175|NCT01448824|102077946|FG007|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||0||
48403842|NCT04099836|101321704|FG000|STARTED|Overall Study||7||
48403843|NCT04099836|101321704|FG000|COMPLETED|Overall Study||7||
48710176|NCT01448824|102077939|FG000|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||12||
48710177|NCT01448824|102077940|FG001|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||4||
48710178|NCT01448824|102077941|FG002|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||4||
48710179|NCT01448824|102077942|FG003|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||9||
48710180|NCT01448824|102077943|FG004|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||14||
48710181|NCT01448824|102077944|FG005|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||10||
48710182|NCT01448824|102077945|FG006|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||11||
48710183|NCT01448824|102077946|FG007|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0||
48710184|NCT01448824|102077939|FG000|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0||
48710779|NCT00899717|102078015|FG001|NOT COMPLETED|Overall Study||0||
48403844|NCT04099836|101321704|FG000|NOT COMPLETED|Overall Study||0||
48293824|NCT03346161|101047457|FG001|COMPLETED|Overall Study||60||
48293825|NCT03346161|101047456|FG000|NOT COMPLETED|Overall Study||0||
48293826|NCT03346161|101047457|FG001|NOT COMPLETED|Overall Study||0||
48293827|NCT00799513|101047458|FG000|STARTED|Overall Study||48||
48293828|NCT00799513|101047458|FG000|COMPLETED|Overall Study||46||
48293829|NCT00799513|101047458|FG000|NOT COMPLETED|Overall Study||2||
48403845|NCT03238352|101321705|FG000|STARTED|Overall Study||43||
48403846|NCT03238352|101321706|FG001|STARTED|Overall Study||23||
48403847|NCT03238352|101321707|FG002|STARTED|Overall Study||23||
48403848|NCT03238352|101321705|FG000|COMPLETED|Overall Study||43||
48403849|NCT03238352|101321706|FG001|COMPLETED|Overall Study||20||
48403850|NCT03238352|101321707|FG002|COMPLETED|Overall Study||22||
48403851|NCT03238352|101321705|FG000|NOT COMPLETED|Overall Study||0||
48403852|NCT03238352|101321706|FG001|NOT COMPLETED|Overall Study||3||
48403853|NCT03238352|101321707|FG002|NOT COMPLETED|Overall Study||1||
48403854|NCT00291187|101321708|FG000|STARTED|Overall Study||103||
48403855|NCT00291187|101321709|FG001|STARTED|Overall Study||100||
48403856|NCT00291187|101321710|FG002|STARTED|Overall Study||103||
48403857|NCT00291187|101321711|FG003|STARTED|Overall Study||106||
48403858|NCT00291187|101321708|FG000|COMPLETED|Overall Study||103||
48403859|NCT00291187|101321709|FG001|COMPLETED|Overall Study||100||
48403860|NCT00291187|101321710|FG002|COMPLETED|Overall Study||102||
48293830|NCT00180323|101047459|FG000|STARTED|Overall Study||43||
48293831|NCT00180323|101047459|FG000|COMPLETED|Overall Study||43||
48293832|NCT00180323|101047459|FG000|NOT COMPLETED|Overall Study||0||
48293833|NCT00421707|101047460|FG000|STARTED|Period 1: Treatment Period 1||67||
48293834|NCT00421707|101047461|FG001|STARTED|Period 1: Treatment Period 1||65||
48293835|NCT00421707|101047460|FG000|COMPLETED|Period 1: Treatment Period 1||56||
48293836|NCT00421707|101047461|FG001|COMPLETED|Period 1: Treatment Period 1||56||
48293837|NCT00421707|101047460|FG000|NOT COMPLETED|Period 1: Treatment Period 1||11||
48293838|NCT00421707|101047461|FG001|NOT COMPLETED|Period 1: Treatment Period 1||9||
48293839|NCT00421707|101047460|FG000|STARTED|Period 2: Washout||56||
48293840|NCT00421707|101047461|FG001|STARTED|Period 2: Washout||56||
48293841|NCT00421707|101047460|FG000|COMPLETED|Period 2: Washout||55||
48293842|NCT00421707|101047461|FG001|COMPLETED|Period 2: Washout||52||
48293843|NCT00421707|101047460|FG000|NOT COMPLETED|Period 2: Washout||1||
48293844|NCT00421707|101047461|FG001|NOT COMPLETED|Period 2: Washout||4||
48293845|NCT00421707|101047460|FG000|STARTED|Period 3:Treatment Period 2||55||
48293846|NCT00421707|101047461|FG001|STARTED|Period 3:Treatment Period 2||52||
48293847|NCT00421707|101047460|FG000|COMPLETED|Period 3:Treatment Period 2||53||
48293848|NCT00421707|101047461|FG001|COMPLETED|Period 3:Treatment Period 2||49||
48293849|NCT00421707|101047460|FG000|NOT COMPLETED|Period 3:Treatment Period 2||2||
48293850|NCT00421707|101047461|FG001|NOT COMPLETED|Period 3:Treatment Period 2||3||
48293851|NCT01710332|101047462|FG000|STARTED|Overall Study||6||
48293852|NCT01710332|101047463|FG001|STARTED|Overall Study||6||
48293853|NCT01710332|101047462|FG000|COMPLETED|Overall Study||6||
48293854|NCT01710332|101047463|FG001|COMPLETED|Overall Study||6||
48293855|NCT01710332|101047462|FG000|NOT COMPLETED|Overall Study||0||
48293856|NCT01710332|101047463|FG001|NOT COMPLETED|Overall Study||0||
48403861|NCT00291187|101321711|FG003|COMPLETED|Overall Study||106||
48403862|NCT00291187|101321708|FG000|NOT COMPLETED|Overall Study||0||
48293857|NCT03032393|101047464|FG000|STARTED|Overall Study||15||
48293858|NCT03032393|101047465|FG001|STARTED|Overall Study||15||
48293859|NCT03032393|101047464|FG000|COMPLETED|Overall Study||15||
48293860|NCT03032393|101047465|FG001|COMPLETED|Overall Study||15||
48293861|NCT03032393|101047464|FG000|NOT COMPLETED|Overall Study||0||
48293862|NCT03032393|101047465|FG001|NOT COMPLETED|Overall Study||0||
48293863|NCT03718533|101047466|FG000|STARTED|Overall Study||10||
48293864|NCT03718533|101047466|FG000|COMPLETED|Overall Study||3||
48293865|NCT03718533|101047466|FG000|NOT COMPLETED|Overall Study||7||
48293866|NCT02271477|101047467|FG000|STARTED|Overall Study||80||
48293867|NCT02271477|101047468|FG001|STARTED|Overall Study||80||
48293868|NCT02271477|101047467|FG000|COMPLETED|Overall Study||80||
48293869|NCT02271477|101047468|FG001|COMPLETED|Overall Study||80||
48293870|NCT02271477|101047467|FG000|NOT COMPLETED|Overall Study||0||
48293871|NCT02271477|101047468|FG001|NOT COMPLETED|Overall Study||0||
48403863|NCT00291187|101321709|FG001|NOT COMPLETED|Overall Study||0||
48403864|NCT00291187|101321710|FG002|NOT COMPLETED|Overall Study||1||
48403865|NCT00291187|101321711|FG003|NOT COMPLETED|Overall Study||0||
48403866|NCT01055457|101321712|FG000|STARTED|Overall Study||40||
48403867|NCT01055457|101321713|FG001|STARTED|Overall Study||40||
48403868|NCT01055457|101321714|FG002|STARTED|Overall Study||38||
48403869|NCT01055457|101321715|FG003|STARTED|Overall Study||40||
48293872|NCT01616056|101047469|FG000|STARTED|Overall Study||20||
48293873|NCT01616056|101047469|FG000|COMPLETED|Overall Study||19||
48293874|NCT01616056|101047469|FG000|NOT COMPLETED|Overall Study||1||
48293875|NCT02640157|101047470|FG000|STARTED|Overall Study||233||
48293876|NCT02640157|101047471|FG001|STARTED|Overall Study||116||
48293877|NCT02640157|101047472|FG002|STARTED|Overall Study||157||
48293878|NCT02640157|101047470|FG000|Received Study Drug|Overall Study||233||
48293879|NCT02640157|101047471|FG001|Received Study Drug|Overall Study||115||
48293880|NCT02640157|101047472|FG002|Received Study Drug|Overall Study||157||
48293881|NCT02640157|101047470|FG000|Completed Study Drug|Overall Study||225||
48293882|NCT02640157|101047471|FG001|Completed Study Drug|Overall Study||112||
48293883|NCT02640157|101047472|FG002|Completed Study Drug|Overall Study||154||
48293884|NCT02640157|101047470|FG000|Discontinued Study Drug|Overall Study||8||
48293885|NCT02640157|101047471|FG001|Discontinued Study Drug|Overall Study||3||
48293886|NCT02640157|101047472|FG002|Discontinued Study Drug|Overall Study||3||
48293887|NCT02640157|101047470|FG000|COMPLETED|Overall Study||220||
48293888|NCT02640157|101047471|FG001|COMPLETED|Overall Study||111||
48293889|NCT02640157|101047472|FG002|COMPLETED|Overall Study||147||
48293890|NCT02640157|101047470|FG000|NOT COMPLETED|Overall Study||13||
48293891|NCT02640157|101047471|FG001|NOT COMPLETED|Overall Study||5||
48293892|NCT02640157|101047472|FG002|NOT COMPLETED|Overall Study||10||
48293893|NCT01146054|101047473|FG000|STARTED|Overall Study||59||
48293894|NCT01146054|101047473|FG000|COMPLETED|Overall Study||49||
48293895|NCT01146054|101047473|FG000|NOT COMPLETED|Overall Study||10||
48293896|NCT03170154|101047474|FG000|STARTED|Overall Study||350||
48293897|NCT03170154|101047474|FG000|Rotational Stability Sub-study|Overall Study||141||
48293898|NCT03170154|101047474|FG000|COMPLETED|Overall Study||342||
48293899|NCT03170154|101047474|FG000|NOT COMPLETED|Overall Study||8||
48591843|NCT03085238|101782948|FG000|NOT COMPLETED|Overall Study||4||
48591844|NCT01378975|101782949|FG000|STARTED|Overall Study||90||
48591845|NCT01378975|101782950|FG001|STARTED|Overall Study||56||
48591846|NCT01378975|101782949|FG000|COMPLETED|Overall Study||4||
48591847|NCT01378975|101782950|FG001|COMPLETED|Overall Study||6||
48591848|NCT01378975|101782949|FG000|NOT COMPLETED|Overall Study||86||
48591849|NCT01378975|101782950|FG001|NOT COMPLETED|Overall Study||50||
48591850|NCT03521817|101782951|FG000|STARTED|Overall Study||7||
48591851|NCT03521817|101782952|FG001|STARTED|Overall Study||5||
48591852|NCT03521817|101782951|FG000|COMPLETED|Overall Study||7||
48591853|NCT03521817|101782952|FG001|COMPLETED|Overall Study||4||
48591854|NCT03521817|101782951|FG000|NOT COMPLETED|Overall Study||0||
48591855|NCT03521817|101782952|FG001|NOT COMPLETED|Overall Study||1||
48591856|NCT00810017|101782953|FG000|STARTED|Overall Study||2||
48591857|NCT00810017|101782953|FG000|COMPLETED|Overall Study||0||
48591858|NCT00810017|101782953|FG000|NOT COMPLETED|Overall Study||2||
48591859|NCT03336268|101782954|FG000|STARTED|Overall Study||159||
48591860|NCT03336268|101782955|FG001|STARTED|Overall Study||90||
48591861|NCT03336268|101782954|FG000|COMPLETED|Overall Study||159||
48591862|NCT03336268|101782955|FG001|COMPLETED|Overall Study||90||
48591863|NCT03336268|101782954|FG000|NOT COMPLETED|Overall Study||0||
48591864|NCT03336268|101782955|FG001|NOT COMPLETED|Overall Study||0||
48591865|NCT00962091|101782956|FG000|STARTED|Overall Study||4||
48591866|NCT00962091|101782957|FG001|STARTED|Overall Study||9||
48591867|NCT00962091|101782958|FG002|STARTED|Overall Study||10||
48591868|NCT00962091|101782959|FG003|STARTED|Overall Study||3||
48710185|NCT01448824|102077940|FG001|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0||
48710186|NCT01448824|102077941|FG002|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0||
48710187|NCT01448824|102077942|FG003|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||1||
48293900|NCT02245672|101047475|FG000|STARTED|Overall Study||512||
48293901|NCT02245672|101047476|FG001|STARTED|Overall Study||513||
48293902|NCT02245672|101047477|FG002|STARTED|Overall Study||103||
48293903|NCT02245672|101047475|FG000|COMPLETED|Overall Study||499||
48293904|NCT02245672|101047476|FG001|COMPLETED|Overall Study||500||
48293905|NCT02245672|101047477|FG002|COMPLETED|Overall Study||98||
48293906|NCT02245672|101047475|FG000|NOT COMPLETED|Overall Study||13||
48293907|NCT02245672|101047476|FG001|NOT COMPLETED|Overall Study||13||
48293908|NCT02245672|101047477|FG002|NOT COMPLETED|Overall Study||5||
48293909|NCT01386788|101047478|FG000|STARTED|Overall Study||102||
48591869|NCT00962091|101782960|FG004|STARTED|Overall Study||3||
48591870|NCT00962091|101782961|FG005|STARTED|Overall Study||12||
48293910|NCT01386788|101047478|FG000|COMPLETED|Overall Study||100||
48293911|NCT01386788|101047478|FG000|NOT COMPLETED|Overall Study||2||
48293912|NCT04875676|101047479|FG000|STARTED|Overall Study||10||
48293913|NCT04875676|101047480|FG001|STARTED|Overall Study||10||
48293914|NCT04875676|101047481|FG002|STARTED|Overall Study||10||
48591871|NCT00962091|101782962|FG006|STARTED|Overall Study||12||
48591872|NCT00962091|101782956|FG000|COMPLETED|Overall Study||3||
48293915|NCT04875676|101047479|FG000|COMPLETED|Overall Study||9||
48591873|NCT00962091|101782957|FG001|COMPLETED|Overall Study||7||
48591874|NCT00962091|101782958|FG002|COMPLETED|Overall Study||9||
48591875|NCT00962091|101782959|FG003|COMPLETED|Overall Study||2||
48591876|NCT00962091|101782960|FG004|COMPLETED|Overall Study||3||
48591877|NCT00962091|101782961|FG005|COMPLETED|Overall Study||11||
48591878|NCT00962091|101782962|FG006|COMPLETED|Overall Study||11||
48710188|NCT01448824|102077943|FG004|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||2||
48591879|NCT00962091|101782956|FG000|NOT COMPLETED|Overall Study||1||
48591880|NCT00962091|101782957|FG001|NOT COMPLETED|Overall Study||2||
48591881|NCT00962091|101782958|FG002|NOT COMPLETED|Overall Study||1||
48591882|NCT00962091|101782959|FG003|NOT COMPLETED|Overall Study||1||
48591883|NCT00962091|101782960|FG004|NOT COMPLETED|Overall Study||0||
48591884|NCT00962091|101782961|FG005|NOT COMPLETED|Overall Study||1||
48591885|NCT00962091|101782962|FG006|NOT COMPLETED|Overall Study||1||
48591886|NCT03703908|101782963|FG000|STARTED|Overall Study||5||
48591887|NCT03703908|101782963|FG000|COMPLETED|Overall Study||2||
48591888|NCT03703908|101782963|FG000|NOT COMPLETED|Overall Study||3||
48591889|NCT02567409|101782964|FG000|STARTED|Overall Study||46||
48591890|NCT02567409|101782965|FG001|STARTED|Overall Study||41||
48591891|NCT02567409|101782964|FG000|COMPLETED|Overall Study||46||
48591892|NCT02567409|101782965|FG001|COMPLETED|Overall Study||41||
48591893|NCT02567409|101782964|FG000|NOT COMPLETED|Overall Study||0||
48591894|NCT02567409|101782965|FG001|NOT COMPLETED|Overall Study||0||
48591895|NCT02332239|101782966|FG000|STARTED|Overall Study||58||
48591896|NCT02332239|101782967|FG001|STARTED|Overall Study||58||
48591897|NCT02332239|101782966|FG000|COMPLETED|Overall Study||54||
48591898|NCT02332239|101782967|FG001|COMPLETED|Overall Study||52||
48591899|NCT02332239|101782966|FG000|NOT COMPLETED|Overall Study||4||
48591900|NCT02332239|101782967|FG001|NOT COMPLETED|Overall Study||6||
48591901|NCT04231396|101782968|FG000|STARTED|Overall Study||27||
48591902|NCT04231396|101782968|FG000|COMPLETED|Overall Study||27||
48591903|NCT04231396|101782968|FG000|NOT COMPLETED|Overall Study||0||
48591904|NCT01534208|101782969|FG000|STARTED|Overall Study||216||
48591905|NCT01534208|101782970|FG001|STARTED|Overall Study||283||
48591906|NCT01534208|101782969|FG000|COMPLETED|Overall Study||159||
48591907|NCT01534208|101782970|FG001|COMPLETED|Overall Study||234||
48591908|NCT01534208|101782969|FG000|NOT COMPLETED|Overall Study||57||
48591909|NCT01534208|101782970|FG001|NOT COMPLETED|Overall Study||49||
48591910|NCT01149421|101782971|FG000|STARTED|Overall Study||251||
48591911|NCT01149421|101782972|FG001|STARTED|Overall Study||254||
48591912|NCT01149421|101782973|FG002|STARTED|Overall Study||250||
48591913|NCT01149421|101782971|FG000|Received at Least One Dose of Study Drug|Overall Study||251||
48591914|NCT01149421|101782972|FG001|Received at Least One Dose of Study Drug|Overall Study||254||
48591915|NCT01149421|101782973|FG002|Received at Least One Dose of Study Drug|Overall Study||250||
48591916|NCT01149421|101782971|FG000|COMPLETED|Overall Study||199||
48591917|NCT01149421|101782972|FG001|COMPLETED|Overall Study||225||
48591918|NCT01149421|101782973|FG002|COMPLETED|Overall Study||206||
48591919|NCT01149421|101782971|FG000|NOT COMPLETED|Overall Study||52||
48591920|NCT01149421|101782972|FG001|NOT COMPLETED|Overall Study||29||
48591921|NCT01149421|101782973|FG002|NOT COMPLETED|Overall Study||44||
48591922|NCT02956447|101782974|FG000|STARTED|Overall Study||21||
48591923|NCT02956447|101782975|FG001|STARTED|Overall Study||15||
48591924|NCT02956447|101782974|FG000|COMPLETED|Overall Study||10||
48591925|NCT02956447|101782975|FG001|COMPLETED|Overall Study||5||
48591926|NCT02956447|101782974|FG000|NOT COMPLETED|Overall Study||11||
48591927|NCT02956447|101782975|FG001|NOT COMPLETED|Overall Study||10||
48591928|NCT00070018|101782976|FG000|STARTED|Overall Study||46||
48591929|NCT00070018|101782976|FG000|Eligible|Overall Study||46||
48591930|NCT00070018|101782976|FG000|Eligible and Began Protocol Therapy|Overall Study||46||
48591931|NCT00070018|101782976|FG000|COMPLETED|Overall Study||42||
48591932|NCT00070018|101782976|FG000|NOT COMPLETED|Overall Study||4||
48591933|NCT01695330|101782977|FG000|STARTED|Overall Study||52||
48591934|NCT01695330|101782978|FG001|STARTED|Overall Study||0||
48591935|NCT01695330|101782977|FG000|COMPLETED|Overall Study||5||
48591936|NCT01695330|101782978|FG001|COMPLETED|Overall Study||0||
48591937|NCT01695330|101782977|FG000|NOT COMPLETED|Overall Study||47||
48591938|NCT01695330|101782978|FG001|NOT COMPLETED|Overall Study||0||
48591939|NCT03488849|101782979|FG000|STARTED|Overall Study||10||
48591940|NCT03488849|101782980|FG001|STARTED|Overall Study||8||
48591941|NCT03488849|101782981|FG002|STARTED|Overall Study||6||
48591942|NCT03488849|101782979|FG000|COMPLETED|Overall Study||10||
48591943|NCT03488849|101782980|FG001|COMPLETED|Overall Study||8||
48591944|NCT03488849|101782981|FG002|COMPLETED|Overall Study||6||
48591945|NCT03488849|101782979|FG000|NOT COMPLETED|Overall Study||0||
48591946|NCT03488849|101782980|FG001|NOT COMPLETED|Overall Study||0||
48591947|NCT03488849|101782981|FG002|NOT COMPLETED|Overall Study||0||
48591948|NCT00784550|101782982|FG000|STARTED|Overall Study||173||
48591949|NCT00784550|101782983|FG001|STARTED|Overall Study||169||
48591950|NCT00784550|101782982|FG000|COMPLETED|Overall Study||137||
48591951|NCT00784550|101782983|FG001|COMPLETED|Overall Study||127||
48591952|NCT00784550|101782982|FG000|NOT COMPLETED|Overall Study||36||
48591953|NCT00784550|101782983|FG001|NOT COMPLETED|Overall Study||42||
48591954|NCT02719353|101782984|FG000|STARTED|First Intervention||7||
48591955|NCT02719353|101782985|FG001|STARTED|First Intervention||7||
48591956|NCT02719353|101782984|FG000|COMPLETED|First Intervention||7||
48591957|NCT02719353|101782985|FG001|COMPLETED|First Intervention||6||
48591958|NCT02719353|101782984|FG000|NOT COMPLETED|First Intervention||0||
48591959|NCT02719353|101782985|FG001|NOT COMPLETED|First Intervention||1||
48591960|NCT02719353|101782984|FG000|STARTED|Second Intervention||7||
48591961|NCT02719353|101782985|FG001|STARTED|Second Intervention||6||
48591962|NCT02719353|101782984|FG000|COMPLETED|Second Intervention||7||
48591963|NCT02719353|101782985|FG001|COMPLETED|Second Intervention||6||
48591964|NCT02719353|101782984|FG000|NOT COMPLETED|Second Intervention||0||
48591965|NCT02719353|101782985|FG001|NOT COMPLETED|Second Intervention||0||
48591966|NCT01527487|101782986|FG000|STARTED|Overall Study||54||
48591967|NCT01527487|101782987|FG001|STARTED|Overall Study||22||
48591968|NCT01527487|101782986|FG000|COMPLETED|Overall Study||46||
48591969|NCT01527487|101782987|FG001|COMPLETED|Overall Study||15||
48591970|NCT01527487|101782986|FG000|NOT COMPLETED|Overall Study||8||
48591971|NCT01527487|101782987|FG001|NOT COMPLETED|Overall Study||7||
48591972|NCT04495816|101782988|FG000|STARTED|Overall Study||70||
48591973|NCT04495816|101782989|FG001|STARTED|Overall Study||69||
48591974|NCT04495816|101782988|FG000|COMPLETED|Overall Study||57||
48591975|NCT04495816|101782989|FG001|COMPLETED|Overall Study||60||
48591976|NCT04495816|101782988|FG000|NOT COMPLETED|Overall Study||13||
48591977|NCT04495816|101782989|FG001|NOT COMPLETED|Overall Study||9||
48591978|NCT01664949|101782990|FG000|STARTED|Overall Study||224||
48591979|NCT01664949|101782991|FG001|STARTED|Overall Study||236||
48591980|NCT01664949|101782990|FG000|COMPLETED|Overall Study||200||
48591981|NCT01664949|101782991|FG001|COMPLETED|Overall Study||211||
48591982|NCT01664949|101782990|FG000|NOT COMPLETED|Overall Study||24||
48591983|NCT01664949|101782991|FG001|NOT COMPLETED|Overall Study||25||
48591984|NCT01768845|101782992|FG000|STARTED|Overall Study||34||
48591985|NCT01768845|101782992|FG000|COMPLETED|Overall Study||11||
48591986|NCT01768845|101782992|FG000|NOT COMPLETED|Overall Study||23||
48591987|NCT02091375|101782993|FG000|STARTED|Overall Study||61||
48591988|NCT02091375|101782994|FG001|STARTED|Overall Study||59||
48591989|NCT02091375|101782993|FG000|Safety Analysis Set|Overall Study||61|All randomized participants who received at least 1 dose of investigational medicinal product (IMP)|
48591990|NCT02091375|101782994|FG001|Safety Analysis Set|Overall Study||59|All randomized participants who received at least 1 dose of investigational medicinal product (IMP)|
48710189|NCT01448824|102077944|FG005|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||2||
48710190|NCT01448824|102077945|FG006|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||1||
48710191|NCT01448824|102077946|FG007|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0||
48710192|NCT01448824|102077939|FG000|STARTED|Part 1: Washout Period||12||
48710193|NCT01448824|102077940|FG001|STARTED|Part 1: Washout Period||4||
48591991|NCT02091375|101782993|FG000|Intention to Treat (ITT) Analysis Set|Overall Study||61|All participants in the Part B Safety Analysis Set who had post-baseline efficacy data|
48591992|NCT02091375|101782994|FG001|Intention to Treat (ITT) Analysis Set|Overall Study||59|All participants in the Part B Safety Analysis Set who had post-baseline efficacy data|
48591993|NCT02091375|101782993|FG000|COMPLETED|Overall Study||52||
48591994|NCT02091375|101782994|FG001|COMPLETED|Overall Study||56||
48591995|NCT02091375|101782993|FG000|NOT COMPLETED|Overall Study||9||
48591996|NCT02091375|101782994|FG001|NOT COMPLETED|Overall Study||3||
48591997|NCT02061683|101782995|FG000|STARTED|Overall Study||263||
48591998|NCT02061683|101782995|FG000|COMPLETED|Overall Study||203||
48591999|NCT02061683|101782995|FG000|NOT COMPLETED|Overall Study||60||
48592000|NCT01451632|101782996|FG000|STARTED|Overall Study||8||
48592001|NCT01451632|101782997|FG001|STARTED|Overall Study||4||
48592002|NCT01451632|101782998|FG002|STARTED|Overall Study||3||
48592003|NCT01451632|101782999|FG003|STARTED|Overall Study||3||
48592004|NCT01451632|101783000|FG004|STARTED|Overall Study||4||
48592005|NCT01451632|101783001|FG005|STARTED|Overall Study||4||
48592006|NCT01451632|101783002|FG006|STARTED|Overall Study||8||
48592007|NCT01451632|101783003|FG007|STARTED|Overall Study||6||
48592008|NCT01451632|101783004|FG008|STARTED|Overall Study||4||
48592009|NCT01451632|101783005|FG009|STARTED|Overall Study||4||
48592010|NCT01451632|101782996|FG000|COMPLETED|Overall Study||8||
48592011|NCT01451632|101782997|FG001|COMPLETED|Overall Study||4||
48592012|NCT01451632|101782998|FG002|COMPLETED|Overall Study||3||
48592013|NCT01451632|101782999|FG003|COMPLETED|Overall Study||3||
48592014|NCT01451632|101783000|FG004|COMPLETED|Overall Study||4||
48592015|NCT01451632|101783001|FG005|COMPLETED|Overall Study||4||
48592016|NCT01451632|101783002|FG006|COMPLETED|Overall Study||8||
48592017|NCT01451632|101783003|FG007|COMPLETED|Overall Study||6||
48592018|NCT01451632|101783004|FG008|COMPLETED|Overall Study||4||
48592019|NCT01451632|101783005|FG009|COMPLETED|Overall Study||4||
48592020|NCT01451632|101782996|FG000|NOT COMPLETED|Overall Study||0||
48592021|NCT01451632|101782997|FG001|NOT COMPLETED|Overall Study||0||
48592022|NCT01451632|101782998|FG002|NOT COMPLETED|Overall Study||0||
48592023|NCT01451632|101782999|FG003|NOT COMPLETED|Overall Study||0||
48592024|NCT01451632|101783000|FG004|NOT COMPLETED|Overall Study||0||
48592025|NCT01451632|101783001|FG005|NOT COMPLETED|Overall Study||0||
48592026|NCT01451632|101783002|FG006|NOT COMPLETED|Overall Study||0||
48592027|NCT01451632|101783003|FG007|NOT COMPLETED|Overall Study||0||
48710194|NCT01448824|102077941|FG002|STARTED|Part 1: Washout Period||4||
48710195|NCT01448824|102077942|FG003|STARTED|Part 1: Washout Period||0||
48710196|NCT01448824|102077943|FG004|STARTED|Part 1: Washout Period||0||
48710197|NCT01448824|102077944|FG005|STARTED|Part 1: Washout Period||0||
48710198|NCT01448824|102077945|FG006|STARTED|Part 1: Washout Period||0||
48710199|NCT01448824|102077946|FG007|STARTED|Part 1: Washout Period||0||
48710200|NCT01448824|102077939|FG000|COMPLETED|Part 1: Washout Period||11||
48710201|NCT01448824|102077940|FG001|COMPLETED|Part 1: Washout Period||4||
48592028|NCT01451632|101783004|FG008|NOT COMPLETED|Overall Study||0||
48592029|NCT01451632|101783005|FG009|NOT COMPLETED|Overall Study||0||
48592030|NCT01001598|101783006|FG000|STARTED|Overall Study||5|Monitoring visits at 2, 5, 8, 12, 18, 24 wks - visits at 14 and/or 20 weeks if dose escalation|
48592031|NCT01001598|101783006|FG000|COMPLETED|Overall Study||3||
48592032|NCT01001598|101783006|FG000|NOT COMPLETED|Overall Study||2||
48592033|NCT02255552|101783007|FG000|STARTED|Overall Study||79||
48592034|NCT02255552|101783008|FG001|STARTED|Overall Study||30||
48592035|NCT02255552|101783007|FG000|COMPLETED|Overall Study||78||
48592036|NCT02255552|101783008|FG001|COMPLETED|Overall Study||15||
48592037|NCT02255552|101783007|FG000|NOT COMPLETED|Overall Study||1||
48592038|NCT02255552|101783008|FG001|NOT COMPLETED|Overall Study||15||
48592039|NCT03260426|101783009|FG000|STARTED|Overall Study||50||
48592040|NCT03260426|101783010|FG001|STARTED|Overall Study||50||
48592041|NCT03260426|101783009|FG000|COMPLETED|Overall Study||50||
48592042|NCT03260426|101783010|FG001|COMPLETED|Overall Study||50||
48592043|NCT03260426|101783009|FG000|NOT COMPLETED|Overall Study||0||
48592044|NCT03260426|101783010|FG001|NOT COMPLETED|Overall Study||0||
48592045|NCT01783821|101783011|FG000|STARTED|Overall Study||30||
48592046|NCT01783821|101783012|FG001|STARTED|Overall Study||31||
48592047|NCT01783821|101783011|FG000|COMPLETED|Overall Study||29||
48592048|NCT01783821|101783012|FG001|COMPLETED|Overall Study||30||
48592049|NCT01783821|101783011|FG000|NOT COMPLETED|Overall Study||1||
48592050|NCT01783821|101783012|FG001|NOT COMPLETED|Overall Study||1||
48592051|NCT02918552|101783013|FG000|STARTED|Overall Study||7||
48592052|NCT02918552|101783014|FG001|STARTED|Overall Study||8||
48592053|NCT02918552|101783013|FG000|COMPLETED|Overall Study||6||
48592054|NCT02918552|101783014|FG001|COMPLETED|Overall Study||6||
48592055|NCT02918552|101783013|FG000|NOT COMPLETED|Overall Study||1||
48592056|NCT02918552|101783014|FG001|NOT COMPLETED|Overall Study||2||
48592057|NCT03495154|101783015|FG000|STARTED|Overall Study||145||
48592058|NCT03495154|101783015|FG000|Full Analysis Set|Overall Study||125||
48592059|NCT03495154|101783015|FG000|COMPLETED|Overall Study||104||
48592060|NCT03495154|101783015|FG000|NOT COMPLETED|Overall Study||41||
48592061|NCT00477607|101783016|FG000|STARTED|Overall Study||19||
48592062|NCT00477607|101783017|FG001|STARTED|Overall Study||20||
48592063|NCT00477607|101783016|FG000|COMPLETED|Overall Study||12||
48592064|NCT00477607|101783017|FG001|COMPLETED|Overall Study||13||
48592065|NCT00477607|101783016|FG000|NOT COMPLETED|Overall Study||7||
48592066|NCT00477607|101783017|FG001|NOT COMPLETED|Overall Study||7||
48592067|NCT00001656|101783018|FG000|STARTED|Overall Study||13||
48592068|NCT00001656|101783019|FG001|STARTED|Overall Study||12||
48592069|NCT00001656|101783018|FG000|COMPLETED|Overall Study||12||
48592070|NCT00001656|101783019|FG001|COMPLETED|Overall Study||12||
48592071|NCT00001656|101783018|FG000|NOT COMPLETED|Overall Study||1||
48592072|NCT00001656|101783019|FG001|NOT COMPLETED|Overall Study||0||
48592073|NCT04608344|101783020|FG000|STARTED|Period 1 (AB: 3 Days, BA: 11 Days)||14||
48293916|NCT04875676|101047480|FG001|COMPLETED|Overall Study||10||
48293917|NCT04875676|101047481|FG002|COMPLETED|Overall Study||10||
48293918|NCT04875676|101047479|FG000|NOT COMPLETED|Overall Study||1||
48293919|NCT04875676|101047480|FG001|NOT COMPLETED|Overall Study||0||
48293920|NCT04875676|101047481|FG002|NOT COMPLETED|Overall Study||0||
48293921|NCT01079130|101047482|FG000|STARTED|Overall Study||85||
48592074|NCT04608344|101783021|FG001|STARTED|Period 1 (AB: 3 Days, BA: 11 Days)||13||
48592075|NCT04608344|101783020|FG000|COMPLETED|Period 1 (AB: 3 Days, BA: 11 Days)||13||
48592076|NCT04608344|101783021|FG001|COMPLETED|Period 1 (AB: 3 Days, BA: 11 Days)||12||
48592077|NCT04608344|101783020|FG000|NOT COMPLETED|Period 1 (AB: 3 Days, BA: 11 Days)||1||
48592078|NCT04608344|101783021|FG001|NOT COMPLETED|Period 1 (AB: 3 Days, BA: 11 Days)||1||
48592079|NCT04608344|101783020|FG000|STARTED|Period 2 (AB: 11 Days, BA: 3 Days)||13||
48592080|NCT04608344|101783021|FG001|STARTED|Period 2 (AB: 11 Days, BA: 3 Days)||12||
48592081|NCT04608344|101783020|FG000|COMPLETED|Period 2 (AB: 11 Days, BA: 3 Days)||13||
48592082|NCT04608344|101783021|FG001|COMPLETED|Period 2 (AB: 11 Days, BA: 3 Days)||12||
48592083|NCT04608344|101783020|FG000|NOT COMPLETED|Period 2 (AB: 11 Days, BA: 3 Days)||0||
48592084|NCT04608344|101783021|FG001|NOT COMPLETED|Period 2 (AB: 11 Days, BA: 3 Days)||0||
48592085|NCT01732471|101783022|FG000|STARTED|Overall Study||90||
48592086|NCT01732471|101783022|FG000|COMPLETED|Overall Study||89||
48592087|NCT01732471|101783022|FG000|NOT COMPLETED|Overall Study||1||
48592088|NCT01404208|101783023|FG000|STARTED|Overall Study||70||
48592089|NCT01404208|101783024|FG001|STARTED|Overall Study||72||
48592090|NCT01404208|101783023|FG000|COMPLETED|Overall Study||67||
48592091|NCT01404208|101783024|FG001|COMPLETED|Overall Study||72||
48592092|NCT01404208|101783023|FG000|NOT COMPLETED|Overall Study||3||
48293922|NCT01079130|101047483|FG001|STARTED|Overall Study||85||
48293923|NCT01079130|101047484|FG002|STARTED|Overall Study||84||
48293924|NCT01079130|101047485|FG003|STARTED|Overall Study||86||
48592093|NCT01404208|101783024|FG001|NOT COMPLETED|Overall Study||0||
48592094|NCT01537068|101783025|FG000|STARTED|Overall Study||30||
48592095|NCT01537068|101783026|FG001|STARTED|Overall Study||29||
48592096|NCT01537068|101783025|FG000|COMPLETED|Overall Study||26||
48592097|NCT01537068|101783026|FG001|COMPLETED|Overall Study||26||
48592098|NCT01537068|101783025|FG000|NOT COMPLETED|Overall Study||4||
48592099|NCT01537068|101783026|FG001|NOT COMPLETED|Overall Study||3||
48592100|NCT03026530|101783027|FG000|STARTED|Overall Study||100||
48592101|NCT03026530|101783028|FG001|STARTED|Overall Study||100||
48592102|NCT03026530|101783027|FG000|COMPLETED|Overall Study||79||
48592103|NCT03026530|101783028|FG001|COMPLETED|Overall Study||71||
48592104|NCT03026530|101783027|FG000|NOT COMPLETED|Overall Study||21||
48592105|NCT03026530|101783028|FG001|NOT COMPLETED|Overall Study||29||
48592106|NCT00956631|101783029|FG000|STARTED|Overall Study||78||
48592107|NCT00956631|101783029|FG000|COMPLETED|Overall Study||62||
48592108|NCT00956631|101783029|FG000|NOT COMPLETED|Overall Study||16||
48592109|NCT01472965|101783030|FG000|STARTED|Overall Study||49||
48592110|NCT01472965|101783031|FG001|STARTED|Overall Study||46||
48592111|NCT01472965|101783030|FG000|COMPLETED|Overall Study||48||
48592112|NCT01472965|101783031|FG001|COMPLETED|Overall Study||46||
48592113|NCT01472965|101783030|FG000|NOT COMPLETED|Overall Study||1||
48592114|NCT01472965|101783031|FG001|NOT COMPLETED|Overall Study||0||
48592115|NCT04829331|101783032|FG000|STARTED|Overall Study||3||
48592116|NCT04829331|101783033|FG001|STARTED|Overall Study||2||
48592117|NCT04829331|101783032|FG000|COMPLETED|Overall Study||2||
48592118|NCT04829331|101783033|FG001|COMPLETED|Overall Study||2||
48592119|NCT04829331|101783032|FG000|NOT COMPLETED|Overall Study||1||
48592120|NCT04829331|101783033|FG001|NOT COMPLETED|Overall Study||0||
48592121|NCT04566133|101783034|FG000|STARTED|Overall Study||2||
48592122|NCT04566133|101783034|FG000|COMPLETED|Overall Study||2||
48592123|NCT04566133|101783034|FG000|NOT COMPLETED|Overall Study||0||
48592124|NCT03301740|101783035|FG000|STARTED|Phase 1 Intervention (3 Weeks)||18||
48592125|NCT03301740|101783036|FG001|STARTED|Phase 1 Intervention (3 Weeks)||16||
48592126|NCT03301740|101783035|FG000|COMPLETED|Phase 1 Intervention (3 Weeks)||18||
48592127|NCT03301740|101783036|FG001|COMPLETED|Phase 1 Intervention (3 Weeks)||16||
48592128|NCT03301740|101783035|FG000|NOT COMPLETED|Phase 1 Intervention (3 Weeks)||0||
48592129|NCT03301740|101783036|FG001|NOT COMPLETED|Phase 1 Intervention (3 Weeks)||0||
48592130|NCT03301740|101783035|FG000|STARTED|First Washout (1 Week)||18||
48592131|NCT03301740|101783036|FG001|STARTED|First Washout (1 Week)||16||
48592132|NCT03301740|101783035|FG000|COMPLETED|First Washout (1 Week)||18||
48592133|NCT03301740|101783036|FG001|COMPLETED|First Washout (1 Week)||16||
48592134|NCT03301740|101783035|FG000|NOT COMPLETED|First Washout (1 Week)||0||
48592135|NCT03301740|101783036|FG001|NOT COMPLETED|First Washout (1 Week)||0||
48592136|NCT03301740|101783035|FG000|STARTED|Phase 2 Intervention (3 Weeks)||18||
48592137|NCT03301740|101783036|FG001|STARTED|Phase 2 Intervention (3 Weeks)||16||
48592138|NCT03301740|101783035|FG000|COMPLETED|Phase 2 Intervention (3 Weeks)||17||
48592139|NCT03301740|101783036|FG001|COMPLETED|Phase 2 Intervention (3 Weeks)||16||
48592140|NCT03301740|101783035|FG000|NOT COMPLETED|Phase 2 Intervention (3 Weeks)||1||
48592141|NCT03301740|101783036|FG001|NOT COMPLETED|Phase 2 Intervention (3 Weeks)||0||
48592142|NCT03301740|101783035|FG000|STARTED|Second Washout (1 Week)||17||
48592143|NCT03301740|101783036|FG001|STARTED|Second Washout (1 Week)||16||
48592144|NCT03301740|101783035|FG000|COMPLETED|Second Washout (1 Week)||17||
48592145|NCT03301740|101783036|FG001|COMPLETED|Second Washout (1 Week)||16||
48592146|NCT03301740|101783035|FG000|NOT COMPLETED|Second Washout (1 Week)||0||
48592147|NCT03301740|101783036|FG001|NOT COMPLETED|Second Washout (1 Week)||0||
48592148|NCT03301740|101783035|FG000|STARTED|Phase 3 Intervention (3 Weeks)||17||
48592149|NCT03301740|101783036|FG001|STARTED|Phase 3 Intervention (3 Weeks)||16||
48592150|NCT03301740|101783035|FG000|COMPLETED|Phase 3 Intervention (3 Weeks)||17||
48592151|NCT03301740|101783036|FG001|COMPLETED|Phase 3 Intervention (3 Weeks)||16||
48592152|NCT03301740|101783035|FG000|NOT COMPLETED|Phase 3 Intervention (3 Weeks)||0||
48592153|NCT03301740|101783036|FG001|NOT COMPLETED|Phase 3 Intervention (3 Weeks)||0||
48592154|NCT03301740|101783035|FG000|STARTED|Third Washout (1 Week)||17||
48592155|NCT03301740|101783036|FG001|STARTED|Third Washout (1 Week)||16||
48592156|NCT03301740|101783035|FG000|COMPLETED|Third Washout (1 Week)||17||
48592157|NCT03301740|101783036|FG001|COMPLETED|Third Washout (1 Week)||16||
48592158|NCT03301740|101783035|FG000|NOT COMPLETED|Third Washout (1 Week)||0||
48293925|NCT01079130|101047486|FG004|STARTED|Overall Study||86||
48293926|NCT01079130|101047487|FG005|STARTED|Overall Study||85||
48293927|NCT01079130|101047482|FG000|Safety Set: Received Study Drug|Overall Study||84||
48293928|NCT01079130|101047483|FG001|Safety Set: Received Study Drug|Overall Study||81||
48293929|NCT01079130|101047484|FG002|Safety Set: Received Study Drug|Overall Study||84||
48293930|NCT01079130|101047485|FG003|Safety Set: Received Study Drug|Overall Study||85||
48293931|NCT01079130|101047486|FG004|Safety Set: Received Study Drug|Overall Study||84||
48293932|NCT01079130|101047487|FG005|Safety Set: Received Study Drug|Overall Study||84||
48293933|NCT01079130|101047482|FG000|Full Analysis Set (FAS)|Overall Study||84||
48710202|NCT01448824|102077941|FG002|COMPLETED|Part 1: Washout Period||4||
48710203|NCT01448824|102077942|FG003|COMPLETED|Part 1: Washout Period||0||
48710204|NCT01448824|102077943|FG004|COMPLETED|Part 1: Washout Period||0||
48293934|NCT01079130|101047483|FG001|Full Analysis Set (FAS)|Overall Study||80||
48293935|NCT01079130|101047484|FG002|Full Analysis Set (FAS)|Overall Study||83||
48293936|NCT01079130|101047485|FG003|Full Analysis Set (FAS)|Overall Study||85||
48293937|NCT01079130|101047486|FG004|Full Analysis Set (FAS)|Overall Study||84||
48710205|NCT01448824|102077944|FG005|COMPLETED|Part 1: Washout Period||0||
48710206|NCT01448824|102077945|FG006|COMPLETED|Part 1: Washout Period||0||
48710207|NCT01448824|102077946|FG007|COMPLETED|Part 1: Washout Period||0||
48710208|NCT01448824|102077939|FG000|NOT COMPLETED|Part 1: Washout Period||1||
48710209|NCT01448824|102077940|FG001|NOT COMPLETED|Part 1: Washout Period||0||
48710210|NCT01448824|102077941|FG002|NOT COMPLETED|Part 1: Washout Period||0||
48710211|NCT01448824|102077942|FG003|NOT COMPLETED|Part 1: Washout Period||0||
48403870|NCT01055457|101321716|FG004|STARTED|Overall Study||41||
48403871|NCT01055457|101321717|FG005|STARTED|Overall Study||18||
48403872|NCT01055457|101321718|FG006|STARTED|Overall Study||19||
48403873|NCT01055457|101321719|FG007|STARTED|Overall Study||19||
48710212|NCT01448824|102077943|FG004|NOT COMPLETED|Part 1: Washout Period||0||
48710213|NCT01448824|102077944|FG005|NOT COMPLETED|Part 1: Washout Period||0||
48403874|NCT01055457|101321720|FG008|STARTED|Overall Study||20||
48403875|NCT01055457|101321721|FG009|STARTED|Overall Study||20||
48403876|NCT01055457|101321712|FG000|COMPLETED|Overall Study||39||
48403877|NCT01055457|101321713|FG001|COMPLETED|Overall Study||39||
48403878|NCT01055457|101321714|FG002|COMPLETED|Overall Study||36||
48403879|NCT01055457|101321715|FG003|COMPLETED|Overall Study||37||
48403880|NCT01055457|101321716|FG004|COMPLETED|Overall Study||38||
48403881|NCT01055457|101321717|FG005|COMPLETED|Overall Study||15||
48403882|NCT01055457|101321718|FG006|COMPLETED|Overall Study||18||
48403883|NCT01055457|101321719|FG007|COMPLETED|Overall Study||18||
48403884|NCT01055457|101321720|FG008|COMPLETED|Overall Study||20||
48403885|NCT01055457|101321721|FG009|COMPLETED|Overall Study||19||
48403886|NCT01055457|101321712|FG000|NOT COMPLETED|Overall Study||1||
48403887|NCT01055457|101321713|FG001|NOT COMPLETED|Overall Study||1||
48403888|NCT01055457|101321714|FG002|NOT COMPLETED|Overall Study||2||
48403889|NCT01055457|101321715|FG003|NOT COMPLETED|Overall Study||3||
48403890|NCT01055457|101321716|FG004|NOT COMPLETED|Overall Study||3||
48403891|NCT01055457|101321717|FG005|NOT COMPLETED|Overall Study||3||
48403892|NCT01055457|101321718|FG006|NOT COMPLETED|Overall Study||1||
48403893|NCT01055457|101321719|FG007|NOT COMPLETED|Overall Study||1||
48403894|NCT01055457|101321720|FG008|NOT COMPLETED|Overall Study||0||
48403895|NCT01055457|101321721|FG009|NOT COMPLETED|Overall Study||1||
48403896|NCT00223652|101321722|FG000|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||41||
48403897|NCT00223652|101321723|FG001|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||44||
48403898|NCT00223652|101321722|FG000|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||40||
48403899|NCT00223652|101321723|FG001|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||41||
48403900|NCT00223652|101321722|FG000|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||1||
48403901|NCT00223652|101321723|FG001|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||3||
48403902|NCT00223652|101321722|FG000|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||40||
48403903|NCT00223652|101321723|FG001|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||41||
48403904|NCT00223652|101321722|FG000|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||40||
48592159|NCT03301740|101783036|FG001|NOT COMPLETED|Third Washout (1 Week)||0||
48403905|NCT00223652|101321723|FG001|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||41||
48403906|NCT00223652|101321722|FG000|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0||
48403907|NCT00223652|101321723|FG001|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0||
48403908|NCT00223652|101321722|FG000|STARTED|T-CBT and TAU 6 Month Follow-up||40||
48403909|NCT00223652|101321723|FG001|STARTED|T-CBT and TAU 6 Month Follow-up||41||
48403910|NCT00223652|101321722|FG000|COMPLETED|T-CBT and TAU 6 Month Follow-up||39||
48403911|NCT00223652|101321723|FG001|COMPLETED|T-CBT and TAU 6 Month Follow-up||37||
48403912|NCT00223652|101321722|FG000|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||1||
48403913|NCT00223652|101321723|FG001|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||4||
48403914|NCT03127852|101321724|FG000|STARTED|Overall Study||46||
48403915|NCT03127852|101321725|FG001|STARTED|Overall Study||50||
48403916|NCT03127852|101321724|FG000|COMPLETED|Overall Study||41||
48403917|NCT03127852|101321725|FG001|COMPLETED|Overall Study||48||
48403918|NCT03127852|101321724|FG000|NOT COMPLETED|Overall Study||5||
48403919|NCT03127852|101321725|FG001|NOT COMPLETED|Overall Study||2||
48403920|NCT03154294|101321726|FG000|STARTED|Overall Study||4||
48403921|NCT03154294|101321727|FG001|STARTED|Overall Study||3||
48403922|NCT03154294|101321728|FG002|STARTED|Overall Study||3||
48403923|NCT03154294|101321729|FG003|STARTED|Overall Study||6||
48140883|NCT03053050|100670285|FG002|NOT COMPLETED|Open-label Phase||0||
48140884|NCT03053050|100670286|FG003|NOT COMPLETED|Open-label Phase||99||
48710214|NCT01448824|102077945|FG006|NOT COMPLETED|Part 1: Washout Period||0||
48710215|NCT01448824|102077946|FG007|NOT COMPLETED|Part 1: Washout Period||0||
48710216|NCT01448824|102077939|FG000|STARTED|Part 1 Period 2: Multiple Ascending Dose||11||
48710217|NCT01448824|102077940|FG001|STARTED|Part 1 Period 2: Multiple Ascending Dose||4||
48140885|NCT01880424|100670287|FG000|STARTED|Overall Study||417||
48140886|NCT01880424|100670288|FG001|STARTED|Overall Study||422||
48140887|NCT01880424|100670287|FG000|COMPLETED|Overall Study||384||
48403924|NCT03154294|101321730|FG004|STARTED|Overall Study||3||
48403925|NCT03154294|101321726|FG000|COMPLETED|Overall Study||4||
48403926|NCT03154294|101321727|FG001|COMPLETED|Overall Study||3||
48403927|NCT03154294|101321728|FG002|COMPLETED|Overall Study||3||
48403928|NCT03154294|101321729|FG003|COMPLETED|Overall Study||4||
48403929|NCT03154294|101321730|FG004|COMPLETED|Overall Study||2||
48403930|NCT03154294|101321726|FG000|NOT COMPLETED|Overall Study||0||
48403931|NCT03154294|101321727|FG001|NOT COMPLETED|Overall Study||0||
48403932|NCT03154294|101321728|FG002|NOT COMPLETED|Overall Study||0||
48403933|NCT03154294|101321729|FG003|NOT COMPLETED|Overall Study||2||
48403934|NCT03154294|101321730|FG004|NOT COMPLETED|Overall Study||1||
48403935|NCT03967847|101321731|FG000|STARTED|Overall Study||21||
48403936|NCT03967847|101321732|FG001|STARTED|Overall Study||23||
48403937|NCT03967847|101321731|FG000|COMPLETED|Overall Study||21||
48403938|NCT03967847|101321732|FG001|COMPLETED|Overall Study||23||
48403939|NCT03967847|101321731|FG000|NOT COMPLETED|Overall Study||0||
48403940|NCT03967847|101321732|FG001|NOT COMPLETED|Overall Study||0||
48403941|NCT02683707|101321733|FG000|STARTED|Overall Study||105||
48403942|NCT02683707|101321734|FG001|STARTED|Overall Study||107||
48592160|NCT03301740|101783035|FG000|STARTED|Phase 4 Intervention (3 Weeks)||17||
48592161|NCT03301740|101783036|FG001|STARTED|Phase 4 Intervention (3 Weeks)||16||
48710218|NCT01448824|102077941|FG002|STARTED|Part 1 Period 2: Multiple Ascending Dose||4||
48403943|NCT02683707|101321733|FG000|COMPLETED|Overall Study||105||
48403944|NCT02683707|101321734|FG001|COMPLETED|Overall Study||107||
48403945|NCT02683707|101321733|FG000|NOT COMPLETED|Overall Study||0||
48403946|NCT02683707|101321734|FG001|NOT COMPLETED|Overall Study||0||
48403947|NCT00367341|101321735|FG000|STARTED|Overall Study||42||
48403948|NCT00367341|101321736|FG001|STARTED|Overall Study||40||
48710219|NCT01448824|102077942|FG003|STARTED|Part 1 Period 2: Multiple Ascending Dose||0||
48710220|NCT01448824|102077943|FG004|STARTED|Part 1 Period 2: Multiple Ascending Dose||0||
48710221|NCT01448824|102077944|FG005|STARTED|Part 1 Period 2: Multiple Ascending Dose||0||
48592162|NCT03301740|101783035|FG000|COMPLETED|Phase 4 Intervention (3 Weeks)||16||
48592163|NCT03301740|101783036|FG001|COMPLETED|Phase 4 Intervention (3 Weeks)||16||
48592164|NCT03301740|101783035|FG000|NOT COMPLETED|Phase 4 Intervention (3 Weeks)||1||
48592165|NCT03301740|101783036|FG001|NOT COMPLETED|Phase 4 Intervention (3 Weeks)||0||
48592166|NCT01185509|101783037|FG000|STARTED|Overall Study||11||
48592167|NCT01185509|101783038|FG001|STARTED|Overall Study||20||
48592168|NCT01185509|101783037|FG000|COMPLETED|Overall Study||0||
48592169|NCT01185509|101783038|FG001|COMPLETED|Overall Study||0||
48592170|NCT01185509|101783037|FG000|NOT COMPLETED|Overall Study||11||
48592171|NCT01185509|101783038|FG001|NOT COMPLETED|Overall Study||20||
48592172|NCT03426436|101783039|FG000|STARTED|Overall Study||314||
48592173|NCT03426436|101783039|FG000|COMPLETED|Overall Study||295|16 subjects excluded from analysis|
48592174|NCT03426436|101783039|FG000|NOT COMPLETED|Overall Study||19||
48592175|NCT02579343|101783040|FG000|STARTED|Overall Study||7||
48592176|NCT02579343|101783041|FG001|STARTED|Overall Study||6||
48592177|NCT02579343|101783040|FG000|COMPLETED|Overall Study||7||
48592178|NCT02579343|101783041|FG001|COMPLETED|Overall Study||6||
48592179|NCT02579343|101783040|FG000|NOT COMPLETED|Overall Study||0||
48592180|NCT02579343|101783041|FG001|NOT COMPLETED|Overall Study||0||
48592181|NCT01841567|101783042|FG000|STARTED|Overall Study||60||
48592182|NCT01841567|101783042|FG000|COMPLETED|Overall Study||57||
48592183|NCT01841567|101783042|FG000|NOT COMPLETED|Overall Study||3||
48592184|NCT02429310|101783043|FG000|STARTED|Overall Study||22||
48592185|NCT02429310|101783044|FG001|STARTED|Overall Study||20||
48592186|NCT02429310|101783043|FG000|COMPLETED|Overall Study||20||
48592187|NCT02429310|101783044|FG001|COMPLETED|Overall Study||17||
48592188|NCT02429310|101783043|FG000|NOT COMPLETED|Overall Study||2||
48592189|NCT02429310|101783044|FG001|NOT COMPLETED|Overall Study||3||
48592190|NCT00157820|101783045|FG000|STARTED|Randomized||118||
48592191|NCT00157820|101783046|FG001|STARTED|Randomized||116||
48592192|NCT00157820|101783047|FG002|STARTED|Randomized||120||
48592193|NCT00157820|101783045|FG000|COMPLETED|Randomized||111||
48592194|NCT00157820|101783046|FG001|COMPLETED|Randomized||111||
48592195|NCT00157820|101783047|FG002|COMPLETED|Randomized||112||
48592196|NCT00157820|101783045|FG000|NOT COMPLETED|Randomized||7||
48592197|NCT00157820|101783046|FG001|NOT COMPLETED|Randomized||5||
48592198|NCT00157820|101783047|FG002|NOT COMPLETED|Randomized||8||
48592199|NCT00157820|101783045|FG000|STARTED|1st 8 Month||111||
48592200|NCT00157820|101783046|FG001|STARTED|1st 8 Month||111||
48592201|NCT00157820|101783047|FG002|STARTED|1st 8 Month||112||
48592202|NCT00157820|101783045|FG000|COMPLETED|1st 8 Month||103||
48592203|NCT00157820|101783046|FG001|COMPLETED|1st 8 Month||99||
48592204|NCT00157820|101783047|FG002|COMPLETED|1st 8 Month||106||
48592205|NCT00157820|101783045|FG000|NOT COMPLETED|1st 8 Month||8||
48592206|NCT00157820|101783046|FG001|NOT COMPLETED|1st 8 Month||12||
48592207|NCT00157820|101783047|FG002|NOT COMPLETED|1st 8 Month||6||
48592208|NCT00157820|101783045|FG000|STARTED|1 Month Wash Out Period||103||
48592209|NCT00157820|101783046|FG001|STARTED|1 Month Wash Out Period||101||
48592210|NCT00157820|101783047|FG002|STARTED|1 Month Wash Out Period||108||
48592211|NCT00157820|101783045|FG000|COMPLETED|1 Month Wash Out Period||103||
48592212|NCT00157820|101783046|FG001|COMPLETED|1 Month Wash Out Period||101||
48592213|NCT00157820|101783047|FG002|COMPLETED|1 Month Wash Out Period||108||
48592214|NCT00157820|101783045|FG000|NOT COMPLETED|1 Month Wash Out Period||0||
48592215|NCT00157820|101783046|FG001|NOT COMPLETED|1 Month Wash Out Period||0||
48592216|NCT00157820|101783047|FG002|NOT COMPLETED|1 Month Wash Out Period||0||
48592217|NCT00157820|101783045|FG000|STARTED|2nd 8 Months||103||
48592218|NCT00157820|101783046|FG001|STARTED|2nd 8 Months||101||
48592219|NCT00157820|101783047|FG002|STARTED|2nd 8 Months||108||
48592220|NCT00157820|101783045|FG000|COMPLETED|2nd 8 Months||98||
48592221|NCT00157820|101783046|FG001|COMPLETED|2nd 8 Months||88||
48592222|NCT00157820|101783047|FG002|COMPLETED|2nd 8 Months||94||
48592223|NCT00157820|101783045|FG000|NOT COMPLETED|2nd 8 Months||5||
48592224|NCT00157820|101783046|FG001|NOT COMPLETED|2nd 8 Months||13||
48592225|NCT00157820|101783047|FG002|NOT COMPLETED|2nd 8 Months||14||
48592226|NCT03332628|101783048|FG000|STARTED|Overall Study||113||
48592227|NCT03332628|101783048|FG000|COMPLETED|Overall Study||111||
48592228|NCT03332628|101783048|FG000|NOT COMPLETED|Overall Study||2||
48592229|NCT00715728|101783049|FG000|STARTED|Overall Study||14||
48592230|NCT00715728|101783050|FG001|STARTED|Overall Study||14||
48592231|NCT00715728|101783049|FG000|COMPLETED|Overall Study||14||
48592232|NCT00715728|101783050|FG001|COMPLETED|Overall Study||14||
48592233|NCT00715728|101783049|FG000|NOT COMPLETED|Overall Study||0||
48592234|NCT00715728|101783050|FG001|NOT COMPLETED|Overall Study||0||
48592235|NCT00714753|101783051|FG000|STARTED|Overall Study||5||
48592236|NCT00714753|101783051|FG000|HDR Brachytherapy|Overall Study||5||
48592237|NCT00714753|101783051|FG000|External Beam Radiotherapy (EBRT)|Overall Study||1||
48592238|NCT00714753|101783051|FG000|COMPLETED|Overall Study||5||
48592239|NCT00714753|101783051|FG000|NOT COMPLETED|Overall Study||0||
48592240|NCT00860249|101783052|FG000|STARTED|Overall Study||21||
48592241|NCT00860249|101783053|FG001|STARTED|Overall Study||18||
48592242|NCT00860249|101783054|FG002|STARTED|Overall Study||21||
48592243|NCT00860249|101783052|FG000|COMPLETED|Overall Study||0||
48592244|NCT00860249|101783053|FG001|COMPLETED|Overall Study||0||
48592245|NCT00860249|101783054|FG002|COMPLETED|Overall Study||0||
48592246|NCT00860249|101783052|FG000|NOT COMPLETED|Overall Study||21||
48592247|NCT00860249|101783053|FG001|NOT COMPLETED|Overall Study||18||
48592248|NCT00860249|101783054|FG002|NOT COMPLETED|Overall Study||21||
48592249|NCT01041976|101783055|FG000|STARTED|Overall Study||42||
48592250|NCT01041976|101783056|FG001|STARTED|Overall Study||42||
48592251|NCT01041976|101783055|FG000|6 Month Follow-up|Overall Study||39||
48592252|NCT01041976|101783056|FG001|6 Month Follow-up|Overall Study||41||
48592253|NCT01041976|101783055|FG000|12 Month Follow-up|Overall Study||37||
48592254|NCT01041976|101783056|FG001|12 Month Follow-up|Overall Study||38||
48592255|NCT01041976|101783055|FG000|18 Month Follow-up|Overall Study||37||
48592256|NCT01041976|101783056|FG001|18 Month Follow-up|Overall Study||38||
48592257|NCT01041976|101783055|FG000|COMPLETED|Overall Study||37||
48592258|NCT01041976|101783056|FG001|COMPLETED|Overall Study||38||
48592259|NCT01041976|101783055|FG000|NOT COMPLETED|Overall Study||5||
48592260|NCT01041976|101783056|FG001|NOT COMPLETED|Overall Study||4||
48592261|NCT01319851|101783057|FG000|STARTED|Overall Study||3||
48592262|NCT01319851|101783057|FG000|COMPLETED|Overall Study||3||
48592263|NCT01319851|101783057|FG000|NOT COMPLETED|Overall Study||0||
48592264|NCT00379808|101783058|FG000|STARTED|Intervention Period 1 (4 Weeks)||11||
48293938|NCT01079130|101047487|FG005|Full Analysis Set (FAS)|Overall Study||84||
48592265|NCT00379808|101783059|FG001|STARTED|Intervention Period 1 (4 Weeks)||11||
48592266|NCT00379808|101783058|FG000|COMPLETED|Intervention Period 1 (4 Weeks)||11||
48592267|NCT00379808|101783059|FG001|COMPLETED|Intervention Period 1 (4 Weeks)||11||
48592268|NCT00379808|101783058|FG000|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0||
48592269|NCT00379808|101783059|FG001|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0||
48710222|NCT01448824|102077945|FG006|STARTED|Part 1 Period 2: Multiple Ascending Dose||0||
48710223|NCT01448824|102077946|FG007|STARTED|Part 1 Period 2: Multiple Ascending Dose||0||
48710224|NCT01448824|102077939|FG000|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||11||
48710225|NCT01448824|102077940|FG001|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||4||
48592270|NCT00379808|101783058|FG000|STARTED|Intervention Period 2 (4 Weeks)||11||
48592271|NCT00379808|101783059|FG001|STARTED|Intervention Period 2 (4 Weeks)||11||
48592272|NCT00379808|101783058|FG000|COMPLETED|Intervention Period 2 (4 Weeks)||11||
48592273|NCT00379808|101783059|FG001|COMPLETED|Intervention Period 2 (4 Weeks)||10||
48592274|NCT00379808|101783058|FG000|NOT COMPLETED|Intervention Period 2 (4 Weeks)||0||
48592275|NCT00379808|101783059|FG001|NOT COMPLETED|Intervention Period 2 (4 Weeks)||1||
48592276|NCT01834716|101783060|FG000|STARTED|Overall Study||4||
48592277|NCT01834716|101783061|FG001|STARTED|Overall Study||12||
48592278|NCT01834716|101783060|FG000|COMPLETED|Overall Study||4||
48592279|NCT01834716|101783061|FG001|COMPLETED|Overall Study||11||
48592280|NCT01834716|101783060|FG000|NOT COMPLETED|Overall Study||0||
48592281|NCT01834716|101783061|FG001|NOT COMPLETED|Overall Study||1||
48592282|NCT02071810|101783062|FG000|STARTED|Overall Study||6||
48592283|NCT02071810|101783063|FG001|STARTED|Overall Study||6||
48592284|NCT02071810|101783064|FG002|STARTED|Overall Study||6||
48592285|NCT02071810|101783065|FG003|STARTED|Overall Study||7||
48592286|NCT02071810|101783066|FG004|STARTED|Overall Study||9||
48592287|NCT02071810|101783062|FG000|COMPLETED|Overall Study||6||
48592288|NCT02071810|101783063|FG001|COMPLETED|Overall Study||6||
48592289|NCT02071810|101783064|FG002|COMPLETED|Overall Study||6||
48592290|NCT02071810|101783065|FG003|COMPLETED|Overall Study||6||
48592291|NCT02071810|101783066|FG004|COMPLETED|Overall Study||8||
48592292|NCT02071810|101783062|FG000|NOT COMPLETED|Overall Study||0||
48592293|NCT02071810|101783063|FG001|NOT COMPLETED|Overall Study||0||
48592294|NCT02071810|101783064|FG002|NOT COMPLETED|Overall Study||0||
48592295|NCT02071810|101783065|FG003|NOT COMPLETED|Overall Study||1||
48592296|NCT02071810|101783066|FG004|NOT COMPLETED|Overall Study||1||
48592297|NCT03124121|101783067|FG000|STARTED|Overall Study||42||
48592298|NCT03124121|101783068|FG001|STARTED|Overall Study||70||
48592299|NCT03124121|101783067|FG000|COMPLETED|Overall Study||39||
48592300|NCT03124121|101783068|FG001|COMPLETED|Overall Study||67||
48592301|NCT03124121|101783067|FG000|NOT COMPLETED|Overall Study||3||
48592302|NCT03124121|101783068|FG001|NOT COMPLETED|Overall Study||3||
48592303|NCT05210101|101783069|FG000|STARTED|Overall Study||93||
48592304|NCT05210101|101783069|FG000|COMPLETED|Overall Study||88||
48592305|NCT05210101|101783069|FG000|NOT COMPLETED|Overall Study||5||
48592306|NCT03840148|101783070|FG000|STARTED|Study Drug Disposition||441||
48710226|NCT01448824|102077941|FG002|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||4||
48710227|NCT01448824|102077942|FG003|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0||
48710228|NCT01448824|102077943|FG004|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0||
48710229|NCT01448824|102077944|FG005|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0||
48710780|NCT01215110|102078016|FG000|STARTED|Overall Study||15||
48710230|NCT01448824|102077945|FG006|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0||
48710231|NCT01448824|102077946|FG007|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0||
48710232|NCT01448824|102077939|FG000|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||11||
48710233|NCT01448824|102077940|FG001|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||4||
48710234|NCT01448824|102077941|FG002|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||4||
48710235|NCT01448824|102077942|FG003|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0||
48710236|NCT01448824|102077943|FG004|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0||
48710237|NCT01448824|102077944|FG005|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0||
48710238|NCT01448824|102077945|FG006|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0||
48710239|NCT01448824|102077946|FG007|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0||
48710240|NCT01448824|102077939|FG000|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0||
48710241|NCT01448824|102077940|FG001|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0||
48710242|NCT01448824|102077941|FG002|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0||
48710243|NCT01448824|102077942|FG003|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0||
48710244|NCT01448824|102077943|FG004|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0||
48710245|NCT01448824|102077944|FG005|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0||
48710246|NCT01448824|102077945|FG006|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0||
48710247|NCT01448824|102077946|FG007|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0||
48710248|NCT01448824|102077939|FG000|STARTED|Part 2 Period 1: Drug-drug Interaction||0||
48710249|NCT01448824|102077940|FG001|STARTED|Part 2 Period 1: Drug-drug Interaction||0||
48710250|NCT01448824|102077941|FG002|STARTED|Part 2 Period 1: Drug-drug Interaction||0||
48710251|NCT01448824|102077942|FG003|STARTED|Part 2 Period 1: Drug-drug Interaction||0||
48710252|NCT01448824|102077943|FG004|STARTED|Part 2 Period 1: Drug-drug Interaction||0||
48710253|NCT01448824|102077944|FG005|STARTED|Part 2 Period 1: Drug-drug Interaction||0||
48710254|NCT01448824|102077945|FG006|STARTED|Part 2 Period 1: Drug-drug Interaction||0||
48710255|NCT01448824|102077946|FG007|STARTED|Part 2 Period 1: Drug-drug Interaction||12||
48710256|NCT01448824|102077939|FG000|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0||
48710257|NCT01448824|102077940|FG001|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0||
48710258|NCT01448824|102077941|FG002|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0||
48710259|NCT01448824|102077942|FG003|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0||
48710260|NCT01448824|102077943|FG004|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0||
48592307|NCT03840148|101783071|FG001|STARTED|Study Drug Disposition||220||
48592308|NCT03840148|101783070|FG000|COMPLETED|Study Drug Disposition||414|Randomized patients that completed study drug treatment.|
48592309|NCT03840148|101783071|FG001|COMPLETED|Study Drug Disposition||212|Randomized patients that completed study drug treatment.|
48592310|NCT03840148|101783070|FG000|NOT COMPLETED|Study Drug Disposition||27||
48293939|NCT01079130|101047482|FG000|COMPLETED|Overall Study||83||
48293940|NCT01079130|101047483|FG001|COMPLETED|Overall Study||78||
48293941|NCT01079130|101047484|FG002|COMPLETED|Overall Study||83||
48293942|NCT01079130|101047485|FG003|COMPLETED|Overall Study||81||
48293943|NCT01079130|101047486|FG004|COMPLETED|Overall Study||78||
48592311|NCT03840148|101783071|FG001|NOT COMPLETED|Study Drug Disposition||8||
48592312|NCT03840148|101783070|FG000|STARTED|Study Completion Disposition||441|The patients in this period are inclusive of those patients that either completed or did not complete the Study Drug Disposition period.|
48592313|NCT03840148|101783071|FG001|STARTED|Study Completion Disposition||220|The patients in this period are inclusive of those patients that either completed or did not complete the Study Drug Disposition period.|
48710261|NCT01448824|102077944|FG005|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0||
48710262|NCT01448824|102077945|FG006|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0||
48710263|NCT01448824|102077946|FG007|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||12||
48710264|NCT01448824|102077939|FG000|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0||
48293944|NCT01079130|101047487|FG005|COMPLETED|Overall Study||80||
48592854|NCT02059434|101786332|FG007|STARTED|Period 1 (After Screening/run-in Period)||3||
48710265|NCT01448824|102077940|FG001|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0||
48710266|NCT01448824|102077941|FG002|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0||
48710267|NCT01448824|102077942|FG003|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0||
48710268|NCT01448824|102077943|FG004|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0||
48710269|NCT01448824|102077944|FG005|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0||
48710270|NCT01448824|102077945|FG006|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0||
48710271|NCT01448824|102077946|FG007|COMPLETED|Part 2 Period 1: Drug-drug Interaction||11||
48710272|NCT01448824|102077939|FG000|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0||
48710273|NCT01448824|102077940|FG001|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0||
48710274|NCT01448824|102077941|FG002|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0||
48710275|NCT01448824|102077942|FG003|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0||
48293945|NCT01079130|101047482|FG000|NOT COMPLETED|Overall Study||2||
48293946|NCT01079130|101047483|FG001|NOT COMPLETED|Overall Study||7||
48293947|NCT01079130|101047484|FG002|NOT COMPLETED|Overall Study||1||
48710276|NCT01448824|102077943|FG004|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0||
48710277|NCT01448824|102077944|FG005|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0||
48710278|NCT01448824|102077945|FG006|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0||
48710279|NCT01448824|102077946|FG007|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||1||
48710280|NCT01448824|102077939|FG000|STARTED|Part 2: Washout Period||0||
48710281|NCT01448824|102077940|FG001|STARTED|Part 2: Washout Period||0||
48710282|NCT01448824|102077941|FG002|STARTED|Part 2: Washout Period||0||
48710283|NCT01448824|102077942|FG003|STARTED|Part 2: Washout Period||0||
48710284|NCT01448824|102077943|FG004|STARTED|Part 2: Washout Period||0||
48710285|NCT01448824|102077944|FG005|STARTED|Part 2: Washout Period||0||
48710286|NCT01448824|102077945|FG006|STARTED|Part 2: Washout Period||0||
48710287|NCT01448824|102077946|FG007|STARTED|Part 2: Washout Period||11||
48710288|NCT01448824|102077939|FG000|COMPLETED|Part 2: Washout Period||0||
48710289|NCT01448824|102077940|FG001|COMPLETED|Part 2: Washout Period||0||
48592314|NCT03840148|101783070|FG000|COMPLETED|Study Completion Disposition||426|Randomized patients that completed the Late Follow-up Visit.|
48592315|NCT03840148|101783071|FG001|COMPLETED|Study Completion Disposition||214|Randomized patients that completed the Late Follow-up Visit.|
48592316|NCT03840148|101783070|FG000|NOT COMPLETED|Study Completion Disposition||15||
48592317|NCT03840148|101783071|FG001|NOT COMPLETED|Study Completion Disposition||6||
48592318|NCT00980174|101783072|FG000|STARTED|Overall Study||121||
48592319|NCT00980174|101783073|FG001|STARTED|Overall Study||121||
48710290|NCT01448824|102077941|FG002|COMPLETED|Part 2: Washout Period||0||
48710291|NCT01448824|102077942|FG003|COMPLETED|Part 2: Washout Period||0||
48710292|NCT01448824|102077943|FG004|COMPLETED|Part 2: Washout Period||0||
48710293|NCT01448824|102077944|FG005|COMPLETED|Part 2: Washout Period||0||
48710294|NCT01448824|102077945|FG006|COMPLETED|Part 2: Washout Period||0||
48710295|NCT01448824|102077946|FG007|COMPLETED|Part 2: Washout Period||11||
48710296|NCT01448824|102077939|FG000|NOT COMPLETED|Part 2: Washout Period||0||
48710297|NCT01448824|102077940|FG001|NOT COMPLETED|Part 2: Washout Period||0||
48710298|NCT01448824|102077941|FG002|NOT COMPLETED|Part 2: Washout Period||0||
48710299|NCT01448824|102077942|FG003|NOT COMPLETED|Part 2: Washout Period||0||
48710300|NCT01448824|102077943|FG004|NOT COMPLETED|Part 2: Washout Period||0||
48710301|NCT01448824|102077944|FG005|NOT COMPLETED|Part 2: Washout Period||0||
48710302|NCT01448824|102077945|FG006|NOT COMPLETED|Part 2: Washout Period||0||
48710303|NCT01448824|102077946|FG007|NOT COMPLETED|Part 2: Washout Period||0||
48710304|NCT01448824|102077939|FG000|STARTED|Part 2 Period 2: Drug-drug Interaction||0||
48710305|NCT01448824|102077940|FG001|STARTED|Part 2 Period 2: Drug-drug Interaction||0||
48710306|NCT01448824|102077941|FG002|STARTED|Part 2 Period 2: Drug-drug Interaction||0||
48710307|NCT01448824|102077942|FG003|STARTED|Part 2 Period 2: Drug-drug Interaction||0||
48710308|NCT01448824|102077943|FG004|STARTED|Part 2 Period 2: Drug-drug Interaction||0||
48710309|NCT01448824|102077944|FG005|STARTED|Part 2 Period 2: Drug-drug Interaction||0||
48293948|NCT01079130|101047485|FG003|NOT COMPLETED|Overall Study||5||
48293949|NCT01079130|101047486|FG004|NOT COMPLETED|Overall Study||8||
48592320|NCT00980174|101783072|FG000|COMPLETED|Overall Study||117||
48592321|NCT00980174|101783073|FG001|COMPLETED|Overall Study||111||
48592322|NCT00980174|101783072|FG000|NOT COMPLETED|Overall Study||4||
48710310|NCT01448824|102077945|FG006|STARTED|Part 2 Period 2: Drug-drug Interaction||0||
48710311|NCT01448824|102077946|FG007|STARTED|Part 2 Period 2: Drug-drug Interaction||11||
48710312|NCT01448824|102077939|FG000|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0||
48710313|NCT01448824|102077940|FG001|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0||
48710314|NCT01448824|102077941|FG002|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0||
48710315|NCT01448824|102077942|FG003|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0||
48710316|NCT01448824|102077943|FG004|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0||
48710317|NCT01448824|102077944|FG005|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0||
48710318|NCT01448824|102077945|FG006|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0||
48710319|NCT01448824|102077946|FG007|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||11||
48710320|NCT01448824|102077939|FG000|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0||
48710321|NCT01448824|102077940|FG001|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0||
48710322|NCT01448824|102077941|FG002|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0||
48710323|NCT01448824|102077942|FG003|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0||
48710324|NCT01448824|102077943|FG004|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0||
48710325|NCT01448824|102077944|FG005|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0||
48710326|NCT01448824|102077945|FG006|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0||
48710327|NCT01448824|102077946|FG007|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||10||
48710328|NCT01448824|102077939|FG000|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0||
48710329|NCT01448824|102077940|FG001|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0||
48293950|NCT01079130|101047487|FG005|NOT COMPLETED|Overall Study||5||
48592323|NCT00980174|101783073|FG001|NOT COMPLETED|Overall Study||10||
48592324|NCT01966419|101783074|FG000|STARTED|Overall Study||115||
48592325|NCT01966419|101783075|FG001|STARTED|Overall Study||116||
48293951|NCT01720173|101047488|FG000|STARTED|Overall Study||30||
48140888|NCT01880424|100670288|FG001|COMPLETED|Overall Study||367||
48140889|NCT01880424|100670287|FG000|NOT COMPLETED|Overall Study||33||
48140890|NCT01880424|100670288|FG001|NOT COMPLETED|Overall Study||55||
48140891|NCT00325468|100670289|FG000|STARTED|Overall Study||23||
48140892|NCT00325468|100670290|FG001|STARTED|Overall Study||17||
48140893|NCT00325468|100670291|FG002|STARTED|Overall Study||14||
48140894|NCT00325468|100670292|FG003|STARTED|Overall Study||124||
48140895|NCT00325468|100670293|FG004|STARTED|Overall Study||22||
48293952|NCT01720173|101047488|FG000|COMPLETED|Overall Study||30|Eligible and treated patients.|
48293953|NCT01720173|101047488|FG000|NOT COMPLETED|Overall Study||0||
48293954|NCT00927160|101047489|FG000|STARTED|Overall Study||173||
48293955|NCT00927160|101047490|FG001|STARTED|Overall Study||173||
48293956|NCT00927160|101047489|FG000|COMPLETED|Overall Study||173||
48293957|NCT00927160|101047490|FG001|COMPLETED|Overall Study||173||
48293958|NCT00927160|101047489|FG000|NOT COMPLETED|Overall Study||0||
48293959|NCT00927160|101047490|FG001|NOT COMPLETED|Overall Study||0||
48293960|NCT04751656|101047491|FG000|STARTED|Overall Study||39||
48293961|NCT04751656|101047491|FG000|COMPLETED|Overall Study||38||
48293962|NCT04751656|101047491|FG000|NOT COMPLETED|Overall Study||1||
48293963|NCT00709696|101047492|FG000|STARTED|Overall Study||4||
48293964|NCT00709696|101047493|FG001|STARTED|Overall Study||3||
48293965|NCT00709696|101047492|FG000|COMPLETED|Overall Study||4||
48293966|NCT00709696|101047493|FG001|COMPLETED|Overall Study||3||
48293967|NCT00709696|101047492|FG000|NOT COMPLETED|Overall Study||0||
48293968|NCT00709696|101047493|FG001|NOT COMPLETED|Overall Study||0||
48293969|NCT00609765|101047494|FG000|STARTED|Overall Study||1||
48293970|NCT00609765|101047494|FG000|COMPLETED|Overall Study||0||
48293971|NCT00609765|101047494|FG000|NOT COMPLETED|Overall Study||1||
48140896|NCT00325468|100670289|FG000|COMPLETED|Overall Study||12||
48140897|NCT00325468|100670290|FG001|COMPLETED|Overall Study||12||
48140898|NCT00325468|100670291|FG002|COMPLETED|Overall Study||10||
48140899|NCT00325468|100670292|FG003|COMPLETED|Overall Study||90||
48140900|NCT00325468|100670293|FG004|COMPLETED|Overall Study||14||
48140901|NCT00325468|100670289|FG000|NOT COMPLETED|Overall Study||11||
48140902|NCT00325468|100670290|FG001|NOT COMPLETED|Overall Study||5||
48140903|NCT00325468|100670291|FG002|NOT COMPLETED|Overall Study||4||
48293972|NCT04633551|101047495|FG000|STARTED|Overall Study||6||
48293973|NCT04633551|101047496|FG001|STARTED|Overall Study||3||
48293974|NCT04633551|101047495|FG000|COMPLETED|Overall Study||5||
48293975|NCT04633551|101047496|FG001|COMPLETED|Overall Study||3||
48293976|NCT04633551|101047495|FG000|NOT COMPLETED|Overall Study||1||
48293977|NCT04633551|101047496|FG001|NOT COMPLETED|Overall Study||0||
48140904|NCT00325468|100670292|FG003|NOT COMPLETED|Overall Study||34||
48140905|NCT00325468|100670293|FG004|NOT COMPLETED|Overall Study||8||
48140906|NCT02955511|100670294|FG000|STARTED|Overall Study||1||
48140907|NCT02955511|100670295|FG001|STARTED|Overall Study||3||
48140908|NCT02955511|100670296|FG002|STARTED|Overall Study||1||
48140909|NCT02955511|100670294|FG000|COMPLETED|Overall Study||1||
48140910|NCT02955511|100670295|FG001|COMPLETED|Overall Study||3||
48140911|NCT02955511|100670296|FG002|COMPLETED|Overall Study||1||
48140912|NCT02955511|100670294|FG000|NOT COMPLETED|Overall Study||0||
48140913|NCT02955511|100670295|FG001|NOT COMPLETED|Overall Study||0||
48140914|NCT02955511|100670296|FG002|NOT COMPLETED|Overall Study||0||
48140915|NCT00373334|100670297|FG000|STARTED|Overall Study||43||
48140916|NCT00373334|100670298|FG001|STARTED|Overall Study||50||
48140917|NCT00373334|100670299|FG002|STARTED|Overall Study||45||
48140918|NCT00373334|100670297|FG000|COMPLETED|Overall Study||33||
48140919|NCT00373334|100670298|FG001|COMPLETED|Overall Study||32||
48140920|NCT00373334|100670299|FG002|COMPLETED|Overall Study||32||
48140921|NCT00373334|100670297|FG000|NOT COMPLETED|Overall Study||10||
48140922|NCT00373334|100670298|FG001|NOT COMPLETED|Overall Study||18||
48140923|NCT00373334|100670299|FG002|NOT COMPLETED|Overall Study||13||
48140924|NCT02081846|100670300|FG000|STARTED|Overall Study||751||
48140925|NCT02081846|100670301|FG001|STARTED|Overall Study||749||
48140926|NCT02081846|100670300|FG000|COMPLETED|Overall Study||749||
48140927|NCT02081846|100670301|FG001|COMPLETED|Overall Study||749||
48140928|NCT02081846|100670300|FG000|NOT COMPLETED|Overall Study||2||
48140929|NCT02081846|100670301|FG001|NOT COMPLETED|Overall Study||0||
48140930|NCT04460742|100670302|FG000|STARTED|Overall Study||16||
48140931|NCT04460742|100670303|FG001|STARTED|Overall Study||15||
48140932|NCT04460742|100670302|FG000|COMPLETED|Overall Study||14||
48140933|NCT04460742|100670303|FG001|COMPLETED|Overall Study||14||
48140934|NCT04460742|100670302|FG000|NOT COMPLETED|Overall Study||2||
48140935|NCT04460742|100670303|FG001|NOT COMPLETED|Overall Study||1||
48140936|NCT01808690|100670304|FG000|STARTED|Overall Study||25||
48140937|NCT01808690|100670305|FG001|STARTED|Overall Study||23||
48140938|NCT01808690|100670304|FG000|COMPLETED|Overall Study||24||
48140939|NCT01808690|100670305|FG001|COMPLETED|Overall Study||21||
48592326|NCT01966419|101783074|FG000|Intent to Treat Population (ITT)T)115|Overall Study||115||
48592327|NCT01966419|101783075|FG001|Intent to Treat Population (ITT)T)115|Overall Study||116||
48592328|NCT01966419|101783074|FG000|Safety Analysis Set (SAS)|Overall Study||112||
48592329|NCT01966419|101783075|FG001|Safety Analysis Set (SAS)|Overall Study||114||
48140940|NCT01808690|100670304|FG000|NOT COMPLETED|Overall Study||1||
48140941|NCT01808690|100670305|FG001|NOT COMPLETED|Overall Study||2||
48140942|NCT00727272|100670306|FG000|STARTED|Period I||9||
48140943|NCT00727272|100670307|FG001|STARTED|Period I||9||
48140944|NCT00727272|100670308|FG002|STARTED|Period I||9||
48140945|NCT00727272|100670306|FG000|COMPLETED|Period I||9||
48140946|NCT00727272|100670307|FG001|COMPLETED|Period I||9||
48140947|NCT00727272|100670308|FG002|COMPLETED|Period I||9||
48140948|NCT00727272|100670306|FG000|NOT COMPLETED|Period I||0||
48140949|NCT00727272|100670307|FG001|NOT COMPLETED|Period I||0||
48140950|NCT00727272|100670308|FG002|NOT COMPLETED|Period I||0||
48140951|NCT00727272|100670306|FG000|STARTED|Washout Period A||9||
48140952|NCT00727272|100670307|FG001|STARTED|Washout Period A||9||
48140953|NCT00727272|100670308|FG002|STARTED|Washout Period A||9||
48140954|NCT00727272|100670306|FG000|COMPLETED|Washout Period A||9||
48140955|NCT00727272|100670307|FG001|COMPLETED|Washout Period A||9||
48140956|NCT00727272|100670308|FG002|COMPLETED|Washout Period A||8||
48140957|NCT00727272|100670306|FG000|NOT COMPLETED|Washout Period A||0||
48140958|NCT00727272|100670307|FG001|NOT COMPLETED|Washout Period A||0||
48140959|NCT00727272|100670308|FG002|NOT COMPLETED|Washout Period A||1||
48140960|NCT00727272|100670306|FG000|STARTED|Period II||9||
48140961|NCT00727272|100670307|FG001|STARTED|Period II||9||
48140962|NCT00727272|100670308|FG002|STARTED|Period II||8||
48140963|NCT00727272|100670306|FG000|COMPLETED|Period II||9||
48140964|NCT00727272|100670307|FG001|COMPLETED|Period II||9||
48140965|NCT00727272|100670308|FG002|COMPLETED|Period II||8||
48140966|NCT00727272|100670306|FG000|NOT COMPLETED|Period II||0||
48140967|NCT00727272|100670307|FG001|NOT COMPLETED|Period II||0||
48140968|NCT00727272|100670308|FG002|NOT COMPLETED|Period II||0||
48140969|NCT00727272|100670306|FG000|STARTED|Washout Period B||9||
48140970|NCT00727272|100670307|FG001|STARTED|Washout Period B||9||
48140971|NCT00727272|100670308|FG002|STARTED|Washout Period B||8||
48140972|NCT00727272|100670306|FG000|COMPLETED|Washout Period B||9||
48140973|NCT00727272|100670307|FG001|COMPLETED|Washout Period B||9||
48140974|NCT00727272|100670308|FG002|COMPLETED|Washout Period B||7||
48140975|NCT00727272|100670306|FG000|NOT COMPLETED|Washout Period B||0||
48140976|NCT00727272|100670307|FG001|NOT COMPLETED|Washout Period B||0||
48140977|NCT00727272|100670308|FG002|NOT COMPLETED|Washout Period B||1||
48140978|NCT00727272|100670306|FG000|STARTED|Period III||9||
48140979|NCT00727272|100670307|FG001|STARTED|Period III||9||
48140980|NCT00727272|100670308|FG002|STARTED|Period III||7||
48140981|NCT00727272|100670306|FG000|COMPLETED|Period III||9||
48140982|NCT00727272|100670307|FG001|COMPLETED|Period III||9||
48140983|NCT00727272|100670308|FG002|COMPLETED|Period III||7||
48140984|NCT00727272|100670306|FG000|NOT COMPLETED|Period III||0||
48140985|NCT00727272|100670307|FG001|NOT COMPLETED|Period III||0||
48140986|NCT00727272|100670308|FG002|NOT COMPLETED|Period III||0||
48140987|NCT00526123|100670309|FG000|STARTED|Overall Study||303||
48140988|NCT00526123|100670310|FG001|STARTED|Overall Study||296||
48140989|NCT00526123|100670309|FG000|COMPLETED|Overall Study||39||
48140990|NCT00526123|100670310|FG001|COMPLETED|Overall Study||50||
48140991|NCT00526123|100670309|FG000|NOT COMPLETED|Overall Study||264||
48140992|NCT00526123|100670310|FG001|NOT COMPLETED|Overall Study||246||
48140993|NCT01904448|100670311|FG000|STARTED|Overall Study||5||
48140994|NCT01904448|100670311|FG000|COMPLETED|Overall Study||5||
48140995|NCT01904448|100670311|FG000|NOT COMPLETED|Overall Study||0||
48140996|NCT03341910|100670312|FG000|STARTED|Overall Study||54||
48140997|NCT03341910|100670313|FG001|STARTED|Overall Study||49||
48403949|NCT00367341|101321735|FG000|COMPLETED|Overall Study||40||
48403950|NCT00367341|101321736|FG001|COMPLETED|Overall Study||40||
48403951|NCT00367341|101321735|FG000|NOT COMPLETED|Overall Study||2||
48403952|NCT00367341|101321736|FG001|NOT COMPLETED|Overall Study||0||
48403953|NCT03561246|101321737|FG000|STARTED|Overall Study||19||
48403954|NCT03561246|101321738|FG001|STARTED|Overall Study||19||
48293978|NCT01093521|101047497|FG000|STARTED|Overall Study||20||
48293979|NCT01093521|101047497|FG000|COMPLETED|Overall Study||20||
48293980|NCT01093521|101047497|FG000|NOT COMPLETED|Overall Study||0||
48293981|NCT00210470|101047498|FG000|STARTED|Overall Study||27||
48293982|NCT00210470|101047498|FG000|COMPLETED|Overall Study||27||
48293983|NCT00210470|101047498|FG000|NOT COMPLETED|Overall Study||0||
48293984|NCT03481023|101047499|FG000|STARTED|Overall Study||3||
48293985|NCT03481023|101047500|FG001|STARTED|Overall Study||3||
48293986|NCT03481023|101047499|FG000|COMPLETED|Overall Study||3||
48293987|NCT03481023|101047500|FG001|COMPLETED|Overall Study||3||
48293988|NCT03481023|101047499|FG000|NOT COMPLETED|Overall Study||0||
48403955|NCT03561246|101321739|FG002|STARTED|Overall Study||17||
48140998|NCT03341910|100670314|FG002|STARTED|Overall Study||26||
48140999|NCT03341910|100670315|FG003|STARTED|Overall Study||26||
48293989|NCT03481023|101047500|FG001|NOT COMPLETED|Overall Study||0||
48293990|NCT00985946|101047501|FG000|STARTED|Overall Study||15||
48293991|NCT00985946|101047501|FG000|COMPLETED|Overall Study||8||
48293992|NCT00985946|101047501|FG000|NOT COMPLETED|Overall Study||7||
48293993|NCT01765465|101047502|FG000|STARTED|Overall Study||71||
48293994|NCT01765465|101047503|FG001|STARTED|Overall Study||67||
48293995|NCT01765465|101047502|FG000|COMPLETED|Overall Study||64||
48293996|NCT01765465|101047503|FG001|COMPLETED|Overall Study||63||
48293997|NCT01765465|101047502|FG000|NOT COMPLETED|Overall Study||7||
48293998|NCT01765465|101047503|FG001|NOT COMPLETED|Overall Study||4||
48293999|NCT05220254|101047504|FG000|STARTED|Overall Study||20||
48294000|NCT05220254|101047504|FG000|Used the MindCotine Intervention|Overall Study||9||
48294001|NCT05220254|101047504|FG000|Completed End of Treatment Survey|Overall Study||8||
48294002|NCT05220254|101047504|FG000|COMPLETED|Overall Study||8||
48294003|NCT05220254|101047504|FG000|NOT COMPLETED|Overall Study||12||
48294004|NCT02208999|101047505|FG000|STARTED|Overall Study||106||
48294005|NCT02208999|101047505|FG000|COMPLETED|Overall Study||105||
48294006|NCT02208999|101047505|FG000|NOT COMPLETED|Overall Study||1||
48294007|NCT03240874|101047506|FG000|STARTED|Overall Study||16||
48294008|NCT03240874|101047507|FG001|STARTED|Overall Study||24||
48403956|NCT03561246|101321737|FG000|COMPLETED|Overall Study||19||
48403957|NCT03561246|101321738|FG001|COMPLETED|Overall Study||18||
48403958|NCT03561246|101321739|FG002|COMPLETED|Overall Study||17||
48403959|NCT03561246|101321737|FG000|NOT COMPLETED|Overall Study||0||
48403960|NCT03561246|101321738|FG001|NOT COMPLETED|Overall Study||1||
48403961|NCT03561246|101321739|FG002|NOT COMPLETED|Overall Study||0||
48403962|NCT01856855|101321740|FG000|STARTED|Overall Study||26||
48403963|NCT01856855|101321740|FG000|COMPLETED|Overall Study||26||
48403964|NCT01856855|101321740|FG000|NOT COMPLETED|Overall Study||0||
48403965|NCT03613818|101321741|FG000|STARTED|Overall Study||174||
48403966|NCT03613818|101321742|FG001|STARTED|Overall Study||137||
48403967|NCT03613818|101321741|FG000|COMPLETED|Overall Study||137||
48403968|NCT03613818|101321742|FG001|COMPLETED|Overall Study||110||
48403969|NCT03613818|101321741|FG000|NOT COMPLETED|Overall Study||37||
48403970|NCT03613818|101321742|FG001|NOT COMPLETED|Overall Study||27||
48141000|NCT03341910|100670312|FG000|COMPLETED|Overall Study||54||
48294009|NCT03240874|101047508|FG002|STARTED|Overall Study||30||
48294010|NCT03240874|101047509|FG003|STARTED|Overall Study||10||
48294011|NCT03240874|101047506|FG000|COMPLETED|Overall Study||16||
48403971|NCT03296280|101321743|FG000|STARTED|Overall Study||73||
48403972|NCT03296280|101321744|FG001|STARTED|Overall Study||43||
48403973|NCT03296280|101321743|FG000|COMPLETED|Overall Study||67||
48403974|NCT03296280|101321744|FG001|COMPLETED|Overall Study||36||
48403975|NCT03296280|101321743|FG000|NOT COMPLETED|Overall Study||6||
48403976|NCT03296280|101321744|FG001|NOT COMPLETED|Overall Study||7||
48141001|NCT03341910|100670313|FG001|COMPLETED|Overall Study||49||
48403977|NCT00250497|101321745|FG000|STARTED|Overall Study||182||
48403978|NCT00250497|101321746|FG001|STARTED|Overall Study||174||
48141002|NCT03341910|100670314|FG002|COMPLETED|Overall Study||26||
48141003|NCT03341910|100670315|FG003|COMPLETED|Overall Study||26||
48294012|NCT03240874|101047507|FG001|COMPLETED|Overall Study||22||
48294013|NCT03240874|101047508|FG002|COMPLETED|Overall Study||26||
48294014|NCT03240874|101047509|FG003|COMPLETED|Overall Study||9||
48294015|NCT03240874|101047506|FG000|NOT COMPLETED|Overall Study||0||
48294016|NCT03240874|101047507|FG001|NOT COMPLETED|Overall Study||2||
48403979|NCT00250497|101321745|FG000|COMPLETED|Overall Study||177||
48141004|NCT03341910|100670312|FG000|NOT COMPLETED|Overall Study||0||
48141005|NCT03341910|100670313|FG001|NOT COMPLETED|Overall Study||0||
48141006|NCT03341910|100670314|FG002|NOT COMPLETED|Overall Study||0||
48141007|NCT03341910|100670315|FG003|NOT COMPLETED|Overall Study||0||
48141008|NCT02105116|100670316|FG000|STARTED|Overall Study||6||
48141009|NCT02105116|100670316|FG000|COMPLETED|Overall Study||0||
48141010|NCT02105116|100670316|FG000|NOT COMPLETED|Overall Study||6||
48141011|NCT00722761|100670317|FG000|STARTED|Overall Study||16||
48141012|NCT00722761|100670318|FG001|STARTED|Overall Study||14||
48141013|NCT00722761|100670317|FG000|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||15||
48141014|NCT00722761|100670318|FG001|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||10||
48141015|NCT00722761|100670317|FG000|COMPLETED|Overall Study||10||
48141016|NCT00722761|100670318|FG001|COMPLETED|Overall Study||8||
48141017|NCT00722761|100670317|FG000|NOT COMPLETED|Overall Study||6||
48141018|NCT00722761|100670318|FG001|NOT COMPLETED|Overall Study||6||
48141019|NCT03319277|100670319|FG000|STARTED|Overall Study||59||
48141020|NCT03319277|100670320|FG001|STARTED|Overall Study||59||
48141021|NCT03319277|100670319|FG000|COMPLETED|Overall Study||59||
48141022|NCT03319277|100670320|FG001|COMPLETED|Overall Study||59||
48141023|NCT03319277|100670319|FG000|NOT COMPLETED|Overall Study||0||
48141024|NCT03319277|100670320|FG001|NOT COMPLETED|Overall Study||0||
48141025|NCT01673802|100670321|FG000|STARTED|Gadoxetate Standard Dose 0.025 mmol/kg||8||
48141026|NCT01673802|100670321|FG000|COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||8||
48141027|NCT01673802|100670321|FG000|NOT COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||0||
48141028|NCT01673802|100670321|FG000|STARTED|Gadoxetate Double Dose 0.050 mmol/kg||10||
48141029|NCT01673802|100670321|FG000|COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||10||
48141030|NCT01673802|100670321|FG000|NOT COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||0||
48141031|NCT00440050|100670322|FG000|STARTED|Overall Study||164||
48141032|NCT00440050|100670323|FG001|STARTED|Overall Study||238||
48141033|NCT00440050|100670322|FG000|COMPLETED|Overall Study||124||
48141034|NCT00440050|100670323|FG001|COMPLETED|Overall Study||171||
48141035|NCT00440050|100670322|FG000|NOT COMPLETED|Overall Study||40||
48141036|NCT00440050|100670323|FG001|NOT COMPLETED|Overall Study||67||
48141037|NCT00924885|100670324|FG000|STARTED|Overall Study||129||
48141038|NCT00924885|100670325|FG001|STARTED|Overall Study||128||
48141039|NCT00924885|100670324|FG000|COMPLETED|Overall Study||126||
48141040|NCT00924885|100670325|FG001|COMPLETED|Overall Study||124||
48141041|NCT00924885|100670324|FG000|NOT COMPLETED|Overall Study||3||
48141042|NCT00924885|100670325|FG001|NOT COMPLETED|Overall Study||4||
48141043|NCT01587651|100670326|FG000|STARTED|Overall Study||34||
48141044|NCT01587651|100670327|FG001|STARTED|Overall Study||41||
48141045|NCT01587651|100670328|FG002|STARTED|Overall Study||35||
48141046|NCT01587651|100670326|FG000|COMPLETED|Overall Study||34||
48141047|NCT01587651|100670327|FG001|COMPLETED|Overall Study||38||
48141048|NCT01587651|100670328|FG002|COMPLETED|Overall Study||34||
48141049|NCT01587651|100670326|FG000|NOT COMPLETED|Overall Study||0||
48141050|NCT01587651|100670327|FG001|NOT COMPLETED|Overall Study||3||
48141051|NCT01587651|100670328|FG002|NOT COMPLETED|Overall Study||1||
48141052|NCT02277106|100670329|FG000|STARTED|Stage 1: Treatment Period 1||13||
48141053|NCT02277106|100670330|FG001|STARTED|Stage 1: Treatment Period 1||12||
48141054|NCT02277106|100670331|FG002|STARTED|Stage 1: Treatment Period 1||0||
48141055|NCT02277106|100670329|FG000|COMPLETED|Stage 1: Treatment Period 1||13||
48141056|NCT02277106|100670330|FG001|COMPLETED|Stage 1: Treatment Period 1||12||
48141057|NCT02277106|100670331|FG002|COMPLETED|Stage 1: Treatment Period 1||0||
48141058|NCT02277106|100670329|FG000|NOT COMPLETED|Stage 1: Treatment Period 1||0||
48141059|NCT02277106|100670330|FG001|NOT COMPLETED|Stage 1: Treatment Period 1||0||
48141060|NCT02277106|100670331|FG002|NOT COMPLETED|Stage 1: Treatment Period 1||0||
48141061|NCT02277106|100670329|FG000|STARTED|Washout||13||
48141062|NCT02277106|100670330|FG001|STARTED|Washout||12||
48141063|NCT02277106|100670331|FG002|STARTED|Washout||0||
48141064|NCT02277106|100670329|FG000|COMPLETED|Washout||13||
48141065|NCT02277106|100670330|FG001|COMPLETED|Washout||12||
48141066|NCT02277106|100670331|FG002|COMPLETED|Washout||0||
48141067|NCT02277106|100670329|FG000|NOT COMPLETED|Washout||0||
48141068|NCT02277106|100670330|FG001|NOT COMPLETED|Washout||0||
48141069|NCT02277106|100670331|FG002|NOT COMPLETED|Washout||0||
48141070|NCT02277106|100670329|FG000|STARTED|Stage 1: Treatment Period 2||13||
48141071|NCT02277106|100670330|FG001|STARTED|Stage 1: Treatment Period 2||12||
48141072|NCT02277106|100670331|FG002|STARTED|Stage 1: Treatment Period 2||0||
48141073|NCT02277106|100670329|FG000|COMPLETED|Stage 1: Treatment Period 2||13||
48141074|NCT02277106|100670330|FG001|COMPLETED|Stage 1: Treatment Period 2||12||
48141075|NCT02277106|100670331|FG002|COMPLETED|Stage 1: Treatment Period 2||0||
48141076|NCT02277106|100670329|FG000|NOT COMPLETED|Stage 1: Treatment Period 2||0||
48141077|NCT02277106|100670330|FG001|NOT COMPLETED|Stage 1: Treatment Period 2||0||
48141078|NCT02277106|100670331|FG002|NOT COMPLETED|Stage 1: Treatment Period 2||0||
48141079|NCT02277106|100670329|FG000|STARTED|Stage 2||0||
48141080|NCT02277106|100670330|FG001|STARTED|Stage 2||0||
48141081|NCT02277106|100670331|FG002|STARTED|Stage 2||17||
48141082|NCT02277106|100670329|FG000|COMPLETED|Stage 2||0||
48141083|NCT02277106|100670330|FG001|COMPLETED|Stage 2||0||
48141084|NCT02277106|100670331|FG002|COMPLETED|Stage 2||16||
48141085|NCT02277106|100670329|FG000|NOT COMPLETED|Stage 2||0||
48294017|NCT03240874|101047508|FG002|NOT COMPLETED|Overall Study||4||
48294018|NCT03240874|101047509|FG003|NOT COMPLETED|Overall Study||1||
48294019|NCT00896051|101047510|FG000|STARTED|Overall Study||25||
48294020|NCT00896051|101047511|FG001|STARTED|Overall Study||25||
48294021|NCT00896051|101047510|FG000|COMPLETED|Overall Study||15||
48294022|NCT00896051|101047511|FG001|COMPLETED|Overall Study||16||
48294023|NCT00896051|101047510|FG000|NOT COMPLETED|Overall Study||10||
48294024|NCT00896051|101047511|FG001|NOT COMPLETED|Overall Study||9||
48294025|NCT02216357|101047512|FG000|STARTED|Overall Study||14||
48294026|NCT02216357|101047513|FG001|STARTED|Overall Study||5||
48294027|NCT02216357|101047512|FG000|COMPLETED|Overall Study||12||
48294028|NCT02216357|101047513|FG001|COMPLETED|Overall Study||4||
48294029|NCT02216357|101047512|FG000|NOT COMPLETED|Overall Study||2||
48294030|NCT02216357|101047513|FG001|NOT COMPLETED|Overall Study||1||
48710330|NCT01448824|102077941|FG002|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0||
48710331|NCT01448824|102077942|FG003|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0||
48710332|NCT01448824|102077943|FG004|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0||
48710333|NCT01448824|102077944|FG005|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0||
48710334|NCT01448824|102077945|FG006|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0||
48710335|NCT01448824|102077946|FG007|COMPLETED|Part 2 Period 2: Drug-drug Interaction||8||
48710336|NCT01448824|102077939|FG000|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0||
48710337|NCT01448824|102077940|FG001|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0||
48710338|NCT01448824|102077941|FG002|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0||
48710339|NCT01448824|102077942|FG003|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0||
48294031|NCT02739360|101047514|FG000|STARTED|Overall Study||3||
48294032|NCT02739360|101047514|FG000|COMPLETED|Overall Study||0||
48294033|NCT02739360|101047514|FG000|NOT COMPLETED|Overall Study||3||
48294034|NCT02796560|101047515|FG000|STARTED|Overall Study||38||
48294035|NCT02796560|101047516|FG001|STARTED|Overall Study||38||
48294036|NCT02796560|101047515|FG000|COMPLETED|Overall Study||34||
48592330|NCT01966419|101783074|FG000|COMPLETED|Overall Study||74||
48592331|NCT01966419|101783075|FG001|COMPLETED|Overall Study||80||
48592332|NCT01966419|101783074|FG000|NOT COMPLETED|Overall Study||41||
48592333|NCT01966419|101783075|FG001|NOT COMPLETED|Overall Study||36||
48592334|NCT01343667|101783076|FG000|STARTED|Overall Study||425||
48592335|NCT01343667|101783077|FG001|STARTED|Overall Study||972||
48592336|NCT01343667|101783076|FG000|COMPLETED|Overall Study||413||
48592337|NCT01343667|101783077|FG001|COMPLETED|Overall Study||916||
48294037|NCT02796560|101047516|FG001|COMPLETED|Overall Study||36||
48294038|NCT02796560|101047515|FG000|NOT COMPLETED|Overall Study||4||
48294039|NCT02796560|101047516|FG001|NOT COMPLETED|Overall Study||2||
48294040|NCT03153137|101047517|FG000|STARTED|Overall Study||69||
48294041|NCT03153137|101047518|FG001|STARTED|Overall Study||68||
48294042|NCT03153137|101047517|FG000|COMPLETED|Overall Study||66||
48294043|NCT03153137|101047518|FG001|COMPLETED|Overall Study||64||
48294044|NCT03153137|101047517|FG000|NOT COMPLETED|Overall Study||3||
48294045|NCT03153137|101047518|FG001|NOT COMPLETED|Overall Study||4||
48294046|NCT00141726|101047519|FG000|STARTED|Overall Study||34||
48294047|NCT00141726|101047519|FG000|COMPLETED|Overall Study||31||
48294048|NCT00141726|101047519|FG000|NOT COMPLETED|Overall Study||3||
48294049|NCT00796120|101047520|FG000|STARTED|Overall Study||61||
48294050|NCT00796120|101047521|FG001|STARTED|Overall Study||60||
48294051|NCT00796120|101047520|FG000|Treated|Overall Study||61||
48294052|NCT00796120|101047521|FG001|Treated|Overall Study||57||
48592338|NCT01343667|101783076|FG000|NOT COMPLETED|Overall Study||12||
48592339|NCT01343667|101783077|FG001|NOT COMPLETED|Overall Study||56||
48294053|NCT00796120|101047520|FG000|COMPLETED|Overall Study||0||
48294054|NCT00796120|101047521|FG001|COMPLETED|Overall Study||0||
48294055|NCT00796120|101047520|FG000|NOT COMPLETED|Overall Study||61||
48294056|NCT00796120|101047521|FG001|NOT COMPLETED|Overall Study||60||
48592340|NCT04810247|101783078|FG000|STARTED|Overall Study||46||
48592341|NCT04810247|101783078|FG000|COMPLETED|Overall Study||39||
48592342|NCT04810247|101783078|FG000|NOT COMPLETED|Overall Study||7||
48294057|NCT02349360|101047522|FG000|STARTED|Overall Study||21||
48294058|NCT02349360|101047523|FG001|STARTED|Overall Study||21||
48294059|NCT02349360|101047522|FG000|COMPLETED|Overall Study||21||
48294060|NCT02349360|101047523|FG001|COMPLETED|Overall Study||20||
48592343|NCT04530591|101783079|FG000|STARTED|Overall Study||97||
48592344|NCT04530591|101783079|FG000|COMPLETED|Overall Study||97||
48592345|NCT04530591|101783079|FG000|NOT COMPLETED|Overall Study||0||
48592346|NCT00655473|101783080|FG000|STARTED|Overall Study||64||
48592347|NCT00655473|101783081|FG001|STARTED|Overall Study||66||
48592348|NCT00655473|101783080|FG000|COMPLETED|Overall Study||53||
48592349|NCT00655473|101783081|FG001|COMPLETED|Overall Study||51||
48592350|NCT00655473|101783080|FG000|NOT COMPLETED|Overall Study||11||
48592351|NCT00655473|101783081|FG001|NOT COMPLETED|Overall Study||15||
48592352|NCT02624388|101783082|FG000|STARTED|Overall Study||2||
48592353|NCT02624388|101783083|FG001|STARTED|Overall Study||2||
48592354|NCT02624388|101783082|FG000|COMPLETED|Overall Study||2||
48592355|NCT02624388|101783083|FG001|COMPLETED|Overall Study||2||
48592356|NCT02624388|101783082|FG000|NOT COMPLETED|Overall Study||0||
48592357|NCT02624388|101783083|FG001|NOT COMPLETED|Overall Study||0||
48592358|NCT00454818|101783084|FG000|STARTED|Phase I: Open-label Dose-escalation||3||
48592359|NCT00454818|101783085|FG001|STARTED|Phase I: Open-label Dose-escalation||3||
48592360|NCT00454818|101783086|FG002|STARTED|Phase I: Open-label Dose-escalation||3||
48592361|NCT00454818|101783087|FG003|STARTED|Phase I: Open-label Dose-escalation||3||
48592362|NCT00454818|101783088|FG004|STARTED|Phase I: Open-label Dose-escalation||0||
48592363|NCT00454818|101783084|FG000|COMPLETED|Phase I: Open-label Dose-escalation||2||
48592364|NCT00454818|101783085|FG001|COMPLETED|Phase I: Open-label Dose-escalation||2||
48592365|NCT00454818|101783086|FG002|COMPLETED|Phase I: Open-label Dose-escalation||2||
48592366|NCT00454818|101783087|FG003|COMPLETED|Phase I: Open-label Dose-escalation||2||
48592367|NCT00454818|101783088|FG004|COMPLETED|Phase I: Open-label Dose-escalation||0||
48592368|NCT00454818|101783084|FG000|NOT COMPLETED|Phase I: Open-label Dose-escalation||1||
48592369|NCT00454818|101783085|FG001|NOT COMPLETED|Phase I: Open-label Dose-escalation||1||
48592370|NCT00454818|101783086|FG002|NOT COMPLETED|Phase I: Open-label Dose-escalation||1||
48592371|NCT00454818|101783087|FG003|NOT COMPLETED|Phase I: Open-label Dose-escalation||1||
48592372|NCT00454818|101783088|FG004|NOT COMPLETED|Phase I: Open-label Dose-escalation||0||
48592373|NCT00454818|101783084|FG000|STARTED|Phase 2: Randomized Double-blind||0||
48710340|NCT01448824|102077943|FG004|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0||
48710341|NCT01448824|102077944|FG005|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0||
48710342|NCT01448824|102077945|FG006|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0||
48710343|NCT01448824|102077946|FG007|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||3||
48710344|NCT03060512|102077947|FG000|STARTED|Overall Study||137||
48710345|NCT03060512|102077948|FG001|STARTED|Overall Study||139||
48141086|NCT02277106|100670330|FG001|NOT COMPLETED|Stage 2||0||
48141087|NCT02277106|100670331|FG002|NOT COMPLETED|Stage 2||1||
48141088|NCT01854827|100670332|FG000|STARTED|Overall Study||30||
48592374|NCT00454818|101783085|FG001|STARTED|Phase 2: Randomized Double-blind||8||
48592375|NCT00454818|101783086|FG002|STARTED|Phase 2: Randomized Double-blind||8||
48592376|NCT00454818|101783087|FG003|STARTED|Phase 2: Randomized Double-blind||9||
48592377|NCT00454818|101783088|FG004|STARTED|Phase 2: Randomized Double-blind||14||
48592378|NCT00454818|101783084|FG000|COMPLETED|Phase 2: Randomized Double-blind||0||
48710346|NCT03060512|102077947|FG000|Treated With Movantik|Overall Study||136||
48710347|NCT03060512|102077948|FG001|Treated With Movantik|Overall Study||135||
48592379|NCT00454818|101783085|FG001|COMPLETED|Phase 2: Randomized Double-blind||6||
48592380|NCT00454818|101783086|FG002|COMPLETED|Phase 2: Randomized Double-blind||5||
48592381|NCT00454818|101783087|FG003|COMPLETED|Phase 2: Randomized Double-blind||8||
48592382|NCT00454818|101783088|FG004|COMPLETED|Phase 2: Randomized Double-blind||10||
48592383|NCT00454818|101783084|FG000|NOT COMPLETED|Phase 2: Randomized Double-blind||0||
48592384|NCT00454818|101783085|FG001|NOT COMPLETED|Phase 2: Randomized Double-blind||2||
48592385|NCT00454818|101783086|FG002|NOT COMPLETED|Phase 2: Randomized Double-blind||3||
48592386|NCT00454818|101783087|FG003|NOT COMPLETED|Phase 2: Randomized Double-blind||1||
48592387|NCT00454818|101783088|FG004|NOT COMPLETED|Phase 2: Randomized Double-blind||4||
48592388|NCT03738800|101783089|FG000|STARTED|Double-blind Treatment Period||23||
48592389|NCT03738800|101783090|FG001|STARTED|Double-blind Treatment Period||21||
48592390|NCT03738800|101783091|FG002|STARTED|Double-blind Treatment Period||21||
48592391|NCT03738800|101783089|FG000|COMPLETED|Double-blind Treatment Period||14||
48141089|NCT01854827|100670332|FG000|COMPLETED|Overall Study||29||
48141090|NCT01854827|100670332|FG000|NOT COMPLETED|Overall Study||1||
48141091|NCT00518115|100670333|FG000|STARTED|Overall Study||52||
48141092|NCT00518115|100670334|FG001|STARTED|Overall Study||35||
48141093|NCT00518115|100670335|FG002|STARTED|Overall Study||36||
48592392|NCT03738800|101783090|FG001|COMPLETED|Double-blind Treatment Period||18||
48592393|NCT03738800|101783091|FG002|COMPLETED|Double-blind Treatment Period||17||
48592394|NCT03738800|101783089|FG000|NOT COMPLETED|Double-blind Treatment Period||9||
48592395|NCT03738800|101783090|FG001|NOT COMPLETED|Double-blind Treatment Period||3||
48592396|NCT03738800|101783091|FG002|NOT COMPLETED|Double-blind Treatment Period||4||
48592397|NCT03738800|101783089|FG000|STARTED|Open Label Extension||49||
48592398|NCT03738800|101783090|FG001|STARTED|Open Label Extension||0||
48592399|NCT03738800|101783091|FG002|STARTED|Open Label Extension||0||
48592400|NCT03738800|101783089|FG000|COMPLETED|Open Label Extension||39||
48141094|NCT00518115|100670336|FG003|STARTED|Overall Study||35||
48141095|NCT00518115|100670337|FG004|STARTED|Overall Study||31||
48592401|NCT03738800|101783090|FG001|COMPLETED|Open Label Extension||0||
48592402|NCT03738800|101783091|FG002|COMPLETED|Open Label Extension||0||
48592403|NCT03738800|101783089|FG000|NOT COMPLETED|Open Label Extension||10||
48592404|NCT03738800|101783090|FG001|NOT COMPLETED|Open Label Extension||0||
48592405|NCT03738800|101783091|FG002|NOT COMPLETED|Open Label Extension||0||
48592406|NCT02669082|101783092|FG000|STARTED|Overall Study||26||
48710348|NCT03060512|102077947|FG000|Treated With PEG 3350|Overall Study||130||
48710349|NCT03060512|102077948|FG001|Treated With PEG 3350|Overall Study||138||
48710350|NCT03060512|102077947|FG000|COMPLETED|Overall Study||130||
48710351|NCT03060512|102077948|FG001|COMPLETED|Overall Study||130||
48710352|NCT03060512|102077947|FG000|NOT COMPLETED|Overall Study||7||
48710353|NCT03060512|102077948|FG001|NOT COMPLETED|Overall Study||9||
48710354|NCT02908685|102077949|FG000|STARTED|Part 1 Placebo-Controlled||7||
48710355|NCT02908685|102077950|FG001|STARTED|Part 1 Placebo-Controlled||7||
48710356|NCT02908685|102077951|FG002|STARTED|Part 1 Placebo-Controlled||3||
48710357|NCT02908685|102077952|FG003|STARTED|Part 1 Placebo-Controlled||3||
48710358|NCT02908685|102077953|FG004|STARTED|Part 1 Placebo-Controlled||7||
48710359|NCT02908685|102077954|FG005|STARTED|Part 1 Placebo-Controlled||7||
48710360|NCT02908685|102077955|FG006|STARTED|Part 1 Placebo-Controlled||7||
48710361|NCT02908685|102077956|FG007|STARTED|Part 1 Placebo-Controlled||3||
48141096|NCT00518115|100670338|FG005|STARTED|Overall Study||34||
48141097|NCT00518115|100670339|FG006|STARTED|Overall Study||33||
48141098|NCT00518115|100670340|FG007|STARTED|Overall Study||35||
48141099|NCT00518115|100670341|FG008|STARTED|Overall Study||35||
48141100|NCT00518115|100670342|FG009|STARTED|Overall Study||35||
48141101|NCT00518115|100670333|FG000|Safety Population|Overall Study||51||
48141102|NCT00518115|100670334|FG001|Safety Population|Overall Study||35||
48141103|NCT00518115|100670335|FG002|Safety Population|Overall Study||35||
48141104|NCT00518115|100670336|FG003|Safety Population|Overall Study||35||
48141105|NCT00518115|100670337|FG004|Safety Population|Overall Study||31||
48141106|NCT00518115|100670338|FG005|Safety Population|Overall Study||33||
48141107|NCT00518115|100670339|FG006|Safety Population|Overall Study||32||
48141108|NCT00518115|100670340|FG007|Safety Population|Overall Study||35||
48141109|NCT00518115|100670341|FG008|Safety Population|Overall Study||35||
48141110|NCT00518115|100670342|FG009|Safety Population|Overall Study||34||
48141111|NCT00518115|100670333|FG000|COMPLETED|Overall Study||40||
48141112|NCT00518115|100670334|FG001|COMPLETED|Overall Study||29||
48141113|NCT00518115|100670335|FG002|COMPLETED|Overall Study||19||
48141114|NCT00518115|100670336|FG003|COMPLETED|Overall Study||24||
48141115|NCT00518115|100670337|FG004|COMPLETED|Overall Study||21||
48141116|NCT00518115|100670338|FG005|COMPLETED|Overall Study||19||
48141117|NCT00518115|100670339|FG006|COMPLETED|Overall Study||25||
48141118|NCT00518115|100670340|FG007|COMPLETED|Overall Study||20||
48141119|NCT00518115|100670341|FG008|COMPLETED|Overall Study||30||
48141120|NCT00518115|100670342|FG009|COMPLETED|Overall Study||20||
48141121|NCT00518115|100670333|FG000|NOT COMPLETED|Overall Study||12||
48141122|NCT00518115|100670334|FG001|NOT COMPLETED|Overall Study||6||
48141123|NCT00518115|100670335|FG002|NOT COMPLETED|Overall Study||17||
48141124|NCT00518115|100670336|FG003|NOT COMPLETED|Overall Study||11||
48294061|NCT02349360|101047522|FG000|NOT COMPLETED|Overall Study||0||
48294062|NCT02349360|101047523|FG001|NOT COMPLETED|Overall Study||1||
48294063|NCT00690235|101047524|FG000|STARTED|Overall Study||17||
48592407|NCT02669082|101783092|FG000|COMPLETED|Overall Study||25||
48592408|NCT02669082|101783092|FG000|NOT COMPLETED|Overall Study||1||
48592409|NCT00622336|101783093|FG000|STARTED|Treatment Phase||330||
48592410|NCT00622336|101783093|FG000|Safety Population|Treatment Phase||330||
48592411|NCT00622336|101783093|FG000|COMPLETED|Treatment Phase||21||
48592412|NCT00622336|101783093|FG000|NOT COMPLETED|Treatment Phase||309||
48592413|NCT00622336|101783093|FG000|STARTED|Extension Phase||21||
48710362|NCT02908685|102077957|FG008|STARTED|Part 1 Placebo-Controlled||4||
48710363|NCT02908685|102077958|FG009|STARTED|Part 1 Placebo-Controlled||3||
48710364|NCT02908685|102077959|FG010|STARTED|Part 1 Placebo-Controlled||0||
48141125|NCT00518115|100670337|FG004|NOT COMPLETED|Overall Study||10||
48141126|NCT00518115|100670338|FG005|NOT COMPLETED|Overall Study||15||
48141127|NCT00518115|100670339|FG006|NOT COMPLETED|Overall Study||8||
48141128|NCT00518115|100670340|FG007|NOT COMPLETED|Overall Study||15||
48141129|NCT00518115|100670341|FG008|NOT COMPLETED|Overall Study||5||
48141130|NCT00518115|100670342|FG009|NOT COMPLETED|Overall Study||15||
48294064|NCT00690235|101047525|FG001|STARTED|Overall Study||16||
48710365|NCT02908685|102077960|FG011|STARTED|Part 1 Placebo-Controlled||0||
48710366|NCT02908685|102077961|FG012|STARTED|Part 1 Placebo-Controlled||0||
48710367|NCT02908685|102077962|FG013|STARTED|Part 1 Placebo-Controlled||0||
48710368|NCT02908685|102077949|FG000|COMPLETED|Part 1 Placebo-Controlled||7||
48710369|NCT02908685|102077950|FG001|COMPLETED|Part 1 Placebo-Controlled||7||
48710370|NCT02908685|102077951|FG002|COMPLETED|Part 1 Placebo-Controlled||3||
48710371|NCT02908685|102077952|FG003|COMPLETED|Part 1 Placebo-Controlled||3||
48710372|NCT02908685|102077953|FG004|COMPLETED|Part 1 Placebo-Controlled||7||
48710373|NCT02908685|102077954|FG005|COMPLETED|Part 1 Placebo-Controlled||7||
48710374|NCT02908685|102077955|FG006|COMPLETED|Part 1 Placebo-Controlled||7||
48710375|NCT02908685|102077956|FG007|COMPLETED|Part 1 Placebo-Controlled||3||
48710376|NCT02908685|102077957|FG008|COMPLETED|Part 1 Placebo-Controlled||4||
48710377|NCT02908685|102077958|FG009|COMPLETED|Part 1 Placebo-Controlled||3||
48710378|NCT02908685|102077959|FG010|COMPLETED|Part 1 Placebo-Controlled||0||
48710379|NCT02908685|102077960|FG011|COMPLETED|Part 1 Placebo-Controlled||0||
48710380|NCT02908685|102077961|FG012|COMPLETED|Part 1 Placebo-Controlled||0||
48710381|NCT02908685|102077962|FG013|COMPLETED|Part 1 Placebo-Controlled||0||
48710382|NCT02908685|102077949|FG000|NOT COMPLETED|Part 1 Placebo-Controlled||0||
48710383|NCT02908685|102077950|FG001|NOT COMPLETED|Part 1 Placebo-Controlled||0||
48710384|NCT02908685|102077951|FG002|NOT COMPLETED|Part 1 Placebo-Controlled||0||
48710385|NCT02908685|102077952|FG003|NOT COMPLETED|Part 1 Placebo-Controlled||0||
48710386|NCT02908685|102077953|FG004|NOT COMPLETED|Part 1 Placebo-Controlled||0||
48710387|NCT02908685|102077954|FG005|NOT COMPLETED|Part 1 Placebo-Controlled||0||
48710388|NCT02908685|102077955|FG006|NOT COMPLETED|Part 1 Placebo-Controlled||0||
48710389|NCT02908685|102077956|FG007|NOT COMPLETED|Part 1 Placebo-Controlled||0||
48710390|NCT02908685|102077957|FG008|NOT COMPLETED|Part 1 Placebo-Controlled||0||
48710391|NCT02908685|102077958|FG009|NOT COMPLETED|Part 1 Placebo-Controlled||0||
48710392|NCT02908685|102077959|FG010|NOT COMPLETED|Part 1 Placebo-Controlled||0||
48710393|NCT02908685|102077960|FG011|NOT COMPLETED|Part 1 Placebo-Controlled||0||
48710394|NCT02908685|102077961|FG012|NOT COMPLETED|Part 1 Placebo-Controlled||0||
48592414|NCT00622336|101783093|FG000|COMPLETED|Extension Phase||0||
48592415|NCT00622336|101783093|FG000|NOT COMPLETED|Extension Phase||21||
48592416|NCT01801358|101783094|FG000|STARTED|Overall Study||6||
48592417|NCT01801358|101783095|FG001|STARTED|Overall Study||6||
48592418|NCT01801358|101783096|FG002|STARTED|Overall Study||6||
48710395|NCT02908685|102077962|FG013|NOT COMPLETED|Part 1 Placebo-Controlled||0||
48710396|NCT02908685|102077949|FG000|STARTED|Part 1 OLE||0||
48710397|NCT02908685|102077950|FG001|STARTED|Part 1 OLE||0||
48710398|NCT02908685|102077951|FG002|STARTED|Part 1 OLE||0||
48710399|NCT02908685|102077952|FG003|STARTED|Part 1 OLE||0||
48710400|NCT02908685|102077953|FG004|STARTED|Part 1 OLE||0||
48710401|NCT02908685|102077954|FG005|STARTED|Part 1 OLE||0||
48710402|NCT02908685|102077955|FG006|STARTED|Part 1 OLE||0||
48710403|NCT02908685|102077956|FG007|STARTED|Part 1 OLE||0||
48710404|NCT02908685|102077957|FG008|STARTED|Part 1 OLE||0||
48710405|NCT02908685|102077958|FG009|STARTED|Part 1 OLE||0||
48710406|NCT02908685|102077959|FG010|STARTED|Part 1 OLE||20||
48710407|NCT02908685|102077960|FG011|STARTED|Part 1 OLE||31||
48710408|NCT02908685|102077961|FG012|STARTED|Part 1 OLE||0||
48710409|NCT02908685|102077962|FG013|STARTED|Part 1 OLE||0||
48710410|NCT02908685|102077949|FG000|COMPLETED|Part 1 OLE||0||
48710411|NCT02908685|102077950|FG001|COMPLETED|Part 1 OLE||0||
48710412|NCT02908685|102077951|FG002|COMPLETED|Part 1 OLE||0||
48710413|NCT02908685|102077952|FG003|COMPLETED|Part 1 OLE||0||
48710414|NCT02908685|102077953|FG004|COMPLETED|Part 1 OLE||0||
48592419|NCT01801358|101783097|FG003|STARTED|Overall Study||6||
48592420|NCT01801358|101783098|FG004|STARTED|Overall Study||6||
48592421|NCT01801358|101783099|FG005|STARTED|Overall Study||8||
48710415|NCT02908685|102077954|FG005|COMPLETED|Part 1 OLE||0||
48710416|NCT02908685|102077955|FG006|COMPLETED|Part 1 OLE||0||
48710417|NCT02908685|102077956|FG007|COMPLETED|Part 1 OLE||0||
48710418|NCT02908685|102077957|FG008|COMPLETED|Part 1 OLE||0||
48710419|NCT02908685|102077958|FG009|COMPLETED|Part 1 OLE||0||
48710420|NCT02908685|102077959|FG010|COMPLETED|Part 1 OLE||18||
48710421|NCT02908685|102077960|FG011|COMPLETED|Part 1 OLE||30||
48710422|NCT02908685|102077961|FG012|COMPLETED|Part 1 OLE||0||
48710423|NCT02908685|102077962|FG013|COMPLETED|Part 1 OLE||0||
48710424|NCT02908685|102077949|FG000|NOT COMPLETED|Part 1 OLE||0||
48710425|NCT02908685|102077950|FG001|NOT COMPLETED|Part 1 OLE||0||
48710426|NCT02908685|102077951|FG002|NOT COMPLETED|Part 1 OLE||0||
48710427|NCT02908685|102077952|FG003|NOT COMPLETED|Part 1 OLE||0||
48592422|NCT01801358|101783094|FG000|COMPLETED|Overall Study||0||
48710428|NCT02908685|102077953|FG004|NOT COMPLETED|Part 1 OLE||0||
48710429|NCT02908685|102077954|FG005|NOT COMPLETED|Part 1 OLE||0||
48710430|NCT02908685|102077955|FG006|NOT COMPLETED|Part 1 OLE||0||
48710431|NCT02908685|102077956|FG007|NOT COMPLETED|Part 1 OLE||0||
48592423|NCT01801358|101783095|FG001|COMPLETED|Overall Study||0||
48710432|NCT02908685|102077957|FG008|NOT COMPLETED|Part 1 OLE||0||
48710433|NCT02908685|102077958|FG009|NOT COMPLETED|Part 1 OLE||0||
48710434|NCT02908685|102077959|FG010|NOT COMPLETED|Part 1 OLE||2||
48710435|NCT02908685|102077960|FG011|NOT COMPLETED|Part 1 OLE||1||
48710436|NCT02908685|102077961|FG012|NOT COMPLETED|Part 1 OLE||0||
48710437|NCT02908685|102077962|FG013|NOT COMPLETED|Part 1 OLE||0||
48710438|NCT02908685|102077949|FG000|STARTED|Part 2 Placebo-Controlled: Month 1-12||0||
48710439|NCT02908685|102077950|FG001|STARTED|Part 2 Placebo-Controlled: Month 1-12||0||
48710440|NCT02908685|102077951|FG002|STARTED|Part 2 Placebo-Controlled: Month 1-12||0||
48710441|NCT02908685|102077952|FG003|STARTED|Part 2 Placebo-Controlled: Month 1-12||0||
48710442|NCT02908685|102077953|FG004|STARTED|Part 2 Placebo-Controlled: Month 1-12||0||
48710443|NCT02908685|102077954|FG005|STARTED|Part 2 Placebo-Controlled: Month 1-12||0||
48710444|NCT02908685|102077955|FG006|STARTED|Part 2 Placebo-Controlled: Month 1-12||0||
48710445|NCT02908685|102077956|FG007|STARTED|Part 2 Placebo-Controlled: Month 1-12||0||
48710446|NCT02908685|102077957|FG008|STARTED|Part 2 Placebo-Controlled: Month 1-12||0||
48710447|NCT02908685|102077958|FG009|STARTED|Part 2 Placebo-Controlled: Month 1-12||0||
48710448|NCT02908685|102077959|FG010|STARTED|Part 2 Placebo-Controlled: Month 1-12||0||
48710449|NCT02908685|102077960|FG011|STARTED|Part 2 Placebo-Controlled: Month 1-12||0||
48710450|NCT02908685|102077961|FG012|STARTED|Part 2 Placebo-Controlled: Month 1-12||120||
48710451|NCT02908685|102077962|FG013|STARTED|Part 2 Placebo-Controlled: Month 1-12||60||
48710452|NCT02908685|102077949|FG000|COMPLETED|Part 2 Placebo-Controlled: Month 1-12||0||
48710453|NCT02908685|102077950|FG001|COMPLETED|Part 2 Placebo-Controlled: Month 1-12||0||
48710454|NCT02908685|102077951|FG002|COMPLETED|Part 2 Placebo-Controlled: Month 1-12||0||
48710455|NCT02908685|102077952|FG003|COMPLETED|Part 2 Placebo-Controlled: Month 1-12||0||
48710456|NCT02908685|102077953|FG004|COMPLETED|Part 2 Placebo-Controlled: Month 1-12||0||
48710457|NCT02908685|102077954|FG005|COMPLETED|Part 2 Placebo-Controlled: Month 1-12||0||
48710458|NCT02908685|102077955|FG006|COMPLETED|Part 2 Placebo-Controlled: Month 1-12||0||
48710459|NCT02908685|102077956|FG007|COMPLETED|Part 2 Placebo-Controlled: Month 1-12||0||
48710460|NCT02908685|102077957|FG008|COMPLETED|Part 2 Placebo-Controlled: Month 1-12||0||
48710461|NCT02908685|102077958|FG009|COMPLETED|Part 2 Placebo-Controlled: Month 1-12||0||
48710462|NCT02908685|102077959|FG010|COMPLETED|Part 2 Placebo-Controlled: Month 1-12||0||
48710463|NCT02908685|102077960|FG011|COMPLETED|Part 2 Placebo-Controlled: Month 1-12||0||
48710464|NCT02908685|102077961|FG012|COMPLETED|Part 2 Placebo-Controlled: Month 1-12||117||
48710465|NCT02908685|102077962|FG013|COMPLETED|Part 2 Placebo-Controlled: Month 1-12||59||
48710466|NCT02908685|102077949|FG000|NOT COMPLETED|Part 2 Placebo-Controlled: Month 1-12||0||
48710467|NCT02908685|102077950|FG001|NOT COMPLETED|Part 2 Placebo-Controlled: Month 1-12||0||
48710468|NCT02908685|102077951|FG002|NOT COMPLETED|Part 2 Placebo-Controlled: Month 1-12||0||
48710469|NCT02908685|102077952|FG003|NOT COMPLETED|Part 2 Placebo-Controlled: Month 1-12||0||
48710470|NCT02908685|102077953|FG004|NOT COMPLETED|Part 2 Placebo-Controlled: Month 1-12||0||
48710471|NCT02908685|102077954|FG005|NOT COMPLETED|Part 2 Placebo-Controlled: Month 1-12||0||
48710472|NCT02908685|102077955|FG006|NOT COMPLETED|Part 2 Placebo-Controlled: Month 1-12||0||
48710473|NCT02908685|102077956|FG007|NOT COMPLETED|Part 2 Placebo-Controlled: Month 1-12||0||
48710474|NCT02908685|102077957|FG008|NOT COMPLETED|Part 2 Placebo-Controlled: Month 1-12||0||
48710475|NCT02908685|102077958|FG009|NOT COMPLETED|Part 2 Placebo-Controlled: Month 1-12||0||
48710476|NCT02908685|102077959|FG010|NOT COMPLETED|Part 2 Placebo-Controlled: Month 1-12||0||
48710477|NCT02908685|102077960|FG011|NOT COMPLETED|Part 2 Placebo-Controlled: Month 1-12||0||
48403980|NCT00250497|101321746|FG001|COMPLETED|Overall Study||159||
48294065|NCT00690235|101047524|FG000|COMPLETED|Overall Study||12||
48294066|NCT00690235|101047525|FG001|COMPLETED|Overall Study||12||
48294067|NCT00690235|101047524|FG000|NOT COMPLETED|Overall Study||5||
48294068|NCT00690235|101047525|FG001|NOT COMPLETED|Overall Study||4||
48294069|NCT02471833|101047526|FG000|STARTED|Overall Study||19||
48710478|NCT02908685|102077961|FG012|NOT COMPLETED|Part 2 Placebo-Controlled: Month 1-12||3||
48710479|NCT02908685|102077962|FG013|NOT COMPLETED|Part 2 Placebo-Controlled: Month 1-12||1||
48710480|NCT02908685|102077949|FG000|STARTED|Part 2 OLT: Month 12-24||0||
48710481|NCT02908685|102077950|FG001|STARTED|Part 2 OLT: Month 12-24||0||
48710482|NCT02908685|102077951|FG002|STARTED|Part 2 OLT: Month 12-24||0||
48710483|NCT02908685|102077952|FG003|STARTED|Part 2 OLT: Month 12-24||0||
48710484|NCT02908685|102077953|FG004|STARTED|Part 2 OLT: Month 12-24||0||
48710485|NCT02908685|102077954|FG005|STARTED|Part 2 OLT: Month 12-24||0||
48710486|NCT02908685|102077955|FG006|STARTED|Part 2 OLT: Month 12-24||0||
48710487|NCT02908685|102077956|FG007|STARTED|Part 2 OLT: Month 12-24||0||
48710488|NCT02908685|102077957|FG008|STARTED|Part 2 OLT: Month 12-24||0||
48710489|NCT02908685|102077958|FG009|STARTED|Part 2 OLT: Month 12-24||0||
48710490|NCT02908685|102077959|FG010|STARTED|Part 2 OLT: Month 12-24||0||
48710491|NCT02908685|102077960|FG011|STARTED|Part 2 OLT: Month 12-24||0||
48710492|NCT02908685|102077961|FG012|STARTED|Part 2 OLT: Month 12-24||117||
48710493|NCT02908685|102077962|FG013|STARTED|Part 2 OLT: Month 12-24||59||
48710494|NCT02908685|102077949|FG000|COMPLETED|Part 2 OLT: Month 12-24||0||
48294070|NCT02471833|101047527|FG001|STARTED|Overall Study||18||
48294071|NCT02471833|101047528|FG002|STARTED|Overall Study||24||
48294072|NCT02471833|101047526|FG000|Completed 8 Months of Study Treatment|Overall Study||12|Four participants in the Telmisartan 20mg group, 1 participant in the Telmisartan 40mg group, and 2 participants in the Placebo group were withdrawn from study medication prior to completing 8 months of treatment. These participants attended the Month 8 study visit and are considered as completing the study.|
48294073|NCT02471833|101047527|FG001|Completed 8 Months of Study Treatment|Overall Study||16|Four participants in the Telmisartan 20mg group, 1 participant in the Telmisartan 40mg group, and 2 participants in the Placebo group were withdrawn from study medication prior to completing 8 months of treatment. These participants attended the Month 8 study visit and are considered as completing the study.|
48710495|NCT02908685|102077950|FG001|COMPLETED|Part 2 OLT: Month 12-24||0||
48710496|NCT02908685|102077951|FG002|COMPLETED|Part 2 OLT: Month 12-24||0||
48710497|NCT02908685|102077952|FG003|COMPLETED|Part 2 OLT: Month 12-24||0||
48710498|NCT02908685|102077953|FG004|COMPLETED|Part 2 OLT: Month 12-24||0||
48710499|NCT02908685|102077954|FG005|COMPLETED|Part 2 OLT: Month 12-24||0||
48710500|NCT02908685|102077955|FG006|COMPLETED|Part 2 OLT: Month 12-24||0||
48710501|NCT02908685|102077956|FG007|COMPLETED|Part 2 OLT: Month 12-24||0||
48710502|NCT02908685|102077957|FG008|COMPLETED|Part 2 OLT: Month 12-24||0||
48592424|NCT01801358|101783096|FG002|COMPLETED|Overall Study||0||
48592425|NCT01801358|101783097|FG003|COMPLETED|Overall Study||0||
48592426|NCT01801358|101783098|FG004|COMPLETED|Overall Study||0||
48592427|NCT01801358|101783099|FG005|COMPLETED|Overall Study||0||
48592428|NCT01801358|101783094|FG000|NOT COMPLETED|Overall Study||6||
48592429|NCT01801358|101783095|FG001|NOT COMPLETED|Overall Study||6||
48592430|NCT01801358|101783096|FG002|NOT COMPLETED|Overall Study||6||
48141131|NCT01576536|100670343|FG000|STARTED|Overall Study||117||
48294074|NCT02471833|101047528|FG002|Completed 8 Months of Study Treatment|Overall Study||17|Four participants in the Telmisartan 20mg group, 1 participant in the Telmisartan 40mg group, and 2 participants in the Placebo group were withdrawn from study medication prior to completing 8 months of treatment. These participants attended the Month 8 study visit and are considered as completing the study.|
48294075|NCT02471833|101047526|FG000|COMPLETED|Overall Study||16||
48294076|NCT02471833|101047527|FG001|COMPLETED|Overall Study||17||
48294077|NCT02471833|101047528|FG002|COMPLETED|Overall Study||19||
48294078|NCT02471833|101047526|FG000|NOT COMPLETED|Overall Study||3||
48294079|NCT02471833|101047527|FG001|NOT COMPLETED|Overall Study||1||
48403981|NCT00250497|101321745|FG000|NOT COMPLETED|Overall Study||5||
48403982|NCT00250497|101321746|FG001|NOT COMPLETED|Overall Study||15||
48403983|NCT02590640|101321747|FG000|STARTED|Overall Study||40||
48403984|NCT02590640|101321747|FG000|COMPLETED|Overall Study||37||
48403985|NCT02590640|101321747|FG000|NOT COMPLETED|Overall Study||3||
48592431|NCT01801358|101783097|FG003|NOT COMPLETED|Overall Study||6||
48592432|NCT01801358|101783098|FG004|NOT COMPLETED|Overall Study||6||
48592433|NCT01801358|101783099|FG005|NOT COMPLETED|Overall Study||8||
48592434|NCT02638259|101783100|FG000|STARTED|Treatment Period 1||186||
48592435|NCT02638259|101783101|FG001|STARTED|Treatment Period 1||190||
48592436|NCT02638259|101783100|FG000|COMPLETED|Treatment Period 1||181||
48592437|NCT02638259|101783101|FG001|COMPLETED|Treatment Period 1||172||
48592438|NCT02638259|101783100|FG000|NOT COMPLETED|Treatment Period 1||5||
48592439|NCT02638259|101783101|FG001|NOT COMPLETED|Treatment Period 1||18||
48592440|NCT02638259|101783100|FG000|STARTED|Treatment Period 2||175||
48710503|NCT02908685|102077958|FG009|COMPLETED|Part 2 OLT: Month 12-24||0||
48710504|NCT02908685|102077959|FG010|COMPLETED|Part 2 OLT: Month 12-24||0||
48710505|NCT02908685|102077960|FG011|COMPLETED|Part 2 OLT: Month 12-24||0||
48710506|NCT02908685|102077961|FG012|COMPLETED|Part 2 OLT: Month 12-24||116||
48710507|NCT02908685|102077962|FG013|COMPLETED|Part 2 OLT: Month 12-24||59||
48710508|NCT02908685|102077949|FG000|NOT COMPLETED|Part 2 OLT: Month 12-24||0||
48710509|NCT02908685|102077950|FG001|NOT COMPLETED|Part 2 OLT: Month 12-24||0||
48710510|NCT02908685|102077951|FG002|NOT COMPLETED|Part 2 OLT: Month 12-24||0||
48141132|NCT01576536|100670343|FG000|COMPLETED|Overall Study||117||
48141133|NCT01576536|100670343|FG000|NOT COMPLETED|Overall Study||0||
48141134|NCT00729833|100670344|FG000|STARTED|Overall Study||20||
48141135|NCT00729833|100670345|FG001|STARTED|Overall Study||7||
48141136|NCT00729833|100670346|FG002|STARTED|Overall Study||12||
48141137|NCT00729833|100670347|FG003|STARTED|Overall Study||6||
48141138|NCT00729833|100670344|FG000|COMPLETED|Overall Study||0||
48141139|NCT00729833|100670345|FG001|COMPLETED|Overall Study||0||
48141140|NCT00729833|100670346|FG002|COMPLETED|Overall Study||0||
48141141|NCT00729833|100670347|FG003|COMPLETED|Overall Study||0||
48141142|NCT00729833|100670344|FG000|NOT COMPLETED|Overall Study||20||
48141143|NCT00729833|100670345|FG001|NOT COMPLETED|Overall Study||7||
48710511|NCT02908685|102077952|FG003|NOT COMPLETED|Part 2 OLT: Month 12-24||0||
48710512|NCT02908685|102077953|FG004|NOT COMPLETED|Part 2 OLT: Month 12-24||0||
48710513|NCT02908685|102077954|FG005|NOT COMPLETED|Part 2 OLT: Month 12-24||0||
48710514|NCT02908685|102077955|FG006|NOT COMPLETED|Part 2 OLT: Month 12-24||0||
48710515|NCT02908685|102077956|FG007|NOT COMPLETED|Part 2 OLT: Month 12-24||0||
48710516|NCT02908685|102077957|FG008|NOT COMPLETED|Part 2 OLT: Month 12-24||0||
48592441|NCT02638259|101783101|FG001|STARTED|Treatment Period 2||166||
48592442|NCT02638259|101783100|FG000|COMPLETED|Treatment Period 2||169||
48592443|NCT02638259|101783101|FG001|COMPLETED|Treatment Period 2||155||
48592444|NCT02638259|101783100|FG000|NOT COMPLETED|Treatment Period 2||6||
48592445|NCT02638259|101783101|FG001|NOT COMPLETED|Treatment Period 2||11||
48592446|NCT02203851|101783102|FG000|STARTED|Overall Study||110||
48592447|NCT02203851|101783102|FG000|COMPLETED|Overall Study||99||
48592448|NCT02203851|101783102|FG000|NOT COMPLETED|Overall Study||11||
48710517|NCT02908685|102077958|FG009|NOT COMPLETED|Part 2 OLT: Month 12-24||0||
48710518|NCT02908685|102077959|FG010|NOT COMPLETED|Part 2 OLT: Month 12-24||0||
48710519|NCT02908685|102077960|FG011|NOT COMPLETED|Part 2 OLT: Month 12-24||0||
48710520|NCT02908685|102077961|FG012|NOT COMPLETED|Part 2 OLT: Month 12-24||1||
48710521|NCT02908685|102077962|FG013|NOT COMPLETED|Part 2 OLT: Month 12-24||0||
48710522|NCT02908685|102077949|FG000|STARTED|Part 2 OLE: > Month 24||0||
48710523|NCT02908685|102077950|FG001|STARTED|Part 2 OLE: > Month 24||0||
48710524|NCT02908685|102077951|FG002|STARTED|Part 2 OLE: > Month 24||0||
48710525|NCT02908685|102077952|FG003|STARTED|Part 2 OLE: > Month 24||0||
48710526|NCT02908685|102077953|FG004|STARTED|Part 2 OLE: > Month 24||0||
48710527|NCT02908685|102077954|FG005|STARTED|Part 2 OLE: > Month 24||0||
48710528|NCT02908685|102077955|FG006|STARTED|Part 2 OLE: > Month 24||0||
48710529|NCT02908685|102077956|FG007|STARTED|Part 2 OLE: > Month 24||0||
48710530|NCT02908685|102077957|FG008|STARTED|Part 2 OLE: > Month 24||0||
48710531|NCT02908685|102077958|FG009|STARTED|Part 2 OLE: > Month 24||0||
48710532|NCT02908685|102077959|FG010|STARTED|Part 2 OLE: > Month 24||0||
48710533|NCT02908685|102077960|FG011|STARTED|Part 2 OLE: > Month 24||0||
48710534|NCT02908685|102077961|FG012|STARTED|Part 2 OLE: > Month 24||116||
48710535|NCT02908685|102077962|FG013|STARTED|Part 2 OLE: > Month 24||59||
48710536|NCT02908685|102077949|FG000|COMPLETED|Part 2 OLE: > Month 24||0||
48710537|NCT02908685|102077950|FG001|COMPLETED|Part 2 OLE: > Month 24||0||
48710538|NCT02908685|102077951|FG002|COMPLETED|Part 2 OLE: > Month 24||0||
48710539|NCT02908685|102077952|FG003|COMPLETED|Part 2 OLE: > Month 24||0||
48710540|NCT02908685|102077953|FG004|COMPLETED|Part 2 OLE: > Month 24||0||
48710541|NCT02908685|102077954|FG005|COMPLETED|Part 2 OLE: > Month 24||0||
48710542|NCT02908685|102077955|FG006|COMPLETED|Part 2 OLE: > Month 24||0||
48710543|NCT02908685|102077956|FG007|COMPLETED|Part 2 OLE: > Month 24||0||
48710544|NCT02908685|102077957|FG008|COMPLETED|Part 2 OLE: > Month 24||0||
48710545|NCT02908685|102077958|FG009|COMPLETED|Part 2 OLE: > Month 24||0||
48710546|NCT02908685|102077959|FG010|COMPLETED|Part 2 OLE: > Month 24||0||
48710547|NCT02908685|102077960|FG011|COMPLETED|Part 2 OLE: > Month 24||0||
48710548|NCT02908685|102077961|FG012|COMPLETED|Part 2 OLE: > Month 24||103||
48710549|NCT02908685|102077962|FG013|COMPLETED|Part 2 OLE: > Month 24||53||
48710550|NCT02908685|102077949|FG000|NOT COMPLETED|Part 2 OLE: > Month 24||0||
48710551|NCT02908685|102077950|FG001|NOT COMPLETED|Part 2 OLE: > Month 24||0||
48710552|NCT02908685|102077951|FG002|NOT COMPLETED|Part 2 OLE: > Month 24||0||
48710553|NCT02908685|102077952|FG003|NOT COMPLETED|Part 2 OLE: > Month 24||0||
48592449|NCT01902758|101783103|FG000|STARTED|Overall Study||14||
48592450|NCT01902758|101783104|FG001|STARTED|Overall Study||14||
48592451|NCT01902758|101783103|FG000|COMPLETED|Overall Study||14||
48592452|NCT01902758|101783104|FG001|COMPLETED|Overall Study||14||
48592453|NCT01902758|101783103|FG000|NOT COMPLETED|Overall Study||0||
48592454|NCT01902758|101783104|FG001|NOT COMPLETED|Overall Study||0||
48592455|NCT00595114|101783105|FG000|STARTED|Overall Study||24||
48592456|NCT00595114|101783106|FG001|STARTED|Overall Study||19||
48592457|NCT00595114|101783105|FG000|COMPLETED|Overall Study||24||
48592458|NCT00595114|101783106|FG001|COMPLETED|Overall Study||19||
48592459|NCT00595114|101783105|FG000|NOT COMPLETED|Overall Study||0||
48592460|NCT00595114|101783106|FG001|NOT COMPLETED|Overall Study||0||
48592461|NCT02407132|101783107|FG000|STARTED|Immediate Post-intervention||110||
48592462|NCT02407132|101783108|FG001|STARTED|Immediate Post-intervention||111||
48592463|NCT02407132|101783107|FG000|COMPLETED|Immediate Post-intervention||107||
48592464|NCT02407132|101783108|FG001|COMPLETED|Immediate Post-intervention||101||
48710554|NCT02908685|102077953|FG004|NOT COMPLETED|Part 2 OLE: > Month 24||0||
48710555|NCT02908685|102077954|FG005|NOT COMPLETED|Part 2 OLE: > Month 24||0||
48710556|NCT02908685|102077955|FG006|NOT COMPLETED|Part 2 OLE: > Month 24||0||
48592465|NCT02407132|101783107|FG000|NOT COMPLETED|Immediate Post-intervention||3||
48592466|NCT02407132|101783108|FG001|NOT COMPLETED|Immediate Post-intervention||10||
48592467|NCT02407132|101783107|FG000|STARTED|6 Months Post-intervention||107|All participants were recontacted whether or not they completed post-intervention data collection.|
48592468|NCT02407132|101783108|FG001|STARTED|6 Months Post-intervention||101|All participants were recontacted whether or not they completed post-intervention data collection.|
48592469|NCT02407132|101783107|FG000|COMPLETED|6 Months Post-intervention||96||
48592470|NCT02407132|101783108|FG001|COMPLETED|6 Months Post-intervention||92||
48592471|NCT02407132|101783107|FG000|NOT COMPLETED|6 Months Post-intervention||11||
48592472|NCT02407132|101783108|FG001|NOT COMPLETED|6 Months Post-intervention||9||
48710557|NCT02908685|102077956|FG007|NOT COMPLETED|Part 2 OLE: > Month 24||0||
48592473|NCT02407132|101783107|FG000|STARTED|12 Months Post-intervention||96|All participants were recontacted whether or not they completed previous data collection events.|
48592474|NCT02407132|101783108|FG001|STARTED|12 Months Post-intervention||92|All participants were recontacted whether or not they completed previous data collection events.|
48592475|NCT02407132|101783107|FG000|COMPLETED|12 Months Post-intervention||83||
48592476|NCT02407132|101783108|FG001|COMPLETED|12 Months Post-intervention||90||
48592477|NCT02407132|101783107|FG000|NOT COMPLETED|12 Months Post-intervention||13||
48592478|NCT02407132|101783108|FG001|NOT COMPLETED|12 Months Post-intervention||2||
48592479|NCT01726036|101783109|FG000|STARTED|Overall Study||137||
48592480|NCT01726036|101783110|FG001|STARTED|Overall Study||137||
48592481|NCT01726036|101783109|FG000|COMPLETED|Overall Study||121||
48592482|NCT01726036|101783110|FG001|COMPLETED|Overall Study||130||
48592483|NCT01726036|101783109|FG000|NOT COMPLETED|Overall Study||16||
48592484|NCT01726036|101783110|FG001|NOT COMPLETED|Overall Study||7||
48592485|NCT01928797|101783111|FG000|STARTED|Overall Study||30||
48592486|NCT01928797|101783112|FG001|STARTED|Overall Study||30||
48592487|NCT01928797|101783111|FG000|COMPLETED|Overall Study||30||
48592488|NCT01928797|101783112|FG001|COMPLETED|Overall Study||30||
48592489|NCT01928797|101783111|FG000|NOT COMPLETED|Overall Study||0||
48592490|NCT01928797|101783112|FG001|NOT COMPLETED|Overall Study||0||
48592491|NCT01846221|101783113|FG000|STARTED|Overall Study||50||
48592492|NCT01846221|101783114|FG001|STARTED|Overall Study||51||
48592493|NCT01846221|101783113|FG000|COMPLETED|Overall Study||47||
48592494|NCT01846221|101783114|FG001|COMPLETED|Overall Study||51||
48592495|NCT01846221|101783113|FG000|NOT COMPLETED|Overall Study||3||
48592496|NCT01846221|101783114|FG001|NOT COMPLETED|Overall Study||0||
48710558|NCT02908685|102077957|FG008|NOT COMPLETED|Part 2 OLE: > Month 24||0||
48710559|NCT02908685|102077958|FG009|NOT COMPLETED|Part 2 OLE: > Month 24||0||
48710560|NCT02908685|102077959|FG010|NOT COMPLETED|Part 2 OLE: > Month 24||0||
48710561|NCT02908685|102077960|FG011|NOT COMPLETED|Part 2 OLE: > Month 24||0||
48710562|NCT02908685|102077961|FG012|NOT COMPLETED|Part 2 OLE: > Month 24||13||
48710563|NCT02908685|102077962|FG013|NOT COMPLETED|Part 2 OLE: > Month 24||6||
48710564|NCT01258153|102077963|FG000|STARTED|Overall Study||40||
48403986|NCT03961295|101321748|FG000|STARTED|Overall Study||12||
48403987|NCT03961295|101321749|FG001|STARTED|Overall Study||12||
48403988|NCT03961295|101321748|FG000|COMPLETED|Overall Study||12||
48403989|NCT03961295|101321749|FG001|COMPLETED|Overall Study||12||
48592497|NCT02657577|101783115|FG000|STARTED|Overall Study||201||
48592498|NCT02657577|101783116|FG001|STARTED|Overall Study||427||
48592499|NCT02657577|101783115|FG000|COMPLETED|Overall Study||164||
48592500|NCT02657577|101783116|FG001|COMPLETED|Overall Study||383||
48592501|NCT02657577|101783115|FG000|NOT COMPLETED|Overall Study||37||
48592502|NCT02657577|101783116|FG001|NOT COMPLETED|Overall Study||44||
48592503|NCT02342548|101783117|FG000|STARTED|Overall Study||51||
48592504|NCT02342548|101783118|FG001|STARTED|Overall Study||71||
48592505|NCT02342548|101783119|FG002|STARTED|Overall Study||66||
48592506|NCT02342548|101783117|FG000|COMPLETED|Overall Study||17||
48592507|NCT02342548|101783118|FG001|COMPLETED|Overall Study||9||
48592508|NCT02342548|101783119|FG002|COMPLETED|Overall Study||23||
48592509|NCT02342548|101783117|FG000|NOT COMPLETED|Overall Study||34||
48592510|NCT02342548|101783118|FG001|NOT COMPLETED|Overall Study||62||
48592511|NCT02342548|101783119|FG002|NOT COMPLETED|Overall Study||43||
48592512|NCT01632150|101783120|FG000|STARTED|Overall Study||40||
48592513|NCT01632150|101783120|FG000|Received Cyclophosphamide|Overall Study||11||
48592514|NCT01632150|101783120|FG000|COMPLETED|Overall Study||0||
48592515|NCT01632150|101783120|FG000|NOT COMPLETED|Overall Study||40||
48592516|NCT02603562|101783121|FG000|STARTED|Overall Study||8||
48592517|NCT02603562|101783121|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8||
48592518|NCT02603562|101783121|FG000|COMPLETED|Overall Study||7||
48592519|NCT02603562|101783121|FG000|NOT COMPLETED|Overall Study||1||
48592520|NCT00558896|101783122|FG000|STARTED|Overall Study||60||
48592521|NCT00558896|101783123|FG001|STARTED|Overall Study||34||
48592522|NCT00558896|101783124|FG002|STARTED|Overall Study||35||
48592523|NCT00558896|101783125|FG003|STARTED|Overall Study||35||
48592524|NCT00558896|101783126|FG004|STARTED|Overall Study||60||
48592525|NCT00558896|101783127|FG005|STARTED|Overall Study||120||
48592526|NCT00558896|101783128|FG006|STARTED|Overall Study||33||
48592527|NCT00558896|101783122|FG000|COMPLETED|Overall Study||39||
48592528|NCT00558896|101783123|FG001|COMPLETED|Overall Study||27||
48592529|NCT00558896|101783124|FG002|COMPLETED|Overall Study||30||
48592530|NCT00558896|101783125|FG003|COMPLETED|Overall Study||23||
48403990|NCT03961295|101321748|FG000|NOT COMPLETED|Overall Study||0||
48403991|NCT03961295|101321749|FG001|NOT COMPLETED|Overall Study||0||
48403992|NCT01690988|101321750|FG000|STARTED|Overall Study||227||
48403993|NCT01690988|101321751|FG001|STARTED|Overall Study||222||
48403994|NCT01690988|101321752|FG002|STARTED|Overall Study||223||
48403995|NCT01690988|101321750|FG000|COMPLETED|Overall Study||221||
48403996|NCT01690988|101321751|FG001|COMPLETED|Overall Study||217||
48403997|NCT01690988|101321752|FG002|COMPLETED|Overall Study||216||
48403998|NCT01690988|101321750|FG000|NOT COMPLETED|Overall Study||6||
48403999|NCT01690988|101321751|FG001|NOT COMPLETED|Overall Study||5||
48404000|NCT01690988|101321752|FG002|NOT COMPLETED|Overall Study||7||
48404001|NCT00544466|101321753|FG000|STARTED|Overall Study||62||
48710565|NCT01258153|102077964|FG001|STARTED|Overall Study||38||
48710566|NCT01258153|102077965|FG002|STARTED|Overall Study||37||
48710567|NCT01258153|102077963|FG000|COMPLETED|Overall Study||39||
48710568|NCT01258153|102077964|FG001|COMPLETED|Overall Study||37||
48710569|NCT01258153|102077965|FG002|COMPLETED|Overall Study||36||
48710570|NCT01258153|102077963|FG000|NOT COMPLETED|Overall Study||1||
48592531|NCT00558896|101783126|FG004|COMPLETED|Overall Study||37||
48592532|NCT00558896|101783127|FG005|COMPLETED|Overall Study||68||
48592533|NCT00558896|101783128|FG006|COMPLETED|Overall Study||9||
48592534|NCT00558896|101783122|FG000|NOT COMPLETED|Overall Study||21||
48592535|NCT00558896|101783123|FG001|NOT COMPLETED|Overall Study||7||
48592536|NCT00558896|101783124|FG002|NOT COMPLETED|Overall Study||5||
48592537|NCT00558896|101783125|FG003|NOT COMPLETED|Overall Study||12||
48592538|NCT00558896|101783126|FG004|NOT COMPLETED|Overall Study||23||
48592539|NCT00558896|101783127|FG005|NOT COMPLETED|Overall Study||52||
48592540|NCT00558896|101783128|FG006|NOT COMPLETED|Overall Study||24||
48592541|NCT00985959|101783129|FG000|STARTED|Overall Study||6||
48592542|NCT00985959|101783130|FG001|STARTED|Overall Study||6||
48592543|NCT00985959|101783131|FG002|STARTED|Overall Study||87||
48592544|NCT00985959|101783129|FG000|COMPLETED|Overall Study||3||
48141144|NCT00729833|100670346|FG002|NOT COMPLETED|Overall Study||12||
48141145|NCT00729833|100670347|FG003|NOT COMPLETED|Overall Study||6||
48141146|NCT04224155|100670348|FG000|STARTED|Overall Study||111||
48141147|NCT04224155|100670349|FG001|STARTED|Overall Study||54||
48141148|NCT04224155|100670348|FG000|COMPLETED|Overall Study||110||
48141149|NCT04224155|100670349|FG001|COMPLETED|Overall Study||52||
48294080|NCT02471833|101047528|FG002|NOT COMPLETED|Overall Study||5||
48294081|NCT01828073|101047529|FG000|STARTED|Overall Study||22||
48294082|NCT01828073|101047530|FG001|STARTED|Overall Study||18||
48294083|NCT01828073|101047529|FG000|COMPLETED|Overall Study||21||
48294084|NCT01828073|101047530|FG001|COMPLETED|Overall Study||16||
48592545|NCT00985959|101783130|FG001|COMPLETED|Overall Study||3||
48592546|NCT00985959|101783131|FG002|COMPLETED|Overall Study||28||
48592547|NCT00985959|101783129|FG000|NOT COMPLETED|Overall Study||3||
48592548|NCT00985959|101783130|FG001|NOT COMPLETED|Overall Study||3||
48592549|NCT00985959|101783131|FG002|NOT COMPLETED|Overall Study||59||
48592550|NCT02872857|101783132|FG000|STARTED|Phase 1||15||
48592551|NCT02872857|101783133|FG001|STARTED|Phase 1||15||
48592552|NCT02872857|101783134|FG002|STARTED|Phase 1||0||
48592553|NCT02872857|101783135|FG003|STARTED|Phase 1||0||
48592554|NCT02872857|101783132|FG000|COMPLETED|Phase 1||15||
48592555|NCT02872857|101783133|FG001|COMPLETED|Phase 1||15||
48592556|NCT02872857|101783134|FG002|COMPLETED|Phase 1||0||
48592557|NCT02872857|101783135|FG003|COMPLETED|Phase 1||0||
48592558|NCT02872857|101783132|FG000|NOT COMPLETED|Phase 1||0||
48592559|NCT02872857|101783133|FG001|NOT COMPLETED|Phase 1||0||
48592560|NCT02872857|101783134|FG002|NOT COMPLETED|Phase 1||0||
48592561|NCT02872857|101783135|FG003|NOT COMPLETED|Phase 1||0||
48592562|NCT02872857|101783132|FG000|STARTED|Phase 2||0||
48592563|NCT02872857|101783133|FG001|STARTED|Phase 2||0||
48710571|NCT01258153|102077964|FG001|NOT COMPLETED|Overall Study||1||
48710572|NCT01258153|102077965|FG002|NOT COMPLETED|Overall Study||1||
48710573|NCT00523705|102077966|FG000|STARTED|Overall Study||7||
48710574|NCT00523705|102077967|FG001|STARTED|Overall Study||4||
48710575|NCT00523705|102077966|FG000|COMPLETED|Overall Study||7||
48710576|NCT00523705|102077967|FG001|COMPLETED|Overall Study||3||
48710577|NCT00523705|102077966|FG000|NOT COMPLETED|Overall Study||0||
48710578|NCT00523705|102077967|FG001|NOT COMPLETED|Overall Study||1||
48710579|NCT01007123|102077968|FG000|STARTED|Overall Study||48||
48710580|NCT01007123|102077969|FG001|STARTED|Overall Study||47||
48141150|NCT04224155|100670348|FG000|NOT COMPLETED|Overall Study||1||
48294085|NCT01828073|101047529|FG000|NOT COMPLETED|Overall Study||1||
48592564|NCT02872857|101783134|FG002|STARTED|Phase 2||15||
48592565|NCT02872857|101783135|FG003|STARTED|Phase 2||15||
48710581|NCT01007123|102077970|FG002|STARTED|Overall Study||48||
48710582|NCT01007123|102077971|FG003|STARTED|Overall Study||47||
48710583|NCT01007123|102077968|FG000|COMPLETED|Overall Study||42||
48710584|NCT01007123|102077969|FG001|COMPLETED|Overall Study||41||
48592566|NCT02872857|101783132|FG000|COMPLETED|Phase 2||0||
48592567|NCT02872857|101783133|FG001|COMPLETED|Phase 2||0||
48592568|NCT02872857|101783134|FG002|COMPLETED|Phase 2||15||
48592569|NCT02872857|101783135|FG003|COMPLETED|Phase 2||15||
48592570|NCT02872857|101783132|FG000|NOT COMPLETED|Phase 2||0||
48592571|NCT02872857|101783133|FG001|NOT COMPLETED|Phase 2||0||
48592572|NCT02872857|101783134|FG002|NOT COMPLETED|Phase 2||0||
48710585|NCT01007123|102077970|FG002|COMPLETED|Overall Study||37||
48710586|NCT01007123|102077971|FG003|COMPLETED|Overall Study||41||
48710587|NCT01007123|102077968|FG000|NOT COMPLETED|Overall Study||6||
48710588|NCT01007123|102077969|FG001|NOT COMPLETED|Overall Study||6||
48710589|NCT01007123|102077970|FG002|NOT COMPLETED|Overall Study||11||
48294086|NCT01828073|101047530|FG001|NOT COMPLETED|Overall Study||2||
48294087|NCT02795429|101047531|FG000|STARTED|Overall Study||6||
48294088|NCT02795429|101047532|FG001|STARTED|Overall Study||10||
48294089|NCT02795429|101047533|FG002|STARTED|Overall Study||11||
48294090|NCT02795429|101047534|FG003|STARTED|Overall Study||32||
48294091|NCT02795429|101047535|FG004|STARTED|Overall Study||30||
48294092|NCT02795429|101047531|FG000|COMPLETED|Overall Study||0||
48294093|NCT02795429|101047532|FG001|COMPLETED|Overall Study||0||
48294094|NCT02795429|101047533|FG002|COMPLETED|Overall Study||0||
48294095|NCT02795429|101047534|FG003|COMPLETED|Overall Study||0||
48294096|NCT02795429|101047535|FG004|COMPLETED|Overall Study||0||
48294097|NCT02795429|101047531|FG000|NOT COMPLETED|Overall Study||6||
48294098|NCT02795429|101047532|FG001|NOT COMPLETED|Overall Study||10||
48710590|NCT01007123|102077971|FG003|NOT COMPLETED|Overall Study||6||
48710591|NCT01340937|102077972|FG000|STARTED|Period 1: Infant Series||800||
48710592|NCT01340937|102077973|FG001|STARTED|Period 1: Infant Series||797||
48710593|NCT01340937|102077974|FG002|STARTED|Period 1: Infant Series||809||
48710594|NCT01340937|102077975|FG003|STARTED|Period 1: Infant Series||402||
48710595|NCT01340937|102077972|FG000|COMPLETED|Period 1: Infant Series||742||
48294099|NCT02795429|101047533|FG002|NOT COMPLETED|Overall Study||11||
48294100|NCT02795429|101047534|FG003|NOT COMPLETED|Overall Study||32||
48710596|NCT01340937|102077973|FG001|COMPLETED|Period 1: Infant Series||737||
48710597|NCT01340937|102077974|FG002|COMPLETED|Period 1: Infant Series||753||
48710598|NCT01340937|102077975|FG003|COMPLETED|Period 1: Infant Series||370||
48710599|NCT01340937|102077972|FG000|NOT COMPLETED|Period 1: Infant Series||58||
48710600|NCT01340937|102077973|FG001|NOT COMPLETED|Period 1: Infant Series||60||
48710601|NCT01340937|102077974|FG002|NOT COMPLETED|Period 1: Infant Series||56||
48710602|NCT01340937|102077975|FG003|NOT COMPLETED|Period 1: Infant Series||32||
48710603|NCT01340937|102077972|FG000|STARTED|Period 2: Interim Period||742||
48294101|NCT02795429|101047535|FG004|NOT COMPLETED|Overall Study||30||
48294102|NCT02527343|101047536|FG000|STARTED|RT Period: Weeks 1 to 52||19||
48294103|NCT02527343|101047537|FG001|STARTED|RT Period: Weeks 1 to 52||21||
48294104|NCT02527343|101047538|FG002|STARTED|RT Period: Weeks 1 to 52||0||
48294105|NCT02527343|101047539|FG003|STARTED|RT Period: Weeks 1 to 52||0||
48294106|NCT02527343|101047540|FG004|STARTED|RT Period: Weeks 1 to 52||0||
48294107|NCT02527343|101047541|FG005|STARTED|RT Period: Weeks 1 to 52||0||
48294108|NCT02527343|101047536|FG000|COMPLETED|RT Period: Weeks 1 to 52||13||
48294109|NCT02527343|101047537|FG001|COMPLETED|RT Period: Weeks 1 to 52||14||
48294110|NCT02527343|101047538|FG002|COMPLETED|RT Period: Weeks 1 to 52||0||
48294111|NCT02527343|101047539|FG003|COMPLETED|RT Period: Weeks 1 to 52||0||
48294112|NCT02527343|101047540|FG004|COMPLETED|RT Period: Weeks 1 to 52||0||
48294113|NCT02527343|101047541|FG005|COMPLETED|RT Period: Weeks 1 to 52||0||
48294114|NCT02527343|101047536|FG000|NOT COMPLETED|RT Period: Weeks 1 to 52||6||
48592573|NCT02872857|101783135|FG003|NOT COMPLETED|Phase 2||0||
48592574|NCT00655681|101783136|FG000|STARTED|Overall Study||12||
48592575|NCT00655681|101783137|FG001|STARTED|Overall Study||10||
48592576|NCT00655681|101783136|FG000|COMPLETED|Overall Study||11||
48592577|NCT00655681|101783137|FG001|COMPLETED|Overall Study||9||
48592578|NCT00655681|101783136|FG000|NOT COMPLETED|Overall Study||1||
48710604|NCT01340937|102077973|FG001|STARTED|Period 2: Interim Period||737||
48710605|NCT01340937|102077974|FG002|STARTED|Period 2: Interim Period||753||
48710606|NCT01340937|102077975|FG003|STARTED|Period 2: Interim Period||370||
48710607|NCT01340937|102077972|FG000|COMPLETED|Period 2: Interim Period||675||
48710608|NCT01340937|102077973|FG001|COMPLETED|Period 2: Interim Period||658||
48710609|NCT01340937|102077974|FG002|COMPLETED|Period 2: Interim Period||669||
48710610|NCT01340937|102077975|FG003|COMPLETED|Period 2: Interim Period||329||
48710611|NCT01340937|102077972|FG000|NOT COMPLETED|Period 2: Interim Period||67||
48710612|NCT01340937|102077973|FG001|NOT COMPLETED|Period 2: Interim Period||79||
48710613|NCT01340937|102077974|FG002|NOT COMPLETED|Period 2: Interim Period||84||
48710614|NCT01340937|102077975|FG003|NOT COMPLETED|Period 2: Interim Period||41||
48592579|NCT00655681|101783137|FG001|NOT COMPLETED|Overall Study||1||
48592580|NCT04481191|101783138|FG000|STARTED|Overall Study||200||
48592581|NCT04481191|101783139|FG001|STARTED|Overall Study||200||
48592582|NCT04481191|101783138|FG000|≥1 V260 Vaccination|Overall Study||189||
48592583|NCT04481191|101783139|FG001|≥1 V260 Vaccination|Overall Study||200||
48710615|NCT01340937|102077972|FG000|STARTED|Period 3: Toddler Vaccinations||675||
48592584|NCT04481191|101783138|FG000|COMPLETED|Overall Study||185||
48592585|NCT04481191|101783139|FG001|COMPLETED|Overall Study||190||
48592586|NCT04481191|101783138|FG000|NOT COMPLETED|Overall Study||15||
48592587|NCT04481191|101783139|FG001|NOT COMPLETED|Overall Study||10||
48592588|NCT03769675|101783140|FG000|STARTED|Overall Study||10||
48592589|NCT03769675|101783140|FG000|COMPLETED|Overall Study||9||
48592590|NCT03769675|101783140|FG000|NOT COMPLETED|Overall Study||1||
48592591|NCT00250458|101783141|FG000|STARTED|Overall Study||232||
48592592|NCT00250458|101783142|FG001|STARTED|Overall Study||114||
48592593|NCT00250458|101783141|FG000|COMPLETED|Overall Study||200||
48592594|NCT00250458|101783142|FG001|COMPLETED|Overall Study||97||
48592595|NCT00250458|101783141|FG000|NOT COMPLETED|Overall Study||32||
48592596|NCT00250458|101783142|FG001|NOT COMPLETED|Overall Study||17||
48592597|NCT01346540|101783143|FG000|STARTED|Overall Study||4||
48592598|NCT01346540|101783144|FG001|STARTED|Overall Study||12||
48592599|NCT01346540|101783143|FG000|COMPLETED|Overall Study||1||
48592600|NCT01346540|101783144|FG001|COMPLETED|Overall Study||0||
48592601|NCT01346540|101783143|FG000|NOT COMPLETED|Overall Study||3||
48592602|NCT01346540|101783144|FG001|NOT COMPLETED|Overall Study||12||
48592603|NCT01131884|101783145|FG000|STARTED|Overall Study||1||
48592604|NCT01131884|101783146|FG001|STARTED|Overall Study||0||
48592605|NCT01131884|101783145|FG000|COMPLETED|Overall Study||1||
48141151|NCT04224155|100670349|FG001|NOT COMPLETED|Overall Study||2||
48141152|NCT00522275|100670350|FG000|STARTED|Overall Study||308||
48141153|NCT00522275|100670350|FG000|COMPLETED|Overall Study||138||
48141154|NCT00522275|100670350|FG000|NOT COMPLETED|Overall Study||170||
48141155|NCT02366338|100670351|FG000|STARTED|Overall Study||73||
48141156|NCT02366338|100670352|FG001|STARTED|Overall Study||39||
48294115|NCT02527343|101047537|FG001|NOT COMPLETED|RT Period: Weeks 1 to 52||7||
48294116|NCT02527343|101047538|FG002|NOT COMPLETED|RT Period: Weeks 1 to 52||0||
48294117|NCT02527343|101047539|FG003|NOT COMPLETED|RT Period: Weeks 1 to 52||0||
48294118|NCT02527343|101047540|FG004|NOT COMPLETED|RT Period: Weeks 1 to 52||0||
48592606|NCT01131884|101783146|FG001|COMPLETED|Overall Study||0||
48592607|NCT01131884|101783145|FG000|NOT COMPLETED|Overall Study||0||
48592608|NCT01131884|101783146|FG001|NOT COMPLETED|Overall Study||0||
48294119|NCT02527343|101047541|FG005|NOT COMPLETED|RT Period: Weeks 1 to 52||0||
48294120|NCT02527343|101047536|FG000|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0||
48294121|NCT02527343|101047537|FG001|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0||
48294122|NCT02527343|101047538|FG002|STARTED|RT Post Treatment Follow-up: Weeks 54-65||7||
48294123|NCT02527343|101047539|FG003|STARTED|RT Post Treatment Follow-up: Weeks 54-65||9||
48294124|NCT02527343|101047540|FG004|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0||
48294125|NCT02527343|101047541|FG005|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0||
48592609|NCT00843037|101783147|FG000|STARTED|Overall Study||25||
48592610|NCT00843037|101783147|FG000|COMPLETED|Overall Study||24||
48592611|NCT00843037|101783147|FG000|NOT COMPLETED|Overall Study||1||
48592612|NCT01546168|101783148|FG000|STARTED|Overall Study||55||
48592613|NCT01546168|101783149|FG001|STARTED|Overall Study||33||
48592614|NCT01546168|101783148|FG000|COMPLETED|Overall Study||51||
48592615|NCT01546168|101783149|FG001|COMPLETED|Overall Study||33||
48710616|NCT01340937|102077973|FG001|STARTED|Period 3: Toddler Vaccinations||658||
48710617|NCT01340937|102077974|FG002|STARTED|Period 3: Toddler Vaccinations||669||
48710618|NCT01340937|102077975|FG003|STARTED|Period 3: Toddler Vaccinations||329||
48710619|NCT01340937|102077972|FG000|COMPLETED|Period 3: Toddler Vaccinations||666||
48710620|NCT01340937|102077973|FG001|COMPLETED|Period 3: Toddler Vaccinations||641||
48710621|NCT01340937|102077974|FG002|COMPLETED|Period 3: Toddler Vaccinations||660||
48710622|NCT01340937|102077975|FG003|COMPLETED|Period 3: Toddler Vaccinations||319||
48710623|NCT01340937|102077972|FG000|NOT COMPLETED|Period 3: Toddler Vaccinations||9||
48710624|NCT01340937|102077973|FG001|NOT COMPLETED|Period 3: Toddler Vaccinations||17||
48710625|NCT01340937|102077974|FG002|NOT COMPLETED|Period 3: Toddler Vaccinations||9||
48710626|NCT01340937|102077975|FG003|NOT COMPLETED|Period 3: Toddler Vaccinations||10||
48710627|NCT00383643|102077976|FG000|STARTED|Overall Study||18||
48710628|NCT00383643|102077977|FG001|STARTED|Overall Study||16||
48710629|NCT00383643|102077978|FG002|STARTED|Overall Study||14||
48710630|NCT00383643|102077976|FG000|COMPLETED|Overall Study||17||
48710631|NCT00383643|102077977|FG001|COMPLETED|Overall Study||15||
48294174|NCT02527343|101047536|FG000|STARTED|PT Follow-up: Weeks 104 to 169||0||
48294175|NCT02527343|101047537|FG001|STARTED|PT Follow-up: Weeks 104 to 169||0||
48294176|NCT02527343|101047538|FG002|STARTED|PT Follow-up: Weeks 104 to 169||0||
48294177|NCT02527343|101047539|FG003|STARTED|PT Follow-up: Weeks 104 to 169||0||
48294178|NCT02527343|101047540|FG004|STARTED|PT Follow-up: Weeks 104 to 169||12||
48294179|NCT02527343|101047541|FG005|STARTED|PT Follow-up: Weeks 104 to 169||12||
48294180|NCT02527343|101047536|FG000|COMPLETED|PT Follow-up: Weeks 104 to 169||0||
48294181|NCT02527343|101047537|FG001|COMPLETED|PT Follow-up: Weeks 104 to 169||0||
48294182|NCT02527343|101047538|FG002|COMPLETED|PT Follow-up: Weeks 104 to 169||0||
48294183|NCT02527343|101047539|FG003|COMPLETED|PT Follow-up: Weeks 104 to 169||0||
48294184|NCT02527343|101047540|FG004|COMPLETED|PT Follow-up: Weeks 104 to 169||11||
48294185|NCT02527343|101047541|FG005|COMPLETED|PT Follow-up: Weeks 104 to 169||11||
48294186|NCT02527343|101047536|FG000|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0||
48294187|NCT02527343|101047537|FG001|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0||
48294188|NCT02527343|101047538|FG002|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0||
48294189|NCT02527343|101047539|FG003|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0||
48710830|NCT03446053|102078032|FG002|Randomized Set|Overall Study||6||
48710831|NCT03446053|102078033|FG003|Randomized Set|Overall Study||7||
48710832|NCT03446053|102078034|FG004|Randomized Set|Overall Study||6||
48710833|NCT03446053|102078035|FG005|Randomized Set|Overall Study||6||
48710834|NCT03446053|102078030|FG000|Safety Analysis Set|Overall Study||2||
48710835|NCT03446053|102078031|FG001|Safety Analysis Set|Overall Study||6||
48710836|NCT03446053|102078032|FG002|Safety Analysis Set|Overall Study||6||
48710837|NCT03446053|102078033|FG003|Safety Analysis Set|Overall Study||6||
48710838|NCT03446053|102078034|FG004|Safety Analysis Set|Overall Study||6||
48710839|NCT03446053|102078035|FG005|Safety Analysis Set|Overall Study||6||
48710840|NCT03446053|102078030|FG000|PK/PD Analysis Set|Overall Study||2||
48710841|NCT03446053|102078031|FG001|PK/PD Analysis Set|Overall Study||6||
48710842|NCT03446053|102078032|FG002|PK/PD Analysis Set|Overall Study||6||
48710843|NCT03446053|102078033|FG003|PK/PD Analysis Set|Overall Study||6||
48710844|NCT03446053|102078034|FG004|PK/PD Analysis Set|Overall Study||6||
48710845|NCT03446053|102078035|FG005|PK/PD Analysis Set|Overall Study||5||
48710846|NCT03446053|102078030|FG000|COMPLETED|Overall Study||2||
48710847|NCT03446053|102078031|FG001|COMPLETED|Overall Study||5||
48710848|NCT03446053|102078032|FG002|COMPLETED|Overall Study||6||
48710849|NCT03446053|102078033|FG003|COMPLETED|Overall Study||6||
48710850|NCT03446053|102078034|FG004|COMPLETED|Overall Study||6||
48710851|NCT03446053|102078035|FG005|COMPLETED|Overall Study||5||
48710852|NCT03446053|102078030|FG000|NOT COMPLETED|Overall Study||0||
48710853|NCT03446053|102078031|FG001|NOT COMPLETED|Overall Study||1||
48710854|NCT03446053|102078032|FG002|NOT COMPLETED|Overall Study||0||
48710855|NCT03446053|102078033|FG003|NOT COMPLETED|Overall Study||1||
48710856|NCT03446053|102078034|FG004|NOT COMPLETED|Overall Study||0||
48710857|NCT03446053|102078035|FG005|NOT COMPLETED|Overall Study||1||
48710858|NCT03849690|102078036|FG000|STARTED|Period 1 (3 Days)||12||
48710859|NCT03849690|102078036|FG000|COMPLETED|Period 1 (3 Days)||12||
48710860|NCT03849690|102078036|FG000|NOT COMPLETED|Period 1 (3 Days)||0||
48710861|NCT03849690|102078036|FG000|STARTED|Washout Period (at Least 4 Days)||12||
48710862|NCT03849690|102078036|FG000|COMPLETED|Washout Period (at Least 4 Days)||12||
48710863|NCT03849690|102078036|FG000|NOT COMPLETED|Washout Period (at Least 4 Days)||0||
48710864|NCT03849690|102078036|FG000|STARTED|Period 2 (6 Days)||12||
48710865|NCT03849690|102078036|FG000|COMPLETED|Period 2 (6 Days)||12||
48710866|NCT03849690|102078036|FG000|NOT COMPLETED|Period 2 (6 Days)||0||
48710867|NCT02275117|102078037|FG000|STARTED|Overall Study||131||
48710868|NCT02275117|102078038|FG001|STARTED|Overall Study||133||
48710869|NCT02275117|102078039|FG002|STARTED|Overall Study||134||
48710870|NCT02275117|102078040|FG003|STARTED|Overall Study||133||
48710871|NCT02275117|102078041|FG004|STARTED|Overall Study||134||
48710872|NCT02275117|102078037|FG000|Randomized and Treated|Overall Study||120|3 participants received duplicate randomization, participants are summarized in first group assigned|
48294190|NCT02527343|101047540|FG004|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||1||
48294191|NCT02527343|101047541|FG005|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||1||
48294192|NCT03353350|101047542|FG000|STARTED|30-week Core Treatment Period||102||
48294193|NCT03353350|101047543|FG001|STARTED|30-week Core Treatment Period||100||
48367931|NCT01856491|101230076|FG000|NOT COMPLETED|Overall Study||15||
48710873|NCT02275117|102078038|FG001|Randomized and Treated|Overall Study||123|3 participants received duplicate randomization, participants are summarized in first group assigned|
48710874|NCT02275117|102078039|FG002|Randomized and Treated|Overall Study||122|3 participants received duplicate randomization, participants are summarized in first group assigned|
48710875|NCT02275117|102078040|FG003|Randomized and Treated|Overall Study||130|3 participants received duplicate randomization, participants are summarized in first group assigned|
48710876|NCT02275117|102078041|FG004|Randomized and Treated|Overall Study||121|3 participants received duplicate randomization, participants are summarized in first group assigned|
48710877|NCT02275117|102078037|FG000|COMPLETED|Overall Study||97||
48710878|NCT02275117|102078038|FG001|COMPLETED|Overall Study||96||
48294194|NCT03353350|101047544|FG002|STARTED|30-week Core Treatment Period||101||
48294195|NCT03353350|101047545|FG003|STARTED|30-week Core Treatment Period||103||
48294196|NCT03353350|101047542|FG000|COMPLETED|30-week Core Treatment Period||80||
48710879|NCT02275117|102078039|FG002|COMPLETED|Overall Study||92||
48710880|NCT02275117|102078040|FG003|COMPLETED|Overall Study||100||
48710881|NCT02275117|102078041|FG004|COMPLETED|Overall Study||98||
48710882|NCT02275117|102078037|FG000|NOT COMPLETED|Overall Study||34||
48710883|NCT02275117|102078038|FG001|NOT COMPLETED|Overall Study||37||
48710884|NCT02275117|102078039|FG002|NOT COMPLETED|Overall Study||42||
48710885|NCT02275117|102078040|FG003|NOT COMPLETED|Overall Study||33||
48710886|NCT02275117|102078041|FG004|NOT COMPLETED|Overall Study||36||
48710887|NCT01728077|102078042|FG000|STARTED|Overall Study||19||
48710888|NCT01728077|102078043|FG001|STARTED|Overall Study||7||
48710889|NCT01728077|102078042|FG000|COMPLETED|Overall Study||11||
48710890|NCT01728077|102078043|FG001|COMPLETED|Overall Study||2||
48710891|NCT01728077|102078042|FG000|NOT COMPLETED|Overall Study||8||
48710892|NCT01728077|102078043|FG001|NOT COMPLETED|Overall Study||5||
48710893|NCT01971463|102078044|FG000|STARTED|Overall Study||81||
48710894|NCT01971463|102078044|FG000|COMPLETED|Overall Study||81||
48710895|NCT01971463|102078044|FG000|NOT COMPLETED|Overall Study||0||
48710896|NCT02046174|102078045|FG000|STARTED|Overall Study||42||
48710897|NCT02046174|102078046|FG001|STARTED|Overall Study||3||
48710898|NCT02046174|102078045|FG000|COMPLETED|Overall Study||41||
48710899|NCT02046174|102078046|FG001|COMPLETED|Overall Study||3||
48710900|NCT02046174|102078045|FG000|NOT COMPLETED|Overall Study||1||
48710901|NCT02046174|102078046|FG001|NOT COMPLETED|Overall Study||0||
48710902|NCT01933230|102078047|FG000|STARTED|Overall Study||2||
48710903|NCT01933230|102078047|FG000|COMPLETED|Overall Study||2||
48710904|NCT01933230|102078047|FG000|NOT COMPLETED|Overall Study||0||
48710905|NCT00309140|102078048|FG000|STARTED|Overall Study||23||
48710906|NCT00309140|102078048|FG000|Received at Least 1 Dose of Study Drug|Overall Study||23||
48710907|NCT00309140|102078048|FG000|COMPLETED|Overall Study||23||
48710908|NCT00309140|102078048|FG000|NOT COMPLETED|Overall Study||0||
48710909|NCT03946124|102078049|FG000|STARTED|Overall Study||74||
48710910|NCT03946124|102078049|FG000|COMPLETED|Overall Study||55||
48710911|NCT03946124|102078049|FG000|NOT COMPLETED|Overall Study||19||
48710912|NCT01143051|102078050|FG000|STARTED|Visit 1||4||
48710913|NCT01143051|102078051|FG001|STARTED|Visit 1||4||
48710914|NCT01143051|102078052|FG002|STARTED|Visit 1||4||
48710915|NCT01143051|102078053|FG003|STARTED|Visit 1||4||
48710916|NCT01143051|102078054|FG004|STARTED|Visit 1||4||
48710917|NCT01143051|102078055|FG005|STARTED|Visit 1||4||
48710918|NCT01143051|102078050|FG000|COMPLETED|Visit 1||4||
48710919|NCT01143051|102078051|FG001|COMPLETED|Visit 1||4||
48710920|NCT01143051|102078052|FG002|COMPLETED|Visit 1||4||
48710921|NCT01143051|102078053|FG003|COMPLETED|Visit 1||4||
48710922|NCT01143051|102078054|FG004|COMPLETED|Visit 1||4||
48710923|NCT01143051|102078055|FG005|COMPLETED|Visit 1||4||
48710924|NCT01143051|102078050|FG000|NOT COMPLETED|Visit 1||0||
48710925|NCT01143051|102078051|FG001|NOT COMPLETED|Visit 1||0||
48710926|NCT01143051|102078052|FG002|NOT COMPLETED|Visit 1||0||
48710927|NCT01143051|102078053|FG003|NOT COMPLETED|Visit 1||0||
48710928|NCT01143051|102078054|FG004|NOT COMPLETED|Visit 1||0||
48294197|NCT03353350|101047543|FG001|COMPLETED|30-week Core Treatment Period||81||
48294198|NCT03353350|101047544|FG002|COMPLETED|30-week Core Treatment Period||77||
48294199|NCT03353350|101047545|FG003|COMPLETED|30-week Core Treatment Period||81||
48294200|NCT03353350|101047542|FG000|NOT COMPLETED|30-week Core Treatment Period||22||
48294201|NCT03353350|101047543|FG001|NOT COMPLETED|30-week Core Treatment Period||19||
48294202|NCT03353350|101047544|FG002|NOT COMPLETED|30-week Core Treatment Period||24||
48294203|NCT03353350|101047545|FG003|NOT COMPLETED|30-week Core Treatment Period||22||
48294204|NCT03353350|101047542|FG000|STARTED|26-week Treatment Extension Period||80||
48294205|NCT03353350|101047543|FG001|STARTED|26-week Treatment Extension Period||81||
48294206|NCT03353350|101047544|FG002|STARTED|26-week Treatment Extension Period||77||
48710929|NCT01143051|102078055|FG005|NOT COMPLETED|Visit 1||0||
48710930|NCT01143051|102078050|FG000|STARTED|3-14 Day Washout||4||
48710931|NCT01143051|102078051|FG001|STARTED|3-14 Day Washout||4||
48710932|NCT01143051|102078052|FG002|STARTED|3-14 Day Washout||4||
48710933|NCT01143051|102078053|FG003|STARTED|3-14 Day Washout||4||
48710934|NCT01143051|102078054|FG004|STARTED|3-14 Day Washout||4||
48710935|NCT01143051|102078055|FG005|STARTED|3-14 Day Washout||4||
48710936|NCT01143051|102078050|FG000|COMPLETED|3-14 Day Washout||4||
48710937|NCT01143051|102078051|FG001|COMPLETED|3-14 Day Washout||4||
48710938|NCT01143051|102078052|FG002|COMPLETED|3-14 Day Washout||3||
48710939|NCT01143051|102078053|FG003|COMPLETED|3-14 Day Washout||4||
48710940|NCT01143051|102078054|FG004|COMPLETED|3-14 Day Washout||4||
48710941|NCT01143051|102078055|FG005|COMPLETED|3-14 Day Washout||4||
48710942|NCT01143051|102078050|FG000|NOT COMPLETED|3-14 Day Washout||0||
48710943|NCT01143051|102078051|FG001|NOT COMPLETED|3-14 Day Washout||0||
48710944|NCT01143051|102078052|FG002|NOT COMPLETED|3-14 Day Washout||1||
48710945|NCT01143051|102078053|FG003|NOT COMPLETED|3-14 Day Washout||0||
48710946|NCT01143051|102078054|FG004|NOT COMPLETED|3-14 Day Washout||0||
48710947|NCT01143051|102078055|FG005|NOT COMPLETED|3-14 Day Washout||0||
48710948|NCT01143051|102078050|FG000|STARTED|Visit 2||4||
48294207|NCT03353350|101047545|FG003|STARTED|26-week Treatment Extension Period||81||
48294208|NCT03353350|101047542|FG000|COMPLETED|26-week Treatment Extension Period||75||
48294209|NCT03353350|101047543|FG001|COMPLETED|26-week Treatment Extension Period||78||
48294210|NCT03353350|101047544|FG002|COMPLETED|26-week Treatment Extension Period||73||
48294211|NCT03353350|101047545|FG003|COMPLETED|26-week Treatment Extension Period||67||
48294212|NCT03353350|101047542|FG000|NOT COMPLETED|26-week Treatment Extension Period||5||
48294213|NCT03353350|101047543|FG001|NOT COMPLETED|26-week Treatment Extension Period||3||
48294214|NCT03353350|101047544|FG002|NOT COMPLETED|26-week Treatment Extension Period||4||
48294215|NCT03353350|101047545|FG003|NOT COMPLETED|26-week Treatment Extension Period||14||
48294216|NCT06135675|101047546|FG000|STARTED|Overall Study||8||
48294217|NCT06135675|101047547|FG001|STARTED|Overall Study||8||
48294218|NCT06135675|101047548|FG002|STARTED|Overall Study||8||
48294219|NCT06135675|101047549|FG003|STARTED|Overall Study||12||
48294220|NCT06135675|101047546|FG000|COMPLETED|Overall Study||7||
48592855|NCT02059434|101786333|FG008|STARTED|Period 1 (After Screening/run-in Period)||0||
48592856|NCT02059434|101786325|FG000|COMPLETED|Period 1 (After Screening/run-in Period)||2||
48592857|NCT02059434|101786326|FG001|COMPLETED|Period 1 (After Screening/run-in Period)||2||
48592858|NCT02059434|101786327|FG002|COMPLETED|Period 1 (After Screening/run-in Period)||2||
48294221|NCT06135675|101047547|FG001|COMPLETED|Overall Study||8||
48294222|NCT06135675|101047548|FG002|COMPLETED|Overall Study||8||
48294223|NCT06135675|101047549|FG003|COMPLETED|Overall Study||11||
48294224|NCT06135675|101047546|FG000|NOT COMPLETED|Overall Study||1||
48294225|NCT06135675|101047547|FG001|NOT COMPLETED|Overall Study||0||
48294226|NCT06135675|101047548|FG002|NOT COMPLETED|Overall Study||0||
48294227|NCT06135675|101047549|FG003|NOT COMPLETED|Overall Study||1||
48294228|NCT02699983|101047550|FG000|STARTED|Overall Study||18||
48294229|NCT02699983|101047551|FG001|STARTED|Overall Study||17||
48592859|NCT02059434|101786328|FG003|COMPLETED|Period 1 (After Screening/run-in Period)||2||
48592860|NCT02059434|101786329|FG004|COMPLETED|Period 1 (After Screening/run-in Period)||2||
48592861|NCT02059434|101786330|FG005|COMPLETED|Period 1 (After Screening/run-in Period)||2||
48592862|NCT02059434|101786331|FG006|COMPLETED|Period 1 (After Screening/run-in Period)||2||
48592863|NCT02059434|101786332|FG007|COMPLETED|Period 1 (After Screening/run-in Period)||3||
48592864|NCT02059434|101786333|FG008|COMPLETED|Period 1 (After Screening/run-in Period)||0||
48294230|NCT02699983|101047550|FG000|COMPLETED|Overall Study||17||
48294231|NCT02699983|101047551|FG001|COMPLETED|Overall Study||17||
48294232|NCT02699983|101047550|FG000|NOT COMPLETED|Overall Study||1||
48294233|NCT02699983|101047551|FG001|NOT COMPLETED|Overall Study||0||
48294234|NCT01174160|101047552|FG000|STARTED|Overall Study||61||
48294235|NCT01174160|101047553|FG001|STARTED|Overall Study||62||
48592865|NCT02059434|101786325|FG000|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0||
48592866|NCT02059434|101786326|FG001|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0||
48592867|NCT02059434|101786327|FG002|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0||
48294236|NCT01174160|101047552|FG000|Discontinued Pre Dose|Overall Study||6||
48294237|NCT01174160|101047553|FG001|Discontinued Pre Dose|Overall Study||6||
48294238|NCT01174160|101047552|FG000|Dosed|Overall Study||55||
48294239|NCT01174160|101047553|FG001|Dosed|Overall Study||56||
48294240|NCT01174160|101047552|FG000|Discontinued Post Dose|Overall Study||2||
48404094|NCT03689972|101321766|FG000|STARTED|Part2CrossoverPeriod(Week108uptoWeek156)||0||
48404095|NCT03689972|101321767|FG001|STARTED|Part2CrossoverPeriod(Week108uptoWeek156)||0||
48404096|NCT03689972|101321768|FG002|STARTED|Part2CrossoverPeriod(Week108uptoWeek156)||0||
48404097|NCT03689972|101321769|FG003|STARTED|Part2CrossoverPeriod(Week108uptoWeek156)||75||
48404098|NCT03689972|101321770|FG004|STARTED|Part2CrossoverPeriod(Week108uptoWeek156)||78||
48404099|NCT03689972|101321766|FG000|COMPLETED|Part2CrossoverPeriod(Week108uptoWeek156)||0|Completed denotes the participants that completed the study treatment.|
48404100|NCT03689972|101321767|FG001|COMPLETED|Part2CrossoverPeriod(Week108uptoWeek156)||0|Completed denotes the participants that completed the study treatment.|
48404101|NCT03689972|101321768|FG002|COMPLETED|Part2CrossoverPeriod(Week108uptoWeek156)||0|Completed denotes the participants that completed the study treatment.|
48404102|NCT03689972|101321769|FG003|COMPLETED|Part2CrossoverPeriod(Week108uptoWeek156)||63|Completed denotes the participants that completed the study treatment.|
48404103|NCT03689972|101321770|FG004|COMPLETED|Part2CrossoverPeriod(Week108uptoWeek156)||60|Completed denotes the participants that completed the study treatment.|
48710949|NCT01143051|102078051|FG001|STARTED|Visit 2||4||
48710950|NCT01143051|102078052|FG002|STARTED|Visit 2||3||
48710951|NCT01143051|102078053|FG003|STARTED|Visit 2||4||
48710952|NCT01143051|102078054|FG004|STARTED|Visit 2||4||
48710953|NCT01143051|102078055|FG005|STARTED|Visit 2||4||
48710954|NCT01143051|102078050|FG000|COMPLETED|Visit 2||4||
48710955|NCT01143051|102078051|FG001|COMPLETED|Visit 2||4||
48710956|NCT01143051|102078052|FG002|COMPLETED|Visit 2||3||
48710957|NCT01143051|102078053|FG003|COMPLETED|Visit 2||4||
48404104|NCT03689972|101321766|FG000|NOT COMPLETED|Part2CrossoverPeriod(Week108uptoWeek156)||0||
48404105|NCT03689972|101321767|FG001|NOT COMPLETED|Part2CrossoverPeriod(Week108uptoWeek156)||0||
48404106|NCT03689972|101321768|FG002|NOT COMPLETED|Part2CrossoverPeriod(Week108uptoWeek156)||0||
48404107|NCT03689972|101321769|FG003|NOT COMPLETED|Part2CrossoverPeriod(Week108uptoWeek156)||12||
48404108|NCT03689972|101321770|FG004|NOT COMPLETED|Part2CrossoverPeriod(Week108uptoWeek156)||18||
48404109|NCT00107172|101321771|FG000|STARTED|Overall Study||114||
48710958|NCT01143051|102078054|FG004|COMPLETED|Visit 2||4||
48710959|NCT01143051|102078055|FG005|COMPLETED|Visit 2||4||
48710960|NCT01143051|102078050|FG000|NOT COMPLETED|Visit 2||0||
48710961|NCT01143051|102078051|FG001|NOT COMPLETED|Visit 2||0||
48294241|NCT01174160|101047553|FG001|Discontinued Post Dose|Overall Study||0||
48294242|NCT01174160|101047552|FG000|COMPLETED|Overall Study||53||
48294243|NCT01174160|101047553|FG001|COMPLETED|Overall Study||56||
48294244|NCT01174160|101047552|FG000|NOT COMPLETED|Overall Study||8||
48294245|NCT01174160|101047553|FG001|NOT COMPLETED|Overall Study||6||
48294246|NCT01280812|101047554|FG000|STARTED|Overall Study||70||
48294247|NCT01280812|101047555|FG001|STARTED|Overall Study||71||
48294248|NCT01280812|101047556|FG002|STARTED|Overall Study||69||
48294249|NCT01280812|101047554|FG000|COMPLETED|Overall Study||67||
48294250|NCT01280812|101047555|FG001|COMPLETED|Overall Study||69||
48294251|NCT01280812|101047556|FG002|COMPLETED|Overall Study||68||
48294252|NCT01280812|101047554|FG000|NOT COMPLETED|Overall Study||3||
48404110|NCT00107172|101321772|FG001|STARTED|Overall Study||108||
48404111|NCT00107172|101321771|FG000|COMPLETED|Overall Study||109||
48404112|NCT00107172|101321772|FG001|COMPLETED|Overall Study||103||
48404113|NCT00107172|101321771|FG000|NOT COMPLETED|Overall Study||5||
48404114|NCT00107172|101321772|FG001|NOT COMPLETED|Overall Study||5||
48404115|NCT04083794|101321773|FG000|STARTED|Overall Study||90||
48404116|NCT04083794|101321773|FG000|COMPLETED|Overall Study||81||
48404117|NCT04083794|101321773|FG000|NOT COMPLETED|Overall Study||9||
48404118|NCT01863901|101321774|FG000|STARTED|Overall Study||19||
48710962|NCT01143051|102078052|FG002|NOT COMPLETED|Visit 2||0||
48710963|NCT01143051|102078053|FG003|NOT COMPLETED|Visit 2||0||
48710964|NCT01143051|102078054|FG004|NOT COMPLETED|Visit 2||0||
48710965|NCT01143051|102078055|FG005|NOT COMPLETED|Visit 2||0||
48710966|NCT01143051|102078050|FG000|STARTED|3-14 Day Washout||4||
48710967|NCT01143051|102078051|FG001|STARTED|3-14 Day Washout||4||
48710968|NCT01143051|102078052|FG002|STARTED|3-14 Day Washout||3||
48710969|NCT01143051|102078053|FG003|STARTED|3-14 Day Washout||4||
48710970|NCT01143051|102078054|FG004|STARTED|3-14 Day Washout||4||
48710971|NCT01143051|102078055|FG005|STARTED|3-14 Day Washout||4||
48710972|NCT01143051|102078050|FG000|COMPLETED|3-14 Day Washout||4||
48710973|NCT01143051|102078051|FG001|COMPLETED|3-14 Day Washout||4||
48710974|NCT01143051|102078052|FG002|COMPLETED|3-14 Day Washout||3||
48710975|NCT01143051|102078053|FG003|COMPLETED|3-14 Day Washout||4||
48710976|NCT01143051|102078054|FG004|COMPLETED|3-14 Day Washout||4||
48710977|NCT01143051|102078055|FG005|COMPLETED|3-14 Day Washout||3||
48294253|NCT01280812|101047555|FG001|NOT COMPLETED|Overall Study||2||
48294254|NCT01280812|101047556|FG002|NOT COMPLETED|Overall Study||1||
48294255|NCT01337115|101047557|FG000|STARTED|Overall Study||25||
48710978|NCT01143051|102078050|FG000|NOT COMPLETED|3-14 Day Washout||0||
48710979|NCT01143051|102078051|FG001|NOT COMPLETED|3-14 Day Washout||0||
48294256|NCT01337115|101047558|FG001|STARTED|Overall Study||25||
48294257|NCT01337115|101047557|FG000|COMPLETED|Overall Study||23||
48710980|NCT01143051|102078052|FG002|NOT COMPLETED|3-14 Day Washout||0||
48710981|NCT01143051|102078053|FG003|NOT COMPLETED|3-14 Day Washout||0||
48710982|NCT01143051|102078054|FG004|NOT COMPLETED|3-14 Day Washout||0||
48710983|NCT01143051|102078055|FG005|NOT COMPLETED|3-14 Day Washout||1||
48710984|NCT01143051|102078050|FG000|STARTED|Visit 3||4||
48710985|NCT01143051|102078051|FG001|STARTED|Visit 3||4||
48710986|NCT01143051|102078052|FG002|STARTED|Visit 3||3||
48710987|NCT01143051|102078053|FG003|STARTED|Visit 3||4||
48710988|NCT01143051|102078054|FG004|STARTED|Visit 3||4||
48710989|NCT01143051|102078055|FG005|STARTED|Visit 3||3||
48710990|NCT01143051|102078050|FG000|COMPLETED|Visit 3||4||
48710991|NCT01143051|102078051|FG001|COMPLETED|Visit 3||4||
48710992|NCT01143051|102078052|FG002|COMPLETED|Visit 3||3||
48710993|NCT01143051|102078053|FG003|COMPLETED|Visit 3||4||
48710994|NCT01143051|102078054|FG004|COMPLETED|Visit 3||4||
48710995|NCT01143051|102078055|FG005|COMPLETED|Visit 3||3||
48294258|NCT01337115|101047558|FG001|COMPLETED|Overall Study||25||
48294259|NCT01337115|101047557|FG000|NOT COMPLETED|Overall Study||2||
48294260|NCT01337115|101047558|FG001|NOT COMPLETED|Overall Study||0||
48294261|NCT00029172|101047559|FG000|STARTED|Overall Study||188||
48294262|NCT00029172|101047559|FG000|COMPLETED|Overall Study||182||
48294263|NCT00029172|101047559|FG000|NOT COMPLETED|Overall Study||6||
48294264|NCT02038543|101047560|FG000|STARTED|Overall Study||7||
48294265|NCT02038543|101047561|FG001|STARTED|Overall Study||4||
48294266|NCT02038543|101047562|FG002|STARTED|Overall Study||8||
48710996|NCT01143051|102078050|FG000|NOT COMPLETED|Visit 3||0||
48710997|NCT01143051|102078051|FG001|NOT COMPLETED|Visit 3||0||
48710998|NCT01143051|102078052|FG002|NOT COMPLETED|Visit 3||0||
48294267|NCT02038543|101047563|FG003|STARTED|Overall Study||3||
48294268|NCT02038543|101047560|FG000|COMPLETED|Overall Study||7||
48294269|NCT02038543|101047561|FG001|COMPLETED|Overall Study||4||
48294270|NCT02038543|101047562|FG002|COMPLETED|Overall Study||8||
48294271|NCT02038543|101047563|FG003|COMPLETED|Overall Study||1||
48294272|NCT02038543|101047560|FG000|NOT COMPLETED|Overall Study||0||
48294273|NCT02038543|101047561|FG001|NOT COMPLETED|Overall Study||0||
48294274|NCT02038543|101047562|FG002|NOT COMPLETED|Overall Study||0||
48710999|NCT01143051|102078053|FG003|NOT COMPLETED|Visit 3||0||
48711000|NCT01143051|102078054|FG004|NOT COMPLETED|Visit 3||0||
48711001|NCT01143051|102078055|FG005|NOT COMPLETED|Visit 3||0||
48711002|NCT00118352|102078056|FG000|STARTED|Overall Study||12||
48711003|NCT00118352|102078057|FG001|STARTED|Overall Study||0||
48711004|NCT00118352|102078058|FG002|STARTED|Overall Study||0||
48711005|NCT00118352|102078056|FG000|COMPLETED|Overall Study||12||
48711006|NCT00118352|102078057|FG001|COMPLETED|Overall Study||0||
48711007|NCT00118352|102078058|FG002|COMPLETED|Overall Study||0||
48711008|NCT00118352|102078056|FG000|NOT COMPLETED|Overall Study||0||
48711009|NCT00118352|102078057|FG001|NOT COMPLETED|Overall Study||0||
48711010|NCT00118352|102078058|FG002|NOT COMPLETED|Overall Study||0||
48711011|NCT02573246|102078059|FG000|STARTED|Overall Study||14||
48711012|NCT02573246|102078060|FG001|STARTED|Overall Study||15||
48711013|NCT02573246|102078061|FG002|STARTED|Overall Study||18||
48711014|NCT02573246|102078062|FG003|STARTED|Overall Study||16||
48711015|NCT02573246|102078063|FG004|STARTED|Overall Study||15||
48711016|NCT02573246|102078059|FG000|COMPLETED|Overall Study||11||
48711017|NCT02573246|102078060|FG001|COMPLETED|Overall Study||14||
48711018|NCT02573246|102078061|FG002|COMPLETED|Overall Study||15||
48711019|NCT02573246|102078062|FG003|COMPLETED|Overall Study||14||
48711020|NCT02573246|102078063|FG004|COMPLETED|Overall Study||11||
48711021|NCT02573246|102078059|FG000|NOT COMPLETED|Overall Study||3||
48711022|NCT02573246|102078060|FG001|NOT COMPLETED|Overall Study||1||
48711023|NCT02573246|102078061|FG002|NOT COMPLETED|Overall Study||3||
48711024|NCT02573246|102078062|FG003|NOT COMPLETED|Overall Study||2||
48711025|NCT02573246|102078063|FG004|NOT COMPLETED|Overall Study||4||
48711026|NCT01007071|102078064|FG000|STARTED|Overall Study||6||
48711027|NCT01007071|102078065|FG001|STARTED|Overall Study||5||
48711028|NCT01007071|102078064|FG000|COMPLETED|Overall Study||6||
48711029|NCT01007071|102078065|FG001|COMPLETED|Overall Study||5||
48711030|NCT01007071|102078064|FG000|NOT COMPLETED|Overall Study||0||
48294275|NCT02038543|101047563|FG003|NOT COMPLETED|Overall Study||2||
48294276|NCT00491829|101047564|FG000|STARTED|Overall Study||311||
48294277|NCT00491829|101047565|FG001|STARTED|Overall Study||316||
48294278|NCT00491829|101047566|FG002|STARTED|Overall Study||318||
48294279|NCT00491829|101047564|FG000|COMPLETED|Overall Study||216||
48294280|NCT00491829|101047565|FG001|COMPLETED|Overall Study||202||
48294281|NCT00491829|101047566|FG002|COMPLETED|Overall Study||243||
48294282|NCT00491829|101047564|FG000|NOT COMPLETED|Overall Study||95||
48294283|NCT00491829|101047565|FG001|NOT COMPLETED|Overall Study||114||
48294284|NCT00491829|101047566|FG002|NOT COMPLETED|Overall Study||75||
48294285|NCT01422226|101047567|FG000|STARTED|Overall Study||1||
48294286|NCT01422226|101047568|FG001|STARTED|Overall Study||2||
48294287|NCT01422226|101047567|FG000|COMPLETED|Overall Study||1||
48711031|NCT01007071|102078065|FG001|NOT COMPLETED|Overall Study||0||
48711032|NCT01457950|102078066|FG000|STARTED|Double-Blind Phase||69||
48711033|NCT01457950|102078067|FG001|STARTED|Double-Blind Phase||66||
48711034|NCT01457950|102078068|FG002|STARTED|Double-Blind Phase||0||
48711035|NCT01457950|102078069|FG003|STARTED|Double-Blind Phase||0||
48711036|NCT01457950|102078066|FG000|Completed the 6 Month Assessment|Double-Blind Phase||62||
48711037|NCT01457950|102078067|FG001|Completed the 6 Month Assessment|Double-Blind Phase||64||
48711038|NCT01457950|102078068|FG002|Completed the 6 Month Assessment|Double-Blind Phase||0||
48711039|NCT01457950|102078069|FG003|Completed the 6 Month Assessment|Double-Blind Phase||0||
48711040|NCT01457950|102078066|FG000|COMPLETED|Double-Blind Phase||60||
48711041|NCT01457950|102078067|FG001|COMPLETED|Double-Blind Phase||63||
48294288|NCT01422226|101047568|FG001|COMPLETED|Overall Study||2||
48711042|NCT01457950|102078068|FG002|COMPLETED|Double-Blind Phase||0||
48711043|NCT01457950|102078069|FG003|COMPLETED|Double-Blind Phase||0||
48711044|NCT01457950|102078066|FG000|NOT COMPLETED|Double-Blind Phase||9||
48711045|NCT01457950|102078067|FG001|NOT COMPLETED|Double-Blind Phase||3||
48711046|NCT01457950|102078068|FG002|NOT COMPLETED|Double-Blind Phase||0||
48294289|NCT01422226|101047567|FG000|NOT COMPLETED|Overall Study||0||
48294290|NCT01422226|101047568|FG001|NOT COMPLETED|Overall Study||0||
48294291|NCT03019185|101047569|FG000|STARTED|Overall Study||30||
48711047|NCT01457950|102078069|FG003|NOT COMPLETED|Double-Blind Phase||0||
48711048|NCT01457950|102078066|FG000|STARTED|Open-Label Phase||0||
48711049|NCT01457950|102078067|FG001|STARTED|Open-Label Phase||0||
48711050|NCT01457950|102078068|FG002|STARTED|Open-Label Phase||60||
48711051|NCT01457950|102078069|FG003|STARTED|Open-Label Phase||63||
48294292|NCT03019185|101047570|FG001|STARTED|Overall Study||80||
48294293|NCT03019185|101047571|FG002|STARTED|Overall Study||77||
48294294|NCT03019185|101047569|FG000|COMPLETED|Overall Study||24||
48294295|NCT03019185|101047570|FG001|COMPLETED|Overall Study||79||
48294296|NCT03019185|101047571|FG002|COMPLETED|Overall Study||75||
48294297|NCT03019185|101047569|FG000|NOT COMPLETED|Overall Study||6||
48711052|NCT01457950|102078066|FG000|COMPLETED|Open-Label Phase||0||
48711053|NCT01457950|102078067|FG001|COMPLETED|Open-Label Phase||0||
48711054|NCT01457950|102078068|FG002|COMPLETED|Open-Label Phase||58||
48711055|NCT01457950|102078069|FG003|COMPLETED|Open-Label Phase||61||
48711056|NCT01457950|102078066|FG000|NOT COMPLETED|Open-Label Phase||0||
48711057|NCT01457950|102078067|FG001|NOT COMPLETED|Open-Label Phase||0||
48711058|NCT01457950|102078068|FG002|NOT COMPLETED|Open-Label Phase||2||
48711059|NCT01457950|102078069|FG003|NOT COMPLETED|Open-Label Phase||2||
48711060|NCT03190265|102078070|FG000|STARTED|Overall Study||31||
48711061|NCT03190265|102078071|FG001|STARTED|Overall Study||30||
48404119|NCT01863901|101321774|FG000|COMPLETED|Overall Study||19|Completion of Day 30 timepoint is considered a completed subject.|
48404120|NCT01863901|101321774|FG000|NOT COMPLETED|Overall Study||0||
48711062|NCT03190265|102078070|FG000|COMPLETED|Overall Study||11||
48711063|NCT03190265|102078071|FG001|COMPLETED|Overall Study||8||
48711064|NCT03190265|102078070|FG000|NOT COMPLETED|Overall Study||20||
48711065|NCT03190265|102078071|FG001|NOT COMPLETED|Overall Study||22||
48711066|NCT00875056|102078072|FG000|STARTED|Overall Study||39||
48711067|NCT00875056|102078073|FG001|STARTED|Overall Study||11||
48711068|NCT00875056|102078074|FG002|STARTED|Overall Study||6||
48711069|NCT00875056|102078072|FG000|COMPLETED|Overall Study||16||
48294298|NCT03019185|101047570|FG001|NOT COMPLETED|Overall Study||1||
48294299|NCT03019185|101047571|FG002|NOT COMPLETED|Overall Study||2||
48294300|NCT03021954|101047572|FG000|STARTED|Overall Study||43||
48294301|NCT03021954|101047573|FG001|STARTED|Overall Study||73||
48294302|NCT03021954|101047572|FG000|COMPLETED|Overall Study||29||
48294303|NCT03021954|101047573|FG001|COMPLETED|Overall Study||29||
48294304|NCT03021954|101047572|FG000|NOT COMPLETED|Overall Study||14||
48294305|NCT03021954|101047573|FG001|NOT COMPLETED|Overall Study||44||
48294306|NCT03628898|101047574|FG000|STARTED|Overall Study||27||
48294307|NCT03628898|101047574|FG000|COMPLETED|Overall Study||26||
48294308|NCT03628898|101047574|FG000|NOT COMPLETED|Overall Study||1||
48294309|NCT01620255|101047575|FG000|STARTED|Overall Study||73||
48294310|NCT01620255|101047576|FG001|STARTED|Overall Study||71||
48294311|NCT01620255|101047577|FG002|STARTED|Overall Study||70||
48294312|NCT01620255|101047578|FG003|STARTED|Overall Study||73||
48294313|NCT01620255|101047579|FG004|STARTED|Overall Study||70||
48294314|NCT01620255|101047575|FG000|Treated|Overall Study||73||
48294315|NCT01620255|101047576|FG001|Treated|Overall Study||71||
48294316|NCT01620255|101047577|FG002|Treated|Overall Study||70||
48294317|NCT01620255|101047578|FG003|Treated|Overall Study||73||
48294318|NCT01620255|101047579|FG004|Treated|Overall Study||70||
48294319|NCT01620255|101047575|FG000|COMPLETED|Overall Study||69||
48294320|NCT01620255|101047576|FG001|COMPLETED|Overall Study||65||
48294321|NCT01620255|101047577|FG002|COMPLETED|Overall Study||68||
48294322|NCT01620255|101047578|FG003|COMPLETED|Overall Study||70||
48294323|NCT01620255|101047579|FG004|COMPLETED|Overall Study||64||
48294324|NCT01620255|101047575|FG000|NOT COMPLETED|Overall Study||4||
48294325|NCT01620255|101047576|FG001|NOT COMPLETED|Overall Study||6||
48294326|NCT01620255|101047577|FG002|NOT COMPLETED|Overall Study||2||
48294327|NCT01620255|101047578|FG003|NOT COMPLETED|Overall Study||3||
48294328|NCT01620255|101047579|FG004|NOT COMPLETED|Overall Study||6||
48294329|NCT00250679|101047580|FG000|STARTED|Overall Study||147||
48711070|NCT00875056|102078073|FG001|COMPLETED|Overall Study||2||
48711071|NCT00875056|102078074|FG002|COMPLETED|Overall Study||0||
48711072|NCT00875056|102078072|FG000|NOT COMPLETED|Overall Study||23||
48711073|NCT00875056|102078073|FG001|NOT COMPLETED|Overall Study||9||
48711074|NCT00875056|102078074|FG002|NOT COMPLETED|Overall Study||6||
48711075|NCT02956850|102078075|FG000|STARTED|Overall Study||16||
48711076|NCT02956850|102078076|FG001|STARTED|Overall Study||8||
48711077|NCT02956850|102078077|FG002|STARTED|Overall Study||8||
48294330|NCT00250679|101047581|FG001|STARTED|Overall Study||149||
48294331|NCT00250679|101047582|FG002|STARTED|Overall Study||147||
48294332|NCT00250679|101047580|FG000|COMPLETED|Overall Study||108||
48294333|NCT00250679|101047581|FG001|COMPLETED|Overall Study||100||
48404121|NCT00557323|101321775|FG000|STARTED|Overall Study||34||
48404122|NCT00557323|101321775|FG000|COMPLETED|Overall Study||27||
48294334|NCT00250679|101047582|FG002|COMPLETED|Overall Study||103||
48404123|NCT00557323|101321775|FG000|NOT COMPLETED|Overall Study||7||
48711078|NCT02956850|102078078|FG003|STARTED|Overall Study||8||
48711079|NCT02956850|102078079|FG004|STARTED|Overall Study||8||
48711080|NCT02956850|102078080|FG005|STARTED|Overall Study||8||
48711081|NCT02956850|102078081|FG006|STARTED|Overall Study||8||
48294335|NCT00250679|101047580|FG000|NOT COMPLETED|Overall Study||39||
48294336|NCT00250679|101047581|FG001|NOT COMPLETED|Overall Study||49||
48294337|NCT00250679|101047582|FG002|NOT COMPLETED|Overall Study||44||
48294338|NCT00717067|101047583|FG000|STARTED|Part 1a: Normal/Mild/Moderate Group||6||
48294339|NCT00717067|101047584|FG001|STARTED|Part 1a: Normal/Mild/Moderate Group||6||
48711082|NCT02956850|102078082|FG007|STARTED|Overall Study||8||
48711083|NCT02956850|102078083|FG008|STARTED|Overall Study||8||
48711084|NCT02956850|102078084|FG009|STARTED|Overall Study||6||
48592868|NCT02059434|101786328|FG003|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0||
48592869|NCT02059434|101786329|FG004|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0||
48592870|NCT02059434|101786330|FG005|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0||
48592871|NCT02059434|101786331|FG006|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0||
48592872|NCT02059434|101786332|FG007|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0||
48592873|NCT02059434|101786333|FG008|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0||
48592874|NCT02059434|101786325|FG000|STARTED|Washout Between Periods 1 and 2||2||
48592875|NCT02059434|101786326|FG001|STARTED|Washout Between Periods 1 and 2||2||
48592876|NCT02059434|101786327|FG002|STARTED|Washout Between Periods 1 and 2||2||
48592877|NCT02059434|101786328|FG003|STARTED|Washout Between Periods 1 and 2||2||
48294340|NCT00717067|101047585|FG002|STARTED|Part 1a: Normal/Mild/Moderate Group||6||
48294341|NCT00717067|101047586|FG003|STARTED|Part 1a: Normal/Mild/Moderate Group||0||
48294342|NCT00717067|101047587|FG004|STARTED|Part 1a: Normal/Mild/Moderate Group||0||
48294343|NCT00717067|101047583|FG000|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6||
48294344|NCT00717067|101047584|FG001|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6||
48592878|NCT02059434|101786329|FG004|STARTED|Washout Between Periods 1 and 2||2||
48592879|NCT02059434|101786330|FG005|STARTED|Washout Between Periods 1 and 2||2||
48592880|NCT02059434|101786331|FG006|STARTED|Washout Between Periods 1 and 2||2||
48592881|NCT02059434|101786332|FG007|STARTED|Washout Between Periods 1 and 2||3||
48592882|NCT02059434|101786333|FG008|STARTED|Washout Between Periods 1 and 2||0||
48592883|NCT02059434|101786325|FG000|COMPLETED|Washout Between Periods 1 and 2||2||
48592884|NCT02059434|101786326|FG001|COMPLETED|Washout Between Periods 1 and 2||2||
48592885|NCT02059434|101786327|FG002|COMPLETED|Washout Between Periods 1 and 2||2||
48592886|NCT02059434|101786328|FG003|COMPLETED|Washout Between Periods 1 and 2||2||
48592887|NCT02059434|101786329|FG004|COMPLETED|Washout Between Periods 1 and 2||2||
48592888|NCT02059434|101786330|FG005|COMPLETED|Washout Between Periods 1 and 2||2||
48592889|NCT02059434|101786331|FG006|COMPLETED|Washout Between Periods 1 and 2||2||
48592890|NCT02059434|101786332|FG007|COMPLETED|Washout Between Periods 1 and 2||2||
48592891|NCT02059434|101786333|FG008|COMPLETED|Washout Between Periods 1 and 2||0||
48592892|NCT02059434|101786325|FG000|NOT COMPLETED|Washout Between Periods 1 and 2||0||
48592893|NCT02059434|101786326|FG001|NOT COMPLETED|Washout Between Periods 1 and 2||0||
48592894|NCT02059434|101786327|FG002|NOT COMPLETED|Washout Between Periods 1 and 2||0||
48592895|NCT02059434|101786328|FG003|NOT COMPLETED|Washout Between Periods 1 and 2||0||
48592896|NCT02059434|101786329|FG004|NOT COMPLETED|Washout Between Periods 1 and 2||0||
48592897|NCT02059434|101786330|FG005|NOT COMPLETED|Washout Between Periods 1 and 2||0||
48592898|NCT02059434|101786331|FG006|NOT COMPLETED|Washout Between Periods 1 and 2||0||
48294345|NCT00717067|101047585|FG002|COMPLETED|Part 1a: Normal/Mild/Moderate Group||5||
48294346|NCT00717067|101047586|FG003|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0||
48294347|NCT00717067|101047587|FG004|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0||
48294348|NCT00717067|101047583|FG000|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0||
48294349|NCT00717067|101047584|FG001|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0||
48294350|NCT00717067|101047585|FG002|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||1||
48294351|NCT00717067|101047586|FG003|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0||
48294352|NCT00717067|101047587|FG004|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0||
48294353|NCT00717067|101047583|FG000|STARTED|Part 1b: Severe Renal Impairment||0||
48592899|NCT02059434|101786332|FG007|NOT COMPLETED|Washout Between Periods 1 and 2||1||
48592900|NCT02059434|101786333|FG008|NOT COMPLETED|Washout Between Periods 1 and 2||0||
48592901|NCT02059434|101786325|FG000|STARTED|Period 2||2||
48592902|NCT02059434|101786326|FG001|STARTED|Period 2||2||
48592903|NCT02059434|101786327|FG002|STARTED|Period 2||2||
48294354|NCT00717067|101047584|FG001|STARTED|Part 1b: Severe Renal Impairment||0||
48294355|NCT00717067|101047585|FG002|STARTED|Part 1b: Severe Renal Impairment||0||
48294356|NCT00717067|101047586|FG003|STARTED|Part 1b: Severe Renal Impairment||6||
48294357|NCT00717067|101047587|FG004|STARTED|Part 1b: Severe Renal Impairment||0||
48294358|NCT00717067|101047583|FG000|COMPLETED|Part 1b: Severe Renal Impairment||0||
48294359|NCT00717067|101047584|FG001|COMPLETED|Part 1b: Severe Renal Impairment||0||
48294360|NCT00717067|101047585|FG002|COMPLETED|Part 1b: Severe Renal Impairment||0||
48294361|NCT00717067|101047586|FG003|COMPLETED|Part 1b: Severe Renal Impairment||6||
48294362|NCT00717067|101047587|FG004|COMPLETED|Part 1b: Severe Renal Impairment||0||
48294363|NCT00717067|101047583|FG000|NOT COMPLETED|Part 1b: Severe Renal Impairment||0||
48294364|NCT00717067|101047584|FG001|NOT COMPLETED|Part 1b: Severe Renal Impairment||0||
48294365|NCT00717067|101047585|FG002|NOT COMPLETED|Part 1b: Severe Renal Impairment||0||
48294366|NCT00717067|101047586|FG003|NOT COMPLETED|Part 1b: Severe Renal Impairment||0||
48592904|NCT02059434|101786328|FG003|STARTED|Period 2||2||
48592905|NCT02059434|101786329|FG004|STARTED|Period 2||2||
48294367|NCT00717067|101047587|FG004|NOT COMPLETED|Part 1b: Severe Renal Impairment||0||
48294368|NCT00717067|101047583|FG000|STARTED|Part 2: End Stage Renal Disease||0||
48294369|NCT00717067|101047584|FG001|STARTED|Part 2: End Stage Renal Disease||0||
48294370|NCT00717067|101047585|FG002|STARTED|Part 2: End Stage Renal Disease||0||
48294371|NCT00717067|101047586|FG003|STARTED|Part 2: End Stage Renal Disease||0||
48592906|NCT02059434|101786330|FG005|STARTED|Period 2||2||
48592907|NCT02059434|101786331|FG006|STARTED|Period 2||2||
48592908|NCT02059434|101786332|FG007|STARTED|Period 2||2||
48294372|NCT00717067|101047587|FG004|STARTED|Part 2: End Stage Renal Disease||6||
48592909|NCT02059434|101786333|FG008|STARTED|Period 2||0||
48592910|NCT02059434|101786325|FG000|COMPLETED|Period 2||2||
48592911|NCT02059434|101786326|FG001|COMPLETED|Period 2||2||
48592912|NCT02059434|101786327|FG002|COMPLETED|Period 2||2||
48592913|NCT02059434|101786328|FG003|COMPLETED|Period 2||2||
48592914|NCT02059434|101786329|FG004|COMPLETED|Period 2||2||
48592915|NCT02059434|101786330|FG005|COMPLETED|Period 2||2||
48592916|NCT02059434|101786331|FG006|COMPLETED|Period 2||2||
48592917|NCT02059434|101786332|FG007|COMPLETED|Period 2||2||
48592918|NCT02059434|101786333|FG008|COMPLETED|Period 2||0||
48592919|NCT02059434|101786325|FG000|NOT COMPLETED|Period 2||0||
48592920|NCT02059434|101786326|FG001|NOT COMPLETED|Period 2||0||
48592921|NCT02059434|101786327|FG002|NOT COMPLETED|Period 2||0||
48592922|NCT02059434|101786328|FG003|NOT COMPLETED|Period 2||0||
48592923|NCT02059434|101786329|FG004|NOT COMPLETED|Period 2||0||
48592924|NCT02059434|101786330|FG005|NOT COMPLETED|Period 2||0||
48592925|NCT02059434|101786331|FG006|NOT COMPLETED|Period 2||0||
48592926|NCT02059434|101786332|FG007|NOT COMPLETED|Period 2||0||
48592927|NCT02059434|101786333|FG008|NOT COMPLETED|Period 2||0||
48592928|NCT02059434|101786325|FG000|STARTED|Washout Between Periods 2 and 3||2||
48294373|NCT00717067|101047583|FG000|COMPLETED|Part 2: End Stage Renal Disease||0||
48294374|NCT00717067|101047584|FG001|COMPLETED|Part 2: End Stage Renal Disease||0||
48294375|NCT00717067|101047585|FG002|COMPLETED|Part 2: End Stage Renal Disease||0||
48592929|NCT02059434|101786326|FG001|STARTED|Washout Between Periods 2 and 3||2||
48294376|NCT00717067|101047586|FG003|COMPLETED|Part 2: End Stage Renal Disease||0||
48592930|NCT02059434|101786327|FG002|STARTED|Washout Between Periods 2 and 3||2||
48592931|NCT02059434|101786328|FG003|STARTED|Washout Between Periods 2 and 3||2||
48592932|NCT02059434|101786329|FG004|STARTED|Washout Between Periods 2 and 3||2||
48592933|NCT02059434|101786330|FG005|STARTED|Washout Between Periods 2 and 3||2||
48592934|NCT02059434|101786331|FG006|STARTED|Washout Between Periods 2 and 3||2||
48592935|NCT02059434|101786332|FG007|STARTED|Washout Between Periods 2 and 3||2||
48592936|NCT02059434|101786333|FG008|STARTED|Washout Between Periods 2 and 3||0||
48592937|NCT02059434|101786325|FG000|COMPLETED|Washout Between Periods 2 and 3||2||
48592938|NCT02059434|101786326|FG001|COMPLETED|Washout Between Periods 2 and 3||2||
48592939|NCT02059434|101786327|FG002|COMPLETED|Washout Between Periods 2 and 3||2||
48294377|NCT00717067|101047587|FG004|COMPLETED|Part 2: End Stage Renal Disease||6||
48294378|NCT00717067|101047583|FG000|NOT COMPLETED|Part 2: End Stage Renal Disease||0||
48592940|NCT02059434|101786328|FG003|COMPLETED|Washout Between Periods 2 and 3||2||
48592941|NCT02059434|101786329|FG004|COMPLETED|Washout Between Periods 2 and 3||2||
48592942|NCT02059434|101786330|FG005|COMPLETED|Washout Between Periods 2 and 3||2||
48592943|NCT02059434|101786331|FG006|COMPLETED|Washout Between Periods 2 and 3||2||
48592944|NCT02059434|101786332|FG007|COMPLETED|Washout Between Periods 2 and 3||2||
48592945|NCT02059434|101786333|FG008|COMPLETED|Washout Between Periods 2 and 3||0||
48592946|NCT02059434|101786325|FG000|NOT COMPLETED|Washout Between Periods 2 and 3||0||
48592947|NCT02059434|101786326|FG001|NOT COMPLETED|Washout Between Periods 2 and 3||0||
48592948|NCT02059434|101786327|FG002|NOT COMPLETED|Washout Between Periods 2 and 3||0||
48592949|NCT02059434|101786328|FG003|NOT COMPLETED|Washout Between Periods 2 and 3||0||
48592950|NCT02059434|101786329|FG004|NOT COMPLETED|Washout Between Periods 2 and 3||0||
48592951|NCT02059434|101786330|FG005|NOT COMPLETED|Washout Between Periods 2 and 3||0||
48592952|NCT02059434|101786331|FG006|NOT COMPLETED|Washout Between Periods 2 and 3||0||
48592953|NCT02059434|101786332|FG007|NOT COMPLETED|Washout Between Periods 2 and 3||0||
48592954|NCT02059434|101786333|FG008|NOT COMPLETED|Washout Between Periods 2 and 3||0||
48592955|NCT02059434|101786325|FG000|STARTED|Period 3||2||
48592956|NCT02059434|101786326|FG001|STARTED|Period 3||2||
48592957|NCT02059434|101786327|FG002|STARTED|Period 3||2||
48592958|NCT02059434|101786328|FG003|STARTED|Period 3||2||
48592959|NCT02059434|101786329|FG004|STARTED|Period 3||2||
48592960|NCT02059434|101786330|FG005|STARTED|Period 3||2||
48592961|NCT02059434|101786331|FG006|STARTED|Period 3||2||
48592962|NCT02059434|101786332|FG007|STARTED|Period 3||2||
48592963|NCT02059434|101786333|FG008|STARTED|Period 3||0||
48592964|NCT02059434|101786325|FG000|COMPLETED|Period 3||2||
48592965|NCT02059434|101786326|FG001|COMPLETED|Period 3||2||
48592966|NCT02059434|101786327|FG002|COMPLETED|Period 3||2||
48592967|NCT02059434|101786328|FG003|COMPLETED|Period 3||2||
48294379|NCT00717067|101047584|FG001|NOT COMPLETED|Part 2: End Stage Renal Disease||0||
48294380|NCT00717067|101047585|FG002|NOT COMPLETED|Part 2: End Stage Renal Disease||0||
48294381|NCT00717067|101047586|FG003|NOT COMPLETED|Part 2: End Stage Renal Disease||0||
48592968|NCT02059434|101786329|FG004|COMPLETED|Period 3||2||
48592969|NCT02059434|101786330|FG005|COMPLETED|Period 3||2||
48592970|NCT02059434|101786331|FG006|COMPLETED|Period 3||2||
48294382|NCT00717067|101047587|FG004|NOT COMPLETED|Part 2: End Stage Renal Disease||0||
48294383|NCT01935180|101047588|FG000|STARTED|Overall Study||573||
48592971|NCT02059434|101786332|FG007|COMPLETED|Period 3||2||
48592972|NCT02059434|101786333|FG008|COMPLETED|Period 3||0||
48592973|NCT02059434|101786325|FG000|NOT COMPLETED|Period 3||0||
48592974|NCT02059434|101786326|FG001|NOT COMPLETED|Period 3||0||
48592975|NCT02059434|101786327|FG002|NOT COMPLETED|Period 3||0||
48294384|NCT01935180|101047589|FG001|STARTED|Overall Study||575||
48592976|NCT02059434|101786328|FG003|NOT COMPLETED|Period 3||0||
48592977|NCT02059434|101786329|FG004|NOT COMPLETED|Period 3||0||
48592978|NCT02059434|101786330|FG005|NOT COMPLETED|Period 3||0||
48592979|NCT02059434|101786331|FG006|NOT COMPLETED|Period 3||0||
48592980|NCT02059434|101786332|FG007|NOT COMPLETED|Period 3||0||
48592981|NCT02059434|101786333|FG008|NOT COMPLETED|Period 3||0||
48592982|NCT02059434|101786325|FG000|STARTED|Period 4 (After Screening/run-in Period)||0||
48592983|NCT02059434|101786326|FG001|STARTED|Period 4 (After Screening/run-in Period)||0||
48592984|NCT02059434|101786327|FG002|STARTED|Period 4 (After Screening/run-in Period)||0||
48592985|NCT02059434|101786328|FG003|STARTED|Period 4 (After Screening/run-in Period)||0||
48592986|NCT02059434|101786329|FG004|STARTED|Period 4 (After Screening/run-in Period)||0||
48592987|NCT02059434|101786330|FG005|STARTED|Period 4 (After Screening/run-in Period)||0||
48592988|NCT02059434|101786331|FG006|STARTED|Period 4 (After Screening/run-in Period)||0||
48592989|NCT02059434|101786332|FG007|STARTED|Period 4 (After Screening/run-in Period)||0||
48592990|NCT02059434|101786333|FG008|STARTED|Period 4 (After Screening/run-in Period)||38||
48294385|NCT01935180|101047588|FG000|COMPLETED|Overall Study||552||
48294386|NCT01935180|101047589|FG001|COMPLETED|Overall Study||561||
48294387|NCT01935180|101047588|FG000|NOT COMPLETED|Overall Study||21||
48294388|NCT01935180|101047589|FG001|NOT COMPLETED|Overall Study||14||
48294389|NCT03143816|101047590|FG000|STARTED|Overall Study||26||
48294390|NCT03143816|101047591|FG001|STARTED|Overall Study||34||
48294391|NCT03143816|101047590|FG000|COMPLETED|Overall Study||22||
48294392|NCT03143816|101047591|FG001|COMPLETED|Overall Study||34||
48294393|NCT03143816|101047590|FG000|NOT COMPLETED|Overall Study||4||
48294394|NCT03143816|101047591|FG001|NOT COMPLETED|Overall Study||0||
48294395|NCT01110876|101047592|FG000|STARTED|Overall Study||13||
48294396|NCT01110876|101047593|FG001|STARTED|Overall Study||5||
48294397|NCT01110876|101047592|FG000|COMPLETED|Overall Study||13||
48294398|NCT01110876|101047593|FG001|COMPLETED|Overall Study||5||
48294399|NCT01110876|101047592|FG000|NOT COMPLETED|Overall Study||0||
48294400|NCT01110876|101047593|FG001|NOT COMPLETED|Overall Study||0||
48294401|NCT01485354|101047594|FG000|STARTED|Overall Study||17||
48294402|NCT01485354|101047594|FG000|COMPLETED|Overall Study||12||
48294403|NCT01485354|101047594|FG000|NOT COMPLETED|Overall Study||5||
48294404|NCT00666679|101047595|FG000|STARTED|First Intervention||66||
48294405|NCT00666679|101047596|FG001|STARTED|First Intervention||68||
48592991|NCT02059434|101786325|FG000|COMPLETED|Period 4 (After Screening/run-in Period)||0||
48592992|NCT02059434|101786326|FG001|COMPLETED|Period 4 (After Screening/run-in Period)||0||
48592993|NCT02059434|101786327|FG002|COMPLETED|Period 4 (After Screening/run-in Period)||0||
48592994|NCT02059434|101786328|FG003|COMPLETED|Period 4 (After Screening/run-in Period)||0||
48592995|NCT02059434|101786329|FG004|COMPLETED|Period 4 (After Screening/run-in Period)||0||
48592996|NCT02059434|101786330|FG005|COMPLETED|Period 4 (After Screening/run-in Period)||0||
48592997|NCT02059434|101786331|FG006|COMPLETED|Period 4 (After Screening/run-in Period)||0||
48592998|NCT02059434|101786332|FG007|COMPLETED|Period 4 (After Screening/run-in Period)||0||
48592999|NCT02059434|101786333|FG008|COMPLETED|Period 4 (After Screening/run-in Period)||38||
48593000|NCT02059434|101786325|FG000|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0||
48593001|NCT02059434|101786326|FG001|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0||
48593002|NCT02059434|101786327|FG002|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0||
48294406|NCT00666679|101047595|FG000|COMPLETED|First Intervention||62||
48294407|NCT00666679|101047596|FG001|COMPLETED|First Intervention||67||
48294408|NCT00666679|101047595|FG000|NOT COMPLETED|First Intervention||4||
48593003|NCT02059434|101786328|FG003|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0||
48593004|NCT02059434|101786329|FG004|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0||
48593005|NCT02059434|101786330|FG005|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0||
48593006|NCT02059434|101786331|FG006|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0||
48593007|NCT02059434|101786332|FG007|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0||
48593008|NCT02059434|101786333|FG008|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0||
48593009|NCT02059434|101786325|FG000|STARTED|Washout Between Periods 4 and 5||0||
48593010|NCT02059434|101786326|FG001|STARTED|Washout Between Periods 4 and 5||0||
48593011|NCT02059434|101786327|FG002|STARTED|Washout Between Periods 4 and 5||0||
48294409|NCT00666679|101047596|FG001|NOT COMPLETED|First Intervention||1||
48294410|NCT00666679|101047595|FG000|STARTED|Washout Period of 1 Week||62||
48294411|NCT00666679|101047596|FG001|STARTED|Washout Period of 1 Week||67||
48294412|NCT00666679|101047595|FG000|COMPLETED|Washout Period of 1 Week||62||
48294413|NCT00666679|101047596|FG001|COMPLETED|Washout Period of 1 Week||65||
48294414|NCT00666679|101047595|FG000|NOT COMPLETED|Washout Period of 1 Week||0||
48294415|NCT00666679|101047596|FG001|NOT COMPLETED|Washout Period of 1 Week||2||
48294416|NCT00666679|101047595|FG000|STARTED|Second Intervention||62||
48294417|NCT00666679|101047596|FG001|STARTED|Second Intervention||65||
48294418|NCT00666679|101047595|FG000|COMPLETED|Second Intervention||61||
48593012|NCT02059434|101786328|FG003|STARTED|Washout Between Periods 4 and 5||0||
48593013|NCT02059434|101786329|FG004|STARTED|Washout Between Periods 4 and 5||0||
48593014|NCT02059434|101786330|FG005|STARTED|Washout Between Periods 4 and 5||0||
48294419|NCT00666679|101047596|FG001|COMPLETED|Second Intervention||64||
48294420|NCT00666679|101047595|FG000|NOT COMPLETED|Second Intervention||1||
48294421|NCT00666679|101047596|FG001|NOT COMPLETED|Second Intervention||1||
48404124|NCT02031627|101321776|FG000|STARTED|Overall Study||7||
48294422|NCT04388774|101047597|FG000|STARTED|Overall Study||10||
48593015|NCT02059434|101786331|FG006|STARTED|Washout Between Periods 4 and 5||0||
48593016|NCT02059434|101786332|FG007|STARTED|Washout Between Periods 4 and 5||0||
48593017|NCT02059434|101786333|FG008|STARTED|Washout Between Periods 4 and 5||38||
48593018|NCT02059434|101786325|FG000|COMPLETED|Washout Between Periods 4 and 5||0||
48593019|NCT02059434|101786326|FG001|COMPLETED|Washout Between Periods 4 and 5||0||
48593020|NCT02059434|101786327|FG002|COMPLETED|Washout Between Periods 4 and 5||0||
48593021|NCT02059434|101786328|FG003|COMPLETED|Washout Between Periods 4 and 5||0||
48593022|NCT02059434|101786329|FG004|COMPLETED|Washout Between Periods 4 and 5||0||
48593023|NCT02059434|101786330|FG005|COMPLETED|Washout Between Periods 4 and 5||0||
48593024|NCT02059434|101786331|FG006|COMPLETED|Washout Between Periods 4 and 5||0||
48593025|NCT02059434|101786332|FG007|COMPLETED|Washout Between Periods 4 and 5||0||
48593026|NCT02059434|101786333|FG008|COMPLETED|Washout Between Periods 4 and 5||37||
48593027|NCT02059434|101786325|FG000|NOT COMPLETED|Washout Between Periods 4 and 5||0||
48593028|NCT02059434|101786326|FG001|NOT COMPLETED|Washout Between Periods 4 and 5||0||
48593029|NCT02059434|101786327|FG002|NOT COMPLETED|Washout Between Periods 4 and 5||0||
48593030|NCT02059434|101786328|FG003|NOT COMPLETED|Washout Between Periods 4 and 5||0||
48593031|NCT02059434|101786329|FG004|NOT COMPLETED|Washout Between Periods 4 and 5||0||
48593032|NCT02059434|101786330|FG005|NOT COMPLETED|Washout Between Periods 4 and 5||0||
48593033|NCT02059434|101786331|FG006|NOT COMPLETED|Washout Between Periods 4 and 5||0||
48593034|NCT02059434|101786332|FG007|NOT COMPLETED|Washout Between Periods 4 and 5||0||
48593035|NCT02059434|101786333|FG008|NOT COMPLETED|Washout Between Periods 4 and 5||1||
48593036|NCT02059434|101786325|FG000|STARTED|Period 5||0||
48593037|NCT02059434|101786326|FG001|STARTED|Period 5||0||
48593038|NCT02059434|101786327|FG002|STARTED|Period 5||0||
48593039|NCT02059434|101786328|FG003|STARTED|Period 5||0||
48593040|NCT02059434|101786329|FG004|STARTED|Period 5||0||
48593041|NCT02059434|101786330|FG005|STARTED|Period 5||0||
48593042|NCT02059434|101786331|FG006|STARTED|Period 5||0||
48593043|NCT02059434|101786332|FG007|STARTED|Period 5||0||
48593044|NCT02059434|101786333|FG008|STARTED|Period 5||37||
48593045|NCT02059434|101786325|FG000|COMPLETED|Period 5||0||
48593046|NCT02059434|101786326|FG001|COMPLETED|Period 5||0||
48593047|NCT02059434|101786327|FG002|COMPLETED|Period 5||0||
48593048|NCT02059434|101786328|FG003|COMPLETED|Period 5||0||
48593049|NCT02059434|101786329|FG004|COMPLETED|Period 5||0||
48593050|NCT02059434|101786330|FG005|COMPLETED|Period 5||0||
48593051|NCT02059434|101786331|FG006|COMPLETED|Period 5||0||
48593052|NCT02059434|101786332|FG007|COMPLETED|Period 5||0||
48593053|NCT02059434|101786333|FG008|COMPLETED|Period 5||37||
48593054|NCT02059434|101786325|FG000|NOT COMPLETED|Period 5||0||
48593055|NCT02059434|101786326|FG001|NOT COMPLETED|Period 5||0||
48593056|NCT02059434|101786327|FG002|NOT COMPLETED|Period 5||0||
48593057|NCT02059434|101786328|FG003|NOT COMPLETED|Period 5||0||
48593058|NCT02059434|101786329|FG004|NOT COMPLETED|Period 5||0||
48593059|NCT02059434|101786330|FG005|NOT COMPLETED|Period 5||0||
48593060|NCT02059434|101786331|FG006|NOT COMPLETED|Period 5||0||
48593061|NCT02059434|101786332|FG007|NOT COMPLETED|Period 5||0||
48593062|NCT02059434|101786333|FG008|NOT COMPLETED|Period 5||0||
48593063|NCT02059434|101786325|FG000|STARTED|Washout Between Periods 5 and 6||0||
48593064|NCT02059434|101786326|FG001|STARTED|Washout Between Periods 5 and 6||0||
48593065|NCT02059434|101786327|FG002|STARTED|Washout Between Periods 5 and 6||0||
48593066|NCT02059434|101786328|FG003|STARTED|Washout Between Periods 5 and 6||0||
48593067|NCT02059434|101786329|FG004|STARTED|Washout Between Periods 5 and 6||0||
48593068|NCT02059434|101786330|FG005|STARTED|Washout Between Periods 5 and 6||0||
48593069|NCT02059434|101786331|FG006|STARTED|Washout Between Periods 5 and 6||0||
48593070|NCT02059434|101786332|FG007|STARTED|Washout Between Periods 5 and 6||0||
48593071|NCT02059434|101786333|FG008|STARTED|Washout Between Periods 5 and 6||37||
48593072|NCT02059434|101786325|FG000|COMPLETED|Washout Between Periods 5 and 6||0||
48593073|NCT02059434|101786326|FG001|COMPLETED|Washout Between Periods 5 and 6||0||
48593074|NCT02059434|101786327|FG002|COMPLETED|Washout Between Periods 5 and 6||0||
48593075|NCT02059434|101786328|FG003|COMPLETED|Washout Between Periods 5 and 6||0||
48593076|NCT02059434|101786329|FG004|COMPLETED|Washout Between Periods 5 and 6||0||
48593077|NCT02059434|101786330|FG005|COMPLETED|Washout Between Periods 5 and 6||0||
48593078|NCT02059434|101786331|FG006|COMPLETED|Washout Between Periods 5 and 6||0||
48593079|NCT02059434|101786332|FG007|COMPLETED|Washout Between Periods 5 and 6||0||
48593080|NCT02059434|101786333|FG008|COMPLETED|Washout Between Periods 5 and 6||37||
48593081|NCT02059434|101786325|FG000|NOT COMPLETED|Washout Between Periods 5 and 6||0||
48593082|NCT02059434|101786326|FG001|NOT COMPLETED|Washout Between Periods 5 and 6||0||
48593083|NCT02059434|101786327|FG002|NOT COMPLETED|Washout Between Periods 5 and 6||0||
48593084|NCT02059434|101786328|FG003|NOT COMPLETED|Washout Between Periods 5 and 6||0||
48593085|NCT02059434|101786329|FG004|NOT COMPLETED|Washout Between Periods 5 and 6||0||
48593086|NCT02059434|101786330|FG005|NOT COMPLETED|Washout Between Periods 5 and 6||0||
48593087|NCT02059434|101786331|FG006|NOT COMPLETED|Washout Between Periods 5 and 6||0||
48593088|NCT02059434|101786332|FG007|NOT COMPLETED|Washout Between Periods 5 and 6||0||
48593089|NCT02059434|101786333|FG008|NOT COMPLETED|Washout Between Periods 5 and 6||0||
48593090|NCT02059434|101786325|FG000|STARTED|Period 6||0||
48593091|NCT02059434|101786326|FG001|STARTED|Period 6||0||
48593092|NCT02059434|101786327|FG002|STARTED|Period 6||0||
48593093|NCT02059434|101786328|FG003|STARTED|Period 6||0||
48593094|NCT02059434|101786329|FG004|STARTED|Period 6||0||
48711085|NCT02956850|102078085|FG010|STARTED|Overall Study||8||
48711086|NCT02956850|102078086|FG011|STARTED|Overall Study||8||
48711087|NCT02956850|102078087|FG012|STARTED|Overall Study||8||
48711088|NCT02956850|102078088|FG013|STARTED|Overall Study||6||
48711089|NCT02956850|102078089|FG014|STARTED|Overall Study||16||
48711090|NCT02956850|102078090|FG015|STARTED|Overall Study||8||
48711091|NCT02956850|102078091|FG016|STARTED|Overall Study||5||
48711092|NCT02956850|102078092|FG017|STARTED|Overall Study||15||
48711093|NCT02956850|102078075|FG000|COMPLETED|Overall Study||16||
48711094|NCT02956850|102078076|FG001|COMPLETED|Overall Study||8||
48711095|NCT02956850|102078077|FG002|COMPLETED|Overall Study||8||
48711096|NCT02956850|102078078|FG003|COMPLETED|Overall Study||8||
48711097|NCT02956850|102078079|FG004|COMPLETED|Overall Study||8||
48711098|NCT02956850|102078080|FG005|COMPLETED|Overall Study||8||
48711099|NCT02956850|102078081|FG006|COMPLETED|Overall Study||8||
48711100|NCT02956850|102078082|FG007|COMPLETED|Overall Study||8||
48711101|NCT02956850|102078083|FG008|COMPLETED|Overall Study||8||
48711102|NCT02956850|102078084|FG009|COMPLETED|Overall Study||6||
48711103|NCT02956850|102078085|FG010|COMPLETED|Overall Study||8||
48711104|NCT02956850|102078086|FG011|COMPLETED|Overall Study||8||
48711105|NCT02956850|102078087|FG012|COMPLETED|Overall Study||8||
48711106|NCT02956850|102078088|FG013|COMPLETED|Overall Study||6||
48711107|NCT02956850|102078089|FG014|COMPLETED|Overall Study||16||
48711108|NCT02956850|102078090|FG015|COMPLETED|Overall Study||8||
48711109|NCT02956850|102078091|FG016|COMPLETED|Overall Study||5||
48711110|NCT02956850|102078092|FG017|COMPLETED|Overall Study||14||
48711111|NCT02956850|102078075|FG000|NOT COMPLETED|Overall Study||0||
48711112|NCT02956850|102078076|FG001|NOT COMPLETED|Overall Study||0||
48711113|NCT02956850|102078077|FG002|NOT COMPLETED|Overall Study||0||
48711114|NCT02956850|102078078|FG003|NOT COMPLETED|Overall Study||0||
48711115|NCT02956850|102078079|FG004|NOT COMPLETED|Overall Study||0||
48711116|NCT02956850|102078080|FG005|NOT COMPLETED|Overall Study||0||
48711117|NCT02956850|102078081|FG006|NOT COMPLETED|Overall Study||0||
48711118|NCT02956850|102078082|FG007|NOT COMPLETED|Overall Study||0||
48711119|NCT02956850|102078083|FG008|NOT COMPLETED|Overall Study||0||
48711120|NCT02956850|102078084|FG009|NOT COMPLETED|Overall Study||0||
48711121|NCT02956850|102078085|FG010|NOT COMPLETED|Overall Study||0||
48711122|NCT02956850|102078086|FG011|NOT COMPLETED|Overall Study||0||
48711123|NCT02956850|102078087|FG012|NOT COMPLETED|Overall Study||0||
48711124|NCT02956850|102078088|FG013|NOT COMPLETED|Overall Study||0||
48711125|NCT02956850|102078089|FG014|NOT COMPLETED|Overall Study||0||
48711126|NCT02956850|102078090|FG015|NOT COMPLETED|Overall Study||0||
48593095|NCT02059434|101786330|FG005|STARTED|Period 6||0||
48593096|NCT02059434|101786331|FG006|STARTED|Period 6||0||
48593097|NCT02059434|101786332|FG007|STARTED|Period 6||0||
48593098|NCT02059434|101786333|FG008|STARTED|Period 6||37||
48593099|NCT02059434|101786325|FG000|COMPLETED|Period 6||0||
48711127|NCT02956850|102078091|FG016|NOT COMPLETED|Overall Study||0||
48711128|NCT02956850|102078092|FG017|NOT COMPLETED|Overall Study||1||
48711129|NCT02034175|102078093|FG000|STARTED|Overall Study||190||
48711130|NCT02034175|102078093|FG000|COMPLETED|Overall Study||190||
48711131|NCT02034175|102078093|FG000|NOT COMPLETED|Overall Study||0||
48767570|NCT01614886|102222770|FG001|Safety Population (SAF)|Overall Study||108||
48593100|NCT02059434|101786326|FG001|COMPLETED|Period 6||0||
48593101|NCT02059434|101786327|FG002|COMPLETED|Period 6||0||
48593102|NCT02059434|101786328|FG003|COMPLETED|Period 6||0||
48593103|NCT02059434|101786329|FG004|COMPLETED|Period 6||0||
48593104|NCT02059434|101786330|FG005|COMPLETED|Period 6||0||
48593105|NCT02059434|101786331|FG006|COMPLETED|Period 6||0||
48593106|NCT02059434|101786332|FG007|COMPLETED|Period 6||0||
48593107|NCT02059434|101786333|FG008|COMPLETED|Period 6||37||
48593108|NCT02059434|101786325|FG000|NOT COMPLETED|Period 6||0||
48593109|NCT02059434|101786326|FG001|NOT COMPLETED|Period 6||0||
48593110|NCT02059434|101786327|FG002|NOT COMPLETED|Period 6||0||
48593111|NCT02059434|101786328|FG003|NOT COMPLETED|Period 6||0||
48593112|NCT02059434|101786329|FG004|NOT COMPLETED|Period 6||0||
48593113|NCT02059434|101786330|FG005|NOT COMPLETED|Period 6||0||
48593114|NCT02059434|101786331|FG006|NOT COMPLETED|Period 6||0||
48593115|NCT02059434|101786332|FG007|NOT COMPLETED|Period 6||0||
48593116|NCT02059434|101786333|FG008|NOT COMPLETED|Period 6||0||
48593117|NCT02059434|101786325|FG000|STARTED|Washout Between Periods 6 and 7||0||
48294423|NCT04388774|101047597|FG000|COMPLETED|Overall Study||10||
48294424|NCT04388774|101047597|FG000|NOT COMPLETED|Overall Study||0||
48294425|NCT04507126|101047598|FG000|STARTED|Overall Study||20||
48593118|NCT02059434|101786326|FG001|STARTED|Washout Between Periods 6 and 7||0||
48593119|NCT02059434|101786327|FG002|STARTED|Washout Between Periods 6 and 7||0||
48593120|NCT02059434|101786328|FG003|STARTED|Washout Between Periods 6 and 7||0||
48593121|NCT02059434|101786329|FG004|STARTED|Washout Between Periods 6 and 7||0||
48593122|NCT02059434|101786330|FG005|STARTED|Washout Between Periods 6 and 7||0||
48593123|NCT02059434|101786331|FG006|STARTED|Washout Between Periods 6 and 7||0||
48711132|NCT02154048|102081484|FG000|STARTED|Overall Study||2||
48711133|NCT02154048|102081485|FG001|STARTED|Overall Study||2||
48711134|NCT02154048|102081486|FG002|STARTED|Overall Study||1||
48711135|NCT02154048|102081484|FG000|COMPLETED|Overall Study||2||
48711136|NCT02154048|102081485|FG001|COMPLETED|Overall Study||2||
48711137|NCT02154048|102081486|FG002|COMPLETED|Overall Study||1||
48711138|NCT02154048|102081484|FG000|NOT COMPLETED|Overall Study||0||
48711139|NCT02154048|102081485|FG001|NOT COMPLETED|Overall Study||0||
48711140|NCT02154048|102081486|FG002|NOT COMPLETED|Overall Study||0||
48711141|NCT00297102|102081487|FG000|STARTED|Overall Study||765||
48711142|NCT00297102|102081488|FG001|STARTED|Overall Study||758||
48711143|NCT00297102|102081487|FG000|COMPLETED|Overall Study||502||
48711144|NCT00297102|102081488|FG001|COMPLETED|Overall Study||525||
48711145|NCT00297102|102081487|FG000|NOT COMPLETED|Overall Study||263||
48711146|NCT00297102|102081488|FG001|NOT COMPLETED|Overall Study||233||
48711147|NCT02081638|102081489|FG000|STARTED|Overall Study||26||
48711148|NCT02081638|102081490|FG001|STARTED|Overall Study||27||
48711149|NCT02081638|102081489|FG000|COMPLETED|Overall Study||24||
48711150|NCT02081638|102081490|FG001|COMPLETED|Overall Study||20||
48711151|NCT02081638|102081489|FG000|NOT COMPLETED|Overall Study||2||
48711152|NCT02081638|102081490|FG001|NOT COMPLETED|Overall Study||7||
48711153|NCT01537081|102081491|FG000|STARTED|Overall Study||1123||
48711154|NCT01537081|102081492|FG001|STARTED|Overall Study||1124||
48711155|NCT01537081|102081493|FG002|STARTED|Overall Study||563||
48711156|NCT01537081|102081491|FG000|Safety Population|Overall Study||1122||
48711157|NCT01537081|102081492|FG001|Safety Population|Overall Study||1122||
48711158|NCT01537081|102081493|FG002|Safety Population|Overall Study||561||
48711159|NCT01537081|102081491|FG000|Modified Intent to Treat Population|Overall Study||1106||
48711160|NCT01537081|102081492|FG001|Modified Intent to Treat Population|Overall Study||1109||
48711161|NCT01537081|102081493|FG002|Modified Intent to Treat Population|Overall Study||556||
48711162|NCT01537081|102081491|FG000|COMPLETED|Overall Study||1084||
48711163|NCT01537081|102081492|FG001|COMPLETED|Overall Study||1086||
48711164|NCT01537081|102081493|FG002|COMPLETED|Overall Study||547||
48711165|NCT01537081|102081491|FG000|NOT COMPLETED|Overall Study||39||
48711166|NCT01537081|102081492|FG001|NOT COMPLETED|Overall Study||38||
48711167|NCT01537081|102081493|FG002|NOT COMPLETED|Overall Study||16||
48711168|NCT00525629|102081494|FG000|STARTED|First Intervention||20||
48711169|NCT00525629|102081495|FG001|STARTED|First Intervention||20||
48711170|NCT00525629|102081494|FG000|COMPLETED|First Intervention||15||
48711171|NCT00525629|102081495|FG001|COMPLETED|First Intervention||15||
48711172|NCT00525629|102081494|FG000|NOT COMPLETED|First Intervention||5||
48711173|NCT00525629|102081495|FG001|NOT COMPLETED|First Intervention||5||
48711174|NCT00525629|102081494|FG000|STARTED|Washout||15||
48711175|NCT00525629|102081495|FG001|STARTED|Washout||15||
48711176|NCT00525629|102081494|FG000|COMPLETED|Washout||15||
48711177|NCT00525629|102081495|FG001|COMPLETED|Washout||15||
48294426|NCT04507126|101047598|FG000|COMPLETED|Overall Study||16||
48711178|NCT00525629|102081494|FG000|NOT COMPLETED|Washout||0||
48711179|NCT00525629|102081495|FG001|NOT COMPLETED|Washout||0||
48711180|NCT00525629|102081494|FG000|STARTED|Second Intervention||15||
48711181|NCT00525629|102081495|FG001|STARTED|Second Intervention||15||
48711182|NCT00525629|102081494|FG000|COMPLETED|Second Intervention||0||
48711183|NCT00525629|102081495|FG001|COMPLETED|Second Intervention||0||
48711184|NCT00525629|102081494|FG000|NOT COMPLETED|Second Intervention||15||
48294427|NCT04507126|101047598|FG000|NOT COMPLETED|Overall Study||4||
48294428|NCT03719170|101047599|FG000|STARTED|Overall Study||119494||9
48294429|NCT03719170|101047600|FG001|STARTED|Overall Study||100812||8
48294430|NCT03719170|101047599|FG000|COMPLETED|Overall Study||119494||9
48294431|NCT03719170|101047600|FG001|COMPLETED|Overall Study||100812||8
48294432|NCT03719170|101047599|FG000|NOT COMPLETED|Overall Study||0||0
48294433|NCT03719170|101047600|FG001|NOT COMPLETED|Overall Study||0||0
48294434|NCT02164383|101047601|FG000|STARTED|Overall Study||16||
48593124|NCT02059434|101786332|FG007|STARTED|Washout Between Periods 6 and 7||0||
48593125|NCT02059434|101786333|FG008|STARTED|Washout Between Periods 6 and 7||37||
48711185|NCT00525629|102081495|FG001|NOT COMPLETED|Second Intervention||15||
48711186|NCT00066469|102081496|FG000|STARTED|Overall Study||55||
48294435|NCT02164383|101047602|FG001|STARTED|Overall Study||14||
48294436|NCT02164383|101047601|FG000|COMPLETED|Overall Study||15||
48294437|NCT02164383|101047602|FG001|COMPLETED|Overall Study||14||
48294438|NCT02164383|101047601|FG000|NOT COMPLETED|Overall Study||1||
48294439|NCT02164383|101047602|FG001|NOT COMPLETED|Overall Study||0||
48294440|NCT00012298|101047603|FG000|STARTED|Overall Study||11||
48593126|NCT02059434|101786325|FG000|COMPLETED|Washout Between Periods 6 and 7||0||
48593127|NCT02059434|101786326|FG001|COMPLETED|Washout Between Periods 6 and 7||0||
48593128|NCT02059434|101786327|FG002|COMPLETED|Washout Between Periods 6 and 7||0||
48593129|NCT02059434|101786328|FG003|COMPLETED|Washout Between Periods 6 and 7||0||
48593130|NCT02059434|101786329|FG004|COMPLETED|Washout Between Periods 6 and 7||0||
48593131|NCT02059434|101786330|FG005|COMPLETED|Washout Between Periods 6 and 7||0||
48593132|NCT02059434|101786331|FG006|COMPLETED|Washout Between Periods 6 and 7||0||
48593133|NCT02059434|101786332|FG007|COMPLETED|Washout Between Periods 6 and 7||0||
48593134|NCT02059434|101786333|FG008|COMPLETED|Washout Between Periods 6 and 7||36||
48294441|NCT00012298|101047604|FG001|STARTED|Overall Study||7||
48294442|NCT00012298|101047605|FG002|STARTED|Overall Study||9||
48593135|NCT02059434|101786325|FG000|NOT COMPLETED|Washout Between Periods 6 and 7||0||
48593136|NCT02059434|101786326|FG001|NOT COMPLETED|Washout Between Periods 6 and 7||0||
48593137|NCT02059434|101786327|FG002|NOT COMPLETED|Washout Between Periods 6 and 7||0||
48593138|NCT02059434|101786328|FG003|NOT COMPLETED|Washout Between Periods 6 and 7||0||
48593139|NCT02059434|101786329|FG004|NOT COMPLETED|Washout Between Periods 6 and 7||0||
48593140|NCT02059434|101786330|FG005|NOT COMPLETED|Washout Between Periods 6 and 7||0||
48593141|NCT02059434|101786331|FG006|NOT COMPLETED|Washout Between Periods 6 and 7||0||
48593142|NCT02059434|101786332|FG007|NOT COMPLETED|Washout Between Periods 6 and 7||0||
48593143|NCT02059434|101786333|FG008|NOT COMPLETED|Washout Between Periods 6 and 7||1||
48593144|NCT02059434|101786325|FG000|STARTED|Period 7||0||
48593145|NCT02059434|101786326|FG001|STARTED|Period 7||0||
48593146|NCT02059434|101786327|FG002|STARTED|Period 7||0||
48593147|NCT02059434|101786328|FG003|STARTED|Period 7||0||
48593148|NCT02059434|101786329|FG004|STARTED|Period 7||0||
48593149|NCT02059434|101786330|FG005|STARTED|Period 7||0||
48593150|NCT02059434|101786331|FG006|STARTED|Period 7||0||
48593151|NCT02059434|101786332|FG007|STARTED|Period 7||0||
48593152|NCT02059434|101786333|FG008|STARTED|Period 7||36||
48593153|NCT02059434|101786325|FG000|COMPLETED|Period 7||0||
48593154|NCT02059434|101786326|FG001|COMPLETED|Period 7||0||
48593155|NCT02059434|101786327|FG002|COMPLETED|Period 7||0||
48593156|NCT02059434|101786328|FG003|COMPLETED|Period 7||0||
48593157|NCT02059434|101786329|FG004|COMPLETED|Period 7||0||
48593158|NCT02059434|101786330|FG005|COMPLETED|Period 7||0||
48593159|NCT02059434|101786331|FG006|COMPLETED|Period 7||0||
48593160|NCT02059434|101786332|FG007|COMPLETED|Period 7||0||
48593161|NCT02059434|101786333|FG008|COMPLETED|Period 7||36||
48593162|NCT02059434|101786325|FG000|NOT COMPLETED|Period 7||0||
48593163|NCT02059434|101786326|FG001|NOT COMPLETED|Period 7||0||
48593164|NCT02059434|101786327|FG002|NOT COMPLETED|Period 7||0||
48593165|NCT02059434|101786328|FG003|NOT COMPLETED|Period 7||0||
48593166|NCT02059434|101786329|FG004|NOT COMPLETED|Period 7||0||
48593167|NCT02059434|101786330|FG005|NOT COMPLETED|Period 7||0||
48593168|NCT02059434|101786331|FG006|NOT COMPLETED|Period 7||0||
48593169|NCT02059434|101786332|FG007|NOT COMPLETED|Period 7||0||
48593170|NCT02059434|101786333|FG008|NOT COMPLETED|Period 7||0||
48593171|NCT02059434|101786325|FG000|STARTED|Washout Between Periods 7 and 8||0||
48593172|NCT02059434|101786326|FG001|STARTED|Washout Between Periods 7 and 8||0||
48593173|NCT02059434|101786327|FG002|STARTED|Washout Between Periods 7 and 8||0||
48593174|NCT02059434|101786328|FG003|STARTED|Washout Between Periods 7 and 8||0||
48593175|NCT02059434|101786329|FG004|STARTED|Washout Between Periods 7 and 8||0||
48593176|NCT02059434|101786330|FG005|STARTED|Washout Between Periods 7 and 8||0||
48593177|NCT02059434|101786331|FG006|STARTED|Washout Between Periods 7 and 8||0||
48593178|NCT02059434|101786332|FG007|STARTED|Washout Between Periods 7 and 8||0||
48593179|NCT02059434|101786333|FG008|STARTED|Washout Between Periods 7 and 8||36||
48593180|NCT02059434|101786325|FG000|COMPLETED|Washout Between Periods 7 and 8||0||
48593181|NCT02059434|101786326|FG001|COMPLETED|Washout Between Periods 7 and 8||0||
48593182|NCT02059434|101786327|FG002|COMPLETED|Washout Between Periods 7 and 8||0||
48593183|NCT02059434|101786328|FG003|COMPLETED|Washout Between Periods 7 and 8||0||
48593184|NCT02059434|101786329|FG004|COMPLETED|Washout Between Periods 7 and 8||0||
48593185|NCT02059434|101786330|FG005|COMPLETED|Washout Between Periods 7 and 8||0||
48593186|NCT02059434|101786331|FG006|COMPLETED|Washout Between Periods 7 and 8||0||
48593187|NCT02059434|101786332|FG007|COMPLETED|Washout Between Periods 7 and 8||0||
48593188|NCT02059434|101786333|FG008|COMPLETED|Washout Between Periods 7 and 8||34||
48593189|NCT02059434|101786325|FG000|NOT COMPLETED|Washout Between Periods 7 and 8||0||
48593190|NCT02059434|101786326|FG001|NOT COMPLETED|Washout Between Periods 7 and 8||0||
48593191|NCT02059434|101786327|FG002|NOT COMPLETED|Washout Between Periods 7 and 8||0||
48593192|NCT02059434|101786328|FG003|NOT COMPLETED|Washout Between Periods 7 and 8||0||
48188506|NCT04582045|100783260|FG002|NOT COMPLETED|Overall Study||0||
48593193|NCT02059434|101786329|FG004|NOT COMPLETED|Washout Between Periods 7 and 8||0||
48593194|NCT02059434|101786330|FG005|NOT COMPLETED|Washout Between Periods 7 and 8||0||
48294443|NCT00012298|101047606|FG003|STARTED|Overall Study||4||
48294444|NCT00012298|101047607|FG004|STARTED|Overall Study||5||
48593195|NCT02059434|101786331|FG006|NOT COMPLETED|Washout Between Periods 7 and 8||0||
48593196|NCT02059434|101786332|FG007|NOT COMPLETED|Washout Between Periods 7 and 8||0||
48593197|NCT02059434|101786333|FG008|NOT COMPLETED|Washout Between Periods 7 and 8||2||
48593198|NCT02059434|101786325|FG000|STARTED|Period 8||0||
48593199|NCT02059434|101786326|FG001|STARTED|Period 8||0||
48593200|NCT02059434|101786327|FG002|STARTED|Period 8||0||
48593201|NCT02059434|101786328|FG003|STARTED|Period 8||0||
48593202|NCT02059434|101786329|FG004|STARTED|Period 8||0||
48593203|NCT02059434|101786330|FG005|STARTED|Period 8||0||
48593204|NCT02059434|101786331|FG006|STARTED|Period 8||0||
48593205|NCT02059434|101786332|FG007|STARTED|Period 8||0||
48593206|NCT02059434|101786333|FG008|STARTED|Period 8||34||
48593207|NCT02059434|101786325|FG000|COMPLETED|Period 8||0||
48593208|NCT02059434|101786326|FG001|COMPLETED|Period 8||0||
48593209|NCT02059434|101786327|FG002|COMPLETED|Period 8||0||
48593210|NCT02059434|101786328|FG003|COMPLETED|Period 8||0||
48593211|NCT02059434|101786329|FG004|COMPLETED|Period 8||0||
48593212|NCT02059434|101786330|FG005|COMPLETED|Period 8||0||
48593213|NCT02059434|101786331|FG006|COMPLETED|Period 8||0||
48593214|NCT02059434|101786332|FG007|COMPLETED|Period 8||0||
48593215|NCT02059434|101786333|FG008|COMPLETED|Period 8||34||
48711187|NCT00066469|102081496|FG000|COMPLETED|Overall Study||39||
48711188|NCT00066469|102081496|FG000|NOT COMPLETED|Overall Study||16||
48711189|NCT04274153|102081497|FG000|STARTED|Overall Study||225||
48711190|NCT04274153|102081497|FG000|COMPLETED|Overall Study||169||
48711191|NCT04274153|102081497|FG000|NOT COMPLETED|Overall Study||56||
48711192|NCT00353431|102081498|FG000|STARTED|Overall Study||63||
48711193|NCT00353431|102081499|FG001|STARTED|Overall Study||67||
48711194|NCT00353431|102081498|FG000|COMPLETED|Overall Study||63||
48711195|NCT00353431|102081499|FG001|COMPLETED|Overall Study||67||
48711196|NCT00353431|102081498|FG000|NOT COMPLETED|Overall Study||0||
48711197|NCT00353431|102081499|FG001|NOT COMPLETED|Overall Study||0||
48711198|NCT01703117|102081500|FG000|STARTED|Overall Study||26||
48711199|NCT01703117|102081501|FG001|STARTED|Overall Study||24||
48711200|NCT01703117|102081500|FG000|COMPLETED|Overall Study||22||
48711201|NCT01703117|102081501|FG001|COMPLETED|Overall Study||20||
48711202|NCT01703117|102081500|FG000|NOT COMPLETED|Overall Study||4||
48711203|NCT01703117|102081501|FG001|NOT COMPLETED|Overall Study||4||
48711204|NCT02434354|102081502|FG000|STARTED|Overall Study||33||
48711205|NCT02434354|102081502|FG000|Post Consent Screening|Overall Study||30||
48711206|NCT02434354|102081502|FG000|COMPLETED|Overall Study||30||
48711207|NCT02434354|102081502|FG000|NOT COMPLETED|Overall Study||3||
48711208|NCT02761694|102081503|FG000|STARTED|Overall Study||4||
48711209|NCT02761694|102081504|FG001|STARTED|Overall Study||4||
48711210|NCT02761694|102081505|FG002|STARTED|Overall Study||1||
48711211|NCT02761694|102081506|FG003|STARTED|Overall Study||3||
48711212|NCT02761694|102081507|FG004|STARTED|Overall Study||3||
48711213|NCT02761694|102081508|FG005|STARTED|Overall Study||3||
48711214|NCT02761694|102081509|FG006|STARTED|Overall Study||33||
48711215|NCT02761694|102081510|FG007|STARTED|Overall Study||8||
48711216|NCT02761694|102081511|FG008|STARTED|Overall Study||5||
48711217|NCT02761694|102081512|FG009|STARTED|Overall Study||5||
48711218|NCT02761694|102081513|FG010|STARTED|Overall Study||3||
48711219|NCT02761694|102081514|FG011|STARTED|Overall Study||6||
48711220|NCT02761694|102081503|FG000|Treated|Overall Study||4||
48711221|NCT02761694|102081504|FG001|Treated|Overall Study||4||
48593216|NCT02059434|101786325|FG000|NOT COMPLETED|Period 8||0||
48593217|NCT02059434|101786326|FG001|NOT COMPLETED|Period 8||0||
48593218|NCT02059434|101786327|FG002|NOT COMPLETED|Period 8||0||
48593219|NCT02059434|101786328|FG003|NOT COMPLETED|Period 8||0||
48593220|NCT02059434|101786329|FG004|NOT COMPLETED|Period 8||0||
48593221|NCT02059434|101786330|FG005|NOT COMPLETED|Period 8||0||
48593222|NCT02059434|101786331|FG006|NOT COMPLETED|Period 8||0||
48593223|NCT02059434|101786332|FG007|NOT COMPLETED|Period 8||0||
48593224|NCT02059434|101786333|FG008|NOT COMPLETED|Period 8||0||
48593225|NCT03168919|101786334|FG000|STARTED|Overall Study||5||
48593226|NCT03168919|101786334|FG000|COMPLETED|Overall Study||3||
48593227|NCT03168919|101786334|FG000|NOT COMPLETED|Overall Study||2||
48593228|NCT03717051|101786335|FG000|STARTED|Overall Study||352||
48593229|NCT03717051|101786336|FG001|STARTED|Overall Study||482||
48593230|NCT03717051|101786335|FG000|COMPLETED|Overall Study||352||
48593231|NCT03717051|101786336|FG001|COMPLETED|Overall Study||482||
48711222|NCT02761694|102081505|FG002|Treated|Overall Study||1||
48711223|NCT02761694|102081506|FG003|Treated|Overall Study||3||
48711224|NCT02761694|102081507|FG004|Treated|Overall Study||3||
48593232|NCT03717051|101786335|FG000|NOT COMPLETED|Overall Study||0||
48593233|NCT03717051|101786336|FG001|NOT COMPLETED|Overall Study||0||
48593234|NCT00081731|101786337|FG000|STARTED|Overall Study||480||
48593235|NCT00081731|101786338|FG001|STARTED|Overall Study||467||
48593236|NCT00081731|101786337|FG000|COMPLETED|Overall Study||472||
48593237|NCT00081731|101786338|FG001|COMPLETED|Overall Study||459||
48711225|NCT02761694|102081508|FG005|Treated|Overall Study||3||
48711226|NCT02761694|102081509|FG006|Treated|Overall Study||32||
48711227|NCT02761694|102081510|FG007|Treated|Overall Study||8||
48711228|NCT02761694|102081511|FG008|Treated|Overall Study||5||
48711229|NCT02761694|102081512|FG009|Treated|Overall Study||5||
48711230|NCT02761694|102081513|FG010|Treated|Overall Study||3||
48294445|NCT00012298|101047608|FG005|STARTED|Overall Study||6||
48294446|NCT00012298|101047609|FG006|STARTED|Overall Study||39||
48294447|NCT00012298|101047603|FG000|COMPLETED|Overall Study||11||
48294448|NCT00012298|101047604|FG001|COMPLETED|Overall Study||7||
48294449|NCT00012298|101047605|FG002|COMPLETED|Overall Study||9||
48294450|NCT00012298|101047606|FG003|COMPLETED|Overall Study||4||
48593238|NCT00081731|101786337|FG000|NOT COMPLETED|Overall Study||8||
48593239|NCT00081731|101786338|FG001|NOT COMPLETED|Overall Study||8||
48593240|NCT02631746|101786339|FG000|STARTED|Overall Study||3||
48711231|NCT02761694|102081514|FG011|Treated|Overall Study||6||
48711232|NCT02761694|102081503|FG000|COMPLETED|Overall Study||0||
48711233|NCT02761694|102081504|FG001|COMPLETED|Overall Study||0||
48711234|NCT02761694|102081505|FG002|COMPLETED|Overall Study||0||
48711235|NCT02761694|102081506|FG003|COMPLETED|Overall Study||0||
48711236|NCT02761694|102081507|FG004|COMPLETED|Overall Study||0||
48711237|NCT02761694|102081508|FG005|COMPLETED|Overall Study||0||
48711238|NCT02761694|102081509|FG006|COMPLETED|Overall Study||0||
48711239|NCT02761694|102081510|FG007|COMPLETED|Overall Study||0||
48711240|NCT02761694|102081511|FG008|COMPLETED|Overall Study||0||
48711241|NCT02761694|102081512|FG009|COMPLETED|Overall Study||0||
48711242|NCT02761694|102081513|FG010|COMPLETED|Overall Study||0||
48711243|NCT02761694|102081514|FG011|COMPLETED|Overall Study||0||
48711244|NCT02761694|102081503|FG000|NOT COMPLETED|Overall Study||4||
48294451|NCT00012298|101047607|FG004|COMPLETED|Overall Study||5||
48294452|NCT00012298|101047608|FG005|COMPLETED|Overall Study||6||
48294453|NCT00012298|101047609|FG006|COMPLETED|Overall Study||39||
48294454|NCT00012298|101047603|FG000|NOT COMPLETED|Overall Study||0||
48294455|NCT00012298|101047604|FG001|NOT COMPLETED|Overall Study||0||
48593241|NCT02631746|101786339|FG000|COMPLETED|Overall Study||0||
48593242|NCT02631746|101786339|FG000|NOT COMPLETED|Overall Study||3||
48593243|NCT03207074|101786340|FG000|STARTED|Overall Study||150||
48593244|NCT03207074|101786340|FG000|COMPLETED|Overall Study||150||
48593245|NCT03207074|101786340|FG000|NOT COMPLETED|Overall Study||0||
48593246|NCT01272141|101786341|FG000|STARTED|Overall Study||5||
48593247|NCT01272141|101786341|FG000|COMPLETED|Overall Study||5||
48711245|NCT02761694|102081504|FG001|NOT COMPLETED|Overall Study||4||
48711246|NCT02761694|102081505|FG002|NOT COMPLETED|Overall Study||1||
48711247|NCT02761694|102081506|FG003|NOT COMPLETED|Overall Study||3||
48711248|NCT02761694|102081507|FG004|NOT COMPLETED|Overall Study||3||
48711249|NCT02761694|102081508|FG005|NOT COMPLETED|Overall Study||3||
48711250|NCT02761694|102081509|FG006|NOT COMPLETED|Overall Study||33||
48711251|NCT02761694|102081510|FG007|NOT COMPLETED|Overall Study||8||
48711252|NCT02761694|102081511|FG008|NOT COMPLETED|Overall Study||5||
48711253|NCT02761694|102081512|FG009|NOT COMPLETED|Overall Study||5||
48711254|NCT02761694|102081513|FG010|NOT COMPLETED|Overall Study||3||
48711255|NCT02761694|102081514|FG011|NOT COMPLETED|Overall Study||6||
48711256|NCT02891681|102081515|FG000|STARTED|Overall Study||39||
48711257|NCT02891681|102081516|FG001|STARTED|Overall Study||1||
48711258|NCT02891681|102081517|FG002|STARTED|Overall Study||1||
48711259|NCT02891681|102081515|FG000|COMPLETED|Overall Study||36||
48711260|NCT02891681|102081516|FG001|COMPLETED|Overall Study||1||
48711261|NCT02891681|102081517|FG002|COMPLETED|Overall Study||0||
48711262|NCT02891681|102081515|FG000|NOT COMPLETED|Overall Study||3||
48711263|NCT02891681|102081516|FG001|NOT COMPLETED|Overall Study||0||
48711264|NCT02891681|102081517|FG002|NOT COMPLETED|Overall Study||1||
48711265|NCT01515475|102081518|FG000|STARTED|Overall Study||61||
48711266|NCT01515475|102081519|FG001|STARTED|Overall Study||58||
48711267|NCT01515475|102081520|FG002|STARTED|Overall Study||65||
48711268|NCT01515475|102081521|FG003|STARTED|Overall Study||65||
48711269|NCT01515475|102081518|FG000|COMPLETED|Overall Study||41||
48711270|NCT01515475|102081519|FG001|COMPLETED|Overall Study||43||
48711271|NCT01515475|102081520|FG002|COMPLETED|Overall Study||53||
48711272|NCT01515475|102081521|FG003|COMPLETED|Overall Study||53||
48711273|NCT01515475|102081518|FG000|NOT COMPLETED|Overall Study||20||
48294456|NCT00012298|101047605|FG002|NOT COMPLETED|Overall Study||0||
48294457|NCT00012298|101047606|FG003|NOT COMPLETED|Overall Study||0||
48294458|NCT00012298|101047607|FG004|NOT COMPLETED|Overall Study||0||
48294459|NCT00012298|101047608|FG005|NOT COMPLETED|Overall Study||0||
48294460|NCT00012298|101047609|FG006|NOT COMPLETED|Overall Study||0||
48294461|NCT02683941|101047610|FG000|STARTED|Double-blind Phase||51||
48711274|NCT01515475|102081519|FG001|NOT COMPLETED|Overall Study||15||
48711275|NCT01515475|102081520|FG002|NOT COMPLETED|Overall Study||12||
48711276|NCT01515475|102081521|FG003|NOT COMPLETED|Overall Study||12||
48711277|NCT02630017|102081522|FG000|STARTED|Overall Study||13||
48711278|NCT02630017|102081523|FG001|STARTED|Overall Study||12||
48294462|NCT02683941|101047611|FG001|STARTED|Double-blind Phase||26||
48593248|NCT01272141|101786341|FG000|NOT COMPLETED|Overall Study||0||
48593249|NCT01952080|101786342|FG000|STARTED|Overall Study||5||
48711279|NCT02630017|102081524|FG002|STARTED|Overall Study||13||
48711280|NCT02630017|102081525|FG003|STARTED|Overall Study||13||
48711281|NCT02630017|102081522|FG000|COMPLETED|Overall Study||12||
48711282|NCT02630017|102081523|FG001|COMPLETED|Overall Study||11||
48711283|NCT02630017|102081524|FG002|COMPLETED|Overall Study||11||
48711284|NCT02630017|102081525|FG003|COMPLETED|Overall Study||12||
48711285|NCT02630017|102081522|FG000|NOT COMPLETED|Overall Study||1||
48294463|NCT02683941|101047610|FG000|COMPLETED|Double-blind Phase||41|Completers are subjects who complete the double-blind phase of the study or die.|
48294464|NCT02683941|101047611|FG001|COMPLETED|Double-blind Phase||21|Completers are subjects who complete the double-blind phase of the study or die.|
48294465|NCT02683941|101047610|FG000|NOT COMPLETED|Double-blind Phase||10||
48294466|NCT02683941|101047611|FG001|NOT COMPLETED|Double-blind Phase||5||
48294467|NCT02683941|101047610|FG000|STARTED|Open-label Treatment Phase||21|"Prior to protocol amendment #5, subjects qualified for the option to continue into the open-label treatment phase if they met the following additional inclusion criteria:~* Subjects have central review confirmed/documented disease progression;~* There was a request from the subject to receive open-label lanreotide plus BSC;~* Subjects were randomized in the placebo plus BSC arm.~Following protocol amendment #5, the open-label treatment phase remained optional for all subjects."|
48294468|NCT02683941|101047611|FG001|STARTED|Open-label Treatment Phase||19|"Prior to protocol amendment #5, subjects qualified for the option to continue into the open-label treatment phase if they met the following additional inclusion criteria:~* Subjects have central review confirmed/documented disease progression;~* There was a request from the subject to receive open-label lanreotide plus BSC;~* Subjects were randomized in the placebo plus BSC arm.~Following protocol amendment #5, the open-label treatment phase remained optional for all subjects."|
48294469|NCT02683941|101047610|FG000|COMPLETED|Open-label Treatment Phase||1|Completers are subjects who complete the open-label treatment phase of the study or die.|
48294470|NCT02683941|101047611|FG001|COMPLETED|Open-label Treatment Phase||6|Completers are subjects who complete the open-label treatment phase of the study or die.|
48294471|NCT02683941|101047610|FG000|NOT COMPLETED|Open-label Treatment Phase||20||
48294472|NCT02683941|101047611|FG001|NOT COMPLETED|Open-label Treatment Phase||13||
48294473|NCT02683941|101047610|FG000|STARTED|Open-label Follow-up Phase||18|Inclusive of subjects who progressed during the double-blind phase or open-label treatment phase.|
48294474|NCT02683941|101047611|FG001|STARTED|Open-label Follow-up Phase||8|Inclusive of subjects who progressed during the double-blind phase or open-label treatment phase.|
48294475|NCT02683941|101047610|FG000|COMPLETED|Open-label Follow-up Phase||0||
48294476|NCT02683941|101047611|FG001|COMPLETED|Open-label Follow-up Phase||0||
48294477|NCT02683941|101047610|FG000|NOT COMPLETED|Open-label Follow-up Phase||18||
48294478|NCT02683941|101047611|FG001|NOT COMPLETED|Open-label Follow-up Phase||8||
48294479|NCT04299438|101047612|FG000|STARTED|Overall Study||84||
48294480|NCT04299438|101047613|FG001|STARTED|Overall Study||80||
48294481|NCT04299438|101047612|FG000|COMPLETED|Overall Study||84||
48294482|NCT04299438|101047613|FG001|COMPLETED|Overall Study||80||
48294483|NCT04299438|101047612|FG000|NOT COMPLETED|Overall Study||0||
48294484|NCT04299438|101047613|FG001|NOT COMPLETED|Overall Study||0||
48294485|NCT00701779|101047614|FG000|STARTED|Overall Study||63||
48294486|NCT00701779|101047614|FG000|3 Month|Overall Study||60||
48294487|NCT00701779|101047614|FG000|6 Month|Overall Study||58||
48294488|NCT00701779|101047614|FG000|9 Month|Overall Study||56||
48294489|NCT00701779|101047614|FG000|12 Month|Overall Study||54||
48294490|NCT00701779|101047614|FG000|COMPLETED|Overall Study||54||
48294491|NCT00701779|101047614|FG000|NOT COMPLETED|Overall Study||9||
48294492|NCT00275262|101047615|FG000|STARTED|Overall Study||12||
48294493|NCT00275262|101047616|FG001|STARTED|Overall Study||13||
48294494|NCT00275262|101047615|FG000|COMPLETED|Overall Study||6||
48294495|NCT00275262|101047616|FG001|COMPLETED|Overall Study||4||
48294496|NCT00275262|101047615|FG000|NOT COMPLETED|Overall Study||6||
48294497|NCT00275262|101047616|FG001|NOT COMPLETED|Overall Study||9||
48294498|NCT00593957|101047617|FG000|STARTED|Overall Study||13||
48294499|NCT00593957|101047618|FG001|STARTED|Overall Study||13||
48294500|NCT00593957|101047619|FG002|STARTED|Overall Study||12||
48294501|NCT00593957|101047617|FG000|COMPLETED|Overall Study||13||
48294502|NCT00593957|101047618|FG001|COMPLETED|Overall Study||12||
48294503|NCT00593957|101047619|FG002|COMPLETED|Overall Study||10||
48294504|NCT00593957|101047617|FG000|NOT COMPLETED|Overall Study||0||
48294505|NCT00593957|101047618|FG001|NOT COMPLETED|Overall Study||1||
48294506|NCT00593957|101047619|FG002|NOT COMPLETED|Overall Study||2||
48294507|NCT00575029|101047620|FG000|STARTED|Overall Study||7||
48294508|NCT00575029|101047620|FG000|COMPLETED|Overall Study||7||
48294509|NCT00575029|101047620|FG000|NOT COMPLETED|Overall Study||0||
48294510|NCT04433585|101047621|FG000|STARTED|Overall Study||73||
48294511|NCT04433585|101047622|FG001|STARTED|Overall Study||70||
48294512|NCT04433585|101047623|FG002|STARTED|Overall Study||74||
48294513|NCT04433585|101047624|FG003|STARTED|Overall Study||74||
48294514|NCT04433585|101047621|FG000|COMPLETED|Overall Study||44||
48294515|NCT04433585|101047622|FG001|COMPLETED|Overall Study||57||
48294516|NCT04433585|101047623|FG002|COMPLETED|Overall Study||55||
48294517|NCT04433585|101047624|FG003|COMPLETED|Overall Study||65||
48294518|NCT04433585|101047621|FG000|NOT COMPLETED|Overall Study||29||
48294519|NCT04433585|101047622|FG001|NOT COMPLETED|Overall Study||13||
48294520|NCT04433585|101047623|FG002|NOT COMPLETED|Overall Study||19||
48294521|NCT04433585|101047624|FG003|NOT COMPLETED|Overall Study||9||
48294522|NCT04823221|101047625|FG000|STARTED|Overall Study||22||
48141463|NCT01780922|100670426|FG003|STARTED|Second Intervention (1 Day)||2||
48141464|NCT01780922|100670427|FG004|STARTED|Second Intervention (1 Day)||2||
48141465|NCT01780922|100670428|FG005|STARTED|Second Intervention (1 Day)||2||
48141466|NCT01780922|100670423|FG000|COMPLETED|Second Intervention (1 Day)||2||
48141467|NCT01780922|100670424|FG001|COMPLETED|Second Intervention (1 Day)||2||
48141468|NCT01780922|100670425|FG002|COMPLETED|Second Intervention (1 Day)||2||
48141469|NCT01780922|100670426|FG003|COMPLETED|Second Intervention (1 Day)||2||
48141470|NCT01780922|100670427|FG004|COMPLETED|Second Intervention (1 Day)||2||
48141471|NCT01780922|100670428|FG005|COMPLETED|Second Intervention (1 Day)||2||
48141472|NCT01780922|100670423|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48141473|NCT01780922|100670424|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48141474|NCT01780922|100670425|FG002|NOT COMPLETED|Second Intervention (1 Day)||0||
48141475|NCT01780922|100670426|FG003|NOT COMPLETED|Second Intervention (1 Day)||0||
48141476|NCT01780922|100670427|FG004|NOT COMPLETED|Second Intervention (1 Day)||0||
48141477|NCT01780922|100670428|FG005|NOT COMPLETED|Second Intervention (1 Day)||0||
48141478|NCT01780922|100670423|FG000|STARTED|Washout (7 Days)||2||
48141479|NCT01780922|100670424|FG001|STARTED|Washout (7 Days)||2||
48141480|NCT01780922|100670425|FG002|STARTED|Washout (7 Days)||2||
48141481|NCT01780922|100670426|FG003|STARTED|Washout (7 Days)||2||
48141482|NCT01780922|100670427|FG004|STARTED|Washout (7 Days)||2||
48141483|NCT01780922|100670428|FG005|STARTED|Washout (7 Days)||2||
48141484|NCT01780922|100670423|FG000|COMPLETED|Washout (7 Days)||2||
48141485|NCT01780922|100670424|FG001|COMPLETED|Washout (7 Days)||2||
48141486|NCT01780922|100670425|FG002|COMPLETED|Washout (7 Days)||2||
48141487|NCT01780922|100670426|FG003|COMPLETED|Washout (7 Days)||2||
48141488|NCT01780922|100670427|FG004|COMPLETED|Washout (7 Days)||2||
48141489|NCT01780922|100670428|FG005|COMPLETED|Washout (7 Days)||2||
48141490|NCT01780922|100670423|FG000|NOT COMPLETED|Washout (7 Days)||0||
48141491|NCT01780922|100670424|FG001|NOT COMPLETED|Washout (7 Days)||0||
48141492|NCT01780922|100670425|FG002|NOT COMPLETED|Washout (7 Days)||0||
48141493|NCT01780922|100670426|FG003|NOT COMPLETED|Washout (7 Days)||0||
48141494|NCT01780922|100670427|FG004|NOT COMPLETED|Washout (7 Days)||0||
48141495|NCT01780922|100670428|FG005|NOT COMPLETED|Washout (7 Days)||0||
48141496|NCT01780922|100670423|FG000|STARTED|Third Intervention (1 Day)||2||
48141497|NCT01780922|100670424|FG001|STARTED|Third Intervention (1 Day)||2||
48141498|NCT01780922|100670425|FG002|STARTED|Third Intervention (1 Day)||2||
48141499|NCT01780922|100670426|FG003|STARTED|Third Intervention (1 Day)||2||
48141500|NCT01780922|100670427|FG004|STARTED|Third Intervention (1 Day)||2||
48141501|NCT01780922|100670428|FG005|STARTED|Third Intervention (1 Day)||2||
48141502|NCT01780922|100670423|FG000|COMPLETED|Third Intervention (1 Day)||2||
48141503|NCT01780922|100670424|FG001|COMPLETED|Third Intervention (1 Day)||2||
48593250|NCT01952080|101786343|FG001|STARTED|Overall Study||8||
48593251|NCT01952080|101786344|FG002|STARTED|Overall Study||14||
48593252|NCT01952080|101786345|FG003|STARTED|Overall Study||15||
48593253|NCT01952080|101786342|FG000|Treated|Overall Study||5||
48593254|NCT01952080|101786343|FG001|Treated|Overall Study||8||
48593255|NCT01952080|101786344|FG002|Treated|Overall Study||14||
48593256|NCT01952080|101786345|FG003|Treated|Overall Study||15||
48593257|NCT01952080|101786342|FG000|COMPLETED|Overall Study||5||
48593258|NCT01952080|101786343|FG001|COMPLETED|Overall Study||7||
48593259|NCT01952080|101786344|FG002|COMPLETED|Overall Study||14||
48593260|NCT01952080|101786345|FG003|COMPLETED|Overall Study||14||
48593261|NCT01952080|101786342|FG000|NOT COMPLETED|Overall Study||0||
48593262|NCT01952080|101786343|FG001|NOT COMPLETED|Overall Study||1||
48593263|NCT01952080|101786344|FG002|NOT COMPLETED|Overall Study||0||
48593264|NCT01952080|101786345|FG003|NOT COMPLETED|Overall Study||1||
48141504|NCT01780922|100670425|FG002|COMPLETED|Third Intervention (1 Day)||2||
48141505|NCT01780922|100670426|FG003|COMPLETED|Third Intervention (1 Day)||2||
48141506|NCT01780922|100670427|FG004|COMPLETED|Third Intervention (1 Day)||2||
48141507|NCT01780922|100670428|FG005|COMPLETED|Third Intervention (1 Day)||2||
48141508|NCT01780922|100670423|FG000|NOT COMPLETED|Third Intervention (1 Day)||0||
48141509|NCT01780922|100670424|FG001|NOT COMPLETED|Third Intervention (1 Day)||0||
48141510|NCT01780922|100670425|FG002|NOT COMPLETED|Third Intervention (1 Day)||0||
48141511|NCT01780922|100670426|FG003|NOT COMPLETED|Third Intervention (1 Day)||0||
48141512|NCT01780922|100670427|FG004|NOT COMPLETED|Third Intervention (1 Day)||0||
48141513|NCT01780922|100670428|FG005|NOT COMPLETED|Third Intervention (1 Day)||0||
48141514|NCT03526250|100670429|FG000|STARTED|Overall Study||23||
48141515|NCT03526250|100670429|FG000|COMPLETED|Overall Study||0||
48141516|NCT03526250|100670429|FG000|NOT COMPLETED|Overall Study||23||
48141517|NCT01913600|100670430|FG000|STARTED|Overall Study||56||
48141518|NCT01913600|100670430|FG000|COMPLETED|Overall Study||55||
48141519|NCT01913600|100670430|FG000|NOT COMPLETED|Overall Study||1||
48593265|NCT02124759|101786346|FG000|STARTED|Overall Study||6|Subjects gave informed consent to be screened for study.|
48657065|NCT03648372|101943763|FG006|COMPLETED|Overall Study||2||
48141520|NCT01055769|100670431|FG000|STARTED|First Intervention||10||
48141521|NCT01055769|100670432|FG001|STARTED|First Intervention||10||
48141522|NCT01055769|100670431|FG000|COMPLETED|First Intervention||10||
48141523|NCT01055769|100670432|FG001|COMPLETED|First Intervention||10||
48141524|NCT01055769|100670431|FG000|NOT COMPLETED|First Intervention||0||
48141525|NCT01055769|100670432|FG001|NOT COMPLETED|First Intervention||0||
48404125|NCT02031627|101321777|FG001|STARTED|Overall Study||7||
48404126|NCT02031627|101321778|FG002|STARTED|Overall Study||7||
48404127|NCT02031627|101321776|FG000|COMPLETED|Overall Study||7||
48404128|NCT02031627|101321777|FG001|COMPLETED|Overall Study||7||
48404129|NCT02031627|101321778|FG002|COMPLETED|Overall Study||7||
48404130|NCT02031627|101321776|FG000|NOT COMPLETED|Overall Study||0||
48404131|NCT02031627|101321777|FG001|NOT COMPLETED|Overall Study||0||
48141526|NCT01055769|100670431|FG000|STARTED|Washout Period of Atleast 4 Days||10||
48141527|NCT01055769|100670432|FG001|STARTED|Washout Period of Atleast 4 Days||10||
48141528|NCT01055769|100670431|FG000|COMPLETED|Washout Period of Atleast 4 Days||10||
48404132|NCT02031627|101321778|FG002|NOT COMPLETED|Overall Study||0||
48404133|NCT03136913|101321779|FG000|STARTED|Overall Study||13||
48404134|NCT03136913|101321779|FG000|Subjects Received Both Intervention|Overall Study||10||
48404135|NCT03136913|101321779|FG000|COMPLETED|Overall Study||8||
48404136|NCT03136913|101321779|FG000|NOT COMPLETED|Overall Study||5||
48404137|NCT04964557|101321780|FG000|STARTED|Overall Study||206||
48404138|NCT04964557|101321781|FG001|STARTED|Overall Study||205||
48141529|NCT01055769|100670432|FG001|COMPLETED|Washout Period of Atleast 4 Days||10||
48141530|NCT01055769|100670431|FG000|NOT COMPLETED|Washout Period of Atleast 4 Days||0||
48141531|NCT01055769|100670432|FG001|NOT COMPLETED|Washout Period of Atleast 4 Days||0||
48141532|NCT01055769|100670431|FG000|STARTED|Second Intervention||10||
48141533|NCT01055769|100670432|FG001|STARTED|Second Intervention||10||
48141534|NCT01055769|100670431|FG000|COMPLETED|Second Intervention||10||
48141535|NCT01055769|100670432|FG001|COMPLETED|Second Intervention||10||
48141536|NCT01055769|100670431|FG000|NOT COMPLETED|Second Intervention||0||
48141537|NCT01055769|100670432|FG001|NOT COMPLETED|Second Intervention||0||
48141538|NCT02959996|100670433|FG000|STARTED|Overall Study||40||
48141539|NCT02959996|100670434|FG001|STARTED|Overall Study||39||
48141540|NCT02959996|100670433|FG000|COMPLETED|Overall Study||40||
48141541|NCT02959996|100670434|FG001|COMPLETED|Overall Study||39||
48141542|NCT02959996|100670433|FG000|NOT COMPLETED|Overall Study||0||
48141543|NCT02959996|100670434|FG001|NOT COMPLETED|Overall Study||0||
48141544|NCT02341417|100670435|FG000|STARTED|Overall Study||13||
48141545|NCT02341417|100670436|FG001|STARTED|Overall Study||14||
48141546|NCT02341417|100670437|FG002|STARTED|Overall Study||1||
48141547|NCT02341417|100670435|FG000|COMPLETED|Overall Study||11||
48141548|NCT02341417|100670436|FG001|COMPLETED|Overall Study||12||
48141549|NCT02341417|100670437|FG002|COMPLETED|Overall Study||0||
48141550|NCT02341417|100670435|FG000|NOT COMPLETED|Overall Study||2||
48141551|NCT02341417|100670436|FG001|NOT COMPLETED|Overall Study||2||
48141552|NCT02341417|100670437|FG002|NOT COMPLETED|Overall Study||1||
48141553|NCT00058123|100670438|FG000|STARTED|Overall Study||55||
48141554|NCT00058123|100670438|FG000|COMPLETED|Overall Study||45||
48141555|NCT00058123|100670438|FG000|NOT COMPLETED|Overall Study||10||
48141556|NCT03695172|100670439|FG000|STARTED|Overall Study||5||
48141557|NCT03695172|100670440|FG001|STARTED|Overall Study||4||
48141558|NCT03695172|100670441|FG002|STARTED|Overall Study||3||
48141559|NCT03695172|100670439|FG000|COMPLETED|Overall Study||4||
48141560|NCT03695172|100670440|FG001|COMPLETED|Overall Study||3||
48141561|NCT03695172|100670441|FG002|COMPLETED|Overall Study||3||
48404139|NCT04964557|101321780|FG000|COMPLETED|Overall Study||196||
48404140|NCT04964557|101321781|FG001|COMPLETED|Overall Study||201||
48404141|NCT04964557|101321780|FG000|NOT COMPLETED|Overall Study||10||
48593266|NCT02124759|101786347|FG001|STARTED|Overall Study||7|Subjects gave informed consent to be screened for study.|
48593267|NCT02124759|101786348|FG002|STARTED|Overall Study||7|Subjects gave informed consent to be screened for study.|
48593268|NCT02124759|101786346|FG000|Subjects Randomized to Intervention|Overall Study||4||
48593269|NCT02124759|101786347|FG001|Subjects Randomized to Intervention|Overall Study||5||
48593270|NCT02124759|101786348|FG002|Subjects Randomized to Intervention|Overall Study||4||
48593271|NCT02124759|101786346|FG000|Low Fat Diet|Overall Study||4||
48593272|NCT02124759|101786347|FG001|Low Fat Diet|Overall Study||4||
48141562|NCT03695172|100670439|FG000|NOT COMPLETED|Overall Study||1||
48404142|NCT04964557|101321781|FG001|NOT COMPLETED|Overall Study||4||
48404143|NCT03382262|101321782|FG000|STARTED|Overall Study||12||
48404144|NCT03382262|101321783|FG001|STARTED|Overall Study||13||
48404145|NCT03382262|101321784|FG002|STARTED|Overall Study||15||
48404146|NCT03382262|101321785|FG003|STARTED|Overall Study||15||
48404147|NCT03382262|101321782|FG000|COMPLETED|Overall Study||12||
48593273|NCT02124759|101786348|FG002|Low Fat Diet|Overall Study||4||
48593274|NCT02124759|101786346|FG000|High Fat Diet|Overall Study||2||
48711286|NCT02630017|102081523|FG001|NOT COMPLETED|Overall Study||1||
48141563|NCT03695172|100670440|FG001|NOT COMPLETED|Overall Study||1||
48141564|NCT03695172|100670441|FG002|NOT COMPLETED|Overall Study||0||
48141565|NCT03137303|100670442|FG000|STARTED|T0: Time of Enrollment - Baseline Visit||231||
48141566|NCT03137303|100670443|FG001|STARTED|T0: Time of Enrollment - Baseline Visit||171||
48404148|NCT03382262|101321783|FG001|COMPLETED|Overall Study||13||
48404149|NCT03382262|101321784|FG002|COMPLETED|Overall Study||14||
48404150|NCT03382262|101321785|FG003|COMPLETED|Overall Study||14||
48404151|NCT03382262|101321782|FG000|NOT COMPLETED|Overall Study||0||
48141567|NCT03137303|100670442|FG000|COMPLETED|T0: Time of Enrollment - Baseline Visit||231||
48188507|NCT04582045|100783261|FG003|NOT COMPLETED|Overall Study||0||
48404152|NCT03382262|101321783|FG001|NOT COMPLETED|Overall Study||0||
48294523|NCT04823221|101047625|FG000|COMPLETED|Overall Study||22||
48294524|NCT04823221|101047625|FG000|NOT COMPLETED|Overall Study||0||
48294525|NCT00743275|101047626|FG000|STARTED|Overall Study||59||
48294526|NCT00743275|101047627|FG001|STARTED|Overall Study||61||
48404153|NCT03382262|101321784|FG002|NOT COMPLETED|Overall Study||1||
48404154|NCT03382262|101321785|FG003|NOT COMPLETED|Overall Study||1||
48404155|NCT00439725|101321786|FG000|STARTED|Treatment Period||602||
48294527|NCT00743275|101047626|FG000|COMPLETED|Overall Study||59||
48294528|NCT00743275|101047627|FG001|COMPLETED|Overall Study||60||
48294529|NCT00743275|101047626|FG000|NOT COMPLETED|Overall Study||0||
48404156|NCT00439725|101321787|FG001|STARTED|Treatment Period||595||
48404157|NCT00439725|101321786|FG000|Participants Received Treatment|Treatment Period||598||
48404158|NCT00439725|101321787|FG001|Participants Received Treatment|Treatment Period||590||
48404159|NCT00439725|101321786|FG000|COMPLETED|Treatment Period||366||
48404160|NCT00439725|101321787|FG001|COMPLETED|Treatment Period||349||
48404161|NCT00439725|101321786|FG000|NOT COMPLETED|Treatment Period||236||
48294530|NCT00743275|101047627|FG001|NOT COMPLETED|Overall Study||1||
48294531|NCT01139021|101047628|FG000|STARTED|Overall Study||152||
48294532|NCT01139021|101047629|FG001|STARTED|Overall Study||153||
48141568|NCT03137303|100670443|FG001|COMPLETED|T0: Time of Enrollment - Baseline Visit||171||
48141569|NCT03137303|100670442|FG000|NOT COMPLETED|T0: Time of Enrollment - Baseline Visit||0||
48141570|NCT03137303|100670443|FG001|NOT COMPLETED|T0: Time of Enrollment - Baseline Visit||0||
48294533|NCT01139021|101047630|FG002|STARTED|Overall Study||67||
48294534|NCT01139021|101047631|FG003|STARTED|Overall Study||19||
48294535|NCT01139021|101047632|FG004|STARTED|Overall Study||116||
48294536|NCT01139021|101047633|FG005|STARTED|Overall Study||1||
48294537|NCT01139021|101047628|FG000|COMPLETED|Overall Study||151||
48294538|NCT01139021|101047629|FG001|COMPLETED|Overall Study||153||
48294539|NCT01139021|101047630|FG002|COMPLETED|Overall Study||67||
48294540|NCT01139021|101047631|FG003|COMPLETED|Overall Study||18||
48294541|NCT01139021|101047632|FG004|COMPLETED|Overall Study||107||
48294542|NCT01139021|101047633|FG005|COMPLETED|Overall Study||1||
48294543|NCT01139021|101047628|FG000|NOT COMPLETED|Overall Study||1||
48294544|NCT01139021|101047629|FG001|NOT COMPLETED|Overall Study||0||
48294545|NCT01139021|101047630|FG002|NOT COMPLETED|Overall Study||0||
48294546|NCT01139021|101047631|FG003|NOT COMPLETED|Overall Study||1||
48404162|NCT00439725|101321787|FG001|NOT COMPLETED|Treatment Period||246||
48404163|NCT00439725|101321786|FG000|STARTED|Observational Period||577||
48404164|NCT00439725|101321787|FG001|STARTED|Observational Period||560||
48404165|NCT00439725|101321786|FG000|COMPLETED|Observational Period||569||
48141571|NCT03137303|100670442|FG000|STARTED|T1: 3-month Follow-up||231||
48141572|NCT03137303|100670443|FG001|STARTED|T1: 3-month Follow-up||171||
48141573|NCT03137303|100670442|FG000|COMPLETED|T1: 3-month Follow-up||225||
48141574|NCT03137303|100670443|FG001|COMPLETED|T1: 3-month Follow-up||161||
48141575|NCT03137303|100670442|FG000|NOT COMPLETED|T1: 3-month Follow-up||6||
48141576|NCT03137303|100670443|FG001|NOT COMPLETED|T1: 3-month Follow-up||10||
48141577|NCT03137303|100670442|FG000|STARTED|T2: 6-month Follow-up||230||
48141578|NCT03137303|100670443|FG001|STARTED|T2: 6-month Follow-up||167||
48141579|NCT03137303|100670442|FG000|COMPLETED|T2: 6-month Follow-up||225||
48141580|NCT03137303|100670443|FG001|COMPLETED|T2: 6-month Follow-up||162||
48141581|NCT03137303|100670442|FG000|NOT COMPLETED|T2: 6-month Follow-up||5||
48141582|NCT03137303|100670443|FG001|NOT COMPLETED|T2: 6-month Follow-up||5||
48141583|NCT03137303|100670442|FG000|STARTED|T3: 9-month Follow-up||230||
48141584|NCT03137303|100670443|FG001|STARTED|T3: 9-month Follow-up||167||
48141585|NCT03137303|100670442|FG000|COMPLETED|T3: 9-month Follow-up||225||
48141586|NCT03137303|100670443|FG001|COMPLETED|T3: 9-month Follow-up||163||
48404166|NCT00439725|101321787|FG001|COMPLETED|Observational Period||553||
48404167|NCT00439725|101321786|FG000|NOT COMPLETED|Observational Period||8||
48141587|NCT03137303|100670442|FG000|NOT COMPLETED|T3: 9-month Follow-up||5||
48141588|NCT03137303|100670443|FG001|NOT COMPLETED|T3: 9-month Follow-up||4||
48141589|NCT03137303|100670442|FG000|STARTED|T4: 12-month Follow-up||229||
48141590|NCT03137303|100670443|FG001|STARTED|T4: 12-month Follow-up||167||
48141591|NCT03137303|100670442|FG000|COMPLETED|T4: 12-month Follow-up||222||
48294547|NCT01139021|101047632|FG004|NOT COMPLETED|Overall Study||9||
48294548|NCT01139021|101047633|FG005|NOT COMPLETED|Overall Study||0||
48294549|NCT00838929|101047634|FG000|STARTED|Overall Study||3||
48294550|NCT00838929|101047635|FG001|STARTED|Overall Study||8||
48294551|NCT00838929|101047636|FG002|STARTED|Overall Study||6||
48294552|NCT00838929|101047634|FG000|COMPLETED|Overall Study||3||
48404168|NCT00439725|101321787|FG001|NOT COMPLETED|Observational Period||7||
48404169|NCT01313039|101321788|FG000|STARTED|Overall Study||4||
48404170|NCT01313039|101321788|FG000|COMPLETED|Overall Study||2||
48404171|NCT01313039|101321788|FG000|NOT COMPLETED|Overall Study||2||
48404172|NCT02748525|101321789|FG000|STARTED|Overall Study||50||
48404173|NCT02748525|101321789|FG000|Completed Study Intervention|Overall Study||50||
48404174|NCT02748525|101321789|FG000|COMPLETED|Overall Study||39||
48404175|NCT02748525|101321789|FG000|NOT COMPLETED|Overall Study||11||
48404176|NCT01620593|101321790|FG000|STARTED|Overall Study||21||
48404177|NCT01620593|101321791|FG001|STARTED|Overall Study||20||
48294553|NCT00838929|101047635|FG001|COMPLETED|Overall Study||5||
48294554|NCT00838929|101047636|FG002|COMPLETED|Overall Study||5||
48294555|NCT00838929|101047634|FG000|NOT COMPLETED|Overall Study||0||
48294556|NCT00838929|101047635|FG001|NOT COMPLETED|Overall Study||3||
48294557|NCT00838929|101047636|FG002|NOT COMPLETED|Overall Study||1||
48294558|NCT00372385|101047637|FG000|STARTED|Overall Study||82||
48294559|NCT00372385|101047638|FG001|STARTED|Overall Study||81||
48294560|NCT00372385|101047639|FG002|STARTED|Overall Study||82||
48294561|NCT00372385|101047640|FG003|STARTED|Overall Study||78||
48294562|NCT00372385|101047637|FG000|COMPLETED|Overall Study||49||
48294563|NCT00372385|101047638|FG001|COMPLETED|Overall Study||61||
48294564|NCT00372385|101047639|FG002|COMPLETED|Overall Study||72||
48294565|NCT00372385|101047640|FG003|COMPLETED|Overall Study||70||
48294566|NCT00372385|101047637|FG000|NOT COMPLETED|Overall Study||33||
48294567|NCT00372385|101047638|FG001|NOT COMPLETED|Overall Study||20||
48294568|NCT00372385|101047639|FG002|NOT COMPLETED|Overall Study||10||
48294569|NCT00372385|101047640|FG003|NOT COMPLETED|Overall Study||8||
48294570|NCT00138671|101047641|FG000|STARTED|Overall Study||59||
48294571|NCT00138671|101047642|FG001|STARTED|Overall Study||46||
48294572|NCT00138671|101047641|FG000|COMPLETED|Overall Study||46||
48294573|NCT00138671|101047642|FG001|COMPLETED|Overall Study||30||
48294574|NCT00138671|101047641|FG000|NOT COMPLETED|Overall Study||13||
48294575|NCT00138671|101047642|FG001|NOT COMPLETED|Overall Study||16||
48294576|NCT02513745|101047643|FG000|STARTED|Overall Study||42|Contralateral eye study. 42 subjects/84 eyes. Each subject had 1 eye (randomized) in each group.|42
48294577|NCT02513745|101047644|FG001|STARTED|Overall Study||42|Contralateral eye study. 42 subjects/84 eyes. Each subject had 1 eye (randomized) in each group.|42
48294578|NCT02513745|101047643|FG000|COMPLETED|Overall Study||39|Contralateral eye study. 39 subjects/78 eyes. Each subject had 1 eye (randomized) in each group.|39
48294579|NCT02513745|101047644|FG001|COMPLETED|Overall Study||39|Contralateral eye study. 39 subjects/78 eyes. Each subject had 1 eye (randomized) in each group.|39
48294580|NCT02513745|101047643|FG000|NOT COMPLETED|Overall Study||3||3
48294581|NCT02513745|101047644|FG001|NOT COMPLETED|Overall Study||3||3
48294582|NCT03103763|101047645|FG000|STARTED|Overall Study||44||
48294583|NCT03103763|101047646|FG001|STARTED|Overall Study||44||
48294584|NCT03103763|101047647|FG002|STARTED|Overall Study||44||
48294585|NCT03103763|101047645|FG000|COMPLETED|Overall Study||29||
48294586|NCT03103763|101047646|FG001|COMPLETED|Overall Study||36||
48294587|NCT03103763|101047647|FG002|COMPLETED|Overall Study||37||
48294588|NCT03103763|101047645|FG000|NOT COMPLETED|Overall Study||15||
48294589|NCT03103763|101047646|FG001|NOT COMPLETED|Overall Study||8||
48294590|NCT03103763|101047647|FG002|NOT COMPLETED|Overall Study||7||
48294591|NCT00871780|101047648|FG000|STARTED|Overall Study||224||
48294592|NCT00871780|101047648|FG000|Safety Analysis Population|Overall Study||218||
48294593|NCT00871780|101047648|FG000|Efficacy Analysis Population|Overall Study||215||
48294594|NCT00871780|101047648|FG000|COMPLETED|Overall Study||197||
48294595|NCT00871780|101047648|FG000|NOT COMPLETED|Overall Study||27||
48294596|NCT04335812|101047649|FG000|STARTED|Overall Study||63||
48294597|NCT04335812|101047650|FG001|STARTED|Overall Study||63||
48294598|NCT04335812|101047649|FG000|COMPLETED|Overall Study||28||
48294599|NCT04335812|101047650|FG001|COMPLETED|Overall Study||30||
48294600|NCT04335812|101047649|FG000|NOT COMPLETED|Overall Study||35||
48294601|NCT04335812|101047650|FG001|NOT COMPLETED|Overall Study||33||
48294602|NCT03022032|101047651|FG000|STARTED|Overall Study||10||
48294603|NCT03022032|101047652|FG001|STARTED|Overall Study||23||
48294604|NCT03022032|101047653|FG002|STARTED|Overall Study||21||
48294605|NCT03022032|101047654|FG003|STARTED|Overall Study||22||
48294606|NCT03022032|101047655|FG004|STARTED|Overall Study||22||
48294607|NCT03022032|101047656|FG005|STARTED|Overall Study||4||
48294608|NCT03022032|101047651|FG000|COMPLETED|Overall Study||10||
48294609|NCT03022032|101047652|FG001|COMPLETED|Overall Study||23||
48294610|NCT03022032|101047653|FG002|COMPLETED|Overall Study||21||
48294611|NCT03022032|101047654|FG003|COMPLETED|Overall Study||22||
48294612|NCT03022032|101047655|FG004|COMPLETED|Overall Study||22||
48294613|NCT03022032|101047656|FG005|COMPLETED|Overall Study||4||
48294614|NCT03022032|101047651|FG000|NOT COMPLETED|Overall Study||0||
48294615|NCT03022032|101047652|FG001|NOT COMPLETED|Overall Study||0||
48294616|NCT03022032|101047653|FG002|NOT COMPLETED|Overall Study||0||
48294617|NCT03022032|101047654|FG003|NOT COMPLETED|Overall Study||0||
48294618|NCT03022032|101047655|FG004|NOT COMPLETED|Overall Study||0||
48294619|NCT03022032|101047656|FG005|NOT COMPLETED|Overall Study||0||
48294620|NCT00686725|101047657|FG000|STARTED|Overall Study||47||
48294621|NCT00686725|101047658|FG001|STARTED|Overall Study||52||
48294622|NCT00686725|101047657|FG000|COMPLETED|Overall Study||1||
48294623|NCT00686725|101047658|FG001|COMPLETED|Overall Study||10||
48294624|NCT00686725|101047657|FG000|NOT COMPLETED|Overall Study||46||
48294625|NCT00686725|101047658|FG001|NOT COMPLETED|Overall Study||42||
48404178|NCT01620593|101321790|FG000|COMPLETED|Overall Study||17||
48711287|NCT02630017|102081524|FG002|NOT COMPLETED|Overall Study||2||
48711288|NCT02630017|102081525|FG003|NOT COMPLETED|Overall Study||1||
48711289|NCT02436408|102081526|FG000|STARTED|Overall Study||35||
48711290|NCT02436408|102081526|FG000|COMPLETED|Overall Study||34||
48711291|NCT02436408|102081526|FG000|NOT COMPLETED|Overall Study||1||
48711292|NCT02209948|102081527|FG000|STARTED|Overall Study||80||
48711293|NCT02209948|102081528|FG001|STARTED|Overall Study||79||
48711294|NCT02209948|102081527|FG000|Recieved Alocated Intervention|Overall Study||80||
48711295|NCT02209948|102081528|FG001|Recieved Alocated Intervention|Overall Study||79||
48711296|NCT02209948|102081527|FG000|Lost to Follow up|Overall Study||0||
48711297|NCT02209948|102081528|FG001|Lost to Follow up|Overall Study||1||
48711298|NCT02209948|102081527|FG000|Discontinued Due to Progression|Overall Study||31||
48294626|NCT00690040|101047659|FG000|STARTED|Overall Study||145||
48294627|NCT00690040|101047660|FG001|STARTED|Overall Study||148||
48294628|NCT00690040|101047659|FG000|COMPLETED|Overall Study||145||
48294629|NCT00690040|101047660|FG001|COMPLETED|Overall Study||148||
48294630|NCT00690040|101047659|FG000|NOT COMPLETED|Overall Study||0||
48294631|NCT00690040|101047660|FG001|NOT COMPLETED|Overall Study||0||
48711299|NCT02209948|102081528|FG001|Discontinued Due to Progression|Overall Study||39||
48711300|NCT02209948|102081527|FG000|COMPLETED|Overall Study||80|Used for analysis|
48711301|NCT02209948|102081528|FG001|COMPLETED|Overall Study||79|Used for analysis|
48294632|NCT02186223|101047661|FG000|STARTED|Overall Study||172|(i.e., consented)|
48294633|NCT02186223|101047661|FG000|Device Placed|Overall Study||163||
48294634|NCT02186223|101047661|FG000|COMPLETED|Overall Study||151|(i.e., Device in place for at least 48 hours)|
48294635|NCT02186223|101047661|FG000|NOT COMPLETED|Overall Study||21||
48294636|NCT01607554|101047662|FG000|STARTED|Overall Study||2||
48294637|NCT01607554|101047662|FG000|COMPLETED|Overall Study||0||
48294638|NCT01607554|101047662|FG000|NOT COMPLETED|Overall Study||2||
48294639|NCT01295034|101047663|FG000|STARTED|Overall Study||32||
48404179|NCT01620593|101321791|FG001|COMPLETED|Overall Study||19||
48404180|NCT01620593|101321790|FG000|NOT COMPLETED|Overall Study||4||
48404181|NCT01620593|101321791|FG001|NOT COMPLETED|Overall Study||1||
48404182|NCT02392468|101321792|FG000|STARTED|Overall Study||10||
48711302|NCT02209948|102081527|FG000|NOT COMPLETED|Overall Study||0||
48711303|NCT02209948|102081528|FG001|NOT COMPLETED|Overall Study||0||
48711304|NCT02635347|102081529|FG000|STARTED|Overall Study||51||
48711305|NCT02635347|102081530|FG001|STARTED|Overall Study||70||
48711306|NCT02635347|102081529|FG000|Screening|Overall Study||51||
48711307|NCT02635347|102081530|FG001|Screening|Overall Study||70||
48294640|NCT01295034|101047664|FG001|STARTED|Overall Study||30||
48294641|NCT01295034|101047663|FG000|COMPLETED|Overall Study||27||
48294642|NCT01295034|101047664|FG001|COMPLETED|Overall Study||25||
48294643|NCT01295034|101047663|FG000|NOT COMPLETED|Overall Study||5||
48294644|NCT01295034|101047664|FG001|NOT COMPLETED|Overall Study||5||
48294645|NCT03486457|101047665|FG000|STARTED|Up to Month 3||136||
48294646|NCT03486457|101047666|FG001|STARTED|Up to Month 3||68||
48711308|NCT02635347|102081529|FG000|Enrollment|Overall Study||31||
48711309|NCT02635347|102081530|FG001|Enrollment|Overall Study||63||
48711310|NCT02635347|102081529|FG000|Protocol Completion|Overall Study||22||
48404183|NCT02392468|101321793|FG001|STARTED|Overall Study||11||
48404184|NCT02392468|101321794|FG002|STARTED|Overall Study||10||
48404185|NCT02392468|101321795|FG003|STARTED|Overall Study||10||
48404186|NCT02392468|101321796|FG004|STARTED|Overall Study||9||
48711311|NCT02635347|102081530|FG001|Protocol Completion|Overall Study||63||
48711312|NCT02635347|102081529|FG000|Follow up|Overall Study||31||
48711313|NCT02635347|102081530|FG001|Follow up|Overall Study||63||
48711314|NCT02635347|102081529|FG000|Analyses|Overall Study||30|One in RIC cohort excluded in analyses of graft related outcomes since no transplant was performed|
48711315|NCT02635347|102081530|FG001|Analyses|Overall Study||63|One in RIC cohort excluded in analyses of graft related outcomes since no transplant was performed|
48711316|NCT02635347|102081529|FG000|COMPLETED|Overall Study||31||
48711317|NCT02635347|102081530|FG001|COMPLETED|Overall Study||63||
48711318|NCT02635347|102081529|FG000|NOT COMPLETED|Overall Study||20||
48711319|NCT02635347|102081530|FG001|NOT COMPLETED|Overall Study||7||
48711320|NCT00300482|102081531|FG000|STARTED|Overall Study||261||
48711321|NCT00300482|102081532|FG001|STARTED|Overall Study||261||
48711322|NCT00300482|102081533|FG002|STARTED|Overall Study||259||
48711323|NCT00300482|102081534|FG003|STARTED|Overall Study||261||
48711324|NCT00300482|102081535|FG004|STARTED|Overall Study||266||
48711325|NCT00300482|102081536|FG005|STARTED|Overall Study||131||
48711326|NCT00300482|102081531|FG000|COMPLETED|Overall Study||220||
48711327|NCT00300482|102081532|FG001|COMPLETED|Overall Study||220||
48711328|NCT00300482|102081533|FG002|COMPLETED|Overall Study||208||
48711329|NCT00300482|102081534|FG003|COMPLETED|Overall Study||237||
48711330|NCT00300482|102081535|FG004|COMPLETED|Overall Study||243||
48711331|NCT00300482|102081536|FG005|COMPLETED|Overall Study||115||
48711332|NCT00300482|102081531|FG000|NOT COMPLETED|Overall Study||41||
48711333|NCT00300482|102081532|FG001|NOT COMPLETED|Overall Study||41||
48711334|NCT00300482|102081533|FG002|NOT COMPLETED|Overall Study||51||
48711335|NCT00300482|102081534|FG003|NOT COMPLETED|Overall Study||24||
48711336|NCT00300482|102081535|FG004|NOT COMPLETED|Overall Study||23||
48711337|NCT00300482|102081536|FG005|NOT COMPLETED|Overall Study||16||
48711338|NCT00904618|102081537|FG000|STARTED|Overall Study||48||
48711339|NCT00904618|102081537|FG000|COMPLETED|Overall Study||48||
48711340|NCT00904618|102081537|FG000|NOT COMPLETED|Overall Study||0||
48711341|NCT00908648|102081538|FG000|STARTED|Overall Study||108||
48711342|NCT00908648|102081539|FG001|STARTED|Overall Study||103||
48711343|NCT00908648|102081538|FG000|COMPLETED|Overall Study||108||
48711344|NCT00908648|102081539|FG001|COMPLETED|Overall Study||103||
48711345|NCT00908648|102081538|FG000|NOT COMPLETED|Overall Study||0||
48711346|NCT00908648|102081539|FG001|NOT COMPLETED|Overall Study||0||
48404187|NCT02392468|101321797|FG005|STARTED|Overall Study||11||
48711347|NCT02653495|102081540|FG000|STARTED|Overall Study||15||
48711348|NCT02653495|102081541|FG001|STARTED|Overall Study||2||
48711349|NCT02653495|102081540|FG000|COMPLETED|Overall Study||3||
48711350|NCT02653495|102081541|FG001|COMPLETED|Overall Study||2||
48711351|NCT02653495|102081540|FG000|NOT COMPLETED|Overall Study||12||
48711352|NCT02653495|102081541|FG001|NOT COMPLETED|Overall Study||0||
48711353|NCT02963987|102081542|FG000|STARTED|First Intervention Period||31||
48711354|NCT02963987|102081543|FG001|STARTED|First Intervention Period||19||
48711355|NCT02963987|102081542|FG000|COMPLETED|First Intervention Period||31||
48711356|NCT02963987|102081543|FG001|COMPLETED|First Intervention Period||19||
48711357|NCT02963987|102081542|FG000|NOT COMPLETED|First Intervention Period||0||
48711358|NCT02963987|102081543|FG001|NOT COMPLETED|First Intervention Period||0||
48711359|NCT02963987|102081542|FG000|STARTED|Second Intervention Period||31||
48711360|NCT02963987|102081543|FG001|STARTED|Second Intervention Period||19||
48711361|NCT02963987|102081542|FG000|COMPLETED|Second Intervention Period||31||
48711362|NCT02963987|102081543|FG001|COMPLETED|Second Intervention Period||19||
48711363|NCT02963987|102081542|FG000|NOT COMPLETED|Second Intervention Period||0||
48711364|NCT02963987|102081543|FG001|NOT COMPLETED|Second Intervention Period||0||
48711365|NCT02851407|102081544|FG000|STARTED|Overall Study||190||
48711366|NCT02851407|102081545|FG001|STARTED|Overall Study||182||
48404188|NCT02392468|101321792|FG000|COMPLETED|Overall Study||10||
48404189|NCT02392468|101321793|FG001|COMPLETED|Overall Study||10||
48404190|NCT02392468|101321794|FG002|COMPLETED|Overall Study||10||
48404191|NCT02392468|101321795|FG003|COMPLETED|Overall Study||10||
48404192|NCT02392468|101321796|FG004|COMPLETED|Overall Study||9||
48404193|NCT02392468|101321797|FG005|COMPLETED|Overall Study||10||
48404194|NCT02392468|101321792|FG000|NOT COMPLETED|Overall Study||0||
48404195|NCT02392468|101321793|FG001|NOT COMPLETED|Overall Study||1||
48404196|NCT02392468|101321794|FG002|NOT COMPLETED|Overall Study||0||
48711367|NCT02851407|102081544|FG000|COMPLETED|Overall Study||120||
48711368|NCT02851407|102081545|FG001|COMPLETED|Overall Study||121||
48711369|NCT02851407|102081544|FG000|NOT COMPLETED|Overall Study||70||
48711370|NCT02851407|102081545|FG001|NOT COMPLETED|Overall Study||61||
48711371|NCT02867618|102081546|FG000|STARTED|Overall Study||11||
48711372|NCT02867618|102081546|FG000|COMPLETED|Overall Study||11||
48711373|NCT02867618|102081546|FG000|NOT COMPLETED|Overall Study||0||
48711374|NCT00171925|102081547|FG000|STARTED|Overall Study||72||
48711375|NCT00171925|102081548|FG001|STARTED|Overall Study||71||
48711376|NCT00171925|102081547|FG000|COMPLETED|Overall Study||42||
48711377|NCT00171925|102081548|FG001|COMPLETED|Overall Study||40||
48711378|NCT00171925|102081547|FG000|NOT COMPLETED|Overall Study||30||
48711379|NCT00171925|102081548|FG001|NOT COMPLETED|Overall Study||31||
48294647|NCT03486457|101047665|FG000|COMPLETED|Up to Month 3||129||
48294648|NCT03486457|101047666|FG001|COMPLETED|Up to Month 3||63||
48294649|NCT03486457|101047665|FG000|NOT COMPLETED|Up to Month 3||7||
48294650|NCT03486457|101047666|FG001|NOT COMPLETED|Up to Month 3||5||
48294651|NCT03486457|101047665|FG000|STARTED|Month 3 to Month 6||129||
48294652|NCT03486457|101047666|FG001|STARTED|Month 3 to Month 6||63||
48294653|NCT03486457|101047665|FG000|COMPLETED|Month 3 to Month 6||126||
48294654|NCT03486457|101047666|FG001|COMPLETED|Month 3 to Month 6||61||
48294655|NCT03486457|101047665|FG000|NOT COMPLETED|Month 3 to Month 6||3||
48294656|NCT03486457|101047666|FG001|NOT COMPLETED|Month 3 to Month 6||2||
48294657|NCT00031551|101047667|FG000|STARTED|Overall Study||2||
48294658|NCT00031551|101047668|FG001|STARTED|Overall Study||25||
48294659|NCT00031551|101047667|FG000|COMPLETED|Overall Study||0||
48294660|NCT00031551|101047668|FG001|COMPLETED|Overall Study||25||
48294661|NCT00031551|101047667|FG000|NOT COMPLETED|Overall Study||2||
48294662|NCT00031551|101047668|FG001|NOT COMPLETED|Overall Study||0||
48711380|NCT00977938|102081549|FG000|STARTED|Treatment (12-30 mo. Post Procedure)||5020||
48711381|NCT00977938|102081550|FG001|STARTED|Treatment (12-30 mo. Post Procedure)||4941||
48711382|NCT00977938|102081551|FG002|STARTED|Treatment (12-30 mo. Post Procedure)||842||
48711383|NCT00977938|102081552|FG003|STARTED|Treatment (12-30 mo. Post Procedure)||845||
48294663|NCT00475033|101047669|FG000|STARTED|Infant Series||300||
48294664|NCT00475033|101047670|FG001|STARTED|Infant Series||303||
48294665|NCT00475033|101047669|FG000|Vaccinated Dose 1|Infant Series||300||
48711384|NCT00977938|102081549|FG000|COMPLETED|Treatment (12-30 mo. Post Procedure)||4783||
48711385|NCT00977938|102081550|FG001|COMPLETED|Treatment (12-30 mo. Post Procedure)||4716||
48711386|NCT00977938|102081551|FG002|COMPLETED|Treatment (12-30 mo. Post Procedure)||796||
48711387|NCT00977938|102081552|FG003|COMPLETED|Treatment (12-30 mo. Post Procedure)||784||
48711388|NCT00977938|102081549|FG000|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||237||
48711389|NCT00977938|102081550|FG001|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||225||
48711390|NCT00977938|102081551|FG002|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||46||
48711391|NCT00977938|102081552|FG003|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||61||
48711392|NCT00977938|102081549|FG000|STARTED|Observation (30-33 mo. Post Procedure)||4783||
48711393|NCT00977938|102081550|FG001|STARTED|Observation (30-33 mo. Post Procedure)||4716||
48711394|NCT00977938|102081551|FG002|STARTED|Observation (30-33 mo. Post Procedure)||796||
48711395|NCT00977938|102081552|FG003|STARTED|Observation (30-33 mo. Post Procedure)||784||
48294666|NCT00475033|101047670|FG001|Vaccinated Dose 1|Infant Series||303||
48294667|NCT00475033|101047669|FG000|Vaccinated Dose 2|Infant Series||297||
48294668|NCT00475033|101047670|FG001|Vaccinated Dose 2|Infant Series||296||
48294669|NCT00475033|101047669|FG000|Vaccinated Dose 3|Infant Series||293||
48294670|NCT00475033|101047670|FG001|Vaccinated Dose 3|Infant Series||294||
48294671|NCT00475033|101047669|FG000|COMPLETED|Infant Series||293||
48711396|NCT00977938|102081549|FG000|COMPLETED|Observation (30-33 mo. Post Procedure)||4732||
48711397|NCT00977938|102081550|FG001|COMPLETED|Observation (30-33 mo. Post Procedure)||4658||
48294672|NCT00475033|101047670|FG001|COMPLETED|Infant Series||290||
48294673|NCT00475033|101047669|FG000|NOT COMPLETED|Infant Series||7||
48294674|NCT00475033|101047670|FG001|NOT COMPLETED|Infant Series||13||
48294675|NCT00475033|101047669|FG000|STARTED|After the Infant Series||293||
48294676|NCT00475033|101047670|FG001|STARTED|After the Infant Series||290||
48294677|NCT00475033|101047669|FG000|Withdrawn After Infant Series|After the Infant Series||6||
48294678|NCT00475033|101047670|FG001|Withdrawn After Infant Series|After the Infant Series||8||
48294679|NCT00475033|101047669|FG000|COMPLETED|After the Infant Series||287||
48294680|NCT00475033|101047670|FG001|COMPLETED|After the Infant Series||282||
48294681|NCT00475033|101047669|FG000|NOT COMPLETED|After the Infant Series||6||
48294682|NCT00475033|101047670|FG001|NOT COMPLETED|After the Infant Series||8||
48294683|NCT00475033|101047669|FG000|STARTED|Toddler Dose||287||
48294684|NCT00475033|101047670|FG001|STARTED|Toddler Dose||282||
48294685|NCT00475033|101047669|FG000|COMPLETED|Toddler Dose||283||
48294686|NCT00475033|101047670|FG001|COMPLETED|Toddler Dose||282||
48294687|NCT00475033|101047669|FG000|NOT COMPLETED|Toddler Dose||4||
48294688|NCT00475033|101047670|FG001|NOT COMPLETED|Toddler Dose||0||
48294689|NCT01749904|101047671|FG000|STARTED|Overall Study||286||
48294690|NCT01749904|101047672|FG001|STARTED|Overall Study||134||
48294691|NCT01749904|101047671|FG000|COMPLETED|Overall Study||264||
48294692|NCT01749904|101047672|FG001|COMPLETED|Overall Study||123||
48294693|NCT01749904|101047671|FG000|NOT COMPLETED|Overall Study||22||
48294694|NCT01749904|101047672|FG001|NOT COMPLETED|Overall Study||11||
48294695|NCT04214600|101047673|FG000|STARTED|Overall Study||50||
48294696|NCT04214600|101047674|FG001|STARTED|Overall Study||50||
48711398|NCT00977938|102081551|FG002|COMPLETED|Observation (30-33 mo. Post Procedure)||784||
48294697|NCT04214600|101047673|FG000|COMPLETED|Overall Study||41||
48294698|NCT04214600|101047674|FG001|COMPLETED|Overall Study||36||
48294699|NCT04214600|101047673|FG000|NOT COMPLETED|Overall Study||9||
48294700|NCT04214600|101047674|FG001|NOT COMPLETED|Overall Study||14||
48294701|NCT00992433|101047675|FG000|STARTED|Overall Study||95||
48294702|NCT00992433|101047676|FG001|STARTED|Overall Study||97||
48294703|NCT00992433|101047675|FG000|COMPLETED|Overall Study||91||
48294704|NCT00992433|101047676|FG001|COMPLETED|Overall Study||90||
48294705|NCT00992433|101047675|FG000|NOT COMPLETED|Overall Study||4||
48294706|NCT00992433|101047676|FG001|NOT COMPLETED|Overall Study||7||
48294707|NCT02043678|101047677|FG000|STARTED|Overall Study||401||
48711399|NCT00977938|102081552|FG003|COMPLETED|Observation (30-33 mo. Post Procedure)||781||
48711400|NCT00977938|102081549|FG000|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||51||
48711401|NCT00977938|102081550|FG001|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||58||
48711402|NCT00977938|102081551|FG002|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||12||
48711403|NCT00977938|102081552|FG003|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||3||
48711404|NCT00276094|102081553|FG000|STARTED|Overall Study||282||
48294708|NCT02043678|101047678|FG001|STARTED|Overall Study||405||
48294709|NCT02043678|101047677|FG000|Treated|Overall Study||390||
48294710|NCT02043678|101047678|FG001|Treated|Overall Study||396||
48294711|NCT02043678|101047677|FG000|COMPLETED|Overall Study||0|Completed treatment|
48711405|NCT00276094|102081554|FG001|STARTED|Overall Study||276||
48294712|NCT02043678|101047678|FG001|COMPLETED|Overall Study||0|Completed treatment|
48294713|NCT02043678|101047677|FG000|NOT COMPLETED|Overall Study||401||
48294714|NCT02043678|101047678|FG001|NOT COMPLETED|Overall Study||405||
48294715|NCT03609853|101047679|FG000|STARTED|Overall Study||35||
48294716|NCT03609853|101047679|FG000|Placebo|Overall Study||28||
48294717|NCT03609853|101047679|FG000|Vaporized Low Delta-9-tetrahydrocannabinol (THC)|Overall Study||25||
48294718|NCT03609853|101047679|FG000|Vaporized High THC|Overall Study||27||
48294719|NCT03609853|101047679|FG000|Vaporized Low D-limonene|Overall Study||30||
48294720|NCT03609853|101047679|FG000|Vaporized High D-limonene|Overall Study||27||
48294721|NCT03609853|101047679|FG000|Low THC and Low D-limonene|Overall Study||27||
48294722|NCT03609853|101047679|FG000|High THC and Low D-limonene|Overall Study||31||
48294723|NCT03609853|101047679|FG000|Low THC and High D-limonene|Overall Study||25||
48294724|NCT03609853|101047679|FG000|High THC and High D-limonene|Overall Study||26||
48294725|NCT03609853|101047679|FG000|High THC and 15mg Limonene|Overall Study||12||
48294726|NCT03609853|101047679|FG000|COMPLETED|Overall Study||20||
48294727|NCT03609853|101047679|FG000|NOT COMPLETED|Overall Study||15||
48294728|NCT03226275|101047680|FG000|STARTED|Treatment Period 1 (8 Days)||8||
48294729|NCT03226275|101047681|FG001|STARTED|Treatment Period 1 (8 Days)||8||
48294730|NCT03226275|101047682|FG002|STARTED|Treatment Period 1 (8 Days)||8||
48294731|NCT03226275|101047683|FG003|STARTED|Treatment Period 1 (8 Days)||8||
48294732|NCT03226275|101047680|FG000|COMPLETED|Treatment Period 1 (8 Days)||8||
48294733|NCT03226275|101047681|FG001|COMPLETED|Treatment Period 1 (8 Days)||8||
48294734|NCT03226275|101047682|FG002|COMPLETED|Treatment Period 1 (8 Days)||7||
48294735|NCT03226275|101047683|FG003|COMPLETED|Treatment Period 1 (8 Days)||7||
48294736|NCT03226275|101047680|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
48294737|NCT03226275|101047681|FG001|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
48294738|NCT03226275|101047682|FG002|NOT COMPLETED|Treatment Period 1 (8 Days)||1||
48294739|NCT03226275|101047683|FG003|NOT COMPLETED|Treatment Period 1 (8 Days)||1||
48294740|NCT03226275|101047680|FG000|STARTED|Treatment Period 2 (8 Days)||8||
48294741|NCT03226275|101047681|FG001|STARTED|Treatment Period 2 (8 Days)||8||
48294742|NCT03226275|101047682|FG002|STARTED|Treatment Period 2 (8 Days)||7||
48294743|NCT03226275|101047683|FG003|STARTED|Treatment Period 2 (8 Days)||7||
48294744|NCT03226275|101047680|FG000|COMPLETED|Treatment Period 2 (8 Days)||8||
48294745|NCT03226275|101047681|FG001|COMPLETED|Treatment Period 2 (8 Days)||8||
48294746|NCT03226275|101047682|FG002|COMPLETED|Treatment Period 2 (8 Days)||7||
48294747|NCT03226275|101047683|FG003|COMPLETED|Treatment Period 2 (8 Days)||7||
48294748|NCT03226275|101047680|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
48294749|NCT03226275|101047681|FG001|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
48294750|NCT03226275|101047682|FG002|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
48294751|NCT03226275|101047683|FG003|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
48294752|NCT00400985|101047684|FG000|STARTED|Overall Study||501||
48294753|NCT00400985|101047684|FG000|COMPLETED|Overall Study||449||
48294754|NCT00400985|101047684|FG000|NOT COMPLETED|Overall Study||52||
48711406|NCT00276094|102081555|FG002|STARTED|Overall Study||268||
48711407|NCT00276094|102081553|FG000|COMPLETED|Overall Study||225||
48711408|NCT00276094|102081554|FG001|COMPLETED|Overall Study||234||
48711409|NCT00276094|102081555|FG002|COMPLETED|Overall Study||230||
48711410|NCT00276094|102081553|FG000|NOT COMPLETED|Overall Study||57||
48711411|NCT00276094|102081554|FG001|NOT COMPLETED|Overall Study||42||
48711412|NCT00276094|102081555|FG002|NOT COMPLETED|Overall Study||38||
48711413|NCT03283098|102081556|FG000|STARTED|Overall Study||8||
48711414|NCT03283098|102081557|FG001|STARTED|Overall Study||25||
48711415|NCT03283098|102081556|FG000|COMPLETED|Overall Study||8||
48711416|NCT03283098|102081557|FG001|COMPLETED|Overall Study||24||
48711417|NCT03283098|102081556|FG000|NOT COMPLETED|Overall Study||0||
48294755|NCT00419666|101047685|FG000|STARTED|Overall Study||25||
48294756|NCT00419666|101047685|FG000|COMPLETED|Overall Study||25||
48294757|NCT00419666|101047685|FG000|NOT COMPLETED|Overall Study||0||
48711418|NCT03283098|102081557|FG001|NOT COMPLETED|Overall Study||1||
48711419|NCT01309906|102081558|FG000|STARTED|Overall Study||33||
48294758|NCT03253926|101047686|FG000|STARTED|Overall Study||7||
48294759|NCT03253926|101047687|FG001|STARTED|Overall Study||8||
48294760|NCT03253926|101047686|FG000|COMPLETED|Overall Study||7||
48711420|NCT01309906|102081559|FG001|STARTED|Overall Study||33||
48711421|NCT01309906|102081558|FG000|COMPLETED|Overall Study||32||
48711422|NCT01309906|102081559|FG001|COMPLETED|Overall Study||32||
48294761|NCT03253926|101047687|FG001|COMPLETED|Overall Study||8||
48294762|NCT03253926|101047686|FG000|NOT COMPLETED|Overall Study||0||
48294763|NCT03253926|101047687|FG001|NOT COMPLETED|Overall Study||0||
48294764|NCT01054846|101047688|FG000|STARTED|Overall Study||322||
48593275|NCT02124759|101786347|FG001|High Fat Diet|Overall Study||5||
48593276|NCT02124759|101786348|FG002|High Fat Diet|Overall Study||4||
48294765|NCT01054846|101047689|FG001|STARTED|Overall Study||68||
48294766|NCT01054846|101047688|FG000|COMPLETED|Overall Study||246||
48294767|NCT01054846|101047689|FG001|COMPLETED|Overall Study||51||
48593277|NCT02124759|101786346|FG000|COMPLETED|Overall Study||1||
48593278|NCT02124759|101786347|FG001|COMPLETED|Overall Study||4||
48593279|NCT02124759|101786348|FG002|COMPLETED|Overall Study||3||
48593280|NCT02124759|101786346|FG000|NOT COMPLETED|Overall Study||5||
48593281|NCT02124759|101786347|FG001|NOT COMPLETED|Overall Study||3||
48593282|NCT02124759|101786348|FG002|NOT COMPLETED|Overall Study||4||
48593283|NCT02278367|101786349|FG000|STARTED|Overall Study||69||
48593284|NCT02278367|101786350|FG001|STARTED|Overall Study||110||
48593285|NCT02278367|101786349|FG000|COMPLETED|Overall Study||59||
48593286|NCT02278367|101786350|FG001|COMPLETED|Overall Study||110||
48593287|NCT02278367|101786349|FG000|NOT COMPLETED|Overall Study||10||
48593288|NCT02278367|101786350|FG001|NOT COMPLETED|Overall Study||0||
48593289|NCT01135069|101786351|FG000|STARTED|Overall Study||205||
48593290|NCT01135069|101786352|FG001|STARTED|Overall Study||209||
48593291|NCT01135069|101786353|FG002|STARTED|Overall Study||66||
48593292|NCT01135069|101786351|FG000|COMPLETED|Overall Study||169||
48593293|NCT01135069|101786352|FG001|COMPLETED|Overall Study||177||
48593294|NCT01135069|101786353|FG002|COMPLETED|Overall Study||56||
48593295|NCT01135069|101786351|FG000|NOT COMPLETED|Overall Study||36||
48593296|NCT01135069|101786352|FG001|NOT COMPLETED|Overall Study||32||
48593297|NCT01135069|101786353|FG002|NOT COMPLETED|Overall Study||10||
48593298|NCT00756600|101786354|FG000|STARTED|Overall Study||287||
48593299|NCT00756600|101786355|FG001|STARTED|Overall Study||356||
48711423|NCT01309906|102081558|FG000|NOT COMPLETED|Overall Study||1||
48711424|NCT01309906|102081559|FG001|NOT COMPLETED|Overall Study||1||
48711425|NCT02228343|102081560|FG000|STARTED|Overall Study||22||
48711426|NCT02228343|102081560|FG000|COMPLETED|Overall Study||19||
48711427|NCT02228343|102081560|FG000|NOT COMPLETED|Overall Study||3||
48711428|NCT01095653|102081561|FG000|STARTED|Overall Study||132||
48711429|NCT01095653|102081562|FG001|STARTED|Overall Study||128||
48711430|NCT01095653|102081563|FG002|STARTED|Overall Study||133||
48711431|NCT01095653|102081561|FG000|COMPLETED|Overall Study||113||
48711432|NCT01095653|102081562|FG001|COMPLETED|Overall Study||113||
48711433|NCT01095653|102081563|FG002|COMPLETED|Overall Study||117||
48711434|NCT01095653|102081561|FG000|NOT COMPLETED|Overall Study||19||
48711435|NCT01095653|102081562|FG001|NOT COMPLETED|Overall Study||15||
48711436|NCT01095653|102081563|FG002|NOT COMPLETED|Overall Study||16||
48711437|NCT02549352|102081564|FG000|STARTED|3-day Treatment and 8-week Follow-up||209||
48711438|NCT02549352|102081565|FG001|STARTED|3-day Treatment and 8-week Follow-up||102||
48711439|NCT02549352|102081564|FG000|Treated|3-day Treatment and 8-week Follow-up||209||
48711440|NCT02549352|102081565|FG001|Treated|3-day Treatment and 8-week Follow-up||101||
48711441|NCT02549352|102081564|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||207||
48711442|NCT02549352|102081565|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||96||
48711443|NCT02549352|102081564|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||2||
48711444|NCT02549352|102081565|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||6||
48711445|NCT02549352|102081564|FG000|STARTED|12-month Follow-up||207||
48294768|NCT01054846|101047688|FG000|NOT COMPLETED|Overall Study||76||
48294769|NCT01054846|101047689|FG001|NOT COMPLETED|Overall Study||17||
48593300|NCT00756600|101786354|FG000|COMPLETED|Overall Study||287||
48593301|NCT00756600|101786355|FG001|COMPLETED|Overall Study||356||
48593302|NCT00756600|101786354|FG000|NOT COMPLETED|Overall Study||0||
48593303|NCT00756600|101786355|FG001|NOT COMPLETED|Overall Study||0||
48593304|NCT01472757|101786356|FG000|STARTED|Overall Study||91||
48593305|NCT01472757|101786357|FG001|STARTED|Overall Study||93||
48593306|NCT01472757|101786358|FG002|STARTED|Overall Study||95||
48593307|NCT01472757|101786359|FG003|STARTED|Overall Study||94||
48593308|NCT01472757|101786356|FG000|Full Analysis Set|Overall Study||91|Five subjects had no post-dose efficacy assessments and were excluded from the Full Analysis Set.|
48656865|NCT03735498|101943720|FG000|Started Intervention|Overall Study||10||
48711446|NCT02549352|102081565|FG001|STARTED|12-month Follow-up||93||
48711447|NCT02549352|102081564|FG000|COMPLETED|12-month Follow-up||199||
48294770|NCT00679627|101047690|FG000|STARTED|Overall Study||1021||
48294771|NCT00679627|101047691|FG001|STARTED|Overall Study||1024||
48294772|NCT00679627|101047690|FG000|COMPLETED|Overall Study||322||
48294773|NCT00679627|101047691|FG001|COMPLETED|Overall Study||339||
48294774|NCT00679627|101047690|FG000|NOT COMPLETED|Overall Study||699||
48294775|NCT00679627|101047691|FG001|NOT COMPLETED|Overall Study||685||
48294776|NCT04975438|101050722|FG000|STARTED|Overall Study||20||
48294777|NCT04975438|101050723|FG001|STARTED|Overall Study||10||
48404197|NCT02392468|101321795|FG003|NOT COMPLETED|Overall Study||0||
48404198|NCT02392468|101321796|FG004|NOT COMPLETED|Overall Study||0||
48404199|NCT02392468|101321797|FG005|NOT COMPLETED|Overall Study||1||
48404200|NCT00610207|101321798|FG000|STARTED|Overall Study||21||
48404201|NCT00610207|101321798|FG000|COMPLETED|Overall Study||18||
48404202|NCT00610207|101321798|FG000|NOT COMPLETED|Overall Study||3||
48593309|NCT01472757|101786357|FG001|Full Analysis Set|Overall Study||93|Five subjects had no post-dose efficacy assessments and were excluded from the Full Analysis Set.|
48593310|NCT01472757|101786358|FG002|Full Analysis Set|Overall Study||92|Five subjects had no post-dose efficacy assessments and were excluded from the Full Analysis Set.|
48593311|NCT01472757|101786359|FG003|Full Analysis Set|Overall Study||92|Five subjects had no post-dose efficacy assessments and were excluded from the Full Analysis Set.|
48593312|NCT01472757|101786356|FG000|COMPLETED|Overall Study||61||
48593313|NCT01472757|101786357|FG001|COMPLETED|Overall Study||80||
48593314|NCT01472757|101786358|FG002|COMPLETED|Overall Study||76||
48593315|NCT01472757|101786359|FG003|COMPLETED|Overall Study||75||
48593316|NCT01472757|101786356|FG000|NOT COMPLETED|Overall Study||30||
48593317|NCT01472757|101786357|FG001|NOT COMPLETED|Overall Study||13||
48593318|NCT01472757|101786358|FG002|NOT COMPLETED|Overall Study||19||
48404203|NCT00003838|101321799|FG000|STARTED|Overall Study||102||
48404204|NCT00003838|101321800|FG001|STARTED|Overall Study||43||
48404205|NCT00003838|101321801|FG002|STARTED|Overall Study||57||
48294778|NCT04975438|101050724|FG002|STARTED|Overall Study||3||
48294779|NCT04975438|101050725|FG003|STARTED|Overall Study||1||
48294780|NCT04975438|101050722|FG000|COMPLETED|Overall Study||18||
48294781|NCT04975438|101050723|FG001|COMPLETED|Overall Study||10||
48294782|NCT04975438|101050724|FG002|COMPLETED|Overall Study||2||
48294783|NCT04975438|101050725|FG003|COMPLETED|Overall Study||1||
48294784|NCT04975438|101050722|FG000|NOT COMPLETED|Overall Study||2||
48294785|NCT04975438|101050723|FG001|NOT COMPLETED|Overall Study||0||
48404206|NCT00003838|101321799|FG000|COMPLETED|Overall Study||102||
48404207|NCT00003838|101321800|FG001|COMPLETED|Overall Study||18||
48404208|NCT00003838|101321801|FG002|COMPLETED|Overall Study||49||
48404209|NCT00003838|101321799|FG000|NOT COMPLETED|Overall Study||0||
48404210|NCT00003838|101321800|FG001|NOT COMPLETED|Overall Study||25||
48404211|NCT00003838|101321801|FG002|NOT COMPLETED|Overall Study||8||
48404212|NCT02005510|101321802|FG000|STARTED|Randomized (Round 1)||8120||
48404213|NCT02005510|101321803|FG001|STARTED|Randomized (Round 1)||8111||
48404214|NCT02005510|101321802|FG000|COMPLETED|Randomized (Round 1)||8120||
48404215|NCT02005510|101321803|FG001|COMPLETED|Randomized (Round 1)||8111||
48593319|NCT01472757|101786359|FG003|NOT COMPLETED|Overall Study||19||
48593320|NCT03417024|101786360|FG000|STARTED|Overall Study||13||
48593321|NCT03417024|101786360|FG000|COMPLETED|Overall Study||0||
48593322|NCT03417024|101786360|FG000|NOT COMPLETED|Overall Study||13||
48593323|NCT00329641|101786361|FG000|STARTED|Overall Study||25||
48593324|NCT00329641|101786361|FG000|Eligible|Overall Study||25||
48593325|NCT00329641|101786361|FG000|Eligible and Received Treatment|Overall Study||24||
48593326|NCT00329641|101786361|FG000|COMPLETED|Overall Study||19||
48593327|NCT00329641|101786361|FG000|NOT COMPLETED|Overall Study||6||
48593328|NCT00929474|101786362|FG000|STARTED|Overall Study||8||
48593329|NCT00929474|101786363|FG001|STARTED|Overall Study||9||
48593330|NCT00929474|101786362|FG000|COMPLETED|Overall Study||0||
48294786|NCT04975438|101050724|FG002|NOT COMPLETED|Overall Study||1||
48404216|NCT02005510|101321802|FG000|NOT COMPLETED|Randomized (Round 1)||0||
48404217|NCT02005510|101321803|FG001|NOT COMPLETED|Randomized (Round 1)||0||
48404218|NCT02005510|101321802|FG000|STARTED|Rerandomized (Round 2)||1631||
48404219|NCT02005510|101321803|FG001|STARTED|Rerandomized (Round 2)||1585||
48593331|NCT00929474|101786363|FG001|COMPLETED|Overall Study||0||
48593332|NCT00929474|101786362|FG000|NOT COMPLETED|Overall Study||8||
48593333|NCT00929474|101786363|FG001|NOT COMPLETED|Overall Study||9||
48593334|NCT00585715|101786364|FG000|STARTED|Overall Study||11||
48593335|NCT00585715|101786365|FG001|STARTED|Overall Study||11||
48593336|NCT00585715|101786364|FG000|COMPLETED|Overall Study||8||
48593337|NCT00585715|101786365|FG001|COMPLETED|Overall Study||11||
48593338|NCT00585715|101786364|FG000|NOT COMPLETED|Overall Study||3||
48593339|NCT00585715|101786365|FG001|NOT COMPLETED|Overall Study||0||
48593340|NCT00115037|101786366|FG000|STARTED|Phase1||152||
48593341|NCT00115037|101786367|FG001|STARTED|Phase1||150||
48593342|NCT00115037|101786368|FG002|STARTED|Phase1||0||
48593343|NCT00115037|101786369|FG003|STARTED|Phase1||0||
48593344|NCT00115037|101786370|FG004|STARTED|Phase1||0||
48593345|NCT00115037|101786371|FG005|STARTED|Phase1||0||
48593346|NCT00115037|101786366|FG000|COMPLETED|Phase1||127||
48593347|NCT00115037|101786367|FG001|COMPLETED|Phase1||123||
48593348|NCT00115037|101786368|FG002|COMPLETED|Phase1||0||
48593349|NCT00115037|101786369|FG003|COMPLETED|Phase1||0||
48593350|NCT00115037|101786370|FG004|COMPLETED|Phase1||0||
48593351|NCT00115037|101786371|FG005|COMPLETED|Phase1||0||
48593352|NCT00115037|101786366|FG000|NOT COMPLETED|Phase1||25||
48593353|NCT00115037|101786367|FG001|NOT COMPLETED|Phase1||27||
48593354|NCT00115037|101786368|FG002|NOT COMPLETED|Phase1||0||
48593355|NCT00115037|101786369|FG003|NOT COMPLETED|Phase1||0||
48593356|NCT00115037|101786370|FG004|NOT COMPLETED|Phase1||0||
48593357|NCT00115037|101786371|FG005|NOT COMPLETED|Phase1||0||
48593358|NCT00115037|101786366|FG000|STARTED|Phase2||0||
48593359|NCT00115037|101786367|FG001|STARTED|Phase2||0||
48593360|NCT00115037|101786368|FG002|STARTED|Phase2||91||
48593361|NCT00115037|101786369|FG003|STARTED|Phase2||92||
48593362|NCT00115037|101786370|FG004|STARTED|Phase2||34||
48593363|NCT00115037|101786371|FG005|STARTED|Phase2||33||
48593364|NCT00115037|101786366|FG000|COMPLETED|Phase2||0||
48593365|NCT00115037|101786367|FG001|COMPLETED|Phase2||0||
48593366|NCT00115037|101786368|FG002|COMPLETED|Phase2||76||
48593367|NCT00115037|101786369|FG003|COMPLETED|Phase2||77||
48593368|NCT00115037|101786370|FG004|COMPLETED|Phase2||28||
48593369|NCT00115037|101786371|FG005|COMPLETED|Phase2||21||
48593370|NCT00115037|101786366|FG000|NOT COMPLETED|Phase2||0||
48711448|NCT02549352|102081565|FG001|COMPLETED|12-month Follow-up||81||
48711449|NCT02549352|102081564|FG000|NOT COMPLETED|12-month Follow-up||8||
48711450|NCT02549352|102081565|FG001|NOT COMPLETED|12-month Follow-up||12||
48711451|NCT01342965|102081566|FG000|STARTED|Overall Study||110||
48711452|NCT01342965|102081567|FG001|STARTED|Overall Study||107||
48711453|NCT01342965|102081566|FG000|Received Treatment|Overall Study||110||
48711454|NCT01342965|102081567|FG001|Received Treatment|Overall Study||104||
48711455|NCT01342965|102081566|FG000|COMPLETED|Overall Study||1||
48711456|NCT01342965|102081567|FG001|COMPLETED|Overall Study||0||
48711457|NCT01342965|102081566|FG000|NOT COMPLETED|Overall Study||109||
48711458|NCT01342965|102081567|FG001|NOT COMPLETED|Overall Study||107||
48711459|NCT04316741|102081568|FG000|STARTED|Baseline Enrollment||30||
48711460|NCT04316741|102081569|FG001|STARTED|Baseline Enrollment||28||
48593371|NCT00115037|101786367|FG001|NOT COMPLETED|Phase2||0||
48593372|NCT00115037|101786368|FG002|NOT COMPLETED|Phase2||15||
48593373|NCT00115037|101786369|FG003|NOT COMPLETED|Phase2||15||
48593374|NCT00115037|101786370|FG004|NOT COMPLETED|Phase2||6||
48593375|NCT00115037|101786371|FG005|NOT COMPLETED|Phase2||12||
48593376|NCT00334802|101786372|FG000|STARTED|Overall Study||6||
48593377|NCT00334802|101786373|FG001|STARTED|Overall Study||56||
48593378|NCT00334802|101786372|FG000|COMPLETED|Overall Study||0||
48593379|NCT00334802|101786373|FG001|COMPLETED|Overall Study||16||
48593380|NCT00334802|101786372|FG000|NOT COMPLETED|Overall Study||6||
48593381|NCT00334802|101786373|FG001|NOT COMPLETED|Overall Study||40||
48593382|NCT00715104|101786374|FG000|STARTED|Overall Study||18||
48593383|NCT00715104|101786375|FG001|STARTED|Overall Study||16||
48593384|NCT00715104|101786376|FG002|STARTED|Overall Study||8||
48593385|NCT00715104|101786374|FG000|COMPLETED|Overall Study||18||
48593386|NCT00715104|101786375|FG001|COMPLETED|Overall Study||16||
48593387|NCT00715104|101786376|FG002|COMPLETED|Overall Study||8||
48593388|NCT00715104|101786374|FG000|NOT COMPLETED|Overall Study||0||
48593389|NCT00715104|101786375|FG001|NOT COMPLETED|Overall Study||0||
48593390|NCT00715104|101786376|FG002|NOT COMPLETED|Overall Study||0||
48593391|NCT03244618|101786377|FG000|STARTED|Overall Study||132||
48593392|NCT03244618|101786378|FG001|STARTED|Overall Study||131||
48711461|NCT04316741|102081568|FG000|COMPLETED|Baseline Enrollment||29||
48711462|NCT04316741|102081569|FG001|COMPLETED|Baseline Enrollment||27||
48711463|NCT04316741|102081568|FG000|NOT COMPLETED|Baseline Enrollment||1||
48593393|NCT03244618|101786377|FG000|Week 2|Overall Study||128||
48593394|NCT03244618|101786378|FG001|Week 2|Overall Study||125||
48593395|NCT03244618|101786377|FG000|COMPLETED|Overall Study||125||
48593396|NCT03244618|101786378|FG001|COMPLETED|Overall Study||122||
48593397|NCT03244618|101786377|FG000|NOT COMPLETED|Overall Study||7||
48593398|NCT03244618|101786378|FG001|NOT COMPLETED|Overall Study||9||
48593399|NCT04331067|101786379|FG000|STARTED|Overall Study||6||
48593400|NCT04331067|101786380|FG001|STARTED|Overall Study||6||
48593401|NCT04331067|101786381|FG002|STARTED|Overall Study||3||
48593402|NCT04331067|101786379|FG000|COMPLETED|Overall Study||4||
48711464|NCT04316741|102081569|FG001|NOT COMPLETED|Baseline Enrollment||1||
48593403|NCT04331067|101786380|FG001|COMPLETED|Overall Study||3||
48593404|NCT04331067|101786381|FG002|COMPLETED|Overall Study||2||
48593405|NCT04331067|101786379|FG000|NOT COMPLETED|Overall Study||2||
48593406|NCT04331067|101786380|FG001|NOT COMPLETED|Overall Study||3||
48593407|NCT04331067|101786381|FG002|NOT COMPLETED|Overall Study||1||
48593408|NCT00415597|101786382|FG000|STARTED|Enrollment||467||
48593409|NCT00415597|101786382|FG000|COMPLETED|Enrollment||465||
48593410|NCT00415597|101786382|FG000|NOT COMPLETED|Enrollment||2||
48593411|NCT00415597|101786382|FG000|STARTED|Treatment||465||
48593412|NCT00415597|101786382|FG000|COMPLETED|Treatment||160||
48593413|NCT00415597|101786382|FG000|NOT COMPLETED|Treatment||305||
48593414|NCT01323153|101786383|FG000|STARTED|Overall Study||150||
48593415|NCT01323153|101786384|FG001|STARTED|Overall Study||150||
48593416|NCT01323153|101786383|FG000|COMPLETED|Overall Study||133||
48593417|NCT01323153|101786384|FG001|COMPLETED|Overall Study||142||
48593418|NCT01323153|101786383|FG000|NOT COMPLETED|Overall Study||17||
48593419|NCT01323153|101786384|FG001|NOT COMPLETED|Overall Study||8||
48593420|NCT05749068|101786385|FG000|STARTED|Overall Study||10||
48593421|NCT05749068|101786385|FG000|COMPLETED|Overall Study||10||
48593422|NCT05749068|101786385|FG000|NOT COMPLETED|Overall Study||0||
48593423|NCT00783224|101786386|FG000|STARTED|Overall Study||32||
48593424|NCT00783224|101786387|FG001|STARTED|Overall Study||34||
48593425|NCT00783224|101786388|FG002|STARTED|Overall Study||143||
48593426|NCT00783224|101786389|FG003|STARTED|Overall Study||142||
48593427|NCT00783224|101786386|FG000|COMPLETED|Overall Study||32||
48593428|NCT00783224|101786387|FG001|COMPLETED|Overall Study||34||
48593429|NCT00783224|101786388|FG002|COMPLETED|Overall Study||142||
48593430|NCT00783224|101786389|FG003|COMPLETED|Overall Study||140||
48593431|NCT00783224|101786386|FG000|NOT COMPLETED|Overall Study||0||
48593432|NCT00783224|101786387|FG001|NOT COMPLETED|Overall Study||0||
48593433|NCT00783224|101786388|FG002|NOT COMPLETED|Overall Study||1||
48593434|NCT00783224|101786389|FG003|NOT COMPLETED|Overall Study||2||
48593435|NCT01914159|101786390|FG000|STARTED|Overall Study||24||
48593436|NCT01914159|101786390|FG000|COMPLETED|Overall Study||21||
48593437|NCT01914159|101786390|FG000|NOT COMPLETED|Overall Study||3||
48593438|NCT01524783|101786391|FG000|STARTED|Blinded Period||205||
48593439|NCT01524783|101786392|FG001|STARTED|Blinded Period||97||
48593440|NCT01524783|101786393|FG002|STARTED|Blinded Period||0||
48593441|NCT01524783|101786391|FG000|COMPLETED|Blinded Period||26|Participants who entered the open-label part of the study|
48593442|NCT01524783|101786392|FG001|COMPLETED|Blinded Period||6|Participants who entered the open-label part of the study|
48593443|NCT01524783|101786393|FG002|COMPLETED|Blinded Period||0|Participants who entered the open-label part of the study|
48593444|NCT01524783|101786391|FG000|NOT COMPLETED|Blinded Period||179||
48593445|NCT01524783|101786392|FG001|NOT COMPLETED|Blinded Period||91||
48593446|NCT01524783|101786393|FG002|NOT COMPLETED|Blinded Period||0||
48593447|NCT01524783|101786391|FG000|STARTED|Open-label Period||26||
48593448|NCT01524783|101786392|FG001|STARTED|Open-label Period||0||
48593449|NCT01524783|101786393|FG002|STARTED|Open-label Period||6||
48711465|NCT04316741|102081568|FG000|STARTED|Immediate Post-Test||29||
48593450|NCT01524783|101786391|FG000|COMPLETED|Open-label Period||0||
48593451|NCT01524783|101786392|FG001|COMPLETED|Open-label Period||0||
48593452|NCT01524783|101786393|FG002|COMPLETED|Open-label Period||0||
48593453|NCT01524783|101786391|FG000|NOT COMPLETED|Open-label Period||26||
48593454|NCT01524783|101786392|FG001|NOT COMPLETED|Open-label Period||0||
48593455|NCT01524783|101786393|FG002|NOT COMPLETED|Open-label Period||6||
48593456|NCT03083769|101786394|FG000|STARTED|Overall Study||839||
48593457|NCT03083769|101786395|FG001|STARTED|Overall Study||663||
48593458|NCT03083769|101786394|FG000|COMPLETED|Overall Study||819||
48593459|NCT03083769|101786395|FG001|COMPLETED|Overall Study||631||
48593460|NCT03083769|101786394|FG000|NOT COMPLETED|Overall Study||20||
48593461|NCT03083769|101786395|FG001|NOT COMPLETED|Overall Study||32||
48593462|NCT04208321|101786396|FG000|STARTED|Overall Study||6||
48593463|NCT04208321|101786397|FG001|STARTED|Overall Study||6||
48593464|NCT04208321|101786398|FG002|STARTED|Overall Study||6||
48593465|NCT04208321|101786399|FG003|STARTED|Overall Study||6||
48593466|NCT04208321|101786400|FG004|STARTED|Overall Study||6||
48593467|NCT04208321|101786401|FG005|STARTED|Overall Study||6||
48593468|NCT04208321|101786402|FG006|STARTED|Overall Study||12||
48593469|NCT04208321|101786396|FG000|COMPLETED|Overall Study||6||
48593470|NCT04208321|101786397|FG001|COMPLETED|Overall Study||6||
48593471|NCT04208321|101786398|FG002|COMPLETED|Overall Study||6||
48593472|NCT04208321|101786399|FG003|COMPLETED|Overall Study||6||
48593473|NCT04208321|101786400|FG004|COMPLETED|Overall Study||6||
48593474|NCT04208321|101786401|FG005|COMPLETED|Overall Study||6||
48593475|NCT04208321|101786402|FG006|COMPLETED|Overall Study||12||
48593476|NCT04208321|101786396|FG000|NOT COMPLETED|Overall Study||0||
48593477|NCT04208321|101786397|FG001|NOT COMPLETED|Overall Study||0||
48593478|NCT04208321|101786398|FG002|NOT COMPLETED|Overall Study||0||
48593479|NCT04208321|101786399|FG003|NOT COMPLETED|Overall Study||0||
48593480|NCT04208321|101786400|FG004|NOT COMPLETED|Overall Study||0||
48593481|NCT04208321|101786401|FG005|NOT COMPLETED|Overall Study||0||
48593482|NCT04208321|101786402|FG006|NOT COMPLETED|Overall Study||0||
48593483|NCT00850096|101786403|FG000|STARTED|Overall Study||47||
48593484|NCT00850096|101786404|FG001|STARTED|Overall Study||47||
48593485|NCT00850096|101786403|FG000|COMPLETED|Overall Study||44||
48593486|NCT00850096|101786404|FG001|COMPLETED|Overall Study||45||
48593487|NCT00850096|101786403|FG000|NOT COMPLETED|Overall Study||3||
48593488|NCT00850096|101786404|FG001|NOT COMPLETED|Overall Study||2||
48593489|NCT01690910|101786405|FG000|STARTED|Overall Study||0||
48593490|NCT01690910|101786406|FG001|STARTED|Overall Study||0||
48593491|NCT01690910|101786405|FG000|COMPLETED|Overall Study||0||
48593492|NCT01690910|101786406|FG001|COMPLETED|Overall Study||0||
48593493|NCT01690910|101786405|FG000|NOT COMPLETED|Overall Study||0||
48593494|NCT01690910|101786406|FG001|NOT COMPLETED|Overall Study||0||
48593495|NCT00624559|101786407|FG000|STARTED|Overall Study||3||
48593496|NCT00624559|101786408|FG001|STARTED|Overall Study||3||
48593497|NCT00624559|101786409|FG002|STARTED|Overall Study||3||
48593498|NCT00624559|101786410|FG003|STARTED|Overall Study||3||
48593499|NCT00624559|101786407|FG000|COMPLETED|Overall Study||3||
48593500|NCT00624559|101786408|FG001|COMPLETED|Overall Study||3||
48593501|NCT00624559|101786409|FG002|COMPLETED|Overall Study||3||
48593502|NCT00624559|101786410|FG003|COMPLETED|Overall Study||3||
48593503|NCT00624559|101786407|FG000|NOT COMPLETED|Overall Study||0||
48593504|NCT00624559|101786408|FG001|NOT COMPLETED|Overall Study||0||
48593505|NCT00624559|101786409|FG002|NOT COMPLETED|Overall Study||0||
48593506|NCT00624559|101786410|FG003|NOT COMPLETED|Overall Study||0||
48593507|NCT03258008|101786411|FG000|STARTED|Overall Study||2||
48593508|NCT03258008|101786411|FG000|COMPLETED|Overall Study||2||
48593509|NCT03258008|101786411|FG000|NOT COMPLETED|Overall Study||0||
48294787|NCT04975438|101050725|FG003|NOT COMPLETED|Overall Study||0||
48294788|NCT01912456|101050726|FG000|STARTED|Period 1||22||
48294789|NCT01912456|101050727|FG001|STARTED|Period 1||23||
48294790|NCT01912456|101050728|FG002|STARTED|Period 1||23||
48294791|NCT01912456|101050729|FG003|STARTED|Period 1||22||
48294792|NCT01912456|101050726|FG000|COMPLETED|Period 1||20||
48294793|NCT01912456|101050727|FG001|COMPLETED|Period 1||22||
48294794|NCT01912456|101050728|FG002|COMPLETED|Period 1||21||
48294795|NCT01912456|101050729|FG003|COMPLETED|Period 1||19||
48294796|NCT01912456|101050726|FG000|NOT COMPLETED|Period 1||2||
48294797|NCT01912456|101050727|FG001|NOT COMPLETED|Period 1||1||
48294798|NCT01912456|101050728|FG002|NOT COMPLETED|Period 1||2||
48294799|NCT01912456|101050729|FG003|NOT COMPLETED|Period 1||3||
48294800|NCT01912456|101050726|FG000|STARTED|Period 2||20||
48294801|NCT01912456|101050727|FG001|STARTED|Period 2||22||
48294802|NCT01912456|101050728|FG002|STARTED|Period 2||21||
48294803|NCT01912456|101050729|FG003|STARTED|Period 2||19||
48593510|NCT01294371|101786412|FG000|STARTED|Overall Study||391||
48593511|NCT01294371|101786412|FG000|Treated|Overall Study||390||
48593512|NCT01294371|101786412|FG000|COMPLETED|Overall Study||357||
48593513|NCT01294371|101786412|FG000|NOT COMPLETED|Overall Study||34||
48593514|NCT00526331|101786413|FG000|STARTED|Overall Study||55||
48593515|NCT00526331|101786413|FG000|COMPLETED|Overall Study||0||
48593516|NCT00526331|101786413|FG000|NOT COMPLETED|Overall Study||55||
48593517|NCT02360475|101786414|FG000|STARTED|Overall Study||126|A total of 507 subjects were screened, but only 500 subjects received vaccination.|
48593518|NCT02360475|101786415|FG001|STARTED|Overall Study||124|A total of 507 subjects were screened, but only 500 subjects received vaccination.|
48593519|NCT02360475|101786416|FG002|STARTED|Overall Study||125|A total of 507 subjects were screened, but only 500 subjects received vaccination.|
48593520|NCT02360475|101786417|FG003|STARTED|Overall Study||125|A total of 507 subjects were screened, but only 500 subjects received vaccination.|
48593521|NCT02360475|101786414|FG000|COMPLETED|Overall Study||122||
48593522|NCT02360475|101786415|FG001|COMPLETED|Overall Study||111||
48593523|NCT02360475|101786416|FG002|COMPLETED|Overall Study||117||
48593524|NCT02360475|101786417|FG003|COMPLETED|Overall Study||120||
48593525|NCT02360475|101786414|FG000|NOT COMPLETED|Overall Study||4||
48593526|NCT02360475|101786415|FG001|NOT COMPLETED|Overall Study||13||
48593527|NCT02360475|101786416|FG002|NOT COMPLETED|Overall Study||8||
48593528|NCT02360475|101786417|FG003|NOT COMPLETED|Overall Study||5||
48593529|NCT00719914|101786418|FG000|STARTED|Overall Study||10||
48593530|NCT00719914|101786419|FG001|STARTED|Overall Study||7||
48593531|NCT00719914|101786418|FG000|COMPLETED|Overall Study||10||
48593532|NCT00719914|101786419|FG001|COMPLETED|Overall Study||7||
48593533|NCT00719914|101786418|FG000|NOT COMPLETED|Overall Study||0||
48593534|NCT00719914|101786419|FG001|NOT COMPLETED|Overall Study||0||
48593535|NCT00574795|101786420|FG000|STARTED|Infant Series||193||
48593536|NCT00574795|101786420|FG000|Vaccinated Dose 1|Infant Series||193||
48593537|NCT00574795|101786420|FG000|Vaccinated Dose 2|Infant Series||190||
48593538|NCT00574795|101786420|FG000|Vaccinated Dose 3|Infant Series||190||
48593539|NCT00574795|101786420|FG000|COMPLETED|Infant Series||188||
48593540|NCT00574795|101786420|FG000|NOT COMPLETED|Infant Series||5||
48593541|NCT00574795|101786420|FG000|STARTED|After Infant Series||188||
48593542|NCT00574795|101786420|FG000|COMPLETED|After Infant Series||185||
48294804|NCT01912456|101050726|FG000|COMPLETED|Period 2||20||
48294805|NCT01912456|101050727|FG001|COMPLETED|Period 2||20||
48294806|NCT01912456|101050728|FG002|COMPLETED|Period 2||21||
48593543|NCT00574795|101786420|FG000|NOT COMPLETED|After Infant Series||3||
48593544|NCT00574795|101786420|FG000|STARTED|Toddler Dose||185||
48593545|NCT00574795|101786420|FG000|COMPLETED|Toddler Dose||184||
48593546|NCT00574795|101786420|FG000|NOT COMPLETED|Toddler Dose||1||
48404220|NCT02005510|101321802|FG000|COMPLETED|Rerandomized (Round 2)||1631||
48404221|NCT02005510|101321803|FG001|COMPLETED|Rerandomized (Round 2)||1585||
48404222|NCT02005510|101321802|FG000|NOT COMPLETED|Rerandomized (Round 2)||0||
48404223|NCT02005510|101321803|FG001|NOT COMPLETED|Rerandomized (Round 2)||0||
48404224|NCT02005510|101321802|FG000|STARTED|Rerandomized (Round 3)||209||
48404225|NCT02005510|101321803|FG001|STARTED|Rerandomized (Round 3)||195||
48404226|NCT02005510|101321802|FG000|COMPLETED|Rerandomized (Round 3)||209||
48404227|NCT02005510|101321803|FG001|COMPLETED|Rerandomized (Round 3)||195||
48404228|NCT02005510|101321802|FG000|NOT COMPLETED|Rerandomized (Round 3)||0||
48404229|NCT02005510|101321803|FG001|NOT COMPLETED|Rerandomized (Round 3)||0||
48593547|NCT00943670|101786421|FG000|STARTED|Single-agent Trastuzumab Emtansine||51||
48593548|NCT00943670|101786421|FG000|Treated|Single-agent Trastuzumab Emtansine||51||
48593549|NCT00943670|101786421|FG000|COMPLETED|Single-agent Trastuzumab Emtansine||9||
48593550|NCT00943670|101786421|FG000|NOT COMPLETED|Single-agent Trastuzumab Emtansine||42||
48593551|NCT00943670|101786421|FG000|STARTED|Trastuzumab Emtansine + Pertuzumab||20||
48593552|NCT00943670|101786421|FG000|COMPLETED|Trastuzumab Emtansine + Pertuzumab||2||
48593553|NCT00943670|101786421|FG000|NOT COMPLETED|Trastuzumab Emtansine + Pertuzumab||18||
48593554|NCT00727090|101786422|FG000|STARTED|Overall Study||3||
48593555|NCT00727090|101786423|FG001|STARTED|Overall Study||3||
48593556|NCT00727090|101786422|FG000|COMPLETED|Overall Study||3||
48593557|NCT00727090|101786423|FG001|COMPLETED|Overall Study||3||
48593558|NCT00727090|101786422|FG000|NOT COMPLETED|Overall Study||0||
48593559|NCT00727090|101786423|FG001|NOT COMPLETED|Overall Study||0||
48593560|NCT00335959|101786424|FG000|STARTED|Overall Study||7||
48593561|NCT00335959|101786424|FG000|Eligible|Overall Study||6||
48593562|NCT00335959|101786424|FG000|Eligible and Began Protocol Therapy|Overall Study||6||
48593563|NCT00335959|101786424|FG000|COMPLETED|Overall Study||4||
48593564|NCT00335959|101786424|FG000|NOT COMPLETED|Overall Study||3||
48593565|NCT02806544|101786425|FG000|STARTED|Overall Study||35||
48593566|NCT02806544|101786425|FG000|COMPLETED|Overall Study||31||
48593567|NCT02806544|101786425|FG000|NOT COMPLETED|Overall Study||4||
48593568|NCT02515994|101786426|FG000|STARTED|Overall Study||109||
48593569|NCT02515994|101786427|FG001|STARTED|Overall Study||112||
48593570|NCT02515994|101786426|FG000|COMPLETED|Overall Study||99||
48593571|NCT02515994|101786427|FG001|COMPLETED|Overall Study||105||
48593572|NCT02515994|101786426|FG000|NOT COMPLETED|Overall Study||10||
48711466|NCT04316741|102081569|FG001|STARTED|Immediate Post-Test||27||
48711467|NCT04316741|102081568|FG000|COMPLETED|Immediate Post-Test||24||
48294807|NCT01912456|101050729|FG003|COMPLETED|Period 2||18||
48294808|NCT01912456|101050726|FG000|NOT COMPLETED|Period 2||0||
48294809|NCT01912456|101050727|FG001|NOT COMPLETED|Period 2||2||
48593573|NCT02515994|101786427|FG001|NOT COMPLETED|Overall Study||7||
48593574|NCT01549041|101786428|FG000|STARTED|Overall Study||12||
48593575|NCT01549041|101786429|FG001|STARTED|Overall Study||18||
48711468|NCT04316741|102081569|FG001|COMPLETED|Immediate Post-Test||26||
48593576|NCT01549041|101786428|FG000|COMPLETED|Overall Study||10||
48593577|NCT01549041|101786429|FG001|COMPLETED|Overall Study||10||
48593578|NCT01549041|101786428|FG000|NOT COMPLETED|Overall Study||2||
48593579|NCT01549041|101786429|FG001|NOT COMPLETED|Overall Study||8||
48593580|NCT01384019|101786430|FG000|STARTED|Overall Study||65||
48593581|NCT01384019|101786431|FG001|STARTED|Overall Study||61||
48593582|NCT01384019|101786430|FG000|COMPLETED|Overall Study||55||
48593583|NCT01384019|101786431|FG001|COMPLETED|Overall Study||55||
48593584|NCT01384019|101786430|FG000|NOT COMPLETED|Overall Study||10||
48593585|NCT01384019|101786431|FG001|NOT COMPLETED|Overall Study||6||
48593586|NCT01280682|101786432|FG000|STARTED|Overall Study||30||
48593587|NCT01280682|101786433|FG001|STARTED|Overall Study||90||
48593588|NCT01280682|101786432|FG000|COMPLETED|Overall Study||30||
48593589|NCT01280682|101786433|FG001|COMPLETED|Overall Study||77||
48711469|NCT04316741|102081568|FG000|NOT COMPLETED|Immediate Post-Test||5||
48294810|NCT01912456|101050728|FG002|NOT COMPLETED|Period 2||0||
48294811|NCT01912456|101050729|FG003|NOT COMPLETED|Period 2||1||
48294812|NCT00604812|101050730|FG000|STARTED|Overall Study||9||
48294813|NCT00604812|101050731|FG001|STARTED|Overall Study||3||
48294814|NCT00604812|101050732|FG002|STARTED|Overall Study||10||
48404230|NCT01235338|101321804|FG000|STARTED|Overall Study||42||
48404231|NCT01235338|101321805|FG001|STARTED|Overall Study||38||
48404232|NCT01235338|101321804|FG000|COMPLETED|Overall Study||31||
48593590|NCT01280682|101786432|FG000|NOT COMPLETED|Overall Study||0||
48294815|NCT00604812|101050733|FG003|STARTED|Overall Study||3||
48294816|NCT00604812|101050734|FG004|STARTED|Overall Study||5||
48404233|NCT01235338|101321805|FG001|COMPLETED|Overall Study||33||
48404234|NCT01235338|101321804|FG000|NOT COMPLETED|Overall Study||11||
48404235|NCT01235338|101321805|FG001|NOT COMPLETED|Overall Study||5||
48404236|NCT00427791|101321806|FG000|STARTED|Overall Study||10||
48294817|NCT00604812|101050735|FG005|STARTED|Overall Study||1||
48593591|NCT01280682|101786433|FG001|NOT COMPLETED|Overall Study||13||
48593592|NCT01801280|101786434|FG000|STARTED|Period 1||5||
48593593|NCT01801280|101786435|FG001|STARTED|Period 1||5||
48593594|NCT01801280|101786436|FG002|STARTED|Period 1||5||
48593595|NCT01801280|101786437|FG003|STARTED|Period 1||5||
48593596|NCT01801280|101786434|FG000|COMPLETED|Period 1||5||
48593597|NCT01801280|101786435|FG001|COMPLETED|Period 1||4||
48593598|NCT01801280|101786436|FG002|COMPLETED|Period 1||5||
48593599|NCT01801280|101786437|FG003|COMPLETED|Period 1||5||
48593600|NCT01801280|101786434|FG000|NOT COMPLETED|Period 1||0||
48593601|NCT01801280|101786435|FG001|NOT COMPLETED|Period 1||1||
48593602|NCT01801280|101786436|FG002|NOT COMPLETED|Period 1||0||
48593603|NCT01801280|101786437|FG003|NOT COMPLETED|Period 1||0||
48593604|NCT01801280|101786434|FG000|STARTED|Period 2||5||
48593605|NCT01801280|101786435|FG001|STARTED|Period 2||4||
48593606|NCT01801280|101786436|FG002|STARTED|Period 2||5||
48593607|NCT01801280|101786437|FG003|STARTED|Period 2||5||
48593608|NCT01801280|101786434|FG000|COMPLETED|Period 2||4||
48593609|NCT01801280|101786435|FG001|COMPLETED|Period 2||4||
48593610|NCT01801280|101786436|FG002|COMPLETED|Period 2||5||
48593611|NCT01801280|101786437|FG003|COMPLETED|Period 2||5||
48593612|NCT01801280|101786434|FG000|NOT COMPLETED|Period 2||1||
48593613|NCT01801280|101786435|FG001|NOT COMPLETED|Period 2||0||
48593614|NCT01801280|101786436|FG002|NOT COMPLETED|Period 2||0||
48593615|NCT01801280|101786437|FG003|NOT COMPLETED|Period 2||0||
48593616|NCT01801280|101786434|FG000|STARTED|Period 3||4||
48593617|NCT01801280|101786435|FG001|STARTED|Period 3||4||
48593618|NCT01801280|101786436|FG002|STARTED|Period 3||5||
48593619|NCT01801280|101786437|FG003|STARTED|Period 3||5||
48593620|NCT01801280|101786434|FG000|COMPLETED|Period 3||4||
48593621|NCT01801280|101786435|FG001|COMPLETED|Period 3||4||
48593622|NCT01801280|101786436|FG002|COMPLETED|Period 3||5||
48593623|NCT01801280|101786437|FG003|COMPLETED|Period 3||5||
48593624|NCT01801280|101786434|FG000|NOT COMPLETED|Period 3||0||
48593625|NCT01801280|101786435|FG001|NOT COMPLETED|Period 3||0||
48593626|NCT01801280|101786436|FG002|NOT COMPLETED|Period 3||0||
48593627|NCT01801280|101786437|FG003|NOT COMPLETED|Period 3||0||
48593628|NCT01801280|101786434|FG000|STARTED|Period 4||4||
48593629|NCT01801280|101786435|FG001|STARTED|Period 4||4||
48593630|NCT01801280|101786436|FG002|STARTED|Period 4||5||
48593631|NCT01801280|101786437|FG003|STARTED|Period 4||5||
48593632|NCT01801280|101786434|FG000|COMPLETED|Period 4||4||
48593633|NCT01801280|101786435|FG001|COMPLETED|Period 4||4||
48593634|NCT01801280|101786436|FG002|COMPLETED|Period 4||4||
48593635|NCT01801280|101786437|FG003|COMPLETED|Period 4||5||
48593636|NCT01801280|101786434|FG000|NOT COMPLETED|Period 4||0||
48593637|NCT01801280|101786435|FG001|NOT COMPLETED|Period 4||0||
48593638|NCT01801280|101786436|FG002|NOT COMPLETED|Period 4||1||
48593639|NCT01801280|101786437|FG003|NOT COMPLETED|Period 4||0||
48593640|NCT01314105|101786438|FG000|STARTED|Overall Study||7||
48593641|NCT01314105|101786439|FG001|STARTED|Overall Study||12||
48593642|NCT01314105|101786438|FG000|COMPLETED|Overall Study||0||
48593643|NCT01314105|101786439|FG001|COMPLETED|Overall Study||0||
48593644|NCT01314105|101786438|FG000|NOT COMPLETED|Overall Study||7||
48593645|NCT01314105|101786439|FG001|NOT COMPLETED|Overall Study||12||
48593646|NCT02195427|101786440|FG000|STARTED|Overall Study||73||
48593647|NCT02195427|101786441|FG001|STARTED|Overall Study||74||
48656866|NCT03735498|101943720|FG000|COMPLETED|Overall Study||8||
48593648|NCT02195427|101786440|FG000|N Patients at W24 (Primary Outcome)|Overall Study||67||
48593649|NCT02195427|101786441|FG001|N Patients at W24 (Primary Outcome)|Overall Study||62||
48593650|NCT02195427|101786440|FG000|N Patients at W36|Overall Study||65||
48593651|NCT02195427|101786441|FG001|N Patients at W36|Overall Study||59||
48593652|NCT02195427|101786440|FG000|N Patients at W52|Overall Study||63||
48593653|NCT02195427|101786441|FG001|N Patients at W52|Overall Study||56||
48711470|NCT04316741|102081569|FG001|NOT COMPLETED|Immediate Post-Test||1||
48711471|NCT04316741|102081568|FG000|STARTED|1-month Post-test||29||
48711472|NCT04316741|102081569|FG001|STARTED|1-month Post-test||27||
48711473|NCT04316741|102081568|FG000|COMPLETED|1-month Post-test||22||
48711474|NCT04316741|102081569|FG001|COMPLETED|1-month Post-test||25||
48294818|NCT00604812|101050730|FG000|COMPLETED|Overall Study||9||
48294819|NCT00604812|101050731|FG001|COMPLETED|Overall Study||3||
48294820|NCT00604812|101050732|FG002|COMPLETED|Overall Study||10||
48294821|NCT00604812|101050733|FG003|COMPLETED|Overall Study||3||
48294822|NCT00604812|101050734|FG004|COMPLETED|Overall Study||5||
48294823|NCT00604812|101050735|FG005|COMPLETED|Overall Study||1||
48294824|NCT00604812|101050730|FG000|NOT COMPLETED|Overall Study||0||
48294825|NCT00604812|101050731|FG001|NOT COMPLETED|Overall Study||0||
48294826|NCT00604812|101050732|FG002|NOT COMPLETED|Overall Study||0||
48294827|NCT00604812|101050733|FG003|NOT COMPLETED|Overall Study||0||
48404237|NCT00427791|101321807|FG001|STARTED|Overall Study||13||
48404238|NCT00427791|101321806|FG000|COMPLETED|Overall Study||10||
48404239|NCT00427791|101321807|FG001|COMPLETED|Overall Study||13||
48404240|NCT00427791|101321806|FG000|NOT COMPLETED|Overall Study||0||
48593654|NCT02195427|101786440|FG000|COMPLETED|Overall Study||47|N patients completed W64|
48593655|NCT02195427|101786441|FG001|COMPLETED|Overall Study||47|N patients completed W64|
48593656|NCT02195427|101786440|FG000|NOT COMPLETED|Overall Study||26||
48593657|NCT02195427|101786441|FG001|NOT COMPLETED|Overall Study||27||
48593658|NCT00672841|101786442|FG000|STARTED|Overall Study||17||
48593659|NCT00672841|101786443|FG001|STARTED|Overall Study||47||
48711475|NCT04316741|102081568|FG000|NOT COMPLETED|1-month Post-test||7||
48711476|NCT04316741|102081569|FG001|NOT COMPLETED|1-month Post-test||2||
48711477|NCT04316741|102081568|FG000|STARTED|3-month Follow-up||29||
48711478|NCT04316741|102081569|FG001|STARTED|3-month Follow-up||27||
48711479|NCT04316741|102081568|FG000|COMPLETED|3-month Follow-up||19||
48711480|NCT04316741|102081569|FG001|COMPLETED|3-month Follow-up||25||
48711481|NCT04316741|102081568|FG000|NOT COMPLETED|3-month Follow-up||10||
48711482|NCT04316741|102081569|FG001|NOT COMPLETED|3-month Follow-up||2||
48711483|NCT01294462|102081570|FG000|STARTED|Overall Study||401||
48711484|NCT01294462|102081571|FG001|STARTED|Overall Study||400||
48711485|NCT01294462|102081570|FG000|Received Randomized Treatment|Overall Study||387||
48711486|NCT01294462|102081571|FG001|Received Randomized Treatment|Overall Study||380||
48711487|NCT01294462|102081570|FG000|COMPLETED|Overall Study||335||
48711488|NCT01294462|102081571|FG001|COMPLETED|Overall Study||337||
48711489|NCT01294462|102081570|FG000|NOT COMPLETED|Overall Study||66||
48711490|NCT01294462|102081571|FG001|NOT COMPLETED|Overall Study||63||
48711491|NCT01697462|102081572|FG000|STARTED|Overall Study||258||
48711492|NCT01697462|102081572|FG000|COMPLETED|Overall Study||181||
48711493|NCT01697462|102081572|FG000|NOT COMPLETED|Overall Study||77||
48711494|NCT02744612|102081573|FG000|STARTED|Overall Study||3||
48711495|NCT02744612|102081574|FG001|STARTED|Overall Study||36||
48711496|NCT02744612|102081573|FG000|COMPLETED|Overall Study||3||
48711497|NCT02744612|102081574|FG001|COMPLETED|Overall Study||34||
48711498|NCT02744612|102081573|FG000|NOT COMPLETED|Overall Study||0||
48711499|NCT02744612|102081574|FG001|NOT COMPLETED|Overall Study||2||
48711500|NCT02174523|102081575|FG000|STARTED|Overall Study||10||
48711501|NCT02174523|102081576|FG001|STARTED|Overall Study||4||
48711502|NCT02174523|102081575|FG000|COMPLETED|Overall Study||9||
48711503|NCT02174523|102081576|FG001|COMPLETED|Overall Study||4||
48711504|NCT02174523|102081575|FG000|NOT COMPLETED|Overall Study||1||
48404241|NCT00427791|101321807|FG001|NOT COMPLETED|Overall Study||0||
48404242|NCT00044213|101321808|FG000|STARTED|Overall Study||421||
48593660|NCT00672841|101786442|FG000|COMPLETED|Overall Study||16||
48711505|NCT02174523|102081576|FG001|NOT COMPLETED|Overall Study||0||
48711506|NCT00048815|102081577|FG000|STARTED|Overall Study||24||
48711507|NCT00048815|102081578|FG001|STARTED|Overall Study||26||
48294828|NCT00604812|101050734|FG004|NOT COMPLETED|Overall Study||0||
48294829|NCT00604812|101050735|FG005|NOT COMPLETED|Overall Study||0||
48294830|NCT02080312|101050736|FG000|STARTED|Overall Study||6||
48593661|NCT00672841|101786443|FG001|COMPLETED|Overall Study||32||
48711508|NCT00048815|102081579|FG002|STARTED|Overall Study||23||
48711509|NCT00048815|102081577|FG000|COMPLETED|Overall Study||18||
48711510|NCT00048815|102081578|FG001|COMPLETED|Overall Study||22||
48404243|NCT00044213|101321809|FG001|STARTED|Overall Study||418||
48141592|NCT03137303|100670443|FG001|COMPLETED|T4: 12-month Follow-up||162||
48141593|NCT03137303|100670442|FG000|NOT COMPLETED|T4: 12-month Follow-up||7||
48141594|NCT03137303|100670443|FG001|NOT COMPLETED|T4: 12-month Follow-up||5||
48141595|NCT02298192|100670444|FG000|STARTED|Overall Study||210||
48141596|NCT02298192|100670445|FG001|STARTED|Overall Study||210||
48404244|NCT00044213|101321810|FG002|STARTED|Overall Study||432||
48404245|NCT00044213|101321811|FG003|STARTED|Overall Study||437||
48593662|NCT00672841|101786442|FG000|NOT COMPLETED|Overall Study||1||
48593663|NCT00672841|101786443|FG001|NOT COMPLETED|Overall Study||15||
48593664|NCT02333383|101786444|FG000|STARTED|Overall Study||201||
48593665|NCT02333383|101786444|FG000|COMPLETED|Overall Study||160||
48141597|NCT02298192|100670444|FG000|COMPLETED|Overall Study||191||
48141598|NCT02298192|100670445|FG001|COMPLETED|Overall Study||204||
48141599|NCT02298192|100670444|FG000|NOT COMPLETED|Overall Study||19||
48141600|NCT02298192|100670445|FG001|NOT COMPLETED|Overall Study||6||
48141601|NCT02679690|100670446|FG000|STARTED|Overall Study||10||
48141602|NCT02679690|100670446|FG000|COMPLETED|Overall Study||9||
48141603|NCT02679690|100670446|FG000|NOT COMPLETED|Overall Study||1||
48141604|NCT01178086|100670447|FG000|STARTED|Overall Study||681||
48141605|NCT01178086|100670447|FG000|Effectiveness Analysis Set (EAS)|Overall Study||661||
48141606|NCT01178086|100670447|FG000|COMPLETED|Overall Study||349||
48141607|NCT01178086|100670447|FG000|NOT COMPLETED|Overall Study||332||
48141608|NCT01181050|100670448|FG000|STARTED|Overall Study||41||
48141609|NCT01181050|100670449|FG001|STARTED|Overall Study||22||
48141610|NCT01181050|100670448|FG000|COMPLETED|Overall Study||41||
48141611|NCT01181050|100670449|FG001|COMPLETED|Overall Study||22||
48141612|NCT01181050|100670448|FG000|NOT COMPLETED|Overall Study||0||
48404246|NCT00044213|101321808|FG000|COMPLETED|Overall Study||321||
48404247|NCT00044213|101321809|FG001|COMPLETED|Overall Study||306||
48141613|NCT01181050|100670449|FG001|NOT COMPLETED|Overall Study||0||
48141614|NCT03273946|100670450|FG000|STARTED|Overall Study||158||
48141615|NCT03273946|100670450|FG000|COMPLETED|Overall Study||149||
48141616|NCT03273946|100670450|FG000|NOT COMPLETED|Overall Study||9||
48141617|NCT00726752|100670451|FG000|STARTED|Overall Study||6||
48141618|NCT00726752|100670451|FG000|COMPLETED|Overall Study||0||
48141619|NCT00726752|100670451|FG000|NOT COMPLETED|Overall Study||6||
48404248|NCT00044213|101321810|FG002|COMPLETED|Overall Study||294||
48404249|NCT00044213|101321811|FG003|COMPLETED|Overall Study||301||
48404250|NCT00044213|101321808|FG000|NOT COMPLETED|Overall Study||100||
48404251|NCT00044213|101321809|FG001|NOT COMPLETED|Overall Study||112||
48404252|NCT00044213|101321810|FG002|NOT COMPLETED|Overall Study||138||
48404253|NCT00044213|101321811|FG003|NOT COMPLETED|Overall Study||136||
48404254|NCT03565991|101321812|FG000|STARTED|Overall Study||159||
48404255|NCT03565991|101321813|FG001|STARTED|Overall Study||41||
48404256|NCT03565991|101321812|FG000|COMPLETED|Overall Study||1||
48593666|NCT02333383|101786444|FG000|NOT COMPLETED|Overall Study||41||
48593667|NCT01959698|101786445|FG000|STARTED|Overall Study||3||
48593668|NCT01959698|101786446|FG001|STARTED|Overall Study||3||
48593669|NCT01959698|101786447|FG002|STARTED|Overall Study||3||
48593670|NCT01959698|101786448|FG003|STARTED|Overall Study||3||
48593671|NCT01959698|101786449|FG004|STARTED|Overall Study||3||
48141620|NCT04656847|100670452|FG000|STARTED|1 Month After Inclusion||504||
48404257|NCT03565991|101321813|FG001|COMPLETED|Overall Study||0||
48404258|NCT03565991|101321812|FG000|NOT COMPLETED|Overall Study||158||
48404259|NCT03565991|101321813|FG001|NOT COMPLETED|Overall Study||41||
48141621|NCT04656847|100670452|FG000|Lipid Lowering Therapy|1 Month After Inclusion||463||
48141622|NCT04656847|100670452|FG000|COMPLETED|1 Month After Inclusion||504||
48404260|NCT02667392|101321814|FG000|STARTED|Overall Study||11||
48404261|NCT02667392|101321814|FG000|COMPLETED|Overall Study||11||
48404262|NCT02667392|101321814|FG000|NOT COMPLETED|Overall Study||0||
48404263|NCT04599972|101321815|FG000|STARTED|Overall Study||154||
48141623|NCT04656847|100670452|FG000|NOT COMPLETED|1 Month After Inclusion||0||
48141624|NCT04656847|100670452|FG000|STARTED|3 Month After Inclusion||504||
48141625|NCT04656847|100670452|FG000|3 Month After Inclusion|3 Month After Inclusion||504||
48188508|NCT01686932|100783262|FG000|STARTED|Period 1||25||
48404264|NCT04599972|101321816|FG001|STARTED|Overall Study||150||
48404265|NCT04599972|101321815|FG000|COMPLETED|Overall Study||144||
48188509|NCT01686932|100783263|FG001|STARTED|Period 1||26||
48404266|NCT04599972|101321816|FG001|COMPLETED|Overall Study||142||
48404267|NCT04599972|101321815|FG000|NOT COMPLETED|Overall Study||10||
48404268|NCT04599972|101321816|FG001|NOT COMPLETED|Overall Study||8||
48404269|NCT03512275|101321817|FG000|STARTED|Overall Study||24||
48593672|NCT01959698|101786450|FG005|STARTED|Overall Study||6||
48404270|NCT03512275|101321818|FG001|STARTED|Overall Study||18||
48404271|NCT03512275|101321817|FG000|COMPLETED|Overall Study||22||
48404272|NCT03512275|101321818|FG001|COMPLETED|Overall Study||11||
48404273|NCT03512275|101321817|FG000|NOT COMPLETED|Overall Study||2||
48404274|NCT03512275|101321818|FG001|NOT COMPLETED|Overall Study||7||
48404275|NCT01436357|101321819|FG000|STARTED|Overall Study||274||
48404276|NCT01436357|101321820|FG001|STARTED|Overall Study||274||
48404277|NCT01436357|101321819|FG000|Stage 1|Overall Study||49||
48404278|NCT01436357|101321820|FG001|Stage 1|Overall Study||48||
48404279|NCT01436357|101321819|FG000|Stage 2|Overall Study||225||
48404280|NCT01436357|101321820|FG001|Stage 2|Overall Study||226||
48404281|NCT01436357|101321819|FG000|COMPLETED|Overall Study||152||
48404282|NCT01436357|101321820|FG001|COMPLETED|Overall Study||146||
48404283|NCT01436357|101321819|FG000|NOT COMPLETED|Overall Study||122||
48404284|NCT01436357|101321820|FG001|NOT COMPLETED|Overall Study||128||
48404285|NCT00654420|101321821|FG000|STARTED|Phase I (Dose Escalation)||4||
48593673|NCT01959698|101786451|FG006|STARTED|Overall Study||8||
48593674|NCT01959698|101786445|FG000|COMPLETED|Overall Study||2||
48593675|NCT01959698|101786446|FG001|COMPLETED|Overall Study||3||
48593676|NCT01959698|101786447|FG002|COMPLETED|Overall Study||2||
48593677|NCT01959698|101786448|FG003|COMPLETED|Overall Study||1||
48593678|NCT01959698|101786449|FG004|COMPLETED|Overall Study||3||
48593679|NCT01959698|101786450|FG005|COMPLETED|Overall Study||3||
48593680|NCT01959698|101786451|FG006|COMPLETED|Overall Study||4||
48593681|NCT01959698|101786445|FG000|NOT COMPLETED|Overall Study||1||
48593682|NCT01959698|101786446|FG001|NOT COMPLETED|Overall Study||0||
48593683|NCT01959698|101786447|FG002|NOT COMPLETED|Overall Study||1||
48593684|NCT01959698|101786448|FG003|NOT COMPLETED|Overall Study||2||
48593685|NCT01959698|101786449|FG004|NOT COMPLETED|Overall Study||0||
48593686|NCT01959698|101786450|FG005|NOT COMPLETED|Overall Study||3||
48593687|NCT01959698|101786451|FG006|NOT COMPLETED|Overall Study||4||
48593688|NCT01944670|101786452|FG000|STARTED|Overall Study||26||
48404286|NCT00654420|101321822|FG001|STARTED|Phase I (Dose Escalation)||16||
48404287|NCT00654420|101321823|FG002|STARTED|Phase I (Dose Escalation)||0||
48404288|NCT00654420|101321824|FG003|STARTED|Phase I (Dose Escalation)||0||
48404289|NCT00654420|101321821|FG000|COMPLETED|Phase I (Dose Escalation)||0||
48404290|NCT00654420|101321822|FG001|COMPLETED|Phase I (Dose Escalation)||0||
48404291|NCT00654420|101321823|FG002|COMPLETED|Phase I (Dose Escalation)||0||
48404292|NCT00654420|101321824|FG003|COMPLETED|Phase I (Dose Escalation)||0||
48404293|NCT00654420|101321821|FG000|NOT COMPLETED|Phase I (Dose Escalation)||4||
48404294|NCT00654420|101321822|FG001|NOT COMPLETED|Phase I (Dose Escalation)||16||
48404295|NCT00654420|101321823|FG002|NOT COMPLETED|Phase I (Dose Escalation)||0||
48404296|NCT00654420|101321824|FG003|NOT COMPLETED|Phase I (Dose Escalation)||0||
48593689|NCT01944670|101786452|FG000|COMPLETED|Overall Study||24||
48593690|NCT01944670|101786452|FG000|NOT COMPLETED|Overall Study||2||
48593691|NCT00803205|101786453|FG000|STARTED|Overall Study||120||
48593692|NCT00803205|101786454|FG001|STARTED|Overall Study||118||
48593693|NCT00803205|101786453|FG000|Completed Week 16|Overall Study||107||
48593694|NCT00803205|101786454|FG001|Completed Week 16|Overall Study||113||
48593695|NCT00803205|101786453|FG000|Completed Week 24|Overall Study||103||
48593696|NCT00803205|101786454|FG001|Completed Week 24|Overall Study||110||
48593697|NCT00803205|101786453|FG000|As-Treated Population*|Overall Study||120|"Randomized participants who received at least 1 dose of study drug~\*assessed for safety"|
48593698|NCT00803205|101786454|FG001|As-Treated Population*|Overall Study||118|"Randomized participants who received at least 1 dose of study drug~\*assessed for safety"|
48593699|NCT00803205|101786453|FG000|ITT Population|Overall Study||116|Randomized participants with FEV1 data at Baseline and 1 post-Baseline assessment by Week 8|
48593700|NCT00803205|101786454|FG001|ITT Population|Overall Study||116|Randomized participants with FEV1 data at Baseline and 1 post-Baseline assessment by Week 8|
48593701|NCT00803205|101786453|FG000|Per Protocol Population|Overall Study||100|Randomized participants who completed study treatment and had FEV1 data at Week 48|
48656867|NCT03735498|101943720|FG000|NOT COMPLETED|Overall Study||5||
48404297|NCT00654420|101321821|FG000|STARTED|Phase II||0||
48404298|NCT00654420|101321822|FG001|STARTED|Phase II||0||
48404299|NCT00654420|101321823|FG002|STARTED|Phase II||37||
48404300|NCT00654420|101321824|FG003|STARTED|Phase II||38||
48404301|NCT00654420|101321821|FG000|COMPLETED|Phase II||0||
48404302|NCT00654420|101321822|FG001|COMPLETED|Phase II||0||
48404303|NCT00654420|101321823|FG002|COMPLETED|Phase II||0||
48404304|NCT00654420|101321824|FG003|COMPLETED|Phase II||0||
48404305|NCT00654420|101321821|FG000|NOT COMPLETED|Phase II||0||
48404306|NCT00654420|101321822|FG001|NOT COMPLETED|Phase II||0||
48404307|NCT00654420|101321823|FG002|NOT COMPLETED|Phase II||37||
48404308|NCT00654420|101321824|FG003|NOT COMPLETED|Phase II||38||
48404309|NCT03964493|101321825|FG000|STARTED|Overall Study||80||
48404310|NCT03964493|101321826|FG001|STARTED|Overall Study||40||
48404311|NCT03964493|101321825|FG000|COMPLETED|Overall Study||63||
48404312|NCT03964493|101321826|FG001|COMPLETED|Overall Study||35||
48404313|NCT03964493|101321825|FG000|NOT COMPLETED|Overall Study||17||
48404314|NCT03964493|101321826|FG001|NOT COMPLETED|Overall Study||5||
48404315|NCT01529450|101321827|FG000|STARTED|Overall Study||3||
48404316|NCT01529450|101321828|FG001|STARTED|Overall Study||8||
48404317|NCT01529450|101321827|FG000|COMPLETED|Overall Study||3||
48404318|NCT01529450|101321828|FG001|COMPLETED|Overall Study||6||
48404319|NCT01529450|101321827|FG000|NOT COMPLETED|Overall Study||0||
48404320|NCT01529450|101321828|FG001|NOT COMPLETED|Overall Study||2||
48404321|NCT02187224|101321829|FG000|STARTED|Overall Study||8||
48404322|NCT02187224|101321830|FG001|STARTED|Overall Study||5||
48404323|NCT02187224|101321829|FG000|Received Trauma Script First|Overall Study||1||
48404324|NCT02187224|101321830|FG001|Received Trauma Script First|Overall Study||4||
48404325|NCT02187224|101321829|FG000|Received Neutral Script First|Overall Study||7||
48404326|NCT02187224|101321830|FG001|Received Neutral Script First|Overall Study||1||
48404327|NCT02187224|101321829|FG000|COMPLETED|Overall Study||7||
48404328|NCT02187224|101321830|FG001|COMPLETED|Overall Study||5||
48404329|NCT02187224|101321829|FG000|NOT COMPLETED|Overall Study||1||
48404330|NCT02187224|101321830|FG001|NOT COMPLETED|Overall Study||0||
48404331|NCT03032250|101321831|FG000|STARTED|Overall Study||17||
48404332|NCT03032250|101321832|FG001|STARTED|Overall Study||18||
48404333|NCT03032250|101321831|FG000|COMPLETED|Overall Study||17||
48404334|NCT03032250|101321832|FG001|COMPLETED|Overall Study||18||
48404335|NCT03032250|101321831|FG000|NOT COMPLETED|Overall Study||0||
48404336|NCT03032250|101321832|FG001|NOT COMPLETED|Overall Study||0||
48404337|NCT00422240|101321833|FG000|STARTED|Overall Study||415||
48404338|NCT00422240|101321834|FG001|STARTED|Overall Study||420||
48404339|NCT00422240|101321835|FG002|STARTED|Overall Study||415||
48404340|NCT00422240|101321836|FG003|STARTED|Overall Study||418||
48404341|NCT00422240|101321833|FG000|COMPLETED|Overall Study||347||
48404342|NCT00422240|101321834|FG001|COMPLETED|Overall Study||363||
48404343|NCT00422240|101321835|FG002|COMPLETED|Overall Study||372||
48404344|NCT00422240|101321836|FG003|COMPLETED|Overall Study||347||
48404345|NCT00422240|101321833|FG000|NOT COMPLETED|Overall Study||68||
48404346|NCT00422240|101321834|FG001|NOT COMPLETED|Overall Study||57||
48404347|NCT00422240|101321835|FG002|NOT COMPLETED|Overall Study||43||
48404348|NCT00422240|101321836|FG003|NOT COMPLETED|Overall Study||71||
48404349|NCT03813199|101321837|FG000|STARTED|Overall Study||21||
48404350|NCT03813199|101321838|FG001|STARTED|Overall Study||19||
48404351|NCT03813199|101321839|FG002|STARTED|Overall Study||20||
48404352|NCT03813199|101321837|FG000|COMPLETED|Overall Study||18||
48404353|NCT03813199|101321838|FG001|COMPLETED|Overall Study||6||
48404354|NCT03813199|101321839|FG002|COMPLETED|Overall Study||19||
48404355|NCT03813199|101321837|FG000|NOT COMPLETED|Overall Study||3||
48404356|NCT03813199|101321838|FG001|NOT COMPLETED|Overall Study||13||
48404357|NCT03813199|101321839|FG002|NOT COMPLETED|Overall Study||1||
48593702|NCT00803205|101786454|FG001|Per Protocol Population|Overall Study||103|Randomized participants who completed study treatment and had FEV1 data at Week 48|
48593703|NCT00803205|101786453|FG000|COMPLETED|Overall Study||100||
48593704|NCT00803205|101786454|FG001|COMPLETED|Overall Study||104||
48593705|NCT00803205|101786453|FG000|NOT COMPLETED|Overall Study||20||
48593706|NCT00803205|101786454|FG001|NOT COMPLETED|Overall Study||14||
48593707|NCT00623597|101786455|FG000|STARTED|Overall Study||5||
48593708|NCT00623597|101786456|FG001|STARTED|Overall Study||13||
48593709|NCT00623597|101786455|FG000|COMPLETED|Overall Study||4||
48593710|NCT00623597|101786456|FG001|COMPLETED|Overall Study||13||
48711511|NCT00048815|102081579|FG002|COMPLETED|Overall Study||19||
48711512|NCT00048815|102081577|FG000|NOT COMPLETED|Overall Study||6||
48711513|NCT00048815|102081578|FG001|NOT COMPLETED|Overall Study||4||
48711514|NCT00048815|102081579|FG002|NOT COMPLETED|Overall Study||4||
48711515|NCT00569309|102081580|FG000|STARTED|Overall Study||30||
48711516|NCT00569309|102081580|FG000|COMPLETED|Overall Study||30||
48711517|NCT00569309|102081580|FG000|NOT COMPLETED|Overall Study||0||
48711518|NCT00160199|102081581|FG000|STARTED|Overall Study||122||
48711519|NCT00160199|102081582|FG001|STARTED|Overall Study||118||
48711520|NCT00160199|102081581|FG000|COMPLETED|Overall Study||98||
48711521|NCT00160199|102081582|FG001|COMPLETED|Overall Study||81||
48711522|NCT00160199|102081581|FG000|NOT COMPLETED|Overall Study||24||
48711523|NCT00160199|102081582|FG001|NOT COMPLETED|Overall Study||37||
48711524|NCT02740543|102081583|FG000|STARTED|Overall Study||9||
48711525|NCT02740543|102081584|FG001|STARTED|Overall Study||9||
48711526|NCT02740543|102081583|FG000|COMPLETED|Overall Study||9||
48711527|NCT02740543|102081584|FG001|COMPLETED|Overall Study||9||
48711528|NCT02740543|102081583|FG000|NOT COMPLETED|Overall Study||0||
48711529|NCT02740543|102081584|FG001|NOT COMPLETED|Overall Study||0||
48711530|NCT02193087|102081585|FG000|STARTED|Overall Study||199||
48711531|NCT02193087|102081586|FG001|STARTED|Overall Study||100||
48711532|NCT02193087|102081587|FG002|STARTED|Overall Study||100||
48711533|NCT02193087|102081588|FG003|STARTED|Overall Study||603||
48404358|NCT02963766|101321840|FG000|STARTED|Double-Blind Period||51||
48404359|NCT02963766|101321841|FG001|STARTED|Double-Blind Period||51||
48404360|NCT02963766|101321842|FG002|STARTED|Double-Blind Period||52||
48593711|NCT00623597|101786455|FG000|NOT COMPLETED|Overall Study||1||
48593712|NCT00623597|101786456|FG001|NOT COMPLETED|Overall Study||0||
48593713|NCT00550862|101786457|FG000|STARTED|Double-Blind Phase (Day 1 to Day 85)||38||
48593714|NCT00550862|101786458|FG001|STARTED|Double-Blind Phase (Day 1 to Day 85)||48||
48593715|NCT00550862|101786459|FG002|STARTED|Double-Blind Phase (Day 1 to Day 85)||41||
48711534|NCT02193087|102081585|FG000|Received Vaccination|Overall Study||197||
48141626|NCT04656847|100670452|FG000|Lipid Lowering Therapy|3 Month After Inclusion||463|Proportion of patients who were taking lipid lowering therapy (LLT) at week 12 of treatment|
48141627|NCT04656847|100670452|FG000|COMPLETED|3 Month After Inclusion||481|The study enrolled 504 patients. Of them, 481 (95.44%) were included in the population for full analysis set (FAS ).|
48404361|NCT02963766|101321840|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Period||51||
48404362|NCT02963766|101321841|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Period||51||
48404363|NCT02963766|101321842|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Period||52||
48593716|NCT00550862|101786460|FG003|STARTED|Double-Blind Phase (Day 1 to Day 85)||38||
48593717|NCT00550862|101786461|FG004|STARTED|Double-Blind Phase (Day 1 to Day 85)||0||
48593718|NCT00550862|101786457|FG000|COMPLETED|Double-Blind Phase (Day 1 to Day 85)||32||
48593719|NCT00550862|101786458|FG001|COMPLETED|Double-Blind Phase (Day 1 to Day 85)||42||
48593720|NCT00550862|101786459|FG002|COMPLETED|Double-Blind Phase (Day 1 to Day 85)||25||
48711535|NCT02193087|102081586|FG001|Received Vaccination|Overall Study||97||
48711536|NCT02193087|102081587|FG002|Received Vaccination|Overall Study||100||
48711537|NCT02193087|102081588|FG003|Received Vaccination|Overall Study||602||
48711538|NCT02193087|102081585|FG000|COMPLETED|Overall Study||162||
48711539|NCT02193087|102081586|FG001|COMPLETED|Overall Study||86||
48711540|NCT02193087|102081587|FG002|COMPLETED|Overall Study||93||
48711541|NCT02193087|102081588|FG003|COMPLETED|Overall Study||524||
48711542|NCT02193087|102081585|FG000|NOT COMPLETED|Overall Study||37||
48711543|NCT02193087|102081586|FG001|NOT COMPLETED|Overall Study||14||
48711544|NCT02193087|102081587|FG002|NOT COMPLETED|Overall Study||7||
48711545|NCT02193087|102081588|FG003|NOT COMPLETED|Overall Study||79||
48711546|NCT02418312|102081589|FG000|STARTED|Overall Study||114||
48711547|NCT02418312|102081590|FG001|STARTED|Overall Study||114||
48711548|NCT02418312|102081589|FG000|COMPLETED|Overall Study||114||
48711549|NCT02418312|102081590|FG001|COMPLETED|Overall Study||114||
48711550|NCT02418312|102081589|FG000|NOT COMPLETED|Overall Study||0||
48404364|NCT02963766|101321840|FG000|COMPLETED|Double-Blind Period||47||
48711551|NCT02418312|102081590|FG001|NOT COMPLETED|Overall Study||0||
48711552|NCT01920893|102081591|FG000|STARTED|Overall Study||30||
48711553|NCT01920893|102081592|FG001|STARTED|Overall Study||30||
48711554|NCT01920893|102081591|FG000|Treated (Safety Population)|Overall Study||30||
48711555|NCT01920893|102081592|FG001|Treated (Safety Population)|Overall Study||30||
48404365|NCT02963766|101321841|FG001|COMPLETED|Double-Blind Period||49||
48404366|NCT02963766|101321842|FG002|COMPLETED|Double-Blind Period||50||
48404367|NCT02963766|101321840|FG000|NOT COMPLETED|Double-Blind Period||4||
48404368|NCT02963766|101321841|FG001|NOT COMPLETED|Double-Blind Period||2||
48404369|NCT02963766|101321842|FG002|NOT COMPLETED|Double-Blind Period||2||
48404370|NCT02963766|101321840|FG000|STARTED|Open Label Extension (OLE)||47||
48404371|NCT02963766|101321841|FG001|STARTED|Open Label Extension (OLE)||49||
48404372|NCT02963766|101321842|FG002|STARTED|Open Label Extension (OLE)||50||
48404373|NCT02963766|101321840|FG000|COMPLETED|Open Label Extension (OLE)||45||
48404374|NCT02963766|101321841|FG001|COMPLETED|Open Label Extension (OLE)||46||
48404375|NCT02963766|101321842|FG002|COMPLETED|Open Label Extension (OLE)||48||
48404376|NCT02963766|101321840|FG000|NOT COMPLETED|Open Label Extension (OLE)||2||
48404377|NCT02963766|101321841|FG001|NOT COMPLETED|Open Label Extension (OLE)||3||
48404378|NCT02963766|101321842|FG002|NOT COMPLETED|Open Label Extension (OLE)||2||
48404379|NCT00255008|101321843|FG000|STARTED|Overall Study||45||
48404380|NCT00255008|101321844|FG001|STARTED|Overall Study||9||
48404381|NCT00255008|101321845|FG002|STARTED|Overall Study||33||
48404382|NCT00255008|101321846|FG003|STARTED|Overall Study||34||
48404383|NCT00255008|101321843|FG000|COMPLETED|Overall Study||13||
48404384|NCT00255008|101321844|FG001|COMPLETED|Overall Study||0||
48404385|NCT00255008|101321845|FG002|COMPLETED|Overall Study||17||
48404386|NCT00255008|101321846|FG003|COMPLETED|Overall Study||12||
48593721|NCT00550862|101786460|FG003|COMPLETED|Double-Blind Phase (Day 1 to Day 85)||37||
48593722|NCT00550862|101786461|FG004|COMPLETED|Double-Blind Phase (Day 1 to Day 85)||0||
48593723|NCT00550862|101786457|FG000|NOT COMPLETED|Double-Blind Phase (Day 1 to Day 85)||6||
48593724|NCT00550862|101786458|FG001|NOT COMPLETED|Double-Blind Phase (Day 1 to Day 85)||6||
48593725|NCT00550862|101786459|FG002|NOT COMPLETED|Double-Blind Phase (Day 1 to Day 85)||16||
48294831|NCT02080312|101050736|FG000|COMPLETED|Overall Study||6||
48294832|NCT02080312|101050736|FG000|NOT COMPLETED|Overall Study||0||
48294833|NCT01749605|101050737|FG000|STARTED|Overall Study||18||
48294834|NCT01749605|101050738|FG001|STARTED|Overall Study||17||
48294835|NCT01749605|101050737|FG000|COMPLETED|Overall Study||14||
48294836|NCT01749605|101050738|FG001|COMPLETED|Overall Study||14||
48294837|NCT01749605|101050737|FG000|NOT COMPLETED|Overall Study||4||
48294838|NCT01749605|101050738|FG001|NOT COMPLETED|Overall Study||3||
48294839|NCT00969878|101050739|FG000|STARTED|Overall Study||148||
48294840|NCT00969878|101050740|FG001|STARTED|Overall Study||152||
48294841|NCT00969878|101050739|FG000|COMPLETED|Overall Study||118||
48294842|NCT00969878|101050740|FG001|COMPLETED|Overall Study||126||
48294843|NCT00969878|101050739|FG000|NOT COMPLETED|Overall Study||30||
48294844|NCT00969878|101050740|FG001|NOT COMPLETED|Overall Study||26||
48294845|NCT01127139|101050741|FG000|STARTED|Overall Study||3828||
48294846|NCT01127139|101050741|FG000|Number of Participants Analyzed|Overall Study||3828||
48294847|NCT01127139|101050741|FG000|COMPLETED|Overall Study||3771||
48294848|NCT01127139|101050741|FG000|NOT COMPLETED|Overall Study||57||
48294849|NCT00081770|101050742|FG000|STARTED|Overall Study||1019||
48294850|NCT00081770|101050743|FG001|STARTED|Overall Study||1016||
48294851|NCT00081770|101050744|FG002|STARTED|Overall Study||1035||
48294852|NCT00081770|101050742|FG000|COMPLETED|Overall Study||517||
48294853|NCT00081770|101050743|FG001|COMPLETED|Overall Study||470||
48294854|NCT00081770|101050744|FG002|COMPLETED|Overall Study||579||
48294855|NCT00081770|101050742|FG000|NOT COMPLETED|Overall Study||502||
48294856|NCT00081770|101050743|FG001|NOT COMPLETED|Overall Study||546||
48294857|NCT00081770|101050744|FG002|NOT COMPLETED|Overall Study||456||
48294858|NCT04329832|101050745|FG000|STARTED|Overall Study||42||
48294859|NCT04329832|101050746|FG001|STARTED|Overall Study||43||
48294860|NCT04329832|101050745|FG000|COMPLETED|Overall Study||42||
48294861|NCT04329832|101050746|FG001|COMPLETED|Overall Study||43||
48294862|NCT04329832|101050745|FG000|NOT COMPLETED|Overall Study||0||
48294863|NCT04329832|101050746|FG001|NOT COMPLETED|Overall Study||0||
48294864|NCT01658826|101050747|FG000|STARTED|Period 1: First Intervention (28 Days)||45||
48294865|NCT01658826|101050748|FG001|STARTED|Period 1: First Intervention (28 Days)||46||
48404387|NCT00255008|101321843|FG000|NOT COMPLETED|Overall Study||32||
48404388|NCT00255008|101321844|FG001|NOT COMPLETED|Overall Study||9||
48404389|NCT00255008|101321845|FG002|NOT COMPLETED|Overall Study||16||
48404390|NCT00255008|101321846|FG003|NOT COMPLETED|Overall Study||22||
48404391|NCT04055844|101321847|FG000|STARTED|Overall Study||14||
48404392|NCT04055844|101321847|FG000|COMPLETED|Overall Study||0||
48404393|NCT04055844|101321847|FG000|NOT COMPLETED|Overall Study||14||
48404394|NCT02043509|101321848|FG000|STARTED|Baseline to 1st Follow-up||203||
48404395|NCT02043509|101321849|FG001|STARTED|Baseline to 1st Follow-up||204||
48404396|NCT02043509|101321848|FG000|COMPLETED|Baseline to 1st Follow-up||138||
48404397|NCT02043509|101321849|FG001|COMPLETED|Baseline to 1st Follow-up||157||
48404398|NCT02043509|101321848|FG000|NOT COMPLETED|Baseline to 1st Follow-up||65||
48294866|NCT01658826|101050747|FG000|COMPLETED|Period 1: First Intervention (28 Days)||38||
48294867|NCT01658826|101050748|FG001|COMPLETED|Period 1: First Intervention (28 Days)||36||
48294868|NCT01658826|101050747|FG000|NOT COMPLETED|Period 1: First Intervention (28 Days)||7||
48367932|NCT03661541|101230077|FG000|STARTED|Overall Study||12||
48404399|NCT02043509|101321849|FG001|NOT COMPLETED|Baseline to 1st Follow-up||47||
48404400|NCT02043509|101321848|FG000|STARTED|Baseline to 2nd Follow-up||203|Note that participants who were lost to 1st follow-up could be present at 2nd follow-up.|
48593726|NCT00550862|101786460|FG003|NOT COMPLETED|Double-Blind Phase (Day 1 to Day 85)||1||
48593727|NCT00550862|101786461|FG004|NOT COMPLETED|Double-Blind Phase (Day 1 to Day 85)||0||
48593728|NCT00550862|101786457|FG000|STARTED|LTSE Phase (Up to 12 Months)||0||
48593729|NCT00550862|101786458|FG001|STARTED|LTSE Phase (Up to 12 Months)||0||
48593730|NCT00550862|101786459|FG002|STARTED|LTSE Phase (Up to 12 Months)||0||
48593731|NCT00550862|101786460|FG003|STARTED|LTSE Phase (Up to 12 Months)||0||
48593732|NCT00550862|101786461|FG004|STARTED|LTSE Phase (Up to 12 Months)||78||
48593733|NCT00550862|101786457|FG000|COMPLETED|LTSE Phase (Up to 12 Months)||0||
48593734|NCT00550862|101786458|FG001|COMPLETED|LTSE Phase (Up to 12 Months)||0||
48593735|NCT00550862|101786459|FG002|COMPLETED|LTSE Phase (Up to 12 Months)||0||
48593736|NCT00550862|101786460|FG003|COMPLETED|LTSE Phase (Up to 12 Months)||0||
48593737|NCT00550862|101786461|FG004|COMPLETED|LTSE Phase (Up to 12 Months)||0||
48593738|NCT00550862|101786457|FG000|NOT COMPLETED|LTSE Phase (Up to 12 Months)||0||
48593739|NCT00550862|101786458|FG001|NOT COMPLETED|LTSE Phase (Up to 12 Months)||0||
48593740|NCT00550862|101786459|FG002|NOT COMPLETED|LTSE Phase (Up to 12 Months)||0||
48593741|NCT00550862|101786460|FG003|NOT COMPLETED|LTSE Phase (Up to 12 Months)||0||
48593742|NCT00550862|101786461|FG004|NOT COMPLETED|LTSE Phase (Up to 12 Months)||78||
48593743|NCT02663752|101786462|FG000|STARTED|Overall Study||1||
48593744|NCT02663752|101786462|FG000|COMPLETED|Overall Study||1||
48593745|NCT02663752|101786462|FG000|NOT COMPLETED|Overall Study||0||
48593746|NCT02382796|101786463|FG000|STARTED|Overall Study||7||
48593747|NCT02382796|101786463|FG000|COMPLETED|Overall Study||0||
48593748|NCT02382796|101786463|FG000|NOT COMPLETED|Overall Study||7||
48593749|NCT00401544|101786464|FG000|STARTED|Overall Study||56||
48593750|NCT00401544|101786465|FG001|STARTED|Overall Study||62||
48593751|NCT00401544|101786466|FG002|STARTED|Overall Study||60||
48593752|NCT00401544|101786467|FG003|STARTED|Overall Study||60||
48593753|NCT00401544|101786464|FG000|COMPLETED|Overall Study||38||
48593754|NCT00401544|101786465|FG001|COMPLETED|Overall Study||44||
48593755|NCT00401544|101786466|FG002|COMPLETED|Overall Study||48||
48593756|NCT00401544|101786467|FG003|COMPLETED|Overall Study||44||
48593757|NCT00401544|101786464|FG000|NOT COMPLETED|Overall Study||18||
48593758|NCT00401544|101786465|FG001|NOT COMPLETED|Overall Study||18||
48593759|NCT00401544|101786466|FG002|NOT COMPLETED|Overall Study||12||
48593760|NCT00401544|101786467|FG003|NOT COMPLETED|Overall Study||16||
48593761|NCT01833936|101786468|FG000|STARTED|Overall Study||20||
48593762|NCT01833936|101786469|FG001|STARTED|Overall Study||20||
48593763|NCT01833936|101786468|FG000|COMPLETED|Overall Study||16||
48593764|NCT01833936|101786469|FG001|COMPLETED|Overall Study||18||
48593765|NCT01833936|101786468|FG000|NOT COMPLETED|Overall Study||4||
48593766|NCT01833936|101786469|FG001|NOT COMPLETED|Overall Study||2||
48593767|NCT01777568|101786470|FG000|STARTED|Overall Study||2853||
48593768|NCT01777568|101786471|FG001|STARTED|Overall Study||2896||
48593769|NCT01777568|101786470|FG000|COMPLETED|Overall Study||2853||
48593770|NCT01777568|101786471|FG001|COMPLETED|Overall Study||2896||
48593771|NCT01777568|101786470|FG000|NOT COMPLETED|Overall Study||0||
48593772|NCT01777568|101786471|FG001|NOT COMPLETED|Overall Study||0||
48593773|NCT02637713|101786472|FG000|STARTED|Overall Study||5||
48593774|NCT02637713|101786472|FG000|COMPLETED|Overall Study||3||
48593775|NCT02637713|101786472|FG000|NOT COMPLETED|Overall Study||2||
48593776|NCT03787303|101786473|FG000|STARTED|Overall Study||7||
48593777|NCT03787303|101786473|FG000|COMPLETED|Overall Study||5||
48593778|NCT03787303|101786473|FG000|NOT COMPLETED|Overall Study||2||
48593779|NCT02167815|101786474|FG000|STARTED|Overall Study||9||
48593780|NCT02167815|101786475|FG001|STARTED|Overall Study||21||
48593781|NCT02167815|101786474|FG000|COMPLETED|Overall Study||9||
48593782|NCT02167815|101786475|FG001|COMPLETED|Overall Study||21||
48593783|NCT02167815|101786474|FG000|NOT COMPLETED|Overall Study||0||
48593784|NCT02167815|101786475|FG001|NOT COMPLETED|Overall Study||0||
48593785|NCT00291161|101786476|FG000|STARTED|Overall Study||316||
48593786|NCT00291161|101786477|FG001|STARTED|Overall Study||192||
48593787|NCT00291161|101786478|FG002|STARTED|Overall Study||299||
48593788|NCT00291161|101786479|FG003|STARTED|Overall Study||187||
48593789|NCT00291161|101786476|FG000|COMPLETED|Overall Study||235||
48593790|NCT00291161|101786477|FG001|COMPLETED|Overall Study||134||
48593791|NCT00291161|101786478|FG002|COMPLETED|Overall Study||206||
48593792|NCT00291161|101786479|FG003|COMPLETED|Overall Study||122||
48593793|NCT00291161|101786476|FG000|NOT COMPLETED|Overall Study||81||
48593794|NCT00291161|101786477|FG001|NOT COMPLETED|Overall Study||58||
48593795|NCT00291161|101786478|FG002|NOT COMPLETED|Overall Study||93||
48593796|NCT00291161|101786479|FG003|NOT COMPLETED|Overall Study||65||
48593797|NCT00326781|101786480|FG000|STARTED|Overall Study||344||
48593798|NCT00326781|101786481|FG001|STARTED|Overall Study||330||
48593799|NCT00326781|101786480|FG000|COMPLETED|Overall Study||302||
48593800|NCT00326781|101786481|FG001|COMPLETED|Overall Study||298||
48593801|NCT00326781|101786480|FG000|NOT COMPLETED|Overall Study||42||
48593802|NCT00326781|101786481|FG001|NOT COMPLETED|Overall Study||32||
48593803|NCT02653170|101786482|FG000|STARTED|Overall Study||87|Numbers are reported for patient participants only.|
48593804|NCT02653170|101786483|FG001|STARTED|Overall Study||88|Numbers are reported for patient participants only.|
48593805|NCT02653170|101786484|FG002|STARTED|Overall Study||90|Numbers are reported for patient participants only.|
48593806|NCT02653170|101786482|FG000|COMPLETED|Overall Study||70||
48593807|NCT02653170|101786483|FG001|COMPLETED|Overall Study||72||
48593808|NCT02653170|101786484|FG002|COMPLETED|Overall Study||72||
48593809|NCT02653170|101786482|FG000|NOT COMPLETED|Overall Study||17||
48593810|NCT02653170|101786483|FG001|NOT COMPLETED|Overall Study||16||
48593811|NCT02653170|101786484|FG002|NOT COMPLETED|Overall Study||18||
48593812|NCT00326170|101786485|FG000|STARTED|Overall Study||34||
48593813|NCT00326170|101786485|FG000|COMPLETED|Overall Study||34||
48593814|NCT00326170|101786485|FG000|NOT COMPLETED|Overall Study||0||
48593815|NCT02101359|101786486|FG000|STARTED|Overall Study||295||
48593816|NCT02101359|101786487|FG001|STARTED|Overall Study||296||
48593817|NCT02101359|101786486|FG000|COMPLETED|Overall Study||266||
48593818|NCT02101359|101786487|FG001|COMPLETED|Overall Study||277||
48593819|NCT02101359|101786486|FG000|NOT COMPLETED|Overall Study||29||
48593820|NCT02101359|101786487|FG001|NOT COMPLETED|Overall Study||19||
48593821|NCT01043562|101786488|FG000|STARTED|Overall Study||20||
48593822|NCT01043562|101786488|FG000|COMPLETED|Overall Study||20||
48593823|NCT01043562|101786488|FG000|NOT COMPLETED|Overall Study||0||
48593824|NCT00977704|101786489|FG000|STARTED|Overall Study||20||
48593825|NCT00977704|101786489|FG000|COMPLETED|Overall Study||20||
48593826|NCT00977704|101786489|FG000|NOT COMPLETED|Overall Study||0||
48593827|NCT00435019|101786490|FG000|STARTED|Overall Study||177||
48593828|NCT00435019|101786491|FG001|STARTED|Overall Study||171||
48593829|NCT00435019|101786490|FG000|Exposed to Study Drug|Overall Study||177||
48593830|NCT00435019|101786491|FG001|Exposed to Study Drug|Overall Study||170||
48593831|NCT00435019|101786490|FG000|COMPLETED|Overall Study||164||
48593832|NCT00435019|101786491|FG001|COMPLETED|Overall Study||161||
48593833|NCT00435019|101786490|FG000|NOT COMPLETED|Overall Study||13||
48593834|NCT00435019|101786491|FG001|NOT COMPLETED|Overall Study||10||
48593835|NCT00835679|101786492|FG000|STARTED|Overall Study||9||
48593836|NCT00835679|101786493|FG001|STARTED|Overall Study||0||
48593837|NCT00835679|101786494|FG002|STARTED|Overall Study||0||
48593838|NCT00835679|101786495|FG003|STARTED|Overall Study||0||
48593839|NCT00835679|101786492|FG000|COMPLETED|Overall Study||8||
48593840|NCT00835679|101786493|FG001|COMPLETED|Overall Study||0||
48593841|NCT00835679|101786494|FG002|COMPLETED|Overall Study||0||
48593842|NCT00835679|101786495|FG003|COMPLETED|Overall Study||0||
48593843|NCT00835679|101786492|FG000|NOT COMPLETED|Overall Study||1||
48593844|NCT00835679|101786493|FG001|NOT COMPLETED|Overall Study||0||
48593845|NCT00835679|101786494|FG002|NOT COMPLETED|Overall Study||0||
48593846|NCT00835679|101786495|FG003|NOT COMPLETED|Overall Study||0||
48593847|NCT00527644|101786496|FG000|STARTED|Overall Study||14||
48593848|NCT00527644|101786496|FG000|COMPLETED|Overall Study||14||
48593849|NCT00527644|101786496|FG000|NOT COMPLETED|Overall Study||0||
48593850|NCT00842075|101786497|FG000|STARTED|Overall Study||5||
48593851|NCT00842075|101786498|FG001|STARTED|Overall Study||5||
48593852|NCT00842075|101786497|FG000|COMPLETED|Overall Study||5||
48593853|NCT00842075|101786498|FG001|COMPLETED|Overall Study||5||
48593854|NCT00842075|101786497|FG000|NOT COMPLETED|Overall Study||0||
48593855|NCT00842075|101786498|FG001|NOT COMPLETED|Overall Study||0||
48593856|NCT02777944|101786499|FG000|STARTED|Overall Study||157||
48593857|NCT02777944|101786500|FG001|STARTED|Overall Study||156||
48593858|NCT02777944|101786499|FG000|COMPLETED|Overall Study||157||
48593859|NCT02777944|101786500|FG001|COMPLETED|Overall Study||156||
48593860|NCT02777944|101786499|FG000|NOT COMPLETED|Overall Study||0||
48593861|NCT02777944|101786500|FG001|NOT COMPLETED|Overall Study||0||
48593862|NCT01258075|101786501|FG000|STARTED|Overall Study||141||
48593863|NCT01258075|101786502|FG001|STARTED|Overall Study||95||
48593864|NCT01258075|101786501|FG000|COMPLETED|Overall Study||99||
48593865|NCT01258075|101786502|FG001|COMPLETED|Overall Study||72||
48593866|NCT01258075|101786501|FG000|NOT COMPLETED|Overall Study||42||
48593867|NCT01258075|101786502|FG001|NOT COMPLETED|Overall Study||23||
48593868|NCT02604550|101786503|FG000|STARTED|Overall Study||56||
48593869|NCT02604550|101786504|FG001|STARTED|Overall Study||59||
48593870|NCT02604550|101786503|FG000|COMPLETED|Overall Study||31||
48593871|NCT02604550|101786504|FG001|COMPLETED|Overall Study||33||
48593872|NCT02604550|101786503|FG000|NOT COMPLETED|Overall Study||25||
48593873|NCT02604550|101786504|FG001|NOT COMPLETED|Overall Study||26||
48593874|NCT03956615|101786505|FG000|STARTED|Overall Study||10||
48593875|NCT03956615|101786505|FG000|COMPLETED|Overall Study||3||
48593876|NCT03956615|101786505|FG000|NOT COMPLETED|Overall Study||7||
48593877|NCT01623037|101786506|FG000|STARTED|Overall Study||15||
48404401|NCT02043509|101321849|FG001|STARTED|Baseline to 2nd Follow-up||204|Note that participants who were lost to 1st follow-up could be present at 2nd follow-up.|
48404402|NCT02043509|101321848|FG000|COMPLETED|Baseline to 2nd Follow-up||129||
48404403|NCT02043509|101321849|FG001|COMPLETED|Baseline to 2nd Follow-up||132||
48404404|NCT02043509|101321848|FG000|NOT COMPLETED|Baseline to 2nd Follow-up||74||
48141628|NCT04656847|100670452|FG000|NOT COMPLETED|3 Month After Inclusion||23||
48141629|NCT01565707|100670453|FG000|STARTED|Overall Study||75||
48404405|NCT02043509|101321849|FG001|NOT COMPLETED|Baseline to 2nd Follow-up||72||
48404406|NCT00638690|101321850|FG000|STARTED|Overall Study||797||
48404407|NCT00638690|101321851|FG001|STARTED|Overall Study||398||
48404408|NCT00638690|101321850|FG000|COMPLETED|Overall Study||116||
48404409|NCT00638690|101321851|FG001|COMPLETED|Overall Study||56||
48404410|NCT00638690|101321850|FG000|NOT COMPLETED|Overall Study||681||
48404411|NCT00638690|101321851|FG001|NOT COMPLETED|Overall Study||342||
48404412|NCT02959190|101321852|FG000|STARTED|Open Label||120||
48404413|NCT02959190|101321853|FG001|STARTED|Open Label||126||
48404414|NCT02959190|101321854|FG002|STARTED|Open Label||32||
48404415|NCT02959190|101321855|FG003|STARTED|Open Label||33||
48404416|NCT02959190|101321852|FG000|Received at Least 1 Dose of Study Drug|Open Label||120||
48404417|NCT02959190|101321853|FG001|Received at Least 1 Dose of Study Drug|Open Label||126||
48404418|NCT02959190|101321854|FG002|Received at Least 1 Dose of Study Drug|Open Label||32||
48404419|NCT02959190|101321855|FG003|Received at Least 1 Dose of Study Drug|Open Label||33||
48404420|NCT02959190|101321852|FG000|120mg/120mg Galcanezumab - EM|Open Label||58||
48404421|NCT02959190|101321853|FG001|120mg/120mg Galcanezumab - EM|Open Label||0||
48404422|NCT02959190|101321854|FG002|120mg/120mg Galcanezumab - EM|Open Label||0||
48404423|NCT02959190|101321855|FG003|120mg/120mg Galcanezumab - EM|Open Label||0||
48404424|NCT02959190|101321852|FG000|240mg/240mg Galcanezumab - EM|Open Label||0||
48404425|NCT02959190|101321853|FG001|240mg/240mg Galcanezumab - EM|Open Label||62||
48404426|NCT02959190|101321854|FG002|240mg/240mg Galcanezumab - EM|Open Label||0||
48404427|NCT02959190|101321855|FG003|240mg/240mg Galcanezumab - EM|Open Label||0||
48404428|NCT02959190|101321852|FG000|Placebo/ 120mg Galcanezumab - EM|Open Label||62||
48404429|NCT02959190|101321853|FG001|Placebo/ 120mg Galcanezumab - EM|Open Label||0||
48404430|NCT02959190|101321854|FG002|Placebo/ 120mg Galcanezumab - EM|Open Label||0||
48404431|NCT02959190|101321855|FG003|Placebo/ 120mg Galcanezumab - EM|Open Label||0||
48593878|NCT01623037|101786506|FG000|COMPLETED|Overall Study||15||
48593879|NCT01623037|101786506|FG000|NOT COMPLETED|Overall Study||0||
48593880|NCT04907227|101786507|FG000|STARTED|Overall Study||41||
48593881|NCT04907227|101786508|FG001|STARTED|Overall Study||40||
48593882|NCT04907227|101786507|FG000|Treated|Overall Study||41||
48593883|NCT04907227|101786508|FG001|Treated|Overall Study||40||
48593884|NCT04907227|101786507|FG000|COMPLETED|Overall Study||0||
48593885|NCT04907227|101786508|FG001|COMPLETED|Overall Study||0||
48593886|NCT04907227|101786507|FG000|NOT COMPLETED|Overall Study||41||
48593887|NCT04907227|101786508|FG001|NOT COMPLETED|Overall Study||40||
48593888|NCT04198584|101786509|FG000|STARTED|Overall Study||24||
48593889|NCT04198584|101786510|FG001|STARTED|Overall Study||8||
48593890|NCT04198584|101786509|FG000|Randomized to Wave 1|Overall Study||5||
48593891|NCT04198584|101786510|FG001|Randomized to Wave 1|Overall Study||2||
48593892|NCT04198584|101786509|FG000|Randomized to Wave 2|Overall Study||7||
48593893|NCT04198584|101786510|FG001|Randomized to Wave 2|Overall Study||2||
48593894|NCT04198584|101786509|FG000|Randomized to Wave 3|Overall Study||6||
48593895|NCT04198584|101786510|FG001|Randomized to Wave 3|Overall Study||2||
48593896|NCT04198584|101786509|FG000|Randomized to Wave 4|Overall Study||6||
48593897|NCT04198584|101786510|FG001|Randomized to Wave 4|Overall Study||2||
48593898|NCT04198584|101786509|FG000|Total Randomized|Overall Study||24||
48593899|NCT04198584|101786510|FG001|Total Randomized|Overall Study||8||
48593900|NCT04198584|101786509|FG000|Actually Received Treatment|Overall Study||21||
48593901|NCT04198584|101786510|FG001|Actually Received Treatment|Overall Study||8||
48593902|NCT04198584|101786509|FG000|COMPLETED|Overall Study||19||
48593903|NCT04198584|101786510|FG001|COMPLETED|Overall Study||8||
48593904|NCT04198584|101786509|FG000|NOT COMPLETED|Overall Study||5||
48593905|NCT04198584|101786510|FG001|NOT COMPLETED|Overall Study||0||
48593906|NCT00711828|101786511|FG000|STARTED|Overall Study||21||
48593907|NCT00711828|101786511|FG000|COMPLETED|Overall Study||21||
48593908|NCT00711828|101786511|FG000|NOT COMPLETED|Overall Study||0||
48593909|NCT04339179|101786512|FG000|STARTED|Overall Study||185||
48593910|NCT04339179|101786512|FG000|COMPLETED|Overall Study||185||
48593911|NCT04339179|101786512|FG000|NOT COMPLETED|Overall Study||0||
48593912|NCT02833935|101786513|FG000|STARTED|Overall Study||12||
48593913|NCT02833935|101786514|FG001|STARTED|Overall Study||12||
48593914|NCT02833935|101786513|FG000|COMPLETED|Overall Study||10||
48593915|NCT02833935|101786514|FG001|COMPLETED|Overall Study||12||
48593916|NCT02833935|101786513|FG000|NOT COMPLETED|Overall Study||2||
48593917|NCT02833935|101786514|FG001|NOT COMPLETED|Overall Study||0||
48593918|NCT02370667|101786515|FG000|STARTED|Overall Study||10||
48593919|NCT02370667|101786516|FG001|STARTED|Overall Study||11||
48593920|NCT02370667|101786517|FG002|STARTED|Overall Study||10||
48593921|NCT02370667|101786515|FG000|COMPLETED|Overall Study||10||
48593922|NCT02370667|101786516|FG001|COMPLETED|Overall Study||10||
48593923|NCT02370667|101786517|FG002|COMPLETED|Overall Study||10||
48593924|NCT02370667|101786515|FG000|NOT COMPLETED|Overall Study||0||
48593925|NCT02370667|101786516|FG001|NOT COMPLETED|Overall Study||1||
48593926|NCT02370667|101786517|FG002|NOT COMPLETED|Overall Study||0||
48593927|NCT01279564|101786518|FG000|STARTED|Overall Study||40||
48593928|NCT01279564|101786519|FG001|STARTED|Overall Study||32||
48593929|NCT01279564|101786518|FG000|COMPLETED|Overall Study||40||
48593930|NCT01279564|101786519|FG001|COMPLETED|Overall Study||32||
48593931|NCT01279564|101786518|FG000|NOT COMPLETED|Overall Study||0||
48593932|NCT01279564|101786519|FG001|NOT COMPLETED|Overall Study||0||
48593933|NCT01844206|101786520|FG000|STARTED|Overall Study||2||
48593934|NCT01844206|101786521|FG001|STARTED|Overall Study||3||
48593935|NCT01844206|101786520|FG000|COMPLETED|Overall Study||2||
48593936|NCT01844206|101786521|FG001|COMPLETED|Overall Study||2||
48593937|NCT01844206|101786520|FG000|NOT COMPLETED|Overall Study||0||
48593938|NCT01844206|101786521|FG001|NOT COMPLETED|Overall Study||1||
48593939|NCT02186847|101786522|FG000|STARTED|Overall Study||84||
48593940|NCT02186847|101786523|FG001|STARTED|Overall Study||86||
48593941|NCT02186847|101786522|FG000|Eligible Population|Overall Study||81||
48593942|NCT02186847|101786523|FG001|Eligible Population|Overall Study||86||
48593943|NCT02186847|101786522|FG000|Eligible and Started Protocol Treatment|Overall Study||76||
48593944|NCT02186847|101786523|FG001|Eligible and Started Protocol Treatment|Overall Study||82||
48593945|NCT02186847|101786522|FG000|COMPLETED|Overall Study||81|Participants contributing data to results are considered to have completed the study.|
48593946|NCT02186847|101786523|FG001|COMPLETED|Overall Study||86|Participants contributing data to results are considered to have completed the study.|
48141630|NCT01565707|100670454|FG001|STARTED|Overall Study||73||
48593947|NCT02186847|101786522|FG000|NOT COMPLETED|Overall Study||3||
48593948|NCT02186847|101786523|FG001|NOT COMPLETED|Overall Study||0||
48593949|NCT00438802|101786524|FG000|STARTED|Overall Study||6||
48593950|NCT00438802|101786525|FG001|STARTED|Overall Study||8||
48593951|NCT00438802|101786526|FG002|STARTED|Overall Study||9||
48294869|NCT01658826|101050748|FG001|NOT COMPLETED|Period 1: First Intervention (28 Days)||10||
48294870|NCT01658826|101050747|FG000|STARTED|Washout Period: 28 Days||38||
48294871|NCT01658826|101050748|FG001|STARTED|Washout Period: 28 Days||36||
48294872|NCT01658826|101050747|FG000|COMPLETED|Washout Period: 28 Days||32||
48294873|NCT01658826|101050748|FG001|COMPLETED|Washout Period: 28 Days||32||
48294874|NCT01658826|101050747|FG000|NOT COMPLETED|Washout Period: 28 Days||6||
48593952|NCT00438802|101786524|FG000|COMPLETED|Overall Study||6||
48593953|NCT00438802|101786525|FG001|COMPLETED|Overall Study||8||
48593954|NCT00438802|101786526|FG002|COMPLETED|Overall Study||9||
48593955|NCT00438802|101786524|FG000|NOT COMPLETED|Overall Study||0||
48593956|NCT00438802|101786525|FG001|NOT COMPLETED|Overall Study||0||
48593957|NCT00438802|101786526|FG002|NOT COMPLETED|Overall Study||0||
48593958|NCT01907217|101786527|FG000|STARTED|Overall Study||69||
48593959|NCT01907217|101786528|FG001|STARTED|Overall Study||69||
48593960|NCT01907217|101786527|FG000|COMPLETED|Overall Study||69||
48593961|NCT01907217|101786528|FG001|COMPLETED|Overall Study||67||
48593962|NCT01907217|101786527|FG000|NOT COMPLETED|Overall Study||0||
48593963|NCT01907217|101786528|FG001|NOT COMPLETED|Overall Study||2||
48593964|NCT02870205|101786529|FG000|STARTED|Overall Study||294||
48593965|NCT02870205|101786530|FG001|STARTED|Overall Study||294||
48593966|NCT02870205|101786531|FG002|STARTED|Overall Study||294||
48294875|NCT01658826|101050748|FG001|NOT COMPLETED|Washout Period: 28 Days||4||
48294876|NCT01658826|101050747|FG000|STARTED|Period 2: Second Intervention (28 Days)||32||
48593967|NCT02870205|101786532|FG003|STARTED|Overall Study||294||
48593968|NCT02870205|101786529|FG000|COMPLETED|Overall Study||284||
48593969|NCT02870205|101786530|FG001|COMPLETED|Overall Study||289||
48593970|NCT02870205|101786531|FG002|COMPLETED|Overall Study||287||
48593971|NCT02870205|101786532|FG003|COMPLETED|Overall Study||287||
48593972|NCT02870205|101786529|FG000|NOT COMPLETED|Overall Study||10||
48593973|NCT02870205|101786530|FG001|NOT COMPLETED|Overall Study||5||
48593974|NCT02870205|101786531|FG002|NOT COMPLETED|Overall Study||7||
48593975|NCT02870205|101786532|FG003|NOT COMPLETED|Overall Study||7||
48593976|NCT00597506|101786533|FG000|STARTED|Overall Study||50||
48593977|NCT00597506|101786533|FG000|COMPLETED|Overall Study||49||
48593978|NCT00597506|101786533|FG000|NOT COMPLETED|Overall Study||1||
48593979|NCT00742508|101786534|FG000|STARTED|8-Week Primary Evaluation Period||22||
48593980|NCT00742508|101786535|FG001|STARTED|8-Week Primary Evaluation Period||19||
48593981|NCT00742508|101786534|FG000|COMPLETED|8-Week Primary Evaluation Period||11||
48593982|NCT00742508|101786535|FG001|COMPLETED|8-Week Primary Evaluation Period||8||
48593983|NCT00742508|101786534|FG000|NOT COMPLETED|8-Week Primary Evaluation Period||11||
48593984|NCT00742508|101786535|FG001|NOT COMPLETED|8-Week Primary Evaluation Period||11||
48593985|NCT00742508|101786534|FG000|STARTED|4-Week Exploratory Evaluation Period||0||
48593986|NCT00742508|101786535|FG001|STARTED|4-Week Exploratory Evaluation Period||8||
48593987|NCT00742508|101786534|FG000|COMPLETED|4-Week Exploratory Evaluation Period||0||
48593988|NCT00742508|101786535|FG001|COMPLETED|4-Week Exploratory Evaluation Period||7||
48593989|NCT00742508|101786534|FG000|NOT COMPLETED|4-Week Exploratory Evaluation Period||0||
48593990|NCT00742508|101786535|FG001|NOT COMPLETED|4-Week Exploratory Evaluation Period||1||
48593991|NCT02071082|101786536|FG000|STARTED|Overall Study||4||
48593992|NCT02071082|101786537|FG001|STARTED|Overall Study||75||
48593993|NCT02071082|101786536|FG000|COMPLETED|Overall Study||2||
48294877|NCT01658826|101050748|FG001|STARTED|Period 2: Second Intervention (28 Days)||32||
48593994|NCT02071082|101786537|FG001|COMPLETED|Overall Study||68||
48593995|NCT02071082|101786536|FG000|NOT COMPLETED|Overall Study||2||
48294878|NCT01658826|101050747|FG000|COMPLETED|Period 2: Second Intervention (28 Days)||29||
48294879|NCT01658826|101050748|FG001|COMPLETED|Period 2: Second Intervention (28 Days)||27||
48294880|NCT01658826|101050747|FG000|NOT COMPLETED|Period 2: Second Intervention (28 Days)||3||
48294881|NCT01658826|101050748|FG001|NOT COMPLETED|Period 2: Second Intervention (28 Days)||5||
48294882|NCT00607022|101050749|FG000|STARTED|Overall Study||7||
48593996|NCT02071082|101786537|FG001|NOT COMPLETED|Overall Study||7||
48593997|NCT00990665|101786538|FG000|STARTED|Overall Study||178||
48593998|NCT00990665|101786538|FG000|COMPLETED|Overall Study||130||
48593999|NCT00990665|101786538|FG000|NOT COMPLETED|Overall Study||48||
48594000|NCT02554318|101786539|FG000|STARTED|Overall Study||75||
48294883|NCT00607022|101050750|FG001|STARTED|Overall Study||15||
48594001|NCT02554318|101786540|FG001|STARTED|Overall Study||72||
48594002|NCT02554318|101786539|FG000|COMPLETED|Overall Study||65||
48594003|NCT02554318|101786540|FG001|COMPLETED|Overall Study||64||
48594004|NCT02554318|101786539|FG000|NOT COMPLETED|Overall Study||10||
48594005|NCT02554318|101786540|FG001|NOT COMPLETED|Overall Study||8||
48594006|NCT03040427|101786541|FG000|STARTED|Overall Study||2||
48594007|NCT03040427|101786542|FG001|STARTED|Overall Study||6||
48594008|NCT03040427|101786543|FG002|STARTED|Overall Study||4||
48594009|NCT03040427|101786541|FG000|COMPLETED|Overall Study||2||
48594010|NCT03040427|101786542|FG001|COMPLETED|Overall Study||6||
48594011|NCT03040427|101786543|FG002|COMPLETED|Overall Study||4||
48594012|NCT03040427|101786541|FG000|NOT COMPLETED|Overall Study||0||
48594013|NCT03040427|101786542|FG001|NOT COMPLETED|Overall Study||0||
48594014|NCT03040427|101786543|FG002|NOT COMPLETED|Overall Study||0||
48594015|NCT05098067|101786544|FG000|STARTED|Overall Study||15||
48594016|NCT05098067|101786545|FG001|STARTED|Overall Study||15||
48594017|NCT05098067|101786544|FG000|COMPLETED|Overall Study||15||
48594018|NCT05098067|101786545|FG001|COMPLETED|Overall Study||15||
48594019|NCT05098067|101786544|FG000|NOT COMPLETED|Overall Study||0||
48594020|NCT05098067|101786545|FG001|NOT COMPLETED|Overall Study||0||
48594021|NCT02635542|101786546|FG000|STARTED|Overall Study||50||
48594022|NCT02635542|101786547|FG001|STARTED|Overall Study||50||
48594023|NCT02635542|101786546|FG000|COMPLETED|Overall Study||50||
48594024|NCT02635542|101786547|FG001|COMPLETED|Overall Study||50||
48594025|NCT02635542|101786546|FG000|NOT COMPLETED|Overall Study||0||
48594026|NCT02635542|101786547|FG001|NOT COMPLETED|Overall Study||0||
48594027|NCT02607306|101786548|FG000|STARTED|Overall Study||275||
48594028|NCT02607306|101786549|FG001|STARTED|Overall Study||271||
48594029|NCT02607306|101786550|FG002|STARTED|Overall Study||273||
48594030|NCT02607306|101786548|FG000|COMPLETED|Overall Study||254||
48594031|NCT02607306|101786549|FG001|COMPLETED|Overall Study||248||
48594032|NCT02607306|101786550|FG002|COMPLETED|Overall Study||263||
48594033|NCT02607306|101786548|FG000|NOT COMPLETED|Overall Study||21||
48294884|NCT00607022|101050751|FG002|STARTED|Overall Study||19||
48294885|NCT00607022|101050749|FG000|COMPLETED|Overall Study||6||
48294886|NCT00607022|101050750|FG001|COMPLETED|Overall Study||15||
48294887|NCT00607022|101050751|FG002|COMPLETED|Overall Study||19||
48294888|NCT00607022|101050749|FG000|NOT COMPLETED|Overall Study||1||
48294889|NCT00607022|101050750|FG001|NOT COMPLETED|Overall Study||0||
48294890|NCT00607022|101050751|FG002|NOT COMPLETED|Overall Study||0||
48294891|NCT01498653|101050752|FG000|STARTED|Overall Study||155||
48594034|NCT02607306|101786549|FG001|NOT COMPLETED|Overall Study||23||
48594035|NCT02607306|101786550|FG002|NOT COMPLETED|Overall Study||10||
48594036|NCT01099774|101786551|FG000|STARTED|Overall Study||302||
48594037|NCT01099774|101786552|FG001|STARTED|Overall Study||295||
48594038|NCT01099774|101786551|FG000|COMPLETED|Overall Study||296||
48594039|NCT01099774|101786552|FG001|COMPLETED|Overall Study||289||
48594040|NCT01099774|101786551|FG000|NOT COMPLETED|Overall Study||6||
48594041|NCT01099774|101786552|FG001|NOT COMPLETED|Overall Study||6||
48594042|NCT03054064|101786553|FG000|STARTED|Overall Study||48||
48594043|NCT03054064|101786553|FG000|Screen Failure|Overall Study||2||
48594044|NCT03054064|101786553|FG000|COMPLETED|Overall Study||42||
48594045|NCT03054064|101786553|FG000|NOT COMPLETED|Overall Study||6||
48594046|NCT00480493|101786554|FG000|STARTED|Overall Study||32||
48594047|NCT00480493|101786555|FG001|STARTED|Overall Study||28||
48594048|NCT00480493|101786554|FG000|Randomized|Overall Study||32||
48594049|NCT00480493|101786555|FG001|Randomized|Overall Study||28||
48594050|NCT00480493|101786554|FG000|COMPLETED|Overall Study||30||
48594051|NCT00480493|101786555|FG001|COMPLETED|Overall Study||21||
48594052|NCT00480493|101786554|FG000|NOT COMPLETED|Overall Study||2||
48594053|NCT00480493|101786555|FG001|NOT COMPLETED|Overall Study||7||
48594054|NCT02454075|101786556|FG000|STARTED|Overall Study||3||
48594055|NCT02454075|101786556|FG000|COMPLETED|Overall Study||3||
48294892|NCT01498653|101050753|FG001|STARTED|Overall Study||154||
48294893|NCT01498653|101050752|FG000|COMPLETED|Overall Study||136||
48294894|NCT01498653|101050753|FG001|COMPLETED|Overall Study||119||
48294895|NCT01498653|101050752|FG000|NOT COMPLETED|Overall Study||19||
48294896|NCT01498653|101050753|FG001|NOT COMPLETED|Overall Study||35||
48294897|NCT00069238|101050754|FG000|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||25||
48294898|NCT00069238|101050755|FG001|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0||
48294899|NCT00069238|101050756|FG002|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0||
48294900|NCT00069238|101050754|FG000|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||16||
48594056|NCT02454075|101786556|FG000|NOT COMPLETED|Overall Study||0||
48594057|NCT00501059|101786557|FG000|STARTED|Overall Study||6270||
48594058|NCT00501059|101786558|FG001|STARTED|Overall Study||6276||
48594059|NCT00501059|101786557|FG000|COMPLETED|Overall Study||4402||
48594060|NCT00501059|101786558|FG001|COMPLETED|Overall Study||4384||
48594061|NCT00501059|101786557|FG000|NOT COMPLETED|Overall Study||1868||
48594062|NCT00501059|101786558|FG001|NOT COMPLETED|Overall Study||1892||
48594063|NCT00785213|101786559|FG000|STARTED|Rosiglitazone Alone||23||
48594064|NCT00785213|101786559|FG000|COMPLETED|Rosiglitazone Alone||23||
48594065|NCT00785213|101786559|FG000|NOT COMPLETED|Rosiglitazone Alone||0||
48594066|NCT00785213|101786559|FG000|STARTED|2 Day Washout Period||23||
48594067|NCT00785213|101786559|FG000|COMPLETED|2 Day Washout Period||23||
48594068|NCT00785213|101786559|FG000|NOT COMPLETED|2 Day Washout Period||0||
48594069|NCT00785213|101786559|FG000|STARTED|Quinine Sulfate Alone||23||
48594070|NCT00785213|101786559|FG000|COMPLETED|Quinine Sulfate Alone||19||
48594071|NCT00785213|101786559|FG000|NOT COMPLETED|Quinine Sulfate Alone||4||
48594072|NCT00785213|101786559|FG000|STARTED|Rosiglitazone With Quinine Sulfate||19||
48594073|NCT00785213|101786559|FG000|COMPLETED|Rosiglitazone With Quinine Sulfate||18||
48594074|NCT00785213|101786559|FG000|NOT COMPLETED|Rosiglitazone With Quinine Sulfate||1||
48594075|NCT02134353|101786560|FG000|STARTED|Overall Study||209||
48594076|NCT02134353|101786561|FG001|STARTED|Overall Study||214||
48594077|NCT02134353|101786560|FG000|COMPLETED|Overall Study||183||
48594078|NCT02134353|101786561|FG001|COMPLETED|Overall Study||190||
48594079|NCT02134353|101786560|FG000|NOT COMPLETED|Overall Study||26||
48594080|NCT02134353|101786561|FG001|NOT COMPLETED|Overall Study||24||
48594081|NCT01397786|101786562|FG000|STARTED|Phase A||12||
48594082|NCT01397786|101786563|FG001|STARTED|Phase A||0||
48594083|NCT01397786|101786564|FG002|STARTED|Phase A||227||
48594084|NCT01397786|101786562|FG000|COMPLETED|Phase A||12||
48594085|NCT01397786|101786563|FG001|COMPLETED|Phase A||0||
48594086|NCT01397786|101786564|FG002|COMPLETED|Phase A||199||
48594087|NCT01397786|101786562|FG000|NOT COMPLETED|Phase A||0||
48594088|NCT01397786|101786563|FG001|NOT COMPLETED|Phase A||0||
48594089|NCT01397786|101786564|FG002|NOT COMPLETED|Phase A||28||
48594090|NCT01397786|101786562|FG000|STARTED|Phase B||611||
48594091|NCT01397786|101786563|FG001|STARTED|Phase B||204||
48594092|NCT01397786|101786564|FG002|STARTED|Phase B||229||
48594093|NCT01397786|101786562|FG000|COMPLETED|Phase B||308||
48594094|NCT01397786|101786563|FG001|COMPLETED|Phase B||109||
48594095|NCT01397786|101786564|FG002|COMPLETED|Phase B||91||
48594096|NCT01397786|101786562|FG000|NOT COMPLETED|Phase B||303||
48294901|NCT00069238|101050755|FG001|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0||
48294902|NCT00069238|101050756|FG002|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0||
48294903|NCT00069238|101050754|FG000|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||9||
48294904|NCT00069238|101050755|FG001|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0||
48294905|NCT00069238|101050756|FG002|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0||
48294906|NCT00069238|101050754|FG000|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0||
48594097|NCT01397786|101786563|FG001|NOT COMPLETED|Phase B||95||
48594098|NCT01397786|101786564|FG002|NOT COMPLETED|Phase B||138||
48594099|NCT03806231|101786565|FG000|STARTED|Overall Study||4||
48594100|NCT03806231|101786566|FG001|STARTED|Overall Study||4||
48594101|NCT03806231|101786565|FG000|COMPLETED|Overall Study||2||
48594102|NCT03806231|101786566|FG001|COMPLETED|Overall Study||4||
48294907|NCT00069238|101050755|FG001|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||3||
48594103|NCT03806231|101786565|FG000|NOT COMPLETED|Overall Study||2||
48594104|NCT03806231|101786566|FG001|NOT COMPLETED|Overall Study||0||
48594105|NCT01629823|101786567|FG000|STARTED|Trial Period||66||
48594106|NCT01629823|101786568|FG001|STARTED|Trial Period||69||
48594107|NCT01629823|101786569|FG002|STARTED|Trial Period||59||
48594108|NCT01629823|101786567|FG000|COMPLETED|Trial Period||53||
48594109|NCT01629823|101786568|FG001|COMPLETED|Trial Period||56||
48594110|NCT01629823|101786569|FG002|COMPLETED|Trial Period||49||
48594111|NCT01629823|101786567|FG000|NOT COMPLETED|Trial Period||13||
48594112|NCT01629823|101786568|FG001|NOT COMPLETED|Trial Period||13||
48594113|NCT01629823|101786569|FG002|NOT COMPLETED|Trial Period||10||
48594114|NCT01629823|101786567|FG000|STARTED|Washout Period||54||
48594115|NCT01629823|101786568|FG001|STARTED|Washout Period||57||
48594116|NCT01629823|101786569|FG002|STARTED|Washout Period||50||
48594117|NCT01629823|101786567|FG000|COMPLETED|Washout Period||51||
48594118|NCT01629823|101786568|FG001|COMPLETED|Washout Period||51||
48594119|NCT01629823|101786569|FG002|COMPLETED|Washout Period||50||
48594120|NCT01629823|101786567|FG000|NOT COMPLETED|Washout Period||3||
48594121|NCT01629823|101786568|FG001|NOT COMPLETED|Washout Period||6||
48594122|NCT01629823|101786569|FG002|NOT COMPLETED|Washout Period||0||
48594123|NCT01254851|101786570|FG000|STARTED|Overall Study||69||
48294908|NCT00069238|101050756|FG002|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0||
48294909|NCT00069238|101050754|FG000|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0||
48294910|NCT00069238|101050755|FG001|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||1||
48294911|NCT00069238|101050756|FG002|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0||
48294912|NCT00069238|101050754|FG000|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0||
48594124|NCT01254851|101786571|FG001|STARTED|Overall Study||77||
48594125|NCT01254851|101786570|FG000|COMPLETED|Overall Study||61||
48594126|NCT01254851|101786571|FG001|COMPLETED|Overall Study||68||
48594127|NCT01254851|101786570|FG000|NOT COMPLETED|Overall Study||8||
48594128|NCT01254851|101786571|FG001|NOT COMPLETED|Overall Study||9||
48594129|NCT03640481|101786572|FG000|STARTED|Overall Study||78||
48594130|NCT03640481|101786573|FG001|STARTED|Overall Study||78||
48594131|NCT03640481|101786574|FG002|STARTED|Overall Study||2||
48594132|NCT03640481|101786575|FG003|STARTED|Overall Study||1||
48594133|NCT03640481|101786572|FG000|COMPLETED|Overall Study||0||
48594134|NCT03640481|101786573|FG001|COMPLETED|Overall Study||0||
48594135|NCT03640481|101786574|FG002|COMPLETED|Overall Study||0||
48594136|NCT03640481|101786575|FG003|COMPLETED|Overall Study||0||
48594137|NCT03640481|101786572|FG000|NOT COMPLETED|Overall Study||78||
48594138|NCT03640481|101786573|FG001|NOT COMPLETED|Overall Study||78||
48594139|NCT03640481|101786574|FG002|NOT COMPLETED|Overall Study||2||
48594140|NCT03640481|101786575|FG003|NOT COMPLETED|Overall Study||1||
48594141|NCT00628095|101786576|FG000|STARTED|Overall Study||53||
48594142|NCT00628095|101786577|FG001|STARTED|Overall Study||47||
48594143|NCT00628095|101786576|FG000|COMPLETED|Overall Study||46||
48594144|NCT00628095|101786577|FG001|COMPLETED|Overall Study||40||
48594145|NCT00628095|101786576|FG000|NOT COMPLETED|Overall Study||7||
48594146|NCT00628095|101786577|FG001|NOT COMPLETED|Overall Study||7||
48594147|NCT01210495|101786578|FG000|STARTED|Overall Study||15||
48594148|NCT01210495|101786579|FG001|STARTED|Overall Study||7||
48594149|NCT01210495|101786580|FG002|STARTED|Overall Study||134||
48594150|NCT01210495|101786581|FG003|STARTED|Overall Study||68||
48594151|NCT01210495|101786578|FG000|COMPLETED|Overall Study||0||
48594152|NCT01210495|101786579|FG001|COMPLETED|Overall Study||0||
48594153|NCT01210495|101786580|FG002|COMPLETED|Overall Study||0||
48594154|NCT01210495|101786581|FG003|COMPLETED|Overall Study||0||
48594155|NCT01210495|101786578|FG000|NOT COMPLETED|Overall Study||15||
48594156|NCT01210495|101786579|FG001|NOT COMPLETED|Overall Study||7||
48594157|NCT01210495|101786580|FG002|NOT COMPLETED|Overall Study||134||
48594158|NCT01210495|101786581|FG003|NOT COMPLETED|Overall Study||68||
48594159|NCT03199612|101786582|FG000|STARTED|Overall Study||10||
48594160|NCT03199612|101786583|FG001|STARTED|Overall Study||10||
48594161|NCT03199612|101786582|FG000|COMPLETED|Overall Study||9||
48594162|NCT03199612|101786583|FG001|COMPLETED|Overall Study||10||
48594163|NCT03199612|101786582|FG000|NOT COMPLETED|Overall Study||1||
48594164|NCT03199612|101786583|FG001|NOT COMPLETED|Overall Study||0||
48594165|NCT00581542|101786584|FG000|STARTED|Overall Study||62||
48594166|NCT00581542|101786585|FG001|STARTED|Overall Study||62||
48594167|NCT00581542|101786584|FG000|COMPLETED|Overall Study||51||
48594168|NCT00581542|101786585|FG001|COMPLETED|Overall Study||39||
48594169|NCT00581542|101786584|FG000|NOT COMPLETED|Overall Study||11||
48594170|NCT00581542|101786585|FG001|NOT COMPLETED|Overall Study||23||
48594171|NCT02326298|101786586|FG000|STARTED|Initial Period (Week 0 to Week 16)||51||
48594172|NCT02326298|101786587|FG001|STARTED|Initial Period (Week 0 to Week 16)||95||
48594173|NCT02326298|101786588|FG002|STARTED|Initial Period (Week 0 to Week 16)||88||
48594174|NCT02326298|101786589|FG003|STARTED|Initial Period (Week 0 to Week 16)||0||
48594175|NCT02326298|101786590|FG004|STARTED|Initial Period (Week 0 to Week 16)||0||
48594176|NCT02326298|101786591|FG005|STARTED|Initial Period (Week 0 to Week 16)||0||
48594177|NCT02326298|101786592|FG006|STARTED|Initial Period (Week 0 to Week 16)||0||
48594178|NCT02326298|101786593|FG007|STARTED|Initial Period (Week 0 to Week 16)||0||
48594179|NCT02326298|101786594|FG008|STARTED|Initial Period (Week 0 to Week 16)||0||
48594180|NCT02326298|101786595|FG009|STARTED|Initial Period (Week 0 to Week 16)||0||
48594181|NCT02326298|101786596|FG010|STARTED|Initial Period (Week 0 to Week 16)||0||
48594182|NCT02326298|101786597|FG011|STARTED|Initial Period (Week 0 to Week 16)||0||
48594183|NCT02326298|101786598|FG012|STARTED|Initial Period (Week 0 to Week 16)||0||
48594184|NCT02326298|101786599|FG013|STARTED|Initial Period (Week 0 to Week 16)||0||
48594185|NCT02326298|101786586|FG000|Completed Week 16|Initial Period (Week 0 to Week 16)||46||
48594186|NCT02326298|101786587|FG001|Completed Week 16|Initial Period (Week 0 to Week 16)||92||
48594187|NCT02326298|101786588|FG002|Completed Week 16|Initial Period (Week 0 to Week 16)||87||
48594188|NCT02326298|101786589|FG003|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
48594189|NCT02326298|101786590|FG004|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
48594190|NCT02326298|101786591|FG005|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
48594191|NCT02326298|101786592|FG006|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
48594192|NCT02326298|101786593|FG007|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
48594193|NCT02326298|101786594|FG008|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
48594194|NCT02326298|101786595|FG009|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
48594195|NCT02326298|101786596|FG010|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
48594196|NCT02326298|101786597|FG011|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
48594197|NCT02326298|101786598|FG012|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
48594198|NCT02326298|101786599|FG013|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
48594199|NCT02326298|101786586|FG000|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||46||
48594200|NCT02326298|101786587|FG001|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||92||
48594201|NCT02326298|101786588|FG002|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||85||
48594202|NCT02326298|101786589|FG003|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0||
48594203|NCT02326298|101786590|FG004|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0||
48594204|NCT02326298|101786591|FG005|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0||
48594205|NCT02326298|101786592|FG006|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0||
48594206|NCT02326298|101786593|FG007|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0||
48594207|NCT02326298|101786594|FG008|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0||
48594208|NCT02326298|101786595|FG009|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0||
48594209|NCT02326298|101786596|FG010|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0||
48594210|NCT02326298|101786597|FG011|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0||
48594211|NCT02326298|101786598|FG012|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0||
48594212|NCT02326298|101786599|FG013|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0||
48594213|NCT02326298|101786586|FG000|COMPLETED|Initial Period (Week 0 to Week 16)||46||
48594214|NCT02326298|101786587|FG001|COMPLETED|Initial Period (Week 0 to Week 16)||92||
48711556|NCT01920893|102081591|FG000|COMPLETED|Overall Study||23||
48711557|NCT01920893|102081592|FG001|COMPLETED|Overall Study||28||
48711558|NCT01920893|102081591|FG000|NOT COMPLETED|Overall Study||7||
48711559|NCT01920893|102081592|FG001|NOT COMPLETED|Overall Study||2||
48711560|NCT02133664|102081593|FG000|STARTED|Overall Study||26||
48711561|NCT02133664|102081594|FG001|STARTED|Overall Study||28||
48711562|NCT02133664|102081593|FG000|COMPLETED|Overall Study||21||
48711563|NCT02133664|102081594|FG001|COMPLETED|Overall Study||21||
48711564|NCT02133664|102081593|FG000|NOT COMPLETED|Overall Study||5||
48711565|NCT02133664|102081594|FG001|NOT COMPLETED|Overall Study||7||
48711566|NCT01628614|102081595|FG000|STARTED|Overall Study||4812||
48711567|NCT01628614|102081595|FG000|COMPLETED|Overall Study||3037||
48711568|NCT01628614|102081595|FG000|NOT COMPLETED|Overall Study||1775||
48711569|NCT02726880|102081596|FG000|STARTED|Overall Study||17||
48711570|NCT02726880|102081597|FG001|STARTED|Overall Study||19||
48711571|NCT02726880|102081596|FG000|COMPLETED|Overall Study||14||
48711572|NCT02726880|102081597|FG001|COMPLETED|Overall Study||16||
48711573|NCT02726880|102081596|FG000|NOT COMPLETED|Overall Study||3||
48711574|NCT02726880|102081597|FG001|NOT COMPLETED|Overall Study||3||
48711575|NCT00167180|102081598|FG000|STARTED|Overall Study||0||
48711576|NCT00167180|102081599|FG001|STARTED|Overall Study||57||
48711577|NCT00167180|102081598|FG000|COMPLETED|Overall Study||0||
48711578|NCT00167180|102081599|FG001|COMPLETED|Overall Study||57||
48594215|NCT02326298|101786588|FG002|COMPLETED|Initial Period (Week 0 to Week 16)||85||
48594216|NCT02326298|101786589|FG003|COMPLETED|Initial Period (Week 0 to Week 16)||0||
48594217|NCT02326298|101786590|FG004|COMPLETED|Initial Period (Week 0 to Week 16)||0||
48711579|NCT00167180|102081598|FG000|NOT COMPLETED|Overall Study||0||
48711580|NCT00167180|102081599|FG001|NOT COMPLETED|Overall Study||0||
48711581|NCT03455829|102081600|FG000|STARTED|Overall Study||7||
48711582|NCT03455829|102081601|FG001|STARTED|Overall Study||6||
48711583|NCT03455829|102081602|FG002|STARTED|Overall Study||4||
48711584|NCT03455829|102081603|FG003|STARTED|Overall Study||7||
48711585|NCT03455829|102081604|FG004|STARTED|Overall Study||6||
48711586|NCT03455829|102081600|FG000|COMPLETED|Overall Study||0||
48711587|NCT03455829|102081601|FG001|COMPLETED|Overall Study||0||
48711588|NCT03455829|102081602|FG002|COMPLETED|Overall Study||0||
48711589|NCT03455829|102081603|FG003|COMPLETED|Overall Study||0||
48711590|NCT03455829|102081604|FG004|COMPLETED|Overall Study||0||
48711591|NCT03455829|102081600|FG000|NOT COMPLETED|Overall Study||7||
48711592|NCT03455829|102081601|FG001|NOT COMPLETED|Overall Study||6||
48711593|NCT03455829|102081602|FG002|NOT COMPLETED|Overall Study||4||
48711594|NCT03455829|102081603|FG003|NOT COMPLETED|Overall Study||7||
48711595|NCT03455829|102081604|FG004|NOT COMPLETED|Overall Study||6||
48711596|NCT02739321|102081605|FG000|STARTED|Overall Study||23||
48711597|NCT02739321|102081606|FG001|STARTED|Overall Study||22||
48711598|NCT02739321|102081605|FG000|COMPLETED|Overall Study||20||
48711599|NCT02739321|102081606|FG001|COMPLETED|Overall Study||18||
48711600|NCT02739321|102081605|FG000|NOT COMPLETED|Overall Study||3||
48711601|NCT02739321|102081606|FG001|NOT COMPLETED|Overall Study||4||
48711602|NCT01902888|102081607|FG000|STARTED|Overall Study||3||
48711603|NCT01902888|102081607|FG000|COMPLETED|Overall Study||0||
48711604|NCT01902888|102081607|FG000|NOT COMPLETED|Overall Study||3||
48711605|NCT00847665|102081608|FG000|STARTED|Overall Study||165||
48711606|NCT00847665|102081609|FG001|STARTED|Overall Study||165||
48711607|NCT00847665|102081608|FG000|COMPLETED|Overall Study||164||
48711608|NCT00847665|102081609|FG001|COMPLETED|Overall Study||165||
48711609|NCT00847665|102081608|FG000|NOT COMPLETED|Overall Study||1||
48711610|NCT00847665|102081609|FG001|NOT COMPLETED|Overall Study||0||
48711611|NCT03846531|102081610|FG000|STARTED|Overall Study||58||174
48711612|NCT03846531|102081610|FG000|COMPLETED|Overall Study||58||174
48711613|NCT03846531|102081610|FG000|NOT COMPLETED|Overall Study||0||0
48711614|NCT04942665|102081611|FG000|STARTED|Overall Study||32||
48711615|NCT04942665|102081612|FG001|STARTED|Overall Study||28||
48711616|NCT04942665|102081611|FG000|COMPLETED|Overall Study||32||
48711617|NCT04942665|102081612|FG001|COMPLETED|Overall Study||28||
48711618|NCT04942665|102081611|FG000|NOT COMPLETED|Overall Study||0||
48711619|NCT04942665|102081612|FG001|NOT COMPLETED|Overall Study||0||
48711620|NCT03410797|102081613|FG000|STARTED|Overall Study||11||
48711621|NCT03410797|102081613|FG000|COMPLETED|Overall Study||11||
48711622|NCT03410797|102081613|FG000|NOT COMPLETED|Overall Study||0||
48711623|NCT00496197|102081614|FG000|STARTED|Overall Study||282||
48711624|NCT00496197|102081614|FG000|COMPLETED|Overall Study||160||
48594218|NCT02326298|101786591|FG005|COMPLETED|Initial Period (Week 0 to Week 16)||0||
48594219|NCT02326298|101786592|FG006|COMPLETED|Initial Period (Week 0 to Week 16)||0||
48594220|NCT02326298|101786593|FG007|COMPLETED|Initial Period (Week 0 to Week 16)||0||
48594221|NCT02326298|101786594|FG008|COMPLETED|Initial Period (Week 0 to Week 16)||0||
48594222|NCT02326298|101786595|FG009|COMPLETED|Initial Period (Week 0 to Week 16)||0||
48594223|NCT02326298|101786596|FG010|COMPLETED|Initial Period (Week 0 to Week 16)||0||
48594224|NCT02326298|101786597|FG011|COMPLETED|Initial Period (Week 0 to Week 16)||0||
48594225|NCT02326298|101786598|FG012|COMPLETED|Initial Period (Week 0 to Week 16)||0||
48711625|NCT00496197|102081614|FG000|NOT COMPLETED|Overall Study||122||
48711626|NCT03351114|102081615|FG000|STARTED|Overall Study||8||
48711627|NCT03351114|102081615|FG000|COMPLETED|Overall Study||7||
48711628|NCT03351114|102081615|FG000|NOT COMPLETED|Overall Study||1||
48711629|NCT00106691|102081616|FG000|STARTED|Overall Study||802||
48711630|NCT00106691|102081617|FG001|STARTED|Overall Study||787||
48711631|NCT00106691|102081616|FG000|COMPLETED|Overall Study||598||
48711632|NCT00106691|102081617|FG001|COMPLETED|Overall Study||588||
48711633|NCT00106691|102081616|FG000|NOT COMPLETED|Overall Study||204||
48294913|NCT00069238|101050755|FG001|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||2||
48294914|NCT00069238|101050756|FG002|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0||
48711634|NCT00106691|102081617|FG001|NOT COMPLETED|Overall Study||199||
48711635|NCT01735708|102081618|FG000|STARTED|Overall Study||95||
48711636|NCT01735708|102081619|FG001|STARTED|Overall Study||92||
48711637|NCT01735708|102081618|FG000|Month 3 Assessment|Overall Study||79||
48711638|NCT01735708|102081619|FG001|Month 3 Assessment|Overall Study||79||
48711639|NCT01735708|102081618|FG000|COMPLETED|Overall Study||84||
48711640|NCT01735708|102081619|FG001|COMPLETED|Overall Study||79||
48711641|NCT01735708|102081618|FG000|NOT COMPLETED|Overall Study||11||
48711642|NCT01735708|102081619|FG001|NOT COMPLETED|Overall Study||13||
48711643|NCT02419131|102081620|FG000|STARTED|Consent and Randomization||65||
48711644|NCT02419131|102081621|FG001|STARTED|Consent and Randomization||64||
48711645|NCT02419131|102081622|FG002|STARTED|Consent and Randomization||64||
48711646|NCT02419131|102081620|FG000|COMPLETED|Consent and Randomization||55||
48711647|NCT02419131|102081621|FG001|COMPLETED|Consent and Randomization||48||
48711648|NCT02419131|102081622|FG002|COMPLETED|Consent and Randomization||57||
48711649|NCT02419131|102081620|FG000|NOT COMPLETED|Consent and Randomization||10||
48711650|NCT02419131|102081621|FG001|NOT COMPLETED|Consent and Randomization||16||
48711651|NCT02419131|102081622|FG002|NOT COMPLETED|Consent and Randomization||7||
48711652|NCT02419131|102081620|FG000|STARTED|Randomization and Treatment||55|Started treament|
48711653|NCT02419131|102081621|FG001|STARTED|Randomization and Treatment||48|Started treament|
48711654|NCT02419131|102081622|FG002|STARTED|Randomization and Treatment||57|Started treament|
48711655|NCT02419131|102081620|FG000|Completed 3-month Follow-up|Randomization and Treatment||31||
48711656|NCT02419131|102081621|FG001|Completed 3-month Follow-up|Randomization and Treatment||21||
48711657|NCT02419131|102081622|FG002|Completed 3-month Follow-up|Randomization and Treatment||40||
48711658|NCT02419131|102081620|FG000|Completed 6-month Follow-up|Randomization and Treatment||32||
48711659|NCT02419131|102081621|FG001|Completed 6-month Follow-up|Randomization and Treatment||23||
48711660|NCT02419131|102081622|FG002|Completed 6-month Follow-up|Randomization and Treatment||40||
48711661|NCT02419131|102081620|FG000|Completed Post-Treatment Follow-up|Randomization and Treatment||33||
48711662|NCT02419131|102081621|FG001|Completed Post-Treatment Follow-up|Randomization and Treatment||23||
48711663|NCT02419131|102081622|FG002|Completed Post-Treatment Follow-up|Randomization and Treatment||48||
48711664|NCT02419131|102081620|FG000|Completed All Follow-up|Randomization and Treatment||23||
48711665|NCT02419131|102081621|FG001|Completed All Follow-up|Randomization and Treatment||21||
48711666|NCT02419131|102081622|FG002|Completed All Follow-up|Randomization and Treatment||36||
48711667|NCT02419131|102081620|FG000|Included in Analysis|Randomization and Treatment||65|Intent-to-treat analysis was primary: Treatment completion defined as: attending 6/8 CBTH sessions; attending 9/12 CPT sessions|
48711668|NCT02419131|102081621|FG001|Included in Analysis|Randomization and Treatment||64|Intent-to-treat analysis was primary: Treatment completion defined as: attending 6/8 CBTH sessions; attending 9/12 CPT sessions|
48711669|NCT02419131|102081622|FG002|Included in Analysis|Randomization and Treatment||64|Intent-to-treat analysis was primary: Treatment completion defined as: attending 6/8 CBTH sessions; attending 9/12 CPT sessions|
48711670|NCT02419131|102081620|FG000|COMPLETED|Randomization and Treatment||33|Completed all sessions|
48711671|NCT02419131|102081621|FG001|COMPLETED|Randomization and Treatment||23|Completed all sessions|
48711672|NCT02419131|102081622|FG002|COMPLETED|Randomization and Treatment||48|Completed all sessions|
48711673|NCT02419131|102081620|FG000|NOT COMPLETED|Randomization and Treatment||22||
48711674|NCT02419131|102081621|FG001|NOT COMPLETED|Randomization and Treatment||25||
48711675|NCT02419131|102081622|FG002|NOT COMPLETED|Randomization and Treatment||9||
48711676|NCT03943550|102081623|FG000|STARTED|Overall Study||9||
48711677|NCT03943550|102081624|FG001|STARTED|Overall Study||9||
48711678|NCT03943550|102081625|FG002|STARTED|Overall Study||27||
48711679|NCT03943550|102081623|FG000|COMPLETED|Overall Study||9||
48711680|NCT03943550|102081624|FG001|COMPLETED|Overall Study||8||
48711681|NCT03943550|102081625|FG002|COMPLETED|Overall Study||23||
48711682|NCT03943550|102081623|FG000|NOT COMPLETED|Overall Study||0||
48711683|NCT03943550|102081624|FG001|NOT COMPLETED|Overall Study||1||
48711684|NCT03943550|102081625|FG002|NOT COMPLETED|Overall Study||4||
48711685|NCT02466074|102081626|FG000|STARTED|Overall Study||5||
48711686|NCT02466074|102081627|FG001|STARTED|Overall Study||0||
48711687|NCT02466074|102081626|FG000|COMPLETED|Overall Study||5||
48711688|NCT02466074|102081627|FG001|COMPLETED|Overall Study||0||
48711689|NCT02466074|102081626|FG000|NOT COMPLETED|Overall Study||0||
48711690|NCT02466074|102081627|FG001|NOT COMPLETED|Overall Study||0||
48711691|NCT01229943|102081628|FG000|STARTED|Overall Study||75||
48711692|NCT01229943|102081629|FG001|STARTED|Overall Study||75||
48711693|NCT01229943|102081628|FG000|COMPLETED|Overall Study||57||
48711694|NCT01229943|102081629|FG001|COMPLETED|Overall Study||58||
48711695|NCT01229943|102081628|FG000|NOT COMPLETED|Overall Study||18||
48404432|NCT02959190|101321852|FG000|Placebo/ 240mg Galcanezumab - EM|Open Label||0||
48404433|NCT02959190|101321853|FG001|Placebo/ 240mg Galcanezumab - EM|Open Label||64||
48404434|NCT02959190|101321854|FG002|Placebo/ 240mg Galcanezumab - EM|Open Label||0||
48141631|NCT01565707|100670455|FG002|STARTED|Overall Study||19||
48294915|NCT00069238|101050754|FG000|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0||
48294916|NCT00069238|101050755|FG001|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0||
48294917|NCT00069238|101050756|FG002|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||3||
48294918|NCT00069238|101050754|FG000|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0||
48294919|NCT00069238|101050755|FG001|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0||
48294920|NCT00069238|101050756|FG002|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||1||
48294921|NCT00069238|101050754|FG000|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0||
48404435|NCT02959190|101321855|FG003|Placebo/ 240mg Galcanezumab - EM|Open Label||0||
48404436|NCT02959190|101321852|FG000|COMPLETED|Open Label||113||
48404437|NCT02959190|101321853|FG001|COMPLETED|Open Label||110||
48294922|NCT00069238|101050755|FG001|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0||
48294923|NCT00069238|101050756|FG002|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||2||
48294924|NCT00203476|101050757|FG000|STARTED|Overall Study||10||
48294925|NCT00203476|101050758|FG001|STARTED|Overall Study||10||
48404438|NCT02959190|101321854|FG002|COMPLETED|Open Label||28||
48404439|NCT02959190|101321855|FG003|COMPLETED|Open Label||27||
48141632|NCT01565707|100670456|FG003|STARTED|Overall Study||22||
48141633|NCT01565707|100670453|FG000|Treated|Overall Study||73||
48141634|NCT01565707|100670454|FG001|Treated|Overall Study||73||
48404440|NCT02959190|101321852|FG000|NOT COMPLETED|Open Label||7||
48404441|NCT02959190|101321853|FG001|NOT COMPLETED|Open Label||16||
48404442|NCT02959190|101321854|FG002|NOT COMPLETED|Open Label||4||
48404443|NCT02959190|101321855|FG003|NOT COMPLETED|Open Label||6||
48404444|NCT02959190|101321852|FG000|STARTED|Post Treatment Follow Up||117||
48141635|NCT01565707|100670455|FG002|Treated|Overall Study||19||
48141636|NCT01565707|100670456|FG003|Treated|Overall Study||22||
48404445|NCT02959190|101321853|FG001|STARTED|Post Treatment Follow Up||120||
48404446|NCT02959190|101321854|FG002|STARTED|Post Treatment Follow Up||32||
48141637|NCT01565707|100670453|FG000|COMPLETED|Overall Study||66||
48141638|NCT01565707|100670454|FG001|COMPLETED|Overall Study||65||
48141639|NCT01565707|100670455|FG002|COMPLETED|Overall Study||16||
48141640|NCT01565707|100670456|FG003|COMPLETED|Overall Study||17||
48141641|NCT01565707|100670453|FG000|NOT COMPLETED|Overall Study||9||
48141642|NCT01565707|100670454|FG001|NOT COMPLETED|Overall Study||8||
48141643|NCT01565707|100670455|FG002|NOT COMPLETED|Overall Study||3||
48141644|NCT01565707|100670456|FG003|NOT COMPLETED|Overall Study||5||
48141645|NCT02491671|100670457|FG000|STARTED|Overall Study||129||
48141646|NCT02491671|100670458|FG001|STARTED|Overall Study||131||
48141647|NCT02491671|100670457|FG000|COMPLETED|Overall Study||118||
48141648|NCT02491671|100670458|FG001|COMPLETED|Overall Study||118||
48141649|NCT02491671|100670457|FG000|NOT COMPLETED|Overall Study||11||
48404447|NCT02959190|101321855|FG003|STARTED|Post Treatment Follow Up||32||
48404448|NCT02959190|101321852|FG000|COMPLETED|Post Treatment Follow Up||114||
48141650|NCT02491671|100670458|FG001|NOT COMPLETED|Overall Study||13||
48141651|NCT02099838|100670459|FG000|STARTED|Overall Study||47||
48141652|NCT02099838|100670460|FG001|STARTED|Overall Study||51||
48141653|NCT02099838|100670459|FG000|COMPLETED|Overall Study||43||
48141654|NCT02099838|100670460|FG001|COMPLETED|Overall Study||49||
48141655|NCT02099838|100670459|FG000|NOT COMPLETED|Overall Study||4||
48141656|NCT02099838|100670460|FG001|NOT COMPLETED|Overall Study||2||
48141657|NCT00303966|100670461|FG000|STARTED|Overall Study||5||
48141658|NCT00303966|100670461|FG000|COMPLETED|Overall Study||5||
48141659|NCT00303966|100670461|FG000|NOT COMPLETED|Overall Study||0||
48141660|NCT04827212|100670462|FG000|STARTED|Baseline to 16 Weeks||23||
48404449|NCT02959190|101321853|FG001|COMPLETED|Post Treatment Follow Up||119||
48141661|NCT04827212|100670463|FG001|STARTED|Baseline to 16 Weeks||23||
48141662|NCT04827212|100670462|FG000|COMPLETED|Baseline to 16 Weeks||21||
48141663|NCT04827212|100670463|FG001|COMPLETED|Baseline to 16 Weeks||21||
48141664|NCT04827212|100670462|FG000|NOT COMPLETED|Baseline to 16 Weeks||2||
48141665|NCT04827212|100670463|FG001|NOT COMPLETED|Baseline to 16 Weeks||2||
48141666|NCT04827212|100670462|FG000|STARTED|16 to 24 Weeks||21||
48141667|NCT04827212|100670463|FG001|STARTED|16 to 24 Weeks||21||
48141668|NCT04827212|100670462|FG000|COMPLETED|16 to 24 Weeks||18||
48141669|NCT04827212|100670463|FG001|COMPLETED|16 to 24 Weeks||17||
48141670|NCT04827212|100670462|FG000|NOT COMPLETED|16 to 24 Weeks||3||
48141671|NCT04827212|100670463|FG001|NOT COMPLETED|16 to 24 Weeks||4||
48141672|NCT01814371|100670464|FG000|STARTED|Overall Study||248||
48141673|NCT01814371|100670465|FG001|STARTED|Overall Study||226||
48141674|NCT01814371|100670464|FG000|COMPLETED|Overall Study||218||
48141675|NCT01814371|100670465|FG001|COMPLETED|Overall Study||199||
48141676|NCT01814371|100670464|FG000|NOT COMPLETED|Overall Study||30||
48141677|NCT01814371|100670465|FG001|NOT COMPLETED|Overall Study||27||
48141678|NCT02087163|100670466|FG000|STARTED|Overall Study||90||
48141679|NCT02087163|100670466|FG000|COMPLETED|Overall Study||73||
48141680|NCT02087163|100670466|FG000|NOT COMPLETED|Overall Study||17||
48141681|NCT02347761|100670467|FG000|STARTED|All Collected||218||
48141682|NCT02347761|100670468|FG001|STARTED|All Collected||217||
48141683|NCT02347761|100670469|FG002|STARTED|All Collected||218||
48141684|NCT02347761|100670467|FG000|COMPLETED|All Collected||201||
48141685|NCT02347761|100670468|FG001|COMPLETED|All Collected||203||
48141686|NCT02347761|100670469|FG002|COMPLETED|All Collected||191||
48141687|NCT02347761|100670467|FG000|NOT COMPLETED|All Collected||17||
48141688|NCT02347761|100670468|FG001|NOT COMPLETED|All Collected||14||
48141689|NCT02347761|100670469|FG002|NOT COMPLETED|All Collected||27||
48141690|NCT02347761|100670467|FG000|STARTED|On Study Treatment||218||
48141691|NCT02347761|100670468|FG001|STARTED|On Study Treatment||217||
48141692|NCT02347761|100670469|FG002|STARTED|On Study Treatment||218||
48141693|NCT02347761|100670467|FG000|COMPLETED|On Study Treatment||191||
48141694|NCT02347761|100670468|FG001|COMPLETED|On Study Treatment||194||
48141695|NCT02347761|100670469|FG002|COMPLETED|On Study Treatment||176||
48141696|NCT02347761|100670467|FG000|NOT COMPLETED|On Study Treatment||27||
48141697|NCT02347761|100670468|FG001|NOT COMPLETED|On Study Treatment||23||
48141698|NCT02347761|100670469|FG002|NOT COMPLETED|On Study Treatment||42||
48141699|NCT04365660|100670470|FG000|STARTED|Overall Study||1||
48141700|NCT04365660|100670470|FG000|Received PET/CT Scan|Overall Study||0||
48141701|NCT04365660|100670470|FG000|COMPLETED|Overall Study||0||
48141702|NCT04365660|100670470|FG000|NOT COMPLETED|Overall Study||1||
48141703|NCT04177758|100670471|FG000|STARTED|Overall Study||69||
48141704|NCT04177758|100670472|FG001|STARTED|Overall Study||68||
48141705|NCT04177758|100670471|FG000|COMPLETED|Overall Study||50||
48141706|NCT04177758|100670472|FG001|COMPLETED|Overall Study||57||
48141707|NCT04177758|100670471|FG000|NOT COMPLETED|Overall Study||19||
48141708|NCT04177758|100670472|FG001|NOT COMPLETED|Overall Study||11||
48141709|NCT01988246|100670473|FG000|STARTED|Overall Study||15||
48141710|NCT01988246|100670474|FG001|STARTED|Overall Study||15||
48141711|NCT01988246|100670473|FG000|COMPLETED|Overall Study||14||
48141712|NCT01988246|100670474|FG001|COMPLETED|Overall Study||15||
48141713|NCT01988246|100670473|FG000|NOT COMPLETED|Overall Study||1||
48141714|NCT01988246|100670474|FG001|NOT COMPLETED|Overall Study||0||
48141715|NCT02388633|100670475|FG000|STARTED|Overall Study||8||
48141716|NCT02388633|100670475|FG000|COMPLETED|Overall Study||8||
48141717|NCT02388633|100670475|FG000|NOT COMPLETED|Overall Study||0||
48141718|NCT01816594|100670476|FG000|STARTED|Overall Study||25||
48141719|NCT01816594|100670477|FG001|STARTED|Overall Study||25||
48141720|NCT01816594|100670476|FG000|Randomized to the wt Cohort|Overall Study||21||
48141721|NCT01816594|100670477|FG001|Randomized to the wt Cohort|Overall Study||21||
48141722|NCT01816594|100670476|FG000|Randomized to the mt Cohort|Overall Study||4||
48141723|NCT01816594|100670477|FG001|Randomized to the mt Cohort|Overall Study||4||
48141724|NCT01816594|100670476|FG000|COMPLETED|Overall Study||14||
48141725|NCT01816594|100670477|FG001|COMPLETED|Overall Study||23||
48141726|NCT01816594|100670476|FG000|NOT COMPLETED|Overall Study||11||
48141727|NCT01816594|100670477|FG001|NOT COMPLETED|Overall Study||2||
48141728|NCT01540851|100670478|FG000|STARTED|Overall Study||154||
48141729|NCT01540851|100670479|FG001|STARTED|Overall Study||154||
48141730|NCT01540851|100670478|FG000|COMPLETED|Overall Study||133||
48141731|NCT01540851|100670479|FG001|COMPLETED|Overall Study||136||
48141732|NCT01540851|100670478|FG000|NOT COMPLETED|Overall Study||21||
48141733|NCT01540851|100670479|FG001|NOT COMPLETED|Overall Study||18||
48141734|NCT00251745|100670480|FG000|STARTED|Overall Study||292||
48141735|NCT00251745|100670481|FG001|STARTED|Overall Study||312||
48141736|NCT00251745|100670482|FG002|STARTED|Overall Study||304||
48141737|NCT00251745|100670480|FG000|COMPLETED|Overall Study||264||
48141738|NCT00251745|100670481|FG001|COMPLETED|Overall Study||285||
48594226|NCT02326298|101786599|FG013|COMPLETED|Initial Period (Week 0 to Week 16)||0||
48594227|NCT02326298|101786586|FG000|NOT COMPLETED|Initial Period (Week 0 to Week 16)||5||
48594228|NCT02326298|101786587|FG001|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3||
48594229|NCT02326298|101786588|FG002|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3||
48594230|NCT02326298|101786589|FG003|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
48594231|NCT02326298|101786590|FG004|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
48594232|NCT02326298|101786591|FG005|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
48594233|NCT02326298|101786592|FG006|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
48594234|NCT02326298|101786593|FG007|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
48594235|NCT02326298|101786594|FG008|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
48404450|NCT02959190|101321854|FG002|COMPLETED|Post Treatment Follow Up||31||
48711696|NCT01229943|102081629|FG001|NOT COMPLETED|Overall Study||17||
48711697|NCT00197145|102081630|FG000|STARTED|Period 1: Randomized Treatment Phase||13||
48711698|NCT00197145|102081631|FG001|STARTED|Period 1: Randomized Treatment Phase||11||
48711699|NCT00197145|102081630|FG000|COMPLETED|Period 1: Randomized Treatment Phase||0||
48711700|NCT00197145|102081631|FG001|COMPLETED|Period 1: Randomized Treatment Phase||0||
48294926|NCT00203476|101050759|FG002|STARTED|Overall Study||10||
48294927|NCT00203476|101050757|FG000|COMPLETED|Overall Study||9||
48294928|NCT00203476|101050758|FG001|COMPLETED|Overall Study||9||
48294929|NCT00203476|101050759|FG002|COMPLETED|Overall Study||10||
48594236|NCT02326298|101786595|FG009|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
48594237|NCT02326298|101786596|FG010|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
48711701|NCT00197145|102081630|FG000|NOT COMPLETED|Period 1: Randomized Treatment Phase||13||
48711702|NCT00197145|102081631|FG001|NOT COMPLETED|Period 1: Randomized Treatment Phase||11||
48711703|NCT00197145|102081630|FG000|STARTED|Period 2 : Open Label Phase||10||
48711704|NCT00197145|102081631|FG001|STARTED|Period 2 : Open Label Phase||0||
48711705|NCT00197145|102081630|FG000|COMPLETED|Period 2 : Open Label Phase||0||
48711706|NCT00197145|102081631|FG001|COMPLETED|Period 2 : Open Label Phase||0||
48594238|NCT02326298|101786597|FG011|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
48594239|NCT02326298|101786598|FG012|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
48594240|NCT02326298|101786599|FG013|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
48594241|NCT02326298|101786586|FG000|STARTED|Maintenance Period (Week 16 to Week 48)||0||
48594242|NCT02326298|101786587|FG001|STARTED|Maintenance Period (Week 16 to Week 48)||0||
48594243|NCT02326298|101786588|FG002|STARTED|Maintenance Period (Week 16 to Week 48)||0||
48594244|NCT02326298|101786589|FG003|STARTED|Maintenance Period (Week 16 to Week 48)||3||
48594245|NCT02326298|101786590|FG004|STARTED|Maintenance Period (Week 16 to Week 48)||5||
48594246|NCT02326298|101786591|FG005|STARTED|Maintenance Period (Week 16 to Week 48)||74||
48594247|NCT02326298|101786592|FG006|STARTED|Maintenance Period (Week 16 to Week 48)||77||
48594248|NCT02326298|101786593|FG007|STARTED|Maintenance Period (Week 16 to Week 48)||38||
48594249|NCT02326298|101786594|FG008|STARTED|Maintenance Period (Week 16 to Week 48)||18||
48594250|NCT02326298|101786595|FG009|STARTED|Maintenance Period (Week 16 to Week 48)||8||
48711707|NCT00197145|102081630|FG000|NOT COMPLETED|Period 2 : Open Label Phase||10||
48711708|NCT00197145|102081631|FG001|NOT COMPLETED|Period 2 : Open Label Phase||0||
48711709|NCT03089879|102081632|FG000|STARTED|Overall Study||7||
48711710|NCT03089879|102081633|FG001|STARTED|Overall Study||2||
48711711|NCT03089879|102081634|FG002|STARTED|Overall Study||26||
48294930|NCT00203476|101050757|FG000|NOT COMPLETED|Overall Study||1||
48294931|NCT00203476|101050758|FG001|NOT COMPLETED|Overall Study||1||
48711712|NCT03089879|102081632|FG000|COMPLETED|Overall Study||7||
48711713|NCT03089879|102081633|FG001|COMPLETED|Overall Study||2||
48711714|NCT03089879|102081634|FG002|COMPLETED|Overall Study||26||
48711715|NCT03089879|102081632|FG000|NOT COMPLETED|Overall Study||0||
48711716|NCT03089879|102081633|FG001|NOT COMPLETED|Overall Study||0||
48711717|NCT03089879|102081634|FG002|NOT COMPLETED|Overall Study||0||
48711718|NCT03058666|102081635|FG000|STARTED|Overall Study||241||
48711719|NCT03058666|102081636|FG001|STARTED|Overall Study||236||
48711720|NCT03058666|102081635|FG000|COMPLETED|Overall Study||241||
48711721|NCT03058666|102081636|FG001|COMPLETED|Overall Study||236||
48711722|NCT03058666|102081635|FG000|NOT COMPLETED|Overall Study||0||
48711723|NCT03058666|102081636|FG001|NOT COMPLETED|Overall Study||0||
48711724|NCT00953524|102081637|FG000|STARTED|Overall Study||249||
48711725|NCT00953524|102081638|FG001|STARTED|Overall Study||254||
48711726|NCT00953524|102081639|FG002|STARTED|Overall Study||247||
48711727|NCT00953524|102081640|FG003|STARTED|Overall Study||99||
48711728|NCT00953524|102081637|FG000|COMPLETED|Overall Study||227||
48711729|NCT00953524|102081638|FG001|COMPLETED|Overall Study||239||
48711730|NCT00953524|102081639|FG002|COMPLETED|Overall Study||233||
48711731|NCT00953524|102081640|FG003|COMPLETED|Overall Study||91||
48711732|NCT00953524|102081637|FG000|NOT COMPLETED|Overall Study||22||
48294932|NCT00203476|101050759|FG002|NOT COMPLETED|Overall Study||0||
48294933|NCT02564926|101050760|FG000|STARTED|Overall Study||60|121 patients received study treatment and were included in the SAF population.|
48367933|NCT03661541|101230078|FG001|STARTED|Overall Study||12||
48594251|NCT02326298|101786596|FG010|STARTED|Maintenance Period (Week 16 to Week 48)||0||
48594252|NCT02326298|101786597|FG011|STARTED|Maintenance Period (Week 16 to Week 48)||0||
48594253|NCT02326298|101786598|FG012|STARTED|Maintenance Period (Week 16 to Week 48)||0||
48594254|NCT02326298|101786599|FG013|STARTED|Maintenance Period (Week 16 to Week 48)||0||
48594255|NCT02326298|101786586|FG000|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0||
48594256|NCT02326298|101786587|FG001|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0||
48594257|NCT02326298|101786588|FG002|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0||
48594258|NCT02326298|101786589|FG003|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3||
48594259|NCT02326298|101786590|FG004|Completed Week 48|Maintenance Period (Week 16 to Week 48)||5||
48594260|NCT02326298|101786591|FG005|Completed Week 48|Maintenance Period (Week 16 to Week 48)||71||
48594261|NCT02326298|101786592|FG006|Completed Week 48|Maintenance Period (Week 16 to Week 48)||70||
48594262|NCT02326298|101786593|FG007|Completed Week 48|Maintenance Period (Week 16 to Week 48)||33||
48594263|NCT02326298|101786594|FG008|Completed Week 48|Maintenance Period (Week 16 to Week 48)||13||
48594264|NCT02326298|101786595|FG009|Completed Week 48|Maintenance Period (Week 16 to Week 48)||7||
48594265|NCT02326298|101786596|FG010|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0||
48594266|NCT02326298|101786597|FG011|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0||
48594267|NCT02326298|101786598|FG012|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0||
48594268|NCT02326298|101786599|FG013|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0||
48594269|NCT02326298|101786586|FG000|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
48594270|NCT02326298|101786587|FG001|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
48594271|NCT02326298|101786588|FG002|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
48594272|NCT02326298|101786589|FG003|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3||
48594273|NCT02326298|101786590|FG004|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||5||
48594274|NCT02326298|101786591|FG005|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||69||
48594275|NCT02326298|101786592|FG006|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||70||
48594276|NCT02326298|101786593|FG007|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||33||
48594277|NCT02326298|101786594|FG008|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||13||
48594278|NCT02326298|101786595|FG009|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||7||
48594279|NCT02326298|101786596|FG010|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
48594280|NCT02326298|101786597|FG011|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
48594281|NCT02326298|101786598|FG012|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
48594282|NCT02326298|101786599|FG013|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
48594283|NCT02326298|101786586|FG000|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48594284|NCT02326298|101786587|FG001|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48294934|NCT02564926|101050761|FG001|STARTED|Overall Study||61|121 patients received study treatment and were included in the SAF population.|
48294935|NCT02564926|101050760|FG000|COMPLETED|Overall Study||52|Study Treatment/Entire Study Completed|
48294936|NCT02564926|101050761|FG001|COMPLETED|Overall Study||54|Study Treatment/Entire Study Completed|
48294937|NCT02564926|101050760|FG000|NOT COMPLETED|Overall Study||8||
48294938|NCT02564926|101050761|FG001|NOT COMPLETED|Overall Study||7||
48294939|NCT03588728|101050762|FG000|STARTED|Overall Study||10||
48294940|NCT03588728|101050763|FG001|STARTED|Overall Study||6||
48294941|NCT03588728|101050764|FG002|STARTED|Overall Study||12||
48294942|NCT03588728|101050765|FG003|STARTED|Overall Study||11||
48294943|NCT03588728|101050762|FG000|COMPLETED|Overall Study||7||
48294944|NCT03588728|101050763|FG001|COMPLETED|Overall Study||6||
48294945|NCT03588728|101050764|FG002|COMPLETED|Overall Study||9||
48294946|NCT03588728|101050765|FG003|COMPLETED|Overall Study||8||
48294947|NCT03588728|101050762|FG000|NOT COMPLETED|Overall Study||3||
48294948|NCT03588728|101050763|FG001|NOT COMPLETED|Overall Study||0||
48294949|NCT03588728|101050764|FG002|NOT COMPLETED|Overall Study||3||
48294950|NCT03588728|101050765|FG003|NOT COMPLETED|Overall Study||3||
48294951|NCT02313233|101050766|FG000|STARTED|Overall Study||20||
48294952|NCT02313233|101050767|FG001|STARTED|Overall Study||21||
48294953|NCT02313233|101050766|FG000|COMPLETED|Overall Study||18||
48294954|NCT02313233|101050767|FG001|COMPLETED|Overall Study||18||
48294955|NCT02313233|101050766|FG000|NOT COMPLETED|Overall Study||2||
48294956|NCT02313233|101050767|FG001|NOT COMPLETED|Overall Study||3||
48294957|NCT00511472|101050768|FG000|STARTED|Overall Study||47||
48294958|NCT00511472|101050769|FG001|STARTED|Overall Study||23||
48294959|NCT00511472|101050768|FG000|COMPLETED|Overall Study||44||
48294960|NCT00511472|101050769|FG001|COMPLETED|Overall Study||17||
48294961|NCT00511472|101050768|FG000|NOT COMPLETED|Overall Study||3||
48294962|NCT00511472|101050769|FG001|NOT COMPLETED|Overall Study||6||
48294963|NCT02446886|101050770|FG000|STARTED|Overall Study||8||
48294964|NCT02446886|101050771|FG001|STARTED|Overall Study||7||
48294965|NCT02446886|101050770|FG000|COMPLETED|Overall Study||6||
48594285|NCT02326298|101786588|FG002|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48656868|NCT01708941|101943721|FG000|STARTED|Overall Study||21||
48294966|NCT02446886|101050771|FG001|COMPLETED|Overall Study||3||
48294967|NCT02446886|101050770|FG000|NOT COMPLETED|Overall Study||2||
48294968|NCT02446886|101050771|FG001|NOT COMPLETED|Overall Study||4||
48294969|NCT04744285|101050772|FG000|STARTED|Overall Study||31||
48294970|NCT04744285|101050773|FG001|STARTED|Overall Study||29||
48294971|NCT04744285|101050774|FG002|STARTED|Overall Study||33||
48294972|NCT04744285|101050775|FG003|STARTED|Overall Study||22||
48594286|NCT02326298|101786589|FG003|COMPLETED|Maintenance Period (Week 16 to Week 48)||3||
48594287|NCT02326298|101786590|FG004|COMPLETED|Maintenance Period (Week 16 to Week 48)||5||
48594288|NCT02326298|101786591|FG005|COMPLETED|Maintenance Period (Week 16 to Week 48)||69||
48594289|NCT02326298|101786592|FG006|COMPLETED|Maintenance Period (Week 16 to Week 48)||70||
48594290|NCT02326298|101786593|FG007|COMPLETED|Maintenance Period (Week 16 to Week 48)||33||
48594291|NCT02326298|101786594|FG008|COMPLETED|Maintenance Period (Week 16 to Week 48)||13||
48594292|NCT02326298|101786595|FG009|COMPLETED|Maintenance Period (Week 16 to Week 48)||7||
48594293|NCT02326298|101786596|FG010|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48594294|NCT02326298|101786597|FG011|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48594295|NCT02326298|101786598|FG012|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48594296|NCT02326298|101786599|FG013|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48594297|NCT02326298|101786586|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48594298|NCT02326298|101786587|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48594299|NCT02326298|101786588|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48594300|NCT02326298|101786589|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48594301|NCT02326298|101786590|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48594302|NCT02326298|101786591|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5||
48594303|NCT02326298|101786592|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7||
48594304|NCT02326298|101786593|FG007|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5||
48294973|NCT04744285|101050772|FG000|COMPLETED|Overall Study||30||
48294974|NCT04744285|101050773|FG001|COMPLETED|Overall Study||28||
48294975|NCT04744285|101050774|FG002|COMPLETED|Overall Study||31||
48294976|NCT04744285|101050775|FG003|COMPLETED|Overall Study||21||
48594305|NCT02326298|101786594|FG008|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5||
48594306|NCT02326298|101786595|FG009|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1||
48594307|NCT02326298|101786596|FG010|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48594308|NCT02326298|101786597|FG011|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48594309|NCT02326298|101786598|FG012|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48594310|NCT02326298|101786599|FG013|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48594311|NCT02326298|101786586|FG000|STARTED|Open-label Period (Week 48 to Week 144)||0||
48594312|NCT02326298|101786587|FG001|STARTED|Open-label Period (Week 48 to Week 144)||0||
48594313|NCT02326298|101786588|FG002|STARTED|Open-label Period (Week 48 to Week 144)||0||
48594314|NCT02326298|101786589|FG003|STARTED|Open-label Period (Week 48 to Week 144)||0||
48594315|NCT02326298|101786590|FG004|STARTED|Open-label Period (Week 48 to Week 144)||0||
48594316|NCT02326298|101786591|FG005|STARTED|Open-label Period (Week 48 to Week 144)||0||
48594317|NCT02326298|101786592|FG006|STARTED|Open-label Period (Week 48 to Week 144)||0||
48594318|NCT02326298|101786593|FG007|STARTED|Open-label Period (Week 48 to Week 144)||0||
48594319|NCT02326298|101786594|FG008|STARTED|Open-label Period (Week 48 to Week 144)||0||
48594320|NCT02326298|101786595|FG009|STARTED|Open-label Period (Week 48 to Week 144)||0||
48594321|NCT02326298|101786596|FG010|STARTED|Open-label Period (Week 48 to Week 144)||3||
48594322|NCT02326298|101786597|FG011|STARTED|Open-label Period (Week 48 to Week 144)||74||
48594323|NCT02326298|101786598|FG012|STARTED|Open-label Period (Week 48 to Week 144)||70||
48594324|NCT02326298|101786599|FG013|STARTED|Open-label Period (Week 48 to Week 144)||53||
48594325|NCT02326298|101786586|FG000|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48594326|NCT02326298|101786587|FG001|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48594327|NCT02326298|101786588|FG002|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48594328|NCT02326298|101786589|FG003|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48594329|NCT02326298|101786590|FG004|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48594330|NCT02326298|101786591|FG005|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48594331|NCT02326298|101786592|FG006|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48594332|NCT02326298|101786593|FG007|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48594333|NCT02326298|101786594|FG008|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48594334|NCT02326298|101786595|FG009|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48594335|NCT02326298|101786596|FG010|COMPLETED|Open-label Period (Week 48 to Week 144)||3||
48594336|NCT02326298|101786597|FG011|COMPLETED|Open-label Period (Week 48 to Week 144)||54||
48594337|NCT02326298|101786598|FG012|COMPLETED|Open-label Period (Week 48 to Week 144)||51||
48594338|NCT02326298|101786599|FG013|COMPLETED|Open-label Period (Week 48 to Week 144)||44||
48594339|NCT02326298|101786586|FG000|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48594340|NCT02326298|101786587|FG001|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48594341|NCT02326298|101786588|FG002|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48594342|NCT02326298|101786589|FG003|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48594343|NCT02326298|101786590|FG004|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48594344|NCT02326298|101786591|FG005|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48594345|NCT02326298|101786592|FG006|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48594346|NCT02326298|101786593|FG007|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48594347|NCT02326298|101786594|FG008|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48294977|NCT04744285|101050772|FG000|NOT COMPLETED|Overall Study||1||
48294978|NCT04744285|101050773|FG001|NOT COMPLETED|Overall Study||1||
48294979|NCT04744285|101050774|FG002|NOT COMPLETED|Overall Study||2||
48594348|NCT02326298|101786595|FG009|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48594349|NCT02326298|101786596|FG010|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48594350|NCT02326298|101786597|FG011|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||20||
48594351|NCT02326298|101786598|FG012|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||19||
48594352|NCT02326298|101786599|FG013|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||9||
48594353|NCT01585324|101786600|FG000|STARTED|Overall Study||30||
48594354|NCT01585324|101786600|FG000|COMPLETED|Overall Study||30||
48594355|NCT01585324|101786600|FG000|NOT COMPLETED|Overall Study||0||
48594356|NCT04601103|101786601|FG000|STARTED|Overall Study||18||
48594357|NCT04601103|101786602|FG001|STARTED|Overall Study||18||
48594358|NCT04601103|101786603|FG002|STARTED|Overall Study||17||
48294980|NCT04744285|101050775|FG003|NOT COMPLETED|Overall Study||1||
48294981|NCT02778932|101050776|FG000|STARTED|Overall Study||74||
48294982|NCT02778932|101050777|FG001|STARTED|Overall Study||74||
48294983|NCT02778932|101050776|FG000|COMPLETED|Overall Study||74||
48294984|NCT02778932|101050777|FG001|COMPLETED|Overall Study||74||
48294985|NCT02778932|101050776|FG000|NOT COMPLETED|Overall Study||0||
48294986|NCT02778932|101050777|FG001|NOT COMPLETED|Overall Study||0||
48294987|NCT01350336|101050778|FG000|STARTED|Overall Study||284||279
48294988|NCT01350336|101050778|FG000|COMPLETED|Overall Study||227||227
48294989|NCT01350336|101050778|FG000|NOT COMPLETED|Overall Study||57||52
48294990|NCT01444456|101050779|FG000|STARTED|Overall Study||1262||
48294991|NCT01444456|101050779|FG000|Received Darbepoetin Alfa or Other ESA|Overall Study||1158||
48594359|NCT04601103|101786601|FG000|COMPLETED|Overall Study||0||
48594360|NCT04601103|101786602|FG001|COMPLETED|Overall Study||0||
48594361|NCT04601103|101786603|FG002|COMPLETED|Overall Study||0||
48594362|NCT04601103|101786601|FG000|NOT COMPLETED|Overall Study||18||
48594363|NCT04601103|101786602|FG001|NOT COMPLETED|Overall Study||18||
48594364|NCT04601103|101786603|FG002|NOT COMPLETED|Overall Study||17||
48294992|NCT01444456|101050779|FG000|Received Darbepoetin Alfa|Overall Study||1134||
48294993|NCT01444456|101050779|FG000|COMPLETED|Overall Study||977||
48294994|NCT01444456|101050779|FG000|NOT COMPLETED|Overall Study||285||
48294995|NCT02501538|101050780|FG000|STARTED|Overall Study||23||
48294996|NCT02501538|101050780|FG000|COMPLETED|Overall Study||20||
48294997|NCT02501538|101050780|FG000|NOT COMPLETED|Overall Study||3||
48294998|NCT05208866|101050781|FG000|STARTED|Lixivaptan Re-titration Period||1||
48294999|NCT05208866|101050781|FG000|COMPLETED|Lixivaptan Re-titration Period||1||
48295000|NCT05208866|101050781|FG000|NOT COMPLETED|Lixivaptan Re-titration Period||0||
48295001|NCT05208866|101050781|FG000|STARTED|Maintenance Treatment Period||1||
48295002|NCT05208866|101050781|FG000|COMPLETED|Maintenance Treatment Period||0||
48295003|NCT05208866|101050781|FG000|NOT COMPLETED|Maintenance Treatment Period||1||
48295004|NCT05208866|101050781|FG000|STARTED|Follow-up Period||1||
48295005|NCT05208866|101050781|FG000|COMPLETED|Follow-up Period||1||
48295006|NCT05208866|101050781|FG000|NOT COMPLETED|Follow-up Period||0||
48295007|NCT01247571|101050782|FG000|STARTED|Overall Study||22||
48295008|NCT01247571|101050782|FG000|COMPLETED|Overall Study||19||
48295009|NCT01247571|101050782|FG000|NOT COMPLETED|Overall Study||3||
48295010|NCT01207726|101050783|FG000|STARTED|Overall Study||7||
48594365|NCT02160847|101786604|FG000|STARTED|Overall Study||16||
48594366|NCT02160847|101786605|FG001|STARTED|Overall Study||16||
48594367|NCT02160847|101786604|FG000|COMPLETED|Overall Study||16||
48594368|NCT02160847|101786605|FG001|COMPLETED|Overall Study||16||
48594369|NCT02160847|101786604|FG000|NOT COMPLETED|Overall Study||0||
48594370|NCT02160847|101786605|FG001|NOT COMPLETED|Overall Study||0||
48594371|NCT03141983|101786606|FG000|STARTED|Overall Study||38||
48594372|NCT03141983|101786607|FG001|STARTED|Overall Study||42||
48594373|NCT03141983|101786606|FG000|COMPLETED|Overall Study||30||
48594374|NCT03141983|101786607|FG001|COMPLETED|Overall Study||34||
48594375|NCT03141983|101786606|FG000|NOT COMPLETED|Overall Study||8||
48594376|NCT03141983|101786607|FG001|NOT COMPLETED|Overall Study||8||
48594377|NCT01211483|101786608|FG000|STARTED|Phase 1b||7||
48594378|NCT01211483|101786609|FG001|STARTED|Phase 1b||0||
48594379|NCT01211483|101786610|FG002|STARTED|Phase 1b||0||
48594380|NCT01211483|101786611|FG003|STARTED|Phase 1b||0||
48594381|NCT01211483|101786608|FG000|COMPLETED|Phase 1b||0||
48594382|NCT01211483|101786609|FG001|COMPLETED|Phase 1b||0||
48594383|NCT01211483|101786610|FG002|COMPLETED|Phase 1b||0||
48594384|NCT01211483|101786611|FG003|COMPLETED|Phase 1b||0||
48594385|NCT01211483|101786608|FG000|NOT COMPLETED|Phase 1b||7||
48594386|NCT01211483|101786609|FG001|NOT COMPLETED|Phase 1b||0||
48295011|NCT01207726|101050784|FG001|STARTED|Overall Study||6||
48295012|NCT01207726|101050783|FG000|COMPLETED|Overall Study||7||
48594387|NCT01211483|101786610|FG002|NOT COMPLETED|Phase 1b||0||
48295013|NCT01207726|101050784|FG001|COMPLETED|Overall Study||6||
48295014|NCT01207726|101050783|FG000|NOT COMPLETED|Overall Study||0||
48295015|NCT01207726|101050784|FG001|NOT COMPLETED|Overall Study||0||
48295016|NCT02260882|101050785|FG000|STARTED|Overall Study||161||
48295017|NCT02260882|101050786|FG001|STARTED|Overall Study||82||
48295018|NCT02260882|101050785|FG000|COMPLETED|Overall Study||161||
48295019|NCT02260882|101050786|FG001|COMPLETED|Overall Study||81||
48594388|NCT01211483|101786611|FG003|NOT COMPLETED|Phase 1b||0||
48594389|NCT01211483|101786608|FG000|STARTED|Phase 2||0||
48594390|NCT01211483|101786609|FG001|STARTED|Phase 2||72||
48594391|NCT01211483|101786610|FG002|STARTED|Phase 2||72||
48594392|NCT01211483|101786611|FG003|STARTED|Phase 2||71||
48594393|NCT01211483|101786608|FG000|COMPLETED|Phase 2||0||
48594394|NCT01211483|101786609|FG001|COMPLETED|Phase 2||0||
48594395|NCT01211483|101786610|FG002|COMPLETED|Phase 2||0||
48594396|NCT01211483|101786611|FG003|COMPLETED|Phase 2||0||
48594397|NCT01211483|101786608|FG000|NOT COMPLETED|Phase 2||0||
48594398|NCT01211483|101786609|FG001|NOT COMPLETED|Phase 2||72||
48594399|NCT01211483|101786610|FG002|NOT COMPLETED|Phase 2||72||
48594400|NCT01211483|101786611|FG003|NOT COMPLETED|Phase 2||71||
48594401|NCT00948506|101786612|FG000|STARTED|Overall Study||11||
48594402|NCT00948506|101786613|FG001|STARTED|Overall Study||9||
48594403|NCT00948506|101786612|FG000|COMPLETED|Overall Study||8||
48594404|NCT00948506|101786613|FG001|COMPLETED|Overall Study||8||
48594405|NCT00948506|101786612|FG000|NOT COMPLETED|Overall Study||3||
48594406|NCT00948506|101786613|FG001|NOT COMPLETED|Overall Study||1||
48594407|NCT02306694|101786614|FG000|STARTED|Overall Study||16||
48594408|NCT02306694|101786614|FG000|COMPLETED|Overall Study||12||
48594409|NCT02306694|101786614|FG000|NOT COMPLETED|Overall Study||4||
48594410|NCT04984681|101786615|FG000|STARTED|Overall Study||15||
48594411|NCT04984681|101786616|FG001|STARTED|Overall Study||15||
48594412|NCT04984681|101786615|FG000|COMPLETED|Overall Study||12||
48594413|NCT04984681|101786616|FG001|COMPLETED|Overall Study||14||
48594414|NCT04984681|101786615|FG000|NOT COMPLETED|Overall Study||3||
48594415|NCT04984681|101786616|FG001|NOT COMPLETED|Overall Study||1||
48594416|NCT02258334|101786617|FG000|STARTED|Overall Study||50||
48594417|NCT02258334|101786618|FG001|STARTED|Overall Study||54||
48594418|NCT02258334|101786619|FG002|STARTED|Overall Study||52||
48594419|NCT02258334|101786620|FG003|STARTED|Overall Study||52||
48594420|NCT02258334|101786617|FG000|COMPLETED|Overall Study||49||
48594421|NCT02258334|101786618|FG001|COMPLETED|Overall Study||54||
48594422|NCT02258334|101786619|FG002|COMPLETED|Overall Study||52||
48594423|NCT02258334|101786620|FG003|COMPLETED|Overall Study||52||
48594424|NCT02258334|101786617|FG000|NOT COMPLETED|Overall Study||1||
48594425|NCT02258334|101786618|FG001|NOT COMPLETED|Overall Study||0||
48594426|NCT02258334|101786619|FG002|NOT COMPLETED|Overall Study||0||
48594427|NCT02258334|101786620|FG003|NOT COMPLETED|Overall Study||0||
48594428|NCT01131065|101786621|FG000|STARTED|Overall Study||15||
48594429|NCT01131065|101786621|FG000|COMPLETED|Overall Study||15||
48594430|NCT01131065|101786621|FG000|NOT COMPLETED|Overall Study||0||
48594431|NCT00503997|101786622|FG000|STARTED|Overall Study||42||
48594432|NCT00503997|101786622|FG000|COMPLETED|Overall Study||34||
48594433|NCT00503997|101786622|FG000|NOT COMPLETED|Overall Study||8||
48594434|NCT02906033|101786623|FG000|STARTED|Baseline||231||
48594435|NCT02906033|101786624|FG001|STARTED|Baseline||222||
48594436|NCT02906033|101786623|FG000|15 D at Baseline|Baseline||211|Analyzed at baseline for 15 D|
48594437|NCT02906033|101786624|FG001|15 D at Baseline|Baseline||189|Analyzed at baseline for 15 D|
48594438|NCT02906033|101786623|FG000|STATE at Baseline|Baseline||199|Analyzed at baseline for STATE anxiety|
48594439|NCT02906033|101786624|FG001|STATE at Baseline|Baseline||190|Analyzed at baseline for STATE anxiety|
48594440|NCT02906033|101786623|FG000|TRAIT at Baseline|Baseline||194|Analyzed at baseline for TRAIT anxiety|
48594441|NCT02906033|101786624|FG001|TRAIT at Baseline|Baseline||189|Analyzed at baseline for TRAIT anxiety|
48594442|NCT02906033|101786623|FG000|COMPLETED|Baseline||194||
48594443|NCT02906033|101786624|FG001|COMPLETED|Baseline||189||
48594444|NCT02906033|101786623|FG000|NOT COMPLETED|Baseline||37||
48594445|NCT02906033|101786624|FG001|NOT COMPLETED|Baseline||33||
48594446|NCT02906033|101786623|FG000|STARTED|Follow-up||194||
48594447|NCT02906033|101786624|FG001|STARTED|Follow-up||189||
48594448|NCT02906033|101786623|FG000|15 D at Follow-up|Follow-up||151|Analyzed for 15 D at follow-up|
48594449|NCT02906033|101786624|FG001|15 D at Follow-up|Follow-up||135|Analyzed for 15 D at follow-up|
48594450|NCT02906033|101786623|FG000|STATE at Follow-up|Follow-up||154|Analyzed for STATE anxiety at follow-up|
48594451|NCT02906033|101786624|FG001|STATE at Follow-up|Follow-up||135|Analyzed for STATE anxiety at follow-up|
48594452|NCT02906033|101786623|FG000|TRAIT at Follow-up|Follow-up||148|Analyzed for TRAIT anxiety at follow-up|
48594453|NCT02906033|101786624|FG001|TRAIT at Follow-up|Follow-up||127|Analyzed for TRAIT anxiety at follow-up|
48594454|NCT02906033|101786623|FG000|COMPLETED|Follow-up||148||
48594455|NCT02906033|101786624|FG001|COMPLETED|Follow-up||127||
48594456|NCT02906033|101786623|FG000|NOT COMPLETED|Follow-up||46||
48594457|NCT02906033|101786624|FG001|NOT COMPLETED|Follow-up||62||
48594458|NCT04108988|101786625|FG000|STARTED|Overall Study||61||
48594459|NCT04108988|101786626|FG001|STARTED|Overall Study||56||
48594460|NCT04108988|101786625|FG000|Consent and Baseline|Overall Study||40|Excluded participants did not attend initial meeting for consenting, baseline and gameplay.|
48594461|NCT04108988|101786626|FG001|Consent and Baseline|Overall Study||39|Excluded participants did not attend initial meeting for consenting, baseline and gameplay.|
48594462|NCT04108988|101786625|FG000|Completed Post Gameplay Survey|Overall Study||40||
48594463|NCT04108988|101786626|FG001|Completed Post Gameplay Survey|Overall Study||38||
48711733|NCT00953524|102081638|FG001|NOT COMPLETED|Overall Study||15||
48711734|NCT00953524|102081639|FG002|NOT COMPLETED|Overall Study||14||
48711735|NCT00953524|102081640|FG003|NOT COMPLETED|Overall Study||8||
48594464|NCT04108988|101786625|FG000|Completed One Month Follow-up|Overall Study||40||
48594465|NCT04108988|101786626|FG001|Completed One Month Follow-up|Overall Study||39||
48594466|NCT04108988|101786625|FG000|Completed Four Month Follow-up|Overall Study||38||
48711736|NCT00047619|102081641|FG000|STARTED|Overall Study||14||
48594467|NCT04108988|101786626|FG001|Completed Four Month Follow-up|Overall Study||39||
48594468|NCT04108988|101786625|FG000|COMPLETED|Overall Study||40||
48594469|NCT04108988|101786626|FG001|COMPLETED|Overall Study||39||
48594470|NCT04108988|101786625|FG000|NOT COMPLETED|Overall Study||21||
48594471|NCT04108988|101786626|FG001|NOT COMPLETED|Overall Study||17||
48594472|NCT02505334|101786627|FG000|STARTED|Main Treatment Period||233||
48594473|NCT02505334|101786628|FG001|STARTED|Main Treatment Period||233||
48594474|NCT02505334|101786627|FG000|COMPLETED|Main Treatment Period||218||
48594475|NCT02505334|101786628|FG001|COMPLETED|Main Treatment Period||194||
48594476|NCT02505334|101786627|FG000|NOT COMPLETED|Main Treatment Period||15||
48594477|NCT02505334|101786628|FG001|NOT COMPLETED|Main Treatment Period||39||
48594478|NCT02505334|101786627|FG000|STARTED|Extension Treatment Period||212||
48594479|NCT02505334|101786628|FG001|STARTED|Extension Treatment Period||0||
48594480|NCT02505334|101786627|FG000|COMPLETED|Extension Treatment Period||194||
48594481|NCT02505334|101786628|FG001|COMPLETED|Extension Treatment Period||0||
48594482|NCT02505334|101786627|FG000|NOT COMPLETED|Extension Treatment Period||18||
48594483|NCT02505334|101786628|FG001|NOT COMPLETED|Extension Treatment Period||0||
48594484|NCT04599933|101786629|FG000|STARTED|Overall Study||155||
48594485|NCT04599933|101786630|FG001|STARTED|Overall Study||154||
48594486|NCT04599933|101786629|FG000|COMPLETED|Overall Study||146||
48594487|NCT04599933|101786630|FG001|COMPLETED|Overall Study||147||
48594488|NCT04599933|101786629|FG000|NOT COMPLETED|Overall Study||9||
48594489|NCT04599933|101786630|FG001|NOT COMPLETED|Overall Study||7||
48594490|NCT04586634|101786631|FG000|STARTED|Overall Study||16||
48594491|NCT04586634|101786632|FG001|STARTED|Overall Study||16||
48594492|NCT04586634|101786631|FG000|COMPLETED|Overall Study||15||
48594493|NCT04586634|101786632|FG001|COMPLETED|Overall Study||15||
48594494|NCT04586634|101786631|FG000|NOT COMPLETED|Overall Study||1||
48594495|NCT04586634|101786632|FG001|NOT COMPLETED|Overall Study||1||
48594496|NCT01890226|101786633|FG000|STARTED|Overall Study||155||
48594497|NCT01890226|101786634|FG001|STARTED|Overall Study||156||
48594498|NCT01890226|101786633|FG000|COMPLETED|Overall Study||155||
48594499|NCT01890226|101786634|FG001|COMPLETED|Overall Study||156||
48594500|NCT01890226|101786633|FG000|NOT COMPLETED|Overall Study||0||
48594501|NCT01890226|101786634|FG001|NOT COMPLETED|Overall Study||0||
48594502|NCT01844505|101789433|FG000|STARTED|Overall Study||313||
48594503|NCT01844505|101789434|FG001|STARTED|Overall Study||313||
48594504|NCT01844505|101789435|FG002|STARTED|Overall Study||311||
48594505|NCT01844505|101789433|FG000|COMPLETED|Overall Study||64||
48594506|NCT01844505|101789434|FG001|COMPLETED|Overall Study||44||
48594507|NCT01844505|101789435|FG002|COMPLETED|Overall Study||16||
48594508|NCT01844505|101789433|FG000|NOT COMPLETED|Overall Study||249||
48594509|NCT01844505|101789434|FG001|NOT COMPLETED|Overall Study||269||
48594510|NCT01844505|101789435|FG002|NOT COMPLETED|Overall Study||295||
48594511|NCT00866333|101789436|FG000|STARTED|Overall Study||16||
48594512|NCT00866333|101789437|FG001|STARTED|Overall Study||17||
48594513|NCT00866333|101789438|FG002|STARTED|Overall Study||16||
48594514|NCT00866333|101789436|FG000|COMPLETED|Overall Study||11||
48594515|NCT00866333|101789437|FG001|COMPLETED|Overall Study||10||
48594516|NCT00866333|101789438|FG002|COMPLETED|Overall Study||4||
48594517|NCT00866333|101789436|FG000|NOT COMPLETED|Overall Study||5||
48594518|NCT00866333|101789437|FG001|NOT COMPLETED|Overall Study||7||
48594519|NCT00866333|101789438|FG002|NOT COMPLETED|Overall Study||12||
48594520|NCT01642485|101789439|FG000|STARTED|Period 1, Day 1||4||
48594521|NCT01642485|101789440|FG001|STARTED|Period 1, Day 1||4||
48594522|NCT01642485|101789441|FG002|STARTED|Period 1, Day 1||4||
48594523|NCT01642485|101789442|FG003|STARTED|Period 1, Day 1||4||
48594524|NCT01642485|101789443|FG004|STARTED|Period 1, Day 1||4||
48594525|NCT01642485|101789444|FG005|STARTED|Period 1, Day 1||4||
48594526|NCT01642485|101789445|FG006|STARTED|Period 1, Day 1||4||
48295020|NCT02260882|101050785|FG000|NOT COMPLETED|Overall Study||0||
48295021|NCT02260882|101050786|FG001|NOT COMPLETED|Overall Study||1||
48594527|NCT01642485|101789446|FG007|STARTED|Period 1, Day 1||4||
48594528|NCT01642485|101789439|FG000|COMPLETED|Period 1, Day 1||4||
48594529|NCT01642485|101789440|FG001|COMPLETED|Period 1, Day 1||4||
48594530|NCT01642485|101789441|FG002|COMPLETED|Period 1, Day 1||4||
48594531|NCT01642485|101789442|FG003|COMPLETED|Period 1, Day 1||4||
48594532|NCT01642485|101789443|FG004|COMPLETED|Period 1, Day 1||4||
48594533|NCT01642485|101789444|FG005|COMPLETED|Period 1, Day 1||4||
48594534|NCT01642485|101789445|FG006|COMPLETED|Period 1, Day 1||4||
48594535|NCT01642485|101789446|FG007|COMPLETED|Period 1, Day 1||4||
48594536|NCT01642485|101789439|FG000|NOT COMPLETED|Period 1, Day 1||0||
48295022|NCT00624923|101050787|FG000|STARTED|Overall Study||127||
48295023|NCT00624923|101050788|FG001|STARTED|Overall Study||124||
48295024|NCT00624923|101050787|FG000|COMPLETED|Overall Study||89||
48594537|NCT01642485|101789440|FG001|NOT COMPLETED|Period 1, Day 1||0||
48594538|NCT01642485|101789441|FG002|NOT COMPLETED|Period 1, Day 1||0||
48594539|NCT01642485|101789442|FG003|NOT COMPLETED|Period 1, Day 1||0||
48594540|NCT01642485|101789443|FG004|NOT COMPLETED|Period 1, Day 1||0||
48594541|NCT01642485|101789444|FG005|NOT COMPLETED|Period 1, Day 1||0||
48594542|NCT01642485|101789445|FG006|NOT COMPLETED|Period 1, Day 1||0||
48594543|NCT01642485|101789446|FG007|NOT COMPLETED|Period 1, Day 1||0||
48594544|NCT01642485|101789439|FG000|STARTED|Period 1, Day 2||4||
48594545|NCT01642485|101789440|FG001|STARTED|Period 1, Day 2||4||
48594546|NCT01642485|101789441|FG002|STARTED|Period 1, Day 2||4||
48594547|NCT01642485|101789442|FG003|STARTED|Period 1, Day 2||4||
48594548|NCT01642485|101789443|FG004|STARTED|Period 1, Day 2||4||
48594549|NCT01642485|101789444|FG005|STARTED|Period 1, Day 2||4||
48594550|NCT01642485|101789445|FG006|STARTED|Period 1, Day 2||4||
48594551|NCT01642485|101789446|FG007|STARTED|Period 1, Day 2||4||
48594552|NCT01642485|101789439|FG000|COMPLETED|Period 1, Day 2||4||
48594553|NCT01642485|101789440|FG001|COMPLETED|Period 1, Day 2||4||
48594554|NCT01642485|101789441|FG002|COMPLETED|Period 1, Day 2||4||
48594555|NCT01642485|101789442|FG003|COMPLETED|Period 1, Day 2||4||
48594556|NCT01642485|101789443|FG004|COMPLETED|Period 1, Day 2||4||
48594557|NCT01642485|101789444|FG005|COMPLETED|Period 1, Day 2||4||
48594558|NCT01642485|101789445|FG006|COMPLETED|Period 1, Day 2||4||
48594559|NCT01642485|101789446|FG007|COMPLETED|Period 1, Day 2||4||
48594560|NCT01642485|101789439|FG000|NOT COMPLETED|Period 1, Day 2||0||
48594561|NCT01642485|101789440|FG001|NOT COMPLETED|Period 1, Day 2||0||
48594562|NCT01642485|101789441|FG002|NOT COMPLETED|Period 1, Day 2||0||
48594563|NCT01642485|101789442|FG003|NOT COMPLETED|Period 1, Day 2||0||
48594564|NCT01642485|101789443|FG004|NOT COMPLETED|Period 1, Day 2||0||
48594565|NCT01642485|101789444|FG005|NOT COMPLETED|Period 1, Day 2||0||
48594566|NCT01642485|101789445|FG006|NOT COMPLETED|Period 1, Day 2||0||
48594567|NCT01642485|101789446|FG007|NOT COMPLETED|Period 1, Day 2||0||
48594568|NCT01642485|101789439|FG000|STARTED|Period 1, Day 3||4||
48594569|NCT01642485|101789440|FG001|STARTED|Period 1, Day 3||4||
48594570|NCT01642485|101789441|FG002|STARTED|Period 1, Day 3||4||
48594571|NCT01642485|101789442|FG003|STARTED|Period 1, Day 3||4||
48594572|NCT01642485|101789443|FG004|STARTED|Period 1, Day 3||4||
48594573|NCT01642485|101789444|FG005|STARTED|Period 1, Day 3||4||
48594574|NCT01642485|101789445|FG006|STARTED|Period 1, Day 3||4||
48594575|NCT01642485|101789446|FG007|STARTED|Period 1, Day 3||4||
48594576|NCT01642485|101789439|FG000|COMPLETED|Period 1, Day 3||4||
48594577|NCT01642485|101789440|FG001|COMPLETED|Period 1, Day 3||4||
48594578|NCT01642485|101789441|FG002|COMPLETED|Period 1, Day 3||4||
48594579|NCT01642485|101789442|FG003|COMPLETED|Period 1, Day 3||4||
48594580|NCT01642485|101789443|FG004|COMPLETED|Period 1, Day 3||4||
48594581|NCT01642485|101789444|FG005|COMPLETED|Period 1, Day 3||4||
48594582|NCT01642485|101789445|FG006|COMPLETED|Period 1, Day 3||4||
48594583|NCT01642485|101789446|FG007|COMPLETED|Period 1, Day 3||4||
48594584|NCT01642485|101789439|FG000|NOT COMPLETED|Period 1, Day 3||0||
48594585|NCT01642485|101789440|FG001|NOT COMPLETED|Period 1, Day 3||0||
48594586|NCT01642485|101789441|FG002|NOT COMPLETED|Period 1, Day 3||0||
48594587|NCT01642485|101789442|FG003|NOT COMPLETED|Period 1, Day 3||0||
48594588|NCT01642485|101789443|FG004|NOT COMPLETED|Period 1, Day 3||0||
48594589|NCT01642485|101789444|FG005|NOT COMPLETED|Period 1, Day 3||0||
48594590|NCT01642485|101789445|FG006|NOT COMPLETED|Period 1, Day 3||0||
48594591|NCT01642485|101789446|FG007|NOT COMPLETED|Period 1, Day 3||0||
48594592|NCT01642485|101789439|FG000|STARTED|Period 2, Day 1||4||
48594593|NCT01642485|101789440|FG001|STARTED|Period 2, Day 1||4||
48594594|NCT01642485|101789441|FG002|STARTED|Period 2, Day 1||4||
48594595|NCT01642485|101789442|FG003|STARTED|Period 2, Day 1||4||
48594596|NCT01642485|101789443|FG004|STARTED|Period 2, Day 1||4||
48594597|NCT01642485|101789444|FG005|STARTED|Period 2, Day 1||4||
48594598|NCT01642485|101789445|FG006|STARTED|Period 2, Day 1||4||
48594599|NCT01642485|101789446|FG007|STARTED|Period 2, Day 1||4||
48594600|NCT01642485|101789439|FG000|COMPLETED|Period 2, Day 1||4||
48594601|NCT01642485|101789440|FG001|COMPLETED|Period 2, Day 1||4||
48594602|NCT01642485|101789441|FG002|COMPLETED|Period 2, Day 1||4||
48594603|NCT01642485|101789442|FG003|COMPLETED|Period 2, Day 1||4||
48594604|NCT01642485|101789443|FG004|COMPLETED|Period 2, Day 1||4||
48594605|NCT01642485|101789444|FG005|COMPLETED|Period 2, Day 1||4||
48594606|NCT01642485|101789445|FG006|COMPLETED|Period 2, Day 1||4||
48594607|NCT01642485|101789446|FG007|COMPLETED|Period 2, Day 1||4||
48594608|NCT01642485|101789439|FG000|NOT COMPLETED|Period 2, Day 1||0||
48594609|NCT01642485|101789440|FG001|NOT COMPLETED|Period 2, Day 1||0||
48594610|NCT01642485|101789441|FG002|NOT COMPLETED|Period 2, Day 1||0||
48594611|NCT01642485|101789442|FG003|NOT COMPLETED|Period 2, Day 1||0||
48594612|NCT01642485|101789443|FG004|NOT COMPLETED|Period 2, Day 1||0||
48594613|NCT01642485|101789444|FG005|NOT COMPLETED|Period 2, Day 1||0||
48594614|NCT01642485|101789445|FG006|NOT COMPLETED|Period 2, Day 1||0||
48594615|NCT01642485|101789446|FG007|NOT COMPLETED|Period 2, Day 1||0||
48594616|NCT01642485|101789439|FG000|STARTED|Period 2, Day 2||4||
48711737|NCT00047619|102081642|FG001|STARTED|Overall Study||14||
48594617|NCT01642485|101789440|FG001|STARTED|Period 2, Day 2||4||
48594618|NCT01642485|101789441|FG002|STARTED|Period 2, Day 2||4||
48594619|NCT01642485|101789442|FG003|STARTED|Period 2, Day 2||4||
48594620|NCT01642485|101789443|FG004|STARTED|Period 2, Day 2||4||
48594621|NCT01642485|101789444|FG005|STARTED|Period 2, Day 2||4||
48594622|NCT01642485|101789445|FG006|STARTED|Period 2, Day 2||4||
48594623|NCT01642485|101789446|FG007|STARTED|Period 2, Day 2||4||
48594624|NCT01642485|101789439|FG000|COMPLETED|Period 2, Day 2||4||
48594625|NCT01642485|101789440|FG001|COMPLETED|Period 2, Day 2||4||
48594626|NCT01642485|101789441|FG002|COMPLETED|Period 2, Day 2||4||
48594627|NCT01642485|101789442|FG003|COMPLETED|Period 2, Day 2||4||
48594628|NCT01642485|101789443|FG004|COMPLETED|Period 2, Day 2||4||
48594629|NCT01642485|101789444|FG005|COMPLETED|Period 2, Day 2||4||
48594630|NCT01642485|101789445|FG006|COMPLETED|Period 2, Day 2||4||
48594631|NCT01642485|101789446|FG007|COMPLETED|Period 2, Day 2||4||
48594632|NCT01642485|101789439|FG000|NOT COMPLETED|Period 2, Day 2||0||
48594633|NCT01642485|101789440|FG001|NOT COMPLETED|Period 2, Day 2||0||
48594634|NCT01642485|101789441|FG002|NOT COMPLETED|Period 2, Day 2||0||
48594635|NCT01642485|101789442|FG003|NOT COMPLETED|Period 2, Day 2||0||
48594636|NCT01642485|101789443|FG004|NOT COMPLETED|Period 2, Day 2||0||
48594637|NCT01642485|101789444|FG005|NOT COMPLETED|Period 2, Day 2||0||
48594638|NCT01642485|101789445|FG006|NOT COMPLETED|Period 2, Day 2||0||
48594639|NCT01642485|101789446|FG007|NOT COMPLETED|Period 2, Day 2||0||
48594640|NCT01642485|101789439|FG000|STARTED|Period 2, Day 3||4||
48594641|NCT01642485|101789440|FG001|STARTED|Period 2, Day 3||4||
48594642|NCT01642485|101789441|FG002|STARTED|Period 2, Day 3||4||
48594643|NCT01642485|101789442|FG003|STARTED|Period 2, Day 3||4||
48594644|NCT01642485|101789443|FG004|STARTED|Period 2, Day 3||4||
48594645|NCT01642485|101789444|FG005|STARTED|Period 2, Day 3||4||
48594646|NCT01642485|101789445|FG006|STARTED|Period 2, Day 3||4||
48594647|NCT01642485|101789446|FG007|STARTED|Period 2, Day 3||4||
48594648|NCT01642485|101789439|FG000|COMPLETED|Period 2, Day 3||4||
48594649|NCT01642485|101789440|FG001|COMPLETED|Period 2, Day 3||4||
48594650|NCT01642485|101789441|FG002|COMPLETED|Period 2, Day 3||4||
48594651|NCT01642485|101789442|FG003|COMPLETED|Period 2, Day 3||4||
48594652|NCT01642485|101789443|FG004|COMPLETED|Period 2, Day 3||4||
48594653|NCT01642485|101789444|FG005|COMPLETED|Period 2, Day 3||4||
48594654|NCT01642485|101789445|FG006|COMPLETED|Period 2, Day 3||4||
48594655|NCT01642485|101789446|FG007|COMPLETED|Period 2, Day 3||4||
48295025|NCT00624923|101050788|FG001|COMPLETED|Overall Study||101||
48295026|NCT00624923|101050787|FG000|NOT COMPLETED|Overall Study||38||
48295027|NCT00624923|101050788|FG001|NOT COMPLETED|Overall Study||23||
48295028|NCT00642382|101050789|FG000|STARTED|Overall Study||0||
48295029|NCT00642382|101050790|FG001|STARTED|Overall Study||0||
48295030|NCT00642382|101050789|FG000|COMPLETED|Overall Study||0||
48295031|NCT00642382|101050790|FG001|COMPLETED|Overall Study||0||
48295032|NCT00642382|101050789|FG000|NOT COMPLETED|Overall Study||0||
48295033|NCT00642382|101050790|FG001|NOT COMPLETED|Overall Study||0||
48295034|NCT03451162|101050791|FG000|STARTED|Overall Study||3||
48295035|NCT03451162|101050792|FG001|STARTED|Overall Study||3||
48295036|NCT03451162|101050793|FG002|STARTED|Overall Study||3||
48295037|NCT03451162|101050794|FG003|STARTED|Overall Study||3||
48295038|NCT03451162|101050795|FG004|STARTED|Overall Study||2||
48295039|NCT03451162|101050791|FG000|COMPLETED|Overall Study||1||
48295040|NCT03451162|101050792|FG001|COMPLETED|Overall Study||1||
48295041|NCT03451162|101050793|FG002|COMPLETED|Overall Study||3||
48295042|NCT03451162|101050794|FG003|COMPLETED|Overall Study||3||
48295043|NCT03451162|101050795|FG004|COMPLETED|Overall Study||2||
48295044|NCT03451162|101050791|FG000|NOT COMPLETED|Overall Study||2||
48295045|NCT03451162|101050792|FG001|NOT COMPLETED|Overall Study||2||
48295046|NCT03451162|101050793|FG002|NOT COMPLETED|Overall Study||0||
48295047|NCT03451162|101050794|FG003|NOT COMPLETED|Overall Study||0||
48295048|NCT03451162|101050795|FG004|NOT COMPLETED|Overall Study||0||
48295049|NCT04878731|101050796|FG000|STARTED|Overall Study||6||
48295050|NCT04878731|101050796|FG000|COMPLETED|Overall Study||6||
48295051|NCT04878731|101050796|FG000|NOT COMPLETED|Overall Study||0||
48295052|NCT01640054|101050797|FG000|STARTED|Overall Study||115||
48295053|NCT01640054|101050797|FG000|Did Not Receive Treatment|Overall Study||0||
48594656|NCT01642485|101789439|FG000|NOT COMPLETED|Period 2, Day 3||0||
48594657|NCT01642485|101789440|FG001|NOT COMPLETED|Period 2, Day 3||0||
48594658|NCT01642485|101789441|FG002|NOT COMPLETED|Period 2, Day 3||0||
48594659|NCT01642485|101789442|FG003|NOT COMPLETED|Period 2, Day 3||0||
48594660|NCT01642485|101789443|FG004|NOT COMPLETED|Period 2, Day 3||0||
48594661|NCT01642485|101789444|FG005|NOT COMPLETED|Period 2, Day 3||0||
48594662|NCT01642485|101789445|FG006|NOT COMPLETED|Period 2, Day 3||0||
48594663|NCT01642485|101789446|FG007|NOT COMPLETED|Period 2, Day 3||0||
48594664|NCT01143064|101789447|FG000|STARTED|Overall Study||597||
48594665|NCT01143064|101789448|FG001|STARTED|Overall Study||598||
48594666|NCT01143064|101789447|FG000|COMPLETED|Overall Study||464||
48594667|NCT01143064|101789448|FG001|COMPLETED|Overall Study||483||
48594668|NCT01143064|101789447|FG000|NOT COMPLETED|Overall Study||133||
48594669|NCT01143064|101789448|FG001|NOT COMPLETED|Overall Study||115||
48594670|NCT01904903|101789449|FG000|STARTED|Overall Study||31||
48594671|NCT01904903|101789449|FG000|COMPLETED|Overall Study||30||
48594672|NCT01904903|101789449|FG000|NOT COMPLETED|Overall Study||1||
48594673|NCT01195844|101789450|FG000|STARTED|Overall Study||230||
48594674|NCT01195844|101789450|FG000|COMPLETED|Overall Study||190||
48594675|NCT01195844|101789450|FG000|NOT COMPLETED|Overall Study||40||
48594676|NCT01005888|101789451|FG000|STARTED|First Intervention||12||
48594677|NCT01005888|101789452|FG001|STARTED|First Intervention||12||
48594678|NCT01005888|101789451|FG000|COMPLETED|First Intervention||11||
48594679|NCT01005888|101789452|FG001|COMPLETED|First Intervention||11||
48594680|NCT01005888|101789451|FG000|NOT COMPLETED|First Intervention||1||
48594681|NCT01005888|101789452|FG001|NOT COMPLETED|First Intervention||1||
48594682|NCT01005888|101789451|FG000|STARTED|Second Intervention||11||
48594683|NCT01005888|101789452|FG001|STARTED|Second Intervention||11||
48594684|NCT01005888|101789451|FG000|COMPLETED|Second Intervention||10||
48594685|NCT01005888|101789452|FG001|COMPLETED|Second Intervention||10||
48594686|NCT01005888|101789451|FG000|NOT COMPLETED|Second Intervention||1||
48295054|NCT01640054|101050797|FG000|COMPLETED|Overall Study||109||
48295055|NCT01640054|101050797|FG000|NOT COMPLETED|Overall Study||6||
48295056|NCT01570036|101050798|FG000|STARTED|Overall Study||136||
48295057|NCT01570036|101050799|FG001|STARTED|Overall Study||139||
48295058|NCT01570036|101050798|FG000|Primary Vaccine Series Completed|Overall Study||121||
48295059|NCT01570036|101050799|FG001|Primary Vaccine Series Completed|Overall Study||132||
48295060|NCT01570036|101050798|FG000|Booster Series Completed|Overall Study||40||
48295061|NCT01570036|101050799|FG001|Booster Series Completed|Overall Study||30||
48295062|NCT01570036|101050798|FG000|COMPLETED|Overall Study||18||
48295063|NCT01570036|101050799|FG001|COMPLETED|Overall Study||17||
48295064|NCT01570036|101050798|FG000|NOT COMPLETED|Overall Study||118||
48295065|NCT01570036|101050799|FG001|NOT COMPLETED|Overall Study||122||
48295066|NCT01637623|101050800|FG000|STARTED|Overall Study||29||
48594687|NCT01005888|101789452|FG001|NOT COMPLETED|Second Intervention||1||
48594688|NCT02243046|101789453|FG000|STARTED|Overall Study||55||
48594689|NCT02243046|101789454|FG001|STARTED|Overall Study||54||
48594690|NCT02243046|101789455|FG002|STARTED|Overall Study||53||
48594691|NCT02243046|101789453|FG000|3 Month|Overall Study||54||
48594692|NCT02243046|101789454|FG001|3 Month|Overall Study||53||
48594693|NCT02243046|101789455|FG002|3 Month|Overall Study||51||
48594694|NCT02243046|101789453|FG000|6 Month|Overall Study||54||
48594695|NCT02243046|101789454|FG001|6 Month|Overall Study||53||
48594696|NCT02243046|101789455|FG002|6 Month|Overall Study||49||
48594697|NCT02243046|101789453|FG000|COMPLETED|Overall Study||54||
48594698|NCT02243046|101789454|FG001|COMPLETED|Overall Study||53||
48594699|NCT02243046|101789455|FG002|COMPLETED|Overall Study||49||
48594700|NCT02243046|101789453|FG000|NOT COMPLETED|Overall Study||1||
48594701|NCT02243046|101789454|FG001|NOT COMPLETED|Overall Study||1||
48594702|NCT02243046|101789455|FG002|NOT COMPLETED|Overall Study||4||
48594703|NCT03180515|101789456|FG000|STARTED|Aim 1||12||
48594704|NCT03180515|101789456|FG000|COMPLETED|Aim 1||12||
48594705|NCT03180515|101789456|FG000|NOT COMPLETED|Aim 1||0||
48594706|NCT03180515|101789456|FG000|STARTED|Aim 2||12||
48594707|NCT03180515|101789456|FG000|COMPLETED|Aim 2||12||
48594708|NCT03180515|101789456|FG000|NOT COMPLETED|Aim 2||0||
48594709|NCT03180515|101789456|FG000|STARTED|Aim 3||1||
48594710|NCT03180515|101789456|FG000|COMPLETED|Aim 3||1||
48594711|NCT03180515|101789456|FG000|NOT COMPLETED|Aim 3||0||
48594712|NCT01876979|101789457|FG000|STARTED|Overall Study||2||
48594713|NCT01876979|101789458|FG001|STARTED|Overall Study||3||
48594714|NCT01876979|101789457|FG000|COMPLETED|Overall Study||0||
48594715|NCT01876979|101789458|FG001|COMPLETED|Overall Study||0||
48594716|NCT01876979|101789457|FG000|NOT COMPLETED|Overall Study||2||
48594717|NCT01876979|101789458|FG001|NOT COMPLETED|Overall Study||3||
48594718|NCT05011890|101789459|FG000|STARTED|Overall Study||41||
48594719|NCT05011890|101789459|FG000|COMPLETED|Overall Study||41|Forty-one participants completed the baseline assessment and thirty- three subjects completed the six-month evaluation.|
48594720|NCT05011890|101789459|FG000|NOT COMPLETED|Overall Study||0||
48594721|NCT03515629|101789460|FG000|STARTED|Overall Study||0||
48594722|NCT03515629|101789461|FG001|STARTED|Overall Study||3||
48594723|NCT03515629|101789462|FG002|STARTED|Overall Study||2||
48594724|NCT03515629|101789460|FG000|COMPLETED|Overall Study||0|Completed study|
48594725|NCT03515629|101789461|FG001|COMPLETED|Overall Study||1|Completed study|
48594726|NCT03515629|101789462|FG002|COMPLETED|Overall Study||1|Completed study|
48594727|NCT03515629|101789460|FG000|NOT COMPLETED|Overall Study||0||
48594728|NCT03515629|101789461|FG001|NOT COMPLETED|Overall Study||2||
48594729|NCT03515629|101789462|FG002|NOT COMPLETED|Overall Study||1||
48594730|NCT00669552|101789463|FG000|STARTED|Overall Study||11||
48594731|NCT00669552|101789463|FG000|COMPLETED|Overall Study||11||
48594732|NCT00669552|101789463|FG000|NOT COMPLETED|Overall Study||0||
48594733|NCT02294175|101789464|FG000|STARTED|Overall Study||23||
48594734|NCT02294175|101789465|FG001|STARTED|Overall Study||22||
48295067|NCT01637623|101050801|FG001|STARTED|Overall Study||30||
48295068|NCT01637623|101050802|FG002|STARTED|Overall Study||28||
48295069|NCT01637623|101050800|FG000|Received Intervention|Overall Study||28||
48295070|NCT01637623|101050801|FG001|Received Intervention|Overall Study||30||
48295071|NCT01637623|101050802|FG002|Received Intervention|Overall Study||27||
48295072|NCT01637623|101050800|FG000|Did Not Receive Intervention|Overall Study||1||
48295073|NCT01637623|101050801|FG001|Did Not Receive Intervention|Overall Study||0||
48295074|NCT01637623|101050802|FG002|Did Not Receive Intervention|Overall Study||1||
48295075|NCT01637623|101050800|FG000|Analyzed|Overall Study||28|baseline characteristics data is for the 86 participants analyzed|
48295076|NCT01637623|101050801|FG001|Analyzed|Overall Study||30|baseline characteristics data is for the 86 participants analyzed|
48295077|NCT01637623|101050802|FG002|Analyzed|Overall Study||28|baseline characteristics data is for the 86 participants analyzed|
48295078|NCT01637623|101050800|FG000|COMPLETED|Overall Study||28||
48295079|NCT01637623|101050801|FG001|COMPLETED|Overall Study||30||
48295080|NCT01637623|101050802|FG002|COMPLETED|Overall Study||25||
48295081|NCT01637623|101050800|FG000|NOT COMPLETED|Overall Study||1||
48594735|NCT02294175|101789464|FG000|COMPLETED|Overall Study||18||
48594736|NCT02294175|101789465|FG001|COMPLETED|Overall Study||16||
48594737|NCT02294175|101789464|FG000|NOT COMPLETED|Overall Study||5||
48594738|NCT02294175|101789465|FG001|NOT COMPLETED|Overall Study||6||
48594739|NCT02939716|101789466|FG000|STARTED|Overall Study||3||
48711738|NCT00047619|102081641|FG000|COMPLETED|Overall Study||14||
48711739|NCT00047619|102081642|FG001|COMPLETED|Overall Study||14||
48711740|NCT00047619|102081641|FG000|NOT COMPLETED|Overall Study||0||
48711741|NCT00047619|102081642|FG001|NOT COMPLETED|Overall Study||0||
48711742|NCT01545232|102081643|FG000|STARTED|Overall Study||338||
48711743|NCT01545232|102081644|FG001|STARTED|Overall Study||342||
48295082|NCT01637623|101050801|FG001|NOT COMPLETED|Overall Study||0||
48295083|NCT01637623|101050802|FG002|NOT COMPLETED|Overall Study||3||
48295084|NCT00828841|101050803|FG000|STARTED|Overall Study||235||
48295085|NCT00828841|101050804|FG001|STARTED|Overall Study||236||
48295086|NCT00828841|101050805|FG002|STARTED|Overall Study||130||
48404451|NCT02959190|101321855|FG003|COMPLETED|Post Treatment Follow Up||32||
48404452|NCT02959190|101321852|FG000|NOT COMPLETED|Post Treatment Follow Up||3||
48404453|NCT02959190|101321853|FG001|NOT COMPLETED|Post Treatment Follow Up||1||
48295087|NCT00828841|101050803|FG000|COMPLETED|Overall Study||231||
48295088|NCT00828841|101050804|FG001|COMPLETED|Overall Study||232||
48295089|NCT00828841|101050805|FG002|COMPLETED|Overall Study||126||
48295090|NCT00828841|101050803|FG000|NOT COMPLETED|Overall Study||4||
48295091|NCT00828841|101050804|FG001|NOT COMPLETED|Overall Study||4||
48295092|NCT00828841|101050805|FG002|NOT COMPLETED|Overall Study||4||
48295093|NCT01778023|101050806|FG000|STARTED|Overall Study||36||
48295094|NCT01778023|101050807|FG001|STARTED|Overall Study||18||
48295095|NCT01778023|101050806|FG000|Exposed|Overall Study||36||
48295096|NCT01778023|101050807|FG001|Exposed|Overall Study||15||
48295097|NCT01778023|101050806|FG000|COMPLETED|Overall Study||36||
48295098|NCT01778023|101050807|FG001|COMPLETED|Overall Study||15||
48295099|NCT01778023|101050806|FG000|NOT COMPLETED|Overall Study||0||
48295100|NCT01778023|101050807|FG001|NOT COMPLETED|Overall Study||3||
48295101|NCT00724308|101050808|FG000|STARTED|Overall Study||270||
48295102|NCT00724308|101050809|FG001|STARTED|Overall Study||307||
48295103|NCT00724308|101050808|FG000|COMPLETED|Overall Study||190||
48404454|NCT02959190|101321854|FG002|NOT COMPLETED|Post Treatment Follow Up||1||
48404455|NCT02959190|101321855|FG003|NOT COMPLETED|Post Treatment Follow Up||0||
48711744|NCT01545232|102081643|FG000|COMPLETED|Overall Study||338||
48711745|NCT01545232|102081644|FG001|COMPLETED|Overall Study||342||
48711746|NCT01545232|102081643|FG000|NOT COMPLETED|Overall Study||0||
48711747|NCT01545232|102081644|FG001|NOT COMPLETED|Overall Study||0||
48711748|NCT01479595|102081645|FG000|STARTED|Overall Study||44||
48711749|NCT01479595|102081646|FG001|STARTED|Overall Study||21||
48711750|NCT01479595|102081645|FG000|PK Analysis Set|Overall Study||42||
48711751|NCT01479595|102081646|FG001|PK Analysis Set|Overall Study||0||
48711752|NCT01479595|102081645|FG000|Per Protocol Analysis Set|Overall Study||41||
48295104|NCT00724308|101050809|FG001|COMPLETED|Overall Study||210||
48295105|NCT00724308|101050808|FG000|NOT COMPLETED|Overall Study||80||
48295106|NCT00724308|101050809|FG001|NOT COMPLETED|Overall Study||97||
48295107|NCT02169453|101050810|FG000|STARTED|Overall Study||3||
48295108|NCT02169453|101050811|FG001|STARTED|Overall Study||3||
48295109|NCT02169453|101050812|FG002|STARTED|Overall Study||3||
48295110|NCT02169453|101050813|FG003|STARTED|Overall Study||3||
48295111|NCT02169453|101050810|FG000|25 mg BIA 9-1067|Overall Study||3||
48295112|NCT02169453|101050811|FG001|25 mg BIA 9-1067|Overall Study||3||
48295113|NCT02169453|101050812|FG002|25 mg BIA 9-1067|Overall Study||3||
48295114|NCT02169453|101050813|FG003|25 mg BIA 9-1067|Overall Study||3||
48295115|NCT02169453|101050810|FG000|50 mg BIA 9-1067|Overall Study||3||
48295116|NCT02169453|101050811|FG001|50 mg BIA 9-1067|Overall Study||3||
48295117|NCT02169453|101050812|FG002|50 mg BIA 9-1067|Overall Study||2||
48295118|NCT02169453|101050813|FG003|50 mg BIA 9-1067|Overall Study||3||
48295119|NCT02169453|101050810|FG000|100 mg BIA 9-1067|Overall Study||3||
48295120|NCT02169453|101050811|FG001|100 mg BIA 9-1067|Overall Study||3||
48295121|NCT02169453|101050812|FG002|100 mg BIA 9-1067|Overall Study||3||
48295122|NCT02169453|101050813|FG003|100 mg BIA 9-1067|Overall Study||3||
48295123|NCT02169453|101050810|FG000|Placebo|Overall Study||3||
48295124|NCT02169453|101050811|FG001|Placebo|Overall Study||3||
48295125|NCT02169453|101050812|FG002|Placebo|Overall Study||3||
48295126|NCT02169453|101050813|FG003|Placebo|Overall Study||3||
48295127|NCT02169453|101050810|FG000|COMPLETED|Overall Study||3||
48295128|NCT02169453|101050811|FG001|COMPLETED|Overall Study||3||
48295129|NCT02169453|101050812|FG002|COMPLETED|Overall Study||2||
48295130|NCT02169453|101050813|FG003|COMPLETED|Overall Study||3||
48295131|NCT02169453|101050810|FG000|NOT COMPLETED|Overall Study||0||
48295132|NCT02169453|101050811|FG001|NOT COMPLETED|Overall Study||0||
48295133|NCT02169453|101050812|FG002|NOT COMPLETED|Overall Study||1||
48295134|NCT02169453|101050813|FG003|NOT COMPLETED|Overall Study||0||
48295135|NCT00706433|101050814|FG000|STARTED|Overall Study||68||
48295136|NCT00706433|101050815|FG001|STARTED|Overall Study||65||
48295137|NCT00706433|101050816|FG002|STARTED|Overall Study||67||
48295138|NCT00706433|101050817|FG003|STARTED|Overall Study||66||
48295139|NCT00706433|101050814|FG000|COMPLETED|Overall Study||63||
48295140|NCT00706433|101050815|FG001|COMPLETED|Overall Study||62||
48295141|NCT00706433|101050816|FG002|COMPLETED|Overall Study||57||
48295142|NCT00706433|101050817|FG003|COMPLETED|Overall Study||64||
48404456|NCT01098032|101321856|FG000|STARTED|Overall Study||147||
48711753|NCT01479595|102081646|FG001|Per Protocol Analysis Set|Overall Study||20||
48711754|NCT01479595|102081645|FG000|COMPLETED|Overall Study||42||
48594740|NCT02939716|101789467|FG001|STARTED|Overall Study||3||
48594741|NCT02939716|101789468|FG002|STARTED|Overall Study||3||
48594742|NCT02939716|101789469|FG003|STARTED|Overall Study||3||
48594743|NCT02939716|101789470|FG004|STARTED|Overall Study||3||
48594744|NCT02939716|101789471|FG005|STARTED|Overall Study||3||
48594745|NCT02939716|101789466|FG000|COMPLETED|Overall Study||3||
48594746|NCT02939716|101789467|FG001|COMPLETED|Overall Study||3||
48594747|NCT02939716|101789468|FG002|COMPLETED|Overall Study||3||
48594748|NCT02939716|101789469|FG003|COMPLETED|Overall Study||2||
48594749|NCT02939716|101789470|FG004|COMPLETED|Overall Study||2||
48594750|NCT02939716|101789471|FG005|COMPLETED|Overall Study||2||
48594751|NCT02939716|101789466|FG000|NOT COMPLETED|Overall Study||0||
48594752|NCT02939716|101789467|FG001|NOT COMPLETED|Overall Study||0||
48594753|NCT02939716|101789468|FG002|NOT COMPLETED|Overall Study||0||
48594754|NCT02939716|101789469|FG003|NOT COMPLETED|Overall Study||1||
48594755|NCT02939716|101789470|FG004|NOT COMPLETED|Overall Study||1||
48594756|NCT02939716|101789471|FG005|NOT COMPLETED|Overall Study||1||
48594757|NCT01779167|101789472|FG000|STARTED|Overall Study||4||
48594758|NCT01779167|101789472|FG000|COMPLETED|Overall Study||3||
48594759|NCT01779167|101789472|FG000|NOT COMPLETED|Overall Study||1||
48594760|NCT00365209|101789473|FG000|STARTED|Stage 1: Receiving 2g Curcumin||23||
48594761|NCT00365209|101789473|FG000|COMPLETED|Stage 1: Receiving 2g Curcumin||21||
48594762|NCT00365209|101789473|FG000|NOT COMPLETED|Stage 1: Receiving 2g Curcumin||2||
48594763|NCT00365209|101789473|FG000|STARTED|Stage 2: Receiving 4g Curcumin||21||
48594764|NCT00365209|101789473|FG000|COMPLETED|Stage 2: Receiving 4g Curcumin||19||
48594765|NCT00365209|101789473|FG000|NOT COMPLETED|Stage 2: Receiving 4g Curcumin||2||
48594766|NCT02073565|101789474|FG000|STARTED|Intention-To-Treat Subjects-Cohorts AB&C||287||
48594767|NCT02073565|101789475|FG001|STARTED|Intention-To-Treat Subjects-Cohorts AB&C||285||
48594768|NCT02073565|101789474|FG000|COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||285||
48594769|NCT02073565|101789475|FG001|COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||279||
48594770|NCT02073565|101789474|FG000|NOT COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||2||
48594771|NCT02073565|101789475|FG001|NOT COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||6||
48594772|NCT02073565|101789474|FG000|STARTED|Cohort A||16||
48594773|NCT02073565|101789475|FG001|STARTED|Cohort A||14||
48594774|NCT02073565|101789474|FG000|COMPLETED|Cohort A||15||
48594775|NCT02073565|101789475|FG001|COMPLETED|Cohort A||14||
48594776|NCT02073565|101789474|FG000|NOT COMPLETED|Cohort A||1||
48594777|NCT02073565|101789475|FG001|NOT COMPLETED|Cohort A||0||
48594778|NCT02073565|101789474|FG000|STARTED|Cohort B||54||
48594779|NCT02073565|101789475|FG001|STARTED|Cohort B||56||
48295143|NCT00706433|101050814|FG000|NOT COMPLETED|Overall Study||5||
48295144|NCT00706433|101050815|FG001|NOT COMPLETED|Overall Study||3||
48295145|NCT00706433|101050816|FG002|NOT COMPLETED|Overall Study||10||
48295146|NCT00706433|101050817|FG003|NOT COMPLETED|Overall Study||2||
48295147|NCT03740997|101050818|FG000|STARTED|Overall Study||31||
48404457|NCT01098032|101321857|FG001|STARTED|Overall Study||147||
48594780|NCT02073565|101789474|FG000|COMPLETED|Cohort B||53||
48594781|NCT02073565|101789475|FG001|COMPLETED|Cohort B||54||
48594782|NCT02073565|101789474|FG000|NOT COMPLETED|Cohort B||1||
48594783|NCT02073565|101789475|FG001|NOT COMPLETED|Cohort B||2||
48594784|NCT02073565|101789474|FG000|STARTED|Cohort C||217||
48594785|NCT02073565|101789475|FG001|STARTED|Cohort C||215||
48594786|NCT02073565|101789474|FG000|COMPLETED|Cohort C||217||
48594787|NCT02073565|101789475|FG001|COMPLETED|Cohort C||211||
48594788|NCT02073565|101789474|FG000|NOT COMPLETED|Cohort C||0||
48594789|NCT02073565|101789475|FG001|NOT COMPLETED|Cohort C||4||
48594790|NCT00367484|101789476|FG000|STARTED|Overall Study||460||
48594791|NCT00367484|101789476|FG000|COMPLETED|Overall Study||443||
48594792|NCT00367484|101789476|FG000|NOT COMPLETED|Overall Study||17||
48594793|NCT00766467|101789477|FG000|STARTED|Overall Study||42||
48594794|NCT00766467|101789478|FG001|STARTED|Overall Study||39||
48594795|NCT00766467|101789477|FG000|Initiated Treatment|Overall Study||39||
48594796|NCT00766467|101789478|FG001|Initiated Treatment|Overall Study||38||
48594797|NCT00766467|101789477|FG000|COMPLETED|Overall Study||31||
48594798|NCT00766467|101789478|FG001|COMPLETED|Overall Study||31||
48594799|NCT00766467|101789477|FG000|NOT COMPLETED|Overall Study||11||
48594800|NCT00766467|101789478|FG001|NOT COMPLETED|Overall Study||8||
48594801|NCT04493151|101789479|FG000|STARTED|Overall Study||8||
48594802|NCT04493151|101789479|FG000|COMPLETED|Overall Study||7||
48594803|NCT04493151|101789479|FG000|NOT COMPLETED|Overall Study||1||
48295148|NCT03740997|101050819|FG001|STARTED|Overall Study||8||
48295149|NCT03740997|101050818|FG000|Safety Population (Treated)|Overall Study||29|The Safety population consisted of all enrolled participants who received \>=1 dose of OPTISON in the study.|
48295150|NCT03740997|101050819|FG001|Safety Population (Treated)|Overall Study||8|The Safety population consisted of all enrolled participants who received \>=1 dose of OPTISON in the study.|
48404458|NCT01098032|101321856|FG000|COMPLETED|Overall Study||146||
48594804|NCT03646305|101789480|FG000|STARTED|Overall Study||32||
48594805|NCT03646305|101789481|FG001|STARTED|Overall Study||35||
48594806|NCT03646305|101789482|FG002|STARTED|Overall Study||33||
48594807|NCT03646305|101789483|FG003|STARTED|Overall Study||33||
48594808|NCT03646305|101789480|FG000|Received Treatment|Overall Study||31||
48594809|NCT03646305|101789481|FG001|Received Treatment|Overall Study||35||
48594810|NCT03646305|101789482|FG002|Received Treatment|Overall Study||32||
48594811|NCT03646305|101789483|FG003|Received Treatment|Overall Study||32||
48594812|NCT03646305|101789480|FG000|No Treatment Recieved|Overall Study||1||
48594813|NCT03646305|101789481|FG001|No Treatment Recieved|Overall Study||0||
48594814|NCT03646305|101789482|FG002|No Treatment Recieved|Overall Study||1||
48594815|NCT03646305|101789483|FG003|No Treatment Recieved|Overall Study||1||
48594816|NCT03646305|101789480|FG000|COMPLETED|Overall Study||27||
48141739|NCT00251745|100670482|FG002|COMPLETED|Overall Study||277||
48141740|NCT00251745|100670480|FG000|NOT COMPLETED|Overall Study||28||
48141741|NCT00251745|100670481|FG001|NOT COMPLETED|Overall Study||27||
48141742|NCT00251745|100670482|FG002|NOT COMPLETED|Overall Study||27||
48141743|NCT05374421|100670483|FG000|STARTED|Overall Study||8||
48141744|NCT05374421|100670484|FG001|STARTED|Overall Study||7||
48141745|NCT05374421|100670483|FG000|COMPLETED|Overall Study||5||
48141746|NCT05374421|100670484|FG001|COMPLETED|Overall Study||3||
48141747|NCT05374421|100670483|FG000|NOT COMPLETED|Overall Study||3||
48141748|NCT05374421|100670484|FG001|NOT COMPLETED|Overall Study||4||
48141749|NCT03595904|100673389|FG000|STARTED|Overall Study||39||
48141750|NCT03595904|100673390|FG001|STARTED|Overall Study||39||
48141751|NCT03595904|100673389|FG000|COMPLETED|Overall Study||29||
48141752|NCT03595904|100673390|FG001|COMPLETED|Overall Study||34||
48141753|NCT03595904|100673389|FG000|NOT COMPLETED|Overall Study||10||
48141754|NCT03595904|100673390|FG001|NOT COMPLETED|Overall Study||5||
48141755|NCT02526693|100673391|FG000|STARTED|Overall Study||53||
48141756|NCT02526693|100673392|FG001|STARTED|Overall Study||51||
48141757|NCT02526693|100673391|FG000|COMPLETED|Overall Study||50||
48141758|NCT02526693|100673392|FG001|COMPLETED|Overall Study||50||
48141759|NCT02526693|100673391|FG000|NOT COMPLETED|Overall Study||3||
48141760|NCT02526693|100673392|FG001|NOT COMPLETED|Overall Study||1||
48141761|NCT00989287|100673393|FG000|STARTED|Overall Study||65||
48141762|NCT00989287|100673394|FG001|STARTED|Overall Study||66||
48141763|NCT00989287|100673393|FG000|COMPLETED|Overall Study||64||
48141764|NCT00989287|100673394|FG001|COMPLETED|Overall Study||65||
48141765|NCT00989287|100673393|FG000|NOT COMPLETED|Overall Study||1||
48141766|NCT00989287|100673394|FG001|NOT COMPLETED|Overall Study||1||
48141767|NCT00983073|100673395|FG000|STARTED|Observation Period||224||
48141768|NCT00983073|100673395|FG000|COMPLETED|Observation Period||200||
48141769|NCT00983073|100673395|FG000|NOT COMPLETED|Observation Period||24||
48141770|NCT00983073|100673395|FG000|STARTED|Titration and Optimal Dose Period||200||
48141771|NCT00983073|100673395|FG000|COMPLETED|Titration and Optimal Dose Period||160||
48141772|NCT00983073|100673395|FG000|NOT COMPLETED|Titration and Optimal Dose Period||40||
48141773|NCT00983073|100673395|FG000|STARTED|Maintenance Period||160||
48141774|NCT00983073|100673395|FG000|COMPLETED|Maintenance Period||144||
48141775|NCT00983073|100673395|FG000|NOT COMPLETED|Maintenance Period||16||
48141776|NCT02430194|100673396|FG000|STARTED|Overall Study||4||
48141777|NCT02430194|100673397|FG001|STARTED|Overall Study||4||
48141778|NCT02430194|100673398|FG002|STARTED|Overall Study||5||
48141779|NCT02430194|100673399|FG003|STARTED|Overall Study||3||
48141780|NCT02430194|100673400|FG004|STARTED|Overall Study||3||
48141781|NCT02430194|100673401|FG005|STARTED|Overall Study||6||
48141782|NCT02430194|100673402|FG006|STARTED|Overall Study||13||
48141783|NCT02430194|100673403|FG007|STARTED|Overall Study||5||
48141784|NCT02430194|100673404|FG008|STARTED|Overall Study||7||
48141785|NCT02430194|100673405|FG009|STARTED|Overall Study||5||
48141786|NCT02430194|100673396|FG000|COMPLETED|Overall Study||3||
48141787|NCT02430194|100673397|FG001|COMPLETED|Overall Study||3||
48141788|NCT02430194|100673398|FG002|COMPLETED|Overall Study||3||
48141789|NCT02430194|100673399|FG003|COMPLETED|Overall Study||3||
48141790|NCT02430194|100673400|FG004|COMPLETED|Overall Study||3||
48141791|NCT02430194|100673401|FG005|COMPLETED|Overall Study||6||
48594817|NCT03646305|101789481|FG001|COMPLETED|Overall Study||33||
48141792|NCT02430194|100673402|FG006|COMPLETED|Overall Study||11||
48141793|NCT02430194|100673403|FG007|COMPLETED|Overall Study||4||
48141794|NCT02430194|100673404|FG008|COMPLETED|Overall Study||3||
48141795|NCT02430194|100673405|FG009|COMPLETED|Overall Study||5||
48594818|NCT03646305|101789482|FG002|COMPLETED|Overall Study||31||
48594819|NCT03646305|101789483|FG003|COMPLETED|Overall Study||31||
48141796|NCT02430194|100673396|FG000|NOT COMPLETED|Overall Study||1||
48404459|NCT01098032|101321857|FG001|COMPLETED|Overall Study||146||
48404460|NCT01098032|101321856|FG000|NOT COMPLETED|Overall Study||1||
48711755|NCT01479595|102081646|FG001|COMPLETED|Overall Study||19||
48711756|NCT01479595|102081645|FG000|NOT COMPLETED|Overall Study||2||
48141797|NCT02430194|100673397|FG001|NOT COMPLETED|Overall Study||1||
48141798|NCT02430194|100673398|FG002|NOT COMPLETED|Overall Study||2||
48141799|NCT02430194|100673399|FG003|NOT COMPLETED|Overall Study||0||
48141800|NCT02430194|100673400|FG004|NOT COMPLETED|Overall Study||0||
48141801|NCT02430194|100673401|FG005|NOT COMPLETED|Overall Study||0||
48141802|NCT02430194|100673402|FG006|NOT COMPLETED|Overall Study||2||
48141803|NCT02430194|100673403|FG007|NOT COMPLETED|Overall Study||1||
48141804|NCT02430194|100673404|FG008|NOT COMPLETED|Overall Study||4||
48141805|NCT02430194|100673405|FG009|NOT COMPLETED|Overall Study||0||
48141806|NCT02891187|100673406|FG000|STARTED|Overall Study||51||
48141807|NCT02891187|100673407|FG001|STARTED|Overall Study||52||
48141808|NCT02891187|100673406|FG000|COMPLETED|Overall Study||50||
48141809|NCT02891187|100673407|FG001|COMPLETED|Overall Study||50||
48404461|NCT01098032|101321857|FG001|NOT COMPLETED|Overall Study||1||
48404462|NCT02108223|101321858|FG000|STARTED|Overall Study||52||
48404463|NCT02108223|101321859|FG001|STARTED|Overall Study||50||
48295151|NCT03740997|101050818|FG000|Per-protocol (PP) Population|Overall Study||23|The PP population consisted of all participants who had available non-contrast harmonic images and OPTISON-enhanced echocardiographic images, irrespective of the quality of contrast-enhanced (CE)-echo and who did not have an important protocol deviation impacting the study primary endpoint.|
48295152|NCT03740997|101050819|FG001|Per-protocol (PP) Population|Overall Study||7|The PP population consisted of all participants who had available non-contrast harmonic images and OPTISON-enhanced echocardiographic images, irrespective of the quality of contrast-enhanced (CE)-echo and who did not have an important protocol deviation impacting the study primary endpoint.|
48295153|NCT03740997|101050818|FG000|COMPLETED|Overall Study||29||
48295154|NCT03740997|101050819|FG001|COMPLETED|Overall Study||8||
48404464|NCT02108223|101321860|FG002|STARTED|Overall Study||35||
48711757|NCT01479595|102081646|FG001|NOT COMPLETED|Overall Study||2||
48141810|NCT02891187|100673406|FG000|NOT COMPLETED|Overall Study||1||
48141811|NCT02891187|100673407|FG001|NOT COMPLETED|Overall Study||2||
48141812|NCT03996473|100673408|FG000|STARTED|Treatment Assignment||8||
48141813|NCT03996473|100673408|FG000|COMPLETED|Treatment Assignment||0||
48141814|NCT03996473|100673408|FG000|NOT COMPLETED|Treatment Assignment||8||
48141815|NCT03996473|100673408|FG000|STARTED|Active Follow-up||1||
48141816|NCT03996473|100673408|FG000|COMPLETED|Active Follow-up||0||
48141817|NCT03996473|100673408|FG000|NOT COMPLETED|Active Follow-up||1||
48141818|NCT03996473|100673408|FG000|STARTED|Long-term Follow-up||6||
48141819|NCT03996473|100673408|FG000|COMPLETED|Long-term Follow-up||1||
48141820|NCT03996473|100673408|FG000|NOT COMPLETED|Long-term Follow-up||5||
48141821|NCT04575467|100673409|FG000|STARTED|Overall Study||6||
48141822|NCT04575467|100673410|FG001|STARTED|Overall Study||7||
48141823|NCT04575467|100673411|FG002|STARTED|Overall Study||6||
48141824|NCT04575467|100673412|FG003|STARTED|Overall Study||6||
48141825|NCT04575467|100673409|FG000|COMPLETED|Overall Study||6||
48141826|NCT04575467|100673410|FG001|COMPLETED|Overall Study||6||
48711758|NCT01463111|102081647|FG000|STARTED|Overall Study||26||
48711759|NCT01463111|102081647|FG000|COMPLETED|Overall Study||17||
48711760|NCT01463111|102081647|FG000|NOT COMPLETED|Overall Study||9||
48711761|NCT03344640|102081648|FG000|STARTED|Overall Study||49||
48711762|NCT03344640|102081649|FG001|STARTED|Overall Study||47||
48711763|NCT03344640|102081648|FG000|COMPLETED|Overall Study||46||
48711764|NCT03344640|102081649|FG001|COMPLETED|Overall Study||44||
48711765|NCT03344640|102081648|FG000|NOT COMPLETED|Overall Study||3||
48711766|NCT03344640|102081649|FG001|NOT COMPLETED|Overall Study||3||
48711767|NCT03344640|102081648|FG000|STARTED|Follow-up Epoch||46||
48711768|NCT03344640|102081649|FG001|STARTED|Follow-up Epoch||44||
48711769|NCT03344640|102081648|FG000|COMPLETED|Follow-up Epoch||46||
48711770|NCT03344640|102081649|FG001|COMPLETED|Follow-up Epoch||42||
48711771|NCT03344640|102081648|FG000|NOT COMPLETED|Follow-up Epoch||0||
48711772|NCT03344640|102081649|FG001|NOT COMPLETED|Follow-up Epoch||2||
48711773|NCT00598078|102081650|FG000|STARTED|Period 1 (Day 1)||10||
48711774|NCT00598078|102081651|FG001|STARTED|Period 1 (Day 1)||10||
48711775|NCT00598078|102081650|FG000|COMPLETED|Period 1 (Day 1)||10||
48711776|NCT00598078|102081651|FG001|COMPLETED|Period 1 (Day 1)||10||
48711777|NCT00598078|102081650|FG000|NOT COMPLETED|Period 1 (Day 1)||0||
48711778|NCT00598078|102081651|FG001|NOT COMPLETED|Period 1 (Day 1)||0||
48141827|NCT04575467|100673411|FG002|COMPLETED|Overall Study||6||
48141828|NCT04575467|100673412|FG003|COMPLETED|Overall Study||6||
48141829|NCT04575467|100673409|FG000|NOT COMPLETED|Overall Study||0||
48141830|NCT04575467|100673410|FG001|NOT COMPLETED|Overall Study||1||
48141831|NCT04575467|100673411|FG002|NOT COMPLETED|Overall Study||0||
48141832|NCT04575467|100673412|FG003|NOT COMPLETED|Overall Study||0||
48141833|NCT03117738|100673413|FG000|STARTED|Overall Study||11||
48141834|NCT03117738|100673414|FG001|STARTED|Overall Study||10||
48141835|NCT03117738|100673413|FG000|COMPLETED|Overall Study||7||
48295155|NCT03740997|101050818|FG000|NOT COMPLETED|Overall Study||2||
48295156|NCT03740997|101050819|FG001|NOT COMPLETED|Overall Study||0||
48711779|NCT00598078|102081650|FG000|STARTED|Period 2 (Day 2)||10||
48711780|NCT00598078|102081651|FG001|STARTED|Period 2 (Day 2)||10||
48404465|NCT02108223|101321858|FG000|COMPLETED|Overall Study||52||
48404466|NCT02108223|101321859|FG001|COMPLETED|Overall Study||50||
48404467|NCT02108223|101321860|FG002|COMPLETED|Overall Study||35||
48711781|NCT00598078|102081650|FG000|COMPLETED|Period 2 (Day 2)||9||
48711782|NCT00598078|102081651|FG001|COMPLETED|Period 2 (Day 2)||10||
48141836|NCT03117738|100673414|FG001|COMPLETED|Overall Study||5||
48141837|NCT03117738|100673413|FG000|NOT COMPLETED|Overall Study||4||
48141838|NCT03117738|100673414|FG001|NOT COMPLETED|Overall Study||5||
48141839|NCT02804594|100673415|FG000|STARTED|Overall Study||10||
48141840|NCT02804594|100673416|FG001|STARTED|Overall Study||5||
48141841|NCT02804594|100673415|FG000|COMPLETED|Overall Study||10||
48711783|NCT00598078|102081650|FG000|NOT COMPLETED|Period 2 (Day 2)||1||
48711784|NCT00598078|102081651|FG001|NOT COMPLETED|Period 2 (Day 2)||0||
48711785|NCT00598078|102081650|FG000|STARTED|Period 3 (Day 3)||9||
48711786|NCT00598078|102081651|FG001|STARTED|Period 3 (Day 3)||10||
48711787|NCT00598078|102081650|FG000|COMPLETED|Period 3 (Day 3)||9||
48711788|NCT00598078|102081651|FG001|COMPLETED|Period 3 (Day 3)||10||
48711789|NCT00598078|102081650|FG000|NOT COMPLETED|Period 3 (Day 3)||0||
48141842|NCT02804594|100673416|FG001|COMPLETED|Overall Study||5||
48141843|NCT02804594|100673415|FG000|NOT COMPLETED|Overall Study||0||
48141844|NCT02804594|100673416|FG001|NOT COMPLETED|Overall Study||0||
48141845|NCT00205348|100673417|FG000|STARTED|Overall Study||146||
48141846|NCT00205348|100673417|FG000|COMPLETED|Overall Study||116||
48141847|NCT00205348|100673417|FG000|NOT COMPLETED|Overall Study||30||
48141848|NCT04988308|100673418|FG000|STARTED|Placebo Controlled Period (Weeks 0-16)||50||
48711790|NCT00598078|102081651|FG001|NOT COMPLETED|Period 3 (Day 3)||0||
48404468|NCT02108223|101321858|FG000|NOT COMPLETED|Overall Study||0||
48711791|NCT00545532|102081652|FG000|STARTED|Overall Study||105||
48711792|NCT00545532|102081653|FG001|STARTED|Overall Study||110||
48404469|NCT02108223|101321859|FG001|NOT COMPLETED|Overall Study||0||
48404470|NCT02108223|101321860|FG002|NOT COMPLETED|Overall Study||0||
48141849|NCT04988308|100673419|FG001|STARTED|Placebo Controlled Period (Weeks 0-16)||51||
48404471|NCT01135394|101321861|FG000|STARTED|Screening||114||
48404472|NCT01135394|101321861|FG000|COMPLETED|Screening||81||
48711793|NCT00545532|102081652|FG000|COMPLETED|Overall Study||99||
48711794|NCT00545532|102081653|FG001|COMPLETED|Overall Study||100||
48711795|NCT00545532|102081652|FG000|NOT COMPLETED|Overall Study||6||
48711796|NCT00545532|102081653|FG001|NOT COMPLETED|Overall Study||10||
48711797|NCT00900146|102081654|FG000|STARTED|Dose Finding: Period II (4 Months)||93||
48711798|NCT00900146|102081655|FG001|STARTED|Dose Finding: Period II (4 Months)||95||
48711799|NCT00900146|102081656|FG002|STARTED|Dose Finding: Period II (4 Months)||92||
48711800|NCT00900146|102081657|FG003|STARTED|Dose Finding: Period II (4 Months)||92||
48711801|NCT00900146|102081658|FG004|STARTED|Dose Finding: Period II (4 Months)||179||
48711802|NCT00900146|102081654|FG000|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||93||
48711803|NCT00900146|102081655|FG001|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||95||
48711804|NCT00900146|102081656|FG002|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92||
48711805|NCT00900146|102081657|FG003|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92||
48404473|NCT01135394|101321861|FG000|NOT COMPLETED|Screening||33||
48404474|NCT01135394|101321861|FG000|STARTED|Baseline Assessment||81||
48404475|NCT01135394|101321861|FG000|COMPLETED|Baseline Assessment||66||
48404476|NCT01135394|101321861|FG000|NOT COMPLETED|Baseline Assessment||15||
48404477|NCT01135394|101321861|FG000|STARTED|Study Treatment||66||
48404478|NCT01135394|101321861|FG000|COMPLETED|Study Treatment||62||
48404479|NCT01135394|101321861|FG000|NOT COMPLETED|Study Treatment||4||
48404480|NCT03807778|101321862|FG000|STARTED|Overall Study||4||
48404481|NCT03807778|101321863|FG001|STARTED|Overall Study||4||
48404482|NCT03807778|101321864|FG002|STARTED|Overall Study||12||
48404483|NCT03807778|101321865|FG003|STARTED|Overall Study||33||
48404484|NCT03807778|101321862|FG000|COMPLETED|Overall Study||0||
48404485|NCT03807778|101321863|FG001|COMPLETED|Overall Study||0||
48404486|NCT03807778|101321864|FG002|COMPLETED|Overall Study||0||
48404487|NCT03807778|101321865|FG003|COMPLETED|Overall Study||0||
48404488|NCT03807778|101321862|FG000|NOT COMPLETED|Overall Study||4||
48594820|NCT03646305|101789480|FG000|NOT COMPLETED|Overall Study||5||
48594821|NCT03646305|101789481|FG001|NOT COMPLETED|Overall Study||2||
48594822|NCT03646305|101789482|FG002|NOT COMPLETED|Overall Study||2||
48594823|NCT03646305|101789483|FG003|NOT COMPLETED|Overall Study||2||
48594824|NCT03672461|101789484|FG000|STARTED|Overall Study||121||
48594825|NCT03672461|101789485|FG001|STARTED|Overall Study||119||
48594826|NCT03672461|101789484|FG000|COMPLETED|Overall Study||101||
48594827|NCT03672461|101789485|FG001|COMPLETED|Overall Study||109||
48594828|NCT03672461|101789484|FG000|NOT COMPLETED|Overall Study||20||
48594829|NCT03672461|101789485|FG001|NOT COMPLETED|Overall Study||10||
48594830|NCT02865590|101789486|FG000|STARTED|Overall Study||8||
48594831|NCT02865590|101789487|FG001|STARTED|Overall Study||8||
48594832|NCT02865590|101789486|FG000|COMPLETED|Overall Study||8||
48594833|NCT02865590|101789487|FG001|COMPLETED|Overall Study||8||
48594834|NCT02865590|101789486|FG000|NOT COMPLETED|Overall Study||0||
48404489|NCT03807778|101321863|FG001|NOT COMPLETED|Overall Study||4||
48711806|NCT00900146|102081658|FG004|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||179||
48711807|NCT00900146|102081654|FG000|COMPLETED|Dose Finding: Period II (4 Months)||88||
48404490|NCT03807778|101321864|FG002|NOT COMPLETED|Overall Study||12||
48404491|NCT03807778|101321865|FG003|NOT COMPLETED|Overall Study||33||
48404492|NCT02327078|101321866|FG000|STARTED|Overall Study||3||
48594835|NCT02865590|101789487|FG001|NOT COMPLETED|Overall Study||0||
48594836|NCT00844480|101789488|FG000|STARTED|Overall Study||8||
48594837|NCT00844480|101789489|FG001|STARTED|Overall Study||9||
48594838|NCT00844480|101789488|FG000|COMPLETED|Overall Study||6||
48711808|NCT00900146|102081655|FG001|COMPLETED|Dose Finding: Period II (4 Months)||93||
48711809|NCT00900146|102081656|FG002|COMPLETED|Dose Finding: Period II (4 Months)||87||
48711810|NCT00900146|102081657|FG003|COMPLETED|Dose Finding: Period II (4 Months)||90||
48711811|NCT00900146|102081658|FG004|COMPLETED|Dose Finding: Period II (4 Months)||167||
48711812|NCT00900146|102081654|FG000|NOT COMPLETED|Dose Finding: Period II (4 Months)||5||
48711813|NCT00900146|102081655|FG001|NOT COMPLETED|Dose Finding: Period II (4 Months)||2||
48711814|NCT00900146|102081656|FG002|NOT COMPLETED|Dose Finding: Period II (4 Months)||5||
48711815|NCT00900146|102081657|FG003|NOT COMPLETED|Dose Finding: Period II (4 Months)||2||
48711816|NCT00900146|102081658|FG004|NOT COMPLETED|Dose Finding: Period II (4 Months)||12||
48711817|NCT00900146|102081654|FG000|STARTED|Intermediate: Period III||87||
48711818|NCT00900146|102081655|FG001|STARTED|Intermediate: Period III||93||
48711819|NCT00900146|102081656|FG002|STARTED|Intermediate: Period III||84||
48711820|NCT00900146|102081657|FG003|STARTED|Intermediate: Period III||90||
48711821|NCT00900146|102081658|FG004|STARTED|Intermediate: Period III||167||
48711822|NCT00900146|102081654|FG000|Safety Set|Intermediate: Period III||86||
48711823|NCT00900146|102081655|FG001|Safety Set|Intermediate: Period III||92||
48711824|NCT00900146|102081656|FG002|Safety Set|Intermediate: Period III||84||
48711825|NCT00900146|102081657|FG003|Safety Set|Intermediate: Period III||90||
48711826|NCT00900146|102081658|FG004|Safety Set|Intermediate: Period III||166||
48711827|NCT00900146|102081654|FG000|COMPLETED|Intermediate: Period III||0||
48711828|NCT00900146|102081655|FG001|COMPLETED|Intermediate: Period III||0||
48711829|NCT00900146|102081656|FG002|COMPLETED|Intermediate: Period III||0||
48711830|NCT00900146|102081657|FG003|COMPLETED|Intermediate: Period III||0||
48711831|NCT00900146|102081658|FG004|COMPLETED|Intermediate: Period III||0||
48711832|NCT00900146|102081654|FG000|NOT COMPLETED|Intermediate: Period III||87||
48711833|NCT00900146|102081655|FG001|NOT COMPLETED|Intermediate: Period III||93||
48711834|NCT00900146|102081656|FG002|NOT COMPLETED|Intermediate: Period III||84||
48594839|NCT00844480|101789489|FG001|COMPLETED|Overall Study||6||
48594840|NCT00844480|101789488|FG000|NOT COMPLETED|Overall Study||2||
48594841|NCT00844480|101789489|FG001|NOT COMPLETED|Overall Study||3||
48594842|NCT00725101|101789490|FG000|STARTED|Overall Study||1700||
48594843|NCT00725101|101789490|FG000|COMPLETED|Overall Study||1205||
48594844|NCT00725101|101789490|FG000|NOT COMPLETED|Overall Study||495||
48594845|NCT03325894|101789491|FG000|STARTED|Overall Study||64||
48594846|NCT03325894|101789492|FG001|STARTED|Overall Study||77||
48594847|NCT03325894|101789491|FG000|COMPLETED|Overall Study||0||
48594848|NCT03325894|101789492|FG001|COMPLETED|Overall Study||0||
48594849|NCT03325894|101789491|FG000|NOT COMPLETED|Overall Study||64||
48594850|NCT03325894|101789492|FG001|NOT COMPLETED|Overall Study||77||
48594851|NCT02984267|101789493|FG000|STARTED|Overall Study||8||
48594852|NCT02984267|101789494|FG001|STARTED|Overall Study||10||
48594853|NCT02984267|101789493|FG000|COMPLETED|Overall Study||7||
48594854|NCT02984267|101789494|FG001|COMPLETED|Overall Study||9||
48594855|NCT02984267|101789493|FG000|NOT COMPLETED|Overall Study||1||
48594856|NCT02984267|101789494|FG001|NOT COMPLETED|Overall Study||1||
48594857|NCT01327313|101789495|FG000|STARTED|Overall Study||8||
48594858|NCT01327313|101789496|FG001|STARTED|Overall Study||6||
48594859|NCT01327313|101789497|FG002|STARTED|Overall Study||6||
48594860|NCT01327313|101789498|FG003|STARTED|Overall Study||7||
48594861|NCT01327313|101789495|FG000|COMPLETED|Overall Study||8||
48711835|NCT00900146|102081657|FG003|NOT COMPLETED|Intermediate: Period III||90||
48711836|NCT00900146|102081658|FG004|NOT COMPLETED|Intermediate: Period III||167||
48711837|NCT01794741|102081659|FG000|STARTED|Overall Study||304||
48711838|NCT01794741|102081660|FG001|STARTED|Overall Study||101||
48594862|NCT01327313|101789496|FG001|COMPLETED|Overall Study||6||
48594863|NCT01327313|101789497|FG002|COMPLETED|Overall Study||6||
48594864|NCT01327313|101789498|FG003|COMPLETED|Overall Study||7||
48594865|NCT01327313|101789495|FG000|NOT COMPLETED|Overall Study||0||
48594866|NCT01327313|101789496|FG001|NOT COMPLETED|Overall Study||0||
48594867|NCT01327313|101789497|FG002|NOT COMPLETED|Overall Study||0||
48711839|NCT01794741|102081659|FG000|COMPLETED|Overall Study||285||
48711840|NCT01794741|102081660|FG001|COMPLETED|Overall Study||92||
48711841|NCT01794741|102081659|FG000|NOT COMPLETED|Overall Study||19||
48711842|NCT01794741|102081660|FG001|NOT COMPLETED|Overall Study||9||
48711843|NCT01344538|102081661|FG000|STARTED|Overall Study||16||
48594868|NCT01327313|101789498|FG003|NOT COMPLETED|Overall Study||0||
48594869|NCT01371877|101789499|FG000|STARTED|Overall Study||21||
48594870|NCT01371877|101789500|FG001|STARTED|Overall Study||21||
48594871|NCT01371877|101789499|FG000|COMPLETED|Overall Study||21||
48594872|NCT01371877|101789500|FG001|COMPLETED|Overall Study||17||
48711844|NCT01344538|102081662|FG001|STARTED|Overall Study||17||
48711845|NCT01344538|102081661|FG000|COMPLETED|Overall Study||14||
48711846|NCT01344538|102081662|FG001|COMPLETED|Overall Study||16||
48711847|NCT01344538|102081661|FG000|NOT COMPLETED|Overall Study||2||
48711848|NCT01344538|102081662|FG001|NOT COMPLETED|Overall Study||1||
48711849|NCT01561755|102081663|FG000|STARTED|Overall Study||6||
48711850|NCT01561755|102081664|FG001|STARTED|Overall Study||6||
48711851|NCT01561755|102081663|FG000|COMPLETED|Overall Study||6||
48711852|NCT01561755|102081664|FG001|COMPLETED|Overall Study||5||
48711853|NCT01561755|102081663|FG000|NOT COMPLETED|Overall Study||0||
48711854|NCT01561755|102081664|FG001|NOT COMPLETED|Overall Study||1||
48711855|NCT01256281|102081665|FG000|STARTED|Overall Study||2||
48711856|NCT01256281|102081665|FG000|COMPLETED|Overall Study||2||
48711857|NCT01256281|102081665|FG000|NOT COMPLETED|Overall Study||0||
48711858|NCT02312219|102081666|FG000|STARTED|Overall Study||13||
48711859|NCT02312219|102081667|FG001|STARTED|Overall Study||22||
48711860|NCT02312219|102081666|FG000|COMPLETED|Overall Study||12||
48711861|NCT02312219|102081667|FG001|COMPLETED|Overall Study||16||
48711862|NCT02312219|102081666|FG000|NOT COMPLETED|Overall Study||1||
48711863|NCT02312219|102081667|FG001|NOT COMPLETED|Overall Study||6||
48594873|NCT01371877|101789499|FG000|NOT COMPLETED|Overall Study||0||
48594874|NCT01371877|101789500|FG001|NOT COMPLETED|Overall Study||4||
48594875|NCT01801241|101789501|FG000|STARTED|Overall Study||29||
48594876|NCT01801241|101789502|FG001|STARTED|Overall Study||27||
48594877|NCT01801241|101789501|FG000|COMPLETED|Overall Study||21||
48594878|NCT01801241|101789502|FG001|COMPLETED|Overall Study||25||
48711864|NCT00320255|102081668|FG000|STARTED|Overall Study||30||
48711865|NCT00320255|102081669|FG001|STARTED|Overall Study||32||
48594879|NCT01801241|101789501|FG000|NOT COMPLETED|Overall Study||8||
48594880|NCT01801241|101789502|FG001|NOT COMPLETED|Overall Study||2||
48594881|NCT03673501|101789503|FG000|STARTED|Overall Study||226||
48594882|NCT03673501|101789504|FG001|STARTED|Overall Study||227||
48404493|NCT02327078|101321867|FG001|STARTED|Overall Study||6||
48594883|NCT03673501|101789503|FG000|COMPLETED|Overall Study||190|Completed patients are defined as patients that are followed until death or until the sponsor terminates the study.|
48594884|NCT03673501|101789504|FG001|COMPLETED|Overall Study||203|Completed patients are defined as patients that are followed until death or until the sponsor terminates the study.|
48594885|NCT03673501|101789503|FG000|NOT COMPLETED|Overall Study||36||
48594886|NCT03673501|101789504|FG001|NOT COMPLETED|Overall Study||24||
48594887|NCT03408444|101789505|FG000|STARTED|Overall Study||50||
48295157|NCT02502097|101050820|FG000|STARTED|Period 1||4||
48295158|NCT02502097|101050821|FG001|STARTED|Period 1||3||
48295159|NCT02502097|101050822|FG002|STARTED|Period 1||22||
48295160|NCT02502097|101050823|FG003|STARTED|Period 1||22||
48295161|NCT02502097|101050820|FG000|COMPLETED|Period 1||4||
48295162|NCT02502097|101050821|FG001|COMPLETED|Period 1||3||
48404494|NCT02327078|101321868|FG002|STARTED|Overall Study||14||
48711866|NCT00320255|102081670|FG002|STARTED|Overall Study||30||
48711867|NCT00320255|102081671|FG003|STARTED|Overall Study||33||
48711868|NCT00320255|102081672|FG004|STARTED|Overall Study||2||
48711869|NCT00320255|102081673|FG005|STARTED|Overall Study||3||
48711870|NCT00320255|102081668|FG000|Received Treatment|Overall Study||29||
48711871|NCT00320255|102081669|FG001|Received Treatment|Overall Study||32||
48711872|NCT00320255|102081670|FG002|Received Treatment|Overall Study||29||
48711873|NCT00320255|102081671|FG003|Received Treatment|Overall Study||32||
48711874|NCT00320255|102081672|FG004|Received Treatment|Overall Study||2||
48711875|NCT00320255|102081673|FG005|Received Treatment|Overall Study||3||
48711876|NCT00320255|102081668|FG000|COMPLETED|Overall Study||19||
48711877|NCT00320255|102081669|FG001|COMPLETED|Overall Study||25||
48711878|NCT00320255|102081670|FG002|COMPLETED|Overall Study||24||
48711879|NCT00320255|102081671|FG003|COMPLETED|Overall Study||25||
48711880|NCT00320255|102081672|FG004|COMPLETED|Overall Study||2||
48711881|NCT00320255|102081673|FG005|COMPLETED|Overall Study||3||
48711882|NCT00320255|102081668|FG000|NOT COMPLETED|Overall Study||11||
48711883|NCT00320255|102081669|FG001|NOT COMPLETED|Overall Study||7||
48711884|NCT00320255|102081670|FG002|NOT COMPLETED|Overall Study||6||
48711885|NCT00320255|102081671|FG003|NOT COMPLETED|Overall Study||8||
48711886|NCT00320255|102081672|FG004|NOT COMPLETED|Overall Study||0||
48711887|NCT00320255|102081673|FG005|NOT COMPLETED|Overall Study||0||
48711888|NCT00590824|102081674|FG000|STARTED|Overall Study||11||
48711889|NCT00590824|102081675|FG001|STARTED|Overall Study||9||
48711890|NCT00590824|102081676|FG002|STARTED|Overall Study||2||
48711891|NCT00590824|102081677|FG003|STARTED|Overall Study||1||
48711892|NCT00590824|102081674|FG000|COMPLETED|Overall Study||11||
48711893|NCT00590824|102081675|FG001|COMPLETED|Overall Study||7||
48711894|NCT00590824|102081676|FG002|COMPLETED|Overall Study||1||
48711895|NCT00590824|102081677|FG003|COMPLETED|Overall Study||0||
48711896|NCT00590824|102081674|FG000|NOT COMPLETED|Overall Study||0||
48711897|NCT00590824|102081675|FG001|NOT COMPLETED|Overall Study||2||
48711898|NCT00590824|102081676|FG002|NOT COMPLETED|Overall Study||1||
48711899|NCT00590824|102081677|FG003|NOT COMPLETED|Overall Study||1||
48711900|NCT00628589|102081678|FG000|STARTED|Overall Study||115||
48711901|NCT00628589|102081679|FG001|STARTED|Overall Study||116||
48711902|NCT00628589|102081680|FG002|STARTED|Overall Study||113||
48711903|NCT00628589|102081678|FG000|COMPLETED|Overall Study||114||
48711904|NCT00628589|102081679|FG001|COMPLETED|Overall Study||114||
48711905|NCT00628589|102081680|FG002|COMPLETED|Overall Study||110||
48711906|NCT00628589|102081678|FG000|NOT COMPLETED|Overall Study||1||
48711907|NCT00628589|102081679|FG001|NOT COMPLETED|Overall Study||2||
48711908|NCT00628589|102081680|FG002|NOT COMPLETED|Overall Study||3||
48711909|NCT00934947|102081681|FG000|STARTED|Overall Study||23||
48711910|NCT00934947|102081682|FG001|STARTED|Overall Study||22||
48711911|NCT00934947|102081681|FG000|COMPLETED|Overall Study||23||
48711912|NCT00934947|102081682|FG001|COMPLETED|Overall Study||20||
48711913|NCT00934947|102081681|FG000|NOT COMPLETED|Overall Study||0||
48711914|NCT00934947|102081682|FG001|NOT COMPLETED|Overall Study||2||
48711915|NCT03002818|102081683|FG000|STARTED|Overall Study||41|eligible participants who received 3D regimen at least once|
48711916|NCT03002818|102081683|FG000|COMPLETED|Overall Study||40||
48711917|NCT03002818|102081683|FG000|NOT COMPLETED|Overall Study||1||
48711918|NCT02142283|102081684|FG000|STARTED|Overall Study||107||
48711919|NCT02142283|102081685|FG001|STARTED|Overall Study||99||
48711920|NCT02142283|102081684|FG000|COMPLETED|Overall Study||86||
48711921|NCT02142283|102081685|FG001|COMPLETED|Overall Study||78||
48711922|NCT02142283|102081684|FG000|NOT COMPLETED|Overall Study||21||
48711923|NCT02142283|102081685|FG001|NOT COMPLETED|Overall Study||21||
48711924|NCT01996592|102081686|FG000|STARTED|Overall Study||575||
48711925|NCT01996592|102081686|FG000|COMPLETED|Overall Study||530||
48711926|NCT01996592|102081686|FG000|NOT COMPLETED|Overall Study||45||
48711927|NCT02470754|102081687|FG000|STARTED|Overall Study||19||
48295163|NCT02502097|101050822|FG002|COMPLETED|Period 1||21||
48295164|NCT02502097|101050823|FG003|COMPLETED|Period 1||22||
48295165|NCT02502097|101050820|FG000|NOT COMPLETED|Period 1||0||
48295166|NCT02502097|101050821|FG001|NOT COMPLETED|Period 1||0||
48295167|NCT02502097|101050822|FG002|NOT COMPLETED|Period 1||1||
48295168|NCT02502097|101050823|FG003|NOT COMPLETED|Period 1||0||
48295169|NCT02502097|101050820|FG000|STARTED|Wash Out Period||4||
48295170|NCT02502097|101050821|FG001|STARTED|Wash Out Period||3||
48295171|NCT02502097|101050822|FG002|STARTED|Wash Out Period||21||
48295172|NCT02502097|101050823|FG003|STARTED|Wash Out Period||22||
48295173|NCT02502097|101050820|FG000|COMPLETED|Wash Out Period||4||
48295174|NCT02502097|101050821|FG001|COMPLETED|Wash Out Period||2||
48711928|NCT02470754|102081688|FG001|STARTED|Overall Study||19||
48711929|NCT02470754|102081687|FG000|COMPLETED|Overall Study||17||
48711930|NCT02470754|102081688|FG001|COMPLETED|Overall Study||19||
48295175|NCT02502097|101050822|FG002|COMPLETED|Wash Out Period||20||
48295176|NCT02502097|101050823|FG003|COMPLETED|Wash Out Period||21||
48295177|NCT02502097|101050820|FG000|NOT COMPLETED|Wash Out Period||0||
48295178|NCT02502097|101050821|FG001|NOT COMPLETED|Wash Out Period||1||
48295179|NCT02502097|101050822|FG002|NOT COMPLETED|Wash Out Period||1||
48295180|NCT02502097|101050823|FG003|NOT COMPLETED|Wash Out Period||1||
48295181|NCT02502097|101050820|FG000|STARTED|Period 2||4||
48295182|NCT02502097|101050821|FG001|STARTED|Period 2||2||
48295183|NCT02502097|101050822|FG002|STARTED|Period 2||20||
48295184|NCT02502097|101050823|FG003|STARTED|Period 2||21||
48295185|NCT02502097|101050820|FG000|COMPLETED|Period 2||4||
48295186|NCT02502097|101050821|FG001|COMPLETED|Period 2||2||
48295187|NCT02502097|101050822|FG002|COMPLETED|Period 2||19||
48295188|NCT02502097|101050823|FG003|COMPLETED|Period 2||21||
48295189|NCT02502097|101050820|FG000|NOT COMPLETED|Period 2||0||
48295190|NCT02502097|101050821|FG001|NOT COMPLETED|Period 2||0||
48295191|NCT02502097|101050822|FG002|NOT COMPLETED|Period 2||1||
48295192|NCT02502097|101050823|FG003|NOT COMPLETED|Period 2||0||
48295193|NCT02340767|101050824|FG000|STARTED|Overall Study||28||
48404495|NCT02327078|101321869|FG003|STARTED|Overall Study||13||
48404496|NCT02327078|101321870|FG004|STARTED|Overall Study||6||
48404497|NCT02327078|101321871|FG005|STARTED|Overall Study||3||
48404498|NCT02327078|101321872|FG006|STARTED|Overall Study||3||
48404499|NCT02327078|101321873|FG007|STARTED|Overall Study||83||
48404500|NCT02327078|101321874|FG008|STARTED|Overall Study||176||
48594888|NCT03408444|101789506|FG001|STARTED|Overall Study||48||
48594889|NCT03408444|101789507|FG002|STARTED|Overall Study||50||
48594890|NCT03408444|101789508|FG003|STARTED|Overall Study||51||
48404501|NCT02327078|101321866|FG000|COMPLETED|Overall Study||0||
48404502|NCT02327078|101321867|FG001|COMPLETED|Overall Study||0||
48404503|NCT02327078|101321868|FG002|COMPLETED|Overall Study||0||
48404504|NCT02327078|101321869|FG003|COMPLETED|Overall Study||0||
48404505|NCT02327078|101321870|FG004|COMPLETED|Overall Study||0||
48404506|NCT02327078|101321871|FG005|COMPLETED|Overall Study||0||
48404507|NCT02327078|101321872|FG006|COMPLETED|Overall Study||0||
48404508|NCT02327078|101321873|FG007|COMPLETED|Overall Study||0||
48404509|NCT02327078|101321874|FG008|COMPLETED|Overall Study||0||
48404510|NCT02327078|101321866|FG000|NOT COMPLETED|Overall Study||3||
48404511|NCT02327078|101321867|FG001|NOT COMPLETED|Overall Study||6||
48404512|NCT02327078|101321868|FG002|NOT COMPLETED|Overall Study||14||
48404513|NCT02327078|101321869|FG003|NOT COMPLETED|Overall Study||13||
48404514|NCT02327078|101321870|FG004|NOT COMPLETED|Overall Study||6||
48404515|NCT02327078|101321871|FG005|NOT COMPLETED|Overall Study||3||
48404516|NCT02327078|101321872|FG006|NOT COMPLETED|Overall Study||3||
48404517|NCT02327078|101321873|FG007|NOT COMPLETED|Overall Study||83||
48404518|NCT02327078|101321874|FG008|NOT COMPLETED|Overall Study||176||
48404519|NCT01237301|101321875|FG000|STARTED|Overall Study||65||
48404520|NCT01237301|101321876|FG001|STARTED|Overall Study||59||
48404521|NCT01237301|101321875|FG000|COMPLETED|Overall Study||60||
48404522|NCT01237301|101321876|FG001|COMPLETED|Overall Study||55||
48404523|NCT01237301|101321875|FG000|NOT COMPLETED|Overall Study||5||
48404524|NCT01237301|101321876|FG001|NOT COMPLETED|Overall Study||4||
48404525|NCT00299416|101321877|FG000|STARTED|Overall Study||30||
48594891|NCT03408444|101789505|FG000|COMPLETED|Overall Study||49||
48594892|NCT03408444|101789506|FG001|COMPLETED|Overall Study||45||
48594893|NCT03408444|101789507|FG002|COMPLETED|Overall Study||44||
48594894|NCT03408444|101789508|FG003|COMPLETED|Overall Study||47||
48594895|NCT03408444|101789505|FG000|NOT COMPLETED|Overall Study||1||
48594896|NCT03408444|101789506|FG001|NOT COMPLETED|Overall Study||3||
48594897|NCT03408444|101789507|FG002|NOT COMPLETED|Overall Study||6||
48594898|NCT03408444|101789508|FG003|NOT COMPLETED|Overall Study||4||
48594899|NCT05007041|101789509|FG000|STARTED|Overall Study||130||
48594900|NCT05007041|101789510|FG001|STARTED|Overall Study||137||
48295194|NCT02340767|101050825|FG001|STARTED|Overall Study||28||
48295195|NCT02340767|101050826|FG002|STARTED|Overall Study||29||
48295196|NCT02340767|101050827|FG003|STARTED|Overall Study||500||
48295197|NCT02340767|101050828|FG004|STARTED|Overall Study||474||
48295198|NCT02340767|101050829|FG005|STARTED|Overall Study||526||
48295199|NCT02340767|101050830|FG006|STARTED|Overall Study||525||
48404526|NCT00299416|101321877|FG000|COMPLETED|Overall Study||30||
48404527|NCT00299416|101321877|FG000|NOT COMPLETED|Overall Study||0||
48404528|NCT00373880|101321878|FG000|STARTED|Overall Study||26||
48404529|NCT00373880|101321878|FG000|COMPLETED|Overall Study||8||
48404530|NCT00373880|101321878|FG000|NOT COMPLETED|Overall Study||18||
48594901|NCT05007041|101789509|FG000|COMPLETED|Overall Study||130||
48594902|NCT05007041|101789510|FG001|COMPLETED|Overall Study||136||
48594903|NCT05007041|101789509|FG000|NOT COMPLETED|Overall Study||0||
48594904|NCT05007041|101789510|FG001|NOT COMPLETED|Overall Study||1||
48594905|NCT04102865|101789511|FG000|STARTED|Overall Study||68||
48594906|NCT04102865|101789512|FG001|STARTED|Overall Study||22||
48594907|NCT04102865|101789511|FG000|COMPLETED|Overall Study||61||
48594908|NCT04102865|101789512|FG001|COMPLETED|Overall Study||22||
48594909|NCT04102865|101789511|FG000|NOT COMPLETED|Overall Study||7||
48295200|NCT02340767|101050831|FG007|STARTED|Overall Study||444||
48295201|NCT02340767|101050832|FG008|STARTED|Overall Study||531||
48295202|NCT02340767|101050824|FG000|COMPLETED|Overall Study||28||
48404531|NCT01248585|101321879|FG000|STARTED|Overall Study||148||
48404532|NCT01248585|101321880|FG001|STARTED|Overall Study||150||
48594910|NCT04102865|101789512|FG001|NOT COMPLETED|Overall Study||0||
48594911|NCT01592292|101789513|FG000|STARTED|Overall Study||46||
48594912|NCT01592292|101789514|FG001|STARTED|Overall Study||20||
48594913|NCT01592292|101789515|FG002|STARTED|Overall Study||13||
48594914|NCT01592292|101789516|FG003|STARTED|Overall Study||11||
48594915|NCT01592292|101789513|FG000|Intention to Treat (ITT) Set|Overall Study||34||
48594916|NCT01592292|101789514|FG001|Intention to Treat (ITT) Set|Overall Study||13||
48594917|NCT01592292|101789515|FG002|Intention to Treat (ITT) Set|Overall Study||10||
48594918|NCT01592292|101789516|FG003|Intention to Treat (ITT) Set|Overall Study||8||
48295203|NCT02340767|101050825|FG001|COMPLETED|Overall Study||28||
48295204|NCT02340767|101050826|FG002|COMPLETED|Overall Study||29||
48295205|NCT02340767|101050827|FG003|COMPLETED|Overall Study||500||
48594919|NCT01592292|101789513|FG000|Standard Population Set (SPS)|Overall Study||31||
48594920|NCT01592292|101789514|FG001|Standard Population Set (SPS)|Overall Study||10||
48594921|NCT01592292|101789515|FG002|Standard Population Set (SPS)|Overall Study||7||
48594922|NCT01592292|101789516|FG003|Standard Population Set (SPS)|Overall Study||7||
48594923|NCT01592292|101789513|FG000|COMPLETED|Overall Study||40||
48594924|NCT01592292|101789514|FG001|COMPLETED|Overall Study||15||
48594925|NCT01592292|101789515|FG002|COMPLETED|Overall Study||10||
48594926|NCT01592292|101789516|FG003|COMPLETED|Overall Study||10||
48594927|NCT01592292|101789513|FG000|NOT COMPLETED|Overall Study||6||
48594928|NCT01592292|101789514|FG001|NOT COMPLETED|Overall Study||5||
48594929|NCT01592292|101789515|FG002|NOT COMPLETED|Overall Study||3||
48594930|NCT01592292|101789516|FG003|NOT COMPLETED|Overall Study||1||
48295206|NCT02340767|101050828|FG004|COMPLETED|Overall Study||474||
48295207|NCT02340767|101050829|FG005|COMPLETED|Overall Study||526||
48295208|NCT02340767|101050830|FG006|COMPLETED|Overall Study||525||
48594931|NCT02865811|101789517|FG000|STARTED|Overall Study||26||
48295209|NCT02340767|101050831|FG007|COMPLETED|Overall Study||444||
48295210|NCT02340767|101050832|FG008|COMPLETED|Overall Study||531||
48594932|NCT02865811|101789517|FG000|COMPLETED|Overall Study||26||
48594933|NCT02865811|101789517|FG000|NOT COMPLETED|Overall Study||0||
48594934|NCT00248833|101789518|FG000|STARTED|Overall Study||12||
48594935|NCT00248833|101789519|FG001|STARTED|Overall Study||11||
48594936|NCT00248833|101789520|FG002|STARTED|Overall Study||11||
48594937|NCT00248833|101789518|FG000|COMPLETED|Overall Study||9||
48594938|NCT00248833|101789519|FG001|COMPLETED|Overall Study||8||
48594939|NCT00248833|101789520|FG002|COMPLETED|Overall Study||9||
48594940|NCT00248833|101789518|FG000|NOT COMPLETED|Overall Study||3||
48594941|NCT00248833|101789519|FG001|NOT COMPLETED|Overall Study||3||
48594942|NCT00248833|101789520|FG002|NOT COMPLETED|Overall Study||2||
48594943|NCT02569086|101789521|FG000|STARTED|Overall Study||22||
48594944|NCT02569086|101789521|FG000|COMPLETED|Overall Study||22||
48594945|NCT02569086|101789521|FG000|NOT COMPLETED|Overall Study||0||
48594946|NCT00505661|101789522|FG000|STARTED|Overall Study||16||
48295211|NCT02340767|101050824|FG000|NOT COMPLETED|Overall Study||0||
48295212|NCT02340767|101050825|FG001|NOT COMPLETED|Overall Study||0||
48295213|NCT02340767|101050826|FG002|NOT COMPLETED|Overall Study||0||
48295214|NCT02340767|101050827|FG003|NOT COMPLETED|Overall Study||0||
48295215|NCT02340767|101050828|FG004|NOT COMPLETED|Overall Study||0||
48594947|NCT00505661|101789522|FG000|COMPLETED|Overall Study||12||
48594948|NCT00505661|101789522|FG000|NOT COMPLETED|Overall Study||4||
48295216|NCT02340767|101050829|FG005|NOT COMPLETED|Overall Study||0||
48594949|NCT00061373|101789523|FG000|STARTED|Overall Study||15||
48594950|NCT00061373|101789524|FG001|STARTED|Overall Study||3||
48594951|NCT00061373|101789523|FG000|Aspirin and Tinzaparin|Overall Study||15||
48594952|NCT00061373|101789524|FG001|Aspirin and Tinzaparin|Overall Study||3||
48594953|NCT00061373|101789523|FG000|COMPLETED|Overall Study||15||
48594954|NCT00061373|101789524|FG001|COMPLETED|Overall Study||3||
48594955|NCT00061373|101789523|FG000|NOT COMPLETED|Overall Study||0||
48594956|NCT00061373|101789524|FG001|NOT COMPLETED|Overall Study||0||
48594957|NCT04779606|101789525|FG000|STARTED|First Phase: Tolerability and Safety||16||
48594958|NCT04779606|101789526|FG001|STARTED|First Phase: Tolerability and Safety||4||
48594959|NCT04779606|101789525|FG000|COMPLETED|First Phase: Tolerability and Safety||16||
48594960|NCT04779606|101789526|FG001|COMPLETED|First Phase: Tolerability and Safety||4||
48594961|NCT04779606|101789525|FG000|NOT COMPLETED|First Phase: Tolerability and Safety||0||
48594962|NCT04779606|101789526|FG001|NOT COMPLETED|First Phase: Tolerability and Safety||0||
48594963|NCT04779606|101789525|FG000|STARTED|Second Phase: Efficacy||68||
48594964|NCT04779606|101789526|FG001|STARTED|Second Phase: Efficacy||17||
48594965|NCT04779606|101789525|FG000|COMPLETED|Second Phase: Efficacy||68||
48594966|NCT04779606|101789526|FG001|COMPLETED|Second Phase: Efficacy||17||
48594967|NCT04779606|101789525|FG000|NOT COMPLETED|Second Phase: Efficacy||0||
48594968|NCT04779606|101789526|FG001|NOT COMPLETED|Second Phase: Efficacy||0||
48594969|NCT01298141|101789527|FG000|STARTED|Overall Study||171||
48594970|NCT01298141|101789527|FG000|Treated|Overall Study||167||
48594971|NCT01298141|101789527|FG000|COMPLETED|Overall Study||140||
48594972|NCT01298141|101789527|FG000|NOT COMPLETED|Overall Study||31||
48594973|NCT02961062|101789528|FG000|STARTED|Overall Study||20||
48594974|NCT02961062|101789529|FG001|STARTED|Overall Study||20||
48141850|NCT04988308|100673420|FG002|STARTED|Placebo Controlled Period (Weeks 0-16)||50||
48141851|NCT04988308|100673421|FG003|STARTED|Placebo Controlled Period (Weeks 0-16)||0||
48141852|NCT04988308|100673422|FG004|STARTED|Placebo Controlled Period (Weeks 0-16)||0||
48141853|NCT04988308|100673423|FG005|STARTED|Placebo Controlled Period (Weeks 0-16)||0||
48594975|NCT02961062|101789528|FG000|COMPLETED|Overall Study||20||
48141854|NCT04988308|100673418|FG000|Full- Analysis Set (FAS)|Placebo Controlled Period (Weeks 0-16)||35||
48141855|NCT04988308|100673419|FG001|Full- Analysis Set (FAS)|Placebo Controlled Period (Weeks 0-16)||35||
48594976|NCT02961062|101789529|FG001|COMPLETED|Overall Study||20||
48594977|NCT02961062|101789528|FG000|NOT COMPLETED|Overall Study||0||
48594978|NCT02961062|101789529|FG001|NOT COMPLETED|Overall Study||0||
48594979|NCT02386345|101789530|FG000|STARTED|Overall Study||299||
48594980|NCT02386345|101789530|FG000|COMPLETED|Overall Study||197||
48594981|NCT02386345|101789530|FG000|NOT COMPLETED|Overall Study||102||
48594982|NCT00481767|101789531|FG000|STARTED|Overall Study||450||
48594983|NCT00481767|101789532|FG001|STARTED|Overall Study||226||
48594984|NCT00481767|101789531|FG000|COMPLETED|Overall Study||418||
48594985|NCT00481767|101789532|FG001|COMPLETED|Overall Study||205||
48594986|NCT00481767|101789531|FG000|NOT COMPLETED|Overall Study||32||
48594987|NCT00481767|101789532|FG001|NOT COMPLETED|Overall Study||21||
48594988|NCT04438499|101789533|FG000|STARTED|Overall Study||61||
48594989|NCT04438499|101789533|FG000|COMPLETED|Overall Study||58||
48594990|NCT04438499|101789533|FG000|NOT COMPLETED|Overall Study||3||
48594991|NCT05873335|101789534|FG000|STARTED|Overall Study||12||
48594992|NCT05873335|101789534|FG000|COMPLETED|Overall Study||12||
48594993|NCT05873335|101789534|FG000|NOT COMPLETED|Overall Study||0||
48594994|NCT01432275|101789535|FG000|STARTED|First BG Meter System (7 Days)||90||
48594995|NCT01432275|101789536|FG001|STARTED|First BG Meter System (7 Days)||87||
48594996|NCT01432275|101789535|FG000|COMPLETED|First BG Meter System (7 Days)||90||
48594997|NCT01432275|101789536|FG001|COMPLETED|First BG Meter System (7 Days)||84||
48594998|NCT01432275|101789535|FG000|NOT COMPLETED|First BG Meter System (7 Days)||0||
48594999|NCT01432275|101789536|FG001|NOT COMPLETED|First BG Meter System (7 Days)||3||
48595000|NCT01432275|101789535|FG000|STARTED|Second BG Meter System (7 Days)||90||
48595001|NCT01432275|101789536|FG001|STARTED|Second BG Meter System (7 Days)||84||
48595002|NCT01432275|101789535|FG000|COMPLETED|Second BG Meter System (7 Days)||88||
48595003|NCT01432275|101789536|FG001|COMPLETED|Second BG Meter System (7 Days)||81||
48595004|NCT01432275|101789535|FG000|NOT COMPLETED|Second BG Meter System (7 Days)||2||
48595005|NCT01432275|101789536|FG001|NOT COMPLETED|Second BG Meter System (7 Days)||3||
48595006|NCT01432275|101789535|FG000|STARTED|ADC With Calculator (10 Days)||88||
48188510|NCT01686932|100783262|FG000|COMPLETED|Period 1||24||
48595007|NCT01432275|101789536|FG001|STARTED|ADC With Calculator (10 Days)||81||
48595008|NCT01432275|101789535|FG000|COMPLETED|ADC With Calculator (10 Days)||85||
48595009|NCT01432275|101789536|FG001|COMPLETED|ADC With Calculator (10 Days)||79||
48595010|NCT01432275|101789535|FG000|NOT COMPLETED|ADC With Calculator (10 Days)||3||
48595011|NCT01432275|101789536|FG001|NOT COMPLETED|ADC With Calculator (10 Days)||2||
48595012|NCT00561470|101789537|FG000|STARTED|Overall Study||614||
48595013|NCT00561470|101789538|FG001|STARTED|Overall Study||612||
48595014|NCT00561470|101789537|FG000|TREATED|Overall Study||609||
48595015|NCT00561470|101789538|FG001|TREATED|Overall Study||607||
48595016|NCT00561470|101789537|FG000|SAFETY POPULATION|Overall Study||605||
48595017|NCT00561470|101789538|FG001|SAFETY POPULATION|Overall Study||611||
48595018|NCT00561470|101789537|FG000|ONGOING TREATMENT|Overall Study||11||
48595019|NCT00561470|101789538|FG001|ONGOING TREATMENT|Overall Study||14||
48595020|NCT00561470|101789537|FG000|COMPLETED|Overall Study||0||
48595021|NCT00561470|101789538|FG001|COMPLETED|Overall Study||0||
48595022|NCT00561470|101789537|FG000|NOT COMPLETED|Overall Study||614||
48595023|NCT00561470|101789538|FG001|NOT COMPLETED|Overall Study||612||
48595024|NCT02747849|101789539|FG000|STARTED|Overall Study||13||
48595025|NCT02747849|101789540|FG001|STARTED|Overall Study||14||
48595026|NCT02747849|101789539|FG000|COMPLETED|Overall Study||12||
48595027|NCT02747849|101789540|FG001|COMPLETED|Overall Study||14||
48595028|NCT02747849|101789539|FG000|NOT COMPLETED|Overall Study||1||
48595029|NCT02747849|101789540|FG001|NOT COMPLETED|Overall Study||0||
48595030|NCT01473394|101789541|FG000|STARTED|Overall Study||253||
48295217|NCT02340767|101050830|FG006|NOT COMPLETED|Overall Study||0||
48295218|NCT02340767|101050831|FG007|NOT COMPLETED|Overall Study||0||
48295219|NCT02340767|101050832|FG008|NOT COMPLETED|Overall Study||0||
48295220|NCT01029652|101050833|FG000|STARTED|Core Study (0-12 Weeks)||115||
48295221|NCT01029652|101050834|FG001|STARTED|Core Study (0-12 Weeks)||115||
48295222|NCT01029652|101050833|FG000|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||113||
48295223|NCT01029652|101050834|FG001|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||115||
48295224|NCT01029652|101050833|FG000|COMPLETED|Core Study (0-12 Weeks)||109||
48295225|NCT01029652|101050834|FG001|COMPLETED|Core Study (0-12 Weeks)||105||
48295226|NCT01029652|101050833|FG000|NOT COMPLETED|Core Study (0-12 Weeks)||6||
48295227|NCT01029652|101050834|FG001|NOT COMPLETED|Core Study (0-12 Weeks)||10||
48295228|NCT01029652|101050833|FG000|STARTED|Extension Study 1 (12-24 Weeks)||90||
48295229|NCT01029652|101050834|FG001|STARTED|Extension Study 1 (12-24 Weeks)||85||
48295230|NCT01029652|101050833|FG000|COMPLETED|Extension Study 1 (12-24 Weeks)||87||
48295231|NCT01029652|101050834|FG001|COMPLETED|Extension Study 1 (12-24 Weeks)||80||
48295232|NCT01029652|101050833|FG000|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||3||
48295233|NCT01029652|101050834|FG001|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||5||
48295234|NCT01029652|101050833|FG000|STARTED|Extension Study 2 (25-72 Weeks)||69||
48295235|NCT01029652|101050834|FG001|STARTED|Extension Study 2 (25-72 Weeks)||66||
48295236|NCT01029652|101050833|FG000|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)||69||
48595031|NCT01473394|101789542|FG001|STARTED|Overall Study||255||
48595032|NCT01473394|101789541|FG000|COMPLETED|Overall Study||208||
48595033|NCT01473394|101789542|FG001|COMPLETED|Overall Study||212||
48595034|NCT01473394|101789541|FG000|NOT COMPLETED|Overall Study||45||
48595035|NCT01473394|101789542|FG001|NOT COMPLETED|Overall Study||43||
48595036|NCT00787917|101789543|FG000|STARTED|Blinded Treatment||9||
48595037|NCT00787917|101789544|FG001|STARTED|Blinded Treatment||5||
48595038|NCT00787917|101789543|FG000|COMPLETED|Blinded Treatment||4||
48595039|NCT00787917|101789544|FG001|COMPLETED|Blinded Treatment||3||
48595040|NCT00787917|101789543|FG000|NOT COMPLETED|Blinded Treatment||5||
48595041|NCT00787917|101789544|FG001|NOT COMPLETED|Blinded Treatment||2||
48595042|NCT00787917|101789543|FG000|STARTED|Open Label||7||
48595043|NCT00787917|101789544|FG001|STARTED|Open Label||0||
48595044|NCT00787917|101789543|FG000|COMPLETED|Open Label||3||
48711931|NCT02470754|102081687|FG000|NOT COMPLETED|Overall Study||2||
48711932|NCT02470754|102081688|FG001|NOT COMPLETED|Overall Study||0||
48711933|NCT01133626|102081689|FG000|STARTED|Overall Study||50||
48711934|NCT01133626|102081690|FG001|STARTED|Overall Study||46||
48711935|NCT01133626|102081691|FG002|STARTED|Overall Study||11||
48711936|NCT01133626|102081689|FG000|Safety Population|Overall Study||50||
48711937|NCT01133626|102081690|FG001|Safety Population|Overall Study||46||
48711938|NCT01133626|102081691|FG002|Safety Population|Overall Study||11||
48711939|NCT01133626|102081689|FG000|Per Protocol Population|Overall Study||48||
48711940|NCT01133626|102081690|FG001|Per Protocol Population|Overall Study||41||
48711941|NCT01133626|102081691|FG002|Per Protocol Population|Overall Study||9||
48711942|NCT01133626|102081689|FG000|COMPLETED|Overall Study||49||
48295237|NCT01029652|101050834|FG001|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)||39||
48711943|NCT01133626|102081690|FG001|COMPLETED|Overall Study||41||
48711944|NCT01133626|102081691|FG002|COMPLETED|Overall Study||9||
48711945|NCT01133626|102081689|FG000|NOT COMPLETED|Overall Study||1||
48711946|NCT01133626|102081690|FG001|NOT COMPLETED|Overall Study||5||
48711947|NCT01133626|102081691|FG002|NOT COMPLETED|Overall Study||2||
48711948|NCT03811847|102081692|FG000|STARTED|Block 1A||1||
48711949|NCT03811847|102081693|FG001|STARTED|Block 1A||1||
48711950|NCT03811847|102081694|FG002|STARTED|Block 1A||1||
48711951|NCT03811847|102081695|FG003|STARTED|Block 1A||2||
48711952|NCT03811847|102081696|FG004|STARTED|Block 1A||1||
48711953|NCT03811847|102081697|FG005|STARTED|Block 1A||1||
48711954|NCT03811847|102081692|FG000|COMPLETED|Block 1A||1||
48295238|NCT01029652|101050833|FG000|COMPLETED|Extension Study 2 (25-72 Weeks)||68||
48295239|NCT01029652|101050834|FG001|COMPLETED|Extension Study 2 (25-72 Weeks)||63||
48595045|NCT00787917|101789544|FG001|COMPLETED|Open Label||0||
48595046|NCT00787917|101789543|FG000|NOT COMPLETED|Open Label||4||
48711955|NCT03811847|102081693|FG001|COMPLETED|Block 1A||1||
48711956|NCT03811847|102081694|FG002|COMPLETED|Block 1A||1||
48595047|NCT00787917|101789544|FG001|NOT COMPLETED|Open Label||0||
48595048|NCT03502018|101789545|FG000|STARTED|Overall Study||25||
48595049|NCT03502018|101789546|FG001|STARTED|Overall Study||25||
48595050|NCT03502018|101789545|FG000|COMPLETED|Overall Study||24||
48595051|NCT03502018|101789546|FG001|COMPLETED|Overall Study||25||
48595052|NCT03502018|101789545|FG000|NOT COMPLETED|Overall Study||1||
48595053|NCT03502018|101789546|FG001|NOT COMPLETED|Overall Study||0||
48595054|NCT04472026|101789547|FG000|STARTED|Overall Study||66|Patients and clinicians starting the study. Guest are not considered as units of analysis/participants.|
48595055|NCT04472026|101789547|FG000|Clinicians Starting|Overall Study||13||
48595056|NCT04472026|101789547|FG000|Clinicians Completing|Overall Study||12||
48595057|NCT04472026|101789547|FG000|Patients Starting|Overall Study||53||
48595058|NCT04472026|101789547|FG000|Patient Completing|Overall Study||49||
48656869|NCT01708941|101943722|FG001|STARTED|Overall Study||23||
48711957|NCT03811847|102081695|FG003|COMPLETED|Block 1A||2||
48295240|NCT01029652|101050833|FG000|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||1||
48295241|NCT01029652|101050834|FG001|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||3||
48295242|NCT00256451|101050835|FG000|STARTED|Session1||10|Crossover design: no of subjs who completed the PRIOR session|
48595059|NCT04472026|101789547|FG000|COMPLETED|Overall Study||61|Patients and clinicians completing the study|
48595060|NCT04472026|101789547|FG000|NOT COMPLETED|Overall Study||5||
48595061|NCT04326439|101789548|FG000|STARTED|Overall Study||5||
48595062|NCT04326439|101789549|FG001|STARTED|Overall Study||3||
48595063|NCT04326439|101789548|FG000|COMPLETED|Overall Study||3||
48595064|NCT04326439|101789549|FG001|COMPLETED|Overall Study||0||
48595065|NCT04326439|101789548|FG000|NOT COMPLETED|Overall Study||2||
48595066|NCT04326439|101789549|FG001|NOT COMPLETED|Overall Study||3||
48595067|NCT00987402|101789550|FG000|STARTED|Overall Study||1682||
48595068|NCT00987402|101789551|FG001|STARTED|Overall Study||1635||
48595069|NCT00987402|101789550|FG000|COMPLETED|Overall Study||1596||
48595070|NCT00987402|101789551|FG001|COMPLETED|Overall Study||1537||
48595071|NCT00987402|101789550|FG000|NOT COMPLETED|Overall Study||86||
48595072|NCT00987402|101789551|FG001|NOT COMPLETED|Overall Study||98||
48595073|NCT01313494|101789552|FG000|STARTED|Overall Study||313||
48595074|NCT01313494|101789553|FG001|STARTED|Overall Study||313||
48595075|NCT01313494|101789552|FG000|Safety Set|Overall Study||315||
48595076|NCT01313494|101789553|FG001|Safety Set|Overall Study||311||
48595077|NCT01313494|101789552|FG000|COMPLETED|Overall Study||246||
48595078|NCT01313494|101789553|FG001|COMPLETED|Overall Study||263||
48595079|NCT01313494|101789552|FG000|NOT COMPLETED|Overall Study||67||
48595080|NCT01313494|101789553|FG001|NOT COMPLETED|Overall Study||50||
48295243|NCT00256451|101050836|FG001|STARTED|Session1||11|Crossover design: no of subjs who completed the PRIOR session|
48295244|NCT00256451|101050837|FG002|STARTED|Session1||11|Crossover design: no of subjs who completed the PRIOR session|
48295245|NCT00256451|101050838|FG003|STARTED|Session1||11|Crossover design: no of subjs who completed the PRIOR session|
48595081|NCT00894244|101789554|FG000|STARTED|Overall Study||25||
48595082|NCT00894244|101789554|FG000|COMPLETED|Overall Study||24||
48595083|NCT00894244|101789554|FG000|NOT COMPLETED|Overall Study||1||
48595084|NCT01683422|101789555|FG000|STARTED|Overall Study||9||
48595085|NCT01683422|101789555|FG000|COMPLETED|Overall Study||9||
48595086|NCT01683422|101789555|FG000|NOT COMPLETED|Overall Study||0||
48595087|NCT01085136|101789556|FG000|STARTED|Part A||1154||
48595088|NCT01085136|101789557|FG001|STARTED|Part A||0||
48595089|NCT01085136|101789558|FG002|STARTED|Part A||0||
48595090|NCT01085136|101789556|FG000|Randomized to Part B|Part A||206||
48595091|NCT01085136|101789557|FG001|Randomized to Part B|Part A||0||
48595092|NCT01085136|101789558|FG002|Randomized to Part B|Part A||0||
48595093|NCT01085136|101789556|FG000|COMPLETED|Part A||831||
48595094|NCT01085136|101789557|FG001|COMPLETED|Part A||0||
48595095|NCT01085136|101789558|FG002|COMPLETED|Part A||0||
48595096|NCT01085136|101789556|FG000|NOT COMPLETED|Part A||323||
48595097|NCT01085136|101789557|FG001|NOT COMPLETED|Part A||0||
48595098|NCT01085136|101789558|FG002|NOT COMPLETED|Part A||0||
48595099|NCT01085136|101789556|FG000|STARTED|Part B||0||
48595100|NCT01085136|101789557|FG001|STARTED|Part B||138||
48595101|NCT01085136|101789558|FG002|STARTED|Part B||68||
48595102|NCT01085136|101789556|FG000|COMPLETED|Part B||0||
48595103|NCT01085136|101789557|FG001|COMPLETED|Part B||87||
48595104|NCT01085136|101789558|FG002|COMPLETED|Part B||42||
48595105|NCT01085136|101789556|FG000|NOT COMPLETED|Part B||0||
48595106|NCT01085136|101789557|FG001|NOT COMPLETED|Part B||51||
48595107|NCT01085136|101789558|FG002|NOT COMPLETED|Part B||26||
48595108|NCT00328094|101789559|FG000|STARTED|Overall Study||117||
48595109|NCT00328094|101789560|FG001|STARTED|Overall Study||125||
48595110|NCT00328094|101789559|FG000|COMPLETED|Overall Study||114||
48595111|NCT00328094|101789560|FG001|COMPLETED|Overall Study||122||
48595112|NCT00328094|101789559|FG000|NOT COMPLETED|Overall Study||3||
48595113|NCT00328094|101789560|FG001|NOT COMPLETED|Overall Study||3||
48595114|NCT02921750|101789561|FG000|STARTED|Overall Study||124|Safety population|
48595115|NCT02921750|101789562|FG001|STARTED|Overall Study||124|Safety population|
48595116|NCT02921750|101789561|FG000|Intention to Treat (ITT)|Overall Study||122||
48711958|NCT03811847|102081696|FG004|COMPLETED|Block 1A||1||
48711959|NCT03811847|102081697|FG005|COMPLETED|Block 1A||1||
48711960|NCT03811847|102081692|FG000|NOT COMPLETED|Block 1A||0||
48595117|NCT02921750|101789562|FG001|Intention to Treat (ITT)|Overall Study||123||
48595118|NCT02921750|101789561|FG000|Per Protocol (PP)|Overall Study||100||
48595119|NCT02921750|101789562|FG001|Per Protocol (PP)|Overall Study||107||
48595120|NCT02921750|101789561|FG000|Completed 6 Weeks Follow-up (PP)|Overall Study||97||
48595121|NCT02921750|101789562|FG001|Completed 6 Weeks Follow-up (PP)|Overall Study||104||
48711961|NCT03811847|102081693|FG001|NOT COMPLETED|Block 1A||0||
48711962|NCT03811847|102081694|FG002|NOT COMPLETED|Block 1A||0||
48711963|NCT03811847|102081695|FG003|NOT COMPLETED|Block 1A||0||
48711964|NCT03811847|102081696|FG004|NOT COMPLETED|Block 1A||0||
48595122|NCT02921750|101789561|FG000|Subgroup Followed for 24 Weeks (ITT)|Overall Study||35||
48595123|NCT02921750|101789562|FG001|Subgroup Followed for 24 Weeks (ITT)|Overall Study||40||
48595124|NCT02921750|101789561|FG000|Subgroup Followed for 24 Weeks (PP)|Overall Study||19||
48595125|NCT02921750|101789562|FG001|Subgroup Followed for 24 Weeks (PP)|Overall Study||36||
48711965|NCT03811847|102081697|FG005|NOT COMPLETED|Block 1A||0||
48711966|NCT03811847|102081692|FG000|STARTED|Block 1B||1||
48711967|NCT03811847|102081693|FG001|STARTED|Block 1B||1||
48711968|NCT03811847|102081694|FG002|STARTED|Block 1B||1||
48711969|NCT03811847|102081695|FG003|STARTED|Block 1B||2||
48711970|NCT03811847|102081696|FG004|STARTED|Block 1B||1||
48711971|NCT03811847|102081697|FG005|STARTED|Block 1B||1||
48711972|NCT03811847|102081692|FG000|COMPLETED|Block 1B||1||
48711973|NCT03811847|102081693|FG001|COMPLETED|Block 1B||1||
48711974|NCT03811847|102081694|FG002|COMPLETED|Block 1B||1||
48711975|NCT03811847|102081695|FG003|COMPLETED|Block 1B||2||
48711976|NCT03811847|102081696|FG004|COMPLETED|Block 1B||1||
48711977|NCT03811847|102081697|FG005|COMPLETED|Block 1B||1||
48711978|NCT03811847|102081692|FG000|NOT COMPLETED|Block 1B||0||
48711979|NCT03811847|102081693|FG001|NOT COMPLETED|Block 1B||0||
48711980|NCT03811847|102081694|FG002|NOT COMPLETED|Block 1B||0||
48711981|NCT03811847|102081695|FG003|NOT COMPLETED|Block 1B||0||
48711982|NCT03811847|102081696|FG004|NOT COMPLETED|Block 1B||0||
48711983|NCT03811847|102081697|FG005|NOT COMPLETED|Block 1B||0||
48711984|NCT03811847|102081692|FG000|STARTED|Block 2 A||1||
48711985|NCT03811847|102081693|FG001|STARTED|Block 2 A||1||
48711986|NCT03811847|102081694|FG002|STARTED|Block 2 A||1||
48711987|NCT03811847|102081695|FG003|STARTED|Block 2 A||2||
48711988|NCT03811847|102081696|FG004|STARTED|Block 2 A||1||
48711989|NCT03811847|102081697|FG005|STARTED|Block 2 A||1||
48711990|NCT03811847|102081692|FG000|COMPLETED|Block 2 A||1||
48711991|NCT03811847|102081693|FG001|COMPLETED|Block 2 A||1||
48711992|NCT03811847|102081694|FG002|COMPLETED|Block 2 A||1||
48711993|NCT03811847|102081695|FG003|COMPLETED|Block 2 A||2||
48711994|NCT03811847|102081696|FG004|COMPLETED|Block 2 A||1||
48711995|NCT03811847|102081697|FG005|COMPLETED|Block 2 A||1||
48711996|NCT03811847|102081692|FG000|NOT COMPLETED|Block 2 A||0||
48711997|NCT03811847|102081693|FG001|NOT COMPLETED|Block 2 A||0||
48711998|NCT03811847|102081694|FG002|NOT COMPLETED|Block 2 A||0||
48711999|NCT03811847|102081695|FG003|NOT COMPLETED|Block 2 A||0||
48712000|NCT03811847|102081696|FG004|NOT COMPLETED|Block 2 A||0||
48712001|NCT03811847|102081697|FG005|NOT COMPLETED|Block 2 A||0||
48712002|NCT03811847|102081692|FG000|STARTED|Block 2B||1||
48712003|NCT03811847|102081693|FG001|STARTED|Block 2B||1||
48712004|NCT03811847|102081694|FG002|STARTED|Block 2B||1||
48712005|NCT03811847|102081695|FG003|STARTED|Block 2B||2||
48712006|NCT03811847|102081696|FG004|STARTED|Block 2B||1||
48712007|NCT03811847|102081697|FG005|STARTED|Block 2B||1||
48712008|NCT03811847|102081692|FG000|COMPLETED|Block 2B||1||
48712009|NCT03811847|102081693|FG001|COMPLETED|Block 2B||1||
48712010|NCT03811847|102081694|FG002|COMPLETED|Block 2B||1||
48712011|NCT03811847|102081695|FG003|COMPLETED|Block 2B||2||
48712012|NCT03811847|102081696|FG004|COMPLETED|Block 2B||1||
48712013|NCT03811847|102081697|FG005|COMPLETED|Block 2B||1||
48712014|NCT03811847|102081692|FG000|NOT COMPLETED|Block 2B||0||
48712015|NCT03811847|102081693|FG001|NOT COMPLETED|Block 2B||0||
48712016|NCT03811847|102081694|FG002|NOT COMPLETED|Block 2B||0||
48712017|NCT03811847|102081695|FG003|NOT COMPLETED|Block 2B||0||
48712018|NCT03811847|102081696|FG004|NOT COMPLETED|Block 2B||0||
48712019|NCT03811847|102081697|FG005|NOT COMPLETED|Block 2B||0||
48712020|NCT03811847|102081692|FG000|STARTED|Block 3A||1||
48712021|NCT03811847|102081693|FG001|STARTED|Block 3A||1||
48712022|NCT03811847|102081694|FG002|STARTED|Block 3A||1||
48712023|NCT03811847|102081695|FG003|STARTED|Block 3A||2||
48712024|NCT03811847|102081696|FG004|STARTED|Block 3A||1||
48712025|NCT03811847|102081697|FG005|STARTED|Block 3A||1||
48712026|NCT03811847|102081692|FG000|COMPLETED|Block 3A||1||
48712027|NCT03811847|102081693|FG001|COMPLETED|Block 3A||1||
48712028|NCT03811847|102081694|FG002|COMPLETED|Block 3A||1||
48712029|NCT03811847|102081695|FG003|COMPLETED|Block 3A||2||
48712030|NCT03811847|102081696|FG004|COMPLETED|Block 3A||1||
48712031|NCT03811847|102081697|FG005|COMPLETED|Block 3A||1||
48712032|NCT03811847|102081692|FG000|NOT COMPLETED|Block 3A||0||
48712033|NCT03811847|102081693|FG001|NOT COMPLETED|Block 3A||0||
48712034|NCT03811847|102081694|FG002|NOT COMPLETED|Block 3A||0||
48712035|NCT03811847|102081695|FG003|NOT COMPLETED|Block 3A||0||
48712036|NCT03811847|102081696|FG004|NOT COMPLETED|Block 3A||0||
48712037|NCT03811847|102081697|FG005|NOT COMPLETED|Block 3A||0||
48712038|NCT03811847|102081692|FG000|STARTED|Block 3B||1||
48712039|NCT03811847|102081693|FG001|STARTED|Block 3B||1||
48712040|NCT03811847|102081694|FG002|STARTED|Block 3B||1||
48712041|NCT03811847|102081695|FG003|STARTED|Block 3B||2||
48712042|NCT03811847|102081696|FG004|STARTED|Block 3B||1||
48712043|NCT03811847|102081697|FG005|STARTED|Block 3B||1||
48712044|NCT03811847|102081692|FG000|COMPLETED|Block 3B||1||
48712045|NCT03811847|102081693|FG001|COMPLETED|Block 3B||1||
48712046|NCT03811847|102081694|FG002|COMPLETED|Block 3B||1||
48712047|NCT03811847|102081695|FG003|COMPLETED|Block 3B||2||
48712048|NCT03811847|102081696|FG004|COMPLETED|Block 3B||1||
48712049|NCT03811847|102081697|FG005|COMPLETED|Block 3B||1||
48712050|NCT03811847|102081692|FG000|NOT COMPLETED|Block 3B||0||
48712051|NCT03811847|102081693|FG001|NOT COMPLETED|Block 3B||0||
48712052|NCT03811847|102081694|FG002|NOT COMPLETED|Block 3B||0||
48712053|NCT03811847|102081695|FG003|NOT COMPLETED|Block 3B||0||
48712054|NCT03811847|102081696|FG004|NOT COMPLETED|Block 3B||0||
48712055|NCT03811847|102081697|FG005|NOT COMPLETED|Block 3B||0||
48712056|NCT01540409|102081698|FG000|STARTED|Overall Study||6||
48712057|NCT01540409|102081699|FG001|STARTED|Overall Study||6||
48712058|NCT01540409|102081698|FG000|COMPLETED|Overall Study||6||
48712059|NCT01540409|102081699|FG001|COMPLETED|Overall Study||6||
48712060|NCT01540409|102081698|FG000|NOT COMPLETED|Overall Study||0||
48595126|NCT02921750|101789561|FG000|COMPLETED|Overall Study||115|Completed 6 weeks follow-up|
48595127|NCT02921750|101789562|FG001|COMPLETED|Overall Study||113|Completed 6 weeks follow-up|
48595128|NCT02921750|101789561|FG000|NOT COMPLETED|Overall Study||9||
48595129|NCT02921750|101789562|FG001|NOT COMPLETED|Overall Study||11||
48595130|NCT03578146|101789563|FG000|STARTED|Overall Study||16||
48712061|NCT01540409|102081699|FG001|NOT COMPLETED|Overall Study||0||
48595131|NCT03578146|101789564|FG001|STARTED|Overall Study||6||
48595132|NCT03578146|101789565|FG002|STARTED|Overall Study||6||
48595133|NCT03578146|101789566|FG003|STARTED|Overall Study||6||
48595134|NCT03578146|101789567|FG004|STARTED|Overall Study||6||
48595135|NCT03578146|101789568|FG005|STARTED|Overall Study||8||
48595136|NCT03578146|101789563|FG000|COMPLETED|Overall Study||15||
48595137|NCT03578146|101789564|FG001|COMPLETED|Overall Study||5||
48595138|NCT03578146|101789565|FG002|COMPLETED|Overall Study||5||
48595139|NCT03578146|101789566|FG003|COMPLETED|Overall Study||6||
48595140|NCT03578146|101789567|FG004|COMPLETED|Overall Study||6||
48595141|NCT03578146|101789568|FG005|COMPLETED|Overall Study||5||
48595142|NCT03578146|101789563|FG000|NOT COMPLETED|Overall Study||1||
48595143|NCT03578146|101789564|FG001|NOT COMPLETED|Overall Study||1||
48595144|NCT03578146|101789565|FG002|NOT COMPLETED|Overall Study||1||
48595145|NCT03578146|101789566|FG003|NOT COMPLETED|Overall Study||0||
48595146|NCT03578146|101789567|FG004|NOT COMPLETED|Overall Study||0||
48595147|NCT03578146|101789568|FG005|NOT COMPLETED|Overall Study||3||
48595148|NCT00394771|101789569|FG000|STARTED|Overall Study||140||
48595149|NCT00394771|101789570|FG001|STARTED|Overall Study||136||
48595150|NCT00394771|101789571|FG002|STARTED|Overall Study||143||
48595151|NCT00394771|101789572|FG003|STARTED|Overall Study||148||
48595152|NCT00394771|101789569|FG000|Intent to Treat (ITT) Population|Overall Study||110||
48595153|NCT00394771|101789570|FG001|Intent to Treat (ITT) Population|Overall Study||110||
48595154|NCT00394771|101789571|FG002|Intent to Treat (ITT) Population|Overall Study||108||
48595155|NCT00394771|101789572|FG003|Intent to Treat (ITT) Population|Overall Study||120||
48595156|NCT00394771|101789569|FG000|COMPLETED|Overall Study||99||
48595157|NCT00394771|101789570|FG001|COMPLETED|Overall Study||102||
48595158|NCT00394771|101789571|FG002|COMPLETED|Overall Study||96||
48595159|NCT00394771|101789572|FG003|COMPLETED|Overall Study||109||
48595160|NCT00394771|101789569|FG000|NOT COMPLETED|Overall Study||41||
48595161|NCT00394771|101789570|FG001|NOT COMPLETED|Overall Study||34||
48595162|NCT00394771|101789571|FG002|NOT COMPLETED|Overall Study||47||
48595163|NCT00394771|101789572|FG003|NOT COMPLETED|Overall Study||39||
48595164|NCT00316862|101789573|FG000|STARTED|Overall Study||82||
48595165|NCT00316862|101789573|FG000|COMPLETED|Overall Study||82||
48595166|NCT00316862|101789573|FG000|NOT COMPLETED|Overall Study||0||
48595167|NCT00637806|101789574|FG000|STARTED|Double-blind Phase||2||
48595168|NCT00637806|101789575|FG001|STARTED|Double-blind Phase||0||
48595169|NCT00637806|101789576|FG002|STARTED|Double-blind Phase||2||
48595170|NCT00637806|101789577|FG003|STARTED|Double-blind Phase||0||
48595171|NCT00637806|101789574|FG000|COMPLETED|Double-blind Phase||0||
48595172|NCT00637806|101789575|FG001|COMPLETED|Double-blind Phase||0||
48595173|NCT00637806|101789576|FG002|COMPLETED|Double-blind Phase||1||
48595174|NCT00637806|101789577|FG003|COMPLETED|Double-blind Phase||0||
48595175|NCT00637806|101789574|FG000|NOT COMPLETED|Double-blind Phase||2||
48595176|NCT00637806|101789575|FG001|NOT COMPLETED|Double-blind Phase||0||
48595177|NCT00637806|101789576|FG002|NOT COMPLETED|Double-blind Phase||1||
48595178|NCT00637806|101789577|FG003|NOT COMPLETED|Double-blind Phase||0||
48595179|NCT00637806|101789574|FG000|STARTED|Extension Phase||0||
48595180|NCT00637806|101789575|FG001|STARTED|Extension Phase||0||
48595181|NCT00637806|101789576|FG002|STARTED|Extension Phase||0||
48712062|NCT03831945|102081700|FG000|STARTED|Overall Study||10||
48712063|NCT03831945|102081701|FG001|STARTED|Overall Study||10||
48712064|NCT03831945|102081700|FG000|COMPLETED|Overall Study||3||
48712065|NCT03831945|102081701|FG001|COMPLETED|Overall Study||4||
48595182|NCT00637806|101789577|FG003|STARTED|Extension Phase||1||
48595183|NCT00637806|101789574|FG000|COMPLETED|Extension Phase||0||
48595184|NCT00637806|101789575|FG001|COMPLETED|Extension Phase||0||
48595185|NCT00637806|101789576|FG002|COMPLETED|Extension Phase||0||
48595186|NCT00637806|101789577|FG003|COMPLETED|Extension Phase||0||
48595187|NCT00637806|101789574|FG000|NOT COMPLETED|Extension Phase||0||
48595188|NCT00637806|101789575|FG001|NOT COMPLETED|Extension Phase||0||
48595189|NCT00637806|101789576|FG002|NOT COMPLETED|Extension Phase||0||
48595190|NCT00637806|101789577|FG003|NOT COMPLETED|Extension Phase||1||
48595191|NCT01416155|101789578|FG000|STARTED|Overall Study||97||
48595192|NCT01416155|101789578|FG000|COMPLETED|Overall Study||39||
48595193|NCT01416155|101789578|FG000|NOT COMPLETED|Overall Study||58||
48595194|NCT01023841|101789579|FG000|STARTED|Overall Study||48||
48595195|NCT01023841|101789580|FG001|STARTED|Overall Study||23||
48595196|NCT01023841|101789579|FG000|COMPLETED|Overall Study||47||
48712066|NCT03831945|102081700|FG000|NOT COMPLETED|Overall Study||7||
48712067|NCT03831945|102081701|FG001|NOT COMPLETED|Overall Study||6||
48712068|NCT01269385|102081702|FG000|STARTED|Overall Study||4||
48712069|NCT01269385|102081703|FG001|STARTED|Overall Study||4||
48712070|NCT01269385|102081704|FG002|STARTED|Overall Study||6||
48712071|NCT01269385|102081705|FG003|STARTED|Overall Study||8||
48712072|NCT01269385|102081702|FG000|COMPLETED|Overall Study||3||
48712073|NCT01269385|102081703|FG001|COMPLETED|Overall Study||3||
48712074|NCT01269385|102081704|FG002|COMPLETED|Overall Study||6||
48712075|NCT01269385|102081705|FG003|COMPLETED|Overall Study||8||
48712076|NCT01269385|102081702|FG000|NOT COMPLETED|Overall Study||1||
48712077|NCT01269385|102081703|FG001|NOT COMPLETED|Overall Study||1||
48712078|NCT01269385|102081704|FG002|NOT COMPLETED|Overall Study||0||
48712079|NCT01269385|102081705|FG003|NOT COMPLETED|Overall Study||0||
48712080|NCT04699812|102081706|FG000|STARTED|Overall Study||78||
48712081|NCT04699812|102081707|FG001|STARTED|Overall Study||82||
48712082|NCT04699812|102081708|FG002|STARTED|Overall Study||366||
48712083|NCT04699812|102081709|FG003|STARTED|Overall Study||47||
48712084|NCT04699812|102081706|FG000|COMPLETED|Overall Study||70||
48712085|NCT04699812|102081707|FG001|COMPLETED|Overall Study||64||
48712086|NCT04699812|102081708|FG002|COMPLETED|Overall Study||304||
48712087|NCT04699812|102081709|FG003|COMPLETED|Overall Study||45||
48712088|NCT04699812|102081706|FG000|NOT COMPLETED|Overall Study||8||
48712089|NCT04699812|102081707|FG001|NOT COMPLETED|Overall Study||18||
48712090|NCT04699812|102081708|FG002|NOT COMPLETED|Overall Study||62||
48712091|NCT04699812|102081709|FG003|NOT COMPLETED|Overall Study||2||
48712092|NCT00686842|102081710|FG000|STARTED|Overall Study||17||
48712093|NCT00686842|102081710|FG000|COMPLETED|Overall Study||17||
48712094|NCT00686842|102081710|FG000|NOT COMPLETED|Overall Study||0||
48712095|NCT02061397|102081711|FG000|STARTED|Simvastatin 20 mg Oral Daily for 2 Month||10||
48712096|NCT02061397|102081711|FG000|COMPLETED|Simvastatin 20 mg Oral Daily for 2 Month||10||
48712097|NCT02061397|102081711|FG000|NOT COMPLETED|Simvastatin 20 mg Oral Daily for 2 Month||0||
48712098|NCT02061397|102081711|FG000|STARTED|Simvastatin 40 mg Oral Daily for 2 Month||10||
48712099|NCT02061397|102081711|FG000|COMPLETED|Simvastatin 40 mg Oral Daily for 2 Month||10||
48712100|NCT02061397|102081711|FG000|NOT COMPLETED|Simvastatin 40 mg Oral Daily for 2 Month||0||
48712101|NCT00681564|102081712|FG000|STARTED|Overall Study||47||
48712102|NCT00681564|102081713|FG001|STARTED|Overall Study||55||
48712103|NCT00681564|102081712|FG000|COMPLETED|Overall Study||41||
48712104|NCT00681564|102081713|FG001|COMPLETED|Overall Study||47||
48712105|NCT00681564|102081712|FG000|NOT COMPLETED|Overall Study||6||
48712106|NCT00681564|102081713|FG001|NOT COMPLETED|Overall Study||8||
48712107|NCT02262078|102081714|FG000|STARTED|Overall Study||13||
48712108|NCT02262078|102081715|FG001|STARTED|Overall Study||13||
48712109|NCT02262078|102081714|FG000|COMPLETED|Overall Study||13||
48712110|NCT02262078|102081715|FG001|COMPLETED|Overall Study||13||
48712111|NCT02262078|102081714|FG000|NOT COMPLETED|Overall Study||0||
48712112|NCT02262078|102081715|FG001|NOT COMPLETED|Overall Study||0||
48595197|NCT01023841|101789580|FG001|COMPLETED|Overall Study||23||
48595198|NCT01023841|101789579|FG000|NOT COMPLETED|Overall Study||1||
48595199|NCT01023841|101789580|FG001|NOT COMPLETED|Overall Study||0||
48595200|NCT02670382|101789581|FG000|STARTED|Placebo lead-in Phase||12||
48595201|NCT02670382|101789582|FG001|STARTED|Placebo lead-in Phase||12||
48595202|NCT02670382|101789581|FG000|COMPLETED|Placebo lead-in Phase||10||
48595203|NCT02670382|101789582|FG001|COMPLETED|Placebo lead-in Phase||11||
48595204|NCT02670382|101789581|FG000|NOT COMPLETED|Placebo lead-in Phase||2||
48595205|NCT02670382|101789582|FG001|NOT COMPLETED|Placebo lead-in Phase||1||
48595206|NCT02670382|101789581|FG000|STARTED|First Active Intervention||10||
48595207|NCT02670382|101789582|FG001|STARTED|First Active Intervention||11||
48712113|NCT01962987|102081716|FG000|STARTED|Overall Study||190||
48712114|NCT01962987|102081717|FG001|STARTED|Overall Study||191||
48712115|NCT01962987|102081718|FG002|STARTED|Overall Study||95||
48712116|NCT01962987|102081716|FG000|COMPLETED|Overall Study||160||
48712117|NCT01962987|102081717|FG001|COMPLETED|Overall Study||163||
48712118|NCT01962987|102081718|FG002|COMPLETED|Overall Study||83||
48712119|NCT01962987|102081716|FG000|NOT COMPLETED|Overall Study||30||
48712120|NCT01962987|102081717|FG001|NOT COMPLETED|Overall Study||28||
48712121|NCT01962987|102081718|FG002|NOT COMPLETED|Overall Study||12||
48712122|NCT00320749|102081719|FG000|STARTED|Overall Study||3||
48712123|NCT00320749|102081720|FG001|STARTED|Overall Study||8||
48712124|NCT00320749|102081721|FG002|STARTED|Overall Study||10||
48712125|NCT00320749|102081719|FG000|COMPLETED|Overall Study||3||
48712126|NCT00320749|102081720|FG001|COMPLETED|Overall Study||6||
48712127|NCT00320749|102081721|FG002|COMPLETED|Overall Study||1||
48712128|NCT00320749|102081719|FG000|NOT COMPLETED|Overall Study||0||
48712129|NCT00320749|102081720|FG001|NOT COMPLETED|Overall Study||2||
48712130|NCT00320749|102081721|FG002|NOT COMPLETED|Overall Study||9||
48712131|NCT01666119|102081722|FG000|STARTED|Overall Study||249||
48712132|NCT01666119|102081722|FG000|COMPLETED|Overall Study||197||
48712133|NCT01666119|102081722|FG000|NOT COMPLETED|Overall Study||52||
48712134|NCT00868530|102081723|FG000|STARTED|Overall Study||53||
48712135|NCT00868530|102081723|FG000|COMPLETED|Overall Study||49||
48712136|NCT00868530|102081723|FG000|NOT COMPLETED|Overall Study||4||
48712137|NCT03366103|102081724|FG000|STARTED|Overall Study||9||
48712138|NCT03366103|102081725|FG001|STARTED|Overall Study||5||
48712139|NCT03366103|102081726|FG002|STARTED|Overall Study||1||
48712140|NCT03366103|102081724|FG000|COMPLETED|Overall Study||6||
48712141|NCT03366103|102081725|FG001|COMPLETED|Overall Study||3||
48712142|NCT03366103|102081726|FG002|COMPLETED|Overall Study||1||
48712143|NCT03366103|102081724|FG000|NOT COMPLETED|Overall Study||3||
48712144|NCT03366103|102081725|FG001|NOT COMPLETED|Overall Study||2||
48595208|NCT02670382|101789581|FG000|COMPLETED|First Active Intervention||10||
48595209|NCT02670382|101789582|FG001|COMPLETED|First Active Intervention||11||
48595210|NCT02670382|101789581|FG000|NOT COMPLETED|First Active Intervention||0||
48712145|NCT03366103|102081726|FG002|NOT COMPLETED|Overall Study||0||
48712146|NCT00511433|102081727|FG000|STARTED|Overall Study||32||
48712147|NCT00511433|102081728|FG001|STARTED|Overall Study||16||
48712148|NCT00511433|102081727|FG000|COMPLETED|Overall Study||26||
48712149|NCT00511433|102081728|FG001|COMPLETED|Overall Study||15||
48712150|NCT00511433|102081727|FG000|NOT COMPLETED|Overall Study||6||
48712151|NCT00511433|102081728|FG001|NOT COMPLETED|Overall Study||1||
48712152|NCT00815191|102081729|FG000|STARTED|Overall Study||38||
48712153|NCT00815191|102081730|FG001|STARTED|Overall Study||35||
48712154|NCT00815191|102081729|FG000|COMPLETED|Overall Study||37||
48712155|NCT00815191|102081730|FG001|COMPLETED|Overall Study||34||
48712156|NCT00815191|102081729|FG000|NOT COMPLETED|Overall Study||1||
48712157|NCT00815191|102081730|FG001|NOT COMPLETED|Overall Study||1||
48712158|NCT04580277|102081731|FG000|STARTED|Overall Study||6||
48712159|NCT04580277|102081731|FG000|COMPLETED|Overall Study||6||
48712160|NCT04580277|102081731|FG000|NOT COMPLETED|Overall Study||0||
48712161|NCT00182767|102081732|FG000|STARTED|Overall Study||6||
48712162|NCT00182767|102081733|FG001|STARTED|Overall Study||6||
48712163|NCT00182767|102081734|FG002|STARTED|Overall Study||6||
48712164|NCT00182767|102081735|FG003|STARTED|Overall Study||3||
48712165|NCT00182767|102081736|FG004|STARTED|Overall Study||24||
48712166|NCT00182767|102081732|FG000|COMPLETED|Overall Study||6||
48712167|NCT00182767|102081733|FG001|COMPLETED|Overall Study||6||
48712168|NCT00182767|102081734|FG002|COMPLETED|Overall Study||6||
48712169|NCT00182767|102081735|FG003|COMPLETED|Overall Study||3||
48712170|NCT00182767|102081736|FG004|COMPLETED|Overall Study||24||
48712171|NCT00182767|102081732|FG000|NOT COMPLETED|Overall Study||0||
48712172|NCT00182767|102081733|FG001|NOT COMPLETED|Overall Study||0||
48712173|NCT00182767|102081734|FG002|NOT COMPLETED|Overall Study||0||
48712174|NCT00182767|102081735|FG003|NOT COMPLETED|Overall Study||0||
48712175|NCT00182767|102081736|FG004|NOT COMPLETED|Overall Study||0||
48712176|NCT00438854|102081737|FG000|STARTED|Overall Study||15||
48712177|NCT00438854|102081737|FG000|COMPLETED|Overall Study||15||
48404533|NCT01248585|101321879|FG000|COMPLETED|Overall Study||148||
48404534|NCT01248585|101321880|FG001|COMPLETED|Overall Study||150||
48404535|NCT01248585|101321879|FG000|NOT COMPLETED|Overall Study||0||
48404536|NCT01248585|101321880|FG001|NOT COMPLETED|Overall Study||0||
48404537|NCT02470429|101321881|FG000|STARTED|Overall Study||50||
48404538|NCT02470429|101321882|FG001|STARTED|Overall Study||49||
48404539|NCT02470429|101321881|FG000|COMPLETED|Overall Study||48||
48595211|NCT02670382|101789582|FG001|NOT COMPLETED|First Active Intervention||0||
48595212|NCT02670382|101789581|FG000|STARTED|Second Active Intervention||10||
48595213|NCT02670382|101789582|FG001|STARTED|Second Active Intervention||11||
48595214|NCT02670382|101789581|FG000|COMPLETED|Second Active Intervention||10||
48595215|NCT02670382|101789582|FG001|COMPLETED|Second Active Intervention||11||
48595216|NCT02670382|101789581|FG000|NOT COMPLETED|Second Active Intervention||0||
48712178|NCT00438854|102081737|FG000|NOT COMPLETED|Overall Study||0||
48404540|NCT02470429|101321882|FG001|COMPLETED|Overall Study||49||
48404541|NCT02470429|101321881|FG000|NOT COMPLETED|Overall Study||2||
48595217|NCT02670382|101789582|FG001|NOT COMPLETED|Second Active Intervention||0||
48595218|NCT00456508|101789583|FG000|STARTED|Overall Study||147||
48595219|NCT00456508|101789583|FG000|COMPLETED|Overall Study||147||
48595220|NCT00456508|101789583|FG000|NOT COMPLETED|Overall Study||0||
48712179|NCT00358332|102081738|FG000|STARTED|Overall Study||15||
48404542|NCT02470429|101321882|FG001|NOT COMPLETED|Overall Study||0||
48404543|NCT02774668|101321883|FG000|STARTED|Overall Study||10||
48404544|NCT02774668|101321884|FG001|STARTED|Overall Study||10||
48404545|NCT02774668|101321883|FG000|COMPLETED|Overall Study||10||
48404546|NCT02774668|101321884|FG001|COMPLETED|Overall Study||10||
48404547|NCT02774668|101321883|FG000|NOT COMPLETED|Overall Study||0||
48404548|NCT02774668|101321884|FG001|NOT COMPLETED|Overall Study||0||
48404549|NCT02623699|101321885|FG000|STARTED|Part A (Up to 63 Days)||5||
48404550|NCT02623699|101321886|FG001|STARTED|Part A (Up to 63 Days)||3||
48404551|NCT02623699|101321887|FG002|STARTED|Part A (Up to 63 Days)||3||
48404552|NCT02623699|101321888|FG003|STARTED|Part A (Up to 63 Days)||3||
48404553|NCT02623699|101321889|FG004|STARTED|Part A (Up to 63 Days)||6||
48404554|NCT02623699|101321890|FG005|STARTED|Part A (Up to 63 Days)||0||
48712180|NCT00358332|102081739|FG001|STARTED|Overall Study||30||
48595221|NCT01625689|101789584|FG000|STARTED|Overall Study||150||
48595222|NCT01625689|101789585|FG001|STARTED|Overall Study||150||
48595223|NCT01625689|101789584|FG000|COMPLETED|Overall Study||148||
48595224|NCT01625689|101789585|FG001|COMPLETED|Overall Study||149||
48595225|NCT01625689|101789584|FG000|NOT COMPLETED|Overall Study||2||
48595226|NCT01625689|101789585|FG001|NOT COMPLETED|Overall Study||1||
48595227|NCT02908074|101789586|FG000|STARTED|Overall Study||38||
48595228|NCT02908074|101789587|FG001|STARTED|Overall Study||33||
48595229|NCT02908074|101789588|FG002|STARTED|Overall Study||31||
48595230|NCT02908074|101789589|FG003|STARTED|Overall Study||13||
48595231|NCT02908074|101789590|FG004|STARTED|Overall Study||17||
48595232|NCT02908074|101789591|FG005|STARTED|Overall Study||11||
48595233|NCT02908074|101789586|FG000|Received at Least 1 Dose of Study Drug|Overall Study||38||
48595234|NCT02908074|101789587|FG001|Received at Least 1 Dose of Study Drug|Overall Study||33||
48595235|NCT02908074|101789588|FG002|Received at Least 1 Dose of Study Drug|Overall Study||30||
48595236|NCT02908074|101789589|FG003|Received at Least 1 Dose of Study Drug|Overall Study||13||
48595237|NCT02908074|101789590|FG004|Received at Least 1 Dose of Study Drug|Overall Study||17||
48595238|NCT02908074|101789591|FG005|Received at Least 1 Dose of Study Drug|Overall Study||10||
48595239|NCT02908074|101789586|FG000|Safety Population|Overall Study||38||
48595240|NCT02908074|101789587|FG001|Safety Population|Overall Study||33||
48595241|NCT02908074|101789588|FG002|Safety Population|Overall Study||30||
48595242|NCT02908074|101789589|FG003|Safety Population|Overall Study||13||
48595243|NCT02908074|101789590|FG004|Safety Population|Overall Study||17||
48595244|NCT02908074|101789591|FG005|Safety Population|Overall Study||10||
48595245|NCT02908074|101789586|FG000|Intention-to-treat (ITT) Population|Overall Study||38||
48595246|NCT02908074|101789587|FG001|Intention-to-treat (ITT) Population|Overall Study||33||
48595247|NCT02908074|101789588|FG002|Intention-to-treat (ITT) Population|Overall Study||30||
48595248|NCT02908074|101789589|FG003|Intention-to-treat (ITT) Population|Overall Study||0||
48595249|NCT02908074|101789590|FG004|Intention-to-treat (ITT) Population|Overall Study||0||
48595250|NCT02908074|101789591|FG005|Intention-to-treat (ITT) Population|Overall Study||0||
48595251|NCT02908074|101789586|FG000|COMPLETED|Overall Study||29||
48595252|NCT02908074|101789587|FG001|COMPLETED|Overall Study||27||
48595253|NCT02908074|101789588|FG002|COMPLETED|Overall Study||25||
48595254|NCT02908074|101789589|FG003|COMPLETED|Overall Study||10||
48595255|NCT02908074|101789590|FG004|COMPLETED|Overall Study||13||
48595256|NCT02908074|101789591|FG005|COMPLETED|Overall Study||7||
48595257|NCT02908074|101789586|FG000|NOT COMPLETED|Overall Study||9||
48595258|NCT02908074|101789587|FG001|NOT COMPLETED|Overall Study||6||
48595259|NCT02908074|101789588|FG002|NOT COMPLETED|Overall Study||6||
48595260|NCT02908074|101789589|FG003|NOT COMPLETED|Overall Study||3||
48595261|NCT02908074|101789590|FG004|NOT COMPLETED|Overall Study||4||
48595262|NCT02908074|101789591|FG005|NOT COMPLETED|Overall Study||4||
48595263|NCT00771264|101789592|FG000|STARTED|Overall Study||110||
48595264|NCT00771264|101789593|FG001|STARTED|Overall Study||110||
48595265|NCT00771264|101789592|FG000|COMPLETED|Overall Study||103||
48595266|NCT00771264|101789593|FG001|COMPLETED|Overall Study||105||
48595267|NCT00771264|101789592|FG000|NOT COMPLETED|Overall Study||7||
48595268|NCT00771264|101789593|FG001|NOT COMPLETED|Overall Study||5||
48595269|NCT05604794|101789594|FG000|STARTED|Overall Study||1806||
48595270|NCT05604794|101789594|FG000|COMPLETED|Overall Study||94||
48595271|NCT05604794|101789594|FG000|NOT COMPLETED|Overall Study||1712||
48595272|NCT00741091|101789595|FG000|STARTED|Overall Study||1097||
48595273|NCT00741091|101789595|FG000|COMPLETED|Overall Study||1040||
48595274|NCT00741091|101789595|FG000|NOT COMPLETED|Overall Study||57||
48595275|NCT01069419|101789596|FG000|STARTED|Overall Study||1117||
48595276|NCT01069419|101789596|FG000|Safety Set|Overall Study||1111||
48595277|NCT01069419|101789596|FG000|Full Analysis Set|Overall Study||851||
48595278|NCT01069419|101789596|FG000|COMPLETED|Overall Study||402||
48595279|NCT01069419|101789596|FG000|NOT COMPLETED|Overall Study||715||
48595280|NCT02436031|101789597|FG000|STARTED|First Study Night||8||
48595281|NCT02436031|101789598|FG001|STARTED|First Study Night||8||
48595282|NCT02436031|101789597|FG000|COMPLETED|First Study Night||8||
48595283|NCT02436031|101789598|FG001|COMPLETED|First Study Night||8||
48595284|NCT02436031|101789597|FG000|NOT COMPLETED|First Study Night||0||
48595285|NCT02436031|101789598|FG001|NOT COMPLETED|First Study Night||0||
48595286|NCT02436031|101789597|FG000|STARTED|Second Study Night||7||
48595287|NCT02436031|101789598|FG001|STARTED|Second Study Night||8||
48595288|NCT02436031|101789597|FG000|COMPLETED|Second Study Night||7||
48595289|NCT02436031|101789598|FG001|COMPLETED|Second Study Night||8||
48595290|NCT02436031|101789597|FG000|NOT COMPLETED|Second Study Night||0||
48595291|NCT02436031|101789598|FG001|NOT COMPLETED|Second Study Night||0||
48595292|NCT00207727|101789599|FG000|STARTED|Overall Study||49||
48712181|NCT00358332|102081740|FG002|STARTED|Overall Study||30||
48712182|NCT00358332|102081741|FG003|STARTED|Overall Study||25||
48712183|NCT00358332|102081738|FG000|COMPLETED|Overall Study||15||
48712184|NCT00358332|102081739|FG001|COMPLETED|Overall Study||27||
48712185|NCT00358332|102081740|FG002|COMPLETED|Overall Study||29||
48712186|NCT00358332|102081741|FG003|COMPLETED|Overall Study||25||
48295246|NCT00256451|101050835|FG000|COMPLETED|Session1||10||
48595293|NCT00207727|101789600|FG001|STARTED|Overall Study||50||
48595294|NCT00207727|101789601|FG002|STARTED|Overall Study||50||
48595295|NCT00207727|101789602|FG003|STARTED|Overall Study||50||
48595296|NCT00207727|101789603|FG004|STARTED|Overall Study||50||
48595297|NCT00207727|101789599|FG000|COMPLETED|Overall Study||11||
48595298|NCT00207727|101789600|FG001|COMPLETED|Overall Study||8||
48595299|NCT00207727|101789601|FG002|COMPLETED|Overall Study||9||
48595300|NCT00207727|101789602|FG003|COMPLETED|Overall Study||13||
48595301|NCT00207727|101789603|FG004|COMPLETED|Overall Study||16||
48595302|NCT00207727|101789599|FG000|NOT COMPLETED|Overall Study||38||
48595303|NCT00207727|101789600|FG001|NOT COMPLETED|Overall Study||42||
48595304|NCT00207727|101789601|FG002|NOT COMPLETED|Overall Study||41||
48595305|NCT00207727|101789602|FG003|NOT COMPLETED|Overall Study||37||
48595306|NCT00207727|101789603|FG004|NOT COMPLETED|Overall Study||34||
48595307|NCT00430352|101789604|FG000|STARTED|Overall Study||545||
48595308|NCT00430352|101789604|FG000|COMPLETED|Overall Study||407||
48595309|NCT00430352|101789604|FG000|NOT COMPLETED|Overall Study||138||
48595310|NCT01124292|101789605|FG000|STARTED|Overall Study||16||
48595311|NCT01124292|101789606|FG001|STARTED|Overall Study||24||
48595312|NCT01124292|101789607|FG002|STARTED|Overall Study||21||
48595313|NCT01124292|101789605|FG000|COMPLETED|Overall Study||14||
48595314|NCT01124292|101789606|FG001|COMPLETED|Overall Study||9||
48595315|NCT01124292|101789607|FG002|COMPLETED|Overall Study||11||
48595316|NCT01124292|101789605|FG000|NOT COMPLETED|Overall Study||2||
48595317|NCT01124292|101789606|FG001|NOT COMPLETED|Overall Study||15||
48595318|NCT01124292|101789607|FG002|NOT COMPLETED|Overall Study||10||
48595319|NCT01935700|101789608|FG000|STARTED|Overall Study||14||
48595320|NCT01935700|101789609|FG001|STARTED|Overall Study||86||
48712187|NCT00358332|102081738|FG000|NOT COMPLETED|Overall Study||0||
48712188|NCT00358332|102081739|FG001|NOT COMPLETED|Overall Study||3||
48712189|NCT00358332|102081740|FG002|NOT COMPLETED|Overall Study||1||
48404555|NCT02623699|101321891|FG006|STARTED|Part A (Up to 63 Days)||0||
48404556|NCT02623699|101321892|FG007|STARTED|Part A (Up to 63 Days)||0||
48404557|NCT02623699|101321893|FG008|STARTED|Part A (Up to 63 Days)||0||
48404558|NCT02623699|101321894|FG009|STARTED|Part A (Up to 63 Days)||0||
48404559|NCT02623699|101321895|FG010|STARTED|Part A (Up to 63 Days)||0||
48595321|NCT01935700|101789608|FG000|COMPLETED|Overall Study||9|The participant received more than 8 courses of colchicine management.|
48595322|NCT01935700|101789609|FG001|COMPLETED|Overall Study||86|The participant received more than 8 courses of colchicine management.|
48595323|NCT01935700|101789608|FG000|NOT COMPLETED|Overall Study||5||
48595324|NCT01935700|101789609|FG001|NOT COMPLETED|Overall Study||0||
48595325|NCT01863498|101789610|FG000|STARTED|Overall Study||33||
48712190|NCT00358332|102081741|FG003|NOT COMPLETED|Overall Study||0||
48712191|NCT00042432|102081742|FG000|STARTED|Overall Study||27||
48295247|NCT00256451|101050836|FG001|COMPLETED|Session1||11||
48295248|NCT00256451|101050837|FG002|COMPLETED|Session1||11||
48295249|NCT00256451|101050838|FG003|COMPLETED|Session1||11||
48295250|NCT00256451|101050835|FG000|NOT COMPLETED|Session1||0||
48295251|NCT00256451|101050836|FG001|NOT COMPLETED|Session1||0||
48295252|NCT00256451|101050837|FG002|NOT COMPLETED|Session1||0||
48295253|NCT00256451|101050838|FG003|NOT COMPLETED|Session1||0||
48295254|NCT00256451|101050835|FG000|STARTED|Session2||9|Crossover design: no of subjs who completed the PRIOR session|
48295255|NCT00256451|101050836|FG001|STARTED|Session2||11|Crossover design: no of subjs who completed the PRIOR session|
48295256|NCT00256451|101050837|FG002|STARTED|Session2||10|Crossover design: no of subjs who completed the PRIOR session|
48295257|NCT00256451|101050838|FG003|STARTED|Session2||10|Crossover design: no of subjs who completed the PRIOR session|
48595326|NCT01863498|101789611|FG001|STARTED|Overall Study||32||
48595327|NCT01863498|101789610|FG000|COMPLETED|Overall Study||33||
48595328|NCT01863498|101789611|FG001|COMPLETED|Overall Study||32||
48595329|NCT01863498|101789610|FG000|NOT COMPLETED|Overall Study||0||
48595330|NCT01863498|101789611|FG001|NOT COMPLETED|Overall Study||0||
48595331|NCT02457832|101789612|FG000|STARTED|Training||34||
48295258|NCT00256451|101050835|FG000|COMPLETED|Session2||9||
48295259|NCT00256451|101050836|FG001|COMPLETED|Session2||11||
48295260|NCT00256451|101050837|FG002|COMPLETED|Session2||10||
48295261|NCT00256451|101050838|FG003|COMPLETED|Session2||10||
48595332|NCT02457832|101789613|FG001|STARTED|Training||31||
48595333|NCT02457832|101789614|FG002|STARTED|Training||22||
48595334|NCT02457832|101789612|FG000|COMPLETED|Training||24||
48595335|NCT02457832|101789613|FG001|COMPLETED|Training||25||
48595336|NCT02457832|101789614|FG002|COMPLETED|Training||19||
48595337|NCT02457832|101789612|FG000|NOT COMPLETED|Training||10||
48595338|NCT02457832|101789613|FG001|NOT COMPLETED|Training||6||
48595339|NCT02457832|101789614|FG002|NOT COMPLETED|Training||3||
48595340|NCT02457832|101789612|FG000|STARTED|One Month Washout||24||
48595341|NCT02457832|101789613|FG001|STARTED|One Month Washout||25||
48595342|NCT02457832|101789614|FG002|STARTED|One Month Washout||19||
48595343|NCT02457832|101789612|FG000|COMPLETED|One Month Washout||24||
48595344|NCT02457832|101789613|FG001|COMPLETED|One Month Washout||24||
48595345|NCT02457832|101789614|FG002|COMPLETED|One Month Washout||18||
48595346|NCT02457832|101789612|FG000|NOT COMPLETED|One Month Washout||0||
48595347|NCT02457832|101789613|FG001|NOT COMPLETED|One Month Washout||1||
48595348|NCT02457832|101789614|FG002|NOT COMPLETED|One Month Washout||1||
48595349|NCT03570554|101789615|FG000|STARTED|Overall Study||10||
48595350|NCT03570554|101789616|FG001|STARTED|Overall Study||10||
48595351|NCT03570554|101789617|FG002|STARTED|Overall Study||11||
48595352|NCT03570554|101789618|FG003|STARTED|Overall Study||10||
48595353|NCT03570554|101789615|FG000|COMPLETED|Overall Study||10||
48595354|NCT03570554|101789616|FG001|COMPLETED|Overall Study||10||
48595355|NCT03570554|101789617|FG002|COMPLETED|Overall Study||10||
48595356|NCT03570554|101789618|FG003|COMPLETED|Overall Study||9||
48595357|NCT03570554|101789615|FG000|NOT COMPLETED|Overall Study||0||
48595358|NCT03570554|101789616|FG001|NOT COMPLETED|Overall Study||0||
48595359|NCT03570554|101789617|FG002|NOT COMPLETED|Overall Study||1||
48595360|NCT03570554|101789618|FG003|NOT COMPLETED|Overall Study||1||
48595361|NCT00525902|101789619|FG000|STARTED|Overall Study||31||
48595362|NCT00525902|101789619|FG000|10 Weeks|Overall Study||30||
48595363|NCT00525902|101789619|FG000|50 Weeks|Overall Study||12||
48595364|NCT00525902|101789619|FG000|COMPLETED|Overall Study||30||
48595365|NCT00525902|101789619|FG000|NOT COMPLETED|Overall Study||1||
48712192|NCT00042432|102081743|FG001|STARTED|Overall Study||27||
48188511|NCT01686932|100783263|FG001|COMPLETED|Period 1||25||
48295262|NCT00256451|101050835|FG000|NOT COMPLETED|Session2||0||
48295263|NCT00256451|101050836|FG001|NOT COMPLETED|Session2||0||
48295264|NCT00256451|101050837|FG002|NOT COMPLETED|Session2||0||
48595366|NCT01214252|101789620|FG000|STARTED|Overall Study||425||
48595367|NCT01214252|101789620|FG000|COMPLETED|Overall Study||343||
48595368|NCT01214252|101789620|FG000|NOT COMPLETED|Overall Study||82||
48595369|NCT03782974|101789621|FG000|STARTED|Overall Study||70||
48595370|NCT03782974|101789622|FG001|STARTED|Overall Study||68||
48595371|NCT03782974|101789621|FG000|COMPLETED|Overall Study||62||
48595372|NCT03782974|101789622|FG001|COMPLETED|Overall Study||61||
48595373|NCT03782974|101789621|FG000|NOT COMPLETED|Overall Study||8||
48595374|NCT03782974|101789622|FG001|NOT COMPLETED|Overall Study||7||
48595375|NCT02470403|101789623|FG000|STARTED|Overall Study||44||
48595376|NCT02470403|101789624|FG001|STARTED|Overall Study||44||
48595377|NCT02470403|101789625|FG002|STARTED|Overall Study||40||
48595378|NCT02470403|101789626|FG003|STARTED|Overall Study||43||
48595379|NCT02470403|101789627|FG004|STARTED|Overall Study||10||
48595380|NCT02470403|101789623|FG000|Dysglycemic|Overall Study||24||
48595381|NCT02470403|101789624|FG001|Dysglycemic|Overall Study||24||
48595382|NCT02470403|101789625|FG002|Dysglycemic|Overall Study||20||
48595383|NCT02470403|101789626|FG003|Dysglycemic|Overall Study||20||
48595384|NCT02470403|101789627|FG004|Dysglycemic|Overall Study||5||
48595385|NCT02470403|101789623|FG000|Normoglycemic|Overall Study||20||
48595386|NCT02470403|101789624|FG001|Normoglycemic|Overall Study||20||
48595387|NCT02470403|101789625|FG002|Normoglycemic|Overall Study||20||
48595388|NCT02470403|101789626|FG003|Normoglycemic|Overall Study||23||
48595389|NCT02470403|101789627|FG004|Normoglycemic|Overall Study||5||
48595390|NCT02470403|101789623|FG000|COMPLETED|Overall Study||42||
48595391|NCT02470403|101789624|FG001|COMPLETED|Overall Study||43||
48595392|NCT02470403|101789625|FG002|COMPLETED|Overall Study||40||
48595393|NCT02470403|101789626|FG003|COMPLETED|Overall Study||39||
48595394|NCT02470403|101789627|FG004|COMPLETED|Overall Study||10||
48595395|NCT02470403|101789623|FG000|NOT COMPLETED|Overall Study||2||
48595396|NCT02470403|101789624|FG001|NOT COMPLETED|Overall Study||1||
48595397|NCT02470403|101789625|FG002|NOT COMPLETED|Overall Study||0||
48595398|NCT02470403|101789626|FG003|NOT COMPLETED|Overall Study||4||
48595399|NCT02470403|101789627|FG004|NOT COMPLETED|Overall Study||0||
48595400|NCT02147522|101789628|FG000|STARTED|Overall Study||178||
48595401|NCT02147522|101789629|FG001|STARTED|Overall Study||170||
48595402|NCT02147522|101789628|FG000|COMPLETED|Overall Study||122||
48595403|NCT02147522|101789629|FG001|COMPLETED|Overall Study||122||
48595404|NCT02147522|101789628|FG000|NOT COMPLETED|Overall Study||56||
48595405|NCT02147522|101789629|FG001|NOT COMPLETED|Overall Study||48||
48595406|NCT01706575|101789630|FG000|STARTED|Overall Study||76||
48595407|NCT01706575|101789630|FG000|Treated|Overall Study||70||
48595408|NCT01706575|101789630|FG000|COMPLETED|Overall Study||64||
48595409|NCT01706575|101789630|FG000|NOT COMPLETED|Overall Study||12||
48595410|NCT01712334|101789631|FG000|STARTED|Treatment Period 1||44||
48595411|NCT01712334|101789632|FG001|STARTED|Treatment Period 1||43||
48595412|NCT01712334|101789631|FG000|Received Treatment|Treatment Period 1||44||
48595413|NCT01712334|101789632|FG001|Received Treatment|Treatment Period 1||41||
48595414|NCT01712334|101789631|FG000|COMPLETED|Treatment Period 1||44||
48595415|NCT01712334|101789632|FG001|COMPLETED|Treatment Period 1||41||
48595416|NCT01712334|101789631|FG000|NOT COMPLETED|Treatment Period 1||0||
48595417|NCT01712334|101789632|FG001|NOT COMPLETED|Treatment Period 1||2||
48595418|NCT01712334|101789631|FG000|STARTED|Treatment Period 2||44||
48595419|NCT01712334|101789632|FG001|STARTED|Treatment Period 2||41||
48595420|NCT01712334|101789631|FG000|COMPLETED|Treatment Period 2||44||
48595421|NCT01712334|101789632|FG001|COMPLETED|Treatment Period 2||41||
48595422|NCT01712334|101789631|FG000|NOT COMPLETED|Treatment Period 2||0||
48595423|NCT01712334|101789632|FG001|NOT COMPLETED|Treatment Period 2||0||
48595424|NCT01886781|101789633|FG000|STARTED|Overall Study||54||
48595425|NCT01886781|101789634|FG001|STARTED|Overall Study||27||
48595426|NCT01886781|101789633|FG000|COMPLETED|Overall Study||40||
48595427|NCT01886781|101789634|FG001|COMPLETED|Overall Study||25||
48595428|NCT01886781|101789633|FG000|NOT COMPLETED|Overall Study||14||
48595429|NCT01886781|101789634|FG001|NOT COMPLETED|Overall Study||2||
48595430|NCT02223819|101789635|FG000|STARTED|Overall Study||34||
48595431|NCT02223819|101789635|FG000|COMPLETED|Overall Study||32||
48595432|NCT02223819|101789635|FG000|NOT COMPLETED|Overall Study||2||
48595433|NCT03870529|101789636|FG000|STARTED|Overall Study||11||
48595434|NCT03870529|101789637|FG001|STARTED|Overall Study||9||
48595435|NCT03870529|101789636|FG000|COMPLETED|Overall Study||11||
48595436|NCT03870529|101789637|FG001|COMPLETED|Overall Study||9||
48595437|NCT03870529|101789636|FG000|NOT COMPLETED|Overall Study||0||
48595438|NCT03870529|101789637|FG001|NOT COMPLETED|Overall Study||0||
48595439|NCT00583375|101789638|FG000|STARTED|Overall Study||142||
48595440|NCT00583375|101789639|FG001|STARTED|Overall Study||272||
48712193|NCT00042432|102081742|FG000|COMPLETED|Overall Study||18||
48712194|NCT00042432|102081743|FG001|COMPLETED|Overall Study||20||
48712195|NCT00042432|102081742|FG000|NOT COMPLETED|Overall Study||9||
48595441|NCT00583375|101789638|FG000|COMPLETED|Overall Study||142||
48595442|NCT00583375|101789639|FG001|COMPLETED|Overall Study||272||
48595443|NCT00583375|101789638|FG000|NOT COMPLETED|Overall Study||0||
48595444|NCT00583375|101789639|FG001|NOT COMPLETED|Overall Study||0||
48595445|NCT05805085|101789640|FG000|STARTED|Period 1: Lens A, 15 Minutes||40||
48595446|NCT05805085|101789641|FG001|STARTED|Period 1: Lens A, 15 Minutes||0||
48595447|NCT05805085|101789640|FG000|COMPLETED|Period 1: Lens A, 15 Minutes||40||
48595448|NCT05805085|101789641|FG001|COMPLETED|Period 1: Lens A, 15 Minutes||0||
48595449|NCT05805085|101789640|FG000|NOT COMPLETED|Period 1: Lens A, 15 Minutes||0||
48595450|NCT05805085|101789641|FG001|NOT COMPLETED|Period 1: Lens A, 15 Minutes||0||
48595451|NCT05805085|101789640|FG000|STARTED|Period 2: Lens B, 15 Minutes||0||
48595452|NCT05805085|101789641|FG001|STARTED|Period 2: Lens B, 15 Minutes||40||
48595453|NCT05805085|101789640|FG000|COMPLETED|Period 2: Lens B, 15 Minutes||0||
48595454|NCT05805085|101789641|FG001|COMPLETED|Period 2: Lens B, 15 Minutes||40||
48595455|NCT05805085|101789640|FG000|NOT COMPLETED|Period 2: Lens B, 15 Minutes||0||
48712196|NCT00042432|102081743|FG001|NOT COMPLETED|Overall Study||7||
48595456|NCT05805085|101789641|FG001|NOT COMPLETED|Period 2: Lens B, 15 Minutes||0||
48595457|NCT00033657|101789642|FG000|STARTED|Neoadjuvant Chemotherapy||50||
48595458|NCT00033657|101789643|FG001|STARTED|Neoadjuvant Chemotherapy||47||
48595459|NCT00033657|101789642|FG000|Eligible|Neoadjuvant Chemotherapy||42||
48595460|NCT00033657|101789643|FG001|Eligible|Neoadjuvant Chemotherapy||43||
48595461|NCT00033657|101789642|FG000|Eligible and Treated|Neoadjuvant Chemotherapy||39||
48595462|NCT00033657|101789643|FG001|Eligible and Treated|Neoadjuvant Chemotherapy||42||
48595463|NCT00033657|101789642|FG000|COMPLETED|Neoadjuvant Chemotherapy||36||
48595464|NCT00033657|101789643|FG001|COMPLETED|Neoadjuvant Chemotherapy||36||
48595465|NCT00033657|101789642|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||14||
48595466|NCT00033657|101789643|FG001|NOT COMPLETED|Neoadjuvant Chemotherapy||11||
48141856|NCT04988308|100673420|FG002|Full- Analysis Set (FAS)|Placebo Controlled Period (Weeks 0-16)||35||
48141857|NCT04988308|100673421|FG003|Full- Analysis Set (FAS)|Placebo Controlled Period (Weeks 0-16)||0||
48141858|NCT04988308|100673422|FG004|Full- Analysis Set (FAS)|Placebo Controlled Period (Weeks 0-16)||0||
48141859|NCT04988308|100673423|FG005|Full- Analysis Set (FAS)|Placebo Controlled Period (Weeks 0-16)||0||
48141860|NCT04988308|100673418|FG000|COMPLETED|Placebo Controlled Period (Weeks 0-16)||28||
48141861|NCT04988308|100673419|FG001|COMPLETED|Placebo Controlled Period (Weeks 0-16)||30||
48141862|NCT04988308|100673420|FG002|COMPLETED|Placebo Controlled Period (Weeks 0-16)||28||
48404560|NCT02623699|101321896|FG011|STARTED|Part A (Up to 63 Days)||0||
48404561|NCT02623699|101321885|FG000|COMPLETED|Part A (Up to 63 Days)||5||
48404562|NCT02623699|101321886|FG001|COMPLETED|Part A (Up to 63 Days)||2||
48141863|NCT04988308|100673421|FG003|COMPLETED|Placebo Controlled Period (Weeks 0-16)||0||
48141864|NCT04988308|100673422|FG004|COMPLETED|Placebo Controlled Period (Weeks 0-16)||0||
48141865|NCT04988308|100673423|FG005|COMPLETED|Placebo Controlled Period (Weeks 0-16)||0||
48141866|NCT04988308|100673418|FG000|NOT COMPLETED|Placebo Controlled Period (Weeks 0-16)||22||
48404563|NCT02623699|101321887|FG002|COMPLETED|Part A (Up to 63 Days)||3||
48404564|NCT02623699|101321888|FG003|COMPLETED|Part A (Up to 63 Days)||3||
48404565|NCT02623699|101321889|FG004|COMPLETED|Part A (Up to 63 Days)||6||
48595467|NCT00033657|101789642|FG000|STARTED|Surgical Resection||36||
48141867|NCT04988308|100673419|FG001|NOT COMPLETED|Placebo Controlled Period (Weeks 0-16)||21||
48141868|NCT04988308|100673420|FG002|NOT COMPLETED|Placebo Controlled Period (Weeks 0-16)||22||
48141869|NCT04988308|100673421|FG003|NOT COMPLETED|Placebo Controlled Period (Weeks 0-16)||0||
48404566|NCT02623699|101321890|FG005|COMPLETED|Part A (Up to 63 Days)||0||
48404567|NCT02623699|101321891|FG006|COMPLETED|Part A (Up to 63 Days)||0||
48404568|NCT02623699|101321892|FG007|COMPLETED|Part A (Up to 63 Days)||0||
48141870|NCT04988308|100673422|FG004|NOT COMPLETED|Placebo Controlled Period (Weeks 0-16)||0||
48141871|NCT04988308|100673423|FG005|NOT COMPLETED|Placebo Controlled Period (Weeks 0-16)||0||
48141872|NCT04988308|100673418|FG000|STARTED|Active Treatment+Safety F-U (Week 17-36)||0||
48404569|NCT02623699|101321893|FG008|COMPLETED|Part A (Up to 63 Days)||0||
48404570|NCT02623699|101321894|FG009|COMPLETED|Part A (Up to 63 Days)||0||
48404571|NCT02623699|101321895|FG010|COMPLETED|Part A (Up to 63 Days)||0||
48404572|NCT02623699|101321896|FG011|COMPLETED|Part A (Up to 63 Days)||0||
48404573|NCT02623699|101321885|FG000|NOT COMPLETED|Part A (Up to 63 Days)||0||
48404574|NCT02623699|101321886|FG001|NOT COMPLETED|Part A (Up to 63 Days)||1||
48404575|NCT02623699|101321887|FG002|NOT COMPLETED|Part A (Up to 63 Days)||0||
48404576|NCT02623699|101321888|FG003|NOT COMPLETED|Part A (Up to 63 Days)||0||
48404577|NCT02623699|101321889|FG004|NOT COMPLETED|Part A (Up to 63 Days)||0||
48404578|NCT02623699|101321890|FG005|NOT COMPLETED|Part A (Up to 63 Days)||0||
48712197|NCT01660737|102081744|FG000|STARTED|Overall Study||123||
48712198|NCT01660737|102081744|FG000|COMPLETED|Overall Study||123||
48712199|NCT01660737|102081744|FG000|NOT COMPLETED|Overall Study||0||
48712200|NCT01777542|102081745|FG000|STARTED|First Intervention (20 Weeks)||15||
48712201|NCT01777542|102081746|FG001|STARTED|First Intervention (20 Weeks)||15||
48141873|NCT04988308|100673419|FG001|STARTED|Active Treatment+Safety F-U (Week 17-36)||0||
48141874|NCT04988308|100673420|FG002|STARTED|Active Treatment+Safety F-U (Week 17-36)||0||
48141875|NCT04988308|100673421|FG003|STARTED|Active Treatment+Safety F-U (Week 17-36)||28||
48141876|NCT04988308|100673422|FG004|STARTED|Active Treatment+Safety F-U (Week 17-36)||30||
48141877|NCT04988308|100673423|FG005|STARTED|Active Treatment+Safety F-U (Week 17-36)||28||
48141878|NCT04988308|100673418|FG000|COMPLETED|Active Treatment+Safety F-U (Week 17-36)||0||
48141879|NCT04988308|100673419|FG001|COMPLETED|Active Treatment+Safety F-U (Week 17-36)||0||
48141880|NCT04988308|100673420|FG002|COMPLETED|Active Treatment+Safety F-U (Week 17-36)||0||
48141881|NCT04988308|100673421|FG003|COMPLETED|Active Treatment+Safety F-U (Week 17-36)||7||
48141882|NCT04988308|100673422|FG004|COMPLETED|Active Treatment+Safety F-U (Week 17-36)||9||
48141883|NCT04988308|100673423|FG005|COMPLETED|Active Treatment+Safety F-U (Week 17-36)||10||
48141884|NCT04988308|100673418|FG000|NOT COMPLETED|Active Treatment+Safety F-U (Week 17-36)||0||
48141885|NCT04988308|100673419|FG001|NOT COMPLETED|Active Treatment+Safety F-U (Week 17-36)||0||
48141886|NCT04988308|100673420|FG002|NOT COMPLETED|Active Treatment+Safety F-U (Week 17-36)||0||
48141887|NCT04988308|100673421|FG003|NOT COMPLETED|Active Treatment+Safety F-U (Week 17-36)||21||
48141888|NCT04988308|100673422|FG004|NOT COMPLETED|Active Treatment+Safety F-U (Week 17-36)||21||
48141889|NCT04988308|100673423|FG005|NOT COMPLETED|Active Treatment+Safety F-U (Week 17-36)||18||
48141890|NCT02862106|100673424|FG000|STARTED|Overall Study||183||
48141891|NCT02862106|100673425|FG001|STARTED|Overall Study||26||
48141892|NCT02862106|100673424|FG000|COMPLETED|Overall Study||145||
48141893|NCT02862106|100673425|FG001|COMPLETED|Overall Study||20||
48141894|NCT02862106|100673424|FG000|NOT COMPLETED|Overall Study||38||
48141895|NCT02862106|100673425|FG001|NOT COMPLETED|Overall Study||6||
48141896|NCT01781728|100673426|FG000|STARTED|Overall Study||48||
48141897|NCT01781728|100673426|FG000|COMPLETED|Overall Study||48|45 patients were followed until death and 3 patients were still alive at last follow-up|
48141898|NCT01781728|100673426|FG000|NOT COMPLETED|Overall Study||0||
48141899|NCT01578993|100673427|FG000|STARTED|Overall Study||101||
48141900|NCT01578993|100673427|FG000|COMPLETED|Overall Study||101||
48141901|NCT01578993|100673427|FG000|NOT COMPLETED|Overall Study||0||
48141902|NCT01733056|100673428|FG000|STARTED|Overall Study||21||
48404579|NCT02623699|101321891|FG006|NOT COMPLETED|Part A (Up to 63 Days)||0||
48404580|NCT02623699|101321892|FG007|NOT COMPLETED|Part A (Up to 63 Days)||0||
48404581|NCT02623699|101321893|FG008|NOT COMPLETED|Part A (Up to 63 Days)||0||
48404582|NCT02623699|101321894|FG009|NOT COMPLETED|Part A (Up to 63 Days)||0||
48404583|NCT02623699|101321895|FG010|NOT COMPLETED|Part A (Up to 63 Days)||0||
48404584|NCT02623699|101321896|FG011|NOT COMPLETED|Part A (Up to 63 Days)||0||
48404585|NCT02623699|101321885|FG000|STARTED|Part B (Up to 289 Days)||0||
48712202|NCT01777542|102081745|FG000|COMPLETED|First Intervention (20 Weeks)||15||
48712203|NCT01777542|102081746|FG001|COMPLETED|First Intervention (20 Weeks)||15||
48712204|NCT01777542|102081745|FG000|NOT COMPLETED|First Intervention (20 Weeks)||0||
48712205|NCT01777542|102081746|FG001|NOT COMPLETED|First Intervention (20 Weeks)||0||
48712206|NCT01777542|102081745|FG000|STARTED|Washout Period (28 +/- 2 Weeks)||15||
48712207|NCT01777542|102081746|FG001|STARTED|Washout Period (28 +/- 2 Weeks)||15||
48712208|NCT01777542|102081745|FG000|COMPLETED|Washout Period (28 +/- 2 Weeks)||15||
48712209|NCT01777542|102081746|FG001|COMPLETED|Washout Period (28 +/- 2 Weeks)||15||
48712210|NCT01777542|102081745|FG000|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0||
48712211|NCT01777542|102081746|FG001|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0||
48712212|NCT01777542|102081745|FG000|STARTED|Second Intervention (20 Weeks)||15||
48712213|NCT01777542|102081746|FG001|STARTED|Second Intervention (20 Weeks)||15||
48595468|NCT00033657|101789643|FG001|STARTED|Surgical Resection||36||
48595469|NCT00033657|101789642|FG000|COMPLETED|Surgical Resection||36||
48595470|NCT00033657|101789643|FG001|COMPLETED|Surgical Resection||33||
48595471|NCT00033657|101789642|FG000|NOT COMPLETED|Surgical Resection||0||
48595472|NCT00033657|101789643|FG001|NOT COMPLETED|Surgical Resection||3||
48595473|NCT00033657|101789642|FG000|STARTED|Adjuvant Chemotherapy||36||
48595474|NCT00033657|101789643|FG001|STARTED|Adjuvant Chemotherapy||33||
48595475|NCT00033657|101789642|FG000|COMPLETED|Adjuvant Chemotherapy||18||
48595476|NCT00033657|101789643|FG001|COMPLETED|Adjuvant Chemotherapy||16||
48595477|NCT00033657|101789642|FG000|NOT COMPLETED|Adjuvant Chemotherapy||18||
48595478|NCT00033657|101789643|FG001|NOT COMPLETED|Adjuvant Chemotherapy||17||
48595479|NCT02418585|101789644|FG000|STARTED|Double Blind (DB) Phase (4 Weeks)||116||
48595480|NCT02418585|101789645|FG001|STARTED|Double Blind (DB) Phase (4 Weeks)||111||
48595481|NCT02418585|101789644|FG000|Safety Analysis Set|Double Blind (DB) Phase (4 Weeks)||115||
48595482|NCT02418585|101789645|FG001|Safety Analysis Set|Double Blind (DB) Phase (4 Weeks)||109||
48595483|NCT02418585|101789644|FG000|Full Analysis Set|Double Blind (DB) Phase (4 Weeks)||114||
48595484|NCT02418585|101789645|FG001|Full Analysis Set|Double Blind (DB) Phase (4 Weeks)||109||
48595485|NCT02418585|101789644|FG000|COMPLETED|Double Blind (DB) Phase (4 Weeks)||98||
48595486|NCT02418585|101789645|FG001|COMPLETED|Double Blind (DB) Phase (4 Weeks)||99||
48595487|NCT02418585|101789644|FG000|NOT COMPLETED|Double Blind (DB) Phase (4 Weeks)||18||
48595488|NCT02418585|101789645|FG001|NOT COMPLETED|Double Blind (DB) Phase (4 Weeks)||12||
48595489|NCT02418585|101789644|FG000|STARTED|Follow-up Phase (24 Weeks)||34||
48595490|NCT02418585|101789645|FG001|STARTED|Follow-up Phase (24 Weeks)||52||
48595491|NCT02418585|101789644|FG000|COMPLETED|Follow-up Phase (24 Weeks)||16||
48595492|NCT02418585|101789645|FG001|COMPLETED|Follow-up Phase (24 Weeks)||27||
48595493|NCT02418585|101789644|FG000|NOT COMPLETED|Follow-up Phase (24 Weeks)||18||
48595494|NCT02418585|101789645|FG001|NOT COMPLETED|Follow-up Phase (24 Weeks)||25||
48595495|NCT00616603|101789646|FG000|STARTED|Overall Study||14||
48595496|NCT00616603|101789647|FG001|STARTED|Overall Study||14||
48595497|NCT00616603|101789648|FG002|STARTED|Overall Study||15||
48595498|NCT00616603|101789646|FG000|COMPLETED|Overall Study||12||
48595499|NCT00616603|101789647|FG001|COMPLETED|Overall Study||14||
48595500|NCT00616603|101789648|FG002|COMPLETED|Overall Study||13||
48595501|NCT00616603|101789646|FG000|NOT COMPLETED|Overall Study||2||
48595502|NCT00616603|101789647|FG001|NOT COMPLETED|Overall Study||0||
48595503|NCT00616603|101789648|FG002|NOT COMPLETED|Overall Study||2||
48595504|NCT02672332|101789649|FG000|STARTED|Overall Study||653||
48595505|NCT02672332|101789650|FG001|STARTED|Overall Study||654||
48595506|NCT02672332|101789649|FG000|COMPLETED|Overall Study||571||
48595507|NCT02672332|101789650|FG001|COMPLETED|Overall Study||577||
48595508|NCT02672332|101789649|FG000|NOT COMPLETED|Overall Study||82||
48595509|NCT02672332|101789650|FG001|NOT COMPLETED|Overall Study||77||
48595510|NCT01420679|101789651|FG000|STARTED|Overall Study||14||
48595511|NCT01420679|101789652|FG001|STARTED|Overall Study||7||
48595512|NCT01420679|101789651|FG000|COMPLETED|Overall Study||0||
48595513|NCT01420679|101789652|FG001|COMPLETED|Overall Study||0||
48595514|NCT01420679|101789651|FG000|NOT COMPLETED|Overall Study||14||
48595515|NCT01420679|101789652|FG001|NOT COMPLETED|Overall Study||7||
48295265|NCT00256451|101050838|FG003|NOT COMPLETED|Session2||0||
48295266|NCT00256451|101050835|FG000|STARTED|Session3||9|Crossover design: no of subjs who completed the PRIOR session|
48295267|NCT00256451|101050836|FG001|STARTED|Session3||9|Crossover design: no of subjs who completed the PRIOR session|
48295268|NCT00256451|101050837|FG002|STARTED|Session3||10|Crossover design: no of subjs who completed the PRIOR session|
48295269|NCT00256451|101050838|FG003|STARTED|Session3||9|Crossover design: no of subjs who completed the PRIOR session|
48595516|NCT01236326|101789653|FG000|STARTED|Overall Study||50||
48595517|NCT01236326|101789654|FG001|STARTED|Overall Study||55||
48595518|NCT01236326|101789653|FG000|COMPLETED|Overall Study||49||
48595519|NCT01236326|101789654|FG001|COMPLETED|Overall Study||51||
48595520|NCT01236326|101789653|FG000|NOT COMPLETED|Overall Study||1||
48595521|NCT01236326|101789654|FG001|NOT COMPLETED|Overall Study||4||
48595522|NCT00109876|101789655|FG000|STARTED|Overall Study||51||
48595523|NCT00109876|101789655|FG000|COMPLETED|Overall Study||51||
48595524|NCT00109876|101789655|FG000|NOT COMPLETED|Overall Study||0||
48595525|NCT04392167|101789656|FG000|STARTED|Overall Study||37||
48595526|NCT04392167|101789656|FG000|COMPLETED|Overall Study||31||
48595527|NCT04392167|101789656|FG000|NOT COMPLETED|Overall Study||6||
48595528|NCT00908076|101789657|FG000|STARTED|Overall Study||27||
48595529|NCT00908076|101789658|FG001|STARTED|Overall Study||27||
48595530|NCT00908076|101789657|FG000|COMPLETED|Overall Study||26||
48595531|NCT00908076|101789658|FG001|COMPLETED|Overall Study||26||
48595532|NCT00908076|101789657|FG000|NOT COMPLETED|Overall Study||1||
48595533|NCT00908076|101789658|FG001|NOT COMPLETED|Overall Study||1||
48595534|NCT02335749|101789659|FG000|STARTED|Overall Study||40||
48595535|NCT02335749|101789659|FG000|COMPLETED|Overall Study||40||
48595536|NCT02335749|101789659|FG000|NOT COMPLETED|Overall Study||0||
48595537|NCT03536949|101789660|FG000|STARTED|Overall Study||157||
48595538|NCT03536949|101789661|FG001|STARTED|Overall Study||77||
48595539|NCT03536949|101789660|FG000|COMPLETED|Overall Study||143||
48595540|NCT03536949|101789661|FG001|COMPLETED|Overall Study||75||
48595541|NCT03536949|101789660|FG000|NOT COMPLETED|Overall Study||14||
48595542|NCT03536949|101789661|FG001|NOT COMPLETED|Overall Study||2||
48595543|NCT04679051|101789662|FG000|STARTED|Overall Study||12||
48595544|NCT04679051|101789663|FG001|STARTED|Overall Study||11||
48295270|NCT00256451|101050835|FG000|COMPLETED|Session3||9||
48295271|NCT00256451|101050836|FG001|COMPLETED|Session3||9||
48295272|NCT00256451|101050837|FG002|COMPLETED|Session3||10||
48295273|NCT00256451|101050838|FG003|COMPLETED|Session3||9||
48295274|NCT00256451|101050835|FG000|NOT COMPLETED|Session3||0||
48295275|NCT00256451|101050836|FG001|NOT COMPLETED|Session3||0||
48295276|NCT00256451|101050837|FG002|NOT COMPLETED|Session3||0||
48295277|NCT00256451|101050838|FG003|NOT COMPLETED|Session3||0||
48295278|NCT00256451|101050835|FG000|STARTED|Session4||9|Crossover design: no of subjs who completed the PRIOR session|
48295279|NCT00256451|101050836|FG001|STARTED|Session4||8|Crossover design: no of subjs who completed the PRIOR session|
48595545|NCT04679051|101789662|FG000|COMPLETED|Overall Study||6||
48595546|NCT04679051|101789663|FG001|COMPLETED|Overall Study||6||
48595547|NCT04679051|101789662|FG000|NOT COMPLETED|Overall Study||6||
48595548|NCT04679051|101789663|FG001|NOT COMPLETED|Overall Study||5||
48595549|NCT03861871|101789664|FG000|STARTED|Overall Study||7||
48595550|NCT03861871|101789664|FG000|COMPLETED|Overall Study||7||
48595551|NCT03861871|101789664|FG000|NOT COMPLETED|Overall Study||0||
48595552|NCT02320227|101789665|FG000|STARTED|Overall Study||30||
48595553|NCT02320227|101789665|FG000|COMPLETED|Overall Study||30||
48595554|NCT02320227|101789665|FG000|NOT COMPLETED|Overall Study||0||
48595555|NCT04327661|101789666|FG000|STARTED|Overall Study||121||
48595556|NCT04327661|101789667|FG001|STARTED|Overall Study||123||
48595557|NCT04327661|101789668|FG002|STARTED|Overall Study||122||
48595558|NCT04327661|101789666|FG000|COMPLETED|Overall Study||120||
48595559|NCT04327661|101789667|FG001|COMPLETED|Overall Study||123||
48595560|NCT04327661|101789668|FG002|COMPLETED|Overall Study||122||
48595561|NCT04327661|101789666|FG000|NOT COMPLETED|Overall Study||1||
48367934|NCT03661541|101230079|FG002|STARTED|Overall Study||12||
48595562|NCT04327661|101789667|FG001|NOT COMPLETED|Overall Study||0||
48595563|NCT04327661|101789668|FG002|NOT COMPLETED|Overall Study||0||
48595564|NCT03479944|101789669|FG000|STARTED|Overall Study||55||110
48595565|NCT03479944|101789669|FG000|FLACS|Overall Study||55|left or right eye|55
48595566|NCT03479944|101789669|FG000|Conventional|Overall Study||55|fellow eye|55
48595567|NCT03479944|101789669|FG000|Full Analysis Set|Overall Study||53||106
48595568|NCT03479944|101789669|FG000|COMPLETED|Overall Study||55||110
48595569|NCT03479944|101789669|FG000|NOT COMPLETED|Overall Study||0||0
48595570|NCT02614131|101789670|FG000|STARTED|Overall Study||11||
48595571|NCT02614131|101789671|FG001|STARTED|Overall Study||8||
48595572|NCT02614131|101789672|FG002|STARTED|Overall Study||8||
48595573|NCT02614131|101789673|FG003|STARTED|Overall Study||8||
48595574|NCT02614131|101789674|FG004|STARTED|Overall Study||8||
48595575|NCT02614131|101789675|FG005|STARTED|Overall Study||2||
48595576|NCT02614131|101789676|FG006|STARTED|Overall Study||5||
48595577|NCT02614131|101789670|FG000|Received at Least One Dose of Drug|Overall Study||11||
48595578|NCT02614131|101789671|FG001|Received at Least One Dose of Drug|Overall Study||8||
48595579|NCT02614131|101789672|FG002|Received at Least One Dose of Drug|Overall Study||8||
48595580|NCT02614131|101789673|FG003|Received at Least One Dose of Drug|Overall Study||8||
48595581|NCT02614131|101789674|FG004|Received at Least One Dose of Drug|Overall Study||8||
48595582|NCT02614131|101789675|FG005|Received at Least One Dose of Drug|Overall Study||2||
48595583|NCT02614131|101789676|FG006|Received at Least One Dose of Drug|Overall Study||5||
48595584|NCT02614131|101789670|FG000|COMPLETED|Overall Study||10||
48595585|NCT02614131|101789671|FG001|COMPLETED|Overall Study||8||
48595586|NCT02614131|101789672|FG002|COMPLETED|Overall Study||8||
48595587|NCT02614131|101789673|FG003|COMPLETED|Overall Study||8||
48295280|NCT00256451|101050837|FG002|STARTED|Session4||10|Crossover design: no of subjs who completed the PRIOR session|
48295281|NCT00256451|101050838|FG003|STARTED|Session4||8|Crossover design: no of subjs who completed the PRIOR session|
48295282|NCT00256451|101050835|FG000|COMPLETED|Session4||9||
48295283|NCT00256451|101050836|FG001|COMPLETED|Session4||8||
48295284|NCT00256451|101050837|FG002|COMPLETED|Session4||10||
48295285|NCT00256451|101050838|FG003|COMPLETED|Session4||8||
48295286|NCT00256451|101050835|FG000|NOT COMPLETED|Session4||0||
48295287|NCT00256451|101050836|FG001|NOT COMPLETED|Session4||0||
48295288|NCT00256451|101050837|FG002|NOT COMPLETED|Session4||0||
48295289|NCT00256451|101050838|FG003|NOT COMPLETED|Session4||0||
48295290|NCT01211522|101050839|FG000|STARTED|Overall Study||192||
48295291|NCT01211522|101050840|FG001|STARTED|Overall Study||190||
48295292|NCT01211522|101050841|FG002|STARTED|Overall Study||184||
48295293|NCT01211522|101050839|FG000|COMPLETED|Overall Study||189||
48295294|NCT01211522|101050840|FG001|COMPLETED|Overall Study||183||
48295295|NCT01211522|101050841|FG002|COMPLETED|Overall Study||179||
48295296|NCT01211522|101050839|FG000|NOT COMPLETED|Overall Study||3||
48295297|NCT01211522|101050840|FG001|NOT COMPLETED|Overall Study||7||
48295298|NCT01211522|101050841|FG002|NOT COMPLETED|Overall Study||5||
48295299|NCT03610165|101050842|FG000|STARTED|Overall Study||108||
48295300|NCT03610165|101050843|FG001|STARTED|Overall Study||106||
48295301|NCT03610165|101050842|FG000|COMPLETED|Overall Study||108||
48295302|NCT03610165|101050843|FG001|COMPLETED|Overall Study||105||
48295303|NCT03610165|101050842|FG000|NOT COMPLETED|Overall Study||0||
48295304|NCT03610165|101050843|FG001|NOT COMPLETED|Overall Study||1||
48404586|NCT02623699|101321886|FG001|STARTED|Part B (Up to 289 Days)||0||
48404587|NCT02623699|101321887|FG002|STARTED|Part B (Up to 289 Days)||0||
48404588|NCT02623699|101321888|FG003|STARTED|Part B (Up to 289 Days)||0||
48404589|NCT02623699|101321889|FG004|STARTED|Part B (Up to 289 Days)||0||
48404590|NCT02623699|101321890|FG005|STARTED|Part B (Up to 289 Days)||12||
48404591|NCT02623699|101321891|FG006|STARTED|Part B (Up to 289 Days)||10||
48404592|NCT02623699|101321892|FG007|STARTED|Part B (Up to 289 Days)||9||
48404593|NCT02623699|101321893|FG008|STARTED|Part B (Up to 289 Days)||9||
48404594|NCT02623699|101321894|FG009|STARTED|Part B (Up to 289 Days)||10||
48404595|NCT02623699|101321895|FG010|STARTED|Part B (Up to 289 Days)||0||
48404596|NCT02623699|101321896|FG011|STARTED|Part B (Up to 289 Days)||0||
48295305|NCT01016977|101050844|FG000|STARTED|Overall Study||20||
48295306|NCT01016977|101050845|FG001|STARTED|Overall Study||20||
48404597|NCT02623699|101321885|FG000|COMPLETED|Part B (Up to 289 Days)||0||
48404598|NCT02623699|101321886|FG001|COMPLETED|Part B (Up to 289 Days)||0||
48404599|NCT02623699|101321887|FG002|COMPLETED|Part B (Up to 289 Days)||0||
48404600|NCT02623699|101321888|FG003|COMPLETED|Part B (Up to 289 Days)||0||
48295307|NCT01016977|101050844|FG000|COMPLETED|Overall Study||17||
48295308|NCT01016977|101050845|FG001|COMPLETED|Overall Study||18||
48295309|NCT01016977|101050844|FG000|NOT COMPLETED|Overall Study||3||
48295310|NCT01016977|101050845|FG001|NOT COMPLETED|Overall Study||2||
48404601|NCT02623699|101321889|FG004|COMPLETED|Part B (Up to 289 Days)||0||
48404602|NCT02623699|101321890|FG005|COMPLETED|Part B (Up to 289 Days)||10||
48404603|NCT02623699|101321891|FG006|COMPLETED|Part B (Up to 289 Days)||8||
48404604|NCT02623699|101321892|FG007|COMPLETED|Part B (Up to 289 Days)||9||
48404605|NCT02623699|101321893|FG008|COMPLETED|Part B (Up to 289 Days)||8||
48404606|NCT02623699|101321894|FG009|COMPLETED|Part B (Up to 289 Days)||10||
48295311|NCT02370810|101050846|FG000|STARTED|Overall Study||73||
48295312|NCT02370810|101050847|FG001|STARTED|Overall Study||73||
48295313|NCT02370810|101050846|FG000|COMPLETED|Overall Study||50||
48295314|NCT02370810|101050847|FG001|COMPLETED|Overall Study||54||
48295315|NCT02370810|101050846|FG000|NOT COMPLETED|Overall Study||23||
48404607|NCT02623699|101321895|FG010|COMPLETED|Part B (Up to 289 Days)||0||
48404608|NCT02623699|101321896|FG011|COMPLETED|Part B (Up to 289 Days)||0||
48595588|NCT02614131|101789674|FG004|COMPLETED|Overall Study||8||
48595589|NCT02614131|101789675|FG005|COMPLETED|Overall Study||2||
48295316|NCT02370810|101050847|FG001|NOT COMPLETED|Overall Study||19||
48295317|NCT03098420|101050848|FG000|STARTED|Overall Study||7||
48595590|NCT02614131|101789676|FG006|COMPLETED|Overall Study||4||
48595591|NCT02614131|101789670|FG000|NOT COMPLETED|Overall Study||1||
48295318|NCT03098420|101050849|FG001|STARTED|Overall Study||9||
48295319|NCT03098420|101050850|FG002|STARTED|Overall Study||13||
48295320|NCT03098420|101050848|FG000|COMPLETED|Overall Study||7||
48295321|NCT03098420|101050849|FG001|COMPLETED|Overall Study||9||
48295322|NCT03098420|101050850|FG002|COMPLETED|Overall Study||13||
48295323|NCT03098420|101050848|FG000|NOT COMPLETED|Overall Study||0||
48295324|NCT03098420|101050849|FG001|NOT COMPLETED|Overall Study||0||
48295325|NCT03098420|101050850|FG002|NOT COMPLETED|Overall Study||0||
48295326|NCT02919657|101050851|FG000|STARTED|Overall Study||10||
48295327|NCT02919657|101050852|FG001|STARTED|Overall Study||10||
48295328|NCT02919657|101050851|FG000|COMPLETED|Overall Study||10||
48295329|NCT02919657|101050852|FG001|COMPLETED|Overall Study||10||
48295330|NCT02919657|101050851|FG000|NOT COMPLETED|Overall Study||0||
48295331|NCT02919657|101050852|FG001|NOT COMPLETED|Overall Study||0||
48295332|NCT00822172|101050853|FG000|STARTED|Overall Study||80||
48295333|NCT00822172|101050854|FG001|STARTED|Overall Study||83||
48295334|NCT00822172|101050853|FG000|COMPLETED|Overall Study||65||
48295335|NCT00822172|101050854|FG001|COMPLETED|Overall Study||64||
48295336|NCT00822172|101050853|FG000|NOT COMPLETED|Overall Study||15||
48295337|NCT00822172|101050854|FG001|NOT COMPLETED|Overall Study||19||
48295338|NCT04187053|101050855|FG000|STARTED|Overall Study||30||
48295339|NCT04187053|101050856|FG001|STARTED|Overall Study||26||
48295340|NCT04187053|101050855|FG000|COMPLETED|Overall Study||26||
48295341|NCT04187053|101050856|FG001|COMPLETED|Overall Study||19||
48295342|NCT04187053|101050855|FG000|NOT COMPLETED|Overall Study||4||
48295343|NCT04187053|101050856|FG001|NOT COMPLETED|Overall Study||7||
48295344|NCT00692978|101050857|FG000|STARTED|FP From Active 250 ug MDI Inhaler||15||
48295345|NCT00692978|101050858|FG001|STARTED|FP From Active 250 ug MDI Inhaler||15||
48295346|NCT00692978|101050857|FG000|COMPLETED|FP From Active 250 ug MDI Inhaler||15||
48295347|NCT00692978|101050858|FG001|COMPLETED|FP From Active 250 ug MDI Inhaler||15||
48295348|NCT00692978|101050857|FG000|NOT COMPLETED|FP From Active 250 ug MDI Inhaler||0||
48295349|NCT00692978|101050858|FG001|NOT COMPLETED|FP From Active 250 ug MDI Inhaler||0||
48295350|NCT00692978|101050857|FG000|STARTED|FP1.5 Microns Size With MDI Inhaler||15||
48295351|NCT00692978|101050858|FG001|STARTED|FP1.5 Microns Size With MDI Inhaler||15||
48295352|NCT00692978|101050857|FG000|COMPLETED|FP1.5 Microns Size With MDI Inhaler||15||
48295353|NCT00692978|101050858|FG001|COMPLETED|FP1.5 Microns Size With MDI Inhaler||15||
48295354|NCT00692978|101050857|FG000|NOT COMPLETED|FP1.5 Microns Size With MDI Inhaler||0||
48295355|NCT00692978|101050858|FG001|NOT COMPLETED|FP1.5 Microns Size With MDI Inhaler||0||
48295356|NCT00692978|101050857|FG000|STARTED|FP 3 Microns Size With MDI Inhaler||15||
48295357|NCT00692978|101050858|FG001|STARTED|FP 3 Microns Size With MDI Inhaler||15||
48295358|NCT00692978|101050857|FG000|COMPLETED|FP 3 Microns Size With MDI Inhaler||15||
48295359|NCT00692978|101050858|FG001|COMPLETED|FP 3 Microns Size With MDI Inhaler||15||
48295360|NCT00692978|101050857|FG000|NOT COMPLETED|FP 3 Microns Size With MDI Inhaler||0||
48295361|NCT00692978|101050858|FG001|NOT COMPLETED|FP 3 Microns Size With MDI Inhaler||0||
48295362|NCT00692978|101050857|FG000|STARTED|FP 6 Microns Size With MDI Inhaler||15||
48295363|NCT00692978|101050858|FG001|STARTED|FP 6 Microns Size With MDI Inhaler||15||
48295364|NCT00692978|101050857|FG000|COMPLETED|FP 6 Microns Size With MDI Inhaler||15||
48295365|NCT00692978|101050858|FG001|COMPLETED|FP 6 Microns Size With MDI Inhaler||15||
48295366|NCT00692978|101050857|FG000|NOT COMPLETED|FP 6 Microns Size With MDI Inhaler||0||
48295367|NCT00692978|101050858|FG001|NOT COMPLETED|FP 6 Microns Size With MDI Inhaler||0||
48295368|NCT00402363|101050859|FG000|STARTED|Overall Study||266||
48295369|NCT00402363|101050860|FG001|STARTED|Overall Study||276||
48295370|NCT00402363|101050861|FG002|STARTED|Overall Study||66||
48595592|NCT02614131|101789671|FG001|NOT COMPLETED|Overall Study||0||
48595593|NCT02614131|101789672|FG002|NOT COMPLETED|Overall Study||0||
48295371|NCT00402363|101050862|FG003|STARTED|Overall Study||55||
48295372|NCT00402363|101050859|FG000|COMPLETED|Overall Study||233||
48295373|NCT00402363|101050860|FG001|COMPLETED|Overall Study||246||
48295374|NCT00402363|101050861|FG002|COMPLETED|Overall Study||60||
48295375|NCT00402363|101050862|FG003|COMPLETED|Overall Study||45||
48295376|NCT00402363|101050859|FG000|NOT COMPLETED|Overall Study||33||
48295377|NCT00402363|101050860|FG001|NOT COMPLETED|Overall Study||30||
48295378|NCT00402363|101050861|FG002|NOT COMPLETED|Overall Study||6||
48295379|NCT00402363|101050862|FG003|NOT COMPLETED|Overall Study||10||
48295380|NCT01703663|101050863|FG000|STARTED|First Treatment Period||20||
48295381|NCT01703663|101050864|FG001|STARTED|First Treatment Period||20||
48595594|NCT02614131|101789673|FG003|NOT COMPLETED|Overall Study||0||
48295382|NCT01703663|101050863|FG000|COMPLETED|First Treatment Period||20||
48295383|NCT01703663|101050864|FG001|COMPLETED|First Treatment Period||20||
48295384|NCT01703663|101050863|FG000|NOT COMPLETED|First Treatment Period||0||
48295385|NCT01703663|101050864|FG001|NOT COMPLETED|First Treatment Period||0||
48295386|NCT01703663|101050863|FG000|STARTED|Second Treatment Period||11||
48295387|NCT01703663|101050864|FG001|STARTED|Second Treatment Period||8||
48295388|NCT01703663|101050863|FG000|COMPLETED|Second Treatment Period||11||
48295389|NCT01703663|101050864|FG001|COMPLETED|Second Treatment Period||8||
48295390|NCT01703663|101050863|FG000|NOT COMPLETED|Second Treatment Period||0||
48295391|NCT01703663|101050864|FG001|NOT COMPLETED|Second Treatment Period||0||
48295392|NCT01804062|101050865|FG000|STARTED|Overall Study||30||
48295393|NCT01804062|101050865|FG000|COMPLETED|Overall Study||30||
48295394|NCT01804062|101050865|FG000|NOT COMPLETED|Overall Study||0||
48295395|NCT01662115|101050866|FG000|STARTED|Overall Study||2||
48295396|NCT01662115|101050867|FG001|STARTED|Overall Study||2||
48295397|NCT01662115|101050868|FG002|STARTED|Overall Study||0||
48295398|NCT01662115|101050866|FG000|COMPLETED|Overall Study||2||
48295399|NCT01662115|101050867|FG001|COMPLETED|Overall Study||2||
48295400|NCT01662115|101050868|FG002|COMPLETED|Overall Study||0||
48595595|NCT02614131|101789674|FG004|NOT COMPLETED|Overall Study||0||
48595596|NCT02614131|101789675|FG005|NOT COMPLETED|Overall Study||0||
48595597|NCT02614131|101789676|FG006|NOT COMPLETED|Overall Study||1||
48595598|NCT00101036|101789677|FG000|STARTED|Overall Study||17||
48595599|NCT00101036|101789678|FG001|STARTED|Overall Study||40||
48595600|NCT00101036|101789677|FG000|COMPLETED|Overall Study||17||
48595601|NCT00101036|101789678|FG001|COMPLETED|Overall Study||40||
48595602|NCT00101036|101789677|FG000|NOT COMPLETED|Overall Study||0||
48595603|NCT00101036|101789678|FG001|NOT COMPLETED|Overall Study||0||
48595604|NCT00684749|101789679|FG000|STARTED|Overall Study||142||
48595605|NCT00684749|101789679|FG000|COMPLETED|Overall Study||142||
48595606|NCT00684749|101789679|FG000|NOT COMPLETED|Overall Study||0||
48595607|NCT03704948|101789680|FG000|STARTED|Overall Study||22||
48595608|NCT03704948|101789681|FG001|STARTED|Overall Study||23||
48595609|NCT03704948|101789682|FG002|STARTED|Overall Study||10||
48595610|NCT03704948|101789680|FG000|COMPLETED|Overall Study||20||
48595611|NCT03704948|101789681|FG001|COMPLETED|Overall Study||22||
48595612|NCT03704948|101789682|FG002|COMPLETED|Overall Study||9||
48595613|NCT03704948|101789680|FG000|NOT COMPLETED|Overall Study||2||
48595614|NCT03704948|101789681|FG001|NOT COMPLETED|Overall Study||1||
48595615|NCT03704948|101789682|FG002|NOT COMPLETED|Overall Study||1||
48595616|NCT02258542|101789683|FG000|STARTED|Overall Study||953||
48595617|NCT02258542|101789684|FG001|STARTED|Overall Study||973||
48595618|NCT02258542|101789685|FG002|STARTED|Overall Study||100||
48595619|NCT02258542|101789686|FG003|STARTED|Overall Study||97||
48595620|NCT02258542|101789683|FG000|Treated|Overall Study||953||
48595621|NCT02258542|101789684|FG001|Treated|Overall Study||971||
48595622|NCT02258542|101789685|FG002|Treated|Overall Study||100||
48595623|NCT02258542|101789686|FG003|Treated|Overall Study||97||
48595624|NCT02258542|101789683|FG000|Adolescents Only|Overall Study||25||
48595625|NCT02258542|101789684|FG001|Adolescents Only|Overall Study||61||
48595626|NCT02258542|101789685|FG002|Adolescents Only|Overall Study||0||
48595627|NCT02258542|101789686|FG003|Adolescents Only|Overall Study||0||
48595628|NCT02258542|101789683|FG000|COMPLETED|Overall Study||911|Include patients enrolled into study MELTEMI (study 37)|
48595629|NCT02258542|101789684|FG001|COMPLETED|Overall Study||924|Include patients enrolled into study MELTEMI (study 37)|
48595630|NCT02258542|101789685|FG002|COMPLETED|Overall Study||92|Include patients enrolled into study MELTEMI (study 37)|
48595631|NCT02258542|101789686|FG003|COMPLETED|Overall Study||92|Include patients enrolled into study MELTEMI (study 37)|
48595632|NCT02258542|101789683|FG000|NOT COMPLETED|Overall Study||42||
48595633|NCT02258542|101789684|FG001|NOT COMPLETED|Overall Study||49||
48595634|NCT02258542|101789685|FG002|NOT COMPLETED|Overall Study||8||
48595635|NCT02258542|101789686|FG003|NOT COMPLETED|Overall Study||5||
48595636|NCT01047332|101789687|FG000|STARTED|Overall Study||61||
48595637|NCT01047332|101789688|FG001|STARTED|Overall Study||68||
48595638|NCT01047332|101789687|FG000|COMPLETED|Overall Study||4||
48595639|NCT01047332|101789688|FG001|COMPLETED|Overall Study||4||
48595640|NCT01047332|101789687|FG000|NOT COMPLETED|Overall Study||57||
48595641|NCT01047332|101789688|FG001|NOT COMPLETED|Overall Study||64||
48295401|NCT01662115|101050866|FG000|NOT COMPLETED|Overall Study||0||
48295402|NCT01662115|101050867|FG001|NOT COMPLETED|Overall Study||0||
48295403|NCT01662115|101050868|FG002|NOT COMPLETED|Overall Study||0||
48295404|NCT02737917|101050869|FG000|STARTED|Overall Study||103||
48295405|NCT02737917|101050870|FG001|STARTED|Overall Study||103||
48295406|NCT02737917|101050869|FG000|COMPLETED|Overall Study||100||
48295407|NCT02737917|101050870|FG001|COMPLETED|Overall Study||100||
48595642|NCT03309696|101789689|FG000|STARTED|Overall Study||5||
48595643|NCT03309696|101789690|FG001|STARTED|Overall Study||5||
48595644|NCT03309696|101789691|FG002|STARTED|Overall Study||0||
48595645|NCT03309696|101789692|FG003|STARTED|Overall Study||0||
48595646|NCT03309696|101789689|FG000|COMPLETED|Overall Study||5||
48295408|NCT02737917|101050869|FG000|NOT COMPLETED|Overall Study||3||
48295409|NCT02737917|101050870|FG001|NOT COMPLETED|Overall Study||3||
48295410|NCT03064035|101050871|FG000|STARTED|Overall Study||39||
48295411|NCT03064035|101050872|FG001|STARTED|Overall Study||40||
48295412|NCT03064035|101050871|FG000|COMPLETED|Overall Study||34||
48595647|NCT03309696|101789690|FG001|COMPLETED|Overall Study||0||
48141903|NCT01733056|100673429|FG001|STARTED|Overall Study||10||
48141904|NCT01733056|100673430|FG002|STARTED|Overall Study||12||
48141905|NCT01733056|100673428|FG000|COMPLETED|Overall Study||21||
48595648|NCT03309696|101789691|FG002|COMPLETED|Overall Study||0||
48595649|NCT03309696|101789692|FG003|COMPLETED|Overall Study||0||
48595650|NCT03309696|101789689|FG000|NOT COMPLETED|Overall Study||0||
48595651|NCT03309696|101789690|FG001|NOT COMPLETED|Overall Study||5||
48141906|NCT01733056|100673429|FG001|COMPLETED|Overall Study||10||
48141907|NCT01733056|100673430|FG002|COMPLETED|Overall Study||12||
48141908|NCT01733056|100673428|FG000|NOT COMPLETED|Overall Study||0||
48141909|NCT01733056|100673429|FG001|NOT COMPLETED|Overall Study||0||
48141910|NCT01733056|100673430|FG002|NOT COMPLETED|Overall Study||0||
48141911|NCT02716974|100673431|FG000|STARTED|Overall Study||26||
48141912|NCT02716974|100673431|FG000|COMPLETED|Overall Study||26||
48141913|NCT02716974|100673431|FG000|NOT COMPLETED|Overall Study||0||
48141914|NCT01392560|100673432|FG000|STARTED|Overall Study||52||
48295413|NCT03064035|101050872|FG001|COMPLETED|Overall Study||37||
48295414|NCT03064035|101050871|FG000|NOT COMPLETED|Overall Study||5||
48295415|NCT03064035|101050872|FG001|NOT COMPLETED|Overall Study||3||
48295416|NCT02049151|101050873|FG000|STARTED|Overall Study||15||
48295417|NCT02049151|101050874|FG001|STARTED|Overall Study||17||
48295418|NCT02049151|101050873|FG000|COMPLETED|Overall Study||15||
48295419|NCT02049151|101050874|FG001|COMPLETED|Overall Study||17||
48295420|NCT02049151|101050873|FG000|NOT COMPLETED|Overall Study||0||
48295421|NCT02049151|101050874|FG001|NOT COMPLETED|Overall Study||0||
48295422|NCT02564354|101050875|FG000|STARTED|Overall Study||10||
48295423|NCT02564354|101050876|FG001|STARTED|Overall Study||8||
48295424|NCT02564354|101050875|FG000|COMPLETED|Overall Study||10||
48295425|NCT02564354|101050876|FG001|COMPLETED|Overall Study||8||
48295426|NCT02564354|101050875|FG000|NOT COMPLETED|Overall Study||0||
48404609|NCT02623699|101321885|FG000|NOT COMPLETED|Part B (Up to 289 Days)||0||
48404610|NCT02623699|101321886|FG001|NOT COMPLETED|Part B (Up to 289 Days)||0||
48404611|NCT02623699|101321887|FG002|NOT COMPLETED|Part B (Up to 289 Days)||0||
48404612|NCT02623699|101321888|FG003|NOT COMPLETED|Part B (Up to 289 Days)||0||
48404613|NCT02623699|101321889|FG004|NOT COMPLETED|Part B (Up to 289 Days)||0||
48404614|NCT02623699|101321890|FG005|NOT COMPLETED|Part B (Up to 289 Days)||2||
48404615|NCT02623699|101321891|FG006|NOT COMPLETED|Part B (Up to 289 Days)||2||
48404616|NCT02623699|101321892|FG007|NOT COMPLETED|Part B (Up to 289 Days)||0||
48404617|NCT02623699|101321893|FG008|NOT COMPLETED|Part B (Up to 289 Days)||1||
48404618|NCT02623699|101321894|FG009|NOT COMPLETED|Part B (Up to 289 Days)||0||
48404619|NCT02623699|101321895|FG010|NOT COMPLETED|Part B (Up to 289 Days)||0||
48404620|NCT02623699|101321896|FG011|NOT COMPLETED|Part B (Up to 289 Days)||0||
48404621|NCT02623699|101321885|FG000|STARTED|Part C (Up to 236 Days)||0||
48404622|NCT02623699|101321886|FG001|STARTED|Part C (Up to 236 Days)||0||
48404623|NCT02623699|101321887|FG002|STARTED|Part C (Up to 236 Days)||0||
48404624|NCT02623699|101321888|FG003|STARTED|Part C (Up to 236 Days)||0||
48404625|NCT02623699|101321889|FG004|STARTED|Part C (Up to 236 Days)||0||
48404626|NCT02623699|101321890|FG005|STARTED|Part C (Up to 236 Days)||0||
48404627|NCT02623699|101321891|FG006|STARTED|Part C (Up to 236 Days)||0||
48404628|NCT02623699|101321892|FG007|STARTED|Part C (Up to 236 Days)||0||
48404629|NCT02623699|101321893|FG008|STARTED|Part C (Up to 236 Days)||0||
48404630|NCT02623699|101321894|FG009|STARTED|Part C (Up to 236 Days)||0||
48404631|NCT02623699|101321895|FG010|STARTED|Part C (Up to 236 Days)||36||
48404632|NCT02623699|101321896|FG011|STARTED|Part C (Up to 236 Days)||72||
48595652|NCT03309696|101789691|FG002|NOT COMPLETED|Overall Study||0||
48595653|NCT03309696|101789692|FG003|NOT COMPLETED|Overall Study||0||
48595654|NCT00737893|101789693|FG000|STARTED|Overall Study||29||
48595655|NCT00737893|101789694|FG001|STARTED|Overall Study||27||
48595656|NCT00737893|101789693|FG000|COMPLETED|Overall Study||29||
48141915|NCT01392560|100673432|FG000|COMPLETED|Overall Study||40||
48141916|NCT01392560|100673432|FG000|NOT COMPLETED|Overall Study||12||
48141917|NCT01775904|100673433|FG000|STARTED|LY2886721 ODT (no Water, Fasting)||26||
48295427|NCT02564354|101050876|FG001|NOT COMPLETED|Overall Study||0||
48295428|NCT00938470|101050877|FG000|STARTED|Overall Study||34||
48295429|NCT00938470|101050878|FG001|STARTED|Overall Study||28||
48295430|NCT00938470|101050877|FG000|COMPLETED|Overall Study||27||
48595657|NCT00737893|101789694|FG001|COMPLETED|Overall Study||27||
48141918|NCT01775904|100673433|FG000|Received at Least One Dose of Drug|LY2886721 ODT (no Water, Fasting)||26||
48141919|NCT01775904|100673433|FG000|COMPLETED|LY2886721 ODT (no Water, Fasting)||26||
48141920|NCT01775904|100673433|FG000|NOT COMPLETED|LY2886721 ODT (no Water, Fasting)||0||
48141921|NCT01775904|100673433|FG000|STARTED|First Washout (7 Days)||26||
48141922|NCT01775904|100673433|FG000|COMPLETED|First Washout (7 Days)||26||
48141923|NCT01775904|100673433|FG000|NOT COMPLETED|First Washout (7 Days)||0||
48141924|NCT01775904|100673433|FG000|STARTED|LY2886721 Capsule (Water, Fasting)||26||
48141925|NCT01775904|100673433|FG000|Received at Least One Dose of Drug|LY2886721 Capsule (Water, Fasting)||26||
48141926|NCT01775904|100673433|FG000|COMPLETED|LY2886721 Capsule (Water, Fasting)||25||
48141927|NCT01775904|100673433|FG000|NOT COMPLETED|LY2886721 Capsule (Water, Fasting)||1||
48141928|NCT01775904|100673433|FG000|STARTED|Second Washout (7 Days)||25||
48141929|NCT01775904|100673433|FG000|COMPLETED|Second Washout (7 Days)||25||
48141930|NCT01775904|100673433|FG000|NOT COMPLETED|Second Washout (7 Days)||0||
48141931|NCT01775904|100673433|FG000|STARTED|LY2886721 ODT (Water, Fed)||25||
48141932|NCT01775904|100673433|FG000|Received at Least One Dose of Drug|LY2886721 ODT (Water, Fed)||25||
48141933|NCT01775904|100673433|FG000|COMPLETED|LY2886721 ODT (Water, Fed)||25||
48141934|NCT01775904|100673433|FG000|NOT COMPLETED|LY2886721 ODT (Water, Fed)||0||
48141935|NCT01775904|100673433|FG000|STARTED|Third Washout (7 Days)||25||
48141936|NCT01775904|100673433|FG000|COMPLETED|Third Washout (7 Days)||25||
48141937|NCT01775904|100673433|FG000|NOT COMPLETED|Third Washout (7 Days)||0||
48141938|NCT01775904|100673433|FG000|STARTED|LY2886721 ODT (Water, Fasting)||25||
48141939|NCT01775904|100673433|FG000|Received at Least One Dose of Drug|LY2886721 ODT (Water, Fasting)||24||
48141940|NCT01775904|100673433|FG000|COMPLETED|LY2886721 ODT (Water, Fasting)||24||
48141941|NCT01775904|100673433|FG000|NOT COMPLETED|LY2886721 ODT (Water, Fasting)||1||
48141942|NCT03100617|100673434|FG000|STARTED|Overall Study||6||
48141943|NCT03100617|100673434|FG000|COMPLETED|Overall Study||6||
48141944|NCT03100617|100673434|FG000|NOT COMPLETED|Overall Study||0||
48141945|NCT03342638|100673435|FG000|STARTED|Overall Study||34||
48141946|NCT03342638|100673436|FG001|STARTED|Overall Study||32||
48141947|NCT03342638|100673435|FG000|COMPLETED|Overall Study||33||
48141948|NCT03342638|100673436|FG001|COMPLETED|Overall Study||31||
48141949|NCT03342638|100673435|FG000|NOT COMPLETED|Overall Study||1||
48141950|NCT03342638|100673436|FG001|NOT COMPLETED|Overall Study||1||
48141951|NCT00780208|100673437|FG000|STARTED|Overall Study||14||
48141952|NCT00780208|100673437|FG000|COMPLETED|Overall Study||8||
48295431|NCT00938470|101050878|FG001|COMPLETED|Overall Study||25||
48404633|NCT02623699|101321885|FG000|COMPLETED|Part C (Up to 236 Days)||0||
48404634|NCT02623699|101321886|FG001|COMPLETED|Part C (Up to 236 Days)||0||
48404635|NCT02623699|101321887|FG002|COMPLETED|Part C (Up to 236 Days)||0||
48404636|NCT02623699|101321888|FG003|COMPLETED|Part C (Up to 236 Days)||0||
48404637|NCT02623699|101321889|FG004|COMPLETED|Part C (Up to 236 Days)||0||
48404638|NCT02623699|101321890|FG005|COMPLETED|Part C (Up to 236 Days)||0||
48404639|NCT02623699|101321891|FG006|COMPLETED|Part C (Up to 236 Days)||0||
48404640|NCT02623699|101321892|FG007|COMPLETED|Part C (Up to 236 Days)||0||
48712214|NCT01777542|102081745|FG000|COMPLETED|Second Intervention (20 Weeks)||15||
48712215|NCT01777542|102081746|FG001|COMPLETED|Second Intervention (20 Weeks)||14||
48712216|NCT01777542|102081745|FG000|NOT COMPLETED|Second Intervention (20 Weeks)||0||
48712217|NCT01777542|102081746|FG001|NOT COMPLETED|Second Intervention (20 Weeks)||1||
48712218|NCT02594098|102081747|FG000|STARTED|Overall Study||27||
48404641|NCT02623699|101321893|FG008|COMPLETED|Part C (Up to 236 Days)||0||
48404642|NCT02623699|101321894|FG009|COMPLETED|Part C (Up to 236 Days)||0||
48404643|NCT02623699|101321895|FG010|COMPLETED|Part C (Up to 236 Days)||33||
48404644|NCT02623699|101321896|FG011|COMPLETED|Part C (Up to 236 Days)||64||
48404645|NCT02623699|101321885|FG000|NOT COMPLETED|Part C (Up to 236 Days)||0||
48404646|NCT02623699|101321886|FG001|NOT COMPLETED|Part C (Up to 236 Days)||0||
48712219|NCT02594098|102081748|FG001|STARTED|Overall Study||14||
48712220|NCT02594098|102081747|FG000|COMPLETED|Overall Study||1||
48712221|NCT02594098|102081748|FG001|COMPLETED|Overall Study||1||
48712222|NCT02594098|102081747|FG000|NOT COMPLETED|Overall Study||26||
48712223|NCT02594098|102081748|FG001|NOT COMPLETED|Overall Study||13||
48712224|NCT01156389|102081749|FG000|STARTED|Overall Study||17||
48712225|NCT01156389|102081750|FG001|STARTED|Overall Study||17||
48712226|NCT01156389|102081749|FG000|COMPLETED|Overall Study||13||
48712227|NCT01156389|102081750|FG001|COMPLETED|Overall Study||16||
48712228|NCT01156389|102081749|FG000|NOT COMPLETED|Overall Study||4||
48712229|NCT01156389|102081750|FG001|NOT COMPLETED|Overall Study||1||
48712230|NCT03784846|102081751|FG000|STARTED|Pre-COVID Study||17||
48712231|NCT03784846|102081752|FG001|STARTED|Pre-COVID Study||14||
48404647|NCT02623699|101321887|FG002|NOT COMPLETED|Part C (Up to 236 Days)||0||
48404648|NCT02623699|101321888|FG003|NOT COMPLETED|Part C (Up to 236 Days)||0||
48404649|NCT02623699|101321889|FG004|NOT COMPLETED|Part C (Up to 236 Days)||0||
48712232|NCT03784846|102081753|FG002|STARTED|Pre-COVID Study||5||
48712233|NCT03784846|102081751|FG000|COMPLETED|Pre-COVID Study||6||
48712234|NCT03784846|102081752|FG001|COMPLETED|Pre-COVID Study||3||
48712235|NCT03784846|102081753|FG002|COMPLETED|Pre-COVID Study||0||
48141953|NCT00780208|100673437|FG000|NOT COMPLETED|Overall Study||6||
48712236|NCT03784846|102081751|FG000|NOT COMPLETED|Pre-COVID Study||11||
48141954|NCT01581281|100673438|FG000|STARTED|Overall Study||145||
48141955|NCT01581281|100673439|FG001|STARTED|Overall Study||72||
48712237|NCT03784846|102081752|FG001|NOT COMPLETED|Pre-COVID Study||11||
48141956|NCT01581281|100673440|FG002|STARTED|Overall Study||144||
48141957|NCT01581281|100673438|FG000|COMPLETED|Overall Study||130||
48141958|NCT01581281|100673439|FG001|COMPLETED|Overall Study||66||
48141959|NCT01581281|100673440|FG002|COMPLETED|Overall Study||132||
48141960|NCT01581281|100673438|FG000|NOT COMPLETED|Overall Study||15||
48141961|NCT01581281|100673439|FG001|NOT COMPLETED|Overall Study||6||
48141962|NCT01581281|100673440|FG002|NOT COMPLETED|Overall Study||12||
48141963|NCT02388724|100673441|FG000|STARTED|Overall Study||244||
48141964|NCT02388724|100673442|FG001|STARTED|Overall Study||237||
48141965|NCT02388724|100673441|FG000|Safety Set: Randomized But Not Treated|Overall Study||0||
48141966|NCT02388724|100673442|FG001|Safety Set: Randomized But Not Treated|Overall Study||2||
48141967|NCT02388724|100673441|FG000|COMPLETED|Overall Study||232|Completed=Completed Treatment|
48141968|NCT02388724|100673442|FG001|COMPLETED|Overall Study||224|Completed=Completed Treatment|
48141969|NCT02388724|100673441|FG000|NOT COMPLETED|Overall Study||12||
48141970|NCT02388724|100673442|FG001|NOT COMPLETED|Overall Study||13||
48141971|NCT01747772|100673443|FG000|STARTED|Overall Study||180||
48141972|NCT01747772|100673443|FG000|Analysis Population|Overall Study||164||
48141973|NCT01747772|100673443|FG000|COMPLETED|Overall Study||171||
48141974|NCT01747772|100673443|FG000|NOT COMPLETED|Overall Study||9||
48141975|NCT02119416|100673444|FG000|STARTED|Overall Study||32||
48141976|NCT02119416|100673445|FG001|STARTED|Overall Study||36||
48141977|NCT02119416|100673446|FG002|STARTED|Overall Study||33||
48141978|NCT02119416|100673444|FG000|COMPLETED|Overall Study||30||
48141979|NCT02119416|100673445|FG001|COMPLETED|Overall Study||35||
48141980|NCT02119416|100673446|FG002|COMPLETED|Overall Study||31||
48141981|NCT02119416|100673444|FG000|NOT COMPLETED|Overall Study||2||
48141982|NCT02119416|100673445|FG001|NOT COMPLETED|Overall Study||1||
48141983|NCT02119416|100673446|FG002|NOT COMPLETED|Overall Study||2||
48141984|NCT01300546|100673447|FG000|STARTED|Overall Study||19||
48141985|NCT01300546|100673448|FG001|STARTED|Overall Study||20||
48141986|NCT01300546|100673447|FG000|COMPLETED|Overall Study||18||
48141987|NCT01300546|100673448|FG001|COMPLETED|Overall Study||14||
48141988|NCT01300546|100673447|FG000|NOT COMPLETED|Overall Study||1||
48141989|NCT01300546|100673448|FG001|NOT COMPLETED|Overall Study||6||
48141990|NCT04393441|100673449|FG000|STARTED|Overall Study||200||
48141991|NCT04393441|100673450|FG001|STARTED|Overall Study||200||
48712238|NCT03784846|102081753|FG002|NOT COMPLETED|Pre-COVID Study||5||
48712239|NCT03784846|102081751|FG000|STARTED|Post-COVID Study||33||
48712240|NCT03784846|102081752|FG001|STARTED|Post-COVID Study||24||
48712241|NCT03784846|102081753|FG002|STARTED|Post-COVID Study||16||
48712242|NCT03784846|102081751|FG000|COMPLETED|Post-COVID Study||29||
48712243|NCT03784846|102081752|FG001|COMPLETED|Post-COVID Study||17||
48712244|NCT03784846|102081753|FG002|COMPLETED|Post-COVID Study||15||
48712245|NCT03784846|102081751|FG000|NOT COMPLETED|Post-COVID Study||4||
48712246|NCT03784846|102081752|FG001|NOT COMPLETED|Post-COVID Study||7||
48712247|NCT03784846|102081753|FG002|NOT COMPLETED|Post-COVID Study||1||
48712248|NCT02650128|102081754|FG000|STARTED|Overall Study||60||
48712249|NCT02650128|102081754|FG000|30 Day Primary and Safety Endpoint|Overall Study||60||
48141992|NCT04393441|100673449|FG000|Safety Population|Overall Study||199|Safety Population consisted of all treated participants who received/took ≥1 administration of study intervention.|
48141993|NCT04393441|100673450|FG001|Safety Population|Overall Study||200|Safety Population consisted of all treated participants who received/took ≥1 administration of study intervention.|
48141994|NCT04393441|100673449|FG000|COMPLETED|Overall Study||192||
48141995|NCT04393441|100673450|FG001|COMPLETED|Overall Study||186||
48141996|NCT04393441|100673449|FG000|NOT COMPLETED|Overall Study||8||
48141997|NCT04393441|100673450|FG001|NOT COMPLETED|Overall Study||14||
48141998|NCT00657618|100673451|FG000|STARTED|Overall Study||77||
48141999|NCT00657618|100673451|FG000|COMPLETED|Overall Study||34||
48142000|NCT00657618|100673451|FG000|NOT COMPLETED|Overall Study||43||
48142001|NCT01262651|100673452|FG000|STARTED|Overall Study||199||
48142002|NCT01262651|100673453|FG001|STARTED|Overall Study||198||
48142003|NCT01262651|100673452|FG000|Received at Least 1 Dose of Study Drug|Overall Study||199||
48142004|NCT01262651|100673453|FG001|Received at Least 1 Dose of Study Drug|Overall Study||198||
48142005|NCT01262651|100673452|FG000|Safety Population|Overall Study||199||
48142006|NCT01262651|100673453|FG001|Safety Population|Overall Study||198||
48142007|NCT01262651|100673452|FG000|ITT Population|Overall Study||199||
48142008|NCT01262651|100673453|FG001|ITT Population|Overall Study||198||
48142009|NCT01262651|100673452|FG000|COMPLETED|Overall Study||141||
48142010|NCT01262651|100673453|FG001|COMPLETED|Overall Study||150||
48142011|NCT01262651|100673452|FG000|NOT COMPLETED|Overall Study||58||
48142012|NCT01262651|100673453|FG001|NOT COMPLETED|Overall Study||48||
48142013|NCT00234065|100673454|FG000|STARTED|Overall Study||1356||
48712250|NCT02650128|102081754|FG000|COMPLETED|Overall Study||58|180 day major adverse cardiac event (Post-Market Clinical Follow-up)|
48712251|NCT02650128|102081754|FG000|NOT COMPLETED|Overall Study||2||
48142014|NCT00234065|100673455|FG001|STARTED|Overall Study||1360||
48142015|NCT00234065|100673454|FG000|COMPLETED|Overall Study||881||
48142016|NCT00234065|100673455|FG001|COMPLETED|Overall Study||1004||
48142017|NCT00234065|100673454|FG000|NOT COMPLETED|Overall Study||475||
48142018|NCT00234065|100673455|FG001|NOT COMPLETED|Overall Study||356||
48142019|NCT03969719|100673456|FG000|STARTED|Overall Study||54||
48142020|NCT03969719|100673457|FG001|STARTED|Overall Study||55||
48295432|NCT00938470|101050877|FG000|NOT COMPLETED|Overall Study||7||
48295433|NCT00938470|101050878|FG001|NOT COMPLETED|Overall Study||3||
48295434|NCT00381303|101050879|FG000|STARTED|Overall Study||287||
48295435|NCT00381303|101050880|FG001|STARTED|Overall Study||142||
48295436|NCT00381303|101050879|FG000|COMPLETED|Overall Study||193||
48295437|NCT00381303|101050880|FG001|COMPLETED|Overall Study||109||
48295438|NCT00381303|101050879|FG000|NOT COMPLETED|Overall Study||94||
48295439|NCT00381303|101050880|FG001|NOT COMPLETED|Overall Study||33||
48295440|NCT02647866|101050881|FG000|STARTED|Overall Study||9||
48295441|NCT02647866|101050882|FG001|STARTED|Overall Study||10||
48295442|NCT02647866|101050883|FG002|STARTED|Overall Study||9||
48295443|NCT02647866|101050884|FG003|STARTED|Overall Study||21||
48295444|NCT02647866|101050885|FG004|STARTED|Overall Study||17||
48295445|NCT02647866|101050881|FG000|Completed Induction Therapy|Overall Study||8||
48295446|NCT02647866|101050882|FG001|Completed Induction Therapy|Overall Study||9||
48295447|NCT02647866|101050883|FG002|Completed Induction Therapy|Overall Study||8||
48295448|NCT02647866|101050884|FG003|Completed Induction Therapy|Overall Study||19||
48295449|NCT02647866|101050885|FG004|Completed Induction Therapy|Overall Study||17||
48295450|NCT02647866|101050881|FG000|Completed Induction Therapy Follow-Up|Overall Study||5||
48295451|NCT02647866|101050882|FG001|Completed Induction Therapy Follow-Up|Overall Study||1||
48295452|NCT02647866|101050883|FG002|Completed Induction Therapy Follow-Up|Overall Study||2||
48295453|NCT02647866|101050884|FG003|Completed Induction Therapy Follow-Up|Overall Study||0||
48295454|NCT02647866|101050885|FG004|Completed Induction Therapy Follow-Up|Overall Study||2||
48295455|NCT02647866|101050881|FG000|Completed Long-Term Extension Therapy|Overall Study||3||
48295456|NCT02647866|101050882|FG001|Completed Long-Term Extension Therapy|Overall Study||0||
48295457|NCT02647866|101050883|FG002|Completed Long-Term Extension Therapy|Overall Study||0||
48295458|NCT02647866|101050884|FG003|Completed Long-Term Extension Therapy|Overall Study||0||
48404650|NCT02623699|101321890|FG005|NOT COMPLETED|Part C (Up to 236 Days)||0||
48404651|NCT02623699|101321891|FG006|NOT COMPLETED|Part C (Up to 236 Days)||0||
48404652|NCT02623699|101321892|FG007|NOT COMPLETED|Part C (Up to 236 Days)||0||
48712252|NCT01710527|102081755|FG000|STARTED|Period 1: Intervention Period 1||16||
48712253|NCT01710527|102081756|FG001|STARTED|Period 1: Intervention Period 1||16||
48712254|NCT01710527|102081755|FG000|COMPLETED|Period 1: Intervention Period 1||16||
48712255|NCT01710527|102081756|FG001|COMPLETED|Period 1: Intervention Period 1||16||
48712256|NCT01710527|102081755|FG000|NOT COMPLETED|Period 1: Intervention Period 1||0||
48712257|NCT01710527|102081756|FG001|NOT COMPLETED|Period 1: Intervention Period 1||0||
48712258|NCT01710527|102081755|FG000|STARTED|Period 2: Washout Period (7 Days)||16||
48712259|NCT01710527|102081756|FG001|STARTED|Period 2: Washout Period (7 Days)||16||
48712260|NCT01710527|102081755|FG000|COMPLETED|Period 2: Washout Period (7 Days)||16||
48712261|NCT01710527|102081756|FG001|COMPLETED|Period 2: Washout Period (7 Days)||15||
48712262|NCT01710527|102081755|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0||
48712263|NCT01710527|102081756|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||1||
48712264|NCT01710527|102081755|FG000|STARTED|Period 3: Intervention Period 2||16||
48712265|NCT01710527|102081756|FG001|STARTED|Period 3: Intervention Period 2||15||
48712266|NCT01710527|102081755|FG000|COMPLETED|Period 3: Intervention Period 2||16||
48712267|NCT01710527|102081756|FG001|COMPLETED|Period 3: Intervention Period 2||15||
48295459|NCT02647866|101050885|FG004|Completed Long-Term Extension Therapy|Overall Study||0||
48295460|NCT02647866|101050881|FG000|Completed LTE Follow-up|Overall Study||2||
48295461|NCT02647866|101050882|FG001|Completed LTE Follow-up|Overall Study||0||
48295462|NCT02647866|101050883|FG002|Completed LTE Follow-up|Overall Study||0||
48295463|NCT02647866|101050884|FG003|Completed LTE Follow-up|Overall Study||0||
48295464|NCT02647866|101050885|FG004|Completed LTE Follow-up|Overall Study||0||
48295465|NCT02647866|101050881|FG000|Completed Open-Label Extension Therapy|Overall Study||0||
48295466|NCT02647866|101050882|FG001|Completed Open-Label Extension Therapy|Overall Study||7||
48295467|NCT02647866|101050883|FG002|Completed Open-Label Extension Therapy|Overall Study||4||
48404653|NCT02623699|101321893|FG008|NOT COMPLETED|Part C (Up to 236 Days)||0||
48712268|NCT01710527|102081755|FG000|NOT COMPLETED|Period 3: Intervention Period 2||0||
48712269|NCT01710527|102081756|FG001|NOT COMPLETED|Period 3: Intervention Period 2||0||
48712270|NCT01873729|102081757|FG000|STARTED|Overall Study||3||
48404654|NCT02623699|101321894|FG009|NOT COMPLETED|Part C (Up to 236 Days)||0||
48404655|NCT02623699|101321895|FG010|NOT COMPLETED|Part C (Up to 236 Days)||3||
48404656|NCT02623699|101321896|FG011|NOT COMPLETED|Part C (Up to 236 Days)||8||
48404657|NCT01256918|101321897|FG000|STARTED|Overall Study||200||
48404658|NCT01256918|101321897|FG000|Full Thickness Nuclear Crack Achieved|Overall Study||200||
48404659|NCT01256918|101321897|FG000|COMPLETED|Overall Study||200||
48404660|NCT01256918|101321897|FG000|NOT COMPLETED|Overall Study||0||
48404661|NCT00804986|101321898|FG000|STARTED|Overall Study||36||
48404662|NCT00804986|101321899|FG001|STARTED|Overall Study||43||
48404663|NCT00804986|101321900|FG002|STARTED|Overall Study||42||
48295468|NCT02647866|101050884|FG003|Completed Open-Label Extension Therapy|Overall Study||17||
48295469|NCT02647866|101050885|FG004|Completed Open-Label Extension Therapy|Overall Study||13||
48295470|NCT02647866|101050881|FG000|Completed OLE Follow-up|Overall Study||0||
48295471|NCT02647866|101050882|FG001|Completed OLE Follow-up|Overall Study||6||
48295472|NCT02647866|101050883|FG002|Completed OLE Follow-up|Overall Study||4||
48295473|NCT02647866|101050884|FG003|Completed OLE Follow-up|Overall Study||14||
48404664|NCT00804986|101321901|FG003|STARTED|Overall Study||42||
48404665|NCT00804986|101321902|FG004|STARTED|Overall Study||43||
48404666|NCT00804986|101321903|FG005|STARTED|Overall Study||41||
48404667|NCT00804986|101321898|FG000|COMPLETED|Overall Study||35||
48404668|NCT00804986|101321899|FG001|COMPLETED|Overall Study||35||
48404669|NCT00804986|101321900|FG002|COMPLETED|Overall Study||40||
48404670|NCT00804986|101321901|FG003|COMPLETED|Overall Study||34||
48404671|NCT00804986|101321902|FG004|COMPLETED|Overall Study||34||
48404672|NCT00804986|101321903|FG005|COMPLETED|Overall Study||31||
48295474|NCT02647866|101050885|FG004|Completed OLE Follow-up|Overall Study||10||
48295475|NCT02647866|101050881|FG000|Moved From LTE to OLE Therapy|Overall Study||0||
48295476|NCT02647866|101050882|FG001|Moved From LTE to OLE Therapy|Overall Study||5||
48295477|NCT02647866|101050883|FG002|Moved From LTE to OLE Therapy|Overall Study||0||
48295478|NCT02647866|101050884|FG003|Moved From LTE to OLE Therapy|Overall Study||0||
48295479|NCT02647866|101050885|FG004|Moved From LTE to OLE Therapy|Overall Study||2||
48295480|NCT02647866|101050881|FG000|Discontinued the Treatment|Overall Study||4||
48295481|NCT02647866|101050882|FG001|Discontinued the Treatment|Overall Study||5||
48295482|NCT02647866|101050883|FG002|Discontinued the Treatment|Overall Study||5||
48295483|NCT02647866|101050884|FG003|Discontinued the Treatment|Overall Study||5||
48404673|NCT00804986|101321898|FG000|NOT COMPLETED|Overall Study||1||
48595658|NCT00737893|101789693|FG000|NOT COMPLETED|Overall Study||0||
48595659|NCT00737893|101789694|FG001|NOT COMPLETED|Overall Study||0||
48595660|NCT02919267|101789695|FG000|STARTED|Overall Study||10||
48595661|NCT02919267|101789696|FG001|STARTED|Overall Study||12||
48595662|NCT02919267|101789697|FG002|STARTED|Overall Study||13||
48595663|NCT02919267|101789698|FG003|STARTED|Overall Study||14||
48595664|NCT02919267|101789695|FG000|COMPLETED|Overall Study||10||
48595665|NCT02919267|101789696|FG001|COMPLETED|Overall Study||9||
48595666|NCT02919267|101789697|FG002|COMPLETED|Overall Study||10||
48595667|NCT02919267|101789698|FG003|COMPLETED|Overall Study||10||
48595668|NCT02919267|101789695|FG000|NOT COMPLETED|Overall Study||0||
48595669|NCT02919267|101789696|FG001|NOT COMPLETED|Overall Study||3||
48595670|NCT02919267|101789697|FG002|NOT COMPLETED|Overall Study||3||
48595671|NCT02919267|101789698|FG003|NOT COMPLETED|Overall Study||4||
48595672|NCT00979420|101789699|FG000|STARTED|Overall Study||178||
48595673|NCT00979420|101789700|FG001|STARTED|Overall Study||57||
48595674|NCT00979420|101789701|FG002|STARTED|Overall Study||60||
48595675|NCT00979420|101789702|FG003|STARTED|Overall Study||61||
48595676|NCT00979420|101789699|FG000|COMPLETED|Overall Study||171||
48595677|NCT00979420|101789700|FG001|COMPLETED|Overall Study||57||
48595678|NCT00979420|101789701|FG002|COMPLETED|Overall Study||59||
48595679|NCT00979420|101789702|FG003|COMPLETED|Overall Study||59||
48595680|NCT00979420|101789699|FG000|NOT COMPLETED|Overall Study||7||
48595681|NCT00979420|101789700|FG001|NOT COMPLETED|Overall Study||0||
48595682|NCT00979420|101789701|FG002|NOT COMPLETED|Overall Study||1||
48595683|NCT00979420|101789702|FG003|NOT COMPLETED|Overall Study||2||
48595684|NCT01267201|101789703|FG000|STARTED|First Intervention Period||4||
48595685|NCT01267201|101789704|FG001|STARTED|First Intervention Period||4||
48595686|NCT01267201|101789705|FG002|STARTED|First Intervention Period||4||
48595687|NCT01267201|101789706|FG003|STARTED|First Intervention Period||4||
48595688|NCT01267201|101789707|FG004|STARTED|First Intervention Period||4||
48595689|NCT01267201|101789708|FG005|STARTED|First Intervention Period||4||
48595690|NCT01267201|101789703|FG000|COMPLETED|First Intervention Period||3||
48595691|NCT01267201|101789704|FG001|COMPLETED|First Intervention Period||4||
48595692|NCT01267201|101789705|FG002|COMPLETED|First Intervention Period||4||
48595693|NCT01267201|101789706|FG003|COMPLETED|First Intervention Period||4||
48595694|NCT01267201|101789707|FG004|COMPLETED|First Intervention Period||4||
48595695|NCT01267201|101789708|FG005|COMPLETED|First Intervention Period||4||
48595696|NCT01267201|101789703|FG000|NOT COMPLETED|First Intervention Period||1||
48595697|NCT01267201|101789704|FG001|NOT COMPLETED|First Intervention Period||0||
48595698|NCT01267201|101789705|FG002|NOT COMPLETED|First Intervention Period||0||
48595699|NCT01267201|101789706|FG003|NOT COMPLETED|First Intervention Period||0||
48595700|NCT01267201|101789707|FG004|NOT COMPLETED|First Intervention Period||0||
48595701|NCT01267201|101789708|FG005|NOT COMPLETED|First Intervention Period||0||
48595702|NCT01267201|101789703|FG000|STARTED|Washout Period (At Least 2 Days)||3||
48595703|NCT01267201|101789704|FG001|STARTED|Washout Period (At Least 2 Days)||4||
48595704|NCT01267201|101789705|FG002|STARTED|Washout Period (At Least 2 Days)||4||
48595705|NCT01267201|101789706|FG003|STARTED|Washout Period (At Least 2 Days)||4||
48595706|NCT01267201|101789707|FG004|STARTED|Washout Period (At Least 2 Days)||4||
48595707|NCT01267201|101789708|FG005|STARTED|Washout Period (At Least 2 Days)||4||
48595708|NCT01267201|101789703|FG000|COMPLETED|Washout Period (At Least 2 Days)||3||
48595709|NCT01267201|101789704|FG001|COMPLETED|Washout Period (At Least 2 Days)||4||
48595710|NCT01267201|101789705|FG002|COMPLETED|Washout Period (At Least 2 Days)||4||
48595711|NCT01267201|101789706|FG003|COMPLETED|Washout Period (At Least 2 Days)||4||
48595712|NCT01267201|101789707|FG004|COMPLETED|Washout Period (At Least 2 Days)||4||
48595713|NCT01267201|101789708|FG005|COMPLETED|Washout Period (At Least 2 Days)||4||
48595714|NCT01267201|101789703|FG000|NOT COMPLETED|Washout Period (At Least 2 Days)||0||
48595715|NCT01267201|101789704|FG001|NOT COMPLETED|Washout Period (At Least 2 Days)||0||
48595716|NCT01267201|101789705|FG002|NOT COMPLETED|Washout Period (At Least 2 Days)||0||
48595717|NCT01267201|101789706|FG003|NOT COMPLETED|Washout Period (At Least 2 Days)||0||
48595718|NCT01267201|101789707|FG004|NOT COMPLETED|Washout Period (At Least 2 Days)||0||
48595719|NCT01267201|101789708|FG005|NOT COMPLETED|Washout Period (At Least 2 Days)||0||
48595720|NCT01267201|101789703|FG000|STARTED|Second Intervention Period||3||
48595721|NCT01267201|101789704|FG001|STARTED|Second Intervention Period||4||
48595722|NCT01267201|101789705|FG002|STARTED|Second Intervention Period||4||
48595723|NCT01267201|101789706|FG003|STARTED|Second Intervention Period||4||
48595724|NCT01267201|101789707|FG004|STARTED|Second Intervention Period||4||
48595725|NCT01267201|101789708|FG005|STARTED|Second Intervention Period||4||
48595726|NCT01267201|101789703|FG000|COMPLETED|Second Intervention Period||3||
48595727|NCT01267201|101789704|FG001|COMPLETED|Second Intervention Period||3||
48595728|NCT01267201|101789705|FG002|COMPLETED|Second Intervention Period||4||
48712271|NCT01873729|102081757|FG000|COMPLETED|Overall Study||2||
48712272|NCT01873729|102081757|FG000|NOT COMPLETED|Overall Study||1||
48595729|NCT01267201|101789706|FG003|COMPLETED|Second Intervention Period||4||
48595730|NCT01267201|101789707|FG004|COMPLETED|Second Intervention Period||4||
48595731|NCT01267201|101789708|FG005|COMPLETED|Second Intervention Period||4||
48595732|NCT01267201|101789703|FG000|NOT COMPLETED|Second Intervention Period||0||
48595733|NCT01267201|101789704|FG001|NOT COMPLETED|Second Intervention Period||1||
48595734|NCT01267201|101789705|FG002|NOT COMPLETED|Second Intervention Period||0||
48295484|NCT02647866|101050885|FG004|Discontinued the Treatment|Overall Study||8||
48295485|NCT02647866|101050881|FG000|Discontinued the Study|Overall Study||5||
48295486|NCT02647866|101050882|FG001|Discontinued the Study|Overall Study||4||
48295487|NCT02647866|101050883|FG002|Discontinued the Study|Overall Study||5||
48295488|NCT02647866|101050884|FG003|Discontinued the Study|Overall Study||6||
48295489|NCT02647866|101050885|FG004|Discontinued the Study|Overall Study||8||
48295490|NCT02647866|101050881|FG000|COMPLETED|Overall Study||4||
48295491|NCT02647866|101050882|FG001|COMPLETED|Overall Study||6||
48295492|NCT02647866|101050883|FG002|COMPLETED|Overall Study||4||
48295493|NCT02647866|101050884|FG003|COMPLETED|Overall Study||15||
48295494|NCT02647866|101050885|FG004|COMPLETED|Overall Study||9||
48295495|NCT02647866|101050881|FG000|NOT COMPLETED|Overall Study||5||
48295496|NCT02647866|101050882|FG001|NOT COMPLETED|Overall Study||4||
48295497|NCT02647866|101050883|FG002|NOT COMPLETED|Overall Study||5||
48295498|NCT02647866|101050884|FG003|NOT COMPLETED|Overall Study||6||
48295499|NCT02647866|101050885|FG004|NOT COMPLETED|Overall Study||8||
48595735|NCT01267201|101789706|FG003|NOT COMPLETED|Second Intervention Period||0||
48595736|NCT01267201|101789707|FG004|NOT COMPLETED|Second Intervention Period||0||
48712273|NCT00869050|102081758|FG000|STARTED|Overall Study||41||
48295500|NCT03658668|101050886|FG000|STARTED|Overall Study||13||
48295501|NCT03658668|101050887|FG001|STARTED|Overall Study||9||
48295502|NCT03658668|101050886|FG000|COMPLETED|Overall Study||12||
48295503|NCT03658668|101050887|FG001|COMPLETED|Overall Study||8||
48295504|NCT03658668|101050886|FG000|NOT COMPLETED|Overall Study||1||
48295505|NCT03658668|101050887|FG001|NOT COMPLETED|Overall Study||1||
48295506|NCT00440700|101050888|FG000|STARTED|Overall Study||122||
48295507|NCT00440700|101050889|FG001|STARTED|Overall Study||118||
48295508|NCT00440700|101050890|FG002|STARTED|Overall Study||124||
48295509|NCT00440700|101050888|FG000|COMPLETED|Overall Study||114||
48295510|NCT00440700|101050889|FG001|COMPLETED|Overall Study||110||
48295511|NCT00440700|101050890|FG002|COMPLETED|Overall Study||120||
48295512|NCT00440700|101050888|FG000|NOT COMPLETED|Overall Study||8||
48295513|NCT00440700|101050889|FG001|NOT COMPLETED|Overall Study||8||
48295514|NCT00440700|101050890|FG002|NOT COMPLETED|Overall Study||4||
48295515|NCT01003990|101050891|FG000|STARTED|Overall Study||459||
48295516|NCT01003990|101050892|FG001|STARTED|Overall Study||154||
48295517|NCT01003990|101050893|FG002|STARTED|Overall Study||96||
48295518|NCT01003990|101050891|FG000|COMPLETED|Overall Study||367||
48295519|NCT01003990|101050892|FG001|COMPLETED|Overall Study||103||
48295520|NCT01003990|101050893|FG002|COMPLETED|Overall Study||53||
48595737|NCT01267201|101789708|FG005|NOT COMPLETED|Second Intervention Period||0||
48595738|NCT01267201|101789703|FG000|STARTED|Washout Period (At Least 2 Days)||3||
48595739|NCT01267201|101789704|FG001|STARTED|Washout Period (At Least 2 Days)||3||
48595740|NCT01267201|101789705|FG002|STARTED|Washout Period (At Least 2 Days)||4||
48595741|NCT01267201|101789706|FG003|STARTED|Washout Period (At Least 2 Days)||4||
48595742|NCT01267201|101789707|FG004|STARTED|Washout Period (At Least 2 Days)||4||
48595743|NCT01267201|101789708|FG005|STARTED|Washout Period (At Least 2 Days)||4||
48595744|NCT01267201|101789703|FG000|COMPLETED|Washout Period (At Least 2 Days)||3||
48595745|NCT01267201|101789704|FG001|COMPLETED|Washout Period (At Least 2 Days)||3||
48595746|NCT01267201|101789705|FG002|COMPLETED|Washout Period (At Least 2 Days)||4||
48595747|NCT01267201|101789706|FG003|COMPLETED|Washout Period (At Least 2 Days)||4||
48712274|NCT00869050|102081758|FG000|COMPLETED|Overall Study||38||
48712275|NCT00869050|102081758|FG000|NOT COMPLETED|Overall Study||3||
48712276|NCT00611468|102081759|FG000|STARTED|Overall Study||3||
48712277|NCT00611468|102081760|FG001|STARTED|Overall Study||7||
48712278|NCT00611468|102081761|FG002|STARTED|Overall Study||6||
48712279|NCT00611468|102081762|FG003|STARTED|Overall Study||13||
48712280|NCT00611468|102081759|FG000|COMPLETED|Overall Study||3||
48712281|NCT00611468|102081760|FG001|COMPLETED|Overall Study||6||
48295521|NCT01003990|101050891|FG000|NOT COMPLETED|Overall Study||92||
48295522|NCT01003990|101050892|FG001|NOT COMPLETED|Overall Study||51||
48295523|NCT01003990|101050893|FG002|NOT COMPLETED|Overall Study||43||
48295524|NCT00835120|101050894|FG000|STARTED|Overall Study||34||
48295525|NCT00835120|101050894|FG000|COMPLETED|Overall Study||26||
48295526|NCT00835120|101050894|FG000|NOT COMPLETED|Overall Study||8||
48295527|NCT02370043|101050895|FG000|STARTED|Overall Study||3||
48295528|NCT02370043|101050896|FG001|STARTED|Overall Study||3||
48295529|NCT02370043|101050897|FG002|STARTED|Overall Study||3||
48295530|NCT02370043|101050898|FG003|STARTED|Overall Study||3||
48295531|NCT02370043|101050899|FG004|STARTED|Overall Study||3||
48295532|NCT02370043|101050900|FG005|STARTED|Overall Study||4||
48295533|NCT02370043|101050895|FG000|COMPLETED|Overall Study||3||
48295534|NCT02370043|101050896|FG001|COMPLETED|Overall Study||3||
48295535|NCT02370043|101050897|FG002|COMPLETED|Overall Study||3||
48295536|NCT02370043|101050898|FG003|COMPLETED|Overall Study||3||
48295537|NCT02370043|101050899|FG004|COMPLETED|Overall Study||2||
48295538|NCT02370043|101050900|FG005|COMPLETED|Overall Study||3||
48295539|NCT02370043|101050895|FG000|NOT COMPLETED|Overall Study||0||
48295540|NCT02370043|101050896|FG001|NOT COMPLETED|Overall Study||0||
48295541|NCT02370043|101050897|FG002|NOT COMPLETED|Overall Study||0||
48295542|NCT02370043|101050898|FG003|NOT COMPLETED|Overall Study||0||
48295543|NCT02370043|101050899|FG004|NOT COMPLETED|Overall Study||1||
48295544|NCT02370043|101050900|FG005|NOT COMPLETED|Overall Study||1||
48295545|NCT01020448|101050901|FG000|STARTED|Pre-assignment||339||
48295546|NCT01020448|101050901|FG000|COMPLETED|Pre-assignment||326||
48295547|NCT01020448|101050901|FG000|NOT COMPLETED|Pre-assignment||13||
48295548|NCT01020448|101050901|FG000|STARTED|Treatment||325||
48295549|NCT01020448|101050901|FG000|COMPLETED|Treatment||299||
48295550|NCT01020448|101050901|FG000|NOT COMPLETED|Treatment||26||
48295551|NCT01142596|101050902|FG000|STARTED|Overall Study||44||
48295552|NCT01142596|101050903|FG001|STARTED|Overall Study||157||
48295553|NCT01142596|101050902|FG000|COMPLETED|Overall Study||15||
48295554|NCT01142596|101050903|FG001|COMPLETED|Overall Study||71||
48295555|NCT01142596|101050902|FG000|NOT COMPLETED|Overall Study||29||
48295556|NCT01142596|101050903|FG001|NOT COMPLETED|Overall Study||86||
48295557|NCT02319525|101050904|FG000|STARTED|Overall Study||153||
48295558|NCT02319525|101050905|FG001|STARTED|Overall Study||148||
48295559|NCT02319525|101050904|FG000|Primary Research Completion|Overall Study||151||
48295560|NCT02319525|101050905|FG001|Primary Research Completion|Overall Study||147||
48295561|NCT02319525|101050904|FG000|COMPLETED|Overall Study||151||
48295562|NCT02319525|101050905|FG001|COMPLETED|Overall Study||147||
48295563|NCT02319525|101050904|FG000|NOT COMPLETED|Overall Study||2||
48295564|NCT02319525|101050905|FG001|NOT COMPLETED|Overall Study||1||
48295565|NCT01259726|101050906|FG000|STARTED|Overall Study||43||
48295566|NCT01259726|101050907|FG001|STARTED|Overall Study||41||
48295567|NCT01259726|101050908|FG002|STARTED|Overall Study||43||
48295568|NCT01259726|101050909|FG003|STARTED|Overall Study||41||
48295569|NCT01259726|101050906|FG000|Treated|Overall Study||40||
48295570|NCT01259726|101050907|FG001|Treated|Overall Study||37||
48295571|NCT01259726|101050908|FG002|Treated|Overall Study||41||
48295572|NCT01259726|101050909|FG003|Treated|Overall Study||39||
48295573|NCT01259726|101050906|FG000|COMPLETED|Overall Study||38||
48295574|NCT01259726|101050907|FG001|COMPLETED|Overall Study||37||
48295575|NCT01259726|101050908|FG002|COMPLETED|Overall Study||39||
48295576|NCT01259726|101050909|FG003|COMPLETED|Overall Study||36||
48295577|NCT01259726|101050906|FG000|NOT COMPLETED|Overall Study||5||
48295578|NCT01259726|101050907|FG001|NOT COMPLETED|Overall Study||4||
48295579|NCT01259726|101050908|FG002|NOT COMPLETED|Overall Study||4||
48295580|NCT01259726|101050909|FG003|NOT COMPLETED|Overall Study||5||
48295581|NCT02170389|101050910|FG000|STARTED|Overall Study||5||
48295582|NCT02170389|101050910|FG000|COMPLETED|Overall Study||4||
48295583|NCT02170389|101050910|FG000|NOT COMPLETED|Overall Study||1||
48295584|NCT00866723|101050911|FG000|STARTED|Overall Study||5||
48295585|NCT00866723|101050911|FG000|COMPLETED|Overall Study||0||
48295586|NCT00866723|101050911|FG000|NOT COMPLETED|Overall Study||5||
48295587|NCT02158520|101050912|FG000|STARTED|Overall Study||12||
48295588|NCT02158520|101050913|FG001|STARTED|Overall Study||12||
48295589|NCT02158520|101050912|FG000|AE Evaluated Prior to Crossover|Overall Study||12||
48295590|NCT02158520|101050913|FG001|AE Evaluated Prior to Crossover|Overall Study||12||
48595748|NCT01267201|101789707|FG004|COMPLETED|Washout Period (At Least 2 Days)||4||
48595749|NCT01267201|101789708|FG005|COMPLETED|Washout Period (At Least 2 Days)||4||
48595750|NCT01267201|101789703|FG000|NOT COMPLETED|Washout Period (At Least 2 Days)||0||
48595751|NCT01267201|101789704|FG001|NOT COMPLETED|Washout Period (At Least 2 Days)||0||
48595752|NCT01267201|101789705|FG002|NOT COMPLETED|Washout Period (At Least 2 Days)||0||
48595753|NCT01267201|101789706|FG003|NOT COMPLETED|Washout Period (At Least 2 Days)||0||
48595754|NCT01267201|101789707|FG004|NOT COMPLETED|Washout Period (At Least 2 Days)||0||
48595755|NCT01267201|101789708|FG005|NOT COMPLETED|Washout Period (At Least 2 Days)||0||
48295591|NCT02158520|101050912|FG000|Eligible for Crossover|Overall Study||8|Discontinued initial treatment due to disease progression|
48295592|NCT02158520|101050913|FG001|Eligible for Crossover|Overall Study||8|Discontinued initial treatment due to disease progression|
48295593|NCT02158520|101050912|FG000|Eligible for Crossover With AE Evaluated|Overall Study||7|Patients eligible for crossover AND evaluated for adverse events|
48295594|NCT02158520|101050913|FG001|Eligible for Crossover With AE Evaluated|Overall Study||7|Patients eligible for crossover AND evaluated for adverse events|
48295595|NCT02158520|101050912|FG000|Crossover Cohort|Overall Study||4|Patients who experienced progressive disease and did crossover|
48295596|NCT02158520|101050913|FG001|Crossover Cohort|Overall Study||6|Patients who experienced progressive disease and did crossover|
48295597|NCT02158520|101050912|FG000|COMPLETED|Overall Study||12|Eligible patients|
48295598|NCT02158520|101050913|FG001|COMPLETED|Overall Study||12|Eligible patients|
48295599|NCT02158520|101050912|FG000|NOT COMPLETED|Overall Study||0||
48295600|NCT02158520|101050913|FG001|NOT COMPLETED|Overall Study||0||
48295601|NCT01222260|101050914|FG000|STARTED|Overall Study||31||
48295602|NCT01222260|101050914|FG000|COMPLETED|Overall Study||29||
48295603|NCT01222260|101050914|FG000|NOT COMPLETED|Overall Study||2||
48295604|NCT01716117|101050915|FG000|STARTED|Overall Study||180||
48295605|NCT01716117|101050916|FG001|STARTED|Overall Study||33||
48295606|NCT01716117|101050915|FG000|Discharge|Overall Study||177||
48295607|NCT01716117|101050916|FG001|Discharge|Overall Study||33||
48295608|NCT01716117|101050915|FG000|1-Month Visit|Overall Study||176||
48295609|NCT01716117|101050916|FG001|1-Month Visit|Overall Study||33||
48295610|NCT01716117|101050915|FG000|6-Month Visit|Overall Study||174||
48295611|NCT01716117|101050916|FG001|6-Month Visit|Overall Study||32||
48295612|NCT01716117|101050915|FG000|COMPLETED|Overall Study||173||
48295613|NCT01716117|101050916|FG001|COMPLETED|Overall Study||31||
48295614|NCT01716117|101050915|FG000|NOT COMPLETED|Overall Study||7||
48295615|NCT01716117|101050916|FG001|NOT COMPLETED|Overall Study||2||
48295616|NCT03881553|101050917|FG000|STARTED|Overall Study||11||
48595756|NCT01267201|101789703|FG000|STARTED|Third Intervention Period||3||
48595757|NCT01267201|101789704|FG001|STARTED|Third Intervention Period||3||
48595758|NCT01267201|101789705|FG002|STARTED|Third Intervention Period||4||
48595759|NCT01267201|101789706|FG003|STARTED|Third Intervention Period||4||
48595760|NCT01267201|101789707|FG004|STARTED|Third Intervention Period||4||
48595761|NCT01267201|101789708|FG005|STARTED|Third Intervention Period||4||
48595762|NCT01267201|101789703|FG000|COMPLETED|Third Intervention Period||3||
48295617|NCT03881553|101050918|FG001|STARTED|Overall Study||2||
48295618|NCT03881553|101050919|FG002|STARTED|Overall Study||4||
48295619|NCT03881553|101050917|FG000|COMPLETED|Overall Study||10||
48295620|NCT03881553|101050918|FG001|COMPLETED|Overall Study||1||
48295621|NCT03881553|101050919|FG002|COMPLETED|Overall Study||3||
48295622|NCT03881553|101050917|FG000|NOT COMPLETED|Overall Study||1||
48295623|NCT03881553|101050918|FG001|NOT COMPLETED|Overall Study||1||
48295624|NCT03881553|101050919|FG002|NOT COMPLETED|Overall Study||1||
48595763|NCT01267201|101789704|FG001|COMPLETED|Third Intervention Period||3||
48595764|NCT01267201|101789705|FG002|COMPLETED|Third Intervention Period||4||
48595765|NCT01267201|101789706|FG003|COMPLETED|Third Intervention Period||4||
48595766|NCT01267201|101789707|FG004|COMPLETED|Third Intervention Period||4||
48595767|NCT01267201|101789708|FG005|COMPLETED|Third Intervention Period||4||
48595768|NCT01267201|101789703|FG000|NOT COMPLETED|Third Intervention Period||0||
48595769|NCT01267201|101789704|FG001|NOT COMPLETED|Third Intervention Period||0||
48595770|NCT01267201|101789705|FG002|NOT COMPLETED|Third Intervention Period||0||
48595771|NCT01267201|101789706|FG003|NOT COMPLETED|Third Intervention Period||0||
48595772|NCT01267201|101789707|FG004|NOT COMPLETED|Third Intervention Period||0||
48595773|NCT01267201|101789708|FG005|NOT COMPLETED|Third Intervention Period||0||
48595774|NCT00334295|101789709|FG000|STARTED|Overall Study||35||
48595775|NCT00334295|101789709|FG000|COMPLETED|Overall Study||30||
48595776|NCT00334295|101789709|FG000|NOT COMPLETED|Overall Study||5||
48595777|NCT02240069|101789710|FG000|STARTED|Overall Study||49||47
48595778|NCT02240069|101789711|FG001|STARTED|Overall Study||47||46
48595779|NCT02240069|101789712|FG002|STARTED|Overall Study||47||45
48595780|NCT02240069|101789710|FG000|COMPLETED|Overall Study||44||43
48595781|NCT02240069|101789711|FG001|COMPLETED|Overall Study||42||41
48595782|NCT02240069|101789712|FG002|COMPLETED|Overall Study||45||43
48595783|NCT02240069|101789710|FG000|NOT COMPLETED|Overall Study||5||4
48595784|NCT02240069|101789711|FG001|NOT COMPLETED|Overall Study||5||5
48595785|NCT02240069|101789712|FG002|NOT COMPLETED|Overall Study||2||2
48595786|NCT00676572|101789713|FG000|STARTED|Overall Study||6||
48595787|NCT00676572|101789714|FG001|STARTED|Overall Study||6||
48595788|NCT00676572|101789713|FG000|COMPLETED|Overall Study||6||
48595789|NCT00676572|101789714|FG001|COMPLETED|Overall Study||6||
48595790|NCT00676572|101789713|FG000|NOT COMPLETED|Overall Study||0||
48595791|NCT00676572|101789714|FG001|NOT COMPLETED|Overall Study||0||
48595792|NCT01541839|101789715|FG000|STARTED|Overall Study||8||
48595793|NCT01541839|101789716|FG001|STARTED|Overall Study||8||
48595794|NCT01541839|101789715|FG000|COMPLETED|Overall Study||8||
48595795|NCT01541839|101789716|FG001|COMPLETED|Overall Study||8||
48295625|NCT00104676|101050920|FG000|STARTED|Overall Study||98||
48295626|NCT00104676|101050921|FG001|STARTED|Overall Study||105||
48295627|NCT00104676|101050920|FG000|COMPLETED|Overall Study||91||
48295628|NCT00104676|101050921|FG001|COMPLETED|Overall Study||91||
48295629|NCT00104676|101050920|FG000|NOT COMPLETED|Overall Study||7||
48295630|NCT00104676|101050921|FG001|NOT COMPLETED|Overall Study||14||
48295631|NCT02569957|101050922|FG000|STARTED|Overall Study||0||
48295632|NCT02569957|101050923|FG001|STARTED|Overall Study||1||
48295633|NCT02569957|101050922|FG000|COMPLETED|Overall Study||0||
48595796|NCT01541839|101789715|FG000|NOT COMPLETED|Overall Study||0||
48595797|NCT01541839|101789716|FG001|NOT COMPLETED|Overall Study||0||
48595798|NCT00778102|101789717|FG000|STARTED|Overall Study||39||
48595799|NCT00778102|101789718|FG001|STARTED|Overall Study||41||
48595800|NCT00778102|101789717|FG000|COMPLETED|Overall Study||18||
48295634|NCT02569957|101050923|FG001|COMPLETED|Overall Study||0||
48295635|NCT02569957|101050922|FG000|NOT COMPLETED|Overall Study||0||
48295636|NCT02569957|101050923|FG001|NOT COMPLETED|Overall Study||1||
48295637|NCT00762970|101050924|FG000|STARTED|Overall Study||46||
48295638|NCT00762970|101050925|FG001|STARTED|Overall Study||44||
48595801|NCT00778102|101789718|FG001|COMPLETED|Overall Study||19||
48595802|NCT00778102|101789717|FG000|NOT COMPLETED|Overall Study||21||
48595803|NCT00778102|101789718|FG001|NOT COMPLETED|Overall Study||22||
48595804|NCT00551161|101789719|FG000|STARTED|Overall Study||12||
48595805|NCT00551161|101789719|FG000|COMPLETED|Overall Study||11||
48595806|NCT00551161|101789719|FG000|NOT COMPLETED|Overall Study||1||
48595807|NCT02033200|101789720|FG000|STARTED|Overall Study||40||
48595808|NCT02033200|101789721|FG001|STARTED|Overall Study||40||
48595809|NCT02033200|101789720|FG000|COMPLETED|Overall Study||40||
48595810|NCT02033200|101789721|FG001|COMPLETED|Overall Study||40||
48595811|NCT02033200|101789720|FG000|NOT COMPLETED|Overall Study||0||
48595812|NCT02033200|101789721|FG001|NOT COMPLETED|Overall Study||0||
48595813|NCT03197870|101789722|FG000|STARTED|Overall Study||55||
48595814|NCT03197870|101789723|FG001|STARTED|Overall Study||55||
48595815|NCT03197870|101789724|FG002|STARTED|Overall Study||57||
48595816|NCT03197870|101789722|FG000|COMPLETED|Overall Study||41||
48595817|NCT03197870|101789723|FG001|COMPLETED|Overall Study||45||
48595818|NCT03197870|101789724|FG002|COMPLETED|Overall Study||51||
48595819|NCT03197870|101789722|FG000|NOT COMPLETED|Overall Study||14||
48295639|NCT00762970|101050926|FG002|STARTED|Overall Study||47||
48295640|NCT00762970|101050924|FG000|COMPLETED|Overall Study||34||
48295641|NCT00762970|101050925|FG001|COMPLETED|Overall Study||35||
48295642|NCT00762970|101050926|FG002|COMPLETED|Overall Study||46||
48295643|NCT00762970|101050924|FG000|NOT COMPLETED|Overall Study||12||
48595820|NCT03197870|101789723|FG001|NOT COMPLETED|Overall Study||10||
48595821|NCT03197870|101789724|FG002|NOT COMPLETED|Overall Study||6||
48595822|NCT01678885|101789725|FG000|STARTED|Phase I; 2 Wks Duration, Both Sub-study||22||
48595823|NCT01678885|101789726|FG001|STARTED|Phase I; 2 Wks Duration, Both Sub-study||18||
48595824|NCT01678885|101789727|FG002|STARTED|Phase I; 2 Wks Duration, Both Sub-study||23||
48595825|NCT01678885|101789728|FG003|STARTED|Phase I; 2 Wks Duration, Both Sub-study||24||
48595826|NCT01678885|101789729|FG004|STARTED|Phase I; 2 Wks Duration, Both Sub-study||0||
48595827|NCT01678885|101789725|FG000|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22||
48595828|NCT01678885|101789726|FG001|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||15||
48595829|NCT01678885|101789727|FG002|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22||
48595830|NCT01678885|101789728|FG003|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||21||
48595831|NCT01678885|101789729|FG004|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0||
48595832|NCT01678885|101789725|FG000|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0||
48595833|NCT01678885|101789726|FG001|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3||
48595834|NCT01678885|101789727|FG002|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||1||
48595835|NCT01678885|101789728|FG003|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3||
48595836|NCT01678885|101789729|FG004|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0||
48595837|NCT01678885|101789725|FG000|STARTED|Phase II; 8 Week Low Calorie Diet||0||
48595838|NCT01678885|101789726|FG001|STARTED|Phase II; 8 Week Low Calorie Diet||0||
48595839|NCT01678885|101789727|FG002|STARTED|Phase II; 8 Week Low Calorie Diet||0||
48595840|NCT01678885|101789728|FG003|STARTED|Phase II; 8 Week Low Calorie Diet||0||
48595841|NCT01678885|101789729|FG004|STARTED|Phase II; 8 Week Low Calorie Diet||87||
48595842|NCT01678885|101789725|FG000|COMPLETED|Phase II; 8 Week Low Calorie Diet||0||
48595843|NCT01678885|101789726|FG001|COMPLETED|Phase II; 8 Week Low Calorie Diet||0||
48595844|NCT01678885|101789727|FG002|COMPLETED|Phase II; 8 Week Low Calorie Diet||0||
48595845|NCT01678885|101789728|FG003|COMPLETED|Phase II; 8 Week Low Calorie Diet||0||
48295644|NCT00762970|101050925|FG001|NOT COMPLETED|Overall Study||9||
48295645|NCT00762970|101050926|FG002|NOT COMPLETED|Overall Study||1||
48295646|NCT03118674|101050927|FG000|STARTED|Overall Study||23||
48595846|NCT01678885|101789729|FG004|COMPLETED|Phase II; 8 Week Low Calorie Diet||70||
48595847|NCT01678885|101789725|FG000|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0||
48595848|NCT01678885|101789726|FG001|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0||
48595849|NCT01678885|101789727|FG002|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0||
48595850|NCT01678885|101789728|FG003|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0||
48595851|NCT01678885|101789729|FG004|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||17||
48595852|NCT01043705|101789730|FG000|STARTED|Overall Study||459||
48595853|NCT01043705|101789731|FG001|STARTED|Overall Study||578||
48595854|NCT01043705|101789732|FG002|STARTED|Overall Study||578||
48595855|NCT01043705|101789730|FG000|COMPLETED|Overall Study||352||
48595856|NCT01043705|101789731|FG001|COMPLETED|Overall Study||447||
48595857|NCT01043705|101789732|FG002|COMPLETED|Overall Study||498||
48595858|NCT01043705|101789730|FG000|NOT COMPLETED|Overall Study||107||
48595859|NCT01043705|101789731|FG001|NOT COMPLETED|Overall Study||131||
48595860|NCT01043705|101789732|FG002|NOT COMPLETED|Overall Study||80||
48595861|NCT02315872|101789733|FG000|STARTED|Overall Study||4||
48595862|NCT02315872|101789734|FG001|STARTED|Overall Study||4||
48595863|NCT02315872|101789733|FG000|COMPLETED|Overall Study||1||
48595864|NCT02315872|101789734|FG001|COMPLETED|Overall Study||3||
48595865|NCT02315872|101789733|FG000|NOT COMPLETED|Overall Study||3||
48595866|NCT02315872|101789734|FG001|NOT COMPLETED|Overall Study||1||
48595867|NCT02956057|101789735|FG000|STARTED|Overall Study||174||
48595868|NCT02956057|101789736|FG001|STARTED|Overall Study||174||
48595869|NCT02956057|101789737|FG002|STARTED|Overall Study||174||
48595870|NCT02956057|101789738|FG003|STARTED|Overall Study||174||
48595871|NCT02956057|101789739|FG004|STARTED|Overall Study||174||
48595872|NCT02956057|101789740|FG005|STARTED|Overall Study||174||
48595873|NCT02956057|101789735|FG000|COMPLETED|Overall Study||160||
48595874|NCT02956057|101789736|FG001|COMPLETED|Overall Study||162||
48595875|NCT02956057|101789737|FG002|COMPLETED|Overall Study||166||
48595876|NCT02956057|101789738|FG003|COMPLETED|Overall Study||159||
48295647|NCT03118674|101050927|FG000|COMPLETED|Overall Study||8||
48295648|NCT03118674|101050927|FG000|NOT COMPLETED|Overall Study||15||
48295649|NCT01519466|101050928|FG000|STARTED|Overall Study||33||
48295650|NCT01519466|101050929|FG001|STARTED|Overall Study||16||
48295651|NCT01519466|101050928|FG000|COMPLETED|Overall Study||33||
48295652|NCT01519466|101050929|FG001|COMPLETED|Overall Study||16||
48295653|NCT01519466|101050928|FG000|NOT COMPLETED|Overall Study||0||
48295654|NCT01519466|101050929|FG001|NOT COMPLETED|Overall Study||0||
48295655|NCT02489123|101050930|FG000|STARTED|Overall Study||8||
48295656|NCT02489123|101050930|FG000|COMPLETED|Overall Study||8||
48595877|NCT02956057|101789739|FG004|COMPLETED|Overall Study||169||
48595878|NCT02956057|101789740|FG005|COMPLETED|Overall Study||157||
48595879|NCT02956057|101789735|FG000|NOT COMPLETED|Overall Study||14||
48595880|NCT02956057|101789736|FG001|NOT COMPLETED|Overall Study||12||
48595881|NCT02956057|101789737|FG002|NOT COMPLETED|Overall Study||8||
48295657|NCT02489123|101050930|FG000|NOT COMPLETED|Overall Study||0||
48295658|NCT01610011|101050931|FG000|STARTED|Overall Study||19||
48295659|NCT01610011|101050932|FG001|STARTED|Overall Study||2||
48295660|NCT01610011|101050931|FG000|COMPLETED|Overall Study||9||
48295661|NCT01610011|101050932|FG001|COMPLETED|Overall Study||2||
48295662|NCT01610011|101050931|FG000|NOT COMPLETED|Overall Study||10||
48295663|NCT01610011|101050932|FG001|NOT COMPLETED|Overall Study||0||
48295664|NCT03603028|101050933|FG000|STARTED|Overall Study||13||
48295665|NCT03603028|101050933|FG000|COMPLETED|Overall Study||12||
48295666|NCT03603028|101050933|FG000|NOT COMPLETED|Overall Study||1||
48295667|NCT02095951|101050934|FG000|STARTED|Overall Study||13|12 infection episodes from 6 participants; 6 of these episodes (3 participants) were in both groups.|15
48295668|NCT02095951|101050935|FG001|STARTED|Overall Study||14|12 infection episodes from 6 participants; 6 of these episodes (3 participants) were in both groups.|18
48295669|NCT02095951|101050934|FG000|COMPLETED|Overall Study||4|Catheter Infection Episodes (Cases) reflect completed episodes with Positive blood cultures|5
48295670|NCT02095951|101050935|FG001|COMPLETED|Overall Study||8|Catheter Infection Episodes (Cases) reflect completed episodes with Positive blood cultures|9
48295671|NCT02095951|101050934|FG000|NOT COMPLETED|Overall Study||9||10
48295672|NCT02095951|101050935|FG001|NOT COMPLETED|Overall Study||6||9
48295673|NCT01180998|101050936|FG000|STARTED|Overall Study||67||
48295674|NCT01180998|101050937|FG001|STARTED|Overall Study||72||
48295675|NCT01180998|101050938|FG002|STARTED|Overall Study||61||
48295676|NCT01180998|101050936|FG000|COMPLETED|Overall Study||63||
48295677|NCT01180998|101050937|FG001|COMPLETED|Overall Study||68||
48295678|NCT01180998|101050938|FG002|COMPLETED|Overall Study||51||
48295679|NCT01180998|101050936|FG000|NOT COMPLETED|Overall Study||4||
48295680|NCT01180998|101050937|FG001|NOT COMPLETED|Overall Study||4||
48295681|NCT01180998|101050938|FG002|NOT COMPLETED|Overall Study||10||
48295682|NCT04497142|101050939|FG000|STARTED|Overall Study||8||
48295683|NCT04497142|101050940|FG001|STARTED|Overall Study||4||
48295684|NCT04497142|101050939|FG000|COMPLETED|Overall Study||7||
48295685|NCT04497142|101050940|FG001|COMPLETED|Overall Study||4||
48295686|NCT04497142|101050939|FG000|NOT COMPLETED|Overall Study||1||
48295687|NCT04497142|101050940|FG001|NOT COMPLETED|Overall Study||0||
48595882|NCT02956057|101789738|FG003|NOT COMPLETED|Overall Study||15||
48595883|NCT02956057|101789739|FG004|NOT COMPLETED|Overall Study||5||
48595884|NCT02956057|101789740|FG005|NOT COMPLETED|Overall Study||17||
48295688|NCT00320541|101050941|FG000|STARTED|Overall Study||94||
48295689|NCT00320541|101050942|FG001|STARTED|Overall Study||93||
48295690|NCT00320541|101050941|FG000|COMPLETED|Overall Study||44||
48295691|NCT00320541|101050942|FG001|COMPLETED|Overall Study||36||
48295692|NCT00320541|101050941|FG000|NOT COMPLETED|Overall Study||50||
48295693|NCT00320541|101050942|FG001|NOT COMPLETED|Overall Study||57||
48295694|NCT03278106|101050943|FG000|STARTED|Overall Study||28||
48295695|NCT03278106|101050943|FG000|COMPLETED|Overall Study||27||
48295696|NCT03278106|101050943|FG000|NOT COMPLETED|Overall Study||1||
48595885|NCT01542034|101792748|FG000|STARTED|Overall Study||256||
48595886|NCT01542034|101792749|FG001|STARTED|Overall Study||250||
48595887|NCT01542034|101792748|FG000|Received Treatment|Overall Study||256||
48295697|NCT01340196|101050944|FG000|STARTED|Treat. Period 1 (Tenofovir)||16||
48295698|NCT01340196|101050944|FG000|COMPLETED|Treat. Period 1 (Tenofovir)||16||
48295699|NCT01340196|101050944|FG000|NOT COMPLETED|Treat. Period 1 (Tenofovir)||0||
48295700|NCT01340196|101050944|FG000|STARTED|Treat. Period 2 (Tenofovir/Faldaprevir)||16||
48295701|NCT01340196|101050944|FG000|COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||16||
48295702|NCT01340196|101050944|FG000|NOT COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||0||
48295703|NCT01340196|101050944|FG000|STARTED|Treat. Period 3 (Faldaprevir)||16||
48295704|NCT01340196|101050944|FG000|COMPLETED|Treat. Period 3 (Faldaprevir)||14||
48295705|NCT01340196|101050944|FG000|NOT COMPLETED|Treat. Period 3 (Faldaprevir)||2||
48295706|NCT01477333|101050945|FG000|STARTED|Overall Study||18||
48295707|NCT01477333|101050945|FG000|COMPLETED|Overall Study||15||
48295708|NCT01477333|101050945|FG000|NOT COMPLETED|Overall Study||3||
48295709|NCT04578574|101050946|FG000|STARTED|Overall Study||6||
48295710|NCT04578574|101050947|FG001|STARTED|Overall Study||2||
48295711|NCT04578574|101050946|FG000|COMPLETED|Overall Study||6||
48295712|NCT04578574|101050947|FG001|COMPLETED|Overall Study||2||
48295713|NCT04578574|101050946|FG000|NOT COMPLETED|Overall Study||0||
48595888|NCT01542034|101792749|FG001|Received Treatment|Overall Study||249||
48595889|NCT01542034|101792748|FG000|COMPLETED|Overall Study||226||
48595890|NCT01542034|101792749|FG001|COMPLETED|Overall Study||227||
48595891|NCT01542034|101792748|FG000|NOT COMPLETED|Overall Study||30||
48595892|NCT01542034|101792749|FG001|NOT COMPLETED|Overall Study||23||
48595893|NCT00574249|101792750|FG000|STARTED|Overall Study||364||
48595894|NCT00574249|101792751|FG001|STARTED|Overall Study||366||
48595895|NCT00574249|101792750|FG000|COMPLETED|Overall Study||338||
48595896|NCT00574249|101792751|FG001|COMPLETED|Overall Study||338||
48595897|NCT00574249|101792750|FG000|NOT COMPLETED|Overall Study||26||
48595898|NCT00574249|101792751|FG001|NOT COMPLETED|Overall Study||28||
48295714|NCT04578574|101050947|FG001|NOT COMPLETED|Overall Study||0||
48295715|NCT01498289|101050948|FG000|STARTED|Overall Study||98||
48295716|NCT01498289|101050949|FG001|STARTED|Overall Study||104||
48295717|NCT01498289|101050948|FG000|Participants Assessed for AEs|Overall Study||91||
48295718|NCT01498289|101050949|FG001|Participants Assessed for AEs|Overall Study||98||
48295719|NCT01498289|101050948|FG000|COMPLETED|Overall Study||0||
48295720|NCT01498289|101050949|FG001|COMPLETED|Overall Study||0||
48295721|NCT01498289|101050948|FG000|NOT COMPLETED|Overall Study||98||
48295722|NCT01498289|101050949|FG001|NOT COMPLETED|Overall Study||104||
48295723|NCT02261597|101050950|FG000|STARTED|Overall Study||22||
48295724|NCT02261597|101050951|FG001|STARTED|Overall Study||22||
48295725|NCT02261597|101050950|FG000|COMPLETED|Overall Study||22||
48295726|NCT02261597|101050951|FG001|COMPLETED|Overall Study||22||
48295727|NCT02261597|101050950|FG000|NOT COMPLETED|Overall Study||0||
48295728|NCT02261597|101050951|FG001|NOT COMPLETED|Overall Study||0||
48295729|NCT01078675|101050952|FG000|STARTED|Overall Study||250||
48295730|NCT01078675|101050953|FG001|STARTED|Overall Study||65||
48295731|NCT01078675|101050952|FG000|Patients Treated|Overall Study||198||
48295732|NCT01078675|101050953|FG001|Patients Treated|Overall Study||0||
48295733|NCT01078675|101050952|FG000|COMPLETED|Overall Study||182||
48295734|NCT01078675|101050953|FG001|COMPLETED|Overall Study||59||
48295735|NCT01078675|101050952|FG000|NOT COMPLETED|Overall Study||68||
48295736|NCT01078675|101050953|FG001|NOT COMPLETED|Overall Study||6||
48295737|NCT00409773|101050954|FG000|STARTED|Overall Study||229||
48595899|NCT03077659|101792752|FG000|STARTED|Overall Study||3||
48595900|NCT03077659|101792753|FG001|STARTED|Overall Study||3||
48595901|NCT03077659|101792754|FG002|STARTED|Overall Study||10||
48595902|NCT03077659|101792752|FG000|COMPLETED|Overall Study||3||
48595903|NCT03077659|101792753|FG001|COMPLETED|Overall Study||3||
48595904|NCT03077659|101792754|FG002|COMPLETED|Overall Study||9||
48595905|NCT03077659|101792752|FG000|NOT COMPLETED|Overall Study||0||
48595906|NCT03077659|101792753|FG001|NOT COMPLETED|Overall Study||0||
48595907|NCT03077659|101792754|FG002|NOT COMPLETED|Overall Study||1||
48595908|NCT03677934|101792755|FG000|STARTED|Overall Study||248||
48595909|NCT03677934|101792756|FG001|STARTED|Overall Study||167||
48595910|NCT03677934|101792755|FG000|COMPLETED|Overall Study||234||
48595911|NCT03677934|101792756|FG001|COMPLETED|Overall Study||154||
48595912|NCT03677934|101792755|FG000|NOT COMPLETED|Overall Study||14||
48595913|NCT03677934|101792756|FG001|NOT COMPLETED|Overall Study||13||
48595914|NCT04459598|101792757|FG000|STARTED|Overall Study||16||
48595915|NCT04459598|101792758|FG001|STARTED|Overall Study||16||
48595916|NCT04459598|101792757|FG000|COMPLETED|Overall Study||15||
48595917|NCT04459598|101792758|FG001|COMPLETED|Overall Study||15||
48595918|NCT04459598|101792757|FG000|NOT COMPLETED|Overall Study||1||
48595919|NCT04459598|101792758|FG001|NOT COMPLETED|Overall Study||1||
48595920|NCT01987232|101792759|FG000|STARTED|Overall Study||5||
48595921|NCT01987232|101792760|FG001|STARTED|Overall Study||3||
48595922|NCT01987232|101792761|FG002|STARTED|Overall Study||3||
48595923|NCT01987232|101792762|FG003|STARTED|Overall Study||15||
48595924|NCT01987232|101792763|FG004|STARTED|Overall Study||6||
48595925|NCT01987232|101792759|FG000|COMPLETED|Overall Study||5||
48295738|NCT00409773|101050955|FG001|STARTED|Overall Study||229||
48595926|NCT01987232|101792760|FG001|COMPLETED|Overall Study||3||
48595927|NCT01987232|101792761|FG002|COMPLETED|Overall Study||3||
48595928|NCT01987232|101792762|FG003|COMPLETED|Overall Study||14||
48595929|NCT01987232|101792763|FG004|COMPLETED|Overall Study||6||
48595930|NCT01987232|101792759|FG000|NOT COMPLETED|Overall Study||0||
48595931|NCT01987232|101792760|FG001|NOT COMPLETED|Overall Study||0||
48295739|NCT00409773|101050956|FG002|STARTED|Overall Study||229||
48295740|NCT00409773|101050957|FG003|STARTED|Overall Study||228||
48295741|NCT00409773|101050958|FG004|STARTED|Overall Study||228||
48295742|NCT00409773|101050954|FG000|COMPLETED|Overall Study||220||
48295743|NCT00409773|101050955|FG001|COMPLETED|Overall Study||222||
48295744|NCT00409773|101050956|FG002|COMPLETED|Overall Study||220||
48295745|NCT00409773|101050957|FG003|COMPLETED|Overall Study||216||
48295746|NCT00409773|101050958|FG004|COMPLETED|Overall Study||218||
48295747|NCT00409773|101050954|FG000|NOT COMPLETED|Overall Study||9||
48595932|NCT01987232|101792761|FG002|NOT COMPLETED|Overall Study||0||
48595933|NCT01987232|101792762|FG003|NOT COMPLETED|Overall Study||1||
48595934|NCT01987232|101792763|FG004|NOT COMPLETED|Overall Study||0||
48595935|NCT03422159|101792764|FG000|STARTED|Overall Study||70||
48595936|NCT03422159|101792765|FG001|STARTED|Overall Study||70||
48595937|NCT03422159|101792764|FG000|COMPLETED|Overall Study||68||
48595938|NCT03422159|101792765|FG001|COMPLETED|Overall Study||69||
48595939|NCT03422159|101792764|FG000|NOT COMPLETED|Overall Study||2||
48295748|NCT00409773|101050955|FG001|NOT COMPLETED|Overall Study||7||
48295749|NCT00409773|101050956|FG002|NOT COMPLETED|Overall Study||9||
48295750|NCT00409773|101050957|FG003|NOT COMPLETED|Overall Study||12||
48295751|NCT00409773|101050958|FG004|NOT COMPLETED|Overall Study||10||
48595940|NCT03422159|101792765|FG001|NOT COMPLETED|Overall Study||1||
48595941|NCT03003000|101792766|FG000|STARTED|Overall Study||126|Randomized and treated|
48595942|NCT03003000|101792767|FG001|STARTED|Overall Study||253|Randomized and treated|
48595943|NCT03003000|101792768|FG002|STARTED|Overall Study||256|Randomized and treated|
48595944|NCT03003000|101792766|FG000|COMPLETED|Overall Study||121||
48595945|NCT03003000|101792767|FG001|COMPLETED|Overall Study||249||
48595946|NCT03003000|101792768|FG002|COMPLETED|Overall Study||251||
48595947|NCT03003000|101792766|FG000|NOT COMPLETED|Overall Study||5||
48595948|NCT03003000|101792767|FG001|NOT COMPLETED|Overall Study||4||
48595949|NCT03003000|101792768|FG002|NOT COMPLETED|Overall Study||5||
48595950|NCT01996657|101792769|FG000|STARTED|Overall Study||250||
48595951|NCT01996657|101792770|FG001|STARTED|Overall Study||250||
48595952|NCT01996657|101792771|FG002|STARTED|Overall Study||248||
48595953|NCT01996657|101792769|FG000|COMPLETED|Overall Study||237||
48595954|NCT01996657|101792770|FG001|COMPLETED|Overall Study||239||
48595955|NCT01996657|101792771|FG002|COMPLETED|Overall Study||234||
48295752|NCT01602562|101050959|FG000|STARTED|Overall Study||21||
48295753|NCT01602562|101050960|FG001|STARTED|Overall Study||19||
48295754|NCT01602562|101050959|FG000|COMPLETED|Overall Study||16||
48295755|NCT01602562|101050960|FG001|COMPLETED|Overall Study||16||
48295756|NCT01602562|101050959|FG000|NOT COMPLETED|Overall Study||5||
48295757|NCT01602562|101050960|FG001|NOT COMPLETED|Overall Study||3||
48595956|NCT01996657|101792769|FG000|NOT COMPLETED|Overall Study||13||
48595957|NCT01996657|101792770|FG001|NOT COMPLETED|Overall Study||11||
48595958|NCT01996657|101792771|FG002|NOT COMPLETED|Overall Study||14||
48595959|NCT00980018|101792772|FG000|STARTED|Overall Study||52||
48595960|NCT00980018|101792772|FG000|COMPLETED|Overall Study||40||
48595961|NCT00980018|101792772|FG000|NOT COMPLETED|Overall Study||12||
48595962|NCT03557476|101792773|FG000|STARTED|Overall Study||13||
48295758|NCT00395460|101050961|FG000|STARTED|Overall Study||72||
48295759|NCT00395460|101050962|FG001|STARTED|Overall Study||75||
48295760|NCT00395460|101050961|FG000|Received Treatment|Overall Study||71||
48295761|NCT00395460|101050962|FG001|Received Treatment|Overall Study||75||
48295762|NCT00395460|101050961|FG000|COMPLETED|Overall Study||71||
48295763|NCT00395460|101050962|FG001|COMPLETED|Overall Study||75||
48295764|NCT00395460|101050961|FG000|NOT COMPLETED|Overall Study||1||
48295765|NCT00395460|101050962|FG001|NOT COMPLETED|Overall Study||0||
48295766|NCT04079803|101050963|FG000|STARTED|Overall Study||22||
48295767|NCT04079803|101050964|FG001|STARTED|Overall Study||21||
48295768|NCT04079803|101050965|FG002|STARTED|Overall Study||21||
48295769|NCT04079803|101050963|FG000|COMPLETED|Overall Study||22||
48595963|NCT03557476|101792774|FG001|STARTED|Overall Study||13||
48595964|NCT03557476|101792773|FG000|COMPLETED|Overall Study||13||
48595965|NCT03557476|101792774|FG001|COMPLETED|Overall Study||13||
48595966|NCT03557476|101792773|FG000|NOT COMPLETED|Overall Study||0||
48595967|NCT03557476|101792774|FG001|NOT COMPLETED|Overall Study||0||
48595968|NCT00310076|101792775|FG000|STARTED|Overall Study||29||
48595969|NCT00310076|101792775|FG000|COMPLETED|Overall Study||26||
48595970|NCT00310076|101792775|FG000|NOT COMPLETED|Overall Study||3||
48595971|NCT03235115|101792776|FG000|STARTED|First Intervention (1 Hour, Visit 2)||9||
48595972|NCT03235115|101792777|FG001|STARTED|First Intervention (1 Hour, Visit 2)||6||
48595973|NCT03235115|101792778|FG002|STARTED|First Intervention (1 Hour, Visit 2)||7||
48595974|NCT03235115|101792779|FG003|STARTED|First Intervention (1 Hour, Visit 2)||6||
48595975|NCT03235115|101792780|FG004|STARTED|First Intervention (1 Hour, Visit 2)||6||
48595976|NCT03235115|101792781|FG005|STARTED|First Intervention (1 Hour, Visit 2)||6||
48595977|NCT03235115|101792776|FG000|COMPLETED|First Intervention (1 Hour, Visit 2)||9||
48595978|NCT03235115|101792777|FG001|COMPLETED|First Intervention (1 Hour, Visit 2)||6||
48595979|NCT03235115|101792778|FG002|COMPLETED|First Intervention (1 Hour, Visit 2)||7||
48595980|NCT03235115|101792779|FG003|COMPLETED|First Intervention (1 Hour, Visit 2)||6||
48295770|NCT04079803|101050964|FG001|COMPLETED|Overall Study||21||
48295771|NCT04079803|101050965|FG002|COMPLETED|Overall Study||20||
48295772|NCT04079803|101050963|FG000|NOT COMPLETED|Overall Study||0||
48295773|NCT04079803|101050964|FG001|NOT COMPLETED|Overall Study||0||
48295774|NCT04079803|101050965|FG002|NOT COMPLETED|Overall Study||1||
48295775|NCT02308020|101050966|FG000|STARTED|Overall Study||27||
48595981|NCT03235115|101792780|FG004|COMPLETED|First Intervention (1 Hour, Visit 2)||6||
48595982|NCT03235115|101792781|FG005|COMPLETED|First Intervention (1 Hour, Visit 2)||5||
48295776|NCT02308020|101050967|FG001|STARTED|Overall Study||58||
48656870|NCT01708941|101943723|FG002|STARTED|Overall Study||22||
48295777|NCT02308020|101050968|FG002|STARTED|Overall Study||9||
48295778|NCT02308020|101050969|FG003|STARTED|Overall Study||28||
48295779|NCT02308020|101050970|FG004|STARTED|Overall Study||23||
48142021|NCT03969719|100673458|FG002|STARTED|Overall Study||55||
48142022|NCT03969719|100673456|FG000|COMPLETED|Overall Study||50||
48142023|NCT03969719|100673457|FG001|COMPLETED|Overall Study||46||
48142024|NCT03969719|100673458|FG002|COMPLETED|Overall Study||50||
48142025|NCT03969719|100673456|FG000|NOT COMPLETED|Overall Study||4||
48142026|NCT03969719|100673457|FG001|NOT COMPLETED|Overall Study||9||
48142027|NCT03969719|100673458|FG002|NOT COMPLETED|Overall Study||5||
48142028|NCT02015676|100673459|FG000|STARTED|Overall Study||15||
48142029|NCT02015676|100673460|FG001|STARTED|Overall Study||48||
48142030|NCT02015676|100673461|FG002|STARTED|Overall Study||6||
48142031|NCT02015676|100673459|FG000|COMPLETED|Overall Study||6||
48142032|NCT02015676|100673460|FG001|COMPLETED|Overall Study||14||
48142033|NCT02015676|100673461|FG002|COMPLETED|Overall Study||3||
48142034|NCT02015676|100673459|FG000|NOT COMPLETED|Overall Study||9||
48142035|NCT02015676|100673460|FG001|NOT COMPLETED|Overall Study||34||
48142036|NCT02015676|100673461|FG002|NOT COMPLETED|Overall Study||3||
48142037|NCT02539342|100673462|FG000|STARTED|Overall Study||1||
48142038|NCT02539342|100673463|FG001|STARTED|Overall Study||0||
48142039|NCT02539342|100673462|FG000|COMPLETED|Overall Study||1||
48142040|NCT02539342|100673463|FG001|COMPLETED|Overall Study||0||
48595983|NCT03235115|101792776|FG000|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0||
48595984|NCT03235115|101792777|FG001|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0||
48595985|NCT03235115|101792778|FG002|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0||
48595986|NCT03235115|101792779|FG003|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0||
48595987|NCT03235115|101792780|FG004|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0||
48142041|NCT02539342|100673462|FG000|NOT COMPLETED|Overall Study||0||
48142042|NCT02539342|100673463|FG001|NOT COMPLETED|Overall Study||0||
48142043|NCT00092131|100673464|FG000|STARTED|Treatment Period I||25||
48142044|NCT00092131|100673465|FG001|STARTED|Treatment Period I||26||
48142045|NCT00092131|100673464|FG000|COMPLETED|Treatment Period I||24||
48142046|NCT00092131|100673465|FG001|COMPLETED|Treatment Period I||26||
48142047|NCT00092131|100673464|FG000|NOT COMPLETED|Treatment Period I||1||
48142048|NCT00092131|100673465|FG001|NOT COMPLETED|Treatment Period I||0||
48142049|NCT00092131|100673464|FG000|STARTED|Treatment Period II||24||
48595988|NCT03235115|101792781|FG005|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||1||
48142050|NCT00092131|100673465|FG001|STARTED|Treatment Period II||26||
48142051|NCT00092131|100673464|FG000|COMPLETED|Treatment Period II||24||
48142052|NCT00092131|100673465|FG001|COMPLETED|Treatment Period II||25||
48142053|NCT00092131|100673464|FG000|NOT COMPLETED|Treatment Period II||0||
48142054|NCT00092131|100673465|FG001|NOT COMPLETED|Treatment Period II||1||
48142055|NCT03369444|100673466|FG000|STARTED|Overall Study||2||
48142056|NCT03369444|100673467|FG001|STARTED|Overall Study||2||
48142057|NCT03369444|100673468|FG002|STARTED|Overall Study||2||
48142058|NCT03369444|100673469|FG003|STARTED|Overall Study||4||
48142059|NCT03369444|100673466|FG000|COMPLETED|Overall Study||2||
48142060|NCT03369444|100673467|FG001|COMPLETED|Overall Study||2||
48142061|NCT03369444|100673468|FG002|COMPLETED|Overall Study||2||
48142062|NCT03369444|100673469|FG003|COMPLETED|Overall Study||4||
48142063|NCT03369444|100673466|FG000|NOT COMPLETED|Overall Study||0||
48142064|NCT03369444|100673467|FG001|NOT COMPLETED|Overall Study||0||
48142065|NCT03369444|100673468|FG002|NOT COMPLETED|Overall Study||0||
48142066|NCT03369444|100673469|FG003|NOT COMPLETED|Overall Study||0||
48142067|NCT04391023|100673470|FG000|STARTED|Overall Study||9||
48142068|NCT04391023|100673471|FG001|STARTED|Overall Study||9||
48142069|NCT04391023|100673470|FG000|COMPLETED|Overall Study||7||
48142070|NCT04391023|100673471|FG001|COMPLETED|Overall Study||7||
48142071|NCT04391023|100673470|FG000|NOT COMPLETED|Overall Study||2||
48142072|NCT04391023|100673471|FG001|NOT COMPLETED|Overall Study||2||
48142073|NCT02243943|100673472|FG000|STARTED|Overall Study||50||
48142074|NCT02243943|100673473|FG001|STARTED|Overall Study||50||
48142075|NCT02243943|100673472|FG000|COMPLETED|Overall Study||50||
48142076|NCT02243943|100673473|FG001|COMPLETED|Overall Study||50||
48142077|NCT02243943|100673472|FG000|NOT COMPLETED|Overall Study||0||
48142078|NCT02243943|100673473|FG001|NOT COMPLETED|Overall Study||0||
48142079|NCT00937924|100673474|FG000|STARTED|Overall Study||102||
48142080|NCT00937924|100673475|FG001|STARTED|Overall Study||101||
48142081|NCT00937924|100673476|FG002|STARTED|Overall Study||101||
48142082|NCT00937924|100673474|FG000|COMPLETED|Overall Study||58||
48142083|NCT00937924|100673475|FG001|COMPLETED|Overall Study||57||
48142084|NCT00937924|100673476|FG002|COMPLETED|Overall Study||60||
48142085|NCT00937924|100673474|FG000|NOT COMPLETED|Overall Study||44||
48142086|NCT00937924|100673475|FG001|NOT COMPLETED|Overall Study||44||
48142087|NCT00937924|100673476|FG002|NOT COMPLETED|Overall Study||41||
48142088|NCT01787617|100673477|FG000|STARTED|Overall Study||56||
48142089|NCT01787617|100673478|FG001|STARTED|Overall Study||57||
48142090|NCT01787617|100673477|FG000|COMPLETED|Overall Study||54||
48142091|NCT01787617|100673478|FG001|COMPLETED|Overall Study||51||
48142092|NCT01787617|100673477|FG000|NOT COMPLETED|Overall Study||2||
48142093|NCT01787617|100673478|FG001|NOT COMPLETED|Overall Study||6||
48142094|NCT03819491|100673479|FG000|STARTED|Before Randomization||24||
48142095|NCT03819491|100673480|FG001|STARTED|Before Randomization||0||
48142096|NCT03819491|100673479|FG000|COMPLETED|Before Randomization||24||
48142097|NCT03819491|100673480|FG001|COMPLETED|Before Randomization||0||
48295780|NCT02308020|101050971|FG005|STARTED|Overall Study||17||
48295781|NCT02308020|101050966|FG000|Received at Least One Dose of Study Drug|Overall Study||27||
48295782|NCT02308020|101050967|FG001|Received at Least One Dose of Study Drug|Overall Study||58||
48142098|NCT03819491|100673479|FG000|NOT COMPLETED|Before Randomization||0||
48142099|NCT03819491|100673480|FG001|NOT COMPLETED|Before Randomization||0||
48295783|NCT02308020|101050968|FG002|Received at Least One Dose of Study Drug|Overall Study||9||
48295784|NCT02308020|101050969|FG003|Received at Least One Dose of Study Drug|Overall Study||28||
48295785|NCT02308020|101050970|FG004|Received at Least One Dose of Study Drug|Overall Study||23||
48595989|NCT03235115|101792776|FG000|STARTED|Second Intervention (1 Hour, Visit 4)||9||
48595990|NCT03235115|101792777|FG001|STARTED|Second Intervention (1 Hour, Visit 4)||6||
48595991|NCT03235115|101792778|FG002|STARTED|Second Intervention (1 Hour, Visit 4)||7||
48595992|NCT03235115|101792779|FG003|STARTED|Second Intervention (1 Hour, Visit 4)||6||
48595993|NCT03235115|101792780|FG004|STARTED|Second Intervention (1 Hour, Visit 4)||6||
48595994|NCT03235115|101792781|FG005|STARTED|Second Intervention (1 Hour, Visit 4)||5||
48595995|NCT03235115|101792776|FG000|COMPLETED|Second Intervention (1 Hour, Visit 4)||9||
48595996|NCT03235115|101792777|FG001|COMPLETED|Second Intervention (1 Hour, Visit 4)||6||
48595997|NCT03235115|101792778|FG002|COMPLETED|Second Intervention (1 Hour, Visit 4)||7||
48595998|NCT03235115|101792779|FG003|COMPLETED|Second Intervention (1 Hour, Visit 4)||6||
48595999|NCT03235115|101792780|FG004|COMPLETED|Second Intervention (1 Hour, Visit 4)||6||
48596000|NCT03235115|101792781|FG005|COMPLETED|Second Intervention (1 Hour, Visit 4)||5||
48596001|NCT03235115|101792776|FG000|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0||
48596002|NCT03235115|101792777|FG001|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0||
48596003|NCT03235115|101792778|FG002|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0||
48596004|NCT03235115|101792779|FG003|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0||
48596005|NCT03235115|101792780|FG004|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0||
48596006|NCT03235115|101792781|FG005|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0||
48596007|NCT03235115|101792776|FG000|STARTED|Third Intervention ( 1 Hour, Visit 6)||9||
48596008|NCT03235115|101792777|FG001|STARTED|Third Intervention ( 1 Hour, Visit 6)||6||
48596009|NCT03235115|101792778|FG002|STARTED|Third Intervention ( 1 Hour, Visit 6)||7||
48596010|NCT03235115|101792779|FG003|STARTED|Third Intervention ( 1 Hour, Visit 6)||6||
48596011|NCT03235115|101792780|FG004|STARTED|Third Intervention ( 1 Hour, Visit 6)||6||
48596012|NCT03235115|101792781|FG005|STARTED|Third Intervention ( 1 Hour, Visit 6)||5||
48596013|NCT03235115|101792776|FG000|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||9||
48596014|NCT03235115|101792777|FG001|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6||
48596015|NCT03235115|101792778|FG002|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||7||
48596016|NCT03235115|101792779|FG003|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6||
48596017|NCT03235115|101792780|FG004|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6||
48596018|NCT03235115|101792781|FG005|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||5||
48596019|NCT03235115|101792776|FG000|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0||
48596020|NCT03235115|101792777|FG001|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0||
48596021|NCT03235115|101792778|FG002|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0||
48596022|NCT03235115|101792779|FG003|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0||
48596023|NCT03235115|101792780|FG004|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0||
48596024|NCT03235115|101792781|FG005|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0||
48596025|NCT04068688|101792782|FG000|STARTED|Overall Study||17||
48596026|NCT04068688|101792783|FG001|STARTED|Overall Study||17||
48596027|NCT04068688|101792784|FG002|STARTED|Overall Study||2||
48596028|NCT04068688|101792785|FG003|STARTED|Overall Study||2||
48596029|NCT04068688|101792786|FG004|STARTED|Overall Study||12||
48596030|NCT04068688|101792787|FG005|STARTED|Overall Study||12||
48596031|NCT04068688|101792788|FG006|STARTED|Overall Study||2||
48596032|NCT04068688|101792789|FG007|STARTED|Overall Study||1||
48596033|NCT04068688|101792790|FG008|STARTED|Overall Study||4||
48596034|NCT04068688|101792791|FG009|STARTED|Overall Study||3||
48295786|NCT02308020|101050971|FG005|Received at Least One Dose of Study Drug|Overall Study||17||
48295787|NCT02308020|101050966|FG000|COMPLETED|Overall Study||23||
48295788|NCT02308020|101050967|FG001|COMPLETED|Overall Study||38||
48295789|NCT02308020|101050968|FG002|COMPLETED|Overall Study||6||
48295790|NCT02308020|101050969|FG003|COMPLETED|Overall Study||24||
48295791|NCT02308020|101050970|FG004|COMPLETED|Overall Study||19||
48295792|NCT02308020|101050971|FG005|COMPLETED|Overall Study||12||
48295793|NCT02308020|101050966|FG000|NOT COMPLETED|Overall Study||4||
48295794|NCT02308020|101050967|FG001|NOT COMPLETED|Overall Study||20||
48295795|NCT02308020|101050968|FG002|NOT COMPLETED|Overall Study||3||
48295796|NCT02308020|101050969|FG003|NOT COMPLETED|Overall Study||4||
48295797|NCT02308020|101050970|FG004|NOT COMPLETED|Overall Study||4||
48295798|NCT02308020|101050971|FG005|NOT COMPLETED|Overall Study||5||
48295799|NCT02647320|101050972|FG000|STARTED|Overall Study||46||
48295800|NCT02647320|101050973|FG001|STARTED|Overall Study||46||
48295801|NCT02647320|101050974|FG002|STARTED|Overall Study||69||
48142100|NCT03819491|100673479|FG000|STARTED|After Randomization||12||
48142101|NCT03819491|100673480|FG001|STARTED|After Randomization||12||
48142102|NCT03819491|100673479|FG000|COMPLETED|After Randomization||12||
48142103|NCT03819491|100673480|FG001|COMPLETED|After Randomization||12||
48596035|NCT04068688|101792782|FG000|COMPLETED|Overall Study||8||
48712282|NCT00611468|102081761|FG002|COMPLETED|Overall Study||6||
48712283|NCT00611468|102081762|FG003|COMPLETED|Overall Study||13||
48712284|NCT00611468|102081759|FG000|NOT COMPLETED|Overall Study||0||
48712285|NCT00611468|102081760|FG001|NOT COMPLETED|Overall Study||1||
48295802|NCT02647320|101050975|FG003|STARTED|Overall Study||68||
48295803|NCT02647320|101050976|FG004|STARTED|Overall Study||69||
48596036|NCT04068688|101792783|FG001|COMPLETED|Overall Study||8||
48596037|NCT04068688|101792784|FG002|COMPLETED|Overall Study||2||
48596038|NCT04068688|101792785|FG003|COMPLETED|Overall Study||2||
48596039|NCT04068688|101792786|FG004|COMPLETED|Overall Study||7||
48596040|NCT04068688|101792787|FG005|COMPLETED|Overall Study||7||
48596041|NCT04068688|101792788|FG006|COMPLETED|Overall Study||2||
48596042|NCT04068688|101792789|FG007|COMPLETED|Overall Study||1||
48596043|NCT04068688|101792790|FG008|COMPLETED|Overall Study||3||
48596044|NCT04068688|101792791|FG009|COMPLETED|Overall Study||3||
48596045|NCT04068688|101792782|FG000|NOT COMPLETED|Overall Study||9||
48596046|NCT04068688|101792783|FG001|NOT COMPLETED|Overall Study||9||
48596047|NCT04068688|101792784|FG002|NOT COMPLETED|Overall Study||0||
48596048|NCT04068688|101792785|FG003|NOT COMPLETED|Overall Study||0||
48596049|NCT04068688|101792786|FG004|NOT COMPLETED|Overall Study||5||
48596050|NCT04068688|101792787|FG005|NOT COMPLETED|Overall Study||5||
48596051|NCT04068688|101792788|FG006|NOT COMPLETED|Overall Study||0||
48596052|NCT04068688|101792789|FG007|NOT COMPLETED|Overall Study||0||
48596053|NCT04068688|101792790|FG008|NOT COMPLETED|Overall Study||1||
48596054|NCT04068688|101792791|FG009|NOT COMPLETED|Overall Study||0||
48596055|NCT04063657|101792792|FG000|STARTED|Overall Study||1||
48596056|NCT04063657|101792793|FG001|STARTED|Overall Study||0||
48596057|NCT04063657|101792792|FG000|COMPLETED|Overall Study||0||
48596058|NCT04063657|101792793|FG001|COMPLETED|Overall Study||0||
48596059|NCT04063657|101792792|FG000|NOT COMPLETED|Overall Study||1||
48596060|NCT04063657|101792793|FG001|NOT COMPLETED|Overall Study||0||
48596061|NCT03802565|101792794|FG000|STARTED|Overall Study||82||
48596062|NCT03802565|101792795|FG001|STARTED|Overall Study||87||
48596063|NCT03802565|101792796|FG002|STARTED|Overall Study||83||
48596064|NCT03802565|101792797|FG003|STARTED|Overall Study||85||
48596065|NCT03802565|101792798|FG004|STARTED|Overall Study||78||
48596066|NCT03802565|101792794|FG000|COMPLETED|Overall Study||77||
48596067|NCT03802565|101792795|FG001|COMPLETED|Overall Study||83||
48596068|NCT03802565|101792796|FG002|COMPLETED|Overall Study||74||
48596069|NCT03802565|101792797|FG003|COMPLETED|Overall Study||77||
48712286|NCT00611468|102081761|FG002|NOT COMPLETED|Overall Study||0||
48712287|NCT00611468|102081762|FG003|NOT COMPLETED|Overall Study||0||
48712288|NCT05445206|102081763|FG000|STARTED|Overall Study||40||
48712289|NCT05445206|102081763|FG000|COMPLETED|Overall Study||40||
48712290|NCT05445206|102081763|FG000|NOT COMPLETED|Overall Study||0||
48712291|NCT01371643|102081764|FG000|STARTED|Overall Study||15||
48712292|NCT01371643|102081765|FG001|STARTED|Overall Study||26||
48712293|NCT01371643|102081764|FG000|COMPLETED|Overall Study||12||
48712294|NCT01371643|102081765|FG001|COMPLETED|Overall Study||26||
48712295|NCT01371643|102081764|FG000|NOT COMPLETED|Overall Study||3||
48712296|NCT01371643|102081765|FG001|NOT COMPLETED|Overall Study||0||
48712297|NCT02153346|102081766|FG000|STARTED|Overall Study||101||
48712298|NCT02153346|102081766|FG000|COMPLETED|Overall Study||90||
48712299|NCT02153346|102081766|FG000|NOT COMPLETED|Overall Study||11||
48712300|NCT00367744|102081767|FG000|STARTED|Overall Study||34||
48712301|NCT00367744|102081768|FG001|STARTED|Overall Study||37||
48712302|NCT00367744|102081767|FG000|COMPLETED|Overall Study||30||
48712303|NCT00367744|102081768|FG001|COMPLETED|Overall Study||32||
48712304|NCT00367744|102081767|FG000|NOT COMPLETED|Overall Study||4||
48712305|NCT00367744|102081768|FG001|NOT COMPLETED|Overall Study||5||
48712306|NCT00546260|102081769|FG000|STARTED|Overall Study||36||
48712307|NCT00546260|102081770|FG001|STARTED|Overall Study||34||
48712308|NCT00546260|102081769|FG000|COMPLETED|Overall Study||28||
48712309|NCT00546260|102081770|FG001|COMPLETED|Overall Study||32||
48712310|NCT00546260|102081769|FG000|NOT COMPLETED|Overall Study||8||
48712311|NCT00546260|102081770|FG001|NOT COMPLETED|Overall Study||2||
48295804|NCT02647320|101050972|FG000|Inadvertently Randomized|Overall Study||0||
48295805|NCT02647320|101050973|FG001|Inadvertently Randomized|Overall Study||0||
48295806|NCT02647320|101050974|FG002|Inadvertently Randomized|Overall Study||0||
48295807|NCT02647320|101050975|FG003|Inadvertently Randomized|Overall Study||1||
48596070|NCT03802565|101792798|FG004|COMPLETED|Overall Study||72||
48596071|NCT03802565|101792794|FG000|NOT COMPLETED|Overall Study||5||
48712312|NCT02966795|102081771|FG000|STARTED|Overall Study||23||
48712313|NCT02966795|102081772|FG001|STARTED|Overall Study||61||
48712314|NCT02966795|102081771|FG000|COMPLETED|Overall Study||23||
48596072|NCT03802565|101792795|FG001|NOT COMPLETED|Overall Study||4||
48596073|NCT03802565|101792796|FG002|NOT COMPLETED|Overall Study||9||
48596074|NCT03802565|101792797|FG003|NOT COMPLETED|Overall Study||8||
48596075|NCT03802565|101792798|FG004|NOT COMPLETED|Overall Study||6||
48596076|NCT03653091|101792799|FG000|STARTED|First 24 Weeks||6||
48596077|NCT03653091|101792800|FG001|STARTED|First 24 Weeks||3||
48596078|NCT03653091|101792799|FG000|Intent-to-Treat|First 24 Weeks||6||
48712315|NCT02966795|102081772|FG001|COMPLETED|Overall Study||60||
48712316|NCT02966795|102081771|FG000|NOT COMPLETED|Overall Study||0||
48596079|NCT03653091|101792800|FG001|Intent-to-Treat|First 24 Weeks||3||
48596080|NCT03653091|101792799|FG000|As-Treated|First 24 Weeks||5|One participant randomized to the DMR arm received Sham, had the option to crossover, and was included in the Sham arm.|
48596081|NCT03653091|101792800|FG001|As-Treated|First 24 Weeks||4|One participant randomized to the DMR arm received Sham, had the option to crossover, and was included in the Sham arm.|
48596082|NCT03653091|101792799|FG000|Safety|First 24 Weeks||5||
48596083|NCT03653091|101792800|FG001|Safety|First 24 Weeks||4||
48596084|NCT03653091|101792799|FG000|COMPLETED|First 24 Weeks||6||
48596085|NCT03653091|101792800|FG001|COMPLETED|First 24 Weeks||3||
48596086|NCT03653091|101792799|FG000|NOT COMPLETED|First 24 Weeks||0||
48596087|NCT03653091|101792800|FG001|NOT COMPLETED|First 24 Weeks||0||
48596088|NCT03653091|101792799|FG000|STARTED|Second 24 Weeks||5|The As-Treated population is being used|
48596089|NCT03653091|101792800|FG001|STARTED|Second 24 Weeks||4|The As-Treated population is being used|
48596090|NCT03653091|101792799|FG000|Crossed Over to DMR at Week 24|Second 24 Weeks||0||
48596091|NCT03653091|101792800|FG001|Crossed Over to DMR at Week 24|Second 24 Weeks||3||
48596092|NCT03653091|101792799|FG000|COMPLETED|Second 24 Weeks||5||
48596093|NCT03653091|101792800|FG001|COMPLETED|Second 24 Weeks||3||
48596094|NCT03653091|101792799|FG000|NOT COMPLETED|Second 24 Weeks||0||
48295808|NCT02647320|101050976|FG004|Inadvertently Randomized|Overall Study||0||
48295809|NCT02647320|101050972|FG000|Safety Set|Overall Study||43||
48596095|NCT03653091|101792800|FG001|NOT COMPLETED|Second 24 Weeks||1||
48596096|NCT02686658|101792801|FG000|STARTED|Overall Study||26||
48596097|NCT02686658|101792802|FG001|STARTED|Overall Study||25||
48596098|NCT02686658|101792803|FG002|STARTED|Overall Study||26||
48596099|NCT02686658|101792804|FG003|STARTED|Overall Study||42||
48596100|NCT02686658|101792805|FG004|STARTED|Overall Study||83||
48596101|NCT02686658|101792806|FG005|STARTED|Overall Study||84||
48596102|NCT02686658|101792801|FG000|Month 12|Overall Study||23||
48596103|NCT02686658|101792802|FG001|Month 12|Overall Study||19||
48596104|NCT02686658|101792803|FG002|Month 12|Overall Study||19||
48596105|NCT02686658|101792804|FG003|Month 12|Overall Study||34||
48596106|NCT02686658|101792805|FG004|Month 12|Overall Study||56||
48596107|NCT02686658|101792806|FG005|Month 12|Overall Study||72||
48596108|NCT02686658|101792801|FG000|COMPLETED|Overall Study||22||
48596109|NCT02686658|101792802|FG001|COMPLETED|Overall Study||18||
48596110|NCT02686658|101792803|FG002|COMPLETED|Overall Study||17||
48596111|NCT02686658|101792804|FG003|COMPLETED|Overall Study||30||
48596112|NCT02686658|101792805|FG004|COMPLETED|Overall Study||46||
48596113|NCT02686658|101792806|FG005|COMPLETED|Overall Study||68||
48596114|NCT02686658|101792801|FG000|NOT COMPLETED|Overall Study||4||
48596115|NCT02686658|101792802|FG001|NOT COMPLETED|Overall Study||7||
48596116|NCT02686658|101792803|FG002|NOT COMPLETED|Overall Study||9||
48596117|NCT02686658|101792804|FG003|NOT COMPLETED|Overall Study||12||
48596118|NCT02686658|101792805|FG004|NOT COMPLETED|Overall Study||37||
48596119|NCT02686658|101792806|FG005|NOT COMPLETED|Overall Study||16||
48596120|NCT00722566|101792807|FG000|STARTED|Overall Study||148||
48596121|NCT00722566|101792808|FG001|STARTED|Overall Study||74||
48596122|NCT00722566|101792807|FG000|COMPLETED|Overall Study||81||
48596123|NCT00722566|101792808|FG001|COMPLETED|Overall Study||39||
48596124|NCT00722566|101792807|FG000|NOT COMPLETED|Overall Study||67||
48596125|NCT00722566|101792808|FG001|NOT COMPLETED|Overall Study||35||
48596126|NCT01463267|101792809|FG000|STARTED|Overall Study||15||
48596127|NCT01463267|101792810|FG001|STARTED|Overall Study||15||
48596128|NCT01463267|101792811|FG002|STARTED|Overall Study||15||
48596129|NCT01463267|101792812|FG003|STARTED|Overall Study||15||
48596130|NCT01463267|101792809|FG000|COMPLETED|Overall Study||14||
48596131|NCT01463267|101792810|FG001|COMPLETED|Overall Study||15||
48596132|NCT01463267|101792811|FG002|COMPLETED|Overall Study||13||
48712317|NCT02966795|102081772|FG001|NOT COMPLETED|Overall Study||1||
48712318|NCT03630302|102081773|FG000|STARTED|Surgery||10||
48712319|NCT03630302|102081773|FG000|COMPLETED|Surgery||9||
48712320|NCT03630302|102081773|FG000|NOT COMPLETED|Surgery||1||
48712321|NCT03630302|102081773|FG000|STARTED|3 Month Visit||9||
48712322|NCT03630302|102081773|FG000|COMPLETED|3 Month Visit||7||
48712323|NCT03630302|102081773|FG000|NOT COMPLETED|3 Month Visit||2||
48712324|NCT03630302|102081773|FG000|STARTED|Data Post Analyses||7||
48712325|NCT03630302|102081773|FG000|COMPLETED|Data Post Analyses||5||
48295810|NCT02647320|101050973|FG001|Safety Set|Overall Study||44||
48712326|NCT03630302|102081773|FG000|NOT COMPLETED|Data Post Analyses||2||
48596133|NCT01463267|101792812|FG003|COMPLETED|Overall Study||13||
48596134|NCT01463267|101792809|FG000|NOT COMPLETED|Overall Study||1||
48596135|NCT01463267|101792810|FG001|NOT COMPLETED|Overall Study||0||
48596136|NCT01463267|101792811|FG002|NOT COMPLETED|Overall Study||2||
48596137|NCT01463267|101792812|FG003|NOT COMPLETED|Overall Study||2||
48596138|NCT03725033|101792813|FG000|STARTED|Overall Study||105||
48596139|NCT03725033|101792814|FG001|STARTED|Overall Study||97||
48712327|NCT01146652|102081774|FG000|STARTED|Overall Study||1912||
48142104|NCT03819491|100673479|FG000|NOT COMPLETED|After Randomization||0||
48295811|NCT02647320|101050974|FG002|Safety Set|Overall Study||68||
48596140|NCT03725033|101792813|FG000|COMPLETED|Overall Study||105||
48596141|NCT03725033|101792814|FG001|COMPLETED|Overall Study||97||
48596142|NCT03725033|101792813|FG000|NOT COMPLETED|Overall Study||0||
48596143|NCT03725033|101792814|FG001|NOT COMPLETED|Overall Study||0||
48712328|NCT01146652|102081775|FG001|STARTED|Overall Study||111||
48596144|NCT01680653|101792815|FG000|STARTED|Overall Study||57||
48596145|NCT01680653|101792815|FG000|COMPLETED|Overall Study||57||
48596146|NCT01680653|101792815|FG000|NOT COMPLETED|Overall Study||0||
48596147|NCT00565669|101792816|FG000|STARTED|Overall Study||11||
48596148|NCT00565669|101792817|FG001|STARTED|Overall Study||9||
48596149|NCT00565669|101792816|FG000|COMPLETED|Overall Study||11||
48596150|NCT00565669|101792817|FG001|COMPLETED|Overall Study||9||
48596151|NCT00565669|101792816|FG000|NOT COMPLETED|Overall Study||0||
48712329|NCT01146652|102081774|FG000|Treated|Overall Study||1910||
48712330|NCT01146652|102081775|FG001|Treated|Overall Study||111||
48712331|NCT01146652|102081774|FG000|Enrolled in the Sub-study|Overall Study||110|Participants who were eligible and entered sub-study from Week 24 of main study.|
48712332|NCT01146652|102081775|FG001|Enrolled in the Sub-study|Overall Study||14|Participants who were eligible and entered sub-study from Week 24 of main study.|
48712333|NCT01146652|102081774|FG000|Discontinued From the Sub-study|Overall Study||1|Sub-study discontinued participants were included in the discontinuation count of the main study.|
48712334|NCT01146652|102081775|FG001|Discontinued From the Sub-study|Overall Study||2|Sub-study discontinued participants were included in the discontinuation count of the main study.|
48712335|NCT01146652|102081774|FG000|Switched Back to Main Study|Overall Study||108|Participants who were willing to switch back to the main study regardless of if they completed the sub-study.|
48712336|NCT01146652|102081775|FG001|Switched Back to Main Study|Overall Study||13|Participants who were willing to switch back to the main study regardless of if they completed the sub-study.|
48712337|NCT01146652|102081774|FG000|COMPLETED|Overall Study||961||
48712338|NCT01146652|102081775|FG001|COMPLETED|Overall Study||66||
48712339|NCT01146652|102081774|FG000|NOT COMPLETED|Overall Study||951||
48712340|NCT01146652|102081775|FG001|NOT COMPLETED|Overall Study||45||
48712341|NCT03353922|102081776|FG000|STARTED|Overall Study||6||
48712342|NCT03353922|102081777|FG001|STARTED|Overall Study||6||
48712343|NCT03353922|102081778|FG002|STARTED|Overall Study||6||
48712344|NCT03353922|102081779|FG003|STARTED|Overall Study||6||
48712345|NCT03353922|102081780|FG004|STARTED|Overall Study||5||
48712346|NCT03353922|102081781|FG005|STARTED|Overall Study||6||
48712347|NCT03353922|102081776|FG000|COMPLETED|Overall Study||5|35 subjects signed consent; 4 discont.-3 withdrew consent before tx, 1 for AE in tolperisone tx arm|
48712348|NCT03353922|102081777|FG001|COMPLETED|Overall Study||5|35 subjects signed consent; 4 discont.-3 withdrew consent before tx, 1 for AE in tolperisone tx arm|
48712349|NCT03353922|102081778|FG002|COMPLETED|Overall Study||5|35 subjects signed consent; 4 discont.-3 withdrew consent before tx, 1 for AE in tolperisone tx arm|
48712350|NCT03353922|102081779|FG003|COMPLETED|Overall Study||5|35 subjects signed consent; 4 discont.-3 withdrew consent before tx, 1 for AE in tolperisone tx arm|
48712351|NCT03353922|102081780|FG004|COMPLETED|Overall Study||5|35 subjects signed consent; 4 discont.-3 withdrew consent before tx, 1 for AE in tolperisone tx arm|
48712352|NCT03353922|102081781|FG005|COMPLETED|Overall Study||6|35 subjects signed consent; 4 discont.-3 withdrew consent before tx, 1 for AE in tolperisone tx arm|
48712353|NCT03353922|102081776|FG000|NOT COMPLETED|Overall Study||1||
48712354|NCT03353922|102081777|FG001|NOT COMPLETED|Overall Study||1||
48712355|NCT03353922|102081778|FG002|NOT COMPLETED|Overall Study||1||
48712356|NCT03353922|102081779|FG003|NOT COMPLETED|Overall Study||1||
48712357|NCT03353922|102081780|FG004|NOT COMPLETED|Overall Study||0||
48712358|NCT03353922|102081781|FG005|NOT COMPLETED|Overall Study||0||
48712359|NCT00701636|102081782|FG000|STARTED|Overall Study||15||
48712360|NCT00701636|102081783|FG001|STARTED|Overall Study||15||
48712361|NCT00701636|102081782|FG000|COMPLETED|Overall Study||15||
48712362|NCT00701636|102081783|FG001|COMPLETED|Overall Study||15||
48712363|NCT00701636|102081782|FG000|NOT COMPLETED|Overall Study||0||
48712364|NCT00701636|102081783|FG001|NOT COMPLETED|Overall Study||0||
48712365|NCT03093974|102081784|FG000|STARTED|Overall Study||177||
48712366|NCT03093974|102081785|FG001|STARTED|Overall Study||200||
48712367|NCT03093974|102081784|FG000|Modified Intention to Treat Population - (mITT)|Overall Study||176||
48712368|NCT03093974|102081785|FG001|Modified Intention to Treat Population - (mITT)|Overall Study||197||
48712369|NCT03093974|102081784|FG000|Safety Population (SAF)|Overall Study||176||
48712370|NCT03093974|102081785|FG001|Safety Population (SAF)|Overall Study||197||
48712371|NCT03093974|102081784|FG000|Per -Protocol Population (PP)|Overall Study||117||
48712372|NCT03093974|102081785|FG001|Per -Protocol Population (PP)|Overall Study||122||
48712373|NCT03093974|102081784|FG000|COMPLETED|Overall Study||123||
48712374|NCT03093974|102081785|FG001|COMPLETED|Overall Study||129||
48712375|NCT03093974|102081784|FG000|NOT COMPLETED|Overall Study||54||
48712376|NCT03093974|102081785|FG001|NOT COMPLETED|Overall Study||71||
48712377|NCT00413920|102081786|FG000|STARTED|Overall Study||112||
48712378|NCT00413920|102081787|FG001|STARTED|Overall Study||110||
48712379|NCT00413920|102081786|FG000|COMPLETED|Overall Study||84||
48712380|NCT00413920|102081787|FG001|COMPLETED|Overall Study||82||
48712381|NCT00413920|102081786|FG000|NOT COMPLETED|Overall Study||28||
48712382|NCT00413920|102081787|FG001|NOT COMPLETED|Overall Study||28||
48712383|NCT04143217|102081788|FG000|STARTED|Overall Study||159|"Number of subjects Started is based on the Safety Population (defined as subjects who signed an Informed Consent and took at least one dose of SPN-812)"|
48712384|NCT04143217|102081788|FG000|Not Treated|Overall Study||5|One subject signed Informed Consent and met eligibility criteria but did not dose, and four subjects signed Informed Consent but did not meet eligibility criteria.|
48712385|NCT04143217|102081788|FG000|COMPLETED|Overall Study||26|"Per protocol, a subject was considered as Completed if they either received 156 weeks of SPN-812 treatment or were discontinued prior to Week 156 due to SPN-812 being commercially available. All subjects considered Completed (n=26) were discontinued due to SPN-812 being commercially available prior to Week 156 (maximum SPN-812 exposure was 124 weeks)."|
48712386|NCT04143217|102081788|FG000|NOT COMPLETED|Overall Study||133||
48712387|NCT01691014|102081789|FG000|STARTED|Overall Study||8||
48712388|NCT01691014|102081790|FG001|STARTED|Overall Study||26||
48712389|NCT01691014|102081791|FG002|STARTED|Overall Study||36||
48712390|NCT01691014|102081792|FG003|STARTED|Overall Study||9||
48712391|NCT01691014|102081789|FG000|COMPLETED|Overall Study||5||
48295812|NCT02647320|101050975|FG003|Safety Set|Overall Study||68||
48295813|NCT02647320|101050976|FG004|Safety Set|Overall Study||69||
48295814|NCT02647320|101050972|FG000|Modified Intent-to-Treat Set (mITT)|Overall Study||40||
48295815|NCT02647320|101050973|FG001|Modified Intent-to-Treat Set (mITT)|Overall Study||38||
48295816|NCT02647320|101050974|FG002|Modified Intent-to-Treat Set (mITT)|Overall Study||61||
48295817|NCT02647320|101050975|FG003|Modified Intent-to-Treat Set (mITT)|Overall Study||62||
48295818|NCT02647320|101050976|FG004|Modified Intent-to-Treat Set (mITT)|Overall Study||62||
48295819|NCT02647320|101050972|FG000|COMPLETED|Overall Study||34||
48295820|NCT02647320|101050973|FG001|COMPLETED|Overall Study||35||
48295821|NCT02647320|101050974|FG002|COMPLETED|Overall Study||54||
48295822|NCT02647320|101050975|FG003|COMPLETED|Overall Study||58||
48295823|NCT02647320|101050976|FG004|COMPLETED|Overall Study||52||
48295824|NCT02647320|101050972|FG000|NOT COMPLETED|Overall Study||12||
48295825|NCT02647320|101050973|FG001|NOT COMPLETED|Overall Study||11||
48295826|NCT02647320|101050974|FG002|NOT COMPLETED|Overall Study||15||
48295827|NCT02647320|101050975|FG003|NOT COMPLETED|Overall Study||10||
48295828|NCT02647320|101050976|FG004|NOT COMPLETED|Overall Study||17||
48295829|NCT04225221|101050977|FG000|STARTED|Lupron and Placebo Baseline (6 Weeks)||6|One participant experienced a topical skin reaction to the Lupron injection and received only 1 Lupron injection and no placebo during the first period. The participant completed a shortened phase of Lupron alone for 2 weeks and proceeded directly to the first intervention followed by the second intervention (with no washout in between). Because this participant did not complete the full 6-weeks, they are counted as not complete.|
48295830|NCT04225221|101050978|FG001|STARTED|Lupron and Placebo Baseline (6 Weeks)||4|One participant experienced a topical skin reaction to the Lupron injection and received only 1 Lupron injection and no placebo during the first period. The participant completed a shortened phase of Lupron alone for 2 weeks and proceeded directly to the first intervention followed by the second intervention (with no washout in between). Because this participant did not complete the full 6-weeks, they are counted as not complete.|
48295831|NCT04225221|101050977|FG000|COMPLETED|Lupron and Placebo Baseline (6 Weeks)||5||
48295832|NCT04225221|101050978|FG001|COMPLETED|Lupron and Placebo Baseline (6 Weeks)||4||
48295833|NCT04225221|101050977|FG000|NOT COMPLETED|Lupron and Placebo Baseline (6 Weeks)||1||
48295834|NCT04225221|101050978|FG001|NOT COMPLETED|Lupron and Placebo Baseline (6 Weeks)||0||
48295835|NCT04225221|101050977|FG000|STARTED|First Intervention (2 Weeks)||6||
48295836|NCT04225221|101050978|FG001|STARTED|First Intervention (2 Weeks)||4||
48295837|NCT04225221|101050977|FG000|COMPLETED|First Intervention (2 Weeks)||6||
48295838|NCT04225221|101050978|FG001|COMPLETED|First Intervention (2 Weeks)||4||
48295839|NCT04225221|101050977|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0||
48295840|NCT04225221|101050978|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0||
48295841|NCT04225221|101050977|FG000|STARTED|Washout (2 Weeks)||5|One participant experienced a topical skin reaction to the Lupron injection and received only 1 Lupron injection. The participant remained on Lupron alone for 2 weeks and proceeded directly to the first intervention followed by the second intervention (with no washout in between).|
48295842|NCT04225221|101050978|FG001|STARTED|Washout (2 Weeks)||4|One participant experienced a topical skin reaction to the Lupron injection and received only 1 Lupron injection. The participant remained on Lupron alone for 2 weeks and proceeded directly to the first intervention followed by the second intervention (with no washout in between).|
48295843|NCT04225221|101050977|FG000|COMPLETED|Washout (2 Weeks)||4||
48295844|NCT04225221|101050978|FG001|COMPLETED|Washout (2 Weeks)||4||
48295845|NCT04225221|101050977|FG000|NOT COMPLETED|Washout (2 Weeks)||1||
48295846|NCT04225221|101050978|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
48295847|NCT04225221|101050977|FG000|STARTED|Second Intervention (2 Weeks)||5||
48295848|NCT04225221|101050978|FG001|STARTED|Second Intervention (2 Weeks)||4||
48295849|NCT04225221|101050977|FG000|COMPLETED|Second Intervention (2 Weeks)||5||
48295850|NCT04225221|101050978|FG001|COMPLETED|Second Intervention (2 Weeks)||4||
48295851|NCT04225221|101050977|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48295852|NCT04225221|101050978|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48295853|NCT03645954|101050979|FG000|STARTED|Overall Study||40||
48295854|NCT03645954|101050980|FG001|STARTED|Overall Study||40||
48295855|NCT03645954|101050979|FG000|COMPLETED|Overall Study||37||
48295856|NCT03645954|101050980|FG001|COMPLETED|Overall Study||40||
48295857|NCT03645954|101050979|FG000|NOT COMPLETED|Overall Study||3||
48295858|NCT03645954|101050980|FG001|NOT COMPLETED|Overall Study||0||
48295859|NCT00247377|101050981|FG000|STARTED|Overall Study||111||
48295860|NCT00247377|101050982|FG001|STARTED|Overall Study||86||
48295861|NCT00247377|101050981|FG000|COMPLETED|Overall Study||111||
48295862|NCT00247377|101050982|FG001|COMPLETED|Overall Study||86||
48295863|NCT00247377|101050981|FG000|NOT COMPLETED|Overall Study||0||
48295864|NCT00247377|101050982|FG001|NOT COMPLETED|Overall Study||0||
48295865|NCT00892723|101050983|FG000|STARTED|Overall Study||21||
48295866|NCT00892723|101050984|FG001|STARTED|Overall Study||19||
48295867|NCT00892723|101050985|FG002|STARTED|Overall Study||19||
48295868|NCT00892723|101050983|FG000|COMPLETED|Overall Study||19||
48295869|NCT00892723|101050984|FG001|COMPLETED|Overall Study||15||
48295870|NCT00892723|101050985|FG002|COMPLETED|Overall Study||17||
48295871|NCT00892723|101050983|FG000|NOT COMPLETED|Overall Study||2||
48295872|NCT00892723|101050984|FG001|NOT COMPLETED|Overall Study||4||
48295873|NCT00892723|101050985|FG002|NOT COMPLETED|Overall Study||2||
48295874|NCT02147353|101050986|FG000|STARTED|Overall Study||21||
48295875|NCT02147353|101050987|FG001|STARTED|Overall Study||21||
48295876|NCT02147353|101050986|FG000|COMPLETED|Overall Study||12||
48295877|NCT02147353|101050987|FG001|COMPLETED|Overall Study||21||
48295878|NCT02147353|101050986|FG000|NOT COMPLETED|Overall Study||9||
48295879|NCT02147353|101050987|FG001|NOT COMPLETED|Overall Study||0||
48295880|NCT02777385|101050988|FG000|STARTED|Overall Study||41||
48295881|NCT02777385|101050989|FG001|STARTED|Overall Study||39||
48596152|NCT00565669|101792817|FG001|NOT COMPLETED|Overall Study||0||
48596153|NCT00546455|101792818|FG000|STARTED|Overall Study||0||
48596154|NCT00546455|101792819|FG001|STARTED|Overall Study||0||
48596155|NCT00546455|101792818|FG000|COMPLETED|Overall Study||0||
48596156|NCT00546455|101792819|FG001|COMPLETED|Overall Study||0||
48596157|NCT00546455|101792818|FG000|NOT COMPLETED|Overall Study||0||
48596158|NCT00546455|101792819|FG001|NOT COMPLETED|Overall Study||0||
48596159|NCT00114738|101792820|FG000|STARTED|Bortezomib Then Bortezomib + Induction||53||
48596160|NCT00114738|101792821|FG001|STARTED|Bortezomib Then Bortezomib + Induction||0||
48596161|NCT00114738|101792822|FG002|STARTED|Bortezomib Then Bortezomib + Induction||0||
48596162|NCT00114738|101792820|FG000|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||47||
48596163|NCT00114738|101792821|FG001|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0||
48596164|NCT00114738|101792822|FG002|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0||
48596165|NCT00114738|101792820|FG000|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||6||
48596166|NCT00114738|101792821|FG001|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0||
48596167|NCT00114738|101792822|FG002|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0||
48596168|NCT00114738|101792820|FG000|COMPLETED|Bortezomib Then Bortezomib + Induction||51||
48596169|NCT00114738|101792821|FG001|COMPLETED|Bortezomib Then Bortezomib + Induction||0||
48596170|NCT00114738|101792822|FG002|COMPLETED|Bortezomib Then Bortezomib + Induction||0||
48596171|NCT00114738|101792820|FG000|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||2||
48596172|NCT00114738|101792821|FG001|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||0||
48596173|NCT00114738|101792822|FG002|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||0||
48596174|NCT00114738|101792820|FG000|STARTED|Screening for Randomization||51||
48596175|NCT00114738|101792821|FG001|STARTED|Screening for Randomization||0||
48596176|NCT00114738|101792822|FG002|STARTED|Screening for Randomization||0||
48596177|NCT00114738|101792820|FG000|COMPLETED|Screening for Randomization||30||
48596178|NCT00114738|101792821|FG001|COMPLETED|Screening for Randomization||0||
48596179|NCT00114738|101792822|FG002|COMPLETED|Screening for Randomization||0||
48596180|NCT00114738|101792820|FG000|NOT COMPLETED|Screening for Randomization||21||
48596181|NCT00114738|101792821|FG001|NOT COMPLETED|Screening for Randomization||0||
48596182|NCT00114738|101792822|FG002|NOT COMPLETED|Screening for Randomization||0||
48596183|NCT00114738|101792820|FG000|STARTED|Randomization||0||
48596184|NCT00114738|101792821|FG001|STARTED|Randomization||14||
48596185|NCT00114738|101792822|FG002|STARTED|Randomization||16||
48596186|NCT00114738|101792820|FG000|COMPLETED|Randomization||0||
48596187|NCT00114738|101792821|FG001|COMPLETED|Randomization||14||
48596188|NCT00114738|101792822|FG002|COMPLETED|Randomization||16||
48596189|NCT00114738|101792820|FG000|NOT COMPLETED|Randomization||0||
48596190|NCT00114738|101792821|FG001|NOT COMPLETED|Randomization||0||
48596191|NCT00114738|101792822|FG002|NOT COMPLETED|Randomization||0||
48596192|NCT02086448|101792823|FG000|STARTED|Overall Study||25||
48596193|NCT02086448|101792824|FG001|STARTED|Overall Study||26||
48596194|NCT02086448|101792825|FG002|STARTED|Overall Study||20||
48596195|NCT02086448|101792826|FG003|STARTED|Overall Study||18||
48596196|NCT02086448|101792823|FG000|COMPLETED|Overall Study||24||
48596197|NCT02086448|101792824|FG001|COMPLETED|Overall Study||26||
48596198|NCT02086448|101792825|FG002|COMPLETED|Overall Study||20||
48596199|NCT02086448|101792826|FG003|COMPLETED|Overall Study||16||
48596200|NCT02086448|101792823|FG000|NOT COMPLETED|Overall Study||1||
48596201|NCT02086448|101792824|FG001|NOT COMPLETED|Overall Study||0||
48596202|NCT02086448|101792825|FG002|NOT COMPLETED|Overall Study||0||
48596203|NCT02086448|101792826|FG003|NOT COMPLETED|Overall Study||2||
48596204|NCT00424021|101792827|FG000|STARTED|NCT00046319 Study Period||16||
48596205|NCT00424021|101792828|FG001|STARTED|NCT00046319 Study Period||19||
48596206|NCT00424021|101792829|FG002|STARTED|NCT00046319 Study Period||16||
48596207|NCT00424021|101792830|FG003|STARTED|NCT00046319 Study Period||13||
48596208|NCT00424021|101792827|FG000|COMPLETED|NCT00046319 Study Period||15||
48596209|NCT00424021|101792828|FG001|COMPLETED|NCT00046319 Study Period||16||
48596210|NCT00424021|101792829|FG002|COMPLETED|NCT00046319 Study Period||15||
48596211|NCT00424021|101792830|FG003|COMPLETED|NCT00046319 Study Period||12||
48596212|NCT00424021|101792827|FG000|NOT COMPLETED|NCT00046319 Study Period||1||
48596213|NCT00424021|101792828|FG001|NOT COMPLETED|NCT00046319 Study Period||3||
48596214|NCT00424021|101792829|FG002|NOT COMPLETED|NCT00046319 Study Period||1||
48596215|NCT00424021|101792830|FG003|NOT COMPLETED|NCT00046319 Study Period||1||
48596216|NCT00424021|101792827|FG000|STARTED|AMB-220-E Study Period||2||
48596217|NCT00424021|101792828|FG001|STARTED|AMB-220-E Study Period||7||
48596218|NCT00424021|101792829|FG002|STARTED|AMB-220-E Study Period||19||
48596219|NCT00424021|101792830|FG003|STARTED|AMB-220-E Study Period||26||
48596220|NCT00424021|101792827|FG000|COMPLETED|AMB-220-E Study Period||1||
48596221|NCT00424021|101792828|FG001|COMPLETED|AMB-220-E Study Period||5||
48596222|NCT00424021|101792829|FG002|COMPLETED|AMB-220-E Study Period||14||
48596223|NCT00424021|101792830|FG003|COMPLETED|AMB-220-E Study Period||16||
48596224|NCT00424021|101792827|FG000|NOT COMPLETED|AMB-220-E Study Period||1||
48596225|NCT00424021|101792828|FG001|NOT COMPLETED|AMB-220-E Study Period||2||
48596226|NCT00424021|101792829|FG002|NOT COMPLETED|AMB-220-E Study Period||5||
48596227|NCT00424021|101792830|FG003|NOT COMPLETED|AMB-220-E Study Period||10||
48596228|NCT02093390|101792831|FG000|STARTED|Overall Study||20||
48596229|NCT02093390|101792832|FG001|STARTED|Overall Study||20||
48596230|NCT02093390|101792831|FG000|COMPLETED|Overall Study||20||
48596231|NCT02093390|101792832|FG001|COMPLETED|Overall Study||19||
48596232|NCT02093390|101792831|FG000|NOT COMPLETED|Overall Study||0||
48596233|NCT02093390|101792832|FG001|NOT COMPLETED|Overall Study||1||
48596234|NCT02923245|101792833|FG000|STARTED|Overall Study||60||
48596235|NCT02923245|101792834|FG001|STARTED|Overall Study||60||
48596236|NCT02923245|101792833|FG000|COMPLETED|Overall Study||58||
48596237|NCT02923245|101792834|FG001|COMPLETED|Overall Study||59||
48596238|NCT02923245|101792833|FG000|NOT COMPLETED|Overall Study||2||
48596239|NCT02923245|101792834|FG001|NOT COMPLETED|Overall Study||1||
48596240|NCT01472939|101792835|FG000|STARTED|Overall Study||123||
48596241|NCT01472939|101792836|FG001|STARTED|Overall Study||119||
48596242|NCT01472939|101792837|FG002|STARTED|Overall Study||119||
48596243|NCT01472939|101792838|FG003|STARTED|Overall Study||119||
48596244|NCT01472939|101792835|FG000|COMPLETED|Overall Study||103||
48596245|NCT01472939|101792836|FG001|COMPLETED|Overall Study||105||
48596246|NCT01472939|101792837|FG002|COMPLETED|Overall Study||108||
48596247|NCT01472939|101792838|FG003|COMPLETED|Overall Study||99||
48596248|NCT01472939|101792835|FG000|NOT COMPLETED|Overall Study||20||
48596249|NCT01472939|101792836|FG001|NOT COMPLETED|Overall Study||14||
48596250|NCT01472939|101792837|FG002|NOT COMPLETED|Overall Study||11||
48596251|NCT01472939|101792838|FG003|NOT COMPLETED|Overall Study||20||
48596252|NCT00603382|101792839|FG000|STARTED|Overall Study||94||
48596253|NCT00603382|101792840|FG001|STARTED|Overall Study||97||
48596254|NCT00603382|101792841|FG002|STARTED|Overall Study||100||
48596255|NCT00603382|101792842|FG003|STARTED|Overall Study||110||
48596256|NCT00603382|101792843|FG004|STARTED|Overall Study||95||
48596257|NCT00603382|101792844|FG005|STARTED|Overall Study||102||
48596258|NCT00603382|101792839|FG000|COMPLETED|Overall Study||76||
48596259|NCT00603382|101792840|FG001|COMPLETED|Overall Study||83||
48596260|NCT00603382|101792841|FG002|COMPLETED|Overall Study||91||
48596261|NCT00603382|101792842|FG003|COMPLETED|Overall Study||98||
48596262|NCT00603382|101792843|FG004|COMPLETED|Overall Study||86||
48596263|NCT00603382|101792844|FG005|COMPLETED|Overall Study||84||
48596264|NCT00603382|101792839|FG000|NOT COMPLETED|Overall Study||18||
48596265|NCT00603382|101792840|FG001|NOT COMPLETED|Overall Study||14||
48596266|NCT00603382|101792841|FG002|NOT COMPLETED|Overall Study||9||
48596267|NCT00603382|101792842|FG003|NOT COMPLETED|Overall Study||12||
48712392|NCT01691014|102081790|FG001|COMPLETED|Overall Study||11||
48596268|NCT00603382|101792843|FG004|NOT COMPLETED|Overall Study||9||
48596269|NCT00603382|101792844|FG005|NOT COMPLETED|Overall Study||18||
48596270|NCT05530980|101792845|FG000|STARTED|Overall Study||7||
48712393|NCT01691014|102081791|FG002|COMPLETED|Overall Study||25||
48596271|NCT05530980|101792845|FG000|COMPLETED|Overall Study||4||
48596272|NCT05530980|101792845|FG000|NOT COMPLETED|Overall Study||3||
48596273|NCT00314132|101792846|FG000|STARTED|Overall Study||403||
48596274|NCT00314132|101792847|FG001|STARTED|Overall Study||1601||
48596275|NCT00314132|101792846|FG000|COMPLETED|Overall Study||395||
48596276|NCT00314132|101792847|FG001|COMPLETED|Overall Study||1583||
48596277|NCT00314132|101792846|FG000|NOT COMPLETED|Overall Study||8||
48596278|NCT00314132|101792847|FG001|NOT COMPLETED|Overall Study||18||
48596279|NCT02631070|101792848|FG000|STARTED|Overall Study||153||
48596280|NCT02631070|101792849|FG001|STARTED|Overall Study||76||
48596281|NCT02631070|101792848|FG000|COMPLETED|Overall Study||4||
48596282|NCT02631070|101792849|FG001|COMPLETED|Overall Study||12||
48596283|NCT02631070|101792848|FG000|NOT COMPLETED|Overall Study||149||
48596284|NCT02631070|101792849|FG001|NOT COMPLETED|Overall Study||64||
48596285|NCT04515641|101792850|FG000|STARTED|Overall Study||6||
48596286|NCT04515641|101792851|FG001|STARTED|Overall Study||6||
48596287|NCT04515641|101792850|FG000|COMPLETED|Overall Study||6||
48596288|NCT04515641|101792851|FG001|COMPLETED|Overall Study||6||
48596289|NCT04515641|101792850|FG000|NOT COMPLETED|Overall Study||0||
48596290|NCT04515641|101792851|FG001|NOT COMPLETED|Overall Study||0||
48596291|NCT00423189|101792852|FG000|STARTED|Overall Study||2||
48596292|NCT00423189|101792853|FG001|STARTED|Overall Study||3||
48596293|NCT00423189|101792854|FG002|STARTED|Overall Study||2||
48596294|NCT00423189|101792852|FG000|COMPLETED|Overall Study||2||
48596295|NCT00423189|101792853|FG001|COMPLETED|Overall Study||2||
48596296|NCT00423189|101792854|FG002|COMPLETED|Overall Study||2||
48596297|NCT00423189|101792852|FG000|NOT COMPLETED|Overall Study||0||
48596298|NCT00423189|101792853|FG001|NOT COMPLETED|Overall Study||1||
48596299|NCT00423189|101792854|FG002|NOT COMPLETED|Overall Study||0||
48596300|NCT01430624|101792855|FG000|STARTED|Overall Study||82||
48596301|NCT01430624|101792856|FG001|STARTED|Overall Study||82||
48596302|NCT01430624|101792857|FG002|STARTED|Overall Study||81||
48596303|NCT01430624|101792855|FG000|Eligible Baseline Completes|Overall Study||77||
48596304|NCT01430624|101792856|FG001|Eligible Baseline Completes|Overall Study||77||
48596305|NCT01430624|101792857|FG002|Eligible Baseline Completes|Overall Study||79||
48596306|NCT01430624|101792855|FG000|COMPLETED|Overall Study||54||
48596307|NCT01430624|101792856|FG001|COMPLETED|Overall Study||48||
48596308|NCT01430624|101792857|FG002|COMPLETED|Overall Study||52||
48596309|NCT01430624|101792855|FG000|NOT COMPLETED|Overall Study||28||
48596310|NCT01430624|101792856|FG001|NOT COMPLETED|Overall Study||34||
48596311|NCT01430624|101792857|FG002|NOT COMPLETED|Overall Study||29||
48596312|NCT04240457|101792858|FG000|STARTED|Overall Study||7||13
48596313|NCT04240457|101792859|FG001|STARTED|Overall Study||4||4
48404674|NCT00804986|101321899|FG001|NOT COMPLETED|Overall Study||8||
48404675|NCT00804986|101321900|FG002|NOT COMPLETED|Overall Study||2||
48404676|NCT00804986|101321901|FG003|NOT COMPLETED|Overall Study||8||
48404677|NCT00804986|101321902|FG004|NOT COMPLETED|Overall Study||9||
48404678|NCT00804986|101321903|FG005|NOT COMPLETED|Overall Study||10||
48404679|NCT02583711|101321904|FG000|STARTED|Overall Study||11||
48404680|NCT02583711|101321905|FG001|STARTED|Overall Study||38||
48404681|NCT02583711|101321906|FG002|STARTED|Overall Study||10||
48404682|NCT02583711|101321904|FG000|COMPLETED|Overall Study||11||
48404683|NCT02583711|101321905|FG001|COMPLETED|Overall Study||28||
48404684|NCT02583711|101321906|FG002|COMPLETED|Overall Study||10||
48404685|NCT02583711|101321904|FG000|NOT COMPLETED|Overall Study||0||
48404686|NCT02583711|101321905|FG001|NOT COMPLETED|Overall Study||10||
48404687|NCT02583711|101321906|FG002|NOT COMPLETED|Overall Study||0||
48404688|NCT02224274|101321907|FG000|STARTED|Overall Study||17||
48404689|NCT02224274|101321908|FG001|STARTED|Overall Study||20||
48404690|NCT02224274|101321907|FG000|COMPLETED|Overall Study||16||
48404691|NCT02224274|101321908|FG001|COMPLETED|Overall Study||20||
48404692|NCT02224274|101321907|FG000|NOT COMPLETED|Overall Study||1||
48404693|NCT02224274|101321908|FG001|NOT COMPLETED|Overall Study||0||
48404694|NCT01707095|101321909|FG000|STARTED|Overall Study||42||
48404695|NCT01707095|101321910|FG001|STARTED|Overall Study||42||
48404696|NCT01707095|101321909|FG000|COMPLETED|Overall Study||42||
48404697|NCT01707095|101321910|FG001|COMPLETED|Overall Study||42||
48404698|NCT01707095|101321909|FG000|NOT COMPLETED|Overall Study||0||
48404699|NCT01707095|101321910|FG001|NOT COMPLETED|Overall Study||0||
48404700|NCT00605358|101321911|FG000|STARTED|Overall Study||81||
48404701|NCT00605358|101321912|FG001|STARTED|Overall Study||80||
48596314|NCT04240457|101792858|FG000|COMPLETED|Overall Study||2||4
48596315|NCT04240457|101792859|FG001|COMPLETED|Overall Study||3||3
48596316|NCT04240457|101792858|FG000|NOT COMPLETED|Overall Study||5||9
48596317|NCT04240457|101792859|FG001|NOT COMPLETED|Overall Study||1||1
48596318|NCT00624650|101792860|FG000|STARTED|Overall Study||17||
48596319|NCT00624650|101792861|FG001|STARTED|Overall Study||16||
48596320|NCT00624650|101792860|FG000|COMPLETED|Overall Study||16||
48596321|NCT00624650|101792861|FG001|COMPLETED|Overall Study||15||
48596322|NCT00624650|101792860|FG000|NOT COMPLETED|Overall Study||1||
48596323|NCT00624650|101792861|FG001|NOT COMPLETED|Overall Study||1||
48596324|NCT04742309|101792862|FG000|STARTED|Overall Study||60||
48596325|NCT04742309|101792863|FG001|STARTED|Overall Study||59||
48596326|NCT04742309|101792862|FG000|COMPLETED|Overall Study||60||
48596327|NCT04742309|101792863|FG001|COMPLETED|Overall Study||59||
48596328|NCT04742309|101792862|FG000|NOT COMPLETED|Overall Study||0||
48596329|NCT04742309|101792863|FG001|NOT COMPLETED|Overall Study||0||
48404702|NCT00605358|101321911|FG000|COMPLETED|Overall Study||81||
48596330|NCT00388297|101792864|FG000|STARTED|Overall Study||339||
48404703|NCT00605358|101321912|FG001|COMPLETED|Overall Study||80||
48404704|NCT00605358|101321911|FG000|NOT COMPLETED|Overall Study||0||
48404705|NCT00605358|101321912|FG001|NOT COMPLETED|Overall Study||0||
48404706|NCT03300427|101321913|FG000|STARTED|Overall Study||27||
48404707|NCT03300427|101321914|FG001|STARTED|Overall Study||28||
48404708|NCT03300427|101321913|FG000|COMPLETED|Overall Study||27||
48712394|NCT01691014|102081792|FG003|COMPLETED|Overall Study||4||
48712395|NCT01691014|102081789|FG000|NOT COMPLETED|Overall Study||3||
48712396|NCT01691014|102081790|FG001|NOT COMPLETED|Overall Study||15||
48712397|NCT01691014|102081791|FG002|NOT COMPLETED|Overall Study||11||
48712398|NCT01691014|102081792|FG003|NOT COMPLETED|Overall Study||5||
48712399|NCT01155466|102081793|FG000|STARTED|Overall Study||156||
48712400|NCT01155466|102081794|FG001|STARTED|Overall Study||155||
48712401|NCT01155466|102081795|FG002|STARTED|Overall Study||156||
48712402|NCT01155466|102081796|FG003|STARTED|Overall Study||155||
48712403|NCT01155466|102081797|FG004|STARTED|Overall Study||156||
48712404|NCT01155466|102081793|FG000|Treated|Overall Study||154||
48712405|NCT01155466|102081794|FG001|Treated|Overall Study||153||
48712406|NCT01155466|102081795|FG002|Treated|Overall Study||153||
48142105|NCT03819491|100673480|FG001|NOT COMPLETED|After Randomization||0||
48142106|NCT03325712|100673481|FG000|STARTED|Overall Study||10||
48142107|NCT03325712|100673482|FG001|STARTED|Overall Study||2||
48712407|NCT01155466|102081796|FG003|Treated|Overall Study||155||
48712408|NCT01155466|102081797|FG004|Treated|Overall Study||154||
48712409|NCT01155466|102081793|FG000|COMPLETED|Overall Study||134||
48712410|NCT01155466|102081794|FG001|COMPLETED|Overall Study||130||
48712411|NCT01155466|102081795|FG002|COMPLETED|Overall Study||136||
48712412|NCT01155466|102081796|FG003|COMPLETED|Overall Study||134||
48712413|NCT01155466|102081797|FG004|COMPLETED|Overall Study||129||
48712414|NCT01155466|102081793|FG000|NOT COMPLETED|Overall Study||22||
48712415|NCT01155466|102081794|FG001|NOT COMPLETED|Overall Study||25||
48712416|NCT01155466|102081795|FG002|NOT COMPLETED|Overall Study||20||
48712417|NCT01155466|102081796|FG003|NOT COMPLETED|Overall Study||21||
48712418|NCT01155466|102081797|FG004|NOT COMPLETED|Overall Study||27||
48712419|NCT01669421|102081798|FG000|STARTED|Phase 1: Standard Dose Therapy||10||
48712420|NCT01669421|102081798|FG000|COMPLETED|Phase 1: Standard Dose Therapy||8||
48712421|NCT01669421|102081798|FG000|NOT COMPLETED|Phase 1: Standard Dose Therapy||2||
48712422|NCT01669421|102081798|FG000|STARTED|Phase 2: Double Dose Therapy||8||
48712423|NCT01669421|102081798|FG000|COMPLETED|Phase 2: Double Dose Therapy||8||
48712424|NCT01669421|102081798|FG000|NOT COMPLETED|Phase 2: Double Dose Therapy||0||
48142108|NCT03325712|100673483|FG002|STARTED|Overall Study||8||
48142109|NCT03325712|100673484|FG003|STARTED|Overall Study||8||
48142110|NCT03325712|100673485|FG004|STARTED|Overall Study||8||
48142111|NCT03325712|100673486|FG005|STARTED|Overall Study||8||
48142112|NCT03325712|100673487|FG006|STARTED|Overall Study||8||
48142113|NCT03325712|100673488|FG007|STARTED|Overall Study||8||
48404709|NCT03300427|101321914|FG001|COMPLETED|Overall Study||28||
48404710|NCT03300427|101321913|FG000|NOT COMPLETED|Overall Study||0||
48404711|NCT03300427|101321914|FG001|NOT COMPLETED|Overall Study||0||
48404712|NCT02242760|101321915|FG000|STARTED|Overall Study||27||
48404713|NCT02242760|101321916|FG001|STARTED|Overall Study||29||
48404714|NCT02242760|101321917|FG002|STARTED|Overall Study||53||
48404715|NCT02242760|101321918|FG003|STARTED|Overall Study||52||
48404716|NCT02242760|101321919|FG004|STARTED|Overall Study||52||
48404717|NCT02242760|101321915|FG000|Number of Subjects Excluded From ITT Population|Overall Study||0|One subject in the SB204 4% BID group was not dispensed study medication after randomization.|
48404718|NCT02242760|101321916|FG001|Number of Subjects Excluded From ITT Population|Overall Study||0|One subject in the SB204 4% BID group was not dispensed study medication after randomization.|
48439901|NCT00563706|101409982|FG005|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5||
48712425|NCT01669421|102081798|FG000|STARTED|Phase 3: Standard Dose Therapy||8||
48712426|NCT01669421|102081798|FG000|COMPLETED|Phase 3: Standard Dose Therapy||8||
48712427|NCT01669421|102081798|FG000|NOT COMPLETED|Phase 3: Standard Dose Therapy||0||
48712428|NCT01053013|102081799|FG000|STARTED|Overall Study||24||
48712429|NCT01053013|102081800|FG001|STARTED|Overall Study||34||
48712430|NCT01053013|102081799|FG000|COMPLETED|Overall Study||24||
48712431|NCT01053013|102081800|FG001|COMPLETED|Overall Study||34||
48712432|NCT01053013|102081799|FG000|NOT COMPLETED|Overall Study||0||
48142114|NCT03325712|100673481|FG000|COMPLETED|Overall Study||10||
48142115|NCT03325712|100673482|FG001|COMPLETED|Overall Study||2||
48142116|NCT03325712|100673483|FG002|COMPLETED|Overall Study||8||
48142117|NCT03325712|100673484|FG003|COMPLETED|Overall Study||8||
48142118|NCT03325712|100673485|FG004|COMPLETED|Overall Study||6||
48142119|NCT03325712|100673486|FG005|COMPLETED|Overall Study||8||
48142120|NCT03325712|100673487|FG006|COMPLETED|Overall Study||8||
48142121|NCT03325712|100673488|FG007|COMPLETED|Overall Study||8||
48142122|NCT03325712|100673481|FG000|NOT COMPLETED|Overall Study||0||
48142123|NCT03325712|100673482|FG001|NOT COMPLETED|Overall Study||0||
48142124|NCT03325712|100673483|FG002|NOT COMPLETED|Overall Study||0||
48142125|NCT03325712|100673484|FG003|NOT COMPLETED|Overall Study||0||
48142126|NCT03325712|100673485|FG004|NOT COMPLETED|Overall Study||2||
48142127|NCT03325712|100673486|FG005|NOT COMPLETED|Overall Study||0||
48142128|NCT03325712|100673487|FG006|NOT COMPLETED|Overall Study||0||
48712433|NCT01053013|102081800|FG001|NOT COMPLETED|Overall Study||0||
48712434|NCT01084278|102081801|FG000|STARTED|Overall Study||8||
48712435|NCT01084278|102081802|FG001|STARTED|Overall Study||8||
48712436|NCT01084278|102081803|FG002|STARTED|Overall Study||8||
48712437|NCT01084278|102081804|FG003|STARTED|Overall Study||8||
48712438|NCT01084278|102081805|FG004|STARTED|Overall Study||8||
48712439|NCT01084278|102081801|FG000|COMPLETED|Overall Study||8||
48712440|NCT01084278|102081802|FG001|COMPLETED|Overall Study||8||
48712441|NCT01084278|102081803|FG002|COMPLETED|Overall Study||8||
48712442|NCT01084278|102081804|FG003|COMPLETED|Overall Study||8||
48712443|NCT01084278|102081805|FG004|COMPLETED|Overall Study||8||
48712444|NCT01084278|102081801|FG000|NOT COMPLETED|Overall Study||0||
48712445|NCT01084278|102081802|FG001|NOT COMPLETED|Overall Study||0||
48712446|NCT01084278|102081803|FG002|NOT COMPLETED|Overall Study||0||
48712447|NCT01084278|102081804|FG003|NOT COMPLETED|Overall Study||0||
48142129|NCT03325712|100673488|FG007|NOT COMPLETED|Overall Study||0||
48142130|NCT01453595|100673489|FG000|STARTED|Overall Study||2||
48142131|NCT01453595|100673490|FG001|STARTED|Overall Study||6||
48142132|NCT01453595|100673491|FG002|STARTED|Overall Study||2||
48142133|NCT01453595|100673489|FG000|COMPLETED|Overall Study||0||
48142134|NCT01453595|100673490|FG001|COMPLETED|Overall Study||5||
48142135|NCT01453595|100673491|FG002|COMPLETED|Overall Study||0||
48142136|NCT01453595|100673489|FG000|NOT COMPLETED|Overall Study||2||
48142137|NCT01453595|100673490|FG001|NOT COMPLETED|Overall Study||1||
48142138|NCT01453595|100673491|FG002|NOT COMPLETED|Overall Study||2||
48142139|NCT02269670|100673492|FG000|STARTED|Overall Study||3||
48142140|NCT02269670|100673492|FG000|COMPLETED|Overall Study||0||
48142141|NCT02269670|100673492|FG000|NOT COMPLETED|Overall Study||3||
48295882|NCT02777385|101050988|FG000|COMPLETED|Overall Study||41||
48295883|NCT02777385|101050989|FG001|COMPLETED|Overall Study||39||
48295884|NCT02777385|101050988|FG000|NOT COMPLETED|Overall Study||0||
48295885|NCT02777385|101050989|FG001|NOT COMPLETED|Overall Study||0||
48295886|NCT00718640|101050990|FG000|STARTED|Overall Study||10||
48295887|NCT00718640|101050990|FG000|COMPLETED|Overall Study||3||
48295888|NCT00718640|101050990|FG000|NOT COMPLETED|Overall Study||7||
48295889|NCT03646656|101054134|FG000|STARTED|Overall Study||12||
48295890|NCT03646656|101054135|FG001|STARTED|Overall Study||3||
48295891|NCT03646656|101054134|FG000|Attended 1st Group Session|Overall Study||10||
48295892|NCT03646656|101054135|FG001|Attended 1st Group Session|Overall Study||3||
48295893|NCT03646656|101054134|FG000|COMPLETED|Overall Study||9||
48295894|NCT03646656|101054135|FG001|COMPLETED|Overall Study||3||
48295895|NCT03646656|101054134|FG000|NOT COMPLETED|Overall Study||3||
48295896|NCT03646656|101054135|FG001|NOT COMPLETED|Overall Study||0||
48295897|NCT02482870|101054136|FG000|STARTED|Overall Study||186|Period 1 started with the patient enrollment on 01.01.2014.|
48295898|NCT02482870|101054137|FG001|STARTED|Overall Study||202|Period 1 started with the patient enrollment on 01.01.2014.|
48712448|NCT01084278|102081805|FG004|NOT COMPLETED|Overall Study||0||
48712449|NCT02124512|102081806|FG000|STARTED|Overall Study||6||
48295899|NCT02482870|101054136|FG000|COMPLETED|Overall Study||186|Period 1 ended on 21.01.2014.|
48295900|NCT02482870|101054137|FG001|COMPLETED|Overall Study||202|Period 1 ended on 21.01.2014.|
48295901|NCT02482870|101054136|FG000|NOT COMPLETED|Overall Study||0||
48295902|NCT02482870|101054137|FG001|NOT COMPLETED|Overall Study||0||
48295903|NCT00185679|101054138|FG000|STARTED|Overall Study||13||
48295904|NCT00185679|101054138|FG000|COMPLETED|Overall Study||13||
48295905|NCT00185679|101054138|FG000|NOT COMPLETED|Overall Study||0||
48712450|NCT02124512|102081807|FG001|STARTED|Overall Study||6||
48712451|NCT02124512|102081806|FG000|COMPLETED|Overall Study||6||
48712452|NCT02124512|102081807|FG001|COMPLETED|Overall Study||6||
48712453|NCT02124512|102081806|FG000|NOT COMPLETED|Overall Study||0||
48712454|NCT02124512|102081807|FG001|NOT COMPLETED|Overall Study||0||
48712455|NCT01628367|102081808|FG000|STARTED|Overall Study||16||
48142142|NCT01371851|100673493|FG000|STARTED|Overall Study||11||
48142143|NCT01371851|100673494|FG001|STARTED|Overall Study||11||
48142144|NCT01371851|100673493|FG000|COMPLETED|Overall Study||3||
48142145|NCT01371851|100673494|FG001|COMPLETED|Overall Study||2||
48142146|NCT01371851|100673493|FG000|NOT COMPLETED|Overall Study||8||
48142147|NCT01371851|100673494|FG001|NOT COMPLETED|Overall Study||9||
48142148|NCT01388816|100673495|FG000|STARTED|Overall Study||45||
48142149|NCT01388816|100673496|FG001|STARTED|Overall Study||43||
48142150|NCT01388816|100673497|FG002|STARTED|Overall Study||44||
48142151|NCT01388816|100673498|FG003|STARTED|Overall Study||44||
48142152|NCT01388816|100673495|FG000|COMPLETED|Overall Study||43||
48142153|NCT01388816|100673496|FG001|COMPLETED|Overall Study||39||
48142154|NCT01388816|100673497|FG002|COMPLETED|Overall Study||41||
48142155|NCT01388816|100673498|FG003|COMPLETED|Overall Study||44||
48142156|NCT01388816|100673495|FG000|NOT COMPLETED|Overall Study||2||
48142157|NCT01388816|100673496|FG001|NOT COMPLETED|Overall Study||4||
48142158|NCT01388816|100673497|FG002|NOT COMPLETED|Overall Study||3||
48142159|NCT01388816|100673498|FG003|NOT COMPLETED|Overall Study||0||
48142160|NCT01786512|100673499|FG000|STARTED|Overall Study||11||
48142161|NCT01786512|100673500|FG001|STARTED|Overall Study||11||
48142162|NCT01786512|100673501|FG002|STARTED|Overall Study||14||
48142163|NCT01786512|100673502|FG003|STARTED|Overall Study||13||
48142164|NCT01786512|100673503|FG004|STARTED|Overall Study||10||
48142165|NCT01786512|100673504|FG005|STARTED|Overall Study||11||
48596331|NCT00388297|101792865|FG001|STARTED|Overall Study||338||
48596332|NCT00388297|101792866|FG002|STARTED|Overall Study||265||
48596333|NCT00388297|101792867|FG003|STARTED|Overall Study||261||
48596334|NCT00388297|101792864|FG000|COMPLETED|Overall Study||323||
48596335|NCT00388297|101792865|FG001|COMPLETED|Overall Study||326||
48596336|NCT00388297|101792866|FG002|COMPLETED|Overall Study||254||
48596337|NCT00388297|101792867|FG003|COMPLETED|Overall Study||253||
48404719|NCT02242760|101321917|FG002|Number of Subjects Excluded From ITT Population|Overall Study||0|One subject in the SB204 4% BID group was not dispensed study medication after randomization.|
48404720|NCT02242760|101321918|FG003|Number of Subjects Excluded From ITT Population|Overall Study||0|One subject in the SB204 4% BID group was not dispensed study medication after randomization.|
48404721|NCT02242760|101321919|FG004|Number of Subjects Excluded From ITT Population|Overall Study||1|One subject in the SB204 4% BID group was not dispensed study medication after randomization.|
48404722|NCT02242760|101321915|FG000|COMPLETED|Overall Study||24||
48404723|NCT02242760|101321916|FG001|COMPLETED|Overall Study||20||
48404724|NCT02242760|101321917|FG002|COMPLETED|Overall Study||51||
48404725|NCT02242760|101321918|FG003|COMPLETED|Overall Study||48||
48404726|NCT02242760|101321919|FG004|COMPLETED|Overall Study||48||
48404727|NCT02242760|101321915|FG000|NOT COMPLETED|Overall Study||3||
48404728|NCT02242760|101321916|FG001|NOT COMPLETED|Overall Study||9||
48404729|NCT02242760|101321917|FG002|NOT COMPLETED|Overall Study||2||
48404730|NCT02242760|101321918|FG003|NOT COMPLETED|Overall Study||4||
48404731|NCT02242760|101321919|FG004|NOT COMPLETED|Overall Study||4||
48712456|NCT01628367|102081809|FG001|STARTED|Overall Study||16||
48712457|NCT01628367|102081808|FG000|COMPLETED|Overall Study||15||
48712458|NCT01628367|102081809|FG001|COMPLETED|Overall Study||16||
48712459|NCT01628367|102081808|FG000|NOT COMPLETED|Overall Study||1||
48712460|NCT01628367|102081809|FG001|NOT COMPLETED|Overall Study||0||
48712461|NCT01011933|102081810|FG000|STARTED|Overall Study||54||
48712462|NCT01011933|102081810|FG000|COMPLETED|Overall Study||50||
48712463|NCT01011933|102081810|FG000|NOT COMPLETED|Overall Study||4||
48712464|NCT00989235|102081811|FG000|STARTED|Overall Study||58||
48712465|NCT00989235|102081812|FG001|STARTED|Overall Study||50||
48712466|NCT00989235|102081811|FG000|Number Rescued to Open-Label Treatment|Overall Study||4||
48712467|NCT00989235|102081812|FG001|Number Rescued to Open-Label Treatment|Overall Study||4||
48712468|NCT00989235|102081811|FG000|Number Completing Double-Blind Treatment|Overall Study||51||
48712469|NCT00989235|102081812|FG001|Number Completing Double-Blind Treatment|Overall Study||41||
48712470|NCT00989235|102081811|FG000|COMPLETED|Overall Study||55||
48712471|NCT00989235|102081812|FG001|COMPLETED|Overall Study||44||
48712472|NCT00989235|102081811|FG000|NOT COMPLETED|Overall Study||3||
48712473|NCT00989235|102081812|FG001|NOT COMPLETED|Overall Study||6||
48712474|NCT00457977|102081813|FG000|STARTED|Overall Study||90||
48712475|NCT00457977|102081814|FG001|STARTED|Overall Study||91||
48712476|NCT00457977|102081813|FG000|1-Month|Overall Study||88||
48712477|NCT00457977|102081814|FG001|1-Month|Overall Study||87||
48712478|NCT00457977|102081813|FG000|1-Year|Overall Study||69||
48712479|NCT00457977|102081814|FG001|1-Year|Overall Study||76||
48712480|NCT00457977|102081813|FG000|2-Year|Overall Study||62||
48712481|NCT00457977|102081814|FG001|2-Year|Overall Study||66||
48712482|NCT00457977|102081813|FG000|COMPLETED|Overall Study||62||
48712483|NCT00457977|102081814|FG001|COMPLETED|Overall Study||66||
48712484|NCT00457977|102081813|FG000|NOT COMPLETED|Overall Study||28||
48712485|NCT00457977|102081814|FG001|NOT COMPLETED|Overall Study||25||
48712486|NCT03094286|102081815|FG000|STARTED|Overall Study||20||
48712487|NCT03094286|102081815|FG000|COMPLETED|Overall Study||20||
48712488|NCT03094286|102081815|FG000|NOT COMPLETED|Overall Study||0||
48712489|NCT01822535|102081816|FG000|STARTED|Visit 1 - Tetraplegia and Able-Bodied||17||
48712490|NCT01822535|102081817|FG001|STARTED|Visit 1 - Tetraplegia and Able-Bodied||13||
48712491|NCT01822535|102081816|FG000|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11||
48712492|NCT01822535|102081817|FG001|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11||
48712493|NCT01822535|102081816|FG000|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||6||
48712494|NCT01822535|102081817|FG001|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||2||
48712495|NCT01822535|102081816|FG000|STARTED|Visit 2 - Tetraplegia Only - Drug||11||
48712496|NCT01822535|102081817|FG001|STARTED|Visit 2 - Tetraplegia Only - Drug||0||
48404732|NCT01769612|101321920|FG000|STARTED|Overall Study||168||
48404733|NCT01769612|101321920|FG000|COMPLETED|Overall Study||168||
48404734|NCT01769612|101321920|FG000|NOT COMPLETED|Overall Study||0||
48404735|NCT02707601|101321921|FG000|STARTED|Overall Study||76||
48404736|NCT02707601|101321922|FG001|STARTED|Overall Study||74||
48404737|NCT02707601|101321921|FG000|COMPLETED|Overall Study||72||
48404738|NCT02707601|101321922|FG001|COMPLETED|Overall Study||70||
48404739|NCT02707601|101321921|FG000|NOT COMPLETED|Overall Study||4||
48404740|NCT02707601|101321922|FG001|NOT COMPLETED|Overall Study||4||
48404741|NCT00560794|101321923|FG000|STARTED|Overall Study||21||
48404742|NCT00560794|101321923|FG000|Completed 1 Treatment Cycle|Overall Study||20||
48404743|NCT00560794|101321923|FG000|COMPLETED|Overall Study||10||
48404744|NCT00560794|101321923|FG000|NOT COMPLETED|Overall Study||11||
48404745|NCT00246376|101321924|FG000|STARTED|Overall Study||41||
48404746|NCT00246376|101321925|FG001|STARTED|Overall Study||43||
48404747|NCT00246376|101321926|FG002|STARTED|Overall Study||45||
48404748|NCT00246376|101321927|FG003|STARTED|Overall Study||47||
48404749|NCT00246376|101321928|FG004|STARTED|Overall Study||45||
48404750|NCT00246376|101321924|FG000|After Dietary run-in at Two Weeks|Overall Study||30||
48404751|NCT00246376|101321925|FG001|After Dietary run-in at Two Weeks|Overall Study||38||
48712497|NCT01822535|102081816|FG000|COMPLETED|Visit 2 - Tetraplegia Only - Drug||10||
48712498|NCT01822535|102081817|FG001|COMPLETED|Visit 2 - Tetraplegia Only - Drug||0||
48712499|NCT01822535|102081816|FG000|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||1||
48596338|NCT00388297|101792864|FG000|NOT COMPLETED|Overall Study||16||
48596339|NCT00388297|101792865|FG001|NOT COMPLETED|Overall Study||12||
48596340|NCT00388297|101792866|FG002|NOT COMPLETED|Overall Study||11||
48596341|NCT00388297|101792867|FG003|NOT COMPLETED|Overall Study||8||
48596342|NCT00798018|101792868|FG000|STARTED|Overall Study||25||
48596343|NCT00798018|101792869|FG001|STARTED|Overall Study||25||
48596344|NCT00798018|101792870|FG002|STARTED|Overall Study||25||
48596345|NCT00798018|101792871|FG003|STARTED|Overall Study||25||
48596346|NCT00798018|101792868|FG000|COMPLETED|Overall Study||25||
48295906|NCT04040400|101054139|FG000|STARTED|Cohort 1||5||
48295907|NCT04040400|101054140|FG001|STARTED|Cohort 1||0||
48295908|NCT04040400|101054141|FG002|STARTED|Cohort 1||0||
48295909|NCT04040400|101054139|FG000|COMPLETED|Cohort 1||5||
48295910|NCT04040400|101054140|FG001|COMPLETED|Cohort 1||0||
48295911|NCT04040400|101054141|FG002|COMPLETED|Cohort 1||0||
48295912|NCT04040400|101054139|FG000|NOT COMPLETED|Cohort 1||0||
48295913|NCT04040400|101054140|FG001|NOT COMPLETED|Cohort 1||0||
48596347|NCT00798018|101792869|FG001|COMPLETED|Overall Study||25||
48596348|NCT00798018|101792870|FG002|COMPLETED|Overall Study||25||
48596349|NCT00798018|101792871|FG003|COMPLETED|Overall Study||25||
48596350|NCT00798018|101792868|FG000|NOT COMPLETED|Overall Study||0||
48596351|NCT00798018|101792869|FG001|NOT COMPLETED|Overall Study||0||
48596352|NCT00798018|101792870|FG002|NOT COMPLETED|Overall Study||0||
48596353|NCT00798018|101792871|FG003|NOT COMPLETED|Overall Study||0||
48596354|NCT01361113|101792872|FG000|STARTED|Overall Study||21||
48596355|NCT01361113|101792872|FG000|COMPLETED|Overall Study||21||
48596356|NCT01361113|101792872|FG000|NOT COMPLETED|Overall Study||0||
48596357|NCT00401960|101792873|FG000|STARTED|Overall Study||5||
48596358|NCT00401960|101792874|FG001|STARTED|Overall Study||1||
48596359|NCT00401960|101792873|FG000|COMPLETED|Overall Study||0||
48596360|NCT00401960|101792874|FG001|COMPLETED|Overall Study||1||
48596361|NCT00401960|101792873|FG000|NOT COMPLETED|Overall Study||5||
48295914|NCT04040400|101054141|FG002|NOT COMPLETED|Cohort 1||0||
48295915|NCT04040400|101054139|FG000|STARTED|Cohort 1:||5||
48295916|NCT04040400|101054140|FG001|STARTED|Cohort 1:||0||
48295917|NCT04040400|101054141|FG002|STARTED|Cohort 1:||0||
48295918|NCT04040400|101054139|FG000|COMPLETED|Cohort 1:||4|1 participant died of respiratory failure unrelated to treatment.|
48295919|NCT04040400|101054140|FG001|COMPLETED|Cohort 1:||0|1 participant died of respiratory failure unrelated to treatment.|
48295920|NCT04040400|101054141|FG002|COMPLETED|Cohort 1:||0|1 participant died of respiratory failure unrelated to treatment.|
48295921|NCT04040400|101054139|FG000|NOT COMPLETED|Cohort 1:||1||
48404752|NCT00246376|101321926|FG002|After Dietary run-in at Two Weeks|Overall Study||41||
48295922|NCT04040400|101054140|FG001|NOT COMPLETED|Cohort 1:||0||
48295923|NCT04040400|101054141|FG002|NOT COMPLETED|Cohort 1:||0||
48295924|NCT01740323|101054142|FG000|STARTED|Overall Study||15||
48295925|NCT01740323|101054143|FG001|STARTED|Overall Study||15||
48596362|NCT00401960|101792874|FG001|NOT COMPLETED|Overall Study||0||
48596363|NCT01945294|101792875|FG000|STARTED|Period 1: 12-Week PR + BOC Lead-In||257||
48596364|NCT01945294|101792876|FG001|STARTED|Period 1: 12-Week PR + BOC Lead-In||0||
48596365|NCT01945294|101792877|FG002|STARTED|Period 1: 12-Week PR + BOC Lead-In||0||
48596366|NCT01945294|101792878|FG003|STARTED|Period 1: 12-Week PR + BOC Lead-In||0||
48596367|NCT01945294|101792875|FG000|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||236||
48596368|NCT01945294|101792876|FG001|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0||
48596369|NCT01945294|101792877|FG002|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0||
48596370|NCT01945294|101792878|FG003|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0||
48295926|NCT01740323|101054142|FG000|COMPLETED|Overall Study||13||
48404753|NCT00246376|101321927|FG003|After Dietary run-in at Two Weeks|Overall Study||40||
48596371|NCT01945294|101792875|FG000|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||21||
48596372|NCT01945294|101792876|FG001|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0||
48596373|NCT01945294|101792877|FG002|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0||
48596374|NCT01945294|101792878|FG003|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0||
48596375|NCT01945294|101792875|FG000|STARTED|Period 2: BOC+ PR Treatment & Follow-up||0||
48596376|NCT01945294|101792876|FG001|STARTED|Period 2: BOC+ PR Treatment & Follow-up||102||
48596377|NCT01945294|101792877|FG002|STARTED|Period 2: BOC+ PR Treatment & Follow-up||105||
48596378|NCT01945294|101792878|FG003|STARTED|Period 2: BOC+ PR Treatment & Follow-up||29||
48596379|NCT01945294|101792875|FG000|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0||
48596380|NCT01945294|101792876|FG001|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97||
48596381|NCT01945294|101792877|FG002|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97||
48596382|NCT01945294|101792878|FG003|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||23||
48596383|NCT01945294|101792875|FG000|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0||
48596384|NCT01945294|101792876|FG001|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||5||
48596385|NCT01945294|101792877|FG002|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||8||
48596386|NCT01945294|101792878|FG003|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||6||
48596387|NCT01342172|101792879|FG000|STARTED|Overall Study||9||
48596388|NCT01342172|101792879|FG000|COMPLETED|Overall Study||9||
48596389|NCT01342172|101792879|FG000|NOT COMPLETED|Overall Study||0||
48596390|NCT02046772|101792880|FG000|STARTED|Overall Study||30||
48596391|NCT02046772|101792881|FG001|STARTED|Overall Study||33||
48596392|NCT02046772|101792880|FG000|COMPLETED|Overall Study||30||
48596393|NCT02046772|101792881|FG001|COMPLETED|Overall Study||33||
48596394|NCT02046772|101792880|FG000|NOT COMPLETED|Overall Study||0||
48596395|NCT02046772|101792881|FG001|NOT COMPLETED|Overall Study||0||
48596396|NCT01606748|101792882|FG000|STARTED|Overall Study||18||
48596397|NCT01606748|101792883|FG001|STARTED|Overall Study||17||
48596398|NCT01606748|101792882|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18||
48596399|NCT01606748|101792883|FG001|Received at Least 1 Dose of Study Drug|Overall Study||17||
48596400|NCT01606748|101792882|FG000|COMPLETED|Overall Study||15||
48596401|NCT01606748|101792883|FG001|COMPLETED|Overall Study||17||
48596402|NCT01606748|101792882|FG000|NOT COMPLETED|Overall Study||3||
48596403|NCT01606748|101792883|FG001|NOT COMPLETED|Overall Study||0||
48596404|NCT02117713|101792884|FG000|STARTED|Week 48||34||
48596405|NCT02117713|101792884|FG000|COMPLETED|Week 48||26||
48596406|NCT02117713|101792884|FG000|NOT COMPLETED|Week 48||8||
48596407|NCT02117713|101792884|FG000|STARTED|Long Term Follow-up Treatment||26||
48596408|NCT02117713|101792884|FG000|COMPLETED|Long Term Follow-up Treatment||20||
48596409|NCT02117713|101792884|FG000|NOT COMPLETED|Long Term Follow-up Treatment||6||
48596410|NCT00732680|101792885|FG000|STARTED|Overall Study||9||
48295927|NCT01740323|101054143|FG001|COMPLETED|Overall Study||15||
48295928|NCT01740323|101054142|FG000|NOT COMPLETED|Overall Study||2||
48295929|NCT01740323|101054143|FG001|NOT COMPLETED|Overall Study||0||
48295930|NCT02027623|101054144|FG000|STARTED|Overall Study||77||
48596411|NCT00732680|101792885|FG000|COMPLETED|Overall Study||9||
48596412|NCT00732680|101792885|FG000|NOT COMPLETED|Overall Study||0||
48596413|NCT04312841|101792886|FG000|STARTED|Overall Study||6||
48596414|NCT04312841|101792886|FG000|COMPLETED|Overall Study||6||
48596415|NCT04312841|101792886|FG000|NOT COMPLETED|Overall Study||0||
48596416|NCT02539654|101792887|FG000|STARTED|Overall Study||14||
48596417|NCT02539654|101792887|FG000|COMPLETED|Overall Study||14||
48596418|NCT02539654|101792887|FG000|NOT COMPLETED|Overall Study||0||
48596419|NCT02949908|101792888|FG000|STARTED|Overall Study||2||
48596420|NCT02949908|101792888|FG000|COMPLETED|Overall Study||0||
48596421|NCT02949908|101792888|FG000|NOT COMPLETED|Overall Study||2||
48596422|NCT00259285|101792889|FG000|STARTED|Overall Study||10||
48596423|NCT00259285|101792889|FG000|COMPLETED|Overall Study||10||
48596424|NCT00259285|101792889|FG000|NOT COMPLETED|Overall Study||0||
48596425|NCT03759366|101792890|FG000|STARTED|Primary Evaluation Period (26 Weeks)||11||
48596426|NCT03759366|101792890|FG000|Received at Least 1 Dose of Study Drug|Primary Evaluation Period (26 Weeks)||11||
48596427|NCT03759366|101792890|FG000|COMPLETED|Primary Evaluation Period (26 Weeks)||10||
48596428|NCT03759366|101792890|FG000|NOT COMPLETED|Primary Evaluation Period (26 Weeks)||1||
48596429|NCT03759366|101792890|FG000|STARTED|Extension Period (Up to 208 Weeks)||10||
48596430|NCT03759366|101792890|FG000|Received at Least 1 Dose of Study Drug|Extension Period (Up to 208 Weeks)||10||
48596431|NCT03759366|101792890|FG000|COMPLETED|Extension Period (Up to 208 Weeks)||2||
48596432|NCT03759366|101792890|FG000|NOT COMPLETED|Extension Period (Up to 208 Weeks)||8||
48596433|NCT00770133|101792891|FG000|STARTED|Overall Study||35||
48596434|NCT00770133|101792892|FG001|STARTED|Overall Study||36||
48596435|NCT00770133|101792893|FG002|STARTED|Overall Study||35||
48596436|NCT00770133|101792894|FG003|STARTED|Overall Study||35||
48596437|NCT00770133|101792891|FG000|COMPLETED|Overall Study||32||
48596438|NCT00770133|101792892|FG001|COMPLETED|Overall Study||35||
48596439|NCT00770133|101792893|FG002|COMPLETED|Overall Study||32||
48596440|NCT00770133|101792894|FG003|COMPLETED|Overall Study||32||
48596441|NCT00770133|101792891|FG000|NOT COMPLETED|Overall Study||3||
48596442|NCT00770133|101792892|FG001|NOT COMPLETED|Overall Study||1||
48596443|NCT00770133|101792893|FG002|NOT COMPLETED|Overall Study||3||
48295931|NCT02027623|101054145|FG001|STARTED|Overall Study||77||
48295932|NCT02027623|101054144|FG000|COMPLETED|Overall Study||68||
48295933|NCT02027623|101054145|FG001|COMPLETED|Overall Study||65||
48295934|NCT02027623|101054144|FG000|NOT COMPLETED|Overall Study||9||
48295935|NCT02027623|101054145|FG001|NOT COMPLETED|Overall Study||12||
48295936|NCT01222507|101054146|FG000|STARTED|Overall Study||62||
48295937|NCT01222507|101054146|FG000|COMPLETED|Overall Study||60||
48295938|NCT01222507|101054146|FG000|NOT COMPLETED|Overall Study||2||
48295939|NCT02092220|101054147|FG000|STARTED|Period 1||21||
48295940|NCT02092220|101054148|FG001|STARTED|Period 1||22||
48596444|NCT00770133|101792894|FG003|NOT COMPLETED|Overall Study||3||
48596445|NCT04027075|101792895|FG000|STARTED|Overall Study||129||
48596446|NCT04027075|101792896|FG001|STARTED|Overall Study||128||
48596447|NCT04027075|101792895|FG000|COMPLETED|Overall Study||88||
48596448|NCT04027075|101792896|FG001|COMPLETED|Overall Study||106||
48596449|NCT04027075|101792895|FG000|NOT COMPLETED|Overall Study||41||
48596450|NCT04027075|101792896|FG001|NOT COMPLETED|Overall Study||22||
48596451|NCT00552032|101792897|FG000|STARTED|Overall Study||66||
48596452|NCT00552032|101792898|FG001|STARTED|Overall Study||66||
48596453|NCT00552032|101792897|FG000|COMPLETED|Overall Study||49||
48596454|NCT00552032|101792898|FG001|COMPLETED|Overall Study||47||
48596455|NCT00552032|101792897|FG000|NOT COMPLETED|Overall Study||17||
48596456|NCT00552032|101792898|FG001|NOT COMPLETED|Overall Study||19||
48596457|NCT04272606|101792899|FG000|STARTED|Overall Study||44||
48596458|NCT04272606|101792900|FG001|STARTED|Overall Study||42||
48596459|NCT04272606|101792899|FG000|COMPLETED|Overall Study||43||
48596460|NCT04272606|101792900|FG001|COMPLETED|Overall Study||40||
48596461|NCT04272606|101792899|FG000|NOT COMPLETED|Overall Study||1||
48596462|NCT04272606|101792900|FG001|NOT COMPLETED|Overall Study||2||
48596463|NCT00345878|101792901|FG000|STARTED|Overall Study||135||
48596464|NCT00345878|101792902|FG001|STARTED|Overall Study||136||
48295941|NCT02092220|101054147|FG000|COMPLETED|Period 1||21||
48295942|NCT02092220|101054148|FG001|COMPLETED|Period 1||20||
48295943|NCT02092220|101054147|FG000|NOT COMPLETED|Period 1||0||
48295944|NCT02092220|101054148|FG001|NOT COMPLETED|Period 1||2||
48295945|NCT02092220|101054147|FG000|STARTED|Period 2||21||
48295946|NCT02092220|101054148|FG001|STARTED|Period 2||20||
48295947|NCT02092220|101054147|FG000|COMPLETED|Period 2||20||
48295948|NCT02092220|101054148|FG001|COMPLETED|Period 2||19||
48295949|NCT02092220|101054147|FG000|NOT COMPLETED|Period 2||1||
48295950|NCT02092220|101054148|FG001|NOT COMPLETED|Period 2||1||
48295951|NCT00232141|101054149|FG000|STARTED|Overall Study||151||
48295952|NCT00232141|101054150|FG001|STARTED|Overall Study||151||
48295953|NCT00232141|101054149|FG000|COMPLETED|Overall Study||120||
48295954|NCT00232141|101054150|FG001|COMPLETED|Overall Study||125||
48295955|NCT00232141|101054149|FG000|NOT COMPLETED|Overall Study||31||
48295956|NCT00232141|101054150|FG001|NOT COMPLETED|Overall Study||26||
48596465|NCT00345878|101792901|FG000|COMPLETED|Overall Study||131||
48596466|NCT00345878|101792902|FG001|COMPLETED|Overall Study||135||
48596467|NCT00345878|101792901|FG000|NOT COMPLETED|Overall Study||4||
48596468|NCT00345878|101792902|FG001|NOT COMPLETED|Overall Study||1||
48596469|NCT03755518|101792903|FG000|STARTED|Overall Study||38||
48596470|NCT03755518|101792903|FG000|COMPLETED|Overall Study||0|Completed = continuing treatment|
48596471|NCT03755518|101792903|FG000|NOT COMPLETED|Overall Study||38||
48596472|NCT01712308|101792904|FG000|STARTED|Overall Study||35||
48596473|NCT01712308|101792905|FG001|STARTED|Overall Study||21||
48596474|NCT01712308|101792904|FG000|COMPLETED|Overall Study||35||
48596475|NCT01712308|101792905|FG001|COMPLETED|Overall Study||21||
48596476|NCT01712308|101792904|FG000|NOT COMPLETED|Overall Study||0||
48596477|NCT01712308|101792905|FG001|NOT COMPLETED|Overall Study||0||
48596478|NCT03489941|101792906|FG000|STARTED|Overall Study||51||51
48596479|NCT03489941|101792907|FG001|STARTED|Overall Study||52||52
48712500|NCT01822535|102081817|FG001|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||0||
48712501|NCT01165320|102081818|FG000|STARTED|Overall Study||12||
48712502|NCT01165320|102081819|FG001|STARTED|Overall Study||8||
48712503|NCT01165320|102081820|FG002|STARTED|Overall Study||0||
48712504|NCT01165320|102081818|FG000|COMPLETED|Overall Study||9||
48596480|NCT03489941|101792908|FG002|STARTED|Overall Study||27||27
48596481|NCT03489941|101792906|FG000|COMPLETED|Overall Study||51||51
48712505|NCT01165320|102081819|FG001|COMPLETED|Overall Study||4||
48712506|NCT01165320|102081820|FG002|COMPLETED|Overall Study||0||
48712507|NCT01165320|102081818|FG000|NOT COMPLETED|Overall Study||3||
48712508|NCT01165320|102081819|FG001|NOT COMPLETED|Overall Study||4||
48712509|NCT01165320|102081820|FG002|NOT COMPLETED|Overall Study||0||
48596482|NCT03489941|101792907|FG001|COMPLETED|Overall Study||52||52
48596483|NCT03489941|101792908|FG002|COMPLETED|Overall Study||27||27
48596484|NCT03489941|101792906|FG000|NOT COMPLETED|Overall Study||0||0
48295957|NCT00846547|101054151|FG000|STARTED|Overall Study||32||
48295958|NCT00846547|101054151|FG000|COMPLETED|Overall Study||25||
48596485|NCT03489941|101792907|FG001|NOT COMPLETED|Overall Study||0||0
48596486|NCT03489941|101792908|FG002|NOT COMPLETED|Overall Study||0||0
48596487|NCT02844907|101792909|FG000|STARTED|Hyperglycemic Clamp + Exendin (9-39)||6||
48596488|NCT02844907|101792909|FG000|COMPLETED|Hyperglycemic Clamp + Exendin (9-39)||6||
48596489|NCT02844907|101792909|FG000|NOT COMPLETED|Hyperglycemic Clamp + Exendin (9-39)||0||
48596490|NCT02844907|101792909|FG000|STARTED|With Dexamethasone||6||
48596491|NCT02844907|101792909|FG000|COMPLETED|With Dexamethasone||5||
48596492|NCT02844907|101792909|FG000|NOT COMPLETED|With Dexamethasone||1||
48596493|NCT01167634|101792910|FG000|STARTED|Overall Study||33||
48596494|NCT01167634|101792911|FG001|STARTED|Overall Study||33||
48596495|NCT01167634|101792912|FG002|STARTED|Overall Study||33||
48596496|NCT01167634|101792913|FG003|STARTED|Overall Study||33||
48596497|NCT01167634|101792910|FG000|COMPLETED|Overall Study||31||
48596498|NCT01167634|101792911|FG001|COMPLETED|Overall Study||29||
48596499|NCT01167634|101792912|FG002|COMPLETED|Overall Study||30||
48596500|NCT01167634|101792913|FG003|COMPLETED|Overall Study||29||
48596501|NCT01167634|101792910|FG000|NOT COMPLETED|Overall Study||2||
48295959|NCT00846547|101054151|FG000|NOT COMPLETED|Overall Study||7||
48295960|NCT00093808|101054152|FG000|STARTED|Overall Study||47||
48295961|NCT00093808|101054152|FG000|COMPLETED|Overall Study||45||
48295962|NCT00093808|101054152|FG000|NOT COMPLETED|Overall Study||2||
48295963|NCT01607112|101054153|FG000|STARTED|Overall Study||60||
48295964|NCT01607112|101054154|FG001|STARTED|Overall Study||59||
48295965|NCT01607112|101054153|FG000|COMPLETED|Overall Study||60||
48295966|NCT01607112|101054154|FG001|COMPLETED|Overall Study||59||
48295967|NCT01607112|101054153|FG000|NOT COMPLETED|Overall Study||0||
48295968|NCT01607112|101054154|FG001|NOT COMPLETED|Overall Study||0||
48295969|NCT01100034|101054155|FG000|STARTED|Overall Study||72||
48295970|NCT01100034|101054155|FG000|COMPLETED|Overall Study||29||
48295971|NCT01100034|101054155|FG000|NOT COMPLETED|Overall Study||43||
48295972|NCT00051363|101054156|FG000|STARTED|Overall Study||558||
48295973|NCT00051363|101054157|FG001|STARTED|Overall Study||547||
48295974|NCT00051363|101054156|FG000|Randomized & Analyzed|Overall Study||556||
48295975|NCT00051363|101054157|FG001|Randomized & Analyzed|Overall Study||542||
48295976|NCT00051363|101054156|FG000|Completed 2M Visit On-Treatment|Overall Study||456||
48295977|NCT00051363|101054157|FG001|Completed 2M Visit On-Treatment|Overall Study||417||
48295978|NCT00051363|101054156|FG000|Completed 2M Visit On-Study|Overall Study||468||
48295979|NCT00051363|101054157|FG001|Completed 2M Visit On-Study|Overall Study||432||
48596502|NCT01167634|101792911|FG001|NOT COMPLETED|Overall Study||4||
48596503|NCT01167634|101792912|FG002|NOT COMPLETED|Overall Study||3||
48596504|NCT01167634|101792913|FG003|NOT COMPLETED|Overall Study||4||
48596505|NCT02655419|101792914|FG000|STARTED|Overall Study||17||
48596506|NCT02655419|101792915|FG001|STARTED|Overall Study||23||
48596507|NCT02655419|101792914|FG000|Treated|Overall Study||16||
48295980|NCT00051363|101054156|FG000|Completed 6M Visit On-Treatment|Overall Study||427||
48295981|NCT00051363|101054157|FG001|Completed 6M Visit On-Treatment|Overall Study||372||
48295982|NCT00051363|101054156|FG000|Completed 6M Vist On-Study|Overall Study||443||
48295983|NCT00051363|101054157|FG001|Completed 6M Vist On-Study|Overall Study||403||
48295984|NCT00051363|101054156|FG000|COMPLETED|Overall Study||443||
48295985|NCT00051363|101054157|FG001|COMPLETED|Overall Study||403||
48295986|NCT00051363|101054156|FG000|NOT COMPLETED|Overall Study||115||
48295987|NCT00051363|101054157|FG001|NOT COMPLETED|Overall Study||144||
48295988|NCT01658150|101054158|FG000|STARTED|Overall Study||11||
48295989|NCT01658150|101054158|FG000|COMPLETED|Overall Study||10||
48295990|NCT01658150|101054158|FG000|NOT COMPLETED|Overall Study||1||
48295991|NCT01274585|101054159|FG000|STARTED|Overall Study||2||
48295992|NCT01274585|101054160|FG001|STARTED|Overall Study||3||
48596508|NCT02655419|101792915|FG001|Treated|Overall Study||18||
48596509|NCT02655419|101792914|FG000|COMPLETED|Overall Study||12||
48596510|NCT02655419|101792915|FG001|COMPLETED|Overall Study||16||
48596511|NCT02655419|101792914|FG000|NOT COMPLETED|Overall Study||5||
48596512|NCT02655419|101792915|FG001|NOT COMPLETED|Overall Study||7||
48596513|NCT00394433|101792916|FG000|STARTED|Overall Study||38||
48596514|NCT00394433|101792916|FG000|Evaluable and Treated|Overall Study||35||
48596515|NCT00394433|101792916|FG000|COMPLETED|Overall Study||35||
48596516|NCT00394433|101792916|FG000|NOT COMPLETED|Overall Study||3||
48596517|NCT01428115|101792917|FG000|STARTED|Overall Study||83||
48596518|NCT01428115|101792917|FG000|COMPLETED|Overall Study||62||
48596519|NCT01428115|101792917|FG000|NOT COMPLETED|Overall Study||21||
48596520|NCT03597022|101792918|FG000|STARTED|Overall Study||8||
48596521|NCT03597022|101792919|FG001|STARTED|Overall Study||8||
48596522|NCT03597022|101792920|FG002|STARTED|Overall Study||8||
48295993|NCT01274585|101054159|FG000|COMPLETED|Overall Study||2||
48295994|NCT01274585|101054160|FG001|COMPLETED|Overall Study||3||
48295995|NCT01274585|101054159|FG000|NOT COMPLETED|Overall Study||0||
48295996|NCT01274585|101054160|FG001|NOT COMPLETED|Overall Study||0||
48295997|NCT01143038|101054161|FG000|STARTED|Overall Study||75||
48295998|NCT01143038|101054161|FG000|COMPLETED|Overall Study||59||
48596523|NCT03597022|101792918|FG000|COMPLETED|Overall Study||0||
48596524|NCT03597022|101792919|FG001|COMPLETED|Overall Study||0||
48596525|NCT03597022|101792920|FG002|COMPLETED|Overall Study||0||
48404754|NCT00246376|101321928|FG004|After Dietary run-in at Two Weeks|Overall Study||42||
48712510|NCT04224272|102081821|FG000|STARTED|Part 1 - Dose Finding||8||
48712511|NCT04224272|102081821|FG000|COMPLETED|Part 1 - Dose Finding||1||
48596526|NCT03597022|101792918|FG000|NOT COMPLETED|Overall Study||8||
48596527|NCT03597022|101792919|FG001|NOT COMPLETED|Overall Study||8||
48596528|NCT03597022|101792920|FG002|NOT COMPLETED|Overall Study||8||
48596529|NCT00796744|101792921|FG000|STARTED|Overall Study||24||
48596530|NCT00796744|101792922|FG001|STARTED|Overall Study||26||
48596531|NCT00796744|101792923|FG002|STARTED|Overall Study||28||
48596532|NCT00796744|101792921|FG000|COMPLETED|Overall Study||24||
48596533|NCT00796744|101792922|FG001|COMPLETED|Overall Study||26||
48596534|NCT00796744|101792923|FG002|COMPLETED|Overall Study||27||
48596535|NCT00796744|101792921|FG000|NOT COMPLETED|Overall Study||0||
48596536|NCT00796744|101792922|FG001|NOT COMPLETED|Overall Study||0||
48596537|NCT00796744|101792923|FG002|NOT COMPLETED|Overall Study||1||
48596538|NCT03781583|101792924|FG000|STARTED|Overall Study||4|started means first participation was with this intervention and for this form of test|
48596539|NCT03781583|101792925|FG001|STARTED|Overall Study||5|started means first participation was with this intervention and for this form of test|
48596540|NCT03781583|101792926|FG002|STARTED|Overall Study||8|started means first participation was with this intervention and for this form of test|
48712512|NCT04224272|102081821|FG000|NOT COMPLETED|Part 1 - Dose Finding||7||
48712513|NCT04224272|102081821|FG000|STARTED|Part 2 - Dose Expansion||43||
48712514|NCT04224272|102081821|FG000|COMPLETED|Part 2 - Dose Expansion||30||
48712515|NCT04224272|102081821|FG000|NOT COMPLETED|Part 2 - Dose Expansion||13||
48712516|NCT00541099|102081822|FG000|STARTED|Overall Study||11||
48712517|NCT00541099|102081822|FG000|COMPLETED|Overall Study||8||
48712518|NCT00541099|102081822|FG000|NOT COMPLETED|Overall Study||3||
48712519|NCT01300819|102084754|FG000|STARTED|Overall Study||125||
48712520|NCT01300819|102084755|FG001|STARTED|Overall Study||224||
48712521|NCT01300819|102084754|FG000|COMPLETED|Overall Study||103||
48712522|NCT01300819|102084755|FG001|COMPLETED|Overall Study||180||
48404755|NCT00246376|101321924|FG000|COMPLETED|Overall Study||26||
48404756|NCT00246376|101321925|FG001|COMPLETED|Overall Study||24||
48404757|NCT00246376|101321926|FG002|COMPLETED|Overall Study||29||
48404758|NCT00246376|101321927|FG003|COMPLETED|Overall Study||21||
48404759|NCT00246376|101321928|FG004|COMPLETED|Overall Study||28||
48404760|NCT00246376|101321924|FG000|NOT COMPLETED|Overall Study||15||
48404761|NCT00246376|101321925|FG001|NOT COMPLETED|Overall Study||19||
48404762|NCT00246376|101321926|FG002|NOT COMPLETED|Overall Study||16||
48596541|NCT03781583|101792927|FG003|STARTED|Overall Study||1|started means first participation was with this intervention and for this form of test|
48596542|NCT03781583|101792924|FG000|Participated and Completed Indoor Doorfinding Test|Overall Study||1||
48596543|NCT03781583|101792925|FG001|Participated and Completed Indoor Doorfinding Test|Overall Study||3||
48596544|NCT03781583|101792926|FG002|Participated and Completed Indoor Doorfinding Test|Overall Study||0||
48596545|NCT03781583|101792927|FG003|Participated and Completed Indoor Doorfinding Test|Overall Study||0||
48596546|NCT03781583|101792924|FG000|RGBD & Jetson Test|Overall Study||0||
48596547|NCT03781583|101792925|FG001|RGBD & Jetson Test|Overall Study||2||
48596548|NCT03781583|101792926|FG002|RGBD & Jetson Test|Overall Study||8||
48596549|NCT03781583|101792927|FG003|RGBD & Jetson Test|Overall Study||0||
48596550|NCT03781583|101792924|FG000|RGBD Outdoor Crosswalk Test|Overall Study||0||
48596551|NCT03781583|101792925|FG001|RGBD Outdoor Crosswalk Test|Overall Study||1||
48596552|NCT03781583|101792926|FG002|RGBD Outdoor Crosswalk Test|Overall Study||1||
48596553|NCT03781583|101792927|FG003|RGBD Outdoor Crosswalk Test|Overall Study||1||
48596554|NCT03781583|101792924|FG000|COMPLETED|Overall Study||2|This row shows those who began in that arm and completed its test, but for any specific test other than the first (pre-pandemic crosswalk), the number of people who completed that test can be read by adding across the row of the milestone.|
48596555|NCT03781583|101792925|FG001|COMPLETED|Overall Study||3|This row shows those who began in that arm and completed its test, but for any specific test other than the first (pre-pandemic crosswalk), the number of people who completed that test can be read by adding across the row of the milestone.|
48596556|NCT03781583|101792926|FG002|COMPLETED|Overall Study||8|This row shows those who began in that arm and completed its test, but for any specific test other than the first (pre-pandemic crosswalk), the number of people who completed that test can be read by adding across the row of the milestone.|
48656871|NCT01708941|101943724|FG003|STARTED|Overall Study||22||
48712523|NCT01300819|102084754|FG000|NOT COMPLETED|Overall Study||22||
48712524|NCT01300819|102084755|FG001|NOT COMPLETED|Overall Study||44||
48712525|NCT00579995|102084756|FG000|STARTED|Overall Study||18||
48712526|NCT00579995|102084757|FG001|STARTED|Overall Study||23||
48712527|NCT00579995|102084756|FG000|COMPLETED|Overall Study||18||
48404763|NCT00246376|101321927|FG003|NOT COMPLETED|Overall Study||26||
48404764|NCT00246376|101321928|FG004|NOT COMPLETED|Overall Study||17||
48404765|NCT00666536|101321929|FG000|STARTED|Overall Study||369||
48404766|NCT00666536|101321930|FG001|STARTED|Overall Study||359||
48404767|NCT00666536|101321929|FG000|COMPLETED|Overall Study||336||
48404768|NCT00666536|101321930|FG001|COMPLETED|Overall Study||322||
48404769|NCT00666536|101321929|FG000|NOT COMPLETED|Overall Study||33||
48404770|NCT00666536|101321930|FG001|NOT COMPLETED|Overall Study||37||
48404771|NCT02260388|101321931|FG000|STARTED|Overall Study||134||
48404772|NCT02260388|101321932|FG001|STARTED|Overall Study||126||
48404773|NCT02260388|101321933|FG002|STARTED|Overall Study||73||
48596557|NCT03781583|101792927|FG003|COMPLETED|Overall Study||1|This row shows those who began in that arm and completed its test, but for any specific test other than the first (pre-pandemic crosswalk), the number of people who completed that test can be read by adding across the row of the milestone.|
48404774|NCT02260388|101321934|FG003|STARTED|Overall Study||69||
48404775|NCT02260388|101321931|FG000|COMPLETED|Overall Study||132||
48404776|NCT02260388|101321932|FG001|COMPLETED|Overall Study||118||
48404777|NCT02260388|101321933|FG002|COMPLETED|Overall Study||70||
48404778|NCT02260388|101321934|FG003|COMPLETED|Overall Study||65||
48404779|NCT02260388|101321931|FG000|NOT COMPLETED|Overall Study||2||
48404780|NCT02260388|101321932|FG001|NOT COMPLETED|Overall Study||8||
48404781|NCT02260388|101321933|FG002|NOT COMPLETED|Overall Study||3||
48404782|NCT02260388|101321934|FG003|NOT COMPLETED|Overall Study||4||
48404783|NCT02650440|101321935|FG000|STARTED|Overall Study||10||
48404784|NCT02650440|101321936|FG001|STARTED|Overall Study||10||
48404785|NCT02650440|101321935|FG000|COMPLETED|Overall Study||10||
48404786|NCT02650440|101321936|FG001|COMPLETED|Overall Study||8||
48404787|NCT02650440|101321935|FG000|NOT COMPLETED|Overall Study||0||
48404788|NCT02650440|101321936|FG001|NOT COMPLETED|Overall Study||2||
48404789|NCT00333970|101321937|FG000|STARTED|Overall Study||50||
48404790|NCT00333970|101321938|FG001|STARTED|Overall Study||25||
48404791|NCT00333970|101321937|FG000|COMPLETED|Overall Study||37||
48404792|NCT00333970|101321938|FG001|COMPLETED|Overall Study||18||
48404793|NCT00333970|101321937|FG000|NOT COMPLETED|Overall Study||13||
48404794|NCT00333970|101321938|FG001|NOT COMPLETED|Overall Study||7||
48404795|NCT00815776|101321939|FG000|STARTED|Overall Study||60||
48404796|NCT00815776|101321940|FG001|STARTED|Overall Study||64||
48596558|NCT03781583|101792924|FG000|NOT COMPLETED|Overall Study||2||
48404797|NCT00815776|101321941|FG002|STARTED|Overall Study||28||
48404798|NCT00815776|101321939|FG000|COMPLETED|Overall Study||52||
48404799|NCT00815776|101321940|FG001|COMPLETED|Overall Study||56||
48404800|NCT00815776|101321941|FG002|COMPLETED|Overall Study||22||
48404801|NCT00815776|101321939|FG000|NOT COMPLETED|Overall Study||8||
48404802|NCT00815776|101321940|FG001|NOT COMPLETED|Overall Study||8||
48404803|NCT00815776|101321941|FG002|NOT COMPLETED|Overall Study||6||
48404804|NCT02225925|101321942|FG000|STARTED|Overall Study||45||
48404805|NCT02225925|101321942|FG000|COMPLETED|Overall Study||45||
48404806|NCT02225925|101321942|FG000|NOT COMPLETED|Overall Study||0||
48404807|NCT04922710|101321943|FG000|STARTED|Overall Study||5||
48404808|NCT04922710|101321943|FG000|COMPLETED|Overall Study||4||
48404809|NCT04922710|101321943|FG000|NOT COMPLETED|Overall Study||1||
48404810|NCT01300767|101321944|FG000|STARTED|Overall Study||74||
48404811|NCT01300767|101321944|FG000|COMPLETED|Overall Study||70||
48404812|NCT01300767|101321944|FG000|NOT COMPLETED|Overall Study||4||
48404813|NCT00054756|101321945|FG000|STARTED|Overall Study||96||
48404814|NCT00054756|101321945|FG000|COMPLETED|Overall Study||94||
48404815|NCT00054756|101321945|FG000|NOT COMPLETED|Overall Study||2||
48596559|NCT03781583|101792925|FG001|NOT COMPLETED|Overall Study||2||
48596560|NCT03781583|101792926|FG002|NOT COMPLETED|Overall Study||0||
48596561|NCT03781583|101792927|FG003|NOT COMPLETED|Overall Study||0||
48596562|NCT00939471|101792928|FG000|STARTED|Overall Study||44||
48596563|NCT00939471|101792928|FG000|COMPLETED|Overall Study||33||
48596564|NCT00939471|101792928|FG000|NOT COMPLETED|Overall Study||11||
48596565|NCT02014051|101792929|FG000|STARTED|Overall Study||3||
48596566|NCT02014051|101792930|FG001|STARTED|Overall Study||6||
48596567|NCT02014051|101792929|FG000|COMPLETED|Overall Study||2||
48596568|NCT02014051|101792930|FG001|COMPLETED|Overall Study||5||
48596569|NCT02014051|101792929|FG000|NOT COMPLETED|Overall Study||1||
48596570|NCT02014051|101792930|FG001|NOT COMPLETED|Overall Study||1||
48596571|NCT03114657|101792931|FG000|STARTED|Overall Study||399||
48596572|NCT03114657|101792932|FG001|STARTED|Overall Study||407||
48596573|NCT03114657|101792931|FG000|COMPLETED|Overall Study||0||
48596574|NCT03114657|101792932|FG001|COMPLETED|Overall Study||0||
48596575|NCT03114657|101792931|FG000|NOT COMPLETED|Overall Study||399||
48596576|NCT03114657|101792932|FG001|NOT COMPLETED|Overall Study||407||
48596577|NCT00630747|101792933|FG000|STARTED|Overall Study||94||
48404816|NCT02708966|101321946|FG000|STARTED|Overall Study||15||
48404817|NCT02708966|101321947|FG001|STARTED|Overall Study||15||
48404818|NCT02708966|101321946|FG000|COMPLETED|Overall Study||13||
48404819|NCT02708966|101321947|FG001|COMPLETED|Overall Study||13||
48404820|NCT02708966|101321946|FG000|NOT COMPLETED|Overall Study||2||
48404821|NCT02708966|101321947|FG001|NOT COMPLETED|Overall Study||2||
48404822|NCT00946023|101321948|FG000|STARTED|Overall Study||83||
48404823|NCT00946023|101321948|FG000|COMPLETED|Overall Study||83||
48404824|NCT00946023|101321948|FG000|NOT COMPLETED|Overall Study||0||
48404825|NCT01249157|101321949|FG000|STARTED|Overall Study||1||
48404826|NCT01249157|101321949|FG000|COMPLETED|Overall Study||0||
48404827|NCT01249157|101321949|FG000|NOT COMPLETED|Overall Study||1||
48404828|NCT01922739|101321950|FG000|STARTED|Titration/Adjustment Period||182||
48404829|NCT01922739|101321950|FG000|Safety Analysis Set|Titration/Adjustment Period||182||
48404830|NCT01922739|101321950|FG000|COMPLETED|Titration/Adjustment Period||170||
48404831|NCT01922739|101321950|FG000|NOT COMPLETED|Titration/Adjustment Period||12||
48404832|NCT01922739|101321950|FG000|STARTED|Open-label Treatment Period||170||
48404833|NCT01922739|101321950|FG000|Treatment SAS and FAS|Open-label Treatment Period||170||
48404834|NCT01922739|101321950|FG000|COMPLETED|Open-label Treatment Period||136||
48404835|NCT01922739|101321950|FG000|NOT COMPLETED|Open-label Treatment Period||34||
48404836|NCT01929018|101321951|FG000|STARTED|Overall Study||19||
48404837|NCT01929018|101321952|FG001|STARTED|Overall Study||19||
48404838|NCT01929018|101321951|FG000|COMPLETED|Overall Study||18||
48404839|NCT01929018|101321952|FG001|COMPLETED|Overall Study||18||
48404840|NCT01929018|101321951|FG000|NOT COMPLETED|Overall Study||1||
48404841|NCT01929018|101321952|FG001|NOT COMPLETED|Overall Study||1||
48404842|NCT01895634|101321953|FG000|STARTED|Overall Study||49||
48404843|NCT01895634|101321953|FG000|COMPLETED|Overall Study||46||
48404844|NCT01895634|101321953|FG000|NOT COMPLETED|Overall Study||3||
48404845|NCT01405027|101321954|FG000|STARTED|Overall Study||84||
48404846|NCT01405027|101321955|FG001|STARTED|Overall Study||113||
48404847|NCT01405027|101321954|FG000|COMPLETED|Overall Study||52||
48404848|NCT01405027|101321955|FG001|COMPLETED|Overall Study||62||
48404849|NCT01405027|101321954|FG000|NOT COMPLETED|Overall Study||32||
48404850|NCT01405027|101321955|FG001|NOT COMPLETED|Overall Study||51||
48404851|NCT01224106|101321956|FG000|STARTED|Double-Blind Treatment Phase||266||
48404852|NCT01224106|101321957|FG001|STARTED|Double-Blind Treatment Phase||271||
48404853|NCT01224106|101321958|FG002|STARTED|Double-Blind Treatment Phase||260||
48404854|NCT01224106|101321959|FG003|STARTED|Double-Blind Treatment Phase||0||
48404855|NCT01224106|101321960|FG004|STARTED|Double-Blind Treatment Phase||0||
48404856|NCT01224106|101321956|FG000|COMPLETED|Double-Blind Treatment Phase||187||
48404857|NCT01224106|101321957|FG001|COMPLETED|Double-Blind Treatment Phase||185||
48404858|NCT01224106|101321958|FG002|COMPLETED|Double-Blind Treatment Phase||180||
48404859|NCT01224106|101321959|FG003|COMPLETED|Double-Blind Treatment Phase||0||
48404860|NCT01224106|101321960|FG004|COMPLETED|Double-Blind Treatment Phase||0||
48404861|NCT01224106|101321956|FG000|NOT COMPLETED|Double-Blind Treatment Phase||79||
48404862|NCT01224106|101321957|FG001|NOT COMPLETED|Double-Blind Treatment Phase||86||
48404863|NCT01224106|101321958|FG002|NOT COMPLETED|Double-Blind Treatment Phase||80||
48404864|NCT01224106|101321959|FG003|NOT COMPLETED|Double-Blind Treatment Phase||0||
48404865|NCT01224106|101321960|FG004|NOT COMPLETED|Double-Blind Treatment Phase||0||
48404866|NCT01224106|101321956|FG000|STARTED|Open-Label Extension (OLE) Phase||0||
48404867|NCT01224106|101321957|FG001|STARTED|Open-Label Extension (OLE) Phase||0||
48404868|NCT01224106|101321958|FG002|STARTED|Open-Label Extension (OLE) Phase||0||
48404869|NCT01224106|101321959|FG003|STARTED|Open-Label Extension (OLE) Phase||49||
48404870|NCT01224106|101321960|FG004|STARTED|Open-Label Extension (OLE) Phase||105||
48404871|NCT01224106|101321956|FG000|COMPLETED|Open-Label Extension (OLE) Phase||0||
48404872|NCT01224106|101321957|FG001|COMPLETED|Open-Label Extension (OLE) Phase||0||
48404873|NCT01224106|101321958|FG002|COMPLETED|Open-Label Extension (OLE) Phase||0||
48404874|NCT01224106|101321959|FG003|COMPLETED|Open-Label Extension (OLE) Phase||33||
48295999|NCT01143038|101054161|FG000|NOT COMPLETED|Overall Study||16||
48296000|NCT01272804|101054162|FG000|STARTED|Overall Study||9||
48296001|NCT01272804|101054163|FG001|STARTED|Overall Study||9||
48296002|NCT01272804|101054164|FG002|STARTED|Overall Study||9||
48596578|NCT00630747|101792933|FG000|Participants Treated in Phase I of Study|Overall Study||94||
48596579|NCT00630747|101792933|FG000|COMPLETED|Overall Study||85||
48596580|NCT00630747|101792933|FG000|NOT COMPLETED|Overall Study||9||
48596581|NCT00662558|101792934|FG000|STARTED|Overall Study||398||
48596582|NCT00662558|101792935|FG001|STARTED|Overall Study||404||
48596583|NCT00662558|101792934|FG000|Received Treatment|Overall Study||396||
48596584|NCT00662558|101792935|FG001|Received Treatment|Overall Study||396||
48296003|NCT01272804|101054165|FG003|STARTED|Overall Study||9||
48296004|NCT01272804|101054166|FG004|STARTED|Overall Study||9||
48296005|NCT01272804|101054167|FG005|STARTED|Overall Study||16||
48296006|NCT01272804|101054162|FG000|COMPLETED|Overall Study||8||
48296007|NCT01272804|101054163|FG001|COMPLETED|Overall Study||9||
48296008|NCT01272804|101054164|FG002|COMPLETED|Overall Study||9||
48296009|NCT01272804|101054165|FG003|COMPLETED|Overall Study||9||
48296010|NCT01272804|101054166|FG004|COMPLETED|Overall Study||7||
48296011|NCT01272804|101054167|FG005|COMPLETED|Overall Study||15||
48296012|NCT01272804|101054162|FG000|NOT COMPLETED|Overall Study||1||
48296013|NCT01272804|101054163|FG001|NOT COMPLETED|Overall Study||0||
48296014|NCT01272804|101054164|FG002|NOT COMPLETED|Overall Study||0||
48296015|NCT01272804|101054165|FG003|NOT COMPLETED|Overall Study||0||
48404875|NCT01224106|101321960|FG004|COMPLETED|Open-Label Extension (OLE) Phase||71||
48596585|NCT00662558|101792934|FG000|COMPLETED|Overall Study||342||
48596586|NCT00662558|101792935|FG001|COMPLETED|Overall Study||294||
48596587|NCT00662558|101792934|FG000|NOT COMPLETED|Overall Study||56||
48596588|NCT00662558|101792935|FG001|NOT COMPLETED|Overall Study||110||
48596589|NCT00100841|101792936|FG000|STARTED|Overall Study||66||
48596590|NCT00100841|101792936|FG000|COMPLETED|Overall Study||66||
48596591|NCT00100841|101792936|FG000|NOT COMPLETED|Overall Study||0||
48296016|NCT01272804|101054166|FG004|NOT COMPLETED|Overall Study||2||
48404876|NCT01224106|101321956|FG000|NOT COMPLETED|Open-Label Extension (OLE) Phase||0||
48404877|NCT01224106|101321957|FG001|NOT COMPLETED|Open-Label Extension (OLE) Phase||0||
48404878|NCT01224106|101321958|FG002|NOT COMPLETED|Open-Label Extension (OLE) Phase||0||
48596592|NCT01259375|101792937|FG000|STARTED|Overall Study||24||
48596593|NCT01259375|101792937|FG000|COMPLETED|Overall Study||23||
48296017|NCT01272804|101054167|FG005|NOT COMPLETED|Overall Study||1||
48296018|NCT00298090|101054168|FG000|STARTED|Overall Study||47||
48596594|NCT01259375|101792937|FG000|NOT COMPLETED|Overall Study||1||
48596595|NCT01969084|101792938|FG000|STARTED|Overall Study||19||
48596596|NCT01969084|101792939|FG001|STARTED|Overall Study||22||
48596597|NCT01969084|101792938|FG000|COMPLETED|Overall Study||19||
48596598|NCT01969084|101792939|FG001|COMPLETED|Overall Study||21||
48596599|NCT01969084|101792938|FG000|NOT COMPLETED|Overall Study||0||
48596600|NCT01969084|101792939|FG001|NOT COMPLETED|Overall Study||1||
48596601|NCT01420016|101792940|FG000|STARTED|Primary Analysis||6970||
48596602|NCT01420016|101792941|FG001|STARTED|Primary Analysis||6411||
48596603|NCT01420016|101792942|FG002|STARTED|Primary Analysis||0||
48596604|NCT01420016|101792943|FG003|STARTED|Primary Analysis||0||
48596605|NCT01420016|101792940|FG000|COMPLETED|Primary Analysis||4043||
48596606|NCT01420016|101792941|FG001|COMPLETED|Primary Analysis||3871||
48596607|NCT01420016|101792942|FG002|COMPLETED|Primary Analysis||0||
48596608|NCT01420016|101792943|FG003|COMPLETED|Primary Analysis||0||
48596609|NCT01420016|101792940|FG000|NOT COMPLETED|Primary Analysis||2927||
48596610|NCT01420016|101792941|FG001|NOT COMPLETED|Primary Analysis||2540||
48596611|NCT01420016|101792942|FG002|NOT COMPLETED|Primary Analysis||0||
48596612|NCT01420016|101792943|FG003|NOT COMPLETED|Primary Analysis||0||
48596613|NCT01420016|101792940|FG000|STARTED|Safety Analysis||0||
48596614|NCT01420016|101792941|FG001|STARTED|Safety Analysis||0||
48596615|NCT01420016|101792942|FG002|STARTED|Safety Analysis||6392||
48596616|NCT01420016|101792943|FG003|STARTED|Safety Analysis||5159||
48596617|NCT01420016|101792940|FG000|COMPLETED|Safety Analysis||0||
48596618|NCT01420016|101792941|FG001|COMPLETED|Safety Analysis||0||
48596619|NCT01420016|101792942|FG002|COMPLETED|Safety Analysis||6392||
48596620|NCT01420016|101792943|FG003|COMPLETED|Safety Analysis||5159||
48596621|NCT01420016|101792940|FG000|NOT COMPLETED|Safety Analysis||0||
48596622|NCT01420016|101792941|FG001|NOT COMPLETED|Safety Analysis||0||
48596623|NCT01420016|101792942|FG002|NOT COMPLETED|Safety Analysis||0||
48596624|NCT01420016|101792943|FG003|NOT COMPLETED|Safety Analysis||0||
48596625|NCT02732327|101792944|FG000|STARTED|Overall Study||0||
48596626|NCT02732327|101792945|FG001|STARTED|Overall Study||2||
48596627|NCT02732327|101792944|FG000|COMPLETED|Overall Study||0||
48596628|NCT02732327|101792945|FG001|COMPLETED|Overall Study||1||
48596629|NCT02732327|101792944|FG000|NOT COMPLETED|Overall Study||0||
48596630|NCT02732327|101792945|FG001|NOT COMPLETED|Overall Study||1||
48596631|NCT01573325|101792946|FG000|STARTED|Overall Study||50||
48596632|NCT01573325|101792946|FG000|COMPLETED|Overall Study||50||
48596633|NCT01573325|101792946|FG000|NOT COMPLETED|Overall Study||0||
48596634|NCT05027048|101792947|FG000|STARTED|Overall Study||60||
48596635|NCT05027048|101792948|FG001|STARTED|Overall Study||60||
48596636|NCT05027048|101792947|FG000|COMPLETED|Overall Study||60||
48596637|NCT05027048|101792948|FG001|COMPLETED|Overall Study||60||
48596638|NCT05027048|101792947|FG000|NOT COMPLETED|Overall Study||0||
48596639|NCT05027048|101792948|FG001|NOT COMPLETED|Overall Study||0||
48596640|NCT02978885|101792949|FG000|STARTED|Overall Study||0||
48596641|NCT02978885|101792950|FG001|STARTED|Overall Study||1||
48596642|NCT02978885|101792949|FG000|COMPLETED|Overall Study||0||
48596643|NCT02978885|101792950|FG001|COMPLETED|Overall Study||1||
48596644|NCT02978885|101792949|FG000|NOT COMPLETED|Overall Study||0||
48596645|NCT02978885|101792950|FG001|NOT COMPLETED|Overall Study||0||
48596646|NCT01523704|101792951|FG000|STARTED|Overall Study||636||
48596647|NCT01523704|101792952|FG001|STARTED|Overall Study||638||
48596648|NCT01523704|101792951|FG000|COMPLETED|Overall Study||558||
48596649|NCT01523704|101792952|FG001|COMPLETED|Overall Study||550||
48596650|NCT01523704|101792951|FG000|NOT COMPLETED|Overall Study||78||
48596651|NCT01523704|101792952|FG001|NOT COMPLETED|Overall Study||88||
48596652|NCT03878875|101792953|FG000|STARTED|Overall Study||16||
48596653|NCT03878875|101792954|FG001|STARTED|Overall Study||16||
48596654|NCT03878875|101792953|FG000|COMPLETED|Overall Study||16||
48596655|NCT03878875|101792954|FG001|COMPLETED|Overall Study||16||
48596656|NCT03878875|101792953|FG000|NOT COMPLETED|Overall Study||0||
48596657|NCT03878875|101792954|FG001|NOT COMPLETED|Overall Study||0||
48596658|NCT01973335|101792955|FG000|STARTED|Overall Study||9||
48596659|NCT01973335|101792956|FG001|STARTED|Overall Study||7||
48596660|NCT01973335|101792957|FG002|STARTED|Overall Study||9||
48596661|NCT01973335|101792958|FG003|STARTED|Overall Study||9||
48596662|NCT01973335|101792955|FG000|COMPLETED|Overall Study||9||
48596663|NCT01973335|101792956|FG001|COMPLETED|Overall Study||7||
48596664|NCT01973335|101792957|FG002|COMPLETED|Overall Study||9||
48596665|NCT01973335|101792958|FG003|COMPLETED|Overall Study||9||
48596666|NCT01973335|101792955|FG000|NOT COMPLETED|Overall Study||0||
48596667|NCT01973335|101792956|FG001|NOT COMPLETED|Overall Study||0||
48596668|NCT01973335|101792957|FG002|NOT COMPLETED|Overall Study||0||
48596669|NCT01973335|101792958|FG003|NOT COMPLETED|Overall Study||0||
48596670|NCT03434249|101792959|FG000|STARTED|Overall Study||40||
48596671|NCT03434249|101792960|FG001|STARTED|Overall Study||40||
48596672|NCT03434249|101792959|FG000|COMPLETED|Overall Study||35||
48596673|NCT03434249|101792960|FG001|COMPLETED|Overall Study||37||
48596674|NCT03434249|101792959|FG000|NOT COMPLETED|Overall Study||5||
48596675|NCT03434249|101792960|FG001|NOT COMPLETED|Overall Study||3||
48596676|NCT03053427|101792961|FG000|STARTED|Overall Study||186||
48596677|NCT03053427|101792962|FG001|STARTED|Overall Study||189||
48596678|NCT03053427|101792961|FG000|COMPLETED|Overall Study||173||
48596679|NCT03053427|101792962|FG001|COMPLETED|Overall Study||173||
48596680|NCT03053427|101792961|FG000|NOT COMPLETED|Overall Study||13||
48596681|NCT03053427|101792962|FG001|NOT COMPLETED|Overall Study||16||
48596682|NCT02073656|101792963|FG000|STARTED|Primary Study||335||
48596683|NCT02073656|101792963|FG000|COMPLETED|Primary Study||327||
48596684|NCT02073656|101792963|FG000|NOT COMPLETED|Primary Study||8||
48596685|NCT02073656|101792963|FG000|STARTED|Retreatment Substudy||9||
48596686|NCT02073656|101792963|FG000|COMPLETED|Retreatment Substudy||9||
48596687|NCT02073656|101792963|FG000|NOT COMPLETED|Retreatment Substudy||0||
48596688|NCT01554176|101792964|FG000|STARTED|Treatment Phase||65||
48596689|NCT01554176|101792965|FG001|STARTED|Treatment Phase||64||
48596690|NCT01554176|101792966|FG002|STARTED|Treatment Phase||0||
48596691|NCT01554176|101792967|FG003|STARTED|Treatment Phase||0||
48596692|NCT01554176|101792968|FG004|STARTED|Treatment Phase||0||
48596693|NCT01554176|101792964|FG000|Treated|Treatment Phase||64||
48596694|NCT01554176|101792965|FG001|Treated|Treatment Phase||64||
48596695|NCT01554176|101792966|FG002|Treated|Treatment Phase||0||
48596696|NCT01554176|101792967|FG003|Treated|Treatment Phase||0||
48596697|NCT01554176|101792968|FG004|Treated|Treatment Phase||0||
48596698|NCT01554176|101792964|FG000|COMPLETED|Treatment Phase||57||
48596699|NCT01554176|101792965|FG001|COMPLETED|Treatment Phase||59||
48596700|NCT01554176|101792966|FG002|COMPLETED|Treatment Phase||0||
48596701|NCT01554176|101792967|FG003|COMPLETED|Treatment Phase||0||
48596702|NCT01554176|101792968|FG004|COMPLETED|Treatment Phase||0||
48596703|NCT01554176|101792964|FG000|NOT COMPLETED|Treatment Phase||8||
48596704|NCT01554176|101792965|FG001|NOT COMPLETED|Treatment Phase||5||
48596705|NCT01554176|101792966|FG002|NOT COMPLETED|Treatment Phase||0||
48596706|NCT01554176|101792967|FG003|NOT COMPLETED|Treatment Phase||0||
48596707|NCT01554176|101792968|FG004|NOT COMPLETED|Treatment Phase||0||
48596708|NCT01554176|101792964|FG000|STARTED|Run-out Phase||0||
48596709|NCT01554176|101792965|FG001|STARTED|Run-out Phase||0||
48596710|NCT01554176|101792966|FG002|STARTED|Run-out Phase||29||
48596711|NCT01554176|101792967|FG003|STARTED|Run-out Phase||28||
48596712|NCT01554176|101792968|FG004|STARTED|Run-out Phase||59||
48596713|NCT01554176|101792964|FG000|Treated|Run-out Phase||0||
48596714|NCT01554176|101792965|FG001|Treated|Run-out Phase||0||
48596715|NCT01554176|101792966|FG002|Treated|Run-out Phase||29||
48596716|NCT01554176|101792967|FG003|Treated|Run-out Phase||28||
48596717|NCT01554176|101792968|FG004|Treated|Run-out Phase||59||
48596718|NCT01554176|101792964|FG000|COMPLETED|Run-out Phase||0||
48596719|NCT01554176|101792965|FG001|COMPLETED|Run-out Phase||0||
48596720|NCT01554176|101792966|FG002|COMPLETED|Run-out Phase||29||
48596721|NCT01554176|101792967|FG003|COMPLETED|Run-out Phase||27||
48596722|NCT01554176|101792968|FG004|COMPLETED|Run-out Phase||59||
48596723|NCT01554176|101792964|FG000|NOT COMPLETED|Run-out Phase||0||
48596724|NCT01554176|101792965|FG001|NOT COMPLETED|Run-out Phase||0||
48596725|NCT01554176|101792966|FG002|NOT COMPLETED|Run-out Phase||0||
48596726|NCT01554176|101792967|FG003|NOT COMPLETED|Run-out Phase||1||
48596727|NCT01554176|101792968|FG004|NOT COMPLETED|Run-out Phase||0||
48596728|NCT05385224|101792969|FG000|STARTED|Overall Study||131||
48596729|NCT05385224|101792969|FG000|Modified Intent-to-Treat (Effectiveness Population)|Overall Study||124||
48596730|NCT05385224|101792969|FG000|Safety Population|Overall Study||126||
48596731|NCT05385224|101792969|FG000|COMPLETED|Overall Study||126||
48596732|NCT05385224|101792969|FG000|NOT COMPLETED|Overall Study||5||
48596733|NCT00087126|101792970|FG000|STARTED|Overall Study||27||
48596734|NCT00087126|101792970|FG000|COMPLETED|Overall Study||25|Eligible and treated patients|
48596735|NCT00087126|101792970|FG000|NOT COMPLETED|Overall Study||2||
48596736|NCT03078127|101792971|FG000|STARTED|First Intervention||4||
48596737|NCT03078127|101792972|FG001|STARTED|First Intervention||3||
48596738|NCT03078127|101792973|FG002|STARTED|First Intervention||3||
48596739|NCT03078127|101792971|FG000|COMPLETED|First Intervention||4||
48596740|NCT03078127|101792972|FG001|COMPLETED|First Intervention||3||
48596741|NCT03078127|101792973|FG002|COMPLETED|First Intervention||3||
48596742|NCT03078127|101792971|FG000|NOT COMPLETED|First Intervention||0||
48596743|NCT03078127|101792972|FG001|NOT COMPLETED|First Intervention||0||
48596744|NCT03078127|101792973|FG002|NOT COMPLETED|First Intervention||0||
48596745|NCT03078127|101792971|FG000|STARTED|Washout (3-21 Days)||4||
48596746|NCT03078127|101792972|FG001|STARTED|Washout (3-21 Days)||3||
48596747|NCT03078127|101792973|FG002|STARTED|Washout (3-21 Days)||3||
48596748|NCT03078127|101792971|FG000|COMPLETED|Washout (3-21 Days)||4||
48596749|NCT03078127|101792972|FG001|COMPLETED|Washout (3-21 Days)||3||
48596750|NCT03078127|101792973|FG002|COMPLETED|Washout (3-21 Days)||3||
48596751|NCT03078127|101792971|FG000|NOT COMPLETED|Washout (3-21 Days)||0||
48596752|NCT03078127|101792972|FG001|NOT COMPLETED|Washout (3-21 Days)||0||
48596753|NCT03078127|101792973|FG002|NOT COMPLETED|Washout (3-21 Days)||0||
48596754|NCT03078127|101792971|FG000|STARTED|Second Intervention||4||
48596755|NCT03078127|101792972|FG001|STARTED|Second Intervention||3||
48596756|NCT03078127|101792973|FG002|STARTED|Second Intervention||3||
48596757|NCT03078127|101792971|FG000|COMPLETED|Second Intervention||4||
48596758|NCT03078127|101792972|FG001|COMPLETED|Second Intervention||3||
48596759|NCT03078127|101792973|FG002|COMPLETED|Second Intervention||3||
48596760|NCT03078127|101792971|FG000|NOT COMPLETED|Second Intervention||0||
48596761|NCT03078127|101792972|FG001|NOT COMPLETED|Second Intervention||0||
48596762|NCT03078127|101792973|FG002|NOT COMPLETED|Second Intervention||0||
48596763|NCT03078127|101792971|FG000|STARTED|Washout (3-21 Days)||4||
48596764|NCT03078127|101792972|FG001|STARTED|Washout (3-21 Days)||3||
48596765|NCT03078127|101792973|FG002|STARTED|Washout (3-21 Days)||3||
48596766|NCT03078127|101792971|FG000|COMPLETED|Washout (3-21 Days)||4||
48596767|NCT03078127|101792972|FG001|COMPLETED|Washout (3-21 Days)||3||
48596768|NCT03078127|101792973|FG002|COMPLETED|Washout (3-21 Days)||3||
48596769|NCT03078127|101792971|FG000|NOT COMPLETED|Washout (3-21 Days)||0||
48596770|NCT03078127|101792972|FG001|NOT COMPLETED|Washout (3-21 Days)||0||
48596771|NCT03078127|101792973|FG002|NOT COMPLETED|Washout (3-21 Days)||0||
48596772|NCT03078127|101792971|FG000|STARTED|Third Intervention||4||
48596773|NCT03078127|101792972|FG001|STARTED|Third Intervention||3||
48596774|NCT03078127|101792973|FG002|STARTED|Third Intervention||3||
48596775|NCT03078127|101792971|FG000|COMPLETED|Third Intervention||4||
48596776|NCT03078127|101792972|FG001|COMPLETED|Third Intervention||3||
48596777|NCT03078127|101792973|FG002|COMPLETED|Third Intervention||3||
48596778|NCT03078127|101792971|FG000|NOT COMPLETED|Third Intervention||0||
48596779|NCT03078127|101792972|FG001|NOT COMPLETED|Third Intervention||0||
48596780|NCT03078127|101792973|FG002|NOT COMPLETED|Third Intervention||0||
48596781|NCT05765253|101792974|FG000|STARTED|Overall Study||2||
48596782|NCT05765253|101792975|FG001|STARTED|Overall Study||1||
48596783|NCT05765253|101792974|FG000|COMPLETED|Overall Study||2||
48596784|NCT05765253|101792975|FG001|COMPLETED|Overall Study||1||
48596785|NCT05765253|101792974|FG000|NOT COMPLETED|Overall Study||0||
48596786|NCT05765253|101792975|FG001|NOT COMPLETED|Overall Study||0||
48596787|NCT01546038|101792976|FG000|STARTED|Overall Study||17||
48596788|NCT01546038|101792977|FG001|STARTED|Overall Study||6||
48596789|NCT01546038|101792978|FG002|STARTED|Overall Study||4||
48596790|NCT01546038|101792979|FG003|STARTED|Overall Study||3||
48596791|NCT01546038|101792980|FG004|STARTED|Overall Study||16||
48596792|NCT01546038|101792981|FG005|STARTED|Overall Study||6||
48596793|NCT01546038|101792982|FG006|STARTED|Overall Study||71||
48596794|NCT01546038|101792983|FG007|STARTED|Overall Study||88||
48596795|NCT01546038|101792984|FG008|STARTED|Overall Study||44||
48596796|NCT01546038|101792976|FG000|Received Treatment|Overall Study||17||
48596797|NCT01546038|101792977|FG001|Received Treatment|Overall Study||6||
48596798|NCT01546038|101792978|FG002|Received Treatment|Overall Study||4||
48596799|NCT01546038|101792979|FG003|Received Treatment|Overall Study||3||
48596800|NCT01546038|101792980|FG004|Received Treatment|Overall Study||16||
48596801|NCT01546038|101792981|FG005|Received Treatment|Overall Study||6||
48596802|NCT01546038|101792982|FG006|Received Treatment|Overall Study||69||
48596803|NCT01546038|101792983|FG007|Received Treatment|Overall Study||84||
48596804|NCT01546038|101792984|FG008|Received Treatment|Overall Study||41||
48596805|NCT01546038|101792976|FG000|COMPLETED|Overall Study||1||
48596806|NCT01546038|101792977|FG001|COMPLETED|Overall Study||0||
48596807|NCT01546038|101792978|FG002|COMPLETED|Overall Study||0||
48596808|NCT01546038|101792979|FG003|COMPLETED|Overall Study||0||
48596809|NCT01546038|101792980|FG004|COMPLETED|Overall Study||6||
48596810|NCT01546038|101792981|FG005|COMPLETED|Overall Study||2||
48596811|NCT01546038|101792982|FG006|COMPLETED|Overall Study||18||
48596812|NCT01546038|101792983|FG007|COMPLETED|Overall Study||4||
48596813|NCT01546038|101792984|FG008|COMPLETED|Overall Study||1||
48596814|NCT01546038|101792976|FG000|NOT COMPLETED|Overall Study||16||
48596815|NCT01546038|101792977|FG001|NOT COMPLETED|Overall Study||6||
48596816|NCT01546038|101792978|FG002|NOT COMPLETED|Overall Study||4||
48596817|NCT01546038|101792979|FG003|NOT COMPLETED|Overall Study||3||
48596818|NCT01546038|101792980|FG004|NOT COMPLETED|Overall Study||10||
48596819|NCT01546038|101792981|FG005|NOT COMPLETED|Overall Study||4||
48296019|NCT00298090|101054168|FG000|COMPLETED|Overall Study||29||
48296020|NCT00298090|101054168|FG000|NOT COMPLETED|Overall Study||18||
48596820|NCT01546038|101792982|FG006|NOT COMPLETED|Overall Study||53||
48596821|NCT01546038|101792983|FG007|NOT COMPLETED|Overall Study||84||
48596822|NCT01546038|101792984|FG008|NOT COMPLETED|Overall Study||43||
48596823|NCT03051516|101792985|FG000|STARTED|Overall Study||93||
48596824|NCT03051516|101792986|FG001|STARTED|Overall Study||95||
48596825|NCT03051516|101792985|FG000|Vaccination 1|Overall Study||93||
48596826|NCT03051516|101792986|FG001|Vaccination 1|Overall Study||95||
48296021|NCT01444209|101054169|FG000|STARTED|Overall Study||2||
48596827|NCT03051516|101792985|FG000|Vaccination 2|Overall Study||91||
48596828|NCT03051516|101792986|FG001|Vaccination 2|Overall Study||94||
48596829|NCT03051516|101792985|FG000|Vaccination 3|Overall Study||83||
48596830|NCT03051516|101792986|FG001|Vaccination 3|Overall Study||90||
48596831|NCT03051516|101792985|FG000|Month 7 Follow-Up|Overall Study||80||
48596832|NCT03051516|101792986|FG001|Month 7 Follow-Up|Overall Study||87||
48596833|NCT03051516|101792985|FG000|Month 12 Follow-Up|Overall Study||78||
48296022|NCT01444209|101054169|FG000|COMPLETED|Overall Study||2||
48596834|NCT03051516|101792986|FG001|Month 12 Follow-Up|Overall Study||81||
48596835|NCT03051516|101792985|FG000|Month 18 Follow-Up|Overall Study||66||
48596836|NCT03051516|101792986|FG001|Month 18 Follow-Up|Overall Study||75||
48596837|NCT03051516|101792985|FG000|Month 24 Follow-Up|Overall Study||59||
48596838|NCT03051516|101792986|FG001|Month 24 Follow-Up|Overall Study||70||
48596839|NCT03051516|101792985|FG000|Month 36 Follow-Up|Overall Study||44||
48596840|NCT03051516|101792986|FG001|Month 36 Follow-Up|Overall Study||53||
48596841|NCT03051516|101792985|FG000|COMPLETED|Overall Study||38||
48596842|NCT03051516|101792986|FG001|COMPLETED|Overall Study||42||
48596843|NCT03051516|101792985|FG000|NOT COMPLETED|Overall Study||55||
48596844|NCT03051516|101792986|FG001|NOT COMPLETED|Overall Study||53||
48596845|NCT01362517|101792987|FG000|STARTED|Overall Study||131||
48596846|NCT01362517|101792987|FG000|COMPLETED|Overall Study||129||
48596847|NCT01362517|101792987|FG000|NOT COMPLETED|Overall Study||2||
48596848|NCT03391232|101792988|FG000|STARTED|Part A - First Dose (1-12weeks)||5||
48596849|NCT03391232|101792989|FG001|STARTED|Part A - First Dose (1-12weeks)||6||
48596850|NCT03391232|101792988|FG000|COMPLETED|Part A - First Dose (1-12weeks)||5||
48596851|NCT03391232|101792989|FG001|COMPLETED|Part A - First Dose (1-12weeks)||6||
48596852|NCT03391232|101792988|FG000|NOT COMPLETED|Part A - First Dose (1-12weeks)||0||
48596853|NCT03391232|101792989|FG001|NOT COMPLETED|Part A - First Dose (1-12weeks)||0||
48596854|NCT03391232|101792988|FG000|STARTED|Part B - Additional 2 Doses (13-38weeks)||0||
48596855|NCT03391232|101792989|FG001|STARTED|Part B - Additional 2 Doses (13-38weeks)||6||
48596856|NCT03391232|101792988|FG000|COMPLETED|Part B - Additional 2 Doses (13-38weeks)||0||
48596857|NCT03391232|101792989|FG001|COMPLETED|Part B - Additional 2 Doses (13-38weeks)||3||
48596858|NCT03391232|101792988|FG000|NOT COMPLETED|Part B - Additional 2 Doses (13-38weeks)||0||
48596859|NCT03391232|101792989|FG001|NOT COMPLETED|Part B - Additional 2 Doses (13-38weeks)||3||
48596860|NCT02993354|101792990|FG000|STARTED|Overall Study||48||
48596861|NCT02993354|101792990|FG000|COMPLETED|Overall Study||48||
48596862|NCT02993354|101792990|FG000|NOT COMPLETED|Overall Study||0||
48596863|NCT04686266|101792991|FG000|STARTED|Overall Study||15||
48596864|NCT04686266|101792992|FG001|STARTED|Overall Study||16||
48596865|NCT04686266|101792991|FG000|Month 1|Overall Study||15||
48596866|NCT04686266|101792992|FG001|Month 1|Overall Study||16||
48596867|NCT04686266|101792991|FG000|Month 3|Overall Study||15||
48596868|NCT04686266|101792992|FG001|Month 3|Overall Study||15||
48596869|NCT04686266|101792991|FG000|Month 6|Overall Study||15||
48596870|NCT04686266|101792992|FG001|Month 6|Overall Study||15||
48596871|NCT04686266|101792991|FG000|COMPLETED|Overall Study||15||
48596872|NCT04686266|101792992|FG001|COMPLETED|Overall Study||15||
48596873|NCT04686266|101792991|FG000|NOT COMPLETED|Overall Study||0||
48596874|NCT04686266|101792992|FG001|NOT COMPLETED|Overall Study||1||
48596875|NCT03233204|101792993|FG000|STARTED|Overall Study||6||
48596876|NCT03233204|101792993|FG000|COMPLETED|Overall Study||0||
48596877|NCT03233204|101792993|FG000|NOT COMPLETED|Overall Study||6||
48596878|NCT01826370|101792994|FG000|STARTED|Overall Study||678||
48596879|NCT01826370|101792994|FG000|COMPLETED|Overall Study||658||
48596880|NCT01826370|101792994|FG000|NOT COMPLETED|Overall Study||20||
48596881|NCT01398410|101792995|FG000|STARTED|Overall Study||201||
48596882|NCT01398410|101792996|FG001|STARTED|Overall Study||204||
48596883|NCT01398410|101792995|FG000|COMPLETED|Overall Study||143||
48596884|NCT01398410|101792996|FG001|COMPLETED|Overall Study||148||
48596885|NCT01398410|101792995|FG000|NOT COMPLETED|Overall Study||58||
48596886|NCT01398410|101792996|FG001|NOT COMPLETED|Overall Study||56||
48596887|NCT04233671|101792997|FG000|STARTED|Overall Study||13||
48596888|NCT04233671|101792998|FG001|STARTED|Overall Study||8||
48596889|NCT04233671|101792997|FG000|COMPLETED|Overall Study||8||
48596890|NCT04233671|101792998|FG001|COMPLETED|Overall Study||4||
48596891|NCT04233671|101792997|FG000|NOT COMPLETED|Overall Study||5||
48596892|NCT04233671|101792998|FG001|NOT COMPLETED|Overall Study||4||
48596893|NCT01500213|101792999|FG000|STARTED|Overall Study||278||
48596894|NCT01500213|101793000|FG001|STARTED|Overall Study||277||
48596895|NCT01500213|101792999|FG000|COMPLETED|Overall Study||61||
48596896|NCT01500213|101793000|FG001|COMPLETED|Overall Study||53||
48596897|NCT01500213|101792999|FG000|NOT COMPLETED|Overall Study||217||
48596898|NCT01500213|101793000|FG001|NOT COMPLETED|Overall Study||224||
48596899|NCT04015518|101793001|FG000|STARTED|Overall Study||43||
48596900|NCT04015518|101793002|FG001|STARTED|Overall Study||22||
48596901|NCT04015518|101793003|FG002|STARTED|Overall Study||21||
48596902|NCT04015518|101793004|FG003|STARTED|Overall Study||22||
48596903|NCT04015518|101793005|FG004|STARTED|Overall Study||44||
48596904|NCT04015518|101793001|FG000|Full Analysis Set (FAS)|Overall Study||43||
48596905|NCT04015518|101793002|FG001|Full Analysis Set (FAS)|Overall Study||22||
48596906|NCT04015518|101793003|FG002|Full Analysis Set (FAS)|Overall Study||21||
48596907|NCT04015518|101793004|FG003|Full Analysis Set (FAS)|Overall Study||22||
48596908|NCT04015518|101793005|FG004|Full Analysis Set (FAS)|Overall Study||44||
48596909|NCT04015518|101793001|FG000|COMPLETED|Overall Study||32||
48596910|NCT04015518|101793002|FG001|COMPLETED|Overall Study||19||
48596911|NCT04015518|101793003|FG002|COMPLETED|Overall Study||18||
48596912|NCT04015518|101793004|FG003|COMPLETED|Overall Study||17||
48596913|NCT04015518|101793005|FG004|COMPLETED|Overall Study||32||
48596914|NCT04015518|101793001|FG000|NOT COMPLETED|Overall Study||11||
48596915|NCT04015518|101793002|FG001|NOT COMPLETED|Overall Study||3||
48596916|NCT04015518|101793003|FG002|NOT COMPLETED|Overall Study||3||
48596917|NCT04015518|101793004|FG003|NOT COMPLETED|Overall Study||5||
48596918|NCT04015518|101793005|FG004|NOT COMPLETED|Overall Study||12||
48596919|NCT03448939|101793006|FG000|STARTED|Overall Study||243||
48596920|NCT03448939|101793007|FG001|STARTED|Overall Study||118||
48596921|NCT03448939|101793006|FG000|Received at Least 1 Dose of Study Drug|Overall Study||239||
48596922|NCT03448939|101793007|FG001|Received at Least 1 Dose of Study Drug|Overall Study||113||
48596923|NCT03448939|101793006|FG000|COMPLETED|Overall Study||222||
48596924|NCT03448939|101793007|FG001|COMPLETED|Overall Study||107||
48596925|NCT03448939|101793006|FG000|NOT COMPLETED|Overall Study||21||
48596926|NCT03448939|101793007|FG001|NOT COMPLETED|Overall Study||11||
48596927|NCT02798120|101793008|FG000|STARTED|Overall Study||296||
48296023|NCT01444209|101054169|FG000|NOT COMPLETED|Overall Study||0||
48296024|NCT02700945|101054170|FG000|STARTED|Overall Study||242||
48296025|NCT02700945|101054171|FG001|STARTED|Overall Study||250||
48596928|NCT02798120|101793009|FG001|STARTED|Overall Study||305||
48596929|NCT02798120|101793008|FG000|COMPLETED|Overall Study||232||
48596930|NCT02798120|101793009|FG001|COMPLETED|Overall Study||216||
48596931|NCT02798120|101793008|FG000|NOT COMPLETED|Overall Study||64||
48596932|NCT02798120|101793009|FG001|NOT COMPLETED|Overall Study||89||
48596933|NCT01576003|101793010|FG000|STARTED|Overall Study||2||
48596934|NCT01576003|101793011|FG001|STARTED|Overall Study||3||
48596935|NCT01576003|101793012|FG002|STARTED|Overall Study||4||
48596936|NCT01576003|101793010|FG000|COMPLETED|Overall Study||1||
48596937|NCT01576003|101793011|FG001|COMPLETED|Overall Study||1||
48596938|NCT01576003|101793012|FG002|COMPLETED|Overall Study||4||
48596939|NCT01576003|101793010|FG000|NOT COMPLETED|Overall Study||1||
48596940|NCT01576003|101793011|FG001|NOT COMPLETED|Overall Study||2||
48596941|NCT01576003|101793012|FG002|NOT COMPLETED|Overall Study||0||
48596942|NCT01440569|101793013|FG000|STARTED|Main Study||296||
48596943|NCT01440569|101793014|FG001|STARTED|Main Study||18||
48596944|NCT01440569|101793013|FG000|Enrolled and Treated|Main Study||295||
48596945|NCT01440569|101793014|FG001|Enrolled and Treated|Main Study||18||
48596946|NCT01440569|101793013|FG000|COMPLETED|Main Study||260||
48596947|NCT01440569|101793014|FG001|COMPLETED|Main Study||14||
48596948|NCT01440569|101793013|FG000|NOT COMPLETED|Main Study||36||
48596949|NCT01440569|101793014|FG001|NOT COMPLETED|Main Study||4||
48596950|NCT01440569|101793013|FG000|STARTED|Open-Label Rollover Phase||251||
48596951|NCT01440569|101793014|FG001|STARTED|Open-Label Rollover Phase||13||
48596952|NCT01440569|101793013|FG000|COMPLETED|Open-Label Rollover Phase||204||
48596953|NCT01440569|101793014|FG001|COMPLETED|Open-Label Rollover Phase||7||
48596954|NCT01440569|101793013|FG000|NOT COMPLETED|Open-Label Rollover Phase||47||
48596955|NCT01440569|101793014|FG001|NOT COMPLETED|Open-Label Rollover Phase||6||
48596956|NCT03858894|101793015|FG000|STARTED|Overall Study||48||
48596957|NCT03858894|101793016|FG001|STARTED|Overall Study||50||
48596958|NCT03858894|101793015|FG000|COMPLETED|Overall Study||44||
48596959|NCT03858894|101793016|FG001|COMPLETED|Overall Study||50||
48596960|NCT03858894|101793015|FG000|NOT COMPLETED|Overall Study||4||
48596961|NCT03858894|101793016|FG001|NOT COMPLETED|Overall Study||0||
48596962|NCT02176083|101793017|FG000|STARTED|Overall Study||11||
48596963|NCT02176083|101793018|FG001|STARTED|Overall Study||27||
48596964|NCT02176083|101793017|FG000|COMPLETED|Overall Study||11||
48596965|NCT02176083|101793018|FG001|COMPLETED|Overall Study||27||
48596966|NCT02176083|101793017|FG000|NOT COMPLETED|Overall Study||0||
48596967|NCT02176083|101793018|FG001|NOT COMPLETED|Overall Study||0||
48596968|NCT02248974|101793019|FG000|STARTED|Baseline||47||
48596969|NCT02248974|101793020|FG001|STARTED|Baseline||51||
48596970|NCT02248974|101793019|FG000|COMPLETED|Baseline||47||
48596971|NCT02248974|101793020|FG001|COMPLETED|Baseline||51||
48596972|NCT02248974|101793019|FG000|NOT COMPLETED|Baseline||0||
48596973|NCT02248974|101793020|FG001|NOT COMPLETED|Baseline||0||
48596974|NCT02248974|101793019|FG000|STARTED|1-Day Follow-Up||47||
48596975|NCT02248974|101793020|FG001|STARTED|1-Day Follow-Up||0||
48596976|NCT02248974|101793019|FG000|COMPLETED|1-Day Follow-Up||37||
48596977|NCT02248974|101793020|FG001|COMPLETED|1-Day Follow-Up||0||
48596978|NCT02248974|101793019|FG000|NOT COMPLETED|1-Day Follow-Up||10||
48596979|NCT02248974|101793020|FG001|NOT COMPLETED|1-Day Follow-Up||0||
48596980|NCT02248974|101793019|FG000|STARTED|1-Week Follow-Up||37||
48596981|NCT02248974|101793020|FG001|STARTED|1-Week Follow-Up||51||
48596982|NCT02248974|101793019|FG000|COMPLETED|1-Week Follow-Up||29||
48596983|NCT02248974|101793020|FG001|COMPLETED|1-Week Follow-Up||34||
48596984|NCT02248974|101793019|FG000|NOT COMPLETED|1-Week Follow-Up||8||
48596985|NCT02248974|101793020|FG001|NOT COMPLETED|1-Week Follow-Up||17||
48596986|NCT02248974|101793019|FG000|STARTED|1-Month Follow-Up||29||
48596987|NCT02248974|101793020|FG001|STARTED|1-Month Follow-Up||34||
48596988|NCT02248974|101793019|FG000|COMPLETED|1-Month Follow-Up||27||
48296026|NCT02700945|101054170|FG000|COMPLETED|Overall Study||210||
48296027|NCT02700945|101054171|FG001|COMPLETED|Overall Study||207||
48296028|NCT02700945|101054170|FG000|NOT COMPLETED|Overall Study||32||
48296029|NCT02700945|101054171|FG001|NOT COMPLETED|Overall Study||43||
48596989|NCT02248974|101793020|FG001|COMPLETED|1-Month Follow-Up||31||
48596990|NCT02248974|101793019|FG000|NOT COMPLETED|1-Month Follow-Up||2||
48596991|NCT02248974|101793020|FG001|NOT COMPLETED|1-Month Follow-Up||3||
48596992|NCT02791438|101793021|FG000|STARTED|Run-In Period||22||
48296030|NCT01136811|101054172|FG000|STARTED|Overall Study||11||
48296031|NCT01136811|101054172|FG000|COMPLETED|Overall Study||0||
48596993|NCT02791438|101793022|FG001|STARTED|Run-In Period||5||
48596994|NCT02791438|101793021|FG000|COMPLETED|Run-In Period||22||
48596995|NCT02791438|101793022|FG001|COMPLETED|Run-In Period||5||
48596996|NCT02791438|101793021|FG000|NOT COMPLETED|Run-In Period||0||
48596997|NCT02791438|101793022|FG001|NOT COMPLETED|Run-In Period||0||
48596998|NCT02791438|101793021|FG000|STARTED|Treatment Period||22||
48596999|NCT02791438|101793022|FG001|STARTED|Treatment Period||5||
48597000|NCT02791438|101793021|FG000|COMPLETED|Treatment Period||19||
48597001|NCT02791438|101793022|FG001|COMPLETED|Treatment Period||4||
48597002|NCT02791438|101793021|FG000|NOT COMPLETED|Treatment Period||3||
48597003|NCT02791438|101793022|FG001|NOT COMPLETED|Treatment Period||1||
48597004|NCT03488225|101793023|FG000|STARTED|Overall Study||4||
48597005|NCT03488225|101793023|FG000|COMPLETED|Overall Study||0||
48597006|NCT03488225|101793023|FG000|NOT COMPLETED|Overall Study||4||
48597007|NCT01797159|101793024|FG000|STARTED|Overall Study||20||
48597008|NCT01797159|101793024|FG000|COMPLETED|Overall Study||20||
48597009|NCT01797159|101793024|FG000|NOT COMPLETED|Overall Study||0||
48597010|NCT01810705|101793025|FG000|STARTED|Overall Study||83||
48597011|NCT01810705|101793026|FG001|STARTED|Overall Study||40||
48597012|NCT01810705|101793025|FG000|COMPLETED|Overall Study||10||
48597013|NCT01810705|101793026|FG001|COMPLETED|Overall Study||5||
48597014|NCT01810705|101793025|FG000|NOT COMPLETED|Overall Study||73||
48597015|NCT01810705|101793026|FG001|NOT COMPLETED|Overall Study||35||
48597016|NCT02303990|101793027|FG000|STARTED|Overall Study||59||
48597017|NCT02303990|101793027|FG000|COMPLETED|Overall Study||59||
48597018|NCT02303990|101793027|FG000|NOT COMPLETED|Overall Study||0||
48597019|NCT01889355|101793028|FG000|STARTED|Overall Study||115||
48597020|NCT01889355|101793028|FG000|COMPLETED|Overall Study||113||
48597021|NCT01889355|101793028|FG000|NOT COMPLETED|Overall Study||2||
48597022|NCT00717275|101793029|FG000|STARTED|Overall Study||3||
48296032|NCT01136811|101054172|FG000|NOT COMPLETED|Overall Study||11||
48296033|NCT01037244|101054173|FG000|STARTED|Overall Study||154||
48296034|NCT01037244|101054174|FG001|STARTED|Overall Study||152||
48296035|NCT01037244|101054175|FG002|STARTED|Overall Study||158||
48296036|NCT01037244|101054176|FG003|STARTED|Overall Study||154||
48296037|NCT01037244|101054173|FG000|mITT (Modified Intent-to-Treat)|Overall Study||150||
48296038|NCT01037244|101054174|FG001|mITT (Modified Intent-to-Treat)|Overall Study||148||
48296039|NCT01037244|101054175|FG002|mITT (Modified Intent-to-Treat)|Overall Study||154||
48296040|NCT01037244|101054176|FG003|mITT (Modified Intent-to-Treat)|Overall Study||153||
48296041|NCT01037244|101054173|FG000|Safety Population|Overall Study||155||
48296042|NCT01037244|101054174|FG001|Safety Population|Overall Study||150||
48597023|NCT00717275|101793029|FG000|COMPLETED|Overall Study||0||
48597024|NCT00717275|101793029|FG000|NOT COMPLETED|Overall Study||3||
48597025|NCT04395274|101793030|FG000|STARTED|Overall Study||52||
48597026|NCT04395274|101793031|FG001|STARTED|Overall Study||53||
48597027|NCT04395274|101793030|FG000|3-month|Overall Study||26||
48597028|NCT04395274|101793031|FG001|3-month|Overall Study||46||
48597029|NCT04395274|101793030|FG000|6-month|Overall Study||19||
48597030|NCT04395274|101793031|FG001|6-month|Overall Study||36||
48597031|NCT04395274|101793030|FG000|9-month|Overall Study||12||
48597032|NCT04395274|101793031|FG001|9-month|Overall Study||34||
48597033|NCT04395274|101793030|FG000|12-month|Overall Study||19||
48597034|NCT04395274|101793031|FG001|12-month|Overall Study||31||
48597035|NCT04395274|101793030|FG000|COMPLETED|Overall Study||19||
48597036|NCT04395274|101793031|FG001|COMPLETED|Overall Study||31||
48597037|NCT04395274|101793030|FG000|NOT COMPLETED|Overall Study||33||
48597038|NCT04395274|101793031|FG001|NOT COMPLETED|Overall Study||22||
48597039|NCT01606202|101793032|FG000|STARTED|Overall Study||56||
48597040|NCT01606202|101793033|FG001|STARTED|Overall Study||60||
48597041|NCT01606202|101793032|FG000|COMPLETED|Overall Study||49||
48597042|NCT01606202|101793033|FG001|COMPLETED|Overall Study||57||
48597043|NCT01606202|101793032|FG000|NOT COMPLETED|Overall Study||7||
48597044|NCT01606202|101793033|FG001|NOT COMPLETED|Overall Study||3||
48597045|NCT00410059|101793034|FG000|STARTED|Overall Study||59||
48597046|NCT00410059|101793034|FG000|COMPLETED|Overall Study||59||
48597047|NCT00410059|101793034|FG000|NOT COMPLETED|Overall Study||0||
48597048|NCT03933020|101793035|FG000|STARTED|Overall Study||0||
48296043|NCT01037244|101054175|FG002|Safety Population|Overall Study||159||
48296044|NCT01037244|101054176|FG003|Safety Population|Overall Study||152||
48296045|NCT01037244|101054173|FG000|COMPLETED|Overall Study||141||
48296046|NCT01037244|101054174|FG001|COMPLETED|Overall Study||138||
48597049|NCT03933020|101793035|FG000|Received an Intervention|Overall Study||0||
48597050|NCT03933020|101793035|FG000|COMPLETED|Overall Study||0||
48597051|NCT03933020|101793035|FG000|NOT COMPLETED|Overall Study||0||
48597052|NCT02858180|101793036|FG000|STARTED|Overall Study||10||
48597053|NCT02858180|101793037|FG001|STARTED|Overall Study||5||
48296047|NCT01037244|101054175|FG002|COMPLETED|Overall Study||144||
48597054|NCT02858180|101793036|FG000|COMPLETED|Overall Study||10||
48597055|NCT02858180|101793037|FG001|COMPLETED|Overall Study||3||
48597056|NCT02858180|101793036|FG000|NOT COMPLETED|Overall Study||0||
48597057|NCT02858180|101793037|FG001|NOT COMPLETED|Overall Study||2||
48597058|NCT02397291|101793038|FG000|STARTED|Overall Study||19||
48597059|NCT02397291|101793039|FG001|STARTED|Overall Study||5||
48597060|NCT02397291|101793038|FG000|COMPLETED|Overall Study||19||
48597061|NCT02397291|101793039|FG001|COMPLETED|Overall Study||5||
48597062|NCT02397291|101793038|FG000|NOT COMPLETED|Overall Study||0||
48296048|NCT01037244|101054176|FG003|COMPLETED|Overall Study||140||
48597063|NCT02397291|101793039|FG001|NOT COMPLETED|Overall Study||0||
48597064|NCT04756128|101796541|FG000|STARTED|Overall Study||35||
48597065|NCT04756128|101796542|FG001|STARTED|Overall Study||35||
48597066|NCT04756128|101796543|FG002|STARTED|Overall Study||36||
48597067|NCT04756128|101796544|FG003|STARTED|Overall Study||36||
48597068|NCT04756128|101796541|FG000|COMPLETED|Overall Study||34||
48712528|NCT00579995|102084757|FG001|COMPLETED|Overall Study||23||
48142166|NCT01786512|100673505|FG006|STARTED|Overall Study||12||
48142167|NCT01786512|100673506|FG007|STARTED|Overall Study||14||
48142168|NCT01786512|100673507|FG008|STARTED|Overall Study||149||
48142169|NCT01786512|100673508|FG009|STARTED|Overall Study||150||
48142170|NCT01786512|100673509|FG010|STARTED|Overall Study||149||
48142171|NCT01786512|100673499|FG000|Received Study Treatment|Overall Study||11||
48142172|NCT01786512|100673500|FG001|Received Study Treatment|Overall Study||10||
48142173|NCT01786512|100673501|FG002|Received Study Treatment|Overall Study||14||
48142174|NCT01786512|100673502|FG003|Received Study Treatment|Overall Study||13||
48597069|NCT04756128|101796542|FG001|COMPLETED|Overall Study||33||
48597070|NCT04756128|101796543|FG002|COMPLETED|Overall Study||35||
48597071|NCT04756128|101796544|FG003|COMPLETED|Overall Study||35||
48597072|NCT04756128|101796541|FG000|NOT COMPLETED|Overall Study||1||
48597073|NCT04756128|101796542|FG001|NOT COMPLETED|Overall Study||2||
48712529|NCT00579995|102084756|FG000|NOT COMPLETED|Overall Study||0||
48712530|NCT00579995|102084757|FG001|NOT COMPLETED|Overall Study||0||
48712531|NCT01170598|102084758|FG000|STARTED|Overall Study||35||
48712532|NCT01170598|102084758|FG000|COMPLETED|Overall Study||29||
48142175|NCT01786512|100673503|FG004|Received Study Treatment|Overall Study||10||
48142176|NCT01786512|100673504|FG005|Received Study Treatment|Overall Study||11||
48142177|NCT01786512|100673505|FG006|Received Study Treatment|Overall Study||11||
48142178|NCT01786512|100673506|FG007|Received Study Treatment|Overall Study||14||
48142179|NCT01786512|100673507|FG008|Received Study Treatment|Overall Study||149||
48142180|NCT01786512|100673508|FG009|Received Study Treatment|Overall Study||150||
48142181|NCT01786512|100673509|FG010|Received Study Treatment|Overall Study||146||
48142182|NCT01786512|100673499|FG000|COMPLETED|Overall Study||11||
48142183|NCT01786512|100673500|FG001|COMPLETED|Overall Study||10||
48142184|NCT01786512|100673501|FG002|COMPLETED|Overall Study||14||
48142185|NCT01786512|100673502|FG003|COMPLETED|Overall Study||13||
48142186|NCT01786512|100673503|FG004|COMPLETED|Overall Study||10||
48142187|NCT01786512|100673504|FG005|COMPLETED|Overall Study||11||
48142188|NCT01786512|100673505|FG006|COMPLETED|Overall Study||11||
48142189|NCT01786512|100673506|FG007|COMPLETED|Overall Study||14||
48404879|NCT01224106|101321959|FG003|NOT COMPLETED|Open-Label Extension (OLE) Phase||16||
48404880|NCT01224106|101321960|FG004|NOT COMPLETED|Open-Label Extension (OLE) Phase||34||
48404881|NCT00805038|101321961|FG000|STARTED|Overall Study||75||
48404882|NCT00805038|101321962|FG001|STARTED|Overall Study||92||
48404883|NCT00805038|101321961|FG000|COMPLETED|Overall Study||75||
48404884|NCT00805038|101321962|FG001|COMPLETED|Overall Study||92||
48404885|NCT00805038|101321961|FG000|NOT COMPLETED|Overall Study||0||
48404886|NCT00805038|101321962|FG001|NOT COMPLETED|Overall Study||0||
48404887|NCT02120469|101321963|FG000|STARTED|Overall Study||13||
48404888|NCT02120469|101321964|FG001|STARTED|Overall Study||10||
48404889|NCT02120469|101321965|FG002|STARTED|Overall Study||4||
48404890|NCT02120469|101321963|FG000|COMPLETED|Overall Study||12||
48404891|NCT02120469|101321964|FG001|COMPLETED|Overall Study||10||
48404892|NCT02120469|101321965|FG002|COMPLETED|Overall Study||3||
48404893|NCT02120469|101321963|FG000|NOT COMPLETED|Overall Study||1||
48404894|NCT02120469|101321964|FG001|NOT COMPLETED|Overall Study||0||
48404895|NCT02120469|101321965|FG002|NOT COMPLETED|Overall Study||1||
48404896|NCT03221660|101321966|FG000|STARTED|Overall Study||50||75
48404897|NCT03221660|101321966|FG000|COMPLETED|Overall Study||50||75
48404898|NCT03221660|101321966|FG000|NOT COMPLETED|Overall Study||0||0
48404899|NCT03256136|101321967|FG000|STARTED|Overall Study||3||
48404900|NCT03256136|101321968|FG001|STARTED|Overall Study||1||
48404901|NCT03256136|101321969|FG002|STARTED|Overall Study||4||
48404902|NCT03256136|101321970|FG003|STARTED|Overall Study||1||
48404903|NCT03256136|101321967|FG000|COMPLETED|Overall Study||3||
48404904|NCT03256136|101321968|FG001|COMPLETED|Overall Study||1||
48404905|NCT03256136|101321969|FG002|COMPLETED|Overall Study||4||
48404906|NCT03256136|101321970|FG003|COMPLETED|Overall Study||1||
48404907|NCT03256136|101321967|FG000|NOT COMPLETED|Overall Study||0||
48404908|NCT03256136|101321968|FG001|NOT COMPLETED|Overall Study||0||
48597074|NCT04756128|101796543|FG002|NOT COMPLETED|Overall Study||1||
48597075|NCT04756128|101796544|FG003|NOT COMPLETED|Overall Study||1||
48597076|NCT00310466|101796545|FG000|STARTED|Overall Study||113||
48597077|NCT00310466|101796546|FG001|STARTED|Overall Study||113||
48597078|NCT00310466|101796545|FG000|COMPLETED|Overall Study||95||
48712533|NCT01170598|102084758|FG000|NOT COMPLETED|Overall Study||6||
48712534|NCT04465877|102084759|FG000|STARTED|Overall Study||9||
48712535|NCT04465877|102084760|FG001|STARTED|Overall Study||9||
48404909|NCT03256136|101321969|FG002|NOT COMPLETED|Overall Study||0||
48404910|NCT03256136|101321970|FG003|NOT COMPLETED|Overall Study||0||
48142190|NCT01786512|100673507|FG008|COMPLETED|Overall Study||145||
48142191|NCT01786512|100673508|FG009|COMPLETED|Overall Study||145||
48142192|NCT01786512|100673509|FG010|COMPLETED|Overall Study||137||
48404911|NCT01894555|101321971|FG000|STARTED|Overall Study||33||
48404912|NCT01894555|101321971|FG000|COMPLETED|Overall Study||33||
48404913|NCT01894555|101321971|FG000|NOT COMPLETED|Overall Study||0||
48404914|NCT02282930|101321972|FG000|STARTED|Overall Study||20||
48404915|NCT02282930|101321972|FG000|COMPLETED|Overall Study||19||
48597079|NCT00310466|101796546|FG001|COMPLETED|Overall Study||101||
48597080|NCT00310466|101796545|FG000|NOT COMPLETED|Overall Study||18||
48712536|NCT04465877|102084761|FG002|STARTED|Overall Study||10||
48712537|NCT04465877|102084762|FG003|STARTED|Overall Study||9||
48142193|NCT01786512|100673499|FG000|NOT COMPLETED|Overall Study||0||
48142194|NCT01786512|100673500|FG001|NOT COMPLETED|Overall Study||1||
48142195|NCT01786512|100673501|FG002|NOT COMPLETED|Overall Study||0||
48142196|NCT01786512|100673502|FG003|NOT COMPLETED|Overall Study||0||
48142197|NCT01786512|100673503|FG004|NOT COMPLETED|Overall Study||0||
48142198|NCT01786512|100673504|FG005|NOT COMPLETED|Overall Study||0||
48142199|NCT01786512|100673505|FG006|NOT COMPLETED|Overall Study||1||
48142200|NCT01786512|100673506|FG007|NOT COMPLETED|Overall Study||0||
48597081|NCT00310466|101796546|FG001|NOT COMPLETED|Overall Study||12||
48597082|NCT02920177|101796547|FG000|STARTED|Overall Study||2||
48597083|NCT02920177|101796548|FG001|STARTED|Overall Study||2||
48597084|NCT02920177|101796547|FG000|COMPLETED|Overall Study||0||
48597085|NCT02920177|101796548|FG001|COMPLETED|Overall Study||0||
48597086|NCT02920177|101796547|FG000|NOT COMPLETED|Overall Study||2||
48142201|NCT01786512|100673507|FG008|NOT COMPLETED|Overall Study||4||
48142202|NCT01786512|100673508|FG009|NOT COMPLETED|Overall Study||5||
48142203|NCT01786512|100673509|FG010|NOT COMPLETED|Overall Study||12||
48142204|NCT01662310|100673510|FG000|STARTED|Run-In or Stabilization Phase||201||
48142205|NCT01662310|100673511|FG001|STARTED|Run-In or Stabilization Phase||0||
48142206|NCT01662310|100673512|FG002|STARTED|Run-In or Stabilization Phase||0||
48142207|NCT01662310|100673513|FG003|STARTED|Run-In or Stabilization Phase||0||
48142208|NCT01662310|100673514|FG004|STARTED|Run-In or Stabilization Phase||0||
48142209|NCT01662310|100673510|FG000|COMPLETED|Run-In or Stabilization Phase||136||
48142210|NCT01662310|100673511|FG001|COMPLETED|Run-In or Stabilization Phase||0||
48142211|NCT01662310|100673512|FG002|COMPLETED|Run-In or Stabilization Phase||0||
48142212|NCT01662310|100673513|FG003|COMPLETED|Run-In or Stabilization Phase||0||
48597087|NCT02920177|101796548|FG001|NOT COMPLETED|Overall Study||2||
48597088|NCT01785849|101796549|FG000|STARTED|Overall Study||254||
48597089|NCT01785849|101796550|FG001|STARTED|Overall Study||254||
48597090|NCT01785849|101796549|FG000|Received Treatment|Overall Study||254||
48597091|NCT01785849|101796550|FG001|Received Treatment|Overall Study||251||
48597092|NCT01785849|101796549|FG000|COMPLETED|Overall Study||193||
48597093|NCT01785849|101796550|FG001|COMPLETED|Overall Study||220||
48597094|NCT01785849|101796549|FG000|NOT COMPLETED|Overall Study||61||
48597095|NCT01785849|101796550|FG001|NOT COMPLETED|Overall Study||34||
48597096|NCT02379273|101796551|FG000|STARTED|Overall Study||35||
48597097|NCT02379273|101796551|FG000|COMPLETED|Overall Study||35||
48597098|NCT02379273|101796551|FG000|NOT COMPLETED|Overall Study||0||
48597099|NCT03172364|101796552|FG000|STARTED|Overall Study||55||
48597100|NCT03172364|101796553|FG001|STARTED|Overall Study||58||
48597101|NCT03172364|101796552|FG000|COMPLETED|Overall Study||53||
48597102|NCT03172364|101796553|FG001|COMPLETED|Overall Study||57||
48142213|NCT01662310|100673514|FG004|COMPLETED|Run-In or Stabilization Phase||0||
48142214|NCT01662310|100673510|FG000|NOT COMPLETED|Run-In or Stabilization Phase||65||
48142215|NCT01662310|100673511|FG001|NOT COMPLETED|Run-In or Stabilization Phase||0||
48142216|NCT01662310|100673512|FG002|NOT COMPLETED|Run-In or Stabilization Phase||0||
48142217|NCT01662310|100673513|FG003|NOT COMPLETED|Run-In or Stabilization Phase||0||
48142218|NCT01662310|100673514|FG004|NOT COMPLETED|Run-In or Stabilization Phase||0||
48142219|NCT01662310|100673510|FG000|STARTED|Double-Blind Phase||0||
48142220|NCT01662310|100673511|FG001|STARTED|Double-Blind Phase||65||
48142221|NCT01662310|100673512|FG002|STARTED|Double-Blind Phase||71||
48142222|NCT01662310|100673513|FG003|STARTED|Double-Blind Phase||0||
48142223|NCT01662310|100673514|FG004|STARTED|Double-Blind Phase||0||
48142224|NCT01662310|100673510|FG000|Treated|Double-Blind Phase||0||
48142225|NCT01662310|100673511|FG001|Treated|Double-Blind Phase||64||
48142226|NCT01662310|100673512|FG002|Treated|Double-Blind Phase||71||
48597103|NCT03172364|101796552|FG000|NOT COMPLETED|Overall Study||2||
48597104|NCT03172364|101796553|FG001|NOT COMPLETED|Overall Study||1||
48597105|NCT00772005|101796554|FG000|STARTED|Overall Study||71||
48142227|NCT01662310|100673513|FG003|Treated|Double-Blind Phase||0||
48597106|NCT00772005|101796555|FG001|STARTED|Overall Study||70||
48597107|NCT00772005|101796556|FG002|STARTED|Overall Study||72||
48597108|NCT00772005|101796557|FG003|STARTED|Overall Study||72||
48597109|NCT00772005|101796554|FG000|COMPLETED|Overall Study||46||
48597110|NCT00772005|101796555|FG001|COMPLETED|Overall Study||40||
48597111|NCT00772005|101796556|FG002|COMPLETED|Overall Study||44||
48597112|NCT00772005|101796557|FG003|COMPLETED|Overall Study||46||
48767571|NCT01614886|102222769|FG000|Full Analysis Set (FAS)|Overall Study||104||
48142228|NCT01662310|100673514|FG004|Treated|Double-Blind Phase||0||
48597113|NCT00772005|101796554|FG000|NOT COMPLETED|Overall Study||25||
48597114|NCT00772005|101796555|FG001|NOT COMPLETED|Overall Study||30||
48597115|NCT00772005|101796556|FG002|NOT COMPLETED|Overall Study||28||
48597116|NCT00772005|101796557|FG003|NOT COMPLETED|Overall Study||26||
48597117|NCT01675154|101796558|FG000|STARTED|First Intervention Period (4 Weeks)||2||
48142229|NCT01662310|100673510|FG000|COMPLETED|Double-Blind Phase||0||
48142230|NCT01662310|100673511|FG001|COMPLETED|Double-Blind Phase||50||
48142231|NCT01662310|100673512|FG002|COMPLETED|Double-Blind Phase||66||
48142232|NCT01662310|100673513|FG003|COMPLETED|Double-Blind Phase||0||
48657066|NCT03648372|101943764|FG007|COMPLETED|Overall Study||1||
48597118|NCT01675154|101796559|FG001|STARTED|First Intervention Period (4 Weeks)||1||
48597119|NCT01675154|101796560|FG002|STARTED|First Intervention Period (4 Weeks)||1||
48597120|NCT01675154|101796561|FG003|STARTED|First Intervention Period (4 Weeks)||1||
48597121|NCT01675154|101796558|FG000|COMPLETED|First Intervention Period (4 Weeks)||2||
48597122|NCT01675154|101796559|FG001|COMPLETED|First Intervention Period (4 Weeks)||1||
48597123|NCT01675154|101796560|FG002|COMPLETED|First Intervention Period (4 Weeks)||1||
48597124|NCT01675154|101796561|FG003|COMPLETED|First Intervention Period (4 Weeks)||1||
48597125|NCT01675154|101796558|FG000|NOT COMPLETED|First Intervention Period (4 Weeks)||0||
48597126|NCT01675154|101796559|FG001|NOT COMPLETED|First Intervention Period (4 Weeks)||0||
48597127|NCT01675154|101796560|FG002|NOT COMPLETED|First Intervention Period (4 Weeks)||0||
48597128|NCT01675154|101796561|FG003|NOT COMPLETED|First Intervention Period (4 Weeks)||0||
48597129|NCT01675154|101796558|FG000|STARTED|First Washout Period (1 Week)||2||
48597130|NCT01675154|101796559|FG001|STARTED|First Washout Period (1 Week)||1||
48597131|NCT01675154|101796560|FG002|STARTED|First Washout Period (1 Week)||1||
48597132|NCT01675154|101796561|FG003|STARTED|First Washout Period (1 Week)||1||
48597133|NCT01675154|101796558|FG000|COMPLETED|First Washout Period (1 Week)||2||
48597134|NCT01675154|101796559|FG001|COMPLETED|First Washout Period (1 Week)||1||
48597135|NCT01675154|101796560|FG002|COMPLETED|First Washout Period (1 Week)||1||
48142233|NCT01662310|100673514|FG004|COMPLETED|Double-Blind Phase||0||
48142234|NCT01662310|100673510|FG000|NOT COMPLETED|Double-Blind Phase||0||
48142235|NCT01662310|100673511|FG001|NOT COMPLETED|Double-Blind Phase||15||
48142236|NCT01662310|100673512|FG002|NOT COMPLETED|Double-Blind Phase||5||
48142237|NCT01662310|100673513|FG003|NOT COMPLETED|Double-Blind Phase||0||
48597136|NCT01675154|101796561|FG003|COMPLETED|First Washout Period (1 Week)||1||
48597137|NCT01675154|101796558|FG000|NOT COMPLETED|First Washout Period (1 Week)||0||
48597138|NCT01675154|101796559|FG001|NOT COMPLETED|First Washout Period (1 Week)||0||
48712538|NCT04465877|102084759|FG000|Randomized Population|Overall Study||9|Randomized Population consists of all subjects randomized to receive JTT-662 or placebo on Day 1.|
48712539|NCT04465877|102084760|FG001|Randomized Population|Overall Study||9|Randomized Population consists of all subjects randomized to receive JTT-662 or placebo on Day 1.|
48712540|NCT04465877|102084761|FG002|Randomized Population|Overall Study||10|Randomized Population consists of all subjects randomized to receive JTT-662 or placebo on Day 1.|
48712541|NCT04465877|102084762|FG003|Randomized Population|Overall Study||9|Randomized Population consists of all subjects randomized to receive JTT-662 or placebo on Day 1.|
48712542|NCT04465877|102084759|FG000|Safety Population|Overall Study||9|Safety Population consists of subjects who were randomly assigned to treatment and who received at least one dose of study drug.|
48712543|NCT04465877|102084760|FG001|Safety Population|Overall Study||9|Safety Population consists of subjects who were randomly assigned to treatment and who received at least one dose of study drug.|
48712544|NCT04465877|102084761|FG002|Safety Population|Overall Study||10|Safety Population consists of subjects who were randomly assigned to treatment and who received at least one dose of study drug.|
48712545|NCT04465877|102084762|FG003|Safety Population|Overall Study||9|Safety Population consists of subjects who were randomly assigned to treatment and who received at least one dose of study drug.|
48712546|NCT04465877|102084759|FG000|PK (Pharmacokinetic) Population|Overall Study||9|PK (Pharmacokinetic) Population consists of subjects randomized to JTT-662 treatment groups who received at least one dose of JTT-662 and had available PK data.|
48712547|NCT04465877|102084760|FG001|PK (Pharmacokinetic) Population|Overall Study||9|PK (Pharmacokinetic) Population consists of subjects randomized to JTT-662 treatment groups who received at least one dose of JTT-662 and had available PK data.|
48712548|NCT04465877|102084761|FG002|PK (Pharmacokinetic) Population|Overall Study||10|PK (Pharmacokinetic) Population consists of subjects randomized to JTT-662 treatment groups who received at least one dose of JTT-662 and had available PK data.|
48712549|NCT04465877|102084762|FG003|PK (Pharmacokinetic) Population|Overall Study||0|PK (Pharmacokinetic) Population consists of subjects randomized to JTT-662 treatment groups who received at least one dose of JTT-662 and had available PK data.|
48712550|NCT04465877|102084759|FG000|PD (Pharmacodynamic) Population|Overall Study||9|PD (Pharmacodynamic) Population consists of subjects who were randomly assigned to treatment, received at least one dose of JTT-662 or placebo starting on Day 1 and had evaluable PD data.|
48712551|NCT04465877|102084760|FG001|PD (Pharmacodynamic) Population|Overall Study||9|PD (Pharmacodynamic) Population consists of subjects who were randomly assigned to treatment, received at least one dose of JTT-662 or placebo starting on Day 1 and had evaluable PD data.|
48712552|NCT04465877|102084761|FG002|PD (Pharmacodynamic) Population|Overall Study||10|PD (Pharmacodynamic) Population consists of subjects who were randomly assigned to treatment, received at least one dose of JTT-662 or placebo starting on Day 1 and had evaluable PD data.|
48142238|NCT01662310|100673514|FG004|NOT COMPLETED|Double-Blind Phase||0||
48142239|NCT01662310|100673510|FG000|STARTED|Open-Label Extension Phase||0||
48142240|NCT01662310|100673511|FG001|STARTED|Open-Label Extension Phase||0||
48142241|NCT01662310|100673512|FG002|STARTED|Open-Label Extension Phase||0||
48142242|NCT01662310|100673513|FG003|STARTED|Open-Label Extension Phase||47||
48142243|NCT01662310|100673514|FG004|STARTED|Open-Label Extension Phase||59||
48597139|NCT01675154|101796560|FG002|NOT COMPLETED|First Washout Period (1 Week)||0||
48597140|NCT01675154|101796561|FG003|NOT COMPLETED|First Washout Period (1 Week)||0||
48597141|NCT01675154|101796558|FG000|STARTED|Second Intervention Period (4 Weeks)||1||
48597142|NCT01675154|101796559|FG001|STARTED|Second Intervention Period (4 Weeks)||1||
48597143|NCT01675154|101796560|FG002|STARTED|Second Intervention Period (4 Weeks)||1||
48597144|NCT01675154|101796561|FG003|STARTED|Second Intervention Period (4 Weeks)||2||
48142244|NCT01662310|100673510|FG000|COMPLETED|Open-Label Extension Phase||0||
48142245|NCT01662310|100673511|FG001|COMPLETED|Open-Label Extension Phase||0||
48142246|NCT01662310|100673512|FG002|COMPLETED|Open-Label Extension Phase||0||
48142247|NCT01662310|100673513|FG003|COMPLETED|Open-Label Extension Phase||36||
48142248|NCT01662310|100673514|FG004|COMPLETED|Open-Label Extension Phase||49||
48142249|NCT01662310|100673510|FG000|NOT COMPLETED|Open-Label Extension Phase||0||
48142250|NCT01662310|100673511|FG001|NOT COMPLETED|Open-Label Extension Phase||0||
48142251|NCT01662310|100673512|FG002|NOT COMPLETED|Open-Label Extension Phase||0||
48142252|NCT01662310|100673513|FG003|NOT COMPLETED|Open-Label Extension Phase||11||
48142253|NCT01662310|100673514|FG004|NOT COMPLETED|Open-Label Extension Phase||10||
48142254|NCT00074282|100673515|FG000|STARTED|Step 1||102||
48142255|NCT00074282|100673516|FG001|STARTED|Step 1||0||
48142256|NCT00074282|100673517|FG002|STARTED|Step 1||0||
48142257|NCT00074282|100673515|FG000|Eligible|Step 1||98||
48142258|NCT00074282|100673516|FG001|Eligible|Step 1||0||
48142259|NCT00074282|100673517|FG002|Eligible|Step 1||0||
48142260|NCT00074282|100673515|FG000|Started Treatment|Step 1||96||
48142261|NCT00074282|100673516|FG001|Started Treatment|Step 1||0||
48142262|NCT00074282|100673517|FG002|Started Treatment|Step 1||0||
48142263|NCT00074282|100673515|FG000|COMPLETED|Step 1||44||
48142264|NCT00074282|100673516|FG001|COMPLETED|Step 1||0||
48142265|NCT00074282|100673517|FG002|COMPLETED|Step 1||0||
48142266|NCT00074282|100673515|FG000|NOT COMPLETED|Step 1||58||
48142267|NCT00074282|100673516|FG001|NOT COMPLETED|Step 1||0||
48142268|NCT00074282|100673517|FG002|NOT COMPLETED|Step 1||0||
48142269|NCT00074282|100673515|FG000|STARTED|Step 2||0||
48142270|NCT00074282|100673516|FG001|STARTED|Step 2||9||
48142271|NCT00074282|100673517|FG002|STARTED|Step 2||31||
48296049|NCT01037244|101054173|FG000|NOT COMPLETED|Overall Study||13||
48296050|NCT01037244|101054174|FG001|NOT COMPLETED|Overall Study||14||
48296051|NCT01037244|101054175|FG002|NOT COMPLETED|Overall Study||14||
48296052|NCT01037244|101054176|FG003|NOT COMPLETED|Overall Study||14||
48142272|NCT00074282|100673515|FG000|COMPLETED|Step 2||0||
48142273|NCT00074282|100673516|FG001|COMPLETED|Step 2||7||
48142274|NCT00074282|100673517|FG002|COMPLETED|Step 2||7||
48142275|NCT00074282|100673515|FG000|NOT COMPLETED|Step 2||0||
48142276|NCT00074282|100673516|FG001|NOT COMPLETED|Step 2||2||
48142277|NCT00074282|100673517|FG002|NOT COMPLETED|Step 2||24||
48142278|NCT02007291|100673518|FG000|STARTED|Overall Study||48||
48142279|NCT02007291|100673519|FG001|STARTED|Overall Study||23||
48142280|NCT02007291|100673518|FG000|COMPLETED|Overall Study||48||
48142281|NCT02007291|100673519|FG001|COMPLETED|Overall Study||23||
48142282|NCT02007291|100673518|FG000|NOT COMPLETED|Overall Study||0||
48142283|NCT02007291|100673519|FG001|NOT COMPLETED|Overall Study||0||
48142284|NCT01227889|100673520|FG000|STARTED|Randomized Phase (RP)||187||
48142285|NCT01227889|100673521|FG001|STARTED|Randomized Phase (RP)||63||
48142286|NCT01227889|100673520|FG000|COMPLETED|Randomized Phase (RP)||0||
48142287|NCT01227889|100673521|FG001|COMPLETED|Randomized Phase (RP)||0||
48142288|NCT01227889|100673520|FG000|NOT COMPLETED|Randomized Phase (RP)||187||
48142289|NCT01227889|100673521|FG001|NOT COMPLETED|Randomized Phase (RP)||63||
48142290|NCT01227889|100673520|FG000|STARTED|Crossover Phase||0||
48296053|NCT00402597|101054177|FG000|STARTED|Overall Study||1153||
48296054|NCT00402597|101054178|FG001|STARTED|Overall Study||307||
48296055|NCT00402597|101054179|FG002|STARTED|Overall Study||1046||
48296056|NCT00402597|101054180|FG003|STARTED|Overall Study||353||
48296057|NCT00402597|101054181|FG004|STARTED|Overall Study||603||
48296058|NCT00402597|101054177|FG000|COMPLETED|Overall Study||962||
48296059|NCT00402597|101054178|FG001|COMPLETED|Overall Study||261||
48296060|NCT00402597|101054179|FG002|COMPLETED|Overall Study||834||
48296061|NCT00402597|101054180|FG003|COMPLETED|Overall Study||279||
48296062|NCT00402597|101054181|FG004|COMPLETED|Overall Study||479||
48296063|NCT00402597|101054177|FG000|NOT COMPLETED|Overall Study||191||
48296064|NCT00402597|101054178|FG001|NOT COMPLETED|Overall Study||46||
48296065|NCT00402597|101054179|FG002|NOT COMPLETED|Overall Study||212||
48296066|NCT00402597|101054180|FG003|NOT COMPLETED|Overall Study||74||
48296067|NCT00402597|101054181|FG004|NOT COMPLETED|Overall Study||124||
48296068|NCT04086433|101054182|FG000|STARTED|Overall Study||17||
48296069|NCT04086433|101054183|FG001|STARTED|Overall Study||18||
48296070|NCT04086433|101054182|FG000|COMPLETED|Overall Study||17||
48142291|NCT01227889|100673521|FG001|STARTED|Crossover Phase||37||
48142292|NCT01227889|100673520|FG000|COMPLETED|Crossover Phase||0||
48142293|NCT01227889|100673521|FG001|COMPLETED|Crossover Phase||0||
48142294|NCT01227889|100673520|FG000|NOT COMPLETED|Crossover Phase||0||
48142295|NCT01227889|100673521|FG001|NOT COMPLETED|Crossover Phase||37||
48296071|NCT04086433|101054183|FG001|COMPLETED|Overall Study||18||
48296072|NCT04086433|101054182|FG000|NOT COMPLETED|Overall Study||0||
48296073|NCT04086433|101054183|FG001|NOT COMPLETED|Overall Study||0||
48142296|NCT01024569|100673522|FG000|STARTED|Overall Study||276||
48142297|NCT01024569|100673523|FG001|STARTED|Overall Study||279||
48142298|NCT01024569|100673522|FG000|COMPLETED|Overall Study||251||
48142299|NCT01024569|100673523|FG001|COMPLETED|Overall Study||268||
48142300|NCT01024569|100673522|FG000|NOT COMPLETED|Overall Study||25||
48296074|NCT01592864|101054184|FG000|STARTED|Overall Study||60||
48142301|NCT01024569|100673523|FG001|NOT COMPLETED|Overall Study||11||
48142302|NCT04450108|100673524|FG000|STARTED|Overall Study||122||
48142303|NCT04450108|100673524|FG000|COMPLETED|Overall Study||120||
48296075|NCT01592864|101054185|FG001|STARTED|Overall Study||58||
48296076|NCT01592864|101054184|FG000|COMPLETED|Overall Study||60||
48296077|NCT01592864|101054185|FG001|COMPLETED|Overall Study||57||
48296078|NCT01592864|101054184|FG000|NOT COMPLETED|Overall Study||0||
48296079|NCT01592864|101054185|FG001|NOT COMPLETED|Overall Study||1||
48404916|NCT02282930|101321972|FG000|NOT COMPLETED|Overall Study||1||
48404917|NCT01452191|101325146|FG000|STARTED|Overall Study||373||12
48597145|NCT01675154|101796558|FG000|COMPLETED|Second Intervention Period (4 Weeks)||0||
48597146|NCT01675154|101796559|FG001|COMPLETED|Second Intervention Period (4 Weeks)||1||
48597147|NCT01675154|101796560|FG002|COMPLETED|Second Intervention Period (4 Weeks)||1||
48597148|NCT01675154|101796561|FG003|COMPLETED|Second Intervention Period (4 Weeks)||1||
48296080|NCT01244451|101054186|FG000|STARTED|Overall Study||49||
48296081|NCT01244451|101054186|FG000|COMPLETED|Overall Study||36||
48712553|NCT04465877|102084762|FG003|PD (Pharmacodynamic) Population|Overall Study||9|PD (Pharmacodynamic) Population consists of subjects who were randomly assigned to treatment, received at least one dose of JTT-662 or placebo starting on Day 1 and had evaluable PD data.|
48597149|NCT01675154|101796558|FG000|NOT COMPLETED|Second Intervention Period (4 Weeks)||1||
48597150|NCT01675154|101796559|FG001|NOT COMPLETED|Second Intervention Period (4 Weeks)||0||
48597151|NCT01675154|101796560|FG002|NOT COMPLETED|Second Intervention Period (4 Weeks)||0||
48597152|NCT01675154|101796561|FG003|NOT COMPLETED|Second Intervention Period (4 Weeks)||1||
48597153|NCT01675154|101796558|FG000|STARTED|Second Washout Period (1 Week)||1||
48597154|NCT01675154|101796559|FG001|STARTED|Second Washout Period (1 Week)||1||
48597155|NCT01675154|101796560|FG002|STARTED|Second Washout Period (1 Week)||1||
48597156|NCT01675154|101796561|FG003|STARTED|Second Washout Period (1 Week)||2||
48597157|NCT01675154|101796558|FG000|COMPLETED|Second Washout Period (1 Week)||1||
48597158|NCT01675154|101796559|FG001|COMPLETED|Second Washout Period (1 Week)||1||
48597159|NCT01675154|101796560|FG002|COMPLETED|Second Washout Period (1 Week)||1||
48597160|NCT01675154|101796561|FG003|COMPLETED|Second Washout Period (1 Week)||2||
48597161|NCT01675154|101796558|FG000|NOT COMPLETED|Second Washout Period (1 Week)||0||
48597162|NCT01675154|101796559|FG001|NOT COMPLETED|Second Washout Period (1 Week)||0||
48597163|NCT01675154|101796560|FG002|NOT COMPLETED|Second Washout Period (1 Week)||0||
48712554|NCT04465877|102084759|FG000|COMPLETED|Overall Study||9||
48712555|NCT04465877|102084760|FG001|COMPLETED|Overall Study||9||
48712556|NCT04465877|102084761|FG002|COMPLETED|Overall Study||9||
48712557|NCT04465877|102084762|FG003|COMPLETED|Overall Study||9||
48712558|NCT04465877|102084759|FG000|NOT COMPLETED|Overall Study||0||
48712559|NCT04465877|102084760|FG001|NOT COMPLETED|Overall Study||0||
48712560|NCT04465877|102084761|FG002|NOT COMPLETED|Overall Study||1||
48712561|NCT04465877|102084762|FG003|NOT COMPLETED|Overall Study||0||
48712562|NCT01852825|102084763|FG000|STARTED|Overall Study||16||
48597164|NCT01675154|101796561|FG003|NOT COMPLETED|Second Washout Period (1 Week)||0||
48597165|NCT01675154|101796558|FG000|STARTED|Third Intervention Period (4 Weeks)||1|Further participation of two patients was halted after Period 2 due to unavailability of the study medications.|
48597166|NCT01675154|101796559|FG001|STARTED|Third Intervention Period (4 Weeks)||1|Further participation of two patients was halted after Period 2 due to unavailability of the study medications.|
48597167|NCT01675154|101796560|FG002|STARTED|Third Intervention Period (4 Weeks)||1|Further participation of two patients was halted after Period 2 due to unavailability of the study medications.|
48712563|NCT01852825|102084764|FG001|STARTED|Overall Study||7||
48712564|NCT01852825|102084765|FG002|STARTED|Overall Study||3||
48712565|NCT01852825|102084763|FG000|COMPLETED|Overall Study||14||
48712566|NCT01852825|102084764|FG001|COMPLETED|Overall Study||7||
48712567|NCT01852825|102084765|FG002|COMPLETED|Overall Study||3||
48712568|NCT01852825|102084763|FG000|NOT COMPLETED|Overall Study||2||
48712569|NCT01852825|102084764|FG001|NOT COMPLETED|Overall Study||0||
48712570|NCT01852825|102084765|FG002|NOT COMPLETED|Overall Study||0||
48712571|NCT00933244|102084766|FG000|STARTED|Overall Study||79||
48712572|NCT00933244|102084767|FG001|STARTED|Overall Study||75||
48296082|NCT01244451|101054186|FG000|NOT COMPLETED|Overall Study||13||
48296083|NCT01440374|101054187|FG000|STARTED|Part 1: Open-label Phase||17||
48404918|NCT01452191|101325147|FG001|STARTED|Overall Study||369||12
48597168|NCT01675154|101796561|FG003|STARTED|Third Intervention Period (4 Weeks)||0|Further participation of two patients was halted after Period 2 due to unavailability of the study medications.|
48597169|NCT01675154|101796558|FG000|COMPLETED|Third Intervention Period (4 Weeks)||1||
48597170|NCT01675154|101796559|FG001|COMPLETED|Third Intervention Period (4 Weeks)||0||
48712573|NCT00933244|102084768|FG002|STARTED|Overall Study||76||
48712574|NCT00933244|102084766|FG000|COMPLETED|Overall Study||74||
48712575|NCT00933244|102084767|FG001|COMPLETED|Overall Study||74||
48712576|NCT00933244|102084768|FG002|COMPLETED|Overall Study||73||
48712577|NCT00933244|102084766|FG000|NOT COMPLETED|Overall Study||5||
48712578|NCT00933244|102084767|FG001|NOT COMPLETED|Overall Study||1||
48712579|NCT00933244|102084768|FG002|NOT COMPLETED|Overall Study||3||
48712580|NCT04863248|102084769|FG000|STARTED|Overall Study||4||
48296084|NCT01440374|101054188|FG001|STARTED|Part 1: Open-label Phase||0||
48296085|NCT01440374|101054189|FG002|STARTED|Part 1: Open-label Phase||0||
48296086|NCT01440374|101054190|FG003|STARTED|Part 1: Open-label Phase||0||
48404919|NCT01452191|101325148|FG002|STARTED|Overall Study||370||12
48404920|NCT01452191|101325146|FG000|COMPLETED|Overall Study||241||12
48404921|NCT01452191|101325147|FG001|COMPLETED|Overall Study||252||12
48597171|NCT01675154|101796560|FG002|COMPLETED|Third Intervention Period (4 Weeks)||1||
48597172|NCT01675154|101796561|FG003|COMPLETED|Third Intervention Period (4 Weeks)||0||
48597173|NCT01675154|101796558|FG000|NOT COMPLETED|Third Intervention Period (4 Weeks)||0||
48597174|NCT01675154|101796559|FG001|NOT COMPLETED|Third Intervention Period (4 Weeks)||1||
48597175|NCT01675154|101796560|FG002|NOT COMPLETED|Third Intervention Period (4 Weeks)||0||
48142304|NCT04450108|100673524|FG000|NOT COMPLETED|Overall Study||2||
48142305|NCT02313428|100673525|FG000|STARTED|Overall Study||2||
48142306|NCT02313428|100673526|FG001|STARTED|Overall Study||2||
48597176|NCT01675154|101796561|FG003|NOT COMPLETED|Third Intervention Period (4 Weeks)||0||
48597177|NCT01675154|101796558|FG000|STARTED|Third Washout Period (1 Week)||1||
48597178|NCT01675154|101796559|FG001|STARTED|Third Washout Period (1 Week)||0||
48142307|NCT02313428|100673525|FG000|Completing 16 wk Visit|Overall Study||1||
48142308|NCT02313428|100673526|FG001|Completing 16 wk Visit|Overall Study||1||
48142309|NCT02313428|100673525|FG000|COMPLETED|Overall Study||1||
48142310|NCT02313428|100673526|FG001|COMPLETED|Overall Study||1||
48142311|NCT02313428|100673525|FG000|NOT COMPLETED|Overall Study||1||
48142312|NCT02313428|100673526|FG001|NOT COMPLETED|Overall Study||1||
48142313|NCT00374322|100673527|FG000|STARTED|Overall Study||1579||
48142314|NCT00374322|100673528|FG001|STARTED|Overall Study||1582||
48142315|NCT00374322|100673527|FG000|Received >=1 Dose of Study Treatment|Overall Study||1571||
48142316|NCT00374322|100673528|FG001|Received >=1 Dose of Study Treatment|Overall Study||1576||
48142317|NCT00374322|100673527|FG000|COMPLETED|Overall Study||322||
48142318|NCT00374322|100673528|FG001|COMPLETED|Overall Study||278||
48597179|NCT01675154|101796560|FG002|STARTED|Third Washout Period (1 Week)||1||
48597180|NCT01675154|101796561|FG003|STARTED|Third Washout Period (1 Week)||0||
48142319|NCT00374322|100673527|FG000|NOT COMPLETED|Overall Study||1257||
48142320|NCT00374322|100673528|FG001|NOT COMPLETED|Overall Study||1304||
48142321|NCT02962908|100673529|FG000|STARTED|Overall Study||58||
48142322|NCT02962908|100673530|FG001|STARTED|Overall Study||58||
48142323|NCT02962908|100673531|FG002|STARTED|Overall Study||32||
48142324|NCT02962908|100673532|FG003|STARTED|Overall Study||27||
48142325|NCT02962908|100673529|FG000|COMPLETED|Overall Study||58||
48142326|NCT02962908|100673530|FG001|COMPLETED|Overall Study||50||
48597181|NCT01675154|101796558|FG000|COMPLETED|Third Washout Period (1 Week)||1||
48597182|NCT01675154|101796559|FG001|COMPLETED|Third Washout Period (1 Week)||0||
48142327|NCT02962908|100673531|FG002|COMPLETED|Overall Study||32||
48296087|NCT01440374|101054187|FG000|COMPLETED|Part 1: Open-label Phase||11||
48296088|NCT01440374|101054188|FG001|COMPLETED|Part 1: Open-label Phase||0||
48296089|NCT01440374|101054189|FG002|COMPLETED|Part 1: Open-label Phase||0||
48296090|NCT01440374|101054190|FG003|COMPLETED|Part 1: Open-label Phase||0||
48296091|NCT01440374|101054187|FG000|NOT COMPLETED|Part 1: Open-label Phase||6||
48296092|NCT01440374|101054188|FG001|NOT COMPLETED|Part 1: Open-label Phase||0||
48296093|NCT01440374|101054189|FG002|NOT COMPLETED|Part 1: Open-label Phase||0||
48296094|NCT01440374|101054190|FG003|NOT COMPLETED|Part 1: Open-label Phase||0||
48296095|NCT01440374|101054187|FG000|STARTED|Part 2; Double-blind Phase||0||
48296096|NCT01440374|101054188|FG001|STARTED|Part 2; Double-blind Phase||47||
48296097|NCT01440374|101054189|FG002|STARTED|Part 2; Double-blind Phase||98||
48296098|NCT01440374|101054190|FG003|STARTED|Part 2; Double-blind Phase||0||
48296099|NCT01440374|101054187|FG000|COMPLETED|Part 2; Double-blind Phase||0||
48296100|NCT01440374|101054188|FG001|COMPLETED|Part 2; Double-blind Phase||27||
48296101|NCT01440374|101054189|FG002|COMPLETED|Part 2; Double-blind Phase||43||
48296102|NCT01440374|101054190|FG003|COMPLETED|Part 2; Double-blind Phase||0||
48296103|NCT01440374|101054187|FG000|NOT COMPLETED|Part 2; Double-blind Phase||0||
48296104|NCT01440374|101054188|FG001|NOT COMPLETED|Part 2; Double-blind Phase||20||
48296105|NCT01440374|101054189|FG002|NOT COMPLETED|Part 2; Double-blind Phase||55||
48296106|NCT01440374|101054190|FG003|NOT COMPLETED|Part 2; Double-blind Phase||0||
48296107|NCT01440374|101054187|FG000|STARTED|Part 3: Extension||0||
48296108|NCT01440374|101054188|FG001|STARTED|Part 3: Extension||0||
48296109|NCT01440374|101054189|FG002|STARTED|Part 3: Extension||0||
48296110|NCT01440374|101054190|FG003|STARTED|Part 3: Extension||59||
48296111|NCT01440374|101054187|FG000|COMPLETED|Part 3: Extension||0||
48296112|NCT01440374|101054188|FG001|COMPLETED|Part 3: Extension||0||
48296113|NCT01440374|101054189|FG002|COMPLETED|Part 3: Extension||0||
48296114|NCT01440374|101054190|FG003|COMPLETED|Part 3: Extension||27||
48296115|NCT01440374|101054187|FG000|NOT COMPLETED|Part 3: Extension||0||
48296116|NCT01440374|101054188|FG001|NOT COMPLETED|Part 3: Extension||0||
48296117|NCT01440374|101054189|FG002|NOT COMPLETED|Part 3: Extension||0||
48296118|NCT01440374|101054190|FG003|NOT COMPLETED|Part 3: Extension||32||
48296119|NCT03057808|101054191|FG000|STARTED|Overall Study||144||
48296120|NCT03057808|101054192|FG001|STARTED|Overall Study||142||
48296121|NCT03057808|101054193|FG002|STARTED|Overall Study||144||
48296122|NCT03057808|101054191|FG000|32-36 Weeks Gestation|Overall Study||129||
48296123|NCT03057808|101054192|FG001|32-36 Weeks Gestation|Overall Study||129||
48296124|NCT03057808|101054193|FG002|32-36 Weeks Gestation|Overall Study||120||
48296125|NCT03057808|101054191|FG000|COMPLETED|Overall Study||132||
48296126|NCT03057808|101054192|FG001|COMPLETED|Overall Study||121||
48296127|NCT03057808|101054193|FG002|COMPLETED|Overall Study||127||
48296128|NCT03057808|101054191|FG000|NOT COMPLETED|Overall Study||12||
48296129|NCT03057808|101054192|FG001|NOT COMPLETED|Overall Study||21||
48296130|NCT03057808|101054193|FG002|NOT COMPLETED|Overall Study||17||
48296131|NCT00759291|101054194|FG000|STARTED|First Treatment Period||17||
48296132|NCT00759291|101054195|FG001|STARTED|First Treatment Period||23||
48296133|NCT00759291|101054194|FG000|COMPLETED|First Treatment Period||17||
48296134|NCT00759291|101054195|FG001|COMPLETED|First Treatment Period||23||
48296135|NCT00759291|101054194|FG000|NOT COMPLETED|First Treatment Period||0||
48296136|NCT00759291|101054195|FG001|NOT COMPLETED|First Treatment Period||0||
48296137|NCT00759291|101054194|FG000|STARTED|Crossover||17||
48296138|NCT00759291|101054195|FG001|STARTED|Crossover||23||
48296139|NCT00759291|101054194|FG000|COMPLETED|Crossover||17||
48296140|NCT00759291|101054195|FG001|COMPLETED|Crossover||23||
48296141|NCT00759291|101054194|FG000|NOT COMPLETED|Crossover||0||
48296142|NCT00759291|101054195|FG001|NOT COMPLETED|Crossover||0||
48296143|NCT01313650|101054196|FG000|STARTED|Overall Study||280||
48296144|NCT01313650|101054197|FG001|STARTED|Overall Study||418||
48296145|NCT01313650|101054198|FG002|STARTED|Overall Study||421||
48296146|NCT01313650|101054199|FG003|STARTED|Overall Study||413||
48296147|NCT01313650|101054196|FG000|COMPLETED|Overall Study||204||
48597183|NCT01675154|101796560|FG002|COMPLETED|Third Washout Period (1 Week)||1||
48597184|NCT01675154|101796561|FG003|COMPLETED|Third Washout Period (1 Week)||0||
48597185|NCT01675154|101796558|FG000|NOT COMPLETED|Third Washout Period (1 Week)||0||
48597186|NCT01675154|101796559|FG001|NOT COMPLETED|Third Washout Period (1 Week)||0||
48597187|NCT01675154|101796560|FG002|NOT COMPLETED|Third Washout Period (1 Week)||0||
48597188|NCT01675154|101796561|FG003|NOT COMPLETED|Third Washout Period (1 Week)||0||
48597189|NCT01675154|101796558|FG000|STARTED|Fourth Intervention Period (4 Weeks)||1||
48597190|NCT01675154|101796559|FG001|STARTED|Fourth Intervention Period (4 Weeks)||0||
48597191|NCT01675154|101796560|FG002|STARTED|Fourth Intervention Period (4 Weeks)||1||
48597192|NCT01675154|101796561|FG003|STARTED|Fourth Intervention Period (4 Weeks)||0||
48597193|NCT01675154|101796558|FG000|COMPLETED|Fourth Intervention Period (4 Weeks)||1|One patient dropped out during Period 3 due to personal reasons. Therefore, not included in this intervention period.|
48597194|NCT01675154|101796559|FG001|COMPLETED|Fourth Intervention Period (4 Weeks)||0|One patient dropped out during Period 3 due to personal reasons. Therefore, not included in this intervention period.|
48597195|NCT01675154|101796560|FG002|COMPLETED|Fourth Intervention Period (4 Weeks)||1|One patient dropped out during Period 3 due to personal reasons. Therefore, not included in this intervention period.|
48597196|NCT01675154|101796561|FG003|COMPLETED|Fourth Intervention Period (4 Weeks)||0|One patient dropped out during Period 3 due to personal reasons. Therefore, not included in this intervention period.|
48712581|NCT04863248|102084770|FG001|STARTED|Overall Study||3||
48712582|NCT04863248|102084769|FG000|COMPLETED|Overall Study||0||
48712583|NCT04863248|102084770|FG001|COMPLETED|Overall Study||0||
48712584|NCT04863248|102084769|FG000|NOT COMPLETED|Overall Study||4||
48712585|NCT04863248|102084770|FG001|NOT COMPLETED|Overall Study||3||
48712586|NCT02836873|102084771|FG000|STARTED|Overall Study||157||
48712587|NCT02836873|102084772|FG001|STARTED|Overall Study||155||
48712588|NCT02836873|102084771|FG000|COMPLETED|Overall Study||152||
48712589|NCT02836873|102084772|FG001|COMPLETED|Overall Study||144||
48712590|NCT02836873|102084771|FG000|NOT COMPLETED|Overall Study||5||
48712591|NCT02836873|102084772|FG001|NOT COMPLETED|Overall Study||11||
48712592|NCT02649192|102084773|FG000|STARTED|Overall Study||5||
48296148|NCT01313650|101054197|FG001|COMPLETED|Overall Study||324||
48296149|NCT01313650|101054198|FG002|COMPLETED|Overall Study||318||
48296150|NCT01313650|101054199|FG003|COMPLETED|Overall Study||332||
48712593|NCT02649192|102084774|FG001|STARTED|Overall Study||4||
48712594|NCT02649192|102084775|FG002|STARTED|Overall Study||22||
48712595|NCT02649192|102084776|FG003|STARTED|Overall Study||22||
48712596|NCT02649192|102084777|FG004|STARTED|Overall Study||12||
48712597|NCT02649192|102084778|FG005|STARTED|Overall Study||14||
48712598|NCT02649192|102084773|FG000|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||2||
48712599|NCT02649192|102084774|FG001|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||2||
48296151|NCT01313650|101054196|FG000|NOT COMPLETED|Overall Study||76||
48296152|NCT01313650|101054197|FG001|NOT COMPLETED|Overall Study||94||
48296153|NCT01313650|101054198|FG002|NOT COMPLETED|Overall Study||103||
48296154|NCT01313650|101054199|FG003|NOT COMPLETED|Overall Study||81||
48296155|NCT02168842|101054200|FG000|STARTED|Overall Study||170||
48296156|NCT02168842|101054201|FG001|STARTED|Overall Study||166||
48712600|NCT02649192|102084775|FG002|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||11||
48712601|NCT02649192|102084776|FG003|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||12||
48712602|NCT02649192|102084777|FG004|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||7||
48712603|NCT02649192|102084778|FG005|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||8||
48296157|NCT02168842|101054200|FG000|COMPLETED|Overall Study||162||
48296158|NCT02168842|101054201|FG001|COMPLETED|Overall Study||158||
48296159|NCT02168842|101054200|FG000|NOT COMPLETED|Overall Study||8||
48296160|NCT02168842|101054201|FG001|NOT COMPLETED|Overall Study||8||
48597197|NCT01675154|101796558|FG000|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0||
48597198|NCT01675154|101796559|FG001|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0||
48597199|NCT01675154|101796560|FG002|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0||
48597200|NCT01675154|101796561|FG003|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0||
48597201|NCT02667626|101796562|FG000|STARTED|Overall Study||86||
48597202|NCT02667626|101796563|FG001|STARTED|Overall Study||96||
48597203|NCT02667626|101796562|FG000|COMPLETED|Overall Study||86||
48597204|NCT02667626|101796563|FG001|COMPLETED|Overall Study||95||
48597205|NCT02667626|101796562|FG000|NOT COMPLETED|Overall Study||0||
48597206|NCT02667626|101796563|FG001|NOT COMPLETED|Overall Study||1||
48597207|NCT03383692|101796564|FG000|STARTED|Overall Study||17||
48597208|NCT03383692|101796565|FG001|STARTED|Overall Study||23||
48597209|NCT03383692|101796564|FG000|COMPLETED|Overall Study||11|Ongoing on study drug as of 26 Sep 2018|
48597210|NCT03383692|101796565|FG001|COMPLETED|Overall Study||19|Ongoing on study drug as of 26 Sep 2018|
48597211|NCT03383692|101796564|FG000|NOT COMPLETED|Overall Study||6||
48597212|NCT03383692|101796565|FG001|NOT COMPLETED|Overall Study||4||
48597213|NCT03605849|101796566|FG000|STARTED|Overall Study||156||
48597214|NCT03605849|101796567|FG001|STARTED|Overall Study||151||
48597215|NCT03605849|101796568|FG002|STARTED|Overall Study||187||
48597216|NCT03605849|101796569|FG003|STARTED|Overall Study||168||
48597217|NCT03605849|101796566|FG000|Safety Sample|Overall Study||154|Safety Sample comprised all participants who received at least 1 dose of investigational medicinal product (IMP).|
48597218|NCT03605849|101796567|FG001|Safety Sample|Overall Study||149|Safety Sample comprised all participants who received at least 1 dose of investigational medicinal product (IMP).|
48597219|NCT03605849|101796568|FG002|Safety Sample|Overall Study||184|Safety Sample comprised all participants who received at least 1 dose of investigational medicinal product (IMP).|
48597220|NCT03605849|101796569|FG003|Safety Sample|Overall Study||166|Safety Sample comprised all participants who received at least 1 dose of investigational medicinal product (IMP).|
48597221|NCT03605849|101796566|FG000|COMPLETED|Overall Study||78||
48597222|NCT03605849|101796567|FG001|COMPLETED|Overall Study||72||
48597223|NCT03605849|101796568|FG002|COMPLETED|Overall Study||92||
48597224|NCT03605849|101796569|FG003|COMPLETED|Overall Study||103||
48597225|NCT03605849|101796566|FG000|NOT COMPLETED|Overall Study||78||
48597226|NCT03605849|101796567|FG001|NOT COMPLETED|Overall Study||79||
48597227|NCT03605849|101796568|FG002|NOT COMPLETED|Overall Study||95||
48597228|NCT03605849|101796569|FG003|NOT COMPLETED|Overall Study||65||
48597229|NCT00925652|101796570|FG000|STARTED|Overall Study||13||
48597230|NCT00925652|101796571|FG001|STARTED|Overall Study||13||
48597231|NCT00925652|101796572|FG002|STARTED|Overall Study||11||
48597232|NCT00925652|101796573|FG003|STARTED|Overall Study||13||
48597233|NCT00925652|101796570|FG000|Withdraw|Overall Study||6||
48142328|NCT02962908|100673532|FG003|COMPLETED|Overall Study||24||
48142329|NCT02962908|100673529|FG000|NOT COMPLETED|Overall Study||0||
48142330|NCT02962908|100673530|FG001|NOT COMPLETED|Overall Study||8||
48142331|NCT02962908|100673531|FG002|NOT COMPLETED|Overall Study||0||
48142332|NCT02962908|100673532|FG003|NOT COMPLETED|Overall Study||3||
48142333|NCT01777854|100673533|FG000|STARTED|Overall Study||3|Study was terminated before patients had intervention.|
48142334|NCT01777854|100673534|FG001|STARTED|Overall Study||3|Study was terminated before patients had intervention.|
48142335|NCT01777854|100673533|FG000|COMPLETED|Overall Study||0||
48142336|NCT01777854|100673534|FG001|COMPLETED|Overall Study||0||
48142337|NCT01777854|100673533|FG000|NOT COMPLETED|Overall Study||3||
48142338|NCT01777854|100673534|FG001|NOT COMPLETED|Overall Study||3||
48142339|NCT01549613|100673535|FG000|STARTED|Overall Study||50||
48142340|NCT01549613|100673536|FG001|STARTED|Overall Study||50||
48142341|NCT01549613|100673535|FG000|COMPLETED|Overall Study||39||
48142342|NCT01549613|100673536|FG001|COMPLETED|Overall Study||39||
48142343|NCT01549613|100673535|FG000|NOT COMPLETED|Overall Study||11||
48142344|NCT01549613|100673536|FG001|NOT COMPLETED|Overall Study||11||
48142345|NCT03966157|100673537|FG000|STARTED|Overall Study||17||
48142346|NCT03966157|100673538|FG001|STARTED|Overall Study||14||
48142347|NCT03966157|100673537|FG000|COMPLETED|Overall Study||16||
48597234|NCT00925652|101796571|FG001|Withdraw|Overall Study||5||
48597235|NCT00925652|101796572|FG002|Withdraw|Overall Study||3||
48597236|NCT00925652|101796573|FG003|Withdraw|Overall Study||1||
48597237|NCT00925652|101796570|FG000|Off Treatment Because of Other Complicating Disease|Overall Study||0||
48597238|NCT00925652|101796571|FG001|Off Treatment Because of Other Complicating Disease|Overall Study||0||
48597239|NCT00925652|101796572|FG002|Off Treatment Because of Other Complicating Disease|Overall Study||2||
48597240|NCT00925652|101796573|FG003|Off Treatment Because of Other Complicating Disease|Overall Study||3||
48597241|NCT00925652|101796570|FG000|Off Treatment Because of Disease Recurrence|Overall Study||1||
48597242|NCT00925652|101796571|FG001|Off Treatment Because of Disease Recurrence|Overall Study||3||
48597243|NCT00925652|101796572|FG002|Off Treatment Because of Disease Recurrence|Overall Study||0||
48597244|NCT00925652|101796573|FG003|Off Treatment Because of Disease Recurrence|Overall Study||0||
48597245|NCT00925652|101796570|FG000|Lost of Follow-up|Overall Study||0||
48597246|NCT00925652|101796571|FG001|Lost of Follow-up|Overall Study||1||
48597247|NCT00925652|101796572|FG002|Lost of Follow-up|Overall Study||0||
48597248|NCT00925652|101796573|FG003|Lost of Follow-up|Overall Study||0||
48597249|NCT00925652|101796570|FG000|Death|Overall Study||0||
48597250|NCT00925652|101796571|FG001|Death|Overall Study||0||
48597251|NCT00925652|101796572|FG002|Death|Overall Study||0||
48597252|NCT00925652|101796573|FG003|Death|Overall Study||3||
48597253|NCT00925652|101796570|FG000|COMPLETED|Overall Study||6||
48597254|NCT00925652|101796571|FG001|COMPLETED|Overall Study||4||
48597255|NCT00925652|101796572|FG002|COMPLETED|Overall Study||6||
48597256|NCT00925652|101796573|FG003|COMPLETED|Overall Study||6||
48597257|NCT00925652|101796570|FG000|NOT COMPLETED|Overall Study||7||
48597258|NCT00925652|101796571|FG001|NOT COMPLETED|Overall Study||9||
48597259|NCT00925652|101796572|FG002|NOT COMPLETED|Overall Study||5||
48597260|NCT00925652|101796573|FG003|NOT COMPLETED|Overall Study||7||
48597261|NCT00078949|101796574|FG000|STARTED|Overall Study||310||
48597262|NCT00078949|101796575|FG001|STARTED|Overall Study||309||
48597263|NCT00078949|101796576|FG002|STARTED|Overall Study||115||
48597264|NCT00078949|101796577|FG003|STARTED|Overall Study||115||
48142348|NCT03966157|100673538|FG001|COMPLETED|Overall Study||14||
48142349|NCT03966157|100673537|FG000|NOT COMPLETED|Overall Study||1||
48142350|NCT03966157|100673538|FG001|NOT COMPLETED|Overall Study||0||
48142351|NCT04690855|100673539|FG000|STARTED|Overall Study||1||
48142352|NCT04690855|100673539|FG000|COMPLETED|Overall Study||1||
48142353|NCT04690855|100673539|FG000|NOT COMPLETED|Overall Study||0||
48142354|NCT00581230|100673540|FG000|STARTED|Overall Study||51||
48142355|NCT00581230|100673540|FG000|Laryngoscopy Without RAMP|Overall Study||51||
48142356|NCT00581230|100673540|FG000|Laryngoscopy With RAMP|Overall Study||51||
48142357|NCT00581230|100673540|FG000|COMPLETED|Overall Study||51||
48142358|NCT00581230|100673540|FG000|NOT COMPLETED|Overall Study||0||
48142359|NCT03215095|100673541|FG000|STARTED|Overall Study||11||
48142360|NCT03215095|100673541|FG000|COMPLETED|Overall Study||11||
48142361|NCT03215095|100673541|FG000|NOT COMPLETED|Overall Study||0||
48142362|NCT00864032|100673542|FG000|STARTED|Overall Study||3||
48142363|NCT00864032|100673543|FG001|STARTED|Overall Study||5||
48142364|NCT00864032|100673544|FG002|STARTED|Overall Study||0||
48142365|NCT00864032|100673542|FG000|COMPLETED|Overall Study||3||
48142366|NCT00864032|100673543|FG001|COMPLETED|Overall Study||5||
48142367|NCT00864032|100673544|FG002|COMPLETED|Overall Study||0||
48712604|NCT02649192|102084773|FG000|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||3||
48712605|NCT02649192|102084774|FG001|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||2||
48712606|NCT02649192|102084775|FG002|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||11||
48712607|NCT02649192|102084776|FG003|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||10||
48712608|NCT02649192|102084777|FG004|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||5||
48712609|NCT02649192|102084778|FG005|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||6||
48712610|NCT02649192|102084773|FG000|COMPLETED|Overall Study||5||
48712611|NCT02649192|102084774|FG001|COMPLETED|Overall Study||4||
48712612|NCT02649192|102084775|FG002|COMPLETED|Overall Study||21||
48712613|NCT02649192|102084776|FG003|COMPLETED|Overall Study||20||
48712614|NCT02649192|102084777|FG004|COMPLETED|Overall Study||11||
48712615|NCT02649192|102084778|FG005|COMPLETED|Overall Study||14||
48712616|NCT02649192|102084773|FG000|NOT COMPLETED|Overall Study||0||
48712617|NCT02649192|102084774|FG001|NOT COMPLETED|Overall Study||0||
48712618|NCT02649192|102084775|FG002|NOT COMPLETED|Overall Study||1||
48712619|NCT02649192|102084776|FG003|NOT COMPLETED|Overall Study||2||
48712620|NCT02649192|102084777|FG004|NOT COMPLETED|Overall Study||1||
48712621|NCT02649192|102084778|FG005|NOT COMPLETED|Overall Study||0||
48712622|NCT02118597|102084779|FG000|STARTED|Overall Study||19||
48712623|NCT02118597|102084779|FG000|COMPLETED|Overall Study||3||
48712624|NCT02118597|102084779|FG000|NOT COMPLETED|Overall Study||16||
48712625|NCT00303446|102084780|FG000|STARTED|Overall Study||25||
48712626|NCT00303446|102084781|FG001|STARTED|Overall Study||25||
48712627|NCT00303446|102084780|FG000|COMPLETED|Overall Study||23||
48712628|NCT00303446|102084781|FG001|COMPLETED|Overall Study||21||
48712629|NCT00303446|102084780|FG000|NOT COMPLETED|Overall Study||2||
48712630|NCT00303446|102084781|FG001|NOT COMPLETED|Overall Study||4||
48712631|NCT00354107|102084782|FG000|STARTED|Overall Study||5||
48712632|NCT00354107|102084782|FG000|COMPLETED|Overall Study||0||
48712633|NCT00354107|102084782|FG000|NOT COMPLETED|Overall Study||5||
48142368|NCT00864032|100673542|FG000|NOT COMPLETED|Overall Study||0||
48142369|NCT00864032|100673543|FG001|NOT COMPLETED|Overall Study||0||
48142370|NCT00864032|100673544|FG002|NOT COMPLETED|Overall Study||0||
48142371|NCT01428765|100673545|FG000|STARTED|Overall Study||1063||
48142372|NCT01428765|100673545|FG000|COMPLETED|Overall Study||1063||
48142373|NCT01428765|100673545|FG000|NOT COMPLETED|Overall Study||0||
48142374|NCT03835533|100673546|FG000|STARTED|Overall Study||14||
48712634|NCT00966719|102084783|FG000|STARTED|Overall Study||50||
48142375|NCT03835533|100673547|FG001|STARTED|Overall Study||15||
48142376|NCT03835533|100673548|FG002|STARTED|Overall Study||14||
48712635|NCT00966719|102084784|FG001|STARTED|Overall Study||49||
48142377|NCT03835533|100673546|FG000|COMPLETED|Overall Study||6||
48142378|NCT03835533|100673547|FG001|COMPLETED|Overall Study||3||
48142379|NCT03835533|100673548|FG002|COMPLETED|Overall Study||3||
48142380|NCT03835533|100673546|FG000|NOT COMPLETED|Overall Study||8||
48712636|NCT00966719|102084783|FG000|COMPLETED|Overall Study||44||
48712637|NCT00966719|102084784|FG001|COMPLETED|Overall Study||38||
48712638|NCT00966719|102084783|FG000|NOT COMPLETED|Overall Study||6||
48142381|NCT03835533|100673547|FG001|NOT COMPLETED|Overall Study||12||
48142382|NCT03835533|100673548|FG002|NOT COMPLETED|Overall Study||11||
48142383|NCT01347333|100673549|FG000|STARTED|Overall Study||23||
48142384|NCT01347333|100673550|FG001|STARTED|Overall Study||0||
48142385|NCT01347333|100673549|FG000|COMPLETED|Overall Study||23||
48142386|NCT01347333|100673550|FG001|COMPLETED|Overall Study||0||
48142387|NCT01347333|100673549|FG000|NOT COMPLETED|Overall Study||0||
48142388|NCT01347333|100673550|FG001|NOT COMPLETED|Overall Study||0||
48142389|NCT00594854|100673551|FG000|STARTED|Overall Study||9||
48142390|NCT00594854|100673552|FG001|STARTED|Overall Study||11||
48142391|NCT00594854|100673551|FG000|COMPLETED|Overall Study||2||
48142392|NCT00594854|100673552|FG001|COMPLETED|Overall Study||1||
48142393|NCT00594854|100673551|FG000|NOT COMPLETED|Overall Study||7||
48142394|NCT00594854|100673552|FG001|NOT COMPLETED|Overall Study||10||
48142395|NCT03762473|100673553|FG000|STARTED|Overall Study||44||
48142396|NCT03762473|100673554|FG001|STARTED|Overall Study||45||
48142397|NCT03762473|100673553|FG000|COMPLETED|Overall Study||43||
48142398|NCT03762473|100673554|FG001|COMPLETED|Overall Study||45||
48142399|NCT03762473|100673553|FG000|NOT COMPLETED|Overall Study||1||
48142400|NCT03762473|100673554|FG001|NOT COMPLETED|Overall Study||0||
48142401|NCT01474681|100673555|FG000|STARTED|Overall Study||1||
48142402|NCT01474681|100673556|FG001|STARTED|Overall Study||8||
48142403|NCT01474681|100673557|FG002|STARTED|Overall Study||3||
48142404|NCT01474681|100673558|FG003|STARTED|Overall Study||15||
48142405|NCT01474681|100673555|FG000|COMPLETED|Overall Study||1||
48142406|NCT01474681|100673556|FG001|COMPLETED|Overall Study||5||
48142407|NCT01474681|100673557|FG002|COMPLETED|Overall Study||1||
48142408|NCT01474681|100673558|FG003|COMPLETED|Overall Study||9||
48142409|NCT01474681|100673555|FG000|NOT COMPLETED|Overall Study||0||
48142410|NCT01474681|100673556|FG001|NOT COMPLETED|Overall Study||3||
48142411|NCT01474681|100673557|FG002|NOT COMPLETED|Overall Study||2||
48142412|NCT01474681|100673558|FG003|NOT COMPLETED|Overall Study||6||
48142413|NCT00377234|100673559|FG000|STARTED|Overall Study||180||
48142414|NCT00377234|100673560|FG001|STARTED|Overall Study||176||
48142415|NCT00377234|100673559|FG000|Randomized|Overall Study||180||
48142416|NCT00377234|100673560|FG001|Randomized|Overall Study||176||
48142417|NCT00377234|100673559|FG000|Did Not Receive Study Treatment|Overall Study||3||
48142418|NCT00377234|100673560|FG001|Did Not Receive Study Treatment|Overall Study||2||
48142419|NCT00377234|100673559|FG000|Received Treatment|Overall Study||177||
48142420|NCT00377234|100673560|FG001|Received Treatment|Overall Study||174||
48142421|NCT00377234|100673559|FG000|Safety Analysis Set: Period 1|Overall Study||177||
48142422|NCT00377234|100673560|FG001|Safety Analysis Set: Period 1|Overall Study||174||
48142423|NCT00377234|100673559|FG000|Safety Analysis Set: Period 2|Overall Study||153||
48142424|NCT00377234|100673560|FG001|Safety Analysis Set: Period 2|Overall Study||150||
48142425|NCT00377234|100673559|FG000|Safety Analysis Set: Ibandronate|Overall Study||177||
48142426|NCT00377234|100673560|FG001|Safety Analysis Set: Ibandronate|Overall Study||150||
48142427|NCT00377234|100673559|FG000|Safety Analysis Set: Risedronate|Overall Study||153||
48142428|NCT00377234|100673560|FG001|Safety Analysis Set: Risedronate|Overall Study||174||
48142429|NCT00377234|100673559|FG000|COMPLETED|Overall Study||146||
48142430|NCT00377234|100673560|FG001|COMPLETED|Overall Study||145||
48142431|NCT00377234|100673559|FG000|NOT COMPLETED|Overall Study||34||
48142432|NCT00377234|100673560|FG001|NOT COMPLETED|Overall Study||31||
48142433|NCT04575896|100673561|FG000|STARTED|Overall Study||10||
48142434|NCT04575896|100673561|FG000|COMPLETED|Overall Study||10||
48142435|NCT04575896|100673561|FG000|NOT COMPLETED|Overall Study||0||
48142436|NCT01386528|100673562|FG000|STARTED|Overall Study||13||
48142437|NCT01386528|100673562|FG000|COMPLETED|Overall Study||13||
48142438|NCT01386528|100673562|FG000|NOT COMPLETED|Overall Study||0||
48142439|NCT03028974|100673563|FG000|STARTED|2014-2015||1|LAIV was not recommended in Group B and C age groups starting in 2014-2015.|
48142440|NCT03028974|100673564|FG001|STARTED|2014-2015||0|LAIV was not recommended in Group B and C age groups starting in 2014-2015.|
48142441|NCT03028974|100673565|FG002|STARTED|2014-2015||0|LAIV was not recommended in Group B and C age groups starting in 2014-2015.|
48142442|NCT03028974|100673566|FG003|STARTED|2014-2015||3|LAIV was not recommended in Group B and C age groups starting in 2014-2015.|
48142443|NCT03028974|100673567|FG004|STARTED|2014-2015||0|LAIV was not recommended in Group B and C age groups starting in 2014-2015.|
48142444|NCT03028974|100673568|FG005|STARTED|2014-2015||11|LAIV was not recommended in Group B and C age groups starting in 2014-2015.|
48142445|NCT03028974|100673569|FG006|STARTED|2014-2015||13|LAIV was not recommended in Group B and C age groups starting in 2014-2015.|
48142446|NCT03028974|100673563|FG000|COMPLETED|2014-2015||1||
48142447|NCT03028974|100673564|FG001|COMPLETED|2014-2015||0||
48142448|NCT03028974|100673565|FG002|COMPLETED|2014-2015||0||
48142449|NCT03028974|100673566|FG003|COMPLETED|2014-2015||3||
48142450|NCT03028974|100673567|FG004|COMPLETED|2014-2015||0||
48142451|NCT03028974|100673568|FG005|COMPLETED|2014-2015||11||
48142452|NCT03028974|100673569|FG006|COMPLETED|2014-2015||13||
48142453|NCT03028974|100673563|FG000|NOT COMPLETED|2014-2015||0||
48142454|NCT03028974|100673564|FG001|NOT COMPLETED|2014-2015||0||
48142455|NCT03028974|100673565|FG002|NOT COMPLETED|2014-2015||0||
48142456|NCT03028974|100673566|FG003|NOT COMPLETED|2014-2015||0||
48142457|NCT03028974|100673567|FG004|NOT COMPLETED|2014-2015||0||
48142458|NCT03028974|100673568|FG005|NOT COMPLETED|2014-2015||0||
48142459|NCT03028974|100673569|FG006|NOT COMPLETED|2014-2015||0||
48142460|NCT03028974|100673563|FG000|STARTED|2015-2016||0|LAIV was not recommended in Groups A, B, C and F in 2015-2016.|
48142461|NCT03028974|100673564|FG001|STARTED|2015-2016||0|LAIV was not recommended in Groups A, B, C and F in 2015-2016.|
48142462|NCT03028974|100673565|FG002|STARTED|2015-2016||0|LAIV was not recommended in Groups A, B, C and F in 2015-2016.|
48142463|NCT03028974|100673566|FG003|STARTED|2015-2016||6|LAIV was not recommended in Groups A, B, C and F in 2015-2016.|
48142464|NCT03028974|100673567|FG004|STARTED|2015-2016||0|LAIV was not recommended in Groups A, B, C and F in 2015-2016.|
48142465|NCT03028974|100673568|FG005|STARTED|2015-2016||14|LAIV was not recommended in Groups A, B, C and F in 2015-2016.|
48142466|NCT03028974|100673569|FG006|STARTED|2015-2016||20|LAIV was not recommended in Groups A, B, C and F in 2015-2016.|
48142467|NCT03028974|100673563|FG000|COMPLETED|2015-2016||0||
48142468|NCT03028974|100673564|FG001|COMPLETED|2015-2016||0||
48142469|NCT03028974|100673565|FG002|COMPLETED|2015-2016||0||
48142470|NCT03028974|100673566|FG003|COMPLETED|2015-2016||6||
48142471|NCT03028974|100673567|FG004|COMPLETED|2015-2016||0||
48142472|NCT03028974|100673568|FG005|COMPLETED|2015-2016||14||
48142473|NCT03028974|100673569|FG006|COMPLETED|2015-2016||20||
48142474|NCT03028974|100673563|FG000|NOT COMPLETED|2015-2016||0||
48142475|NCT03028974|100673564|FG001|NOT COMPLETED|2015-2016||0||
48142476|NCT03028974|100673565|FG002|NOT COMPLETED|2015-2016||0||
48142477|NCT03028974|100673566|FG003|NOT COMPLETED|2015-2016||0||
48142478|NCT03028974|100673567|FG004|NOT COMPLETED|2015-2016||0||
48404922|NCT01452191|101325148|FG002|COMPLETED|Overall Study||258||12
48404923|NCT01452191|101325146|FG000|NOT COMPLETED|Overall Study||132||0
48404924|NCT01452191|101325147|FG001|NOT COMPLETED|Overall Study||117||0
48404925|NCT01452191|101325148|FG002|NOT COMPLETED|Overall Study||112||0
48404926|NCT01791465|101325149|FG000|STARTED|Overall Study||6||
48404927|NCT01791465|101325149|FG000|COMPLETED|Overall Study||6||
48597265|NCT00078949|101796574|FG000|COMPLETED|Overall Study||306||
48597266|NCT00078949|101796575|FG001|COMPLETED|Overall Study||304||
48597267|NCT00078949|101796576|FG002|COMPLETED|Overall Study||112||
48404928|NCT01791465|101325149|FG000|NOT COMPLETED|Overall Study||0||
48404929|NCT00948428|101325150|FG000|STARTED|Overall Study||185||
48597268|NCT00078949|101796577|FG003|COMPLETED|Overall Study||112||
48142479|NCT03028974|100673568|FG005|NOT COMPLETED|2015-2016||0||
48142480|NCT03028974|100673569|FG006|NOT COMPLETED|2015-2016||0||
48142481|NCT03028974|100673563|FG000|STARTED|2016-2017||0|Groups A, B, C and F closed to enrollment. LAIV4 not recommended.|
48142482|NCT03028974|100673564|FG001|STARTED|2016-2017||0|Groups A, B, C and F closed to enrollment. LAIV4 not recommended.|
48142483|NCT03028974|100673565|FG002|STARTED|2016-2017||0|Groups A, B, C and F closed to enrollment. LAIV4 not recommended.|
48142484|NCT03028974|100673566|FG003|STARTED|2016-2017||4|Groups A, B, C and F closed to enrollment. LAIV4 not recommended.|
48142485|NCT03028974|100673567|FG004|STARTED|2016-2017||2|Groups A, B, C and F closed to enrollment. LAIV4 not recommended.|
48142486|NCT03028974|100673568|FG005|STARTED|2016-2017||0|Groups A, B, C and F closed to enrollment. LAIV4 not recommended.|
48142487|NCT03028974|100673569|FG006|STARTED|2016-2017||18|Groups A, B, C and F closed to enrollment. LAIV4 not recommended.|
48142488|NCT03028974|100673563|FG000|COMPLETED|2016-2017||0||
48142489|NCT03028974|100673564|FG001|COMPLETED|2016-2017||0||
48142490|NCT03028974|100673565|FG002|COMPLETED|2016-2017||0||
48142491|NCT03028974|100673566|FG003|COMPLETED|2016-2017||4||
48142492|NCT03028974|100673567|FG004|COMPLETED|2016-2017||2||
48142493|NCT03028974|100673568|FG005|COMPLETED|2016-2017||0||
48142494|NCT03028974|100673569|FG006|COMPLETED|2016-2017||18||
48142495|NCT03028974|100673563|FG000|NOT COMPLETED|2016-2017||0||
48142496|NCT03028974|100673564|FG001|NOT COMPLETED|2016-2017||0||
48142497|NCT03028974|100673565|FG002|NOT COMPLETED|2016-2017||0||
48142498|NCT03028974|100673566|FG003|NOT COMPLETED|2016-2017||0||
48142499|NCT03028974|100673567|FG004|NOT COMPLETED|2016-2017||0||
48142500|NCT03028974|100673568|FG005|NOT COMPLETED|2016-2017||0||
48142501|NCT03028974|100673569|FG006|NOT COMPLETED|2016-2017||0||
48142502|NCT03028974|100673563|FG000|STARTED|2017-2018||0||
48142503|NCT03028974|100673564|FG001|STARTED|2017-2018||0||
48142504|NCT03028974|100673565|FG002|STARTED|2017-2018||0||
48142505|NCT03028974|100673566|FG003|STARTED|2017-2018||5||
48142506|NCT03028974|100673567|FG004|STARTED|2017-2018||0||
48142507|NCT03028974|100673568|FG005|STARTED|2017-2018||0||
48142508|NCT03028974|100673569|FG006|STARTED|2017-2018||5||
48142509|NCT03028974|100673563|FG000|COMPLETED|2017-2018||0||
48142510|NCT03028974|100673564|FG001|COMPLETED|2017-2018||0||
48142511|NCT03028974|100673565|FG002|COMPLETED|2017-2018||0||
48142512|NCT03028974|100673566|FG003|COMPLETED|2017-2018||5||
48142513|NCT03028974|100673567|FG004|COMPLETED|2017-2018||0||
48142514|NCT03028974|100673568|FG005|COMPLETED|2017-2018||0||
48142515|NCT03028974|100673569|FG006|COMPLETED|2017-2018||5||
48142516|NCT03028974|100673563|FG000|NOT COMPLETED|2017-2018||0||
48142517|NCT03028974|100673564|FG001|NOT COMPLETED|2017-2018||0||
48142518|NCT03028974|100673565|FG002|NOT COMPLETED|2017-2018||0||
48142519|NCT03028974|100673566|FG003|NOT COMPLETED|2017-2018||0||
48142520|NCT03028974|100673567|FG004|NOT COMPLETED|2017-2018||0||
48142521|NCT03028974|100673568|FG005|NOT COMPLETED|2017-2018||0||
48142522|NCT03028974|100673569|FG006|NOT COMPLETED|2017-2018||0||
48142523|NCT00829387|100673570|FG000|STARTED|Overall Study||23||
48142524|NCT00829387|100673571|FG001|STARTED|Overall Study||24||
48142525|NCT00829387|100673570|FG000|COMPLETED|Overall Study||20||
48142526|NCT00829387|100673571|FG001|COMPLETED|Overall Study||21||
48142527|NCT00829387|100673570|FG000|NOT COMPLETED|Overall Study||3||
48142528|NCT00829387|100673571|FG001|NOT COMPLETED|Overall Study||3||
48142529|NCT01754467|100673572|FG000|STARTED|Overall Study||9||
48142530|NCT01754467|100673572|FG000|COMPLETED|Overall Study||8||
48142531|NCT01754467|100673572|FG000|NOT COMPLETED|Overall Study||1||
48142532|NCT00126438|100673573|FG000|STARTED|Overall Study||453||
48142533|NCT00126438|100673574|FG001|STARTED|Overall Study||62||
48142534|NCT00126438|100673573|FG000|COMPLETED|Overall Study||419||
48142535|NCT00126438|100673574|FG001|COMPLETED|Overall Study||52||
48142536|NCT00126438|100673573|FG000|NOT COMPLETED|Overall Study||34||
48142537|NCT00126438|100673574|FG001|NOT COMPLETED|Overall Study||10||
48142538|NCT02301143|100673575|FG000|STARTED|Induction Period||107|Participants enrolled.|
48142539|NCT02301143|100673576|FG001|STARTED|Induction Period||0|Participants enrolled.|
48142540|NCT02301143|100673575|FG000|COMPLETED|Induction Period||62||
48142541|NCT02301143|100673576|FG001|COMPLETED|Induction Period||0||
48142542|NCT02301143|100673575|FG000|NOT COMPLETED|Induction Period||45||
48142543|NCT02301143|100673576|FG001|NOT COMPLETED|Induction Period||0||
48142544|NCT02301143|100673575|FG000|STARTED|Investigator's Choice||0||
48142545|NCT02301143|100673576|FG001|STARTED|Investigator's Choice||47||
48142546|NCT02301143|100673575|FG000|COMPLETED|Investigator's Choice||0||
48142547|NCT02301143|100673576|FG001|COMPLETED|Investigator's Choice||37||
48142548|NCT02301143|100673575|FG000|NOT COMPLETED|Investigator's Choice||0||
48142549|NCT02301143|100673576|FG001|NOT COMPLETED|Investigator's Choice||10||
48142550|NCT03834779|100673577|FG000|STARTED|Overall Study||17||
48142551|NCT03834779|100673578|FG001|STARTED|Overall Study||14||
48142552|NCT03834779|100673577|FG000|COMPLETED|Overall Study||10||
48142553|NCT03834779|100673578|FG001|COMPLETED|Overall Study||8||
48142554|NCT03834779|100673577|FG000|NOT COMPLETED|Overall Study||7||
48142555|NCT03834779|100673578|FG001|NOT COMPLETED|Overall Study||6||
48142556|NCT03593655|100673579|FG000|STARTED|First Product Use Period||124||
48142557|NCT03593655|100673580|FG001|STARTED|First Product Use Period||123||
48142558|NCT03593655|100673579|FG000|COMPLETED|First Product Use Period||122||
48142559|NCT03593655|100673580|FG001|COMPLETED|First Product Use Period||119||
48142560|NCT03593655|100673579|FG000|NOT COMPLETED|First Product Use Period||2||
48142561|NCT03593655|100673580|FG001|NOT COMPLETED|First Product Use Period||4||
48142562|NCT03593655|100673579|FG000|STARTED|Second Product Use Period||122||
48142563|NCT03593655|100673580|FG001|STARTED|Second Product Use Period||119||
48142564|NCT03593655|100673579|FG000|COMPLETED|Second Product Use Period||120||
48142565|NCT03593655|100673580|FG001|COMPLETED|Second Product Use Period||118||
48142566|NCT03593655|100673579|FG000|NOT COMPLETED|Second Product Use Period||2||
48142567|NCT03593655|100673580|FG001|NOT COMPLETED|Second Product Use Period||1||
48142568|NCT03593655|100673579|FG000|STARTED|Third Product Use Period||120||
48142569|NCT03593655|100673580|FG001|STARTED|Third Product Use Period||118||
48142570|NCT03593655|100673579|FG000|Always Chose Dapivirine Vaginal Ring|Third Product Use Period||66||
48142571|NCT03593655|100673580|FG001|Always Chose Dapivirine Vaginal Ring|Third Product Use Period||71||
48142572|NCT03593655|100673579|FG000|Always Chose FTC/TDF|Third Product Use Period||35||
48142573|NCT03593655|100673580|FG001|Always Chose FTC/TDF|Third Product Use Period||27||
48142574|NCT03593655|100673579|FG000|At Least One Switch|Third Product Use Period||17|This category includes participants who switched between the ring and FTC/TDF, as well as participants who switched between using one/both of the products and using neither product.|
48142575|NCT03593655|100673580|FG001|At Least One Switch|Third Product Use Period||13|This category includes participants who switched between the ring and FTC/TDF, as well as participants who switched between using one/both of the products and using neither product.|
48142576|NCT03593655|100673579|FG000|Never Chose Either Product|Third Product Use Period||2||
48597269|NCT00078949|101796574|FG000|NOT COMPLETED|Overall Study||4||
48597270|NCT00078949|101796575|FG001|NOT COMPLETED|Overall Study||5||
48142577|NCT03593655|100673580|FG001|Never Chose Either Product|Third Product Use Period||7||
48142578|NCT03593655|100673579|FG000|COMPLETED|Third Product Use Period||119||
48142579|NCT03593655|100673580|FG001|COMPLETED|Third Product Use Period||114||
48142580|NCT03593655|100673579|FG000|NOT COMPLETED|Third Product Use Period||1||
48142581|NCT03593655|100673580|FG001|NOT COMPLETED|Third Product Use Period||4||
48142582|NCT01953081|100673581|FG000|STARTED|Overall Study||7||
48142583|NCT01953081|100673582|FG001|STARTED|Overall Study||6||
48142584|NCT01953081|100673581|FG000|COMPLETED|Overall Study||5||
48142585|NCT01953081|100673582|FG001|COMPLETED|Overall Study||3||
48142586|NCT01953081|100673581|FG000|NOT COMPLETED|Overall Study||2||
48142587|NCT01953081|100673582|FG001|NOT COMPLETED|Overall Study||3||
48142588|NCT00386880|100673583|FG000|STARTED|Overall Study||30||
48142589|NCT00386880|100673584|FG001|STARTED|Overall Study||8||
48142590|NCT00386880|100673583|FG000|COMPLETED|Overall Study||30||
48142591|NCT00386880|100673584|FG001|COMPLETED|Overall Study||8||
48142592|NCT00386880|100673583|FG000|NOT COMPLETED|Overall Study||0||
48142593|NCT00386880|100673584|FG001|NOT COMPLETED|Overall Study||0||
48142594|NCT00754845|100673585|FG000|STARTED|Overall Study||959||
48142595|NCT00754845|100673586|FG001|STARTED|Overall Study||959||
48142596|NCT00754845|100673585|FG000|COMPLETED|Overall Study||959||
48142597|NCT00754845|100673586|FG001|COMPLETED|Overall Study||959||
48142598|NCT00754845|100673585|FG000|NOT COMPLETED|Overall Study||0||
48142599|NCT00754845|100673586|FG001|NOT COMPLETED|Overall Study||0||
48142600|NCT04313881|100673587|FG000|STARTED|Overall Study||268||
48142601|NCT04313881|100673588|FG001|STARTED|Overall Study||271||
48142602|NCT04313881|100673587|FG000|COMPLETED|Overall Study||0||
48142603|NCT04313881|100673588|FG001|COMPLETED|Overall Study||0||
48142604|NCT04313881|100673587|FG000|NOT COMPLETED|Overall Study||268||
48142605|NCT04313881|100673588|FG001|NOT COMPLETED|Overall Study||271||
48142606|NCT01011829|100673589|FG000|STARTED|Overall Study||10||
48142607|NCT01011829|100673590|FG001|STARTED|Overall Study||10||
48142608|NCT01011829|100673589|FG000|COMPLETED|Overall Study||6||
48142609|NCT01011829|100673590|FG001|COMPLETED|Overall Study||1||
48142610|NCT01011829|100673589|FG000|NOT COMPLETED|Overall Study||4||
48142611|NCT01011829|100673590|FG001|NOT COMPLETED|Overall Study||9||
48142612|NCT00791765|100673591|FG000|STARTED|Weeks 1 to 12||62||
48142613|NCT00791765|100673592|FG001|STARTED|Weeks 1 to 12||62||
48142614|NCT00791765|100673591|FG000|Treated|Weeks 1 to 12||62||
48142615|NCT00791765|100673592|FG001|Treated|Weeks 1 to 12||59||
48142616|NCT00791765|100673591|FG000|COMPLETED|Weeks 1 to 12||54||
48142617|NCT00791765|100673592|FG001|COMPLETED|Weeks 1 to 12||58||
48142618|NCT00791765|100673591|FG000|NOT COMPLETED|Weeks 1 to 12||8||
48142619|NCT00791765|100673592|FG001|NOT COMPLETED|Weeks 1 to 12||4||
48142620|NCT00791765|100673591|FG000|STARTED|Weeks 13 to 24||54||
48142621|NCT00791765|100673592|FG001|STARTED|Weeks 13 to 24||57||
48142622|NCT00791765|100673591|FG000|COMPLETED|Weeks 13 to 24||49||
48142623|NCT00791765|100673592|FG001|COMPLETED|Weeks 13 to 24||49||
48142624|NCT00791765|100673591|FG000|NOT COMPLETED|Weeks 13 to 24||5||
48142625|NCT00791765|100673592|FG001|NOT COMPLETED|Weeks 13 to 24||8||
48142626|NCT00907153|100673593|FG000|STARTED|Overall Study||13||
48142627|NCT00907153|100673594|FG001|STARTED|Overall Study||15||
48142628|NCT00907153|100673593|FG000|COMPLETED|Overall Study||11||
48142629|NCT00907153|100673594|FG001|COMPLETED|Overall Study||11||
48597271|NCT00078949|101796576|FG002|NOT COMPLETED|Overall Study||3||
48597272|NCT00078949|101796577|FG003|NOT COMPLETED|Overall Study||3||
48597273|NCT01078298|101796578|FG000|STARTED|Overall Study||256||
48597274|NCT01078298|101796579|FG001|STARTED|Overall Study||269||
48597275|NCT01078298|101796578|FG000|COMPLETED|Overall Study||175||
48597276|NCT01078298|101796579|FG001|COMPLETED|Overall Study||179||
48142630|NCT00907153|100673593|FG000|NOT COMPLETED|Overall Study||2||
48142631|NCT00907153|100673594|FG001|NOT COMPLETED|Overall Study||4||
48142632|NCT00417079|100673595|FG000|STARTED|Overall Study||377||
48142633|NCT00417079|100673596|FG001|STARTED|Overall Study||378||
48142634|NCT00417079|100673595|FG000|COMPLETED|Overall Study||46||
48142635|NCT00417079|100673596|FG001|COMPLETED|Overall Study||105||
48142636|NCT00417079|100673595|FG000|NOT COMPLETED|Overall Study||331||
48142637|NCT00417079|100673596|FG001|NOT COMPLETED|Overall Study||273||
48142638|NCT01016769|100673597|FG000|STARTED|Overall Study||4||
48142639|NCT01016769|100673598|FG001|STARTED|Overall Study||7||
48142640|NCT01016769|100673599|FG002|STARTED|Overall Study||7||
48142641|NCT01016769|100673600|FG003|STARTED|Overall Study||30||
48142642|NCT01016769|100673597|FG000|COMPLETED|Overall Study||3||
48142643|NCT01016769|100673598|FG001|COMPLETED|Overall Study||6||
48142644|NCT01016769|100673599|FG002|COMPLETED|Overall Study||6||
48142645|NCT01016769|100673600|FG003|COMPLETED|Overall Study||30||
48142646|NCT01016769|100673597|FG000|NOT COMPLETED|Overall Study||1||
48142647|NCT01016769|100673598|FG001|NOT COMPLETED|Overall Study||1||
48142648|NCT01016769|100673599|FG002|NOT COMPLETED|Overall Study||1||
48142649|NCT01016769|100673600|FG003|NOT COMPLETED|Overall Study||0||
48142650|NCT02297308|100673601|FG000|STARTED|Overall Study||90||
48142651|NCT02297308|100673601|FG000|COMPLETED|Overall Study||90||
48142652|NCT02297308|100673601|FG000|NOT COMPLETED|Overall Study||0||
48142653|NCT03774186|100673602|FG000|STARTED|Overall Study||12||
48142654|NCT03774186|100673603|FG001|STARTED|Overall Study||12||
48142655|NCT03774186|100673602|FG000|COMPLETED|Overall Study||12||
48142656|NCT03774186|100673603|FG001|COMPLETED|Overall Study||11||
48142657|NCT03774186|100673602|FG000|NOT COMPLETED|Overall Study||0||
48142658|NCT03774186|100673603|FG001|NOT COMPLETED|Overall Study||1||
48142659|NCT03543254|100673604|FG000|STARTED|Overall Study||20||
48142660|NCT03543254|100673604|FG000|COMPLETED|Overall Study||19||
48142661|NCT03543254|100673604|FG000|NOT COMPLETED|Overall Study||1||
48142662|NCT02834780|100673605|FG000|STARTED|Overall Study||3||
48142663|NCT02834780|100673606|FG001|STARTED|Overall Study||3||
48142664|NCT02834780|100673607|FG002|STARTED|Overall Study||4||
48142665|NCT02834780|100673608|FG003|STARTED|Overall Study||10||
48142666|NCT02834780|100673609|FG004|STARTED|Overall Study||3||
48142667|NCT02834780|100673610|FG005|STARTED|Overall Study||7||
48142668|NCT02834780|100673611|FG006|STARTED|Overall Study||4||
48142669|NCT02834780|100673612|FG007|STARTED|Overall Study||7||
48142670|NCT02834780|100673613|FG008|STARTED|Overall Study||3||
48142671|NCT02834780|100673614|FG009|STARTED|Overall Study||10||
48142672|NCT02834780|100673615|FG010|STARTED|Overall Study||5||
48142673|NCT02834780|100673616|FG011|STARTED|Overall Study||29||
48142674|NCT02834780|100673617|FG012|STARTED|Overall Study||40||
48712639|NCT00966719|102084784|FG001|NOT COMPLETED|Overall Study||11||
48712640|NCT01958021|102084785|FG000|STARTED|Overall Study||334||
48712641|NCT01958021|102084786|FG001|STARTED|Overall Study||334||
48712642|NCT01958021|102084785|FG000|Patients Untreated|Overall Study||0||
48142675|NCT02834780|100673605|FG000|COMPLETED|Overall Study||0||
48142676|NCT02834780|100673606|FG001|COMPLETED|Overall Study||0||
48142677|NCT02834780|100673607|FG002|COMPLETED|Overall Study||0||
48142678|NCT02834780|100673608|FG003|COMPLETED|Overall Study||0||
48712643|NCT01958021|102084786|FG001|Patients Untreated|Overall Study||4||
48712644|NCT01958021|102084785|FG000|Patients Treated|Overall Study||334||
48712645|NCT01958021|102084786|FG001|Patients Treated|Overall Study||330||
48712646|NCT01958021|102084785|FG000|COMPLETED|Overall Study||195||
48142679|NCT02834780|100673609|FG004|COMPLETED|Overall Study||0||
48142680|NCT02834780|100673610|FG005|COMPLETED|Overall Study||0||
48142681|NCT02834780|100673611|FG006|COMPLETED|Overall Study||0||
48142682|NCT02834780|100673612|FG007|COMPLETED|Overall Study||0||
48142683|NCT02834780|100673613|FG008|COMPLETED|Overall Study||0||
48142684|NCT02834780|100673614|FG009|COMPLETED|Overall Study||0||
48142685|NCT02834780|100673615|FG010|COMPLETED|Overall Study||0||
48142686|NCT02834780|100673616|FG011|COMPLETED|Overall Study||0||
48142687|NCT02834780|100673617|FG012|COMPLETED|Overall Study||0||
48142688|NCT02834780|100673605|FG000|NOT COMPLETED|Overall Study||3||
48142689|NCT02834780|100673606|FG001|NOT COMPLETED|Overall Study||3||
48142690|NCT02834780|100673607|FG002|NOT COMPLETED|Overall Study||4||
48142691|NCT02834780|100673608|FG003|NOT COMPLETED|Overall Study||10||
48142692|NCT02834780|100673609|FG004|NOT COMPLETED|Overall Study||3||
48142693|NCT02834780|100673610|FG005|NOT COMPLETED|Overall Study||7||
48142694|NCT02834780|100673611|FG006|NOT COMPLETED|Overall Study||4||
48142695|NCT02834780|100673612|FG007|NOT COMPLETED|Overall Study||7||
48142696|NCT02834780|100673613|FG008|NOT COMPLETED|Overall Study||3||
48142697|NCT02834780|100673614|FG009|NOT COMPLETED|Overall Study||10||
48142698|NCT02834780|100673615|FG010|NOT COMPLETED|Overall Study||5||
48142699|NCT02834780|100673616|FG011|NOT COMPLETED|Overall Study||29||
48142700|NCT02834780|100673617|FG012|NOT COMPLETED|Overall Study||40||
48142701|NCT02820623|100673618|FG000|STARTED|Overall Study||41||
48142702|NCT02820623|100673619|FG001|STARTED|Overall Study||42||
48142703|NCT02820623|100673620|FG002|STARTED|Overall Study||43||
48712647|NCT01958021|102084786|FG001|COMPLETED|Overall Study||154||
48712648|NCT01958021|102084785|FG000|NOT COMPLETED|Overall Study||139||
48142704|NCT02820623|100673618|FG000|COMPLETED|Overall Study||36||
48142705|NCT02820623|100673619|FG001|COMPLETED|Overall Study||35||
48142706|NCT02820623|100673620|FG002|COMPLETED|Overall Study||32||
48142707|NCT02820623|100673618|FG000|NOT COMPLETED|Overall Study||5||
48142708|NCT02820623|100673619|FG001|NOT COMPLETED|Overall Study||7||
48142709|NCT02820623|100673620|FG002|NOT COMPLETED|Overall Study||11||
48142710|NCT00054353|100673621|FG000|STARTED|Overall Study||12||
48142711|NCT00054353|100673622|FG001|STARTED|Overall Study||4||
48142712|NCT00054353|100673621|FG000|COMPLETED|Overall Study||12||
48142713|NCT00054353|100673622|FG001|COMPLETED|Overall Study||4||
48142714|NCT00054353|100673621|FG000|NOT COMPLETED|Overall Study||0||
48142715|NCT00054353|100673622|FG001|NOT COMPLETED|Overall Study||0||
48142716|NCT01090453|100673623|FG000|STARTED|Overall Study||238||
48142717|NCT01090453|100673624|FG001|STARTED|Overall Study||242||
48142718|NCT01090453|100673623|FG000|COMPLETED|Overall Study||225||
48142719|NCT01090453|100673624|FG001|COMPLETED|Overall Study||228||
48142720|NCT01090453|100673623|FG000|NOT COMPLETED|Overall Study||13||
48142721|NCT01090453|100673624|FG001|NOT COMPLETED|Overall Study||14||
48142722|NCT03320070|100673625|FG000|STARTED|DBT Phase (Week 1 to Week 24)||27||
48142723|NCT03320070|100673626|FG001|STARTED|DBT Phase (Week 1 to Week 24)||28||
48142724|NCT03320070|100673625|FG000|Modified Intent-to-Treat Population (mITT)|DBT Phase (Week 1 to Week 24)||27|The mITT population included all randomized participants who received at least 1 dose of investigational medicinal product (IMP) and who contributed any efficacy data to the study.|
48142725|NCT03320070|100673626|FG001|Modified Intent-to-Treat Population (mITT)|DBT Phase (Week 1 to Week 24)||28|The mITT population included all randomized participants who received at least 1 dose of investigational medicinal product (IMP) and who contributed any efficacy data to the study.|
48142726|NCT03320070|100673625|FG000|Safety Population|DBT Phase (Week 1 to Week 24)||27|The safety population included all randomized participants who received at least 1 dose of IMP.|
48142727|NCT03320070|100673626|FG001|Safety Population|DBT Phase (Week 1 to Week 24)||28|The safety population included all randomized participants who received at least 1 dose of IMP.|
48142728|NCT03320070|100673625|FG000|COMPLETED|DBT Phase (Week 1 to Week 24)||24||
48142729|NCT03320070|100673626|FG001|COMPLETED|DBT Phase (Week 1 to Week 24)||25||
48142730|NCT03320070|100673625|FG000|NOT COMPLETED|DBT Phase (Week 1 to Week 24)||3||
48142731|NCT03320070|100673626|FG001|NOT COMPLETED|DBT Phase (Week 1 to Week 24)||3||
48597277|NCT01078298|101796578|FG000|NOT COMPLETED|Overall Study||81||
48597278|NCT01078298|101796579|FG001|NOT COMPLETED|Overall Study||90||
48597279|NCT00597012|101796580|FG000|STARTED|Overall Study||174||
48597280|NCT00597012|101796581|FG001|STARTED|Overall Study||177||
48597281|NCT00597012|101796580|FG000|COMPLETED|Overall Study||161||
48597282|NCT00597012|101796581|FG001|COMPLETED|Overall Study||169||
48597283|NCT00597012|101796580|FG000|NOT COMPLETED|Overall Study||13||
48597284|NCT00597012|101796581|FG001|NOT COMPLETED|Overall Study||8||
48597285|NCT02450552|101796582|FG000|STARTED|Overall Study||19||
48597286|NCT02450552|101796583|FG001|STARTED|Overall Study||23||
48597287|NCT02450552|101796584|FG002|STARTED|Overall Study||23||
48597288|NCT02450552|101796582|FG000|COMPLETED|Overall Study||14||
48597289|NCT02450552|101796583|FG001|COMPLETED|Overall Study||23||
48597290|NCT02450552|101796584|FG002|COMPLETED|Overall Study||18||
48597291|NCT02450552|101796582|FG000|NOT COMPLETED|Overall Study||5||
48597292|NCT02450552|101796583|FG001|NOT COMPLETED|Overall Study||0||
48597293|NCT02450552|101796584|FG002|NOT COMPLETED|Overall Study||5||
48597294|NCT01634659|101796585|FG000|STARTED|Period 1 - First 8 Days of Wear||155||
48597295|NCT01634659|101796586|FG001|STARTED|Period 1 - First 8 Days of Wear||158||
48597296|NCT01634659|101796585|FG000|COMPLETED|Period 1 - First 8 Days of Wear||155||
48597297|NCT01634659|101796586|FG001|COMPLETED|Period 1 - First 8 Days of Wear||158||
48597298|NCT01634659|101796585|FG000|NOT COMPLETED|Period 1 - First 8 Days of Wear||0||
48597299|NCT01634659|101796586|FG001|NOT COMPLETED|Period 1 - First 8 Days of Wear||0||
48597300|NCT01634659|101796585|FG000|STARTED|Period 2 - Second 8 Days of Wear||155||
48597301|NCT01634659|101796586|FG001|STARTED|Period 2 - Second 8 Days of Wear||158||
48597302|NCT01634659|101796585|FG000|COMPLETED|Period 2 - Second 8 Days of Wear||152||
48597303|NCT01634659|101796586|FG001|COMPLETED|Period 2 - Second 8 Days of Wear||158||
48597304|NCT01634659|101796585|FG000|NOT COMPLETED|Period 2 - Second 8 Days of Wear||3||
48597305|NCT01634659|101796586|FG001|NOT COMPLETED|Period 2 - Second 8 Days of Wear||0||
48597306|NCT04594941|101796587|FG000|STARTED|Overall Study||7||
48597307|NCT04594941|101796588|FG001|STARTED|Overall Study||10||
48142732|NCT03320070|100673625|FG000|STARTED|OLE Phase (Week 25 to Week 48)||22||
48142733|NCT03320070|100673626|FG001|STARTED|OLE Phase (Week 25 to Week 48)||25||
48188512|NCT01686932|100783262|FG000|NOT COMPLETED|Period 1||1||
48367935|NCT03661541|101230077|FG000|COMPLETED|Overall Study||10||
48597308|NCT04594941|101796589|FG002|STARTED|Overall Study||11||
48597309|NCT04594941|101796590|FG003|STARTED|Overall Study||7||
48597310|NCT04594941|101796587|FG000|Modified Intent-to-Treat (mITT) Population|Overall Study||7|mITT population included all participants who were randomized to receive \>=1 dose of Flurpiridaz (18F) Injection and who completed the 2 rest Flurpiridaz (18F) Injection PET-MPI procedures.|
48597311|NCT04594941|101796588|FG001|Modified Intent-to-Treat (mITT) Population|Overall Study||7|mITT population included all participants who were randomized to receive \>=1 dose of Flurpiridaz (18F) Injection and who completed the 2 rest Flurpiridaz (18F) Injection PET-MPI procedures.|
48597312|NCT04594941|101796589|FG002|Modified Intent-to-Treat (mITT) Population|Overall Study||10|mITT population included all participants who were randomized to receive \>=1 dose of Flurpiridaz (18F) Injection and who completed the 2 rest Flurpiridaz (18F) Injection PET-MPI procedures.|
48656872|NCT01708941|101943721|FG000|Eligible and Started Treatment|Overall Study||18||
48142734|NCT03320070|100673625|FG000|Open-label Safety Population|OLE Phase (Week 25 to Week 48)||22|The open-label safety population included participants who continued into the optional OLE phase and received at least one dose of IMP during the OLE phase.|
48142735|NCT03320070|100673626|FG001|Open-label Safety Population|OLE Phase (Week 25 to Week 48)||25|The open-label safety population included participants who continued into the optional OLE phase and received at least one dose of IMP during the OLE phase.|
48142736|NCT03320070|100673625|FG000|COMPLETED|OLE Phase (Week 25 to Week 48)||17||
48142737|NCT03320070|100673626|FG001|COMPLETED|OLE Phase (Week 25 to Week 48)||23||
48142738|NCT03320070|100673625|FG000|NOT COMPLETED|OLE Phase (Week 25 to Week 48)||5||
48142739|NCT03320070|100673626|FG001|NOT COMPLETED|OLE Phase (Week 25 to Week 48)||2||
48142740|NCT01003899|100673627|FG000|STARTED|Overall Study||47||
48142741|NCT01003899|100673627|FG000|COMPLETED|Overall Study||0||
48142742|NCT01003899|100673627|FG000|NOT COMPLETED|Overall Study||47||
48142743|NCT01997398|100673628|FG000|STARTED|Overall Study||35||
48142744|NCT01997398|100673628|FG000|COMPLETED|Overall Study||34||
48142745|NCT01997398|100673628|FG000|NOT COMPLETED|Overall Study||1||
48142746|NCT01667432|100673629|FG000|STARTED|Overall Study||141||
48142747|NCT01667432|100673629|FG000|COMPLETED|Overall Study||84||
48142748|NCT01667432|100673629|FG000|NOT COMPLETED|Overall Study||57||
48142749|NCT01990950|100673630|FG000|STARTED|Overall Study||21||
48142750|NCT01990950|100673630|FG000|COMPLETED|Overall Study||10||
48142751|NCT01990950|100673630|FG000|NOT COMPLETED|Overall Study||11||
48142752|NCT00209417|100673631|FG000|STARTED|Overall Study||321||
48142753|NCT00209417|100673632|FG001|STARTED|Overall Study||327||
48142754|NCT00209417|100673631|FG000|COMPLETED|Overall Study||321||
48142755|NCT00209417|100673632|FG001|COMPLETED|Overall Study||327||
48142756|NCT00209417|100673631|FG000|NOT COMPLETED|Overall Study||0||
48142757|NCT00209417|100673632|FG001|NOT COMPLETED|Overall Study||0||
48142758|NCT02372396|100673633|FG000|STARTED|Overall Study||17||
48142759|NCT02372396|100673634|FG001|STARTED|Overall Study||20||
48142760|NCT02372396|100673633|FG000|Began Intervention|Overall Study||14||
48142761|NCT02372396|100673634|FG001|Began Intervention|Overall Study||14||
48142762|NCT02372396|100673633|FG000|COMPLETED|Overall Study||10||
48142763|NCT02372396|100673634|FG001|COMPLETED|Overall Study||11||
48142764|NCT02372396|100673633|FG000|NOT COMPLETED|Overall Study||7||
48142765|NCT02372396|100673634|FG001|NOT COMPLETED|Overall Study||9||
48142766|NCT01250977|100673635|FG000|STARTED|Overall Study||6||
48142767|NCT01250977|100673636|FG001|STARTED|Overall Study||14||
48142768|NCT01250977|100673635|FG000|COMPLETED|Overall Study||6||
48142769|NCT01250977|100673636|FG001|COMPLETED|Overall Study||12||
48142770|NCT01250977|100673635|FG000|NOT COMPLETED|Overall Study||0||
48142771|NCT01250977|100673636|FG001|NOT COMPLETED|Overall Study||2||
48142772|NCT00423176|100673637|FG000|STARTED|Overall Study||114||
48142773|NCT00423176|100673638|FG001|STARTED|Overall Study||123||
48142774|NCT00423176|100673637|FG000|COMPLETED|Overall Study||98||
48142775|NCT00423176|100673638|FG001|COMPLETED|Overall Study||94||
48142776|NCT00423176|100673637|FG000|NOT COMPLETED|Overall Study||16||
48142777|NCT00423176|100673638|FG001|NOT COMPLETED|Overall Study||29||
48142778|NCT01308918|100673639|FG000|STARTED|Overall Study||50||
48142779|NCT01308918|100673639|FG000|COMPLETED|Overall Study||50||
48142780|NCT01308918|100673639|FG000|NOT COMPLETED|Overall Study||0||
48142781|NCT03543826|100673640|FG000|STARTED|Overall Study||163||
48142782|NCT03543826|100673640|FG000|COMPLETED|Overall Study||163||
48142783|NCT03543826|100673640|FG000|NOT COMPLETED|Overall Study||0||
48142784|NCT01641978|100673641|FG000|STARTED|Overall Study||125||
48142785|NCT01641978|100673641|FG000|COMPLETED|Overall Study||125||
48142786|NCT01641978|100673641|FG000|NOT COMPLETED|Overall Study||0||
48142787|NCT00674986|100673642|FG000|STARTED|Overall Study||230||
48404930|NCT00948428|101325151|FG001|STARTED|Overall Study||185||
48404931|NCT00948428|101325152|FG002|STARTED|Overall Study||92||
48404932|NCT00948428|101325150|FG000|COMPLETED|Overall Study||167||
48404933|NCT00948428|101325151|FG001|COMPLETED|Overall Study||167||
48404934|NCT00948428|101325152|FG002|COMPLETED|Overall Study||84||
48404935|NCT00948428|101325150|FG000|NOT COMPLETED|Overall Study||18||
48404936|NCT00948428|101325151|FG001|NOT COMPLETED|Overall Study||18||
48404937|NCT00948428|101325152|FG002|NOT COMPLETED|Overall Study||8||
48404938|NCT00552344|101325153|FG000|STARTED|Overall Study||402||
48404939|NCT00552344|101325153|FG000|COMPLETED|Overall Study||87||
48142788|NCT00674986|100673643|FG001|STARTED|Overall Study||269||
48142789|NCT00674986|100673642|FG000|Intent to Treat Population|Overall Study||227||
48142790|NCT00674986|100673643|FG001|Intent to Treat Population|Overall Study||256||
48142791|NCT00674986|100673642|FG000|COMPLETED|Overall Study||187||
48142792|NCT00674986|100673643|FG001|COMPLETED|Overall Study||188||
48142793|NCT00674986|100673642|FG000|NOT COMPLETED|Overall Study||43||
48142794|NCT00674986|100673643|FG001|NOT COMPLETED|Overall Study||81||
48142795|NCT02576678|100673644|FG000|STARTED|Overall Study||13||
48142796|NCT02576678|100673645|FG001|STARTED|Overall Study||8||
48404940|NCT00552344|101325153|FG000|NOT COMPLETED|Overall Study||315||
48404941|NCT01201967|101325154|FG000|STARTED|Overall Study||92||
48142797|NCT02576678|100673646|FG002|STARTED|Overall Study||21||
48142798|NCT02576678|100673644|FG000|Pharmacokinetic (PK) Population|Overall Study||12|PK participants had at least 1 dose of drug and had evaluable PK data|
48142799|NCT02576678|100673645|FG001|Pharmacokinetic (PK) Population|Overall Study||8|PK participants had at least 1 dose of drug and had evaluable PK data|
48404942|NCT01201967|101325155|FG001|STARTED|Overall Study||91||
48404943|NCT01201967|101325154|FG000|COMPLETED|Overall Study||86||
48404944|NCT01201967|101325155|FG001|COMPLETED|Overall Study||86||
48404945|NCT01201967|101325154|FG000|NOT COMPLETED|Overall Study||6||
48142800|NCT02576678|100673646|FG002|Pharmacokinetic (PK) Population|Overall Study||18|PK participants had at least 1 dose of drug and had evaluable PK data|
48142801|NCT02576678|100673644|FG000|COMPLETED|Overall Study||8|Completed = participants who completed week 50.|
48142802|NCT02576678|100673645|FG001|COMPLETED|Overall Study||7|Completed = participants who completed week 50.|
48142803|NCT02576678|100673646|FG002|COMPLETED|Overall Study||16|Completed = participants who completed week 50.|
48142804|NCT02576678|100673644|FG000|NOT COMPLETED|Overall Study||5||
48142805|NCT02576678|100673645|FG001|NOT COMPLETED|Overall Study||1||
48142806|NCT02576678|100673646|FG002|NOT COMPLETED|Overall Study||5||
48142807|NCT03591068|100673647|FG000|STARTED|Overall Study||11||
48142808|NCT03591068|100673647|FG000|COMPLETED|Overall Study||9||
48142809|NCT03591068|100673647|FG000|NOT COMPLETED|Overall Study||2||
48142810|NCT01640808|100673648|FG000|STARTED|Overall Study||309||
48142811|NCT01640808|100673649|FG001|STARTED|Overall Study||307||
48142812|NCT01640808|100673648|FG000|Subjects Received Treatment|Overall Study||305||
48142813|NCT01640808|100673649|FG001|Subjects Received Treatment|Overall Study||305||
48142814|NCT01640808|100673648|FG000|COMPLETED|Overall Study||251||
48142815|NCT01640808|100673649|FG001|COMPLETED|Overall Study||291||
48142816|NCT01640808|100673648|FG000|NOT COMPLETED|Overall Study||58||
48142817|NCT01640808|100673649|FG001|NOT COMPLETED|Overall Study||16||
48142818|NCT03905655|100673650|FG000|STARTED|Overall Study||13||
48142819|NCT03905655|100673651|FG001|STARTED|Overall Study||13||
48142820|NCT03905655|100673652|FG002|STARTED|Overall Study||11||
48142821|NCT03905655|100673653|FG003|STARTED|Overall Study||14||
48142822|NCT03905655|100673650|FG000|COMPLETED|Overall Study||12||
48142823|NCT03905655|100673651|FG001|COMPLETED|Overall Study||13||
48142824|NCT03905655|100673652|FG002|COMPLETED|Overall Study||10||
48142825|NCT03905655|100673653|FG003|COMPLETED|Overall Study||13||
48142826|NCT03905655|100673650|FG000|NOT COMPLETED|Overall Study||1||
48142827|NCT03905655|100673651|FG001|NOT COMPLETED|Overall Study||0||
48142828|NCT03905655|100673652|FG002|NOT COMPLETED|Overall Study||1||
48142829|NCT03905655|100673653|FG003|NOT COMPLETED|Overall Study||1||
48142830|NCT02968420|100673654|FG000|STARTED|Overall Study||6||
48142831|NCT02968420|100673655|FG001|STARTED|Overall Study||6||
48142832|NCT02968420|100673656|FG002|STARTED|Overall Study||6||
48142833|NCT02968420|100673654|FG000|COMPLETED|Overall Study||6||
48142834|NCT02968420|100673655|FG001|COMPLETED|Overall Study||6||
48597313|NCT04594941|101796590|FG003|Modified Intent-to-Treat (mITT) Population|Overall Study||7|mITT population included all participants who were randomized to receive \>=1 dose of Flurpiridaz (18F) Injection and who completed the 2 rest Flurpiridaz (18F) Injection PET-MPI procedures.|
48597314|NCT04594941|101796587|FG000|COMPLETED|Overall Study||7||
48597315|NCT04594941|101796588|FG001|COMPLETED|Overall Study||7||
48597316|NCT04594941|101796589|FG002|COMPLETED|Overall Study||10||
48597317|NCT04594941|101796590|FG003|COMPLETED|Overall Study||7||
48597318|NCT04594941|101796587|FG000|NOT COMPLETED|Overall Study||0||
48597319|NCT04594941|101796588|FG001|NOT COMPLETED|Overall Study||3||
48597320|NCT04594941|101796589|FG002|NOT COMPLETED|Overall Study||1||
48597321|NCT04594941|101796590|FG003|NOT COMPLETED|Overall Study||0||
48597322|NCT02603926|101796591|FG000|STARTED|Overall Study||6||
48597323|NCT02603926|101796591|FG000|COMPLETED|Overall Study||6||
48597324|NCT02603926|101796591|FG000|NOT COMPLETED|Overall Study||0||
48597325|NCT04504175|101796592|FG000|STARTED|Acute Phase||25||
48597326|NCT04504175|101796592|FG000|COMPLETED|Acute Phase||23||
48597327|NCT04504175|101796592|FG000|NOT COMPLETED|Acute Phase||2||
48597328|NCT04504175|101796592|FG000|STARTED|Continuation Phase||15||
48597329|NCT04504175|101796592|FG000|COMPLETED|Continuation Phase||15||
48597330|NCT04504175|101796592|FG000|NOT COMPLETED|Continuation Phase||0||
48597331|NCT03117881|101796593|FG000|STARTED|Baseline||425||
48597332|NCT03117881|101796594|FG001|STARTED|Baseline||412||
48597333|NCT03117881|101796595|FG002|STARTED|Baseline||74||
48597334|NCT03117881|101796593|FG000|COMPLETED|Baseline||382||
48597335|NCT03117881|101796594|FG001|COMPLETED|Baseline||377||
48597336|NCT03117881|101796595|FG002|COMPLETED|Baseline||74||
48142835|NCT02968420|100673656|FG002|COMPLETED|Overall Study||6||
48142836|NCT02968420|100673654|FG000|NOT COMPLETED|Overall Study||0||
48142837|NCT02968420|100673655|FG001|NOT COMPLETED|Overall Study||0||
48142838|NCT02968420|100673656|FG002|NOT COMPLETED|Overall Study||0||
48142839|NCT00682734|100673657|FG000|STARTED|Emergency Department Portion||113||
48597337|NCT03117881|101796593|FG000|NOT COMPLETED|Baseline||43||
48597338|NCT03117881|101796594|FG001|NOT COMPLETED|Baseline||35||
48597339|NCT03117881|101796595|FG002|NOT COMPLETED|Baseline||0||
48142840|NCT00682734|100673658|FG001|STARTED|Emergency Department Portion||118||
48142841|NCT00682734|100673659|FG002|STARTED|Emergency Department Portion||118||
48142842|NCT00682734|100673657|FG000|COMPLETED|Emergency Department Portion||113||
48142843|NCT00682734|100673658|FG001|COMPLETED|Emergency Department Portion||117||
48142844|NCT00682734|100673659|FG002|COMPLETED|Emergency Department Portion||117||
48142845|NCT00682734|100673657|FG000|NOT COMPLETED|Emergency Department Portion||0||
48142846|NCT00682734|100673658|FG001|NOT COMPLETED|Emergency Department Portion||1||
48404946|NCT01201967|101325155|FG001|NOT COMPLETED|Overall Study||5||
48404947|NCT01525745|101325156|FG000|STARTED|Overall Study||4||
48142847|NCT00682734|100673659|FG002|NOT COMPLETED|Emergency Department Portion||1||
48142848|NCT00682734|100673657|FG000|STARTED|48 Hour Follow-up||113||
48142849|NCT00682734|100673658|FG001|STARTED|48 Hour Follow-up||117||
48142850|NCT00682734|100673659|FG002|STARTED|48 Hour Follow-up||117||
48142851|NCT00682734|100673657|FG000|COMPLETED|48 Hour Follow-up||107||
48142852|NCT00682734|100673658|FG001|COMPLETED|48 Hour Follow-up||111||
48142853|NCT00682734|100673659|FG002|COMPLETED|48 Hour Follow-up||106||
48142854|NCT00682734|100673657|FG000|NOT COMPLETED|48 Hour Follow-up||6||
48142855|NCT00682734|100673658|FG001|NOT COMPLETED|48 Hour Follow-up||6||
48142856|NCT00682734|100673659|FG002|NOT COMPLETED|48 Hour Follow-up||11||
48142857|NCT01212770|100673660|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||169||
48142858|NCT01212770|100673661|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||169||
48142859|NCT01212770|100673662|FG002|STARTED|Placebo-controlled Phase (Week 0 - 24)||167||
48142860|NCT01212770|100673663|FG003|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
48142861|NCT01212770|100673664|FG004|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
48142862|NCT01212770|100673665|FG005|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
48142863|NCT01212770|100673666|FG006|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
48142864|NCT01212770|100673667|FG007|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
48142865|NCT01212770|100673668|FG008|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
48142866|NCT01212770|100673660|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169||
48142867|NCT01212770|100673661|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169||
48142868|NCT01212770|100673662|FG002|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||167||
48142869|NCT01212770|100673663|FG003|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
48142870|NCT01212770|100673664|FG004|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
48142871|NCT01212770|100673665|FG005|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
48142872|NCT01212770|100673666|FG006|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
48142873|NCT01212770|100673667|FG007|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
48142874|NCT01212770|100673668|FG008|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
48142875|NCT01212770|100673660|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156||
48142876|NCT01212770|100673661|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||157||
48142877|NCT01212770|100673662|FG002|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156||
48142878|NCT01212770|100673663|FG003|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48142879|NCT01212770|100673664|FG004|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48142880|NCT01212770|100673665|FG005|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48142881|NCT01212770|100673666|FG006|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48142882|NCT01212770|100673667|FG007|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48142883|NCT01212770|100673668|FG008|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48142884|NCT01212770|100673660|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||97||
48142885|NCT01212770|100673661|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||76||
48142886|NCT01212770|100673662|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||53||
48142887|NCT01212770|100673663|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48142888|NCT01212770|100673664|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48404948|NCT01525745|101325157|FG001|STARTED|Overall Study||2||
48404949|NCT01525745|101325156|FG000|COMPLETED|Overall Study||3||
48404950|NCT01525745|101325157|FG001|COMPLETED|Overall Study||1||
48404951|NCT01525745|101325156|FG000|NOT COMPLETED|Overall Study||1||
48404952|NCT01525745|101325157|FG001|NOT COMPLETED|Overall Study||1||
48404953|NCT01637090|101325158|FG000|STARTED|Overall Study||3||
48404954|NCT01637090|101325158|FG000|COMPLETED|Overall Study||0||
48404955|NCT01637090|101325158|FG000|NOT COMPLETED|Overall Study||3||
48404956|NCT01636453|101325159|FG000|STARTED|Overall Study||120||
48404957|NCT01636453|101325159|FG000|COMPLETED|Overall Study||112||
48597340|NCT03117881|101796593|FG000|STARTED|Post-Intervention Follow-Up (3 Months)||382||
48597341|NCT03117881|101796594|FG001|STARTED|Post-Intervention Follow-Up (3 Months)||377||
48597342|NCT03117881|101796595|FG002|STARTED|Post-Intervention Follow-Up (3 Months)||74||
48597343|NCT03117881|101796593|FG000|COMPLETED|Post-Intervention Follow-Up (3 Months)||289||
48597344|NCT03117881|101796594|FG001|COMPLETED|Post-Intervention Follow-Up (3 Months)||296||
48597345|NCT03117881|101796595|FG002|COMPLETED|Post-Intervention Follow-Up (3 Months)||67||
48597346|NCT03117881|101796593|FG000|NOT COMPLETED|Post-Intervention Follow-Up (3 Months)||93||
48597347|NCT03117881|101796594|FG001|NOT COMPLETED|Post-Intervention Follow-Up (3 Months)||81||
48597348|NCT03117881|101796595|FG002|NOT COMPLETED|Post-Intervention Follow-Up (3 Months)||7||
48597349|NCT03117881|101796593|FG000|STARTED|6-Month Follow-Up||344||
48597350|NCT03117881|101796594|FG001|STARTED|6-Month Follow-Up||318||
48597351|NCT03117881|101796595|FG002|STARTED|6-Month Follow-Up||69||
48597352|NCT03117881|101796593|FG000|COMPLETED|6-Month Follow-Up||269||
48597353|NCT03117881|101796594|FG001|COMPLETED|6-Month Follow-Up||277||
48142889|NCT01212770|100673665|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48142890|NCT01212770|100673666|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48142891|NCT01212770|100673667|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48142892|NCT01212770|100673668|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48404958|NCT01636453|101325159|FG000|NOT COMPLETED|Overall Study||8||
48142893|NCT01212770|100673660|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||146||
48142894|NCT01212770|100673661|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||147||
48142895|NCT01212770|100673662|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||145||
48142896|NCT01212770|100673663|FG003|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48142897|NCT01212770|100673664|FG004|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48142898|NCT01212770|100673665|FG005|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48142899|NCT01212770|100673666|FG006|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48142900|NCT01212770|100673667|FG007|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48142901|NCT01212770|100673668|FG008|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48142902|NCT01212770|100673660|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23||
48296161|NCT03681951|101054202|FG000|STARTED|Part1: Monotherapy DE (Up to Day 95)||8||
48296162|NCT03681951|101054203|FG001|STARTED|Part1: Monotherapy DE (Up to Day 95)||0||
48296163|NCT03681951|101054204|FG002|STARTED|Part1: Monotherapy DE (Up to Day 95)||0||
48296164|NCT03681951|101054205|FG003|STARTED|Part1: Monotherapy DE (Up to Day 95)||0||
48296165|NCT03681951|101054206|FG004|STARTED|Part1: Monotherapy DE (Up to Day 95)||0||
48296166|NCT03681951|101054207|FG005|STARTED|Part1: Monotherapy DE (Up to Day 95)||0||
48296167|NCT03681951|101054208|FG006|STARTED|Part1: Monotherapy DE (Up to Day 95)||0||
48296168|NCT03681951|101054209|FG007|STARTED|Part1: Monotherapy DE (Up to Day 95)||0||
48296169|NCT03681951|101054202|FG000|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0||
48296170|NCT03681951|101054203|FG001|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0||
48296171|NCT03681951|101054204|FG002|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0||
48296172|NCT03681951|101054205|FG003|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0||
48296173|NCT03681951|101054206|FG004|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0||
48296174|NCT03681951|101054207|FG005|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0||
48296175|NCT03681951|101054208|FG006|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0||
48296176|NCT03681951|101054209|FG007|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0||
48296177|NCT03681951|101054202|FG000|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||8||
48296178|NCT03681951|101054203|FG001|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0||
48296179|NCT03681951|101054204|FG002|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0||
48296180|NCT03681951|101054205|FG003|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0||
48296181|NCT03681951|101054206|FG004|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0||
48296182|NCT03681951|101054207|FG005|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0||
48296183|NCT03681951|101054208|FG006|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0||
48296184|NCT03681951|101054209|FG007|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0||
48296185|NCT03681951|101054202|FG000|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0||
48712649|NCT01958021|102084786|FG001|NOT COMPLETED|Overall Study||180||
48712650|NCT02621398|102084787|FG000|STARTED|Overall Study||0||
48712651|NCT02621398|102084788|FG001|STARTED|Overall Study||4||
48712652|NCT02621398|102084789|FG002|STARTED|Overall Study||4||
48712653|NCT02621398|102084790|FG003|STARTED|Overall Study||3||
48712654|NCT02621398|102084791|FG004|STARTED|Overall Study||3||
48712655|NCT02621398|102084792|FG005|STARTED|Overall Study||3||
48712656|NCT02621398|102084793|FG006|STARTED|Overall Study||6||
48712657|NCT02621398|102084787|FG000|COMPLETED|Overall Study||0||
48712658|NCT02621398|102084788|FG001|COMPLETED|Overall Study||4||
48712659|NCT02621398|102084789|FG002|COMPLETED|Overall Study||4||
48712660|NCT02621398|102084790|FG003|COMPLETED|Overall Study||3||
48712661|NCT02621398|102084791|FG004|COMPLETED|Overall Study||3||
48712662|NCT02621398|102084792|FG005|COMPLETED|Overall Study||3||
48712663|NCT02621398|102084793|FG006|COMPLETED|Overall Study||6||
48712664|NCT02621398|102084787|FG000|NOT COMPLETED|Overall Study||0||
48712665|NCT02621398|102084788|FG001|NOT COMPLETED|Overall Study||0||
48712666|NCT02621398|102084789|FG002|NOT COMPLETED|Overall Study||0||
48712667|NCT02621398|102084790|FG003|NOT COMPLETED|Overall Study||0||
48712668|NCT02621398|102084791|FG004|NOT COMPLETED|Overall Study||0||
48712669|NCT02621398|102084792|FG005|NOT COMPLETED|Overall Study||0||
48712670|NCT02621398|102084793|FG006|NOT COMPLETED|Overall Study||0||
48712671|NCT04584346|102084794|FG000|STARTED|Phase 1 - Inpatient (Blinded)||7||
48712672|NCT04584346|102084795|FG001|STARTED|Phase 1 - Inpatient (Blinded)||9||
48296186|NCT03681951|101054203|FG001|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0||
48296187|NCT03681951|101054204|FG002|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0||
48296188|NCT03681951|101054205|FG003|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0||
48296189|NCT03681951|101054206|FG004|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0||
48296190|NCT03681951|101054207|FG005|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0||
48712673|NCT04584346|102084794|FG000|COMPLETED|Phase 1 - Inpatient (Blinded)||7||
48712674|NCT04584346|102084795|FG001|COMPLETED|Phase 1 - Inpatient (Blinded)||9||
48712675|NCT04584346|102084794|FG000|NOT COMPLETED|Phase 1 - Inpatient (Blinded)||0||
48712676|NCT04584346|102084795|FG001|NOT COMPLETED|Phase 1 - Inpatient (Blinded)||0||
48712677|NCT04584346|102084794|FG000|STARTED|Phase 2 - At Home (Unblinded)||7||
48712678|NCT04584346|102084795|FG001|STARTED|Phase 2 - At Home (Unblinded)||9||
48712679|NCT04584346|102084794|FG000|COMPLETED|Phase 2 - At Home (Unblinded)||7||
48712680|NCT04584346|102084795|FG001|COMPLETED|Phase 2 - At Home (Unblinded)||8||
48712681|NCT04584346|102084794|FG000|NOT COMPLETED|Phase 2 - At Home (Unblinded)||0||
48296191|NCT03681951|101054208|FG006|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0||
48142903|NCT01212770|100673661|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22||
48142904|NCT01212770|100673662|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22||
48142905|NCT01212770|100673663|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48142906|NCT01212770|100673664|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48142907|NCT01212770|100673665|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48142908|NCT01212770|100673666|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48142909|NCT01212770|100673667|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48142910|NCT01212770|100673668|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48142911|NCT01212770|100673660|FG000|STARTED|Active Treatment Phase (Weeks 25 - 52)||0||
48142912|NCT01212770|100673661|FG001|STARTED|Active Treatment Phase (Weeks 25 - 52)||139||
48142913|NCT01212770|100673662|FG002|STARTED|Active Treatment Phase (Weeks 25 - 52)||138||
48142914|NCT01212770|100673663|FG003|STARTED|Active Treatment Phase (Weeks 25 - 52)||43||
48142915|NCT01212770|100673664|FG004|STARTED|Active Treatment Phase (Weeks 25 - 52)||25||
48142916|NCT01212770|100673665|FG005|STARTED|Active Treatment Phase (Weeks 25 - 52)||47||
48142917|NCT01212770|100673666|FG006|STARTED|Active Treatment Phase (Weeks 25 - 52)||25||
48142918|NCT01212770|100673667|FG007|STARTED|Active Treatment Phase (Weeks 25 - 52)||0||
48142919|NCT01212770|100673668|FG008|STARTED|Active Treatment Phase (Weeks 25 - 52)||0||
48142920|NCT01212770|100673660|FG000|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0||
48142921|NCT01212770|100673661|FG001|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||120||
48142922|NCT01212770|100673662|FG002|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||126||
48142923|NCT01212770|100673663|FG003|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||32||
48142924|NCT01212770|100673664|FG004|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23||
48142925|NCT01212770|100673665|FG005|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||44||
48142926|NCT01212770|100673666|FG006|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23||
48142927|NCT01212770|100673667|FG007|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0||
48142928|NCT01212770|100673668|FG008|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0||
48142929|NCT01212770|100673660|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0||
48142930|NCT01212770|100673661|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||19||
48142931|NCT01212770|100673662|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||12||
48142932|NCT01212770|100673663|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||11||
48142933|NCT01212770|100673664|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2||
48142934|NCT01212770|100673665|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||3||
48142935|NCT01212770|100673666|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2||
48142936|NCT01212770|100673667|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0||
48142937|NCT01212770|100673668|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0||
48142938|NCT01212770|100673660|FG000|STARTED|Long-term Safety Phase (Year 2)||0||
48142939|NCT01212770|100673661|FG001|STARTED|Long-term Safety Phase (Year 2)||111||
48142940|NCT01212770|100673662|FG002|STARTED|Long-term Safety Phase (Year 2)||121||
48142941|NCT01212770|100673663|FG003|STARTED|Long-term Safety Phase (Year 2)||0||
48142942|NCT01212770|100673664|FG004|STARTED|Long-term Safety Phase (Year 2)||0||
48142943|NCT01212770|100673665|FG005|STARTED|Long-term Safety Phase (Year 2)||0||
48142944|NCT01212770|100673666|FG006|STARTED|Long-term Safety Phase (Year 2)||0||
48142945|NCT01212770|100673667|FG007|STARTED|Long-term Safety Phase (Year 2)||51||
48142946|NCT01212770|100673668|FG008|STARTED|Long-term Safety Phase (Year 2)||64||
48142947|NCT01212770|100673660|FG000|COMPLETED|Long-term Safety Phase (Year 2)||0||
48142948|NCT01212770|100673661|FG001|COMPLETED|Long-term Safety Phase (Year 2)||88||
48142949|NCT01212770|100673662|FG002|COMPLETED|Long-term Safety Phase (Year 2)||106||
48142950|NCT01212770|100673663|FG003|COMPLETED|Long-term Safety Phase (Year 2)||0||
48142951|NCT01212770|100673664|FG004|COMPLETED|Long-term Safety Phase (Year 2)||0||
48142952|NCT01212770|100673665|FG005|COMPLETED|Long-term Safety Phase (Year 2)||0||
48142953|NCT01212770|100673666|FG006|COMPLETED|Long-term Safety Phase (Year 2)||0||
48142954|NCT01212770|100673667|FG007|COMPLETED|Long-term Safety Phase (Year 2)||42||
48142955|NCT01212770|100673668|FG008|COMPLETED|Long-term Safety Phase (Year 2)||50||
48142956|NCT01212770|100673660|FG000|NOT COMPLETED|Long-term Safety Phase (Year 2)||0||
48142957|NCT01212770|100673661|FG001|NOT COMPLETED|Long-term Safety Phase (Year 2)||23||
48142958|NCT01212770|100673662|FG002|NOT COMPLETED|Long-term Safety Phase (Year 2)||15||
48142959|NCT01212770|100673663|FG003|NOT COMPLETED|Long-term Safety Phase (Year 2)||0||
48142960|NCT01212770|100673664|FG004|NOT COMPLETED|Long-term Safety Phase (Year 2)||0||
48142961|NCT01212770|100673665|FG005|NOT COMPLETED|Long-term Safety Phase (Year 2)||0||
48142962|NCT01212770|100673666|FG006|NOT COMPLETED|Long-term Safety Phase (Year 2)||0||
48142963|NCT01212770|100673667|FG007|NOT COMPLETED|Long-term Safety Phase (Year 2)||9||
48142964|NCT01212770|100673668|FG008|NOT COMPLETED|Long-term Safety Phase (Year 2)||14||
48142965|NCT01212770|100673660|FG000|STARTED|Long-term Safety Phase (Year 3)||0||
48142966|NCT01212770|100673661|FG001|STARTED|Long-term Safety Phase (Year 3)||87||
48142967|NCT01212770|100673662|FG002|STARTED|Long-term Safety Phase (Year 3)||105||
48142968|NCT01212770|100673663|FG003|STARTED|Long-term Safety Phase (Year 3)||0||
48142969|NCT01212770|100673664|FG004|STARTED|Long-term Safety Phase (Year 3)||0||
48142970|NCT01212770|100673665|FG005|STARTED|Long-term Safety Phase (Year 3)||0||
48142971|NCT01212770|100673666|FG006|STARTED|Long-term Safety Phase (Year 3)||0||
48142972|NCT01212770|100673667|FG007|STARTED|Long-term Safety Phase (Year 3)||42||
48142973|NCT01212770|100673668|FG008|STARTED|Long-term Safety Phase (Year 3)||49||
48142974|NCT01212770|100673660|FG000|COMPLETED|Long-term Safety Phase (Year 3)||0||
48142975|NCT01212770|100673661|FG001|COMPLETED|Long-term Safety Phase (Year 3)||76||
48142976|NCT01212770|100673662|FG002|COMPLETED|Long-term Safety Phase (Year 3)||94||
48142977|NCT01212770|100673663|FG003|COMPLETED|Long-term Safety Phase (Year 3)||0||
48142978|NCT01212770|100673664|FG004|COMPLETED|Long-term Safety Phase (Year 3)||0||
48142979|NCT01212770|100673665|FG005|COMPLETED|Long-term Safety Phase (Year 3)||0||
48142980|NCT01212770|100673666|FG006|COMPLETED|Long-term Safety Phase (Year 3)||0||
48142981|NCT01212770|100673667|FG007|COMPLETED|Long-term Safety Phase (Year 3)||35||
48142982|NCT01212770|100673668|FG008|COMPLETED|Long-term Safety Phase (Year 3)||44||
48142983|NCT01212770|100673660|FG000|NOT COMPLETED|Long-term Safety Phase (Year 3)||0||
48142984|NCT01212770|100673661|FG001|NOT COMPLETED|Long-term Safety Phase (Year 3)||11||
48142985|NCT01212770|100673662|FG002|NOT COMPLETED|Long-term Safety Phase (Year 3)||11||
48142986|NCT01212770|100673663|FG003|NOT COMPLETED|Long-term Safety Phase (Year 3)||0||
48142987|NCT01212770|100673664|FG004|NOT COMPLETED|Long-term Safety Phase (Year 3)||0||
48142988|NCT01212770|100673665|FG005|NOT COMPLETED|Long-term Safety Phase (Year 3)||0||
48142989|NCT01212770|100673666|FG006|NOT COMPLETED|Long-term Safety Phase (Year 3)||0||
48142990|NCT01212770|100673667|FG007|NOT COMPLETED|Long-term Safety Phase (Year 3)||7||
48142991|NCT01212770|100673668|FG008|NOT COMPLETED|Long-term Safety Phase (Year 3)||5||
48142992|NCT01212770|100673660|FG000|STARTED|Long-term Safety Phase (Year 4)||0||
48142993|NCT01212770|100673661|FG001|STARTED|Long-term Safety Phase (Year 4)||77||
48142994|NCT01212770|100673662|FG002|STARTED|Long-term Safety Phase (Year 4)||94||
48142995|NCT01212770|100673663|FG003|STARTED|Long-term Safety Phase (Year 4)||0||
48142996|NCT01212770|100673664|FG004|STARTED|Long-term Safety Phase (Year 4)||0||
48142997|NCT01212770|100673665|FG005|STARTED|Long-term Safety Phase (Year 4)||0||
48142998|NCT01212770|100673666|FG006|STARTED|Long-term Safety Phase (Year 4)||0||
48142999|NCT01212770|100673667|FG007|STARTED|Long-term Safety Phase (Year 4)||35||
48143000|NCT01212770|100673668|FG008|STARTED|Long-term Safety Phase (Year 4)||44||
48143001|NCT01212770|100673660|FG000|COMPLETED|Long-term Safety Phase (Year 4)||0||
48143002|NCT01212770|100673661|FG001|COMPLETED|Long-term Safety Phase (Year 4)||71||
48143003|NCT01212770|100673662|FG002|COMPLETED|Long-term Safety Phase (Year 4)||83||
48143004|NCT01212770|100673663|FG003|COMPLETED|Long-term Safety Phase (Year 4)||0||
48143005|NCT01212770|100673664|FG004|COMPLETED|Long-term Safety Phase (Year 4)||0||
48143006|NCT01212770|100673665|FG005|COMPLETED|Long-term Safety Phase (Year 4)||0||
48143007|NCT01212770|100673666|FG006|COMPLETED|Long-term Safety Phase (Year 4)||0||
48143008|NCT01212770|100673667|FG007|COMPLETED|Long-term Safety Phase (Year 4)||32||
48143009|NCT01212770|100673668|FG008|COMPLETED|Long-term Safety Phase (Year 4)||42||
48143010|NCT01212770|100673660|FG000|NOT COMPLETED|Long-term Safety Phase (Year 4)||0||
48143011|NCT01212770|100673661|FG001|NOT COMPLETED|Long-term Safety Phase (Year 4)||6||
48143012|NCT01212770|100673662|FG002|NOT COMPLETED|Long-term Safety Phase (Year 4)||11||
48143013|NCT01212770|100673663|FG003|NOT COMPLETED|Long-term Safety Phase (Year 4)||0||
48143014|NCT01212770|100673664|FG004|NOT COMPLETED|Long-term Safety Phase (Year 4)||0||
48143015|NCT01212770|100673665|FG005|NOT COMPLETED|Long-term Safety Phase (Year 4)||0||
48143016|NCT01212770|100673666|FG006|NOT COMPLETED|Long-term Safety Phase (Year 4)||0||
48143017|NCT01212770|100673667|FG007|NOT COMPLETED|Long-term Safety Phase (Year 4)||3||
48143018|NCT01212770|100673668|FG008|NOT COMPLETED|Long-term Safety Phase (Year 4)||2||
48143019|NCT01212770|100673660|FG000|STARTED|Long-term Safety Phase (Year 5)||0||
48143020|NCT01212770|100673661|FG001|STARTED|Long-term Safety Phase (Year 5)||70||
48143021|NCT01212770|100673662|FG002|STARTED|Long-term Safety Phase (Year 5)||83||
48143022|NCT01212770|100673663|FG003|STARTED|Long-term Safety Phase (Year 5)||0||
48143023|NCT01212770|100673664|FG004|STARTED|Long-term Safety Phase (Year 5)||0||
48143024|NCT01212770|100673665|FG005|STARTED|Long-term Safety Phase (Year 5)||0||
48143025|NCT01212770|100673666|FG006|STARTED|Long-term Safety Phase (Year 5)||0||
48143026|NCT01212770|100673667|FG007|STARTED|Long-term Safety Phase (Year 5)||32||
48143027|NCT01212770|100673668|FG008|STARTED|Long-term Safety Phase (Year 5)||42||
48143028|NCT01212770|100673660|FG000|COMPLETED|Long-term Safety Phase (Year 5)||0||
48143029|NCT01212770|100673661|FG001|COMPLETED|Long-term Safety Phase (Year 5)||68||
48143030|NCT01212770|100673662|FG002|COMPLETED|Long-term Safety Phase (Year 5)||72||
48143031|NCT01212770|100673663|FG003|COMPLETED|Long-term Safety Phase (Year 5)||0||
48143032|NCT01212770|100673664|FG004|COMPLETED|Long-term Safety Phase (Year 5)||0||
48143033|NCT01212770|100673665|FG005|COMPLETED|Long-term Safety Phase (Year 5)||0||
48143034|NCT01212770|100673666|FG006|COMPLETED|Long-term Safety Phase (Year 5)||0||
48143035|NCT01212770|100673667|FG007|COMPLETED|Long-term Safety Phase (Year 5)||30||
48143036|NCT01212770|100673668|FG008|COMPLETED|Long-term Safety Phase (Year 5)||41||
48143037|NCT01212770|100673660|FG000|NOT COMPLETED|Long-term Safety Phase (Year 5)||0||
48143038|NCT01212770|100673661|FG001|NOT COMPLETED|Long-term Safety Phase (Year 5)||2||
48296192|NCT03681951|101054209|FG007|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0||
48143039|NCT01212770|100673662|FG002|NOT COMPLETED|Long-term Safety Phase (Year 5)||11||
48143040|NCT01212770|100673663|FG003|NOT COMPLETED|Long-term Safety Phase (Year 5)||0||
48143041|NCT01212770|100673664|FG004|NOT COMPLETED|Long-term Safety Phase (Year 5)||0||
48143042|NCT01212770|100673665|FG005|NOT COMPLETED|Long-term Safety Phase (Year 5)||0||
48143043|NCT01212770|100673666|FG006|NOT COMPLETED|Long-term Safety Phase (Year 5)||0||
48143044|NCT01212770|100673667|FG007|NOT COMPLETED|Long-term Safety Phase (Year 5)||2||
48143045|NCT01212770|100673668|FG008|NOT COMPLETED|Long-term Safety Phase (Year 5)||1||
48143046|NCT02489500|100673669|FG000|STARTED|Overall Study||2||
48143047|NCT02489500|100673670|FG001|STARTED|Overall Study||1||
48143048|NCT02489500|100673669|FG000|COMPLETED|Overall Study||1||
48143049|NCT02489500|100673670|FG001|COMPLETED|Overall Study||0||
48143050|NCT02489500|100673669|FG000|NOT COMPLETED|Overall Study||1||
48143051|NCT02489500|100673670|FG001|NOT COMPLETED|Overall Study||1||
48143052|NCT00506064|100673671|FG000|STARTED|Overall Study||1||
48143053|NCT00506064|100673672|FG001|STARTED|Overall Study||0||
48143054|NCT00506064|100673671|FG000|COMPLETED|Overall Study||1||
48143055|NCT00506064|100673672|FG001|COMPLETED|Overall Study||0||
48143056|NCT00506064|100673671|FG000|NOT COMPLETED|Overall Study||0||
48143057|NCT00506064|100673672|FG001|NOT COMPLETED|Overall Study||0||
48143058|NCT00778648|100673673|FG000|STARTED|Overall Study||272||
48143059|NCT00778648|100673674|FG001|STARTED|Overall Study||271||
48143060|NCT00778648|100673673|FG000|COMPLETED|Overall Study||263||
48143061|NCT00778648|100673674|FG001|COMPLETED|Overall Study||266||
48143062|NCT00778648|100673673|FG000|NOT COMPLETED|Overall Study||9||
48143063|NCT00778648|100673674|FG001|NOT COMPLETED|Overall Study||5||
48143064|NCT04022668|100673675|FG000|STARTED|Overall Study||1000||
48143065|NCT04022668|100673676|FG001|STARTED|Overall Study||1000||
48143066|NCT04022668|100673677|FG002|STARTED|Overall Study||1000||
48143067|NCT04022668|100673675|FG000|COMPLETED|Overall Study||986||
48143068|NCT04022668|100673676|FG001|COMPLETED|Overall Study||973||
48143069|NCT04022668|100673677|FG002|COMPLETED|Overall Study||1000||
48143070|NCT04022668|100673675|FG000|NOT COMPLETED|Overall Study||14||
48143071|NCT04022668|100673676|FG001|NOT COMPLETED|Overall Study||27||
48143072|NCT04022668|100673677|FG002|NOT COMPLETED|Overall Study||0||
48143073|NCT01353313|100673678|FG000|STARTED|Overall Study||398||
48143074|NCT01353313|100673679|FG001|STARTED|Overall Study||402||
48143075|NCT01353313|100673678|FG000|Completed Assessment for Neurodevelopmental Impairment|Overall Study||321||
48143076|NCT01353313|100673679|FG001|Completed Assessment for Neurodevelopmental Impairment|Overall Study||318||
48143077|NCT01353313|100673678|FG000|Died After Discharge|Overall Study||8||
48143078|NCT01353313|100673679|FG001|Died After Discharge|Overall Study||6||
48143079|NCT01353313|100673678|FG000|Died Before Discharge|Overall Study||35||
48143080|NCT01353313|100673679|FG001|Died Before Discharge|Overall Study||40||
48143081|NCT01353313|100673678|FG000|Survived to Discharge|Overall Study||363||
48404959|NCT04159701|101325160|FG000|STARTED|Period 1: Treatment Period||39||
48404960|NCT04159701|101325161|FG001|STARTED|Period 1: Treatment Period||13||
48712682|NCT04584346|102084795|FG001|NOT COMPLETED|Phase 2 - At Home (Unblinded)||1||
48712683|NCT02387164|102084796|FG000|STARTED|Overall Study||13||
48143082|NCT01353313|100673679|FG001|Survived to Discharge|Overall Study||362||
48143083|NCT01353313|100673678|FG000|COMPLETED|Overall Study||364|Complete data for Neurodevelopmental Impairment or died|
48143084|NCT01353313|100673679|FG001|COMPLETED|Overall Study||364|Complete data for Neurodevelopmental Impairment or died|
48143085|NCT01353313|100673678|FG000|NOT COMPLETED|Overall Study||34||
48143086|NCT01353313|100673679|FG001|NOT COMPLETED|Overall Study||38||
48143087|NCT03036163|100673680|FG000|STARTED|Overall Study||6||
48143088|NCT03036163|100673681|FG001|STARTED|Overall Study||6||
48143089|NCT03036163|100673682|FG002|STARTED|Overall Study||6||
48143090|NCT03036163|100673683|FG003|STARTED|Overall Study||6||
48712684|NCT02387164|102084797|FG001|STARTED|Overall Study||13||
48712685|NCT02387164|102084796|FG000|COMPLETED|Overall Study||10||
48712686|NCT02387164|102084797|FG001|COMPLETED|Overall Study||11||
48712687|NCT02387164|102084796|FG000|NOT COMPLETED|Overall Study||3||
48712688|NCT02387164|102084797|FG001|NOT COMPLETED|Overall Study||2||
48712689|NCT03383783|102084798|FG000|STARTED|Overall Study||27||
48712690|NCT03383783|102084798|FG000|COMPLETED|Overall Study||25||
48712691|NCT03383783|102084798|FG000|NOT COMPLETED|Overall Study||2||
48712692|NCT02257177|102084799|FG000|STARTED|Overall Study||4||
48143091|NCT03036163|100673684|FG004|STARTED|Overall Study||6||
48143092|NCT03036163|100673685|FG005|STARTED|Overall Study||5||
48143093|NCT03036163|100673686|FG006|STARTED|Overall Study||5||
48404961|NCT04159701|101325160|FG000|Received at Least One Dose of Study Drug|Period 1: Treatment Period||39||
48404962|NCT04159701|101325161|FG001|Received at Least One Dose of Study Drug|Period 1: Treatment Period||13||
48712693|NCT02257177|102084800|FG001|STARTED|Overall Study||4||
48143094|NCT03036163|100673680|FG000|COMPLETED|Overall Study||6||
48143095|NCT03036163|100673681|FG001|COMPLETED|Overall Study||6||
48712694|NCT02257177|102084801|FG002|STARTED|Overall Study||4||
48712695|NCT02257177|102084802|FG003|STARTED|Overall Study||4||
48712696|NCT02257177|102084803|FG004|STARTED|Overall Study||4||
48712697|NCT02257177|102084804|FG005|STARTED|Overall Study||4||
48143096|NCT03036163|100673682|FG002|COMPLETED|Overall Study||6||
48143097|NCT03036163|100673683|FG003|COMPLETED|Overall Study||6||
48143098|NCT03036163|100673684|FG004|COMPLETED|Overall Study||6||
48143099|NCT03036163|100673685|FG005|COMPLETED|Overall Study||5||
48143100|NCT03036163|100673686|FG006|COMPLETED|Overall Study||5||
48143101|NCT03036163|100673680|FG000|NOT COMPLETED|Overall Study||0||
48597354|NCT03117881|101796595|FG002|COMPLETED|6-Month Follow-Up||60||
48143102|NCT03036163|100673681|FG001|NOT COMPLETED|Overall Study||0||
48143103|NCT03036163|100673682|FG002|NOT COMPLETED|Overall Study||0||
48143104|NCT03036163|100673683|FG003|NOT COMPLETED|Overall Study||0||
48143105|NCT03036163|100673684|FG004|NOT COMPLETED|Overall Study||0||
48143106|NCT03036163|100673685|FG005|NOT COMPLETED|Overall Study||0||
48143107|NCT03036163|100673686|FG006|NOT COMPLETED|Overall Study||0||
48143108|NCT03240692|100673687|FG000|STARTED|Overall Study||23||
48143109|NCT03240692|100673687|FG000|COMPLETED|Overall Study||21||
48143110|NCT03240692|100673687|FG000|NOT COMPLETED|Overall Study||2||
48143111|NCT02293538|100673688|FG000|STARTED|Overall Study||73||
48143112|NCT02293538|100673689|FG001|STARTED|Overall Study||71||
48143113|NCT02293538|100673688|FG000|COMPLETED|Overall Study||72||
48143114|NCT02293538|100673689|FG001|COMPLETED|Overall Study||69||
48143115|NCT02293538|100673688|FG000|NOT COMPLETED|Overall Study||1||
48712698|NCT02257177|102084805|FG006|STARTED|Overall Study||12||
48712699|NCT02257177|102084806|FG007|STARTED|Overall Study||5||
48712700|NCT02257177|102084807|FG008|STARTED|Overall Study||5||
48712701|NCT02257177|102084808|FG009|STARTED|Overall Study||5||
48712702|NCT02257177|102084809|FG010|STARTED|Overall Study||9||
48712703|NCT02257177|102084799|FG000|COMPLETED|Overall Study||4||
48712704|NCT02257177|102084800|FG001|COMPLETED|Overall Study||4||
48712705|NCT02257177|102084801|FG002|COMPLETED|Overall Study||4||
48712706|NCT02257177|102084802|FG003|COMPLETED|Overall Study||4||
48712707|NCT02257177|102084803|FG004|COMPLETED|Overall Study||4||
48712708|NCT02257177|102084804|FG005|COMPLETED|Overall Study||4||
48712709|NCT02257177|102084805|FG006|COMPLETED|Overall Study||12||
48712710|NCT02257177|102084806|FG007|COMPLETED|Overall Study||5||
48143116|NCT02293538|100673689|FG001|NOT COMPLETED|Overall Study||2||
48143117|NCT05878197|100673690|FG000|STARTED|Overall Study||11||
48143118|NCT05878197|100673691|FG001|STARTED|Overall Study||11||
48143119|NCT05878197|100673692|FG002|STARTED|Overall Study||8||
48143120|NCT05878197|100673690|FG000|COMPLETED|Overall Study||11||
48143121|NCT05878197|100673691|FG001|COMPLETED|Overall Study||11||
48143122|NCT05878197|100673692|FG002|COMPLETED|Overall Study||8||
48143123|NCT05878197|100673690|FG000|NOT COMPLETED|Overall Study||0||
48143124|NCT05878197|100673691|FG001|NOT COMPLETED|Overall Study||0||
48143125|NCT05878197|100673692|FG002|NOT COMPLETED|Overall Study||0||
48143126|NCT00955357|100673693|FG000|STARTED|Titration Phase||96||
48143127|NCT00955357|100673694|FG001|STARTED|Titration Phase||360||
48143128|NCT00955357|100673693|FG000|COMPLETED|Titration Phase||80||
48143129|NCT00955357|100673694|FG001|COMPLETED|Titration Phase||294||
48143130|NCT00955357|100673693|FG000|NOT COMPLETED|Titration Phase||16||
48143131|NCT00955357|100673694|FG001|NOT COMPLETED|Titration Phase||66||
48143132|NCT00955357|100673693|FG000|STARTED|Maintenance Phase||80||
48143133|NCT00955357|100673694|FG001|STARTED|Maintenance Phase||294||
48143134|NCT00955357|100673693|FG000|COMPLETED|Maintenance Phase||68||
48143135|NCT00955357|100673694|FG001|COMPLETED|Maintenance Phase||249||
48143136|NCT00955357|100673693|FG000|NOT COMPLETED|Maintenance Phase||12||
48143137|NCT00955357|100673694|FG001|NOT COMPLETED|Maintenance Phase||45||
48143138|NCT00941330|100673695|FG000|STARTED|Overall Study||15||
48143139|NCT00941330|100673696|FG001|STARTED|Overall Study||11||
48143140|NCT00941330|100673695|FG000|COMPLETED|Overall Study||14||
48143141|NCT00941330|100673696|FG001|COMPLETED|Overall Study||9||
48143142|NCT00941330|100673695|FG000|NOT COMPLETED|Overall Study||1||
48143143|NCT00941330|100673696|FG001|NOT COMPLETED|Overall Study||2||
48143144|NCT00818753|100673697|FG000|STARTED|Overall Study||22||
48143145|NCT00818753|100673698|FG001|STARTED|Overall Study||21||
48143146|NCT00818753|100673699|FG002|STARTED|Overall Study||10||
48143147|NCT00818753|100673697|FG000|COMPLETED|Overall Study||19||
48143148|NCT00818753|100673698|FG001|COMPLETED|Overall Study||21||
48143149|NCT00818753|100673699|FG002|COMPLETED|Overall Study||9||
48143150|NCT00818753|100673697|FG000|NOT COMPLETED|Overall Study||3||
48143151|NCT00818753|100673698|FG001|NOT COMPLETED|Overall Study||0||
48143152|NCT00818753|100673699|FG002|NOT COMPLETED|Overall Study||1||
48143153|NCT02085252|100673700|FG000|STARTED|Overall Study||58||
48712711|NCT02257177|102084807|FG008|COMPLETED|Overall Study||5||
48712712|NCT02257177|102084808|FG009|COMPLETED|Overall Study||4||
48712713|NCT02257177|102084809|FG010|COMPLETED|Overall Study||9||
48143154|NCT02085252|100673701|FG001|STARTED|Overall Study||57||
48143155|NCT02085252|100673700|FG000|COMPLETED|Overall Study||57||
48143156|NCT02085252|100673701|FG001|COMPLETED|Overall Study||53||
48143157|NCT02085252|100673700|FG000|NOT COMPLETED|Overall Study||1||
48143158|NCT02085252|100673701|FG001|NOT COMPLETED|Overall Study||4||
48712714|NCT02257177|102084799|FG000|NOT COMPLETED|Overall Study||0||
48143159|NCT02844946|100673702|FG000|STARTED|Overall Study||27||
48143160|NCT02844946|100673703|FG001|STARTED|Overall Study||12||
48143161|NCT02844946|100673702|FG000|COMPLETED|Overall Study||20||
48712715|NCT02257177|102084800|FG001|NOT COMPLETED|Overall Study||0||
48712716|NCT02257177|102084801|FG002|NOT COMPLETED|Overall Study||0||
48712717|NCT02257177|102084802|FG003|NOT COMPLETED|Overall Study||0||
48712718|NCT02257177|102084803|FG004|NOT COMPLETED|Overall Study||0||
48143162|NCT02844946|100673703|FG001|COMPLETED|Overall Study||12||
48143163|NCT02844946|100673702|FG000|NOT COMPLETED|Overall Study||7||
48143164|NCT02844946|100673703|FG001|NOT COMPLETED|Overall Study||0||
48143165|NCT05238233|100676491|FG000|STARTED|Overall Study||11||11
48143166|NCT05238233|100676492|FG001|STARTED|Overall Study||0||0
48143167|NCT05238233|100676491|FG000|COMPLETED|Overall Study||10||10
48143168|NCT05238233|100676492|FG001|COMPLETED|Overall Study||0||0
48143169|NCT05238233|100676491|FG000|NOT COMPLETED|Overall Study||1||1
48143170|NCT05238233|100676492|FG001|NOT COMPLETED|Overall Study||0||0
48143171|NCT01798927|100676493|FG000|STARTED|Overall Study||4||
48143172|NCT01798927|100676493|FG000|COMPLETED|Overall Study||3||
48143173|NCT01798927|100676493|FG000|NOT COMPLETED|Overall Study||1||
48143174|NCT04154956|100676494|FG000|STARTED|Overall Study||194||
48143175|NCT04154956|100676495|FG001|STARTED|Overall Study||195||
48143176|NCT04154956|100676494|FG000|Randomized and Treated|Overall Study||194||
48143177|NCT04154956|100676495|FG001|Randomized and Treated|Overall Study||177||
48143178|NCT04154956|100676494|FG000|COMPLETED|Overall Study||48||
48143179|NCT04154956|100676495|FG001|COMPLETED|Overall Study||52||
48143180|NCT04154956|100676494|FG000|NOT COMPLETED|Overall Study||146||
48143181|NCT04154956|100676495|FG001|NOT COMPLETED|Overall Study||143||
48143182|NCT01857531|100676496|FG000|STARTED|Overall Study||16||
48143183|NCT01857531|100676496|FG000|COMPLETED|Overall Study||12||
48143184|NCT01857531|100676496|FG000|NOT COMPLETED|Overall Study||4||
48296193|NCT03681951|101054202|FG000|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0||
48296194|NCT03681951|101054203|FG001|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0||
48296195|NCT03681951|101054204|FG002|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0||
48296196|NCT03681951|101054205|FG003|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0||
48296197|NCT03681951|101054206|FG004|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0||
48296198|NCT03681951|101054207|FG005|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0||
48296199|NCT03681951|101054208|FG006|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0||
48296200|NCT03681951|101054209|FG007|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0||
48296201|NCT03681951|101054202|FG000|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0||
48296202|NCT03681951|101054203|FG001|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0||
48296203|NCT03681951|101054204|FG002|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0||
48296204|NCT03681951|101054205|FG003|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0||
48712719|NCT02257177|102084804|FG005|NOT COMPLETED|Overall Study||0||
48712720|NCT02257177|102084805|FG006|NOT COMPLETED|Overall Study||0||
48712721|NCT02257177|102084806|FG007|NOT COMPLETED|Overall Study||0||
48712722|NCT02257177|102084807|FG008|NOT COMPLETED|Overall Study||0||
48712723|NCT02257177|102084808|FG009|NOT COMPLETED|Overall Study||1||
48712724|NCT02257177|102084809|FG010|NOT COMPLETED|Overall Study||0||
48712725|NCT00410826|102084810|FG000|STARTED|Overall Study||105||
48712726|NCT00410826|102084811|FG001|STARTED|Overall Study||99||
48712727|NCT00410826|102084810|FG000|COMPLETED|Overall Study||96||
48712728|NCT00410826|102084811|FG001|COMPLETED|Overall Study||95||
48712729|NCT00410826|102084810|FG000|NOT COMPLETED|Overall Study||9||
48712730|NCT00410826|102084811|FG001|NOT COMPLETED|Overall Study||4||
48712731|NCT03372551|102084812|FG000|STARTED|First Intervention (1 Week)||17||
48712732|NCT03372551|102084813|FG001|STARTED|First Intervention (1 Week)||16||
48143185|NCT02635880|100676497|FG000|STARTED|Overall Study||32||
48143186|NCT02635880|100676497|FG000|COMPLETED|Overall Study||32||
48143187|NCT02635880|100676497|FG000|NOT COMPLETED|Overall Study||0||
48143188|NCT03929029|100676498|FG000|STARTED|Nivolumab Lead-In (Weeks 1-12)||6||
48143189|NCT03929029|100676499|FG001|STARTED|Nivolumab Lead-In (Weeks 1-12)||5||
48296205|NCT03681951|101054206|FG004|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0||
48296206|NCT03681951|101054207|FG005|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0||
48296207|NCT03681951|101054208|FG006|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0||
48296208|NCT03681951|101054209|FG007|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0||
48296209|NCT03681951|101054202|FG000|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0||
48296210|NCT03681951|101054203|FG001|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0||
48296211|NCT03681951|101054204|FG002|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0||
48712733|NCT03372551|102084812|FG000|COMPLETED|First Intervention (1 Week)||16||
48712734|NCT03372551|102084813|FG001|COMPLETED|First Intervention (1 Week)||16||
48143190|NCT03929029|100676498|FG000|COMPLETED|Nivolumab Lead-In (Weeks 1-12)||6||
48143191|NCT03929029|100676499|FG001|COMPLETED|Nivolumab Lead-In (Weeks 1-12)||5||
48143192|NCT03929029|100676498|FG000|NOT COMPLETED|Nivolumab Lead-In (Weeks 1-12)||0||
48143193|NCT03929029|100676499|FG001|NOT COMPLETED|Nivolumab Lead-In (Weeks 1-12)||0||
48143194|NCT03929029|100676498|FG000|STARTED|Nivo, NeoVax, Ipilimumab (Weeks 12-21)||5||
48143195|NCT03929029|100676499|FG001|STARTED|Nivo, NeoVax, Ipilimumab (Weeks 12-21)||5||
48143196|NCT03929029|100676498|FG000|COMPLETED|Nivo, NeoVax, Ipilimumab (Weeks 12-21)||5||
48143197|NCT03929029|100676499|FG001|COMPLETED|Nivo, NeoVax, Ipilimumab (Weeks 12-21)||5||
48143198|NCT03929029|100676498|FG000|NOT COMPLETED|Nivo, NeoVax, Ipilimumab (Weeks 12-21)||0||
48597355|NCT03117881|101796593|FG000|NOT COMPLETED|6-Month Follow-Up||75||
48597356|NCT03117881|101796594|FG001|NOT COMPLETED|6-Month Follow-Up||41||
48597357|NCT03117881|101796595|FG002|NOT COMPLETED|6-Month Follow-Up||9||
48597358|NCT03117881|101796593|FG000|STARTED|12-Month Follow-Up||322||
48597359|NCT03117881|101796594|FG001|STARTED|12-Month Follow-Up||302||
48597360|NCT03117881|101796595|FG002|STARTED|12-Month Follow-Up||0||
48597361|NCT03117881|101796593|FG000|COMPLETED|12-Month Follow-Up||261||
48597362|NCT03117881|101796594|FG001|COMPLETED|12-Month Follow-Up||278||
48597363|NCT03117881|101796595|FG002|COMPLETED|12-Month Follow-Up||0||
48597364|NCT03117881|101796593|FG000|NOT COMPLETED|12-Month Follow-Up||61||
48597365|NCT03117881|101796594|FG001|NOT COMPLETED|12-Month Follow-Up||24||
48597366|NCT03117881|101796595|FG002|NOT COMPLETED|12-Month Follow-Up||0||
48597367|NCT04529850|101796596|FG000|STARTED|Overall Study||37||
48597368|NCT04529850|101796596|FG000|COMPLETED|Overall Study||32||
48597369|NCT04529850|101796596|FG000|NOT COMPLETED|Overall Study||5||
48597370|NCT04643964|101796597|FG000|STARTED|Overall Study||86||
48597371|NCT04643964|101796598|FG001|STARTED|Overall Study||90||
48597372|NCT04643964|101796599|FG002|STARTED|Overall Study||89||
48597373|NCT04643964|101796600|FG003|STARTED|Overall Study||258||
48597374|NCT04643964|101796601|FG004|STARTED|Overall Study||132||
48597375|NCT04643964|101796597|FG000|COMPLETED|Overall Study||30||
48597376|NCT04643964|101796598|FG001|COMPLETED|Overall Study||23||
48597377|NCT04643964|101796599|FG002|COMPLETED|Overall Study||33||
48597378|NCT04643964|101796600|FG003|COMPLETED|Overall Study||115||
48597379|NCT04643964|101796601|FG004|COMPLETED|Overall Study||73||
48597380|NCT04643964|101796597|FG000|NOT COMPLETED|Overall Study||56||
48597381|NCT04643964|101796598|FG001|NOT COMPLETED|Overall Study||67||
48597382|NCT04643964|101796599|FG002|NOT COMPLETED|Overall Study||56||
48597383|NCT04643964|101796600|FG003|NOT COMPLETED|Overall Study||143||
48597384|NCT04643964|101796601|FG004|NOT COMPLETED|Overall Study||59||
48597385|NCT03304184|101796602|FG000|STARTED|Overall Study||15||
48597386|NCT03304184|101796603|FG001|STARTED|Overall Study||9||
48597387|NCT03304184|101796602|FG000|COMPLETED|Overall Study||14|Participants that completed all of the survey questions over a 3 month period.|
48597388|NCT03304184|101796603|FG001|COMPLETED|Overall Study||7|Participants that completed all of the survey questions over a 3 month period.|
48597389|NCT03304184|101796602|FG000|NOT COMPLETED|Overall Study||1||
48597390|NCT03304184|101796603|FG001|NOT COMPLETED|Overall Study||2||
48597391|NCT00904839|101796604|FG000|STARTED|Overall Study||4||
48597392|NCT00904839|101796605|FG001|STARTED|Overall Study||82||
48597393|NCT00904839|101796606|FG002|STARTED|Overall Study||42||
48597394|NCT00904839|101796604|FG000|COMPLETED|Overall Study||3||
48597395|NCT00904839|101796605|FG001|COMPLETED|Overall Study||64||
48597396|NCT00904839|101796606|FG002|COMPLETED|Overall Study||27||
48597397|NCT00904839|101796604|FG000|NOT COMPLETED|Overall Study||1||
48597398|NCT00904839|101796605|FG001|NOT COMPLETED|Overall Study||18||
48597399|NCT00904839|101796606|FG002|NOT COMPLETED|Overall Study||15||
48597400|NCT04226495|101796607|FG000|STARTED|Overall Study||32||
48597401|NCT04226495|101796608|FG001|STARTED|Overall Study||33||
48597402|NCT04226495|101796607|FG000|COMPLETED|Overall Study||26||
48597403|NCT04226495|101796608|FG001|COMPLETED|Overall Study||26||
48597404|NCT04226495|101796607|FG000|NOT COMPLETED|Overall Study||6||
48597405|NCT04226495|101796608|FG001|NOT COMPLETED|Overall Study||7||
48597406|NCT03329248|101796609|FG000|STARTED|Overall Study||6||
48597407|NCT03329248|101796609|FG000|COMPLETED|Overall Study||0||
48597408|NCT03329248|101796609|FG000|NOT COMPLETED|Overall Study||6||
48597409|NCT01032070|101796610|FG000|STARTED|Overall Study||13||
48597410|NCT01032070|101796611|FG001|STARTED|Overall Study||12||
48597411|NCT01032070|101796610|FG000|COMPLETED|Overall Study||0||
48597412|NCT01032070|101796611|FG001|COMPLETED|Overall Study||0||
48597413|NCT01032070|101796610|FG000|NOT COMPLETED|Overall Study||13||
48143199|NCT03929029|100676499|FG001|NOT COMPLETED|Nivo, NeoVax, Ipilimumab (Weeks 12-21)||0||
48143200|NCT03929029|100676498|FG000|STARTED|Nivolumab (Week 24+, Every 4 Weeks)||4||
48143201|NCT03929029|100676499|FG001|STARTED|Nivolumab (Week 24+, Every 4 Weeks)||4||
48597414|NCT01032070|101796611|FG001|NOT COMPLETED|Overall Study||12||
48597415|NCT02339155|101796612|FG000|STARTED|Overall Study||287|This includes Intent-to-treat population (ITT)|
48597416|NCT02339155|101796613|FG001|STARTED|Overall Study||286|This includes Intent-to-treat population (ITT)|
48597417|NCT02339155|101796612|FG000|Received Study Treatment|Overall Study||286||
48597418|NCT02339155|101796613|FG001|Received Study Treatment|Overall Study||280||
48597419|NCT02339155|101796612|FG000|COMPLETED|Overall Study||272||
48597420|NCT02339155|101796613|FG001|COMPLETED|Overall Study||265||
48597421|NCT02339155|101796612|FG000|NOT COMPLETED|Overall Study||15||
48597422|NCT02339155|101796613|FG001|NOT COMPLETED|Overall Study||21||
48597423|NCT01249833|101796614|FG000|STARTED|Overall Study||59||
48597424|NCT01249833|101796615|FG001|STARTED|Overall Study||63||
48597425|NCT01249833|101796614|FG000|COMPLETED|Overall Study||59||
48597426|NCT01249833|101796615|FG001|COMPLETED|Overall Study||62||
48597427|NCT01249833|101796614|FG000|NOT COMPLETED|Overall Study||0||
48597428|NCT01249833|101796615|FG001|NOT COMPLETED|Overall Study||1||
48597429|NCT01440387|101796616|FG000|STARTED|Overall Study||56||
48597430|NCT01440387|101796617|FG001|STARTED|Overall Study||56||
48597431|NCT01440387|101796616|FG000|COMPLETED|Overall Study||56||
48597432|NCT01440387|101796617|FG001|COMPLETED|Overall Study||56||
48597433|NCT01440387|101796616|FG000|NOT COMPLETED|Overall Study||0||
48597434|NCT01440387|101796617|FG001|NOT COMPLETED|Overall Study||0||
48597435|NCT01451554|101796618|FG000|STARTED|Overall Study||33||
48597436|NCT01451554|101796619|FG001|STARTED|Overall Study||32||
48597437|NCT01451554|101796618|FG000|COMPLETED|Overall Study||19||
48597438|NCT01451554|101796619|FG001|COMPLETED|Overall Study||23||
48597439|NCT01451554|101796618|FG000|NOT COMPLETED|Overall Study||14||
48597440|NCT01451554|101796619|FG001|NOT COMPLETED|Overall Study||9||
48597441|NCT03226678|101796620|FG000|STARTED|Part A (Core Study Phase)||5||
48597442|NCT03226678|101796621|FG001|STARTED|Part A (Core Study Phase)||6||
48296212|NCT03681951|101054205|FG003|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0||
48296213|NCT03681951|101054206|FG004|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0||
48296214|NCT03681951|101054207|FG005|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0||
48296215|NCT03681951|101054208|FG006|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0||
48296216|NCT03681951|101054209|FG007|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0||
48597443|NCT03226678|101796622|FG002|STARTED|Part A (Core Study Phase)||7||
48597444|NCT03226678|101796623|FG003|STARTED|Part A (Core Study Phase)||6||
48597445|NCT03226678|101796624|FG004|STARTED|Part A (Core Study Phase)||0||
48597446|NCT03226678|101796625|FG005|STARTED|Part A (Core Study Phase)||0||
48296217|NCT03681951|101054202|FG000|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0||
48404963|NCT04159701|101325160|FG000|COMPLETED|Period 1: Treatment Period||31||
48597447|NCT03226678|101796620|FG000|COMPLETED|Part A (Core Study Phase)||3||
48597448|NCT03226678|101796621|FG001|COMPLETED|Part A (Core Study Phase)||3||
48597449|NCT03226678|101796622|FG002|COMPLETED|Part A (Core Study Phase)||5||
48597450|NCT03226678|101796623|FG003|COMPLETED|Part A (Core Study Phase)||5||
48143202|NCT03929029|100676498|FG000|COMPLETED|Nivolumab (Week 24+, Every 4 Weeks)||4||
48143203|NCT03929029|100676499|FG001|COMPLETED|Nivolumab (Week 24+, Every 4 Weeks)||4||
48143204|NCT03929029|100676498|FG000|NOT COMPLETED|Nivolumab (Week 24+, Every 4 Weeks)||0||
48143205|NCT03929029|100676499|FG001|NOT COMPLETED|Nivolumab (Week 24+, Every 4 Weeks)||0||
48143206|NCT00867217|100676500|FG000|STARTED|Overall Study||80||
48597451|NCT03226678|101796624|FG004|COMPLETED|Part A (Core Study Phase)||0||
48597452|NCT03226678|101796625|FG005|COMPLETED|Part A (Core Study Phase)||0||
48597453|NCT03226678|101796620|FG000|NOT COMPLETED|Part A (Core Study Phase)||2||
48597454|NCT03226678|101796621|FG001|NOT COMPLETED|Part A (Core Study Phase)||3||
48597455|NCT03226678|101796622|FG002|NOT COMPLETED|Part A (Core Study Phase)||2||
48597456|NCT03226678|101796623|FG003|NOT COMPLETED|Part A (Core Study Phase)||1||
48597457|NCT03226678|101796624|FG004|NOT COMPLETED|Part A (Core Study Phase)||0||
48597458|NCT03226678|101796625|FG005|NOT COMPLETED|Part A (Core Study Phase)||0||
48597459|NCT03226678|101796620|FG000|STARTED|Part B (Long-Term Extension Phase)||0||
48597460|NCT03226678|101796621|FG001|STARTED|Part B (Long-Term Extension Phase)||0||
48597461|NCT03226678|101796622|FG002|STARTED|Part B (Long-Term Extension Phase)||0||
48597462|NCT03226678|101796623|FG003|STARTED|Part B (Long-Term Extension Phase)||0||
48597463|NCT03226678|101796624|FG004|STARTED|Part B (Long-Term Extension Phase)||5||
48597464|NCT03226678|101796625|FG005|STARTED|Part B (Long-Term Extension Phase)||9||
48597465|NCT03226678|101796620|FG000|COMPLETED|Part B (Long-Term Extension Phase)||0||
48597466|NCT03226678|101796621|FG001|COMPLETED|Part B (Long-Term Extension Phase)||0||
48597467|NCT03226678|101796622|FG002|COMPLETED|Part B (Long-Term Extension Phase)||0||
48597468|NCT03226678|101796623|FG003|COMPLETED|Part B (Long-Term Extension Phase)||0||
48597469|NCT03226678|101796624|FG004|COMPLETED|Part B (Long-Term Extension Phase)||0||
48597470|NCT03226678|101796625|FG005|COMPLETED|Part B (Long-Term Extension Phase)||0||
48597471|NCT03226678|101796620|FG000|NOT COMPLETED|Part B (Long-Term Extension Phase)||0||
48597472|NCT03226678|101796621|FG001|NOT COMPLETED|Part B (Long-Term Extension Phase)||0||
48597473|NCT03226678|101796622|FG002|NOT COMPLETED|Part B (Long-Term Extension Phase)||0||
48597474|NCT03226678|101796623|FG003|NOT COMPLETED|Part B (Long-Term Extension Phase)||0||
48597475|NCT03226678|101796624|FG004|NOT COMPLETED|Part B (Long-Term Extension Phase)||5||
48597476|NCT03226678|101796625|FG005|NOT COMPLETED|Part B (Long-Term Extension Phase)||9||
48597477|NCT02539134|101796626|FG000|STARTED|Overall Study||10||
48597478|NCT02539134|101796627|FG001|STARTED|Overall Study||6||
48597479|NCT02539134|101796628|FG002|STARTED|Overall Study||6||
48597480|NCT02539134|101796629|FG003|STARTED|Overall Study||6||
48143207|NCT00867217|100676501|FG001|STARTED|Overall Study||80||
48143208|NCT00867217|100676500|FG000|COMPLETED|Overall Study||77||
48143209|NCT00867217|100676501|FG001|COMPLETED|Overall Study||70||
48143210|NCT00867217|100676500|FG000|NOT COMPLETED|Overall Study||3||
48143211|NCT00867217|100676501|FG001|NOT COMPLETED|Overall Study||10||
48143212|NCT00802074|100676502|FG000|STARTED|Overall Study||9||
48143213|NCT00802074|100676503|FG001|STARTED|Overall Study||8||
48143214|NCT00802074|100676504|FG002|STARTED|Overall Study||7||
48143215|NCT00802074|100676505|FG003|STARTED|Overall Study||7||
48143216|NCT00802074|100676506|FG004|STARTED|Overall Study||7||
48143217|NCT00802074|100676507|FG005|STARTED|Overall Study||7||
48143218|NCT00802074|100676502|FG000|COMPLETED|Overall Study||7||
48143219|NCT00802074|100676503|FG001|COMPLETED|Overall Study||7||
48143220|NCT00802074|100676504|FG002|COMPLETED|Overall Study||6||
48143221|NCT00802074|100676505|FG003|COMPLETED|Overall Study||7||
48597481|NCT02539134|101796630|FG004|STARTED|Overall Study||6||
48597482|NCT02539134|101796631|FG005|STARTED|Overall Study||6||
48597483|NCT02539134|101796626|FG000|COMPLETED|Overall Study||9||
48597484|NCT02539134|101796627|FG001|COMPLETED|Overall Study||6||
48597485|NCT02539134|101796628|FG002|COMPLETED|Overall Study||6||
48597486|NCT02539134|101796629|FG003|COMPLETED|Overall Study||6||
48143222|NCT00802074|100676506|FG004|COMPLETED|Overall Study||7||
48143223|NCT00802074|100676507|FG005|COMPLETED|Overall Study||7||
48597487|NCT02539134|101796630|FG004|COMPLETED|Overall Study||6||
48597488|NCT02539134|101796631|FG005|COMPLETED|Overall Study||6||
48143224|NCT00802074|100676502|FG000|NOT COMPLETED|Overall Study||2||
48143225|NCT00802074|100676503|FG001|NOT COMPLETED|Overall Study||1||
48143226|NCT00802074|100676504|FG002|NOT COMPLETED|Overall Study||1||
48143227|NCT00802074|100676505|FG003|NOT COMPLETED|Overall Study||0||
48296218|NCT03681951|101054203|FG001|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0||
48296219|NCT03681951|101054204|FG002|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0||
48296220|NCT03681951|101054205|FG003|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0||
48296221|NCT03681951|101054206|FG004|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0||
48296222|NCT03681951|101054207|FG005|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0||
48296223|NCT03681951|101054208|FG006|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0||
48296224|NCT03681951|101054209|FG007|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0||
48296225|NCT03681951|101054202|FG000|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0||
48296226|NCT03681951|101054203|FG001|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0||
48296227|NCT03681951|101054204|FG002|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0||
48296228|NCT03681951|101054205|FG003|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0||
48296229|NCT03681951|101054206|FG004|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0||
48296230|NCT03681951|101054207|FG005|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0||
48296231|NCT03681951|101054208|FG006|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0||
48296232|NCT03681951|101054209|FG007|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0||
48296233|NCT03681951|101054202|FG000|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
48296234|NCT03681951|101054203|FG001|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
48296235|NCT03681951|101054204|FG002|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
48296236|NCT03681951|101054205|FG003|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
48296237|NCT03681951|101054206|FG004|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
48296238|NCT03681951|101054207|FG005|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
48296239|NCT03681951|101054208|FG006|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
48296240|NCT03681951|101054209|FG007|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
48296241|NCT03681951|101054202|FG000|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
48296242|NCT03681951|101054203|FG001|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
48296243|NCT03681951|101054204|FG002|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
48296244|NCT03681951|101054205|FG003|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
48296245|NCT03681951|101054206|FG004|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
48296246|NCT03681951|101054207|FG005|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
48296247|NCT03681951|101054208|FG006|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
48296248|NCT03681951|101054209|FG007|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
48296249|NCT03681951|101054202|FG000|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
48296250|NCT03681951|101054203|FG001|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
48296251|NCT03681951|101054204|FG002|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
48296252|NCT03681951|101054205|FG003|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
48296253|NCT03681951|101054206|FG004|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
48296254|NCT03681951|101054207|FG005|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
48296255|NCT03681951|101054208|FG006|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
48296256|NCT03681951|101054209|FG007|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
48296257|NCT00701220|101054210|FG000|STARTED|Overall Study||3||
48296258|NCT00701220|101054211|FG001|STARTED|Overall Study||6||
48296259|NCT00701220|101054210|FG000|COMPLETED|Overall Study||1||
48296260|NCT00701220|101054211|FG001|COMPLETED|Overall Study||4||
48296261|NCT00701220|101054210|FG000|NOT COMPLETED|Overall Study||2||
48296262|NCT00701220|101054211|FG001|NOT COMPLETED|Overall Study||2||
48296263|NCT00676065|101054212|FG000|STARTED|Overall Study||16534||
48296264|NCT00676065|101054213|FG001|STARTED|Overall Study||15428||
48296265|NCT00676065|101054214|FG002|STARTED|Overall Study||26341||
48296266|NCT00676065|101054212|FG000|COMPLETED|Overall Study||16534||
48296267|NCT00676065|101054213|FG001|COMPLETED|Overall Study||15428||
48296268|NCT00676065|101054214|FG002|COMPLETED|Overall Study||26341||
48296269|NCT00676065|101054212|FG000|NOT COMPLETED|Overall Study||0||
48296270|NCT00676065|101054213|FG001|NOT COMPLETED|Overall Study||0||
48296271|NCT00676065|101054214|FG002|NOT COMPLETED|Overall Study||0||
48296272|NCT00705523|101054215|FG000|STARTED|Overall Study||19||
48296273|NCT00705523|101054216|FG001|STARTED|Overall Study||21||
48296274|NCT00705523|101054215|FG000|COMPLETED|Overall Study||17||
48296275|NCT00705523|101054216|FG001|COMPLETED|Overall Study||18||
48296276|NCT00705523|101054215|FG000|NOT COMPLETED|Overall Study||2||
48296277|NCT00705523|101054216|FG001|NOT COMPLETED|Overall Study||3||
48296278|NCT00223678|101054217|FG000|STARTED|Overall Study||13||
48296279|NCT00223678|101054218|FG001|STARTED|Overall Study||7||
48296280|NCT00223678|101054217|FG000|COMPLETED|Overall Study||13||
48296281|NCT00223678|101054218|FG001|COMPLETED|Overall Study||7||
48296282|NCT00223678|101054217|FG000|NOT COMPLETED|Overall Study||0||
48296283|NCT00223678|101054218|FG001|NOT COMPLETED|Overall Study||0||
48296284|NCT02080221|101054219|FG000|STARTED|Overall Study||50||
48296285|NCT02080221|101054219|FG000|COMPLETED|Overall Study||48||
48296286|NCT02080221|101054219|FG000|NOT COMPLETED|Overall Study||2||
48296287|NCT02374021|101054220|FG000|STARTED|Overall Study||80||
48296288|NCT02374021|101054221|FG001|STARTED|Overall Study||79||
48296289|NCT02374021|101054220|FG000|COMPLETED|Overall Study||57||
48296290|NCT02374021|101054221|FG001|COMPLETED|Overall Study||58||
48296291|NCT02374021|101054220|FG000|NOT COMPLETED|Overall Study||23||
48296292|NCT02374021|101054221|FG001|NOT COMPLETED|Overall Study||21||
48296293|NCT01351753|101054222|FG000|STARTED|Overall Study||22||
48296294|NCT01351753|101054223|FG001|STARTED|Overall Study||20||
48296295|NCT01351753|101054224|FG002|STARTED|Overall Study||21||
48296296|NCT01351753|101054225|FG003|STARTED|Overall Study||21||
48597489|NCT02539134|101796626|FG000|NOT COMPLETED|Overall Study||1||
48597490|NCT02539134|101796627|FG001|NOT COMPLETED|Overall Study||0||
48597491|NCT02539134|101796628|FG002|NOT COMPLETED|Overall Study||0||
48597492|NCT02539134|101796629|FG003|NOT COMPLETED|Overall Study||0||
48597493|NCT02539134|101796630|FG004|NOT COMPLETED|Overall Study||0||
48597494|NCT02539134|101796631|FG005|NOT COMPLETED|Overall Study||0||
48597495|NCT01643798|101796632|FG000|STARTED|Pretreatment 1 and Stimulation||7||
48597496|NCT01643798|101796633|FG001|STARTED|Pretreatment 1 and Stimulation||8||
48597497|NCT01643798|101796632|FG000|COMPLETED|Pretreatment 1 and Stimulation||6||
48597498|NCT01643798|101796633|FG001|COMPLETED|Pretreatment 1 and Stimulation||8||
48597499|NCT01643798|101796632|FG000|NOT COMPLETED|Pretreatment 1 and Stimulation||1||
48597500|NCT01643798|101796633|FG001|NOT COMPLETED|Pretreatment 1 and Stimulation||0||
48597501|NCT01643798|101796632|FG000|STARTED|Pretreatment 2 and Stimulation||6||
48597502|NCT01643798|101796633|FG001|STARTED|Pretreatment 2 and Stimulation||8||
48597503|NCT01643798|101796632|FG000|COMPLETED|Pretreatment 2 and Stimulation||6||
48597504|NCT01643798|101796633|FG001|COMPLETED|Pretreatment 2 and Stimulation||8||
48597505|NCT01643798|101796632|FG000|NOT COMPLETED|Pretreatment 2 and Stimulation||0||
48597506|NCT01643798|101796633|FG001|NOT COMPLETED|Pretreatment 2 and Stimulation||0||
48597507|NCT02607280|101796634|FG000|STARTED|Overall Study||30||
48597508|NCT02607280|101796635|FG001|STARTED|Overall Study||5||
48597509|NCT02607280|101796634|FG000|Received Study Drug|Overall Study||30||
48597510|NCT02607280|101796635|FG001|Received Study Drug|Overall Study||5||
48597511|NCT02607280|101796634|FG000|COMPLETED|Overall Study||26||
48597512|NCT02607280|101796635|FG001|COMPLETED|Overall Study||4||
48597513|NCT02607280|101796634|FG000|NOT COMPLETED|Overall Study||4||
48597514|NCT02607280|101796635|FG001|NOT COMPLETED|Overall Study||1||
48597515|NCT01656187|101796636|FG000|STARTED|First Intervention (24 Weeks)||20||
48597516|NCT01656187|101796637|FG001|STARTED|First Intervention (24 Weeks)||26||
48597517|NCT01656187|101796636|FG000|COMPLETED|First Intervention (24 Weeks)||14||
48597518|NCT01656187|101796637|FG001|COMPLETED|First Intervention (24 Weeks)||23||
48597519|NCT01656187|101796636|FG000|NOT COMPLETED|First Intervention (24 Weeks)||6||
48597520|NCT01656187|101796637|FG001|NOT COMPLETED|First Intervention (24 Weeks)||3||
48597521|NCT01656187|101796636|FG000|STARTED|Washout (4 Weeks)||14||
48597522|NCT01656187|101796637|FG001|STARTED|Washout (4 Weeks)||23||
48597523|NCT01656187|101796636|FG000|COMPLETED|Washout (4 Weeks)||14||
48597524|NCT01656187|101796637|FG001|COMPLETED|Washout (4 Weeks)||22||
48597525|NCT01656187|101796636|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
48597526|NCT01656187|101796637|FG001|NOT COMPLETED|Washout (4 Weeks)||1||
48597527|NCT01656187|101796636|FG000|STARTED|Second Intervention (24 Weeks)||14||
48597528|NCT01656187|101796637|FG001|STARTED|Second Intervention (24 Weeks)||22||
48597529|NCT01656187|101796636|FG000|COMPLETED|Second Intervention (24 Weeks)||13||
48597530|NCT01656187|101796637|FG001|COMPLETED|Second Intervention (24 Weeks)||19||
48597531|NCT01656187|101796636|FG000|NOT COMPLETED|Second Intervention (24 Weeks)||1||
48597532|NCT01656187|101796637|FG001|NOT COMPLETED|Second Intervention (24 Weeks)||3||
48597533|NCT00829829|101796638|FG000|STARTED|Overall Study||80||
48597534|NCT00829829|101796639|FG001|STARTED|Overall Study||80||
48597535|NCT00829829|101796640|FG002|STARTED|Overall Study||81||
48597536|NCT00829829|101796638|FG000|Treated|Overall Study||79|Participants treated were included in safety population.|
48597537|NCT00829829|101796639|FG001|Treated|Overall Study||80|Participants treated were included in safety population.|
48597538|NCT00829829|101796640|FG002|Treated|Overall Study||81|Participants treated were included in safety population.|
48597539|NCT00829829|101796638|FG000|COMPLETED|Overall Study||58||
48296297|NCT01351753|101054226|FG004|STARTED|Overall Study||21||
48296298|NCT01351753|101054227|FG005|STARTED|Overall Study||23||
48296299|NCT01351753|101054222|FG000|COMPLETED|Overall Study||15||
48597540|NCT00829829|101796639|FG001|COMPLETED|Overall Study||64||
48597541|NCT00829829|101796640|FG002|COMPLETED|Overall Study||70||
48296300|NCT01351753|101054223|FG001|COMPLETED|Overall Study||13||
48296301|NCT01351753|101054224|FG002|COMPLETED|Overall Study||14||
48597542|NCT00829829|101796638|FG000|NOT COMPLETED|Overall Study||22||
48597543|NCT00829829|101796639|FG001|NOT COMPLETED|Overall Study||16||
48597544|NCT00829829|101796640|FG002|NOT COMPLETED|Overall Study||11||
48597545|NCT01349933|101796641|FG000|STARTED|Overall Study||21||
48597546|NCT01349933|101796641|FG000|COMPLETED|Overall Study||21||
48597547|NCT01349933|101796641|FG000|NOT COMPLETED|Overall Study||0||
48597548|NCT00792116|101796642|FG000|STARTED|Overall Study||53||
48597549|NCT00792116|101796643|FG001|STARTED|Overall Study||55||
48597550|NCT00792116|101796642|FG000|COMPLETED|Overall Study||52||
48597551|NCT00792116|101796643|FG001|COMPLETED|Overall Study||54||
48597552|NCT00792116|101796642|FG000|NOT COMPLETED|Overall Study||1||
48597553|NCT00792116|101796643|FG001|NOT COMPLETED|Overall Study||1||
48597554|NCT02634710|101796644|FG000|STARTED|Overall Study||35||
48597555|NCT02634710|101796644|FG000|COMPLETED|Overall Study||31||
48597556|NCT02634710|101796644|FG000|NOT COMPLETED|Overall Study||4||
48597557|NCT00524173|101796645|FG000|STARTED|Overall Study||17||
48597558|NCT00524173|101796646|FG001|STARTED|Overall Study||15||
48597559|NCT00524173|101796645|FG000|COMPLETED|Overall Study||12||
48597560|NCT00524173|101796646|FG001|COMPLETED|Overall Study||13||
48597561|NCT00524173|101796645|FG000|NOT COMPLETED|Overall Study||5||
48597562|NCT00524173|101796646|FG001|NOT COMPLETED|Overall Study||2||
48597563|NCT01881087|101796647|FG000|STARTED|Overall Study||60||
48597564|NCT01881087|101796648|FG001|STARTED|Overall Study||61||
48597565|NCT01881087|101796649|FG002|STARTED|Overall Study||62||
48597566|NCT01881087|101796647|FG000|COMPLETED|Overall Study||59||
48597567|NCT01881087|101796648|FG001|COMPLETED|Overall Study||61||
48597568|NCT01881087|101796649|FG002|COMPLETED|Overall Study||60||
48597569|NCT01881087|101796647|FG000|NOT COMPLETED|Overall Study||1||
48597570|NCT01881087|101796648|FG001|NOT COMPLETED|Overall Study||0||
48597571|NCT01881087|101796649|FG002|NOT COMPLETED|Overall Study||2||
48597572|NCT00667186|101796650|FG000|STARTED|Overall Study||4692||
48597573|NCT00667186|101796651|FG001|STARTED|Overall Study||4880||
48597574|NCT00667186|101796650|FG000|COMPLETED|Overall Study||4692||
48597575|NCT00667186|101796651|FG001|COMPLETED|Overall Study||4880||
48597576|NCT00667186|101796650|FG000|NOT COMPLETED|Overall Study||0||
48597577|NCT00667186|101796651|FG001|NOT COMPLETED|Overall Study||0||
48597578|NCT04652700|101796652|FG000|STARTED|Part 1: Blinded Study Medication||328|Started randomized treatment|
48597579|NCT04652700|101796653|FG001|STARTED|Part 1: Blinded Study Medication||166|Started randomized treatment|
48597580|NCT04652700|101796652|FG000|COMPLETED|Part 1: Blinded Study Medication||0||
48597581|NCT04652700|101796653|FG001|COMPLETED|Part 1: Blinded Study Medication||0||
48597582|NCT04652700|101796652|FG000|NOT COMPLETED|Part 1: Blinded Study Medication||328||
48597583|NCT04652700|101796653|FG001|NOT COMPLETED|Part 1: Blinded Study Medication||166||
48597584|NCT04652700|101796652|FG000|STARTED|Parts 2 and 3: Open-Label FTC TDF or TAF||306|Started optional open-label therapy|
48597585|NCT04652700|101796653|FG001|STARTED|Parts 2 and 3: Open-Label FTC TDF or TAF||154|Started optional open-label therapy|
48597586|NCT04652700|101796652|FG000|COMPLETED|Parts 2 and 3: Open-Label FTC TDF or TAF||0||
48597587|NCT04652700|101796653|FG001|COMPLETED|Parts 2 and 3: Open-Label FTC TDF or TAF||0||
48597588|NCT04652700|101796652|FG000|NOT COMPLETED|Parts 2 and 3: Open-Label FTC TDF or TAF||306||
48597589|NCT04652700|101796653|FG001|NOT COMPLETED|Parts 2 and 3: Open-Label FTC TDF or TAF||154||
48597590|NCT01093651|101796654|FG000|STARTED|Overall Study||10||
48597591|NCT01093651|101796655|FG001|STARTED|Overall Study||10||
48597592|NCT01093651|101796654|FG000|COMPLETED|Overall Study||10||
48597593|NCT01093651|101796655|FG001|COMPLETED|Overall Study||10||
48597594|NCT01093651|101796654|FG000|NOT COMPLETED|Overall Study||0||
48597595|NCT01093651|101796655|FG001|NOT COMPLETED|Overall Study||0||
48597596|NCT00738062|101796656|FG000|STARTED|Open Label Treatment||103||
48597597|NCT00738062|101796657|FG001|STARTED|Open Label Treatment||0||
48597598|NCT00738062|101796658|FG002|STARTED|Open Label Treatment||0||
48597599|NCT00738062|101796656|FG000|COMPLETED|Open Label Treatment||75||
48597600|NCT00738062|101796657|FG001|COMPLETED|Open Label Treatment||0||
48597601|NCT00738062|101796658|FG002|COMPLETED|Open Label Treatment||0||
48597602|NCT00738062|101796656|FG000|NOT COMPLETED|Open Label Treatment||28||
48597603|NCT00738062|101796657|FG001|NOT COMPLETED|Open Label Treatment||0||
48597604|NCT00738062|101796658|FG002|NOT COMPLETED|Open Label Treatment||0||
48597605|NCT00738062|101796656|FG000|STARTED|2 Week Randomized Withdrawal||0||
48597606|NCT00738062|101796657|FG001|STARTED|2 Week Randomized Withdrawal||38||
48597607|NCT00738062|101796658|FG002|STARTED|2 Week Randomized Withdrawal||37||
48597608|NCT00738062|101796656|FG000|COMPLETED|2 Week Randomized Withdrawal||0||
48597609|NCT00738062|101796657|FG001|COMPLETED|2 Week Randomized Withdrawal||38||
48597610|NCT00738062|101796658|FG002|COMPLETED|2 Week Randomized Withdrawal||37||
48597611|NCT00738062|101796656|FG000|NOT COMPLETED|2 Week Randomized Withdrawal||0||
48597612|NCT00738062|101796657|FG001|NOT COMPLETED|2 Week Randomized Withdrawal||0||
48597613|NCT00738062|101796658|FG002|NOT COMPLETED|2 Week Randomized Withdrawal||0||
48597614|NCT00738062|101796656|FG000|STARTED|Open-Label Extension||74||
48597615|NCT00738062|101796657|FG001|STARTED|Open-Label Extension||0||
48597616|NCT00738062|101796658|FG002|STARTED|Open-Label Extension||0||
48597617|NCT00738062|101796656|FG000|COMPLETED|Open-Label Extension||57||
48597618|NCT00738062|101796657|FG001|COMPLETED|Open-Label Extension||0||
48597619|NCT00738062|101796658|FG002|COMPLETED|Open-Label Extension||0||
48657067|NCT03648372|101943765|FG008|COMPLETED|Overall Study||1||
48296302|NCT01351753|101054225|FG003|COMPLETED|Overall Study||21||
48296303|NCT01351753|101054226|FG004|COMPLETED|Overall Study||14||
48296304|NCT01351753|101054227|FG005|COMPLETED|Overall Study||22||
48296305|NCT01351753|101054222|FG000|NOT COMPLETED|Overall Study||7||
48296306|NCT01351753|101054223|FG001|NOT COMPLETED|Overall Study||7||
48296307|NCT01351753|101054224|FG002|NOT COMPLETED|Overall Study||7||
48296308|NCT01351753|101054225|FG003|NOT COMPLETED|Overall Study||0||
48296309|NCT01351753|101054226|FG004|NOT COMPLETED|Overall Study||7||
48296310|NCT01351753|101054227|FG005|NOT COMPLETED|Overall Study||1||
48296311|NCT02720536|101054228|FG000|STARTED|Overall Study||53||
48296312|NCT02720536|101054228|FG000|COMPLETED|Overall Study||34||
48296313|NCT02720536|101054228|FG000|NOT COMPLETED|Overall Study||19||
48296314|NCT01942720|101054229|FG000|STARTED|Overall Study||74||
48296315|NCT01942720|101054229|FG000|COMPLETED|Overall Study||53||
48597620|NCT00738062|101796656|FG000|NOT COMPLETED|Open-Label Extension||17||
48597621|NCT00738062|101796657|FG001|NOT COMPLETED|Open-Label Extension||0||
48597622|NCT00738062|101796658|FG002|NOT COMPLETED|Open-Label Extension||0||
48597623|NCT02817698|101796659|FG000|STARTED|Overall Study||25||
48597624|NCT02817698|101796659|FG000|COMPLETED|Overall Study||25||
48597625|NCT02817698|101796659|FG000|NOT COMPLETED|Overall Study||0||
48597626|NCT01380691|101796660|FG000|STARTED|Period 1||7||
48597627|NCT01380691|101796661|FG001|STARTED|Period 1||7||
48597628|NCT01380691|101796662|FG002|STARTED|Period 1||7||
48597629|NCT01380691|101796663|FG003|STARTED|Period 1||7||
48597630|NCT01380691|101796660|FG000|COMPLETED|Period 1||7||
48597631|NCT01380691|101796661|FG001|COMPLETED|Period 1||7||
48597632|NCT01380691|101796662|FG002|COMPLETED|Period 1||7||
48597633|NCT01380691|101796663|FG003|COMPLETED|Period 1||7||
48597634|NCT01380691|101796660|FG000|NOT COMPLETED|Period 1||0||
48597635|NCT01380691|101796661|FG001|NOT COMPLETED|Period 1||0||
48597636|NCT01380691|101796662|FG002|NOT COMPLETED|Period 1||0||
48597637|NCT01380691|101796663|FG003|NOT COMPLETED|Period 1||0||
48597638|NCT01380691|101796660|FG000|STARTED|Washout (7 Days)||7||
48597639|NCT01380691|101796661|FG001|STARTED|Washout (7 Days)||7||
48597640|NCT01380691|101796662|FG002|STARTED|Washout (7 Days)||7||
48597641|NCT01380691|101796663|FG003|STARTED|Washout (7 Days)||7||
48597642|NCT01380691|101796660|FG000|COMPLETED|Washout (7 Days)||7||
48597643|NCT01380691|101796661|FG001|COMPLETED|Washout (7 Days)||7||
48597644|NCT01380691|101796662|FG002|COMPLETED|Washout (7 Days)||6||
48597645|NCT01380691|101796663|FG003|COMPLETED|Washout (7 Days)||6||
48597646|NCT01380691|101796660|FG000|NOT COMPLETED|Washout (7 Days)||0||
48597647|NCT01380691|101796661|FG001|NOT COMPLETED|Washout (7 Days)||0||
48597648|NCT01380691|101796662|FG002|NOT COMPLETED|Washout (7 Days)||1||
48597649|NCT01380691|101796663|FG003|NOT COMPLETED|Washout (7 Days)||1||
48597650|NCT01380691|101796660|FG000|STARTED|Period 2||7||
48597651|NCT01380691|101796661|FG001|STARTED|Period 2||7||
48597652|NCT01380691|101796662|FG002|STARTED|Period 2||6||
48597653|NCT01380691|101796663|FG003|STARTED|Period 2||6||
48296316|NCT01942720|101054229|FG000|NOT COMPLETED|Overall Study||21||
48296317|NCT00426153|101054230|FG000|STARTED|Overall Study||28||
48296318|NCT00426153|101054231|FG001|STARTED|Overall Study||14||
48296319|NCT00426153|101054230|FG000|COMPLETED|Overall Study||28||
48296320|NCT00426153|101054231|FG001|COMPLETED|Overall Study||14||
48296321|NCT00426153|101054230|FG000|NOT COMPLETED|Overall Study||0||
48296322|NCT00426153|101054231|FG001|NOT COMPLETED|Overall Study||0||
48296323|NCT01395316|101054232|FG000|STARTED|Overall Study||8||
48296324|NCT01395316|101054232|FG000|COMPLETED|Overall Study||5||
48296325|NCT01395316|101054232|FG000|NOT COMPLETED|Overall Study||3||
48296326|NCT00995020|101054233|FG000|STARTED|Overall Study||51||
48296327|NCT00995020|101054234|FG001|STARTED|Overall Study||52||
48296328|NCT00995020|101054233|FG000|COMPLETED|Overall Study||48||
48296329|NCT00995020|101054234|FG001|COMPLETED|Overall Study||45||
48296330|NCT00995020|101054233|FG000|NOT COMPLETED|Overall Study||3||
48597654|NCT01380691|101796660|FG000|COMPLETED|Period 2||7||
48597655|NCT01380691|101796661|FG001|COMPLETED|Period 2||7||
48597656|NCT01380691|101796662|FG002|COMPLETED|Period 2||6||
48597657|NCT01380691|101796663|FG003|COMPLETED|Period 2||6||
48597658|NCT01380691|101796660|FG000|NOT COMPLETED|Period 2||0||
48597659|NCT01380691|101796661|FG001|NOT COMPLETED|Period 2||0||
48597660|NCT01380691|101796662|FG002|NOT COMPLETED|Period 2||0||
48296331|NCT00995020|101054234|FG001|NOT COMPLETED|Overall Study||7||
48296332|NCT04964414|101054235|FG000|STARTED|Overall Study||11||
48296333|NCT04964414|101054236|FG001|STARTED|Overall Study||9||
48296334|NCT04964414|101054235|FG000|8-12 Week Follow-up|Overall Study||7||
48296335|NCT04964414|101054236|FG001|8-12 Week Follow-up|Overall Study||1||
48367936|NCT03661541|101230078|FG001|COMPLETED|Overall Study||10||
48367937|NCT03661541|101230079|FG002|COMPLETED|Overall Study||10||
48597661|NCT01380691|101796663|FG003|NOT COMPLETED|Period 2||0||
48597662|NCT04245202|101796664|FG000|STARTED|Overall Study||48||
48597663|NCT04245202|101796665|FG001|STARTED|Overall Study||39||
48597664|NCT04245202|101796664|FG000|COMPLETED|Overall Study||38||
48597665|NCT04245202|101796665|FG001|COMPLETED|Overall Study||38||
48597666|NCT04245202|101796664|FG000|NOT COMPLETED|Overall Study||10||
48597667|NCT04245202|101796665|FG001|NOT COMPLETED|Overall Study||1||
48597668|NCT03280225|101796666|FG000|STARTED|Overall Study||0||28
48597669|NCT03280225|101796666|FG000|COMPLETED|Overall Study||0||23
48143228|NCT00802074|100676506|FG004|NOT COMPLETED|Overall Study||0||
48143229|NCT00802074|100676507|FG005|NOT COMPLETED|Overall Study||0||
48143230|NCT02811861|100676508|FG000|STARTED|Overall Study||357||
48143231|NCT02811861|100676509|FG001|STARTED|Overall Study||355||
48143232|NCT02811861|100676510|FG002|STARTED|Overall Study||357||
48143233|NCT02811861|100676508|FG000|Treated|Overall Study||355||
48143234|NCT02811861|100676509|FG001|Treated|Overall Study||352||
48143235|NCT02811861|100676510|FG002|Treated|Overall Study||340||
48143236|NCT02811861|100676508|FG000|COMPLETED|Overall Study||0||
48143237|NCT02811861|100676509|FG001|COMPLETED|Overall Study||0||
48143238|NCT02811861|100676510|FG002|COMPLETED|Overall Study||0||
48143239|NCT02811861|100676508|FG000|NOT COMPLETED|Overall Study||357||
48143240|NCT02811861|100676509|FG001|NOT COMPLETED|Overall Study||355||
48143241|NCT02811861|100676510|FG002|NOT COMPLETED|Overall Study||357||
48143242|NCT04704375|100676511|FG000|STARTED|Overall Study||10||
48143243|NCT04704375|100676512|FG001|STARTED|Overall Study||10||
48143244|NCT04704375|100676513|FG002|STARTED|Overall Study||10||
48143245|NCT04704375|100676514|FG003|STARTED|Overall Study||10||
48143246|NCT04704375|100676511|FG000|COMPLETED|Overall Study||10||
48143247|NCT04704375|100676512|FG001|COMPLETED|Overall Study||10||
48143248|NCT04704375|100676513|FG002|COMPLETED|Overall Study||10||
48143249|NCT04704375|100676514|FG003|COMPLETED|Overall Study||10||
48143250|NCT04704375|100676511|FG000|NOT COMPLETED|Overall Study||0||
48143251|NCT04704375|100676512|FG001|NOT COMPLETED|Overall Study||0||
48143252|NCT04704375|100676513|FG002|NOT COMPLETED|Overall Study||0||
48143253|NCT04704375|100676514|FG003|NOT COMPLETED|Overall Study||0||
48143254|NCT02527798|100676515|FG000|STARTED|Overall Study||32||
48143255|NCT02527798|100676516|FG001|STARTED|Overall Study||10||
48143256|NCT02527798|100676517|FG002|STARTED|Overall Study||30||
48143257|NCT02527798|100676518|FG003|STARTED|Overall Study||10||
48143258|NCT02527798|100676519|FG004|STARTED|Overall Study||0||
48143259|NCT02527798|100676520|FG005|STARTED|Overall Study||0||
48143260|NCT02527798|100676515|FG000|Randomized, Not Dosed|Overall Study||31||
48143261|NCT02527798|100676516|FG001|Randomized, Not Dosed|Overall Study||9||
48143262|NCT02527798|100676517|FG002|Randomized, Not Dosed|Overall Study||30||
48143263|NCT02527798|100676518|FG003|Randomized, Not Dosed|Overall Study||10||
48143264|NCT02527798|100676519|FG004|Randomized, Not Dosed|Overall Study||0||
48143265|NCT02527798|100676520|FG005|Randomized, Not Dosed|Overall Study||0||
48143266|NCT02527798|100676515|FG000|Pharmacokinetic (PK) Population|Overall Study||20||
48143267|NCT02527798|100676516|FG001|Pharmacokinetic (PK) Population|Overall Study||0||
48143268|NCT02527798|100676517|FG002|Pharmacokinetic (PK) Population|Overall Study||19||
48143269|NCT02527798|100676518|FG003|Pharmacokinetic (PK) Population|Overall Study||0||
48143270|NCT02527798|100676519|FG004|Pharmacokinetic (PK) Population|Overall Study||0||
48143271|NCT02527798|100676520|FG005|Pharmacokinetic (PK) Population|Overall Study||0||
48143272|NCT02527798|100676515|FG000|COMPLETED|Overall Study||29||
48143273|NCT02527798|100676516|FG001|COMPLETED|Overall Study||8||
48143274|NCT02527798|100676517|FG002|COMPLETED|Overall Study||25||
48143275|NCT02527798|100676518|FG003|COMPLETED|Overall Study||9||
48143276|NCT02527798|100676519|FG004|COMPLETED|Overall Study||0||
48143277|NCT02527798|100676520|FG005|COMPLETED|Overall Study||0||
48143278|NCT02527798|100676515|FG000|NOT COMPLETED|Overall Study||3||
48143279|NCT02527798|100676516|FG001|NOT COMPLETED|Overall Study||2||
48143280|NCT02527798|100676517|FG002|NOT COMPLETED|Overall Study||5||
48143281|NCT02527798|100676518|FG003|NOT COMPLETED|Overall Study||1||
48143282|NCT02527798|100676519|FG004|NOT COMPLETED|Overall Study||0||
48597670|NCT03280225|101796666|FG000|NOT COMPLETED|Overall Study||0||5
48597671|NCT00986986|101796667|FG000|STARTED|Overall Study||10||
48597672|NCT00986986|101796668|FG001|STARTED|Overall Study||10||
48597673|NCT00986986|101796667|FG000|COMPLETED|Overall Study||10||
48143283|NCT02527798|100676520|FG005|NOT COMPLETED|Overall Study||0||
48143284|NCT01140880|100676521|FG000|STARTED|Overall Study||70||
48597674|NCT00986986|101796668|FG001|COMPLETED|Overall Study||9||
48143285|NCT01140880|100676522|FG001|STARTED|Overall Study||100||
48143286|NCT01140880|100676521|FG000|COMPLETED|Overall Study||56||
48143287|NCT01140880|100676522|FG001|COMPLETED|Overall Study||56||
48143288|NCT01140880|100676521|FG000|NOT COMPLETED|Overall Study||14||
48143289|NCT01140880|100676522|FG001|NOT COMPLETED|Overall Study||44||
48597675|NCT00986986|101796667|FG000|NOT COMPLETED|Overall Study||0||
48143290|NCT04334668|100676523|FG000|STARTED|Overall Study||34||
48143291|NCT04334668|100676524|FG001|STARTED|Overall Study||33||
48143292|NCT04334668|100676523|FG000|COMPLETED|Overall Study||34||
48143293|NCT04334668|100676524|FG001|COMPLETED|Overall Study||31||
48143294|NCT04334668|100676523|FG000|NOT COMPLETED|Overall Study||0||
48143295|NCT04334668|100676524|FG001|NOT COMPLETED|Overall Study||2||
48143296|NCT04794803|100676525|FG000|STARTED|Overall Study||37||
48143297|NCT04794803|100676526|FG001|STARTED|Overall Study||19||
48143298|NCT04794803|100676525|FG000|FAS Population|Overall Study||36||
48143299|NCT04794803|100676526|FG001|FAS Population|Overall Study||19||
48143300|NCT04794803|100676525|FG000|Safety Set|Overall Study||36||
48143301|NCT04794803|100676526|FG001|Safety Set|Overall Study||19||
48143302|NCT04794803|100676525|FG000|Per Protocol Set|Overall Study||17||
48143303|NCT04794803|100676526|FG001|Per Protocol Set|Overall Study||11||
48143304|NCT04794803|100676525|FG000|COMPLETED|Overall Study||27||
48143305|NCT04794803|100676526|FG001|COMPLETED|Overall Study||11||
48143306|NCT04794803|100676525|FG000|NOT COMPLETED|Overall Study||10||
48143307|NCT04794803|100676526|FG001|NOT COMPLETED|Overall Study||8||
48143308|NCT02638948|100676527|FG000|STARTED|Overall Study||75||
48143309|NCT02638948|100676528|FG001|STARTED|Overall Study||73||
48143310|NCT02638948|100676529|FG002|STARTED|Overall Study||73||
48143311|NCT02638948|100676530|FG003|STARTED|Overall Study||26||
48597676|NCT00986986|101796668|FG001|NOT COMPLETED|Overall Study||1||
48597677|NCT04946552|101796669|FG000|STARTED|Overall Study||3||
48597678|NCT04946552|101796670|FG001|STARTED|Overall Study||2||
48597679|NCT04946552|101796669|FG000|COMPLETED|Overall Study||3||
48597680|NCT04946552|101796670|FG001|COMPLETED|Overall Study||2||
48597681|NCT04946552|101796669|FG000|NOT COMPLETED|Overall Study||0||
48143312|NCT02638948|100676527|FG000|COMPLETED|Overall Study||66||
48143313|NCT02638948|100676528|FG001|COMPLETED|Overall Study||62||
48143314|NCT02638948|100676529|FG002|COMPLETED|Overall Study||66||
48143315|NCT02638948|100676530|FG003|COMPLETED|Overall Study||18||
48597682|NCT04946552|101796670|FG001|NOT COMPLETED|Overall Study||0||
48597683|NCT01199822|101796671|FG000|STARTED|Overall Study||3||
48597684|NCT01199822|101796672|FG001|STARTED|Overall Study||7||
48597685|NCT01199822|101796673|FG002|STARTED|Overall Study||6||
48597686|NCT01199822|101796671|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
48597687|NCT01199822|101796672|FG001|Received at Least 1 Dose of Study Drug|Overall Study||7||
48597688|NCT01199822|101796673|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
48597689|NCT01199822|101796671|FG000|COMPLETED|Overall Study||3||
48597690|NCT01199822|101796672|FG001|COMPLETED|Overall Study||6||
48597691|NCT01199822|101796673|FG002|COMPLETED|Overall Study||6||
48597692|NCT01199822|101796671|FG000|NOT COMPLETED|Overall Study||0||
48597693|NCT01199822|101796672|FG001|NOT COMPLETED|Overall Study||1||
48597694|NCT01199822|101796673|FG002|NOT COMPLETED|Overall Study||0||
48143316|NCT02638948|100676527|FG000|NOT COMPLETED|Overall Study||9||
48143317|NCT02638948|100676528|FG001|NOT COMPLETED|Overall Study||11||
48143318|NCT02638948|100676529|FG002|NOT COMPLETED|Overall Study||7||
48143319|NCT02638948|100676530|FG003|NOT COMPLETED|Overall Study||8||
48143320|NCT01009931|100676531|FG000|STARTED|Overall Study||1||
48143321|NCT01009931|100676531|FG000|COMPLETED|Overall Study||0||
48143322|NCT01009931|100676531|FG000|NOT COMPLETED|Overall Study||1||
48143323|NCT02278328|100676532|FG000|STARTED|Neuropsych Screening||10||
48143324|NCT02278328|100676533|FG001|STARTED|Neuropsych Screening||7||
48143325|NCT02278328|100676534|FG002|STARTED|Neuropsych Screening||8||
48143326|NCT02278328|100676532|FG000|COMPLETED|Neuropsych Screening||9||
48143327|NCT02278328|100676533|FG001|COMPLETED|Neuropsych Screening||6||
48143328|NCT02278328|100676534|FG002|COMPLETED|Neuropsych Screening||6||
48143329|NCT02278328|100676532|FG000|NOT COMPLETED|Neuropsych Screening||1||
48143330|NCT02278328|100676533|FG001|NOT COMPLETED|Neuropsych Screening||1||
48143331|NCT02278328|100676534|FG002|NOT COMPLETED|Neuropsych Screening||2||
48143332|NCT02278328|100676532|FG000|STARTED|First Intervention (1 Day)||9||
48597695|NCT02600767|101796674|FG000|STARTED|Overall Study||79||
48597696|NCT02600767|101796674|FG000|COMPLETED|Overall Study||74||
48597697|NCT02600767|101796674|FG000|NOT COMPLETED|Overall Study||5||
48597698|NCT01324570|101796675|FG000|STARTED|Overall Study||6||
48597699|NCT01324570|101796676|FG001|STARTED|Overall Study||35||
48597700|NCT01324570|101796675|FG000|COMPLETED|Overall Study||2||
48597701|NCT01324570|101796676|FG001|COMPLETED|Overall Study||21||
48597702|NCT01324570|101796675|FG000|NOT COMPLETED|Overall Study||4||
48597703|NCT01324570|101796676|FG001|NOT COMPLETED|Overall Study||14||
48597704|NCT01573754|101796677|FG000|STARTED|Overall Study||16||
48143333|NCT02278328|100676533|FG001|STARTED|First Intervention (1 Day)||6||
48143334|NCT02278328|100676534|FG002|STARTED|First Intervention (1 Day)||6||
48143335|NCT02278328|100676532|FG000|COMPLETED|First Intervention (1 Day)||9||
48597705|NCT01573754|101796678|FG001|STARTED|Overall Study||32||
48597706|NCT01573754|101796677|FG000|COMPLETED|Overall Study||13||
48143336|NCT02278328|100676533|FG001|COMPLETED|First Intervention (1 Day)||6||
48597707|NCT01573754|101796678|FG001|COMPLETED|Overall Study||17||
48143337|NCT02278328|100676534|FG002|COMPLETED|First Intervention (1 Day)||6||
48597708|NCT01573754|101796677|FG000|NOT COMPLETED|Overall Study||3||
48597709|NCT01573754|101796678|FG001|NOT COMPLETED|Overall Study||15||
48597710|NCT02230540|101796679|FG000|STARTED|Overall Study||8||
48143338|NCT02278328|100676532|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48143339|NCT02278328|100676533|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48143340|NCT02278328|100676534|FG002|NOT COMPLETED|First Intervention (1 Day)||0||
48143341|NCT02278328|100676532|FG000|STARTED|Washout (1 Week)||9||
48143342|NCT02278328|100676533|FG001|STARTED|Washout (1 Week)||6||
48143343|NCT02278328|100676534|FG002|STARTED|Washout (1 Week)||6||
48143344|NCT02278328|100676532|FG000|COMPLETED|Washout (1 Week)||9||
48143345|NCT02278328|100676533|FG001|COMPLETED|Washout (1 Week)||6||
48597711|NCT02230540|101796680|FG001|STARTED|Overall Study||0||
48597712|NCT02230540|101796679|FG000|COMPLETED|Overall Study||8||
48597713|NCT02230540|101796680|FG001|COMPLETED|Overall Study||0||
48597714|NCT02230540|101796679|FG000|NOT COMPLETED|Overall Study||0||
48143346|NCT02278328|100676534|FG002|COMPLETED|Washout (1 Week)||6||
48143347|NCT02278328|100676532|FG000|NOT COMPLETED|Washout (1 Week)||0||
48143348|NCT02278328|100676533|FG001|NOT COMPLETED|Washout (1 Week)||0||
48143349|NCT02278328|100676534|FG002|NOT COMPLETED|Washout (1 Week)||0||
48143350|NCT02278328|100676532|FG000|STARTED|Second Intervention (1 Day)||9||
48143351|NCT02278328|100676533|FG001|STARTED|Second Intervention (1 Day)||6||
48143352|NCT02278328|100676534|FG002|STARTED|Second Intervention (1 Day)||6||
48143353|NCT02278328|100676532|FG000|COMPLETED|Second Intervention (1 Day)||9||
48597715|NCT02230540|101796680|FG001|NOT COMPLETED|Overall Study||0||
48597716|NCT00634049|101796681|FG000|STARTED|Overall Study||149||
48597717|NCT00634049|101796681|FG000|COMPLETED|Overall Study||146||
48597718|NCT00634049|101796681|FG000|NOT COMPLETED|Overall Study||3||
48597719|NCT00678470|101796682|FG000|STARTED|Overall Study||18||
48597720|NCT00678470|101796682|FG000|COMPLETED|Overall Study||14||
48597721|NCT00678470|101796682|FG000|NOT COMPLETED|Overall Study||4||
48597722|NCT03240406|101796683|FG000|STARTED|Burst 1 (Baseline)||144||
48597723|NCT03240406|101796684|FG001|STARTED|Burst 1 (Baseline)||146||
48597724|NCT03240406|101796683|FG000|COMPLETED|Burst 1 (Baseline)||144||
48597725|NCT03240406|101796684|FG001|COMPLETED|Burst 1 (Baseline)||146||
48597726|NCT03240406|101796683|FG000|NOT COMPLETED|Burst 1 (Baseline)||0||
48143354|NCT02278328|100676533|FG001|COMPLETED|Second Intervention (1 Day)||6||
48143355|NCT02278328|100676534|FG002|COMPLETED|Second Intervention (1 Day)||6||
48143356|NCT02278328|100676532|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48143357|NCT02278328|100676533|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48143358|NCT02278328|100676534|FG002|NOT COMPLETED|Second Intervention (1 Day)||0||
48143359|NCT02278328|100676532|FG000|STARTED|Second Washout (1 Week)||9||
48143360|NCT02278328|100676533|FG001|STARTED|Second Washout (1 Week)||6||
48143361|NCT02278328|100676534|FG002|STARTED|Second Washout (1 Week)||6||
48597727|NCT03240406|101796684|FG001|NOT COMPLETED|Burst 1 (Baseline)||0||
48597728|NCT03240406|101796683|FG000|STARTED|Burst 2 (9 Months)||144||
48597729|NCT03240406|101796684|FG001|STARTED|Burst 2 (9 Months)||146||
48597730|NCT03240406|101796683|FG000|COMPLETED|Burst 2 (9 Months)||126||
48597731|NCT03240406|101796684|FG001|COMPLETED|Burst 2 (9 Months)||129||
48597732|NCT03240406|101796683|FG000|NOT COMPLETED|Burst 2 (9 Months)||18||
48597733|NCT03240406|101796684|FG001|NOT COMPLETED|Burst 2 (9 Months)||17||
48597734|NCT03240406|101796683|FG000|STARTED|Burst 3 (18 Months)||122||
48597735|NCT03240406|101796684|FG001|STARTED|Burst 3 (18 Months)||126||
48597736|NCT03240406|101796683|FG000|COMPLETED|Burst 3 (18 Months)||98||
48597737|NCT03240406|101796684|FG001|COMPLETED|Burst 3 (18 Months)||93||
48597738|NCT03240406|101796683|FG000|NOT COMPLETED|Burst 3 (18 Months)||24||
48597739|NCT03240406|101796684|FG001|NOT COMPLETED|Burst 3 (18 Months)||33||
48143362|NCT02278328|100676532|FG000|COMPLETED|Second Washout (1 Week)||9||
48143363|NCT02278328|100676533|FG001|COMPLETED|Second Washout (1 Week)||6||
48143364|NCT02278328|100676534|FG002|COMPLETED|Second Washout (1 Week)||6||
48143365|NCT02278328|100676532|FG000|NOT COMPLETED|Second Washout (1 Week)||0||
48597740|NCT03240406|101796683|FG000|STARTED|Burst 4 (27 Months)||77||
48597741|NCT03240406|101796684|FG001|STARTED|Burst 4 (27 Months)||72||
48597742|NCT03240406|101796683|FG000|COMPLETED|Burst 4 (27 Months)||57||
48597743|NCT03240406|101796684|FG001|COMPLETED|Burst 4 (27 Months)||57||
48597744|NCT03240406|101796683|FG000|NOT COMPLETED|Burst 4 (27 Months)||20||
48597745|NCT03240406|101796684|FG001|NOT COMPLETED|Burst 4 (27 Months)||15||
48597746|NCT01393132|101796685|FG000|STARTED|Overall Study||6||
48597747|NCT01393132|101796686|FG001|STARTED|Overall Study||3||
48597748|NCT01393132|101796685|FG000|COMPLETED|Overall Study||6||
48597749|NCT01393132|101796686|FG001|COMPLETED|Overall Study||3||
48597750|NCT01393132|101796685|FG000|NOT COMPLETED|Overall Study||0||
48143366|NCT02278328|100676533|FG001|NOT COMPLETED|Second Washout (1 Week)||0||
48143367|NCT02278328|100676534|FG002|NOT COMPLETED|Second Washout (1 Week)||0||
48143368|NCT02278328|100676532|FG000|STARTED|Third Intervention (1 Day)||9||
48143369|NCT02278328|100676533|FG001|STARTED|Third Intervention (1 Day)||6||
48143370|NCT02278328|100676534|FG002|STARTED|Third Intervention (1 Day)||6||
48143371|NCT02278328|100676532|FG000|COMPLETED|Third Intervention (1 Day)||9||
48143372|NCT02278328|100676533|FG001|COMPLETED|Third Intervention (1 Day)||6||
48143373|NCT02278328|100676534|FG002|COMPLETED|Third Intervention (1 Day)||6||
48143374|NCT02278328|100676532|FG000|NOT COMPLETED|Third Intervention (1 Day)||0||
48143375|NCT02278328|100676533|FG001|NOT COMPLETED|Third Intervention (1 Day)||0||
48712735|NCT03372551|102084812|FG000|NOT COMPLETED|First Intervention (1 Week)||1||
48712736|NCT03372551|102084813|FG001|NOT COMPLETED|First Intervention (1 Week)||0||
48712737|NCT03372551|102084812|FG000|STARTED|Second Intervention (1 Week)||16||
48712738|NCT03372551|102084813|FG001|STARTED|Second Intervention (1 Week)||16||
48712739|NCT03372551|102084812|FG000|COMPLETED|Second Intervention (1 Week)||16||
48712740|NCT03372551|102084813|FG001|COMPLETED|Second Intervention (1 Week)||16||
48712741|NCT03372551|102084812|FG000|NOT COMPLETED|Second Intervention (1 Week)||0||
48712742|NCT03372551|102084813|FG001|NOT COMPLETED|Second Intervention (1 Week)||0||
48712743|NCT00794365|102084814|FG000|STARTED|Overall Study||330||
48712744|NCT00794365|102084814|FG000|COMPLETED|Overall Study||251||
48712745|NCT00794365|102084814|FG000|NOT COMPLETED|Overall Study||79||
48712746|NCT00919867|102084815|FG000|STARTED|First Intervention||7||
48712747|NCT00919867|102084816|FG001|STARTED|First Intervention||7||
48712748|NCT00919867|102084817|FG002|STARTED|First Intervention||7||
48712749|NCT00919867|102084818|FG003|STARTED|First Intervention||7||
48712750|NCT00919867|102084819|FG004|STARTED|First Intervention||7||
48712751|NCT00919867|102084820|FG005|STARTED|First Intervention||7||
48712752|NCT00919867|102084815|FG000|COMPLETED|First Intervention||7||
48712753|NCT00919867|102084816|FG001|COMPLETED|First Intervention||7||
48712754|NCT00919867|102084817|FG002|COMPLETED|First Intervention||6||
48712755|NCT00919867|102084818|FG003|COMPLETED|First Intervention||7||
48712756|NCT00919867|102084819|FG004|COMPLETED|First Intervention||7||
48712757|NCT00919867|102084820|FG005|COMPLETED|First Intervention||6||
48712758|NCT00919867|102084815|FG000|NOT COMPLETED|First Intervention||0||
48712759|NCT00919867|102084816|FG001|NOT COMPLETED|First Intervention||0||
48712760|NCT00919867|102084817|FG002|NOT COMPLETED|First Intervention||1||
48712761|NCT00919867|102084818|FG003|NOT COMPLETED|First Intervention||0||
48712762|NCT00919867|102084819|FG004|NOT COMPLETED|First Intervention||0||
48712763|NCT00919867|102084820|FG005|NOT COMPLETED|First Intervention||1||
48712764|NCT00919867|102084815|FG000|STARTED|Washout||7||
48712765|NCT00919867|102084816|FG001|STARTED|Washout||7||
48712766|NCT00919867|102084817|FG002|STARTED|Washout||6||
48712767|NCT00919867|102084818|FG003|STARTED|Washout||7||
48712768|NCT00919867|102084819|FG004|STARTED|Washout||7||
48712769|NCT00919867|102084820|FG005|STARTED|Washout||6||
48712770|NCT00919867|102084815|FG000|COMPLETED|Washout||7||
48712771|NCT00919867|102084816|FG001|COMPLETED|Washout||7||
48712772|NCT00919867|102084817|FG002|COMPLETED|Washout||6||
48712773|NCT00919867|102084818|FG003|COMPLETED|Washout||7||
48712774|NCT00919867|102084819|FG004|COMPLETED|Washout||7||
48712775|NCT00919867|102084820|FG005|COMPLETED|Washout||6||
48712776|NCT00919867|102084815|FG000|NOT COMPLETED|Washout||0||
48712777|NCT00919867|102084816|FG001|NOT COMPLETED|Washout||0||
48712778|NCT00919867|102084817|FG002|NOT COMPLETED|Washout||0||
48712779|NCT00919867|102084818|FG003|NOT COMPLETED|Washout||0||
48712780|NCT00919867|102084819|FG004|NOT COMPLETED|Washout||0||
48712781|NCT00919867|102084820|FG005|NOT COMPLETED|Washout||0||
48712782|NCT00919867|102084815|FG000|STARTED|Second Intervention||7||
48712783|NCT00919867|102084816|FG001|STARTED|Second Intervention||7||
48712784|NCT00919867|102084817|FG002|STARTED|Second Intervention||6||
48712785|NCT00919867|102084818|FG003|STARTED|Second Intervention||7||
48712786|NCT00919867|102084819|FG004|STARTED|Second Intervention||7||
48712787|NCT00919867|102084820|FG005|STARTED|Second Intervention||6||
48143376|NCT02278328|100676534|FG002|NOT COMPLETED|Third Intervention (1 Day)||0||
48404964|NCT04159701|101325161|FG001|COMPLETED|Period 1: Treatment Period||12||
48404965|NCT04159701|101325160|FG000|NOT COMPLETED|Period 1: Treatment Period||8||
48404966|NCT04159701|101325161|FG001|NOT COMPLETED|Period 1: Treatment Period||1||
48404967|NCT04159701|101325160|FG000|STARTED|Washout Period||31||
48404968|NCT04159701|101325161|FG001|STARTED|Washout Period||12||
48712788|NCT00919867|102084815|FG000|COMPLETED|Second Intervention||7||
48712789|NCT00919867|102084816|FG001|COMPLETED|Second Intervention||7||
48712790|NCT00919867|102084817|FG002|COMPLETED|Second Intervention||6||
48712791|NCT00919867|102084818|FG003|COMPLETED|Second Intervention||7||
48712792|NCT00919867|102084819|FG004|COMPLETED|Second Intervention||7||
48712793|NCT00919867|102084820|FG005|COMPLETED|Second Intervention||6||
48404969|NCT04159701|101325160|FG000|COMPLETED|Washout Period||18||
48404970|NCT04159701|101325161|FG001|COMPLETED|Washout Period||8||
48404971|NCT04159701|101325160|FG000|NOT COMPLETED|Washout Period||13||
48404972|NCT04159701|101325161|FG001|NOT COMPLETED|Washout Period||4||
48404973|NCT04159701|101325160|FG000|STARTED|Period 2: Treatment Period (Crossover)||18||
48404974|NCT04159701|101325161|FG001|STARTED|Period 2: Treatment Period (Crossover)||8||
48404975|NCT04159701|101325160|FG000|COMPLETED|Period 2: Treatment Period (Crossover)||18||
48404976|NCT04159701|101325161|FG001|COMPLETED|Period 2: Treatment Period (Crossover)||5||
48712794|NCT00919867|102084815|FG000|NOT COMPLETED|Second Intervention||0||
48143377|NCT02278328|100676532|FG000|STARTED|Third Washout (1 Week)||9||
48143378|NCT02278328|100676533|FG001|STARTED|Third Washout (1 Week)||6||
48143379|NCT02278328|100676534|FG002|STARTED|Third Washout (1 Week)||6||
48712795|NCT00919867|102084816|FG001|NOT COMPLETED|Second Intervention||0||
48712796|NCT00919867|102084817|FG002|NOT COMPLETED|Second Intervention||0||
48712797|NCT00919867|102084818|FG003|NOT COMPLETED|Second Intervention||0||
48712798|NCT00919867|102084819|FG004|NOT COMPLETED|Second Intervention||0||
48712799|NCT00919867|102084820|FG005|NOT COMPLETED|Second Intervention||0||
48404977|NCT04159701|101325160|FG000|NOT COMPLETED|Period 2: Treatment Period (Crossover)||0||
48143380|NCT02278328|100676532|FG000|COMPLETED|Third Washout (1 Week)||9||
48143381|NCT02278328|100676533|FG001|COMPLETED|Third Washout (1 Week)||6||
48143382|NCT02278328|100676534|FG002|COMPLETED|Third Washout (1 Week)||6||
48143383|NCT02278328|100676532|FG000|NOT COMPLETED|Third Washout (1 Week)||0||
48143384|NCT02278328|100676533|FG001|NOT COMPLETED|Third Washout (1 Week)||0||
48143385|NCT02278328|100676534|FG002|NOT COMPLETED|Third Washout (1 Week)||0||
48143386|NCT03031938|100676535|FG000|STARTED|Overall Study||2||
48143387|NCT03031938|100676536|FG001|STARTED|Overall Study||2||
48143388|NCT03031938|100676535|FG000|COMPLETED|Overall Study||1||
48143389|NCT03031938|100676536|FG001|COMPLETED|Overall Study||2||
48143390|NCT03031938|100676535|FG000|NOT COMPLETED|Overall Study||1||
48143391|NCT03031938|100676536|FG001|NOT COMPLETED|Overall Study||0||
48143392|NCT00675766|100676537|FG000|STARTED|Overall Study||106||
48143393|NCT00675766|100676538|FG001|STARTED|Overall Study||30||
48143394|NCT00675766|100676539|FG002|STARTED|Overall Study||50||
48143395|NCT00675766|100676540|FG003|STARTED|Overall Study||37||
48143396|NCT00675766|100676537|FG000|Year 2|Overall Study||105||
48143397|NCT00675766|100676538|FG001|Year 2|Overall Study||28||
48143398|NCT00675766|100676539|FG002|Year 2|Overall Study||34||
48143399|NCT00675766|100676540|FG003|Year 2|Overall Study||20||
48143400|NCT00675766|100676537|FG000|Year 3|Overall Study||100||
48143401|NCT00675766|100676538|FG001|Year 3|Overall Study||25||
48143402|NCT00675766|100676539|FG002|Year 3|Overall Study||29||
48143403|NCT00675766|100676540|FG003|Year 3|Overall Study||11||
48143404|NCT00675766|100676537|FG000|COMPLETED|Overall Study||100||
48143405|NCT00675766|100676538|FG001|COMPLETED|Overall Study||25||
48143406|NCT00675766|100676539|FG002|COMPLETED|Overall Study||29||
48143407|NCT00675766|100676540|FG003|COMPLETED|Overall Study||11||
48143408|NCT00675766|100676537|FG000|NOT COMPLETED|Overall Study||6||
48143409|NCT00675766|100676538|FG001|NOT COMPLETED|Overall Study||5||
48404978|NCT04159701|101325161|FG001|NOT COMPLETED|Period 2: Treatment Period (Crossover)||3||
48404979|NCT04159701|101325160|FG000|STARTED|Post-treatment Follow-up||29||
48404980|NCT04159701|101325161|FG001|STARTED|Post-treatment Follow-up||9||
48404981|NCT04159701|101325160|FG000|COMPLETED|Post-treatment Follow-up||19||
48404982|NCT04159701|101325161|FG001|COMPLETED|Post-treatment Follow-up||6||
48404983|NCT04159701|101325160|FG000|NOT COMPLETED|Post-treatment Follow-up||10||
48404984|NCT04159701|101325161|FG001|NOT COMPLETED|Post-treatment Follow-up||3||
48404985|NCT01804842|101325162|FG000|STARTED|Overall Study||9||
48404986|NCT01804842|101325163|FG001|STARTED|Overall Study||8||
48404987|NCT01804842|101325164|FG002|STARTED|Overall Study||9||
48404988|NCT01804842|101325162|FG000|Completed Treatment A|Overall Study||9||
48404989|NCT01804842|101325163|FG001|Completed Treatment A|Overall Study||6||
48404990|NCT01804842|101325164|FG002|Completed Treatment A|Overall Study||8||
48404991|NCT01804842|101325162|FG000|Completed Treatment B|Overall Study||8||
48404992|NCT01804842|101325163|FG001|Completed Treatment B|Overall Study||8||
48404993|NCT01804842|101325164|FG002|Completed Treatment B|Overall Study||8||
48404994|NCT01804842|101325162|FG000|Completed Treatment C|Overall Study||7||
48597751|NCT01393132|101796686|FG001|NOT COMPLETED|Overall Study||0||
48404995|NCT01804842|101325163|FG001|Completed Treatment C|Overall Study||7||
48404996|NCT01804842|101325164|FG002|Completed Treatment C|Overall Study||9||
48404997|NCT01804842|101325162|FG000|COMPLETED|Overall Study||6||
48404998|NCT01804842|101325163|FG001|COMPLETED|Overall Study||6||
48404999|NCT01804842|101325164|FG002|COMPLETED|Overall Study||8||
48405000|NCT01804842|101325162|FG000|NOT COMPLETED|Overall Study||3||
48405001|NCT01804842|101325163|FG001|NOT COMPLETED|Overall Study||2||
48405002|NCT01804842|101325164|FG002|NOT COMPLETED|Overall Study||1||
48405003|NCT05241288|101325165|FG000|STARTED|Overall Study||54||
48405004|NCT05241288|101325165|FG000|COMPLETED|Overall Study||40||
48405005|NCT05241288|101325165|FG000|NOT COMPLETED|Overall Study||14||
48597752|NCT02562235|101796687|FG000|STARTED|Overall Study||24||
48143410|NCT00675766|100676539|FG002|NOT COMPLETED|Overall Study||21||
48143411|NCT00675766|100676540|FG003|NOT COMPLETED|Overall Study||26||
48143412|NCT02349295|100676541|FG000|STARTED|Double Blind Treatment (Week 0-24)||123||
48143413|NCT02349295|100676542|FG001|STARTED|Double Blind Treatment (Week 0-24)||122||
48143414|NCT02349295|100676543|FG002|STARTED|Double Blind Treatment (Week 0-24)||118||
48143415|NCT02349295|100676544|FG003|STARTED|Double Blind Treatment (Week 0-24)||0||
48143416|NCT02349295|100676545|FG004|STARTED|Double Blind Treatment (Week 0-24)||0||
48143417|NCT02349295|100676546|FG005|STARTED|Double Blind Treatment (Week 0-24)||0||
48143418|NCT02349295|100676547|FG006|STARTED|Double Blind Treatment (Week 0-24)||0||
48143419|NCT02349295|100676548|FG007|STARTED|Double Blind Treatment (Week 0-24)||0||
48143420|NCT02349295|100676549|FG008|STARTED|Double Blind Treatment (Week 0-24)||0||
48143421|NCT02349295|100676550|FG009|STARTED|Double Blind Treatment (Week 0-24)||0||
48143422|NCT02349295|100676551|FG010|STARTED|Double Blind Treatment (Week 0-24)||0||
48143423|NCT02349295|100676552|FG011|STARTED|Double Blind Treatment (Week 0-24)||0||
48143424|NCT02349295|100676553|FG012|STARTED|Double Blind Treatment (Week 0-24)||0||
48143425|NCT02349295|100676554|FG013|STARTED|Double Blind Treatment (Week 0-24)||0||
48188513|NCT01686932|100783263|FG001|NOT COMPLETED|Period 1||1||
48405006|NCT03325010|101325166|FG000|STARTED|Overall Study||64||
48405007|NCT03325010|101325167|FG001|STARTED|Overall Study||63||
48143426|NCT02349295|100676541|FG000|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||123||
48143427|NCT02349295|100676542|FG001|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||122||
48143428|NCT02349295|100676543|FG002|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||118||
48143429|NCT02349295|100676544|FG003|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0||
48143430|NCT02349295|100676545|FG004|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0||
48143431|NCT02349295|100676546|FG005|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0||
48143432|NCT02349295|100676547|FG006|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0||
48143433|NCT02349295|100676548|FG007|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0||
48143434|NCT02349295|100676549|FG008|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0||
48143435|NCT02349295|100676550|FG009|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0||
48143436|NCT02349295|100676551|FG010|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0||
48143437|NCT02349295|100676552|FG011|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0||
48143438|NCT02349295|100676553|FG012|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0||
48597753|NCT02562235|101796687|FG000|COMPLETED|Overall Study||21||
48597754|NCT02562235|101796687|FG000|NOT COMPLETED|Overall Study||3||
48597755|NCT01449513|101796688|FG000|STARTED|Overall Study||16||
48143439|NCT02349295|100676554|FG013|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0||
48143440|NCT02349295|100676541|FG000|COMPLETED|Double Blind Treatment (Week 0-24)||109||
48143441|NCT02349295|100676542|FG001|COMPLETED|Double Blind Treatment (Week 0-24)||111||
48143442|NCT02349295|100676543|FG002|COMPLETED|Double Blind Treatment (Week 0-24)||94||
48143443|NCT02349295|100676544|FG003|COMPLETED|Double Blind Treatment (Week 0-24)||0||
48143444|NCT02349295|100676545|FG004|COMPLETED|Double Blind Treatment (Week 0-24)||0||
48143445|NCT02349295|100676546|FG005|COMPLETED|Double Blind Treatment (Week 0-24)||0||
48143446|NCT02349295|100676547|FG006|COMPLETED|Double Blind Treatment (Week 0-24)||0||
48143447|NCT02349295|100676548|FG007|COMPLETED|Double Blind Treatment (Week 0-24)||0||
48143448|NCT02349295|100676549|FG008|COMPLETED|Double Blind Treatment (Week 0-24)||0||
48143449|NCT02349295|100676550|FG009|COMPLETED|Double Blind Treatment (Week 0-24)||0||
48143450|NCT02349295|100676551|FG010|COMPLETED|Double Blind Treatment (Week 0-24)||0||
48143451|NCT02349295|100676552|FG011|COMPLETED|Double Blind Treatment (Week 0-24)||0||
48143452|NCT02349295|100676553|FG012|COMPLETED|Double Blind Treatment (Week 0-24)||0||
48143453|NCT02349295|100676554|FG013|COMPLETED|Double Blind Treatment (Week 0-24)||0||
48143454|NCT02349295|100676541|FG000|NOT COMPLETED|Double Blind Treatment (Week 0-24)||14||
48143455|NCT02349295|100676542|FG001|NOT COMPLETED|Double Blind Treatment (Week 0-24)||11||
48143456|NCT02349295|100676543|FG002|NOT COMPLETED|Double Blind Treatment (Week 0-24)||24||
48597756|NCT01449513|101796689|FG001|STARTED|Overall Study||8||
48597757|NCT01449513|101796688|FG000|COMPLETED|Overall Study||16||
48597758|NCT01449513|101796689|FG001|COMPLETED|Overall Study||8||
48597759|NCT01449513|101796688|FG000|NOT COMPLETED|Overall Study||0||
48597760|NCT01449513|101796689|FG001|NOT COMPLETED|Overall Study||0||
48597761|NCT00090584|101796690|FG000|STARTED|Baseline to 10 Weeks||154||
48597762|NCT00090584|101796691|FG001|STARTED|Baseline to 10 Weeks||153||
48597763|NCT00090584|101796690|FG000|COMPLETED|Baseline to 10 Weeks||139||
48597764|NCT00090584|101796691|FG001|COMPLETED|Baseline to 10 Weeks||141||
48597765|NCT00090584|101796690|FG000|NOT COMPLETED|Baseline to 10 Weeks||15||
48597766|NCT00090584|101796691|FG001|NOT COMPLETED|Baseline to 10 Weeks||12||
48597767|NCT00090584|101796690|FG000|STARTED|Baseline to 8 Months||154||
48597768|NCT00090584|101796691|FG001|STARTED|Baseline to 8 Months||153||
48597769|NCT00090584|101796690|FG000|COMPLETED|Baseline to 8 Months||110||
48597770|NCT00090584|101796691|FG001|COMPLETED|Baseline to 8 Months||112||
48597771|NCT00090584|101796690|FG000|NOT COMPLETED|Baseline to 8 Months||44||
48597772|NCT00090584|101796691|FG001|NOT COMPLETED|Baseline to 8 Months||41||
48597773|NCT03379792|101796692|FG000|STARTED|Overall Study||6||
48597774|NCT03379792|101796693|FG001|STARTED|Overall Study||9||
48597775|NCT03379792|101796694|FG002|STARTED|Overall Study||5||
48143457|NCT02349295|100676544|FG003|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0||
48143458|NCT02349295|100676545|FG004|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0||
48143459|NCT02349295|100676546|FG005|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0||
48143460|NCT02349295|100676547|FG006|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0||
48143461|NCT02349295|100676548|FG007|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0||
48143462|NCT02349295|100676549|FG008|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0||
48143463|NCT02349295|100676550|FG009|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0||
48597776|NCT03379792|101796695|FG003|STARTED|Overall Study||4||
48597777|NCT03379792|101796696|FG004|STARTED|Overall Study||4||
48597778|NCT03379792|101796697|FG005|STARTED|Overall Study||4||
48597779|NCT03379792|101796692|FG000|COMPLETED|Overall Study||6||
48143464|NCT02349295|100676551|FG010|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0||
48143465|NCT02349295|100676552|FG011|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0||
48143466|NCT02349295|100676553|FG012|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0||
48143467|NCT02349295|100676554|FG013|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0||
48143468|NCT02349295|100676541|FG000|STARTED|IR (Week 16-24)||0||
48597780|NCT03379792|101796693|FG001|COMPLETED|Overall Study||9||
48143469|NCT02349295|100676542|FG001|STARTED|IR (Week 16-24)||0||
48143470|NCT02349295|100676543|FG002|STARTED|IR (Week 16-24)||0||
48143471|NCT02349295|100676544|FG003|STARTED|IR (Week 16-24)||17||
48143472|NCT02349295|100676545|FG004|STARTED|IR (Week 16-24)||15||
48143473|NCT02349295|100676546|FG005|STARTED|IR (Week 16-24)||16||
48143474|NCT02349295|100676547|FG006|STARTED|IR (Week 16-24)||16||
48143475|NCT02349295|100676548|FG007|STARTED|IR (Week 16-24)||0||
48143476|NCT02349295|100676549|FG008|STARTED|IR (Week 16-24)||0||
48143477|NCT02349295|100676550|FG009|STARTED|IR (Week 16-24)||0||
48143478|NCT02349295|100676551|FG010|STARTED|IR (Week 16-24)||0||
48143479|NCT02349295|100676552|FG011|STARTED|IR (Week 16-24)||0||
48143480|NCT02349295|100676553|FG012|STARTED|IR (Week 16-24)||0||
48143481|NCT02349295|100676554|FG013|STARTED|IR (Week 16-24)||0||
48405008|NCT03325010|101325166|FG000|Safety Analysis Set|Overall Study||62|The safety analysis set includes all participants who received at least one dose of study drug and have any post-baseline safety data collected.|
48143482|NCT02349295|100676541|FG000|COMPLETED|IR (Week 16-24)||0||
48143483|NCT02349295|100676542|FG001|COMPLETED|IR (Week 16-24)||0||
48143484|NCT02349295|100676543|FG002|COMPLETED|IR (Week 16-24)||0||
48143485|NCT02349295|100676544|FG003|COMPLETED|IR (Week 16-24)||16||
48143486|NCT02349295|100676545|FG004|COMPLETED|IR (Week 16-24)||15||
48143487|NCT02349295|100676546|FG005|COMPLETED|IR (Week 16-24)||16||
48143488|NCT02349295|100676547|FG006|COMPLETED|IR (Week 16-24)||16||
48143489|NCT02349295|100676548|FG007|COMPLETED|IR (Week 16-24)||0||
48143490|NCT02349295|100676549|FG008|COMPLETED|IR (Week 16-24)||0||
48143491|NCT02349295|100676550|FG009|COMPLETED|IR (Week 16-24)||0||
48143492|NCT02349295|100676551|FG010|COMPLETED|IR (Week 16-24)||0||
48143493|NCT02349295|100676552|FG011|COMPLETED|IR (Week 16-24)||0||
48143494|NCT02349295|100676553|FG012|COMPLETED|IR (Week 16-24)||0||
48143495|NCT02349295|100676554|FG013|COMPLETED|IR (Week 16-24)||0||
48143496|NCT02349295|100676541|FG000|NOT COMPLETED|IR (Week 16-24)||0||
48143497|NCT02349295|100676542|FG001|NOT COMPLETED|IR (Week 16-24)||0||
48143498|NCT02349295|100676543|FG002|NOT COMPLETED|IR (Week 16-24)||0||
48143499|NCT02349295|100676544|FG003|NOT COMPLETED|IR (Week 16-24)||1||
48143500|NCT02349295|100676545|FG004|NOT COMPLETED|IR (Week 16-24)||0||
48143501|NCT02349295|100676546|FG005|NOT COMPLETED|IR (Week 16-24)||0||
48143502|NCT02349295|100676547|FG006|NOT COMPLETED|IR (Week 16-24)||0||
48143503|NCT02349295|100676548|FG007|NOT COMPLETED|IR (Week 16-24)||0||
48143504|NCT02349295|100676549|FG008|NOT COMPLETED|IR (Week 16-24)||0||
48143505|NCT02349295|100676550|FG009|NOT COMPLETED|IR (Week 16-24)||0||
48143506|NCT02349295|100676551|FG010|NOT COMPLETED|IR (Week 16-24)||0||
48143507|NCT02349295|100676552|FG011|NOT COMPLETED|IR (Week 16-24)||0||
48143508|NCT02349295|100676553|FG012|NOT COMPLETED|IR (Week 16-24)||0||
48143509|NCT02349295|100676554|FG013|NOT COMPLETED|IR (Week 16-24)||0||
48143510|NCT02349295|100676541|FG000|STARTED|Long-Term Extension Period (Week 24-156)||0||
48143511|NCT02349295|100676542|FG001|STARTED|Long-Term Extension Period (Week 24-156)||0||
48143512|NCT02349295|100676543|FG002|STARTED|Long-Term Extension Period (Week 24-156)||0||
48405009|NCT03325010|101325167|FG001|Safety Analysis Set|Overall Study||59|The safety analysis set includes all participants who received at least one dose of study drug and have any post-baseline safety data collected.|
48405010|NCT03325010|101325166|FG000|Full Analysis Set|Overall Study||61|The full analysis set includes all randomized participants who have at least one evaluable change from baseline value for Total Tic Score reported at a visit (either scheduled or mapped early termination visit) during the treatment period.|
48405011|NCT03325010|101325167|FG001|Full Analysis Set|Overall Study||58|The full analysis set includes all randomized participants who have at least one evaluable change from baseline value for Total Tic Score reported at a visit (either scheduled or mapped early termination visit) during the treatment period.|
48405012|NCT03325010|101325166|FG000|COMPLETED|Overall Study||55||
48405013|NCT03325010|101325167|FG001|COMPLETED|Overall Study||43||
48296336|NCT04964414|101054235|FG000|6 Month Follow-up|Overall Study||3|Budesonide was added to smell retraining for one of these patients at time of the 8-12 week follow-up visit.|
48296337|NCT04964414|101054236|FG001|6 Month Follow-up|Overall Study||0|Budesonide was added to smell retraining for one of these patients at time of the 8-12 week follow-up visit.|
48296338|NCT04964414|101054235|FG000|12 Month Follow-up|Overall Study||0||
48143513|NCT02349295|100676544|FG003|STARTED|Long-Term Extension Period (Week 24-156)||0||
48296339|NCT04964414|101054236|FG001|12 Month Follow-up|Overall Study||0||
48296340|NCT04964414|101054235|FG000|COMPLETED|Overall Study||0||
48296341|NCT04964414|101054236|FG001|COMPLETED|Overall Study||0||
48296342|NCT04964414|101054235|FG000|NOT COMPLETED|Overall Study||11||
48296343|NCT04964414|101054236|FG001|NOT COMPLETED|Overall Study||9||
48296344|NCT04754477|101054237|FG000|STARTED|Overall Study||20||
48143514|NCT02349295|100676545|FG004|STARTED|Long-Term Extension Period (Week 24-156)||0||
48143515|NCT02349295|100676546|FG005|STARTED|Long-Term Extension Period (Week 24-156)||0||
48143516|NCT02349295|100676547|FG006|STARTED|Long-Term Extension Period (Week 24-156)||0||
48143517|NCT02349295|100676548|FG007|STARTED|Long-Term Extension Period (Week 24-156)||107||
48143518|NCT02349295|100676549|FG008|STARTED|Long-Term Extension Period (Week 24-156)||111||
48143519|NCT02349295|100676550|FG009|STARTED|Long-Term Extension Period (Week 24-156)||46||
48188514|NCT01686932|100783262|FG000|STARTED|Period 2||24||
48296345|NCT04754477|101054237|FG000|COMPLETED|Overall Study||19||
48296346|NCT04754477|101054237|FG000|NOT COMPLETED|Overall Study||1||
48296347|NCT01692691|101054238|FG000|STARTED|Overall Study||1||
48296348|NCT01692691|101054238|FG000|COMPLETED|Overall Study||1||
48296349|NCT01692691|101054238|FG000|NOT COMPLETED|Overall Study||0||
48296350|NCT02824263|101054239|FG000|STARTED|First Intervention (1 Night)||61||
48296351|NCT02824263|101054240|FG001|STARTED|First Intervention (1 Night)||68||
48296352|NCT02824263|101054239|FG000|COMPLETED|First Intervention (1 Night)||61||
48296353|NCT02824263|101054240|FG001|COMPLETED|First Intervention (1 Night)||68||
48296354|NCT02824263|101054239|FG000|NOT COMPLETED|First Intervention (1 Night)||0||
48296355|NCT02824263|101054240|FG001|NOT COMPLETED|First Intervention (1 Night)||0||
48296356|NCT02824263|101054239|FG000|STARTED|Washout (1 to 4 Weeks)||61||
48296357|NCT02824263|101054240|FG001|STARTED|Washout (1 to 4 Weeks)||68||
48296358|NCT02824263|101054239|FG000|COMPLETED|Washout (1 to 4 Weeks)||59||
48296359|NCT02824263|101054240|FG001|COMPLETED|Washout (1 to 4 Weeks)||62||
48296360|NCT02824263|101054239|FG000|NOT COMPLETED|Washout (1 to 4 Weeks)||2||
48296361|NCT02824263|101054240|FG001|NOT COMPLETED|Washout (1 to 4 Weeks)||6||
48296362|NCT02824263|101054239|FG000|STARTED|Second Intervention (1 Night)||59||
48296363|NCT02824263|101054240|FG001|STARTED|Second Intervention (1 Night)||62||
48296364|NCT02824263|101054239|FG000|COMPLETED|Second Intervention (1 Night)||55||
48296365|NCT02824263|101054240|FG001|COMPLETED|Second Intervention (1 Night)||59||
48296366|NCT02824263|101054239|FG000|NOT COMPLETED|Second Intervention (1 Night)||4||
48296367|NCT02824263|101054240|FG001|NOT COMPLETED|Second Intervention (1 Night)||3||
48296368|NCT05105789|101054241|FG000|STARTED|Overall Study||100||
48296369|NCT05105789|101054241|FG000|Number of Participants Who Took the Nasal PCR Test at School|Overall Study||100||
48296370|NCT05105789|101054241|FG000|Number of Participants Who Took the Lollipop Test at School|Overall Study||100||
48296371|NCT05105789|101054241|FG000|Number of Participants Who Took the BinaxNow Test at School|Overall Study||100||
48296372|NCT05105789|101054241|FG000|Number of Participants Who Were Required to Take At-home BinaxNow Test|Overall Study||79||
48296373|NCT05105789|101054241|FG000|Number of Participants Who Actually Took the At-home BinaxNow Test|Overall Study||73||
48296374|NCT05105789|101054241|FG000|COMPLETED|Overall Study||99|99 Participants had data from all three COVID-19 tests.|
48296375|NCT05105789|101054241|FG000|NOT COMPLETED|Overall Study||1||
48296376|NCT05779397|101054242|FG000|STARTED|Overall Study||68||
48296377|NCT05779397|101054242|FG000|COMPLETED|Overall Study||68||
48712800|NCT00919867|102084815|FG000|STARTED|Washout||7||
48712801|NCT00919867|102084816|FG001|STARTED|Washout||7||
48712802|NCT00919867|102084817|FG002|STARTED|Washout||6||
48712803|NCT00919867|102084818|FG003|STARTED|Washout||7||
48712804|NCT00919867|102084819|FG004|STARTED|Washout||7||
48712805|NCT00919867|102084820|FG005|STARTED|Washout||6||
48296378|NCT05779397|101054242|FG000|NOT COMPLETED|Overall Study||0||
48296379|NCT00537485|101054243|FG000|STARTED|Overall Study||90||
48296380|NCT00537485|101054244|FG001|STARTED|Overall Study||90||
48296381|NCT00537485|101054243|FG000|COMPLETED|Overall Study||75||
48296382|NCT00537485|101054244|FG001|COMPLETED|Overall Study||80||
48296383|NCT00537485|101054243|FG000|NOT COMPLETED|Overall Study||15||
48296384|NCT00537485|101054244|FG001|NOT COMPLETED|Overall Study||10||
48296385|NCT00696761|101054245|FG000|STARTED|Overall Study||61||
48296386|NCT00696761|101054246|FG001|STARTED|Overall Study||76||
48296387|NCT00696761|101054247|FG002|STARTED|Overall Study||41||
48296388|NCT00696761|101054248|FG003|STARTED|Overall Study||54||
48296389|NCT00696761|101054245|FG000|COMPLETED|Overall Study||41||
48296390|NCT00696761|101054246|FG001|COMPLETED|Overall Study||50||
48296391|NCT00696761|101054247|FG002|COMPLETED|Overall Study||30||
48296392|NCT00696761|101054248|FG003|COMPLETED|Overall Study||44||
48296393|NCT00696761|101054245|FG000|NOT COMPLETED|Overall Study||20||
48296394|NCT00696761|101054246|FG001|NOT COMPLETED|Overall Study||26||
48296395|NCT00696761|101054247|FG002|NOT COMPLETED|Overall Study||11||
48296396|NCT00696761|101054248|FG003|NOT COMPLETED|Overall Study||10||
48712806|NCT00919867|102084815|FG000|COMPLETED|Washout||7||
48712807|NCT00919867|102084816|FG001|COMPLETED|Washout||7||
48712808|NCT00919867|102084817|FG002|COMPLETED|Washout||6||
48712809|NCT00919867|102084818|FG003|COMPLETED|Washout||7||
48712810|NCT00919867|102084819|FG004|COMPLETED|Washout||7||
48712811|NCT00919867|102084820|FG005|COMPLETED|Washout||6||
48712812|NCT00919867|102084815|FG000|NOT COMPLETED|Washout||0||
48712813|NCT00919867|102084816|FG001|NOT COMPLETED|Washout||0||
48712814|NCT00919867|102084817|FG002|NOT COMPLETED|Washout||0||
48712815|NCT00919867|102084818|FG003|NOT COMPLETED|Washout||0||
48712816|NCT00919867|102084819|FG004|NOT COMPLETED|Washout||0||
48712817|NCT00919867|102084820|FG005|NOT COMPLETED|Washout||0||
48712818|NCT00919867|102084815|FG000|STARTED|Third Intervention||7||
48712819|NCT00919867|102084816|FG001|STARTED|Third Intervention||7||
48712820|NCT00919867|102084817|FG002|STARTED|Third Intervention||6||
48296397|NCT00688181|101054249|FG000|STARTED|Overall Study||36||
48296398|NCT00688181|101054249|FG000|COMPLETED|Overall Study||13||
48296399|NCT00688181|101054249|FG000|NOT COMPLETED|Overall Study||23||
48296400|NCT00926211|101054250|FG000|STARTED|Overall Study||36||
48296401|NCT00926211|101054250|FG000|COMPLETED|Overall Study||35||
48296402|NCT00926211|101054250|FG000|NOT COMPLETED|Overall Study||1||
48296403|NCT00881608|101054251|FG000|STARTED|Overall Study||11||
48296404|NCT00881608|101054251|FG000|COMPLETED|Overall Study||0||
48296405|NCT00881608|101054251|FG000|NOT COMPLETED|Overall Study||11||
48296406|NCT02244996|101054252|FG000|STARTED|Overall Study||25||
48296407|NCT02244996|101054253|FG001|STARTED|Overall Study||25||
48296408|NCT02244996|101054252|FG000|COMPLETED|Overall Study||23||
48296409|NCT02244996|101054253|FG001|COMPLETED|Overall Study||19||
48296410|NCT02244996|101054252|FG000|NOT COMPLETED|Overall Study||2||
48296411|NCT02244996|101054253|FG001|NOT COMPLETED|Overall Study||6||
48296412|NCT00637923|101054254|FG000|STARTED|Overall Study||75||
48296413|NCT00637923|101054255|FG001|STARTED|Overall Study||37||
48296414|NCT00637923|101054254|FG000|COMPLETED|Overall Study||45||
48296415|NCT00637923|101054255|FG001|COMPLETED|Overall Study||18||
48296416|NCT00637923|101054254|FG000|NOT COMPLETED|Overall Study||30||
48296417|NCT00637923|101054255|FG001|NOT COMPLETED|Overall Study||19||
48296418|NCT02388646|101054256|FG000|STARTED|Overall Study||20||
48296419|NCT02388646|101054257|FG001|STARTED|Overall Study||20||
48296420|NCT02388646|101054258|FG002|STARTED|Overall Study||20||
48296421|NCT02388646|101054256|FG000|COMPLETED|Overall Study||16||
48296422|NCT02388646|101054257|FG001|COMPLETED|Overall Study||19||
48296423|NCT02388646|101054258|FG002|COMPLETED|Overall Study||14||
48296424|NCT02388646|101054256|FG000|NOT COMPLETED|Overall Study||4||
48296425|NCT02388646|101054257|FG001|NOT COMPLETED|Overall Study||1||
48296426|NCT02388646|101054258|FG002|NOT COMPLETED|Overall Study||6||
48296427|NCT01971203|101054259|FG000|STARTED|Overall Study||26||
48296428|NCT01971203|101054260|FG001|STARTED|Overall Study||29||
48296429|NCT01971203|101054259|FG000|COMPLETED|Overall Study||17||
48296430|NCT01971203|101054260|FG001|COMPLETED|Overall Study||21||
48296431|NCT01971203|101054259|FG000|NOT COMPLETED|Overall Study||9||
48296432|NCT01971203|101054260|FG001|NOT COMPLETED|Overall Study||8||
48296433|NCT02079610|101054261|FG000|STARTED|Overall Study||19||
48296434|NCT02079610|101054262|FG001|STARTED|Overall Study||17||
48296435|NCT02079610|101054261|FG000|COMPLETED|Overall Study||18||
48296436|NCT02079610|101054262|FG001|COMPLETED|Overall Study||16||
48296437|NCT02079610|101054261|FG000|NOT COMPLETED|Overall Study||1||
48296438|NCT02079610|101054262|FG001|NOT COMPLETED|Overall Study||1||
48296439|NCT00832637|101054263|FG000|STARTED|Overall Study||33||
48296440|NCT00832637|101054263|FG000|COMPLETED|Overall Study||33||
48296441|NCT00832637|101054263|FG000|NOT COMPLETED|Overall Study||0||
48296442|NCT01155375|101054264|FG000|STARTED|Overall Study||8|Data are for the combined AMAG-FER-CKD-251 and AMAG-FER-CKD-252 studies.|
48296443|NCT01155375|101054265|FG001|STARTED|Overall Study||6|Data are for the combined AMAG-FER-CKD-251 and AMAG-FER-CKD-252 studies.|
48296444|NCT01155375|101054264|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8||
48296445|NCT01155375|101054265|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
48296446|NCT01155375|101054264|FG000|COMPLETED|Overall Study||7||
48296447|NCT01155375|101054265|FG001|COMPLETED|Overall Study||6||
48296448|NCT01155375|101054264|FG000|NOT COMPLETED|Overall Study||1||
48296449|NCT01155375|101054265|FG001|NOT COMPLETED|Overall Study||0||
48296450|NCT00294554|101054266|FG000|STARTED|Overall Study||10||
48712821|NCT00919867|102084818|FG003|STARTED|Third Intervention||7||
48712822|NCT00919867|102084819|FG004|STARTED|Third Intervention||7||
48712823|NCT00919867|102084820|FG005|STARTED|Third Intervention||6||
48712824|NCT00919867|102084815|FG000|COMPLETED|Third Intervention||7||
48712825|NCT00919867|102084816|FG001|COMPLETED|Third Intervention||7||
48712826|NCT00919867|102084817|FG002|COMPLETED|Third Intervention||6||
48296451|NCT00294554|101054267|FG001|STARTED|Overall Study||10||
48296452|NCT00294554|101054266|FG000|COMPLETED|Overall Study||10||
48296453|NCT00294554|101054267|FG001|COMPLETED|Overall Study||8||
48296454|NCT00294554|101054266|FG000|NOT COMPLETED|Overall Study||0||
48296455|NCT00294554|101054267|FG001|NOT COMPLETED|Overall Study||2||
48296456|NCT03267940|101054268|FG000|STARTED|Run-in Portion (Max. Exposure: 508 Days)||9||
48296457|NCT03267940|101054269|FG001|STARTED|Run-in Portion (Max. Exposure: 508 Days)||9||
48296458|NCT03267940|101054270|FG002|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0||
48296459|NCT03267940|101054271|FG003|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0||
48296460|NCT03267940|101054272|FG004|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0||
48296461|NCT03267940|101054273|FG005|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0||
48296462|NCT03267940|101054268|FG000|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||9||
48296463|NCT03267940|101054269|FG001|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||9||
48296464|NCT03267940|101054270|FG002|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0||
48296465|NCT03267940|101054271|FG003|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0||
48296466|NCT03267940|101054272|FG004|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0||
48296467|NCT03267940|101054273|FG005|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0||
48296468|NCT03267940|101054268|FG000|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||1||
48296469|NCT03267940|101054269|FG001|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||2||
48296470|NCT03267940|101054270|FG002|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0||
48296471|NCT03267940|101054271|FG003|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0||
48405014|NCT03325010|101325166|FG000|NOT COMPLETED|Overall Study||9||
48405015|NCT03325010|101325167|FG001|NOT COMPLETED|Overall Study||20||
48597781|NCT03379792|101796694|FG002|COMPLETED|Overall Study||5||
48597782|NCT03379792|101796695|FG003|COMPLETED|Overall Study||3||
48597783|NCT03379792|101796696|FG004|COMPLETED|Overall Study||3||
48597784|NCT03379792|101796697|FG005|COMPLETED|Overall Study||3||
48597785|NCT03379792|101796692|FG000|NOT COMPLETED|Overall Study||0||
48597786|NCT03379792|101796693|FG001|NOT COMPLETED|Overall Study||0||
48597787|NCT03379792|101796694|FG002|NOT COMPLETED|Overall Study||0||
48597788|NCT03379792|101796695|FG003|NOT COMPLETED|Overall Study||1||
48597789|NCT03379792|101796696|FG004|NOT COMPLETED|Overall Study||1||
48597790|NCT03379792|101796697|FG005|NOT COMPLETED|Overall Study||1||
48597791|NCT03050541|101796698|FG000|STARTED|Overall Study||28||
48597792|NCT03050541|101796699|FG001|STARTED|Overall Study||28||
48597793|NCT03050541|101796700|FG002|STARTED|Overall Study||28||
48597794|NCT03050541|101796698|FG000|COMPLETED|Overall Study||20||
48597795|NCT03050541|101796699|FG001|COMPLETED|Overall Study||20||
48597796|NCT03050541|101796700|FG002|COMPLETED|Overall Study||20||
48597797|NCT03050541|101796698|FG000|NOT COMPLETED|Overall Study||8||
48597798|NCT03050541|101796699|FG001|NOT COMPLETED|Overall Study||8||
48597799|NCT03050541|101796700|FG002|NOT COMPLETED|Overall Study||8||
48597800|NCT02368210|101796701|FG000|STARTED|Overall Study||75||
48597801|NCT02368210|101796702|FG001|STARTED|Overall Study||76||
48597802|NCT02368210|101796701|FG000|COMPLETED|Overall Study||74||
48597803|NCT02368210|101796702|FG001|COMPLETED|Overall Study||75||
48597804|NCT02368210|101796701|FG000|NOT COMPLETED|Overall Study||1||
48597805|NCT02368210|101796702|FG001|NOT COMPLETED|Overall Study||1||
48597806|NCT03722407|101796703|FG000|STARTED|Overall Study||29||
48597807|NCT03722407|101796703|FG000|COMPLETED|Overall Study||29||
48296472|NCT03267940|101054272|FG004|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0||
48296473|NCT03267940|101054273|FG005|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0||
48296474|NCT03267940|101054268|FG000|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||8||
48296475|NCT03267940|101054269|FG001|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||7||
48296476|NCT03267940|101054270|FG002|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0||
48296477|NCT03267940|101054271|FG003|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0||
48296478|NCT03267940|101054272|FG004|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0||
48296479|NCT03267940|101054273|FG005|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0||
48597808|NCT03722407|101796703|FG000|NOT COMPLETED|Overall Study||0||
48296480|NCT03267940|101054268|FG000|STARTED|Expansion (Maximum Exposure: 421 Days)||0||
48405016|NCT02128958|101325168|FG000|STARTED|Overall Study||50||
48597809|NCT02774005|101796704|FG000|STARTED|Overall Study||199||
48597810|NCT02774005|101796704|FG000|Safety Population|Overall Study||198||
48597811|NCT02774005|101796704|FG000|Intent-to-Treat (ITT) Population|Overall Study||196||
48597812|NCT02774005|101796704|FG000|Modified Intent-to-Treat (mITT) Population|Overall Study||181||
48597813|NCT02774005|101796704|FG000|COMPLETED|Overall Study||138||
48597814|NCT02774005|101796704|FG000|NOT COMPLETED|Overall Study||61||
48597815|NCT02664922|101796705|FG000|STARTED|Overall Study||11||
48597816|NCT02664922|101796706|FG001|STARTED|Overall Study||12||
48597817|NCT02664922|101796707|FG002|STARTED|Overall Study||7||
48597818|NCT02664922|101796708|FG003|STARTED|Overall Study||5||
48597819|NCT02664922|101796705|FG000|COMPLETED|Overall Study||10||
48597820|NCT02664922|101796706|FG001|COMPLETED|Overall Study||12||
48597821|NCT02664922|101796707|FG002|COMPLETED|Overall Study||7||
48597822|NCT02664922|101796708|FG003|COMPLETED|Overall Study||5||
48597823|NCT02664922|101796705|FG000|NOT COMPLETED|Overall Study||1||
48597824|NCT02664922|101796706|FG001|NOT COMPLETED|Overall Study||0||
48597825|NCT02664922|101796707|FG002|NOT COMPLETED|Overall Study||0||
48597826|NCT02664922|101796708|FG003|NOT COMPLETED|Overall Study||0||
48597827|NCT01037816|101796709|FG000|STARTED|Overall Study||126||
48597828|NCT01037816|101796710|FG001|STARTED|Overall Study||126||
48597829|NCT01037816|101796709|FG000|COMPLETED|Overall Study||124||
48597830|NCT01037816|101796710|FG001|COMPLETED|Overall Study||126||
48597831|NCT01037816|101796709|FG000|NOT COMPLETED|Overall Study||2||
48597832|NCT01037816|101796710|FG001|NOT COMPLETED|Overall Study||0||
48597833|NCT02772276|101796711|FG000|STARTED|Overall Study||31||
48597834|NCT02772276|101796712|FG001|STARTED|Overall Study||29||
48597835|NCT02772276|101796713|FG002|STARTED|Overall Study||20||
48597836|NCT02772276|101796714|FG003|STARTED|Overall Study||40||
48597837|NCT02772276|101796715|FG004|STARTED|Overall Study||9||
48597838|NCT02772276|101796716|FG005|STARTED|Overall Study||7||
48597839|NCT02772276|101796717|FG006|STARTED|Overall Study||18||
48597840|NCT02772276|101796718|FG007|STARTED|Overall Study||30||
48597841|NCT02772276|101796719|FG008|STARTED|Overall Study||18||
48597842|NCT02772276|101796720|FG009|STARTED|Overall Study||12||
48597843|NCT02772276|101796721|FG010|STARTED|Overall Study||4||
48597844|NCT02772276|101796722|FG011|STARTED|Overall Study||4||
48597845|NCT02772276|101796723|FG012|STARTED|Overall Study||12||
48597846|NCT02772276|101796711|FG000|COMPLETED|Overall Study||31||
48597847|NCT02772276|101796712|FG001|COMPLETED|Overall Study||29||
48597848|NCT02772276|101796713|FG002|COMPLETED|Overall Study||20||
48597849|NCT02772276|101796714|FG003|COMPLETED|Overall Study||40||
48712827|NCT00919867|102084818|FG003|COMPLETED|Third Intervention||7||
48712828|NCT00919867|102084819|FG004|COMPLETED|Third Intervention||7||
48712829|NCT00919867|102084820|FG005|COMPLETED|Third Intervention||6||
48712830|NCT00919867|102084815|FG000|NOT COMPLETED|Third Intervention||0||
48712831|NCT00919867|102084816|FG001|NOT COMPLETED|Third Intervention||0||
48712832|NCT00919867|102084817|FG002|NOT COMPLETED|Third Intervention||0||
48712833|NCT00919867|102084818|FG003|NOT COMPLETED|Third Intervention||0||
48712834|NCT00919867|102084819|FG004|NOT COMPLETED|Third Intervention||0||
48712835|NCT00919867|102084820|FG005|NOT COMPLETED|Third Intervention||0||
48712836|NCT00852527|102084821|FG000|STARTED|Overall Study||196||
48712837|NCT00852527|102084822|FG001|STARTED|Overall Study||242||
48712838|NCT00852527|102084821|FG000|COMPLETED|Overall Study||196||
48712839|NCT00852527|102084822|FG001|COMPLETED|Overall Study||242||
48712840|NCT00852527|102084821|FG000|NOT COMPLETED|Overall Study||0||
48712841|NCT00852527|102084822|FG001|NOT COMPLETED|Overall Study||0||
48712842|NCT05044104|102084823|FG000|STARTED|Overall Study||292||
48712843|NCT05044104|102084823|FG000|COMPLETED|Overall Study||292||
48712844|NCT05044104|102084823|FG000|NOT COMPLETED|Overall Study||0||
48597850|NCT02772276|101796715|FG004|COMPLETED|Overall Study||9||
48597851|NCT02772276|101796716|FG005|COMPLETED|Overall Study||7||
48597852|NCT02772276|101796717|FG006|COMPLETED|Overall Study||17||
48597853|NCT02772276|101796718|FG007|COMPLETED|Overall Study||29||
48597854|NCT02772276|101796719|FG008|COMPLETED|Overall Study||18||
48597855|NCT02772276|101796720|FG009|COMPLETED|Overall Study||12||
48597856|NCT02772276|101796721|FG010|COMPLETED|Overall Study||4||
48597857|NCT02772276|101796722|FG011|COMPLETED|Overall Study||4||
48597858|NCT02772276|101796723|FG012|COMPLETED|Overall Study||12||
48712845|NCT00609791|102084824|FG000|STARTED|Overall Study||40||
48143520|NCT02349295|100676551|FG010|STARTED|Long-Term Extension Period (Week 24-156)||46||
48143521|NCT02349295|100676552|FG011|STARTED|Long-Term Extension Period (Week 24-156)||0||
48143522|NCT02349295|100676553|FG012|STARTED|Long-Term Extension Period (Week 24-156)||0||
48597859|NCT02772276|101796711|FG000|NOT COMPLETED|Overall Study||0||
48597860|NCT02772276|101796712|FG001|NOT COMPLETED|Overall Study||0||
48597861|NCT02772276|101796713|FG002|NOT COMPLETED|Overall Study||0||
48597862|NCT02772276|101796714|FG003|NOT COMPLETED|Overall Study||0||
48597863|NCT02772276|101796715|FG004|NOT COMPLETED|Overall Study||0||
48597864|NCT02772276|101796716|FG005|NOT COMPLETED|Overall Study||0||
48597865|NCT02772276|101796717|FG006|NOT COMPLETED|Overall Study||1||
48597866|NCT02772276|101796718|FG007|NOT COMPLETED|Overall Study||1||
48597867|NCT02772276|101796719|FG008|NOT COMPLETED|Overall Study||0||
48597868|NCT02772276|101796720|FG009|NOT COMPLETED|Overall Study||0||
48143523|NCT02349295|100676554|FG013|STARTED|Long-Term Extension Period (Week 24-156)||0||
48143524|NCT02349295|100676541|FG000|COMPLETED|Long-Term Extension Period (Week 24-156)||0||
48188515|NCT01686932|100783263|FG001|STARTED|Period 2||25||
48597869|NCT02772276|101796721|FG010|NOT COMPLETED|Overall Study||0||
48597870|NCT02772276|101796722|FG011|NOT COMPLETED|Overall Study||0||
48597871|NCT02772276|101796723|FG012|NOT COMPLETED|Overall Study||0||
48712846|NCT00609791|102084824|FG000|COMPLETED|Overall Study||39||
48712847|NCT00609791|102084824|FG000|NOT COMPLETED|Overall Study||1||
48712848|NCT01440517|102084825|FG000|STARTED|Overall Study||5||
48712849|NCT01440517|102084825|FG000|COMPLETED|Overall Study||4||
48712850|NCT01440517|102084825|FG000|NOT COMPLETED|Overall Study||1||
48405017|NCT02128958|101325169|FG001|STARTED|Overall Study||28||
48405018|NCT02128958|101325168|FG000|COMPLETED|Overall Study||29||
48405019|NCT02128958|101325169|FG001|COMPLETED|Overall Study||18||
48405020|NCT02128958|101325168|FG000|NOT COMPLETED|Overall Study||21||
48405021|NCT02128958|101325169|FG001|NOT COMPLETED|Overall Study||10||
48405022|NCT02903368|101325170|FG000|STARTED|Part 1||59||
48405023|NCT02903368|101325171|FG001|STARTED|Part 1||59||
48405024|NCT02903368|101325172|FG002|STARTED|Part 1||0||
48405025|NCT02903368|101325173|FG003|STARTED|Part 1||0||
48405026|NCT02903368|101325170|FG000|COMPLETED|Part 1||55||
48405027|NCT02903368|101325171|FG001|COMPLETED|Part 1||59||
48405028|NCT02903368|101325172|FG002|COMPLETED|Part 1||0||
48405029|NCT02903368|101325173|FG003|COMPLETED|Part 1||0||
48143525|NCT02349295|100676542|FG001|COMPLETED|Long-Term Extension Period (Week 24-156)||0||
48405030|NCT02903368|101325170|FG000|NOT COMPLETED|Part 1||4||
48405031|NCT02903368|101325171|FG001|NOT COMPLETED|Part 1||0||
48405032|NCT02903368|101325172|FG002|NOT COMPLETED|Part 1||0||
48405033|NCT02903368|101325173|FG003|NOT COMPLETED|Part 1||0||
48405034|NCT02903368|101325170|FG000|STARTED|Part 2||0|Only 82 patients underwent part 2 randomization; the remaining 36 patients did not participate in part 2 randomization.|
48405035|NCT02903368|101325171|FG001|STARTED|Part 2||0|Only 82 patients underwent part 2 randomization; the remaining 36 patients did not participate in part 2 randomization.|
48405036|NCT02903368|101325172|FG002|STARTED|Part 2||42|Only 82 patients underwent part 2 randomization; the remaining 36 patients did not participate in part 2 randomization.|
48405037|NCT02903368|101325173|FG003|STARTED|Part 2||40|Only 82 patients underwent part 2 randomization; the remaining 36 patients did not participate in part 2 randomization.|
48405038|NCT02903368|101325170|FG000|COMPLETED|Part 2||0||
48405039|NCT02903368|101325171|FG001|COMPLETED|Part 2||0||
48712851|NCT01442064|102084826|FG000|STARTED|Overall Study||97||
48405040|NCT02903368|101325172|FG002|COMPLETED|Part 2||31||
48405041|NCT02903368|101325173|FG003|COMPLETED|Part 2||38||
48712852|NCT01442064|102084827|FG001|STARTED|Overall Study||103||
48712853|NCT01442064|102084828|FG002|STARTED|Overall Study||104||
48712854|NCT01442064|102084829|FG003|STARTED|Overall Study||98||
48712855|NCT01442064|102084830|FG004|STARTED|Overall Study||107||
48712856|NCT01442064|102084831|FG005|STARTED|Overall Study||99||
48712857|NCT01442064|102084826|FG000|Ranibizumab-Treated Subjects|Overall Study||93||
48712858|NCT01442064|102084827|FG001|Ranibizumab-Treated Subjects|Overall Study||103||
48597872|NCT01853696|101796724|FG000|STARTED|Overall Study||84||
48597873|NCT01853696|101796725|FG001|STARTED|Overall Study||83||
48597874|NCT01853696|101796724|FG000|COMPLETED|Overall Study||78||
48597875|NCT01853696|101796725|FG001|COMPLETED|Overall Study||78||
48597876|NCT01853696|101796724|FG000|NOT COMPLETED|Overall Study||6||
48597877|NCT01853696|101796725|FG001|NOT COMPLETED|Overall Study||5||
48597878|NCT01254721|101796726|FG000|STARTED|Overall Study||67||
48597879|NCT01254721|101796727|FG001|STARTED|Overall Study||64||
48597880|NCT01254721|101796726|FG000|COMPLETED|Overall Study||52||
48597881|NCT01254721|101796727|FG001|COMPLETED|Overall Study||42||
48597882|NCT01254721|101796726|FG000|NOT COMPLETED|Overall Study||15||
48597883|NCT01254721|101796727|FG001|NOT COMPLETED|Overall Study||22||
48143526|NCT02349295|100676543|FG002|COMPLETED|Long-Term Extension Period (Week 24-156)||0||
48143527|NCT02349295|100676544|FG003|COMPLETED|Long-Term Extension Period (Week 24-156)||0||
48143528|NCT02349295|100676545|FG004|COMPLETED|Long-Term Extension Period (Week 24-156)||0||
48143529|NCT02349295|100676546|FG005|COMPLETED|Long-Term Extension Period (Week 24-156)||0||
48143530|NCT02349295|100676547|FG006|COMPLETED|Long-Term Extension Period (Week 24-156)||0||
48143531|NCT02349295|100676548|FG007|COMPLETED|Long-Term Extension Period (Week 24-156)||55||
48143532|NCT02349295|100676549|FG008|COMPLETED|Long-Term Extension Period (Week 24-156)||70||
48143533|NCT02349295|100676550|FG009|COMPLETED|Long-Term Extension Period (Week 24-156)||20||
48143534|NCT02349295|100676551|FG010|COMPLETED|Long-Term Extension Period (Week 24-156)||23||
48143535|NCT02349295|100676552|FG011|COMPLETED|Long-Term Extension Period (Week 24-156)||0||
48143536|NCT02349295|100676553|FG012|COMPLETED|Long-Term Extension Period (Week 24-156)||0||
48143537|NCT02349295|100676554|FG013|COMPLETED|Long-Term Extension Period (Week 24-156)||0||
48296481|NCT03267940|101054269|FG001|STARTED|Expansion (Maximum Exposure: 421 Days)||0||
48296482|NCT03267940|101054270|FG002|STARTED|Expansion (Maximum Exposure: 421 Days)||24||
48296483|NCT03267940|101054271|FG003|STARTED|Expansion (Maximum Exposure: 421 Days)||22||
48296484|NCT03267940|101054272|FG004|STARTED|Expansion (Maximum Exposure: 421 Days)||11||
48296485|NCT03267940|101054273|FG005|STARTED|Expansion (Maximum Exposure: 421 Days)||10||
48296486|NCT03267940|101054268|FG000|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||0||
48296487|NCT03267940|101054269|FG001|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||0||
48296488|NCT03267940|101054270|FG002|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||24||
48296489|NCT03267940|101054271|FG003|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||22||
48296490|NCT03267940|101054272|FG004|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||11||
48296491|NCT03267940|101054273|FG005|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||10||
48296492|NCT03267940|101054268|FG000|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0||
48296493|NCT03267940|101054269|FG001|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0||
48296494|NCT03267940|101054270|FG002|COMPLETED|Expansion (Maximum Exposure: 421 Days)||3||
48296495|NCT03267940|101054271|FG003|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0||
48296496|NCT03267940|101054272|FG004|COMPLETED|Expansion (Maximum Exposure: 421 Days)||1||
48296497|NCT03267940|101054273|FG005|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0||
48405042|NCT02903368|101325170|FG000|NOT COMPLETED|Part 2||0||
48597884|NCT01490697|101796728|FG000|STARTED|Overall Study||16||
48597885|NCT01490697|101796729|FG001|STARTED|Overall Study||18||
48597886|NCT01490697|101796728|FG000|COMPLETED|Overall Study||15||
48597887|NCT01490697|101796729|FG001|COMPLETED|Overall Study||16||
48597888|NCT01490697|101796728|FG000|NOT COMPLETED|Overall Study||1||
48143538|NCT02349295|100676541|FG000|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0||
48143539|NCT02349295|100676542|FG001|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0||
48143540|NCT02349295|100676543|FG002|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0||
48143541|NCT02349295|100676544|FG003|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0||
48143542|NCT02349295|100676545|FG004|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0||
48143543|NCT02349295|100676546|FG005|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0||
48143544|NCT02349295|100676547|FG006|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0||
48143545|NCT02349295|100676548|FG007|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||52||
48143546|NCT02349295|100676549|FG008|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||41||
48143547|NCT02349295|100676550|FG009|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||26||
48143548|NCT02349295|100676551|FG010|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||23||
48296498|NCT03267940|101054268|FG000|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||0||
48296499|NCT03267940|101054269|FG001|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||0||
48296500|NCT03267940|101054270|FG002|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||21||
48296501|NCT03267940|101054271|FG003|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||22||
48296502|NCT03267940|101054272|FG004|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||10||
48296503|NCT03267940|101054273|FG005|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||10||
48597889|NCT01490697|101796729|FG001|NOT COMPLETED|Overall Study||2||
48597890|NCT01429064|101796730|FG000|STARTED|Overall Study||19||
48597891|NCT01429064|101796731|FG001|STARTED|Overall Study||22||
48597892|NCT01429064|101796732|FG002|STARTED|Overall Study||19||
48597893|NCT01429064|101796733|FG003|STARTED|Overall Study||16||
48597894|NCT01429064|101796730|FG000|COMPLETED|Overall Study||19||
48597895|NCT01429064|101796731|FG001|COMPLETED|Overall Study||22||
48712859|NCT01442064|102084828|FG002|Ranibizumab-Treated Subjects|Overall Study||104||
48712860|NCT01442064|102084829|FG003|Ranibizumab-Treated Subjects|Overall Study||96||
48143549|NCT02349295|100676552|FG011|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0||
48143550|NCT02349295|100676553|FG012|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0||
48143551|NCT02349295|100676554|FG013|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0||
48143552|NCT02349295|100676541|FG000|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0||
48296504|NCT05062083|101054274|FG000|STARTED|Overall Study||5||
48296505|NCT05062083|101054274|FG000|COMPLETED|Overall Study||5||
48296506|NCT05062083|101054274|FG000|NOT COMPLETED|Overall Study||0||
48296507|NCT04409886|101054275|FG000|STARTED|Overall Study||1||
48296508|NCT04409886|101054275|FG000|COMPLETED|Overall Study||1||
48296509|NCT04409886|101054275|FG000|NOT COMPLETED|Overall Study||0||
48296510|NCT03077360|101054276|FG000|STARTED|Overall Study||17||
48296511|NCT03077360|101054277|FG001|STARTED|Overall Study||17||
48296512|NCT03077360|101054278|FG002|STARTED|Overall Study||14||
48296513|NCT03077360|101054276|FG000|COMPLETED|Overall Study||17||
48296514|NCT03077360|101054277|FG001|COMPLETED|Overall Study||16||
48296515|NCT03077360|101054278|FG002|COMPLETED|Overall Study||12||
48143553|NCT02349295|100676542|FG001|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0||
48143554|NCT02349295|100676543|FG002|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0||
48143555|NCT02349295|100676544|FG003|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0||
48143556|NCT02349295|100676545|FG004|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0||
48143557|NCT02349295|100676546|FG005|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0||
48143558|NCT02349295|100676547|FG006|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0||
48143559|NCT02349295|100676548|FG007|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0||
48143560|NCT02349295|100676549|FG008|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0||
48296516|NCT03077360|101054276|FG000|NOT COMPLETED|Overall Study||0||
48296517|NCT03077360|101054277|FG001|NOT COMPLETED|Overall Study||1||
48296518|NCT03077360|101054278|FG002|NOT COMPLETED|Overall Study||2||
48296519|NCT04532372|101054279|FG000|STARTED|Overall Study||2||
48143561|NCT02349295|100676550|FG009|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0||
48296520|NCT04532372|101054280|FG001|STARTED|Overall Study||0||
48296521|NCT04532372|101054281|FG002|STARTED|Overall Study||0||
48296522|NCT04532372|101054279|FG000|COMPLETED|Overall Study||2||
48296523|NCT04532372|101054280|FG001|COMPLETED|Overall Study||0||
48296524|NCT04532372|101054281|FG002|COMPLETED|Overall Study||0||
48296525|NCT04532372|101054279|FG000|NOT COMPLETED|Overall Study||0||
48405043|NCT02903368|101325171|FG001|NOT COMPLETED|Part 2||0||
48712861|NCT01442064|102084830|FG004|Ranibizumab-Treated Subjects|Overall Study||107||
48143562|NCT02349295|100676551|FG010|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0||
48143563|NCT02349295|100676552|FG011|STARTED|Follow-Up Period (Up to 12-24 Weeks)||142||
48143564|NCT02349295|100676553|FG012|STARTED|Follow-Up Period (Up to 12-24 Weeks)||145||
48296526|NCT04532372|101054280|FG001|NOT COMPLETED|Overall Study||0||
48296527|NCT04532372|101054281|FG002|NOT COMPLETED|Overall Study||0||
48296528|NCT03442985|101054282|FG000|STARTED|Overall Study||62|Received treatment|
48296529|NCT03442985|101054283|FG001|STARTED|Overall Study||66|Received treatment|
48296530|NCT03442985|101054284|FG002|STARTED|Overall Study||65|Received treatment|
48296531|NCT03442985|101054282|FG000|COMPLETED|Overall Study||0||
48296532|NCT03442985|101054283|FG001|COMPLETED|Overall Study||0||
48296533|NCT03442985|101054284|FG002|COMPLETED|Overall Study||0||
48296534|NCT03442985|101054282|FG000|NOT COMPLETED|Overall Study||62||
48296535|NCT03442985|101054283|FG001|NOT COMPLETED|Overall Study||66||
48296536|NCT03442985|101054284|FG002|NOT COMPLETED|Overall Study||65||
48296537|NCT02740972|101054285|FG000|STARTED|4-week Double-blinded Placebo-controlled||5||
48296538|NCT02740972|101054286|FG001|STARTED|4-week Double-blinded Placebo-controlled||6||
48296539|NCT02740972|101054287|FG002|STARTED|4-week Double-blinded Placebo-controlled||5||
48296540|NCT02740972|101054288|FG003|STARTED|4-week Double-blinded Placebo-controlled||0||
48296541|NCT02740972|101054289|FG004|STARTED|4-week Double-blinded Placebo-controlled||0||
48296542|NCT02740972|101054285|FG000|COMPLETED|4-week Double-blinded Placebo-controlled||5||
48296543|NCT02740972|101054286|FG001|COMPLETED|4-week Double-blinded Placebo-controlled||6||
48296544|NCT02740972|101054287|FG002|COMPLETED|4-week Double-blinded Placebo-controlled||5||
48296545|NCT02740972|101054288|FG003|COMPLETED|4-week Double-blinded Placebo-controlled||0||
48296546|NCT02740972|101054289|FG004|COMPLETED|4-week Double-blinded Placebo-controlled||0||
48712862|NCT01442064|102084831|FG005|Ranibizumab-Treated Subjects|Overall Study||99||
48712863|NCT01442064|102084826|FG000|Received Study Drug in Extension Study|Overall Study||61||
48712864|NCT01442064|102084827|FG001|Received Study Drug in Extension Study|Overall Study||70||
48188516|NCT01686932|100783262|FG000|COMPLETED|Period 2||24||
48296547|NCT02740972|101054285|FG000|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0||
48296548|NCT02740972|101054286|FG001|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0||
48296549|NCT02740972|101054287|FG002|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0||
48296550|NCT02740972|101054288|FG003|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0||
48296551|NCT02740972|101054289|FG004|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0||
48296552|NCT02740972|101054285|FG000|STARTED|20-week Open Label Treatment Period||0||
48296553|NCT02740972|101054286|FG001|STARTED|20-week Open Label Treatment Period||0||
48296554|NCT02740972|101054287|FG002|STARTED|20-week Open Label Treatment Period||0||
48405044|NCT02903368|101325172|FG002|NOT COMPLETED|Part 2||11||
48405045|NCT02903368|101325173|FG003|NOT COMPLETED|Part 2||2||
48405046|NCT04268303|101325174|FG000|STARTED|Overall Study||129||
48405047|NCT04268303|101325175|FG001|STARTED|Overall Study||125||
48405048|NCT04268303|101325176|FG002|STARTED|Overall Study||126||
48405049|NCT04268303|101325174|FG000|COMPLETED|Overall Study||126||
48405050|NCT04268303|101325175|FG001|COMPLETED|Overall Study||123||
48405051|NCT04268303|101325176|FG002|COMPLETED|Overall Study||123||
48405052|NCT04268303|101325174|FG000|NOT COMPLETED|Overall Study||3||
48405053|NCT04268303|101325175|FG001|NOT COMPLETED|Overall Study||2||
48405054|NCT04268303|101325176|FG002|NOT COMPLETED|Overall Study||3||
48405055|NCT00595868|101325177|FG000|STARTED|Overall Study||107||
48597896|NCT01429064|101796732|FG002|COMPLETED|Overall Study||19||
48597897|NCT01429064|101796733|FG003|COMPLETED|Overall Study||16||
48597898|NCT01429064|101796730|FG000|NOT COMPLETED|Overall Study||0||
48597899|NCT01429064|101796731|FG001|NOT COMPLETED|Overall Study||0||
48597900|NCT01429064|101796732|FG002|NOT COMPLETED|Overall Study||0||
48597901|NCT01429064|101796733|FG003|NOT COMPLETED|Overall Study||0||
48597902|NCT00583102|101796734|FG000|STARTED|Overall Study||23||
48597903|NCT00583102|101796734|FG000|COMPLETED|Overall Study||20||
48597904|NCT00583102|101796734|FG000|NOT COMPLETED|Overall Study||3||
48597905|NCT00323037|101796735|FG000|STARTED|Overall Study||165||
48597906|NCT00323037|101796736|FG001|STARTED|Overall Study||153||
48597907|NCT00323037|101796735|FG000|COMPLETED|Overall Study||132||
48597908|NCT00323037|101796736|FG001|COMPLETED|Overall Study||126||
48597909|NCT00323037|101796735|FG000|NOT COMPLETED|Overall Study||33||
48597910|NCT00323037|101796736|FG001|NOT COMPLETED|Overall Study||27||
48597911|NCT05070468|101796737|FG000|STARTED|Overall Study||42||
48597912|NCT05070468|101796738|FG001|STARTED|Overall Study||42||
48597913|NCT05070468|101796737|FG000|COMPLETED|Overall Study||41||
48597914|NCT05070468|101796738|FG001|COMPLETED|Overall Study||42||
48597915|NCT05070468|101796737|FG000|NOT COMPLETED|Overall Study||1||
48597916|NCT05070468|101796738|FG001|NOT COMPLETED|Overall Study||0||
48597917|NCT00096993|101796739|FG000|STARTED|Overall Study||66||
48597918|NCT00096993|101796740|FG001|STARTED|Overall Study||65||
48597919|NCT00096993|101796739|FG000|COMPLETED|Overall Study||1||
48597920|NCT00096993|101796740|FG001|COMPLETED|Overall Study||0||
48597921|NCT00096993|101796739|FG000|NOT COMPLETED|Overall Study||65||
48597922|NCT00096993|101796740|FG001|NOT COMPLETED|Overall Study||65||
48597923|NCT03557684|101796741|FG000|STARTED|Overall Study||23||
48597924|NCT03557684|101796742|FG001|STARTED|Overall Study||18||
48597925|NCT03557684|101796743|FG002|STARTED|Overall Study||8||
48597926|NCT03557684|101796744|FG003|STARTED|Overall Study||10||
48597927|NCT03557684|101796741|FG000|COMPLETED|Overall Study||23||
48597928|NCT03557684|101796742|FG001|COMPLETED|Overall Study||18||
48597929|NCT03557684|101796743|FG002|COMPLETED|Overall Study||8||
48597930|NCT03557684|101796744|FG003|COMPLETED|Overall Study||10||
48597931|NCT03557684|101796741|FG000|NOT COMPLETED|Overall Study||0||
48597932|NCT03557684|101796742|FG001|NOT COMPLETED|Overall Study||0||
48597933|NCT03557684|101796743|FG002|NOT COMPLETED|Overall Study||0||
48597934|NCT03557684|101796744|FG003|NOT COMPLETED|Overall Study||0||
48597935|NCT01900431|101796745|FG000|STARTED|Principal Treatment Period (Part A)||20||
48597936|NCT01900431|101796746|FG001|STARTED|Principal Treatment Period (Part A)||38||
48597937|NCT01900431|101796747|FG002|STARTED|Principal Treatment Period (Part A)||0||
48597938|NCT01900431|101796745|FG000|COMPLETED|Principal Treatment Period (Part A)||13||
48597939|NCT01900431|101796746|FG001|COMPLETED|Principal Treatment Period (Part A)||28||
48597940|NCT01900431|101796747|FG002|COMPLETED|Principal Treatment Period (Part A)||0||
48597941|NCT01900431|101796745|FG000|NOT COMPLETED|Principal Treatment Period (Part A)||7||
48597942|NCT01900431|101796746|FG001|NOT COMPLETED|Principal Treatment Period (Part A)||10||
48597943|NCT01900431|101796747|FG002|NOT COMPLETED|Principal Treatment Period (Part A)||0||
48597944|NCT01900431|101796745|FG000|STARTED|Extended Treatment Period (Part B)||8||
48597945|NCT01900431|101796746|FG001|STARTED|Extended Treatment Period (Part B)||22||
48597946|NCT01900431|101796747|FG002|STARTED|Extended Treatment Period (Part B)||0||
48597947|NCT01900431|101796745|FG000|COMPLETED|Extended Treatment Period (Part B)||7||
48597948|NCT01900431|101796746|FG001|COMPLETED|Extended Treatment Period (Part B)||12||
48405056|NCT00595868|101325178|FG001|STARTED|Overall Study||111||
48405057|NCT00595868|101325177|FG000|COMPLETED|Overall Study||62||
48405058|NCT00595868|101325178|FG001|COMPLETED|Overall Study||61||
48405059|NCT00595868|101325177|FG000|NOT COMPLETED|Overall Study||45||
48405060|NCT00595868|101325178|FG001|NOT COMPLETED|Overall Study||50||
48597949|NCT01900431|101796747|FG002|COMPLETED|Extended Treatment Period (Part B)||0||
48597950|NCT01900431|101796745|FG000|NOT COMPLETED|Extended Treatment Period (Part B)||1||
48597951|NCT01900431|101796746|FG001|NOT COMPLETED|Extended Treatment Period (Part B)||10||
48597952|NCT01900431|101796747|FG002|NOT COMPLETED|Extended Treatment Period (Part B)||0||
48405061|NCT01041404|101325179|FG000|STARTED|Overall Study||290||
48405062|NCT01041404|101325180|FG001|STARTED|Overall Study||294||
48405063|NCT01041404|101325179|FG000|Entered Follow-Up|Overall Study||251||
48405064|NCT01041404|101325180|FG001|Entered Follow-Up|Overall Study||251||
48405065|NCT01041404|101325179|FG000|Died in Follow-up|Overall Study||199||
48405066|NCT01041404|101325180|FG001|Died in Follow-up|Overall Study||200||
48405067|NCT01041404|101325179|FG000|Lost to Follow-up|Overall Study||12||
48296555|NCT02740972|101054288|FG003|STARTED|20-week Open Label Treatment Period||8||
48296556|NCT02740972|101054289|FG004|STARTED|20-week Open Label Treatment Period||8||
48296557|NCT02740972|101054285|FG000|COMPLETED|20-week Open Label Treatment Period||0||
48296558|NCT02740972|101054286|FG001|COMPLETED|20-week Open Label Treatment Period||0||
48296559|NCT02740972|101054287|FG002|COMPLETED|20-week Open Label Treatment Period||0||
48296560|NCT02740972|101054288|FG003|COMPLETED|20-week Open Label Treatment Period||8||
48296561|NCT02740972|101054289|FG004|COMPLETED|20-week Open Label Treatment Period||8||
48296562|NCT02740972|101054285|FG000|NOT COMPLETED|20-week Open Label Treatment Period||0||
48296563|NCT02740972|101054286|FG001|NOT COMPLETED|20-week Open Label Treatment Period||0||
48296564|NCT02740972|101054287|FG002|NOT COMPLETED|20-week Open Label Treatment Period||0||
48296565|NCT02740972|101054288|FG003|NOT COMPLETED|20-week Open Label Treatment Period||0||
48597953|NCT01900431|101796745|FG000|STARTED|Open-Label Treatment Period (Part C)||0||
48597954|NCT01900431|101796746|FG001|STARTED|Open-Label Treatment Period (Part C)||0||
48597955|NCT01900431|101796747|FG002|STARTED|Open-Label Treatment Period (Part C)||21||
48597956|NCT01900431|101796745|FG000|COMPLETED|Open-Label Treatment Period (Part C)||0||
48597957|NCT01900431|101796746|FG001|COMPLETED|Open-Label Treatment Period (Part C)||0||
48597958|NCT01900431|101796747|FG002|COMPLETED|Open-Label Treatment Period (Part C)||13||
48597959|NCT01900431|101796745|FG000|NOT COMPLETED|Open-Label Treatment Period (Part C)||0||
48597960|NCT01900431|101796746|FG001|NOT COMPLETED|Open-Label Treatment Period (Part C)||0||
48597961|NCT01900431|101796747|FG002|NOT COMPLETED|Open-Label Treatment Period (Part C)||8||
48296566|NCT02740972|101054289|FG004|NOT COMPLETED|20-week Open Label Treatment Period||0||
48597962|NCT01618019|101796748|FG000|STARTED|Overall Study||55||
48597963|NCT01618019|101796749|FG001|STARTED|Overall Study||54||
48597964|NCT01618019|101796748|FG000|COMPLETED|Overall Study||41||
48597965|NCT01618019|101796749|FG001|COMPLETED|Overall Study||40||
48597966|NCT01618019|101796748|FG000|NOT COMPLETED|Overall Study||14||
48597967|NCT01618019|101796749|FG001|NOT COMPLETED|Overall Study||14||
48597968|NCT03427268|101796750|FG000|STARTED|Overall Study||32||
48597969|NCT03427268|101796750|FG000|COMPLETED|Overall Study||0||
48597970|NCT03427268|101796750|FG000|NOT COMPLETED|Overall Study||32||
48597971|NCT02348359|101796751|FG000|STARTED|Overall Study||40||
48597972|NCT02348359|101796752|FG001|STARTED|Overall Study||39||
48405068|NCT01041404|101325180|FG001|Lost to Follow-up|Overall Study||10||
48405069|NCT01041404|101325179|FG000|Alive in Follow-up|Overall Study||40||
48597973|NCT02348359|101796753|FG002|STARTED|Overall Study||39||
48597974|NCT02348359|101796754|FG003|STARTED|Overall Study||39||
48597975|NCT02348359|101796751|FG000|COMPLETED|Overall Study||29||
48597976|NCT02348359|101796752|FG001|COMPLETED|Overall Study||22||
48597977|NCT02348359|101796753|FG002|COMPLETED|Overall Study||25||
48597978|NCT02348359|101796754|FG003|COMPLETED|Overall Study||27||
48597979|NCT02348359|101796751|FG000|NOT COMPLETED|Overall Study||11||
48597980|NCT02348359|101796752|FG001|NOT COMPLETED|Overall Study||17||
48597981|NCT02348359|101796753|FG002|NOT COMPLETED|Overall Study||14||
48597982|NCT02348359|101796754|FG003|NOT COMPLETED|Overall Study||12||
48597983|NCT01752634|101796755|FG000|STARTED|Up to Week 24 (Primary Analysis)||99||
48597984|NCT01752634|101796756|FG001|STARTED|Up to Week 24 (Primary Analysis)||100||
48597985|NCT01752634|101796757|FG002|STARTED|Up to Week 24 (Primary Analysis)||100||
48597986|NCT01752634|101796758|FG003|STARTED|Up to Week 24 (Primary Analysis)||43||
48597987|NCT01752634|101796759|FG004|STARTED|Up to Week 24 (Primary Analysis)||45||
48597988|NCT01752634|101796760|FG005|STARTED|Up to Week 24 (Primary Analysis)||10||
48597989|NCT01752634|101796755|FG000|COMPLETED|Up to Week 24 (Primary Analysis)||93||
48597990|NCT01752634|101796756|FG001|COMPLETED|Up to Week 24 (Primary Analysis)||95||
48597991|NCT01752634|101796757|FG002|COMPLETED|Up to Week 24 (Primary Analysis)||97||
48597992|NCT01752634|101796758|FG003|COMPLETED|Up to Week 24 (Primary Analysis)||43||
48597993|NCT01752634|101796759|FG004|COMPLETED|Up to Week 24 (Primary Analysis)||45||
48597994|NCT01752634|101796760|FG005|COMPLETED|Up to Week 24 (Primary Analysis)||0||
48597995|NCT01752634|101796755|FG000|NOT COMPLETED|Up to Week 24 (Primary Analysis)||6||
48597996|NCT01752634|101796756|FG001|NOT COMPLETED|Up to Week 24 (Primary Analysis)||5||
48597997|NCT01752634|101796757|FG002|NOT COMPLETED|Up to Week 24 (Primary Analysis)||3||
48597998|NCT01752634|101796758|FG003|NOT COMPLETED|Up to Week 24 (Primary Analysis)||0||
48597999|NCT01752634|101796759|FG004|NOT COMPLETED|Up to Week 24 (Primary Analysis)||0||
48598000|NCT01752634|101796760|FG005|NOT COMPLETED|Up to Week 24 (Primary Analysis)||10||
48296567|NCT03136328|101054290|FG000|STARTED|Overall Study||11||
48296568|NCT03136328|101054290|FG000|COMPLETED|Overall Study||11||
48296569|NCT03136328|101054290|FG000|NOT COMPLETED|Overall Study||0||
48296570|NCT02271425|101054291|FG000|STARTED|Overall Study||8||
48296571|NCT02271425|101054291|FG000|COMPLETED|Overall Study||8||
48296572|NCT02271425|101054291|FG000|NOT COMPLETED|Overall Study||0||
48296573|NCT00171704|101054292|FG000|STARTED|Overall Study||133||
48296574|NCT00171704|101054293|FG001|STARTED|Overall Study||130||
48296575|NCT00171704|101054292|FG000|COMPLETED|Overall Study||89||
48598001|NCT01752634|101796755|FG000|STARTED|Week 24 to Week 260||93||
48598002|NCT01752634|101796756|FG001|STARTED|Week 24 to Week 260||95||
48405070|NCT01041404|101325180|FG001|Alive in Follow-up|Overall Study||41||
48598003|NCT01752634|101796757|FG002|STARTED|Week 24 to Week 260||97||
48598004|NCT01752634|101796758|FG003|STARTED|Week 24 to Week 260||43||
48598005|NCT01752634|101796759|FG004|STARTED|Week 24 to Week 260||45||
48296576|NCT00171704|101054293|FG001|COMPLETED|Overall Study||81||
48296577|NCT00171704|101054292|FG000|NOT COMPLETED|Overall Study||44||
48598006|NCT01752634|101796760|FG005|STARTED|Week 24 to Week 260||0||
48598007|NCT01752634|101796755|FG000|COMPLETED|Week 24 to Week 260||59||
48598008|NCT01752634|101796756|FG001|COMPLETED|Week 24 to Week 260||65||
48598009|NCT01752634|101796757|FG002|COMPLETED|Week 24 to Week 260||64||
48598010|NCT01752634|101796758|FG003|COMPLETED|Week 24 to Week 260||29||
48598011|NCT01752634|101796759|FG004|COMPLETED|Week 24 to Week 260||31||
48598012|NCT01752634|101796760|FG005|COMPLETED|Week 24 to Week 260||0||
48598013|NCT01752634|101796755|FG000|NOT COMPLETED|Week 24 to Week 260||34||
48598014|NCT01752634|101796756|FG001|NOT COMPLETED|Week 24 to Week 260||30||
48598015|NCT01752634|101796757|FG002|NOT COMPLETED|Week 24 to Week 260||33||
48598016|NCT01752634|101796758|FG003|NOT COMPLETED|Week 24 to Week 260||14||
48598017|NCT01752634|101796759|FG004|NOT COMPLETED|Week 24 to Week 260||14||
48598018|NCT01752634|101796760|FG005|NOT COMPLETED|Week 24 to Week 260||0||
48598019|NCT00083720|101796761|FG000|STARTED|Overall Study||85||
48598020|NCT00083720|101796761|FG000|COMPLETED|Overall Study||85||
48598021|NCT00083720|101796761|FG000|NOT COMPLETED|Overall Study||0||
48598022|NCT01068626|101796762|FG000|STARTED|Overall Study||30||
48598023|NCT01068626|101796763|FG001|STARTED|Overall Study||29||
48598024|NCT01068626|101796762|FG000|COMPLETED|Overall Study||27||
48598025|NCT01068626|101796763|FG001|COMPLETED|Overall Study||27||
48598026|NCT01068626|101796762|FG000|NOT COMPLETED|Overall Study||3||
48598027|NCT01068626|101796763|FG001|NOT COMPLETED|Overall Study||2||
48296578|NCT00171704|101054293|FG001|NOT COMPLETED|Overall Study||49||
48296579|NCT00551460|101054294|FG000|STARTED|Overall Study||78||
48296580|NCT00551460|101054294|FG000|COMPLETED|Overall Study||60||
48296581|NCT00551460|101054294|FG000|NOT COMPLETED|Overall Study||18||
48296582|NCT01136772|101054295|FG000|STARTED|Overall Study||157||
48296583|NCT01136772|101054296|FG001|STARTED|Overall Study||154||
48296584|NCT01136772|101054295|FG000|Safety Population|Overall Study||147||
48296585|NCT01136772|101054296|FG001|Safety Population|Overall Study||147||
48296586|NCT01136772|101054295|FG000|COMPLETED|Overall Study||41||
48598028|NCT01897766|101796764|FG000|STARTED|Overall Study||482||
48598029|NCT01897766|101796764|FG000|COMPLETED|Overall Study||482||
48598030|NCT01897766|101796764|FG000|NOT COMPLETED|Overall Study||0||
48598031|NCT00306787|101796765|FG000|STARTED|Overall Study||579||
48598032|NCT00306787|101796766|FG001|STARTED|Overall Study||600||
48296587|NCT01136772|101054296|FG001|COMPLETED|Overall Study||44||
48598033|NCT00306787|101796765|FG000|Received Study Drug (Safety Population)|Overall Study||371||
48598034|NCT00306787|101796766|FG001|Received Study Drug (Safety Population)|Overall Study||385||
48598035|NCT00306787|101796765|FG000|Intent to Treat (ITT) Population|Overall Study||370||
48598036|NCT00306787|101796766|FG001|Intent to Treat (ITT) Population|Overall Study||381||
48598037|NCT00306787|101796765|FG000|COMPLETED|Overall Study||345||
48598038|NCT00306787|101796766|FG001|COMPLETED|Overall Study||359||
48598039|NCT00306787|101796765|FG000|NOT COMPLETED|Overall Study||234||
48598040|NCT00306787|101796766|FG001|NOT COMPLETED|Overall Study||241||
48598041|NCT00539032|101796767|FG000|STARTED|Overall Study||153||
48598042|NCT00539032|101796768|FG001|STARTED|Overall Study||85||
48598043|NCT00539032|101796767|FG000|COMPLETED|Overall Study||151||
48598044|NCT00539032|101796768|FG001|COMPLETED|Overall Study||84||
48598045|NCT00539032|101796767|FG000|NOT COMPLETED|Overall Study||2||
48598046|NCT00539032|101796768|FG001|NOT COMPLETED|Overall Study||1||
48598047|NCT03946670|101796769|FG000|STARTED|Overall Study||65||
48598048|NCT03946670|101796770|FG001|STARTED|Overall Study||62||
48598049|NCT03946670|101796769|FG000|Treated|Overall Study||64||
48598050|NCT03946670|101796770|FG001|Treated|Overall Study||61||
48712865|NCT01442064|102084828|FG002|Received Study Drug in Extension Study|Overall Study||60||
48296588|NCT01136772|101054295|FG000|NOT COMPLETED|Overall Study||116||
48598051|NCT03946670|101796769|FG000|Not Treated|Overall Study||1||
48598052|NCT03946670|101796770|FG001|Not Treated|Overall Study||1||
48712866|NCT01442064|102084829|FG003|Received Study Drug in Extension Study|Overall Study||70||
48712867|NCT01442064|102084830|FG004|Received Study Drug in Extension Study|Overall Study||89||
48712868|NCT01442064|102084831|FG005|Received Study Drug in Extension Study|Overall Study||81||
48712869|NCT01442064|102084826|FG000|COMPLETED|Overall Study||0||
48712870|NCT01442064|102084827|FG001|COMPLETED|Overall Study||2||
48296589|NCT01136772|101054296|FG001|NOT COMPLETED|Overall Study||110||
48296590|NCT04615247|101054297|FG000|STARTED|Overall Study||17||
48598053|NCT03946670|101796769|FG000|Treatment Ongoing|Overall Study||13||
48598054|NCT03946670|101796770|FG001|Treatment Ongoing|Overall Study||10||
48598055|NCT03946670|101796769|FG000|Discontinued From Treatment|Overall Study||51||
48598056|NCT03946670|101796770|FG001|Discontinued From Treatment|Overall Study||51||
48296591|NCT04615247|101054298|FG001|STARTED|Overall Study||19||
48598057|NCT03946670|101796769|FG000|COMPLETED|Overall Study||13|Completed = Ongoing|
48598058|NCT03946670|101796770|FG001|COMPLETED|Overall Study||10|Completed = Ongoing|
48598059|NCT03946670|101796769|FG000|NOT COMPLETED|Overall Study||52||
48598060|NCT03946670|101796770|FG001|NOT COMPLETED|Overall Study||52||
48598061|NCT01237327|101796771|FG000|STARTED|Overall Study||43||
48598062|NCT01237327|101796772|FG001|STARTED|Overall Study||41||
48598063|NCT01237327|101796771|FG000|Stopped Treatment in Core Study (D/C)|Overall Study||22||
48598064|NCT01237327|101796772|FG001|Stopped Treatment in Core Study (D/C)|Overall Study||24||
48598065|NCT01237327|101796771|FG000|Completed Treatment in Core Study|Overall Study||3||
48598066|NCT01237327|101796772|FG001|Completed Treatment in Core Study|Overall Study||2||
48598067|NCT01237327|101796771|FG000|Continued Treatment in Extension Study|Overall Study||21||
48598068|NCT01237327|101796772|FG001|Continued Treatment in Extension Study|Overall Study||17||
48598069|NCT01237327|101796771|FG000|COMPLETED|Overall Study||1||
48598070|NCT01237327|101796772|FG001|COMPLETED|Overall Study||1||
48598071|NCT01237327|101796771|FG000|NOT COMPLETED|Overall Study||42||
48598072|NCT01237327|101796772|FG001|NOT COMPLETED|Overall Study||40||
48598073|NCT05362695|101796773|FG000|STARTED|Overall Study||6||
48598074|NCT05362695|101796774|FG001|STARTED|Overall Study||6||
48598075|NCT05362695|101796775|FG002|STARTED|Overall Study||6||
48598076|NCT05362695|101796773|FG000|COMPLETED|Overall Study||6||
48598077|NCT05362695|101796774|FG001|COMPLETED|Overall Study||6||
48598078|NCT05362695|101796775|FG002|COMPLETED|Overall Study||6||
48598079|NCT05362695|101796773|FG000|NOT COMPLETED|Overall Study||0||
48598080|NCT05362695|101796774|FG001|NOT COMPLETED|Overall Study||0||
48598081|NCT05362695|101796775|FG002|NOT COMPLETED|Overall Study||0||
48598082|NCT01836809|101796776|FG000|STARTED|Overall Study||0||
48598083|NCT01836809|101796777|FG001|STARTED|Overall Study||0||
48598084|NCT01836809|101796778|FG002|STARTED|Overall Study||0||
48598085|NCT01836809|101796779|FG003|STARTED|Overall Study||2||
48598086|NCT01836809|101796776|FG000|COMPLETED|Overall Study||0||
48598087|NCT01836809|101796777|FG001|COMPLETED|Overall Study||0||
48598088|NCT01836809|101796778|FG002|COMPLETED|Overall Study||0||
48143565|NCT02349295|100676554|FG013|STARTED|Follow-Up Period (Up to 12-24 Weeks)||17||
48143566|NCT02349295|100676541|FG000|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
48143567|NCT02349295|100676542|FG001|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
48143568|NCT02349295|100676543|FG002|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
48143569|NCT02349295|100676544|FG003|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
48143570|NCT02349295|100676545|FG004|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
48143571|NCT02349295|100676546|FG005|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
48143572|NCT02349295|100676547|FG006|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
48143573|NCT02349295|100676548|FG007|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
48143574|NCT02349295|100676549|FG008|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
48143575|NCT02349295|100676550|FG009|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
48143576|NCT02349295|100676551|FG010|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
48143577|NCT02349295|100676552|FG011|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||133||
48143578|NCT02349295|100676553|FG012|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||137||
48143579|NCT02349295|100676554|FG013|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||16||
48143580|NCT02349295|100676541|FG000|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
48143581|NCT02349295|100676542|FG001|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
48143582|NCT02349295|100676543|FG002|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
48143583|NCT02349295|100676544|FG003|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
48143584|NCT02349295|100676545|FG004|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
48143585|NCT02349295|100676546|FG005|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
48143586|NCT02349295|100676547|FG006|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
48143587|NCT02349295|100676548|FG007|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
48143588|NCT02349295|100676549|FG008|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
48143589|NCT02349295|100676550|FG009|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
48143590|NCT02349295|100676551|FG010|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
48143591|NCT02349295|100676552|FG011|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||9||
48143592|NCT02349295|100676553|FG012|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||8||
48143593|NCT02349295|100676554|FG013|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||1||
48143594|NCT03561090|100676555|FG000|STARTED|Overall Study||247|Randomized|
48143595|NCT03561090|100676556|FG001|STARTED|Overall Study||248|Randomized|
48143596|NCT03561090|100676555|FG000|Randomized and Treated|Overall Study||246||
48143597|NCT03561090|100676556|FG001|Randomized and Treated|Overall Study||247||
48598089|NCT01836809|101796779|FG003|COMPLETED|Overall Study||0||
48598090|NCT01836809|101796776|FG000|NOT COMPLETED|Overall Study||0||
48598091|NCT01836809|101796777|FG001|NOT COMPLETED|Overall Study||0||
48598092|NCT01836809|101796778|FG002|NOT COMPLETED|Overall Study||0||
48598093|NCT01836809|101796779|FG003|NOT COMPLETED|Overall Study||2||
48598094|NCT00932451|101796780|FG000|STARTED|Overall Study||1066||
48598095|NCT00932451|101796780|FG000|COMPLETED|Overall Study||244||
48598096|NCT00932451|101796780|FG000|NOT COMPLETED|Overall Study||822||
48598097|NCT02612610|101796781|FG000|STARTED|Overall Study||63||
48598098|NCT02612610|101796782|FG001|STARTED|Overall Study||64||
48598099|NCT02612610|101796783|FG002|STARTED|Overall Study||63||
48598100|NCT02612610|101796784|FG003|STARTED|Overall Study||63||
48143598|NCT03561090|100676555|FG000|COMPLETED|Overall Study||207||
48143599|NCT03561090|100676556|FG001|COMPLETED|Overall Study||212||
48598101|NCT02612610|101796781|FG000|Treated|Overall Study||63||
48598102|NCT02612610|101796782|FG001|Treated|Overall Study||63||
48598103|NCT02612610|101796783|FG002|Treated|Overall Study||63||
48598104|NCT02612610|101796784|FG003|Treated|Overall Study||63||
48598105|NCT02612610|101796781|FG000|COMPLETED|Overall Study||58||
48598106|NCT02612610|101796782|FG001|COMPLETED|Overall Study||56||
48143600|NCT03561090|100676555|FG000|NOT COMPLETED|Overall Study||40||
48143601|NCT03561090|100676556|FG001|NOT COMPLETED|Overall Study||36||
48143602|NCT00036569|100676557|FG000|STARTED|Overall Study||32||
48143603|NCT00036569|100676557|FG000|COMPLETED|Overall Study||32||
48143604|NCT00036569|100676557|FG000|NOT COMPLETED|Overall Study||0||
48143605|NCT01880723|100676558|FG000|STARTED|Overall Study||16||
48143606|NCT01880723|100676559|FG001|STARTED|Overall Study||16||
48143607|NCT01880723|100676558|FG000|COMPLETED|Overall Study||16||
48143608|NCT01880723|100676559|FG001|COMPLETED|Overall Study||16||
48143609|NCT01880723|100676558|FG000|NOT COMPLETED|Overall Study||0||
48143610|NCT01880723|100676559|FG001|NOT COMPLETED|Overall Study||0||
48143611|NCT04341116|100676560|FG000|STARTED|Overall Study||8||
48143612|NCT04341116|100676561|FG001|STARTED|Overall Study||8||
48143613|NCT04341116|100676562|FG002|STARTED|Overall Study||8||
48143614|NCT04341116|100676563|FG003|STARTED|Overall Study||77||
48143615|NCT04341116|100676564|FG004|STARTED|Overall Study||6||
48143616|NCT04341116|100676565|FG005|STARTED|Overall Study||42||
48143617|NCT04341116|100676560|FG000|COMPLETED|Overall Study||7||
48143618|NCT04341116|100676561|FG001|COMPLETED|Overall Study||6||
48143619|NCT04341116|100676562|FG002|COMPLETED|Overall Study||6||
48143620|NCT04341116|100676563|FG003|COMPLETED|Overall Study||66||
48143621|NCT04341116|100676564|FG004|COMPLETED|Overall Study||5||
48143622|NCT04341116|100676565|FG005|COMPLETED|Overall Study||34||
48143623|NCT04341116|100676560|FG000|NOT COMPLETED|Overall Study||1||
48143624|NCT04341116|100676561|FG001|NOT COMPLETED|Overall Study||2||
48143625|NCT04341116|100676562|FG002|NOT COMPLETED|Overall Study||2||
48143626|NCT04341116|100676563|FG003|NOT COMPLETED|Overall Study||11||
48143627|NCT04341116|100676564|FG004|NOT COMPLETED|Overall Study||1||
48143628|NCT04341116|100676565|FG005|NOT COMPLETED|Overall Study||8||
48143629|NCT01491854|100676566|FG000|STARTED|Overall Study||130||
48143630|NCT01491854|100676566|FG000|COMPLETED|Overall Study||0||
48143631|NCT01491854|100676566|FG000|NOT COMPLETED|Overall Study||130||
48598107|NCT02612610|101796783|FG002|COMPLETED|Overall Study||58||
48598108|NCT02612610|101796784|FG003|COMPLETED|Overall Study||50||
48598109|NCT02612610|101796781|FG000|NOT COMPLETED|Overall Study||5||
48598110|NCT02612610|101796782|FG001|NOT COMPLETED|Overall Study||8||
48598111|NCT02612610|101796783|FG002|NOT COMPLETED|Overall Study||5||
48598112|NCT02612610|101796784|FG003|NOT COMPLETED|Overall Study||13||
48712871|NCT01442064|102084828|FG002|COMPLETED|Overall Study||0||
48712872|NCT01442064|102084829|FG003|COMPLETED|Overall Study||0||
48712873|NCT01442064|102084830|FG004|COMPLETED|Overall Study||1||
48712874|NCT01442064|102084831|FG005|COMPLETED|Overall Study||0||
48712875|NCT01442064|102084826|FG000|NOT COMPLETED|Overall Study||97||
48712876|NCT01442064|102084827|FG001|NOT COMPLETED|Overall Study||101||
48712877|NCT01442064|102084828|FG002|NOT COMPLETED|Overall Study||104||
48143632|NCT05054374|100676567|FG000|STARTED|Overall Study||6||
48143633|NCT05054374|100676568|FG001|STARTED|Overall Study||0||
48143634|NCT05054374|100676569|FG002|STARTED|Overall Study||0||
48143635|NCT05054374|100676570|FG003|STARTED|Overall Study||0||
48143636|NCT05054374|100676567|FG000|COMPLETED|Overall Study||0||
48143637|NCT05054374|100676568|FG001|COMPLETED|Overall Study||0||
48143638|NCT05054374|100676569|FG002|COMPLETED|Overall Study||0||
48712878|NCT01442064|102084829|FG003|NOT COMPLETED|Overall Study||98||
48712879|NCT01442064|102084830|FG004|NOT COMPLETED|Overall Study||106||
48143639|NCT05054374|100676570|FG003|COMPLETED|Overall Study||0||
48143640|NCT05054374|100676567|FG000|NOT COMPLETED|Overall Study||6||
48143641|NCT05054374|100676568|FG001|NOT COMPLETED|Overall Study||0||
48143642|NCT05054374|100676569|FG002|NOT COMPLETED|Overall Study||0||
48143643|NCT05054374|100676570|FG003|NOT COMPLETED|Overall Study||0||
48143644|NCT02492100|100676571|FG000|STARTED|Overall Study||47||
48712880|NCT01442064|102084831|FG005|NOT COMPLETED|Overall Study||99||
48712881|NCT02075632|102084832|FG000|STARTED|Overall Study||162||
48712882|NCT02075632|102084833|FG001|STARTED|Overall Study||148||
48712883|NCT02075632|102084832|FG000|COMPLETED|Overall Study||161||
48712884|NCT02075632|102084833|FG001|COMPLETED|Overall Study||143||
48712885|NCT02075632|102084832|FG000|NOT COMPLETED|Overall Study||1||
48143645|NCT02492100|100676571|FG000|COMPLETED|Overall Study||46||
48143646|NCT02492100|100676571|FG000|NOT COMPLETED|Overall Study||1||
48143647|NCT00902304|100676572|FG000|STARTED|Overall Study||524||
48143648|NCT00902304|100676573|FG001|STARTED|Overall Study||360||
48143649|NCT00902304|100676574|FG002|STARTED|Overall Study||678||
48598113|NCT01075399|101796785|FG000|STARTED|Overall Study||50||
48598114|NCT01075399|101796785|FG000|COMPLETED|Overall Study||42||
48598115|NCT01075399|101796785|FG000|NOT COMPLETED|Overall Study||8||
48598116|NCT01702532|101796786|FG000|STARTED|Overall Study||161||
48712886|NCT02075632|102084833|FG001|NOT COMPLETED|Overall Study||5||
48712887|NCT02170363|102084834|FG000|STARTED|Overall Study||50||
48712888|NCT02170363|102084834|FG000|COMPLETED|Overall Study||50||
48712889|NCT02170363|102084834|FG000|NOT COMPLETED|Overall Study||0||
48712890|NCT03554772|102084835|FG000|STARTED|Overall Study||30||
48712891|NCT03554772|102084836|FG001|STARTED|Overall Study||30||
48712892|NCT03554772|102084837|FG002|STARTED|Overall Study||29||
48712893|NCT03554772|102084838|FG003|STARTED|Overall Study||31||
48143650|NCT00902304|100676572|FG000|COMPLETED|Overall Study||466||
48143651|NCT00902304|100676573|FG001|COMPLETED|Overall Study||289||
48143652|NCT00902304|100676574|FG002|COMPLETED|Overall Study||568||
48143653|NCT00902304|100676572|FG000|NOT COMPLETED|Overall Study||58||
48143654|NCT00902304|100676573|FG001|NOT COMPLETED|Overall Study||71||
48143655|NCT00902304|100676574|FG002|NOT COMPLETED|Overall Study||110||
48143656|NCT00529399|100676575|FG000|STARTED|Overall Study||48||
48143657|NCT00529399|100676576|FG001|STARTED|Overall Study||49||
48143658|NCT00529399|100676577|FG002|STARTED|Overall Study||48||
48143659|NCT00529399|100676575|FG000|COMPLETED|Overall Study||46||
48143660|NCT00529399|100676576|FG001|COMPLETED|Overall Study||48||
48143661|NCT00529399|100676577|FG002|COMPLETED|Overall Study||46||
48143662|NCT00529399|100676575|FG000|NOT COMPLETED|Overall Study||2||
48143663|NCT00529399|100676576|FG001|NOT COMPLETED|Overall Study||1||
48143664|NCT00529399|100676577|FG002|NOT COMPLETED|Overall Study||2||
48712894|NCT03554772|102084835|FG000|Completed Treatment Period (8 Hours Post Dose)|Overall Study||30||
48143665|NCT00951483|100676578|FG000|STARTED|Overall Study||47||
48143666|NCT00951483|100676579|FG001|STARTED|Overall Study||44||
48143667|NCT00951483|100676578|FG000|COMPLETED|Overall Study||28||
48143668|NCT00951483|100676579|FG001|COMPLETED|Overall Study||44||
48143669|NCT00951483|100676578|FG000|NOT COMPLETED|Overall Study||19||
48712895|NCT03554772|102084836|FG001|Completed Treatment Period (8 Hours Post Dose)|Overall Study||30||
48712896|NCT03554772|102084837|FG002|Completed Treatment Period (8 Hours Post Dose)|Overall Study||29||
48712897|NCT03554772|102084838|FG003|Completed Treatment Period (8 Hours Post Dose)|Overall Study||31||
48712898|NCT03554772|102084835|FG000|COMPLETED|Overall Study||30||
48712899|NCT03554772|102084836|FG001|COMPLETED|Overall Study||30||
48712900|NCT03554772|102084837|FG002|COMPLETED|Overall Study||29||
48712901|NCT03554772|102084838|FG003|COMPLETED|Overall Study||29||
48712902|NCT03554772|102084835|FG000|NOT COMPLETED|Overall Study||0||
48712903|NCT03554772|102084836|FG001|NOT COMPLETED|Overall Study||0||
48712904|NCT03554772|102084837|FG002|NOT COMPLETED|Overall Study||0||
48712905|NCT03554772|102084838|FG003|NOT COMPLETED|Overall Study||2||
48712906|NCT03236168|102084839|FG000|STARTED|Overall Study||118||
48712907|NCT03236168|102084839|FG000|COMPLETED|Overall Study||107||
48712908|NCT03236168|102084839|FG000|NOT COMPLETED|Overall Study||11||
48712909|NCT02075047|102084840|FG000|STARTED|Treatment Phase (4 Weeks)||86||
48712910|NCT02075047|102084841|FG001|STARTED|Treatment Phase (4 Weeks)||85||
48712911|NCT02075047|102084840|FG000|COMPLETED|Treatment Phase (4 Weeks)||63||
48712912|NCT02075047|102084841|FG001|COMPLETED|Treatment Phase (4 Weeks)||75||
48712913|NCT02075047|102084840|FG000|NOT COMPLETED|Treatment Phase (4 Weeks)||23||
48712914|NCT02075047|102084841|FG001|NOT COMPLETED|Treatment Phase (4 Weeks)||10||
48712915|NCT02075047|102084840|FG000|STARTED|Follow up Phase (5 Weeks)||86||
48712916|NCT02075047|102084841|FG001|STARTED|Follow up Phase (5 Weeks)||85||
48712917|NCT02075047|102084840|FG000|COMPLETED|Follow up Phase (5 Weeks)||60||
48143670|NCT00951483|100676579|FG001|NOT COMPLETED|Overall Study||0||
48143671|NCT03950739|100676580|FG000|STARTED|Treatment Phase||51||
48143672|NCT03950739|100676580|FG000|COMPLETED|Treatment Phase||49||
48143673|NCT03950739|100676580|FG000|NOT COMPLETED|Treatment Phase||2||
48712918|NCT02075047|102084841|FG001|COMPLETED|Follow up Phase (5 Weeks)||72||
48712919|NCT02075047|102084840|FG000|NOT COMPLETED|Follow up Phase (5 Weeks)||26||
48712920|NCT02075047|102084841|FG001|NOT COMPLETED|Follow up Phase (5 Weeks)||13||
48712921|NCT04612842|102084842|FG000|STARTED|Overall Study||101||
48712922|NCT04612842|102084843|FG001|STARTED|Overall Study||99||
48712923|NCT04612842|102084842|FG000|Baseline Assessment|Overall Study||90||
48712924|NCT04612842|102084843|FG001|Baseline Assessment|Overall Study||95||
48712925|NCT04612842|102084842|FG000|6-month Assessment|Overall Study||69||
48712926|NCT04612842|102084843|FG001|6-month Assessment|Overall Study||81||
48712927|NCT04612842|102084842|FG000|12-month Assessment|Overall Study||53||
48712928|NCT04612842|102084843|FG001|12-month Assessment|Overall Study||71||
48712929|NCT04612842|102084842|FG000|COMPLETED|Overall Study||53||
48712930|NCT04612842|102084843|FG001|COMPLETED|Overall Study||71||
48712931|NCT04612842|102084842|FG000|NOT COMPLETED|Overall Study||48||
48712932|NCT04612842|102084843|FG001|NOT COMPLETED|Overall Study||28||
48712933|NCT00089986|102084844|FG000|STARTED|Overall Study||599||
48712934|NCT00089986|102084845|FG001|STARTED|Overall Study||598||
48712935|NCT00089986|102084846|FG002|STARTED|Overall Study||182||
48143674|NCT03950739|100676580|FG000|STARTED|Optional Extension Phase||49||
48712936|NCT00089986|102084844|FG000|COMPLETED|Overall Study||584||
48712937|NCT00089986|102084845|FG001|COMPLETED|Overall Study||574||
48712938|NCT00089986|102084846|FG002|COMPLETED|Overall Study||172||
48712939|NCT00089986|102084844|FG000|NOT COMPLETED|Overall Study||15||
48712940|NCT00089986|102084845|FG001|NOT COMPLETED|Overall Study||24||
48143675|NCT03950739|100676580|FG000|COMPLETED|Optional Extension Phase||31||
48143676|NCT03950739|100676580|FG000|NOT COMPLETED|Optional Extension Phase||18||
48143677|NCT01163097|100676581|FG000|STARTED|Overall Study||20||
48143678|NCT01163097|100676582|FG001|STARTED|Overall Study||16||
48143679|NCT01163097|100676583|FG002|STARTED|Overall Study||8||
48143680|NCT01163097|100676581|FG000|COMPLETED|Overall Study||14||
48143681|NCT01163097|100676582|FG001|COMPLETED|Overall Study||16||
48296592|NCT04615247|101054297|FG000|COMPLETED|Overall Study||16||
48712941|NCT00089986|102084846|FG002|NOT COMPLETED|Overall Study||10||
48712942|NCT05242354|102084847|FG000|STARTED|Overall Study||10||
48712943|NCT05242354|102084848|FG001|STARTED|Overall Study||8||
48143682|NCT01163097|100676583|FG002|COMPLETED|Overall Study||8||
48143683|NCT01163097|100676581|FG000|NOT COMPLETED|Overall Study||6||
48143684|NCT01163097|100676582|FG001|NOT COMPLETED|Overall Study||0||
48296593|NCT04615247|101054298|FG001|COMPLETED|Overall Study||16||
48296594|NCT04615247|101054297|FG000|NOT COMPLETED|Overall Study||1||
48296595|NCT04615247|101054298|FG001|NOT COMPLETED|Overall Study||3||
48296596|NCT00822588|101054299|FG000|STARTED|Overall Study||113||
48296597|NCT00822588|101054300|FG001|STARTED|Overall Study||114||
48296598|NCT00822588|101054299|FG000|COMPLETED|Overall Study||106||
48405071|NCT01041404|101325179|FG000|COMPLETED|Overall Study||0||
48712944|NCT05242354|102084849|FG002|STARTED|Overall Study||9||
48712945|NCT05242354|102084850|FG003|STARTED|Overall Study||9||
48712946|NCT05242354|102084847|FG000|COMPLETED|Overall Study||10||
48712947|NCT05242354|102084848|FG001|COMPLETED|Overall Study||8||
48712948|NCT05242354|102084849|FG002|COMPLETED|Overall Study||9||
48712949|NCT05242354|102084850|FG003|COMPLETED|Overall Study||9||
48712950|NCT05242354|102084847|FG000|NOT COMPLETED|Overall Study||0||
48143685|NCT01163097|100676583|FG002|NOT COMPLETED|Overall Study||0||
48143686|NCT01417026|100676584|FG000|STARTED|Overall Study||16||
48143687|NCT01417026|100676585|FG001|STARTED|Overall Study||13||
48143688|NCT01417026|100676584|FG000|COMPLETED|Overall Study||14||
48143689|NCT01417026|100676585|FG001|COMPLETED|Overall Study||13||
48143690|NCT01417026|100676584|FG000|NOT COMPLETED|Overall Study||2||
48143691|NCT01417026|100676585|FG001|NOT COMPLETED|Overall Study||0||
48143692|NCT00686166|100676586|FG000|STARTED|Overall Study||83||
48143693|NCT00686166|100676586|FG000|Eligible|Overall Study||78||
48143694|NCT00686166|100676586|FG000|Eligible and Began Protocol Therapy|Overall Study||74||
48143695|NCT00686166|100676586|FG000|COMPLETED|Overall Study||63||
48143696|NCT00686166|100676586|FG000|NOT COMPLETED|Overall Study||20||
48143697|NCT02925455|100676587|FG000|STARTED|Overall Study||9||
48143698|NCT02925455|100676588|FG001|STARTED|Overall Study||6||
48143699|NCT02925455|100676587|FG000|COMPLETED|Overall Study||7||
48143700|NCT02925455|100676588|FG001|COMPLETED|Overall Study||6||
48143701|NCT02925455|100676587|FG000|NOT COMPLETED|Overall Study||2||
48143702|NCT02925455|100676588|FG001|NOT COMPLETED|Overall Study||0||
48143703|NCT05338333|100676589|FG000|STARTED|Period 1, Approximately 30 Days||51||102
48143704|NCT05338333|100676590|FG001|STARTED|Period 1, Approximately 30 Days||50||100
48143705|NCT05338333|100676589|FG000|COMPLETED|Period 1, Approximately 30 Days||50||100
48143706|NCT05338333|100676590|FG001|COMPLETED|Period 1, Approximately 30 Days||50||100
48143707|NCT05338333|100676589|FG000|NOT COMPLETED|Period 1, Approximately 30 Days||1||2
48143708|NCT05338333|100676590|FG001|NOT COMPLETED|Period 1, Approximately 30 Days||0||0
48143709|NCT05338333|100676589|FG000|STARTED|Period 2, Approximately 30 Days||50||100
48296599|NCT00822588|101054300|FG001|COMPLETED|Overall Study||110||
48296600|NCT00822588|101054299|FG000|NOT COMPLETED|Overall Study||7||
48296601|NCT00822588|101054300|FG001|NOT COMPLETED|Overall Study||4||
48296602|NCT01177787|101054301|FG000|STARTED|Clinical Efficacy of Cryolipolysis||28||
48296603|NCT01177787|101054301|FG000|COMPLETED|Clinical Efficacy of Cryolipolysis||28||
48712951|NCT05242354|102084848|FG001|NOT COMPLETED|Overall Study||0||
48143710|NCT05338333|100676590|FG001|STARTED|Period 2, Approximately 30 Days||50||100
48296604|NCT01177787|101054301|FG000|NOT COMPLETED|Clinical Efficacy of Cryolipolysis||0||
48296605|NCT01177787|101054301|FG000|STARTED|Cryolipolysis on Thigh||28||
48296606|NCT01177787|101054301|FG000|COMPLETED|Cryolipolysis on Thigh||14||
48405072|NCT01041404|101325180|FG001|COMPLETED|Overall Study||0||
48712952|NCT05242354|102084849|FG002|NOT COMPLETED|Overall Study||0||
48143711|NCT05338333|100676589|FG000|COMPLETED|Period 2, Approximately 30 Days||50||100
48143712|NCT05338333|100676590|FG001|COMPLETED|Period 2, Approximately 30 Days||50||100
48143713|NCT05338333|100676589|FG000|NOT COMPLETED|Period 2, Approximately 30 Days||0||0
48143714|NCT05338333|100676590|FG001|NOT COMPLETED|Period 2, Approximately 30 Days||0||0
48143715|NCT01270126|100676591|FG000|STARTED|Overall Study||12||
48143716|NCT01270126|100676592|FG001|STARTED|Overall Study||10||
48143717|NCT01270126|100676591|FG000|COMPLETED|Overall Study||12||
48143718|NCT01270126|100676592|FG001|COMPLETED|Overall Study||10||
48712953|NCT05242354|102084850|FG003|NOT COMPLETED|Overall Study||0||
48143719|NCT01270126|100676591|FG000|NOT COMPLETED|Overall Study||0||
48296607|NCT01177787|101054301|FG000|NOT COMPLETED|Cryolipolysis on Thigh||14||
48296608|NCT00807235|101054302|FG000|STARTED|Overall Study||11||
48296609|NCT00807235|101054303|FG001|STARTED|Overall Study||6||
48712954|NCT01811303|102084851|FG000|STARTED|First Intervention (1 Day)||4||
48712955|NCT01811303|102084852|FG001|STARTED|First Intervention (1 Day)||4||
48143720|NCT01270126|100676592|FG001|NOT COMPLETED|Overall Study||0||
48143721|NCT03896035|100676593|FG000|STARTED|Overall Study||24||
48143722|NCT03896035|100676594|FG001|STARTED|Overall Study||26||
48143723|NCT03896035|100676593|FG000|COMPLETED|Overall Study||22||
48143724|NCT03896035|100676594|FG001|COMPLETED|Overall Study||15||
48143725|NCT03896035|100676593|FG000|NOT COMPLETED|Overall Study||2||
48143726|NCT03896035|100676594|FG001|NOT COMPLETED|Overall Study||11||
48143727|NCT00045110|100676595|FG000|STARTED|100mg Phase 1 Dose Escalalation||6||
48143728|NCT00045110|100676596|FG001|STARTED|100mg Phase 1 Dose Escalalation||59||
48296610|NCT00807235|101054302|FG000|COMPLETED|Overall Study||10||
48296611|NCT00807235|101054303|FG001|COMPLETED|Overall Study||6||
48296612|NCT00807235|101054302|FG000|NOT COMPLETED|Overall Study||1||
48296613|NCT00807235|101054303|FG001|NOT COMPLETED|Overall Study||0||
48296614|NCT01762722|101054304|FG000|STARTED|Overall Study||12||
48296615|NCT01762722|101054305|FG001|STARTED|Overall Study||11||
48296616|NCT01762722|101054304|FG000|COMPLETED|Overall Study||12||
48296617|NCT01762722|101054305|FG001|COMPLETED|Overall Study||11||
48296618|NCT01762722|101054304|FG000|NOT COMPLETED|Overall Study||0||
48296619|NCT01762722|101054305|FG001|NOT COMPLETED|Overall Study||0||
48296620|NCT02917278|101054306|FG000|STARTED|Overall Study||10||
48296621|NCT02917278|101054307|FG001|STARTED|Overall Study||9||
48296622|NCT02917278|101054306|FG000|COMPLETED|Overall Study||9||
48296623|NCT02917278|101054307|FG001|COMPLETED|Overall Study||9||
48296624|NCT02917278|101054306|FG000|NOT COMPLETED|Overall Study||1||
48296625|NCT02917278|101054307|FG001|NOT COMPLETED|Overall Study||0||
48296626|NCT02225353|101054308|FG000|STARTED|Overall Study||91||
48296627|NCT02225353|101054309|FG001|STARTED|Overall Study||90||
48296628|NCT02225353|101054310|FG002|STARTED|Overall Study||90||
48712956|NCT01811303|102084853|FG002|STARTED|First Intervention (1 Day)||4||
48712957|NCT01811303|102084854|FG003|STARTED|First Intervention (1 Day)||2||
48712958|NCT01811303|102084851|FG000|COMPLETED|First Intervention (1 Day)||4||
48296629|NCT02225353|101054308|FG000|COMPLETED|Overall Study||87||
48296630|NCT02225353|101054309|FG001|COMPLETED|Overall Study||84||
48296631|NCT02225353|101054310|FG002|COMPLETED|Overall Study||75||
48296632|NCT02225353|101054308|FG000|NOT COMPLETED|Overall Study||4||
48296633|NCT02225353|101054309|FG001|NOT COMPLETED|Overall Study||6||
48296634|NCT02225353|101054310|FG002|NOT COMPLETED|Overall Study||15||
48296635|NCT03607539|101054311|FG000|STARTED|Overall Study||266||
48296636|NCT03607539|101054312|FG001|STARTED|Overall Study||131||
48296637|NCT03607539|101054311|FG000|COMPLETED|Overall Study||0||
48296638|NCT03607539|101054312|FG001|COMPLETED|Overall Study||0||
48296639|NCT03607539|101054311|FG000|NOT COMPLETED|Overall Study||266||
48296640|NCT03607539|101054312|FG001|NOT COMPLETED|Overall Study||131||
48296641|NCT01541553|101054313|FG000|STARTED|Overall Study||167||
48296642|NCT01541553|101054314|FG001|STARTED|Overall Study||162||
48296643|NCT01541553|101054313|FG000|COMPLETED|Overall Study||155||
48296644|NCT01541553|101054314|FG001|COMPLETED|Overall Study||148||
48712959|NCT01811303|102084852|FG001|COMPLETED|First Intervention (1 Day)||4||
48712960|NCT01811303|102084853|FG002|COMPLETED|First Intervention (1 Day)||4||
48712961|NCT01811303|102084854|FG003|COMPLETED|First Intervention (1 Day)||2||
48712962|NCT01811303|102084851|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48712963|NCT01811303|102084852|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48143729|NCT00045110|100676597|FG002|STARTED|100mg Phase 1 Dose Escalalation||45||
48143730|NCT00045110|100676595|FG000|COMPLETED|100mg Phase 1 Dose Escalalation||6||
48143731|NCT00045110|100676596|FG001|COMPLETED|100mg Phase 1 Dose Escalalation||53||
48143732|NCT00045110|100676597|FG002|COMPLETED|100mg Phase 1 Dose Escalalation||43||
48143733|NCT00045110|100676595|FG000|NOT COMPLETED|100mg Phase 1 Dose Escalalation||0||
48143734|NCT00045110|100676596|FG001|NOT COMPLETED|100mg Phase 1 Dose Escalalation||6||
48143735|NCT00045110|100676597|FG002|NOT COMPLETED|100mg Phase 1 Dose Escalalation||2||
48143736|NCT00045110|100676595|FG000|STARTED|200mg Phase 1 Dose Escalation||4||
48143737|NCT00045110|100676596|FG001|STARTED|200mg Phase 1 Dose Escalation||0||
48188517|NCT01686932|100783263|FG001|COMPLETED|Period 2||25||
48296645|NCT01541553|101054313|FG000|NOT COMPLETED|Overall Study||12||
48296646|NCT01541553|101054314|FG001|NOT COMPLETED|Overall Study||14||
48296647|NCT01829399|101054315|FG000|STARTED|Visit 1||12||
48296648|NCT01829399|101054316|FG001|STARTED|Visit 1||12||
48712964|NCT01811303|102084853|FG002|NOT COMPLETED|First Intervention (1 Day)||0||
48712965|NCT01811303|102084854|FG003|NOT COMPLETED|First Intervention (1 Day)||0||
48712966|NCT01811303|102084851|FG000|STARTED|Washout (2 Days or More)||4||
48712967|NCT01811303|102084852|FG001|STARTED|Washout (2 Days or More)||4||
48712968|NCT01811303|102084853|FG002|STARTED|Washout (2 Days or More)||4||
48712969|NCT01811303|102084854|FG003|STARTED|Washout (2 Days or More)||2||
48712970|NCT01811303|102084851|FG000|COMPLETED|Washout (2 Days or More)||4||
48712971|NCT01811303|102084852|FG001|COMPLETED|Washout (2 Days or More)||4||
48712972|NCT01811303|102084853|FG002|COMPLETED|Washout (2 Days or More)||4||
48712973|NCT01811303|102084854|FG003|COMPLETED|Washout (2 Days or More)||2||
48712974|NCT01811303|102084851|FG000|NOT COMPLETED|Washout (2 Days or More)||0||
48712975|NCT01811303|102084852|FG001|NOT COMPLETED|Washout (2 Days or More)||0||
48712976|NCT01811303|102084853|FG002|NOT COMPLETED|Washout (2 Days or More)||0||
48712977|NCT01811303|102084854|FG003|NOT COMPLETED|Washout (2 Days or More)||0||
48296649|NCT01829399|101054315|FG000|COMPLETED|Visit 1||12||
48296650|NCT01829399|101054316|FG001|COMPLETED|Visit 1||12||
48296651|NCT01829399|101054315|FG000|NOT COMPLETED|Visit 1||0||
48143738|NCT00045110|100676597|FG002|STARTED|200mg Phase 1 Dose Escalation||0||
48143739|NCT00045110|100676595|FG000|COMPLETED|200mg Phase 1 Dose Escalation||4||
48712978|NCT01811303|102084851|FG000|STARTED|Second Intervention (1 Day)||4||
48712979|NCT01811303|102084852|FG001|STARTED|Second Intervention (1 Day)||4||
48712980|NCT01811303|102084853|FG002|STARTED|Second Intervention (1 Day)||4||
48712981|NCT01811303|102084854|FG003|STARTED|Second Intervention (1 Day)||2||
48712982|NCT01811303|102084851|FG000|COMPLETED|Second Intervention (1 Day)||4||
48712983|NCT01811303|102084852|FG001|COMPLETED|Second Intervention (1 Day)||4||
48712984|NCT01811303|102084853|FG002|COMPLETED|Second Intervention (1 Day)||4||
48712985|NCT01811303|102084854|FG003|COMPLETED|Second Intervention (1 Day)||2||
48712986|NCT01811303|102084851|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48143740|NCT00045110|100676596|FG001|COMPLETED|200mg Phase 1 Dose Escalation||0||
48143741|NCT00045110|100676597|FG002|COMPLETED|200mg Phase 1 Dose Escalation||0||
48143742|NCT00045110|100676595|FG000|NOT COMPLETED|200mg Phase 1 Dose Escalation||0||
48143743|NCT00045110|100676596|FG001|NOT COMPLETED|200mg Phase 1 Dose Escalation||0||
48143744|NCT00045110|100676597|FG002|NOT COMPLETED|200mg Phase 1 Dose Escalation||0||
48143745|NCT00045110|100676595|FG000|STARTED|275mg Phase 1 Dose Escalation||3||
48143746|NCT00045110|100676596|FG001|STARTED|275mg Phase 1 Dose Escalation||0||
48712987|NCT01811303|102084852|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48712988|NCT01811303|102084853|FG002|NOT COMPLETED|Second Intervention (1 Day)||0||
48712989|NCT01811303|102084854|FG003|NOT COMPLETED|Second Intervention (1 Day)||0||
48712990|NCT01811303|102084851|FG000|STARTED|Washout (2 Days or More)||4||
48712991|NCT01811303|102084852|FG001|STARTED|Washout (2 Days or More)||4||
48712992|NCT01811303|102084853|FG002|STARTED|Washout (2 Days or More)||4||
48712993|NCT01811303|102084854|FG003|STARTED|Washout (2 Days or More)||2||
48143747|NCT00045110|100676597|FG002|STARTED|275mg Phase 1 Dose Escalation||0||
48143748|NCT00045110|100676595|FG000|COMPLETED|275mg Phase 1 Dose Escalation||3||
48143749|NCT00045110|100676596|FG001|COMPLETED|275mg Phase 1 Dose Escalation||0||
48143750|NCT00045110|100676597|FG002|COMPLETED|275mg Phase 1 Dose Escalation||0||
48143751|NCT00045110|100676595|FG000|NOT COMPLETED|275mg Phase 1 Dose Escalation||0||
48143752|NCT00045110|100676596|FG001|NOT COMPLETED|275mg Phase 1 Dose Escalation||0||
48143753|NCT00045110|100676597|FG002|NOT COMPLETED|275mg Phase 1 Dose Escalation||0||
48143754|NCT00045110|100676595|FG000|STARTED|400mg Phase 1 Dose Escalation||3||
48143755|NCT00045110|100676596|FG001|STARTED|400mg Phase 1 Dose Escalation||0||
48143756|NCT00045110|100676597|FG002|STARTED|400mg Phase 1 Dose Escalation||0||
48143757|NCT00045110|100676595|FG000|COMPLETED|400mg Phase 1 Dose Escalation||3||
48143758|NCT00045110|100676596|FG001|COMPLETED|400mg Phase 1 Dose Escalation||0||
48143759|NCT00045110|100676597|FG002|COMPLETED|400mg Phase 1 Dose Escalation||0||
48143760|NCT00045110|100676595|FG000|NOT COMPLETED|400mg Phase 1 Dose Escalation||0||
48143761|NCT00045110|100676596|FG001|NOT COMPLETED|400mg Phase 1 Dose Escalation||0||
48143762|NCT00045110|100676597|FG002|NOT COMPLETED|400mg Phase 1 Dose Escalation||0||
48143763|NCT00045110|100676595|FG000|STARTED|525mg Phase 1 Dose Escalation||3||
48143764|NCT00045110|100676596|FG001|STARTED|525mg Phase 1 Dose Escalation||0||
48143765|NCT00045110|100676597|FG002|STARTED|525mg Phase 1 Dose Escalation||0||
48143766|NCT00045110|100676595|FG000|COMPLETED|525mg Phase 1 Dose Escalation||3||
48143767|NCT00045110|100676596|FG001|COMPLETED|525mg Phase 1 Dose Escalation||0||
48143768|NCT00045110|100676597|FG002|COMPLETED|525mg Phase 1 Dose Escalation||0||
48143769|NCT00045110|100676595|FG000|NOT COMPLETED|525mg Phase 1 Dose Escalation||0||
48143770|NCT00045110|100676596|FG001|NOT COMPLETED|525mg Phase 1 Dose Escalation||0||
48143771|NCT00045110|100676597|FG002|NOT COMPLETED|525mg Phase 1 Dose Escalation||0||
48143772|NCT00045110|100676595|FG000|STARTED|650mg Phase 1 Dose Escalation||6||
48143773|NCT00045110|100676596|FG001|STARTED|650mg Phase 1 Dose Escalation||0||
48143774|NCT00045110|100676597|FG002|STARTED|650mg Phase 1 Dose Escalation||0||
48143775|NCT00045110|100676595|FG000|COMPLETED|650mg Phase 1 Dose Escalation||6||
48143776|NCT00045110|100676596|FG001|COMPLETED|650mg Phase 1 Dose Escalation||0||
48143777|NCT00045110|100676597|FG002|COMPLETED|650mg Phase 1 Dose Escalation||0||
48143778|NCT00045110|100676595|FG000|NOT COMPLETED|650mg Phase 1 Dose Escalation||0||
48143779|NCT00045110|100676596|FG001|NOT COMPLETED|650mg Phase 1 Dose Escalation||0||
48143780|NCT00045110|100676597|FG002|NOT COMPLETED|650mg Phase 1 Dose Escalation||0||
48143781|NCT00045110|100676595|FG000|STARTED|775mg Dose Escalation||7||
48143782|NCT00045110|100676596|FG001|STARTED|775mg Dose Escalation||0||
48143783|NCT00045110|100676597|FG002|STARTED|775mg Dose Escalation||0||
48143784|NCT00045110|100676595|FG000|COMPLETED|775mg Dose Escalation||7||
48712994|NCT01811303|102084851|FG000|COMPLETED|Washout (2 Days or More)||4||
48712995|NCT01811303|102084852|FG001|COMPLETED|Washout (2 Days or More)||4||
48712996|NCT01811303|102084853|FG002|COMPLETED|Washout (2 Days or More)||4||
48712997|NCT01811303|102084854|FG003|COMPLETED|Washout (2 Days or More)||2||
48712998|NCT01811303|102084851|FG000|NOT COMPLETED|Washout (2 Days or More)||0||
48712999|NCT01811303|102084852|FG001|NOT COMPLETED|Washout (2 Days or More)||0||
48713000|NCT01811303|102084853|FG002|NOT COMPLETED|Washout (2 Days or More)||0||
48713001|NCT01811303|102084854|FG003|NOT COMPLETED|Washout (2 Days or More)||0||
48296652|NCT01829399|101054316|FG001|NOT COMPLETED|Visit 1||0||
48296653|NCT01829399|101054315|FG000|STARTED|Visit 2 (One Month Later)||12||
48296654|NCT01829399|101054316|FG001|STARTED|Visit 2 (One Month Later)||12||
48296655|NCT01829399|101054315|FG000|COMPLETED|Visit 2 (One Month Later)||12||
48296656|NCT01829399|101054316|FG001|COMPLETED|Visit 2 (One Month Later)||12||
48296657|NCT01829399|101054315|FG000|NOT COMPLETED|Visit 2 (One Month Later)||0||
48296658|NCT01829399|101054316|FG001|NOT COMPLETED|Visit 2 (One Month Later)||0||
48296659|NCT00001984|101054317|FG000|STARTED|Overall Study||5||
48296660|NCT00001984|101054317|FG000|COMPLETED|Overall Study||5||
48296661|NCT00001984|101054317|FG000|NOT COMPLETED|Overall Study||0||
48296662|NCT02453360|101054318|FG000|STARTED|Overall Study||20||
48296663|NCT02453360|101054319|FG001|STARTED|Overall Study||20||
48296664|NCT02453360|101054320|FG002|STARTED|Overall Study||20||
48296665|NCT02453360|101054318|FG000|COMPLETED|Overall Study||20||
48296666|NCT02453360|101054319|FG001|COMPLETED|Overall Study||20||
48296667|NCT02453360|101054320|FG002|COMPLETED|Overall Study||20||
48296668|NCT02453360|101054318|FG000|NOT COMPLETED|Overall Study||0||
48296669|NCT02453360|101054319|FG001|NOT COMPLETED|Overall Study||0||
48296670|NCT02453360|101054320|FG002|NOT COMPLETED|Overall Study||0||
48296671|NCT01326533|101054321|FG000|STARTED|Overall Study||17||
48296672|NCT01326533|101054322|FG001|STARTED|Overall Study||15||
48296673|NCT01326533|101054321|FG000|COMPLETED|Overall Study||13||
48296674|NCT01326533|101054322|FG001|COMPLETED|Overall Study||15||
48296675|NCT01326533|101054321|FG000|NOT COMPLETED|Overall Study||4||
48296676|NCT01326533|101054322|FG001|NOT COMPLETED|Overall Study||0||
48296677|NCT03294109|101054323|FG000|STARTED|Overall Study||46||
48296678|NCT03294109|101054324|FG001|STARTED|Overall Study||57||
48296679|NCT03294109|101054323|FG000|Underwent Surgery|Overall Study||40||
48296680|NCT03294109|101054324|FG001|Underwent Surgery|Overall Study||52||
48296681|NCT03294109|101054323|FG000|COMPLETED|Overall Study||40||
48296682|NCT03294109|101054324|FG001|COMPLETED|Overall Study||52||
48296683|NCT03294109|101054323|FG000|NOT COMPLETED|Overall Study||6||
48296684|NCT03294109|101054324|FG001|NOT COMPLETED|Overall Study||5||
48296685|NCT01794923|101054325|FG000|STARTED|Overall Study||83||
48296686|NCT01794923|101054326|FG001|STARTED|Overall Study||60||
48296687|NCT01794923|101054327|FG002|STARTED|Overall Study||62||
48296688|NCT01794923|101054325|FG000|COMPLETED|Overall Study||83||
48296689|NCT01794923|101054326|FG001|COMPLETED|Overall Study||60||
48296690|NCT01794923|101054327|FG002|COMPLETED|Overall Study||61||
48296691|NCT01794923|101054325|FG000|NOT COMPLETED|Overall Study||0||
48296692|NCT01794923|101054326|FG001|NOT COMPLETED|Overall Study||0||
48296693|NCT01794923|101054327|FG002|NOT COMPLETED|Overall Study||1||
48296694|NCT02359877|101054328|FG000|STARTED|Overall Study||34||
48296695|NCT02359877|101054329|FG001|STARTED|Overall Study||6||
48296696|NCT02359877|101054330|FG002|STARTED|Overall Study||6||
48296697|NCT02359877|101054331|FG003|STARTED|Overall Study||14||
48296698|NCT02359877|101054328|FG000|COMPLETED|Overall Study||33||
48296699|NCT02359877|101054329|FG001|COMPLETED|Overall Study||6||
48296700|NCT02359877|101054330|FG002|COMPLETED|Overall Study||6||
48296701|NCT02359877|101054331|FG003|COMPLETED|Overall Study||11||
48296702|NCT02359877|101054328|FG000|NOT COMPLETED|Overall Study||1||
48296703|NCT02359877|101054329|FG001|NOT COMPLETED|Overall Study||0||
48296704|NCT02359877|101054330|FG002|NOT COMPLETED|Overall Study||0||
48713002|NCT01811303|102084851|FG000|STARTED|Third Intervention (1 Day)||4||
48713003|NCT01811303|102084852|FG001|STARTED|Third Intervention (1 Day)||4||
48296705|NCT02359877|101054331|FG003|NOT COMPLETED|Overall Study||3||
48296706|NCT00427336|101054332|FG000|STARTED|Overall Study||9||
48296707|NCT00427336|101054332|FG000|COMPLETED|Overall Study||9||
48296708|NCT00427336|101054332|FG000|NOT COMPLETED|Overall Study||0||
48296709|NCT00388453|101054333|FG000|STARTED|Overall Study||20||
48296710|NCT00388453|101054334|FG001|STARTED|Overall Study||17||
48296711|NCT00388453|101054335|FG002|STARTED|Overall Study||10||
48713004|NCT01811303|102084853|FG002|STARTED|Third Intervention (1 Day)||4||
48713005|NCT01811303|102084854|FG003|STARTED|Third Intervention (1 Day)||2||
48296712|NCT00388453|101054333|FG000|COMPLETED|Overall Study||20||
48296713|NCT00388453|101054334|FG001|COMPLETED|Overall Study||17||
48296714|NCT00388453|101054335|FG002|COMPLETED|Overall Study||10||
48296715|NCT00388453|101054333|FG000|NOT COMPLETED|Overall Study||0||
48296716|NCT00388453|101054334|FG001|NOT COMPLETED|Overall Study||0||
48296717|NCT00388453|101054335|FG002|NOT COMPLETED|Overall Study||0||
48296718|NCT00876928|101054336|FG000|STARTED|Overall Study||56||
48296719|NCT00876928|101054337|FG001|STARTED|Overall Study||61||
48296720|NCT00876928|101054336|FG000|COMPLETED|Overall Study||53||
48296721|NCT00876928|101054337|FG001|COMPLETED|Overall Study||56||
48296722|NCT00876928|101054336|FG000|NOT COMPLETED|Overall Study||3||
48296723|NCT00876928|101054337|FG001|NOT COMPLETED|Overall Study||5||
48296724|NCT01271803|101054338|FG000|STARTED|Overall Study||66||
48296725|NCT01271803|101054339|FG001|STARTED|Overall Study||63||
48296726|NCT01271803|101054340|FG002|STARTED|Overall Study||2||
48296727|NCT01271803|101054338|FG000|COMPLETED|Overall Study||11||
48296728|NCT01271803|101054339|FG001|COMPLETED|Overall Study||24||
48296729|NCT01271803|101054340|FG002|COMPLETED|Overall Study||0||
48296730|NCT01271803|101054338|FG000|NOT COMPLETED|Overall Study||55||
48296731|NCT01271803|101054339|FG001|NOT COMPLETED|Overall Study||39||
48296732|NCT01271803|101054340|FG002|NOT COMPLETED|Overall Study||2||
48296733|NCT03836989|101054341|FG000|STARTED|Overall Study||4||
48296734|NCT03836989|101054342|FG001|STARTED|Overall Study||0||
48296735|NCT03836989|101054341|FG000|Subjects > 60 Years Old With Complete Paralysis|Overall Study||1||
48296736|NCT03836989|101054342|FG001|Subjects > 60 Years Old With Complete Paralysis|Overall Study||0||
48296737|NCT03836989|101054341|FG000|Subjects > 60 Years Old With Incomplete Paralysis|Overall Study||1||
48296738|NCT03836989|101054342|FG001|Subjects > 60 Years Old With Incomplete Paralysis|Overall Study||0||
48296739|NCT03836989|101054341|FG000|Subject < 60 Years Old + Complete Paralysis < 15 Days Duration|Overall Study||1||
48296740|NCT03836989|101054342|FG001|Subject < 60 Years Old + Complete Paralysis < 15 Days Duration|Overall Study||0||
48296741|NCT03836989|101054341|FG000|Subjects < 60 Years Old + Complete Paralysis > 15 Days|Overall Study||1||
48296742|NCT03836989|101054342|FG001|Subjects < 60 Years Old + Complete Paralysis > 15 Days|Overall Study||0||
48296743|NCT03836989|101054341|FG000|COMPLETED|Overall Study||4||
48296744|NCT03836989|101054342|FG001|COMPLETED|Overall Study||0||
48296745|NCT03836989|101054341|FG000|NOT COMPLETED|Overall Study||0||
48296746|NCT03836989|101054342|FG001|NOT COMPLETED|Overall Study||0||
48296747|NCT02038920|101054343|FG000|STARTED|Induction Phase (Week 0 to 14)||79||
48296748|NCT02038920|101054344|FG001|STARTED|Induction Phase (Week 0 to 14)||78||
48296749|NCT02038920|101054345|FG002|STARTED|Induction Phase (Week 0 to 14)||0||
48296750|NCT02038920|101054346|FG003|STARTED|Induction Phase (Week 0 to 14)||0||
48296751|NCT02038920|101054347|FG004|STARTED|Induction Phase (Week 0 to 14)||0||
48296752|NCT02038920|101054348|FG005|STARTED|Induction Phase (Week 0 to 14)||0||
48296753|NCT02038920|101054343|FG000|COMPLETED|Induction Phase (Week 0 to 14)||73||
48296754|NCT02038920|101054344|FG001|COMPLETED|Induction Phase (Week 0 to 14)||66||
48296755|NCT02038920|101054345|FG002|COMPLETED|Induction Phase (Week 0 to 14)||0||
48296756|NCT02038920|101054346|FG003|COMPLETED|Induction Phase (Week 0 to 14)||0||
48296757|NCT02038920|101054347|FG004|COMPLETED|Induction Phase (Week 0 to 14)||0||
48296758|NCT02038920|101054348|FG005|COMPLETED|Induction Phase (Week 0 to 14)||0||
48296759|NCT02038920|101054343|FG000|NOT COMPLETED|Induction Phase (Week 0 to 14)||6||
48296760|NCT02038920|101054344|FG001|NOT COMPLETED|Induction Phase (Week 0 to 14)||12||
48296761|NCT02038920|101054345|FG002|NOT COMPLETED|Induction Phase (Week 0 to 14)||0||
48296762|NCT02038920|101054346|FG003|NOT COMPLETED|Induction Phase (Week 0 to 14)||0||
48296763|NCT02038920|101054347|FG004|NOT COMPLETED|Induction Phase (Week 0 to 14)||0||
48296764|NCT02038920|101054348|FG005|NOT COMPLETED|Induction Phase (Week 0 to 14)||0||
48296765|NCT02038920|101054343|FG000|STARTED|Maintenance Phase (Week 14 to 60)||0|Participants who achieved clinical response at Week 10 entered into the maintenance phase.|
48296766|NCT02038920|101054344|FG001|STARTED|Maintenance Phase (Week 14 to 60)||0|Participants who achieved clinical response at Week 10 entered into the maintenance phase.|
48296767|NCT02038920|101054345|FG002|STARTED|Maintenance Phase (Week 14 to 60)||12|Participants who achieved clinical response at Week 10 entered into the maintenance phase.|
48296768|NCT02038920|101054346|FG003|STARTED|Maintenance Phase (Week 14 to 60)||12|Participants who achieved clinical response at Week 10 entered into the maintenance phase.|
48296769|NCT02038920|101054347|FG004|STARTED|Maintenance Phase (Week 14 to 60)||17|Participants who achieved clinical response at Week 10 entered into the maintenance phase.|
48296770|NCT02038920|101054348|FG005|STARTED|Maintenance Phase (Week 14 to 60)||0|Participants who achieved clinical response at Week 10 entered into the maintenance phase.|
48296771|NCT02038920|101054343|FG000|COMPLETED|Maintenance Phase (Week 14 to 60)||0||
48296772|NCT02038920|101054344|FG001|COMPLETED|Maintenance Phase (Week 14 to 60)||0||
48296773|NCT02038920|101054345|FG002|COMPLETED|Maintenance Phase (Week 14 to 60)||7||
48296774|NCT02038920|101054346|FG003|COMPLETED|Maintenance Phase (Week 14 to 60)||4||
48296775|NCT02038920|101054347|FG004|COMPLETED|Maintenance Phase (Week 14 to 60)||5||
48296776|NCT02038920|101054348|FG005|COMPLETED|Maintenance Phase (Week 14 to 60)||0||
48296777|NCT02038920|101054343|FG000|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0||
48296778|NCT02038920|101054344|FG001|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0||
48296779|NCT02038920|101054345|FG002|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||5||
48296780|NCT02038920|101054346|FG003|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||8||
48296781|NCT02038920|101054347|FG004|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||12||
48296782|NCT02038920|101054348|FG005|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0||
48296783|NCT02038920|101054343|FG000|STARTED|Open Label Cohort (Week 10 to 154)||0|23 out of 157 participants from induction/maintenance phase did not enter the open-label cohort.|
48296784|NCT02038920|101054344|FG001|STARTED|Open Label Cohort (Week 10 to 154)||0|23 out of 157 participants from induction/maintenance phase did not enter the open-label cohort.|
48296785|NCT02038920|101054345|FG002|STARTED|Open Label Cohort (Week 10 to 154)||0|23 out of 157 participants from induction/maintenance phase did not enter the open-label cohort.|
48296786|NCT02038920|101054346|FG003|STARTED|Open Label Cohort (Week 10 to 154)||0|23 out of 157 participants from induction/maintenance phase did not enter the open-label cohort.|
48143785|NCT00045110|100676596|FG001|COMPLETED|775mg Dose Escalation||0||
48713006|NCT01811303|102084851|FG000|COMPLETED|Third Intervention (1 Day)||4||
48713007|NCT01811303|102084852|FG001|COMPLETED|Third Intervention (1 Day)||4||
48713008|NCT01811303|102084853|FG002|COMPLETED|Third Intervention (1 Day)||4||
48713009|NCT01811303|102084854|FG003|COMPLETED|Third Intervention (1 Day)||2||
48713010|NCT01811303|102084851|FG000|NOT COMPLETED|Third Intervention (1 Day)||0||
48713011|NCT01811303|102084852|FG001|NOT COMPLETED|Third Intervention (1 Day)||0||
48713012|NCT01811303|102084853|FG002|NOT COMPLETED|Third Intervention (1 Day)||0||
48713013|NCT01811303|102084854|FG003|NOT COMPLETED|Third Intervention (1 Day)||0||
48713014|NCT01811303|102084851|FG000|STARTED|Washout (2 Days or More)||4||
48143786|NCT00045110|100676597|FG002|COMPLETED|775mg Dose Escalation||0||
48143787|NCT00045110|100676595|FG000|NOT COMPLETED|775mg Dose Escalation||0||
48143788|NCT00045110|100676596|FG001|NOT COMPLETED|775mg Dose Escalation||0||
48143789|NCT00045110|100676597|FG002|NOT COMPLETED|775mg Dose Escalation||0||
48143790|NCT02346383|100676598|FG000|STARTED|Overall Study||40||
48143791|NCT02346383|100676598|FG000|COMPLETED|Overall Study||40||
48143792|NCT02346383|100676598|FG000|NOT COMPLETED|Overall Study||0||
48143793|NCT01152580|100676599|FG000|STARTED|Overall Study||5||
48143794|NCT01152580|100676600|FG001|STARTED|Overall Study||14||
48143795|NCT01152580|100676599|FG000|COMPLETED|Overall Study||5||
48143796|NCT01152580|100676600|FG001|COMPLETED|Overall Study||13||
48143797|NCT01152580|100676599|FG000|NOT COMPLETED|Overall Study||0||
48143798|NCT01152580|100676600|FG001|NOT COMPLETED|Overall Study||1||
48143799|NCT00092534|100676601|FG000|STARTED|Base Study Vaccination Period||6087||
48143800|NCT00092534|100676602|FG001|STARTED|Base Study Vaccination Period||6080||
48143801|NCT00092534|100676603|FG002|STARTED|Base Study Vaccination Period||0||
48143802|NCT00092534|100676604|FG003|STARTED|Base Study Vaccination Period||0||
48143803|NCT00092534|100676605|FG004|STARTED|Base Study Vaccination Period||0||
48143804|NCT00092534|100676601|FG000|COMPLETED|Base Study Vaccination Period||5916||
48143805|NCT00092534|100676602|FG001|COMPLETED|Base Study Vaccination Period||5954||
48143806|NCT00092534|100676603|FG002|COMPLETED|Base Study Vaccination Period||0||
48143807|NCT00092534|100676604|FG003|COMPLETED|Base Study Vaccination Period||0||
48143808|NCT00092534|100676605|FG004|COMPLETED|Base Study Vaccination Period||0||
48143809|NCT00092534|100676601|FG000|NOT COMPLETED|Base Study Vaccination Period||171||
48143810|NCT00092534|100676602|FG001|NOT COMPLETED|Base Study Vaccination Period||126||
48143811|NCT00092534|100676603|FG002|NOT COMPLETED|Base Study Vaccination Period||0||
48143812|NCT00092534|100676604|FG003|NOT COMPLETED|Base Study Vaccination Period||0||
48143813|NCT00092534|100676605|FG004|NOT COMPLETED|Base Study Vaccination Period||0||
48143814|NCT00092534|100676601|FG000|STARTED|Base Study Follow-Up Period||5942||
48143815|NCT00092534|100676602|FG001|STARTED|Base Study Follow-Up Period||5971||
48143816|NCT00092534|100676603|FG002|STARTED|Base Study Follow-Up Period||0||
48713015|NCT01811303|102084852|FG001|STARTED|Washout (2 Days or More)||4||
48713016|NCT01811303|102084853|FG002|STARTED|Washout (2 Days or More)||4||
48713017|NCT01811303|102084854|FG003|STARTED|Washout (2 Days or More)||2||
48713018|NCT01811303|102084851|FG000|COMPLETED|Washout (2 Days or More)||4||
48713019|NCT01811303|102084852|FG001|COMPLETED|Washout (2 Days or More)||4||
48713020|NCT01811303|102084853|FG002|COMPLETED|Washout (2 Days or More)||4||
48143817|NCT00092534|100676604|FG003|STARTED|Base Study Follow-Up Period||0||
48143818|NCT00092534|100676605|FG004|STARTED|Base Study Follow-Up Period||0||
48143819|NCT00092534|100676601|FG000|COMPLETED|Base Study Follow-Up Period||5626||
48143820|NCT00092534|100676602|FG001|COMPLETED|Base Study Follow-Up Period||5277||
48143821|NCT00092534|100676603|FG002|COMPLETED|Base Study Follow-Up Period||0||
48143822|NCT00092534|100676604|FG003|COMPLETED|Base Study Follow-Up Period||0||
48143823|NCT00092534|100676605|FG004|COMPLETED|Base Study Follow-Up Period||0||
48143824|NCT00092534|100676601|FG000|NOT COMPLETED|Base Study Follow-Up Period||316||
48143825|NCT00092534|100676602|FG001|NOT COMPLETED|Base Study Follow-Up Period||694||
48143826|NCT00092534|100676603|FG002|NOT COMPLETED|Base Study Follow-Up Period||0||
48143827|NCT00092534|100676604|FG003|NOT COMPLETED|Base Study Follow-Up Period||0||
48143828|NCT00092534|100676605|FG004|NOT COMPLETED|Base Study Follow-Up Period||0||
48143829|NCT00092534|100676601|FG000|STARTED|Base Study EXT||0||
48143830|NCT00092534|100676602|FG001|STARTED|Base Study EXT||0||
48143831|NCT00092534|100676603|FG002|STARTED|Base Study EXT||594||
48143832|NCT00092534|100676604|FG003|STARTED|Base Study EXT||0||
48143833|NCT00092534|100676605|FG004|STARTED|Base Study EXT||0||
48143834|NCT00092534|100676601|FG000|COMPLETED|Base Study EXT||0||
48143835|NCT00092534|100676602|FG001|COMPLETED|Base Study EXT||0||
48143836|NCT00092534|100676603|FG002|COMPLETED|Base Study EXT||449||
48143837|NCT00092534|100676604|FG003|COMPLETED|Base Study EXT||0||
48143838|NCT00092534|100676605|FG004|COMPLETED|Base Study EXT||0||
48143839|NCT00092534|100676601|FG000|NOT COMPLETED|Base Study EXT||0||
48143840|NCT00092534|100676602|FG001|NOT COMPLETED|Base Study EXT||0||
48143841|NCT00092534|100676603|FG002|NOT COMPLETED|Base Study EXT||145||
48143842|NCT00092534|100676604|FG003|NOT COMPLETED|Base Study EXT||0||
48143843|NCT00092534|100676605|FG004|NOT COMPLETED|Base Study EXT||0||
48143844|NCT00092534|100676601|FG000|STARTED|Long-Term Follow-Up (LTFU) Study||0|Eligible for inclusion in the LTFU study|
48143845|NCT00092534|100676602|FG001|STARTED|Long-Term Follow-Up (LTFU) Study||0|Eligible for inclusion in the LTFU study|
48188518|NCT01686932|100783262|FG000|NOT COMPLETED|Period 2||0||
48143846|NCT00092534|100676603|FG002|STARTED|Long-Term Follow-Up (LTFU) Study||0|Eligible for inclusion in the LTFU study|
48143847|NCT00092534|100676604|FG003|STARTED|Long-Term Follow-Up (LTFU) Study||2750|Eligible for inclusion in the LTFU study|
48143848|NCT00092534|100676605|FG004|STARTED|Long-Term Follow-Up (LTFU) Study||2097|Eligible for inclusion in the LTFU study|
48143849|NCT00092534|100676601|FG000|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0|Eligible and consented to inclusion in registry-based searches for effectiveness information|
48143850|NCT00092534|100676602|FG001|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0|Eligible and consented to inclusion in registry-based searches for effectiveness information|
48143851|NCT00092534|100676603|FG002|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0|Eligible and consented to inclusion in registry-based searches for effectiveness information|
48188519|NCT01686932|100783263|FG001|NOT COMPLETED|Period 2||0||
48188520|NCT00031447|100783264|FG000|STARTED|Overall Study||14||
48143852|NCT00092534|100676604|FG003|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||2650|Eligible and consented to inclusion in registry-based searches for effectiveness information|
48143853|NCT00092534|100676605|FG004|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||2050|Eligible and consented to inclusion in registry-based searches for effectiveness information|
48143854|NCT00092534|100676601|FG000|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0|Eligible and consented to provide blood samples for immunogenicity anaysis|
48143855|NCT00092534|100676602|FG001|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0|Eligible and consented to provide blood samples for immunogenicity anaysis|
48143856|NCT00092534|100676603|FG002|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0|Eligible and consented to provide blood samples for immunogenicity anaysis|
48143857|NCT00092534|100676604|FG003|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||2385|Eligible and consented to provide blood samples for immunogenicity anaysis|
48143858|NCT00092534|100676605|FG004|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||1849|Eligible and consented to provide blood samples for immunogenicity anaysis|
48296787|NCT02038920|101054347|FG004|STARTED|Open Label Cohort (Week 10 to 154)||0|23 out of 157 participants from induction/maintenance phase did not enter the open-label cohort.|
48296788|NCT02038920|101054348|FG005|STARTED|Open Label Cohort (Week 10 to 154)||134|23 out of 157 participants from induction/maintenance phase did not enter the open-label cohort.|
48296789|NCT02038920|101054343|FG000|COMPLETED|Open Label Cohort (Week 10 to 154)||0||
48296790|NCT02038920|101054344|FG001|COMPLETED|Open Label Cohort (Week 10 to 154)||0||
48296791|NCT02038920|101054345|FG002|COMPLETED|Open Label Cohort (Week 10 to 154)||0||
48296792|NCT02038920|101054346|FG003|COMPLETED|Open Label Cohort (Week 10 to 154)||0||
48296793|NCT02038920|101054347|FG004|COMPLETED|Open Label Cohort (Week 10 to 154)||0||
48296794|NCT02038920|101054348|FG005|COMPLETED|Open Label Cohort (Week 10 to 154)||57||
48296795|NCT02038920|101054343|FG000|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0||
48405073|NCT01041404|101325179|FG000|NOT COMPLETED|Overall Study||290||
48405074|NCT01041404|101325180|FG001|NOT COMPLETED|Overall Study||294||
48405075|NCT01973972|101325181|FG000|STARTED|Overall Study||127||
48713021|NCT01811303|102084854|FG003|COMPLETED|Washout (2 Days or More)||2||
48713022|NCT01811303|102084851|FG000|NOT COMPLETED|Washout (2 Days or More)||0||
48713023|NCT01811303|102084852|FG001|NOT COMPLETED|Washout (2 Days or More)||0||
48713024|NCT01811303|102084853|FG002|NOT COMPLETED|Washout (2 Days or More)||0||
48713025|NCT01811303|102084854|FG003|NOT COMPLETED|Washout (2 Days or More)||0||
48713026|NCT01811303|102084851|FG000|STARTED|Fourth Intervention (1 Day)||4||
48713027|NCT01811303|102084852|FG001|STARTED|Fourth Intervention (1 Day)||4||
48713028|NCT01811303|102084853|FG002|STARTED|Fourth Intervention (1 Day)||4||
48713029|NCT01811303|102084854|FG003|STARTED|Fourth Intervention (1 Day)||2||
48713030|NCT01811303|102084851|FG000|COMPLETED|Fourth Intervention (1 Day)||4||
48713031|NCT01811303|102084852|FG001|COMPLETED|Fourth Intervention (1 Day)||4||
48405076|NCT01973972|101325182|FG001|STARTED|Overall Study||136||
48713032|NCT01811303|102084853|FG002|COMPLETED|Fourth Intervention (1 Day)||4||
48713033|NCT01811303|102084854|FG003|COMPLETED|Fourth Intervention (1 Day)||2||
48713034|NCT01811303|102084851|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0||
48713035|NCT01811303|102084852|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0||
48713036|NCT01811303|102084853|FG002|NOT COMPLETED|Fourth Intervention (1 Day)||0||
48713037|NCT01811303|102084854|FG003|NOT COMPLETED|Fourth Intervention (1 Day)||0||
48713038|NCT01484834|102084855|FG000|STARTED|Overall Study||65||
48713039|NCT01484834|102084856|FG001|STARTED|Overall Study||62||
48296796|NCT02038920|101054344|FG001|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0||
48296797|NCT02038920|101054345|FG002|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0||
48296798|NCT02038920|101054346|FG003|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0||
48296799|NCT02038920|101054347|FG004|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0||
48296800|NCT02038920|101054348|FG005|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||77||
48296801|NCT03285178|101054349|FG000|STARTED|Single-Blind Run-In Period||88||
48296802|NCT03285178|101054350|FG001|STARTED|Single-Blind Run-In Period||0||
48296803|NCT03285178|101054351|FG002|STARTED|Single-Blind Run-In Period||0||
48296804|NCT03285178|101054352|FG003|STARTED|Single-Blind Run-In Period||0||
48296805|NCT03285178|101054353|FG004|STARTED|Single-Blind Run-In Period||0||
48296806|NCT03285178|101054354|FG005|STARTED|Single-Blind Run-In Period||0||
48296807|NCT03285178|101054355|FG006|STARTED|Single-Blind Run-In Period||0||
48296808|NCT03285178|101054349|FG000|COMPLETED|Single-Blind Run-In Period||70||
48296809|NCT03285178|101054350|FG001|COMPLETED|Single-Blind Run-In Period||0||
48296810|NCT03285178|101054351|FG002|COMPLETED|Single-Blind Run-In Period||0||
48296811|NCT03285178|101054352|FG003|COMPLETED|Single-Blind Run-In Period||0||
48296812|NCT03285178|101054353|FG004|COMPLETED|Single-Blind Run-In Period||0||
48296813|NCT03285178|101054354|FG005|COMPLETED|Single-Blind Run-In Period||0||
48296814|NCT03285178|101054355|FG006|COMPLETED|Single-Blind Run-In Period||0||
48296815|NCT03285178|101054349|FG000|NOT COMPLETED|Single-Blind Run-In Period||18||
48296816|NCT03285178|101054350|FG001|NOT COMPLETED|Single-Blind Run-In Period||0||
48296817|NCT03285178|101054351|FG002|NOT COMPLETED|Single-Blind Run-In Period||0||
48296818|NCT03285178|101054352|FG003|NOT COMPLETED|Single-Blind Run-In Period||0||
48296819|NCT03285178|101054353|FG004|NOT COMPLETED|Single-Blind Run-In Period||0||
48296820|NCT03285178|101054354|FG005|NOT COMPLETED|Single-Blind Run-In Period||0||
48296821|NCT03285178|101054355|FG006|NOT COMPLETED|Single-Blind Run-In Period||0||
48296822|NCT03285178|101054349|FG000|STARTED|Double-Blind Treatment Period||0||
48296823|NCT03285178|101054350|FG001|STARTED|Double-Blind Treatment Period||10||
48296824|NCT03285178|101054351|FG002|STARTED|Double-Blind Treatment Period||9||
48296825|NCT03285178|101054352|FG003|STARTED|Double-Blind Treatment Period||8||
48296826|NCT03285178|101054353|FG004|STARTED|Double-Blind Treatment Period||8||
48296827|NCT03285178|101054354|FG005|STARTED|Double-Blind Treatment Period||11||
48296828|NCT03285178|101054355|FG006|STARTED|Double-Blind Treatment Period||24||
48296829|NCT03285178|101054349|FG000|COMPLETED|Double-Blind Treatment Period||0||
48296830|NCT03285178|101054350|FG001|COMPLETED|Double-Blind Treatment Period||8||
48296831|NCT03285178|101054351|FG002|COMPLETED|Double-Blind Treatment Period||6||
48296832|NCT03285178|101054352|FG003|COMPLETED|Double-Blind Treatment Period||7||
48296833|NCT03285178|101054353|FG004|COMPLETED|Double-Blind Treatment Period||6||
48296834|NCT03285178|101054354|FG005|COMPLETED|Double-Blind Treatment Period||9||
48296835|NCT03285178|101054355|FG006|COMPLETED|Double-Blind Treatment Period||21||
48296836|NCT03285178|101054349|FG000|NOT COMPLETED|Double-Blind Treatment Period||0||
48296837|NCT03285178|101054350|FG001|NOT COMPLETED|Double-Blind Treatment Period||2||
48296838|NCT03285178|101054351|FG002|NOT COMPLETED|Double-Blind Treatment Period||3||
48296839|NCT03285178|101054352|FG003|NOT COMPLETED|Double-Blind Treatment Period||1||
48296840|NCT03285178|101054353|FG004|NOT COMPLETED|Double-Blind Treatment Period||2||
48296841|NCT03285178|101054354|FG005|NOT COMPLETED|Double-Blind Treatment Period||2||
48296842|NCT03285178|101054355|FG006|NOT COMPLETED|Double-Blind Treatment Period||3||
48296843|NCT03086213|101054356|FG000|STARTED|Overall Study||24||
48296844|NCT03086213|101054357|FG001|STARTED|Overall Study||24||
48296845|NCT03086213|101054356|FG000|COMPLETED|Overall Study||24||
48296846|NCT03086213|101054357|FG001|COMPLETED|Overall Study||24||
48296847|NCT03086213|101054356|FG000|NOT COMPLETED|Overall Study||0||
48296848|NCT03086213|101054357|FG001|NOT COMPLETED|Overall Study||0||
48296849|NCT03182725|101054358|FG000|STARTED|Treatment Arm 1 (First Half of Study)||16||
48296850|NCT03182725|101054359|FG001|STARTED|Treatment Arm 1 (First Half of Study)||10||
48296851|NCT03182725|101054358|FG000|COMPLETED|Treatment Arm 1 (First Half of Study)||16||
48296852|NCT03182725|101054359|FG001|COMPLETED|Treatment Arm 1 (First Half of Study)||7||
48296853|NCT03182725|101054358|FG000|NOT COMPLETED|Treatment Arm 1 (First Half of Study)||0||
48296854|NCT03182725|101054359|FG001|NOT COMPLETED|Treatment Arm 1 (First Half of Study)||3||
48296855|NCT03182725|101054358|FG000|STARTED|Treatment Arm 2 (Second Half of Study)||16||
48296856|NCT03182725|101054359|FG001|STARTED|Treatment Arm 2 (Second Half of Study)||6||
48296857|NCT03182725|101054358|FG000|COMPLETED|Treatment Arm 2 (Second Half of Study)||16||
48296858|NCT03182725|101054359|FG001|COMPLETED|Treatment Arm 2 (Second Half of Study)||6||
48296859|NCT03182725|101054358|FG000|NOT COMPLETED|Treatment Arm 2 (Second Half of Study)||0||
48296860|NCT03182725|101054359|FG001|NOT COMPLETED|Treatment Arm 2 (Second Half of Study)||0||
48296861|NCT01978262|101054360|FG000|STARTED|Overall Study||103||
48296862|NCT01978262|101054360|FG000|COMPLETED|Overall Study||92||
48296863|NCT01978262|101054360|FG000|NOT COMPLETED|Overall Study||11||
48296864|NCT03260595|101054361|FG000|STARTED|Overall Study||20||
48296865|NCT03260595|101054362|FG001|STARTED|Overall Study||10||
48296866|NCT03260595|101054363|FG002|STARTED|Overall Study||2||
48296867|NCT03260595|101054361|FG000|COMPLETED|Overall Study||20||
48296868|NCT03260595|101054362|FG001|COMPLETED|Overall Study||10||
48296869|NCT03260595|101054363|FG002|COMPLETED|Overall Study||2||
48296870|NCT03260595|101054361|FG000|NOT COMPLETED|Overall Study||0||
48296871|NCT03260595|101054362|FG001|NOT COMPLETED|Overall Study||0||
48296872|NCT03260595|101054363|FG002|NOT COMPLETED|Overall Study||0||
48296873|NCT02454179|101054364|FG000|STARTED|Overall Study||39||
48296874|NCT02454179|101054365|FG001|STARTED|Overall Study||39||
48296875|NCT02454179|101054364|FG000|Enrolled|Overall Study||39||
48296876|NCT02454179|101054365|FG001|Enrolled|Overall Study||39||
48296877|NCT02454179|101054364|FG000|Received Study Medication|Overall Study||39||
48296878|NCT02454179|101054365|FG001|Received Study Medication|Overall Study||37||
48296879|NCT02454179|101054364|FG000|Discontinue Study|Overall Study||39||
48296880|NCT02454179|101054365|FG001|Discontinue Study|Overall Study||39||
48296881|NCT02454179|101054364|FG000|COMPLETED|Overall Study||0||
48296882|NCT02454179|101054365|FG001|COMPLETED|Overall Study||0||
48296883|NCT02454179|101054364|FG000|NOT COMPLETED|Overall Study||39||
48296884|NCT02454179|101054365|FG001|NOT COMPLETED|Overall Study||39||
48296885|NCT02204176|101054366|FG000|STARTED|Overall Study||74||
48296886|NCT02204176|101054367|FG001|STARTED|Overall Study||73||
48296887|NCT02204176|101054368|FG002|STARTED|Overall Study||74||
48296888|NCT02204176|101054366|FG000|COMPLETED|Overall Study||64||
48296889|NCT02204176|101054367|FG001|COMPLETED|Overall Study||61||
48296890|NCT02204176|101054368|FG002|COMPLETED|Overall Study||58||
48296891|NCT02204176|101054366|FG000|NOT COMPLETED|Overall Study||10||
48296892|NCT02204176|101054367|FG001|NOT COMPLETED|Overall Study||12||
48598117|NCT01702532|101796787|FG001|STARTED|Overall Study||161||
48598118|NCT01702532|101796786|FG000|Safety Population|Overall Study||161||
48598119|NCT01702532|101796787|FG001|Safety Population|Overall Study||160||
48598120|NCT01702532|101796786|FG000|COMPLETED|Overall Study||161||
48598121|NCT01702532|101796787|FG001|COMPLETED|Overall Study||160||
48598122|NCT01702532|101796786|FG000|NOT COMPLETED|Overall Study||0||
48296893|NCT02204176|101054368|FG002|NOT COMPLETED|Overall Study||16||
48296894|NCT03604523|101054369|FG000|STARTED|Overall Study||5||
48296895|NCT03604523|101054370|FG001|STARTED|Overall Study||5||
48296896|NCT03604523|101054369|FG000|COMPLETED|Overall Study||4||
48296897|NCT03604523|101054370|FG001|COMPLETED|Overall Study||5||
48296898|NCT03604523|101054369|FG000|NOT COMPLETED|Overall Study||1||
48296899|NCT03604523|101054370|FG001|NOT COMPLETED|Overall Study||0||
48296900|NCT01350453|101054371|FG000|STARTED|Overall Study||11||
48296901|NCT01350453|101054372|FG001|STARTED|Overall Study||8||
48296902|NCT01350453|101054371|FG000|COMPLETED|Overall Study||9||
48296903|NCT01350453|101054372|FG001|COMPLETED|Overall Study||7||
48296904|NCT01350453|101054371|FG000|NOT COMPLETED|Overall Study||2||
48296905|NCT01350453|101054372|FG001|NOT COMPLETED|Overall Study||1||
48296906|NCT03437278|101054373|FG000|STARTED|Overall Study||24||
48296907|NCT03437278|101054374|FG001|STARTED|Overall Study||13||
48296908|NCT03437278|101054375|FG002|STARTED|Overall Study||12||
48296909|NCT03437278|101054373|FG000|COMPLETED|Overall Study||22||
48296910|NCT03437278|101054374|FG001|COMPLETED|Overall Study||13||
48296911|NCT03437278|101054375|FG002|COMPLETED|Overall Study||10||
48296912|NCT03437278|101054373|FG000|NOT COMPLETED|Overall Study||2||
48296913|NCT03437278|101054374|FG001|NOT COMPLETED|Overall Study||0||
48296914|NCT03437278|101054375|FG002|NOT COMPLETED|Overall Study||2||
48296915|NCT00928174|101054376|FG000|STARTED|Overall Study||27||
48598123|NCT01702532|101796787|FG001|NOT COMPLETED|Overall Study||1||
48598124|NCT00431067|101796788|FG000|STARTED|Overall Study||41||
48598125|NCT00431067|101796788|FG000|COMPLETED|Overall Study||0||
48598126|NCT00431067|101796788|FG000|NOT COMPLETED|Overall Study||41||
48296916|NCT00928174|101054376|FG000|COMPLETED|Overall Study||22||
48296917|NCT00928174|101054376|FG000|NOT COMPLETED|Overall Study||5||
48296918|NCT00117845|101054377|FG000|STARTED|Overall Study||17||
48598127|NCT01522235|101796789|FG000|STARTED|Overall Study||3||
48296919|NCT00117845|101054377|FG000|COMPLETED|Overall Study||16||
48598128|NCT01522235|101796790|FG001|STARTED|Overall Study||3||
48598129|NCT01522235|101796789|FG000|Randomized|Overall Study||2||
48296920|NCT00117845|101054377|FG000|NOT COMPLETED|Overall Study||1||
48296921|NCT01206777|101054378|FG000|STARTED|Overall Study||52||
48598130|NCT01522235|101796790|FG001|Randomized|Overall Study||3||
48598131|NCT01522235|101796789|FG000|COMPLETED|Overall Study||2||
48598132|NCT01522235|101796790|FG001|COMPLETED|Overall Study||2||
48598133|NCT01522235|101796789|FG000|NOT COMPLETED|Overall Study||1||
48598134|NCT01522235|101796790|FG001|NOT COMPLETED|Overall Study||1||
48598135|NCT04663087|101796791|FG000|STARTED|Overall Study||0||
48598136|NCT04663087|101796792|FG001|STARTED|Overall Study||1||
48598137|NCT04663087|101796791|FG000|COMPLETED|Overall Study||0||
48598138|NCT04663087|101796792|FG001|COMPLETED|Overall Study||1||
48598139|NCT04663087|101796791|FG000|NOT COMPLETED|Overall Study||0||
48598140|NCT04663087|101796792|FG001|NOT COMPLETED|Overall Study||0||
48598141|NCT04984278|101796793|FG000|STARTED|Period 1||16||
48598142|NCT04984278|101796794|FG001|STARTED|Period 1||15||
48598143|NCT04984278|101796793|FG000|COMPLETED|Period 1||15||
48598144|NCT04984278|101796794|FG001|COMPLETED|Period 1||14||
48598145|NCT04984278|101796793|FG000|NOT COMPLETED|Period 1||1||
48598146|NCT04984278|101796794|FG001|NOT COMPLETED|Period 1||1||
48598147|NCT04984278|101796793|FG000|STARTED|Period 2||15||
48598148|NCT04984278|101796794|FG001|STARTED|Period 2||14||
48598149|NCT04984278|101796793|FG000|COMPLETED|Period 2||14||
48598150|NCT04984278|101796794|FG001|COMPLETED|Period 2||13||
48598151|NCT04984278|101796793|FG000|NOT COMPLETED|Period 2||1||
48598152|NCT04984278|101796794|FG001|NOT COMPLETED|Period 2||1||
48598153|NCT02172040|101796795|FG000|STARTED|Overall Study||49||
48598154|NCT02172040|101796796|FG001|STARTED|Overall Study||45||
48598155|NCT02172040|101796797|FG002|STARTED|Overall Study||31||
48598156|NCT02172040|101796798|FG003|STARTED|Overall Study||27||
48598157|NCT02172040|101796795|FG000|COMPLETED|Overall Study||49||
48598158|NCT02172040|101796796|FG001|COMPLETED|Overall Study||42||
48598159|NCT02172040|101796797|FG002|COMPLETED|Overall Study||29||
48598160|NCT02172040|101796798|FG003|COMPLETED|Overall Study||26||
48598161|NCT02172040|101796795|FG000|NOT COMPLETED|Overall Study||0||
48598162|NCT02172040|101796796|FG001|NOT COMPLETED|Overall Study||3||
48598163|NCT02172040|101796797|FG002|NOT COMPLETED|Overall Study||2||
48598164|NCT02172040|101796798|FG003|NOT COMPLETED|Overall Study||1||
48598165|NCT01877551|101796799|FG000|STARTED|Overall Study||13||
48598166|NCT01877551|101796800|FG001|STARTED|Overall Study||14||
48598167|NCT01877551|101796799|FG000|COMPLETED|Overall Study||13||
48598168|NCT01877551|101796800|FG001|COMPLETED|Overall Study||13||
48598169|NCT01877551|101796799|FG000|NOT COMPLETED|Overall Study||0||
48598170|NCT01877551|101796800|FG001|NOT COMPLETED|Overall Study||1||
48598171|NCT01178814|101796801|FG000|STARTED|Overall Study||57||
48598172|NCT01178814|101796801|FG000|COMPLETED|Overall Study||57||
48598173|NCT01178814|101796801|FG000|NOT COMPLETED|Overall Study||0||
48598174|NCT01714609|101796802|FG000|STARTED|Overall Study||5||
48598175|NCT01714609|101796803|FG001|STARTED|Overall Study||5||
48598176|NCT01714609|101796802|FG000|COMPLETED|Overall Study||4||
48598177|NCT01714609|101796803|FG001|COMPLETED|Overall Study||5||
48598178|NCT01714609|101796802|FG000|NOT COMPLETED|Overall Study||1||
48598179|NCT01714609|101796803|FG001|NOT COMPLETED|Overall Study||0||
48598180|NCT00455520|101796804|FG000|STARTED|Open Label Tapentadol Extended Release||591||
48598181|NCT00455520|101796805|FG001|STARTED|Open Label Tapentadol Extended Release||0||
48598182|NCT00455520|101796804|FG000|COMPLETED|Open Label Tapentadol Extended Release||395||
48598183|NCT00455520|101796805|FG001|COMPLETED|Open Label Tapentadol Extended Release||0||
48598184|NCT00455520|101796804|FG000|NOT COMPLETED|Open Label Tapentadol Extended Release||196||
48598185|NCT00455520|101796805|FG001|NOT COMPLETED|Open Label Tapentadol Extended Release||0||
48598186|NCT00455520|101796804|FG000|STARTED|Double Blind Tapentadol ER vs Placebo||196||
48598187|NCT00455520|101796805|FG001|STARTED|Double Blind Tapentadol ER vs Placebo||193||
48598188|NCT00455520|101796804|FG000|COMPLETED|Double Blind Tapentadol ER vs Placebo||133||
48598189|NCT00455520|101796805|FG001|COMPLETED|Double Blind Tapentadol ER vs Placebo||131||
48598190|NCT00455520|101796804|FG000|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||63||
48598191|NCT00455520|101796805|FG001|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||62||
48598192|NCT03617861|101796806|FG000|STARTED|First Intervention (1 Day)||5||
48598193|NCT03617861|101796807|FG001|STARTED|First Intervention (1 Day)||5||
48598194|NCT03617861|101796808|FG002|STARTED|First Intervention (1 Day)||5||
48598195|NCT03617861|101796809|FG003|STARTED|First Intervention (1 Day)||5||
48598196|NCT03617861|101796806|FG000|COMPLETED|First Intervention (1 Day)||5||
48598197|NCT03617861|101796807|FG001|COMPLETED|First Intervention (1 Day)||5||
48598198|NCT03617861|101796808|FG002|COMPLETED|First Intervention (1 Day)||5||
48598199|NCT03617861|101796809|FG003|COMPLETED|First Intervention (1 Day)||5||
48598200|NCT03617861|101796806|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48598201|NCT03617861|101796807|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48598202|NCT03617861|101796808|FG002|NOT COMPLETED|First Intervention (1 Day)||0||
48598203|NCT03617861|101796809|FG003|NOT COMPLETED|First Intervention (1 Day)||0||
48598204|NCT03617861|101796806|FG000|STARTED|Washout (1 to 4 Weeks)||5||
48598205|NCT03617861|101796807|FG001|STARTED|Washout (1 to 4 Weeks)||5||
48598206|NCT03617861|101796808|FG002|STARTED|Washout (1 to 4 Weeks)||5||
48598207|NCT03617861|101796809|FG003|STARTED|Washout (1 to 4 Weeks)||5||
48598208|NCT03617861|101796806|FG000|COMPLETED|Washout (1 to 4 Weeks)||5||
48598209|NCT03617861|101796807|FG001|COMPLETED|Washout (1 to 4 Weeks)||5||
48598210|NCT03617861|101796808|FG002|COMPLETED|Washout (1 to 4 Weeks)||5||
48598211|NCT03617861|101796809|FG003|COMPLETED|Washout (1 to 4 Weeks)||5||
48598212|NCT03617861|101796806|FG000|NOT COMPLETED|Washout (1 to 4 Weeks)||0||
48296922|NCT01206777|101054378|FG000|Discontinued Trial and Deemed Ineligible|Overall Study||2||
48296923|NCT01206777|101054378|FG000|COMPLETED|Overall Study||50||
48598213|NCT03617861|101796807|FG001|NOT COMPLETED|Washout (1 to 4 Weeks)||0||
48598214|NCT03617861|101796808|FG002|NOT COMPLETED|Washout (1 to 4 Weeks)||0||
48598215|NCT03617861|101796809|FG003|NOT COMPLETED|Washout (1 to 4 Weeks)||0||
48598216|NCT03617861|101796806|FG000|STARTED|Second Intervention (1 Day)||5||
48598217|NCT03617861|101796807|FG001|STARTED|Second Intervention (1 Day)||5||
48598218|NCT03617861|101796808|FG002|STARTED|Second Intervention (1 Day)||5||
48598219|NCT03617861|101796809|FG003|STARTED|Second Intervention (1 Day)||5||
48598220|NCT03617861|101796806|FG000|COMPLETED|Second Intervention (1 Day)||5||
48598221|NCT03617861|101796807|FG001|COMPLETED|Second Intervention (1 Day)||5||
48598222|NCT03617861|101796808|FG002|COMPLETED|Second Intervention (1 Day)||4||
48598223|NCT03617861|101796809|FG003|COMPLETED|Second Intervention (1 Day)||5||
48598224|NCT03617861|101796806|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48598225|NCT03617861|101796807|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48598226|NCT03617861|101796808|FG002|NOT COMPLETED|Second Intervention (1 Day)||1||
48598227|NCT03617861|101796809|FG003|NOT COMPLETED|Second Intervention (1 Day)||0||
48598228|NCT02638129|101796810|FG000|STARTED|Overall Study||28||
48598229|NCT02638129|101796811|FG001|STARTED|Overall Study||30||
48598230|NCT02638129|101796810|FG000|COMPLETED|Overall Study||0||
48598231|NCT02638129|101796811|FG001|COMPLETED|Overall Study||0||
48598232|NCT02638129|101796810|FG000|NOT COMPLETED|Overall Study||28||
48598233|NCT02638129|101796811|FG001|NOT COMPLETED|Overall Study||30||
48296924|NCT01206777|101054378|FG000|NOT COMPLETED|Overall Study||2||
48296925|NCT03384654|101054379|FG000|STARTED|Overall Study||7||
48296926|NCT03384654|101054380|FG001|STARTED|Overall Study||24||
48296927|NCT03384654|101054381|FG002|STARTED|Overall Study||5||
48296928|NCT03384654|101054382|FG003|STARTED|Overall Study||10||
48296929|NCT03384654|101054379|FG000|COMPLETED|Overall Study||7||
48296930|NCT03384654|101054380|FG001|COMPLETED|Overall Study||24||
48296931|NCT03384654|101054381|FG002|COMPLETED|Overall Study||4||
48296932|NCT03384654|101054382|FG003|COMPLETED|Overall Study||10||
48296933|NCT03384654|101054379|FG000|NOT COMPLETED|Overall Study||0||
48296934|NCT03384654|101054380|FG001|NOT COMPLETED|Overall Study||0||
48296935|NCT03384654|101054381|FG002|NOT COMPLETED|Overall Study||1||
48296936|NCT03384654|101054382|FG003|NOT COMPLETED|Overall Study||0||
48296937|NCT04250987|101054383|FG000|STARTED|Overall Study||12||
48296938|NCT04250987|101054383|FG000|COMPLETED|Overall Study||12||
48405077|NCT01973972|101325181|FG000|COMPLETED|Overall Study||109||
48598234|NCT03924505|101796812|FG000|STARTED|Overall Study||53||53
48598235|NCT03924505|101796813|FG001|STARTED|Overall Study||52||52
48598236|NCT03924505|101796812|FG000|COMPLETED|Overall Study||51||51
48598237|NCT03924505|101796813|FG001|COMPLETED|Overall Study||51||51
48598238|NCT03924505|101796812|FG000|NOT COMPLETED|Overall Study||2||2
48598239|NCT03924505|101796813|FG001|NOT COMPLETED|Overall Study||1||1
48598240|NCT04812795|101796814|FG000|STARTED|Overall Study||501||
48598241|NCT04812795|101796815|FG001|STARTED|Overall Study||501||
48598242|NCT04812795|101796816|FG002|STARTED|Overall Study||613||
48598243|NCT04812795|101796817|FG003|STARTED|Overall Study||599||
48598244|NCT04812795|101796814|FG000|COMPLETED|Overall Study||407||
48296939|NCT04250987|101054383|FG000|NOT COMPLETED|Overall Study||0||
48296940|NCT01488487|101054384|FG000|STARTED|Overall Study||24||
48296941|NCT01488487|101054384|FG000|Received Treatment|Overall Study||24||
48598245|NCT04812795|101796815|FG001|COMPLETED|Overall Study||401||
48598246|NCT04812795|101796816|FG002|COMPLETED|Overall Study||492||
48296942|NCT01488487|101054384|FG000|COMPLETED|Overall Study||15||
48598247|NCT04812795|101796817|FG003|COMPLETED|Overall Study||476||
48598248|NCT04812795|101796814|FG000|NOT COMPLETED|Overall Study||94||
48598249|NCT04812795|101796815|FG001|NOT COMPLETED|Overall Study||100||
48598250|NCT04812795|101796816|FG002|NOT COMPLETED|Overall Study||121||
48598251|NCT04812795|101796817|FG003|NOT COMPLETED|Overall Study||123||
48598252|NCT00478699|101796818|FG000|STARTED|Overall Study||108||
48598253|NCT00478699|101796819|FG001|STARTED|Overall Study||392||
48598254|NCT00478699|101796818|FG000|COMPLETED|Overall Study||101||
48598255|NCT00478699|101796819|FG001|COMPLETED|Overall Study||355||
48598256|NCT00478699|101796818|FG000|NOT COMPLETED|Overall Study||7||
48598257|NCT00478699|101796819|FG001|NOT COMPLETED|Overall Study||37||
48598258|NCT05119569|101800050|FG000|STARTED|Double Blind Treatment Phase||73||
48598259|NCT05119569|101800051|FG001|STARTED|Double Blind Treatment Phase||36||
48598260|NCT05119569|101800052|FG002|STARTED|Double Blind Treatment Phase||0||
48598261|NCT05119569|101800053|FG003|STARTED|Double Blind Treatment Phase||0||
48598262|NCT05119569|101800050|FG000|COMPLETED|Double Blind Treatment Phase||65||
48598263|NCT05119569|101800051|FG001|COMPLETED|Double Blind Treatment Phase||34||
48598264|NCT05119569|101800052|FG002|COMPLETED|Double Blind Treatment Phase||0||
48598265|NCT05119569|101800053|FG003|COMPLETED|Double Blind Treatment Phase||0||
48598266|NCT05119569|101800050|FG000|NOT COMPLETED|Double Blind Treatment Phase||8||
48598267|NCT05119569|101800051|FG001|NOT COMPLETED|Double Blind Treatment Phase||2||
48598268|NCT05119569|101800052|FG002|NOT COMPLETED|Double Blind Treatment Phase||0||
48598269|NCT05119569|101800053|FG003|NOT COMPLETED|Double Blind Treatment Phase||0||
48598270|NCT05119569|101800050|FG000|STARTED|Open Label Extension Phase||0||
48598271|NCT05119569|101800051|FG001|STARTED|Open Label Extension Phase||0||
48598272|NCT05119569|101800052|FG002|STARTED|Open Label Extension Phase||65||
48598273|NCT05119569|101800053|FG003|STARTED|Open Label Extension Phase||34||
48598274|NCT05119569|101800050|FG000|COMPLETED|Open Label Extension Phase||0||
48598275|NCT05119569|101800051|FG001|COMPLETED|Open Label Extension Phase||0||
48598276|NCT05119569|101800052|FG002|COMPLETED|Open Label Extension Phase||0||
48598277|NCT05119569|101800053|FG003|COMPLETED|Open Label Extension Phase||0||
48598278|NCT05119569|101800050|FG000|NOT COMPLETED|Open Label Extension Phase||0||
48598279|NCT05119569|101800051|FG001|NOT COMPLETED|Open Label Extension Phase||0||
48598280|NCT05119569|101800052|FG002|NOT COMPLETED|Open Label Extension Phase||65||
48598281|NCT05119569|101800053|FG003|NOT COMPLETED|Open Label Extension Phase||34||
48598282|NCT02604173|101800054|FG000|STARTED|Overall Study||33||
48598283|NCT02604173|101800055|FG001|STARTED|Overall Study||35||
48598284|NCT02604173|101800056|FG002|STARTED|Overall Study||35||
48598285|NCT02604173|101800054|FG000|COMPLETED|Overall Study||33||
48598286|NCT02604173|101800055|FG001|COMPLETED|Overall Study||35||
48598287|NCT02604173|101800056|FG002|COMPLETED|Overall Study||35||
48598288|NCT02604173|101800054|FG000|NOT COMPLETED|Overall Study||0||
48598289|NCT02604173|101800055|FG001|NOT COMPLETED|Overall Study||0||
48598290|NCT02604173|101800056|FG002|NOT COMPLETED|Overall Study||0||
48598291|NCT02826577|101800057|FG000|STARTED|Overall Study||0||
48598292|NCT02826577|101800058|FG001|STARTED|Overall Study||0||
48598293|NCT02826577|101800059|FG002|STARTED|Overall Study||0||
48598294|NCT02826577|101800060|FG003|STARTED|Overall Study||0||
48598295|NCT02826577|101800057|FG000|COMPLETED|Overall Study||0||
48598296|NCT02826577|101800058|FG001|COMPLETED|Overall Study||0||
48598297|NCT02826577|101800059|FG002|COMPLETED|Overall Study||0||
48598298|NCT02826577|101800060|FG003|COMPLETED|Overall Study||0||
48598299|NCT02826577|101800057|FG000|NOT COMPLETED|Overall Study||0||
48598300|NCT02826577|101800058|FG001|NOT COMPLETED|Overall Study||0||
48598301|NCT02826577|101800059|FG002|NOT COMPLETED|Overall Study||0||
48598302|NCT02826577|101800060|FG003|NOT COMPLETED|Overall Study||0||
48598303|NCT03913104|101800061|FG000|STARTED|Overall Study||536||540
48598304|NCT03913104|101800061|FG000|Patient's Clinical Outcome Information Obtained|Overall Study||506||510
48598305|NCT03913104|101800061|FG000|COMPLETED|Overall Study||506||510
48598306|NCT03913104|101800061|FG000|NOT COMPLETED|Overall Study||30||30
48598307|NCT00958412|101800062|FG000|STARTED|Overall Study||18||
48598308|NCT00958412|101800062|FG000|COMPLETED|Overall Study||0||
48598309|NCT00958412|101800062|FG000|NOT COMPLETED|Overall Study||18||
48598310|NCT01687387|101800063|FG000|STARTED|Overall Study||51||
48598311|NCT01687387|101800064|FG001|STARTED|Overall Study||50||
48598312|NCT01687387|101800065|FG002|STARTED|Overall Study||51||
48713040|NCT01484834|102084857|FG002|STARTED|Overall Study||39||
48598313|NCT01687387|101800063|FG000|COMPLETED|Overall Study||10||
48598314|NCT01687387|101800064|FG001|COMPLETED|Overall Study||12||
48713041|NCT01484834|102084858|FG003|STARTED|Overall Study||24||
48713042|NCT01484834|102084855|FG000|COMPLETED|Overall Study||60||
48713043|NCT01484834|102084856|FG001|COMPLETED|Overall Study||54||
48713044|NCT01484834|102084857|FG002|COMPLETED|Overall Study||38||
48713045|NCT01484834|102084858|FG003|COMPLETED|Overall Study||20||
48713046|NCT01484834|102084855|FG000|NOT COMPLETED|Overall Study||5||
48713047|NCT01484834|102084856|FG001|NOT COMPLETED|Overall Study||8||
48713048|NCT01484834|102084857|FG002|NOT COMPLETED|Overall Study||1||
48713049|NCT01484834|102084858|FG003|NOT COMPLETED|Overall Study||4||
48713050|NCT03762616|102084859|FG000|STARTED|Overall Study||120||
48713051|NCT03762616|102084859|FG000|COMPLETED|Overall Study||118||
48713052|NCT03762616|102084859|FG000|NOT COMPLETED|Overall Study||2||
48713053|NCT00183963|102084860|FG000|STARTED|Overall Study||1||
48713054|NCT00183963|102084861|FG001|STARTED|Overall Study||1||
48713055|NCT00183963|102084862|FG002|STARTED|Overall Study||1||
48713056|NCT00183963|102084863|FG003|STARTED|Overall Study||1||
48713057|NCT00183963|102084860|FG000|COMPLETED|Overall Study||0||
48598315|NCT01687387|101800065|FG002|COMPLETED|Overall Study||13||
48143859|NCT00092534|100676601|FG000|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0|Eligible and consented to inclusion in registry-based searches for safety information|
48143860|NCT00092534|100676602|FG001|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0|Eligible and consented to inclusion in registry-based searches for safety information|
48143861|NCT00092534|100676603|FG002|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0|Eligible and consented to inclusion in registry-based searches for safety information|
48143862|NCT00092534|100676604|FG003|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||2448|Eligible and consented to inclusion in registry-based searches for safety information|
48143863|NCT00092534|100676605|FG004|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||1888|Eligible and consented to inclusion in registry-based searches for safety information|
48713058|NCT00183963|102084861|FG001|COMPLETED|Overall Study||0||
48713059|NCT00183963|102084862|FG002|COMPLETED|Overall Study||0||
48713060|NCT00183963|102084863|FG003|COMPLETED|Overall Study||0||
48713061|NCT00183963|102084860|FG000|NOT COMPLETED|Overall Study||1||
48713062|NCT00183963|102084861|FG001|NOT COMPLETED|Overall Study||1||
48713063|NCT00183963|102084862|FG002|NOT COMPLETED|Overall Study||1||
48713064|NCT00183963|102084863|FG003|NOT COMPLETED|Overall Study||1||
48713065|NCT00357656|102084864|FG000|STARTED|Overall Study||31||
48713066|NCT00357656|102084865|FG001|STARTED|Overall Study||32||
48713067|NCT00357656|102084864|FG000|COMPLETED|Overall Study||31||
48713068|NCT00357656|102084865|FG001|COMPLETED|Overall Study||29||
48713069|NCT00357656|102084864|FG000|NOT COMPLETED|Overall Study||0||
48713070|NCT00357656|102084865|FG001|NOT COMPLETED|Overall Study||3||
48713071|NCT02011490|102084866|FG000|STARTED|Part 1||8||
48713072|NCT02011490|102084867|FG001|STARTED|Part 1||8||
48713073|NCT02011490|102084868|FG002|STARTED|Part 1||8||
48713074|NCT02011490|102084869|FG003|STARTED|Part 1||0||
48713075|NCT02011490|102084870|FG004|STARTED|Part 1||0||
48296943|NCT01488487|101054384|FG000|NOT COMPLETED|Overall Study||9||
48296944|NCT00619762|101054385|FG000|STARTED|Overall Study||17||
48296945|NCT00619762|101054385|FG000|COMPLETED|Overall Study||14||
48296946|NCT00619762|101054385|FG000|NOT COMPLETED|Overall Study||3||
48296947|NCT02634346|101054386|FG000|STARTED|Overall Study||134||
48296948|NCT02634346|101054387|FG001|STARTED|Overall Study||133||
48296949|NCT02634346|101054388|FG002|STARTED|Overall Study||134||
48296950|NCT02634346|101054386|FG000|COMPLETED|Overall Study||122||
48296951|NCT02634346|101054387|FG001|COMPLETED|Overall Study||119||
48296952|NCT02634346|101054388|FG002|COMPLETED|Overall Study||111||
48296953|NCT02634346|101054386|FG000|NOT COMPLETED|Overall Study||12||
48296954|NCT02634346|101054387|FG001|NOT COMPLETED|Overall Study||14||
48296955|NCT02634346|101054388|FG002|NOT COMPLETED|Overall Study||23||
48296956|NCT00447382|101054389|FG000|STARTED|Overall Study||164||
48296957|NCT00447382|101054390|FG001|STARTED|Overall Study||166||
48296958|NCT00447382|101054389|FG000|COMPLETED|Overall Study||158||
48296959|NCT00447382|101054390|FG001|COMPLETED|Overall Study||160||
48296960|NCT00447382|101054389|FG000|NOT COMPLETED|Overall Study||6||
48296961|NCT00447382|101054390|FG001|NOT COMPLETED|Overall Study||6||
48296962|NCT01849822|101054391|FG000|STARTED|Overall Study||1||
48296963|NCT01849822|101054391|FG000|COMPLETED|Overall Study||1||
48296964|NCT01849822|101054391|FG000|NOT COMPLETED|Overall Study||0||
48296965|NCT00973362|101054392|FG000|STARTED|Baseline Evaluation||11644||
48296966|NCT00973362|101054393|FG001|STARTED|Baseline Evaluation||1252||
48296967|NCT00973362|101054392|FG000|Evaluable for Analysis|Baseline Evaluation||10871||
48296968|NCT00973362|101054393|FG001|Evaluable for Analysis|Baseline Evaluation||958||
48296969|NCT00973362|101054392|FG000|Conclusive Disease Status|Baseline Evaluation||819||
48296970|NCT00973362|101054393|FG001|Conclusive Disease Status|Baseline Evaluation||939||
48296971|NCT00973362|101054392|FG000|COMPLETED|Baseline Evaluation||10871||
48296972|NCT00973362|101054393|FG001|COMPLETED|Baseline Evaluation||1029||
48296973|NCT00973362|101054392|FG000|NOT COMPLETED|Baseline Evaluation||773||
48296974|NCT00973362|101054393|FG001|NOT COMPLETED|Baseline Evaluation||223||
48296975|NCT00973362|101054392|FG000|STARTED|3-Year Follow-up||10871||
48296976|NCT00973362|101054393|FG001|STARTED|3-Year Follow-up||0||
48296977|NCT00973362|101054392|FG000|COMPLETED|3-Year Follow-up||10854||
48296978|NCT00973362|101054393|FG001|COMPLETED|3-Year Follow-up||0||
48296979|NCT00973362|101054392|FG000|NOT COMPLETED|3-Year Follow-up||17||
48296980|NCT00973362|101054393|FG001|NOT COMPLETED|3-Year Follow-up||0||
48296981|NCT04508023|101054394|FG000|STARTED|Overall Study||641||
48296982|NCT04508023|101054395|FG001|STARTED|Overall Study||643||
48296983|NCT04508023|101054394|FG000|Treated (Safety Analysis Set)|Overall Study||599||
48296984|NCT04508023|101054395|FG001|Treated (Safety Analysis Set)|Overall Study||598||
48296985|NCT04508023|101054394|FG000|COMPLETED|Overall Study||640|This also included participants who were not treated with study drug, but were still followed-up as per the planned visits.|
48296986|NCT04508023|101054395|FG001|COMPLETED|Overall Study||641|This also included participants who were not treated with study drug, but were still followed-up as per the planned visits.|
48296987|NCT04508023|101054394|FG000|NOT COMPLETED|Overall Study||1||
48296988|NCT04508023|101054395|FG001|NOT COMPLETED|Overall Study||2||
48296989|NCT01139658|101054396|FG000|STARTED|Overall Study||747||
48296990|NCT01139658|101054397|FG001|STARTED|Overall Study||929||
48296991|NCT01139658|101054396|FG000|COMPLETED|Overall Study||691||
48296992|NCT01139658|101054397|FG001|COMPLETED|Overall Study||816||
48296993|NCT01139658|101054396|FG000|NOT COMPLETED|Overall Study||56||
48296994|NCT01139658|101054397|FG001|NOT COMPLETED|Overall Study||113||
48296995|NCT04487834|101054398|FG000|STARTED|Overall Study||33||
48296996|NCT04487834|101054399|FG001|STARTED|Overall Study||54||
48296997|NCT04487834|101054398|FG000|COMPLETED|Overall Study||33||
48296998|NCT04487834|101054399|FG001|COMPLETED|Overall Study||54||
48296999|NCT04487834|101054398|FG000|NOT COMPLETED|Overall Study||0||
48297000|NCT04487834|101054399|FG001|NOT COMPLETED|Overall Study||0||
48297001|NCT00756470|101054400|FG000|STARTED|Overall Study||15||
48297002|NCT00756470|101054400|FG000|COMPLETED|Overall Study||10||
48297003|NCT00756470|101054400|FG000|NOT COMPLETED|Overall Study||5||
48297004|NCT01259284|101054401|FG000|STARTED|Overall Study||2||
48297005|NCT01259284|101054402|FG001|STARTED|Overall Study||0||
48297006|NCT01259284|101054403|FG002|STARTED|Overall Study||0||
48297007|NCT01259284|101054401|FG000|COMPLETED|Overall Study||0||
48297008|NCT01259284|101054402|FG001|COMPLETED|Overall Study||0||
48297009|NCT01259284|101054403|FG002|COMPLETED|Overall Study||0||
48297010|NCT01259284|101054401|FG000|NOT COMPLETED|Overall Study||2||
48297011|NCT01259284|101054402|FG001|NOT COMPLETED|Overall Study||0||
48297012|NCT01259284|101054403|FG002|NOT COMPLETED|Overall Study||0||
48598316|NCT01687387|101800063|FG000|NOT COMPLETED|Overall Study||41||
48598317|NCT01687387|101800064|FG001|NOT COMPLETED|Overall Study||38||
48598318|NCT01687387|101800065|FG002|NOT COMPLETED|Overall Study||38||
48598319|NCT03535194|101800066|FG000|STARTED|Induction Period||454||
48598320|NCT03535194|101800067|FG001|STARTED|Induction Period||451||
48598321|NCT03535194|101800068|FG002|STARTED|Induction Period||112||
48598322|NCT03535194|101800069|FG003|STARTED|Induction Period||448||
48598323|NCT03535194|101800070|FG004|STARTED|Induction Period||19||
48598324|NCT03535194|101800066|FG000|Received at Least One Dose of Study Drug|Induction Period||454||
48598325|NCT03535194|101800067|FG001|Received at Least One Dose of Study Drug|Induction Period||450||
48598326|NCT03535194|101800068|FG002|Received at Least One Dose of Study Drug|Induction Period||112||
48598327|NCT03535194|101800069|FG003|Received at Least One Dose of Study Drug|Induction Period||448||
48598328|NCT03535194|101800070|FG004|Received at Least One Dose of Study Drug|Induction Period||19||
48598329|NCT03535194|101800066|FG000|COMPLETED|Induction Period||443||
48598330|NCT03535194|101800067|FG001|COMPLETED|Induction Period||434||
48598331|NCT03535194|101800068|FG002|COMPLETED|Induction Period||104||
48598332|NCT03535194|101800069|FG003|COMPLETED|Induction Period||437||
48598333|NCT03535194|101800070|FG004|COMPLETED|Induction Period||19||
48598334|NCT03535194|101800066|FG000|NOT COMPLETED|Induction Period||11||
48598335|NCT03535194|101800067|FG001|NOT COMPLETED|Induction Period||17||
48598336|NCT03535194|101800068|FG002|NOT COMPLETED|Induction Period||8||
48297013|NCT01831856|101054404|FG000|STARTED|Overall Study||67||
48297014|NCT01831856|101054405|FG001|STARTED|Overall Study||67||
48297015|NCT01831856|101054404|FG000|COMPLETED|Overall Study||33||
48297016|NCT01831856|101054405|FG001|COMPLETED|Overall Study||30||
48297017|NCT01831856|101054404|FG000|NOT COMPLETED|Overall Study||34||
48598337|NCT03535194|101800069|FG003|NOT COMPLETED|Induction Period||11||
48598338|NCT03535194|101800070|FG004|NOT COMPLETED|Induction Period||0||
48598339|NCT03535194|101800066|FG000|STARTED|Maintenance Period||443||
48598340|NCT03535194|101800067|FG001|STARTED|Maintenance Period||434||
48598341|NCT03535194|101800068|FG002|STARTED|Maintenance Period||104||
48598342|NCT03535194|101800069|FG003|STARTED|Maintenance Period||437||
48598343|NCT03535194|101800070|FG004|STARTED|Maintenance Period||19||
48598344|NCT03535194|101800066|FG000|COMPLETED|Maintenance Period||421||
48598345|NCT03535194|101800067|FG001|COMPLETED|Maintenance Period||418||
48297018|NCT01831856|101054405|FG001|NOT COMPLETED|Overall Study||37||
48297019|NCT01343485|101054406|FG000|STARTED|Overall Study||185||
48297020|NCT01343485|101054407|FG001|STARTED|Overall Study||180||
48297021|NCT01343485|101054406|FG000|COMPLETED|Overall Study||36||
48297022|NCT01343485|101054407|FG001|COMPLETED|Overall Study||46||
48598346|NCT03535194|101800068|FG002|COMPLETED|Maintenance Period||96||
48598347|NCT03535194|101800069|FG003|COMPLETED|Maintenance Period||400||
48143864|NCT00092534|100676601|FG000|COMPLETED|Long-Term Follow-Up (LTFU) Study||0||
48598348|NCT03535194|101800070|FG004|COMPLETED|Maintenance Period||13||
48598349|NCT03535194|101800066|FG000|NOT COMPLETED|Maintenance Period||22||
48598350|NCT03535194|101800067|FG001|NOT COMPLETED|Maintenance Period||16||
48598351|NCT03535194|101800068|FG002|NOT COMPLETED|Maintenance Period||8||
48598352|NCT03535194|101800069|FG003|NOT COMPLETED|Maintenance Period||37||
48598353|NCT03535194|101800070|FG004|NOT COMPLETED|Maintenance Period||6||
48143865|NCT00092534|100676602|FG001|COMPLETED|Long-Term Follow-Up (LTFU) Study||0||
48143866|NCT00092534|100676603|FG002|COMPLETED|Long-Term Follow-Up (LTFU) Study||0||
48598354|NCT03535194|101800066|FG000|STARTED|Post-Treatment Followup Period||38||
48598355|NCT03535194|101800067|FG001|STARTED|Post-Treatment Followup Period||35||
48598356|NCT03535194|101800068|FG002|STARTED|Post-Treatment Followup Period||18||
48598357|NCT03535194|101800069|FG003|STARTED|Post-Treatment Followup Period||47||
48598358|NCT03535194|101800070|FG004|STARTED|Post-Treatment Followup Period||8||
48598359|NCT03535194|101800066|FG000|COMPLETED|Post-Treatment Followup Period||27||
48598360|NCT03535194|101800067|FG001|COMPLETED|Post-Treatment Followup Period||21||
48598361|NCT03535194|101800068|FG002|COMPLETED|Post-Treatment Followup Period||7||
48598362|NCT03535194|101800069|FG003|COMPLETED|Post-Treatment Followup Period||23||
48598363|NCT03535194|101800070|FG004|COMPLETED|Post-Treatment Followup Period||8||
48598364|NCT03535194|101800066|FG000|NOT COMPLETED|Post-Treatment Followup Period||11||
48143867|NCT00092534|100676604|FG003|COMPLETED|Long-Term Follow-Up (LTFU) Study||2749||
48598365|NCT03535194|101800067|FG001|NOT COMPLETED|Post-Treatment Followup Period||14||
48598366|NCT03535194|101800068|FG002|NOT COMPLETED|Post-Treatment Followup Period||11||
48598367|NCT03535194|101800069|FG003|NOT COMPLETED|Post-Treatment Followup Period||24||
48598368|NCT03535194|101800070|FG004|NOT COMPLETED|Post-Treatment Followup Period||0||
48598369|NCT01094782|101800071|FG000|STARTED|Overall Study||39||
48598370|NCT01094782|101800072|FG001|STARTED|Overall Study||39||
48598371|NCT01094782|101800073|FG002|STARTED|Overall Study||34||
48598372|NCT01094782|101800074|FG003|STARTED|Overall Study||56||
48598373|NCT01094782|101800075|FG004|STARTED|Overall Study||42||
48598374|NCT01094782|101800076|FG005|STARTED|Overall Study||38||
48598375|NCT01094782|101800071|FG000|COMPLETED|Overall Study||31||
48598376|NCT01094782|101800072|FG001|COMPLETED|Overall Study||29||
48598377|NCT01094782|101800073|FG002|COMPLETED|Overall Study||31||
48598378|NCT01094782|101800074|FG003|COMPLETED|Overall Study||45||
48598379|NCT01094782|101800075|FG004|COMPLETED|Overall Study||31||
48598380|NCT01094782|101800076|FG005|COMPLETED|Overall Study||30||
48598381|NCT01094782|101800071|FG000|NOT COMPLETED|Overall Study||8||
48598382|NCT01094782|101800072|FG001|NOT COMPLETED|Overall Study||10||
48598383|NCT01094782|101800073|FG002|NOT COMPLETED|Overall Study||3||
48598384|NCT01094782|101800074|FG003|NOT COMPLETED|Overall Study||11||
48598385|NCT01094782|101800075|FG004|NOT COMPLETED|Overall Study||11||
48598386|NCT01094782|101800076|FG005|NOT COMPLETED|Overall Study||8||
48598387|NCT02636439|101800077|FG000|STARTED|Overall Study||44||
48598388|NCT02636439|101800078|FG001|STARTED|Overall Study||44||
48598389|NCT02636439|101800077|FG000|COMPLETED|Overall Study||38||
48598390|NCT02636439|101800078|FG001|COMPLETED|Overall Study||41||
48598391|NCT02636439|101800077|FG000|NOT COMPLETED|Overall Study||6||
48598392|NCT02636439|101800078|FG001|NOT COMPLETED|Overall Study||3||
48598393|NCT04607980|101800079|FG000|STARTED|Overall Study||281||
48598394|NCT04607980|101800080|FG001|STARTED|Overall Study||282||
48598395|NCT04607980|101800079|FG000|Treated|Overall Study||280||
48598396|NCT04607980|101800080|FG001|Treated|Overall Study||282||
48598397|NCT04607980|101800079|FG000|Re-randomized to ABP 654 at Week 28|Overall Study||247||
48598398|NCT04607980|101800080|FG001|Re-randomized to ABP 654 at Week 28|Overall Study||117||
48598399|NCT04607980|101800079|FG000|Re-randomized to Ustekinumab at Week 28|Overall Study||0||
48598400|NCT04607980|101800080|FG001|Re-randomized to Ustekinumab at Week 28|Overall Study||116||
48598401|NCT04607980|101800079|FG000|Not Re-randomized at Week 28 and Dose Intensified|Overall Study||25||
48598402|NCT04607980|101800080|FG001|Not Re-randomized at Week 28 and Dose Intensified|Overall Study||34||
48598403|NCT04607980|101800079|FG000|COMPLETED|Overall Study||269||
48598404|NCT04607980|101800080|FG001|COMPLETED|Overall Study||261||
48598405|NCT04607980|101800079|FG000|NOT COMPLETED|Overall Study||12||
48598406|NCT04607980|101800080|FG001|NOT COMPLETED|Overall Study||21||
48598407|NCT02945254|101800081|FG000|STARTED|Overall Study||10||
48598408|NCT02945254|101800082|FG001|STARTED|Overall Study||10||
48297023|NCT01343485|101054406|FG000|NOT COMPLETED|Overall Study||149||
48297024|NCT01343485|101054407|FG001|NOT COMPLETED|Overall Study||134||
48297025|NCT01087931|101054408|FG000|STARTED|Overall Study||20||
48297026|NCT01087931|101054409|FG001|STARTED|Overall Study||20||
48297027|NCT01087931|101054408|FG000|1st Follow up|Overall Study||20||
48297028|NCT01087931|101054409|FG001|1st Follow up|Overall Study||19||
48297029|NCT01087931|101054408|FG000|Final Follow up|Overall Study||19||
48297030|NCT01087931|101054409|FG001|Final Follow up|Overall Study||17||
48297031|NCT01087931|101054408|FG000|COMPLETED|Overall Study||20|all participants completed either the 1st follow-up evaluation or the final evaluation|
48297032|NCT01087931|101054409|FG001|COMPLETED|Overall Study||20|all participants completed either the 1st follow-up evaluation or the final evaluation|
48297033|NCT01087931|101054408|FG000|NOT COMPLETED|Overall Study||0||
48297034|NCT01087931|101054409|FG001|NOT COMPLETED|Overall Study||0||
48297035|NCT01917513|101054410|FG000|STARTED|Overall Study||502||
48297036|NCT01917513|101054411|FG001|STARTED|Overall Study||498||
48297037|NCT01917513|101054410|FG000|COMPLETED|Overall Study||407||
48297038|NCT01917513|101054411|FG001|COMPLETED|Overall Study||396||
48297039|NCT01917513|101054410|FG000|NOT COMPLETED|Overall Study||95||
48297040|NCT01917513|101054411|FG001|NOT COMPLETED|Overall Study||102||
48297041|NCT00092495|101054412|FG000|STARTED|Base Study Vaccination Period||504||
48297042|NCT00092495|101054413|FG001|STARTED|Base Study Vaccination Period||514||
48297043|NCT00092495|101054414|FG002|STARTED|Base Study Vaccination Period||508||
48297044|NCT00092495|101054415|FG003|STARTED|Base Study Vaccination Period||1529||
48297045|NCT00092495|101054416|FG004|STARTED|Base Study Vaccination Period||0||
48297046|NCT00092495|101054412|FG000|With Long-term Follow-up *|Base Study Vaccination Period||2||
48297047|NCT00092495|101054413|FG001|With Long-term Follow-up *|Base Study Vaccination Period||2||
48297048|NCT00092495|101054414|FG002|With Long-term Follow-up *|Base Study Vaccination Period||6||
48297049|NCT00092495|101054415|FG003|With Long-term Follow-up *|Base Study Vaccination Period||10||
48297050|NCT00092495|101054416|FG004|With Long-term Follow-up *|Base Study Vaccination Period||0||
48297051|NCT00092495|101054412|FG000|Without Long-term Follow-up|Base Study Vaccination Period||34||
48297052|NCT00092495|101054413|FG001|Without Long-term Follow-up|Base Study Vaccination Period||20||
48297053|NCT00092495|101054414|FG002|Without Long-term Follow-up|Base Study Vaccination Period||28||
48367938|NCT03661541|101230077|FG000|NOT COMPLETED|Overall Study||2||
48598409|NCT02945254|101800081|FG000|COMPLETED|Overall Study||8||
48598410|NCT02945254|101800082|FG001|COMPLETED|Overall Study||10||
48598411|NCT02945254|101800081|FG000|NOT COMPLETED|Overall Study||2||
48598412|NCT02945254|101800082|FG001|NOT COMPLETED|Overall Study||0||
48598413|NCT02223364|101800083|FG000|STARTED|Overall Study||55||
48598414|NCT02223364|101800084|FG001|STARTED|Overall Study||55||
48598415|NCT02223364|101800085|FG002|STARTED|Overall Study||55||
48598416|NCT02223364|101800083|FG000|COMPLETED|Overall Study||50||
48598417|NCT02223364|101800084|FG001|COMPLETED|Overall Study||55||
48598418|NCT02223364|101800085|FG002|COMPLETED|Overall Study||52||
48598419|NCT02223364|101800083|FG000|NOT COMPLETED|Overall Study||5||
48598420|NCT02223364|101800084|FG001|NOT COMPLETED|Overall Study||0||
48598421|NCT02223364|101800085|FG002|NOT COMPLETED|Overall Study||3||
48598422|NCT02638051|101800086|FG000|STARTED|Overall Study||130||
48598423|NCT02638051|101800087|FG001|STARTED|Overall Study||130||
48598424|NCT02638051|101800086|FG000|COMPLETED|Overall Study||130||
48598425|NCT02638051|101800087|FG001|COMPLETED|Overall Study||130||
48598426|NCT02638051|101800086|FG000|NOT COMPLETED|Overall Study||0||
48598427|NCT02638051|101800087|FG001|NOT COMPLETED|Overall Study||0||
48598428|NCT01731470|101800088|FG000|STARTED|Overall Study||16||
48598429|NCT01731470|101800088|FG000|COMPLETED|Overall Study||14||
48598430|NCT01731470|101800088|FG000|NOT COMPLETED|Overall Study||2||
48598431|NCT03004924|101800089|FG000|STARTED|Overall Study||324||
48598432|NCT03004924|101800090|FG001|STARTED|Overall Study||108||
48598433|NCT03004924|101800091|FG002|STARTED|Overall Study||321||
48598434|NCT03004924|101800089|FG000|COMPLETED|Overall Study||297||
48598435|NCT03004924|101800090|FG001|COMPLETED|Overall Study||94||
48598436|NCT03004924|101800091|FG002|COMPLETED|Overall Study||293||
48598437|NCT03004924|101800089|FG000|NOT COMPLETED|Overall Study||27||
48598438|NCT03004924|101800090|FG001|NOT COMPLETED|Overall Study||14||
48598439|NCT03004924|101800091|FG002|NOT COMPLETED|Overall Study||28||
48598440|NCT00312572|101800092|FG000|STARTED|Overall Study||101||
48598441|NCT00312572|101800093|FG001|STARTED|Overall Study||103||
48598442|NCT00312572|101800092|FG000|COMPLETED|Overall Study||85||
48598443|NCT00312572|101800093|FG001|COMPLETED|Overall Study||82||
48598444|NCT00312572|101800092|FG000|NOT COMPLETED|Overall Study||16||
48598445|NCT00312572|101800093|FG001|NOT COMPLETED|Overall Study||21||
48598446|NCT01069315|101800094|FG000|STARTED|Overall Study||27||
48598447|NCT01069315|101800095|FG001|STARTED|Overall Study||30||
48598448|NCT01069315|101800096|FG002|STARTED|Overall Study||28||
48598449|NCT01069315|101800097|FG003|STARTED|Overall Study||26||
48598450|NCT01069315|101800094|FG000|COMPLETED|Overall Study||23||
48598451|NCT01069315|101800095|FG001|COMPLETED|Overall Study||24||
48598452|NCT01069315|101800096|FG002|COMPLETED|Overall Study||23||
48598453|NCT01069315|101800097|FG003|COMPLETED|Overall Study||19||
48598454|NCT01069315|101800094|FG000|NOT COMPLETED|Overall Study||4||
48598455|NCT01069315|101800095|FG001|NOT COMPLETED|Overall Study||6||
48598456|NCT01069315|101800096|FG002|NOT COMPLETED|Overall Study||5||
48598457|NCT01069315|101800097|FG003|NOT COMPLETED|Overall Study||7||
48598458|NCT02722837|101800098|FG000|STARTED|Overall Study||119||
48598459|NCT02722837|101800098|FG000|COMPLETED|Overall Study||119||
48297054|NCT00092495|101054415|FG003|Without Long-term Follow-up|Base Study Vaccination Period||73||
48297055|NCT00092495|101054416|FG004|Without Long-term Follow-up|Base Study Vaccination Period||0||
48297056|NCT00092495|101054412|FG000|COMPLETED|Base Study Vaccination Period||467||
48598460|NCT02722837|101800098|FG000|NOT COMPLETED|Overall Study||0||
48598461|NCT00934856|101800099|FG000|STARTED|Feasibility Part||6||
48598462|NCT00934856|101800100|FG001|STARTED|Feasibility Part||6||
48598463|NCT00934856|101800101|FG002|STARTED|Feasibility Part||3||
48598464|NCT00934856|101800102|FG003|STARTED|Feasibility Part||6||
48598465|NCT00934856|101800103|FG004|STARTED|Feasibility Part||12||
48598466|NCT00934856|101800104|FG005|STARTED|Feasibility Part||9||
48598467|NCT00934856|101800099|FG000|COMPLETED|Feasibility Part||1||
48598468|NCT00934856|101800100|FG001|COMPLETED|Feasibility Part||1||
48598469|NCT00934856|101800101|FG002|COMPLETED|Feasibility Part||0||
48598470|NCT00934856|101800102|FG003|COMPLETED|Feasibility Part||1||
48598471|NCT00934856|101800103|FG004|COMPLETED|Feasibility Part||12||
48598472|NCT00934856|101800104|FG005|COMPLETED|Feasibility Part||6||
48598473|NCT00934856|101800099|FG000|NOT COMPLETED|Feasibility Part||5||
48598474|NCT00934856|101800100|FG001|NOT COMPLETED|Feasibility Part||5||
48598475|NCT00934856|101800101|FG002|NOT COMPLETED|Feasibility Part||3||
48598476|NCT00934856|101800102|FG003|NOT COMPLETED|Feasibility Part||5||
48598477|NCT00934856|101800103|FG004|NOT COMPLETED|Feasibility Part||0||
48598478|NCT00934856|101800104|FG005|NOT COMPLETED|Feasibility Part||3||
48598479|NCT00934856|101800099|FG000|STARTED|Extension Part||0||
48598480|NCT00934856|101800100|FG001|STARTED|Extension Part||0||
48598481|NCT00934856|101800101|FG002|STARTED|Extension Part||0||
48598482|NCT00934856|101800102|FG003|STARTED|Extension Part||4||
48598483|NCT00934856|101800103|FG004|STARTED|Extension Part||28||
48598484|NCT00934856|101800104|FG005|STARTED|Extension Part||24||
48598485|NCT00934856|101800099|FG000|COMPLETED|Extension Part||0||
48598486|NCT00934856|101800100|FG001|COMPLETED|Extension Part||0||
48598487|NCT00934856|101800101|FG002|COMPLETED|Extension Part||0||
48598488|NCT00934856|101800102|FG003|COMPLETED|Extension Part||2||
48598489|NCT00934856|101800103|FG004|COMPLETED|Extension Part||24||
48598490|NCT00934856|101800104|FG005|COMPLETED|Extension Part||19||
48598491|NCT00934856|101800099|FG000|NOT COMPLETED|Extension Part||0||
48598492|NCT00934856|101800100|FG001|NOT COMPLETED|Extension Part||0||
48598493|NCT00934856|101800101|FG002|NOT COMPLETED|Extension Part||0||
48598494|NCT00934856|101800102|FG003|NOT COMPLETED|Extension Part||2||
48598495|NCT00934856|101800103|FG004|NOT COMPLETED|Extension Part||4||
48598496|NCT00934856|101800104|FG005|NOT COMPLETED|Extension Part||5||
48598497|NCT01153620|101800105|FG000|STARTED|Overall Study||30||
48598498|NCT01153620|101800106|FG001|STARTED|Overall Study||30||
48598499|NCT01153620|101800105|FG000|COMPLETED|Overall Study||30||
48297057|NCT00092495|101054413|FG001|COMPLETED|Base Study Vaccination Period||492||
48297058|NCT00092495|101054414|FG002|COMPLETED|Base Study Vaccination Period||474||
48297059|NCT00092495|101054415|FG003|COMPLETED|Base Study Vaccination Period||1441||
48297060|NCT00092495|101054416|FG004|COMPLETED|Base Study Vaccination Period||0||
48297061|NCT00092495|101054412|FG000|NOT COMPLETED|Base Study Vaccination Period||37||
48297062|NCT00092495|101054413|FG001|NOT COMPLETED|Base Study Vaccination Period||22||
48297063|NCT00092495|101054414|FG002|NOT COMPLETED|Base Study Vaccination Period||34||
48297064|NCT00092495|101054415|FG003|NOT COMPLETED|Base Study Vaccination Period||88||
48297065|NCT00092495|101054416|FG004|NOT COMPLETED|Base Study Vaccination Period||0||
48598500|NCT01153620|101800106|FG001|COMPLETED|Overall Study||30||
48598501|NCT01153620|101800105|FG000|NOT COMPLETED|Overall Study||0||
48598502|NCT01153620|101800106|FG001|NOT COMPLETED|Overall Study||0||
48598503|NCT01505179|101800107|FG000|STARTED|Overall Study||6||
48598504|NCT01505179|101800108|FG001|STARTED|Overall Study||4||
48598505|NCT01505179|101800107|FG000|COMPLETED|Overall Study||6||
48598506|NCT01505179|101800108|FG001|COMPLETED|Overall Study||4||
48598507|NCT01505179|101800107|FG000|NOT COMPLETED|Overall Study||0||
48598508|NCT01505179|101800108|FG001|NOT COMPLETED|Overall Study||0||
48598509|NCT03403621|101800109|FG000|STARTED|Overall Study||6||6
48598510|NCT03403621|101800110|FG001|STARTED|Overall Study||6||6
48598511|NCT03403621|101800109|FG000|COMPLETED|Overall Study||4||4
48598512|NCT03403621|101800110|FG001|COMPLETED|Overall Study||4||4
48713076|NCT02011490|102084871|FG005|STARTED|Part 1||0||
48713077|NCT02011490|102084866|FG000|COMPLETED|Part 1||8||
48713078|NCT02011490|102084867|FG001|COMPLETED|Part 1||8||
48598513|NCT03403621|101800109|FG000|NOT COMPLETED|Overall Study||2||2
48598514|NCT03403621|101800110|FG001|NOT COMPLETED|Overall Study||2||2
48598515|NCT00231283|101800111|FG000|STARTED|Overall Study||100||
48598516|NCT00231283|101800111|FG000|COMPLETED|Overall Study||95||
48598517|NCT00231283|101800111|FG000|NOT COMPLETED|Overall Study||5||
48713079|NCT02011490|102084868|FG002|COMPLETED|Part 1||8||
48713080|NCT02011490|102084869|FG003|COMPLETED|Part 1||0||
48713081|NCT02011490|102084870|FG004|COMPLETED|Part 1||0||
48713082|NCT02011490|102084871|FG005|COMPLETED|Part 1||0||
48713083|NCT02011490|102084866|FG000|NOT COMPLETED|Part 1||0||
48713084|NCT02011490|102084867|FG001|NOT COMPLETED|Part 1||0||
48713085|NCT02011490|102084868|FG002|NOT COMPLETED|Part 1||0||
48713086|NCT02011490|102084869|FG003|NOT COMPLETED|Part 1||0||
48713087|NCT02011490|102084870|FG004|NOT COMPLETED|Part 1||0||
48713088|NCT02011490|102084871|FG005|NOT COMPLETED|Part 1||0||
48713089|NCT02011490|102084866|FG000|STARTED|Part 2||0||
48713090|NCT02011490|102084867|FG001|STARTED|Part 2||0||
48713091|NCT02011490|102084868|FG002|STARTED|Part 2||0||
48713092|NCT02011490|102084869|FG003|STARTED|Part 2||6||
48713093|NCT02011490|102084870|FG004|STARTED|Part 2||6||
48713094|NCT02011490|102084871|FG005|STARTED|Part 2||6||
48713095|NCT02011490|102084866|FG000|COMPLETED|Part 2||0||
48713096|NCT02011490|102084867|FG001|COMPLETED|Part 2||0||
48713097|NCT02011490|102084868|FG002|COMPLETED|Part 2||0||
48713098|NCT02011490|102084869|FG003|COMPLETED|Part 2||6||
48713099|NCT02011490|102084870|FG004|COMPLETED|Part 2||6||
48713100|NCT02011490|102084871|FG005|COMPLETED|Part 2||6||
48713101|NCT02011490|102084866|FG000|NOT COMPLETED|Part 2||0||
48713102|NCT02011490|102084867|FG001|NOT COMPLETED|Part 2||0||
48713103|NCT02011490|102084868|FG002|NOT COMPLETED|Part 2||0||
48713104|NCT02011490|102084869|FG003|NOT COMPLETED|Part 2||0||
48297066|NCT00092495|101054412|FG000|STARTED|Base Study Follow-up Period||115||
48598518|NCT01701505|101800112|FG000|STARTED|Overall Study||8||
48598519|NCT01701505|101800113|FG001|STARTED|Overall Study||8||
48598520|NCT01701505|101800114|FG002|STARTED|Overall Study||8||
48598521|NCT01701505|101800115|FG003|STARTED|Overall Study||8||
48713105|NCT02011490|102084870|FG004|NOT COMPLETED|Part 2||0||
48713106|NCT02011490|102084871|FG005|NOT COMPLETED|Part 2||0||
48713107|NCT02680574|102084872|FG000|STARTED|Overall Study||862||
48713108|NCT02680574|102084873|FG001|STARTED|Overall Study||863||
48713109|NCT02680574|102084872|FG000|COMPLETED|Overall Study||704||
48713110|NCT02680574|102084873|FG001|COMPLETED|Overall Study||711||
48713111|NCT02680574|102084872|FG000|NOT COMPLETED|Overall Study||158||
48297067|NCT00092495|101054413|FG001|STARTED|Base Study Follow-up Period||125||
48297068|NCT00092495|101054414|FG002|STARTED|Base Study Follow-up Period||130||
48297069|NCT00092495|101054415|FG003|STARTED|Base Study Follow-up Period||460||
48297070|NCT00092495|101054416|FG004|STARTED|Base Study Follow-up Period||0||
48297071|NCT00092495|101054412|FG000|COMPLETED|Base Study Follow-up Period||112||
48297072|NCT00092495|101054413|FG001|COMPLETED|Base Study Follow-up Period||122||
48297073|NCT00092495|101054414|FG002|COMPLETED|Base Study Follow-up Period||126||
48297074|NCT00092495|101054415|FG003|COMPLETED|Base Study Follow-up Period||446||
48297075|NCT00092495|101054416|FG004|COMPLETED|Base Study Follow-up Period||0||
48297076|NCT00092495|101054412|FG000|NOT COMPLETED|Base Study Follow-up Period||3||
48297077|NCT00092495|101054413|FG001|NOT COMPLETED|Base Study Follow-up Period||3||
48297078|NCT00092495|101054414|FG002|NOT COMPLETED|Base Study Follow-up Period||4||
48297079|NCT00092495|101054415|FG003|NOT COMPLETED|Base Study Follow-up Period||14||
48598522|NCT01701505|101800116|FG004|STARTED|Overall Study||8||
48598523|NCT01701505|101800117|FG005|STARTED|Overall Study||8||
48598524|NCT01701505|101800112|FG000|COMPLETED|Overall Study||8||
48598525|NCT01701505|101800113|FG001|COMPLETED|Overall Study||8||
48598526|NCT01701505|101800114|FG002|COMPLETED|Overall Study||8||
48598527|NCT01701505|101800115|FG003|COMPLETED|Overall Study||8||
48598528|NCT01701505|101800116|FG004|COMPLETED|Overall Study||8||
48598529|NCT01701505|101800117|FG005|COMPLETED|Overall Study||8||
48598530|NCT01701505|101800112|FG000|NOT COMPLETED|Overall Study||0||
48598531|NCT01701505|101800113|FG001|NOT COMPLETED|Overall Study||0||
48598532|NCT01701505|101800114|FG002|NOT COMPLETED|Overall Study||0||
48598533|NCT01701505|101800115|FG003|NOT COMPLETED|Overall Study||0||
48598534|NCT01701505|101800116|FG004|NOT COMPLETED|Overall Study||0||
48598535|NCT01701505|101800117|FG005|NOT COMPLETED|Overall Study||0||
48598536|NCT04811664|101800118|FG000|STARTED|Overall Study||725||
48598537|NCT04811664|101800119|FG001|STARTED|Overall Study||728||
48598538|NCT04811664|101800120|FG002|STARTED|Overall Study||470||
48598539|NCT04811664|101800118|FG000|Full Analysis Set (FAS)|Overall Study||725||
48598540|NCT04811664|101800119|FG001|Full Analysis Set (FAS)|Overall Study||728||
48598541|NCT04811664|101800120|FG002|Full Analysis Set (FAS)|Overall Study||470||
48598542|NCT04811664|101800118|FG000|Full Analysis Set With Study PCR (FAS-P)|Overall Study||701||
48598543|NCT04811664|101800119|FG001|Full Analysis Set With Study PCR (FAS-P)|Overall Study||646||
48598544|NCT04811664|101800120|FG002|Full Analysis Set With Study PCR (FAS-P)|Overall Study||454||
48598545|NCT04811664|101800118|FG000|FAS-P With Outside Vaccination Censored Incidence Rate Follow-up|Overall Study||563||
48598546|NCT04811664|101800119|FG001|FAS-P With Outside Vaccination Censored Incidence Rate Follow-up|Overall Study||622||
48598547|NCT04811664|101800120|FG002|FAS-P With Outside Vaccination Censored Incidence Rate Follow-up|Overall Study||452||
48598548|NCT04811664|101800118|FG000|Baseline Negative|Overall Study||600||
48598549|NCT04811664|101800119|FG001|Baseline Negative|Overall Study||549||
48598550|NCT04811664|101800120|FG002|Baseline Negative|Overall Study||311||
48598551|NCT04811664|101800118|FG000|Baseline Negative With Outside Vaccination Censored Incidence Rate Follow-up|Overall Study||489||
48598552|NCT04811664|101800119|FG001|Baseline Negative With Outside Vaccination Censored Incidence Rate Follow-up|Overall Study||531||
48598553|NCT04811664|101800120|FG002|Baseline Negative With Outside Vaccination Censored Incidence Rate Follow-up|Overall Study||311||
48598554|NCT04811664|101800118|FG000|FAS-P Viral Load|Overall Study||22||
48598555|NCT04811664|101800119|FG001|FAS-P Viral Load|Overall Study||23||
48598556|NCT04811664|101800120|FG002|FAS-P Viral Load|Overall Study||44||
48598557|NCT04811664|101800118|FG000|COMPLETED|Overall Study||571||
48598558|NCT04811664|101800119|FG001|COMPLETED|Overall Study||450||
48598559|NCT04811664|101800120|FG002|COMPLETED|Overall Study||255||
48598560|NCT04811664|101800118|FG000|NOT COMPLETED|Overall Study||154||
48598561|NCT04811664|101800119|FG001|NOT COMPLETED|Overall Study||278||
48598562|NCT04811664|101800120|FG002|NOT COMPLETED|Overall Study||215||
48598563|NCT01732445|101800121|FG000|STARTED|Overall Study||14||
48598564|NCT01732445|101800121|FG000|COMPLETED|Overall Study||14||
48598565|NCT01732445|101800121|FG000|NOT COMPLETED|Overall Study||0||
48598566|NCT01810783|101800122|FG000|STARTED|Overall Study||210||
48598567|NCT01810783|101800122|FG000|COMPLETED|Overall Study||101||
48598568|NCT01810783|101800122|FG000|NOT COMPLETED|Overall Study||109||
48598569|NCT03796676|101800123|FG000|STARTED|Overall Study||96||
48143868|NCT00092534|100676605|FG004|COMPLETED|Long-Term Follow-Up (LTFU) Study||2097||
48143869|NCT00092534|100676601|FG000|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0||
48143870|NCT00092534|100676602|FG001|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0||
48143871|NCT00092534|100676603|FG002|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0||
48143872|NCT00092534|100676604|FG003|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||1||
48143873|NCT00092534|100676605|FG004|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0||
48143874|NCT01362140|100676606|FG000|STARTED|Overall Study||49||
48143875|NCT01362140|100676607|FG001|STARTED|Overall Study||98||
48143876|NCT01362140|100676606|FG000|Received Treatment|Overall Study||49||
48143877|NCT01362140|100676607|FG001|Received Treatment|Overall Study||97||
48143878|NCT01362140|100676606|FG000|COMPLETED|Overall Study||39||
48598570|NCT03796676|101800124|FG001|STARTED|Overall Study||95||
48598571|NCT03796676|101800125|FG002|STARTED|Overall Study||94||
48598572|NCT03796676|101800123|FG000|COMPLETED|Overall Study||90||
48598573|NCT03796676|101800124|FG001|COMPLETED|Overall Study||92||
48598574|NCT03796676|101800125|FG002|COMPLETED|Overall Study||91||
48598575|NCT03796676|101800123|FG000|NOT COMPLETED|Overall Study||6||
48598576|NCT03796676|101800124|FG001|NOT COMPLETED|Overall Study||3||
48598577|NCT03796676|101800125|FG002|NOT COMPLETED|Overall Study||3||
48598578|NCT03092934|101800126|FG000|STARTED|Overall Study||8||
48143879|NCT01362140|100676607|FG001|COMPLETED|Overall Study||87||
48143880|NCT01362140|100676606|FG000|NOT COMPLETED|Overall Study||10||
48143881|NCT01362140|100676607|FG001|NOT COMPLETED|Overall Study||11||
48598579|NCT03092934|101800127|FG001|STARTED|Overall Study||2||
48598580|NCT03092934|101800128|FG002|STARTED|Overall Study||2||
48598581|NCT03092934|101800129|FG003|STARTED|Overall Study||1||
48143882|NCT03195010|100676608|FG000|STARTED|Overall Study||2||
48143883|NCT03195010|100676609|FG001|STARTED|Overall Study||2||
48143884|NCT03195010|100676608|FG000|COMPLETED|Overall Study||2||
48143885|NCT03195010|100676609|FG001|COMPLETED|Overall Study||2||
48143886|NCT03195010|100676608|FG000|NOT COMPLETED|Overall Study||0||
48598582|NCT03092934|101800126|FG000|Received at Least One Dose of Study Drug|Overall Study||8||
48598583|NCT03092934|101800127|FG001|Received at Least One Dose of Study Drug|Overall Study||2||
48598584|NCT03092934|101800128|FG002|Received at Least One Dose of Study Drug|Overall Study||2||
48598585|NCT03092934|101800129|FG003|Received at Least One Dose of Study Drug|Overall Study||1||
48598586|NCT03092934|101800126|FG000|COMPLETED|Overall Study||8||
48598587|NCT03092934|101800127|FG001|COMPLETED|Overall Study||2||
48598588|NCT03092934|101800128|FG002|COMPLETED|Overall Study||2||
48405078|NCT01973972|101325182|FG001|COMPLETED|Overall Study||117||
48405079|NCT01973972|101325181|FG000|NOT COMPLETED|Overall Study||18||
48405080|NCT01973972|101325182|FG001|NOT COMPLETED|Overall Study||19||
48405081|NCT00671970|101325183|FG000|STARTED|Overall Study||32||
48405082|NCT00671970|101325184|FG001|STARTED|Overall Study||25||
48405083|NCT00671970|101325183|FG000|COMPLETED|Overall Study||32||
48405084|NCT00671970|101325184|FG001|COMPLETED|Overall Study||25||
48405085|NCT00671970|101325183|FG000|NOT COMPLETED|Overall Study||0||
48405086|NCT00671970|101325184|FG001|NOT COMPLETED|Overall Study||0||
48405087|NCT02971007|101325185|FG000|STARTED|Overall Study||46||
48405088|NCT02971007|101325186|FG001|STARTED|Overall Study||45||
48405089|NCT02971007|101325187|FG002|STARTED|Overall Study||46||
48405090|NCT02971007|101325185|FG000|COMPLETED|Overall Study||44||
48405091|NCT02971007|101325186|FG001|COMPLETED|Overall Study||42||
48405092|NCT02971007|101325187|FG002|COMPLETED|Overall Study||45||
48405093|NCT02971007|101325185|FG000|NOT COMPLETED|Overall Study||2||
48405094|NCT02971007|101325186|FG001|NOT COMPLETED|Overall Study||3||
48405095|NCT02971007|101325187|FG002|NOT COMPLETED|Overall Study||1||
48405096|NCT00741260|101325188|FG000|STARTED|Overall Study||6||
48405097|NCT00741260|101325189|FG001|STARTED|Overall Study||8||
48405098|NCT00741260|101325190|FG002|STARTED|Overall Study||4||
48405099|NCT00741260|101325191|FG003|STARTED|Overall Study||6||
48405100|NCT00741260|101325192|FG004|STARTED|Overall Study||9||
48405101|NCT00741260|101325193|FG005|STARTED|Overall Study||65||
48598589|NCT03092934|101800129|FG003|COMPLETED|Overall Study||1||
48598590|NCT03092934|101800126|FG000|NOT COMPLETED|Overall Study||0||
48405102|NCT00741260|101325194|FG006|STARTED|Overall Study||7||
48405103|NCT00741260|101325188|FG000|COMPLETED|Overall Study||0||
48405104|NCT00741260|101325189|FG001|COMPLETED|Overall Study||0||
48405105|NCT00741260|101325190|FG002|COMPLETED|Overall Study||0||
48405106|NCT00741260|101325191|FG003|COMPLETED|Overall Study||0||
48405107|NCT00741260|101325192|FG004|COMPLETED|Overall Study||0||
48405108|NCT00741260|101325193|FG005|COMPLETED|Overall Study||20||
48405109|NCT00741260|101325194|FG006|COMPLETED|Overall Study||0||
48405110|NCT00741260|101325188|FG000|NOT COMPLETED|Overall Study||6||
48598591|NCT03092934|101800127|FG001|NOT COMPLETED|Overall Study||0||
48143887|NCT03195010|100676609|FG001|NOT COMPLETED|Overall Study||0||
48713112|NCT02680574|102084873|FG001|NOT COMPLETED|Overall Study||152||
48713113|NCT02226198|102084874|FG000|STARTED|Lead-in Phase||11||
48713114|NCT02226198|102084875|FG001|STARTED|Lead-in Phase||0||
48713115|NCT02226198|102084876|FG002|STARTED|Lead-in Phase||0||
48713116|NCT02226198|102084874|FG000|COMPLETED|Lead-in Phase||10||
48713117|NCT02226198|102084875|FG001|COMPLETED|Lead-in Phase||0||
48713118|NCT02226198|102084876|FG002|COMPLETED|Lead-in Phase||0||
48713119|NCT02226198|102084874|FG000|NOT COMPLETED|Lead-in Phase||1||
48713120|NCT02226198|102084875|FG001|NOT COMPLETED|Lead-in Phase||0||
48713121|NCT02226198|102084876|FG002|NOT COMPLETED|Lead-in Phase||0||
48598592|NCT03092934|101800128|FG002|NOT COMPLETED|Overall Study||0||
48598593|NCT03092934|101800129|FG003|NOT COMPLETED|Overall Study||0||
48598594|NCT02700698|101800130|FG000|STARTED|Overall Study||17||
48598595|NCT02700698|101800131|FG001|STARTED|Overall Study||18||
48598596|NCT02700698|101800130|FG000|COMPLETED|Overall Study||16||
48598597|NCT02700698|101800131|FG001|COMPLETED|Overall Study||18||
48598598|NCT02700698|101800130|FG000|NOT COMPLETED|Overall Study||1||
48713122|NCT02226198|102084874|FG000|STARTED|Cross-Over: First Intervention (6 Weeks)||0||
48143888|NCT03088267|100676610|FG000|STARTED|Overall Study||9||
48143889|NCT03088267|100676611|FG001|STARTED|Overall Study||9||
48143890|NCT03088267|100676610|FG000|COMPLETED|Overall Study||9||
48143891|NCT03088267|100676611|FG001|COMPLETED|Overall Study||9||
48143892|NCT03088267|100676610|FG000|NOT COMPLETED|Overall Study||0||
48143893|NCT03088267|100676611|FG001|NOT COMPLETED|Overall Study||0||
48143894|NCT00608582|100676612|FG000|STARTED|Overall Study||14||
48143895|NCT00608582|100676613|FG001|STARTED|Overall Study||11||
48143896|NCT00608582|100676612|FG000|COMPLETED|Overall Study||10||
48143897|NCT00608582|100676613|FG001|COMPLETED|Overall Study||7||
48598599|NCT02700698|101800131|FG001|NOT COMPLETED|Overall Study||0||
48598600|NCT03681184|101800132|FG000|STARTED|6-Month Double-Blind Period||13||
48598601|NCT03681184|101800133|FG001|STARTED|6-Month Double-Blind Period||26||
48598602|NCT03681184|101800132|FG000|COMPLETED|6-Month Double-Blind Period||13||
48598603|NCT03681184|101800133|FG001|COMPLETED|6-Month Double-Blind Period||25||
48598604|NCT03681184|101800132|FG000|NOT COMPLETED|6-Month Double-Blind Period||0||
48598605|NCT03681184|101800133|FG001|NOT COMPLETED|6-Month Double-Blind Period||1||
48598606|NCT03681184|101800132|FG000|STARTED|3-Month Blinded Extension Period||13||
48598607|NCT03681184|101800133|FG001|STARTED|3-Month Blinded Extension Period||24||
48598608|NCT03681184|101800132|FG000|COMPLETED|3-Month Blinded Extension Period||13||
48598609|NCT03681184|101800133|FG001|COMPLETED|3-Month Blinded Extension Period||24||
48598610|NCT03681184|101800132|FG000|NOT COMPLETED|3-Month Blinded Extension Period||0||
48598611|NCT03681184|101800133|FG001|NOT COMPLETED|3-Month Blinded Extension Period||0||
48598612|NCT03681184|101800132|FG000|STARTED|Open-Label Extension Period||13||
48598613|NCT03681184|101800133|FG001|STARTED|Open-Label Extension Period||24||
48598614|NCT03681184|101800132|FG000|COMPLETED|Open-Label Extension Period||13||
48598615|NCT03681184|101800133|FG001|COMPLETED|Open-Label Extension Period||24||
48598616|NCT03681184|101800132|FG000|NOT COMPLETED|Open-Label Extension Period||0||
48598617|NCT03681184|101800133|FG001|NOT COMPLETED|Open-Label Extension Period||0||
48598618|NCT05645432|101800134|FG000|STARTED|Overall Study||10||
48713123|NCT02226198|102084875|FG001|STARTED|Cross-Over: First Intervention (6 Weeks)||7||
48713124|NCT02226198|102084876|FG002|STARTED|Cross-Over: First Intervention (6 Weeks)||7||
48713125|NCT02226198|102084874|FG000|COMPLETED|Cross-Over: First Intervention (6 Weeks)||0||
48713126|NCT02226198|102084875|FG001|COMPLETED|Cross-Over: First Intervention (6 Weeks)||6||
48713127|NCT02226198|102084876|FG002|COMPLETED|Cross-Over: First Intervention (6 Weeks)||7||
48143898|NCT00608582|100676612|FG000|NOT COMPLETED|Overall Study||4||
48143899|NCT00608582|100676613|FG001|NOT COMPLETED|Overall Study||4||
48143900|NCT02154763|100676614|FG000|STARTED|Overall Study||60||
48598619|NCT05645432|101800134|FG000|COMPLETED|Overall Study||9||
48143901|NCT02154763|100676615|FG001|STARTED|Overall Study||60||
48143902|NCT02154763|100676614|FG000|COMPLETED|Overall Study||46||
48143903|NCT02154763|100676615|FG001|COMPLETED|Overall Study||46||
48598620|NCT05645432|101800134|FG000|NOT COMPLETED|Overall Study||1||
48143904|NCT02154763|100676614|FG000|NOT COMPLETED|Overall Study||14||
48143905|NCT02154763|100676615|FG001|NOT COMPLETED|Overall Study||14||
48143906|NCT03538015|100676616|FG000|STARTED|Overall Study||0||
48143907|NCT03538015|100676617|FG001|STARTED|Overall Study||0||
48143908|NCT03538015|100676618|FG002|STARTED|Overall Study||1||
48143909|NCT03538015|100676616|FG000|COMPLETED|Overall Study||0||
48143910|NCT03538015|100676617|FG001|COMPLETED|Overall Study||0||
48143911|NCT03538015|100676618|FG002|COMPLETED|Overall Study||0||
48598621|NCT02183909|101800135|FG000|STARTED|Overall Study||378||
48598622|NCT02183909|101800135|FG000|COMPLETED|Overall Study||324||
48598623|NCT02183909|101800135|FG000|NOT COMPLETED|Overall Study||54||
48598624|NCT01458951|101800136|FG000|STARTED|Overall Study||429||
48598625|NCT01458951|101800137|FG001|STARTED|Overall Study||6||
48598626|NCT01458951|101800138|FG002|STARTED|Overall Study||112||
48598627|NCT01458951|101800136|FG000|COMPLETED|Overall Study||397||
48598628|NCT01458951|101800137|FG001|COMPLETED|Overall Study||5||
48598629|NCT01458951|101800138|FG002|COMPLETED|Overall Study||97||
48598630|NCT01458951|101800136|FG000|NOT COMPLETED|Overall Study||32||
48598631|NCT01458951|101800137|FG001|NOT COMPLETED|Overall Study||1||
48143912|NCT03538015|100676616|FG000|NOT COMPLETED|Overall Study||0||
48143913|NCT03538015|100676617|FG001|NOT COMPLETED|Overall Study||0||
48143914|NCT03538015|100676618|FG002|NOT COMPLETED|Overall Study||1||
48143915|NCT02040116|100676619|FG000|STARTED|Overall Study||19||
48143916|NCT02040116|100676619|FG000|COMPLETED|Overall Study||19||
48143917|NCT02040116|100676619|FG000|NOT COMPLETED|Overall Study||0||
48143918|NCT03822533|100676620|FG000|STARTED|Baseline||35||
48143919|NCT03822533|100676621|FG001|STARTED|Baseline||34||
48143920|NCT03822533|100676620|FG000|COMPLETED|Baseline||35||
48143921|NCT03822533|100676621|FG001|COMPLETED|Baseline||34||
48143922|NCT03822533|100676620|FG000|NOT COMPLETED|Baseline||0||
48143923|NCT03822533|100676621|FG001|NOT COMPLETED|Baseline||0||
48143924|NCT03822533|100676620|FG000|STARTED|3 Month Follow-up||35||
48143925|NCT03822533|100676621|FG001|STARTED|3 Month Follow-up||34||
48143926|NCT03822533|100676620|FG000|COMPLETED|3 Month Follow-up||30||
48143927|NCT03822533|100676621|FG001|COMPLETED|3 Month Follow-up||28||
48143928|NCT03822533|100676620|FG000|NOT COMPLETED|3 Month Follow-up||5||
48143929|NCT03822533|100676621|FG001|NOT COMPLETED|3 Month Follow-up||6||
48143930|NCT03822533|100676620|FG000|STARTED|6 Month Follow-up||30||
48143931|NCT03822533|100676621|FG001|STARTED|6 Month Follow-up||28||
48143932|NCT03822533|100676620|FG000|COMPLETED|6 Month Follow-up||27||
48143933|NCT03822533|100676621|FG001|COMPLETED|6 Month Follow-up||28||
48143934|NCT03822533|100676620|FG000|NOT COMPLETED|6 Month Follow-up||3||
48598632|NCT01458951|101800138|FG002|NOT COMPLETED|Overall Study||15||
48598633|NCT00416793|101800139|FG000|STARTED|Overall Study||9||
48598634|NCT00416793|101800139|FG000|COMPLETED|Overall Study||9||
48598635|NCT00416793|101800139|FG000|NOT COMPLETED|Overall Study||0||
48598636|NCT03338569|101800140|FG000|STARTED|Overall Study||64||
48598637|NCT03338569|101800141|FG001|STARTED|Overall Study||61||
48598638|NCT03338569|101800140|FG000|COMPLETED|Overall Study||56||
48598639|NCT03338569|101800141|FG001|COMPLETED|Overall Study||56||
48598640|NCT03338569|101800140|FG000|NOT COMPLETED|Overall Study||8||
48598641|NCT03338569|101800141|FG001|NOT COMPLETED|Overall Study||5||
48598642|NCT05020899|101800142|FG000|STARTED|8 Week Follow-up||54||
48598643|NCT05020899|101800143|FG001|STARTED|8 Week Follow-up||55||
48598644|NCT05020899|101800142|FG000|COMPLETED|8 Week Follow-up||51||
48598645|NCT05020899|101800143|FG001|COMPLETED|8 Week Follow-up||49||
48598646|NCT05020899|101800142|FG000|NOT COMPLETED|8 Week Follow-up||3||
48143935|NCT03822533|100676621|FG001|NOT COMPLETED|6 Month Follow-up||0||
48598647|NCT05020899|101800143|FG001|NOT COMPLETED|8 Week Follow-up||6||
48598648|NCT05020899|101800142|FG000|STARTED|12 Week Follow-up||51||
48598649|NCT05020899|101800143|FG001|STARTED|12 Week Follow-up||49||
48598650|NCT05020899|101800142|FG000|COMPLETED|12 Week Follow-up||50||
48143936|NCT03822533|100676620|FG000|STARTED|12 Month Follow-up||27||
48143937|NCT03822533|100676621|FG001|STARTED|12 Month Follow-up||28||
48143938|NCT03822533|100676620|FG000|COMPLETED|12 Month Follow-up||21||
48143939|NCT03822533|100676621|FG001|COMPLETED|12 Month Follow-up||23||
48143940|NCT03822533|100676620|FG000|NOT COMPLETED|12 Month Follow-up||6||
48143941|NCT03822533|100676621|FG001|NOT COMPLETED|12 Month Follow-up||5||
48143942|NCT04403698|100676622|FG000|STARTED|Overall Study||15||
48143943|NCT04403698|100676623|FG001|STARTED|Overall Study||15||
48143944|NCT04403698|100676622|FG000|COMPLETED|Overall Study||13||
48143945|NCT04403698|100676623|FG001|COMPLETED|Overall Study||13||
48143946|NCT04403698|100676622|FG000|NOT COMPLETED|Overall Study||2||
48143947|NCT04403698|100676623|FG001|NOT COMPLETED|Overall Study||2||
48143948|NCT05349617|100676624|FG000|STARTED|Overall Study||206||
48143949|NCT05349617|100676625|FG001|STARTED|Overall Study||207||
48143950|NCT05349617|100676624|FG000|COMPLETED|Overall Study||200||
48143951|NCT05349617|100676625|FG001|COMPLETED|Overall Study||188||
48143952|NCT05349617|100676624|FG000|NOT COMPLETED|Overall Study||6||
48143953|NCT05349617|100676625|FG001|NOT COMPLETED|Overall Study||19||
48143954|NCT01654549|100676626|FG000|STARTED|Overall Study||20||
48143955|NCT01654549|100676627|FG001|STARTED|Overall Study||20||
48143956|NCT01654549|100676626|FG000|COMPLETED|Overall Study||20||
48143957|NCT01654549|100676627|FG001|COMPLETED|Overall Study||19||
48143958|NCT01654549|100676626|FG000|NOT COMPLETED|Overall Study||0||
48143959|NCT01654549|100676627|FG001|NOT COMPLETED|Overall Study||1||
48598651|NCT05020899|101800143|FG001|COMPLETED|12 Week Follow-up||48||
48598652|NCT05020899|101800142|FG000|NOT COMPLETED|12 Week Follow-up||1||
48598653|NCT05020899|101800143|FG001|NOT COMPLETED|12 Week Follow-up||1||
48598654|NCT02503254|101800144|FG000|STARTED|Overall Study||41||
48143960|NCT02962687|100676628|FG000|STARTED|Overall Study||40||
48598655|NCT02503254|101800145|FG001|STARTED|Overall Study||39||
48143961|NCT02962687|100676629|FG001|STARTED|Overall Study||40||
48143962|NCT02962687|100676628|FG000|COMPLETED|Overall Study||30||
48367939|NCT03661541|101230078|FG001|NOT COMPLETED|Overall Study||2||
48143963|NCT02962687|100676629|FG001|COMPLETED|Overall Study||32||
48143964|NCT02962687|100676628|FG000|NOT COMPLETED|Overall Study||10||
48143965|NCT02962687|100676629|FG001|NOT COMPLETED|Overall Study||8||
48143966|NCT03078270|100676630|FG000|STARTED|Overall Study||4||
48143967|NCT03078270|100676631|FG001|STARTED|Overall Study||0||
48143968|NCT03078270|100676630|FG000|COMPLETED|Overall Study||0||
48143969|NCT03078270|100676631|FG001|COMPLETED|Overall Study||0||
48143970|NCT03078270|100676630|FG000|NOT COMPLETED|Overall Study||4||
48143971|NCT03078270|100676631|FG001|NOT COMPLETED|Overall Study||0||
48143972|NCT02522494|100676632|FG000|STARTED|Overall Study||51||
48143973|NCT02522494|100676633|FG001|STARTED|Overall Study||51||
48143974|NCT02522494|100676632|FG000|Post-CVT Visit Interview|Overall Study||37||
48143975|NCT02522494|100676633|FG001|Post-CVT Visit Interview|Overall Study||48||
48143976|NCT02522494|100676632|FG000|4-Week Follow Up|Overall Study||37||
48143977|NCT02522494|100676633|FG001|4-Week Follow Up|Overall Study||46||
48143978|NCT02522494|100676632|FG000|COMPLETED|Overall Study||37||
48143979|NCT02522494|100676633|FG001|COMPLETED|Overall Study||46||
48143980|NCT02522494|100676632|FG000|NOT COMPLETED|Overall Study||14||
48143981|NCT02522494|100676633|FG001|NOT COMPLETED|Overall Study||5||
48143982|NCT01835626|100676634|FG000|STARTED|Overall Study||24||
48143983|NCT01835626|100676634|FG000|COMPLETED|Overall Study||17||
48143984|NCT01835626|100676634|FG000|NOT COMPLETED|Overall Study||7||
48143985|NCT00651664|100676635|FG000|STARTED|Overall Study||3||
48143986|NCT00651664|100676636|FG001|STARTED|Overall Study||3||
48143987|NCT00651664|100676637|FG002|STARTED|Overall Study||3||
48143988|NCT00651664|100676638|FG003|STARTED|Overall Study||14||
48143989|NCT00651664|100676639|FG004|STARTED|Overall Study||6||
48143990|NCT00651664|100676640|FG005|STARTED|Overall Study||3||
48143991|NCT00651664|100676641|FG006|STARTED|Overall Study||6||
48143992|NCT00651664|100676642|FG007|STARTED|Overall Study||7||
48143993|NCT00651664|100676643|FG008|STARTED|Overall Study||7||
48143994|NCT00651664|100676644|FG009|STARTED|Overall Study||7||
48143995|NCT00651664|100676635|FG000|COMPLETED|Overall Study||0||
48143996|NCT00651664|100676636|FG001|COMPLETED|Overall Study||0||
48143997|NCT00651664|100676637|FG002|COMPLETED|Overall Study||0||
48143998|NCT00651664|100676638|FG003|COMPLETED|Overall Study||0||
48143999|NCT00651664|100676639|FG004|COMPLETED|Overall Study||0||
48144000|NCT00651664|100676640|FG005|COMPLETED|Overall Study||0||
48144001|NCT00651664|100676641|FG006|COMPLETED|Overall Study||0||
48144002|NCT00651664|100676642|FG007|COMPLETED|Overall Study||0||
48144003|NCT00651664|100676643|FG008|COMPLETED|Overall Study||0||
48144004|NCT00651664|100676644|FG009|COMPLETED|Overall Study||0||
48144005|NCT00651664|100676635|FG000|NOT COMPLETED|Overall Study||3||
48144006|NCT00651664|100676636|FG001|NOT COMPLETED|Overall Study||3||
48144007|NCT00651664|100676637|FG002|NOT COMPLETED|Overall Study||3||
48144008|NCT00651664|100676638|FG003|NOT COMPLETED|Overall Study||14||
48144009|NCT00651664|100676639|FG004|NOT COMPLETED|Overall Study||6||
48144010|NCT00651664|100676640|FG005|NOT COMPLETED|Overall Study||3||
48144011|NCT00651664|100676641|FG006|NOT COMPLETED|Overall Study||6||
48144012|NCT00651664|100676642|FG007|NOT COMPLETED|Overall Study||7||
48144013|NCT00651664|100676643|FG008|NOT COMPLETED|Overall Study||7||
48144014|NCT00651664|100676644|FG009|NOT COMPLETED|Overall Study||7||
48144015|NCT01597050|100676645|FG000|STARTED|Overall Study||36||
48144016|NCT01597050|100676646|FG001|STARTED|Overall Study||18||
48144017|NCT01597050|100676645|FG000|COMPLETED|Overall Study||35||
48144018|NCT01597050|100676646|FG001|COMPLETED|Overall Study||18||
48144019|NCT01597050|100676645|FG000|NOT COMPLETED|Overall Study||1||
48144020|NCT01597050|100676646|FG001|NOT COMPLETED|Overall Study||0||
48144021|NCT02172755|100676647|FG000|STARTED|Overall Study||14||
48144022|NCT02172755|100676648|FG001|STARTED|Overall Study||16||
48144023|NCT02172755|100676647|FG000|COMPLETED|Overall Study||12||
48144024|NCT02172755|100676648|FG001|COMPLETED|Overall Study||12||
48144025|NCT02172755|100676647|FG000|NOT COMPLETED|Overall Study||2||
48144026|NCT02172755|100676648|FG001|NOT COMPLETED|Overall Study||4||
48144027|NCT03492281|100676649|FG000|STARTED|Overall Study||540||
48144028|NCT03492281|100676650|FG001|STARTED|Overall Study||547||
48144029|NCT03492281|100676651|FG002|STARTED|Overall Study||431||
48144030|NCT03492281|100676649|FG000|COMPLETED|Overall Study||486||
48144031|NCT03492281|100676650|FG001|COMPLETED|Overall Study||502||
48144032|NCT03492281|100676651|FG002|COMPLETED|Overall Study||385||
48144033|NCT03492281|100676649|FG000|NOT COMPLETED|Overall Study||54||
48144034|NCT03492281|100676650|FG001|NOT COMPLETED|Overall Study||45||
48144035|NCT03492281|100676651|FG002|NOT COMPLETED|Overall Study||46||
48144036|NCT01460940|100676652|FG000|STARTED|Overall Study||24||
48144037|NCT01460940|100676652|FG000|COMPLETED|Overall Study||24||
48144038|NCT01460940|100676652|FG000|NOT COMPLETED|Overall Study||0||
48144039|NCT01774149|100676653|FG000|STARTED|Overall Study||15||
48144040|NCT01774149|100676654|FG001|STARTED|Overall Study||15||
48144041|NCT01774149|100676653|FG000|COMPLETED|Overall Study||14||
48144042|NCT01774149|100676654|FG001|COMPLETED|Overall Study||12||
48144043|NCT01774149|100676653|FG000|NOT COMPLETED|Overall Study||1||
48144044|NCT01774149|100676654|FG001|NOT COMPLETED|Overall Study||3||
48144045|NCT02280044|100676655|FG000|STARTED|Overall Study||15||
48144046|NCT02280044|100676656|FG001|STARTED|Overall Study||15||
48144047|NCT02280044|100676655|FG000|COMPLETED|Overall Study||15||
48144048|NCT02280044|100676656|FG001|COMPLETED|Overall Study||13||
48144049|NCT02280044|100676655|FG000|NOT COMPLETED|Overall Study||0||
48144050|NCT02280044|100676656|FG001|NOT COMPLETED|Overall Study||2||
48144051|NCT04546581|100676657|FG000|STARTED|Overall Study||301||
48144052|NCT04546581|100676658|FG001|STARTED|Overall Study||292||
48144053|NCT04546581|100676657|FG000|COMPLETED|Overall Study||288||
48144054|NCT04546581|100676658|FG001|COMPLETED|Overall Study||279||
48144055|NCT04546581|100676657|FG000|NOT COMPLETED|Overall Study||13||
48144056|NCT04546581|100676658|FG001|NOT COMPLETED|Overall Study||13||
48144057|NCT01625897|100676659|FG000|STARTED|Overall Study||83||
48144058|NCT01625897|100676660|FG001|STARTED|Overall Study||42||
48144059|NCT01625897|100676659|FG000|COMPLETED|Overall Study||31||
48144060|NCT01625897|100676660|FG001|COMPLETED|Overall Study||28||
48144061|NCT01625897|100676659|FG000|NOT COMPLETED|Overall Study||52||
48144062|NCT01625897|100676660|FG001|NOT COMPLETED|Overall Study||14||
48144063|NCT02477696|100676661|FG000|STARTED|Overall Study||268||
48144064|NCT02477696|100676662|FG001|STARTED|Overall Study||265||
48144065|NCT02477696|100676661|FG000|Treated|Overall Study||265||
48144066|NCT02477696|100676662|FG001|Treated|Overall Study||264||
48598656|NCT02503254|101800144|FG000|COMPLETED|Overall Study||41||
48598657|NCT02503254|101800145|FG001|COMPLETED|Overall Study||39||
48598658|NCT02503254|101800144|FG000|NOT COMPLETED|Overall Study||0||
48598659|NCT02503254|101800145|FG001|NOT COMPLETED|Overall Study||0||
48144067|NCT02477696|100676661|FG000|COMPLETED|Overall Study||0||
48144068|NCT02477696|100676662|FG001|COMPLETED|Overall Study||0||
48144069|NCT02477696|100676661|FG000|NOT COMPLETED|Overall Study||268||
48144070|NCT02477696|100676662|FG001|NOT COMPLETED|Overall Study||265||
48144071|NCT00884585|100676663|FG000|STARTED|Double-Masked Phase (Day 1-Month 3)||89||
48144072|NCT00884585|100676664|FG001|STARTED|Double-Masked Phase (Day 1-Month 3)||87||
48144073|NCT00884585|100676663|FG000|COMPLETED|Double-Masked Phase (Day 1-Month 3)||79||
48144074|NCT00884585|100676664|FG001|COMPLETED|Double-Masked Phase (Day 1-Month 3)||83||
48144075|NCT00884585|100676663|FG000|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||10||
48144076|NCT00884585|100676664|FG001|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||4||
48144077|NCT00884585|100676663|FG000|STARTED|Open-Label Phase (Months 3-9)||162||
48144078|NCT00884585|100676664|FG001|STARTED|Open-Label Phase (Months 3-9)||0||
48144079|NCT00884585|100676663|FG000|COMPLETED|Open-Label Phase (Months 3-9)||147||
48144080|NCT00884585|100676664|FG001|COMPLETED|Open-Label Phase (Months 3-9)||0||
48144081|NCT00884585|100676663|FG000|NOT COMPLETED|Open-Label Phase (Months 3-9)||15||
48144082|NCT00884585|100676664|FG001|NOT COMPLETED|Open-Label Phase (Months 3-9)||0||
48144083|NCT00884585|100676663|FG000|STARTED|Open-Label Maintenance (Months 9-12)||147||
48144084|NCT00884585|100676664|FG001|STARTED|Open-Label Maintenance (Months 9-12)||0||
48144085|NCT00884585|100676663|FG000|COMPLETED|Open-Label Maintenance (Months 9-12)||144||
48144086|NCT00884585|100676664|FG001|COMPLETED|Open-Label Maintenance (Months 9-12)||0||
48144087|NCT00884585|100676663|FG000|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||3||
48144088|NCT00884585|100676664|FG001|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||0||
48144089|NCT01669629|100676665|FG000|STARTED|Period 1||92||
48144090|NCT01669629|100676666|FG001|STARTED|Period 1||91||
48144091|NCT01669629|100676665|FG000|COMPLETED|Period 1||91||
48144092|NCT01669629|100676666|FG001|COMPLETED|Period 1||89||
48144093|NCT01669629|100676665|FG000|NOT COMPLETED|Period 1||1||
48144094|NCT01669629|100676666|FG001|NOT COMPLETED|Period 1||2||
48144095|NCT01669629|100676665|FG000|STARTED|Period 2||91||
48598660|NCT00586508|101800146|FG000|STARTED|Overall Study||68||
48598661|NCT00586508|101800147|FG001|STARTED|Overall Study||13||
48598662|NCT00586508|101800146|FG000|Received at Least 1 Dose of Study Drug|Overall Study||68||
48598663|NCT00586508|101800147|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13||
48598664|NCT00586508|101800146|FG000|COMPLETED|Overall Study||0||
48598665|NCT00586508|101800147|FG001|COMPLETED|Overall Study||0||
48598666|NCT00586508|101800146|FG000|NOT COMPLETED|Overall Study||68||
48598667|NCT00586508|101800147|FG001|NOT COMPLETED|Overall Study||13||
48144096|NCT01669629|100676666|FG001|STARTED|Period 2||89||
48144097|NCT01669629|100676665|FG000|COMPLETED|Period 2||91||
48144098|NCT01669629|100676666|FG001|COMPLETED|Period 2||89||
48144099|NCT01669629|100676665|FG000|NOT COMPLETED|Period 2||0||
48144100|NCT01669629|100676666|FG001|NOT COMPLETED|Period 2||0||
48144101|NCT01995461|100676667|FG000|STARTED|Overall Study||26||
48144102|NCT01995461|100676667|FG000|COMPLETED|Overall Study||21||
48144103|NCT01995461|100676667|FG000|NOT COMPLETED|Overall Study||5||
48144104|NCT01683864|100676668|FG000|STARTED|Overall Study||0||
48144105|NCT01683864|100676669|FG001|STARTED|Overall Study||0||
48144106|NCT01683864|100676670|FG002|STARTED|Overall Study||0||
48144107|NCT01683864|100676668|FG000|COMPLETED|Overall Study||0||
48598668|NCT00986947|101800148|FG000|STARTED|Overall Study||20||
48598669|NCT00986947|101800148|FG000|COMPLETED|Overall Study||0||
48598670|NCT00986947|101800148|FG000|NOT COMPLETED|Overall Study||20||
48144108|NCT01683864|100676669|FG001|COMPLETED|Overall Study||0||
48144109|NCT01683864|100676670|FG002|COMPLETED|Overall Study||0||
48144110|NCT01683864|100676668|FG000|NOT COMPLETED|Overall Study||0||
48144111|NCT01683864|100676669|FG001|NOT COMPLETED|Overall Study||0||
48144112|NCT01683864|100676670|FG002|NOT COMPLETED|Overall Study||0||
48144113|NCT00707031|100676671|FG000|STARTED|Overall Study||320||
48144114|NCT00707031|100676672|FG001|STARTED|Overall Study||319||
48144115|NCT00707031|100676671|FG000|Treated/Safety Population|Overall Study||318||
48598671|NCT03747302|101800149|FG000|STARTED|Overall Study||834||
48598672|NCT03747302|101800150|FG001|STARTED|Overall Study||164||
48713128|NCT02226198|102084874|FG000|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0||
48713129|NCT02226198|102084875|FG001|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||1||
48713130|NCT02226198|102084876|FG002|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0||
48713131|NCT02226198|102084874|FG000|STARTED|Cross-Over: Second Interv. (6 Weeks)||0||
48713132|NCT02226198|102084875|FG001|STARTED|Cross-Over: Second Interv. (6 Weeks)||6||
48713133|NCT02226198|102084876|FG002|STARTED|Cross-Over: Second Interv. (6 Weeks)||7||
48713134|NCT02226198|102084874|FG000|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0||
48713135|NCT02226198|102084875|FG001|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||6||
48713136|NCT02226198|102084876|FG002|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||7||
48713137|NCT02226198|102084874|FG000|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0||
48144116|NCT00707031|100676672|FG001|Treated/Safety Population|Overall Study||316||
48144117|NCT00707031|100676671|FG000|Modified Intent-to-Treat Population|Overall Study||315||
48144118|NCT00707031|100676672|FG001|Modified Intent-to-Treat Population|Overall Study||315||
48144119|NCT00707031|100676671|FG000|COMPLETED|Overall Study||216||
48713138|NCT02226198|102084875|FG001|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0||
48713139|NCT02226198|102084876|FG002|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0||
48713140|NCT02226198|102084874|FG000|STARTED|Maintenance Phase (12 Weeks)||13||
48713141|NCT02226198|102084875|FG001|STARTED|Maintenance Phase (12 Weeks)||0||
48713142|NCT02226198|102084876|FG002|STARTED|Maintenance Phase (12 Weeks)||0||
48713143|NCT02226198|102084874|FG000|COMPLETED|Maintenance Phase (12 Weeks)||13||
48713144|NCT02226198|102084875|FG001|COMPLETED|Maintenance Phase (12 Weeks)||0||
48713145|NCT02226198|102084876|FG002|COMPLETED|Maintenance Phase (12 Weeks)||0||
48713146|NCT02226198|102084874|FG000|NOT COMPLETED|Maintenance Phase (12 Weeks)||0||
48713147|NCT02226198|102084875|FG001|NOT COMPLETED|Maintenance Phase (12 Weeks)||0||
48713148|NCT02226198|102084876|FG002|NOT COMPLETED|Maintenance Phase (12 Weeks)||0||
48713149|NCT00791557|102084877|FG000|STARTED|Overall Study||2||
48713150|NCT00791557|102084877|FG000|COMPLETED|Overall Study||1||
48144120|NCT00707031|100676672|FG001|COMPLETED|Overall Study||220||
48144121|NCT00707031|100676671|FG000|NOT COMPLETED|Overall Study||104||
48144122|NCT00707031|100676672|FG001|NOT COMPLETED|Overall Study||99||
48144123|NCT02863926|100676673|FG000|STARTED|Overall Study||5||
48144124|NCT02863926|100676674|FG001|STARTED|Overall Study||1||
48144125|NCT02863926|100676673|FG000|Per Protocol Population Week 6|Overall Study||4||
48144126|NCT02863926|100676674|FG001|Per Protocol Population Week 6|Overall Study||1||
48713151|NCT00791557|102084877|FG000|NOT COMPLETED|Overall Study||1||
48713152|NCT02251717|102084878|FG000|STARTED|Overall Study||57||
48713153|NCT02251717|102084879|FG001|STARTED|Overall Study||57||
48713154|NCT02251717|102084878|FG000|COMPLETED|Overall Study||56||
48713155|NCT02251717|102084879|FG001|COMPLETED|Overall Study||56||
48713156|NCT02251717|102084878|FG000|NOT COMPLETED|Overall Study||1||
48713157|NCT02251717|102084879|FG001|NOT COMPLETED|Overall Study||1||
48713158|NCT04178993|102084880|FG000|STARTED|Overall Study||4||
48713159|NCT04178993|102084881|FG001|STARTED|Overall Study||4||
48713160|NCT04178993|102084880|FG000|COMPLETED|Overall Study||3||
48713161|NCT04178993|102084881|FG001|COMPLETED|Overall Study||4||
48713162|NCT04178993|102084880|FG000|NOT COMPLETED|Overall Study||1||
48144127|NCT02863926|100676673|FG000|Per Protocol Population Week 52|Overall Study||3||
48297080|NCT00092495|101054416|FG004|NOT COMPLETED|Base Study Follow-up Period||0||
48297081|NCT00092495|101054412|FG000|STARTED|Extension Study||0||
48297082|NCT00092495|101054413|FG001|STARTED|Extension Study||0||
48297083|NCT00092495|101054414|FG002|STARTED|Extension Study||0||
48297084|NCT00092495|101054415|FG003|STARTED|Extension Study||0||
48297085|NCT00092495|101054416|FG004|STARTED|Extension Study||12||
48297086|NCT00092495|101054412|FG000|COMPLETED|Extension Study||0||
48297087|NCT00092495|101054413|FG001|COMPLETED|Extension Study||0||
48297088|NCT00092495|101054414|FG002|COMPLETED|Extension Study||0||
48297089|NCT00092495|101054415|FG003|COMPLETED|Extension Study||0||
48598673|NCT03747302|101800149|FG000|COMPLETED|Overall Study||833||
48598674|NCT03747302|101800150|FG001|COMPLETED|Overall Study||162||
48598675|NCT03747302|101800149|FG000|NOT COMPLETED|Overall Study||1||
48598676|NCT03747302|101800150|FG001|NOT COMPLETED|Overall Study||2||
48297090|NCT00092495|101054416|FG004|COMPLETED|Extension Study||12||
48297091|NCT00092495|101054412|FG000|NOT COMPLETED|Extension Study||0||
48297092|NCT00092495|101054413|FG001|NOT COMPLETED|Extension Study||0||
48297093|NCT00092495|101054414|FG002|NOT COMPLETED|Extension Study||0||
48297094|NCT00092495|101054415|FG003|NOT COMPLETED|Extension Study||0||
48598677|NCT04292639|101800151|FG000|STARTED|Overall Study||20||
48297095|NCT00092495|101054416|FG004|NOT COMPLETED|Extension Study||0||
48297096|NCT04427501|101054417|FG000|STARTED|Overall Study||156||
48297097|NCT04427501|101054418|FG001|STARTED|Overall Study||101||
48297098|NCT04427501|101054419|FG002|STARTED|Overall Study||107||
48297099|NCT04427501|101054420|FG003|STARTED|Overall Study||101||
48297100|NCT04427501|101054421|FG004|STARTED|Overall Study||112||
48297101|NCT04427501|101054422|FG005|STARTED|Overall Study||776||
48297102|NCT04427501|101054423|FG006|STARTED|Overall Study||518||
48297103|NCT04427501|101054424|FG007|STARTED|Overall Study||513||
48297104|NCT04427501|101054425|FG008|STARTED|Overall Study||141||
48297105|NCT04427501|101054426|FG009|STARTED|Overall Study||213||
48297106|NCT04427501|101054427|FG010|STARTED|Overall Study||94||
48297107|NCT04427501|101054428|FG011|STARTED|Overall Study||17||
48297108|NCT04427501|101054417|FG000|Received at Least One Dose of Study Drug|Overall Study||156||
48297109|NCT04427501|101054418|FG001|Received at Least One Dose of Study Drug|Overall Study||101||
48297110|NCT04427501|101054419|FG002|Received at Least One Dose of Study Drug|Overall Study||107||
48297111|NCT04427501|101054420|FG003|Received at Least One Dose of Study Drug|Overall Study||101||
48297112|NCT04427501|101054421|FG004|Received at Least One Dose of Study Drug|Overall Study||112||
48297113|NCT04427501|101054422|FG005|Received at Least One Dose of Study Drug|Overall Study||776||
48297114|NCT04427501|101054423|FG006|Received at Least One Dose of Study Drug|Overall Study||518||
48297115|NCT04427501|101054424|FG007|Received at Least One Dose of Study Drug|Overall Study||513||
48297116|NCT04427501|101054425|FG008|Received at Least One Dose of Study Drug|Overall Study||141||
48297117|NCT04427501|101054426|FG009|Received at Least One Dose of Study Drug|Overall Study||213||
48297118|NCT04427501|101054427|FG010|Received at Least One Dose of Study Drug|Overall Study||94||
48297119|NCT04427501|101054428|FG011|Received at Least One Dose of Study Drug|Overall Study||17||
48297120|NCT04427501|101054417|FG000|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0||
48297121|NCT04427501|101054418|FG001|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0||
48297122|NCT04427501|101054419|FG002|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0||
48297123|NCT04427501|101054420|FG003|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0||
48297124|NCT04427501|101054421|FG004|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0||
48297125|NCT04427501|101054422|FG005|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||517||
48297126|NCT04427501|101054423|FG006|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0||
48297127|NCT04427501|101054424|FG007|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0||
48297128|NCT04427501|101054425|FG008|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0||
48297129|NCT04427501|101054426|FG009|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0||
48297130|NCT04427501|101054427|FG010|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0||
48297131|NCT04427501|101054428|FG011|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0||
48297132|NCT04427501|101054417|FG000|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0||
48297133|NCT04427501|101054418|FG001|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0||
48297134|NCT04427501|101054419|FG002|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0||
48297135|NCT04427501|101054420|FG003|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0||
48297136|NCT04427501|101054421|FG004|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0||
48297137|NCT04427501|101054422|FG005|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||776||
48297138|NCT04427501|101054423|FG006|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0||
48297139|NCT04427501|101054424|FG007|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0||
48297140|NCT04427501|101054425|FG008|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0||
48297141|NCT04427501|101054426|FG009|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0||
48297142|NCT04427501|101054427|FG010|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0||
48297143|NCT04427501|101054428|FG011|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0||
48297144|NCT04427501|101054417|FG000|COMPLETED|Overall Study||141||
48297145|NCT04427501|101054418|FG001|COMPLETED|Overall Study||95||
48297146|NCT04427501|101054419|FG002|COMPLETED|Overall Study||103||
48297147|NCT04427501|101054420|FG003|COMPLETED|Overall Study||98||
48297148|NCT04427501|101054421|FG004|COMPLETED|Overall Study||103||
48297149|NCT04427501|101054422|FG005|COMPLETED|Overall Study||719||
48297150|NCT04427501|101054423|FG006|COMPLETED|Overall Study||485||
48297151|NCT04427501|101054424|FG007|COMPLETED|Overall Study||496||
48297152|NCT04427501|101054425|FG008|COMPLETED|Overall Study||135||
48297153|NCT04427501|101054426|FG009|COMPLETED|Overall Study||207||
48297154|NCT04427501|101054427|FG010|COMPLETED|Overall Study||88||
48297155|NCT04427501|101054428|FG011|COMPLETED|Overall Study||16||
48297156|NCT04427501|101054417|FG000|NOT COMPLETED|Overall Study||15||
48297157|NCT04427501|101054418|FG001|NOT COMPLETED|Overall Study||6||
48297158|NCT04427501|101054419|FG002|NOT COMPLETED|Overall Study||4||
48297159|NCT04427501|101054420|FG003|NOT COMPLETED|Overall Study||3||
48297160|NCT04427501|101054421|FG004|NOT COMPLETED|Overall Study||9||
48297161|NCT04427501|101054422|FG005|NOT COMPLETED|Overall Study||57||
48297162|NCT04427501|101054423|FG006|NOT COMPLETED|Overall Study||33||
48297163|NCT04427501|101054424|FG007|NOT COMPLETED|Overall Study||17||
48297164|NCT04427501|101054425|FG008|NOT COMPLETED|Overall Study||6||
48297165|NCT04427501|101054426|FG009|NOT COMPLETED|Overall Study||6||
48297166|NCT04427501|101054427|FG010|NOT COMPLETED|Overall Study||6||
48297167|NCT04427501|101054428|FG011|NOT COMPLETED|Overall Study||1||
48297168|NCT02101034|101054429|FG000|STARTED|Overall Study||3||
48297169|NCT02101034|101054430|FG001|STARTED|Overall Study||6||
48297170|NCT02101034|101054431|FG002|STARTED|Overall Study||31||
48297171|NCT02101034|101054432|FG003|STARTED|Overall Study||32||
48297172|NCT02101034|101054433|FG004|STARTED|Overall Study||24||
48297173|NCT02101034|101054429|FG000|COMPLETED|Overall Study||3||
48297174|NCT02101034|101054430|FG001|COMPLETED|Overall Study||6||
48297175|NCT02101034|101054431|FG002|COMPLETED|Overall Study||30||
48297176|NCT02101034|101054432|FG003|COMPLETED|Overall Study||32||
48297177|NCT02101034|101054433|FG004|COMPLETED|Overall Study||24||
48297178|NCT02101034|101054429|FG000|NOT COMPLETED|Overall Study||0||
48297179|NCT02101034|101054430|FG001|NOT COMPLETED|Overall Study||0||
48297180|NCT02101034|101054431|FG002|NOT COMPLETED|Overall Study||1||
48297181|NCT02101034|101054432|FG003|NOT COMPLETED|Overall Study||0||
48297182|NCT02101034|101054433|FG004|NOT COMPLETED|Overall Study||0||
48297183|NCT01633814|101054434|FG000|STARTED|Overall Study||4||
48297184|NCT01633814|101054434|FG000|COMPLETED|Overall Study||4||
48297185|NCT01633814|101054434|FG000|NOT COMPLETED|Overall Study||0||
48297186|NCT02986334|101054435|FG000|STARTED|Overall Study||14||
48297187|NCT02986334|101054436|FG001|STARTED|Overall Study||40||
48297188|NCT02986334|101054437|FG002|STARTED|Overall Study||40||
48297189|NCT02986334|101054435|FG000|COMPLETED|Overall Study||11||
48297190|NCT02986334|101054436|FG001|COMPLETED|Overall Study||33||
48297191|NCT02986334|101054437|FG002|COMPLETED|Overall Study||33||
48297192|NCT02986334|101054435|FG000|NOT COMPLETED|Overall Study||3||
48297193|NCT02986334|101054436|FG001|NOT COMPLETED|Overall Study||7||
48297194|NCT02986334|101054437|FG002|NOT COMPLETED|Overall Study||7||
48297195|NCT00460551|101054438|FG000|STARTED|Overall Study||13||
48297196|NCT00460551|101054438|FG000|COMPLETED|Overall Study||13||
48297197|NCT00460551|101054438|FG000|NOT COMPLETED|Overall Study||0||
48297198|NCT02594163|101054439|FG000|STARTED|Treatment Period||12||
48297199|NCT02594163|101054440|FG001|STARTED|Treatment Period||13||
48297200|NCT02594163|101054439|FG000|COMPLETED|Treatment Period||5||
48297201|NCT02594163|101054440|FG001|COMPLETED|Treatment Period||1||
48297202|NCT02594163|101054439|FG000|NOT COMPLETED|Treatment Period||7||
48297203|NCT02594163|101054440|FG001|NOT COMPLETED|Treatment Period||12||
48297204|NCT02594163|101054439|FG000|STARTED|Follow-up Period||12||
48297205|NCT02594163|101054440|FG001|STARTED|Follow-up Period||13||
48297206|NCT02594163|101054439|FG000|COMPLETED|Follow-up Period||1||
48297207|NCT02594163|101054440|FG001|COMPLETED|Follow-up Period||1||
48297208|NCT02594163|101054439|FG000|NOT COMPLETED|Follow-up Period||11||
48297209|NCT02594163|101054440|FG001|NOT COMPLETED|Follow-up Period||12||
48297210|NCT00695253|101054441|FG000|STARTED|Overall Study||49||
48297211|NCT00695253|101054441|FG000|COMPLETED|Overall Study||18||
48297212|NCT00695253|101054441|FG000|NOT COMPLETED|Overall Study||31||
48297213|NCT03618823|101054442|FG000|STARTED|Overall Study||132||
48297214|NCT03618823|101054443|FG001|STARTED|Overall Study||136||
48297215|NCT03618823|101054442|FG000|COMPLETED|Overall Study||69||
48297216|NCT03618823|101054443|FG001|COMPLETED|Overall Study||75||
48297217|NCT03618823|101054442|FG000|NOT COMPLETED|Overall Study||63||
48297218|NCT03618823|101054443|FG001|NOT COMPLETED|Overall Study||61||
48297219|NCT00195507|101054444|FG000|STARTED|Overall Study||357||
48297220|NCT00195507|101054445|FG001|STARTED|Overall Study||363||
48297221|NCT00195507|101054444|FG000|COMPLETED|Overall Study||258||
48297222|NCT00195507|101054445|FG001|COMPLETED|Overall Study||245||
48297223|NCT00195507|101054444|FG000|NOT COMPLETED|Overall Study||99||
48297224|NCT00195507|101054445|FG001|NOT COMPLETED|Overall Study||118||
48297225|NCT02808143|101054446|FG000|STARTED|Pre-Induction Period||3||
48297226|NCT02808143|101054447|FG001|STARTED|Pre-Induction Period||6||
48297227|NCT02808143|101054446|FG000|COMPLETED|Pre-Induction Period||3||
48297228|NCT02808143|101054447|FG001|COMPLETED|Pre-Induction Period||6||
48297229|NCT02808143|101054446|FG000|NOT COMPLETED|Pre-Induction Period||0||
48297230|NCT02808143|101054447|FG001|NOT COMPLETED|Pre-Induction Period||0||
48297231|NCT02808143|101054446|FG000|STARTED|Induction Period||3||
48297232|NCT02808143|101054447|FG001|STARTED|Induction Period||6||
48297233|NCT02808143|101054446|FG000|COMPLETED|Induction Period||3||
48297234|NCT02808143|101054447|FG001|COMPLETED|Induction Period||6||
48297235|NCT02808143|101054446|FG000|NOT COMPLETED|Induction Period||0||
48297236|NCT02808143|101054447|FG001|NOT COMPLETED|Induction Period||0||
48297237|NCT02808143|101054446|FG000|STARTED|Maintenance Phase||3||
48297238|NCT02808143|101054447|FG001|STARTED|Maintenance Phase||6||
48297239|NCT02808143|101054446|FG000|COMPLETED|Maintenance Phase||1||
48297240|NCT02808143|101054447|FG001|COMPLETED|Maintenance Phase||1||
48297241|NCT02808143|101054446|FG000|NOT COMPLETED|Maintenance Phase||2||
48297242|NCT02808143|101054447|FG001|NOT COMPLETED|Maintenance Phase||5||
48297243|NCT02808143|101054446|FG000|STARTED|Survival Follow-Up||3|Once off treatment, patients were followed clinically for disease recurrence and survival according to protocol schedule until death, withdrawal, or end of study (whichever occurs first).|
48297244|NCT02808143|101054447|FG001|STARTED|Survival Follow-Up||6|Once off treatment, patients were followed clinically for disease recurrence and survival according to protocol schedule until death, withdrawal, or end of study (whichever occurs first).|
48297245|NCT02808143|101054446|FG000|COMPLETED|Survival Follow-Up||0||
48297246|NCT02808143|101054447|FG001|COMPLETED|Survival Follow-Up||0||
48297247|NCT02808143|101054446|FG000|NOT COMPLETED|Survival Follow-Up||3||
48297248|NCT02808143|101054447|FG001|NOT COMPLETED|Survival Follow-Up||6||
48297249|NCT01709747|101054448|FG000|STARTED|Overall Study||364||
48297250|NCT01709747|101054448|FG000|COMPLETED|Overall Study||287||
48297251|NCT01709747|101054448|FG000|NOT COMPLETED|Overall Study||77||
48297252|NCT02265367|101054449|FG000|STARTED|Overall Study||28||
48297253|NCT02265367|101054450|FG001|STARTED|Overall Study||28||
48297254|NCT02265367|101054449|FG000|Completed First 3-week Period|Overall Study||24||
48297255|NCT02265367|101054450|FG001|Completed First 3-week Period|Overall Study||26||
48297256|NCT02265367|101054449|FG000|COMPLETED|Overall Study||18|Completer defined as participants who completed at least 2 of the 5 assessments occurring during the third week of each three-week period.|
48297257|NCT02265367|101054450|FG001|COMPLETED|Overall Study||22|Completer defined as participants who completed at least 2 of the 5 assessments occurring during the third week of each three-week period.|
48598678|NCT04292639|101800151|FG000|COMPLETED|Overall Study||20||
48598679|NCT04292639|101800151|FG000|NOT COMPLETED|Overall Study||0||
48598680|NCT01651000|101800152|FG000|STARTED|Overall Study||72||
48598681|NCT01651000|101800153|FG001|STARTED|Overall Study||141||
48598682|NCT01651000|101800152|FG000|Entered Extension Study|Overall Study||50||
48598683|NCT01651000|101800153|FG001|Entered Extension Study|Overall Study||93||
48598684|NCT01651000|101800152|FG000|COMPLETED|Overall Study||62||
48144128|NCT02863926|100676674|FG001|Per Protocol Population Week 52|Overall Study||0||
48144129|NCT02863926|100676673|FG000|COMPLETED|Overall Study||3||
48144130|NCT02863926|100676674|FG001|COMPLETED|Overall Study||0||
48144131|NCT02863926|100676673|FG000|NOT COMPLETED|Overall Study||2||
48144132|NCT02863926|100676674|FG001|NOT COMPLETED|Overall Study||1||
48144133|NCT00226239|100676675|FG000|STARTED|TPE, Induction Therapy||39||
48144134|NCT00226239|100676675|FG000|COMPLETED|TPE, Induction Therapy||37||
48144135|NCT00226239|100676675|FG000|NOT COMPLETED|TPE, Induction Therapy||2||
48144136|NCT00226239|100676675|FG000|STARTED|XPE, Definitive Therapy||37||
48144137|NCT00226239|100676675|FG000|COMPLETED|XPE, Definitive Therapy||33||
48144138|NCT00226239|100676675|FG000|NOT COMPLETED|XPE, Definitive Therapy||4||
48144139|NCT00226239|100676675|FG000|STARTED|Maintenance Cetuximab||31||
48144140|NCT00226239|100676675|FG000|COMPLETED|Maintenance Cetuximab||17||
48144141|NCT00226239|100676675|FG000|NOT COMPLETED|Maintenance Cetuximab||14||
48144142|NCT03625570|100676676|FG000|STARTED|Primary Endpoint - Immediate Post||23||
48144143|NCT03625570|100676677|FG001|STARTED|Primary Endpoint - Immediate Post||20||
48144144|NCT03625570|100676676|FG000|COMPLETED|Primary Endpoint - Immediate Post||20|Completed Intervention|
48144145|NCT03625570|100676677|FG001|COMPLETED|Primary Endpoint - Immediate Post||18|Completed Intervention|
48144146|NCT03625570|100676676|FG000|NOT COMPLETED|Primary Endpoint - Immediate Post||3||
48144147|NCT03625570|100676677|FG001|NOT COMPLETED|Primary Endpoint - Immediate Post||2||
48144148|NCT03625570|100676676|FG000|STARTED|Secondary Endpoint - 2 Months Post||20||
48144149|NCT03625570|100676677|FG001|STARTED|Secondary Endpoint - 2 Months Post||18||
48144150|NCT03625570|100676676|FG000|COMPLETED|Secondary Endpoint - 2 Months Post||18|2mo. Post Follow-up|
48144151|NCT03625570|100676677|FG001|COMPLETED|Secondary Endpoint - 2 Months Post||17|2mo. Post Follow-up|
48144152|NCT03625570|100676676|FG000|NOT COMPLETED|Secondary Endpoint - 2 Months Post||2||
48144153|NCT03625570|100676677|FG001|NOT COMPLETED|Secondary Endpoint - 2 Months Post||1||
48144154|NCT03625570|100676676|FG000|STARTED|Secondary Endpoint - 6 Months Post||18||
48144155|NCT03625570|100676677|FG001|STARTED|Secondary Endpoint - 6 Months Post||17||
48144156|NCT03625570|100676676|FG000|COMPLETED|Secondary Endpoint - 6 Months Post||18||
48144157|NCT03625570|100676677|FG001|COMPLETED|Secondary Endpoint - 6 Months Post||16||
48144158|NCT03625570|100676676|FG000|NOT COMPLETED|Secondary Endpoint - 6 Months Post||0||
48144159|NCT03625570|100676677|FG001|NOT COMPLETED|Secondary Endpoint - 6 Months Post||1||
48144160|NCT01261611|100676678|FG000|STARTED|Treatment Cycle 1||156||
48144161|NCT01261611|100676679|FG001|STARTED|Treatment Cycle 1||159||
48144162|NCT01261611|100676680|FG002|STARTED|Treatment Cycle 1||54||
48144163|NCT01261611|100676678|FG000|COMPLETED|Treatment Cycle 1||152||
48144164|NCT01261611|100676679|FG001|COMPLETED|Treatment Cycle 1||156||
48144165|NCT01261611|100676680|FG002|COMPLETED|Treatment Cycle 1||52||
48144166|NCT01261611|100676678|FG000|NOT COMPLETED|Treatment Cycle 1||4||
48144167|NCT01261611|100676679|FG001|NOT COMPLETED|Treatment Cycle 1||3||
48144168|NCT01261611|100676680|FG002|NOT COMPLETED|Treatment Cycle 1||2||
48144169|NCT01261611|100676678|FG000|STARTED|Treatment Cycle 2||359||
48144170|NCT01261611|100676679|FG001|STARTED|Treatment Cycle 2||0||
48144171|NCT01261611|100676680|FG002|STARTED|Treatment Cycle 2||0||
48144172|NCT01261611|100676678|FG000|COMPLETED|Treatment Cycle 2||346||
48144173|NCT01261611|100676679|FG001|COMPLETED|Treatment Cycle 2||0||
48144174|NCT01261611|100676680|FG002|COMPLETED|Treatment Cycle 2||0||
48144175|NCT01261611|100676678|FG000|NOT COMPLETED|Treatment Cycle 2||13||
48144176|NCT01261611|100676679|FG001|NOT COMPLETED|Treatment Cycle 2||0||
48144177|NCT01261611|100676680|FG002|NOT COMPLETED|Treatment Cycle 2||0||
48144178|NCT01261611|100676678|FG000|STARTED|Treatment Cycle 3||346||
48144179|NCT01261611|100676679|FG001|STARTED|Treatment Cycle 3||0||
48144180|NCT01261611|100676680|FG002|STARTED|Treatment Cycle 3||0||
48297258|NCT02265367|101054449|FG000|NOT COMPLETED|Overall Study||10||
48297259|NCT02265367|101054450|FG001|NOT COMPLETED|Overall Study||6||
48297260|NCT04344600|101054451|FG000|STARTED|Overall Study||2||
48297261|NCT04344600|101054452|FG001|STARTED|Overall Study||4||
48598685|NCT01651000|101800153|FG001|COMPLETED|Overall Study||113||
48598686|NCT01651000|101800152|FG000|NOT COMPLETED|Overall Study||10||
48144181|NCT01261611|100676678|FG000|COMPLETED|Treatment Cycle 3||316||
48144182|NCT01261611|100676679|FG001|COMPLETED|Treatment Cycle 3||0||
48144183|NCT01261611|100676680|FG002|COMPLETED|Treatment Cycle 3||0||
48144184|NCT01261611|100676678|FG000|NOT COMPLETED|Treatment Cycle 3||30||
48144185|NCT01261611|100676679|FG001|NOT COMPLETED|Treatment Cycle 3||0||
48144186|NCT01261611|100676680|FG002|NOT COMPLETED|Treatment Cycle 3||0||
48144187|NCT01261611|100676678|FG000|STARTED|Treatment Cycle 4||316||
48144188|NCT01261611|100676679|FG001|STARTED|Treatment Cycle 4||0||
48598687|NCT01651000|101800153|FG001|NOT COMPLETED|Overall Study||28||
48598688|NCT00475878|101800154|FG000|STARTED|Overall Study||75||
48598689|NCT00475878|101800155|FG001|STARTED|Overall Study||72||
48144189|NCT01261611|100676680|FG002|STARTED|Treatment Cycle 4||0||
48144190|NCT01261611|100676678|FG000|COMPLETED|Treatment Cycle 4||220||
48144191|NCT01261611|100676679|FG001|COMPLETED|Treatment Cycle 4||0||
48144192|NCT01261611|100676680|FG002|COMPLETED|Treatment Cycle 4||0||
48144193|NCT01261611|100676678|FG000|NOT COMPLETED|Treatment Cycle 4||96||
48144194|NCT01261611|100676679|FG001|NOT COMPLETED|Treatment Cycle 4||0||
48144195|NCT01261611|100676680|FG002|NOT COMPLETED|Treatment Cycle 4||0||
48144196|NCT01261611|100676678|FG000|STARTED|Treatment Cycle 5||220||
48144197|NCT01261611|100676679|FG001|STARTED|Treatment Cycle 5||0||
48144198|NCT01261611|100676680|FG002|STARTED|Treatment Cycle 5||0||
48144199|NCT01261611|100676678|FG000|COMPLETED|Treatment Cycle 5||217||
48144200|NCT01261611|100676679|FG001|COMPLETED|Treatment Cycle 5||0||
48144201|NCT01261611|100676680|FG002|COMPLETED|Treatment Cycle 5||0||
48144202|NCT01261611|100676678|FG000|NOT COMPLETED|Treatment Cycle 5||3||
48144203|NCT01261611|100676679|FG001|NOT COMPLETED|Treatment Cycle 5||0||
48144204|NCT01261611|100676680|FG002|NOT COMPLETED|Treatment Cycle 5||0||
48144205|NCT02439710|100676681|FG000|STARTED|Overall Study||656||
48144206|NCT02439710|100676681|FG000|COMPLETED|Overall Study||656||
48144207|NCT02439710|100676681|FG000|NOT COMPLETED|Overall Study||0||
48144208|NCT00450411|100676682|FG000|STARTED|Overall Study||100||
48144209|NCT00450411|100676682|FG000|Eligible and Started Protocol Treatment|Overall Study||92||
48144210|NCT00450411|100676682|FG000|COMPLETED|Overall Study||92|Subjects contributing data to analysis are considered to have completed the study.|
48144211|NCT00450411|100676682|FG000|NOT COMPLETED|Overall Study||8||
48144212|NCT00862134|100676683|FG000|STARTED|Overall Study||19||
48144213|NCT00862134|100676684|FG001|STARTED|Overall Study||23||
48144214|NCT00862134|100676683|FG000|COMPLETED|Overall Study||8||
48144215|NCT00862134|100676684|FG001|COMPLETED|Overall Study||11||
48144216|NCT00862134|100676683|FG000|NOT COMPLETED|Overall Study||11||
48144217|NCT00862134|100676684|FG001|NOT COMPLETED|Overall Study||12||
48144218|NCT02212028|100676685|FG000|STARTED|Overall Study||26||
48144219|NCT02212028|100676686|FG001|STARTED|Overall Study||26||
48144220|NCT02212028|100676685|FG000|COMPLETED|Overall Study||26||
48144221|NCT02212028|100676686|FG001|COMPLETED|Overall Study||26||
48144222|NCT02212028|100676685|FG000|NOT COMPLETED|Overall Study||0||
48144223|NCT02212028|100676686|FG001|NOT COMPLETED|Overall Study||0||
48144224|NCT00003298|100676687|FG000|STARTED|Step 1 (Neoadjuvant Therapy)||39||
48144225|NCT00003298|100676687|FG000|Eligible and Treated|Step 1 (Neoadjuvant Therapy)||38||
48144226|NCT00003298|100676687|FG000|Complete 3 Cycles of Neoadjuvant Therapy|Step 1 (Neoadjuvant Therapy)||35||
48144227|NCT00003298|100676687|FG000|COMPLETED|Step 1 (Neoadjuvant Therapy)||35||
48144228|NCT00003298|100676687|FG000|NOT COMPLETED|Step 1 (Neoadjuvant Therapy)||4||
48144229|NCT00003298|100676687|FG000|STARTED|Surgery||35||
48144230|NCT00003298|100676687|FG000|COMPLETED|Surgery||28||
48144231|NCT00003298|100676687|FG000|NOT COMPLETED|Surgery||7||
48144232|NCT00003298|100676687|FG000|STARTED|Re-register to Step 2 After Surgery||28||
48144233|NCT00003298|100676687|FG000|COMPLETED|Re-register to Step 2 After Surgery||10||
48144234|NCT00003298|100676687|FG000|NOT COMPLETED|Re-register to Step 2 After Surgery||18||
48144235|NCT00003298|100676687|FG000|STARTED|Step 2 (Adjuvant Therapy)||10||
48144236|NCT00003298|100676687|FG000|Eligible and Treated on Step 2|Step 2 (Adjuvant Therapy)||7||
48144237|NCT00003298|100676687|FG000|COMPLETED|Step 2 (Adjuvant Therapy)||4||
48144238|NCT00003298|100676687|FG000|NOT COMPLETED|Step 2 (Adjuvant Therapy)||6||
48144239|NCT00605280|100676688|FG000|STARTED|Year 1||145||
48144240|NCT00605280|100676689|FG001|STARTED|Year 1||22||
48144241|NCT00605280|100676690|FG002|STARTED|Year 1||7||
48144242|NCT00605280|100676691|FG003|STARTED|Year 1||143||
48144243|NCT00605280|100676688|FG000|Received 0.3 mg Treatment|Year 1||144||
48144244|NCT00605280|100676689|FG001|Received 0.3 mg Treatment|Year 1||13||
48144245|NCT00605280|100676690|FG002|Received 0.3 mg Treatment|Year 1||3||
48144246|NCT00605280|100676691|FG003|Received 0.3 mg Treatment|Year 1||0||
48144247|NCT00605280|100676688|FG000|COMPLETED|Year 1||126||
48144248|NCT00605280|100676689|FG001|COMPLETED|Year 1||11||
48144249|NCT00605280|100676690|FG002|COMPLETED|Year 1||6||
48144250|NCT00605280|100676691|FG003|COMPLETED|Year 1||124||
48144251|NCT00605280|100676688|FG000|NOT COMPLETED|Year 1||19||
48144252|NCT00605280|100676689|FG001|NOT COMPLETED|Year 1||11||
48144253|NCT00605280|100676690|FG002|NOT COMPLETED|Year 1||1||
48144254|NCT00605280|100676691|FG003|NOT COMPLETED|Year 1||19||
48144255|NCT00605280|100676688|FG000|STARTED|Year 2||126||
48144256|NCT00605280|100676689|FG001|STARTED|Year 2||11||
48144257|NCT00605280|100676690|FG002|STARTED|Year 2||6||
48144258|NCT00605280|100676691|FG003|STARTED|Year 2||124||
48144259|NCT00605280|100676688|FG000|Received 0.3 mg Treatment|Year 2||126||
48144260|NCT00605280|100676689|FG001|Received 0.3 mg Treatment|Year 2||3||
48144261|NCT00605280|100676690|FG002|Received 0.3 mg Treatment|Year 2||2||
48144262|NCT00605280|100676691|FG003|Received 0.3 mg Treatment|Year 2||0||
48144263|NCT00605280|100676688|FG000|COMPLETED|Year 2||102||
48144264|NCT00605280|100676689|FG001|COMPLETED|Year 2||5||
48144265|NCT00605280|100676690|FG002|COMPLETED|Year 2||0||
48144266|NCT00605280|100676691|FG003|COMPLETED|Year 2||102||
48144267|NCT00605280|100676688|FG000|NOT COMPLETED|Year 2||24||
48144268|NCT00605280|100676689|FG001|NOT COMPLETED|Year 2||6||
48144269|NCT00605280|100676690|FG002|NOT COMPLETED|Year 2||6||
48144270|NCT00605280|100676691|FG003|NOT COMPLETED|Year 2||22||
48144271|NCT00605280|100676688|FG000|STARTED|Year 3 Extension||46||
48297262|NCT04344600|101054451|FG000|COMPLETED|Overall Study||2||
48297263|NCT04344600|101054452|FG001|COMPLETED|Overall Study||4||
48297264|NCT04344600|101054451|FG000|NOT COMPLETED|Overall Study||0||
48297265|NCT04344600|101054452|FG001|NOT COMPLETED|Overall Study||0||
48367940|NCT03661541|101230079|FG002|NOT COMPLETED|Overall Study||2||
48367941|NCT02815397|101230080|FG000|STARTED|Overall Study||2||
48367942|NCT02815397|101230080|FG000|COMPLETED|Overall Study||0||
48367943|NCT02815397|101230080|FG000|NOT COMPLETED|Overall Study||2||
48367944|NCT00390780|101230081|FG000|STARTED|Overall Study||291||
48367945|NCT00390780|101230082|FG001|STARTED|Overall Study||287||
48367946|NCT00390780|101230081|FG000|Treatment|Overall Study||290||
48367947|NCT00390780|101230082|FG001|Treatment|Overall Study||287||
48367948|NCT00390780|101230081|FG000|COMPLETED|Overall Study||268||
48367949|NCT00390780|101230082|FG001|COMPLETED|Overall Study||260||
48367950|NCT00390780|101230081|FG000|NOT COMPLETED|Overall Study||23||
48367951|NCT00390780|101230082|FG001|NOT COMPLETED|Overall Study||27||
48367952|NCT00138125|101230083|FG000|STARTED|Overall Study||2||
48367953|NCT00138125|101230083|FG000|COMPLETED|Overall Study||2||
48367954|NCT00138125|101230083|FG000|NOT COMPLETED|Overall Study||0||
48367955|NCT01509586|101230084|FG000|STARTED|Overall Study||626||
48367956|NCT01509586|101230085|FG001|STARTED|Overall Study||610||
48367957|NCT01509586|101230084|FG000|Week 3|Overall Study||574||
48367958|NCT01509586|101230085|FG001|Week 3|Overall Study||585||
48367959|NCT01509586|101230084|FG000|Week 6|Overall Study||551||
48367960|NCT01509586|101230085|FG001|Week 6|Overall Study||585||
48367961|NCT01509586|101230084|FG000|Week 10|Overall Study||537||
48367962|NCT01509586|101230085|FG001|Week 10|Overall Study||574||
48367963|NCT01509586|101230084|FG000|Week 14|Overall Study||528||
48367964|NCT01509586|101230085|FG001|Week 14|Overall Study||566||
48367965|NCT01509586|101230084|FG000|Week18|Overall Study||529||
48367966|NCT01509586|101230085|FG001|Week18|Overall Study||555||
48367967|NCT01509586|101230084|FG000|Week 32 (Month 6)|Overall Study||504||
48367968|NCT01509586|101230085|FG001|Week 32 (Month 6)|Overall Study||523||
48367969|NCT01509586|101230084|FG000|Week 46|Overall Study||483||
48367970|NCT01509586|101230085|FG001|Week 46|Overall Study||494||
48367971|NCT01509586|101230084|FG000|Week 58 (Month 12)|Overall Study||492||
48367972|NCT01509586|101230085|FG001|Week 58 (Month 12)|Overall Study||499||
48367973|NCT01509586|101230084|FG000|COMPLETED|Overall Study||626||
48367974|NCT01509586|101230085|FG001|COMPLETED|Overall Study||610||
48367975|NCT01509586|101230084|FG000|NOT COMPLETED|Overall Study||0||
48367976|NCT01509586|101230085|FG001|NOT COMPLETED|Overall Study||0||
48367977|NCT01158534|101230086|FG000|STARTED|Overall Study||17||
48367978|NCT01158534|101230086|FG000|COMPLETED|Overall Study||14||
48367979|NCT01158534|101230086|FG000|NOT COMPLETED|Overall Study||3||
48367980|NCT01108809|101230087|FG000|STARTED|Overall Study||295||
48367981|NCT01108809|101230087|FG000|COMPLETED|Overall Study||291||
48367982|NCT01108809|101230087|FG000|NOT COMPLETED|Overall Study||4||
48367983|NCT00717418|101230088|FG000|STARTED|Baseline||180||
48367984|NCT00717418|101230089|FG001|STARTED|Baseline||74||
48367985|NCT00717418|101230090|FG002|STARTED|Baseline||508||
48367986|NCT00717418|101230091|FG003|STARTED|Baseline||19||
48144272|NCT00605280|100676689|FG001|STARTED|Year 3 Extension||0||
48144273|NCT00605280|100676690|FG002|STARTED|Year 3 Extension||0||
48144274|NCT00605280|100676691|FG003|STARTED|Year 3 Extension||54||
48144275|NCT00605280|100676688|FG000|Received 0.3 mg Treatment|Year 3 Extension||46||
48144276|NCT00605280|100676689|FG001|Received 0.3 mg Treatment|Year 3 Extension||0||
48144277|NCT00605280|100676690|FG002|Received 0.3 mg Treatment|Year 3 Extension||0||
48144278|NCT00605280|100676691|FG003|Received 0.3 mg Treatment|Year 3 Extension||54||
48144279|NCT00605280|100676688|FG000|COMPLETED|Year 3 Extension||38||
48144280|NCT00605280|100676689|FG001|COMPLETED|Year 3 Extension||0||
48144281|NCT00605280|100676690|FG002|COMPLETED|Year 3 Extension||0||
48144282|NCT00605280|100676691|FG003|COMPLETED|Year 3 Extension||45||
48144283|NCT00605280|100676688|FG000|NOT COMPLETED|Year 3 Extension||8||
48144284|NCT00605280|100676689|FG001|NOT COMPLETED|Year 3 Extension||0||
48144285|NCT00605280|100676690|FG002|NOT COMPLETED|Year 3 Extension||0||
48144286|NCT00605280|100676691|FG003|NOT COMPLETED|Year 3 Extension||9||
48144287|NCT04368429|100676692|FG000|STARTED|Overall Study||180||
48144288|NCT04368429|100676693|FG001|STARTED|Overall Study||180||
48144289|NCT04368429|100676692|FG000|Safety Analysis Set|Overall Study||179|Participants who received at least one dose of the study vaccine and had any safety data available; analyzed according to the vaccine they actually received.|
48188521|NCT00031447|100783265|FG001|STARTED|Overall Study||15||
48297266|NCT01214187|101056895|FG000|STARTED|Overall Study||29||
48297267|NCT01214187|101056896|FG001|STARTED|Overall Study||29||
48297268|NCT01214187|101056895|FG000|COMPLETED|Overall Study||22||
48598690|NCT00475878|101800154|FG000|COMPLETED|Overall Study||75||
48598691|NCT00475878|101800155|FG001|COMPLETED|Overall Study||72||
48598692|NCT00475878|101800154|FG000|NOT COMPLETED|Overall Study||0||
48598693|NCT00475878|101800155|FG001|NOT COMPLETED|Overall Study||0||
48598694|NCT00380718|101800156|FG000|STARTED|Overall Study||33||
48598695|NCT00380718|101800156|FG000|Received at Least One Dose of Study Drug|Overall Study||33||
48598696|NCT00380718|101800156|FG000|Received Escalated Dose in Cycle 2|Overall Study||25||
48598697|NCT00380718|101800156|FG000|COMPLETED|Overall Study||15||
48598698|NCT00380718|101800156|FG000|NOT COMPLETED|Overall Study||18||
48598699|NCT01738191|101800157|FG000|STARTED|Overall Study||15||
48598700|NCT01738191|101800158|FG001|STARTED|Overall Study||15||
48598701|NCT01738191|101800157|FG000|COMPLETED|Overall Study||11||
48598702|NCT01738191|101800158|FG001|COMPLETED|Overall Study||14||
48598703|NCT01738191|101800157|FG000|NOT COMPLETED|Overall Study||4||
48598704|NCT01738191|101800158|FG001|NOT COMPLETED|Overall Study||1||
48598705|NCT02179749|101800159|FG000|STARTED|Overall Study||49||
48598706|NCT02179749|101800160|FG001|STARTED|Overall Study||32||
48598707|NCT02179749|101800161|FG002|STARTED|Overall Study||22||
48598708|NCT02179749|101800159|FG000|COMPLETED|Overall Study||49||
48598709|NCT02179749|101800160|FG001|COMPLETED|Overall Study||32||
48598710|NCT02179749|101800161|FG002|COMPLETED|Overall Study||20||
48598711|NCT02179749|101800159|FG000|NOT COMPLETED|Overall Study||0||
48598712|NCT02179749|101800160|FG001|NOT COMPLETED|Overall Study||0||
48598713|NCT02179749|101800161|FG002|NOT COMPLETED|Overall Study||2||
48598714|NCT02431806|101800162|FG000|STARTED|Double-blind Treatment Period||142||
48598715|NCT02431806|101800163|FG001|STARTED|Double-blind Treatment Period||136||
48598716|NCT02431806|101800164|FG002|STARTED|Double-blind Treatment Period||139||
48598717|NCT02431806|101800165|FG003|STARTED|Double-blind Treatment Period||135||
48598718|NCT02431806|101800162|FG000|Safety Population|Double-blind Treatment Period||141||
48598719|NCT02431806|101800163|FG001|Safety Population|Double-blind Treatment Period||134||
48598720|NCT02431806|101800164|FG002|Safety Population|Double-blind Treatment Period||138||
48598721|NCT02431806|101800165|FG003|Safety Population|Double-blind Treatment Period||134||
48598722|NCT02431806|101800162|FG000|COMPLETED|Double-blind Treatment Period||117||
48598723|NCT02431806|101800163|FG001|COMPLETED|Double-blind Treatment Period||115||
48598724|NCT02431806|101800164|FG002|COMPLETED|Double-blind Treatment Period||107||
48598725|NCT02431806|101800165|FG003|COMPLETED|Double-blind Treatment Period||109||
48598726|NCT02431806|101800162|FG000|NOT COMPLETED|Double-blind Treatment Period||25||
48598727|NCT02431806|101800163|FG001|NOT COMPLETED|Double-blind Treatment Period||21||
48598728|NCT02431806|101800164|FG002|NOT COMPLETED|Double-blind Treatment Period||32||
48598729|NCT02431806|101800165|FG003|NOT COMPLETED|Double-blind Treatment Period||26||
48598730|NCT02431806|101800162|FG000|STARTED|Double-blind Down-taper Period||111||
48598731|NCT02431806|101800163|FG001|STARTED|Double-blind Down-taper Period||109||
48598732|NCT02431806|101800164|FG002|STARTED|Double-blind Down-taper Period||104||
48598733|NCT02431806|101800165|FG003|STARTED|Double-blind Down-taper Period||107||
48598734|NCT02431806|101800162|FG000|COMPLETED|Double-blind Down-taper Period||111||
48598735|NCT02431806|101800163|FG001|COMPLETED|Double-blind Down-taper Period||109||
48598736|NCT02431806|101800164|FG002|COMPLETED|Double-blind Down-taper Period||104||
48598737|NCT02431806|101800165|FG003|COMPLETED|Double-blind Down-taper Period||107||
48598738|NCT02431806|101800162|FG000|NOT COMPLETED|Double-blind Down-taper Period||0||
48598739|NCT02431806|101800163|FG001|NOT COMPLETED|Double-blind Down-taper Period||0||
48598740|NCT02431806|101800164|FG002|NOT COMPLETED|Double-blind Down-taper Period||0||
48598741|NCT02431806|101800165|FG003|NOT COMPLETED|Double-blind Down-taper Period||0||
48598742|NCT00382109|101800166|FG000|STARTED|Overall Study||76||
48598743|NCT00382109|101800167|FG001|STARTED|Overall Study||70||
48598744|NCT00382109|101800166|FG000|COMPLETED|Overall Study||64||
48598745|NCT00382109|101800167|FG001|COMPLETED|Overall Study||66||
48598746|NCT00382109|101800166|FG000|NOT COMPLETED|Overall Study||12||
48598747|NCT00382109|101800167|FG001|NOT COMPLETED|Overall Study||4||
48598748|NCT04006509|101800168|FG000|STARTED|Overall Study||49||
48598749|NCT04006509|101800169|FG001|STARTED|Overall Study||25||
48598750|NCT04006509|101800168|FG000|COMPLETED|Overall Study||36||
48598751|NCT04006509|101800169|FG001|COMPLETED|Overall Study||25||
48598752|NCT04006509|101800168|FG000|NOT COMPLETED|Overall Study||13||
48598753|NCT04006509|101800169|FG001|NOT COMPLETED|Overall Study||0||
48598754|NCT03099694|101800170|FG000|STARTED|Overall Study||170||
48598755|NCT03099694|101800171|FG001|STARTED|Overall Study||170||
48598756|NCT03099694|101800170|FG000|COMPLETED|Overall Study||150||
48598757|NCT03099694|101800171|FG001|COMPLETED|Overall Study||152||
48598758|NCT03099694|101800170|FG000|NOT COMPLETED|Overall Study||20||
48598759|NCT03099694|101800171|FG001|NOT COMPLETED|Overall Study||18||
48598760|NCT02003963|101800172|FG000|STARTED|Overall Study||22||
48598761|NCT02003963|101800173|FG001|STARTED|Overall Study||19||
48598762|NCT02003963|101800172|FG000|COMPLETED|Overall Study||20||
48598763|NCT02003963|101800173|FG001|COMPLETED|Overall Study||18||
48598764|NCT02003963|101800172|FG000|NOT COMPLETED|Overall Study||2||
48598765|NCT02003963|101800173|FG001|NOT COMPLETED|Overall Study||1||
48598766|NCT05121740|101800174|FG000|STARTED|Overall Study||9||
48598767|NCT05121740|101800175|FG001|STARTED|Overall Study||14||
48598768|NCT05121740|101800176|FG002|STARTED|Overall Study||11||
48598769|NCT05121740|101800174|FG000|COMPLETED|Overall Study||9||
48598770|NCT05121740|101800175|FG001|COMPLETED|Overall Study||14||
48598771|NCT05121740|101800176|FG002|COMPLETED|Overall Study||11||
48598772|NCT05121740|101800174|FG000|NOT COMPLETED|Overall Study||0||
48598773|NCT05121740|101800175|FG001|NOT COMPLETED|Overall Study||0||
48598774|NCT05121740|101800176|FG002|NOT COMPLETED|Overall Study||0||
48598775|NCT00743288|101800177|FG000|STARTED|Overall Study||3||
48598776|NCT00743288|101800178|FG001|STARTED|Overall Study||3||
48598777|NCT00743288|101800179|FG002|STARTED|Overall Study||6||
48598778|NCT00743288|101800180|FG003|STARTED|Overall Study||7||
48598779|NCT00743288|101800181|FG004|STARTED|Overall Study||6||
48598780|NCT00743288|101800182|FG005|STARTED|Overall Study||6||
48598781|NCT00743288|101800183|FG006|STARTED|Overall Study||9||
48598782|NCT00743288|101800177|FG000|COMPLETED|Overall Study||0||
48598783|NCT00743288|101800178|FG001|COMPLETED|Overall Study||0||
48598784|NCT00743288|101800179|FG002|COMPLETED|Overall Study||1||
48598785|NCT00743288|101800180|FG003|COMPLETED|Overall Study||0||
48598786|NCT00743288|101800181|FG004|COMPLETED|Overall Study||0||
48598787|NCT00743288|101800182|FG005|COMPLETED|Overall Study||1||
48598788|NCT00743288|101800183|FG006|COMPLETED|Overall Study||0||
48598789|NCT00743288|101800177|FG000|NOT COMPLETED|Overall Study||3||
48598790|NCT00743288|101800178|FG001|NOT COMPLETED|Overall Study||3||
48598791|NCT00743288|101800179|FG002|NOT COMPLETED|Overall Study||5||
48598792|NCT00743288|101800180|FG003|NOT COMPLETED|Overall Study||7||
48598793|NCT00743288|101800181|FG004|NOT COMPLETED|Overall Study||6||
48598794|NCT00743288|101800182|FG005|NOT COMPLETED|Overall Study||5||
48598795|NCT00743288|101800183|FG006|NOT COMPLETED|Overall Study||9||
48598796|NCT00985426|101800184|FG000|STARTED|Overall Study||258||
48598797|NCT00985426|101800185|FG001|STARTED|Overall Study||263||
48598798|NCT00985426|101800184|FG000|COMPLETED|Overall Study||215||
48598799|NCT00985426|101800185|FG001|COMPLETED|Overall Study||219||
48598800|NCT00985426|101800184|FG000|NOT COMPLETED|Overall Study||43||
48598801|NCT00985426|101800185|FG001|NOT COMPLETED|Overall Study||44||
48598802|NCT03564795|101800186|FG000|STARTED|Overall Study||14|Each subject received KeraStat Gel as well as Silver Sulfadiazine. Total subjects enrolled was 14, not 28.|28
48598803|NCT03564795|101800186|FG000|KeraStat Gel-treated:|Overall Study||14|One (of two) wounds present on enrolled participants was treated with KeraStat Gel.|14
48598804|NCT03564795|101800186|FG000|Silver Sulfadiazine-treated:|Overall Study||14|One (of two) wounds present on enrolled participants was treated with SSD.|14
48598805|NCT03564795|101800186|FG000|COMPLETED|Overall Study||3|Each subject received KeraStat Gel and Silver Sulfadiazine. Total number of subjects that completed the study was 3, not 6.|6
48598806|NCT03564795|101800186|FG000|NOT COMPLETED|Overall Study||11||22
48598807|NCT00625404|101800187|FG000|STARTED|Overall Study||1062||
48598808|NCT00625404|101800188|FG001|STARTED|Overall Study||1058||
48598809|NCT00625404|101800187|FG000|COMPLETED|Overall Study||855||
48598810|NCT00625404|101800188|FG001|COMPLETED|Overall Study||885||
48598811|NCT00625404|101800187|FG000|NOT COMPLETED|Overall Study||207||
48598812|NCT00625404|101800188|FG001|NOT COMPLETED|Overall Study||173||
48598813|NCT01010399|101800189|FG000|STARTED|Overall Study||36||
48598814|NCT01010399|101800189|FG000|COMPLETED|Overall Study||31||
48598815|NCT01010399|101800189|FG000|NOT COMPLETED|Overall Study||5||
48598816|NCT03436199|101800190|FG000|STARTED|Overall Study||187||
48598817|NCT03436199|101800191|FG001|STARTED|Overall Study||185||
48598818|NCT03436199|101800192|FG002|STARTED|Overall Study||186||
48598819|NCT03436199|101800190|FG000|COMPLETED|Overall Study||165||
48598820|NCT03436199|101800191|FG001|COMPLETED|Overall Study||132||
48598821|NCT03436199|101800192|FG002|COMPLETED|Overall Study||174||
48598822|NCT03436199|101800190|FG000|NOT COMPLETED|Overall Study||22||
48598823|NCT03436199|101800191|FG001|NOT COMPLETED|Overall Study||53||
48598824|NCT03436199|101800192|FG002|NOT COMPLETED|Overall Study||12||
48598825|NCT03646149|101800193|FG000|STARTED|Overall Study||35||
48598826|NCT03646149|101800193|FG000|COMPLETED|Overall Study||35||
48598827|NCT03646149|101800193|FG000|NOT COMPLETED|Overall Study||0||
48598828|NCT00006305|101800194|FG000|STARTED|Overall Study||592||
48598829|NCT00006305|101800195|FG001|STARTED|Overall Study||584||
48598830|NCT00006305|101800196|FG002|STARTED|Overall Study||593||
48598831|NCT00006305|101800197|FG003|STARTED|Overall Study||599||
48598832|NCT00006305|101800194|FG000|COMPLETED|Overall Study||575||
48598833|NCT00006305|101800195|FG001|COMPLETED|Overall Study||574||
48598834|NCT00006305|101800196|FG002|COMPLETED|Overall Study||578||
48598835|NCT00006305|101800197|FG003|COMPLETED|Overall Study||585||
48598836|NCT00006305|101800194|FG000|NOT COMPLETED|Overall Study||17||
48598837|NCT00006305|101800195|FG001|NOT COMPLETED|Overall Study||10||
48598838|NCT00006305|101800196|FG002|NOT COMPLETED|Overall Study||15||
48598839|NCT00006305|101800197|FG003|NOT COMPLETED|Overall Study||14||
48598840|NCT02494401|101800198|FG000|STARTED|Overall Study||134||
48598841|NCT02494401|101800199|FG001|STARTED|Overall Study||133||
48598842|NCT02494401|101800198|FG000|Week 16|Overall Study||123||
48598843|NCT02494401|101800199|FG001|Week 16|Overall Study||124||
48598844|NCT02494401|101800198|FG000|6 Month Follow up|Overall Study||109||
48598845|NCT02494401|101800199|FG001|6 Month Follow up|Overall Study||106||
48598846|NCT02494401|101800198|FG000|COMPLETED|Overall Study||109||
48598847|NCT02494401|101800199|FG001|COMPLETED|Overall Study||106||
48598848|NCT02494401|101800198|FG000|NOT COMPLETED|Overall Study||25||
48598849|NCT02494401|101800199|FG001|NOT COMPLETED|Overall Study||27||
48598850|NCT03217968|101800200|FG000|STARTED|Overall Study||59||
48598851|NCT03217968|101800200|FG000|COMPLETED|Overall Study||48||
48598852|NCT03217968|101800200|FG000|NOT COMPLETED|Overall Study||11||
48598853|NCT00231309|101800201|FG000|STARTED|Overall Study||10||
48598854|NCT00231309|101800201|FG000|COMPLETED|Overall Study||10||
48598855|NCT00231309|101800201|FG000|NOT COMPLETED|Overall Study||0||
48598856|NCT00869557|101800202|FG000|STARTED|Randomized Phase||48||
48598857|NCT00869557|101800203|FG001|STARTED|Randomized Phase||23||
48598858|NCT00869557|101800202|FG000|COMPLETED|Randomized Phase||45||
48598859|NCT00869557|101800203|FG001|COMPLETED|Randomized Phase||21||
48598860|NCT00869557|101800202|FG000|NOT COMPLETED|Randomized Phase||3||
48598861|NCT00869557|101800203|FG001|NOT COMPLETED|Randomized Phase||2||
48598862|NCT00869557|101800202|FG000|STARTED|Extension Phase||45||
48598863|NCT00869557|101800203|FG001|STARTED|Extension Phase||14||
48598864|NCT00869557|101800202|FG000|COMPLETED|Extension Phase||35||
48598865|NCT00869557|101800203|FG001|COMPLETED|Extension Phase||11||
48598866|NCT00869557|101800202|FG000|NOT COMPLETED|Extension Phase||10||
48598867|NCT00869557|101800203|FG001|NOT COMPLETED|Extension Phase||3||
48598868|NCT00636636|101800204|FG000|STARTED|Overall Study||221||
48598869|NCT00636636|101800205|FG001|STARTED|Overall Study||231||
48598870|NCT00636636|101800204|FG000|Safety & Efficacy of Gabapentin ER|Overall Study||186||
48713163|NCT04178993|102084881|FG001|NOT COMPLETED|Overall Study||0||
48713164|NCT02982018|102084882|FG000|STARTED|Overall Study||67||
48713165|NCT02982018|102084883|FG001|STARTED|Overall Study||64||
48598871|NCT00636636|101800205|FG001|Safety & Efficacy of Gabapentin ER|Overall Study||194||
48598872|NCT00636636|101800204|FG000|379|Overall Study||186||
48713166|NCT02982018|102084882|FG000|COMPLETED|Overall Study||62||
48713167|NCT02982018|102084883|FG001|COMPLETED|Overall Study||61||
48598873|NCT00636636|101800205|FG001|379|Overall Study||194||
48598874|NCT00636636|101800204|FG000|COMPLETED|Overall Study||185||
48598875|NCT00636636|101800205|FG001|COMPLETED|Overall Study||192||
48713168|NCT02982018|102084882|FG000|NOT COMPLETED|Overall Study||5||
48713169|NCT02982018|102084883|FG001|NOT COMPLETED|Overall Study||3||
48713170|NCT03515941|102084884|FG000|STARTED|Overall Study||4||
48713171|NCT03515941|102084885|FG001|STARTED|Overall Study||2||
48713172|NCT03515941|102084884|FG000|COMPLETED|Overall Study||3||
48713173|NCT03515941|102084885|FG001|COMPLETED|Overall Study||2||
48713174|NCT03515941|102084884|FG000|NOT COMPLETED|Overall Study||1||
48713175|NCT03515941|102084885|FG001|NOT COMPLETED|Overall Study||0||
48713176|NCT01428336|102084886|FG000|STARTED|Overall Study||10||
48713177|NCT01428336|102084887|FG001|STARTED|Overall Study||12||
48713178|NCT01428336|102084886|FG000|COMPLETED|Overall Study||10||
48713179|NCT01428336|102084887|FG001|COMPLETED|Overall Study||12||
48713180|NCT01428336|102084886|FG000|NOT COMPLETED|Overall Study||0||
48713181|NCT01428336|102084887|FG001|NOT COMPLETED|Overall Study||0||
48713182|NCT00085982|102084888|FG000|STARTED|Overall Study||11||
48713183|NCT00085982|102084888|FG000|COMPLETED|Overall Study||5||
48713184|NCT00085982|102084888|FG000|NOT COMPLETED|Overall Study||6||
48713185|NCT00431951|102084889|FG000|STARTED|Overall Study||8||
48713186|NCT00431951|102084890|FG001|STARTED|Overall Study||8||
48713187|NCT00431951|102084891|FG002|STARTED|Overall Study||8||
48713188|NCT00431951|102084892|FG003|STARTED|Overall Study||6||
48598876|NCT00636636|101800204|FG000|NOT COMPLETED|Overall Study||36||
48598877|NCT00636636|101800205|FG001|NOT COMPLETED|Overall Study||39||
48713189|NCT00431951|102084889|FG000|COMPLETED|Overall Study||7||
48713190|NCT00431951|102084890|FG001|COMPLETED|Overall Study||6||
48713191|NCT00431951|102084891|FG002|COMPLETED|Overall Study||6||
48713192|NCT00431951|102084892|FG003|COMPLETED|Overall Study||4||
48713193|NCT00431951|102084889|FG000|NOT COMPLETED|Overall Study||1||
48713194|NCT00431951|102084890|FG001|NOT COMPLETED|Overall Study||2||
48713195|NCT00431951|102084891|FG002|NOT COMPLETED|Overall Study||2||
48713196|NCT00431951|102084892|FG003|NOT COMPLETED|Overall Study||2||
48713197|NCT02312765|102084893|FG000|STARTED|Overall Study||74||
48713198|NCT02312765|102084894|FG001|STARTED|Overall Study||72||
48598878|NCT02839876|101800206|FG000|STARTED|Overall Study||41||
48598879|NCT02839876|101800207|FG001|STARTED|Overall Study||40||
48598880|NCT02839876|101800206|FG000|COMPLETED|Overall Study||31||
48598881|NCT02839876|101800207|FG001|COMPLETED|Overall Study||29||
48598882|NCT02839876|101800206|FG000|NOT COMPLETED|Overall Study||10||
48598883|NCT02839876|101800207|FG001|NOT COMPLETED|Overall Study||11||
48598884|NCT00483704|101800208|FG000|STARTED|Randomization||644||
48598885|NCT00483704|101800209|FG001|STARTED|Randomization||645||
48713199|NCT02312765|102084893|FG000|COMPLETED|Overall Study||19||
48713200|NCT02312765|102084894|FG001|COMPLETED|Overall Study||36||
48713201|NCT02312765|102084893|FG000|NOT COMPLETED|Overall Study||55||
48713202|NCT02312765|102084894|FG001|NOT COMPLETED|Overall Study||36||
48713203|NCT01739933|102084895|FG000|STARTED|Overall Study||214||
48713204|NCT01739933|102084896|FG001|STARTED|Overall Study||208||
48713205|NCT01739933|102084895|FG000|Discharged From Hospital and Eligible for Follow-up|Overall Study||140||
48713206|NCT01739933|102084896|FG001|Discharged From Hospital and Eligible for Follow-up|Overall Study||147||
48713207|NCT01739933|102084895|FG000|COMPLETED|Overall Study||108|Alive and completed 6 mos follow-up|
48713208|NCT01739933|102084896|FG001|COMPLETED|Overall Study||101|Alive and completed 6 mos follow-up|
48713209|NCT01739933|102084895|FG000|NOT COMPLETED|Overall Study||106||
48713210|NCT01739933|102084896|FG001|NOT COMPLETED|Overall Study||107||
48713211|NCT00737594|102084897|FG000|STARTED|Overall Study||0||
48713212|NCT00737594|102084898|FG001|STARTED|Overall Study||0||
48713213|NCT00737594|102084899|FG002|STARTED|Overall Study||0||
48713214|NCT00737594|102084897|FG000|COMPLETED|Overall Study||0||
48713215|NCT00737594|102084898|FG001|COMPLETED|Overall Study||0||
48713216|NCT00737594|102084899|FG002|COMPLETED|Overall Study||0||
48713217|NCT00737594|102084897|FG000|NOT COMPLETED|Overall Study||0||
48713218|NCT00737594|102084898|FG001|NOT COMPLETED|Overall Study||0||
48713219|NCT00737594|102084899|FG002|NOT COMPLETED|Overall Study||0||
48713220|NCT02351349|102084900|FG000|STARTED|Overall Study||6||
48713221|NCT02351349|102084901|FG001|STARTED|Overall Study||8||
48713222|NCT02351349|102084900|FG000|COMPLETED|Overall Study||4||
48713223|NCT02351349|102084901|FG001|COMPLETED|Overall Study||5||
48713224|NCT02351349|102084900|FG000|NOT COMPLETED|Overall Study||2||
48713225|NCT02351349|102084901|FG001|NOT COMPLETED|Overall Study||3||
48713226|NCT00098722|102084902|FG000|STARTED|Double Blind Phase||186||
48713227|NCT00098722|102084903|FG001|STARTED|Double Blind Phase||194||
48713228|NCT00098722|102084904|FG002|STARTED|Double Blind Phase||94||
48713229|NCT00098722|102084905|FG003|STARTED|Double Blind Phase||0||
48713230|NCT00098722|102084906|FG004|STARTED|Double Blind Phase||0||
48713231|NCT00098722|102084907|FG005|STARTED|Double Blind Phase||0||
48713232|NCT00098722|102084908|FG006|STARTED|Double Blind Phase||0||
48713233|NCT00098722|102084902|FG000|Treated|Double Blind Phase||182||
48713234|NCT00098722|102084903|FG001|Treated|Double Blind Phase||191||
48713235|NCT00098722|102084904|FG002|Treated|Double Blind Phase||91||
48713236|NCT00098722|102084905|FG003|Treated|Double Blind Phase||0||
48713237|NCT00098722|102084906|FG004|Treated|Double Blind Phase||0||
48713238|NCT00098722|102084907|FG005|Treated|Double Blind Phase||0||
48713239|NCT00098722|102084908|FG006|Treated|Double Blind Phase||0||
48713240|NCT00098722|102084902|FG000|COMPLETED|Double Blind Phase||0||
48713241|NCT00098722|102084903|FG001|COMPLETED|Double Blind Phase||0||
48713242|NCT00098722|102084904|FG002|COMPLETED|Double Blind Phase||0||
48713243|NCT00098722|102084905|FG003|COMPLETED|Double Blind Phase||0||
48713244|NCT00098722|102084906|FG004|COMPLETED|Double Blind Phase||0||
48713245|NCT00098722|102084907|FG005|COMPLETED|Double Blind Phase||0||
48713246|NCT00098722|102084908|FG006|COMPLETED|Double Blind Phase||0||
48713247|NCT00098722|102084902|FG000|NOT COMPLETED|Double Blind Phase||186||
48713248|NCT00098722|102084903|FG001|NOT COMPLETED|Double Blind Phase||194||
48713249|NCT00098722|102084904|FG002|NOT COMPLETED|Double Blind Phase||94||
48713250|NCT00098722|102084905|FG003|NOT COMPLETED|Double Blind Phase||0||
48713251|NCT00098722|102084906|FG004|NOT COMPLETED|Double Blind Phase||0||
48713252|NCT00098722|102084907|FG005|NOT COMPLETED|Double Blind Phase||0||
48713253|NCT00098722|102084908|FG006|NOT COMPLETED|Double Blind Phase||0||
48713254|NCT00098722|102084902|FG000|STARTED|Open Label Phase||0||
48713255|NCT00098722|102084903|FG001|STARTED|Open Label Phase||0||
48713256|NCT00098722|102084904|FG002|STARTED|Open Label Phase||0||
48713257|NCT00098722|102084905|FG003|STARTED|Open Label Phase||272||
48713258|NCT00098722|102084906|FG004|STARTED|Open Label Phase||50||
48713259|NCT00098722|102084907|FG005|STARTED|Open Label Phase||0||
48713260|NCT00098722|102084908|FG006|STARTED|Open Label Phase||0||
48713261|NCT00098722|102084902|FG000|COMPLETED|Open Label Phase||0||
48713262|NCT00098722|102084903|FG001|COMPLETED|Open Label Phase||0||
48713263|NCT00098722|102084904|FG002|COMPLETED|Open Label Phase||0||
48713264|NCT00098722|102084905|FG003|COMPLETED|Open Label Phase||0||
48713265|NCT00098722|102084906|FG004|COMPLETED|Open Label Phase||0||
48713266|NCT00098722|102084907|FG005|COMPLETED|Open Label Phase||0||
48713267|NCT00098722|102084908|FG006|COMPLETED|Open Label Phase||0||
48713268|NCT00098722|102084902|FG000|NOT COMPLETED|Open Label Phase||0||
48713269|NCT00098722|102084903|FG001|NOT COMPLETED|Open Label Phase||0||
48713270|NCT00098722|102084904|FG002|NOT COMPLETED|Open Label Phase||0||
48713271|NCT00098722|102084905|FG003|NOT COMPLETED|Open Label Phase||272||
48713272|NCT00098722|102084906|FG004|NOT COMPLETED|Open Label Phase||50||
48713273|NCT00098722|102084907|FG005|NOT COMPLETED|Open Label Phase||0||
48713274|NCT00098722|102084908|FG006|NOT COMPLETED|Open Label Phase||0||
48713275|NCT00098722|102084902|FG000|STARTED|Observation Phase||0||
48713276|NCT00098722|102084903|FG001|STARTED|Observation Phase||0||
48713277|NCT00098722|102084904|FG002|STARTED|Observation Phase||0||
48713278|NCT00098722|102084905|FG003|STARTED|Observation Phase||0||
48713279|NCT00098722|102084906|FG004|STARTED|Observation Phase||0||
48713280|NCT00098722|102084907|FG005|STARTED|Observation Phase||205||
48713281|NCT00098722|102084908|FG006|STARTED|Observation Phase||65||
48713282|NCT00098722|102084902|FG000|COMPLETED|Observation Phase||0||
48713283|NCT00098722|102084903|FG001|COMPLETED|Observation Phase||0||
48144290|NCT04368429|100676693|FG001|Safety Analysis Set|Overall Study||180|Participants who received at least one dose of the study vaccine and had any safety data available; analyzed according to the vaccine they actually received.|
48144291|NCT04368429|100676692|FG000|COMPLETED|Overall Study||179||
48144292|NCT04368429|100676693|FG001|COMPLETED|Overall Study||180||
48713284|NCT00098722|102084904|FG002|COMPLETED|Observation Phase||0||
48713285|NCT00098722|102084905|FG003|COMPLETED|Observation Phase||0||
48713286|NCT00098722|102084906|FG004|COMPLETED|Observation Phase||0||
48713287|NCT00098722|102084907|FG005|COMPLETED|Observation Phase||160||
48713288|NCT00098722|102084908|FG006|COMPLETED|Observation Phase||48||
48713289|NCT00098722|102084902|FG000|NOT COMPLETED|Observation Phase||0||
48713290|NCT00098722|102084903|FG001|NOT COMPLETED|Observation Phase||0||
48713291|NCT00098722|102084904|FG002|NOT COMPLETED|Observation Phase||0||
48713292|NCT00098722|102084905|FG003|NOT COMPLETED|Observation Phase||0||
48713293|NCT00098722|102084906|FG004|NOT COMPLETED|Observation Phase||0||
48713294|NCT00098722|102084907|FG005|NOT COMPLETED|Observation Phase||45||
48713295|NCT00098722|102084908|FG006|NOT COMPLETED|Observation Phase||17||
48713296|NCT00711490|102084909|FG000|STARTED|Overall Study||5||
48713297|NCT00711490|102084909|FG000|COMPLETED|Overall Study||5||
48713298|NCT00711490|102084909|FG000|NOT COMPLETED|Overall Study||0||
48713299|NCT00706329|102084910|FG000|STARTED|Overall Study||25||
48713300|NCT00706329|102084910|FG000|COMPLETED|Overall Study||25||
48713301|NCT00706329|102084910|FG000|NOT COMPLETED|Overall Study||0||
48713302|NCT00376805|102084911|FG000|STARTED|Overall Study||6||
48713303|NCT00376805|102084911|FG000|COMPLETED|Overall Study||6||
48713304|NCT00376805|102084911|FG000|NOT COMPLETED|Overall Study||0||
48713305|NCT00868218|102084912|FG000|STARTED|Overall Study||15||
48713306|NCT00868218|102084913|FG001|STARTED|Overall Study||15||
48713307|NCT00868218|102084914|FG002|STARTED|Overall Study||15||
48713308|NCT00868218|102084915|FG003|STARTED|Overall Study||15||
48144293|NCT04368429|100676692|FG000|NOT COMPLETED|Overall Study||1||
48144294|NCT04368429|100676693|FG001|NOT COMPLETED|Overall Study||0||
48144295|NCT04184791|100676694|FG000|STARTED|OFF Med/OFF DBS||24||
48144296|NCT04184791|100676694|FG000|COMPLETED|OFF Med/OFF DBS||22||
48144297|NCT04184791|100676694|FG000|NOT COMPLETED|OFF Med/OFF DBS||2||
48144298|NCT04184791|100676694|FG000|STARTED|180Hz DBS ( OFF MED)||24||
48144299|NCT04184791|100676694|FG000|COMPLETED|180Hz DBS ( OFF MED)||22||
48144300|NCT04184791|100676694|FG000|NOT COMPLETED|180Hz DBS ( OFF MED)||2||
48144301|NCT04184791|100676694|FG000|STARTED|180Hz (ON MED)||24||
48144302|NCT04184791|100676694|FG000|COMPLETED|180Hz (ON MED)||22||
48144303|NCT04184791|100676694|FG000|NOT COMPLETED|180Hz (ON MED)||2||
48713309|NCT00868218|102084912|FG000|COMPLETED|Overall Study||15||
48713310|NCT00868218|102084913|FG001|COMPLETED|Overall Study||15||
48713311|NCT00868218|102084914|FG002|COMPLETED|Overall Study||15||
48713312|NCT00868218|102084915|FG003|COMPLETED|Overall Study||15||
48713313|NCT00868218|102084912|FG000|NOT COMPLETED|Overall Study||0||
48713314|NCT00868218|102084913|FG001|NOT COMPLETED|Overall Study||0||
48713315|NCT00868218|102084914|FG002|NOT COMPLETED|Overall Study||0||
48713316|NCT00868218|102084915|FG003|NOT COMPLETED|Overall Study||0||
48713317|NCT02916407|102084916|FG000|STARTED|Overall Study||28||
48713318|NCT02916407|102084917|FG001|STARTED|Overall Study||28||
48713319|NCT02916407|102084916|FG000|COMPLETED|Overall Study||28||
48713320|NCT02916407|102084917|FG001|COMPLETED|Overall Study||28||
48713321|NCT02916407|102084916|FG000|NOT COMPLETED|Overall Study||0||
48713322|NCT02916407|102084917|FG001|NOT COMPLETED|Overall Study||0||
48713323|NCT04883528|102084918|FG000|STARTED|Overall Study||20||
48713324|NCT04883528|102084919|FG001|STARTED|Overall Study||22||
48713325|NCT04883528|102084918|FG000|COMPLETED|Overall Study||20||
48713326|NCT04883528|102084919|FG001|COMPLETED|Overall Study||22||
48713327|NCT04883528|102084918|FG000|NOT COMPLETED|Overall Study||0||
48713328|NCT04883528|102084919|FG001|NOT COMPLETED|Overall Study||0||
48713329|NCT03703310|102084920|FG000|STARTED|Overall Study||87||
48713330|NCT03703310|102084921|FG001|STARTED|Overall Study||87||
48713331|NCT03703310|102084920|FG000|COMPLETED|Overall Study||67||
48713332|NCT03703310|102084921|FG001|COMPLETED|Overall Study||70||
48713333|NCT03703310|102084920|FG000|NOT COMPLETED|Overall Study||20||
48713334|NCT03703310|102084921|FG001|NOT COMPLETED|Overall Study||17||
48713335|NCT01341301|102084922|FG000|STARTED|Overall Study||25||
48713336|NCT01341301|102084922|FG000|COMPLETED|Overall Study||25||
48713337|NCT01341301|102084922|FG000|NOT COMPLETED|Overall Study||0||
48713338|NCT00490139|102084923|FG000|STARTED|Overall Study||2093||
48713339|NCT00490139|102084924|FG001|STARTED|Overall Study||2091||
48713340|NCT00490139|102084925|FG002|STARTED|Overall Study||2100||
48144304|NCT04184791|100676694|FG000|STARTED|60Hz DBS (OFF MED)||24||
48713341|NCT00490139|102084926|FG003|STARTED|Overall Study||2097||
48713342|NCT00490139|102084923|FG000|COMPLETED|Overall Study||1785||
48713343|NCT00490139|102084924|FG001|COMPLETED|Overall Study||1816||
48713344|NCT00490139|102084925|FG002|COMPLETED|Overall Study||1666||
48713345|NCT00490139|102084926|FG003|COMPLETED|Overall Study||1790||
48713346|NCT00490139|102084923|FG000|NOT COMPLETED|Overall Study||308||
48713347|NCT00490139|102084924|FG001|NOT COMPLETED|Overall Study||275||
48713348|NCT00490139|102084925|FG002|NOT COMPLETED|Overall Study||434||
48144305|NCT04184791|100676694|FG000|COMPLETED|60Hz DBS (OFF MED)||22||
48713349|NCT00490139|102084926|FG003|NOT COMPLETED|Overall Study||307||
48713350|NCT01485380|102084927|FG000|STARTED|Overall Study||20||
48144306|NCT04184791|100676694|FG000|NOT COMPLETED|60Hz DBS (OFF MED)||2||
48144307|NCT04184791|100676694|FG000|STARTED|60Hz (ON Med)||24||
48144308|NCT04184791|100676694|FG000|COMPLETED|60Hz (ON Med)||22||
48144309|NCT04184791|100676694|FG000|NOT COMPLETED|60Hz (ON Med)||2||
48144310|NCT04184791|100676694|FG000|STARTED|ON MED/OFF DBS||24||
48144311|NCT04184791|100676694|FG000|COMPLETED|ON MED/OFF DBS||22||
48144312|NCT04184791|100676694|FG000|NOT COMPLETED|ON MED/OFF DBS||2||
48144313|NCT04427202|100676695|FG000|STARTED|Baseline||306||
48144314|NCT04427202|100676695|FG000|COMPLETED|Baseline||306||
48144315|NCT04427202|100676695|FG000|NOT COMPLETED|Baseline||0||
48144316|NCT04427202|100676695|FG000|STARTED|6 Months||306||
48144317|NCT04427202|100676695|FG000|COMPLETED|6 Months||74||
48144318|NCT04427202|100676695|FG000|NOT COMPLETED|6 Months||232||
48144319|NCT04427202|100676695|FG000|STARTED|12 Months||74||
48144320|NCT04427202|100676695|FG000|COMPLETED|12 Months||44||
48144321|NCT04427202|100676695|FG000|NOT COMPLETED|12 Months||30||
48144322|NCT04427202|100676695|FG000|STARTED|18 Months||44||
48144323|NCT04427202|100676695|FG000|COMPLETED|18 Months||17||
48144324|NCT04427202|100676695|FG000|NOT COMPLETED|18 Months||27||
48144325|NCT04427202|100676695|FG000|STARTED|24 Months||17||
48144326|NCT04427202|100676695|FG000|COMPLETED|24 Months||4||
48144327|NCT04427202|100676695|FG000|NOT COMPLETED|24 Months||13||
48144328|NCT01016938|100676696|FG000|STARTED|Overall Study||16||
48144329|NCT01016938|100676696|FG000|COMPLETED|Overall Study||7||
48713351|NCT01485380|102084927|FG000|COMPLETED|Overall Study||17||
48713352|NCT01485380|102084927|FG000|NOT COMPLETED|Overall Study||3||
48713353|NCT02358044|102084928|FG000|STARTED|Overall Study||129||
48713354|NCT02358044|102084929|FG001|STARTED|Overall Study||128||
48144330|NCT01016938|100676696|FG000|NOT COMPLETED|Overall Study||9||
48144331|NCT03221387|100676697|FG000|STARTED|Overall Study||30||
48144332|NCT03221387|100676697|FG000|COMPLETED|Overall Study||28||
48144333|NCT03221387|100676697|FG000|NOT COMPLETED|Overall Study||2||
48144334|NCT02293044|100676698|FG000|STARTED|Overall Study||15||
48144335|NCT02293044|100676698|FG000|COMPLETED|Overall Study||15||
48144336|NCT02293044|100676698|FG000|NOT COMPLETED|Overall Study||0||
48144337|NCT00617344|100676699|FG000|STARTED|Overall Study||104||
48144338|NCT00617344|100676700|FG001|STARTED|Overall Study||103||
48713355|NCT02358044|102084928|FG000|Treated|Overall Study||129||
48713356|NCT02358044|102084929|FG001|Treated|Overall Study||126||
48713357|NCT02358044|102084928|FG000|COMPLETED|Overall Study||127||
48713358|NCT02358044|102084929|FG001|COMPLETED|Overall Study||121||
48713359|NCT02358044|102084928|FG000|NOT COMPLETED|Overall Study||2||
48713360|NCT02358044|102084929|FG001|NOT COMPLETED|Overall Study||7||
48713361|NCT03224403|102084930|FG000|STARTED|Overall Study||59||
48713362|NCT03224403|102084931|FG001|STARTED|Overall Study||249||
48713363|NCT03224403|102084932|FG002|STARTED|Overall Study||232||
48713364|NCT03224403|102084933|FG003|STARTED|Overall Study||124||
48713365|NCT03224403|102084930|FG000|COMPLETED|Overall Study||59||
48713366|NCT03224403|102084931|FG001|COMPLETED|Overall Study||249||
48713367|NCT03224403|102084932|FG002|COMPLETED|Overall Study||232||
48713368|NCT03224403|102084933|FG003|COMPLETED|Overall Study||124||
48713369|NCT03224403|102084930|FG000|NOT COMPLETED|Overall Study||0||
48713370|NCT03224403|102084931|FG001|NOT COMPLETED|Overall Study||0||
48713371|NCT03224403|102084932|FG002|NOT COMPLETED|Overall Study||0||
48713372|NCT03224403|102084933|FG003|NOT COMPLETED|Overall Study||0||
48713373|NCT01416441|102084934|FG000|STARTED|Overall Study||170||
48713374|NCT01416441|102084934|FG000|COMPLETED|Overall Study||89||
48713375|NCT01416441|102084934|FG000|NOT COMPLETED|Overall Study||81||
48713376|NCT00837876|102084935|FG000|STARTED|Overall Study||37||
48713377|NCT00837876|102084935|FG000|COMPLETED|Overall Study||0||
48713378|NCT00837876|102084935|FG000|NOT COMPLETED|Overall Study||37||
48713379|NCT04562597|102084936|FG000|STARTED|Overall Study||5||
48713380|NCT04562597|102084937|FG001|STARTED|Overall Study||5||
48713381|NCT04562597|102084938|FG002|STARTED|Overall Study||5||
48713382|NCT04562597|102084939|FG003|STARTED|Overall Study||5||
48713383|NCT04562597|102084940|FG004|STARTED|Overall Study||15||
48144339|NCT00617344|100676701|FG002|STARTED|Overall Study||53||
48144340|NCT00617344|100676699|FG000|Received Vaccination 1|Overall Study||104||
48144341|NCT00617344|100676700|FG001|Received Vaccination 1|Overall Study||103||
48144342|NCT00617344|100676701|FG002|Received Vaccination 1|Overall Study||53||
48144343|NCT00617344|100676699|FG000|Received Vaccination 2|Overall Study||86||
48144344|NCT00617344|100676700|FG001|Received Vaccination 2|Overall Study||85||
48713384|NCT04562597|102084941|FG005|STARTED|Overall Study||15||
48713385|NCT04562597|102084936|FG000|COMPLETED|Overall Study||5||
48713386|NCT04562597|102084937|FG001|COMPLETED|Overall Study||5||
48713387|NCT04562597|102084938|FG002|COMPLETED|Overall Study||5||
48713388|NCT04562597|102084939|FG003|COMPLETED|Overall Study||5||
48713389|NCT04562597|102084940|FG004|COMPLETED|Overall Study||15||
48713390|NCT04562597|102084941|FG005|COMPLETED|Overall Study||15||
48713391|NCT04562597|102084936|FG000|NOT COMPLETED|Overall Study||0||
48713392|NCT04562597|102084937|FG001|NOT COMPLETED|Overall Study||0||
48713393|NCT04562597|102084938|FG002|NOT COMPLETED|Overall Study||0||
48713394|NCT04562597|102084939|FG003|NOT COMPLETED|Overall Study||0||
48713395|NCT04562597|102084940|FG004|NOT COMPLETED|Overall Study||0||
48713396|NCT04562597|102084941|FG005|NOT COMPLETED|Overall Study||0||
48713397|NCT01994863|102084942|FG000|STARTED|Period 1||11||
48144345|NCT00617344|100676701|FG002|Received Vaccination 2|Overall Study||46||
48144346|NCT00617344|100676699|FG000|Received Vaccination 3|Overall Study||79||
48144347|NCT00617344|100676700|FG001|Received Vaccination 3|Overall Study||81||
48144348|NCT00617344|100676701|FG002|Received Vaccination 3|Overall Study||45||
48144349|NCT00617344|100676699|FG000|COMPLETED|Overall Study||79||
48144350|NCT00617344|100676700|FG001|COMPLETED|Overall Study||81||
48144351|NCT00617344|100676701|FG002|COMPLETED|Overall Study||45||
48144352|NCT00617344|100676699|FG000|NOT COMPLETED|Overall Study||25||
48144353|NCT00617344|100676700|FG001|NOT COMPLETED|Overall Study||22||
48144354|NCT00617344|100676701|FG002|NOT COMPLETED|Overall Study||8||
48144355|NCT02339831|100676702|FG000|STARTED|Overall Study||58||
48144356|NCT02339831|100676703|FG001|STARTED|Overall Study||52||
48144357|NCT02339831|100676702|FG000|Lost to Follow Up|Overall Study||20||
48144358|NCT02339831|100676703|FG001|Lost to Follow Up|Overall Study||7||
48144359|NCT02339831|100676702|FG000|COMPLETED|Overall Study||38||
48144360|NCT02339831|100676703|FG001|COMPLETED|Overall Study||45||
48144361|NCT02339831|100676702|FG000|NOT COMPLETED|Overall Study||20||
48144362|NCT02339831|100676703|FG001|NOT COMPLETED|Overall Study||7||
48144363|NCT04294966|100676704|FG000|STARTED|Overall Study||8||
48713398|NCT01994863|102084943|FG001|STARTED|Period 1||12||
48713399|NCT01994863|102084942|FG000|COMPLETED|Period 1||4||
48713400|NCT01994863|102084943|FG001|COMPLETED|Period 1||9||
48713401|NCT01994863|102084942|FG000|NOT COMPLETED|Period 1||7||
48144364|NCT04294966|100676705|FG001|STARTED|Overall Study||8||
48144365|NCT04294966|100676706|FG002|STARTED|Overall Study||8||
48144366|NCT04294966|100676704|FG000|COMPLETED|Overall Study||8||
48144367|NCT04294966|100676705|FG001|COMPLETED|Overall Study||8||
48144368|NCT04294966|100676706|FG002|COMPLETED|Overall Study||8||
48144369|NCT04294966|100676704|FG000|NOT COMPLETED|Overall Study||0||
48144370|NCT04294966|100676705|FG001|NOT COMPLETED|Overall Study||0||
48144371|NCT04294966|100676706|FG002|NOT COMPLETED|Overall Study||0||
48144372|NCT01830127|100676707|FG000|STARTED|Overall Study||18||
48144373|NCT01830127|100676708|FG001|STARTED|Overall Study||17||
48144374|NCT01830127|100676707|FG000|COMPLETED|Overall Study||13||
48144375|NCT01830127|100676708|FG001|COMPLETED|Overall Study||8||
48144376|NCT01830127|100676707|FG000|NOT COMPLETED|Overall Study||5||
48144377|NCT01830127|100676708|FG001|NOT COMPLETED|Overall Study||9||
48144378|NCT02085408|100676709|FG000|STARTED|Step 1: Induction||363||
48144379|NCT02085408|100676710|FG001|STARTED|Step 1: Induction||364||
48144380|NCT02085408|100676709|FG000|Adverse Event Data Available|Step 1: Induction||356||
48144381|NCT02085408|100676710|FG001|Adverse Event Data Available|Step 1: Induction||360||
48144382|NCT02085408|100676709|FG000|Donor Information Available|Step 1: Induction||191||
48144383|NCT02085408|100676710|FG001|Donor Information Available|Step 1: Induction||195||
48144384|NCT02085408|100676709|FG000|COMPLETED|Step 1: Induction||227||
48144385|NCT02085408|100676710|FG001|COMPLETED|Step 1: Induction||225||
48144386|NCT02085408|100676709|FG000|NOT COMPLETED|Step 1: Induction||136||
48144387|NCT02085408|100676710|FG001|NOT COMPLETED|Step 1: Induction||139||
48144388|NCT02085408|100676709|FG000|STARTED|Step 2: Consolidation||174||
48144389|NCT02085408|100676710|FG001|STARTED|Step 2: Consolidation||154||
48144390|NCT02085408|100676709|FG000|Adverse Event Data Available|Step 2: Consolidation||170||
48144391|NCT02085408|100676710|FG001|Adverse Event Data Available|Step 2: Consolidation||148||
48144392|NCT02085408|100676709|FG000|COMPLETED|Step 2: Consolidation||129||
48144393|NCT02085408|100676710|FG001|COMPLETED|Step 2: Consolidation||104||
48144394|NCT02085408|100676709|FG000|NOT COMPLETED|Step 2: Consolidation||45||
48144395|NCT02085408|100676710|FG001|NOT COMPLETED|Step 2: Consolidation||50||
48144396|NCT02085408|100676709|FG000|STARTED|Step 3: Maintenance||103||
48144397|NCT02085408|100676710|FG001|STARTED|Step 3: Maintenance||89||
48144398|NCT02085408|100676709|FG000|Randomized to Observation|Step 3: Maintenance||35||
48144399|NCT02085408|100676710|FG001|Randomized to Observation|Step 3: Maintenance||26||
48144400|NCT02085408|100676709|FG000|Randomized to Decitabine|Step 3: Maintenance||32||
48144401|NCT02085408|100676710|FG001|Randomized to Decitabine|Step 3: Maintenance||27||
48144402|NCT02085408|100676709|FG000|Received Transplant|Step 3: Maintenance||36||
48713402|NCT01994863|102084943|FG001|NOT COMPLETED|Period 1||3||
48713403|NCT01994863|102084942|FG000|STARTED|Period 2||8||
48713404|NCT01994863|102084943|FG001|STARTED|Period 2||9||
48713405|NCT01994863|102084942|FG000|COMPLETED|Period 2||7||
48144403|NCT02085408|100676710|FG001|Received Transplant|Step 3: Maintenance||36||
48144404|NCT02085408|100676709|FG000|COMPLETED|Step 3: Maintenance||78||
48144405|NCT02085408|100676710|FG001|COMPLETED|Step 3: Maintenance||67||
48144406|NCT02085408|100676709|FG000|NOT COMPLETED|Step 3: Maintenance||25||
48144407|NCT02085408|100676710|FG001|NOT COMPLETED|Step 3: Maintenance||22||
48144408|NCT00636610|100676711|FG000|STARTED|Overall Study||98||
48144409|NCT00636610|100676712|FG001|STARTED|Overall Study||101||
48144410|NCT00636610|100676711|FG000|COMPLETED|Overall Study||6||
48713406|NCT01994863|102084943|FG001|COMPLETED|Period 2||5||
48713407|NCT01994863|102084942|FG000|NOT COMPLETED|Period 2||1||
48713408|NCT01994863|102084943|FG001|NOT COMPLETED|Period 2||4||
48144411|NCT00636610|100676712|FG001|COMPLETED|Overall Study||18||
48144412|NCT00636610|100676711|FG000|NOT COMPLETED|Overall Study||92||
48144413|NCT00636610|100676712|FG001|NOT COMPLETED|Overall Study||83||
48144414|NCT03461003|100676713|FG000|STARTED|Overall Study||23||
48713409|NCT00413374|102084944|FG000|STARTED|Overall Study||40||40
48144415|NCT03461003|100676714|FG001|STARTED|Overall Study||26||
48144416|NCT03461003|100676713|FG000|Received Intervention|Overall Study||21||
48144417|NCT03461003|100676714|FG001|Received Intervention|Overall Study||22||
48144418|NCT03461003|100676713|FG000|Completed 6-month Follow up|Overall Study||18||
48144419|NCT03461003|100676714|FG001|Completed 6-month Follow up|Overall Study||23||
48144420|NCT03461003|100676713|FG000|COMPLETED|Overall Study||18||
48144421|NCT03461003|100676714|FG001|COMPLETED|Overall Study||23||
48144422|NCT03461003|100676713|FG000|NOT COMPLETED|Overall Study||5||
48144423|NCT03461003|100676714|FG001|NOT COMPLETED|Overall Study||3||
48144424|NCT03919422|100676715|FG000|STARTED|Overall Study||40||
48144425|NCT03919422|100676716|FG001|STARTED|Overall Study||40||
48144426|NCT03919422|100676715|FG000|COMPLETED|Overall Study||40||
48144427|NCT03919422|100676716|FG001|COMPLETED|Overall Study||40||
48144428|NCT03919422|100676715|FG000|NOT COMPLETED|Overall Study||0||
48144429|NCT03919422|100676716|FG001|NOT COMPLETED|Overall Study||0||
48144430|NCT02045238|100676717|FG000|STARTED|Overall Study||16||
48144431|NCT02045238|100676718|FG001|STARTED|Overall Study||15||
48144432|NCT02045238|100676717|FG000|COMPLETED|Overall Study||9||
48144433|NCT02045238|100676718|FG001|COMPLETED|Overall Study||14||
48144434|NCT02045238|100676717|FG000|NOT COMPLETED|Overall Study||7||
48144435|NCT02045238|100676718|FG001|NOT COMPLETED|Overall Study||1||
48144436|NCT03204279|100676719|FG000|STARTED|Overall Study||34||
48144437|NCT03204279|100676720|FG001|STARTED|Overall Study||33||
48144438|NCT03204279|100676719|FG000|COMPLETED|Overall Study||34||
48144439|NCT03204279|100676720|FG001|COMPLETED|Overall Study||32||
48144440|NCT03204279|100676719|FG000|NOT COMPLETED|Overall Study||0||
48144441|NCT03204279|100676720|FG001|NOT COMPLETED|Overall Study||1||
48144442|NCT02726451|100676721|FG000|STARTED|Overall Study||10||
48144443|NCT02726451|100676722|FG001|STARTED|Overall Study||10||
48144444|NCT02726451|100676721|FG000|COMPLETED|Overall Study||10||
48144445|NCT02726451|100676722|FG001|COMPLETED|Overall Study||10||
48144446|NCT02726451|100676721|FG000|NOT COMPLETED|Overall Study||0||
48144447|NCT02726451|100676722|FG001|NOT COMPLETED|Overall Study||0||
48144448|NCT02660827|100676723|FG000|STARTED|From Study to End of Continued Access||151||
48144449|NCT02660827|100676723|FG000|COMPLETED|From Study to End of Continued Access||120||
48144450|NCT02660827|100676723|FG000|NOT COMPLETED|From Study to End of Continued Access||31||
48144451|NCT02660827|100676723|FG000|STARTED|Period 1: Study Period||151||
48144452|NCT02660827|100676723|FG000|COMPLETED|Period 1: Study Period||150||
48144453|NCT02660827|100676723|FG000|NOT COMPLETED|Period 1: Study Period||1||
48144454|NCT02660827|100676723|FG000|STARTED|Period 2: Continued Access Period||145||
48144455|NCT02660827|100676723|FG000|COMPLETED|Period 2: Continued Access Period||120||
48144456|NCT02660827|100676723|FG000|NOT COMPLETED|Period 2: Continued Access Period||25||
48144457|NCT01018394|100676724|FG000|STARTED|Overall Study||40||
48144458|NCT01018394|100676725|FG001|STARTED|Overall Study||41||
48144459|NCT01018394|100676724|FG000|COMPLETED|Overall Study||31||
48144460|NCT01018394|100676725|FG001|COMPLETED|Overall Study||33||
48144461|NCT01018394|100676724|FG000|NOT COMPLETED|Overall Study||9||
48144462|NCT01018394|100676725|FG001|NOT COMPLETED|Overall Study||8||
48144463|NCT05725317|100676726|FG000|STARTED|Overall Study||56||112
48144464|NCT05725317|100676727|FG001|STARTED|Overall Study||57||114
48144465|NCT05725317|100676726|FG000|COMPLETED|Overall Study||56||112
48144466|NCT05725317|100676727|FG001|COMPLETED|Overall Study||57||114
48144467|NCT05725317|100676726|FG000|NOT COMPLETED|Overall Study||0||0
48144468|NCT05725317|100676727|FG001|NOT COMPLETED|Overall Study||0||0
48144469|NCT03166761|100676728|FG000|STARTED|Overall Study||9||
48144470|NCT03166761|100676729|FG001|STARTED|Overall Study||14||
48144471|NCT03166761|100676728|FG000|COMPLETED|Overall Study||9||
48144472|NCT03166761|100676729|FG001|COMPLETED|Overall Study||10||
48144473|NCT03166761|100676728|FG000|NOT COMPLETED|Overall Study||0||
48144474|NCT03166761|100676729|FG001|NOT COMPLETED|Overall Study||4||
48144475|NCT02187991|100676730|FG000|STARTED|Overall Study||70||
48144476|NCT02187991|100676731|FG001|STARTED|Overall Study||66||
48144477|NCT02187991|100676732|FG002|STARTED|Overall Study||15||
48144478|NCT02187991|100676733|FG003|STARTED|Overall Study||18||
48144479|NCT02187991|100676730|FG000|COMPLETED|Overall Study||36||
48144480|NCT02187991|100676731|FG001|COMPLETED|Overall Study||38||
48144481|NCT02187991|100676732|FG002|COMPLETED|Overall Study||8||
48144482|NCT02187991|100676733|FG003|COMPLETED|Overall Study||10||
48144483|NCT02187991|100676730|FG000|NOT COMPLETED|Overall Study||34||
48144484|NCT02187991|100676731|FG001|NOT COMPLETED|Overall Study||28||
48144485|NCT02187991|100676732|FG002|NOT COMPLETED|Overall Study||7||
48144486|NCT02187991|100676733|FG003|NOT COMPLETED|Overall Study||8||
48144487|NCT02161133|100676734|FG000|STARTED|Overall Study||135||
48144488|NCT02161133|100676735|FG001|STARTED|Overall Study||133||
48144489|NCT02161133|100676734|FG000|COMPLETED|Overall Study||116||
48144490|NCT02161133|100676735|FG001|COMPLETED|Overall Study||122||
48144491|NCT02161133|100676734|FG000|NOT COMPLETED|Overall Study||19||
48144492|NCT02161133|100676735|FG001|NOT COMPLETED|Overall Study||11||
48144493|NCT04301778|100676736|FG000|STARTED|Overall Study||5||
48144494|NCT04301778|100676736|FG000|COMPLETED|Overall Study||5||
48144495|NCT04301778|100676736|FG000|NOT COMPLETED|Overall Study||0||
48144496|NCT00558428|100676737|FG000|STARTED|Overall Study||267||
48144497|NCT00558428|100676738|FG001|STARTED|Overall Study||276||
48144498|NCT00558428|100676739|FG002|STARTED|Overall Study||277||
48144499|NCT00558428|100676740|FG003|STARTED|Overall Study||277||
48144500|NCT00558428|100676737|FG000|COMPLETED|Overall Study||255||
48144501|NCT00558428|100676738|FG001|COMPLETED|Overall Study||252||
48144502|NCT00558428|100676739|FG002|COMPLETED|Overall Study||273||
48144503|NCT00558428|100676740|FG003|COMPLETED|Overall Study||266||
48144504|NCT00558428|100676737|FG000|NOT COMPLETED|Overall Study||12||
48144505|NCT00558428|100676738|FG001|NOT COMPLETED|Overall Study||24||
48144506|NCT00558428|100676739|FG002|NOT COMPLETED|Overall Study||4||
48144507|NCT00558428|100676740|FG003|NOT COMPLETED|Overall Study||11||
48144508|NCT02858895|100676741|FG000|STARTED|Overall Study||47||
48144509|NCT02858895|100676741|FG000|Intent to Treat/Safety Population|Overall Study||47||
48144510|NCT02858895|100676741|FG000|Per Protocol Population|Overall Study||44||
48144511|NCT02858895|100676741|FG000|COMPLETED|Overall Study||8||
48144512|NCT02858895|100676741|FG000|NOT COMPLETED|Overall Study||39||
48144513|NCT03712891|100676742|FG000|STARTED|Overall Study||89||
48144514|NCT03712891|100676743|FG001|STARTED|Overall Study||89||
48144515|NCT03712891|100676742|FG000|COMPLETED|Overall Study||89||
48144516|NCT03712891|100676743|FG001|COMPLETED|Overall Study||89||
48144517|NCT03712891|100676742|FG000|NOT COMPLETED|Overall Study||0||
48144518|NCT03712891|100676743|FG001|NOT COMPLETED|Overall Study||0||
48144519|NCT03818672|100676744|FG000|STARTED|Overall Study||5||
48144520|NCT03818672|100676744|FG000|COMPLETED|Overall Study||5||
48144521|NCT03818672|100676744|FG000|NOT COMPLETED|Overall Study||0||
48144522|NCT00574587|100676745|FG000|STARTED|Overall Study||3||
48144523|NCT00574587|100676746|FG001|STARTED|Overall Study||23||
48144524|NCT00574587|100676747|FG002|STARTED|Overall Study||16||
48144525|NCT00574587|100676748|FG003|STARTED|Overall Study||13||
48144526|NCT00574587|100676745|FG000|COMPLETED|Overall Study||3||
48144527|NCT00574587|100676746|FG001|COMPLETED|Overall Study||23||
48144528|NCT00574587|100676747|FG002|COMPLETED|Overall Study||16||
48144529|NCT00574587|100676748|FG003|COMPLETED|Overall Study||13||
48144530|NCT00574587|100676745|FG000|NOT COMPLETED|Overall Study||0||
48144531|NCT00574587|100676746|FG001|NOT COMPLETED|Overall Study||0||
48144532|NCT00574587|100676747|FG002|NOT COMPLETED|Overall Study||0||
48144533|NCT00574587|100676748|FG003|NOT COMPLETED|Overall Study||0||
48144534|NCT00535730|100676749|FG000|STARTED|Overall Study||236||
48144535|NCT00535730|100676750|FG001|STARTED|Overall Study||237||
48144536|NCT00535730|100676749|FG000|COMPLETED|Overall Study||234||
48144537|NCT00535730|100676750|FG001|COMPLETED|Overall Study||230||
48144538|NCT00535730|100676749|FG000|NOT COMPLETED|Overall Study||2||
48144539|NCT00535730|100676750|FG001|NOT COMPLETED|Overall Study||7||
48144540|NCT00454051|100676751|FG000|STARTED|Overall Study||20||
48144541|NCT00454051|100676752|FG001|STARTED|Overall Study||11||
48144542|NCT00454051|100676751|FG000|COMPLETED|Overall Study||17||
48144543|NCT00454051|100676752|FG001|COMPLETED|Overall Study||8||
48144544|NCT00454051|100676751|FG000|NOT COMPLETED|Overall Study||3||
48144545|NCT00454051|100676752|FG001|NOT COMPLETED|Overall Study||3||
48144546|NCT03519854|100676753|FG000|STARTED|Overall Study||4||
48144547|NCT03519854|100676754|FG001|STARTED|Overall Study||6||
48144548|NCT03519854|100676755|FG002|STARTED|Overall Study||5||
48144549|NCT03519854|100676756|FG003|STARTED|Overall Study||6||
48144550|NCT03519854|100676757|FG004|STARTED|Overall Study||6||
48144551|NCT03519854|100676758|FG005|STARTED|Overall Study||6||
48144552|NCT03519854|100676759|FG006|STARTED|Overall Study||3||
48144553|NCT03519854|100676760|FG007|STARTED|Overall Study||6||
48144554|NCT03519854|100676761|FG008|STARTED|Overall Study||6||
48144555|NCT03519854|100676762|FG009|STARTED|Overall Study||6||
48144556|NCT03519854|100676763|FG010|STARTED|Overall Study||6||
48144557|NCT03519854|100676764|FG011|STARTED|Overall Study||6||
48144558|NCT03519854|100676765|FG012|STARTED|Overall Study||3||
48144559|NCT03519854|100676766|FG013|STARTED|Overall Study||6||
48144560|NCT03519854|100676767|FG014|STARTED|Overall Study||6||
48144561|NCT03519854|100676768|FG015|STARTED|Overall Study||6||
48144562|NCT03519854|100676769|FG016|STARTED|Overall Study||6||
48144563|NCT03519854|100676770|FG017|STARTED|Overall Study||6||
48144564|NCT03519854|100676753|FG000|Treated|Overall Study||4||
48144565|NCT03519854|100676754|FG001|Treated|Overall Study||6||
48144566|NCT03519854|100676755|FG002|Treated|Overall Study||4||
48144567|NCT03519854|100676756|FG003|Treated|Overall Study||6||
48144568|NCT03519854|100676757|FG004|Treated|Overall Study||6||
48144569|NCT03519854|100676758|FG005|Treated|Overall Study||6||
48144570|NCT03519854|100676759|FG006|Treated|Overall Study||3||
48144571|NCT03519854|100676760|FG007|Treated|Overall Study||6||
48144572|NCT03519854|100676761|FG008|Treated|Overall Study||6||
48144573|NCT03519854|100676762|FG009|Treated|Overall Study||6||
48144574|NCT03519854|100676763|FG010|Treated|Overall Study||6||
48144575|NCT03519854|100676764|FG011|Treated|Overall Study||6||
48144576|NCT03519854|100676765|FG012|Treated|Overall Study||3||
48144577|NCT03519854|100676766|FG013|Treated|Overall Study||6||
48144578|NCT03519854|100676767|FG014|Treated|Overall Study||6||
48144579|NCT03519854|100676768|FG015|Treated|Overall Study||6||
48144580|NCT03519854|100676769|FG016|Treated|Overall Study||6||
48144581|NCT03519854|100676770|FG017|Treated|Overall Study||6||
48144582|NCT03519854|100676753|FG000|COMPLETED|Overall Study||4||
48144583|NCT03519854|100676754|FG001|COMPLETED|Overall Study||6||
48144584|NCT03519854|100676755|FG002|COMPLETED|Overall Study||4||
48713410|NCT00413374|102084945|FG001|STARTED|Overall Study||80||80
48713411|NCT00413374|102084944|FG000|COMPLETED|Overall Study||34||34
48713412|NCT00413374|102084945|FG001|COMPLETED|Overall Study||80||80
48713413|NCT00413374|102084944|FG000|NOT COMPLETED|Overall Study||6||6
48713414|NCT00413374|102084945|FG001|NOT COMPLETED|Overall Study||0||0
48713415|NCT01667146|102084946|FG000|STARTED|Overall Study||58||
48713416|NCT01667146|102084947|FG001|STARTED|Overall Study||57||
48713417|NCT01667146|102084946|FG000|COMPLETED|Overall Study||57||
48713418|NCT01667146|102084947|FG001|COMPLETED|Overall Study||56||
48713419|NCT01667146|102084946|FG000|NOT COMPLETED|Overall Study||1||
48713420|NCT01667146|102084947|FG001|NOT COMPLETED|Overall Study||1||
48713421|NCT03523273|102084948|FG000|STARTED|Overall Study||67||
48713422|NCT03523273|102084949|FG001|STARTED|Overall Study||69||
48713423|NCT03523273|102084948|FG000|COMPLETED|Overall Study||59||
48713424|NCT03523273|102084949|FG001|COMPLETED|Overall Study||65||
48713425|NCT03523273|102084948|FG000|NOT COMPLETED|Overall Study||8||
48144585|NCT03519854|100676756|FG003|COMPLETED|Overall Study||6||
48144586|NCT03519854|100676757|FG004|COMPLETED|Overall Study||6||
48144587|NCT03519854|100676758|FG005|COMPLETED|Overall Study||6||
48144588|NCT03519854|100676759|FG006|COMPLETED|Overall Study||3||
48144589|NCT03519854|100676760|FG007|COMPLETED|Overall Study||6||
48144590|NCT03519854|100676761|FG008|COMPLETED|Overall Study||6||
48144591|NCT03519854|100676762|FG009|COMPLETED|Overall Study||6||
48144592|NCT03519854|100676763|FG010|COMPLETED|Overall Study||6||
48144593|NCT03519854|100676764|FG011|COMPLETED|Overall Study||6||
48144594|NCT03519854|100676765|FG012|COMPLETED|Overall Study||3||
48144595|NCT03519854|100676766|FG013|COMPLETED|Overall Study||6||
48144596|NCT03519854|100676767|FG014|COMPLETED|Overall Study||6||
48144597|NCT03519854|100676768|FG015|COMPLETED|Overall Study||6||
48144598|NCT03519854|100676769|FG016|COMPLETED|Overall Study||6||
48144599|NCT03519854|100676770|FG017|COMPLETED|Overall Study||6||
48144600|NCT03519854|100676753|FG000|NOT COMPLETED|Overall Study||0||
48144601|NCT03519854|100676754|FG001|NOT COMPLETED|Overall Study||0||
48144602|NCT03519854|100676755|FG002|NOT COMPLETED|Overall Study||1||
48144603|NCT03519854|100676756|FG003|NOT COMPLETED|Overall Study||0||
48144604|NCT03519854|100676757|FG004|NOT COMPLETED|Overall Study||0||
48144605|NCT03519854|100676758|FG005|NOT COMPLETED|Overall Study||0||
48144606|NCT03519854|100676759|FG006|NOT COMPLETED|Overall Study||0||
48144607|NCT03519854|100676760|FG007|NOT COMPLETED|Overall Study||0||
48144608|NCT03519854|100676761|FG008|NOT COMPLETED|Overall Study||0||
48144609|NCT03519854|100676762|FG009|NOT COMPLETED|Overall Study||0||
48144610|NCT03519854|100676763|FG010|NOT COMPLETED|Overall Study||0||
48144611|NCT03519854|100676764|FG011|NOT COMPLETED|Overall Study||0||
48144612|NCT03519854|100676765|FG012|NOT COMPLETED|Overall Study||0||
48144613|NCT03519854|100676766|FG013|NOT COMPLETED|Overall Study||0||
48144614|NCT03519854|100676767|FG014|NOT COMPLETED|Overall Study||0||
48144615|NCT03519854|100676768|FG015|NOT COMPLETED|Overall Study||0||
48144616|NCT03519854|100676769|FG016|NOT COMPLETED|Overall Study||0||
48144617|NCT03519854|100676770|FG017|NOT COMPLETED|Overall Study||0||
48144618|NCT04149405|100676771|FG000|STARTED|Overall Study||12||
48144619|NCT04149405|100676772|FG001|STARTED|Overall Study||10||
48144620|NCT04149405|100676773|FG002|STARTED|Overall Study||11||
48144621|NCT04149405|100676774|FG003|STARTED|Overall Study||10||
48144622|NCT04149405|100676771|FG000|COMPLETED|Overall Study||12||
48144623|NCT04149405|100676772|FG001|COMPLETED|Overall Study||10||
48144624|NCT04149405|100676773|FG002|COMPLETED|Overall Study||11||
48144625|NCT04149405|100676774|FG003|COMPLETED|Overall Study||10||
48144626|NCT04149405|100676771|FG000|NOT COMPLETED|Overall Study||0||
48144627|NCT04149405|100676772|FG001|NOT COMPLETED|Overall Study||0||
48144628|NCT04149405|100676773|FG002|NOT COMPLETED|Overall Study||0||
48144629|NCT04149405|100676774|FG003|NOT COMPLETED|Overall Study||0||
48144630|NCT02693743|100676775|FG000|STARTED|Overall Study||1||
48144631|NCT02693743|100676776|FG001|STARTED|Overall Study||0||
48144632|NCT02693743|100676775|FG000|COMPLETED|Overall Study||0||
48144633|NCT02693743|100676776|FG001|COMPLETED|Overall Study||0||
48144634|NCT02693743|100676775|FG000|NOT COMPLETED|Overall Study||1||
48144635|NCT02693743|100676776|FG001|NOT COMPLETED|Overall Study||0||
48144636|NCT03707977|100676777|FG000|STARTED|PK Step||6||
48144637|NCT03707977|100676778|FG001|STARTED|PK Step||6||
48144638|NCT03707977|100676779|FG002|STARTED|PK Step||0||
48144639|NCT03707977|100676777|FG000|COMPLETED|PK Step||6||
48144640|NCT03707977|100676778|FG001|COMPLETED|PK Step||6||
48297269|NCT01214187|101056896|FG001|COMPLETED|Overall Study||23||
48297270|NCT01214187|101056895|FG000|NOT COMPLETED|Overall Study||7||
48297271|NCT01214187|101056896|FG001|NOT COMPLETED|Overall Study||6||
48297272|NCT02027701|101056897|FG000|STARTED|Overall Study||82||
48297273|NCT02027701|101056897|FG000|COMPLETED|Overall Study||66||
48297274|NCT02027701|101056897|FG000|NOT COMPLETED|Overall Study||16||
48297275|NCT04147650|101056898|FG000|STARTED|Overall Study||127||
48297276|NCT04147650|101056899|FG001|STARTED|Overall Study||126||
48297277|NCT04147650|101056900|FG002|STARTED|Overall Study||128||
48297278|NCT04147650|101056901|FG003|STARTED|Overall Study||127||
48297279|NCT04147650|101056898|FG000|Modified Intent to Treat (mITT)|Overall Study||120||
48297280|NCT04147650|101056899|FG001|Modified Intent to Treat (mITT)|Overall Study||119||
48297281|NCT04147650|101056900|FG002|Modified Intent to Treat (mITT)|Overall Study||122||
48297282|NCT04147650|101056901|FG003|Modified Intent to Treat (mITT)|Overall Study||121||
48297283|NCT04147650|101056898|FG000|COMPLETED|Overall Study||116||
48297284|NCT04147650|101056899|FG001|COMPLETED|Overall Study||107||
48297285|NCT04147650|101056900|FG002|COMPLETED|Overall Study||121||
48297286|NCT04147650|101056901|FG003|COMPLETED|Overall Study||120||
48297287|NCT04147650|101056898|FG000|NOT COMPLETED|Overall Study||11||
48297288|NCT04147650|101056899|FG001|NOT COMPLETED|Overall Study||19||
48297289|NCT04147650|101056900|FG002|NOT COMPLETED|Overall Study||7||
48297290|NCT04147650|101056901|FG003|NOT COMPLETED|Overall Study||7||
48297291|NCT01080677|101056902|FG000|STARTED|Overall Study||20||
48297292|NCT01080677|101056903|FG001|STARTED|Overall Study||20||
48297293|NCT01080677|101056904|FG002|STARTED|Overall Study||20||
48297294|NCT01080677|101056902|FG000|COMPLETED|Overall Study||20||
48297295|NCT01080677|101056903|FG001|COMPLETED|Overall Study||20||
48297296|NCT01080677|101056904|FG002|COMPLETED|Overall Study||20||
48297297|NCT01080677|101056902|FG000|NOT COMPLETED|Overall Study||0||
48297298|NCT01080677|101056903|FG001|NOT COMPLETED|Overall Study||0||
48297299|NCT01080677|101056904|FG002|NOT COMPLETED|Overall Study||0||
48297300|NCT01959048|101056905|FG000|STARTED|Overall Study||3||
48297301|NCT01959048|101056905|FG000|COMPLETED|Overall Study||3||
48297302|NCT01959048|101056905|FG000|NOT COMPLETED|Overall Study||0||
48297303|NCT01688856|101056906|FG000|STARTED|Overall Study||28||
48297304|NCT01688856|101056907|FG001|STARTED|Overall Study||28||
48297305|NCT01688856|101056908|FG002|STARTED|Overall Study||11||
48297306|NCT01688856|101056906|FG000|COMPLETED|Overall Study||21||
48297307|NCT01688856|101056907|FG001|COMPLETED|Overall Study||24||
48297308|NCT01688856|101056908|FG002|COMPLETED|Overall Study||8||
48297309|NCT01688856|101056906|FG000|NOT COMPLETED|Overall Study||7||
48297310|NCT01688856|101056907|FG001|NOT COMPLETED|Overall Study||4||
48297311|NCT01688856|101056908|FG002|NOT COMPLETED|Overall Study||3||
48297312|NCT03575754|101056909|FG000|STARTED|Overall Study||25||
48297313|NCT03575754|101056910|FG001|STARTED|Overall Study||25||
48297314|NCT03575754|101056909|FG000|COMPLETED|Overall Study||25||
48297315|NCT03575754|101056910|FG001|COMPLETED|Overall Study||25||
48297316|NCT03575754|101056909|FG000|NOT COMPLETED|Overall Study||0||
48297317|NCT03575754|101056910|FG001|NOT COMPLETED|Overall Study||0||
48297318|NCT01230788|101056911|FG000|STARTED|Overall Study||1||
48297319|NCT01230788|101056911|FG000|COMPLETED|Overall Study||0||
48297320|NCT01230788|101056911|FG000|NOT COMPLETED|Overall Study||1||
48297321|NCT01389765|101056912|FG000|STARTED|First Intervention (Day 1)||12||
48297322|NCT01389765|101056913|FG001|STARTED|First Intervention (Day 1)||12||
48297323|NCT01389765|101056912|FG000|COMPLETED|First Intervention (Day 1)||12||
48297324|NCT01389765|101056913|FG001|COMPLETED|First Intervention (Day 1)||12||
48297325|NCT01389765|101056912|FG000|NOT COMPLETED|First Intervention (Day 1)||0||
48297326|NCT01389765|101056913|FG001|NOT COMPLETED|First Intervention (Day 1)||0||
48297327|NCT01389765|101056912|FG000|STARTED|Washout Period (7 Days)||12||
48297328|NCT01389765|101056913|FG001|STARTED|Washout Period (7 Days)||12||
48297329|NCT01389765|101056912|FG000|COMPLETED|Washout Period (7 Days)||12||
48297330|NCT01389765|101056913|FG001|COMPLETED|Washout Period (7 Days)||12||
48297331|NCT01389765|101056912|FG000|NOT COMPLETED|Washout Period (7 Days)||0||
48297332|NCT01389765|101056913|FG001|NOT COMPLETED|Washout Period (7 Days)||0||
48297333|NCT01389765|101056912|FG000|STARTED|Second Intervention (Day 1)||12||
48297334|NCT01389765|101056913|FG001|STARTED|Second Intervention (Day 1)||12||
48713426|NCT03523273|102084949|FG001|NOT COMPLETED|Overall Study||4||
48713427|NCT03582813|102084950|FG000|STARTED|Overall Study||114||
48713428|NCT03582813|102084951|FG001|STARTED|Overall Study||102||
48713429|NCT03582813|102084950|FG000|COMPLETED|Overall Study||95||
48713430|NCT03582813|102084951|FG001|COMPLETED|Overall Study||81||
48713431|NCT03582813|102084950|FG000|NOT COMPLETED|Overall Study||19||
48713432|NCT03582813|102084951|FG001|NOT COMPLETED|Overall Study||21||
48713433|NCT02536300|102084952|FG000|STARTED|Overall Study||47||
48713434|NCT02536300|102084953|FG001|STARTED|Overall Study||27||
48713435|NCT02536300|102084954|FG002|STARTED|Overall Study||22||
48713436|NCT02536300|102084952|FG000|COMPLETED|Overall Study||0||
48297335|NCT01389765|101056912|FG000|COMPLETED|Second Intervention (Day 1)||12||
48297336|NCT01389765|101056913|FG001|COMPLETED|Second Intervention (Day 1)||12||
48297337|NCT01389765|101056912|FG000|NOT COMPLETED|Second Intervention (Day 1)||0||
48297338|NCT01389765|101056913|FG001|NOT COMPLETED|Second Intervention (Day 1)||0||
48297339|NCT03097133|101056914|FG000|STARTED|Overall Study||115||
48297340|NCT03097133|101056915|FG001|STARTED|Overall Study||115||
48297341|NCT03097133|101056914|FG000|Treated|Overall Study||113||
48297342|NCT03097133|101056915|FG001|Treated|Overall Study||114||
48297343|NCT03097133|101056914|FG000|COMPLETED|Overall Study||85||
48297344|NCT03097133|101056915|FG001|COMPLETED|Overall Study||81||
48713437|NCT02536300|102084953|FG001|COMPLETED|Overall Study||0||
48713438|NCT02536300|102084954|FG002|COMPLETED|Overall Study||0||
48713439|NCT02536300|102084952|FG000|NOT COMPLETED|Overall Study||47||
48713440|NCT02536300|102084953|FG001|NOT COMPLETED|Overall Study||27||
48713441|NCT02536300|102084954|FG002|NOT COMPLETED|Overall Study||22||
48713442|NCT01066780|102084955|FG000|STARTED|Overall Study||24||
48713443|NCT01066780|102084956|FG001|STARTED|Overall Study||24||
48713444|NCT01066780|102084955|FG000|COMPLETED|Overall Study||23||
48297345|NCT03097133|101056914|FG000|NOT COMPLETED|Overall Study||30||
48297346|NCT03097133|101056915|FG001|NOT COMPLETED|Overall Study||34||
48297347|NCT03586687|101056916|FG000|STARTED|Overall Study||6||
48297348|NCT03586687|101056917|FG001|STARTED|Overall Study||9||
48297349|NCT03586687|101056918|FG002|STARTED|Overall Study||4||
48297350|NCT03586687|101056916|FG000|COMPLETED|Overall Study||6||
48297351|NCT03586687|101056917|FG001|COMPLETED|Overall Study||9||
48297352|NCT03586687|101056918|FG002|COMPLETED|Overall Study||4||
48297353|NCT03586687|101056916|FG000|NOT COMPLETED|Overall Study||0||
48297354|NCT03586687|101056917|FG001|NOT COMPLETED|Overall Study||0||
48297355|NCT03586687|101056918|FG002|NOT COMPLETED|Overall Study||0||
48297356|NCT00639223|101056919|FG000|STARTED|Overall Study||22||
48297357|NCT00639223|101056920|FG001|STARTED|Overall Study||21||
48297358|NCT00639223|101056919|FG000|COMPLETED|Overall Study||22||
48297359|NCT00639223|101056920|FG001|COMPLETED|Overall Study||19||
48297360|NCT00639223|101056919|FG000|NOT COMPLETED|Overall Study||0||
48297361|NCT00639223|101056920|FG001|NOT COMPLETED|Overall Study||2||
48297362|NCT00846391|101056921|FG000|STARTED|Overall Study||4||
48598886|NCT00483704|101800210|FG002|STARTED|Randomization||646||
48598887|NCT00483704|101800208|FG000|COMPLETED|Randomization||573||
48598888|NCT00483704|101800209|FG001|COMPLETED|Randomization||549||
48598889|NCT00483704|101800210|FG002|COMPLETED|Randomization||555||
48598890|NCT00483704|101800208|FG000|NOT COMPLETED|Randomization||71||
48598891|NCT00483704|101800209|FG001|NOT COMPLETED|Randomization||96||
48598892|NCT00483704|101800210|FG002|NOT COMPLETED|Randomization||91||
48598893|NCT00483704|101800208|FG000|STARTED|Treatment||573||
48598894|NCT00483704|101800209|FG001|STARTED|Treatment||549||
48598895|NCT00483704|101800210|FG002|STARTED|Treatment||555||
48598896|NCT00483704|101800208|FG000|COMPLETED|Treatment||444||
48598897|NCT00483704|101800209|FG001|COMPLETED|Treatment||420||
48598898|NCT00483704|101800210|FG002|COMPLETED|Treatment||399||
48598899|NCT00483704|101800208|FG000|NOT COMPLETED|Treatment||129||
48598900|NCT00483704|101800209|FG001|NOT COMPLETED|Treatment||129||
48598901|NCT00483704|101800210|FG002|NOT COMPLETED|Treatment||156||
48598902|NCT00195494|101800211|FG000|STARTED|Year 1||0||
48297363|NCT00846391|101056922|FG001|STARTED|Overall Study||4||
48297364|NCT00846391|101056923|FG002|STARTED|Overall Study||6||
48297365|NCT00846391|101056921|FG000|COMPLETED|Overall Study||3||
48297366|NCT00846391|101056922|FG001|COMPLETED|Overall Study||2||
48297367|NCT00846391|101056923|FG002|COMPLETED|Overall Study||3||
48297368|NCT00846391|101056921|FG000|NOT COMPLETED|Overall Study||1||
48297369|NCT00846391|101056922|FG001|NOT COMPLETED|Overall Study||2||
48297370|NCT00846391|101056923|FG002|NOT COMPLETED|Overall Study||3||
48297371|NCT04824521|101056924|FG000|STARTED|Overall Study||1||
48598903|NCT00195494|101800212|FG001|STARTED|Year 1||0||
48598904|NCT00195494|101800213|FG002|STARTED|Year 1||0||
48598905|NCT00195494|101800214|FG003|STARTED|Year 1||0||
48598906|NCT00195494|101800215|FG004|STARTED|Year 1||268||
48297372|NCT04824521|101056924|FG000|COMPLETED|Overall Study||0||
48598907|NCT00195494|101800216|FG005|STARTED|Year 1||274||
48297373|NCT04824521|101056924|FG000|NOT COMPLETED|Overall Study||1||
48297374|NCT02435966|101056925|FG000|STARTED|Overall Study||47||
48297375|NCT02435966|101056926|FG001|STARTED|Overall Study||54||
48297376|NCT02435966|101056927|FG002|STARTED|Overall Study||30||
48297377|NCT02435966|101056925|FG000|First Intervention|Overall Study||47||
48297378|NCT02435966|101056926|FG001|First Intervention|Overall Study||54||
48297379|NCT02435966|101056927|FG002|First Intervention|Overall Study||30||
48297380|NCT02435966|101056925|FG000|Second Intervention|Overall Study||47||
48297381|NCT02435966|101056926|FG001|Second Intervention|Overall Study||53||
48297382|NCT02435966|101056927|FG002|Second Intervention|Overall Study||30||
48297383|NCT02435966|101056925|FG000|Follow-up|Overall Study||47||
48297384|NCT02435966|101056926|FG001|Follow-up|Overall Study||53||
48297385|NCT02435966|101056927|FG002|Follow-up|Overall Study||30||
48297386|NCT02435966|101056925|FG000|COMPLETED|Overall Study||47||
48297387|NCT02435966|101056926|FG001|COMPLETED|Overall Study||53||
48598908|NCT00195494|101800211|FG000|COMPLETED|Year 1||0||
48598909|NCT00195494|101800212|FG001|COMPLETED|Year 1||0||
48598910|NCT00195494|101800213|FG002|COMPLETED|Year 1||0||
48598911|NCT00195494|101800214|FG003|COMPLETED|Year 1||0||
48598912|NCT00195494|101800215|FG004|COMPLETED|Year 1||189||
48598913|NCT00195494|101800216|FG005|COMPLETED|Year 1||221||
48598914|NCT00195494|101800211|FG000|NOT COMPLETED|Year 1||0||
48598915|NCT00195494|101800212|FG001|NOT COMPLETED|Year 1||0||
48598916|NCT00195494|101800213|FG002|NOT COMPLETED|Year 1||0||
48598917|NCT00195494|101800214|FG003|NOT COMPLETED|Year 1||0||
48713445|NCT01066780|102084956|FG001|COMPLETED|Overall Study||23||
48713446|NCT01066780|102084955|FG000|NOT COMPLETED|Overall Study||1||
48713447|NCT01066780|102084956|FG001|NOT COMPLETED|Overall Study||1||
48713448|NCT00273754|102084957|FG000|STARTED|Overall Study||36||
48713449|NCT00273754|102084958|FG001|STARTED|Overall Study||36||
48713450|NCT00273754|102084957|FG000|COMPLETED|Overall Study||36||
48713451|NCT00273754|102084958|FG001|COMPLETED|Overall Study||36||
48713452|NCT00273754|102084957|FG000|NOT COMPLETED|Overall Study||0||
48713453|NCT00273754|102084958|FG001|NOT COMPLETED|Overall Study||0||
48713454|NCT04495868|102084959|FG000|STARTED|Overall Study||19||
48713455|NCT04495868|102084960|FG001|STARTED|Overall Study||21||
48713456|NCT04495868|102084959|FG000|COMPLETED|Overall Study||19||
48713457|NCT04495868|102084960|FG001|COMPLETED|Overall Study||21||
48713458|NCT04495868|102084959|FG000|NOT COMPLETED|Overall Study||0||
48713459|NCT04495868|102084960|FG001|NOT COMPLETED|Overall Study||0||
48713460|NCT00740714|102084961|FG000|STARTED|Overall Study||196||
48713461|NCT00740714|102084962|FG001|STARTED|Overall Study||201||
48713462|NCT00740714|102084963|FG002|STARTED|Overall Study||203||
48713463|NCT00740714|102084961|FG000|Reaching Endpoint Before May 6, 2011|Overall Study||86||
48713464|NCT00740714|102084962|FG001|Reaching Endpoint Before May 6, 2011|Overall Study||87||
48713465|NCT00740714|102084963|FG002|Reaching Endpoint Before May 6, 2011|Overall Study||94||
48713466|NCT00740714|102084961|FG000|Active Patients at Study Termination|Overall Study||24||
48713467|NCT00740714|102084962|FG001|Active Patients at Study Termination|Overall Study||12||
48713468|NCT00740714|102084963|FG002|Active Patients at Study Termination|Overall Study||33||
48713469|NCT00740714|102084961|FG000|COMPLETED|Overall Study||179||
48713470|NCT00740714|102084962|FG001|COMPLETED|Overall Study||182||
48713471|NCT00740714|102084963|FG002|COMPLETED|Overall Study||174||
48297388|NCT02435966|101056927|FG002|COMPLETED|Overall Study||30||
48297389|NCT02435966|101056925|FG000|NOT COMPLETED|Overall Study||0||
48598918|NCT00195494|101800215|FG004|NOT COMPLETED|Year 1||79||
48598919|NCT00195494|101800216|FG005|NOT COMPLETED|Year 1||53||
48598920|NCT00195494|101800211|FG000|STARTED|Year 2||111||
48598921|NCT00195494|101800212|FG001|STARTED|Year 2||90||
48713472|NCT00740714|102084961|FG000|NOT COMPLETED|Overall Study||17||
48713473|NCT00740714|102084962|FG001|NOT COMPLETED|Overall Study||19||
48713474|NCT00740714|102084963|FG002|NOT COMPLETED|Overall Study||29||
48713475|NCT03597178|102084964|FG000|STARTED|Overall Study||14||
48297390|NCT02435966|101056926|FG001|NOT COMPLETED|Overall Study||1||
48297391|NCT02435966|101056927|FG002|NOT COMPLETED|Overall Study||0||
48297392|NCT03660553|101056928|FG000|STARTED|Overall Study||3||
48297393|NCT03660553|101056929|FG001|STARTED|Overall Study||4||
48297394|NCT03660553|101056928|FG000|COMPLETED|Overall Study||3||
48598922|NCT00195494|101800213|FG002|STARTED|Year 2||111||
48598923|NCT00195494|101800214|FG003|STARTED|Year 2||99||
48713476|NCT03597178|102084964|FG000|COMPLETED|Overall Study||14||
48713477|NCT03597178|102084964|FG000|NOT COMPLETED|Overall Study||0||
48713478|NCT01945775|102084965|FG000|STARTED|Overall Study||287||
48713479|NCT01945775|102084966|FG001|STARTED|Overall Study||144||
48598924|NCT00195494|101800215|FG004|STARTED|Year 2||0||
48598925|NCT00195494|101800216|FG005|STARTED|Year 2||0||
48297395|NCT03660553|101056929|FG001|COMPLETED|Overall Study||4||
48297396|NCT03660553|101056928|FG000|NOT COMPLETED|Overall Study||0||
48297397|NCT03660553|101056929|FG001|NOT COMPLETED|Overall Study||0||
48297398|NCT00730171|101056930|FG000|STARTED|Overall Study||1725||
48297399|NCT00730171|101056930|FG000|CC Safety Population|Overall Study||607|met the modified Rome II criteria for chronic constipation (CC)|
48297400|NCT00730171|101056930|FG000|IBS-C Safety Population|Overall Study||1119|met the modified Rome II criteria for irritable bowel syndrome with constipation (IBS-C)|
48297401|NCT00730171|101056930|FG000|COMPLETED|Overall Study||954||
48297402|NCT00730171|101056930|FG000|NOT COMPLETED|Overall Study||771||
48297403|NCT02604433|101056931|FG000|STARTED|Overall Study||224|Participants randomized|
48297404|NCT02604433|101056932|FG001|STARTED|Overall Study||112|Participants randomized|
48297405|NCT02604433|101056931|FG000|Participants Treated|Overall Study||223|All participants who received at least 1 dose of study drug|
48297406|NCT02604433|101056932|FG001|Participants Treated|Overall Study||109|All participants who received at least 1 dose of study drug|
48297407|NCT02604433|101056931|FG000|Completed 24 Weeks of Treatment|Overall Study||211||
48713480|NCT01945775|102084965|FG000|Treated|Overall Study||286||
48713481|NCT01945775|102084966|FG001|Treated|Overall Study||126||
48713482|NCT01945775|102084965|FG000|COMPLETED|Overall Study||0||
48713483|NCT01945775|102084966|FG001|COMPLETED|Overall Study||0||
48713484|NCT01945775|102084965|FG000|NOT COMPLETED|Overall Study||287||
48713485|NCT01945775|102084966|FG001|NOT COMPLETED|Overall Study||144||
48713486|NCT00747344|102084967|FG000|STARTED|Controlled Period||60||
48713487|NCT00747344|102084968|FG001|STARTED|Controlled Period||61||
48713488|NCT00747344|102084969|FG002|STARTED|Controlled Period||0||
48713489|NCT00747344|102084970|FG003|STARTED|Controlled Period||0||
48713490|NCT00747344|102084967|FG000|COMPLETED|Controlled Period||55||
48713491|NCT00747344|102084968|FG001|COMPLETED|Controlled Period||57||
48713492|NCT00747344|102084969|FG002|COMPLETED|Controlled Period||0||
48713493|NCT00747344|102084970|FG003|COMPLETED|Controlled Period||0||
48713494|NCT00747344|102084967|FG000|NOT COMPLETED|Controlled Period||5||
48713495|NCT00747344|102084968|FG001|NOT COMPLETED|Controlled Period||4||
48713496|NCT00747344|102084969|FG002|NOT COMPLETED|Controlled Period||0||
48713497|NCT00747344|102084970|FG003|NOT COMPLETED|Controlled Period||0||
48713498|NCT00747344|102084967|FG000|STARTED|After Controlled Period||0||
48713499|NCT00747344|102084968|FG001|STARTED|After Controlled Period||0||
48297408|NCT02604433|101056932|FG001|Completed 24 Weeks of Treatment|Overall Study||102||
48297409|NCT02604433|101056931|FG000|Completed 48 Weeks of Treatment|Overall Study||202||
48297410|NCT02604433|101056932|FG001|Completed 48 Weeks of Treatment|Overall Study||96||
48297411|NCT02604433|101056931|FG000|Completed 96 Weeks of Treatment|Overall Study||155||
48297412|NCT02604433|101056932|FG001|Completed 96 Weeks of Treatment|Overall Study||3||
48297413|NCT02604433|101056931|FG000|Completed 144 Weeks of Treatment|Overall Study||125||
48297414|NCT02604433|101056932|FG001|Completed 144 Weeks of Treatment|Overall Study||0||
48297415|NCT02604433|101056931|FG000|Completed 192 Weeks of Treatment|Overall Study||6||
48297416|NCT02604433|101056932|FG001|Completed 192 Weeks of Treatment|Overall Study||0||
48297417|NCT02604433|101056931|FG000|COMPLETED|Overall Study||6|Completed study per original protocol|
48297418|NCT02604433|101056932|FG001|COMPLETED|Overall Study||6|Completed study per original protocol|
48297419|NCT02604433|101056931|FG000|NOT COMPLETED|Overall Study||218||
48297420|NCT02604433|101056932|FG001|NOT COMPLETED|Overall Study||106||
48297421|NCT01285050|101056933|FG000|STARTED|Overall Study||20||
48297422|NCT01285050|101056933|FG000|COMPLETED|Overall Study||19||
48297423|NCT01285050|101056933|FG000|NOT COMPLETED|Overall Study||1||
48297424|NCT02960113|101056934|FG000|STARTED|Overall Study||80||
48713500|NCT00747344|102084969|FG002|STARTED|After Controlled Period||55||
48713501|NCT00747344|102084970|FG003|STARTED|After Controlled Period||57||
48713502|NCT00747344|102084967|FG000|COMPLETED|After Controlled Period||0||
48713503|NCT00747344|102084968|FG001|COMPLETED|After Controlled Period||0||
48297425|NCT02960113|101056935|FG001|STARTED|Overall Study||80||
48297426|NCT02960113|101056936|FG002|STARTED|Overall Study||80||
48297427|NCT02960113|101056934|FG000|COMPLETED|Overall Study||80||
48297428|NCT02960113|101056935|FG001|COMPLETED|Overall Study||80||
48297429|NCT02960113|101056936|FG002|COMPLETED|Overall Study||80||
48297430|NCT02960113|101056934|FG000|NOT COMPLETED|Overall Study||0||
48297431|NCT02960113|101056935|FG001|NOT COMPLETED|Overall Study||0||
48297432|NCT02960113|101056936|FG002|NOT COMPLETED|Overall Study||0||
48297433|NCT01673568|101056937|FG000|STARTED|Overall Study||28||
48297434|NCT01673568|101056938|FG001|STARTED|Overall Study||28||
48297435|NCT01673568|101056937|FG000|COMPLETED|Overall Study||28||
48297436|NCT01673568|101056938|FG001|COMPLETED|Overall Study||28||
48297437|NCT01673568|101056937|FG000|NOT COMPLETED|Overall Study||0||
48297438|NCT01673568|101056938|FG001|NOT COMPLETED|Overall Study||0||
48297439|NCT02316366|101056939|FG000|STARTED|Overall Study||40||
48297440|NCT02316366|101056940|FG001|STARTED|Overall Study||40||
48297441|NCT02316366|101056939|FG000|COMPLETED|Overall Study||40||
48297442|NCT02316366|101056940|FG001|COMPLETED|Overall Study||40||
48297443|NCT02316366|101056939|FG000|NOT COMPLETED|Overall Study||0||
48297444|NCT02316366|101056940|FG001|NOT COMPLETED|Overall Study||0||
48297445|NCT01376349|101056941|FG000|STARTED|Raondomized Treatment||147||
48297446|NCT01376349|101056942|FG001|STARTED|Raondomized Treatment||149||
48297447|NCT01376349|101056943|FG002|STARTED|Raondomized Treatment||147||
48297448|NCT01376349|101056941|FG000|COMPLETED|Raondomized Treatment||123||
48297449|NCT01376349|101056942|FG001|COMPLETED|Raondomized Treatment||114||
48297450|NCT01376349|101056943|FG002|COMPLETED|Raondomized Treatment||118||
48297451|NCT01376349|101056941|FG000|NOT COMPLETED|Raondomized Treatment||24||
48297452|NCT01376349|101056942|FG001|NOT COMPLETED|Raondomized Treatment||35||
48297453|NCT01376349|101056943|FG002|NOT COMPLETED|Raondomized Treatment||29||
48297454|NCT01376349|101056941|FG000|STARTED|Optional Continuation Phase||0||
48297455|NCT01376349|101056942|FG001|STARTED|Optional Continuation Phase||0||
48297456|NCT01376349|101056943|FG002|STARTED|Optional Continuation Phase||94||
48297457|NCT01376349|101056941|FG000|COMPLETED|Optional Continuation Phase||0||
48297458|NCT01376349|101056942|FG001|COMPLETED|Optional Continuation Phase||0||
48297459|NCT01376349|101056943|FG002|COMPLETED|Optional Continuation Phase||94||
48297460|NCT01376349|101056941|FG000|NOT COMPLETED|Optional Continuation Phase||0||
48297461|NCT01376349|101056942|FG001|NOT COMPLETED|Optional Continuation Phase||0||
48297462|NCT01376349|101056943|FG002|NOT COMPLETED|Optional Continuation Phase||0||
48297463|NCT00985166|101056944|FG000|STARTED|Overall Study||401||
48297464|NCT00985166|101056945|FG001|STARTED|Overall Study||205||
48297465|NCT00985166|101056946|FG002|STARTED|Overall Study||195||
48297466|NCT00985166|101056944|FG000|Vaccinated at Visit 1|Overall Study||399||
48297467|NCT00985166|101056945|FG001|Vaccinated at Visit 1|Overall Study||205||
48297468|NCT00985166|101056946|FG002|Vaccinated at Visit 1|Overall Study||195||
48297469|NCT00985166|101056944|FG000|COMPLETED|Overall Study||392||
48297470|NCT00985166|101056945|FG001|COMPLETED|Overall Study||201||
48297471|NCT00985166|101056946|FG002|COMPLETED|Overall Study||188||
48297472|NCT00985166|101056944|FG000|NOT COMPLETED|Overall Study||9||
48297473|NCT00985166|101056945|FG001|NOT COMPLETED|Overall Study||4||
48297474|NCT00985166|101056946|FG002|NOT COMPLETED|Overall Study||7||
48297475|NCT02566265|101056947|FG000|STARTED|Overall Study||81|Initial Vaccine|
48297476|NCT02566265|101056948|FG001|STARTED|Overall Study||41|Initial Vaccine|
48297477|NCT02566265|101056947|FG000|Day 7 (+/- 2 Days) (Optional)|Overall Study||19|Research blood draw only|
48297478|NCT02566265|101056948|FG001|Day 7 (+/- 2 Days) (Optional)|Overall Study||12|Research blood draw only|
48297479|NCT02566265|101056947|FG000|Day of Second Vaccine|Overall Study||74|30 Days After Initial Vaccine|
48297480|NCT02566265|101056948|FG001|Day of Second Vaccine|Overall Study||41|30 Days After Initial Vaccine|
48297481|NCT02566265|101056947|FG000|30 Days Following 2nd Vaccine|Overall Study||72|30 Days After Second Vaccine|
48297482|NCT02566265|101056948|FG001|30 Days Following 2nd Vaccine|Overall Study||35|30 Days After Second Vaccine|
48297483|NCT02566265|101056947|FG000|End of Study Visit (Optional)|Overall Study||38||
48297484|NCT02566265|101056948|FG001|End of Study Visit (Optional)|Overall Study||18||
48297485|NCT02566265|101056947|FG000|COMPLETED|Overall Study||72|All Required Milestones|
48297486|NCT02566265|101056948|FG001|COMPLETED|Overall Study||35|All Required Milestones|
48297487|NCT02566265|101056947|FG000|NOT COMPLETED|Overall Study||9||
48297488|NCT02566265|101056948|FG001|NOT COMPLETED|Overall Study||6||
48297489|NCT01845220|101056949|FG000|STARTED|Overall Study||30||30
48297490|NCT01845220|101056950|FG001|STARTED|Overall Study||30||30
48297491|NCT01845220|101056949|FG000|COMPLETED|Overall Study||30||30
48297492|NCT01845220|101056950|FG001|COMPLETED|Overall Study||30||30
48297493|NCT01845220|101056949|FG000|NOT COMPLETED|Overall Study||0||0
48297494|NCT01845220|101056950|FG001|NOT COMPLETED|Overall Study||0||0
48297495|NCT00863109|101056951|FG000|STARTED|Treatment Period||130||
48297496|NCT00863109|101056951|FG000|COMPLETED|Treatment Period||53||
48297497|NCT00863109|101056951|FG000|NOT COMPLETED|Treatment Period||77||
48297498|NCT00863109|101056951|FG000|STARTED|Follow-up Period||59||
48297499|NCT00863109|101056951|FG000|COMPLETED|Follow-up Period||48||
48297500|NCT00863109|101056951|FG000|NOT COMPLETED|Follow-up Period||11||
48297501|NCT03406260|101056952|FG000|STARTED|Period 1||6||
48297502|NCT03406260|101056953|FG001|STARTED|Period 1||6||
48297503|NCT03406260|101056954|FG002|STARTED|Period 1||6||
48297504|NCT03406260|101056955|FG003|STARTED|Period 1||6||
48297505|NCT03406260|101056956|FG004|STARTED|Period 1||6||
48297506|NCT03406260|101056957|FG005|STARTED|Period 1||6||
48297507|NCT03406260|101056952|FG000|Received at Least 1 Dose of Study Drug|Period 1||6||
48297508|NCT03406260|101056953|FG001|Received at Least 1 Dose of Study Drug|Period 1||6||
48297509|NCT03406260|101056954|FG002|Received at Least 1 Dose of Study Drug|Period 1||6||
48297510|NCT03406260|101056955|FG003|Received at Least 1 Dose of Study Drug|Period 1||6||
48297511|NCT03406260|101056956|FG004|Received at Least 1 Dose of Study Drug|Period 1||6||
48297512|NCT03406260|101056957|FG005|Received at Least 1 Dose of Study Drug|Period 1||6||
48297513|NCT03406260|101056952|FG000|COMPLETED|Period 1||6||
48297514|NCT03406260|101056953|FG001|COMPLETED|Period 1||6||
48297515|NCT03406260|101056954|FG002|COMPLETED|Period 1||6||
48297516|NCT03406260|101056955|FG003|COMPLETED|Period 1||6||
48297517|NCT03406260|101056956|FG004|COMPLETED|Period 1||5||
48297518|NCT03406260|101056957|FG005|COMPLETED|Period 1||6||
48297519|NCT03406260|101056952|FG000|NOT COMPLETED|Period 1||0||
48297520|NCT03406260|101056953|FG001|NOT COMPLETED|Period 1||0||
48297521|NCT03406260|101056954|FG002|NOT COMPLETED|Period 1||0||
48297522|NCT03406260|101056955|FG003|NOT COMPLETED|Period 1||0||
48297523|NCT03406260|101056956|FG004|NOT COMPLETED|Period 1||1||
48297524|NCT03406260|101056957|FG005|NOT COMPLETED|Period 1||0||
48297525|NCT03406260|101056952|FG000|STARTED|Period 2||6||
48297526|NCT03406260|101056953|FG001|STARTED|Period 2||6||
48297527|NCT03406260|101056954|FG002|STARTED|Period 2||6||
48297528|NCT03406260|101056955|FG003|STARTED|Period 2||6||
48297529|NCT03406260|101056956|FG004|STARTED|Period 2||5||
48297530|NCT03406260|101056957|FG005|STARTED|Period 2||6||
48297531|NCT03406260|101056952|FG000|COMPLETED|Period 2||6||
48297532|NCT03406260|101056953|FG001|COMPLETED|Period 2||6||
48297533|NCT03406260|101056954|FG002|COMPLETED|Period 2||6||
48297534|NCT03406260|101056955|FG003|COMPLETED|Period 2||6||
48297535|NCT03406260|101056956|FG004|COMPLETED|Period 2||5||
48297536|NCT03406260|101056957|FG005|COMPLETED|Period 2||6||
48297537|NCT03406260|101056952|FG000|NOT COMPLETED|Period 2||0||
48297538|NCT03406260|101056953|FG001|NOT COMPLETED|Period 2||0||
48297539|NCT03406260|101056954|FG002|NOT COMPLETED|Period 2||0||
48297540|NCT03406260|101056955|FG003|NOT COMPLETED|Period 2||0||
48297541|NCT03406260|101056956|FG004|NOT COMPLETED|Period 2||0||
48297542|NCT03406260|101056957|FG005|NOT COMPLETED|Period 2||0||
48297543|NCT03406260|101056952|FG000|STARTED|Period 3||6||
48297544|NCT03406260|101056953|FG001|STARTED|Period 3||6||
48297545|NCT03406260|101056954|FG002|STARTED|Period 3||6||
48297546|NCT03406260|101056955|FG003|STARTED|Period 3||6||
48297547|NCT03406260|101056956|FG004|STARTED|Period 3||5||
48297548|NCT03406260|101056957|FG005|STARTED|Period 3||6||
48297549|NCT03406260|101056952|FG000|COMPLETED|Period 3||6||
48297550|NCT03406260|101056953|FG001|COMPLETED|Period 3||6||
48297551|NCT03406260|101056954|FG002|COMPLETED|Period 3||6||
48297552|NCT03406260|101056955|FG003|COMPLETED|Period 3||6||
48297553|NCT03406260|101056956|FG004|COMPLETED|Period 3||5||
48297554|NCT03406260|101056957|FG005|COMPLETED|Period 3||6||
48297555|NCT03406260|101056952|FG000|NOT COMPLETED|Period 3||0||
48297556|NCT03406260|101056953|FG001|NOT COMPLETED|Period 3||0||
48297557|NCT03406260|101056954|FG002|NOT COMPLETED|Period 3||0||
48297558|NCT03406260|101056955|FG003|NOT COMPLETED|Period 3||0||
48297559|NCT03406260|101056956|FG004|NOT COMPLETED|Period 3||0||
48297560|NCT03406260|101056957|FG005|NOT COMPLETED|Period 3||0||
48297561|NCT00998426|101056958|FG000|STARTED|Overall Study||5||
48297562|NCT00998426|101056958|FG000|Blood Glucose Monitoring|Overall Study||5||
48297563|NCT00998426|101056958|FG000|COMPLETED|Overall Study||5||
48297564|NCT00998426|101056958|FG000|NOT COMPLETED|Overall Study||0||
48297565|NCT00908232|101056959|FG000|STARTED|Cycle 1 to 4||163||
48297566|NCT00908232|101056960|FG001|STARTED|Cycle 1 to 4||0||
48297567|NCT00908232|101056961|FG002|STARTED|Cycle 1 to 4||0||
48297568|NCT00908232|101056962|FG003|STARTED|Cycle 1 to 4||0||
48297569|NCT00908232|101056959|FG000|COMPLETED|Cycle 1 to 4||135||
48297570|NCT00908232|101056960|FG001|COMPLETED|Cycle 1 to 4||0||
48297571|NCT00908232|101056961|FG002|COMPLETED|Cycle 1 to 4||0||
48297572|NCT00908232|101056962|FG003|COMPLETED|Cycle 1 to 4||0||
48297573|NCT00908232|101056959|FG000|NOT COMPLETED|Cycle 1 to 4||28||
48297574|NCT00908232|101056960|FG001|NOT COMPLETED|Cycle 1 to 4||0||
48297575|NCT00908232|101056961|FG002|NOT COMPLETED|Cycle 1 to 4||0||
48297576|NCT00908232|101056962|FG003|NOT COMPLETED|Cycle 1 to 4||0||
48297577|NCT00908232|101056959|FG000|STARTED|Randomization (Cycle 5) to Cycle 8||98||
48297578|NCT00908232|101056960|FG001|STARTED|Randomization (Cycle 5) to Cycle 8||7||
48297579|NCT00908232|101056961|FG002|STARTED|Randomization (Cycle 5) to Cycle 8||8||
48297580|NCT00908232|101056962|FG003|STARTED|Randomization (Cycle 5) to Cycle 8||4||
48297581|NCT00908232|101056959|FG000|COMPLETED|Randomization (Cycle 5) to Cycle 8||63||
48297582|NCT00908232|101056960|FG001|COMPLETED|Randomization (Cycle 5) to Cycle 8||4||
48297583|NCT00908232|101056961|FG002|COMPLETED|Randomization (Cycle 5) to Cycle 8||7||
48297584|NCT00908232|101056962|FG003|COMPLETED|Randomization (Cycle 5) to Cycle 8||4||
48297585|NCT00908232|101056959|FG000|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||35||
48297586|NCT00908232|101056960|FG001|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||3||
48297587|NCT00908232|101056961|FG002|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||1||
48297588|NCT00908232|101056962|FG003|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||0||
48297589|NCT00975507|101056963|FG000|STARTED|Overall Study||323||
48297590|NCT00975507|101056964|FG001|STARTED|Overall Study||157||
48297591|NCT00975507|101056963|FG000|Vaccinated at Visit 1|Overall Study||323||
48297592|NCT00975507|101056964|FG001|Vaccinated at Visit 1|Overall Study||157||
48297593|NCT00975507|101056963|FG000|Vaccinated at Visit 2|Overall Study||310||
48297594|NCT00975507|101056964|FG001|Vaccinated at Visit 2|Overall Study||0||
48297595|NCT00975507|101056963|FG000|COMPLETED|Overall Study||303||
48297596|NCT00975507|101056964|FG001|COMPLETED|Overall Study||153||
48297597|NCT00975507|101056963|FG000|NOT COMPLETED|Overall Study||20||
48297598|NCT00975507|101056964|FG001|NOT COMPLETED|Overall Study||4||
48297599|NCT01862640|101056965|FG000|STARTED|Overall Study||20||
48297600|NCT01862640|101056966|FG001|STARTED|Overall Study||137||
48297601|NCT01862640|101056967|FG002|STARTED|Overall Study||140||
48297602|NCT01862640|101056968|FG003|STARTED|Overall Study||136||
48297603|NCT01862640|101056965|FG000|COMPLETED|Overall Study||13||
48405111|NCT00741260|101325189|FG001|NOT COMPLETED|Overall Study||8||
48405112|NCT00741260|101325190|FG002|NOT COMPLETED|Overall Study||4||
48297604|NCT01862640|101056966|FG001|COMPLETED|Overall Study||121||
48297605|NCT01862640|101056967|FG002|COMPLETED|Overall Study||122||
48297606|NCT01862640|101056968|FG003|COMPLETED|Overall Study||121||
48297607|NCT01862640|101056965|FG000|NOT COMPLETED|Overall Study||7||
48297608|NCT01862640|101056966|FG001|NOT COMPLETED|Overall Study||16||
48297609|NCT01862640|101056967|FG002|NOT COMPLETED|Overall Study||18||
48297610|NCT01862640|101056968|FG003|NOT COMPLETED|Overall Study||15||
48297611|NCT01906346|101056969|FG000|STARTED|Overall Study||9||
48297612|NCT01906346|101056969|FG000|COMPLETED|Overall Study||8||
48297613|NCT01906346|101056969|FG000|NOT COMPLETED|Overall Study||1||
48297614|NCT04484831|101056970|FG000|STARTED|Overall Study||20||
48297615|NCT04484831|101056971|FG001|STARTED|Overall Study||20||
48297616|NCT04484831|101056970|FG000|COMPLETED|Overall Study||19||
48297617|NCT04484831|101056971|FG001|COMPLETED|Overall Study||20||
48297618|NCT04484831|101056970|FG000|NOT COMPLETED|Overall Study||1||
48297619|NCT04484831|101056971|FG001|NOT COMPLETED|Overall Study||0||
48297620|NCT00107120|101056972|FG000|STARTED|Overall Study||155||
48297621|NCT00107120|101056973|FG001|STARTED|Overall Study||157||
48297622|NCT00107120|101056972|FG000|COMPLETED|Overall Study||126||
48297623|NCT00107120|101056973|FG001|COMPLETED|Overall Study||133||
48297624|NCT00107120|101056972|FG000|NOT COMPLETED|Overall Study||29||
48297625|NCT00107120|101056973|FG001|NOT COMPLETED|Overall Study||24||
48297626|NCT00394953|101056974|FG000|STARTED|First Treatment Period||245||
48297627|NCT00394953|101056975|FG001|STARTED|First Treatment Period||244||
48297628|NCT00394953|101056974|FG000|COMPLETED|First Treatment Period||216||
48297629|NCT00394953|101056975|FG001|COMPLETED|First Treatment Period||222||
48297630|NCT00394953|101056974|FG000|NOT COMPLETED|First Treatment Period||29||
48297631|NCT00394953|101056975|FG001|NOT COMPLETED|First Treatment Period||22||
48297632|NCT00394953|101056974|FG000|STARTED|Second Treatment Period||216||
48297633|NCT00394953|101056975|FG001|STARTED|Second Treatment Period||222||
48297634|NCT00394953|101056974|FG000|COMPLETED|Second Treatment Period||187||
48297635|NCT00394953|101056975|FG001|COMPLETED|Second Treatment Period||148||
48297636|NCT00394953|101056974|FG000|NOT COMPLETED|Second Treatment Period||29||
48297637|NCT00394953|101056975|FG001|NOT COMPLETED|Second Treatment Period||74||
48297638|NCT04318951|101056976|FG000|STARTED|Overall Study||30||
48297639|NCT04318951|101056977|FG001|STARTED|Overall Study||30||
48297640|NCT04318951|101056976|FG000|COMPLETED|Overall Study||30||
48297641|NCT04318951|101056977|FG001|COMPLETED|Overall Study||30||
48297642|NCT04318951|101056976|FG000|NOT COMPLETED|Overall Study||0||
48297643|NCT04318951|101056977|FG001|NOT COMPLETED|Overall Study||0||
48297644|NCT01390181|101056978|FG000|STARTED|Overall Study||4||
48297645|NCT01390181|101056978|FG000|COMPLETED|Overall Study||0||
48297646|NCT01390181|101056978|FG000|NOT COMPLETED|Overall Study||4||
48297647|NCT01557283|101056979|FG000|STARTED|Overall Study||140||
48297648|NCT01557283|101056979|FG000|COMPLETED|Overall Study||96||
48297649|NCT01557283|101056979|FG000|NOT COMPLETED|Overall Study||44||
48297650|NCT04808622|101056980|FG000|STARTED|Overall Study||5||
48297651|NCT04808622|101056981|FG001|STARTED|Overall Study||5||
48297652|NCT04808622|101056982|FG002|STARTED|Overall Study||5||
48297653|NCT04808622|101056983|FG003|STARTED|Overall Study||5||
48297654|NCT04808622|101056984|FG004|STARTED|Overall Study||5||
48297655|NCT04808622|101056985|FG005|STARTED|Overall Study||5||
48297656|NCT04808622|101056980|FG000|COMPLETED|Overall Study||5||
48297657|NCT04808622|101056981|FG001|COMPLETED|Overall Study||5||
48297658|NCT04808622|101056982|FG002|COMPLETED|Overall Study||5||
48297659|NCT04808622|101056983|FG003|COMPLETED|Overall Study||5||
48297660|NCT04808622|101056984|FG004|COMPLETED|Overall Study||5||
48297661|NCT04808622|101056985|FG005|COMPLETED|Overall Study||5||
48297662|NCT04808622|101056980|FG000|NOT COMPLETED|Overall Study||0||
48297663|NCT04808622|101056981|FG001|NOT COMPLETED|Overall Study||0||
48297664|NCT04808622|101056982|FG002|NOT COMPLETED|Overall Study||0||
48297665|NCT04808622|101056983|FG003|NOT COMPLETED|Overall Study||0||
48297666|NCT04808622|101056984|FG004|NOT COMPLETED|Overall Study||0||
48297667|NCT04808622|101056985|FG005|NOT COMPLETED|Overall Study||0||
48297668|NCT00876694|101056986|FG000|STARTED|Overall Study||125||
48297669|NCT00876694|101056987|FG001|STARTED|Overall Study||61||
48297670|NCT00876694|101056986|FG000|COMPLETED|Overall Study||104||
48297671|NCT00876694|101056987|FG001|COMPLETED|Overall Study||49||
48297672|NCT00876694|101056986|FG000|NOT COMPLETED|Overall Study||21||
48297673|NCT00876694|101056987|FG001|NOT COMPLETED|Overall Study||12||
48297674|NCT03311334|101056988|FG000|STARTED|Overall Study||7||
48297675|NCT03311334|101056989|FG001|STARTED|Overall Study||9||
48297676|NCT03311334|101056990|FG002|STARTED|Overall Study||31||
48297677|NCT03311334|101056988|FG000|COMPLETED|Overall Study||7||
48297678|NCT03311334|101056989|FG001|COMPLETED|Overall Study||9||
48297679|NCT03311334|101056990|FG002|COMPLETED|Overall Study||31||
48297680|NCT03311334|101056988|FG000|NOT COMPLETED|Overall Study||0||
48297681|NCT03311334|101056989|FG001|NOT COMPLETED|Overall Study||0||
48297682|NCT03311334|101056990|FG002|NOT COMPLETED|Overall Study||0||
48297683|NCT00803270|101056991|FG000|STARTED|Overall Study||13||
48297684|NCT00803270|101056992|FG001|STARTED|Overall Study||14||
48297685|NCT00803270|101056991|FG000|COMPLETED|Overall Study||12||
48598926|NCT00195494|101800211|FG000|COMPLETED|Year 2||104||
48598927|NCT00195494|101800212|FG001|COMPLETED|Year 2||74||
48598928|NCT00195494|101800213|FG002|COMPLETED|Year 2||93||
48598929|NCT00195494|101800214|FG003|COMPLETED|Year 2||76||
48598930|NCT00195494|101800215|FG004|COMPLETED|Year 2||0||
48598931|NCT00195494|101800216|FG005|COMPLETED|Year 2||0||
48598932|NCT00195494|101800211|FG000|NOT COMPLETED|Year 2||7||
48598933|NCT00195494|101800212|FG001|NOT COMPLETED|Year 2||16||
48598934|NCT00195494|101800213|FG002|NOT COMPLETED|Year 2||18||
48598935|NCT00195494|101800214|FG003|NOT COMPLETED|Year 2||23||
48598936|NCT00195494|101800215|FG004|NOT COMPLETED|Year 2||0||
48598937|NCT00195494|101800216|FG005|NOT COMPLETED|Year 2||0||
48598938|NCT05940077|101800217|FG000|STARTED|Overall Study||20||
48598939|NCT05940077|101800217|FG000|COMPLETED|Overall Study||19||
48598940|NCT05940077|101800217|FG000|NOT COMPLETED|Overall Study||1||
48598941|NCT00308750|101800218|FG000|STARTED|Overall Study||72||
48598942|NCT00308750|101800219|FG001|STARTED|Overall Study||74||
48598943|NCT00308750|101800220|FG002|STARTED|Overall Study||72||
48598944|NCT00308750|101800218|FG000|Received at Least 1 Dose of Study Drug|Overall Study||67||
48598945|NCT00308750|101800219|FG001|Received at Least 1 Dose of Study Drug|Overall Study||72||
48598946|NCT00308750|101800220|FG002|Received at Least 1 Dose of Study Drug|Overall Study||70||
48598947|NCT00308750|101800218|FG000|COMPLETED|Overall Study||0||
48297686|NCT00803270|101056992|FG001|COMPLETED|Overall Study||12||
48297687|NCT00803270|101056991|FG000|NOT COMPLETED|Overall Study||1||
48598948|NCT00308750|101800219|FG001|COMPLETED|Overall Study||34||
48598949|NCT00308750|101800220|FG002|COMPLETED|Overall Study||23||
48598950|NCT00308750|101800218|FG000|NOT COMPLETED|Overall Study||72||
48598951|NCT00308750|101800219|FG001|NOT COMPLETED|Overall Study||40||
48598952|NCT00308750|101800220|FG002|NOT COMPLETED|Overall Study||49||
48297688|NCT00803270|101056992|FG001|NOT COMPLETED|Overall Study||2||
48598953|NCT02445859|101800221|FG000|STARTED|Overall Study||45||
48598954|NCT02445859|101800222|FG001|STARTED|Overall Study||45||
48598955|NCT02445859|101800221|FG000|COMPLETED|Overall Study||43||
48297689|NCT03093350|101056993|FG000|STARTED|Overall Study||12||
48598956|NCT02445859|101800222|FG001|COMPLETED|Overall Study||42||
48598957|NCT02445859|101800221|FG000|NOT COMPLETED|Overall Study||2||
48598958|NCT02445859|101800222|FG001|NOT COMPLETED|Overall Study||3||
48598959|NCT02565706|101800223|FG000|STARTED|Overall Study||178||
48598960|NCT02565706|101800224|FG001|STARTED|Overall Study||172||
48297690|NCT03093350|101056993|FG000|Started Treatment|Overall Study||10||
48297691|NCT03093350|101056993|FG000|COMPLETED|Overall Study||10||
48598961|NCT02565706|101800225|FG002|STARTED|Overall Study||193||
48598962|NCT02565706|101800226|FG003|STARTED|Overall Study||201||
48598963|NCT02565706|101800223|FG000|COMPLETED|Overall Study||101||
48598964|NCT02565706|101800224|FG001|COMPLETED|Overall Study||90||
48598965|NCT02565706|101800225|FG002|COMPLETED|Overall Study||104||
48598966|NCT02565706|101800226|FG003|COMPLETED|Overall Study||116||
48598967|NCT02565706|101800223|FG000|NOT COMPLETED|Overall Study||77||
48598968|NCT02565706|101800224|FG001|NOT COMPLETED|Overall Study||82||
48598969|NCT02565706|101800225|FG002|NOT COMPLETED|Overall Study||89||
48598970|NCT02565706|101800226|FG003|NOT COMPLETED|Overall Study||85||
48598971|NCT01273155|101800227|FG000|STARTED|Overall Study||14||
48598972|NCT01273155|101800228|FG001|STARTED|Overall Study||12||
48297692|NCT03093350|101056993|FG000|NOT COMPLETED|Overall Study||2||
48598973|NCT01273155|101800229|FG002|STARTED|Overall Study||18||
48598974|NCT01273155|101800230|FG003|STARTED|Overall Study||5||
48598975|NCT01273155|101800231|FG004|STARTED|Overall Study||5||
48598976|NCT01273155|101800232|FG005|STARTED|Overall Study||10||
48598977|NCT01273155|101800233|FG006|STARTED|Overall Study||8||
48598978|NCT01273155|101800227|FG000|COMPLETED|Overall Study||12||
48598979|NCT01273155|101800228|FG001|COMPLETED|Overall Study||8||
48598980|NCT01273155|101800229|FG002|COMPLETED|Overall Study||6||
48598981|NCT01273155|101800230|FG003|COMPLETED|Overall Study||4||
48598982|NCT01273155|101800231|FG004|COMPLETED|Overall Study||3||
48598983|NCT01273155|101800232|FG005|COMPLETED|Overall Study||5||
48598984|NCT01273155|101800233|FG006|COMPLETED|Overall Study||2||
48598985|NCT01273155|101800227|FG000|NOT COMPLETED|Overall Study||2||
48598986|NCT01273155|101800228|FG001|NOT COMPLETED|Overall Study||4||
48598987|NCT01273155|101800229|FG002|NOT COMPLETED|Overall Study||12||
48598988|NCT01273155|101800230|FG003|NOT COMPLETED|Overall Study||1||
48598989|NCT01273155|101800231|FG004|NOT COMPLETED|Overall Study||2||
48598990|NCT01273155|101800232|FG005|NOT COMPLETED|Overall Study||5||
48598991|NCT01273155|101800233|FG006|NOT COMPLETED|Overall Study||6||
48598992|NCT00568334|101800234|FG000|STARTED|Overall Study||122||
48598993|NCT00568334|101800235|FG001|STARTED|Overall Study||122||
48598994|NCT00568334|101800234|FG000|COMPLETED|Overall Study||121||
48598995|NCT00568334|101800235|FG001|COMPLETED|Overall Study||121||
48598996|NCT00568334|101800234|FG000|NOT COMPLETED|Overall Study||1||
48598997|NCT00568334|101800235|FG001|NOT COMPLETED|Overall Study||1||
48598998|NCT02572856|101800236|FG000|STARTED|Overall Study||10||
48598999|NCT02572856|101800236|FG000|COMPLETED|Overall Study||10||
48599000|NCT02572856|101800236|FG000|NOT COMPLETED|Overall Study||0||
48599001|NCT04526574|101800237|FG000|STARTED|Overall Study||898||
48599002|NCT04526574|101800238|FG001|STARTED|Overall Study||898||
48599003|NCT04526574|101800237|FG000|Vaccination 1|Overall Study||895||
48599004|NCT04526574|101800238|FG001|Vaccination 1|Overall Study||896||
48599005|NCT04526574|101800237|FG000|Vaccination 2|Overall Study||874||
48599006|NCT04526574|101800238|FG001|Vaccination 2|Overall Study||878||
48599007|NCT04526574|101800237|FG000|COMPLETED|Overall Study||862||
48599008|NCT04526574|101800238|FG001|COMPLETED|Overall Study||865||
48599009|NCT04526574|101800237|FG000|NOT COMPLETED|Overall Study||36||
48599010|NCT04526574|101800238|FG001|NOT COMPLETED|Overall Study||33||
48599011|NCT02371668|101800239|FG000|STARTED|Overall Study||49||
48599012|NCT02371668|101800240|FG001|STARTED|Overall Study||42||
48599013|NCT02371668|101800239|FG000|COMPLETED|Overall Study||49||
48599014|NCT02371668|101800240|FG001|COMPLETED|Overall Study||42||
48599015|NCT02371668|101800239|FG000|NOT COMPLETED|Overall Study||0||
48599016|NCT02371668|101800240|FG001|NOT COMPLETED|Overall Study||0||
48599017|NCT00106639|101800241|FG000|STARTED|Overall Study||20||
48599018|NCT00106639|101800242|FG001|STARTED|Overall Study||20||
48599019|NCT00106639|101800243|FG002|STARTED|Overall Study||21||
48599020|NCT00106639|101800241|FG000|COMPLETED|Overall Study||17||
48599021|NCT00106639|101800242|FG001|COMPLETED|Overall Study||13||
48599022|NCT00106639|101800243|FG002|COMPLETED|Overall Study||19||
48599023|NCT00106639|101800241|FG000|NOT COMPLETED|Overall Study||3||
48599024|NCT00106639|101800242|FG001|NOT COMPLETED|Overall Study||7||
48599025|NCT00106639|101800243|FG002|NOT COMPLETED|Overall Study||2||
48599026|NCT01764659|101800244|FG000|STARTED|Overall Study||14||
48599027|NCT01764659|101800244|FG000|COMPLETED|Overall Study||12||
48599028|NCT01764659|101800244|FG000|NOT COMPLETED|Overall Study||2||
48599029|NCT02305446|101800245|FG000|STARTED|Overall Study||55||
48599030|NCT02305446|101800245|FG000|COMPLETED|Overall Study||54||
48599031|NCT02305446|101800245|FG000|NOT COMPLETED|Overall Study||1||
48599032|NCT00830518|101800246|FG000|STARTED|Overall Study||46||
48599033|NCT00830518|101800247|FG001|STARTED|Overall Study||11||
48599034|NCT00830518|101800246|FG000|COMPLETED|Overall Study||0||
48599035|NCT00830518|101800247|FG001|COMPLETED|Overall Study||0||
48599036|NCT00830518|101800246|FG000|NOT COMPLETED|Overall Study||46||
48599037|NCT00830518|101800247|FG001|NOT COMPLETED|Overall Study||11||
48599038|NCT02912455|101800248|FG000|STARTED|Overall Study||11||
48599039|NCT02912455|101800249|FG001|STARTED|Overall Study||5||
48599040|NCT02912455|101800248|FG000|COMPLETED|Overall Study||9||
48599041|NCT02912455|101800249|FG001|COMPLETED|Overall Study||2||
48599042|NCT02912455|101800248|FG000|NOT COMPLETED|Overall Study||2||
48599043|NCT02912455|101800249|FG001|NOT COMPLETED|Overall Study||3||
48599044|NCT00269477|101800250|FG000|STARTED|Overall Study||9||
48599045|NCT00269477|101800251|FG001|STARTED|Overall Study||18||
48599046|NCT00269477|101800252|FG002|STARTED|Overall Study||58||
48599047|NCT00269477|101800253|FG003|STARTED|Overall Study||60||
48599048|NCT00269477|101800250|FG000|COMPLETED|Overall Study||4||
48599049|NCT00269477|101800251|FG001|COMPLETED|Overall Study||12||
48599050|NCT00269477|101800252|FG002|COMPLETED|Overall Study||57||
48599051|NCT00269477|101800253|FG003|COMPLETED|Overall Study||60||
48599052|NCT00269477|101800250|FG000|NOT COMPLETED|Overall Study||5||
48599053|NCT00269477|101800251|FG001|NOT COMPLETED|Overall Study||6||
48599054|NCT00269477|101800252|FG002|NOT COMPLETED|Overall Study||1||
48599055|NCT00269477|101800253|FG003|NOT COMPLETED|Overall Study||0||
48599056|NCT04344535|101800254|FG000|STARTED|Overall Study||59||
48599057|NCT04344535|101800255|FG001|STARTED|Overall Study||15||
48599058|NCT04344535|101800254|FG000|COMPLETED|Overall Study||59||
48599059|NCT04344535|101800255|FG001|COMPLETED|Overall Study||15||
48599060|NCT04344535|101800254|FG000|NOT COMPLETED|Overall Study||0||
48599061|NCT04344535|101800255|FG001|NOT COMPLETED|Overall Study||0||
48599062|NCT03769194|101800256|FG000|STARTED|Overall Study||29||
48599063|NCT03769194|101800257|FG001|STARTED|Overall Study||214||
48599064|NCT03769194|101800258|FG002|STARTED|Overall Study||205||
48599065|NCT03769194|101800259|FG003|STARTED|Overall Study||124||
48599066|NCT03769194|101800256|FG000|COMPLETED|Overall Study||25|Subjects that completed Day 85 (Visit 4)|
48599067|NCT03769194|101800257|FG001|COMPLETED|Overall Study||196|Subjects that completed Day 85 (Visit 4)|
48599068|NCT03769194|101800258|FG002|COMPLETED|Overall Study||197|Subjects that completed Day 85 (Visit 4)|
48599069|NCT03769194|101800259|FG003|COMPLETED|Overall Study||115|Subjects that completed Day 85 (Visit 4)|
48713504|NCT00747344|102084969|FG002|COMPLETED|After Controlled Period||55||
48713505|NCT00747344|102084970|FG003|COMPLETED|After Controlled Period||56||
48713506|NCT00747344|102084967|FG000|NOT COMPLETED|After Controlled Period||0||
48713507|NCT00747344|102084968|FG001|NOT COMPLETED|After Controlled Period||0||
48713508|NCT00747344|102084969|FG002|NOT COMPLETED|After Controlled Period||0||
48599070|NCT03769194|101800256|FG000|NOT COMPLETED|Overall Study||4||
48599071|NCT03769194|101800257|FG001|NOT COMPLETED|Overall Study||18||
48599072|NCT03769194|101800258|FG002|NOT COMPLETED|Overall Study||8||
48599073|NCT03769194|101800259|FG003|NOT COMPLETED|Overall Study||9||
48599074|NCT01688141|101800260|FG000|STARTED|Overall Study||11706||
48599075|NCT01688141|101800261|FG001|STARTED|Overall Study||11651||
48599076|NCT01688141|101800260|FG000|COMPLETED|Overall Study||11706||
48599077|NCT01688141|101800261|FG001|COMPLETED|Overall Study||11651||
48599078|NCT01688141|101800260|FG000|NOT COMPLETED|Overall Study||0||
48599079|NCT01688141|101800261|FG001|NOT COMPLETED|Overall Study||0||
48599080|NCT02028169|101800262|FG000|STARTED|Overall Study||120||
48599081|NCT02028169|101800262|FG000|COMPLETED|Overall Study||92||
48599082|NCT02028169|101800262|FG000|NOT COMPLETED|Overall Study||28||
48599083|NCT01839799|101800263|FG000|STARTED|Overall Study||17||
48599084|NCT01839799|101800264|FG001|STARTED|Overall Study||15||
48599085|NCT01839799|101800263|FG000|COMPLETED|Overall Study||17||
48599086|NCT01839799|101800264|FG001|COMPLETED|Overall Study||15||
48599087|NCT01839799|101800263|FG000|NOT COMPLETED|Overall Study||0||
48599088|NCT01839799|101800264|FG001|NOT COMPLETED|Overall Study||0||
48599089|NCT01294748|101800265|FG000|STARTED|Overall Study||123||
48599090|NCT01294748|101800266|FG001|STARTED|Overall Study||61||
48599091|NCT01294748|101800265|FG000|COMPLETED|Overall Study||118||
48599092|NCT01294748|101800266|FG001|COMPLETED|Overall Study||59||
48599093|NCT01294748|101800265|FG000|NOT COMPLETED|Overall Study||5||
48713509|NCT00747344|102084970|FG003|NOT COMPLETED|After Controlled Period||1||
48713510|NCT03900923|102084971|FG000|STARTED|Overall Study||6||
48713511|NCT03900923|102084972|FG001|STARTED|Overall Study||9||
48713512|NCT03900923|102084973|FG002|STARTED|Overall Study||8||
48713513|NCT03900923|102084971|FG000|Participants Started Part 1: 3 mg/kg/Day|Overall Study||6||
48599094|NCT01294748|101800266|FG001|NOT COMPLETED|Overall Study||2||
48599095|NCT01618916|101800267|FG000|STARTED|Overall Study||12||
48599096|NCT01618916|101800268|FG001|STARTED|Overall Study||10||
48599097|NCT01618916|101800269|FG002|STARTED|Overall Study||11||
48599098|NCT01618916|101800270|FG003|STARTED|Overall Study||9||
48599099|NCT01618916|101800271|FG004|STARTED|Overall Study||5||
48599100|NCT01618916|101800272|FG005|STARTED|Overall Study||4||
48599101|NCT01618916|101800267|FG000|Received At Least 1 Dose of Study Drug|Overall Study||12||
48599102|NCT01618916|101800268|FG001|Received At Least 1 Dose of Study Drug|Overall Study||10||
48599103|NCT01618916|101800269|FG002|Received At Least 1 Dose of Study Drug|Overall Study||11||
48599104|NCT01618916|101800270|FG003|Received At Least 1 Dose of Study Drug|Overall Study||9||
48599105|NCT01618916|101800271|FG004|Received At Least 1 Dose of Study Drug|Overall Study||5||
48599106|NCT01618916|101800272|FG005|Received At Least 1 Dose of Study Drug|Overall Study||4||
48599107|NCT01618916|101800267|FG000|COMPLETED|Overall Study||10||
48599108|NCT01618916|101800268|FG001|COMPLETED|Overall Study||9||
48599109|NCT01618916|101800269|FG002|COMPLETED|Overall Study||10||
48599110|NCT01618916|101800270|FG003|COMPLETED|Overall Study||7||
48599111|NCT01618916|101800271|FG004|COMPLETED|Overall Study||4||
48599112|NCT01618916|101800272|FG005|COMPLETED|Overall Study||4||
48599113|NCT01618916|101800267|FG000|NOT COMPLETED|Overall Study||2||
48599114|NCT01618916|101800268|FG001|NOT COMPLETED|Overall Study||1||
48599115|NCT01618916|101800269|FG002|NOT COMPLETED|Overall Study||1||
48599116|NCT01618916|101800270|FG003|NOT COMPLETED|Overall Study||2||
48599117|NCT01618916|101800271|FG004|NOT COMPLETED|Overall Study||1||
48599118|NCT01618916|101800272|FG005|NOT COMPLETED|Overall Study||0||
48599119|NCT01926197|101800273|FG000|STARTED|Overall Study||13||
48599120|NCT01926197|101800274|FG001|STARTED|Overall Study||14||
48599121|NCT01926197|101800273|FG000|COMPLETED|Overall Study||12||
48599122|NCT01926197|101800274|FG001|COMPLETED|Overall Study||13||
48599123|NCT01926197|101800273|FG000|NOT COMPLETED|Overall Study||1||
48599124|NCT01926197|101800274|FG001|NOT COMPLETED|Overall Study||1||
48599125|NCT02685072|101800275|FG000|STARTED|Treatment Period||33||
48599126|NCT02685072|101800276|FG001|STARTED|Treatment Period||31||
48599127|NCT02685072|101800275|FG000|Completed Week 2 Visit|Treatment Period||23||
48599128|NCT02685072|101800276|FG001|Completed Week 2 Visit|Treatment Period||26||
48599129|NCT02685072|101800275|FG000|Completed Week 3 Visit|Treatment Period||20||
48599130|NCT02685072|101800276|FG001|Completed Week 3 Visit|Treatment Period||23||
48599131|NCT02685072|101800275|FG000|Completed Week 4 Visit|Treatment Period||19||
48599132|NCT02685072|101800276|FG001|Completed Week 4 Visit|Treatment Period||23||
48599133|NCT02685072|101800275|FG000|Completed Week 5 Visit|Treatment Period||19||
48599134|NCT02685072|101800276|FG001|Completed Week 5 Visit|Treatment Period||22||
48599135|NCT02685072|101800275|FG000|Completed Week 6 Visit|Treatment Period||18||
48599136|NCT02685072|101800276|FG001|Completed Week 6 Visit|Treatment Period||19||
48599137|NCT02685072|101800275|FG000|Completed Week 7 Visit|Treatment Period||17||
48599138|NCT02685072|101800276|FG001|Completed Week 7 Visit|Treatment Period||18||
48599139|NCT02685072|101800275|FG000|Completed Week 8 Visit|Treatment Period||20|End of study treatment period|
48599140|NCT02685072|101800276|FG001|Completed Week 8 Visit|Treatment Period||22|End of study treatment period|
48599141|NCT02685072|101800275|FG000|COMPLETED|Treatment Period||20||
48599142|NCT02685072|101800276|FG001|COMPLETED|Treatment Period||22||
48599143|NCT02685072|101800275|FG000|NOT COMPLETED|Treatment Period||13||
48599144|NCT02685072|101800276|FG001|NOT COMPLETED|Treatment Period||9||
48599145|NCT02685072|101800275|FG000|STARTED|1-Month Follow-Up||20||
48599146|NCT02685072|101800276|FG001|STARTED|1-Month Follow-Up||22||
48599147|NCT02685072|101800275|FG000|COMPLETED|1-Month Follow-Up||19||
48599148|NCT02685072|101800276|FG001|COMPLETED|1-Month Follow-Up||22||
48599149|NCT02685072|101800275|FG000|NOT COMPLETED|1-Month Follow-Up||1||
48599150|NCT02685072|101800276|FG001|NOT COMPLETED|1-Month Follow-Up||0||
48599151|NCT02685072|101800275|FG000|STARTED|3-Month Follow-Up||19||
48599152|NCT02685072|101800276|FG001|STARTED|3-Month Follow-Up||22||
48599153|NCT02685072|101800275|FG000|COMPLETED|3-Month Follow-Up||19||
48599154|NCT02685072|101800276|FG001|COMPLETED|3-Month Follow-Up||22||
48599155|NCT02685072|101800275|FG000|NOT COMPLETED|3-Month Follow-Up||0||
48599156|NCT02685072|101800276|FG001|NOT COMPLETED|3-Month Follow-Up||0||
48599157|NCT00669019|101800277|FG000|STARTED|Overall Study||23||
48599158|NCT00669019|101800277|FG000|COMPLETED|Overall Study||23||
48599159|NCT00669019|101800277|FG000|NOT COMPLETED|Overall Study||0||
48599160|NCT00659776|101800278|FG000|STARTED|Overall Study||230||
48599161|NCT00659776|101800279|FG001|STARTED|Overall Study||25||
48599162|NCT00659776|101800280|FG002|STARTED|Overall Study||0||
48599163|NCT00659776|101800278|FG000|Number of Lesions Gadolinium|Overall Study||145||
48599164|NCT00659776|101800279|FG001|Number of Lesions Gadolinium|Overall Study||0||
48599165|NCT00659776|101800280|FG002|Number of Lesions Gadolinium|Overall Study||0||
48599166|NCT00659776|101800278|FG000|Number of Lesions Ferumoxytol|Overall Study||152||
48599167|NCT00659776|101800279|FG001|Number of Lesions Ferumoxytol|Overall Study||0||
48599168|NCT00659776|101800280|FG002|Number of Lesions Ferumoxytol|Overall Study||0||
48599169|NCT00659776|101800278|FG000|Degree of Contrast Enhancement Gadolinium|Overall Study||128||
48599170|NCT00659776|101800279|FG001|Degree of Contrast Enhancement Gadolinium|Overall Study||0||
48599171|NCT00659776|101800280|FG002|Degree of Contrast Enhancement Gadolinium|Overall Study||0||
48599172|NCT00659776|101800278|FG000|Degree of Contrast Enhancement Ferumoxytol|Overall Study||131||
48144641|NCT03707977|100676779|FG002|COMPLETED|PK Step||0||
48144642|NCT03707977|100676777|FG000|NOT COMPLETED|PK Step||0||
48144643|NCT03707977|100676778|FG001|NOT COMPLETED|PK Step||0||
48144644|NCT03707977|100676779|FG002|NOT COMPLETED|PK Step||0||
48144645|NCT03707977|100676777|FG000|STARTED|Steps 1 (ART+bNAbs)||0||
48144646|NCT03707977|100676778|FG001|STARTED|Steps 1 (ART+bNAbs)||0||
48144647|NCT03707977|100676779|FG002|STARTED|Steps 1 (ART+bNAbs)||28||
48144648|NCT03707977|100676777|FG000|COMPLETED|Steps 1 (ART+bNAbs)||0||
48599173|NCT00659776|101800279|FG001|Degree of Contrast Enhancement Ferumoxytol|Overall Study||0||
48599174|NCT00659776|101800280|FG002|Degree of Contrast Enhancement Ferumoxytol|Overall Study||0||
48713514|NCT03900923|102084972|FG001|Participants Started Part 1: 3 mg/kg/Day|Overall Study||0||
48713515|NCT03900923|102084973|FG002|Participants Started Part 1: 3 mg/kg/Day|Overall Study||0||
48713516|NCT03900923|102084971|FG000|Participants Completed Part 1: 3 mg/kg/Day|Overall Study||6||
48713517|NCT03900923|102084972|FG001|Participants Completed Part 1: 3 mg/kg/Day|Overall Study||0||
48713518|NCT03900923|102084973|FG002|Participants Completed Part 1: 3 mg/kg/Day|Overall Study||0||
48713519|NCT03900923|102084971|FG000|Participants Started Part 1: 6 mg/kg/Day|Overall Study||0||
48713520|NCT03900923|102084972|FG001|Participants Started Part 1: 6 mg/kg/Day|Overall Study||9||
48713521|NCT03900923|102084973|FG002|Participants Started Part 1: 6 mg/kg/Day|Overall Study||0||
48713522|NCT03900923|102084971|FG000|Participants Completed Part 1: 6 mg/kg/Day|Overall Study||0||
48713523|NCT03900923|102084972|FG001|Participants Completed Part 1: 6 mg/kg/Day|Overall Study||9||
48405113|NCT00741260|101325191|FG003|NOT COMPLETED|Overall Study||6||
48599175|NCT00659776|101800278|FG000|Border Delineation Gadolinium|Overall Study||128||
48599176|NCT00659776|101800279|FG001|Border Delineation Gadolinium|Overall Study||0||
48599177|NCT00659776|101800280|FG002|Border Delineation Gadolinium|Overall Study||0||
48599178|NCT00659776|101800278|FG000|Border Delineation Ferumoxytol|Overall Study||131||
48405114|NCT00741260|101325192|FG004|NOT COMPLETED|Overall Study||9||
48405115|NCT00741260|101325193|FG005|NOT COMPLETED|Overall Study||45||
48405116|NCT00741260|101325194|FG006|NOT COMPLETED|Overall Study||7||
48599179|NCT00659776|101800279|FG001|Border Delineation Ferumoxytol|Overall Study||0||
48599180|NCT00659776|101800280|FG002|Border Delineation Ferumoxytol|Overall Study||0||
48599181|NCT00659776|101800278|FG000|Internal Morphology of Lesions Gadolinium|Overall Study||128||
48599182|NCT00659776|101800279|FG001|Internal Morphology of Lesions Gadolinium|Overall Study||0||
48599183|NCT00659776|101800280|FG002|Internal Morphology of Lesions Gadolinium|Overall Study||0||
48599184|NCT00659776|101800278|FG000|Internal Morphology of Lesions Ferumoxytol|Overall Study||131||
48599185|NCT00659776|101800279|FG001|Internal Morphology of Lesions Ferumoxytol|Overall Study||0||
48599186|NCT00659776|101800280|FG002|Internal Morphology of Lesions Ferumoxytol|Overall Study||0||
48599187|NCT00659776|101800278|FG000|COMPLETED|Overall Study||218||
48599188|NCT00659776|101800279|FG001|COMPLETED|Overall Study||23||
48599189|NCT00659776|101800280|FG002|COMPLETED|Overall Study||0||
48713524|NCT03900923|102084973|FG002|Participants Completed Part 1: 6 mg/kg/Day|Overall Study||0||
48713525|NCT03900923|102084971|FG000|Participants Started Part 2: 9 mg/kg/Day|Overall Study||0||
48713526|NCT03900923|102084972|FG001|Participants Started Part 2: 9 mg/kg/Day|Overall Study||0||
48713527|NCT03900923|102084973|FG002|Participants Started Part 2: 9 mg/kg/Day|Overall Study||8||
48713528|NCT03900923|102084971|FG000|Participants Completed Part 2: 9 mg/kg/Day|Overall Study||0||
48713529|NCT03900923|102084972|FG001|Participants Completed Part 2: 9 mg/kg/Day|Overall Study||0||
48713530|NCT03900923|102084973|FG002|Participants Completed Part 2: 9 mg/kg/Day|Overall Study||8||
48713531|NCT03900923|102084971|FG000|COMPLETED|Overall Study||6||
48713532|NCT03900923|102084972|FG001|COMPLETED|Overall Study||9||
48713533|NCT03900923|102084973|FG002|COMPLETED|Overall Study||8||
48713534|NCT03900923|102084971|FG000|NOT COMPLETED|Overall Study||0||
48713535|NCT03900923|102084972|FG001|NOT COMPLETED|Overall Study||0||
48713536|NCT03900923|102084973|FG002|NOT COMPLETED|Overall Study||0||
48713537|NCT01430325|102084974|FG000|STARTED|Overall Study||10||
48713538|NCT01430325|102084975|FG001|STARTED|Overall Study||12||
48713539|NCT01430325|102084976|FG002|STARTED|Overall Study||8||
48713540|NCT01430325|102084977|FG003|STARTED|Overall Study||12||
48713541|NCT01430325|102084974|FG000|COMPLETED|Overall Study||10||
48713542|NCT01430325|102084975|FG001|COMPLETED|Overall Study||12||
48713543|NCT01430325|102084976|FG002|COMPLETED|Overall Study||8||
48713544|NCT01430325|102084977|FG003|COMPLETED|Overall Study||12||
48713545|NCT01430325|102084974|FG000|NOT COMPLETED|Overall Study||0||
48713546|NCT01430325|102084975|FG001|NOT COMPLETED|Overall Study||0||
48599190|NCT00659776|101800278|FG000|NOT COMPLETED|Overall Study||12||
48599191|NCT00659776|101800279|FG001|NOT COMPLETED|Overall Study||2||
48713547|NCT01430325|102084976|FG002|NOT COMPLETED|Overall Study||0||
48144649|NCT03707977|100676778|FG001|COMPLETED|Steps 1 (ART+bNAbs)||0||
48297693|NCT03739437|101056994|FG000|STARTED|Overall Study||9||
48144650|NCT03707977|100676779|FG002|COMPLETED|Steps 1 (ART+bNAbs)||25||
48405117|NCT03954704|101325195|FG000|STARTED|Overall Study||1||
48144651|NCT03707977|100676777|FG000|NOT COMPLETED|Steps 1 (ART+bNAbs)||0||
48144652|NCT03707977|100676778|FG001|NOT COMPLETED|Steps 1 (ART+bNAbs)||0||
48144653|NCT03707977|100676779|FG002|NOT COMPLETED|Steps 1 (ART+bNAbs)||3||
48144654|NCT03707977|100676777|FG000|STARTED|Step 2 (bNAbs Only)||0||
48144655|NCT03707977|100676778|FG001|STARTED|Step 2 (bNAbs Only)||0||
48144656|NCT03707977|100676779|FG002|STARTED|Step 2 (bNAbs Only)||25||
48144657|NCT03707977|100676777|FG000|COMPLETED|Step 2 (bNAbs Only)||0||
48144658|NCT03707977|100676778|FG001|COMPLETED|Step 2 (bNAbs Only)||0||
48144659|NCT03707977|100676779|FG002|COMPLETED|Step 2 (bNAbs Only)||11||
48144660|NCT03707977|100676777|FG000|NOT COMPLETED|Step 2 (bNAbs Only)||0||
48144661|NCT03707977|100676778|FG001|NOT COMPLETED|Step 2 (bNAbs Only)||0||
48144662|NCT03707977|100676779|FG002|NOT COMPLETED|Step 2 (bNAbs Only)||14||
48144663|NCT03707977|100676777|FG000|STARTED|Step 3 (Stop bNABs, Resume ART)||0||
48144664|NCT03707977|100676778|FG001|STARTED|Step 3 (Stop bNABs, Resume ART)||0||
48144665|NCT03707977|100676779|FG002|STARTED|Step 3 (Stop bNABs, Resume ART)||28||
48144666|NCT03707977|100676777|FG000|COMPLETED|Step 3 (Stop bNABs, Resume ART)||0||
48144667|NCT03707977|100676778|FG001|COMPLETED|Step 3 (Stop bNABs, Resume ART)||0||
48144668|NCT03707977|100676779|FG002|COMPLETED|Step 3 (Stop bNABs, Resume ART)||28||
48144669|NCT03707977|100676777|FG000|NOT COMPLETED|Step 3 (Stop bNABs, Resume ART)||0||
48144670|NCT03707977|100676778|FG001|NOT COMPLETED|Step 3 (Stop bNABs, Resume ART)||0||
48144671|NCT03707977|100676779|FG002|NOT COMPLETED|Step 3 (Stop bNABs, Resume ART)||0||
48144672|NCT00930293|100676780|FG000|STARTED|Overall Study||24||
48144673|NCT00930293|100676781|FG001|STARTED|Overall Study||26||
48144674|NCT00930293|100676780|FG000|COMPLETED|Overall Study||17||
48144675|NCT00930293|100676781|FG001|COMPLETED|Overall Study||19||
48144676|NCT00930293|100676780|FG000|NOT COMPLETED|Overall Study||7||
48144677|NCT00930293|100676781|FG001|NOT COMPLETED|Overall Study||7||
48144678|NCT03009045|100676782|FG000|STARTED|Overall Study||44||
48144679|NCT03009045|100676782|FG000|COMPLETED|Overall Study||37||
48144680|NCT03009045|100676782|FG000|NOT COMPLETED|Overall Study||7||
48144681|NCT00760929|100676783|FG000|STARTED|Overall Study||26||
48713548|NCT01430325|102084977|FG003|NOT COMPLETED|Overall Study||0||
48713549|NCT01081301|102084978|FG000|STARTED|Overall Study||36||
48713550|NCT01081301|102084978|FG000|COMPLETED|Overall Study||22||
48713551|NCT01081301|102084978|FG000|NOT COMPLETED|Overall Study||14||
48713552|NCT00937118|102084979|FG000|STARTED|Overall Study||41||
48713553|NCT00937118|102084979|FG000|COMPLETED|Overall Study||41||
48713554|NCT00937118|102084979|FG000|NOT COMPLETED|Overall Study||0||
48713555|NCT00520013|102084980|FG000|STARTED|Overall Study||23||
48713556|NCT00520013|102084981|FG001|STARTED|Overall Study||25||
48713557|NCT00520013|102084982|FG002|STARTED|Overall Study||11||
48713558|NCT00520013|102084980|FG000|Treated|Overall Study||23||
48713559|NCT00520013|102084981|FG001|Treated|Overall Study||25||
48144682|NCT00760929|100676784|FG001|STARTED|Overall Study||29||
48144683|NCT00760929|100676785|FG002|STARTED|Overall Study||59||
48144684|NCT00760929|100676786|FG003|STARTED|Overall Study||57||
48144685|NCT00760929|100676783|FG000|COMPLETED|Overall Study||0||
48144686|NCT00760929|100676784|FG001|COMPLETED|Overall Study||1||
48144687|NCT00760929|100676785|FG002|COMPLETED|Overall Study||1||
48144688|NCT00760929|100676786|FG003|COMPLETED|Overall Study||2||
48144689|NCT00760929|100676783|FG000|NOT COMPLETED|Overall Study||26||
48144690|NCT00760929|100676784|FG001|NOT COMPLETED|Overall Study||28||
48144691|NCT00760929|100676785|FG002|NOT COMPLETED|Overall Study||58||
48144692|NCT00760929|100676786|FG003|NOT COMPLETED|Overall Study||55||
48144693|NCT01773070|100676787|FG000|STARTED|Overall Study||478||
48144694|NCT01773070|100676787|FG000|COMPLETED|Overall Study||397||
48144695|NCT01773070|100676787|FG000|NOT COMPLETED|Overall Study||81||
48144696|NCT00127101|100676788|FG000|STARTED|Base Protocol||3||
48144697|NCT00127101|100676789|FG001|STARTED|Base Protocol||5||
48144698|NCT00127101|100676790|FG002|STARTED|Base Protocol||3||
48144699|NCT00127101|100676791|FG003|STARTED|Base Protocol||3||
48144700|NCT00127101|100676792|FG004|STARTED|Base Protocol||5||
48144701|NCT00127101|100676793|FG005|STARTED|Base Protocol||4||
48144702|NCT00127101|100676788|FG000|COMPLETED|Base Protocol||1||
48144703|NCT00127101|100676789|FG001|COMPLETED|Base Protocol||1||
48144704|NCT00127101|100676790|FG002|COMPLETED|Base Protocol||1||
48144705|NCT00127101|100676791|FG003|COMPLETED|Base Protocol||3||
48144706|NCT00127101|100676792|FG004|COMPLETED|Base Protocol||3||
48144707|NCT00127101|100676793|FG005|COMPLETED|Base Protocol||3||
48144708|NCT00127101|100676788|FG000|NOT COMPLETED|Base Protocol||2||
48144709|NCT00127101|100676789|FG001|NOT COMPLETED|Base Protocol||4||
48144710|NCT00127101|100676790|FG002|NOT COMPLETED|Base Protocol||2||
48144711|NCT00127101|100676791|FG003|NOT COMPLETED|Base Protocol||0||
48144712|NCT00127101|100676792|FG004|NOT COMPLETED|Base Protocol||2||
48144713|NCT00127101|100676793|FG005|NOT COMPLETED|Base Protocol||1||
48144714|NCT00127101|100676788|FG000|STARTED|Continuation Phase||0||
48144715|NCT00127101|100676789|FG001|STARTED|Continuation Phase||0||
48144716|NCT00127101|100676790|FG002|STARTED|Continuation Phase||1||
48144717|NCT00127101|100676791|FG003|STARTED|Continuation Phase||0||
48144718|NCT00127101|100676792|FG004|STARTED|Continuation Phase||3||
48144719|NCT00127101|100676793|FG005|STARTED|Continuation Phase||3||
48144720|NCT00127101|100676788|FG000|COMPLETED|Continuation Phase||0||
48144721|NCT00127101|100676789|FG001|COMPLETED|Continuation Phase||0||
48713560|NCT00520013|102084982|FG002|Treated|Overall Study||11||
48713561|NCT00520013|102084980|FG000|COMPLETED|Overall Study||11||
48713562|NCT00520013|102084981|FG001|COMPLETED|Overall Study||10||
48713563|NCT00520013|102084982|FG002|COMPLETED|Overall Study||0||
48713564|NCT00520013|102084980|FG000|NOT COMPLETED|Overall Study||12||
48713565|NCT00520013|102084981|FG001|NOT COMPLETED|Overall Study||15||
48713566|NCT00520013|102084982|FG002|NOT COMPLETED|Overall Study||11||
48713567|NCT02741570|102084983|FG000|STARTED|Pre-Treatment Period||472||
48713568|NCT02741570|102084984|FG001|STARTED|Pre-Treatment Period||475||
48713569|NCT02741570|102084983|FG000|COMPLETED|Pre-Treatment Period||468|Continuing into treatment period|
48713570|NCT02741570|102084984|FG001|COMPLETED|Pre-Treatment Period||441|Continuing into treatment period|
48713571|NCT02741570|102084983|FG000|NOT COMPLETED|Pre-Treatment Period||4||
48713572|NCT02741570|102084984|FG001|NOT COMPLETED|Pre-Treatment Period||34||
48713573|NCT02741570|102084983|FG000|STARTED|Treatment Period||468||
48713574|NCT02741570|102084984|FG001|STARTED|Treatment Period||441||
48713575|NCT02741570|102084983|FG000|COMPLETED|Treatment Period||0|Participants continuing in the treatment period|
48713576|NCT02741570|102084984|FG001|COMPLETED|Treatment Period||0|Participants continuing in the treatment period|
48713577|NCT02741570|102084983|FG000|NOT COMPLETED|Treatment Period||468||
48713578|NCT02741570|102084984|FG001|NOT COMPLETED|Treatment Period||441||
48713579|NCT00033540|102084985|FG000|STARTED|Overall Study||57||
48713580|NCT00033540|102084985|FG000|Eligible|Overall Study||54||
48713581|NCT00033540|102084985|FG000|Eligible and Began Protocol Therapy|Overall Study||52||
48713582|NCT00033540|102084985|FG000|COMPLETED|Overall Study||0||
48713583|NCT00033540|102084985|FG000|NOT COMPLETED|Overall Study||57||
48713584|NCT02689076|102084986|FG000|STARTED|Overall Study||268||
48713585|NCT02689076|102084987|FG001|STARTED|Overall Study||337||
48713586|NCT02689076|102084988|FG002|STARTED|Overall Study||191||
48713587|NCT02689076|102084986|FG000|COMPLETED|Overall Study||87||
48713588|NCT02689076|102084987|FG001|COMPLETED|Overall Study||115||
48713589|NCT02689076|102084988|FG002|COMPLETED|Overall Study||191||
48713590|NCT02689076|102084986|FG000|NOT COMPLETED|Overall Study||181||
48713591|NCT02689076|102084987|FG001|NOT COMPLETED|Overall Study||222||
48713592|NCT02689076|102084988|FG002|NOT COMPLETED|Overall Study||0||
48713593|NCT05257148|102084989|FG000|STARTED|Run in||137||
48713594|NCT05257148|102084990|FG001|STARTED|Run in||146||
48713595|NCT05257148|102084989|FG000|COMPLETED|Run in||130||
48713596|NCT05257148|102084990|FG001|COMPLETED|Run in||139||
48713597|NCT05257148|102084989|FG000|NOT COMPLETED|Run in||7||
48713598|NCT05257148|102084990|FG001|NOT COMPLETED|Run in||7||
48713599|NCT05257148|102084989|FG000|STARTED|Assessment||119||
48713600|NCT05257148|102084990|FG001|STARTED|Assessment||127||
48713601|NCT05257148|102084989|FG000|COMPLETED|Assessment||115||
48713602|NCT05257148|102084990|FG001|COMPLETED|Assessment||123||
48713603|NCT05257148|102084989|FG000|NOT COMPLETED|Assessment||4||
48713604|NCT05257148|102084990|FG001|NOT COMPLETED|Assessment||4||
48713605|NCT03356977|102084991|FG000|STARTED|Overall Study||137||
48713606|NCT03356977|102084991|FG000|COMPLETED|Overall Study||132||
48713607|NCT03356977|102084991|FG000|NOT COMPLETED|Overall Study||5||
48713608|NCT02688868|102084992|FG000|STARTED|Overall Study||38||
48713609|NCT02688868|102084992|FG000|COMPLETED|Overall Study||34||
48713610|NCT02688868|102084992|FG000|NOT COMPLETED|Overall Study||4||
48713611|NCT02608450|102084993|FG000|STARTED|Overall Study||353||
48713612|NCT02608450|102084994|FG001|STARTED|Overall Study||355||
48713613|NCT02608450|102084993|FG000|COMPLETED|Overall Study||287||
48713614|NCT02608450|102084994|FG001|COMPLETED|Overall Study||290||
48713615|NCT02608450|102084993|FG000|NOT COMPLETED|Overall Study||66||
48713616|NCT02608450|102084994|FG001|NOT COMPLETED|Overall Study||65||
48713617|NCT02366767|102084995|FG000|STARTED|Overall Study||11||
48713618|NCT02366767|102084996|FG001|STARTED|Overall Study||10||
48713619|NCT02366767|102084995|FG000|COMPLETED|Overall Study||10||
48713620|NCT02366767|102084996|FG001|COMPLETED|Overall Study||10||
48713621|NCT02366767|102084995|FG000|NOT COMPLETED|Overall Study||1||
48713622|NCT02366767|102084996|FG001|NOT COMPLETED|Overall Study||0||
48713623|NCT00353873|102084997|FG000|STARTED|Overall Study||153||
48713624|NCT00353873|102084998|FG001|STARTED|Overall Study||150||
48713625|NCT00353873|102084997|FG000|COMPLETED|Overall Study||147||
48713626|NCT00353873|102084998|FG001|COMPLETED|Overall Study||147||
48713627|NCT00353873|102084997|FG000|NOT COMPLETED|Overall Study||6||
48713628|NCT00353873|102084998|FG001|NOT COMPLETED|Overall Study||3||
48713629|NCT00787137|102084999|FG000|STARTED|Overall Study||6||
48713630|NCT00787137|102085000|FG001|STARTED|Overall Study||6||
48713631|NCT00787137|102085001|FG002|STARTED|Overall Study||5||
48144722|NCT00127101|100676790|FG002|COMPLETED|Continuation Phase||0||
48144723|NCT00127101|100676791|FG003|COMPLETED|Continuation Phase||0||
48144724|NCT00127101|100676792|FG004|COMPLETED|Continuation Phase||0||
48144725|NCT00127101|100676793|FG005|COMPLETED|Continuation Phase||0||
48599192|NCT00659776|101800280|FG002|NOT COMPLETED|Overall Study||0||
48599193|NCT04482036|101800281|FG000|STARTED|Overall Study||5||
48599194|NCT04482036|101800282|FG001|STARTED|Overall Study||5||
48144726|NCT00127101|100676788|FG000|NOT COMPLETED|Continuation Phase||0||
48144727|NCT00127101|100676789|FG001|NOT COMPLETED|Continuation Phase||0||
48144728|NCT00127101|100676790|FG002|NOT COMPLETED|Continuation Phase||1||
48144729|NCT00127101|100676791|FG003|NOT COMPLETED|Continuation Phase||0||
48144730|NCT00127101|100676792|FG004|NOT COMPLETED|Continuation Phase||3||
48144731|NCT00127101|100676793|FG005|NOT COMPLETED|Continuation Phase||3||
48144732|NCT03422250|100676794|FG000|STARTED|Intervention||11||
48144733|NCT03422250|100676795|FG001|STARTED|Intervention||11||
48144734|NCT03422250|100676796|FG002|STARTED|Intervention||12||
48144735|NCT03422250|100676797|FG003|STARTED|Intervention||11||
48144736|NCT03422250|100676794|FG000|COMPLETED|Intervention||10||
48144737|NCT03422250|100676795|FG001|COMPLETED|Intervention||10||
48144738|NCT03422250|100676796|FG002|COMPLETED|Intervention||10||
48144739|NCT03422250|100676797|FG003|COMPLETED|Intervention||10||
48144740|NCT03422250|100676794|FG000|NOT COMPLETED|Intervention||1||
48144741|NCT03422250|100676795|FG001|NOT COMPLETED|Intervention||1||
48144742|NCT03422250|100676796|FG002|NOT COMPLETED|Intervention||2||
48144743|NCT03422250|100676797|FG003|NOT COMPLETED|Intervention||1||
48599195|NCT04482036|101800283|FG002|STARTED|Overall Study||5||
48599196|NCT04482036|101800284|FG003|STARTED|Overall Study||5||
48144744|NCT03422250|100676794|FG000|STARTED|Follow-up||10||
48144745|NCT03422250|100676795|FG001|STARTED|Follow-up||10||
48144746|NCT03422250|100676796|FG002|STARTED|Follow-up||10||
48144747|NCT03422250|100676797|FG003|STARTED|Follow-up||10||
48144748|NCT03422250|100676794|FG000|COMPLETED|Follow-up||10||
48144749|NCT03422250|100676795|FG001|COMPLETED|Follow-up||10||
48144750|NCT03422250|100676796|FG002|COMPLETED|Follow-up||10||
48144751|NCT03422250|100676797|FG003|COMPLETED|Follow-up||8||
48144752|NCT03422250|100676794|FG000|NOT COMPLETED|Follow-up||0||
48144753|NCT03422250|100676795|FG001|NOT COMPLETED|Follow-up||0||
48144754|NCT03422250|100676796|FG002|NOT COMPLETED|Follow-up||0||
48144755|NCT03422250|100676797|FG003|NOT COMPLETED|Follow-up||2||
48144756|NCT02464449|100676798|FG000|STARTED|Overall Study||166||
48144757|NCT02464449|100676799|FG001|STARTED|Overall Study||112||
48599197|NCT04482036|101800281|FG000|COMPLETED|Overall Study||2||
48144758|NCT02464449|100676798|FG000|COMPLETED|Overall Study||151||
48144759|NCT02464449|100676799|FG001|COMPLETED|Overall Study||100||
48297694|NCT03739437|101056995|FG001|STARTED|Overall Study||11||
48144760|NCT02464449|100676798|FG000|NOT COMPLETED|Overall Study||15||
48144761|NCT02464449|100676799|FG001|NOT COMPLETED|Overall Study||12||
48297695|NCT03739437|101056994|FG000|COMPLETED|Overall Study||7||
48297696|NCT03739437|101056995|FG001|COMPLETED|Overall Study||6||
48297697|NCT03739437|101056994|FG000|NOT COMPLETED|Overall Study||2||
48297698|NCT03739437|101056995|FG001|NOT COMPLETED|Overall Study||5||
48297699|NCT00617188|101056996|FG000|STARTED|Overall Study||26||
48297700|NCT00617188|101056996|FG000|COMPLETED|Overall Study||26||
48297701|NCT00617188|101056996|FG000|NOT COMPLETED|Overall Study||0||
48297702|NCT01774110|101056997|FG000|STARTED|Overall Study||12||
48297703|NCT01774110|101056997|FG000|COMPLETED|Overall Study||5||
48297704|NCT01774110|101056997|FG000|NOT COMPLETED|Overall Study||7||
48297705|NCT01000636|101056998|FG000|STARTED|Overall Study||9||
48297706|NCT01000636|101056998|FG000|COMPLETED|Overall Study||7||
48297707|NCT01000636|101056998|FG000|NOT COMPLETED|Overall Study||2||
48297708|NCT01387230|101056999|FG000|STARTED|Overall Study||68||
48297709|NCT01387230|101057000|FG001|STARTED|Overall Study||69||
48297710|NCT01387230|101057001|FG002|STARTED|Overall Study||69||
48297711|NCT01387230|101056999|FG000|COMPLETED|Overall Study||50||
48297712|NCT01387230|101057000|FG001|COMPLETED|Overall Study||62||
48297713|NCT01387230|101057001|FG002|COMPLETED|Overall Study||56||
48297714|NCT01387230|101056999|FG000|NOT COMPLETED|Overall Study||18||
48297715|NCT01387230|101057000|FG001|NOT COMPLETED|Overall Study||7||
48297716|NCT01387230|101057001|FG002|NOT COMPLETED|Overall Study||13||
48297717|NCT03333837|101057002|FG000|STARTED|Overall Study||24|Shows number of dyads who signed consent. Total number of participants is double the number of dyads. e.g., 20 dyads noted here = 40 participants|
48297718|NCT03333837|101057003|FG001|STARTED|Overall Study||25|Shows number of dyads who signed consent. Total number of participants is double the number of dyads. e.g., 20 dyads noted here = 40 participants|
48297719|NCT03333837|101057004|FG002|STARTED|Overall Study||27|Shows number of dyads who signed consent. Total number of participants is double the number of dyads. e.g., 20 dyads noted here = 40 participants|
48297720|NCT03333837|101057005|FG003|STARTED|Overall Study||25|Shows number of dyads who signed consent. Total number of participants is double the number of dyads. e.g., 20 dyads noted here = 40 participants|
48297721|NCT03333837|101057006|FG004|STARTED|Overall Study||3|Shows number of dyads who signed consent. Total number of participants is double the number of dyads. e.g., 20 dyads noted here = 40 participants|
48297722|NCT03333837|101057002|FG000|COMPLETED|Overall Study||22|Shows number of dyads. Total number of participants is double the number of dyads. e.g., 20 dyads noted here = 40 participants|
48367987|NCT00717418|101230088|FG000|COMPLETED|Baseline||180||
48599198|NCT04482036|101800282|FG001|COMPLETED|Overall Study||2||
48599199|NCT04482036|101800283|FG002|COMPLETED|Overall Study||0||
48144762|NCT01692782|100676800|FG000|STARTED|Overall Study||116||
48144763|NCT01692782|100676801|FG001|STARTED|Overall Study||115||
48144764|NCT01692782|100676802|FG002|STARTED|Overall Study||110||
48144765|NCT01692782|100676800|FG000|COMPLETED|Overall Study||96||
48144766|NCT01692782|100676801|FG001|COMPLETED|Overall Study||59||
48144767|NCT01692782|100676802|FG002|COMPLETED|Overall Study||100||
48144768|NCT01692782|100676800|FG000|NOT COMPLETED|Overall Study||20||
48144769|NCT01692782|100676801|FG001|NOT COMPLETED|Overall Study||56||
48144770|NCT01692782|100676802|FG002|NOT COMPLETED|Overall Study||10||
48144771|NCT02261493|100676803|FG000|STARTED|Overall Study||156||
48144772|NCT02261493|100676804|FG001|STARTED|Overall Study||318||
48144773|NCT02261493|100676805|FG002|STARTED|Overall Study||313||
48144774|NCT02261493|100676803|FG000|COMPLETED|Overall Study||126||
48144775|NCT02261493|100676804|FG001|COMPLETED|Overall Study||271||
48144776|NCT02261493|100676805|FG002|COMPLETED|Overall Study||287||
48144777|NCT02261493|100676803|FG000|NOT COMPLETED|Overall Study||30||
48144778|NCT02261493|100676804|FG001|NOT COMPLETED|Overall Study||47||
48144779|NCT02261493|100676805|FG002|NOT COMPLETED|Overall Study||26||
48144780|NCT02519348|100679558|FG000|STARTED|Overall Study||40||
48144781|NCT02519348|100679559|FG001|STARTED|Overall Study||104||
48144782|NCT02519348|100679560|FG002|STARTED|Overall Study||75||
48144783|NCT02519348|100679561|FG003|STARTED|Overall Study||69||
48144784|NCT02519348|100679562|FG004|STARTED|Overall Study||84||
48144785|NCT02519348|100679563|FG005|STARTED|Overall Study||47||
48144786|NCT02519348|100679564|FG006|STARTED|Overall Study||3||
48144787|NCT02519348|100679565|FG007|STARTED|Overall Study||5||
48144788|NCT02519348|100679566|FG008|STARTED|Overall Study||6||
48144789|NCT02519348|100679558|FG000|Treated|Overall Study||40||
48144790|NCT02519348|100679559|FG001|Treated|Overall Study||101||
48144791|NCT02519348|100679560|FG002|Treated|Overall Study||74||
48144792|NCT02519348|100679561|FG003|Treated|Overall Study||69||
48144793|NCT02519348|100679562|FG004|Treated|Overall Study||82||
48144794|NCT02519348|100679563|FG005|Treated|Overall Study||47||
48144795|NCT02519348|100679564|FG006|Treated|Overall Study||3||
48144796|NCT02519348|100679565|FG007|Treated|Overall Study||5||
48144797|NCT02519348|100679566|FG008|Treated|Overall Study||5||
48144798|NCT02519348|100679558|FG000|COMPLETED|Overall Study||0||
48144799|NCT02519348|100679559|FG001|COMPLETED|Overall Study||0||
48144800|NCT02519348|100679560|FG002|COMPLETED|Overall Study||0||
48144801|NCT02519348|100679561|FG003|COMPLETED|Overall Study||0||
48144802|NCT02519348|100679562|FG004|COMPLETED|Overall Study||0||
48144803|NCT02519348|100679563|FG005|COMPLETED|Overall Study||0||
48144804|NCT02519348|100679564|FG006|COMPLETED|Overall Study||0||
48144805|NCT02519348|100679565|FG007|COMPLETED|Overall Study||0||
48144806|NCT02519348|100679566|FG008|COMPLETED|Overall Study||0||
48144807|NCT02519348|100679558|FG000|NOT COMPLETED|Overall Study||40||
48144808|NCT02519348|100679559|FG001|NOT COMPLETED|Overall Study||104||
48144809|NCT02519348|100679560|FG002|NOT COMPLETED|Overall Study||75||
48144810|NCT02519348|100679561|FG003|NOT COMPLETED|Overall Study||69||
48144811|NCT02519348|100679562|FG004|NOT COMPLETED|Overall Study||84||
48144812|NCT02519348|100679563|FG005|NOT COMPLETED|Overall Study||47||
48144813|NCT02519348|100679564|FG006|NOT COMPLETED|Overall Study||3||
48144814|NCT02519348|100679565|FG007|NOT COMPLETED|Overall Study||5||
48144815|NCT02519348|100679566|FG008|NOT COMPLETED|Overall Study||6||
48144816|NCT03750552|100679567|FG000|STARTED|Overall Study||98||
48144817|NCT03750552|100679568|FG001|STARTED|Overall Study||97||
48144818|NCT03750552|100679567|FG000|Safety Analysis Set|Overall Study||96||
48144819|NCT03750552|100679568|FG001|Safety Analysis Set|Overall Study||90||
48144820|NCT03750552|100679567|FG000|Full Analysis Set|Overall Study||94||
48144821|NCT03750552|100679568|FG001|Full Analysis Set|Overall Study||90||
48144822|NCT03750552|100679567|FG000|COMPLETED|Overall Study||90||
48144823|NCT03750552|100679568|FG001|COMPLETED|Overall Study||95||
48144824|NCT03750552|100679567|FG000|NOT COMPLETED|Overall Study||8||
48144825|NCT03750552|100679568|FG001|NOT COMPLETED|Overall Study||2||
48144826|NCT01387139|100679569|FG000|STARTED|Overall Study||99||
48144827|NCT01387139|100679570|FG001|STARTED|Overall Study||84||
48144828|NCT01387139|100679569|FG000|COMPLETED|Overall Study||99||
48144829|NCT01387139|100679570|FG001|COMPLETED|Overall Study||84||
48144830|NCT01387139|100679569|FG000|NOT COMPLETED|Overall Study||0||
48144831|NCT01387139|100679570|FG001|NOT COMPLETED|Overall Study||0||
48144832|NCT00605293|100679571|FG000|STARTED|Overall Study||65||
48144833|NCT00605293|100679572|FG001|STARTED|Overall Study||36||
48144834|NCT00605293|100679571|FG000|COMPLETED|Overall Study||48||
48144835|NCT00605293|100679572|FG001|COMPLETED|Overall Study||31||
48144836|NCT00605293|100679571|FG000|NOT COMPLETED|Overall Study||17||
48144837|NCT00605293|100679572|FG001|NOT COMPLETED|Overall Study||5||
48144838|NCT01483924|100679573|FG000|STARTED|Overall Study||12||
48144839|NCT01483924|100679574|FG001|STARTED|Overall Study||12||
48144840|NCT01483924|100679575|FG002|STARTED|Overall Study||12||
48144841|NCT01483924|100679576|FG003|STARTED|Overall Study||12||
48144842|NCT01483924|100679577|FG004|STARTED|Overall Study||12||
48144843|NCT01483924|100679573|FG000|COMPLETED|Overall Study||10||
48144844|NCT01483924|100679574|FG001|COMPLETED|Overall Study||12||
48144845|NCT01483924|100679575|FG002|COMPLETED|Overall Study||11||
48297723|NCT03333837|101057003|FG001|COMPLETED|Overall Study||22|Shows number of dyads. Total number of participants is double the number of dyads. e.g., 20 dyads noted here = 40 participants|
48297724|NCT03333837|101057004|FG002|COMPLETED|Overall Study||22|Shows number of dyads. Total number of participants is double the number of dyads. e.g., 20 dyads noted here = 40 participants|
48297725|NCT03333837|101057005|FG003|COMPLETED|Overall Study||23|Shows number of dyads. Total number of participants is double the number of dyads. e.g., 20 dyads noted here = 40 participants|
48297726|NCT03333837|101057006|FG004|COMPLETED|Overall Study||0|Shows number of dyads. Total number of participants is double the number of dyads. e.g., 20 dyads noted here = 40 participants|
48297727|NCT03333837|101057002|FG000|NOT COMPLETED|Overall Study||2||
48297728|NCT03333837|101057003|FG001|NOT COMPLETED|Overall Study||3||
48297729|NCT03333837|101057004|FG002|NOT COMPLETED|Overall Study||5||
48297730|NCT03333837|101057005|FG003|NOT COMPLETED|Overall Study||2||
48297731|NCT03333837|101057006|FG004|NOT COMPLETED|Overall Study||3||
48297732|NCT06172881|101057007|FG000|STARTED|Overall Study||10||
48297733|NCT06172881|101057007|FG000|COMPLETED|Overall Study||10||
48297734|NCT06172881|101057007|FG000|NOT COMPLETED|Overall Study||0||
48297735|NCT03040622|101057008|FG000|STARTED|Overall Study||35||
48297736|NCT03040622|101057008|FG000|COMPLETED|Overall Study||32||
48297737|NCT03040622|101057008|FG000|NOT COMPLETED|Overall Study||3||
48297738|NCT01405937|101057009|FG000|STARTED|Overall Study||25||
48297739|NCT01405937|101057010|FG001|STARTED|Overall Study||26||
48297740|NCT01405937|101057009|FG000|COMPLETED|Overall Study||25||
48297741|NCT01405937|101057010|FG001|COMPLETED|Overall Study||26||
48297742|NCT01405937|101057009|FG000|NOT COMPLETED|Overall Study||0||
48297743|NCT01405937|101057010|FG001|NOT COMPLETED|Overall Study||0||
48297744|NCT01272947|101057011|FG000|STARTED|Overall Study||104||
48297745|NCT01272947|101057012|FG001|STARTED|Overall Study||100||
48297746|NCT01272947|101057011|FG000|COMPLETED|Overall Study||102||
48297747|NCT01272947|101057012|FG001|COMPLETED|Overall Study||98||
48297748|NCT01272947|101057011|FG000|NOT COMPLETED|Overall Study||2||
48297749|NCT01272947|101057012|FG001|NOT COMPLETED|Overall Study||2||
48297750|NCT01840605|101057013|FG000|STARTED|Overall Study||151||
48297751|NCT01840605|101057014|FG001|STARTED|Overall Study||152||
48297752|NCT01840605|101057013|FG000|COMPLETED|Overall Study||149||
48297753|NCT01840605|101057014|FG001|COMPLETED|Overall Study||150||
48297754|NCT01840605|101057013|FG000|NOT COMPLETED|Overall Study||2||
48297755|NCT01840605|101057014|FG001|NOT COMPLETED|Overall Study||2||
48297756|NCT01016964|101057015|FG000|STARTED|Overall Study||21||
48297757|NCT01016964|101057016|FG001|STARTED|Overall Study||42||
48297758|NCT01016964|101057015|FG000|COMPLETED|Overall Study||18||
48297759|NCT01016964|101057016|FG001|COMPLETED|Overall Study||39||
48297760|NCT01016964|101057015|FG000|NOT COMPLETED|Overall Study||3||
48297761|NCT01016964|101057016|FG001|NOT COMPLETED|Overall Study||3||
48297762|NCT00286078|101057017|FG000|STARTED|Overall Study||72||
48297763|NCT00286078|101057018|FG001|STARTED|Overall Study||68||
48405118|NCT03954704|101325196|FG001|STARTED|Overall Study||1||
48144846|NCT01483924|100679576|FG003|COMPLETED|Overall Study||8||
48144847|NCT01483924|100679577|FG004|COMPLETED|Overall Study||10||
48144848|NCT01483924|100679573|FG000|NOT COMPLETED|Overall Study||2||
48144849|NCT01483924|100679574|FG001|NOT COMPLETED|Overall Study||0||
48144850|NCT01483924|100679575|FG002|NOT COMPLETED|Overall Study||1||
48144851|NCT01483924|100679576|FG003|NOT COMPLETED|Overall Study||4||
48144852|NCT01483924|100679577|FG004|NOT COMPLETED|Overall Study||2||
48144853|NCT03015402|100679578|FG000|STARTED|First Intervention (10 Weeks)||13||
48144854|NCT03015402|100679579|FG001|STARTED|First Intervention (10 Weeks)||11||
48144855|NCT03015402|100679578|FG000|COMPLETED|First Intervention (10 Weeks)||13||
48144856|NCT03015402|100679579|FG001|COMPLETED|First Intervention (10 Weeks)||9||
48144857|NCT03015402|100679578|FG000|NOT COMPLETED|First Intervention (10 Weeks)||0||
48144858|NCT03015402|100679579|FG001|NOT COMPLETED|First Intervention (10 Weeks)||2||
48144859|NCT03015402|100679578|FG000|STARTED|Washout (2 Weeks)||13||
48144860|NCT03015402|100679579|FG001|STARTED|Washout (2 Weeks)||9||
48144861|NCT03015402|100679578|FG000|COMPLETED|Washout (2 Weeks)||12||
48297764|NCT00286078|101057017|FG000|12 Weeks|Overall Study||63||
48297765|NCT00286078|101057018|FG001|12 Weeks|Overall Study||62||
48599200|NCT04482036|101800284|FG003|COMPLETED|Overall Study||0||
48599201|NCT04482036|101800281|FG000|NOT COMPLETED|Overall Study||3||
48297766|NCT00286078|101057017|FG000|COMPLETED|Overall Study||40||
48599202|NCT04482036|101800282|FG001|NOT COMPLETED|Overall Study||3||
48599203|NCT04482036|101800283|FG002|NOT COMPLETED|Overall Study||5||
48599204|NCT04482036|101800284|FG003|NOT COMPLETED|Overall Study||5||
48599205|NCT01210144|101800285|FG000|STARTED|Overall Study||13||
48599206|NCT01210144|101800286|FG001|STARTED|Overall Study||11||
48599207|NCT01210144|101800285|FG000|COMPLETED|Overall Study||10||
48599208|NCT01210144|101800286|FG001|COMPLETED|Overall Study||11||
48599209|NCT01210144|101800285|FG000|NOT COMPLETED|Overall Study||3||
48599210|NCT01210144|101800286|FG001|NOT COMPLETED|Overall Study||0||
48599211|NCT04150068|101800287|FG000|STARTED|Functional Mono/Oral Lead-in (14 Days)||24||
48599212|NCT04150068|101800288|FG001|STARTED|Functional Mono/Oral Lead-in (14 Days)||12||
48599213|NCT04150068|101800289|FG002|STARTED|Functional Mono/Oral Lead-in (14 Days)||36||
48599214|NCT04150068|101800287|FG000|COMPLETED|Functional Mono/Oral Lead-in (14 Days)||24||
48599215|NCT04150068|101800288|FG001|COMPLETED|Functional Mono/Oral Lead-in (14 Days)||12||
48599216|NCT04150068|101800289|FG002|COMPLETED|Functional Mono/Oral Lead-in (14 Days)||36||
48599217|NCT04150068|101800287|FG000|NOT COMPLETED|Functional Mono/Oral Lead-in (14 Days)||0||
48599218|NCT04150068|101800288|FG001|NOT COMPLETED|Functional Mono/Oral Lead-in (14 Days)||0||
48599219|NCT04150068|101800289|FG002|NOT COMPLETED|Functional Mono/Oral Lead-in (14 Days)||0||
48599220|NCT04150068|101800287|FG000|STARTED|Maintenance Period (Week 26 Analysis)||24|Received Day 1 subcutaneous lenacapavir injection.|
48599221|NCT04150068|101800288|FG001|STARTED|Maintenance Period (Week 26 Analysis)||12|Received Day 1 subcutaneous lenacapavir injection.|
48599222|NCT04150068|101800289|FG002|STARTED|Maintenance Period (Week 26 Analysis)||36|Received Day 1 subcutaneous lenacapavir injection.|
48599223|NCT04150068|101800287|FG000|COMPLETED|Maintenance Period (Week 26 Analysis)||0||
48599224|NCT04150068|101800288|FG001|COMPLETED|Maintenance Period (Week 26 Analysis)||0||
48599225|NCT04150068|101800289|FG002|COMPLETED|Maintenance Period (Week 26 Analysis)||0||
48713632|NCT00787137|102084999|FG000|COMPLETED|Overall Study||6||
48713633|NCT00787137|102085000|FG001|COMPLETED|Overall Study||6||
48713634|NCT00787137|102085001|FG002|COMPLETED|Overall Study||4||
48713635|NCT00787137|102084999|FG000|NOT COMPLETED|Overall Study||0||
48713636|NCT00787137|102085000|FG001|NOT COMPLETED|Overall Study||0||
48713637|NCT00787137|102085001|FG002|NOT COMPLETED|Overall Study||1||
48713638|NCT02078102|102085002|FG000|STARTED|Overall Study||25||
48713639|NCT02078102|102085003|FG001|STARTED|Overall Study||13||
48713640|NCT02078102|102085002|FG000|COMPLETED|Overall Study||23||
48713641|NCT02078102|102085003|FG001|COMPLETED|Overall Study||12||
48713642|NCT02078102|102085002|FG000|NOT COMPLETED|Overall Study||2||
48713643|NCT02078102|102085003|FG001|NOT COMPLETED|Overall Study||1||
48713644|NCT03781791|102085004|FG000|STARTED|Overall Study||93||
48713645|NCT03781791|102085005|FG001|STARTED|Overall Study||57||
48713646|NCT03781791|102085004|FG000|COMPLETED|Overall Study||67||
48713647|NCT03781791|102085005|FG001|COMPLETED|Overall Study||50||
48713648|NCT03781791|102085004|FG000|NOT COMPLETED|Overall Study||26||
48713649|NCT03781791|102085005|FG001|NOT COMPLETED|Overall Study||7||
48713650|NCT01999218|102085006|FG000|STARTED|Overall Study||448||
48713651|NCT01999218|102085007|FG001|STARTED|Overall Study||441||
48713652|NCT01999218|102085008|FG002|STARTED|Overall Study||437||
48713653|NCT01999218|102085006|FG000|Treated|Overall Study||448||
48713654|NCT01999218|102085007|FG001|Treated|Overall Study||440||
48713655|NCT01999218|102085008|FG002|Treated|Overall Study||437||
48713656|NCT01999218|102085006|FG000|Site Issue|Overall Study||445|Treated (excluding 1 trial site)|
48713657|NCT01999218|102085007|FG001|Site Issue|Overall Study||435|Treated (excluding 1 trial site)|
48599226|NCT04150068|101800287|FG000|NOT COMPLETED|Maintenance Period (Week 26 Analysis)||24||
48599227|NCT04150068|101800288|FG001|NOT COMPLETED|Maintenance Period (Week 26 Analysis)||12||
48599228|NCT04150068|101800289|FG002|NOT COMPLETED|Maintenance Period (Week 26 Analysis)||36||
48599229|NCT01285492|101800290|FG000|STARTED|Overall Study||121||
48599230|NCT01285492|101800291|FG001|STARTED|Overall Study||39||
48599231|NCT01285492|101800290|FG000|Safety Set (for Demographics)|Overall Study||119||
48599232|NCT01285492|101800291|FG001|Safety Set (for Demographics)|Overall Study||39||
48713658|NCT01999218|102085008|FG002|Site Issue|Overall Study||435|Treated (excluding 1 trial site)|
48713659|NCT01999218|102085006|FG000|COMPLETED|Overall Study||339||
48713660|NCT01999218|102085007|FG001|COMPLETED|Overall Study||340||
48713661|NCT01999218|102085008|FG002|COMPLETED|Overall Study||327||
48713662|NCT01999218|102085006|FG000|NOT COMPLETED|Overall Study||109||
48713663|NCT01999218|102085007|FG001|NOT COMPLETED|Overall Study||101||
48713664|NCT01999218|102085008|FG002|NOT COMPLETED|Overall Study||110||
48713665|NCT00289198|102085009|FG000|STARTED|Overall Study||151||
48713666|NCT00289198|102085010|FG001|STARTED|Overall Study||151||
48297767|NCT00286078|101057018|FG001|COMPLETED|Overall Study||34||
48297768|NCT00286078|101057017|FG000|NOT COMPLETED|Overall Study||32||
48297769|NCT00286078|101057018|FG001|NOT COMPLETED|Overall Study||34||
48713667|NCT00289198|102085009|FG000|COMPLETED|Overall Study||120||
48713668|NCT00289198|102085010|FG001|COMPLETED|Overall Study||121||
48713669|NCT00289198|102085009|FG000|NOT COMPLETED|Overall Study||31||
48713670|NCT00289198|102085010|FG001|NOT COMPLETED|Overall Study||30||
48599233|NCT01285492|101800290|FG000|COMPLETED|Overall Study||104||
48297770|NCT02198430|101057019|FG000|STARTED|Overall Study||53||
48297771|NCT02198430|101057020|FG001|STARTED|Overall Study||51||
48297772|NCT02198430|101057019|FG000|COMPLETED|Overall Study||53||
48297773|NCT02198430|101057020|FG001|COMPLETED|Overall Study||51||
48297774|NCT02198430|101057019|FG000|NOT COMPLETED|Overall Study||0||
48297775|NCT02198430|101057020|FG001|NOT COMPLETED|Overall Study||0||
48297776|NCT01037881|101057021|FG000|STARTED|Overall Study||25||
48599234|NCT01285492|101800291|FG001|COMPLETED|Overall Study||38||
48599235|NCT01285492|101800290|FG000|NOT COMPLETED|Overall Study||17||
48599236|NCT01285492|101800291|FG001|NOT COMPLETED|Overall Study||1||
48599237|NCT00535392|101800292|FG000|STARTED|Overall Study||33||
48599238|NCT00535392|101800292|FG000|COMPLETED|Overall Study||33||
48599239|NCT00535392|101800292|FG000|NOT COMPLETED|Overall Study||0||
48599240|NCT00494221|101800293|FG000|STARTED|Overall Study||58||
48599241|NCT00494221|101800294|FG001|STARTED|Overall Study||56||
48599242|NCT00494221|101800295|FG002|STARTED|Overall Study||58||
48599243|NCT00494221|101800293|FG000|COMPLETED|Overall Study||42||
48599244|NCT00494221|101800294|FG001|COMPLETED|Overall Study||45||
48599245|NCT00494221|101800295|FG002|COMPLETED|Overall Study||44||
48599246|NCT00494221|101800293|FG000|NOT COMPLETED|Overall Study||16||
48599247|NCT00494221|101800294|FG001|NOT COMPLETED|Overall Study||11||
48599248|NCT00494221|101800295|FG002|NOT COMPLETED|Overall Study||14||
48599249|NCT01366638|101800296|FG000|STARTED|Overall Study||24||
48599250|NCT01366638|101800297|FG001|STARTED|Overall Study||29||
48599251|NCT01366638|101800298|FG002|STARTED|Overall Study||26||
48599252|NCT01366638|101800296|FG000|COMPLETED|Overall Study||23||
48599253|NCT01366638|101800297|FG001|COMPLETED|Overall Study||29||
48599254|NCT01366638|101800298|FG002|COMPLETED|Overall Study||20||
48599255|NCT01366638|101800296|FG000|NOT COMPLETED|Overall Study||1||
48599256|NCT01366638|101800297|FG001|NOT COMPLETED|Overall Study||0||
48599257|NCT01366638|101800298|FG002|NOT COMPLETED|Overall Study||6||
48599258|NCT00889187|101800299|FG000|STARTED|Overall Study||3||
48599259|NCT00889187|101800300|FG001|STARTED|Overall Study||3||
48599260|NCT00889187|101800301|FG002|STARTED|Overall Study||4||
48599261|NCT00889187|101800302|FG003|STARTED|Overall Study||0||
48599262|NCT00889187|101800299|FG000|COMPLETED|Overall Study||3||
48599263|NCT00889187|101800300|FG001|COMPLETED|Overall Study||3||
48599264|NCT00889187|101800301|FG002|COMPLETED|Overall Study||4||
48599265|NCT00889187|101800302|FG003|COMPLETED|Overall Study||0||
48599266|NCT00889187|101800299|FG000|NOT COMPLETED|Overall Study||0||
48599267|NCT00889187|101800300|FG001|NOT COMPLETED|Overall Study||0||
48599268|NCT00889187|101800301|FG002|NOT COMPLETED|Overall Study||0||
48599269|NCT00889187|101800302|FG003|NOT COMPLETED|Overall Study||0||
48599270|NCT03611582|101800303|FG000|STARTED|Overall Study||407||
48599271|NCT03611582|101800304|FG001|STARTED|Overall Study||204||
48599272|NCT03611582|101800303|FG000|Full Analysis Set (FAS)|Overall Study||407||
48599273|NCT03611582|101800304|FG001|Full Analysis Set (FAS)|Overall Study||204||
48599274|NCT03611582|101800303|FG000|Safety Analysis Set (SAS)|Overall Study||407||
48599275|NCT03611582|101800304|FG001|Safety Analysis Set (SAS)|Overall Study||204||
48599276|NCT03611582|101800303|FG000|COMPLETED|Overall Study||339||
48599277|NCT03611582|101800304|FG001|COMPLETED|Overall Study||166||
48599278|NCT03611582|101800303|FG000|NOT COMPLETED|Overall Study||68||
48599279|NCT03611582|101800304|FG001|NOT COMPLETED|Overall Study||38||
48599280|NCT01001806|101800305|FG000|STARTED|Overall Study||42||
48599281|NCT01001806|101800306|FG001|STARTED|Overall Study||42||
48599282|NCT01001806|101800307|FG002|STARTED|Overall Study||42||
48599283|NCT01001806|101800305|FG000|COMPLETED|Overall Study||42||
48599284|NCT01001806|101800306|FG001|COMPLETED|Overall Study||41||
48599285|NCT01001806|101800307|FG002|COMPLETED|Overall Study||38||
48599286|NCT01001806|101800305|FG000|NOT COMPLETED|Overall Study||0||
48599287|NCT01001806|101800306|FG001|NOT COMPLETED|Overall Study||1||
48599288|NCT01001806|101800307|FG002|NOT COMPLETED|Overall Study||4||
48599289|NCT03877224|101800308|FG000|STARTED|Overall Study||253||
48599290|NCT03877224|101800309|FG001|STARTED|Overall Study||251||
48599291|NCT03877224|101800308|FG000|Treated|Overall Study||252||
48599292|NCT03877224|101800309|FG001|Treated|Overall Study||249||
48599293|NCT03877224|101800308|FG000|COMPLETED|Overall Study||248||
48599294|NCT03877224|101800309|FG001|COMPLETED|Overall Study||243||
48599295|NCT03877224|101800308|FG000|NOT COMPLETED|Overall Study||5||
48599296|NCT03877224|101800309|FG001|NOT COMPLETED|Overall Study||8||
48599297|NCT04060199|101800310|FG000|STARTED|Overall Study||38||
48297777|NCT01037881|101057022|FG001|STARTED|Overall Study||24||
48297778|NCT01037881|101057023|FG002|STARTED|Overall Study||25||
48297779|NCT01037881|101057024|FG003|STARTED|Overall Study||25||
48297780|NCT01037881|101057025|FG004|STARTED|Overall Study||29||
48297781|NCT01037881|101057026|FG005|STARTED|Overall Study||30||
48297782|NCT01037881|101057027|FG006|STARTED|Overall Study||25||
48297783|NCT01037881|101057021|FG000|COMPLETED|Overall Study||19||
48599298|NCT04060199|101800311|FG001|STARTED|Overall Study||39||
48599299|NCT04060199|101800310|FG000|COMPLETED|Overall Study||36||
48599300|NCT04060199|101800311|FG001|COMPLETED|Overall Study||38||
48599301|NCT04060199|101800310|FG000|NOT COMPLETED|Overall Study||2||
48599302|NCT04060199|101800311|FG001|NOT COMPLETED|Overall Study||1||
48297784|NCT01037881|101057022|FG001|COMPLETED|Overall Study||22||
48599303|NCT02669914|101800312|FG000|STARTED|Overall Study||4||
48599304|NCT02669914|101800313|FG001|STARTED|Overall Study||0||
48599305|NCT02669914|101800314|FG002|STARTED|Overall Study||0||
48599306|NCT02669914|101800312|FG000|COMPLETED|Overall Study||4||
48599307|NCT02669914|101800313|FG001|COMPLETED|Overall Study||0||
48599308|NCT02669914|101800314|FG002|COMPLETED|Overall Study||0||
48599309|NCT02669914|101800312|FG000|NOT COMPLETED|Overall Study||0||
48297785|NCT01037881|101057023|FG002|COMPLETED|Overall Study||22||
48297786|NCT01037881|101057024|FG003|COMPLETED|Overall Study||24||
48297787|NCT01037881|101057025|FG004|COMPLETED|Overall Study||26||
48297788|NCT01037881|101057026|FG005|COMPLETED|Overall Study||27||
48297789|NCT01037881|101057027|FG006|COMPLETED|Overall Study||23||
48297790|NCT01037881|101057021|FG000|NOT COMPLETED|Overall Study||6||
48297791|NCT01037881|101057022|FG001|NOT COMPLETED|Overall Study||2||
48297792|NCT01037881|101057023|FG002|NOT COMPLETED|Overall Study||3||
48297793|NCT01037881|101057024|FG003|NOT COMPLETED|Overall Study||1||
48297794|NCT01037881|101057025|FG004|NOT COMPLETED|Overall Study||3||
48297795|NCT01037881|101057026|FG005|NOT COMPLETED|Overall Study||3||
48297796|NCT01037881|101057027|FG006|NOT COMPLETED|Overall Study||2||
48297797|NCT00769860|101057028|FG000|STARTED|Overall Study||16||
48297798|NCT00769860|101057029|FG001|STARTED|Overall Study||8||
48297799|NCT00769860|101057028|FG000|Month 4|Overall Study||16||
48297800|NCT00769860|101057029|FG001|Month 4|Overall Study||8||
48297801|NCT00769860|101057028|FG000|Month 8|Overall Study||14||
48297802|NCT00769860|101057029|FG001|Month 8|Overall Study||8||
48297803|NCT00769860|101057028|FG000|COMPLETED|Overall Study||14||
48297804|NCT00769860|101057029|FG001|COMPLETED|Overall Study||8||
48297805|NCT00769860|101057028|FG000|NOT COMPLETED|Overall Study||2||
48297806|NCT00769860|101057029|FG001|NOT COMPLETED|Overall Study||0||
48297807|NCT02742766|101057030|FG000|STARTED|Part 1 (Up to 8 Days)||20||
48297808|NCT02742766|101057031|FG001|STARTED|Part 1 (Up to 8 Days)||6||
48297809|NCT02742766|101057032|FG002|STARTED|Part 1 (Up to 8 Days)||6||
48297810|NCT02742766|101057033|FG003|STARTED|Part 1 (Up to 8 Days)||6||
48297811|NCT02742766|101057034|FG004|STARTED|Part 1 (Up to 8 Days)||6||
48297812|NCT02742766|101057035|FG005|STARTED|Part 1 (Up to 8 Days)||6||
48297813|NCT02742766|101057036|FG006|STARTED|Part 1 (Up to 8 Days)||6||
48297814|NCT02742766|101057037|FG007|STARTED|Part 1 (Up to 8 Days)||6||
48297815|NCT02742766|101057038|FG008|STARTED|Part 1 (Up to 8 Days)||6||
48297816|NCT02742766|101057039|FG009|STARTED|Part 1 (Up to 8 Days)||0||
48297817|NCT02742766|101057040|FG010|STARTED|Part 1 (Up to 8 Days)||6||
48297818|NCT02742766|101057041|FG011|STARTED|Part 1 (Up to 8 Days)||6||
48297819|NCT02742766|101057042|FG012|STARTED|Part 1 (Up to 8 Days)||0||
48297820|NCT02742766|101057043|FG013|STARTED|Part 1 (Up to 8 Days)||0||
48297821|NCT02742766|101057044|FG014|STARTED|Part 1 (Up to 8 Days)||0||
48297822|NCT02742766|101057045|FG015|STARTED|Part 1 (Up to 8 Days)||0||
48297823|NCT02742766|101057046|FG016|STARTED|Part 1 (Up to 8 Days)||0||
48297824|NCT02742766|101057047|FG017|STARTED|Part 1 (Up to 8 Days)||0||
48297825|NCT02742766|101057048|FG018|STARTED|Part 1 (Up to 8 Days)||0||
48297826|NCT02742766|101057030|FG000|COMPLETED|Part 1 (Up to 8 Days)||20||
48297827|NCT02742766|101057031|FG001|COMPLETED|Part 1 (Up to 8 Days)||6||
48297828|NCT02742766|101057032|FG002|COMPLETED|Part 1 (Up to 8 Days)||6||
48297829|NCT02742766|101057033|FG003|COMPLETED|Part 1 (Up to 8 Days)||6||
48297830|NCT02742766|101057034|FG004|COMPLETED|Part 1 (Up to 8 Days)||6||
48297831|NCT02742766|101057035|FG005|COMPLETED|Part 1 (Up to 8 Days)||6||
48297832|NCT02742766|101057036|FG006|COMPLETED|Part 1 (Up to 8 Days)||6||
48599310|NCT02669914|101800313|FG001|NOT COMPLETED|Overall Study||0||
48599311|NCT02669914|101800314|FG002|NOT COMPLETED|Overall Study||0||
48599312|NCT02798354|101800315|FG000|STARTED|First Intervention Period||1184|Clinic attrition occurred after enrollment due to data collection burden|14
48599313|NCT02798354|101800316|FG001|STARTED|First Intervention Period||2176|Clinic attrition occurred after enrollment due to data collection burden|16
48599314|NCT02798354|101800317|FG002|STARTED|First Intervention Period||990|Clinic attrition occurred after enrollment due to data collection burden|13
48599315|NCT02798354|101800315|FG000|Control Data Error 1|First Intervention Period||440||11
48599316|NCT02798354|101800316|FG001|Control Data Error 1|First Intervention Period||549||10
48599317|NCT02798354|101800317|FG002|Control Data Error 1|First Intervention Period||345||10
48599318|NCT02798354|101800315|FG000|Intervention Data Error 1|First Intervention Period||744||11
48599319|NCT02798354|101800316|FG001|Intervention Data Error 1|First Intervention Period||1627||10
48297833|NCT02742766|101057037|FG007|COMPLETED|Part 1 (Up to 8 Days)||6||
48297834|NCT02742766|101057038|FG008|COMPLETED|Part 1 (Up to 8 Days)||6||
48297835|NCT02742766|101057039|FG009|COMPLETED|Part 1 (Up to 8 Days)||0||
48297836|NCT02742766|101057040|FG010|COMPLETED|Part 1 (Up to 8 Days)||6||
48297837|NCT02742766|101057041|FG011|COMPLETED|Part 1 (Up to 8 Days)||6||
48297838|NCT02742766|101057042|FG012|COMPLETED|Part 1 (Up to 8 Days)||0||
48297839|NCT02742766|101057043|FG013|COMPLETED|Part 1 (Up to 8 Days)||0||
48297840|NCT02742766|101057044|FG014|COMPLETED|Part 1 (Up to 8 Days)||0||
48297841|NCT02742766|101057045|FG015|COMPLETED|Part 1 (Up to 8 Days)||0||
48297842|NCT02742766|101057046|FG016|COMPLETED|Part 1 (Up to 8 Days)||0||
48297843|NCT02742766|101057047|FG017|COMPLETED|Part 1 (Up to 8 Days)||0||
48297844|NCT02742766|101057048|FG018|COMPLETED|Part 1 (Up to 8 Days)||0||
48297845|NCT02742766|101057030|FG000|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
48297846|NCT02742766|101057031|FG001|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
48297847|NCT02742766|101057032|FG002|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
48297848|NCT02742766|101057033|FG003|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
48297849|NCT02742766|101057034|FG004|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
48297850|NCT02742766|101057035|FG005|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
48297851|NCT02742766|101057036|FG006|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
48297852|NCT02742766|101057037|FG007|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
48297853|NCT02742766|101057038|FG008|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
48297854|NCT02742766|101057039|FG009|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
48297855|NCT02742766|101057040|FG010|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
48297856|NCT02742766|101057041|FG011|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
48297857|NCT02742766|101057042|FG012|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
48297858|NCT02742766|101057043|FG013|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
48297859|NCT02742766|101057044|FG014|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
48297860|NCT02742766|101057045|FG015|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
48297861|NCT02742766|101057046|FG016|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
48297862|NCT02742766|101057047|FG017|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
48297863|NCT02742766|101057048|FG018|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
48297864|NCT02742766|101057030|FG000|STARTED|Part 2 (Up to 22 Days)||0||
48297865|NCT02742766|101057031|FG001|STARTED|Part 2 (Up to 22 Days)||0||
48297866|NCT02742766|101057032|FG002|STARTED|Part 2 (Up to 22 Days)||0||
48297867|NCT02742766|101057033|FG003|STARTED|Part 2 (Up to 22 Days)||0||
48297868|NCT02742766|101057034|FG004|STARTED|Part 2 (Up to 22 Days)||0||
48297869|NCT02742766|101057035|FG005|STARTED|Part 2 (Up to 22 Days)||0||
48297870|NCT02742766|101057036|FG006|STARTED|Part 2 (Up to 22 Days)||0||
48297871|NCT02742766|101057037|FG007|STARTED|Part 2 (Up to 22 Days)||0||
48297872|NCT02742766|101057038|FG008|STARTED|Part 2 (Up to 22 Days)||0||
48297873|NCT02742766|101057039|FG009|STARTED|Part 2 (Up to 22 Days)||0||
48297874|NCT02742766|101057040|FG010|STARTED|Part 2 (Up to 22 Days)||0||
48297875|NCT02742766|101057041|FG011|STARTED|Part 2 (Up to 22 Days)||0||
48297876|NCT02742766|101057042|FG012|STARTED|Part 2 (Up to 22 Days)||6||
48297877|NCT02742766|101057043|FG013|STARTED|Part 2 (Up to 22 Days)||6||
48297878|NCT02742766|101057044|FG014|STARTED|Part 2 (Up to 22 Days)||6||
48297879|NCT02742766|101057045|FG015|STARTED|Part 2 (Up to 22 Days)||6||
48297880|NCT02742766|101057046|FG016|STARTED|Part 2 (Up to 22 Days)||0||
48297881|NCT02742766|101057047|FG017|STARTED|Part 2 (Up to 22 Days)||0||
48297882|NCT02742766|101057048|FG018|STARTED|Part 2 (Up to 22 Days)||0||
48297883|NCT02742766|101057030|FG000|COMPLETED|Part 2 (Up to 22 Days)||0||
48297884|NCT02742766|101057031|FG001|COMPLETED|Part 2 (Up to 22 Days)||0||
48297885|NCT02742766|101057032|FG002|COMPLETED|Part 2 (Up to 22 Days)||0||
48297886|NCT02742766|101057033|FG003|COMPLETED|Part 2 (Up to 22 Days)||0||
48297887|NCT02742766|101057034|FG004|COMPLETED|Part 2 (Up to 22 Days)||0||
48297888|NCT02742766|101057035|FG005|COMPLETED|Part 2 (Up to 22 Days)||0||
48297889|NCT02742766|101057036|FG006|COMPLETED|Part 2 (Up to 22 Days)||0||
48297890|NCT02742766|101057037|FG007|COMPLETED|Part 2 (Up to 22 Days)||0||
48297891|NCT02742766|101057038|FG008|COMPLETED|Part 2 (Up to 22 Days)||0||
48297892|NCT02742766|101057039|FG009|COMPLETED|Part 2 (Up to 22 Days)||0||
48297893|NCT02742766|101057040|FG010|COMPLETED|Part 2 (Up to 22 Days)||0||
48297894|NCT02742766|101057041|FG011|COMPLETED|Part 2 (Up to 22 Days)||0||
48297895|NCT02742766|101057042|FG012|COMPLETED|Part 2 (Up to 22 Days)||4||
48297896|NCT02742766|101057043|FG013|COMPLETED|Part 2 (Up to 22 Days)||0||
48297897|NCT02742766|101057044|FG014|COMPLETED|Part 2 (Up to 22 Days)||6||
48297898|NCT02742766|101057045|FG015|COMPLETED|Part 2 (Up to 22 Days)||5||
48297899|NCT02742766|101057046|FG016|COMPLETED|Part 2 (Up to 22 Days)||0||
48297900|NCT02742766|101057047|FG017|COMPLETED|Part 2 (Up to 22 Days)||0||
48297901|NCT02742766|101057048|FG018|COMPLETED|Part 2 (Up to 22 Days)||0||
48297902|NCT02742766|101057030|FG000|NOT COMPLETED|Part 2 (Up to 22 Days)||0||
48297903|NCT02742766|101057031|FG001|NOT COMPLETED|Part 2 (Up to 22 Days)||0||
48297904|NCT02742766|101057032|FG002|NOT COMPLETED|Part 2 (Up to 22 Days)||0||
48297905|NCT02742766|101057033|FG003|NOT COMPLETED|Part 2 (Up to 22 Days)||0||
48297906|NCT02742766|101057034|FG004|NOT COMPLETED|Part 2 (Up to 22 Days)||0||
48297907|NCT02742766|101057035|FG005|NOT COMPLETED|Part 2 (Up to 22 Days)||0||
48297908|NCT02742766|101057036|FG006|NOT COMPLETED|Part 2 (Up to 22 Days)||0||
48297909|NCT02742766|101057037|FG007|NOT COMPLETED|Part 2 (Up to 22 Days)||0||
48297910|NCT02742766|101057038|FG008|NOT COMPLETED|Part 2 (Up to 22 Days)||0||
48297911|NCT02742766|101057039|FG009|NOT COMPLETED|Part 2 (Up to 22 Days)||0||
48297912|NCT02742766|101057040|FG010|NOT COMPLETED|Part 2 (Up to 22 Days)||0||
48297913|NCT02742766|101057041|FG011|NOT COMPLETED|Part 2 (Up to 22 Days)||0||
48297914|NCT02742766|101057042|FG012|NOT COMPLETED|Part 2 (Up to 22 Days)||2||
48297915|NCT02742766|101057043|FG013|NOT COMPLETED|Part 2 (Up to 22 Days)||6||
48297916|NCT02742766|101057044|FG014|NOT COMPLETED|Part 2 (Up to 22 Days)||0||
48297917|NCT02742766|101057045|FG015|NOT COMPLETED|Part 2 (Up to 22 Days)||1||
48297918|NCT02742766|101057046|FG016|NOT COMPLETED|Part 2 (Up to 22 Days)||0||
48297919|NCT02742766|101057047|FG017|NOT COMPLETED|Part 2 (Up to 22 Days)||0||
48297920|NCT02742766|101057048|FG018|NOT COMPLETED|Part 2 (Up to 22 Days)||0||
48297921|NCT02742766|101057030|FG000|STARTED|Part 3 (Up to 36 Days)||0||
48297922|NCT02742766|101057031|FG001|STARTED|Part 3 (Up to 36 Days)||0||
48297923|NCT02742766|101057032|FG002|STARTED|Part 3 (Up to 36 Days)||0||
48297924|NCT02742766|101057033|FG003|STARTED|Part 3 (Up to 36 Days)||0||
48297925|NCT02742766|101057034|FG004|STARTED|Part 3 (Up to 36 Days)||0||
48144862|NCT03015402|100679579|FG001|COMPLETED|Washout (2 Weeks)||9||
48144863|NCT03015402|100679578|FG000|NOT COMPLETED|Washout (2 Weeks)||1||
48144864|NCT03015402|100679579|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
48144865|NCT03015402|100679578|FG000|STARTED|Second Intervention (10 Weeks)||12||
48144866|NCT03015402|100679579|FG001|STARTED|Second Intervention (10 Weeks)||9||
48144867|NCT03015402|100679578|FG000|COMPLETED|Second Intervention (10 Weeks)||12||
48144868|NCT03015402|100679579|FG001|COMPLETED|Second Intervention (10 Weeks)||9||
48144869|NCT03015402|100679578|FG000|NOT COMPLETED|Second Intervention (10 Weeks)||0||
48144870|NCT03015402|100679579|FG001|NOT COMPLETED|Second Intervention (10 Weeks)||0||
48144871|NCT00262821|100679580|FG000|STARTED|Overall Study||198||
48144872|NCT00262821|100679581|FG001|STARTED|Overall Study||204||
48144873|NCT00262821|100679580|FG000|COMPLETED|Overall Study||194||
48144874|NCT00262821|100679581|FG001|COMPLETED|Overall Study||185||
48144875|NCT00262821|100679580|FG000|NOT COMPLETED|Overall Study||4||
48144876|NCT00262821|100679581|FG001|NOT COMPLETED|Overall Study||19||
48144877|NCT01625221|100679582|FG000|STARTED|Overall Study||35||
48144878|NCT01625221|100679582|FG000|COMPLETED|Overall Study||28||
48144879|NCT01625221|100679582|FG000|NOT COMPLETED|Overall Study||7||
48144880|NCT04648150|100679583|FG000|STARTED|Overall Study||30||
48144881|NCT04648150|100679584|FG001|STARTED|Overall Study||30||
48144882|NCT04648150|100679583|FG000|COMPLETED|Overall Study||30||
48144883|NCT04648150|100679584|FG001|COMPLETED|Overall Study||30||
48144884|NCT04648150|100679583|FG000|NOT COMPLETED|Overall Study||0||
48144885|NCT04648150|100679584|FG001|NOT COMPLETED|Overall Study||0||
48144886|NCT02332590|100679585|FG000|STARTED|DB Period (up to 24 Weeks)||185||
48144887|NCT02332590|100679586|FG001|STARTED|DB Period (up to 24 Weeks)||184||
48144888|NCT02332590|100679585|FG000|Treated|DB Period (up to 24 Weeks)||184||
48144889|NCT02332590|100679586|FG001|Treated|DB Period (up to 24 Weeks)||184||
48144890|NCT02332590|100679585|FG000|COMPLETED|DB Period (up to 24 Weeks)||156||
48144891|NCT02332590|100679586|FG001|COMPLETED|DB Period (up to 24 Weeks)||165||
48144892|NCT02332590|100679585|FG000|NOT COMPLETED|DB Period (up to 24 Weeks)||29||
48144893|NCT02332590|100679586|FG001|NOT COMPLETED|DB Period (up to 24 Weeks)||19||
48144894|NCT02332590|100679585|FG000|STARTED|OLE Period (Week 24 up to Week 300)||155||
48144895|NCT02332590|100679586|FG001|STARTED|OLE Period (Week 24 up to Week 300)||165||
48144896|NCT02332590|100679585|FG000|COMPLETED|OLE Period (Week 24 up to Week 300)||108||
48144897|NCT02332590|100679586|FG001|COMPLETED|OLE Period (Week 24 up to Week 300)||120||
48144898|NCT02332590|100679585|FG000|NOT COMPLETED|OLE Period (Week 24 up to Week 300)||47||
48144899|NCT02332590|100679586|FG001|NOT COMPLETED|OLE Period (Week 24 up to Week 300)||45||
48144900|NCT01618162|100679587|FG000|STARTED|Overall Study||289||
48144901|NCT01618162|100679588|FG001|STARTED|Overall Study||146||
48144902|NCT01618162|100679587|FG000|Exposed|Overall Study||288||
48144903|NCT01618162|100679588|FG001|Exposed|Overall Study||146||
48144904|NCT01618162|100679587|FG000|COMPLETED|Overall Study||251||
48144905|NCT01618162|100679588|FG001|COMPLETED|Overall Study||111||
48144906|NCT01618162|100679587|FG000|NOT COMPLETED|Overall Study||38||
48144907|NCT01618162|100679588|FG001|NOT COMPLETED|Overall Study||35||
48144908|NCT03265600|100679589|FG000|STARTED|Overall Study||92||
48144909|NCT03265600|100679590|FG001|STARTED|Overall Study||44||
48144910|NCT03265600|100679589|FG000|COMPLETED|Overall Study||68||
48144911|NCT03265600|100679590|FG001|COMPLETED|Overall Study||32||
48144912|NCT03265600|100679589|FG000|NOT COMPLETED|Overall Study||24||
48144913|NCT03265600|100679590|FG001|NOT COMPLETED|Overall Study||12||
48144914|NCT00381940|100679591|FG000|STARTED|Overall Study||26||
48144915|NCT00381940|100679591|FG000|COMPLETED|Overall Study||21||
48144916|NCT00381940|100679591|FG000|NOT COMPLETED|Overall Study||5||
48144917|NCT00162370|100679592|FG000|STARTED|Completed Echocardiography Imaging||366||
48144918|NCT00162370|100679592|FG000|COMPLETED|Completed Echocardiography Imaging||366||
48144919|NCT00162370|100679592|FG000|NOT COMPLETED|Completed Echocardiography Imaging||0||
48144920|NCT00162370|100679592|FG000|STARTED|Efficacy Population||366||
48144921|NCT00162370|100679592|FG000|COMPLETED|Efficacy Population||315||
48144922|NCT00162370|100679592|FG000|NOT COMPLETED|Efficacy Population||51||
48144923|NCT02621931|100679593|FG000|STARTED|Overall Study||375||
48144924|NCT02621931|100679594|FG001|STARTED|Overall Study||376||
48144925|NCT02621931|100679595|FG002|STARTED|Overall Study||379||
48144926|NCT02621931|100679593|FG000|Safety and ITT Populations|Overall Study||375||
48144927|NCT02621931|100679594|FG001|Safety and ITT Populations|Overall Study||376||
48144928|NCT02621931|100679595|FG002|Safety and ITT Populations|Overall Study||379||
48144929|NCT02621931|100679593|FG000|Full Analysis Set|Overall Study||371||
48144930|NCT02621931|100679594|FG001|Full Analysis Set|Overall Study||375||
48144931|NCT02621931|100679595|FG002|Full Analysis Set|Overall Study||375||
48144932|NCT02621931|100679593|FG000|COMPLETED|Overall Study||342||
48144933|NCT02621931|100679594|FG001|COMPLETED|Overall Study||349||
48144934|NCT02621931|100679595|FG002|COMPLETED|Overall Study||343||
48144935|NCT02621931|100679593|FG000|NOT COMPLETED|Overall Study||33||
48144936|NCT02621931|100679594|FG001|NOT COMPLETED|Overall Study||27||
48144937|NCT02621931|100679595|FG002|NOT COMPLETED|Overall Study||36||
48144938|NCT01967732|100679596|FG000|STARTED|Washout Period of 1 Day (Day 0)||22||
48144939|NCT01967732|100679597|FG001|STARTED|Washout Period of 1 Day (Day 0)||22||
48713671|NCT01605942|102085011|FG000|STARTED|Overall Study||6||
48713672|NCT01605942|102085012|FG001|STARTED|Overall Study||2||
48713673|NCT01605942|102085011|FG000|COMPLETED|Overall Study||6||
48713674|NCT01605942|102085012|FG001|COMPLETED|Overall Study||2||
48144940|NCT01967732|100679598|FG002|STARTED|Washout Period of 1 Day (Day 0)||9||
48713675|NCT01605942|102085011|FG000|NOT COMPLETED|Overall Study||0||
48713676|NCT01605942|102085012|FG001|NOT COMPLETED|Overall Study||0||
48713677|NCT00526110|102085013|FG000|STARTED|Overall Study||53||
48713678|NCT00526110|102085014|FG001|STARTED|Overall Study||45||
48713679|NCT00526110|102085013|FG000|COMPLETED|Overall Study||51||
48713680|NCT00526110|102085014|FG001|COMPLETED|Overall Study||4||
48713681|NCT00526110|102085013|FG000|NOT COMPLETED|Overall Study||2||
48713682|NCT00526110|102085014|FG001|NOT COMPLETED|Overall Study||41||
48713683|NCT01816906|102085015|FG000|STARTED|Six Months||41||
48713684|NCT01816906|102085016|FG001|STARTED|Six Months||41||
48713685|NCT01816906|102085015|FG000|COMPLETED|Six Months||20||
48713686|NCT01816906|102085016|FG001|COMPLETED|Six Months||19||
48713687|NCT01816906|102085015|FG000|NOT COMPLETED|Six Months||21||
48713688|NCT01816906|102085016|FG001|NOT COMPLETED|Six Months||22||
48713689|NCT01816906|102085015|FG000|STARTED|12 Months||20||
48713690|NCT01816906|102085016|FG001|STARTED|12 Months||19||
48713691|NCT01816906|102085015|FG000|COMPLETED|12 Months||16||
48713692|NCT01816906|102085016|FG001|COMPLETED|12 Months||14||
48713693|NCT01816906|102085015|FG000|NOT COMPLETED|12 Months||4||
48713694|NCT01816906|102085016|FG001|NOT COMPLETED|12 Months||5||
48713695|NCT00700102|102085017|FG000|STARTED|Overall Study||411||
48713696|NCT00700102|102085018|FG001|STARTED|Overall Study||409||
48713697|NCT00700102|102085017|FG000|Intention to Treat|Overall Study||410||
48713698|NCT00700102|102085018|FG001|Intention to Treat|Overall Study||409||
48713699|NCT00700102|102085017|FG000|Received at Least One Dose|Overall Study||407||
48713700|NCT00700102|102085018|FG001|Received at Least One Dose|Overall Study||403||
48713701|NCT00700102|102085017|FG000|COMPLETED|Overall Study||9||
48713702|NCT00700102|102085018|FG001|COMPLETED|Overall Study||14||
48713703|NCT00700102|102085017|FG000|NOT COMPLETED|Overall Study||402||
48713704|NCT00700102|102085018|FG001|NOT COMPLETED|Overall Study||395||
48713705|NCT03412097|102085019|FG000|STARTED|Overall Study||89||
48713706|NCT03412097|102085019|FG000|COMPLETED|Overall Study||89||
48713707|NCT03412097|102085019|FG000|NOT COMPLETED|Overall Study||0||
48713708|NCT01332188|102085020|FG000|STARTED|Overall Study||25||
48713709|NCT01332188|102085021|FG001|STARTED|Overall Study||26||
48713710|NCT01332188|102085022|FG002|STARTED|Overall Study||25||
48713711|NCT01332188|102085023|FG003|STARTED|Overall Study||25||
48713712|NCT01332188|102085020|FG000|COMPLETED|Overall Study||23||
48144941|NCT01967732|100679599|FG003|STARTED|Washout Period of 1 Day (Day 0)||9||
48144942|NCT01967732|100679596|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22||
48713713|NCT01332188|102085021|FG001|COMPLETED|Overall Study||25||
48713714|NCT01332188|102085022|FG002|COMPLETED|Overall Study||21||
48713715|NCT01332188|102085023|FG003|COMPLETED|Overall Study||25||
48713716|NCT01332188|102085020|FG000|NOT COMPLETED|Overall Study||2||
48713717|NCT01332188|102085021|FG001|NOT COMPLETED|Overall Study||1||
48144943|NCT01967732|100679597|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||21||
48144944|NCT01967732|100679598|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9||
48713718|NCT01332188|102085022|FG002|NOT COMPLETED|Overall Study||4||
48144945|NCT01967732|100679599|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9||
48713719|NCT01332188|102085023|FG003|NOT COMPLETED|Overall Study||0||
48144946|NCT01967732|100679596|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0||
48713720|NCT01565941|102085024|FG000|STARTED|Overall Study||360||
48713721|NCT01565941|102085025|FG001|STARTED|Overall Study||353||
48713722|NCT01565941|102085024|FG000|COMPLETED|Overall Study||349||
48713723|NCT01565941|102085025|FG001|COMPLETED|Overall Study||349||
48713724|NCT01565941|102085024|FG000|NOT COMPLETED|Overall Study||11||
48713725|NCT01565941|102085025|FG001|NOT COMPLETED|Overall Study||4||
48713726|NCT02740413|102085026|FG000|STARTED|Overall Study||86||
48713727|NCT02740413|102085026|FG000|COMPLETED|Overall Study||86||
48713728|NCT02740413|102085026|FG000|NOT COMPLETED|Overall Study||0||
48713729|NCT03859739|102085027|FG000|STARTED|Overall Study||5||
48713730|NCT03859739|102085028|FG001|STARTED|Overall Study||6||
48713731|NCT03859739|102085029|FG002|STARTED|Overall Study||6||
48297926|NCT02742766|101057035|FG005|STARTED|Part 3 (Up to 36 Days)||0||
48297927|NCT02742766|101057036|FG006|STARTED|Part 3 (Up to 36 Days)||0||
48297928|NCT02742766|101057037|FG007|STARTED|Part 3 (Up to 36 Days)||0||
48297929|NCT02742766|101057038|FG008|STARTED|Part 3 (Up to 36 Days)||0||
48297930|NCT02742766|101057039|FG009|STARTED|Part 3 (Up to 36 Days)||0||
48297931|NCT02742766|101057040|FG010|STARTED|Part 3 (Up to 36 Days)||0||
48297932|NCT02742766|101057041|FG011|STARTED|Part 3 (Up to 36 Days)||0||
48297933|NCT02742766|101057042|FG012|STARTED|Part 3 (Up to 36 Days)||0||
48297934|NCT02742766|101057043|FG013|STARTED|Part 3 (Up to 36 Days)||0||
48297935|NCT02742766|101057044|FG014|STARTED|Part 3 (Up to 36 Days)||0||
48297936|NCT02742766|101057045|FG015|STARTED|Part 3 (Up to 36 Days)||0||
48297937|NCT02742766|101057046|FG016|STARTED|Part 3 (Up to 36 Days)||0||
48297938|NCT02742766|101057047|FG017|STARTED|Part 3 (Up to 36 Days)||0||
48297939|NCT02742766|101057048|FG018|STARTED|Part 3 (Up to 36 Days)||0||
48297940|NCT02742766|101057030|FG000|COMPLETED|Part 3 (Up to 36 Days)||0||
48297941|NCT02742766|101057031|FG001|COMPLETED|Part 3 (Up to 36 Days)||0||
48713732|NCT03859739|102085030|FG003|STARTED|Overall Study||4||
48713733|NCT03859739|102085027|FG000|COMPLETED|Overall Study||5||
48713734|NCT03859739|102085028|FG001|COMPLETED|Overall Study||6||
48713735|NCT03859739|102085029|FG002|COMPLETED|Overall Study||6||
48713736|NCT03859739|102085030|FG003|COMPLETED|Overall Study||4||
48713737|NCT03859739|102085027|FG000|NOT COMPLETED|Overall Study||0||
48713738|NCT03859739|102085028|FG001|NOT COMPLETED|Overall Study||0||
48713739|NCT03859739|102085029|FG002|NOT COMPLETED|Overall Study||0||
48713740|NCT03859739|102085030|FG003|NOT COMPLETED|Overall Study||0||
48713741|NCT00235391|102085031|FG000|STARTED|Overall Study||97||
48713742|NCT00235391|102085032|FG001|STARTED|Overall Study||200||
48713743|NCT00235391|102085033|FG002|STARTED|Overall Study||172||
48713744|NCT00235391|102085034|FG003|STARTED|Overall Study||1164||
48713745|NCT00235391|102085035|FG004|STARTED|Overall Study||43||
48713746|NCT00235391|102085036|FG005|STARTED|Overall Study||7||
48713747|NCT00235391|102085031|FG000|Deferasirox Treatment|Overall Study||97||
48713748|NCT00235391|102085032|FG001|Deferasirox Treatment|Overall Study||200||
48713749|NCT00235391|102085033|FG002|Deferasirox Treatment|Overall Study||172||
48713750|NCT00235391|102085034|FG003|Deferasirox Treatment|Overall Study||1164||
48713751|NCT00235391|102085035|FG004|Deferasirox Treatment|Overall Study||43||
48713752|NCT00235391|102085036|FG005|Deferasirox Treatment|Overall Study||7||
48713753|NCT00235391|102085031|FG000|COMPLETED|Overall Study||85||
48713754|NCT00235391|102085032|FG001|COMPLETED|Overall Study||182||
48713755|NCT00235391|102085033|FG002|COMPLETED|Overall Study||148||
48713756|NCT00235391|102085034|FG003|COMPLETED|Overall Study||944||
48713757|NCT00235391|102085035|FG004|COMPLETED|Overall Study||31||
48713758|NCT00235391|102085036|FG005|COMPLETED|Overall Study||3||
48713759|NCT00235391|102085031|FG000|NOT COMPLETED|Overall Study||12||
48713760|NCT00235391|102085032|FG001|NOT COMPLETED|Overall Study||18||
48713761|NCT00235391|102085033|FG002|NOT COMPLETED|Overall Study||24||
48713762|NCT00235391|102085034|FG003|NOT COMPLETED|Overall Study||220||
48713763|NCT00235391|102085035|FG004|NOT COMPLETED|Overall Study||12||
48713764|NCT00235391|102085036|FG005|NOT COMPLETED|Overall Study||4||
48713765|NCT02463032|102085037|FG000|STARTED|Overall Study||72||
48713766|NCT02463032|102085038|FG001|STARTED|Overall Study||64||
48713767|NCT02463032|102085037|FG000|COMPLETED|Overall Study||1||
48713768|NCT02463032|102085038|FG001|COMPLETED|Overall Study||0||
48713769|NCT02463032|102085037|FG000|NOT COMPLETED|Overall Study||71||
48713770|NCT02463032|102085038|FG001|NOT COMPLETED|Overall Study||64||
48713771|NCT01688843|102085039|FG000|STARTED|Overall Study||1060||1599
48713772|NCT01688843|102085039|FG000|COMPLETED|Overall Study||1060||1599
48713773|NCT01688843|102085039|FG000|NOT COMPLETED|Overall Study||0||0
48713774|NCT00385723|102085040|FG000|STARTED|Overall Study||46||
48713775|NCT00385723|102085041|FG001|STARTED|Overall Study||46||
48713776|NCT00385723|102085042|FG002|STARTED|Overall Study||46||
48713777|NCT00385723|102085040|FG000|COMPLETED|Overall Study||44||
48713778|NCT00385723|102085041|FG001|COMPLETED|Overall Study||45||
48713779|NCT00385723|102085042|FG002|COMPLETED|Overall Study||44||
48713780|NCT00385723|102085040|FG000|NOT COMPLETED|Overall Study||2||
48713781|NCT00385723|102085041|FG001|NOT COMPLETED|Overall Study||1||
48713782|NCT00385723|102085042|FG002|NOT COMPLETED|Overall Study||2||
48297942|NCT02742766|101057032|FG002|COMPLETED|Part 3 (Up to 36 Days)||0||
48297943|NCT02742766|101057033|FG003|COMPLETED|Part 3 (Up to 36 Days)||0||
48297944|NCT02742766|101057034|FG004|COMPLETED|Part 3 (Up to 36 Days)||0||
48297945|NCT02742766|101057035|FG005|COMPLETED|Part 3 (Up to 36 Days)||0||
48297946|NCT02742766|101057036|FG006|COMPLETED|Part 3 (Up to 36 Days)||0||
48713783|NCT01509677|102085043|FG000|STARTED|Overall Study||79||
48713784|NCT01509677|102085044|FG001|STARTED|Overall Study||79||
48713785|NCT01509677|102085043|FG000|COMPLETED|Overall Study||76||
48713786|NCT01509677|102085044|FG001|COMPLETED|Overall Study||73||
48713787|NCT01509677|102085043|FG000|NOT COMPLETED|Overall Study||3||
48713788|NCT01509677|102085044|FG001|NOT COMPLETED|Overall Study||6||
48713789|NCT03283436|102085045|FG000|STARTED|Overall Study||50||
48713790|NCT03283436|102085046|FG001|STARTED|Overall Study||50||
48297947|NCT02742766|101057037|FG007|COMPLETED|Part 3 (Up to 36 Days)||0||
48297948|NCT02742766|101057038|FG008|COMPLETED|Part 3 (Up to 36 Days)||0||
48297949|NCT02742766|101057039|FG009|COMPLETED|Part 3 (Up to 36 Days)||0||
48297950|NCT02742766|101057040|FG010|COMPLETED|Part 3 (Up to 36 Days)||0||
48297951|NCT02742766|101057041|FG011|COMPLETED|Part 3 (Up to 36 Days)||0||
48297952|NCT02742766|101057042|FG012|COMPLETED|Part 3 (Up to 36 Days)||0||
48297953|NCT02742766|101057043|FG013|COMPLETED|Part 3 (Up to 36 Days)||0||
48297954|NCT02742766|101057044|FG014|COMPLETED|Part 3 (Up to 36 Days)||0||
48297955|NCT02742766|101057045|FG015|COMPLETED|Part 3 (Up to 36 Days)||0||
48297956|NCT02742766|101057046|FG016|COMPLETED|Part 3 (Up to 36 Days)||0||
48297957|NCT02742766|101057047|FG017|COMPLETED|Part 3 (Up to 36 Days)||0||
48297958|NCT02742766|101057048|FG018|COMPLETED|Part 3 (Up to 36 Days)||0||
48297959|NCT02742766|101057030|FG000|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
48297960|NCT02742766|101057031|FG001|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
48297961|NCT02742766|101057032|FG002|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
48297962|NCT02742766|101057033|FG003|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
48297963|NCT02742766|101057034|FG004|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
48297964|NCT02742766|101057035|FG005|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
48297965|NCT02742766|101057036|FG006|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
48297966|NCT02742766|101057037|FG007|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
48297967|NCT02742766|101057038|FG008|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
48297968|NCT02742766|101057039|FG009|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
48297969|NCT02742766|101057040|FG010|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
48297970|NCT02742766|101057041|FG011|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
48297971|NCT02742766|101057042|FG012|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
48297972|NCT02742766|101057043|FG013|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
48297973|NCT02742766|101057044|FG014|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
48297974|NCT02742766|101057045|FG015|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
48297975|NCT02742766|101057046|FG016|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
48297976|NCT02742766|101057047|FG017|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
48297977|NCT02742766|101057048|FG018|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
48297978|NCT02342743|101057049|FG000|STARTED|Baseline Period||73||
48297979|NCT02342743|101057049|FG000|COMPLETED|Baseline Period||58||
48297980|NCT02342743|101057049|FG000|NOT COMPLETED|Baseline Period||15||
48297981|NCT02342743|101057049|FG000|STARTED|Treatment Period||58||
48297982|NCT02342743|101057049|FG000|COMPLETED|Treatment Period||47||
48297983|NCT02342743|101057049|FG000|NOT COMPLETED|Treatment Period||11||
48713791|NCT03283436|102085045|FG000|COMPLETED|Overall Study||44||
48713792|NCT03283436|102085046|FG001|COMPLETED|Overall Study||50||
48297984|NCT00655486|101057050|FG000|STARTED|Overall Study||97||
48297985|NCT00655486|101057050|FG000|COMPLETED|Overall Study||69||
48297986|NCT00655486|101057050|FG000|NOT COMPLETED|Overall Study||28||
48367988|NCT00717418|101230089|FG001|COMPLETED|Baseline||74||
48713793|NCT03283436|102085045|FG000|NOT COMPLETED|Overall Study||6||
48713794|NCT03283436|102085046|FG001|NOT COMPLETED|Overall Study||0||
48713795|NCT04790812|102085047|FG000|STARTED|Overall Study||32||
48713796|NCT04790812|102085048|FG001|STARTED|Overall Study||33||
48713797|NCT04790812|102085047|FG000|Received Intervention|Overall Study||23||
48713798|NCT04790812|102085048|FG001|Received Intervention|Overall Study||26||
48713799|NCT04790812|102085047|FG000|COMPLETED|Overall Study||4||
48713800|NCT04790812|102085048|FG001|COMPLETED|Overall Study||6||
48713801|NCT04790812|102085047|FG000|NOT COMPLETED|Overall Study||28||
48713802|NCT04790812|102085048|FG001|NOT COMPLETED|Overall Study||27||
48713803|NCT04962230|102085049|FG000|STARTED|PF-07321332 300 mg/Ritonavir 100 mg||12||
48713804|NCT04962230|102085049|FG000|COMPLETED|PF-07321332 300 mg/Ritonavir 100 mg||12||
48713805|NCT04962230|102085049|FG000|NOT COMPLETED|PF-07321332 300 mg/Ritonavir 100 mg||0||
48713806|NCT04962230|102085049|FG000|STARTED|Carbamazepine+PF-07321332/Ritonavir||12||
48713807|NCT04962230|102085049|FG000|COMPLETED|Carbamazepine+PF-07321332/Ritonavir||10||
48713808|NCT04962230|102085049|FG000|NOT COMPLETED|Carbamazepine+PF-07321332/Ritonavir||2||
48713809|NCT01018095|102085050|FG000|STARTED|Overall Study||135||
48713810|NCT01018095|102085051|FG001|STARTED|Overall Study||135||
48713811|NCT01018095|102085050|FG000|COMPLETED|Overall Study||79||
48713812|NCT01018095|102085051|FG001|COMPLETED|Overall Study||73||
48599320|NCT02798354|101800317|FG002|Intervention Data Error 1|First Intervention Period||645||10
48599321|NCT02798354|101800315|FG000|COMPLETED|First Intervention Period||1184||11
48599322|NCT02798354|101800316|FG001|COMPLETED|First Intervention Period||2176||10
48599323|NCT02798354|101800317|FG002|COMPLETED|First Intervention Period||990||10
48599324|NCT02798354|101800315|FG000|NOT COMPLETED|First Intervention Period||0||3
48599325|NCT02798354|101800316|FG001|NOT COMPLETED|First Intervention Period||0||6
48599326|NCT02798354|101800317|FG002|NOT COMPLETED|First Intervention Period||0||3
48144947|NCT01967732|100679597|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||1||
48297987|NCT01295281|101057051|FG000|STARTED|First Intervention (7 Days)||53||
48297988|NCT01295281|101057052|FG001|STARTED|First Intervention (7 Days)||52||
48297989|NCT01295281|101057051|FG000|COMPLETED|First Intervention (7 Days)||53||
48297990|NCT01295281|101057052|FG001|COMPLETED|First Intervention (7 Days)||51||
48599327|NCT02798354|101800315|FG000|STARTED|Second Intervention Period||2617||11
48599328|NCT02798354|101800316|FG001|STARTED|Second Intervention Period||1047||10
48144948|NCT01967732|100679598|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0||
48144949|NCT01967732|100679599|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0||
48144950|NCT01967732|100679596|FG000|STARTED|First Intervention (Day 1)||22||
48144951|NCT01967732|100679597|FG001|STARTED|First Intervention (Day 1)||21||
48144952|NCT01967732|100679598|FG002|STARTED|First Intervention (Day 1)||9||
48144953|NCT01967732|100679599|FG003|STARTED|First Intervention (Day 1)||9||
48144954|NCT01967732|100679596|FG000|COMPLETED|First Intervention (Day 1)||22||
48144955|NCT01967732|100679597|FG001|COMPLETED|First Intervention (Day 1)||20||
48144956|NCT01967732|100679598|FG002|COMPLETED|First Intervention (Day 1)||9||
48144957|NCT01967732|100679599|FG003|COMPLETED|First Intervention (Day 1)||9||
48144958|NCT01967732|100679596|FG000|NOT COMPLETED|First Intervention (Day 1)||0||
48144959|NCT01967732|100679597|FG001|NOT COMPLETED|First Intervention (Day 1)||1||
48144960|NCT01967732|100679598|FG002|NOT COMPLETED|First Intervention (Day 1)||0||
48144961|NCT01967732|100679599|FG003|NOT COMPLETED|First Intervention (Day 1)||0||
48144962|NCT01967732|100679596|FG000|STARTED|Washout Period of 1 Day (Day 2)||22||
48144963|NCT01967732|100679597|FG001|STARTED|Washout Period of 1 Day (Day 2)||20||
48599329|NCT02798354|101800317|FG002|STARTED|Second Intervention Period||1368||10
48599330|NCT02798354|101800315|FG000|Control Data Error 2|Second Intervention Period||1378||11
48599331|NCT02798354|101800316|FG001|Control Data Error 2|Second Intervention Period||593||10
48599332|NCT02798354|101800317|FG002|Control Data Error 2|Second Intervention Period||668||9
48599333|NCT02798354|101800315|FG000|Intervention Data Error 2|Second Intervention Period||1239||11
48144964|NCT01967732|100679598|FG002|STARTED|Washout Period of 1 Day (Day 2)||9||
48297991|NCT01295281|101057051|FG000|NOT COMPLETED|First Intervention (7 Days)||0||
48297992|NCT01295281|101057052|FG001|NOT COMPLETED|First Intervention (7 Days)||1||
48599334|NCT02798354|101800316|FG001|Intervention Data Error 2|Second Intervention Period||454||9
48599335|NCT02798354|101800317|FG002|Intervention Data Error 2|Second Intervention Period||700||10
48599336|NCT02798354|101800315|FG000|COMPLETED|Second Intervention Period||2617||11
48599337|NCT02798354|101800316|FG001|COMPLETED|Second Intervention Period||1047||9
48599338|NCT02798354|101800317|FG002|COMPLETED|Second Intervention Period||1368||10
48599339|NCT02798354|101800315|FG000|NOT COMPLETED|Second Intervention Period||0||0
48599340|NCT02798354|101800316|FG001|NOT COMPLETED|Second Intervention Period||0||1
48599341|NCT02798354|101800317|FG002|NOT COMPLETED|Second Intervention Period||0||0
48599342|NCT02798354|101800315|FG000|STARTED|Third Intervention Period||746||11
48599343|NCT02798354|101800316|FG001|STARTED|Third Intervention Period||1010||9
48297993|NCT01295281|101057051|FG000|STARTED|Second Intervention (7days)||53||
48297994|NCT01295281|101057052|FG001|STARTED|Second Intervention (7days)||51||
48297995|NCT01295281|101057051|FG000|COMPLETED|Second Intervention (7days)||53||
48297996|NCT01295281|101057052|FG001|COMPLETED|Second Intervention (7days)||51||
48297997|NCT01295281|101057051|FG000|NOT COMPLETED|Second Intervention (7days)||0||
48297998|NCT01295281|101057052|FG001|NOT COMPLETED|Second Intervention (7days)||0||
48297999|NCT04771611|101057053|FG000|STARTED|Overall Study||29||
48298000|NCT04771611|101057054|FG001|STARTED|Overall Study||26||
48298001|NCT04771611|101057053|FG000|COMPLETED|Overall Study||29||
48298002|NCT04771611|101057054|FG001|COMPLETED|Overall Study||26||
48298003|NCT04771611|101057053|FG000|NOT COMPLETED|Overall Study||0||
48298004|NCT04771611|101057054|FG001|NOT COMPLETED|Overall Study||0||
48298005|NCT03349892|101057055|FG000|STARTED|Overall Study||1||
48298006|NCT03349892|101057055|FG000|COMPLETED|Overall Study||1||
48298007|NCT03349892|101057055|FG000|NOT COMPLETED|Overall Study||0||
48298008|NCT02690558|101057056|FG000|STARTED|Overall Study||39||
48298009|NCT02690558|101057056|FG000|COMPLETED|Overall Study||39||
48298010|NCT02690558|101057056|FG000|NOT COMPLETED|Overall Study||0||
48298011|NCT02019888|101057057|FG000|STARTED|Overall Study||148||
48298012|NCT02019888|101057058|FG001|STARTED|Overall Study||113||
48298013|NCT02019888|101057059|FG002|STARTED|Overall Study||59||
48298014|NCT02019888|101057057|FG000|COMPLETED|Overall Study||108||
48298015|NCT02019888|101057058|FG001|COMPLETED|Overall Study||83||
48298016|NCT02019888|101057059|FG002|COMPLETED|Overall Study||54||
48298017|NCT02019888|101057057|FG000|NOT COMPLETED|Overall Study||40||
48298018|NCT02019888|101057058|FG001|NOT COMPLETED|Overall Study||30||
48298019|NCT02019888|101057059|FG002|NOT COMPLETED|Overall Study||5||
48298020|NCT02967354|101057060|FG000|STARTED|Overall Study||8||
48298021|NCT02967354|101057061|FG001|STARTED|Overall Study||7||
48298022|NCT02967354|101057062|FG002|STARTED|Overall Study||9||
48298023|NCT02967354|101057063|FG003|STARTED|Overall Study||7||
48298024|NCT02967354|101057064|FG004|STARTED|Overall Study||8||
48298025|NCT02967354|101057060|FG000|COMPLETED|Overall Study||8||
48298026|NCT02967354|101057061|FG001|COMPLETED|Overall Study||7||
48298027|NCT02967354|101057062|FG002|COMPLETED|Overall Study||9||
48599344|NCT02798354|101800317|FG002|STARTED|Third Intervention Period||2715||10
48599345|NCT02798354|101800315|FG000|Control Data Error 3|Third Intervention Period||419||11
48599346|NCT02798354|101800316|FG001|Control Data Error 3|Third Intervention Period||620||9
48599347|NCT02798354|101800317|FG002|Control Data Error 3|Third Intervention Period||1467||10
48599348|NCT02798354|101800315|FG000|Intervention Data Error 3|Third Intervention Period||327||11
48599349|NCT02798354|101800316|FG001|Intervention Data Error 3|Third Intervention Period||390||9
48599350|NCT02798354|101800317|FG002|Intervention Data Error 3|Third Intervention Period||1248||10
48599351|NCT02798354|101800315|FG000|COMPLETED|Third Intervention Period||746||11
48599352|NCT02798354|101800316|FG001|COMPLETED|Third Intervention Period||1010||9
48599353|NCT02798354|101800317|FG002|COMPLETED|Third Intervention Period||2715||10
48599354|NCT02798354|101800315|FG000|NOT COMPLETED|Third Intervention Period||0||0
48599355|NCT02798354|101800316|FG001|NOT COMPLETED|Third Intervention Period||0||0
48599356|NCT02798354|101800317|FG002|NOT COMPLETED|Third Intervention Period||0||0
48298028|NCT02967354|101057063|FG003|COMPLETED|Overall Study||7||
48599357|NCT02893423|101800318|FG000|STARTED|Overall Study||17||
48599358|NCT02893423|101800319|FG001|STARTED|Overall Study||16||
48599359|NCT02893423|101800320|FG002|STARTED|Overall Study||18||
48599360|NCT02893423|101800318|FG000|COMPLETED|Overall Study||17||
48599361|NCT02893423|101800319|FG001|COMPLETED|Overall Study||16||
48599362|NCT02893423|101800320|FG002|COMPLETED|Overall Study||18||
48599363|NCT02893423|101800318|FG000|NOT COMPLETED|Overall Study||0||
48599364|NCT02893423|101800319|FG001|NOT COMPLETED|Overall Study||0||
48599365|NCT02893423|101800320|FG002|NOT COMPLETED|Overall Study||0||
48599366|NCT02147067|101800321|FG000|STARTED|Overall Study||13||
48599367|NCT02147067|101800322|FG001|STARTED|Overall Study||13||
48298029|NCT02967354|101057064|FG004|COMPLETED|Overall Study||8||
48298030|NCT02967354|101057060|FG000|NOT COMPLETED|Overall Study||0||
48298031|NCT02967354|101057061|FG001|NOT COMPLETED|Overall Study||0||
48298032|NCT02967354|101057062|FG002|NOT COMPLETED|Overall Study||0||
48298033|NCT02967354|101057063|FG003|NOT COMPLETED|Overall Study||0||
48298034|NCT02967354|101057064|FG004|NOT COMPLETED|Overall Study||0||
48599368|NCT02147067|101800321|FG000|COMPLETED|Overall Study||11||
48599369|NCT02147067|101800322|FG001|COMPLETED|Overall Study||11||
48599370|NCT02147067|101800321|FG000|NOT COMPLETED|Overall Study||2||
48298035|NCT02318992|101057065|FG000|STARTED|Overall Study||27||
48599371|NCT02147067|101800322|FG001|NOT COMPLETED|Overall Study||2||
48599372|NCT02919007|101800323|FG000|STARTED|Overall Study||25||
48599373|NCT02919007|101800323|FG000|COMPLETED|Overall Study||25||
48599374|NCT02919007|101800323|FG000|NOT COMPLETED|Overall Study||0||
48599375|NCT02612688|101800324|FG000|STARTED|Overall Study||33035||
48599376|NCT02612688|101800325|FG001|STARTED|Overall Study||70013||
48599377|NCT02612688|101800324|FG000|COMPLETED|Overall Study||33035||
48599378|NCT02612688|101800325|FG001|COMPLETED|Overall Study||70013||
48599379|NCT02612688|101800324|FG000|NOT COMPLETED|Overall Study||0||
48599380|NCT02612688|101800325|FG001|NOT COMPLETED|Overall Study||0||
48599381|NCT01627782|101800326|FG000|STARTED|Overall Study||17||
48599382|NCT01627782|101800327|FG001|STARTED|Overall Study||18||
48599383|NCT01627782|101800328|FG002|STARTED|Overall Study||16||
48599384|NCT01627782|101800329|FG003|STARTED|Overall Study||17||
48599385|NCT01627782|101800326|FG000|Treated|Overall Study||16||
48599386|NCT01627782|101800327|FG001|Treated|Overall Study||18||
48599387|NCT01627782|101800328|FG002|Treated|Overall Study||16||
48599388|NCT01627782|101800329|FG003|Treated|Overall Study||17||
48599389|NCT01627782|101800326|FG000|COMPLETED|Overall Study||1||
48599390|NCT01627782|101800327|FG001|COMPLETED|Overall Study||12||
48599391|NCT01627782|101800328|FG002|COMPLETED|Overall Study||1||
48599392|NCT01627782|101800329|FG003|COMPLETED|Overall Study||11||
48599393|NCT01627782|101800326|FG000|NOT COMPLETED|Overall Study||16||
48599394|NCT01627782|101800327|FG001|NOT COMPLETED|Overall Study||6||
48188522|NCT00031447|100783264|FG000|COMPLETED|Overall Study||4||
48298036|NCT02318992|101057066|FG001|STARTED|Overall Study||27||
48298037|NCT02318992|101057067|FG002|STARTED|Overall Study||24||
48298038|NCT02318992|101057065|FG000|COMPLETED|Overall Study||25||
48298039|NCT02318992|101057066|FG001|COMPLETED|Overall Study||25||
48298040|NCT02318992|101057067|FG002|COMPLETED|Overall Study||20||
48298041|NCT02318992|101057065|FG000|NOT COMPLETED|Overall Study||2||
48298042|NCT02318992|101057066|FG001|NOT COMPLETED|Overall Study||2||
48298043|NCT02318992|101057067|FG002|NOT COMPLETED|Overall Study||4||
48298044|NCT00852592|101057068|FG000|STARTED|Overall Study||23||
48298045|NCT00852592|101057069|FG001|STARTED|Overall Study||23||
48298046|NCT00852592|101057068|FG000|COMPLETED|Overall Study||20||
48298047|NCT00852592|101057069|FG001|COMPLETED|Overall Study||19||
48298048|NCT00852592|101057068|FG000|NOT COMPLETED|Overall Study||3||
48298049|NCT00852592|101057069|FG001|NOT COMPLETED|Overall Study||4||
48298050|NCT00615836|101057070|FG000|STARTED|Part I of Core Study (FE992026 CS29)||163||
48298051|NCT00615836|101057071|FG001|STARTED|Part I of Core Study (FE992026 CS29)||158||
48298052|NCT00615836|101057072|FG002|STARTED|Part I of Core Study (FE992026 CS29)||158||
48298053|NCT00615836|101057073|FG003|STARTED|Part I of Core Study (FE992026 CS29)||160||
48298054|NCT00615836|101057074|FG004|STARTED|Part I of Core Study (FE992026 CS29)||160||
48298055|NCT00615836|101057070|FG000|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)||155||
48298056|NCT00615836|101057071|FG001|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)||152||
48298057|NCT00615836|101057072|FG002|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)||148||
48298058|NCT00615836|101057073|FG003|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)||146||
48298059|NCT00615836|101057074|FG004|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)||156||
48298060|NCT00615836|101057070|FG000|COMPLETED|Part I of Core Study (FE992026 CS29)||144||
48298061|NCT00615836|101057071|FG001|COMPLETED|Part I of Core Study (FE992026 CS29)||148||
48298062|NCT00615836|101057072|FG002|COMPLETED|Part I of Core Study (FE992026 CS29)||138||
48298063|NCT00615836|101057073|FG003|COMPLETED|Part I of Core Study (FE992026 CS29)||135||
48298064|NCT00615836|101057074|FG004|COMPLETED|Part I of Core Study (FE992026 CS29)||145||
48599395|NCT01627782|101800328|FG002|NOT COMPLETED|Overall Study||15||
48599396|NCT01627782|101800329|FG003|NOT COMPLETED|Overall Study||6||
48599397|NCT01669785|101800330|FG000|STARTED|Overall Study||45||
48599398|NCT01669785|101800331|FG001|STARTED|Overall Study||48||
48298065|NCT00615836|101057070|FG000|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||19||
48298066|NCT00615836|101057071|FG001|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||10||
48298067|NCT00615836|101057072|FG002|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||20||
48298068|NCT00615836|101057073|FG003|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||25||
48298069|NCT00615836|101057074|FG004|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||15||
48599399|NCT01669785|101800332|FG002|STARTED|Overall Study||46||
48599400|NCT01669785|101800330|FG000|COMPLETED|Overall Study||45||
48599401|NCT01669785|101800331|FG001|COMPLETED|Overall Study||48||
48599402|NCT01669785|101800332|FG002|COMPLETED|Overall Study||46||
48599403|NCT01669785|101800330|FG000|NOT COMPLETED|Overall Study||0||
48599404|NCT01669785|101800331|FG001|NOT COMPLETED|Overall Study||0||
48599405|NCT01669785|101800332|FG002|NOT COMPLETED|Overall Study||0||
48599406|NCT00336323|101800333|FG000|STARTED|Overall Study||19||
48599407|NCT00336323|101800334|FG001|STARTED|Overall Study||22||
48599408|NCT00336323|101800335|FG002|STARTED|Overall Study||24||
48599409|NCT00336323|101800336|FG003|STARTED|Overall Study||22||
48599410|NCT00336323|101800337|FG004|STARTED|Overall Study||22||
48599411|NCT00336323|101800333|FG000|3 Week Visit|Overall Study||18||
48599412|NCT00336323|101800334|FG001|3 Week Visit|Overall Study||21||
48298070|NCT00615836|101057070|FG000|STARTED|Extension Study (FE992026 CS31)||141||
48298071|NCT00615836|101057071|FG001|STARTED|Extension Study (FE992026 CS31)||144||
48298072|NCT00615836|101057072|FG002|STARTED|Extension Study (FE992026 CS31)||132||
48298073|NCT00615836|101057073|FG003|STARTED|Extension Study (FE992026 CS31)||137||
48298074|NCT00615836|101057074|FG004|STARTED|Extension Study (FE992026 CS31)||0||
48599413|NCT00336323|101800335|FG002|3 Week Visit|Overall Study||24||
48599414|NCT00336323|101800336|FG003|3 Week Visit|Overall Study||22||
48599415|NCT00336323|101800337|FG004|3 Week Visit|Overall Study||20||
48599416|NCT00336323|101800333|FG000|6 Week Visit|Overall Study||18||
48599417|NCT00336323|101800334|FG001|6 Week Visit|Overall Study||22||
48599418|NCT00336323|101800335|FG002|6 Week Visit|Overall Study||24||
48599419|NCT00336323|101800336|FG003|6 Week Visit|Overall Study||22||
48599420|NCT00336323|101800337|FG004|6 Week Visit|Overall Study||20||
48599421|NCT00336323|101800333|FG000|9 Week Visit|Overall Study||18||
48599422|NCT00336323|101800334|FG001|9 Week Visit|Overall Study||21||
48599423|NCT00336323|101800335|FG002|9 Week Visit|Overall Study||23||
48599424|NCT00336323|101800336|FG003|9 Week Visit|Overall Study||21||
48599425|NCT00336323|101800337|FG004|9 Week Visit|Overall Study||19||
48599426|NCT00336323|101800333|FG000|12 Week Visit|Overall Study||19||
48599427|NCT00336323|101800334|FG001|12 Week Visit|Overall Study||21||
48599428|NCT00336323|101800335|FG002|12 Week Visit|Overall Study||24||
48599429|NCT00336323|101800336|FG003|12 Week Visit|Overall Study||22||
48599430|NCT00336323|101800337|FG004|12 Week Visit|Overall Study||20||
48599431|NCT00336323|101800333|FG000|18 Week Visit|Overall Study||19||
48599432|NCT00336323|101800334|FG001|18 Week Visit|Overall Study||22||
48599433|NCT00336323|101800335|FG002|18 Week Visit|Overall Study||23||
48599434|NCT00336323|101800336|FG003|18 Week Visit|Overall Study||21||
48599435|NCT00336323|101800337|FG004|18 Week Visit|Overall Study||18||
48298075|NCT00615836|101057070|FG000|COMPLETED|Extension Study (FE992026 CS31)||0||
48298076|NCT00615836|101057071|FG001|COMPLETED|Extension Study (FE992026 CS31)||58||
48298077|NCT00615836|101057072|FG002|COMPLETED|Extension Study (FE992026 CS31)||59||
48298078|NCT00615836|101057073|FG003|COMPLETED|Extension Study (FE992026 CS31)||53||
48298079|NCT00615836|101057074|FG004|COMPLETED|Extension Study (FE992026 CS31)||0||
48298080|NCT00615836|101057070|FG000|NOT COMPLETED|Extension Study (FE992026 CS31)||141||
48599436|NCT00336323|101800333|FG000|24 Week Visit|Overall Study||18||
48599437|NCT00336323|101800334|FG001|24 Week Visit|Overall Study||20||
48599438|NCT00336323|101800335|FG002|24 Week Visit|Overall Study||22||
48599439|NCT00336323|101800336|FG003|24 Week Visit|Overall Study||22||
48599440|NCT00336323|101800337|FG004|24 Week Visit|Overall Study||19||
48599441|NCT00336323|101800333|FG000|COMPLETED|Overall Study||19||
48599442|NCT00336323|101800334|FG001|COMPLETED|Overall Study||21||
48599443|NCT00336323|101800335|FG002|COMPLETED|Overall Study||23||
48599444|NCT00336323|101800336|FG003|COMPLETED|Overall Study||22||
48599445|NCT00336323|101800337|FG004|COMPLETED|Overall Study||19||
48599446|NCT00336323|101800333|FG000|NOT COMPLETED|Overall Study||0||
48599447|NCT00336323|101800334|FG001|NOT COMPLETED|Overall Study||1||
48599448|NCT00336323|101800335|FG002|NOT COMPLETED|Overall Study||1||
48599449|NCT00336323|101800336|FG003|NOT COMPLETED|Overall Study||0||
48599450|NCT00336323|101800337|FG004|NOT COMPLETED|Overall Study||3||
48599451|NCT02525536|101800338|FG000|STARTED|Overall Study||6||
48599452|NCT02525536|101800339|FG001|STARTED|Overall Study||6||
48599453|NCT02525536|101800340|FG002|STARTED|Overall Study||6||
48599454|NCT02525536|101800338|FG000|COMPLETED|Overall Study||6||
48298081|NCT00615836|101057071|FG001|NOT COMPLETED|Extension Study (FE992026 CS31)||86||
48298082|NCT00615836|101057072|FG002|NOT COMPLETED|Extension Study (FE992026 CS31)||73||
48298083|NCT00615836|101057073|FG003|NOT COMPLETED|Extension Study (FE992026 CS31)||84||
48298084|NCT00615836|101057074|FG004|NOT COMPLETED|Extension Study (FE992026 CS31)||0||
48298085|NCT01480674|101057075|FG000|STARTED|Overall Study||160||
48298086|NCT01480674|101057075|FG000|Safety Set|Overall Study||154||
48298087|NCT01480674|101057075|FG000|Analysed Set|Overall Study||128||
48298088|NCT01480674|101057075|FG000|COMPLETED|Overall Study||125||
48298089|NCT01480674|101057075|FG000|NOT COMPLETED|Overall Study||35||
48298090|NCT02141984|101057076|FG000|STARTED|Overall Study||28||
48405119|NCT03954704|101325197|FG002|STARTED|Overall Study||3||
48405120|NCT03954704|101325198|FG003|STARTED|Overall Study||3||
48405121|NCT03954704|101325199|FG004|STARTED|Overall Study||3||
48599455|NCT02525536|101800339|FG001|COMPLETED|Overall Study||6||
48599456|NCT02525536|101800340|FG002|COMPLETED|Overall Study||6||
48599457|NCT02525536|101800338|FG000|NOT COMPLETED|Overall Study||0||
48599458|NCT02525536|101800339|FG001|NOT COMPLETED|Overall Study||0||
48599459|NCT02525536|101800340|FG002|NOT COMPLETED|Overall Study||0||
48599460|NCT06020534|101800341|FG000|STARTED|Overall Study||524||
48298091|NCT02141984|101057076|FG000|COMPLETED|Overall Study||26||
48298092|NCT02141984|101057076|FG000|NOT COMPLETED|Overall Study||2||
48599461|NCT06020534|101800342|FG001|STARTED|Overall Study||96||
48599462|NCT06020534|101800343|FG002|STARTED|Overall Study||35||
48599463|NCT06020534|101800341|FG000|COMPLETED|Overall Study||524||
48599464|NCT06020534|101800342|FG001|COMPLETED|Overall Study||96||
48599465|NCT06020534|101800343|FG002|COMPLETED|Overall Study||35||
48599466|NCT06020534|101800341|FG000|NOT COMPLETED|Overall Study||0||
48599467|NCT06020534|101800342|FG001|NOT COMPLETED|Overall Study||0||
48599468|NCT06020534|101800343|FG002|NOT COMPLETED|Overall Study||0||
48298093|NCT00733993|101057077|FG000|STARTED|Overall Study||13||
48298094|NCT00733993|101057078|FG001|STARTED|Overall Study||10||
48298095|NCT00733993|101057077|FG000|COMPLETED|Overall Study||13||
48298096|NCT00733993|101057078|FG001|COMPLETED|Overall Study||10||
48298097|NCT00733993|101057077|FG000|NOT COMPLETED|Overall Study||0||
48298098|NCT00733993|101057078|FG001|NOT COMPLETED|Overall Study||0||
48298099|NCT01891721|101057079|FG000|STARTED|Overall Study||39||
48298100|NCT01891721|101057080|FG001|STARTED|Overall Study||40||
48298101|NCT01891721|101057081|FG002|STARTED|Overall Study||20||
48298102|NCT01891721|101057079|FG000|COMPLETED|Overall Study||29||
48298103|NCT01891721|101057080|FG001|COMPLETED|Overall Study||35||
48298104|NCT01891721|101057081|FG002|COMPLETED|Overall Study||19||
48298105|NCT01891721|101057079|FG000|NOT COMPLETED|Overall Study||10||
48298106|NCT01891721|101057080|FG001|NOT COMPLETED|Overall Study||5||
48298107|NCT01891721|101057081|FG002|NOT COMPLETED|Overall Study||1||
48298108|NCT01072877|101057082|FG000|STARTED|Overall Study||56||
48298109|NCT01072877|101057083|FG001|STARTED|Overall Study||57||
48298110|NCT01072877|101057084|FG002|STARTED|Overall Study||51||
48298111|NCT01072877|101057085|FG003|STARTED|Overall Study||52||
48599469|NCT03973697|101800344|FG000|STARTED|Overall Study||5||
48599470|NCT03973697|101800345|FG001|STARTED|Overall Study||4||
48599471|NCT03973697|101800344|FG000|COMPLETED|Overall Study||5||
48599472|NCT03973697|101800345|FG001|COMPLETED|Overall Study||4||
48599473|NCT03973697|101800344|FG000|NOT COMPLETED|Overall Study||0||
48599474|NCT03973697|101800345|FG001|NOT COMPLETED|Overall Study||0||
48599475|NCT01333956|101800346|FG000|STARTED|Overall Study||30||
48599476|NCT01333956|101800347|FG001|STARTED|Overall Study||30||
48599477|NCT01333956|101800348|FG002|STARTED|Overall Study||30||
48599478|NCT01333956|101800349|FG003|STARTED|Overall Study||30||
48599479|NCT01333956|101800346|FG000|COMPLETED|Overall Study||28||
48599480|NCT01333956|101800347|FG001|COMPLETED|Overall Study||26||
48599481|NCT01333956|101800348|FG002|COMPLETED|Overall Study||29||
48599482|NCT01333956|101800349|FG003|COMPLETED|Overall Study||28||
48599483|NCT01333956|101800346|FG000|NOT COMPLETED|Overall Study||2||
48599484|NCT01333956|101800347|FG001|NOT COMPLETED|Overall Study||4||
48599485|NCT01333956|101800348|FG002|NOT COMPLETED|Overall Study||1||
48599486|NCT01333956|101800349|FG003|NOT COMPLETED|Overall Study||2||
48599487|NCT03743402|101800350|FG000|STARTED|Overall Study||79||
48599488|NCT03743402|101800351|FG001|STARTED|Overall Study||74||
48599489|NCT03743402|101800350|FG000|Availability of at Least One Primary Outcome Measure at 6 Months Post-baseline|Overall Study||79||
48599490|NCT03743402|101800351|FG001|Availability of at Least One Primary Outcome Measure at 6 Months Post-baseline|Overall Study||74||
48599491|NCT03743402|101800350|FG000|COMPLETED|Overall Study||78|Defined to be availability of at least one primary outcome measure at 12 months post-baseline.|
48599492|NCT03743402|101800351|FG001|COMPLETED|Overall Study||73|Defined to be availability of at least one primary outcome measure at 12 months post-baseline.|
48599493|NCT03743402|101800350|FG000|NOT COMPLETED|Overall Study||1||
48599494|NCT03743402|101800351|FG001|NOT COMPLETED|Overall Study||1||
48656873|NCT01708941|101943722|FG001|Eligible and Started Treatment|Overall Study||22||
48656874|NCT01708941|101943723|FG002|Eligible and Started Treatment|Overall Study||19||
48656875|NCT01708941|101943724|FG003|Eligible and Started Treatment|Overall Study||22||
48656876|NCT01708941|101943721|FG000|COMPLETED|Overall Study||3||
48656877|NCT01708941|101943722|FG001|COMPLETED|Overall Study||5||
48656878|NCT01708941|101943723|FG002|COMPLETED|Overall Study||3||
48656879|NCT01708941|101943724|FG003|COMPLETED|Overall Study||4||
48656880|NCT01708941|101943721|FG000|NOT COMPLETED|Overall Study||18||
48656881|NCT01708941|101943722|FG001|NOT COMPLETED|Overall Study||18||
48656882|NCT01708941|101943723|FG002|NOT COMPLETED|Overall Study||19||
48656883|NCT01708941|101943724|FG003|NOT COMPLETED|Overall Study||18||
48656884|NCT04274218|101943725|FG000|STARTED|Demographic Information (10 Minutes)||5||
48656885|NCT04274218|101943726|FG001|STARTED|Demographic Information (10 Minutes)||6||
48656886|NCT04274218|101943727|FG002|STARTED|Demographic Information (10 Minutes)||5||
48656887|NCT04274218|101943728|FG003|STARTED|Demographic Information (10 Minutes)||4||
48656888|NCT04274218|101943725|FG000|COMPLETED|Demographic Information (10 Minutes)||5||
48656889|NCT04274218|101943726|FG001|COMPLETED|Demographic Information (10 Minutes)||6||
48656890|NCT04274218|101943727|FG002|COMPLETED|Demographic Information (10 Minutes)||5||
48298112|NCT01072877|101057086|FG004|STARTED|Overall Study||63||
48298113|NCT01072877|101057082|FG000|COMPLETED|Overall Study||55||
48298114|NCT01072877|101057083|FG001|COMPLETED|Overall Study||56||
48298115|NCT01072877|101057084|FG002|COMPLETED|Overall Study||51||
48298116|NCT01072877|101057085|FG003|COMPLETED|Overall Study||50||
48298117|NCT01072877|101057086|FG004|COMPLETED|Overall Study||63||
48298118|NCT01072877|101057082|FG000|NOT COMPLETED|Overall Study||1||
48298119|NCT01072877|101057083|FG001|NOT COMPLETED|Overall Study||1||
48298120|NCT01072877|101057084|FG002|NOT COMPLETED|Overall Study||0||
48298121|NCT01072877|101057085|FG003|NOT COMPLETED|Overall Study||2||
48656891|NCT04274218|101943728|FG003|COMPLETED|Demographic Information (10 Minutes)||4||
48298122|NCT01072877|101057086|FG004|NOT COMPLETED|Overall Study||0||
48298123|NCT04051827|101057087|FG000|STARTED|Overall Study||26||
48298124|NCT04051827|101057087|FG000|COMPLETED|Overall Study||0||
48298125|NCT04051827|101057087|FG000|NOT COMPLETED|Overall Study||26||
48298126|NCT03598088|101057088|FG000|STARTED|Screening/Baseline PCT Visits 1-4||38||
48599495|NCT02952872|101803190|FG000|STARTED|Overall Study||22||
48599496|NCT02952872|101803191|FG001|STARTED|Overall Study||22||
48599497|NCT02952872|101803192|FG002|STARTED|Overall Study||22||
48599498|NCT02952872|101803193|FG003|STARTED|Overall Study||22||
48599499|NCT02952872|101803194|FG004|STARTED|Overall Study||22||
48599500|NCT02952872|101803195|FG005|STARTED|Overall Study||21||
48599501|NCT02952872|101803196|FG006|STARTED|Overall Study||22||
48599502|NCT02952872|101803197|FG007|STARTED|Overall Study||21||
48599503|NCT02952872|101803198|FG008|STARTED|Overall Study||22||
48599504|NCT02952872|101803199|FG009|STARTED|Overall Study||22||
48599505|NCT02952872|101803200|FG010|STARTED|Overall Study||23||
48599506|NCT02952872|101803201|FG011|STARTED|Overall Study||22||
48599507|NCT02952872|101803202|FG012|STARTED|Overall Study||22||
48599508|NCT02952872|101803203|FG013|STARTED|Overall Study||22||
48599509|NCT02952872|101803204|FG014|STARTED|Overall Study||22||
48599510|NCT02952872|101803205|FG015|STARTED|Overall Study||23||
48599511|NCT02952872|101803190|FG000|COMPLETED|Overall Study||22||
48599512|NCT02952872|101803191|FG001|COMPLETED|Overall Study||22||
48599513|NCT02952872|101803192|FG002|COMPLETED|Overall Study||22||
48599514|NCT02952872|101803193|FG003|COMPLETED|Overall Study||22||
48599515|NCT02952872|101803194|FG004|COMPLETED|Overall Study||22||
48599516|NCT02952872|101803195|FG005|COMPLETED|Overall Study||21||
48599517|NCT02952872|101803196|FG006|COMPLETED|Overall Study||22||
48599518|NCT02952872|101803197|FG007|COMPLETED|Overall Study||21||
48599519|NCT02952872|101803198|FG008|COMPLETED|Overall Study||22||
48599520|NCT02952872|101803199|FG009|COMPLETED|Overall Study||22||
48599521|NCT02952872|101803200|FG010|COMPLETED|Overall Study||23||
48599522|NCT02952872|101803201|FG011|COMPLETED|Overall Study||22||
48599523|NCT02952872|101803202|FG012|COMPLETED|Overall Study||22||
48599524|NCT02952872|101803203|FG013|COMPLETED|Overall Study||22||
48599525|NCT02952872|101803204|FG014|COMPLETED|Overall Study||22||
48599526|NCT02952872|101803205|FG015|COMPLETED|Overall Study||23||
48599527|NCT02952872|101803190|FG000|NOT COMPLETED|Overall Study||0||
48599528|NCT02952872|101803191|FG001|NOT COMPLETED|Overall Study||0||
48599529|NCT02952872|101803192|FG002|NOT COMPLETED|Overall Study||0||
48599530|NCT02952872|101803193|FG003|NOT COMPLETED|Overall Study||0||
48599531|NCT02952872|101803194|FG004|NOT COMPLETED|Overall Study||0||
48599532|NCT02952872|101803195|FG005|NOT COMPLETED|Overall Study||0||
48599533|NCT02952872|101803196|FG006|NOT COMPLETED|Overall Study||0||
48599534|NCT02952872|101803197|FG007|NOT COMPLETED|Overall Study||0||
48599535|NCT02952872|101803198|FG008|NOT COMPLETED|Overall Study||0||
48599536|NCT02952872|101803199|FG009|NOT COMPLETED|Overall Study||0||
48599537|NCT02952872|101803200|FG010|NOT COMPLETED|Overall Study||0||
48599538|NCT02952872|101803201|FG011|NOT COMPLETED|Overall Study||0||
48599539|NCT02952872|101803202|FG012|NOT COMPLETED|Overall Study||0||
48599540|NCT02952872|101803203|FG013|NOT COMPLETED|Overall Study||0||
48599541|NCT02952872|101803204|FG014|NOT COMPLETED|Overall Study||0||
48599542|NCT02952872|101803205|FG015|NOT COMPLETED|Overall Study||0||
48599543|NCT04490018|101803206|FG000|STARTED|Overall Study||173||
48713813|NCT01018095|102085050|FG000|NOT COMPLETED|Overall Study||56||
48713814|NCT01018095|102085051|FG001|NOT COMPLETED|Overall Study||62||
48713815|NCT01318070|102085052|FG000|STARTED|Overall Study||111||
48599544|NCT04490018|101803207|FG001|STARTED|Overall Study||173||
48599545|NCT04490018|101803208|FG002|STARTED|Overall Study||117||
48599546|NCT04490018|101803206|FG000|Safety Analysis Set|Overall Study||171|Participants who had received at least one dose of the study vaccines (all groups) and had any safety data available.|
48599547|NCT04490018|101803207|FG001|Safety Analysis Set|Overall Study||171|Participants who had received at least one dose of the study vaccines (all groups) and had any safety data available.|
48599548|NCT04490018|101803208|FG002|Safety Analysis Set|Overall Study||116|Participants who had received at least one dose of the study vaccines (all groups) and had any safety data available.|
48599549|NCT04490018|101803206|FG000|Vaccinated at Day 01|Overall Study||170||
48599550|NCT04490018|101803207|FG001|Vaccinated at Day 01|Overall Study||172||
48599551|NCT04490018|101803208|FG002|Vaccinated at Day 01|Overall Study||116||
48599552|NCT04490018|101803206|FG000|Vaccinated at Day 31|Overall Study||168||
48599553|NCT04490018|101803207|FG001|Vaccinated at Day 31|Overall Study||169||
48599554|NCT04490018|101803208|FG002|Vaccinated at Day 31|Overall Study||0||
48599555|NCT04490018|101803206|FG000|COMPLETED|Overall Study||167||
48599556|NCT04490018|101803207|FG001|COMPLETED|Overall Study||165||
48599557|NCT04490018|101803208|FG002|COMPLETED|Overall Study||116||
48599558|NCT04490018|101803206|FG000|NOT COMPLETED|Overall Study||6||
48599559|NCT04490018|101803207|FG001|NOT COMPLETED|Overall Study||8||
48599560|NCT04490018|101803208|FG002|NOT COMPLETED|Overall Study||1||
48599561|NCT02696434|101803209|FG000|STARTED|Overall Study||50||
48599562|NCT02696434|101803210|FG001|STARTED|Overall Study||51||
48599563|NCT02696434|101803209|FG000|COMPLETED|Overall Study||28||
48599564|NCT02696434|101803210|FG001|COMPLETED|Overall Study||33||
48599565|NCT02696434|101803209|FG000|NOT COMPLETED|Overall Study||22||
48599566|NCT02696434|101803210|FG001|NOT COMPLETED|Overall Study||18||
48599567|NCT02203162|101803211|FG000|STARTED|Overall Study||30||
48599568|NCT02203162|101803211|FG000|COMPLETED|Overall Study||30||
48599569|NCT02203162|101803211|FG000|NOT COMPLETED|Overall Study||0||
48599570|NCT02485418|101803212|FG000|STARTED|Overall Study||40||
48599571|NCT02485418|101803212|FG000|COMPLETED|Overall Study||38||
48599572|NCT02485418|101803212|FG000|NOT COMPLETED|Overall Study||2||
48599573|NCT00426660|101803213|FG000|STARTED|Overall Study||1047||
48599574|NCT00426660|101803213|FG000|Treated|Overall Study||1032||
48599575|NCT00426660|101803213|FG000|Safety Analysis Set|Overall Study||1032||
48599576|NCT00426660|101803213|FG000|COMPLETED|Overall Study||916||
48599577|NCT00426660|101803213|FG000|NOT COMPLETED|Overall Study||131||
48599578|NCT01739764|101803214|FG000|STARTED|Overall Study||29||
48599579|NCT01739764|101803215|FG001|STARTED|Overall Study||40||
48599580|NCT01739764|101803216|FG002|STARTED|Overall Study||146||
48599581|NCT01739764|101803214|FG000|COMPLETED|Overall Study||3||
48599582|NCT01739764|101803215|FG001|COMPLETED|Overall Study||4||
48599583|NCT01739764|101803216|FG002|COMPLETED|Overall Study||20||
48599584|NCT01739764|101803214|FG000|NOT COMPLETED|Overall Study||26||
48599585|NCT01739764|101803215|FG001|NOT COMPLETED|Overall Study||36||
48599586|NCT01739764|101803216|FG002|NOT COMPLETED|Overall Study||126||
48599587|NCT02735096|101803217|FG000|STARTED|Overall Study||4||
48599588|NCT02735096|101803217|FG000|COMPLETED|Overall Study||3||
48599589|NCT02735096|101803217|FG000|NOT COMPLETED|Overall Study||1||
48599590|NCT02828137|101803218|FG000|STARTED|Overall Study||41||
48599591|NCT02828137|101803219|FG001|STARTED|Overall Study||41||
48599592|NCT02828137|101803220|FG002|STARTED|Overall Study||41||
48599593|NCT02828137|101803218|FG000|COMPLETED|Overall Study||41||
48599594|NCT02828137|101803219|FG001|COMPLETED|Overall Study||41||
48599595|NCT02828137|101803220|FG002|COMPLETED|Overall Study||41||
48599596|NCT02828137|101803218|FG000|NOT COMPLETED|Overall Study||0||
48599597|NCT02828137|101803219|FG001|NOT COMPLETED|Overall Study||0||
48599598|NCT02828137|101803220|FG002|NOT COMPLETED|Overall Study||0||
48599599|NCT01389258|101803221|FG000|STARTED|Overall Study||45||47
48599600|NCT01389258|101803221|FG000|COMPLETED|Overall Study||40||42
48599601|NCT01389258|101803221|FG000|NOT COMPLETED|Overall Study||5||5
48599602|NCT02971800|101803222|FG000|STARTED|Overall Study||37||
48599603|NCT02971800|101803222|FG000|COMPLETED|Overall Study||30||
48599604|NCT02971800|101803222|FG000|NOT COMPLETED|Overall Study||7||
48599605|NCT02536781|101803223|FG000|STARTED|Overall Study||36||
48599606|NCT02536781|101803224|FG001|STARTED|Overall Study||34||
48599607|NCT02536781|101803223|FG000|COMPLETED|Overall Study||34||
48599608|NCT02536781|101803224|FG001|COMPLETED|Overall Study||34||
48599609|NCT02536781|101803223|FG000|NOT COMPLETED|Overall Study||2||
48599610|NCT02536781|101803224|FG001|NOT COMPLETED|Overall Study||0||
48599611|NCT01903993|101803225|FG000|STARTED|Overall Study||143||
48599612|NCT01903993|101803226|FG001|STARTED|Overall Study||144||
48599613|NCT01903993|101803225|FG000|Received Treatment|Overall Study||135|Two patients in the docetaxel arm crossed over to receive atezolizumab treatment.|
48599614|NCT01903993|101803226|FG001|Received Treatment|Overall Study||142|Two patients in the docetaxel arm crossed over to receive atezolizumab treatment.|
48599615|NCT01903993|101803225|FG000|COMPLETED|Overall Study||0|Study terminated by Sponsor participants either discontinued or enrolled in extension study|
48599616|NCT01903993|101803226|FG001|COMPLETED|Overall Study||0|Study terminated by Sponsor participants either discontinued or enrolled in extension study|
48599617|NCT01903993|101803225|FG000|NOT COMPLETED|Overall Study||143||
48599618|NCT01903993|101803226|FG001|NOT COMPLETED|Overall Study||144||
48599619|NCT00862459|101803227|FG000|STARTED|Overall Study||72||
48599620|NCT00862459|101803228|FG001|STARTED|Overall Study||93||
48599621|NCT00862459|101803229|FG002|STARTED|Overall Study||72||
48599622|NCT00862459|101803227|FG000|Participants Received Treatment|Overall Study||70||
48599623|NCT00862459|101803228|FG001|Participants Received Treatment|Overall Study||90||
48599624|NCT00862459|101803229|FG002|Participants Received Treatment|Overall Study||69||
48599625|NCT00862459|101803227|FG000|COMPLETED|Overall Study||66||
48599626|NCT00862459|101803228|FG001|COMPLETED|Overall Study||85||
48599627|NCT00862459|101803229|FG002|COMPLETED|Overall Study||66||
48599628|NCT00862459|101803227|FG000|NOT COMPLETED|Overall Study||6||
48599629|NCT00862459|101803228|FG001|NOT COMPLETED|Overall Study||8||
48599630|NCT00862459|101803229|FG002|NOT COMPLETED|Overall Study||6||
48599631|NCT00396383|101803230|FG000|STARTED|Overall Study||9||
48599632|NCT00396383|101803230|FG000|COMPLETED|Overall Study||6||
48599633|NCT00396383|101803230|FG000|NOT COMPLETED|Overall Study||3||
48599634|NCT00577005|101803231|FG000|STARTED|Overall Study||16||
48599635|NCT00577005|101803232|FG001|STARTED|Overall Study||12||
48599636|NCT00577005|101803231|FG000|COMPLETED|Overall Study||11||
48599637|NCT00577005|101803232|FG001|COMPLETED|Overall Study||9||
48599638|NCT00577005|101803231|FG000|NOT COMPLETED|Overall Study||5||
48599639|NCT00577005|101803232|FG001|NOT COMPLETED|Overall Study||3||
48599640|NCT00401401|101803233|FG000|STARTED|Overall Study||6||
48599641|NCT00401401|101803234|FG001|STARTED|Overall Study||6||
48599642|NCT00401401|101803235|FG002|STARTED|Overall Study||6||
48599643|NCT00401401|101803236|FG003|STARTED|Overall Study||12||
48599644|NCT00401401|101803233|FG000|COMPLETED|Overall Study||6||
48599645|NCT00401401|101803234|FG001|COMPLETED|Overall Study||6||
48599646|NCT00401401|101803235|FG002|COMPLETED|Overall Study||5||
48599647|NCT00401401|101803236|FG003|COMPLETED|Overall Study||9||
48599648|NCT00401401|101803233|FG000|NOT COMPLETED|Overall Study||0||
48599649|NCT00401401|101803234|FG001|NOT COMPLETED|Overall Study||0||
48599650|NCT00401401|101803235|FG002|NOT COMPLETED|Overall Study||1||
48599651|NCT00401401|101803236|FG003|NOT COMPLETED|Overall Study||3||
48599652|NCT01918072|101803237|FG000|STARTED|Controlled Trial Step One - Six Months||11||
48599653|NCT01918072|101803238|FG001|STARTED|Controlled Trial Step One - Six Months||0||
48599654|NCT01918072|101803239|FG002|STARTED|Controlled Trial Step One - Six Months||0||
48599655|NCT01918072|101803237|FG000|Intervention|Controlled Trial Step One - Six Months||1|First primary care provider group steps into intervention|
48599656|NCT01918072|101803238|FG001|Intervention|Controlled Trial Step One - Six Months||0|First primary care provider group steps into intervention|
48599657|NCT01918072|101803239|FG002|Intervention|Controlled Trial Step One - Six Months||0|First primary care provider group steps into intervention|
48599658|NCT01918072|101803237|FG000|Control|Controlled Trial Step One - Six Months||10||
48599659|NCT01918072|101803238|FG001|Control|Controlled Trial Step One - Six Months||0||
48599660|NCT01918072|101803239|FG002|Control|Controlled Trial Step One - Six Months||0||
48599661|NCT01918072|101803237|FG000|COMPLETED|Controlled Trial Step One - Six Months||11||
48599662|NCT01918072|101803238|FG001|COMPLETED|Controlled Trial Step One - Six Months||0||
48599663|NCT01918072|101803239|FG002|COMPLETED|Controlled Trial Step One - Six Months||0||
48599664|NCT01918072|101803237|FG000|NOT COMPLETED|Controlled Trial Step One - Six Months||0||
48599665|NCT01918072|101803238|FG001|NOT COMPLETED|Controlled Trial Step One - Six Months||0||
48599666|NCT01918072|101803239|FG002|NOT COMPLETED|Controlled Trial Step One - Six Months||0||
48599667|NCT01918072|101803237|FG000|STARTED|Controlled Trial Step Two - Six Months||11||
48599668|NCT01918072|101803238|FG001|STARTED|Controlled Trial Step Two - Six Months||0||
48599669|NCT01918072|101803239|FG002|STARTED|Controlled Trial Step Two - Six Months||0||
48599670|NCT01918072|101803237|FG000|Intervention|Controlled Trial Step Two - Six Months||7|Second primary care provider group steps into intervention|
48599671|NCT01918072|101803238|FG001|Intervention|Controlled Trial Step Two - Six Months||0|Second primary care provider group steps into intervention|
48599672|NCT01918072|101803239|FG002|Intervention|Controlled Trial Step Two - Six Months||0|Second primary care provider group steps into intervention|
48599673|NCT01918072|101803237|FG000|Control|Controlled Trial Step Two - Six Months||4||
48599674|NCT01918072|101803238|FG001|Control|Controlled Trial Step Two - Six Months||0||
48599675|NCT01918072|101803239|FG002|Control|Controlled Trial Step Two - Six Months||0||
48599676|NCT01918072|101803237|FG000|COMPLETED|Controlled Trial Step Two - Six Months||11||
48599677|NCT01918072|101803238|FG001|COMPLETED|Controlled Trial Step Two - Six Months||0||
48599678|NCT01918072|101803239|FG002|COMPLETED|Controlled Trial Step Two - Six Months||0||
48599679|NCT01918072|101803237|FG000|NOT COMPLETED|Controlled Trial Step Two - Six Months||0||
48599680|NCT01918072|101803238|FG001|NOT COMPLETED|Controlled Trial Step Two - Six Months||0||
48599681|NCT01918072|101803239|FG002|NOT COMPLETED|Controlled Trial Step Two - Six Months||0||
48599682|NCT01918072|101803237|FG000|STARTED|Controlled Trial Step Three - Six Months||11||
48599683|NCT01918072|101803238|FG001|STARTED|Controlled Trial Step Three - Six Months||0||
48599684|NCT01918072|101803239|FG002|STARTED|Controlled Trial Step Three - Six Months||0||
48599685|NCT01918072|101803237|FG000|Intervention|Controlled Trial Step Three - Six Months||9|Third primary care provider group steps into intervention|
48599686|NCT01918072|101803238|FG001|Intervention|Controlled Trial Step Three - Six Months||0|Third primary care provider group steps into intervention|
48599687|NCT01918072|101803239|FG002|Intervention|Controlled Trial Step Three - Six Months||0|Third primary care provider group steps into intervention|
48599688|NCT01918072|101803237|FG000|Control|Controlled Trial Step Three - Six Months||2||
48599689|NCT01918072|101803238|FG001|Control|Controlled Trial Step Three - Six Months||0||
48599690|NCT01918072|101803239|FG002|Control|Controlled Trial Step Three - Six Months||0||
48599691|NCT01918072|101803237|FG000|COMPLETED|Controlled Trial Step Three - Six Months||11||
48599692|NCT01918072|101803238|FG001|COMPLETED|Controlled Trial Step Three - Six Months||0||
48599693|NCT01918072|101803239|FG002|COMPLETED|Controlled Trial Step Three - Six Months||0||
48599694|NCT01918072|101803237|FG000|NOT COMPLETED|Controlled Trial Step Three - Six Months||0||
48599695|NCT01918072|101803238|FG001|NOT COMPLETED|Controlled Trial Step Three - Six Months||0||
48599696|NCT01918072|101803239|FG002|NOT COMPLETED|Controlled Trial Step Three - Six Months||0||
48599697|NCT01918072|101803237|FG000|STARTED|Controlled Trial Step Four - Six Months||11||
48713816|NCT01318070|102085053|FG001|STARTED|Overall Study||113||
48599698|NCT01918072|101803238|FG001|STARTED|Controlled Trial Step Four - Six Months||0||
48599699|NCT01918072|101803239|FG002|STARTED|Controlled Trial Step Four - Six Months||0||
48599700|NCT01918072|101803237|FG000|Intervention|Controlled Trial Step Four - Six Months||11|Fourth primary care provider group steps into intervention|
48599701|NCT01918072|101803238|FG001|Intervention|Controlled Trial Step Four - Six Months||0|Fourth primary care provider group steps into intervention|
48599702|NCT01918072|101803239|FG002|Intervention|Controlled Trial Step Four - Six Months||0|Fourth primary care provider group steps into intervention|
48599703|NCT01918072|101803237|FG000|Control|Controlled Trial Step Four - Six Months||0||
48599704|NCT01918072|101803238|FG001|Control|Controlled Trial Step Four - Six Months||0||
48599705|NCT01918072|101803239|FG002|Control|Controlled Trial Step Four - Six Months||0||
48599706|NCT01918072|101803237|FG000|COMPLETED|Controlled Trial Step Four - Six Months||11||
48599707|NCT01918072|101803238|FG001|COMPLETED|Controlled Trial Step Four - Six Months||0||
48599708|NCT01918072|101803239|FG002|COMPLETED|Controlled Trial Step Four - Six Months||0||
48657068|NCT03648372|101943766|FG009|COMPLETED|Overall Study||1||
48599709|NCT01918072|101803237|FG000|NOT COMPLETED|Controlled Trial Step Four - Six Months||0||
48599710|NCT01918072|101803238|FG001|NOT COMPLETED|Controlled Trial Step Four - Six Months||0||
48599711|NCT01918072|101803239|FG002|NOT COMPLETED|Controlled Trial Step Four - Six Months||0||
48599712|NCT01918072|101803237|FG000|STARTED|Controlled Trial Step Five - Four Months||11||
48599713|NCT01918072|101803238|FG001|STARTED|Controlled Trial Step Five - Four Months||0||
48599714|NCT01918072|101803239|FG002|STARTED|Controlled Trial Step Five - Four Months||0||
48599715|NCT01918072|101803237|FG000|Intervention|Controlled Trial Step Five - Four Months||11|All primary care provider groups fully in intervention|
48599716|NCT01918072|101803238|FG001|Intervention|Controlled Trial Step Five - Four Months||0|All primary care provider groups fully in intervention|
48599717|NCT01918072|101803239|FG002|Intervention|Controlled Trial Step Five - Four Months||0|All primary care provider groups fully in intervention|
48599718|NCT01918072|101803237|FG000|Control|Controlled Trial Step Five - Four Months||0||
48599719|NCT01918072|101803238|FG001|Control|Controlled Trial Step Five - Four Months||0||
48599720|NCT01918072|101803239|FG002|Control|Controlled Trial Step Five - Four Months||0||
48599721|NCT01918072|101803237|FG000|COMPLETED|Controlled Trial Step Five - Four Months||11||
48599722|NCT01918072|101803238|FG001|COMPLETED|Controlled Trial Step Five - Four Months||0||
48599723|NCT01918072|101803239|FG002|COMPLETED|Controlled Trial Step Five - Four Months||0||
48599724|NCT01918072|101803237|FG000|NOT COMPLETED|Controlled Trial Step Five - Four Months||0||
48599725|NCT01918072|101803238|FG001|NOT COMPLETED|Controlled Trial Step Five - Four Months||0||
48599726|NCT01918072|101803239|FG002|NOT COMPLETED|Controlled Trial Step Five - Four Months||0||
48599727|NCT01918072|101803237|FG000|STARTED|E-consult Assessment Period||0||
48599728|NCT01918072|101803238|FG001|STARTED|E-consult Assessment Period||42||
48599729|NCT01918072|101803239|FG002|STARTED|E-consult Assessment Period||0||
48599730|NCT01918072|101803237|FG000|COMPLETED|E-consult Assessment Period||0||
48599731|NCT01918072|101803238|FG001|COMPLETED|E-consult Assessment Period||42||
48599732|NCT01918072|101803239|FG002|COMPLETED|E-consult Assessment Period||0||
48599733|NCT01918072|101803237|FG000|NOT COMPLETED|E-consult Assessment Period||0||
48599734|NCT01918072|101803238|FG001|NOT COMPLETED|E-consult Assessment Period||0||
48599735|NCT01918072|101803239|FG002|NOT COMPLETED|E-consult Assessment Period||0||
48599736|NCT01918072|101803237|FG000|STARTED|Quality Assessment Period||0||
48599737|NCT01918072|101803238|FG001|STARTED|Quality Assessment Period||0||
48599738|NCT01918072|101803239|FG002|STARTED|Quality Assessment Period||202||
48599739|NCT01918072|101803237|FG000|COMPLETED|Quality Assessment Period||0||
48713817|NCT01318070|102085054|FG002|STARTED|Overall Study||115||
48599740|NCT01918072|101803238|FG001|COMPLETED|Quality Assessment Period||0||
48599741|NCT01918072|101803239|FG002|COMPLETED|Quality Assessment Period||202||
48599742|NCT01918072|101803237|FG000|NOT COMPLETED|Quality Assessment Period||0||
48599743|NCT01918072|101803238|FG001|NOT COMPLETED|Quality Assessment Period||0||
48599744|NCT01918072|101803239|FG002|NOT COMPLETED|Quality Assessment Period||0||
48599745|NCT02787083|101803240|FG000|STARTED|Overall Study||4||
48599746|NCT02787083|101803241|FG001|STARTED|Overall Study||5||
48599747|NCT02787083|101803240|FG000|COMPLETED|Overall Study||1||
48599748|NCT02787083|101803241|FG001|COMPLETED|Overall Study||3||
48599749|NCT02787083|101803240|FG000|NOT COMPLETED|Overall Study||3||
48599750|NCT02787083|101803241|FG001|NOT COMPLETED|Overall Study||2||
48599751|NCT02273908|101803242|FG000|STARTED|Overall Study||157||
48599752|NCT02273908|101803243|FG001|STARTED|Overall Study||174||
48599753|NCT02273908|101803242|FG000|COMPLETED|Overall Study||124||
48599754|NCT02273908|101803243|FG001|COMPLETED|Overall Study||169||
48599755|NCT02273908|101803242|FG000|NOT COMPLETED|Overall Study||33||
48599756|NCT02273908|101803243|FG001|NOT COMPLETED|Overall Study||5||
48599757|NCT02083653|101803244|FG000|STARTED|Overall Study||83||
48599758|NCT02083653|101803245|FG001|STARTED|Overall Study||86||
48599759|NCT02083653|101803246|FG002|STARTED|Overall Study||85||
48599760|NCT02083653|101803244|FG000|COMPLETED|Overall Study||1||
48599761|NCT02083653|101803245|FG001|COMPLETED|Overall Study||1||
48599762|NCT02083653|101803246|FG002|COMPLETED|Overall Study||1||
48599763|NCT02083653|101803244|FG000|NOT COMPLETED|Overall Study||82||
48599764|NCT02083653|101803245|FG001|NOT COMPLETED|Overall Study||85||
48599765|NCT02083653|101803246|FG002|NOT COMPLETED|Overall Study||84||
48599766|NCT02102100|101803247|FG000|STARTED|Overall Study||32||
48599767|NCT02102100|101803248|FG001|STARTED|Overall Study||25||
48599768|NCT02102100|101803247|FG000|COMPLETED|Overall Study||23||
48599769|NCT02102100|101803248|FG001|COMPLETED|Overall Study||18||
48599770|NCT02102100|101803247|FG000|NOT COMPLETED|Overall Study||9||
48599771|NCT02102100|101803248|FG001|NOT COMPLETED|Overall Study||7||
48599772|NCT00076258|101803249|FG000|STARTED|Overall Study||62||
48599773|NCT00076258|101803250|FG001|STARTED|Overall Study||64||
48599774|NCT00076258|101803249|FG000|COMPLETED|Overall Study||61||
48599775|NCT00076258|101803250|FG001|COMPLETED|Overall Study||61||
48599776|NCT00076258|101803249|FG000|NOT COMPLETED|Overall Study||1||
48599777|NCT00076258|101803250|FG001|NOT COMPLETED|Overall Study||3||
48713818|NCT01318070|102085052|FG000|COMPLETED|Overall Study||109||
48713819|NCT01318070|102085053|FG001|COMPLETED|Overall Study||111||
48599778|NCT00422292|101803251|FG000|STARTED|Overall Study||257||
48599779|NCT00422292|101803252|FG001|STARTED|Overall Study||664||
48599780|NCT00422292|101803253|FG002|STARTED|Overall Study||246||
48599781|NCT00422292|101803254|FG003|STARTED|Overall Study||476||
48713820|NCT01318070|102085054|FG002|COMPLETED|Overall Study||108||
48599782|NCT00422292|101803251|FG000|COMPLETED|Overall Study||239||
48599783|NCT00422292|101803252|FG001|COMPLETED|Overall Study||598||
48599784|NCT00422292|101803253|FG002|COMPLETED|Overall Study||224||
48599785|NCT00422292|101803254|FG003|COMPLETED|Overall Study||452||
48599786|NCT00422292|101803251|FG000|NOT COMPLETED|Overall Study||18||
48599787|NCT00422292|101803252|FG001|NOT COMPLETED|Overall Study||66||
48599788|NCT00422292|101803253|FG002|NOT COMPLETED|Overall Study||22||
48599789|NCT00422292|101803254|FG003|NOT COMPLETED|Overall Study||24||
48599790|NCT01665677|101803255|FG000|STARTED|Overall Study||30||
48599791|NCT01665677|101803256|FG001|STARTED|Overall Study||39||
48599792|NCT01665677|101803255|FG000|COMPLETED|Overall Study||30||
48599793|NCT01665677|101803256|FG001|COMPLETED|Overall Study||39||
48599794|NCT01665677|101803255|FG000|NOT COMPLETED|Overall Study||0||
48599795|NCT01665677|101803256|FG001|NOT COMPLETED|Overall Study||0||
48599796|NCT01156051|101803257|FG000|STARTED|Overall Study||12||
48599797|NCT01156051|101803258|FG001|STARTED|Overall Study||17||
48599798|NCT01156051|101803257|FG000|COMPLETED|Overall Study||11||
48599799|NCT01156051|101803258|FG001|COMPLETED|Overall Study||16||
48599800|NCT01156051|101803257|FG000|NOT COMPLETED|Overall Study||1||
48599801|NCT01156051|101803258|FG001|NOT COMPLETED|Overall Study||1||
48599802|NCT01726621|101803259|FG000|STARTED|Overall Study||55||
48599803|NCT01726621|101803259|FG000|COMPLETED|Overall Study||51||
48599804|NCT01726621|101803259|FG000|NOT COMPLETED|Overall Study||4||
48599805|NCT05095311|101803260|FG000|STARTED|Overall Study||12||
48599806|NCT05095311|101803261|FG001|STARTED|Overall Study||2||
48599807|NCT05095311|101803262|FG002|STARTED|Overall Study||2||
48599808|NCT05095311|101803260|FG000|COMPLETED|Overall Study||5||
48599809|NCT05095311|101803261|FG001|COMPLETED|Overall Study||2||
48599810|NCT05095311|101803262|FG002|COMPLETED|Overall Study||2||
48599811|NCT05095311|101803260|FG000|NOT COMPLETED|Overall Study||7||
48599812|NCT05095311|101803261|FG001|NOT COMPLETED|Overall Study||0||
48599813|NCT05095311|101803262|FG002|NOT COMPLETED|Overall Study||0||
48599814|NCT00911586|101803263|FG000|STARTED|Overall Study||15||
48599815|NCT00911586|101803263|FG000|COMPLETED|Overall Study||15||
48599816|NCT00911586|101803263|FG000|NOT COMPLETED|Overall Study||0||
48599817|NCT00520767|101803264|FG000|STARTED|Overall Study||35||
48599818|NCT00520767|101803264|FG000|COMPLETED|Overall Study||33||
48599819|NCT00520767|101803264|FG000|NOT COMPLETED|Overall Study||2||
48599820|NCT03763058|101803265|FG000|STARTED|Overall Study||20||
48298127|NCT03598088|101057088|FG000|COMPLETED|Screening/Baseline PCT Visits 1-4||38||
48298128|NCT03598088|101057088|FG000|NOT COMPLETED|Screening/Baseline PCT Visits 1-4||0||
48298129|NCT03598088|101057088|FG000|STARTED|Caya PCT Cycle, Visit 5 & 6||38||
48298130|NCT03598088|101057088|FG000|COMPLETED|Caya PCT Cycle, Visit 5 & 6||35||
48298131|NCT03598088|101057088|FG000|NOT COMPLETED|Caya PCT Cycle, Visit 5 & 6||3||
48298132|NCT03598088|101057088|FG000|STARTED|OVP Safety Cycle Visits 7-11||33||
48298133|NCT03598088|101057088|FG000|Used the OVP Device During the Study|OVP Safety Cycle Visits 7-11||33||
48298134|NCT03598088|101057088|FG000|COMPLETED|OVP Safety Cycle Visits 7-11||28|2 subjects completed Visit 6, but discontinued prior to Visit 7|
48599821|NCT03763058|101803265|FG000|COMPLETED|Overall Study||18||
48599822|NCT03763058|101803265|FG000|NOT COMPLETED|Overall Study||2||
48599823|NCT02787057|101803266|FG000|STARTED|Overall Study||40||
48599824|NCT02787057|101803267|FG001|STARTED|Overall Study||40||
48599825|NCT02787057|101803266|FG000|COMPLETED|Overall Study||40||
48599826|NCT02787057|101803267|FG001|COMPLETED|Overall Study||40||
48599827|NCT02787057|101803266|FG000|NOT COMPLETED|Overall Study||0||
48599828|NCT02787057|101803267|FG001|NOT COMPLETED|Overall Study||0||
48599829|NCT02661061|101803268|FG000|STARTED|Overall Study||5||
48599830|NCT02661061|101803269|FG001|STARTED|Overall Study||4||
48599831|NCT02661061|101803268|FG000|COMPLETED|Overall Study||3||
48599832|NCT02661061|101803269|FG001|COMPLETED|Overall Study||2||
48599833|NCT02661061|101803268|FG000|NOT COMPLETED|Overall Study||2||
48599834|NCT02661061|101803269|FG001|NOT COMPLETED|Overall Study||2||
48599835|NCT06046209|101803270|FG000|STARTED|Period 1: First Intervention-90 Minutes||15||
48599836|NCT06046209|101803271|FG001|STARTED|Period 1: First Intervention-90 Minutes||15||
48599837|NCT06046209|101803270|FG000|COMPLETED|Period 1: First Intervention-90 Minutes||15||
48599838|NCT06046209|101803271|FG001|COMPLETED|Period 1: First Intervention-90 Minutes||15||
48599839|NCT06046209|101803270|FG000|NOT COMPLETED|Period 1: First Intervention-90 Minutes||0||
48599840|NCT06046209|101803271|FG001|NOT COMPLETED|Period 1: First Intervention-90 Minutes||0||
48599841|NCT06046209|101803270|FG000|STARTED|Period 2: Second Intervention-90 Minutes||15||
48599842|NCT06046209|101803271|FG001|STARTED|Period 2: Second Intervention-90 Minutes||15||
48599843|NCT06046209|101803270|FG000|COMPLETED|Period 2: Second Intervention-90 Minutes||15||
48599844|NCT06046209|101803271|FG001|COMPLETED|Period 2: Second Intervention-90 Minutes||15||
48599845|NCT06046209|101803270|FG000|NOT COMPLETED|Period 2: Second Intervention-90 Minutes||0||
48599846|NCT06046209|101803271|FG001|NOT COMPLETED|Period 2: Second Intervention-90 Minutes||0||
48599847|NCT02045732|101803272|FG000|STARTED|Overall Study||1||
48599848|NCT02045732|101803273|FG001|STARTED|Overall Study||3||
48599849|NCT02045732|101803272|FG000|COMPLETED|Overall Study||0||
48599850|NCT02045732|101803273|FG001|COMPLETED|Overall Study||2||
48599851|NCT02045732|101803272|FG000|NOT COMPLETED|Overall Study||1||
48599852|NCT02045732|101803273|FG001|NOT COMPLETED|Overall Study||1||
48599853|NCT04150705|101803274|FG000|STARTED|Overall Study||14||
48298135|NCT03598088|101057088|FG000|NOT COMPLETED|OVP Safety Cycle Visits 7-11||5||
48298136|NCT03598088|101057088|FG000|STARTED|OVP PCT Cycle A Visits 12-16||28||
48298137|NCT03598088|101057088|FG000|Completed 1 OVP PCT Cycle|OVP PCT Cycle A Visits 12-16||26||
48298138|NCT03598088|101057088|FG000|COMPLETED|OVP PCT Cycle A Visits 12-16||24||
48298139|NCT03598088|101057088|FG000|NOT COMPLETED|OVP PCT Cycle A Visits 12-16||4||
48599854|NCT04150705|101803274|FG000|COMPLETED|Overall Study||14||
48599855|NCT04150705|101803274|FG000|NOT COMPLETED|Overall Study||0||
48599856|NCT00586898|101803275|FG000|STARTED|Overall Study||36||
48599857|NCT00586898|101803275|FG000|COMPLETED|Overall Study||29||
48599858|NCT00586898|101803275|FG000|NOT COMPLETED|Overall Study||7||
48599859|NCT01250171|101803276|FG000|STARTED|Overall Study||26||
48599860|NCT01250171|101803277|FG001|STARTED|Overall Study||22||
48599861|NCT01250171|101803278|FG002|STARTED|Overall Study||24||
48599862|NCT01250171|101803276|FG000|COMPLETED|Overall Study||25||
48599863|NCT01250171|101803277|FG001|COMPLETED|Overall Study||22||
48599864|NCT01250171|101803278|FG002|COMPLETED|Overall Study||24||
48599865|NCT01250171|101803276|FG000|NOT COMPLETED|Overall Study||1||
48599866|NCT01250171|101803277|FG001|NOT COMPLETED|Overall Study||0||
48599867|NCT01250171|101803278|FG002|NOT COMPLETED|Overall Study||0||
48599868|NCT00628927|101803279|FG000|STARTED|Overall Study||183||
48599869|NCT00628927|101803280|FG001|STARTED|Overall Study||30||
48599870|NCT00628927|101803279|FG000|COMPLETED|Overall Study||175||
48599871|NCT00628927|101803280|FG001|COMPLETED|Overall Study||30||
48599872|NCT00628927|101803279|FG000|NOT COMPLETED|Overall Study||8||
48298140|NCT03598088|101057088|FG000|STARTED|OVP PCT Cycle B Visits 17-21||24||
48298141|NCT03598088|101057088|FG000|COMPLETED|OVP PCT Cycle B Visits 17-21||23||
48298142|NCT03598088|101057088|FG000|NOT COMPLETED|OVP PCT Cycle B Visits 17-21||1||
48298143|NCT02090374|101057089|FG000|STARTED|Overall Study||8||
48298144|NCT02090374|101057090|FG001|STARTED|Overall Study||4||
48298145|NCT02090374|101057091|FG002|STARTED|Overall Study||4||
48298146|NCT02090374|101057092|FG003|STARTED|Overall Study||9||
48298147|NCT02090374|101057093|FG004|STARTED|Overall Study||35||
48298148|NCT02090374|101057094|FG005|STARTED|Overall Study||15||
48298149|NCT02090374|101057095|FG006|STARTED|Overall Study||16||
48298150|NCT02090374|101057096|FG007|STARTED|Overall Study||2||
48298151|NCT02090374|101057089|FG000|COMPLETED|Overall Study||8||
48298152|NCT02090374|101057090|FG001|COMPLETED|Overall Study||4||
48298153|NCT02090374|101057091|FG002|COMPLETED|Overall Study||4||
48298154|NCT02090374|101057092|FG003|COMPLETED|Overall Study||9||
48298155|NCT02090374|101057093|FG004|COMPLETED|Overall Study||35||
48298156|NCT02090374|101057094|FG005|COMPLETED|Overall Study||15||
48298157|NCT02090374|101057095|FG006|COMPLETED|Overall Study||16||
48298158|NCT02090374|101057096|FG007|COMPLETED|Overall Study||2||
48298159|NCT02090374|101057089|FG000|NOT COMPLETED|Overall Study||0||
48298160|NCT02090374|101057090|FG001|NOT COMPLETED|Overall Study||0||
48298161|NCT02090374|101057091|FG002|NOT COMPLETED|Overall Study||0||
48298162|NCT02090374|101057092|FG003|NOT COMPLETED|Overall Study||0||
48298163|NCT02090374|101057093|FG004|NOT COMPLETED|Overall Study||0||
48298164|NCT02090374|101057094|FG005|NOT COMPLETED|Overall Study||0||
48298165|NCT02090374|101057095|FG006|NOT COMPLETED|Overall Study||0||
48298166|NCT02090374|101057096|FG007|NOT COMPLETED|Overall Study||0||
48298167|NCT02354443|101057097|FG000|STARTED|Overall Study||1||
48298168|NCT02354443|101057097|FG000|COMPLETED|Overall Study||1||
48298169|NCT02354443|101057097|FG000|NOT COMPLETED|Overall Study||0||
48298170|NCT01786174|101057098|FG000|STARTED|Overall Study||18||
48298171|NCT01786174|101057099|FG001|STARTED|Overall Study||10||
48599873|NCT00628927|101803280|FG001|NOT COMPLETED|Overall Study||0||
48599874|NCT03597139|101803281|FG000|STARTED|Overall Study||51||
48599875|NCT03597139|101803282|FG001|STARTED|Overall Study||49||
48599876|NCT03597139|101803281|FG000|COMPLETED|Overall Study||47||
48599877|NCT03597139|101803282|FG001|COMPLETED|Overall Study||49||
48599878|NCT03597139|101803281|FG000|NOT COMPLETED|Overall Study||4||
48599879|NCT03597139|101803282|FG001|NOT COMPLETED|Overall Study||0||
48599880|NCT01446250|101803283|FG000|STARTED|Treatment Period 1||5||
48599881|NCT01446250|101803284|FG001|STARTED|Treatment Period 1||3||
48599882|NCT01446250|101803285|FG002|STARTED|Treatment Period 1||0||
48599883|NCT01446250|101803286|FG003|STARTED|Treatment Period 1||0||
48599884|NCT01446250|101803283|FG000|COMPLETED|Treatment Period 1||5||
48599885|NCT01446250|101803284|FG001|COMPLETED|Treatment Period 1||2||
48599886|NCT01446250|101803285|FG002|COMPLETED|Treatment Period 1||0||
48599887|NCT01446250|101803286|FG003|COMPLETED|Treatment Period 1||0||
48599888|NCT01446250|101803283|FG000|NOT COMPLETED|Treatment Period 1||0||
48599889|NCT01446250|101803284|FG001|NOT COMPLETED|Treatment Period 1||1||
48599890|NCT01446250|101803285|FG002|NOT COMPLETED|Treatment Period 1||0||
48298172|NCT01786174|101057098|FG000|Randomized|Overall Study||19||
48599891|NCT01446250|101803286|FG003|NOT COMPLETED|Treatment Period 1||0||
48599892|NCT01446250|101803283|FG000|STARTED|Clinical Hold||0||
48599893|NCT01446250|101803284|FG001|STARTED|Clinical Hold||2||
48599894|NCT01446250|101803285|FG002|STARTED|Clinical Hold||5||
48599895|NCT01446250|101803286|FG003|STARTED|Clinical Hold||0||
48599896|NCT01446250|101803283|FG000|COMPLETED|Clinical Hold||0||
48599897|NCT01446250|101803284|FG001|COMPLETED|Clinical Hold||2||
48599898|NCT01446250|101803285|FG002|COMPLETED|Clinical Hold||5||
48599899|NCT01446250|101803286|FG003|COMPLETED|Clinical Hold||0||
48599900|NCT01446250|101803283|FG000|NOT COMPLETED|Clinical Hold||0||
48298173|NCT01786174|101057099|FG001|Randomized|Overall Study||11||
48298174|NCT01786174|101057098|FG000|COMPLETED|Overall Study||16||
48599901|NCT01446250|101803284|FG001|NOT COMPLETED|Clinical Hold||0||
48599902|NCT01446250|101803285|FG002|NOT COMPLETED|Clinical Hold||0||
48599903|NCT01446250|101803286|FG003|NOT COMPLETED|Clinical Hold||0||
48298175|NCT01786174|101057099|FG001|COMPLETED|Overall Study||10||
48298176|NCT01786174|101057098|FG000|NOT COMPLETED|Overall Study||2||
48298177|NCT01786174|101057099|FG001|NOT COMPLETED|Overall Study||0||
48298178|NCT04209621|101057100|FG000|STARTED|Overall Study||3||
48298179|NCT04209621|101057100|FG000|Dose Level 1|Overall Study||3||
48298180|NCT04209621|101057100|FG000|COMPLETED|Overall Study||0||
48298181|NCT04209621|101057100|FG000|NOT COMPLETED|Overall Study||3||
48298182|NCT01699789|101057101|FG000|STARTED|Overall Study||606||
48599904|NCT01446250|101803283|FG000|STARTED|Treatment Period 2||0||
48599905|NCT01446250|101803284|FG001|STARTED|Treatment Period 2||7||
48599906|NCT01446250|101803285|FG002|STARTED|Treatment Period 2||0||
48599907|NCT01446250|101803286|FG003|STARTED|Treatment Period 2||0||
48599908|NCT01446250|101803283|FG000|COMPLETED|Treatment Period 2||0||
48599909|NCT01446250|101803284|FG001|COMPLETED|Treatment Period 2||6||
48599910|NCT01446250|101803285|FG002|COMPLETED|Treatment Period 2||0||
48599911|NCT01446250|101803286|FG003|COMPLETED|Treatment Period 2||0||
48599912|NCT01446250|101803283|FG000|NOT COMPLETED|Treatment Period 2||0||
48599913|NCT01446250|101803284|FG001|NOT COMPLETED|Treatment Period 2||1||
48599914|NCT01446250|101803285|FG002|NOT COMPLETED|Treatment Period 2||0||
48599915|NCT01446250|101803286|FG003|NOT COMPLETED|Treatment Period 2||0||
48599916|NCT01446250|101803283|FG000|STARTED|Follow-up||0||
48599917|NCT01446250|101803284|FG001|STARTED|Follow-up||0||
48599918|NCT01446250|101803285|FG002|STARTED|Follow-up||0||
48599919|NCT01446250|101803286|FG003|STARTED|Follow-up||6||
48599920|NCT01446250|101803283|FG000|COMPLETED|Follow-up||0||
48599921|NCT01446250|101803284|FG001|COMPLETED|Follow-up||0||
48599922|NCT01446250|101803285|FG002|COMPLETED|Follow-up||0||
48599923|NCT01446250|101803286|FG003|COMPLETED|Follow-up||0||
48599924|NCT01446250|101803283|FG000|NOT COMPLETED|Follow-up||0||
48599925|NCT01446250|101803284|FG001|NOT COMPLETED|Follow-up||0||
48599926|NCT01446250|101803285|FG002|NOT COMPLETED|Follow-up||0||
48599927|NCT01446250|101803286|FG003|NOT COMPLETED|Follow-up||6||
48599928|NCT03970200|101803287|FG000|STARTED|Overall Study||5||
48599929|NCT03970200|101803288|FG001|STARTED|Overall Study||4||
48599930|NCT03970200|101803289|FG002|STARTED|Overall Study||6||
48599931|NCT03970200|101803287|FG000|COMPLETED|Overall Study||3||
48599932|NCT03970200|101803288|FG001|COMPLETED|Overall Study||2||
48599933|NCT03970200|101803289|FG002|COMPLETED|Overall Study||4||
48599934|NCT03970200|101803287|FG000|NOT COMPLETED|Overall Study||2||
48599935|NCT03970200|101803288|FG001|NOT COMPLETED|Overall Study||2||
48599936|NCT03970200|101803289|FG002|NOT COMPLETED|Overall Study||2||
48599937|NCT01935128|101803290|FG000|STARTED|Overall Study||50||
48599938|NCT01935128|101803290|FG000|COMPLETED|Overall Study||43||
48599939|NCT01935128|101803290|FG000|NOT COMPLETED|Overall Study||7||
48599940|NCT02867202|101803291|FG000|STARTED|Overall Study||83||
48599941|NCT02867202|101803292|FG001|STARTED|Overall Study||88||
48599942|NCT02867202|101803291|FG000|COMPLETED|Overall Study||62||
48599943|NCT02867202|101803292|FG001|COMPLETED|Overall Study||56||
48599944|NCT02867202|101803291|FG000|NOT COMPLETED|Overall Study||21||
48599945|NCT02867202|101803292|FG001|NOT COMPLETED|Overall Study||32||
48599946|NCT00636961|101803293|FG000|STARTED|Period 1||14||
48599947|NCT00636961|101803294|FG001|STARTED|Period 1||13||
48599948|NCT00636961|101803293|FG000|COMPLETED|Period 1||13||
48599949|NCT00636961|101803294|FG001|COMPLETED|Period 1||12||
48599950|NCT00636961|101803293|FG000|NOT COMPLETED|Period 1||1||
48599951|NCT00636961|101803294|FG001|NOT COMPLETED|Period 1||1||
48599952|NCT00636961|101803293|FG000|STARTED|Period 2||13||
48599953|NCT00636961|101803294|FG001|STARTED|Period 2||12||
48599954|NCT00636961|101803293|FG000|COMPLETED|Period 2||12||
48599955|NCT00636961|101803294|FG001|COMPLETED|Period 2||12||
48599956|NCT00636961|101803293|FG000|NOT COMPLETED|Period 2||1||
48599957|NCT00636961|101803294|FG001|NOT COMPLETED|Period 2||0||
48599958|NCT01666210|101803295|FG000|STARTED|Overall Study||30||
48599959|NCT01666210|101803296|FG001|STARTED|Overall Study||30||
48298183|NCT01699789|101057102|FG001|STARTED|Overall Study||640||
48599960|NCT01666210|101803295|FG000|COMPLETED|Overall Study||28||
48599961|NCT01666210|101803296|FG001|COMPLETED|Overall Study||29||
48599962|NCT01666210|101803295|FG000|NOT COMPLETED|Overall Study||2||
48599963|NCT01666210|101803296|FG001|NOT COMPLETED|Overall Study||1||
48599964|NCT03760458|101803297|FG000|STARTED|Main Study (Through Week 48)||9||
48599965|NCT03760458|101803298|FG001|STARTED|Main Study (Through Week 48)||12||
48599966|NCT03760458|101803299|FG002|STARTED|Main Study (Through Week 48)||15||
48599967|NCT03760458|101803300|FG003|STARTED|Main Study (Through Week 48)||10||
48599968|NCT03760458|101803301|FG004|STARTED|Main Study (Through Week 48)||11||
48599969|NCT03760458|101803297|FG000|COMPLETED|Main Study (Through Week 48)||8||
48599970|NCT03760458|101803298|FG001|COMPLETED|Main Study (Through Week 48)||11||
48599971|NCT03760458|101803299|FG002|COMPLETED|Main Study (Through Week 48)||15||
48599972|NCT03760458|101803300|FG003|COMPLETED|Main Study (Through Week 48)||10||
48599973|NCT03760458|101803301|FG004|COMPLETED|Main Study (Through Week 48)||11||
48599974|NCT03760458|101803297|FG000|NOT COMPLETED|Main Study (Through Week 48)||1||
48599975|NCT03760458|101803298|FG001|NOT COMPLETED|Main Study (Through Week 48)||1||
48599976|NCT03760458|101803299|FG002|NOT COMPLETED|Main Study (Through Week 48)||0||
48599977|NCT03760458|101803300|FG003|NOT COMPLETED|Main Study (Through Week 48)||0||
48599978|NCT03760458|101803301|FG004|NOT COMPLETED|Main Study (Through Week 48)||0||
48599979|NCT03760458|101803297|FG000|STARTED|Extended Follow-up (Weeks 48 Through 60)||0||
48599980|NCT03760458|101803298|FG001|STARTED|Extended Follow-up (Weeks 48 Through 60)||0||
48599981|NCT03760458|101803299|FG002|STARTED|Extended Follow-up (Weeks 48 Through 60)||4||
48599982|NCT03760458|101803300|FG003|STARTED|Extended Follow-up (Weeks 48 Through 60)||3||
48599983|NCT03760458|101803301|FG004|STARTED|Extended Follow-up (Weeks 48 Through 60)||3||
48599984|NCT03760458|101803297|FG000|COMPLETED|Extended Follow-up (Weeks 48 Through 60)||0||
48599985|NCT03760458|101803298|FG001|COMPLETED|Extended Follow-up (Weeks 48 Through 60)||0||
48599986|NCT03760458|101803299|FG002|COMPLETED|Extended Follow-up (Weeks 48 Through 60)||4||
48599987|NCT03760458|101803300|FG003|COMPLETED|Extended Follow-up (Weeks 48 Through 60)||3||
48599988|NCT03760458|101803301|FG004|COMPLETED|Extended Follow-up (Weeks 48 Through 60)||3||
48599989|NCT03760458|101803297|FG000|NOT COMPLETED|Extended Follow-up (Weeks 48 Through 60)||0||
48599990|NCT03760458|101803298|FG001|NOT COMPLETED|Extended Follow-up (Weeks 48 Through 60)||0||
48599991|NCT03760458|101803299|FG002|NOT COMPLETED|Extended Follow-up (Weeks 48 Through 60)||0||
48599992|NCT03760458|101803300|FG003|NOT COMPLETED|Extended Follow-up (Weeks 48 Through 60)||0||
48599993|NCT03760458|101803301|FG004|NOT COMPLETED|Extended Follow-up (Weeks 48 Through 60)||0||
48599994|NCT01451164|101803302|FG000|STARTED|Overall Study||115||
48599995|NCT01451164|101803303|FG001|STARTED|Overall Study||115||
48599996|NCT01451164|101803304|FG002|STARTED|Overall Study||113||
48599997|NCT01451164|101803305|FG003|STARTED|Overall Study||116||
48599998|NCT01451164|101803302|FG000|COMPLETED|Overall Study||72||
48599999|NCT01451164|101803303|FG001|COMPLETED|Overall Study||81||
48600000|NCT01451164|101803304|FG002|COMPLETED|Overall Study||68||
48600001|NCT01451164|101803305|FG003|COMPLETED|Overall Study||70||
48600002|NCT01451164|101803302|FG000|NOT COMPLETED|Overall Study||43||
48600003|NCT01451164|101803303|FG001|NOT COMPLETED|Overall Study||34||
48600004|NCT01451164|101803304|FG002|NOT COMPLETED|Overall Study||45||
48600005|NCT01451164|101803305|FG003|NOT COMPLETED|Overall Study||46||
48600006|NCT00935064|101803306|FG000|STARTED|Overall Study||30||
48600007|NCT00935064|101803307|FG001|STARTED|Overall Study||30||
48600008|NCT00935064|101803306|FG000|COMPLETED|Overall Study||30||
48600009|NCT00935064|101803307|FG001|COMPLETED|Overall Study||30||
48600010|NCT00935064|101803306|FG000|NOT COMPLETED|Overall Study||0||
48600011|NCT00935064|101803307|FG001|NOT COMPLETED|Overall Study||0||
48600012|NCT00089635|101803308|FG000|STARTED|Overall Study||203||
48600013|NCT00089635|101803308|FG000|COMPLETED|Overall Study||160||
48600014|NCT00089635|101803308|FG000|NOT COMPLETED|Overall Study||43||
48600015|NCT01790516|101803309|FG000|STARTED|Overall Study||1||
48298184|NCT01699789|101057101|FG000|Baseline|Overall Study||492||
48298185|NCT01699789|101057102|FG001|Baseline|Overall Study||489||
48298186|NCT01699789|101057101|FG000|6-Month Follow-Up|Overall Study||380||
48600016|NCT01790516|101803310|FG001|STARTED|Overall Study||1||
48600017|NCT01790516|101803309|FG000|COMPLETED|Overall Study||0||
48600018|NCT01790516|101803310|FG001|COMPLETED|Overall Study||1||
48600019|NCT01790516|101803309|FG000|NOT COMPLETED|Overall Study||1||
48600020|NCT01790516|101803310|FG001|NOT COMPLETED|Overall Study||0||
48600021|NCT01004718|101803311|FG000|STARTED|Overall Study||10||
48600022|NCT01004718|101803311|FG000|COMPLETED|Overall Study||10||
48600023|NCT01004718|101803311|FG000|NOT COMPLETED|Overall Study||0||
48600024|NCT01593254|101803312|FG000|STARTED|Overall Study||86|Started = Started Treatment Period|
48600025|NCT01593254|101803313|FG001|STARTED|Overall Study||174|Started = Started Treatment Period|
48600026|NCT01593254|101803312|FG000|Crossed Over to Dasatinib|Overall Study||46||
48600027|NCT01593254|101803313|FG001|Crossed Over to Dasatinib|Overall Study||0||
48600028|NCT01593254|101803312|FG000|COMPLETED|Overall Study||0|Completed = Continuing in Treatment Period|
48600029|NCT01593254|101803313|FG001|COMPLETED|Overall Study||0|Completed = Continuing in Treatment Period|
48600030|NCT01593254|101803312|FG000|NOT COMPLETED|Overall Study||86||
48600031|NCT01593254|101803313|FG001|NOT COMPLETED|Overall Study||174||
48600032|NCT01912352|101803314|FG000|STARTED|Overall Study||83||
48600033|NCT01912352|101803314|FG000|COMPLETED|Overall Study||78||
48600034|NCT01912352|101803314|FG000|NOT COMPLETED|Overall Study||5||
48600035|NCT03303391|101803315|FG000|STARTED|Overall Study||9||
48600036|NCT03303391|101803316|FG001|STARTED|Overall Study||3||
48600037|NCT03303391|101803315|FG000|COMPLETED|Overall Study||9||
48600038|NCT03303391|101803316|FG001|COMPLETED|Overall Study||3||
48600039|NCT03303391|101803315|FG000|NOT COMPLETED|Overall Study||0||
48600040|NCT03303391|101803316|FG001|NOT COMPLETED|Overall Study||0||
48298187|NCT01699789|101057102|FG001|6-Month Follow-Up|Overall Study||379||
48600041|NCT00422422|101803317|FG000|STARTED|Overall Study||100||
48600042|NCT00422422|101803317|FG000|COMPLETED|Overall Study||90||
48600043|NCT00422422|101803317|FG000|NOT COMPLETED|Overall Study||10||
48298188|NCT01699789|101057101|FG000|12-Month Follow-Up|Overall Study||364||
48600044|NCT05229952|101803318|FG000|STARTED|Overall Study||23||
48600045|NCT05229952|101803318|FG000|COMPLETED|Overall Study||23||
48600046|NCT05229952|101803318|FG000|NOT COMPLETED|Overall Study||0||
48600047|NCT03338244|101803319|FG000|STARTED|Overall Study||33173||295
48600048|NCT03338244|101803320|FG001|STARTED|Overall Study||33055||297
48600049|NCT03338244|101803319|FG000|COMPLETED|Overall Study||25995||295
48600050|NCT03338244|101803320|FG001|COMPLETED|Overall Study||25568||297
48600051|NCT03338244|101803319|FG000|NOT COMPLETED|Overall Study||7178||0
48600052|NCT03338244|101803320|FG001|NOT COMPLETED|Overall Study||7487||0
48600053|NCT00099632|101803321|FG000|STARTED|Overall Study||73||
48600054|NCT00099632|101803322|FG001|STARTED|Overall Study||68||
48600055|NCT00099632|101803323|FG002|STARTED|Overall Study||75||
48600056|NCT00099632|101803324|FG003|STARTED|Overall Study||67||
48298189|NCT01699789|101057102|FG001|12-Month Follow-Up|Overall Study||369||
48298190|NCT01699789|101057101|FG000|3-Year Follow-up|Overall Study||293||
48298191|NCT01699789|101057102|FG001|3-Year Follow-up|Overall Study||307||
48298192|NCT01699789|101057101|FG000|4-Year Follow-up|Overall Study||143|We attempted to contact 598 3-year participants who did not decline follow-up|
48298193|NCT01699789|101057102|FG001|4-Year Follow-up|Overall Study||140|We attempted to contact 598 3-year participants who did not decline follow-up|
48298194|NCT01699789|101057101|FG000|COMPLETED|Overall Study||504|Analytic sample comprises 1018 individuals who completed 1 or more surveys at baseline, 6 or 12 months with item level imputation for missing data and wave-level imputation for missing surveys.|
48298195|NCT01699789|101057102|FG001|COMPLETED|Overall Study||514|Analytic sample comprises 1018 individuals who completed 1 or more surveys at baseline, 6 or 12 months with item level imputation for missing data and wave-level imputation for missing surveys.|
48298196|NCT01699789|101057101|FG000|NOT COMPLETED|Overall Study||102||
48298197|NCT01699789|101057102|FG001|NOT COMPLETED|Overall Study||126||
48298198|NCT03310268|101057103|FG000|STARTED|Overall Study||62||
48298199|NCT03310268|101057104|FG001|STARTED|Overall Study||62||
48298200|NCT03310268|101057105|FG002|STARTED|Overall Study||61||
48298201|NCT03310268|101057103|FG000|COMPLETED|Overall Study||61||
48298202|NCT03310268|101057104|FG001|COMPLETED|Overall Study||57||
48298203|NCT03310268|101057105|FG002|COMPLETED|Overall Study||61||
48298204|NCT03310268|101057103|FG000|NOT COMPLETED|Overall Study||1||
48298205|NCT03310268|101057104|FG001|NOT COMPLETED|Overall Study||5||
48298206|NCT03310268|101057105|FG002|NOT COMPLETED|Overall Study||0||
48298207|NCT01500525|101057106|FG000|STARTED|Overall Study||286||
48298208|NCT01500525|101057107|FG001|STARTED|Overall Study||301||
48298209|NCT01500525|101057106|FG000|COMPLETED|Overall Study||286||
48298210|NCT01500525|101057107|FG001|COMPLETED|Overall Study||301||
48298211|NCT01500525|101057106|FG000|NOT COMPLETED|Overall Study||0||
48298212|NCT01500525|101057107|FG001|NOT COMPLETED|Overall Study||0||
48298213|NCT04756960|101057108|FG000|STARTED|Overall Study||8||
48298214|NCT04756960|101057108|FG000|COMPLETED|Overall Study||8||
48298215|NCT04756960|101057108|FG000|NOT COMPLETED|Overall Study||0||
48298216|NCT03602066|101057109|FG000|STARTED|Overall Study||8||
48298217|NCT03602066|101057110|FG001|STARTED|Overall Study||6||
48298218|NCT03602066|101057109|FG000|COMPLETED|Overall Study||5||
48298219|NCT03602066|101057110|FG001|COMPLETED|Overall Study||6||
48298220|NCT03602066|101057109|FG000|NOT COMPLETED|Overall Study||3||
48298221|NCT03602066|101057110|FG001|NOT COMPLETED|Overall Study||0||
48298222|NCT01019317|101057111|FG000|STARTED|Overall Study||151||
48298223|NCT01019317|101057111|FG000|COMPLETED|Overall Study||147||
48298224|NCT01019317|101057111|FG000|NOT COMPLETED|Overall Study||4||
48298225|NCT01366495|101057112|FG000|STARTED|Testing Study||0||
48298226|NCT01366495|101057113|FG001|STARTED|Testing Study||0||
48298227|NCT01366495|101057114|FG002|STARTED|Testing Study||349||
48298228|NCT01366495|101057115|FG003|STARTED|Testing Study||348||
48298229|NCT01366495|101057112|FG000|COMPLETED|Testing Study||0||
48298230|NCT01366495|101057113|FG001|COMPLETED|Testing Study||0||
48298231|NCT01366495|101057114|FG002|COMPLETED|Testing Study||349||
48298232|NCT01366495|101057115|FG003|COMPLETED|Testing Study||348||
48298233|NCT01366495|101057112|FG000|NOT COMPLETED|Testing Study||0||
48298234|NCT01366495|101057113|FG001|NOT COMPLETED|Testing Study||0||
48298235|NCT01366495|101057114|FG002|NOT COMPLETED|Testing Study||0||
48298236|NCT01366495|101057115|FG003|NOT COMPLETED|Testing Study||0||
48298237|NCT01366495|101057112|FG000|STARTED|HIV Study||50||
48298238|NCT01366495|101057113|FG001|STARTED|HIV Study||50||
48298239|NCT01366495|101057114|FG002|STARTED|HIV Study||0||
48298240|NCT01366495|101057115|FG003|STARTED|HIV Study||0||
48298241|NCT01366495|101057112|FG000|COMPLETED|HIV Study||49||
48298242|NCT01366495|101057113|FG001|COMPLETED|HIV Study||50||
48298243|NCT01366495|101057114|FG002|COMPLETED|HIV Study||0||
48298244|NCT01366495|101057115|FG003|COMPLETED|HIV Study||0||
48298245|NCT01366495|101057112|FG000|NOT COMPLETED|HIV Study||1||
48298246|NCT01366495|101057113|FG001|NOT COMPLETED|HIV Study||0||
48298247|NCT01366495|101057114|FG002|NOT COMPLETED|HIV Study||0||
48298248|NCT01366495|101057115|FG003|NOT COMPLETED|HIV Study||0||
48298249|NCT03566810|101057116|FG000|STARTED|Treatment Period 1 (Day 1-Day 3)||19||
48298250|NCT03566810|101057117|FG001|STARTED|Treatment Period 1 (Day 1-Day 3)||19||
48298251|NCT03566810|101057118|FG002|STARTED|Treatment Period 1 (Day 1-Day 3)||8||
48298252|NCT03566810|101057119|FG003|STARTED|Treatment Period 1 (Day 1-Day 3)||8||
48298253|NCT03566810|101057116|FG000|Treated|Treatment Period 1 (Day 1-Day 3)||19||
48298254|NCT03566810|101057117|FG001|Treated|Treatment Period 1 (Day 1-Day 3)||18||
48298255|NCT03566810|101057118|FG002|Treated|Treatment Period 1 (Day 1-Day 3)||8||
48298256|NCT03566810|101057119|FG003|Treated|Treatment Period 1 (Day 1-Day 3)||8||
48298257|NCT03566810|101057116|FG000|COMPLETED|Treatment Period 1 (Day 1-Day 3)||19||
48298258|NCT03566810|101057117|FG001|COMPLETED|Treatment Period 1 (Day 1-Day 3)||18||
48367989|NCT00717418|101230090|FG002|COMPLETED|Baseline||508||
48600057|NCT00099632|101803325|FG004|STARTED|Overall Study||71||
48600058|NCT00099632|101803326|FG005|STARTED|Overall Study||68||
48600059|NCT00099632|101803321|FG000|COMPLETED|Overall Study||72||
48600060|NCT00099632|101803322|FG001|COMPLETED|Overall Study||67||
48298259|NCT03566810|101057118|FG002|COMPLETED|Treatment Period 1 (Day 1-Day 3)||8||
48298260|NCT03566810|101057119|FG003|COMPLETED|Treatment Period 1 (Day 1-Day 3)||8||
48298261|NCT03566810|101057116|FG000|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0||
48298262|NCT03566810|101057117|FG001|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||1||
48298263|NCT03566810|101057118|FG002|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0||
48298264|NCT03566810|101057119|FG003|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0||
48298265|NCT03566810|101057116|FG000|STARTED|Treatment Period 2 (Day 8- Day 10)||19||
48298266|NCT03566810|101057117|FG001|STARTED|Treatment Period 2 (Day 8- Day 10)||18||
48298267|NCT03566810|101057118|FG002|STARTED|Treatment Period 2 (Day 8- Day 10)||8||
48298268|NCT03566810|101057119|FG003|STARTED|Treatment Period 2 (Day 8- Day 10)||8||
48298269|NCT03566810|101057116|FG000|COMPLETED|Treatment Period 2 (Day 8- Day 10)||19||
48298270|NCT03566810|101057117|FG001|COMPLETED|Treatment Period 2 (Day 8- Day 10)||18||
48298271|NCT03566810|101057118|FG002|COMPLETED|Treatment Period 2 (Day 8- Day 10)||8||
48298272|NCT03566810|101057119|FG003|COMPLETED|Treatment Period 2 (Day 8- Day 10)||8||
48298273|NCT03566810|101057116|FG000|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0||
48298274|NCT03566810|101057117|FG001|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0||
48298275|NCT03566810|101057118|FG002|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0||
48298276|NCT03566810|101057119|FG003|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0||
48298277|NCT00710996|101057120|FG000|STARTED|Overall Study||17||
48298278|NCT00710996|101057121|FG001|STARTED|Overall Study||20||
48298279|NCT00710996|101057122|FG002|STARTED|Overall Study||21||
48298280|NCT00710996|101057120|FG000|COMPLETED|Overall Study||16||
48298281|NCT00710996|101057121|FG001|COMPLETED|Overall Study||16||
48298282|NCT00710996|101057122|FG002|COMPLETED|Overall Study||21||
48298283|NCT00710996|101057120|FG000|NOT COMPLETED|Overall Study||1||
48298284|NCT00710996|101057121|FG001|NOT COMPLETED|Overall Study||4||
48298285|NCT00710996|101057122|FG002|NOT COMPLETED|Overall Study||0||
48298286|NCT01176773|101057123|FG000|STARTED|Overall Study||62||
48298287|NCT01176773|101057123|FG000|COMPLETED|Overall Study||59||
48298288|NCT01176773|101057123|FG000|NOT COMPLETED|Overall Study||3||
48298289|NCT00059839|101057124|FG000|STARTED|Overall Study||65||
48298290|NCT00059839|101057125|FG001|STARTED|Overall Study||64||
48298291|NCT00059839|101057124|FG000|COMPLETED|Overall Study||53||
48298292|NCT00059839|101057125|FG001|COMPLETED|Overall Study||47||
48298293|NCT00059839|101057124|FG000|NOT COMPLETED|Overall Study||12||
48298294|NCT00059839|101057125|FG001|NOT COMPLETED|Overall Study||17||
48298295|NCT01117857|101057126|FG000|STARTED|Overall Study||22||
48298296|NCT01117857|101057126|FG000|COMPLETED|Overall Study||13||
48298297|NCT01117857|101057126|FG000|NOT COMPLETED|Overall Study||9||
48298298|NCT03890419|101057127|FG000|STARTED|Overall Study||34||
48298299|NCT03890419|101057128|FG001|STARTED|Overall Study||30||
48298300|NCT03890419|101057129|FG002|STARTED|Overall Study||30||
48298301|NCT03890419|101057127|FG000|COMPLETED|Overall Study||27||
48298302|NCT03890419|101057128|FG001|COMPLETED|Overall Study||27||
48298303|NCT03890419|101057129|FG002|COMPLETED|Overall Study||25||
48298304|NCT03890419|101057127|FG000|NOT COMPLETED|Overall Study||7||
48298305|NCT03890419|101057128|FG001|NOT COMPLETED|Overall Study||3||
48298306|NCT03890419|101057129|FG002|NOT COMPLETED|Overall Study||5||
48298307|NCT00001962|101057130|FG000|STARTED|Overall Study||100||
48298308|NCT00001962|101057130|FG000|COMPLETED|Overall Study||72||
48298309|NCT00001962|101057130|FG000|NOT COMPLETED|Overall Study||28||
48298310|NCT00634010|101057131|FG000|STARTED|Overall Study||18||
48298311|NCT00634010|101057132|FG001|STARTED|Overall Study||18||
48298312|NCT00634010|101057131|FG000|COMPLETED|Overall Study||8||
48298313|NCT00634010|101057132|FG001|COMPLETED|Overall Study||4||
48298314|NCT00634010|101057131|FG000|NOT COMPLETED|Overall Study||10||
48298315|NCT00634010|101057132|FG001|NOT COMPLETED|Overall Study||14||
48298316|NCT00728481|101057133|FG000|STARTED|Overall Study||19||
48298317|NCT00728481|101057134|FG001|STARTED|Overall Study||32||
48298318|NCT00728481|101057133|FG000|COMPLETED|Overall Study||18||
48298319|NCT00728481|101057134|FG001|COMPLETED|Overall Study||28||
48298320|NCT00728481|101057133|FG000|NOT COMPLETED|Overall Study||1||
48298321|NCT00728481|101057134|FG001|NOT COMPLETED|Overall Study||4||
48405122|NCT03954704|101325200|FG005|STARTED|Overall Study||8||
48405123|NCT03954704|101325201|FG006|STARTED|Overall Study||3||
48298322|NCT03837379|101057135|FG000|STARTED|Overall Study||50||
48298323|NCT03837379|101057136|FG001|STARTED|Overall Study||114||
48298324|NCT03837379|101057135|FG000|COMPLETED|Overall Study||47||
48298325|NCT03837379|101057136|FG001|COMPLETED|Overall Study||103||
48298326|NCT03837379|101057135|FG000|NOT COMPLETED|Overall Study||3||
48298327|NCT03837379|101057136|FG001|NOT COMPLETED|Overall Study||11||
48298328|NCT04109196|101057137|FG000|STARTED|Overall Study||24||
48600061|NCT00099632|101803323|FG002|COMPLETED|Overall Study||72||
48600062|NCT00099632|101803324|FG003|COMPLETED|Overall Study||66||
48600063|NCT00099632|101803325|FG004|COMPLETED|Overall Study||70||
48600064|NCT00099632|101803326|FG005|COMPLETED|Overall Study||66||
48600065|NCT00099632|101803321|FG000|NOT COMPLETED|Overall Study||1||
48600066|NCT00099632|101803322|FG001|NOT COMPLETED|Overall Study||1||
48600067|NCT00099632|101803323|FG002|NOT COMPLETED|Overall Study||3||
48600068|NCT00099632|101803324|FG003|NOT COMPLETED|Overall Study||1||
48600069|NCT00099632|101803325|FG004|NOT COMPLETED|Overall Study||1||
48298329|NCT04109196|101057137|FG000|COMPLETED|Overall Study||24||
48298330|NCT04109196|101057137|FG000|NOT COMPLETED|Overall Study||0||
48600070|NCT00099632|101803326|FG005|NOT COMPLETED|Overall Study||2||
48600071|NCT04521114|101803327|FG000|STARTED|Overall Study||30||
48600072|NCT04521114|101803328|FG001|STARTED|Overall Study||27||
48713821|NCT01318070|102085052|FG000|NOT COMPLETED|Overall Study||2||
48713822|NCT01318070|102085053|FG001|NOT COMPLETED|Overall Study||2||
48713823|NCT01318070|102085054|FG002|NOT COMPLETED|Overall Study||7||
48713824|NCT01891344|102085055|FG000|STARTED|Overall Study||40||
48713825|NCT01891344|102085056|FG001|STARTED|Overall Study||82||
48713826|NCT01891344|102085057|FG002|STARTED|Overall Study||70||
48713827|NCT01891344|102085058|FG003|STARTED|Overall Study||12||
48713828|NCT01891344|102085059|FG004|STARTED|Overall Study||84||
48713829|NCT01891344|102085060|FG005|STARTED|Overall Study||73||
48713830|NCT01891344|102085061|FG006|STARTED|Overall Study||107||
48713831|NCT01891344|102085062|FG007|STARTED|Overall Study||23||
48713832|NCT01891344|102085055|FG000|COMPLETED|Overall Study||34||
48713833|NCT01891344|102085056|FG001|COMPLETED|Overall Study||80||
48713834|NCT01891344|102085057|FG002|COMPLETED|Overall Study||70||
48713835|NCT01891344|102085058|FG003|COMPLETED|Overall Study||11||
48713836|NCT01891344|102085059|FG004|COMPLETED|Overall Study||80||
48713837|NCT01891344|102085060|FG005|COMPLETED|Overall Study||72||
48713838|NCT01891344|102085061|FG006|COMPLETED|Overall Study||107||
48713839|NCT01891344|102085062|FG007|COMPLETED|Overall Study||23||
48713840|NCT01891344|102085055|FG000|NOT COMPLETED|Overall Study||6||
48298331|NCT00221195|101057138|FG000|STARTED|Therapy 1 (Months 1-6)||17||
48298332|NCT00221195|101057139|FG001|STARTED|Therapy 1 (Months 1-6)||17||
48298333|NCT00221195|101057138|FG000|COMPLETED|Therapy 1 (Months 1-6)||14||
48298334|NCT00221195|101057139|FG001|COMPLETED|Therapy 1 (Months 1-6)||15||
48298335|NCT00221195|101057138|FG000|NOT COMPLETED|Therapy 1 (Months 1-6)||3||
48298336|NCT00221195|101057139|FG001|NOT COMPLETED|Therapy 1 (Months 1-6)||2||
48298337|NCT00221195|101057138|FG000|STARTED|Washout Period (Months 7-9)||14||
48298338|NCT00221195|101057139|FG001|STARTED|Washout Period (Months 7-9)||15||
48713841|NCT01891344|102085056|FG001|NOT COMPLETED|Overall Study||2||
48713842|NCT01891344|102085057|FG002|NOT COMPLETED|Overall Study||0||
48713843|NCT01891344|102085058|FG003|NOT COMPLETED|Overall Study||1||
48713844|NCT01891344|102085059|FG004|NOT COMPLETED|Overall Study||4||
48713845|NCT01891344|102085060|FG005|NOT COMPLETED|Overall Study||1||
48713846|NCT01891344|102085061|FG006|NOT COMPLETED|Overall Study||0||
48713847|NCT01891344|102085062|FG007|NOT COMPLETED|Overall Study||0||
48713848|NCT03538444|102085063|FG000|STARTED|Overall Study||4||
48298339|NCT00221195|101057138|FG000|COMPLETED|Washout Period (Months 7-9)||14||
48298340|NCT00221195|101057139|FG001|COMPLETED|Washout Period (Months 7-9)||14||
48713849|NCT03538444|102085064|FG001|STARTED|Overall Study||3||
48713850|NCT03538444|102085063|FG000|COMPLETED|Overall Study||3||
48713851|NCT03538444|102085064|FG001|COMPLETED|Overall Study||3||
48713852|NCT03538444|102085063|FG000|NOT COMPLETED|Overall Study||1||
48713853|NCT03538444|102085064|FG001|NOT COMPLETED|Overall Study||0||
48713854|NCT02278614|102085065|FG000|STARTED|Overall Study||127||
48713855|NCT02278614|102085066|FG001|STARTED|Overall Study||115||
48713856|NCT02278614|102085065|FG000|COMPLETED|Overall Study||122||
48713857|NCT02278614|102085066|FG001|COMPLETED|Overall Study||110||
48713858|NCT02278614|102085065|FG000|NOT COMPLETED|Overall Study||5||
48713859|NCT02278614|102085066|FG001|NOT COMPLETED|Overall Study||5||
48713860|NCT02395055|102085067|FG000|STARTED|Overall Study||47||
48298341|NCT00221195|101057138|FG000|NOT COMPLETED|Washout Period (Months 7-9)||0||
48600073|NCT04521114|101803329|FG002|STARTED|Overall Study||30||
48600074|NCT04521114|101803327|FG000|COMPLETED|Overall Study||24||
48600075|NCT04521114|101803328|FG001|COMPLETED|Overall Study||21||
48600076|NCT04521114|101803329|FG002|COMPLETED|Overall Study||28||
48600077|NCT04521114|101803327|FG000|NOT COMPLETED|Overall Study||6||
48600078|NCT04521114|101803328|FG001|NOT COMPLETED|Overall Study||6||
48600079|NCT04521114|101803329|FG002|NOT COMPLETED|Overall Study||2||
48600080|NCT01260584|101803330|FG000|STARTED|Period 1||27||
48600081|NCT01260584|101803331|FG001|STARTED|Period 1||28||
48600082|NCT01260584|101803332|FG002|STARTED|Period 1||27||
48600083|NCT01260584|101803333|FG003|STARTED|Period 1||28||
48600084|NCT01260584|101803330|FG000|COMPLETED|Period 1||27||
48600085|NCT01260584|101803331|FG001|COMPLETED|Period 1||28||
48600086|NCT01260584|101803332|FG002|COMPLETED|Period 1||25||
48600087|NCT01260584|101803333|FG003|COMPLETED|Period 1||27||
48600088|NCT01260584|101803330|FG000|NOT COMPLETED|Period 1||0||
48600089|NCT01260584|101803331|FG001|NOT COMPLETED|Period 1||0||
48600090|NCT01260584|101803332|FG002|NOT COMPLETED|Period 1||2||
48600091|NCT01260584|101803333|FG003|NOT COMPLETED|Period 1||1||
48600092|NCT01260584|101803330|FG000|STARTED|Period 2||27||
48600093|NCT01260584|101803331|FG001|STARTED|Period 2||28||
48600094|NCT01260584|101803332|FG002|STARTED|Period 2||25||
48600095|NCT01260584|101803333|FG003|STARTED|Period 2||27||
48600096|NCT01260584|101803330|FG000|COMPLETED|Period 2||26||
48600097|NCT01260584|101803331|FG001|COMPLETED|Period 2||25||
48600098|NCT01260584|101803332|FG002|COMPLETED|Period 2||20||
48600099|NCT01260584|101803333|FG003|COMPLETED|Period 2||26||
48600100|NCT01260584|101803330|FG000|NOT COMPLETED|Period 2||1||
48600101|NCT01260584|101803331|FG001|NOT COMPLETED|Period 2||3||
48600102|NCT01260584|101803332|FG002|NOT COMPLETED|Period 2||5||
48600103|NCT01260584|101803333|FG003|NOT COMPLETED|Period 2||1||
48600104|NCT00395642|101803334|FG000|STARTED|Overall Study||66||
48600105|NCT00395642|101803334|FG000|COMPLETED|Overall Study||53||
48600106|NCT00395642|101803334|FG000|NOT COMPLETED|Overall Study||13||
48600107|NCT04318132|101803335|FG000|STARTED|Overall Study||45||45
48600108|NCT04318132|101803336|FG001|STARTED|Overall Study||47||47
48600109|NCT04318132|101803337|FG002|STARTED|Overall Study||46||46
48600110|NCT04318132|101803338|FG003|STARTED|Overall Study||32||32
48600111|NCT04318132|101803335|FG000|COMPLETED|Overall Study||45||45
48600112|NCT04318132|101803336|FG001|COMPLETED|Overall Study||47||47
48600113|NCT04318132|101803337|FG002|COMPLETED|Overall Study||43||43
48600114|NCT04318132|101803338|FG003|COMPLETED|Overall Study||32||32
48600115|NCT04318132|101803335|FG000|NOT COMPLETED|Overall Study||0||0
48600116|NCT04318132|101803336|FG001|NOT COMPLETED|Overall Study||0||0
48600117|NCT04318132|101803337|FG002|NOT COMPLETED|Overall Study||3||3
48600118|NCT04318132|101803338|FG003|NOT COMPLETED|Overall Study||0||0
48600119|NCT00473824|101803339|FG000|STARTED|Overall Study||5||
48600120|NCT00473824|101803340|FG001|STARTED|Overall Study||2||
48298342|NCT00221195|101057139|FG001|NOT COMPLETED|Washout Period (Months 7-9)||1||
48298343|NCT00221195|101057138|FG000|STARTED|Therapy 2 (Months 10-15)||14||
48298344|NCT00221195|101057139|FG001|STARTED|Therapy 2 (Months 10-15)||14||
48298345|NCT00221195|101057138|FG000|COMPLETED|Therapy 2 (Months 10-15)||12||
48298346|NCT00221195|101057139|FG001|COMPLETED|Therapy 2 (Months 10-15)||14||
48298347|NCT00221195|101057138|FG000|NOT COMPLETED|Therapy 2 (Months 10-15)||2||
48298348|NCT00221195|101057139|FG001|NOT COMPLETED|Therapy 2 (Months 10-15)||0||
48298349|NCT03057977|101057140|FG000|STARTED|Discontinuation From Treatment||1867|Randomized|
48298350|NCT03057977|101057141|FG001|STARTED|Discontinuation From Treatment||1863|Randomized|
48600121|NCT00473824|101803339|FG000|COMPLETED|Overall Study||0||
48600122|NCT00473824|101803340|FG001|COMPLETED|Overall Study||2||
48600123|NCT00473824|101803339|FG000|NOT COMPLETED|Overall Study||5||
48600124|NCT00473824|101803340|FG001|NOT COMPLETED|Overall Study||0||
48600125|NCT03402230|101803341|FG000|STARTED|Overall Study||25||
48600126|NCT03402230|101803342|FG001|STARTED|Overall Study||24||
48600127|NCT03402230|101803341|FG000|COMPLETED|Overall Study||25||
48600128|NCT03402230|101803342|FG001|COMPLETED|Overall Study||23||
48600129|NCT03402230|101803341|FG000|NOT COMPLETED|Overall Study||0||
48600130|NCT03402230|101803342|FG001|NOT COMPLETED|Overall Study||1||
48600131|NCT02440854|101803343|FG000|STARTED|Overall Study||80|Enrolled|
48600132|NCT02440854|101803343|FG000|Analyzed|Overall Study||77||
48600133|NCT02440854|101803343|FG000|COMPLETED|Overall Study||0|Completed 48 month follow up|
48600134|NCT02440854|101803343|FG000|NOT COMPLETED|Overall Study||80||
48600135|NCT02301039|101803344|FG000|STARTED|Overall Study||42||
48600136|NCT02301039|101803345|FG001|STARTED|Overall Study||42||
48600137|NCT02301039|101803346|FG002|STARTED|Overall Study||60||
48600138|NCT02301039|101803344|FG000|COMPLETED|Overall Study||42||
48600139|NCT02301039|101803345|FG001|COMPLETED|Overall Study||42||
48600140|NCT02301039|101803346|FG002|COMPLETED|Overall Study||60||
48600141|NCT02301039|101803344|FG000|NOT COMPLETED|Overall Study||0||
48600142|NCT02301039|101803345|FG001|NOT COMPLETED|Overall Study||0||
48600143|NCT02301039|101803346|FG002|NOT COMPLETED|Overall Study||0||
48600144|NCT01955109|101803347|FG000|STARTED|Overall Study||123||
48600145|NCT01955109|101803348|FG001|STARTED|Overall Study||48||
48713861|NCT02395055|102085068|FG001|STARTED|Overall Study||47||
48298351|NCT03057977|101057140|FG000|Treated|Discontinuation From Treatment||1863||
48298352|NCT03057977|101057141|FG001|Treated|Discontinuation From Treatment||1863||
48298353|NCT03057977|101057140|FG000|COMPLETED|Discontinuation From Treatment||1352|Completed treatment|
48298354|NCT03057977|101057141|FG001|COMPLETED|Discontinuation From Treatment||1381|Completed treatment|
48298355|NCT03057977|101057140|FG000|NOT COMPLETED|Discontinuation From Treatment||515||
48298356|NCT03057977|101057141|FG001|NOT COMPLETED|Discontinuation From Treatment||482||
48298357|NCT03057977|101057140|FG000|STARTED|Discontinuation From Trial||1867|Randomized|
48298358|NCT03057977|101057141|FG001|STARTED|Discontinuation From Trial||1863|Randomized|
48298359|NCT03057977|101057140|FG000|Treated|Discontinuation From Trial||1863||
48298360|NCT03057977|101057141|FG001|Treated|Discontinuation From Trial||1863||
48600146|NCT01955109|101803347|FG000|Completed Study Until Month 12|Overall Study||103||
48600147|NCT01955109|101803348|FG001|Completed Study Until Month 12|Overall Study||46||
48600148|NCT01955109|101803347|FG000|COMPLETED|Overall Study||78|Completed Month 24 (or Month 26 if applicable)|
48656892|NCT04274218|101943725|FG000|NOT COMPLETED|Demographic Information (10 Minutes)||0||
48713862|NCT02395055|102085067|FG000|COMPLETED|Overall Study||40||
48600149|NCT01955109|101803348|FG001|COMPLETED|Overall Study||39|Completed Month 24 (or Month 26 if applicable)|
48600150|NCT01955109|101803347|FG000|NOT COMPLETED|Overall Study||45||
48600151|NCT01955109|101803348|FG001|NOT COMPLETED|Overall Study||9||
48600152|NCT02006056|101803349|FG000|STARTED|Overall Study||26||
48600153|NCT02006056|101803350|FG001|STARTED|Overall Study||4||
48600154|NCT02006056|101803349|FG000|COMPLETED|Overall Study||26||
48600155|NCT02006056|101803350|FG001|COMPLETED|Overall Study||4||
48600156|NCT02006056|101803349|FG000|NOT COMPLETED|Overall Study||0||
48600157|NCT02006056|101803350|FG001|NOT COMPLETED|Overall Study||0||
48600158|NCT01454414|101803351|FG000|STARTED|Overall Study||79||
48600159|NCT01454414|101803352|FG001|STARTED|Overall Study||80||
48600160|NCT01454414|101803351|FG000|Baseline: Subjects That Sent Uniforms|Overall Study||67||
48600161|NCT01454414|101803352|FG001|Baseline: Subjects That Sent Uniforms|Overall Study||66||
48600162|NCT01454414|101803351|FG000|COMPLETED|Overall Study||66||
48600163|NCT01454414|101803352|FG001|COMPLETED|Overall Study||64||
48600164|NCT01454414|101803351|FG000|NOT COMPLETED|Overall Study||13||
48600165|NCT01454414|101803352|FG001|NOT COMPLETED|Overall Study||16||
48600166|NCT03292471|101803353|FG000|STARTED|Overall Study||8||
48600167|NCT03292471|101803354|FG001|STARTED|Overall Study||8||
48600168|NCT03292471|101803353|FG000|COMPLETED|Overall Study||8||
48600169|NCT03292471|101803354|FG001|COMPLETED|Overall Study||8||
48600170|NCT03292471|101803353|FG000|NOT COMPLETED|Overall Study||0||
48600171|NCT03292471|101803354|FG001|NOT COMPLETED|Overall Study||0||
48600172|NCT03439462|101803355|FG000|STARTED|Overall Study||6||
48600173|NCT03439462|101803356|FG001|STARTED|Overall Study||10||
48600174|NCT03439462|101803357|FG002|STARTED|Overall Study||44||
48600175|NCT03439462|101803355|FG000|COMPLETED|Overall Study||6||
48600176|NCT03439462|101803356|FG001|COMPLETED|Overall Study||10||
48600177|NCT03439462|101803357|FG002|COMPLETED|Overall Study||44||
48600178|NCT03439462|101803355|FG000|NOT COMPLETED|Overall Study||0||
48600179|NCT03439462|101803356|FG001|NOT COMPLETED|Overall Study||0||
48600180|NCT03439462|101803357|FG002|NOT COMPLETED|Overall Study||0||
48600181|NCT01586871|101803358|FG000|STARTED|Overall Study||560||
48600182|NCT01586871|101803359|FG001|STARTED|Overall Study||554||
48600183|NCT01586871|101803360|FG002|STARTED|Overall Study||33||
48600184|NCT01586871|101803358|FG000|COMPLETED|Overall Study||560||
48600185|NCT01586871|101803359|FG001|COMPLETED|Overall Study||554||
48600186|NCT01586871|101803360|FG002|COMPLETED|Overall Study||33||
48600187|NCT01586871|101803358|FG000|NOT COMPLETED|Overall Study||0||
48600188|NCT01586871|101803359|FG001|NOT COMPLETED|Overall Study||0||
48600189|NCT01586871|101803360|FG002|NOT COMPLETED|Overall Study||0||
48600190|NCT03014622|101803361|FG000|STARTED|Overall Study||201||
48600191|NCT03014622|101803362|FG001|STARTED|Overall Study||102||
48600192|NCT03014622|101803361|FG000|COMPLETED|Overall Study||182||
48600193|NCT03014622|101803362|FG001|COMPLETED|Overall Study||93||
48600194|NCT03014622|101803361|FG000|NOT COMPLETED|Overall Study||19||
48144965|NCT01967732|100679599|FG003|STARTED|Washout Period of 1 Day (Day 2)||9||
48144966|NCT01967732|100679596|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||22||
48144967|NCT01967732|100679597|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||20||
48144968|NCT01967732|100679598|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9||
48600195|NCT03014622|101803362|FG001|NOT COMPLETED|Overall Study||9||
48600196|NCT03442699|101803363|FG000|STARTED|Overall Study||6||
48600197|NCT03442699|101803363|FG000|COMPLETED|Overall Study||6||
48600198|NCT03442699|101803363|FG000|NOT COMPLETED|Overall Study||0||
48600199|NCT01092637|101803364|FG000|STARTED|Overall Study||145||
48600200|NCT01092637|101803365|FG001|STARTED|Overall Study||135||
48600201|NCT01092637|101803364|FG000|COMPLETED|Overall Study||98||
48600202|NCT01092637|101803365|FG001|COMPLETED|Overall Study||86||
48600203|NCT01092637|101803364|FG000|NOT COMPLETED|Overall Study||47||
48600204|NCT01092637|101803365|FG001|NOT COMPLETED|Overall Study||49||
48600205|NCT00204477|101803366|FG000|STARTED|Baseline||161||
48600206|NCT00204477|101803367|FG001|STARTED|Baseline||160||
48600207|NCT00204477|101803366|FG000|COMPLETED|Baseline||161||
48600208|NCT00204477|101803367|FG001|COMPLETED|Baseline||160||
48600209|NCT00204477|101803366|FG000|NOT COMPLETED|Baseline||0||
48600210|NCT00204477|101803367|FG001|NOT COMPLETED|Baseline||0||
48600211|NCT00204477|101803366|FG000|STARTED|One Year After Diet||128|Picked up the diet|
48600212|NCT00204477|101803367|FG001|STARTED|One Year After Diet||125|Picked up the diet|
48600213|NCT00204477|101803366|FG000|COMPLETED|One Year After Diet||86|Complete 1 year of diet|
48600214|NCT00204477|101803367|FG001|COMPLETED|One Year After Diet||87|Complete 1 year of diet|
48600215|NCT00204477|101803366|FG000|NOT COMPLETED|One Year After Diet||42||
48600216|NCT00204477|101803367|FG001|NOT COMPLETED|One Year After Diet||38||
48600217|NCT00204477|101803366|FG000|STARTED|Two Years After Diet||55|Complete full 2nd year of diet.|
48600218|NCT00204477|101803367|FG001|STARTED|Two Years After Diet||62|Complete full 2nd year of diet.|
48600219|NCT00204477|101803366|FG000|COMPLETED|Two Years After Diet||39||
48600220|NCT00204477|101803367|FG001|COMPLETED|Two Years After Diet||49||
48600221|NCT00204477|101803366|FG000|NOT COMPLETED|Two Years After Diet||16||
48600222|NCT00204477|101803367|FG001|NOT COMPLETED|Two Years After Diet||13||
48600223|NCT00795769|101803368|FG000|STARTED|Overall Study||49||
48600224|NCT00795769|101803368|FG000|COMPLETED|Overall Study||49||
48600225|NCT00795769|101803368|FG000|NOT COMPLETED|Overall Study||0||
48600226|NCT00463840|101803369|FG000|STARTED|Overall Study||24||
48600227|NCT00463840|101803369|FG000|COMPLETED|Overall Study||12||
48600228|NCT00463840|101803369|FG000|NOT COMPLETED|Overall Study||12||
48600229|NCT00438256|101803370|FG000|STARTED|Overall Study||3||
48600230|NCT00438256|101803371|FG001|STARTED|Overall Study||3||
48600231|NCT00438256|101803372|FG002|STARTED|Overall Study||3||
48600232|NCT00438256|101803373|FG003|STARTED|Overall Study||41||
48600233|NCT00438256|101803370|FG000|Surgical Resection|Overall Study||1||
48600234|NCT00438256|101803371|FG001|Surgical Resection|Overall Study||2||
48600235|NCT00438256|101803372|FG002|Surgical Resection|Overall Study||2||
48600236|NCT00438256|101803373|FG003|Surgical Resection|Overall Study||34||
48600237|NCT00438256|101803370|FG000|COMPLETED|Overall Study||1||
48600238|NCT00438256|101803371|FG001|COMPLETED|Overall Study||2||
48600239|NCT00438256|101803372|FG002|COMPLETED|Overall Study||2||
48600240|NCT00438256|101803373|FG003|COMPLETED|Overall Study||32||
48600241|NCT00438256|101803370|FG000|NOT COMPLETED|Overall Study||2||
48600242|NCT00438256|101803371|FG001|NOT COMPLETED|Overall Study||1||
48600243|NCT00438256|101803372|FG002|NOT COMPLETED|Overall Study||1||
48600244|NCT00438256|101803373|FG003|NOT COMPLETED|Overall Study||9||
48600245|NCT02343380|101803374|FG000|STARTED|Overall Study||10||
48600246|NCT02343380|101803375|FG001|STARTED|Overall Study||10||
48298361|NCT03057977|101057140|FG000|COMPLETED|Discontinuation From Trial||1847||
48298362|NCT03057977|101057141|FG001|COMPLETED|Discontinuation From Trial||1841||
48298363|NCT03057977|101057140|FG000|NOT COMPLETED|Discontinuation From Trial||20||
48298364|NCT03057977|101057141|FG001|NOT COMPLETED|Discontinuation From Trial||22||
48298365|NCT02901041|101057142|FG000|STARTED|Overall Study||40||
48600247|NCT02343380|101803374|FG000|COMPLETED|Overall Study||10||
48600248|NCT02343380|101803375|FG001|COMPLETED|Overall Study||10||
48600249|NCT02343380|101803374|FG000|NOT COMPLETED|Overall Study||0||
48600250|NCT02343380|101803375|FG001|NOT COMPLETED|Overall Study||0||
48600251|NCT02578940|101803376|FG000|STARTED|Overall Study||109||
48600252|NCT02578940|101803376|FG000|Received 18F-fluciclovine|Overall Study||104||
48600253|NCT02578940|101803376|FG000|COMPLETED|Overall Study||103||
48600254|NCT02578940|101803376|FG000|NOT COMPLETED|Overall Study||6||
48600255|NCT03646487|101803377|FG000|STARTED|Overall Study||12||
48600256|NCT03646487|101803378|FG001|STARTED|Overall Study||8||
48600257|NCT03646487|101803377|FG000|COMPLETED|Overall Study||7||
48600258|NCT03646487|101803378|FG001|COMPLETED|Overall Study||6||
48600259|NCT03646487|101803377|FG000|NOT COMPLETED|Overall Study||5||
48600260|NCT03646487|101803378|FG001|NOT COMPLETED|Overall Study||2||
48600261|NCT02634983|101803379|FG000|STARTED|Period One (First Treatment, 8-10 Days)||16||
48600262|NCT02634983|101803380|FG001|STARTED|Period One (First Treatment, 8-10 Days)||15||
48600263|NCT02634983|101803379|FG000|COMPLETED|Period One (First Treatment, 8-10 Days)||16||
48600264|NCT02634983|101803380|FG001|COMPLETED|Period One (First Treatment, 8-10 Days)||15||
48600265|NCT02634983|101803379|FG000|NOT COMPLETED|Period One (First Treatment, 8-10 Days)||0||
48600266|NCT02634983|101803380|FG001|NOT COMPLETED|Period One (First Treatment, 8-10 Days)||0||
48600267|NCT02634983|101803379|FG000|STARTED|Washout (Approximately 7-14 Days)||16||
48600268|NCT02634983|101803380|FG001|STARTED|Washout (Approximately 7-14 Days)||15||
48600269|NCT02634983|101803379|FG000|COMPLETED|Washout (Approximately 7-14 Days)||16||
48600270|NCT02634983|101803380|FG001|COMPLETED|Washout (Approximately 7-14 Days)||15||
48600271|NCT02634983|101803379|FG000|NOT COMPLETED|Washout (Approximately 7-14 Days)||0||
48600272|NCT02634983|101803380|FG001|NOT COMPLETED|Washout (Approximately 7-14 Days)||0||
48600273|NCT02634983|101803379|FG000|STARTED|Period 2 (Second Treatment, 8-10 Days)||16||
48600274|NCT02634983|101803380|FG001|STARTED|Period 2 (Second Treatment, 8-10 Days)||15||
48600275|NCT02634983|101803379|FG000|COMPLETED|Period 2 (Second Treatment, 8-10 Days)||14||
48600276|NCT02634983|101803380|FG001|COMPLETED|Period 2 (Second Treatment, 8-10 Days)||15||
48600277|NCT02634983|101803379|FG000|NOT COMPLETED|Period 2 (Second Treatment, 8-10 Days)||2||
48600278|NCT02634983|101803380|FG001|NOT COMPLETED|Period 2 (Second Treatment, 8-10 Days)||0||
48600279|NCT00957905|101803381|FG000|STARTED|Part A||7||
48600280|NCT00957905|101803382|FG001|STARTED|Part A||0||
48600281|NCT00957905|101803381|FG000|COMPLETED|Part A||7||
48600282|NCT00957905|101803382|FG001|COMPLETED|Part A||0||
48600283|NCT00957905|101803381|FG000|NOT COMPLETED|Part A||0||
48600284|NCT00957905|101803382|FG001|NOT COMPLETED|Part A||0||
48600285|NCT00957905|101803381|FG000|STARTED|Part B||0||
48600286|NCT00957905|101803382|FG001|STARTED|Part B||29||
48600287|NCT00957905|101803381|FG000|COMPLETED|Part B||0||
48600288|NCT00957905|101803382|FG001|COMPLETED|Part B||25||
48600289|NCT00957905|101803381|FG000|NOT COMPLETED|Part B||0||
48600290|NCT00957905|101803382|FG001|NOT COMPLETED|Part B||4||
48600291|NCT03409120|101803383|FG000|STARTED|Overall Study||38||
48600292|NCT03409120|101803383|FG000|COMPLETED|Overall Study||38||
48600293|NCT03409120|101803383|FG000|NOT COMPLETED|Overall Study||0||
48600294|NCT03887117|101803384|FG000|STARTED|Overall Study||25||
48600295|NCT03887117|101803385|FG001|STARTED|Overall Study||15||
48298366|NCT02901041|101057143|FG001|STARTED|Overall Study||41||
48298367|NCT02901041|101057142|FG000|COMPLETED|Overall Study||29||
48298368|NCT02901041|101057143|FG001|COMPLETED|Overall Study||30||
48298369|NCT02901041|101057142|FG000|NOT COMPLETED|Overall Study||11||
48298370|NCT02901041|101057143|FG001|NOT COMPLETED|Overall Study||11||
48298371|NCT01298518|101057144|FG000|STARTED|Overall Study||16||
48298372|NCT01298518|101057145|FG001|STARTED|Overall Study||16||
48298373|NCT01298518|101057146|FG002|STARTED|Overall Study||16||
48600296|NCT03887117|101803386|FG002|STARTED|Overall Study||26||
48600297|NCT03887117|101803387|FG003|STARTED|Overall Study||27||
48600298|NCT03887117|101803384|FG000|COMPLETED|Overall Study||25||
48600299|NCT03887117|101803385|FG001|COMPLETED|Overall Study||14||
48600300|NCT03887117|101803386|FG002|COMPLETED|Overall Study||25||
48600301|NCT03887117|101803387|FG003|COMPLETED|Overall Study||25||
48600302|NCT03887117|101803384|FG000|NOT COMPLETED|Overall Study||0||
48600303|NCT03887117|101803385|FG001|NOT COMPLETED|Overall Study||1||
48600304|NCT03887117|101803386|FG002|NOT COMPLETED|Overall Study||1||
48600305|NCT03887117|101803387|FG003|NOT COMPLETED|Overall Study||2||
48600306|NCT02477709|101803388|FG000|STARTED|Overall Study||6||
48600307|NCT02477709|101803388|FG000|COMPLETED|Overall Study||6||
48600308|NCT02477709|101803388|FG000|NOT COMPLETED|Overall Study||0||
48600309|NCT00821015|101803389|FG000|STARTED|Overall Study||27||
48600310|NCT00821015|101803389|FG000|COMPLETED|Overall Study||15||
48600311|NCT00821015|101803389|FG000|NOT COMPLETED|Overall Study||12||
48600312|NCT00856843|101803390|FG000|STARTED|Overall Study||68||
48600313|NCT00856843|101803391|FG001|STARTED|Overall Study||68||
48600314|NCT00856843|101803390|FG000|COMPLETED|Overall Study||66||
48600315|NCT00856843|101803391|FG001|COMPLETED|Overall Study||63||
48600316|NCT00856843|101803390|FG000|NOT COMPLETED|Overall Study||2||
48600317|NCT00856843|101803391|FG001|NOT COMPLETED|Overall Study||5||
48600318|NCT01196936|101803392|FG000|STARTED|Overall Study||34||
48600319|NCT01196936|101803393|FG001|STARTED|Overall Study||38||
48600320|NCT01196936|101803392|FG000|Year One Post Treatment|Overall Study||27||
48600321|NCT01196936|101803393|FG001|Year One Post Treatment|Overall Study||28||
48600322|NCT01196936|101803392|FG000|COMPLETED|Overall Study||23||
48600323|NCT01196936|101803393|FG001|COMPLETED|Overall Study||21||
48600324|NCT01196936|101803392|FG000|NOT COMPLETED|Overall Study||11||
48600325|NCT01196936|101803393|FG001|NOT COMPLETED|Overall Study||17||
48600326|NCT02772809|101803394|FG000|STARTED|Overall Study||23||
48600327|NCT02772809|101803394|FG000|COMPLETED|Overall Study||17||
48600328|NCT02772809|101803394|FG000|NOT COMPLETED|Overall Study||6||
48600329|NCT03885999|101803395|FG000|STARTED|Overall Study||12||
48600330|NCT03885999|101803395|FG000|COMPLETED|Overall Study||11||
48600331|NCT03885999|101803395|FG000|NOT COMPLETED|Overall Study||1||
48600332|NCT00466206|101803396|FG000|STARTED|Overall Study||10||
48600333|NCT00466206|101803396|FG000|COMPLETED|Overall Study||10||
48600334|NCT00466206|101803396|FG000|NOT COMPLETED|Overall Study||0||
48600335|NCT00858468|101803397|FG000|STARTED|Overall Study||201||
48600336|NCT00858468|101803398|FG001|STARTED|Overall Study||192||
48600337|NCT00858468|101803397|FG000|COMPLETED|Overall Study||201||
48600338|NCT00858468|101803398|FG001|COMPLETED|Overall Study||192||
48600339|NCT00858468|101803397|FG000|NOT COMPLETED|Overall Study||0||
48600340|NCT00858468|101803398|FG001|NOT COMPLETED|Overall Study||0||
48600341|NCT02716506|101803399|FG000|STARTED|Overall Study||3515||
48600342|NCT02716506|101803399|FG000|6 Months|Overall Study||2528||
48600343|NCT02716506|101803399|FG000|2 Years|Overall Study||2351||
48600344|NCT02716506|101803399|FG000|COMPLETED|Overall Study||2351||
48600345|NCT02716506|101803399|FG000|NOT COMPLETED|Overall Study||1164||
48600346|NCT00085098|101803400|FG000|STARTED|Overall Study||11||
48600347|NCT00085098|101803401|FG001|STARTED|Overall Study||13||
48600348|NCT00085098|101803400|FG000|COMPLETED|Overall Study||10||
48600349|NCT00085098|101803401|FG001|COMPLETED|Overall Study||11||
48600350|NCT00085098|101803400|FG000|NOT COMPLETED|Overall Study||1||
48600351|NCT00085098|101803401|FG001|NOT COMPLETED|Overall Study||2||
48600352|NCT03943823|101803402|FG000|STARTED|Overall Study||2||
48600353|NCT03943823|101803403|FG001|STARTED|Overall Study||2||
48600354|NCT03943823|101803402|FG000|COMPLETED|Overall Study||1||
48600355|NCT03943823|101803403|FG001|COMPLETED|Overall Study||2||
48600356|NCT03943823|101803402|FG000|NOT COMPLETED|Overall Study||1||
48600357|NCT03943823|101803403|FG001|NOT COMPLETED|Overall Study||0||
48600358|NCT00002525|101803404|FG000|STARTED|Overall Study||427||
48600359|NCT00002525|101803405|FG001|STARTED|Overall Study||428||
48600360|NCT00002525|101803404|FG000|Treated|Overall Study||419||
48600361|NCT00002525|101803405|FG001|Treated|Overall Study||0||
48600362|NCT00002525|101803404|FG000|Dukes' B3 or C Stage|Overall Study||156||
48600363|NCT00002525|101803405|FG001|Dukes' B3 or C Stage|Overall Study||158||
48600364|NCT00002525|101803404|FG000|Dukes' B2 Stage|Overall Study||150||
48600365|NCT00002525|101803405|FG001|Dukes' B2 Stage|Overall Study||139||
48600366|NCT00002525|101803404|FG000|COMPLETED|Overall Study||241||
48600367|NCT00002525|101803405|FG001|COMPLETED|Overall Study||428||
48600368|NCT00002525|101803404|FG000|NOT COMPLETED|Overall Study||186||
48600369|NCT00002525|101803405|FG001|NOT COMPLETED|Overall Study||0||
48600370|NCT01225289|101803406|FG000|STARTED|Overall Study||18||
48600371|NCT01225289|101803407|FG001|STARTED|Overall Study||18||
48600372|NCT01225289|101803406|FG000|COMPLETED|Overall Study||18||
48600373|NCT01225289|101803407|FG001|COMPLETED|Overall Study||17||
48600374|NCT01225289|101803406|FG000|NOT COMPLETED|Overall Study||0||
48600375|NCT01225289|101803407|FG001|NOT COMPLETED|Overall Study||1||
48600376|NCT02717442|101803408|FG000|STARTED|Overall Study||88||
48600377|NCT02717442|101803409|FG001|STARTED|Overall Study||88||
48600378|NCT02717442|101803408|FG000|COMPLETED|Overall Study||53||
48600379|NCT02717442|101803409|FG001|COMPLETED|Overall Study||59||
48600380|NCT02717442|101803408|FG000|NOT COMPLETED|Overall Study||35||
48600381|NCT02717442|101803409|FG001|NOT COMPLETED|Overall Study||29||
48600382|NCT01868165|101803410|FG000|STARTED|Overall Study||337||
48600383|NCT01868165|101803410|FG000|COMPLETED|Overall Study||292||
48600384|NCT01868165|101803410|FG000|NOT COMPLETED|Overall Study||45||
48600385|NCT04631107|101803411|FG000|STARTED|First Intervention (1 Night)||32||
48600386|NCT04631107|101803411|FG000|Treatment A|First Intervention (1 Night)||11||
48600387|NCT04631107|101803411|FG000|Treatment B|First Intervention (1 Night)||9||
48600388|NCT04631107|101803411|FG000|Treatment C|First Intervention (1 Night)||11||
48600389|NCT04631107|101803411|FG000|COMPLETED|First Intervention (1 Night)||31||
48600390|NCT04631107|101803411|FG000|NOT COMPLETED|First Intervention (1 Night)||1||
48600391|NCT04631107|101803411|FG000|STARTED|Washout 1 Week||31||
48600392|NCT04631107|101803411|FG000|COMPLETED|Washout 1 Week||31||
48600393|NCT04631107|101803411|FG000|NOT COMPLETED|Washout 1 Week||0||
48600394|NCT04631107|101803411|FG000|STARTED|Second Intervention (1 Night)||31||
48600395|NCT04631107|101803411|FG000|Treatment A|Second Intervention (1 Night)||11||
48600396|NCT04631107|101803411|FG000|Treatment B|Second Intervention (1 Night)||9||
48600397|NCT04631107|101803411|FG000|Treatment C|Second Intervention (1 Night)||9||
48600398|NCT04631107|101803411|FG000|COMPLETED|Second Intervention (1 Night)||29||
48600399|NCT04631107|101803411|FG000|NOT COMPLETED|Second Intervention (1 Night)||2||
48600400|NCT04631107|101803411|FG000|STARTED|Washout-1 Week||29||
48600401|NCT04631107|101803411|FG000|COMPLETED|Washout-1 Week||29||
48600402|NCT04631107|101803411|FG000|NOT COMPLETED|Washout-1 Week||0||
48600403|NCT04631107|101803411|FG000|STARTED|Third Intervention (1 Night)||29||
48600404|NCT04631107|101803411|FG000|Treatment A|Third Intervention (1 Night)||8||
48600405|NCT04631107|101803411|FG000|Treatment B|Third Intervention (1 Night)||10||
48600406|NCT04631107|101803411|FG000|Treatment C|Third Intervention (1 Night)||9||
48600407|NCT04631107|101803411|FG000|COMPLETED|Third Intervention (1 Night)||27||
48600408|NCT04631107|101803411|FG000|NOT COMPLETED|Third Intervention (1 Night)||2||
48600409|NCT01065714|101803412|FG000|STARTED|Overall Study||20||
48600410|NCT01065714|101803412|FG000|COMPLETED|Overall Study||20||
48600411|NCT01065714|101803412|FG000|NOT COMPLETED|Overall Study||0||
48600412|NCT01010009|101803413|FG000|STARTED|Overall Study||8||
48600413|NCT01010009|101803414|FG001|STARTED|Overall Study||8||
48600414|NCT01010009|101803415|FG002|STARTED|Overall Study||8||
48600415|NCT01010009|101803413|FG000|COMPLETED|Overall Study||8||
48600416|NCT01010009|101803414|FG001|COMPLETED|Overall Study||8||
48600417|NCT01010009|101803415|FG002|COMPLETED|Overall Study||8||
48600418|NCT01010009|101803413|FG000|NOT COMPLETED|Overall Study||0||
48600419|NCT01010009|101803414|FG001|NOT COMPLETED|Overall Study||0||
48600420|NCT01010009|101803415|FG002|NOT COMPLETED|Overall Study||0||
48600421|NCT02474355|101803416|FG000|STARTED|Overall Study||3014||
48600422|NCT02474355|101803416|FG000|COMPLETED|Overall Study||1386|Participants who withdrew from the study owing to study closure in their country. The participants received the study drug at time of study closure and continued treatment with reimbursed commercial drug or in a local patient support program, those who had discontinued study drug at study closure had their survival follow-up stopped.|
48600423|NCT02474355|101803416|FG000|NOT COMPLETED|Overall Study||1628||
48600424|NCT00369161|101803417|FG000|STARTED|Overall Study||109||
48600425|NCT00369161|101803418|FG001|STARTED|Overall Study||119||
48600426|NCT00369161|101803417|FG000|Intention to Treat (ITT)|Overall Study||107||
48600427|NCT00369161|101803418|FG001|Intention to Treat (ITT)|Overall Study||117||
48600428|NCT00369161|101803417|FG000|COMPLETED|Overall Study||82||
48600429|NCT00369161|101803418|FG001|COMPLETED|Overall Study||95||
48600430|NCT00369161|101803417|FG000|NOT COMPLETED|Overall Study||27||
48600431|NCT00369161|101803418|FG001|NOT COMPLETED|Overall Study||24||
48600432|NCT01085084|101803419|FG000|STARTED|Overall Study||26||
48600433|NCT01085084|101803420|FG001|STARTED|Overall Study||28||
48600434|NCT01085084|101803421|FG002|STARTED|Overall Study||28||
48600435|NCT01085084|101803419|FG000|Received at Least 1 Dose of Study Drug|Overall Study||26||
48600436|NCT01085084|101803420|FG001|Received at Least 1 Dose of Study Drug|Overall Study||28||
48600437|NCT01085084|101803421|FG002|Received at Least 1 Dose of Study Drug|Overall Study||28||
48600438|NCT01085084|101803419|FG000|Safety Analysis Set|Overall Study||25||
48600439|NCT01085084|101803420|FG001|Safety Analysis Set|Overall Study||29||
48600440|NCT01085084|101803421|FG002|Safety Analysis Set|Overall Study||28||
48600441|NCT01085084|101803419|FG000|COMPLETED|Overall Study||19||
48600442|NCT01085084|101803420|FG001|COMPLETED|Overall Study||23||
48600443|NCT01085084|101803421|FG002|COMPLETED|Overall Study||19||
48600444|NCT01085084|101803419|FG000|NOT COMPLETED|Overall Study||7||
48600445|NCT01085084|101803420|FG001|NOT COMPLETED|Overall Study||5||
48600446|NCT01085084|101803421|FG002|NOT COMPLETED|Overall Study||9||
48600447|NCT00448812|101803422|FG000|STARTED|Year 1||45||
48600448|NCT00448812|101803423|FG001|STARTED|Year 1||24||
48600449|NCT00448812|101803422|FG000|COMPLETED|Year 1||45||
48600450|NCT00448812|101803423|FG001|COMPLETED|Year 1||24||
48600451|NCT00448812|101803422|FG000|NOT COMPLETED|Year 1||0||
48600452|NCT00448812|101803423|FG001|NOT COMPLETED|Year 1||0||
48600453|NCT00448812|101803422|FG000|STARTED|Year 2||45||
48600454|NCT00448812|101803423|FG001|STARTED|Year 2||24||
48298374|NCT01298518|101057144|FG000|COMPLETED|Overall Study||16||
48298375|NCT01298518|101057145|FG001|COMPLETED|Overall Study||16||
48298376|NCT01298518|101057146|FG002|COMPLETED|Overall Study||15||
48298377|NCT01298518|101057144|FG000|NOT COMPLETED|Overall Study||0||
48600455|NCT00448812|101803422|FG000|COMPLETED|Year 2||41||
48600456|NCT00448812|101803423|FG001|COMPLETED|Year 2||23||
48600457|NCT00448812|101803422|FG000|NOT COMPLETED|Year 2||4||
48600458|NCT00448812|101803423|FG001|NOT COMPLETED|Year 2||1||
48600459|NCT00448812|101803422|FG000|STARTED|Year 3||45||
48600460|NCT00448812|101803423|FG001|STARTED|Year 3||24||
48600461|NCT00448812|101803422|FG000|COMPLETED|Year 3||41||
48600462|NCT00448812|101803423|FG001|COMPLETED|Year 3||21||
48600463|NCT00448812|101803422|FG000|NOT COMPLETED|Year 3||4||
48600464|NCT00448812|101803423|FG001|NOT COMPLETED|Year 3||3||
48600465|NCT00448812|101803422|FG000|STARTED|Year 4||43||
48600466|NCT00448812|101803423|FG001|STARTED|Year 4||0||
48600467|NCT00448812|101803422|FG000|COMPLETED|Year 4||43||
48600468|NCT00448812|101803423|FG001|COMPLETED|Year 4||0||
48600469|NCT00448812|101803422|FG000|NOT COMPLETED|Year 4||0||
48600470|NCT00448812|101803423|FG001|NOT COMPLETED|Year 4||0||
48600471|NCT00448812|101803422|FG000|STARTED|Year 5||43||
48600472|NCT00448812|101803423|FG001|STARTED|Year 5||0||
48600473|NCT00448812|101803422|FG000|COMPLETED|Year 5||42||
48600474|NCT00448812|101803423|FG001|COMPLETED|Year 5||0||
48600475|NCT00448812|101803422|FG000|NOT COMPLETED|Year 5||1||
48600476|NCT00448812|101803423|FG001|NOT COMPLETED|Year 5||0||
48600477|NCT02724410|101803424|FG000|STARTED|Overall Study||44||
48600478|NCT02724410|101803425|FG001|STARTED|Overall Study||38||
48600479|NCT02724410|101803424|FG000|COMPLETED|Overall Study||44||
48600480|NCT02724410|101803425|FG001|COMPLETED|Overall Study||38||
48600481|NCT02724410|101803424|FG000|NOT COMPLETED|Overall Study||0||
48600482|NCT02724410|101803425|FG001|NOT COMPLETED|Overall Study||0||
48298378|NCT01298518|101057145|FG001|NOT COMPLETED|Overall Study||0||
48298379|NCT01298518|101057146|FG002|NOT COMPLETED|Overall Study||1||
48298380|NCT01163721|101057147|FG000|STARTED|Overall Study||39||
48298381|NCT01163721|101057148|FG001|STARTED|Overall Study||41||
48298382|NCT01163721|101057147|FG000|COMPLETED|Overall Study||31||
48298383|NCT01163721|101057148|FG001|COMPLETED|Overall Study||29||
48298384|NCT01163721|101057147|FG000|NOT COMPLETED|Overall Study||8||
48298385|NCT01163721|101057148|FG001|NOT COMPLETED|Overall Study||12||
48600483|NCT05020366|101803426|FG000|STARTED|Overall Study||15||
48600484|NCT05020366|101803427|FG001|STARTED|Overall Study||5||
48600485|NCT05020366|101803426|FG000|COMPLETED|Overall Study||11||
48600486|NCT05020366|101803427|FG001|COMPLETED|Overall Study||5||
48600487|NCT05020366|101803426|FG000|NOT COMPLETED|Overall Study||4||
48600488|NCT05020366|101803427|FG001|NOT COMPLETED|Overall Study||0||
48600489|NCT00224406|101803428|FG000|STARTED|Overall Study||55||
48600490|NCT00224406|101803429|FG001|STARTED|Overall Study||59||
48600491|NCT00224406|101803428|FG000|Intention to Treat Population (ITT)|Overall Study||46||
48600492|NCT00224406|101803429|FG001|Intention to Treat Population (ITT)|Overall Study||55||
48600493|NCT00224406|101803428|FG000|Per Protocol Population (PP)|Overall Study||46||
48600494|NCT00224406|101803429|FG001|Per Protocol Population (PP)|Overall Study||53||
48600495|NCT00224406|101803428|FG000|Safety Population (SAF)|Overall Study||46||
48600496|NCT00224406|101803429|FG001|Safety Population (SAF)|Overall Study||55||
48600497|NCT00224406|101803428|FG000|COMPLETED|Overall Study||46||
48600498|NCT00224406|101803429|FG001|COMPLETED|Overall Study||52||
48600499|NCT00224406|101803428|FG000|NOT COMPLETED|Overall Study||9||
48600500|NCT00224406|101803429|FG001|NOT COMPLETED|Overall Study||7||
48600501|NCT01361867|101803430|FG000|STARTED|Overall Study||15||
48600502|NCT01361867|101803430|FG000|COMPLETED|Overall Study||15||
48600503|NCT01361867|101803430|FG000|NOT COMPLETED|Overall Study||0||
48600504|NCT02289105|101803431|FG000|STARTED|Overall Study||642||
48298386|NCT01929980|101057149|FG000|STARTED|Overall Study||4||
48298387|NCT01929980|101057149|FG000|COMPLETED|Overall Study||3||
48298388|NCT01929980|101057149|FG000|NOT COMPLETED|Overall Study||1||
48298389|NCT01868139|101057150|FG000|STARTED|Overall Study||1||
48298390|NCT01868139|101057150|FG000|COMPLETED|Overall Study||0||
48298391|NCT01868139|101057150|FG000|NOT COMPLETED|Overall Study||1||
48600505|NCT02289105|101803432|FG001|STARTED|Overall Study||637||
48600506|NCT02289105|101803431|FG000|COMPLETED|Overall Study||642||
48600507|NCT02289105|101803432|FG001|COMPLETED|Overall Study||637||
48600508|NCT02289105|101803431|FG000|NOT COMPLETED|Overall Study||0||
48600509|NCT02289105|101803432|FG001|NOT COMPLETED|Overall Study||0||
48600510|NCT02552888|101803433|FG000|STARTED|Overall Study||35||
48600511|NCT02552888|101803434|FG001|STARTED|Overall Study||35||
48600512|NCT02552888|101803433|FG000|COMPLETED|Overall Study||34||
48600513|NCT02552888|101803434|FG001|COMPLETED|Overall Study||34||
48600514|NCT02552888|101803433|FG000|NOT COMPLETED|Overall Study||1||
48600515|NCT02552888|101803434|FG001|NOT COMPLETED|Overall Study||1||
48144969|NCT01967732|100679599|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||9||
48144970|NCT01967732|100679596|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
48144971|NCT01967732|100679597|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
48144972|NCT01967732|100679598|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
48144973|NCT01967732|100679599|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
48144974|NCT01967732|100679596|FG000|STARTED|Second Intervention (Day 3)||22||
48144975|NCT01967732|100679597|FG001|STARTED|Second Intervention (Day 3)||20||
48144976|NCT01967732|100679598|FG002|STARTED|Second Intervention (Day 3)||9||
48144977|NCT01967732|100679599|FG003|STARTED|Second Intervention (Day 3)||9||
48144978|NCT01967732|100679596|FG000|COMPLETED|Second Intervention (Day 3)||22||
48144979|NCT01967732|100679597|FG001|COMPLETED|Second Intervention (Day 3)||20||
48144980|NCT01967732|100679598|FG002|COMPLETED|Second Intervention (Day 3)||9||
48144981|NCT01967732|100679599|FG003|COMPLETED|Second Intervention (Day 3)||9||
48144982|NCT01967732|100679596|FG000|NOT COMPLETED|Second Intervention (Day 3)||0||
48144983|NCT01967732|100679597|FG001|NOT COMPLETED|Second Intervention (Day 3)||0||
48298392|NCT01175356|101057151|FG000|STARTED|Overall Study||99||
48298393|NCT01175356|101057151|FG000|COMPLETED|Overall Study||18||
48600516|NCT01819844|101803435|FG000|STARTED|Overall Study||12||
48600517|NCT01819844|101803435|FG000|COMPLETED|Overall Study||12||
48600518|NCT01819844|101803435|FG000|NOT COMPLETED|Overall Study||0||
48600519|NCT01243294|101803436|FG000|STARTED|First Intervention (10 Days +/- 2 Days)||28||
48600520|NCT01243294|101803437|FG001|STARTED|First Intervention (10 Days +/- 2 Days)||26||
48144984|NCT01967732|100679598|FG002|NOT COMPLETED|Second Intervention (Day 3)||0||
48188523|NCT00031447|100783265|FG001|COMPLETED|Overall Study||8||
48657069|NCT03648372|101943767|FG010|COMPLETED|Overall Study||2||
48144985|NCT01967732|100679599|FG003|NOT COMPLETED|Second Intervention (Day 3)||0||
48144986|NCT03832595|100679600|FG000|STARTED|Overall Study||754|These are patients who were eligible at initial screening|48
48144987|NCT03832595|100679601|FG001|STARTED|Overall Study||842|These are patients who were eligible at initial screening|50
48144988|NCT03832595|100679600|FG000|COMPLETED|Overall Study||575||48
48144989|NCT03832595|100679601|FG001|COMPLETED|Overall Study||711||50
48144990|NCT03832595|100679600|FG000|NOT COMPLETED|Overall Study||179||0
48144991|NCT03832595|100679601|FG001|NOT COMPLETED|Overall Study||131||0
48713863|NCT02395055|102085068|FG001|COMPLETED|Overall Study||44||
48713864|NCT02395055|102085067|FG000|NOT COMPLETED|Overall Study||7||
48713865|NCT02395055|102085068|FG001|NOT COMPLETED|Overall Study||3||
48713866|NCT02649855|102088475|FG000|STARTED|Overall Study||23||
48713867|NCT02649855|102088476|FG001|STARTED|Overall Study||23||
48713868|NCT02649855|102088477|FG002|STARTED|Overall Study||28||
48713869|NCT02649855|102088475|FG000|COMPLETED|Overall Study||19||
48713870|NCT02649855|102088476|FG001|COMPLETED|Overall Study||19||
48713871|NCT02649855|102088477|FG002|COMPLETED|Overall Study||25||
48713872|NCT02649855|102088475|FG000|NOT COMPLETED|Overall Study||4||
48713873|NCT02649855|102088476|FG001|NOT COMPLETED|Overall Study||4||
48713874|NCT02649855|102088477|FG002|NOT COMPLETED|Overall Study||3||
48713875|NCT00885768|102088478|FG000|STARTED|Overall Study||146||
48713876|NCT00885768|102088478|FG000|COMPLETED|Overall Study||146||
48713877|NCT00885768|102088478|FG000|NOT COMPLETED|Overall Study||0||
48144992|NCT00636649|100679602|FG000|STARTED|Overall Study||20||
48713878|NCT01670565|102088479|FG000|STARTED|Overall Study||10||
48713879|NCT01670565|102088480|FG001|STARTED|Overall Study||10||
48144993|NCT00636649|100679603|FG001|STARTED|Overall Study||20||
48144994|NCT00636649|100679602|FG000|COMPLETED|Overall Study||20||
48144995|NCT00636649|100679603|FG001|COMPLETED|Overall Study||20||
48144996|NCT00636649|100679602|FG000|NOT COMPLETED|Overall Study||0||
48144997|NCT00636649|100679603|FG001|NOT COMPLETED|Overall Study||0||
48298394|NCT01175356|101057151|FG000|NOT COMPLETED|Overall Study||81||
48298395|NCT01067326|101057152|FG000|STARTED|Overall Study||14||
48298396|NCT01067326|101057153|FG001|STARTED|Overall Study||8||
48298397|NCT01067326|101057152|FG000|COMPLETED|Overall Study||12||
48298398|NCT01067326|101057153|FG001|COMPLETED|Overall Study||5||
48298399|NCT01067326|101057152|FG000|NOT COMPLETED|Overall Study||2||
48298400|NCT01067326|101057153|FG001|NOT COMPLETED|Overall Study||3||
48298401|NCT01013285|101057154|FG000|STARTED|Overall Study||70||
48298402|NCT01013285|101057155|FG001|STARTED|Overall Study||110||
48298403|NCT01013285|101057154|FG000|COMPLETED|Overall Study||22||
48298404|NCT01013285|101057155|FG001|COMPLETED|Overall Study||21||
48298405|NCT01013285|101057154|FG000|NOT COMPLETED|Overall Study||48||
48298406|NCT01013285|101057155|FG001|NOT COMPLETED|Overall Study||89||
48144998|NCT03792126|100679604|FG000|STARTED|Overall Study||30||
48144999|NCT03792126|100679605|FG001|STARTED|Overall Study||24||
48145000|NCT03792126|100679604|FG000|COMPLETED|Overall Study||27||
48145001|NCT03792126|100679605|FG001|COMPLETED|Overall Study||14||
48145002|NCT03792126|100679604|FG000|NOT COMPLETED|Overall Study||3||
48145003|NCT03792126|100679605|FG001|NOT COMPLETED|Overall Study||10||
48145004|NCT01022762|100679606|FG000|STARTED|Overall Study||218||
48145005|NCT01022762|100679607|FG001|STARTED|Overall Study||222||
48145006|NCT01022762|100679606|FG000|Exposed to Trial Drug|Overall Study||217||
48145007|NCT01022762|100679607|FG001|Exposed to Trial Drug|Overall Study||218||
48145008|NCT01022762|100679606|FG000|COMPLETED|Overall Study||196||
48145009|NCT01022762|100679607|FG001|COMPLETED|Overall Study||194||
48145010|NCT01022762|100679606|FG000|NOT COMPLETED|Overall Study||22||
48145011|NCT01022762|100679607|FG001|NOT COMPLETED|Overall Study||28||
48145012|NCT01839110|100679608|FG000|STARTED|Overall Study||7||
48145013|NCT01839110|100679609|FG001|STARTED|Overall Study||6||
48145014|NCT01839110|100679610|FG002|STARTED|Overall Study||9||
48145015|NCT01839110|100679608|FG000|COMPLETED|Overall Study||4||
48145016|NCT01839110|100679609|FG001|COMPLETED|Overall Study||4||
48145017|NCT01839110|100679610|FG002|COMPLETED|Overall Study||6||
48298407|NCT02340091|101057156|FG000|STARTED|Overall Study||62||
48298408|NCT02340091|101057156|FG000|COMPLETED|Overall Study||60||
48145018|NCT01839110|100679608|FG000|NOT COMPLETED|Overall Study||3||
48145019|NCT01839110|100679609|FG001|NOT COMPLETED|Overall Study||2||
48298409|NCT02340091|101057156|FG000|NOT COMPLETED|Overall Study||2||
48298410|NCT00711529|101057157|FG000|STARTED|Overall Study||13||
48298411|NCT00711529|101057158|FG001|STARTED|Overall Study||14||
48145020|NCT01839110|100679610|FG002|NOT COMPLETED|Overall Study||3||
48145021|NCT03430674|100679611|FG000|STARTED|Overall Study||10||
48145022|NCT03430674|100679611|FG000|COMPLETED|Overall Study||10||
48298412|NCT00711529|101057157|FG000|COMPLETED|Overall Study||9||
48298413|NCT00711529|101057158|FG001|COMPLETED|Overall Study||8||
48298414|NCT00711529|101057157|FG000|NOT COMPLETED|Overall Study||4||
48298415|NCT00711529|101057158|FG001|NOT COMPLETED|Overall Study||6||
48298416|NCT00292461|101057159|FG000|STARTED|Overall Study||34||
48298417|NCT00292461|101057160|FG001|STARTED|Overall Study||30||
48298418|NCT00292461|101057159|FG000|COMPLETED|Overall Study||24||
48298419|NCT00292461|101057160|FG001|COMPLETED|Overall Study||24||
48298420|NCT00292461|101057159|FG000|NOT COMPLETED|Overall Study||10||
48298421|NCT00292461|101057160|FG001|NOT COMPLETED|Overall Study||6||
48298422|NCT00820027|101057161|FG000|STARTED|Overall Study||224||
48298423|NCT00820027|101057162|FG001|STARTED|Overall Study||230||
48298424|NCT00820027|101057163|FG002|STARTED|Overall Study||224||
48298425|NCT00820027|101057164|FG003|STARTED|Overall Study||98||
48298426|NCT00820027|101057161|FG000|COMPLETED|Overall Study||198||
48298427|NCT00820027|101057162|FG001|COMPLETED|Overall Study||216||
48298428|NCT00820027|101057163|FG002|COMPLETED|Overall Study||203||
48298429|NCT00820027|101057164|FG003|COMPLETED|Overall Study||85||
48298430|NCT00820027|101057161|FG000|NOT COMPLETED|Overall Study||26||
48298431|NCT00820027|101057162|FG001|NOT COMPLETED|Overall Study||14||
48298432|NCT00820027|101057163|FG002|NOT COMPLETED|Overall Study||21||
48298433|NCT00820027|101057164|FG003|NOT COMPLETED|Overall Study||13||
48298434|NCT02656160|101057165|FG000|STARTED|First Study Night||7||
48298435|NCT02656160|101057166|FG001|STARTED|First Study Night||6||
48298436|NCT02656160|101057165|FG000|COMPLETED|First Study Night||7||
48145023|NCT03430674|100679611|FG000|NOT COMPLETED|Overall Study||0||
48145024|NCT04435665|100679612|FG000|STARTED|Overall Study||12||
48145025|NCT04435665|100679613|FG001|STARTED|Overall Study||11||
48145026|NCT04435665|100679614|FG002|STARTED|Overall Study||12||
48298437|NCT02656160|101057166|FG001|COMPLETED|First Study Night||6||
48145027|NCT04435665|100679615|FG003|STARTED|Overall Study||13||
48145028|NCT04435665|100679612|FG000|COMPLETED|Overall Study||12||
48145029|NCT04435665|100679613|FG001|COMPLETED|Overall Study||11||
48145030|NCT04435665|100679614|FG002|COMPLETED|Overall Study||12||
48145031|NCT04435665|100679615|FG003|COMPLETED|Overall Study||12||
48298438|NCT02656160|101057165|FG000|NOT COMPLETED|First Study Night||0||
48298439|NCT02656160|101057166|FG001|NOT COMPLETED|First Study Night||0||
48298440|NCT02656160|101057165|FG000|STARTED|Second Study Night||4||
48298441|NCT02656160|101057166|FG001|STARTED|Second Study Night||6||
48298442|NCT02656160|101057165|FG000|COMPLETED|Second Study Night||4||
48298443|NCT02656160|101057166|FG001|COMPLETED|Second Study Night||6||
48145032|NCT04435665|100679612|FG000|NOT COMPLETED|Overall Study||0||
48713880|NCT01670565|102088479|FG000|COMPLETED|Overall Study||9||
48713881|NCT01670565|102088480|FG001|COMPLETED|Overall Study||9||
48713882|NCT01670565|102088479|FG000|NOT COMPLETED|Overall Study||1||
48713883|NCT01670565|102088480|FG001|NOT COMPLETED|Overall Study||1||
48713884|NCT02688088|102088481|FG000|STARTED|Single Dose Drug Cocktail - Period 1||44||
48713885|NCT02688088|102088482|FG001|STARTED|Single Dose Drug Cocktail - Period 1||0||
48713886|NCT02688088|102088483|FG002|STARTED|Single Dose Drug Cocktail - Period 1||0||
48713887|NCT02688088|102088484|FG003|STARTED|Single Dose Drug Cocktail - Period 1||0||
48713888|NCT02688088|102088485|FG004|STARTED|Single Dose Drug Cocktail - Period 1||0||
48713889|NCT02688088|102088481|FG000|Received One Dose of Drug Cocktail|Single Dose Drug Cocktail - Period 1||44||
48713890|NCT02688088|102088482|FG001|Received One Dose of Drug Cocktail|Single Dose Drug Cocktail - Period 1||0||
48713891|NCT02688088|102088483|FG002|Received One Dose of Drug Cocktail|Single Dose Drug Cocktail - Period 1||0||
48713892|NCT02688088|102088484|FG003|Received One Dose of Drug Cocktail|Single Dose Drug Cocktail - Period 1||0||
48713893|NCT02688088|102088485|FG004|Received One Dose of Drug Cocktail|Single Dose Drug Cocktail - Period 1||0||
48713894|NCT02688088|102088481|FG000|COMPLETED|Single Dose Drug Cocktail - Period 1||44||
48713895|NCT02688088|102088482|FG001|COMPLETED|Single Dose Drug Cocktail - Period 1||0||
48713896|NCT02688088|102088483|FG002|COMPLETED|Single Dose Drug Cocktail - Period 1||0||
48713897|NCT02688088|102088484|FG003|COMPLETED|Single Dose Drug Cocktail - Period 1||0||
48713898|NCT02688088|102088485|FG004|COMPLETED|Single Dose Drug Cocktail - Period 1||0||
48713899|NCT02688088|102088481|FG000|NOT COMPLETED|Single Dose Drug Cocktail - Period 1||0||
48713900|NCT02688088|102088482|FG001|NOT COMPLETED|Single Dose Drug Cocktail - Period 1||0||
48713901|NCT02688088|102088483|FG002|NOT COMPLETED|Single Dose Drug Cocktail - Period 1||0||
48713902|NCT02688088|102088484|FG003|NOT COMPLETED|Single Dose Drug Cocktail - Period 1||0||
48713903|NCT02688088|102088485|FG004|NOT COMPLETED|Single Dose Drug Cocktail - Period 1||0||
48713904|NCT02688088|102088481|FG000|STARTED|Abemaciclib + Drug Cocktail - Period 2||0||
48713905|NCT02688088|102088482|FG001|STARTED|Abemaciclib + Drug Cocktail - Period 2||44||
48713906|NCT02688088|102088483|FG002|STARTED|Abemaciclib + Drug Cocktail - Period 2||0||
48713907|NCT02688088|102088484|FG003|STARTED|Abemaciclib + Drug Cocktail - Period 2||0||
48713908|NCT02688088|102088485|FG004|STARTED|Abemaciclib + Drug Cocktail - Period 2||0||
48713909|NCT02688088|102088481|FG000|Received at Least One Dose of Study Drug|Abemaciclib + Drug Cocktail - Period 2||0||
48713910|NCT02688088|102088482|FG001|Received at Least One Dose of Study Drug|Abemaciclib + Drug Cocktail - Period 2||42||
48713911|NCT02688088|102088483|FG002|Received at Least One Dose of Study Drug|Abemaciclib + Drug Cocktail - Period 2||0||
48713912|NCT02688088|102088484|FG003|Received at Least One Dose of Study Drug|Abemaciclib + Drug Cocktail - Period 2||0||
48713913|NCT02688088|102088485|FG004|Received at Least One Dose of Study Drug|Abemaciclib + Drug Cocktail - Period 2||0||
48713914|NCT02688088|102088481|FG000|COMPLETED|Abemaciclib + Drug Cocktail - Period 2||0||
48713915|NCT02688088|102088482|FG001|COMPLETED|Abemaciclib + Drug Cocktail - Period 2||37||
48713916|NCT02688088|102088483|FG002|COMPLETED|Abemaciclib + Drug Cocktail - Period 2||0||
48713917|NCT02688088|102088484|FG003|COMPLETED|Abemaciclib + Drug Cocktail - Period 2||0||
48713918|NCT02688088|102088485|FG004|COMPLETED|Abemaciclib + Drug Cocktail - Period 2||0||
48713919|NCT02688088|102088481|FG000|NOT COMPLETED|Abemaciclib + Drug Cocktail - Period 2||0||
48713920|NCT02688088|102088482|FG001|NOT COMPLETED|Abemaciclib + Drug Cocktail - Period 2||7||
48713921|NCT02688088|102088483|FG002|NOT COMPLETED|Abemaciclib + Drug Cocktail - Period 2||0||
48713922|NCT02688088|102088484|FG003|NOT COMPLETED|Abemaciclib + Drug Cocktail - Period 2||0||
48713923|NCT02688088|102088485|FG004|NOT COMPLETED|Abemaciclib + Drug Cocktail - Period 2||0||
48713924|NCT02688088|102088481|FG000|STARTED|Abemaciclib Days 13 to 28 - Period 3||0||
48713925|NCT02688088|102088482|FG001|STARTED|Abemaciclib Days 13 to 28 - Period 3||0||
48713926|NCT02688088|102088483|FG002|STARTED|Abemaciclib Days 13 to 28 - Period 3||37||
48713927|NCT02688088|102088484|FG003|STARTED|Abemaciclib Days 13 to 28 - Period 3||0||
48713928|NCT02688088|102088485|FG004|STARTED|Abemaciclib Days 13 to 28 - Period 3||0||
48713929|NCT02688088|102088481|FG000|Received at Least One Dose of Study Drug|Abemaciclib Days 13 to 28 - Period 3||0||
48713930|NCT02688088|102088482|FG001|Received at Least One Dose of Study Drug|Abemaciclib Days 13 to 28 - Period 3||0||
48713931|NCT02688088|102088483|FG002|Received at Least One Dose of Study Drug|Abemaciclib Days 13 to 28 - Period 3||36||
48713932|NCT02688088|102088484|FG003|Received at Least One Dose of Study Drug|Abemaciclib Days 13 to 28 - Period 3||0||
48713933|NCT02688088|102088485|FG004|Received at Least One Dose of Study Drug|Abemaciclib Days 13 to 28 - Period 3||0||
48713934|NCT02688088|102088481|FG000|COMPLETED|Abemaciclib Days 13 to 28 - Period 3||0||
48713935|NCT02688088|102088482|FG001|COMPLETED|Abemaciclib Days 13 to 28 - Period 3||0||
48713936|NCT02688088|102088483|FG002|COMPLETED|Abemaciclib Days 13 to 28 - Period 3||29||
48713937|NCT02688088|102088484|FG003|COMPLETED|Abemaciclib Days 13 to 28 - Period 3||0||
48713938|NCT02688088|102088485|FG004|COMPLETED|Abemaciclib Days 13 to 28 - Period 3||0||
48713939|NCT02688088|102088481|FG000|NOT COMPLETED|Abemaciclib Days 13 to 28 - Period 3||0||
48713940|NCT02688088|102088482|FG001|NOT COMPLETED|Abemaciclib Days 13 to 28 - Period 3||0||
48713941|NCT02688088|102088483|FG002|NOT COMPLETED|Abemaciclib Days 13 to 28 - Period 3||8||
48713942|NCT02688088|102088484|FG003|NOT COMPLETED|Abemaciclib Days 13 to 28 - Period 3||0||
48713943|NCT02688088|102088485|FG004|NOT COMPLETED|Abemaciclib Days 13 to 28 - Period 3||0||
48713944|NCT02688088|102088481|FG000|STARTED|Abemaciclib Days 1 to 28 - Period 4||0||
48713945|NCT02688088|102088482|FG001|STARTED|Abemaciclib Days 1 to 28 - Period 4||0||
48600521|NCT01243294|101803436|FG000|COMPLETED|First Intervention (10 Days +/- 2 Days)||28||
48600522|NCT01243294|101803437|FG001|COMPLETED|First Intervention (10 Days +/- 2 Days)||26||
48600523|NCT01243294|101803436|FG000|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0||
48600524|NCT01243294|101803437|FG001|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0||
48713946|NCT02688088|102088483|FG002|STARTED|Abemaciclib Days 1 to 28 - Period 4||0||
48713947|NCT02688088|102088484|FG003|STARTED|Abemaciclib Days 1 to 28 - Period 4||29||
48600525|NCT01243294|101803436|FG000|STARTED|Second Intervention (10 Days +/- 2 Days)||28||
48600526|NCT01243294|101803437|FG001|STARTED|Second Intervention (10 Days +/- 2 Days)||26||
48600527|NCT01243294|101803436|FG000|COMPLETED|Second Intervention (10 Days +/- 2 Days)||28||
48600528|NCT01243294|101803437|FG001|COMPLETED|Second Intervention (10 Days +/- 2 Days)||26||
48600529|NCT01243294|101803436|FG000|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0||
48600530|NCT01243294|101803437|FG001|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0||
48600531|NCT03000530|101803438|FG000|STARTED|Overall Study||13||
48713948|NCT02688088|102088485|FG004|STARTED|Abemaciclib Days 1 to 28 - Period 4||0||
48713949|NCT02688088|102088481|FG000|COMPLETED|Abemaciclib Days 1 to 28 - Period 4||0||
48713950|NCT02688088|102088482|FG001|COMPLETED|Abemaciclib Days 1 to 28 - Period 4||0||
48713951|NCT02688088|102088483|FG002|COMPLETED|Abemaciclib Days 1 to 28 - Period 4||0||
48600532|NCT03000530|101803439|FG001|STARTED|Overall Study||44||
48600533|NCT03000530|101803440|FG002|STARTED|Overall Study||45||
48600534|NCT03000530|101803438|FG000|COMPLETED|Overall Study||13||
48600535|NCT03000530|101803439|FG001|COMPLETED|Overall Study||39||
48600536|NCT03000530|101803440|FG002|COMPLETED|Overall Study||41||
48600537|NCT03000530|101803438|FG000|NOT COMPLETED|Overall Study||0||
48600538|NCT03000530|101803439|FG001|NOT COMPLETED|Overall Study||5||
48600539|NCT03000530|101803440|FG002|NOT COMPLETED|Overall Study||4||
48600540|NCT00938587|101803441|FG000|STARTED|Overall Study||21||
48600541|NCT00938587|101803442|FG001|STARTED|Overall Study||22||
48600542|NCT00938587|101803443|FG002|STARTED|Overall Study||21||
48600543|NCT00938587|101803444|FG003|STARTED|Overall Study||22||
48600544|NCT00938587|101803441|FG000|COMPLETED|Overall Study||18||
48600545|NCT00938587|101803442|FG001|COMPLETED|Overall Study||21||
48600546|NCT00938587|101803443|FG002|COMPLETED|Overall Study||20||
48600547|NCT00938587|101803444|FG003|COMPLETED|Overall Study||20||
48600548|NCT00938587|101803441|FG000|NOT COMPLETED|Overall Study||3||
48600549|NCT00938587|101803442|FG001|NOT COMPLETED|Overall Study||1||
48600550|NCT00938587|101803443|FG002|NOT COMPLETED|Overall Study||1||
48600551|NCT00938587|101803444|FG003|NOT COMPLETED|Overall Study||2||
48600552|NCT01603394|101803445|FG000|STARTED|Overall Study||9||
48600553|NCT01603394|101803445|FG000|COMPLETED|Overall Study||8||
48600554|NCT01603394|101803445|FG000|NOT COMPLETED|Overall Study||1||
48600555|NCT03882957|101807468|FG000|STARTED|Overall Study||92||
48600556|NCT03882957|101807468|FG000|Participant Flow 1|Overall Study||17||
48600557|NCT03882957|101807468|FG000|Participant Flow 2|Overall Study||16||
48600558|NCT03882957|101807468|FG000|Participant Flow 3|Overall Study||13||
48600559|NCT03882957|101807468|FG000|Participant Flow 4|Overall Study||15||
48600560|NCT03882957|101807468|FG000|Participant Flow 5|Overall Study||16||
48713952|NCT02688088|102088484|FG003|COMPLETED|Abemaciclib Days 1 to 28 - Period 4||21||
48713953|NCT02688088|102088485|FG004|COMPLETED|Abemaciclib Days 1 to 28 - Period 4||0||
48713954|NCT02688088|102088481|FG000|NOT COMPLETED|Abemaciclib Days 1 to 28 - Period 4||0||
48713955|NCT02688088|102088482|FG001|NOT COMPLETED|Abemaciclib Days 1 to 28 - Period 4||0||
48713956|NCT02688088|102088483|FG002|NOT COMPLETED|Abemaciclib Days 1 to 28 - Period 4||0||
48713957|NCT02688088|102088484|FG003|NOT COMPLETED|Abemaciclib Days 1 to 28 - Period 4||8||
48713958|NCT02688088|102088485|FG004|NOT COMPLETED|Abemaciclib Days 1 to 28 - Period 4||0||
48713959|NCT02688088|102088481|FG000|STARTED|Abemaciclib Safety Extension Period||0||
48713960|NCT02688088|102088482|FG001|STARTED|Abemaciclib Safety Extension Period||0||
48713961|NCT02688088|102088483|FG002|STARTED|Abemaciclib Safety Extension Period||0||
48600561|NCT03882957|101807468|FG000|Participant Flow 6|Overall Study||14||
48600562|NCT03882957|101807468|FG000|COMPLETED|Overall Study||91||
48600563|NCT03882957|101807468|FG000|NOT COMPLETED|Overall Study||1||
48713962|NCT02688088|102088484|FG003|STARTED|Abemaciclib Safety Extension Period||0||
48713963|NCT02688088|102088485|FG004|STARTED|Abemaciclib Safety Extension Period||18||
48713964|NCT02688088|102088481|FG000|Received at Least One Dose of Study Drug|Abemaciclib Safety Extension Period||0||
48713965|NCT02688088|102088482|FG001|Received at Least One Dose of Study Drug|Abemaciclib Safety Extension Period||0||
48713966|NCT02688088|102088483|FG002|Received at Least One Dose of Study Drug|Abemaciclib Safety Extension Period||0||
48713967|NCT02688088|102088484|FG003|Received at Least One Dose of Study Drug|Abemaciclib Safety Extension Period||0||
48600564|NCT01603407|101807469|FG000|STARTED|Overall Study||65||
48600565|NCT01603407|101807470|FG001|STARTED|Overall Study||65||
48600566|NCT01603407|101807471|FG002|STARTED|Overall Study||66||
48600567|NCT01603407|101807469|FG000|COMPLETED|Overall Study||54||
48600568|NCT01603407|101807470|FG001|COMPLETED|Overall Study||54||
48600569|NCT01603407|101807471|FG002|COMPLETED|Overall Study||56||
48600570|NCT01603407|101807469|FG000|NOT COMPLETED|Overall Study||11||
48600571|NCT01603407|101807470|FG001|NOT COMPLETED|Overall Study||11||
48600572|NCT01603407|101807471|FG002|NOT COMPLETED|Overall Study||10||
48600573|NCT02949141|101807472|FG000|STARTED|Overall Study||62||
48600574|NCT02949141|101807472|FG000|COMPLETED|Overall Study||62||
48600575|NCT02949141|101807472|FG000|NOT COMPLETED|Overall Study||0||
48600576|NCT00492232|101807473|FG000|STARTED|Placebo Run-in||0||
48600577|NCT00492232|101807474|FG001|STARTED|Placebo Run-in||205||
48600578|NCT00492232|101807473|FG000|COMPLETED|Placebo Run-in||0||
48713968|NCT02688088|102088485|FG004|Received at Least One Dose of Study Drug|Abemaciclib Safety Extension Period||18||
48713969|NCT02688088|102088481|FG000|COMPLETED|Abemaciclib Safety Extension Period||0||
48713970|NCT02688088|102088482|FG001|COMPLETED|Abemaciclib Safety Extension Period||0||
48713971|NCT02688088|102088483|FG002|COMPLETED|Abemaciclib Safety Extension Period||0||
48713972|NCT02688088|102088484|FG003|COMPLETED|Abemaciclib Safety Extension Period||0||
48713973|NCT02688088|102088485|FG004|COMPLETED|Abemaciclib Safety Extension Period||0||
48713974|NCT02688088|102088481|FG000|NOT COMPLETED|Abemaciclib Safety Extension Period||0||
48713975|NCT02688088|102088482|FG001|NOT COMPLETED|Abemaciclib Safety Extension Period||0||
48713976|NCT02688088|102088483|FG002|NOT COMPLETED|Abemaciclib Safety Extension Period||0||
48713977|NCT02688088|102088484|FG003|NOT COMPLETED|Abemaciclib Safety Extension Period||0||
48713978|NCT02688088|102088485|FG004|NOT COMPLETED|Abemaciclib Safety Extension Period||18||
48713979|NCT03383757|102088486|FG000|STARTED|Overall Study||117||
48713980|NCT03383757|102088486|FG000|TruSignal AllFit Sensor Subjects|Overall Study||56||
48713981|NCT03383757|102088486|FG000|TruSignal Sensitive Sensor Subjects|Overall Study||59||
48713982|NCT03383757|102088486|FG000|TruSignal AllFit Sensor Data Pairs|Overall Study||52||
48713983|NCT03383757|102088486|FG000|TruSignal Sensitive Sensor Data Pairs|Overall Study||51||
48713984|NCT03383757|102088486|FG000|COMPLETED|Overall Study||78||
48713985|NCT03383757|102088486|FG000|NOT COMPLETED|Overall Study||39||
48600579|NCT00492232|101807474|FG001|COMPLETED|Placebo Run-in||135||
48600580|NCT00492232|101807473|FG000|NOT COMPLETED|Placebo Run-in||0||
48600581|NCT00492232|101807474|FG001|NOT COMPLETED|Placebo Run-in||70||
48600582|NCT00492232|101807473|FG000|STARTED|Double-Blind Treatment||65||
48600583|NCT00492232|101807474|FG001|STARTED|Double-Blind Treatment||70||
48600584|NCT00492232|101807473|FG000|COMPLETED|Double-Blind Treatment||47||
48600585|NCT00492232|101807474|FG001|COMPLETED|Double-Blind Treatment||45||
48600586|NCT00492232|101807473|FG000|NOT COMPLETED|Double-Blind Treatment||18||
48600587|NCT00492232|101807474|FG001|NOT COMPLETED|Double-Blind Treatment||25||
48600588|NCT00492232|101807473|FG000|STARTED|Open-Label Treatment||89||
48600589|NCT00492232|101807474|FG001|STARTED|Open-Label Treatment||0||
48600590|NCT00492232|101807473|FG000|COMPLETED|Open-Label Treatment||88||
48600591|NCT00492232|101807474|FG001|COMPLETED|Open-Label Treatment||0||
48600592|NCT00492232|101807473|FG000|NOT COMPLETED|Open-Label Treatment||1||
48600593|NCT00492232|101807474|FG001|NOT COMPLETED|Open-Label Treatment||0||
48600594|NCT01260272|101807475|FG000|STARTED|Overall Study||17||
48600595|NCT01260272|101807476|FG001|STARTED|Overall Study||32||
48600596|NCT01260272|101807475|FG000|COMPLETED|Overall Study||15||
48600597|NCT01260272|101807476|FG001|COMPLETED|Overall Study||30||
48600598|NCT01260272|101807475|FG000|NOT COMPLETED|Overall Study||2||
48600599|NCT01260272|101807476|FG001|NOT COMPLETED|Overall Study||2||
48600600|NCT02012959|101807477|FG000|STARTED|Treatment Phase A||9||
48600601|NCT02012959|101807478|FG001|STARTED|Treatment Phase A||0||
48600602|NCT02012959|101807479|FG002|STARTED|Treatment Phase A||0||
48600603|NCT02012959|101807480|FG003|STARTED|Treatment Phase A||0||
48600604|NCT02012959|101807481|FG004|STARTED|Treatment Phase A||0||
48600605|NCT02012959|101807477|FG000|Received At Least 1 Dose of Study Drug|Treatment Phase A||9|Phase A Safety Sample|
48600606|NCT02012959|101807478|FG001|Received At Least 1 Dose of Study Drug|Treatment Phase A||0|Phase A Safety Sample|
48600607|NCT02012959|101807479|FG002|Received At Least 1 Dose of Study Drug|Treatment Phase A||0|Phase A Safety Sample|
48600608|NCT02012959|101807480|FG003|Received At Least 1 Dose of Study Drug|Treatment Phase A||0|Phase A Safety Sample|
48600609|NCT02012959|101807481|FG004|Received At Least 1 Dose of Study Drug|Treatment Phase A||0|Phase A Safety Sample|
48600610|NCT02012959|101807477|FG000|COMPLETED|Treatment Phase A||7||
48600611|NCT02012959|101807478|FG001|COMPLETED|Treatment Phase A||0||
48600612|NCT02012959|101807479|FG002|COMPLETED|Treatment Phase A||0||
48600613|NCT02012959|101807480|FG003|COMPLETED|Treatment Phase A||0||
48600614|NCT02012959|101807481|FG004|COMPLETED|Treatment Phase A||0||
48600615|NCT02012959|101807477|FG000|NOT COMPLETED|Treatment Phase A||2||
48600616|NCT02012959|101807478|FG001|NOT COMPLETED|Treatment Phase A||0||
48600617|NCT02012959|101807479|FG002|NOT COMPLETED|Treatment Phase A||0||
48600618|NCT02012959|101807480|FG003|NOT COMPLETED|Treatment Phase A||0||
48600619|NCT02012959|101807481|FG004|NOT COMPLETED|Treatment Phase A||0||
48600620|NCT02012959|101807477|FG000|STARTED|Treatment Phase B||0||
48600621|NCT02012959|101807478|FG001|STARTED|Treatment Phase B||2||
48600622|NCT02012959|101807479|FG002|STARTED|Treatment Phase B||3||
48600623|NCT02012959|101807480|FG003|STARTED|Treatment Phase B||1||
48600624|NCT02012959|101807481|FG004|STARTED|Treatment Phase B||1||
48600625|NCT02012959|101807477|FG000|Received At Least 1 Dose of Study Drug|Treatment Phase B||0|Phase B Safety Sample|
48600626|NCT02012959|101807478|FG001|Received At Least 1 Dose of Study Drug|Treatment Phase B||2|Phase B Safety Sample|
48600627|NCT02012959|101807479|FG002|Received At Least 1 Dose of Study Drug|Treatment Phase B||3|Phase B Safety Sample|
48657070|NCT03648372|101943768|FG011|COMPLETED|Overall Study||2||
48405124|NCT03954704|101325195|FG000|COMPLETED|Overall Study||0||
48405125|NCT03954704|101325196|FG001|COMPLETED|Overall Study||0||
48405126|NCT03954704|101325197|FG002|COMPLETED|Overall Study||0||
48405127|NCT03954704|101325198|FG003|COMPLETED|Overall Study||0||
48405128|NCT03954704|101325199|FG004|COMPLETED|Overall Study||0||
48405129|NCT03954704|101325200|FG005|COMPLETED|Overall Study||0||
48405130|NCT03954704|101325201|FG006|COMPLETED|Overall Study||0||
48405131|NCT03954704|101325195|FG000|NOT COMPLETED|Overall Study||1||
48405132|NCT03954704|101325196|FG001|NOT COMPLETED|Overall Study||1||
48405133|NCT03954704|101325197|FG002|NOT COMPLETED|Overall Study||3||
48405134|NCT03954704|101325198|FG003|NOT COMPLETED|Overall Study||3||
48405135|NCT03954704|101325199|FG004|NOT COMPLETED|Overall Study||3||
48405136|NCT03954704|101325200|FG005|NOT COMPLETED|Overall Study||8||
48405137|NCT03954704|101325201|FG006|NOT COMPLETED|Overall Study||3||
48145033|NCT04435665|100679613|FG001|NOT COMPLETED|Overall Study||0||
48600628|NCT02012959|101807480|FG003|Received At Least 1 Dose of Study Drug|Treatment Phase B||1|Phase B Safety Sample|
48600629|NCT02012959|101807481|FG004|Received At Least 1 Dose of Study Drug|Treatment Phase B||1|Phase B Safety Sample|
48600630|NCT02012959|101807477|FG000|COMPLETED|Treatment Phase B||0||
48600631|NCT02012959|101807478|FG001|COMPLETED|Treatment Phase B||2||
48145034|NCT04435665|100679614|FG002|NOT COMPLETED|Overall Study||0||
48145035|NCT04435665|100679615|FG003|NOT COMPLETED|Overall Study||1||
48145036|NCT01895972|100679616|FG000|STARTED|Overall Study||130||
48145037|NCT01895972|100679616|FG000|COMPLETED|Overall Study||121||
48145038|NCT01895972|100679616|FG000|NOT COMPLETED|Overall Study||9||
48145039|NCT00771810|100679617|FG000|STARTED|Overall Study||10||
48145040|NCT00771810|100679618|FG001|STARTED|Overall Study||11||
48145041|NCT00771810|100679619|FG002|STARTED|Overall Study||13||
48145042|NCT00771810|100679617|FG000|COMPLETED|Overall Study||5||
48145043|NCT00771810|100679618|FG001|COMPLETED|Overall Study||6||
48145044|NCT00771810|100679619|FG002|COMPLETED|Overall Study||6||
48145045|NCT00771810|100679617|FG000|NOT COMPLETED|Overall Study||5||
48145046|NCT00771810|100679618|FG001|NOT COMPLETED|Overall Study||5||
48145047|NCT00771810|100679619|FG002|NOT COMPLETED|Overall Study||7||
48145048|NCT00322348|100679620|FG000|STARTED|Overall Study||49||
48145049|NCT00322348|100679621|FG001|STARTED|Overall Study||49||
48145050|NCT00322348|100679620|FG000|Received Study Treatment|Overall Study||50||
48145051|NCT00322348|100679621|FG001|Received Study Treatment|Overall Study||48||
48145052|NCT00322348|100679620|FG000|COMPLETED|Overall Study||12||
48145053|NCT00322348|100679621|FG001|COMPLETED|Overall Study||16||
48145054|NCT00322348|100679620|FG000|NOT COMPLETED|Overall Study||37||
48145055|NCT00322348|100679621|FG001|NOT COMPLETED|Overall Study||33||
48145056|NCT01261338|100679622|FG000|STARTED|Overall Study||14||
48145057|NCT01261338|100679623|FG001|STARTED|Overall Study||14||
48145058|NCT01261338|100679622|FG000|COMPLETED|Overall Study||11||
48145059|NCT01261338|100679623|FG001|COMPLETED|Overall Study||12||
48145060|NCT01261338|100679622|FG000|NOT COMPLETED|Overall Study||3||
48145061|NCT01261338|100679623|FG001|NOT COMPLETED|Overall Study||2||
48145062|NCT01928719|100679624|FG000|STARTED|Overall Study||122||
48145063|NCT01928719|100679625|FG001|STARTED|Overall Study||123||
48145064|NCT01928719|100679624|FG000|COMPLETED|Overall Study||70||
48145065|NCT01928719|100679625|FG001|COMPLETED|Overall Study||104||
48145066|NCT01928719|100679624|FG000|NOT COMPLETED|Overall Study||52||
48145067|NCT01928719|100679625|FG001|NOT COMPLETED|Overall Study||19||
48145068|NCT01680848|100679626|FG000|STARTED|Overall Study||282||
48145069|NCT01680848|100679626|FG000|COMPLETED|Overall Study||189||
48145070|NCT01680848|100679626|FG000|NOT COMPLETED|Overall Study||93||
48145071|NCT03152526|100679627|FG000|STARTED|Overall Study||0||
48145072|NCT03152526|100679628|FG001|STARTED|Overall Study||1||
48145073|NCT03152526|100679627|FG000|COMPLETED|Overall Study||0||
48600632|NCT02012959|101807479|FG002|COMPLETED|Treatment Phase B||3||
48600633|NCT02012959|101807480|FG003|COMPLETED|Treatment Phase B||1||
48600634|NCT02012959|101807481|FG004|COMPLETED|Treatment Phase B||1||
48600635|NCT02012959|101807477|FG000|NOT COMPLETED|Treatment Phase B||0||
48600636|NCT02012959|101807478|FG001|NOT COMPLETED|Treatment Phase B||0||
48600637|NCT02012959|101807479|FG002|NOT COMPLETED|Treatment Phase B||0||
48145074|NCT03152526|100679628|FG001|COMPLETED|Overall Study||0||
48145075|NCT03152526|100679627|FG000|NOT COMPLETED|Overall Study||0||
48600638|NCT02012959|101807480|FG003|NOT COMPLETED|Treatment Phase B||0||
48600639|NCT02012959|101807481|FG004|NOT COMPLETED|Treatment Phase B||0||
48145076|NCT03152526|100679628|FG001|NOT COMPLETED|Overall Study||1||
48145077|NCT00265889|100679629|FG000|STARTED|Overall Study||42||
48145078|NCT00265889|100679629|FG000|Cycle 1: 1st Regimen/Transplant|Overall Study||37||
48145079|NCT00265889|100679629|FG000|Cycle 2: 2nd Regimen/Transplant|Overall Study||37||
48600640|NCT02854605|101807482|FG000|STARTED|Overall Study||56||
48145080|NCT00265889|100679629|FG000|COMPLETED|Overall Study||37||
48145081|NCT00265889|100679629|FG000|NOT COMPLETED|Overall Study||5||
48145082|NCT01877538|100679630|FG000|STARTED|Overall Study||7||
48145083|NCT01877538|100679630|FG000|COMPLETED|Overall Study||7||
48145084|NCT01877538|100679630|FG000|NOT COMPLETED|Overall Study||0||
48145085|NCT00430768|100679631|FG000|STARTED|Overall Study||3||
48145086|NCT00430768|100679632|FG001|STARTED|Overall Study||3||
48145087|NCT00430768|100679633|FG002|STARTED|Overall Study||3||
48145088|NCT00430768|100679631|FG000|COMPLETED|Overall Study||3||
48145089|NCT00430768|100679632|FG001|COMPLETED|Overall Study||3||
48145090|NCT00430768|100679633|FG002|COMPLETED|Overall Study||3||
48145091|NCT00430768|100679631|FG000|NOT COMPLETED|Overall Study||0||
48145092|NCT00430768|100679632|FG001|NOT COMPLETED|Overall Study||0||
48145093|NCT00430768|100679633|FG002|NOT COMPLETED|Overall Study||0||
48145094|NCT00695669|100679634|FG000|STARTED|Overall Study||78||
48145095|NCT00695669|100679635|FG001|STARTED|Overall Study||78||
48145096|NCT00695669|100679636|FG002|STARTED|Overall Study||78||
48145097|NCT00695669|100679637|FG003|STARTED|Overall Study||78||
48145098|NCT00695669|100679634|FG000|COMPLETED|Overall Study||74||
48145099|NCT00695669|100679635|FG001|COMPLETED|Overall Study||74||
48145100|NCT00695669|100679636|FG002|COMPLETED|Overall Study||75||
48145101|NCT00695669|100679637|FG003|COMPLETED|Overall Study||74||
48145102|NCT00695669|100679634|FG000|NOT COMPLETED|Overall Study||4||
48600641|NCT02854605|101807483|FG001|STARTED|Overall Study||56||
48600642|NCT02854605|101807484|FG002|STARTED|Overall Study||28||
48600643|NCT02854605|101807482|FG000|COMPLETED|Overall Study||53||
48145103|NCT00695669|100679635|FG001|NOT COMPLETED|Overall Study||4||
48145104|NCT00695669|100679636|FG002|NOT COMPLETED|Overall Study||3||
48145105|NCT00695669|100679637|FG003|NOT COMPLETED|Overall Study||4||
48145106|NCT04575051|100679638|FG000|STARTED|Time Period 0||62||2
48145107|NCT04575051|100679639|FG001|STARTED|Time Period 0||55||2
48145108|NCT04575051|100679640|FG002|STARTED|Time Period 0||87||2
48145109|NCT04575051|100679641|FG003|STARTED|Time Period 0||77||2
48145110|NCT04575051|100679642|FG004|STARTED|Time Period 0||44||2
48145111|NCT04575051|100679638|FG000|COMPLETED|Time Period 0||47||2
48145112|NCT04575051|100679639|FG001|COMPLETED|Time Period 0||49||2
48145113|NCT04575051|100679640|FG002|COMPLETED|Time Period 0||68||2
48145114|NCT04575051|100679641|FG003|COMPLETED|Time Period 0||68||2
48145115|NCT04575051|100679642|FG004|COMPLETED|Time Period 0||36||2
48145116|NCT04575051|100679638|FG000|NOT COMPLETED|Time Period 0||15||0
48600644|NCT02854605|101807483|FG001|COMPLETED|Overall Study||49||
48600645|NCT02854605|101807484|FG002|COMPLETED|Overall Study||24||
48600646|NCT02854605|101807482|FG000|NOT COMPLETED|Overall Study||3||
48600647|NCT02854605|101807483|FG001|NOT COMPLETED|Overall Study||7||
48145117|NCT04575051|100679639|FG001|NOT COMPLETED|Time Period 0||6||0
48145118|NCT04575051|100679640|FG002|NOT COMPLETED|Time Period 0||19||0
48145119|NCT04575051|100679641|FG003|NOT COMPLETED|Time Period 0||9||0
48145120|NCT04575051|100679642|FG004|NOT COMPLETED|Time Period 0||8||0
48145121|NCT04575051|100679638|FG000|STARTED|Time Period 1||69||2
48145122|NCT04575051|100679639|FG001|STARTED|Time Period 1||84||2
48145123|NCT04575051|100679640|FG002|STARTED|Time Period 1||89||2
48145124|NCT04575051|100679641|FG003|STARTED|Time Period 1||87||2
48145125|NCT04575051|100679642|FG004|STARTED|Time Period 1||58||2
48145126|NCT04575051|100679638|FG000|COMPLETED|Time Period 1||55||2
48145127|NCT04575051|100679639|FG001|COMPLETED|Time Period 1||67||2
48145128|NCT04575051|100679640|FG002|COMPLETED|Time Period 1||79||2
48145129|NCT04575051|100679641|FG003|COMPLETED|Time Period 1||69||2
48145130|NCT04575051|100679642|FG004|COMPLETED|Time Period 1||42||2
48145131|NCT04575051|100679638|FG000|NOT COMPLETED|Time Period 1||14||0
48145132|NCT04575051|100679639|FG001|NOT COMPLETED|Time Period 1||17||0
48145133|NCT04575051|100679640|FG002|NOT COMPLETED|Time Period 1||10||0
48145134|NCT04575051|100679641|FG003|NOT COMPLETED|Time Period 1||18||0
48145135|NCT04575051|100679642|FG004|NOT COMPLETED|Time Period 1||16||0
48145136|NCT04575051|100679638|FG000|STARTED|Time Period 2||75||2
48145137|NCT04575051|100679639|FG001|STARTED|Time Period 2||75||2
48145138|NCT04575051|100679640|FG002|STARTED|Time Period 2||99||2
48145139|NCT04575051|100679641|FG003|STARTED|Time Period 2||80||2
48145140|NCT04575051|100679642|FG004|STARTED|Time Period 2||51||2
48600648|NCT02854605|101807484|FG002|NOT COMPLETED|Overall Study||4||
48600649|NCT02570750|101807485|FG000|STARTED|Overall Study||110||
48600650|NCT02570750|101807486|FG001|STARTED|Overall Study||73||
48600651|NCT02570750|101807485|FG000|COMPLETED|Overall Study||96||
48600652|NCT02570750|101807486|FG001|COMPLETED|Overall Study||68||
48600653|NCT02570750|101807485|FG000|NOT COMPLETED|Overall Study||14||
48600654|NCT02570750|101807486|FG001|NOT COMPLETED|Overall Study||5||
48600655|NCT01897571|101807487|FG000|STARTED|Overall Study||6||
48600656|NCT01897571|101807488|FG001|STARTED|Overall Study||3||
48600657|NCT01897571|101807489|FG002|STARTED|Overall Study||3||
48145141|NCT04575051|100679638|FG000|COMPLETED|Time Period 2||59||2
48145142|NCT04575051|100679639|FG001|COMPLETED|Time Period 2||59||2
48145143|NCT04575051|100679640|FG002|COMPLETED|Time Period 2||72||2
48145144|NCT04575051|100679641|FG003|COMPLETED|Time Period 2||65||2
48600658|NCT01897571|101807490|FG003|STARTED|Overall Study||14||
48600659|NCT01897571|101807491|FG004|STARTED|Overall Study||12||
48145145|NCT04575051|100679642|FG004|COMPLETED|Time Period 2||42||2
48145146|NCT04575051|100679638|FG000|NOT COMPLETED|Time Period 2||16||0
48145147|NCT04575051|100679639|FG001|NOT COMPLETED|Time Period 2||16||0
48145148|NCT04575051|100679640|FG002|NOT COMPLETED|Time Period 2||27||0
48145149|NCT04575051|100679641|FG003|NOT COMPLETED|Time Period 2||15||0
48145150|NCT04575051|100679642|FG004|NOT COMPLETED|Time Period 2||9||0
48145151|NCT04575051|100679638|FG000|STARTED|Time Period 3||87||2
48145152|NCT04575051|100679639|FG001|STARTED|Time Period 3||82||2
48145153|NCT04575051|100679640|FG002|STARTED|Time Period 3||96||2
48145154|NCT04575051|100679641|FG003|STARTED|Time Period 3||65||2
48145155|NCT04575051|100679642|FG004|STARTED|Time Period 3||56||2
48145156|NCT04575051|100679638|FG000|COMPLETED|Time Period 3||74||2
48145157|NCT04575051|100679639|FG001|COMPLETED|Time Period 3||72||2
48145158|NCT04575051|100679640|FG002|COMPLETED|Time Period 3||81||2
48145159|NCT04575051|100679641|FG003|COMPLETED|Time Period 3||59||2
48145160|NCT04575051|100679642|FG004|COMPLETED|Time Period 3||53||2
48145161|NCT04575051|100679638|FG000|NOT COMPLETED|Time Period 3||13||0
48145162|NCT04575051|100679639|FG001|NOT COMPLETED|Time Period 3||10||0
48145163|NCT04575051|100679640|FG002|NOT COMPLETED|Time Period 3||15||0
48145164|NCT04575051|100679641|FG003|NOT COMPLETED|Time Period 3||6||0
48145165|NCT04575051|100679642|FG004|NOT COMPLETED|Time Period 3||3||0
48600660|NCT01897571|101807492|FG005|STARTED|Overall Study||13||
48600661|NCT01897571|101807493|FG006|STARTED|Overall Study||13||
48600662|NCT01897571|101807494|FG007|STARTED|Overall Study||48||
48600663|NCT01897571|101807495|FG008|STARTED|Overall Study||54||
48600664|NCT01897571|101807496|FG009|STARTED|Overall Study||163||
48600665|NCT01897571|101807497|FG010|STARTED|Overall Study||71||
48600666|NCT01897571|101807487|FG000|COMPLETED|Overall Study||0||
48600667|NCT01897571|101807488|FG001|COMPLETED|Overall Study||1||
48145166|NCT04575051|100679638|FG000|STARTED|Time Period 4||96||2
48145167|NCT04575051|100679639|FG001|STARTED|Time Period 4||92||2
48145168|NCT04575051|100679640|FG002|STARTED|Time Period 4||100||2
48145169|NCT04575051|100679641|FG003|STARTED|Time Period 4||70||2
48145170|NCT04575051|100679642|FG004|STARTED|Time Period 4||62||2
48145171|NCT04575051|100679638|FG000|COMPLETED|Time Period 4||77||2
48145172|NCT04575051|100679639|FG001|COMPLETED|Time Period 4||86||2
48145173|NCT04575051|100679640|FG002|COMPLETED|Time Period 4||87||2
48145174|NCT04575051|100679641|FG003|COMPLETED|Time Period 4||67||2
48145175|NCT04575051|100679642|FG004|COMPLETED|Time Period 4||52||2
48145176|NCT04575051|100679638|FG000|NOT COMPLETED|Time Period 4||19||0
48600668|NCT01897571|101807489|FG002|COMPLETED|Overall Study||0||
48600669|NCT01897571|101807490|FG003|COMPLETED|Overall Study||5||
48600670|NCT01897571|101807491|FG004|COMPLETED|Overall Study||0||
48600671|NCT01897571|101807492|FG005|COMPLETED|Overall Study||0||
48600672|NCT01897571|101807493|FG006|COMPLETED|Overall Study||1||
48600673|NCT01897571|101807494|FG007|COMPLETED|Overall Study||16||
48600674|NCT01897571|101807495|FG008|COMPLETED|Overall Study||19||
48600675|NCT01897571|101807496|FG009|COMPLETED|Overall Study||20||
48713986|NCT03397134|102088487|FG000|STARTED|Double Blind||0||
48713987|NCT03397134|102088488|FG001|STARTED|Double Blind||0||
48713988|NCT03397134|102088489|FG002|STARTED|Double Blind||170||
48713989|NCT03397134|102088490|FG003|STARTED|Double Blind||171||
48713990|NCT03397134|102088491|FG004|STARTED|Double Blind||172||
48713991|NCT03397134|102088487|FG000|COMPLETED|Double Blind||0||
48713992|NCT03397134|102088488|FG001|COMPLETED|Double Blind||0||
48713993|NCT03397134|102088489|FG002|COMPLETED|Double Blind||107||
48713994|NCT03397134|102088490|FG003|COMPLETED|Double Blind||104||
48713995|NCT03397134|102088491|FG004|COMPLETED|Double Blind||122||
48713996|NCT03397134|102088487|FG000|NOT COMPLETED|Double Blind||0||
48713997|NCT03397134|102088488|FG001|NOT COMPLETED|Double Blind||0||
48713998|NCT03397134|102088489|FG002|NOT COMPLETED|Double Blind||63||
48713999|NCT03397134|102088490|FG003|NOT COMPLETED|Double Blind||67||
48714000|NCT03397134|102088491|FG004|NOT COMPLETED|Double Blind||50||
48714001|NCT03397134|102088487|FG000|STARTED|Open-Label Extension||59||
48145177|NCT04575051|100679639|FG001|NOT COMPLETED|Time Period 4||6||0
48145178|NCT04575051|100679640|FG002|NOT COMPLETED|Time Period 4||13||0
48145179|NCT04575051|100679641|FG003|NOT COMPLETED|Time Period 4||3||0
48145180|NCT04575051|100679642|FG004|NOT COMPLETED|Time Period 4||10||0
48145181|NCT04575051|100679638|FG000|STARTED|Time Period 5||112||2
48145182|NCT04575051|100679639|FG001|STARTED|Time Period 5||98||2
48298444|NCT02656160|101057165|FG000|NOT COMPLETED|Second Study Night||0||
48298445|NCT02656160|101057166|FG001|NOT COMPLETED|Second Study Night||0||
48600676|NCT01897571|101807497|FG010|COMPLETED|Overall Study||6||
48145183|NCT04575051|100679640|FG002|STARTED|Time Period 5||97||2
48145184|NCT04575051|100679641|FG003|STARTED|Time Period 5||80||2
48145185|NCT04575051|100679642|FG004|STARTED|Time Period 5||59||2
48145186|NCT04575051|100679638|FG000|COMPLETED|Time Period 5||101||2
48145187|NCT04575051|100679639|FG001|COMPLETED|Time Period 5||90||2
48145188|NCT04575051|100679640|FG002|COMPLETED|Time Period 5||85||2
48145189|NCT04575051|100679641|FG003|COMPLETED|Time Period 5||77||2
48145190|NCT04575051|100679642|FG004|COMPLETED|Time Period 5||48||2
48145191|NCT04575051|100679638|FG000|NOT COMPLETED|Time Period 5||11||0
48298446|NCT02441062|101057167|FG000|STARTED|Overall Study||122||
48298447|NCT02441062|101057167|FG000|COMPLETED|Overall Study||122||
48600677|NCT01897571|101807487|FG000|NOT COMPLETED|Overall Study||6||
48600678|NCT01897571|101807488|FG001|NOT COMPLETED|Overall Study||2||
48600679|NCT01897571|101807489|FG002|NOT COMPLETED|Overall Study||3||
48600680|NCT01897571|101807490|FG003|NOT COMPLETED|Overall Study||9||
48600681|NCT01897571|101807491|FG004|NOT COMPLETED|Overall Study||12||
48600682|NCT01897571|101807492|FG005|NOT COMPLETED|Overall Study||13||
48600683|NCT01897571|101807493|FG006|NOT COMPLETED|Overall Study||12||
48600684|NCT01897571|101807494|FG007|NOT COMPLETED|Overall Study||32||
48145192|NCT04575051|100679639|FG001|NOT COMPLETED|Time Period 5||8||0
48145193|NCT04575051|100679640|FG002|NOT COMPLETED|Time Period 5||12||0
48145194|NCT04575051|100679641|FG003|NOT COMPLETED|Time Period 5||3||0
48298448|NCT02441062|101057167|FG000|NOT COMPLETED|Overall Study||0||
48298449|NCT00026208|101057168|FG000|STARTED|Overall Study||72||
48600685|NCT01897571|101807495|FG008|NOT COMPLETED|Overall Study||35||
48714002|NCT03397134|102088488|FG001|STARTED|Open-Label Extension||63||
48714003|NCT03397134|102088489|FG002|STARTED|Open-Label Extension||107||
48714004|NCT03397134|102088490|FG003|STARTED|Open-Label Extension||104||
48714005|NCT03397134|102088491|FG004|STARTED|Open-Label Extension||0||
48714006|NCT03397134|102088487|FG000|COMPLETED|Open-Label Extension||35||
48145195|NCT04575051|100679642|FG004|NOT COMPLETED|Time Period 5||11||0
48714007|NCT03397134|102088488|FG001|COMPLETED|Open-Label Extension||36||
48714008|NCT03397134|102088489|FG002|COMPLETED|Open-Label Extension||72||
48714009|NCT03397134|102088490|FG003|COMPLETED|Open-Label Extension||59||
48714010|NCT03397134|102088491|FG004|COMPLETED|Open-Label Extension||0||
48714011|NCT03397134|102088487|FG000|NOT COMPLETED|Open-Label Extension||24||
48714012|NCT03397134|102088488|FG001|NOT COMPLETED|Open-Label Extension||27||
48714013|NCT03397134|102088489|FG002|NOT COMPLETED|Open-Label Extension||35||
48714014|NCT03397134|102088490|FG003|NOT COMPLETED|Open-Label Extension||45||
48298450|NCT00026208|101057169|FG001|STARTED|Overall Study||4||
48298451|NCT00026208|101057168|FG000|COMPLETED|Overall Study||71||
48298452|NCT00026208|101057169|FG001|COMPLETED|Overall Study||4||
48600686|NCT01897571|101807496|FG009|NOT COMPLETED|Overall Study||143||
48600687|NCT01897571|101807497|FG010|NOT COMPLETED|Overall Study||65||
48600688|NCT00253370|101807498|FG000|STARTED|Overall Study||44||
48600689|NCT00253370|101807498|FG000|COMPLETED|Overall Study||1||
48600690|NCT00253370|101807498|FG000|NOT COMPLETED|Overall Study||43||
48600691|NCT02820181|101807499|FG000|STARTED|Overall Study||30||
48600692|NCT02820181|101807500|FG001|STARTED|Overall Study||30||
48600693|NCT02820181|101807499|FG000|COMPLETED|Overall Study||30||
48600694|NCT02820181|101807500|FG001|COMPLETED|Overall Study||30||
48600695|NCT02820181|101807499|FG000|NOT COMPLETED|Overall Study||0||
48600696|NCT02820181|101807500|FG001|NOT COMPLETED|Overall Study||0||
48600697|NCT02447575|101807501|FG000|STARTED|Overall Study||23||
48600698|NCT02447575|101807501|FG000|COMPLETED|Overall Study||23||
48600699|NCT02447575|101807501|FG000|NOT COMPLETED|Overall Study||0||
48600700|NCT00575510|101807502|FG000|STARTED|Overall Study||114||
48600701|NCT00575510|101807503|FG001|STARTED|Overall Study||114||
48600702|NCT00575510|101807504|FG002|STARTED|Overall Study||113||
48298453|NCT00026208|101057168|FG000|NOT COMPLETED|Overall Study||1||
48298454|NCT00026208|101057169|FG001|NOT COMPLETED|Overall Study||0||
48298455|NCT04223830|101057170|FG000|STARTED|Overall Study||200||
48298456|NCT04223830|101057170|FG000|COMPLETED|Overall Study||190||
48298457|NCT04223830|101057170|FG000|NOT COMPLETED|Overall Study||10||
48298458|NCT04526197|101057171|FG000|STARTED|Period 1||18||
48298459|NCT04526197|101057172|FG001|STARTED|Period 1||18||
48298460|NCT04526197|101057171|FG000|Received at Least 1 Dose of Study Drug|Period 1||18||
48298461|NCT04526197|101057172|FG001|Received at Least 1 Dose of Study Drug|Period 1||18||
48298462|NCT04526197|101057171|FG000|COMPLETED|Period 1||17||
48298463|NCT04526197|101057172|FG001|COMPLETED|Period 1||17||
48298464|NCT04526197|101057171|FG000|NOT COMPLETED|Period 1||1||
48298465|NCT04526197|101057172|FG001|NOT COMPLETED|Period 1||1||
48298466|NCT04526197|101057171|FG000|STARTED|Period 2||17||
48298467|NCT04526197|101057172|FG001|STARTED|Period 2||17||
48298468|NCT04526197|101057171|FG000|Received at Least 1 Dose of Study Drug|Period 2||17||
48298469|NCT04526197|101057172|FG001|Received at Least 1 Dose of Study Drug|Period 2||17||
48298470|NCT04526197|101057171|FG000|COMPLETED|Period 2||17||
48298471|NCT04526197|101057172|FG001|COMPLETED|Period 2||15||
48298472|NCT04526197|101057171|FG000|NOT COMPLETED|Period 2||0||
48298473|NCT04526197|101057172|FG001|NOT COMPLETED|Period 2||2||
48298474|NCT02594826|101057173|FG000|STARTED|Overall Study||347||
48298475|NCT02594826|101057174|FG001|STARTED|Overall Study||358||
48298476|NCT02594826|101057173|FG000|COMPLETED|Overall Study||290||
48298477|NCT02594826|101057174|FG001|COMPLETED|Overall Study||298||
48600703|NCT00575510|101807502|FG000|COMPLETED|Overall Study||102||
48600704|NCT00575510|101807503|FG001|COMPLETED|Overall Study||101||
48600705|NCT00575510|101807504|FG002|COMPLETED|Overall Study||96||
48600706|NCT00575510|101807502|FG000|NOT COMPLETED|Overall Study||12||
48600707|NCT00575510|101807503|FG001|NOT COMPLETED|Overall Study||13||
48298478|NCT02594826|101057173|FG000|NOT COMPLETED|Overall Study||57||
48600708|NCT00575510|101807504|FG002|NOT COMPLETED|Overall Study||17||
48600709|NCT02453256|101807505|FG000|STARTED|Double Blind Period||106||
48600710|NCT02453256|101807506|FG001|STARTED|Double Blind Period||104||
48600711|NCT02453256|101807505|FG000|COMPLETED|Double Blind Period||93||
48298479|NCT02594826|101057174|FG001|NOT COMPLETED|Overall Study||60||
48298480|NCT01026454|101057175|FG000|STARTED|First Intervention||18||
48298481|NCT01026454|101057176|FG001|STARTED|First Intervention||14||
48298482|NCT01026454|101057175|FG000|COMPLETED|First Intervention||18||
48298483|NCT01026454|101057176|FG001|COMPLETED|First Intervention||14||
48298484|NCT01026454|101057175|FG000|NOT COMPLETED|First Intervention||0||
48298485|NCT01026454|101057176|FG001|NOT COMPLETED|First Intervention||0||
48298486|NCT01026454|101057175|FG000|STARTED|Washout||18||
48600712|NCT02453256|101807506|FG001|COMPLETED|Double Blind Period||95||
48600713|NCT02453256|101807505|FG000|NOT COMPLETED|Double Blind Period||13||
48600714|NCT02453256|101807506|FG001|NOT COMPLETED|Double Blind Period||9||
48714015|NCT03397134|102088491|FG004|NOT COMPLETED|Open-Label Extension||0||
48767572|NCT01614886|102222770|FG001|Full Analysis Set (FAS)|Overall Study||105||
48767573|NCT01614886|102222769|FG000|COMPLETED|Overall Study||87||
48767574|NCT01614886|102222770|FG001|COMPLETED|Overall Study||83||
48298487|NCT01026454|101057176|FG001|STARTED|Washout||14||
48298488|NCT01026454|101057175|FG000|COMPLETED|Washout||18||
48298489|NCT01026454|101057176|FG001|COMPLETED|Washout||14||
48298490|NCT01026454|101057175|FG000|NOT COMPLETED|Washout||0||
48298491|NCT01026454|101057176|FG001|NOT COMPLETED|Washout||0||
48600715|NCT02453256|101807505|FG000|STARTED|Open Label Period||89||
48600716|NCT02453256|101807506|FG001|STARTED|Open Label Period||92||
48600717|NCT02453256|101807505|FG000|COMPLETED|Open Label Period||82||
48600718|NCT02453256|101807506|FG001|COMPLETED|Open Label Period||85||
48600719|NCT02453256|101807505|FG000|NOT COMPLETED|Open Label Period||7||
48600720|NCT02453256|101807506|FG001|NOT COMPLETED|Open Label Period||7||
48600721|NCT04769739|101807507|FG000|STARTED|Overall Study||73||
48600722|NCT04769739|101807508|FG001|STARTED|Overall Study||75||
48600723|NCT04769739|101807509|FG002|STARTED|Overall Study||76||
48600724|NCT04769739|101807510|FG003|STARTED|Overall Study||77||
48600725|NCT04769739|101807507|FG000|COMPLETED|Overall Study||70||
48600726|NCT04769739|101807508|FG001|COMPLETED|Overall Study||75||
48600727|NCT04769739|101807509|FG002|COMPLETED|Overall Study||76||
48600728|NCT04769739|101807510|FG003|COMPLETED|Overall Study||75||
48600729|NCT04769739|101807507|FG000|NOT COMPLETED|Overall Study||3||
48600730|NCT04769739|101807508|FG001|NOT COMPLETED|Overall Study||0||
48600731|NCT04769739|101807509|FG002|NOT COMPLETED|Overall Study||0||
48600732|NCT04769739|101807510|FG003|NOT COMPLETED|Overall Study||2||
48600733|NCT00184093|101807511|FG000|STARTED|Overall Study||35||
48600734|NCT00184093|101807511|FG000|COMPLETED|Overall Study||26||
48600735|NCT00184093|101807511|FG000|NOT COMPLETED|Overall Study||9||
48600736|NCT02864316|101807512|FG000|STARTED|Overall Study||2||
48600737|NCT02864316|101807513|FG001|STARTED|Overall Study||2||
48600738|NCT02864316|101807512|FG000|COMPLETED|Overall Study||0||
48600739|NCT02864316|101807513|FG001|COMPLETED|Overall Study||0||
48600740|NCT02864316|101807512|FG000|NOT COMPLETED|Overall Study||2||
48600741|NCT02864316|101807513|FG001|NOT COMPLETED|Overall Study||2||
48600742|NCT02410213|101807514|FG000|STARTED|Overall Study||16||
48600743|NCT02410213|101807515|FG001|STARTED|Overall Study||19||
48600744|NCT02410213|101807514|FG000|COMPLETED|Overall Study||16||
48600745|NCT02410213|101807515|FG001|COMPLETED|Overall Study||19||
48600746|NCT02410213|101807514|FG000|NOT COMPLETED|Overall Study||0||
48600747|NCT02410213|101807515|FG001|NOT COMPLETED|Overall Study||0||
48600748|NCT03526055|101807516|FG000|STARTED|Initial Program||5||
48600749|NCT03526055|101807517|FG001|STARTED|Initial Program||5||
48600750|NCT03526055|101807516|FG000|COMPLETED|Initial Program||5||
48600751|NCT03526055|101807517|FG001|COMPLETED|Initial Program||5||
48600752|NCT03526055|101807516|FG000|NOT COMPLETED|Initial Program||0||
48600753|NCT03526055|101807517|FG001|NOT COMPLETED|Initial Program||0||
48600754|NCT03526055|101807516|FG000|STARTED|Second Program||5||
48600755|NCT03526055|101807517|FG001|STARTED|Second Program||5||
48600756|NCT03526055|101807516|FG000|COMPLETED|Second Program||5||
48600757|NCT03526055|101807517|FG001|COMPLETED|Second Program||5||
48600758|NCT03526055|101807516|FG000|NOT COMPLETED|Second Program||0||
48600759|NCT03526055|101807517|FG001|NOT COMPLETED|Second Program||0||
48600760|NCT00980655|101807518|FG000|STARTED|Overall Study||61||
48600761|NCT00980655|101807519|FG001|STARTED|Overall Study||190||
48600762|NCT00980655|101807518|FG000|Vaccinated 13vPnC Dose 1|Overall Study||59||
48600763|NCT00980655|101807519|FG001|Vaccinated 13vPnC Dose 1|Overall Study||188||
48600764|NCT00980655|101807518|FG000|Vaccinated 13vPnC Dose 2|Overall Study||55||
48600765|NCT00980655|101807519|FG001|Vaccinated 13vPnC Dose 2|Overall Study||176||
48600766|NCT00980655|101807518|FG000|Vaccinated 13vPnC Dose 3|Overall Study||54||
48600767|NCT00980655|101807519|FG001|Vaccinated 13vPnC Dose 3|Overall Study||167||
48600768|NCT00980655|101807518|FG000|Vaccinated 13vPnC Dose 4|Overall Study||46||
48600769|NCT00980655|101807519|FG001|Vaccinated 13vPnC Dose 4|Overall Study||146||
48600770|NCT00980655|101807518|FG000|Vaccinated 23vPS Dose|Overall Study||45||
48600771|NCT00980655|101807519|FG001|Vaccinated 23vPS Dose|Overall Study||140||
48600772|NCT00980655|101807518|FG000|COMPLETED|Overall Study||45||
48600773|NCT00980655|101807519|FG001|COMPLETED|Overall Study||139||
48600774|NCT00980655|101807518|FG000|NOT COMPLETED|Overall Study||16||
48600775|NCT00980655|101807519|FG001|NOT COMPLETED|Overall Study||51||
48600776|NCT00236899|101807520|FG000|STARTED|Overall Study||60||
48600777|NCT00236899|101807521|FG001|STARTED|Overall Study||64||
48600778|NCT00236899|101807522|FG002|STARTED|Overall Study||58||
48600779|NCT00236899|101807523|FG003|STARTED|Overall Study||59||
48600780|NCT00236899|101807520|FG000|COMPLETED|Overall Study||18||
48600781|NCT00236899|101807521|FG001|COMPLETED|Overall Study||24||
48600782|NCT00236899|101807522|FG002|COMPLETED|Overall Study||14||
48600783|NCT00236899|101807523|FG003|COMPLETED|Overall Study||19||
48600784|NCT00236899|101807520|FG000|NOT COMPLETED|Overall Study||42||
48600785|NCT00236899|101807521|FG001|NOT COMPLETED|Overall Study||40||
48600786|NCT00236899|101807522|FG002|NOT COMPLETED|Overall Study||44||
48600787|NCT00236899|101807523|FG003|NOT COMPLETED|Overall Study||40||
48600788|NCT01492101|101807524|FG000|STARTED|Overall Study||429||
48600789|NCT01492101|101807525|FG001|STARTED|Overall Study||423||
48600790|NCT01492101|101807524|FG000|COMPLETED|Overall Study||92||
48600791|NCT01492101|101807525|FG001|COMPLETED|Overall Study||81||
48600792|NCT01492101|101807524|FG000|NOT COMPLETED|Overall Study||337||
48600793|NCT01492101|101807525|FG001|NOT COMPLETED|Overall Study||342||
48600794|NCT00359294|101807526|FG000|STARTED|Overall Study||1||
48600795|NCT00359294|101807527|FG001|STARTED|Overall Study||1||
48600796|NCT00359294|101807528|FG002|STARTED|Overall Study||3||
48600797|NCT00359294|101807529|FG003|STARTED|Overall Study||4||
48600798|NCT00359294|101807530|FG004|STARTED|Overall Study||3||
48600799|NCT00359294|101807526|FG000|COMPLETED|Overall Study||0||
48600800|NCT00359294|101807527|FG001|COMPLETED|Overall Study||0||
48600801|NCT00359294|101807528|FG002|COMPLETED|Overall Study||0||
48600802|NCT00359294|101807529|FG003|COMPLETED|Overall Study||0||
48600803|NCT00359294|101807530|FG004|COMPLETED|Overall Study||0||
48600804|NCT00359294|101807526|FG000|NOT COMPLETED|Overall Study||1||
48600805|NCT00359294|101807527|FG001|NOT COMPLETED|Overall Study||1||
48600806|NCT00359294|101807528|FG002|NOT COMPLETED|Overall Study||3||
48600807|NCT00359294|101807529|FG003|NOT COMPLETED|Overall Study||4||
48600808|NCT00359294|101807530|FG004|NOT COMPLETED|Overall Study||3||
48600809|NCT01797094|101807531|FG000|STARTED|Overall Study||48||
48600810|NCT01797094|101807532|FG001|STARTED|Overall Study||53||
48600811|NCT01797094|101807531|FG000|COMPLETED|Overall Study||42||
48600812|NCT01797094|101807532|FG001|COMPLETED|Overall Study||51||
48600813|NCT01797094|101807531|FG000|NOT COMPLETED|Overall Study||6||
48600814|NCT01797094|101807532|FG001|NOT COMPLETED|Overall Study||2||
48600815|NCT04679948|101807533|FG000|STARTED|Period 1||16||
48600816|NCT04679948|101807533|FG000|COMPLETED|Period 1||16||
48600817|NCT04679948|101807533|FG000|NOT COMPLETED|Period 1||0||
48600818|NCT04679948|101807533|FG000|STARTED|Period 2||16||
48600819|NCT04679948|101807533|FG000|COMPLETED|Period 2||16||
48600820|NCT04679948|101807533|FG000|NOT COMPLETED|Period 2||0||
48600821|NCT00513357|101807534|FG000|STARTED|Overall Study||38||
48600822|NCT00513357|101807535|FG001|STARTED|Overall Study||35||
48600823|NCT00513357|101807534|FG000|COMPLETED|Overall Study||23||
48600824|NCT00513357|101807535|FG001|COMPLETED|Overall Study||25||
48600825|NCT00513357|101807534|FG000|NOT COMPLETED|Overall Study||15||
48600826|NCT00513357|101807535|FG001|NOT COMPLETED|Overall Study||10||
48600827|NCT02308371|101807536|FG000|STARTED|Overall Study||50||
48600828|NCT02308371|101807537|FG001|STARTED|Overall Study||50||
48600829|NCT02308371|101807536|FG000|COMPLETED|Overall Study||50||
48600830|NCT02308371|101807537|FG001|COMPLETED|Overall Study||50||
48600831|NCT02308371|101807536|FG000|NOT COMPLETED|Overall Study||0||
48600832|NCT02308371|101807537|FG001|NOT COMPLETED|Overall Study||0||
48600833|NCT00723697|101807538|FG000|STARTED|Overall Study||1307||
48600834|NCT00723697|101807538|FG000|COMPLETED|Overall Study||1289||
48600835|NCT00723697|101807538|FG000|NOT COMPLETED|Overall Study||18||
48600836|NCT01048905|101807539|FG000|STARTED|Overall Study||13||
48600837|NCT01048905|101807539|FG000|COMPLETED|Overall Study||12||
48600838|NCT01048905|101807539|FG000|NOT COMPLETED|Overall Study||1||
48600839|NCT01836185|101807540|FG000|STARTED|Overall Study||10||
48600840|NCT01836185|101807541|FG001|STARTED|Overall Study||8||
48600841|NCT01836185|101807542|FG002|STARTED|Overall Study||8||
48600842|NCT01836185|101807543|FG003|STARTED|Overall Study||6||
48600843|NCT01836185|101807540|FG000|Received Single Dose of Study Treatment|Overall Study||10||
48600844|NCT01836185|101807541|FG001|Received Single Dose of Study Treatment|Overall Study||8||
48600845|NCT01836185|101807542|FG002|Received Single Dose of Study Treatment|Overall Study||8||
48600846|NCT01836185|101807543|FG003|Received Single Dose of Study Treatment|Overall Study||6||
48600847|NCT01836185|101807540|FG000|COMPLETED|Overall Study||10||
48600848|NCT01836185|101807541|FG001|COMPLETED|Overall Study||8||
48600849|NCT01836185|101807542|FG002|COMPLETED|Overall Study||8||
48600850|NCT01836185|101807543|FG003|COMPLETED|Overall Study||6||
48600851|NCT01836185|101807540|FG000|NOT COMPLETED|Overall Study||0||
48600852|NCT01836185|101807541|FG001|NOT COMPLETED|Overall Study||0||
48600853|NCT01836185|101807542|FG002|NOT COMPLETED|Overall Study||0||
48600854|NCT01836185|101807543|FG003|NOT COMPLETED|Overall Study||0||
48600855|NCT00824434|101807544|FG000|STARTED|Overall Study||100||
48600856|NCT00824434|101807544|FG000|COMPLETED|Overall Study||100||
48600857|NCT00824434|101807544|FG000|NOT COMPLETED|Overall Study||0||
48600858|NCT00337779|101807545|FG000|STARTED|Overall Study||586||
48600859|NCT00337779|101807546|FG001|STARTED|Overall Study||569||
48600860|NCT00337779|101807545|FG000|COMPLETED|Overall Study||534||
48600861|NCT00337779|101807546|FG001|COMPLETED|Overall Study||490||
48600862|NCT00337779|101807545|FG000|NOT COMPLETED|Overall Study||52||
48600863|NCT00337779|101807546|FG001|NOT COMPLETED|Overall Study||79||
48600864|NCT04525131|101807547|FG000|STARTED|Overall Study||12||
48600865|NCT04525131|101807547|FG000|COMPLETED|Overall Study||12||
48600866|NCT04525131|101807547|FG000|NOT COMPLETED|Overall Study||0||
48600867|NCT02069093|101807548|FG000|STARTED|Overall Study||86||
48600868|NCT02069093|101807548|FG000|Pharmacokinetic Analysis Set|Overall Study||50||
48600869|NCT02069093|101807548|FG000|COMPLETED|Overall Study||56||
48600870|NCT02069093|101807548|FG000|NOT COMPLETED|Overall Study||30||
48600871|NCT01828216|101807549|FG000|STARTED|Overall Study||159||
48600872|NCT01828216|101807550|FG001|STARTED|Overall Study||157||
48600873|NCT01828216|101807549|FG000|COMPLETED|Overall Study||159||
48600874|NCT01828216|101807550|FG001|COMPLETED|Overall Study||157||
48600875|NCT01828216|101807549|FG000|NOT COMPLETED|Overall Study||0||
48600876|NCT01828216|101807550|FG001|NOT COMPLETED|Overall Study||0||
48600877|NCT03084315|101807551|FG000|STARTED|Overall Study||116||
48600878|NCT03084315|101807552|FG001|STARTED|Overall Study||118||
48600879|NCT03084315|101807551|FG000|COMPLETED|Overall Study||106||
48600880|NCT03084315|101807552|FG001|COMPLETED|Overall Study||109||
48600881|NCT03084315|101807551|FG000|NOT COMPLETED|Overall Study||10||
48600882|NCT03084315|101807552|FG001|NOT COMPLETED|Overall Study||9||
48600883|NCT01813734|101807553|FG000|STARTED|Overall Study||9||
48600884|NCT01813734|101807553|FG000|COMPLETED|Overall Study||9||
48298492|NCT01026454|101057175|FG000|STARTED|Second Intervention||17||
48298493|NCT01026454|101057176|FG001|STARTED|Second Intervention||14||
48298494|NCT01026454|101057175|FG000|COMPLETED|Second Intervention||16||
48298495|NCT01026454|101057176|FG001|COMPLETED|Second Intervention||13||
48298496|NCT01026454|101057175|FG000|NOT COMPLETED|Second Intervention||1||
48298497|NCT01026454|101057176|FG001|NOT COMPLETED|Second Intervention||1||
48298498|NCT01353079|101057177|FG000|STARTED|Overall Study||218||
48298499|NCT01353079|101057178|FG001|STARTED|Overall Study||211||
48298500|NCT01353079|101057177|FG000|COMPLETED|Overall Study||191||
48298501|NCT01353079|101057178|FG001|COMPLETED|Overall Study||190||
48298502|NCT01353079|101057177|FG000|NOT COMPLETED|Overall Study||27||
48298503|NCT01353079|101057178|FG001|NOT COMPLETED|Overall Study||21||
48298504|NCT02110147|101059976|FG000|STARTED|Overall Study||4||
48298505|NCT02110147|101059976|FG000|COMPLETED|Overall Study||4||
48298506|NCT02110147|101059976|FG000|NOT COMPLETED|Overall Study||0||
48600885|NCT01813734|101807553|FG000|NOT COMPLETED|Overall Study||0||
48600886|NCT01994902|101807554|FG000|STARTED|Test Period 1||63||
48600887|NCT01994902|101807555|FG001|STARTED|Test Period 1||64||
48298507|NCT01201343|101059977|FG000|STARTED|Overall Study||79||
48298508|NCT01201343|101059977|FG000|Treated|Overall Study||76||
48298509|NCT01201343|101059977|FG000|COMPLETED|Overall Study||60||
48298510|NCT01201343|101059977|FG000|NOT COMPLETED|Overall Study||19||
48298511|NCT02469896|101059978|FG000|STARTED|Overall Study||8||
48298512|NCT02469896|101059979|FG001|STARTED|Overall Study||14||
48298513|NCT02469896|101059978|FG000|COMPLETED|Overall Study||6||
48298514|NCT02469896|101059979|FG001|COMPLETED|Overall Study||14||
48298515|NCT02469896|101059978|FG000|NOT COMPLETED|Overall Study||2||
48298516|NCT02469896|101059979|FG001|NOT COMPLETED|Overall Study||0||
48298517|NCT04845633|101059980|FG000|STARTED|Overall Study||12||
48298518|NCT04845633|101059981|FG001|STARTED|Overall Study||12||
48298519|NCT04845633|101059982|FG002|STARTED|Overall Study||12||
48298520|NCT04845633|101059983|FG003|STARTED|Overall Study||12||
48298521|NCT04845633|101059980|FG000|COMPLETED|Overall Study||12||
48298522|NCT04845633|101059981|FG001|COMPLETED|Overall Study||12||
48298523|NCT04845633|101059982|FG002|COMPLETED|Overall Study||12||
48298524|NCT04845633|101059983|FG003|COMPLETED|Overall Study||12||
48298525|NCT04845633|101059980|FG000|NOT COMPLETED|Overall Study||0||
48298526|NCT04845633|101059981|FG001|NOT COMPLETED|Overall Study||0||
48298527|NCT04845633|101059982|FG002|NOT COMPLETED|Overall Study||0||
48298528|NCT04845633|101059983|FG003|NOT COMPLETED|Overall Study||0||
48298529|NCT03678103|101059984|FG000|STARTED|Overall Study||30||
48298530|NCT03678103|101059984|FG000|COMPLETED|Overall Study||26||
48298531|NCT03678103|101059984|FG000|NOT COMPLETED|Overall Study||4||
48298532|NCT03756350|101059985|FG000|STARTED|Overall Study||30||
48298533|NCT03756350|101059985|FG000|COMPLETED|Overall Study||29||
48298534|NCT03756350|101059985|FG000|NOT COMPLETED|Overall Study||1||
48298535|NCT00362453|101059986|FG000|STARTED|Overall Study||20||
48298536|NCT00362453|101059987|FG001|STARTED|Overall Study||20||
48298537|NCT00362453|101059986|FG000|COMPLETED|Overall Study||20||
48600888|NCT01994902|101807554|FG000|COMPLETED|Test Period 1||57||
48600889|NCT01994902|101807555|FG001|COMPLETED|Test Period 1||61||
48600890|NCT01994902|101807554|FG000|NOT COMPLETED|Test Period 1||6||
48600891|NCT01994902|101807555|FG001|NOT COMPLETED|Test Period 1||3||
48600892|NCT01994902|101807554|FG000|STARTED|Test Period 2||57||
48600893|NCT01994902|101807555|FG001|STARTED|Test Period 2||61||
48600894|NCT01994902|101807554|FG000|COMPLETED|Test Period 2||57||
48600895|NCT01994902|101807555|FG001|COMPLETED|Test Period 2||55||
48600896|NCT01994902|101807554|FG000|NOT COMPLETED|Test Period 2||0||
48600897|NCT01994902|101807555|FG001|NOT COMPLETED|Test Period 2||6||
48600898|NCT00427999|101807556|FG000|STARTED|Overall Study||65||
48600899|NCT00427999|101807556|FG000|Intent to Treat (ITT)|Overall Study||61||
48298538|NCT00362453|101059987|FG001|COMPLETED|Overall Study||20||
48298539|NCT00362453|101059986|FG000|NOT COMPLETED|Overall Study||0||
48298540|NCT00362453|101059987|FG001|NOT COMPLETED|Overall Study||0||
48298541|NCT03181451|101059988|FG000|STARTED|Overall Study||12||
48298542|NCT03181451|101059989|FG001|STARTED|Overall Study||13||
48298543|NCT03181451|101059990|FG002|STARTED|Overall Study||12||
48298544|NCT03181451|101059988|FG000|COMPLETED|Overall Study||12||
48298545|NCT03181451|101059989|FG001|COMPLETED|Overall Study||11||
48298546|NCT03181451|101059990|FG002|COMPLETED|Overall Study||12||
48600900|NCT00427999|101807556|FG000|Extension Follow-up|Overall Study||19||
48298547|NCT03181451|101059988|FG000|NOT COMPLETED|Overall Study||0||
48600901|NCT00427999|101807556|FG000|COMPLETED|Overall Study||33||
48600902|NCT00427999|101807556|FG000|NOT COMPLETED|Overall Study||32||
48600903|NCT00182000|101807557|FG000|STARTED|Overall Study||14||
48298548|NCT03181451|101059989|FG001|NOT COMPLETED|Overall Study||2||
48298549|NCT03181451|101059990|FG002|NOT COMPLETED|Overall Study||0||
48298550|NCT05426759|101059991|FG000|STARTED|Overall Study||12||
48298551|NCT05426759|101059991|FG000|COMPLETED|Overall Study||12||
48298552|NCT05426759|101059991|FG000|NOT COMPLETED|Overall Study||0||
48298553|NCT00778622|101059992|FG000|STARTED|Overall Study||125||
48298554|NCT00778622|101059993|FG001|STARTED|Overall Study||122||
48298555|NCT00778622|101059994|FG002|STARTED|Overall Study||124||
48298556|NCT00778622|101059992|FG000|COMPLETED|Overall Study||109||
48298557|NCT00778622|101059993|FG001|COMPLETED|Overall Study||107||
48298558|NCT00778622|101059994|FG002|COMPLETED|Overall Study||109||
48298559|NCT00778622|101059992|FG000|NOT COMPLETED|Overall Study||16||
48298560|NCT00778622|101059993|FG001|NOT COMPLETED|Overall Study||15||
48298561|NCT00778622|101059994|FG002|NOT COMPLETED|Overall Study||15||
48298562|NCT00792805|101059995|FG000|STARTED|Overall Study||188||
48298563|NCT00792805|101059996|FG001|STARTED|Overall Study||188||
48298564|NCT00792805|101059997|FG002|STARTED|Overall Study||187||
48298565|NCT00792805|101059995|FG000|Exposed to Study Medication or Placebo|Overall Study||187||
48600904|NCT00182000|101807558|FG001|STARTED|Overall Study||15||
48600905|NCT00182000|101807557|FG000|COMPLETED|Overall Study||9||
48600906|NCT00182000|101807558|FG001|COMPLETED|Overall Study||13||
48600907|NCT00182000|101807557|FG000|NOT COMPLETED|Overall Study||5||
48600908|NCT00182000|101807558|FG001|NOT COMPLETED|Overall Study||2||
48600909|NCT01711619|101807559|FG000|STARTED|Overall Study||56||
48298566|NCT00792805|101059996|FG001|Exposed to Study Medication or Placebo|Overall Study||188||
48298567|NCT00792805|101059997|FG002|Exposed to Study Medication or Placebo|Overall Study||186||
48298568|NCT00792805|101059995|FG000|COMPLETED|Overall Study||166||
48298569|NCT00792805|101059996|FG001|COMPLETED|Overall Study||162||
48298570|NCT00792805|101059997|FG002|COMPLETED|Overall Study||154||
48298571|NCT00792805|101059995|FG000|NOT COMPLETED|Overall Study||22||
48298572|NCT00792805|101059996|FG001|NOT COMPLETED|Overall Study||26||
48298573|NCT00792805|101059997|FG002|NOT COMPLETED|Overall Study||33||
48298574|NCT03707925|101059998|FG000|STARTED|Overall Study||4||
48298575|NCT03707925|101059998|FG000|COMPLETED|Overall Study||3||
48298576|NCT03707925|101059998|FG000|NOT COMPLETED|Overall Study||1||
48298577|NCT01290601|101059999|FG000|STARTED|Overall Study||46||
48600910|NCT01711619|101807560|FG001|STARTED|Overall Study||60||
48600911|NCT01711619|101807559|FG000|COMPLETED|Overall Study||38||
48600912|NCT01711619|101807560|FG001|COMPLETED|Overall Study||36||
48600913|NCT01711619|101807559|FG000|NOT COMPLETED|Overall Study||18||
48600914|NCT01711619|101807560|FG001|NOT COMPLETED|Overall Study||24||
48600915|NCT03951753|101807561|FG000|STARTED|Overall Study||45||
48600916|NCT03951753|101807562|FG001|STARTED|Overall Study||44||
48600917|NCT03951753|101807563|FG002|STARTED|Overall Study||28||
48600918|NCT03951753|101807561|FG000|COMPLETED|Overall Study||41||
48600919|NCT03951753|101807562|FG001|COMPLETED|Overall Study||43||
48600920|NCT03951753|101807563|FG002|COMPLETED|Overall Study||24||
48600921|NCT03951753|101807561|FG000|NOT COMPLETED|Overall Study||4||
48600922|NCT03951753|101807562|FG001|NOT COMPLETED|Overall Study||1||
48600923|NCT03951753|101807563|FG002|NOT COMPLETED|Overall Study||4||
48600924|NCT00467558|101807564|FG000|STARTED|Overall Study||4||
48600925|NCT00467558|101807565|FG001|STARTED|Overall Study||3||
48298578|NCT01290601|101060000|FG001|STARTED|Overall Study||24||
48298579|NCT01290601|101060001|FG002|STARTED|Overall Study||0||
48298580|NCT01290601|101060002|FG003|STARTED|Overall Study||0||
48298581|NCT01290601|101059999|FG000|COMPLETED|Overall Study||35||
48298582|NCT01290601|101060000|FG001|COMPLETED|Overall Study||19||
48298583|NCT01290601|101060001|FG002|COMPLETED|Overall Study||0||
48298584|NCT01290601|101060002|FG003|COMPLETED|Overall Study||0||
48298585|NCT01290601|101059999|FG000|NOT COMPLETED|Overall Study||11||
48298586|NCT01290601|101060000|FG001|NOT COMPLETED|Overall Study||5||
48298587|NCT01290601|101060001|FG002|NOT COMPLETED|Overall Study||0||
48298588|NCT01290601|101060002|FG003|NOT COMPLETED|Overall Study||0||
48298589|NCT01231516|101060003|FG000|STARTED|Double-blind Phase (Up to Week [Wk] 48)||360|Randomized|
48298590|NCT01231516|101060004|FG001|STARTED|Double-blind Phase (Up to Week [Wk] 48)||364|Randomized|
48298591|NCT01231516|101060003|FG000|ITT-E Population|Double-blind Phase (Up to Week [Wk] 48)||357||
48298592|NCT01231516|101060004|FG001|ITT-E Population|Double-blind Phase (Up to Week [Wk] 48)||362||
48298593|NCT01231516|101060003|FG000|Modified (m)ITT-E Population|Double-blind Phase (Up to Week [Wk] 48)||354||
48600926|NCT00467558|101807564|FG000|COMPLETED|Overall Study||2||
48600927|NCT00467558|101807565|FG001|COMPLETED|Overall Study||3||
48600928|NCT00467558|101807564|FG000|NOT COMPLETED|Overall Study||2||
48600929|NCT00467558|101807565|FG001|NOT COMPLETED|Overall Study||0||
48600930|NCT02282163|101807566|FG000|STARTED|Overall Study||13||
48600931|NCT02282163|101807566|FG000|COMPLETED|Overall Study||12||
48600932|NCT02282163|101807566|FG000|NOT COMPLETED|Overall Study||1||
48600933|NCT02669667|101807567|FG000|STARTED|Overall Study||12||
48600934|NCT02669667|101807568|FG001|STARTED|Overall Study||4||
48600935|NCT02669667|101807569|FG002|STARTED|Overall Study||4||
48600936|NCT02669667|101807570|FG003|STARTED|Overall Study||6||
48600937|NCT02669667|101807571|FG004|STARTED|Overall Study||6||
48145196|NCT01270347|100679643|FG000|STARTED|Core Phase||93||
48145197|NCT01270347|100679644|FG001|STARTED|Core Phase||189||
48145198|NCT01270347|100679643|FG000|COMPLETED|Core Phase||83||
48145199|NCT01270347|100679644|FG001|COMPLETED|Core Phase||166||
48145200|NCT01270347|100679643|FG000|NOT COMPLETED|Core Phase||10||
48145201|NCT01270347|100679644|FG001|NOT COMPLETED|Core Phase||23||
48600938|NCT02669667|101807572|FG005|STARTED|Overall Study||6||
48600939|NCT02669667|101807573|FG006|STARTED|Overall Study||6||
48600940|NCT02669667|101807567|FG000|COMPLETED|Overall Study||12||
48145202|NCT01270347|100679643|FG000|STARTED|Extension Phase||32||
48145203|NCT01270347|100679644|FG001|STARTED|Extension Phase||56||
48145204|NCT01270347|100679643|FG000|COMPLETED|Extension Phase||26||
48600941|NCT02669667|101807568|FG001|COMPLETED|Overall Study||4||
48600942|NCT02669667|101807569|FG002|COMPLETED|Overall Study||4||
48600943|NCT02669667|101807570|FG003|COMPLETED|Overall Study||6||
48600944|NCT02669667|101807571|FG004|COMPLETED|Overall Study||6||
48600945|NCT02669667|101807572|FG005|COMPLETED|Overall Study||5||
48600946|NCT02669667|101807573|FG006|COMPLETED|Overall Study||6||
48600947|NCT02669667|101807567|FG000|NOT COMPLETED|Overall Study||0||
48600948|NCT02669667|101807568|FG001|NOT COMPLETED|Overall Study||0||
48600949|NCT02669667|101807569|FG002|NOT COMPLETED|Overall Study||0||
48600950|NCT02669667|101807570|FG003|NOT COMPLETED|Overall Study||0||
48600951|NCT02669667|101807571|FG004|NOT COMPLETED|Overall Study||0||
48600952|NCT02669667|101807572|FG005|NOT COMPLETED|Overall Study||1||
48600953|NCT02669667|101807573|FG006|NOT COMPLETED|Overall Study||0||
48405138|NCT04146038|101325202|FG000|STARTED|Overall Study||5||
48405139|NCT04146038|101325202|FG000|COMPLETED|Overall Study||5||
48405140|NCT04146038|101325202|FG000|NOT COMPLETED|Overall Study||0||
48405141|NCT02237898|101325203|FG000|STARTED|Overall Study||12||
48600954|NCT02943785|101807574|FG000|STARTED|Overall Study||713||
48145205|NCT01270347|100679644|FG001|COMPLETED|Extension Phase||47||
48145206|NCT01270347|100679643|FG000|NOT COMPLETED|Extension Phase||6||
48145207|NCT01270347|100679644|FG001|NOT COMPLETED|Extension Phase||9||
48145208|NCT02570126|100679645|FG000|STARTED|Overall Study||615||
48145209|NCT02570126|100679646|FG001|STARTED|Overall Study||616||
48145210|NCT02570126|100679645|FG000|COMPLETED|Overall Study||609||
48145211|NCT02570126|100679646|FG001|COMPLETED|Overall Study||607||
48145212|NCT02570126|100679645|FG000|NOT COMPLETED|Overall Study||6||
48600955|NCT02943785|101807575|FG001|STARTED|Overall Study||713||
48600956|NCT02943785|101807574|FG000|COMPLETED|Overall Study||431||
48600957|NCT02943785|101807575|FG001|COMPLETED|Overall Study||350||
48145213|NCT02570126|100679646|FG001|NOT COMPLETED|Overall Study||9||
48405142|NCT02237898|101325204|FG001|STARTED|Overall Study||14||
48405143|NCT02237898|101325203|FG000|Completed 12 Weeks of CM|Overall Study||7||
48405144|NCT02237898|101325204|FG001|Completed 12 Weeks of CM|Overall Study||2||
48145214|NCT02303184|100679647|FG000|STARTED|Overall Study||23||
48405145|NCT02237898|101325203|FG000|Completed 3 Month Follow-up|Overall Study||6||
48600958|NCT02943785|101807574|FG000|NOT COMPLETED|Overall Study||282||
48145215|NCT02303184|100679648|FG001|STARTED|Overall Study||23||
48145216|NCT02303184|100679647|FG000|COMPLETED|Overall Study||23||
48600959|NCT02943785|101807575|FG001|NOT COMPLETED|Overall Study||363||
48600960|NCT03013985|101807576|FG000|STARTED|Overall Study||108||
48600961|NCT03013985|101807577|FG001|STARTED|Overall Study||103||
48145217|NCT02303184|100679648|FG001|COMPLETED|Overall Study||23||
48145218|NCT02303184|100679647|FG000|NOT COMPLETED|Overall Study||0||
48145219|NCT02303184|100679648|FG001|NOT COMPLETED|Overall Study||0||
48145220|NCT02192502|100679649|FG000|STARTED|Overall Study||76||
48145221|NCT02192502|100679650|FG001|STARTED|Overall Study||73||
48145222|NCT02192502|100679649|FG000|COMPLETED|Overall Study||69||
48145223|NCT02192502|100679650|FG001|COMPLETED|Overall Study||72||
48145224|NCT02192502|100679649|FG000|NOT COMPLETED|Overall Study||7||
48145225|NCT02192502|100679650|FG001|NOT COMPLETED|Overall Study||1||
48145226|NCT01302847|100679651|FG000|STARTED|Overall Study||23||
48145227|NCT01302847|100679652|FG001|STARTED|Overall Study||23||
48145228|NCT01302847|100679653|FG002|STARTED|Overall Study||15||
48145229|NCT01302847|100679654|FG003|STARTED|Overall Study||17||
48145230|NCT01302847|100679655|FG004|STARTED|Overall Study||7||
48145231|NCT01302847|100679656|FG005|STARTED|Overall Study||36||
48145232|NCT01302847|100679657|FG006|STARTED|Overall Study||35||
48145233|NCT01302847|100679658|FG007|STARTED|Overall Study||25||
48145234|NCT01302847|100679651|FG000|COMPLETED|Overall Study||10||
48145235|NCT01302847|100679652|FG001|COMPLETED|Overall Study||16||
48145236|NCT01302847|100679653|FG002|COMPLETED|Overall Study||14||
48145237|NCT01302847|100679654|FG003|COMPLETED|Overall Study||15||
48145238|NCT01302847|100679655|FG004|COMPLETED|Overall Study||5||
48145239|NCT01302847|100679656|FG005|COMPLETED|Overall Study||31||
48145240|NCT01302847|100679657|FG006|COMPLETED|Overall Study||30||
48145241|NCT01302847|100679658|FG007|COMPLETED|Overall Study||20||
48145242|NCT01302847|100679651|FG000|NOT COMPLETED|Overall Study||13||
48145243|NCT01302847|100679652|FG001|NOT COMPLETED|Overall Study||7||
48145244|NCT01302847|100679653|FG002|NOT COMPLETED|Overall Study||1||
48145245|NCT01302847|100679654|FG003|NOT COMPLETED|Overall Study||2||
48145246|NCT01302847|100679655|FG004|NOT COMPLETED|Overall Study||2||
48145247|NCT01302847|100679656|FG005|NOT COMPLETED|Overall Study||5||
48145248|NCT01302847|100679657|FG006|NOT COMPLETED|Overall Study||5||
48145249|NCT01302847|100679658|FG007|NOT COMPLETED|Overall Study||5||
48145250|NCT02133534|100679659|FG000|STARTED|Overall Study||1||
48145251|NCT02133534|100679659|FG000|COMPLETED|Overall Study||1||
48145252|NCT02133534|100679659|FG000|NOT COMPLETED|Overall Study||0||
48145253|NCT00686881|100679660|FG000|STARTED|Overall Study||127||
48145254|NCT00686881|100679661|FG001|STARTED|Overall Study||134||
48145255|NCT00686881|100679660|FG000|COMPLETED|Overall Study||45||
48145256|NCT00686881|100679661|FG001|COMPLETED|Overall Study||53||
48145257|NCT00686881|100679660|FG000|NOT COMPLETED|Overall Study||82||
48145258|NCT00686881|100679661|FG001|NOT COMPLETED|Overall Study||81||
48145259|NCT00447057|100679662|FG000|STARTED|Overall Study||83||
48145260|NCT00447057|100679663|FG001|STARTED|Overall Study||76||
48145261|NCT00447057|100679664|FG002|STARTED|Overall Study||19||
48145262|NCT00447057|100679665|FG003|STARTED|Overall Study||26||
48145263|NCT00447057|100679662|FG000|COMPLETED|Overall Study||0||
48145264|NCT00447057|100679663|FG001|COMPLETED|Overall Study||3||
48145265|NCT00447057|100679664|FG002|COMPLETED|Overall Study||0||
48145266|NCT00447057|100679665|FG003|COMPLETED|Overall Study||0||
48145267|NCT00447057|100679662|FG000|NOT COMPLETED|Overall Study||83||
48145268|NCT00447057|100679663|FG001|NOT COMPLETED|Overall Study||73||
48145269|NCT00447057|100679664|FG002|NOT COMPLETED|Overall Study||19||
48145270|NCT00447057|100679665|FG003|NOT COMPLETED|Overall Study||26||
48145271|NCT01795833|100679666|FG000|STARTED|Overall Study||1031||
48145272|NCT01795833|100679667|FG001|STARTED|Overall Study||1031||
48145273|NCT01795833|100679666|FG000|COMPLETED|Overall Study||881||
48145274|NCT01795833|100679667|FG001|COMPLETED|Overall Study||882||
48145275|NCT01795833|100679666|FG000|NOT COMPLETED|Overall Study||150||
48145276|NCT01795833|100679667|FG001|NOT COMPLETED|Overall Study||149||
48298594|NCT01231516|101060004|FG001|Modified (m)ITT-E Population|Double-blind Phase (Up to Week [Wk] 48)||361||
48298595|NCT01231516|101060003|FG000|COMPLETED|Double-blind Phase (Up to Week [Wk] 48)||299||
48145277|NCT03213158|100679668|FG000|STARTED|Overall Study||10||
48298596|NCT01231516|101060004|FG001|COMPLETED|Double-blind Phase (Up to Week [Wk] 48)||283||
48145278|NCT03213158|100679668|FG000|COMPLETED|Overall Study||7||
48145279|NCT03213158|100679668|FG000|NOT COMPLETED|Overall Study||3||
48145280|NCT05045625|100679669|FG000|STARTED|Overall Study||12||
48145281|NCT05045625|100679669|FG000|COMPLETED|Overall Study||9||
48145282|NCT05045625|100679669|FG000|NOT COMPLETED|Overall Study||3||
48145283|NCT03178266|100679670|FG000|STARTED|Overall Study||21||
48145284|NCT03178266|100679671|FG001|STARTED|Overall Study||20||
48298597|NCT01231516|101060003|FG000|NOT COMPLETED|Double-blind Phase (Up to Week [Wk] 48)||61||
48145285|NCT03178266|100679670|FG000|COMPLETED|Overall Study||21||
48145286|NCT03178266|100679671|FG001|COMPLETED|Overall Study||16||
48145287|NCT03178266|100679670|FG000|NOT COMPLETED|Overall Study||0||
48145288|NCT03178266|100679671|FG001|NOT COMPLETED|Overall Study||4||
48145289|NCT03141359|100679672|FG000|STARTED|Overall Study||61||
48145290|NCT03141359|100679672|FG000|COMPLETED|Overall Study||0||
48145291|NCT03141359|100679672|FG000|NOT COMPLETED|Overall Study||61||
48145292|NCT04085328|100679673|FG000|STARTED|Overall Study||323|Includes Primary Cohort and Supplemental Cohort|646
48145293|NCT04085328|100679674|FG001|STARTED|Overall Study||322|Includes Primary Cohort and Supplemental Cohort|644
48405146|NCT02237898|101325204|FG001|Completed 3 Month Follow-up|Overall Study||6||
48714016|NCT03397134|102088487|FG000|STARTED|Whole Study||0|"Patients who were initially randomized in the double-blind to Roluperidone 32 mg or Roluperidone 64 mg continued treatment with the same dose during the 40-week open-label treatment extension, while patients who were initially randomized to placebo crossed over to Roluperidone 32 mg or Roluperidone 64 mg in a 1:1 ratio.~The entire study included the double-blind and open-label periods from Baseline to Week 54, referred to as the whole study period."|
48714017|NCT03397134|102088488|FG001|STARTED|Whole Study||0|"Patients who were initially randomized in the double-blind to Roluperidone 32 mg or Roluperidone 64 mg continued treatment with the same dose during the 40-week open-label treatment extension, while patients who were initially randomized to placebo crossed over to Roluperidone 32 mg or Roluperidone 64 mg in a 1:1 ratio.~The entire study included the double-blind and open-label periods from Baseline to Week 54, referred to as the whole study period."|
48714018|NCT03397134|102088489|FG002|STARTED|Whole Study||229|"Patients who were initially randomized in the double-blind to Roluperidone 32 mg or Roluperidone 64 mg continued treatment with the same dose during the 40-week open-label treatment extension, while patients who were initially randomized to placebo crossed over to Roluperidone 32 mg or Roluperidone 64 mg in a 1:1 ratio.~The entire study included the double-blind and open-label periods from Baseline to Week 54, referred to as the whole study period."|
48714019|NCT03397134|102088490|FG003|STARTED|Whole Study||234|"Patients who were initially randomized in the double-blind to Roluperidone 32 mg or Roluperidone 64 mg continued treatment with the same dose during the 40-week open-label treatment extension, while patients who were initially randomized to placebo crossed over to Roluperidone 32 mg or Roluperidone 64 mg in a 1:1 ratio.~The entire study included the double-blind and open-label periods from Baseline to Week 54, referred to as the whole study period."|
48714020|NCT03397134|102088491|FG004|STARTED|Whole Study||50|"Patients who were initially randomized in the double-blind to Roluperidone 32 mg or Roluperidone 64 mg continued treatment with the same dose during the 40-week open-label treatment extension, while patients who were initially randomized to placebo crossed over to Roluperidone 32 mg or Roluperidone 64 mg in a 1:1 ratio.~The entire study included the double-blind and open-label periods from Baseline to Week 54, referred to as the whole study period."|
48714021|NCT03397134|102088487|FG000|COMPLETED|Whole Study||0||
48714022|NCT03397134|102088488|FG001|COMPLETED|Whole Study||0||
48714023|NCT03397134|102088489|FG002|COMPLETED|Whole Study||107||
48714024|NCT03397134|102088490|FG003|COMPLETED|Whole Study||95||
48714025|NCT03397134|102088491|FG004|COMPLETED|Whole Study||0||
48714026|NCT03397134|102088487|FG000|NOT COMPLETED|Whole Study||0||
48714027|NCT03397134|102088488|FG001|NOT COMPLETED|Whole Study||0||
48714028|NCT03397134|102088489|FG002|NOT COMPLETED|Whole Study||122||
48714029|NCT03397134|102088490|FG003|NOT COMPLETED|Whole Study||139||
48714030|NCT03397134|102088491|FG004|NOT COMPLETED|Whole Study||50||
48714031|NCT02863523|102088492|FG000|STARTED|Overall Study||67||
48145294|NCT04085328|100679673|FG000|Primary Cohort Started|Overall Study||291||582
48145295|NCT04085328|100679674|FG001|Primary Cohort Started|Overall Study||290||580
48145296|NCT04085328|100679673|FG000|Primary Cohort Completed|Overall Study||256||512
48145297|NCT04085328|100679674|FG001|Primary Cohort Completed|Overall Study||257||514
48145298|NCT04085328|100679673|FG000|Primary Cohort Discontinued|Overall Study||35||70
48145299|NCT04085328|100679674|FG001|Primary Cohort Discontinued|Overall Study||33||66
48145300|NCT04085328|100679673|FG000|COMPLETED|Overall Study||285|Includes Primary Cohort and Supplemental Cohort|570
48145301|NCT04085328|100679674|FG001|COMPLETED|Overall Study||286|Includes Primary Cohort and Supplemental Cohort|572
48405147|NCT02237898|101325203|FG000|Completed 9 Month Follow-up|Overall Study||6||
48600962|NCT03013985|101807576|FG000|COMPLETED|Overall Study||92||
48600963|NCT03013985|101807577|FG001|COMPLETED|Overall Study||84||
48600964|NCT03013985|101807576|FG000|NOT COMPLETED|Overall Study||16||
48600965|NCT03013985|101807577|FG001|NOT COMPLETED|Overall Study||19||
48714032|NCT02863523|102088493|FG001|STARTED|Overall Study||72||
48714033|NCT02863523|102088492|FG000|COMPLETED|Overall Study||67||
48714034|NCT02863523|102088493|FG001|COMPLETED|Overall Study||72||
48714035|NCT02863523|102088492|FG000|NOT COMPLETED|Overall Study||0||
48714036|NCT02863523|102088493|FG001|NOT COMPLETED|Overall Study||0||
48714037|NCT02576860|102088494|FG000|STARTED|Overall Study||136||
48714038|NCT02576860|102088495|FG001|STARTED|Overall Study||127||
48600966|NCT00404924|101807578|FG000|STARTED|Overall Study||617||
48600967|NCT00404924|101807579|FG001|STARTED|Overall Study||307||
48600968|NCT00404924|101807578|FG000|COMPLETED|Overall Study||14||
48600969|NCT00404924|101807579|FG001|COMPLETED|Overall Study||1||
48145302|NCT04085328|100679673|FG000|NOT COMPLETED|Overall Study||38||76
48145303|NCT04085328|100679674|FG001|NOT COMPLETED|Overall Study||36||72
48145304|NCT01992380|100679675|FG000|STARTED|Overall Study||6||
48145305|NCT01992380|100679676|FG001|STARTED|Overall Study||8||
48145306|NCT01992380|100679677|FG002|STARTED|Overall Study||10||
48145307|NCT01992380|100679675|FG000|COMPLETED|Overall Study||6||
48145308|NCT01992380|100679676|FG001|COMPLETED|Overall Study||8||
48145309|NCT01992380|100679677|FG002|COMPLETED|Overall Study||10||
48145310|NCT01992380|100679675|FG000|NOT COMPLETED|Overall Study||0||
48600970|NCT00404924|101807578|FG000|NOT COMPLETED|Overall Study||603||
48714039|NCT02576860|102088494|FG000|COMPLETED|Overall Study||111||
48600971|NCT00404924|101807579|FG001|NOT COMPLETED|Overall Study||306||
48600972|NCT03124537|101807580|FG000|STARTED|Overall Study||41||
48600973|NCT03124537|101807581|FG001|STARTED|Overall Study||45||
48600974|NCT03124537|101807580|FG000|COMPLETED|Overall Study||31||
48600975|NCT03124537|101807581|FG001|COMPLETED|Overall Study||32||
48600976|NCT03124537|101807580|FG000|NOT COMPLETED|Overall Study||10||
48600977|NCT03124537|101807581|FG001|NOT COMPLETED|Overall Study||13||
48600978|NCT00428922|101807582|FG000|STARTED|Overall Study||26||
48600979|NCT00428922|101807582|FG000|COMPLETED|Overall Study||26||
48600980|NCT00428922|101807582|FG000|NOT COMPLETED|Overall Study||0||
48600981|NCT01658904|101807583|FG000|STARTED|Overall Study||3||
48600982|NCT01658904|101807584|FG001|STARTED|Overall Study||0||
48600983|NCT01658904|101807585|FG002|STARTED|Overall Study||0||
48600984|NCT01658904|101807583|FG000|COMPLETED|Overall Study||1||
48600985|NCT01658904|101807584|FG001|COMPLETED|Overall Study||0||
48600986|NCT01658904|101807585|FG002|COMPLETED|Overall Study||0||
48600987|NCT01658904|101807583|FG000|NOT COMPLETED|Overall Study||2||
48600988|NCT01658904|101807584|FG001|NOT COMPLETED|Overall Study||0||
48600989|NCT01658904|101807585|FG002|NOT COMPLETED|Overall Study||0||
48600990|NCT01911780|101807586|FG000|STARTED|Double-blind Period (8 Weeks)||68||
48714040|NCT02576860|102088495|FG001|COMPLETED|Overall Study||103||
48714041|NCT02576860|102088494|FG000|NOT COMPLETED|Overall Study||25||
48714042|NCT02576860|102088495|FG001|NOT COMPLETED|Overall Study||24||
48145311|NCT01992380|100679676|FG001|NOT COMPLETED|Overall Study||0||
48145312|NCT01992380|100679677|FG002|NOT COMPLETED|Overall Study||0||
48714043|NCT05182580|102088496|FG000|STARTED|Overall Study||494||51
48714044|NCT05182580|102088497|FG001|STARTED|Overall Study||499||54
48714045|NCT05182580|102088496|FG000|COMPLETED|Overall Study||494||51
48714046|NCT05182580|102088497|FG001|COMPLETED|Overall Study||499||54
48714047|NCT05182580|102088496|FG000|NOT COMPLETED|Overall Study||0||0
48714048|NCT05182580|102088497|FG001|NOT COMPLETED|Overall Study||0||0
48714049|NCT04493684|102088498|FG000|STARTED|Part 1:Treatment Period 1-Up to 9 Weeks||3||
48714050|NCT04493684|102088499|FG001|STARTED|Part 1:Treatment Period 1-Up to 9 Weeks||3||
48714051|NCT04493684|102088500|FG002|STARTED|Part 1:Treatment Period 1-Up to 9 Weeks||3||
48714052|NCT04493684|102088501|FG003|STARTED|Part 1:Treatment Period 1-Up to 9 Weeks||6||
48714053|NCT04493684|102088502|FG004|STARTED|Part 1:Treatment Period 1-Up to 9 Weeks||3||
48714054|NCT04493684|102088503|FG005|STARTED|Part 1:Treatment Period 1-Up to 9 Weeks||3||
48714055|NCT04493684|102088504|FG006|STARTED|Part 1:Treatment Period 1-Up to 9 Weeks||3||
48714056|NCT04493684|102088505|FG007|STARTED|Part 1:Treatment Period 1-Up to 9 Weeks||3||
48714057|NCT04493684|102088506|FG008|STARTED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
48714058|NCT04493684|102088507|FG009|STARTED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
48714059|NCT04493684|102088508|FG010|STARTED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
48714060|NCT04493684|102088509|FG011|STARTED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
48714061|NCT04493684|102088510|FG012|STARTED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
48714062|NCT04493684|102088511|FG013|STARTED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
48714063|NCT04493684|102088512|FG014|STARTED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
48714064|NCT04493684|102088513|FG015|STARTED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
48714065|NCT04493684|102088514|FG016|STARTED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
48145313|NCT01846182|100679678|FG000|STARTED|Overall Study||0||
48714066|NCT04493684|102088498|FG000|COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||2||
48714067|NCT04493684|102088499|FG001|COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||3||
48714068|NCT04493684|102088500|FG002|COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||2||
48714069|NCT04493684|102088501|FG003|COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||6||
48145314|NCT01846182|100679679|FG001|STARTED|Overall Study||0||
48145315|NCT01846182|100679680|FG002|STARTED|Overall Study||0||
48600991|NCT01911780|101807587|FG001|STARTED|Double-blind Period (8 Weeks)||64||
48600992|NCT01911780|101807586|FG000|COMPLETED|Double-blind Period (8 Weeks)||65||
48600993|NCT01911780|101807587|FG001|COMPLETED|Double-blind Period (8 Weeks)||61||
48600994|NCT01911780|101807586|FG000|NOT COMPLETED|Double-blind Period (8 Weeks)||3||
48714070|NCT04493684|102088502|FG004|COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||3||
48714071|NCT04493684|102088503|FG005|COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||2||
48714072|NCT04493684|102088504|FG006|COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||3||
48714073|NCT04493684|102088505|FG007|COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||3||
48714074|NCT04493684|102088506|FG008|COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
48714075|NCT04493684|102088507|FG009|COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
48714076|NCT04493684|102088508|FG010|COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
48714077|NCT04493684|102088509|FG011|COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
48714078|NCT04493684|102088510|FG012|COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
48714079|NCT04493684|102088511|FG013|COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
48714080|NCT04493684|102088512|FG014|COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
48767575|NCT01614886|102222769|FG000|NOT COMPLETED|Overall Study||20||
48145316|NCT01846182|100679678|FG000|COMPLETED|Overall Study||0||
48145317|NCT01846182|100679679|FG001|COMPLETED|Overall Study||0||
48714081|NCT04493684|102088513|FG015|COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
48714082|NCT04493684|102088514|FG016|COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
48714083|NCT04493684|102088498|FG000|NOT COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||1||
48714084|NCT04493684|102088499|FG001|NOT COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
48714085|NCT04493684|102088500|FG002|NOT COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||1||
48714086|NCT04493684|102088501|FG003|NOT COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
48714087|NCT04493684|102088502|FG004|NOT COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
48298598|NCT01231516|101060004|FG001|NOT COMPLETED|Double-blind Phase (Up to Week [Wk] 48)||81||
48298599|NCT01231516|101060003|FG000|STARTED|Open-label Phase:From Wk 48 up to Wk 480||295||
48298600|NCT01231516|101060004|FG001|STARTED|Open-label Phase:From Wk 48 up to Wk 480||126||
48298601|NCT01231516|101060003|FG000|COMPLETED|Open-label Phase:From Wk 48 up to Wk 480||227||
48298602|NCT01231516|101060004|FG001|COMPLETED|Open-label Phase:From Wk 48 up to Wk 480||109||
48298603|NCT01231516|101060003|FG000|NOT COMPLETED|Open-label Phase:From Wk 48 up to Wk 480||68||
48298604|NCT01231516|101060004|FG001|NOT COMPLETED|Open-label Phase:From Wk 48 up to Wk 480||17||
48298605|NCT00056862|101060005|FG000|STARTED|Overall Study||31||
48298606|NCT00056862|101060006|FG001|STARTED|Overall Study||27||
48298607|NCT00056862|101060005|FG000|COMPLETED|Overall Study||30||
48298608|NCT00056862|101060006|FG001|COMPLETED|Overall Study||27||
48298609|NCT00056862|101060005|FG000|NOT COMPLETED|Overall Study||1||
48298610|NCT00056862|101060006|FG001|NOT COMPLETED|Overall Study||0||
48298611|NCT01211197|101060007|FG000|STARTED|Treatment Period 1 (1 Day)||3||
48298612|NCT01211197|101060008|FG001|STARTED|Treatment Period 1 (1 Day)||3||
48298613|NCT01211197|101060009|FG002|STARTED|Treatment Period 1 (1 Day)||3||
48298614|NCT01211197|101060010|FG003|STARTED|Treatment Period 1 (1 Day)||3||
48298615|NCT01211197|101060011|FG004|STARTED|Treatment Period 1 (1 Day)||2||
48298616|NCT01211197|101060012|FG005|STARTED|Treatment Period 1 (1 Day)||2||
48298617|NCT01211197|101060007|FG000|COMPLETED|Treatment Period 1 (1 Day)||3||
48298618|NCT01211197|101060008|FG001|COMPLETED|Treatment Period 1 (1 Day)||3||
48298619|NCT01211197|101060009|FG002|COMPLETED|Treatment Period 1 (1 Day)||3||
48298620|NCT01211197|101060010|FG003|COMPLETED|Treatment Period 1 (1 Day)||3||
48298621|NCT01211197|101060011|FG004|COMPLETED|Treatment Period 1 (1 Day)||2||
48714088|NCT04493684|102088503|FG005|NOT COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||1||
48714089|NCT04493684|102088504|FG006|NOT COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
48298622|NCT01211197|101060012|FG005|COMPLETED|Treatment Period 1 (1 Day)||2||
48298623|NCT01211197|101060007|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
48298624|NCT01211197|101060008|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
48298625|NCT01211197|101060009|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
48298626|NCT01211197|101060010|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
48298627|NCT01211197|101060011|FG004|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
48298628|NCT01211197|101060012|FG005|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
48298629|NCT01211197|101060007|FG000|STARTED|Washout Period 1 (7 Days)||3||
48298630|NCT01211197|101060008|FG001|STARTED|Washout Period 1 (7 Days)||3||
48298631|NCT01211197|101060009|FG002|STARTED|Washout Period 1 (7 Days)||3||
48298632|NCT01211197|101060010|FG003|STARTED|Washout Period 1 (7 Days)||3||
48298633|NCT01211197|101060011|FG004|STARTED|Washout Period 1 (7 Days)||2||
48298634|NCT01211197|101060012|FG005|STARTED|Washout Period 1 (7 Days)||2||
48714090|NCT04493684|102088505|FG007|NOT COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
48714091|NCT04493684|102088506|FG008|NOT COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
48714092|NCT04493684|102088507|FG009|NOT COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
48714093|NCT04493684|102088508|FG010|NOT COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
48714094|NCT04493684|102088509|FG011|NOT COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
48714095|NCT04493684|102088510|FG012|NOT COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
48714096|NCT04493684|102088511|FG013|NOT COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
48714097|NCT04493684|102088512|FG014|NOT COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
48714098|NCT04493684|102088513|FG015|NOT COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
48714099|NCT04493684|102088514|FG016|NOT COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
48714100|NCT04493684|102088498|FG000|STARTED|Part 1:Treatment Period 2-Up to 9 Weeks||4||
48714101|NCT04493684|102088499|FG001|STARTED|Part 1:Treatment Period 2-Up to 9 Weeks||3||
48714102|NCT04493684|102088500|FG002|STARTED|Part 1:Treatment Period 2-Up to 9 Weeks||3||
48714103|NCT04493684|102088501|FG003|STARTED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714104|NCT04493684|102088502|FG004|STARTED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714105|NCT04493684|102088503|FG005|STARTED|Part 1:Treatment Period 2-Up to 9 Weeks||3||
48714106|NCT04493684|102088504|FG006|STARTED|Part 1:Treatment Period 2-Up to 9 Weeks||3||
48298635|NCT01211197|101060007|FG000|COMPLETED|Washout Period 1 (7 Days)||3||
48298636|NCT01211197|101060008|FG001|COMPLETED|Washout Period 1 (7 Days)||3||
48298637|NCT01211197|101060009|FG002|COMPLETED|Washout Period 1 (7 Days)||2||
48298638|NCT01211197|101060010|FG003|COMPLETED|Washout Period 1 (7 Days)||3||
48298639|NCT01211197|101060011|FG004|COMPLETED|Washout Period 1 (7 Days)||2||
48298640|NCT01211197|101060012|FG005|COMPLETED|Washout Period 1 (7 Days)||2||
48298641|NCT01211197|101060007|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48298642|NCT01211197|101060008|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48298643|NCT01211197|101060009|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||1||
48714107|NCT04493684|102088505|FG007|STARTED|Part 1:Treatment Period 2-Up to 9 Weeks||3||
48714108|NCT04493684|102088506|FG008|STARTED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714109|NCT04493684|102088507|FG009|STARTED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714110|NCT04493684|102088508|FG010|STARTED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714111|NCT04493684|102088509|FG011|STARTED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48298644|NCT01211197|101060010|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48298645|NCT01211197|101060011|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48298646|NCT01211197|101060012|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48298647|NCT01211197|101060007|FG000|STARTED|Treatment Period 2 (1 Day)||3||
48298648|NCT01211197|101060008|FG001|STARTED|Treatment Period 2 (1 Day)||3||
48298649|NCT01211197|101060009|FG002|STARTED|Treatment Period 2 (1 Day)||2||
48298650|NCT01211197|101060010|FG003|STARTED|Treatment Period 2 (1 Day)||3||
48298651|NCT01211197|101060011|FG004|STARTED|Treatment Period 2 (1 Day)||2||
48298652|NCT01211197|101060012|FG005|STARTED|Treatment Period 2 (1 Day)||2||
48298653|NCT01211197|101060007|FG000|COMPLETED|Treatment Period 2 (1 Day)||3||
48298654|NCT01211197|101060008|FG001|COMPLETED|Treatment Period 2 (1 Day)||3||
48298655|NCT01211197|101060009|FG002|COMPLETED|Treatment Period 2 (1 Day)||2||
48298656|NCT01211197|101060010|FG003|COMPLETED|Treatment Period 2 (1 Day)||3||
48298657|NCT01211197|101060011|FG004|COMPLETED|Treatment Period 2 (1 Day)||2||
48298658|NCT01211197|101060012|FG005|COMPLETED|Treatment Period 2 (1 Day)||2||
48298659|NCT01211197|101060007|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
48298660|NCT01211197|101060008|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
48298661|NCT01211197|101060009|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
48714112|NCT04493684|102088510|FG012|STARTED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714113|NCT04493684|102088511|FG013|STARTED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714114|NCT04493684|102088512|FG014|STARTED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714115|NCT04493684|102088513|FG015|STARTED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714116|NCT04493684|102088514|FG016|STARTED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714117|NCT04493684|102088498|FG000|COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||3||
48714118|NCT04493684|102088499|FG001|COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||3||
48714119|NCT04493684|102088500|FG002|COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||3||
48714120|NCT04493684|102088501|FG003|COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714121|NCT04493684|102088502|FG004|COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714122|NCT04493684|102088503|FG005|COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||3||
48714123|NCT04493684|102088504|FG006|COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||2||
48714124|NCT04493684|102088505|FG007|COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||3||
48714125|NCT04493684|102088506|FG008|COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714126|NCT04493684|102088507|FG009|COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714127|NCT04493684|102088508|FG010|COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714128|NCT04493684|102088509|FG011|COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714129|NCT04493684|102088510|FG012|COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714130|NCT04493684|102088511|FG013|COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714131|NCT04493684|102088512|FG014|COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714132|NCT04493684|102088513|FG015|COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714133|NCT04493684|102088514|FG016|COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714134|NCT04493684|102088498|FG000|NOT COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||1||
48714135|NCT04493684|102088499|FG001|NOT COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714136|NCT04493684|102088500|FG002|NOT COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714137|NCT04493684|102088501|FG003|NOT COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714138|NCT04493684|102088502|FG004|NOT COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714139|NCT04493684|102088503|FG005|NOT COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714140|NCT04493684|102088504|FG006|NOT COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||1||
48767576|NCT01614886|102222770|FG001|NOT COMPLETED|Overall Study||26||
48298662|NCT01211197|101060010|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
48298663|NCT01211197|101060011|FG004|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
48298664|NCT01211197|101060012|FG005|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
48298665|NCT01211197|101060007|FG000|STARTED|Washout Period 2 (7 Days)||3||
48298666|NCT01211197|101060008|FG001|STARTED|Washout Period 2 (7 Days)||3||
48298667|NCT01211197|101060009|FG002|STARTED|Washout Period 2 (7 Days)||2||
48298668|NCT01211197|101060010|FG003|STARTED|Washout Period 2 (7 Days)||3||
48298669|NCT01211197|101060011|FG004|STARTED|Washout Period 2 (7 Days)||2||
48298670|NCT01211197|101060012|FG005|STARTED|Washout Period 2 (7 Days)||2||
48298671|NCT01211197|101060007|FG000|COMPLETED|Washout Period 2 (7 Days)||2||
48298672|NCT01211197|101060008|FG001|COMPLETED|Washout Period 2 (7 Days)||3||
48298673|NCT01211197|101060009|FG002|COMPLETED|Washout Period 2 (7 Days)||2||
48298674|NCT01211197|101060010|FG003|COMPLETED|Washout Period 2 (7 Days)||3||
48298675|NCT01211197|101060011|FG004|COMPLETED|Washout Period 2 (7 Days)||2||
48298676|NCT01211197|101060012|FG005|COMPLETED|Washout Period 2 (7 Days)||2||
48298677|NCT01211197|101060007|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||1||
48298678|NCT01211197|101060008|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48298679|NCT01211197|101060009|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48298680|NCT01211197|101060010|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48298681|NCT01211197|101060011|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48298682|NCT01211197|101060012|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48298683|NCT01211197|101060007|FG000|STARTED|Treatment Period 3 (1 Day)||2||
48298684|NCT01211197|101060008|FG001|STARTED|Treatment Period 3 (1 Day)||3||
48298685|NCT01211197|101060009|FG002|STARTED|Treatment Period 3 (1 Day)||2||
48298686|NCT01211197|101060010|FG003|STARTED|Treatment Period 3 (1 Day)||3||
48298687|NCT01211197|101060011|FG004|STARTED|Treatment Period 3 (1 Day)||2||
48298688|NCT01211197|101060012|FG005|STARTED|Treatment Period 3 (1 Day)||2||
48298689|NCT01211197|101060007|FG000|COMPLETED|Treatment Period 3 (1 Day)||2||
48298690|NCT01211197|101060008|FG001|COMPLETED|Treatment Period 3 (1 Day)||3||
48298691|NCT01211197|101060009|FG002|COMPLETED|Treatment Period 3 (1 Day)||2||
48298692|NCT01211197|101060010|FG003|COMPLETED|Treatment Period 3 (1 Day)||3||
48298693|NCT01211197|101060011|FG004|COMPLETED|Treatment Period 3 (1 Day)||2||
48298694|NCT01211197|101060012|FG005|COMPLETED|Treatment Period 3 (1 Day)||2||
48298695|NCT01211197|101060007|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
48298696|NCT01211197|101060008|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
48298697|NCT01211197|101060009|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
48298698|NCT01211197|101060010|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
48298699|NCT01211197|101060011|FG004|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
48298700|NCT01211197|101060012|FG005|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
48298701|NCT00887679|101060013|FG000|STARTED|Overall Study||30||
48298702|NCT00887679|101060013|FG000|COMPLETED|Overall Study||20||
48298703|NCT00887679|101060013|FG000|NOT COMPLETED|Overall Study||10||
48298704|NCT02113241|101060014|FG000|STARTED|Overall Study||12||
48298705|NCT02113241|101060015|FG001|STARTED|Overall Study||12||
48298706|NCT02113241|101060014|FG000|COMPLETED|Overall Study||12||
48298707|NCT02113241|101060015|FG001|COMPLETED|Overall Study||11||
48298708|NCT02113241|101060014|FG000|NOT COMPLETED|Overall Study||0||
48298709|NCT02113241|101060015|FG001|NOT COMPLETED|Overall Study||1||
48298710|NCT00412971|101060016|FG000|STARTED|Overall Study||115||
48298711|NCT00412971|101060017|FG001|STARTED|Overall Study||118||
48298712|NCT00412971|101060016|FG000|COMPLETED|Overall Study||85||
48298713|NCT00412971|101060017|FG001|COMPLETED|Overall Study||108||
48298714|NCT00412971|101060016|FG000|NOT COMPLETED|Overall Study||30||
48298715|NCT00412971|101060017|FG001|NOT COMPLETED|Overall Study||10||
48298716|NCT03783546|101060018|FG000|STARTED|Overall Study||39||
48298717|NCT03783546|101060019|FG001|STARTED|Overall Study||39||
48298718|NCT03783546|101060018|FG000|COMPLETED|Overall Study||35||
48298719|NCT03783546|101060019|FG001|COMPLETED|Overall Study||36||
48298720|NCT03783546|101060018|FG000|NOT COMPLETED|Overall Study||4||
48298721|NCT03783546|101060019|FG001|NOT COMPLETED|Overall Study||3||
48298722|NCT02196714|101060020|FG000|STARTED|Overall Study||24||
48298723|NCT02196714|101060021|FG001|STARTED|Overall Study||23||
48298724|NCT02196714|101060022|FG002|STARTED|Overall Study||24||
48298725|NCT02196714|101060023|FG003|STARTED|Overall Study||24||
48298726|NCT02196714|101060020|FG000|COMPLETED|Overall Study||24||
48298727|NCT02196714|101060021|FG001|COMPLETED|Overall Study||23||
48298728|NCT02196714|101060022|FG002|COMPLETED|Overall Study||23||
48298729|NCT02196714|101060023|FG003|COMPLETED|Overall Study||24||
48298730|NCT02196714|101060020|FG000|NOT COMPLETED|Overall Study||0||
48298731|NCT02196714|101060021|FG001|NOT COMPLETED|Overall Study||0||
48298732|NCT02196714|101060022|FG002|NOT COMPLETED|Overall Study||1||
48298733|NCT02196714|101060023|FG003|NOT COMPLETED|Overall Study||0||
48298734|NCT01388790|101060024|FG000|STARTED|Overall Study||40||
48298735|NCT01388790|101060024|FG000|COMPLETED|Overall Study||32||
48298736|NCT01388790|101060024|FG000|NOT COMPLETED|Overall Study||8||
48298737|NCT01708213|101060025|FG000|STARTED|Overall Study||72||
48298738|NCT01708213|101060025|FG000|COMPLETED|Overall Study||71||
48298739|NCT01708213|101060025|FG000|NOT COMPLETED|Overall Study||1||
48298740|NCT00775450|101060026|FG000|STARTED|Overall Study||295||
48298741|NCT00775450|101060027|FG001|STARTED|Overall Study||98||
48298742|NCT00775450|101060028|FG002|STARTED|Overall Study||105||
48298743|NCT00775450|101060029|FG003|STARTED|Overall Study||108||
48298744|NCT00775450|101060030|FG004|STARTED|Overall Study||201||
48298745|NCT00775450|101060026|FG000|COMPLETED|Overall Study||292||
48298746|NCT00775450|101060027|FG001|COMPLETED|Overall Study||98||
48298747|NCT00775450|101060028|FG002|COMPLETED|Overall Study||105||
48298748|NCT00775450|101060029|FG003|COMPLETED|Overall Study||108||
48298749|NCT00775450|101060030|FG004|COMPLETED|Overall Study||199||
48298750|NCT00775450|101060026|FG000|NOT COMPLETED|Overall Study||3||
48298751|NCT00775450|101060027|FG001|NOT COMPLETED|Overall Study||0||
48298752|NCT00775450|101060028|FG002|NOT COMPLETED|Overall Study||0||
48298753|NCT00775450|101060029|FG003|NOT COMPLETED|Overall Study||0||
48298754|NCT00775450|101060030|FG004|NOT COMPLETED|Overall Study||2||
48298755|NCT01791803|101060031|FG000|STARTED|Overall Study||41||
48298756|NCT01791803|101060032|FG001|STARTED|Overall Study||41||
48298757|NCT01791803|101060033|FG002|STARTED|Overall Study||40||
48298758|NCT01791803|101060034|FG003|STARTED|Overall Study||42||
48298759|NCT01791803|101060031|FG000|COMPLETED|Overall Study||41||
48298760|NCT01791803|101060032|FG001|COMPLETED|Overall Study||39||
48298761|NCT01791803|101060033|FG002|COMPLETED|Overall Study||38||
48298762|NCT01791803|101060034|FG003|COMPLETED|Overall Study||37||
48298763|NCT01791803|101060031|FG000|NOT COMPLETED|Overall Study||0||
48298764|NCT01791803|101060032|FG001|NOT COMPLETED|Overall Study||2||
48298765|NCT01791803|101060033|FG002|NOT COMPLETED|Overall Study||2||
48298766|NCT01791803|101060034|FG003|NOT COMPLETED|Overall Study||5||
48298767|NCT03552822|101060035|FG000|STARTED|Overall Study||112||
48298768|NCT03552822|101060036|FG001|STARTED|Overall Study||429||
48298769|NCT03552822|101060035|FG000|COMPLETED|Overall Study||112||
48298770|NCT03552822|101060036|FG001|COMPLETED|Overall Study||429||
48298771|NCT03552822|101060035|FG000|NOT COMPLETED|Overall Study||0||
48298772|NCT03552822|101060036|FG001|NOT COMPLETED|Overall Study||0||
48298773|NCT01137955|101060037|FG000|STARTED|Overall Study||25||
48298774|NCT01137955|101060038|FG001|STARTED|Overall Study||25||
48298775|NCT01137955|101060037|FG000|COMPLETED|Overall Study||20||
48298776|NCT01137955|101060038|FG001|COMPLETED|Overall Study||21||
48298777|NCT01137955|101060037|FG000|NOT COMPLETED|Overall Study||5||
48298778|NCT01137955|101060038|FG001|NOT COMPLETED|Overall Study||4||
48298779|NCT02054325|101060039|FG000|STARTED|Overall Study||51||
48298780|NCT02054325|101060040|FG001|STARTED|Overall Study||55||
48298781|NCT02054325|101060039|FG000|COMPLETED|Overall Study||43||
48298782|NCT02054325|101060040|FG001|COMPLETED|Overall Study||50||
48298783|NCT02054325|101060039|FG000|NOT COMPLETED|Overall Study||8||
48298784|NCT02054325|101060040|FG001|NOT COMPLETED|Overall Study||5||
48298785|NCT03933774|101060041|FG000|STARTED|Overall Study||12||
48298786|NCT03933774|101060042|FG001|STARTED|Overall Study||13||
48298787|NCT03933774|101060041|FG000|COMPLETED|Overall Study||10||
48298788|NCT03933774|101060042|FG001|COMPLETED|Overall Study||11||
48298789|NCT03933774|101060041|FG000|NOT COMPLETED|Overall Study||2||
48298790|NCT03933774|101060042|FG001|NOT COMPLETED|Overall Study||2||
48298791|NCT02460666|101060043|FG000|STARTED|Overall Study||89||
48298792|NCT02460666|101060044|FG001|STARTED|Overall Study||89||
48600995|NCT01911780|101807587|FG001|NOT COMPLETED|Double-blind Period (8 Weeks)||3||
48600996|NCT01911780|101807586|FG000|STARTED|Extension Period (52 Weeks)||65||
48600997|NCT01911780|101807587|FG001|STARTED|Extension Period (52 Weeks)||61||
48600998|NCT01911780|101807586|FG000|COMPLETED|Extension Period (52 Weeks)||61||
48600999|NCT01911780|101807587|FG001|COMPLETED|Extension Period (52 Weeks)||58||
48601000|NCT01911780|101807586|FG000|NOT COMPLETED|Extension Period (52 Weeks)||4||
48601001|NCT01911780|101807587|FG001|NOT COMPLETED|Extension Period (52 Weeks)||3||
48601002|NCT01180049|101807588|FG000|STARTED|Overall Study||53||
48601003|NCT01180049|101807589|FG001|STARTED|Overall Study||48||
48601004|NCT01180049|101807588|FG000|COMPLETED|Overall Study||0||
48601005|NCT01180049|101807589|FG001|COMPLETED|Overall Study||0||
48601006|NCT01180049|101807588|FG000|NOT COMPLETED|Overall Study||53||
48601007|NCT01180049|101807589|FG001|NOT COMPLETED|Overall Study||48||
48601008|NCT03887429|101807590|FG000|STARTED|Overall Study||8||
48601009|NCT03887429|101807591|FG001|STARTED|Overall Study||9||
48601010|NCT03887429|101807592|FG002|STARTED|Overall Study||9||
48601011|NCT03887429|101807593|FG003|STARTED|Overall Study||8||
48601012|NCT03887429|101807590|FG000|Completed First Intervention (5 Days)|Overall Study||7||
48601013|NCT03887429|101807591|FG001|Completed First Intervention (5 Days)|Overall Study||8||
48601014|NCT03887429|101807592|FG002|Completed First Intervention (5 Days)|Overall Study||7||
48601015|NCT03887429|101807593|FG003|Completed First Intervention (5 Days)|Overall Study||7||
48601016|NCT03887429|101807590|FG000|Completed Washout (9 Days)|Overall Study||7||
48601017|NCT03887429|101807591|FG001|Completed Washout (9 Days)|Overall Study||8||
48601018|NCT03887429|101807592|FG002|Completed Washout (9 Days)|Overall Study||7||
48601019|NCT03887429|101807593|FG003|Completed Washout (9 Days)|Overall Study||7||
48601020|NCT03887429|101807590|FG000|Completed Second Intervention (5 Days)|Overall Study||7||
48601021|NCT03887429|101807591|FG001|Completed Second Intervention (5 Days)|Overall Study||8||
48298793|NCT02460666|101060043|FG000|COMPLETED|Overall Study||62||
48298794|NCT02460666|101060044|FG001|COMPLETED|Overall Study||63||
48298795|NCT02460666|101060043|FG000|NOT COMPLETED|Overall Study||27||
48298796|NCT02460666|101060044|FG001|NOT COMPLETED|Overall Study||26||
48298797|NCT03357952|101060045|FG000|STARTED|Overall Study||9||
48298798|NCT03357952|101060046|FG001|STARTED|Overall Study||1||
48298799|NCT03357952|101060045|FG000|COMPLETED|Overall Study||0||
48298800|NCT03357952|101060046|FG001|COMPLETED|Overall Study||0||
48298801|NCT03357952|101060045|FG000|NOT COMPLETED|Overall Study||9||
48298802|NCT03357952|101060046|FG001|NOT COMPLETED|Overall Study||1||
48298803|NCT00084266|101060047|FG000|STARTED|Overall Study||618||
48298804|NCT00084266|101060048|FG001|STARTED|Overall Study||607||
48298805|NCT00084266|101060047|FG000|Treated|Overall Study||597||
48298806|NCT00084266|101060048|FG001|Treated|Overall Study||587||
48298807|NCT00084266|101060047|FG000|COMPLETED|Overall Study||177||
48298808|NCT00084266|101060048|FG001|COMPLETED|Overall Study||184||
48298809|NCT00084266|101060047|FG000|NOT COMPLETED|Overall Study||441||
48298810|NCT00084266|101060048|FG001|NOT COMPLETED|Overall Study||423||
48298811|NCT01101477|101060049|FG000|STARTED|Overall Study||49||
48298812|NCT01101477|101060050|FG001|STARTED|Overall Study||49||
48298813|NCT01101477|101060051|FG002|STARTED|Overall Study||46||
48298814|NCT01101477|101060049|FG000|COMPLETED|Overall Study||44||
48298815|NCT01101477|101060050|FG001|COMPLETED|Overall Study||46||
48298816|NCT01101477|101060051|FG002|COMPLETED|Overall Study||45||
48298817|NCT01101477|101060049|FG000|NOT COMPLETED|Overall Study||5||
48298818|NCT01101477|101060050|FG001|NOT COMPLETED|Overall Study||3||
48298819|NCT01101477|101060051|FG002|NOT COMPLETED|Overall Study||1||
48601022|NCT03887429|101807592|FG002|Completed Second Intervention (5 Days)|Overall Study||7||
48601023|NCT03887429|101807593|FG003|Completed Second Intervention (5 Days)|Overall Study||7||
48601024|NCT03887429|101807590|FG000|COMPLETED|Overall Study||7||
48601025|NCT03887429|101807591|FG001|COMPLETED|Overall Study||8||
48601026|NCT03887429|101807592|FG002|COMPLETED|Overall Study||7||
48601027|NCT03887429|101807593|FG003|COMPLETED|Overall Study||7||
48601028|NCT03887429|101807590|FG000|NOT COMPLETED|Overall Study||1||
48601029|NCT03887429|101807591|FG001|NOT COMPLETED|Overall Study||1||
48601030|NCT03887429|101807592|FG002|NOT COMPLETED|Overall Study||2||
48601031|NCT03887429|101807593|FG003|NOT COMPLETED|Overall Study||1||
48601032|NCT00524680|101807594|FG000|STARTED|Overall Study||37||
48601033|NCT00524680|101807595|FG001|STARTED|Overall Study||35||
48601034|NCT00524680|101807596|FG002|STARTED|Overall Study||36||
48601035|NCT00524680|101807597|FG003|STARTED|Overall Study||40||
48601036|NCT00524680|101807594|FG000|COMPLETED|Overall Study||34||
48601037|NCT00524680|101807595|FG001|COMPLETED|Overall Study||34||
48601038|NCT00524680|101807596|FG002|COMPLETED|Overall Study||33||
48601039|NCT00524680|101807597|FG003|COMPLETED|Overall Study||34||
48601040|NCT00524680|101807594|FG000|NOT COMPLETED|Overall Study||3||
48601041|NCT00524680|101807595|FG001|NOT COMPLETED|Overall Study||1||
48601042|NCT00524680|101807596|FG002|NOT COMPLETED|Overall Study||3||
48601043|NCT00524680|101807597|FG003|NOT COMPLETED|Overall Study||6||
48601044|NCT03717415|101807598|FG000|STARTED|Overall Study||3||
48601045|NCT03717415|101807599|FG001|STARTED|Overall Study||14||
48601046|NCT03717415|101807600|FG002|STARTED|Overall Study||5||
48601047|NCT03717415|101807601|FG003|STARTED|Overall Study||9||
48601048|NCT03717415|101807602|FG004|STARTED|Overall Study||2||
48601049|NCT03717415|101807603|FG005|STARTED|Overall Study||18||
48601050|NCT03717415|101807604|FG006|STARTED|Overall Study||2||
48601051|NCT03717415|101807605|FG007|STARTED|Overall Study||6||
48601052|NCT03717415|101807606|FG008|STARTED|Overall Study||11||
48601053|NCT03717415|101807598|FG000|mITT Population|Overall Study||3|Modified Intent-to-Treat (mITT) Population includes all participants who had at least one full dose of the combined study drugs, had measurable disease at baseline, and had at least one post-baseline assessment. Participants without a post-baseline assessment who discontinued study treatment due to clinical progression, death, or a rebastinib-related AE will also be included in the mITT population.|
48601054|NCT03717415|101807599|FG001|mITT Population|Overall Study||12|Modified Intent-to-Treat (mITT) Population includes all participants who had at least one full dose of the combined study drugs, had measurable disease at baseline, and had at least one post-baseline assessment. Participants without a post-baseline assessment who discontinued study treatment due to clinical progression, death, or a rebastinib-related AE will also be included in the mITT population.|
48601055|NCT03717415|101807600|FG002|mITT Population|Overall Study||5|Modified Intent-to-Treat (mITT) Population includes all participants who had at least one full dose of the combined study drugs, had measurable disease at baseline, and had at least one post-baseline assessment. Participants without a post-baseline assessment who discontinued study treatment due to clinical progression, death, or a rebastinib-related AE will also be included in the mITT population.|
48601056|NCT03717415|101807601|FG003|mITT Population|Overall Study||9|Modified Intent-to-Treat (mITT) Population includes all participants who had at least one full dose of the combined study drugs, had measurable disease at baseline, and had at least one post-baseline assessment. Participants without a post-baseline assessment who discontinued study treatment due to clinical progression, death, or a rebastinib-related AE will also be included in the mITT population.|
48601057|NCT03717415|101807602|FG004|mITT Population|Overall Study||2|Modified Intent-to-Treat (mITT) Population includes all participants who had at least one full dose of the combined study drugs, had measurable disease at baseline, and had at least one post-baseline assessment. Participants without a post-baseline assessment who discontinued study treatment due to clinical progression, death, or a rebastinib-related AE will also be included in the mITT population.|
48656893|NCT04274218|101943726|FG001|NOT COMPLETED|Demographic Information (10 Minutes)||0||
48656894|NCT04274218|101943727|FG002|NOT COMPLETED|Demographic Information (10 Minutes)||0||
48656895|NCT04274218|101943728|FG003|NOT COMPLETED|Demographic Information (10 Minutes)||0||
48145318|NCT01846182|100679680|FG002|COMPLETED|Overall Study||0||
48145319|NCT01846182|100679678|FG000|NOT COMPLETED|Overall Study||0||
48145320|NCT01846182|100679679|FG001|NOT COMPLETED|Overall Study||0||
48145321|NCT01846182|100679680|FG002|NOT COMPLETED|Overall Study||0||
48656896|NCT04274218|101943725|FG000|STARTED|Baseline Walking (1 Minute)||5||
48767577|NCT01435382|102222771|FG000|STARTED|Overall Study||12||
48145322|NCT03597568|100679681|FG000|STARTED|Overall Study||13||
48145323|NCT03597568|100679682|FG001|STARTED|Overall Study||12||
48145324|NCT03597568|100679681|FG000|COMPLETED|Overall Study||11||
48145325|NCT03597568|100679682|FG001|COMPLETED|Overall Study||10||
48145326|NCT03597568|100679681|FG000|NOT COMPLETED|Overall Study||2||
48145327|NCT03597568|100679682|FG001|NOT COMPLETED|Overall Study||2||
48145328|NCT01911403|100679683|FG000|STARTED|Overall Study||61||
48145329|NCT01911403|100679684|FG001|STARTED|Overall Study||62||
48145330|NCT01911403|100679683|FG000|COMPLETED|Overall Study||52||
48145331|NCT01911403|100679684|FG001|COMPLETED|Overall Study||59||
48145332|NCT01911403|100679683|FG000|NOT COMPLETED|Overall Study||9||
48145333|NCT01911403|100679684|FG001|NOT COMPLETED|Overall Study||3||
48145334|NCT01461668|100679685|FG000|STARTED|Overall Study||27||
48145335|NCT01461668|100679686|FG001|STARTED|Overall Study||26||
48145336|NCT01461668|100679685|FG000|COMPLETED|Overall Study||25||
48145337|NCT01461668|100679686|FG001|COMPLETED|Overall Study||25||
48145338|NCT01461668|100679685|FG000|NOT COMPLETED|Overall Study||2||
48145339|NCT01461668|100679686|FG001|NOT COMPLETED|Overall Study||1||
48145340|NCT01881126|100679687|FG000|STARTED|Overall Study||47||
48145341|NCT01881126|100679688|FG001|STARTED|Overall Study||46||
48145342|NCT01881126|100679687|FG000|COMPLETED|Overall Study||46||
48145343|NCT01881126|100679688|FG001|COMPLETED|Overall Study||44||
48145344|NCT01881126|100679687|FG000|NOT COMPLETED|Overall Study||1||
48145345|NCT01881126|100679688|FG001|NOT COMPLETED|Overall Study||2||
48145346|NCT02498483|100679689|FG000|STARTED|Overall Study||6||
48145347|NCT02498483|100679690|FG001|STARTED|Overall Study||5||
48145348|NCT02498483|100679689|FG000|COMPLETED|Overall Study||6||
48145349|NCT02498483|100679690|FG001|COMPLETED|Overall Study||5||
48145350|NCT02498483|100679689|FG000|NOT COMPLETED|Overall Study||0||
48145351|NCT02498483|100679690|FG001|NOT COMPLETED|Overall Study||0||
48145352|NCT01570829|100679691|FG000|STARTED|Overall Study||164||
48145353|NCT01570829|100679692|FG001|STARTED|Overall Study||167||
48145354|NCT01570829|100679691|FG000|COMPLETED|Overall Study||164||
48145355|NCT01570829|100679692|FG001|COMPLETED|Overall Study||167||
48145356|NCT01570829|100679691|FG000|NOT COMPLETED|Overall Study||0||
48145357|NCT01570829|100679692|FG001|NOT COMPLETED|Overall Study||0||
48145358|NCT03901326|100679693|FG000|STARTED|Overall Study||608||
48145359|NCT03901326|100679694|FG001|STARTED|Overall Study||608||
48145360|NCT03901326|100679693|FG000|COMPLETED|Overall Study||608||
48145361|NCT03901326|100679694|FG001|COMPLETED|Overall Study||608||
48145362|NCT03901326|100679693|FG000|NOT COMPLETED|Overall Study||0||
48145363|NCT03901326|100679694|FG001|NOT COMPLETED|Overall Study||0||
48145364|NCT03923933|100679695|FG000|STARTED|Overall Study||17||
48145365|NCT03923933|100679696|FG001|STARTED|Overall Study||17||
48145366|NCT03923933|100679695|FG000|COMPLETED|Overall Study||16||
48145367|NCT03923933|100679696|FG001|COMPLETED|Overall Study||16||
48145368|NCT03923933|100679695|FG000|NOT COMPLETED|Overall Study||1||
48145369|NCT03923933|100679696|FG001|NOT COMPLETED|Overall Study||1||
48145370|NCT02257099|100679697|FG000|STARTED|Overall Study||20||
48145371|NCT02257099|100679697|FG000|COMPLETED|Overall Study||20||
48145372|NCT02257099|100679697|FG000|NOT COMPLETED|Overall Study||0||
48145373|NCT02207816|100679698|FG000|STARTED|Overall Study||1046||
48145374|NCT02207816|100679699|FG001|STARTED|Overall Study||1010||
48145375|NCT02207816|100679700|FG002|STARTED|Overall Study||1028||
48145376|NCT02207816|100679698|FG000|COMPLETED|Overall Study||995||
48145377|NCT02207816|100679699|FG001|COMPLETED|Overall Study||924||
48145378|NCT02207816|100679700|FG002|COMPLETED|Overall Study||961||
48145379|NCT02207816|100679698|FG000|NOT COMPLETED|Overall Study||51||
48145380|NCT02207816|100679699|FG001|NOT COMPLETED|Overall Study||86||
48145381|NCT02207816|100679700|FG002|NOT COMPLETED|Overall Study||67||
48145382|NCT04109703|100679701|FG000|STARTED|Overall Study||49||
48145383|NCT04109703|100679702|FG001|STARTED|Overall Study||51||
48145384|NCT04109703|100679701|FG000|COMPLETED|Overall Study||49||
48145385|NCT04109703|100679702|FG001|COMPLETED|Overall Study||51||
48145386|NCT04109703|100679701|FG000|NOT COMPLETED|Overall Study||0||
48145387|NCT04109703|100679702|FG001|NOT COMPLETED|Overall Study||0||
48145388|NCT04495179|100679703|FG000|STARTED|Overall Study||2||
48145389|NCT04495179|100679704|FG001|STARTED|Overall Study||28||
48145390|NCT04495179|100679703|FG000|COMPLETED|Overall Study||0||
48145391|NCT04495179|100679704|FG001|COMPLETED|Overall Study||0||
48145392|NCT04495179|100679703|FG000|NOT COMPLETED|Overall Study||2||
48145393|NCT04495179|100679704|FG001|NOT COMPLETED|Overall Study||28||
48145394|NCT01041638|100679705|FG000|STARTED|Overall Study||105||
48145395|NCT01041638|100679705|FG000|COMPLETED|Overall Study||78||
48145396|NCT01041638|100679705|FG000|NOT COMPLETED|Overall Study||27||
48145397|NCT02862457|100679706|FG000|STARTED|Overall Study||3||
48145398|NCT02862457|100679707|FG001|STARTED|Overall Study||3||
48145399|NCT02862457|100679708|FG002|STARTED|Overall Study||3||
48145400|NCT02862457|100679709|FG003|STARTED|Overall Study||6||
48145401|NCT02862457|100679710|FG004|STARTED|Overall Study||7||
48145402|NCT02862457|100679711|FG005|STARTED|Overall Study||6||
48145403|NCT02862457|100679712|FG006|STARTED|Overall Study||6||
48145404|NCT02862457|100679706|FG000|COMPLETED|Overall Study||1||
48145405|NCT02862457|100679707|FG001|COMPLETED|Overall Study||0||
48145406|NCT02862457|100679708|FG002|COMPLETED|Overall Study||0||
48145407|NCT02862457|100679709|FG003|COMPLETED|Overall Study||2||
48298820|NCT04631796|101060052|FG000|STARTED|Overall Study||35||70
48298821|NCT04631796|101060052|FG000|COMPLETED|Overall Study||35||70
48298822|NCT04631796|101060052|FG000|NOT COMPLETED|Overall Study||0||0
48298823|NCT00509587|101060053|FG000|STARTED|Overall Study||21||
48298824|NCT00509587|101060053|FG000|COMPLETED|Overall Study||21||
48145408|NCT02862457|100679710|FG004|COMPLETED|Overall Study||7||
48145409|NCT02862457|100679711|FG005|COMPLETED|Overall Study||3||
48145410|NCT02862457|100679712|FG006|COMPLETED|Overall Study||5||
48145411|NCT02862457|100679706|FG000|NOT COMPLETED|Overall Study||2||
48145412|NCT02862457|100679707|FG001|NOT COMPLETED|Overall Study||3||
48145413|NCT02862457|100679708|FG002|NOT COMPLETED|Overall Study||3||
48145414|NCT02862457|100679709|FG003|NOT COMPLETED|Overall Study||4||
48145415|NCT02862457|100679710|FG004|NOT COMPLETED|Overall Study||0||
48145416|NCT02862457|100679711|FG005|NOT COMPLETED|Overall Study||3||
48145417|NCT02862457|100679712|FG006|NOT COMPLETED|Overall Study||1||
48145418|NCT04088409|100679713|FG000|STARTED|Part A||25||
48145419|NCT04088409|100679714|FG001|STARTED|Part A||5||
48145420|NCT04088409|100679713|FG000|Received At Least 1 Dose of Study Drug|Part A||24||
48145421|NCT04088409|100679714|FG001|Received At Least 1 Dose of Study Drug|Part A||5||
48145422|NCT04088409|100679713|FG000|COMPLETED|Part A||10||
48145423|NCT04088409|100679714|FG001|COMPLETED|Part A||0||
48145424|NCT04088409|100679713|FG000|NOT COMPLETED|Part A||15||
48145425|NCT04088409|100679714|FG001|NOT COMPLETED|Part A||5||
48145426|NCT04088409|100679713|FG000|STARTED|Part B||10||
48145427|NCT04088409|100679714|FG001|STARTED|Part B||0||
48145428|NCT04088409|100679713|FG000|COMPLETED|Part B||0||
48145429|NCT04088409|100679714|FG001|COMPLETED|Part B||0||
48145430|NCT04088409|100679713|FG000|NOT COMPLETED|Part B||10||
48145431|NCT04088409|100679714|FG001|NOT COMPLETED|Part B||0||
48145432|NCT01912612|100679715|FG000|STARTED|Overall Study||36||
48145433|NCT01912612|100679716|FG001|STARTED|Overall Study||40||
48145434|NCT01912612|100679717|FG002|STARTED|Overall Study||3||
48145435|NCT01912612|100679715|FG000|COMPLETED|Overall Study||31||
48145436|NCT01912612|100679716|FG001|COMPLETED|Overall Study||40||
48145437|NCT01912612|100679717|FG002|COMPLETED|Overall Study||0||
48145438|NCT01912612|100679715|FG000|NOT COMPLETED|Overall Study||5||
48145439|NCT01912612|100679716|FG001|NOT COMPLETED|Overall Study||0||
48145440|NCT01912612|100679717|FG002|NOT COMPLETED|Overall Study||3||
48145441|NCT03088826|100679718|FG000|STARTED|Overall Study||40||
48145442|NCT03088826|100679719|FG001|STARTED|Overall Study||40||
48714141|NCT04493684|102088505|FG007|NOT COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714142|NCT04493684|102088506|FG008|NOT COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714143|NCT04493684|102088507|FG009|NOT COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714144|NCT04493684|102088508|FG010|NOT COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714145|NCT04493684|102088509|FG011|NOT COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714146|NCT04493684|102088510|FG012|NOT COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714147|NCT04493684|102088511|FG013|NOT COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714148|NCT04493684|102088512|FG014|NOT COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714149|NCT04493684|102088513|FG015|NOT COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714150|NCT04493684|102088514|FG016|NOT COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
48714151|NCT04493684|102088498|FG000|STARTED|Part 1:Treatment Period 3-Up to 9 Weeks||4||
48145443|NCT03088826|100679718|FG000|COMPLETED|Overall Study||40||
48145444|NCT03088826|100679719|FG001|COMPLETED|Overall Study||40||
48145445|NCT03088826|100679718|FG000|NOT COMPLETED|Overall Study||0||
48145446|NCT03088826|100679719|FG001|NOT COMPLETED|Overall Study||0||
48145447|NCT03583554|100679720|FG000|STARTED|Period 1||4||
48145448|NCT03583554|100679721|FG001|STARTED|Period 1||4||
48145449|NCT03583554|100679722|FG002|STARTED|Period 1||4||
48145450|NCT03583554|100679720|FG000|COMPLETED|Period 1||4||
48145451|NCT03583554|100679721|FG001|COMPLETED|Period 1||4||
48145452|NCT03583554|100679722|FG002|COMPLETED|Period 1||4||
48145453|NCT03583554|100679720|FG000|NOT COMPLETED|Period 1||0||
48145454|NCT03583554|100679721|FG001|NOT COMPLETED|Period 1||0||
48145455|NCT03583554|100679722|FG002|NOT COMPLETED|Period 1||0||
48145456|NCT03583554|100679720|FG000|STARTED|Period 2||4||
48145457|NCT03583554|100679721|FG001|STARTED|Period 2||4||
48145458|NCT03583554|100679722|FG002|STARTED|Period 2||4||
48145459|NCT03583554|100679720|FG000|COMPLETED|Period 2||3||
48145460|NCT03583554|100679721|FG001|COMPLETED|Period 2||4||
48145461|NCT03583554|100679722|FG002|COMPLETED|Period 2||3||
48145462|NCT03583554|100679720|FG000|NOT COMPLETED|Period 2||1||
48145463|NCT03583554|100679721|FG001|NOT COMPLETED|Period 2||0||
48145464|NCT03583554|100679722|FG002|NOT COMPLETED|Period 2||1||
48145465|NCT03583554|100679720|FG000|STARTED|Period 3||3||
48145466|NCT03583554|100679721|FG001|STARTED|Period 3||4||
48714152|NCT04493684|102088499|FG001|STARTED|Part 1:Treatment Period 3-Up to 9 Weeks||3||
48714153|NCT04493684|102088500|FG002|STARTED|Part 1:Treatment Period 3-Up to 9 Weeks||3||
48714154|NCT04493684|102088501|FG003|STARTED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714155|NCT04493684|102088502|FG004|STARTED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714156|NCT04493684|102088503|FG005|STARTED|Part 1:Treatment Period 3-Up to 9 Weeks||4||
48714157|NCT04493684|102088504|FG006|STARTED|Part 1:Treatment Period 3-Up to 9 Weeks||3||
48714158|NCT04493684|102088505|FG007|STARTED|Part 1:Treatment Period 3-Up to 9 Weeks||3||
48714159|NCT04493684|102088506|FG008|STARTED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714160|NCT04493684|102088507|FG009|STARTED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714161|NCT04493684|102088508|FG010|STARTED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714162|NCT04493684|102088509|FG011|STARTED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714163|NCT04493684|102088510|FG012|STARTED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714164|NCT04493684|102088511|FG013|STARTED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48145467|NCT03583554|100679722|FG002|STARTED|Period 3||3||
48145468|NCT03583554|100679720|FG000|COMPLETED|Period 3||3||
48145469|NCT03583554|100679721|FG001|COMPLETED|Period 3||4||
48145470|NCT03583554|100679722|FG002|COMPLETED|Period 3||3||
48145471|NCT03583554|100679720|FG000|NOT COMPLETED|Period 3||0||
48145472|NCT03583554|100679721|FG001|NOT COMPLETED|Period 3||0||
48145473|NCT03583554|100679722|FG002|NOT COMPLETED|Period 3||0||
48145474|NCT00626431|100679723|FG000|STARTED|Overall Study||151||
48145475|NCT00626431|100679724|FG001|STARTED|Overall Study||159||
48145476|NCT00626431|100679723|FG000|COMPLETED|Overall Study||134||
48714165|NCT04493684|102088512|FG014|STARTED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48145477|NCT00626431|100679724|FG001|COMPLETED|Overall Study||114||
48145478|NCT00626431|100679723|FG000|NOT COMPLETED|Overall Study||17||
48145479|NCT00626431|100679724|FG001|NOT COMPLETED|Overall Study||45||
48145480|NCT05198466|100679725|FG000|STARTED|Overall Study||10||
48145481|NCT05198466|100679726|FG001|STARTED|Overall Study||9||
48145482|NCT05198466|100679725|FG000|COMPLETED|Overall Study||10||
48145483|NCT05198466|100679726|FG001|COMPLETED|Overall Study||8||
48145484|NCT05198466|100679725|FG000|NOT COMPLETED|Overall Study||0||
48145485|NCT05198466|100679726|FG001|NOT COMPLETED|Overall Study||1||
48145486|NCT01684748|100679727|FG000|STARTED|First Intervention - 8 Weeks||10||
48145487|NCT01684748|100679728|FG001|STARTED|First Intervention - 8 Weeks||10||
48145488|NCT01684748|100679727|FG000|COMPLETED|First Intervention - 8 Weeks||8||
48145489|NCT01684748|100679728|FG001|COMPLETED|First Intervention - 8 Weeks||8||
48145490|NCT01684748|100679727|FG000|NOT COMPLETED|First Intervention - 8 Weeks||2||
48145491|NCT01684748|100679728|FG001|NOT COMPLETED|First Intervention - 8 Weeks||2||
48145492|NCT01684748|100679727|FG000|STARTED|Second Intervention - 8 Weeks||8||
48145493|NCT01684748|100679728|FG001|STARTED|Second Intervention - 8 Weeks||8||
48145494|NCT01684748|100679727|FG000|COMPLETED|Second Intervention - 8 Weeks||8||
48145495|NCT01684748|100679728|FG001|COMPLETED|Second Intervention - 8 Weeks||8||
48145496|NCT01684748|100679727|FG000|NOT COMPLETED|Second Intervention - 8 Weeks||0||
48601058|NCT03717415|101807603|FG005|mITT Population|Overall Study||18|Modified Intent-to-Treat (mITT) Population includes all participants who had at least one full dose of the combined study drugs, had measurable disease at baseline, and had at least one post-baseline assessment. Participants without a post-baseline assessment who discontinued study treatment due to clinical progression, death, or a rebastinib-related AE will also be included in the mITT population.|
48601059|NCT03717415|101807604|FG006|mITT Population|Overall Study||2|Modified Intent-to-Treat (mITT) Population includes all participants who had at least one full dose of the combined study drugs, had measurable disease at baseline, and had at least one post-baseline assessment. Participants without a post-baseline assessment who discontinued study treatment due to clinical progression, death, or a rebastinib-related AE will also be included in the mITT population.|
48601060|NCT03717415|101807605|FG007|mITT Population|Overall Study||6|Modified Intent-to-Treat (mITT) Population includes all participants who had at least one full dose of the combined study drugs, had measurable disease at baseline, and had at least one post-baseline assessment. Participants without a post-baseline assessment who discontinued study treatment due to clinical progression, death, or a rebastinib-related AE will also be included in the mITT population.|
48601061|NCT03717415|101807606|FG008|mITT Population|Overall Study||11|Modified Intent-to-Treat (mITT) Population includes all participants who had at least one full dose of the combined study drugs, had measurable disease at baseline, and had at least one post-baseline assessment. Participants without a post-baseline assessment who discontinued study treatment due to clinical progression, death, or a rebastinib-related AE will also be included in the mITT population.|
48601062|NCT03717415|101807598|FG000|COMPLETED|Overall Study||3||
48601063|NCT03717415|101807599|FG001|COMPLETED|Overall Study||7||
48601064|NCT03717415|101807600|FG002|COMPLETED|Overall Study||0||
48601065|NCT03717415|101807601|FG003|COMPLETED|Overall Study||4||
48601066|NCT03717415|101807602|FG004|COMPLETED|Overall Study||0||
48601067|NCT03717415|101807603|FG005|COMPLETED|Overall Study||12||
48601068|NCT03717415|101807604|FG006|COMPLETED|Overall Study||0||
48601069|NCT03717415|101807605|FG007|COMPLETED|Overall Study||3||
48601070|NCT03717415|101807606|FG008|COMPLETED|Overall Study||3||
48601071|NCT03717415|101807598|FG000|NOT COMPLETED|Overall Study||0||
48601072|NCT03717415|101807599|FG001|NOT COMPLETED|Overall Study||7||
48601073|NCT03717415|101807600|FG002|NOT COMPLETED|Overall Study||5||
48601074|NCT03717415|101807601|FG003|NOT COMPLETED|Overall Study||5||
48601075|NCT03717415|101807602|FG004|NOT COMPLETED|Overall Study||2||
48145497|NCT01684748|100679728|FG001|NOT COMPLETED|Second Intervention - 8 Weeks||0||
48145498|NCT01627327|100679729|FG000|STARTED|Overall Study||310||
48145499|NCT01627327|100679730|FG001|STARTED|Overall Study||313||
48145500|NCT01627327|100679729|FG000|COMPLETED|Overall Study||291||
48145501|NCT01627327|100679730|FG001|COMPLETED|Overall Study||274||
48145502|NCT01627327|100679729|FG000|NOT COMPLETED|Overall Study||19||
48145503|NCT01627327|100679730|FG001|NOT COMPLETED|Overall Study||39||
48145504|NCT02525874|100679731|FG000|STARTED|Overall Study||218||
48145505|NCT02525874|100679731|FG000|COMPLETED|Overall Study||158||
48145506|NCT02525874|100679731|FG000|NOT COMPLETED|Overall Study||60||
48145507|NCT00951275|100679732|FG000|STARTED|Overall Study||105||
48145508|NCT00951275|100679732|FG000|COMPLETED|Overall Study||92||
48145509|NCT00951275|100679732|FG000|NOT COMPLETED|Overall Study||13||
48145510|NCT00802854|100679733|FG000|STARTED|Overall Study||244||
48145511|NCT00802854|100679733|FG000|COMPLETED|Overall Study||244||
48145512|NCT00802854|100679733|FG000|NOT COMPLETED|Overall Study||0||
48601076|NCT03717415|101807603|FG005|NOT COMPLETED|Overall Study||6||
48601077|NCT03717415|101807604|FG006|NOT COMPLETED|Overall Study||2||
48601078|NCT03717415|101807605|FG007|NOT COMPLETED|Overall Study||3||
48601079|NCT03717415|101807606|FG008|NOT COMPLETED|Overall Study||8||
48145513|NCT03162224|100679734|FG000|STARTED|Overall Study||15||
48145514|NCT03162224|100679735|FG001|STARTED|Overall Study||9||
48145515|NCT03162224|100679736|FG002|STARTED|Overall Study||11||
48145516|NCT03162224|100679734|FG000|COMPLETED|Overall Study||4||
48145517|NCT03162224|100679735|FG001|COMPLETED|Overall Study||1||
48145518|NCT03162224|100679736|FG002|COMPLETED|Overall Study||1||
48714166|NCT04493684|102088513|FG015|STARTED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714167|NCT04493684|102088514|FG016|STARTED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714168|NCT04493684|102088498|FG000|COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||3||
48145519|NCT03162224|100679734|FG000|NOT COMPLETED|Overall Study||11||
48145520|NCT03162224|100679735|FG001|NOT COMPLETED|Overall Study||8||
48145521|NCT03162224|100679736|FG002|NOT COMPLETED|Overall Study||10||
48145522|NCT00527566|100679737|FG000|STARTED|Overall Study||10||
48601080|NCT01964716|101807607|FG000|STARTED|Overall Study||250||
48601081|NCT01964716|101807608|FG001|STARTED|Overall Study||250||
48601082|NCT01964716|101807607|FG000|Vaccinated Dose 1|Overall Study||250||
48601083|NCT01964716|101807608|FG001|Vaccinated Dose 1|Overall Study||250||
48601084|NCT01964716|101807607|FG000|Vaccinated Dose 2|Overall Study||249||
48601085|NCT01964716|101807608|FG001|Vaccinated Dose 2|Overall Study||248||
48601086|NCT01964716|101807607|FG000|Vaccinated Dose 3|Overall Study||247||
48601087|NCT01964716|101807608|FG001|Vaccinated Dose 3|Overall Study||244||
48601088|NCT01964716|101807607|FG000|COMPLETED|Overall Study||245||
48601089|NCT01964716|101807608|FG001|COMPLETED|Overall Study||244||
48601090|NCT01964716|101807607|FG000|NOT COMPLETED|Overall Study||5||
48601091|NCT01964716|101807608|FG001|NOT COMPLETED|Overall Study||6||
48601092|NCT01653327|101807609|FG000|STARTED|Overall Study||11||
48601093|NCT01653327|101807609|FG000|COMPLETED|Overall Study||10|8 participants received both Ketamine and Placebo; 1 received Ketamine only; 2 received Placebo only|
48601094|NCT01653327|101807609|FG000|NOT COMPLETED|Overall Study||1||
48714169|NCT04493684|102088499|FG001|COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||3||
48714170|NCT04493684|102088500|FG002|COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||3||
48714171|NCT04493684|102088501|FG003|COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714172|NCT04493684|102088502|FG004|COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714173|NCT04493684|102088503|FG005|COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||3||
48714174|NCT04493684|102088504|FG006|COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||3||
48714175|NCT04493684|102088505|FG007|COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||3||
48714176|NCT04493684|102088506|FG008|COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714177|NCT04493684|102088507|FG009|COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714178|NCT04493684|102088508|FG010|COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714179|NCT04493684|102088509|FG011|COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714180|NCT04493684|102088510|FG012|COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714181|NCT04493684|102088511|FG013|COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714182|NCT04493684|102088512|FG014|COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714183|NCT04493684|102088513|FG015|COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714184|NCT04493684|102088514|FG016|COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714185|NCT04493684|102088498|FG000|NOT COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||1||
48714186|NCT04493684|102088499|FG001|NOT COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714187|NCT04493684|102088500|FG002|NOT COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714188|NCT04493684|102088501|FG003|NOT COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714189|NCT04493684|102088502|FG004|NOT COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714190|NCT04493684|102088503|FG005|NOT COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||1||
48714191|NCT04493684|102088504|FG006|NOT COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714192|NCT04493684|102088505|FG007|NOT COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714193|NCT04493684|102088506|FG008|NOT COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714194|NCT04493684|102088507|FG009|NOT COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714195|NCT04493684|102088508|FG010|NOT COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714196|NCT04493684|102088509|FG011|NOT COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714197|NCT04493684|102088510|FG012|NOT COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714198|NCT04493684|102088511|FG013|NOT COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714199|NCT04493684|102088512|FG014|NOT COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714200|NCT04493684|102088513|FG015|NOT COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714201|NCT04493684|102088514|FG016|NOT COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
48714202|NCT04493684|102088498|FG000|STARTED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48714203|NCT04493684|102088499|FG001|STARTED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48714204|NCT04493684|102088500|FG002|STARTED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48714205|NCT04493684|102088501|FG003|STARTED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48714206|NCT04493684|102088502|FG004|STARTED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48601095|NCT01080391|101807610|FG000|STARTED|Overall Study||396||
48601096|NCT01080391|101807611|FG001|STARTED|Overall Study||396||
48601097|NCT01080391|101807610|FG000|Treated|Overall Study||389||
48601098|NCT01080391|101807611|FG001|Treated|Overall Study||392||
48601099|NCT01080391|101807610|FG000|COMPLETED|Overall Study||389|Completed represents patients who discontinued treatment as of 05 December 2017|
48601100|NCT01080391|101807611|FG001|COMPLETED|Overall Study||392|Completed represents patients who discontinued treatment as of 05 December 2017|
48601101|NCT01080391|101807610|FG000|NOT COMPLETED|Overall Study||7||
48145523|NCT00527566|100679737|FG000|COMPLETED|Overall Study||10||
48145524|NCT00527566|100679737|FG000|NOT COMPLETED|Overall Study||0||
48601102|NCT01080391|101807611|FG001|NOT COMPLETED|Overall Study||4||
48767578|NCT01435382|102222772|FG001|STARTED|Overall Study||13||
48145525|NCT02065336|100679738|FG000|STARTED|Main Study||6||
48145526|NCT02065336|100679739|FG001|STARTED|Main Study||6||
48145527|NCT02065336|100679740|FG002|STARTED|Main Study||6||
48145528|NCT02065336|100679741|FG003|STARTED|Main Study||6||
48145529|NCT02065336|100679742|FG004|STARTED|Main Study||6||
48145530|NCT02065336|100679743|FG005|STARTED|Main Study||6||
48145531|NCT02065336|100679744|FG006|STARTED|Main Study||12||
48145532|NCT02065336|100679745|FG007|STARTED|Main Study||10||
48145533|NCT02065336|100679746|FG008|STARTED|Main Study||0||
48145534|NCT02065336|100679747|FG009|STARTED|Main Study||0||
48145535|NCT02065336|100679738|FG000|COMPLETED|Main Study||6||
48145536|NCT02065336|100679739|FG001|COMPLETED|Main Study||6||
48145537|NCT02065336|100679740|FG002|COMPLETED|Main Study||6||
48145538|NCT02065336|100679741|FG003|COMPLETED|Main Study||6||
48145539|NCT02065336|100679742|FG004|COMPLETED|Main Study||6||
48145540|NCT02065336|100679743|FG005|COMPLETED|Main Study||6||
48145541|NCT02065336|100679744|FG006|COMPLETED|Main Study||12||
48145542|NCT02065336|100679745|FG007|COMPLETED|Main Study||10||
48145543|NCT02065336|100679746|FG008|COMPLETED|Main Study||0||
48145544|NCT02065336|100679747|FG009|COMPLETED|Main Study||0||
48145545|NCT02065336|100679738|FG000|NOT COMPLETED|Main Study||0||
48145546|NCT02065336|100679739|FG001|NOT COMPLETED|Main Study||0||
48145547|NCT02065336|100679740|FG002|NOT COMPLETED|Main Study||0||
48145548|NCT02065336|100679741|FG003|NOT COMPLETED|Main Study||0||
48145549|NCT02065336|100679742|FG004|NOT COMPLETED|Main Study||0||
48714207|NCT04493684|102088503|FG005|STARTED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48714208|NCT04493684|102088504|FG006|STARTED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48714209|NCT04493684|102088505|FG007|STARTED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48714210|NCT04493684|102088506|FG008|STARTED|Part 2:Treatment Period 1-Up to 5 Weeks||9||
48714211|NCT04493684|102088507|FG009|STARTED|Part 2:Treatment Period 1-Up to 5 Weeks||7||
48714212|NCT04493684|102088508|FG010|STARTED|Part 2:Treatment Period 1-Up to 5 Weeks||7||
48714213|NCT04493684|102088509|FG011|STARTED|Part 2:Treatment Period 1-Up to 5 Weeks||7||
48714214|NCT04493684|102088510|FG012|STARTED|Part 2:Treatment Period 1-Up to 5 Weeks||3||
48714215|NCT04493684|102088511|FG013|STARTED|Part 2:Treatment Period 1-Up to 5 Weeks||7||
48714216|NCT04493684|102088512|FG014|STARTED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48714217|NCT04493684|102088513|FG015|STARTED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48714218|NCT04493684|102088514|FG016|STARTED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48714219|NCT04493684|102088498|FG000|COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48714220|NCT04493684|102088499|FG001|COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48714221|NCT04493684|102088500|FG002|COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48714222|NCT04493684|102088501|FG003|COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48145550|NCT02065336|100679743|FG005|NOT COMPLETED|Main Study||0||
48145551|NCT02065336|100679744|FG006|NOT COMPLETED|Main Study||0||
48145552|NCT02065336|100679745|FG007|NOT COMPLETED|Main Study||0||
48145553|NCT02065336|100679746|FG008|NOT COMPLETED|Main Study||0||
48145554|NCT02065336|100679747|FG009|NOT COMPLETED|Main Study||0||
48145555|NCT02065336|100679738|FG000|STARTED|Extension Phase||0||
48145556|NCT02065336|100679739|FG001|STARTED|Extension Phase||0||
48145557|NCT02065336|100679740|FG002|STARTED|Extension Phase||0||
48145558|NCT02065336|100679741|FG003|STARTED|Extension Phase||0||
48145559|NCT02065336|100679742|FG004|STARTED|Extension Phase||0||
48145560|NCT02065336|100679743|FG005|STARTED|Extension Phase||0||
48145561|NCT02065336|100679744|FG006|STARTED|Extension Phase||0||
48145562|NCT02065336|100679745|FG007|STARTED|Extension Phase||0||
48145563|NCT02065336|100679746|FG008|STARTED|Extension Phase||2||
48145564|NCT02065336|100679747|FG009|STARTED|Extension Phase||8||
48145565|NCT02065336|100679738|FG000|COMPLETED|Extension Phase||0||
48145566|NCT02065336|100679739|FG001|COMPLETED|Extension Phase||0||
48145567|NCT02065336|100679740|FG002|COMPLETED|Extension Phase||0||
48145568|NCT02065336|100679741|FG003|COMPLETED|Extension Phase||0||
48145569|NCT02065336|100679742|FG004|COMPLETED|Extension Phase||0||
48145570|NCT02065336|100679743|FG005|COMPLETED|Extension Phase||0||
48145571|NCT02065336|100679744|FG006|COMPLETED|Extension Phase||0||
48145572|NCT02065336|100679745|FG007|COMPLETED|Extension Phase||0||
48145573|NCT02065336|100679746|FG008|COMPLETED|Extension Phase||0||
48145574|NCT02065336|100679747|FG009|COMPLETED|Extension Phase||0||
48145575|NCT02065336|100679738|FG000|NOT COMPLETED|Extension Phase||0||
48145576|NCT02065336|100679739|FG001|NOT COMPLETED|Extension Phase||0||
48145577|NCT02065336|100679740|FG002|NOT COMPLETED|Extension Phase||0||
48145578|NCT02065336|100679741|FG003|NOT COMPLETED|Extension Phase||0||
48145579|NCT02065336|100679742|FG004|NOT COMPLETED|Extension Phase||0||
48145580|NCT02065336|100679743|FG005|NOT COMPLETED|Extension Phase||0||
48145581|NCT02065336|100679744|FG006|NOT COMPLETED|Extension Phase||0||
48145582|NCT02065336|100679745|FG007|NOT COMPLETED|Extension Phase||0||
48145583|NCT02065336|100679746|FG008|NOT COMPLETED|Extension Phase||2||
48145584|NCT02065336|100679747|FG009|NOT COMPLETED|Extension Phase||8||
48145585|NCT00698646|100679748|FG000|STARTED|Overall Study||128||
48145586|NCT00698646|100679749|FG001|STARTED|Overall Study||128||
48145587|NCT00698646|100679750|FG002|STARTED|Overall Study||128||
48145588|NCT00698646|100679748|FG000|COMPLETED|Overall Study||92||
48145589|NCT00698646|100679749|FG001|COMPLETED|Overall Study||97||
48145590|NCT00698646|100679750|FG002|COMPLETED|Overall Study||99||
48145591|NCT00698646|100679748|FG000|NOT COMPLETED|Overall Study||36||
48298825|NCT00509587|101060053|FG000|NOT COMPLETED|Overall Study||0||
48298826|NCT03877432|101060054|FG000|STARTED|Overall Study||10||
48298827|NCT03877432|101060054|FG000|COMPLETED|Overall Study||10||
48298828|NCT03877432|101060054|FG000|NOT COMPLETED|Overall Study||0||
48298829|NCT01933113|101060055|FG000|STARTED|Overall Study||3||
48298830|NCT01933113|101060055|FG000|COMPLETED|Overall Study||2||
48298831|NCT01933113|101060055|FG000|NOT COMPLETED|Overall Study||1||
48298832|NCT00231153|101060056|FG000|STARTED|Overall Study||907||
48298833|NCT00231153|101060057|FG001|STARTED|Overall Study||908||
48298834|NCT00231153|101060056|FG000|COMPLETED|Overall Study||690||
48298835|NCT00231153|101060057|FG001|COMPLETED|Overall Study||720||
48298836|NCT00231153|101060056|FG000|NOT COMPLETED|Overall Study||217||
48298837|NCT00231153|101060057|FG001|NOT COMPLETED|Overall Study||188||
48298838|NCT00564018|101060058|FG000|STARTED|Overall Study||11||
48298839|NCT00564018|101060059|FG001|STARTED|Overall Study||10||
48298840|NCT00564018|101060060|FG002|STARTED|Overall Study||12||
48298841|NCT00564018|101060058|FG000|COMPLETED|Overall Study||9||
48298842|NCT00564018|101060059|FG001|COMPLETED|Overall Study||7||
48298843|NCT00564018|101060060|FG002|COMPLETED|Overall Study||11||
48298844|NCT00564018|101060058|FG000|NOT COMPLETED|Overall Study||2||
48298845|NCT00564018|101060059|FG001|NOT COMPLETED|Overall Study||3||
48298846|NCT00564018|101060060|FG002|NOT COMPLETED|Overall Study||1||
48298847|NCT00759330|101060061|FG000|STARTED|Overall Study||20||
48298848|NCT00759330|101060062|FG001|STARTED|Overall Study||42||
48298849|NCT00759330|101060063|FG002|STARTED|Overall Study||22||
48298850|NCT00759330|101060064|FG003|STARTED|Overall Study||43||
48298851|NCT00759330|101060061|FG000|COMPLETED|Overall Study||19||
48298852|NCT00759330|101060062|FG001|COMPLETED|Overall Study||41||
48298853|NCT00759330|101060063|FG002|COMPLETED|Overall Study||22||
48298854|NCT00759330|101060064|FG003|COMPLETED|Overall Study||41||
48298855|NCT00759330|101060061|FG000|NOT COMPLETED|Overall Study||1||
48298856|NCT00759330|101060062|FG001|NOT COMPLETED|Overall Study||1||
48298857|NCT00759330|101060063|FG002|NOT COMPLETED|Overall Study||0||
48298858|NCT00759330|101060064|FG003|NOT COMPLETED|Overall Study||2||
48298859|NCT00823901|101060065|FG000|STARTED|Overall Study||43||
48298860|NCT00823901|101060066|FG001|STARTED|Overall Study||40||
48298861|NCT00823901|101060065|FG000|COMPLETED|Overall Study||39||
48298862|NCT00823901|101060066|FG001|COMPLETED|Overall Study||38||
48298863|NCT00823901|101060065|FG000|NOT COMPLETED|Overall Study||4||
48298864|NCT00823901|101060066|FG001|NOT COMPLETED|Overall Study||2||
48298865|NCT01464229|101060067|FG000|STARTED|Overall Study||10||
48298866|NCT01464229|101060068|FG001|STARTED|Overall Study||10||
48298867|NCT01464229|101060067|FG000|COMPLETED|Overall Study||5||
48298868|NCT01464229|101060068|FG001|COMPLETED|Overall Study||8||
48298869|NCT01464229|101060067|FG000|NOT COMPLETED|Overall Study||5||
48298870|NCT01464229|101060068|FG001|NOT COMPLETED|Overall Study||2||
48298871|NCT02456662|101060069|FG000|STARTED|Overall Study||159||
48298872|NCT02456662|101060070|FG001|STARTED|Overall Study||160||
48298873|NCT02456662|101060069|FG000|COMPLETED|Overall Study||157||
48298874|NCT02456662|101060070|FG001|COMPLETED|Overall Study||159||
48298875|NCT02456662|101060069|FG000|NOT COMPLETED|Overall Study||2||
48298876|NCT02456662|101060070|FG001|NOT COMPLETED|Overall Study||1||
48298877|NCT00867113|101060071|FG000|STARTED|Treatment Period||91||
48298878|NCT00867113|101060071|FG000|Safety Set|Treatment Period||91||
48298879|NCT00867113|101060071|FG000|Full Analysis Set (FAS)|Treatment Period||91||
48298880|NCT00867113|101060071|FG000|COMPLETED|Treatment Period||46||
48298881|NCT00867113|101060071|FG000|NOT COMPLETED|Treatment Period||45||
48298882|NCT00867113|101060071|FG000|STARTED|Post Treatment After Survival Follow-up||68||
48298883|NCT00867113|101060071|FG000|COMPLETED|Post Treatment After Survival Follow-up||57||
48298884|NCT00867113|101060071|FG000|NOT COMPLETED|Post Treatment After Survival Follow-up||11||
48298885|NCT02039726|101060072|FG000|STARTED|Overall Study||245||
48298886|NCT02039726|101060073|FG001|STARTED|Overall Study||122||
48298887|NCT02039726|101060072|FG000|Ongoing (as of Data Cutoff)|Overall Study||45||
48298888|NCT02039726|101060073|FG001|Ongoing (as of Data Cutoff)|Overall Study||16||
48298889|NCT02039726|101060072|FG000|Did Not Receive Treatment|Overall Study||4||
48298890|NCT02039726|101060073|FG001|Did Not Receive Treatment|Overall Study||28||
48298891|NCT02039726|101060072|FG000|COMPLETED|Overall Study||200||
48298892|NCT02039726|101060073|FG001|COMPLETED|Overall Study||106||
48298893|NCT02039726|101060072|FG000|NOT COMPLETED|Overall Study||45||
48298894|NCT02039726|101060073|FG001|NOT COMPLETED|Overall Study||16||
48298895|NCT00954421|101060074|FG000|STARTED|Screening||16||
48298896|NCT00954421|101060074|FG000|COMPLETED|Screening||13||
48298897|NCT00954421|101060074|FG000|NOT COMPLETED|Screening||3||
48298898|NCT00954421|101060074|FG000|STARTED|Baseline||13||
48298899|NCT00954421|101060074|FG000|COMPLETED|Baseline||13||
48298900|NCT00954421|101060074|FG000|NOT COMPLETED|Baseline||0||
48298901|NCT00954421|101060074|FG000|STARTED|6 Months of DBS||13||
48298902|NCT00954421|101060074|FG000|COMPLETED|6 Months of DBS||12||
48298903|NCT00954421|101060074|FG000|NOT COMPLETED|6 Months of DBS||1||
48298904|NCT00954421|101060074|FG000|STARTED|VIM=ON VO=ON at 6 Months||12||
48298905|NCT00954421|101060074|FG000|COMPLETED|VIM=ON VO=ON at 6 Months||12||
48298906|NCT00954421|101060074|FG000|NOT COMPLETED|VIM=ON VO=ON at 6 Months||0||
48714223|NCT04493684|102088502|FG004|COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48714224|NCT04493684|102088503|FG005|COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48714225|NCT04493684|102088504|FG006|COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48714226|NCT04493684|102088505|FG007|COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48714227|NCT04493684|102088506|FG008|COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||9||
48714228|NCT04493684|102088507|FG009|COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||7||
48714229|NCT04493684|102088508|FG010|COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||7||
48714230|NCT04493684|102088509|FG011|COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||6||
48714231|NCT04493684|102088510|FG012|COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||3||
48714232|NCT04493684|102088511|FG013|COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||7||
48714233|NCT04493684|102088512|FG014|COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48714234|NCT04493684|102088513|FG015|COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48298907|NCT00954421|101060074|FG000|STARTED|VIM=OFF VO=OFF at 6 Months||12||
48298908|NCT00954421|101060074|FG000|COMPLETED|VIM=OFF VO=OFF at 6 Months||12||
48298909|NCT00954421|101060074|FG000|NOT COMPLETED|VIM=OFF VO=OFF at 6 Months||0||
48298910|NCT00954421|101060074|FG000|STARTED|VIM=OFF VO=ON at 6 Months||12||
48298911|NCT00954421|101060074|FG000|COMPLETED|VIM=OFF VO=ON at 6 Months||12||
48298912|NCT00954421|101060074|FG000|NOT COMPLETED|VIM=OFF VO=ON at 6 Months||0||
48298913|NCT00954421|101060074|FG000|STARTED|VIM=ON VO=OFF at 6 Months||12||
48298914|NCT00954421|101060074|FG000|COMPLETED|VIM=ON VO=OFF at 6 Months||11||
48298915|NCT00954421|101060074|FG000|NOT COMPLETED|VIM=ON VO=OFF at 6 Months||1||
48298916|NCT01968070|101060075|FG000|STARTED|Period 1||4||
48714235|NCT04493684|102088514|FG016|COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48714236|NCT04493684|102088498|FG000|NOT COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48714237|NCT04493684|102088499|FG001|NOT COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48714238|NCT04493684|102088500|FG002|NOT COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48714239|NCT04493684|102088501|FG003|NOT COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48714240|NCT04493684|102088502|FG004|NOT COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48714241|NCT04493684|102088503|FG005|NOT COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48714242|NCT04493684|102088504|FG006|NOT COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48714243|NCT04493684|102088505|FG007|NOT COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48714244|NCT04493684|102088506|FG008|NOT COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48714245|NCT04493684|102088507|FG009|NOT COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48714246|NCT04493684|102088508|FG010|NOT COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48714247|NCT04493684|102088509|FG011|NOT COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||1||
48714248|NCT04493684|102088510|FG012|NOT COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48714249|NCT04493684|102088511|FG013|NOT COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48714250|NCT04493684|102088512|FG014|NOT COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48714251|NCT04493684|102088513|FG015|NOT COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48714252|NCT04493684|102088514|FG016|NOT COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
48298917|NCT01968070|101060076|FG001|STARTED|Period 1||4||
48298918|NCT01968070|101060077|FG002|STARTED|Period 1||4||
48298919|NCT01968070|101060078|FG003|STARTED|Period 1||4||
48298920|NCT01968070|101060079|FG004|STARTED|Period 1||4||
48298921|NCT01968070|101060080|FG005|STARTED|Period 1||4||
48298922|NCT01968070|101060081|FG006|STARTED|Period 1||10||
48298923|NCT01968070|101060082|FG007|STARTED|Period 1||2||
48298924|NCT01968070|101060083|FG008|STARTED|Period 1||2||
48298925|NCT01968070|101060084|FG009|STARTED|Period 1||9||
48298926|NCT01968070|101060085|FG010|STARTED|Period 1||2||
48298927|NCT01968070|101060086|FG011|STARTED|Period 1||2||
48298928|NCT01968070|101060087|FG012|STARTED|Period 1||9||
48298929|NCT01968070|101060088|FG013|STARTED|Period 1||2||
48298930|NCT01968070|101060089|FG014|STARTED|Period 1||2||
48298931|NCT01968070|101060090|FG015|STARTED|Period 1||9||
48298932|NCT01968070|101060091|FG016|STARTED|Period 1||2||
48405148|NCT02237898|101325204|FG001|Completed 9 Month Follow-up|Overall Study||7||
48714253|NCT04493684|102088498|FG000|STARTED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48714254|NCT04493684|102088499|FG001|STARTED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48714255|NCT04493684|102088500|FG002|STARTED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48714256|NCT04493684|102088501|FG003|STARTED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48298933|NCT01968070|101060092|FG017|STARTED|Period 1||2||
48298934|NCT01968070|101060075|FG000|COMPLETED|Period 1||4||
48298935|NCT01968070|101060076|FG001|COMPLETED|Period 1||3||
48298936|NCT01968070|101060077|FG002|COMPLETED|Period 1||4||
48298937|NCT01968070|101060078|FG003|COMPLETED|Period 1||2||
48298938|NCT01968070|101060079|FG004|COMPLETED|Period 1||3||
48298939|NCT01968070|101060080|FG005|COMPLETED|Period 1||4||
48298940|NCT01968070|101060081|FG006|COMPLETED|Period 1||8||
48298941|NCT01968070|101060082|FG007|COMPLETED|Period 1||2||
48405149|NCT02237898|101325203|FG000|Completed 15 Month Follow-up|Overall Study||8||
48714257|NCT04493684|102088502|FG004|STARTED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48298942|NCT01968070|101060083|FG008|COMPLETED|Period 1||2||
48298943|NCT01968070|101060084|FG009|COMPLETED|Period 1||9||
48298944|NCT01968070|101060085|FG010|COMPLETED|Period 1||2||
48298945|NCT01968070|101060086|FG011|COMPLETED|Period 1||1||
48298946|NCT01968070|101060087|FG012|COMPLETED|Period 1||9||
48298947|NCT01968070|101060088|FG013|COMPLETED|Period 1||2||
48298948|NCT01968070|101060089|FG014|COMPLETED|Period 1||2||
48298949|NCT01968070|101060090|FG015|COMPLETED|Period 1||8||
48298950|NCT01968070|101060091|FG016|COMPLETED|Period 1||2||
48298951|NCT01968070|101060092|FG017|COMPLETED|Period 1||2||
48298952|NCT01968070|101060075|FG000|NOT COMPLETED|Period 1||0||
48298953|NCT01968070|101060076|FG001|NOT COMPLETED|Period 1||1||
48298954|NCT01968070|101060077|FG002|NOT COMPLETED|Period 1||0||
48298955|NCT01968070|101060078|FG003|NOT COMPLETED|Period 1||2||
48298956|NCT01968070|101060079|FG004|NOT COMPLETED|Period 1||1||
48298957|NCT01968070|101060080|FG005|NOT COMPLETED|Period 1||0||
48298958|NCT01968070|101060081|FG006|NOT COMPLETED|Period 1||2||
48298959|NCT01968070|101060082|FG007|NOT COMPLETED|Period 1||0||
48298960|NCT01968070|101060083|FG008|NOT COMPLETED|Period 1||0||
48298961|NCT01968070|101060084|FG009|NOT COMPLETED|Period 1||0||
48298962|NCT01968070|101060085|FG010|NOT COMPLETED|Period 1||0||
48298963|NCT01968070|101060086|FG011|NOT COMPLETED|Period 1||1||
48298964|NCT01968070|101060087|FG012|NOT COMPLETED|Period 1||0||
48298965|NCT01968070|101060088|FG013|NOT COMPLETED|Period 1||0||
48298966|NCT01968070|101060089|FG014|NOT COMPLETED|Period 1||0||
48298967|NCT01968070|101060090|FG015|NOT COMPLETED|Period 1||1||
48298968|NCT01968070|101060091|FG016|NOT COMPLETED|Period 1||0||
48298969|NCT01968070|101060092|FG017|NOT COMPLETED|Period 1||0||
48298970|NCT01968070|101060075|FG000|STARTED|Period 2||4||
48298971|NCT01968070|101060076|FG001|STARTED|Period 2||4||
48298972|NCT01968070|101060077|FG002|STARTED|Period 2||4||
48298973|NCT01968070|101060078|FG003|STARTED|Period 2||4||
48298974|NCT01968070|101060079|FG004|STARTED|Period 2||3||
48298975|NCT01968070|101060080|FG005|STARTED|Period 2||4||
48298976|NCT01968070|101060081|FG006|STARTED|Period 2||0||
48298977|NCT01968070|101060082|FG007|STARTED|Period 2||0||
48298978|NCT01968070|101060083|FG008|STARTED|Period 2||0||
48298979|NCT01968070|101060084|FG009|STARTED|Period 2||0||
48298980|NCT01968070|101060085|FG010|STARTED|Period 2||0||
48298981|NCT01968070|101060086|FG011|STARTED|Period 2||0||
48298982|NCT01968070|101060087|FG012|STARTED|Period 2||0||
48298983|NCT01968070|101060088|FG013|STARTED|Period 2||0||
48298984|NCT01968070|101060089|FG014|STARTED|Period 2||0||
48298985|NCT01968070|101060090|FG015|STARTED|Period 2||0||
48298986|NCT01968070|101060091|FG016|STARTED|Period 2||0||
48298987|NCT01968070|101060092|FG017|STARTED|Period 2||0||
48298988|NCT01968070|101060075|FG000|COMPLETED|Period 2||4||
48298989|NCT01968070|101060076|FG001|COMPLETED|Period 2||4||
48405150|NCT02237898|101325204|FG001|Completed 15 Month Follow-up|Overall Study||8||
48405151|NCT02237898|101325203|FG000|COMPLETED|Overall Study||5||
48405152|NCT02237898|101325204|FG001|COMPLETED|Overall Study||2||
48405153|NCT02237898|101325203|FG000|NOT COMPLETED|Overall Study||7||
48405154|NCT02237898|101325204|FG001|NOT COMPLETED|Overall Study||12||
48714258|NCT04493684|102088503|FG005|STARTED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48714259|NCT04493684|102088504|FG006|STARTED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48714260|NCT04493684|102088505|FG007|STARTED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48714261|NCT04493684|102088506|FG008|STARTED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48714262|NCT04493684|102088507|FG009|STARTED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48405155|NCT02000219|101325205|FG000|STARTED|14-Week Study Period||12||
48405156|NCT02000219|101325205|FG000|COMPLETED|14-Week Study Period||9||
48405157|NCT02000219|101325205|FG000|NOT COMPLETED|14-Week Study Period||3||
48298990|NCT01968070|101060077|FG002|COMPLETED|Period 2||4||
48298991|NCT01968070|101060078|FG003|COMPLETED|Period 2||4||
48298992|NCT01968070|101060079|FG004|COMPLETED|Period 2||2||
48298993|NCT01968070|101060080|FG005|COMPLETED|Period 2||4||
48298994|NCT01968070|101060081|FG006|COMPLETED|Period 2||0||
48298995|NCT01968070|101060082|FG007|COMPLETED|Period 2||0||
48298996|NCT01968070|101060083|FG008|COMPLETED|Period 2||0||
48298997|NCT01968070|101060084|FG009|COMPLETED|Period 2||0||
48298998|NCT01968070|101060085|FG010|COMPLETED|Period 2||0||
48298999|NCT01968070|101060086|FG011|COMPLETED|Period 2||0||
48299000|NCT01968070|101060087|FG012|COMPLETED|Period 2||0||
48405158|NCT02000219|101325205|FG000|STARTED|Continuation Period||8|One patient chose not to enter the continuation period, and returned to their home country|
48405159|NCT02000219|101325205|FG000|COMPLETED|Continuation Period||3||
48145592|NCT00698646|100679749|FG001|NOT COMPLETED|Overall Study||31||
48299001|NCT01968070|101060088|FG013|COMPLETED|Period 2||0||
48299002|NCT01968070|101060089|FG014|COMPLETED|Period 2||0||
48299003|NCT01968070|101060090|FG015|COMPLETED|Period 2||0||
48299004|NCT01968070|101060091|FG016|COMPLETED|Period 2||0||
48299005|NCT01968070|101060092|FG017|COMPLETED|Period 2||0||
48299006|NCT01968070|101060075|FG000|NOT COMPLETED|Period 2||0||
48299007|NCT01968070|101060076|FG001|NOT COMPLETED|Period 2||0||
48299008|NCT01968070|101060077|FG002|NOT COMPLETED|Period 2||0||
48299009|NCT01968070|101060078|FG003|NOT COMPLETED|Period 2||0||
48145593|NCT00698646|100679750|FG002|NOT COMPLETED|Overall Study||29||
48145594|NCT00810264|100679751|FG000|STARTED|Overall Study||2499||
48145595|NCT00810264|100679751|FG000|COMPLETED|Overall Study||946||
48145596|NCT00810264|100679751|FG000|NOT COMPLETED|Overall Study||1553||
48145597|NCT00344461|100679752|FG000|STARTED|Overall Study||54||
48145598|NCT00344461|100679752|FG000|COMPLETED|Overall Study||33||
48145599|NCT00344461|100679752|FG000|NOT COMPLETED|Overall Study||21||
48145600|NCT01692340|100679753|FG000|STARTED|Overall Study||8||
48145601|NCT01692340|100679754|FG001|STARTED|Overall Study||4||
48145602|NCT01692340|100679755|FG002|STARTED|Overall Study||0||
48145603|NCT01692340|100679753|FG000|COMPLETED|Overall Study||8||
48145604|NCT01692340|100679754|FG001|COMPLETED|Overall Study||4||
48145605|NCT01692340|100679755|FG002|COMPLETED|Overall Study||0||
48145606|NCT01692340|100679753|FG000|NOT COMPLETED|Overall Study||0||
48145607|NCT01692340|100679754|FG001|NOT COMPLETED|Overall Study||0||
48145608|NCT01692340|100679755|FG002|NOT COMPLETED|Overall Study||0||
48145609|NCT02744534|100679756|FG000|STARTED|Overall Study||21||
48145610|NCT02744534|100679756|FG000|COMPLETED|Overall Study||21||
48145611|NCT02744534|100679756|FG000|NOT COMPLETED|Overall Study||0||
48145612|NCT00554970|100679757|FG000|STARTED|Period 1||8||
48145613|NCT00554970|100679758|FG001|STARTED|Period 1||8||
48145614|NCT00554970|100679759|FG002|STARTED|Period 1||8||
48145615|NCT00554970|100679760|FG003|STARTED|Period 1||8||
48145616|NCT00554970|100679757|FG000|COMPLETED|Period 1||7||
48145617|NCT00554970|100679758|FG001|COMPLETED|Period 1||8||
48145618|NCT00554970|100679759|FG002|COMPLETED|Period 1||8||
48145619|NCT00554970|100679760|FG003|COMPLETED|Period 1||8||
48145620|NCT00554970|100679757|FG000|NOT COMPLETED|Period 1||1||
48145621|NCT00554970|100679758|FG001|NOT COMPLETED|Period 1||0||
48145622|NCT00554970|100679759|FG002|NOT COMPLETED|Period 1||0||
48145623|NCT00554970|100679760|FG003|NOT COMPLETED|Period 1||0||
48145624|NCT00554970|100679757|FG000|STARTED|Period 2||7||
48145625|NCT00554970|100679758|FG001|STARTED|Period 2||8||
48601103|NCT00791492|101807612|FG000|STARTED|Overall Study||45||
48601104|NCT00791492|101807613|FG001|STARTED|Overall Study||41||
48601105|NCT00791492|101807612|FG000|TREATED|Overall Study||44||
48601106|NCT00791492|101807613|FG001|TREATED|Overall Study||41||
48601107|NCT00791492|101807612|FG000|COMPLETED|Overall Study||39||
48145626|NCT00554970|100679759|FG002|STARTED|Period 2||8||
48145627|NCT00554970|100679760|FG003|STARTED|Period 2||8||
48145628|NCT00554970|100679757|FG000|COMPLETED|Period 2||7||
48145629|NCT00554970|100679758|FG001|COMPLETED|Period 2||8||
48145630|NCT00554970|100679759|FG002|COMPLETED|Period 2||7||
48145631|NCT00554970|100679760|FG003|COMPLETED|Period 2||8||
48145632|NCT00554970|100679757|FG000|NOT COMPLETED|Period 2||0||
48145633|NCT00554970|100679758|FG001|NOT COMPLETED|Period 2||0||
48145634|NCT00554970|100679759|FG002|NOT COMPLETED|Period 2||1||
48145635|NCT00554970|100679760|FG003|NOT COMPLETED|Period 2||0||
48145636|NCT03074630|100679761|FG000|STARTED|Overall Study||12||
48145637|NCT03074630|100679761|FG000|COMPLETED|Overall Study||11||
48145638|NCT03074630|100679761|FG000|NOT COMPLETED|Overall Study||1||
48145639|NCT00818116|100679762|FG000|STARTED|Overall Study||34||
48145640|NCT00818116|100679762|FG000|COMPLETED|Overall Study||34||
48145641|NCT00818116|100679762|FG000|NOT COMPLETED|Overall Study||0||
48145642|NCT00528775|100679763|FG000|STARTED|Overall Study||6||
48601108|NCT00791492|101807613|FG001|COMPLETED|Overall Study||38||
48601109|NCT00791492|101807612|FG000|NOT COMPLETED|Overall Study||6||
48601110|NCT00791492|101807613|FG001|NOT COMPLETED|Overall Study||3||
48145643|NCT00528775|100679763|FG000|COMPLETED|Overall Study||5||
48145644|NCT00528775|100679763|FG000|NOT COMPLETED|Overall Study||1||
48145645|NCT01410773|100679764|FG000|STARTED|Overall Study||110||
48145646|NCT01410773|100679764|FG000|COMPLETED|Overall Study||110||
48145647|NCT01410773|100679764|FG000|NOT COMPLETED|Overall Study||0||
48145648|NCT02308748|100679765|FG000|STARTED|Period 1||2||
48145649|NCT02308748|100679766|FG001|STARTED|Period 1||2||
48145650|NCT02308748|100679767|FG002|STARTED|Period 1||2||
48145651|NCT02308748|100679768|FG003|STARTED|Period 1||2||
48145652|NCT02308748|100679769|FG004|STARTED|Period 1||2||
48145653|NCT02308748|100679770|FG005|STARTED|Period 1||3||
48145654|NCT02308748|100679771|FG006|STARTED|Period 1||2||
48145655|NCT02308748|100679772|FG007|STARTED|Period 1||2||
48145656|NCT02308748|100679773|FG008|STARTED|Period 1||2||
48145657|NCT02308748|100679774|FG009|STARTED|Period 1||3||
48145658|NCT02308748|100679765|FG000|COMPLETED|Period 1||2||
48145659|NCT02308748|100679766|FG001|COMPLETED|Period 1||2||
48145660|NCT02308748|100679767|FG002|COMPLETED|Period 1||1||
48145661|NCT02308748|100679768|FG003|COMPLETED|Period 1||2||
48145662|NCT02308748|100679769|FG004|COMPLETED|Period 1||2||
48601111|NCT04475718|101807614|FG000|STARTED|Overall Study||87||
48601112|NCT04475718|101807614|FG000|COMPLETED|Overall Study||79||
48601113|NCT04475718|101807614|FG000|NOT COMPLETED|Overall Study||8||
48145663|NCT02308748|100679770|FG005|COMPLETED|Period 1||3||
48145664|NCT02308748|100679771|FG006|COMPLETED|Period 1||2||
48145665|NCT02308748|100679772|FG007|COMPLETED|Period 1||2||
48145666|NCT02308748|100679773|FG008|COMPLETED|Period 1||2||
48145667|NCT02308748|100679774|FG009|COMPLETED|Period 1||3||
48145668|NCT02308748|100679765|FG000|NOT COMPLETED|Period 1||0||
48145669|NCT02308748|100679766|FG001|NOT COMPLETED|Period 1||0||
48145670|NCT02308748|100679767|FG002|NOT COMPLETED|Period 1||1||
48299010|NCT01968070|101060079|FG004|NOT COMPLETED|Period 2||1||
48299011|NCT01968070|101060080|FG005|NOT COMPLETED|Period 2||0||
48299012|NCT01968070|101060081|FG006|NOT COMPLETED|Period 2||0||
48299013|NCT01968070|101060082|FG007|NOT COMPLETED|Period 2||0||
48299014|NCT01968070|101060083|FG008|NOT COMPLETED|Period 2||0||
48299015|NCT01968070|101060084|FG009|NOT COMPLETED|Period 2||0||
48714263|NCT04493684|102088508|FG010|STARTED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48299016|NCT01968070|101060085|FG010|NOT COMPLETED|Period 2||0||
48299017|NCT01968070|101060086|FG011|NOT COMPLETED|Period 2||0||
48299018|NCT01968070|101060087|FG012|NOT COMPLETED|Period 2||0||
48299019|NCT01968070|101060088|FG013|NOT COMPLETED|Period 2||0||
48299020|NCT01968070|101060089|FG014|NOT COMPLETED|Period 2||0||
48299021|NCT01968070|101060090|FG015|NOT COMPLETED|Period 2||0||
48299022|NCT01968070|101060091|FG016|NOT COMPLETED|Period 2||0||
48299023|NCT01968070|101060092|FG017|NOT COMPLETED|Period 2||0||
48299024|NCT01968070|101060075|FG000|STARTED|Period 3||4||
48299025|NCT01968070|101060076|FG001|STARTED|Period 3||4||
48299026|NCT01968070|101060077|FG002|STARTED|Period 3||4||
48299027|NCT01968070|101060078|FG003|STARTED|Period 3||4||
48299028|NCT01968070|101060079|FG004|STARTED|Period 3||3||
48299029|NCT01968070|101060080|FG005|STARTED|Period 3||4||
48299030|NCT01968070|101060081|FG006|STARTED|Period 3||0||
48299031|NCT01968070|101060082|FG007|STARTED|Period 3||0||
48299032|NCT01968070|101060083|FG008|STARTED|Period 3||0||
48299033|NCT01968070|101060084|FG009|STARTED|Period 3||0||
48299034|NCT01968070|101060085|FG010|STARTED|Period 3||0||
48299035|NCT01968070|101060086|FG011|STARTED|Period 3||0||
48299036|NCT01968070|101060087|FG012|STARTED|Period 3||0||
48299037|NCT01968070|101060088|FG013|STARTED|Period 3||0||
48299038|NCT01968070|101060089|FG014|STARTED|Period 3||0||
48299039|NCT01968070|101060090|FG015|STARTED|Period 3||0||
48299040|NCT01968070|101060091|FG016|STARTED|Period 3||0||
48299041|NCT01968070|101060092|FG017|STARTED|Period 3||0||
48299042|NCT01968070|101060075|FG000|COMPLETED|Period 3||4||
48299043|NCT01968070|101060076|FG001|COMPLETED|Period 3||4||
48299044|NCT01968070|101060077|FG002|COMPLETED|Period 3||4||
48299045|NCT01968070|101060078|FG003|COMPLETED|Period 3||4||
48299046|NCT01968070|101060079|FG004|COMPLETED|Period 3||3||
48299047|NCT01968070|101060080|FG005|COMPLETED|Period 3||4||
48299048|NCT01968070|101060081|FG006|COMPLETED|Period 3||0||
48299049|NCT01968070|101060082|FG007|COMPLETED|Period 3||0||
48299050|NCT01968070|101060083|FG008|COMPLETED|Period 3||0||
48299051|NCT01968070|101060084|FG009|COMPLETED|Period 3||0||
48299052|NCT01968070|101060085|FG010|COMPLETED|Period 3||0||
48299053|NCT01968070|101060086|FG011|COMPLETED|Period 3||0||
48299054|NCT01968070|101060087|FG012|COMPLETED|Period 3||0||
48299055|NCT01968070|101060088|FG013|COMPLETED|Period 3||0||
48299056|NCT01968070|101060089|FG014|COMPLETED|Period 3||0||
48299057|NCT01968070|101060090|FG015|COMPLETED|Period 3||0||
48299058|NCT01968070|101060091|FG016|COMPLETED|Period 3||0||
48299059|NCT01968070|101060092|FG017|COMPLETED|Period 3||0||
48299060|NCT01968070|101060075|FG000|NOT COMPLETED|Period 3||0||
48299061|NCT01968070|101060076|FG001|NOT COMPLETED|Period 3||0||
48299062|NCT01968070|101060077|FG002|NOT COMPLETED|Period 3||0||
48299063|NCT01968070|101060078|FG003|NOT COMPLETED|Period 3||0||
48299064|NCT01968070|101060079|FG004|NOT COMPLETED|Period 3||0||
48299065|NCT01968070|101060080|FG005|NOT COMPLETED|Period 3||0||
48299066|NCT01968070|101060081|FG006|NOT COMPLETED|Period 3||0||
48405160|NCT02000219|101325205|FG000|NOT COMPLETED|Continuation Period||5||
48714264|NCT04493684|102088509|FG011|STARTED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48714265|NCT04493684|102088510|FG012|STARTED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48714266|NCT04493684|102088511|FG013|STARTED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48714267|NCT04493684|102088512|FG014|STARTED|Part 3:Treatment Period 1-Up to 4 Weeks||5||
48714268|NCT04493684|102088513|FG015|STARTED|Part 3:Treatment Period 1-Up to 4 Weeks||6||
48714269|NCT04493684|102088514|FG016|STARTED|Part 3:Treatment Period 1-Up to 4 Weeks||6||
48299067|NCT01968070|101060082|FG007|NOT COMPLETED|Period 3||0||
48299068|NCT01968070|101060083|FG008|NOT COMPLETED|Period 3||0||
48299069|NCT01968070|101060084|FG009|NOT COMPLETED|Period 3||0||
48299070|NCT01968070|101060085|FG010|NOT COMPLETED|Period 3||0||
48299071|NCT01968070|101060086|FG011|NOT COMPLETED|Period 3||0||
48299072|NCT01968070|101060087|FG012|NOT COMPLETED|Period 3||0||
48405161|NCT01553591|101325206|FG000|STARTED|Overall Study||429||
48767579|NCT01435382|102222773|FG002|STARTED|Overall Study||13||
48299073|NCT01968070|101060088|FG013|NOT COMPLETED|Period 3||0||
48299074|NCT01968070|101060089|FG014|NOT COMPLETED|Period 3||0||
48299075|NCT01968070|101060090|FG015|NOT COMPLETED|Period 3||0||
48299076|NCT01968070|101060091|FG016|NOT COMPLETED|Period 3||0||
48299077|NCT01968070|101060092|FG017|NOT COMPLETED|Period 3||0||
48299078|NCT04195958|101060093|FG000|STARTED|Overall Study||3||
48299079|NCT04195958|101060093|FG000|COMPLETED|Overall Study||1||
48299080|NCT04195958|101060093|FG000|NOT COMPLETED|Overall Study||2||
48299081|NCT02684279|101060094|FG000|STARTED|Overall Study||528||
48299082|NCT02684279|101060094|FG000|COMPLETED|Overall Study||249||
48299083|NCT02684279|101060094|FG000|NOT COMPLETED|Overall Study||279||
48299084|NCT00389857|101060095|FG000|STARTED|Overall Study||14||
48299085|NCT00389857|101060096|FG001|STARTED|Overall Study||17||
48299086|NCT00389857|101060095|FG000|COMPLETED|Overall Study||14||
48299087|NCT00389857|101060096|FG001|COMPLETED|Overall Study||17||
48299088|NCT00389857|101060095|FG000|NOT COMPLETED|Overall Study||0||
48299089|NCT00389857|101060096|FG001|NOT COMPLETED|Overall Study||0||
48299090|NCT01372410|101060097|FG000|STARTED|Treatment Period 1 (7 Days)||20||
48299091|NCT01372410|101060098|FG001|STARTED|Treatment Period 1 (7 Days)||21||
48299092|NCT01372410|101060099|FG002|STARTED|Treatment Period 1 (7 Days)||19||
48299093|NCT01372410|101060100|FG003|STARTED|Treatment Period 1 (7 Days)||20||
48299094|NCT01372410|101060101|FG004|STARTED|Treatment Period 1 (7 Days)||21||
48299095|NCT01372410|101060102|FG005|STARTED|Treatment Period 1 (7 Days)||21||
48299096|NCT01372410|101060103|FG006|STARTED|Treatment Period 1 (7 Days)||22||
48299097|NCT01372410|101060104|FG007|STARTED|Treatment Period 1 (7 Days)||19||
48299098|NCT01372410|101060097|FG000|COMPLETED|Treatment Period 1 (7 Days)||19||
48299099|NCT01372410|101060098|FG001|COMPLETED|Treatment Period 1 (7 Days)||19||
48299100|NCT01372410|101060099|FG002|COMPLETED|Treatment Period 1 (7 Days)||19||
48299101|NCT01372410|101060100|FG003|COMPLETED|Treatment Period 1 (7 Days)||20||
48299102|NCT01372410|101060101|FG004|COMPLETED|Treatment Period 1 (7 Days)||19||
48299103|NCT01372410|101060102|FG005|COMPLETED|Treatment Period 1 (7 Days)||21||
48299104|NCT01372410|101060103|FG006|COMPLETED|Treatment Period 1 (7 Days)||20||
48299105|NCT01372410|101060104|FG007|COMPLETED|Treatment Period 1 (7 Days)||19||
48299106|NCT01372410|101060097|FG000|NOT COMPLETED|Treatment Period 1 (7 Days)||1||
48299107|NCT01372410|101060098|FG001|NOT COMPLETED|Treatment Period 1 (7 Days)||2||
48299108|NCT01372410|101060099|FG002|NOT COMPLETED|Treatment Period 1 (7 Days)||0||
48299109|NCT01372410|101060100|FG003|NOT COMPLETED|Treatment Period 1 (7 Days)||0||
48299110|NCT01372410|101060101|FG004|NOT COMPLETED|Treatment Period 1 (7 Days)||2||
48714270|NCT04493684|102088498|FG000|COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48714271|NCT04493684|102088499|FG001|COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48714272|NCT04493684|102088500|FG002|COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48714273|NCT04493684|102088501|FG003|COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48714274|NCT04493684|102088502|FG004|COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48714275|NCT04493684|102088503|FG005|COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48299111|NCT01372410|101060102|FG005|NOT COMPLETED|Treatment Period 1 (7 Days)||0||
48299112|NCT01372410|101060103|FG006|NOT COMPLETED|Treatment Period 1 (7 Days)||2||
48299113|NCT01372410|101060104|FG007|NOT COMPLETED|Treatment Period 1 (7 Days)||0||
48714276|NCT04493684|102088504|FG006|COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48714277|NCT04493684|102088505|FG007|COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48714278|NCT04493684|102088506|FG008|COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48299114|NCT01372410|101060097|FG000|STARTED|Washout Period 1 (10-14 Days)||19||
48299115|NCT01372410|101060098|FG001|STARTED|Washout Period 1 (10-14 Days)||19||
48299116|NCT01372410|101060099|FG002|STARTED|Washout Period 1 (10-14 Days)||19||
48299117|NCT01372410|101060100|FG003|STARTED|Washout Period 1 (10-14 Days)||20||
48299118|NCT01372410|101060101|FG004|STARTED|Washout Period 1 (10-14 Days)||19||
48299119|NCT01372410|101060102|FG005|STARTED|Washout Period 1 (10-14 Days)||21||
48714279|NCT04493684|102088507|FG009|COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48714280|NCT04493684|102088508|FG010|COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48714281|NCT04493684|102088509|FG011|COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48714282|NCT04493684|102088510|FG012|COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48714283|NCT04493684|102088511|FG013|COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48714284|NCT04493684|102088512|FG014|COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||5||
48299120|NCT01372410|101060103|FG006|STARTED|Washout Period 1 (10-14 Days)||20||
48299121|NCT01372410|101060104|FG007|STARTED|Washout Period 1 (10-14 Days)||19||
48299122|NCT01372410|101060097|FG000|COMPLETED|Washout Period 1 (10-14 Days)||18||
48299123|NCT01372410|101060098|FG001|COMPLETED|Washout Period 1 (10-14 Days)||19||
48714285|NCT04493684|102088513|FG015|COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||5||
48714286|NCT04493684|102088514|FG016|COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||6||
48714287|NCT04493684|102088498|FG000|NOT COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48714288|NCT04493684|102088499|FG001|NOT COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48714289|NCT04493684|102088500|FG002|NOT COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48714290|NCT04493684|102088501|FG003|NOT COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48714291|NCT04493684|102088502|FG004|NOT COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48145671|NCT02308748|100679768|FG003|NOT COMPLETED|Period 1||0||
48299124|NCT01372410|101060099|FG002|COMPLETED|Washout Period 1 (10-14 Days)||19||
48299125|NCT01372410|101060100|FG003|COMPLETED|Washout Period 1 (10-14 Days)||20||
48299126|NCT01372410|101060101|FG004|COMPLETED|Washout Period 1 (10-14 Days)||19||
48299127|NCT01372410|101060102|FG005|COMPLETED|Washout Period 1 (10-14 Days)||21||
48299128|NCT01372410|101060103|FG006|COMPLETED|Washout Period 1 (10-14 Days)||20||
48299129|NCT01372410|101060104|FG007|COMPLETED|Washout Period 1 (10-14 Days)||18||
48299130|NCT01372410|101060097|FG000|NOT COMPLETED|Washout Period 1 (10-14 Days)||1||
48299131|NCT01372410|101060098|FG001|NOT COMPLETED|Washout Period 1 (10-14 Days)||0||
48299132|NCT01372410|101060099|FG002|NOT COMPLETED|Washout Period 1 (10-14 Days)||0||
48299133|NCT01372410|101060100|FG003|NOT COMPLETED|Washout Period 1 (10-14 Days)||0||
48299134|NCT01372410|101060101|FG004|NOT COMPLETED|Washout Period 1 (10-14 Days)||0||
48299135|NCT01372410|101060102|FG005|NOT COMPLETED|Washout Period 1 (10-14 Days)||0||
48299136|NCT01372410|101060103|FG006|NOT COMPLETED|Washout Period 1 (10-14 Days)||0||
48299137|NCT01372410|101060104|FG007|NOT COMPLETED|Washout Period 1 (10-14 Days)||1||
48299138|NCT01372410|101060097|FG000|STARTED|Treatment Period 2 (7 Days)||19||
48299139|NCT01372410|101060098|FG001|STARTED|Treatment Period 2 (7 Days)||21||
48299140|NCT01372410|101060099|FG002|STARTED|Treatment Period 2 (7 Days)||22||
48299141|NCT01372410|101060100|FG003|STARTED|Treatment Period 2 (7 Days)||17||
48299142|NCT01372410|101060101|FG004|STARTED|Treatment Period 2 (7 Days)||19||
48714292|NCT04493684|102088503|FG005|NOT COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48714293|NCT04493684|102088504|FG006|NOT COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48714294|NCT04493684|102088505|FG007|NOT COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48714295|NCT04493684|102088506|FG008|NOT COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48714296|NCT04493684|102088507|FG009|NOT COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48299143|NCT01372410|101060102|FG005|STARTED|Treatment Period 2 (7 Days)||16||
48299144|NCT01372410|101060103|FG006|STARTED|Treatment Period 2 (7 Days)||21||
48299145|NCT01372410|101060104|FG007|STARTED|Treatment Period 2 (7 Days)||19||
48299146|NCT01372410|101060097|FG000|COMPLETED|Treatment Period 2 (7 Days)||19||
48299147|NCT01372410|101060098|FG001|COMPLETED|Treatment Period 2 (7 Days)||21||
48299148|NCT01372410|101060099|FG002|COMPLETED|Treatment Period 2 (7 Days)||22||
48299149|NCT01372410|101060100|FG003|COMPLETED|Treatment Period 2 (7 Days)||17||
48299150|NCT01372410|101060101|FG004|COMPLETED|Treatment Period 2 (7 Days)||19||
48299151|NCT01372410|101060102|FG005|COMPLETED|Treatment Period 2 (7 Days)||16||
48299152|NCT01372410|101060103|FG006|COMPLETED|Treatment Period 2 (7 Days)||21||
48299153|NCT01372410|101060104|FG007|COMPLETED|Treatment Period 2 (7 Days)||19||
48299154|NCT01372410|101060097|FG000|NOT COMPLETED|Treatment Period 2 (7 Days)||0||
48299155|NCT01372410|101060098|FG001|NOT COMPLETED|Treatment Period 2 (7 Days)||0||
48299156|NCT01372410|101060099|FG002|NOT COMPLETED|Treatment Period 2 (7 Days)||0||
48299157|NCT01372410|101060100|FG003|NOT COMPLETED|Treatment Period 2 (7 Days)||0||
48299158|NCT01372410|101060101|FG004|NOT COMPLETED|Treatment Period 2 (7 Days)||0||
48299159|NCT01372410|101060102|FG005|NOT COMPLETED|Treatment Period 2 (7 Days)||0||
48299160|NCT01372410|101060103|FG006|NOT COMPLETED|Treatment Period 2 (7 Days)||0||
48299161|NCT01372410|101060104|FG007|NOT COMPLETED|Treatment Period 2 (7 Days)||0||
48299162|NCT01372410|101060097|FG000|STARTED|Washout Period 2 (10-14 Days)||19||
48299163|NCT01372410|101060098|FG001|STARTED|Washout Period 2 (10-14 Days)||21||
48299164|NCT01372410|101060099|FG002|STARTED|Washout Period 2 (10-14 Days)||22||
48299165|NCT01372410|101060100|FG003|STARTED|Washout Period 2 (10-14 Days)||17||
48299166|NCT01372410|101060101|FG004|STARTED|Washout Period 2 (10-14 Days)||19||
48299167|NCT01372410|101060102|FG005|STARTED|Washout Period 2 (10-14 Days)||16||
48299168|NCT01372410|101060103|FG006|STARTED|Washout Period 2 (10-14 Days)||21||
48299169|NCT01372410|101060104|FG007|STARTED|Washout Period 2 (10-14 Days)||19||
48714297|NCT04493684|102088508|FG010|NOT COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48145672|NCT02308748|100679769|FG004|NOT COMPLETED|Period 1||0||
48299170|NCT01372410|101060097|FG000|COMPLETED|Washout Period 2 (10-14 Days)||19||
48299171|NCT01372410|101060098|FG001|COMPLETED|Washout Period 2 (10-14 Days)||21||
48299172|NCT01372410|101060099|FG002|COMPLETED|Washout Period 2 (10-14 Days)||22||
48299173|NCT01372410|101060100|FG003|COMPLETED|Washout Period 2 (10-14 Days)||17||
48714298|NCT04493684|102088509|FG011|NOT COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48714299|NCT04493684|102088510|FG012|NOT COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48714300|NCT04493684|102088511|FG013|NOT COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48714301|NCT04493684|102088512|FG014|NOT COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48601114|NCT01672294|101807615|FG000|STARTED|Overall Study||71||
48601115|NCT01672294|101807616|FG001|STARTED|Overall Study||71||
48601116|NCT01672294|101807617|FG002|STARTED|Overall Study||72||
48601117|NCT01672294|101807618|FG003|STARTED|Overall Study||72||
48601118|NCT01672294|101807615|FG000|COMPLETED|Overall Study||65||
48601119|NCT01672294|101807616|FG001|COMPLETED|Overall Study||50||
48601120|NCT01672294|101807617|FG002|COMPLETED|Overall Study||61||
48601121|NCT01672294|101807618|FG003|COMPLETED|Overall Study||59||
48299174|NCT01372410|101060101|FG004|COMPLETED|Washout Period 2 (10-14 Days)||17||
48299175|NCT01372410|101060102|FG005|COMPLETED|Washout Period 2 (10-14 Days)||16||
48299176|NCT01372410|101060103|FG006|COMPLETED|Washout Period 2 (10-14 Days)||20||
48299177|NCT01372410|101060104|FG007|COMPLETED|Washout Period 2 (10-14 Days)||17||
48299178|NCT01372410|101060097|FG000|NOT COMPLETED|Washout Period 2 (10-14 Days)||0||
48299179|NCT01372410|101060098|FG001|NOT COMPLETED|Washout Period 2 (10-14 Days)||0||
48299180|NCT01372410|101060099|FG002|NOT COMPLETED|Washout Period 2 (10-14 Days)||0||
48299181|NCT01372410|101060100|FG003|NOT COMPLETED|Washout Period 2 (10-14 Days)||0||
48299182|NCT01372410|101060101|FG004|NOT COMPLETED|Washout Period 2 (10-14 Days)||2||
48299183|NCT01372410|101060102|FG005|NOT COMPLETED|Washout Period 2 (10-14 Days)||0||
48299184|NCT01372410|101060103|FG006|NOT COMPLETED|Washout Period 2 (10-14 Days)||1||
48299185|NCT01372410|101060104|FG007|NOT COMPLETED|Washout Period 2 (10-14 Days)||2||
48601122|NCT01672294|101807615|FG000|NOT COMPLETED|Overall Study||6||
48601123|NCT01672294|101807616|FG001|NOT COMPLETED|Overall Study||21||
48601124|NCT01672294|101807617|FG002|NOT COMPLETED|Overall Study||11||
48601125|NCT01672294|101807618|FG003|NOT COMPLETED|Overall Study||13||
48601126|NCT02588664|101807619|FG000|STARTED|Overall Study||3193||
48601127|NCT02588664|101807620|FG001|STARTED|Overall Study||2689||
48601128|NCT02588664|101807619|FG000|COMPLETED|Overall Study||1832||
48601129|NCT02588664|101807620|FG001|COMPLETED|Overall Study||1644||
48601130|NCT02588664|101807619|FG000|NOT COMPLETED|Overall Study||1361||
48601131|NCT02588664|101807620|FG001|NOT COMPLETED|Overall Study||1045||
48601132|NCT05268016|101807621|FG000|STARTED|Overall Study||26||
48601133|NCT05268016|101807622|FG001|STARTED|Overall Study||26||
48601134|NCT05268016|101807623|FG002|STARTED|Overall Study||26||
48601135|NCT05268016|101807624|FG003|STARTED|Overall Study||27||
48601136|NCT05268016|101807625|FG004|STARTED|Overall Study||27||
48601137|NCT05268016|101807621|FG000|COMPLETED|Overall Study||17||
48601138|NCT05268016|101807622|FG001|COMPLETED|Overall Study||14||
48601139|NCT05268016|101807623|FG002|COMPLETED|Overall Study||18||
48601140|NCT05268016|101807624|FG003|COMPLETED|Overall Study||15||
48601141|NCT05268016|101807625|FG004|COMPLETED|Overall Study||16||
48601142|NCT05268016|101807621|FG000|NOT COMPLETED|Overall Study||9||
48601143|NCT05268016|101807622|FG001|NOT COMPLETED|Overall Study||12||
48601144|NCT05268016|101807623|FG002|NOT COMPLETED|Overall Study||8||
48601145|NCT05268016|101807624|FG003|NOT COMPLETED|Overall Study||12||
48601146|NCT05268016|101807625|FG004|NOT COMPLETED|Overall Study||11||
48601147|NCT01289574|101807626|FG000|STARTED|Overall Study||58||
48601148|NCT01289574|101807627|FG001|STARTED|Overall Study||60||
48601149|NCT01289574|101807628|FG002|STARTED|Overall Study||63||
48601150|NCT01289574|101807626|FG000|COMPLETED|Overall Study||51||
48601151|NCT01289574|101807627|FG001|COMPLETED|Overall Study||57||
48601152|NCT01289574|101807628|FG002|COMPLETED|Overall Study||60||
48601153|NCT01289574|101807626|FG000|NOT COMPLETED|Overall Study||7||
48601154|NCT01289574|101807627|FG001|NOT COMPLETED|Overall Study||3||
48601155|NCT01289574|101807628|FG002|NOT COMPLETED|Overall Study||3||
48601156|NCT03749109|101807629|FG000|STARTED|Overall Study||35||
48601157|NCT03749109|101807630|FG001|STARTED|Overall Study||32||
48601158|NCT03749109|101807629|FG000|COMPLETED|Overall Study||33||
48601159|NCT03749109|101807630|FG001|COMPLETED|Overall Study||32||
48299186|NCT01372410|101060097|FG000|STARTED|Treatment Period 3 (7 Days)||21||
48299187|NCT01372410|101060098|FG001|STARTED|Treatment Period 3 (7 Days)||18||
48299188|NCT01372410|101060099|FG002|STARTED|Treatment Period 3 (7 Days)||16||
48299189|NCT01372410|101060100|FG003|STARTED|Treatment Period 3 (7 Days)||22||
48299190|NCT01372410|101060101|FG004|STARTED|Treatment Period 3 (7 Days)||20||
48299191|NCT01372410|101060102|FG005|STARTED|Treatment Period 3 (7 Days)||19||
48299192|NCT01372410|101060103|FG006|STARTED|Treatment Period 3 (7 Days)||15||
48299193|NCT01372410|101060104|FG007|STARTED|Treatment Period 3 (7 Days)||18||
48299194|NCT01372410|101060097|FG000|COMPLETED|Treatment Period 3 (7 Days)||21||
48299195|NCT01372410|101060098|FG001|COMPLETED|Treatment Period 3 (7 Days)||18||
48299196|NCT01372410|101060099|FG002|COMPLETED|Treatment Period 3 (7 Days)||15||
48601160|NCT03749109|101807629|FG000|NOT COMPLETED|Overall Study||2||
48601161|NCT03749109|101807630|FG001|NOT COMPLETED|Overall Study||0||
48601162|NCT00525876|101807631|FG000|STARTED|Overall Study||16||
48601163|NCT00525876|101807632|FG001|STARTED|Overall Study||20||
48601164|NCT00525876|101807631|FG000|COMPLETED|Overall Study||16||
48601165|NCT00525876|101807632|FG001|COMPLETED|Overall Study||20||
48601166|NCT00525876|101807631|FG000|NOT COMPLETED|Overall Study||0||
48601167|NCT00525876|101807632|FG001|NOT COMPLETED|Overall Study||0||
48601168|NCT01870297|101807633|FG000|STARTED|Overall Study||11||
48601169|NCT01870297|101807634|FG001|STARTED|Overall Study||15||
48601170|NCT01870297|101807635|FG002|STARTED|Overall Study||8||
48601171|NCT01870297|101807636|FG003|STARTED|Overall Study||9||
48299197|NCT01372410|101060100|FG003|COMPLETED|Treatment Period 3 (7 Days)||22||
48714302|NCT04493684|102088513|FG015|NOT COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||1||
48714303|NCT04493684|102088514|FG016|NOT COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
48714304|NCT04493684|102088498|FG000|STARTED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714305|NCT04493684|102088499|FG001|STARTED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714306|NCT04493684|102088500|FG002|STARTED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714307|NCT04493684|102088501|FG003|STARTED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714308|NCT04493684|102088502|FG004|STARTED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714309|NCT04493684|102088503|FG005|STARTED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714310|NCT04493684|102088504|FG006|STARTED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714311|NCT04493684|102088505|FG007|STARTED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48601172|NCT01870297|101807637|FG004|STARTED|Overall Study||10||
48601173|NCT01870297|101807638|FG005|STARTED|Overall Study||9||
48601174|NCT01870297|101807639|FG006|STARTED|Overall Study||10||
48601175|NCT01870297|101807633|FG000|COMPLETED|Overall Study||11||
48601176|NCT01870297|101807634|FG001|COMPLETED|Overall Study||8||
48601177|NCT01870297|101807635|FG002|COMPLETED|Overall Study||7||
48601178|NCT01870297|101807636|FG003|COMPLETED|Overall Study||9||
48601179|NCT01870297|101807637|FG004|COMPLETED|Overall Study||7||
48601180|NCT01870297|101807638|FG005|COMPLETED|Overall Study||8||
48601181|NCT01870297|101807639|FG006|COMPLETED|Overall Study||8||
48601182|NCT01870297|101807633|FG000|NOT COMPLETED|Overall Study||0||
48601183|NCT01870297|101807634|FG001|NOT COMPLETED|Overall Study||7||
48601184|NCT01870297|101807635|FG002|NOT COMPLETED|Overall Study||1||
48601185|NCT01870297|101807636|FG003|NOT COMPLETED|Overall Study||0||
48601186|NCT01870297|101807637|FG004|NOT COMPLETED|Overall Study||3||
48601187|NCT01870297|101807638|FG005|NOT COMPLETED|Overall Study||1||
48601188|NCT01870297|101807639|FG006|NOT COMPLETED|Overall Study||2||
48601189|NCT02380859|101807640|FG000|STARTED|Overall Study||19||
48601190|NCT02380859|101807641|FG001|STARTED|Overall Study||13||
48601191|NCT02380859|101807640|FG000|COMPLETED|Overall Study||17||
48601192|NCT02380859|101807641|FG001|COMPLETED|Overall Study||13||
48601193|NCT02380859|101807640|FG000|NOT COMPLETED|Overall Study||2||
48601194|NCT02380859|101807641|FG001|NOT COMPLETED|Overall Study||0||
48299198|NCT01372410|101060101|FG004|COMPLETED|Treatment Period 3 (7 Days)||20||
48299199|NCT01372410|101060102|FG005|COMPLETED|Treatment Period 3 (7 Days)||18||
48299200|NCT01372410|101060103|FG006|COMPLETED|Treatment Period 3 (7 Days)||15||
48299201|NCT01372410|101060104|FG007|COMPLETED|Treatment Period 3 (7 Days)||18||
48299202|NCT01372410|101060097|FG000|NOT COMPLETED|Treatment Period 3 (7 Days)||0||
48299203|NCT01372410|101060098|FG001|NOT COMPLETED|Treatment Period 3 (7 Days)||0||
48601195|NCT05235971|101807642|FG000|STARTED|Overall Study||17||
48601196|NCT05235971|101807643|FG001|STARTED|Overall Study||21||
48601197|NCT05235971|101807644|FG002|STARTED|Overall Study||19||
48601198|NCT05235971|101807645|FG003|STARTED|Overall Study||18||
48601199|NCT05235971|101807642|FG000|COMPLETED|Overall Study||17||
48601200|NCT05235971|101807643|FG001|COMPLETED|Overall Study||21||
48601201|NCT05235971|101807644|FG002|COMPLETED|Overall Study||19||
48601202|NCT05235971|101807645|FG003|COMPLETED|Overall Study||18||
48601203|NCT05235971|101807642|FG000|NOT COMPLETED|Overall Study||0||
48601204|NCT05235971|101807643|FG001|NOT COMPLETED|Overall Study||0||
48601205|NCT05235971|101807644|FG002|NOT COMPLETED|Overall Study||0||
48601206|NCT05235971|101807645|FG003|NOT COMPLETED|Overall Study||0||
48601207|NCT02452554|101807646|FG000|STARTED|Overall Study||17||
48601208|NCT02452554|101807647|FG001|STARTED|Overall Study||17||
48601209|NCT02452554|101807648|FG002|STARTED|Overall Study||12||
48601210|NCT02452554|101807649|FG003|STARTED|Overall Study||1||
48601211|NCT02452554|101807650|FG004|STARTED|Overall Study||5||
48601212|NCT02452554|101807651|FG005|STARTED|Overall Study||10||
48601213|NCT02452554|101807646|FG000|COMPLETED|Overall Study||0||
48601214|NCT02452554|101807647|FG001|COMPLETED|Overall Study||0||
48601215|NCT02452554|101807648|FG002|COMPLETED|Overall Study||1||
48601216|NCT02452554|101807649|FG003|COMPLETED|Overall Study||0||
48601217|NCT02452554|101807650|FG004|COMPLETED|Overall Study||0||
48601218|NCT02452554|101807651|FG005|COMPLETED|Overall Study||1||
48601219|NCT02452554|101807646|FG000|NOT COMPLETED|Overall Study||17||
48601220|NCT02452554|101807647|FG001|NOT COMPLETED|Overall Study||17||
48601221|NCT02452554|101807648|FG002|NOT COMPLETED|Overall Study||11||
48601222|NCT02452554|101807649|FG003|NOT COMPLETED|Overall Study||1||
48601223|NCT02452554|101807650|FG004|NOT COMPLETED|Overall Study||5||
48601224|NCT02452554|101807651|FG005|NOT COMPLETED|Overall Study||9||
48601225|NCT04103515|101807652|FG000|STARTED|Overall Study||25||
48601226|NCT04103515|101807653|FG001|STARTED|Overall Study||25||
48299204|NCT01372410|101060099|FG002|NOT COMPLETED|Treatment Period 3 (7 Days)||1||
48367990|NCT00717418|101230091|FG003|COMPLETED|Baseline||4||
48601227|NCT04103515|101807652|FG000|COMPLETED|Overall Study||25||
48601228|NCT04103515|101807653|FG001|COMPLETED|Overall Study||25||
48601229|NCT04103515|101807652|FG000|NOT COMPLETED|Overall Study||0||
48601230|NCT04103515|101807653|FG001|NOT COMPLETED|Overall Study||0||
48601231|NCT02327013|101807654|FG000|STARTED|Overall Study||49||
48601232|NCT02327013|101807655|FG001|STARTED|Overall Study||45||
48601233|NCT02327013|101807656|FG002|STARTED|Overall Study||96||
48601234|NCT02327013|101807657|FG003|STARTED|Overall Study||21||
48601235|NCT02327013|101807658|FG004|STARTED|Overall Study||16||
48601236|NCT02327013|101807654|FG000|COMPLETED|Overall Study||36||
48601237|NCT02327013|101807655|FG001|COMPLETED|Overall Study||29||
48601238|NCT02327013|101807656|FG002|COMPLETED|Overall Study||54||
48601239|NCT02327013|101807657|FG003|COMPLETED|Overall Study||20||
48601240|NCT02327013|101807658|FG004|COMPLETED|Overall Study||12||
48601241|NCT02327013|101807654|FG000|NOT COMPLETED|Overall Study||13||
48601242|NCT02327013|101807655|FG001|NOT COMPLETED|Overall Study||16||
48601243|NCT02327013|101807656|FG002|NOT COMPLETED|Overall Study||42||
48601244|NCT02327013|101807657|FG003|NOT COMPLETED|Overall Study||1||
48601245|NCT02327013|101807658|FG004|NOT COMPLETED|Overall Study||4||
48601246|NCT00926536|101807659|FG000|STARTED|Overall Study||44||
48601247|NCT00926536|101807660|FG001|STARTED|Overall Study||43||
48601248|NCT00926536|101807659|FG000|COMPLETED|Overall Study||43||
48601249|NCT00926536|101807660|FG001|COMPLETED|Overall Study||41||
48601250|NCT00926536|101807659|FG000|NOT COMPLETED|Overall Study||1||
48601251|NCT00926536|101807660|FG001|NOT COMPLETED|Overall Study||2||
48601252|NCT04126317|101807661|FG000|STARTED|Overall Study||53||
48601253|NCT04126317|101807662|FG001|STARTED|Overall Study||53||
48601254|NCT04126317|101807661|FG000|COMPLETED|Overall Study||49||
48601255|NCT04126317|101807662|FG001|COMPLETED|Overall Study||51||
48601256|NCT04126317|101807661|FG000|NOT COMPLETED|Overall Study||4||
48601257|NCT04126317|101807662|FG001|NOT COMPLETED|Overall Study||2||
48601258|NCT01133288|101807663|FG000|STARTED|Eligibility Assessment||7||
48601259|NCT01133288|101807663|FG000|COMPLETED|Eligibility Assessment||2||
48601260|NCT01133288|101807663|FG000|NOT COMPLETED|Eligibility Assessment||5||
48601261|NCT01133288|101807663|FG000|STARTED|Intervention Allocation||2||
48601262|NCT01133288|101807663|FG000|COMPLETED|Intervention Allocation||0||
48601263|NCT01133288|101807663|FG000|NOT COMPLETED|Intervention Allocation||2||
48601264|NCT02005627|101807664|FG000|STARTED|Overall Study||23||
48601265|NCT02005627|101807665|FG001|STARTED|Overall Study||23||
48601266|NCT02005627|101807664|FG000|COMPLETED|Overall Study||21||
48601267|NCT02005627|101807665|FG001|COMPLETED|Overall Study||19||
48601268|NCT02005627|101807664|FG000|NOT COMPLETED|Overall Study||2||
48601269|NCT02005627|101807665|FG001|NOT COMPLETED|Overall Study||4||
48601270|NCT00360009|101807666|FG000|STARTED|Overall Study||10||
48601271|NCT00360009|101807667|FG001|STARTED|Overall Study||26||
48601272|NCT00360009|101807668|FG002|STARTED|Overall Study||26||
48601273|NCT00360009|101807666|FG000|COMPLETED|Overall Study||10||
48601274|NCT00360009|101807667|FG001|COMPLETED|Overall Study||22||
48601275|NCT00360009|101807668|FG002|COMPLETED|Overall Study||23||
48601276|NCT00360009|101807666|FG000|NOT COMPLETED|Overall Study||0||
48601277|NCT00360009|101807667|FG001|NOT COMPLETED|Overall Study||4||
48601278|NCT00360009|101807668|FG002|NOT COMPLETED|Overall Study||3||
48601279|NCT00594386|101807669|FG000|STARTED|Overall Study||258||
48601280|NCT00594386|101807669|FG000|COMPLETED|Overall Study||0||
48601281|NCT00594386|101807669|FG000|NOT COMPLETED|Overall Study||258||
48601282|NCT02070978|101807670|FG000|STARTED|Overall Study||83||
48601283|NCT02070978|101807671|FG001|STARTED|Overall Study||82||
48601284|NCT02070978|101807672|FG002|STARTED|Overall Study||88||
48601285|NCT02070978|101807670|FG000|COMPLETED|Overall Study||36||
48601286|NCT02070978|101807671|FG001|COMPLETED|Overall Study||29||
48601287|NCT02070978|101807672|FG002|COMPLETED|Overall Study||35||
48601288|NCT02070978|101807670|FG000|NOT COMPLETED|Overall Study||47||
48601289|NCT02070978|101807671|FG001|NOT COMPLETED|Overall Study||53||
48601290|NCT02070978|101807672|FG002|NOT COMPLETED|Overall Study||53||
48601291|NCT02907619|101807673|FG000|STARTED|Overall Study||19||
48601292|NCT02907619|101807674|FG001|STARTED|Overall Study||20||
48601293|NCT02907619|101807675|FG002|STARTED|Overall Study||20||
48601294|NCT02907619|101807673|FG000|Received Treatment|Overall Study||19||
48601295|NCT02907619|101807674|FG001|Received Treatment|Overall Study||20||
48601296|NCT02907619|101807675|FG002|Received Treatment|Overall Study||20||
48601297|NCT02907619|101807673|FG000|COMPLETED|Overall Study||0||
48601298|NCT02907619|101807674|FG001|COMPLETED|Overall Study||0||
48601299|NCT02907619|101807675|FG002|COMPLETED|Overall Study||0||
48601300|NCT02907619|101807673|FG000|NOT COMPLETED|Overall Study||19||
48601301|NCT02907619|101807674|FG001|NOT COMPLETED|Overall Study||20||
48601302|NCT02907619|101807675|FG002|NOT COMPLETED|Overall Study||20||
48601303|NCT00392496|101807676|FG000|STARTED|Overall Study||19||
48601304|NCT00392496|101807676|FG000|COMPLETED|Overall Study||19||
48601305|NCT00392496|101807676|FG000|NOT COMPLETED|Overall Study||0||
48601306|NCT01832818|101807677|FG000|STARTED|Overall Study||14||
48601307|NCT01832818|101807677|FG000|COMPLETED|Overall Study||8||
48601308|NCT01832818|101807677|FG000|NOT COMPLETED|Overall Study||6||
48601309|NCT01438814|101807678|FG000|STARTED|Overall Study||344||
48601310|NCT01438814|101807679|FG001|STARTED|Overall Study||345||
48601311|NCT01438814|101807678|FG000|COMPLETED|Overall Study||330||
48601312|NCT01438814|101807679|FG001|COMPLETED|Overall Study||331||
48601313|NCT01438814|101807678|FG000|NOT COMPLETED|Overall Study||14||
48601314|NCT01438814|101807679|FG001|NOT COMPLETED|Overall Study||14||
48601315|NCT00396877|101807680|FG000|STARTED|Overall Study||439||
48601316|NCT00396877|101807681|FG001|STARTED|Overall Study||467||
48601317|NCT00396877|101807680|FG000|Treated|Overall Study||436||
48601318|NCT00396877|101807681|FG001|Treated|Overall Study||464||
48601319|NCT00396877|101807680|FG000|Completed Treatment|Overall Study||356||
48601320|NCT00396877|101807681|FG001|Completed Treatment|Overall Study||352||
48601321|NCT00396877|101807680|FG000|COMPLETED|Overall Study||433||
48601322|NCT00396877|101807681|FG001|COMPLETED|Overall Study||459||
48601323|NCT00396877|101807680|FG000|NOT COMPLETED|Overall Study||6||
48601324|NCT00396877|101807681|FG001|NOT COMPLETED|Overall Study||8||
48601325|NCT01636947|101807682|FG000|STARTED|Overall Study||244||
48601326|NCT01636947|101807683|FG001|STARTED|Overall Study||250||
48601327|NCT01636947|101807682|FG000|Treated|Overall Study||242||
48601328|NCT01636947|101807683|FG001|Treated|Overall Study||248||
48601329|NCT01636947|101807682|FG000|COMPLETED|Overall Study||232||
48601330|NCT01636947|101807683|FG001|COMPLETED|Overall Study||239||
48601331|NCT01636947|101807682|FG000|NOT COMPLETED|Overall Study||12||
48601332|NCT01636947|101807683|FG001|NOT COMPLETED|Overall Study||11||
48601333|NCT01985958|101807684|FG000|STARTED|Overall Study||4||
48601334|NCT01985958|101807684|FG000|COMPLETED|Overall Study||3||
48601335|NCT01985958|101807684|FG000|NOT COMPLETED|Overall Study||1||
48601336|NCT00957424|101807685|FG000|STARTED|Overall Study||67||
48601337|NCT00957424|101807685|FG000|Follow-up #1|Overall Study||59||
48601338|NCT00957424|101807685|FG000|Follow-up #2|Overall Study||50||
48601339|NCT00957424|101807685|FG000|COMPLETED|Overall Study||44||
48601340|NCT00957424|101807685|FG000|NOT COMPLETED|Overall Study||23||
48601341|NCT03035916|101807686|FG000|STARTED|Overall Study||30||
48601342|NCT03035916|101807687|FG001|STARTED|Overall Study||30||
48601343|NCT03035916|101807688|FG002|STARTED|Overall Study||31||
48601344|NCT03035916|101807686|FG000|COMPLETED|Overall Study||30||
48601345|NCT03035916|101807687|FG001|COMPLETED|Overall Study||28||
48601346|NCT03035916|101807688|FG002|COMPLETED|Overall Study||31||
48601347|NCT03035916|101807686|FG000|NOT COMPLETED|Overall Study||0||
48601348|NCT03035916|101807687|FG001|NOT COMPLETED|Overall Study||2||
48601349|NCT03035916|101807688|FG002|NOT COMPLETED|Overall Study||0||
48601350|NCT02053259|101807689|FG000|STARTED|Overall Study||25||
48601351|NCT02053259|101807690|FG001|STARTED|Overall Study||24||
48601352|NCT02053259|101807691|FG002|STARTED|Overall Study||24||
48299205|NCT01372410|101060100|FG003|NOT COMPLETED|Treatment Period 3 (7 Days)||0||
48299206|NCT01372410|101060101|FG004|NOT COMPLETED|Treatment Period 3 (7 Days)||0||
48299207|NCT01372410|101060102|FG005|NOT COMPLETED|Treatment Period 3 (7 Days)||1||
48299208|NCT01372410|101060103|FG006|NOT COMPLETED|Treatment Period 3 (7 Days)||0||
48299209|NCT01372410|101060104|FG007|NOT COMPLETED|Treatment Period 3 (7 Days)||0||
48299210|NCT00633061|101060105|FG000|STARTED|Overall Study||136||
48299211|NCT00633061|101060106|FG001|STARTED|Overall Study||0||
48299212|NCT00633061|101060105|FG000|Met Criteria for Imaging|Overall Study||25||
48299213|NCT00633061|101060106|FG001|Met Criteria for Imaging|Overall Study||0||
48299214|NCT00633061|101060105|FG000|Had Prior Thrombosis Identified|Overall Study||25||
48299215|NCT00633061|101060106|FG001|Had Prior Thrombosis Identified|Overall Study||0||
48299216|NCT00633061|101060105|FG000|COMPLETED|Overall Study||50||
48299217|NCT00633061|101060106|FG001|COMPLETED|Overall Study||0||
48299218|NCT00633061|101060105|FG000|NOT COMPLETED|Overall Study||86||
48299219|NCT00633061|101060106|FG001|NOT COMPLETED|Overall Study||0||
48299220|NCT00323297|101060107|FG000|STARTED|Part A (Double Blind Randomized)||53||
48299221|NCT00323297|101060108|FG001|STARTED|Part A (Double Blind Randomized)||50||
48299222|NCT00323297|101060107|FG000|COMPLETED|Part A (Double Blind Randomized)||48||
48299223|NCT00323297|101060108|FG001|COMPLETED|Part A (Double Blind Randomized)||43||
48299224|NCT00323297|101060107|FG000|NOT COMPLETED|Part A (Double Blind Randomized)||5||
48299225|NCT00323297|101060108|FG001|NOT COMPLETED|Part A (Double Blind Randomized)||7||
48299226|NCT00323297|101060107|FG000|STARTED|Part B (Open-label)||48||
48299227|NCT00323297|101060108|FG001|STARTED|Part B (Open-label)||43||
48299228|NCT00323297|101060107|FG000|COMPLETED|Part B (Open-label)||39||
48299229|NCT00323297|101060108|FG001|COMPLETED|Part B (Open-label)||31||
48299230|NCT00323297|101060107|FG000|NOT COMPLETED|Part B (Open-label)||9||
48299231|NCT00323297|101060108|FG001|NOT COMPLETED|Part B (Open-label)||12||
48299232|NCT01128894|101060109|FG000|STARTED|Overall Study||404||
48299233|NCT01128894|101060110|FG001|STARTED|Overall Study||408||
48299234|NCT01128894|101060109|FG000|COMPLETED|Overall Study||346||
48299235|NCT01128894|101060110|FG001|COMPLETED|Overall Study||340||
48299236|NCT01128894|101060109|FG000|NOT COMPLETED|Overall Study||58||
48299237|NCT01128894|101060110|FG001|NOT COMPLETED|Overall Study||68||
48299238|NCT00288509|101060111|FG000|STARTED|Treatment Cycle 1||108||
48299239|NCT00288509|101060111|FG000|COMPLETED|Treatment Cycle 1||102||
48299240|NCT00288509|101060111|FG000|NOT COMPLETED|Treatment Cycle 1||6||
48299241|NCT00288509|101060111|FG000|STARTED|Treatment Cycle 2||100||
48299242|NCT00288509|101060111|FG000|COMPLETED|Treatment Cycle 2||97||
48299243|NCT00288509|101060111|FG000|NOT COMPLETED|Treatment Cycle 2||3||
48601353|NCT02053259|101807692|FG003|STARTED|Overall Study||23||
48601354|NCT02053259|101807689|FG000|COMPLETED|Overall Study||25||
48601355|NCT02053259|101807690|FG001|COMPLETED|Overall Study||24||
48601356|NCT02053259|101807691|FG002|COMPLETED|Overall Study||24||
48601357|NCT02053259|101807692|FG003|COMPLETED|Overall Study||23||
48601358|NCT02053259|101807689|FG000|NOT COMPLETED|Overall Study||0||
48601359|NCT02053259|101807690|FG001|NOT COMPLETED|Overall Study||0||
48601360|NCT02053259|101807691|FG002|NOT COMPLETED|Overall Study||0||
48601361|NCT02053259|101807692|FG003|NOT COMPLETED|Overall Study||0||
48601362|NCT04093492|101807693|FG000|STARTED|25 Weeks Gestational Age (GA)||60||
48714312|NCT04493684|102088506|FG008|STARTED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48299244|NCT00288509|101060111|FG000|STARTED|Treatment Cycle 3||96||
48299245|NCT00288509|101060111|FG000|COMPLETED|Treatment Cycle 3||91||
48299246|NCT00288509|101060111|FG000|NOT COMPLETED|Treatment Cycle 3||5||
48299247|NCT00288509|101060111|FG000|STARTED|Treatment Cycle 4||88||
48299248|NCT00288509|101060111|FG000|COMPLETED|Treatment Cycle 4||80||
48601363|NCT04093492|101807694|FG001|STARTED|25 Weeks Gestational Age (GA)||60||
48601364|NCT04093492|101807695|FG002|STARTED|25 Weeks Gestational Age (GA)||34||
48601365|NCT04093492|101807696|FG003|STARTED|25 Weeks Gestational Age (GA)||21||
48601366|NCT04093492|101807693|FG000|COMPLETED|25 Weeks Gestational Age (GA)||54||
48601367|NCT04093492|101807694|FG001|COMPLETED|25 Weeks Gestational Age (GA)||53||
48601368|NCT04093492|101807695|FG002|COMPLETED|25 Weeks Gestational Age (GA)||29||
48601369|NCT04093492|101807696|FG003|COMPLETED|25 Weeks Gestational Age (GA)||18||
48601370|NCT04093492|101807693|FG000|NOT COMPLETED|25 Weeks Gestational Age (GA)||6||
48601371|NCT04093492|101807694|FG001|NOT COMPLETED|25 Weeks Gestational Age (GA)||7||
48601372|NCT04093492|101807695|FG002|NOT COMPLETED|25 Weeks Gestational Age (GA)||5||
48601373|NCT04093492|101807696|FG003|NOT COMPLETED|25 Weeks Gestational Age (GA)||3||
48145673|NCT02308748|100679770|FG005|NOT COMPLETED|Period 1||0||
48145674|NCT02308748|100679771|FG006|NOT COMPLETED|Period 1||0||
48145675|NCT02308748|100679772|FG007|NOT COMPLETED|Period 1||0||
48145676|NCT02308748|100679773|FG008|NOT COMPLETED|Period 1||0||
48145677|NCT02308748|100679774|FG009|NOT COMPLETED|Period 1||0||
48145678|NCT02308748|100679765|FG000|STARTED|Period 2||2||
48145679|NCT02308748|100679766|FG001|STARTED|Period 2||2||
48145680|NCT02308748|100679767|FG002|STARTED|Period 2||1||
48145681|NCT02308748|100679768|FG003|STARTED|Period 2||2||
48145682|NCT02308748|100679769|FG004|STARTED|Period 2||2||
48145683|NCT02308748|100679770|FG005|STARTED|Period 2||3||
48145684|NCT02308748|100679771|FG006|STARTED|Period 2||2||
48145685|NCT02308748|100679772|FG007|STARTED|Period 2||2||
48145686|NCT02308748|100679773|FG008|STARTED|Period 2||2||
48145687|NCT02308748|100679774|FG009|STARTED|Period 2||3||
48145688|NCT02308748|100679765|FG000|COMPLETED|Period 2||2||
48145689|NCT02308748|100679766|FG001|COMPLETED|Period 2||2||
48145690|NCT02308748|100679767|FG002|COMPLETED|Period 2||1||
48145691|NCT02308748|100679768|FG003|COMPLETED|Period 2||2||
48145692|NCT02308748|100679769|FG004|COMPLETED|Period 2||2||
48145693|NCT02308748|100679770|FG005|COMPLETED|Period 2||3||
48145694|NCT02308748|100679771|FG006|COMPLETED|Period 2||2||
48145695|NCT02308748|100679772|FG007|COMPLETED|Period 2||1||
48145696|NCT02308748|100679773|FG008|COMPLETED|Period 2||2||
48145697|NCT02308748|100679774|FG009|COMPLETED|Period 2||3||
48145698|NCT02308748|100679765|FG000|NOT COMPLETED|Period 2||0||
48145699|NCT02308748|100679766|FG001|NOT COMPLETED|Period 2||0||
48145700|NCT02308748|100679767|FG002|NOT COMPLETED|Period 2||0||
48145701|NCT02308748|100679768|FG003|NOT COMPLETED|Period 2||0||
48145702|NCT02308748|100679769|FG004|NOT COMPLETED|Period 2||0||
48145703|NCT02308748|100679770|FG005|NOT COMPLETED|Period 2||0||
48145704|NCT02308748|100679771|FG006|NOT COMPLETED|Period 2||0||
48145705|NCT02308748|100679772|FG007|NOT COMPLETED|Period 2||1||
48145706|NCT02308748|100679773|FG008|NOT COMPLETED|Period 2||0||
48145707|NCT02308748|100679774|FG009|NOT COMPLETED|Period 2||0||
48145708|NCT02308748|100679765|FG000|STARTED|Period 3||2||
48145709|NCT02308748|100679766|FG001|STARTED|Period 3||2||
48145710|NCT02308748|100679767|FG002|STARTED|Period 3||1||
48145711|NCT02308748|100679768|FG003|STARTED|Period 3||2||
48145712|NCT02308748|100679769|FG004|STARTED|Period 3||2||
48145713|NCT02308748|100679770|FG005|STARTED|Period 3||3||
48601374|NCT04093492|101807693|FG000|STARTED|30 Weeks GA||60||
48601375|NCT04093492|101807694|FG001|STARTED|30 Weeks GA||60||
48601376|NCT04093492|101807695|FG002|STARTED|30 Weeks GA||34||
48601377|NCT04093492|101807696|FG003|STARTED|30 Weeks GA||20||
48714313|NCT04493684|102088507|FG009|STARTED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714314|NCT04493684|102088508|FG010|STARTED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48145714|NCT02308748|100679771|FG006|STARTED|Period 3||2||
48145715|NCT02308748|100679772|FG007|STARTED|Period 3||1||
48145716|NCT02308748|100679773|FG008|STARTED|Period 3||2||
48145717|NCT02308748|100679774|FG009|STARTED|Period 3||3||
48145718|NCT02308748|100679765|FG000|COMPLETED|Period 3||2||
48145719|NCT02308748|100679766|FG001|COMPLETED|Period 3||2||
48145720|NCT02308748|100679767|FG002|COMPLETED|Period 3||1||
48145721|NCT02308748|100679768|FG003|COMPLETED|Period 3||2||
48145722|NCT02308748|100679769|FG004|COMPLETED|Period 3||2||
48145723|NCT02308748|100679770|FG005|COMPLETED|Period 3||3||
48601378|NCT04093492|101807693|FG000|COMPLETED|30 Weeks GA||52||
48601379|NCT04093492|101807694|FG001|COMPLETED|30 Weeks GA||52||
48145724|NCT02308748|100679771|FG006|COMPLETED|Period 3||2||
48145725|NCT02308748|100679772|FG007|COMPLETED|Period 3||1||
48145726|NCT02308748|100679773|FG008|COMPLETED|Period 3||2||
48145727|NCT02308748|100679774|FG009|COMPLETED|Period 3||2||
48145728|NCT02308748|100679765|FG000|NOT COMPLETED|Period 3||0||
48145729|NCT02308748|100679766|FG001|NOT COMPLETED|Period 3||0||
48145730|NCT02308748|100679767|FG002|NOT COMPLETED|Period 3||0||
48145731|NCT02308748|100679768|FG003|NOT COMPLETED|Period 3||0||
48145732|NCT02308748|100679769|FG004|NOT COMPLETED|Period 3||0||
48145733|NCT02308748|100679770|FG005|NOT COMPLETED|Period 3||0||
48145734|NCT02308748|100679771|FG006|NOT COMPLETED|Period 3||0||
48145735|NCT02308748|100679772|FG007|NOT COMPLETED|Period 3||0||
48145736|NCT02308748|100679773|FG008|NOT COMPLETED|Period 3||0||
48145737|NCT02308748|100679774|FG009|NOT COMPLETED|Period 3||1||
48145738|NCT02308748|100679765|FG000|STARTED|Period 4||2||
48145739|NCT02308748|100679766|FG001|STARTED|Period 4||2||
48145740|NCT02308748|100679767|FG002|STARTED|Period 4||1||
48145741|NCT02308748|100679768|FG003|STARTED|Period 4||2||
48145742|NCT02308748|100679769|FG004|STARTED|Period 4||2||
48145743|NCT02308748|100679770|FG005|STARTED|Period 4||3||
48145744|NCT02308748|100679771|FG006|STARTED|Period 4||2||
48145745|NCT02308748|100679772|FG007|STARTED|Period 4||1||
48145746|NCT02308748|100679773|FG008|STARTED|Period 4||2||
48145747|NCT02308748|100679774|FG009|STARTED|Period 4||2||
48145748|NCT02308748|100679765|FG000|COMPLETED|Period 4||2||
48601380|NCT04093492|101807695|FG002|COMPLETED|30 Weeks GA||29||
48145749|NCT02308748|100679766|FG001|COMPLETED|Period 4||2||
48145750|NCT02308748|100679767|FG002|COMPLETED|Period 4||1||
48145751|NCT02308748|100679768|FG003|COMPLETED|Period 4||2||
48145752|NCT02308748|100679769|FG004|COMPLETED|Period 4||2||
48145753|NCT02308748|100679770|FG005|COMPLETED|Period 4||3||
48145754|NCT02308748|100679771|FG006|COMPLETED|Period 4||2||
48145755|NCT02308748|100679772|FG007|COMPLETED|Period 4||1||
48145756|NCT02308748|100679773|FG008|COMPLETED|Period 4||2||
48145757|NCT02308748|100679774|FG009|COMPLETED|Period 4||2||
48145758|NCT02308748|100679765|FG000|NOT COMPLETED|Period 4||0||
48145759|NCT02308748|100679766|FG001|NOT COMPLETED|Period 4||0||
48145760|NCT02308748|100679767|FG002|NOT COMPLETED|Period 4||0||
48145761|NCT02308748|100679768|FG003|NOT COMPLETED|Period 4||0||
48145762|NCT02308748|100679769|FG004|NOT COMPLETED|Period 4||0||
48145763|NCT02308748|100679770|FG005|NOT COMPLETED|Period 4||0||
48145764|NCT02308748|100679771|FG006|NOT COMPLETED|Period 4||0||
48145765|NCT02308748|100679772|FG007|NOT COMPLETED|Period 4||0||
48145766|NCT02308748|100679773|FG008|NOT COMPLETED|Period 4||0||
48145767|NCT02308748|100679774|FG009|NOT COMPLETED|Period 4||0||
48145768|NCT02308748|100679765|FG000|STARTED|Period 5||2||
48145769|NCT02308748|100679766|FG001|STARTED|Period 5||2||
48145770|NCT02308748|100679767|FG002|STARTED|Period 5||1||
48601381|NCT04093492|101807696|FG003|COMPLETED|30 Weeks GA||18||
48601382|NCT04093492|101807693|FG000|NOT COMPLETED|30 Weeks GA||8||
48601383|NCT04093492|101807694|FG001|NOT COMPLETED|30 Weeks GA||8||
48601384|NCT04093492|101807695|FG002|NOT COMPLETED|30 Weeks GA||5||
48601385|NCT04093492|101807696|FG003|NOT COMPLETED|30 Weeks GA||2||
48601386|NCT04093492|101807693|FG000|STARTED|34 Weeks GA||60||
48601387|NCT04093492|101807694|FG001|STARTED|34 Weeks GA||60||
48601388|NCT04093492|101807695|FG002|STARTED|34 Weeks GA||34||
48601389|NCT04093492|101807696|FG003|STARTED|34 Weeks GA||20||
48601390|NCT04093492|101807693|FG000|COMPLETED|34 Weeks GA||54||
48601391|NCT04093492|101807694|FG001|COMPLETED|34 Weeks GA||49||
48601392|NCT04093492|101807695|FG002|COMPLETED|34 Weeks GA||29||
48601393|NCT04093492|101807696|FG003|COMPLETED|34 Weeks GA||17||
48601394|NCT04093492|101807693|FG000|NOT COMPLETED|34 Weeks GA||6||
48714315|NCT04493684|102088509|FG011|STARTED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714316|NCT04493684|102088510|FG012|STARTED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714317|NCT04493684|102088511|FG013|STARTED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714318|NCT04493684|102088512|FG014|STARTED|Part 3:Treatment Period 2-Up to 4 Weeks||5||
48714319|NCT04493684|102088513|FG015|STARTED|Part 3:Treatment Period 2-Up to 4 Weeks||5||
48714320|NCT04493684|102088514|FG016|STARTED|Part 3:Treatment Period 2-Up to 4 Weeks||6||
48714321|NCT04493684|102088498|FG000|COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714322|NCT04493684|102088499|FG001|COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714323|NCT04493684|102088500|FG002|COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48145771|NCT02308748|100679768|FG003|STARTED|Period 5||2||
48145772|NCT02308748|100679769|FG004|STARTED|Period 5||2||
48145773|NCT02308748|100679770|FG005|STARTED|Period 5||3||
48601395|NCT04093492|101807694|FG001|NOT COMPLETED|34 Weeks GA||11||
48601396|NCT04093492|101807695|FG002|NOT COMPLETED|34 Weeks GA||5||
48601397|NCT04093492|101807696|FG003|NOT COMPLETED|34 Weeks GA||3||
48601398|NCT00553358|101807697|FG000|STARTED|Overall Study||152||
48601399|NCT00553358|101807698|FG001|STARTED|Overall Study||154||
48601400|NCT00553358|101807699|FG002|STARTED|Overall Study||149||
48714324|NCT04493684|102088501|FG003|COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714325|NCT04493684|102088502|FG004|COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714326|NCT04493684|102088503|FG005|COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714327|NCT04493684|102088504|FG006|COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714328|NCT04493684|102088505|FG007|COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714329|NCT04493684|102088506|FG008|COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714330|NCT04493684|102088507|FG009|COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714331|NCT04493684|102088508|FG010|COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48767580|NCT01435382|102222774|FG003|STARTED|Overall Study||11||
48145774|NCT02308748|100679771|FG006|STARTED|Period 5||2||
48145775|NCT02308748|100679772|FG007|STARTED|Period 5||1||
48145776|NCT02308748|100679773|FG008|STARTED|Period 5||2||
48145777|NCT02308748|100679774|FG009|STARTED|Period 5||2||
48145778|NCT02308748|100679765|FG000|COMPLETED|Period 5||1||
48145779|NCT02308748|100679766|FG001|COMPLETED|Period 5||2||
48145780|NCT02308748|100679767|FG002|COMPLETED|Period 5||1||
48145781|NCT02308748|100679768|FG003|COMPLETED|Period 5||2||
48145782|NCT02308748|100679769|FG004|COMPLETED|Period 5||2||
48145783|NCT02308748|100679770|FG005|COMPLETED|Period 5||3||
48145784|NCT02308748|100679771|FG006|COMPLETED|Period 5||2||
48601401|NCT00553358|101807697|FG000|COMPLETED|Overall Study||73|Completed follow-up per protocol event free. Includes subjects who had a follow-up visit or phone call ≥ 9 years + 6 months after randomization and had no EFS events|
48601402|NCT00553358|101807698|FG001|COMPLETED|Overall Study||58|Completed follow-up per protocol event free. Includes subjects who had a follow-up visit or phone call ≥ 9 years + 6 months after randomization and had no EFS events|
48145785|NCT02308748|100679772|FG007|COMPLETED|Period 5||1||
48145786|NCT02308748|100679773|FG008|COMPLETED|Period 5||1||
48145787|NCT02308748|100679774|FG009|COMPLETED|Period 5||2||
48145788|NCT02308748|100679765|FG000|NOT COMPLETED|Period 5||1||
48145789|NCT02308748|100679766|FG001|NOT COMPLETED|Period 5||0||
48145790|NCT02308748|100679767|FG002|NOT COMPLETED|Period 5||0||
48145791|NCT02308748|100679768|FG003|NOT COMPLETED|Period 5||0||
48145792|NCT02308748|100679769|FG004|NOT COMPLETED|Period 5||0||
48145793|NCT02308748|100679770|FG005|NOT COMPLETED|Period 5||0||
48145794|NCT02308748|100679771|FG006|NOT COMPLETED|Period 5||0||
48145795|NCT02308748|100679772|FG007|NOT COMPLETED|Period 5||0||
48145796|NCT02308748|100679773|FG008|NOT COMPLETED|Period 5||1||
48145797|NCT02308748|100679774|FG009|NOT COMPLETED|Period 5||0||
48145798|NCT02975973|100679775|FG000|STARTED|Overall Study||1||
48145799|NCT02975973|100679776|FG001|STARTED|Overall Study||2||
48145800|NCT02975973|100679777|FG002|STARTED|Overall Study||1||
48145801|NCT02975973|100679778|FG003|STARTED|Overall Study||4||
48145802|NCT02975973|100679775|FG000|COMPLETED|Overall Study||0||
48145803|NCT02975973|100679776|FG001|COMPLETED|Overall Study||1||
48145804|NCT02975973|100679777|FG002|COMPLETED|Overall Study||0||
48145805|NCT02975973|100679778|FG003|COMPLETED|Overall Study||4||
48299249|NCT00288509|101060111|FG000|NOT COMPLETED|Treatment Cycle 4||8||
48299250|NCT01170546|101060112|FG000|STARTED|Overall Study||7||
48299251|NCT01170546|101060113|FG001|STARTED|Overall Study||7||
48299252|NCT01170546|101060114|FG002|STARTED|Overall Study||6||
48299253|NCT01170546|101060115|FG003|STARTED|Overall Study||8||
48299254|NCT01170546|101060112|FG000|COMPLETED|Overall Study||7||
48299255|NCT01170546|101060113|FG001|COMPLETED|Overall Study||7||
48299256|NCT01170546|101060114|FG002|COMPLETED|Overall Study||6||
48299257|NCT01170546|101060115|FG003|COMPLETED|Overall Study||8||
48299258|NCT01170546|101060112|FG000|NOT COMPLETED|Overall Study||0||
48299259|NCT01170546|101060113|FG001|NOT COMPLETED|Overall Study||0||
48299260|NCT01170546|101060114|FG002|NOT COMPLETED|Overall Study||0||
48299261|NCT01170546|101060115|FG003|NOT COMPLETED|Overall Study||0||
48299262|NCT00147823|101060116|FG000|STARTED|Overall Study||32||
48299263|NCT00147823|101060117|FG001|STARTED|Overall Study||31||
48299264|NCT00147823|101060116|FG000|Week 6 Visit|Overall Study||26||
48299265|NCT00147823|101060117|FG001|Week 6 Visit|Overall Study||28||
48299266|NCT00147823|101060116|FG000|Month 3 Visit|Overall Study||25||
48299267|NCT00147823|101060117|FG001|Month 3 Visit|Overall Study||24||
48601403|NCT00553358|101807699|FG002|COMPLETED|Overall Study||61|Completed follow-up per protocol event free. Includes subjects who had a follow-up visit or phone call ≥ 9 years + 6 months after randomization and had no EFS events|
48601404|NCT00553358|101807697|FG000|NOT COMPLETED|Overall Study||79||
48601405|NCT00553358|101807698|FG001|NOT COMPLETED|Overall Study||96||
48299268|NCT00147823|101060116|FG000|Month 6 Visit|Overall Study||25||
48299269|NCT00147823|101060117|FG001|Month 6 Visit|Overall Study||21||
48299270|NCT00147823|101060116|FG000|Month 12 Visit|Overall Study||21||
48299271|NCT00147823|101060117|FG001|Month 12 Visit|Overall Study||25||
48299272|NCT00147823|101060116|FG000|Month 12 CT Scan|Overall Study||20||
48299273|NCT00147823|101060117|FG001|Month 12 CT Scan|Overall Study||25||
48299274|NCT00147823|101060116|FG000|Month 18 Visit|Overall Study||21||
48299275|NCT00147823|101060117|FG001|Month 18 Visit|Overall Study||20||
48299276|NCT00147823|101060116|FG000|Month 24 Visit|Overall Study||21||
48299277|NCT00147823|101060117|FG001|Month 24 Visit|Overall Study||18||
48299278|NCT00147823|101060116|FG000|COMPLETED|Overall Study||19||
48299279|NCT00147823|101060117|FG001|COMPLETED|Overall Study||16||
48299280|NCT00147823|101060116|FG000|NOT COMPLETED|Overall Study||13||
48299281|NCT00147823|101060117|FG001|NOT COMPLETED|Overall Study||15||
48601406|NCT00553358|101807699|FG002|NOT COMPLETED|Overall Study||88||
48601407|NCT02649426|101807700|FG000|STARTED|Overall Study||74||
48601408|NCT02649426|101807701|FG001|STARTED|Overall Study||72||
48601409|NCT02649426|101807702|FG002|STARTED|Overall Study||69||
48601410|NCT02649426|101807703|FG003|STARTED|Overall Study||67||
48601411|NCT02649426|101807700|FG000|Patient Crossed-over From Sham to Renal Denervation|Overall Study||0||
48601412|NCT02649426|101807701|FG001|Patient Crossed-over From Sham to Renal Denervation|Overall Study||37||
48601413|NCT02649426|101807702|FG002|Patient Crossed-over From Sham to Renal Denervation|Overall Study||0||
48601414|NCT02649426|101807703|FG003|Patient Crossed-over From Sham to Renal Denervation|Overall Study||22||
48601415|NCT02649426|101807700|FG000|COMPLETED|Overall Study||73||
48601416|NCT02649426|101807701|FG001|COMPLETED|Overall Study||46||
48145806|NCT02975973|100679775|FG000|NOT COMPLETED|Overall Study||1||
48145807|NCT02975973|100679776|FG001|NOT COMPLETED|Overall Study||1||
48601417|NCT02649426|101807702|FG002|COMPLETED|Overall Study||41||
48145808|NCT02975973|100679777|FG002|NOT COMPLETED|Overall Study||1||
48145809|NCT02975973|100679778|FG003|NOT COMPLETED|Overall Study||0||
48145810|NCT04084314|100679779|FG000|STARTED|Overall Study||701||
48145811|NCT04084314|100679779|FG000|COMPLETED|Overall Study||534|Study Completed|
48145812|NCT04084314|100679779|FG000|NOT COMPLETED|Overall Study||167||
48299282|NCT00041067|101060118|FG000|STARTED|Overall Study||76||
48299283|NCT00041067|101060118|FG000|Eligible|Overall Study||74||
48299284|NCT00041067|101060118|FG000|COMPLETED|Overall Study||0||
48299285|NCT00041067|101060118|FG000|NOT COMPLETED|Overall Study||76||
48601418|NCT02649426|101807703|FG003|COMPLETED|Overall Study||36||
48145813|NCT00335322|100679780|FG000|STARTED|Overall Study||115||
48145814|NCT00335322|100679781|FG001|STARTED|Overall Study||107||
48299286|NCT00671554|101060119|FG000|STARTED|Overall Study||3||
48299287|NCT00671554|101060119|FG000|COMPLETED|Overall Study||0||
48299288|NCT00671554|101060119|FG000|NOT COMPLETED|Overall Study||3||
48145815|NCT00335322|100679782|FG002|STARTED|Overall Study||105||
48601419|NCT02649426|101807700|FG000|NOT COMPLETED|Overall Study||1||
48601420|NCT02649426|101807701|FG001|NOT COMPLETED|Overall Study||26||
48601421|NCT02649426|101807702|FG002|NOT COMPLETED|Overall Study||28||
48601422|NCT02649426|101807703|FG003|NOT COMPLETED|Overall Study||31||
48601423|NCT00506714|101807704|FG000|STARTED|Overall Study||13||
48601424|NCT00506714|101807705|FG001|STARTED|Overall Study||13||
48299289|NCT03196232|101060120|FG000|STARTED|Overall Study||3||
48299290|NCT03196232|101060120|FG000|COMPLETED|Overall Study||3||
48299291|NCT03196232|101060120|FG000|NOT COMPLETED|Overall Study||0||
48299292|NCT01881750|101060121|FG000|STARTED|Overall Study||27||
48299293|NCT01881750|101060122|FG001|STARTED|Overall Study||26||
48299294|NCT01881750|101060121|FG000|COMPLETED|Overall Study||25||
48299295|NCT01881750|101060122|FG001|COMPLETED|Overall Study||22||
48299296|NCT01881750|101060121|FG000|NOT COMPLETED|Overall Study||2||
48299297|NCT01881750|101060122|FG001|NOT COMPLETED|Overall Study||4||
48299298|NCT01423253|101060123|FG000|STARTED|Overall Study||48||
48299299|NCT01423253|101060123|FG000|COMPLETED|Overall Study||39||
48299300|NCT01423253|101060123|FG000|NOT COMPLETED|Overall Study||9||
48299301|NCT03346057|101060124|FG000|STARTED|Overall Study||111||
48299302|NCT03346057|101060125|FG001|STARTED|Overall Study||112||
48299303|NCT03346057|101060126|FG002|STARTED|Overall Study||68||
48299304|NCT03346057|101060127|FG003|STARTED|Overall Study||53||
48299305|NCT03346057|101060124|FG000|Treated|Overall Study||105||
48299306|NCT03346057|101060125|FG001|Treated|Overall Study||107||
48299307|NCT03346057|101060126|FG002|Treated|Overall Study||68||
48299308|NCT03346057|101060127|FG003|Treated|Overall Study||51||
48299309|NCT03346057|101060124|FG000|COMPLETED|Overall Study||104||
48299310|NCT03346057|101060125|FG001|COMPLETED|Overall Study||104||
48299311|NCT03346057|101060126|FG002|COMPLETED|Overall Study||67||
48299312|NCT03346057|101060127|FG003|COMPLETED|Overall Study||51||
48299313|NCT03346057|101060124|FG000|NOT COMPLETED|Overall Study||7||
48299314|NCT03346057|101060125|FG001|NOT COMPLETED|Overall Study||8||
48299315|NCT03346057|101060126|FG002|NOT COMPLETED|Overall Study||1||
48299316|NCT03346057|101060127|FG003|NOT COMPLETED|Overall Study||2||
48299317|NCT03471871|101060128|FG000|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6||
48299318|NCT03471871|101060129|FG001|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5||
48299319|NCT03471871|101060130|FG002|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6||
48299320|NCT03471871|101060131|FG003|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||19||
48299321|NCT03471871|101060132|FG004|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||20||
48299322|NCT03471871|101060128|FG000|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||6||
48299323|NCT03471871|101060129|FG001|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||5||
48299324|NCT03471871|101060130|FG002|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||6||
48299325|NCT03471871|101060131|FG003|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||18||
48299326|NCT03471871|101060132|FG004|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||20||
48299327|NCT03471871|101060128|FG000|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6||
48299328|NCT03471871|101060129|FG001|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5||
48299329|NCT03471871|101060130|FG002|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5||
48299330|NCT03471871|101060131|FG003|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||18||
48299331|NCT03471871|101060132|FG004|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||19||
48299332|NCT03471871|101060128|FG000|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||0||
48299333|NCT03471871|101060129|FG001|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||0||
48299334|NCT03471871|101060130|FG002|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1||
48299335|NCT03471871|101060131|FG003|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1||
48299336|NCT03471871|101060132|FG004|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1||
48299337|NCT03471871|101060128|FG000|STARTED|Washout Period 1 (14 Days)||6||
48299338|NCT03471871|101060129|FG001|STARTED|Washout Period 1 (14 Days)||5||
48299339|NCT03471871|101060130|FG002|STARTED|Washout Period 1 (14 Days)||5||
48299340|NCT03471871|101060131|FG003|STARTED|Washout Period 1 (14 Days)||18||
48299341|NCT03471871|101060132|FG004|STARTED|Washout Period 1 (14 Days)||19||
48299342|NCT03471871|101060128|FG000|COMPLETED|Washout Period 1 (14 Days)||6||
48299343|NCT03471871|101060129|FG001|COMPLETED|Washout Period 1 (14 Days)||5||
48299344|NCT03471871|101060130|FG002|COMPLETED|Washout Period 1 (14 Days)||5||
48299345|NCT03471871|101060131|FG003|COMPLETED|Washout Period 1 (14 Days)||18||
48299346|NCT03471871|101060132|FG004|COMPLETED|Washout Period 1 (14 Days)||19||
48299347|NCT03471871|101060128|FG000|NOT COMPLETED|Washout Period 1 (14 Days)||0||
48299348|NCT03471871|101060129|FG001|NOT COMPLETED|Washout Period 1 (14 Days)||0||
48299349|NCT03471871|101060130|FG002|NOT COMPLETED|Washout Period 1 (14 Days)||0||
48601425|NCT00506714|101807704|FG000|COMPLETED|Overall Study||13||
48299350|NCT03471871|101060131|FG003|NOT COMPLETED|Washout Period 1 (14 Days)||0||
48299351|NCT03471871|101060132|FG004|NOT COMPLETED|Washout Period 1 (14 Days)||0||
48299352|NCT03471871|101060128|FG000|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||6||
48405162|NCT01553591|101325207|FG001|STARTED|Overall Study||426||
48601426|NCT00506714|101807705|FG001|COMPLETED|Overall Study||13||
48601427|NCT00506714|101807704|FG000|NOT COMPLETED|Overall Study||0||
48601428|NCT00506714|101807705|FG001|NOT COMPLETED|Overall Study||0||
48601429|NCT03301831|101807706|FG000|STARTED|Overall Study||46||
48767581|NCT01435382|102222771|FG000|COMPLETED|Overall Study||11||
48299353|NCT03471871|101060129|FG001|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5||
48299354|NCT03471871|101060130|FG002|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5||
48299355|NCT03471871|101060131|FG003|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18||
48299356|NCT03471871|101060132|FG004|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||19||
48299357|NCT03471871|101060128|FG000|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||6||
48299358|NCT03471871|101060129|FG001|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5||
48299359|NCT03471871|101060130|FG002|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5||
48299360|NCT03471871|101060131|FG003|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18||
48299361|NCT03471871|101060132|FG004|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18||
48299362|NCT03471871|101060128|FG000|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0||
48299363|NCT03471871|101060129|FG001|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0||
48299364|NCT03471871|101060130|FG002|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0||
48299365|NCT03471871|101060131|FG003|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0||
48299366|NCT03471871|101060132|FG004|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||1||
48299367|NCT03471871|101060128|FG000|STARTED|Washout Period 2 (14 Days)||6||
48299368|NCT03471871|101060129|FG001|STARTED|Washout Period 2 (14 Days)||5||
48299369|NCT03471871|101060130|FG002|STARTED|Washout Period 2 (14 Days)||5||
48299370|NCT03471871|101060131|FG003|STARTED|Washout Period 2 (14 Days)||0||
48299371|NCT03471871|101060132|FG004|STARTED|Washout Period 2 (14 Days)||0||
48299372|NCT03471871|101060128|FG000|COMPLETED|Washout Period 2 (14 Days)||6||
48299373|NCT03471871|101060129|FG001|COMPLETED|Washout Period 2 (14 Days)||5||
48299374|NCT03471871|101060130|FG002|COMPLETED|Washout Period 2 (14 Days)||5||
48299375|NCT03471871|101060131|FG003|COMPLETED|Washout Period 2 (14 Days)||0||
48299376|NCT03471871|101060132|FG004|COMPLETED|Washout Period 2 (14 Days)||0||
48299377|NCT03471871|101060128|FG000|NOT COMPLETED|Washout Period 2 (14 Days)||0||
48299378|NCT03471871|101060129|FG001|NOT COMPLETED|Washout Period 2 (14 Days)||0||
48299379|NCT03471871|101060130|FG002|NOT COMPLETED|Washout Period 2 (14 Days)||0||
48299380|NCT03471871|101060131|FG003|NOT COMPLETED|Washout Period 2 (14 Days)||0||
48299381|NCT03471871|101060132|FG004|NOT COMPLETED|Washout Period 2 (14 Days)||0||
48714332|NCT04493684|102088509|FG011|COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48299382|NCT03471871|101060128|FG000|STARTED|Treatment Period 3: ( HV:1 Day)||6||
48299383|NCT03471871|101060129|FG001|STARTED|Treatment Period 3: ( HV:1 Day)||5||
48299384|NCT03471871|101060130|FG002|STARTED|Treatment Period 3: ( HV:1 Day)||5||
48299385|NCT03471871|101060131|FG003|STARTED|Treatment Period 3: ( HV:1 Day)||0||
48299386|NCT03471871|101060132|FG004|STARTED|Treatment Period 3: ( HV:1 Day)||0||
48299387|NCT03471871|101060128|FG000|COMPLETED|Treatment Period 3: ( HV:1 Day)||6||
48299388|NCT03471871|101060129|FG001|COMPLETED|Treatment Period 3: ( HV:1 Day)||5||
48299389|NCT03471871|101060130|FG002|COMPLETED|Treatment Period 3: ( HV:1 Day)||5||
48299390|NCT03471871|101060131|FG003|COMPLETED|Treatment Period 3: ( HV:1 Day)||0||
48299391|NCT03471871|101060132|FG004|COMPLETED|Treatment Period 3: ( HV:1 Day)||0||
48299392|NCT03471871|101060128|FG000|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0||
48299393|NCT03471871|101060129|FG001|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0||
48299394|NCT03471871|101060130|FG002|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0||
48299395|NCT03471871|101060131|FG003|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0||
48299396|NCT03471871|101060132|FG004|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0||
48299397|NCT03471871|101060128|FG000|STARTED|Follow Up (14 Days for Both HV and OSA)||6||
48299398|NCT03471871|101060129|FG001|STARTED|Follow Up (14 Days for Both HV and OSA)||5||
48299399|NCT03471871|101060130|FG002|STARTED|Follow Up (14 Days for Both HV and OSA)||5||
48299400|NCT03471871|101060131|FG003|STARTED|Follow Up (14 Days for Both HV and OSA)||18||
48299401|NCT03471871|101060132|FG004|STARTED|Follow Up (14 Days for Both HV and OSA)||18||
48299402|NCT03471871|101060128|FG000|COMPLETED|Follow Up (14 Days for Both HV and OSA)||6||
48299403|NCT03471871|101060129|FG001|COMPLETED|Follow Up (14 Days for Both HV and OSA)||5||
48299404|NCT03471871|101060130|FG002|COMPLETED|Follow Up (14 Days for Both HV and OSA)||5||
48299405|NCT03471871|101060131|FG003|COMPLETED|Follow Up (14 Days for Both HV and OSA)||17||
48299406|NCT03471871|101060132|FG004|COMPLETED|Follow Up (14 Days for Both HV and OSA)||17||
48601430|NCT03301831|101807707|FG001|STARTED|Overall Study||47||
48601431|NCT03301831|101807706|FG000|COMPLETED|Overall Study||26||
48601432|NCT03301831|101807707|FG001|COMPLETED|Overall Study||44||
48601433|NCT03301831|101807706|FG000|NOT COMPLETED|Overall Study||20||
48601434|NCT03301831|101807707|FG001|NOT COMPLETED|Overall Study||3||
48601435|NCT03871829|101807708|FG000|STARTED|Overall Study||44||
48601436|NCT03871829|101807709|FG001|STARTED|Overall Study||44||
48601437|NCT03871829|101807708|FG000|Treated (Safety Analysis Set)|Overall Study||43||
48601438|NCT03871829|101807709|FG001|Treated (Safety Analysis Set)|Overall Study||43||
48601439|NCT03871829|101807708|FG000|COMPLETED|Overall Study||0||
48601440|NCT03871829|101807709|FG001|COMPLETED|Overall Study||0||
48601441|NCT03871829|101807708|FG000|NOT COMPLETED|Overall Study||44||
48601442|NCT03871829|101807709|FG001|NOT COMPLETED|Overall Study||44||
48601443|NCT01717391|101807710|FG000|STARTED|Overall Study||36||
48601444|NCT01717391|101807710|FG000|COMPLETED|Overall Study||27||
48601445|NCT01717391|101807710|FG000|NOT COMPLETED|Overall Study||9||
48601446|NCT02000882|101807711|FG000|STARTED|Overall Study||10||
48601447|NCT02000882|101807711|FG000|COMPLETED|Overall Study||4||
48601448|NCT02000882|101807711|FG000|NOT COMPLETED|Overall Study||6||
48299407|NCT03471871|101060128|FG000|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0||
48299408|NCT03471871|101060129|FG001|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0||
48299409|NCT03471871|101060130|FG002|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0||
48299410|NCT03471871|101060131|FG003|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||1||
48299411|NCT03471871|101060132|FG004|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||1||
48299412|NCT01890148|101060133|FG000|STARTED|Overall Study||5||
48299413|NCT01890148|101060133|FG000|COMPLETED|Overall Study||4||
48299414|NCT01890148|101060133|FG000|NOT COMPLETED|Overall Study||1||
48299415|NCT04464265|101060134|FG000|STARTED|Overall Study||32||
48299416|NCT04464265|101060134|FG000|COMPLETED|Overall Study||30||
48299417|NCT04464265|101060134|FG000|NOT COMPLETED|Overall Study||2||
48299418|NCT02411578|101060135|FG000|STARTED|Crossover Trial Phase||8||
48299419|NCT02411578|101060136|FG001|STARTED|Crossover Trial Phase||12||
48299420|NCT02411578|101060135|FG000|COMPLETED|Crossover Trial Phase||8||
48299421|NCT02411578|101060136|FG001|COMPLETED|Crossover Trial Phase||11||
48299422|NCT02411578|101060135|FG000|NOT COMPLETED|Crossover Trial Phase||0||
48299423|NCT02411578|101060136|FG001|NOT COMPLETED|Crossover Trial Phase||1||
48299424|NCT02411578|101060135|FG000|STARTED|Extension Phase||8||
48299425|NCT02411578|101060136|FG001|STARTED|Extension Phase||9||
48299426|NCT02411578|101060135|FG000|COMPLETED|Extension Phase||8||
48299427|NCT02411578|101060136|FG001|COMPLETED|Extension Phase||9||
48601449|NCT03810235|101807712|FG000|STARTED|Overall Study||32||
48601450|NCT03810235|101807713|FG001|STARTED|Overall Study||31||
48601451|NCT03810235|101807712|FG000|Participant Data Analyzed|Overall Study||30||
48601452|NCT03810235|101807713|FG001|Participant Data Analyzed|Overall Study||31||
48601453|NCT03810235|101807712|FG000|COMPLETED|Overall Study||30||
48299428|NCT02411578|101060135|FG000|NOT COMPLETED|Extension Phase||0||
48299429|NCT02411578|101060136|FG001|NOT COMPLETED|Extension Phase||0||
48299430|NCT01178671|101060137|FG000|STARTED|Overall Study||18||
48299431|NCT01178671|101060138|FG001|STARTED|Overall Study||18||
48601454|NCT03810235|101807713|FG001|COMPLETED|Overall Study||31||
48601455|NCT03810235|101807712|FG000|NOT COMPLETED|Overall Study||2||
48601456|NCT03810235|101807713|FG001|NOT COMPLETED|Overall Study||0||
48601457|NCT02721017|101807714|FG000|STARTED|Hospital Stay||10||
48601458|NCT02721017|101807715|FG001|STARTED|Hospital Stay||10||
48601459|NCT02721017|101807714|FG000|COMPLETED|Hospital Stay||10||
48601460|NCT02721017|101807715|FG001|COMPLETED|Hospital Stay||10||
48601461|NCT02721017|101807714|FG000|NOT COMPLETED|Hospital Stay||0||
48601462|NCT02721017|101807715|FG001|NOT COMPLETED|Hospital Stay||0||
48601463|NCT02721017|101807714|FG000|STARTED|Participant Follow Up||10||
48601464|NCT02721017|101807715|FG001|STARTED|Participant Follow Up||10||
48601465|NCT02721017|101807714|FG000|COMPLETED|Participant Follow Up||10||
48601466|NCT02721017|101807715|FG001|COMPLETED|Participant Follow Up||10||
48601467|NCT02721017|101807714|FG000|NOT COMPLETED|Participant Follow Up||0||
48601468|NCT02721017|101807715|FG001|NOT COMPLETED|Participant Follow Up||0||
48601469|NCT03373461|101807716|FG000|STARTED|Part 1||9||
48601470|NCT03373461|101807717|FG001|STARTED|Part 1||8||
48601471|NCT03373461|101807718|FG002|STARTED|Part 1||0||
48601472|NCT03373461|101807719|FG003|STARTED|Part 1||15||
48601473|NCT03373461|101807720|FG004|STARTED|Part 1||14||
48601474|NCT03373461|101807716|FG000|COMPLETED|Part 1||9||
48601475|NCT03373461|101807717|FG001|COMPLETED|Part 1||8||
48601476|NCT03373461|101807718|FG002|COMPLETED|Part 1||0||
48601477|NCT03373461|101807719|FG003|COMPLETED|Part 1||15||
48601478|NCT03373461|101807720|FG004|COMPLETED|Part 1||14||
48601479|NCT03373461|101807716|FG000|NOT COMPLETED|Part 1||0||
48601480|NCT03373461|101807717|FG001|NOT COMPLETED|Part 1||0||
48601481|NCT03373461|101807718|FG002|NOT COMPLETED|Part 1||0||
48299432|NCT01178671|101060137|FG000|COMPLETED|Overall Study||6||
48299433|NCT01178671|101060138|FG001|COMPLETED|Overall Study||3||
48299434|NCT01178671|101060137|FG000|NOT COMPLETED|Overall Study||12||
48299435|NCT01178671|101060138|FG001|NOT COMPLETED|Overall Study||15||
48299436|NCT02745392|101060139|FG000|STARTED|Overall Study||91||
48299437|NCT02745392|101060140|FG001|STARTED|Overall Study||90||
48299438|NCT02745392|101060141|FG002|STARTED|Overall Study||92||
48299439|NCT02745392|101060142|FG003|STARTED|Overall Study||92||
48299440|NCT02745392|101060139|FG000|COMPLETED|Overall Study||91||
48299441|NCT02745392|101060140|FG001|COMPLETED|Overall Study||89||
48299442|NCT02745392|101060141|FG002|COMPLETED|Overall Study||92||
48299443|NCT02745392|101060142|FG003|COMPLETED|Overall Study||92||
48299444|NCT02745392|101060139|FG000|NOT COMPLETED|Overall Study||0||
48299445|NCT02745392|101060140|FG001|NOT COMPLETED|Overall Study||1||
48299446|NCT02745392|101060141|FG002|NOT COMPLETED|Overall Study||0||
48299447|NCT02745392|101060142|FG003|NOT COMPLETED|Overall Study||0||
48601482|NCT03373461|101807719|FG003|NOT COMPLETED|Part 1||0||
48601483|NCT03373461|101807720|FG004|NOT COMPLETED|Part 1||0||
48601484|NCT03373461|101807716|FG000|STARTED|Part 2||11||
48601485|NCT03373461|101807717|FG001|STARTED|Part 2||11||
48601486|NCT03373461|101807718|FG002|STARTED|Part 2||22||
48601487|NCT03373461|101807719|FG003|STARTED|Part 2||11||
48601488|NCT03373461|101807720|FG004|STARTED|Part 2||11||
48601489|NCT03373461|101807716|FG000|COMPLETED|Part 2||11||
48601490|NCT03373461|101807717|FG001|COMPLETED|Part 2||10||
48601491|NCT03373461|101807718|FG002|COMPLETED|Part 2||22||
48299448|NCT00150969|101060143|FG000|STARTED|24 Month Main Study||217||
48299449|NCT00150969|101060144|FG001|STARTED|24 Month Main Study||223||
48299450|NCT00150969|101060143|FG000|COMPLETED|24 Month Main Study||198||
48299451|NCT00150969|101060144|FG001|COMPLETED|24 Month Main Study||202||
48299452|NCT00150969|101060143|FG000|NOT COMPLETED|24 Month Main Study||19||
48299453|NCT00150969|101060144|FG001|NOT COMPLETED|24 Month Main Study||21||
48299454|NCT00150969|101060143|FG000|STARTED|24-48 Month Extension||121||
48601492|NCT03373461|101807719|FG003|COMPLETED|Part 2||11||
48601493|NCT03373461|101807720|FG004|COMPLETED|Part 2||10||
48601494|NCT03373461|101807716|FG000|NOT COMPLETED|Part 2||0||
48299455|NCT00150969|101060144|FG001|STARTED|24-48 Month Extension||140||
48299456|NCT00150969|101060143|FG000|COMPLETED|24-48 Month Extension||33||
48299457|NCT00150969|101060144|FG001|COMPLETED|24-48 Month Extension||40||
48299458|NCT00150969|101060143|FG000|NOT COMPLETED|24-48 Month Extension||88||
48299459|NCT00150969|101060144|FG001|NOT COMPLETED|24-48 Month Extension||100||
48299460|NCT02120716|101060145|FG000|STARTED|Overall Study||31||
48299461|NCT02120716|101060146|FG001|STARTED|Overall Study||19||
48299462|NCT02120716|101060145|FG000|COMPLETED|Overall Study||30||
48299463|NCT02120716|101060146|FG001|COMPLETED|Overall Study||19||
48299464|NCT02120716|101060145|FG000|NOT COMPLETED|Overall Study||1||
48299465|NCT02120716|101060146|FG001|NOT COMPLETED|Overall Study||0||
48299466|NCT02858349|101060147|FG000|STARTED|Overall Study||10||
48299467|NCT02858349|101060147|FG000|COMPLETED|Overall Study||10||
48299468|NCT02858349|101060147|FG000|NOT COMPLETED|Overall Study||0||
48299469|NCT03236246|101060148|FG000|STARTED|24-Week Dose Titration Period||104||
48299470|NCT03236246|101060149|FG001|STARTED|24-Week Dose Titration Period||102||
48299471|NCT03236246|101060148|FG000|COMPLETED|24-Week Dose Titration Period||80||
48299472|NCT03236246|101060149|FG001|COMPLETED|24-Week Dose Titration Period||75||
48299473|NCT03236246|101060148|FG000|NOT COMPLETED|24-Week Dose Titration Period||24||
48299474|NCT03236246|101060149|FG001|NOT COMPLETED|24-Week Dose Titration Period||27||
48299475|NCT03236246|101060148|FG000|STARTED|24-Week Dose Maintenance Period||76||
48299476|NCT03236246|101060149|FG001|STARTED|24-Week Dose Maintenance Period||72||
48299477|NCT03236246|101060148|FG000|COMPLETED|24-Week Dose Maintenance Period||73||
48299478|NCT03236246|101060149|FG001|COMPLETED|24-Week Dose Maintenance Period||66||
48299479|NCT03236246|101060148|FG000|NOT COMPLETED|24-Week Dose Maintenance Period||3||
48299480|NCT03236246|101060149|FG001|NOT COMPLETED|24-Week Dose Maintenance Period||6||
48299481|NCT00287339|101060150|FG000|STARTED|Overall Study||22||
48299482|NCT00287339|101060151|FG001|STARTED|Overall Study||18||
48299483|NCT00287339|101060150|FG000|COMPLETED|Overall Study||22||
48299484|NCT00287339|101060151|FG001|COMPLETED|Overall Study||18||
48299485|NCT00287339|101060150|FG000|NOT COMPLETED|Overall Study||0||
48299486|NCT00287339|101060151|FG001|NOT COMPLETED|Overall Study||0||
48299487|NCT01369511|101060152|FG000|STARTED|Overall Study||98||
48299488|NCT01369511|101060153|FG001|STARTED|Overall Study||104||
48299489|NCT01369511|101060154|FG002|STARTED|Overall Study||98||
48299490|NCT01369511|101060155|FG003|STARTED|Overall Study||100||
48299491|NCT01369511|101060152|FG000|Received at Least 1 Dose of Study Drug|Overall Study||98||
48299492|NCT01369511|101060153|FG001|Received at Least 1 Dose of Study Drug|Overall Study||103||
48299493|NCT01369511|101060154|FG002|Received at Least 1 Dose of Study Drug|Overall Study||98||
48299494|NCT01369511|101060155|FG003|Received at Least 1 Dose of Study Drug|Overall Study||100||
48299495|NCT01369511|101060152|FG000|COMPLETED|Overall Study||85||
48299496|NCT01369511|101060153|FG001|COMPLETED|Overall Study||91||
48299497|NCT01369511|101060154|FG002|COMPLETED|Overall Study||87||
48299498|NCT01369511|101060155|FG003|COMPLETED|Overall Study||89||
48299499|NCT01369511|101060152|FG000|NOT COMPLETED|Overall Study||13||
48299500|NCT01369511|101060153|FG001|NOT COMPLETED|Overall Study||13||
48601495|NCT03373461|101807717|FG001|NOT COMPLETED|Part 2||1||
48601496|NCT03373461|101807718|FG002|NOT COMPLETED|Part 2||0||
48601497|NCT03373461|101807719|FG003|NOT COMPLETED|Part 2||0||
48601498|NCT03373461|101807720|FG004|NOT COMPLETED|Part 2||1||
48601499|NCT00282152|101807721|FG000|STARTED|Overall Study||15||
48299501|NCT01369511|101060154|FG002|NOT COMPLETED|Overall Study||11||
48299502|NCT01369511|101060155|FG003|NOT COMPLETED|Overall Study||11||
48299503|NCT01744353|101060156|FG000|STARTED|Overall Study||6||
48601500|NCT00282152|101807722|FG001|STARTED|Overall Study||15||
48299504|NCT01744353|101060157|FG001|STARTED|Overall Study||26||
48299505|NCT01744353|101060158|FG002|STARTED|Overall Study||3||
48299506|NCT01744353|101060156|FG000|COMPLETED|Overall Study||6||
48299507|NCT01744353|101060157|FG001|COMPLETED|Overall Study||26||
48299508|NCT01744353|101060158|FG002|COMPLETED|Overall Study||3||
48601501|NCT00282152|101807721|FG000|COMPLETED|Overall Study||14||
48601502|NCT00282152|101807722|FG001|COMPLETED|Overall Study||15||
48601503|NCT00282152|101807721|FG000|NOT COMPLETED|Overall Study||1||
48601504|NCT00282152|101807722|FG001|NOT COMPLETED|Overall Study||0||
48145816|NCT00335322|100679780|FG000|COMPLETED|Overall Study||114||
48145817|NCT00335322|100679781|FG001|COMPLETED|Overall Study||105||
48145818|NCT00335322|100679782|FG002|COMPLETED|Overall Study||103||
48145819|NCT00335322|100679780|FG000|NOT COMPLETED|Overall Study||1||
48145820|NCT00335322|100679781|FG001|NOT COMPLETED|Overall Study||2||
48145821|NCT00335322|100679782|FG002|NOT COMPLETED|Overall Study||2||
48145822|NCT02477111|100679783|FG000|STARTED|Overall Study||150||
48601505|NCT01313351|101807723|FG000|STARTED|Overall Study||206||
48601506|NCT01313351|101807723|FG000|COMPLETED|Overall Study||206||
48601507|NCT01313351|101807723|FG000|NOT COMPLETED|Overall Study||0||
48601508|NCT00750919|101807724|FG000|STARTED|Overall Study||184||
48601509|NCT00750919|101807724|FG000|COMPLETED|Overall Study||126||
48601510|NCT00750919|101807724|FG000|NOT COMPLETED|Overall Study||58||
48601511|NCT01044758|101807725|FG000|STARTED|Overall Study||12||
48601512|NCT01044758|101807726|FG001|STARTED|Overall Study||12||
48601513|NCT01044758|101807727|FG002|STARTED|Overall Study||11||
48601514|NCT01044758|101807728|FG003|STARTED|Overall Study||12||
48601515|NCT01044758|101807729|FG004|STARTED|Overall Study||11||
48601516|NCT01044758|101807730|FG005|STARTED|Overall Study||11||
48601517|NCT01044758|101807731|FG006|STARTED|Overall Study||27||
48601518|NCT01044758|101807725|FG000|COMPLETED|Overall Study||8||
48601519|NCT01044758|101807726|FG001|COMPLETED|Overall Study||12||
48601520|NCT01044758|101807727|FG002|COMPLETED|Overall Study||7||
48145823|NCT02477111|100679783|FG000|COMPLETED|Overall Study||99||
48145824|NCT02477111|100679783|FG000|NOT COMPLETED|Overall Study||51||
48145825|NCT01258608|100679784|FG000|STARTED|Overall Study||51||
48145826|NCT01258608|100679785|FG001|STARTED|Overall Study||50||
48145827|NCT01258608|100679784|FG000|COMPLETED|Overall Study||30|Completed placebo/mapatumumab treatment defined as treated until radiologic disease progression|
48145828|NCT01258608|100679785|FG001|COMPLETED|Overall Study||31|Completed placebo/mapatumumab treatment defined as treated until radiologic disease progression|
48145829|NCT01258608|100679784|FG000|NOT COMPLETED|Overall Study||21||
48145830|NCT01258608|100679785|FG001|NOT COMPLETED|Overall Study||19||
48145831|NCT03355326|100679786|FG000|STARTED|Overall Study||9||
48145832|NCT03355326|100679787|FG001|STARTED|Overall Study||7||
48145833|NCT03355326|100679786|FG000|COMPLETED|Overall Study||6||
48145834|NCT03355326|100679787|FG001|COMPLETED|Overall Study||4||
48145835|NCT03355326|100679786|FG000|NOT COMPLETED|Overall Study||3||
48145836|NCT03355326|100679787|FG001|NOT COMPLETED|Overall Study||3||
48145837|NCT02250612|100679788|FG000|STARTED|Overall Study||37||
48145838|NCT02250612|100679789|FG001|STARTED|Overall Study||40||
48145839|NCT02250612|100679790|FG002|STARTED|Overall Study||37||
48145840|NCT02250612|100679791|FG003|STARTED|Overall Study||33||
48145841|NCT02250612|100679792|FG004|STARTED|Overall Study||37||
48145842|NCT02250612|100679788|FG000|COMPLETED|Overall Study||36||
48145843|NCT02250612|100679789|FG001|COMPLETED|Overall Study||38||
48145844|NCT02250612|100679790|FG002|COMPLETED|Overall Study||35||
48145845|NCT02250612|100679791|FG003|COMPLETED|Overall Study||33||
48145846|NCT02250612|100679792|FG004|COMPLETED|Overall Study||36||
48145847|NCT02250612|100679788|FG000|NOT COMPLETED|Overall Study||1||
48145848|NCT02250612|100679789|FG001|NOT COMPLETED|Overall Study||2||
48145849|NCT02250612|100679790|FG002|NOT COMPLETED|Overall Study||2||
48145850|NCT02250612|100679791|FG003|NOT COMPLETED|Overall Study||0||
48601521|NCT01044758|101807728|FG003|COMPLETED|Overall Study||10||
48601522|NCT01044758|101807729|FG004|COMPLETED|Overall Study||9||
48601523|NCT01044758|101807730|FG005|COMPLETED|Overall Study||8||
48601524|NCT01044758|101807731|FG006|COMPLETED|Overall Study||17||
48145851|NCT02250612|100679792|FG004|NOT COMPLETED|Overall Study||1||
48145852|NCT04653766|100679793|FG000|STARTED|Overall Study||6||
48145853|NCT04653766|100679794|FG001|STARTED|Overall Study||6||
48145854|NCT04653766|100679795|FG002|STARTED|Overall Study||6||
48145855|NCT04653766|100679796|FG003|STARTED|Overall Study||6||
48145856|NCT04653766|100679797|FG004|STARTED|Overall Study||8||
48145857|NCT04653766|100679793|FG000|COMPLETED|Overall Study||6||
48145858|NCT04653766|100679794|FG001|COMPLETED|Overall Study||6||
48145859|NCT04653766|100679795|FG002|COMPLETED|Overall Study||6||
48145860|NCT04653766|100679796|FG003|COMPLETED|Overall Study||6||
48145861|NCT04653766|100679797|FG004|COMPLETED|Overall Study||8||
48145862|NCT04653766|100679793|FG000|NOT COMPLETED|Overall Study||0||
48145863|NCT04653766|100679794|FG001|NOT COMPLETED|Overall Study||0||
48145864|NCT04653766|100679795|FG002|NOT COMPLETED|Overall Study||0||
48145865|NCT04653766|100679796|FG003|NOT COMPLETED|Overall Study||0||
48145866|NCT04653766|100679797|FG004|NOT COMPLETED|Overall Study||0||
48145867|NCT02654808|100679798|FG000|STARTED|Overall Study||33||
48145868|NCT02654808|100679799|FG001|STARTED|Overall Study||33||
48145869|NCT02654808|100679800|FG002|STARTED|Overall Study||33||
48601525|NCT01044758|101807725|FG000|NOT COMPLETED|Overall Study||4||
48601526|NCT01044758|101807726|FG001|NOT COMPLETED|Overall Study||0||
48601527|NCT01044758|101807727|FG002|NOT COMPLETED|Overall Study||4||
48601528|NCT01044758|101807728|FG003|NOT COMPLETED|Overall Study||2||
48601529|NCT01044758|101807729|FG004|NOT COMPLETED|Overall Study||2||
48601530|NCT01044758|101807730|FG005|NOT COMPLETED|Overall Study||3||
48601531|NCT01044758|101807731|FG006|NOT COMPLETED|Overall Study||10||
48601532|NCT01402986|101807732|FG000|STARTED|Overall Study||76||
48601533|NCT01402986|101807733|FG001|STARTED|Overall Study||150||
48601534|NCT01402986|101807734|FG002|STARTED|Overall Study||75||
48601535|NCT01402986|101807735|FG003|STARTED|Overall Study||151||
48601536|NCT01402986|101807732|FG000|COMPLETED|Overall Study||67||
48601537|NCT01402986|101807733|FG001|COMPLETED|Overall Study||135||
48601538|NCT01402986|101807734|FG002|COMPLETED|Overall Study||67||
48601539|NCT01402986|101807735|FG003|COMPLETED|Overall Study||129||
48601540|NCT01402986|101807732|FG000|NOT COMPLETED|Overall Study||9||
48601541|NCT01402986|101807733|FG001|NOT COMPLETED|Overall Study||15||
48714333|NCT04493684|102088510|FG012|COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48145870|NCT02654808|100679801|FG003|STARTED|Overall Study||33||
48145871|NCT02654808|100679798|FG000|COMPLETED|Overall Study||33||
48145872|NCT02654808|100679799|FG001|COMPLETED|Overall Study||33||
48145873|NCT02654808|100679800|FG002|COMPLETED|Overall Study||33||
48601542|NCT01402986|101807734|FG002|NOT COMPLETED|Overall Study||8||
48601543|NCT01402986|101807735|FG003|NOT COMPLETED|Overall Study||22||
48601544|NCT01027897|101807736|FG000|STARTED|Overall Study||30||
48714334|NCT04493684|102088511|FG013|COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714335|NCT04493684|102088512|FG014|COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||5||
48714336|NCT04493684|102088513|FG015|COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||4||
48714337|NCT04493684|102088514|FG016|COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||6||
48145874|NCT02654808|100679801|FG003|COMPLETED|Overall Study||33||
48145875|NCT02654808|100679798|FG000|NOT COMPLETED|Overall Study||0||
48714338|NCT04493684|102088498|FG000|NOT COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714339|NCT04493684|102088499|FG001|NOT COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714340|NCT04493684|102088500|FG002|NOT COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714341|NCT04493684|102088501|FG003|NOT COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714342|NCT04493684|102088502|FG004|NOT COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714343|NCT04493684|102088503|FG005|NOT COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714344|NCT04493684|102088504|FG006|NOT COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714345|NCT04493684|102088505|FG007|NOT COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714346|NCT04493684|102088506|FG008|NOT COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714347|NCT04493684|102088507|FG009|NOT COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714348|NCT04493684|102088508|FG010|NOT COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714349|NCT04493684|102088509|FG011|NOT COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714350|NCT04493684|102088510|FG012|NOT COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714351|NCT04493684|102088511|FG013|NOT COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714352|NCT04493684|102088512|FG014|NOT COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714353|NCT04493684|102088513|FG015|NOT COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||1||
48714354|NCT04493684|102088514|FG016|NOT COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
48714355|NCT04493684|102088498|FG000|STARTED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714356|NCT04493684|102088499|FG001|STARTED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714357|NCT04493684|102088500|FG002|STARTED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714358|NCT04493684|102088501|FG003|STARTED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714359|NCT04493684|102088502|FG004|STARTED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714360|NCT04493684|102088503|FG005|STARTED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714361|NCT04493684|102088504|FG006|STARTED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714362|NCT04493684|102088505|FG007|STARTED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714363|NCT04493684|102088506|FG008|STARTED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714364|NCT04493684|102088507|FG009|STARTED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714365|NCT04493684|102088508|FG010|STARTED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714366|NCT04493684|102088509|FG011|STARTED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714367|NCT04493684|102088510|FG012|STARTED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714368|NCT04493684|102088511|FG013|STARTED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714369|NCT04493684|102088512|FG014|STARTED|Part 3:Treatment Period 3-Up to 4 Weeks||5||
48714370|NCT04493684|102088513|FG015|STARTED|Part 3:Treatment Period 3-Up to 4 Weeks||4||
48714371|NCT04493684|102088514|FG016|STARTED|Part 3:Treatment Period 3-Up to 4 Weeks||6||
48714372|NCT04493684|102088498|FG000|COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714373|NCT04493684|102088499|FG001|COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714374|NCT04493684|102088500|FG002|COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714375|NCT04493684|102088501|FG003|COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714376|NCT04493684|102088502|FG004|COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714377|NCT04493684|102088503|FG005|COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714378|NCT04493684|102088504|FG006|COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714379|NCT04493684|102088505|FG007|COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714380|NCT04493684|102088506|FG008|COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714381|NCT04493684|102088507|FG009|COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48601545|NCT01027897|101807736|FG000|COMPLETED|Overall Study||28||
48601546|NCT01027897|101807736|FG000|NOT COMPLETED|Overall Study||2||
48601547|NCT02427802|101807737|FG000|STARTED|Overall Study||305||
48601548|NCT02427802|101807738|FG001|STARTED|Overall Study||154||
48714382|NCT04493684|102088508|FG010|COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714383|NCT04493684|102088509|FG011|COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714384|NCT04493684|102088510|FG012|COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714385|NCT04493684|102088511|FG013|COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714386|NCT04493684|102088512|FG014|COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||5||
48714387|NCT04493684|102088513|FG015|COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||4||
48145876|NCT02654808|100679799|FG001|NOT COMPLETED|Overall Study||0||
48145877|NCT02654808|100679800|FG002|NOT COMPLETED|Overall Study||0||
48145878|NCT02654808|100679801|FG003|NOT COMPLETED|Overall Study||0||
48145879|NCT02677116|100679802|FG000|STARTED|Overall Study||10||
48145880|NCT02677116|100679803|FG001|STARTED|Overall Study||11||
48145881|NCT02677116|100679804|FG002|STARTED|Overall Study||9||
48145882|NCT02677116|100679805|FG003|STARTED|Overall Study||10||
48145883|NCT02677116|100679806|FG004|STARTED|Overall Study||1||
48145884|NCT02677116|100679807|FG005|STARTED|Overall Study||13||
48145885|NCT02677116|100679808|FG006|STARTED|Overall Study||6||
48299509|NCT01744353|101060156|FG000|NOT COMPLETED|Overall Study||0||
48299510|NCT01744353|101060157|FG001|NOT COMPLETED|Overall Study||0||
48299511|NCT01744353|101060158|FG002|NOT COMPLETED|Overall Study||0||
48299512|NCT00364156|101060159|FG000|STARTED|Overall Study||282||
48299513|NCT00364156|101060160|FG001|STARTED|Overall Study||286||
48714388|NCT04493684|102088514|FG016|COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||6||
48714389|NCT04493684|102088498|FG000|NOT COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714390|NCT04493684|102088499|FG001|NOT COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714391|NCT04493684|102088500|FG002|NOT COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714392|NCT04493684|102088501|FG003|NOT COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714393|NCT04493684|102088502|FG004|NOT COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714394|NCT04493684|102088503|FG005|NOT COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714395|NCT04493684|102088504|FG006|NOT COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714396|NCT04493684|102088505|FG007|NOT COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714397|NCT04493684|102088506|FG008|NOT COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714398|NCT04493684|102088507|FG009|NOT COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714399|NCT04493684|102088508|FG010|NOT COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714400|NCT04493684|102088509|FG011|NOT COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714401|NCT04493684|102088510|FG012|NOT COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714402|NCT04493684|102088511|FG013|NOT COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714403|NCT04493684|102088512|FG014|NOT COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714404|NCT04493684|102088513|FG015|NOT COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714405|NCT04493684|102088514|FG016|NOT COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
48714406|NCT05239221|102088515|FG000|STARTED|Overall Study||3||
48714407|NCT05239221|102088516|FG001|STARTED|Overall Study||6||
48714408|NCT05239221|102088517|FG002|STARTED|Overall Study||6||
48714409|NCT05239221|102088518|FG003|STARTED|Overall Study||6||
48714410|NCT05239221|102088519|FG004|STARTED|Overall Study||6||
48714411|NCT05239221|102088520|FG005|STARTED|Overall Study||6||
48714412|NCT05239221|102088521|FG006|STARTED|Overall Study||6||
48714413|NCT05239221|102088522|FG007|STARTED|Overall Study||13||
48714414|NCT05239221|102088523|FG008|STARTED|Overall Study||8||
48714415|NCT05239221|102088524|FG009|STARTED|Overall Study||8||
48714416|NCT05239221|102088525|FG010|STARTED|Overall Study||10||
48714417|NCT05239221|102088526|FG011|STARTED|Overall Study||8||
48714418|NCT05239221|102088527|FG012|STARTED|Overall Study||8||
48714419|NCT05239221|102088528|FG013|STARTED|Overall Study||10||
48714420|NCT05239221|102088529|FG014|STARTED|Overall Study||12||
48714421|NCT05239221|102088530|FG015|STARTED|Overall Study||16||
48714422|NCT05239221|102088515|FG000|COMPLETED|Overall Study||3||
48714423|NCT05239221|102088516|FG001|COMPLETED|Overall Study||6||
48714424|NCT05239221|102088517|FG002|COMPLETED|Overall Study||6||
48714425|NCT05239221|102088518|FG003|COMPLETED|Overall Study||6||
48714426|NCT05239221|102088519|FG004|COMPLETED|Overall Study||6||
48714427|NCT05239221|102088520|FG005|COMPLETED|Overall Study||6||
48714428|NCT05239221|102088521|FG006|COMPLETED|Overall Study||5||
48714429|NCT05239221|102088522|FG007|COMPLETED|Overall Study||13||
48714430|NCT05239221|102088523|FG008|COMPLETED|Overall Study||8||
48714431|NCT05239221|102088524|FG009|COMPLETED|Overall Study||8||
48714432|NCT05239221|102088525|FG010|COMPLETED|Overall Study||8||
48714433|NCT05239221|102088526|FG011|COMPLETED|Overall Study||7||
48714434|NCT05239221|102088527|FG012|COMPLETED|Overall Study||8||
48714435|NCT05239221|102088528|FG013|COMPLETED|Overall Study||10||
48714436|NCT05239221|102088529|FG014|COMPLETED|Overall Study||12||
48714437|NCT05239221|102088530|FG015|COMPLETED|Overall Study||15||
48714438|NCT05239221|102088515|FG000|NOT COMPLETED|Overall Study||0||
48714439|NCT05239221|102088516|FG001|NOT COMPLETED|Overall Study||0||
48714440|NCT05239221|102088517|FG002|NOT COMPLETED|Overall Study||0||
48714441|NCT05239221|102088518|FG003|NOT COMPLETED|Overall Study||0||
48714442|NCT05239221|102088519|FG004|NOT COMPLETED|Overall Study||0||
48145886|NCT02677116|100679809|FG007|STARTED|Overall Study||4||
48145887|NCT02677116|100679810|FG008|STARTED|Overall Study||4||
48145888|NCT02677116|100679802|FG000|Cycle 1 Olaratumab Alone|Overall Study||10||
48299514|NCT00364156|101060159|FG000|COMPLETED|Overall Study||203||
48299515|NCT00364156|101060160|FG001|COMPLETED|Overall Study||205||
48299516|NCT00364156|101060159|FG000|NOT COMPLETED|Overall Study||79||
48299517|NCT00364156|101060160|FG001|NOT COMPLETED|Overall Study||81||
48299518|NCT01294683|101060161|FG000|STARTED|Precrossover (Periods I/II)||489||
48299519|NCT01294683|101060162|FG001|STARTED|Precrossover (Periods I/II)||488||
48299520|NCT01294683|101060161|FG000|Treated|Precrossover (Periods I/II)||486||
48145889|NCT02677116|100679803|FG001|Cycle 1 Olaratumab Alone|Overall Study||11||
48145890|NCT02677116|100679804|FG002|Cycle 1 Olaratumab Alone|Overall Study||9||
48145891|NCT02677116|100679805|FG003|Cycle 1 Olaratumab Alone|Overall Study||10||
48145892|NCT02677116|100679806|FG004|Cycle 1 Olaratumab Alone|Overall Study||1||
48145893|NCT02677116|100679807|FG005|Cycle 1 Olaratumab Alone|Overall Study||13||
48145894|NCT02677116|100679808|FG006|Cycle 1 Olaratumab Alone|Overall Study||6||
48145895|NCT02677116|100679809|FG007|Cycle 1 Olaratumab Alone|Overall Study||4||
48145896|NCT02677116|100679810|FG008|Cycle 1 Olaratumab Alone|Overall Study||4||
48145897|NCT02677116|100679802|FG000|Progressive Disease|Overall Study||7||
48145898|NCT02677116|100679803|FG001|Progressive Disease|Overall Study||7||
48145899|NCT02677116|100679804|FG002|Progressive Disease|Overall Study||6||
48145900|NCT02677116|100679805|FG003|Progressive Disease|Overall Study||7||
48145901|NCT02677116|100679806|FG004|Progressive Disease|Overall Study||0||
48145902|NCT02677116|100679807|FG005|Progressive Disease|Overall Study||9||
48145903|NCT02677116|100679808|FG006|Progressive Disease|Overall Study||2||
48145904|NCT02677116|100679809|FG007|Progressive Disease|Overall Study||2||
48145905|NCT02677116|100679810|FG008|Progressive Disease|Overall Study||2||
48145906|NCT02677116|100679802|FG000|COMPLETED|Overall Study||7||
48145907|NCT02677116|100679803|FG001|COMPLETED|Overall Study||7||
48145908|NCT02677116|100679804|FG002|COMPLETED|Overall Study||6||
48145909|NCT02677116|100679805|FG003|COMPLETED|Overall Study||7||
48145910|NCT02677116|100679806|FG004|COMPLETED|Overall Study||0||
48145911|NCT02677116|100679807|FG005|COMPLETED|Overall Study||9||
48145912|NCT02677116|100679808|FG006|COMPLETED|Overall Study||2||
48145913|NCT02677116|100679809|FG007|COMPLETED|Overall Study||2||
48145914|NCT02677116|100679810|FG008|COMPLETED|Overall Study||2||
48145915|NCT02677116|100679802|FG000|NOT COMPLETED|Overall Study||3||
48145916|NCT02677116|100679803|FG001|NOT COMPLETED|Overall Study||4||
48145917|NCT02677116|100679804|FG002|NOT COMPLETED|Overall Study||3||
48145918|NCT02677116|100679805|FG003|NOT COMPLETED|Overall Study||3||
48299521|NCT01294683|101060162|FG001|Treated|Precrossover (Periods I/II)||486||
48299522|NCT01294683|101060161|FG000|COMPLETED|Precrossover (Periods I/II)||232||
48299523|NCT01294683|101060162|FG001|COMPLETED|Precrossover (Periods I/II)||222||
48299524|NCT01294683|101060161|FG000|NOT COMPLETED|Precrossover (Periods I/II)||257||
48299525|NCT01294683|101060162|FG001|NOT COMPLETED|Precrossover (Periods I/II)||266||
48299526|NCT01294683|101060161|FG000|STARTED|Post Crossover (Period III)||232||
48299527|NCT01294683|101060162|FG001|STARTED|Post Crossover (Period III)||222||
48299528|NCT01294683|101060161|FG000|COMPLETED|Post Crossover (Period III)||199||
48299529|NCT01294683|101060162|FG001|COMPLETED|Post Crossover (Period III)||190||
48299530|NCT01294683|101060161|FG000|NOT COMPLETED|Post Crossover (Period III)||33||
48299531|NCT01294683|101060162|FG001|NOT COMPLETED|Post Crossover (Period III)||32||
48299532|NCT00315939|101060163|FG000|STARTED|Admission 1 (3 Months)||59||
48714443|NCT05239221|102088520|FG005|NOT COMPLETED|Overall Study||0||
48145919|NCT02677116|100679806|FG004|NOT COMPLETED|Overall Study||1||
48145920|NCT02677116|100679807|FG005|NOT COMPLETED|Overall Study||4||
48145921|NCT02677116|100679808|FG006|NOT COMPLETED|Overall Study||4||
48145922|NCT02677116|100679809|FG007|NOT COMPLETED|Overall Study||2||
48145923|NCT02677116|100679810|FG008|NOT COMPLETED|Overall Study||2||
48145924|NCT02434692|100679811|FG000|STARTED|Overall Study||22|"24 patients with primary open angle glaucoma were initially enrolled. One patient was included due to a misunderstanding of the inclusion and exclusion criteria, which was noticed before the procedure. Of the 23 patients (= Safety Set-Group = Safety Set (SS), as specified by the protocol), 22 patients successfully received the ARGOS-IO implant (= Single-arm intervention ARGOS-IO system-Group = Per-Protocol-Set (PPS), as specified by the protocol) and were subjected to the follow-up visits."|
48145925|NCT02434692|100679811|FG000|COMPLETED|Overall Study||22||
48299533|NCT00315939|101060164|FG001|STARTED|Admission 1 (3 Months)||61||
48299534|NCT00315939|101060163|FG000|COMPLETED|Admission 1 (3 Months)||56||
48299535|NCT00315939|101060164|FG001|COMPLETED|Admission 1 (3 Months)||55||
48145926|NCT02434692|100679811|FG000|NOT COMPLETED|Overall Study||0||
48145927|NCT04866017|100679812|FG000|STARTED|Overall Study||22||
48145928|NCT04866017|100679813|FG001|STARTED|Overall Study||19||
48145929|NCT04866017|100679814|FG002|STARTED|Overall Study||22||
48145930|NCT04866017|100679812|FG000|Treated|Overall Study||22||
48145931|NCT04866017|100679813|FG001|Treated|Overall Study||18||
48145932|NCT04866017|100679814|FG002|Treated|Overall Study||22||
48145933|NCT04866017|100679812|FG000|COMPLETED|Overall Study||0||
48145934|NCT04866017|100679813|FG001|COMPLETED|Overall Study||0||
48145935|NCT04866017|100679814|FG002|COMPLETED|Overall Study||0||
48299536|NCT00315939|101060163|FG000|NOT COMPLETED|Admission 1 (3 Months)||3||
48299537|NCT00315939|101060164|FG001|NOT COMPLETED|Admission 1 (3 Months)||6||
48299538|NCT00315939|101060163|FG000|STARTED|Admission 2 (3 Months)||56||
48714444|NCT05239221|102088521|FG006|NOT COMPLETED|Overall Study||1||
48299539|NCT00315939|101060164|FG001|STARTED|Admission 2 (3 Months)||55||
48714445|NCT05239221|102088522|FG007|NOT COMPLETED|Overall Study||0||
48299540|NCT00315939|101060163|FG000|COMPLETED|Admission 2 (3 Months)||52||
48299541|NCT00315939|101060164|FG001|COMPLETED|Admission 2 (3 Months)||51||
48299542|NCT00315939|101060163|FG000|NOT COMPLETED|Admission 2 (3 Months)||4||
48299543|NCT00315939|101060164|FG001|NOT COMPLETED|Admission 2 (3 Months)||4||
48299544|NCT00315939|101060163|FG000|STARTED|Admission 3 (3 Months)||52||
48299545|NCT00315939|101060164|FG001|STARTED|Admission 3 (3 Months)||51||
48299546|NCT00315939|101060163|FG000|COMPLETED|Admission 3 (3 Months)||48||
48299547|NCT00315939|101060164|FG001|COMPLETED|Admission 3 (3 Months)||49||
48299548|NCT00315939|101060163|FG000|NOT COMPLETED|Admission 3 (3 Months)||4||
48299549|NCT00315939|101060164|FG001|NOT COMPLETED|Admission 3 (3 Months)||2||
48299550|NCT05467774|101060165|FG000|STARTED|Overall Study||7||
48299551|NCT05467774|101060165|FG000|COMPLETED|Overall Study||7||
48299552|NCT05467774|101060165|FG000|NOT COMPLETED|Overall Study||0||
48299553|NCT00140231|101060166|FG000|STARTED|Fed State 1 Day- day5||7||
48299554|NCT00140231|101060167|FG001|STARTED|Fed State 1 Day- day5||6||
48299555|NCT00140231|101060166|FG000|COMPLETED|Fed State 1 Day- day5||7||
48299556|NCT00140231|101060167|FG001|COMPLETED|Fed State 1 Day- day5||6||
48299557|NCT00140231|101060166|FG000|NOT COMPLETED|Fed State 1 Day- day5||0||
48299558|NCT00140231|101060167|FG001|NOT COMPLETED|Fed State 1 Day- day5||0||
48299559|NCT00140231|101060166|FG000|STARTED|Washout 8weeks||7||
48299560|NCT00140231|101060167|FG001|STARTED|Washout 8weeks||6||
48299561|NCT00140231|101060166|FG000|COMPLETED|Washout 8weeks||7||
48299562|NCT00140231|101060167|FG001|COMPLETED|Washout 8weeks||6||
48299563|NCT00140231|101060166|FG000|NOT COMPLETED|Washout 8weeks||0||
48299564|NCT00140231|101060167|FG001|NOT COMPLETED|Washout 8weeks||0||
48299565|NCT00140231|101060166|FG000|STARTED|First Fasting State 3 Days With Placebo||7||
48299566|NCT00140231|101060167|FG001|STARTED|First Fasting State 3 Days With Placebo||6||
48299567|NCT00140231|101060166|FG000|COMPLETED|First Fasting State 3 Days With Placebo||7||
48299568|NCT00140231|101060167|FG001|COMPLETED|First Fasting State 3 Days With Placebo||6||
48299569|NCT00140231|101060166|FG000|NOT COMPLETED|First Fasting State 3 Days With Placebo||0||
48299570|NCT00140231|101060167|FG001|NOT COMPLETED|First Fasting State 3 Days With Placebo||0||
48299571|NCT00140231|101060166|FG000|STARTED|Washout 8 Weeks||7||
48299572|NCT00140231|101060167|FG001|STARTED|Washout 8 Weeks||6||
48299573|NCT00140231|101060166|FG000|COMPLETED|Washout 8 Weeks||7||
48299574|NCT00140231|101060167|FG001|COMPLETED|Washout 8 Weeks||6||
48299575|NCT00140231|101060166|FG000|NOT COMPLETED|Washout 8 Weeks||0||
48299576|NCT00140231|101060167|FG001|NOT COMPLETED|Washout 8 Weeks||0||
48299577|NCT00140231|101060166|FG000|STARTED|Fasting State With Leptin and Crossover||7||
48299578|NCT00140231|101060167|FG001|STARTED|Fasting State With Leptin and Crossover||6||
48299579|NCT00140231|101060166|FG000|COMPLETED|Fasting State With Leptin and Crossover||7||
48299580|NCT00140231|101060167|FG001|COMPLETED|Fasting State With Leptin and Crossover||6||
48299581|NCT00140231|101060166|FG000|NOT COMPLETED|Fasting State With Leptin and Crossover||0||
48299582|NCT00140231|101060167|FG001|NOT COMPLETED|Fasting State With Leptin and Crossover||0||
48299583|NCT02691260|101060168|FG000|STARTED|Overall Study||26||
48299584|NCT02691260|101060169|FG001|STARTED|Overall Study||26||
48299585|NCT02691260|101060170|FG002|STARTED|Overall Study||27||
48299586|NCT02691260|101060171|FG003|STARTED|Overall Study||26||
48299587|NCT02691260|101060168|FG000|COMPLETED|Overall Study||24||
48299588|NCT02691260|101060169|FG001|COMPLETED|Overall Study||24||
48299589|NCT02691260|101060170|FG002|COMPLETED|Overall Study||25||
48299590|NCT02691260|101060171|FG003|COMPLETED|Overall Study||23||
48299591|NCT02691260|101060168|FG000|NOT COMPLETED|Overall Study||2||
48299592|NCT02691260|101060169|FG001|NOT COMPLETED|Overall Study||2||
48299593|NCT02691260|101060170|FG002|NOT COMPLETED|Overall Study||2||
48299594|NCT02691260|101060171|FG003|NOT COMPLETED|Overall Study||3||
48299595|NCT03645057|101060172|FG000|STARTED|Randomization to Baseline||23|46 patient/caregiver dyads were randomized to crisaborole or tacrolimus 0.03% study arms (i.e., 92 subjects total = 46 child patients and 46 caregivers).|
48299596|NCT03645057|101060173|FG001|STARTED|Randomization to Baseline||23|46 patient/caregiver dyads were randomized to crisaborole or tacrolimus 0.03% study arms (i.e., 92 subjects total = 46 child patients and 46 caregivers).|
48299597|NCT03645057|101060174|FG002|STARTED|Randomization to Baseline||23|46 patient/caregiver dyads were randomized to crisaborole or tacrolimus 0.03% study arms (i.e., 92 subjects total = 46 child patients and 46 caregivers).|
48299598|NCT03645057|101060175|FG003|STARTED|Randomization to Baseline||23|46 patient/caregiver dyads were randomized to crisaborole or tacrolimus 0.03% study arms (i.e., 92 subjects total = 46 child patients and 46 caregivers).|
48367991|NCT00717418|101230088|FG000|NOT COMPLETED|Baseline||0||
48367992|NCT00717418|101230089|FG001|NOT COMPLETED|Baseline||0||
48367993|NCT00717418|101230090|FG002|NOT COMPLETED|Baseline||0||
48299599|NCT03645057|101060172|FG000|COMPLETED|Randomization to Baseline||22|One dyad (i.e., 1 child patient with 1 caregiver) was lost to followup after randomization (i.e., crisaborole arm) but before baseline assessment. This dyad was one that required a washout prior to baseline assessment. The Baseline Assessment included clinician-rated severity of the child patient's atopic dermatitis. completion of five outcome measures by the child patient, and completion of three outcome measures by the caregiver.|
48367994|NCT00717418|101230091|FG003|NOT COMPLETED|Baseline||15||
48367995|NCT00717418|101230088|FG000|STARTED|1-Year Follow-Up||180||
48367996|NCT00717418|101230089|FG001|STARTED|1-Year Follow-Up||74||
48367997|NCT00717418|101230090|FG002|STARTED|1-Year Follow-Up||508||
48367998|NCT00717418|101230091|FG003|STARTED|1-Year Follow-Up||4||
48405163|NCT01553591|101325208|FG002|STARTED|Overall Study||427||
48405164|NCT01553591|101325206|FG000|Attended Week 12 Visit|Overall Study||341||
48405165|NCT01553591|101325207|FG001|Attended Week 12 Visit|Overall Study||330||
48145936|NCT04866017|100679812|FG000|NOT COMPLETED|Overall Study||22||
48145937|NCT04866017|100679813|FG001|NOT COMPLETED|Overall Study||19||
48145938|NCT04866017|100679814|FG002|NOT COMPLETED|Overall Study||22||
48145939|NCT01588184|100679815|FG000|STARTED|Overall Study||11||
48145940|NCT01588184|100679816|FG001|STARTED|Overall Study||41||
48145941|NCT01588184|100679817|FG002|STARTED|Overall Study||7||
48145942|NCT01588184|100679818|FG003|STARTED|Overall Study||6||
48145943|NCT01588184|100679819|FG004|STARTED|Overall Study||16||
48145944|NCT01588184|100679820|FG005|STARTED|Overall Study||14||
48145945|NCT01588184|100679815|FG000|COMPLETED|Overall Study||8||
48145946|NCT01588184|100679816|FG001|COMPLETED|Overall Study||28||
48145947|NCT01588184|100679817|FG002|COMPLETED|Overall Study||5||
48405166|NCT01553591|101325208|FG002|Attended Week 12 Visit|Overall Study||342||
48405167|NCT01553591|101325206|FG000|Attended Week 26 Visit|Overall Study||289||
48714446|NCT05239221|102088523|FG008|NOT COMPLETED|Overall Study||0||
48714447|NCT05239221|102088524|FG009|NOT COMPLETED|Overall Study||0||
48714448|NCT05239221|102088525|FG010|NOT COMPLETED|Overall Study||2||
48714449|NCT05239221|102088526|FG011|NOT COMPLETED|Overall Study||1||
48714450|NCT05239221|102088527|FG012|NOT COMPLETED|Overall Study||0||
48714451|NCT05239221|102088528|FG013|NOT COMPLETED|Overall Study||0||
48714452|NCT05239221|102088529|FG014|NOT COMPLETED|Overall Study||0||
48714453|NCT05239221|102088530|FG015|NOT COMPLETED|Overall Study||1||
48714454|NCT01414205|102088531|FG000|STARTED|Overall Study||41||
48714455|NCT01414205|102088532|FG001|STARTED|Overall Study||39||
48714456|NCT01414205|102088531|FG000|Received Study Drug|Overall Study||40||
48714457|NCT01414205|102088532|FG001|Received Study Drug|Overall Study||38||
48714458|NCT01414205|102088531|FG000|COMPLETED|Overall Study||34||
48714459|NCT01414205|102088532|FG001|COMPLETED|Overall Study||32||
48145948|NCT01588184|100679818|FG003|COMPLETED|Overall Study||3||
48145949|NCT01588184|100679819|FG004|COMPLETED|Overall Study||14||
48145950|NCT01588184|100679820|FG005|COMPLETED|Overall Study||10||
48145951|NCT01588184|100679815|FG000|NOT COMPLETED|Overall Study||3||
48145952|NCT01588184|100679816|FG001|NOT COMPLETED|Overall Study||13||
48145953|NCT01588184|100679817|FG002|NOT COMPLETED|Overall Study||2||
48145954|NCT01588184|100679818|FG003|NOT COMPLETED|Overall Study||3||
48145955|NCT01588184|100679819|FG004|NOT COMPLETED|Overall Study||2||
48145956|NCT01588184|100679820|FG005|NOT COMPLETED|Overall Study||4||
48145957|NCT02794285|100679821|FG000|STARTED|Overall Study||257|12 participants were enrolled but excluded due to site non-compliance or lack of source documentation.|
48145958|NCT02794285|100679822|FG001|STARTED|Overall Study||112|12 participants were enrolled but excluded due to site non-compliance or lack of source documentation.|
48145959|NCT02794285|100679823|FG002|STARTED|Overall Study||111|12 participants were enrolled but excluded due to site non-compliance or lack of source documentation.|
48145960|NCT02794285|100679824|FG003|STARTED|Overall Study||67|12 participants were enrolled but excluded due to site non-compliance or lack of source documentation.|
48145961|NCT02794285|100679821|FG000|COMPLETED|Overall Study||178||
48145962|NCT02794285|100679822|FG001|COMPLETED|Overall Study||54||
48145963|NCT02794285|100679823|FG002|COMPLETED|Overall Study||69||
48405168|NCT01553591|101325207|FG001|Attended Week 26 Visit|Overall Study||291||
48405169|NCT01553591|101325208|FG002|Attended Week 26 Visit|Overall Study||290||
48405170|NCT01553591|101325206|FG000|COMPLETED|Overall Study||257||
48714460|NCT01414205|102088531|FG000|NOT COMPLETED|Overall Study||7||
48714461|NCT01414205|102088532|FG001|NOT COMPLETED|Overall Study||7||
48145964|NCT02794285|100679824|FG003|COMPLETED|Overall Study||41||
48145965|NCT02794285|100679821|FG000|NOT COMPLETED|Overall Study||79||
48405171|NCT01553591|101325207|FG001|COMPLETED|Overall Study||257||
48405172|NCT01553591|101325208|FG002|COMPLETED|Overall Study||269||
48405173|NCT01553591|101325206|FG000|NOT COMPLETED|Overall Study||172||
48405174|NCT01553591|101325207|FG001|NOT COMPLETED|Overall Study||169||
48405175|NCT01553591|101325208|FG002|NOT COMPLETED|Overall Study||158||
48405176|NCT04737759|101325209|FG000|STARTED|Overall Study||36||
48405177|NCT04737759|101325210|FG001|STARTED|Overall Study||38||
48714462|NCT04081961|102088533|FG000|STARTED|Overall Study||9||
48714463|NCT04081961|102088534|FG001|STARTED|Overall Study||9||
48714464|NCT04081961|102088535|FG002|STARTED|Overall Study||9||
48714465|NCT04081961|102088533|FG000|COMPLETED|Overall Study||9||
48714466|NCT04081961|102088534|FG001|COMPLETED|Overall Study||9||
48714467|NCT04081961|102088535|FG002|COMPLETED|Overall Study||9||
48714468|NCT04081961|102088533|FG000|NOT COMPLETED|Overall Study||0||
48714469|NCT04081961|102088534|FG001|NOT COMPLETED|Overall Study||0||
48299600|NCT03645057|101060173|FG001|COMPLETED|Randomization to Baseline||23|One dyad (i.e., 1 child patient with 1 caregiver) was lost to followup after randomization (i.e., crisaborole arm) but before baseline assessment. This dyad was one that required a washout prior to baseline assessment. The Baseline Assessment included clinician-rated severity of the child patient's atopic dermatitis. completion of five outcome measures by the child patient, and completion of three outcome measures by the caregiver.|
48299601|NCT03645057|101060174|FG002|COMPLETED|Randomization to Baseline||22|One dyad (i.e., 1 child patient with 1 caregiver) was lost to followup after randomization (i.e., crisaborole arm) but before baseline assessment. This dyad was one that required a washout prior to baseline assessment. The Baseline Assessment included clinician-rated severity of the child patient's atopic dermatitis. completion of five outcome measures by the child patient, and completion of three outcome measures by the caregiver.|
48299602|NCT03645057|101060175|FG003|COMPLETED|Randomization to Baseline||23|One dyad (i.e., 1 child patient with 1 caregiver) was lost to followup after randomization (i.e., crisaborole arm) but before baseline assessment. This dyad was one that required a washout prior to baseline assessment. The Baseline Assessment included clinician-rated severity of the child patient's atopic dermatitis. completion of five outcome measures by the child patient, and completion of three outcome measures by the caregiver.|
48299603|NCT03645057|101060172|FG000|NOT COMPLETED|Randomization to Baseline||1||
48299604|NCT03645057|101060173|FG001|NOT COMPLETED|Randomization to Baseline||0||
48299605|NCT03645057|101060174|FG002|NOT COMPLETED|Randomization to Baseline||1||
48299606|NCT03645057|101060175|FG003|NOT COMPLETED|Randomization to Baseline||0||
48299607|NCT03645057|101060172|FG000|STARTED|Baseline to Six Weeks||22|45 dyads (i.e., 90 subjects total = 45 child patients and 45 caregivers) completed Baseline Assessment. Child patient used the assigned study medication for 6 weeks (baseline visit to 6 week study visit). The 6 week study visit included clinician-rated severity of child patient's atopic dermatitis, completion of five outcome measure by the child patient, and completion of three outcome measure by the caregiver.|
48299608|NCT03645057|101060173|FG001|STARTED|Baseline to Six Weeks||23|45 dyads (i.e., 90 subjects total = 45 child patients and 45 caregivers) completed Baseline Assessment. Child patient used the assigned study medication for 6 weeks (baseline visit to 6 week study visit). The 6 week study visit included clinician-rated severity of child patient's atopic dermatitis, completion of five outcome measure by the child patient, and completion of three outcome measure by the caregiver.|
48367999|NCT00717418|101230088|FG000|COMPLETED|1-Year Follow-Up||33||
48368000|NCT00717418|101230089|FG001|COMPLETED|1-Year Follow-Up||23||
48368001|NCT00717418|101230090|FG002|COMPLETED|1-Year Follow-Up||74||
48405178|NCT04737759|101325209|FG000|Adults With Heart Failure|Overall Study||18||
48601549|NCT02427802|101807739|FG002|STARTED|Overall Study||153||
48601550|NCT02427802|101807737|FG000|COMPLETED|Overall Study||246||
48601551|NCT02427802|101807738|FG001|COMPLETED|Overall Study||120||
48601552|NCT02427802|101807739|FG002|COMPLETED|Overall Study||110||
48601553|NCT02427802|101807737|FG000|NOT COMPLETED|Overall Study||59||
48601554|NCT02427802|101807738|FG001|NOT COMPLETED|Overall Study||34||
48601555|NCT02427802|101807739|FG002|NOT COMPLETED|Overall Study||43||
48601556|NCT05052697|101807740|FG000|STARTED|Substudy A||15||
48601557|NCT05052697|101807741|FG001|STARTED|Substudy A||15||
48601558|NCT05052697|101807742|FG002|STARTED|Substudy A||15||
48601559|NCT05052697|101807743|FG003|STARTED|Substudy A||15||
48601560|NCT05052697|101807744|FG004|STARTED|Substudy A||15||
48601561|NCT05052697|101807745|FG005|STARTED|Substudy A||15||
48601562|NCT05052697|101807746|FG006|STARTED|Substudy A||15||
48601563|NCT05052697|101807747|FG007|STARTED|Substudy A||16||
48601564|NCT05052697|101807748|FG008|STARTED|Substudy A||15||
48601565|NCT05052697|101807749|FG009|STARTED|Substudy A||15||
48601566|NCT05052697|101807750|FG010|STARTED|Substudy A||15||
48601567|NCT05052697|101807751|FG011|STARTED|Substudy A||15||
48601568|NCT05052697|101807752|FG012|STARTED|Substudy A||15||
48714470|NCT04081961|102088535|FG002|NOT COMPLETED|Overall Study||0||
48714471|NCT03242772|102088536|FG000|STARTED|Overall Study||9||
48714472|NCT03242772|102088537|FG001|STARTED|Overall Study||9||
48714473|NCT03242772|102088536|FG000|COMPLETED|Overall Study||6||
48714474|NCT03242772|102088537|FG001|COMPLETED|Overall Study||8||
48714475|NCT03242772|102088536|FG000|NOT COMPLETED|Overall Study||3||
48714476|NCT03242772|102088537|FG001|NOT COMPLETED|Overall Study||1||
48601569|NCT05052697|101807753|FG013|STARTED|Substudy A||15||
48601570|NCT05052697|101807754|FG014|STARTED|Substudy A||15||
48714477|NCT02914548|102088538|FG000|STARTED|Overall Study||67||
48714478|NCT02914548|102088539|FG001|STARTED|Overall Study||67||
48714479|NCT02914548|102088540|FG002|STARTED|Overall Study||66||
48714480|NCT02914548|102088538|FG000|COMPLETED|Overall Study||46||
48145966|NCT02794285|100679822|FG001|NOT COMPLETED|Overall Study||58||
48145967|NCT02794285|100679823|FG002|NOT COMPLETED|Overall Study||42||
48145968|NCT02794285|100679824|FG003|NOT COMPLETED|Overall Study||26||
48145969|NCT03520322|100679825|FG000|STARTED|Overall Study||3||
48145970|NCT03520322|100679826|FG001|STARTED|Overall Study||3||
48145971|NCT03520322|100679825|FG000|COMPLETED|Overall Study||3||
48145972|NCT03520322|100679826|FG001|COMPLETED|Overall Study||3||
48145973|NCT03520322|100679825|FG000|NOT COMPLETED|Overall Study||0||
48714481|NCT02914548|102088539|FG001|COMPLETED|Overall Study||53||
48714482|NCT02914548|102088540|FG002|COMPLETED|Overall Study||46||
48714483|NCT02914548|102088538|FG000|NOT COMPLETED|Overall Study||21||
48714484|NCT02914548|102088539|FG001|NOT COMPLETED|Overall Study||14||
48714485|NCT02914548|102088540|FG002|NOT COMPLETED|Overall Study||20||
48145974|NCT03520322|100679826|FG001|NOT COMPLETED|Overall Study||0||
48145975|NCT04322682|100679827|FG000|STARTED|Overall Study||2235||
48145976|NCT04322682|100679828|FG001|STARTED|Overall Study||2253||
48714486|NCT03444766|102088541|FG000|STARTED|Overall Study||100|Started Treatment Period|
48714487|NCT03444766|102088541|FG000|COMPLETED|Overall Study||34|Completed Treatment Period|
48714488|NCT03444766|102088541|FG000|NOT COMPLETED|Overall Study||66||
48714489|NCT01596335|102088542|FG000|STARTED|Overall Study||16||
48714490|NCT01596335|102088543|FG001|STARTED|Overall Study||15||
48714491|NCT01596335|102088542|FG000|COMPLETED|Overall Study||11||
48714492|NCT01596335|102088543|FG001|COMPLETED|Overall Study||6||
48714493|NCT01596335|102088542|FG000|NOT COMPLETED|Overall Study||5||
48714494|NCT01596335|102088543|FG001|NOT COMPLETED|Overall Study||9||
48714495|NCT04035564|102088544|FG000|STARTED|Overall Study||27||
48714496|NCT04035564|102088545|FG001|STARTED|Overall Study||25||
48714497|NCT04035564|102088544|FG000|COMPLETED|Overall Study||23||
48714498|NCT04035564|102088545|FG001|COMPLETED|Overall Study||19||
48714499|NCT04035564|102088544|FG000|NOT COMPLETED|Overall Study||4||
48601571|NCT05052697|101807755|FG015|STARTED|Substudy A||15||
48601572|NCT05052697|101807756|FG016|STARTED|Substudy A||15||
48601573|NCT05052697|101807757|FG017|STARTED|Substudy A||0||
48601574|NCT05052697|101807758|FG018|STARTED|Substudy A||0||
48601575|NCT05052697|101807759|FG019|STARTED|Substudy A||0||
48601576|NCT05052697|101807760|FG020|STARTED|Substudy A||0||
48714500|NCT04035564|102088545|FG001|NOT COMPLETED|Overall Study||6||
48714501|NCT01328041|102088546|FG000|STARTED|Overall Study||183||
48714502|NCT01328041|102088546|FG000|COMPLETED|Overall Study||126||
48601577|NCT05052697|101807761|FG021|STARTED|Substudy A||0||
48601578|NCT05052697|101807762|FG022|STARTED|Substudy A||0||
48601579|NCT05052697|101807763|FG023|STARTED|Substudy A||0||
48601580|NCT05052697|101807764|FG024|STARTED|Substudy A||0||
48601581|NCT05052697|101807765|FG025|STARTED|Substudy A||0||
48601582|NCT05052697|101807766|FG026|STARTED|Substudy A||0||
48601583|NCT05052697|101807767|FG027|STARTED|Substudy A||0||
48601584|NCT05052697|101807768|FG028|STARTED|Substudy A||0||
48601585|NCT05052697|101807769|FG029|STARTED|Substudy A||0||
48601586|NCT05052697|101807770|FG030|STARTED|Substudy A||0||
48714503|NCT01328041|102088546|FG000|NOT COMPLETED|Overall Study||57||
48714504|NCT03968159|102088547|FG000|STARTED|Overall Study||148||
48714505|NCT03968159|102088548|FG001|STARTED|Overall Study||150||
48714506|NCT03968159|102088547|FG000|COMPLETED|Overall Study||135||
48714507|NCT03968159|102088548|FG001|COMPLETED|Overall Study||135||
48714508|NCT03968159|102088547|FG000|NOT COMPLETED|Overall Study||13||
48299609|NCT03645057|101060174|FG002|STARTED|Baseline to Six Weeks||22|45 dyads (i.e., 90 subjects total = 45 child patients and 45 caregivers) completed Baseline Assessment. Child patient used the assigned study medication for 6 weeks (baseline visit to 6 week study visit). The 6 week study visit included clinician-rated severity of child patient's atopic dermatitis, completion of five outcome measure by the child patient, and completion of three outcome measure by the caregiver.|
48299610|NCT03645057|101060175|FG003|STARTED|Baseline to Six Weeks||23|45 dyads (i.e., 90 subjects total = 45 child patients and 45 caregivers) completed Baseline Assessment. Child patient used the assigned study medication for 6 weeks (baseline visit to 6 week study visit). The 6 week study visit included clinician-rated severity of child patient's atopic dermatitis, completion of five outcome measure by the child patient, and completion of three outcome measure by the caregiver.|
48299611|NCT03645057|101060172|FG000|COMPLETED|Baseline to Six Weeks||16|Child subjects used their assigned topical medication for 6 weeks (baseline to 6 week study visits). 1 dyad (i.e., 2 subject total = 1 child patient and 1 caregiver) in the crisaborole arm withdrew from the study because the caregiver no longer wanted to participate. 5 dyads (i.e., 10 subject total = 5 child patients and 5 caregivers) in the crisaborole arm were lost to followup. 1 dyad (i.e., 2 subjects total = 1 child patient and 1 caregiver) in the tacrolimus arm was lost to follow-up.|
48299612|NCT03645057|101060173|FG001|COMPLETED|Baseline to Six Weeks||21|Child subjects used their assigned topical medication for 6 weeks (baseline to 6 week study visits). 1 dyad (i.e., 2 subject total = 1 child patient and 1 caregiver) in the crisaborole arm withdrew from the study because the caregiver no longer wanted to participate. 5 dyads (i.e., 10 subject total = 5 child patients and 5 caregivers) in the crisaborole arm were lost to followup. 1 dyad (i.e., 2 subjects total = 1 child patient and 1 caregiver) in the tacrolimus arm was lost to follow-up.|
48368002|NCT00717418|101230091|FG003|COMPLETED|1-Year Follow-Up||0||
48405179|NCT04737759|101325210|FG001|Adults With Heart Failure|Overall Study||19||
48405180|NCT04737759|101325209|FG000|Spouse/Partners|Overall Study||18||
48601587|NCT05052697|101807771|FG031|STARTED|Substudy A||0||
48601588|NCT05052697|101807772|FG032|STARTED|Substudy A||0||
48601589|NCT05052697|101807773|FG033|STARTED|Substudy A||0||
48601590|NCT05052697|101807740|FG000|Vaccination 1|Substudy A||15||
48601591|NCT05052697|101807741|FG001|Vaccination 1|Substudy A||15||
48601592|NCT05052697|101807742|FG002|Vaccination 1|Substudy A||15||
48601593|NCT05052697|101807743|FG003|Vaccination 1|Substudy A||14||
48601594|NCT05052697|101807744|FG004|Vaccination 1|Substudy A||15||
48714509|NCT03968159|102088548|FG001|NOT COMPLETED|Overall Study||15||
48714510|NCT02266277|102088549|FG000|STARTED|Overall Study||5000||
48714511|NCT02266277|102088550|FG001|STARTED|Overall Study||5000||
48714512|NCT02266277|102088551|FG002|STARTED|Overall Study||5000||
48714513|NCT02266277|102088552|FG003|STARTED|Overall Study||5000||
48714514|NCT02266277|102088553|FG004|STARTED|Overall Study||5000||
48714515|NCT02266277|102088554|FG005|STARTED|Overall Study||5000||
48714516|NCT02266277|102088549|FG000|COMPLETED|Overall Study||5000||
48714517|NCT02266277|102088550|FG001|COMPLETED|Overall Study||5000||
48714518|NCT02266277|102088551|FG002|COMPLETED|Overall Study||5000||
48714519|NCT02266277|102088552|FG003|COMPLETED|Overall Study||5000||
48714520|NCT02266277|102088553|FG004|COMPLETED|Overall Study||5000||
48601595|NCT05052697|101807745|FG005|Vaccination 1|Substudy A||15||
48601596|NCT05052697|101807746|FG006|Vaccination 1|Substudy A||15||
48601597|NCT05052697|101807747|FG007|Vaccination 1|Substudy A||16||
48601598|NCT05052697|101807748|FG008|Vaccination 1|Substudy A||14||
48601599|NCT05052697|101807749|FG009|Vaccination 1|Substudy A||15||
48601600|NCT05052697|101807750|FG010|Vaccination 1|Substudy A||15||
48601601|NCT05052697|101807751|FG011|Vaccination 1|Substudy A||15||
48601602|NCT05052697|101807752|FG012|Vaccination 1|Substudy A||15||
48601603|NCT05052697|101807753|FG013|Vaccination 1|Substudy A||15||
48601604|NCT05052697|101807754|FG014|Vaccination 1|Substudy A||15||
48601605|NCT05052697|101807755|FG015|Vaccination 1|Substudy A||15||
48601606|NCT05052697|101807756|FG016|Vaccination 1|Substudy A||15||
48601607|NCT05052697|101807757|FG017|Vaccination 1|Substudy A||0||
48601608|NCT05052697|101807758|FG018|Vaccination 1|Substudy A||0||
48601609|NCT05052697|101807759|FG019|Vaccination 1|Substudy A||0||
48601610|NCT05052697|101807760|FG020|Vaccination 1|Substudy A||0||
48601611|NCT05052697|101807761|FG021|Vaccination 1|Substudy A||0||
48601612|NCT05052697|101807762|FG022|Vaccination 1|Substudy A||0||
48601613|NCT05052697|101807763|FG023|Vaccination 1|Substudy A||0||
48601614|NCT05052697|101807764|FG024|Vaccination 1|Substudy A||0||
48601615|NCT05052697|101807765|FG025|Vaccination 1|Substudy A||0||
48601616|NCT05052697|101807766|FG026|Vaccination 1|Substudy A||0||
48601617|NCT05052697|101807767|FG027|Vaccination 1|Substudy A||0||
48601618|NCT05052697|101807768|FG028|Vaccination 1|Substudy A||0||
48601619|NCT05052697|101807769|FG029|Vaccination 1|Substudy A||0||
48601620|NCT05052697|101807770|FG030|Vaccination 1|Substudy A||0||
48601621|NCT05052697|101807771|FG031|Vaccination 1|Substudy A||0||
48601622|NCT05052697|101807772|FG032|Vaccination 1|Substudy A||0||
48601623|NCT05052697|101807773|FG033|Vaccination 1|Substudy A||0||
48601624|NCT05052697|101807740|FG000|Vaccination 2|Substudy A||6||
48601625|NCT05052697|101807741|FG001|Vaccination 2|Substudy A||10||
48601626|NCT05052697|101807742|FG002|Vaccination 2|Substudy A||9||
48601627|NCT05052697|101807743|FG003|Vaccination 2|Substudy A||12||
48601628|NCT05052697|101807744|FG004|Vaccination 2|Substudy A||1||
48601629|NCT05052697|101807745|FG005|Vaccination 2|Substudy A||6||
48601630|NCT05052697|101807746|FG006|Vaccination 2|Substudy A||7||
48601631|NCT05052697|101807747|FG007|Vaccination 2|Substudy A||6||
48601632|NCT05052697|101807748|FG008|Vaccination 2|Substudy A||2||
48714521|NCT02266277|102088554|FG005|COMPLETED|Overall Study||5000||
48714522|NCT02266277|102088549|FG000|NOT COMPLETED|Overall Study||0||
48714523|NCT02266277|102088550|FG001|NOT COMPLETED|Overall Study||0||
48714524|NCT02266277|102088551|FG002|NOT COMPLETED|Overall Study||0||
48714525|NCT02266277|102088552|FG003|NOT COMPLETED|Overall Study||0||
48714526|NCT02266277|102088553|FG004|NOT COMPLETED|Overall Study||0||
48714527|NCT02266277|102088554|FG005|NOT COMPLETED|Overall Study||0||
48601633|NCT05052697|101807749|FG009|Vaccination 2|Substudy A||1||
48714528|NCT02437409|102088555|FG000|STARTED|Overall Study||115||
48714529|NCT02437409|102088555|FG000|COMPLETED|Overall Study||100||
48714530|NCT02437409|102088555|FG000|NOT COMPLETED|Overall Study||15||
48299613|NCT03645057|101060174|FG002|COMPLETED|Baseline to Six Weeks||16|Child subjects used their assigned topical medication for 6 weeks (baseline to 6 week study visits). 1 dyad (i.e., 2 subject total = 1 child patient and 1 caregiver) in the crisaborole arm withdrew from the study because the caregiver no longer wanted to participate. 5 dyads (i.e., 10 subject total = 5 child patients and 5 caregivers) in the crisaborole arm were lost to followup. 1 dyad (i.e., 2 subjects total = 1 child patient and 1 caregiver) in the tacrolimus arm was lost to follow-up.|
48368003|NCT00717418|101230088|FG000|NOT COMPLETED|1-Year Follow-Up||147||
48714531|NCT02410824|102088556|FG000|STARTED|First Intervention (One Week)||22||
48714532|NCT02410824|102088557|FG001|STARTED|First Intervention (One Week)||23||
48714533|NCT02410824|102088556|FG000|COMPLETED|First Intervention (One Week)||22||
48714534|NCT02410824|102088557|FG001|COMPLETED|First Intervention (One Week)||22||
48368004|NCT00717418|101230089|FG001|NOT COMPLETED|1-Year Follow-Up||51||
48601634|NCT05052697|101807750|FG010|Vaccination 2|Substudy A||6||
48601635|NCT05052697|101807751|FG011|Vaccination 2|Substudy A||11||
48601636|NCT05052697|101807752|FG012|Vaccination 2|Substudy A||6||
48601637|NCT05052697|101807753|FG013|Vaccination 2|Substudy A||9||
48601638|NCT05052697|101807754|FG014|Vaccination 2|Substudy A||6||
48601639|NCT05052697|101807755|FG015|Vaccination 2|Substudy A||7||
48601640|NCT05052697|101807756|FG016|Vaccination 2|Substudy A||6||
48601641|NCT05052697|101807757|FG017|Vaccination 2|Substudy A||0||
48601642|NCT05052697|101807758|FG018|Vaccination 2|Substudy A||0||
48601643|NCT05052697|101807759|FG019|Vaccination 2|Substudy A||0||
48601644|NCT05052697|101807760|FG020|Vaccination 2|Substudy A||0||
48601645|NCT05052697|101807761|FG021|Vaccination 2|Substudy A||0||
48601646|NCT05052697|101807762|FG022|Vaccination 2|Substudy A||0||
48601647|NCT05052697|101807763|FG023|Vaccination 2|Substudy A||0||
48601648|NCT05052697|101807764|FG024|Vaccination 2|Substudy A||0||
48714535|NCT02410824|102088556|FG000|NOT COMPLETED|First Intervention (One Week)||0||
48714536|NCT02410824|102088557|FG001|NOT COMPLETED|First Intervention (One Week)||1||
48714537|NCT02410824|102088556|FG000|STARTED|Second Intervention (One Week)||22||
48714538|NCT02410824|102088557|FG001|STARTED|Second Intervention (One Week)||22||
48714539|NCT02410824|102088556|FG000|COMPLETED|Second Intervention (One Week)||22||
48714540|NCT02410824|102088557|FG001|COMPLETED|Second Intervention (One Week)||22||
48714541|NCT02410824|102088556|FG000|NOT COMPLETED|Second Intervention (One Week)||0||
48601649|NCT05052697|101807765|FG025|Vaccination 2|Substudy A||0||
48601650|NCT05052697|101807766|FG026|Vaccination 2|Substudy A||0||
48299614|NCT03645057|101060175|FG003|COMPLETED|Baseline to Six Weeks||21|Child subjects used their assigned topical medication for 6 weeks (baseline to 6 week study visits). 1 dyad (i.e., 2 subject total = 1 child patient and 1 caregiver) in the crisaborole arm withdrew from the study because the caregiver no longer wanted to participate. 5 dyads (i.e., 10 subject total = 5 child patients and 5 caregivers) in the crisaborole arm were lost to followup. 1 dyad (i.e., 2 subjects total = 1 child patient and 1 caregiver) in the tacrolimus arm was lost to follow-up.|
48299615|NCT03645057|101060172|FG000|NOT COMPLETED|Baseline to Six Weeks||6||
48299616|NCT03645057|101060173|FG001|NOT COMPLETED|Baseline to Six Weeks||2||
48299617|NCT03645057|101060174|FG002|NOT COMPLETED|Baseline to Six Weeks||6||
48299618|NCT03645057|101060175|FG003|NOT COMPLETED|Baseline to Six Weeks||2||
48299619|NCT03645057|101060172|FG000|STARTED|6 Weeks to 12 Weeks||16|37 dyads (i.e., 74 subject total = 37 child patients and 37 caregivers) completed the 6 week assessment. The child patients continued using their assigned topical medication for 6 weeks until the 12 week study visit.|
48299620|NCT03645057|101060173|FG001|STARTED|6 Weeks to 12 Weeks||21|37 dyads (i.e., 74 subject total = 37 child patients and 37 caregivers) completed the 6 week assessment. The child patients continued using their assigned topical medication for 6 weeks until the 12 week study visit.|
48299621|NCT03645057|101060174|FG002|STARTED|6 Weeks to 12 Weeks||16|37 dyads (i.e., 74 subject total = 37 child patients and 37 caregivers) completed the 6 week assessment. The child patients continued using their assigned topical medication for 6 weeks until the 12 week study visit.|
48299622|NCT03645057|101060175|FG003|STARTED|6 Weeks to 12 Weeks||21|37 dyads (i.e., 74 subject total = 37 child patients and 37 caregivers) completed the 6 week assessment. The child patients continued using their assigned topical medication for 6 weeks until the 12 week study visit.|
48299623|NCT03645057|101060172|FG000|COMPLETED|6 Weeks to 12 Weeks||16|36 dyads (i.e., 72 subjects total = 36 child patients and 36 caregivers) completed their assigned topical medication for 12 weeks and completed the 12 week study visit. 1 dyad (i.e., 2 subject total = 1 child patient and 1 caregiver) in the tacrolimus arm was lost to followup. The 12 week study visit included clinician-rated severity of the child patient's atopic dermatitis, completion of five outcome measures by the child patient, and completion of three outcome measures by the caregiver.|
48405181|NCT04737759|101325210|FG001|Spouse/Partners|Overall Study||19||
48405182|NCT04737759|101325209|FG000|COMPLETED|Overall Study||16||
48405183|NCT04737759|101325210|FG001|COMPLETED|Overall Study||22||
48405184|NCT04737759|101325209|FG000|NOT COMPLETED|Overall Study||20||
48405185|NCT04737759|101325210|FG001|NOT COMPLETED|Overall Study||16||
48714542|NCT02410824|102088557|FG001|NOT COMPLETED|Second Intervention (One Week)||0||
48368005|NCT00717418|101230090|FG002|NOT COMPLETED|1-Year Follow-Up||434||
48368006|NCT00717418|101230091|FG003|NOT COMPLETED|1-Year Follow-Up||4||
48368007|NCT03567291|101230092|FG000|STARTED|Period I||228||
48405186|NCT00195624|101325211|FG000|STARTED|Overall Study||5||
48405187|NCT00195624|101325212|FG001|STARTED|Overall Study||42||
48405188|NCT00195624|101325211|FG000|COMPLETED|Overall Study||5||
48405189|NCT00195624|101325212|FG001|COMPLETED|Overall Study||42||
48405190|NCT00195624|101325211|FG000|NOT COMPLETED|Overall Study||0||
48405191|NCT00195624|101325212|FG001|NOT COMPLETED|Overall Study||0||
48405192|NCT00796224|101325213|FG000|STARTED|Overall Study||19||
48405193|NCT00796224|101325214|FG001|STARTED|Overall Study||19||
48405194|NCT00796224|101325213|FG000|COMPLETED|Overall Study||18||
48405195|NCT00796224|101325214|FG001|COMPLETED|Overall Study||18||
48405196|NCT00796224|101325213|FG000|NOT COMPLETED|Overall Study||1||
48601651|NCT05052697|101807767|FG027|Vaccination 2|Substudy A||0||
48714543|NCT03180398|102088558|FG000|STARTED|Overall Study||9||
48714544|NCT03180398|102088558|FG000|COMPLETED|Overall Study||9||
48714545|NCT03180398|102088558|FG000|NOT COMPLETED|Overall Study||0||
48714546|NCT00499408|102088559|FG000|STARTED|Overall Study||26||
48714547|NCT00499408|102088559|FG000|COMPLETED|Overall Study||26||
48714548|NCT00499408|102088559|FG000|NOT COMPLETED|Overall Study||0||
48714549|NCT00434759|102088560|FG000|STARTED|Overall Study||46||
48714550|NCT00434759|102088561|FG001|STARTED|Overall Study||43||
48299624|NCT03645057|101060173|FG001|COMPLETED|6 Weeks to 12 Weeks||20|36 dyads (i.e., 72 subjects total = 36 child patients and 36 caregivers) completed their assigned topical medication for 12 weeks and completed the 12 week study visit. 1 dyad (i.e., 2 subject total = 1 child patient and 1 caregiver) in the tacrolimus arm was lost to followup. The 12 week study visit included clinician-rated severity of the child patient's atopic dermatitis, completion of five outcome measures by the child patient, and completion of three outcome measures by the caregiver.|
48299625|NCT03645057|101060174|FG002|COMPLETED|6 Weeks to 12 Weeks||16|36 dyads (i.e., 72 subjects total = 36 child patients and 36 caregivers) completed their assigned topical medication for 12 weeks and completed the 12 week study visit. 1 dyad (i.e., 2 subject total = 1 child patient and 1 caregiver) in the tacrolimus arm was lost to followup. The 12 week study visit included clinician-rated severity of the child patient's atopic dermatitis, completion of five outcome measures by the child patient, and completion of three outcome measures by the caregiver.|
48299626|NCT03645057|101060175|FG003|COMPLETED|6 Weeks to 12 Weeks||20|36 dyads (i.e., 72 subjects total = 36 child patients and 36 caregivers) completed their assigned topical medication for 12 weeks and completed the 12 week study visit. 1 dyad (i.e., 2 subject total = 1 child patient and 1 caregiver) in the tacrolimus arm was lost to followup. The 12 week study visit included clinician-rated severity of the child patient's atopic dermatitis, completion of five outcome measures by the child patient, and completion of three outcome measures by the caregiver.|
48299627|NCT03645057|101060172|FG000|NOT COMPLETED|6 Weeks to 12 Weeks||0||
48299628|NCT03645057|101060173|FG001|NOT COMPLETED|6 Weeks to 12 Weeks||1||
48299629|NCT03645057|101060174|FG002|NOT COMPLETED|6 Weeks to 12 Weeks||0||
48299630|NCT03645057|101060175|FG003|NOT COMPLETED|6 Weeks to 12 Weeks||1||
48299631|NCT01463384|101060176|FG000|STARTED|Overall Study||13||
48601652|NCT05052697|101807768|FG028|Vaccination 2|Substudy A||0||
48601653|NCT05052697|101807769|FG029|Vaccination 2|Substudy A||0||
48601654|NCT05052697|101807770|FG030|Vaccination 2|Substudy A||0||
48601655|NCT05052697|101807771|FG031|Vaccination 2|Substudy A||0||
48601656|NCT05052697|101807772|FG032|Vaccination 2|Substudy A||0||
48601657|NCT05052697|101807773|FG033|Vaccination 2|Substudy A||0||
48601658|NCT05052697|101807740|FG000|COMPLETED|Substudy A||15|Indicates participants randomized to either mIRV A, mIRV B, bIRV A, bIRV B or qIRV and received licensed QIV at vaccination 2. Also, includes participants who were randomized to 'Licensed QIV' and received either 'mIRV A or mIRV B at dose level 4' at vaccination 2.|
48601659|NCT05052697|101807741|FG001|COMPLETED|Substudy A||15|Indicates participants randomized to either mIRV A, mIRV B, bIRV A, bIRV B or qIRV and received licensed QIV at vaccination 2. Also, includes participants who were randomized to 'Licensed QIV' and received either 'mIRV A or mIRV B at dose level 4' at vaccination 2.|
48601660|NCT05052697|101807742|FG002|COMPLETED|Substudy A||15|Indicates participants randomized to either mIRV A, mIRV B, bIRV A, bIRV B or qIRV and received licensed QIV at vaccination 2. Also, includes participants who were randomized to 'Licensed QIV' and received either 'mIRV A or mIRV B at dose level 4' at vaccination 2.|
48601661|NCT05052697|101807743|FG003|COMPLETED|Substudy A||14|Indicates participants randomized to either mIRV A, mIRV B, bIRV A, bIRV B or qIRV and received licensed QIV at vaccination 2. Also, includes participants who were randomized to 'Licensed QIV' and received either 'mIRV A or mIRV B at dose level 4' at vaccination 2.|
48601662|NCT05052697|101807744|FG004|COMPLETED|Substudy A||15|Indicates participants randomized to either mIRV A, mIRV B, bIRV A, bIRV B or qIRV and received licensed QIV at vaccination 2. Also, includes participants who were randomized to 'Licensed QIV' and received either 'mIRV A or mIRV B at dose level 4' at vaccination 2.|
48656897|NCT04274218|101943726|FG001|STARTED|Baseline Walking (1 Minute)||6||
48656898|NCT04274218|101943727|FG002|STARTED|Baseline Walking (1 Minute)||5||
48299632|NCT01463384|101060176|FG000|COMPLETED|Overall Study||13||
48299633|NCT01463384|101060176|FG000|NOT COMPLETED|Overall Study||0||
48299634|NCT01281007|101060177|FG000|STARTED|Overall Study||75||
48299635|NCT01281007|101060178|FG001|STARTED|Overall Study||75||
48299636|NCT01281007|101060177|FG000|COMPLETED|Overall Study||71||
48299637|NCT01281007|101060178|FG001|COMPLETED|Overall Study||67||
48299638|NCT01281007|101060177|FG000|NOT COMPLETED|Overall Study||4||
48299639|NCT01281007|101060178|FG001|NOT COMPLETED|Overall Study||8||
48145977|NCT04322682|100679827|FG000|COMPLETED|Overall Study||2192||
48145978|NCT04322682|100679828|FG001|COMPLETED|Overall Study||2189||
48145979|NCT04322682|100679827|FG000|NOT COMPLETED|Overall Study||43||
48145980|NCT04322682|100679828|FG001|NOT COMPLETED|Overall Study||64||
48145981|NCT00827918|100679829|FG000|STARTED|Overall Study||86||
48145982|NCT00827918|100679830|FG001|STARTED|Overall Study||47||
48145983|NCT00827918|100679831|FG002|STARTED|Overall Study||83||
48145984|NCT00827918|100679829|FG000|COMPLETED|Overall Study||58||
48145985|NCT00827918|100679830|FG001|COMPLETED|Overall Study||38||
48145986|NCT00827918|100679831|FG002|COMPLETED|Overall Study||62||
48145987|NCT00827918|100679829|FG000|NOT COMPLETED|Overall Study||28||
48145988|NCT00827918|100679830|FG001|NOT COMPLETED|Overall Study||9||
48145989|NCT00827918|100679831|FG002|NOT COMPLETED|Overall Study||21||
48145990|NCT05706506|100679832|FG000|STARTED|Overall Study||152||
48145991|NCT05706506|100679832|FG000|Received At Least 1 Dose of Study Drug|Overall Study||152||
48145992|NCT05706506|100679832|FG000|COMPLETED|Overall Study||131||
48145993|NCT05706506|100679832|FG000|NOT COMPLETED|Overall Study||21||
48145994|NCT00324870|100679833|FG000|STARTED|Overall Study||37||
48145995|NCT00324870|100679833|FG000|COMPLETED|Overall Study||37||
48145996|NCT00324870|100679833|FG000|NOT COMPLETED|Overall Study||0||
48145997|NCT03565887|100679834|FG000|STARTED|Overall Study||109||
48299640|NCT01776424|101060179|FG000|STARTED|Antithrombotic Part (Double Blind)||9152|Randomized to antithrombotic treatment; intention-to-treat analysis set (ITT)|
48299641|NCT01776424|101060180|FG001|STARTED|Antithrombotic Part (Double Blind)||9117|Randomized to antithrombotic treatment; intention-to-treat analysis set (ITT)|
48299642|NCT01776424|101060181|FG002|STARTED|Antithrombotic Part (Double Blind)||9126|Randomized to antithrombotic treatment; intention-to-treat analysis set (ITT)|
48299643|NCT01776424|101060179|FG000|Treated With Antithrombotic Treatment|Antithrombotic Part (Double Blind)||9134|Safety analysis set (SAF); Antithrombotic treatment: rivaroxaban/placebo and/or study aspirin/placebo|
48145998|NCT03565887|100679835|FG001|STARTED|Overall Study||55||
48145999|NCT03565887|100679834|FG000|COMPLETED|Overall Study||108||
48146000|NCT03565887|100679835|FG001|COMPLETED|Overall Study||53||
48146001|NCT03565887|100679834|FG000|NOT COMPLETED|Overall Study||1||
48146002|NCT03565887|100679835|FG001|NOT COMPLETED|Overall Study||2||
48146003|NCT00499031|100679836|FG000|STARTED|Overall Study||38||
48146004|NCT00499031|100679836|FG000|COMPLETED|Overall Study||35||
48146005|NCT00499031|100679836|FG000|NOT COMPLETED|Overall Study||3||
48146006|NCT01970982|100679837|FG000|STARTED|Overall Study||80||
48146007|NCT01970982|100679838|FG001|STARTED|Overall Study||40||
48146008|NCT01970982|100679839|FG002|STARTED|Overall Study||40||
48146009|NCT01970982|100679837|FG000|COMPLETED|Overall Study||80||
48146010|NCT01970982|100679838|FG001|COMPLETED|Overall Study||40||
48146011|NCT01970982|100679839|FG002|COMPLETED|Overall Study||38||
48146012|NCT01970982|100679837|FG000|NOT COMPLETED|Overall Study||0||
48146013|NCT01970982|100679838|FG001|NOT COMPLETED|Overall Study||0||
48146014|NCT01970982|100679839|FG002|NOT COMPLETED|Overall Study||2||
48146015|NCT04867369|100679840|FG000|STARTED|Overall Study||80||
48601663|NCT05052697|101807745|FG005|COMPLETED|Substudy A||14|Indicates participants randomized to either mIRV A, mIRV B, bIRV A, bIRV B or qIRV and received licensed QIV at vaccination 2. Also, includes participants who were randomized to 'Licensed QIV' and received either 'mIRV A or mIRV B at dose level 4' at vaccination 2.|
48601664|NCT05052697|101807746|FG006|COMPLETED|Substudy A||15|Indicates participants randomized to either mIRV A, mIRV B, bIRV A, bIRV B or qIRV and received licensed QIV at vaccination 2. Also, includes participants who were randomized to 'Licensed QIV' and received either 'mIRV A or mIRV B at dose level 4' at vaccination 2.|
48601665|NCT05052697|101807747|FG007|COMPLETED|Substudy A||16|Indicates participants randomized to either mIRV A, mIRV B, bIRV A, bIRV B or qIRV and received licensed QIV at vaccination 2. Also, includes participants who were randomized to 'Licensed QIV' and received either 'mIRV A or mIRV B at dose level 4' at vaccination 2.|
48656899|NCT04274218|101943728|FG003|STARTED|Baseline Walking (1 Minute)||4||
48146016|NCT04867369|100679841|FG001|STARTED|Overall Study||80||
48146017|NCT04867369|100679840|FG000|COMPLETED|Overall Study||79||
48146018|NCT04867369|100679841|FG001|COMPLETED|Overall Study||80||
48146019|NCT04867369|100679840|FG000|NOT COMPLETED|Overall Study||1||
48146020|NCT04867369|100679841|FG001|NOT COMPLETED|Overall Study||0||
48146021|NCT02666950|100679842|FG000|STARTED|Overall Study||3||
48146022|NCT02666950|100679842|FG000|COMPLETED|Overall Study||3||
48405197|NCT00796224|101325214|FG001|NOT COMPLETED|Overall Study||1||
48405198|NCT02774291|101325215|FG000|STARTED|Overall Study||3||
48405199|NCT02774291|101325215|FG000|COMPLETED|Overall Study||2||
48405200|NCT02774291|101325215|FG000|NOT COMPLETED|Overall Study||1||
48405201|NCT04362189|101325216|FG000|STARTED|Overall Study||33||
48405202|NCT04362189|101325217|FG001|STARTED|Overall Study||15||
48405203|NCT04362189|101325216|FG000|COMPLETED|Overall Study||18||
48405204|NCT04362189|101325217|FG001|COMPLETED|Overall Study||9||
48656900|NCT04274218|101943725|FG000|COMPLETED|Baseline Walking (1 Minute)||5||
48714551|NCT00434759|102088560|FG000|COMPLETED|Overall Study||22||
48714552|NCT00434759|102088561|FG001|COMPLETED|Overall Study||38||
48714553|NCT00434759|102088560|FG000|NOT COMPLETED|Overall Study||24||
48146023|NCT02666950|100679842|FG000|NOT COMPLETED|Overall Study||0||
48146024|NCT03085485|100679843|FG000|STARTED|Overall Study||30||
48146025|NCT03085485|100679844|FG001|STARTED|Overall Study||10||
48714554|NCT00434759|102088561|FG001|NOT COMPLETED|Overall Study||5||
48146026|NCT03085485|100679843|FG000|COMPLETED|Overall Study||28||
48146027|NCT03085485|100679844|FG001|COMPLETED|Overall Study||10||
48405205|NCT04362189|101325216|FG000|NOT COMPLETED|Overall Study||15||
48405206|NCT04362189|101325217|FG001|NOT COMPLETED|Overall Study||6||
48656901|NCT04274218|101943726|FG001|COMPLETED|Baseline Walking (1 Minute)||6||
48714555|NCT03343080|102088562|FG000|STARTED|Overall Study||14||
48714556|NCT03343080|102088563|FG001|STARTED|Overall Study||18||
48714557|NCT03343080|102088562|FG000|COMPLETED|Overall Study||14||
48714558|NCT03343080|102088563|FG001|COMPLETED|Overall Study||18||
48714559|NCT03343080|102088562|FG000|NOT COMPLETED|Overall Study||0||
48714560|NCT03343080|102088563|FG001|NOT COMPLETED|Overall Study||0||
48714561|NCT02648022|102088564|FG000|STARTED|Overall Study||40||
48714562|NCT02648022|102088565|FG001|STARTED|Overall Study||39||
48714563|NCT02648022|102088564|FG000|COMPLETED|Overall Study||40||
48714564|NCT02648022|102088565|FG001|COMPLETED|Overall Study||39||
48714565|NCT02648022|102088564|FG000|NOT COMPLETED|Overall Study||0||
48714566|NCT02648022|102088565|FG001|NOT COMPLETED|Overall Study||0||
48714567|NCT00149994|102088566|FG000|STARTED|Overall Study||85||
48714568|NCT00149994|102088567|FG001|STARTED|Overall Study||86||
48714569|NCT00149994|102088566|FG000|COMPLETED|Overall Study||84||
48714570|NCT00149994|102088567|FG001|COMPLETED|Overall Study||85||
48714571|NCT00149994|102088566|FG000|NOT COMPLETED|Overall Study||1||
48146028|NCT03085485|100679843|FG000|NOT COMPLETED|Overall Study||2||
48405207|NCT03788967|101325218|FG000|STARTED|Overall Study||685||
48405208|NCT03788967|101325219|FG001|STARTED|Overall Study||687||
48146029|NCT03085485|100679844|FG001|NOT COMPLETED|Overall Study||0||
48188524|NCT00031447|100783264|FG000|NOT COMPLETED|Overall Study||10||
48440009|NCT03046966|101410009|FG000|STARTED|Overall Study||51||
48188525|NCT00031447|100783265|FG001|NOT COMPLETED|Overall Study||7||
48714572|NCT00149994|102088567|FG001|NOT COMPLETED|Overall Study||1||
48714573|NCT03208530|102088568|FG000|STARTED|Overall Study||75||
48714574|NCT03208530|102088568|FG000|COMPLETED|Overall Study||48||
48714575|NCT03208530|102088568|FG000|NOT COMPLETED|Overall Study||27||
48714576|NCT00997425|102088569|FG000|STARTED|Overall Study||19||
48714577|NCT00997425|102088569|FG000|COMPLETED|Overall Study||19||
48714578|NCT00997425|102088569|FG000|NOT COMPLETED|Overall Study||0||
48714579|NCT03398265|102088570|FG000|STARTED|Overall Study||7||
48714580|NCT03398265|102088571|FG001|STARTED|Overall Study||8||
48714581|NCT03398265|102088570|FG000|COMPLETED|Overall Study||7||
48714582|NCT03398265|102088571|FG001|COMPLETED|Overall Study||8||
48714583|NCT03398265|102088570|FG000|NOT COMPLETED|Overall Study||0||
48146030|NCT01429532|100682267|FG000|STARTED|Overall Study||40||
48146031|NCT01429532|100682268|FG001|STARTED|Overall Study||40||
48146032|NCT01429532|100682269|FG002|STARTED|Overall Study||40||
48146033|NCT01429532|100682267|FG000|COMPLETED|Overall Study||40||
48146034|NCT01429532|100682268|FG001|COMPLETED|Overall Study||40||
48146035|NCT01429532|100682269|FG002|COMPLETED|Overall Study||40||
48146036|NCT01429532|100682267|FG000|NOT COMPLETED|Overall Study||0||
48146037|NCT01429532|100682268|FG001|NOT COMPLETED|Overall Study||0||
48146038|NCT01429532|100682269|FG002|NOT COMPLETED|Overall Study||0||
48146039|NCT00796302|100682270|FG000|STARTED|Overall Study||84||
48146040|NCT00796302|100682271|FG001|STARTED|Overall Study||84||
48146041|NCT00796302|100682270|FG000|COMPLETED|Overall Study||71||
48146042|NCT00796302|100682271|FG001|COMPLETED|Overall Study||66||
48146043|NCT00796302|100682270|FG000|NOT COMPLETED|Overall Study||13||
48146044|NCT00796302|100682271|FG001|NOT COMPLETED|Overall Study||18||
48146045|NCT01335204|100682272|FG000|STARTED|Overall Study||4||
48146046|NCT01335204|100682272|FG000|COMPLETED|Overall Study||4||
48405209|NCT03788967|101325218|FG000|Micro-Intent-to-Treat (ITT) Population|Overall Study||449|Micro-ITT=all randomized participants with a confirmed diagnosis of cUTI or AP and a positive Screening urine culture defined as growth of one or two uropathogens at ≥10\^5 CFU/mL and/or positive Screening blood culture with isolation of one or more uropathogens.|
48405210|NCT03788967|101325219|FG001|Micro-Intent-to-Treat (ITT) Population|Overall Study||419|Micro-ITT=all randomized participants with a confirmed diagnosis of cUTI or AP and a positive Screening urine culture defined as growth of one or two uropathogens at ≥10\^5 CFU/mL and/or positive Screening blood culture with isolation of one or more uropathogens.|
48405211|NCT03788967|101325218|FG000|COMPLETED|Overall Study||653||
48405212|NCT03788967|101325219|FG001|COMPLETED|Overall Study||663||
48405213|NCT03788967|101325218|FG000|NOT COMPLETED|Overall Study||32||
48405214|NCT03788967|101325219|FG001|NOT COMPLETED|Overall Study||24||
48405215|NCT01838213|101325220|FG000|STARTED|Overall Study||247||
48405216|NCT01838213|101325221|FG001|STARTED|Overall Study||453||
48405217|NCT01838213|101325220|FG000|COMPLETED|Overall Study||81||
48146047|NCT01335204|100682272|FG000|NOT COMPLETED|Overall Study||0||
48146048|NCT01988779|100682273|FG000|STARTED|Overall Study||12||
48146049|NCT01988779|100682274|FG001|STARTED|Overall Study||13||
48146050|NCT01988779|100682273|FG000|COMPLETED|Overall Study||9||
48146051|NCT01988779|100682274|FG001|COMPLETED|Overall Study||11||
48146052|NCT01988779|100682273|FG000|NOT COMPLETED|Overall Study||3||
48146053|NCT01988779|100682274|FG001|NOT COMPLETED|Overall Study||2||
48146054|NCT02061202|100682275|FG000|STARTED|Overall Study||36||
48146055|NCT02061202|100682276|FG001|STARTED|Overall Study||18||
48405218|NCT01838213|101325221|FG001|COMPLETED|Overall Study||262||
48405219|NCT01838213|101325220|FG000|NOT COMPLETED|Overall Study||166||
48405220|NCT01838213|101325221|FG001|NOT COMPLETED|Overall Study||191||
48405221|NCT01826448|101325222|FG000|STARTED|Overall Study||4||
48405222|NCT01826448|101325223|FG001|STARTED|Overall Study||9||
48714584|NCT03398265|102088571|FG001|NOT COMPLETED|Overall Study||0||
48714585|NCT00543296|102088572|FG000|STARTED|Overall Study||21||
48714586|NCT00543296|102088572|FG000|COMPLETED|Overall Study||14||
48714587|NCT00543296|102088572|FG000|NOT COMPLETED|Overall Study||7||
48714588|NCT00693654|102088573|FG000|STARTED|Overall Study||14||
48714589|NCT00693654|102088574|FG001|STARTED|Overall Study||14||
48714590|NCT00693654|102088573|FG000|COMPLETED|Overall Study||14||
48714591|NCT00693654|102088574|FG001|COMPLETED|Overall Study||14||
48714592|NCT00693654|102088573|FG000|NOT COMPLETED|Overall Study||0||
48714593|NCT00693654|102088574|FG001|NOT COMPLETED|Overall Study||0||
48714594|NCT02753127|102088575|FG000|STARTED|Overall Study||624||
48714595|NCT02753127|102088576|FG001|STARTED|Overall Study||629||
48714596|NCT02753127|102088575|FG000|Discontinued Due to Death|Overall Study||507||
48714597|NCT02753127|102088576|FG001|Discontinued Due to Death|Overall Study||499||
48714598|NCT02753127|102088575|FG000|Completion of Survival Follow-Up Due to Study Completion|Overall Study||64||
48714599|NCT02753127|102088576|FG001|Completion of Survival Follow-Up Due to Study Completion|Overall Study||62||
48714600|NCT02753127|102088575|FG000|COMPLETED|Overall Study||571||
48714601|NCT02753127|102088576|FG001|COMPLETED|Overall Study||561||
48714602|NCT02753127|102088575|FG000|NOT COMPLETED|Overall Study||53||
48714603|NCT02753127|102088576|FG001|NOT COMPLETED|Overall Study||68||
48714604|NCT03879044|102088577|FG000|STARTED|Overall Study||30||
48714605|NCT03879044|102088577|FG000|COMPLETED|Overall Study||26||
48146056|NCT02061202|100682275|FG000|COMPLETED|Overall Study||35||
48146057|NCT02061202|100682276|FG001|COMPLETED|Overall Study||17||
48146058|NCT02061202|100682275|FG000|NOT COMPLETED|Overall Study||1||
48146059|NCT02061202|100682276|FG001|NOT COMPLETED|Overall Study||1||
48146060|NCT04321239|100682277|FG000|STARTED|Overall Study||25||
48146061|NCT04321239|100682278|FG001|STARTED|Overall Study||26||
48405223|NCT01826448|101325222|FG000|COMPLETED|Overall Study||0||
48405224|NCT01826448|101325223|FG001|COMPLETED|Overall Study||0||
48405225|NCT01826448|101325222|FG000|NOT COMPLETED|Overall Study||4||
48405226|NCT01826448|101325223|FG001|NOT COMPLETED|Overall Study||9||
48405227|NCT04228445|101325224|FG000|STARTED|Overall Study||62||
48405228|NCT04228445|101325225|FG001|STARTED|Overall Study||59||
48405229|NCT04228445|101325224|FG000|COMPLETED|Overall Study||59||
48405230|NCT04228445|101325225|FG001|COMPLETED|Overall Study||55||
48405231|NCT04228445|101325224|FG000|NOT COMPLETED|Overall Study||3||
48405232|NCT04228445|101325225|FG001|NOT COMPLETED|Overall Study||4||
48405233|NCT01505114|101325226|FG000|STARTED|Overall Study||148||
48405234|NCT01505114|101325227|FG001|STARTED|Overall Study||148||
48405235|NCT01505114|101325228|FG002|STARTED|Overall Study||147||
48405236|NCT01505114|101325229|FG003|STARTED|Overall Study||151||
48714606|NCT03879044|102088577|FG000|NOT COMPLETED|Overall Study||4||
48714607|NCT03627065|102088578|FG000|STARTED|Overall Study||10||
48714608|NCT03627065|102088578|FG000|COMPLETED|Overall Study||7||
48714609|NCT03627065|102088578|FG000|NOT COMPLETED|Overall Study||3||
48714610|NCT02568449|102088579|FG000|STARTED|Overall Study||20||
48714611|NCT02568449|102088579|FG000|COMPLETED|Overall Study||20||
48714612|NCT02568449|102088579|FG000|NOT COMPLETED|Overall Study||0||
48714613|NCT02330523|102088580|FG000|STARTED|Overall Study||21||
48714614|NCT02330523|102088581|FG001|STARTED|Overall Study||19||
48714615|NCT02330523|102088580|FG000|COMPLETED|Overall Study||21||
48714616|NCT02330523|102088581|FG001|COMPLETED|Overall Study||19||
48714617|NCT02330523|102088580|FG000|NOT COMPLETED|Overall Study||0||
48714618|NCT02330523|102088581|FG001|NOT COMPLETED|Overall Study||0||
48714619|NCT01765426|102088582|FG000|STARTED|Overall Study||18||
48714620|NCT01765426|102088583|FG001|STARTED|Overall Study||17||
48714621|NCT01765426|102088584|FG002|STARTED|Overall Study||17||
48714622|NCT01765426|102088585|FG003|STARTED|Overall Study||15||
48714623|NCT01765426|102088582|FG000|Completed All Vaccinations|Overall Study||17||
48714624|NCT01765426|102088583|FG001|Completed All Vaccinations|Overall Study||16||
48714625|NCT01765426|102088584|FG002|Completed All Vaccinations|Overall Study||17||
48714626|NCT01765426|102088585|FG003|Completed All Vaccinations|Overall Study||15||
48714627|NCT01765426|102088582|FG000|COMPLETED|Overall Study||18||
48714628|NCT01765426|102088583|FG001|COMPLETED|Overall Study||16||
48714629|NCT01765426|102088584|FG002|COMPLETED|Overall Study||17||
48714630|NCT01765426|102088585|FG003|COMPLETED|Overall Study||15||
48714631|NCT01765426|102088582|FG000|NOT COMPLETED|Overall Study||0||
48714632|NCT01765426|102088583|FG001|NOT COMPLETED|Overall Study||1||
48714633|NCT01765426|102088584|FG002|NOT COMPLETED|Overall Study||0||
48714634|NCT01765426|102088585|FG003|NOT COMPLETED|Overall Study||0||
48714635|NCT02827500|102088586|FG000|STARTED|Overall Study||52||
48714636|NCT02827500|102088587|FG001|STARTED|Overall Study||52||
48714637|NCT02827500|102088586|FG000|COMPLETED|Overall Study||33||
48714638|NCT02827500|102088587|FG001|COMPLETED|Overall Study||45||
48714639|NCT02827500|102088586|FG000|NOT COMPLETED|Overall Study||19||
48714640|NCT02827500|102088587|FG001|NOT COMPLETED|Overall Study||7||
48714641|NCT00554619|102088588|FG000|STARTED|Overall Study||21||
48714642|NCT00554619|102088588|FG000|COMPLETED|Overall Study||18||
48714643|NCT00554619|102088588|FG000|NOT COMPLETED|Overall Study||3||
48714644|NCT00657371|102088589|FG000|STARTED|Overall Study||288||
48714645|NCT00657371|102088589|FG000|COMPLETED|Overall Study||249||
48714646|NCT00657371|102088589|FG000|NOT COMPLETED|Overall Study||39||
48714647|NCT03697993|102088590|FG000|STARTED|Overall Study||32||
48714648|NCT03697993|102088591|FG001|STARTED|Overall Study||30||
48714649|NCT03697993|102088590|FG000|Initiated Treatment|Overall Study||30||
48714650|NCT03697993|102088591|FG001|Initiated Treatment|Overall Study||28||
48714651|NCT03697993|102088590|FG000|Switched Treatment|Overall Study||0|All participants who switched treatment within a strategy switched before initiation of the original treatment.|
48714652|NCT03697993|102088591|FG001|Switched Treatment|Overall Study||6|All participants who switched treatment within a strategy switched before initiation of the original treatment.|
48714653|NCT03697993|102088590|FG000|Treated With at Least Two Dose of Fosfomycin|Overall Study||27||
48714654|NCT03697993|102088591|FG001|Treated With at Least Two Dose of Fosfomycin|Overall Study||4||
48714655|NCT03697993|102088590|FG000|COMPLETED|Overall Study||22||
48714656|NCT03697993|102088591|FG001|COMPLETED|Overall Study||25||
48714657|NCT03697993|102088590|FG000|NOT COMPLETED|Overall Study||10||
48714658|NCT03697993|102088591|FG001|NOT COMPLETED|Overall Study||5||
48714659|NCT01287377|102088592|FG000|STARTED|Overall Study||80||
48714660|NCT01287377|102088593|FG001|STARTED|Overall Study||81||
48146062|NCT04321239|100682277|FG000|COMPLETED|Overall Study||22||
48405237|NCT01505114|101325226|FG000|COMPLETED|Overall Study||123||
48405238|NCT01505114|101325227|FG001|COMPLETED|Overall Study||135||
48405239|NCT01505114|101325228|FG002|COMPLETED|Overall Study||129||
48714661|NCT01287377|102088594|FG002|STARTED|Overall Study||82||
48714662|NCT01287377|102088592|FG000|COMPLETED|Overall Study||80||
48714663|NCT01287377|102088593|FG001|COMPLETED|Overall Study||81||
48714664|NCT01287377|102088594|FG002|COMPLETED|Overall Study||82||
48146063|NCT04321239|100682278|FG001|COMPLETED|Overall Study||24||
48405240|NCT01505114|101325229|FG003|COMPLETED|Overall Study||128||
48405241|NCT01505114|101325226|FG000|NOT COMPLETED|Overall Study||25||
48601666|NCT05052697|101807748|FG008|COMPLETED|Substudy A||14|Indicates participants randomized to either mIRV A, mIRV B, bIRV A, bIRV B or qIRV and received licensed QIV at vaccination 2. Also, includes participants who were randomized to 'Licensed QIV' and received either 'mIRV A or mIRV B at dose level 4' at vaccination 2.|
48601667|NCT05052697|101807749|FG009|COMPLETED|Substudy A||15|Indicates participants randomized to either mIRV A, mIRV B, bIRV A, bIRV B or qIRV and received licensed QIV at vaccination 2. Also, includes participants who were randomized to 'Licensed QIV' and received either 'mIRV A or mIRV B at dose level 4' at vaccination 2.|
48601668|NCT05052697|101807750|FG010|COMPLETED|Substudy A||15|Indicates participants randomized to either mIRV A, mIRV B, bIRV A, bIRV B or qIRV and received licensed QIV at vaccination 2. Also, includes participants who were randomized to 'Licensed QIV' and received either 'mIRV A or mIRV B at dose level 4' at vaccination 2.|
48146064|NCT04321239|100682277|FG000|NOT COMPLETED|Overall Study||3||
48146065|NCT04321239|100682278|FG001|NOT COMPLETED|Overall Study||2||
48146066|NCT04004611|100682279|FG000|STARTED|OL Induction Period (Wk 0-12)||10||
48146067|NCT04004611|100682280|FG001|STARTED|OL Induction Period (Wk 0-12)||5||
48146068|NCT04004611|100682281|FG002|STARTED|OL Induction Period (Wk 0-12)||11||
48146069|NCT04004611|100682282|FG003|STARTED|OL Induction Period (Wk 0-12)||0||
48146070|NCT04004611|100682283|FG004|STARTED|OL Induction Period (Wk 0-12)||0||
48146071|NCT04004611|100682284|FG005|STARTED|OL Induction Period (Wk 0-12)||0||
48146072|NCT04004611|100682285|FG006|STARTED|OL Induction Period (Wk 0-12)||0||
48146073|NCT04004611|100682286|FG007|STARTED|OL Induction Period (Wk 0-12)||0||
48146074|NCT04004611|100682287|FG008|STARTED|OL Induction Period (Wk 0-12)||0||
48146075|NCT04004611|100682279|FG000|COMPLETED|OL Induction Period (Wk 0-12)||10||
48146076|NCT04004611|100682280|FG001|COMPLETED|OL Induction Period (Wk 0-12)||5||
48146077|NCT04004611|100682281|FG002|COMPLETED|OL Induction Period (Wk 0-12)||11||
48146078|NCT04004611|100682282|FG003|COMPLETED|OL Induction Period (Wk 0-12)||0||
48146079|NCT04004611|100682283|FG004|COMPLETED|OL Induction Period (Wk 0-12)||0||
48146080|NCT04004611|100682284|FG005|COMPLETED|OL Induction Period (Wk 0-12)||0||
48146081|NCT04004611|100682285|FG006|COMPLETED|OL Induction Period (Wk 0-12)||0||
48146082|NCT04004611|100682286|FG007|COMPLETED|OL Induction Period (Wk 0-12)||0||
48146083|NCT04004611|100682287|FG008|COMPLETED|OL Induction Period (Wk 0-12)||0||
48146084|NCT04004611|100682279|FG000|NOT COMPLETED|OL Induction Period (Wk 0-12)||0||
48146085|NCT04004611|100682280|FG001|NOT COMPLETED|OL Induction Period (Wk 0-12)||0||
48146086|NCT04004611|100682281|FG002|NOT COMPLETED|OL Induction Period (Wk 0-12)||0||
48146087|NCT04004611|100682282|FG003|NOT COMPLETED|OL Induction Period (Wk 0-12)||0||
48146088|NCT04004611|100682283|FG004|NOT COMPLETED|OL Induction Period (Wk 0-12)||0||
48146089|NCT04004611|100682284|FG005|NOT COMPLETED|OL Induction Period (Wk 0-12)||0||
48146090|NCT04004611|100682285|FG006|NOT COMPLETED|OL Induction Period (Wk 0-12)||0||
48714665|NCT01287377|102088592|FG000|NOT COMPLETED|Overall Study||0||
48146091|NCT04004611|100682286|FG007|NOT COMPLETED|OL Induction Period (Wk 0-12)||0||
48146092|NCT04004611|100682287|FG008|NOT COMPLETED|OL Induction Period (Wk 0-12)||0||
48146093|NCT04004611|100682279|FG000|STARTED|OL Maintenance Period (Wk 12-52)||0||
48146094|NCT04004611|100682280|FG001|STARTED|OL Maintenance Period (Wk 12-52)||0||
48146095|NCT04004611|100682281|FG002|STARTED|OL Maintenance Period (Wk 12-52)||0||
48146096|NCT04004611|100682282|FG003|STARTED|OL Maintenance Period (Wk 12-52)||1||
48146097|NCT04004611|100682283|FG004|STARTED|OL Maintenance Period (Wk 12-52)||8||
48146098|NCT04004611|100682284|FG005|STARTED|OL Maintenance Period (Wk 12-52)||9||
48146099|NCT04004611|100682285|FG006|STARTED|OL Maintenance Period (Wk 12-52)||1||
48146100|NCT04004611|100682286|FG007|STARTED|OL Maintenance Period (Wk 12-52)||1||
48601669|NCT05052697|101807751|FG011|COMPLETED|Substudy A||15|Indicates participants randomized to either mIRV A, mIRV B, bIRV A, bIRV B or qIRV and received licensed QIV at vaccination 2. Also, includes participants who were randomized to 'Licensed QIV' and received either 'mIRV A or mIRV B at dose level 4' at vaccination 2.|
48714666|NCT01287377|102088593|FG001|NOT COMPLETED|Overall Study||0||
48714667|NCT01287377|102088594|FG002|NOT COMPLETED|Overall Study||0||
48146101|NCT04004611|100682287|FG008|STARTED|OL Maintenance Period (Wk 12-52)||6||
48146102|NCT04004611|100682279|FG000|COMPLETED|OL Maintenance Period (Wk 12-52)||0||
48146103|NCT04004611|100682280|FG001|COMPLETED|OL Maintenance Period (Wk 12-52)||0||
48146104|NCT04004611|100682281|FG002|COMPLETED|OL Maintenance Period (Wk 12-52)||0||
48146105|NCT04004611|100682282|FG003|COMPLETED|OL Maintenance Period (Wk 12-52)||1||
48146106|NCT04004611|100682283|FG004|COMPLETED|OL Maintenance Period (Wk 12-52)||7||
48146107|NCT04004611|100682284|FG005|COMPLETED|OL Maintenance Period (Wk 12-52)||8||
48146108|NCT04004611|100682285|FG006|COMPLETED|OL Maintenance Period (Wk 12-52)||0||
48146109|NCT04004611|100682286|FG007|COMPLETED|OL Maintenance Period (Wk 12-52)||1||
48146110|NCT04004611|100682287|FG008|COMPLETED|OL Maintenance Period (Wk 12-52)||2||
48146111|NCT04004611|100682279|FG000|NOT COMPLETED|OL Maintenance Period (Wk 12-52)||0||
48146112|NCT04004611|100682280|FG001|NOT COMPLETED|OL Maintenance Period (Wk 12-52)||0||
48146113|NCT04004611|100682281|FG002|NOT COMPLETED|OL Maintenance Period (Wk 12-52)||0||
48146114|NCT04004611|100682282|FG003|NOT COMPLETED|OL Maintenance Period (Wk 12-52)||0||
48146115|NCT04004611|100682283|FG004|NOT COMPLETED|OL Maintenance Period (Wk 12-52)||1||
48146116|NCT04004611|100682284|FG005|NOT COMPLETED|OL Maintenance Period (Wk 12-52)||1||
48146117|NCT04004611|100682285|FG006|NOT COMPLETED|OL Maintenance Period (Wk 12-52)||1||
48146118|NCT04004611|100682286|FG007|NOT COMPLETED|OL Maintenance Period (Wk 12-52)||0||
48146119|NCT04004611|100682287|FG008|NOT COMPLETED|OL Maintenance Period (Wk 12-52)||4||
48146120|NCT04004611|100682279|FG000|STARTED|OL Induction and Maintenance Period||10||
48714668|NCT01149486|102088595|FG000|STARTED|First Intervention||10||
48405242|NCT01505114|101325227|FG001|NOT COMPLETED|Overall Study||13||
48601670|NCT05052697|101807752|FG012|COMPLETED|Substudy A||15|Indicates participants randomized to either mIRV A, mIRV B, bIRV A, bIRV B or qIRV and received licensed QIV at vaccination 2. Also, includes participants who were randomized to 'Licensed QIV' and received either 'mIRV A or mIRV B at dose level 4' at vaccination 2.|
48601671|NCT05052697|101807753|FG013|COMPLETED|Substudy A||14|Indicates participants randomized to either mIRV A, mIRV B, bIRV A, bIRV B or qIRV and received licensed QIV at vaccination 2. Also, includes participants who were randomized to 'Licensed QIV' and received either 'mIRV A or mIRV B at dose level 4' at vaccination 2.|
48714669|NCT01149486|102088596|FG001|STARTED|First Intervention||10||
48714670|NCT01149486|102088595|FG000|COMPLETED|First Intervention||10||
48601672|NCT05052697|101807754|FG014|COMPLETED|Substudy A||15|Indicates participants randomized to either mIRV A, mIRV B, bIRV A, bIRV B or qIRV and received licensed QIV at vaccination 2. Also, includes participants who were randomized to 'Licensed QIV' and received either 'mIRV A or mIRV B at dose level 4' at vaccination 2.|
48601673|NCT05052697|101807755|FG015|COMPLETED|Substudy A||13|Indicates participants randomized to either mIRV A, mIRV B, bIRV A, bIRV B or qIRV and received licensed QIV at vaccination 2. Also, includes participants who were randomized to 'Licensed QIV' and received either 'mIRV A or mIRV B at dose level 4' at vaccination 2.|
48601674|NCT05052697|101807756|FG016|COMPLETED|Substudy A||15|Indicates participants randomized to either mIRV A, mIRV B, bIRV A, bIRV B or qIRV and received licensed QIV at vaccination 2. Also, includes participants who were randomized to 'Licensed QIV' and received either 'mIRV A or mIRV B at dose level 4' at vaccination 2.|
48601675|NCT05052697|101807757|FG017|COMPLETED|Substudy A||0|Indicates participants randomized to either mIRV A, mIRV B, bIRV A, bIRV B or qIRV and received licensed QIV at vaccination 2. Also, includes participants who were randomized to 'Licensed QIV' and received either 'mIRV A or mIRV B at dose level 4' at vaccination 2.|
48146121|NCT04004611|100682280|FG001|STARTED|OL Induction and Maintenance Period||5||
48601676|NCT05052697|101807758|FG018|COMPLETED|Substudy A||0|Indicates participants randomized to either mIRV A, mIRV B, bIRV A, bIRV B or qIRV and received licensed QIV at vaccination 2. Also, includes participants who were randomized to 'Licensed QIV' and received either 'mIRV A or mIRV B at dose level 4' at vaccination 2.|
48146122|NCT04004611|100682281|FG002|STARTED|OL Induction and Maintenance Period||11||
48146123|NCT04004611|100682282|FG003|STARTED|OL Induction and Maintenance Period||0||
48657071|NCT03648372|101943769|FG012|COMPLETED|Overall Study||1||
48714671|NCT01149486|102088596|FG001|COMPLETED|First Intervention||9||
48714672|NCT01149486|102088595|FG000|NOT COMPLETED|First Intervention||0||
48714673|NCT01149486|102088596|FG001|NOT COMPLETED|First Intervention||1||
48714674|NCT01149486|102088595|FG000|STARTED|Washout of 7 Days||10||
48714675|NCT01149486|102088596|FG001|STARTED|Washout of 7 Days||9||
48714676|NCT01149486|102088595|FG000|COMPLETED|Washout of 7 Days||10||
48714677|NCT01149486|102088596|FG001|COMPLETED|Washout of 7 Days||9||
48714678|NCT01149486|102088595|FG000|NOT COMPLETED|Washout of 7 Days||0||
48714679|NCT01149486|102088596|FG001|NOT COMPLETED|Washout of 7 Days||0||
48714680|NCT01149486|102088595|FG000|STARTED|Second Intervention||10||
48714681|NCT01149486|102088596|FG001|STARTED|Second Intervention||9||
48714682|NCT01149486|102088595|FG000|COMPLETED|Second Intervention||10||
48714683|NCT01149486|102088596|FG001|COMPLETED|Second Intervention||9||
48714684|NCT01149486|102088595|FG000|NOT COMPLETED|Second Intervention||0||
48714685|NCT01149486|102088596|FG001|NOT COMPLETED|Second Intervention||0||
48714686|NCT02370095|102088597|FG000|STARTED|Overall Study||10||
48714687|NCT02370095|102088598|FG001|STARTED|Overall Study||4||
48714688|NCT02370095|102088597|FG000|COMPLETED|Overall Study||10||
48714689|NCT02370095|102088598|FG001|COMPLETED|Overall Study||3||
48714690|NCT02370095|102088597|FG000|NOT COMPLETED|Overall Study||0||
48714691|NCT02370095|102088598|FG001|NOT COMPLETED|Overall Study||1||
48146124|NCT04004611|100682283|FG004|STARTED|OL Induction and Maintenance Period||0||
48714692|NCT03824405|102088599|FG000|STARTED|Overall Study||100||
48714693|NCT03824405|102088600|FG001|STARTED|Overall Study||100||
48714694|NCT03824405|102088599|FG000|COMPLETED|Overall Study||65||
48714695|NCT03824405|102088600|FG001|COMPLETED|Overall Study||55||
48714696|NCT03824405|102088599|FG000|NOT COMPLETED|Overall Study||35||
48714697|NCT03824405|102088600|FG001|NOT COMPLETED|Overall Study||45||
48714698|NCT04126564|102088601|FG000|STARTED|Overall Study||35||
48714699|NCT04126564|102088602|FG001|STARTED|Overall Study||36||
48714700|NCT04126564|102088601|FG000|Study Phase I (30 Days)|Overall Study||35|1 Control participant withdrew during Study phase I|
48714701|NCT04126564|102088602|FG001|Study Phase I (30 Days)|Overall Study||35|1 Control participant withdrew during Study phase I|
48714702|NCT04126564|102088601|FG000|Study Phase II (30 Days)|Overall Study||35|"Cross-over period where all of participants from the Control group initiated IEO intervention,~1control participant was Lost to Follow Up"|
48714703|NCT04126564|102088602|FG001|Study Phase II (30 Days)|Overall Study||34|"Cross-over period where all of participants from the Control group initiated IEO intervention,~1control participant was Lost to Follow Up"|
48714704|NCT04126564|102088601|FG000|Follow Up for Control Group Then IEO Intervention Group Only (30 Days)|Overall Study||0|1 participant withdrew consent from the study|
48714705|NCT04126564|102088602|FG001|Follow Up for Control Group Then IEO Intervention Group Only (30 Days)|Overall Study||33|1 participant withdrew consent from the study|
48714706|NCT04126564|102088601|FG000|COMPLETED|Overall Study||35||
48714707|NCT04126564|102088602|FG001|COMPLETED|Overall Study||33||
48714708|NCT04126564|102088601|FG000|NOT COMPLETED|Overall Study||0||
48714709|NCT04126564|102088602|FG001|NOT COMPLETED|Overall Study||3||
48146125|NCT04004611|100682284|FG005|STARTED|OL Induction and Maintenance Period||0||
48601677|NCT05052697|101807759|FG019|COMPLETED|Substudy A||0|Indicates participants randomized to either mIRV A, mIRV B, bIRV A, bIRV B or qIRV and received licensed QIV at vaccination 2. Also, includes participants who were randomized to 'Licensed QIV' and received either 'mIRV A or mIRV B at dose level 4' at vaccination 2.|
48601678|NCT05052697|101807760|FG020|COMPLETED|Substudy A||0|Indicates participants randomized to either mIRV A, mIRV B, bIRV A, bIRV B or qIRV and received licensed QIV at vaccination 2. Also, includes participants who were randomized to 'Licensed QIV' and received either 'mIRV A or mIRV B at dose level 4' at vaccination 2.|
48601679|NCT05052697|101807761|FG021|COMPLETED|Substudy A||0|Indicates participants randomized to either mIRV A, mIRV B, bIRV A, bIRV B or qIRV and received licensed QIV at vaccination 2. Also, includes participants who were randomized to 'Licensed QIV' and received either 'mIRV A or mIRV B at dose level 4' at vaccination 2.|
48656902|NCT04274218|101943727|FG002|COMPLETED|Baseline Walking (1 Minute)||5||
48299644|NCT01776424|101060180|FG001|Treated With Antithrombotic Treatment|Antithrombotic Part (Double Blind)||9109|Safety analysis set (SAF); Antithrombotic treatment: rivaroxaban/placebo and/or study aspirin/placebo|
48299645|NCT01776424|101060181|FG002|Treated With Antithrombotic Treatment|Antithrombotic Part (Double Blind)||9107|Safety analysis set (SAF); Antithrombotic treatment: rivaroxaban/placebo and/or study aspirin/placebo|
48299646|NCT01776424|101060179|FG000|Randomized to Study Pantoprazole/Placebo|Antithrombotic Part (Double Blind)||5878||
48299647|NCT01776424|101060180|FG001|Randomized to Study Pantoprazole/Placebo|Antithrombotic Part (Double Blind)||5859||
48299648|NCT01776424|101060181|FG002|Randomized to Study Pantoprazole/Placebo|Antithrombotic Part (Double Blind)||5861||
48299649|NCT01776424|101060179|FG000|COMPLETED|Antithrombotic Part (Double Blind)||9132||
48299650|NCT01776424|101060180|FG001|COMPLETED|Antithrombotic Part (Double Blind)||9098||
48299651|NCT01776424|101060181|FG002|COMPLETED|Antithrombotic Part (Double Blind)||9102||
48299652|NCT01776424|101060179|FG000|NOT COMPLETED|Antithrombotic Part (Double Blind)||20||
48299653|NCT01776424|101060180|FG001|NOT COMPLETED|Antithrombotic Part (Double Blind)||19||
48299654|NCT01776424|101060181|FG002|NOT COMPLETED|Antithrombotic Part (Double Blind)||24||
48299655|NCT01776424|101060179|FG000|STARTED|LTOLE Part (Open Label)||4399|LTOLE ITT; All participants were assigned to Rivaroxaban 2.5mg + Aspirin 100mg in LTOLE part; the original arms from Antithrombotic part do not fit any more|
48299656|NCT01776424|101060180|FG001|STARTED|LTOLE Part (Open Label)||4292|LTOLE ITT; All participants were assigned to Rivaroxaban 2.5mg + Aspirin 100mg in LTOLE part; the original arms from Antithrombotic part do not fit any more|
48299657|NCT01776424|101060181|FG002|STARTED|LTOLE Part (Open Label)||4273|LTOLE ITT; All participants were assigned to Rivaroxaban 2.5mg + Aspirin 100mg in LTOLE part; the original arms from Antithrombotic part do not fit any more|
48299658|NCT01776424|101060179|FG000|Treated in LTOLE Part|LTOLE Part (Open Label)||4379|LTOLE SAF|
48299659|NCT01776424|101060180|FG001|Treated in LTOLE Part|LTOLE Part (Open Label)||4274|LTOLE SAF|
48299660|NCT01776424|101060181|FG002|Treated in LTOLE Part|LTOLE Part (Open Label)||4250|LTOLE SAF|
48299661|NCT01776424|101060179|FG000|COMPLETED|LTOLE Part (Open Label)||4320|LTOLE part follow-up completed, including death during LTOLE part|
48299662|NCT01776424|101060180|FG001|COMPLETED|LTOLE Part (Open Label)||4230|LTOLE part follow-up completed, including death during LTOLE part|
48299663|NCT01776424|101060181|FG002|COMPLETED|LTOLE Part (Open Label)||4195|LTOLE part follow-up completed, including death during LTOLE part|
48299664|NCT01776424|101060179|FG000|NOT COMPLETED|LTOLE Part (Open Label)||79||
48299665|NCT01776424|101060180|FG001|NOT COMPLETED|LTOLE Part (Open Label)||62||
48299666|NCT01776424|101060181|FG002|NOT COMPLETED|LTOLE Part (Open Label)||78||
48299667|NCT04029961|101060182|FG000|STARTED|Overall Study||13||
48299668|NCT04029961|101060183|FG001|STARTED|Overall Study||13||
48299669|NCT04029961|101060182|FG000|COMPLETED|Overall Study||12||
48299670|NCT04029961|101060183|FG001|COMPLETED|Overall Study||12||
48299671|NCT04029961|101060182|FG000|NOT COMPLETED|Overall Study||1||
48299672|NCT04029961|101060183|FG001|NOT COMPLETED|Overall Study||1||
48299673|NCT02593786|101060184|FG000|STARTED|Overall Study||15||
48299674|NCT02593786|101060185|FG001|STARTED|Overall Study||20||
48299675|NCT02593786|101060186|FG002|STARTED|Overall Study||11||
48299676|NCT02593786|101060187|FG003|STARTED|Overall Study||12||
48299677|NCT02593786|101060184|FG000|COMPLETED|Overall Study||0||
48299678|NCT02593786|101060185|FG001|COMPLETED|Overall Study||0||
48299679|NCT02593786|101060186|FG002|COMPLETED|Overall Study||0||
48299680|NCT02593786|101060187|FG003|COMPLETED|Overall Study||0||
48299681|NCT02593786|101060184|FG000|NOT COMPLETED|Overall Study||15||
48299682|NCT02593786|101060185|FG001|NOT COMPLETED|Overall Study||20||
48299683|NCT02593786|101060186|FG002|NOT COMPLETED|Overall Study||11||
48299684|NCT02593786|101060187|FG003|NOT COMPLETED|Overall Study||12||
48299685|NCT00604279|101060188|FG000|STARTED|Overall Study||229||
48299686|NCT00604279|101060189|FG001|STARTED|Overall Study||223||
48299687|NCT00604279|101060188|FG000|COMPLETED|Overall Study||165||
48405243|NCT01505114|101325228|FG002|NOT COMPLETED|Overall Study||18||
48405244|NCT01505114|101325229|FG003|NOT COMPLETED|Overall Study||23||
48601680|NCT05052697|101807762|FG022|COMPLETED|Substudy A||0|Indicates participants randomized to either mIRV A, mIRV B, bIRV A, bIRV B or qIRV and received licensed QIV at vaccination 2. Also, includes participants who were randomized to 'Licensed QIV' and received either 'mIRV A or mIRV B at dose level 4' at vaccination 2.|
48714710|NCT03812185|102088603|FG000|STARTED|TEE Imaging Before Suctioning||53||
48714711|NCT03812185|102088603|FG000|COMPLETED|TEE Imaging Before Suctioning||50||
48714712|NCT03812185|102088603|FG000|NOT COMPLETED|TEE Imaging Before Suctioning||3||
48714713|NCT03812185|102088603|FG000|STARTED|TEE Imaging After Suctioning||50||
48299688|NCT00604279|101060189|FG001|COMPLETED|Overall Study||185||
48299689|NCT00604279|101060188|FG000|NOT COMPLETED|Overall Study||64||
48299690|NCT00604279|101060189|FG001|NOT COMPLETED|Overall Study||38||
48299691|NCT05722704|101060190|FG000|STARTED|Overall Study||20||
48299692|NCT05722704|101060191|FG001|STARTED|Overall Study||20||
48299693|NCT05722704|101060192|FG002|STARTED|Overall Study||20||
48299694|NCT05722704|101060190|FG000|COMPLETED|Overall Study||20||
48299695|NCT05722704|101060191|FG001|COMPLETED|Overall Study||20||
48299696|NCT05722704|101060192|FG002|COMPLETED|Overall Study||20||
48299697|NCT05722704|101060190|FG000|NOT COMPLETED|Overall Study||0||
48299698|NCT05722704|101060191|FG001|NOT COMPLETED|Overall Study||0||
48299699|NCT05722704|101060192|FG002|NOT COMPLETED|Overall Study||0||
48299700|NCT01324323|101060193|FG000|STARTED|Overall Study||14||
48299701|NCT01324323|101060193|FG000|COMPLETED|Overall Study||13||
48299702|NCT01324323|101060193|FG000|NOT COMPLETED|Overall Study||1||
48601681|NCT05052697|101807763|FG023|COMPLETED|Substudy A||0|Indicates participants randomized to either mIRV A, mIRV B, bIRV A, bIRV B or qIRV and received licensed QIV at vaccination 2. Also, includes participants who were randomized to 'Licensed QIV' and received either 'mIRV A or mIRV B at dose level 4' at vaccination 2.|
48656903|NCT04274218|101943728|FG003|COMPLETED|Baseline Walking (1 Minute)||4||
48299703|NCT01289821|101060194|FG000|STARTED|Treatment Period||54||
48299704|NCT01289821|101060194|FG000|Participants Received Regorafenib|Treatment Period||54||
48299705|NCT01289821|101060194|FG000|COMPLETED|Treatment Period||0||
48299706|NCT01289821|101060194|FG000|NOT COMPLETED|Treatment Period||54||
48299707|NCT01289821|101060194|FG000|STARTED|Safety Follow-up Period||54||
48299708|NCT01289821|101060194|FG000|COMPLETED|Safety Follow-up Period||49||
48299709|NCT01289821|101060194|FG000|NOT COMPLETED|Safety Follow-up Period||5||
48299710|NCT01289821|101060194|FG000|STARTED|Survival Follow-up Period||52||
48299711|NCT01289821|101060194|FG000|COMPLETED|Survival Follow-up Period||34||
48299712|NCT01289821|101060194|FG000|NOT COMPLETED|Survival Follow-up Period||18||
48299713|NCT01416987|101060195|FG000|STARTED|Overall Study||600||
48299714|NCT01416987|101060195|FG000|COMPLETED|Overall Study||600||
48299715|NCT01416987|101060195|FG000|NOT COMPLETED|Overall Study||0||
48656904|NCT04274218|101943725|FG000|NOT COMPLETED|Baseline Walking (1 Minute)||0||
48656905|NCT04274218|101943726|FG001|NOT COMPLETED|Baseline Walking (1 Minute)||0||
48714714|NCT03812185|102088603|FG000|COMPLETED|TEE Imaging After Suctioning||50||
48714715|NCT03812185|102088603|FG000|NOT COMPLETED|TEE Imaging After Suctioning||0||
48299716|NCT01096342|101060196|FG000|STARTED|Overall Study||16||
48299717|NCT01096342|101060196|FG000|COMPLETED|Overall Study||15||
48299718|NCT01096342|101060196|FG000|NOT COMPLETED|Overall Study||1||
48299719|NCT02141074|101060197|FG000|STARTED|Pre-prophylaxis||34||
48299720|NCT02141074|101060198|FG001|STARTED|Pre-prophylaxis||0||
48299721|NCT02141074|101060197|FG000|COMPLETED|Pre-prophylaxis||31||
48299722|NCT02141074|101060198|FG001|COMPLETED|Pre-prophylaxis||0||
48299723|NCT02141074|101060197|FG000|NOT COMPLETED|Pre-prophylaxis||3||
48299724|NCT02141074|101060198|FG001|NOT COMPLETED|Pre-prophylaxis||0||
48299725|NCT02141074|101060197|FG000|STARTED|Prophylaxis||0||
48299726|NCT02141074|101060198|FG001|STARTED|Prophylaxis||51||
48299727|NCT02141074|101060197|FG000|COMPLETED|Prophylaxis||0||
48405245|NCT01226472|101325230|FG000|STARTED|Overall Study||1||
48714716|NCT01636713|102088604|FG000|STARTED|Overall Study||193||
48714717|NCT01636713|102088605|FG001|STARTED|Overall Study||194||
48714718|NCT01636713|102088606|FG002|STARTED|Overall Study||193||
48714719|NCT01636713|102088604|FG000|COMPLETED|Overall Study||161||
48714720|NCT01636713|102088605|FG001|COMPLETED|Overall Study||166||
48714721|NCT01636713|102088606|FG002|COMPLETED|Overall Study||170||
48714722|NCT01636713|102088604|FG000|NOT COMPLETED|Overall Study||32||
48714723|NCT01636713|102088605|FG001|NOT COMPLETED|Overall Study||28||
48714724|NCT01636713|102088606|FG002|NOT COMPLETED|Overall Study||23||
48299728|NCT02141074|101060198|FG001|COMPLETED|Prophylaxis||41||
48299729|NCT02141074|101060197|FG000|NOT COMPLETED|Prophylaxis||0||
48299730|NCT02141074|101060198|FG001|NOT COMPLETED|Prophylaxis||10||
48299731|NCT05266586|101060199|FG000|STARTED|Overall Study||40||
48299732|NCT05266586|101060200|FG001|STARTED|Overall Study||39||
48299733|NCT05266586|101060201|FG002|STARTED|Overall Study||40||
48299734|NCT05266586|101060199|FG000|COMPLETED|Overall Study||36||
48405246|NCT01226472|101325230|FG000|COMPLETED|Overall Study||0||
48405247|NCT01226472|101325230|FG000|NOT COMPLETED|Overall Study||1||
48714725|NCT03461406|102088607|FG000|STARTED|Overall Study||95||
48714726|NCT03461406|102088608|FG001|STARTED|Overall Study||91||
48714727|NCT03461406|102088607|FG000|Parenchymous Surgery|Overall Study||46||
48299735|NCT05266586|101060200|FG001|COMPLETED|Overall Study||36||
48299736|NCT05266586|101060201|FG002|COMPLETED|Overall Study||38||
48299737|NCT05266586|101060199|FG000|NOT COMPLETED|Overall Study||4||
48299738|NCT05266586|101060200|FG001|NOT COMPLETED|Overall Study||3||
48299739|NCT05266586|101060201|FG002|NOT COMPLETED|Overall Study||2||
48299740|NCT02136420|101060202|FG000|STARTED|Overall Study||10||
48299741|NCT02136420|101060203|FG001|STARTED|Overall Study||0||
48299742|NCT02136420|101060204|FG002|STARTED|Overall Study||0||
48299743|NCT02136420|101060205|FG003|STARTED|Overall Study||0||
48299744|NCT02136420|101060206|FG004|STARTED|Overall Study||10||
48299745|NCT02136420|101060207|FG005|STARTED|Overall Study||0||
48299746|NCT02136420|101060208|FG006|STARTED|Overall Study||0||
48299747|NCT02136420|101060209|FG007|STARTED|Overall Study||0||
48299748|NCT02136420|101060210|FG008|STARTED|Overall Study||5||
48299749|NCT02136420|101060211|FG009|STARTED|Overall Study||5||
48299750|NCT02136420|101060202|FG000|COMPLETED|Overall Study||9||
48299751|NCT02136420|101060203|FG001|COMPLETED|Overall Study||0||
48299752|NCT02136420|101060204|FG002|COMPLETED|Overall Study||0||
48299753|NCT02136420|101060205|FG003|COMPLETED|Overall Study||0||
48299754|NCT02136420|101060206|FG004|COMPLETED|Overall Study||10||
48299755|NCT02136420|101060207|FG005|COMPLETED|Overall Study||0||
48299756|NCT02136420|101060208|FG006|COMPLETED|Overall Study||0||
48299757|NCT02136420|101060209|FG007|COMPLETED|Overall Study||0||
48299758|NCT02136420|101060210|FG008|COMPLETED|Overall Study||5||
48299759|NCT02136420|101060211|FG009|COMPLETED|Overall Study||5||
48299760|NCT02136420|101060202|FG000|NOT COMPLETED|Overall Study||1||
48299761|NCT02136420|101060203|FG001|NOT COMPLETED|Overall Study||0||
48299762|NCT02136420|101060204|FG002|NOT COMPLETED|Overall Study||0||
48299763|NCT02136420|101060205|FG003|NOT COMPLETED|Overall Study||0||
48299764|NCT02136420|101060206|FG004|NOT COMPLETED|Overall Study||0||
48299765|NCT02136420|101060207|FG005|NOT COMPLETED|Overall Study||0||
48299766|NCT02136420|101060208|FG006|NOT COMPLETED|Overall Study||0||
48299767|NCT02136420|101060209|FG007|NOT COMPLETED|Overall Study||0||
48299768|NCT02136420|101060210|FG008|NOT COMPLETED|Overall Study||0||
48299769|NCT02136420|101060211|FG009|NOT COMPLETED|Overall Study||0||
48299770|NCT02804178|101060212|FG000|STARTED|Overall Study||10||
48299771|NCT02804178|101060212|FG000|COMPLETED|Overall Study||9||
48299772|NCT02804178|101060212|FG000|NOT COMPLETED|Overall Study||1||
48299773|NCT00690833|101060213|FG000|STARTED|Overall Study||41||
48299774|NCT00690833|101060213|FG000|COMPLETED|Overall Study||39||
48299775|NCT00690833|101060213|FG000|NOT COMPLETED|Overall Study||2||
48299776|NCT01078207|101060214|FG000|STARTED|Overall Study||100||
48299777|NCT01078207|101060214|FG000|COMPLETED|Overall Study||100||
48299778|NCT01078207|101060214|FG000|NOT COMPLETED|Overall Study||0||
48299779|NCT00861263|101060215|FG000|STARTED|Overall Study||193||
48299780|NCT00861263|101060215|FG000|COMPLETED|Overall Study||193||
48299781|NCT00861263|101060215|FG000|NOT COMPLETED|Overall Study||0||
48299782|NCT00651157|101060216|FG000|STARTED|Overall Study||23||
48299783|NCT00651157|101060216|FG000|COMPLETED|Overall Study||21||
48299784|NCT00651157|101060216|FG000|NOT COMPLETED|Overall Study||2||
48299785|NCT02465463|101060217|FG000|STARTED|Overall Study||8||
48299786|NCT02465463|101060218|FG001|STARTED|Overall Study||5||
48714728|NCT03461406|102088608|FG001|Parenchymous Surgery|Overall Study||43||
48714729|NCT03461406|102088607|FG000|Soft Tissue Surgery|Overall Study||45||
48714730|NCT03461406|102088608|FG001|Soft Tissue Surgery|Overall Study||44||
48714731|NCT03461406|102088607|FG000|Safety Population|Overall Study||91|Safety population included all participants who received any amount of IP.|
48767582|NCT01435382|102222772|FG001|COMPLETED|Overall Study||11||
48299787|NCT02465463|101060217|FG000|COMPLETED|Overall Study||4||
48299788|NCT02465463|101060218|FG001|COMPLETED|Overall Study||4||
48299789|NCT02465463|101060217|FG000|NOT COMPLETED|Overall Study||4||
48299790|NCT02465463|101060218|FG001|NOT COMPLETED|Overall Study||1||
48299791|NCT02579174|101060219|FG000|STARTED|Overall Study||29||
48299792|NCT02579174|101060220|FG001|STARTED|Overall Study||30||
48299793|NCT02579174|101060221|FG002|STARTED|Overall Study||28||
48299794|NCT02579174|101060222|FG003|STARTED|Overall Study||25||
48299795|NCT02579174|101060219|FG000|COMPLETED|Overall Study||18||
48299796|NCT02579174|101060220|FG001|COMPLETED|Overall Study||16||
48299797|NCT02579174|101060221|FG002|COMPLETED|Overall Study||16||
48299798|NCT02579174|101060222|FG003|COMPLETED|Overall Study||16||
48299799|NCT02579174|101060219|FG000|NOT COMPLETED|Overall Study||11||
48299800|NCT02579174|101060220|FG001|NOT COMPLETED|Overall Study||14||
48299801|NCT02579174|101060221|FG002|NOT COMPLETED|Overall Study||12||
48299802|NCT02579174|101060222|FG003|NOT COMPLETED|Overall Study||9||
48299803|NCT02069353|101060223|FG000|STARTED|Overall Study||4||
48299804|NCT02069353|101060223|FG000|COMPLETED|Overall Study||4||
48299805|NCT02069353|101060223|FG000|NOT COMPLETED|Overall Study||0||
48299806|NCT02336178|101060224|FG000|STARTED|Overall Study||70||
48299807|NCT02336178|101060224|FG000|COMPLETED|Overall Study||66||
48299808|NCT02336178|101060224|FG000|NOT COMPLETED|Overall Study||4||
48299809|NCT00760669|101060225|FG000|STARTED|Overall Study||1061||
48299810|NCT00760669|101060225|FG000|COMPLETED|Overall Study||1031||
48299811|NCT00760669|101060225|FG000|NOT COMPLETED|Overall Study||30||
48299812|NCT04214301|101060226|FG000|STARTED|Overall Study||40||
48299813|NCT04214301|101060226|FG000|COMPLETED|Overall Study||38||
48299814|NCT04214301|101060226|FG000|NOT COMPLETED|Overall Study||2||
48299815|NCT02974088|101060227|FG000|STARTED|Overall Study||23||
48299816|NCT02974088|101060228|FG001|STARTED|Overall Study||24||
48299817|NCT02974088|101060227|FG000|COMPLETED|Overall Study||23||
48299818|NCT02974088|101060228|FG001|COMPLETED|Overall Study||21||
48299819|NCT02974088|101060227|FG000|NOT COMPLETED|Overall Study||0||
48601682|NCT05052697|101807764|FG024|COMPLETED|Substudy A||0|Indicates participants randomized to either mIRV A, mIRV B, bIRV A, bIRV B or qIRV and received licensed QIV at vaccination 2. Also, includes participants who were randomized to 'Licensed QIV' and received either 'mIRV A or mIRV B at dose level 4' at vaccination 2.|
48601683|NCT05052697|101807765|FG025|COMPLETED|Substudy A||0|Indicates participants randomized to either mIRV A, mIRV B, bIRV A, bIRV B or qIRV and received licensed QIV at vaccination 2. Also, includes participants who were randomized to 'Licensed QIV' and received either 'mIRV A or mIRV B at dose level 4' at vaccination 2.|
48601684|NCT05052697|101807766|FG026|COMPLETED|Substudy A||0|Indicates participants randomized to either mIRV A, mIRV B, bIRV A, bIRV B or qIRV and received licensed QIV at vaccination 2. Also, includes participants who were randomized to 'Licensed QIV' and received either 'mIRV A or mIRV B at dose level 4' at vaccination 2.|
48601685|NCT05052697|101807767|FG027|COMPLETED|Substudy A||0|Indicates participants randomized to either mIRV A, mIRV B, bIRV A, bIRV B or qIRV and received licensed QIV at vaccination 2. Also, includes participants who were randomized to 'Licensed QIV' and received either 'mIRV A or mIRV B at dose level 4' at vaccination 2.|
48601686|NCT05052697|101807768|FG028|COMPLETED|Substudy A||0|Indicates participants randomized to either mIRV A, mIRV B, bIRV A, bIRV B or qIRV and received licensed QIV at vaccination 2. Also, includes participants who were randomized to 'Licensed QIV' and received either 'mIRV A or mIRV B at dose level 4' at vaccination 2.|
48601687|NCT05052697|101807769|FG029|COMPLETED|Substudy A||0|Indicates participants randomized to either mIRV A, mIRV B, bIRV A, bIRV B or qIRV and received licensed QIV at vaccination 2. Also, includes participants who were randomized to 'Licensed QIV' and received either 'mIRV A or mIRV B at dose level 4' at vaccination 2.|
48299820|NCT02974088|101060228|FG001|NOT COMPLETED|Overall Study||3||
48299821|NCT01346488|101060229|FG000|STARTED|Overall Study||1968||
48299822|NCT01346488|101060229|FG000|COMPLETED|Overall Study||1262||
48299823|NCT01346488|101060229|FG000|NOT COMPLETED|Overall Study||706||
48299824|NCT04005053|101060230|FG000|STARTED|Overall Study||16||
48299825|NCT04005053|101060231|FG001|STARTED|Overall Study||13||
48299826|NCT04005053|101060232|FG002|STARTED|Overall Study||15||
48299827|NCT04005053|101060230|FG000|COMPLETED|Overall Study||14||
48299828|NCT04005053|101060231|FG001|COMPLETED|Overall Study||11||
48299829|NCT04005053|101060232|FG002|COMPLETED|Overall Study||14||
48299830|NCT04005053|101060230|FG000|NOT COMPLETED|Overall Study||2||
48299831|NCT04005053|101060231|FG001|NOT COMPLETED|Overall Study||2||
48299832|NCT04005053|101060232|FG002|NOT COMPLETED|Overall Study||1||
48299833|NCT02881957|101060233|FG000|STARTED|Overall Study||136||
48299834|NCT02881957|101060234|FG001|STARTED|Overall Study||138||
48299835|NCT02881957|101060233|FG000|COMPLETED|Overall Study||133||
48299836|NCT02881957|101060234|FG001|COMPLETED|Overall Study||134||
48299837|NCT02881957|101060233|FG000|NOT COMPLETED|Overall Study||3||
48299838|NCT02881957|101060234|FG001|NOT COMPLETED|Overall Study||4||
48299839|NCT02267356|101060235|FG000|STARTED|Initial Study||53||
48299840|NCT02267356|101060236|FG001|STARTED|Initial Study||53||
48299841|NCT02267356|101060237|FG002|STARTED|Initial Study||52||
48299842|NCT02267356|101060238|FG003|STARTED|Initial Study||54||
48299843|NCT02267356|101060239|FG004|STARTED|Initial Study||47||
48299844|NCT02267356|101060235|FG000|COMPLETED|Initial Study||47||
48299845|NCT02267356|101060236|FG001|COMPLETED|Initial Study||48||
48299846|NCT02267356|101060237|FG002|COMPLETED|Initial Study||42||
48299847|NCT02267356|101060238|FG003|COMPLETED|Initial Study||43||
48299848|NCT02267356|101060239|FG004|COMPLETED|Initial Study||42||
48299849|NCT02267356|101060235|FG000|NOT COMPLETED|Initial Study||6||
48299850|NCT02267356|101060236|FG001|NOT COMPLETED|Initial Study||5||
48299851|NCT02267356|101060237|FG002|NOT COMPLETED|Initial Study||10||
48299852|NCT02267356|101060238|FG003|NOT COMPLETED|Initial Study||11||
48299853|NCT02267356|101060239|FG004|NOT COMPLETED|Initial Study||5||
48299854|NCT02267356|101060235|FG000|STARTED|Study Extension||33|Not all subjects completing initial study continued in study extension. Continuation was optional.|
48299855|NCT02267356|101060236|FG001|STARTED|Study Extension||37|Not all subjects completing initial study continued in study extension. Continuation was optional.|
48299856|NCT02267356|101060237|FG002|STARTED|Study Extension||30|Not all subjects completing initial study continued in study extension. Continuation was optional.|
48299857|NCT02267356|101060238|FG003|STARTED|Study Extension||32|Not all subjects completing initial study continued in study extension. Continuation was optional.|
48299858|NCT02267356|101060239|FG004|STARTED|Study Extension||26|Not all subjects completing initial study continued in study extension. Continuation was optional.|
48299859|NCT02267356|101060235|FG000|COMPLETED|Study Extension||32||
48299860|NCT02267356|101060236|FG001|COMPLETED|Study Extension||37||
48299861|NCT02267356|101060237|FG002|COMPLETED|Study Extension||29||
48299862|NCT02267356|101060238|FG003|COMPLETED|Study Extension||30||
48299863|NCT02267356|101060239|FG004|COMPLETED|Study Extension||26||
48299864|NCT02267356|101060235|FG000|NOT COMPLETED|Study Extension||1||
48299865|NCT02267356|101060236|FG001|NOT COMPLETED|Study Extension||0||
48299866|NCT02267356|101060237|FG002|NOT COMPLETED|Study Extension||1||
48299867|NCT02267356|101060238|FG003|NOT COMPLETED|Study Extension||2||
48299868|NCT02267356|101060239|FG004|NOT COMPLETED|Study Extension||0||
48299869|NCT04234425|101060240|FG000|STARTED|Overall Study||18||
48299870|NCT04234425|101060240|FG000|Midpoint-Week 4|Overall Study||18||
48146126|NCT04004611|100682285|FG006|STARTED|OL Induction and Maintenance Period||0||
48146127|NCT04004611|100682286|FG007|STARTED|OL Induction and Maintenance Period||0||
48146128|NCT04004611|100682287|FG008|STARTED|OL Induction and Maintenance Period||0||
48146129|NCT04004611|100682279|FG000|COMPLETED|OL Induction and Maintenance Period||9||
48146130|NCT04004611|100682280|FG001|COMPLETED|OL Induction and Maintenance Period||4||
48146131|NCT04004611|100682281|FG002|COMPLETED|OL Induction and Maintenance Period||6||
48146132|NCT04004611|100682282|FG003|COMPLETED|OL Induction and Maintenance Period||0||
48146133|NCT04004611|100682283|FG004|COMPLETED|OL Induction and Maintenance Period||0||
48146134|NCT04004611|100682284|FG005|COMPLETED|OL Induction and Maintenance Period||0||
48146135|NCT04004611|100682285|FG006|COMPLETED|OL Induction and Maintenance Period||0||
48146136|NCT04004611|100682286|FG007|COMPLETED|OL Induction and Maintenance Period||0||
48146137|NCT04004611|100682287|FG008|COMPLETED|OL Induction and Maintenance Period||0||
48299871|NCT04234425|101060240|FG000|COMPLETED|Overall Study||18||
48299872|NCT04234425|101060240|FG000|NOT COMPLETED|Overall Study||0||
48299873|NCT01197833|101060241|FG000|STARTED|Overall Study||38||
48299874|NCT01197833|101060242|FG001|STARTED|Overall Study||39||
48299875|NCT01197833|101060243|FG002|STARTED|Overall Study||40||
48299876|NCT01197833|101060241|FG000|COMPLETED|Overall Study||38||
48299877|NCT01197833|101060242|FG001|COMPLETED|Overall Study||39||
48299878|NCT01197833|101060243|FG002|COMPLETED|Overall Study||40||
48299879|NCT01197833|101060241|FG000|NOT COMPLETED|Overall Study||0||
48299880|NCT01197833|101060242|FG001|NOT COMPLETED|Overall Study||0||
48299881|NCT01197833|101060243|FG002|NOT COMPLETED|Overall Study||0||
48299882|NCT01505010|101060244|FG000|STARTED|Overall Study||9||
48405248|NCT03304262|101325231|FG000|STARTED|Overall Study||4||
48405249|NCT03304262|101325232|FG001|STARTED|Overall Study||5||
48601688|NCT05052697|101807770|FG030|COMPLETED|Substudy A||0|Indicates participants randomized to either mIRV A, mIRV B, bIRV A, bIRV B or qIRV and received licensed QIV at vaccination 2. Also, includes participants who were randomized to 'Licensed QIV' and received either 'mIRV A or mIRV B at dose level 4' at vaccination 2.|
48601689|NCT05052697|101807771|FG031|COMPLETED|Substudy A||0|Indicates participants randomized to either mIRV A, mIRV B, bIRV A, bIRV B or qIRV and received licensed QIV at vaccination 2. Also, includes participants who were randomized to 'Licensed QIV' and received either 'mIRV A or mIRV B at dose level 4' at vaccination 2.|
48601690|NCT05052697|101807772|FG032|COMPLETED|Substudy A||0|Indicates participants randomized to either mIRV A, mIRV B, bIRV A, bIRV B or qIRV and received licensed QIV at vaccination 2. Also, includes participants who were randomized to 'Licensed QIV' and received either 'mIRV A or mIRV B at dose level 4' at vaccination 2.|
48601691|NCT05052697|101807773|FG033|COMPLETED|Substudy A||0|Indicates participants randomized to either mIRV A, mIRV B, bIRV A, bIRV B or qIRV and received licensed QIV at vaccination 2. Also, includes participants who were randomized to 'Licensed QIV' and received either 'mIRV A or mIRV B at dose level 4' at vaccination 2.|
48601692|NCT05052697|101807740|FG000|NOT COMPLETED|Substudy A||0||
48601693|NCT05052697|101807741|FG001|NOT COMPLETED|Substudy A||0||
48601694|NCT05052697|101807742|FG002|NOT COMPLETED|Substudy A||0||
48601695|NCT05052697|101807743|FG003|NOT COMPLETED|Substudy A||1||
48601696|NCT05052697|101807744|FG004|NOT COMPLETED|Substudy A||0||
48601697|NCT05052697|101807745|FG005|NOT COMPLETED|Substudy A||1||
48601698|NCT05052697|101807746|FG006|NOT COMPLETED|Substudy A||0||
48601699|NCT05052697|101807747|FG007|NOT COMPLETED|Substudy A||0||
48601700|NCT05052697|101807748|FG008|NOT COMPLETED|Substudy A||1||
48601701|NCT05052697|101807749|FG009|NOT COMPLETED|Substudy A||0||
48601702|NCT05052697|101807750|FG010|NOT COMPLETED|Substudy A||0||
48601703|NCT05052697|101807751|FG011|NOT COMPLETED|Substudy A||0||
48601704|NCT05052697|101807752|FG012|NOT COMPLETED|Substudy A||0||
48601705|NCT05052697|101807753|FG013|NOT COMPLETED|Substudy A||1||
48601706|NCT05052697|101807754|FG014|NOT COMPLETED|Substudy A||0||
48601707|NCT05052697|101807755|FG015|NOT COMPLETED|Substudy A||2||
48601708|NCT05052697|101807756|FG016|NOT COMPLETED|Substudy A||0||
48601709|NCT05052697|101807757|FG017|NOT COMPLETED|Substudy A||0||
48601710|NCT05052697|101807758|FG018|NOT COMPLETED|Substudy A||0||
48601711|NCT05052697|101807759|FG019|NOT COMPLETED|Substudy A||0||
48601712|NCT05052697|101807760|FG020|NOT COMPLETED|Substudy A||0||
48601713|NCT05052697|101807761|FG021|NOT COMPLETED|Substudy A||0||
48601714|NCT05052697|101807762|FG022|NOT COMPLETED|Substudy A||0||
48601715|NCT05052697|101807763|FG023|NOT COMPLETED|Substudy A||0||
48601716|NCT05052697|101807764|FG024|NOT COMPLETED|Substudy A||0||
48601717|NCT05052697|101807765|FG025|NOT COMPLETED|Substudy A||0||
48146138|NCT04004611|100682279|FG000|NOT COMPLETED|OL Induction and Maintenance Period||1||
48299883|NCT01505010|101060245|FG001|STARTED|Overall Study||8||
48299884|NCT01505010|101060244|FG000|COMPLETED|Overall Study||9||
48299885|NCT01505010|101060245|FG001|COMPLETED|Overall Study||6||
48299886|NCT01505010|101060244|FG000|NOT COMPLETED|Overall Study||0||
48299887|NCT01505010|101060245|FG001|NOT COMPLETED|Overall Study||2||
48299888|NCT04384848|101060246|FG000|STARTED|Overall Study||94||
48299889|NCT04384848|101060246|FG000|COMPLETED|Overall Study||90||
48405250|NCT03304262|101325233|FG002|STARTED|Overall Study||4||
48601718|NCT05052697|101807766|FG026|NOT COMPLETED|Substudy A||0||
48601719|NCT05052697|101807767|FG027|NOT COMPLETED|Substudy A||0||
48601720|NCT05052697|101807768|FG028|NOT COMPLETED|Substudy A||0||
48601721|NCT05052697|101807769|FG029|NOT COMPLETED|Substudy A||0||
48601722|NCT05052697|101807770|FG030|NOT COMPLETED|Substudy A||0||
48299890|NCT04384848|101060246|FG000|NOT COMPLETED|Overall Study||4||
48601723|NCT05052697|101807771|FG031|NOT COMPLETED|Substudy A||0||
48601724|NCT05052697|101807772|FG032|NOT COMPLETED|Substudy A||0||
48601725|NCT05052697|101807773|FG033|NOT COMPLETED|Substudy A||0||
48601726|NCT05052697|101807740|FG000|STARTED|SubStudy B: Initial Enrollment||0|Participants who were randomized|
48601727|NCT05052697|101807741|FG001|STARTED|SubStudy B: Initial Enrollment||0|Participants who were randomized|
48601728|NCT05052697|101807742|FG002|STARTED|SubStudy B: Initial Enrollment||0|Participants who were randomized|
48601729|NCT05052697|101807743|FG003|STARTED|SubStudy B: Initial Enrollment||0|Participants who were randomized|
48601730|NCT05052697|101807744|FG004|STARTED|SubStudy B: Initial Enrollment||0|Participants who were randomized|
48601731|NCT05052697|101807745|FG005|STARTED|SubStudy B: Initial Enrollment||0|Participants who were randomized|
48601732|NCT05052697|101807746|FG006|STARTED|SubStudy B: Initial Enrollment||0|Participants who were randomized|
48601733|NCT05052697|101807747|FG007|STARTED|SubStudy B: Initial Enrollment||0|Participants who were randomized|
48601734|NCT05052697|101807748|FG008|STARTED|SubStudy B: Initial Enrollment||0|Participants who were randomized|
48601735|NCT05052697|101807749|FG009|STARTED|SubStudy B: Initial Enrollment||0|Participants who were randomized|
48601736|NCT05052697|101807750|FG010|STARTED|SubStudy B: Initial Enrollment||0|Participants who were randomized|
48601737|NCT05052697|101807751|FG011|STARTED|SubStudy B: Initial Enrollment||0|Participants who were randomized|
48601738|NCT05052697|101807752|FG012|STARTED|SubStudy B: Initial Enrollment||0|Participants who were randomized|
48601739|NCT05052697|101807753|FG013|STARTED|SubStudy B: Initial Enrollment||0|Participants who were randomized|
48601740|NCT05052697|101807754|FG014|STARTED|SubStudy B: Initial Enrollment||0|Participants who were randomized|
48601741|NCT05052697|101807755|FG015|STARTED|SubStudy B: Initial Enrollment||0|Participants who were randomized|
48601742|NCT05052697|101807756|FG016|STARTED|SubStudy B: Initial Enrollment||0|Participants who were randomized|
48601743|NCT05052697|101807757|FG017|STARTED|SubStudy B: Initial Enrollment||15|Participants who were randomized|
48601744|NCT05052697|101807758|FG018|STARTED|SubStudy B: Initial Enrollment||15|Participants who were randomized|
48601745|NCT05052697|101807759|FG019|STARTED|SubStudy B: Initial Enrollment||16|Participants who were randomized|
48601746|NCT05052697|101807760|FG020|STARTED|SubStudy B: Initial Enrollment||16|Participants who were randomized|
48601747|NCT05052697|101807761|FG021|STARTED|SubStudy B: Initial Enrollment||16|Participants who were randomized|
48601748|NCT05052697|101807762|FG022|STARTED|SubStudy B: Initial Enrollment||15|Participants who were randomized|
48601749|NCT05052697|101807763|FG023|STARTED|SubStudy B: Initial Enrollment||16|Participants who were randomized|
48601750|NCT05052697|101807764|FG024|STARTED|SubStudy B: Initial Enrollment||16|Participants who were randomized|
48601751|NCT05052697|101807765|FG025|STARTED|SubStudy B: Initial Enrollment||15|Participants who were randomized|
48601752|NCT05052697|101807766|FG026|STARTED|SubStudy B: Initial Enrollment||15|Participants who were randomized|
48601753|NCT05052697|101807767|FG027|STARTED|SubStudy B: Initial Enrollment||16|Participants who were randomized|
48601754|NCT05052697|101807768|FG028|STARTED|SubStudy B: Initial Enrollment||0|Participants who were randomized|
48601755|NCT05052697|101807769|FG029|STARTED|SubStudy B: Initial Enrollment||0|Participants who were randomized|
48601756|NCT05052697|101807770|FG030|STARTED|SubStudy B: Initial Enrollment||0|Participants who were randomized|
48601757|NCT05052697|101807771|FG031|STARTED|SubStudy B: Initial Enrollment||0|Participants who were randomized|
48601758|NCT05052697|101807772|FG032|STARTED|SubStudy B: Initial Enrollment||0|Participants who were randomized|
48601759|NCT05052697|101807773|FG033|STARTED|SubStudy B: Initial Enrollment||0|Participants who were randomized|
48601760|NCT05052697|101807740|FG000|Vaccination 1|SubStudy B: Initial Enrollment||0||
48601761|NCT05052697|101807741|FG001|Vaccination 1|SubStudy B: Initial Enrollment||0||
48601762|NCT05052697|101807742|FG002|Vaccination 1|SubStudy B: Initial Enrollment||0||
48601763|NCT05052697|101807743|FG003|Vaccination 1|SubStudy B: Initial Enrollment||0||
48601764|NCT05052697|101807744|FG004|Vaccination 1|SubStudy B: Initial Enrollment||0||
48601765|NCT05052697|101807745|FG005|Vaccination 1|SubStudy B: Initial Enrollment||0||
48601766|NCT05052697|101807746|FG006|Vaccination 1|SubStudy B: Initial Enrollment||0||
48601767|NCT05052697|101807747|FG007|Vaccination 1|SubStudy B: Initial Enrollment||0||
48601768|NCT05052697|101807748|FG008|Vaccination 1|SubStudy B: Initial Enrollment||0||
48601769|NCT05052697|101807749|FG009|Vaccination 1|SubStudy B: Initial Enrollment||0||
48601770|NCT05052697|101807750|FG010|Vaccination 1|SubStudy B: Initial Enrollment||0||
48601771|NCT05052697|101807751|FG011|Vaccination 1|SubStudy B: Initial Enrollment||0||
48601772|NCT05052697|101807752|FG012|Vaccination 1|SubStudy B: Initial Enrollment||0||
48601773|NCT05052697|101807753|FG013|Vaccination 1|SubStudy B: Initial Enrollment||0||
48601774|NCT05052697|101807754|FG014|Vaccination 1|SubStudy B: Initial Enrollment||0||
48601775|NCT05052697|101807755|FG015|Vaccination 1|SubStudy B: Initial Enrollment||0||
48657072|NCT03648372|101943770|FG013|COMPLETED|Overall Study||1||
48299891|NCT03575143|101060247|FG000|STARTED|Overall Study||66||
48299892|NCT03575143|101060248|FG001|STARTED|Overall Study||55||
48299893|NCT03575143|101060249|FG002|STARTED|Overall Study||11||
48601776|NCT05052697|101807756|FG016|Vaccination 1|SubStudy B: Initial Enrollment||0||
48601777|NCT05052697|101807757|FG017|Vaccination 1|SubStudy B: Initial Enrollment||14||
48601778|NCT05052697|101807758|FG018|Vaccination 1|SubStudy B: Initial Enrollment||15||
48601779|NCT05052697|101807759|FG019|Vaccination 1|SubStudy B: Initial Enrollment||16||
48601780|NCT05052697|101807760|FG020|Vaccination 1|SubStudy B: Initial Enrollment||16||
48601781|NCT05052697|101807761|FG021|Vaccination 1|SubStudy B: Initial Enrollment||16||
48601782|NCT05052697|101807762|FG022|Vaccination 1|SubStudy B: Initial Enrollment||15||
48601783|NCT05052697|101807763|FG023|Vaccination 1|SubStudy B: Initial Enrollment||16||
48601784|NCT05052697|101807764|FG024|Vaccination 1|SubStudy B: Initial Enrollment||16||
48601785|NCT05052697|101807765|FG025|Vaccination 1|SubStudy B: Initial Enrollment||14||
48601786|NCT05052697|101807766|FG026|Vaccination 1|SubStudy B: Initial Enrollment||15||
48601787|NCT05052697|101807767|FG027|Vaccination 1|SubStudy B: Initial Enrollment||16||
48601788|NCT05052697|101807768|FG028|Vaccination 1|SubStudy B: Initial Enrollment||0||
48601789|NCT05052697|101807769|FG029|Vaccination 1|SubStudy B: Initial Enrollment||0||
48601790|NCT05052697|101807770|FG030|Vaccination 1|SubStudy B: Initial Enrollment||0||
48601791|NCT05052697|101807771|FG031|Vaccination 1|SubStudy B: Initial Enrollment||0||
48601792|NCT05052697|101807772|FG032|Vaccination 1|SubStudy B: Initial Enrollment||0||
48601793|NCT05052697|101807773|FG033|Vaccination 1|SubStudy B: Initial Enrollment||0||
48601794|NCT05052697|101807740|FG000|Vaccination 2|SubStudy B: Initial Enrollment||0|Included participants who were randomized to 2-Visit vaccination schedule|
48601795|NCT05052697|101807741|FG001|Vaccination 2|SubStudy B: Initial Enrollment||0|Included participants who were randomized to 2-Visit vaccination schedule|
48601796|NCT05052697|101807742|FG002|Vaccination 2|SubStudy B: Initial Enrollment||0|Included participants who were randomized to 2-Visit vaccination schedule|
48601797|NCT05052697|101807743|FG003|Vaccination 2|SubStudy B: Initial Enrollment||0|Included participants who were randomized to 2-Visit vaccination schedule|
48601798|NCT05052697|101807744|FG004|Vaccination 2|SubStudy B: Initial Enrollment||0|Included participants who were randomized to 2-Visit vaccination schedule|
48601799|NCT05052697|101807745|FG005|Vaccination 2|SubStudy B: Initial Enrollment||0|Included participants who were randomized to 2-Visit vaccination schedule|
48601800|NCT05052697|101807746|FG006|Vaccination 2|SubStudy B: Initial Enrollment||0|Included participants who were randomized to 2-Visit vaccination schedule|
48601801|NCT05052697|101807747|FG007|Vaccination 2|SubStudy B: Initial Enrollment||0|Included participants who were randomized to 2-Visit vaccination schedule|
48601802|NCT05052697|101807748|FG008|Vaccination 2|SubStudy B: Initial Enrollment||0|Included participants who were randomized to 2-Visit vaccination schedule|
48601803|NCT05052697|101807749|FG009|Vaccination 2|SubStudy B: Initial Enrollment||0|Included participants who were randomized to 2-Visit vaccination schedule|
48601804|NCT05052697|101807750|FG010|Vaccination 2|SubStudy B: Initial Enrollment||0|Included participants who were randomized to 2-Visit vaccination schedule|
48299894|NCT03575143|101060247|FG000|COMPLETED|Overall Study||66||
48299895|NCT03575143|101060248|FG001|COMPLETED|Overall Study||55||
48299896|NCT03575143|101060249|FG002|COMPLETED|Overall Study||0||
48299897|NCT03575143|101060247|FG000|NOT COMPLETED|Overall Study||0||
48299898|NCT03575143|101060248|FG001|NOT COMPLETED|Overall Study||0||
48299899|NCT03575143|101060249|FG002|NOT COMPLETED|Overall Study||11||
48299900|NCT02959450|101060250|FG000|STARTED|Overall Study||64||
48299901|NCT02959450|101060251|FG001|STARTED|Overall Study||63||
48299902|NCT02959450|101060250|FG000|COMPLETED|Overall Study||54||
48299903|NCT02959450|101060251|FG001|COMPLETED|Overall Study||51||
48299904|NCT02959450|101060250|FG000|NOT COMPLETED|Overall Study||10||
48299905|NCT02959450|101060251|FG001|NOT COMPLETED|Overall Study||12||
48299906|NCT03907410|101060252|FG000|STARTED|Overall Study||42||
48299907|NCT03907410|101060253|FG001|STARTED|Overall Study||22||
48299908|NCT03907410|101060254|FG002|STARTED|Overall Study||42||
48299909|NCT03907410|101060252|FG000|COMPLETED|Overall Study||38||
48299910|NCT03907410|101060253|FG001|COMPLETED|Overall Study||21||
48299911|NCT03907410|101060254|FG002|COMPLETED|Overall Study||40||
48299912|NCT03907410|101060252|FG000|NOT COMPLETED|Overall Study||4||
48299913|NCT03907410|101060253|FG001|NOT COMPLETED|Overall Study||1||
48299914|NCT03907410|101060254|FG002|NOT COMPLETED|Overall Study||2||
48299915|NCT01601847|101060255|FG000|STARTED|Overall Study||153||
48299916|NCT01601847|101060256|FG001|STARTED|Overall Study||147||
48299917|NCT01601847|101060255|FG000|COMPLETED|Overall Study||140||
48299918|NCT01601847|101060256|FG001|COMPLETED|Overall Study||137||
48299919|NCT01601847|101060255|FG000|NOT COMPLETED|Overall Study||13||
48299920|NCT01601847|101060256|FG001|NOT COMPLETED|Overall Study||10||
48299921|NCT02273726|101060257|FG000|STARTED|Overall Study||370||
48299922|NCT02273726|101060258|FG001|STARTED|Overall Study||371||
48299923|NCT02273726|101060257|FG000|Received at Least 1 Dose of Study Drug|Overall Study||370||
48299924|NCT02273726|101060258|FG001|Received at Least 1 Dose of Study Drug|Overall Study||370||
48299925|NCT02273726|101060257|FG000|COMPLETED|Overall Study||127||
48299926|NCT02273726|101060258|FG001|COMPLETED|Overall Study||183||
48299927|NCT02273726|101060257|FG000|NOT COMPLETED|Overall Study||243||
48299928|NCT02273726|101060258|FG001|NOT COMPLETED|Overall Study||188||
48299929|NCT00454532|101060259|FG000|STARTED|Overall Study||11||
48405251|NCT03304262|101325231|FG000|COMPLETED|Overall Study||4||
48299930|NCT00454532|101060260|FG001|STARTED|Overall Study||6||
48299931|NCT00454532|101060261|FG002|STARTED|Overall Study||3||
48299932|NCT00454532|101060262|FG003|STARTED|Overall Study||7||
48299933|NCT00454532|101060259|FG000|COMPLETED|Overall Study||11||
48299934|NCT00454532|101060260|FG001|COMPLETED|Overall Study||6||
48601805|NCT05052697|101807751|FG011|Vaccination 2|SubStudy B: Initial Enrollment||0|Included participants who were randomized to 2-Visit vaccination schedule|
48601806|NCT05052697|101807752|FG012|Vaccination 2|SubStudy B: Initial Enrollment||0|Included participants who were randomized to 2-Visit vaccination schedule|
48601807|NCT05052697|101807753|FG013|Vaccination 2|SubStudy B: Initial Enrollment||0|Included participants who were randomized to 2-Visit vaccination schedule|
48601808|NCT05052697|101807754|FG014|Vaccination 2|SubStudy B: Initial Enrollment||0|Included participants who were randomized to 2-Visit vaccination schedule|
48601809|NCT05052697|101807755|FG015|Vaccination 2|SubStudy B: Initial Enrollment||0|Included participants who were randomized to 2-Visit vaccination schedule|
48601810|NCT05052697|101807756|FG016|Vaccination 2|SubStudy B: Initial Enrollment||0|Included participants who were randomized to 2-Visit vaccination schedule|
48601811|NCT05052697|101807757|FG017|Vaccination 2|SubStudy B: Initial Enrollment||13|Included participants who were randomized to 2-Visit vaccination schedule|
48601812|NCT05052697|101807758|FG018|Vaccination 2|SubStudy B: Initial Enrollment||13|Included participants who were randomized to 2-Visit vaccination schedule|
48601813|NCT05052697|101807759|FG019|Vaccination 2|SubStudy B: Initial Enrollment||15|Included participants who were randomized to 2-Visit vaccination schedule|
48601814|NCT05052697|101807760|FG020|Vaccination 2|SubStudy B: Initial Enrollment||16|Included participants who were randomized to 2-Visit vaccination schedule|
48601815|NCT05052697|101807761|FG021|Vaccination 2|SubStudy B: Initial Enrollment||1|Included participants who were randomized to 2-Visit vaccination schedule|
48601816|NCT05052697|101807762|FG022|Vaccination 2|SubStudy B: Initial Enrollment||0|Included participants who were randomized to 2-Visit vaccination schedule|
48601817|NCT05052697|101807763|FG023|Vaccination 2|SubStudy B: Initial Enrollment||0|Included participants who were randomized to 2-Visit vaccination schedule|
48601818|NCT05052697|101807764|FG024|Vaccination 2|SubStudy B: Initial Enrollment||0|Included participants who were randomized to 2-Visit vaccination schedule|
48299935|NCT00454532|101060261|FG002|COMPLETED|Overall Study||3||
48299936|NCT00454532|101060262|FG003|COMPLETED|Overall Study||7||
48299937|NCT00454532|101060259|FG000|NOT COMPLETED|Overall Study||0||
48299938|NCT00454532|101060260|FG001|NOT COMPLETED|Overall Study||0||
48299939|NCT00454532|101060261|FG002|NOT COMPLETED|Overall Study||0||
48299940|NCT00454532|101060262|FG003|NOT COMPLETED|Overall Study||0||
48299941|NCT00752622|101060263|FG000|STARTED|Induction Phase||100||
48299942|NCT00752622|101060263|FG000|COMPLETED|Induction Phase||65||
48299943|NCT00752622|101060263|FG000|NOT COMPLETED|Induction Phase||35||
48299944|NCT00752622|101060263|FG000|STARTED|Observational Phase||65||
48299945|NCT00752622|101060263|FG000|COMPLETED|Observational Phase||22||
48299946|NCT00752622|101060263|FG000|NOT COMPLETED|Observational Phase||43||
48299947|NCT00752622|101060263|FG000|STARTED|Interventional Phase||8||
48299948|NCT00752622|101060263|FG000|COMPLETED|Interventional Phase||0||
48299949|NCT00752622|101060263|FG000|NOT COMPLETED|Interventional Phase||8||
48299950|NCT02279862|101060264|FG000|STARTED|Overall Study||26||
48299951|NCT02279862|101060265|FG001|STARTED|Overall Study||27||
48299952|NCT02279862|101060264|FG000|Treated|Overall Study||25||
48299953|NCT02279862|101060265|FG001|Treated|Overall Study||26||
48299954|NCT02279862|101060264|FG000|COMPLETED|Overall Study||0||
48299955|NCT02279862|101060265|FG001|COMPLETED|Overall Study||2||
48299956|NCT02279862|101060264|FG000|NOT COMPLETED|Overall Study||26||
48299957|NCT02279862|101060265|FG001|NOT COMPLETED|Overall Study||25||
48299958|NCT01603082|101060266|FG000|STARTED|Overall Study||51||
48299959|NCT01603082|101060267|FG001|STARTED|Overall Study||49||
48299960|NCT01603082|101060266|FG000|COMPLETED|Overall Study||49||
48299961|NCT01603082|101060267|FG001|COMPLETED|Overall Study||48||
48299962|NCT01603082|101060266|FG000|NOT COMPLETED|Overall Study||2||
48299963|NCT01603082|101060267|FG001|NOT COMPLETED|Overall Study||1||
48299964|NCT01862133|101060268|FG000|STARTED|Overall Study||105||
48299965|NCT01862133|101060269|FG001|STARTED|Overall Study||31||
48299966|NCT01862133|101060268|FG000|Returned During 6 mo Study|Overall Study||92||
48299967|NCT01862133|101060269|FG001|Returned During 6 mo Study|Overall Study||31||
48299968|NCT01862133|101060268|FG000|COMPLETED|Overall Study||105||
48299969|NCT01862133|101060269|FG001|COMPLETED|Overall Study||31||
48299970|NCT01862133|101060268|FG000|NOT COMPLETED|Overall Study||0||
48299971|NCT01862133|101060269|FG001|NOT COMPLETED|Overall Study||0||
48299972|NCT00568321|101060270|FG000|STARTED|Overall Study||33||
48299973|NCT00568321|101060271|FG001|STARTED|Overall Study||33||
48299974|NCT00568321|101060272|FG002|STARTED|Overall Study||33||
48657073|NCT03648372|101943771|FG014|COMPLETED|Overall Study||0||
48714732|NCT03461406|102088608|FG001|Safety Population|Overall Study||87|Safety population included all participants who received any amount of IP.|
48714733|NCT03461406|102088607|FG000|COMPLETED|Overall Study||87||
48714734|NCT03461406|102088608|FG001|COMPLETED|Overall Study||84||
48714735|NCT03461406|102088607|FG000|NOT COMPLETED|Overall Study||8||
48299975|NCT00568321|101060270|FG000|Treated|Overall Study||31||
48299976|NCT00568321|101060271|FG001|Treated|Overall Study||33||
48299977|NCT00568321|101060272|FG002|Treated|Overall Study||32||
48299978|NCT00568321|101060270|FG000|COMPLETED|Overall Study||20||
48299979|NCT00568321|101060271|FG001|COMPLETED|Overall Study||28||
48299980|NCT00568321|101060272|FG002|COMPLETED|Overall Study||24||
48299981|NCT00568321|101060270|FG000|NOT COMPLETED|Overall Study||13||
48299982|NCT00568321|101060271|FG001|NOT COMPLETED|Overall Study||5||
48299983|NCT00568321|101060272|FG002|NOT COMPLETED|Overall Study||9||
48299984|NCT02864381|101060273|FG000|STARTED|Overall Study||72||
48601819|NCT05052697|101807765|FG025|Vaccination 2|SubStudy B: Initial Enrollment||0|Included participants who were randomized to 2-Visit vaccination schedule|
48601820|NCT05052697|101807766|FG026|Vaccination 2|SubStudy B: Initial Enrollment||0|Included participants who were randomized to 2-Visit vaccination schedule|
48601821|NCT05052697|101807767|FG027|Vaccination 2|SubStudy B: Initial Enrollment||0|Included participants who were randomized to 2-Visit vaccination schedule|
48601822|NCT05052697|101807768|FG028|Vaccination 2|SubStudy B: Initial Enrollment||0|Included participants who were randomized to 2-Visit vaccination schedule|
48601823|NCT05052697|101807769|FG029|Vaccination 2|SubStudy B: Initial Enrollment||0|Included participants who were randomized to 2-Visit vaccination schedule|
48601824|NCT05052697|101807770|FG030|Vaccination 2|SubStudy B: Initial Enrollment||0|Included participants who were randomized to 2-Visit vaccination schedule|
48601825|NCT05052697|101807771|FG031|Vaccination 2|SubStudy B: Initial Enrollment||0|Included participants who were randomized to 2-Visit vaccination schedule|
48601826|NCT05052697|101807772|FG032|Vaccination 2|SubStudy B: Initial Enrollment||0|Included participants who were randomized to 2-Visit vaccination schedule|
48405252|NCT03304262|101325232|FG001|COMPLETED|Overall Study||5||
48601827|NCT05052697|101807773|FG033|Vaccination 2|SubStudy B: Initial Enrollment||0|Included participants who were randomized to 2-Visit vaccination schedule|
48601828|NCT05052697|101807740|FG000|COMPLETED|SubStudy B: Initial Enrollment||0||
48601829|NCT05052697|101807741|FG001|COMPLETED|SubStudy B: Initial Enrollment||0||
48601830|NCT05052697|101807742|FG002|COMPLETED|SubStudy B: Initial Enrollment||0||
48601831|NCT05052697|101807743|FG003|COMPLETED|SubStudy B: Initial Enrollment||0||
48601832|NCT05052697|101807744|FG004|COMPLETED|SubStudy B: Initial Enrollment||0||
48601833|NCT05052697|101807745|FG005|COMPLETED|SubStudy B: Initial Enrollment||0||
48601834|NCT05052697|101807746|FG006|COMPLETED|SubStudy B: Initial Enrollment||0||
48601835|NCT05052697|101807747|FG007|COMPLETED|SubStudy B: Initial Enrollment||0||
48601836|NCT05052697|101807748|FG008|COMPLETED|SubStudy B: Initial Enrollment||0||
48601837|NCT05052697|101807749|FG009|COMPLETED|SubStudy B: Initial Enrollment||0||
48601838|NCT05052697|101807750|FG010|COMPLETED|SubStudy B: Initial Enrollment||0||
48601839|NCT05052697|101807751|FG011|COMPLETED|SubStudy B: Initial Enrollment||0||
48601840|NCT05052697|101807752|FG012|COMPLETED|SubStudy B: Initial Enrollment||0||
48601841|NCT05052697|101807753|FG013|COMPLETED|SubStudy B: Initial Enrollment||0||
48601842|NCT05052697|101807754|FG014|COMPLETED|SubStudy B: Initial Enrollment||0||
48714736|NCT03461406|102088608|FG001|NOT COMPLETED|Overall Study||7||
48714737|NCT01460407|102088609|FG000|STARTED|Period 1: Day 1 to Day 5||14||
48405253|NCT03304262|101325233|FG002|COMPLETED|Overall Study||4||
48714738|NCT01460407|102088610|FG001|STARTED|Period 1: Day 1 to Day 5||0||
48714739|NCT01460407|102088609|FG000|COMPLETED|Period 1: Day 1 to Day 5||14||
48714740|NCT01460407|102088610|FG001|COMPLETED|Period 1: Day 1 to Day 5||0||
48714741|NCT01460407|102088609|FG000|NOT COMPLETED|Period 1: Day 1 to Day 5||0||
48714742|NCT01460407|102088610|FG001|NOT COMPLETED|Period 1: Day 1 to Day 5||0||
48714743|NCT01460407|102088609|FG000|STARTED|Period 2: Day 6 to Day 14||0||
48714744|NCT01460407|102088610|FG001|STARTED|Period 2: Day 6 to Day 14||14||
48714745|NCT01460407|102088609|FG000|COMPLETED|Period 2: Day 6 to Day 14||0||
48714746|NCT01460407|102088610|FG001|COMPLETED|Period 2: Day 6 to Day 14||13||
48714747|NCT01460407|102088609|FG000|NOT COMPLETED|Period 2: Day 6 to Day 14||0||
48714748|NCT01460407|102088610|FG001|NOT COMPLETED|Period 2: Day 6 to Day 14||1||
48714749|NCT02657564|102088611|FG000|STARTED|Overall Study||1237||
48146139|NCT04004611|100682280|FG001|NOT COMPLETED|OL Induction and Maintenance Period||1||
48146140|NCT04004611|100682281|FG002|NOT COMPLETED|OL Induction and Maintenance Period||5||
48146141|NCT04004611|100682282|FG003|NOT COMPLETED|OL Induction and Maintenance Period||0||
48146142|NCT04004611|100682283|FG004|NOT COMPLETED|OL Induction and Maintenance Period||0||
48146143|NCT04004611|100682284|FG005|NOT COMPLETED|OL Induction and Maintenance Period||0||
48146144|NCT04004611|100682285|FG006|NOT COMPLETED|OL Induction and Maintenance Period||0||
48146145|NCT04004611|100682286|FG007|NOT COMPLETED|OL Induction and Maintenance Period||0||
48146146|NCT04004611|100682287|FG008|NOT COMPLETED|OL Induction and Maintenance Period||0||
48146147|NCT03871595|100682288|FG000|STARTED|Treatment Period 1 (P1) + Wash-out||7||
48146148|NCT03871595|100682289|FG001|STARTED|Treatment Period 1 (P1) + Wash-out||7||
48146149|NCT03871595|100682288|FG000|COMPLETED|Treatment Period 1 (P1) + Wash-out||7||
48146150|NCT03871595|100682289|FG001|COMPLETED|Treatment Period 1 (P1) + Wash-out||7||
48146151|NCT03871595|100682288|FG000|NOT COMPLETED|Treatment Period 1 (P1) + Wash-out||0||
48146152|NCT03871595|100682289|FG001|NOT COMPLETED|Treatment Period 1 (P1) + Wash-out||0||
48146153|NCT03871595|100682288|FG000|STARTED|Treatment Period 2 (P2)||7||
48146154|NCT03871595|100682289|FG001|STARTED|Treatment Period 2 (P2)||7||
48146155|NCT03871595|100682288|FG000|COMPLETED|Treatment Period 2 (P2)||7||
48146156|NCT03871595|100682289|FG001|COMPLETED|Treatment Period 2 (P2)||7||
48146157|NCT03871595|100682288|FG000|NOT COMPLETED|Treatment Period 2 (P2)||0||
48146158|NCT03871595|100682289|FG001|NOT COMPLETED|Treatment Period 2 (P2)||0||
48146159|NCT00694603|100682290|FG000|STARTED|Overall Study||18||
48146160|NCT00694603|100682290|FG000|COMPLETED|Overall Study||18||
48146161|NCT00694603|100682290|FG000|NOT COMPLETED|Overall Study||0||
48146162|NCT04435366|100682291|FG000|STARTED|Year 1 (12 Months)||225||
48146163|NCT04435366|100682292|FG001|STARTED|Year 1 (12 Months)||0||
48146164|NCT04435366|100682293|FG002|STARTED|Year 1 (12 Months)||223||
48146165|NCT04435366|100682291|FG000|Treated|Year 1 (12 Months)||225||
48146166|NCT04435366|100682292|FG001|Treated|Year 1 (12 Months)||0||
48146167|NCT04435366|100682293|FG002|Treated|Year 1 (12 Months)||222||
48146168|NCT04435366|100682291|FG000|COMPLETED|Year 1 (12 Months)||200||
48146169|NCT04435366|100682292|FG001|COMPLETED|Year 1 (12 Months)||0||
48146170|NCT04435366|100682293|FG002|COMPLETED|Year 1 (12 Months)||205||
48146171|NCT04435366|100682291|FG000|NOT COMPLETED|Year 1 (12 Months)||25||
48146172|NCT04435366|100682292|FG001|NOT COMPLETED|Year 1 (12 Months)||0||
48146173|NCT04435366|100682293|FG002|NOT COMPLETED|Year 1 (12 Months)||18||
48146174|NCT04435366|100682291|FG000|STARTED|Year 2 (12 Months)||96||
48146175|NCT04435366|100682292|FG001|STARTED|Year 2 (12 Months)||93||
48146176|NCT04435366|100682293|FG002|STARTED|Year 2 (12 Months)||203||
48146177|NCT04435366|100682291|FG000|COMPLETED|Year 2 (12 Months)||89||
48146178|NCT04435366|100682292|FG001|COMPLETED|Year 2 (12 Months)||83||
48146179|NCT04435366|100682293|FG002|COMPLETED|Year 2 (12 Months)||184||
48146180|NCT04435366|100682291|FG000|NOT COMPLETED|Year 2 (12 Months)||7||
48146181|NCT04435366|100682292|FG001|NOT COMPLETED|Year 2 (12 Months)||10||
48146182|NCT04435366|100682293|FG002|NOT COMPLETED|Year 2 (12 Months)||19||
48146183|NCT03657277|100682294|FG000|STARTED|Overall Study||46||
48146184|NCT03657277|100682294|FG000|COMPLETED|Overall Study||35||
48146185|NCT03657277|100682294|FG000|NOT COMPLETED|Overall Study||11||
48146186|NCT04197713|100682295|FG000|STARTED|Overall Study||3||
48146187|NCT04197713|100682296|FG001|STARTED|Overall Study||10||
48146188|NCT04197713|100682295|FG000|COMPLETED|Overall Study||3||
48146189|NCT04197713|100682296|FG001|COMPLETED|Overall Study||9||
48146190|NCT04197713|100682295|FG000|NOT COMPLETED|Overall Study||0||
48146191|NCT04197713|100682296|FG001|NOT COMPLETED|Overall Study||1||
48146192|NCT01515410|100682297|FG000|STARTED|Overall Study||19||
48146193|NCT01515410|100682298|FG001|STARTED|Overall Study||15||
48146194|NCT01515410|100682297|FG000|COMPLETED|Overall Study||19||
48146195|NCT01515410|100682298|FG001|COMPLETED|Overall Study||15||
48146196|NCT01515410|100682297|FG000|NOT COMPLETED|Overall Study||0||
48146197|NCT01515410|100682298|FG001|NOT COMPLETED|Overall Study||0||
48146198|NCT00798720|100682299|FG000|STARTED|Overall Study||18||
48146199|NCT00798720|100682299|FG000|COMPLETED|Overall Study||18||
48146200|NCT00798720|100682299|FG000|NOT COMPLETED|Overall Study||0||
48146201|NCT00951041|100682300|FG000|STARTED|Overall Study||64||
48146202|NCT00951041|100682301|FG001|STARTED|Overall Study||66||
48146203|NCT00951041|100682300|FG000|COMPLETED|Overall Study||59||
48146204|NCT00951041|100682301|FG001|COMPLETED|Overall Study||65||
48146205|NCT00951041|100682300|FG000|NOT COMPLETED|Overall Study||5||
48146206|NCT00951041|100682301|FG001|NOT COMPLETED|Overall Study||1||
48146207|NCT01001052|100682302|FG000|STARTED|Overall Study||20||
48146208|NCT01001052|100682303|FG001|STARTED|Overall Study||18||
48146209|NCT01001052|100682302|FG000|COMPLETED|Overall Study||20||
48146210|NCT01001052|100682303|FG001|COMPLETED|Overall Study||18||
48146211|NCT01001052|100682302|FG000|NOT COMPLETED|Overall Study||0||
48146212|NCT01001052|100682303|FG001|NOT COMPLETED|Overall Study||0||
48146213|NCT01506193|100682304|FG000|STARTED|Overall Study||351||
48146214|NCT01506193|100682305|FG001|STARTED|Overall Study||183||
48146215|NCT01506193|100682306|FG002|STARTED|Overall Study||182||
48146216|NCT01506193|100682304|FG000|COMPLETED|Overall Study||337||
48146217|NCT01506193|100682305|FG001|COMPLETED|Overall Study||179||
48146218|NCT01506193|100682306|FG002|COMPLETED|Overall Study||168||
48146219|NCT01506193|100682304|FG000|NOT COMPLETED|Overall Study||14||
48299985|NCT02864381|101060274|FG001|STARTED|Overall Study||72||
48299986|NCT02864381|101060273|FG000|COMPLETED|Overall Study||0||
48299987|NCT02864381|101060274|FG001|COMPLETED|Overall Study||0||
48299988|NCT02864381|101060273|FG000|NOT COMPLETED|Overall Study||72||
48299989|NCT02864381|101060274|FG001|NOT COMPLETED|Overall Study||72||
48299990|NCT01026142|101060275|FG000|STARTED|Overall Study||224||
48299991|NCT01026142|101060276|FG001|STARTED|Overall Study||228||
48299992|NCT01026142|101060275|FG000|COMPLETED|Overall Study||52||
48299993|NCT01026142|101060276|FG001|COMPLETED|Overall Study||65||
48299994|NCT01026142|101060275|FG000|NOT COMPLETED|Overall Study||172||
48299995|NCT01026142|101060276|FG001|NOT COMPLETED|Overall Study||163||
48299996|NCT04178967|101060277|FG000|STARTED|Induction Period||150||
48405254|NCT03304262|101325231|FG000|NOT COMPLETED|Overall Study||0||
48405255|NCT03304262|101325232|FG001|NOT COMPLETED|Overall Study||0||
48405256|NCT03304262|101325233|FG002|NOT COMPLETED|Overall Study||0||
48405257|NCT03991936|101325234|FG000|STARTED|Overall Study||11||11
48714750|NCT02657564|102088611|FG000|COMPLETED|Overall Study||1163||
48714751|NCT02657564|102088611|FG000|NOT COMPLETED|Overall Study||74||
48714752|NCT01224821|102088612|FG000|STARTED|Dosimetric and Therapeutic Treatment||47||
48714753|NCT01224821|102088612|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||1||
48714754|NCT01224821|102088612|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||46||
48714755|NCT01224821|102088612|FG000|STARTED|Long-Term Follow-Up||11||
48714756|NCT01224821|102088612|FG000|COMPLETED|Long-Term Follow-Up||0||
48714757|NCT01224821|102088612|FG000|NOT COMPLETED|Long-Term Follow-Up||11||
48714758|NCT02525094|102088613|FG000|STARTED|Overall Study||57||
48714759|NCT02525094|102088614|FG001|STARTED|Overall Study||56||
48714760|NCT02525094|102088613|FG000|Treated|Overall Study||56||
48714761|NCT02525094|102088614|FG001|Treated|Overall Study||55||
48714762|NCT02525094|102088613|FG000|COMPLETED|Overall Study||49||
48405258|NCT03991936|101325235|FG001|STARTED|Overall Study||11||18
48405259|NCT03991936|101325236|FG002|STARTED|Overall Study||11||19
48714763|NCT02525094|102088614|FG001|COMPLETED|Overall Study||48||
48714764|NCT02525094|102088613|FG000|NOT COMPLETED|Overall Study||8||
48714765|NCT02525094|102088614|FG001|NOT COMPLETED|Overall Study||8||
48714766|NCT03002454|102088615|FG000|STARTED|Overall Study||4||
48714767|NCT03002454|102088615|FG000|COMPLETED|Overall Study||4||
48714768|NCT03002454|102088615|FG000|NOT COMPLETED|Overall Study||0||
48714769|NCT01100528|102088616|FG000|STARTED|Overall Study||38||
48714770|NCT01100528|102088616|FG000|COMPLETED|Overall Study||35||
48714771|NCT01100528|102088616|FG000|NOT COMPLETED|Overall Study||3||
48714772|NCT01760473|102088617|FG000|STARTED|Overall Study||27||
48714773|NCT01760473|102088617|FG000|COMPLETED|Overall Study||12||
48714774|NCT01760473|102088617|FG000|NOT COMPLETED|Overall Study||15||
48714775|NCT04047420|102088618|FG000|STARTED|Enrollment (Pre-dose) Period||23||
48714776|NCT04047420|102088618|FG000|COMPLETED|Enrollment (Pre-dose) Period||21||
48714777|NCT04047420|102088618|FG000|NOT COMPLETED|Enrollment (Pre-dose) Period||2||
48714778|NCT04047420|102088618|FG000|STARTED|One TAF/EVG Insert Dose||21||
48714779|NCT04047420|102088618|FG000|COMPLETED|One TAF/EVG Insert Dose||21||
48714780|NCT04047420|102088618|FG000|NOT COMPLETED|One TAF/EVG Insert Dose||0||
48299997|NCT04178967|101060278|FG001|STARTED|Induction Period||295||
48299998|NCT04178967|101060279|FG002|STARTED|Induction Period||0||
48299999|NCT04178967|101060280|FG003|STARTED|Induction Period||0||
48300000|NCT04178967|101060281|FG004|STARTED|Induction Period||0||
48300001|NCT04178967|101060282|FG005|STARTED|Induction Period||0||
48300002|NCT04178967|101060283|FG006|STARTED|Induction Period||0||
48300003|NCT04178967|101060284|FG007|STARTED|Induction Period||0||
48601843|NCT05052697|101807755|FG015|COMPLETED|SubStudy B: Initial Enrollment||0||
48601844|NCT05052697|101807756|FG016|COMPLETED|SubStudy B: Initial Enrollment||0||
48601845|NCT05052697|101807757|FG017|COMPLETED|SubStudy B: Initial Enrollment||13||
48601846|NCT05052697|101807758|FG018|COMPLETED|SubStudy B: Initial Enrollment||14||
48601847|NCT05052697|101807759|FG019|COMPLETED|SubStudy B: Initial Enrollment||14||
48601848|NCT05052697|101807760|FG020|COMPLETED|SubStudy B: Initial Enrollment||16||
48601849|NCT05052697|101807761|FG021|COMPLETED|SubStudy B: Initial Enrollment||15||
48601850|NCT05052697|101807762|FG022|COMPLETED|SubStudy B: Initial Enrollment||13||
48601851|NCT05052697|101807763|FG023|COMPLETED|SubStudy B: Initial Enrollment||16||
48601852|NCT05052697|101807764|FG024|COMPLETED|SubStudy B: Initial Enrollment||16||
48146220|NCT01506193|100682305|FG001|NOT COMPLETED|Overall Study||4||
48146221|NCT01506193|100682306|FG002|NOT COMPLETED|Overall Study||14||
48146222|NCT02703922|100682307|FG000|STARTED|Overall Study||73||
48146223|NCT02703922|100682308|FG001|STARTED|Overall Study||92||
48146224|NCT02703922|100682307|FG000|COMPLETED|Overall Study||58||
48146225|NCT02703922|100682308|FG001|COMPLETED|Overall Study||74||
48146226|NCT02703922|100682307|FG000|NOT COMPLETED|Overall Study||15||
48146227|NCT02703922|100682308|FG001|NOT COMPLETED|Overall Study||18||
48146228|NCT00440531|100682309|FG000|STARTED|Overall Study||185||
48146229|NCT00440531|100682310|FG001|STARTED|Overall Study||183||
48146230|NCT00440531|100682311|FG002|STARTED|Overall Study||172||
48146231|NCT00440531|100682309|FG000|Vaccination 1|Overall Study||183||
48146232|NCT00440531|100682310|FG001|Vaccination 1|Overall Study||183||
48146233|NCT00440531|100682311|FG002|Vaccination 1|Overall Study||172||
48146234|NCT00440531|100682309|FG000|Vaccination 2|Overall Study||181||
48146235|NCT00440531|100682310|FG001|Vaccination 2|Overall Study||182||
48146236|NCT00440531|100682311|FG002|Vaccination 2|Overall Study||171||
48146237|NCT00440531|100682309|FG000|Vaccination 3|Overall Study||176||
48146238|NCT00440531|100682310|FG001|Vaccination 3|Overall Study||178||
48146239|NCT00440531|100682311|FG002|Vaccination 3|Overall Study||166||
48146240|NCT00440531|100682309|FG000|COMPLETED|Overall Study||175||
48146241|NCT00440531|100682310|FG001|COMPLETED|Overall Study||178||
48146242|NCT00440531|100682311|FG002|COMPLETED|Overall Study||165||
48146243|NCT00440531|100682309|FG000|NOT COMPLETED|Overall Study||10||
48146244|NCT00440531|100682310|FG001|NOT COMPLETED|Overall Study||5||
48146245|NCT00440531|100682311|FG002|NOT COMPLETED|Overall Study||7||
48146246|NCT00514735|100682312|FG000|STARTED|Overall Study||138||
48146247|NCT00514735|100682313|FG001|STARTED|Overall Study||72||
48146248|NCT00514735|100682312|FG000|COMPLETED|Overall Study||124||
48146249|NCT00514735|100682313|FG001|COMPLETED|Overall Study||66||
48146250|NCT00514735|100682312|FG000|NOT COMPLETED|Overall Study||14||
48146251|NCT00514735|100682313|FG001|NOT COMPLETED|Overall Study||6||
48146252|NCT03644186|100682314|FG000|STARTED|Overall Study||74||
48146253|NCT03644186|100682315|FG001|STARTED|Overall Study||73||
48146254|NCT03644186|100682314|FG000|COMPLETED|Overall Study||73||
48146255|NCT03644186|100682315|FG001|COMPLETED|Overall Study||72||
48146256|NCT03644186|100682314|FG000|NOT COMPLETED|Overall Study||1||
48146257|NCT03644186|100682315|FG001|NOT COMPLETED|Overall Study||1||
48146258|NCT02243605|100682316|FG000|STARTED|Stage 1 - Interim Analysis Population||23||
48146259|NCT02243605|100682317|FG001|STARTED|Stage 1 - Interim Analysis Population||22||
48146260|NCT02243605|100682316|FG000|COMPLETED|Stage 1 - Interim Analysis Population||21|Eligible and who received at least one complete cycle or two incomplete cycles of treatment.|
48146261|NCT02243605|100682317|FG001|COMPLETED|Stage 1 - Interim Analysis Population||21|Eligible and who received at least one complete cycle or two incomplete cycles of treatment.|
48146262|NCT02243605|100682316|FG000|NOT COMPLETED|Stage 1 - Interim Analysis Population||2||
48146263|NCT02243605|100682317|FG001|NOT COMPLETED|Stage 1 - Interim Analysis Population||1||
48146264|NCT02243605|100682316|FG000|STARTED|Stage 2 - Final Analysis Population||45||
48146265|NCT02243605|100682317|FG001|STARTED|Stage 2 - Final Analysis Population||45||
48146266|NCT02243605|100682316|FG000|COMPLETED|Stage 2 - Final Analysis Population||39|Eligible and who received at least one complete cycle or two incomplete cycles of treatment.|
48146267|NCT02243605|100682317|FG001|COMPLETED|Stage 2 - Final Analysis Population||42|Eligible and who received at least one complete cycle or two incomplete cycles of treatment.|
48146268|NCT02243605|100682316|FG000|NOT COMPLETED|Stage 2 - Final Analysis Population||6||
48146269|NCT02243605|100682317|FG001|NOT COMPLETED|Stage 2 - Final Analysis Population||3||
48146270|NCT00952367|100682318|FG000|STARTED|Overall Study||3641||
48146271|NCT00952367|100682318|FG000|COMPLETED|Overall Study||3635||
48146272|NCT00952367|100682318|FG000|NOT COMPLETED|Overall Study||6||
48146273|NCT03206203|100682319|FG000|STARTED|Treatment||56||
48146274|NCT03206203|100682320|FG001|STARTED|Treatment||50||
48146275|NCT03206203|100682321|FG002|STARTED|Treatment||0||
48601853|NCT05052697|101807765|FG025|COMPLETED|SubStudy B: Initial Enrollment||14||
48601854|NCT05052697|101807766|FG026|COMPLETED|SubStudy B: Initial Enrollment||15||
48601855|NCT05052697|101807767|FG027|COMPLETED|SubStudy B: Initial Enrollment||15||
48146276|NCT03206203|100682319|FG000|COMPLETED|Treatment||5||
48146277|NCT03206203|100682320|FG001|COMPLETED|Treatment||2||
48146278|NCT03206203|100682321|FG002|COMPLETED|Treatment||0||
48146279|NCT03206203|100682319|FG000|NOT COMPLETED|Treatment||51||
48146280|NCT03206203|100682320|FG001|NOT COMPLETED|Treatment||48||
48146281|NCT03206203|100682321|FG002|NOT COMPLETED|Treatment||0||
48146282|NCT03206203|100682319|FG000|STARTED|Optional Cross-Over||0||
48146283|NCT03206203|100682320|FG001|STARTED|Optional Cross-Over||0||
48146284|NCT03206203|100682321|FG002|STARTED|Optional Cross-Over||19||
48146285|NCT03206203|100682319|FG000|COMPLETED|Optional Cross-Over||0||
48146286|NCT03206203|100682320|FG001|COMPLETED|Optional Cross-Over||0||
48146287|NCT03206203|100682321|FG002|COMPLETED|Optional Cross-Over||3||
48146288|NCT03206203|100682319|FG000|NOT COMPLETED|Optional Cross-Over||0||
48146289|NCT03206203|100682320|FG001|NOT COMPLETED|Optional Cross-Over||0||
48146290|NCT03206203|100682321|FG002|NOT COMPLETED|Optional Cross-Over||16||
48146291|NCT03073148|100682322|FG000|STARTED|Overall Study||21||
48146292|NCT03073148|100682323|FG001|STARTED|Overall Study||10||
48146293|NCT03073148|100682324|FG002|STARTED|Overall Study||4||
48146294|NCT03073148|100682322|FG000|COMPLETED|Overall Study||21||
48146295|NCT03073148|100682323|FG001|COMPLETED|Overall Study||10||
48146296|NCT03073148|100682324|FG002|COMPLETED|Overall Study||0||
48146297|NCT03073148|100682322|FG000|NOT COMPLETED|Overall Study||0||
48146298|NCT03073148|100682323|FG001|NOT COMPLETED|Overall Study||0||
48146299|NCT03073148|100682324|FG002|NOT COMPLETED|Overall Study||4||
48146300|NCT04602728|100682325|FG000|STARTED|Overall Study||20||
48146301|NCT04602728|100682326|FG001|STARTED|Overall Study||20||
48146302|NCT04602728|100682325|FG000|Completed the Study Treatment of the Entire Back2Life Program|Overall Study||16||
48146303|NCT04602728|100682326|FG001|Completed the Study Treatment of the Entire Back2Life Program|Overall Study||16||
48146304|NCT04602728|100682325|FG000|COMPLETED|Overall Study||16||
48146305|NCT04602728|100682326|FG001|COMPLETED|Overall Study||16||
48146306|NCT04602728|100682325|FG000|NOT COMPLETED|Overall Study||4||
48146307|NCT04602728|100682326|FG001|NOT COMPLETED|Overall Study||4||
48146308|NCT01175850|100682327|FG000|STARTED|IN.PACT SFA I Phase||99||
48146309|NCT01175850|100682328|FG001|STARTED|IN.PACT SFA I Phase||51||
48146310|NCT01175850|100682327|FG000|COMPLETED|IN.PACT SFA I Phase||88||
48146311|NCT01175850|100682328|FG001|COMPLETED|IN.PACT SFA I Phase||49||
48146312|NCT01175850|100682327|FG000|NOT COMPLETED|IN.PACT SFA I Phase||11||
48146313|NCT01175850|100682328|FG001|NOT COMPLETED|IN.PACT SFA I Phase||2||
48146314|NCT01175850|100682327|FG000|STARTED|IN.PACT SFA II Phase||121||
48146315|NCT01175850|100682328|FG001|STARTED|IN.PACT SFA II Phase||60||
48146316|NCT01175850|100682327|FG000|COMPLETED|IN.PACT SFA II Phase||109||
48146317|NCT01175850|100682328|FG001|COMPLETED|IN.PACT SFA II Phase||55||
48146318|NCT01175850|100682327|FG000|NOT COMPLETED|IN.PACT SFA II Phase||12||
48146319|NCT01175850|100682328|FG001|NOT COMPLETED|IN.PACT SFA II Phase||5||
48146320|NCT02669784|100682329|FG000|STARTED|Overall Study||18||
48146321|NCT02669784|100682330|FG001|STARTED|Overall Study||16||
48146322|NCT02669784|100682329|FG000|COMPLETED|Overall Study||18||
48146323|NCT02669784|100682330|FG001|COMPLETED|Overall Study||16||
48146324|NCT02669784|100682329|FG000|NOT COMPLETED|Overall Study||0||
48146325|NCT02669784|100682330|FG001|NOT COMPLETED|Overall Study||0||
48300004|NCT04178967|101060285|FG008|STARTED|Induction Period||0||
48300005|NCT04178967|101060286|FG009|STARTED|Induction Period||0||
48300006|NCT04178967|101060287|FG010|STARTED|Induction Period||0||
48300007|NCT04178967|101060277|FG000|Received at Least One Dose of Study Drug|Induction Period||149||
48300008|NCT04178967|101060278|FG001|Received at Least One Dose of Study Drug|Induction Period||295||
48300009|NCT04178967|101060279|FG002|Received at Least One Dose of Study Drug|Induction Period||0||
48300010|NCT04178967|101060280|FG003|Received at Least One Dose of Study Drug|Induction Period||0||
48300011|NCT04178967|101060281|FG004|Received at Least One Dose of Study Drug|Induction Period||0||
48300012|NCT04178967|101060282|FG005|Received at Least One Dose of Study Drug|Induction Period||0||
48300013|NCT04178967|101060283|FG006|Received at Least One Dose of Study Drug|Induction Period||0||
48300014|NCT04178967|101060284|FG007|Received at Least One Dose of Study Drug|Induction Period||0||
48300015|NCT04178967|101060285|FG008|Received at Least One Dose of Study Drug|Induction Period||0||
48300016|NCT04178967|101060286|FG009|Received at Least One Dose of Study Drug|Induction Period||0||
48300017|NCT04178967|101060287|FG010|Received at Least One Dose of Study Drug|Induction Period||0||
48300018|NCT04178967|101060277|FG000|COMPLETED|Induction Period||133||
48300019|NCT04178967|101060278|FG001|COMPLETED|Induction Period||273||
48300020|NCT04178967|101060279|FG002|COMPLETED|Induction Period||0||
48300021|NCT04178967|101060280|FG003|COMPLETED|Induction Period||0||
48300022|NCT04178967|101060281|FG004|COMPLETED|Induction Period||0||
48300023|NCT04178967|101060282|FG005|COMPLETED|Induction Period||0||
48300024|NCT04178967|101060283|FG006|COMPLETED|Induction Period||0||
48300025|NCT04178967|101060284|FG007|COMPLETED|Induction Period||0||
48300026|NCT04178967|101060285|FG008|COMPLETED|Induction Period||0||
48300027|NCT04178967|101060286|FG009|COMPLETED|Induction Period||0||
48405260|NCT03991936|101325237|FG003|STARTED|Overall Study||11||18
48405261|NCT03991936|101325238|FG004|STARTED|Overall Study||11||16
48405262|NCT03991936|101325234|FG000|COMPLETED|Overall Study||10||10
48405263|NCT03991936|101325235|FG001|COMPLETED|Overall Study||10||16
48405264|NCT03991936|101325236|FG002|COMPLETED|Overall Study||10||17
48405265|NCT03991936|101325237|FG003|COMPLETED|Overall Study||10||16
48601856|NCT05052697|101807768|FG028|COMPLETED|SubStudy B: Initial Enrollment||0||
48601857|NCT05052697|101807769|FG029|COMPLETED|SubStudy B: Initial Enrollment||0||
48601858|NCT05052697|101807770|FG030|COMPLETED|SubStudy B: Initial Enrollment||0||
48601859|NCT05052697|101807771|FG031|COMPLETED|SubStudy B: Initial Enrollment||0||
48601860|NCT05052697|101807772|FG032|COMPLETED|SubStudy B: Initial Enrollment||0||
48601861|NCT05052697|101807773|FG033|COMPLETED|SubStudy B: Initial Enrollment||0||
48601862|NCT05052697|101807740|FG000|NOT COMPLETED|SubStudy B: Initial Enrollment||0||
48601863|NCT05052697|101807741|FG001|NOT COMPLETED|SubStudy B: Initial Enrollment||0||
48601864|NCT05052697|101807742|FG002|NOT COMPLETED|SubStudy B: Initial Enrollment||0||
48714781|NCT04047420|102088618|FG000|STARTED|Washout Period||21||
48714782|NCT04047420|102088618|FG000|COMPLETED|Washout Period||19||
48714783|NCT04047420|102088618|FG000|NOT COMPLETED|Washout Period||2||
48714784|NCT04047420|102088618|FG000|STARTED|Two TAF/EVG Inserts Dose||19||
48714785|NCT04047420|102088618|FG000|COMPLETED|Two TAF/EVG Inserts Dose||19||
48714786|NCT04047420|102088618|FG000|NOT COMPLETED|Two TAF/EVG Inserts Dose||0||
48714787|NCT03306641|102088619|FG000|STARTED|First Intervention||23||
48714788|NCT03306641|102088620|FG001|STARTED|First Intervention||22||
48714789|NCT03306641|102088619|FG000|COMPLETED|First Intervention||23||
48714790|NCT03306641|102088620|FG001|COMPLETED|First Intervention||22||
48714791|NCT03306641|102088619|FG000|NOT COMPLETED|First Intervention||0||
48714792|NCT03306641|102088620|FG001|NOT COMPLETED|First Intervention||0||
48714793|NCT03306641|102088619|FG000|STARTED|Second Intervention||23||
48300028|NCT04178967|101060287|FG010|COMPLETED|Induction Period||0||
48300029|NCT04178967|101060277|FG000|NOT COMPLETED|Induction Period||17||
48300030|NCT04178967|101060278|FG001|NOT COMPLETED|Induction Period||22||
48300031|NCT04178967|101060279|FG002|NOT COMPLETED|Induction Period||0||
48300032|NCT04178967|101060280|FG003|NOT COMPLETED|Induction Period||0||
48300033|NCT04178967|101060281|FG004|NOT COMPLETED|Induction Period||0||
48300034|NCT04178967|101060282|FG005|NOT COMPLETED|Induction Period||0||
48300035|NCT04178967|101060283|FG006|NOT COMPLETED|Induction Period||0||
48300036|NCT04178967|101060284|FG007|NOT COMPLETED|Induction Period||0||
48405266|NCT03991936|101325238|FG004|COMPLETED|Overall Study||10||14
48405267|NCT03991936|101325234|FG000|NOT COMPLETED|Overall Study||1||1
48405268|NCT03991936|101325235|FG001|NOT COMPLETED|Overall Study||1||2
48405269|NCT03991936|101325236|FG002|NOT COMPLETED|Overall Study||1||2
48714794|NCT03306641|102088620|FG001|STARTED|Second Intervention||22||
48714795|NCT03306641|102088619|FG000|COMPLETED|Second Intervention||23||
48300037|NCT04178967|101060285|FG008|NOT COMPLETED|Induction Period||0||
48300038|NCT04178967|101060286|FG009|NOT COMPLETED|Induction Period||0||
48300039|NCT04178967|101060287|FG010|NOT COMPLETED|Induction Period||0||
48300040|NCT04178967|101060277|FG000|STARTED|Maintenance Blinded Treatment Period||0||
48300041|NCT04178967|101060278|FG001|STARTED|Maintenance Blinded Treatment Period||0||
48300042|NCT04178967|101060279|FG002|STARTED|Maintenance Blinded Treatment Period||5||
48300043|NCT04178967|101060280|FG003|STARTED|Maintenance Blinded Treatment Period||9||
48300044|NCT04178967|101060281|FG004|STARTED|Maintenance Blinded Treatment Period||11||
48300045|NCT04178967|101060282|FG005|STARTED|Maintenance Blinded Treatment Period||30||
48300046|NCT04178967|101060283|FG006|STARTED|Maintenance Blinded Treatment Period||59||
48300047|NCT04178967|101060284|FG007|STARTED|Maintenance Blinded Treatment Period||59||
48300048|NCT04178967|101060285|FG008|STARTED|Maintenance Blinded Treatment Period||0||
48300049|NCT04178967|101060286|FG009|STARTED|Maintenance Blinded Treatment Period||0||
48300050|NCT04178967|101060287|FG010|STARTED|Maintenance Blinded Treatment Period||0||
48300051|NCT04178967|101060277|FG000|Received at Least One Dose of Study Drug|Maintenance Blinded Treatment Period||0||
48300052|NCT04178967|101060278|FG001|Received at Least One Dose of Study Drug|Maintenance Blinded Treatment Period||0||
48300053|NCT04178967|101060279|FG002|Received at Least One Dose of Study Drug|Maintenance Blinded Treatment Period||5||
48300054|NCT04178967|101060280|FG003|Received at Least One Dose of Study Drug|Maintenance Blinded Treatment Period||9||
48300055|NCT04178967|101060281|FG004|Received at Least One Dose of Study Drug|Maintenance Blinded Treatment Period||11||
48300056|NCT04178967|101060282|FG005|Received at Least One Dose of Study Drug|Maintenance Blinded Treatment Period||30||
48300057|NCT04178967|101060283|FG006|Received at Least One Dose of Study Drug|Maintenance Blinded Treatment Period||59||
48300058|NCT04178967|101060284|FG007|Received at Least One Dose of Study Drug|Maintenance Blinded Treatment Period||59||
48300059|NCT04178967|101060285|FG008|Received at Least One Dose of Study Drug|Maintenance Blinded Treatment Period||0||
48300060|NCT04178967|101060286|FG009|Received at Least One Dose of Study Drug|Maintenance Blinded Treatment Period||0||
48300061|NCT04178967|101060287|FG010|Received at Least One Dose of Study Drug|Maintenance Blinded Treatment Period||0||
48300062|NCT04178967|101060277|FG000|COMPLETED|Maintenance Blinded Treatment Period||0||
48300063|NCT04178967|101060278|FG001|COMPLETED|Maintenance Blinded Treatment Period||0||
48714796|NCT03306641|102088620|FG001|COMPLETED|Second Intervention||22||
48300064|NCT04178967|101060279|FG002|COMPLETED|Maintenance Blinded Treatment Period||4||
48300065|NCT04178967|101060280|FG003|COMPLETED|Maintenance Blinded Treatment Period||6||
48300066|NCT04178967|101060281|FG004|COMPLETED|Maintenance Blinded Treatment Period||9||
48300067|NCT04178967|101060282|FG005|COMPLETED|Maintenance Blinded Treatment Period||22||
48300068|NCT04178967|101060283|FG006|COMPLETED|Maintenance Blinded Treatment Period||51||
48300069|NCT04178967|101060284|FG007|COMPLETED|Maintenance Blinded Treatment Period||42||
48300070|NCT04178967|101060285|FG008|COMPLETED|Maintenance Blinded Treatment Period||0||
48300071|NCT04178967|101060286|FG009|COMPLETED|Maintenance Blinded Treatment Period||0||
48300072|NCT04178967|101060287|FG010|COMPLETED|Maintenance Blinded Treatment Period||0||
48300073|NCT04178967|101060277|FG000|NOT COMPLETED|Maintenance Blinded Treatment Period||0||
48300074|NCT04178967|101060278|FG001|NOT COMPLETED|Maintenance Blinded Treatment Period||0||
48300075|NCT04178967|101060279|FG002|NOT COMPLETED|Maintenance Blinded Treatment Period||1||
48300076|NCT04178967|101060280|FG003|NOT COMPLETED|Maintenance Blinded Treatment Period||3||
48300077|NCT04178967|101060281|FG004|NOT COMPLETED|Maintenance Blinded Treatment Period||2||
48300078|NCT04178967|101060282|FG005|NOT COMPLETED|Maintenance Blinded Treatment Period||8||
48300079|NCT04178967|101060283|FG006|NOT COMPLETED|Maintenance Blinded Treatment Period||8||
48300080|NCT04178967|101060284|FG007|NOT COMPLETED|Maintenance Blinded Treatment Period||17||
48300081|NCT04178967|101060285|FG008|NOT COMPLETED|Maintenance Blinded Treatment Period||0||
48300082|NCT04178967|101060286|FG009|NOT COMPLETED|Maintenance Blinded Treatment Period||0||
48300083|NCT04178967|101060287|FG010|NOT COMPLETED|Maintenance Blinded Treatment Period||0||
48300084|NCT04178967|101060277|FG000|STARTED|Maintenance Open Label Escape Arm||0||
48300085|NCT04178967|101060278|FG001|STARTED|Maintenance Open Label Escape Arm||0||
48300086|NCT04178967|101060279|FG002|STARTED|Maintenance Open Label Escape Arm||0||
48300087|NCT04178967|101060280|FG003|STARTED|Maintenance Open Label Escape Arm||0||
48300088|NCT04178967|101060281|FG004|STARTED|Maintenance Open Label Escape Arm||0||
48300089|NCT04178967|101060282|FG005|STARTED|Maintenance Open Label Escape Arm||0||
48300090|NCT04178967|101060283|FG006|STARTED|Maintenance Open Label Escape Arm||0||
48300091|NCT04178967|101060284|FG007|STARTED|Maintenance Open Label Escape Arm||0||
48300092|NCT04178967|101060285|FG008|STARTED|Maintenance Open Label Escape Arm||108||
48300093|NCT04178967|101060286|FG009|STARTED|Maintenance Open Label Escape Arm||125||
48300094|NCT04178967|101060287|FG010|STARTED|Maintenance Open Label Escape Arm||11||
48300095|NCT04178967|101060277|FG000|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||0||
48300096|NCT04178967|101060278|FG001|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||0||
48300097|NCT04178967|101060279|FG002|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||0||
48714797|NCT03306641|102088619|FG000|NOT COMPLETED|Second Intervention||0||
48714798|NCT03306641|102088620|FG001|NOT COMPLETED|Second Intervention||0||
48714799|NCT02944565|102088621|FG000|STARTED|Overall Study||28||
48714800|NCT02944565|102088621|FG000|COMPLETED|Overall Study||28||
48300098|NCT04178967|101060280|FG003|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||0||
48300099|NCT04178967|101060281|FG004|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||0||
48300100|NCT04178967|101060282|FG005|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||0||
48300101|NCT04178967|101060283|FG006|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||0||
48300102|NCT04178967|101060284|FG007|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||0||
48300103|NCT04178967|101060285|FG008|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||108||
48300104|NCT04178967|101060286|FG009|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||125||
48300105|NCT04178967|101060287|FG010|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||11||
48300106|NCT04178967|101060277|FG000|COMPLETED|Maintenance Open Label Escape Arm||0||
48146326|NCT04702568|100682331|FG000|STARTED|Overall Study||12||
48146327|NCT04702568|100682332|FG001|STARTED|Overall Study||7||
48601865|NCT05052697|101807743|FG003|NOT COMPLETED|SubStudy B: Initial Enrollment||0||
48601866|NCT05052697|101807744|FG004|NOT COMPLETED|SubStudy B: Initial Enrollment||0||
48601867|NCT05052697|101807745|FG005|NOT COMPLETED|SubStudy B: Initial Enrollment||0||
48601868|NCT05052697|101807746|FG006|NOT COMPLETED|SubStudy B: Initial Enrollment||0||
48601869|NCT05052697|101807747|FG007|NOT COMPLETED|SubStudy B: Initial Enrollment||0||
48601870|NCT05052697|101807748|FG008|NOT COMPLETED|SubStudy B: Initial Enrollment||0||
48601871|NCT05052697|101807749|FG009|NOT COMPLETED|SubStudy B: Initial Enrollment||0||
48601872|NCT05052697|101807750|FG010|NOT COMPLETED|SubStudy B: Initial Enrollment||0||
48601873|NCT05052697|101807751|FG011|NOT COMPLETED|SubStudy B: Initial Enrollment||0||
48601874|NCT05052697|101807752|FG012|NOT COMPLETED|SubStudy B: Initial Enrollment||0||
48146328|NCT04702568|100682331|FG000|COMPLETED|Overall Study||0||
48146329|NCT04702568|100682332|FG001|COMPLETED|Overall Study||0||
48146330|NCT04702568|100682331|FG000|NOT COMPLETED|Overall Study||12||
48146331|NCT04702568|100682332|FG001|NOT COMPLETED|Overall Study||7||
48146332|NCT00773968|100682333|FG000|STARTED|Overall Study||140||
48146333|NCT00773968|100682333|FG000|Treated|Overall Study||111||
48146334|NCT00773968|100682333|FG000|COMPLETED|Overall Study||95||
48146335|NCT00773968|100682333|FG000|NOT COMPLETED|Overall Study||45||
48146336|NCT04212091|100682334|FG000|STARTED|Overall Study||3||
48146337|NCT04212091|100682335|FG001|STARTED|Overall Study||4||
48146338|NCT04212091|100682336|FG002|STARTED|Overall Study||3||
48146339|NCT04212091|100682337|FG003|STARTED|Overall Study||3||
48146340|NCT04212091|100682338|FG004|STARTED|Overall Study||10||
48146341|NCT04212091|100682339|FG005|STARTED|Overall Study||10||
48146342|NCT04212091|100682334|FG000|COMPLETED|Overall Study||3||
48146343|NCT04212091|100682335|FG001|COMPLETED|Overall Study||4||
48146344|NCT04212091|100682336|FG002|COMPLETED|Overall Study||3||
48146345|NCT04212091|100682337|FG003|COMPLETED|Overall Study||3||
48146346|NCT04212091|100682338|FG004|COMPLETED|Overall Study||8||
48146347|NCT04212091|100682339|FG005|COMPLETED|Overall Study||9||
48146348|NCT04212091|100682334|FG000|NOT COMPLETED|Overall Study||0||
48146349|NCT04212091|100682335|FG001|NOT COMPLETED|Overall Study||0||
48146350|NCT04212091|100682336|FG002|NOT COMPLETED|Overall Study||0||
48146351|NCT04212091|100682337|FG003|NOT COMPLETED|Overall Study||0||
48146352|NCT04212091|100682338|FG004|NOT COMPLETED|Overall Study||2||
48146353|NCT04212091|100682339|FG005|NOT COMPLETED|Overall Study||1||
48146354|NCT01112579|100682340|FG000|STARTED|Overall Study||42||
48146355|NCT01112579|100682341|FG001|STARTED|Overall Study||24||
48146356|NCT01112579|100682340|FG000|COMPLETED|Overall Study||41||
48146357|NCT01112579|100682341|FG001|COMPLETED|Overall Study||21||
48146358|NCT01112579|100682340|FG000|NOT COMPLETED|Overall Study||1||
48146359|NCT01112579|100682341|FG001|NOT COMPLETED|Overall Study||3||
48146360|NCT04981678|100682342|FG000|STARTED|Overall Study||6||
48300107|NCT04178967|101060278|FG001|COMPLETED|Maintenance Open Label Escape Arm||0||
48300108|NCT04178967|101060279|FG002|COMPLETED|Maintenance Open Label Escape Arm||0||
48601875|NCT05052697|101807753|FG013|NOT COMPLETED|SubStudy B: Initial Enrollment||0||
48601876|NCT05052697|101807754|FG014|NOT COMPLETED|SubStudy B: Initial Enrollment||0||
48601877|NCT05052697|101807755|FG015|NOT COMPLETED|SubStudy B: Initial Enrollment||0||
48601878|NCT05052697|101807756|FG016|NOT COMPLETED|SubStudy B: Initial Enrollment||0||
48601879|NCT05052697|101807757|FG017|NOT COMPLETED|SubStudy B: Initial Enrollment||2||
48601880|NCT05052697|101807758|FG018|NOT COMPLETED|SubStudy B: Initial Enrollment||1||
48146361|NCT04981678|100682343|FG001|STARTED|Overall Study||6||
48146362|NCT04981678|100682342|FG000|COMPLETED|Overall Study||6||
48146363|NCT04981678|100682343|FG001|COMPLETED|Overall Study||5||
48146364|NCT04981678|100682342|FG000|NOT COMPLETED|Overall Study||0||
48657074|NCT03648372|101943772|FG015|COMPLETED|Overall Study||1||
48146365|NCT04981678|100682343|FG001|NOT COMPLETED|Overall Study||1||
48146366|NCT05318287|100682344|FG000|STARTED|Overall Study||52||
48146367|NCT05318287|100682344|FG000|COMPLETED|Overall Study||44||
48146368|NCT05318287|100682344|FG000|NOT COMPLETED|Overall Study||8||
48146369|NCT04891419|100682345|FG000|STARTED|Overall Study||112||
48146370|NCT04891419|100682346|FG001|STARTED|Overall Study||56||
48146371|NCT04891419|100682345|FG000|Completed the Control Period (Month 1 to 6)|Overall Study||107||
48146372|NCT04891419|100682346|FG001|Completed the Control Period (Month 1 to 6)|Overall Study||56||
48146373|NCT04891419|100682345|FG000|Completed the Post Control Period (Months 7 to 12)|Overall Study||107||
48300109|NCT04178967|101060280|FG003|COMPLETED|Maintenance Open Label Escape Arm||0||
48300110|NCT04178967|101060281|FG004|COMPLETED|Maintenance Open Label Escape Arm||0||
48300111|NCT04178967|101060282|FG005|COMPLETED|Maintenance Open Label Escape Arm||0||
48300112|NCT04178967|101060283|FG006|COMPLETED|Maintenance Open Label Escape Arm||0||
48300113|NCT04178967|101060284|FG007|COMPLETED|Maintenance Open Label Escape Arm||0||
48300114|NCT04178967|101060285|FG008|COMPLETED|Maintenance Open Label Escape Arm||85||
48300115|NCT04178967|101060286|FG009|COMPLETED|Maintenance Open Label Escape Arm||83||
48300116|NCT04178967|101060287|FG010|COMPLETED|Maintenance Open Label Escape Arm||8||
48300117|NCT04178967|101060277|FG000|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
48300118|NCT04178967|101060278|FG001|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
48300119|NCT04178967|101060279|FG002|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
48300120|NCT04178967|101060280|FG003|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
48300121|NCT04178967|101060281|FG004|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
48300122|NCT04178967|101060282|FG005|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
48300123|NCT04178967|101060283|FG006|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
48300124|NCT04178967|101060284|FG007|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
48300125|NCT04178967|101060285|FG008|NOT COMPLETED|Maintenance Open Label Escape Arm||23||
48300126|NCT04178967|101060286|FG009|NOT COMPLETED|Maintenance Open Label Escape Arm||42||
48300127|NCT04178967|101060287|FG010|NOT COMPLETED|Maintenance Open Label Escape Arm||3||
48300128|NCT00934141|101060288|FG000|STARTED|Overall Study||49||
48300129|NCT00934141|101060289|FG001|STARTED|Overall Study||50||
48300130|NCT00934141|101060290|FG002|STARTED|Overall Study||48||
48300131|NCT00934141|101060291|FG003|STARTED|Overall Study||54||
48300132|NCT00934141|101060288|FG000|COMPLETED|Overall Study||45||
48300133|NCT00934141|101060289|FG001|COMPLETED|Overall Study||47||
48300134|NCT00934141|101060290|FG002|COMPLETED|Overall Study||48||
48300135|NCT00934141|101060291|FG003|COMPLETED|Overall Study||51||
48300136|NCT00934141|101060288|FG000|NOT COMPLETED|Overall Study||4||
48300137|NCT00934141|101060289|FG001|NOT COMPLETED|Overall Study||3||
48300138|NCT00934141|101060290|FG002|NOT COMPLETED|Overall Study||0||
48300139|NCT00934141|101060291|FG003|NOT COMPLETED|Overall Study||3||
48300140|NCT03224325|101060292|FG000|STARTED|Overall Study||13||
48300141|NCT03224325|101060293|FG001|STARTED|Overall Study||6||
48300142|NCT03224325|101060294|FG002|STARTED|Overall Study||6||
48300143|NCT03224325|101060295|FG003|STARTED|Overall Study||6||
48300144|NCT03224325|101060296|FG004|STARTED|Overall Study||6||
48300145|NCT03224325|101060297|FG005|STARTED|Overall Study||6||
48300146|NCT03224325|101060298|FG006|STARTED|Overall Study||7||
48300147|NCT03224325|101060292|FG000|COMPLETED|Overall Study||12||
48300148|NCT03224325|101060293|FG001|COMPLETED|Overall Study||6||
48300149|NCT03224325|101060294|FG002|COMPLETED|Overall Study||6||
48300150|NCT03224325|101060295|FG003|COMPLETED|Overall Study||5||
48300151|NCT03224325|101060296|FG004|COMPLETED|Overall Study||6||
48300152|NCT03224325|101060297|FG005|COMPLETED|Overall Study||6||
48300153|NCT03224325|101060298|FG006|COMPLETED|Overall Study||6||
48300154|NCT03224325|101060292|FG000|NOT COMPLETED|Overall Study||1||
48300155|NCT03224325|101060293|FG001|NOT COMPLETED|Overall Study||0||
48300156|NCT03224325|101060294|FG002|NOT COMPLETED|Overall Study||0||
48300157|NCT03224325|101060295|FG003|NOT COMPLETED|Overall Study||1||
48300158|NCT03224325|101060296|FG004|NOT COMPLETED|Overall Study||0||
48300159|NCT03224325|101060297|FG005|NOT COMPLETED|Overall Study||0||
48300160|NCT03224325|101060298|FG006|NOT COMPLETED|Overall Study||1||
48714801|NCT02944565|102088621|FG000|NOT COMPLETED|Overall Study||0||
48714802|NCT03190694|102088622|FG000|STARTED|Period 1||27||
48714803|NCT03190694|102088623|FG001|STARTED|Period 1||26||
48714804|NCT03190694|102088622|FG000|COMPLETED|Period 1||26||
48714805|NCT03190694|102088623|FG001|COMPLETED|Period 1||26||
48714806|NCT03190694|102088622|FG000|NOT COMPLETED|Period 1||1||
48714807|NCT03190694|102088623|FG001|NOT COMPLETED|Period 1||0||
48714808|NCT03190694|102088622|FG000|STARTED|Period 2 (After 6 Weeks Wash-out)||26||
48714809|NCT03190694|102088623|FG001|STARTED|Period 2 (After 6 Weeks Wash-out)||26||
48714810|NCT03190694|102088622|FG000|COMPLETED|Period 2 (After 6 Weeks Wash-out)||26||
48714811|NCT03190694|102088623|FG001|COMPLETED|Period 2 (After 6 Weeks Wash-out)||26||
48714812|NCT03190694|102088622|FG000|NOT COMPLETED|Period 2 (After 6 Weeks Wash-out)||0||
48300161|NCT00186069|101060299|FG000|STARTED|Overall Study||15||
48300162|NCT00186069|101060300|FG001|STARTED|Overall Study||15||
48714813|NCT03190694|102088623|FG001|NOT COMPLETED|Period 2 (After 6 Weeks Wash-out)||0||
48300163|NCT00186069|101060299|FG000|COMPLETED|Overall Study||15||
48300164|NCT00186069|101060300|FG001|COMPLETED|Overall Study||15||
48300165|NCT00186069|101060299|FG000|NOT COMPLETED|Overall Study||0||
48300166|NCT00186069|101060300|FG001|NOT COMPLETED|Overall Study||0||
48300167|NCT01774084|101060301|FG000|STARTED|Overall Study||11||
48300168|NCT01774084|101060302|FG001|STARTED|Overall Study||12||
48300169|NCT01774084|101060301|FG000|COMPLETED|Overall Study||10||
48300170|NCT01774084|101060302|FG001|COMPLETED|Overall Study||12||
48714814|NCT03190694|102088622|FG000|STARTED|Wash-out and Follow-up||26||
48300171|NCT01774084|101060301|FG000|NOT COMPLETED|Overall Study||1||
48714815|NCT03190694|102088623|FG001|STARTED|Wash-out and Follow-up||26||
48714816|NCT03190694|102088622|FG000|COMPLETED|Wash-out and Follow-up||24||
48714817|NCT03190694|102088623|FG001|COMPLETED|Wash-out and Follow-up||26||
48601881|NCT05052697|101807759|FG019|NOT COMPLETED|SubStudy B: Initial Enrollment||2||
48601882|NCT05052697|101807760|FG020|NOT COMPLETED|SubStudy B: Initial Enrollment||0||
48300172|NCT01774084|101060302|FG001|NOT COMPLETED|Overall Study||0||
48300173|NCT04201821|101060303|FG000|STARTED|Overall Study||10||
48300174|NCT04201821|101060303|FG000|COMPLETED|Overall Study||8||
48300175|NCT04201821|101060303|FG000|NOT COMPLETED|Overall Study||2||
48300176|NCT00866697|101063900|FG000|STARTED|Overall Study||468||
48300177|NCT00866697|101063901|FG001|STARTED|Overall Study||472||
48300178|NCT00866697|101063900|FG000|COMPLETED|Overall Study||254|Death|
48300179|NCT00866697|101063901|FG001|COMPLETED|Overall Study||244|Death|
48300180|NCT00866697|101063900|FG000|NOT COMPLETED|Overall Study||214||
48300181|NCT00866697|101063901|FG001|NOT COMPLETED|Overall Study||228||
48300182|NCT00972777|101063902|FG000|STARTED|Overall Study||231||
48300183|NCT00972777|101063903|FG001|STARTED|Overall Study||243||
48300184|NCT00972777|101063902|FG000|COMPLETED|Overall Study||217||
48300185|NCT00972777|101063903|FG001|COMPLETED|Overall Study||229||
48300186|NCT00972777|101063902|FG000|NOT COMPLETED|Overall Study||14||
48300187|NCT00972777|101063903|FG001|NOT COMPLETED|Overall Study||14||
48300188|NCT04283981|101063904|FG000|STARTED|Overall Study||15||
48300189|NCT04283981|101063905|FG001|STARTED|Overall Study||13||
48300190|NCT04283981|101063904|FG000|COMPLETED|Overall Study||9||
48300191|NCT04283981|101063905|FG001|COMPLETED|Overall Study||7||
48300192|NCT04283981|101063904|FG000|NOT COMPLETED|Overall Study||6||
48300193|NCT04283981|101063905|FG001|NOT COMPLETED|Overall Study||6||
48300194|NCT00999713|101063906|FG000|STARTED|Overall Study||26||
48300195|NCT00999713|101063907|FG001|STARTED|Overall Study||17||
48300196|NCT00999713|101063906|FG000|COMPLETED|Overall Study||24||
48300197|NCT00999713|101063907|FG001|COMPLETED|Overall Study||17||
48300198|NCT00999713|101063906|FG000|NOT COMPLETED|Overall Study||2||
48300199|NCT00999713|101063907|FG001|NOT COMPLETED|Overall Study||0||
48300200|NCT03421431|101063908|FG000|STARTED|Overall Study||24||
48300201|NCT03421431|101063909|FG001|STARTED|Overall Study||55||
48300202|NCT03421431|101063910|FG002|STARTED|Overall Study||53||
48300203|NCT03421431|101063908|FG000|COMPLETED|Overall Study||18||
48300204|NCT03421431|101063909|FG001|COMPLETED|Overall Study||49||
48300205|NCT03421431|101063910|FG002|COMPLETED|Overall Study||39||
48300206|NCT03421431|101063908|FG000|NOT COMPLETED|Overall Study||6||
48300207|NCT03421431|101063909|FG001|NOT COMPLETED|Overall Study||6||
48300208|NCT03421431|101063910|FG002|NOT COMPLETED|Overall Study||14||
48300209|NCT04014361|101063911|FG000|STARTED|Period 1||4||
48300210|NCT04014361|101063912|FG001|STARTED|Period 1||4||
48300211|NCT04014361|101063913|FG002|STARTED|Period 1||4||
48300212|NCT04014361|101063914|FG003|STARTED|Period 1||4||
48300213|NCT04014361|101063915|FG004|STARTED|Period 1||4||
48300214|NCT04014361|101063916|FG005|STARTED|Period 1||4||
48300215|NCT04014361|101063917|FG006|STARTED|Period 1||9||
48300216|NCT04014361|101063918|FG007|STARTED|Period 1||3||
48300217|NCT04014361|101063911|FG000|Received at Least One Dose of Study Drug|Period 1||4||
48300218|NCT04014361|101063912|FG001|Received at Least One Dose of Study Drug|Period 1||4||
48300219|NCT04014361|101063913|FG002|Received at Least One Dose of Study Drug|Period 1||4||
48601883|NCT05052697|101807761|FG021|NOT COMPLETED|SubStudy B: Initial Enrollment||1||
48601884|NCT05052697|101807762|FG022|NOT COMPLETED|SubStudy B: Initial Enrollment||2||
48601885|NCT05052697|101807763|FG023|NOT COMPLETED|SubStudy B: Initial Enrollment||0||
48601886|NCT05052697|101807764|FG024|NOT COMPLETED|SubStudy B: Initial Enrollment||0||
48601887|NCT05052697|101807765|FG025|NOT COMPLETED|SubStudy B: Initial Enrollment||1||
48300220|NCT04014361|101063914|FG003|Received at Least One Dose of Study Drug|Period 1||4||
48300221|NCT04014361|101063915|FG004|Received at Least One Dose of Study Drug|Period 1||4||
48300222|NCT04014361|101063916|FG005|Received at Least One Dose of Study Drug|Period 1||4||
48300223|NCT04014361|101063917|FG006|Received at Least One Dose of Study Drug|Period 1||9||
48300224|NCT04014361|101063918|FG007|Received at Least One Dose of Study Drug|Period 1||3||
48300225|NCT04014361|101063911|FG000|COMPLETED|Period 1||4||
48300226|NCT04014361|101063912|FG001|COMPLETED|Period 1||4||
48300227|NCT04014361|101063913|FG002|COMPLETED|Period 1||4||
48300228|NCT04014361|101063914|FG003|COMPLETED|Period 1||4||
48300229|NCT04014361|101063915|FG004|COMPLETED|Period 1||4||
48300230|NCT04014361|101063916|FG005|COMPLETED|Period 1||4||
48300231|NCT04014361|101063917|FG006|COMPLETED|Period 1||9||
48300232|NCT04014361|101063918|FG007|COMPLETED|Period 1||3||
48300233|NCT04014361|101063911|FG000|NOT COMPLETED|Period 1||0||
48300234|NCT04014361|101063912|FG001|NOT COMPLETED|Period 1||0||
48300235|NCT04014361|101063913|FG002|NOT COMPLETED|Period 1||0||
48300236|NCT04014361|101063914|FG003|NOT COMPLETED|Period 1||0||
48300237|NCT04014361|101063915|FG004|NOT COMPLETED|Period 1||0||
48300238|NCT04014361|101063916|FG005|NOT COMPLETED|Period 1||0||
48601888|NCT05052697|101807766|FG026|NOT COMPLETED|SubStudy B: Initial Enrollment||0||
48300239|NCT04014361|101063917|FG006|NOT COMPLETED|Period 1||0||
48300240|NCT04014361|101063918|FG007|NOT COMPLETED|Period 1||0||
48300241|NCT04014361|101063911|FG000|STARTED|Washout 1 (7 Days)||4||
48300242|NCT04014361|101063912|FG001|STARTED|Washout 1 (7 Days)||4||
48300243|NCT04014361|101063913|FG002|STARTED|Washout 1 (7 Days)||4||
48601889|NCT05052697|101807767|FG027|NOT COMPLETED|SubStudy B: Initial Enrollment||1||
48300244|NCT04014361|101063914|FG003|STARTED|Washout 1 (7 Days)||4||
48300245|NCT04014361|101063915|FG004|STARTED|Washout 1 (7 Days)||4||
48300246|NCT04014361|101063916|FG005|STARTED|Washout 1 (7 Days)||4||
48601890|NCT05052697|101807768|FG028|NOT COMPLETED|SubStudy B: Initial Enrollment||0||
48601891|NCT05052697|101807769|FG029|NOT COMPLETED|SubStudy B: Initial Enrollment||0||
48601892|NCT05052697|101807770|FG030|NOT COMPLETED|SubStudy B: Initial Enrollment||0||
48601893|NCT05052697|101807771|FG031|NOT COMPLETED|SubStudy B: Initial Enrollment||0||
48601894|NCT05052697|101807772|FG032|NOT COMPLETED|SubStudy B: Initial Enrollment||0||
48601895|NCT05052697|101807773|FG033|NOT COMPLETED|SubStudy B: Initial Enrollment||0||
48601896|NCT05052697|101807740|FG000|STARTED|Substudy B: Expanded Enrollment||0|Participants who were randomized|
48601897|NCT05052697|101807741|FG001|STARTED|Substudy B: Expanded Enrollment||0|Participants who were randomized|
48601898|NCT05052697|101807742|FG002|STARTED|Substudy B: Expanded Enrollment||0|Participants who were randomized|
48601899|NCT05052697|101807743|FG003|STARTED|Substudy B: Expanded Enrollment||0|Participants who were randomized|
48601900|NCT05052697|101807744|FG004|STARTED|Substudy B: Expanded Enrollment||0|Participants who were randomized|
48601901|NCT05052697|101807745|FG005|STARTED|Substudy B: Expanded Enrollment||0|Participants who were randomized|
48300247|NCT04014361|101063917|FG006|STARTED|Washout 1 (7 Days)||9||
48300248|NCT04014361|101063918|FG007|STARTED|Washout 1 (7 Days)||3||
48300249|NCT04014361|101063911|FG000|COMPLETED|Washout 1 (7 Days)||4||
48300250|NCT04014361|101063912|FG001|COMPLETED|Washout 1 (7 Days)||4||
48300251|NCT04014361|101063913|FG002|COMPLETED|Washout 1 (7 Days)||4||
48300252|NCT04014361|101063914|FG003|COMPLETED|Washout 1 (7 Days)||4||
48300253|NCT04014361|101063915|FG004|COMPLETED|Washout 1 (7 Days)||4||
48300254|NCT04014361|101063916|FG005|COMPLETED|Washout 1 (7 Days)||4||
48300255|NCT04014361|101063917|FG006|COMPLETED|Washout 1 (7 Days)||9||
48300256|NCT04014361|101063918|FG007|COMPLETED|Washout 1 (7 Days)||3||
48300257|NCT04014361|101063911|FG000|NOT COMPLETED|Washout 1 (7 Days)||0||
48300258|NCT04014361|101063912|FG001|NOT COMPLETED|Washout 1 (7 Days)||0||
48601902|NCT05052697|101807746|FG006|STARTED|Substudy B: Expanded Enrollment||0|Participants who were randomized|
48601903|NCT05052697|101807747|FG007|STARTED|Substudy B: Expanded Enrollment||0|Participants who were randomized|
48601904|NCT05052697|101807748|FG008|STARTED|Substudy B: Expanded Enrollment||0|Participants who were randomized|
48601905|NCT05052697|101807749|FG009|STARTED|Substudy B: Expanded Enrollment||0|Participants who were randomized|
48601906|NCT05052697|101807750|FG010|STARTED|Substudy B: Expanded Enrollment||0|Participants who were randomized|
48601907|NCT05052697|101807751|FG011|STARTED|Substudy B: Expanded Enrollment||0|Participants who were randomized|
48601908|NCT05052697|101807752|FG012|STARTED|Substudy B: Expanded Enrollment||0|Participants who were randomized|
48601909|NCT05052697|101807753|FG013|STARTED|Substudy B: Expanded Enrollment||0|Participants who were randomized|
48300259|NCT04014361|101063913|FG002|NOT COMPLETED|Washout 1 (7 Days)||0||
48300260|NCT04014361|101063914|FG003|NOT COMPLETED|Washout 1 (7 Days)||0||
48300261|NCT04014361|101063915|FG004|NOT COMPLETED|Washout 1 (7 Days)||0||
48300262|NCT04014361|101063916|FG005|NOT COMPLETED|Washout 1 (7 Days)||0||
48300263|NCT04014361|101063917|FG006|NOT COMPLETED|Washout 1 (7 Days)||0||
48300264|NCT04014361|101063918|FG007|NOT COMPLETED|Washout 1 (7 Days)||0||
48300265|NCT04014361|101063911|FG000|STARTED|Period 2||4||
48300266|NCT04014361|101063912|FG001|STARTED|Period 2||4||
48300267|NCT04014361|101063913|FG002|STARTED|Period 2||4||
48300268|NCT04014361|101063914|FG003|STARTED|Period 2||4||
48300269|NCT04014361|101063915|FG004|STARTED|Period 2||4||
48300270|NCT04014361|101063916|FG005|STARTED|Period 2||4||
48300271|NCT04014361|101063917|FG006|STARTED|Period 2||9||
48300272|NCT04014361|101063918|FG007|STARTED|Period 2||3||
48300273|NCT04014361|101063911|FG000|COMPLETED|Period 2||4||
48300274|NCT04014361|101063912|FG001|COMPLETED|Period 2||4||
48300275|NCT04014361|101063913|FG002|COMPLETED|Period 2||4||
48300276|NCT04014361|101063914|FG003|COMPLETED|Period 2||3||
48300277|NCT04014361|101063915|FG004|COMPLETED|Period 2||4||
48300278|NCT04014361|101063916|FG005|COMPLETED|Period 2||4||
48300279|NCT04014361|101063917|FG006|COMPLETED|Period 2||9||
48300280|NCT04014361|101063918|FG007|COMPLETED|Period 2||3||
48300281|NCT04014361|101063911|FG000|NOT COMPLETED|Period 2||0||
48300282|NCT04014361|101063912|FG001|NOT COMPLETED|Period 2||0||
48300283|NCT04014361|101063913|FG002|NOT COMPLETED|Period 2||0||
48300284|NCT04014361|101063914|FG003|NOT COMPLETED|Period 2||1||
48300285|NCT04014361|101063915|FG004|NOT COMPLETED|Period 2||0||
48300286|NCT04014361|101063916|FG005|NOT COMPLETED|Period 2||0||
48300287|NCT04014361|101063917|FG006|NOT COMPLETED|Period 2||0||
48300288|NCT04014361|101063918|FG007|NOT COMPLETED|Period 2||0||
48300289|NCT04014361|101063911|FG000|STARTED|Washout 2 (7 Days)||4||
48300290|NCT04014361|101063912|FG001|STARTED|Washout 2 (7 Days)||4||
48300291|NCT04014361|101063913|FG002|STARTED|Washout 2 (7 Days)||4||
48300292|NCT04014361|101063914|FG003|STARTED|Washout 2 (7 Days)||3||
48300293|NCT04014361|101063915|FG004|STARTED|Washout 2 (7 Days)||4||
48300294|NCT04014361|101063916|FG005|STARTED|Washout 2 (7 Days)||4||
48300295|NCT04014361|101063917|FG006|STARTED|Washout 2 (7 Days)||0||
48300296|NCT04014361|101063918|FG007|STARTED|Washout 2 (7 Days)||0||
48300297|NCT04014361|101063911|FG000|COMPLETED|Washout 2 (7 Days)||4||
48714818|NCT03190694|102088622|FG000|NOT COMPLETED|Wash-out and Follow-up||2||
48714819|NCT03190694|102088623|FG001|NOT COMPLETED|Wash-out and Follow-up||0||
48714820|NCT01008969|102088624|FG000|STARTED|Overall Study||10||
48714821|NCT01008969|102088624|FG000|COMPLETED|Overall Study||10||
48714822|NCT01008969|102088624|FG000|NOT COMPLETED|Overall Study||0||
48714823|NCT03002623|102088625|FG000|STARTED|Overall Study||4||
48146374|NCT04891419|100682346|FG001|Completed the Post Control Period (Months 7 to 12)|Overall Study||53||
48146375|NCT04891419|100682345|FG000|COMPLETED|Overall Study||107||
48146376|NCT04891419|100682346|FG001|COMPLETED|Overall Study||53||
48146377|NCT04891419|100682345|FG000|NOT COMPLETED|Overall Study||5||
48146378|NCT04891419|100682346|FG001|NOT COMPLETED|Overall Study||3||
48146379|NCT02626780|100682347|FG000|STARTED|Overall Study||7||
48146380|NCT02626780|100682347|FG000|Withdrew From Study|Overall Study||3||
48146381|NCT02626780|100682347|FG000|COMPLETED|Overall Study||4||
48146382|NCT02626780|100682347|FG000|NOT COMPLETED|Overall Study||3||
48146383|NCT04235036|100682348|FG000|STARTED|Overall Study||15||
48146384|NCT04235036|100682348|FG000|COMPLETED|Overall Study||15||
48601910|NCT05052697|101807754|FG014|STARTED|Substudy B: Expanded Enrollment||0|Participants who were randomized|
48601911|NCT05052697|101807755|FG015|STARTED|Substudy B: Expanded Enrollment||0|Participants who were randomized|
48601912|NCT05052697|101807756|FG016|STARTED|Substudy B: Expanded Enrollment||0|Participants who were randomized|
48601913|NCT05052697|101807757|FG017|STARTED|Substudy B: Expanded Enrollment||0|Participants who were randomized|
48601914|NCT05052697|101807758|FG018|STARTED|Substudy B: Expanded Enrollment||0|Participants who were randomized|
48601915|NCT05052697|101807759|FG019|STARTED|Substudy B: Expanded Enrollment||0|Participants who were randomized|
48601916|NCT05052697|101807760|FG020|STARTED|Substudy B: Expanded Enrollment||0|Participants who were randomized|
48601917|NCT05052697|101807761|FG021|STARTED|Substudy B: Expanded Enrollment||0|Participants who were randomized|
48601918|NCT05052697|101807762|FG022|STARTED|Substudy B: Expanded Enrollment||0|Participants who were randomized|
48601919|NCT05052697|101807763|FG023|STARTED|Substudy B: Expanded Enrollment||0|Participants who were randomized|
48601920|NCT05052697|101807764|FG024|STARTED|Substudy B: Expanded Enrollment||0|Participants who were randomized|
48601921|NCT05052697|101807765|FG025|STARTED|Substudy B: Expanded Enrollment||0|Participants who were randomized|
48601922|NCT05052697|101807766|FG026|STARTED|Substudy B: Expanded Enrollment||0|Participants who were randomized|
48714824|NCT03002623|102088626|FG001|STARTED|Overall Study||3||
48714825|NCT03002623|102088625|FG000|COMPLETED|Overall Study||2||
48714826|NCT03002623|102088626|FG001|COMPLETED|Overall Study||2||
48714827|NCT03002623|102088625|FG000|NOT COMPLETED|Overall Study||2||
48714828|NCT03002623|102088626|FG001|NOT COMPLETED|Overall Study||1||
48714829|NCT03691779|102088627|FG000|STARTED|Part A (15 Days)||16||
48714830|NCT03691779|102088628|FG001|STARTED|Part A (15 Days)||0||
48714831|NCT03691779|102088627|FG000|COMPLETED|Part A (15 Days)||16||
48714832|NCT03691779|102088628|FG001|COMPLETED|Part A (15 Days)||0||
48714833|NCT03691779|102088627|FG000|NOT COMPLETED|Part A (15 Days)||0||
48714834|NCT03691779|102088628|FG001|NOT COMPLETED|Part A (15 Days)||0||
48714835|NCT03691779|102088627|FG000|STARTED|Part B (24 Weeks)||0||
48146385|NCT04235036|100682348|FG000|NOT COMPLETED|Overall Study||0||
48300298|NCT04014361|101063912|FG001|COMPLETED|Washout 2 (7 Days)||4||
48300299|NCT04014361|101063913|FG002|COMPLETED|Washout 2 (7 Days)||4||
48300300|NCT04014361|101063914|FG003|COMPLETED|Washout 2 (7 Days)||3||
48601923|NCT05052697|101807767|FG027|STARTED|Substudy B: Expanded Enrollment||0|Participants who were randomized|
48601924|NCT05052697|101807768|FG028|STARTED|Substudy B: Expanded Enrollment||132|Participants who were randomized|
48601925|NCT05052697|101807769|FG029|STARTED|Substudy B: Expanded Enrollment||133|Participants who were randomized|
48601926|NCT05052697|101807770|FG030|STARTED|Substudy B: Expanded Enrollment||117|Participants who were randomized|
48601927|NCT05052697|101807771|FG031|STARTED|Substudy B: Expanded Enrollment||117|Participants who were randomized|
48601928|NCT05052697|101807772|FG032|STARTED|Substudy B: Expanded Enrollment||115|Participants who were randomized|
48300301|NCT04014361|101063915|FG004|COMPLETED|Washout 2 (7 Days)||4||
48300302|NCT04014361|101063916|FG005|COMPLETED|Washout 2 (7 Days)||4||
48300303|NCT04014361|101063917|FG006|COMPLETED|Washout 2 (7 Days)||0||
48601929|NCT05052697|101807773|FG033|STARTED|Substudy B: Expanded Enrollment||117|Participants who were randomized|
48601930|NCT05052697|101807740|FG000|Vaccination 1|Substudy B: Expanded Enrollment||0||
48601931|NCT05052697|101807741|FG001|Vaccination 1|Substudy B: Expanded Enrollment||0||
48601932|NCT05052697|101807742|FG002|Vaccination 1|Substudy B: Expanded Enrollment||0||
48601933|NCT05052697|101807743|FG003|Vaccination 1|Substudy B: Expanded Enrollment||0||
48601934|NCT05052697|101807744|FG004|Vaccination 1|Substudy B: Expanded Enrollment||0||
48601935|NCT05052697|101807745|FG005|Vaccination 1|Substudy B: Expanded Enrollment||0||
48601936|NCT05052697|101807746|FG006|Vaccination 1|Substudy B: Expanded Enrollment||0||
48601937|NCT05052697|101807747|FG007|Vaccination 1|Substudy B: Expanded Enrollment||0||
48601938|NCT05052697|101807748|FG008|Vaccination 1|Substudy B: Expanded Enrollment||0||
48601939|NCT05052697|101807749|FG009|Vaccination 1|Substudy B: Expanded Enrollment||0||
48601940|NCT05052697|101807750|FG010|Vaccination 1|Substudy B: Expanded Enrollment||0||
48300304|NCT04014361|101063918|FG007|COMPLETED|Washout 2 (7 Days)||0||
48300305|NCT04014361|101063911|FG000|NOT COMPLETED|Washout 2 (7 Days)||0||
48300306|NCT04014361|101063912|FG001|NOT COMPLETED|Washout 2 (7 Days)||0||
48300307|NCT04014361|101063913|FG002|NOT COMPLETED|Washout 2 (7 Days)||0||
48300308|NCT04014361|101063914|FG003|NOT COMPLETED|Washout 2 (7 Days)||0||
48300309|NCT04014361|101063915|FG004|NOT COMPLETED|Washout 2 (7 Days)||0||
48300310|NCT04014361|101063916|FG005|NOT COMPLETED|Washout 2 (7 Days)||0||
48601941|NCT05052697|101807751|FG011|Vaccination 1|Substudy B: Expanded Enrollment||0||
48601942|NCT05052697|101807752|FG012|Vaccination 1|Substudy B: Expanded Enrollment||0||
48601943|NCT05052697|101807753|FG013|Vaccination 1|Substudy B: Expanded Enrollment||0||
48601944|NCT05052697|101807754|FG014|Vaccination 1|Substudy B: Expanded Enrollment||0||
48601945|NCT05052697|101807755|FG015|Vaccination 1|Substudy B: Expanded Enrollment||0||
48601946|NCT05052697|101807756|FG016|Vaccination 1|Substudy B: Expanded Enrollment||0||
48601947|NCT05052697|101807757|FG017|Vaccination 1|Substudy B: Expanded Enrollment||0||
48601948|NCT05052697|101807758|FG018|Vaccination 1|Substudy B: Expanded Enrollment||0||
48601949|NCT05052697|101807759|FG019|Vaccination 1|Substudy B: Expanded Enrollment||0||
48601950|NCT05052697|101807760|FG020|Vaccination 1|Substudy B: Expanded Enrollment||0||
48714836|NCT03691779|102088628|FG001|STARTED|Part B (24 Weeks)||66||
48714837|NCT03691779|102088627|FG000|COMPLETED|Part B (24 Weeks)||0||
48714838|NCT03691779|102088628|FG001|COMPLETED|Part B (24 Weeks)||64||
48714839|NCT03691779|102088627|FG000|NOT COMPLETED|Part B (24 Weeks)||0||
48714840|NCT03691779|102088628|FG001|NOT COMPLETED|Part B (24 Weeks)||2||
48714841|NCT03757130|102088629|FG000|STARTED|Overall Study||6||
48714842|NCT03757130|102088630|FG001|STARTED|Overall Study||6||
48714843|NCT03757130|102088631|FG002|STARTED|Overall Study||6||
48714844|NCT03757130|102088632|FG003|STARTED|Overall Study||8||
48714845|NCT03757130|102088633|FG004|STARTED|Overall Study||6||
48300311|NCT04014361|101063917|FG006|NOT COMPLETED|Washout 2 (7 Days)||0||
48300312|NCT04014361|101063918|FG007|NOT COMPLETED|Washout 2 (7 Days)||0||
48300313|NCT04014361|101063911|FG000|STARTED|Period 3||4||
48300314|NCT04014361|101063912|FG001|STARTED|Period 3||4||
48300315|NCT04014361|101063913|FG002|STARTED|Period 3||4||
48300316|NCT04014361|101063914|FG003|STARTED|Period 3||3||
48300317|NCT04014361|101063915|FG004|STARTED|Period 3||4||
48300318|NCT04014361|101063916|FG005|STARTED|Period 3||4||
48601951|NCT05052697|101807761|FG021|Vaccination 1|Substudy B: Expanded Enrollment||0||
48601952|NCT05052697|101807762|FG022|Vaccination 1|Substudy B: Expanded Enrollment||0||
48601953|NCT05052697|101807763|FG023|Vaccination 1|Substudy B: Expanded Enrollment||0||
48601954|NCT05052697|101807764|FG024|Vaccination 1|Substudy B: Expanded Enrollment||0||
48601955|NCT05052697|101807765|FG025|Vaccination 1|Substudy B: Expanded Enrollment||0||
48601956|NCT05052697|101807766|FG026|Vaccination 1|Substudy B: Expanded Enrollment||0||
48601957|NCT05052697|101807767|FG027|Vaccination 1|Substudy B: Expanded Enrollment||0||
48601958|NCT05052697|101807768|FG028|Vaccination 1|Substudy B: Expanded Enrollment||131||
48601959|NCT05052697|101807769|FG029|Vaccination 1|Substudy B: Expanded Enrollment||131||
48714846|NCT03757130|102088634|FG005|STARTED|Overall Study||6||
48714847|NCT03757130|102088635|FG006|STARTED|Overall Study||6||
48714848|NCT03757130|102088636|FG007|STARTED|Overall Study||6||
48714849|NCT03757130|102088629|FG000|COMPLETED|Overall Study||6||
48300319|NCT04014361|101063917|FG006|STARTED|Period 3||0||
48300320|NCT04014361|101063918|FG007|STARTED|Period 3||0||
48300321|NCT04014361|101063911|FG000|COMPLETED|Period 3||4||
48146386|NCT01177904|100682349|FG000|STARTED|Overall Study||100||
48146387|NCT01177904|100682350|FG001|STARTED|Overall Study||100||
48146388|NCT01177904|100682349|FG000|COMPLETED|Overall Study||100||
48300322|NCT04014361|101063912|FG001|COMPLETED|Period 3||4||
48300323|NCT04014361|101063913|FG002|COMPLETED|Period 3||4||
48601960|NCT05052697|101807770|FG030|Vaccination 1|Substudy B: Expanded Enrollment||116||
48601961|NCT05052697|101807771|FG031|Vaccination 1|Substudy B: Expanded Enrollment||117||
48601962|NCT05052697|101807772|FG032|Vaccination 1|Substudy B: Expanded Enrollment||115||
48601963|NCT05052697|101807773|FG033|Vaccination 1|Substudy B: Expanded Enrollment||117||
48601964|NCT05052697|101807740|FG000|Vaccination 2|Substudy B: Expanded Enrollment||0||
48601965|NCT05052697|101807741|FG001|Vaccination 2|Substudy B: Expanded Enrollment||0||
48601966|NCT05052697|101807742|FG002|Vaccination 2|Substudy B: Expanded Enrollment||0||
48601967|NCT05052697|101807743|FG003|Vaccination 2|Substudy B: Expanded Enrollment||0||
48601968|NCT05052697|101807744|FG004|Vaccination 2|Substudy B: Expanded Enrollment||0||
48601969|NCT05052697|101807745|FG005|Vaccination 2|Substudy B: Expanded Enrollment||0||
48601970|NCT05052697|101807746|FG006|Vaccination 2|Substudy B: Expanded Enrollment||0||
48601971|NCT05052697|101807747|FG007|Vaccination 2|Substudy B: Expanded Enrollment||0||
48601972|NCT05052697|101807748|FG008|Vaccination 2|Substudy B: Expanded Enrollment||0||
48601973|NCT05052697|101807749|FG009|Vaccination 2|Substudy B: Expanded Enrollment||0||
48601974|NCT05052697|101807750|FG010|Vaccination 2|Substudy B: Expanded Enrollment||0||
48601975|NCT05052697|101807751|FG011|Vaccination 2|Substudy B: Expanded Enrollment||0||
48601976|NCT05052697|101807752|FG012|Vaccination 2|Substudy B: Expanded Enrollment||0||
48601977|NCT05052697|101807753|FG013|Vaccination 2|Substudy B: Expanded Enrollment||0||
48601978|NCT05052697|101807754|FG014|Vaccination 2|Substudy B: Expanded Enrollment||0||
48601979|NCT05052697|101807755|FG015|Vaccination 2|Substudy B: Expanded Enrollment||0||
48601980|NCT05052697|101807756|FG016|Vaccination 2|Substudy B: Expanded Enrollment||0||
48601981|NCT05052697|101807757|FG017|Vaccination 2|Substudy B: Expanded Enrollment||0||
48601982|NCT05052697|101807758|FG018|Vaccination 2|Substudy B: Expanded Enrollment||0||
48601983|NCT05052697|101807759|FG019|Vaccination 2|Substudy B: Expanded Enrollment||0||
48601984|NCT05052697|101807760|FG020|Vaccination 2|Substudy B: Expanded Enrollment||0||
48601985|NCT05052697|101807761|FG021|Vaccination 2|Substudy B: Expanded Enrollment||0||
48601986|NCT05052697|101807762|FG022|Vaccination 2|Substudy B: Expanded Enrollment||0||
48601987|NCT05052697|101807763|FG023|Vaccination 2|Substudy B: Expanded Enrollment||0||
48601988|NCT05052697|101807764|FG024|Vaccination 2|Substudy B: Expanded Enrollment||0||
48601989|NCT05052697|101807765|FG025|Vaccination 2|Substudy B: Expanded Enrollment||0||
48601990|NCT05052697|101807766|FG026|Vaccination 2|Substudy B: Expanded Enrollment||0||
48601991|NCT05052697|101807767|FG027|Vaccination 2|Substudy B: Expanded Enrollment||0||
48601992|NCT05052697|101807768|FG028|Vaccination 2|Substudy B: Expanded Enrollment||0||
48601993|NCT05052697|101807769|FG029|Vaccination 2|Substudy B: Expanded Enrollment||0||
48601994|NCT05052697|101807770|FG030|Vaccination 2|Substudy B: Expanded Enrollment||0||
48601995|NCT05052697|101807771|FG031|Vaccination 2|Substudy B: Expanded Enrollment||0||
48601996|NCT05052697|101807772|FG032|Vaccination 2|Substudy B: Expanded Enrollment||0||
48601997|NCT05052697|101807773|FG033|Vaccination 2|Substudy B: Expanded Enrollment||101||
48601998|NCT05052697|101807740|FG000|COMPLETED|Substudy B: Expanded Enrollment||0||
48601999|NCT05052697|101807741|FG001|COMPLETED|Substudy B: Expanded Enrollment||0||
48602000|NCT05052697|101807742|FG002|COMPLETED|Substudy B: Expanded Enrollment||0||
48602001|NCT05052697|101807743|FG003|COMPLETED|Substudy B: Expanded Enrollment||0||
48602002|NCT05052697|101807744|FG004|COMPLETED|Substudy B: Expanded Enrollment||0||
48602003|NCT05052697|101807745|FG005|COMPLETED|Substudy B: Expanded Enrollment||0||
48602004|NCT05052697|101807746|FG006|COMPLETED|Substudy B: Expanded Enrollment||0||
48602005|NCT05052697|101807747|FG007|COMPLETED|Substudy B: Expanded Enrollment||0||
48602006|NCT05052697|101807748|FG008|COMPLETED|Substudy B: Expanded Enrollment||0||
48602007|NCT05052697|101807749|FG009|COMPLETED|Substudy B: Expanded Enrollment||0||
48602008|NCT05052697|101807750|FG010|COMPLETED|Substudy B: Expanded Enrollment||0||
48602009|NCT05052697|101807751|FG011|COMPLETED|Substudy B: Expanded Enrollment||0||
48602010|NCT05052697|101807752|FG012|COMPLETED|Substudy B: Expanded Enrollment||0||
48602011|NCT05052697|101807753|FG013|COMPLETED|Substudy B: Expanded Enrollment||0||
48602012|NCT05052697|101807754|FG014|COMPLETED|Substudy B: Expanded Enrollment||0||
48602013|NCT05052697|101807755|FG015|COMPLETED|Substudy B: Expanded Enrollment||0||
48602014|NCT05052697|101807756|FG016|COMPLETED|Substudy B: Expanded Enrollment||0||
48602015|NCT05052697|101807757|FG017|COMPLETED|Substudy B: Expanded Enrollment||0||
48602016|NCT05052697|101807758|FG018|COMPLETED|Substudy B: Expanded Enrollment||0||
48602017|NCT05052697|101807759|FG019|COMPLETED|Substudy B: Expanded Enrollment||0||
48300324|NCT04014361|101063914|FG003|COMPLETED|Period 3||3||
48602018|NCT05052697|101807760|FG020|COMPLETED|Substudy B: Expanded Enrollment||0||
48602019|NCT05052697|101807761|FG021|COMPLETED|Substudy B: Expanded Enrollment||0||
48602020|NCT05052697|101807762|FG022|COMPLETED|Substudy B: Expanded Enrollment||0||
48146389|NCT01177904|100682350|FG001|COMPLETED|Overall Study||100||
48602021|NCT05052697|101807763|FG023|COMPLETED|Substudy B: Expanded Enrollment||0||
48602022|NCT05052697|101807764|FG024|COMPLETED|Substudy B: Expanded Enrollment||0||
48602023|NCT05052697|101807765|FG025|COMPLETED|Substudy B: Expanded Enrollment||0||
48146390|NCT01177904|100682349|FG000|NOT COMPLETED|Overall Study||0||
48146391|NCT01177904|100682350|FG001|NOT COMPLETED|Overall Study||0||
48300325|NCT04014361|101063915|FG004|COMPLETED|Period 3||4||
48300326|NCT04014361|101063916|FG005|COMPLETED|Period 3||4||
48300327|NCT04014361|101063917|FG006|COMPLETED|Period 3||0||
48300328|NCT04014361|101063918|FG007|COMPLETED|Period 3||0||
48300329|NCT04014361|101063911|FG000|NOT COMPLETED|Period 3||0||
48300330|NCT04014361|101063912|FG001|NOT COMPLETED|Period 3||0||
48300331|NCT04014361|101063913|FG002|NOT COMPLETED|Period 3||0||
48300332|NCT04014361|101063914|FG003|NOT COMPLETED|Period 3||0||
48300333|NCT04014361|101063915|FG004|NOT COMPLETED|Period 3||0||
48300334|NCT04014361|101063916|FG005|NOT COMPLETED|Period 3||0||
48300335|NCT04014361|101063917|FG006|NOT COMPLETED|Period 3||0||
48300336|NCT04014361|101063918|FG007|NOT COMPLETED|Period 3||0||
48300337|NCT01983839|101063919|FG000|STARTED|Overall Study||18||
48300338|NCT01983839|101063919|FG000|COMPLETED|Overall Study||18||
48300339|NCT01983839|101063919|FG000|NOT COMPLETED|Overall Study||0||
48300340|NCT02249767|101063920|FG000|STARTED|Overall Study||230||
48300341|NCT02249767|101063921|FG001|STARTED|Overall Study||229||
48300342|NCT02249767|101063922|FG002|STARTED|Overall Study||115||
48300343|NCT02249767|101063920|FG000|COMPLETED|Overall Study||222||
48300344|NCT02249767|101063921|FG001|COMPLETED|Overall Study||220||
48300345|NCT02249767|101063922|FG002|COMPLETED|Overall Study||107||
48300346|NCT02249767|101063920|FG000|NOT COMPLETED|Overall Study||8||
48300347|NCT02249767|101063921|FG001|NOT COMPLETED|Overall Study||9||
48300348|NCT02249767|101063922|FG002|NOT COMPLETED|Overall Study||8||
48300349|NCT03249714|101063923|FG000|STARTED|Double-blind Treatment (Core Part)||43||
48300350|NCT03249714|101063924|FG001|STARTED|Double-blind Treatment (Core Part)||21||
48300351|NCT03249714|101063923|FG000|COMPLETED|Double-blind Treatment (Core Part)||40||
48300352|NCT03249714|101063924|FG001|COMPLETED|Double-blind Treatment (Core Part)||19||
48300353|NCT03249714|101063923|FG000|NOT COMPLETED|Double-blind Treatment (Core Part)||3||
48300354|NCT03249714|101063924|FG001|NOT COMPLETED|Double-blind Treatment (Core Part)||2||
48300355|NCT03249714|101063923|FG000|STARTED|Open-label Treatment (Extension Part)||40||
48300356|NCT03249714|101063924|FG001|STARTED|Open-label Treatment (Extension Part)||19||
48300357|NCT03249714|101063923|FG000|COMPLETED|Open-label Treatment (Extension Part)||38||
48300358|NCT03249714|101063924|FG001|COMPLETED|Open-label Treatment (Extension Part)||19||
48300359|NCT03249714|101063923|FG000|NOT COMPLETED|Open-label Treatment (Extension Part)||2||
48300360|NCT03249714|101063924|FG001|NOT COMPLETED|Open-label Treatment (Extension Part)||0||
48300361|NCT02730988|101063925|FG000|STARTED|Overall Study||47||
48300362|NCT02730988|101063926|FG001|STARTED|Overall Study||49||
48300363|NCT02730988|101063925|FG000|COMPLETED|Overall Study||43||
48300364|NCT02730988|101063926|FG001|COMPLETED|Overall Study||39||
48300365|NCT02730988|101063925|FG000|NOT COMPLETED|Overall Study||4||
48300366|NCT02730988|101063926|FG001|NOT COMPLETED|Overall Study||10||
48300367|NCT01765192|101063927|FG000|STARTED|Treatment Period 1||32||
48300368|NCT01765192|101063928|FG001|STARTED|Treatment Period 1||32||
48300369|NCT01765192|101063927|FG000|COMPLETED|Treatment Period 1||32||
48300370|NCT01765192|101063928|FG001|COMPLETED|Treatment Period 1||31||
48300371|NCT01765192|101063927|FG000|NOT COMPLETED|Treatment Period 1||0||
48300372|NCT01765192|101063928|FG001|NOT COMPLETED|Treatment Period 1||1||
48300373|NCT01765192|101063927|FG000|STARTED|Washout Period||32||
48300374|NCT01765192|101063928|FG001|STARTED|Washout Period||31||
48300375|NCT01765192|101063927|FG000|COMPLETED|Washout Period||30||
48300376|NCT01765192|101063928|FG001|COMPLETED|Washout Period||30||
48300377|NCT01765192|101063927|FG000|NOT COMPLETED|Washout Period||2||
48300378|NCT01765192|101063928|FG001|NOT COMPLETED|Washout Period||1||
48300379|NCT01765192|101063927|FG000|STARTED|Treatment Period 2||30||
48300380|NCT01765192|101063928|FG001|STARTED|Treatment Period 2||30||
48300381|NCT01765192|101063927|FG000|COMPLETED|Treatment Period 2||30||
48300382|NCT01765192|101063928|FG001|COMPLETED|Treatment Period 2||28||
48300383|NCT01765192|101063927|FG000|NOT COMPLETED|Treatment Period 2||0||
48300384|NCT01765192|101063928|FG001|NOT COMPLETED|Treatment Period 2||2||
48300385|NCT01765192|101063927|FG000|STARTED|End of Treatment Period 2 to Final Visit||30||
48300386|NCT01765192|101063928|FG001|STARTED|End of Treatment Period 2 to Final Visit||28||
48300387|NCT01765192|101063927|FG000|COMPLETED|End of Treatment Period 2 to Final Visit||30||
48300388|NCT01765192|101063928|FG001|COMPLETED|End of Treatment Period 2 to Final Visit||27||
48300389|NCT01765192|101063927|FG000|NOT COMPLETED|End of Treatment Period 2 to Final Visit||0||
48300390|NCT01765192|101063928|FG001|NOT COMPLETED|End of Treatment Period 2 to Final Visit||1||
48300391|NCT01138007|101063929|FG000|STARTED|Overall Study||187||
48300392|NCT01138007|101063930|FG001|STARTED|Overall Study||190||
48300393|NCT01138007|101063931|FG002|STARTED|Overall Study||192||
48300394|NCT01138007|101063929|FG000|COMPLETED|Overall Study||165||
48300395|NCT01138007|101063930|FG001|COMPLETED|Overall Study||160||
48300396|NCT01138007|101063931|FG002|COMPLETED|Overall Study||144||
48300397|NCT01138007|101063929|FG000|NOT COMPLETED|Overall Study||22||
48300398|NCT01138007|101063930|FG001|NOT COMPLETED|Overall Study||30||
48300399|NCT01138007|101063931|FG002|NOT COMPLETED|Overall Study||48||
48300400|NCT04217590|101063932|FG000|STARTED|Overall Study||67||
48300401|NCT04217590|101063933|FG001|STARTED|Overall Study||67||
48300402|NCT04217590|101063932|FG000|COMPLETED|Overall Study||63||
48300403|NCT04217590|101063933|FG001|COMPLETED|Overall Study||64||
48300404|NCT04217590|101063932|FG000|NOT COMPLETED|Overall Study||4||
48300405|NCT04217590|101063933|FG001|NOT COMPLETED|Overall Study||3||
48300406|NCT02673151|101063934|FG000|STARTED|Overall Study||61||
48300407|NCT02673151|101063934|FG000|COMPLETED|Overall Study||61||
48300408|NCT02673151|101063934|FG000|NOT COMPLETED|Overall Study||0||
48300409|NCT01244243|101063935|FG000|STARTED|Overall Study||41||
48300410|NCT01244243|101063935|FG000|COMPLETED|Overall Study||41||
48300411|NCT01244243|101063935|FG000|NOT COMPLETED|Overall Study||0||
48300412|NCT01174238|101063936|FG000|STARTED|Overall Study||38||
48300413|NCT01174238|101063936|FG000|Participants That Underwent FLT-PET Scan|Overall Study||6||
48602024|NCT05052697|101807766|FG026|COMPLETED|Substudy B: Expanded Enrollment||0||
48602025|NCT05052697|101807767|FG027|COMPLETED|Substudy B: Expanded Enrollment||0||
48602026|NCT05052697|101807768|FG028|COMPLETED|Substudy B: Expanded Enrollment||128||
48602027|NCT05052697|101807769|FG029|COMPLETED|Substudy B: Expanded Enrollment||130||
48602028|NCT05052697|101807770|FG030|COMPLETED|Substudy B: Expanded Enrollment||110||
48602029|NCT05052697|101807771|FG031|COMPLETED|Substudy B: Expanded Enrollment||111||
48602030|NCT05052697|101807772|FG032|COMPLETED|Substudy B: Expanded Enrollment||109||
48602031|NCT05052697|101807773|FG033|COMPLETED|Substudy B: Expanded Enrollment||117||
48602032|NCT05052697|101807740|FG000|NOT COMPLETED|Substudy B: Expanded Enrollment||0||
48602033|NCT05052697|101807741|FG001|NOT COMPLETED|Substudy B: Expanded Enrollment||0||
48602034|NCT05052697|101807742|FG002|NOT COMPLETED|Substudy B: Expanded Enrollment||0||
48602035|NCT05052697|101807743|FG003|NOT COMPLETED|Substudy B: Expanded Enrollment||0||
48602036|NCT05052697|101807744|FG004|NOT COMPLETED|Substudy B: Expanded Enrollment||0||
48602037|NCT05052697|101807745|FG005|NOT COMPLETED|Substudy B: Expanded Enrollment||0||
48602038|NCT05052697|101807746|FG006|NOT COMPLETED|Substudy B: Expanded Enrollment||0||
48602039|NCT05052697|101807747|FG007|NOT COMPLETED|Substudy B: Expanded Enrollment||0||
48602040|NCT05052697|101807748|FG008|NOT COMPLETED|Substudy B: Expanded Enrollment||0||
48602041|NCT05052697|101807749|FG009|NOT COMPLETED|Substudy B: Expanded Enrollment||0||
48602042|NCT05052697|101807750|FG010|NOT COMPLETED|Substudy B: Expanded Enrollment||0||
48602043|NCT05052697|101807751|FG011|NOT COMPLETED|Substudy B: Expanded Enrollment||0||
48602044|NCT05052697|101807752|FG012|NOT COMPLETED|Substudy B: Expanded Enrollment||0||
48602045|NCT05052697|101807753|FG013|NOT COMPLETED|Substudy B: Expanded Enrollment||0||
48602046|NCT05052697|101807754|FG014|NOT COMPLETED|Substudy B: Expanded Enrollment||0||
48602047|NCT05052697|101807755|FG015|NOT COMPLETED|Substudy B: Expanded Enrollment||0||
48602048|NCT05052697|101807756|FG016|NOT COMPLETED|Substudy B: Expanded Enrollment||0||
48602049|NCT05052697|101807757|FG017|NOT COMPLETED|Substudy B: Expanded Enrollment||0||
48602050|NCT05052697|101807758|FG018|NOT COMPLETED|Substudy B: Expanded Enrollment||0||
48602051|NCT05052697|101807759|FG019|NOT COMPLETED|Substudy B: Expanded Enrollment||0||
48602052|NCT05052697|101807760|FG020|NOT COMPLETED|Substudy B: Expanded Enrollment||0||
48602053|NCT05052697|101807761|FG021|NOT COMPLETED|Substudy B: Expanded Enrollment||0||
48602054|NCT05052697|101807762|FG022|NOT COMPLETED|Substudy B: Expanded Enrollment||0||
48602055|NCT05052697|101807763|FG023|NOT COMPLETED|Substudy B: Expanded Enrollment||0||
48602056|NCT05052697|101807764|FG024|NOT COMPLETED|Substudy B: Expanded Enrollment||0||
48602057|NCT05052697|101807765|FG025|NOT COMPLETED|Substudy B: Expanded Enrollment||0||
48602058|NCT05052697|101807766|FG026|NOT COMPLETED|Substudy B: Expanded Enrollment||0||
48602059|NCT05052697|101807767|FG027|NOT COMPLETED|Substudy B: Expanded Enrollment||0||
48602060|NCT05052697|101807768|FG028|NOT COMPLETED|Substudy B: Expanded Enrollment||4||
48602061|NCT05052697|101807769|FG029|NOT COMPLETED|Substudy B: Expanded Enrollment||3||
48602062|NCT05052697|101807770|FG030|NOT COMPLETED|Substudy B: Expanded Enrollment||7||
48300414|NCT01174238|101063936|FG000|COMPLETED|Overall Study||36||
48300415|NCT01174238|101063936|FG000|NOT COMPLETED|Overall Study||2||
48300416|NCT00455325|101063937|FG000|STARTED|Cohort 1: Placebo||35||
48300417|NCT00455325|101063938|FG001|STARTED|Cohort 1: Placebo||0||
48300418|NCT00455325|101063939|FG002|STARTED|Cohort 1: Placebo||0||
48300419|NCT00455325|101063940|FG003|STARTED|Cohort 1: Placebo||0||
48602063|NCT05052697|101807771|FG031|NOT COMPLETED|Substudy B: Expanded Enrollment||6||
48602064|NCT05052697|101807772|FG032|NOT COMPLETED|Substudy B: Expanded Enrollment||6||
48602065|NCT05052697|101807773|FG033|NOT COMPLETED|Substudy B: Expanded Enrollment||0||
48602066|NCT00435188|101807774|FG000|STARTED|Overall Study||199||
48602067|NCT00435188|101807775|FG001|STARTED|Overall Study||199||
48300420|NCT00455325|101063937|FG000|COMPLETED|Cohort 1: Placebo||27||
48300421|NCT00455325|101063938|FG001|COMPLETED|Cohort 1: Placebo||0||
48300422|NCT00455325|101063939|FG002|COMPLETED|Cohort 1: Placebo||0||
48300423|NCT00455325|101063940|FG003|COMPLETED|Cohort 1: Placebo||0||
48300424|NCT00455325|101063937|FG000|NOT COMPLETED|Cohort 1: Placebo||8||
48300425|NCT00455325|101063938|FG001|NOT COMPLETED|Cohort 1: Placebo||0||
48300426|NCT00455325|101063939|FG002|NOT COMPLETED|Cohort 1: Placebo||0||
48300427|NCT00455325|101063940|FG003|NOT COMPLETED|Cohort 1: Placebo||0||
48300428|NCT00455325|101063937|FG000|STARTED|Cohort 2: 80 mg Chloroquine Weekly||0||
48300429|NCT00455325|101063938|FG001|STARTED|Cohort 2: 80 mg Chloroquine Weekly||27||
48300430|NCT00455325|101063939|FG002|STARTED|Cohort 2: 80 mg Chloroquine Weekly||0||
48602068|NCT00435188|101807774|FG000|COMPLETED|Overall Study||177||
48602069|NCT00435188|101807775|FG001|COMPLETED|Overall Study||176||
48300431|NCT00455325|101063940|FG003|STARTED|Cohort 2: 80 mg Chloroquine Weekly||0||
48300432|NCT00455325|101063937|FG000|COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0|This is a sequential study|
48405270|NCT03991936|101325237|FG003|NOT COMPLETED|Overall Study||1||2
48602070|NCT00435188|101807774|FG000|NOT COMPLETED|Overall Study||22||
48602071|NCT00435188|101807775|FG001|NOT COMPLETED|Overall Study||23||
48602072|NCT02385110|101807776|FG000|STARTED|Overall Study||2||
48602073|NCT02385110|101807777|FG001|STARTED|Overall Study||16||
48602074|NCT02385110|101807776|FG000|COMPLETED|Overall Study||1||
48602075|NCT02385110|101807777|FG001|COMPLETED|Overall Study||16||
48602076|NCT02385110|101807776|FG000|NOT COMPLETED|Overall Study||1||
48602077|NCT02385110|101807777|FG001|NOT COMPLETED|Overall Study||0||
48602078|NCT00602446|101807778|FG000|STARTED|Overall Study||3||
48602079|NCT00602446|101807778|FG000|COMPLETED|Overall Study||3||
48602080|NCT00602446|101807778|FG000|NOT COMPLETED|Overall Study||0||
48602081|NCT04933617|101807779|FG000|STARTED|Dose Escalation||5||
48602082|NCT04933617|101807780|FG001|STARTED|Dose Escalation||3||
48602083|NCT04933617|101807781|FG002|STARTED|Dose Escalation||0||
48602084|NCT04933617|101807782|FG003|STARTED|Dose Escalation||0||
48602085|NCT04933617|101807783|FG004|STARTED|Dose Escalation||0||
48602086|NCT04933617|101807779|FG000|COMPLETED|Dose Escalation||5||
48602087|NCT04933617|101807780|FG001|COMPLETED|Dose Escalation||0||
48602088|NCT04933617|101807781|FG002|COMPLETED|Dose Escalation||0||
48602089|NCT04933617|101807782|FG003|COMPLETED|Dose Escalation||0||
48602090|NCT04933617|101807783|FG004|COMPLETED|Dose Escalation||0||
48146392|NCT00449176|100682351|FG000|STARTED|Overall Study||318||
48146393|NCT00449176|100682352|FG001|STARTED|Overall Study||328||
48146394|NCT00449176|100682353|FG002|STARTED|Overall Study||319||
48146395|NCT00449176|100682351|FG000|COMPLETED|Overall Study||166||
48146396|NCT00449176|100682352|FG001|COMPLETED|Overall Study||133||
48146397|NCT00449176|100682353|FG002|COMPLETED|Overall Study||152||
48146398|NCT00449176|100682351|FG000|NOT COMPLETED|Overall Study||152||
48146399|NCT00449176|100682352|FG001|NOT COMPLETED|Overall Study||195||
48146400|NCT00449176|100682353|FG002|NOT COMPLETED|Overall Study||167||
48146401|NCT02612311|100682354|FG000|STARTED|Overall Study||210||
48146402|NCT02612311|100682355|FG001|STARTED|Overall Study||211||
48146403|NCT02612311|100682356|FG002|STARTED|Overall Study||91||
48146404|NCT02612311|100682357|FG003|STARTED|Overall Study||91||
48146405|NCT02612311|100682354|FG000|Safety Population|Overall Study||206|The safety population included all randomized participants who had received at least one dose of study treatment (ublituximab, TGR-1202, obinutuzumab + chlorambucil, or ublituximab + TGR-1202).|
48146406|NCT02612311|100682355|FG001|Safety Population|Overall Study||200|The safety population included all randomized participants who had received at least one dose of study treatment (ublituximab, TGR-1202, obinutuzumab + chlorambucil, or ublituximab + TGR-1202).|
48146407|NCT02612311|100682356|FG002|Safety Population|Overall Study||91|The safety population included all randomized participants who had received at least one dose of study treatment (ublituximab, TGR-1202, obinutuzumab + chlorambucil, or ublituximab + TGR-1202).|
48146408|NCT02612311|100682357|FG003|Safety Population|Overall Study||86|The safety population included all randomized participants who had received at least one dose of study treatment (ublituximab, TGR-1202, obinutuzumab + chlorambucil, or ublituximab + TGR-1202).|
48146409|NCT02612311|100682354|FG000|COMPLETED|Overall Study||0||
48146410|NCT02612311|100682355|FG001|COMPLETED|Overall Study||0||
48146411|NCT02612311|100682356|FG002|COMPLETED|Overall Study||0||
48146412|NCT02612311|100682357|FG003|COMPLETED|Overall Study||0||
48146413|NCT02612311|100682354|FG000|NOT COMPLETED|Overall Study||210||
48146414|NCT02612311|100682355|FG001|NOT COMPLETED|Overall Study||211||
48146415|NCT02612311|100682356|FG002|NOT COMPLETED|Overall Study||91||
48146416|NCT02612311|100682357|FG003|NOT COMPLETED|Overall Study||91||
48146417|NCT03155997|100682358|FG000|STARTED|Overall Study||2808||
48146418|NCT03155997|100682359|FG001|STARTED|Overall Study||2829||
48146419|NCT03155997|100682358|FG000|Received at Least One Dose of Study Drug|Overall Study||2791||
48146420|NCT03155997|100682359|FG001|Received at Least One Dose of Study Drug|Overall Study||2800||
48146421|NCT03155997|100682358|FG000|COMPLETED|Overall Study||650||
48146422|NCT03155997|100682359|FG001|COMPLETED|Overall Study||607||
48146423|NCT03155997|100682358|FG000|NOT COMPLETED|Overall Study||2158||
48146424|NCT03155997|100682359|FG001|NOT COMPLETED|Overall Study||2222||
48146425|NCT04270292|100682360|FG000|STARTED|Overall Study||164||
48146426|NCT04270292|100682360|FG000|COMPLETED|Overall Study||164||
48146427|NCT04270292|100682360|FG000|NOT COMPLETED|Overall Study||0||
48602091|NCT04933617|101807779|FG000|NOT COMPLETED|Dose Escalation||0||
48602092|NCT04933617|101807780|FG001|NOT COMPLETED|Dose Escalation||3||
48602093|NCT04933617|101807781|FG002|NOT COMPLETED|Dose Escalation||0||
48602094|NCT04933617|101807782|FG003|NOT COMPLETED|Dose Escalation||0||
48602095|NCT04933617|101807783|FG004|NOT COMPLETED|Dose Escalation||0||
48602096|NCT04933617|101807779|FG000|STARTED|Dose Expansion||0||
48146428|NCT03581981|100682361|FG000|STARTED|Overall Study||59||
48146429|NCT03581981|100682362|FG001|STARTED|Overall Study||61||
48146430|NCT03581981|100682361|FG000|COMPLETED|Overall Study||46||
48146431|NCT03581981|100682362|FG001|COMPLETED|Overall Study||42||
48146432|NCT03581981|100682361|FG000|NOT COMPLETED|Overall Study||13||
48146433|NCT03581981|100682362|FG001|NOT COMPLETED|Overall Study||19||
48146434|NCT00313820|100682363|FG000|STARTED|Assigned to Treatment||111||
48146435|NCT00313820|100682364|FG001|STARTED|Assigned to Treatment||109||
48146436|NCT00313820|100682363|FG000|COMPLETED|Assigned to Treatment||110||
48602097|NCT04933617|101807780|FG001|STARTED|Dose Expansion||0||
48602098|NCT04933617|101807781|FG002|STARTED|Dose Expansion||0||
48602099|NCT04933617|101807782|FG003|STARTED|Dose Expansion||0||
48146437|NCT00313820|100682364|FG001|COMPLETED|Assigned to Treatment||109||
48146438|NCT00313820|100682363|FG000|NOT COMPLETED|Assigned to Treatment||1||
48146439|NCT00313820|100682364|FG001|NOT COMPLETED|Assigned to Treatment||0||
48146440|NCT00313820|100682363|FG000|STARTED|Pregabalin or Placebo Treatment Period||110||
48146441|NCT00313820|100682364|FG001|STARTED|Pregabalin or Placebo Treatment Period||109||
48146442|NCT00313820|100682363|FG000|COMPLETED|Pregabalin or Placebo Treatment Period||93||
48146443|NCT00313820|100682364|FG001|COMPLETED|Pregabalin or Placebo Treatment Period||90||
48146444|NCT00313820|100682363|FG000|NOT COMPLETED|Pregabalin or Placebo Treatment Period||17||
48146445|NCT00313820|100682364|FG001|NOT COMPLETED|Pregabalin or Placebo Treatment Period||19||
48146446|NCT02807558|100682365|FG000|STARTED|Overall Study||29||
48146447|NCT02807558|100682366|FG001|STARTED|Overall Study||2||
48146448|NCT02807558|100682367|FG002|STARTED|Overall Study||29||
48146449|NCT02807558|100682368|FG003|STARTED|Overall Study||51||
48146450|NCT02807558|100682369|FG004|STARTED|Overall Study||28||
48146451|NCT02807558|100682370|FG005|STARTED|Overall Study||16||
48146452|NCT02807558|100682365|FG000|Received at Least 1 Dose of Study Drug|Overall Study||29||
48146453|NCT02807558|100682366|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2||
48146454|NCT02807558|100682367|FG002|Received at Least 1 Dose of Study Drug|Overall Study||29||
48146455|NCT02807558|100682368|FG003|Received at Least 1 Dose of Study Drug|Overall Study||51||
48146456|NCT02807558|100682369|FG004|Received at Least 1 Dose of Study Drug|Overall Study||28||
48146457|NCT02807558|100682370|FG005|Received at Least 1 Dose of Study Drug|Overall Study||16||
48146458|NCT02807558|100682365|FG000|Response Evaluable Population|Overall Study||22||
48146459|NCT02807558|100682366|FG001|Response Evaluable Population|Overall Study||2||
48146460|NCT02807558|100682367|FG002|Response Evaluable Population|Overall Study||27||
48146461|NCT02807558|100682368|FG003|Response Evaluable Population|Overall Study||46||
48146462|NCT02807558|100682369|FG004|Response Evaluable Population|Overall Study||21||
48146463|NCT02807558|100682370|FG005|Response Evaluable Population|Overall Study||12||
48146464|NCT02807558|100682365|FG000|Completed Per Study Protocol|Overall Study||29||
48146465|NCT02807558|100682366|FG001|Completed Per Study Protocol|Overall Study||2||
48146466|NCT02807558|100682367|FG002|Completed Per Study Protocol|Overall Study||29||
48146467|NCT02807558|100682368|FG003|Completed Per Study Protocol|Overall Study||51||
48146468|NCT02807558|100682369|FG004|Completed Per Study Protocol|Overall Study||27||
48146469|NCT02807558|100682370|FG005|Completed Per Study Protocol|Overall Study||16||
48146470|NCT02807558|100682365|FG000|Completed Post-Treatment Follow-up|Overall Study||1||
48146471|NCT02807558|100682366|FG001|Completed Post-Treatment Follow-up|Overall Study||0||
48146472|NCT02807558|100682367|FG002|Completed Post-Treatment Follow-up|Overall Study||0||
48146473|NCT02807558|100682368|FG003|Completed Post-Treatment Follow-up|Overall Study||6||
48146474|NCT02807558|100682369|FG004|Completed Post-Treatment Follow-up|Overall Study||1||
48146475|NCT02807558|100682370|FG005|Completed Post-Treatment Follow-up|Overall Study||0||
48146476|NCT02807558|100682365|FG000|Evaluable for Hematological Improvement (HI)|Overall Study||16||
48146477|NCT02807558|100682366|FG001|Evaluable for Hematological Improvement (HI)|Overall Study||2||
48146478|NCT02807558|100682367|FG002|Evaluable for Hematological Improvement (HI)|Overall Study||25||
48146479|NCT02807558|100682368|FG003|Evaluable for Hematological Improvement (HI)|Overall Study||16||
48146480|NCT02807558|100682369|FG004|Evaluable for Hematological Improvement (HI)|Overall Study||17||
48146481|NCT02807558|100682370|FG005|Evaluable for Hematological Improvement (HI)|Overall Study||9||
48146482|NCT02807558|100682365|FG000|COMPLETED|Overall Study||1||
48146483|NCT02807558|100682366|FG001|COMPLETED|Overall Study||0||
48146484|NCT02807558|100682367|FG002|COMPLETED|Overall Study||0||
48146485|NCT02807558|100682368|FG003|COMPLETED|Overall Study||6||
48146486|NCT02807558|100682369|FG004|COMPLETED|Overall Study||2||
48146487|NCT02807558|100682370|FG005|COMPLETED|Overall Study||0||
48146488|NCT02807558|100682365|FG000|NOT COMPLETED|Overall Study||28||
48146489|NCT02807558|100682366|FG001|NOT COMPLETED|Overall Study||2||
48146490|NCT02807558|100682367|FG002|NOT COMPLETED|Overall Study||29||
48146491|NCT02807558|100682368|FG003|NOT COMPLETED|Overall Study||45||
48146492|NCT02807558|100682369|FG004|NOT COMPLETED|Overall Study||26||
48146493|NCT02807558|100682370|FG005|NOT COMPLETED|Overall Study||16||
48146494|NCT01750073|100682371|FG000|STARTED|Overall Study||92||
48146495|NCT01750073|100682371|FG000|HER2-positive|Overall Study||19||
48146496|NCT01750073|100682371|FG000|HER2-negative|Overall Study||73||
48146497|NCT01750073|100682371|FG000|COMPLETED|Overall Study||87||
48146498|NCT01750073|100682371|FG000|NOT COMPLETED|Overall Study||5||
48146499|NCT00743366|100682372|FG000|STARTED|Intervention 1 (8 Days)||10||
48146500|NCT00743366|100682373|FG001|STARTED|Intervention 1 (8 Days)||10||
48146501|NCT00743366|100682372|FG000|COMPLETED|Intervention 1 (8 Days)||7||
48146502|NCT00743366|100682373|FG001|COMPLETED|Intervention 1 (8 Days)||7||
48146503|NCT00743366|100682372|FG000|NOT COMPLETED|Intervention 1 (8 Days)||3||
48300433|NCT00455325|101063938|FG001|COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||26|This is a sequential study|
48300434|NCT00455325|101063939|FG002|COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0|This is a sequential study|
48714850|NCT03757130|102088630|FG001|COMPLETED|Overall Study||6||
48714851|NCT03757130|102088631|FG002|COMPLETED|Overall Study||6||
48714852|NCT03757130|102088632|FG003|COMPLETED|Overall Study||7||
48714853|NCT03757130|102088633|FG004|COMPLETED|Overall Study||6||
48714854|NCT03757130|102088634|FG005|COMPLETED|Overall Study||6||
48714855|NCT03757130|102088635|FG006|COMPLETED|Overall Study||5||
48714856|NCT03757130|102088636|FG007|COMPLETED|Overall Study||5||
48714857|NCT03757130|102088629|FG000|NOT COMPLETED|Overall Study||0||
48714858|NCT03757130|102088630|FG001|NOT COMPLETED|Overall Study||0||
48714859|NCT03757130|102088631|FG002|NOT COMPLETED|Overall Study||0||
48714860|NCT03757130|102088632|FG003|NOT COMPLETED|Overall Study||1||
48714861|NCT03757130|102088633|FG004|NOT COMPLETED|Overall Study||0||
48714862|NCT03757130|102088634|FG005|NOT COMPLETED|Overall Study||0||
48714863|NCT03757130|102088635|FG006|NOT COMPLETED|Overall Study||1||
48714864|NCT03757130|102088636|FG007|NOT COMPLETED|Overall Study||1||
48714865|NCT02581930|102088637|FG000|STARTED|Overall Study||18||
48714866|NCT02581930|102088637|FG000|COMPLETED|Overall Study||16||
48714867|NCT02581930|102088637|FG000|NOT COMPLETED|Overall Study||2||
48714868|NCT01400243|102088638|FG000|STARTED|Overall Study||64||
48146504|NCT00743366|100682373|FG001|NOT COMPLETED|Intervention 1 (8 Days)||3||
48300435|NCT00455325|101063940|FG003|COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0|This is a sequential study|
48300436|NCT00455325|101063937|FG000|NOT COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0||
48300437|NCT00455325|101063938|FG001|NOT COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||1||
48300438|NCT00455325|101063939|FG002|NOT COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0||
48300439|NCT00455325|101063940|FG003|NOT COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0||
48300440|NCT00455325|101063937|FG000|STARTED|Cohort 3: 80 mg Chloroquine Daily||0||
48300441|NCT00455325|101063938|FG001|STARTED|Cohort 3: 80 mg Chloroquine Daily||0||
48300442|NCT00455325|101063939|FG002|STARTED|Cohort 3: 80 mg Chloroquine Daily||26||
48300443|NCT00455325|101063940|FG003|STARTED|Cohort 3: 80 mg Chloroquine Daily||0||
48300444|NCT00455325|101063937|FG000|COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0||
48300445|NCT00455325|101063938|FG001|COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0||
48300446|NCT00455325|101063939|FG002|COMPLETED|Cohort 3: 80 mg Chloroquine Daily||25||
48300447|NCT00455325|101063940|FG003|COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0||
48300448|NCT00455325|101063937|FG000|NOT COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0||
48714869|NCT01400243|102088639|FG001|STARTED|Overall Study||63||
48714870|NCT01400243|102088638|FG000|COMPLETED|Overall Study||56||
48714871|NCT01400243|102088639|FG001|COMPLETED|Overall Study||52||
48714872|NCT01400243|102088638|FG000|NOT COMPLETED|Overall Study||8||
48714873|NCT01400243|102088639|FG001|NOT COMPLETED|Overall Study||11||
48714874|NCT01688739|102088640|FG000|STARTED|Overall Study||13||
48714875|NCT01688739|102088641|FG001|STARTED|Overall Study||3||
48714876|NCT01688739|102088642|FG002|STARTED|Overall Study||3||
48714877|NCT01688739|102088643|FG003|STARTED|Overall Study||6||
48714878|NCT01688739|102088644|FG004|STARTED|Overall Study||6||
48714879|NCT01688739|102088645|FG005|STARTED|Overall Study||6||
48714880|NCT01688739|102088646|FG006|STARTED|Overall Study||6||
48714881|NCT01688739|102088647|FG007|STARTED|Overall Study||6||
48714882|NCT01688739|102088648|FG008|STARTED|Overall Study||6||
48714883|NCT01688739|102088649|FG009|STARTED|Overall Study||6||
48714884|NCT01688739|102088640|FG000|Received Study Drug|Overall Study||12||
48714885|NCT01688739|102088641|FG001|Received Study Drug|Overall Study||3||
48714886|NCT01688739|102088642|FG002|Received Study Drug|Overall Study||3||
48714887|NCT01688739|102088643|FG003|Received Study Drug|Overall Study||6||
48714888|NCT01688739|102088644|FG004|Received Study Drug|Overall Study||6||
48714889|NCT01688739|102088645|FG005|Received Study Drug|Overall Study||6||
48714890|NCT01688739|102088646|FG006|Received Study Drug|Overall Study||6||
48714891|NCT01688739|102088647|FG007|Received Study Drug|Overall Study||6||
48146505|NCT00743366|100682372|FG000|STARTED|Intervention 2 (8 Days)||7||
48146506|NCT00743366|100682373|FG001|STARTED|Intervention 2 (8 Days)||7||
48714892|NCT01688739|102088648|FG008|Received Study Drug|Overall Study||6||
48714893|NCT01688739|102088649|FG009|Received Study Drug|Overall Study||6||
48714894|NCT01688739|102088640|FG000|COMPLETED|Overall Study||12||
48714895|NCT01688739|102088641|FG001|COMPLETED|Overall Study||3||
48714896|NCT01688739|102088642|FG002|COMPLETED|Overall Study||3||
48146507|NCT00743366|100682372|FG000|COMPLETED|Intervention 2 (8 Days)||7||
48146508|NCT00743366|100682373|FG001|COMPLETED|Intervention 2 (8 Days)||7||
48146509|NCT00743366|100682372|FG000|NOT COMPLETED|Intervention 2 (8 Days)||0||
48146510|NCT00743366|100682373|FG001|NOT COMPLETED|Intervention 2 (8 Days)||0||
48146511|NCT00765674|100682374|FG000|STARTED|Overall Study||287||
48300449|NCT00455325|101063938|FG001|NOT COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0||
48146512|NCT00765674|100682375|FG001|STARTED|Overall Study||298||
48146513|NCT00765674|100682376|FG002|STARTED|Overall Study||296||
48146514|NCT00765674|100682377|FG003|STARTED|Overall Study||310||
48146515|NCT00765674|100682374|FG000|COMPLETED|Overall Study||266||
48146516|NCT00765674|100682375|FG001|COMPLETED|Overall Study||276||
48146517|NCT00765674|100682376|FG002|COMPLETED|Overall Study||279||
48146518|NCT00765674|100682377|FG003|COMPLETED|Overall Study||285||
48146519|NCT00765674|100682374|FG000|NOT COMPLETED|Overall Study||21||
48146520|NCT00765674|100682375|FG001|NOT COMPLETED|Overall Study||22||
48146521|NCT00765674|100682376|FG002|NOT COMPLETED|Overall Study||17||
48146522|NCT00765674|100682377|FG003|NOT COMPLETED|Overall Study||25||
48146523|NCT00765388|100682378|FG000|STARTED|Period 1||16||
48146524|NCT00765388|100682379|FG001|STARTED|Period 1||11||
48146525|NCT00765388|100682378|FG000|COMPLETED|Period 1||15||
48146526|NCT00765388|100682379|FG001|COMPLETED|Period 1||6||
48146527|NCT00765388|100682378|FG000|NOT COMPLETED|Period 1||1||
48146528|NCT00765388|100682379|FG001|NOT COMPLETED|Period 1||5||
48146529|NCT00765388|100682378|FG000|STARTED|Period 2||15||
48146530|NCT00765388|100682379|FG001|STARTED|Period 2||6||
48146531|NCT00765388|100682378|FG000|COMPLETED|Period 2||15||
48146532|NCT00765388|100682379|FG001|COMPLETED|Period 2||6||
48146533|NCT00765388|100682378|FG000|NOT COMPLETED|Period 2||0||
48146534|NCT00765388|100682379|FG001|NOT COMPLETED|Period 2||0||
48146535|NCT03163758|100682380|FG000|STARTED|Overall Study||21||
48146536|NCT03163758|100682381|FG001|STARTED|Overall Study||21||
48146537|NCT03163758|100682380|FG000|COMPLETED|Overall Study||13||
48146538|NCT03163758|100682381|FG001|COMPLETED|Overall Study||14||
48146539|NCT03163758|100682380|FG000|NOT COMPLETED|Overall Study||8||
48146540|NCT03163758|100682381|FG001|NOT COMPLETED|Overall Study||7||
48146541|NCT04450264|100682382|FG000|STARTED|Overall Study||70||
48146542|NCT04450264|100682383|FG001|STARTED|Overall Study||85||
48714897|NCT01688739|102088643|FG003|COMPLETED|Overall Study||6||
48714898|NCT01688739|102088644|FG004|COMPLETED|Overall Study||6||
48714899|NCT01688739|102088645|FG005|COMPLETED|Overall Study||6||
48714900|NCT01688739|102088646|FG006|COMPLETED|Overall Study||6||
48714901|NCT01688739|102088647|FG007|COMPLETED|Overall Study||6||
48714902|NCT01688739|102088648|FG008|COMPLETED|Overall Study||6||
48714903|NCT01688739|102088649|FG009|COMPLETED|Overall Study||6||
48146543|NCT04450264|100682382|FG000|COMPLETED|Overall Study||57||
48146544|NCT04450264|100682383|FG001|COMPLETED|Overall Study||66||
48146545|NCT04450264|100682382|FG000|NOT COMPLETED|Overall Study||13||
48714904|NCT01688739|102088640|FG000|NOT COMPLETED|Overall Study||1||
48714905|NCT01688739|102088641|FG001|NOT COMPLETED|Overall Study||0||
48714906|NCT01688739|102088642|FG002|NOT COMPLETED|Overall Study||0||
48714907|NCT01688739|102088643|FG003|NOT COMPLETED|Overall Study||0||
48714908|NCT01688739|102088644|FG004|NOT COMPLETED|Overall Study||0||
48714909|NCT01688739|102088645|FG005|NOT COMPLETED|Overall Study||0||
48714910|NCT01688739|102088646|FG006|NOT COMPLETED|Overall Study||0||
48714911|NCT01688739|102088647|FG007|NOT COMPLETED|Overall Study||0||
48714912|NCT01688739|102088648|FG008|NOT COMPLETED|Overall Study||0||
48714913|NCT01688739|102088649|FG009|NOT COMPLETED|Overall Study||0||
48714914|NCT00901511|102088650|FG000|STARTED|Overall Study||9||
48714915|NCT00901511|102088651|FG001|STARTED|Overall Study||9||
48714916|NCT00901511|102088650|FG000|COMPLETED|Overall Study||8||
48714917|NCT00901511|102088651|FG001|COMPLETED|Overall Study||8||
48714918|NCT00901511|102088650|FG000|NOT COMPLETED|Overall Study||1||
48714919|NCT00901511|102088651|FG001|NOT COMPLETED|Overall Study||1||
48714920|NCT01557881|102088652|FG000|STARTED|Overall Study||98||
48714921|NCT01557881|102088652|FG000|COMPLETED|Overall Study||98||
48714922|NCT01557881|102088652|FG000|NOT COMPLETED|Overall Study||0||
48714923|NCT01001546|102088653|FG000|STARTED|Overall Study||206||
48714924|NCT01001546|102088654|FG001|STARTED|Overall Study||207||
48714925|NCT01001546|102088653|FG000|COMPLETED|Overall Study||206||
48714926|NCT01001546|102088654|FG001|COMPLETED|Overall Study||207||
48714927|NCT01001546|102088653|FG000|NOT COMPLETED|Overall Study||0||
48714928|NCT01001546|102088654|FG001|NOT COMPLETED|Overall Study||0||
48714929|NCT03421743|102088655|FG000|STARTED|Overall Study||14||
48714930|NCT03421743|102088656|FG001|STARTED|Overall Study||18||
48714931|NCT03421743|102088655|FG000|COMPLETED|Overall Study||11||
48146546|NCT04450264|100682383|FG001|NOT COMPLETED|Overall Study||19||
48146547|NCT04098939|100682384|FG000|STARTED|Overall Study||42||
48146548|NCT04098939|100682384|FG000|COMPLETED|Overall Study||42||
48146549|NCT04098939|100682384|FG000|NOT COMPLETED|Overall Study||0||
48146550|NCT00328510|100682385|FG000|STARTED|Overall Study||42||
48146551|NCT00328510|100682386|FG001|STARTED|Overall Study||41||
48146552|NCT00328510|100682385|FG000|COMPLETED|Overall Study||32||
48146553|NCT00328510|100682386|FG001|COMPLETED|Overall Study||37||
48146554|NCT00328510|100682385|FG000|NOT COMPLETED|Overall Study||10||
48146555|NCT00328510|100682386|FG001|NOT COMPLETED|Overall Study||4||
48146556|NCT02721082|100682387|FG000|STARTED|Overall Study||655||
48146557|NCT02721082|100682388|FG001|STARTED|Overall Study||345||
48146558|NCT02721082|100682387|FG000|COMPLETED|Overall Study||469||
48146559|NCT02721082|100682388|FG001|COMPLETED|Overall Study||270||
48146560|NCT02721082|100682387|FG000|NOT COMPLETED|Overall Study||186||
48146561|NCT02721082|100682388|FG001|NOT COMPLETED|Overall Study||75||
48714932|NCT03421743|102088656|FG001|COMPLETED|Overall Study||16||
48146562|NCT04958109|100682389|FG000|STARTED|Overall Study||4||
48146563|NCT04958109|100682390|FG001|STARTED|Overall Study||7||
48146564|NCT04958109|100682389|FG000|COMPLETED|Overall Study||4||
48146565|NCT04958109|100682390|FG001|COMPLETED|Overall Study||5||
48146566|NCT04958109|100682389|FG000|NOT COMPLETED|Overall Study||0||
48146567|NCT04958109|100682390|FG001|NOT COMPLETED|Overall Study||2||
48146568|NCT03806270|100682391|FG000|STARTED|Overall Study||15||
48146569|NCT03806270|100682392|FG001|STARTED|Overall Study||15||
48146570|NCT03806270|100682393|FG002|STARTED|Overall Study||15||
48146571|NCT03806270|100682391|FG000|COMPLETED|Overall Study||15||
48146572|NCT03806270|100682392|FG001|COMPLETED|Overall Study||15||
48146573|NCT03806270|100682393|FG002|COMPLETED|Overall Study||15||
48146574|NCT03806270|100682391|FG000|NOT COMPLETED|Overall Study||0||
48146575|NCT03806270|100682392|FG001|NOT COMPLETED|Overall Study||0||
48146576|NCT03806270|100682393|FG002|NOT COMPLETED|Overall Study||0||
48146577|NCT02392013|100682394|FG000|STARTED|Allocation||155||
48146578|NCT02392013|100682395|FG001|STARTED|Allocation||155||
48146579|NCT02392013|100682394|FG000|COMPLETED|Allocation||140||
48146580|NCT02392013|100682395|FG001|COMPLETED|Allocation||143||
48602100|NCT04933617|101807783|FG004|STARTED|Dose Expansion||0||
48602101|NCT04933617|101807779|FG000|COMPLETED|Dose Expansion||0||
48602102|NCT04933617|101807780|FG001|COMPLETED|Dose Expansion||0||
48602103|NCT04933617|101807781|FG002|COMPLETED|Dose Expansion||0||
48602104|NCT04933617|101807782|FG003|COMPLETED|Dose Expansion||0||
48602105|NCT04933617|101807783|FG004|COMPLETED|Dose Expansion||0||
48146581|NCT02392013|100682394|FG000|NOT COMPLETED|Allocation||15||
48146582|NCT02392013|100682395|FG001|NOT COMPLETED|Allocation||12||
48146583|NCT02392013|100682394|FG000|STARTED|Follow-up||140||
48146584|NCT02392013|100682395|FG001|STARTED|Follow-up||143||
48146585|NCT02392013|100682394|FG000|COMPLETED|Follow-up||127||
48146586|NCT02392013|100682395|FG001|COMPLETED|Follow-up||126||
48146587|NCT02392013|100682394|FG000|NOT COMPLETED|Follow-up||13||
48146588|NCT02392013|100682395|FG001|NOT COMPLETED|Follow-up||17||
48146589|NCT03575325|100682396|FG000|STARTED|Overall Study||11||
48146590|NCT03575325|100682396|FG000|COMPLETED|Overall Study||10||
48602106|NCT04933617|101807779|FG000|NOT COMPLETED|Dose Expansion||0||
48602107|NCT04933617|101807780|FG001|NOT COMPLETED|Dose Expansion||0||
48602108|NCT04933617|101807781|FG002|NOT COMPLETED|Dose Expansion||0||
48602109|NCT04933617|101807782|FG003|NOT COMPLETED|Dose Expansion||0||
48602110|NCT04933617|101807783|FG004|NOT COMPLETED|Dose Expansion||0||
48602111|NCT04575584|101807784|FG000|STARTED|Overall Study||75||
48602112|NCT04575584|101807785|FG001|STARTED|Overall Study||75||
48602113|NCT04575584|101807786|FG002|STARTED|Overall Study||76||
48602114|NCT04575584|101807787|FG003|STARTED|Overall Study||78||
48602115|NCT04575584|101807788|FG004|STARTED|Overall Study||0||
48602116|NCT04575584|101807789|FG005|STARTED|Overall Study||0||
48602117|NCT04575584|101807784|FG000|Treated|Overall Study||73||
48602118|NCT04575584|101807785|FG001|Treated|Overall Study||73||
48602119|NCT04575584|101807786|FG002|Treated|Overall Study||72||
48602120|NCT04575584|101807787|FG003|Treated|Overall Study||75||
48602121|NCT04575584|101807788|FG004|Treated|Overall Study||0||
48602122|NCT04575584|101807789|FG005|Treated|Overall Study||0||
48146591|NCT03575325|100682396|FG000|NOT COMPLETED|Overall Study||1||
48146592|NCT01292928|100682397|FG000|STARTED|Overall Study||299||
48146593|NCT01292928|100682397|FG000|Completed 12-Month Clinical Follow-up|Overall Study||266||
48146594|NCT01292928|100682397|FG000|COMPLETED|Overall Study||275||
48146595|NCT01292928|100682397|FG000|NOT COMPLETED|Overall Study||24||
48146596|NCT00419263|100682398|FG000|STARTED|Overall Study||115||
48146597|NCT00419263|100682399|FG001|STARTED|Overall Study||114||
48146598|NCT00419263|100682400|FG002|STARTED|Overall Study||115||
48146599|NCT00419263|100682398|FG000|COMPLETED|Overall Study||112||
48146600|NCT00419263|100682399|FG001|COMPLETED|Overall Study||112||
48146601|NCT00419263|100682400|FG002|COMPLETED|Overall Study||112||
48146602|NCT00419263|100682398|FG000|NOT COMPLETED|Overall Study||3||
48146603|NCT00419263|100682399|FG001|NOT COMPLETED|Overall Study||2||
48146604|NCT00419263|100682400|FG002|NOT COMPLETED|Overall Study||3||
48146605|NCT02618967|100682401|FG000|STARTED|Overall Study||6||
48146606|NCT02618967|100682402|FG001|STARTED|Overall Study||6||
48146607|NCT02618967|100682403|FG002|STARTED|Overall Study||6||
48602123|NCT04575584|101807784|FG000|COMPLETED|Overall Study||61||
48146608|NCT02618967|100682404|FG003|STARTED|Overall Study||6||
48146609|NCT02618967|100682405|FG004|STARTED|Overall Study||6||
48146610|NCT02618967|100682406|FG005|STARTED|Overall Study||6||
48146611|NCT02618967|100682407|FG006|STARTED|Overall Study||6||
48146612|NCT02618967|100682408|FG007|STARTED|Overall Study||14||
48146613|NCT02618967|100682401|FG000|Received Treatment|Overall Study||6||
48146614|NCT02618967|100682402|FG001|Received Treatment|Overall Study||6||
48146615|NCT02618967|100682403|FG002|Received Treatment|Overall Study||6||
48146616|NCT02618967|100682404|FG003|Received Treatment|Overall Study||6||
48146617|NCT02618967|100682405|FG004|Received Treatment|Overall Study||6||
48146618|NCT02618967|100682406|FG005|Received Treatment|Overall Study||6||
48146619|NCT02618967|100682407|FG006|Received Treatment|Overall Study||6||
48146620|NCT02618967|100682408|FG007|Received Treatment|Overall Study||14||
48146621|NCT02618967|100682401|FG000|COMPLETED|Overall Study||5||
48146622|NCT02618967|100682402|FG001|COMPLETED|Overall Study||6||
48602124|NCT04575584|101807785|FG001|COMPLETED|Overall Study||60||
48300450|NCT00455325|101063939|FG002|NOT COMPLETED|Cohort 3: 80 mg Chloroquine Daily||1||
48714933|NCT03421743|102088655|FG000|NOT COMPLETED|Overall Study||3||
48714934|NCT03421743|102088656|FG001|NOT COMPLETED|Overall Study||2||
48714935|NCT03452033|102088657|FG000|STARTED|Overall Study||21||21
48714936|NCT03452033|102088658|FG001|STARTED|Overall Study||22||22
48714937|NCT03452033|102088659|FG002|STARTED|Overall Study||22||22
48714938|NCT03452033|102088660|FG003|STARTED|Overall Study||22||22
48714939|NCT03452033|102088657|FG000|COMPLETED|Overall Study||21||21
48714940|NCT03452033|102088658|FG001|COMPLETED|Overall Study||22||22
48714941|NCT03452033|102088659|FG002|COMPLETED|Overall Study||22||22
48714942|NCT03452033|102088660|FG003|COMPLETED|Overall Study||22||22
48714943|NCT03452033|102088657|FG000|NOT COMPLETED|Overall Study||0||0
48714944|NCT03452033|102088658|FG001|NOT COMPLETED|Overall Study||0||0
48714945|NCT03452033|102088659|FG002|NOT COMPLETED|Overall Study||0||0
48714946|NCT03452033|102088660|FG003|NOT COMPLETED|Overall Study||0||0
48146623|NCT02618967|100682403|FG002|COMPLETED|Overall Study||5||
48146624|NCT02618967|100682404|FG003|COMPLETED|Overall Study||6||
48146625|NCT02618967|100682405|FG004|COMPLETED|Overall Study||4||
48146626|NCT02618967|100682406|FG005|COMPLETED|Overall Study||6||
48146627|NCT02618967|100682407|FG006|COMPLETED|Overall Study||6||
48146628|NCT02618967|100682408|FG007|COMPLETED|Overall Study||14||
48146629|NCT02618967|100682401|FG000|NOT COMPLETED|Overall Study||1||
48146630|NCT02618967|100682402|FG001|NOT COMPLETED|Overall Study||0||
48146631|NCT02618967|100682403|FG002|NOT COMPLETED|Overall Study||1||
48146632|NCT02618967|100682404|FG003|NOT COMPLETED|Overall Study||0||
48146633|NCT02618967|100682405|FG004|NOT COMPLETED|Overall Study||2||
48146634|NCT02618967|100682406|FG005|NOT COMPLETED|Overall Study||0||
48146635|NCT02618967|100682407|FG006|NOT COMPLETED|Overall Study||0||
48146636|NCT02618967|100682408|FG007|NOT COMPLETED|Overall Study||0||
48146637|NCT01292239|100682409|FG000|STARTED|Overall Study||123||
48146638|NCT01292239|100682410|FG001|STARTED|Overall Study||60||
48146639|NCT01292239|100682409|FG000|COMPLETED|Overall Study||119||
48146640|NCT01292239|100682410|FG001|COMPLETED|Overall Study||53||
48146641|NCT01292239|100682409|FG000|NOT COMPLETED|Overall Study||4||
48146642|NCT01292239|100682410|FG001|NOT COMPLETED|Overall Study||7||
48146643|NCT00361374|100682411|FG000|STARTED|Overall Study||66||
48146644|NCT00361374|100682412|FG001|STARTED|Overall Study||65||
48146645|NCT00361374|100682413|FG002|STARTED|Overall Study||65||
48146646|NCT00361374|100682411|FG000|COMPLETED|Overall Study||51||
48146647|NCT00361374|100682412|FG001|COMPLETED|Overall Study||50||
48146648|NCT00361374|100682413|FG002|COMPLETED|Overall Study||53||
48146649|NCT00361374|100682411|FG000|NOT COMPLETED|Overall Study||15||
48146650|NCT00361374|100682412|FG001|NOT COMPLETED|Overall Study||15||
48146651|NCT00361374|100682413|FG002|NOT COMPLETED|Overall Study||12||
48146652|NCT04508699|100682414|FG000|STARTED|Overall Study||15||
48146653|NCT04508699|100682415|FG001|STARTED|Overall Study||97||
48146654|NCT04508699|100682414|FG000|COMPLETED|Overall Study||13||
48146655|NCT04508699|100682415|FG001|COMPLETED|Overall Study||80||
48146656|NCT04508699|100682414|FG000|NOT COMPLETED|Overall Study||2||
48146657|NCT04508699|100682415|FG001|NOT COMPLETED|Overall Study||17||
48146658|NCT01106833|100682416|FG000|STARTED|Overall Study||74||
48146659|NCT01106833|100682417|FG001|STARTED|Overall Study||77||
48146660|NCT01106833|100682416|FG000|COMPLETED|Overall Study||74||
48146661|NCT01106833|100682417|FG001|COMPLETED|Overall Study||77||
48146662|NCT01106833|100682416|FG000|NOT COMPLETED|Overall Study||0||
48300451|NCT00455325|101063940|FG003|NOT COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0||
48714947|NCT01726673|102088661|FG000|STARTED|Overall Study||30||
48714948|NCT01726673|102088662|FG001|STARTED|Overall Study||24||
48714949|NCT01726673|102088661|FG000|COMPLETED|Overall Study||24||
48714950|NCT01726673|102088662|FG001|COMPLETED|Overall Study||21||
48714951|NCT01726673|102088661|FG000|NOT COMPLETED|Overall Study||6||
48714952|NCT01726673|102088662|FG001|NOT COMPLETED|Overall Study||3||
48714953|NCT04021524|102088663|FG000|STARTED|Overall Study||25||
48714954|NCT04021524|102088664|FG001|STARTED|Overall Study||25||
48714955|NCT04021524|102088663|FG000|COMPLETED|Overall Study||25||
48714956|NCT04021524|102088664|FG001|COMPLETED|Overall Study||24||
48714957|NCT04021524|102088663|FG000|NOT COMPLETED|Overall Study||0||
48714958|NCT04021524|102088664|FG001|NOT COMPLETED|Overall Study||1||
48714959|NCT00810901|102088665|FG000|STARTED|Overall Study||253||
48714960|NCT00810901|102088666|FG001|STARTED|Overall Study||176||
48714961|NCT00810901|102088665|FG000|1-month Follow up|Overall Study||242||
48714962|NCT00810901|102088666|FG001|1-month Follow up|Overall Study||146||
48714963|NCT00810901|102088665|FG000|6-month Follow-up|Overall Study||181||
48714964|NCT00810901|102088666|FG001|6-month Follow-up|Overall Study||122||
48146663|NCT01106833|100682417|FG001|NOT COMPLETED|Overall Study||0||
48146664|NCT02411565|100682418|FG000|STARTED|Overall Study||1||
48146665|NCT02411565|100682419|FG001|STARTED|Overall Study||2||
48146666|NCT02411565|100682418|FG000|COMPLETED|Overall Study||1||
48146667|NCT02411565|100682419|FG001|COMPLETED|Overall Study||2||
48146668|NCT02411565|100682418|FG000|NOT COMPLETED|Overall Study||0||
48146669|NCT02411565|100682419|FG001|NOT COMPLETED|Overall Study||0||
48368008|NCT03567291|101230093|FG001|STARTED|Period I||0||
48714965|NCT00810901|102088665|FG000|COMPLETED|Overall Study||165||
48714966|NCT00810901|102088666|FG001|COMPLETED|Overall Study||118||
48146670|NCT01749982|100682420|FG000|STARTED|Overall Study||15||
48146671|NCT01749982|100682421|FG001|STARTED|Overall Study||15||
48146672|NCT01749982|100682422|FG002|STARTED|Overall Study||15||
48146673|NCT01749982|100682423|FG003|STARTED|Overall Study||15||
48146674|NCT01749982|100682420|FG000|COMPLETED|Overall Study||15||
48146675|NCT01749982|100682421|FG001|COMPLETED|Overall Study||15||
48146676|NCT01749982|100682422|FG002|COMPLETED|Overall Study||15||
48146677|NCT01749982|100682423|FG003|COMPLETED|Overall Study||12||
48146678|NCT01749982|100682420|FG000|NOT COMPLETED|Overall Study||0||
48146679|NCT01749982|100682421|FG001|NOT COMPLETED|Overall Study||0||
48146680|NCT01749982|100682422|FG002|NOT COMPLETED|Overall Study||0||
48146681|NCT01749982|100682423|FG003|NOT COMPLETED|Overall Study||3||
48146682|NCT00515502|100682424|FG000|STARTED|Treatment Period 1||1||
48146683|NCT00515502|100682425|FG001|STARTED|Treatment Period 1||4||
48146684|NCT00515502|100682426|FG002|STARTED|Treatment Period 1||4||
48146685|NCT00515502|100682427|FG003|STARTED|Treatment Period 1||3||
48146686|NCT00515502|100682428|FG004|STARTED|Treatment Period 1||3||
48146687|NCT00515502|100682429|FG005|STARTED|Treatment Period 1||1||
48146688|NCT00515502|100682430|FG006|STARTED|Treatment Period 1||2||
48146689|NCT00515502|100682431|FG007|STARTED|Treatment Period 1||1||
48146690|NCT00515502|100682432|FG008|STARTED|Treatment Period 1||1||
48146691|NCT00515502|100682433|FG009|STARTED|Treatment Period 1||2||
48146692|NCT00515502|100682434|FG010|STARTED|Treatment Period 1||1||
48146693|NCT00515502|100682435|FG011|STARTED|Treatment Period 1||1||
48146694|NCT00515502|100682424|FG000|COMPLETED|Treatment Period 1||1||
48146695|NCT00515502|100682425|FG001|COMPLETED|Treatment Period 1||4||
48146696|NCT00515502|100682426|FG002|COMPLETED|Treatment Period 1||4||
48146697|NCT00515502|100682427|FG003|COMPLETED|Treatment Period 1||3||
48146698|NCT00515502|100682428|FG004|COMPLETED|Treatment Period 1||3||
48146699|NCT00515502|100682429|FG005|COMPLETED|Treatment Period 1||1||
48146700|NCT00515502|100682430|FG006|COMPLETED|Treatment Period 1||1||
48146701|NCT00515502|100682431|FG007|COMPLETED|Treatment Period 1||1||
48146702|NCT00515502|100682432|FG008|COMPLETED|Treatment Period 1||0||
48146703|NCT00515502|100682433|FG009|COMPLETED|Treatment Period 1||2||
48146704|NCT00515502|100682434|FG010|COMPLETED|Treatment Period 1||1||
48146705|NCT00515502|100682435|FG011|COMPLETED|Treatment Period 1||0||
48146706|NCT00515502|100682424|FG000|NOT COMPLETED|Treatment Period 1||0||
48146707|NCT00515502|100682425|FG001|NOT COMPLETED|Treatment Period 1||0||
48146708|NCT00515502|100682426|FG002|NOT COMPLETED|Treatment Period 1||0||
48146709|NCT00515502|100682427|FG003|NOT COMPLETED|Treatment Period 1||0||
48146710|NCT00515502|100682428|FG004|NOT COMPLETED|Treatment Period 1||0||
48146711|NCT00515502|100682429|FG005|NOT COMPLETED|Treatment Period 1||0||
48146712|NCT00515502|100682430|FG006|NOT COMPLETED|Treatment Period 1||1||
48146713|NCT00515502|100682431|FG007|NOT COMPLETED|Treatment Period 1||0||
48146714|NCT00515502|100682432|FG008|NOT COMPLETED|Treatment Period 1||1||
48146715|NCT00515502|100682433|FG009|NOT COMPLETED|Treatment Period 1||0||
48146716|NCT00515502|100682434|FG010|NOT COMPLETED|Treatment Period 1||0||
48146717|NCT00515502|100682435|FG011|NOT COMPLETED|Treatment Period 1||1||
48146718|NCT00515502|100682424|FG000|STARTED|Washout Period 1||1||
48146719|NCT00515502|100682425|FG001|STARTED|Washout Period 1||4||
48146720|NCT00515502|100682426|FG002|STARTED|Washout Period 1||4||
48146721|NCT00515502|100682427|FG003|STARTED|Washout Period 1||3||
48146722|NCT00515502|100682428|FG004|STARTED|Washout Period 1||3||
48146723|NCT00515502|100682429|FG005|STARTED|Washout Period 1||1||
48146724|NCT00515502|100682430|FG006|STARTED|Washout Period 1||1||
48146725|NCT00515502|100682431|FG007|STARTED|Washout Period 1||1||
48146726|NCT00515502|100682432|FG008|STARTED|Washout Period 1||0||
48146727|NCT00515502|100682433|FG009|STARTED|Washout Period 1||2||
48146728|NCT00515502|100682434|FG010|STARTED|Washout Period 1||1||
48146729|NCT00515502|100682435|FG011|STARTED|Washout Period 1||0||
48146730|NCT00515502|100682424|FG000|COMPLETED|Washout Period 1||1||
48146731|NCT00515502|100682425|FG001|COMPLETED|Washout Period 1||4||
48146732|NCT00515502|100682426|FG002|COMPLETED|Washout Period 1||4||
48146733|NCT00515502|100682427|FG003|COMPLETED|Washout Period 1||3||
48146734|NCT00515502|100682428|FG004|COMPLETED|Washout Period 1||3||
48146735|NCT00515502|100682429|FG005|COMPLETED|Washout Period 1||1||
48146736|NCT00515502|100682430|FG006|COMPLETED|Washout Period 1||1||
48146737|NCT00515502|100682431|FG007|COMPLETED|Washout Period 1||1||
48146738|NCT00515502|100682432|FG008|COMPLETED|Washout Period 1||0||
48146739|NCT00515502|100682433|FG009|COMPLETED|Washout Period 1||2||
48146740|NCT00515502|100682434|FG010|COMPLETED|Washout Period 1||1||
48146741|NCT00515502|100682435|FG011|COMPLETED|Washout Period 1||0||
48146742|NCT00515502|100682424|FG000|NOT COMPLETED|Washout Period 1||0||
48146743|NCT00515502|100682425|FG001|NOT COMPLETED|Washout Period 1||0||
48146744|NCT00515502|100682426|FG002|NOT COMPLETED|Washout Period 1||0||
48146745|NCT00515502|100682427|FG003|NOT COMPLETED|Washout Period 1||0||
48146746|NCT00515502|100682428|FG004|NOT COMPLETED|Washout Period 1||0||
48146747|NCT00515502|100682429|FG005|NOT COMPLETED|Washout Period 1||0||
48146748|NCT00515502|100682430|FG006|NOT COMPLETED|Washout Period 1||0||
48146749|NCT00515502|100682431|FG007|NOT COMPLETED|Washout Period 1||0||
48146750|NCT00515502|100682432|FG008|NOT COMPLETED|Washout Period 1||0||
48146751|NCT00515502|100682433|FG009|NOT COMPLETED|Washout Period 1||0||
48146752|NCT00515502|100682434|FG010|NOT COMPLETED|Washout Period 1||0||
48300452|NCT00455325|101063937|FG000|STARTED|Cohort 4: 250mg Chloroquine Daily||0||
48602125|NCT04575584|101807786|FG002|COMPLETED|Overall Study||63||
48602126|NCT04575584|101807787|FG003|COMPLETED|Overall Study||70||
48602127|NCT04575584|101807788|FG004|COMPLETED|Overall Study||0||
48602128|NCT04575584|101807789|FG005|COMPLETED|Overall Study||0||
48602129|NCT04575584|101807784|FG000|NOT COMPLETED|Overall Study||14||
48602130|NCT04575584|101807785|FG001|NOT COMPLETED|Overall Study||15||
48602131|NCT04575584|101807786|FG002|NOT COMPLETED|Overall Study||13||
48714967|NCT00810901|102088665|FG000|NOT COMPLETED|Overall Study||88||
48714968|NCT00810901|102088666|FG001|NOT COMPLETED|Overall Study||58||
48300453|NCT00455325|101063938|FG001|STARTED|Cohort 4: 250mg Chloroquine Daily||0||
48300454|NCT00455325|101063939|FG002|STARTED|Cohort 4: 250mg Chloroquine Daily||0||
48146753|NCT00515502|100682435|FG011|NOT COMPLETED|Washout Period 1||0||
48146754|NCT00515502|100682424|FG000|STARTED|Treatment Period 2||1||
48146755|NCT00515502|100682425|FG001|STARTED|Treatment Period 2||4||
48146756|NCT00515502|100682426|FG002|STARTED|Treatment Period 2||4||
48146757|NCT00515502|100682427|FG003|STARTED|Treatment Period 2||3||
48146758|NCT00515502|100682428|FG004|STARTED|Treatment Period 2||3||
48146759|NCT00515502|100682429|FG005|STARTED|Treatment Period 2||1||
48146760|NCT00515502|100682430|FG006|STARTED|Treatment Period 2||1||
48146761|NCT00515502|100682431|FG007|STARTED|Treatment Period 2||1||
48146762|NCT00515502|100682432|FG008|STARTED|Treatment Period 2||0||
48146763|NCT00515502|100682433|FG009|STARTED|Treatment Period 2||2||
48146764|NCT00515502|100682434|FG010|STARTED|Treatment Period 2||1||
48146765|NCT00515502|100682435|FG011|STARTED|Treatment Period 2||0||
48146766|NCT00515502|100682424|FG000|COMPLETED|Treatment Period 2||1||
48146767|NCT00515502|100682425|FG001|COMPLETED|Treatment Period 2||3||
48146768|NCT00515502|100682426|FG002|COMPLETED|Treatment Period 2||4||
48146769|NCT00515502|100682427|FG003|COMPLETED|Treatment Period 2||3||
48146770|NCT00515502|100682428|FG004|COMPLETED|Treatment Period 2||3||
48146771|NCT00515502|100682429|FG005|COMPLETED|Treatment Period 2||1||
48146772|NCT00515502|100682430|FG006|COMPLETED|Treatment Period 2||1||
48146773|NCT00515502|100682431|FG007|COMPLETED|Treatment Period 2||1||
48146774|NCT00515502|100682432|FG008|COMPLETED|Treatment Period 2||0||
48146775|NCT00515502|100682433|FG009|COMPLETED|Treatment Period 2||2||
48146776|NCT00515502|100682434|FG010|COMPLETED|Treatment Period 2||1||
48146777|NCT00515502|100682435|FG011|COMPLETED|Treatment Period 2||0||
48146778|NCT00515502|100682424|FG000|NOT COMPLETED|Treatment Period 2||0||
48146779|NCT00515502|100682425|FG001|NOT COMPLETED|Treatment Period 2||1||
48146780|NCT00515502|100682426|FG002|NOT COMPLETED|Treatment Period 2||0||
48146781|NCT00515502|100682427|FG003|NOT COMPLETED|Treatment Period 2||0||
48146782|NCT00515502|100682428|FG004|NOT COMPLETED|Treatment Period 2||0||
48146783|NCT00515502|100682429|FG005|NOT COMPLETED|Treatment Period 2||0||
48146784|NCT00515502|100682430|FG006|NOT COMPLETED|Treatment Period 2||0||
48146785|NCT00515502|100682431|FG007|NOT COMPLETED|Treatment Period 2||0||
48146786|NCT00515502|100682432|FG008|NOT COMPLETED|Treatment Period 2||0||
48146787|NCT00515502|100682433|FG009|NOT COMPLETED|Treatment Period 2||0||
48146788|NCT00515502|100682434|FG010|NOT COMPLETED|Treatment Period 2||0||
48146789|NCT00515502|100682435|FG011|NOT COMPLETED|Treatment Period 2||0||
48300455|NCT00455325|101063940|FG003|STARTED|Cohort 4: 250mg Chloroquine Daily||25||
48405271|NCT03991936|101325238|FG004|NOT COMPLETED|Overall Study||1||2
48405272|NCT04728815|101325239|FG000|STARTED|Overall Study||12||
48405273|NCT04728815|101325240|FG001|STARTED|Overall Study||8||
48146790|NCT00515502|100682424|FG000|STARTED|Washout Period 2||1||
48146791|NCT00515502|100682425|FG001|STARTED|Washout Period 2||3||
48146792|NCT00515502|100682426|FG002|STARTED|Washout Period 2||4||
48146793|NCT00515502|100682427|FG003|STARTED|Washout Period 2||3||
48146794|NCT00515502|100682428|FG004|STARTED|Washout Period 2||3||
48146795|NCT00515502|100682429|FG005|STARTED|Washout Period 2||1||
48146796|NCT00515502|100682430|FG006|STARTED|Washout Period 2||1||
48146797|NCT00515502|100682431|FG007|STARTED|Washout Period 2||1||
48146798|NCT00515502|100682432|FG008|STARTED|Washout Period 2||0||
48146799|NCT00515502|100682433|FG009|STARTED|Washout Period 2||2||
48146800|NCT00515502|100682434|FG010|STARTED|Washout Period 2||1||
48146801|NCT00515502|100682435|FG011|STARTED|Washout Period 2||0||
48146802|NCT00515502|100682424|FG000|COMPLETED|Washout Period 2||1||
48146803|NCT00515502|100682425|FG001|COMPLETED|Washout Period 2||3||
48146804|NCT00515502|100682426|FG002|COMPLETED|Washout Period 2||4||
48146805|NCT00515502|100682427|FG003|COMPLETED|Washout Period 2||3||
48146806|NCT00515502|100682428|FG004|COMPLETED|Washout Period 2||3||
48146807|NCT00515502|100682429|FG005|COMPLETED|Washout Period 2||1||
48146808|NCT00515502|100682430|FG006|COMPLETED|Washout Period 2||1||
48146809|NCT00515502|100682431|FG007|COMPLETED|Washout Period 2||1||
48146810|NCT00515502|100682432|FG008|COMPLETED|Washout Period 2||0||
48146811|NCT00515502|100682433|FG009|COMPLETED|Washout Period 2||2||
48146812|NCT00515502|100682434|FG010|COMPLETED|Washout Period 2||1||
48146813|NCT00515502|100682435|FG011|COMPLETED|Washout Period 2||0||
48146814|NCT00515502|100682424|FG000|NOT COMPLETED|Washout Period 2||0||
48300456|NCT00455325|101063937|FG000|COMPLETED|Cohort 4: 250mg Chloroquine Daily||0||
48300457|NCT00455325|101063938|FG001|COMPLETED|Cohort 4: 250mg Chloroquine Daily||0||
48300458|NCT00455325|101063939|FG002|COMPLETED|Cohort 4: 250mg Chloroquine Daily||0||
48602132|NCT04575584|101807787|FG003|NOT COMPLETED|Overall Study||8||
48714969|NCT02989844|102088667|FG000|STARTED|Overall Study||20||
48714970|NCT02989844|102088667|FG000|COMPLETED|Overall Study||20||
48714971|NCT02989844|102088667|FG000|NOT COMPLETED|Overall Study||0||
48714972|NCT02159118|102088668|FG000|STARTED|Overall Study||22||
48714973|NCT02159118|102088669|FG001|STARTED|Overall Study||22||
48714974|NCT02159118|102088668|FG000|COMPLETED|Overall Study||22||
48714975|NCT02159118|102088669|FG001|COMPLETED|Overall Study||22||
48714976|NCT02159118|102088668|FG000|NOT COMPLETED|Overall Study||0||
48714977|NCT02159118|102088669|FG001|NOT COMPLETED|Overall Study||0||
48714978|NCT01689350|102088670|FG000|STARTED|Overall Study||47||
48714979|NCT01689350|102088671|FG001|STARTED|Overall Study||45||
48714980|NCT01689350|102088670|FG000|COMPLETED|Overall Study||47||
48714981|NCT01689350|102088671|FG001|COMPLETED|Overall Study||45||
48714982|NCT01689350|102088670|FG000|NOT COMPLETED|Overall Study||0||
48714983|NCT01689350|102088671|FG001|NOT COMPLETED|Overall Study||0||
48714984|NCT03541187|102088672|FG000|STARTED|Overall Study||40||
48714985|NCT03541187|102088673|FG001|STARTED|Overall Study||42||
48146815|NCT00515502|100682425|FG001|NOT COMPLETED|Washout Period 2||0||
48146816|NCT00515502|100682426|FG002|NOT COMPLETED|Washout Period 2||0||
48146817|NCT00515502|100682427|FG003|NOT COMPLETED|Washout Period 2||0||
48146818|NCT00515502|100682428|FG004|NOT COMPLETED|Washout Period 2||0||
48146819|NCT00515502|100682429|FG005|NOT COMPLETED|Washout Period 2||0||
48146820|NCT00515502|100682430|FG006|NOT COMPLETED|Washout Period 2||0||
48146821|NCT00515502|100682431|FG007|NOT COMPLETED|Washout Period 2||0||
48146822|NCT00515502|100682432|FG008|NOT COMPLETED|Washout Period 2||0||
48146823|NCT00515502|100682433|FG009|NOT COMPLETED|Washout Period 2||0||
48146824|NCT00515502|100682434|FG010|NOT COMPLETED|Washout Period 2||0||
48146825|NCT00515502|100682435|FG011|NOT COMPLETED|Washout Period 2||0||
48146826|NCT00515502|100682424|FG000|STARTED|Treatment Period 3||1||
48146827|NCT00515502|100682425|FG001|STARTED|Treatment Period 3||3||
48146828|NCT00515502|100682426|FG002|STARTED|Treatment Period 3||4||
48146829|NCT00515502|100682427|FG003|STARTED|Treatment Period 3||3||
48146830|NCT00515502|100682428|FG004|STARTED|Treatment Period 3||3||
48146831|NCT00515502|100682429|FG005|STARTED|Treatment Period 3||1||
48146832|NCT00515502|100682430|FG006|STARTED|Treatment Period 3||1||
48146833|NCT00515502|100682431|FG007|STARTED|Treatment Period 3||1||
48146834|NCT00515502|100682432|FG008|STARTED|Treatment Period 3||0||
48146835|NCT00515502|100682433|FG009|STARTED|Treatment Period 3||2||
48146836|NCT00515502|100682434|FG010|STARTED|Treatment Period 3||1||
48146837|NCT00515502|100682435|FG011|STARTED|Treatment Period 3||0||
48146838|NCT00515502|100682424|FG000|COMPLETED|Treatment Period 3||1||
48146839|NCT00515502|100682425|FG001|COMPLETED|Treatment Period 3||3||
48146840|NCT00515502|100682426|FG002|COMPLETED|Treatment Period 3||4||
48146841|NCT00515502|100682427|FG003|COMPLETED|Treatment Period 3||3||
48146842|NCT00515502|100682428|FG004|COMPLETED|Treatment Period 3||3||
48146843|NCT00515502|100682429|FG005|COMPLETED|Treatment Period 3||1||
48146844|NCT00515502|100682430|FG006|COMPLETED|Treatment Period 3||1||
48146845|NCT00515502|100682431|FG007|COMPLETED|Treatment Period 3||1||
48146846|NCT00515502|100682432|FG008|COMPLETED|Treatment Period 3||0||
48146847|NCT00515502|100682433|FG009|COMPLETED|Treatment Period 3||2||
48146848|NCT00515502|100682434|FG010|COMPLETED|Treatment Period 3||1||
48146849|NCT00515502|100682435|FG011|COMPLETED|Treatment Period 3||0||
48146850|NCT00515502|100682424|FG000|NOT COMPLETED|Treatment Period 3||0||
48146851|NCT00515502|100682425|FG001|NOT COMPLETED|Treatment Period 3||0||
48146852|NCT00515502|100682426|FG002|NOT COMPLETED|Treatment Period 3||0||
48146853|NCT00515502|100682427|FG003|NOT COMPLETED|Treatment Period 3||0||
48146854|NCT00515502|100682428|FG004|NOT COMPLETED|Treatment Period 3||0||
48146855|NCT00515502|100682429|FG005|NOT COMPLETED|Treatment Period 3||0||
48146856|NCT00515502|100682430|FG006|NOT COMPLETED|Treatment Period 3||0||
48146857|NCT00515502|100682431|FG007|NOT COMPLETED|Treatment Period 3||0||
48146858|NCT00515502|100682432|FG008|NOT COMPLETED|Treatment Period 3||0||
48146859|NCT00515502|100682433|FG009|NOT COMPLETED|Treatment Period 3||0||
48146860|NCT00515502|100682434|FG010|NOT COMPLETED|Treatment Period 3||0||
48146861|NCT00515502|100682435|FG011|NOT COMPLETED|Treatment Period 3||0||
48714986|NCT03541187|102088672|FG000|COMPLETED|Overall Study||28||
48714987|NCT03541187|102088673|FG001|COMPLETED|Overall Study||29||
48146862|NCT00515502|100682424|FG000|STARTED|Washout Period 3||1||
48146863|NCT00515502|100682425|FG001|STARTED|Washout Period 3||3||
48146864|NCT00515502|100682426|FG002|STARTED|Washout Period 3||4||
48146865|NCT00515502|100682427|FG003|STARTED|Washout Period 3||3||
48714988|NCT03541187|102088672|FG000|NOT COMPLETED|Overall Study||12||
48146866|NCT00515502|100682428|FG004|STARTED|Washout Period 3||3||
48146867|NCT00515502|100682429|FG005|STARTED|Washout Period 3||1||
48146868|NCT00515502|100682430|FG006|STARTED|Washout Period 3||1||
48146869|NCT00515502|100682431|FG007|STARTED|Washout Period 3||1||
48146870|NCT00515502|100682432|FG008|STARTED|Washout Period 3||0||
48146871|NCT00515502|100682433|FG009|STARTED|Washout Period 3||2||
48146872|NCT00515502|100682434|FG010|STARTED|Washout Period 3||1||
48146873|NCT00515502|100682435|FG011|STARTED|Washout Period 3||0||
48146874|NCT00515502|100682424|FG000|COMPLETED|Washout Period 3||1||
48714989|NCT03541187|102088673|FG001|NOT COMPLETED|Overall Study||13||
48714990|NCT00661388|102088674|FG000|STARTED|Overall Study||75||
48714991|NCT00661388|102088674|FG000|COMPLETED|Overall Study||51||
48300459|NCT00455325|101063940|FG003|COMPLETED|Cohort 4: 250mg Chloroquine Daily||25||
48300460|NCT00455325|101063937|FG000|NOT COMPLETED|Cohort 4: 250mg Chloroquine Daily||0||
48300461|NCT00455325|101063938|FG001|NOT COMPLETED|Cohort 4: 250mg Chloroquine Daily||0||
48300462|NCT00455325|101063939|FG002|NOT COMPLETED|Cohort 4: 250mg Chloroquine Daily||0||
48300463|NCT00455325|101063940|FG003|NOT COMPLETED|Cohort 4: 250mg Chloroquine Daily||0||
48300464|NCT03673865|101063941|FG000|STARTED|Overall Study||13||
48300465|NCT03673865|101063942|FG001|STARTED|Overall Study||12||
48300466|NCT03673865|101063941|FG000|COMPLETED|Overall Study||13||
48300467|NCT03673865|101063942|FG001|COMPLETED|Overall Study||12||
48300468|NCT03673865|101063941|FG000|NOT COMPLETED|Overall Study||0||
48300469|NCT03673865|101063942|FG001|NOT COMPLETED|Overall Study||0||
48300470|NCT01215422|101063943|FG000|STARTED|Overall Study||14||
48300471|NCT01215422|101063944|FG001|STARTED|Overall Study||249||
48300472|NCT01215422|101063945|FG002|STARTED|Overall Study||196||
48300473|NCT01215422|101063946|FG003|STARTED|Overall Study||201||
48300474|NCT01215422|101063943|FG000|COMPLETED|Overall Study||6||
48300475|NCT01215422|101063944|FG001|COMPLETED|Overall Study||249||
48300476|NCT01215422|101063945|FG002|COMPLETED|Overall Study||193||
48300477|NCT01215422|101063946|FG003|COMPLETED|Overall Study||193||
48300478|NCT01215422|101063943|FG000|NOT COMPLETED|Overall Study||8||
48300479|NCT01215422|101063944|FG001|NOT COMPLETED|Overall Study||0||
48300480|NCT01215422|101063945|FG002|NOT COMPLETED|Overall Study||3||
48300481|NCT01215422|101063946|FG003|NOT COMPLETED|Overall Study||8||
48300482|NCT03359590|101063947|FG000|STARTED|First Intervention||10||
48300483|NCT03359590|101063948|FG001|STARTED|First Intervention||10||
48300484|NCT03359590|101063947|FG000|Exposed|First Intervention||9||
48300485|NCT03359590|101063948|FG001|Exposed|First Intervention||10||
48300486|NCT03359590|101063947|FG000|Discontinued|First Intervention||1||
48300487|NCT03359590|101063948|FG001|Discontinued|First Intervention||2||
48300488|NCT03359590|101063947|FG000|COMPLETED|First Intervention||9||
48300489|NCT03359590|101063948|FG001|COMPLETED|First Intervention||8||
48300490|NCT03359590|101063947|FG000|NOT COMPLETED|First Intervention||1||
48300491|NCT03359590|101063948|FG001|NOT COMPLETED|First Intervention||2||
48300492|NCT03359590|101063947|FG000|STARTED|Second Intervention||9||
48300493|NCT03359590|101063948|FG001|STARTED|Second Intervention||8||
48602133|NCT04575584|101807788|FG004|NOT COMPLETED|Overall Study||0||
48602134|NCT04575584|101807789|FG005|NOT COMPLETED|Overall Study||0||
48602135|NCT00006110|101807790|FG000|STARTED|Overall Study||52||
48602136|NCT00006110|101807791|FG001|STARTED|Overall Study||30||
48602137|NCT00006110|101807790|FG000|COMPLETED|Overall Study||52||
48602138|NCT00006110|101807791|FG001|COMPLETED|Overall Study||30||
48602139|NCT00006110|101807790|FG000|NOT COMPLETED|Overall Study||0||
48602140|NCT00006110|101807791|FG001|NOT COMPLETED|Overall Study||0||
48714992|NCT00661388|102088674|FG000|NOT COMPLETED|Overall Study||24||
48300494|NCT03359590|101063947|FG000|Exposed|Second Intervention||9||
48300495|NCT03359590|101063948|FG001|Exposed|Second Intervention||8||
48300496|NCT03359590|101063947|FG000|Discontinued|Second Intervention||0||
48300497|NCT03359590|101063948|FG001|Discontinued|Second Intervention||0||
48300498|NCT03359590|101063947|FG000|COMPLETED|Second Intervention||9||
48300499|NCT03359590|101063948|FG001|COMPLETED|Second Intervention||8||
48300500|NCT03359590|101063947|FG000|NOT COMPLETED|Second Intervention||0||
48300501|NCT03359590|101063948|FG001|NOT COMPLETED|Second Intervention||0||
48300502|NCT04974515|101063949|FG000|STARTED|Overall Study||19||
48300503|NCT04974515|101063950|FG001|STARTED|Overall Study||21||
48300504|NCT04974515|101063949|FG000|COMPLETED|Overall Study||19||
48300505|NCT04974515|101063950|FG001|COMPLETED|Overall Study||21||
48300506|NCT04974515|101063949|FG000|NOT COMPLETED|Overall Study||0||
48300507|NCT04974515|101063950|FG001|NOT COMPLETED|Overall Study||0||
48300508|NCT01134016|101063951|FG000|STARTED|Overall Study||13||
48300509|NCT01134016|101063951|FG000|COMPLETED|Overall Study||10||
48300510|NCT01134016|101063951|FG000|NOT COMPLETED|Overall Study||3||
48300511|NCT00928746|101063952|FG000|STARTED|Overall Study||142||
48300512|NCT00928746|101063952|FG000|COMPLETED|Overall Study||136||
48300513|NCT00928746|101063952|FG000|NOT COMPLETED|Overall Study||6||
48300514|NCT00281021|101063953|FG000|STARTED|Overall Study||26||
48300515|NCT00281021|101063953|FG000|COMPLETED|Overall Study||24||
48300516|NCT00281021|101063953|FG000|NOT COMPLETED|Overall Study||2||
48300517|NCT01380639|101063954|FG000|STARTED|Overall Study||42||
48602141|NCT01210352|101807792|FG000|STARTED|Overall Study||6||
48300518|NCT01380639|101063955|FG001|STARTED|Overall Study||40||
48300519|NCT01380639|101063954|FG000|COMPLETED|Overall Study||36||
48300520|NCT01380639|101063955|FG001|COMPLETED|Overall Study||36||
48300521|NCT01380639|101063954|FG000|NOT COMPLETED|Overall Study||6||
48300522|NCT01380639|101063955|FG001|NOT COMPLETED|Overall Study||4||
48300523|NCT02301936|101063956|FG000|STARTED|Overall Study||9||
48300524|NCT02301936|101063957|FG001|STARTED|Overall Study||1||
48300525|NCT02301936|101063956|FG000|COMPLETED|Overall Study||8||
48300526|NCT02301936|101063957|FG001|COMPLETED|Overall Study||1||
48300527|NCT02301936|101063956|FG000|NOT COMPLETED|Overall Study||1||
48300528|NCT02301936|101063957|FG001|NOT COMPLETED|Overall Study||0||
48300529|NCT02024165|101063958|FG000|STARTED|Overall Study||71||
48300530|NCT02024165|101063958|FG000|COMPLETED|Overall Study||71||
48300531|NCT02024165|101063958|FG000|NOT COMPLETED|Overall Study||0||
48300532|NCT01050205|101063959|FG000|STARTED|Overall Study||148||
48300533|NCT01050205|101063960|FG001|STARTED|Overall Study||75||
48300534|NCT01050205|101063959|FG000|COMPLETED|Overall Study||137||
48300535|NCT01050205|101063960|FG001|COMPLETED|Overall Study||71||
48300536|NCT01050205|101063959|FG000|NOT COMPLETED|Overall Study||11||
48300537|NCT01050205|101063960|FG001|NOT COMPLETED|Overall Study||4||
48300538|NCT02335125|101063961|FG000|STARTED|Overall Study||20||
48300539|NCT02335125|101063962|FG001|STARTED|Overall Study||20||
48300540|NCT02335125|101063961|FG000|COMPLETED|Overall Study||20||
48300541|NCT02335125|101063962|FG001|COMPLETED|Overall Study||20||
48300542|NCT02335125|101063961|FG000|NOT COMPLETED|Overall Study||0||
48300543|NCT02335125|101063962|FG001|NOT COMPLETED|Overall Study||0||
48300544|NCT02349451|101063963|FG000|STARTED|Overall Study||24||
48300545|NCT02349451|101063964|FG001|STARTED|Overall Study||72||
48300546|NCT02349451|101063965|FG002|STARTED|Overall Study||71||
48300547|NCT02349451|101063966|FG003|STARTED|Overall Study||73||
48300548|NCT02349451|101063963|FG000|COMPLETED|Overall Study||24||
48300549|NCT02349451|101063964|FG001|COMPLETED|Overall Study||71||
48300550|NCT02349451|101063965|FG002|COMPLETED|Overall Study||69||
48300551|NCT02349451|101063966|FG003|COMPLETED|Overall Study||72||
48300552|NCT02349451|101063963|FG000|NOT COMPLETED|Overall Study||0||
48300553|NCT02349451|101063964|FG001|NOT COMPLETED|Overall Study||1||
48602142|NCT01210352|101807793|FG001|STARTED|Overall Study||6||
48602143|NCT01210352|101807794|FG002|STARTED|Overall Study||7||
48602144|NCT01210352|101807795|FG003|STARTED|Overall Study||7||
48602145|NCT01210352|101807796|FG004|STARTED|Overall Study||6||
48602146|NCT01210352|101807797|FG005|STARTED|Overall Study||6||
48602147|NCT01210352|101807798|FG006|STARTED|Overall Study||7||
48602148|NCT01210352|101807799|FG007|STARTED|Overall Study||10||
48602149|NCT01210352|101807800|FG008|STARTED|Overall Study||6||
48602150|NCT01210352|101807792|FG000|COMPLETED|Overall Study||6||
48602151|NCT01210352|101807793|FG001|COMPLETED|Overall Study||6||
48300554|NCT02349451|101063965|FG002|NOT COMPLETED|Overall Study||2||
48300555|NCT02349451|101063966|FG003|NOT COMPLETED|Overall Study||1||
48300556|NCT00047320|101063967|FG000|STARTED|Overall Study||104||
48300557|NCT00047320|101063967|FG000|COMPLETED|Overall Study||76||
48300558|NCT00047320|101063967|FG000|NOT COMPLETED|Overall Study||28||
48300559|NCT01128738|101063968|FG000|STARTED|First Treatment Phase (TP)||78||
48300560|NCT01128738|101063969|FG001|STARTED|First Treatment Phase (TP)||74||
48300561|NCT01128738|101063968|FG000|COMPLETED|First Treatment Phase (TP)||74||
48300562|NCT01128738|101063969|FG001|COMPLETED|First Treatment Phase (TP)||73||
48300563|NCT01128738|101063968|FG000|NOT COMPLETED|First Treatment Phase (TP)||4||
48300564|NCT01128738|101063969|FG001|NOT COMPLETED|First Treatment Phase (TP)||1||
48300565|NCT01128738|101063968|FG000|STARTED|Second TP||34||
48300566|NCT01128738|101063969|FG001|STARTED|Second TP||66||
48300567|NCT01128738|101063968|FG000|COMPLETED|Second TP||34||
48300568|NCT01128738|101063969|FG001|COMPLETED|Second TP||63||
48300569|NCT01128738|101063968|FG000|NOT COMPLETED|Second TP||0||
48300570|NCT01128738|101063969|FG001|NOT COMPLETED|Second TP||3||
48300571|NCT00559585|101063970|FG000|STARTED|Double Blind ST Period Main Study||736||
48300572|NCT00559585|101063971|FG001|STARTED|Double Blind ST Period Main Study||721||
48300573|NCT00559585|101063970|FG000|COMPLETED|Double Blind ST Period Main Study||693||
48300574|NCT00559585|101063971|FG001|COMPLETED|Double Blind ST Period Main Study||676||
48300575|NCT00559585|101063970|FG000|NOT COMPLETED|Double Blind ST Period Main Study||43||
48300576|NCT00559585|101063971|FG001|NOT COMPLETED|Double Blind ST Period Main Study||45||
48300577|NCT00559585|101063970|FG000|STARTED|Anti-TNF Sub-Study in ST Period||8||
48300578|NCT00559585|101063971|FG001|STARTED|Anti-TNF Sub-Study in ST Period||10||
48300579|NCT00559585|101063970|FG000|COMPLETED|Anti-TNF Sub-Study in ST Period||7||
48300580|NCT00559585|101063971|FG001|COMPLETED|Anti-TNF Sub-Study in ST Period||9||
48300581|NCT00559585|101063970|FG000|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1||
48300582|NCT00559585|101063971|FG001|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1||
48300583|NCT00559585|101063970|FG000|STARTED|Open Label LT Period Main + Sub-Study||1373||
48300584|NCT00559585|101063971|FG001|STARTED|Open Label LT Period Main + Sub-Study||0||
48300585|NCT00559585|101063970|FG000|COMPLETED|Open Label LT Period Main + Sub-Study||945||
48300586|NCT00559585|101063971|FG001|COMPLETED|Open Label LT Period Main + Sub-Study||0||
48405274|NCT04728815|101325241|FG002|STARTED|Overall Study||10||
48602152|NCT01210352|101807794|FG002|COMPLETED|Overall Study||5||
48602153|NCT01210352|101807795|FG003|COMPLETED|Overall Study||7||
48602154|NCT01210352|101807796|FG004|COMPLETED|Overall Study||6||
48602155|NCT01210352|101807797|FG005|COMPLETED|Overall Study||6||
48602156|NCT01210352|101807798|FG006|COMPLETED|Overall Study||5||
48602157|NCT01210352|101807799|FG007|COMPLETED|Overall Study||7||
48602158|NCT01210352|101807800|FG008|COMPLETED|Overall Study||2||
48602159|NCT01210352|101807792|FG000|NOT COMPLETED|Overall Study||0||
48602160|NCT01210352|101807793|FG001|NOT COMPLETED|Overall Study||0||
48602161|NCT01210352|101807794|FG002|NOT COMPLETED|Overall Study||2||
48300587|NCT00559585|101063970|FG000|NOT COMPLETED|Open Label LT Period Main + Sub-Study||428||
48300588|NCT00559585|101063971|FG001|NOT COMPLETED|Open Label LT Period Main + Sub-Study||0||
48405275|NCT04728815|101325242|FG003|STARTED|Overall Study||4||
48602162|NCT01210352|101807795|FG003|NOT COMPLETED|Overall Study||0||
48602163|NCT01210352|101807796|FG004|NOT COMPLETED|Overall Study||0||
48602164|NCT01210352|101807797|FG005|NOT COMPLETED|Overall Study||0||
48146875|NCT00515502|100682425|FG001|COMPLETED|Washout Period 3||3||
48146876|NCT00515502|100682426|FG002|COMPLETED|Washout Period 3||4||
48146877|NCT00515502|100682427|FG003|COMPLETED|Washout Period 3||3||
48146878|NCT00515502|100682428|FG004|COMPLETED|Washout Period 3||3||
48146879|NCT00515502|100682429|FG005|COMPLETED|Washout Period 3||1||
48146880|NCT00515502|100682430|FG006|COMPLETED|Washout Period 3||1||
48146881|NCT00515502|100682431|FG007|COMPLETED|Washout Period 3||1||
48146882|NCT00515502|100682432|FG008|COMPLETED|Washout Period 3||0||
48146883|NCT00515502|100682433|FG009|COMPLETED|Washout Period 3||2||
48146884|NCT00515502|100682434|FG010|COMPLETED|Washout Period 3||1||
48146885|NCT00515502|100682435|FG011|COMPLETED|Washout Period 3||0||
48146886|NCT00515502|100682424|FG000|NOT COMPLETED|Washout Period 3||0||
48146887|NCT00515502|100682425|FG001|NOT COMPLETED|Washout Period 3||0||
48146888|NCT00515502|100682426|FG002|NOT COMPLETED|Washout Period 3||0||
48146889|NCT00515502|100682427|FG003|NOT COMPLETED|Washout Period 3||0||
48146890|NCT00515502|100682428|FG004|NOT COMPLETED|Washout Period 3||0||
48146891|NCT00515502|100682429|FG005|NOT COMPLETED|Washout Period 3||0||
48146892|NCT00515502|100682430|FG006|NOT COMPLETED|Washout Period 3||0||
48146893|NCT00515502|100682431|FG007|NOT COMPLETED|Washout Period 3||0||
48146894|NCT00515502|100682432|FG008|NOT COMPLETED|Washout Period 3||0||
48146895|NCT00515502|100682433|FG009|NOT COMPLETED|Washout Period 3||0||
48146896|NCT00515502|100682434|FG010|NOT COMPLETED|Washout Period 3||0||
48146897|NCT00515502|100682435|FG011|NOT COMPLETED|Washout Period 3||0||
48146898|NCT00515502|100682424|FG000|STARTED|Treatment Period 4||1||
48146899|NCT00515502|100682425|FG001|STARTED|Treatment Period 4||3||
48146900|NCT00515502|100682426|FG002|STARTED|Treatment Period 4||4||
48146901|NCT00515502|100682427|FG003|STARTED|Treatment Period 4||3||
48146902|NCT00515502|100682428|FG004|STARTED|Treatment Period 4||3||
48146903|NCT00515502|100682429|FG005|STARTED|Treatment Period 4||1||
48146904|NCT00515502|100682430|FG006|STARTED|Treatment Period 4||1||
48602165|NCT01210352|101807798|FG006|NOT COMPLETED|Overall Study||2||
48602166|NCT01210352|101807799|FG007|NOT COMPLETED|Overall Study||3||
48602167|NCT01210352|101807800|FG008|NOT COMPLETED|Overall Study||4||
48714993|NCT04258995|102088675|FG000|STARTED|Overall Study||76||
48714994|NCT04258995|102088676|FG001|STARTED|Overall Study||75||
48714995|NCT04258995|102088675|FG000|Vaccinated|Overall Study||76||
48714996|NCT04258995|102088676|FG001|Vaccinated|Overall Study||75||
48714997|NCT04258995|102088675|FG000|COMPLETED|Overall Study||75||
48714998|NCT04258995|102088676|FG001|COMPLETED|Overall Study||74||
48714999|NCT04258995|102088675|FG000|NOT COMPLETED|Overall Study||1||
48715000|NCT04258995|102088676|FG001|NOT COMPLETED|Overall Study||1||
48715001|NCT01049802|102088677|FG000|STARTED|Overall Study||20||
48715002|NCT01049802|102088678|FG001|STARTED|Overall Study||10||
48715003|NCT01049802|102088677|FG000|COMPLETED|Overall Study||20||
48715004|NCT01049802|102088678|FG001|COMPLETED|Overall Study||10||
48715005|NCT01049802|102088677|FG000|NOT COMPLETED|Overall Study||0||
48715006|NCT01049802|102088678|FG001|NOT COMPLETED|Overall Study||0||
48715007|NCT01842594|102088679|FG000|STARTED|Overall Study||13||
48715008|NCT01842594|102088679|FG000|COMPLETED|Overall Study||10||
48715009|NCT01842594|102088679|FG000|NOT COMPLETED|Overall Study||3||
48715010|NCT00746733|102088680|FG000|STARTED|First Intervention||12||
48715011|NCT00746733|102088681|FG001|STARTED|First Intervention||12||
48715012|NCT00746733|102088680|FG000|COMPLETED|First Intervention||12||
48715013|NCT00746733|102088681|FG001|COMPLETED|First Intervention||12||
48715014|NCT00746733|102088680|FG000|NOT COMPLETED|First Intervention||0||
48715015|NCT00746733|102088681|FG001|NOT COMPLETED|First Intervention||0||
48715016|NCT00746733|102088680|FG000|STARTED|Second Intervention||12||
48715017|NCT00746733|102088681|FG001|STARTED|Second Intervention||12||
48715018|NCT00746733|102088680|FG000|COMPLETED|Second Intervention||11||
48715019|NCT00746733|102088681|FG001|COMPLETED|Second Intervention||12||
48715020|NCT00746733|102088680|FG000|NOT COMPLETED|Second Intervention||1||
48715021|NCT00746733|102088681|FG001|NOT COMPLETED|Second Intervention||0||
48146905|NCT00515502|100682431|FG007|STARTED|Treatment Period 4||1||
48146906|NCT00515502|100682432|FG008|STARTED|Treatment Period 4||0||
48602168|NCT00590538|101807801|FG000|STARTED|Overall Study||9||
48602169|NCT00590538|101807801|FG000|COMPLETED|Overall Study||7||
48602170|NCT00590538|101807801|FG000|NOT COMPLETED|Overall Study||2||
48602171|NCT02483572|101807802|FG000|STARTED|Overall Study||2||
48602172|NCT02483572|101807803|FG001|STARTED|Overall Study||2||
48602173|NCT02483572|101807802|FG000|COMPLETED|Overall Study||0||
48602174|NCT02483572|101807803|FG001|COMPLETED|Overall Study||1||
48715022|NCT00746733|102088680|FG000|STARTED|Third Intervention||11||
48715023|NCT00746733|102088681|FG001|STARTED|Third Intervention||12||
48715024|NCT00746733|102088680|FG000|COMPLETED|Third Intervention||10||
48715025|NCT00746733|102088681|FG001|COMPLETED|Third Intervention||11||
48715026|NCT00746733|102088680|FG000|NOT COMPLETED|Third Intervention||1||
48715027|NCT00746733|102088681|FG001|NOT COMPLETED|Third Intervention||1||
48146907|NCT00515502|100682433|FG009|STARTED|Treatment Period 4||2||
48146908|NCT00515502|100682434|FG010|STARTED|Treatment Period 4||1||
48602175|NCT02483572|101807802|FG000|NOT COMPLETED|Overall Study||2||
48146909|NCT00515502|100682435|FG011|STARTED|Treatment Period 4||0||
48146910|NCT00515502|100682424|FG000|COMPLETED|Treatment Period 4||1||
48715028|NCT00746733|102088680|FG000|STARTED|Fourth Intervention||10||
48300589|NCT01083628|101063972|FG000|STARTED|Overall Study||45||
48300590|NCT01083628|101063973|FG001|STARTED|Overall Study||40||
48300591|NCT01083628|101063972|FG000|COMPLETED|Overall Study||45||
48300592|NCT01083628|101063973|FG001|COMPLETED|Overall Study||40||
48300593|NCT01083628|101063972|FG000|NOT COMPLETED|Overall Study||0||
48300594|NCT01083628|101063973|FG001|NOT COMPLETED|Overall Study||0||
48300595|NCT01119001|101063974|FG000|STARTED|Overall Study||13||
48300596|NCT01119001|101063974|FG000|COMPLETED|Overall Study||11||
48300597|NCT01119001|101063974|FG000|NOT COMPLETED|Overall Study||2||
48300598|NCT05640466|101063975|FG000|STARTED|Overall Study||20||
48300599|NCT05640466|101063975|FG000|COMPLETED|Overall Study||20||
48300600|NCT05640466|101063975|FG000|NOT COMPLETED|Overall Study||0||
48300601|NCT01473160|101063976|FG000|STARTED|Overall Study||9||
48300602|NCT01473160|101063976|FG000|COMPLETED|Overall Study||9||
48300603|NCT01473160|101063976|FG000|NOT COMPLETED|Overall Study||0||
48300604|NCT01106027|101063977|FG000|STARTED|Overall Study||2||
48300605|NCT01106027|101063977|FG000|COMPLETED|Overall Study||1||
48300606|NCT01106027|101063977|FG000|NOT COMPLETED|Overall Study||1||
48300607|NCT01717989|101063978|FG000|STARTED|Overall Study||2248||
48300608|NCT01717989|101063978|FG000|COMPLETED|Overall Study||1182||
48300609|NCT01717989|101063978|FG000|NOT COMPLETED|Overall Study||1066||
48300610|NCT04142450|101063979|FG000|STARTED|Overall Study||50||
48300611|NCT04142450|101063979|FG000|Safety Population|Overall Study||49|Safety Population included all treated participants.|
48300612|NCT04142450|101063979|FG000|COMPLETED|Overall Study||48||
48300613|NCT04142450|101063979|FG000|NOT COMPLETED|Overall Study||2||
48300614|NCT00628251|101063980|FG000|STARTED|Randomised Part||32||
48300615|NCT00628251|101063981|FG001|STARTED|Randomised Part||32||
48715029|NCT00746733|102088681|FG001|STARTED|Fourth Intervention||11||
48715030|NCT00746733|102088680|FG000|COMPLETED|Fourth Intervention||10||
48715031|NCT00746733|102088681|FG001|COMPLETED|Fourth Intervention||11||
48715032|NCT00746733|102088680|FG000|NOT COMPLETED|Fourth Intervention||0||
48715033|NCT00746733|102088681|FG001|NOT COMPLETED|Fourth Intervention||0||
48300616|NCT00628251|101063982|FG002|STARTED|Randomised Part||33||
48300617|NCT00628251|101063980|FG000|COMPLETED|Randomised Part||32||
48300618|NCT00628251|101063981|FG001|COMPLETED|Randomised Part||32||
48300619|NCT00628251|101063982|FG002|COMPLETED|Randomised Part||32||
48300620|NCT00628251|101063980|FG000|NOT COMPLETED|Randomised Part||0||
48300621|NCT00628251|101063981|FG001|NOT COMPLETED|Randomised Part||0||
48300622|NCT00628251|101063982|FG002|NOT COMPLETED|Randomised Part||1||
48300623|NCT00628251|101063980|FG000|STARTED|Ongoing Initial Study Treatment at DCO||32||
48300624|NCT00628251|101063981|FG001|STARTED|Ongoing Initial Study Treatment at DCO||32||
48300625|NCT00628251|101063982|FG002|STARTED|Ongoing Initial Study Treatment at DCO||32||
48300626|NCT00628251|101063980|FG000|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||22||
48300627|NCT00628251|101063981|FG001|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||20||
48300628|NCT00628251|101063982|FG002|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||25||
48300629|NCT00628251|101063980|FG000|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO||0||
48300630|NCT00628251|101063981|FG001|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO||0||
48300631|NCT00628251|101063982|FG002|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO||14||
48300632|NCT00628251|101063980|FG000|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||0||
48300633|NCT00628251|101063981|FG001|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||0||
48300634|NCT00628251|101063982|FG002|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||5||
48300635|NCT00628251|101063980|FG000|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||0||
48300636|NCT00628251|101063981|FG001|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||0||
48300637|NCT00628251|101063982|FG002|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||9||
48300638|NCT00628251|101063980|FG000|COMPLETED|Ongoing Initial Study Treatment at DCO||10||
48300639|NCT00628251|101063981|FG001|COMPLETED|Ongoing Initial Study Treatment at DCO||12||
48300640|NCT00628251|101063982|FG002|COMPLETED|Ongoing Initial Study Treatment at DCO||7||
48300641|NCT00628251|101063980|FG000|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||22||
48300642|NCT00628251|101063981|FG001|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||20||
48300643|NCT00628251|101063982|FG002|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||25||
48300644|NCT05745675|101063983|FG000|STARTED|Overall Study||11||
48300645|NCT05745675|101063983|FG000|COMPLETED|Overall Study||11||
48300646|NCT05745675|101063983|FG000|NOT COMPLETED|Overall Study||0||
48300647|NCT00874770|101063984|FG000|STARTED|Overall Study||12||
48300648|NCT00874770|101063985|FG001|STARTED|Overall Study||12||
48300649|NCT00874770|101063986|FG002|STARTED|Overall Study||12||
48300650|NCT00874770|101063987|FG003|STARTED|Overall Study||12||
48300651|NCT00874770|101063984|FG000|COMPLETED|Overall Study||7||
48300652|NCT00874770|101063985|FG001|COMPLETED|Overall Study||11||
48300653|NCT00874770|101063986|FG002|COMPLETED|Overall Study||8||
48300654|NCT00874770|101063987|FG003|COMPLETED|Overall Study||7||
48300655|NCT00874770|101063984|FG000|NOT COMPLETED|Overall Study||5||
48300656|NCT00874770|101063985|FG001|NOT COMPLETED|Overall Study||1||
48300657|NCT00874770|101063986|FG002|NOT COMPLETED|Overall Study||4||
48300658|NCT00874770|101063987|FG003|NOT COMPLETED|Overall Study||5||
48300659|NCT00257686|101063988|FG000|STARTED|Overall Study||209||
48300660|NCT00257686|101063989|FG001|STARTED|Overall Study||108||
48300661|NCT00257686|101063990|FG002|STARTED|Overall Study||226||
48300662|NCT00257686|101063991|FG003|STARTED|Overall Study||99||
48300663|NCT00257686|101063992|FG004|STARTED|Overall Study||216||
48300664|NCT00257686|101063993|FG005|STARTED|Overall Study||104||
48300665|NCT00257686|101063988|FG000|Safety Population|Overall Study||207||
48300666|NCT00257686|101063989|FG001|Safety Population|Overall Study||103||
48300667|NCT00257686|101063990|FG002|Safety Population|Overall Study||224||
48300668|NCT00257686|101063991|FG003|Safety Population|Overall Study||96||
48300669|NCT00257686|101063992|FG004|Safety Population|Overall Study||210||
48300670|NCT00257686|101063993|FG005|Safety Population|Overall Study||102||
48300671|NCT00257686|101063988|FG000|COMPLETED|Overall Study||188||
48300672|NCT00257686|101063989|FG001|COMPLETED|Overall Study||89||
48602176|NCT02483572|101807803|FG001|NOT COMPLETED|Overall Study||1||
48602177|NCT04908475|101811511|FG000|STARTED|Period A (Baseline to Week 16)||234||
48602178|NCT04908475|101811512|FG001|STARTED|Period A (Baseline to Week 16)||118||
48602179|NCT04908475|101811513|FG002|STARTED|Period A (Baseline to Week 16)||0||
48602180|NCT04908475|101811514|FG003|STARTED|Period A (Baseline to Week 16)||0||
48602181|NCT04908475|101811515|FG004|STARTED|Period A (Baseline to Week 16)||0||
48300673|NCT00257686|101063990|FG002|COMPLETED|Overall Study||208||
48300674|NCT00257686|101063991|FG003|COMPLETED|Overall Study||88||
48300675|NCT00257686|101063992|FG004|COMPLETED|Overall Study||194||
48300676|NCT00257686|101063993|FG005|COMPLETED|Overall Study||95||
48300677|NCT00257686|101063988|FG000|NOT COMPLETED|Overall Study||21||
48300678|NCT00257686|101063989|FG001|NOT COMPLETED|Overall Study||19||
48300679|NCT00257686|101063990|FG002|NOT COMPLETED|Overall Study||18||
48300680|NCT00257686|101063991|FG003|NOT COMPLETED|Overall Study||11||
48300681|NCT00257686|101063992|FG004|NOT COMPLETED|Overall Study||22||
48300682|NCT00257686|101063993|FG005|NOT COMPLETED|Overall Study||9||
48300683|NCT02952001|101063994|FG000|STARTED|Overall Study||28||
48300684|NCT02952001|101063995|FG001|STARTED|Overall Study||5||
48300685|NCT02952001|101063994|FG000|COMPLETED|Overall Study||14||
48300686|NCT02952001|101063995|FG001|COMPLETED|Overall Study||2||
48300687|NCT02952001|101063994|FG000|NOT COMPLETED|Overall Study||14||
48300688|NCT02952001|101063995|FG001|NOT COMPLETED|Overall Study||3||
48300689|NCT00909792|101063996|FG000|STARTED|Period 1||130||
48300690|NCT00909792|101063997|FG001|STARTED|Period 1||128||
48300691|NCT00909792|101063996|FG000|COMPLETED|Period 1||130||
48300692|NCT00909792|101063997|FG001|COMPLETED|Period 1||127||
48300693|NCT00909792|101063996|FG000|NOT COMPLETED|Period 1||0||
48300694|NCT00909792|101063997|FG001|NOT COMPLETED|Period 1||1||
48146911|NCT00515502|100682425|FG001|COMPLETED|Treatment Period 4||3||
48146912|NCT00515502|100682426|FG002|COMPLETED|Treatment Period 4||4||
48146913|NCT00515502|100682427|FG003|COMPLETED|Treatment Period 4||3||
48146914|NCT00515502|100682428|FG004|COMPLETED|Treatment Period 4||3||
48146915|NCT00515502|100682429|FG005|COMPLETED|Treatment Period 4||1||
48146916|NCT00515502|100682430|FG006|COMPLETED|Treatment Period 4||1||
48146917|NCT00515502|100682431|FG007|COMPLETED|Treatment Period 4||1||
48146918|NCT00515502|100682432|FG008|COMPLETED|Treatment Period 4||0||
48146919|NCT00515502|100682433|FG009|COMPLETED|Treatment Period 4||2||
48146920|NCT00515502|100682434|FG010|COMPLETED|Treatment Period 4||1||
48146921|NCT00515502|100682435|FG011|COMPLETED|Treatment Period 4||0||
48146922|NCT00515502|100682424|FG000|NOT COMPLETED|Treatment Period 4||0||
48146923|NCT00515502|100682425|FG001|NOT COMPLETED|Treatment Period 4||0||
48300695|NCT00909792|101063996|FG000|STARTED|Period 2||129||
48300696|NCT00909792|101063997|FG001|STARTED|Period 2||125||
48300697|NCT00909792|101063996|FG000|COMPLETED|Period 2||128||
48300698|NCT00909792|101063997|FG001|COMPLETED|Period 2||124||
48300699|NCT00909792|101063996|FG000|NOT COMPLETED|Period 2||1||
48602182|NCT04908475|101811516|FG005|STARTED|Period A (Baseline to Week 16)||0||
48602183|NCT04908475|101811511|FG000|COMPLETED|Period A (Baseline to Week 16)||216||
48300700|NCT00909792|101063997|FG001|NOT COMPLETED|Period 2||1||
48300701|NCT00898443|101063998|FG000|STARTED|Overall Study||10||
48300702|NCT00898443|101063999|FG001|STARTED|Overall Study||8||
48300703|NCT00898443|101063998|FG000|COMPLETED|Overall Study||9||
48300704|NCT00898443|101063999|FG001|COMPLETED|Overall Study||8||
48300705|NCT00898443|101063998|FG000|NOT COMPLETED|Overall Study||1||
48300706|NCT00898443|101063999|FG001|NOT COMPLETED|Overall Study||0||
48300707|NCT01055262|101064000|FG000|STARTED|Overall Study||169||
48715034|NCT04135859|102088682|FG000|STARTED|Overall Study||19||
48715035|NCT04135859|102088683|FG001|STARTED|Overall Study||17||
48146924|NCT00515502|100682426|FG002|NOT COMPLETED|Treatment Period 4||0||
48146925|NCT00515502|100682427|FG003|NOT COMPLETED|Treatment Period 4||0||
48146926|NCT00515502|100682428|FG004|NOT COMPLETED|Treatment Period 4||0||
48146927|NCT00515502|100682429|FG005|NOT COMPLETED|Treatment Period 4||0||
48146928|NCT00515502|100682430|FG006|NOT COMPLETED|Treatment Period 4||0||
48146929|NCT00515502|100682431|FG007|NOT COMPLETED|Treatment Period 4||0||
48146930|NCT00515502|100682432|FG008|NOT COMPLETED|Treatment Period 4||0||
48146931|NCT00515502|100682433|FG009|NOT COMPLETED|Treatment Period 4||0||
48300708|NCT01055262|101064000|FG000|COMPLETED|Overall Study||160||
48300709|NCT01055262|101064000|FG000|NOT COMPLETED|Overall Study||9||
48300710|NCT00826111|101064001|FG000|STARTED|Overall Study||14||
48300711|NCT00826111|101064002|FG001|STARTED|Overall Study||5||
48300712|NCT00826111|101064001|FG000|COMPLETED|Overall Study||7||
48300713|NCT00826111|101064002|FG001|COMPLETED|Overall Study||3||
48300714|NCT00826111|101064001|FG000|NOT COMPLETED|Overall Study||7||
48300715|NCT00826111|101064002|FG001|NOT COMPLETED|Overall Study||2||
48300716|NCT03510988|101064003|FG000|STARTED|Overall Study||14||
48300717|NCT03510988|101064003|FG000|COMPLETED|Overall Study||14||
48300718|NCT03510988|101064003|FG000|NOT COMPLETED|Overall Study||0||
48300719|NCT01774851|101064004|FG000|STARTED|Overall Study||42||
48300720|NCT01774851|101064005|FG001|STARTED|Overall Study||42||
48300721|NCT01774851|101064004|FG000|COMPLETED|Overall Study||42||
48300722|NCT01774851|101064005|FG001|COMPLETED|Overall Study||42||
48300723|NCT01774851|101064004|FG000|NOT COMPLETED|Overall Study||0||
48300724|NCT01774851|101064005|FG001|NOT COMPLETED|Overall Study||0||
48300725|NCT01765179|101064006|FG000|STARTED|Overall Study||144||
48300726|NCT01765179|101064006|FG000|COMPLETED|Overall Study||117||
48300727|NCT01765179|101064006|FG000|NOT COMPLETED|Overall Study||27||
48300728|NCT00550368|101064007|FG000|STARTED|Overall Study||26||
48300729|NCT00550368|101064008|FG001|STARTED|Overall Study||19||
48300730|NCT00550368|101064007|FG000|COMPLETED|Overall Study||26||
48300731|NCT00550368|101064008|FG001|COMPLETED|Overall Study||19||
48300732|NCT00550368|101064007|FG000|NOT COMPLETED|Overall Study||0||
48602184|NCT04908475|101811512|FG001|COMPLETED|Period A (Baseline to Week 16)||118||
48602185|NCT04908475|101811513|FG002|COMPLETED|Period A (Baseline to Week 16)||0||
48602186|NCT04908475|101811514|FG003|COMPLETED|Period A (Baseline to Week 16)||0||
48602187|NCT04908475|101811515|FG004|COMPLETED|Period A (Baseline to Week 16)||0||
48602188|NCT04908475|101811516|FG005|COMPLETED|Period A (Baseline to Week 16)||0||
48602189|NCT04908475|101811511|FG000|NOT COMPLETED|Period A (Baseline to Week 16)||18||
48602190|NCT04908475|101811512|FG001|NOT COMPLETED|Period A (Baseline to Week 16)||0||
48602191|NCT04908475|101811513|FG002|NOT COMPLETED|Period A (Baseline to Week 16)||0||
48602192|NCT04908475|101811514|FG003|NOT COMPLETED|Period A (Baseline to Week 16)||0||
48602193|NCT04908475|101811515|FG004|NOT COMPLETED|Period A (Baseline to Week 16)||0||
48602194|NCT04908475|101811516|FG005|NOT COMPLETED|Period A (Baseline to Week 16)||0||
48602195|NCT04908475|101811511|FG000|STARTED|Period B (Week 16 to Week 52)||0|Participants re-randomized in Period B|
48602196|NCT04908475|101811512|FG001|STARTED|Period B (Week 16 to Week 52)||118|Participants re-randomized in Period B|
48602197|NCT04908475|101811513|FG002|STARTED|Period B (Week 16 to Week 52)||78|Participants re-randomized in Period B|
48715036|NCT04135859|102088682|FG000|COMPLETED|Overall Study||14||
48715037|NCT04135859|102088683|FG001|COMPLETED|Overall Study||10||
48715038|NCT04135859|102088682|FG000|NOT COMPLETED|Overall Study||5||
48715039|NCT04135859|102088683|FG001|NOT COMPLETED|Overall Study||7||
48715040|NCT01643876|102088684|FG000|STARTED|Overall Study||48||
48715041|NCT01643876|102088684|FG000|COMPLETED|Overall Study||48||
48715042|NCT01643876|102088684|FG000|NOT COMPLETED|Overall Study||0||
48715043|NCT04676867|102088685|FG000|STARTED|Overall Study||56||
48715044|NCT04676867|102088686|FG001|STARTED|Overall Study||56||
48715045|NCT04676867|102088687|FG002|STARTED|Overall Study||56||
48715046|NCT04676867|102088688|FG003|STARTED|Overall Study||57||
48715047|NCT04676867|102088685|FG000|Entered Study and Received at Least 1 Dose of Study Medication|Overall Study||53||
48715048|NCT04676867|102088686|FG001|Entered Study and Received at Least 1 Dose of Study Medication|Overall Study||55||
48715049|NCT04676867|102088687|FG002|Entered Study and Received at Least 1 Dose of Study Medication|Overall Study||48||
48715050|NCT04676867|102088688|FG003|Entered Study and Received at Least 1 Dose of Study Medication|Overall Study||52||
48715051|NCT04676867|102088685|FG000|COMPLETED|Overall Study||53||
48715052|NCT04676867|102088686|FG001|COMPLETED|Overall Study||54||
48715053|NCT04676867|102088687|FG002|COMPLETED|Overall Study||45||
48715054|NCT04676867|102088688|FG003|COMPLETED|Overall Study||51||
48715055|NCT04676867|102088685|FG000|NOT COMPLETED|Overall Study||3||
48715056|NCT04676867|102088686|FG001|NOT COMPLETED|Overall Study||2||
48715057|NCT04676867|102088687|FG002|NOT COMPLETED|Overall Study||11||
48300733|NCT00550368|101064008|FG001|NOT COMPLETED|Overall Study||0||
48300734|NCT01431534|101064009|FG000|STARTED|Treatment Phase||4||
48300735|NCT01431534|101064010|FG001|STARTED|Treatment Phase||3||
48300736|NCT01431534|101064011|FG002|STARTED|Treatment Phase||13||
48300737|NCT01431534|101064009|FG000|COMPLETED|Treatment Phase||0||
48300738|NCT01431534|101064010|FG001|COMPLETED|Treatment Phase||0||
48300739|NCT01431534|101064011|FG002|COMPLETED|Treatment Phase||2||
48300740|NCT01431534|101064009|FG000|NOT COMPLETED|Treatment Phase||4||
48300741|NCT01431534|101064010|FG001|NOT COMPLETED|Treatment Phase||3||
48300742|NCT01431534|101064011|FG002|NOT COMPLETED|Treatment Phase||11||
48300743|NCT01431534|101064009|FG000|STARTED|Extension Phase||0||
48300744|NCT01431534|101064010|FG001|STARTED|Extension Phase||0||
48300745|NCT01431534|101064011|FG002|STARTED|Extension Phase||2||
48300746|NCT01431534|101064009|FG000|COMPLETED|Extension Phase||0||
48300747|NCT01431534|101064010|FG001|COMPLETED|Extension Phase||0||
48300748|NCT01431534|101064011|FG002|COMPLETED|Extension Phase||2||
48300749|NCT01431534|101064009|FG000|NOT COMPLETED|Extension Phase||0||
48300750|NCT01431534|101064010|FG001|NOT COMPLETED|Extension Phase||0||
48300751|NCT01431534|101064011|FG002|NOT COMPLETED|Extension Phase||0||
48300752|NCT00719563|101064012|FG000|STARTED|Overall Study||171||
48300753|NCT00719563|101064013|FG001|STARTED|Overall Study||170||
48300754|NCT00719563|101064012|FG000|COMPLETED|Overall Study||133||
48300755|NCT00719563|101064013|FG001|COMPLETED|Overall Study||128||
48300756|NCT00719563|101064012|FG000|NOT COMPLETED|Overall Study||38||
48146932|NCT00515502|100682434|FG010|NOT COMPLETED|Treatment Period 4||0||
48146933|NCT00515502|100682435|FG011|NOT COMPLETED|Treatment Period 4||0||
48146934|NCT05763628|100682436|FG000|STARTED|Period 1: First Intervention, 2 Weeks||29||
48146935|NCT05763628|100682437|FG001|STARTED|Period 1: First Intervention, 2 Weeks||30||
48146936|NCT05763628|100682436|FG000|COMPLETED|Period 1: First Intervention, 2 Weeks||29||
48146937|NCT05763628|100682437|FG001|COMPLETED|Period 1: First Intervention, 2 Weeks||28||
48146938|NCT05763628|100682436|FG000|NOT COMPLETED|Period 1: First Intervention, 2 Weeks||0||
48146939|NCT05763628|100682437|FG001|NOT COMPLETED|Period 1: First Intervention, 2 Weeks||2||
48300757|NCT00719563|101064013|FG001|NOT COMPLETED|Overall Study||42||
48300758|NCT00490009|101064014|FG000|STARTED|Overall Study||9||
48300759|NCT00490009|101064014|FG000|COMPLETED|Overall Study||9||
48300760|NCT00490009|101064014|FG000|NOT COMPLETED|Overall Study||0||
48300761|NCT02616523|101064015|FG000|STARTED|Overall Study||20||
48405276|NCT04728815|101325243|FG004|STARTED|Overall Study||7||
48602198|NCT04908475|101811514|FG003|STARTED|Period B (Week 16 to Week 52)||83|Participants re-randomized in Period B|
48602199|NCT04908475|101811515|FG004|STARTED|Period B (Week 16 to Week 52)||22|Participants re-randomized in Period B|
48602200|NCT04908475|101811516|FG005|STARTED|Period B (Week 16 to Week 52)||20|Participants re-randomized in Period B|
48602201|NCT04908475|101811511|FG000|Received ≥ 1 Dose of Study Drug|Period B (Week 16 to Week 52)||0||
48602202|NCT04908475|101811512|FG001|Received ≥ 1 Dose of Study Drug|Period B (Week 16 to Week 52)||116||
48602203|NCT04908475|101811513|FG002|Received ≥ 1 Dose of Study Drug|Period B (Week 16 to Week 52)||75||
48602204|NCT04908475|101811514|FG003|Received ≥ 1 Dose of Study Drug|Period B (Week 16 to Week 52)||82||
48602205|NCT04908475|101811515|FG004|Received ≥ 1 Dose of Study Drug|Period B (Week 16 to Week 52)||22||
48602206|NCT04908475|101811516|FG005|Received ≥ 1 Dose of Study Drug|Period B (Week 16 to Week 52)||20||
48602207|NCT04908475|101811511|FG000|Received RZB as Rescue Medication|Period B (Week 16 to Week 52)||0||
48602208|NCT04908475|101811512|FG001|Received RZB as Rescue Medication|Period B (Week 16 to Week 52)||0||
48602209|NCT04908475|101811513|FG002|Received RZB as Rescue Medication|Period B (Week 16 to Week 52)||47||
48602210|NCT04908475|101811514|FG003|Received RZB as Rescue Medication|Period B (Week 16 to Week 52)||0||
48602211|NCT04908475|101811515|FG004|Received RZB as Rescue Medication|Period B (Week 16 to Week 52)||1||
48602212|NCT04908475|101811516|FG005|Received RZB as Rescue Medication|Period B (Week 16 to Week 52)||0||
48602213|NCT04908475|101811511|FG000|COMPLETED|Period B (Week 16 to Week 52)||0||
48602214|NCT04908475|101811512|FG001|COMPLETED|Period B (Week 16 to Week 52)||69||
48602215|NCT04908475|101811513|FG002|COMPLETED|Period B (Week 16 to Week 52)||42||
48602216|NCT04908475|101811514|FG003|COMPLETED|Period B (Week 16 to Week 52)||57||
48602217|NCT04908475|101811515|FG004|COMPLETED|Period B (Week 16 to Week 52)||15||
48602218|NCT04908475|101811516|FG005|COMPLETED|Period B (Week 16 to Week 52)||13||
48602219|NCT04908475|101811511|FG000|NOT COMPLETED|Period B (Week 16 to Week 52)||0||
48602220|NCT04908475|101811512|FG001|NOT COMPLETED|Period B (Week 16 to Week 52)||49||
48602221|NCT04908475|101811513|FG002|NOT COMPLETED|Period B (Week 16 to Week 52)||36||
48602222|NCT04908475|101811514|FG003|NOT COMPLETED|Period B (Week 16 to Week 52)||26||
48602223|NCT04908475|101811515|FG004|NOT COMPLETED|Period B (Week 16 to Week 52)||7||
48602224|NCT04908475|101811516|FG005|NOT COMPLETED|Period B (Week 16 to Week 52)||7||
48602225|NCT04640038|101811517|FG000|STARTED|Overall Study||4||
48602226|NCT04640038|101811517|FG000|COMPLETED|Overall Study||4|4 patients were enrolled.|
48602227|NCT04640038|101811517|FG000|NOT COMPLETED|Overall Study||0||
48602228|NCT01556932|101811518|FG000|STARTED|Baseline First Treatment||13||
48602229|NCT01556932|101811519|FG001|STARTED|Baseline First Treatment||9||
48602230|NCT01556932|101811518|FG000|Recieved|Baseline First Treatment||13||
48602231|NCT01556932|101811519|FG001|Recieved|Baseline First Treatment||9||
48602232|NCT01556932|101811518|FG000|COMPLETED|Baseline First Treatment||13||
48602233|NCT01556932|101811519|FG001|COMPLETED|Baseline First Treatment||9||
48602234|NCT01556932|101811518|FG000|NOT COMPLETED|Baseline First Treatment||0||
48602235|NCT01556932|101811519|FG001|NOT COMPLETED|Baseline First Treatment||0||
48602236|NCT01556932|101811518|FG000|STARTED|Time Point 60 Minutes||13||
48602237|NCT01556932|101811519|FG001|STARTED|Time Point 60 Minutes||9||
48602238|NCT01556932|101811518|FG000|Recieved|Time Point 60 Minutes||12||
48602239|NCT01556932|101811519|FG001|Recieved|Time Point 60 Minutes||8||
48602240|NCT01556932|101811518|FG000|COMPLETED|Time Point 60 Minutes||12||
48602241|NCT01556932|101811519|FG001|COMPLETED|Time Point 60 Minutes||8||
48602242|NCT01556932|101811518|FG000|NOT COMPLETED|Time Point 60 Minutes||1||
48602243|NCT01556932|101811519|FG001|NOT COMPLETED|Time Point 60 Minutes||1||
48602244|NCT01556932|101811518|FG000|STARTED|Second Treament||12||
48602245|NCT01556932|101811519|FG001|STARTED|Second Treament||8||
48146940|NCT05763628|100682436|FG000|STARTED|Period 2: Second Intervention, 2 Weeks||29||
48146941|NCT05763628|100682437|FG001|STARTED|Period 2: Second Intervention, 2 Weeks||28||
48146942|NCT05763628|100682436|FG000|COMPLETED|Period 2: Second Intervention, 2 Weeks||28||
48146943|NCT05763628|100682437|FG001|COMPLETED|Period 2: Second Intervention, 2 Weeks||28||
48146944|NCT05763628|100682436|FG000|NOT COMPLETED|Period 2: Second Intervention, 2 Weeks||1||
48146945|NCT05763628|100682437|FG001|NOT COMPLETED|Period 2: Second Intervention, 2 Weeks||0||
48146946|NCT02251990|100682438|FG000|STARTED|Period 1 (Double-blind [DB])||366||
48146947|NCT02251990|100682439|FG001|STARTED|Period 1 (Double-blind [DB])||123||
48146948|NCT02251990|100682438|FG000|Treated|Period 1 (Double-blind [DB])||365||
48602246|NCT01556932|101811518|FG000|Recieved|Second Treament||12||
48602247|NCT01556932|101811519|FG001|Recieved|Second Treament||8||
48602248|NCT01556932|101811518|FG000|COMPLETED|Second Treament||12||
48602249|NCT01556932|101811519|FG001|COMPLETED|Second Treament||8||
48602250|NCT01556932|101811518|FG000|NOT COMPLETED|Second Treament||0||
48602251|NCT01556932|101811519|FG001|NOT COMPLETED|Second Treament||0||
48602252|NCT01162122|101811520|FG000|STARTED|Overall Study||3552||
48602253|NCT01162122|101811521|FG001|STARTED|Overall Study||3552||
48602254|NCT01162122|101811520|FG000|Vaccinated|Overall Study||3541||
48602255|NCT01162122|101811521|FG001|Vaccinated|Overall Study||3541||
48602256|NCT01162122|101811520|FG000|COMPLETED|Overall Study||3361||
48602257|NCT01162122|101811521|FG001|COMPLETED|Overall Study||3356||
48602258|NCT01162122|101811520|FG000|NOT COMPLETED|Overall Study||191||
48602259|NCT01162122|101811521|FG001|NOT COMPLETED|Overall Study||196||
48602260|NCT00445744|101811522|FG000|STARTED|Overall Study||52||
48602261|NCT00445744|101811522|FG000|COMPLETED|Overall Study||51||
48602262|NCT00445744|101811522|FG000|NOT COMPLETED|Overall Study||1||
48602263|NCT00262002|101811523|FG000|STARTED|Overall Study||90||
48602264|NCT00262002|101811524|FG001|STARTED|Overall Study||90||
48602265|NCT00262002|101811525|FG002|STARTED|Overall Study||45||
48602266|NCT00262002|101811526|FG003|STARTED|Overall Study||98||
48602267|NCT00262002|101811527|FG004|STARTED|Overall Study||98||
48602268|NCT00262002|101811528|FG005|STARTED|Overall Study||90||
48602269|NCT00262002|101811529|FG006|STARTED|Overall Study||90||
48602270|NCT00262002|101811523|FG000|COMPLETED|Overall Study||79||
48602271|NCT00262002|101811524|FG001|COMPLETED|Overall Study||84||
48602272|NCT00262002|101811525|FG002|COMPLETED|Overall Study||45||
48602273|NCT00262002|101811526|FG003|COMPLETED|Overall Study||93||
48602274|NCT00262002|101811527|FG004|COMPLETED|Overall Study||91||
48602275|NCT00262002|101811528|FG005|COMPLETED|Overall Study||83||
48602276|NCT00262002|101811529|FG006|COMPLETED|Overall Study||84||
48602277|NCT00262002|101811523|FG000|NOT COMPLETED|Overall Study||11||
48602278|NCT00262002|101811524|FG001|NOT COMPLETED|Overall Study||6||
48602279|NCT00262002|101811525|FG002|NOT COMPLETED|Overall Study||0||
48602280|NCT00262002|101811526|FG003|NOT COMPLETED|Overall Study||5||
48602281|NCT00262002|101811527|FG004|NOT COMPLETED|Overall Study||7||
48602282|NCT00262002|101811528|FG005|NOT COMPLETED|Overall Study||7||
48602283|NCT00262002|101811529|FG006|NOT COMPLETED|Overall Study||6||
48602284|NCT01056913|101811530|FG000|STARTED|Overall Study||62||
48300762|NCT02616523|101064016|FG001|STARTED|Overall Study||20||
48300763|NCT02616523|101064017|FG002|STARTED|Overall Study||20||
48300764|NCT02616523|101064015|FG000|COMPLETED|Overall Study||19||
48300765|NCT02616523|101064016|FG001|COMPLETED|Overall Study||20||
48300766|NCT02616523|101064017|FG002|COMPLETED|Overall Study||20||
48300767|NCT02616523|101064015|FG000|NOT COMPLETED|Overall Study||1||
48300768|NCT02616523|101064016|FG001|NOT COMPLETED|Overall Study||0||
48300769|NCT02616523|101064017|FG002|NOT COMPLETED|Overall Study||0||
48300770|NCT00986440|101064018|FG000|STARTED|Overall Study||41||
48300771|NCT00986440|101064019|FG001|STARTED|Overall Study||43||
48300772|NCT00986440|101064018|FG000|Randomized, But Not Dosed|Overall Study||0||
48300773|NCT00986440|101064019|FG001|Randomized, But Not Dosed|Overall Study||1||
48300774|NCT00986440|101064018|FG000|COMPLETED|Overall Study||0||
48300775|NCT00986440|101064019|FG001|COMPLETED|Overall Study||0||
48300776|NCT00986440|101064018|FG000|NOT COMPLETED|Overall Study||41||
48300777|NCT00986440|101064019|FG001|NOT COMPLETED|Overall Study||43||
48300778|NCT05395104|101064020|FG000|STARTED|Overall Study||14||
48300779|NCT05395104|101064020|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||14|Safety Analysis Population|
48300780|NCT05395104|101064020|FG000|COMPLETED|Overall Study||12||
48300781|NCT05395104|101064020|FG000|NOT COMPLETED|Overall Study||2||
48300782|NCT00892177|101064021|FG000|STARTED|Phase I: Dose Level 0||3||
48300783|NCT00892177|101064022|FG001|STARTED|Phase I: Dose Level 0||0||
48300784|NCT00892177|101064023|FG002|STARTED|Phase I: Dose Level 0||0||
48300785|NCT00892177|101064024|FG003|STARTED|Phase I: Dose Level 0||0||
48300786|NCT00892177|101064025|FG004|STARTED|Phase I: Dose Level 0||0||
48300787|NCT00892177|101064026|FG005|STARTED|Phase I: Dose Level 0||0||
48300788|NCT00892177|101064021|FG000|COMPLETED|Phase I: Dose Level 0||3||
48300789|NCT00892177|101064022|FG001|COMPLETED|Phase I: Dose Level 0||0||
48602285|NCT01056913|101811530|FG000|COMPLETED|Overall Study||62||
48602286|NCT01056913|101811530|FG000|NOT COMPLETED|Overall Study||0||
48300790|NCT00892177|101064023|FG002|COMPLETED|Phase I: Dose Level 0||0||
48300791|NCT00892177|101064024|FG003|COMPLETED|Phase I: Dose Level 0||0||
48602287|NCT01941537|101811531|FG000|STARTED|Overall Study||40||
48602288|NCT01941537|101811532|FG001|STARTED|Overall Study||20||
48602289|NCT01941537|101811531|FG000|COMPLETED|Overall Study||36||
48602290|NCT01941537|101811532|FG001|COMPLETED|Overall Study||17||
48602291|NCT01941537|101811531|FG000|NOT COMPLETED|Overall Study||4||
48602292|NCT01941537|101811532|FG001|NOT COMPLETED|Overall Study||3||
48602293|NCT00808470|101811533|FG000|STARTED|Overall Study||37||
48602294|NCT00808470|101811534|FG001|STARTED|Overall Study||35||
48602295|NCT00808470|101811533|FG000|COMPLETED|Overall Study||35||
48602296|NCT00808470|101811534|FG001|COMPLETED|Overall Study||35||
48602297|NCT00808470|101811533|FG000|NOT COMPLETED|Overall Study||2||
48300792|NCT00892177|101064025|FG004|COMPLETED|Phase I: Dose Level 0||0||
48300793|NCT00892177|101064026|FG005|COMPLETED|Phase I: Dose Level 0||0||
48300794|NCT00892177|101064021|FG000|NOT COMPLETED|Phase I: Dose Level 0||0||
48300795|NCT00892177|101064022|FG001|NOT COMPLETED|Phase I: Dose Level 0||0||
48300796|NCT00892177|101064023|FG002|NOT COMPLETED|Phase I: Dose Level 0||0||
48300797|NCT00892177|101064024|FG003|NOT COMPLETED|Phase I: Dose Level 0||0||
48300798|NCT00892177|101064025|FG004|NOT COMPLETED|Phase I: Dose Level 0||0||
48300799|NCT00892177|101064026|FG005|NOT COMPLETED|Phase I: Dose Level 0||0||
48300800|NCT00892177|101064021|FG000|STARTED|Phase I: Dose Level 1||0||
48300801|NCT00892177|101064022|FG001|STARTED|Phase I: Dose Level 1||4||
48300802|NCT00892177|101064023|FG002|STARTED|Phase I: Dose Level 1||0||
48300803|NCT00892177|101064024|FG003|STARTED|Phase I: Dose Level 1||0||
48602298|NCT00808470|101811534|FG001|NOT COMPLETED|Overall Study||0||
48602299|NCT04333225|101811535|FG000|STARTED|Overall Study||101||
48602300|NCT04333225|101811536|FG001|STARTED|Overall Study||120||
48602301|NCT04333225|101811535|FG000|COMPLETED|Overall Study||98||
48602302|NCT04333225|101811536|FG001|COMPLETED|Overall Study||115||
48602303|NCT04333225|101811535|FG000|NOT COMPLETED|Overall Study||3||
48602304|NCT04333225|101811536|FG001|NOT COMPLETED|Overall Study||5||
48602305|NCT01857102|101811537|FG000|STARTED|Period 1||58||
48602306|NCT01857102|101811538|FG001|STARTED|Period 1||56||
48602307|NCT01857102|101811537|FG000|Habitual Users|Period 1||51||
48602308|NCT01857102|101811538|FG001|Habitual Users|Period 1||52||
48602309|NCT01857102|101811537|FG000|Neophtyes|Period 1||7||
48602310|NCT01857102|101811538|FG001|Neophtyes|Period 1||4||
48602311|NCT01857102|101811537|FG000|COMPLETED|Period 1||55||
48602312|NCT01857102|101811538|FG001|COMPLETED|Period 1||51||
48602313|NCT01857102|101811537|FG000|NOT COMPLETED|Period 1||3||
48602314|NCT01857102|101811538|FG001|NOT COMPLETED|Period 1||5||
48602315|NCT01857102|101811537|FG000|STARTED|Period 2||55||
48602316|NCT01857102|101811538|FG001|STARTED|Period 2||51||
48602317|NCT01857102|101811537|FG000|Habitual Users|Period 2||48||
48602318|NCT01857102|101811538|FG001|Habitual Users|Period 2||47||
48602319|NCT01857102|101811537|FG000|Neophytes|Period 2||7||
48602320|NCT01857102|101811538|FG001|Neophytes|Period 2||4||
48602321|NCT01857102|101811537|FG000|COMPLETED|Period 2||53||
48602322|NCT01857102|101811538|FG001|COMPLETED|Period 2||51||
48602323|NCT01857102|101811537|FG000|NOT COMPLETED|Period 2||2||
48602324|NCT01857102|101811538|FG001|NOT COMPLETED|Period 2||0||
48602325|NCT01074255|101811539|FG000|STARTED|Overall Study||3141||
48602326|NCT01074255|101811539|FG000|Treated|Overall Study||3139||
48602327|NCT01074255|101811539|FG000|COMPLETED|Overall Study||3139||
48602328|NCT01074255|101811539|FG000|NOT COMPLETED|Overall Study||2||
48602329|NCT04103034|101811540|FG000|STARTED|Overall Study||6||
48602330|NCT04103034|101811541|FG001|STARTED|Overall Study||6||
48602331|NCT04103034|101811542|FG002|STARTED|Overall Study||6||
48602332|NCT04103034|101811543|FG003|STARTED|Overall Study||6||
48602333|NCT04103034|101811544|FG004|STARTED|Overall Study||6||
48602334|NCT04103034|101811545|FG005|STARTED|Overall Study||6||
48602335|NCT04103034|101811546|FG006|STARTED|Overall Study||6||
48602336|NCT04103034|101811547|FG007|STARTED|Overall Study||20||
48602337|NCT04103034|101811548|FG008|STARTED|Overall Study||6||
48602338|NCT04103034|101811549|FG009|STARTED|Overall Study||6||
48602339|NCT04103034|101811550|FG010|STARTED|Overall Study||4||
48602340|NCT04103034|101811551|FG011|STARTED|Overall Study||6||
48602341|NCT04103034|101811552|FG012|STARTED|Overall Study||2||
48602342|NCT04103034|101811553|FG013|STARTED|Overall Study||2||
48602343|NCT04103034|101811554|FG014|STARTED|Overall Study||6||
48300804|NCT00892177|101064025|FG004|STARTED|Phase I: Dose Level 1||0||
48300805|NCT00892177|101064026|FG005|STARTED|Phase I: Dose Level 1||0||
48300806|NCT00892177|101064021|FG000|COMPLETED|Phase I: Dose Level 1||0||
48602344|NCT04103034|101811555|FG015|STARTED|Overall Study||6||
48602345|NCT04103034|101811556|FG016|STARTED|Overall Study||6||
48300807|NCT00892177|101064022|FG001|COMPLETED|Phase I: Dose Level 1||4||
48300808|NCT00892177|101064023|FG002|COMPLETED|Phase I: Dose Level 1||0||
48300809|NCT00892177|101064024|FG003|COMPLETED|Phase I: Dose Level 1||0||
48300810|NCT00892177|101064025|FG004|COMPLETED|Phase I: Dose Level 1||0||
48405277|NCT04728815|101325244|FG005|STARTED|Overall Study||1||
48300811|NCT00892177|101064026|FG005|COMPLETED|Phase I: Dose Level 1||0||
48602346|NCT04103034|101811557|FG017|STARTED|Overall Study||6||
48602347|NCT04103034|101811540|FG000|COMPLETED|Overall Study||6||
48602348|NCT04103034|101811541|FG001|COMPLETED|Overall Study||6||
48602349|NCT04103034|101811542|FG002|COMPLETED|Overall Study||6||
48602350|NCT04103034|101811543|FG003|COMPLETED|Overall Study||6||
48602351|NCT04103034|101811544|FG004|COMPLETED|Overall Study||6||
48602352|NCT04103034|101811545|FG005|COMPLETED|Overall Study||6||
48602353|NCT04103034|101811546|FG006|COMPLETED|Overall Study||6||
48602354|NCT04103034|101811547|FG007|COMPLETED|Overall Study||19||
48602355|NCT04103034|101811548|FG008|COMPLETED|Overall Study||6||
48602356|NCT04103034|101811549|FG009|COMPLETED|Overall Study||0||
48602357|NCT04103034|101811550|FG010|COMPLETED|Overall Study||2||
48602358|NCT04103034|101811551|FG011|COMPLETED|Overall Study||6||
48602359|NCT04103034|101811552|FG012|COMPLETED|Overall Study||2||
48602360|NCT04103034|101811553|FG013|COMPLETED|Overall Study||2||
48602361|NCT04103034|101811554|FG014|COMPLETED|Overall Study||5||
48602362|NCT04103034|101811555|FG015|COMPLETED|Overall Study||4||
48602363|NCT04103034|101811556|FG016|COMPLETED|Overall Study||6||
48602364|NCT04103034|101811557|FG017|COMPLETED|Overall Study||6||
48602365|NCT04103034|101811540|FG000|NOT COMPLETED|Overall Study||0||
48602366|NCT04103034|101811541|FG001|NOT COMPLETED|Overall Study||0||
48602367|NCT04103034|101811542|FG002|NOT COMPLETED|Overall Study||0||
48602368|NCT04103034|101811543|FG003|NOT COMPLETED|Overall Study||0||
48602369|NCT04103034|101811544|FG004|NOT COMPLETED|Overall Study||0||
48602370|NCT04103034|101811545|FG005|NOT COMPLETED|Overall Study||0||
48602371|NCT04103034|101811546|FG006|NOT COMPLETED|Overall Study||0||
48602372|NCT04103034|101811547|FG007|NOT COMPLETED|Overall Study||1||
48602373|NCT04103034|101811548|FG008|NOT COMPLETED|Overall Study||0||
48602374|NCT04103034|101811549|FG009|NOT COMPLETED|Overall Study||6||
48602375|NCT04103034|101811550|FG010|NOT COMPLETED|Overall Study||2||
48602376|NCT04103034|101811551|FG011|NOT COMPLETED|Overall Study||0||
48602377|NCT04103034|101811552|FG012|NOT COMPLETED|Overall Study||0||
48602378|NCT04103034|101811553|FG013|NOT COMPLETED|Overall Study||0||
48602379|NCT04103034|101811554|FG014|NOT COMPLETED|Overall Study||1||
48602380|NCT04103034|101811555|FG015|NOT COMPLETED|Overall Study||2||
48602381|NCT04103034|101811556|FG016|NOT COMPLETED|Overall Study||0||
48602382|NCT04103034|101811557|FG017|NOT COMPLETED|Overall Study||0||
48602383|NCT03491397|101811558|FG000|STARTED|Overall Study||40||
48602384|NCT03491397|101811558|FG000|COMPLETED|Overall Study||40||
48602385|NCT03491397|101811558|FG000|NOT COMPLETED|Overall Study||0||
48602386|NCT02085070|101811559|FG000|STARTED|Overall Study||23||
48602387|NCT02085070|101811560|FG001|STARTED|Overall Study||42||
48300812|NCT00892177|101064021|FG000|NOT COMPLETED|Phase I: Dose Level 1||0||
48300813|NCT00892177|101064022|FG001|NOT COMPLETED|Phase I: Dose Level 1||0||
48300814|NCT00892177|101064023|FG002|NOT COMPLETED|Phase I: Dose Level 1||0||
48300815|NCT00892177|101064024|FG003|NOT COMPLETED|Phase I: Dose Level 1||0||
48300816|NCT00892177|101064025|FG004|NOT COMPLETED|Phase I: Dose Level 1||0||
48300817|NCT00892177|101064026|FG005|NOT COMPLETED|Phase I: Dose Level 1||0||
48300818|NCT00892177|101064021|FG000|STARTED|Phase I: Dose Level 2||0||
48300819|NCT00892177|101064022|FG001|STARTED|Phase I: Dose Level 2||0||
48602388|NCT02085070|101811559|FG000|COMPLETED|Overall Study||23||
48300820|NCT00892177|101064023|FG002|STARTED|Phase I: Dose Level 2||3||
48300821|NCT00892177|101064024|FG003|STARTED|Phase I: Dose Level 2||0||
48300822|NCT00892177|101064025|FG004|STARTED|Phase I: Dose Level 2||0||
48300823|NCT00892177|101064026|FG005|STARTED|Phase I: Dose Level 2||0||
48300824|NCT00892177|101064021|FG000|COMPLETED|Phase I: Dose Level 2||0||
48300825|NCT00892177|101064022|FG001|COMPLETED|Phase I: Dose Level 2||0||
48300826|NCT00892177|101064023|FG002|COMPLETED|Phase I: Dose Level 2||3||
48300827|NCT00892177|101064024|FG003|COMPLETED|Phase I: Dose Level 2||0||
48300828|NCT00892177|101064025|FG004|COMPLETED|Phase I: Dose Level 2||0||
48300829|NCT00892177|101064026|FG005|COMPLETED|Phase I: Dose Level 2||0||
48300830|NCT00892177|101064021|FG000|NOT COMPLETED|Phase I: Dose Level 2||0||
48602389|NCT02085070|101811560|FG001|COMPLETED|Overall Study||42||
48602390|NCT02085070|101811559|FG000|NOT COMPLETED|Overall Study||0||
48602391|NCT02085070|101811560|FG001|NOT COMPLETED|Overall Study||0||
48602392|NCT03620383|101811561|FG000|STARTED|Overall Study||30||
48602393|NCT03620383|101811562|FG001|STARTED|Overall Study||15||
48602394|NCT03620383|101811561|FG000|COMPLETED|Overall Study||30||
48602395|NCT03620383|101811562|FG001|COMPLETED|Overall Study||15||
48602396|NCT03620383|101811561|FG000|NOT COMPLETED|Overall Study||0||
48602397|NCT03620383|101811562|FG001|NOT COMPLETED|Overall Study||0||
48602398|NCT01256385|101811563|FG000|STARTED|Overall Study||43||
48602399|NCT01256385|101811564|FG001|STARTED|Overall Study||43||
48602400|NCT01256385|101811563|FG000|Crossover From Arm B to Arm A|Overall Study||0||
48602401|NCT01256385|101811564|FG001|Crossover From Arm B to Arm A|Overall Study||15||
48602402|NCT01256385|101811563|FG000|COMPLETED|Overall Study||40||
48602403|NCT01256385|101811564|FG001|COMPLETED|Overall Study||40||
48602404|NCT01256385|101811563|FG000|NOT COMPLETED|Overall Study||3||
48602405|NCT01256385|101811564|FG001|NOT COMPLETED|Overall Study||3||
48602406|NCT00153816|101811565|FG000|STARTED|Overall Study||415||
48602407|NCT00153816|101811566|FG001|STARTED|Overall Study||419||
48300831|NCT00892177|101064022|FG001|NOT COMPLETED|Phase I: Dose Level 2||0||
48300832|NCT00892177|101064023|FG002|NOT COMPLETED|Phase I: Dose Level 2||0||
48300833|NCT00892177|101064024|FG003|NOT COMPLETED|Phase I: Dose Level 2||0||
48300834|NCT00892177|101064025|FG004|NOT COMPLETED|Phase I: Dose Level 2||0||
48300835|NCT00892177|101064026|FG005|NOT COMPLETED|Phase I: Dose Level 2||0||
48300836|NCT00892177|101064021|FG000|STARTED|Phase I: Dose Level 3||0||
48300837|NCT00892177|101064022|FG001|STARTED|Phase I: Dose Level 3||0||
48300838|NCT00892177|101064023|FG002|STARTED|Phase I: Dose Level 3||0||
48602408|NCT00153816|101811567|FG002|STARTED|Overall Study||420||
48602409|NCT00153816|101811568|FG003|STARTED|Overall Study||421||
48602410|NCT00153816|101811569|FG004|STARTED|Overall Study||295||
48602411|NCT00153816|101811570|FG005|STARTED|Overall Study||289||
48602412|NCT00153816|101811565|FG000|COMPLETED|Overall Study||383||
48602413|NCT00153816|101811566|FG001|COMPLETED|Overall Study||387||
48602414|NCT00153816|101811567|FG002|COMPLETED|Overall Study||388||
48602415|NCT00153816|101811568|FG003|COMPLETED|Overall Study||390||
48602416|NCT00153816|101811569|FG004|COMPLETED|Overall Study||278||
48602417|NCT00153816|101811570|FG005|COMPLETED|Overall Study||262||
48602418|NCT00153816|101811565|FG000|NOT COMPLETED|Overall Study||32||
48602419|NCT00153816|101811566|FG001|NOT COMPLETED|Overall Study||32||
48602420|NCT00153816|101811567|FG002|NOT COMPLETED|Overall Study||32||
48602421|NCT00153816|101811568|FG003|NOT COMPLETED|Overall Study||31||
48602422|NCT00153816|101811569|FG004|NOT COMPLETED|Overall Study||17||
48602423|NCT00153816|101811570|FG005|NOT COMPLETED|Overall Study||27||
48602424|NCT02749799|101811571|FG000|STARTED|Overall Study||45||
48602425|NCT02749799|101811571|FG000|COMPLETED|Overall Study||37||
48602426|NCT02749799|101811571|FG000|NOT COMPLETED|Overall Study||8||
48602427|NCT02635009|101811572|FG000|STARTED|Overall Study||196||
48602428|NCT02635009|101811573|FG001|STARTED|Overall Study||197||
48602429|NCT02635009|101811572|FG000|Phase II Analysis|Overall Study||89|These participants are included in the phase III analysis.|
48602430|NCT02635009|101811573|FG001|Phase II Analysis|Overall Study||87|These participants are included in the phase III analysis.|
48715058|NCT04676867|102088688|FG003|NOT COMPLETED|Overall Study||6||
48602431|NCT02635009|101811572|FG000|Adverse Event Population|Overall Study||191|Received radiation therapy.|
48602432|NCT02635009|101811573|FG001|Adverse Event Population|Overall Study||189|Received radiation therapy.|
48602433|NCT02635009|101811572|FG000|COMPLETED|Overall Study||196||
48602434|NCT02635009|101811573|FG001|COMPLETED|Overall Study||197||
48602435|NCT02635009|101811572|FG000|NOT COMPLETED|Overall Study||0||
48602436|NCT02635009|101811573|FG001|NOT COMPLETED|Overall Study||0||
48602437|NCT00904917|101811574|FG000|STARTED|Overall Study||7||
48602438|NCT00904917|101811575|FG001|STARTED|Overall Study||11||
48300839|NCT00892177|101064024|FG003|STARTED|Phase I: Dose Level 3||6||
48602439|NCT00904917|101811576|FG002|STARTED|Overall Study||8||
48146949|NCT02251990|100682439|FG001|Treated|Period 1 (Double-blind [DB])||123||
48146950|NCT02251990|100682438|FG000|COMPLETED|Period 1 (Double-blind [DB])||358||
48146951|NCT02251990|100682439|FG001|COMPLETED|Period 1 (Double-blind [DB])||122||
48146952|NCT02251990|100682438|FG000|NOT COMPLETED|Period 1 (Double-blind [DB])||8||
48146953|NCT02251990|100682439|FG001|NOT COMPLETED|Period 1 (Double-blind [DB])||1||
48146954|NCT02251990|100682438|FG000|STARTED|Period 2 (ITG Follow-up/DTG Open Label)||360||
48146955|NCT02251990|100682439|FG001|STARTED|Period 2 (ITG Follow-up/DTG Open Label)||121||
48146956|NCT02251990|100682438|FG000|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||360||
48300840|NCT00892177|101064025|FG004|STARTED|Phase I: Dose Level 3||0||
48300841|NCT00892177|101064026|FG005|STARTED|Phase I: Dose Level 3||0||
48300842|NCT00892177|101064021|FG000|COMPLETED|Phase I: Dose Level 3||0||
48300843|NCT00892177|101064022|FG001|COMPLETED|Phase I: Dose Level 3||0||
48300844|NCT00892177|101064023|FG002|COMPLETED|Phase I: Dose Level 3||0||
48300845|NCT00892177|101064024|FG003|COMPLETED|Phase I: Dose Level 3||6||
48146957|NCT02251990|100682439|FG001|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||118||
48146958|NCT02251990|100682438|FG000|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||0||
48146959|NCT02251990|100682439|FG001|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||3||
48602440|NCT00904917|101811577|FG003|STARTED|Overall Study||8||
48602441|NCT00904917|101811574|FG000|COMPLETED|Overall Study||5||
48602442|NCT00904917|101811575|FG001|COMPLETED|Overall Study||9||
48602443|NCT00904917|101811576|FG002|COMPLETED|Overall Study||6||
48602444|NCT00904917|101811577|FG003|COMPLETED|Overall Study||6||
48602445|NCT00904917|101811574|FG000|NOT COMPLETED|Overall Study||2||
48602446|NCT00904917|101811575|FG001|NOT COMPLETED|Overall Study||2||
48602447|NCT00904917|101811576|FG002|NOT COMPLETED|Overall Study||2||
48602448|NCT00904917|101811577|FG003|NOT COMPLETED|Overall Study||2||
48602449|NCT04122625|101811578|FG000|STARTED|Part A (up to 2.92 Years)||3||
48602450|NCT04122625|101811579|FG001|STARTED|Part A (up to 2.92 Years)||8||
48602451|NCT04122625|101811580|FG002|STARTED|Part A (up to 2.92 Years)||0||
48602452|NCT04122625|101811581|FG003|STARTED|Part A (up to 2.92 Years)||0||
48602453|NCT04122625|101811582|FG004|STARTED|Part A (up to 2.92 Years)||0||
48602454|NCT04122625|101811583|FG005|STARTED|Part A (up to 2.92 Years)||0||
48602455|NCT04122625|101811578|FG000|COMPLETED|Part A (up to 2.92 Years)||1|Completed also includes 1 participant in arm group, Part A: Debio 1143 200 mg + Nivolumab who entered and completed the extension phase of Part A.|
48602456|NCT04122625|101811579|FG001|COMPLETED|Part A (up to 2.92 Years)||4|Completed also includes 1 participant in arm group, Part A: Debio 1143 200 mg + Nivolumab who entered and completed the extension phase of Part A.|
48602457|NCT04122625|101811580|FG002|COMPLETED|Part A (up to 2.92 Years)||0|Completed also includes 1 participant in arm group, Part A: Debio 1143 200 mg + Nivolumab who entered and completed the extension phase of Part A.|
48656906|NCT04274218|101943727|FG002|NOT COMPLETED|Baseline Walking (1 Minute)||0||
48715059|NCT05434013|102088689|FG000|STARTED|Overall Study||526||
48715060|NCT05434013|102088690|FG001|STARTED|Overall Study||526||
48146960|NCT02251990|100682438|FG000|STARTED|Period 3 (DTG Follow-up)||0||
48146961|NCT02251990|100682439|FG001|STARTED|Period 3 (DTG Follow-up)||121||
48146962|NCT02251990|100682438|FG000|COMPLETED|Period 3 (DTG Follow-up)||0||
48300846|NCT00892177|101064025|FG004|COMPLETED|Phase I: Dose Level 3||0||
48300847|NCT00892177|101064026|FG005|COMPLETED|Phase I: Dose Level 3||0||
48300848|NCT00892177|101064021|FG000|NOT COMPLETED|Phase I: Dose Level 3||0||
48300849|NCT00892177|101064022|FG001|NOT COMPLETED|Phase I: Dose Level 3||0||
48602458|NCT04122625|101811581|FG003|COMPLETED|Part A (up to 2.92 Years)||0|Completed also includes 1 participant in arm group, Part A: Debio 1143 200 mg + Nivolumab who entered and completed the extension phase of Part A.|
48602459|NCT04122625|101811582|FG004|COMPLETED|Part A (up to 2.92 Years)||0|Completed also includes 1 participant in arm group, Part A: Debio 1143 200 mg + Nivolumab who entered and completed the extension phase of Part A.|
48602460|NCT04122625|101811583|FG005|COMPLETED|Part A (up to 2.92 Years)||0|Completed also includes 1 participant in arm group, Part A: Debio 1143 200 mg + Nivolumab who entered and completed the extension phase of Part A.|
48300850|NCT00892177|101064023|FG002|NOT COMPLETED|Phase I: Dose Level 3||0||
48300851|NCT00892177|101064024|FG003|NOT COMPLETED|Phase I: Dose Level 3||0||
48300852|NCT00892177|101064025|FG004|NOT COMPLETED|Phase I: Dose Level 3||0||
48715061|NCT05434013|102088691|FG002|STARTED|Overall Study||526||
48715062|NCT05434013|102088689|FG000|COMPLETED|Overall Study||526||
48300853|NCT00892177|101064026|FG005|NOT COMPLETED|Phase I: Dose Level 3||0||
48300854|NCT00892177|101064021|FG000|STARTED|Phase II||0||
48300855|NCT00892177|101064022|FG001|STARTED|Phase II||0||
48300856|NCT00892177|101064023|FG002|STARTED|Phase II||0||
48300857|NCT00892177|101064024|FG003|STARTED|Phase II||0||
48300858|NCT00892177|101064025|FG004|STARTED|Phase II||88||
48300859|NCT00892177|101064026|FG005|STARTED|Phase II||40||
48300860|NCT00892177|101064021|FG000|COMPLETED|Phase II||0||
48300861|NCT00892177|101064022|FG001|COMPLETED|Phase II||0||
48300862|NCT00892177|101064023|FG002|COMPLETED|Phase II||0||
48300863|NCT00892177|101064024|FG003|COMPLETED|Phase II||0||
48300864|NCT00892177|101064025|FG004|COMPLETED|Phase II||83||
48300865|NCT00892177|101064026|FG005|COMPLETED|Phase II||38||
48300866|NCT00892177|101064021|FG000|NOT COMPLETED|Phase II||0||
48300867|NCT00892177|101064022|FG001|NOT COMPLETED|Phase II||0||
48300868|NCT00892177|101064023|FG002|NOT COMPLETED|Phase II||0||
48300869|NCT00892177|101064024|FG003|NOT COMPLETED|Phase II||0||
48300870|NCT00892177|101064025|FG004|NOT COMPLETED|Phase II||5||
48300871|NCT00892177|101064026|FG005|NOT COMPLETED|Phase II||2||
48300872|NCT00975715|101064027|FG000|STARTED|Titration Period||48||
48300873|NCT00975715|101064028|FG001|STARTED|Titration Period||51||
48300874|NCT00975715|101064027|FG000|COMPLETED|Titration Period||41||
48300875|NCT00975715|101064028|FG001|COMPLETED|Titration Period||51||
48300876|NCT00975715|101064027|FG000|NOT COMPLETED|Titration Period||7||
48300877|NCT00975715|101064028|FG001|NOT COMPLETED|Titration Period||0||
48300878|NCT00975715|101064027|FG000|STARTED|Maintenance Period||41||
48300879|NCT00975715|101064028|FG001|STARTED|Maintenance Period||51||
48300880|NCT00975715|101064027|FG000|COMPLETED|Maintenance Period||39||
48300881|NCT00975715|101064028|FG001|COMPLETED|Maintenance Period||50||
48300882|NCT00975715|101064027|FG000|NOT COMPLETED|Maintenance Period||2||
48300883|NCT00975715|101064028|FG001|NOT COMPLETED|Maintenance Period||1||
48300884|NCT01873495|101064029|FG000|STARTED|Overall Study||7||
48300885|NCT01873495|101064029|FG000|COMPLETED|Overall Study||0||
48300886|NCT01873495|101064029|FG000|NOT COMPLETED|Overall Study||7||
48602461|NCT04122625|101811578|FG000|NOT COMPLETED|Part A (up to 2.92 Years)||2||
48602462|NCT04122625|101811579|FG001|NOT COMPLETED|Part A (up to 2.92 Years)||4||
48602463|NCT04122625|101811580|FG002|NOT COMPLETED|Part A (up to 2.92 Years)||0||
48602464|NCT04122625|101811581|FG003|NOT COMPLETED|Part A (up to 2.92 Years)||0||
48602465|NCT04122625|101811582|FG004|NOT COMPLETED|Part A (up to 2.92 Years)||0||
48602466|NCT04122625|101811583|FG005|NOT COMPLETED|Part A (up to 2.92 Years)||0||
48602467|NCT04122625|101811578|FG000|STARTED|Part B (up to 2.33 Years)||0||
48602468|NCT04122625|101811579|FG001|STARTED|Part B (up to 2.33 Years)||0||
48602469|NCT04122625|101811580|FG002|STARTED|Part B (up to 2.33 Years)||8||
48602470|NCT04122625|101811581|FG003|STARTED|Part B (up to 2.33 Years)||8||
48602471|NCT04122625|101811582|FG004|STARTED|Part B (up to 2.33 Years)||8||
48602472|NCT04122625|101811583|FG005|STARTED|Part B (up to 2.33 Years)||11||
48602473|NCT04122625|101811578|FG000|COMPLETED|Part B (up to 2.33 Years)||0||
48602474|NCT04122625|101811579|FG001|COMPLETED|Part B (up to 2.33 Years)||0||
48300887|NCT02678416|101064030|FG000|STARTED|Part 1||12||
48300888|NCT02678416|101064030|FG000|Safety Population|Part 1||12||
48300889|NCT02678416|101064030|FG000|Modified Intent to Treat (mITT)|Part 1||12||
48300890|NCT02678416|101064030|FG000|Per Protocol Population|Part 1||8||
48300891|NCT02678416|101064030|FG000|COMPLETED|Part 1||11||
48300892|NCT02678416|101064030|FG000|NOT COMPLETED|Part 1||1||
48300893|NCT02678416|101064030|FG000|STARTED|Part 2||67||
48300894|NCT02678416|101064030|FG000|Treated (Safety Population)|Part 2||66|One participant was randomized but not treated.|
48300895|NCT02678416|101064030|FG000|Modified Intent to Treat Population|Part 2||66||
48300896|NCT02678416|101064030|FG000|Pharmacokinetic Population|Part 2||65||
48300897|NCT02678416|101064030|FG000|Per Protocol Population|Part 2||64||
48300898|NCT02678416|101064030|FG000|COMPLETED|Part 2||64||
48300899|NCT02678416|101064030|FG000|NOT COMPLETED|Part 2||3||
48300900|NCT01210079|101064031|FG000|STARTED|Overall Study||10||
48602475|NCT04122625|101811580|FG002|COMPLETED|Part B (up to 2.33 Years)||2||
48715063|NCT05434013|102088690|FG001|COMPLETED|Overall Study||526||
48715064|NCT05434013|102088691|FG002|COMPLETED|Overall Study||526||
48715065|NCT05434013|102088689|FG000|NOT COMPLETED|Overall Study||0||
48715066|NCT05434013|102088690|FG001|NOT COMPLETED|Overall Study||0||
48300901|NCT01210079|101064032|FG001|STARTED|Overall Study||16||
48300902|NCT01210079|101064031|FG000|COMPLETED|Overall Study||10||
48300903|NCT01210079|101064032|FG001|COMPLETED|Overall Study||16||
48300904|NCT01210079|101064031|FG000|NOT COMPLETED|Overall Study||0||
48300905|NCT01210079|101064032|FG001|NOT COMPLETED|Overall Study||0||
48602476|NCT04122625|101811581|FG003|COMPLETED|Part B (up to 2.33 Years)||0||
48602477|NCT04122625|101811582|FG004|COMPLETED|Part B (up to 2.33 Years)||0||
48602478|NCT04122625|101811583|FG005|COMPLETED|Part B (up to 2.33 Years)||4||
48300906|NCT03431857|101064033|FG000|STARTED|Overall Study||106||
48300907|NCT03431857|101064033|FG000|COMPLETED|Overall Study||52||
48300908|NCT03431857|101064033|FG000|NOT COMPLETED|Overall Study||54||
48300909|NCT01196533|101064034|FG000|STARTED|Overall Study||94||
48300910|NCT01196533|101064034|FG000|COMPLETED|Overall Study||94||
48300911|NCT01196533|101064034|FG000|NOT COMPLETED|Overall Study||0||
48300912|NCT00174265|101064035|FG000|STARTED|Overall Study||86||
48300913|NCT00174265|101064036|FG001|STARTED|Overall Study||110||
48300914|NCT00174265|101064035|FG000|COMPLETED|Overall Study||57||
48300915|NCT00174265|101064036|FG001|COMPLETED|Overall Study||89||
48300916|NCT00174265|101064035|FG000|NOT COMPLETED|Overall Study||29||
48300917|NCT00174265|101064036|FG001|NOT COMPLETED|Overall Study||21||
48300918|NCT01480284|101064037|FG000|STARTED|Overall Study||110||
48300919|NCT01480284|101064038|FG001|STARTED|Overall Study||56||
48300920|NCT01480284|101064037|FG000|COMPLETED|Overall Study||102||
48300921|NCT01480284|101064038|FG001|COMPLETED|Overall Study||56||
48300922|NCT01480284|101064037|FG000|NOT COMPLETED|Overall Study||8||
48300923|NCT01480284|101064038|FG001|NOT COMPLETED|Overall Study||0||
48300924|NCT00888433|101064039|FG000|STARTED|Overall Study||52||
48300925|NCT00888433|101064040|FG001|STARTED|Overall Study||54||
48300926|NCT00888433|101064039|FG000|COMPLETED|Overall Study||49||
48300927|NCT00888433|101064040|FG001|COMPLETED|Overall Study||51||
48300928|NCT00888433|101064039|FG000|NOT COMPLETED|Overall Study||3||
48300929|NCT00888433|101064040|FG001|NOT COMPLETED|Overall Study||3||
48300930|NCT00509665|101064041|FG000|STARTED|Overall Study||18||
48300931|NCT00509665|101064041|FG000|COMPLETED|Overall Study||18||
48300932|NCT00509665|101064041|FG000|NOT COMPLETED|Overall Study||0||
48300933|NCT00375219|101064042|FG000|STARTED|Overall Study||62||
48300934|NCT00375219|101064043|FG001|STARTED|Overall Study||20||
48300935|NCT00375219|101064044|FG002|STARTED|Overall Study||21||
48300936|NCT00375219|101064042|FG000|COMPLETED|Overall Study||3||
48300937|NCT00375219|101064043|FG001|COMPLETED|Overall Study||0||
48300938|NCT00375219|101064044|FG002|COMPLETED|Overall Study||0||
48300939|NCT00375219|101064042|FG000|NOT COMPLETED|Overall Study||59||
48300940|NCT00375219|101064043|FG001|NOT COMPLETED|Overall Study||20||
48602479|NCT04122625|101811578|FG000|NOT COMPLETED|Part B (up to 2.33 Years)||0||
48602480|NCT04122625|101811579|FG001|NOT COMPLETED|Part B (up to 2.33 Years)||0||
48602481|NCT04122625|101811580|FG002|NOT COMPLETED|Part B (up to 2.33 Years)||6||
48602482|NCT04122625|101811581|FG003|NOT COMPLETED|Part B (up to 2.33 Years)||8||
48602483|NCT04122625|101811582|FG004|NOT COMPLETED|Part B (up to 2.33 Years)||8||
48602484|NCT04122625|101811583|FG005|NOT COMPLETED|Part B (up to 2.33 Years)||7||
48602485|NCT04401202|101811584|FG000|STARTED|Overall Study||92||
48602486|NCT04401202|101811585|FG001|STARTED|Overall Study||91||
48602487|NCT04401202|101811584|FG000|COMPLETED|Overall Study||86||
48602488|NCT04401202|101811585|FG001|COMPLETED|Overall Study||87||
48602489|NCT04401202|101811584|FG000|NOT COMPLETED|Overall Study||6||
48602490|NCT04401202|101811585|FG001|NOT COMPLETED|Overall Study||4||
48602491|NCT01118988|101811586|FG000|STARTED|Overall Study||16||
48602492|NCT01118988|101811587|FG001|STARTED|Overall Study||4||
48602493|NCT01118988|101811588|FG002|STARTED|Overall Study||7||
48602494|NCT01118988|101811586|FG000|COMPLETED|Overall Study||11||
48602495|NCT01118988|101811587|FG001|COMPLETED|Overall Study||3||
48300941|NCT00375219|101064044|FG002|NOT COMPLETED|Overall Study||21||
48602496|NCT01118988|101811588|FG002|COMPLETED|Overall Study||3||
48602497|NCT01118988|101811586|FG000|NOT COMPLETED|Overall Study||5||
48300942|NCT01581541|101064045|FG000|STARTED|Overall Study||1||
48300943|NCT01581541|101064046|FG001|STARTED|Overall Study||1||
48300944|NCT01581541|101064047|FG002|STARTED|Overall Study||1||
48300945|NCT01581541|101064048|FG003|STARTED|Overall Study||1||
48300946|NCT01581541|101064049|FG004|STARTED|Overall Study||2||
48300947|NCT01581541|101064050|FG005|STARTED|Overall Study||3||
48300948|NCT01581541|101064051|FG006|STARTED|Overall Study||1||
48300949|NCT01581541|101064052|FG007|STARTED|Overall Study||2||
48300950|NCT01581541|101064053|FG008|STARTED|Overall Study||1||
48300951|NCT01581541|101064054|FG009|STARTED|Overall Study||3||
48300952|NCT01581541|101064055|FG010|STARTED|Overall Study||1||
48300953|NCT01581541|101064045|FG000|COMPLETED|Overall Study||1||
48300954|NCT01581541|101064046|FG001|COMPLETED|Overall Study||1||
48602498|NCT01118988|101811587|FG001|NOT COMPLETED|Overall Study||1||
48300955|NCT01581541|101064047|FG002|COMPLETED|Overall Study||1||
48300956|NCT01581541|101064048|FG003|COMPLETED|Overall Study||1||
48300957|NCT01581541|101064049|FG004|COMPLETED|Overall Study||2||
48602499|NCT01118988|101811588|FG002|NOT COMPLETED|Overall Study||4||
48602500|NCT03015194|101811589|FG000|STARTED|Overall Study||30||
48602501|NCT03015194|101811589|FG000|COMPLETED|Overall Study||18||
48602502|NCT03015194|101811589|FG000|NOT COMPLETED|Overall Study||12||
48602503|NCT01129804|101811590|FG000|STARTED|Overall Study||96||
48602504|NCT01129804|101811591|FG001|STARTED|Overall Study||97||
48602505|NCT01129804|101811590|FG000|COMPLETED|Overall Study||64||
48146963|NCT02251990|100682439|FG001|COMPLETED|Period 3 (DTG Follow-up)||121||
48602506|NCT01129804|101811591|FG001|COMPLETED|Overall Study||66||
48602507|NCT01129804|101811590|FG000|NOT COMPLETED|Overall Study||32||
48602508|NCT01129804|101811591|FG001|NOT COMPLETED|Overall Study||31||
48602509|NCT04489732|101811592|FG000|STARTED|Overall Study||6||
48602510|NCT04489732|101811592|FG000|COMPLETED|Overall Study||6||
48602511|NCT04489732|101811592|FG000|NOT COMPLETED|Overall Study||0||
48602512|NCT00032630|101811593|FG000|STARTED|Overall Study||1099||
48602513|NCT00032630|101811594|FG001|STARTED|Overall Study||1104||
48602514|NCT00032630|101811593|FG000|COMPLETED|Overall Study||1050||
48602515|NCT00032630|101811594|FG001|COMPLETED|Overall Study||1061||
48602516|NCT00032630|101811593|FG000|NOT COMPLETED|Overall Study||49||
48146964|NCT02251990|100682438|FG000|NOT COMPLETED|Period 3 (DTG Follow-up)||0||
48146965|NCT02251990|100682439|FG001|NOT COMPLETED|Period 3 (DTG Follow-up)||0||
48146966|NCT04072159|100682440|FG000|STARTED|Overall Study||16||
48146967|NCT04072159|100682441|FG001|STARTED|Overall Study||17||
48146968|NCT04072159|100682440|FG000|COMPLETED|Overall Study||8||
48146969|NCT04072159|100682441|FG001|COMPLETED|Overall Study||11||
48146970|NCT04072159|100682440|FG000|NOT COMPLETED|Overall Study||8||
48146971|NCT04072159|100682441|FG001|NOT COMPLETED|Overall Study||6||
48146972|NCT01059565|100682442|FG000|STARTED|24-Week Randomized Phase||49||
48146973|NCT01059565|100682443|FG001|STARTED|24-Week Randomized Phase||52||
48146974|NCT01059565|100682442|FG000|Randomized and Treated|24-Week Randomized Phase||48||
48146975|NCT01059565|100682443|FG001|Randomized and Treated|24-Week Randomized Phase||52||
48146976|NCT01059565|100682442|FG000|COMPLETED|24-Week Randomized Phase||39||
48146977|NCT01059565|100682443|FG001|COMPLETED|24-Week Randomized Phase||45||
48146978|NCT01059565|100682442|FG000|NOT COMPLETED|24-Week Randomized Phase||10||
48146979|NCT01059565|100682443|FG001|NOT COMPLETED|24-Week Randomized Phase||7||
48146980|NCT01059565|100682442|FG000|STARTED|24-Week Open-Label Phase||39||
48146981|NCT01059565|100682443|FG001|STARTED|24-Week Open-Label Phase||45||
48146982|NCT01059565|100682442|FG000|COMPLETED|24-Week Open-Label Phase||34||
48146983|NCT01059565|100682443|FG001|COMPLETED|24-Week Open-Label Phase||42||
48146984|NCT01059565|100682442|FG000|NOT COMPLETED|24-Week Open-Label Phase||5||
48146985|NCT01059565|100682443|FG001|NOT COMPLETED|24-Week Open-Label Phase||3||
48146986|NCT03853109|100682444|FG000|STARTED|Overall Study||3||
48146987|NCT03853109|100682445|FG001|STARTED|Overall Study||9||
48146988|NCT03853109|100682446|FG002|STARTED|Overall Study||21||
48146989|NCT03853109|100682447|FG003|STARTED|Overall Study||21||
48146990|NCT03853109|100682448|FG004|STARTED|Overall Study||20||
48146991|NCT03853109|100682449|FG005|STARTED|Overall Study||42||
48146992|NCT03853109|100682450|FG006|STARTED|Overall Study||42||
48146993|NCT03853109|100682451|FG007|STARTED|Overall Study||13||
48146994|NCT03853109|100682444|FG000|Did Not Receive AMG 404|Overall Study||0||
48146995|NCT03853109|100682445|FG001|Did Not Receive AMG 404|Overall Study||0||
48146996|NCT03853109|100682446|FG002|Did Not Receive AMG 404|Overall Study||1||
48146997|NCT03853109|100682447|FG003|Did Not Receive AMG 404|Overall Study||0||
48146998|NCT03853109|100682448|FG004|Did Not Receive AMG 404|Overall Study||0||
48146999|NCT03853109|100682449|FG005|Did Not Receive AMG 404|Overall Study||1||
48147000|NCT03853109|100682450|FG006|Did Not Receive AMG 404|Overall Study||1||
48602517|NCT00032630|101811594|FG001|NOT COMPLETED|Overall Study||43||
48147001|NCT03853109|100682451|FG007|Did Not Receive AMG 404|Overall Study||0||
48147002|NCT03853109|100682444|FG000|COMPLETED|Overall Study||1||
48147003|NCT03853109|100682445|FG001|COMPLETED|Overall Study||4||
48147004|NCT03853109|100682446|FG002|COMPLETED|Overall Study||11||
48147005|NCT03853109|100682447|FG003|COMPLETED|Overall Study||9||
48147006|NCT03853109|100682448|FG004|COMPLETED|Overall Study||14||
48147007|NCT03853109|100682449|FG005|COMPLETED|Overall Study||14||
48147008|NCT03853109|100682450|FG006|COMPLETED|Overall Study||17||
48147009|NCT03853109|100682451|FG007|COMPLETED|Overall Study||3||
48147010|NCT03853109|100682444|FG000|NOT COMPLETED|Overall Study||2||
48147011|NCT03853109|100682445|FG001|NOT COMPLETED|Overall Study||5||
48602518|NCT03472521|101811595|FG000|STARTED|Overall Study||41||
48147012|NCT03853109|100682446|FG002|NOT COMPLETED|Overall Study||10||
48147013|NCT03853109|100682447|FG003|NOT COMPLETED|Overall Study||12||
48147014|NCT03853109|100682448|FG004|NOT COMPLETED|Overall Study||6||
48147015|NCT03853109|100682449|FG005|NOT COMPLETED|Overall Study||28||
48147016|NCT03853109|100682450|FG006|NOT COMPLETED|Overall Study||25||
48147017|NCT03853109|100682451|FG007|NOT COMPLETED|Overall Study||10||
48147018|NCT05460325|100682452|FG000|STARTED|Run-in Period (4 or up to 8 Weeks)||20||
48147019|NCT05460325|100682452|FG000|COMPLETED|Run-in Period (4 or up to 8 Weeks)||20||
48147020|NCT05460325|100682452|FG000|NOT COMPLETED|Run-in Period (4 or up to 8 Weeks)||0||
48147021|NCT05460325|100682452|FG000|STARTED|Treatment Period (Weeks 1 to 26)||20||
48147022|NCT05460325|100682452|FG000|COMPLETED|Treatment Period (Weeks 1 to 26)||20||
48147023|NCT05460325|100682452|FG000|NOT COMPLETED|Treatment Period (Weeks 1 to 26)||0||
48147024|NCT05460325|100682452|FG000|STARTED|Safety Follow-up Period (Weeks 27 to 30)||20||
48147025|NCT05460325|100682452|FG000|COMPLETED|Safety Follow-up Period (Weeks 27 to 30)||20||
48147026|NCT05460325|100682452|FG000|NOT COMPLETED|Safety Follow-up Period (Weeks 27 to 30)||0||
48300958|NCT01581541|101064050|FG005|COMPLETED|Overall Study||3||
48300959|NCT01581541|101064051|FG006|COMPLETED|Overall Study||1||
48300960|NCT01581541|101064052|FG007|COMPLETED|Overall Study||2||
48300961|NCT01581541|101064053|FG008|COMPLETED|Overall Study||1||
48715067|NCT05434013|102088691|FG002|NOT COMPLETED|Overall Study||0||
48715068|NCT03602885|102088692|FG000|STARTED|Overall Study||5||
48715069|NCT03602885|102088693|FG001|STARTED|Overall Study||5||
48147027|NCT00701038|100682453|FG000|STARTED|Overall Study||27||
48300962|NCT01581541|101064054|FG009|COMPLETED|Overall Study||3||
48300963|NCT01581541|101064055|FG010|COMPLETED|Overall Study||1||
48715070|NCT03602885|102088692|FG000|COMPLETED|Overall Study||2|Early closure for failure to accrue|
48715071|NCT03602885|102088693|FG001|COMPLETED|Overall Study||5|Early closure for failure to accrue|
48715072|NCT03602885|102088692|FG000|NOT COMPLETED|Overall Study||3||
48715073|NCT03602885|102088693|FG001|NOT COMPLETED|Overall Study||0||
48715074|NCT01998893|102088694|FG000|STARTED|Overall Study||38||
48715075|NCT01998893|102088694|FG000|1st Treatment Cycle Completed Until PD|Overall Study||30||
48715076|NCT01998893|102088694|FG000|2nd Treatment Cycle Started|Overall Study||5||
48715077|NCT01998893|102088694|FG000|2nd Treatment Cycle Completed Until PD|Overall Study||3||
48715078|NCT01998893|102088694|FG000|COMPLETED|Overall Study||21||
48715079|NCT01998893|102088694|FG000|NOT COMPLETED|Overall Study||17||
48715080|NCT02485925|102088695|FG000|STARTED|Overall Study||200|Patients who signed informed consent forms|
48715081|NCT02485925|102088695|FG000|Safety Population|Overall Study||200|All enrolled subjects who underwent insertion of the study catheter|
48715082|NCT02485925|102088695|FG000|Intent to Treat (ITT) Population|Overall Study||193|All enrolled subjects who met the inclusion/exclusion criteria and signed informed consent form|
48715083|NCT02485925|102088695|FG000|Per-Protocol Population|Overall Study||166|ITT subjects with 12 month primary efficacy data and insertion of the study catheter and ablation|
48715084|NCT02485925|102088695|FG000|COMPLETED|Overall Study||185||
48715085|NCT02485925|102088695|FG000|NOT COMPLETED|Overall Study||15||
48715086|NCT01974752|102088696|FG000|STARTED|Overall Study||97||
48715087|NCT01974752|102088697|FG001|STARTED|Overall Study||32||
48715088|NCT01974752|102088696|FG000|COMPLETED|Overall Study||60||
48715089|NCT01974752|102088697|FG001|COMPLETED|Overall Study||17||
48715090|NCT01974752|102088696|FG000|NOT COMPLETED|Overall Study||37||
48715091|NCT01974752|102088697|FG001|NOT COMPLETED|Overall Study||15||
48715092|NCT03464422|102088698|FG000|STARTED|Overall Study||21||
48715093|NCT03464422|102088698|FG000|COMPLETED|Overall Study||17||
48715094|NCT03464422|102088698|FG000|NOT COMPLETED|Overall Study||4||
48715095|NCT00364533|102088699|FG000|STARTED|Overall Study||77||
48715096|NCT00364533|102088700|FG001|STARTED|Overall Study||71||
48715097|NCT00364533|102088701|FG002|STARTED|Overall Study||75||
48715098|NCT00364533|102088702|FG003|STARTED|Overall Study||67||
48715099|NCT00364533|102088703|FG004|STARTED|Overall Study||75||
48715100|NCT00364533|102088699|FG000|COMPLETED|Overall Study||35||
48715101|NCT00364533|102088700|FG001|COMPLETED|Overall Study||31||
48715102|NCT00364533|102088701|FG002|COMPLETED|Overall Study||30||
48715103|NCT00364533|102088702|FG003|COMPLETED|Overall Study||36||
48715104|NCT00364533|102088703|FG004|COMPLETED|Overall Study||24||
48715105|NCT00364533|102088699|FG000|NOT COMPLETED|Overall Study||42||
48715106|NCT00364533|102088700|FG001|NOT COMPLETED|Overall Study||40||
48715107|NCT00364533|102088701|FG002|NOT COMPLETED|Overall Study||45||
48715108|NCT00364533|102088702|FG003|NOT COMPLETED|Overall Study||31||
48715109|NCT00364533|102088703|FG004|NOT COMPLETED|Overall Study||51||
48715110|NCT00128713|102088704|FG000|STARTED|Overall Study||453||
48715111|NCT00128713|102088705|FG001|STARTED|Overall Study||449||
48715112|NCT00128713|102088706|FG002|STARTED|Overall Study||449||
48715113|NCT00128713|102088704|FG000|COMPLETED|Overall Study||453||
48715114|NCT00128713|102088705|FG001|COMPLETED|Overall Study||449||
48715115|NCT00128713|102088706|FG002|COMPLETED|Overall Study||449||
48715116|NCT00128713|102088704|FG000|NOT COMPLETED|Overall Study||0||
48715117|NCT00128713|102088705|FG001|NOT COMPLETED|Overall Study||0||
48715118|NCT00128713|102088706|FG002|NOT COMPLETED|Overall Study||0||
48715119|NCT01241760|102088707|FG000|STARTED|Overall Study||371||
48147028|NCT00701038|100682454|FG001|STARTED|Overall Study||27||
48147029|NCT00701038|100682453|FG000|COMPLETED|Overall Study||23||
48147030|NCT00701038|100682454|FG001|COMPLETED|Overall Study||23||
48715120|NCT01241760|102088708|FG001|STARTED|Overall Study||369||
48715121|NCT01241760|102088707|FG000|COMPLETED|Overall Study||337||
48715122|NCT01241760|102088708|FG001|COMPLETED|Overall Study||329||
48715123|NCT01241760|102088707|FG000|NOT COMPLETED|Overall Study||34||
48147031|NCT00701038|100682453|FG000|NOT COMPLETED|Overall Study||4||
48147032|NCT00701038|100682454|FG001|NOT COMPLETED|Overall Study||4||
48147033|NCT00713648|100682455|FG000|STARTED|Overall Study||41||
48147034|NCT00713648|100682455|FG000|COMPLETED|Overall Study||33||
48602519|NCT03472521|101811596|FG001|STARTED|Overall Study||37||
48715124|NCT01241760|102088708|FG001|NOT COMPLETED|Overall Study||40||
48715125|NCT04284813|102088709|FG000|STARTED|Overall Study||21||
48715126|NCT04284813|102088709|FG000|COMPLETED|Overall Study||20||
48715127|NCT04284813|102088709|FG000|NOT COMPLETED|Overall Study||1||
48715128|NCT02165462|102088710|FG000|STARTED|Overall Study||17||
48715129|NCT02165462|102088710|FG000|COMPLETED|Overall Study||17||
48715130|NCT02165462|102088710|FG000|NOT COMPLETED|Overall Study||0||
48715131|NCT02032641|102088711|FG000|STARTED|Overall Study||9||
48715132|NCT02032641|102088711|FG000|COMPLETED|Overall Study||8||
48715133|NCT02032641|102088711|FG000|NOT COMPLETED|Overall Study||1||
48147035|NCT00713648|100682455|FG000|NOT COMPLETED|Overall Study||8||
48147036|NCT01328080|100682456|FG000|STARTED|Overall Study||11||
48147037|NCT01328080|100682456|FG000|COMPLETED|Overall Study||6||
48147038|NCT01328080|100682456|FG000|NOT COMPLETED|Overall Study||5||
48602520|NCT03472521|101811595|FG000|Received Allocated Intervention|Overall Study||41||
48602521|NCT03472521|101811596|FG001|Received Allocated Intervention|Overall Study||37||
48147039|NCT01092338|100682457|FG000|STARTED|Overall Study||22||
48147040|NCT01092338|100682458|FG001|STARTED|Overall Study||22||
48147041|NCT01092338|100682457|FG000|COMPLETED|Overall Study||21||
48602522|NCT03472521|101811595|FG000|COMPLETED|Overall Study||35||
48602523|NCT03472521|101811596|FG001|COMPLETED|Overall Study||34||
48602524|NCT03472521|101811595|FG000|NOT COMPLETED|Overall Study||6||
48602525|NCT03472521|101811596|FG001|NOT COMPLETED|Overall Study||3||
48602526|NCT02603107|101811597|FG000|STARTED|Randomized Phase||290||
48602527|NCT02603107|101811598|FG001|STARTED|Randomized Phase||287||
48602528|NCT02603107|101811597|FG000|COMPLETED|Randomized Phase||275||
48602529|NCT02603107|101811598|FG001|COMPLETED|Randomized Phase||266||
48602530|NCT02603107|101811597|FG000|NOT COMPLETED|Randomized Phase||15||
48602531|NCT02603107|101811598|FG001|NOT COMPLETED|Randomized Phase||21||
48602532|NCT02603107|101811597|FG000|STARTED|Optional Extension Phase||272||
48602533|NCT02603107|101811598|FG001|STARTED|Optional Extension Phase||245||
48602534|NCT02603107|101811597|FG000|COMPLETED|Optional Extension Phase||263||
48602535|NCT02603107|101811598|FG001|COMPLETED|Optional Extension Phase||232||
48602536|NCT02603107|101811597|FG000|NOT COMPLETED|Optional Extension Phase||9||
48602537|NCT02603107|101811598|FG001|NOT COMPLETED|Optional Extension Phase||13||
48602538|NCT01146561|101811599|FG000|STARTED|Overall Study||2||
48602539|NCT01146561|101811599|FG000|COMPLETED|Overall Study||0||
48602540|NCT01146561|101811599|FG000|NOT COMPLETED|Overall Study||2||
48602541|NCT02131636|101811600|FG000|STARTED|Overall Study||222||
48602542|NCT02131636|101811601|FG001|STARTED|Overall Study||218||
48602543|NCT02131636|101811600|FG000|COMPLETED|Overall Study||210||
48602544|NCT02131636|101811601|FG001|COMPLETED|Overall Study||213||
48602545|NCT02131636|101811600|FG000|NOT COMPLETED|Overall Study||12||
48602546|NCT02131636|101811601|FG001|NOT COMPLETED|Overall Study||5||
48602547|NCT01937715|101811602|FG000|STARTED|Overall Study||3||
48602548|NCT01937715|101811603|FG001|STARTED|Overall Study||4||
48602549|NCT01937715|101811604|FG002|STARTED|Overall Study||3||
48602550|NCT01937715|101811605|FG003|STARTED|Overall Study||5||
48715134|NCT05260333|102088712|FG000|STARTED|Overall Study||30|The patients acted as there own control. 30 patients were enrolled, but a total of 60 exams (1 TPUS and 1 SVE) were performed.|
48767583|NCT01435382|102222773|FG002|COMPLETED|Overall Study||12||
48147042|NCT01092338|100682458|FG001|COMPLETED|Overall Study||21||
48147043|NCT01092338|100682457|FG000|NOT COMPLETED|Overall Study||1||
48147044|NCT01092338|100682458|FG001|NOT COMPLETED|Overall Study||1||
48147045|NCT03663231|100682459|FG000|STARTED|First Intervention||16||
48147046|NCT03663231|100682460|FG001|STARTED|First Intervention||13||
48147047|NCT03663231|100682459|FG000|COMPLETED|First Intervention||14||
48147048|NCT03663231|100682460|FG001|COMPLETED|First Intervention||12||
48147049|NCT03663231|100682459|FG000|NOT COMPLETED|First Intervention||2||
48147050|NCT03663231|100682460|FG001|NOT COMPLETED|First Intervention||1||
48147051|NCT03663231|100682459|FG000|STARTED|Washout||14||
48602551|NCT01937715|101811606|FG004|STARTED|Overall Study||3||
48602552|NCT01937715|101811602|FG000|COMPLETED|Overall Study||3||
48147052|NCT03663231|100682460|FG001|STARTED|Washout||12||
48602553|NCT01937715|101811603|FG001|COMPLETED|Overall Study||3||
48602554|NCT01937715|101811604|FG002|COMPLETED|Overall Study||3||
48602555|NCT01937715|101811605|FG003|COMPLETED|Overall Study||1||
48602556|NCT01937715|101811606|FG004|COMPLETED|Overall Study||1||
48602557|NCT01937715|101811602|FG000|NOT COMPLETED|Overall Study||0||
48602558|NCT01937715|101811603|FG001|NOT COMPLETED|Overall Study||1||
48602559|NCT01937715|101811604|FG002|NOT COMPLETED|Overall Study||0||
48602560|NCT01937715|101811605|FG003|NOT COMPLETED|Overall Study||4||
48602561|NCT01937715|101811606|FG004|NOT COMPLETED|Overall Study||2||
48602562|NCT02007278|101811607|FG000|STARTED|Overall Study||20||
48602563|NCT02007278|101811608|FG001|STARTED|Overall Study||20||
48602564|NCT02007278|101811607|FG000|COMPLETED|Overall Study||18||
48602565|NCT02007278|101811608|FG001|COMPLETED|Overall Study||17||
48602566|NCT02007278|101811607|FG000|NOT COMPLETED|Overall Study||2||
48602567|NCT02007278|101811608|FG001|NOT COMPLETED|Overall Study||3||
48602568|NCT03706469|101811609|FG000|STARTED|Overall Study||4||
48602569|NCT03706469|101811610|FG001|STARTED|Overall Study||4||
48602570|NCT03706469|101811611|FG002|STARTED|Overall Study||4||
48602571|NCT03706469|101811612|FG003|STARTED|Overall Study||4||
48602572|NCT03706469|101811609|FG000|COMPLETED|Overall Study||4||
48602573|NCT03706469|101811610|FG001|COMPLETED|Overall Study||4||
48602574|NCT03706469|101811611|FG002|COMPLETED|Overall Study||4||
48602575|NCT03706469|101811612|FG003|COMPLETED|Overall Study||4||
48602576|NCT03706469|101811609|FG000|NOT COMPLETED|Overall Study||0||
48602577|NCT03706469|101811610|FG001|NOT COMPLETED|Overall Study||0||
48602578|NCT03706469|101811611|FG002|NOT COMPLETED|Overall Study||0||
48602579|NCT03706469|101811612|FG003|NOT COMPLETED|Overall Study||0||
48602580|NCT03275389|101811613|FG000|STARTED|Overall Study||45||
48602581|NCT03275389|101811614|FG001|STARTED|Overall Study||46||
48602582|NCT03275389|101811615|FG002|STARTED|Overall Study||47||
48602583|NCT03275389|101811616|FG003|STARTED|Overall Study||47||
48602584|NCT03275389|101811617|FG004|STARTED|Overall Study||48||
48602585|NCT03275389|101811618|FG005|STARTED|Overall Study||47||
48602586|NCT03275389|101811619|FG006|STARTED|Overall Study||47||
48602587|NCT03275389|101811620|FG007|STARTED|Overall Study||48||
48602588|NCT03275389|101811621|FG008|STARTED|Overall Study||46||
48602589|NCT03275389|101811622|FG009|STARTED|Overall Study||47||
48602590|NCT03275389|101811613|FG000|COMPLETED|Overall Study||34||
48602591|NCT03275389|101811614|FG001|COMPLETED|Overall Study||30||
48602592|NCT03275389|101811615|FG002|COMPLETED|Overall Study||24||
48602593|NCT03275389|101811616|FG003|COMPLETED|Overall Study||25||
48602594|NCT03275389|101811617|FG004|COMPLETED|Overall Study||32||
48602595|NCT03275389|101811618|FG005|COMPLETED|Overall Study||29||
48602596|NCT03275389|101811619|FG006|COMPLETED|Overall Study||22||
48602597|NCT03275389|101811620|FG007|COMPLETED|Overall Study||30||
48602598|NCT03275389|101811621|FG008|COMPLETED|Overall Study||31||
48602599|NCT03275389|101811622|FG009|COMPLETED|Overall Study||29||
48602600|NCT03275389|101811613|FG000|NOT COMPLETED|Overall Study||11||
48602601|NCT03275389|101811614|FG001|NOT COMPLETED|Overall Study||16||
48602602|NCT03275389|101811615|FG002|NOT COMPLETED|Overall Study||23||
48602603|NCT03275389|101811616|FG003|NOT COMPLETED|Overall Study||22||
48602604|NCT03275389|101811617|FG004|NOT COMPLETED|Overall Study||16||
48602605|NCT03275389|101811618|FG005|NOT COMPLETED|Overall Study||18||
48602606|NCT03275389|101811619|FG006|NOT COMPLETED|Overall Study||25||
48602607|NCT03275389|101811620|FG007|NOT COMPLETED|Overall Study||18||
48767584|NCT01435382|102222774|FG003|COMPLETED|Overall Study||10||
48147053|NCT03663231|100682459|FG000|COMPLETED|Washout||14||
48147054|NCT03663231|100682460|FG001|COMPLETED|Washout||12||
48147055|NCT03663231|100682459|FG000|NOT COMPLETED|Washout||0||
48602608|NCT03275389|101811621|FG008|NOT COMPLETED|Overall Study||15||
48602609|NCT03275389|101811622|FG009|NOT COMPLETED|Overall Study||18||
48602610|NCT00893971|101811623|FG000|STARTED|Overall Study||16||
48602611|NCT00893971|101811623|FG000|Placebo + GP MDI (PT001)|Overall Study||15||
48602612|NCT00893971|101811623|FG000|Placebo + GFF MDI (PT003)|Overall Study||15||
48147056|NCT03663231|100682460|FG001|NOT COMPLETED|Washout||0||
48147057|NCT03663231|100682459|FG000|STARTED|Second Intervention||14||
48147058|NCT03663231|100682460|FG001|STARTED|Second Intervention||12||
48147059|NCT03663231|100682459|FG000|COMPLETED|Second Intervention||14||
48147060|NCT03663231|100682460|FG001|COMPLETED|Second Intervention||12||
48147061|NCT03663231|100682459|FG000|NOT COMPLETED|Second Intervention||0||
48147062|NCT03663231|100682460|FG001|NOT COMPLETED|Second Intervention||0||
48147063|NCT01563536|100682461|FG000|STARTED|Overall Study||6||
48147064|NCT01563536|100682462|FG001|STARTED|Overall Study||6||
48147065|NCT01563536|100682461|FG000|COMPLETED|Overall Study||5||
48147066|NCT01563536|100682462|FG001|COMPLETED|Overall Study||4||
48147067|NCT01563536|100682461|FG000|NOT COMPLETED|Overall Study||1||
48147068|NCT01563536|100682462|FG001|NOT COMPLETED|Overall Study||2||
48405278|NCT04728815|101325245|FG006|STARTED|Overall Study||26||
48602613|NCT00893971|101811623|FG000|Placebo + FF MDI (PT005)|Overall Study||13||
48602614|NCT00893971|101811623|FG000|GP MDI (PT001) + FF MDI (PT005)|Overall Study||16||
48602615|NCT00893971|101811623|FG000|COMPLETED|Overall Study||13||
48602616|NCT00893971|101811623|FG000|NOT COMPLETED|Overall Study||3||
48602617|NCT02242019|101811624|FG000|STARTED|Overall Study||109||
48602618|NCT02242019|101811624|FG000|COMPLETED|Overall Study||109||
48602619|NCT02242019|101811624|FG000|NOT COMPLETED|Overall Study||0||
48602620|NCT03688802|101811625|FG000|STARTED|Overall Study||12||
48602621|NCT03688802|101811626|FG001|STARTED|Overall Study||6||
48602622|NCT03688802|101811625|FG000|COMPLETED|Overall Study||11||
48602623|NCT03688802|101811626|FG001|COMPLETED|Overall Study||6||
48602624|NCT03688802|101811625|FG000|NOT COMPLETED|Overall Study||1||
48602625|NCT03688802|101811626|FG001|NOT COMPLETED|Overall Study||0||
48602626|NCT00423813|101811627|FG000|STARTED|Overall Study||188||
48602627|NCT00423813|101811628|FG001|STARTED|Overall Study||195||
48602628|NCT00423813|101811629|FG002|STARTED|Overall Study||190||
48602629|NCT00423813|101811627|FG000|Treated|Overall Study||188||
48602630|NCT00423813|101811628|FG001|Treated|Overall Study||194||
48602631|NCT00423813|101811629|FG002|Treated|Overall Study||189||
48602632|NCT00423813|101811627|FG000|COMPLETED|Overall Study||131||
48602633|NCT00423813|101811628|FG001|COMPLETED|Overall Study||129||
48602634|NCT00423813|101811629|FG002|COMPLETED|Overall Study||116||
48602635|NCT00423813|101811627|FG000|NOT COMPLETED|Overall Study||57||
48602636|NCT00423813|101811628|FG001|NOT COMPLETED|Overall Study||66||
48602637|NCT00423813|101811629|FG002|NOT COMPLETED|Overall Study||74||
48602638|NCT01900899|101811630|FG000|STARTED|Overall Study||159||
48602639|NCT01900899|101811631|FG001|STARTED|Overall Study||25||
48602640|NCT01900899|101811630|FG000|COMPLETED|Overall Study||150||
48602641|NCT01900899|101811631|FG001|COMPLETED|Overall Study||24||
48602642|NCT01900899|101811630|FG000|NOT COMPLETED|Overall Study||9||
48602643|NCT01900899|101811631|FG001|NOT COMPLETED|Overall Study||1||
48602644|NCT02557516|101811632|FG000|STARTED|Overall Study||3||
48602645|NCT02557516|101811633|FG001|STARTED|Overall Study||6||
48602646|NCT02557516|101811634|FG002|STARTED|Overall Study||4||
48602647|NCT02557516|101811635|FG003|STARTED|Overall Study||9||
48602648|NCT02557516|101811632|FG000|COMPLETED|Overall Study||2||
48602649|NCT02557516|101811633|FG001|COMPLETED|Overall Study||1||
48602650|NCT02557516|101811634|FG002|COMPLETED|Overall Study||0||
48602651|NCT02557516|101811635|FG003|COMPLETED|Overall Study||0||
48602652|NCT02557516|101811632|FG000|NOT COMPLETED|Overall Study||1||
48602653|NCT02557516|101811633|FG001|NOT COMPLETED|Overall Study||5||
48602654|NCT02557516|101811634|FG002|NOT COMPLETED|Overall Study||4||
48602655|NCT02557516|101811635|FG003|NOT COMPLETED|Overall Study||9||
48602656|NCT01897792|101811636|FG000|STARTED|Overall Study||6||
48300964|NCT01581541|101064045|FG000|NOT COMPLETED|Overall Study||0||
48300965|NCT01581541|101064046|FG001|NOT COMPLETED|Overall Study||0||
48300966|NCT01581541|101064047|FG002|NOT COMPLETED|Overall Study||0||
48300967|NCT01581541|101064048|FG003|NOT COMPLETED|Overall Study||0||
48300968|NCT01581541|101064049|FG004|NOT COMPLETED|Overall Study||0||
48300969|NCT01581541|101064050|FG005|NOT COMPLETED|Overall Study||0||
48300970|NCT01581541|101064051|FG006|NOT COMPLETED|Overall Study||0||
48300971|NCT01581541|101064052|FG007|NOT COMPLETED|Overall Study||0||
48300972|NCT01581541|101064053|FG008|NOT COMPLETED|Overall Study||0||
48300973|NCT01581541|101064054|FG009|NOT COMPLETED|Overall Study||0||
48300974|NCT01581541|101064055|FG010|NOT COMPLETED|Overall Study||0||
48300975|NCT00388154|101064056|FG000|STARTED|Overall Study||21||
48300976|NCT00388154|101064056|FG000|COMPLETED|Overall Study||20||
48300977|NCT00388154|101064056|FG000|NOT COMPLETED|Overall Study||1||
48300978|NCT03142438|101064057|FG000|STARTED|Overall Study||57||
48300979|NCT03142438|101064057|FG000|COMPLETED|Overall Study||57||
48300980|NCT03142438|101064057|FG000|NOT COMPLETED|Overall Study||0||
48300981|NCT01009203|101064058|FG000|STARTED|Overall Study||13||
48300982|NCT01009203|101064058|FG000|Received Treatment|Overall Study||12||
48300983|NCT01009203|101064058|FG000|COMPLETED|Overall Study||6||
48300984|NCT01009203|101064058|FG000|NOT COMPLETED|Overall Study||7||
48300985|NCT02080455|101064059|FG000|STARTED|Overall Study||16||
48300986|NCT02080455|101064060|FG001|STARTED|Overall Study||16||
48300987|NCT02080455|101064059|FG000|COMPLETED|Overall Study||16||
48300988|NCT02080455|101064060|FG001|COMPLETED|Overall Study||16||
48300989|NCT02080455|101064059|FG000|NOT COMPLETED|Overall Study||0||
48300990|NCT02080455|101064060|FG001|NOT COMPLETED|Overall Study||0||
48300991|NCT05097716|101064061|FG000|STARTED|Period 1||12||
48300992|NCT05097716|101064061|FG000|COMPLETED|Period 1||10||
48300993|NCT05097716|101064061|FG000|NOT COMPLETED|Period 1||2||
48300994|NCT05097716|101064061|FG000|STARTED|Period 2||10||
48300995|NCT05097716|101064061|FG000|COMPLETED|Period 2||10||
48300996|NCT05097716|101064061|FG000|NOT COMPLETED|Period 2||0||
48300997|NCT00538304|101064062|FG000|STARTED|Overall Study||151||
48300998|NCT00538304|101064063|FG001|STARTED|Overall Study||71||
48300999|NCT00538304|101064062|FG000|COMPLETED|Overall Study||144||
48602657|NCT01897792|101811637|FG001|STARTED|Overall Study||5||
48602658|NCT01897792|101811636|FG000|COMPLETED|Overall Study||6||
48602659|NCT01897792|101811637|FG001|COMPLETED|Overall Study||5||
48602660|NCT01897792|101811636|FG000|NOT COMPLETED|Overall Study||0||
48602661|NCT01897792|101811637|FG001|NOT COMPLETED|Overall Study||0||
48602662|NCT02334384|101811638|FG000|STARTED|Overall Study||4||
48602663|NCT02334384|101811639|FG001|STARTED|Overall Study||2||
48602664|NCT02334384|101811638|FG000|COMPLETED|Overall Study||3||
48602665|NCT02334384|101811639|FG001|COMPLETED|Overall Study||1||
48602666|NCT02334384|101811638|FG000|NOT COMPLETED|Overall Study||1||
48602667|NCT02334384|101811639|FG001|NOT COMPLETED|Overall Study||1||
48602668|NCT03055494|101811640|FG000|STARTED|Overall Study||54||
48602669|NCT03055494|101811641|FG001|STARTED|Overall Study||28||
48301000|NCT00538304|101064063|FG001|COMPLETED|Overall Study||66||
48301001|NCT00538304|101064062|FG000|NOT COMPLETED|Overall Study||7||
48301002|NCT00538304|101064063|FG001|NOT COMPLETED|Overall Study||5||
48301003|NCT00954174|101064064|FG000|STARTED|Overall Study||268||
48301004|NCT00954174|101064065|FG001|STARTED|Overall Study||268||
48301005|NCT00954174|101064066|FG002|STARTED|Overall Study||51||
48301006|NCT00954174|101064067|FG003|STARTED|Overall Study||50||
48301007|NCT00954174|101064064|FG000|COMPLETED|Overall Study||142||
48301008|NCT00954174|101064065|FG001|COMPLETED|Overall Study||145||
48301009|NCT00954174|101064066|FG002|COMPLETED|Overall Study||27||
48301010|NCT00954174|101064067|FG003|COMPLETED|Overall Study||25||
48301011|NCT00954174|101064064|FG000|NOT COMPLETED|Overall Study||126||
48301012|NCT00954174|101064065|FG001|NOT COMPLETED|Overall Study||123||
48301013|NCT00954174|101064066|FG002|NOT COMPLETED|Overall Study||24||
48301014|NCT00954174|101064067|FG003|NOT COMPLETED|Overall Study||25||
48301015|NCT00982007|101064068|FG000|STARTED|Overall Study||250||
48301016|NCT00982007|101064069|FG001|STARTED|Overall Study||257||
48602670|NCT03055494|101811640|FG000|COMPLETED|Overall Study||44||
48602671|NCT03055494|101811641|FG001|COMPLETED|Overall Study||27||
48602672|NCT03055494|101811640|FG000|NOT COMPLETED|Overall Study||10||
48602673|NCT03055494|101811641|FG001|NOT COMPLETED|Overall Study||1||
48602674|NCT02584959|101811642|FG000|STARTED|Period 1||31||
48602675|NCT02584959|101811643|FG001|STARTED|Period 1||29||
48602676|NCT02584959|101811644|FG002|STARTED|Period 1||15||
48602677|NCT02584959|101811642|FG000|COMPLETED|Period 1||28||
48602678|NCT02584959|101811643|FG001|COMPLETED|Period 1||25||
48602679|NCT02584959|101811644|FG002|COMPLETED|Period 1||15||
48602680|NCT02584959|101811642|FG000|NOT COMPLETED|Period 1||3||
48602681|NCT02584959|101811643|FG001|NOT COMPLETED|Period 1||4||
48602682|NCT02584959|101811644|FG002|NOT COMPLETED|Period 1||0||
48602683|NCT02584959|101811642|FG000|STARTED|Period 2||28||
48602684|NCT02584959|101811643|FG001|STARTED|Period 2||25||
48301017|NCT00982007|101064070|FG002|STARTED|Overall Study||253||
48301018|NCT00982007|101064071|FG003|STARTED|Overall Study||251||
48301019|NCT00982007|101064068|FG000|COMPLETED|Overall Study||246||
48301020|NCT00982007|101064069|FG001|COMPLETED|Overall Study||253||
48301021|NCT00982007|101064070|FG002|COMPLETED|Overall Study||253||
48301022|NCT00982007|101064071|FG003|COMPLETED|Overall Study||245||
48301023|NCT00982007|101064068|FG000|NOT COMPLETED|Overall Study||4||
48301024|NCT00982007|101064069|FG001|NOT COMPLETED|Overall Study||4||
48301025|NCT00982007|101064070|FG002|NOT COMPLETED|Overall Study||0||
48301026|NCT00982007|101064071|FG003|NOT COMPLETED|Overall Study||6||
48301027|NCT05211739|101064072|FG000|STARTED|First Wear Period (Approx 30 Days)||36||72
48301028|NCT05211739|101064073|FG001|STARTED|First Wear Period (Approx 30 Days)||38||76
48602685|NCT02584959|101811644|FG002|STARTED|Period 2||15||
48602686|NCT02584959|101811642|FG000|COMPLETED|Period 2||22||
48301029|NCT05211739|101064072|FG000|Exposed to Study Lenses|First Wear Period (Approx 30 Days)||35||70
48301030|NCT05211739|101064073|FG001|Exposed to Study Lenses|First Wear Period (Approx 30 Days)||38||76
48301031|NCT05211739|101064072|FG000|COMPLETED|First Wear Period (Approx 30 Days)||35||70
48301032|NCT05211739|101064073|FG001|COMPLETED|First Wear Period (Approx 30 Days)||36||72
48301033|NCT05211739|101064072|FG000|NOT COMPLETED|First Wear Period (Approx 30 Days)||1||2
48301034|NCT05211739|101064073|FG001|NOT COMPLETED|First Wear Period (Approx 30 Days)||2||4
48405279|NCT04728815|101325246|FG007|STARTED|Overall Study||16||
48602687|NCT02584959|101811643|FG001|COMPLETED|Period 2||24||
48602688|NCT02584959|101811644|FG002|COMPLETED|Period 2||13||
48301035|NCT05211739|101064072|FG000|STARTED|Second Wear Period (Approx 30 Days)||35||70
48301036|NCT05211739|101064073|FG001|STARTED|Second Wear Period (Approx 30 Days)||36||72
48301037|NCT05211739|101064072|FG000|COMPLETED|Second Wear Period (Approx 30 Days)||34||68
48301038|NCT05211739|101064073|FG001|COMPLETED|Second Wear Period (Approx 30 Days)||36||72
48301039|NCT05211739|101064072|FG000|NOT COMPLETED|Second Wear Period (Approx 30 Days)||1||2
48301040|NCT05211739|101064073|FG001|NOT COMPLETED|Second Wear Period (Approx 30 Days)||0||0
48301041|NCT04256603|101064074|FG000|STARTED|Overall Study||21||
48301042|NCT04256603|101064075|FG001|STARTED|Overall Study||6||
48301043|NCT04256603|101064074|FG000|COMPLETED|Overall Study||21||
48301044|NCT04256603|101064075|FG001|COMPLETED|Overall Study||6||
48301045|NCT04256603|101064074|FG000|NOT COMPLETED|Overall Study||0||
48602689|NCT02584959|101811642|FG000|NOT COMPLETED|Period 2||6||
48602690|NCT02584959|101811643|FG001|NOT COMPLETED|Period 2||1||
48602691|NCT02584959|101811644|FG002|NOT COMPLETED|Period 2||2||
48301046|NCT04256603|101064075|FG001|NOT COMPLETED|Overall Study||0||
48301047|NCT01351623|101064076|FG000|STARTED|Overall Study||44||
48301048|NCT01351623|101064076|FG000|COMPLETED|Overall Study||35||
48301049|NCT01351623|101064076|FG000|NOT COMPLETED|Overall Study||9||
48301050|NCT00782288|101064077|FG000|STARTED|Overall Study||8||
48301051|NCT00782288|101064078|FG001|STARTED|Overall Study||8||
48301052|NCT00782288|101064079|FG002|STARTED|Overall Study||8||
48301053|NCT00782288|101064077|FG000|COMPLETED|Overall Study||8||
48301054|NCT00782288|101064078|FG001|COMPLETED|Overall Study||8||
48301055|NCT00782288|101064079|FG002|COMPLETED|Overall Study||8||
48301056|NCT00782288|101064077|FG000|NOT COMPLETED|Overall Study||0||
48301057|NCT00782288|101064078|FG001|NOT COMPLETED|Overall Study||0||
48301058|NCT00782288|101064079|FG002|NOT COMPLETED|Overall Study||0||
48301059|NCT00293722|101064080|FG000|STARTED|Overall Study||1291||
48301060|NCT00293722|101064080|FG000|COMPLETED|Overall Study||864||
48301061|NCT00293722|101064080|FG000|NOT COMPLETED|Overall Study||427||
48301062|NCT02547233|101064081|FG000|STARTED|3-day Treatment and 8-week Follow-up||205||
48301063|NCT02547233|101064082|FG001|STARTED|3-day Treatment and 8-week Follow-up||102||
48301064|NCT02547233|101064081|FG000|Treated|3-day Treatment and 8-week Follow-up||205||
48405280|NCT04728815|101325239|FG000|COMPLETED|Overall Study||9||
48405281|NCT04728815|101325240|FG001|COMPLETED|Overall Study||3||
48405282|NCT04728815|101325241|FG002|COMPLETED|Overall Study||5||
48405283|NCT04728815|101325242|FG003|COMPLETED|Overall Study||3||
48405284|NCT04728815|101325243|FG004|COMPLETED|Overall Study||3||
48405285|NCT04728815|101325244|FG005|COMPLETED|Overall Study||0||
48405286|NCT04728815|101325245|FG006|COMPLETED|Overall Study||14||
48405287|NCT04728815|101325246|FG007|COMPLETED|Overall Study||16||
48405288|NCT04728815|101325239|FG000|NOT COMPLETED|Overall Study||3||
48405289|NCT04728815|101325240|FG001|NOT COMPLETED|Overall Study||5||
48405290|NCT04728815|101325241|FG002|NOT COMPLETED|Overall Study||5||
48405291|NCT04728815|101325242|FG003|NOT COMPLETED|Overall Study||1||
48405292|NCT04728815|101325243|FG004|NOT COMPLETED|Overall Study||4||
48405293|NCT04728815|101325244|FG005|NOT COMPLETED|Overall Study||1||
48405294|NCT04728815|101325245|FG006|NOT COMPLETED|Overall Study||12||
48405295|NCT04728815|101325246|FG007|NOT COMPLETED|Overall Study||0||
48405296|NCT01624467|101325247|FG000|STARTED|Overall Study||75||
48405297|NCT01624467|101325247|FG000|Received at Least One Dose of Study Drug|Overall Study||75||
48405298|NCT01624467|101325247|FG000|COMPLETED|Overall Study||44||
48405299|NCT01624467|101325247|FG000|NOT COMPLETED|Overall Study||31||
48405300|NCT01764022|101325248|FG000|STARTED|Overall Study||115||
48405301|NCT01764022|101325249|FG001|STARTED|Overall Study||110||
48301065|NCT02547233|101064082|FG001|Treated|3-day Treatment and 8-week Follow-up||100||
48301066|NCT02547233|101064081|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||203||
48301067|NCT02547233|101064082|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||92||
48301068|NCT02547233|101064081|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||2||
48301069|NCT02547233|101064082|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||10||
48301070|NCT02547233|101064081|FG000|STARTED|12-month Follow-up||199||
48301071|NCT02547233|101064082|FG001|STARTED|12-month Follow-up||84||
48301072|NCT02547233|101064081|FG000|COMPLETED|12-month Follow-up||185||
48301073|NCT02547233|101064082|FG001|COMPLETED|12-month Follow-up||67||
48301074|NCT02547233|101064081|FG000|NOT COMPLETED|12-month Follow-up||14||
48301075|NCT02547233|101064082|FG001|NOT COMPLETED|12-month Follow-up||17||
48301076|NCT02563093|101064083|FG000|STARTED|Overall Study||52||
48301077|NCT02563093|101064084|FG001|STARTED|Overall Study||52||
48301078|NCT02563093|101064085|FG002|STARTED|Overall Study||53||
48301079|NCT02563093|101064086|FG003|STARTED|Overall Study||51||
48405302|NCT01764022|101325248|FG000|Received at Least 1 Dose of Study Drug|Overall Study||113||
48405303|NCT01764022|101325249|FG001|Received at Least 1 Dose of Study Drug|Overall Study||110||
48405304|NCT01764022|101325248|FG000|COMPLETED|Overall Study||107|Received 6 cycles of therapy during main period of the study or had disease progression|
48440010|NCT03046966|101410010|FG001|STARTED|Overall Study||51||
48147069|NCT04050865|100682463|FG000|STARTED|Overall Study||48||
48602692|NCT01938989|101811645|FG000|STARTED|Overall Study||77||
48602693|NCT01938989|101811646|FG001|STARTED|Overall Study||77||
48147070|NCT04050865|100682464|FG001|STARTED|Overall Study||48||
48147071|NCT04050865|100682463|FG000|COMPLETED|Overall Study||44||
48147072|NCT04050865|100682464|FG001|COMPLETED|Overall Study||43||
48147073|NCT04050865|100682463|FG000|NOT COMPLETED|Overall Study||4||
48147074|NCT04050865|100682464|FG001|NOT COMPLETED|Overall Study||5||
48147075|NCT02472964|100682465|FG000|STARTED|Part 1 (up to Week 24)||246|The disposition of the patients has been provided for the safety sample population.|
48147076|NCT02472964|100682466|FG001|STARTED|Part 1 (up to Week 24)||247|The disposition of the patients has been provided for the safety sample population.|
48147077|NCT02472964|100682465|FG000|COMPLETED|Part 1 (up to Week 24)||171||
48147078|NCT02472964|100682466|FG001|COMPLETED|Part 1 (up to Week 24)||185||
48147079|NCT02472964|100682465|FG000|NOT COMPLETED|Part 1 (up to Week 24)||75||
48147080|NCT02472964|100682466|FG001|NOT COMPLETED|Part 1 (up to Week 24)||62||
48147081|NCT02472964|100682465|FG000|STARTED|Part 2 (Week 24-week 48)||163|The disposition of the patients has been provided for the safety sample.|
48147082|NCT02472964|100682466|FG001|STARTED|Part 2 (Week 24-week 48)||179|The disposition of the patients has been provided for the safety sample.|
48147083|NCT02472964|100682465|FG000|COMPLETED|Part 2 (Week 24-week 48)||98||
48147084|NCT02472964|100682466|FG001|COMPLETED|Part 2 (Week 24-week 48)||116||
48147085|NCT02472964|100682465|FG000|NOT COMPLETED|Part 2 (Week 24-week 48)||65||
48147086|NCT02472964|100682466|FG001|NOT COMPLETED|Part 2 (Week 24-week 48)||63||
48147087|NCT01580072|100682467|FG000|STARTED|Overall Study||28||
48147088|NCT01580072|100682468|FG001|STARTED|Overall Study||37||
48147089|NCT01580072|100682469|FG002|STARTED|Overall Study||0||
48147090|NCT01580072|100682467|FG000|COMPLETED|Overall Study||16||
48147091|NCT01580072|100682468|FG001|COMPLETED|Overall Study||28||
48147092|NCT01580072|100682469|FG002|COMPLETED|Overall Study||0||
48147093|NCT01580072|100682467|FG000|NOT COMPLETED|Overall Study||12||
48147094|NCT01580072|100682468|FG001|NOT COMPLETED|Overall Study||9||
48147095|NCT01580072|100682469|FG002|NOT COMPLETED|Overall Study||0||
48147096|NCT02948569|100682470|FG000|STARTED|Overall Study||12||
48147097|NCT02948569|100682470|FG000|COMPLETED|Overall Study||12||
48147098|NCT02948569|100682470|FG000|NOT COMPLETED|Overall Study||0||
48147099|NCT01791725|100682471|FG000|STARTED|Overall Study||12||
48147100|NCT01791725|100682472|FG001|STARTED|Overall Study||5||
48147101|NCT01791725|100682473|FG002|STARTED|Overall Study||6||
48147102|NCT01791725|100682471|FG000|COMPLETED|Overall Study||12||
48147103|NCT01791725|100682472|FG001|COMPLETED|Overall Study||4||
48147104|NCT01791725|100682473|FG002|COMPLETED|Overall Study||6||
48147105|NCT01791725|100682471|FG000|NOT COMPLETED|Overall Study||0||
48147106|NCT01791725|100682472|FG001|NOT COMPLETED|Overall Study||1||
48147107|NCT01791725|100682473|FG002|NOT COMPLETED|Overall Study||0||
48147108|NCT03318523|100682474|FG000|STARTED|PC Period: Up to Year 1||100||
48147109|NCT03318523|100682475|FG001|STARTED|PC Period: Up to Year 1||55||
48147110|NCT03318523|100682476|FG002|STARTED|PC Period: Up to Year 1||102||
48147111|NCT03318523|100682477|FG003|STARTED|PC Period: Up to Year 1||100||
48147112|NCT03318523|100682478|FG004|STARTED|PC Period: Up to Year 1||0||
48147113|NCT03318523|100682479|FG005|STARTED|PC Period: Up to Year 1||0||
48147114|NCT03318523|100682480|FG006|STARTED|PC Period: Up to Year 1||0||
48147115|NCT03318523|100682481|FG007|STARTED|PC Period: Up to Year 1||0||
48147116|NCT03318523|100682482|FG008|STARTED|PC Period: Up to Year 1||0||
48147117|NCT03318523|100682483|FG009|STARTED|PC Period: Up to Year 1||0||
48147118|NCT03318523|100682474|FG000|COMPLETED|PC Period: Up to Year 1||96||
48147119|NCT03318523|100682475|FG001|COMPLETED|PC Period: Up to Year 1||53||
48147120|NCT03318523|100682476|FG002|COMPLETED|PC Period: Up to Year 1||100||
48147121|NCT03318523|100682477|FG003|COMPLETED|PC Period: Up to Year 1||96||
48147122|NCT03318523|100682478|FG004|COMPLETED|PC Period: Up to Year 1||0||
48147123|NCT03318523|100682479|FG005|COMPLETED|PC Period: Up to Year 1||0||
48147124|NCT03318523|100682480|FG006|COMPLETED|PC Period: Up to Year 1||0||
48147125|NCT03318523|100682481|FG007|COMPLETED|PC Period: Up to Year 1||0||
48147126|NCT03318523|100682482|FG008|COMPLETED|PC Period: Up to Year 1||0||
48147127|NCT03318523|100682483|FG009|COMPLETED|PC Period: Up to Year 1||0||
48147128|NCT03318523|100682474|FG000|NOT COMPLETED|PC Period: Up to Year 1||4||
48147129|NCT03318523|100682475|FG001|NOT COMPLETED|PC Period: Up to Year 1||2||
48147130|NCT03318523|100682476|FG002|NOT COMPLETED|PC Period: Up to Year 1||2||
48147131|NCT03318523|100682477|FG003|NOT COMPLETED|PC Period: Up to Year 1||4||
48147132|NCT03318523|100682478|FG004|NOT COMPLETED|PC Period: Up to Year 1||0||
48147133|NCT03318523|100682479|FG005|NOT COMPLETED|PC Period: Up to Year 1||0||
48147134|NCT03318523|100682480|FG006|NOT COMPLETED|PC Period: Up to Year 1||0||
48147135|NCT03318523|100682481|FG007|NOT COMPLETED|PC Period: Up to Year 1||0||
48147136|NCT03318523|100682482|FG008|NOT COMPLETED|PC Period: Up to Year 1||0||
48147137|NCT03318523|100682483|FG009|NOT COMPLETED|PC Period: Up to Year 1||0||
48147138|NCT03318523|100682474|FG000|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0|Out of 345 participants who completed the PC Period, only 344 entered the DBE Period.|
48147139|NCT03318523|100682475|FG001|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0|Out of 345 participants who completed the PC Period, only 344 entered the DBE Period.|
48147140|NCT03318523|100682476|FG002|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0|Out of 345 participants who completed the PC Period, only 344 entered the DBE Period.|
48602694|NCT01938989|101811645|FG000|COMPLETED|Overall Study||77||
48301080|NCT02563093|101064083|FG000|COMPLETED|Overall Study||52||
48301081|NCT02563093|101064084|FG001|COMPLETED|Overall Study||52||
48301082|NCT02563093|101064085|FG002|COMPLETED|Overall Study||53||
48301083|NCT02563093|101064086|FG003|COMPLETED|Overall Study||51||
48301084|NCT02563093|101064083|FG000|NOT COMPLETED|Overall Study||0||
48301085|NCT02563093|101064084|FG001|NOT COMPLETED|Overall Study||0||
48301086|NCT02563093|101064085|FG002|NOT COMPLETED|Overall Study||0||
48301087|NCT02563093|101064086|FG003|NOT COMPLETED|Overall Study||0||
48301088|NCT01009034|101064087|FG000|STARTED|Overall Study||14||
48301089|NCT01009034|101064087|FG000|COMPLETED|Overall Study||10||
48301090|NCT01009034|101064087|FG000|NOT COMPLETED|Overall Study||4||
48301091|NCT02460497|101064088|FG000|STARTED|Overall Study||61||
48301092|NCT02460497|101064088|FG000|Intent-to-treat (ITT) Population|Overall Study||54||
48301093|NCT02460497|101064088|FG000|Safety Population (SP)|Overall Study||60||
48301094|NCT02460497|101064088|FG000|COMPLETED|Overall Study||52||
48301095|NCT02460497|101064088|FG000|NOT COMPLETED|Overall Study||9||
48301096|NCT04620811|101064089|FG000|STARTED|Overall Study||75||
48301097|NCT04620811|101064090|FG001|STARTED|Overall Study||84||
48301098|NCT04620811|101064089|FG000|COMPLETED|Overall Study||42||
48301099|NCT04620811|101064090|FG001|COMPLETED|Overall Study||40||
48301100|NCT04620811|101064089|FG000|NOT COMPLETED|Overall Study||33||
48301101|NCT04620811|101064090|FG001|NOT COMPLETED|Overall Study||44||
48301102|NCT00528866|101064091|FG000|STARTED|Overall Study||80||
48301103|NCT00528866|101064091|FG000|COMPLETED|Overall Study||74||
48301104|NCT00528866|101064091|FG000|NOT COMPLETED|Overall Study||6||
48301105|NCT01605253|101064092|FG000|STARTED|Overall Study||13||
48301106|NCT01605253|101064093|FG001|STARTED|Overall Study||12||
48301107|NCT01605253|101064092|FG000|COMPLETED|Overall Study||7||
48301108|NCT01605253|101064093|FG001|COMPLETED|Overall Study||9||
48301109|NCT01605253|101064092|FG000|NOT COMPLETED|Overall Study||6||
48301110|NCT01605253|101064093|FG001|NOT COMPLETED|Overall Study||3||
48301111|NCT01478360|101064094|FG000|STARTED|Overall Study||31||
48301112|NCT01478360|101064095|FG001|STARTED|Overall Study||15||
48301113|NCT01478360|101064094|FG000|PD (Pharmacodynamic) Analysis Set|Overall Study||31||
48301114|NCT01478360|101064095|FG001|PD (Pharmacodynamic) Analysis Set|Overall Study||15||
48301115|NCT01478360|101064094|FG000|PK (Pharmacokinetics) Analysis Set|Overall Study||31||
48602695|NCT01938989|101811646|FG001|COMPLETED|Overall Study||77||
48602696|NCT01938989|101811645|FG000|NOT COMPLETED|Overall Study||0||
48301116|NCT01478360|101064095|FG001|PK (Pharmacokinetics) Analysis Set|Overall Study||0||
48301117|NCT01478360|101064094|FG000|COMPLETED|Overall Study||29||
48301118|NCT01478360|101064095|FG001|COMPLETED|Overall Study||12||
48301119|NCT01478360|101064094|FG000|NOT COMPLETED|Overall Study||2||
48301120|NCT01478360|101064095|FG001|NOT COMPLETED|Overall Study||3||
48301121|NCT03933397|101064096|FG000|STARTED|Overall Study||162||
48602697|NCT01938989|101811646|FG001|NOT COMPLETED|Overall Study||0||
48301122|NCT03933397|101064097|FG001|STARTED|Overall Study||166||
48301123|NCT03933397|101064096|FG000|COMPLETED|Overall Study||50||
48301124|NCT03933397|101064097|FG001|COMPLETED|Overall Study||46||
48301125|NCT03933397|101064096|FG000|NOT COMPLETED|Overall Study||112||
48301126|NCT03933397|101064097|FG001|NOT COMPLETED|Overall Study||120||
48301127|NCT04968197|101064098|FG000|STARTED|Overall Study||23||
48602698|NCT03774394|101811647|FG000|STARTED|Overall Study||31||
48301128|NCT04968197|101064098|FG000|Control Condition|Overall Study||23||
48301129|NCT04968197|101064098|FG000|0.33mA Stochastic Vestibular Stimulation|Overall Study||23||
48301130|NCT04968197|101064098|FG000|0.67mA Stochastic Vestibular Stimulation|Overall Study||23||
48301131|NCT04968197|101064098|FG000|1mA Stochastic Vestibular Stimulation|Overall Study||23||
48301132|NCT04968197|101064098|FG000|COMPLETED|Overall Study||23||
48301133|NCT04968197|101064098|FG000|NOT COMPLETED|Overall Study||0||
48301134|NCT02064855|101064099|FG000|STARTED|Overall Study||108||
48301135|NCT02064855|101064099|FG000|COMPLETED|Overall Study||53||
48301136|NCT02064855|101064099|FG000|NOT COMPLETED|Overall Study||55||
48301137|NCT02717754|101064100|FG000|STARTED|Overall Study||10||
48301138|NCT02717754|101064101|FG001|STARTED|Overall Study||19||
48301139|NCT02717754|101064102|FG002|STARTED|Overall Study||20||
48301140|NCT02717754|101064103|FG003|STARTED|Overall Study||10||
48301141|NCT02717754|101064104|FG004|STARTED|Overall Study||20||
48301142|NCT02717754|101064105|FG005|STARTED|Overall Study||20||
48301143|NCT02717754|101064100|FG000|COMPLETED|Overall Study||10||
48301144|NCT02717754|101064101|FG001|COMPLETED|Overall Study||19||
48301145|NCT02717754|101064102|FG002|COMPLETED|Overall Study||20||
48602699|NCT03774394|101811648|FG001|STARTED|Overall Study||30||
48602700|NCT03774394|101811647|FG000|COMPLETED|Overall Study||29||
48602701|NCT03774394|101811648|FG001|COMPLETED|Overall Study||30||
48602702|NCT03774394|101811647|FG000|NOT COMPLETED|Overall Study||2||
48602703|NCT03774394|101811648|FG001|NOT COMPLETED|Overall Study||0||
48602704|NCT04114656|101811649|FG000|STARTED|Treatment Period1+Washout(Up to 28 Days)||11|Discontinuation data were collected until the end of the washout irrespective of whether each participant was in a particular period or began washout. The electronic case report form (eCRF) was not designed to differentiate data collection between treatment periods and washout periods|
48602705|NCT04114656|101811650|FG001|STARTED|Treatment Period1+Washout(Up to 28 Days)||10|Discontinuation data were collected until the end of the washout irrespective of whether each participant was in a particular period or began washout. The electronic case report form (eCRF) was not designed to differentiate data collection between treatment periods and washout periods|
48602706|NCT04114656|101811649|FG000|COMPLETED|Treatment Period1+Washout(Up to 28 Days)||9||
48602707|NCT04114656|101811650|FG001|COMPLETED|Treatment Period1+Washout(Up to 28 Days)||7||
48657075|NCT03648372|101943773|FG016|COMPLETED|Overall Study||1||
48301146|NCT02717754|101064103|FG003|COMPLETED|Overall Study||0||
48602708|NCT04114656|101811649|FG000|NOT COMPLETED|Treatment Period1+Washout(Up to 28 Days)||2||
48602709|NCT04114656|101811650|FG001|NOT COMPLETED|Treatment Period1+Washout(Up to 28 Days)||3||
48602710|NCT04114656|101811649|FG000|STARTED|Treatment Period2+Washout(Up to 28 Days)||9|Discontinuation data were collected until the end of the washout irrespective of whether each participant was in a particular period or began washout. The electronic case report form (eCRF) was not designed to differentiate data collection between treatment periods and washout periods|
48602711|NCT04114656|101811650|FG001|STARTED|Treatment Period2+Washout(Up to 28 Days)||7|Discontinuation data were collected until the end of the washout irrespective of whether each participant was in a particular period or began washout. The electronic case report form (eCRF) was not designed to differentiate data collection between treatment periods and washout periods|
48602712|NCT04114656|101811649|FG000|COMPLETED|Treatment Period2+Washout(Up to 28 Days)||9||
48602713|NCT04114656|101811650|FG001|COMPLETED|Treatment Period2+Washout(Up to 28 Days)||6||
48602714|NCT04114656|101811649|FG000|NOT COMPLETED|Treatment Period2+Washout(Up to 28 Days)||0||
48602715|NCT04114656|101811650|FG001|NOT COMPLETED|Treatment Period2+Washout(Up to 28 Days)||1||
48602716|NCT04114656|101811649|FG000|STARTED|Treatment Period 3 (Up to 28 Days)||9||
48602717|NCT04114656|101811650|FG001|STARTED|Treatment Period 3 (Up to 28 Days)||6||
48602718|NCT04114656|101811649|FG000|COMPLETED|Treatment Period 3 (Up to 28 Days)||9||
48301147|NCT02717754|101064104|FG004|COMPLETED|Overall Study||0||
48301148|NCT02717754|101064105|FG005|COMPLETED|Overall Study||0||
48301149|NCT02717754|101064100|FG000|NOT COMPLETED|Overall Study||0||
48602719|NCT04114656|101811650|FG001|COMPLETED|Treatment Period 3 (Up to 28 Days)||6||
48602720|NCT04114656|101811649|FG000|NOT COMPLETED|Treatment Period 3 (Up to 28 Days)||0||
48602721|NCT04114656|101811650|FG001|NOT COMPLETED|Treatment Period 3 (Up to 28 Days)||0||
48602722|NCT03066778|101811651|FG000|STARTED|Overall Study||228||
48602723|NCT03066778|101811652|FG001|STARTED|Overall Study||225||
48602724|NCT03066778|101811651|FG000|Treated|Overall Study||223||
48602725|NCT03066778|101811652|FG001|Treated|Overall Study||223||
48602726|NCT03066778|101811651|FG000|Received Second Course of Pembrolizumab|Overall Study||1||
48602727|NCT03066778|101811652|FG001|Received Second Course of Pembrolizumab|Overall Study||0||
48602728|NCT03066778|101811651|FG000|COMPLETED|Overall Study||28||
48602729|NCT03066778|101811652|FG001|COMPLETED|Overall Study||13||
48602730|NCT03066778|101811651|FG000|NOT COMPLETED|Overall Study||200||
48602731|NCT03066778|101811652|FG001|NOT COMPLETED|Overall Study||212||
48602732|NCT01348100|101811653|FG000|STARTED|Overall Study||2||
48602733|NCT01348100|101811654|FG001|STARTED|Overall Study||2||
48602734|NCT01348100|101811655|FG002|STARTED|Overall Study||15||
48602735|NCT01348100|101811656|FG003|STARTED|Overall Study||15||
48602736|NCT01348100|101811657|FG004|STARTED|Overall Study||15||
48602737|NCT01348100|101811658|FG005|STARTED|Overall Study||16||
48602738|NCT01348100|101811659|FG006|STARTED|Overall Study||16||
48602739|NCT01348100|101811653|FG000|COMPLETED|Overall Study||2||
48602740|NCT01348100|101811654|FG001|COMPLETED|Overall Study||2||
48602741|NCT01348100|101811655|FG002|COMPLETED|Overall Study||13||
48602742|NCT01348100|101811656|FG003|COMPLETED|Overall Study||14||
48602743|NCT01348100|101811657|FG004|COMPLETED|Overall Study||14||
48602744|NCT01348100|101811658|FG005|COMPLETED|Overall Study||14||
48602745|NCT01348100|101811659|FG006|COMPLETED|Overall Study||13||
48602746|NCT01348100|101811653|FG000|NOT COMPLETED|Overall Study||0||
48602747|NCT01348100|101811654|FG001|NOT COMPLETED|Overall Study||0||
48301150|NCT02717754|101064101|FG001|NOT COMPLETED|Overall Study||0||
48301151|NCT02717754|101064102|FG002|NOT COMPLETED|Overall Study||0||
48301152|NCT02717754|101064103|FG003|NOT COMPLETED|Overall Study||10||
48301153|NCT02717754|101064104|FG004|NOT COMPLETED|Overall Study||20||
48301154|NCT02717754|101064105|FG005|NOT COMPLETED|Overall Study||20||
48301155|NCT02204566|101064106|FG000|STARTED|Overall Study||5||
48301156|NCT02204566|101064106|FG000|COMPLETED|Overall Study||1||
48301157|NCT02204566|101064106|FG000|NOT COMPLETED|Overall Study||4||
48301158|NCT00162032|101064107|FG000|STARTED|Overall Study||329||
48301159|NCT00162032|101064108|FG001|STARTED|Overall Study||116||
48301160|NCT00162032|101064107|FG000|COMPLETED|Overall Study||324||
48301161|NCT00162032|101064108|FG001|COMPLETED|Overall Study||114||
48301162|NCT00162032|101064107|FG000|NOT COMPLETED|Overall Study||5||
48602748|NCT01348100|101811655|FG002|NOT COMPLETED|Overall Study||2||
48602749|NCT01348100|101811656|FG003|NOT COMPLETED|Overall Study||1||
48602750|NCT01348100|101811657|FG004|NOT COMPLETED|Overall Study||1||
48602751|NCT01348100|101811658|FG005|NOT COMPLETED|Overall Study||2||
48602752|NCT01348100|101811659|FG006|NOT COMPLETED|Overall Study||3||
48602753|NCT00123682|101811660|FG000|STARTED|Overall Study||1069||
48602754|NCT00123682|101811661|FG001|STARTED|Overall Study||934||
48602755|NCT00123682|101811662|FG002|STARTED|Overall Study||592||
48602756|NCT00123682|101811663|FG003|STARTED|Overall Study||525||
48602757|NCT00123682|101811660|FG000|COMPLETED|Overall Study||749||
48602758|NCT00123682|101811661|FG001|COMPLETED|Overall Study||731||
48301163|NCT00162032|101064108|FG001|NOT COMPLETED|Overall Study||2||
48301164|NCT01213589|101064109|FG000|STARTED|Overall Study||50||
48301165|NCT01213589|101064110|FG001|STARTED|Overall Study||24||
48602759|NCT00123682|101811662|FG002|COMPLETED|Overall Study||438||
48602760|NCT00123682|101811663|FG003|COMPLETED|Overall Study||430||
48602761|NCT00123682|101811660|FG000|NOT COMPLETED|Overall Study||320||
48602762|NCT00123682|101811661|FG001|NOT COMPLETED|Overall Study||203||
48602763|NCT00123682|101811662|FG002|NOT COMPLETED|Overall Study||154||
48602764|NCT00123682|101811663|FG003|NOT COMPLETED|Overall Study||95||
48602765|NCT01291264|101811664|FG000|STARTED|Overall Study||260||
48602766|NCT01291264|101811664|FG000|COMPLETED|Overall Study||260||
48602767|NCT01291264|101811664|FG000|NOT COMPLETED|Overall Study||0||
48602768|NCT02509078|101811665|FG000|STARTED|Overall Study||502||
48602769|NCT02509078|101811666|FG001|STARTED|Overall Study||506||
48602770|NCT02509078|101811665|FG000|COMPLETED|Overall Study||501||
48602771|NCT02509078|101811666|FG001|COMPLETED|Overall Study||505||
48602772|NCT02509078|101811665|FG000|NOT COMPLETED|Overall Study||1||
48602773|NCT02509078|101811666|FG001|NOT COMPLETED|Overall Study||1||
48602774|NCT02910726|101811667|FG000|STARTED|Overall Study||6||
48602775|NCT02910726|101811667|FG000|COMPLETED|Overall Study||6||
48602776|NCT02910726|101811667|FG000|NOT COMPLETED|Overall Study||0||
48602777|NCT02366403|101811668|FG000|STARTED|Overall Study||41||
48301166|NCT01213589|101064111|FG002|STARTED|Overall Study||26||
48301167|NCT01213589|101064109|FG000|COMPLETED|Overall Study||37||
48301168|NCT01213589|101064110|FG001|COMPLETED|Overall Study||19||
48301169|NCT01213589|101064111|FG002|COMPLETED|Overall Study||18||
48301170|NCT01213589|101064109|FG000|NOT COMPLETED|Overall Study||13||
48301171|NCT01213589|101064110|FG001|NOT COMPLETED|Overall Study||5||
48602778|NCT02366403|101811669|FG001|STARTED|Overall Study||44||
48602779|NCT02366403|101811668|FG000|COMPLETED|Overall Study||30||
48602780|NCT02366403|101811669|FG001|COMPLETED|Overall Study||29||
48602781|NCT02366403|101811668|FG000|NOT COMPLETED|Overall Study||11||
48602782|NCT02366403|101811669|FG001|NOT COMPLETED|Overall Study||15||
48301172|NCT01213589|101064111|FG002|NOT COMPLETED|Overall Study||8||
48301173|NCT00576836|101064112|FG000|STARTED|Overall Study||0||
48301174|NCT00576836|101064113|FG001|STARTED|Overall Study||7||
48301175|NCT00576836|101064112|FG000|COMPLETED|Overall Study||0||
48602783|NCT01196377|101811670|FG000|STARTED|Overall Study||4||
48602784|NCT01196377|101811671|FG001|STARTED|Overall Study||4||
48602785|NCT01196377|101811672|FG002|STARTED|Overall Study||4||
48602786|NCT01196377|101811673|FG003|STARTED|Overall Study||4||
48602787|NCT01196377|101811670|FG000|COMPLETED|Overall Study||4||
48602788|NCT01196377|101811671|FG001|COMPLETED|Overall Study||4||
48602789|NCT01196377|101811672|FG002|COMPLETED|Overall Study||4||
48602790|NCT01196377|101811673|FG003|COMPLETED|Overall Study||4||
48602791|NCT01196377|101811670|FG000|NOT COMPLETED|Overall Study||0||
48602792|NCT01196377|101811671|FG001|NOT COMPLETED|Overall Study||0||
48602793|NCT01196377|101811672|FG002|NOT COMPLETED|Overall Study||0||
48602794|NCT01196377|101811673|FG003|NOT COMPLETED|Overall Study||0||
48602795|NCT03209518|101811674|FG000|STARTED|Overall Study||312||
48602796|NCT03209518|101811674|FG000|COMPLETED|Overall Study||310||
48602797|NCT03209518|101811674|FG000|NOT COMPLETED|Overall Study||2||
48301176|NCT00576836|101064113|FG001|COMPLETED|Overall Study||5||
48301177|NCT00576836|101064112|FG000|NOT COMPLETED|Overall Study||0||
48301178|NCT00576836|101064113|FG001|NOT COMPLETED|Overall Study||2||
48301179|NCT02187809|101064114|FG000|STARTED|Overall Study||3||
48301180|NCT02187809|101064114|FG000|Treated|Overall Study||1||
48602798|NCT00595101|101811675|FG000|STARTED|Overall Study||29||
48602799|NCT00595101|101811676|FG001|STARTED|Overall Study||29||
48602800|NCT00595101|101811677|FG002|STARTED|Overall Study||29||
48602801|NCT00595101|101811678|FG003|STARTED|Overall Study||30||
48301181|NCT02187809|101064114|FG000|COMPLETED|Overall Study||0||
48602802|NCT00595101|101811675|FG000|COMPLETED|Overall Study||29||
48602803|NCT00595101|101811676|FG001|COMPLETED|Overall Study||28||
48602804|NCT00595101|101811677|FG002|COMPLETED|Overall Study||29||
48602805|NCT00595101|101811678|FG003|COMPLETED|Overall Study||30||
48602806|NCT00595101|101811675|FG000|NOT COMPLETED|Overall Study||0||
48602807|NCT00595101|101811676|FG001|NOT COMPLETED|Overall Study||1||
48602808|NCT00595101|101811677|FG002|NOT COMPLETED|Overall Study||0||
48602809|NCT00595101|101811678|FG003|NOT COMPLETED|Overall Study||0||
48602810|NCT04527978|101811679|FG000|STARTED|First Wear Period (8 -0/+3 Days)||27||54
48602811|NCT04527978|101811680|FG001|STARTED|First Wear Period (8 -0/+3 Days)||28||56
48602812|NCT04527978|101811679|FG000|COMPLETED|First Wear Period (8 -0/+3 Days)||26||52
48602813|NCT04527978|101811680|FG001|COMPLETED|First Wear Period (8 -0/+3 Days)||28||56
48602814|NCT04527978|101811679|FG000|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||1||2
48602815|NCT04527978|101811680|FG001|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0||0
48301182|NCT02187809|101064114|FG000|NOT COMPLETED|Overall Study||3||
48602816|NCT04527978|101811679|FG000|STARTED|Second Wear Period (8 -0/+3 Days)||26||52
48602817|NCT04527978|101811680|FG001|STARTED|Second Wear Period (8 -0/+3 Days)||28||56
48602818|NCT04527978|101811679|FG000|COMPLETED|Second Wear Period (8 -0/+3 Days)||26||52
48602819|NCT04527978|101811680|FG001|COMPLETED|Second Wear Period (8 -0/+3 Days)||28||56
48602820|NCT04527978|101811679|FG000|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0||0
48301183|NCT01106404|101064115|FG000|STARTED|Period I (First 6 Weeks)||36||
48301184|NCT01106404|101064116|FG001|STARTED|Period I (First 6 Weeks)||40||
48368009|NCT03567291|101230094|FG002|STARTED|Period I||0||
48602821|NCT04527978|101811680|FG001|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0||0
48602822|NCT01124370|101811681|FG000|STARTED|Overall Study||57||
48602823|NCT01124370|101811681|FG000|Successfully Implanted|Overall Study||50||
48602824|NCT01124370|101811681|FG000|Therapy Initiated|Overall Study||48||
48602825|NCT01124370|101811681|FG000|3 Month Visit|Overall Study||47||
48602826|NCT01124370|101811681|FG000|COMPLETED|Overall Study||37||
48602827|NCT01124370|101811681|FG000|NOT COMPLETED|Overall Study||20||
48602828|NCT03525808|101811682|FG000|STARTED|Overall Study||40||
48602829|NCT03525808|101811682|FG000|COMPLETED|Overall Study||34||
48602830|NCT03525808|101811682|FG000|NOT COMPLETED|Overall Study||6||
48602831|NCT00350779|101811683|FG000|STARTED|Overall Study||170||
48602832|NCT00350779|101811684|FG001|STARTED|Overall Study||92||
48301185|NCT01106404|101064115|FG000|COMPLETED|Period I (First 6 Weeks)||33||
48301186|NCT01106404|101064116|FG001|COMPLETED|Period I (First 6 Weeks)||38||
48602833|NCT00350779|101811683|FG000|COMPLETED|Overall Study||148||
48602834|NCT00350779|101811684|FG001|COMPLETED|Overall Study||71||
48602835|NCT00350779|101811683|FG000|NOT COMPLETED|Overall Study||22||
48602836|NCT00350779|101811684|FG001|NOT COMPLETED|Overall Study||21||
48602837|NCT04100590|101811685|FG000|STARTED|Overall Study||1||
48602838|NCT04100590|101811685|FG000|COMPLETED|Overall Study||1||
48602839|NCT04100590|101811685|FG000|NOT COMPLETED|Overall Study||0||
48602840|NCT00530790|101811686|FG000|STARTED|Overall Study||35||
48602841|NCT00530790|101811686|FG000|COMPLETED|Overall Study||30||
48602842|NCT00530790|101811686|FG000|NOT COMPLETED|Overall Study||5||
48602843|NCT01410240|101811687|FG000|STARTED|Overall Study||53||
48602844|NCT01410240|101811688|FG001|STARTED|Overall Study||53||
48602845|NCT01410240|101811689|FG002|STARTED|Overall Study||12||
48602846|NCT01410240|101811687|FG000|COMPLETED|Overall Study||52||
48602847|NCT01410240|101811688|FG001|COMPLETED|Overall Study||52||
48602848|NCT01410240|101811689|FG002|COMPLETED|Overall Study||10||
48602849|NCT01410240|101811687|FG000|NOT COMPLETED|Overall Study||1||
48602850|NCT01410240|101811688|FG001|NOT COMPLETED|Overall Study||1||
48602851|NCT01410240|101811689|FG002|NOT COMPLETED|Overall Study||2||
48602852|NCT01043133|101811690|FG000|STARTED|Overall Study||75||
48602853|NCT01043133|101811691|FG001|STARTED|Overall Study||80||
48602854|NCT01043133|101811690|FG000|COMPLETED|Overall Study||74||
48602855|NCT01043133|101811691|FG001|COMPLETED|Overall Study||78||
48602856|NCT01043133|101811690|FG000|NOT COMPLETED|Overall Study||1||
48301187|NCT01106404|101064115|FG000|NOT COMPLETED|Period I (First 6 Weeks)||3||
48301188|NCT01106404|101064116|FG001|NOT COMPLETED|Period I (First 6 Weeks)||2||
48602857|NCT01043133|101811691|FG001|NOT COMPLETED|Overall Study||2||
48602858|NCT00840034|101811692|FG000|STARTED|Acute Treatment Phase||111||
48602859|NCT00840034|101811693|FG001|STARTED|Acute Treatment Phase||116||
48602860|NCT00840034|101811692|FG000|COMPLETED|Acute Treatment Phase||90||
48602861|NCT00840034|101811693|FG001|COMPLETED|Acute Treatment Phase||80||
48602862|NCT00840034|101811692|FG000|NOT COMPLETED|Acute Treatment Phase||21||
48602863|NCT00840034|101811693|FG001|NOT COMPLETED|Acute Treatment Phase||36||
48602864|NCT00840034|101811692|FG000|STARTED|Taper Phase||90||
48602865|NCT00840034|101811693|FG001|STARTED|Taper Phase||82||
48602866|NCT00840034|101811692|FG000|COMPLETED|Taper Phase||87||
48301189|NCT01106404|101064115|FG000|STARTED|Period II (Second 6 Weeks)||33||
48301190|NCT01106404|101064116|FG001|STARTED|Period II (Second 6 Weeks)||38||
48301191|NCT01106404|101064115|FG000|COMPLETED|Period II (Second 6 Weeks)||33||
48301192|NCT01106404|101064116|FG001|COMPLETED|Period II (Second 6 Weeks)||38||
48301193|NCT01106404|101064115|FG000|NOT COMPLETED|Period II (Second 6 Weeks)||0||
48301194|NCT01106404|101064116|FG001|NOT COMPLETED|Period II (Second 6 Weeks)||0||
48602867|NCT00840034|101811693|FG001|COMPLETED|Taper Phase||80||
48602868|NCT00840034|101811692|FG000|NOT COMPLETED|Taper Phase||3||
48602869|NCT00840034|101811693|FG001|NOT COMPLETED|Taper Phase||2||
48602870|NCT02417961|101811694|FG000|STARTED|Overall Study||116||
48602871|NCT02417961|101811694|FG000|COMPLETED|Overall Study||112||
48602872|NCT02417961|101811694|FG000|NOT COMPLETED|Overall Study||4||
48602873|NCT01393106|101811695|FG000|STARTED|Overall Study||25||
48602874|NCT01393106|101811695|FG000|COMPLETED|Overall Study||20||
48602875|NCT01393106|101811695|FG000|NOT COMPLETED|Overall Study||5||
48301195|NCT03874325|101064117|FG000|STARTED|Overall Study||17||
48301196|NCT03874325|101064118|FG001|STARTED|Overall Study||0||
48301197|NCT03874325|101064117|FG000|COMPLETED|Overall Study||17||
48602876|NCT00715520|101811696|FG000|STARTED|Overall Study||20||
48602877|NCT00715520|101811697|FG001|STARTED|Overall Study||10||
48602878|NCT00715520|101811698|FG002|STARTED|Overall Study||3||
48602879|NCT00715520|101811696|FG000|COMPLETED|Overall Study||10||
48602880|NCT00715520|101811697|FG001|COMPLETED|Overall Study||9||
48602881|NCT00715520|101811698|FG002|COMPLETED|Overall Study||1||
48602882|NCT00715520|101811696|FG000|NOT COMPLETED|Overall Study||10||
48602883|NCT00715520|101811697|FG001|NOT COMPLETED|Overall Study||1||
48602884|NCT00715520|101811698|FG002|NOT COMPLETED|Overall Study||2||
48602885|NCT01863732|101811699|FG000|STARTED|Overall Study||100||
48602886|NCT01863732|101811700|FG001|STARTED|Overall Study||87||
48602887|NCT01863732|101811701|FG002|STARTED|Overall Study||46||
48602888|NCT01863732|101811702|FG003|STARTED|Overall Study||41||
48602889|NCT01863732|101811699|FG000|COMPLETED|Overall Study||87||
48602890|NCT01863732|101811700|FG001|COMPLETED|Overall Study||75||
48602891|NCT01863732|101811701|FG002|COMPLETED|Overall Study||35||
48602892|NCT01863732|101811702|FG003|COMPLETED|Overall Study||33||
48602893|NCT01863732|101811699|FG000|NOT COMPLETED|Overall Study||13||
48602894|NCT01863732|101811700|FG001|NOT COMPLETED|Overall Study||12||
48602895|NCT01863732|101811701|FG002|NOT COMPLETED|Overall Study||11||
48602896|NCT01863732|101811702|FG003|NOT COMPLETED|Overall Study||8||
48602897|NCT01172808|101811703|FG000|STARTED|Overall Study||269||
48602898|NCT01172808|101811704|FG001|STARTED|Overall Study||262||
48602899|NCT01172808|101811705|FG002|STARTED|Overall Study||264||
48602900|NCT01172808|101811706|FG003|STARTED|Overall Study||275||
48602901|NCT01172808|101811703|FG000|COMPLETED|Overall Study||248||
48602902|NCT01172808|101811704|FG001|COMPLETED|Overall Study||249||
48602903|NCT01172808|101811705|FG002|COMPLETED|Overall Study||241||
48602904|NCT01172808|101811706|FG003|COMPLETED|Overall Study||260||
48602905|NCT01172808|101811703|FG000|NOT COMPLETED|Overall Study||21||
48602906|NCT01172808|101811704|FG001|NOT COMPLETED|Overall Study||13||
48602907|NCT01172808|101811705|FG002|NOT COMPLETED|Overall Study||23||
48602908|NCT01172808|101811706|FG003|NOT COMPLETED|Overall Study||15||
48602909|NCT04399538|101811707|FG000|STARTED|Double-Blind Treatment||15||
48602910|NCT04399538|101811708|FG001|STARTED|Double-Blind Treatment||15||
48602911|NCT04399538|101811709|FG002|STARTED|Double-Blind Treatment||13||
48602912|NCT04399538|101811710|FG003|STARTED|Double-Blind Treatment||18||
48602913|NCT04399538|101811711|FG004|STARTED|Double-Blind Treatment||14||
48602914|NCT04399538|101811707|FG000|COMPLETED|Double-Blind Treatment||15||
48602915|NCT04399538|101811708|FG001|COMPLETED|Double-Blind Treatment||15||
48602916|NCT04399538|101811709|FG002|COMPLETED|Double-Blind Treatment||13||
48602917|NCT04399538|101811710|FG003|COMPLETED|Double-Blind Treatment||17||
48602918|NCT04399538|101811711|FG004|COMPLETED|Double-Blind Treatment||12||
48602919|NCT04399538|101811707|FG000|NOT COMPLETED|Double-Blind Treatment||0||
48602920|NCT04399538|101811708|FG001|NOT COMPLETED|Double-Blind Treatment||0||
48602921|NCT04399538|101811709|FG002|NOT COMPLETED|Double-Blind Treatment||0||
48602922|NCT04399538|101811710|FG003|NOT COMPLETED|Double-Blind Treatment||1||
48602923|NCT04399538|101811711|FG004|NOT COMPLETED|Double-Blind Treatment||2||
48602924|NCT04399538|101811707|FG000|STARTED|Follow-Up||15||
48602925|NCT04399538|101811708|FG001|STARTED|Follow-Up||15||
48602926|NCT04399538|101811709|FG002|STARTED|Follow-Up||13||
48602927|NCT04399538|101811710|FG003|STARTED|Follow-Up||17||
48602928|NCT04399538|101811711|FG004|STARTED|Follow-Up||13||
48602929|NCT04399538|101811707|FG000|COMPLETED|Follow-Up||15||
48602930|NCT04399538|101811708|FG001|COMPLETED|Follow-Up||15||
48602931|NCT04399538|101811709|FG002|COMPLETED|Follow-Up||13||
48602932|NCT04399538|101811710|FG003|COMPLETED|Follow-Up||15||
48602933|NCT04399538|101811711|FG004|COMPLETED|Follow-Up||12||
48602934|NCT04399538|101811707|FG000|NOT COMPLETED|Follow-Up||0||
48602935|NCT04399538|101811708|FG001|NOT COMPLETED|Follow-Up||0||
48602936|NCT04399538|101811709|FG002|NOT COMPLETED|Follow-Up||0||
48602937|NCT04399538|101811710|FG003|NOT COMPLETED|Follow-Up||2||
48602938|NCT04399538|101811711|FG004|NOT COMPLETED|Follow-Up||1||
48602939|NCT00878605|101811712|FG000|STARTED|Overall Study||10||
48602940|NCT00878605|101811713|FG001|STARTED|Overall Study||10||
48602941|NCT00878605|101811714|FG002|STARTED|Overall Study||9||
48602942|NCT00878605|101811715|FG003|STARTED|Overall Study||9||
48602943|NCT00878605|101811712|FG000|COMPLETED|Overall Study||7||
48602944|NCT00878605|101811713|FG001|COMPLETED|Overall Study||7||
48602945|NCT00878605|101811714|FG002|COMPLETED|Overall Study||8||
48602946|NCT00878605|101811715|FG003|COMPLETED|Overall Study||6||
48602947|NCT00878605|101811712|FG000|NOT COMPLETED|Overall Study||3||
48602948|NCT00878605|101811713|FG001|NOT COMPLETED|Overall Study||3||
48602949|NCT00878605|101811714|FG002|NOT COMPLETED|Overall Study||1||
48602950|NCT00878605|101811715|FG003|NOT COMPLETED|Overall Study||3||
48602951|NCT00549601|101811716|FG000|STARTED|Randomized||43||
48602952|NCT00549601|101811717|FG001|STARTED|Randomized||48||
48602953|NCT00549601|101811718|FG002|STARTED|Randomized||51||
48602954|NCT00549601|101811716|FG000|COMPLETED|Randomized||43||
48602955|NCT00549601|101811717|FG001|COMPLETED|Randomized||47||
48602956|NCT00549601|101811718|FG002|COMPLETED|Randomized||49||
48602957|NCT00549601|101811716|FG000|NOT COMPLETED|Randomized||0||
48602958|NCT00549601|101811717|FG001|NOT COMPLETED|Randomized||1||
48602959|NCT00549601|101811718|FG002|NOT COMPLETED|Randomized||2||
48602960|NCT00549601|101811716|FG000|STARTED|Received Study Drug||43||
48602961|NCT00549601|101811717|FG001|STARTED|Received Study Drug||47||
48602962|NCT00549601|101811718|FG002|STARTED|Received Study Drug||49||
48602963|NCT00549601|101811716|FG000|COMPLETED|Received Study Drug||36||
48602964|NCT00549601|101811717|FG001|COMPLETED|Received Study Drug||36||
48602965|NCT00549601|101811718|FG002|COMPLETED|Received Study Drug||45||
48602966|NCT00549601|101811716|FG000|NOT COMPLETED|Received Study Drug||7||
48602967|NCT00549601|101811717|FG001|NOT COMPLETED|Received Study Drug||11||
48602968|NCT00549601|101811718|FG002|NOT COMPLETED|Received Study Drug||4||
48602969|NCT03149822|101811719|FG000|STARTED|Overall Study||5||
48602970|NCT03149822|101811720|FG001|STARTED|Overall Study||3||
48602971|NCT03149822|101811721|FG002|STARTED|Overall Study||37||
48602972|NCT03149822|101811719|FG000|COMPLETED|Overall Study||5||
48602973|NCT03149822|101811720|FG001|COMPLETED|Overall Study||3||
48602974|NCT03149822|101811721|FG002|COMPLETED|Overall Study||37||
48602975|NCT03149822|101811719|FG000|NOT COMPLETED|Overall Study||0||
48602976|NCT03149822|101811720|FG001|NOT COMPLETED|Overall Study||0||
48602977|NCT03149822|101811721|FG002|NOT COMPLETED|Overall Study||0||
48602978|NCT02217800|101811722|FG000|STARTED|Overall Study||8||
48147141|NCT03318523|100682477|FG003|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0|Out of 345 participants who completed the PC Period, only 344 entered the DBE Period.|
48147142|NCT03318523|100682478|FG004|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||20|Out of 345 participants who completed the PC Period, only 344 entered the DBE Period.|
48147143|NCT03318523|100682479|FG005|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||37|Out of 345 participants who completed the PC Period, only 344 entered the DBE Period.|
48147144|NCT03318523|100682480|FG006|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||39|Out of 345 participants who completed the PC Period, only 344 entered the DBE Period.|
48147145|NCT03318523|100682481|FG007|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||52|Out of 345 participants who completed the PC Period, only 344 entered the DBE Period.|
48147146|NCT03318523|100682482|FG008|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||100|Out of 345 participants who completed the PC Period, only 344 entered the DBE Period.|
48147147|NCT03318523|100682483|FG009|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||96|Out of 345 participants who completed the PC Period, only 344 entered the DBE Period.|
48147148|NCT03318523|100682474|FG000|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
48147149|NCT03318523|100682475|FG001|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
48147150|NCT03318523|100682476|FG002|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
48147151|NCT03318523|100682477|FG003|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
48147152|NCT03318523|100682478|FG004|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||20||
48147153|NCT03318523|100682479|FG005|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||37||
48147154|NCT03318523|100682480|FG006|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||39||
48147155|NCT03318523|100682481|FG007|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||52||
48147156|NCT03318523|100682482|FG008|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||100||
48147157|NCT03318523|100682483|FG009|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||94||
48147158|NCT03318523|100682474|FG000|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
48147159|NCT03318523|100682475|FG001|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
48147160|NCT03318523|100682476|FG002|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
48147161|NCT03318523|100682477|FG003|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
48147162|NCT03318523|100682478|FG004|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
48147163|NCT03318523|100682479|FG005|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
48147164|NCT03318523|100682480|FG006|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
48147165|NCT03318523|100682481|FG007|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
48147166|NCT03318523|100682482|FG008|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
48147167|NCT03318523|100682483|FG009|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
48147168|NCT03318523|100682474|FG000|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
48147169|NCT03318523|100682475|FG001|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
48147170|NCT03318523|100682476|FG002|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
48147171|NCT03318523|100682477|FG003|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
48147172|NCT03318523|100682478|FG004|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||20||
48147173|NCT03318523|100682479|FG005|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||37||
48147174|NCT03318523|100682480|FG006|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||39||
48147175|NCT03318523|100682481|FG007|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||52||
48147176|NCT03318523|100682482|FG008|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||100||
48147177|NCT03318523|100682483|FG009|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||96||
48147178|NCT03321396|100682484|FG000|STARTED|Overall Study||13||
48147179|NCT03321396|100682484|FG000|COMPLETED|Overall Study||12||
48147180|NCT03321396|100682484|FG000|NOT COMPLETED|Overall Study||1||
48147181|NCT01994954|100682485|FG000|STARTED|Overall Study||99||
48147182|NCT01994954|100682486|FG001|STARTED|Overall Study||97||
48147183|NCT01994954|100682485|FG000|COMPLETED|Overall Study||74||
48301198|NCT03874325|101064118|FG001|COMPLETED|Overall Study||0||
48301199|NCT03874325|101064117|FG000|NOT COMPLETED|Overall Study||0||
48301200|NCT03874325|101064118|FG001|NOT COMPLETED|Overall Study||0||
48301201|NCT01544023|101064119|FG000|STARTED|Overall Study||207||
48301202|NCT01544023|101064119|FG000|COMPLETED|Overall Study||207||
48301203|NCT01544023|101064119|FG000|NOT COMPLETED|Overall Study||0||
48301204|NCT01975428|101064120|FG000|STARTED|Overall Study||85||
48301205|NCT01975428|101064121|FG001|STARTED|Overall Study||97||
48301206|NCT01975428|101064120|FG000|COMPLETED|Overall Study||65||
48301207|NCT01975428|101064121|FG001|COMPLETED|Overall Study||83||
48301208|NCT01975428|101064120|FG000|NOT COMPLETED|Overall Study||20||
48301209|NCT01975428|101064121|FG001|NOT COMPLETED|Overall Study||14||
48301210|NCT04009850|101064122|FG000|STARTED|Overall Study||3||
48301211|NCT04009850|101064123|FG001|STARTED|Overall Study||0||
48301212|NCT04009850|101064122|FG000|COMPLETED|Overall Study||3||
48440011|NCT03046966|101410009|FG000|COMPLETED|Overall Study||51||
48147184|NCT01994954|100682486|FG001|COMPLETED|Overall Study||67||
48147185|NCT01994954|100682485|FG000|NOT COMPLETED|Overall Study||25||
48147186|NCT01994954|100682486|FG001|NOT COMPLETED|Overall Study||30||
48147187|NCT02071173|100682487|FG000|STARTED|Overall Study||2244||
48188526|NCT05233085|100783266|FG000|STARTED|Overall Study||9||
48301213|NCT04009850|101064123|FG001|COMPLETED|Overall Study||0||
48301214|NCT04009850|101064122|FG000|NOT COMPLETED|Overall Study||0||
48301215|NCT04009850|101064123|FG001|NOT COMPLETED|Overall Study||0||
48147188|NCT02071173|100682487|FG000|Implanted/Attempted With a Study Device|Overall Study||2200|2045 with ACUITY X4 and RELIANCE 4-FRONT, 110 with ACUITY X4 only, 45 with RELIANCE 4-FRONT only|
48147189|NCT02071173|100682487|FG000|RELIANCE 4-FRONT Endpoint Population|Overall Study||1544|The first 1544 subjects implanted/attempted with 4-FRONT lead eligible for 4-FRONT endpoints|
48147190|NCT02071173|100682487|FG000|ACUITY X4 Endpoint Population|Overall Study||764|The first 764 subjects implanted/attempted with ACUITY X4 lead eligible for ACUITY X4 endpoints|
48147191|NCT02071173|100682487|FG000|COMPLETED|Overall Study||409||
48147192|NCT02071173|100682487|FG000|NOT COMPLETED|Overall Study||1835||
48147193|NCT00318357|100682488|FG000|STARTED|Overall Study||173||
48147194|NCT00318357|100682489|FG001|STARTED|Overall Study||136||
48715135|NCT05260333|102088712|FG000|Transperineal Ultrasound|Overall Study||30|The patients acted as there own control. 30 patients were enrolled, but a total of 60 exams (1 TPUS and 1 SVE) were performed.|
48715136|NCT05260333|102088712|FG000|Digital Cervical Exam|Overall Study||30|The patients acted as there own control. 30 patients were enrolled, but a total of 60 exams (1 TPUS and 1 SVE) were performed.|
48715137|NCT05260333|102088712|FG000|COMPLETED|Overall Study||30|The patients acted as there own control. 30 patients were enrolled, but a total of 60 exams (1 TPUS and 1 SVE) were performed.|
48715138|NCT05260333|102088712|FG000|NOT COMPLETED|Overall Study||0||
48715139|NCT03958656|102088713|FG000|STARTED|Overall Study||3||
48715140|NCT03958656|102088714|FG001|STARTED|Overall Study||4||
48715141|NCT03958656|102088715|FG002|STARTED|Overall Study||5||
48715142|NCT03958656|102088716|FG003|STARTED|Overall Study||1||
48147195|NCT00318357|100682488|FG000|COMPLETED|Overall Study||134||
48147196|NCT00318357|100682489|FG001|COMPLETED|Overall Study||104||
48715143|NCT03958656|102088713|FG000|COMPLETED|Overall Study||3||
48715144|NCT03958656|102088714|FG001|COMPLETED|Overall Study||3||
48715145|NCT03958656|102088715|FG002|COMPLETED|Overall Study||3||
48715146|NCT03958656|102088716|FG003|COMPLETED|Overall Study||1||
48715147|NCT03958656|102088713|FG000|NOT COMPLETED|Overall Study||0||
48715148|NCT03958656|102088714|FG001|NOT COMPLETED|Overall Study||1||
48715149|NCT03958656|102088715|FG002|NOT COMPLETED|Overall Study||2||
48715150|NCT03958656|102088716|FG003|NOT COMPLETED|Overall Study||0||
48715151|NCT03759041|102088717|FG000|STARTED|Overall Study||69||
48715152|NCT03759041|102088718|FG001|STARTED|Overall Study||68||
48715153|NCT03759041|102088719|FG002|STARTED|Overall Study||66||
48715154|NCT03759041|102088717|FG000|COMPLETED|Overall Study||42||
48715155|NCT03759041|102088718|FG001|COMPLETED|Overall Study||34||
48715156|NCT03759041|102088719|FG002|COMPLETED|Overall Study||38||
48715157|NCT03759041|102088717|FG000|NOT COMPLETED|Overall Study||27||
48715158|NCT03759041|102088718|FG001|NOT COMPLETED|Overall Study||34||
48715159|NCT03759041|102088719|FG002|NOT COMPLETED|Overall Study||28||
48715160|NCT03276052|102088720|FG000|STARTED|Overall Study||43||
48715161|NCT03276052|102088720|FG000|COMPLETED|Overall Study||20||
48715162|NCT03276052|102088720|FG000|NOT COMPLETED|Overall Study||23||
48715163|NCT00283816|102088721|FG000|STARTED|Overall Study||18||
48715164|NCT00283816|102088722|FG001|STARTED|Overall Study||18||
48715165|NCT00283816|102088721|FG000|COMPLETED|Overall Study||16||
48715166|NCT00283816|102088722|FG001|COMPLETED|Overall Study||16||
48715167|NCT00283816|102088721|FG000|NOT COMPLETED|Overall Study||2||
48715168|NCT00283816|102088722|FG001|NOT COMPLETED|Overall Study||2||
48715169|NCT03242018|102088723|FG000|STARTED|Overall Study||93||
48715170|NCT03242018|102088724|FG001|STARTED|Overall Study||92||
48715171|NCT03242018|102088725|FG002|STARTED|Overall Study||92||
48715172|NCT03242018|102088723|FG000|COMPLETED|Overall Study||75||
48715173|NCT03242018|102088724|FG001|COMPLETED|Overall Study||78||
48715174|NCT03242018|102088725|FG002|COMPLETED|Overall Study||78||
48715175|NCT03242018|102088723|FG000|NOT COMPLETED|Overall Study||18||
48715176|NCT03242018|102088724|FG001|NOT COMPLETED|Overall Study||14||
48715177|NCT03242018|102088725|FG002|NOT COMPLETED|Overall Study||14||
48715178|NCT00882908|102088726|FG000|STARTED|Overall Study||78||
48715179|NCT00882908|102088727|FG001|STARTED|Overall Study||75||
48715180|NCT00882908|102088728|FG002|STARTED|Overall Study||77||
48715181|NCT00882908|102088729|FG003|STARTED|Overall Study||79||
48715182|NCT00882908|102088730|FG004|STARTED|Overall Study||77||
48715183|NCT00882908|102088726|FG000|COMPLETED|Overall Study||75||
48715184|NCT00882908|102088727|FG001|COMPLETED|Overall Study||69||
48715185|NCT00882908|102088728|FG002|COMPLETED|Overall Study||70||
48715186|NCT00882908|102088729|FG003|COMPLETED|Overall Study||72||
48715187|NCT00882908|102088730|FG004|COMPLETED|Overall Study||71||
48715188|NCT00882908|102088726|FG000|NOT COMPLETED|Overall Study||3||
48715189|NCT00882908|102088727|FG001|NOT COMPLETED|Overall Study||6||
48715190|NCT00882908|102088728|FG002|NOT COMPLETED|Overall Study||7||
48715191|NCT00882908|102088729|FG003|NOT COMPLETED|Overall Study||7||
48715192|NCT00882908|102088730|FG004|NOT COMPLETED|Overall Study||6||
48715193|NCT01987219|102088731|FG000|STARTED|Overall Study||2||
48715194|NCT01987219|102088732|FG001|STARTED|Overall Study||2||
48715195|NCT01987219|102088733|FG002|STARTED|Overall Study||7||
48715196|NCT01987219|102088734|FG003|STARTED|Overall Study||2||
48715197|NCT01987219|102088735|FG004|STARTED|Overall Study||1||
48715198|NCT01987219|102088736|FG005|STARTED|Overall Study||1||
48715199|NCT01987219|102088731|FG000|COMPLETED|Overall Study||2||
48715200|NCT01987219|102088732|FG001|COMPLETED|Overall Study||2||
48301216|NCT01940354|101064124|FG000|STARTED|Overall Study||110||
48301217|NCT01940354|101064125|FG001|STARTED|Overall Study||110||
48301218|NCT01940354|101064124|FG000|COMPLETED|Overall Study||106||
48301219|NCT01940354|101064125|FG001|COMPLETED|Overall Study||108||
48301220|NCT01940354|101064124|FG000|NOT COMPLETED|Overall Study||4||
48301221|NCT01940354|101064125|FG001|NOT COMPLETED|Overall Study||2||
48301222|NCT03794908|101064126|FG000|STARTED|Overall Study||29||
48301223|NCT03794908|101064127|FG001|STARTED|Overall Study||28||
48301224|NCT03794908|101064126|FG000|Began Use of Re-Timer|Overall Study||27||
48147197|NCT00318357|100682488|FG000|NOT COMPLETED|Overall Study||39||
48147198|NCT00318357|100682489|FG001|NOT COMPLETED|Overall Study||32||
48147199|NCT01297959|100682490|FG000|STARTED|Overall Study||261||
48301225|NCT03794908|101064127|FG001|Began Use of Re-Timer|Overall Study||27||
48301226|NCT03794908|101064126|FG000|COMPLETED|Overall Study||27||
48301227|NCT03794908|101064127|FG001|COMPLETED|Overall Study||27||
48301228|NCT03794908|101064126|FG000|NOT COMPLETED|Overall Study||2||
48301229|NCT03794908|101064127|FG001|NOT COMPLETED|Overall Study||1||
48147200|NCT01297959|100682491|FG001|STARTED|Overall Study||242||
48147201|NCT01297959|100682490|FG000|COMPLETED|Overall Study||241||
48147202|NCT01297959|100682491|FG001|COMPLETED|Overall Study||226||
48147203|NCT01297959|100682490|FG000|NOT COMPLETED|Overall Study||20||
48147204|NCT01297959|100682491|FG001|NOT COMPLETED|Overall Study||16||
48147205|NCT02934620|100682492|FG000|STARTED|Baseline Visit||248||
48147206|NCT02934620|100682493|FG001|STARTED|Baseline Visit||252||
48147207|NCT02934620|100682494|FG002|STARTED|Baseline Visit||248||
48147208|NCT02934620|100682495|FG003|STARTED|Baseline Visit||252||
48147209|NCT02934620|100682492|FG000|COMPLETED|Baseline Visit||248||
48147210|NCT02934620|100682493|FG001|COMPLETED|Baseline Visit||252||
48147211|NCT02934620|100682494|FG002|COMPLETED|Baseline Visit||248||
48147212|NCT02934620|100682495|FG003|COMPLETED|Baseline Visit||252||
48147213|NCT02934620|100682492|FG000|NOT COMPLETED|Baseline Visit||0||
48147214|NCT02934620|100682493|FG001|NOT COMPLETED|Baseline Visit||0||
48147215|NCT02934620|100682494|FG002|NOT COMPLETED|Baseline Visit||0||
48147216|NCT02934620|100682495|FG003|NOT COMPLETED|Baseline Visit||0||
48147217|NCT02934620|100682492|FG000|STARTED|2-month Visit||248||
48147218|NCT02934620|100682493|FG001|STARTED|2-month Visit||252||
48147219|NCT02934620|100682494|FG002|STARTED|2-month Visit||0||
48147220|NCT02934620|100682495|FG003|STARTED|2-month Visit||0||
48147221|NCT02934620|100682492|FG000|COMPLETED|2-month Visit||233||
48147222|NCT02934620|100682493|FG001|COMPLETED|2-month Visit||228||
48147223|NCT02934620|100682494|FG002|COMPLETED|2-month Visit||0||
48147224|NCT02934620|100682495|FG003|COMPLETED|2-month Visit||0||
48147225|NCT02934620|100682492|FG000|NOT COMPLETED|2-month Visit||15||
48147226|NCT02934620|100682493|FG001|NOT COMPLETED|2-month Visit||24||
48147227|NCT02934620|100682494|FG002|NOT COMPLETED|2-month Visit||0||
48147228|NCT02934620|100682495|FG003|NOT COMPLETED|2-month Visit||0||
48147229|NCT02934620|100682492|FG000|STARTED|4-month Visit||248||
48147230|NCT02934620|100682493|FG001|STARTED|4-month Visit||252||
48147231|NCT02934620|100682494|FG002|STARTED|4-month Visit||0||
48147232|NCT02934620|100682495|FG003|STARTED|4-month Visit||0||
48147233|NCT02934620|100682492|FG000|COMPLETED|4-month Visit||228||
48147234|NCT02934620|100682493|FG001|COMPLETED|4-month Visit||220||
48147235|NCT02934620|100682494|FG002|COMPLETED|4-month Visit||0||
48147236|NCT02934620|100682495|FG003|COMPLETED|4-month Visit||0||
48147237|NCT02934620|100682492|FG000|NOT COMPLETED|4-month Visit||20||
48147238|NCT02934620|100682493|FG001|NOT COMPLETED|4-month Visit||32||
48147239|NCT02934620|100682494|FG002|NOT COMPLETED|4-month Visit||0||
48147240|NCT02934620|100682495|FG003|NOT COMPLETED|4-month Visit||0||
48147241|NCT02934620|100682492|FG000|STARTED|6-month Visit||248||
48147242|NCT02934620|100682493|FG001|STARTED|6-month Visit||252||
48147243|NCT02934620|100682494|FG002|STARTED|6-month Visit||248||
48147244|NCT02934620|100682495|FG003|STARTED|6-month Visit||252||
48147245|NCT02934620|100682492|FG000|COMPLETED|6-month Visit||234||
48147246|NCT02934620|100682493|FG001|COMPLETED|6-month Visit||239||
48147247|NCT02934620|100682494|FG002|COMPLETED|6-month Visit||230||
48301230|NCT01810692|101064128|FG000|STARTED|Overall Study||77||
48301231|NCT01810692|101064129|FG001|STARTED|Overall Study||77||
48301232|NCT01810692|101064128|FG000|COMPLETED|Overall Study||77||
48301233|NCT01810692|101064129|FG001|COMPLETED|Overall Study||77||
48301234|NCT01810692|101064128|FG000|NOT COMPLETED|Overall Study||0||
48301235|NCT01810692|101064129|FG001|NOT COMPLETED|Overall Study||0||
48301236|NCT01158651|101064130|FG000|STARTED|Overall Study||23||
48301237|NCT01158651|101064130|FG000|COMPLETED|Overall Study||22||
48301238|NCT01158651|101064130|FG000|NOT COMPLETED|Overall Study||1||
48301239|NCT01287065|101064131|FG000|STARTED|Treatment Period 1||4||
48147248|NCT02934620|100682495|FG003|COMPLETED|6-month Visit||238||
48147249|NCT02934620|100682492|FG000|NOT COMPLETED|6-month Visit||14||
48301240|NCT01287065|101064132|FG001|STARTED|Treatment Period 1||4||
48301241|NCT01287065|101064133|FG002|STARTED|Treatment Period 1||4||
48147250|NCT02934620|100682493|FG001|NOT COMPLETED|6-month Visit||13||
48147251|NCT02934620|100682494|FG002|NOT COMPLETED|6-month Visit||18||
48147252|NCT02934620|100682495|FG003|NOT COMPLETED|6-month Visit||14||
48147253|NCT02515279|100682496|FG000|STARTED|Overall Study||463||
48147254|NCT02515279|100682496|FG000|COMPLETED|Overall Study||359||
48147255|NCT02515279|100682496|FG000|NOT COMPLETED|Overall Study||104||
48602979|NCT02217800|101811722|FG000|COMPLETED|Overall Study||8||
48602980|NCT02217800|101811722|FG000|NOT COMPLETED|Overall Study||0||
48602981|NCT01464619|101811723|FG000|STARTED|Overall Study||32||
48602982|NCT01464619|101811724|FG001|STARTED|Overall Study||29||
48602983|NCT01464619|101811723|FG000|COMPLETED|Overall Study||29||
48602984|NCT01464619|101811724|FG001|COMPLETED|Overall Study||25||
48602985|NCT01464619|101811723|FG000|NOT COMPLETED|Overall Study||3||
48602986|NCT01464619|101811724|FG001|NOT COMPLETED|Overall Study||4||
48602987|NCT03850691|101811725|FG000|STARTED|Overall Study||1||
48602988|NCT03850691|101811726|FG001|STARTED|Overall Study||3||
48602989|NCT03850691|101811725|FG000|COMPLETED|Overall Study||1||
48602990|NCT03850691|101811726|FG001|COMPLETED|Overall Study||3||
48602991|NCT03850691|101811725|FG000|NOT COMPLETED|Overall Study||0||
48715201|NCT01987219|102088733|FG002|COMPLETED|Overall Study||6||
48715202|NCT01987219|102088734|FG003|COMPLETED|Overall Study||2||
48715203|NCT01987219|102088735|FG004|COMPLETED|Overall Study||1||
48147256|NCT04672941|100682497|FG000|STARTED|Overall Study||1396||
48602992|NCT03850691|101811726|FG001|NOT COMPLETED|Overall Study||0||
48602993|NCT01400906|101811727|FG000|STARTED|Treatment Period 1||6||
48602994|NCT01400906|101811728|FG001|STARTED|Treatment Period 1||6||
48602995|NCT01400906|101811729|FG002|STARTED|Treatment Period 1||6||
48602996|NCT01400906|101811730|FG003|STARTED|Treatment Period 1||6||
48602997|NCT01400906|101811731|FG004|STARTED|Treatment Period 1||6||
48602998|NCT01400906|101811732|FG005|STARTED|Treatment Period 1||5||
48602999|NCT01400906|101811727|FG000|COMPLETED|Treatment Period 1||6||
48715204|NCT01987219|102088736|FG005|COMPLETED|Overall Study||1||
48715205|NCT01987219|102088731|FG000|NOT COMPLETED|Overall Study||0||
48603000|NCT01400906|101811728|FG001|COMPLETED|Treatment Period 1||6||
48603001|NCT01400906|101811729|FG002|COMPLETED|Treatment Period 1||6||
48715206|NCT01987219|102088732|FG001|NOT COMPLETED|Overall Study||0||
48715207|NCT01987219|102088733|FG002|NOT COMPLETED|Overall Study||1||
48715208|NCT01987219|102088734|FG003|NOT COMPLETED|Overall Study||0||
48715209|NCT01987219|102088735|FG004|NOT COMPLETED|Overall Study||0||
48715210|NCT01987219|102088736|FG005|NOT COMPLETED|Overall Study||0||
48715211|NCT03285958|102088737|FG000|STARTED|Overall Study||33||
48715212|NCT03285958|102088738|FG001|STARTED|Overall Study||24||
48715213|NCT03285958|102088737|FG000|COMPLETED|Overall Study||28||
48715214|NCT03285958|102088738|FG001|COMPLETED|Overall Study||23||
48715215|NCT03285958|102088737|FG000|NOT COMPLETED|Overall Study||5||
48715216|NCT03285958|102088738|FG001|NOT COMPLETED|Overall Study||1||
48715217|NCT05418153|102088739|FG000|STARTED|Overall Study||52||
48715218|NCT05418153|102088739|FG000|COMPLETED|Overall Study||52||
48715219|NCT05418153|102088739|FG000|NOT COMPLETED|Overall Study||0||
48715220|NCT01344629|102088740|FG000|STARTED|Crossover Period 1||32||
48715221|NCT01344629|102088741|FG001|STARTED|Crossover Period 1||32||
48715222|NCT01344629|102088740|FG000|COMPLETED|Crossover Period 1||32||
48715223|NCT01344629|102088741|FG001|COMPLETED|Crossover Period 1||32||
48715224|NCT01344629|102088740|FG000|NOT COMPLETED|Crossover Period 1||0||
48715225|NCT01344629|102088741|FG001|NOT COMPLETED|Crossover Period 1||0||
48715226|NCT01344629|102088740|FG000|STARTED|Crossover Period 2||32||
48715227|NCT01344629|102088741|FG001|STARTED|Crossover Period 2||32||
48715228|NCT01344629|102088740|FG000|COMPLETED|Crossover Period 2||32||
48715229|NCT01344629|102088741|FG001|COMPLETED|Crossover Period 2||31||
48715230|NCT01344629|102088740|FG000|NOT COMPLETED|Crossover Period 2||0||
48715231|NCT01344629|102088741|FG001|NOT COMPLETED|Crossover Period 2||1||
48715232|NCT01344629|102088740|FG000|STARTED|Crossover Period 3||32||
48715233|NCT01344629|102088741|FG001|STARTED|Crossover Period 3||31||
48715234|NCT01344629|102088740|FG000|COMPLETED|Crossover Period 3||32||
48715235|NCT01344629|102088741|FG001|COMPLETED|Crossover Period 3||31||
48715236|NCT01344629|102088740|FG000|NOT COMPLETED|Crossover Period 3||0||
48715237|NCT01344629|102088741|FG001|NOT COMPLETED|Crossover Period 3||0||
48715238|NCT01344629|102088740|FG000|STARTED|Crossover Period 4||32||
48715239|NCT01344629|102088741|FG001|STARTED|Crossover Period 4||31||
48715240|NCT01344629|102088740|FG000|COMPLETED|Crossover Period 4||32||
48715241|NCT01344629|102088741|FG001|COMPLETED|Crossover Period 4||31||
48715242|NCT01344629|102088740|FG000|NOT COMPLETED|Crossover Period 4||0||
48715243|NCT01344629|102088741|FG001|NOT COMPLETED|Crossover Period 4||0||
48715244|NCT01420627|102088742|FG000|STARTED|Adagen Lead-in Period||7|3 weeks, minimum|
48715245|NCT01420627|102088742|FG000|COMPLETED|Adagen Lead-in Period||7||
48715246|NCT01420627|102088742|FG000|NOT COMPLETED|Adagen Lead-in Period||0||
48715247|NCT01420627|102088742|FG000|STARTED|EZN-2279 Treatment Period||7|Weeks T-1 through T-21|
48715248|NCT01420627|102088742|FG000|COMPLETED|EZN-2279 Treatment Period||6||
48715249|NCT01420627|102088742|FG000|NOT COMPLETED|EZN-2279 Treatment Period||1||
48715250|NCT01420627|102088742|FG000|STARTED|EZN-2279 Maintenance Period||6|Continuing until end of study, at least 203 weeks|
48715251|NCT01420627|102088742|FG000|COMPLETED|EZN-2279 Maintenance Period||6||
48715252|NCT01420627|102088742|FG000|NOT COMPLETED|EZN-2279 Maintenance Period||0||
48715253|NCT05268744|102088743|FG000|STARTED|Overall Study||16||
48715254|NCT05268744|102088743|FG000|COMPLETED|Overall Study||11||
48715255|NCT05268744|102088743|FG000|NOT COMPLETED|Overall Study||5||
48301242|NCT01287065|101064134|FG003|STARTED|Treatment Period 1||4||
48301243|NCT01287065|101064135|FG004|STARTED|Treatment Period 1||5||
48147257|NCT04672941|100682497|FG000|COMPLETED|Overall Study||1388||
48147258|NCT04672941|100682497|FG000|NOT COMPLETED|Overall Study||8||
48147259|NCT03927950|100682498|FG000|STARTED|Overall Study||135||
48301244|NCT01287065|101064136|FG005|STARTED|Treatment Period 1||5||
48301245|NCT01287065|101064131|FG000|COMPLETED|Treatment Period 1||4||
48301246|NCT01287065|101064132|FG001|COMPLETED|Treatment Period 1||4||
48301247|NCT01287065|101064133|FG002|COMPLETED|Treatment Period 1||4||
48301248|NCT01287065|101064134|FG003|COMPLETED|Treatment Period 1||4||
48301249|NCT01287065|101064135|FG004|COMPLETED|Treatment Period 1||4||
48301250|NCT01287065|101064136|FG005|COMPLETED|Treatment Period 1||4||
48301251|NCT01287065|101064131|FG000|NOT COMPLETED|Treatment Period 1||0||
48301252|NCT01287065|101064132|FG001|NOT COMPLETED|Treatment Period 1||0||
48301253|NCT01287065|101064133|FG002|NOT COMPLETED|Treatment Period 1||0||
48301254|NCT01287065|101064134|FG003|NOT COMPLETED|Treatment Period 1||0||
48301255|NCT01287065|101064135|FG004|NOT COMPLETED|Treatment Period 1||1||
48147260|NCT03927950|100682498|FG000|COMPLETED|Overall Study||126||
48147261|NCT03927950|100682498|FG000|NOT COMPLETED|Overall Study||9||
48147262|NCT03673306|100682499|FG000|STARTED|Overall Study||659||
48147263|NCT03673306|100682500|FG001|STARTED|Overall Study||4073||
48301256|NCT01287065|101064136|FG005|NOT COMPLETED|Treatment Period 1||1||
48301257|NCT01287065|101064131|FG000|STARTED|Washout Period 1||4||
48301258|NCT01287065|101064132|FG001|STARTED|Washout Period 1||4||
48301259|NCT01287065|101064133|FG002|STARTED|Washout Period 1||4||
48301260|NCT01287065|101064134|FG003|STARTED|Washout Period 1||4||
48715256|NCT03077698|102088744|FG000|STARTED|Progestin Monotherapy||16||
48715257|NCT03077698|102088745|FG001|STARTED|Progestin Monotherapy||0||
48715258|NCT03077698|102088744|FG000|COMPLETED|Progestin Monotherapy||6||
48715259|NCT03077698|102088745|FG001|COMPLETED|Progestin Monotherapy||0||
48715260|NCT03077698|102088744|FG000|NOT COMPLETED|Progestin Monotherapy||10||
48715261|NCT03077698|102088745|FG001|NOT COMPLETED|Progestin Monotherapy||0||
48715262|NCT03077698|102088744|FG000|STARTED|Sodium Cridanimod & Progestin Therapy||6||
48147264|NCT03673306|100682499|FG000|COMPLETED|Overall Study||659||
48147265|NCT03673306|100682500|FG001|COMPLETED|Overall Study||4073||
48715263|NCT03077698|102088745|FG001|STARTED|Sodium Cridanimod & Progestin Therapy||9||
48715264|NCT03077698|102088744|FG000|COMPLETED|Sodium Cridanimod & Progestin Therapy||0||
48715265|NCT03077698|102088745|FG001|COMPLETED|Sodium Cridanimod & Progestin Therapy||0||
48715266|NCT03077698|102088744|FG000|NOT COMPLETED|Sodium Cridanimod & Progestin Therapy||6||
48715267|NCT03077698|102088745|FG001|NOT COMPLETED|Sodium Cridanimod & Progestin Therapy||9||
48715268|NCT03077698|102088744|FG000|STARTED|Safety Follow Up||6||
48715269|NCT03077698|102088745|FG001|STARTED|Safety Follow Up||9||
48715270|NCT03077698|102088744|FG000|COMPLETED|Safety Follow Up||3||
48715271|NCT03077698|102088745|FG001|COMPLETED|Safety Follow Up||8||
48715272|NCT03077698|102088744|FG000|NOT COMPLETED|Safety Follow Up||3||
48715273|NCT03077698|102088745|FG001|NOT COMPLETED|Safety Follow Up||1||
48147266|NCT03673306|100682499|FG000|NOT COMPLETED|Overall Study||0||
48147267|NCT03673306|100682500|FG001|NOT COMPLETED|Overall Study||0||
48147268|NCT04330638|100682501|FG000|STARTED|Overall Study||74||
48147269|NCT04330638|100682502|FG001|STARTED|Overall Study||44||
48147270|NCT04330638|100682503|FG002|STARTED|Overall Study||75||
48147271|NCT04330638|100682504|FG003|STARTED|Overall Study||36||
48147272|NCT04330638|100682505|FG004|STARTED|Overall Study||81||
48147273|NCT04330638|100682506|FG005|STARTED|Overall Study||32||
48147274|NCT04330638|100682501|FG000|Randomization 1: No IL-1 Blockade|Overall Study||74||
48147275|NCT04330638|100682502|FG001|Randomization 1: No IL-1 Blockade|Overall Study||0||
48147276|NCT04330638|100682503|FG002|Randomization 1: No IL-1 Blockade|Overall Study||75||
48147277|NCT04330638|100682504|FG003|Randomization 1: No IL-1 Blockade|Overall Study||0||
48147278|NCT04330638|100682505|FG004|Randomization 1: No IL-1 Blockade|Overall Study||81||
48147279|NCT04330638|100682506|FG005|Randomization 1: No IL-1 Blockade|Overall Study||0||
48147280|NCT04330638|100682501|FG000|Randomization 1: IL-1 Blockade|Overall Study||0||
48147281|NCT04330638|100682502|FG001|Randomization 1: IL-1 Blockade|Overall Study||44||
48147282|NCT04330638|100682503|FG002|Randomization 1: IL-1 Blockade|Overall Study||0||
48301261|NCT01287065|101064135|FG004|STARTED|Washout Period 1||4||
48301262|NCT01287065|101064136|FG005|STARTED|Washout Period 1||4||
48301263|NCT01287065|101064131|FG000|COMPLETED|Washout Period 1||4||
48301264|NCT01287065|101064132|FG001|COMPLETED|Washout Period 1||4||
48301265|NCT01287065|101064133|FG002|COMPLETED|Washout Period 1||4||
48301266|NCT01287065|101064134|FG003|COMPLETED|Washout Period 1||4||
48301267|NCT01287065|101064135|FG004|COMPLETED|Washout Period 1||4||
48301268|NCT01287065|101064136|FG005|COMPLETED|Washout Period 1||4||
48715274|NCT01247363|102088746|FG000|STARTED|Overall Study||20||
48715275|NCT01247363|102088746|FG000|COMPLETED|Overall Study||20||
48715276|NCT01247363|102088746|FG000|NOT COMPLETED|Overall Study||0||
48147283|NCT04330638|100682504|FG003|Randomization 1: IL-1 Blockade|Overall Study||36||
48301269|NCT01287065|101064131|FG000|NOT COMPLETED|Washout Period 1||0||
48301270|NCT01287065|101064132|FG001|NOT COMPLETED|Washout Period 1||0||
48301271|NCT01287065|101064133|FG002|NOT COMPLETED|Washout Period 1||0||
48715277|NCT00654004|102088747|FG000|STARTED|Overall Study||14||
48301272|NCT01287065|101064134|FG003|NOT COMPLETED|Washout Period 1||0||
48301273|NCT01287065|101064135|FG004|NOT COMPLETED|Washout Period 1||0||
48301274|NCT01287065|101064136|FG005|NOT COMPLETED|Washout Period 1||0||
48301275|NCT01287065|101064131|FG000|STARTED|Treatment Period 2||4||
48301276|NCT01287065|101064132|FG001|STARTED|Treatment Period 2||4||
48301277|NCT01287065|101064133|FG002|STARTED|Treatment Period 2||4||
48301278|NCT01287065|101064134|FG003|STARTED|Treatment Period 2||4||
48301279|NCT01287065|101064135|FG004|STARTED|Treatment Period 2||4||
48301280|NCT01287065|101064136|FG005|STARTED|Treatment Period 2||4||
48301281|NCT01287065|101064131|FG000|COMPLETED|Treatment Period 2||4||
48301282|NCT01287065|101064132|FG001|COMPLETED|Treatment Period 2||4||
48301283|NCT01287065|101064133|FG002|COMPLETED|Treatment Period 2||4||
48301284|NCT01287065|101064134|FG003|COMPLETED|Treatment Period 2||4||
48301285|NCT01287065|101064135|FG004|COMPLETED|Treatment Period 2||4||
48301286|NCT01287065|101064136|FG005|COMPLETED|Treatment Period 2||4||
48301287|NCT01287065|101064131|FG000|NOT COMPLETED|Treatment Period 2||0||
48301288|NCT01287065|101064132|FG001|NOT COMPLETED|Treatment Period 2||0||
48301289|NCT01287065|101064133|FG002|NOT COMPLETED|Treatment Period 2||0||
48301290|NCT01287065|101064134|FG003|NOT COMPLETED|Treatment Period 2||0||
48301291|NCT01287065|101064135|FG004|NOT COMPLETED|Treatment Period 2||0||
48301292|NCT01287065|101064136|FG005|NOT COMPLETED|Treatment Period 2||0||
48301293|NCT01287065|101064131|FG000|STARTED|Washout Period 2||4||
48301294|NCT01287065|101064132|FG001|STARTED|Washout Period 2||4||
48301295|NCT01287065|101064133|FG002|STARTED|Washout Period 2||4||
48301296|NCT01287065|101064134|FG003|STARTED|Washout Period 2||4||
48301297|NCT01287065|101064135|FG004|STARTED|Washout Period 2||4||
48301298|NCT01287065|101064136|FG005|STARTED|Washout Period 2||4||
48301299|NCT01287065|101064131|FG000|COMPLETED|Washout Period 2||4||
48301300|NCT01287065|101064132|FG001|COMPLETED|Washout Period 2||4||
48301301|NCT01287065|101064133|FG002|COMPLETED|Washout Period 2||4||
48301302|NCT01287065|101064134|FG003|COMPLETED|Washout Period 2||4||
48301303|NCT01287065|101064135|FG004|COMPLETED|Washout Period 2||4||
48301304|NCT01287065|101064136|FG005|COMPLETED|Washout Period 2||4||
48301305|NCT01287065|101064131|FG000|NOT COMPLETED|Washout Period 2||0||
48301306|NCT01287065|101064132|FG001|NOT COMPLETED|Washout Period 2||0||
48301307|NCT01287065|101064133|FG002|NOT COMPLETED|Washout Period 2||0||
48301308|NCT01287065|101064134|FG003|NOT COMPLETED|Washout Period 2||0||
48301309|NCT01287065|101064135|FG004|NOT COMPLETED|Washout Period 2||0||
48301310|NCT01287065|101064136|FG005|NOT COMPLETED|Washout Period 2||0||
48301311|NCT01287065|101064131|FG000|STARTED|Treatment Period 3||4||
48301312|NCT01287065|101064132|FG001|STARTED|Treatment Period 3||4||
48301313|NCT01287065|101064133|FG002|STARTED|Treatment Period 3||4||
48301314|NCT01287065|101064134|FG003|STARTED|Treatment Period 3||4||
48301315|NCT01287065|101064135|FG004|STARTED|Treatment Period 3||4||
48301316|NCT01287065|101064136|FG005|STARTED|Treatment Period 3||4||
48301317|NCT01287065|101064131|FG000|COMPLETED|Treatment Period 3||4||
48301318|NCT01287065|101064132|FG001|COMPLETED|Treatment Period 3||4||
48301319|NCT01287065|101064133|FG002|COMPLETED|Treatment Period 3||4||
48301320|NCT01287065|101064134|FG003|COMPLETED|Treatment Period 3||4||
48301321|NCT01287065|101064135|FG004|COMPLETED|Treatment Period 3||4||
48301322|NCT01287065|101064136|FG005|COMPLETED|Treatment Period 3||4||
48301323|NCT01287065|101064131|FG000|NOT COMPLETED|Treatment Period 3||0||
48301324|NCT01287065|101064132|FG001|NOT COMPLETED|Treatment Period 3||0||
48301325|NCT01287065|101064133|FG002|NOT COMPLETED|Treatment Period 3||0||
48301326|NCT01287065|101064134|FG003|NOT COMPLETED|Treatment Period 3||0||
48301327|NCT01287065|101064135|FG004|NOT COMPLETED|Treatment Period 3||0||
48301328|NCT01287065|101064136|FG005|NOT COMPLETED|Treatment Period 3||0||
48301329|NCT00078754|101064137|FG000|STARTED|Overall Study||29||
48301330|NCT00078754|101064138|FG001|STARTED|Overall Study||30||
48301331|NCT00078754|101064139|FG002|STARTED|Overall Study||31||
48301332|NCT00078754|101064137|FG000|COMPLETED|Overall Study||14||
48301333|NCT00078754|101064138|FG001|COMPLETED|Overall Study||11||
48301334|NCT00078754|101064139|FG002|COMPLETED|Overall Study||16||
48301335|NCT00078754|101064137|FG000|NOT COMPLETED|Overall Study||15||
48301336|NCT00078754|101064138|FG001|NOT COMPLETED|Overall Study||19||
48301337|NCT00078754|101064139|FG002|NOT COMPLETED|Overall Study||15||
48301338|NCT03047551|101064140|FG000|STARTED|Overall Study||319||
48301339|NCT03047551|101064141|FG001|STARTED|Overall Study||315||
48301340|NCT03047551|101064140|FG000|COMPLETED|Overall Study||317||
48301341|NCT03047551|101064141|FG001|COMPLETED|Overall Study||312||
48301342|NCT03047551|101064140|FG000|NOT COMPLETED|Overall Study||2||
48301343|NCT03047551|101064141|FG001|NOT COMPLETED|Overall Study||3||
48301344|NCT02047643|101064142|FG000|STARTED|Overall Study||9||
48301345|NCT02047643|101064143|FG001|STARTED|Overall Study||9||
48301346|NCT02047643|101064142|FG000|COMPLETED|Overall Study||9||
48301347|NCT02047643|101064143|FG001|COMPLETED|Overall Study||9||
48301348|NCT02047643|101064142|FG000|NOT COMPLETED|Overall Study||0||
48301349|NCT02047643|101064143|FG001|NOT COMPLETED|Overall Study||0||
48301350|NCT01446016|101064144|FG000|STARTED|Overall Study||38||
48301351|NCT01446016|101064144|FG000|COMPLETED|Overall Study||31||
48301352|NCT01446016|101064144|FG000|NOT COMPLETED|Overall Study||7||
48301353|NCT02499081|101064145|FG000|STARTED|Overall Study||20||
48301354|NCT02499081|101064145|FG000|COMPLETED|Overall Study||1||
48301355|NCT02499081|101064145|FG000|NOT COMPLETED|Overall Study||19||
48603002|NCT01400906|101811730|FG003|COMPLETED|Treatment Period 1||6||
48603003|NCT01400906|101811731|FG004|COMPLETED|Treatment Period 1||6||
48603004|NCT01400906|101811732|FG005|COMPLETED|Treatment Period 1||5||
48603005|NCT01400906|101811727|FG000|NOT COMPLETED|Treatment Period 1||0||
48603006|NCT01400906|101811728|FG001|NOT COMPLETED|Treatment Period 1||0||
48603007|NCT01400906|101811729|FG002|NOT COMPLETED|Treatment Period 1||0||
48603008|NCT01400906|101811730|FG003|NOT COMPLETED|Treatment Period 1||0||
48603009|NCT01400906|101811731|FG004|NOT COMPLETED|Treatment Period 1||0||
48603010|NCT01400906|101811732|FG005|NOT COMPLETED|Treatment Period 1||0||
48603011|NCT01400906|101811727|FG000|STARTED|Washout Period 1||6||
48715278|NCT00654004|102088748|FG001|STARTED|Overall Study||12||
48715279|NCT00654004|102088747|FG000|COMPLETED|Overall Study||13||
48715280|NCT00654004|102088748|FG001|COMPLETED|Overall Study||12||
48715281|NCT00654004|102088747|FG000|NOT COMPLETED|Overall Study||1||
48715282|NCT00654004|102088748|FG001|NOT COMPLETED|Overall Study||0||
48147284|NCT04330638|100682505|FG004|Randomization 1: IL-1 Blockade|Overall Study||0||
48147285|NCT04330638|100682506|FG005|Randomization 1: IL-1 Blockade|Overall Study||32||
48603012|NCT01400906|101811728|FG001|STARTED|Washout Period 1||6||
48715283|NCT04912895|102088749|FG000|STARTED|Overall Study||51||
48715284|NCT04912895|102088750|FG001|STARTED|Overall Study||0||
48715285|NCT04912895|102088751|FG002|STARTED|Overall Study||18||
48715286|NCT04912895|102088749|FG000|COMPLETED|Overall Study||49||
48715287|NCT04912895|102088750|FG001|COMPLETED|Overall Study||0||
48715288|NCT04912895|102088751|FG002|COMPLETED|Overall Study||18||
48715289|NCT04912895|102088749|FG000|NOT COMPLETED|Overall Study||2||
48715290|NCT04912895|102088750|FG001|NOT COMPLETED|Overall Study||0||
48715291|NCT04912895|102088751|FG002|NOT COMPLETED|Overall Study||0||
48715292|NCT00733135|102088752|FG000|STARTED|Overall Study||133||
48715293|NCT00733135|102088752|FG000|COMPLETED|Overall Study||131||
48715294|NCT00733135|102088752|FG000|NOT COMPLETED|Overall Study||2||
48715295|NCT03923582|102088753|FG000|STARTED|Overall Study||206||
48715296|NCT03923582|102088754|FG001|STARTED|Overall Study||206||
48715297|NCT03923582|102088753|FG000|COMPLETED|Overall Study||203||
48715298|NCT03923582|102088754|FG001|COMPLETED|Overall Study||205||
48715299|NCT03923582|102088753|FG000|NOT COMPLETED|Overall Study||3||
48715300|NCT03923582|102088754|FG001|NOT COMPLETED|Overall Study||1||
48715301|NCT02033213|102088755|FG000|STARTED|Overall Study||8||
48715302|NCT02033213|102088756|FG001|STARTED|Overall Study||8||
48715303|NCT02033213|102088755|FG000|COMPLETED|Overall Study||8||
48715304|NCT02033213|102088756|FG001|COMPLETED|Overall Study||8||
48715305|NCT02033213|102088755|FG000|NOT COMPLETED|Overall Study||0||
48715306|NCT02033213|102088756|FG001|NOT COMPLETED|Overall Study||0||
48715307|NCT03906656|102088757|FG000|STARTED|Fitting/Assessment Prior to Home Use 1||52||
48715308|NCT03906656|102088758|FG001|STARTED|Fitting/Assessment Prior to Home Use 1||50||
48715309|NCT03906656|102088757|FG000|COMPLETED|Fitting/Assessment Prior to Home Use 1||50||
48715310|NCT03906656|102088758|FG001|COMPLETED|Fitting/Assessment Prior to Home Use 1||47||
48715311|NCT03906656|102088757|FG000|NOT COMPLETED|Fitting/Assessment Prior to Home Use 1||2||
48715312|NCT03906656|102088758|FG001|NOT COMPLETED|Fitting/Assessment Prior to Home Use 1||3||
48715313|NCT03906656|102088757|FG000|STARTED|Home Use 1 (3 Months)||50||
48715314|NCT03906656|102088758|FG001|STARTED|Home Use 1 (3 Months)||47||
48715315|NCT03906656|102088757|FG000|COMPLETED|Home Use 1 (3 Months)||47||
48715316|NCT03906656|102088758|FG001|COMPLETED|Home Use 1 (3 Months)||44||
48715317|NCT03906656|102088757|FG000|NOT COMPLETED|Home Use 1 (3 Months)||3||
48715318|NCT03906656|102088758|FG001|NOT COMPLETED|Home Use 1 (3 Months)||3||
48715319|NCT03906656|102088757|FG000|STARTED|Fitting/Assessment Prior to Home Use 2||47||
48715320|NCT03906656|102088758|FG001|STARTED|Fitting/Assessment Prior to Home Use 2||44||
48715321|NCT03906656|102088757|FG000|COMPLETED|Fitting/Assessment Prior to Home Use 2||41||
48715322|NCT03906656|102088758|FG001|COMPLETED|Fitting/Assessment Prior to Home Use 2||43||
48715323|NCT03906656|102088757|FG000|NOT COMPLETED|Fitting/Assessment Prior to Home Use 2||6||
48715324|NCT03906656|102088758|FG001|NOT COMPLETED|Fitting/Assessment Prior to Home Use 2||1||
48715325|NCT03906656|102088757|FG000|STARTED|Home Use 2 (3 Months)||41||
48715326|NCT03906656|102088758|FG001|STARTED|Home Use 2 (3 Months)||43||
48715327|NCT03906656|102088757|FG000|COMPLETED|Home Use 2 (3 Months)||35||
48715328|NCT03906656|102088758|FG001|COMPLETED|Home Use 2 (3 Months)||41||
48147286|NCT04330638|100682501|FG000|Randomization 2: No IL-6 Blockade|Overall Study||74||
48603013|NCT01400906|101811729|FG002|STARTED|Washout Period 1||6||
48603014|NCT01400906|101811730|FG003|STARTED|Washout Period 1||6||
48603015|NCT01400906|101811731|FG004|STARTED|Washout Period 1||6||
48603016|NCT01400906|101811732|FG005|STARTED|Washout Period 1||5||
48715329|NCT03906656|102088757|FG000|NOT COMPLETED|Home Use 2 (3 Months)||6||
48715330|NCT03906656|102088758|FG001|NOT COMPLETED|Home Use 2 (3 Months)||2||
48603017|NCT01400906|101811727|FG000|COMPLETED|Washout Period 1||6||
48715331|NCT01632241|102088759|FG000|STARTED|Double-blinded (Up to Week 52)||165||
48715332|NCT01632241|102088760|FG001|STARTED|Double-blinded (Up to Week 52)||331||
48715333|NCT01632241|102088759|FG000|COMPLETED|Double-blinded (Up to Week 52)||121||
48715334|NCT01632241|102088760|FG001|COMPLETED|Double-blinded (Up to Week 52)||252||
48715335|NCT01632241|102088759|FG000|NOT COMPLETED|Double-blinded (Up to Week 52)||44||
48147287|NCT04330638|100682502|FG001|Randomization 2: No IL-6 Blockade|Overall Study||41||
48147288|NCT04330638|100682503|FG002|Randomization 2: No IL-6 Blockade|Overall Study||0||
48301356|NCT00567268|101064146|FG000|STARTED|Overall Study||1194||
48301357|NCT00567268|101064146|FG000|COMPLETED|Overall Study||1144||
48301358|NCT00567268|101064146|FG000|NOT COMPLETED|Overall Study||50||
48301359|NCT01322048|101064147|FG000|STARTED|Overall Study||21||
48301360|NCT01322048|101064148|FG001|STARTED|Overall Study||26||
48301361|NCT01322048|101064147|FG000|COMPLETED|Overall Study||21||
48301362|NCT01322048|101064148|FG001|COMPLETED|Overall Study||26||
48301363|NCT01322048|101064147|FG000|NOT COMPLETED|Overall Study||0||
48301364|NCT01322048|101064148|FG001|NOT COMPLETED|Overall Study||0||
48603018|NCT01400906|101811728|FG001|COMPLETED|Washout Period 1||6||
48603019|NCT01400906|101811729|FG002|COMPLETED|Washout Period 1||6||
48603020|NCT01400906|101811730|FG003|COMPLETED|Washout Period 1||6||
48603021|NCT01400906|101811731|FG004|COMPLETED|Washout Period 1||6||
48603022|NCT01400906|101811732|FG005|COMPLETED|Washout Period 1||5||
48603023|NCT01400906|101811727|FG000|NOT COMPLETED|Washout Period 1||0||
48603024|NCT01400906|101811728|FG001|NOT COMPLETED|Washout Period 1||0||
48603025|NCT01400906|101811729|FG002|NOT COMPLETED|Washout Period 1||0||
48603026|NCT01400906|101811730|FG003|NOT COMPLETED|Washout Period 1||0||
48603027|NCT01400906|101811731|FG004|NOT COMPLETED|Washout Period 1||0||
48603028|NCT01400906|101811732|FG005|NOT COMPLETED|Washout Period 1||0||
48603029|NCT01400906|101811727|FG000|STARTED|Treatment Period 2||6||
48603030|NCT01400906|101811728|FG001|STARTED|Treatment Period 2||6||
48603031|NCT01400906|101811729|FG002|STARTED|Treatment Period 2||6||
48603032|NCT01400906|101811730|FG003|STARTED|Treatment Period 2||6||
48603033|NCT01400906|101811731|FG004|STARTED|Treatment Period 2||6||
48603034|NCT01400906|101811732|FG005|STARTED|Treatment Period 2||5||
48603035|NCT01400906|101811727|FG000|COMPLETED|Treatment Period 2||6||
48603036|NCT01400906|101811728|FG001|COMPLETED|Treatment Period 2||6||
48301365|NCT03330457|101064149|FG000|STARTED|Overall Study||6||
48301366|NCT03330457|101064150|FG001|STARTED|Overall Study||3||
48301367|NCT03330457|101064151|FG002|STARTED|Overall Study||6||
48301368|NCT03330457|101064152|FG003|STARTED|Overall Study||3||
48301369|NCT03330457|101064149|FG000|COMPLETED|Overall Study||6||
48301370|NCT03330457|101064150|FG001|COMPLETED|Overall Study||3||
48301371|NCT03330457|101064151|FG002|COMPLETED|Overall Study||6||
48301372|NCT03330457|101064152|FG003|COMPLETED|Overall Study||3||
48301373|NCT03330457|101064149|FG000|NOT COMPLETED|Overall Study||0||
48301374|NCT03330457|101064150|FG001|NOT COMPLETED|Overall Study||0||
48301375|NCT03330457|101064151|FG002|NOT COMPLETED|Overall Study||0||
48301376|NCT03330457|101064152|FG003|NOT COMPLETED|Overall Study||0||
48301377|NCT01980654|101064153|FG000|STARTED|Overall Study||60||
48301378|NCT01980654|101064154|FG001|STARTED|Overall Study||20||
48301379|NCT01980654|101064153|FG000|COMPLETED|Overall Study||60||
48301380|NCT01980654|101064154|FG001|COMPLETED|Overall Study||20||
48301381|NCT01980654|101064153|FG000|NOT COMPLETED|Overall Study||0||
48301382|NCT01980654|101064154|FG001|NOT COMPLETED|Overall Study||0||
48301383|NCT01215175|101064155|FG000|STARTED|Overall Study||30||
48301384|NCT01215175|101064156|FG001|STARTED|Overall Study||30||
48301385|NCT01215175|101064157|FG002|STARTED|Overall Study||33||
48301386|NCT01215175|101064158|FG003|STARTED|Overall Study||29||
48301387|NCT01215175|101064159|FG004|STARTED|Overall Study||28||
48301388|NCT01215175|101064155|FG000|Treated|Overall Study||30||
48301389|NCT01215175|101064156|FG001|Treated|Overall Study||30||
48301390|NCT01215175|101064157|FG002|Treated|Overall Study||33||
48301391|NCT01215175|101064158|FG003|Treated|Overall Study||29||
48301392|NCT01215175|101064159|FG004|Treated|Overall Study||28||
48301393|NCT01215175|101064155|FG000|COMPLETED|Overall Study||30||
48603037|NCT01400906|101811729|FG002|COMPLETED|Treatment Period 2||6||
48603038|NCT01400906|101811730|FG003|COMPLETED|Treatment Period 2||6||
48603039|NCT01400906|101811731|FG004|COMPLETED|Treatment Period 2||6||
48603040|NCT01400906|101811732|FG005|COMPLETED|Treatment Period 2||5||
48603041|NCT01400906|101811727|FG000|NOT COMPLETED|Treatment Period 2||0||
48603042|NCT01400906|101811728|FG001|NOT COMPLETED|Treatment Period 2||0||
48603043|NCT01400906|101811729|FG002|NOT COMPLETED|Treatment Period 2||0||
48603044|NCT01400906|101811730|FG003|NOT COMPLETED|Treatment Period 2||0||
48603045|NCT01400906|101811731|FG004|NOT COMPLETED|Treatment Period 2||0||
48603046|NCT01400906|101811732|FG005|NOT COMPLETED|Treatment Period 2||0||
48301394|NCT01215175|101064156|FG001|COMPLETED|Overall Study||29||
48301395|NCT01215175|101064157|FG002|COMPLETED|Overall Study||33||
48301396|NCT01215175|101064158|FG003|COMPLETED|Overall Study||28||
48301397|NCT01215175|101064159|FG004|COMPLETED|Overall Study||28||
48301398|NCT01215175|101064155|FG000|NOT COMPLETED|Overall Study||0||
48301399|NCT01215175|101064156|FG001|NOT COMPLETED|Overall Study||1||
48603047|NCT01400906|101811727|FG000|STARTED|Washout Period 2||6||
48301400|NCT01215175|101064157|FG002|NOT COMPLETED|Overall Study||0||
48301401|NCT01215175|101064158|FG003|NOT COMPLETED|Overall Study||1||
48301402|NCT01215175|101064159|FG004|NOT COMPLETED|Overall Study||0||
48301403|NCT01002456|101064160|FG000|STARTED|Overall Study||98||
48301404|NCT01002456|101064161|FG001|STARTED|Overall Study||122||
48603048|NCT01400906|101811728|FG001|STARTED|Washout Period 2||6||
48603049|NCT01400906|101811729|FG002|STARTED|Washout Period 2||6||
48603050|NCT01400906|101811730|FG003|STARTED|Washout Period 2||6||
48301405|NCT01002456|101064160|FG000|COMPLETED|Overall Study||98||
48301406|NCT01002456|101064161|FG001|COMPLETED|Overall Study||122||
48603051|NCT01400906|101811731|FG004|STARTED|Washout Period 2||6||
48603052|NCT01400906|101811732|FG005|STARTED|Washout Period 2||5||
48147289|NCT04330638|100682504|FG003|Randomization 2: No IL-6 Blockade|Overall Study||0||
48147290|NCT04330638|100682505|FG004|Randomization 2: No IL-6 Blockade|Overall Study||0||
48147291|NCT04330638|100682506|FG005|Randomization 2: No IL-6 Blockade|Overall Study||0||
48147292|NCT04330638|100682501|FG000|Randomization 2: IL-6 Blockade|Overall Study||0||
48147293|NCT04330638|100682502|FG001|Randomization 2: IL-6 Blockade|Overall Study||0||
48147294|NCT04330638|100682503|FG002|Randomization 2: IL-6 Blockade|Overall Study||75||
48147295|NCT04330638|100682504|FG003|Randomization 2: IL-6 Blockade|Overall Study||36||
48147296|NCT04330638|100682505|FG004|Randomization 2: IL-6 Blockade|Overall Study||81||
48147297|NCT04330638|100682506|FG005|Randomization 2: IL-6 Blockade|Overall Study||32||
48147298|NCT04330638|100682501|FG000|COMPLETED|Overall Study||56||
48147299|NCT04330638|100682502|FG001|COMPLETED|Overall Study||30||
48147300|NCT04330638|100682503|FG002|COMPLETED|Overall Study||52||
48147301|NCT04330638|100682504|FG003|COMPLETED|Overall Study||27||
48147302|NCT04330638|100682505|FG004|COMPLETED|Overall Study||65||
48147303|NCT04330638|100682506|FG005|COMPLETED|Overall Study||25||
48147304|NCT04330638|100682501|FG000|NOT COMPLETED|Overall Study||18||
48147305|NCT04330638|100682502|FG001|NOT COMPLETED|Overall Study||14||
48147306|NCT04330638|100682503|FG002|NOT COMPLETED|Overall Study||23||
48147307|NCT04330638|100682504|FG003|NOT COMPLETED|Overall Study||9||
48147308|NCT04330638|100682505|FG004|NOT COMPLETED|Overall Study||16||
48147309|NCT04330638|100682506|FG005|NOT COMPLETED|Overall Study||7||
48147310|NCT03535337|100682507|FG000|STARTED|Stage 1 Randomization||40||
48147311|NCT03535337|100682508|FG001|STARTED|Stage 1 Randomization||43||
48147312|NCT03535337|100682509|FG002|STARTED|Stage 1 Randomization||0||
48147313|NCT03535337|100682510|FG003|STARTED|Stage 1 Randomization||0||
48147314|NCT03535337|100682511|FG004|STARTED|Stage 1 Randomization||0||
48147315|NCT03535337|100682512|FG005|STARTED|Stage 1 Randomization||0||
48147316|NCT03535337|100682513|FG006|STARTED|Stage 1 Randomization||0||
48147317|NCT03535337|100682514|FG007|STARTED|Stage 1 Randomization||0||
48147318|NCT03535337|100682515|FG008|STARTED|Stage 1 Randomization||0||
48147319|NCT03535337|100682516|FG009|STARTED|Stage 1 Randomization||0||
48147320|NCT03535337|100682507|FG000|COMPLETED|Stage 1 Randomization||40||
48301407|NCT01002456|101064160|FG000|NOT COMPLETED|Overall Study||0||
48301408|NCT01002456|101064161|FG001|NOT COMPLETED|Overall Study||0||
48301409|NCT02020863|101064162|FG000|STARTED|Overall Study||40||
48301410|NCT02020863|101064162|FG000|COMPLETED|Overall Study||35||
48603053|NCT01400906|101811727|FG000|COMPLETED|Washout Period 2||6||
48603054|NCT01400906|101811728|FG001|COMPLETED|Washout Period 2||6||
48603055|NCT01400906|101811729|FG002|COMPLETED|Washout Period 2||6||
48603056|NCT01400906|101811730|FG003|COMPLETED|Washout Period 2||6||
48715336|NCT01632241|102088760|FG001|NOT COMPLETED|Double-blinded (Up to Week 52)||79||
48715337|NCT01632241|102088759|FG000|STARTED|Open-label (Week 52 to Week 76)||117||
48715338|NCT01632241|102088760|FG001|STARTED|Open-label (Week 52 to Week 76)||242||
48715339|NCT01632241|102088759|FG000|COMPLETED|Open-label (Week 52 to Week 76)||107||
48715340|NCT01632241|102088760|FG001|COMPLETED|Open-label (Week 52 to Week 76)||220||
48715341|NCT01632241|102088759|FG000|NOT COMPLETED|Open-label (Week 52 to Week 76)||10||
48715342|NCT01632241|102088760|FG001|NOT COMPLETED|Open-label (Week 52 to Week 76)||22||
48715343|NCT02084238|102088761|FG000|STARTED|Overall Study||40||
48147321|NCT03535337|100682508|FG001|COMPLETED|Stage 1 Randomization||43||
48147322|NCT03535337|100682509|FG002|COMPLETED|Stage 1 Randomization||0||
48147323|NCT03535337|100682510|FG003|COMPLETED|Stage 1 Randomization||0||
48147324|NCT03535337|100682511|FG004|COMPLETED|Stage 1 Randomization||0||
48147325|NCT03535337|100682512|FG005|COMPLETED|Stage 1 Randomization||0||
48147326|NCT03535337|100682513|FG006|COMPLETED|Stage 1 Randomization||0||
48301411|NCT02020863|101064162|FG000|NOT COMPLETED|Overall Study||5||
48301412|NCT01178333|101064163|FG000|STARTED|Overall Study||71||
48301413|NCT01178333|101064164|FG001|STARTED|Overall Study||284||
48301414|NCT01178333|101064165|FG002|STARTED|Overall Study||87||
48301415|NCT01178333|101064163|FG000|COMPLETED|Overall Study||71||
48301416|NCT01178333|101064164|FG001|COMPLETED|Overall Study||284||
48603057|NCT01400906|101811731|FG004|COMPLETED|Washout Period 2||6||
48603058|NCT01400906|101811732|FG005|COMPLETED|Washout Period 2||5||
48603059|NCT01400906|101811727|FG000|NOT COMPLETED|Washout Period 2||0||
48603060|NCT01400906|101811728|FG001|NOT COMPLETED|Washout Period 2||0||
48603061|NCT01400906|101811729|FG002|NOT COMPLETED|Washout Period 2||0||
48715344|NCT02084238|102088761|FG000|COMPLETED|Overall Study||38||
48715345|NCT02084238|102088761|FG000|NOT COMPLETED|Overall Study||2||
48147327|NCT03535337|100682514|FG007|COMPLETED|Stage 1 Randomization||0||
48301417|NCT01178333|101064165|FG002|COMPLETED|Overall Study||87||
48301418|NCT01178333|101064163|FG000|NOT COMPLETED|Overall Study||0||
48301419|NCT01178333|101064164|FG001|NOT COMPLETED|Overall Study||0||
48301420|NCT01178333|101064165|FG002|NOT COMPLETED|Overall Study||0||
48603062|NCT01400906|101811730|FG003|NOT COMPLETED|Washout Period 2||0||
48715346|NCT00973102|102088762|FG000|STARTED|Overall Study||24||
48301421|NCT00764751|101064166|FG000|STARTED|Overall Study||39||
48147328|NCT03535337|100682515|FG008|COMPLETED|Stage 1 Randomization||0||
48147329|NCT03535337|100682516|FG009|COMPLETED|Stage 1 Randomization||0||
48147330|NCT03535337|100682507|FG000|NOT COMPLETED|Stage 1 Randomization||0||
48147331|NCT03535337|100682508|FG001|NOT COMPLETED|Stage 1 Randomization||0||
48147332|NCT03535337|100682509|FG002|NOT COMPLETED|Stage 1 Randomization||0||
48147333|NCT03535337|100682510|FG003|NOT COMPLETED|Stage 1 Randomization||0||
48147334|NCT03535337|100682511|FG004|NOT COMPLETED|Stage 1 Randomization||0||
48147335|NCT03535337|100682512|FG005|NOT COMPLETED|Stage 1 Randomization||0||
48147336|NCT03535337|100682513|FG006|NOT COMPLETED|Stage 1 Randomization||0||
48147337|NCT03535337|100682514|FG007|NOT COMPLETED|Stage 1 Randomization||0||
48147338|NCT03535337|100682515|FG008|NOT COMPLETED|Stage 1 Randomization||0||
48715347|NCT00973102|102088763|FG001|STARTED|Overall Study||26||
48715348|NCT00973102|102088762|FG000|COMPLETED|Overall Study||23||
48715349|NCT00973102|102088763|FG001|COMPLETED|Overall Study||25||
48147339|NCT03535337|100682516|FG009|NOT COMPLETED|Stage 1 Randomization||0||
48147340|NCT03535337|100682507|FG000|STARTED|Stage 2 Randomization||0||
48147341|NCT03535337|100682508|FG001|STARTED|Stage 2 Randomization||0||
48147342|NCT03535337|100682509|FG002|STARTED|Stage 2 Randomization||2||
48147343|NCT03535337|100682510|FG003|STARTED|Stage 2 Randomization||4||
48147344|NCT03535337|100682511|FG004|STARTED|Stage 2 Randomization||11||
48147345|NCT03535337|100682512|FG005|STARTED|Stage 2 Randomization||16||
48147346|NCT03535337|100682513|FG006|STARTED|Stage 2 Randomization||14||
48147347|NCT03535337|100682514|FG007|STARTED|Stage 2 Randomization||14||
48147348|NCT03535337|100682515|FG008|STARTED|Stage 2 Randomization||3||
48147349|NCT03535337|100682516|FG009|STARTED|Stage 2 Randomization||5||
48147350|NCT03535337|100682507|FG000|COMPLETED|Stage 2 Randomization||0||
48147351|NCT03535337|100682508|FG001|COMPLETED|Stage 2 Randomization||0||
48147352|NCT03535337|100682509|FG002|COMPLETED|Stage 2 Randomization||0||
48147353|NCT03535337|100682510|FG003|COMPLETED|Stage 2 Randomization||3||
48147354|NCT03535337|100682511|FG004|COMPLETED|Stage 2 Randomization||6||
48147355|NCT03535337|100682512|FG005|COMPLETED|Stage 2 Randomization||12||
48147356|NCT03535337|100682513|FG006|COMPLETED|Stage 2 Randomization||11||
48147357|NCT03535337|100682514|FG007|COMPLETED|Stage 2 Randomization||8||
48147358|NCT03535337|100682515|FG008|COMPLETED|Stage 2 Randomization||3||
48147359|NCT03535337|100682516|FG009|COMPLETED|Stage 2 Randomization||3||
48147360|NCT03535337|100682507|FG000|NOT COMPLETED|Stage 2 Randomization||0||
48147361|NCT03535337|100682508|FG001|NOT COMPLETED|Stage 2 Randomization||0||
48147362|NCT03535337|100682509|FG002|NOT COMPLETED|Stage 2 Randomization||2||
48147363|NCT03535337|100682510|FG003|NOT COMPLETED|Stage 2 Randomization||1||
48147364|NCT03535337|100682511|FG004|NOT COMPLETED|Stage 2 Randomization||5||
48147365|NCT03535337|100682512|FG005|NOT COMPLETED|Stage 2 Randomization||4||
48147366|NCT03535337|100682513|FG006|NOT COMPLETED|Stage 2 Randomization||3||
48147367|NCT03535337|100682514|FG007|NOT COMPLETED|Stage 2 Randomization||6||
48147368|NCT03535337|100682515|FG008|NOT COMPLETED|Stage 2 Randomization||0||
48147369|NCT03535337|100682516|FG009|NOT COMPLETED|Stage 2 Randomization||2||
48147370|NCT01860703|100682517|FG000|STARTED|Overall Study||13||
48147371|NCT01860703|100682518|FG001|STARTED|Overall Study||13||
48147372|NCT01860703|100682519|FG002|STARTED|Overall Study||12||
48147373|NCT01860703|100682520|FG003|STARTED|Overall Study||12||
48147374|NCT01860703|100682517|FG000|COMPLETED|Overall Study||11||
48147375|NCT01860703|100682518|FG001|COMPLETED|Overall Study||8||
48147376|NCT01860703|100682519|FG002|COMPLETED|Overall Study||11||
48603063|NCT01400906|101811731|FG004|NOT COMPLETED|Washout Period 2||0||
48147377|NCT01860703|100682520|FG003|COMPLETED|Overall Study||10||
48147378|NCT01860703|100682517|FG000|NOT COMPLETED|Overall Study||2||
48147379|NCT01860703|100682518|FG001|NOT COMPLETED|Overall Study||5||
48147380|NCT01860703|100682519|FG002|NOT COMPLETED|Overall Study||1||
48147381|NCT01860703|100682520|FG003|NOT COMPLETED|Overall Study||2||
48147382|NCT00626028|100682521|FG000|STARTED|Overall Study||68||
48147383|NCT00626028|100682522|FG001|STARTED|Overall Study||68||
48147384|NCT00626028|100682521|FG000|COMPLETED|Overall Study||62||
48147385|NCT00626028|100682522|FG001|COMPLETED|Overall Study||59||
48147386|NCT00626028|100682521|FG000|NOT COMPLETED|Overall Study||6||
48147387|NCT00626028|100682522|FG001|NOT COMPLETED|Overall Study||9||
48147388|NCT00254202|100682523|FG000|STARTED|Overall Study||295|Randomized (excluding randomization errors)|
48147389|NCT00254202|100682524|FG001|STARTED|Overall Study||149|Randomized (excluding randomization errors)|
48147390|NCT00254202|100682525|FG002|STARTED|Overall Study||149|Randomized (excluding randomization errors)|
48147391|NCT00254202|100682523|FG000|Safety Population|Overall Study||300||
48147392|NCT00254202|100682524|FG001|Safety Population|Overall Study||150||
48147393|NCT00254202|100682525|FG002|Safety Population|Overall Study||147||
48147394|NCT00254202|100682523|FG000|COMPLETED|Overall Study||193||
48147395|NCT00254202|100682524|FG001|COMPLETED|Overall Study||98||
48603064|NCT01400906|101811732|FG005|NOT COMPLETED|Washout Period 2||0||
48603065|NCT01400906|101811727|FG000|STARTED|Treatment Period 3||6||
48603066|NCT01400906|101811728|FG001|STARTED|Treatment Period 3||6||
48603067|NCT01400906|101811729|FG002|STARTED|Treatment Period 3||6||
48603068|NCT01400906|101811730|FG003|STARTED|Treatment Period 3||6||
48603069|NCT01400906|101811731|FG004|STARTED|Treatment Period 3||6||
48603070|NCT01400906|101811732|FG005|STARTED|Treatment Period 3||5||
48603071|NCT01400906|101811727|FG000|COMPLETED|Treatment Period 3||6||
48301422|NCT00764751|101064167|FG001|STARTED|Overall Study||12||
48301423|NCT00764751|101064166|FG000|COMPLETED|Overall Study||37||
48301424|NCT00764751|101064167|FG001|COMPLETED|Overall Study||11||
48301425|NCT00764751|101064166|FG000|NOT COMPLETED|Overall Study||2||
48301426|NCT00764751|101064167|FG001|NOT COMPLETED|Overall Study||1||
48301427|NCT03231943|101064168|FG000|STARTED|Part 1, Period 1 (up to Day 15)||2||
48301428|NCT03231943|101064169|FG001|STARTED|Part 1, Period 1 (up to Day 15)||2||
48405305|NCT01764022|101325249|FG001|COMPLETED|Overall Study||96|Received 6 cycles of therapy during main period of the study or had disease progression|
48405306|NCT01764022|101325248|FG000|NOT COMPLETED|Overall Study||8||
48603072|NCT01400906|101811728|FG001|COMPLETED|Treatment Period 3||6||
48603073|NCT01400906|101811729|FG002|COMPLETED|Treatment Period 3||6||
48603074|NCT01400906|101811730|FG003|COMPLETED|Treatment Period 3||6||
48603075|NCT01400906|101811731|FG004|COMPLETED|Treatment Period 3||6||
48603076|NCT01400906|101811732|FG005|COMPLETED|Treatment Period 3||5||
48603077|NCT01400906|101811727|FG000|NOT COMPLETED|Treatment Period 3||0||
48603078|NCT01400906|101811728|FG001|NOT COMPLETED|Treatment Period 3||0||
48603079|NCT01400906|101811729|FG002|NOT COMPLETED|Treatment Period 3||0||
48603080|NCT01400906|101811730|FG003|NOT COMPLETED|Treatment Period 3||0||
48603081|NCT01400906|101811731|FG004|NOT COMPLETED|Treatment Period 3||0||
48603082|NCT01400906|101811732|FG005|NOT COMPLETED|Treatment Period 3||0||
48603083|NCT04542278|101811733|FG000|STARTED|Overall Study||14||
48603084|NCT04542278|101811734|FG001|STARTED|Overall Study||16||
48603085|NCT04542278|101811733|FG000|COMPLETED|Overall Study||14||
48603086|NCT04542278|101811734|FG001|COMPLETED|Overall Study||16||
48603087|NCT04542278|101811733|FG000|NOT COMPLETED|Overall Study||0||
48603088|NCT04542278|101811734|FG001|NOT COMPLETED|Overall Study||0||
48603089|NCT02886884|101811735|FG000|STARTED|Treatment||3||
48603090|NCT02886884|101811736|FG001|STARTED|Treatment||3||
48603091|NCT02886884|101811737|FG002|STARTED|Treatment||5||
48603092|NCT02886884|101811738|FG003|STARTED|Treatment||5||
48603093|NCT02886884|101811735|FG000|COMPLETED|Treatment||3||
48603094|NCT02886884|101811736|FG001|COMPLETED|Treatment||3||
48603095|NCT02886884|101811737|FG002|COMPLETED|Treatment||5||
48603096|NCT02886884|101811738|FG003|COMPLETED|Treatment||5||
48603097|NCT02886884|101811735|FG000|NOT COMPLETED|Treatment||0||
48603098|NCT02886884|101811736|FG001|NOT COMPLETED|Treatment||0||
48603099|NCT02886884|101811737|FG002|NOT COMPLETED|Treatment||0||
48603100|NCT02886884|101811738|FG003|NOT COMPLETED|Treatment||0||
48603101|NCT02886884|101811735|FG000|STARTED|Follow-up||3||
48603102|NCT02886884|101811736|FG001|STARTED|Follow-up||3||
48603103|NCT02886884|101811737|FG002|STARTED|Follow-up||5||
48603104|NCT02886884|101811738|FG003|STARTED|Follow-up||5||
48603105|NCT02886884|101811735|FG000|COMPLETED|Follow-up||3||
48603106|NCT02886884|101811736|FG001|COMPLETED|Follow-up||3||
48603107|NCT02886884|101811737|FG002|COMPLETED|Follow-up||5||
48603108|NCT02886884|101811738|FG003|COMPLETED|Follow-up||4||
48603109|NCT02886884|101811735|FG000|NOT COMPLETED|Follow-up||0||
48603110|NCT02886884|101811736|FG001|NOT COMPLETED|Follow-up||0||
48603111|NCT02886884|101811737|FG002|NOT COMPLETED|Follow-up||0||
48603112|NCT02886884|101811738|FG003|NOT COMPLETED|Follow-up||1||
48603113|NCT02510820|101811739|FG000|STARTED|First Intervention (4 Weeks)||21||
48603114|NCT02510820|101811740|FG001|STARTED|First Intervention (4 Weeks)||27||
48603115|NCT02510820|101811739|FG000|COMPLETED|First Intervention (4 Weeks)||21||
48603116|NCT02510820|101811740|FG001|COMPLETED|First Intervention (4 Weeks)||26||
48603117|NCT02510820|101811739|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0||
48603118|NCT02510820|101811740|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1||
48603119|NCT02510820|101811739|FG000|STARTED|Washout (1 Week)||21||
48603120|NCT02510820|101811740|FG001|STARTED|Washout (1 Week)||26||
48603121|NCT02510820|101811739|FG000|COMPLETED|Washout (1 Week)||21||
48603122|NCT02510820|101811740|FG001|COMPLETED|Washout (1 Week)||26||
48603123|NCT02510820|101811739|FG000|NOT COMPLETED|Washout (1 Week)||0||
48603124|NCT02510820|101811740|FG001|NOT COMPLETED|Washout (1 Week)||0||
48603125|NCT02510820|101811739|FG000|STARTED|Second Intervention (4 Weeks)||21||
48603126|NCT02510820|101811740|FG001|STARTED|Second Intervention (4 Weeks)||26||
48603127|NCT02510820|101811739|FG000|COMPLETED|Second Intervention (4 Weeks)||20||
48603128|NCT02510820|101811740|FG001|COMPLETED|Second Intervention (4 Weeks)||26||
48603129|NCT02510820|101811739|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1||
48603130|NCT02510820|101811740|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0||
48301429|NCT03231943|101064170|FG002|STARTED|Part 1, Period 1 (up to Day 15)||2||
48301430|NCT03231943|101064171|FG003|STARTED|Part 1, Period 1 (up to Day 15)||2||
48603131|NCT03046056|101811741|FG000|STARTED|Overall Study||28||
48603132|NCT03046056|101811742|FG001|STARTED|Overall Study||32||
48603133|NCT03046056|101811743|FG002|STARTED|Overall Study||18||
48603134|NCT03046056|101811741|FG000|COMPLETED|Overall Study||16||
48603135|NCT03046056|101811742|FG001|COMPLETED|Overall Study||16||
48603136|NCT03046056|101811743|FG002|COMPLETED|Overall Study||11||
48603137|NCT03046056|101811741|FG000|NOT COMPLETED|Overall Study||12||
48301431|NCT03231943|101064172|FG004|STARTED|Part 1, Period 1 (up to Day 15)||2||
48301432|NCT03231943|101064173|FG005|STARTED|Part 1, Period 1 (up to Day 15)||2||
48301433|NCT03231943|101064174|FG006|STARTED|Part 1, Period 1 (up to Day 15)||2||
48603138|NCT03046056|101811742|FG001|NOT COMPLETED|Overall Study||16||
48603139|NCT03046056|101811743|FG002|NOT COMPLETED|Overall Study||7||
48301434|NCT03231943|101064175|FG007|STARTED|Part 1, Period 1 (up to Day 15)||2||
48301435|NCT03231943|101064176|FG008|STARTED|Part 1, Period 1 (up to Day 15)||0||
48301436|NCT03231943|101064177|FG009|STARTED|Part 1, Period 1 (up to Day 15)||0||
48301437|NCT03231943|101064178|FG010|STARTED|Part 1, Period 1 (up to Day 15)||0||
48301438|NCT03231943|101064179|FG011|STARTED|Part 1, Period 1 (up to Day 15)||0||
48301439|NCT03231943|101064180|FG012|STARTED|Part 1, Period 1 (up to Day 15)||0||
48301440|NCT03231943|101064168|FG000|COMPLETED|Part 1, Period 1 (up to Day 15)||2||
48301441|NCT03231943|101064169|FG001|COMPLETED|Part 1, Period 1 (up to Day 15)||2||
48301442|NCT03231943|101064170|FG002|COMPLETED|Part 1, Period 1 (up to Day 15)||2||
48301443|NCT03231943|101064171|FG003|COMPLETED|Part 1, Period 1 (up to Day 15)||2||
48301444|NCT03231943|101064172|FG004|COMPLETED|Part 1, Period 1 (up to Day 15)||2||
48301445|NCT03231943|101064173|FG005|COMPLETED|Part 1, Period 1 (up to Day 15)||2||
48301446|NCT03231943|101064174|FG006|COMPLETED|Part 1, Period 1 (up to Day 15)||2||
48301447|NCT03231943|101064175|FG007|COMPLETED|Part 1, Period 1 (up to Day 15)||2||
48301448|NCT03231943|101064176|FG008|COMPLETED|Part 1, Period 1 (up to Day 15)||0||
48301449|NCT03231943|101064177|FG009|COMPLETED|Part 1, Period 1 (up to Day 15)||0||
48301450|NCT03231943|101064178|FG010|COMPLETED|Part 1, Period 1 (up to Day 15)||0||
48301451|NCT03231943|101064179|FG011|COMPLETED|Part 1, Period 1 (up to Day 15)||0||
48603140|NCT00742027|101811744|FG000|STARTED|Overall Study||129||
48603141|NCT00742027|101811744|FG000|COMPLETED|Overall Study||0|Deaths reported included deaths that occurred more than 28 days after treatment discontinuation.|
48603142|NCT00742027|101811744|FG000|NOT COMPLETED|Overall Study||129||
48603143|NCT01660802|101811745|FG000|STARTED|Overall Study||130||
48603144|NCT01660802|101811746|FG001|STARTED|Overall Study||132||
48603145|NCT01660802|101811745|FG000|COMPLETED|Overall Study||126||
48603146|NCT01660802|101811746|FG001|COMPLETED|Overall Study||121||
48603147|NCT01660802|101811745|FG000|NOT COMPLETED|Overall Study||4||
48603148|NCT01660802|101811746|FG001|NOT COMPLETED|Overall Study||11||
48603149|NCT00703118|101811747|FG000|STARTED|Overall Study||266||
48603150|NCT00703118|101811748|FG001|STARTED|Overall Study||264||
48603151|NCT00703118|101811749|FG002|STARTED|Overall Study||132||
48603152|NCT00703118|101811747|FG000|COMPLETED|Overall Study||245||
48603153|NCT00703118|101811748|FG001|COMPLETED|Overall Study||248||
48603154|NCT00703118|101811749|FG002|COMPLETED|Overall Study||110||
48603155|NCT00703118|101811747|FG000|NOT COMPLETED|Overall Study||21||
48603156|NCT00703118|101811748|FG001|NOT COMPLETED|Overall Study||16||
48603157|NCT00703118|101811749|FG002|NOT COMPLETED|Overall Study||22||
48603158|NCT03765229|101811750|FG000|STARTED|Overall Study||11||
48603159|NCT03765229|101811750|FG000|COMPLETED|Overall Study||11||
48603160|NCT03765229|101811750|FG000|NOT COMPLETED|Overall Study||0||
48603161|NCT03230838|101811751|FG000|STARTED|Overall Study||101||
48603162|NCT03230838|101811752|FG001|STARTED|Overall Study||33||
48603163|NCT03230838|101811751|FG000|Treated|Overall Study||100||
48603164|NCT03230838|101811752|FG001|Treated|Overall Study||33||
48603165|NCT03230838|101811751|FG000|COMPLETED|Overall Study||97||
48603166|NCT03230838|101811752|FG001|COMPLETED|Overall Study||33||
48603167|NCT03230838|101811751|FG000|NOT COMPLETED|Overall Study||4||
48603168|NCT03230838|101811752|FG001|NOT COMPLETED|Overall Study||0||
48301452|NCT03231943|101064180|FG012|COMPLETED|Part 1, Period 1 (up to Day 15)||0||
48301453|NCT03231943|101064168|FG000|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0||
48603169|NCT03278847|101811753|FG000|STARTED|Overall Study||1618||
48603170|NCT03278847|101811754|FG001|STARTED|Overall Study||1618||
48603171|NCT03278847|101811755|FG002|STARTED|Overall Study||1240||
48603172|NCT03278847|101811756|FG003|STARTED|Overall Study||1240||
48603173|NCT03278847|101811753|FG000|COMPLETED|Overall Study||1618||
48603174|NCT03278847|101811754|FG001|COMPLETED|Overall Study||1618||
48603175|NCT03278847|101811755|FG002|COMPLETED|Overall Study||1240||
48603176|NCT03278847|101811756|FG003|COMPLETED|Overall Study||1240||
48603177|NCT03278847|101811753|FG000|NOT COMPLETED|Overall Study||0||
48603178|NCT03278847|101811754|FG001|NOT COMPLETED|Overall Study||0||
48603179|NCT03278847|101811755|FG002|NOT COMPLETED|Overall Study||0||
48603180|NCT03278847|101811756|FG003|NOT COMPLETED|Overall Study||0||
48301454|NCT03231943|101064169|FG001|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0||
48301455|NCT03231943|101064170|FG002|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0||
48301456|NCT03231943|101064171|FG003|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0||
48301457|NCT03231943|101064172|FG004|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0||
48301458|NCT03231943|101064173|FG005|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0||
48301459|NCT03231943|101064174|FG006|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0||
48301460|NCT03231943|101064175|FG007|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0||
48301461|NCT03231943|101064176|FG008|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0||
48301462|NCT03231943|101064177|FG009|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0||
48603181|NCT01313221|101811757|FG000|STARTED|Overall Study||144||
48603182|NCT01313221|101811758|FG001|STARTED|Overall Study||143||
48603183|NCT01313221|101811759|FG002|STARTED|Overall Study||23||
48603184|NCT01313221|101811757|FG000|Randomized|Overall Study||144||
48603185|NCT01313221|101811758|FG001|Randomized|Overall Study||143||
48603186|NCT01313221|101811759|FG002|Randomized|Overall Study||0||
48603187|NCT01313221|101811757|FG000|COMPLETED|Overall Study||132||
48603188|NCT01313221|101811758|FG001|COMPLETED|Overall Study||135||
48603189|NCT01313221|101811759|FG002|COMPLETED|Overall Study||0||
48603190|NCT01313221|101811757|FG000|NOT COMPLETED|Overall Study||12||
48603191|NCT01313221|101811758|FG001|NOT COMPLETED|Overall Study||8||
48603192|NCT01313221|101811759|FG002|NOT COMPLETED|Overall Study||23||
48603193|NCT02412878|101811760|FG000|STARTED|Overall Study||238||
48603194|NCT02412878|101811761|FG001|STARTED|Overall Study||240||
48603195|NCT02412878|101811760|FG000|Received Carfilzomib|Overall Study||235||
48603196|NCT02412878|101811761|FG001|Received Carfilzomib|Overall Study||238||
48603197|NCT02412878|101811760|FG000|COMPLETED|Overall Study||217|Defined as participants who discontinued due to death or study closure|
48603198|NCT02412878|101811761|FG001|COMPLETED|Overall Study||227|Defined as participants who discontinued due to death or study closure|
48603199|NCT02412878|101811760|FG000|NOT COMPLETED|Overall Study||21||
48603200|NCT02412878|101811761|FG001|NOT COMPLETED|Overall Study||13||
48603201|NCT00908596|101811762|FG000|STARTED|Overall Study||47||
48603202|NCT00908596|101811763|FG001|STARTED|Overall Study||32||
48603203|NCT00908596|101811764|FG002|STARTED|Overall Study||193||
48603204|NCT00908596|101811765|FG003|STARTED|Overall Study||85||
48603205|NCT00908596|101811762|FG000|COMPLETED|Overall Study||0||
48603206|NCT00908596|101811763|FG001|COMPLETED|Overall Study||19||
48603207|NCT00908596|101811764|FG002|COMPLETED|Overall Study||119||
48603208|NCT00908596|101811765|FG003|COMPLETED|Overall Study||48||
48603209|NCT00908596|101811762|FG000|NOT COMPLETED|Overall Study||47||
48603210|NCT00908596|101811763|FG001|NOT COMPLETED|Overall Study||13||
48603211|NCT00908596|101811764|FG002|NOT COMPLETED|Overall Study||74||
48603212|NCT00908596|101811765|FG003|NOT COMPLETED|Overall Study||37||
48715350|NCT00973102|102088762|FG000|NOT COMPLETED|Overall Study||1||
48715351|NCT00973102|102088763|FG001|NOT COMPLETED|Overall Study||1||
48715352|NCT00885638|102088764|FG000|STARTED|Overall Study||6||
48715353|NCT00885638|102088765|FG001|STARTED|Overall Study||6||
48715354|NCT00885638|102088764|FG000|COMPLETED|Overall Study||6||
48715355|NCT00885638|102088765|FG001|COMPLETED|Overall Study||6||
48715356|NCT00885638|102088764|FG000|NOT COMPLETED|Overall Study||0||
48715357|NCT00885638|102088765|FG001|NOT COMPLETED|Overall Study||0||
48715358|NCT01288612|102088766|FG000|STARTED|Overall Study||150||
48715359|NCT01288612|102088767|FG001|STARTED|Overall Study||151||
48715360|NCT01288612|102088768|FG002|STARTED|Overall Study||158||
48715361|NCT01288612|102088766|FG000|Contacted|Overall Study||139||
48715362|NCT01288612|102088767|FG001|Contacted|Overall Study||135||
48715363|NCT01288612|102088768|FG002|Contacted|Overall Study||138||
48715364|NCT01288612|102088766|FG000|Agreed to Take Part|Overall Study||61||
48715365|NCT01288612|102088767|FG001|Agreed to Take Part|Overall Study||72||
48715366|NCT01288612|102088768|FG002|Agreed to Take Part|Overall Study||76||
48715367|NCT01288612|102088766|FG000|COMPLETED|Overall Study||61||
48715368|NCT01288612|102088767|FG001|COMPLETED|Overall Study||69||
48715369|NCT01288612|102088768|FG002|COMPLETED|Overall Study||76||
48715370|NCT01288612|102088766|FG000|NOT COMPLETED|Overall Study||89||
48715371|NCT01288612|102088767|FG001|NOT COMPLETED|Overall Study||82||
48715372|NCT01288612|102088768|FG002|NOT COMPLETED|Overall Study||82||
48715373|NCT02043197|102088769|FG000|STARTED|Overall Study||300||
48715374|NCT02043197|102088769|FG000|COMPLETED|Overall Study||292||
48603213|NCT01243177|101811766|FG000|STARTED|Overall Study||444||
48603214|NCT01243177|101811767|FG001|STARTED|Overall Study||442||
48603215|NCT01243177|101811766|FG000|COMPLETED|Overall Study||266||
48603216|NCT01243177|101811767|FG001|COMPLETED|Overall Study||264||
48603217|NCT01243177|101811766|FG000|NOT COMPLETED|Overall Study||178||
48603218|NCT01243177|101811767|FG001|NOT COMPLETED|Overall Study||178||
48603219|NCT01160380|101811768|FG000|STARTED|Overall Study||25||
48603220|NCT01160380|101811769|FG001|STARTED|Overall Study||25||
48603221|NCT01160380|101811768|FG000|COMPLETED|Overall Study||17||
48603222|NCT01160380|101811769|FG001|COMPLETED|Overall Study||20||
48603223|NCT01160380|101811768|FG000|NOT COMPLETED|Overall Study||8||
48603224|NCT01160380|101811769|FG001|NOT COMPLETED|Overall Study||5||
48603225|NCT02946489|101811770|FG000|STARTED|Overall Study||8||
48603226|NCT02946489|101811770|FG000|COMPLETED|Overall Study||8||
48603227|NCT02946489|101811770|FG000|NOT COMPLETED|Overall Study||0||
48603228|NCT00502853|101811771|FG000|STARTED|Overall Study||10||
48603229|NCT00502853|101811771|FG000|COMPLETED|Overall Study||10||
48603230|NCT00502853|101811771|FG000|NOT COMPLETED|Overall Study||0||
48603231|NCT02020512|101811772|FG000|STARTED|Overall Study||87||
48603232|NCT02020512|101811772|FG000|COMPLETED|Overall Study||79||
48603233|NCT02020512|101811772|FG000|NOT COMPLETED|Overall Study||8||
48603234|NCT04485637|101811773|FG000|STARTED|Overall Study||188||
48715375|NCT02043197|102088769|FG000|NOT COMPLETED|Overall Study||8||
48603235|NCT04485637|101811774|FG001|STARTED|Overall Study||176||
48603236|NCT04485637|101811775|FG002|STARTED|Overall Study||178||
48603237|NCT04485637|101811773|FG000|COMPLETED|Overall Study||188||
48603238|NCT04485637|101811774|FG001|COMPLETED|Overall Study||176||
48603239|NCT04485637|101811775|FG002|COMPLETED|Overall Study||178||
48603240|NCT04485637|101811773|FG000|NOT COMPLETED|Overall Study||0||
48603241|NCT04485637|101811774|FG001|NOT COMPLETED|Overall Study||0||
48603242|NCT04485637|101811775|FG002|NOT COMPLETED|Overall Study||0||
48603243|NCT05460078|101811776|FG000|STARTED|Overall Study||3616|Discharges identified as eligible|
48603244|NCT05460078|101811777|FG001|STARTED|Overall Study||3910|Discharges identified as eligible|
48603245|NCT05460078|101811776|FG000|COMPLETED|Overall Study||1382|Actually enrolled in the program|
48603246|NCT05460078|101811777|FG001|COMPLETED|Overall Study||3910|Actually enrolled in the program|
48603247|NCT05460078|101811776|FG000|NOT COMPLETED|Overall Study||2234||
48603248|NCT05460078|101811777|FG001|NOT COMPLETED|Overall Study||0||
48603249|NCT02304380|101811778|FG000|STARTED|Pediatric Claims Data Analysis (Aim 3)||0||
48603250|NCT02304380|101811779|FG001|STARTED|Pediatric Claims Data Analysis (Aim 3)||0||
48603251|NCT02304380|101811780|FG002|STARTED|Pediatric Claims Data Analysis (Aim 3)||0||
48147396|NCT00254202|100682525|FG002|COMPLETED|Overall Study||90||
48147397|NCT00254202|100682523|FG000|NOT COMPLETED|Overall Study||102||
48147398|NCT00254202|100682524|FG001|NOT COMPLETED|Overall Study||51||
48147399|NCT00254202|100682525|FG002|NOT COMPLETED|Overall Study||59||
48147400|NCT03624465|100682526|FG000|STARTED|Overall Study||30||
48147401|NCT03624465|100682526|FG000|COMPLETED|Overall Study||30||
48147402|NCT03624465|100682526|FG000|NOT COMPLETED|Overall Study||0||
48147403|NCT00717860|100682527|FG000|STARTED|Overall Study||61||
48147404|NCT00717860|100682528|FG001|STARTED|Overall Study||60||
48147405|NCT00717860|100682527|FG000|COMPLETED|Overall Study||34||
48147406|NCT00717860|100682528|FG001|COMPLETED|Overall Study||32||
48603252|NCT02304380|101811781|FG003|STARTED|Pediatric Claims Data Analysis (Aim 3)||0||
48603253|NCT02304380|101811782|FG004|STARTED|Pediatric Claims Data Analysis (Aim 3)||17356||
48603254|NCT02304380|101811783|FG005|STARTED|Pediatric Claims Data Analysis (Aim 3)||47026||
48603255|NCT02304380|101811778|FG000|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0||
48603256|NCT02304380|101811779|FG001|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0||
48603257|NCT02304380|101811780|FG002|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0||
48603258|NCT02304380|101811781|FG003|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0||
48603259|NCT02304380|101811782|FG004|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||17356||
48603260|NCT02304380|101811783|FG005|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||47026||
48603261|NCT02304380|101811778|FG000|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0||
48603262|NCT02304380|101811779|FG001|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0||
48603263|NCT02304380|101811780|FG002|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0||
48147407|NCT00717860|100682527|FG000|NOT COMPLETED|Overall Study||27||
48603264|NCT02304380|101811781|FG003|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0||
48603265|NCT02304380|101811782|FG004|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0||
48603266|NCT02304380|101811783|FG005|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0||
48603267|NCT02304380|101811778|FG000|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0||
48603268|NCT02304380|101811779|FG001|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0||
48603269|NCT02304380|101811780|FG002|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0||
48603270|NCT02304380|101811781|FG003|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||2096||
48603271|NCT02304380|101811782|FG004|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0||
48603272|NCT02304380|101811783|FG005|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0||
48603273|NCT02304380|101811778|FG000|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0||
48603274|NCT02304380|101811779|FG001|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0||
48603275|NCT02304380|101811780|FG002|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0||
48603276|NCT02304380|101811781|FG003|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||2062||
48603277|NCT02304380|101811782|FG004|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0||
48603278|NCT02304380|101811783|FG005|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0||
48603279|NCT02304380|101811778|FG000|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0||
48603280|NCT02304380|101811779|FG001|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0||
48603281|NCT02304380|101811780|FG002|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0||
48603282|NCT02304380|101811781|FG003|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||34||
48603283|NCT02304380|101811782|FG004|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0||
48603284|NCT02304380|101811783|FG005|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0||
48603285|NCT02304380|101811778|FG000|STARTED|Interviews & Focus Groups (Aim 1)||0||
48603286|NCT02304380|101811779|FG001|STARTED|Interviews & Focus Groups (Aim 1)||35||
48603287|NCT02304380|101811780|FG002|STARTED|Interviews & Focus Groups (Aim 1)||33||
48603288|NCT02304380|101811781|FG003|STARTED|Interviews & Focus Groups (Aim 1)||0||
48603289|NCT02304380|101811782|FG004|STARTED|Interviews & Focus Groups (Aim 1)||0||
48603290|NCT02304380|101811783|FG005|STARTED|Interviews & Focus Groups (Aim 1)||0||
48147408|NCT00717860|100682528|FG001|NOT COMPLETED|Overall Study||28||
48147409|NCT02578238|100682529|FG000|STARTED|Overall Study||143||
48147410|NCT02578238|100682529|FG000|COMPLETED|Overall Study||143||
48147411|NCT02578238|100682529|FG000|NOT COMPLETED|Overall Study||0||
48147412|NCT01311674|100682530|FG000|STARTED|Overall Study||72||
48147413|NCT01311674|100682531|FG001|STARTED|Overall Study||69||
48147414|NCT01311674|100682530|FG000|COMPLETED|Overall Study||28||
48147415|NCT01311674|100682531|FG001|COMPLETED|Overall Study||29||
48147416|NCT01311674|100682530|FG000|NOT COMPLETED|Overall Study||44||
48147417|NCT01311674|100682531|FG001|NOT COMPLETED|Overall Study||40||
48147418|NCT00850473|100682532|FG000|STARTED|Overall Study||3||
48147419|NCT00850473|100682532|FG000|COMPLETED|Overall Study||3||
48147420|NCT00850473|100682532|FG000|NOT COMPLETED|Overall Study||0||
48147421|NCT01029054|100684985|FG000|STARTED|Phase I||4||
48147422|NCT01029054|100684986|FG001|STARTED|Phase I||13||
48147423|NCT01029054|100684987|FG002|STARTED|Phase I||18||
48147424|NCT01029054|100684985|FG000|COMPLETED|Phase I||4||
48147425|NCT01029054|100684986|FG001|COMPLETED|Phase I||13||
48147426|NCT01029054|100684987|FG002|COMPLETED|Phase I||18||
48147427|NCT01029054|100684985|FG000|NOT COMPLETED|Phase I||0||
48147428|NCT01029054|100684986|FG001|NOT COMPLETED|Phase I||0||
48147429|NCT01029054|100684987|FG002|NOT COMPLETED|Phase I||0||
48147430|NCT01029054|100684985|FG000|STARTED|Phase II||0||
48147431|NCT01029054|100684986|FG001|STARTED|Phase II||0||
48147432|NCT01029054|100684987|FG002|STARTED|Phase II||18||
48603291|NCT02304380|101811778|FG000|COMPLETED|Interviews & Focus Groups (Aim 1)||0||
48603292|NCT02304380|101811779|FG001|COMPLETED|Interviews & Focus Groups (Aim 1)||35||
48603293|NCT02304380|101811780|FG002|COMPLETED|Interviews & Focus Groups (Aim 1)||33||
48603294|NCT02304380|101811781|FG003|COMPLETED|Interviews & Focus Groups (Aim 1)||0||
48603295|NCT02304380|101811782|FG004|COMPLETED|Interviews & Focus Groups (Aim 1)||0||
48603296|NCT02304380|101811783|FG005|COMPLETED|Interviews & Focus Groups (Aim 1)||0||
48147433|NCT01029054|100684985|FG000|COMPLETED|Phase II||0||
48147434|NCT01029054|100684986|FG001|COMPLETED|Phase II||0||
48147435|NCT01029054|100684987|FG002|COMPLETED|Phase II||18||
48147436|NCT01029054|100684985|FG000|NOT COMPLETED|Phase II||0||
48147437|NCT01029054|100684986|FG001|NOT COMPLETED|Phase II||0||
48147438|NCT01029054|100684987|FG002|NOT COMPLETED|Phase II||0||
48147439|NCT02732938|100684988|FG000|STARTED|Overall Study||4||
48147440|NCT02732938|100684989|FG001|STARTED|Overall Study||18||
48147441|NCT02732938|100684990|FG002|STARTED|Overall Study||0||
48147442|NCT02732938|100684988|FG000|Received Treatment|Overall Study||4||
48147443|NCT02732938|100684989|FG001|Received Treatment|Overall Study||17||
48147444|NCT02732938|100684990|FG002|Received Treatment|Overall Study||0||
48147445|NCT02732938|100684988|FG000|COMPLETED|Overall Study||0||
48147446|NCT02732938|100684989|FG001|COMPLETED|Overall Study||0||
48147447|NCT02732938|100684990|FG002|COMPLETED|Overall Study||0||
48715376|NCT00859339|102088770|FG000|STARTED|Overall Study||9||
48147448|NCT02732938|100684988|FG000|NOT COMPLETED|Overall Study||4||
48147449|NCT02732938|100684989|FG001|NOT COMPLETED|Overall Study||18||
48147450|NCT02732938|100684990|FG002|NOT COMPLETED|Overall Study||0||
48147451|NCT03360942|100684991|FG000|STARTED|Overall Study||5||
48147452|NCT03360942|100684991|FG000|COMPLETED|Overall Study||0||
48147453|NCT03360942|100684991|FG000|NOT COMPLETED|Overall Study||5||
48147454|NCT00610116|100684992|FG000|STARTED|Overall Study||305||
48147455|NCT00610116|100684992|FG000|COMPLETED|Overall Study||292||
48147456|NCT00610116|100684992|FG000|NOT COMPLETED|Overall Study||13||
48147457|NCT02676375|100684993|FG000|STARTED|Overall Study||14||
48147458|NCT02676375|100684994|FG001|STARTED|Overall Study||14||
48147459|NCT02676375|100684995|FG002|STARTED|Overall Study||14||
48147460|NCT02676375|100684993|FG000|COMPLETED|Overall Study||13||
48147461|NCT02676375|100684994|FG001|COMPLETED|Overall Study||10||
48147462|NCT02676375|100684995|FG002|COMPLETED|Overall Study||11||
48147463|NCT02676375|100684993|FG000|NOT COMPLETED|Overall Study||1||
48147464|NCT02676375|100684994|FG001|NOT COMPLETED|Overall Study||4||
48147465|NCT02676375|100684995|FG002|NOT COMPLETED|Overall Study||3||
48147466|NCT01428076|100684996|FG000|STARTED|Overall Study||9||
48147467|NCT01428076|100684997|FG001|STARTED|Overall Study||12||
48147468|NCT01428076|100684996|FG000|COMPLETED|Overall Study||9||
48147469|NCT01428076|100684997|FG001|COMPLETED|Overall Study||11||
48147470|NCT01428076|100684996|FG000|NOT COMPLETED|Overall Study||0||
48603297|NCT02304380|101811778|FG000|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0||
48603298|NCT02304380|101811779|FG001|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0||
48603299|NCT02304380|101811780|FG002|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0||
48715377|NCT00859339|102088770|FG000|COMPLETED|Overall Study||9||
48147471|NCT01428076|100684997|FG001|NOT COMPLETED|Overall Study||1||
48147472|NCT05130970|100684998|FG000|STARTED|Overall Study||40||
48147473|NCT05130970|100684999|FG001|STARTED|Overall Study||41||
48147474|NCT05130970|100684998|FG000|COMPLETED|Overall Study||38||
48147475|NCT05130970|100684999|FG001|COMPLETED|Overall Study||36||
48147476|NCT05130970|100684998|FG000|NOT COMPLETED|Overall Study||2||
48147477|NCT05130970|100684999|FG001|NOT COMPLETED|Overall Study||5||
48147478|NCT04496219|100685000|FG000|STARTED|Overall Study||28||
48147479|NCT04496219|100685001|FG001|STARTED|Overall Study||17||
48147480|NCT04496219|100685000|FG000|COMPLETED|Overall Study||25||
48147481|NCT04496219|100685001|FG001|COMPLETED|Overall Study||14||
48147482|NCT04496219|100685000|FG000|NOT COMPLETED|Overall Study||3||
48147483|NCT04496219|100685001|FG001|NOT COMPLETED|Overall Study||3||
48603300|NCT02304380|101811781|FG003|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0||
48603301|NCT02304380|101811782|FG004|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0||
48147484|NCT03842995|100685002|FG000|STARTED|Overall Study||240||
48147485|NCT03842995|100685003|FG001|STARTED|Overall Study||237||
48147486|NCT03842995|100685002|FG000|COMPLETED|Overall Study||98||
48147487|NCT03842995|100685003|FG001|COMPLETED|Overall Study||95||
48147488|NCT03842995|100685002|FG000|NOT COMPLETED|Overall Study||142||
48147489|NCT03842995|100685003|FG001|NOT COMPLETED|Overall Study||142||
48147490|NCT01239030|100685004|FG000|STARTED|Double Blind||49||
48147491|NCT01239030|100685005|FG001|STARTED|Double Blind||44||
48147492|NCT01239030|100685006|FG002|STARTED|Double Blind||45||
48147493|NCT01239030|100685007|FG003|STARTED|Double Blind||45||
48147494|NCT01239030|100685008|FG004|STARTED|Double Blind||47||
48147495|NCT01239030|100685004|FG000|COMPLETED|Double Blind||48||
48147496|NCT01239030|100685005|FG001|COMPLETED|Double Blind||40||
48147497|NCT01239030|100685006|FG002|COMPLETED|Double Blind||44||
48147498|NCT01239030|100685007|FG003|COMPLETED|Double Blind||43||
48147499|NCT01239030|100685008|FG004|COMPLETED|Double Blind||46||
48147500|NCT01239030|100685004|FG000|NOT COMPLETED|Double Blind||1||
48147501|NCT01239030|100685005|FG001|NOT COMPLETED|Double Blind||4||
48147502|NCT01239030|100685006|FG002|NOT COMPLETED|Double Blind||1||
48147503|NCT01239030|100685007|FG003|NOT COMPLETED|Double Blind||2||
48147504|NCT01239030|100685008|FG004|NOT COMPLETED|Double Blind||1||
48147505|NCT01239030|100685004|FG000|STARTED|Dose Optimization (Open Label)||48||
48147506|NCT01239030|100685005|FG001|STARTED|Dose Optimization (Open Label)||40||
48147507|NCT01239030|100685006|FG002|STARTED|Dose Optimization (Open Label)||44||
48147508|NCT01239030|100685007|FG003|STARTED|Dose Optimization (Open Label)||43||
48147509|NCT01239030|100685008|FG004|STARTED|Dose Optimization (Open Label)||46||
48147510|NCT01239030|100685004|FG000|COMPLETED|Dose Optimization (Open Label)||41||
48147511|NCT01239030|100685005|FG001|COMPLETED|Dose Optimization (Open Label)||38||
48147512|NCT01239030|100685006|FG002|COMPLETED|Dose Optimization (Open Label)||42||
48147513|NCT01239030|100685007|FG003|COMPLETED|Dose Optimization (Open Label)||40||
48147514|NCT01239030|100685008|FG004|COMPLETED|Dose Optimization (Open Label)||39||
48147515|NCT01239030|100685004|FG000|NOT COMPLETED|Dose Optimization (Open Label)||7||
48147516|NCT01239030|100685005|FG001|NOT COMPLETED|Dose Optimization (Open Label)||2||
48147517|NCT01239030|100685006|FG002|NOT COMPLETED|Dose Optimization (Open Label)||2||
48147518|NCT01239030|100685007|FG003|NOT COMPLETED|Dose Optimization (Open Label)||3||
48147519|NCT01239030|100685008|FG004|NOT COMPLETED|Dose Optimization (Open Label)||7||
48147520|NCT04401267|100685009|FG000|STARTED|Overall Study||26||
48147521|NCT04401267|100685010|FG001|STARTED|Overall Study||25||
48147522|NCT04401267|100685009|FG000|COMPLETED|Overall Study||21||
48147523|NCT04401267|100685010|FG001|COMPLETED|Overall Study||22||
48147524|NCT04401267|100685009|FG000|NOT COMPLETED|Overall Study||5||
48147525|NCT04401267|100685010|FG001|NOT COMPLETED|Overall Study||3||
48147526|NCT02063828|100685011|FG000|STARTED|Overall Study||14||
48147527|NCT02063828|100685012|FG001|STARTED|Overall Study||14||
48147528|NCT02063828|100685013|FG002|STARTED|Overall Study||18||
48147529|NCT02063828|100685011|FG000|Week 6|Overall Study||11||
48147530|NCT02063828|100685012|FG001|Week 6|Overall Study||9||
48147531|NCT02063828|100685013|FG002|Week 6|Overall Study||14||
48147532|NCT02063828|100685011|FG000|COMPLETED|Overall Study||10||
48147533|NCT02063828|100685012|FG001|COMPLETED|Overall Study||8||
48147534|NCT02063828|100685013|FG002|COMPLETED|Overall Study||14||
48147535|NCT02063828|100685011|FG000|NOT COMPLETED|Overall Study||4||
48147536|NCT02063828|100685012|FG001|NOT COMPLETED|Overall Study||6||
48147537|NCT02063828|100685013|FG002|NOT COMPLETED|Overall Study||4||
48301463|NCT03231943|101064178|FG010|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0||
48301464|NCT03231943|101064179|FG011|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0||
48301465|NCT03231943|101064180|FG012|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0||
48147538|NCT05390970|100685014|FG000|STARTED|Overall Study||25||
48147539|NCT05390970|100685015|FG001|STARTED|Overall Study||25||
48147540|NCT05390970|100685014|FG000|COMPLETED|Overall Study||24||
48147541|NCT05390970|100685015|FG001|COMPLETED|Overall Study||23||
48147542|NCT05390970|100685014|FG000|NOT COMPLETED|Overall Study||1||
48147543|NCT05390970|100685015|FG001|NOT COMPLETED|Overall Study||2||
48147544|NCT04283448|100685016|FG000|STARTED|Overall Study||20||
48147545|NCT04283448|100685017|FG001|STARTED|Overall Study||18||
48147546|NCT04283448|100685016|FG000|COMPLETED|Overall Study||20||
48147547|NCT04283448|100685017|FG001|COMPLETED|Overall Study||18||
48147548|NCT04283448|100685016|FG000|NOT COMPLETED|Overall Study||0||
48147549|NCT04283448|100685017|FG001|NOT COMPLETED|Overall Study||0||
48147550|NCT00643916|100685018|FG000|STARTED|Overall Study||55||
48147551|NCT00643916|100685019|FG001|STARTED|Overall Study||67||
48147552|NCT00643916|100685020|FG002|STARTED|Overall Study||68||
48147553|NCT00643916|100685021|FG003|STARTED|Overall Study||62||
48147554|NCT00643916|100685022|FG004|STARTED|Overall Study||59||
48147555|NCT00643916|100685023|FG005|STARTED|Overall Study||67||
48147556|NCT00643916|100685018|FG000|COMPLETED|Overall Study||51||
48147557|NCT00643916|100685019|FG001|COMPLETED|Overall Study||61||
48147558|NCT00643916|100685020|FG002|COMPLETED|Overall Study||62||
48147559|NCT00643916|100685021|FG003|COMPLETED|Overall Study||60||
48147560|NCT00643916|100685022|FG004|COMPLETED|Overall Study||57||
48147561|NCT00643916|100685023|FG005|COMPLETED|Overall Study||66||
48147562|NCT00643916|100685018|FG000|NOT COMPLETED|Overall Study||4||
48147563|NCT00643916|100685019|FG001|NOT COMPLETED|Overall Study||6||
48147564|NCT00643916|100685020|FG002|NOT COMPLETED|Overall Study||6||
48147565|NCT00643916|100685021|FG003|NOT COMPLETED|Overall Study||2||
48147566|NCT00643916|100685022|FG004|NOT COMPLETED|Overall Study||2||
48147567|NCT00643916|100685023|FG005|NOT COMPLETED|Overall Study||1||
48147568|NCT02395042|100685024|FG000|STARTED|Treatment 1 Period||12||
48147569|NCT02395042|100685025|FG001|STARTED|Treatment 1 Period||31||
48147570|NCT02395042|100685026|FG002|STARTED|Treatment 1 Period||16||
48147571|NCT02395042|100685024|FG000|COMPLETED|Treatment 1 Period||9||
48147572|NCT02395042|100685025|FG001|COMPLETED|Treatment 1 Period||25||
48147573|NCT02395042|100685026|FG002|COMPLETED|Treatment 1 Period||14||
48147574|NCT02395042|100685024|FG000|NOT COMPLETED|Treatment 1 Period||3||
48147575|NCT02395042|100685025|FG001|NOT COMPLETED|Treatment 1 Period||6||
48147576|NCT02395042|100685026|FG002|NOT COMPLETED|Treatment 1 Period||2||
48147577|NCT02395042|100685024|FG000|STARTED|Treatment 2 Period||10||
48147578|NCT02395042|100685025|FG001|STARTED|Treatment 2 Period||24||
48147579|NCT02395042|100685026|FG002|STARTED|Treatment 2 Period||13||
48147580|NCT02395042|100685024|FG000|COMPLETED|Treatment 2 Period||9||
48147581|NCT02395042|100685025|FG001|COMPLETED|Treatment 2 Period||23||
48147582|NCT02395042|100685026|FG002|COMPLETED|Treatment 2 Period||13||
48301466|NCT03231943|101064168|FG000|STARTED|Part 1, Period 2 (up to Day 30)||2||
48301467|NCT03231943|101064169|FG001|STARTED|Part 1, Period 2 (up to Day 30)||2||
48301468|NCT03231943|101064170|FG002|STARTED|Part 1, Period 2 (up to Day 30)||2||
48301469|NCT03231943|101064171|FG003|STARTED|Part 1, Period 2 (up to Day 30)||2||
48301470|NCT03231943|101064172|FG004|STARTED|Part 1, Period 2 (up to Day 30)||2||
48301471|NCT03231943|101064173|FG005|STARTED|Part 1, Period 2 (up to Day 30)||2||
48301472|NCT03231943|101064174|FG006|STARTED|Part 1, Period 2 (up to Day 30)||2||
48301473|NCT03231943|101064175|FG007|STARTED|Part 1, Period 2 (up to Day 30)||2||
48301474|NCT03231943|101064176|FG008|STARTED|Part 1, Period 2 (up to Day 30)||0||
48301475|NCT03231943|101064177|FG009|STARTED|Part 1, Period 2 (up to Day 30)||0||
48147583|NCT02395042|100685024|FG000|NOT COMPLETED|Treatment 2 Period||1||
48147584|NCT02395042|100685025|FG001|NOT COMPLETED|Treatment 2 Period||1||
48147585|NCT02395042|100685026|FG002|NOT COMPLETED|Treatment 2 Period||0||
48147586|NCT04528069|100685027|FG000|STARTED|Overall Study||54||105
48147587|NCT04528069|100685027|FG000|First Eye Implanted|Overall Study||54||54
48147588|NCT04528069|100685027|FG000|Second Eye Implanted|Overall Study||51||51
48147589|NCT04528069|100685027|FG000|COMPLETED|Overall Study||50||97
48147590|NCT04528069|100685027|FG000|NOT COMPLETED|Overall Study||4||8
48147591|NCT00160680|100685028|FG000|STARTED|Overall Study||31||
48147592|NCT00160680|100685029|FG001|STARTED|Overall Study||31||
48147593|NCT00160680|100685028|FG000|COMPLETED|Overall Study||22||
48147594|NCT00160680|100685029|FG001|COMPLETED|Overall Study||18||
48147595|NCT00160680|100685028|FG000|NOT COMPLETED|Overall Study||9||
48301476|NCT03231943|101064178|FG010|STARTED|Part 1, Period 2 (up to Day 30)||0||
48301477|NCT03231943|101064179|FG011|STARTED|Part 1, Period 2 (up to Day 30)||0||
48301478|NCT03231943|101064180|FG012|STARTED|Part 1, Period 2 (up to Day 30)||0||
48301479|NCT03231943|101064168|FG000|COMPLETED|Part 1, Period 2 (up to Day 30)||2||
48301480|NCT03231943|101064169|FG001|COMPLETED|Part 1, Period 2 (up to Day 30)||0||
48301481|NCT03231943|101064170|FG002|COMPLETED|Part 1, Period 2 (up to Day 30)||1||
48301482|NCT03231943|101064171|FG003|COMPLETED|Part 1, Period 2 (up to Day 30)||2||
48301483|NCT03231943|101064172|FG004|COMPLETED|Part 1, Period 2 (up to Day 30)||2||
48301484|NCT03231943|101064173|FG005|COMPLETED|Part 1, Period 2 (up to Day 30)||2||
48301485|NCT03231943|101064174|FG006|COMPLETED|Part 1, Period 2 (up to Day 30)||2||
48301486|NCT03231943|101064175|FG007|COMPLETED|Part 1, Period 2 (up to Day 30)||2||
48301487|NCT03231943|101064176|FG008|COMPLETED|Part 1, Period 2 (up to Day 30)||0||
48301488|NCT03231943|101064177|FG009|COMPLETED|Part 1, Period 2 (up to Day 30)||0||
48301489|NCT03231943|101064178|FG010|COMPLETED|Part 1, Period 2 (up to Day 30)||0||
48301490|NCT03231943|101064179|FG011|COMPLETED|Part 1, Period 2 (up to Day 30)||0||
48301491|NCT03231943|101064180|FG012|COMPLETED|Part 1, Period 2 (up to Day 30)||0||
48301492|NCT03231943|101064168|FG000|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0||
48147596|NCT00160680|100685029|FG001|NOT COMPLETED|Overall Study||13||
48147597|NCT03280121|100685030|FG000|STARTED|Overall Study||14||
48147598|NCT03280121|100685030|FG000|COMPLETED|Overall Study||8||
48147599|NCT03280121|100685030|FG000|NOT COMPLETED|Overall Study||6||
48147600|NCT02355002|100685031|FG000|STARTED|Period 1: Phase 1, Randomized-Controlled||15||
48147601|NCT02355002|100685032|FG001|STARTED|Period 1: Phase 1, Randomized-Controlled||11||
48147602|NCT02355002|100685031|FG000|COMPLETED|Period 1: Phase 1, Randomized-Controlled||12||
48147603|NCT02355002|100685032|FG001|COMPLETED|Period 1: Phase 1, Randomized-Controlled||10||
48147604|NCT02355002|100685031|FG000|NOT COMPLETED|Period 1: Phase 1, Randomized-Controlled||3||
48301493|NCT03231943|101064169|FG001|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||2||
48301494|NCT03231943|101064170|FG002|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||1||
48147605|NCT02355002|100685032|FG001|NOT COMPLETED|Period 1: Phase 1, Randomized-Controlled||1||
48188527|NCT05233085|100783267|FG001|STARTED|Overall Study||9||
48301495|NCT03231943|101064171|FG003|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0||
48301496|NCT03231943|101064172|FG004|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0||
48301497|NCT03231943|101064173|FG005|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0||
48188528|NCT05233085|100783268|FG002|STARTED|Overall Study||9||
48188529|NCT05233085|100783269|FG003|STARTED|Overall Study||9||
48368010|NCT03567291|101230095|FG003|STARTED|Period I||0||
48147606|NCT02355002|100685031|FG000|STARTED|Period 2: Phase 2 Open-Label||16|Six participants from the phase I RCT (2 active TMS, 4 sham) showed sufficient symptom improvement and were not invited to participate in the phase II open-label treatment. All other phase I completers were invited to receive open-label, active TMS in phase II (there were no sham participants in phase II).|
48147607|NCT02355002|100685032|FG001|STARTED|Period 2: Phase 2 Open-Label||0|Six participants from the phase I RCT (2 active TMS, 4 sham) showed sufficient symptom improvement and were not invited to participate in the phase II open-label treatment. All other phase I completers were invited to receive open-label, active TMS in phase II (there were no sham participants in phase II).|
48147608|NCT02355002|100685031|FG000|COMPLETED|Period 2: Phase 2 Open-Label||12||
48147609|NCT02355002|100685032|FG001|COMPLETED|Period 2: Phase 2 Open-Label||0||
48147610|NCT02355002|100685031|FG000|NOT COMPLETED|Period 2: Phase 2 Open-Label||4||
48147611|NCT02355002|100685032|FG001|NOT COMPLETED|Period 2: Phase 2 Open-Label||0||
48147612|NCT00917579|100685033|FG000|STARTED|Period 1: 1st Intervention||39||
48147613|NCT00917579|100685034|FG001|STARTED|Period 1: 1st Intervention||37||
48147614|NCT00917579|100685033|FG000|COMPLETED|Period 1: 1st Intervention||39||
48147615|NCT00917579|100685034|FG001|COMPLETED|Period 1: 1st Intervention||37||
48147616|NCT00917579|100685033|FG000|NOT COMPLETED|Period 1: 1st Intervention||0||
48147617|NCT00917579|100685034|FG001|NOT COMPLETED|Period 1: 1st Intervention||0||
48147618|NCT00917579|100685033|FG000|STARTED|Washout >= 2 Weeks||39||
48147619|NCT00917579|100685034|FG001|STARTED|Washout >= 2 Weeks||37||
48147620|NCT00917579|100685033|FG000|COMPLETED|Washout >= 2 Weeks||37||
48147621|NCT00917579|100685034|FG001|COMPLETED|Washout >= 2 Weeks||37||
48147622|NCT00917579|100685033|FG000|NOT COMPLETED|Washout >= 2 Weeks||2||
48147623|NCT00917579|100685034|FG001|NOT COMPLETED|Washout >= 2 Weeks||0||
48147624|NCT00917579|100685033|FG000|STARTED|Period 2: 2nd Intervention||37||
48147625|NCT00917579|100685034|FG001|STARTED|Period 2: 2nd Intervention||37||
48147626|NCT00917579|100685033|FG000|COMPLETED|Period 2: 2nd Intervention||37||
48147627|NCT00917579|100685034|FG001|COMPLETED|Period 2: 2nd Intervention||37||
48147628|NCT00917579|100685033|FG000|NOT COMPLETED|Period 2: 2nd Intervention||0||
48603302|NCT02304380|101811783|FG005|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0||
48603303|NCT02304380|101811778|FG000|STARTED|ACO Stakeholder Interviews (Aim 1)||24||
48603304|NCT02304380|101811779|FG001|STARTED|ACO Stakeholder Interviews (Aim 1)||0||
48603305|NCT02304380|101811780|FG002|STARTED|ACO Stakeholder Interviews (Aim 1)||0||
48603306|NCT02304380|101811781|FG003|STARTED|ACO Stakeholder Interviews (Aim 1)||0||
48603307|NCT02304380|101811782|FG004|STARTED|ACO Stakeholder Interviews (Aim 1)||0||
48603308|NCT02304380|101811783|FG005|STARTED|ACO Stakeholder Interviews (Aim 1)||0||
48603309|NCT02304380|101811778|FG000|COMPLETED|ACO Stakeholder Interviews (Aim 1)||24||
48603310|NCT02304380|101811779|FG001|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0||
48603311|NCT02304380|101811780|FG002|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0||
48603312|NCT02304380|101811781|FG003|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0||
48603313|NCT02304380|101811782|FG004|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0||
48603314|NCT02304380|101811783|FG005|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0||
48147629|NCT00917579|100685034|FG001|NOT COMPLETED|Period 2: 2nd Intervention||0||
48147630|NCT05616962|100685035|FG000|STARTED|Overall Study||34||
48147631|NCT05616962|100685035|FG000|COMPLETED|Overall Study||34||
48147632|NCT05616962|100685035|FG000|NOT COMPLETED|Overall Study||0||
48147633|NCT00483184|100685036|FG000|STARTED|Overall Study||27||
48147634|NCT00483184|100685037|FG001|STARTED|Overall Study||31||
48147635|NCT00483184|100685038|FG002|STARTED|Overall Study||26||
48147636|NCT00483184|100685036|FG000|COMPLETED|Overall Study||22||
48147637|NCT00483184|100685037|FG001|COMPLETED|Overall Study||27||
48147638|NCT00483184|100685038|FG002|COMPLETED|Overall Study||23||
48147639|NCT00483184|100685036|FG000|NOT COMPLETED|Overall Study||5||
48147640|NCT00483184|100685037|FG001|NOT COMPLETED|Overall Study||4||
48147641|NCT00483184|100685038|FG002|NOT COMPLETED|Overall Study||3||
48147642|NCT01532128|100685039|FG000|STARTED|Overall Study||8||
48147643|NCT01532128|100685040|FG001|STARTED|Overall Study||8||
48147644|NCT01532128|100685041|FG002|STARTED|Overall Study||8||
48147645|NCT01532128|100685039|FG000|COMPLETED|Overall Study||8||
48147646|NCT01532128|100685040|FG001|COMPLETED|Overall Study||8||
48147647|NCT01532128|100685041|FG002|COMPLETED|Overall Study||8||
48147648|NCT01532128|100685039|FG000|NOT COMPLETED|Overall Study||0||
48147649|NCT01532128|100685040|FG001|NOT COMPLETED|Overall Study||0||
48147650|NCT01532128|100685041|FG002|NOT COMPLETED|Overall Study||0||
48147651|NCT01059175|100685042|FG000|STARTED|Overall Study||43||
48147652|NCT01059175|100685043|FG001|STARTED|Overall Study||41||
48147653|NCT01059175|100685042|FG000|COMPLETED|Overall Study||22||
48147654|NCT01059175|100685043|FG001|COMPLETED|Overall Study||21||
48147655|NCT01059175|100685042|FG000|NOT COMPLETED|Overall Study||21||
48147656|NCT01059175|100685043|FG001|NOT COMPLETED|Overall Study||20||
48147657|NCT01338025|100685044|FG000|STARTED|Overall Study||16||
48147658|NCT01338025|100685045|FG001|STARTED|Overall Study||17||
48147659|NCT01338025|100685044|FG000|COMPLETED|Overall Study||5||
48147660|NCT01338025|100685045|FG001|COMPLETED|Overall Study||6||
48147661|NCT01338025|100685044|FG000|NOT COMPLETED|Overall Study||11||
48147662|NCT01338025|100685045|FG001|NOT COMPLETED|Overall Study||11||
48603315|NCT02304380|101811778|FG000|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0||
48603316|NCT02304380|101811779|FG001|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0||
48603317|NCT02304380|101811780|FG002|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0||
48301498|NCT03231943|101064174|FG006|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0||
48301499|NCT03231943|101064175|FG007|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0||
48301500|NCT03231943|101064176|FG008|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0||
48301501|NCT03231943|101064177|FG009|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0||
48603318|NCT02304380|101811781|FG003|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0||
48603319|NCT02304380|101811782|FG004|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0||
48603320|NCT02304380|101811783|FG005|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0||
48603321|NCT01693185|101811784|FG000|STARTED|Overall Study||27||
48603322|NCT01693185|101811785|FG001|STARTED|Overall Study||33||
48603323|NCT01693185|101811784|FG000|COMPLETED|Overall Study||27||
48603324|NCT01693185|101811785|FG001|COMPLETED|Overall Study||27||
48603325|NCT01693185|101811784|FG000|NOT COMPLETED|Overall Study||0||
48603326|NCT01693185|101811785|FG001|NOT COMPLETED|Overall Study||6||
48603327|NCT04750278|101811786|FG000|STARTED|Overall Study||30||
48603328|NCT04750278|101811787|FG001|STARTED|Overall Study||29||
48715378|NCT00859339|102088770|FG000|NOT COMPLETED|Overall Study||0||
48301502|NCT03231943|101064178|FG010|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0||
48301503|NCT03231943|101064179|FG011|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0||
48301504|NCT03231943|101064180|FG012|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0||
48301505|NCT03231943|101064168|FG000|STARTED|Part 1, Period 3 (up to Day 45)||2||
48301506|NCT03231943|101064169|FG001|STARTED|Part 1, Period 3 (up to Day 45)||2||
48301507|NCT03231943|101064170|FG002|STARTED|Part 1, Period 3 (up to Day 45)||2||
48301508|NCT03231943|101064171|FG003|STARTED|Part 1, Period 3 (up to Day 45)||2||
48301509|NCT03231943|101064172|FG004|STARTED|Part 1, Period 3 (up to Day 45)||2||
48603329|NCT04750278|101811788|FG002|STARTED|Overall Study||31||
48603330|NCT04750278|101811786|FG000|Completed D28 Visit|Overall Study||16||
48603331|NCT04750278|101811787|FG001|Completed D28 Visit|Overall Study||16||
48603332|NCT04750278|101811788|FG002|Completed D28 Visit|Overall Study||18||
48405307|NCT01764022|101325249|FG001|NOT COMPLETED|Overall Study||14||
48405308|NCT00533351|101325250|FG000|STARTED|Period 1||7||
48603333|NCT04750278|101811786|FG000|COMPLETED|Overall Study||15||
48603334|NCT04750278|101811787|FG001|COMPLETED|Overall Study||13||
48603335|NCT04750278|101811788|FG002|COMPLETED|Overall Study||15||
48301510|NCT03231943|101064173|FG005|STARTED|Part 1, Period 3 (up to Day 45)||2||
48301511|NCT03231943|101064174|FG006|STARTED|Part 1, Period 3 (up to Day 45)||2||
48301512|NCT03231943|101064175|FG007|STARTED|Part 1, Period 3 (up to Day 45)||2||
48301513|NCT03231943|101064176|FG008|STARTED|Part 1, Period 3 (up to Day 45)||0||
48301514|NCT03231943|101064177|FG009|STARTED|Part 1, Period 3 (up to Day 45)||0||
48301515|NCT03231943|101064178|FG010|STARTED|Part 1, Period 3 (up to Day 45)||0||
48301516|NCT03231943|101064179|FG011|STARTED|Part 1, Period 3 (up to Day 45)||0||
48301517|NCT03231943|101064180|FG012|STARTED|Part 1, Period 3 (up to Day 45)||0||
48301518|NCT03231943|101064168|FG000|COMPLETED|Part 1, Period 3 (up to Day 45)||1||
48301519|NCT03231943|101064169|FG001|COMPLETED|Part 1, Period 3 (up to Day 45)||2||
48301520|NCT03231943|101064170|FG002|COMPLETED|Part 1, Period 3 (up to Day 45)||2||
48301521|NCT03231943|101064171|FG003|COMPLETED|Part 1, Period 3 (up to Day 45)||2||
48301522|NCT03231943|101064172|FG004|COMPLETED|Part 1, Period 3 (up to Day 45)||2||
48301523|NCT03231943|101064173|FG005|COMPLETED|Part 1, Period 3 (up to Day 45)||2||
48301524|NCT03231943|101064174|FG006|COMPLETED|Part 1, Period 3 (up to Day 45)||2||
48301525|NCT03231943|101064175|FG007|COMPLETED|Part 1, Period 3 (up to Day 45)||2||
48603336|NCT04750278|101811786|FG000|NOT COMPLETED|Overall Study||15||
48603337|NCT04750278|101811787|FG001|NOT COMPLETED|Overall Study||16||
48603338|NCT04750278|101811788|FG002|NOT COMPLETED|Overall Study||16||
48603339|NCT02208050|101811789|FG000|STARTED|Baseline Assessment Period: 2 Weeks||36||
48603340|NCT02208050|101811790|FG001|STARTED|Baseline Assessment Period: 2 Weeks||28||
48603341|NCT02208050|101811789|FG000|COMPLETED|Baseline Assessment Period: 2 Weeks||36||
48715379|NCT03780959|102088771|FG000|STARTED|Part 1||69||
48715380|NCT03780959|102088772|FG001|STARTED|Part 1||0||
48715381|NCT03780959|102088773|FG002|STARTED|Part 1||0||
48715382|NCT03780959|102088771|FG000|COMPLETED|Part 1||64||
48715383|NCT03780959|102088772|FG001|COMPLETED|Part 1||0||
48715384|NCT03780959|102088773|FG002|COMPLETED|Part 1||0||
48715385|NCT03780959|102088771|FG000|NOT COMPLETED|Part 1||5||
48301526|NCT03231943|101064176|FG008|COMPLETED|Part 1, Period 3 (up to Day 45)||0||
48301527|NCT03231943|101064177|FG009|COMPLETED|Part 1, Period 3 (up to Day 45)||0||
48405309|NCT00533351|101325251|FG001|STARTED|Period 1||2||
48603342|NCT02208050|101811790|FG001|COMPLETED|Baseline Assessment Period: 2 Weeks||28||
48603343|NCT02208050|101811789|FG000|NOT COMPLETED|Baseline Assessment Period: 2 Weeks||0||
48301528|NCT03231943|101064178|FG010|COMPLETED|Part 1, Period 3 (up to Day 45)||0||
48405310|NCT00533351|101325250|FG000|COMPLETED|Period 1||5||
48405311|NCT00533351|101325251|FG001|COMPLETED|Period 1||1||
48603344|NCT02208050|101811790|FG001|NOT COMPLETED|Baseline Assessment Period: 2 Weeks||0||
48715386|NCT03780959|102088772|FG001|NOT COMPLETED|Part 1||0||
48405312|NCT00533351|101325250|FG000|NOT COMPLETED|Period 1||2||
48603345|NCT02208050|101811789|FG000|STARTED|Treatment Period 1: 8 Weeks Treatment||36||
48603346|NCT02208050|101811790|FG001|STARTED|Treatment Period 1: 8 Weeks Treatment||28||
48603347|NCT02208050|101811789|FG000|COMPLETED|Treatment Period 1: 8 Weeks Treatment||36||
48715387|NCT03780959|102088773|FG002|NOT COMPLETED|Part 1||0||
48715388|NCT03780959|102088771|FG000|STARTED|Part 2||0|Participants who met response criteria at day 90|
48603348|NCT02208050|101811790|FG001|COMPLETED|Treatment Period 1: 8 Weeks Treatment||28||
48603349|NCT02208050|101811789|FG000|NOT COMPLETED|Treatment Period 1: 8 Weeks Treatment||0||
48603350|NCT02208050|101811790|FG001|NOT COMPLETED|Treatment Period 1: 8 Weeks Treatment||0||
48603351|NCT02208050|101811789|FG000|STARTED|Washout Period 1: 2 Weeks||36||
48603352|NCT02208050|101811790|FG001|STARTED|Washout Period 1: 2 Weeks||28||
48603353|NCT02208050|101811789|FG000|COMPLETED|Washout Period 1: 2 Weeks||35||
48603354|NCT02208050|101811790|FG001|COMPLETED|Washout Period 1: 2 Weeks||28||
48603355|NCT02208050|101811789|FG000|NOT COMPLETED|Washout Period 1: 2 Weeks||1||
48603356|NCT02208050|101811790|FG001|NOT COMPLETED|Washout Period 1: 2 Weeks||0||
48603357|NCT02208050|101811789|FG000|STARTED|Treatment Period 2: 8 Weeks Treatment||35||
48603358|NCT02208050|101811790|FG001|STARTED|Treatment Period 2: 8 Weeks Treatment||28||
48603359|NCT02208050|101811789|FG000|COMPLETED|Treatment Period 2: 8 Weeks Treatment||33||
48603360|NCT02208050|101811790|FG001|COMPLETED|Treatment Period 2: 8 Weeks Treatment||28||
48603361|NCT02208050|101811789|FG000|NOT COMPLETED|Treatment Period 2: 8 Weeks Treatment||2||
48301529|NCT03231943|101064179|FG011|COMPLETED|Part 1, Period 3 (up to Day 45)||0||
48301530|NCT03231943|101064180|FG012|COMPLETED|Part 1, Period 3 (up to Day 45)||0||
48603362|NCT02208050|101811790|FG001|NOT COMPLETED|Treatment Period 2: 8 Weeks Treatment||0||
48603363|NCT02208050|101811789|FG000|STARTED|Washout Period 2: 2 Weeks Washout.||33||
48603364|NCT02208050|101811790|FG001|STARTED|Washout Period 2: 2 Weeks Washout.||28||
48603365|NCT02208050|101811789|FG000|COMPLETED|Washout Period 2: 2 Weeks Washout.||33||
48603366|NCT02208050|101811790|FG001|COMPLETED|Washout Period 2: 2 Weeks Washout.||28||
48147663|NCT05072080|100685046|FG000|STARTED|Overall Study||919||
48147664|NCT05072080|100685047|FG001|STARTED|Overall Study||948||
48147665|NCT05072080|100685048|FG002|STARTED|Overall Study||927||
48147666|NCT05072080|100685049|FG003|STARTED|Overall Study||464||
48603367|NCT02208050|101811789|FG000|NOT COMPLETED|Washout Period 2: 2 Weeks Washout.||0||
48603368|NCT02208050|101811790|FG001|NOT COMPLETED|Washout Period 2: 2 Weeks Washout.||0||
48603369|NCT02087943|101811791|FG000|STARTED|Placebo-Controlled Phase Week 0-12||64||
48603370|NCT02087943|101811792|FG001|STARTED|Placebo-Controlled Phase Week 0-12||58||
48603371|NCT02087943|101811793|FG002|STARTED|Placebo-Controlled Phase Week 0-12||63||
48603372|NCT02087943|101811794|FG003|STARTED|Placebo-Controlled Phase Week 0-12||0||
48603373|NCT02087943|101811795|FG004|STARTED|Placebo-Controlled Phase Week 0-12||0||
48603374|NCT02087943|101811791|FG000|Safety Population|Placebo-Controlled Phase Week 0-12||64||
48603375|NCT02087943|101811792|FG001|Safety Population|Placebo-Controlled Phase Week 0-12||58||
48147667|NCT05072080|100685046|FG000|COMPLETED|Overall Study||803||
48147668|NCT05072080|100685047|FG001|COMPLETED|Overall Study||837||
48147669|NCT05072080|100685048|FG002|COMPLETED|Overall Study||832||
48147670|NCT05072080|100685049|FG003|COMPLETED|Overall Study||430||
48147671|NCT05072080|100685046|FG000|NOT COMPLETED|Overall Study||116||
48147672|NCT05072080|100685047|FG001|NOT COMPLETED|Overall Study||111||
48147673|NCT05072080|100685048|FG002|NOT COMPLETED|Overall Study||95||
48147674|NCT05072080|100685049|FG003|NOT COMPLETED|Overall Study||34||
48147675|NCT01698684|100685050|FG000|STARTED|Overall Study||145||
48147676|NCT01698684|100685051|FG001|STARTED|Overall Study||147||
48147677|NCT01698684|100685052|FG002|STARTED|Overall Study||148||
48147678|NCT01698684|100685050|FG000|ITT Population|Overall Study||136||
48147679|NCT01698684|100685051|FG001|ITT Population|Overall Study||139||
48147680|NCT01698684|100685052|FG002|ITT Population|Overall Study||139||
48147681|NCT01698684|100685050|FG000|Safety Population|Overall Study||143||
48301531|NCT03231943|101064168|FG000|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||1||
48147682|NCT01698684|100685051|FG001|Safety Population|Overall Study||146||
48147683|NCT01698684|100685052|FG002|Safety Population|Overall Study||146||
48147684|NCT01698684|100685050|FG000|COMPLETED|Overall Study||116||
48603376|NCT02087943|101811793|FG002|Safety Population|Placebo-Controlled Phase Week 0-12||63||
48603377|NCT02087943|101811794|FG003|Safety Population|Placebo-Controlled Phase Week 0-12||0||
48603378|NCT02087943|101811795|FG004|Safety Population|Placebo-Controlled Phase Week 0-12||0||
48603379|NCT02087943|101811791|FG000|COMPLETED|Placebo-Controlled Phase Week 0-12||50||
48603380|NCT02087943|101811792|FG001|COMPLETED|Placebo-Controlled Phase Week 0-12||46||
48603381|NCT02087943|101811793|FG002|COMPLETED|Placebo-Controlled Phase Week 0-12||50||
48603382|NCT02087943|101811794|FG003|COMPLETED|Placebo-Controlled Phase Week 0-12||0||
48301532|NCT03231943|101064169|FG001|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0||
48301533|NCT03231943|101064170|FG002|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0||
48301534|NCT03231943|101064171|FG003|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0||
48301535|NCT03231943|101064172|FG004|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0||
48301536|NCT03231943|101064173|FG005|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0||
48301537|NCT03231943|101064174|FG006|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0||
48301538|NCT03231943|101064175|FG007|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0||
48301539|NCT03231943|101064176|FG008|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0||
48301540|NCT03231943|101064177|FG009|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0||
48301541|NCT03231943|101064178|FG010|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0||
48301542|NCT03231943|101064179|FG011|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0||
48301543|NCT03231943|101064180|FG012|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0||
48301544|NCT03231943|101064168|FG000|STARTED|Part 1 Period 4 (up to Day 60)||2||
48301545|NCT03231943|101064169|FG001|STARTED|Part 1 Period 4 (up to Day 60)||2||
48301546|NCT03231943|101064170|FG002|STARTED|Part 1 Period 4 (up to Day 60)||2||
48301547|NCT03231943|101064171|FG003|STARTED|Part 1 Period 4 (up to Day 60)||2||
48301548|NCT03231943|101064172|FG004|STARTED|Part 1 Period 4 (up to Day 60)||2||
48301549|NCT03231943|101064173|FG005|STARTED|Part 1 Period 4 (up to Day 60)||2||
48301550|NCT03231943|101064174|FG006|STARTED|Part 1 Period 4 (up to Day 60)||2||
48301551|NCT03231943|101064175|FG007|STARTED|Part 1 Period 4 (up to Day 60)||2||
48301552|NCT03231943|101064176|FG008|STARTED|Part 1 Period 4 (up to Day 60)||0||
48301553|NCT03231943|101064177|FG009|STARTED|Part 1 Period 4 (up to Day 60)||0||
48603383|NCT02087943|101811795|FG004|COMPLETED|Placebo-Controlled Phase Week 0-12||0||
48301554|NCT03231943|101064178|FG010|STARTED|Part 1 Period 4 (up to Day 60)||0||
48603384|NCT02087943|101811791|FG000|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||14||
48603385|NCT02087943|101811792|FG001|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||12||
48603386|NCT02087943|101811793|FG002|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||13||
48603387|NCT02087943|101811794|FG003|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0||
48603388|NCT02087943|101811795|FG004|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0||
48603389|NCT02087943|101811791|FG000|STARTED|Active Treatment Phase Week 12-24||0||
48603390|NCT02087943|101811792|FG001|STARTED|Active Treatment Phase Week 12-24||46||
48603391|NCT02087943|101811793|FG002|STARTED|Active Treatment Phase Week 12-24||49||
48603392|NCT02087943|101811794|FG003|STARTED|Active Treatment Phase Week 12-24||24||
48603393|NCT02087943|101811795|FG004|STARTED|Active Treatment Phase Week 12-24||23||
48301555|NCT03231943|101064179|FG011|STARTED|Part 1 Period 4 (up to Day 60)||0||
48301556|NCT03231943|101064180|FG012|STARTED|Part 1 Period 4 (up to Day 60)||0||
48301557|NCT03231943|101064168|FG000|COMPLETED|Part 1 Period 4 (up to Day 60)||2||
48301558|NCT03231943|101064169|FG001|COMPLETED|Part 1 Period 4 (up to Day 60)||2||
48301559|NCT03231943|101064170|FG002|COMPLETED|Part 1 Period 4 (up to Day 60)||2||
48301560|NCT03231943|101064171|FG003|COMPLETED|Part 1 Period 4 (up to Day 60)||2||
48301561|NCT03231943|101064172|FG004|COMPLETED|Part 1 Period 4 (up to Day 60)||2||
48301562|NCT03231943|101064173|FG005|COMPLETED|Part 1 Period 4 (up to Day 60)||2||
48301563|NCT03231943|101064174|FG006|COMPLETED|Part 1 Period 4 (up to Day 60)||2||
48301564|NCT03231943|101064175|FG007|COMPLETED|Part 1 Period 4 (up to Day 60)||2||
48301565|NCT03231943|101064176|FG008|COMPLETED|Part 1 Period 4 (up to Day 60)||0||
48301566|NCT03231943|101064177|FG009|COMPLETED|Part 1 Period 4 (up to Day 60)||0||
48301567|NCT03231943|101064178|FG010|COMPLETED|Part 1 Period 4 (up to Day 60)||0||
48301568|NCT03231943|101064179|FG011|COMPLETED|Part 1 Period 4 (up to Day 60)||0||
48301569|NCT03231943|101064180|FG012|COMPLETED|Part 1 Period 4 (up to Day 60)||0||
48301570|NCT03231943|101064168|FG000|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0||
48301571|NCT03231943|101064169|FG001|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0||
48301572|NCT03231943|101064170|FG002|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0||
48301573|NCT03231943|101064171|FG003|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0||
48301574|NCT03231943|101064172|FG004|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0||
48301575|NCT03231943|101064173|FG005|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0||
48301576|NCT03231943|101064174|FG006|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0||
48301577|NCT03231943|101064175|FG007|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0||
48301578|NCT03231943|101064176|FG008|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0||
48301579|NCT03231943|101064177|FG009|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0||
48301580|NCT03231943|101064178|FG010|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0||
48301581|NCT03231943|101064179|FG011|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0||
48301582|NCT03231943|101064180|FG012|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0||
48301583|NCT03231943|101064168|FG000|STARTED|Part 2||0||
48301584|NCT03231943|101064169|FG001|STARTED|Part 2||0||
48301585|NCT03231943|101064170|FG002|STARTED|Part 2||0||
48301586|NCT03231943|101064171|FG003|STARTED|Part 2||0||
48301587|NCT03231943|101064172|FG004|STARTED|Part 2||0||
48301588|NCT03231943|101064173|FG005|STARTED|Part 2||0||
48301589|NCT03231943|101064174|FG006|STARTED|Part 2||0||
48301590|NCT03231943|101064175|FG007|STARTED|Part 2||0||
48301591|NCT03231943|101064176|FG008|STARTED|Part 2||6||
48301592|NCT03231943|101064177|FG009|STARTED|Part 2||6||
48301593|NCT03231943|101064178|FG010|STARTED|Part 2||25||
48301594|NCT03231943|101064179|FG011|STARTED|Part 2||7||
48301595|NCT03231943|101064180|FG012|STARTED|Part 2||14||
48603394|NCT02087943|101811791|FG000|COMPLETED|Active Treatment Phase Week 12-24||0||
48603395|NCT02087943|101811792|FG001|COMPLETED|Active Treatment Phase Week 12-24||42||
48603396|NCT02087943|101811793|FG002|COMPLETED|Active Treatment Phase Week 12-24||44||
48603397|NCT02087943|101811794|FG003|COMPLETED|Active Treatment Phase Week 12-24||22||
48603398|NCT02087943|101811795|FG004|COMPLETED|Active Treatment Phase Week 12-24||21||
48603399|NCT02087943|101811791|FG000|NOT COMPLETED|Active Treatment Phase Week 12-24||0||
48603400|NCT02087943|101811792|FG001|NOT COMPLETED|Active Treatment Phase Week 12-24||4||
48603401|NCT02087943|101811793|FG002|NOT COMPLETED|Active Treatment Phase Week 12-24||5||
48603402|NCT02087943|101811794|FG003|NOT COMPLETED|Active Treatment Phase Week 12-24||2||
48603403|NCT02087943|101811795|FG004|NOT COMPLETED|Active Treatment Phase Week 12-24||2||
48603404|NCT02087943|101811791|FG000|STARTED|Observational Follow-up Phase Week 24-30||0||
48603405|NCT02087943|101811792|FG001|STARTED|Observational Follow-up Phase Week 24-30||46||
48603406|NCT02087943|101811793|FG002|STARTED|Observational Follow-up Phase Week 24-30||48||
48603407|NCT02087943|101811794|FG003|STARTED|Observational Follow-up Phase Week 24-30||24||
48603408|NCT02087943|101811795|FG004|STARTED|Observational Follow-up Phase Week 24-30||23||
48603409|NCT02087943|101811791|FG000|COMPLETED|Observational Follow-up Phase Week 24-30||0||
48603410|NCT02087943|101811792|FG001|COMPLETED|Observational Follow-up Phase Week 24-30||46||
48603411|NCT02087943|101811793|FG002|COMPLETED|Observational Follow-up Phase Week 24-30||45||
48603412|NCT02087943|101811794|FG003|COMPLETED|Observational Follow-up Phase Week 24-30||23||
48603413|NCT02087943|101811795|FG004|COMPLETED|Observational Follow-up Phase Week 24-30||22||
48603414|NCT02087943|101811791|FG000|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0||
48301596|NCT03231943|101064168|FG000|COMPLETED|Part 2||0||
48301597|NCT03231943|101064169|FG001|COMPLETED|Part 2||0||
48301598|NCT03231943|101064170|FG002|COMPLETED|Part 2||0||
48301599|NCT03231943|101064171|FG003|COMPLETED|Part 2||0||
48301600|NCT03231943|101064172|FG004|COMPLETED|Part 2||0||
48301601|NCT03231943|101064173|FG005|COMPLETED|Part 2||0||
48301602|NCT03231943|101064174|FG006|COMPLETED|Part 2||0||
48301603|NCT03231943|101064175|FG007|COMPLETED|Part 2||0||
48301604|NCT03231943|101064176|FG008|COMPLETED|Part 2||6||
48301605|NCT03231943|101064177|FG009|COMPLETED|Part 2||6||
48301606|NCT03231943|101064178|FG010|COMPLETED|Part 2||24||
48603415|NCT02087943|101811792|FG001|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0||
48603416|NCT02087943|101811793|FG002|NOT COMPLETED|Observational Follow-up Phase Week 24-30||3||
48603417|NCT02087943|101811794|FG003|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1||
48603418|NCT02087943|101811795|FG004|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1||
48603419|NCT00477204|101811796|FG000|STARTED|Overall Study||4||
48603420|NCT00477204|101811797|FG001|STARTED|Overall Study||5||
48603421|NCT00477204|101811796|FG000|COMPLETED|Overall Study||4||
48603422|NCT00477204|101811797|FG001|COMPLETED|Overall Study||5||
48603423|NCT00477204|101811796|FG000|NOT COMPLETED|Overall Study||0||
48603424|NCT00477204|101811797|FG001|NOT COMPLETED|Overall Study||0||
48603425|NCT03268005|101811798|FG000|STARTED|Overall Study||546||
48603426|NCT03268005|101811799|FG001|STARTED|Overall Study||545||
48603427|NCT03268005|101811798|FG000|Full Analysis Set|Overall Study||546||
48603428|NCT03268005|101811799|FG001|Full Analysis Set|Overall Study||545||
48603429|NCT03268005|101811798|FG000|Safety Analysis Set|Overall Study||544||
48603430|NCT03268005|101811799|FG001|Safety Analysis Set|Overall Study||544||
48301607|NCT03231943|101064179|FG011|COMPLETED|Part 2||6||
48301608|NCT03231943|101064180|FG012|COMPLETED|Part 2||14||
48301609|NCT03231943|101064168|FG000|NOT COMPLETED|Part 2||0||
48301610|NCT03231943|101064169|FG001|NOT COMPLETED|Part 2||0||
48301611|NCT03231943|101064170|FG002|NOT COMPLETED|Part 2||0||
48301612|NCT03231943|101064171|FG003|NOT COMPLETED|Part 2||0||
48301613|NCT03231943|101064172|FG004|NOT COMPLETED|Part 2||0||
48301614|NCT03231943|101064173|FG005|NOT COMPLETED|Part 2||0||
48301615|NCT03231943|101064174|FG006|NOT COMPLETED|Part 2||0||
48301616|NCT03231943|101064175|FG007|NOT COMPLETED|Part 2||0||
48301617|NCT03231943|101064176|FG008|NOT COMPLETED|Part 2||0||
48301618|NCT03231943|101064177|FG009|NOT COMPLETED|Part 2||0||
48301619|NCT03231943|101064178|FG010|NOT COMPLETED|Part 2||1||
48603431|NCT03268005|101811798|FG000|COMPLETED|Overall Study||531||
48603432|NCT03268005|101811799|FG001|COMPLETED|Overall Study||531||
48603433|NCT03268005|101811798|FG000|NOT COMPLETED|Overall Study||15||
48603434|NCT03268005|101811799|FG001|NOT COMPLETED|Overall Study||14||
48603435|NCT03611101|101811800|FG000|STARTED|Overall Study||32||
48603436|NCT03611101|101811801|FG001|STARTED|Overall Study||32||
48603437|NCT03611101|101811802|FG002|STARTED|Overall Study||30||
48603438|NCT03611101|101811803|FG003|STARTED|Overall Study||30||
48603439|NCT03611101|101811800|FG000|COMPLETED|Overall Study||25||
48603440|NCT03611101|101811801|FG001|COMPLETED|Overall Study||28||
48603441|NCT03611101|101811802|FG002|COMPLETED|Overall Study||27||
48603442|NCT03611101|101811803|FG003|COMPLETED|Overall Study||23||
48301620|NCT03231943|101064179|FG011|NOT COMPLETED|Part 2||1||
48301621|NCT03231943|101064180|FG012|NOT COMPLETED|Part 2||0||
48603443|NCT03611101|101811800|FG000|NOT COMPLETED|Overall Study||7||
48715389|NCT03780959|102088772|FG001|STARTED|Part 2||26|Participants who met response criteria at day 90|
48301622|NCT04936841|101064181|FG000|STARTED|Overall Study||5||
48301623|NCT04936841|101064181|FG000|On Treatment|Overall Study||5||
48301624|NCT04936841|101064181|FG000|C1D8|Overall Study||5||
48301625|NCT04936841|101064181|FG000|C2D8|Overall Study||4||
48301626|NCT04936841|101064181|FG000|C3D8|Overall Study||4||
48301627|NCT04936841|101064181|FG000|Off Treatment|Overall Study||4||
48301628|NCT04936841|101064181|FG000|30 Days Post Treatment|Overall Study||4||
48301629|NCT04936841|101064181|FG000|COMPLETED|Overall Study||4||
48301630|NCT04936841|101064181|FG000|NOT COMPLETED|Overall Study||1||
48301631|NCT01721603|101064182|FG000|STARTED|Overall Study||2||
48301632|NCT01721603|101064182|FG000|COMPLETED|Overall Study||2||
48301633|NCT01721603|101064182|FG000|NOT COMPLETED|Overall Study||0||
48301634|NCT00928564|101064183|FG000|STARTED|Overall Study||28||
48301635|NCT00928564|101064184|FG001|STARTED|Overall Study||12||
48301636|NCT00928564|101064183|FG000|COMPLETED|Overall Study||22||
48301637|NCT00928564|101064184|FG001|COMPLETED|Overall Study||12||
48301638|NCT00928564|101064183|FG000|NOT COMPLETED|Overall Study||6||
48301639|NCT00928564|101064184|FG001|NOT COMPLETED|Overall Study||0||
48301640|NCT03270332|101064185|FG000|STARTED|Overall Study||5||
48301641|NCT03270332|101064186|FG001|STARTED|Overall Study||5||
48301642|NCT03270332|101064185|FG000|COMPLETED|Overall Study||5||
48301643|NCT03270332|101064186|FG001|COMPLETED|Overall Study||4||
48301644|NCT03270332|101064185|FG000|NOT COMPLETED|Overall Study||0||
48301645|NCT03270332|101064186|FG001|NOT COMPLETED|Overall Study||1||
48301646|NCT00601250|101064187|FG000|STARTED|Overall Study||177||
48301647|NCT00601250|101064188|FG001|STARTED|Overall Study||523||
48603444|NCT03611101|101811801|FG001|NOT COMPLETED|Overall Study||4||
48603445|NCT03611101|101811802|FG002|NOT COMPLETED|Overall Study||3||
48603446|NCT03611101|101811803|FG003|NOT COMPLETED|Overall Study||7||
48603447|NCT00731731|101811804|FG000|STARTED|Overall Study||12||
48603448|NCT00731731|101811805|FG001|STARTED|Overall Study||3||
48603449|NCT00731731|101811806|FG002|STARTED|Overall Study||110||
48603450|NCT00731731|101811804|FG000|COMPLETED|Overall Study||12||
48603451|NCT00731731|101811805|FG001|COMPLETED|Overall Study||3||
48603452|NCT00731731|101811806|FG002|COMPLETED|Overall Study||107||
48603453|NCT00731731|101811804|FG000|NOT COMPLETED|Overall Study||0||
48301648|NCT00601250|101064187|FG000|COMPLETED|Overall Study||163||
48301649|NCT00601250|101064188|FG001|COMPLETED|Overall Study||484||
48603454|NCT00731731|101811805|FG001|NOT COMPLETED|Overall Study||0||
48301650|NCT00601250|101064187|FG000|NOT COMPLETED|Overall Study||14||
48301651|NCT00601250|101064188|FG001|NOT COMPLETED|Overall Study||39||
48301652|NCT01979835|101064189|FG000|STARTED|Primary Outcome SA Measurment||1030||
48301653|NCT01979835|101064189|FG000|COMPLETED|Primary Outcome SA Measurment||1012||
48301654|NCT01979835|101064189|FG000|NOT COMPLETED|Primary Outcome SA Measurment||18||
48301655|NCT01979835|101064189|FG000|STARTED|Follow-up||1012||
48301656|NCT01979835|101064189|FG000|COMPLETED|Follow-up||980||
48301657|NCT01979835|101064189|FG000|NOT COMPLETED|Follow-up||32||
48301658|NCT00833911|101064190|FG000|STARTED|Titration||392||
48301659|NCT00833911|101064190|FG000|COMPLETED|Titration||371||
48301660|NCT00833911|101064190|FG000|NOT COMPLETED|Titration||21||
48301661|NCT00833911|101064190|FG000|STARTED|Maintenance Phase I||371||
48301662|NCT00833911|101064190|FG000|COMPLETED|Maintenance Phase I||273||
48301663|NCT00833911|101064190|FG000|NOT COMPLETED|Maintenance Phase I||98||
48301664|NCT00833911|101064190|FG000|STARTED|Maintenance Phase II||176||
48301665|NCT00833911|101064190|FG000|COMPLETED|Maintenance Phase II||166||
48301666|NCT00833911|101064190|FG000|NOT COMPLETED|Maintenance Phase II||10||
48301667|NCT01306890|101064191|FG000|STARTED|Overall Study||1976||
48301668|NCT01306890|101064191|FG000|COMPLETED|Overall Study||457||
48301669|NCT01306890|101064191|FG000|NOT COMPLETED|Overall Study||1519||
48301670|NCT02120625|101064192|FG000|STARTED|Overall Study||8||
48301671|NCT02120625|101064192|FG000|COMPLETED|Overall Study||6||
48301672|NCT02120625|101064192|FG000|NOT COMPLETED|Overall Study||2||
48301673|NCT01009554|101064193|FG000|STARTED|Overall Study||48||
48301674|NCT01009554|101064194|FG001|STARTED|Overall Study||48||
48301675|NCT01009554|101064193|FG000|COMPLETED|Overall Study||46||
48301676|NCT01009554|101064194|FG001|COMPLETED|Overall Study||41||
48301677|NCT01009554|101064193|FG000|NOT COMPLETED|Overall Study||2||
48301678|NCT01009554|101064194|FG001|NOT COMPLETED|Overall Study||7||
48301679|NCT00462865|101064195|FG000|STARTED|Overall Study||18||
48301680|NCT00462865|101064195|FG000|COMPLETED|Overall Study||17||
48301681|NCT00462865|101064195|FG000|NOT COMPLETED|Overall Study||1||
48301682|NCT00821431|101064196|FG000|STARTED|Overall Study||38||
48301683|NCT00821431|101064197|FG001|STARTED|Overall Study||52||
48301684|NCT00821431|101064196|FG000|COMPLETED|Overall Study||23||
48301685|NCT00821431|101064197|FG001|COMPLETED|Overall Study||47||
48301686|NCT00821431|101064196|FG000|NOT COMPLETED|Overall Study||15||
48301687|NCT00821431|101064197|FG001|NOT COMPLETED|Overall Study||5||
48301688|NCT02608879|101064198|FG000|STARTED|Overall Study||10||
48301689|NCT02608879|101064199|FG001|STARTED|Overall Study||6||
48301690|NCT02608879|101064200|FG002|STARTED|Overall Study||3||
48301691|NCT02608879|101064198|FG000|COMPLETED|Overall Study||9||
48301692|NCT02608879|101064199|FG001|COMPLETED|Overall Study||6||
48301693|NCT02608879|101064200|FG002|COMPLETED|Overall Study||0||
48301694|NCT02608879|101064198|FG000|NOT COMPLETED|Overall Study||1||
48301695|NCT02608879|101064199|FG001|NOT COMPLETED|Overall Study||0||
48301696|NCT02608879|101064200|FG002|NOT COMPLETED|Overall Study||3||
48301697|NCT01836042|101064201|FG000|STARTED|Overall Study||51||
48301698|NCT01836042|101064202|FG001|STARTED|Overall Study||35||
48301699|NCT01836042|101064203|FG002|STARTED|Overall Study||22||
48301700|NCT01836042|101064201|FG000|COMPLETED|Overall Study||51||
48301701|NCT01836042|101064202|FG001|COMPLETED|Overall Study||35||
48301702|NCT01836042|101064203|FG002|COMPLETED|Overall Study||22||
48301703|NCT01836042|101064201|FG000|NOT COMPLETED|Overall Study||0||
48301704|NCT01836042|101064202|FG001|NOT COMPLETED|Overall Study||0||
48301705|NCT01836042|101064203|FG002|NOT COMPLETED|Overall Study||0||
48301706|NCT01578967|101064204|FG000|STARTED|Overall Study||41||
48301707|NCT01578967|101064204|FG000|COMPLETED|Overall Study||41||
48301708|NCT01578967|101064204|FG000|NOT COMPLETED|Overall Study||0||
48301709|NCT03952806|101064205|FG000|STARTED|Randomization Phase (Weeks 1 Through 48)||168||
48301710|NCT03952806|101064206|FG001|STARTED|Randomization Phase (Weeks 1 Through 48)||168||
48301711|NCT03952806|101064205|FG000|COMPLETED|Randomization Phase (Weeks 1 Through 48)||127||
48301712|NCT03952806|101064206|FG001|COMPLETED|Randomization Phase (Weeks 1 Through 48)||146||
48301713|NCT03952806|101064205|FG000|NOT COMPLETED|Randomization Phase (Weeks 1 Through 48)||41||
48301714|NCT03952806|101064206|FG001|NOT COMPLETED|Randomization Phase (Weeks 1 Through 48)||22||
48301715|NCT03952806|101064205|FG000|STARTED|OLE Phase (48 Weeks)||123||
48301716|NCT03952806|101064206|FG001|STARTED|OLE Phase (48 Weeks)||140||
48301717|NCT03952806|101064205|FG000|COMPLETED|OLE Phase (48 Weeks)||44||
48301718|NCT03952806|101064206|FG001|COMPLETED|OLE Phase (48 Weeks)||46||
48301719|NCT03952806|101064205|FG000|NOT COMPLETED|OLE Phase (48 Weeks)||79||
48301720|NCT03952806|101064206|FG001|NOT COMPLETED|OLE Phase (48 Weeks)||94||
48301721|NCT03872453|101064207|FG000|STARTED|Overall Study||418|Randomized|
48301722|NCT03872453|101064208|FG001|STARTED|Overall Study||417|Randomized|
48301723|NCT03872453|101064209|FG002|STARTED|Overall Study||418|Randomized|
48301724|NCT03872453|101064210|FG003|STARTED|Overall Study||420|Randomized|
48301725|NCT03872453|101064207|FG000|Treated|Overall Study||388||
48301726|NCT03872453|101064208|FG001|Treated|Overall Study||394||
48301727|NCT03872453|101064209|FG002|Treated|Overall Study||403||
48301728|NCT03872453|101064210|FG003|Treated|Overall Study||403||
48301729|NCT03872453|101064207|FG000|Modified Intent-to-Treat (mITT) Participants|Overall Study||387|Treated participants who were randomized only once, had moderate to severe pain at on-study migraine attack onset, and had non-missing, post-baseline efficacy data.|
48301730|NCT03872453|101064208|FG001|Modified Intent-to-Treat (mITT) Participants|Overall Study||391|Treated participants who were randomized only once, had moderate to severe pain at on-study migraine attack onset, and had non-missing, post-baseline efficacy data.|
48301731|NCT03872453|101064209|FG002|Modified Intent-to-Treat (mITT) Participants|Overall Study||402|Treated participants who were randomized only once, had moderate to severe pain at on-study migraine attack onset, and had non-missing, post-baseline efficacy data.|
48301732|NCT03872453|101064210|FG003|Modified Intent-to-Treat (mITT) Participants|Overall Study||401|Treated participants who were randomized only once, had moderate to severe pain at on-study migraine attack onset, and had non-missing, post-baseline efficacy data.|
48301733|NCT03872453|101064207|FG000|COMPLETED|Overall Study||386||
48301734|NCT03872453|101064208|FG001|COMPLETED|Overall Study||391||
48301735|NCT03872453|101064209|FG002|COMPLETED|Overall Study||399||
48301736|NCT03872453|101064210|FG003|COMPLETED|Overall Study||402||
48301737|NCT03872453|101064207|FG000|NOT COMPLETED|Overall Study||32||
48301738|NCT03872453|101064208|FG001|NOT COMPLETED|Overall Study||26||
48301739|NCT03872453|101064209|FG002|NOT COMPLETED|Overall Study||19||
48301740|NCT03872453|101064210|FG003|NOT COMPLETED|Overall Study||18||
48301741|NCT01535014|101064211|FG000|STARTED|Overall Study||210||
48301742|NCT01535014|101064212|FG001|STARTED|Overall Study||200||
48301743|NCT01535014|101064213|FG002|STARTED|Overall Study||50||
48301744|NCT01535014|101064214|FG003|STARTED|Overall Study||33||
48301745|NCT01535014|101064211|FG000|COMPLETED|Overall Study||208||
48301746|NCT01535014|101064212|FG001|COMPLETED|Overall Study||194||
48301747|NCT01535014|101064213|FG002|COMPLETED|Overall Study||49||
48301748|NCT01535014|101064214|FG003|COMPLETED|Overall Study||33||
48301749|NCT01535014|101064211|FG000|NOT COMPLETED|Overall Study||2||
48301750|NCT01535014|101064212|FG001|NOT COMPLETED|Overall Study||6||
48301751|NCT01535014|101064213|FG002|NOT COMPLETED|Overall Study||1||
48301752|NCT01535014|101064214|FG003|NOT COMPLETED|Overall Study||0||
48301753|NCT02178553|101064215|FG000|STARTED|Overall Study||53||
48301754|NCT02178553|101064216|FG001|STARTED|Overall Study||49||
48301755|NCT02178553|101064215|FG000|COMPLETED|Overall Study||45||
48301756|NCT02178553|101064216|FG001|COMPLETED|Overall Study||39||
48301757|NCT02178553|101064215|FG000|NOT COMPLETED|Overall Study||8||
48301758|NCT02178553|101064216|FG001|NOT COMPLETED|Overall Study||10||
48301759|NCT01422850|101064217|FG000|STARTED|Overall Study||21||
48301760|NCT01422850|101064217|FG000|Week 4 - First Treatment|Overall Study||21||
48301761|NCT01422850|101064217|FG000|Week 5|Overall Study||20||
48301762|NCT01422850|101064217|FG000|Week 9 - Second Treatment|Overall Study||20||
48301763|NCT01422850|101064217|FG000|Week 14 - Third Treatment|Overall Study||19||
48301764|NCT01422850|101064217|FG000|Week 15|Overall Study||18||
48301765|NCT01422850|101064217|FG000|COMPLETED|Overall Study||18||
48301766|NCT01422850|101064217|FG000|NOT COMPLETED|Overall Study||3||
48301767|NCT01251120|101064218|FG000|STARTED|Overall Study||1||
48301768|NCT01251120|101064219|FG001|STARTED|Overall Study||1||
48301769|NCT01251120|101064218|FG000|COMPLETED|Overall Study||1||
48301770|NCT01251120|101064219|FG001|COMPLETED|Overall Study||0||
48301771|NCT01251120|101064218|FG000|NOT COMPLETED|Overall Study||0||
48301772|NCT01251120|101064219|FG001|NOT COMPLETED|Overall Study||1||
48301773|NCT03362879|101064220|FG000|STARTED|Overall Study||409||
48301774|NCT03362879|101064220|FG000|COMPLETED|Overall Study||409||
48301775|NCT03362879|101064220|FG000|NOT COMPLETED|Overall Study||0||
48301776|NCT01296035|101064221|FG000|STARTED|Overall Study||8||
48301777|NCT01296035|101064221|FG000|COMPLETED|Overall Study||7||
48301778|NCT01296035|101064221|FG000|NOT COMPLETED|Overall Study||1||
48301779|NCT00640016|101064222|FG000|STARTED|Overall Study||3||
48301780|NCT00640016|101064223|FG001|STARTED|Overall Study||3||
48301781|NCT00640016|101064224|FG002|STARTED|Overall Study||4||
48301782|NCT00640016|101064225|FG003|STARTED|Overall Study||4||
48301783|NCT00640016|101064222|FG000|Treated|Overall Study||3||
48301784|NCT00640016|101064223|FG001|Treated|Overall Study||2||
48301785|NCT00640016|101064224|FG002|Treated|Overall Study||4||
48301786|NCT00640016|101064225|FG003|Treated|Overall Study||4||
48301787|NCT00640016|101064222|FG000|COMPLETED|Overall Study||1||
48301788|NCT00640016|101064223|FG001|COMPLETED|Overall Study||1||
48301789|NCT00640016|101064224|FG002|COMPLETED|Overall Study||1||
48301790|NCT00640016|101064225|FG003|COMPLETED|Overall Study||1||
48301791|NCT00640016|101064222|FG000|NOT COMPLETED|Overall Study||2||
48301792|NCT00640016|101064223|FG001|NOT COMPLETED|Overall Study||2||
48301793|NCT00640016|101064224|FG002|NOT COMPLETED|Overall Study||3||
48301794|NCT00640016|101064225|FG003|NOT COMPLETED|Overall Study||3||
48301795|NCT00300781|101064226|FG000|STARTED|Overall Study||66||
48301796|NCT00300781|101064227|FG001|STARTED|Overall Study||70||
48301797|NCT00300781|101064226|FG000|COMPLETED|Overall Study||3||
48301798|NCT00300781|101064227|FG001|COMPLETED|Overall Study||8||
48301799|NCT00300781|101064226|FG000|NOT COMPLETED|Overall Study||63||
48301800|NCT00300781|101064227|FG001|NOT COMPLETED|Overall Study||62||
48301801|NCT00408603|101064228|FG000|STARTED|Overall Study||69||
48603455|NCT00731731|101811806|FG002|NOT COMPLETED|Overall Study||3||
48603456|NCT01048099|101811807|FG000|STARTED|Patients Enrolled and Blood Collected||283||
48603457|NCT01048099|101811807|FG000|COMPLETED|Patients Enrolled and Blood Collected||226||
48603458|NCT01048099|101811807|FG000|NOT COMPLETED|Patients Enrolled and Blood Collected||57||
48603459|NCT01048099|101811807|FG000|STARTED|Patients Evaluated by PRO Onc Assay||226||
48603460|NCT01048099|101811807|FG000|COMPLETED|Patients Evaluated by PRO Onc Assay||24||
48603461|NCT01048099|101811807|FG000|NOT COMPLETED|Patients Evaluated by PRO Onc Assay||202||
48603462|NCT01048099|101811807|FG000|STARTED|Pts w/ HER2 Overexpression/Activation||24||
48603463|NCT01048099|101811807|FG000|COMPLETED|Pts w/ HER2 Overexpression/Activation||14||
48603464|NCT01048099|101811807|FG000|NOT COMPLETED|Pts w/ HER2 Overexpression/Activation||10||
48603465|NCT01048099|101811807|FG000|STARTED|Treatment Per Protocol||14||
48603466|NCT01048099|101811807|FG000|COMPLETED|Treatment Per Protocol||0||
48603467|NCT01048099|101811807|FG000|NOT COMPLETED|Treatment Per Protocol||14||
48603468|NCT01066871|101811808|FG000|STARTED|Overall Study||20||
48603469|NCT01066871|101811809|FG001|STARTED|Overall Study||18||
48603470|NCT01066871|101811810|FG002|STARTED|Overall Study||18||
48603471|NCT01066871|101811811|FG003|STARTED|Overall Study||18||
48603472|NCT01066871|101811808|FG000|COMPLETED|Overall Study||16||
48603473|NCT01066871|101811809|FG001|COMPLETED|Overall Study||13||
48603474|NCT01066871|101811810|FG002|COMPLETED|Overall Study||12||
48603475|NCT01066871|101811811|FG003|COMPLETED|Overall Study||13||
48603476|NCT01066871|101811808|FG000|NOT COMPLETED|Overall Study||4||
48603477|NCT01066871|101811809|FG001|NOT COMPLETED|Overall Study||5||
48603478|NCT01066871|101811810|FG002|NOT COMPLETED|Overall Study||6||
48603479|NCT01066871|101811811|FG003|NOT COMPLETED|Overall Study||5||
48603480|NCT04702997|101811812|FG000|STARTED|Overall Study||39||
48603481|NCT04702997|101811813|FG001|STARTED|Overall Study||42||
48603482|NCT04702997|101811812|FG000|COMPLETED|Overall Study||38||
48603483|NCT04702997|101811813|FG001|COMPLETED|Overall Study||41||
48603484|NCT04702997|101811812|FG000|NOT COMPLETED|Overall Study||1||
48603485|NCT04702997|101811813|FG001|NOT COMPLETED|Overall Study||1||
48603486|NCT00857961|101811814|FG000|STARTED|Overall Study||21||
48603487|NCT00857961|101811814|FG000|COMPLETED|Overall Study||21||
48603488|NCT00857961|101811814|FG000|NOT COMPLETED|Overall Study||0||
48603489|NCT02109445|101811815|FG000|STARTED|Overall Study||3||
48603490|NCT02109445|101811815|FG000|COMPLETED|Overall Study||0||
48603491|NCT02109445|101811815|FG000|NOT COMPLETED|Overall Study||3||
48603492|NCT02555930|101811816|FG000|STARTED|Overall Study||148||
48603493|NCT02555930|101811816|FG000|COMPLETED|Overall Study||148||
48603494|NCT02555930|101811816|FG000|NOT COMPLETED|Overall Study||0||
48603495|NCT03790618|101811817|FG000|STARTED|Overall Study||9||
48603496|NCT03790618|101811818|FG001|STARTED|Overall Study||9||
48603497|NCT03790618|101811819|FG002|STARTED|Overall Study||9||
48603498|NCT03790618|101811820|FG003|STARTED|Overall Study||9||
48603499|NCT03790618|101811817|FG000|COMPLETED|Overall Study||9||
48603500|NCT03790618|101811818|FG001|COMPLETED|Overall Study||9||
48603501|NCT03790618|101811819|FG002|COMPLETED|Overall Study||9||
48715390|NCT03780959|102088773|FG002|STARTED|Part 2||25|Participants who met response criteria at day 90|
48715391|NCT03780959|102088771|FG000|COMPLETED|Part 2||0||
48715392|NCT03780959|102088772|FG001|COMPLETED|Part 2||7||
48715393|NCT03780959|102088773|FG002|COMPLETED|Part 2||19||
48715394|NCT03780959|102088771|FG000|NOT COMPLETED|Part 2||0||
48715395|NCT03780959|102088772|FG001|NOT COMPLETED|Part 2||19||
48715396|NCT03780959|102088773|FG002|NOT COMPLETED|Part 2||6||
48715397|NCT01243567|102088774|FG000|STARTED|Overall Study||43||
48715398|NCT01243567|102088775|FG001|STARTED|Overall Study||38||
48715399|NCT01243567|102088774|FG000|COMPLETED|Overall Study||42||
48715400|NCT01243567|102088775|FG001|COMPLETED|Overall Study||38||
48715401|NCT01243567|102088774|FG000|NOT COMPLETED|Overall Study||1||
48301802|NCT00408603|101064229|FG001|STARTED|Overall Study||39||
48301803|NCT00408603|101064230|FG002|STARTED|Overall Study||75||
48301804|NCT00408603|101064228|FG000|COMPLETED|Overall Study||65||
48715402|NCT01243567|102088775|FG001|NOT COMPLETED|Overall Study||0||
48715403|NCT01439074|102088776|FG000|STARTED|Overall Study||75||
48301805|NCT00408603|101064229|FG001|COMPLETED|Overall Study||37||
48603502|NCT03790618|101811820|FG003|COMPLETED|Overall Study||9||
48603503|NCT03790618|101811817|FG000|NOT COMPLETED|Overall Study||0||
48603504|NCT03790618|101811818|FG001|NOT COMPLETED|Overall Study||0||
48603505|NCT03790618|101811819|FG002|NOT COMPLETED|Overall Study||0||
48603506|NCT03790618|101811820|FG003|NOT COMPLETED|Overall Study||0||
48603507|NCT02389374|101811821|FG000|STARTED|Overall Study||55||
48603508|NCT02389374|101811822|FG001|STARTED|Overall Study||115||
48603509|NCT02389374|101811823|FG002|STARTED|Overall Study||11||
48603510|NCT02389374|101811821|FG000|COMPLETED|Overall Study||46||
48603511|NCT02389374|101811822|FG001|COMPLETED|Overall Study||87||
48603512|NCT02389374|101811823|FG002|COMPLETED|Overall Study||10||
48603513|NCT02389374|101811821|FG000|NOT COMPLETED|Overall Study||9||
48603514|NCT02389374|101811822|FG001|NOT COMPLETED|Overall Study||28||
48603515|NCT02389374|101811823|FG002|NOT COMPLETED|Overall Study||1||
48603516|NCT02611765|101811824|FG000|STARTED|Overall Study||29||
48603517|NCT02611765|101811825|FG001|STARTED|Overall Study||35||
48603518|NCT02611765|101811824|FG000|COMPLETED|Overall Study||27||
48603519|NCT02611765|101811825|FG001|COMPLETED|Overall Study||29||
48603520|NCT02611765|101811824|FG000|NOT COMPLETED|Overall Study||2||
48603521|NCT02611765|101811825|FG001|NOT COMPLETED|Overall Study||6||
48603522|NCT04710368|101811826|FG000|STARTED|Overall Study||137||
48603523|NCT04710368|101811826|FG000|COMPLETED|Overall Study||110||
48603524|NCT04710368|101811826|FG000|NOT COMPLETED|Overall Study||27||
48603525|NCT01066793|101811827|FG000|STARTED|Overall Study||1128||
48603526|NCT01066793|101811828|FG001|STARTED|Overall Study||572||
48603527|NCT01066793|101811829|FG002|STARTED|Overall Study||484||
48603528|NCT01066793|101811830|FG003|STARTED|Overall Study||143||
48603529|NCT01066793|101811831|FG004|STARTED|Overall Study||11||
48603530|NCT01066793|101811832|FG005|STARTED|Overall Study||5||
48603531|NCT01066793|101811827|FG000|COMPLETED|Overall Study||754||
48603532|NCT01066793|101811828|FG001|COMPLETED|Overall Study||495||
48603533|NCT01066793|101811829|FG002|COMPLETED|Overall Study||369||
48603534|NCT01066793|101811830|FG003|COMPLETED|Overall Study||94||
48603535|NCT01066793|101811831|FG004|COMPLETED|Overall Study||11||
48603536|NCT01066793|101811832|FG005|COMPLETED|Overall Study||4||
48603537|NCT01066793|101811827|FG000|NOT COMPLETED|Overall Study||374||
48603538|NCT01066793|101811828|FG001|NOT COMPLETED|Overall Study||77||
48603539|NCT01066793|101811829|FG002|NOT COMPLETED|Overall Study||115||
48603540|NCT01066793|101811830|FG003|NOT COMPLETED|Overall Study||49||
48603541|NCT01066793|101811831|FG004|NOT COMPLETED|Overall Study||0||
48603542|NCT01066793|101811832|FG005|NOT COMPLETED|Overall Study||1||
48603543|NCT00882661|101816105|FG000|STARTED|Investigational Training||89||
48603544|NCT00882661|101816106|FG001|STARTED|Investigational Training||0||
48603545|NCT00882661|101816105|FG000|COMPLETED|Investigational Training||79||
48603546|NCT00882661|101816106|FG001|COMPLETED|Investigational Training||0||
48603547|NCT00882661|101816105|FG000|NOT COMPLETED|Investigational Training||10||
48603548|NCT00882661|101816106|FG001|NOT COMPLETED|Investigational Training||0||
48603549|NCT00882661|101816105|FG000|STARTED|Treatment||151||
48603550|NCT00882661|101816106|FG001|STARTED|Treatment||140||
48603551|NCT00882661|101816105|FG000|COMPLETED|Treatment||141||
48603552|NCT00882661|101816106|FG001|COMPLETED|Treatment||114||
48603553|NCT00882661|101816105|FG000|NOT COMPLETED|Treatment||10||
48603554|NCT00882661|101816106|FG001|NOT COMPLETED|Treatment||26||
48603555|NCT01030718|101816107|FG000|STARTED|Studies CA180-031 and -036 Combined||30||
48603556|NCT01030718|101816108|FG001|STARTED|Studies CA180-031 and -036 Combined||11||
48603557|NCT01030718|101816109|FG002|STARTED|Studies CA180-031 and -036 Combined||13||
48603558|NCT01030718|101816107|FG000|COMPLETED|Studies CA180-031 and -036 Combined||26||
48603559|NCT01030718|101816108|FG001|COMPLETED|Studies CA180-031 and -036 Combined||2||
48603560|NCT01030718|101816109|FG002|COMPLETED|Studies CA180-031 and -036 Combined||1||
48603561|NCT01030718|101816107|FG000|NOT COMPLETED|Studies CA180-031 and -036 Combined||4||
48603562|NCT01030718|101816108|FG001|NOT COMPLETED|Studies CA180-031 and -036 Combined||9||
48603563|NCT01030718|101816109|FG002|NOT COMPLETED|Studies CA180-031 and -036 Combined||12||
48603564|NCT01030718|101816107|FG000|STARTED|Study CA180-036 Only||29||
48603565|NCT01030718|101816108|FG001|STARTED|Study CA180-036 Only||9||
48603566|NCT01030718|101816109|FG002|STARTED|Study CA180-036 Only||6||
48603567|NCT01030718|101816107|FG000|COMPLETED|Study CA180-036 Only||26||
48603568|NCT01030718|101816108|FG001|COMPLETED|Study CA180-036 Only||2||
48603569|NCT01030718|101816109|FG002|COMPLETED|Study CA180-036 Only||1||
48603570|NCT01030718|101816107|FG000|NOT COMPLETED|Study CA180-036 Only||3||
48603571|NCT01030718|101816108|FG001|NOT COMPLETED|Study CA180-036 Only||7||
48603572|NCT01030718|101816109|FG002|NOT COMPLETED|Study CA180-036 Only||5||
48603573|NCT03699540|101816110|FG000|STARTED|Overall Study||10||
48603574|NCT03699540|101816110|FG000|Inactive Alcohol/ Tetrahydrocannabinol (THC) 0mg|Overall Study||8||
48603575|NCT03699540|101816110|FG000|Inactive Alcohol/THC 15mg|Overall Study||10||
48603576|NCT03699540|101816110|FG000|Inactive Alcohol/THC 30mg|Overall Study||9||
48603577|NCT03699540|101816110|FG000|Inactive Alcohol/Combined THC 15mg/CBD 7.5mg|Overall Study||9||
48603578|NCT03699540|101816110|FG000|Active Alcohol/THC 0mg|Overall Study||10||
48603579|NCT03699540|101816110|FG000|COMPLETED|Overall Study||9||
48603580|NCT03699540|101816110|FG000|NOT COMPLETED|Overall Study||1||
48603581|NCT02933528|101816111|FG000|STARTED|Overall Study||24||
48603582|NCT02933528|101816111|FG000|COMPLETED|Overall Study||22||
48603583|NCT02933528|101816111|FG000|NOT COMPLETED|Overall Study||2||
48603584|NCT02735473|101816112|FG000|STARTED|Overall Study||23||
48603585|NCT02735473|101816113|FG001|STARTED|Overall Study||23||
48603586|NCT02735473|101816112|FG000|COMPLETED|Overall Study||17||
48603587|NCT02735473|101816113|FG001|COMPLETED|Overall Study||16||
48603588|NCT02735473|101816112|FG000|NOT COMPLETED|Overall Study||6||
48603589|NCT02735473|101816113|FG001|NOT COMPLETED|Overall Study||7||
48603590|NCT00462449|101816114|FG000|STARTED|Overall Study||13||
48603591|NCT00462449|101816115|FG001|STARTED|Overall Study||10||
48603592|NCT00462449|101816114|FG000|COMPLETED|Overall Study||13||
48603593|NCT00462449|101816115|FG001|COMPLETED|Overall Study||10||
48603594|NCT00462449|101816114|FG000|NOT COMPLETED|Overall Study||0||
48603595|NCT00462449|101816115|FG001|NOT COMPLETED|Overall Study||0||
48603596|NCT02801370|101816116|FG000|STARTED|Overall Study||130||
48603597|NCT02801370|101816117|FG001|STARTED|Overall Study||132||
48603598|NCT02801370|101816116|FG000|COMPLETED|Overall Study||123||
48603599|NCT02801370|101816117|FG001|COMPLETED|Overall Study||132||
48603600|NCT02801370|101816116|FG000|NOT COMPLETED|Overall Study||7||
48603601|NCT02801370|101816117|FG001|NOT COMPLETED|Overall Study||0||
48603602|NCT03420222|101816118|FG000|STARTED|Overall Study||8||
48603603|NCT03420222|101816119|FG001|STARTED|Overall Study||2||
48603604|NCT03420222|101816118|FG000|COMPLETED|Overall Study||3||
48603605|NCT03420222|101816119|FG001|COMPLETED|Overall Study||1||
48603606|NCT03420222|101816118|FG000|NOT COMPLETED|Overall Study||5||
48603607|NCT03420222|101816119|FG001|NOT COMPLETED|Overall Study||1||
48603608|NCT00661453|101816120|FG000|STARTED|Overall Study||38||
48603609|NCT00661453|101816120|FG000|COMPLETED|Overall Study||25||
48603610|NCT00661453|101816120|FG000|NOT COMPLETED|Overall Study||13||
48603611|NCT03571724|101816121|FG000|STARTED|Week -1 (Prior to Switching)||0||
48603612|NCT03571724|101816122|FG001|STARTED|Week -1 (Prior to Switching)||0||
48603613|NCT03571724|101816123|FG002|STARTED|Week -1 (Prior to Switching)||72||
48603614|NCT03571724|101816124|FG003|STARTED|Week -1 (Prior to Switching)||70||
48603615|NCT03571724|101816121|FG000|Topography|Week -1 (Prior to Switching)||0||
48603616|NCT03571724|101816122|FG001|Topography|Week -1 (Prior to Switching)||0||
48603617|NCT03571724|101816123|FG002|Topography|Week -1 (Prior to Switching)||18||
48603618|NCT03571724|101816124|FG003|Topography|Week -1 (Prior to Switching)||18||
48603619|NCT03571724|101816121|FG000|PK Nicotine|Week -1 (Prior to Switching)||0||
48603620|NCT03571724|101816122|FG001|PK Nicotine|Week -1 (Prior to Switching)||0||
48603621|NCT03571724|101816123|FG002|PK Nicotine|Week -1 (Prior to Switching)||12||
48603622|NCT03571724|101816124|FG003|PK Nicotine|Week -1 (Prior to Switching)||12||
48603623|NCT03571724|101816121|FG000|COMPLETED|Week -1 (Prior to Switching)||0||
48603624|NCT03571724|101816122|FG001|COMPLETED|Week -1 (Prior to Switching)||0||
48603625|NCT03571724|101816123|FG002|COMPLETED|Week -1 (Prior to Switching)||72||
48603626|NCT03571724|101816124|FG003|COMPLETED|Week -1 (Prior to Switching)||70||
48603627|NCT03571724|101816121|FG000|NOT COMPLETED|Week -1 (Prior to Switching)||0||
48603628|NCT03571724|101816122|FG001|NOT COMPLETED|Week -1 (Prior to Switching)||0||
48603629|NCT03571724|101816123|FG002|NOT COMPLETED|Week -1 (Prior to Switching)||0||
48603630|NCT03571724|101816124|FG003|NOT COMPLETED|Week -1 (Prior to Switching)||0||
48603631|NCT03571724|101816121|FG000|STARTED|Week 1-6||50||
48603632|NCT03571724|101816122|FG001|STARTED|Week 1-6||50||
48603633|NCT03571724|101816123|FG002|STARTED|Week 1-6||22||
48603634|NCT03571724|101816124|FG003|STARTED|Week 1-6||20||
48603635|NCT03571724|101816121|FG000|COMPLETED|Week 1-6||43||
48603636|NCT03571724|101816122|FG001|COMPLETED|Week 1-6||42||
48603637|NCT03571724|101816123|FG002|COMPLETED|Week 1-6||19||
48603638|NCT03571724|101816124|FG003|COMPLETED|Week 1-6||20||
48603639|NCT03571724|101816121|FG000|NOT COMPLETED|Week 1-6||7||
48603640|NCT03571724|101816122|FG001|NOT COMPLETED|Week 1-6||8||
48603641|NCT03571724|101816123|FG002|NOT COMPLETED|Week 1-6||3||
48603642|NCT03571724|101816124|FG003|NOT COMPLETED|Week 1-6||0||
48603643|NCT04270695|101816125|FG000|STARTED|Overall Study||17||
48603644|NCT04270695|101816126|FG001|STARTED|Overall Study||17||
48603645|NCT04270695|101816125|FG000|COMPLETED|Overall Study||17||
48603646|NCT04270695|101816126|FG001|COMPLETED|Overall Study||17||
48603647|NCT04270695|101816125|FG000|NOT COMPLETED|Overall Study||0||
48603648|NCT04270695|101816126|FG001|NOT COMPLETED|Overall Study||0||
48603649|NCT00441363|101816127|FG000|STARTED|Overall Study||32||
48603650|NCT00441363|101816128|FG001|STARTED|Overall Study||34||
48603651|NCT00441363|101816127|FG000|COMPLETED|Overall Study||15||
48603652|NCT00441363|101816128|FG001|COMPLETED|Overall Study||19||
48603653|NCT00441363|101816127|FG000|NOT COMPLETED|Overall Study||17||
48603654|NCT00441363|101816128|FG001|NOT COMPLETED|Overall Study||15||
48603655|NCT03594955|101816129|FG000|STARTED|Overall Study||7||
48603656|NCT03594955|101816129|FG000|COMPLETED|Overall Study||0||
48603657|NCT03594955|101816129|FG000|NOT COMPLETED|Overall Study||7||
48603658|NCT02362425|101816130|FG000|STARTED|Phase 1 (up to 6 Months)||53||
48603659|NCT02362425|101816131|FG001|STARTED|Phase 1 (up to 6 Months)||10||
48603660|NCT02362425|101816132|FG002|STARTED|Phase 1 (up to 6 Months)||0||
48603661|NCT02362425|101816133|FG003|STARTED|Phase 1 (up to 6 Months)||0||
48603662|NCT02362425|101816130|FG000|COMPLETED|Phase 1 (up to 6 Months)||37||
48603663|NCT02362425|101816131|FG001|COMPLETED|Phase 1 (up to 6 Months)||10||
48603664|NCT02362425|101816132|FG002|COMPLETED|Phase 1 (up to 6 Months)||0||
48603665|NCT02362425|101816133|FG003|COMPLETED|Phase 1 (up to 6 Months)||0||
48603666|NCT02362425|101816130|FG000|NOT COMPLETED|Phase 1 (up to 6 Months)||16||
48603667|NCT02362425|101816131|FG001|NOT COMPLETED|Phase 1 (up to 6 Months)||0||
48603668|NCT02362425|101816132|FG002|NOT COMPLETED|Phase 1 (up to 6 Months)||0||
48603669|NCT02362425|101816133|FG003|NOT COMPLETED|Phase 1 (up to 6 Months)||0||
48603670|NCT02362425|101816130|FG000|STARTED|Phase 2 (up to 6 Months, Randomized)||0||
48603671|NCT02362425|101816131|FG001|STARTED|Phase 2 (up to 6 Months, Randomized)||0||
48603672|NCT02362425|101816132|FG002|STARTED|Phase 2 (up to 6 Months, Randomized)||16||
48603673|NCT02362425|101816133|FG003|STARTED|Phase 2 (up to 6 Months, Randomized)||17||
48603674|NCT02362425|101816130|FG000|COMPLETED|Phase 2 (up to 6 Months, Randomized)||0||
48603675|NCT02362425|101816131|FG001|COMPLETED|Phase 2 (up to 6 Months, Randomized)||0||
48603676|NCT02362425|101816132|FG002|COMPLETED|Phase 2 (up to 6 Months, Randomized)||15||
48603677|NCT02362425|101816133|FG003|COMPLETED|Phase 2 (up to 6 Months, Randomized)||14||
48603678|NCT02362425|101816130|FG000|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||0||
48603679|NCT02362425|101816131|FG001|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||0||
48603680|NCT02362425|101816132|FG002|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||1||
48603681|NCT02362425|101816133|FG003|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||3||
48603682|NCT00681265|101816134|FG000|STARTED|Overall Study||16||
48603683|NCT00681265|101816134|FG000|COMPLETED|Overall Study||16||
48603684|NCT00681265|101816134|FG000|NOT COMPLETED|Overall Study||0||
48603685|NCT03484403|101816135|FG000|STARTED|Overall Study||34||
48603686|NCT03484403|101816136|FG001|STARTED|Overall Study||25||
48603687|NCT03484403|101816135|FG000|COMPLETED|Overall Study||28||
48603688|NCT03484403|101816136|FG001|COMPLETED|Overall Study||21||
48603689|NCT03484403|101816135|FG000|NOT COMPLETED|Overall Study||6||
48603690|NCT03484403|101816136|FG001|NOT COMPLETED|Overall Study||4||
48603691|NCT01210222|101816137|FG000|STARTED|Overall Study||35||
48301806|NCT00408603|101064230|FG002|COMPLETED|Overall Study||35||
48301807|NCT00408603|101064228|FG000|NOT COMPLETED|Overall Study||4||
48301808|NCT00408603|101064229|FG001|NOT COMPLETED|Overall Study||2||
48301809|NCT00408603|101064230|FG002|NOT COMPLETED|Overall Study||40||
48301810|NCT01256658|101064231|FG000|STARTED|Period 1||6817||
48301811|NCT01256658|101064232|FG001|STARTED|Period 1||7258||
48301812|NCT01256658|101064231|FG000|COMPLETED|Period 1||5897||
48301813|NCT01256658|101064232|FG001|COMPLETED|Period 1||6510||
48301814|NCT01256658|101064231|FG000|NOT COMPLETED|Period 1||920||
48301815|NCT01256658|101064232|FG001|NOT COMPLETED|Period 1||748||
48301816|NCT01256658|101064231|FG000|STARTED|Period 2 - Follow up Only - No Treatment||5854||
48301817|NCT01256658|101064232|FG001|STARTED|Period 2 - Follow up Only - No Treatment||6372||
48301818|NCT01256658|101064231|FG000|Lost to Follow up|Period 2 - Follow up Only - No Treatment||71||
48301819|NCT01256658|101064232|FG001|Lost to Follow up|Period 2 - Follow up Only - No Treatment||77||
48603692|NCT01210222|101816137|FG000|COMPLETED|Overall Study||32||
48603693|NCT01210222|101816137|FG000|NOT COMPLETED|Overall Study||3||
48603694|NCT04046263|101816138|FG000|STARTED|Overall Study||17||
48603695|NCT04046263|101816138|FG000|COMPLETED|Overall Study||12||
48603696|NCT04046263|101816138|FG000|NOT COMPLETED|Overall Study||5||
48603697|NCT00534417|101816139|FG000|STARTED|Overall Study||41||
48603698|NCT00534417|101816139|FG000|COMPLETED|Overall Study||41||
48603699|NCT00534417|101816139|FG000|NOT COMPLETED|Overall Study||0||
48603700|NCT01090141|101816140|FG000|STARTED|Overall Study||0||
48603701|NCT01090141|101816141|FG001|STARTED|Overall Study||0||
48603702|NCT01090141|101816140|FG000|COMPLETED|Overall Study||0||
48603703|NCT01090141|101816141|FG001|COMPLETED|Overall Study||0||
48603704|NCT01090141|101816140|FG000|NOT COMPLETED|Overall Study||0||
48603705|NCT01090141|101816141|FG001|NOT COMPLETED|Overall Study||0||
48603706|NCT02770768|101816142|FG000|STARTED|Overall Study||0||
48603707|NCT02770768|101816143|FG001|STARTED|Overall Study||0||
48603708|NCT02770768|101816142|FG000|COMPLETED|Overall Study||0||
48603709|NCT02770768|101816143|FG001|COMPLETED|Overall Study||0||
48603710|NCT02770768|101816142|FG000|NOT COMPLETED|Overall Study||0||
48603711|NCT02770768|101816143|FG001|NOT COMPLETED|Overall Study||0||
48603712|NCT02860507|101816144|FG000|STARTED|Overall Study||25||
48603713|NCT02860507|101816145|FG001|STARTED|Overall Study||25||
48603714|NCT02860507|101816144|FG000|COMPLETED|Overall Study||25||
48301820|NCT01256658|101064231|FG000|Death|Period 2 - Follow up Only - No Treatment||6||
48301821|NCT01256658|101064232|FG001|Death|Period 2 - Follow up Only - No Treatment||8||
48301822|NCT01256658|101064231|FG000|Study Termination|Period 2 - Follow up Only - No Treatment||5777||
48301823|NCT01256658|101064232|FG001|Study Termination|Period 2 - Follow up Only - No Treatment||6287||
48301824|NCT01256658|101064231|FG000|COMPLETED|Period 2 - Follow up Only - No Treatment||0||
48301825|NCT01256658|101064232|FG001|COMPLETED|Period 2 - Follow up Only - No Treatment||0||
48301826|NCT01256658|101064231|FG000|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||5854||
48301827|NCT01256658|101064232|FG001|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||6372||
48301828|NCT03712189|101064233|FG000|STARTED|Overall Study||15||
48301829|NCT03712189|101064234|FG001|STARTED|Overall Study||15||
48603715|NCT02860507|101816145|FG001|COMPLETED|Overall Study||25||
48603716|NCT02860507|101816144|FG000|NOT COMPLETED|Overall Study||0||
48603717|NCT02860507|101816145|FG001|NOT COMPLETED|Overall Study||0||
48603718|NCT02432144|101816146|FG000|STARTED|Overall Study||12||
48603719|NCT02432144|101816146|FG000|COMPLETED|Overall Study||11|Includes 8 participants who switched to commercially available vestronidase alfa before Week 144.|
48603720|NCT02432144|101816146|FG000|NOT COMPLETED|Overall Study||1||
48603721|NCT01915771|101816147|FG000|STARTED|Day 1||15||
48603722|NCT01915771|101816147|FG000|COMPLETED|Day 1||14||
48603723|NCT01915771|101816147|FG000|NOT COMPLETED|Day 1||1||
48603724|NCT01915771|101816147|FG000|STARTED|Day 15||14||
48603725|NCT01915771|101816147|FG000|COMPLETED|Day 15||13||
48603726|NCT01915771|101816147|FG000|NOT COMPLETED|Day 15||1||
48603727|NCT01096680|101816148|FG000|STARTED|Overall Study||27||
48603728|NCT01096680|101816149|FG001|STARTED|Overall Study||27||
48603729|NCT01096680|101816150|FG002|STARTED|Overall Study||27||
48603730|NCT01096680|101816151|FG003|STARTED|Overall Study||27||
48603731|NCT01096680|101816152|FG004|STARTED|Overall Study||27||
48603732|NCT01096680|101816148|FG000|COMPLETED|Overall Study||27||
48603733|NCT01096680|101816149|FG001|COMPLETED|Overall Study||27||
48603734|NCT01096680|101816150|FG002|COMPLETED|Overall Study||27||
48603735|NCT01096680|101816151|FG003|COMPLETED|Overall Study||27||
48603736|NCT01096680|101816152|FG004|COMPLETED|Overall Study||27||
48603737|NCT01096680|101816148|FG000|NOT COMPLETED|Overall Study||0||
48603738|NCT01096680|101816149|FG001|NOT COMPLETED|Overall Study||0||
48603739|NCT01096680|101816150|FG002|NOT COMPLETED|Overall Study||0||
48603740|NCT01096680|101816151|FG003|NOT COMPLETED|Overall Study||0||
48603741|NCT01096680|101816152|FG004|NOT COMPLETED|Overall Study||0||
48603742|NCT04657094|101816153|FG000|STARTED|Overall Study||4||
48603743|NCT04657094|101816153|FG000|COMPLETED|Overall Study||4||
48603744|NCT04657094|101816153|FG000|NOT COMPLETED|Overall Study||0||
48603745|NCT02020837|101816154|FG000|STARTED|Overall Study||2||
48603746|NCT02020837|101816154|FG000|COMPLETED|Overall Study||2||
48603747|NCT02020837|101816154|FG000|NOT COMPLETED|Overall Study||0||
48603748|NCT01026818|101816155|FG000|STARTED|Screening Period||583||
48603749|NCT01026818|101816156|FG001|STARTED|Screening Period||0||
48603750|NCT01026818|101816157|FG002|STARTED|Screening Period||0||
48603751|NCT01026818|101816158|FG003|STARTED|Screening Period||0||
48603752|NCT01026818|101816155|FG000|COMPLETED|Screening Period||423||
48603753|NCT01026818|101816156|FG001|COMPLETED|Screening Period||0||
48603754|NCT01026818|101816157|FG002|COMPLETED|Screening Period||0||
48603755|NCT01026818|101816158|FG003|COMPLETED|Screening Period||0||
48603756|NCT01026818|101816155|FG000|NOT COMPLETED|Screening Period||160||
48603757|NCT01026818|101816156|FG001|NOT COMPLETED|Screening Period||0||
48603758|NCT01026818|101816157|FG002|NOT COMPLETED|Screening Period||0||
48603759|NCT01026818|101816158|FG003|NOT COMPLETED|Screening Period||0||
48603760|NCT01026818|101816155|FG000|STARTED|DB Treatment Period (Month 0 - 9)||0||
48603761|NCT01026818|101816156|FG001|STARTED|DB Treatment Period (Month 0 - 9)||139||
48603762|NCT01026818|101816157|FG002|STARTED|DB Treatment Period (Month 0 - 9)||143||
48603763|NCT01026818|101816158|FG003|STARTED|DB Treatment Period (Month 0 - 9)||141||
48603764|NCT01026818|101816155|FG000|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||0||
48603765|NCT01026818|101816156|FG001|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||139||
48603766|NCT01026818|101816157|FG002|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||143||
48603767|NCT01026818|101816158|FG003|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||141||
48603768|NCT01026818|101816155|FG000|COMPLETED|DB Treatment Period (Month 0 - 9)||0||
48603769|NCT01026818|101816156|FG001|COMPLETED|DB Treatment Period (Month 0 - 9)||114||
48603770|NCT01026818|101816157|FG002|COMPLETED|DB Treatment Period (Month 0 - 9)||122||
48603771|NCT01026818|101816158|FG003|COMPLETED|DB Treatment Period (Month 0 - 9)||115||
48603772|NCT01026818|101816155|FG000|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||0||
48603773|NCT01026818|101816156|FG001|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||25||
48603774|NCT01026818|101816157|FG002|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||21||
48603775|NCT01026818|101816158|FG003|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||26||
48603776|NCT01026818|101816155|FG000|STARTED|Drug-Free Washout Period (Month 9-10.5)||0||
48603777|NCT01026818|101816156|FG001|STARTED|Drug-Free Washout Period (Month 9-10.5)||114||
48603778|NCT01026818|101816157|FG002|STARTED|Drug-Free Washout Period (Month 9-10.5)||122||
48603779|NCT01026818|101816158|FG003|STARTED|Drug-Free Washout Period (Month 9-10.5)||115||
48603780|NCT01026818|101816155|FG000|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0||
48603781|NCT01026818|101816156|FG001|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||105||
48603782|NCT01026818|101816157|FG002|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||117||
48603783|NCT01026818|101816158|FG003|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||108||
48603784|NCT01026818|101816155|FG000|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0||
48603785|NCT01026818|101816156|FG001|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||9||
48603786|NCT01026818|101816157|FG002|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||5||
48603787|NCT01026818|101816158|FG003|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||7||
48603788|NCT01026818|101816155|FG000|STARTED|OL Period (Month 10.5 - 13.5)||0||
48603789|NCT01026818|101816156|FG001|STARTED|OL Period (Month 10.5 - 13.5)||105||
48603790|NCT01026818|101816157|FG002|STARTED|OL Period (Month 10.5 - 13.5)||117||
48603791|NCT01026818|101816158|FG003|STARTED|OL Period (Month 10.5 - 13.5)||108||
48603792|NCT01026818|101816155|FG000|COMPLETED|OL Period (Month 10.5 - 13.5)||0||
48603793|NCT01026818|101816156|FG001|COMPLETED|OL Period (Month 10.5 - 13.5)||98||
48603794|NCT01026818|101816157|FG002|COMPLETED|OL Period (Month 10.5 - 13.5)||112||
48603795|NCT01026818|101816158|FG003|COMPLETED|OL Period (Month 10.5 - 13.5)||105||
48603796|NCT01026818|101816155|FG000|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||0||
48603797|NCT01026818|101816156|FG001|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||7||
48603798|NCT01026818|101816157|FG002|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||5||
48603799|NCT01026818|101816158|FG003|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||3||
48603800|NCT02284386|101816159|FG000|STARTED|Overall Study||15||
48603801|NCT02284386|101816159|FG000|COMPLETED|Overall Study||15||
48603802|NCT02284386|101816159|FG000|NOT COMPLETED|Overall Study||0||
48603803|NCT01401543|101816160|FG000|STARTED|First Intervention||6||
48603804|NCT01401543|101816161|FG001|STARTED|First Intervention||6||
48603805|NCT01401543|101816162|FG002|STARTED|First Intervention||6||
48603806|NCT01401543|101816163|FG003|STARTED|First Intervention||6||
48603807|NCT01401543|101816160|FG000|COMPLETED|First Intervention||6||
48603808|NCT01401543|101816161|FG001|COMPLETED|First Intervention||6||
48603809|NCT01401543|101816162|FG002|COMPLETED|First Intervention||6||
48603810|NCT01401543|101816163|FG003|COMPLETED|First Intervention||6||
48147685|NCT01698684|100685051|FG001|COMPLETED|Overall Study||124||
48147686|NCT01698684|100685052|FG002|COMPLETED|Overall Study||127||
48147687|NCT01698684|100685050|FG000|NOT COMPLETED|Overall Study||29||
48147688|NCT01698684|100685051|FG001|NOT COMPLETED|Overall Study||23||
48147689|NCT01698684|100685052|FG002|NOT COMPLETED|Overall Study||21||
48147690|NCT02782169|100685053|FG000|STARTED|Overall Study||56||
48147691|NCT02782169|100685054|FG001|STARTED|Overall Study||54||
48147692|NCT02782169|100685053|FG000|COMPLETED|Overall Study||55||
48147693|NCT02782169|100685054|FG001|COMPLETED|Overall Study||52||
48147694|NCT02782169|100685053|FG000|NOT COMPLETED|Overall Study||1||
48301830|NCT03712189|101064233|FG000|COMPLETED|Overall Study||15||
48301831|NCT03712189|101064234|FG001|COMPLETED|Overall Study||15||
48301832|NCT03712189|101064233|FG000|NOT COMPLETED|Overall Study||0||
48301833|NCT03712189|101064234|FG001|NOT COMPLETED|Overall Study||0||
48301834|NCT02291302|101069773|FG000|STARTED|Overall Study||59||
48147695|NCT02782169|100685054|FG001|NOT COMPLETED|Overall Study||2||
48603811|NCT01401543|101816160|FG000|NOT COMPLETED|First Intervention||0||
48147696|NCT02008890|100685055|FG000|STARTED|Period 1||80||
48147697|NCT02008890|100685056|FG001|STARTED|Period 1||79||
48147698|NCT02008890|100685057|FG002|STARTED|Period 1||78||
48147699|NCT02008890|100685058|FG003|STARTED|Period 1||0||
48147700|NCT02008890|100685059|FG004|STARTED|Period 1||0||
48147701|NCT02008890|100685055|FG000|COMPLETED|Period 1||65||
48147702|NCT02008890|100685056|FG001|COMPLETED|Period 1||64||
48147703|NCT02008890|100685057|FG002|COMPLETED|Period 1||66||
48147704|NCT02008890|100685058|FG003|COMPLETED|Period 1||0||
48147705|NCT02008890|100685059|FG004|COMPLETED|Period 1||0||
48147706|NCT02008890|100685055|FG000|NOT COMPLETED|Period 1||15||
48147707|NCT02008890|100685056|FG001|NOT COMPLETED|Period 1||15||
48147708|NCT02008890|100685057|FG002|NOT COMPLETED|Period 1||12||
48147709|NCT02008890|100685058|FG003|NOT COMPLETED|Period 1||0||
48147710|NCT02008890|100685059|FG004|NOT COMPLETED|Period 1||0||
48147711|NCT02008890|100685055|FG000|STARTED|Period 2||65||
48147712|NCT02008890|100685056|FG001|STARTED|Period 2||64||
48147713|NCT02008890|100685057|FG002|STARTED|Period 2||10||
48147714|NCT02008890|100685058|FG003|STARTED|Period 2||27||
48147715|NCT02008890|100685059|FG004|STARTED|Period 2||28||
48147716|NCT02008890|100685055|FG000|COMPLETED|Period 2||38||
48147717|NCT02008890|100685056|FG001|COMPLETED|Period 2||49||
48147718|NCT02008890|100685057|FG002|COMPLETED|Period 2||9||
48147719|NCT02008890|100685058|FG003|COMPLETED|Period 2||13||
48147720|NCT02008890|100685059|FG004|COMPLETED|Period 2||20||
48147721|NCT02008890|100685055|FG000|NOT COMPLETED|Period 2||27||
48147722|NCT02008890|100685056|FG001|NOT COMPLETED|Period 2||15||
48147723|NCT02008890|100685057|FG002|NOT COMPLETED|Period 2||1||
48603812|NCT01401543|101816161|FG001|NOT COMPLETED|First Intervention||0||
48603813|NCT01401543|101816162|FG002|NOT COMPLETED|First Intervention||0||
48603814|NCT01401543|101816163|FG003|NOT COMPLETED|First Intervention||0||
48603815|NCT01401543|101816160|FG000|STARTED|First Washout Period of 1 Week||6||
48603816|NCT01401543|101816161|FG001|STARTED|First Washout Period of 1 Week||6||
48603817|NCT01401543|101816162|FG002|STARTED|First Washout Period of 1 Week||6||
48147724|NCT02008890|100685058|FG003|NOT COMPLETED|Period 2||14||
48147725|NCT02008890|100685059|FG004|NOT COMPLETED|Period 2||8||
48147726|NCT02008890|100685055|FG000|STARTED|Extension Period||31||
48147727|NCT02008890|100685056|FG001|STARTED|Extension Period||36||
48301835|NCT02291302|101069774|FG001|STARTED|Overall Study||59||
48147728|NCT02008890|100685057|FG002|STARTED|Extension Period||0||
48147729|NCT02008890|100685058|FG003|STARTED|Extension Period||10||
48147730|NCT02008890|100685059|FG004|STARTED|Extension Period||17||
48147731|NCT02008890|100685055|FG000|COMPLETED|Extension Period||26||
48147732|NCT02008890|100685056|FG001|COMPLETED|Extension Period||31||
48147733|NCT02008890|100685057|FG002|COMPLETED|Extension Period||0||
48147734|NCT02008890|100685058|FG003|COMPLETED|Extension Period||6||
48147735|NCT02008890|100685059|FG004|COMPLETED|Extension Period||13||
48147736|NCT02008890|100685055|FG000|NOT COMPLETED|Extension Period||5||
48301836|NCT02291302|101069775|FG002|STARTED|Overall Study||59||
48301837|NCT02291302|101069776|FG003|STARTED|Overall Study||59||
48301838|NCT02291302|101069773|FG000|COMPLETED|Overall Study||59||
48301839|NCT02291302|101069774|FG001|COMPLETED|Overall Study||59||
48301840|NCT02291302|101069775|FG002|COMPLETED|Overall Study||59||
48603818|NCT01401543|101816163|FG003|STARTED|First Washout Period of 1 Week||6||
48603819|NCT01401543|101816160|FG000|COMPLETED|First Washout Period of 1 Week||6||
48147737|NCT02008890|100685056|FG001|NOT COMPLETED|Extension Period||5||
48147738|NCT02008890|100685057|FG002|NOT COMPLETED|Extension Period||0||
48147739|NCT02008890|100685058|FG003|NOT COMPLETED|Extension Period||4||
48147740|NCT02008890|100685059|FG004|NOT COMPLETED|Extension Period||4||
48147741|NCT02181803|100685060|FG000|STARTED|Overall Study||1||
48147742|NCT02181803|100685061|FG001|STARTED|Overall Study||13||
48147743|NCT02181803|100685062|FG002|STARTED|Overall Study||4||
48147744|NCT02181803|100685063|FG003|STARTED|Overall Study||13||
48147745|NCT02181803|100685064|FG004|STARTED|Overall Study||6||
48147746|NCT02181803|100685065|FG005|STARTED|Overall Study||6||
48147747|NCT02181803|100685066|FG006|STARTED|Overall Study||9||
48147748|NCT02181803|100685067|FG007|STARTED|Overall Study||1||
48147749|NCT02181803|100685068|FG008|STARTED|Overall Study||2||
48147750|NCT02181803|100685060|FG000|COMPLETED|Overall Study||1||
48147751|NCT02181803|100685061|FG001|COMPLETED|Overall Study||9||
48147752|NCT02181803|100685062|FG002|COMPLETED|Overall Study||4||
48147753|NCT02181803|100685063|FG003|COMPLETED|Overall Study||11||
48147754|NCT02181803|100685064|FG004|COMPLETED|Overall Study||6||
48147755|NCT02181803|100685065|FG005|COMPLETED|Overall Study||6||
48147756|NCT02181803|100685066|FG006|COMPLETED|Overall Study||8||
48147757|NCT02181803|100685067|FG007|COMPLETED|Overall Study||0||
48147758|NCT02181803|100685068|FG008|COMPLETED|Overall Study||2||
48147759|NCT02181803|100685060|FG000|NOT COMPLETED|Overall Study||0||
48147760|NCT02181803|100685061|FG001|NOT COMPLETED|Overall Study||4||
48147761|NCT02181803|100685062|FG002|NOT COMPLETED|Overall Study||0||
48147762|NCT02181803|100685063|FG003|NOT COMPLETED|Overall Study||2||
48603820|NCT01401543|101816161|FG001|COMPLETED|First Washout Period of 1 Week||6||
48603821|NCT01401543|101816162|FG002|COMPLETED|First Washout Period of 1 Week||6||
48603822|NCT01401543|101816163|FG003|COMPLETED|First Washout Period of 1 Week||6||
48603823|NCT01401543|101816160|FG000|NOT COMPLETED|First Washout Period of 1 Week||0||
48603824|NCT01401543|101816161|FG001|NOT COMPLETED|First Washout Period of 1 Week||0||
48603825|NCT01401543|101816162|FG002|NOT COMPLETED|First Washout Period of 1 Week||0||
48147763|NCT02181803|100685064|FG004|NOT COMPLETED|Overall Study||0||
48147764|NCT02181803|100685065|FG005|NOT COMPLETED|Overall Study||0||
48147765|NCT02181803|100685066|FG006|NOT COMPLETED|Overall Study||1||
48147766|NCT02181803|100685067|FG007|NOT COMPLETED|Overall Study||1||
48147767|NCT02181803|100685068|FG008|NOT COMPLETED|Overall Study||0||
48147768|NCT01368965|100685069|FG000|STARTED|Overall Study||52||
48147769|NCT01368965|100685069|FG000|Subject Withdrawal Prior to Treatment|Overall Study||2||
48147770|NCT01368965|100685069|FG000|COMPLETED|Overall Study||40||
48147771|NCT01368965|100685069|FG000|NOT COMPLETED|Overall Study||12||
48147772|NCT02747238|100685070|FG000|STARTED|Overall Study||12||
48147773|NCT02747238|100685071|FG001|STARTED|Overall Study||20||
48147774|NCT02747238|100685070|FG000|COMPLETED|Overall Study||9||
48603826|NCT01401543|101816163|FG003|NOT COMPLETED|First Washout Period of 1 Week||0||
48603827|NCT01401543|101816160|FG000|STARTED|Second Intervention||6||
48603828|NCT01401543|101816161|FG001|STARTED|Second Intervention||6||
48603829|NCT01401543|101816162|FG002|STARTED|Second Intervention||6||
48603830|NCT01401543|101816163|FG003|STARTED|Second Intervention||6||
48603831|NCT01401543|101816160|FG000|COMPLETED|Second Intervention||6||
48603832|NCT01401543|101816161|FG001|COMPLETED|Second Intervention||6||
48603833|NCT01401543|101816162|FG002|COMPLETED|Second Intervention||6||
48603834|NCT01401543|101816163|FG003|COMPLETED|Second Intervention||6||
48603835|NCT01401543|101816160|FG000|NOT COMPLETED|Second Intervention||0||
48603836|NCT01401543|101816161|FG001|NOT COMPLETED|Second Intervention||0||
48603837|NCT01401543|101816162|FG002|NOT COMPLETED|Second Intervention||0||
48603838|NCT01401543|101816163|FG003|NOT COMPLETED|Second Intervention||0||
48603839|NCT01401543|101816160|FG000|STARTED|Second Washout Period of 1 Week||6||
48603840|NCT01401543|101816161|FG001|STARTED|Second Washout Period of 1 Week||6||
48603841|NCT01401543|101816162|FG002|STARTED|Second Washout Period of 1 Week||6||
48603842|NCT01401543|101816163|FG003|STARTED|Second Washout Period of 1 Week||6||
48603843|NCT01401543|101816160|FG000|COMPLETED|Second Washout Period of 1 Week||6||
48603844|NCT01401543|101816161|FG001|COMPLETED|Second Washout Period of 1 Week||6||
48603845|NCT01401543|101816162|FG002|COMPLETED|Second Washout Period of 1 Week||6||
48603846|NCT01401543|101816163|FG003|COMPLETED|Second Washout Period of 1 Week||6||
48603847|NCT01401543|101816160|FG000|NOT COMPLETED|Second Washout Period of 1 Week||0||
48147775|NCT02747238|100685071|FG001|COMPLETED|Overall Study||14||
48603848|NCT01401543|101816161|FG001|NOT COMPLETED|Second Washout Period of 1 Week||0||
48603849|NCT01401543|101816162|FG002|NOT COMPLETED|Second Washout Period of 1 Week||0||
48603850|NCT01401543|101816163|FG003|NOT COMPLETED|Second Washout Period of 1 Week||0||
48603851|NCT01401543|101816160|FG000|STARTED|Third Intervention||6||
48603852|NCT01401543|101816161|FG001|STARTED|Third Intervention||6||
48147776|NCT02747238|100685070|FG000|NOT COMPLETED|Overall Study||3||
48147777|NCT02747238|100685071|FG001|NOT COMPLETED|Overall Study||6||
48147778|NCT00584727|100685072|FG000|STARTED|First Intervention||17||
48147779|NCT00584727|100685073|FG001|STARTED|First Intervention||17||
48147780|NCT00584727|100685074|FG002|STARTED|First Intervention||16||
48603853|NCT01401543|101816162|FG002|STARTED|Third Intervention||6||
48603854|NCT01401543|101816163|FG003|STARTED|Third Intervention||6||
48603855|NCT01401543|101816160|FG000|COMPLETED|Third Intervention||6||
48603856|NCT01401543|101816161|FG001|COMPLETED|Third Intervention||6||
48603857|NCT01401543|101816162|FG002|COMPLETED|Third Intervention||6||
48147781|NCT00584727|100685075|FG003|STARTED|First Intervention||14||
48147782|NCT00584727|100685076|FG004|STARTED|First Intervention||16||
48147783|NCT00584727|100685077|FG005|STARTED|First Intervention||16||
48147784|NCT00584727|100685072|FG000|COMPLETED|First Intervention||17||
48603858|NCT01401543|101816163|FG003|COMPLETED|Third Intervention||6||
48603859|NCT01401543|101816160|FG000|NOT COMPLETED|Third Intervention||0||
48603860|NCT01401543|101816161|FG001|NOT COMPLETED|Third Intervention||0||
48603861|NCT01401543|101816162|FG002|NOT COMPLETED|Third Intervention||0||
48603862|NCT01401543|101816163|FG003|NOT COMPLETED|Third Intervention||0||
48603863|NCT01401543|101816160|FG000|STARTED|Third Washout Period of 1 Week||6||
48603864|NCT01401543|101816161|FG001|STARTED|Third Washout Period of 1 Week||6||
48603865|NCT01401543|101816162|FG002|STARTED|Third Washout Period of 1 Week||6||
48603866|NCT01401543|101816163|FG003|STARTED|Third Washout Period of 1 Week||6||
48603867|NCT01401543|101816160|FG000|COMPLETED|Third Washout Period of 1 Week||6||
48603868|NCT01401543|101816161|FG001|COMPLETED|Third Washout Period of 1 Week||6||
48603869|NCT01401543|101816162|FG002|COMPLETED|Third Washout Period of 1 Week||6||
48603870|NCT01401543|101816163|FG003|COMPLETED|Third Washout Period of 1 Week||6||
48603871|NCT01401543|101816160|FG000|NOT COMPLETED|Third Washout Period of 1 Week||0||
48603872|NCT01401543|101816161|FG001|NOT COMPLETED|Third Washout Period of 1 Week||0||
48603873|NCT01401543|101816162|FG002|NOT COMPLETED|Third Washout Period of 1 Week||0||
48603874|NCT01401543|101816163|FG003|NOT COMPLETED|Third Washout Period of 1 Week||0||
48603875|NCT01401543|101816160|FG000|STARTED|Fourth Intervention||6||
48603876|NCT01401543|101816161|FG001|STARTED|Fourth Intervention||6||
48603877|NCT01401543|101816162|FG002|STARTED|Fourth Intervention||6||
48603878|NCT01401543|101816163|FG003|STARTED|Fourth Intervention||6||
48603879|NCT01401543|101816160|FG000|COMPLETED|Fourth Intervention||6||
48603880|NCT01401543|101816161|FG001|COMPLETED|Fourth Intervention||6||
48603881|NCT01401543|101816162|FG002|COMPLETED|Fourth Intervention||6||
48603882|NCT01401543|101816163|FG003|COMPLETED|Fourth Intervention||6||
48603883|NCT01401543|101816160|FG000|NOT COMPLETED|Fourth Intervention||0||
48603884|NCT01401543|101816161|FG001|NOT COMPLETED|Fourth Intervention||0||
48603885|NCT01401543|101816162|FG002|NOT COMPLETED|Fourth Intervention||0||
48603886|NCT01401543|101816163|FG003|NOT COMPLETED|Fourth Intervention||0||
48603887|NCT03529799|101816164|FG000|STARTED|Overall Study||14||
48603888|NCT03529799|101816165|FG001|STARTED|Overall Study||26||
48603889|NCT03529799|101816164|FG000|COMPLETED|Overall Study||14||
48603890|NCT03529799|101816165|FG001|COMPLETED|Overall Study||26||
48603891|NCT03529799|101816164|FG000|NOT COMPLETED|Overall Study||0||
48603892|NCT03529799|101816165|FG001|NOT COMPLETED|Overall Study||0||
48603893|NCT03326518|101816166|FG000|STARTED|Overall Study||19||
48603894|NCT03326518|101816167|FG001|STARTED|Overall Study||12||
48603895|NCT03326518|101816168|FG002|STARTED|Overall Study||14||
48603896|NCT03326518|101816166|FG000|COMPLETED|Overall Study||16||
48603897|NCT03326518|101816167|FG001|COMPLETED|Overall Study||12||
48603898|NCT03326518|101816168|FG002|COMPLETED|Overall Study||13||
48603899|NCT03326518|101816166|FG000|NOT COMPLETED|Overall Study||3||
48603900|NCT03326518|101816167|FG001|NOT COMPLETED|Overall Study||0||
48603901|NCT03326518|101816168|FG002|NOT COMPLETED|Overall Study||1||
48603902|NCT00433017|101816169|FG000|STARTED|Overall Study||122||
48603903|NCT00433017|101816170|FG001|STARTED|Overall Study||133||
48603904|NCT00433017|101816169|FG000|Completed 12 Month Phase|Overall Study||114||
48603905|NCT00433017|101816170|FG001|Completed 12 Month Phase|Overall Study||126||
48603906|NCT00433017|101816169|FG000|COMPLETED|Overall Study||26||
48603907|NCT00433017|101816170|FG001|COMPLETED|Overall Study||32||
48603908|NCT00433017|101816169|FG000|NOT COMPLETED|Overall Study||96||
48603909|NCT00433017|101816170|FG001|NOT COMPLETED|Overall Study||101||
48603910|NCT01375374|101816171|FG000|STARTED|Overall Study||11||
48603911|NCT01375374|101816171|FG000|COMPLETED|Overall Study||10||
48603912|NCT01375374|101816171|FG000|NOT COMPLETED|Overall Study||1||
48603913|NCT02797678|101816172|FG000|STARTED|Screening Phase||62||
48603914|NCT02797678|101816173|FG001|STARTED|Screening Phase||0||
48301841|NCT02291302|101069776|FG003|COMPLETED|Overall Study||59||
48301842|NCT02291302|101069773|FG000|NOT COMPLETED|Overall Study||0||
48301843|NCT02291302|101069774|FG001|NOT COMPLETED|Overall Study||0||
48301844|NCT02291302|101069775|FG002|NOT COMPLETED|Overall Study||0||
48301845|NCT02291302|101069776|FG003|NOT COMPLETED|Overall Study||0||
48301846|NCT02982187|101069777|FG000|STARTED|Overall Study||20||
48301847|NCT02982187|101069778|FG001|STARTED|Overall Study||20||
48301848|NCT02982187|101069779|FG002|STARTED|Overall Study||20||
48301849|NCT02982187|101069780|FG003|STARTED|Overall Study||20||
48301850|NCT02982187|101069781|FG004|STARTED|Overall Study||20||
48301851|NCT02982187|101069782|FG005|STARTED|Overall Study||20||
48301852|NCT02982187|101069783|FG006|STARTED|Overall Study||20||
48301853|NCT02982187|101069784|FG007|STARTED|Overall Study||20||
48301854|NCT02982187|101069777|FG000|COMPLETED|Overall Study||20||
48301855|NCT02982187|101069778|FG001|COMPLETED|Overall Study||20||
48301856|NCT02982187|101069779|FG002|COMPLETED|Overall Study||20||
48301857|NCT02982187|101069780|FG003|COMPLETED|Overall Study||20||
48301858|NCT02982187|101069781|FG004|COMPLETED|Overall Study||20||
48301859|NCT02982187|101069782|FG005|COMPLETED|Overall Study||20||
48301860|NCT02982187|101069783|FG006|COMPLETED|Overall Study||19||
48301861|NCT02982187|101069784|FG007|COMPLETED|Overall Study||20||
48301862|NCT02982187|101069777|FG000|NOT COMPLETED|Overall Study||0||
48301863|NCT02982187|101069778|FG001|NOT COMPLETED|Overall Study||0||
48301864|NCT02982187|101069779|FG002|NOT COMPLETED|Overall Study||0||
48301865|NCT02982187|101069780|FG003|NOT COMPLETED|Overall Study||0||
48301866|NCT02982187|101069781|FG004|NOT COMPLETED|Overall Study||0||
48301867|NCT02982187|101069782|FG005|NOT COMPLETED|Overall Study||0||
48301868|NCT02982187|101069783|FG006|NOT COMPLETED|Overall Study||1||
48301869|NCT02982187|101069784|FG007|NOT COMPLETED|Overall Study||0||
48301870|NCT01898689|101069785|FG000|STARTED|Overall Study||10||
48301871|NCT01898689|101069786|FG001|STARTED|Overall Study||14||
48301872|NCT01898689|101069785|FG000|COMPLETED|Overall Study||10||
48301873|NCT01898689|101069786|FG001|COMPLETED|Overall Study||14||
48301874|NCT01898689|101069785|FG000|NOT COMPLETED|Overall Study||0||
48301875|NCT01898689|101069786|FG001|NOT COMPLETED|Overall Study||0||
48301876|NCT02598557|101069787|FG000|STARTED|Overall Study||59||
48301877|NCT02598557|101069788|FG001|STARTED|Overall Study||58||
48301878|NCT02598557|101069789|FG002|STARTED|Overall Study||63||
48301879|NCT02598557|101069787|FG000|COMPLETED|Overall Study||55||
48301880|NCT02598557|101069788|FG001|COMPLETED|Overall Study||56||
48301881|NCT02598557|101069789|FG002|COMPLETED|Overall Study||60||
48147785|NCT00584727|100685073|FG001|COMPLETED|First Intervention||17||
48147786|NCT00584727|100685074|FG002|COMPLETED|First Intervention||15||
48147787|NCT00584727|100685075|FG003|COMPLETED|First Intervention||14||
48147788|NCT00584727|100685076|FG004|COMPLETED|First Intervention||16||
48147789|NCT00584727|100685077|FG005|COMPLETED|First Intervention||16||
48147790|NCT00584727|100685072|FG000|NOT COMPLETED|First Intervention||0||
48147791|NCT00584727|100685073|FG001|NOT COMPLETED|First Intervention||0||
48147792|NCT00584727|100685074|FG002|NOT COMPLETED|First Intervention||1||
48603915|NCT02797678|101816174|FG002|STARTED|Screening Phase||0||
48603916|NCT02797678|101816175|FG003|STARTED|Screening Phase||0||
48603917|NCT02797678|101816172|FG000|COMPLETED|Screening Phase||37||
48603918|NCT02797678|101816173|FG001|COMPLETED|Screening Phase||0||
48603919|NCT02797678|101816174|FG002|COMPLETED|Screening Phase||0||
48603920|NCT02797678|101816175|FG003|COMPLETED|Screening Phase||0||
48603921|NCT02797678|101816172|FG000|NOT COMPLETED|Screening Phase||25||
48603922|NCT02797678|101816173|FG001|NOT COMPLETED|Screening Phase||0||
48603923|NCT02797678|101816174|FG002|NOT COMPLETED|Screening Phase||0||
48603924|NCT02797678|101816175|FG003|NOT COMPLETED|Screening Phase||0||
48603925|NCT02797678|101816172|FG000|STARTED|First Intervention (5 Nights)||0||
48603926|NCT02797678|101816173|FG001|STARTED|First Intervention (5 Nights)||20||
48715404|NCT01439074|102088777|FG001|STARTED|Overall Study||87||
48715405|NCT01439074|102088776|FG000|COMPLETED|Overall Study||66||
48715406|NCT01439074|102088777|FG001|COMPLETED|Overall Study||74||
48715407|NCT01439074|102088776|FG000|NOT COMPLETED|Overall Study||9||
48715408|NCT01439074|102088777|FG001|NOT COMPLETED|Overall Study||13||
48715409|NCT00378599|102088778|FG000|STARTED|Overall Study||125||
48715410|NCT00378599|102088778|FG000|COMPLETED|Overall Study||73||
48715411|NCT00378599|102088778|FG000|NOT COMPLETED|Overall Study||52||
48715412|NCT01342549|102088779|FG000|STARTED|Overall Study||31||
48715413|NCT01342549|102088780|FG001|STARTED|Overall Study||31||
48715414|NCT01342549|102088779|FG000|COMPLETED|Overall Study||31||
48715415|NCT01342549|102088780|FG001|COMPLETED|Overall Study||31||
48715416|NCT01342549|102088779|FG000|NOT COMPLETED|Overall Study||0||
48715417|NCT01342549|102088780|FG001|NOT COMPLETED|Overall Study||0||
48715418|NCT02968381|102088781|FG000|STARTED|Overall Study||61||
48715419|NCT02968381|102088782|FG001|STARTED|Overall Study||60||
48715420|NCT02968381|102088781|FG000|COMPLETED|Overall Study||56||
48715421|NCT02968381|102088782|FG001|COMPLETED|Overall Study||50||
48715422|NCT02968381|102088781|FG000|NOT COMPLETED|Overall Study||5||
48715423|NCT02968381|102088782|FG001|NOT COMPLETED|Overall Study||10||
48715424|NCT01246479|102088783|FG000|STARTED|Overall Study||23||
48715425|NCT01246479|102088783|FG000|COMPLETED|Overall Study||18||
48715426|NCT01246479|102088783|FG000|NOT COMPLETED|Overall Study||5||
48715427|NCT04332614|102088784|FG000|STARTED|~1 Week After Study Launch||2350|Randomized and attempted to email|
48715428|NCT04332614|102088785|FG001|STARTED|~1 Week After Study Launch||2350|Randomized and attempted to email|
48715429|NCT04332614|102088786|FG002|STARTED|~1 Week After Study Launch||2350|Randomized and attempted to email|
48715430|NCT04332614|102088787|FG003|STARTED|~1 Week After Study Launch||2350|Randomized and attempted to email|
48715431|NCT04332614|102088788|FG004|STARTED|~1 Week After Study Launch||2350|Randomized and attempted to email|
48715432|NCT04332614|102088789|FG005|STARTED|~1 Week After Study Launch||2349|Randomized and attempted to email|
48715433|NCT04332614|102088784|FG000|Data in EHR|~1 Week After Study Launch||2245|Patient was found in Electronic Health Record \~1 week after intervention|
48715434|NCT04332614|102088785|FG001|Data in EHR|~1 Week After Study Launch||2273|Patient was found in Electronic Health Record \~1 week after intervention|
48715435|NCT04332614|102088786|FG002|Data in EHR|~1 Week After Study Launch||2251|Patient was found in Electronic Health Record \~1 week after intervention|
48715436|NCT04332614|102088787|FG003|Data in EHR|~1 Week After Study Launch||2254|Patient was found in Electronic Health Record \~1 week after intervention|
48715437|NCT04332614|102088788|FG004|Data in EHR|~1 Week After Study Launch||2251|Patient was found in Electronic Health Record \~1 week after intervention|
48715438|NCT04332614|102088789|FG005|Data in EHR|~1 Week After Study Launch||2249|Patient was found in Electronic Health Record \~1 week after intervention|
48715439|NCT04332614|102088784|FG000|COMPLETED|~1 Week After Study Launch||2117|Email delivered (did not bounce back)|
48715440|NCT04332614|102088785|FG001|COMPLETED|~1 Week After Study Launch||2129|Email delivered (did not bounce back)|
48715441|NCT04332614|102088786|FG002|COMPLETED|~1 Week After Study Launch||2124|Email delivered (did not bounce back)|
48715442|NCT04332614|102088787|FG003|COMPLETED|~1 Week After Study Launch||2131|Email delivered (did not bounce back)|
48715443|NCT04332614|102088788|FG004|COMPLETED|~1 Week After Study Launch||2127|Email delivered (did not bounce back)|
48715444|NCT04332614|102088789|FG005|COMPLETED|~1 Week After Study Launch||2115|Email delivered (did not bounce back)|
48715445|NCT04332614|102088784|FG000|NOT COMPLETED|~1 Week After Study Launch||233||
48715446|NCT04332614|102088785|FG001|NOT COMPLETED|~1 Week After Study Launch||221||
48715447|NCT04332614|102088786|FG002|NOT COMPLETED|~1 Week After Study Launch||226||
48715448|NCT04332614|102088787|FG003|NOT COMPLETED|~1 Week After Study Launch||219||
48715449|NCT04332614|102088788|FG004|NOT COMPLETED|~1 Week After Study Launch||223||
48715450|NCT04332614|102088789|FG005|NOT COMPLETED|~1 Week After Study Launch||234||
48147793|NCT00584727|100685075|FG003|NOT COMPLETED|First Intervention||0||
48603927|NCT02797678|101816174|FG002|STARTED|First Intervention (5 Nights)||17||
48603928|NCT02797678|101816175|FG003|STARTED|First Intervention (5 Nights)||0||
48147794|NCT00584727|100685076|FG004|NOT COMPLETED|First Intervention||0||
48603929|NCT02797678|101816172|FG000|COMPLETED|First Intervention (5 Nights)||0||
48301882|NCT02598557|101069787|FG000|NOT COMPLETED|Overall Study||4||
48301883|NCT02598557|101069788|FG001|NOT COMPLETED|Overall Study||2||
48301884|NCT02598557|101069789|FG002|NOT COMPLETED|Overall Study||3||
48603930|NCT02797678|101816173|FG001|COMPLETED|First Intervention (5 Nights)||19||
48603931|NCT02797678|101816174|FG002|COMPLETED|First Intervention (5 Nights)||17||
48603932|NCT02797678|101816175|FG003|COMPLETED|First Intervention (5 Nights)||0||
48603933|NCT02797678|101816172|FG000|NOT COMPLETED|First Intervention (5 Nights)||0||
48301885|NCT01008696|101069790|FG000|STARTED|Overall Study||108||
48301886|NCT01008696|101069791|FG001|STARTED|Overall Study||109||
48301887|NCT01008696|101069790|FG000|COMPLETED|Overall Study||91||
48301888|NCT01008696|101069791|FG001|COMPLETED|Overall Study||92||
48301889|NCT01008696|101069790|FG000|NOT COMPLETED|Overall Study||17||
48301890|NCT01008696|101069791|FG001|NOT COMPLETED|Overall Study||17||
48301891|NCT00705432|101069792|FG000|STARTED|Treatment Period||311||
48301892|NCT00705432|101069793|FG001|STARTED|Treatment Period||316||
48301893|NCT00705432|101069794|FG002|STARTED|Treatment Period||311||
48301894|NCT00705432|101069795|FG003|STARTED|Treatment Period||52||
48301895|NCT00705432|101069796|FG004|STARTED|Treatment Period||52||
48301896|NCT00705432|101069797|FG005|STARTED|Treatment Period||55||
48301897|NCT00705432|101069792|FG000|STARTED BOCEPREVIR/PLACEBO|Treatment Period||297||
48301898|NCT00705432|101069793|FG001|STARTED BOCEPREVIR/PLACEBO|Treatment Period||303||
48301899|NCT00705432|101069794|FG002|STARTED BOCEPREVIR/PLACEBO|Treatment Period||299||
48301900|NCT00705432|101069795|FG003|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47||
48301901|NCT00705432|101069796|FG004|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47||
48301902|NCT00705432|101069797|FG005|STARTED BOCEPREVIR/PLACEBO|Treatment Period||55||
48301903|NCT00705432|101069792|FG000|COMPLETED|Treatment Period||148||
48301904|NCT00705432|101069793|FG001|COMPLETED|Treatment Period||205||
48301905|NCT00705432|101069794|FG002|COMPLETED|Treatment Period||190||
48301906|NCT00705432|101069795|FG003|COMPLETED|Treatment Period||11||
48301907|NCT00705432|101069796|FG004|COMPLETED|Treatment Period||24||
48603934|NCT02797678|101816173|FG001|NOT COMPLETED|First Intervention (5 Nights)||1||
48603935|NCT02797678|101816174|FG002|NOT COMPLETED|First Intervention (5 Nights)||0||
48603936|NCT02797678|101816175|FG003|NOT COMPLETED|First Intervention (5 Nights)||0||
48603937|NCT02797678|101816172|FG000|STARTED|Washout||0||
48603938|NCT02797678|101816173|FG001|STARTED|Washout||19||
48715451|NCT04332614|102088784|FG000|STARTED|~1 Month After Study Launch||2117||
48715452|NCT04332614|102088785|FG001|STARTED|~1 Month After Study Launch||2129||
48715453|NCT04332614|102088786|FG002|STARTED|~1 Month After Study Launch||2124||
48715454|NCT04332614|102088787|FG003|STARTED|~1 Month After Study Launch||2131||
48715455|NCT04332614|102088788|FG004|STARTED|~1 Month After Study Launch||2127||
48715456|NCT04332614|102088789|FG005|STARTED|~1 Month After Study Launch||2115||
48715457|NCT04332614|102088784|FG000|COMPLETED|~1 Month After Study Launch||2095|Record was found in EHR \~1 month after intervention AND email was delivered (did not bounce back)|
48715458|NCT04332614|102088785|FG001|COMPLETED|~1 Month After Study Launch||2107|Record was found in EHR \~1 month after intervention AND email was delivered (did not bounce back)|
48715459|NCT04332614|102088786|FG002|COMPLETED|~1 Month After Study Launch||2094|Record was found in EHR \~1 month after intervention AND email was delivered (did not bounce back)|
48715460|NCT04332614|102088787|FG003|COMPLETED|~1 Month After Study Launch||2107|Record was found in EHR \~1 month after intervention AND email was delivered (did not bounce back)|
48715461|NCT04332614|102088788|FG004|COMPLETED|~1 Month After Study Launch||2107|Record was found in EHR \~1 month after intervention AND email was delivered (did not bounce back)|
48715462|NCT04332614|102088789|FG005|COMPLETED|~1 Month After Study Launch||2096|Record was found in EHR \~1 month after intervention AND email was delivered (did not bounce back)|
48715463|NCT04332614|102088784|FG000|NOT COMPLETED|~1 Month After Study Launch||22||
48715464|NCT04332614|102088785|FG001|NOT COMPLETED|~1 Month After Study Launch||22||
48715465|NCT04332614|102088786|FG002|NOT COMPLETED|~1 Month After Study Launch||30||
48715466|NCT04332614|102088787|FG003|NOT COMPLETED|~1 Month After Study Launch||24||
48715467|NCT04332614|102088788|FG004|NOT COMPLETED|~1 Month After Study Launch||20||
48715468|NCT04332614|102088789|FG005|NOT COMPLETED|~1 Month After Study Launch||19||
48715469|NCT00996801|102088790|FG000|STARTED|Overall Study||88||
48715470|NCT00996801|102088791|FG001|STARTED|Overall Study||88||
48715471|NCT00996801|102088792|FG002|STARTED|Overall Study||88||
48715472|NCT00996801|102088793|FG003|STARTED|Overall Study||87||
48715473|NCT00996801|102088794|FG004|STARTED|Overall Study||88||
48715474|NCT00996801|102088795|FG005|STARTED|Overall Study||87||
48715475|NCT00996801|102088790|FG000|COMPLETED|Overall Study||68||
48715476|NCT00996801|102088791|FG001|COMPLETED|Overall Study||72||
48715477|NCT00996801|102088792|FG002|COMPLETED|Overall Study||65||
48715478|NCT00996801|102088793|FG003|COMPLETED|Overall Study||56||
48715479|NCT00996801|102088794|FG004|COMPLETED|Overall Study||0||
48715480|NCT00996801|102088795|FG005|COMPLETED|Overall Study||68||
48301908|NCT00705432|101069797|FG005|COMPLETED|Treatment Period||25||
48301909|NCT00705432|101069792|FG000|NOT COMPLETED|Treatment Period||163||
48301910|NCT00705432|101069793|FG001|NOT COMPLETED|Treatment Period||111||
48301911|NCT00705432|101069794|FG002|NOT COMPLETED|Treatment Period||121||
48301912|NCT00705432|101069795|FG003|NOT COMPLETED|Treatment Period||41||
48301913|NCT00705432|101069796|FG004|NOT COMPLETED|Treatment Period||28||
48603939|NCT02797678|101816174|FG002|STARTED|Washout||17||
48603940|NCT02797678|101816175|FG003|STARTED|Washout||0||
48301914|NCT00705432|101069797|FG005|NOT COMPLETED|Treatment Period||30||
48301915|NCT00705432|101069792|FG000|STARTED|Follow-up Period (Upto Week 72)||278||
48301916|NCT00705432|101069793|FG001|STARTED|Follow-up Period (Upto Week 72)||295||
48301917|NCT00705432|101069794|FG002|STARTED|Follow-up Period (Upto Week 72)||291||
48301918|NCT00705432|101069795|FG003|STARTED|Follow-up Period (Upto Week 72)||42||
48301919|NCT00705432|101069796|FG004|STARTED|Follow-up Period (Upto Week 72)||44||
48301920|NCT00705432|101069797|FG005|STARTED|Follow-up Period (Upto Week 72)||53||
48301921|NCT00705432|101069792|FG000|COMPLETED|Follow-up Period (Upto Week 72)||207||
48301922|NCT00705432|101069793|FG001|COMPLETED|Follow-up Period (Upto Week 72)||252||
48301923|NCT00705432|101069794|FG002|COMPLETED|Follow-up Period (Upto Week 72)||266||
48301924|NCT00705432|101069795|FG003|COMPLETED|Follow-up Period (Upto Week 72)||28||
48301925|NCT00705432|101069796|FG004|COMPLETED|Follow-up Period (Upto Week 72)||38||
48301926|NCT00705432|101069797|FG005|COMPLETED|Follow-up Period (Upto Week 72)||46||
48405313|NCT00533351|101325251|FG001|NOT COMPLETED|Period 1||1||
48405314|NCT00533351|101325250|FG000|STARTED|Period 2||5||
48301927|NCT00705432|101069792|FG000|NOT COMPLETED|Follow-up Period (Upto Week 72)||71||
48301928|NCT00705432|101069793|FG001|NOT COMPLETED|Follow-up Period (Upto Week 72)||43||
48301929|NCT00705432|101069794|FG002|NOT COMPLETED|Follow-up Period (Upto Week 72)||25||
48301930|NCT00705432|101069795|FG003|NOT COMPLETED|Follow-up Period (Upto Week 72)||14||
48301931|NCT00705432|101069796|FG004|NOT COMPLETED|Follow-up Period (Upto Week 72)||6||
48301932|NCT00705432|101069797|FG005|NOT COMPLETED|Follow-up Period (Upto Week 72)||7||
48301933|NCT00148954|101069798|FG000|STARTED|Overall Study||985||
48301934|NCT00148954|101069799|FG001|STARTED|Overall Study||977||
48301935|NCT00148954|101069798|FG000|COMPLETED|Overall Study||678||
48301936|NCT00148954|101069799|FG001|COMPLETED|Overall Study||677||
48301937|NCT00148954|101069798|FG000|NOT COMPLETED|Overall Study||307||
48301938|NCT00148954|101069799|FG001|NOT COMPLETED|Overall Study||300||
48301939|NCT03037619|101069800|FG000|STARTED|Overall Study||8||
48301940|NCT03037619|101069801|FG001|STARTED|Overall Study||15||
48301941|NCT03037619|101069800|FG000|COMPLETED|Overall Study||8||
48301942|NCT03037619|101069801|FG001|COMPLETED|Overall Study||14||
48301943|NCT03037619|101069800|FG000|NOT COMPLETED|Overall Study||0||
48301944|NCT03037619|101069801|FG001|NOT COMPLETED|Overall Study||1||
48301945|NCT03503513|101069802|FG000|STARTED|Overall Study||23||
48301946|NCT03503513|101069802|FG000|Began Treatment|Overall Study||19||
48301947|NCT03503513|101069802|FG000|Completed More Than 4 Months of Treatment|Overall Study||12||
48603941|NCT02797678|101816172|FG000|COMPLETED|Washout||0||
48603942|NCT02797678|101816173|FG001|COMPLETED|Washout||19||
48603943|NCT02797678|101816174|FG002|COMPLETED|Washout||17||
48603944|NCT02797678|101816175|FG003|COMPLETED|Washout||0||
48603945|NCT02797678|101816172|FG000|NOT COMPLETED|Washout||0||
48603946|NCT02797678|101816173|FG001|NOT COMPLETED|Washout||0||
48603947|NCT02797678|101816174|FG002|NOT COMPLETED|Washout||0||
48603948|NCT02797678|101816175|FG003|NOT COMPLETED|Washout||0||
48603949|NCT02797678|101816172|FG000|STARTED|Second Intervention (5 Nights)||0||
48603950|NCT02797678|101816173|FG001|STARTED|Second Intervention (5 Nights)||19||
48603951|NCT02797678|101816174|FG002|STARTED|Second Intervention (5 Nights)||17||
48603952|NCT02797678|101816175|FG003|STARTED|Second Intervention (5 Nights)||0||
48603953|NCT02797678|101816172|FG000|COMPLETED|Second Intervention (5 Nights)||0||
48603954|NCT02797678|101816173|FG001|COMPLETED|Second Intervention (5 Nights)||19||
48603955|NCT02797678|101816174|FG002|COMPLETED|Second Intervention (5 Nights)||16||
48603956|NCT02797678|101816175|FG003|COMPLETED|Second Intervention (5 Nights)||0||
48603957|NCT02797678|101816172|FG000|NOT COMPLETED|Second Intervention (5 Nights)||0||
48603958|NCT02797678|101816173|FG001|NOT COMPLETED|Second Intervention (5 Nights)||0||
48603959|NCT02797678|101816174|FG002|NOT COMPLETED|Second Intervention (5 Nights)||1||
48603960|NCT02797678|101816175|FG003|NOT COMPLETED|Second Intervention (5 Nights)||0||
48603961|NCT02797678|101816172|FG000|STARTED|Sub-Study||0||
48603962|NCT02797678|101816173|FG001|STARTED|Sub-Study||0||
48603963|NCT02797678|101816174|FG002|STARTED|Sub-Study||0||
48603964|NCT02797678|101816175|FG003|STARTED|Sub-Study||9||
48603965|NCT02797678|101816172|FG000|COMPLETED|Sub-Study||0||
48603966|NCT02797678|101816173|FG001|COMPLETED|Sub-Study||0||
48603967|NCT02797678|101816174|FG002|COMPLETED|Sub-Study||0||
48603968|NCT02797678|101816175|FG003|COMPLETED|Sub-Study||9||
48603969|NCT02797678|101816172|FG000|NOT COMPLETED|Sub-Study||0||
48603970|NCT02797678|101816173|FG001|NOT COMPLETED|Sub-Study||0||
48603971|NCT02797678|101816174|FG002|NOT COMPLETED|Sub-Study||0||
48603972|NCT02797678|101816175|FG003|NOT COMPLETED|Sub-Study||0||
48603973|NCT04571385|101816176|FG000|STARTED|Overall Study||27||
48603974|NCT04571385|101816177|FG001|STARTED|Overall Study||16||
48603975|NCT04571385|101816178|FG002|STARTED|Overall Study||23||
48603976|NCT04571385|101816176|FG000|Part 1|Overall Study||16||
48603977|NCT04571385|101816177|FG001|Part 1|Overall Study||16||
48603978|NCT04571385|101816178|FG002|Part 1|Overall Study||0||
48603979|NCT04571385|101816176|FG000|Part 2|Overall Study||11||
48603980|NCT04571385|101816177|FG001|Part 2|Overall Study||0||
48603981|NCT04571385|101816178|FG002|Part 2|Overall Study||23||
48603982|NCT04571385|101816176|FG000|Full Analysis Set (FAS)|Overall Study||25|Full Analysis Set included all randomized participants who were administered double-blind study treatment and had an evaluable Atrial Fibrillation conversion status within 90 minutes from the start of infusion.|
48603983|NCT04571385|101816177|FG001|Full Analysis Set (FAS)|Overall Study||12|Full Analysis Set included all randomized participants who were administered double-blind study treatment and had an evaluable Atrial Fibrillation conversion status within 90 minutes from the start of infusion.|
48603984|NCT04571385|101816178|FG002|Full Analysis Set (FAS)|Overall Study||22|Full Analysis Set included all randomized participants who were administered double-blind study treatment and had an evaluable Atrial Fibrillation conversion status within 90 minutes from the start of infusion.|
48603985|NCT04571385|101816176|FG000|Safety Set|Overall Study||26|Safety set included all randomized participants who were administered double-blind study treatment and had analyzed according to the treatment received.|
48603986|NCT04571385|101816177|FG001|Safety Set|Overall Study||15|Safety set included all randomized participants who were administered double-blind study treatment and had analyzed according to the treatment received.|
48603987|NCT04571385|101816178|FG002|Safety Set|Overall Study||22|Safety set included all randomized participants who were administered double-blind study treatment and had analyzed according to the treatment received.|
48301948|NCT03503513|101069802|FG000|COMPLETED|Overall Study||11||
48301949|NCT03503513|101069802|FG000|NOT COMPLETED|Overall Study||12||
48301950|NCT02401412|101069803|FG000|STARTED|Overall Study||89||
48301951|NCT02401412|101069804|FG001|STARTED|Overall Study||81||
48301952|NCT02401412|101069803|FG000|Received Study Device|Overall Study||89||
48301953|NCT02401412|101069804|FG001|Received Study Device|Overall Study||80||
48301954|NCT02401412|101069803|FG000|COMPLETED|Overall Study||59||
48301955|NCT02401412|101069804|FG001|COMPLETED|Overall Study||49||
48301956|NCT02401412|101069803|FG000|NOT COMPLETED|Overall Study||30||
48301957|NCT02401412|101069804|FG001|NOT COMPLETED|Overall Study||32||
48301958|NCT01309230|101069805|FG000|STARTED|Overall Study||28||
48301959|NCT01309230|101069806|FG001|STARTED|Overall Study||11||
48301960|NCT01309230|101069805|FG000|COMPLETED|Overall Study||28||
48301961|NCT01309230|101069806|FG001|COMPLETED|Overall Study||7||
48301962|NCT01309230|101069805|FG000|NOT COMPLETED|Overall Study||0||
48301963|NCT01309230|101069806|FG001|NOT COMPLETED|Overall Study||4||
48301964|NCT00201838|101069807|FG000|STARTED|Overall Study||30||
48301965|NCT00201838|101069808|FG001|STARTED|Overall Study||8||
48301966|NCT00201838|101069807|FG000|Treatment Cohort|Overall Study||30||
48301967|NCT00201838|101069808|FG001|Treatment Cohort|Overall Study||8||
48301968|NCT00201838|101069807|FG000|COMPLETED|Overall Study||30||
48301969|NCT00201838|101069808|FG001|COMPLETED|Overall Study||8||
48301970|NCT00201838|101069807|FG000|NOT COMPLETED|Overall Study||0||
48301971|NCT00201838|101069808|FG001|NOT COMPLETED|Overall Study||0||
48301972|NCT01990534|101069809|FG000|STARTED|Overall Study||60||
48301973|NCT01990534|101069809|FG000|COMPLETED|Overall Study||25||
48301974|NCT01990534|101069809|FG000|NOT COMPLETED|Overall Study||35||
48301975|NCT01526551|101069810|FG000|STARTED|Overall Study||935||
48715481|NCT00996801|102088790|FG000|NOT COMPLETED|Overall Study||20||
48715482|NCT00996801|102088791|FG001|NOT COMPLETED|Overall Study||16||
48301976|NCT01526551|101069810|FG000|COMPLETED|Overall Study||511||
48301977|NCT01526551|101069810|FG000|NOT COMPLETED|Overall Study||424||
48301978|NCT01810016|101069811|FG000|STARTED|Overall Study||5||
48301979|NCT01810016|101069812|FG001|STARTED|Overall Study||2||
48301980|NCT01810016|101069813|FG002|STARTED|Overall Study||1||
48301981|NCT01810016|101069811|FG000|COMPLETED|Overall Study||4||
48301982|NCT01810016|101069812|FG001|COMPLETED|Overall Study||1||
48301983|NCT01810016|101069813|FG002|COMPLETED|Overall Study||0||
48301984|NCT01810016|101069811|FG000|NOT COMPLETED|Overall Study||1||
48301985|NCT01810016|101069812|FG001|NOT COMPLETED|Overall Study||1||
48301986|NCT01810016|101069813|FG002|NOT COMPLETED|Overall Study||1||
48301987|NCT00907257|101069814|FG000|STARTED|Overall Study||123||
48301988|NCT00907257|101069815|FG001|STARTED|Overall Study||124||
48301989|NCT00907257|101069814|FG000|COMPLETED|Overall Study||110||
48301990|NCT00907257|101069815|FG001|COMPLETED|Overall Study||112||
48301991|NCT00907257|101069814|FG000|NOT COMPLETED|Overall Study||13||
48301992|NCT00907257|101069815|FG001|NOT COMPLETED|Overall Study||12||
48301993|NCT00536809|101069816|FG000|STARTED|Phase I (Dose-finding Phase)||10||
48301994|NCT00536809|101069816|FG000|COMPLETED|Phase I (Dose-finding Phase)||10||
48301995|NCT00536809|101069816|FG000|NOT COMPLETED|Phase I (Dose-finding Phase)||0||
48301996|NCT00536809|101069816|FG000|STARTED|Phase II||2||
48301997|NCT00536809|101069816|FG000|COMPLETED|Phase II||0||
48301998|NCT00536809|101069816|FG000|NOT COMPLETED|Phase II||2||
48301999|NCT00261846|101069817|FG000|STARTED|Period 1: Part 1 (Dose Escalation)||3||
48302000|NCT00261846|101069818|FG001|STARTED|Period 1: Part 1 (Dose Escalation)||3||
48302001|NCT00261846|101069819|FG002|STARTED|Period 1: Part 1 (Dose Escalation)||12||
48302002|NCT00261846|101069820|FG003|STARTED|Period 1: Part 1 (Dose Escalation)||0||
48302003|NCT00261846|101069821|FG004|STARTED|Period 1: Part 1 (Dose Escalation)||0||
48302004|NCT00261846|101069822|FG005|STARTED|Period 1: Part 1 (Dose Escalation)||0||
48302005|NCT00261846|101069823|FG006|STARTED|Period 1: Part 1 (Dose Escalation)||0||
48302006|NCT00261846|101069824|FG007|STARTED|Period 1: Part 1 (Dose Escalation)||0||
48302007|NCT00261846|101069825|FG008|STARTED|Period 1: Part 1 (Dose Escalation)||0||
48302008|NCT00261846|101069826|FG009|STARTED|Period 1: Part 1 (Dose Escalation)||0||
48302009|NCT00261846|101069827|FG010|STARTED|Period 1: Part 1 (Dose Escalation)||0||
48302010|NCT00261846|101069828|FG011|STARTED|Period 1: Part 1 (Dose Escalation)||0||
48302011|NCT00261846|101069817|FG000|COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
48302012|NCT00261846|101069818|FG001|COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
48302013|NCT00261846|101069819|FG002|COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
48302014|NCT00261846|101069820|FG003|COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
48302015|NCT00261846|101069821|FG004|COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
48302016|NCT00261846|101069822|FG005|COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
48302017|NCT00261846|101069823|FG006|COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
48302018|NCT00261846|101069824|FG007|COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
48302019|NCT00261846|101069825|FG008|COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
48302020|NCT00261846|101069826|FG009|COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
48302021|NCT00261846|101069827|FG010|COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
48302022|NCT00261846|101069828|FG011|COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
48302023|NCT00261846|101069817|FG000|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3||
48302024|NCT00261846|101069818|FG001|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3||
48302025|NCT00261846|101069819|FG002|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||12||
48715483|NCT00996801|102088792|FG002|NOT COMPLETED|Overall Study||23||
48715484|NCT00996801|102088793|FG003|NOT COMPLETED|Overall Study||31||
48603988|NCT04571385|101816176|FG000|Pharmacokinetic (PK) Set|Overall Study||0|The Pharmacokinetic Set included all participants in the Safety Set who had at least one evaluable post-baseline drug concentration value.|
48603989|NCT04571385|101816177|FG001|Pharmacokinetic (PK) Set|Overall Study||15|The Pharmacokinetic Set included all participants in the Safety Set who had at least one evaluable post-baseline drug concentration value.|
48603990|NCT04571385|101816178|FG002|Pharmacokinetic (PK) Set|Overall Study||22|The Pharmacokinetic Set included all participants in the Safety Set who had at least one evaluable post-baseline drug concentration value.|
48603991|NCT04571385|101816176|FG000|Treated|Overall Study||26||
48603992|NCT04571385|101816177|FG001|Treated|Overall Study||15||
48603993|NCT04571385|101816178|FG002|Treated|Overall Study||22||
48603994|NCT04571385|101816176|FG000|COMPLETED|Overall Study||26||
48603995|NCT04571385|101816177|FG001|COMPLETED|Overall Study||15||
48603996|NCT04571385|101816178|FG002|COMPLETED|Overall Study||22||
48603997|NCT04571385|101816176|FG000|NOT COMPLETED|Overall Study||1||
48603998|NCT04571385|101816177|FG001|NOT COMPLETED|Overall Study||1||
48603999|NCT04571385|101816178|FG002|NOT COMPLETED|Overall Study||1||
48604000|NCT03634813|101816179|FG000|STARTED|Overall Study||49||
48604001|NCT03634813|101816180|FG001|STARTED|Overall Study||51||
48604002|NCT03634813|101816179|FG000|COMPLETED|Overall Study||49||
48604003|NCT03634813|101816180|FG001|COMPLETED|Overall Study||51||
48604004|NCT03634813|101816179|FG000|NOT COMPLETED|Overall Study||0||
48604005|NCT03634813|101816180|FG001|NOT COMPLETED|Overall Study||0||
48302026|NCT00261846|101069820|FG003|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
48302027|NCT00261846|101069821|FG004|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
48302028|NCT00261846|101069822|FG005|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
48302029|NCT00261846|101069823|FG006|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
48302030|NCT00261846|101069824|FG007|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
48302031|NCT00261846|101069825|FG008|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
48302032|NCT00261846|101069826|FG009|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
48302033|NCT00261846|101069827|FG010|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
48302034|NCT00261846|101069828|FG011|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
48302035|NCT00261846|101069817|FG000|STARTED|Period 2: Part 2 (Efficacy)||0||
48302036|NCT00261846|101069818|FG001|STARTED|Period 2: Part 2 (Efficacy)||0||
48302037|NCT00261846|101069819|FG002|STARTED|Period 2: Part 2 (Efficacy)||0||
48302038|NCT00261846|101069820|FG003|STARTED|Period 2: Part 2 (Efficacy)||195||
48302039|NCT00261846|101069821|FG004|STARTED|Period 2: Part 2 (Efficacy)||89||
48302040|NCT00261846|101069822|FG005|STARTED|Period 2: Part 2 (Efficacy)||5||
48302041|NCT00261846|101069823|FG006|STARTED|Period 2: Part 2 (Efficacy)||38||
48302042|NCT00261846|101069824|FG007|STARTED|Period 2: Part 2 (Efficacy)||50||
48302043|NCT00261846|101069825|FG008|STARTED|Period 2: Part 2 (Efficacy)||26||
48302044|NCT00261846|101069826|FG009|STARTED|Period 2: Part 2 (Efficacy)||79||
48302045|NCT00261846|101069827|FG010|STARTED|Period 2: Part 2 (Efficacy)||64||
48302046|NCT00261846|101069828|FG011|STARTED|Period 2: Part 2 (Efficacy)||24||
48302047|NCT00261846|101069817|FG000|COMPLETED|Period 2: Part 2 (Efficacy)||0||
48302048|NCT00261846|101069818|FG001|COMPLETED|Period 2: Part 2 (Efficacy)||0||
48302049|NCT00261846|101069819|FG002|COMPLETED|Period 2: Part 2 (Efficacy)||0||
48302050|NCT00261846|101069820|FG003|COMPLETED|Period 2: Part 2 (Efficacy)||60||
48302051|NCT00261846|101069821|FG004|COMPLETED|Period 2: Part 2 (Efficacy)||39||
48302052|NCT00261846|101069822|FG005|COMPLETED|Period 2: Part 2 (Efficacy)||3||
48302053|NCT00261846|101069823|FG006|COMPLETED|Period 2: Part 2 (Efficacy)||16||
48302054|NCT00261846|101069824|FG007|COMPLETED|Period 2: Part 2 (Efficacy)||21||
48302055|NCT00261846|101069825|FG008|COMPLETED|Period 2: Part 2 (Efficacy)||12||
48302056|NCT00261846|101069826|FG009|COMPLETED|Period 2: Part 2 (Efficacy)||30||
48302057|NCT00261846|101069827|FG010|COMPLETED|Period 2: Part 2 (Efficacy)||15||
48302058|NCT00261846|101069828|FG011|COMPLETED|Period 2: Part 2 (Efficacy)||1||
48302059|NCT00261846|101069817|FG000|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0||
48604006|NCT05656885|101816181|FG000|STARTED|Period 1: Lens A, 15 Minutes||40||
48147795|NCT00584727|100685077|FG005|NOT COMPLETED|First Intervention||0||
48147796|NCT00584727|100685072|FG000|STARTED|Second Intervention||17||
48302060|NCT00261846|101069818|FG001|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0||
48302061|NCT00261846|101069819|FG002|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0||
48302062|NCT00261846|101069820|FG003|NOT COMPLETED|Period 2: Part 2 (Efficacy)||135||
48302063|NCT00261846|101069821|FG004|NOT COMPLETED|Period 2: Part 2 (Efficacy)||50||
48302064|NCT00261846|101069822|FG005|NOT COMPLETED|Period 2: Part 2 (Efficacy)||2||
48302065|NCT00261846|101069823|FG006|NOT COMPLETED|Period 2: Part 2 (Efficacy)||22||
48302066|NCT00261846|101069824|FG007|NOT COMPLETED|Period 2: Part 2 (Efficacy)||29||
48302067|NCT00261846|101069825|FG008|NOT COMPLETED|Period 2: Part 2 (Efficacy)||14||
48302068|NCT00261846|101069826|FG009|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49||
48302069|NCT00261846|101069827|FG010|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49||
48302070|NCT00261846|101069828|FG011|NOT COMPLETED|Period 2: Part 2 (Efficacy)||23||
48302071|NCT01032382|101069829|FG000|STARTED|Overall Study||16||
48302072|NCT01032382|101069830|FG001|STARTED|Overall Study||14||
48302073|NCT01032382|101069829|FG000|COMPLETED|Overall Study||11||
48302074|NCT01032382|101069830|FG001|COMPLETED|Overall Study||9||
48302075|NCT01032382|101069829|FG000|NOT COMPLETED|Overall Study||5||
48302076|NCT01032382|101069830|FG001|NOT COMPLETED|Overall Study||5||
48604007|NCT05656885|101816182|FG001|STARTED|Period 1: Lens A, 15 Minutes||0||
48604008|NCT05656885|101816181|FG000|COMPLETED|Period 1: Lens A, 15 Minutes||40||
48604009|NCT05656885|101816182|FG001|COMPLETED|Period 1: Lens A, 15 Minutes||0||
48604010|NCT05656885|101816181|FG000|NOT COMPLETED|Period 1: Lens A, 15 Minutes||0||
48604011|NCT05656885|101816182|FG001|NOT COMPLETED|Period 1: Lens A, 15 Minutes||0||
48604012|NCT05656885|101816181|FG000|STARTED|Period 2: Lens B, 15 Minutes||0||
48302077|NCT03030235|101069831|FG000|STARTED|Overall Study||162||
48302078|NCT03030235|101069832|FG001|STARTED|Overall Study||162||
48302079|NCT03030235|101069831|FG000|COMPLETED|Overall Study||146||
48302080|NCT03030235|101069832|FG001|COMPLETED|Overall Study||145||
48302081|NCT03030235|101069831|FG000|NOT COMPLETED|Overall Study||16||
48302082|NCT03030235|101069832|FG001|NOT COMPLETED|Overall Study||17||
48604013|NCT05656885|101816182|FG001|STARTED|Period 2: Lens B, 15 Minutes||40||
48604014|NCT05656885|101816181|FG000|COMPLETED|Period 2: Lens B, 15 Minutes||0||
48604015|NCT05656885|101816182|FG001|COMPLETED|Period 2: Lens B, 15 Minutes||40||
48604016|NCT05656885|101816181|FG000|NOT COMPLETED|Period 2: Lens B, 15 Minutes||0||
48604017|NCT05656885|101816182|FG001|NOT COMPLETED|Period 2: Lens B, 15 Minutes||0||
48604018|NCT01533688|101816183|FG000|STARTED|Overall Study||71||
48302083|NCT02340728|101069833|FG000|STARTED|Overall Study||13||
48302084|NCT02340728|101069834|FG001|STARTED|Overall Study||11||
48302085|NCT02340728|101069833|FG000|COMPLETED|Overall Study||13||
48302086|NCT02340728|101069834|FG001|COMPLETED|Overall Study||11||
48302087|NCT02340728|101069833|FG000|NOT COMPLETED|Overall Study||0||
48302088|NCT02340728|101069834|FG001|NOT COMPLETED|Overall Study||0||
48302089|NCT01130974|101069835|FG000|STARTED|Overall Study||100||
48302090|NCT01130974|101069836|FG001|STARTED|Overall Study||100||
48302091|NCT01130974|101069835|FG000|COMPLETED|Overall Study||85||
48302092|NCT01130974|101069836|FG001|COMPLETED|Overall Study||87||
48302093|NCT01130974|101069835|FG000|NOT COMPLETED|Overall Study||15||
48302094|NCT01130974|101069836|FG001|NOT COMPLETED|Overall Study||13||
48302095|NCT04540133|101069837|FG000|STARTED|Overall Study||15||
48302096|NCT04540133|101069838|FG001|STARTED|Overall Study||14||
48302097|NCT04540133|101069837|FG000|COMPLETED|Overall Study||14||
48302098|NCT04540133|101069838|FG001|COMPLETED|Overall Study||14||
48604019|NCT01533688|101816184|FG001|STARTED|Overall Study||70||
48604020|NCT01533688|101816185|FG002|STARTED|Overall Study||71||
48604021|NCT01533688|101816183|FG000|COMPLETED|Overall Study||63||
48604022|NCT01533688|101816184|FG001|COMPLETED|Overall Study||60||
48604023|NCT01533688|101816185|FG002|COMPLETED|Overall Study||63||
48604024|NCT01533688|101816183|FG000|NOT COMPLETED|Overall Study||8||
48604025|NCT01533688|101816184|FG001|NOT COMPLETED|Overall Study||10||
48604026|NCT01533688|101816185|FG002|NOT COMPLETED|Overall Study||8||
48302099|NCT04540133|101069837|FG000|NOT COMPLETED|Overall Study||1||
48302100|NCT04540133|101069838|FG001|NOT COMPLETED|Overall Study||0||
48302101|NCT00235326|101069839|FG000|STARTED|Overall Study||1575||
48302102|NCT00235326|101069840|FG001|STARTED|Overall Study||2986||
48302103|NCT00235326|101069839|FG000|COMPLETED|Overall Study||829||
48302104|NCT00235326|101069840|FG001|COMPLETED|Overall Study||1586||
48302105|NCT00235326|101069839|FG000|NOT COMPLETED|Overall Study||746||
48302106|NCT00235326|101069840|FG001|NOT COMPLETED|Overall Study||1400||
48302107|NCT00966823|101069841|FG000|STARTED|Overall Study||3||
48302108|NCT00966823|101069841|FG000|COMPLETED|Overall Study||2||
48302109|NCT00966823|101069841|FG000|NOT COMPLETED|Overall Study||1||
48302110|NCT00887250|101069842|FG000|STARTED|Overall Study||116||
48604027|NCT03423147|101816186|FG000|STARTED|Overall Study||160||
48604028|NCT03423147|101816187|FG001|STARTED|Overall Study||159||
48302111|NCT00887250|101069843|FG001|STARTED|Overall Study||127||
48302112|NCT00887250|101069844|FG002|STARTED|Overall Study||123||
48302113|NCT00887250|101069842|FG000|COMPLETED|Overall Study||98||
48302114|NCT00887250|101069843|FG001|COMPLETED|Overall Study||115||
48302115|NCT00887250|101069844|FG002|COMPLETED|Overall Study||110||
48302116|NCT00887250|101069842|FG000|NOT COMPLETED|Overall Study||18||
48302117|NCT00887250|101069843|FG001|NOT COMPLETED|Overall Study||12||
48302118|NCT00887250|101069844|FG002|NOT COMPLETED|Overall Study||13||
48302119|NCT03873493|101069845|FG000|STARTED|Overall Study||14||
48302120|NCT03873493|101069845|FG000|COMPLETED|Overall Study||0||
48604029|NCT03423147|101816186|FG000|COMPLETED|Overall Study||152||
48604030|NCT03423147|101816187|FG001|COMPLETED|Overall Study||150||
48302121|NCT03873493|101069845|FG000|NOT COMPLETED|Overall Study||14||
48604031|NCT03423147|101816186|FG000|NOT COMPLETED|Overall Study||8||
48604032|NCT03423147|101816187|FG001|NOT COMPLETED|Overall Study||9||
48604033|NCT00496587|101816188|FG000|STARTED|Overall Study||34||
48604034|NCT00496587|101816188|FG000|COMPLETED|Overall Study||3||
48604035|NCT00496587|101816188|FG000|NOT COMPLETED|Overall Study||31||
48604036|NCT01504672|101816189|FG000|STARTED|Overall Study||230||
48604037|NCT01504672|101816190|FG001|STARTED|Overall Study||230||
48604038|NCT01504672|101816189|FG000|COMPLETED|Overall Study||212||
48604039|NCT01504672|101816190|FG001|COMPLETED|Overall Study||217||
48604040|NCT01504672|101816189|FG000|NOT COMPLETED|Overall Study||18||
48604041|NCT01504672|101816190|FG001|NOT COMPLETED|Overall Study||13||
48604042|NCT01041274|101816191|FG000|STARTED|Overall Study||49|Total Randomized|
48604043|NCT01041274|101816192|FG001|STARTED|Overall Study||46|Total Randomized|
48604044|NCT01041274|101816191|FG000|COMPLETED|Overall Study||26|Week 52 Completers|
48604045|NCT01041274|101816192|FG001|COMPLETED|Overall Study||25|Week 52 Completers|
48604046|NCT01041274|101816191|FG000|NOT COMPLETED|Overall Study||23||
48604047|NCT01041274|101816192|FG001|NOT COMPLETED|Overall Study||21||
48604048|NCT01267422|101816193|FG000|STARTED|Intravitreal rAAV2-ND4 Injection||5||
48604049|NCT01267422|101816194|FG001|STARTED|Intravitreal rAAV2-ND4 Injection||4||
48604050|NCT01267422|101816193|FG000|COMPLETED|Intravitreal rAAV2-ND4 Injection||5||
48604051|NCT01267422|101816194|FG001|COMPLETED|Intravitreal rAAV2-ND4 Injection||4||
48604052|NCT01267422|101816193|FG000|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0||
48604053|NCT01267422|101816194|FG001|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0||
48604054|NCT01267422|101816193|FG000|STARTED|Safety and Efficacy Study||5||
48604055|NCT01267422|101816194|FG001|STARTED|Safety and Efficacy Study||4||
48604056|NCT01267422|101816193|FG000|COMPLETED|Safety and Efficacy Study||5||
48604057|NCT01267422|101816194|FG001|COMPLETED|Safety and Efficacy Study||4||
48604058|NCT01267422|101816193|FG000|NOT COMPLETED|Safety and Efficacy Study||0||
48604059|NCT01267422|101816194|FG001|NOT COMPLETED|Safety and Efficacy Study||0||
48604060|NCT01778751|101816195|FG000|STARTED|Overall Study||25||
48604061|NCT01778751|101816196|FG001|STARTED|Overall Study||25||
48604062|NCT01778751|101816195|FG000|COMPLETED|Overall Study||23||
48604063|NCT01778751|101816196|FG001|COMPLETED|Overall Study||23||
48604064|NCT01778751|101816195|FG000|NOT COMPLETED|Overall Study||2||
48604065|NCT01778751|101816196|FG001|NOT COMPLETED|Overall Study||2||
48604066|NCT01125813|101816197|FG000|STARTED|Overall Study||36||
48604067|NCT01125813|101816197|FG000|COMPLETED|Overall Study||30||
48604068|NCT01125813|101816197|FG000|NOT COMPLETED|Overall Study||6||
48604069|NCT02697734|101816198|FG000|STARTED|Core Phase - up to Week 48||48|treated|
48604070|NCT02697734|101816199|FG001|STARTED|Core Phase - up to Week 48||25|treated|
48604071|NCT02697734|101816198|FG000|COMPLETED|Core Phase - up to Week 48||42||
48604072|NCT02697734|101816199|FG001|COMPLETED|Core Phase - up to Week 48||23||
48604073|NCT02697734|101816198|FG000|NOT COMPLETED|Core Phase - up to Week 48||6||
48604074|NCT02697734|101816199|FG001|NOT COMPLETED|Core Phase - up to Week 48||2||
48604075|NCT02697734|101816198|FG000|STARTED|Optional Extension Phase||38||
48604076|NCT02697734|101816199|FG001|STARTED|Optional Extension Phase||22||
48604077|NCT02697734|101816198|FG000|COMPLETED|Optional Extension Phase||33||
48302122|NCT03478163|101069846|FG000|STARTED|Overall Study||5||
48302123|NCT03478163|101069847|FG001|STARTED|Overall Study||6||
48302124|NCT03478163|101069846|FG000|COMPLETED|Overall Study||5||
48302125|NCT03478163|101069847|FG001|COMPLETED|Overall Study||6||
48302126|NCT03478163|101069846|FG000|NOT COMPLETED|Overall Study||0||
48302127|NCT03478163|101069847|FG001|NOT COMPLETED|Overall Study||0||
48302128|NCT03785678|101069848|FG000|STARTED|Overall Study||228||
48302129|NCT03785678|101069849|FG001|STARTED|Overall Study||230||
48302130|NCT03785678|101069848|FG000|COMPLETED|Overall Study||175||
48302131|NCT03785678|101069849|FG001|COMPLETED|Overall Study||181||
48302132|NCT03785678|101069848|FG000|NOT COMPLETED|Overall Study||53||
48302133|NCT03785678|101069849|FG001|NOT COMPLETED|Overall Study||49||
48302134|NCT02973425|101069850|FG000|STARTED|Overall Study||220||
48604078|NCT02697734|101816199|FG001|COMPLETED|Optional Extension Phase||20||
48604079|NCT02697734|101816198|FG000|NOT COMPLETED|Optional Extension Phase||5||
48604080|NCT02697734|101816199|FG001|NOT COMPLETED|Optional Extension Phase||2||
48604081|NCT03519919|101816200|FG000|STARTED|Overall Study||51||
48604082|NCT03519919|101816200|FG000|COMPLETED|Overall Study||48||
48604083|NCT03519919|101816200|FG000|NOT COMPLETED|Overall Study||3||
48604084|NCT01470144|101816201|FG000|STARTED|Overall Study||41||
48604085|NCT01470144|101816201|FG000|COMPLETED|Overall Study||31||
48302135|NCT02973425|101069851|FG001|STARTED|Overall Study||213||
48302136|NCT02973425|101069850|FG000|COMPLETED|Overall Study||171||
48604086|NCT01470144|101816201|FG000|NOT COMPLETED|Overall Study||10||
48604087|NCT00290693|101816202|FG000|STARTED|Overall Study||45||
48604088|NCT00290693|101816202|FG000|COMPLETED|Overall Study||43||
48604089|NCT00290693|101816202|FG000|NOT COMPLETED|Overall Study||2||
48604090|NCT01463358|101816203|FG000|STARTED|Overall Study||49||
48302137|NCT02973425|101069851|FG001|COMPLETED|Overall Study||160||
48302138|NCT02973425|101069850|FG000|NOT COMPLETED|Overall Study||49||
48302139|NCT02973425|101069851|FG001|NOT COMPLETED|Overall Study||53||
48302140|NCT03496324|101069852|FG000|STARTED|Period 1||6||
48302141|NCT03496324|101069853|FG001|STARTED|Period 1||6||
48604091|NCT01463358|101816204|FG001|STARTED|Overall Study||52||
48604092|NCT01463358|101816203|FG000|COMPLETED|Overall Study||46||
48302142|NCT03496324|101069854|FG002|STARTED|Period 1||6||
48302143|NCT03496324|101069855|FG003|STARTED|Period 1||6||
48302144|NCT03496324|101069852|FG000|COMPLETED|Period 1||6||
48302145|NCT03496324|101069853|FG001|COMPLETED|Period 1||6||
48302146|NCT03496324|101069854|FG002|COMPLETED|Period 1||6||
48302147|NCT03496324|101069855|FG003|COMPLETED|Period 1||6||
48302148|NCT03496324|101069852|FG000|NOT COMPLETED|Period 1||0||
48302149|NCT03496324|101069853|FG001|NOT COMPLETED|Period 1||0||
48302150|NCT03496324|101069854|FG002|NOT COMPLETED|Period 1||0||
48302151|NCT03496324|101069855|FG003|NOT COMPLETED|Period 1||0||
48302152|NCT03496324|101069852|FG000|STARTED|Period 1: Washout (3 to 7 Days)||6||
48302153|NCT03496324|101069853|FG001|STARTED|Period 1: Washout (3 to 7 Days)||6||
48604093|NCT01463358|101816204|FG001|COMPLETED|Overall Study||47||
48302154|NCT03496324|101069854|FG002|STARTED|Period 1: Washout (3 to 7 Days)||6||
48302155|NCT03496324|101069855|FG003|STARTED|Period 1: Washout (3 to 7 Days)||6||
48302156|NCT03496324|101069852|FG000|COMPLETED|Period 1: Washout (3 to 7 Days)||6||
48302157|NCT03496324|101069853|FG001|COMPLETED|Period 1: Washout (3 to 7 Days)||6||
48302158|NCT03496324|101069854|FG002|COMPLETED|Period 1: Washout (3 to 7 Days)||6||
48302159|NCT03496324|101069855|FG003|COMPLETED|Period 1: Washout (3 to 7 Days)||6||
48302160|NCT03496324|101069852|FG000|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0||
48302161|NCT03496324|101069853|FG001|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0||
48302162|NCT03496324|101069854|FG002|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0||
48302163|NCT03496324|101069855|FG003|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0||
48302164|NCT03496324|101069852|FG000|STARTED|Period 2||6||
48604094|NCT01463358|101816203|FG000|NOT COMPLETED|Overall Study||3||
48604095|NCT01463358|101816204|FG001|NOT COMPLETED|Overall Study||5||
48604096|NCT03574038|101816205|FG000|STARTED|Overall Study||3||
48604097|NCT03574038|101816206|FG001|STARTED|Overall Study||4||
48604098|NCT03574038|101816207|FG002|STARTED|Overall Study||3||
48604099|NCT03574038|101816205|FG000|COMPLETED|Overall Study||3||
48604100|NCT03574038|101816206|FG001|COMPLETED|Overall Study||4||
48604101|NCT03574038|101816207|FG002|COMPLETED|Overall Study||3||
48604102|NCT03574038|101816205|FG000|NOT COMPLETED|Overall Study||0||
48604103|NCT03574038|101816206|FG001|NOT COMPLETED|Overall Study||0||
48302165|NCT03496324|101069853|FG001|STARTED|Period 2||6||
48302166|NCT03496324|101069854|FG002|STARTED|Period 2||6||
48604104|NCT03574038|101816207|FG002|NOT COMPLETED|Overall Study||0||
48604105|NCT00544908|101816208|FG000|STARTED|Overall Study||7||
48604106|NCT00544908|101816208|FG000|COMPLETED|Overall Study||7||
48604107|NCT00544908|101816208|FG000|NOT COMPLETED|Overall Study||0||
48604108|NCT03754972|101816209|FG000|STARTED|Overall Study||100||
48604109|NCT03754972|101816209|FG000|COMPLETED|Overall Study||75||
48604110|NCT03754972|101816209|FG000|NOT COMPLETED|Overall Study||25||
48604111|NCT02191046|101816210|FG000|STARTED|Overall Study||41||
48604112|NCT02191046|101816211|FG001|STARTED|Overall Study||39||
48604113|NCT02191046|101816210|FG000|COMPLETED|Overall Study||36||
48604114|NCT02191046|101816211|FG001|COMPLETED|Overall Study||38||
48604115|NCT02191046|101816210|FG000|NOT COMPLETED|Overall Study||5||
48604116|NCT02191046|101816211|FG001|NOT COMPLETED|Overall Study||1||
48604117|NCT00560703|101816212|FG000|STARTED|Overall Study||46||
48302167|NCT03496324|101069855|FG003|STARTED|Period 2||6||
48302168|NCT03496324|101069852|FG000|COMPLETED|Period 2||6||
48302169|NCT03496324|101069853|FG001|COMPLETED|Period 2||6||
48302170|NCT03496324|101069854|FG002|COMPLETED|Period 2||6||
48302171|NCT03496324|101069855|FG003|COMPLETED|Period 2||6||
48302172|NCT03496324|101069852|FG000|NOT COMPLETED|Period 2||0||
48604118|NCT00560703|101816213|FG001|STARTED|Overall Study||24||
48302173|NCT03496324|101069853|FG001|NOT COMPLETED|Period 2||0||
48302174|NCT03496324|101069854|FG002|NOT COMPLETED|Period 2||0||
48302175|NCT03496324|101069855|FG003|NOT COMPLETED|Period 2||0||
48302176|NCT03496324|101069852|FG000|STARTED|Period 2: Washout (3 to 7 Days)||6||
48302177|NCT03496324|101069853|FG001|STARTED|Period 2: Washout (3 to 7 Days)||6||
48302178|NCT03496324|101069854|FG002|STARTED|Period 2: Washout (3 to 7 Days)||6||
48302179|NCT03496324|101069855|FG003|STARTED|Period 2: Washout (3 to 7 Days)||6||
48302180|NCT03496324|101069852|FG000|COMPLETED|Period 2: Washout (3 to 7 Days)||6||
48604119|NCT00560703|101816212|FG000|COMPLETED|Overall Study||46||
48604120|NCT00560703|101816213|FG001|COMPLETED|Overall Study||18||
48147797|NCT00584727|100685073|FG001|STARTED|Second Intervention||17||
48604121|NCT00560703|101816212|FG000|NOT COMPLETED|Overall Study||0||
48604122|NCT00560703|101816213|FG001|NOT COMPLETED|Overall Study||6||
48604123|NCT00303472|101816214|FG000|STARTED|Treatment Period||6||
48604124|NCT00303472|101816215|FG001|STARTED|Treatment Period||11||
48604125|NCT00303472|101816216|FG002|STARTED|Treatment Period||11||
48604126|NCT00303472|101816217|FG003|STARTED|Treatment Period||16||
48604127|NCT00303472|101816218|FG004|STARTED|Treatment Period||11||
48604128|NCT00303472|101816219|FG005|STARTED|Treatment Period||12||
48604129|NCT00303472|101816220|FG006|STARTED|Treatment Period||5||
48604130|NCT00303472|101816214|FG000|COMPLETED|Treatment Period||6||
48604131|NCT00303472|101816215|FG001|COMPLETED|Treatment Period||11||
48604132|NCT00303472|101816216|FG002|COMPLETED|Treatment Period||11||
48604133|NCT00303472|101816217|FG003|COMPLETED|Treatment Period||14||
48604134|NCT00303472|101816218|FG004|COMPLETED|Treatment Period||8||
48604135|NCT00303472|101816219|FG005|COMPLETED|Treatment Period||11||
48604136|NCT00303472|101816220|FG006|COMPLETED|Treatment Period||3||
48604137|NCT00303472|101816214|FG000|NOT COMPLETED|Treatment Period||0||
48604138|NCT00303472|101816215|FG001|NOT COMPLETED|Treatment Period||0||
48604139|NCT00303472|101816216|FG002|NOT COMPLETED|Treatment Period||0||
48604140|NCT00303472|101816217|FG003|NOT COMPLETED|Treatment Period||2||
48604141|NCT00303472|101816218|FG004|NOT COMPLETED|Treatment Period||3||
48604142|NCT00303472|101816219|FG005|NOT COMPLETED|Treatment Period||1||
48604143|NCT00303472|101816220|FG006|NOT COMPLETED|Treatment Period||2||
48604144|NCT00303472|101816214|FG000|STARTED|Treatment Extension (Optional)||6||
48604145|NCT00303472|101816215|FG001|STARTED|Treatment Extension (Optional)||11||
48604146|NCT00303472|101816216|FG002|STARTED|Treatment Extension (Optional)||11||
48604147|NCT00303472|101816217|FG003|STARTED|Treatment Extension (Optional)||13||
48604148|NCT00303472|101816218|FG004|STARTED|Treatment Extension (Optional)||5||
48604149|NCT00303472|101816219|FG005|STARTED|Treatment Extension (Optional)||5||
48604150|NCT00303472|101816220|FG006|STARTED|Treatment Extension (Optional)||1||
48604151|NCT00303472|101816214|FG000|COMPLETED|Treatment Extension (Optional)||1||
48604152|NCT00303472|101816215|FG001|COMPLETED|Treatment Extension (Optional)||5||
48604153|NCT00303472|101816216|FG002|COMPLETED|Treatment Extension (Optional)||2||
48604154|NCT00303472|101816217|FG003|COMPLETED|Treatment Extension (Optional)||5||
48604155|NCT00303472|101816218|FG004|COMPLETED|Treatment Extension (Optional)||1||
48604156|NCT00303472|101816219|FG005|COMPLETED|Treatment Extension (Optional)||4||
48604157|NCT00303472|101816220|FG006|COMPLETED|Treatment Extension (Optional)||1||
48604158|NCT00303472|101816214|FG000|NOT COMPLETED|Treatment Extension (Optional)||5||
48604159|NCT00303472|101816215|FG001|NOT COMPLETED|Treatment Extension (Optional)||6||
48604160|NCT00303472|101816216|FG002|NOT COMPLETED|Treatment Extension (Optional)||9||
48604161|NCT00303472|101816217|FG003|NOT COMPLETED|Treatment Extension (Optional)||8||
48147798|NCT00584727|100685074|FG002|STARTED|Second Intervention||15||
48604162|NCT00303472|101816218|FG004|NOT COMPLETED|Treatment Extension (Optional)||4||
48604163|NCT00303472|101816219|FG005|NOT COMPLETED|Treatment Extension (Optional)||1||
48604164|NCT00303472|101816220|FG006|NOT COMPLETED|Treatment Extension (Optional)||0||
48604165|NCT02560623|101816221|FG000|STARTED|Overall Study||19||
48604166|NCT02560623|101816222|FG001|STARTED|Overall Study||22||
48604167|NCT02560623|101816223|FG002|STARTED|Overall Study||112||
48604168|NCT02560623|101816224|FG003|STARTED|Overall Study||89||
48604169|NCT02560623|101816221|FG000|COMPLETED|Overall Study||19||
48604170|NCT02560623|101816222|FG001|COMPLETED|Overall Study||20||
48604171|NCT02560623|101816223|FG002|COMPLETED|Overall Study||112||
48604172|NCT02560623|101816224|FG003|COMPLETED|Overall Study||89||
48604173|NCT02560623|101816221|FG000|NOT COMPLETED|Overall Study||0||
48604174|NCT02560623|101816222|FG001|NOT COMPLETED|Overall Study||2||
48604175|NCT02560623|101816223|FG002|NOT COMPLETED|Overall Study||0||
48604176|NCT02560623|101816224|FG003|NOT COMPLETED|Overall Study||0||
48604177|NCT00290654|101816225|FG000|STARTED|Overall Study||41||
48604178|NCT00290654|101816225|FG000|COMPLETED|Overall Study||41||
48604179|NCT00290654|101816225|FG000|NOT COMPLETED|Overall Study||0||
48604180|NCT01690299|101816226|FG000|STARTED|Placebo-controlled Phase (Weeks 0-16)||84||
48604181|NCT01690299|101816227|FG001|STARTED|Placebo-controlled Phase (Weeks 0-16)||83||
48604182|NCT01690299|101816228|FG002|STARTED|Placebo-controlled Phase (Weeks 0-16)||83||
48604183|NCT01690299|101816229|FG003|STARTED|Placebo-controlled Phase (Weeks 0-16)||0||
48604184|NCT01690299|101816230|FG004|STARTED|Placebo-controlled Phase (Weeks 0-16)||0||
48604185|NCT01690299|101816231|FG005|STARTED|Placebo-controlled Phase (Weeks 0-16)||0||
48604186|NCT01690299|101816226|FG000|Safety Population|Placebo-controlled Phase (Weeks 0-16)||84||
48604187|NCT01690299|101816227|FG001|Safety Population|Placebo-controlled Phase (Weeks 0-16)||83||
48604188|NCT01690299|101816228|FG002|Safety Population|Placebo-controlled Phase (Weeks 0-16)||83||
48604189|NCT01690299|101816229|FG003|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0||
48604190|NCT01690299|101816230|FG004|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0||
48604191|NCT01690299|101816231|FG005|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0||
48604192|NCT01690299|101816226|FG000|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||75||
48604193|NCT01690299|101816227|FG001|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||77||
48604194|NCT01690299|101816228|FG002|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||81||
48604195|NCT01690299|101816229|FG003|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0||
48604196|NCT01690299|101816230|FG004|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0||
48604197|NCT01690299|101816231|FG005|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0||
48604198|NCT01690299|101816226|FG000|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||9||
48604199|NCT01690299|101816227|FG001|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||6||
48604200|NCT01690299|101816228|FG002|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||2||
48604201|NCT01690299|101816229|FG003|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0||
48604202|NCT01690299|101816230|FG004|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0||
48604203|NCT01690299|101816231|FG005|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0||
48604204|NCT01690299|101816226|FG000|STARTED|Apremilast Extension Phase (Weeks16-104)||0||
48604205|NCT01690299|101816227|FG001|STARTED|Apremilast Extension Phase (Weeks16-104)||0||
48604206|NCT01690299|101816228|FG002|STARTED|Apremilast Extension Phase (Weeks16-104)||0||
48604207|NCT01690299|101816229|FG003|STARTED|Apremilast Extension Phase (Weeks16-104)||73||
48604208|NCT01690299|101816230|FG004|STARTED|Apremilast Extension Phase (Weeks16-104)||74||
48604209|NCT01690299|101816231|FG005|STARTED|Apremilast Extension Phase (Weeks16-104)||80||
48604210|NCT01690299|101816226|FG000|Safety Population|Apremilast Extension Phase (Weeks16-104)||0||
48604211|NCT01690299|101816227|FG001|Safety Population|Apremilast Extension Phase (Weeks16-104)||0||
48604212|NCT01690299|101816228|FG002|Safety Population|Apremilast Extension Phase (Weeks16-104)||0||
48604213|NCT01690299|101816229|FG003|Safety Population|Apremilast Extension Phase (Weeks16-104)||73||
48604214|NCT01690299|101816230|FG004|Safety Population|Apremilast Extension Phase (Weeks16-104)||74||
48604215|NCT01690299|101816231|FG005|Safety Population|Apremilast Extension Phase (Weeks16-104)||79||
48604216|NCT01690299|101816226|FG000|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0||
48604217|NCT01690299|101816227|FG001|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0||
48604218|NCT01690299|101816228|FG002|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0||
48604219|NCT01690299|101816229|FG003|COMPLETED|Apremilast Extension Phase (Weeks16-104)||47||
48604220|NCT01690299|101816230|FG004|COMPLETED|Apremilast Extension Phase (Weeks16-104)||41||
48604221|NCT01690299|101816231|FG005|COMPLETED|Apremilast Extension Phase (Weeks16-104)||50||
48604222|NCT01690299|101816226|FG000|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0||
48604223|NCT01690299|101816227|FG001|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0||
48604224|NCT01690299|101816228|FG002|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0||
48604225|NCT01690299|101816229|FG003|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||26||
48604226|NCT01690299|101816230|FG004|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||33||
48604227|NCT01690299|101816231|FG005|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||30||
48604228|NCT02373137|101816232|FG000|STARTED|Overall Study||19||25
48604229|NCT02373137|101816233|FG001|STARTED|Overall Study||19||25
48604230|NCT02373137|101816232|FG000|3-Month Follow-Up|Overall Study||19||25
48604231|NCT02373137|101816233|FG001|3-Month Follow-Up|Overall Study||19||25
48604232|NCT02373137|101816232|FG000|6-Month Follow-Up|Overall Study||19||25
48604233|NCT02373137|101816233|FG001|6-Month Follow-Up|Overall Study||18||24
48604234|NCT02373137|101816232|FG000|12-Month Follow-Up|Overall Study||19||25
48604235|NCT02373137|101816233|FG001|12-Month Follow-Up|Overall Study||19||25
48604236|NCT02373137|101816232|FG000|COMPLETED|Overall Study||18||24
48604237|NCT02373137|101816233|FG001|COMPLETED|Overall Study||18||23
48604238|NCT02373137|101816232|FG000|NOT COMPLETED|Overall Study||1||1
48604239|NCT02373137|101816233|FG001|NOT COMPLETED|Overall Study||1||2
48604240|NCT01309451|101816234|FG000|STARTED|Overall Study||19||
48604241|NCT01309451|101816235|FG001|STARTED|Overall Study||21||
48604242|NCT01309451|101816234|FG000|COMPLETED|Overall Study||17||
48604243|NCT01309451|101816235|FG001|COMPLETED|Overall Study||18||
48604244|NCT01309451|101816234|FG000|NOT COMPLETED|Overall Study||2||
48604245|NCT01309451|101816235|FG001|NOT COMPLETED|Overall Study||3||
48604246|NCT03816007|101816236|FG000|STARTED|End of 12-week Intervention||16||
48604247|NCT03816007|101816237|FG001|STARTED|End of 12-week Intervention||16||
48604248|NCT03816007|101816236|FG000|COMPLETED|End of 12-week Intervention||13||
48604249|NCT03816007|101816237|FG001|COMPLETED|End of 12-week Intervention||10||
48604250|NCT03816007|101816236|FG000|NOT COMPLETED|End of 12-week Intervention||3||
48604251|NCT03816007|101816237|FG001|NOT COMPLETED|End of 12-week Intervention||6||
48604252|NCT03816007|101816236|FG000|STARTED|Final Assessment at 18 Weeks.||16||
48604253|NCT03816007|101816237|FG001|STARTED|Final Assessment at 18 Weeks.||14||
48604254|NCT03816007|101816236|FG000|COMPLETED|Final Assessment at 18 Weeks.||12||
48604255|NCT03816007|101816237|FG001|COMPLETED|Final Assessment at 18 Weeks.||10||
48604256|NCT03816007|101816236|FG000|NOT COMPLETED|Final Assessment at 18 Weeks.||4||
48604257|NCT03816007|101816237|FG001|NOT COMPLETED|Final Assessment at 18 Weeks.||4||
48604258|NCT02946021|101816238|FG000|STARTED|Overall Study||6||
48604259|NCT02946021|101816239|FG001|STARTED|Overall Study||5||
48604260|NCT02946021|101816238|FG000|COMPLETED|Overall Study||6||
48604261|NCT02946021|101816239|FG001|COMPLETED|Overall Study||5||
48604262|NCT02946021|101816238|FG000|NOT COMPLETED|Overall Study||0||
48604263|NCT02946021|101816239|FG001|NOT COMPLETED|Overall Study||0||
48604264|NCT02259699|101816240|FG000|STARTED|Overall Study||64||
48604265|NCT02259699|101816241|FG001|STARTED|Overall Study||60||
48604266|NCT02259699|101816240|FG000|COMPLETED|Overall Study||37||
48604267|NCT02259699|101816241|FG001|COMPLETED|Overall Study||40||
48604268|NCT02259699|101816240|FG000|NOT COMPLETED|Overall Study||27||
48604269|NCT02259699|101816241|FG001|NOT COMPLETED|Overall Study||20||
48604270|NCT01461473|101816242|FG000|STARTED|Overall Study||72||
48604271|NCT01461473|101816243|FG001|STARTED|Overall Study||59||
48604272|NCT01461473|101816242|FG000|COMPLETED|Overall Study||67||
48604273|NCT01461473|101816243|FG001|COMPLETED|Overall Study||55||
48604274|NCT01461473|101816242|FG000|NOT COMPLETED|Overall Study||5||
48604275|NCT01461473|101816243|FG001|NOT COMPLETED|Overall Study||4||
48604276|NCT03092791|101816244|FG000|STARTED|Overall Study||20||
48604277|NCT03092791|101816245|FG001|STARTED|Overall Study||20||
48604278|NCT03092791|101816246|FG002|STARTED|Overall Study||30||
48604279|NCT03092791|101816247|FG003|STARTED|Overall Study||30||
48604280|NCT03092791|101816248|FG004|STARTED|Overall Study||60||
48604281|NCT03092791|101816249|FG005|STARTED|Overall Study||60||
48604282|NCT03092791|101816250|FG006|STARTED|Overall Study||60||
48604283|NCT03092791|101816251|FG007|STARTED|Overall Study||60||
48604284|NCT03092791|101816244|FG000|COMPLETED|Overall Study||20||
48604285|NCT03092791|101816245|FG001|COMPLETED|Overall Study||20||
48604286|NCT03092791|101816246|FG002|COMPLETED|Overall Study||30||
48604287|NCT03092791|101816247|FG003|COMPLETED|Overall Study||30||
48604288|NCT03092791|101816248|FG004|COMPLETED|Overall Study||0||
48604289|NCT03092791|101816249|FG005|COMPLETED|Overall Study||0||
48604290|NCT03092791|101816250|FG006|COMPLETED|Overall Study||0||
48604291|NCT03092791|101816251|FG007|COMPLETED|Overall Study||0||
48604292|NCT03092791|101816244|FG000|NOT COMPLETED|Overall Study||0||
48604293|NCT03092791|101816245|FG001|NOT COMPLETED|Overall Study||0||
48604294|NCT03092791|101816246|FG002|NOT COMPLETED|Overall Study||0||
48604295|NCT03092791|101816247|FG003|NOT COMPLETED|Overall Study||0||
48604296|NCT03092791|101816248|FG004|NOT COMPLETED|Overall Study||60||
48604297|NCT03092791|101816249|FG005|NOT COMPLETED|Overall Study||60||
48604298|NCT03092791|101816250|FG006|NOT COMPLETED|Overall Study||60||
48604299|NCT03092791|101816251|FG007|NOT COMPLETED|Overall Study||60||
48604300|NCT02974803|101816252|FG000|STARTED|Overall Study||6||
48604301|NCT02974803|101816252|FG000|COMPLETED|Overall Study||6||
48604302|NCT02974803|101816252|FG000|NOT COMPLETED|Overall Study||0||
48604303|NCT01554163|101816253|FG000|STARTED|Overall Study||120||
48604304|NCT01554163|101816254|FG001|STARTED|Overall Study||119||
48604305|NCT01554163|101816253|FG000|Number Treated|Overall Study||119||
48604306|NCT01554163|101816254|FG001|Number Treated|Overall Study||119||
48604307|NCT01554163|101816253|FG000|COMPLETED|Overall Study||112||
48604308|NCT01554163|101816254|FG001|COMPLETED|Overall Study||109||
48604309|NCT01554163|101816253|FG000|NOT COMPLETED|Overall Study||8||
48604310|NCT01554163|101816254|FG001|NOT COMPLETED|Overall Study||10||
48604311|NCT03170609|101816255|FG000|STARTED|Overall Study||53||
48604312|NCT03170609|101816256|FG001|STARTED|Overall Study||52||
48604313|NCT03170609|101816257|FG002|STARTED|Overall Study||52||
48604314|NCT03170609|101816258|FG003|STARTED|Overall Study||52||
48604315|NCT03170609|101816259|FG004|STARTED|Overall Study||52||
48604316|NCT03170609|101816260|FG005|STARTED|Overall Study||52||
48604317|NCT03170609|101816261|FG006|STARTED|Overall Study||52||
48604318|NCT03170609|101816255|FG000|Vaccinated|Overall Study||52||
48604319|NCT03170609|101816256|FG001|Vaccinated|Overall Study||52||
48604320|NCT03170609|101816257|FG002|Vaccinated|Overall Study||52||
48604321|NCT03170609|101816258|FG003|Vaccinated|Overall Study||52||
48604322|NCT03170609|101816259|FG004|Vaccinated|Overall Study||52||
48604323|NCT03170609|101816260|FG005|Vaccinated|Overall Study||52||
48604324|NCT03170609|101816261|FG006|Vaccinated|Overall Study||52||
48604325|NCT03170609|101816255|FG000|COMPLETED|Overall Study||50||
48604326|NCT03170609|101816256|FG001|COMPLETED|Overall Study||50||
48604327|NCT03170609|101816257|FG002|COMPLETED|Overall Study||46||
48604328|NCT03170609|101816258|FG003|COMPLETED|Overall Study||50||
48604329|NCT03170609|101816259|FG004|COMPLETED|Overall Study||51||
48604330|NCT03170609|101816260|FG005|COMPLETED|Overall Study||50||
48604331|NCT03170609|101816261|FG006|COMPLETED|Overall Study||51||
48604332|NCT03170609|101816255|FG000|NOT COMPLETED|Overall Study||3||
48604333|NCT03170609|101816256|FG001|NOT COMPLETED|Overall Study||2||
48604334|NCT03170609|101816257|FG002|NOT COMPLETED|Overall Study||6||
48604335|NCT03170609|101816258|FG003|NOT COMPLETED|Overall Study||2||
48604336|NCT03170609|101816259|FG004|NOT COMPLETED|Overall Study||1||
48604337|NCT03170609|101816260|FG005|NOT COMPLETED|Overall Study||2||
48604338|NCT03170609|101816261|FG006|NOT COMPLETED|Overall Study||1||
48604339|NCT02187029|101816262|FG000|STARTED|Overall Study||7||
48604340|NCT02187029|101816263|FG001|STARTED|Overall Study||3||
48604341|NCT02187029|101816264|FG002|STARTED|Overall Study||11||
48604342|NCT02187029|101816265|FG003|STARTED|Overall Study||9||
48604343|NCT02187029|101816262|FG000|COMPLETED|Overall Study||6||
48604344|NCT02187029|101816263|FG001|COMPLETED|Overall Study||2||
48604345|NCT02187029|101816264|FG002|COMPLETED|Overall Study||0||
48604346|NCT02187029|101816265|FG003|COMPLETED|Overall Study||6||
48604347|NCT02187029|101816262|FG000|NOT COMPLETED|Overall Study||1||
48604348|NCT02187029|101816263|FG001|NOT COMPLETED|Overall Study||1||
48604349|NCT02187029|101816264|FG002|NOT COMPLETED|Overall Study||11||
48604350|NCT02187029|101816265|FG003|NOT COMPLETED|Overall Study||3||
48604351|NCT00521885|101816266|FG000|STARTED|Overall Study||0||
48604352|NCT00521885|101816267|FG001|STARTED|Overall Study||0||
48604353|NCT00521885|101816266|FG000|COMPLETED|Overall Study||0||
48604354|NCT00521885|101816267|FG001|COMPLETED|Overall Study||0||
48604355|NCT00521885|101816266|FG000|NOT COMPLETED|Overall Study||0||
48604356|NCT00521885|101816267|FG001|NOT COMPLETED|Overall Study||0||
48604357|NCT01520519|101816268|FG000|STARTED|Overall Study||40||
48604358|NCT01520519|101816268|FG000|COMPLETED|Overall Study||40||
48604359|NCT01520519|101816268|FG000|NOT COMPLETED|Overall Study||0||
48604360|NCT03337048|101816269|FG000|STARTED|Overall Study||10||
48604361|NCT03337048|101816270|FG001|STARTED|Overall Study||10||
48604362|NCT03337048|101816271|FG002|STARTED|Overall Study||10||
48604363|NCT03337048|101816269|FG000|COMPLETED|Overall Study||8||
48604364|NCT03337048|101816270|FG001|COMPLETED|Overall Study||10||
48604365|NCT03337048|101816271|FG002|COMPLETED|Overall Study||10||
48604366|NCT03337048|101816269|FG000|NOT COMPLETED|Overall Study||2||
48604367|NCT03337048|101816270|FG001|NOT COMPLETED|Overall Study||0||
48604368|NCT03337048|101816271|FG002|NOT COMPLETED|Overall Study||0||
48604369|NCT01588405|101816272|FG000|STARTED|Overall Study||33||
48604370|NCT01588405|101816272|FG000|COMPLETED|Overall Study||31||
48604371|NCT01588405|101816272|FG000|NOT COMPLETED|Overall Study||2||
48604372|NCT00868751|101816273|FG000|STARTED|Overall Study||1||
48604373|NCT00868751|101816273|FG000|COMPLETED|Overall Study||0||
48604374|NCT00868751|101816273|FG000|NOT COMPLETED|Overall Study||1||
48604375|NCT01268189|101816274|FG000|STARTED|Overall Study||20||
48604376|NCT01268189|101816274|FG000|COMPLETED|Overall Study||17||
48604377|NCT01268189|101816274|FG000|NOT COMPLETED|Overall Study||3||
48604378|NCT00994214|101816275|FG000|STARTED|ITT (Intention-to-Treat) - Part A||19||
48604379|NCT00994214|101816276|FG001|STARTED|ITT (Intention-to-Treat) - Part A||19||
48604380|NCT00994214|101816277|FG002|STARTED|ITT (Intention-to-Treat) - Part A||18||
48604381|NCT00994214|101816278|FG003|STARTED|ITT (Intention-to-Treat) - Part A||20||
48604382|NCT00994214|101816275|FG000|COMPLETED|ITT (Intention-to-Treat) - Part A||5||
48604383|NCT00994214|101816276|FG001|COMPLETED|ITT (Intention-to-Treat) - Part A||6||
48604384|NCT00994214|101816277|FG002|COMPLETED|ITT (Intention-to-Treat) - Part A||5||
48604385|NCT00994214|101816278|FG003|COMPLETED|ITT (Intention-to-Treat) - Part A||5||
48604386|NCT00994214|101816275|FG000|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||14||
48604387|NCT00994214|101816276|FG001|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13||
48604388|NCT00994214|101816277|FG002|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13||
48604389|NCT00994214|101816278|FG003|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||15||
48604390|NCT00994214|101816275|FG000|STARTED|ITT (Intention-to-Treat) - Part B||4||
48604391|NCT00994214|101816276|FG001|STARTED|ITT (Intention-to-Treat) - Part B||3||
48604392|NCT00994214|101816277|FG002|STARTED|ITT (Intention-to-Treat) - Part B||2||
48604393|NCT00994214|101816278|FG003|STARTED|ITT (Intention-to-Treat) - Part B||3||
48604394|NCT00994214|101816275|FG000|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0||
48604395|NCT00994214|101816276|FG001|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0||
48604396|NCT00994214|101816277|FG002|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0||
48604397|NCT00994214|101816278|FG003|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0||
48604398|NCT00994214|101816275|FG000|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||3||
48604399|NCT00994214|101816276|FG001|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0||
48604400|NCT00994214|101816277|FG002|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0||
48604401|NCT00994214|101816278|FG003|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0||
48604402|NCT00994214|101816275|FG000|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||1||
48604403|NCT00994214|101816276|FG001|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||3||
48604404|NCT00994214|101816277|FG002|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0||
48604405|NCT00994214|101816278|FG003|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0||
48604406|NCT00994214|101816275|FG000|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0||
48604407|NCT00994214|101816276|FG001|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0||
48604408|NCT00994214|101816277|FG002|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||2||
48604409|NCT00994214|101816278|FG003|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||3||
48604410|NCT00994214|101816275|FG000|COMPLETED|ITT (Intention-to-Treat) - Part B||0||
48604411|NCT00994214|101816276|FG001|COMPLETED|ITT (Intention-to-Treat) - Part B||0||
48604412|NCT00994214|101816277|FG002|COMPLETED|ITT (Intention-to-Treat) - Part B||0||
48604413|NCT00994214|101816278|FG003|COMPLETED|ITT (Intention-to-Treat) - Part B||0||
48604414|NCT00994214|101816275|FG000|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||4||
48604415|NCT00994214|101816276|FG001|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3||
48604416|NCT00994214|101816277|FG002|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||2||
48604417|NCT00994214|101816278|FG003|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3||
48604418|NCT01270321|101816279|FG000|STARTED|Overall Study||19||
48604419|NCT01270321|101816280|FG001|STARTED|Overall Study||11||
48604420|NCT01270321|101816281|FG002|STARTED|Overall Study||12||
48604421|NCT01270321|101816279|FG000|COMPLETED|Overall Study||9||
48604422|NCT01270321|101816280|FG001|COMPLETED|Overall Study||1||
48604423|NCT01270321|101816281|FG002|COMPLETED|Overall Study||3||
48604424|NCT01270321|101816279|FG000|NOT COMPLETED|Overall Study||10||
48604425|NCT01270321|101816280|FG001|NOT COMPLETED|Overall Study||10||
48604426|NCT01270321|101816281|FG002|NOT COMPLETED|Overall Study||9||
48604427|NCT01017601|101816282|FG000|STARTED|Overall Study||26||
48604428|NCT01017601|101816283|FG001|STARTED|Overall Study||24||
48604429|NCT01017601|101816282|FG000|COMPLETED|Overall Study||14||
48302181|NCT03496324|101069853|FG001|COMPLETED|Period 2: Washout (3 to 7 Days)||6||
48302182|NCT03496324|101069854|FG002|COMPLETED|Period 2: Washout (3 to 7 Days)||6||
48302183|NCT03496324|101069855|FG003|COMPLETED|Period 2: Washout (3 to 7 Days)||6||
48604430|NCT01017601|101816283|FG001|COMPLETED|Overall Study||11||
48604431|NCT01017601|101816282|FG000|NOT COMPLETED|Overall Study||12||
48147799|NCT00584727|100685075|FG003|STARTED|Second Intervention||14||
48604432|NCT01017601|101816283|FG001|NOT COMPLETED|Overall Study||13||
48604433|NCT01390428|101816284|FG000|STARTED|Overall Study||8||
48604434|NCT01390428|101816285|FG001|STARTED|Overall Study||8||
48604435|NCT01390428|101816286|FG002|STARTED|Overall Study||9||
48604436|NCT01390428|101816287|FG003|STARTED|Overall Study||9||
48604437|NCT01390428|101816288|FG004|STARTED|Overall Study||8||
48604438|NCT01390428|101816289|FG005|STARTED|Overall Study||8||
48604439|NCT01390428|101816284|FG000|COMPLETED|Overall Study||8||
48604440|NCT01390428|101816285|FG001|COMPLETED|Overall Study||8||
48604441|NCT01390428|101816286|FG002|COMPLETED|Overall Study||8||
48604442|NCT01390428|101816287|FG003|COMPLETED|Overall Study||9||
48604443|NCT01390428|101816288|FG004|COMPLETED|Overall Study||7||
48604444|NCT01390428|101816289|FG005|COMPLETED|Overall Study||8||
48604445|NCT01390428|101816284|FG000|NOT COMPLETED|Overall Study||0||
48604446|NCT01390428|101816285|FG001|NOT COMPLETED|Overall Study||0||
48604447|NCT01390428|101816286|FG002|NOT COMPLETED|Overall Study||1||
48604448|NCT01390428|101816287|FG003|NOT COMPLETED|Overall Study||0||
48604449|NCT01390428|101816288|FG004|NOT COMPLETED|Overall Study||1||
48604450|NCT01390428|101816289|FG005|NOT COMPLETED|Overall Study||0||
48604451|NCT00913770|101816290|FG000|STARTED|Overall Study||104||
48604452|NCT00913770|101816291|FG001|STARTED|Overall Study||111||
48604453|NCT00913770|101816292|FG002|STARTED|Overall Study||114||
48604454|NCT00913770|101816290|FG000|COMPLETED|Overall Study||69||
48604455|NCT00913770|101816291|FG001|COMPLETED|Overall Study||82||
48604456|NCT00913770|101816292|FG002|COMPLETED|Overall Study||93||
48604457|NCT00913770|101816290|FG000|NOT COMPLETED|Overall Study||35||
48604458|NCT00913770|101816291|FG001|NOT COMPLETED|Overall Study||29||
48604459|NCT00913770|101816292|FG002|NOT COMPLETED|Overall Study||21||
48604460|NCT02913105|101816293|FG000|STARTED|Overall Study||37||
48604461|NCT02913105|101816294|FG001|STARTED|Overall Study||44||
48604462|NCT02913105|101816295|FG002|STARTED|Overall Study||40||
48604463|NCT02913105|101816293|FG000|COMPLETED|Overall Study||22||
48604464|NCT02913105|101816294|FG001|COMPLETED|Overall Study||39||
48604465|NCT02913105|101816295|FG002|COMPLETED|Overall Study||33||
48604466|NCT02913105|101816293|FG000|NOT COMPLETED|Overall Study||15||
48604467|NCT02913105|101816294|FG001|NOT COMPLETED|Overall Study||5||
48604468|NCT02913105|101816295|FG002|NOT COMPLETED|Overall Study||7||
48147800|NCT00584727|100685076|FG004|STARTED|Second Intervention||16||
48147801|NCT00584727|100685077|FG005|STARTED|Second Intervention||16||
48147802|NCT00584727|100685072|FG000|COMPLETED|Second Intervention||17||
48147803|NCT00584727|100685073|FG001|COMPLETED|Second Intervention||17||
48147804|NCT00584727|100685074|FG002|COMPLETED|Second Intervention||15||
48147805|NCT00584727|100685075|FG003|COMPLETED|Second Intervention||14||
48147806|NCT00584727|100685076|FG004|COMPLETED|Second Intervention||16||
48147807|NCT00584727|100685077|FG005|COMPLETED|Second Intervention||16||
48147808|NCT00584727|100685072|FG000|NOT COMPLETED|Second Intervention||0||
48147809|NCT00584727|100685073|FG001|NOT COMPLETED|Second Intervention||0||
48147810|NCT00584727|100685074|FG002|NOT COMPLETED|Second Intervention||0||
48147811|NCT00584727|100685075|FG003|NOT COMPLETED|Second Intervention||0||
48147812|NCT00584727|100685076|FG004|NOT COMPLETED|Second Intervention||0||
48147813|NCT00584727|100685077|FG005|NOT COMPLETED|Second Intervention||0||
48302184|NCT03496324|101069852|FG000|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0||
48604469|NCT01038752|101816296|FG000|STARTED|Overall Study||8||
48604470|NCT01038752|101816297|FG001|STARTED|Overall Study||6||
48604471|NCT01038752|101816296|FG000|COMPLETED|Overall Study||3||
48604472|NCT01038752|101816297|FG001|COMPLETED|Overall Study||1||
48147814|NCT00584727|100685072|FG000|STARTED|Third Intervention||17||
48147815|NCT00584727|100685073|FG001|STARTED|Third Intervention||17||
48302185|NCT03496324|101069853|FG001|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0||
48302186|NCT03496324|101069854|FG002|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0||
48405315|NCT00533351|101325251|FG001|STARTED|Period 2||1||
48604473|NCT01038752|101816296|FG000|NOT COMPLETED|Overall Study||5||
48604474|NCT01038752|101816297|FG001|NOT COMPLETED|Overall Study||5||
48604475|NCT00135356|101816298|FG000|STARTED|Overall Study||131||
48604476|NCT00135356|101816299|FG001|STARTED|Overall Study||69||
48604477|NCT00135356|101816298|FG000|Discontinued Prior to Week 96 Visit|Overall Study||16||
48604478|NCT00135356|101816299|FG001|Discontinued Prior to Week 96 Visit|Overall Study||9||
48604479|NCT00135356|101816298|FG000|Discontinued on or After Week 96 Visit|Overall Study||1||
48604480|NCT00135356|101816299|FG001|Discontinued on or After Week 96 Visit|Overall Study||0||
48604481|NCT00135356|101816298|FG000|COMPLETED|Overall Study||114||
48604482|NCT00135356|101816299|FG001|COMPLETED|Overall Study||60||
48604483|NCT00135356|101816298|FG000|NOT COMPLETED|Overall Study||17||
48604484|NCT00135356|101816299|FG001|NOT COMPLETED|Overall Study||9||
48604485|NCT01961167|101816300|FG000|STARTED|Overall Study||27||
48405316|NCT00533351|101325250|FG000|COMPLETED|Period 2||5||
48657076|NCT03648372|101943774|FG017|COMPLETED|Overall Study||1||
48147816|NCT00584727|100685074|FG002|STARTED|Third Intervention||15||
48147817|NCT00584727|100685075|FG003|STARTED|Third Intervention||14||
48604486|NCT01961167|101816300|FG000|COMPLETED|Overall Study||27|Completion of primary endpoint milestone at 30 days and secondary endpoints at 6 months.|
48604487|NCT01961167|101816300|FG000|NOT COMPLETED|Overall Study||0||
48147818|NCT00584727|100685076|FG004|STARTED|Third Intervention||16||
48147819|NCT00584727|100685077|FG005|STARTED|Third Intervention||16||
48147820|NCT00584727|100685072|FG000|COMPLETED|Third Intervention||17||
48147821|NCT00584727|100685073|FG001|COMPLETED|Third Intervention||17||
48147822|NCT00584727|100685074|FG002|COMPLETED|Third Intervention||14||
48147823|NCT00584727|100685075|FG003|COMPLETED|Third Intervention||14||
48147824|NCT00584727|100685076|FG004|COMPLETED|Third Intervention||12||
48147825|NCT00584727|100685077|FG005|COMPLETED|Third Intervention||14||
48147826|NCT00584727|100685072|FG000|NOT COMPLETED|Third Intervention||0||
48147827|NCT00584727|100685073|FG001|NOT COMPLETED|Third Intervention||0||
48147828|NCT00584727|100685074|FG002|NOT COMPLETED|Third Intervention||1||
48147829|NCT00584727|100685075|FG003|NOT COMPLETED|Third Intervention||0||
48147830|NCT00584727|100685076|FG004|NOT COMPLETED|Third Intervention||4||
48147831|NCT00584727|100685077|FG005|NOT COMPLETED|Third Intervention||2||
48147832|NCT02291679|100685078|FG000|STARTED|Overall Study||401||
48405317|NCT00533351|101325251|FG001|COMPLETED|Period 2||1||
48604488|NCT00523809|101816301|FG000|STARTED|Overall Study||5||
48604489|NCT00523809|101816301|FG000|COMPLETED|Overall Study||5||
48604490|NCT00523809|101816301|FG000|NOT COMPLETED|Overall Study||0||
48604491|NCT01044589|101816302|FG000|STARTED|Overall Study||6||
48604492|NCT01044589|101816303|FG001|STARTED|Overall Study||7||
48604493|NCT01044589|101816302|FG000|COMPLETED|Overall Study||3||
48604494|NCT01044589|101816303|FG001|COMPLETED|Overall Study||2||
48604495|NCT01044589|101816302|FG000|NOT COMPLETED|Overall Study||3||
48604496|NCT01044589|101816303|FG001|NOT COMPLETED|Overall Study||5||
48604497|NCT02155322|101816304|FG000|STARTED|Overall Study||33||
48604498|NCT02155322|101816304|FG000|Treated|Overall Study||32||
48604499|NCT02155322|101816304|FG000|COMPLETED|Overall Study||19||
48604500|NCT02155322|101816304|FG000|NOT COMPLETED|Overall Study||14||
48604501|NCT01108237|101816305|FG000|STARTED|Overall Study||73||
48604502|NCT01108237|101816306|FG001|STARTED|Overall Study||101||
48604503|NCT01108237|101816305|FG000|COMPLETED|Overall Study||64||
48604504|NCT01108237|101816306|FG001|COMPLETED|Overall Study||86||
48604505|NCT01108237|101816305|FG000|NOT COMPLETED|Overall Study||9||
48604506|NCT01108237|101816306|FG001|NOT COMPLETED|Overall Study||15||
48604507|NCT03628716|101816307|FG000|STARTED|Overall Study||19||
48604508|NCT03628716|101816308|FG001|STARTED|Overall Study||24||
48604509|NCT03628716|101816307|FG000|COMPLETED|Overall Study||0||
48604510|NCT03628716|101816308|FG001|COMPLETED|Overall Study||1||
48604511|NCT03628716|101816307|FG000|NOT COMPLETED|Overall Study||19||
48604512|NCT03628716|101816308|FG001|NOT COMPLETED|Overall Study||23||
48604513|NCT03313310|101816309|FG000|STARTED|Phase 2||51||
48604514|NCT03313310|101816310|FG001|STARTED|Phase 2||0||
48604515|NCT03313310|101816309|FG000|COMPLETED|Phase 2||47||
48604516|NCT03313310|101816310|FG001|COMPLETED|Phase 2||0||
48604517|NCT03313310|101816309|FG000|NOT COMPLETED|Phase 2||4||
48604518|NCT03313310|101816310|FG001|NOT COMPLETED|Phase 2||0||
48604519|NCT03313310|101816309|FG000|STARTED|Phase 3||0||
48604520|NCT03313310|101816310|FG001|STARTED|Phase 3||41||
48604521|NCT03313310|101816309|FG000|COMPLETED|Phase 3||0||
48604522|NCT03313310|101816310|FG001|COMPLETED|Phase 3||40||
48604523|NCT03313310|101816309|FG000|NOT COMPLETED|Phase 3||0||
48604524|NCT03313310|101816310|FG001|NOT COMPLETED|Phase 3||1||
48604525|NCT02030886|101816311|FG000|STARTED|Overall Study||14||
48715485|NCT00996801|102088794|FG004|NOT COMPLETED|Overall Study||88||
48715486|NCT00996801|102088795|FG005|NOT COMPLETED|Overall Study||19||
48147833|NCT02291679|100685079|FG001|STARTED|Overall Study||411||
48147834|NCT02291679|100685080|FG002|STARTED|Overall Study||411||
48147835|NCT02291679|100685078|FG000|COMPLETED|Overall Study||357||
48147836|NCT02291679|100685079|FG001|COMPLETED|Overall Study||369||
48147837|NCT02291679|100685080|FG002|COMPLETED|Overall Study||352||
48604526|NCT02030886|101816312|FG001|STARTED|Overall Study||6||
48604527|NCT02030886|101816311|FG000|COMPLETED|Overall Study||14||
48147838|NCT02291679|100685078|FG000|NOT COMPLETED|Overall Study||44||
48604528|NCT02030886|101816312|FG001|COMPLETED|Overall Study||6||
48604529|NCT02030886|101816311|FG000|NOT COMPLETED|Overall Study||0||
48147839|NCT02291679|100685079|FG001|NOT COMPLETED|Overall Study||42||
48405318|NCT00533351|101325250|FG000|NOT COMPLETED|Period 2||0||
48604530|NCT02030886|101816312|FG001|NOT COMPLETED|Overall Study||0||
48147840|NCT02291679|100685080|FG002|NOT COMPLETED|Overall Study||59||
48147841|NCT01441102|100685081|FG000|STARTED|Overall Study||7||
48147842|NCT01441102|100685081|FG000|COMPLETED|Overall Study||4||
48147843|NCT01441102|100685081|FG000|NOT COMPLETED|Overall Study||3||
48302187|NCT03496324|101069855|FG003|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0||
48302188|NCT03496324|101069852|FG000|STARTED|Period 3||6||
48302189|NCT03496324|101069853|FG001|STARTED|Period 3||6||
48302190|NCT03496324|101069854|FG002|STARTED|Period 3||6||
48302191|NCT03496324|101069855|FG003|STARTED|Period 3||6||
48302192|NCT03496324|101069852|FG000|COMPLETED|Period 3||6||
48302193|NCT03496324|101069853|FG001|COMPLETED|Period 3||6||
48302194|NCT03496324|101069854|FG002|COMPLETED|Period 3||6||
48302195|NCT03496324|101069855|FG003|COMPLETED|Period 3||6||
48405319|NCT00533351|101325251|FG001|NOT COMPLETED|Period 2||0||
48147844|NCT01398280|100685082|FG000|STARTED|Overall Study||11||
48147845|NCT01398280|100685083|FG001|STARTED|Overall Study||4||
48147846|NCT01398280|100685082|FG000|COMPLETED|Overall Study||7||
48147847|NCT01398280|100685083|FG001|COMPLETED|Overall Study||4||
48147848|NCT01398280|100685082|FG000|NOT COMPLETED|Overall Study||4||
48147849|NCT01398280|100685083|FG001|NOT COMPLETED|Overall Study||0||
48147850|NCT00130533|100685084|FG000|STARTED|Overall Study||448||
48147851|NCT00130533|100685085|FG001|STARTED|Overall Study||428||
48147852|NCT00130533|100685084|FG000|COMPLETED|Overall Study||337||
48147853|NCT00130533|100685085|FG001|COMPLETED|Overall Study||398||
48147854|NCT00130533|100685084|FG000|NOT COMPLETED|Overall Study||111||
48147855|NCT00130533|100685085|FG001|NOT COMPLETED|Overall Study||30||
48147856|NCT01939548|100685086|FG000|STARTED|Overall Study||78||
48147857|NCT01939548|100685087|FG001|STARTED|Overall Study||82||
48147858|NCT01939548|100685088|FG002|STARTED|Overall Study||80||
48147859|NCT01939548|100685086|FG000|COMPLETED|Overall Study||41||
48147860|NCT01939548|100685087|FG001|COMPLETED|Overall Study||33||
48147861|NCT01939548|100685088|FG002|COMPLETED|Overall Study||50||
48147862|NCT01939548|100685086|FG000|NOT COMPLETED|Overall Study||37||
48147863|NCT01939548|100685087|FG001|NOT COMPLETED|Overall Study||49||
48147864|NCT01939548|100685088|FG002|NOT COMPLETED|Overall Study||30||
48147865|NCT03899753|100685089|FG000|STARTED|Overall Study||1||
48147866|NCT03899753|100685090|FG001|STARTED|Overall Study||0||
48147867|NCT03899753|100685089|FG000|COMPLETED|Overall Study||1||
48147868|NCT03899753|100685090|FG001|COMPLETED|Overall Study||0||
48147869|NCT03899753|100685089|FG000|NOT COMPLETED|Overall Study||0||
48147870|NCT03899753|100685090|FG001|NOT COMPLETED|Overall Study||0||
48147871|NCT00248781|100685091|FG000|STARTED|Overall Study||52||
48147872|NCT00248781|100685092|FG001|STARTED|Overall Study||51||
48147873|NCT00248781|100685091|FG000|COMPLETED|Overall Study||42||
48147874|NCT00248781|100685092|FG001|COMPLETED|Overall Study||47||
48147875|NCT00248781|100685091|FG000|NOT COMPLETED|Overall Study||10||
48147876|NCT00248781|100685092|FG001|NOT COMPLETED|Overall Study||4||
48147877|NCT03364751|100685093|FG000|STARTED|Overall Study||70||
48147878|NCT03364751|100685094|FG001|STARTED|Overall Study||84||
48147879|NCT03364751|100685095|FG002|STARTED|Overall Study||17||
48147880|NCT03364751|100685096|FG003|STARTED|Overall Study||1||
48147881|NCT03364751|100685093|FG000|COMPLETED|Overall Study||69||
48147882|NCT03364751|100685094|FG001|COMPLETED|Overall Study||83||
48147883|NCT03364751|100685095|FG002|COMPLETED|Overall Study||17||
48147884|NCT03364751|100685096|FG003|COMPLETED|Overall Study||1||
48147885|NCT03364751|100685093|FG000|NOT COMPLETED|Overall Study||1||
48147886|NCT03364751|100685094|FG001|NOT COMPLETED|Overall Study||1||
48147887|NCT03364751|100685095|FG002|NOT COMPLETED|Overall Study||0||
48147888|NCT03364751|100685096|FG003|NOT COMPLETED|Overall Study||0||
48147889|NCT02199028|100685097|FG000|STARTED|Week 1||15||
48147890|NCT02199028|100685098|FG001|STARTED|Week 1||15||
48147891|NCT02199028|100685097|FG000|COMPLETED|Week 1||14||
48147892|NCT02199028|100685098|FG001|COMPLETED|Week 1||15||
48147893|NCT02199028|100685097|FG000|NOT COMPLETED|Week 1||1||
48147894|NCT02199028|100685098|FG001|NOT COMPLETED|Week 1||0||
48302196|NCT03496324|101069852|FG000|NOT COMPLETED|Period 3||0||
48147895|NCT02199028|100685097|FG000|STARTED|Week 2||14||
48147896|NCT02199028|100685098|FG001|STARTED|Week 2||15||
48147897|NCT02199028|100685097|FG000|COMPLETED|Week 2||14||
48147898|NCT02199028|100685098|FG001|COMPLETED|Week 2||15||
48147899|NCT02199028|100685097|FG000|NOT COMPLETED|Week 2||0||
48147900|NCT02199028|100685098|FG001|NOT COMPLETED|Week 2||0||
48147901|NCT02199028|100685097|FG000|STARTED|Week 3||14||
48147902|NCT02199028|100685098|FG001|STARTED|Week 3||15||
48147903|NCT02199028|100685097|FG000|COMPLETED|Week 3||13||
48147904|NCT02199028|100685098|FG001|COMPLETED|Week 3||15||
48147905|NCT02199028|100685097|FG000|NOT COMPLETED|Week 3||1||
48302197|NCT03496324|101069853|FG001|NOT COMPLETED|Period 3||0||
48302198|NCT03496324|101069854|FG002|NOT COMPLETED|Period 3||0||
48302199|NCT03496324|101069855|FG003|NOT COMPLETED|Period 3||0||
48302200|NCT03496324|101069852|FG000|STARTED|Period 3: Washout (3 to 7 Days)||6||
48302201|NCT03496324|101069853|FG001|STARTED|Period 3: Washout (3 to 7 Days)||6||
48302202|NCT03496324|101069854|FG002|STARTED|Period 3: Washout (3 to 7 Days)||6||
48302203|NCT03496324|101069855|FG003|STARTED|Period 3: Washout (3 to 7 Days)||6||
48302204|NCT03496324|101069852|FG000|COMPLETED|Period 3: Washout (3 to 7 Days)||6||
48302205|NCT03496324|101069853|FG001|COMPLETED|Period 3: Washout (3 to 7 Days)||6||
48302206|NCT03496324|101069854|FG002|COMPLETED|Period 3: Washout (3 to 7 Days)||6||
48302207|NCT03496324|101069855|FG003|COMPLETED|Period 3: Washout (3 to 7 Days)||6||
48302208|NCT03496324|101069852|FG000|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0||
48302209|NCT03496324|101069853|FG001|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0||
48302210|NCT03496324|101069854|FG002|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0||
48302211|NCT03496324|101069855|FG003|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0||
48302212|NCT03496324|101069852|FG000|STARTED|Period 7: Period 4||6||
48302213|NCT03496324|101069853|FG001|STARTED|Period 7: Period 4||6||
48302214|NCT03496324|101069854|FG002|STARTED|Period 7: Period 4||6||
48604531|NCT01602679|101816313|FG000|STARTED|Overall Study||4||
48604532|NCT01602679|101816314|FG001|STARTED|Overall Study||3||
48604533|NCT01602679|101816313|FG000|COMPLETED|Overall Study||4||
48302215|NCT03496324|101069855|FG003|STARTED|Period 7: Period 4||6||
48302216|NCT03496324|101069852|FG000|COMPLETED|Period 7: Period 4||6||
48302217|NCT03496324|101069853|FG001|COMPLETED|Period 7: Period 4||6||
48302218|NCT03496324|101069854|FG002|COMPLETED|Period 7: Period 4||6||
48302219|NCT03496324|101069855|FG003|COMPLETED|Period 7: Period 4||6||
48302220|NCT03496324|101069852|FG000|NOT COMPLETED|Period 7: Period 4||0||
48302221|NCT03496324|101069853|FG001|NOT COMPLETED|Period 7: Period 4||0||
48302222|NCT03496324|101069854|FG002|NOT COMPLETED|Period 7: Period 4||0||
48302223|NCT03496324|101069855|FG003|NOT COMPLETED|Period 7: Period 4||0||
48302224|NCT00531882|101069856|FG000|STARTED|Overall Study||10||
48302225|NCT00531882|101069857|FG001|STARTED|Overall Study||10||
48302226|NCT00531882|101069858|FG002|STARTED|Overall Study||5||
48302227|NCT00531882|101069856|FG000|COMPLETED|Overall Study||10||
48302228|NCT00531882|101069857|FG001|COMPLETED|Overall Study||10||
48302229|NCT00531882|101069858|FG002|COMPLETED|Overall Study||5||
48302230|NCT00531882|101069856|FG000|NOT COMPLETED|Overall Study||0||
48302231|NCT00531882|101069857|FG001|NOT COMPLETED|Overall Study||0||
48302232|NCT00531882|101069858|FG002|NOT COMPLETED|Overall Study||0||
48302233|NCT01749540|101069859|FG000|STARTED|Overall Study||6||
48302234|NCT01749540|101069860|FG001|STARTED|Overall Study||6||
48302235|NCT01749540|101069861|FG002|STARTED|Overall Study||6||
48302236|NCT01749540|101069862|FG003|STARTED|Overall Study||6||
48302237|NCT01749540|101069863|FG004|STARTED|Overall Study||6||
48302238|NCT01749540|101069864|FG005|STARTED|Overall Study||5||
48302239|NCT01749540|101069865|FG006|STARTED|Overall Study||29||
48302240|NCT01749540|101069859|FG000|COMPLETED|Overall Study||6||
48302241|NCT01749540|101069860|FG001|COMPLETED|Overall Study||6||
48302242|NCT01749540|101069861|FG002|COMPLETED|Overall Study||6||
48302243|NCT01749540|101069862|FG003|COMPLETED|Overall Study||5||
48302244|NCT01749540|101069863|FG004|COMPLETED|Overall Study||6||
48302245|NCT01749540|101069864|FG005|COMPLETED|Overall Study||2||
48302246|NCT01749540|101069865|FG006|COMPLETED|Overall Study||4||
48302247|NCT01749540|101069859|FG000|NOT COMPLETED|Overall Study||0||
48302248|NCT01749540|101069860|FG001|NOT COMPLETED|Overall Study||0||
48302249|NCT01749540|101069861|FG002|NOT COMPLETED|Overall Study||0||
48302250|NCT01749540|101069862|FG003|NOT COMPLETED|Overall Study||1||
48302251|NCT01749540|101069863|FG004|NOT COMPLETED|Overall Study||0||
48604534|NCT01602679|101816314|FG001|COMPLETED|Overall Study||3||
48604535|NCT01602679|101816313|FG000|NOT COMPLETED|Overall Study||0||
48604536|NCT01602679|101816314|FG001|NOT COMPLETED|Overall Study||0||
48604537|NCT02588092|101816315|FG000|STARTED|Overall Study||4||
48604538|NCT02588092|101816316|FG001|STARTED|Overall Study||3||
48604539|NCT02588092|101816317|FG002|STARTED|Overall Study||3||
48302252|NCT01749540|101069864|FG005|NOT COMPLETED|Overall Study||3||
48302253|NCT01749540|101069865|FG006|NOT COMPLETED|Overall Study||25||
48302254|NCT02218190|101069866|FG000|STARTED|Overall Study||13||
48302255|NCT02218190|101069867|FG001|STARTED|Overall Study||13||
48302256|NCT02218190|101069866|FG000|COMPLETED|Overall Study||13||
48302257|NCT02218190|101069867|FG001|COMPLETED|Overall Study||13||
48302258|NCT02218190|101069866|FG000|NOT COMPLETED|Overall Study||0||
48302259|NCT02218190|101069867|FG001|NOT COMPLETED|Overall Study||0||
48302260|NCT00617604|101069868|FG000|STARTED|Overall Study||110||
48302261|NCT00617604|101069869|FG001|STARTED|Overall Study||108||
48302262|NCT00617604|101069868|FG000|Received Treatment|Overall Study||107||
48604540|NCT02588092|101816318|FG003|STARTED|Overall Study||3||
48604541|NCT02588092|101816319|FG004|STARTED|Overall Study||3||
48604542|NCT02588092|101816320|FG005|STARTED|Overall Study||3||
48302263|NCT00617604|101069869|FG001|Received Treatment|Overall Study||105||
48302264|NCT00617604|101069868|FG000|Completed 12 Weeks of Treatment|Overall Study||89||
48302265|NCT00617604|101069869|FG001|Completed 12 Weeks of Treatment|Overall Study||83||
48302266|NCT00617604|101069868|FG000|COMPLETED|Overall Study||92||
48302267|NCT00617604|101069869|FG001|COMPLETED|Overall Study||88||
48302268|NCT00617604|101069868|FG000|NOT COMPLETED|Overall Study||18||
48302269|NCT00617604|101069869|FG001|NOT COMPLETED|Overall Study||20||
48302270|NCT04448756|101069870|FG000|STARTED|Overall Study||49||
48302271|NCT04448756|101069871|FG001|STARTED|Overall Study||54||
48302272|NCT04448756|101069872|FG002|STARTED|Overall Study||46||
48302273|NCT04448756|101069870|FG000|COMPLETED|Overall Study||46||
48147906|NCT02199028|100685098|FG001|NOT COMPLETED|Week 3||0||
48147907|NCT02199028|100685097|FG000|STARTED|Week 4||13||
48302274|NCT04448756|101069871|FG001|COMPLETED|Overall Study||49||
48147908|NCT02199028|100685098|FG001|STARTED|Week 4||15||
48147909|NCT02199028|100685097|FG000|COMPLETED|Week 4||13||
48147910|NCT02199028|100685098|FG001|COMPLETED|Week 4||15||
48147911|NCT02199028|100685097|FG000|NOT COMPLETED|Week 4||0||
48147912|NCT02199028|100685098|FG001|NOT COMPLETED|Week 4||0||
48147913|NCT00251862|100685099|FG000|STARTED|Overall Study||280||
48147914|NCT00251862|100685100|FG001|STARTED|Overall Study||269||
48147915|NCT00251862|100685101|FG002|STARTED|Overall Study||276||
48147916|NCT00251862|100685099|FG000|COMPLETED|Overall Study||280||
48147917|NCT00251862|100685100|FG001|COMPLETED|Overall Study||269||
48147918|NCT00251862|100685101|FG002|COMPLETED|Overall Study||276||
48302275|NCT04448756|101069872|FG002|COMPLETED|Overall Study||45||
48302276|NCT04448756|101069870|FG000|NOT COMPLETED|Overall Study||3||
48302277|NCT04448756|101069871|FG001|NOT COMPLETED|Overall Study||5||
48302278|NCT04448756|101069872|FG002|NOT COMPLETED|Overall Study||1||
48302279|NCT01798992|101069873|FG000|STARTED|Overall Study||4||
48302280|NCT01798992|101069874|FG001|STARTED|Overall Study||19||
48302281|NCT01798992|101069875|FG002|STARTED|Overall Study||16||
48302282|NCT01798992|101069876|FG003|STARTED|Overall Study||17||
48302283|NCT01798992|101069873|FG000|COMPLETED|Overall Study||4||
48302284|NCT01798992|101069874|FG001|COMPLETED|Overall Study||17||
48302285|NCT01798992|101069875|FG002|COMPLETED|Overall Study||14||
48302286|NCT01798992|101069876|FG003|COMPLETED|Overall Study||16||
48302287|NCT01798992|101069873|FG000|NOT COMPLETED|Overall Study||0||
48302288|NCT01798992|101069874|FG001|NOT COMPLETED|Overall Study||2||
48302289|NCT01798992|101069875|FG002|NOT COMPLETED|Overall Study||2||
48302290|NCT01798992|101069876|FG003|NOT COMPLETED|Overall Study||1||
48302291|NCT00355056|101069877|FG000|STARTED|Randomization Period||107||
48302292|NCT00355056|101069878|FG001|STARTED|Randomization Period||123||
48302293|NCT00355056|101069877|FG000|COMPLETED|Randomization Period||103||
48302294|NCT00355056|101069878|FG001|COMPLETED|Randomization Period||117||
48302295|NCT00355056|101069877|FG000|NOT COMPLETED|Randomization Period||4||
48302296|NCT00355056|101069878|FG001|NOT COMPLETED|Randomization Period||6||
48302297|NCT00355056|101069877|FG000|STARTED|Optional Patent Foramen Ovale Closure||0||
48302298|NCT00355056|101069878|FG001|STARTED|Optional Patent Foramen Ovale Closure||87||
48302299|NCT00355056|101069877|FG000|COMPLETED|Optional Patent Foramen Ovale Closure||0||
48405320|NCT00533351|101325250|FG000|STARTED|Period 3||3||
48405321|NCT00533351|101325251|FG001|STARTED|Period 3||0||
48405322|NCT00533351|101325250|FG000|COMPLETED|Period 3||3||
48405323|NCT00533351|101325251|FG001|COMPLETED|Period 3||0||
48405324|NCT00533351|101325250|FG000|NOT COMPLETED|Period 3||0||
48302300|NCT00355056|101069878|FG001|COMPLETED|Optional Patent Foramen Ovale Closure||84||
48302301|NCT00355056|101069877|FG000|NOT COMPLETED|Optional Patent Foramen Ovale Closure||0||
48302302|NCT00355056|101069878|FG001|NOT COMPLETED|Optional Patent Foramen Ovale Closure||3||
48302303|NCT03938038|101069879|FG000|STARTED|First Half of the Month (15 Days)||112||4
48302304|NCT03938038|101069880|FG001|STARTED|First Half of the Month (15 Days)||100||4
48302305|NCT03938038|101069879|FG000|COMPLETED|First Half of the Month (15 Days)||112||4
48302306|NCT03938038|101069880|FG001|COMPLETED|First Half of the Month (15 Days)||100||4
48302307|NCT03938038|101069879|FG000|NOT COMPLETED|First Half of the Month (15 Days)||0||0
48302308|NCT03938038|101069880|FG001|NOT COMPLETED|First Half of the Month (15 Days)||0||0
48302309|NCT03938038|101069879|FG000|STARTED|Second Half of the Month (15 Days)||89||4
48302310|NCT03938038|101069880|FG001|STARTED|Second Half of the Month (15 Days)||110||4
48302311|NCT03938038|101069879|FG000|COMPLETED|Second Half of the Month (15 Days)||89||4
48302312|NCT03938038|101069880|FG001|COMPLETED|Second Half of the Month (15 Days)||110||4
48302313|NCT03938038|101069879|FG000|NOT COMPLETED|Second Half of the Month (15 Days)||0||0
48302314|NCT03938038|101069880|FG001|NOT COMPLETED|Second Half of the Month (15 Days)||0||0
48302315|NCT00682565|101069881|FG000|STARTED|Overall Study||31||
48302316|NCT00682565|101069882|FG001|STARTED|Overall Study||35||
48302317|NCT00682565|101069883|FG002|STARTED|Overall Study||29||
48302318|NCT00682565|101069881|FG000|COMPLETED|Overall Study||30||
48405325|NCT00533351|101325251|FG001|NOT COMPLETED|Period 3||0||
48405326|NCT00415623|101325252|FG000|STARTED|Overall Study||154||
48405327|NCT00415623|101325253|FG001|STARTED|Overall Study||151||
48405328|NCT00415623|101325252|FG000|COMPLETED|Overall Study||149||
48405329|NCT00415623|101325253|FG001|COMPLETED|Overall Study||146||
48147919|NCT00251862|100685099|FG000|NOT COMPLETED|Overall Study||0||
48147920|NCT00251862|100685100|FG001|NOT COMPLETED|Overall Study||0||
48147921|NCT00251862|100685101|FG002|NOT COMPLETED|Overall Study||0||
48147922|NCT01332227|100685102|FG000|STARTED|Overall Study||72||
48405330|NCT00415623|101325252|FG000|NOT COMPLETED|Overall Study||5||
48405331|NCT00415623|101325253|FG001|NOT COMPLETED|Overall Study||5||
48405332|NCT02977507|101325254|FG000|STARTED|Overall Study||8||
48405333|NCT02977507|101325255|FG001|STARTED|Overall Study||10||
48405334|NCT02977507|101325254|FG000|COMPLETED|Overall Study||6||
48405335|NCT02977507|101325255|FG001|COMPLETED|Overall Study||10||
48405336|NCT02977507|101325254|FG000|NOT COMPLETED|Overall Study||2||
48405337|NCT02977507|101325255|FG001|NOT COMPLETED|Overall Study||0||
48405338|NCT03342404|101325256|FG000|STARTED|Blinded Treatment Phase||96||
48405339|NCT03342404|101325257|FG001|STARTED|Blinded Treatment Phase||49||
48405340|NCT03342404|101325256|FG000|COMPLETED|Blinded Treatment Phase||68||
48405341|NCT03342404|101325257|FG001|COMPLETED|Blinded Treatment Phase||18||
48604543|NCT02588092|101816321|FG006|STARTED|Overall Study||3||
48604544|NCT02588092|101816322|FG007|STARTED|Overall Study||4||
48604545|NCT02588092|101816323|FG008|STARTED|Overall Study||6||
48604546|NCT02588092|101816324|FG009|STARTED|Overall Study||3||
48604547|NCT02588092|101816315|FG000|COMPLETED|Overall Study||0||
48604548|NCT02588092|101816316|FG001|COMPLETED|Overall Study||0||
48604549|NCT02588092|101816317|FG002|COMPLETED|Overall Study||0||
48604550|NCT02588092|101816318|FG003|COMPLETED|Overall Study||0||
48604551|NCT02588092|101816319|FG004|COMPLETED|Overall Study||0||
48405342|NCT03342404|101325256|FG000|NOT COMPLETED|Blinded Treatment Phase||28||
48405343|NCT03342404|101325257|FG001|NOT COMPLETED|Blinded Treatment Phase||31||
48405344|NCT03342404|101325256|FG000|STARTED|Open-Label Phase||0||
48405345|NCT03342404|101325257|FG001|STARTED|Open-Label Phase||38||
48405346|NCT03342404|101325256|FG000|COMPLETED|Open-Label Phase||0||
48405347|NCT03342404|101325257|FG001|COMPLETED|Open-Label Phase||27||
48405348|NCT03342404|101325256|FG000|NOT COMPLETED|Open-Label Phase||0||
48405349|NCT03342404|101325257|FG001|NOT COMPLETED|Open-Label Phase||11||
48604552|NCT02588092|101816320|FG005|COMPLETED|Overall Study||0||
48604553|NCT02588092|101816321|FG006|COMPLETED|Overall Study||0||
48604554|NCT02588092|101816322|FG007|COMPLETED|Overall Study||0||
48405350|NCT00598806|101325258|FG000|STARTED|Overall Study||402||
48405351|NCT00598806|101325259|FG001|STARTED|Overall Study||410||
48405352|NCT00598806|101325258|FG000|COMPLETED|Overall Study||329||
48405353|NCT00598806|101325259|FG001|COMPLETED|Overall Study||346||
48715487|NCT00857948|102088796|FG000|STARTED|Overall Study||18||
48715488|NCT00857948|102088797|FG001|STARTED|Overall Study||18||
48302319|NCT00682565|101069882|FG001|COMPLETED|Overall Study||32||
48302320|NCT00682565|101069883|FG002|COMPLETED|Overall Study||29||
48715489|NCT00857948|102088798|FG002|STARTED|Overall Study||19||
48715490|NCT00857948|102088799|FG003|STARTED|Overall Study||23||
48715491|NCT00857948|102088796|FG000|COMPLETED|Overall Study||15||
48715492|NCT00857948|102088797|FG001|COMPLETED|Overall Study||18||
48715493|NCT00857948|102088798|FG002|COMPLETED|Overall Study||18||
48715494|NCT00857948|102088799|FG003|COMPLETED|Overall Study||23||
48715495|NCT00857948|102088796|FG000|NOT COMPLETED|Overall Study||3||
48715496|NCT00857948|102088797|FG001|NOT COMPLETED|Overall Study||0||
48715497|NCT00857948|102088798|FG002|NOT COMPLETED|Overall Study||1||
48715498|NCT00857948|102088799|FG003|NOT COMPLETED|Overall Study||0||
48715499|NCT00524589|102088800|FG000|STARTED|Overall Study||18||
48715500|NCT00524589|102088800|FG000|COMPLETED|Overall Study||0||
48715501|NCT00524589|102088800|FG000|NOT COMPLETED|Overall Study||18||
48715502|NCT00366028|102088801|FG000|STARTED|Overall Study||889||
48715503|NCT00366028|102088802|FG001|STARTED|Overall Study||735||
48715504|NCT00366028|102088801|FG000|COMPLETED|Overall Study||889||
48715505|NCT00366028|102088802|FG001|COMPLETED|Overall Study||735||
48715506|NCT00366028|102088801|FG000|NOT COMPLETED|Overall Study||0||
48715507|NCT00366028|102088802|FG001|NOT COMPLETED|Overall Study||0||
48715508|NCT02725879|102088803|FG000|STARTED|Overall Study||30||
48715509|NCT02725879|102088804|FG001|STARTED|Overall Study||30||
48715510|NCT02725879|102088805|FG002|STARTED|Overall Study||30||
48302321|NCT00682565|101069881|FG000|NOT COMPLETED|Overall Study||1||
48302322|NCT00682565|101069882|FG001|NOT COMPLETED|Overall Study||3||
48302323|NCT00682565|101069883|FG002|NOT COMPLETED|Overall Study||0||
48302324|NCT02673203|101069884|FG000|STARTED|Overall Study||16||
48302325|NCT02673203|101069885|FG001|STARTED|Overall Study||15||
48302326|NCT02673203|101069884|FG000|COMPLETED|Overall Study||16||
48302327|NCT02673203|101069885|FG001|COMPLETED|Overall Study||15||
48302328|NCT02673203|101069884|FG000|NOT COMPLETED|Overall Study||0||
48715511|NCT02725879|102088803|FG000|COMPLETED|Overall Study||30||
48147923|NCT01332227|100685103|FG001|STARTED|Overall Study||37||
48147924|NCT01332227|100685102|FG000|COMPLETED|Overall Study||56||
48147925|NCT01332227|100685103|FG001|COMPLETED|Overall Study||32||
48147926|NCT01332227|100685102|FG000|NOT COMPLETED|Overall Study||16||
48147927|NCT01332227|100685103|FG001|NOT COMPLETED|Overall Study||5||
48147928|NCT02134587|100685104|FG000|STARTED|Overall Study||203||
48147929|NCT02134587|100685104|FG000|COMPLETED|Overall Study||173||
48147930|NCT02134587|100685104|FG000|NOT COMPLETED|Overall Study||30||
48147931|NCT03317002|100685105|FG000|STARTED|Overall Study||52||
48147932|NCT03317002|100685106|FG001|STARTED|Overall Study||25||
48147933|NCT03317002|100685107|FG002|STARTED|Overall Study||52||
48147934|NCT03317002|100685105|FG000|COMPLETED|Overall Study||50||
48147935|NCT03317002|100685106|FG001|COMPLETED|Overall Study||24||
48147936|NCT03317002|100685107|FG002|COMPLETED|Overall Study||51||
48147937|NCT03317002|100685105|FG000|NOT COMPLETED|Overall Study||2||
48147938|NCT03317002|100685106|FG001|NOT COMPLETED|Overall Study||1||
48147939|NCT03317002|100685107|FG002|NOT COMPLETED|Overall Study||1||
48147940|NCT00156065|100685108|FG000|STARTED|Overall Study||51||
48147941|NCT00156065|100685109|FG001|STARTED|Overall Study||93||
48147942|NCT00156065|100685110|FG002|STARTED|Overall Study||43||
48147943|NCT00156065|100685108|FG000|COMPLETED|Overall Study||20||
48147944|NCT00156065|100685109|FG001|COMPLETED|Overall Study||30||
48302329|NCT02673203|101069885|FG001|NOT COMPLETED|Overall Study||0||
48302330|NCT00066742|101069886|FG000|STARTED|Induction Chemoradiotherapy||72||
48302331|NCT00066742|101069886|FG000|Eligible|Induction Chemoradiotherapy||69||
48302332|NCT00066742|101069886|FG000|Began Protocol Treatment|Induction Chemoradiotherapy||68||
48302333|NCT00066742|101069886|FG000|COMPLETED|Induction Chemoradiotherapy||43||
48302334|NCT00066742|101069886|FG000|NOT COMPLETED|Induction Chemoradiotherapy||29||
48147945|NCT00156065|100685110|FG002|COMPLETED|Overall Study||16||
48604555|NCT02588092|101816323|FG008|COMPLETED|Overall Study||0||
48604556|NCT02588092|101816324|FG009|COMPLETED|Overall Study||0||
48147946|NCT00156065|100685108|FG000|NOT COMPLETED|Overall Study||31||
48147947|NCT00156065|100685109|FG001|NOT COMPLETED|Overall Study||63||
48302335|NCT00066742|101069886|FG000|STARTED|Consolidation Chemotherapy||42||
48604557|NCT02588092|101816315|FG000|NOT COMPLETED|Overall Study||4||
48604558|NCT02588092|101816316|FG001|NOT COMPLETED|Overall Study||3||
48604559|NCT02588092|101816317|FG002|NOT COMPLETED|Overall Study||3||
48604560|NCT02588092|101816318|FG003|NOT COMPLETED|Overall Study||3||
48604561|NCT02588092|101816319|FG004|NOT COMPLETED|Overall Study||3||
48604562|NCT02588092|101816320|FG005|NOT COMPLETED|Overall Study||3||
48604563|NCT02588092|101816321|FG006|NOT COMPLETED|Overall Study||3||
48604564|NCT02588092|101816322|FG007|NOT COMPLETED|Overall Study||4||
48604565|NCT02588092|101816323|FG008|NOT COMPLETED|Overall Study||6||
48604566|NCT02588092|101816324|FG009|NOT COMPLETED|Overall Study||3||
48604567|NCT03034135|101816325|FG000|STARTED|Overall Study||23||
48604568|NCT03034135|101816325|FG000|COMPLETED|Overall Study||21||
48147948|NCT00156065|100685110|FG002|NOT COMPLETED|Overall Study||27||
48147949|NCT00831779|100685111|FG000|STARTED|Overall Study||21||
48147950|NCT00831779|100685112|FG001|STARTED|Overall Study||23||
48147951|NCT00831779|100685111|FG000|COMPLETED|Overall Study||20||
48147952|NCT00831779|100685112|FG001|COMPLETED|Overall Study||22||
48147953|NCT00831779|100685111|FG000|NOT COMPLETED|Overall Study||1||
48147954|NCT00831779|100685112|FG001|NOT COMPLETED|Overall Study||1||
48147955|NCT00860379|100685113|FG000|STARTED|Overall Study||4||
48147956|NCT00860379|100685114|FG001|STARTED|Overall Study||6||
48147957|NCT00860379|100685115|FG002|STARTED|Overall Study||4||
48147958|NCT00860379|100685113|FG000|COMPLETED|Overall Study||4||
48147959|NCT00860379|100685114|FG001|COMPLETED|Overall Study||6||
48147960|NCT00860379|100685115|FG002|COMPLETED|Overall Study||4||
48147961|NCT00860379|100685113|FG000|NOT COMPLETED|Overall Study||0||
48147962|NCT00860379|100685114|FG001|NOT COMPLETED|Overall Study||0||
48147963|NCT00860379|100685115|FG002|NOT COMPLETED|Overall Study||0||
48147964|NCT00725452|100685116|FG000|STARTED|Overall Study||26||
48147965|NCT00725452|100685116|FG000|COMPLETED|Overall Study||15||
48147966|NCT00725452|100685116|FG000|NOT COMPLETED|Overall Study||11||
48147967|NCT03035292|100685117|FG000|STARTED|Overall Study||110||110
48147968|NCT03035292|100685117|FG000|COMPLETED|Overall Study||110||110
48147969|NCT03035292|100685117|FG000|NOT COMPLETED|Overall Study||0||0
48147970|NCT00057551|100685118|FG000|STARTED|Overall Study||200||
48147971|NCT00057551|100685119|FG001|STARTED|Overall Study||195||
48147972|NCT00057551|100685120|FG002|STARTED|Overall Study||96||
48147973|NCT00057551|100685118|FG000|COMPLETED|Overall Study||175||
48147974|NCT00057551|100685119|FG001|COMPLETED|Overall Study||168||
48147975|NCT00057551|100685120|FG002|COMPLETED|Overall Study||80||
48147976|NCT00057551|100685118|FG000|NOT COMPLETED|Overall Study||25||
48147977|NCT00057551|100685119|FG001|NOT COMPLETED|Overall Study||27||
48147978|NCT00057551|100685120|FG002|NOT COMPLETED|Overall Study||16||
48147979|NCT02030015|100685121|FG000|STARTED|Overall Study||16||
48147980|NCT02030015|100685121|FG000|COMPLETED|Overall Study||0||
48147981|NCT02030015|100685121|FG000|NOT COMPLETED|Overall Study||16||
48147982|NCT01522417|100685122|FG000|STARTED|Overall Study||209||
48147983|NCT01522417|100685123|FG001|STARTED|Overall Study||202||
48147984|NCT01522417|100685124|FG002|STARTED|Overall Study||124||
48147985|NCT01522417|100685122|FG000|COMPLETED|Overall Study||209||
48147986|NCT01522417|100685123|FG001|COMPLETED|Overall Study||202||
48147987|NCT01522417|100685124|FG002|COMPLETED|Overall Study||124||
48147988|NCT01522417|100685122|FG000|NOT COMPLETED|Overall Study||0||
48147989|NCT01522417|100685123|FG001|NOT COMPLETED|Overall Study||0||
48147990|NCT01522417|100685124|FG002|NOT COMPLETED|Overall Study||0||
48147991|NCT02184611|100685125|FG000|STARTED|Overall Study||101||
48147992|NCT02184611|100685126|FG001|STARTED|Overall Study||205||
48147993|NCT02184611|100685125|FG000|COMPLETED|Overall Study||80||
48147994|NCT02184611|100685126|FG001|COMPLETED|Overall Study||177||
48147995|NCT02184611|100685125|FG000|NOT COMPLETED|Overall Study||21||
48147996|NCT02184611|100685126|FG001|NOT COMPLETED|Overall Study||28||
48147997|NCT01922115|100685127|FG000|STARTED|Overall Study||28||
48147998|NCT01922115|100685128|FG001|STARTED|Overall Study||31||
48147999|NCT01922115|100685127|FG000|COMPLETED|Overall Study||21||
48148000|NCT01922115|100685128|FG001|COMPLETED|Overall Study||24||
48148001|NCT01922115|100685127|FG000|NOT COMPLETED|Overall Study||7||
48148002|NCT01922115|100685128|FG001|NOT COMPLETED|Overall Study||7||
48148003|NCT01400503|100685129|FG000|STARTED|Overall Study||60||
48148004|NCT01400503|100685129|FG000|COMPLETED|Overall Study||0||
48148005|NCT01400503|100685129|FG000|NOT COMPLETED|Overall Study||60||
48148006|NCT02212574|100685130|FG000|STARTED|Overall Study||6||
48148007|NCT02212574|100685130|FG000|COMPLETED|Overall Study||6||
48148008|NCT02212574|100685130|FG000|NOT COMPLETED|Overall Study||0||
48148009|NCT00989768|100685131|FG000|STARTED|Overall Study||29||
48148010|NCT00989768|100685131|FG000|COMPLETED|Overall Study||28||
48148011|NCT00989768|100685131|FG000|NOT COMPLETED|Overall Study||1||
48148012|NCT05711641|100685132|FG000|STARTED|First Intervention (Single Dose)||16||
48148013|NCT05711641|100685133|FG001|STARTED|First Intervention (Single Dose)||16||
48148014|NCT05711641|100685132|FG000|COMPLETED|First Intervention (Single Dose)||16||
48148015|NCT05711641|100685133|FG001|COMPLETED|First Intervention (Single Dose)||16||
48148016|NCT05711641|100685132|FG000|NOT COMPLETED|First Intervention (Single Dose)||0||
48148017|NCT05711641|100685133|FG001|NOT COMPLETED|First Intervention (Single Dose)||0||
48148018|NCT05711641|100685132|FG000|STARTED|Washout (2 Weeks)||16||
48148019|NCT05711641|100685133|FG001|STARTED|Washout (2 Weeks)||16||
48148020|NCT05711641|100685132|FG000|COMPLETED|Washout (2 Weeks)||14||
48148021|NCT05711641|100685133|FG001|COMPLETED|Washout (2 Weeks)||15||
48148022|NCT05711641|100685132|FG000|NOT COMPLETED|Washout (2 Weeks)||2||
48148023|NCT05711641|100685133|FG001|NOT COMPLETED|Washout (2 Weeks)||1||
48148024|NCT05711641|100685132|FG000|STARTED|Second Intervention (Single Dose)||14||
48148025|NCT05711641|100685133|FG001|STARTED|Second Intervention (Single Dose)||15||
48148026|NCT05711641|100685132|FG000|COMPLETED|Second Intervention (Single Dose)||13||
48148027|NCT05711641|100685133|FG001|COMPLETED|Second Intervention (Single Dose)||15||
48148028|NCT05711641|100685132|FG000|NOT COMPLETED|Second Intervention (Single Dose)||1||
48148029|NCT05711641|100685133|FG001|NOT COMPLETED|Second Intervention (Single Dose)||0||
48148030|NCT01925950|100685134|FG000|STARTED|Part 1||1||
48148031|NCT01925950|100685135|FG001|STARTED|Part 1||1||
48148032|NCT01925950|100685134|FG000|COMPLETED|Part 1||1||
48148033|NCT01925950|100685135|FG001|COMPLETED|Part 1||1||
48148034|NCT01925950|100685134|FG000|NOT COMPLETED|Part 1||0||
48148035|NCT01925950|100685135|FG001|NOT COMPLETED|Part 1||0||
48148036|NCT01925950|100685134|FG000|STARTED|Part 2||1||
48405354|NCT00598806|101325258|FG000|NOT COMPLETED|Overall Study||73||
48604569|NCT03034135|101816325|FG000|NOT COMPLETED|Overall Study||2||
48604570|NCT02769312|101816326|FG000|STARTED|Double-Blind (0-2 Weeks)||25||
48302336|NCT00066742|101069886|FG000|Eligible|Consolidation Chemotherapy||40||
48302337|NCT00066742|101069886|FG000|COMPLETED|Consolidation Chemotherapy||39||
48302338|NCT00066742|101069886|FG000|NOT COMPLETED|Consolidation Chemotherapy||3||
48302339|NCT02072434|101069887|FG000|STARTED|Overall Study||1095||
48302340|NCT02072434|101069888|FG001|STARTED|Overall Study||1104||
48302341|NCT02072434|101069887|FG000|Intent to Treat Analysis Set|Overall Study||1095||
48302342|NCT02072434|101069888|FG001|Intent to Treat Analysis Set|Overall Study||1104||
48302343|NCT02072434|101069887|FG000|Received Study Drug|Overall Study||1067||
48302344|NCT02072434|101069888|FG001|Received Study Drug|Overall Study||1082||
48302345|NCT02072434|101069887|FG000|Safety Analysis Set|Overall Study||1067||
48302346|NCT02072434|101069888|FG001|Safety Analysis Set|Overall Study||1082||
48302347|NCT02072434|101069887|FG000|COMPLETED|Overall Study||1041||
48302348|NCT02072434|101069888|FG001|COMPLETED|Overall Study||1014||
48302349|NCT02072434|101069887|FG000|NOT COMPLETED|Overall Study||54||
48302350|NCT02072434|101069888|FG001|NOT COMPLETED|Overall Study||90||
48302351|NCT02234323|101069889|FG000|STARTED|All Enrolled||108||
48302352|NCT02234323|101069889|FG000|COMPLETED|All Enrolled||103||
48302353|NCT02234323|101069889|FG000|NOT COMPLETED|All Enrolled||5||
48302354|NCT02234323|101069889|FG000|STARTED|All Treated||103||
48405355|NCT00598806|101325259|FG001|NOT COMPLETED|Overall Study||64||
48405356|NCT02801006|101325260|FG000|STARTED|Lens 1||22||44
48604571|NCT02769312|101816327|FG001|STARTED|Double-Blind (0-2 Weeks)||25||
48604572|NCT02769312|101816326|FG000|COMPLETED|Double-Blind (0-2 Weeks)||23||
48604573|NCT02769312|101816327|FG001|COMPLETED|Double-Blind (0-2 Weeks)||24||
48302355|NCT02234323|101069889|FG000|Episodic Treatment Regimen|All Treated||81||
48302356|NCT02234323|101069889|FG000|Prophylactic Treatment Regimen|All Treated||89||
48302357|NCT02234323|101069889|FG000|Immune Tolerance Induction (ITI)|All Treated||15||
48302358|NCT02234323|101069889|FG000|COMPLETED|All Treated||85||
48302359|NCT02234323|101069889|FG000|NOT COMPLETED|All Treated||18||
48302360|NCT02544217|101069890|FG000|STARTED|Overall Study||7||
48302361|NCT02544217|101069891|FG001|STARTED|Overall Study||7||
48302362|NCT02544217|101069892|FG002|STARTED|Overall Study||4||
48302363|NCT02544217|101069893|FG003|STARTED|Overall Study||4||
48302364|NCT02544217|101069894|FG004|STARTED|Overall Study||4||
48302365|NCT02544217|101069895|FG005|STARTED|Overall Study||6||
48302366|NCT02544217|101069890|FG000|COMPLETED|Overall Study||6||
48604574|NCT02769312|101816326|FG000|NOT COMPLETED|Double-Blind (0-2 Weeks)||2||
48302367|NCT02544217|101069891|FG001|COMPLETED|Overall Study||6||
48302368|NCT02544217|101069892|FG002|COMPLETED|Overall Study||4||
48302369|NCT02544217|101069893|FG003|COMPLETED|Overall Study||4||
48302370|NCT02544217|101069894|FG004|COMPLETED|Overall Study||4||
48302371|NCT02544217|101069895|FG005|COMPLETED|Overall Study||6||
48302372|NCT02544217|101069890|FG000|NOT COMPLETED|Overall Study||1||
48302373|NCT02544217|101069891|FG001|NOT COMPLETED|Overall Study||1||
48302374|NCT02544217|101069892|FG002|NOT COMPLETED|Overall Study||0||
48302375|NCT02544217|101069893|FG003|NOT COMPLETED|Overall Study||0||
48302376|NCT02544217|101069894|FG004|NOT COMPLETED|Overall Study||0||
48302377|NCT02544217|101069895|FG005|NOT COMPLETED|Overall Study||0||
48302378|NCT03065023|101069896|FG000|STARTED|Overall Study||3||
48302379|NCT03065023|101069897|FG001|STARTED|Overall Study||3||
48302380|NCT03065023|101069898|FG002|STARTED|Overall Study||3||
48302381|NCT03065023|101069899|FG003|STARTED|Overall Study||6||
48302382|NCT03065023|101069900|FG004|STARTED|Overall Study||0||
48302383|NCT03065023|101069896|FG000|COMPLETED|Overall Study||1||
48302384|NCT03065023|101069897|FG001|COMPLETED|Overall Study||1||
48302385|NCT03065023|101069898|FG002|COMPLETED|Overall Study||2||
48302386|NCT03065023|101069899|FG003|COMPLETED|Overall Study||3||
48302387|NCT03065023|101069900|FG004|COMPLETED|Overall Study||0||
48302388|NCT03065023|101069896|FG000|NOT COMPLETED|Overall Study||2||
48302389|NCT03065023|101069897|FG001|NOT COMPLETED|Overall Study||2||
48302390|NCT03065023|101069898|FG002|NOT COMPLETED|Overall Study||1||
48302391|NCT03065023|101069899|FG003|NOT COMPLETED|Overall Study||3||
48302392|NCT03065023|101069900|FG004|NOT COMPLETED|Overall Study||0||
48302393|NCT00702845|101069901|FG000|STARTED|Overall Study||268||
48302394|NCT00702845|101069902|FG001|STARTED|Overall Study||129||
48302395|NCT00702845|101069901|FG000|Randomized|Overall Study||268||
48302396|NCT00702845|101069902|FG001|Randomized|Overall Study||128||
48302397|NCT00702845|101069901|FG000|COMPLETED|Overall Study||246||
48302398|NCT00702845|101069902|FG001|COMPLETED|Overall Study||121||
48302399|NCT00702845|101069901|FG000|NOT COMPLETED|Overall Study||22||
48302400|NCT00702845|101069902|FG001|NOT COMPLETED|Overall Study||8||
48302401|NCT01821378|101069903|FG000|STARTED|Overall Study||101||
48302402|NCT01821378|101069904|FG001|STARTED|Overall Study||199||
48302403|NCT01821378|101069905|FG002|STARTED|Overall Study||112||
48302404|NCT01821378|101069903|FG000|COMPLETED|Overall Study||74||
48302405|NCT01821378|101069904|FG001|COMPLETED|Overall Study||145||
48302406|NCT01821378|101069905|FG002|COMPLETED|Overall Study||70||
48302407|NCT01821378|101069903|FG000|NOT COMPLETED|Overall Study||27||
48302408|NCT01821378|101069904|FG001|NOT COMPLETED|Overall Study||54||
48302409|NCT01821378|101069905|FG002|NOT COMPLETED|Overall Study||42||
48302410|NCT01479829|101069906|FG000|STARTED|Overall Study||35||
48302411|NCT01479829|101069907|FG001|STARTED|Overall Study||30||
48302412|NCT01479829|101069906|FG000|COMPLETED|Overall Study||27||
48302413|NCT01479829|101069907|FG001|COMPLETED|Overall Study||20||
48302414|NCT01479829|101069906|FG000|NOT COMPLETED|Overall Study||8||
48302415|NCT01479829|101069907|FG001|NOT COMPLETED|Overall Study||10||
48302416|NCT01786239|101069908|FG000|STARTED|Overall Study||25||
48302417|NCT01786239|101069909|FG001|STARTED|Overall Study||25||
48302418|NCT01786239|101069908|FG000|COMPLETED|Overall Study||14||
48302419|NCT01786239|101069909|FG001|COMPLETED|Overall Study||14||
48302420|NCT01786239|101069908|FG000|NOT COMPLETED|Overall Study||11||
48302421|NCT01786239|101069909|FG001|NOT COMPLETED|Overall Study||11||
48302422|NCT00528567|101069910|FG000|STARTED|Overall Study||1301||
48302423|NCT00528567|101069911|FG001|STARTED|Overall Study||1290||
48302424|NCT00528567|101069910|FG000|Intention to Treat|Overall Study||1301||
48302425|NCT00528567|101069911|FG001|Intention to Treat|Overall Study||1290||
48302426|NCT00528567|101069910|FG000|Safety Population|Overall Study||1288||
48302427|NCT00528567|101069911|FG001|Safety Population|Overall Study||1271||
48302428|NCT00528567|101069910|FG000|COMPLETED|Overall Study||870||
48148037|NCT01925950|100685135|FG001|STARTED|Part 2||0||
48148038|NCT01925950|100685134|FG000|COMPLETED|Part 2||0||
48148039|NCT01925950|100685135|FG001|COMPLETED|Part 2||0||
48148040|NCT01925950|100685134|FG000|NOT COMPLETED|Part 2||1||
48148041|NCT01925950|100685135|FG001|NOT COMPLETED|Part 2||0||
48148042|NCT04639128|100685136|FG000|STARTED|Overall Study||63||
48148043|NCT04639128|100685137|FG001|STARTED|Overall Study||63||
48148044|NCT04639128|100685136|FG000|COMPLETED|Overall Study||60||
48148045|NCT04639128|100685137|FG001|COMPLETED|Overall Study||62||
48148046|NCT04639128|100685136|FG000|NOT COMPLETED|Overall Study||3||
48148047|NCT04639128|100685137|FG001|NOT COMPLETED|Overall Study||1||
48405357|NCT02801006|101325261|FG001|STARTED|Lens 1||19||38
48405358|NCT02801006|101325260|FG000|COMPLETED|Lens 1||22||44
48405359|NCT02801006|101325261|FG001|COMPLETED|Lens 1||19||38
48405360|NCT02801006|101325260|FG000|NOT COMPLETED|Lens 1||0||0
48148048|NCT00803452|100685138|FG000|STARTED|Overall Study||9||
48148049|NCT00803452|100685139|FG001|STARTED|Overall Study||22||
48148050|NCT00803452|100685138|FG000|COMPLETED|Overall Study||9||
48405361|NCT02801006|101325261|FG001|NOT COMPLETED|Lens 1||0||0
48405362|NCT02801006|101325260|FG000|STARTED|Lens 2||22||44
48405363|NCT02801006|101325261|FG001|STARTED|Lens 2||19||38
48148051|NCT00803452|100685139|FG001|COMPLETED|Overall Study||17||
48405364|NCT02801006|101325260|FG000|COMPLETED|Lens 2||22||44
48148052|NCT00803452|100685138|FG000|NOT COMPLETED|Overall Study||0||
48148053|NCT00803452|100685139|FG001|NOT COMPLETED|Overall Study||5||
48148054|NCT02453685|100685140|FG000|STARTED|Overall Study||168||
48148055|NCT02453685|100685141|FG001|STARTED|Overall Study||167||
48302429|NCT00528567|101069911|FG001|COMPLETED|Overall Study||982||
48302430|NCT00528567|101069910|FG000|NOT COMPLETED|Overall Study||431||
48302431|NCT00528567|101069911|FG001|NOT COMPLETED|Overall Study||308||
48302432|NCT03250832|101069912|FG000|STARTED|Part 1 (Up to Approximately 51 Months)||3||
48302433|NCT03250832|101069913|FG001|STARTED|Part 1 (Up to Approximately 51 Months)||10||
48302434|NCT03250832|101069914|FG002|STARTED|Part 1 (Up to Approximately 51 Months)||11||
48302435|NCT03250832|101069915|FG003|STARTED|Part 1 (Up to Approximately 51 Months)||10||
48302436|NCT03250832|101069916|FG004|STARTED|Part 1 (Up to Approximately 51 Months)||5||
48302437|NCT03250832|101069917|FG005|STARTED|Part 1 (Up to Approximately 51 Months)||7||
48302438|NCT03250832|101069918|FG006|STARTED|Part 1 (Up to Approximately 51 Months)||6||
48302439|NCT03250832|101069919|FG007|STARTED|Part 1 (Up to Approximately 51 Months)||0||
48302440|NCT03250832|101069920|FG008|STARTED|Part 1 (Up to Approximately 51 Months)||0||
48302441|NCT03250832|101069921|FG009|STARTED|Part 1 (Up to Approximately 51 Months)||0||
48302442|NCT03250832|101069922|FG010|STARTED|Part 1 (Up to Approximately 51 Months)||0||
48302443|NCT03250832|101069923|FG011|STARTED|Part 1 (Up to Approximately 51 Months)||0||
48302444|NCT03250832|101069912|FG000|COMPLETED|Part 1 (Up to Approximately 51 Months)||0||
48302445|NCT03250832|101069913|FG001|COMPLETED|Part 1 (Up to Approximately 51 Months)||0||
48148056|NCT02453685|100685140|FG000|Exposed|Overall Study||166||
48148057|NCT02453685|100685141|FG001|Exposed|Overall Study||166||
48148058|NCT02453685|100685140|FG000|COMPLETED|Overall Study||149||
48148059|NCT02453685|100685141|FG001|COMPLETED|Overall Study||155||
48148060|NCT02453685|100685140|FG000|NOT COMPLETED|Overall Study||19||
48148061|NCT02453685|100685141|FG001|NOT COMPLETED|Overall Study||12||
48148062|NCT04650555|100685142|FG000|STARTED|Overall Study||6||
48148063|NCT04650555|100685143|FG001|STARTED|Overall Study||6||
48148064|NCT04650555|100685144|FG002|STARTED|Overall Study||6||
48148065|NCT04650555|100685145|FG003|STARTED|Overall Study||6||
48148066|NCT04650555|100685146|FG004|STARTED|Overall Study||10||
48148067|NCT04650555|100685142|FG000|COMPLETED|Overall Study||6||
48302446|NCT03250832|101069914|FG002|COMPLETED|Part 1 (Up to Approximately 51 Months)||0||
48302447|NCT03250832|101069915|FG003|COMPLETED|Part 1 (Up to Approximately 51 Months)||0||
48302448|NCT03250832|101069916|FG004|COMPLETED|Part 1 (Up to Approximately 51 Months)||0||
48302449|NCT03250832|101069917|FG005|COMPLETED|Part 1 (Up to Approximately 51 Months)||0||
48302450|NCT03250832|101069918|FG006|COMPLETED|Part 1 (Up to Approximately 51 Months)||0||
48302451|NCT03250832|101069919|FG007|COMPLETED|Part 1 (Up to Approximately 51 Months)||0||
48302452|NCT03250832|101069920|FG008|COMPLETED|Part 1 (Up to Approximately 51 Months)||0||
48302453|NCT03250832|101069921|FG009|COMPLETED|Part 1 (Up to Approximately 51 Months)||0||
48302454|NCT03250832|101069922|FG010|COMPLETED|Part 1 (Up to Approximately 51 Months)||0||
48302455|NCT03250832|101069923|FG011|COMPLETED|Part 1 (Up to Approximately 51 Months)||0||
48302456|NCT03250832|101069912|FG000|NOT COMPLETED|Part 1 (Up to Approximately 51 Months)||3||
48302457|NCT03250832|101069913|FG001|NOT COMPLETED|Part 1 (Up to Approximately 51 Months)||10||
48302458|NCT03250832|101069914|FG002|NOT COMPLETED|Part 1 (Up to Approximately 51 Months)||11||
48302459|NCT03250832|101069915|FG003|NOT COMPLETED|Part 1 (Up to Approximately 51 Months)||10||
48302460|NCT03250832|101069916|FG004|NOT COMPLETED|Part 1 (Up to Approximately 51 Months)||5||
48302461|NCT03250832|101069917|FG005|NOT COMPLETED|Part 1 (Up to Approximately 51 Months)||7||
48302462|NCT03250832|101069918|FG006|NOT COMPLETED|Part 1 (Up to Approximately 51 Months)||6||
48302463|NCT03250832|101069919|FG007|NOT COMPLETED|Part 1 (Up to Approximately 51 Months)||0||
48302464|NCT03250832|101069920|FG008|NOT COMPLETED|Part 1 (Up to Approximately 51 Months)||0||
48302465|NCT03250832|101069921|FG009|NOT COMPLETED|Part 1 (Up to Approximately 51 Months)||0||
48302466|NCT03250832|101069922|FG010|NOT COMPLETED|Part 1 (Up to Approximately 51 Months)||0||
48302467|NCT03250832|101069923|FG011|NOT COMPLETED|Part 1 (Up to Approximately 51 Months)||0||
48302468|NCT03250832|101069912|FG000|STARTED|Part 2A (Up to Approximately 30 Months)||0||
48302469|NCT03250832|101069913|FG001|STARTED|Part 2A (Up to Approximately 30 Months)||0||
48302470|NCT03250832|101069914|FG002|STARTED|Part 2A (Up to Approximately 30 Months)||0||
48302471|NCT03250832|101069915|FG003|STARTED|Part 2A (Up to Approximately 30 Months)||0||
48302472|NCT03250832|101069916|FG004|STARTED|Part 2A (Up to Approximately 30 Months)||0||
48302473|NCT03250832|101069917|FG005|STARTED|Part 2A (Up to Approximately 30 Months)||0||
48302474|NCT03250832|101069918|FG006|STARTED|Part 2A (Up to Approximately 30 Months)||0||
48302475|NCT03250832|101069919|FG007|STARTED|Part 2A (Up to Approximately 30 Months)||34||
48302476|NCT03250832|101069920|FG008|STARTED|Part 2A (Up to Approximately 30 Months)||0||
48302477|NCT03250832|101069921|FG009|STARTED|Part 2A (Up to Approximately 30 Months)||0||
48302478|NCT03250832|101069922|FG010|STARTED|Part 2A (Up to Approximately 30 Months)||0||
48302479|NCT03250832|101069923|FG011|STARTED|Part 2A (Up to Approximately 30 Months)||0||
48302480|NCT03250832|101069912|FG000|COMPLETED|Part 2A (Up to Approximately 30 Months)||0||
48715512|NCT02725879|102088804|FG001|COMPLETED|Overall Study||30||
48715513|NCT02725879|102088805|FG002|COMPLETED|Overall Study||30||
48715514|NCT02725879|102088803|FG000|NOT COMPLETED|Overall Study||0||
48715515|NCT02725879|102088804|FG001|NOT COMPLETED|Overall Study||0||
48302481|NCT03250832|101069913|FG001|COMPLETED|Part 2A (Up to Approximately 30 Months)||0||
48302482|NCT03250832|101069914|FG002|COMPLETED|Part 2A (Up to Approximately 30 Months)||0||
48302483|NCT03250832|101069915|FG003|COMPLETED|Part 2A (Up to Approximately 30 Months)||0||
48302484|NCT03250832|101069916|FG004|COMPLETED|Part 2A (Up to Approximately 30 Months)||0||
48302485|NCT03250832|101069917|FG005|COMPLETED|Part 2A (Up to Approximately 30 Months)||0||
48302486|NCT03250832|101069918|FG006|COMPLETED|Part 2A (Up to Approximately 30 Months)||0||
48302487|NCT03250832|101069919|FG007|COMPLETED|Part 2A (Up to Approximately 30 Months)||1||
48302488|NCT03250832|101069920|FG008|COMPLETED|Part 2A (Up to Approximately 30 Months)||0||
48302489|NCT03250832|101069921|FG009|COMPLETED|Part 2A (Up to Approximately 30 Months)||0||
48302490|NCT03250832|101069922|FG010|COMPLETED|Part 2A (Up to Approximately 30 Months)||0||
48302491|NCT03250832|101069923|FG011|COMPLETED|Part 2A (Up to Approximately 30 Months)||0||
48302492|NCT03250832|101069912|FG000|NOT COMPLETED|Part 2A (Up to Approximately 30 Months)||0||
48302493|NCT03250832|101069913|FG001|NOT COMPLETED|Part 2A (Up to Approximately 30 Months)||0||
48302494|NCT03250832|101069914|FG002|NOT COMPLETED|Part 2A (Up to Approximately 30 Months)||0||
48302495|NCT03250832|101069915|FG003|NOT COMPLETED|Part 2A (Up to Approximately 30 Months)||0||
48302496|NCT03250832|101069916|FG004|NOT COMPLETED|Part 2A (Up to Approximately 30 Months)||0||
48302497|NCT03250832|101069917|FG005|NOT COMPLETED|Part 2A (Up to Approximately 30 Months)||0||
48302498|NCT03250832|101069918|FG006|NOT COMPLETED|Part 2A (Up to Approximately 30 Months)||0||
48302499|NCT03250832|101069919|FG007|NOT COMPLETED|Part 2A (Up to Approximately 30 Months)||33||
48302500|NCT03250832|101069920|FG008|NOT COMPLETED|Part 2A (Up to Approximately 30 Months)||0||
48368011|NCT03567291|101230092|FG000|Safety Set|Period I||227||
48715516|NCT02725879|102088805|FG002|NOT COMPLETED|Overall Study||0||
48715517|NCT02788201|102088806|FG000|STARTED|Overall Study||1||
48715518|NCT02788201|102088807|FG001|STARTED|Overall Study||1||
48715519|NCT02788201|102088808|FG002|STARTED|Overall Study||1||
48715520|NCT02788201|102088809|FG003|STARTED|Overall Study||1||
48715521|NCT02788201|102088810|FG004|STARTED|Overall Study||1||
48148068|NCT04650555|100685143|FG001|COMPLETED|Overall Study||6||
48148069|NCT04650555|100685144|FG002|COMPLETED|Overall Study||5||
48148070|NCT04650555|100685145|FG003|COMPLETED|Overall Study||6||
48148071|NCT04650555|100685146|FG004|COMPLETED|Overall Study||8||
48302501|NCT03250832|101069921|FG009|NOT COMPLETED|Part 2A (Up to Approximately 30 Months)||0||
48302502|NCT03250832|101069922|FG010|NOT COMPLETED|Part 2A (Up to Approximately 30 Months)||0||
48302503|NCT03250832|101069923|FG011|NOT COMPLETED|Part 2A (Up to Approximately 30 Months)||0||
48302504|NCT03250832|101069912|FG000|STARTED|Part 2B (Up to Approximately 29 Months)||0||
48302505|NCT03250832|101069913|FG001|STARTED|Part 2B (Up to Approximately 29 Months)||0||
48302506|NCT03250832|101069914|FG002|STARTED|Part 2B (Up to Approximately 29 Months)||0||
48302507|NCT03250832|101069915|FG003|STARTED|Part 2B (Up to Approximately 29 Months)||0||
48302508|NCT03250832|101069916|FG004|STARTED|Part 2B (Up to Approximately 29 Months)||0||
48715522|NCT02788201|102088811|FG005|STARTED|Overall Study||3||
48715523|NCT02788201|102088806|FG000|Did Not Start Treatment|Overall Study||0||
48715524|NCT02788201|102088807|FG001|Did Not Start Treatment|Overall Study||0||
48715525|NCT02788201|102088808|FG002|Did Not Start Treatment|Overall Study||0||
48715526|NCT02788201|102088809|FG003|Did Not Start Treatment|Overall Study||0||
48715527|NCT02788201|102088810|FG004|Did Not Start Treatment|Overall Study||0||
48715528|NCT02788201|102088811|FG005|Did Not Start Treatment|Overall Study||3||
48715529|NCT02788201|102088806|FG000|COMPLETED|Overall Study||0||
48715530|NCT02788201|102088807|FG001|COMPLETED|Overall Study||0||
48715531|NCT02788201|102088808|FG002|COMPLETED|Overall Study||0||
48715532|NCT02788201|102088809|FG003|COMPLETED|Overall Study||0||
48715533|NCT02788201|102088810|FG004|COMPLETED|Overall Study||1||
48715534|NCT02788201|102088811|FG005|COMPLETED|Overall Study||0||
48715535|NCT02788201|102088806|FG000|NOT COMPLETED|Overall Study||1||
48148072|NCT04650555|100685142|FG000|NOT COMPLETED|Overall Study||0||
48302509|NCT03250832|101069917|FG005|STARTED|Part 2B (Up to Approximately 29 Months)||0||
48302510|NCT03250832|101069918|FG006|STARTED|Part 2B (Up to Approximately 29 Months)||0||
48302511|NCT03250832|101069919|FG007|STARTED|Part 2B (Up to Approximately 29 Months)||0||
48302512|NCT03250832|101069920|FG008|STARTED|Part 2B (Up to Approximately 29 Months)||4||
48302513|NCT03250832|101069921|FG009|STARTED|Part 2B (Up to Approximately 29 Months)||21||
48302514|NCT03250832|101069922|FG010|STARTED|Part 2B (Up to Approximately 29 Months)||0||
48302515|NCT03250832|101069923|FG011|STARTED|Part 2B (Up to Approximately 29 Months)||0||
48302516|NCT03250832|101069912|FG000|COMPLETED|Part 2B (Up to Approximately 29 Months)||0||
48302517|NCT03250832|101069913|FG001|COMPLETED|Part 2B (Up to Approximately 29 Months)||0||
48302518|NCT03250832|101069914|FG002|COMPLETED|Part 2B (Up to Approximately 29 Months)||0||
48302519|NCT03250832|101069915|FG003|COMPLETED|Part 2B (Up to Approximately 29 Months)||0||
48302520|NCT03250832|101069916|FG004|COMPLETED|Part 2B (Up to Approximately 29 Months)||0||
48302521|NCT03250832|101069917|FG005|COMPLETED|Part 2B (Up to Approximately 29 Months)||0||
48302522|NCT03250832|101069918|FG006|COMPLETED|Part 2B (Up to Approximately 29 Months)||0||
48302523|NCT03250832|101069919|FG007|COMPLETED|Part 2B (Up to Approximately 29 Months)||0||
48302524|NCT03250832|101069920|FG008|COMPLETED|Part 2B (Up to Approximately 29 Months)||0||
48302525|NCT03250832|101069921|FG009|COMPLETED|Part 2B (Up to Approximately 29 Months)||1||
48302526|NCT03250832|101069922|FG010|COMPLETED|Part 2B (Up to Approximately 29 Months)||0||
48302527|NCT03250832|101069923|FG011|COMPLETED|Part 2B (Up to Approximately 29 Months)||0||
48302528|NCT03250832|101069912|FG000|NOT COMPLETED|Part 2B (Up to Approximately 29 Months)||0||
48302529|NCT03250832|101069913|FG001|NOT COMPLETED|Part 2B (Up to Approximately 29 Months)||0||
48302530|NCT03250832|101069914|FG002|NOT COMPLETED|Part 2B (Up to Approximately 29 Months)||0||
48302531|NCT03250832|101069915|FG003|NOT COMPLETED|Part 2B (Up to Approximately 29 Months)||0||
48302532|NCT03250832|101069916|FG004|NOT COMPLETED|Part 2B (Up to Approximately 29 Months)||0||
48302533|NCT03250832|101069917|FG005|NOT COMPLETED|Part 2B (Up to Approximately 29 Months)||0||
48302534|NCT03250832|101069918|FG006|NOT COMPLETED|Part 2B (Up to Approximately 29 Months)||0||
48302535|NCT03250832|101069919|FG007|NOT COMPLETED|Part 2B (Up to Approximately 29 Months)||0||
48302536|NCT03250832|101069920|FG008|NOT COMPLETED|Part 2B (Up to Approximately 29 Months)||4||
48302537|NCT03250832|101069921|FG009|NOT COMPLETED|Part 2B (Up to Approximately 29 Months)||20||
48302538|NCT03250832|101069922|FG010|NOT COMPLETED|Part 2B (Up to Approximately 29 Months)||0||
48302539|NCT03250832|101069923|FG011|NOT COMPLETED|Part 2B (Up to Approximately 29 Months)||0||
48302540|NCT03250832|101069912|FG000|STARTED|PACT Phase (up to Approximately 36weeks)||0||
48302541|NCT03250832|101069913|FG001|STARTED|PACT Phase (up to Approximately 36weeks)||0||
48302542|NCT03250832|101069914|FG002|STARTED|PACT Phase (up to Approximately 36weeks)||0||
48302543|NCT03250832|101069915|FG003|STARTED|PACT Phase (up to Approximately 36weeks)||0||
48302544|NCT03250832|101069916|FG004|STARTED|PACT Phase (up to Approximately 36weeks)||0||
48302545|NCT03250832|101069917|FG005|STARTED|PACT Phase (up to Approximately 36weeks)||0||
48302546|NCT03250832|101069918|FG006|STARTED|PACT Phase (up to Approximately 36weeks)||0||
48302547|NCT03250832|101069919|FG007|STARTED|PACT Phase (up to Approximately 36weeks)||0||
48302548|NCT03250832|101069920|FG008|STARTED|PACT Phase (up to Approximately 36weeks)||0||
48302549|NCT03250832|101069921|FG009|STARTED|PACT Phase (up to Approximately 36weeks)||0||
48302550|NCT03250832|101069922|FG010|STARTED|PACT Phase (up to Approximately 36weeks)||1||
48302551|NCT03250832|101069923|FG011|STARTED|PACT Phase (up to Approximately 36weeks)||1||
48302552|NCT03250832|101069912|FG000|COMPLETED|PACT Phase (up to Approximately 36weeks)||0||
48302553|NCT03250832|101069913|FG001|COMPLETED|PACT Phase (up to Approximately 36weeks)||0||
48302554|NCT03250832|101069914|FG002|COMPLETED|PACT Phase (up to Approximately 36weeks)||0||
48302555|NCT03250832|101069915|FG003|COMPLETED|PACT Phase (up to Approximately 36weeks)||0||
48302556|NCT03250832|101069916|FG004|COMPLETED|PACT Phase (up to Approximately 36weeks)||0||
48302557|NCT03250832|101069917|FG005|COMPLETED|PACT Phase (up to Approximately 36weeks)||0||
48302558|NCT03250832|101069918|FG006|COMPLETED|PACT Phase (up to Approximately 36weeks)||0||
48302559|NCT03250832|101069919|FG007|COMPLETED|PACT Phase (up to Approximately 36weeks)||0||
48302560|NCT03250832|101069920|FG008|COMPLETED|PACT Phase (up to Approximately 36weeks)||0||
48302561|NCT03250832|101069921|FG009|COMPLETED|PACT Phase (up to Approximately 36weeks)||0||
48302562|NCT03250832|101069922|FG010|COMPLETED|PACT Phase (up to Approximately 36weeks)||1||
48302563|NCT03250832|101069923|FG011|COMPLETED|PACT Phase (up to Approximately 36weeks)||0||
48302564|NCT03250832|101069912|FG000|NOT COMPLETED|PACT Phase (up to Approximately 36weeks)||0||
48302565|NCT03250832|101069913|FG001|NOT COMPLETED|PACT Phase (up to Approximately 36weeks)||0||
48302566|NCT03250832|101069914|FG002|NOT COMPLETED|PACT Phase (up to Approximately 36weeks)||0||
48302567|NCT03250832|101069915|FG003|NOT COMPLETED|PACT Phase (up to Approximately 36weeks)||0||
48302568|NCT03250832|101069916|FG004|NOT COMPLETED|PACT Phase (up to Approximately 36weeks)||0||
48302569|NCT03250832|101069917|FG005|NOT COMPLETED|PACT Phase (up to Approximately 36weeks)||0||
48302570|NCT03250832|101069918|FG006|NOT COMPLETED|PACT Phase (up to Approximately 36weeks)||0||
48302571|NCT03250832|101069919|FG007|NOT COMPLETED|PACT Phase (up to Approximately 36weeks)||0||
48302572|NCT03250832|101069920|FG008|NOT COMPLETED|PACT Phase (up to Approximately 36weeks)||0||
48405365|NCT02801006|101325261|FG001|COMPLETED|Lens 2||19||38
48405366|NCT02801006|101325260|FG000|NOT COMPLETED|Lens 2||0||0
48405367|NCT02801006|101325261|FG001|NOT COMPLETED|Lens 2||0||0
48405368|NCT02849184|101325262|FG000|STARTED|Overall Study||40||
48405369|NCT02849184|101325263|FG001|STARTED|Overall Study||42||
48405370|NCT02849184|101325262|FG000|COMPLETED|Overall Study||40||
48302573|NCT03250832|101069921|FG009|NOT COMPLETED|PACT Phase (up to Approximately 36weeks)||0||
48302574|NCT03250832|101069922|FG010|NOT COMPLETED|PACT Phase (up to Approximately 36weeks)||0||
48302575|NCT03250832|101069923|FG011|NOT COMPLETED|PACT Phase (up to Approximately 36weeks)||1||
48302576|NCT02673619|101069924|FG000|STARTED|Overall Study||20||
48302577|NCT02673619|101069925|FG001|STARTED|Overall Study||5||
48302578|NCT02673619|101069926|FG002|STARTED|Overall Study||26||
48302579|NCT02673619|101069927|FG003|STARTED|Overall Study||7||
48302580|NCT02673619|101069924|FG000|COMPLETED|Overall Study||18||
48302581|NCT02673619|101069925|FG001|COMPLETED|Overall Study||4||
48302582|NCT02673619|101069926|FG002|COMPLETED|Overall Study||23||
48302583|NCT02673619|101069927|FG003|COMPLETED|Overall Study||7||
48302584|NCT02673619|101069924|FG000|NOT COMPLETED|Overall Study||2||
48302585|NCT02673619|101069925|FG001|NOT COMPLETED|Overall Study||1||
48302586|NCT02673619|101069926|FG002|NOT COMPLETED|Overall Study||3||
48302587|NCT02673619|101069927|FG003|NOT COMPLETED|Overall Study||0||
48302588|NCT00352885|101069928|FG000|STARTED|Overall Study||9||
48302589|NCT00352885|101069929|FG001|STARTED|Overall Study||11||
48302590|NCT00352885|101069928|FG000|Completed Cycle 1 of IL-2 Treatment|Overall Study||9||
48302591|NCT00352885|101069929|FG001|Completed Cycle 1 of IL-2 Treatment|Overall Study||11||
48302592|NCT00352885|101069928|FG000|Completed Cycle 2 of IL-2 Treatment|Overall Study||8||
48302593|NCT00352885|101069929|FG001|Completed Cycle 2 of IL-2 Treatment|Overall Study||9||
48302594|NCT00352885|101069928|FG000|Completed Cycle 3 of IL-2 Treatment|Overall Study||4||
48302595|NCT00352885|101069929|FG001|Completed Cycle 3 of IL-2 Treatment|Overall Study||7||
48302596|NCT00352885|101069928|FG000|COMPLETED|Overall Study||3|Completed all four cycles of IL-2 treatment|
48302597|NCT00352885|101069929|FG001|COMPLETED|Overall Study||4|Completed all four cycles of IL-2 treatment|
48302598|NCT00352885|101069928|FG000|NOT COMPLETED|Overall Study||6||
48302599|NCT00352885|101069929|FG001|NOT COMPLETED|Overall Study||7||
48302600|NCT01869075|101069930|FG000|STARTED|Phase 0 (Baseline)||0||
48302601|NCT01869075|101069931|FG001|STARTED|Phase 0 (Baseline)||418||
48302602|NCT01869075|101069932|FG002|STARTED|Phase 0 (Baseline)||0||
48302603|NCT01869075|101069933|FG003|STARTED|Phase 0 (Baseline)||416||
48302604|NCT01869075|101069934|FG004|STARTED|Phase 0 (Baseline)||0||
48302605|NCT01869075|101069935|FG005|STARTED|Phase 0 (Baseline)||341||
48302606|NCT01869075|101069930|FG000|COMPLETED|Phase 0 (Baseline)||0||
48302607|NCT01869075|101069931|FG001|COMPLETED|Phase 0 (Baseline)||418||
48302608|NCT01869075|101069932|FG002|COMPLETED|Phase 0 (Baseline)||0||
48405371|NCT02849184|101325263|FG001|COMPLETED|Overall Study||42||
48604575|NCT02769312|101816327|FG001|NOT COMPLETED|Double-Blind (0-2 Weeks)||1||
48302609|NCT01869075|101069933|FG003|COMPLETED|Phase 0 (Baseline)||416||
48302610|NCT01869075|101069934|FG004|COMPLETED|Phase 0 (Baseline)||0||
48302611|NCT01869075|101069935|FG005|COMPLETED|Phase 0 (Baseline)||341||
48302612|NCT01869075|101069930|FG000|NOT COMPLETED|Phase 0 (Baseline)||0||
48302613|NCT01869075|101069931|FG001|NOT COMPLETED|Phase 0 (Baseline)||0||
48302614|NCT01869075|101069932|FG002|NOT COMPLETED|Phase 0 (Baseline)||0||
48405372|NCT02849184|101325262|FG000|NOT COMPLETED|Overall Study||0||
48405373|NCT02849184|101325263|FG001|NOT COMPLETED|Overall Study||0||
48405374|NCT01025232|101325264|FG000|STARTED|Overall Study||46||
48604576|NCT02769312|101816326|FG000|STARTED|Unblinded (Optional 2-4 Weeks)||21|Optional unblinded period. All participants received 2 weeks of active stimulation.|
48604577|NCT02769312|101816327|FG001|STARTED|Unblinded (Optional 2-4 Weeks)||24|Optional unblinded period. All participants received 2 weeks of active stimulation.|
48604578|NCT02769312|101816326|FG000|COMPLETED|Unblinded (Optional 2-4 Weeks)||20||
48604579|NCT02769312|101816327|FG001|COMPLETED|Unblinded (Optional 2-4 Weeks)||23||
48604580|NCT02769312|101816326|FG000|NOT COMPLETED|Unblinded (Optional 2-4 Weeks)||1||
48302615|NCT01869075|101069933|FG003|NOT COMPLETED|Phase 0 (Baseline)||0||
48302616|NCT01869075|101069934|FG004|NOT COMPLETED|Phase 0 (Baseline)||0||
48302617|NCT01869075|101069935|FG005|NOT COMPLETED|Phase 0 (Baseline)||0||
48302618|NCT01869075|101069930|FG000|STARTED|Phase 1||45||
48302619|NCT01869075|101069931|FG001|STARTED|Phase 1||75||
48302620|NCT01869075|101069932|FG002|STARTED|Phase 1||45||
48302621|NCT01869075|101069933|FG003|STARTED|Phase 1||75||
48302622|NCT01869075|101069934|FG004|STARTED|Phase 1||30||
48302623|NCT01869075|101069935|FG005|STARTED|Phase 1||90||
48302624|NCT01869075|101069930|FG000|COMPLETED|Phase 1||45||
48302625|NCT01869075|101069931|FG001|COMPLETED|Phase 1||75||
48405375|NCT01025232|101325265|FG001|STARTED|Overall Study||42||
48405376|NCT01025232|101325264|FG000|COMPLETED|Overall Study||43||
48405377|NCT01025232|101325265|FG001|COMPLETED|Overall Study||36||
48405378|NCT01025232|101325264|FG000|NOT COMPLETED|Overall Study||3||
48405379|NCT01025232|101325265|FG001|NOT COMPLETED|Overall Study||6||
48405380|NCT03074318|101325266|FG000|STARTED|Overall Study||6||
48405381|NCT03074318|101325267|FG001|STARTED|Overall Study||7||
48302626|NCT01869075|101069932|FG002|COMPLETED|Phase 1||45||
48302627|NCT01869075|101069933|FG003|COMPLETED|Phase 1||75||
48405382|NCT03074318|101325268|FG002|STARTED|Overall Study||6||
48405383|NCT03074318|101325269|FG003|STARTED|Overall Study||16||
48405384|NCT03074318|101325266|FG000|COMPLETED|Overall Study||2||
48405385|NCT03074318|101325267|FG001|COMPLETED|Overall Study||2||
48405386|NCT03074318|101325268|FG002|COMPLETED|Overall Study||0||
48302628|NCT01869075|101069934|FG004|COMPLETED|Phase 1||30||
48302629|NCT01869075|101069935|FG005|COMPLETED|Phase 1||90||
48604581|NCT02769312|101816327|FG001|NOT COMPLETED|Unblinded (Optional 2-4 Weeks)||1||
48604582|NCT02769312|101816326|FG000|STARTED|Follow-up||23|1 month following the end of intervention.|
48604583|NCT02769312|101816327|FG001|STARTED|Follow-up||24|1 month following the end of intervention.|
48604584|NCT02769312|101816326|FG000|COMPLETED|Follow-up||22|Participants did not have to complete the unblinded period to complete the follow-up period.|
48604585|NCT02769312|101816327|FG001|COMPLETED|Follow-up||23|Participants did not have to complete the unblinded period to complete the follow-up period.|
48604586|NCT02769312|101816326|FG000|NOT COMPLETED|Follow-up||1||
48604587|NCT02769312|101816327|FG001|NOT COMPLETED|Follow-up||1||
48604588|NCT03089853|101816328|FG000|STARTED|Overall Study||4||
48604589|NCT03089853|101816329|FG001|STARTED|Overall Study||3||
48604590|NCT03089853|101816328|FG000|COMPLETED|Overall Study||2||
48604591|NCT03089853|101816329|FG001|COMPLETED|Overall Study||2||
48604592|NCT03089853|101816328|FG000|NOT COMPLETED|Overall Study||2||
48604593|NCT03089853|101816329|FG001|NOT COMPLETED|Overall Study||1||
48604594|NCT04513899|101816330|FG000|STARTED|Overall Study||4||
48604595|NCT04513899|101816331|FG001|STARTED|Overall Study||6||
48604596|NCT04513899|101816330|FG000|COMPLETED|Overall Study||4||
48604597|NCT04513899|101816331|FG001|COMPLETED|Overall Study||6||
48604598|NCT04513899|101816330|FG000|NOT COMPLETED|Overall Study||0||
48604599|NCT04513899|101816331|FG001|NOT COMPLETED|Overall Study||0||
48604600|NCT01204918|101816332|FG000|STARTED|Overall Study||25||
48604601|NCT01204918|101816333|FG001|STARTED|Overall Study||39||
48604602|NCT01204918|101816334|FG002|STARTED|Overall Study||40||
48604603|NCT01204918|101816332|FG000|Stage 1 Begin|Overall Study||25||
48604604|NCT01204918|101816333|FG001|Stage 1 Begin|Overall Study||39||
48302630|NCT01869075|101069930|FG000|NOT COMPLETED|Phase 1||0||
48302631|NCT01869075|101069931|FG001|NOT COMPLETED|Phase 1||0||
48302632|NCT01869075|101069932|FG002|NOT COMPLETED|Phase 1||0||
48302633|NCT01869075|101069933|FG003|NOT COMPLETED|Phase 1||0||
48302634|NCT01869075|101069934|FG004|NOT COMPLETED|Phase 1||0||
48302635|NCT01869075|101069935|FG005|NOT COMPLETED|Phase 1||0||
48604605|NCT01204918|101816334|FG002|Stage 1 Begin|Overall Study||40||
48604606|NCT01204918|101816332|FG000|Stage 1 End|Overall Study||22||
48604607|NCT01204918|101816333|FG001|Stage 1 End|Overall Study||35||
48604608|NCT01204918|101816334|FG002|Stage 1 End|Overall Study||36||
48604609|NCT01204918|101816332|FG000|Stage 2 Begin|Overall Study||22||
48604610|NCT01204918|101816333|FG001|Stage 2 Begin|Overall Study||35||
48604611|NCT01204918|101816334|FG002|Stage 2 Begin|Overall Study||36||
48604612|NCT01204918|101816332|FG000|Stage 2 End|Overall Study||21||
48604613|NCT01204918|101816333|FG001|Stage 2 End|Overall Study||29||
48604614|NCT01204918|101816334|FG002|Stage 2 End|Overall Study||35||
48604615|NCT01204918|101816332|FG000|COMPLETED|Overall Study||21||
48604616|NCT01204918|101816333|FG001|COMPLETED|Overall Study||29||
48604617|NCT01204918|101816334|FG002|COMPLETED|Overall Study||35||
48604618|NCT01204918|101816332|FG000|NOT COMPLETED|Overall Study||4||
48604619|NCT01204918|101816333|FG001|NOT COMPLETED|Overall Study||10||
48604620|NCT01204918|101816334|FG002|NOT COMPLETED|Overall Study||5||
48604621|NCT00909220|101816335|FG000|STARTED|Overall Study||41||
48604622|NCT00909220|101816336|FG001|STARTED|Overall Study||36||
48302636|NCT01869075|101069930|FG000|STARTED|Phase 2||90||
48302637|NCT01869075|101069931|FG001|STARTED|Phase 2||30||
48302638|NCT01869075|101069932|FG002|STARTED|Phase 2||75||
48302639|NCT01869075|101069933|FG003|STARTED|Phase 2||45||
48302640|NCT01869075|101069934|FG004|STARTED|Phase 2||75||
48302641|NCT01869075|101069935|FG005|STARTED|Phase 2||45||
48302642|NCT01869075|101069930|FG000|COMPLETED|Phase 2||90||
48302643|NCT01869075|101069931|FG001|COMPLETED|Phase 2||30||
48302644|NCT01869075|101069932|FG002|COMPLETED|Phase 2||75||
48302645|NCT01869075|101069933|FG003|COMPLETED|Phase 2||45||
48604623|NCT00909220|101816335|FG000|Data Entry|Overall Study||41||
48604624|NCT00909220|101816336|FG001|Data Entry|Overall Study||36||
48604625|NCT00909220|101816335|FG000|Data Analyses|Overall Study||41||
48604626|NCT00909220|101816336|FG001|Data Analyses|Overall Study||36||
48604627|NCT00909220|101816335|FG000|Submission for Publication|Overall Study||41||
48604628|NCT00909220|101816336|FG001|Submission for Publication|Overall Study||36||
48604629|NCT00909220|101816335|FG000|COMPLETED|Overall Study||41||
48604630|NCT00909220|101816336|FG001|COMPLETED|Overall Study||36||
48604631|NCT00909220|101816335|FG000|NOT COMPLETED|Overall Study||0||
48604632|NCT00909220|101816336|FG001|NOT COMPLETED|Overall Study||0||
48604633|NCT04424914|101816337|FG000|STARTED|Overall Study||56||
48604634|NCT04424914|101816338|FG001|STARTED|Overall Study||259||
48405387|NCT03074318|101325269|FG003|COMPLETED|Overall Study||0||
48604635|NCT04424914|101816339|FG002|STARTED|Overall Study||32||
48604636|NCT04424914|101816337|FG000|COMPLETED|Overall Study||27||
48604637|NCT04424914|101816338|FG001|COMPLETED|Overall Study||251||
48604638|NCT04424914|101816339|FG002|COMPLETED|Overall Study||3||
48604639|NCT04424914|101816337|FG000|NOT COMPLETED|Overall Study||29||
48604640|NCT04424914|101816338|FG001|NOT COMPLETED|Overall Study||8||
48302646|NCT01869075|101069934|FG004|COMPLETED|Phase 2||75||
48302647|NCT01869075|101069935|FG005|COMPLETED|Phase 2||45||
48302648|NCT01869075|101069930|FG000|NOT COMPLETED|Phase 2||0||
48302649|NCT01869075|101069931|FG001|NOT COMPLETED|Phase 2||0||
48302650|NCT01869075|101069932|FG002|NOT COMPLETED|Phase 2||0||
48604641|NCT04424914|101816339|FG002|NOT COMPLETED|Overall Study||29||
48604642|NCT02553798|101816340|FG000|STARTED|Overall Study||564||
48604643|NCT02553798|101816340|FG000|COMPLETED|Overall Study||226||
48604644|NCT02553798|101816340|FG000|NOT COMPLETED|Overall Study||338||
48604645|NCT01777139|101816341|FG000|STARTED|Primary Reporting Phase (Up to 4 Years)||30||
48604646|NCT01777139|101816342|FG001|STARTED|Primary Reporting Phase (Up to 4 Years)||0||
48604647|NCT01777139|101816341|FG000|COMPLETED|Primary Reporting Phase (Up to 4 Years)||0||
48604648|NCT01777139|101816342|FG001|COMPLETED|Primary Reporting Phase (Up to 4 Years)||0||
48604649|NCT01777139|101816341|FG000|NOT COMPLETED|Primary Reporting Phase (Up to 4 Years)||30||
48604650|NCT01777139|101816342|FG001|NOT COMPLETED|Primary Reporting Phase (Up to 4 Years)||0||
48604651|NCT01777139|101816341|FG000|STARTED|SFUCP (Up to 1.4 Years)||0||
48604652|NCT01777139|101816342|FG001|STARTED|SFUCP (Up to 1.4 Years)||4||
48302651|NCT01869075|101069933|FG003|NOT COMPLETED|Phase 2||0||
48302652|NCT01869075|101069934|FG004|NOT COMPLETED|Phase 2||0||
48302653|NCT01869075|101069935|FG005|NOT COMPLETED|Phase 2||0||
48302654|NCT02877927|101069936|FG000|STARTED|Overall Study||368||
48302655|NCT02877927|101069937|FG001|STARTED|Overall Study||367||
48302656|NCT02877927|101069936|FG000|COMPLETED|Overall Study||314||
48604653|NCT01777139|101816341|FG000|COMPLETED|SFUCP (Up to 1.4 Years)||0||
48604654|NCT01777139|101816342|FG001|COMPLETED|SFUCP (Up to 1.4 Years)||0||
48604655|NCT01777139|101816341|FG000|NOT COMPLETED|SFUCP (Up to 1.4 Years)||0||
48604656|NCT01777139|101816342|FG001|NOT COMPLETED|SFUCP (Up to 1.4 Years)||4||
48604657|NCT01905592|101816343|FG000|STARTED|Overall Study||71|Based on centrally confirmed intent-to-treat population|
48302657|NCT02877927|101069937|FG001|COMPLETED|Overall Study||310||
48302658|NCT02877927|101069936|FG000|NOT COMPLETED|Overall Study||54||
48302659|NCT02877927|101069937|FG001|NOT COMPLETED|Overall Study||57||
48302660|NCT05116046|101069938|FG000|STARTED|Overall Study||16||
48302661|NCT05116046|101069939|FG001|STARTED|Overall Study||17||
48302662|NCT05116046|101069940|FG002|STARTED|Overall Study||2||
48604658|NCT01905592|101816344|FG001|STARTED|Overall Study||135|Based on centrally confirmed intent-to-treat population|
48604659|NCT01905592|101816343|FG000|COMPLETED|Overall Study||0|Based on centrally confirmed intent-to-treat population|
48604660|NCT01905592|101816344|FG001|COMPLETED|Overall Study||0|Based on centrally confirmed intent-to-treat population|
48604661|NCT01905592|101816343|FG000|NOT COMPLETED|Overall Study||71||
48604662|NCT01905592|101816344|FG001|NOT COMPLETED|Overall Study||135||
48604663|NCT02324699|101816345|FG000|STARTED|Overall Study||1||
48604664|NCT02324699|101816345|FG000|COMPLETED|Overall Study||0||
48604665|NCT02324699|101816345|FG000|NOT COMPLETED|Overall Study||1||
48604666|NCT01607346|101816346|FG000|STARTED|Overall Study||10||
48604667|NCT01607346|101816346|FG000|COMPLETED|Overall Study||7||
48604668|NCT01607346|101816346|FG000|NOT COMPLETED|Overall Study||3||
48604669|NCT00581061|101816347|FG000|STARTED|Overall Study||13||
48302663|NCT05116046|101069938|FG000|COMPLETED|Overall Study||0||
48302664|NCT05116046|101069939|FG001|COMPLETED|Overall Study||0||
48302665|NCT05116046|101069940|FG002|COMPLETED|Overall Study||0||
48302666|NCT05116046|101069938|FG000|NOT COMPLETED|Overall Study||16||
48302667|NCT05116046|101069939|FG001|NOT COMPLETED|Overall Study||17||
48302668|NCT05116046|101069940|FG002|NOT COMPLETED|Overall Study||2||
48302669|NCT00795951|101069941|FG000|STARTED|Overall Study||102||
48302670|NCT00795951|101069941|FG000|COMPLETED|Overall Study||100||
48302671|NCT00795951|101069941|FG000|NOT COMPLETED|Overall Study||2||
48302672|NCT02884427|101069942|FG000|STARTED|Overall Study||48||
48302673|NCT02884427|101069943|FG001|STARTED|Overall Study||52||
48302674|NCT02884427|101069944|FG002|STARTED|Overall Study||50||
48302675|NCT02884427|101069942|FG000|COMPLETED|Overall Study||48||
48302676|NCT02884427|101069943|FG001|COMPLETED|Overall Study||52||
48302677|NCT02884427|101069944|FG002|COMPLETED|Overall Study||50||
48302678|NCT02884427|101069942|FG000|NOT COMPLETED|Overall Study||0||
48302679|NCT02884427|101069943|FG001|NOT COMPLETED|Overall Study||0||
48302680|NCT02884427|101069944|FG002|NOT COMPLETED|Overall Study||0||
48302681|NCT01554488|101069945|FG000|STARTED|Overall Study||13||
48302682|NCT01554488|101069946|FG001|STARTED|Overall Study||12||
48604670|NCT00581061|101816347|FG000|COMPLETED|Overall Study||13||
48604671|NCT00581061|101816347|FG000|NOT COMPLETED|Overall Study||0||
48604672|NCT04165135|101816348|FG000|STARTED|Overall Study||103||
48302683|NCT01554488|101069945|FG000|COMPLETED|Overall Study||12||
48302684|NCT01554488|101069946|FG001|COMPLETED|Overall Study||9||
48302685|NCT01554488|101069945|FG000|NOT COMPLETED|Overall Study||1||
48302686|NCT01554488|101069946|FG001|NOT COMPLETED|Overall Study||3||
48604673|NCT04165135|101816348|FG000|COMPLETED|Overall Study||88||
48604674|NCT04165135|101816348|FG000|NOT COMPLETED|Overall Study||15||
48604675|NCT01842906|101816349|FG000|STARTED|Overall Study||115||
48604676|NCT01842906|101816350|FG001|STARTED|Overall Study||104||
48604677|NCT01842906|101816349|FG000|COMPLETED|Overall Study||115||
48302687|NCT01678209|101069947|FG000|STARTED|Overall Study||47||
48302688|NCT01678209|101069948|FG001|STARTED|Overall Study||40||
48302689|NCT01678209|101069949|FG002|STARTED|Overall Study||40||
48302690|NCT01678209|101069947|FG000|COMPLETED|Overall Study||30||
48302691|NCT01678209|101069948|FG001|COMPLETED|Overall Study||22||
48302692|NCT01678209|101069949|FG002|COMPLETED|Overall Study||22||
48302693|NCT01678209|101069947|FG000|NOT COMPLETED|Overall Study||17||
48302694|NCT01678209|101069948|FG001|NOT COMPLETED|Overall Study||18||
48604678|NCT01842906|101816350|FG001|COMPLETED|Overall Study||104||
48604679|NCT01842906|101816349|FG000|NOT COMPLETED|Overall Study||0||
48604680|NCT01842906|101816350|FG001|NOT COMPLETED|Overall Study||0||
48604681|NCT00548249|101816351|FG000|STARTED|Overall Study||26||
48604682|NCT00548249|101816352|FG001|STARTED|Overall Study||26||
48604683|NCT00548249|101816353|FG002|STARTED|Overall Study||29||
48604684|NCT00548249|101816354|FG003|STARTED|Overall Study||22||
48604685|NCT00548249|101816355|FG004|STARTED|Overall Study||28||
48604686|NCT00548249|101816351|FG000|COMPLETED|Overall Study||10||
48604687|NCT00548249|101816352|FG001|COMPLETED|Overall Study||13||
48604688|NCT00548249|101816353|FG002|COMPLETED|Overall Study||9||
48604689|NCT00548249|101816354|FG003|COMPLETED|Overall Study||9||
48604690|NCT00548249|101816355|FG004|COMPLETED|Overall Study||7||
48604691|NCT00548249|101816351|FG000|NOT COMPLETED|Overall Study||16||
48604692|NCT00548249|101816352|FG001|NOT COMPLETED|Overall Study||13||
48604693|NCT00548249|101816353|FG002|NOT COMPLETED|Overall Study||20||
48148073|NCT04650555|100685143|FG001|NOT COMPLETED|Overall Study||0||
48148074|NCT04650555|100685144|FG002|NOT COMPLETED|Overall Study||1||
48148075|NCT04650555|100685145|FG003|NOT COMPLETED|Overall Study||0||
48148076|NCT04650555|100685146|FG004|NOT COMPLETED|Overall Study||2||
48604694|NCT00548249|101816354|FG003|NOT COMPLETED|Overall Study||13||
48604695|NCT00548249|101816355|FG004|NOT COMPLETED|Overall Study||21||
48148077|NCT02115633|100685147|FG000|STARTED|Overall Study||15||
48148078|NCT02115633|100685148|FG001|STARTED|Overall Study||16||
48148079|NCT02115633|100685147|FG000|COMPLETED|Overall Study||15||
48148080|NCT02115633|100685148|FG001|COMPLETED|Overall Study||16||
48148081|NCT02115633|100685147|FG000|NOT COMPLETED|Overall Study||0||
48148082|NCT02115633|100685148|FG001|NOT COMPLETED|Overall Study||0||
48148083|NCT02013622|100685149|FG000|STARTED|Overall Study||49||
48148084|NCT02013622|100685149|FG000|COMPLETED|Overall Study||25||
48148085|NCT02013622|100685149|FG000|NOT COMPLETED|Overall Study||24||
48148086|NCT03393000|100685150|FG000|STARTED|Overall Study||19||
48148087|NCT03393000|100685150|FG000|COMPLETED|Overall Study||5||
48148088|NCT03393000|100685150|FG000|NOT COMPLETED|Overall Study||14||
48148089|NCT04250727|100685151|FG000|STARTED|Overall Study||15||
48148090|NCT04250727|100685152|FG001|STARTED|Overall Study||15||
48148091|NCT04250727|100685151|FG000|COMPLETED|Overall Study||15||
48148092|NCT04250727|100685152|FG001|COMPLETED|Overall Study||15||
48148093|NCT04250727|100685151|FG000|NOT COMPLETED|Overall Study||0||
48148094|NCT04250727|100685152|FG001|NOT COMPLETED|Overall Study||0||
48148095|NCT02872701|100685153|FG000|STARTED|Overall Study||100||
48148096|NCT02872701|100685153|FG000|COMPLETED|Overall Study||97||
48148097|NCT02872701|100685153|FG000|NOT COMPLETED|Overall Study||3||
48148098|NCT02816138|100685154|FG000|STARTED|Overall Study||15||
48148099|NCT02816138|100685154|FG000|COMPLETED|Overall Study||14||
48148100|NCT02816138|100685154|FG000|NOT COMPLETED|Overall Study||1||
48148101|NCT01970462|100685155|FG000|STARTED|Overall Study||1||
48148102|NCT01970462|100685156|FG001|STARTED|Overall Study||4||
48148103|NCT01970462|100685155|FG000|COMPLETED|Overall Study||1||
48148104|NCT01970462|100685156|FG001|COMPLETED|Overall Study||2||
48148105|NCT01970462|100685155|FG000|NOT COMPLETED|Overall Study||0||
48148106|NCT01970462|100685156|FG001|NOT COMPLETED|Overall Study||2||
48148107|NCT04530448|100685157|FG000|STARTED|Overall Study||3||
48148108|NCT04530448|100685158|FG001|STARTED|Overall Study||0||
48148109|NCT04530448|100685157|FG000|COMPLETED|Overall Study||0||
48148110|NCT04530448|100685158|FG001|COMPLETED|Overall Study||0||
48148111|NCT04530448|100685157|FG000|NOT COMPLETED|Overall Study||3||
48148112|NCT04530448|100685158|FG001|NOT COMPLETED|Overall Study||0||
48148113|NCT02925611|100685159|FG000|STARTED|Overall Study||30||
48148114|NCT02925611|100685160|FG001|STARTED|Overall Study||30||
48148115|NCT02925611|100685159|FG000|COMPLETED|Overall Study||30||
48148116|NCT02925611|100685160|FG001|COMPLETED|Overall Study||30||
48148117|NCT02925611|100685159|FG000|NOT COMPLETED|Overall Study||0||
48148118|NCT02925611|100685160|FG001|NOT COMPLETED|Overall Study||0||
48148119|NCT03311373|100685161|FG000|STARTED|Overall Study||56||
48148120|NCT03311373|100685161|FG000|COMPLETED|Overall Study||47||
48148121|NCT03311373|100685161|FG000|NOT COMPLETED|Overall Study||9||
48148122|NCT03722927|100685162|FG000|STARTED|Overall Study||1||
48148123|NCT03722927|100685163|FG001|STARTED|Overall Study||2||
48148124|NCT03722927|100685162|FG000|COMPLETED|Overall Study||1||
48148125|NCT03722927|100685163|FG001|COMPLETED|Overall Study||2||
48604696|NCT02107313|101816356|FG000|STARTED|Overall Study||9||
48604697|NCT02107313|101816357|FG001|STARTED|Overall Study||9||
48604698|NCT02107313|101816356|FG000|COMPLETED|Overall Study||9||
48604699|NCT02107313|101816357|FG001|COMPLETED|Overall Study||8||
48604700|NCT02107313|101816356|FG000|NOT COMPLETED|Overall Study||0||
48604701|NCT02107313|101816357|FG001|NOT COMPLETED|Overall Study||1||
48604702|NCT02182830|101816358|FG000|STARTED|Overall Study||83||
48604703|NCT02182830|101816359|FG001|STARTED|Overall Study||83||
48604704|NCT02182830|101816358|FG000|Randomised Set (RS)|Overall Study||79|Randomised Patients screened for trial, regardless of whether any trial drug was taken.|
48656907|NCT04274218|101943728|FG003|NOT COMPLETED|Baseline Walking (1 Minute)||0||
48148126|NCT03722927|100685162|FG000|NOT COMPLETED|Overall Study||0||
48148127|NCT03722927|100685163|FG001|NOT COMPLETED|Overall Study||0||
48148128|NCT02186210|100685164|FG000|STARTED|Overall Study||20||
48302695|NCT01678209|101069949|FG002|NOT COMPLETED|Overall Study||18||
48302696|NCT03027557|101069950|FG000|STARTED|Overall Study||15||
48302697|NCT03027557|101069951|FG001|STARTED|Overall Study||16||
48302698|NCT03027557|101069952|FG002|STARTED|Overall Study||15||
48302699|NCT03027557|101069950|FG000|COMPLETED|Overall Study||14||
48302700|NCT03027557|101069951|FG001|COMPLETED|Overall Study||16||
48302701|NCT03027557|101069952|FG002|COMPLETED|Overall Study||15||
48302702|NCT03027557|101069950|FG000|NOT COMPLETED|Overall Study||1||
48302703|NCT03027557|101069951|FG001|NOT COMPLETED|Overall Study||0||
48302704|NCT03027557|101069952|FG002|NOT COMPLETED|Overall Study||0||
48302705|NCT00596934|101069953|FG000|STARTED|Overall Study||9||
48302706|NCT00596934|101069953|FG000|COMPLETED|Overall Study||7||
48302707|NCT00596934|101069953|FG000|NOT COMPLETED|Overall Study||2||
48302708|NCT00786825|101069954|FG000|STARTED|Overall Study||5||
48302709|NCT00786825|101069955|FG001|STARTED|Overall Study||5||
48302710|NCT00786825|101069954|FG000|COMPLETED|Overall Study||5||
48302711|NCT00786825|101069955|FG001|COMPLETED|Overall Study||5||
48302712|NCT00786825|101069954|FG000|NOT COMPLETED|Overall Study||0||
48302713|NCT00786825|101069955|FG001|NOT COMPLETED|Overall Study||0||
48302714|NCT01920594|101069956|FG000|STARTED|Overall Study||27||
48302715|NCT01920594|101069957|FG001|STARTED|Overall Study||28||
48302716|NCT01920594|101069956|FG000|COMPLETED|Overall Study||20||
48302717|NCT01920594|101069957|FG001|COMPLETED|Overall Study||25||
48302718|NCT01920594|101069956|FG000|NOT COMPLETED|Overall Study||7||
48302719|NCT01920594|101069957|FG001|NOT COMPLETED|Overall Study||3||
48302720|NCT01241552|101069958|FG000|STARTED|Overall Study||242||
48302721|NCT01241552|101069959|FG001|STARTED|Overall Study||403||
48302722|NCT01241552|101069960|FG002|STARTED|Overall Study||403||
48302723|NCT01241552|101069961|FG003|STARTED|Overall Study||404||
48302724|NCT01241552|101069958|FG000|Treated|Overall Study||235||
48302725|NCT01241552|101069959|FG001|Treated|Overall Study||392||
48302726|NCT01241552|101069960|FG002|Treated|Overall Study||388||
48302727|NCT01241552|101069961|FG003|Treated|Overall Study||397||
48302728|NCT01241552|101069958|FG000|COMPLETED|Overall Study||201||
48302729|NCT01241552|101069959|FG001|COMPLETED|Overall Study||340||
48302730|NCT01241552|101069960|FG002|COMPLETED|Overall Study||343||
48302731|NCT01241552|101069961|FG003|COMPLETED|Overall Study||340||
48302732|NCT01241552|101069958|FG000|NOT COMPLETED|Overall Study||41||
48302733|NCT01241552|101069959|FG001|NOT COMPLETED|Overall Study||63||
48302734|NCT01241552|101069960|FG002|NOT COMPLETED|Overall Study||60||
48302735|NCT01241552|101069961|FG003|NOT COMPLETED|Overall Study||64||
48302736|NCT01386658|101069962|FG000|STARTED|Initial Icatibant Exposure||11||
48302737|NCT01386658|101069963|FG001|STARTED|Initial Icatibant Exposure||21||
48302738|NCT01386658|101069962|FG000|COMPLETED|Initial Icatibant Exposure||11||
48302739|NCT01386658|101069963|FG001|COMPLETED|Initial Icatibant Exposure||9||
48604705|NCT02182830|101816359|FG001|Randomised Set (RS)|Overall Study||82|Randomised Patients screened for trial, regardless of whether any trial drug was taken.|
48604706|NCT02182830|101816358|FG000|Treated Set (TS)|Overall Study||77|All patients in the RS who received at least one dose of trial medication.|
48604707|NCT02182830|101816359|FG001|Treated Set (TS)|Overall Study||80|All patients in the RS who received at least one dose of trial medication.|
48604708|NCT02182830|101816358|FG000|COMPLETED|Overall Study||68||
48604709|NCT02182830|101816359|FG001|COMPLETED|Overall Study||68||
48604710|NCT02182830|101816358|FG000|NOT COMPLETED|Overall Study||15||
48604711|NCT02182830|101816359|FG001|NOT COMPLETED|Overall Study||15||
48604712|NCT02540161|101816360|FG000|STARTED|Overall Study||20||
48604713|NCT02540161|101816361|FG001|STARTED|Overall Study||7||
48604714|NCT02540161|101816362|FG002|STARTED|Overall Study||5||
48604715|NCT02540161|101816363|FG003|STARTED|Overall Study||7||
48604716|NCT02540161|101816360|FG000|COMPLETED|Overall Study||20||
48604717|NCT02540161|101816361|FG001|COMPLETED|Overall Study||7||
48604718|NCT02540161|101816362|FG002|COMPLETED|Overall Study||5||
48604719|NCT02540161|101816363|FG003|COMPLETED|Overall Study||7||
48604720|NCT02540161|101816360|FG000|NOT COMPLETED|Overall Study||0||
48604721|NCT02540161|101816361|FG001|NOT COMPLETED|Overall Study||0||
48302740|NCT01386658|101069962|FG000|NOT COMPLETED|Initial Icatibant Exposure||0||
48302741|NCT01386658|101069963|FG001|NOT COMPLETED|Initial Icatibant Exposure||12||
48302742|NCT01386658|101069962|FG000|STARTED|Icatibant Exposure 2||0||
48302743|NCT01386658|101069963|FG001|STARTED|Icatibant Exposure 2||9||
48302744|NCT01386658|101069962|FG000|COMPLETED|Icatibant Exposure 2||0||
48302745|NCT01386658|101069963|FG001|COMPLETED|Icatibant Exposure 2||9||
48302746|NCT01386658|101069962|FG000|NOT COMPLETED|Icatibant Exposure 2||0||
48302747|NCT01386658|101069963|FG001|NOT COMPLETED|Icatibant Exposure 2||0||
48302748|NCT01386658|101069962|FG000|STARTED|Icatibant Exposure 3||0||
48302749|NCT01386658|101069963|FG001|STARTED|Icatibant Exposure 3||9||
48604722|NCT02540161|101816362|FG002|NOT COMPLETED|Overall Study||0||
48302750|NCT01386658|101069962|FG000|COMPLETED|Icatibant Exposure 3||0||
48302751|NCT01386658|101069963|FG001|COMPLETED|Icatibant Exposure 3||9||
48302752|NCT01386658|101069962|FG000|NOT COMPLETED|Icatibant Exposure 3||0||
48302753|NCT01386658|101069963|FG001|NOT COMPLETED|Icatibant Exposure 3||0||
48302754|NCT02119325|101069964|FG000|STARTED|Period 1||48||
48302755|NCT02119325|101069965|FG001|STARTED|Period 1||48||
48302756|NCT02119325|101069964|FG000|COMPLETED|Period 1||48||
48302757|NCT02119325|101069965|FG001|COMPLETED|Period 1||48||
48604723|NCT02540161|101816363|FG003|NOT COMPLETED|Overall Study||0||
48604724|NCT03544281|101816364|FG000|STARTED|Overall Study||12||
48604725|NCT03544281|101816365|FG001|STARTED|Overall Study||4||
48604726|NCT03544281|101816366|FG002|STARTED|Overall Study||13||
48604727|NCT03544281|101816367|FG003|STARTED|Overall Study||16||
48604728|NCT03544281|101816368|FG004|STARTED|Overall Study||12||
48604729|NCT03544281|101816369|FG005|STARTED|Overall Study||12||
48604730|NCT03544281|101816370|FG006|STARTED|Overall Study||13||
48604731|NCT03544281|101816371|FG007|STARTED|Overall Study||12||
48604732|NCT03544281|101816372|FG008|STARTED|Overall Study||13||
48604733|NCT03544281|101816373|FG009|STARTED|Overall Study||18||
48604734|NCT03544281|101816374|FG010|STARTED|Overall Study||12||
48604735|NCT03544281|101816375|FG011|STARTED|Overall Study||16||
48604736|NCT03544281|101816364|FG000|All Treated|Overall Study||12|All participants who received at least one dose of study treatment.|
48604737|NCT03544281|101816365|FG001|All Treated|Overall Study||4|All participants who received at least one dose of study treatment.|
48604738|NCT03544281|101816366|FG002|All Treated|Overall Study||13|All participants who received at least one dose of study treatment.|
48604739|NCT03544281|101816367|FG003|All Treated|Overall Study||16|All participants who received at least one dose of study treatment.|
48604740|NCT03544281|101816368|FG004|All Treated|Overall Study||12|All participants who received at least one dose of study treatment.|
48604741|NCT03544281|101816369|FG005|All Treated|Overall Study||12|All participants who received at least one dose of study treatment.|
48604742|NCT03544281|101816370|FG006|All Treated|Overall Study||12|All participants who received at least one dose of study treatment.|
48604743|NCT03544281|101816371|FG007|All Treated|Overall Study||12|All participants who received at least one dose of study treatment.|
48604744|NCT03544281|101816372|FG008|All Treated|Overall Study||13|All participants who received at least one dose of study treatment.|
48604745|NCT03544281|101816373|FG009|All Treated|Overall Study||18|All participants who received at least one dose of study treatment.|
48604746|NCT03544281|101816374|FG010|All Treated|Overall Study||12|All participants who received at least one dose of study treatment.|
48604747|NCT03544281|101816375|FG011|All Treated|Overall Study||16|All participants who received at least one dose of study treatment.|
48656908|NCT04274218|101943725|FG000|STARTED|Perturbation Condition 1 (15 Minutes)||5||
48148129|NCT02186210|100685165|FG001|STARTED|Overall Study||20||
48148130|NCT02186210|100685164|FG000|COMPLETED|Overall Study||20||
48148131|NCT02186210|100685165|FG001|COMPLETED|Overall Study||20||
48148132|NCT02186210|100685164|FG000|NOT COMPLETED|Overall Study||0||
48148133|NCT02186210|100685165|FG001|NOT COMPLETED|Overall Study||0||
48148134|NCT03263429|100685166|FG000|STARTED|Overall Study||3||
48148135|NCT03263429|100685167|FG001|STARTED|Overall Study||8||
48148136|NCT03263429|100685168|FG002|STARTED|Overall Study||18||
48148137|NCT03263429|100685166|FG000|COMPLETED|Overall Study||0||
48148138|NCT03263429|100685167|FG001|COMPLETED|Overall Study||0||
48148139|NCT03263429|100685168|FG002|COMPLETED|Overall Study||0||
48148140|NCT03263429|100685166|FG000|NOT COMPLETED|Overall Study||3||
48148141|NCT03263429|100685167|FG001|NOT COMPLETED|Overall Study||8||
48148142|NCT03263429|100685168|FG002|NOT COMPLETED|Overall Study||18||
48148143|NCT02652481|100685169|FG000|STARTED|Phase 1||239||
48148144|NCT02652481|100685169|FG000|COMPLETED|Phase 1||141||
48148145|NCT02652481|100685169|FG000|NOT COMPLETED|Phase 1||98||
48148146|NCT02652481|100685169|FG000|STARTED|Phase 2||261||
48148147|NCT02652481|100685169|FG000|COMPLETED|Phase 2||243||
48148148|NCT02652481|100685169|FG000|NOT COMPLETED|Phase 2||18||
48148149|NCT00293267|100685170|FG000|STARTED|Primary Study - Double-Blind Week 0-48||234||
48148150|NCT00293267|100685171|FG001|STARTED|Primary Study - Double-Blind Week 0-48||118||
48148151|NCT00293267|100685170|FG000|Treated|Primary Study - Double-Blind Week 0-48||232||
48148152|NCT00293267|100685171|FG001|Treated|Primary Study - Double-Blind Week 0-48||118||
48148153|NCT00293267|100685170|FG000|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48||193||
48148154|NCT00293267|100685171|FG001|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48||50||
48148155|NCT00293267|100685170|FG000|COMPLETED|Primary Study - Double-Blind Week 0-48||193||
48148156|NCT00293267|100685171|FG001|COMPLETED|Primary Study - Double-Blind Week 0-48||50||
48148157|NCT00293267|100685170|FG000|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||41||
48148158|NCT00293267|100685171|FG001|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||68||
48148159|NCT00293267|100685170|FG000|STARTED|Extension - Double-Blind Week 49-156||191||
48148160|NCT00293267|100685171|FG001|STARTED|Extension - Double-Blind Week 49-156||50||
48148161|NCT00293267|100685170|FG000|COMPLETED|Extension - Double-Blind Week 49-156||139||
48148162|NCT00293267|100685171|FG001|COMPLETED|Extension - Double-Blind Week 49-156||35||
48148163|NCT00293267|100685170|FG000|NOT COMPLETED|Extension - Double-Blind Week 49-156||52||
48148164|NCT00293267|100685171|FG001|NOT COMPLETED|Extension - Double-Blind Week 49-156||15||
48148165|NCT00293267|100685170|FG000|STARTED|Extension - Open-Label Week 157-240||131||
48148166|NCT00293267|100685171|FG001|STARTED|Extension - Open-Label Week 157-240||28||
48148167|NCT00293267|100685170|FG000|COMPLETED|Extension - Open-Label Week 157-240||111||
48148168|NCT00293267|100685171|FG001|COMPLETED|Extension - Open-Label Week 157-240||26||
48148169|NCT00293267|100685170|FG000|NOT COMPLETED|Extension - Open-Label Week 157-240||20||
48148170|NCT00293267|100685171|FG001|NOT COMPLETED|Extension - Open-Label Week 157-240||2||
48148171|NCT00293267|100685170|FG000|STARTED|Open-Label Post Virologic Failure Phase||48||
48148172|NCT00293267|100685171|FG001|STARTED|Open-Label Post Virologic Failure Phase||66||
48188530|NCT05233085|100783266|FG000|COMPLETED|Overall Study||8||
48148173|NCT00293267|100685170|FG000|COMPLETED|Open-Label Post Virologic Failure Phase||15||
48148174|NCT00293267|100685171|FG001|COMPLETED|Open-Label Post Virologic Failure Phase||29||
48604748|NCT03544281|101816364|FG000|DLT-evaluable|Overall Study||0|DLT-evaluable population included participants who received at least 1 full dose of belantamab mafodotin and at least 75% of planned doses of Len/Dex by the end of Cycle 1 (Day 28) for treatment A and participants who received at least 1 full dose of belantamab mafodotin and at least 75% of planned doses of Bor/Dex by the end of Cycle 1 (Day 21) for treatment B.|
48604749|NCT03544281|101816365|FG001|DLT-evaluable|Overall Study||3|DLT-evaluable population included participants who received at least 1 full dose of belantamab mafodotin and at least 75% of planned doses of Len/Dex by the end of Cycle 1 (Day 28) for treatment A and participants who received at least 1 full dose of belantamab mafodotin and at least 75% of planned doses of Bor/Dex by the end of Cycle 1 (Day 21) for treatment B.|
48604750|NCT03544281|101816366|FG002|DLT-evaluable|Overall Study||4|DLT-evaluable population included participants who received at least 1 full dose of belantamab mafodotin and at least 75% of planned doses of Len/Dex by the end of Cycle 1 (Day 28) for treatment A and participants who received at least 1 full dose of belantamab mafodotin and at least 75% of planned doses of Bor/Dex by the end of Cycle 1 (Day 21) for treatment B.|
48604751|NCT03544281|101816367|FG003|DLT-evaluable|Overall Study||6|DLT-evaluable population included participants who received at least 1 full dose of belantamab mafodotin and at least 75% of planned doses of Len/Dex by the end of Cycle 1 (Day 28) for treatment A and participants who received at least 1 full dose of belantamab mafodotin and at least 75% of planned doses of Bor/Dex by the end of Cycle 1 (Day 21) for treatment B.|
48604752|NCT03544281|101816368|FG004|DLT-evaluable|Overall Study||0|DLT-evaluable population included participants who received at least 1 full dose of belantamab mafodotin and at least 75% of planned doses of Len/Dex by the end of Cycle 1 (Day 28) for treatment A and participants who received at least 1 full dose of belantamab mafodotin and at least 75% of planned doses of Bor/Dex by the end of Cycle 1 (Day 21) for treatment B.|
48604753|NCT03544281|101816369|FG005|DLT-evaluable|Overall Study||0|DLT-evaluable population included participants who received at least 1 full dose of belantamab mafodotin and at least 75% of planned doses of Len/Dex by the end of Cycle 1 (Day 28) for treatment A and participants who received at least 1 full dose of belantamab mafodotin and at least 75% of planned doses of Bor/Dex by the end of Cycle 1 (Day 21) for treatment B.|
48604754|NCT03544281|101816370|FG006|DLT-evaluable|Overall Study||0|DLT-evaluable population included participants who received at least 1 full dose of belantamab mafodotin and at least 75% of planned doses of Len/Dex by the end of Cycle 1 (Day 28) for treatment A and participants who received at least 1 full dose of belantamab mafodotin and at least 75% of planned doses of Bor/Dex by the end of Cycle 1 (Day 21) for treatment B.|
48604755|NCT03544281|101816371|FG007|DLT-evaluable|Overall Study||0|DLT-evaluable population included participants who received at least 1 full dose of belantamab mafodotin and at least 75% of planned doses of Len/Dex by the end of Cycle 1 (Day 28) for treatment A and participants who received at least 1 full dose of belantamab mafodotin and at least 75% of planned doses of Bor/Dex by the end of Cycle 1 (Day 21) for treatment B.|
48656909|NCT04274218|101943726|FG001|STARTED|Perturbation Condition 1 (15 Minutes)||6||
48148175|NCT00293267|100685170|FG000|NOT COMPLETED|Open-Label Post Virologic Failure Phase||33||
48148176|NCT00293267|100685171|FG001|NOT COMPLETED|Open-Label Post Virologic Failure Phase||37||
48148177|NCT00911534|100685172|FG000|STARTED|Overall Study||147||
48148178|NCT00911534|100685173|FG001|STARTED|Overall Study||153||
48148179|NCT00911534|100685172|FG000|COMPLETED|Overall Study||132||
48148180|NCT00911534|100685173|FG001|COMPLETED|Overall Study||137||
48148181|NCT00911534|100685172|FG000|NOT COMPLETED|Overall Study||15||
48148182|NCT00911534|100685173|FG001|NOT COMPLETED|Overall Study||16||
48148183|NCT03256162|100685174|FG000|STARTED|Overall Study||13||
48148184|NCT03256162|100685175|FG001|STARTED|Overall Study||12||
48148185|NCT03256162|100685174|FG000|COMPLETED|Overall Study||8||
48148186|NCT03256162|100685175|FG001|COMPLETED|Overall Study||8||
48148187|NCT03256162|100685174|FG000|NOT COMPLETED|Overall Study||5||
48148188|NCT03256162|100685175|FG001|NOT COMPLETED|Overall Study||4||
48148189|NCT03982186|100685176|FG000|STARTED|Overall Study||95||
48148190|NCT03982186|100685177|FG001|STARTED|Overall Study||96||
48148191|NCT03982186|100685178|FG002|STARTED|Overall Study||93||
48148192|NCT03982186|100685179|FG003|STARTED|Overall Study||94||
48148193|NCT03982186|100685180|FG004|STARTED|Overall Study||48||
48148194|NCT03982186|100685181|FG005|STARTED|Overall Study||45||
48148195|NCT03982186|100685176|FG000|Double Blind Phase|Overall Study||95||
48148196|NCT03982186|100685177|FG001|Double Blind Phase|Overall Study||96||
48148197|NCT03982186|100685178|FG002|Double Blind Phase|Overall Study||93||
48148198|NCT03982186|100685179|FG003|Double Blind Phase|Overall Study||93||
48148199|NCT03982186|100685180|FG004|Double Blind Phase|Overall Study||48||
48148200|NCT03982186|100685181|FG005|Double Blind Phase|Overall Study||45||
48148201|NCT03982186|100685176|FG000|Follow up Phase 1:|Overall Study||81|Included participants who did not meet NA treatment completion criteria or did not stop NA|
48148202|NCT03982186|100685177|FG001|Follow up Phase 1:|Overall Study||70|Included participants who did not meet NA treatment completion criteria or did not stop NA|
48148203|NCT03982186|100685178|FG002|Follow up Phase 1:|Overall Study||71|Included participants who did not meet NA treatment completion criteria or did not stop NA|
48148204|NCT03982186|100685179|FG003|Follow up Phase 1:|Overall Study||85|Included participants who did not meet NA treatment completion criteria or did not stop NA|
48148205|NCT03982186|100685180|FG004|Follow up Phase 1:|Overall Study||47|Included participants who did not meet NA treatment completion criteria or did not stop NA|
48148206|NCT03982186|100685181|FG005|Follow up Phase 1:|Overall Study||44|Included participants who did not meet NA treatment completion criteria or did not stop NA|
48148207|NCT03982186|100685176|FG000|Follow up Phase 2:|Overall Study||8|Included participants who met NA treatment completion criteria at Week 44 and stopped NA at Week 48|
48656910|NCT04274218|101943727|FG002|STARTED|Perturbation Condition 1 (15 Minutes)||5||
48302758|NCT02119325|101069964|FG000|NOT COMPLETED|Period 1||0||
48302759|NCT02119325|101069965|FG001|NOT COMPLETED|Period 1||0||
48302760|NCT02119325|101069964|FG000|STARTED|Washout Period 1||48||
48302761|NCT02119325|101069965|FG001|STARTED|Washout Period 1||48||
48302762|NCT02119325|101069964|FG000|COMPLETED|Washout Period 1||48||
48302763|NCT02119325|101069965|FG001|COMPLETED|Washout Period 1||47||
48302764|NCT02119325|101069964|FG000|NOT COMPLETED|Washout Period 1||0||
48302765|NCT02119325|101069965|FG001|NOT COMPLETED|Washout Period 1||1||
48302766|NCT02119325|101069964|FG000|STARTED|Period 2||48||
48302767|NCT02119325|101069965|FG001|STARTED|Period 2||47||
48302768|NCT02119325|101069964|FG000|COMPLETED|Period 2||48||
48302769|NCT02119325|101069965|FG001|COMPLETED|Period 2||47||
48302770|NCT02119325|101069964|FG000|NOT COMPLETED|Period 2||0||
48302771|NCT02119325|101069965|FG001|NOT COMPLETED|Period 2||0||
48302772|NCT02921269|101069966|FG000|STARTED|Overall Study||11||
48302773|NCT02921269|101069966|FG000|COMPLETED|Overall Study||10||
48302774|NCT02921269|101069966|FG000|NOT COMPLETED|Overall Study||1||
48302775|NCT03434353|101069967|FG000|STARTED|Overall Study||30||
48302776|NCT03434353|101069968|FG001|STARTED|Overall Study||12||
48302777|NCT03434353|101069969|FG002|STARTED|Overall Study||30||
48302778|NCT03434353|101069970|FG003|STARTED|Overall Study||21||
48302779|NCT03434353|101069971|FG004|STARTED|Overall Study||30||
48302780|NCT03434353|101069967|FG000|COMPLETED|Overall Study||16||
48302781|NCT03434353|101069968|FG001|COMPLETED|Overall Study||9||
48302782|NCT03434353|101069969|FG002|COMPLETED|Overall Study||16||
48302783|NCT03434353|101069970|FG003|COMPLETED|Overall Study||18||
48302784|NCT03434353|101069971|FG004|COMPLETED|Overall Study||12||
48302785|NCT03434353|101069967|FG000|NOT COMPLETED|Overall Study||14||
48302786|NCT03434353|101069968|FG001|NOT COMPLETED|Overall Study||3||
48302787|NCT03434353|101069969|FG002|NOT COMPLETED|Overall Study||14||
48302788|NCT03434353|101069970|FG003|NOT COMPLETED|Overall Study||3||
48302789|NCT03434353|101069971|FG004|NOT COMPLETED|Overall Study||18||
48302790|NCT01118325|101069972|FG000|STARTED|Overall Study||50||
48302791|NCT01118325|101069973|FG001|STARTED|Overall Study||43||
48302792|NCT01118325|101069974|FG002|STARTED|Overall Study||46||
48302793|NCT01118325|101069972|FG000|COMPLETED|Overall Study||49||
48302794|NCT01118325|101069973|FG001|COMPLETED|Overall Study||43||
48302795|NCT01118325|101069974|FG002|COMPLETED|Overall Study||45||
48302796|NCT01118325|101069972|FG000|NOT COMPLETED|Overall Study||1||
48302797|NCT01118325|101069973|FG001|NOT COMPLETED|Overall Study||0||
48302798|NCT01118325|101069974|FG002|NOT COMPLETED|Overall Study||1||
48302799|NCT00523718|101069975|FG000|STARTED|Overall Study||20||
48302800|NCT00523718|101069976|FG001|STARTED|Overall Study||18||
48302801|NCT00523718|101069975|FG000|COMPLETED|Overall Study||17||
48302802|NCT00523718|101069976|FG001|COMPLETED|Overall Study||18||
48302803|NCT00523718|101069975|FG000|NOT COMPLETED|Overall Study||3||
48302804|NCT00523718|101069976|FG001|NOT COMPLETED|Overall Study||0||
48302805|NCT02087748|101069977|FG000|STARTED|Overall Study||24||
48302806|NCT02087748|101069977|FG000|COMPLETED|Overall Study||24||
48302807|NCT02087748|101069977|FG000|NOT COMPLETED|Overall Study||0||
48302808|NCT01770912|101069978|FG000|STARTED|Overall Study||12||
48302809|NCT01770912|101069979|FG001|STARTED|Overall Study||12||
48302810|NCT01770912|101069978|FG000|COMPLETED|Overall Study||10||
48302811|NCT01770912|101069979|FG001|COMPLETED|Overall Study||12||
48302812|NCT01770912|101069978|FG000|NOT COMPLETED|Overall Study||2||
48302813|NCT01770912|101069979|FG001|NOT COMPLETED|Overall Study||0||
48302814|NCT01630434|101069980|FG000|STARTED|Overall Study||151|Intention-to-treat population|
48302815|NCT01630434|101069981|FG001|STARTED|Overall Study||169|Intention-to-treat population|
48302816|NCT01630434|101069980|FG000|Safety Population|Overall Study||150||
48656911|NCT04274218|101943728|FG003|STARTED|Perturbation Condition 1 (15 Minutes)||4||
48302817|NCT01630434|101069981|FG001|Safety Population|Overall Study||169||
48302818|NCT01630434|101069980|FG000|Per Protocol Population|Overall Study||141||
48302819|NCT01630434|101069981|FG001|Per Protocol Population|Overall Study||165||
48302820|NCT01630434|101069980|FG000|COMPLETED|Overall Study||121|Number of per protocol subjects that completed 24-month follow-up|
48302821|NCT01630434|101069981|FG001|COMPLETED|Overall Study||139|Number of per protocol subjects that completed 24-month follow-up|
48302822|NCT01630434|101069980|FG000|NOT COMPLETED|Overall Study||30||
48302823|NCT01630434|101069981|FG001|NOT COMPLETED|Overall Study||30||
48302824|NCT03370471|101069982|FG000|STARTED|Overall Study||23||
48302825|NCT03370471|101069983|FG001|STARTED|Overall Study||5||
48302826|NCT03370471|101069982|FG000|COMPLETED|Overall Study||16||
48302827|NCT03370471|101069983|FG001|COMPLETED|Overall Study||3||
48302828|NCT03370471|101069982|FG000|NOT COMPLETED|Overall Study||7||
48715536|NCT02788201|102088807|FG001|NOT COMPLETED|Overall Study||1||
48715537|NCT02788201|102088808|FG002|NOT COMPLETED|Overall Study||1||
48715538|NCT02788201|102088809|FG003|NOT COMPLETED|Overall Study||1||
48302829|NCT03370471|101069983|FG001|NOT COMPLETED|Overall Study||2||
48302830|NCT01708122|101069984|FG000|STARTED|Overall Study||27||
48302831|NCT01708122|101069985|FG001|STARTED|Overall Study||26||
48302832|NCT01708122|101069984|FG000|COMPLETED|Overall Study||27||
48302833|NCT01708122|101069985|FG001|COMPLETED|Overall Study||26||
48302834|NCT01708122|101069984|FG000|NOT COMPLETED|Overall Study||0||
48302835|NCT01708122|101069985|FG001|NOT COMPLETED|Overall Study||0||
48302836|NCT04721821|101069986|FG000|STARTED|Overall Study||989||
48302837|NCT04721821|101069987|FG001|STARTED|Overall Study||3337||
48302838|NCT04721821|101069988|FG002|STARTED|Overall Study||805||
48302839|NCT04721821|101069989|FG003|STARTED|Overall Study||2676||
48302840|NCT04721821|101069986|FG000|COMPLETED|Overall Study||989||
48302841|NCT04721821|101069987|FG001|COMPLETED|Overall Study||3337||
48302842|NCT04721821|101069988|FG002|COMPLETED|Overall Study||805||
48302843|NCT04721821|101069989|FG003|COMPLETED|Overall Study||2676||
48302844|NCT04721821|101069986|FG000|NOT COMPLETED|Overall Study||0||
48302845|NCT04721821|101069987|FG001|NOT COMPLETED|Overall Study||0||
48302846|NCT04721821|101069988|FG002|NOT COMPLETED|Overall Study||0||
48715539|NCT02788201|102088810|FG004|NOT COMPLETED|Overall Study||0||
48715540|NCT02788201|102088811|FG005|NOT COMPLETED|Overall Study||3||
48715541|NCT02558400|102088812|FG000|STARTED|Overall Study||238||
48715542|NCT02558400|102088813|FG001|STARTED|Overall Study||244||
48715543|NCT02558400|102088814|FG002|STARTED|Overall Study||236||
48715544|NCT02558400|102088812|FG000|COMPLETED|Overall Study||159||
48715545|NCT02558400|102088813|FG001|COMPLETED|Overall Study||148||
48715546|NCT02558400|102088814|FG002|COMPLETED|Overall Study||203||
48715547|NCT02558400|102088812|FG000|NOT COMPLETED|Overall Study||79||
48715548|NCT02558400|102088813|FG001|NOT COMPLETED|Overall Study||96||
48715549|NCT02558400|102088814|FG002|NOT COMPLETED|Overall Study||33||
48715550|NCT01527383|102088815|FG000|STARTED|Overall Study||292||
48715551|NCT01527383|102088816|FG001|STARTED|Overall Study||62||
48715552|NCT01527383|102088815|FG000|Vaccination 1 (Day 1)|Overall Study||291||
48715553|NCT01527383|102088816|FG001|Vaccination 1 (Day 1)|Overall Study||62||
48715554|NCT01527383|102088815|FG000|Vaccination 2 (~Day 30)|Overall Study||283||
48715555|NCT01527383|102088816|FG001|Vaccination 2 (~Day 30)|Overall Study||61||
48715556|NCT01527383|102088815|FG000|Vaccination 3 (~Day 60)|Overall Study||278||
48715557|NCT01527383|102088816|FG001|Vaccination 3 (~Day 60)|Overall Study||58||
48715558|NCT01527383|102088815|FG000|Vaccination 4 (~Day 90)|Overall Study||277||
48715559|NCT01527383|102088816|FG001|Vaccination 4 (~Day 90)|Overall Study||58||
48715560|NCT01527383|102088815|FG000|COMPLETED|Overall Study||277||
48715561|NCT01527383|102088816|FG001|COMPLETED|Overall Study||58||
48715562|NCT01527383|102088815|FG000|NOT COMPLETED|Overall Study||15||
48715563|NCT01527383|102088816|FG001|NOT COMPLETED|Overall Study||4||
48302847|NCT04721821|101069989|FG003|NOT COMPLETED|Overall Study||0||
48302848|NCT01681810|101069990|FG000|STARTED|Overall Study||20||
48302849|NCT01681810|101069990|FG000|COMPLETED|Overall Study||20||
48302850|NCT01681810|101069990|FG000|NOT COMPLETED|Overall Study||0||
48302851|NCT00445068|101069991|FG000|STARTED|Overall Study||38||
48302852|NCT00445068|101069991|FG000|COMPLETED|Overall Study||2||
48302853|NCT00445068|101069991|FG000|NOT COMPLETED|Overall Study||36||
48302854|NCT02366728|101069992|FG000|STARTED|Overall Study||27||
48302855|NCT02366728|101069993|FG001|STARTED|Overall Study||28||
48302856|NCT02366728|101069994|FG002|STARTED|Overall Study||9||
48302857|NCT02366728|101069992|FG000|Received at Least One ppp65 Vaccine|Overall Study||25||
48302858|NCT02366728|101069993|FG001|Received at Least One ppp65 Vaccine|Overall Study||27||
48302859|NCT02366728|101069994|FG002|Received at Least One ppp65 Vaccine|Overall Study||8||
48302860|NCT02366728|101069992|FG000|COMPLETED|Overall Study||23||
48302861|NCT02366728|101069993|FG001|COMPLETED|Overall Study||27||
48302862|NCT02366728|101069994|FG002|COMPLETED|Overall Study||8||
48302863|NCT02366728|101069992|FG000|NOT COMPLETED|Overall Study||4||
48302864|NCT02366728|101069993|FG001|NOT COMPLETED|Overall Study||1||
48302865|NCT02366728|101069994|FG002|NOT COMPLETED|Overall Study||1||
48302866|NCT02545322|101069995|FG000|STARTED|Overall Study||18||
48302867|NCT02545322|101069995|FG000|COMPLETED|Overall Study||15||
48302868|NCT02545322|101069995|FG000|NOT COMPLETED|Overall Study||3||
48302869|NCT02797067|101069996|FG000|STARTED|Overall Study||685||
48302870|NCT02797067|101069997|FG001|STARTED|Overall Study||685||
48715564|NCT01036529|102088817|FG000|STARTED|Overall Study||13||
48715565|NCT01036529|102088818|FG001|STARTED|Overall Study||15||
48302871|NCT02797067|101069996|FG000|COMPLETED|Overall Study||685||
48302872|NCT02797067|101069997|FG001|COMPLETED|Overall Study||685||
48715566|NCT01036529|102088817|FG000|Baseline Visit|Overall Study||10||
48715567|NCT01036529|102088818|FG001|Baseline Visit|Overall Study||13||
48715568|NCT01036529|102088817|FG000|Index Procedure|Overall Study||10||
48302873|NCT02797067|101069996|FG000|NOT COMPLETED|Overall Study||0||
48302874|NCT02797067|101069997|FG001|NOT COMPLETED|Overall Study||0||
48302875|NCT02003014|101069998|FG000|STARTED|Overall Study||899||
48302876|NCT02003014|101069998|FG000|COMPLETED|Overall Study||880||
48302877|NCT02003014|101069998|FG000|NOT COMPLETED|Overall Study||19||
48302878|NCT04071795|101069999|FG000|STARTED|Overall Study||58||
48715569|NCT01036529|102088818|FG001|Index Procedure|Overall Study||11||
48715570|NCT01036529|102088817|FG000|3 Month Follow-up|Overall Study||7||
48715571|NCT01036529|102088818|FG001|3 Month Follow-up|Overall Study||9||
48715572|NCT01036529|102088817|FG000|6 Month Follow-up|Overall Study||6||
48715573|NCT01036529|102088818|FG001|6 Month Follow-up|Overall Study||7||
48715574|NCT01036529|102088817|FG000|12 Month Follow-up|Overall Study||4||
48302879|NCT04071795|101070000|FG001|STARTED|Overall Study||240||
48302880|NCT04071795|101070001|FG002|STARTED|Overall Study||82||
48302881|NCT04071795|101070002|FG003|STARTED|Overall Study||303||
48715575|NCT01036529|102088818|FG001|12 Month Follow-up|Overall Study||3||
48715576|NCT01036529|102088817|FG000|Requested Crossover|Overall Study||1||
48302882|NCT04071795|101069999|FG000|COMPLETED|Overall Study||34||
48302883|NCT04071795|101070000|FG001|COMPLETED|Overall Study||240||
48302884|NCT04071795|101070001|FG002|COMPLETED|Overall Study||55||
48715577|NCT01036529|102088818|FG001|Requested Crossover|Overall Study||2||
48715578|NCT01036529|102088817|FG000|Crossover to Other Group|Overall Study||1||
48715579|NCT01036529|102088818|FG001|Crossover to Other Group|Overall Study||1||
48715580|NCT01036529|102088817|FG000|COMPLETED|Overall Study||0||
48604756|NCT03544281|101816372|FG008|DLT-evaluable|Overall Study||0|DLT-evaluable population included participants who received at least 1 full dose of belantamab mafodotin and at least 75% of planned doses of Len/Dex by the end of Cycle 1 (Day 28) for treatment A and participants who received at least 1 full dose of belantamab mafodotin and at least 75% of planned doses of Bor/Dex by the end of Cycle 1 (Day 21) for treatment B.|
48604757|NCT03544281|101816373|FG009|DLT-evaluable|Overall Study||6|DLT-evaluable population included participants who received at least 1 full dose of belantamab mafodotin and at least 75% of planned doses of Len/Dex by the end of Cycle 1 (Day 28) for treatment A and participants who received at least 1 full dose of belantamab mafodotin and at least 75% of planned doses of Bor/Dex by the end of Cycle 1 (Day 21) for treatment B.|
48604758|NCT03544281|101816374|FG010|DLT-evaluable|Overall Study||0|DLT-evaluable population included participants who received at least 1 full dose of belantamab mafodotin and at least 75% of planned doses of Len/Dex by the end of Cycle 1 (Day 28) for treatment A and participants who received at least 1 full dose of belantamab mafodotin and at least 75% of planned doses of Bor/Dex by the end of Cycle 1 (Day 21) for treatment B.|
48604759|NCT03544281|101816375|FG011|DLT-evaluable|Overall Study||7|DLT-evaluable population included participants who received at least 1 full dose of belantamab mafodotin and at least 75% of planned doses of Len/Dex by the end of Cycle 1 (Day 28) for treatment A and participants who received at least 1 full dose of belantamab mafodotin and at least 75% of planned doses of Bor/Dex by the end of Cycle 1 (Day 21) for treatment B.|
48604760|NCT03544281|101816364|FG000|COMPLETED|Overall Study||0||
48188531|NCT05233085|100783267|FG001|COMPLETED|Overall Study||9||
48604761|NCT03544281|101816365|FG001|COMPLETED|Overall Study||0||
48604762|NCT03544281|101816366|FG002|COMPLETED|Overall Study||0||
48604763|NCT03544281|101816367|FG003|COMPLETED|Overall Study||0||
48604764|NCT03544281|101816368|FG004|COMPLETED|Overall Study||0||
48604765|NCT03544281|101816369|FG005|COMPLETED|Overall Study||0||
48604766|NCT03544281|101816370|FG006|COMPLETED|Overall Study||0||
48604767|NCT03544281|101816371|FG007|COMPLETED|Overall Study||0||
48604768|NCT03544281|101816372|FG008|COMPLETED|Overall Study||0||
48604769|NCT03544281|101816373|FG009|COMPLETED|Overall Study||0||
48604770|NCT03544281|101816374|FG010|COMPLETED|Overall Study||0||
48604771|NCT03544281|101816375|FG011|COMPLETED|Overall Study||0||
48604772|NCT03544281|101816364|FG000|NOT COMPLETED|Overall Study||12||
48604773|NCT03544281|101816365|FG001|NOT COMPLETED|Overall Study||4||
48604774|NCT03544281|101816366|FG002|NOT COMPLETED|Overall Study||13||
48604775|NCT03544281|101816367|FG003|NOT COMPLETED|Overall Study||16||
48604776|NCT03544281|101816368|FG004|NOT COMPLETED|Overall Study||12||
48604777|NCT03544281|101816369|FG005|NOT COMPLETED|Overall Study||12||
48604778|NCT03544281|101816370|FG006|NOT COMPLETED|Overall Study||13||
48604779|NCT03544281|101816371|FG007|NOT COMPLETED|Overall Study||12||
48604780|NCT03544281|101816372|FG008|NOT COMPLETED|Overall Study||13||
48604781|NCT03544281|101816373|FG009|NOT COMPLETED|Overall Study||18||
48604782|NCT03544281|101816374|FG010|NOT COMPLETED|Overall Study||12||
48604783|NCT03544281|101816375|FG011|NOT COMPLETED|Overall Study||16||
48604784|NCT00759655|101816376|FG000|STARTED|Overall Study||1||
48604785|NCT00759655|101816376|FG000|COMPLETED|Overall Study||0||
48604786|NCT00759655|101816376|FG000|NOT COMPLETED|Overall Study||1||
48604787|NCT01741350|101816377|FG000|STARTED|Study Intervention||149||
48604788|NCT01741350|101816378|FG001|STARTED|Study Intervention||155||
48604789|NCT01741350|101816377|FG000|COMPLETED|Study Intervention||149||
48604790|NCT01741350|101816378|FG001|COMPLETED|Study Intervention||155||
48604791|NCT01741350|101816377|FG000|NOT COMPLETED|Study Intervention||0||
48604792|NCT01741350|101816378|FG001|NOT COMPLETED|Study Intervention||0||
48604793|NCT01741350|101816377|FG000|STARTED|Post Intervention Assessment (at Week 4)||149||
48604794|NCT01741350|101816378|FG001|STARTED|Post Intervention Assessment (at Week 4)||155||
48604795|NCT01741350|101816377|FG000|COMPLETED|Post Intervention Assessment (at Week 4)||135||
48604796|NCT01741350|101816378|FG001|COMPLETED|Post Intervention Assessment (at Week 4)||141||
48604797|NCT01741350|101816377|FG000|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14||
48604798|NCT01741350|101816378|FG001|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14||
48604799|NCT01741350|101816377|FG000|STARTED|3-Month Follow-up Assessment||135||
48604800|NCT01741350|101816378|FG001|STARTED|3-Month Follow-up Assessment||141||
48604801|NCT01741350|101816377|FG000|COMPLETED|3-Month Follow-up Assessment||129||
48604802|NCT01741350|101816378|FG001|COMPLETED|3-Month Follow-up Assessment||119||
48604803|NCT01741350|101816377|FG000|NOT COMPLETED|3-Month Follow-up Assessment||6||
48604804|NCT01741350|101816378|FG001|NOT COMPLETED|3-Month Follow-up Assessment||22||
48604805|NCT01741350|101816377|FG000|STARTED|6-Month Follow-up Assessment||129||
48604806|NCT01741350|101816378|FG001|STARTED|6-Month Follow-up Assessment||119||
48604807|NCT01741350|101816377|FG000|COMPLETED|6-Month Follow-up Assessment||114||
48302885|NCT04071795|101070002|FG003|COMPLETED|Overall Study||303||
48302886|NCT04071795|101069999|FG000|NOT COMPLETED|Overall Study||24||
48302887|NCT04071795|101070000|FG001|NOT COMPLETED|Overall Study||0||
48302888|NCT04071795|101070001|FG002|NOT COMPLETED|Overall Study||27||
48302889|NCT04071795|101070002|FG003|NOT COMPLETED|Overall Study||0||
48302890|NCT00974090|101070003|FG000|STARTED|Period 1: Double Blind Period||98||
48405388|NCT03074318|101325266|FG000|NOT COMPLETED|Overall Study||4||
48604808|NCT01741350|101816378|FG001|COMPLETED|6-Month Follow-up Assessment||111||
48604809|NCT01741350|101816377|FG000|NOT COMPLETED|6-Month Follow-up Assessment||15||
48604810|NCT01741350|101816378|FG001|NOT COMPLETED|6-Month Follow-up Assessment||8||
48604811|NCT01741350|101816377|FG000|STARTED|12-Month Follow-up Assessment||114||
48604812|NCT01741350|101816378|FG001|STARTED|12-Month Follow-up Assessment||111||
48604813|NCT01741350|101816377|FG000|COMPLETED|12-Month Follow-up Assessment||111||
48604814|NCT01741350|101816378|FG001|COMPLETED|12-Month Follow-up Assessment||109||
48604815|NCT01741350|101816377|FG000|NOT COMPLETED|12-Month Follow-up Assessment||3||
48604816|NCT01741350|101816378|FG001|NOT COMPLETED|12-Month Follow-up Assessment||2||
48604817|NCT02651688|101816379|FG000|STARTED|Overall Study||18||
48604818|NCT02651688|101816380|FG001|STARTED|Overall Study||17||
48604819|NCT02651688|101816381|FG002|STARTED|Overall Study||15||
48604820|NCT02651688|101816379|FG000|COMPLETED|Overall Study||16||
48604821|NCT02651688|101816380|FG001|COMPLETED|Overall Study||12||
48604822|NCT02651688|101816381|FG002|COMPLETED|Overall Study||12||
48604823|NCT02651688|101816379|FG000|NOT COMPLETED|Overall Study||2||
48604824|NCT02651688|101816380|FG001|NOT COMPLETED|Overall Study||5||
48604825|NCT02651688|101816381|FG002|NOT COMPLETED|Overall Study||3||
48604826|NCT00591019|101816382|FG000|STARTED|Baseline (1 Day)||3||
48604827|NCT00591019|101816383|FG001|STARTED|Baseline (1 Day)||4||
48604828|NCT00591019|101816382|FG000|COMPLETED|Baseline (1 Day)||3||
48604829|NCT00591019|101816383|FG001|COMPLETED|Baseline (1 Day)||4||
48604830|NCT00591019|101816382|FG000|NOT COMPLETED|Baseline (1 Day)||0||
48604831|NCT00591019|101816383|FG001|NOT COMPLETED|Baseline (1 Day)||0||
48604832|NCT00591019|101816382|FG000|STARTED|Intervention 1 (14 Days)||2||
48604833|NCT00591019|101816383|FG001|STARTED|Intervention 1 (14 Days)||3||
48604834|NCT00591019|101816382|FG000|COMPLETED|Intervention 1 (14 Days)||2||
48604835|NCT00591019|101816383|FG001|COMPLETED|Intervention 1 (14 Days)||3||
48604836|NCT00591019|101816382|FG000|NOT COMPLETED|Intervention 1 (14 Days)||0||
48604837|NCT00591019|101816383|FG001|NOT COMPLETED|Intervention 1 (14 Days)||0||
48604838|NCT00591019|101816382|FG000|STARTED|Intevention 2 (14 Days)||2||
48302891|NCT00974090|101070004|FG001|STARTED|Period 1: Double Blind Period||96||
48302892|NCT00974090|101070003|FG000|COMPLETED|Period 1: Double Blind Period||95||
48368012|NCT03567291|101230093|FG001|Safety Set|Period I||0||
48302893|NCT00974090|101070004|FG001|COMPLETED|Period 1: Double Blind Period||95||
48604839|NCT00591019|101816383|FG001|STARTED|Intevention 2 (14 Days)||3||
48604840|NCT00591019|101816382|FG000|COMPLETED|Intevention 2 (14 Days)||2||
48604841|NCT00591019|101816383|FG001|COMPLETED|Intevention 2 (14 Days)||3||
48604842|NCT00591019|101816382|FG000|NOT COMPLETED|Intevention 2 (14 Days)||0||
48604843|NCT00591019|101816383|FG001|NOT COMPLETED|Intevention 2 (14 Days)||0||
48604844|NCT00284154|101816384|FG000|STARTED|Overall Study||51||
48604845|NCT00284154|101816384|FG000|COMPLETED|Overall Study||9||
48604846|NCT00284154|101816384|FG000|NOT COMPLETED|Overall Study||42||
48604847|NCT00791700|101816385|FG000|STARTED|Overall Study||16||
48604848|NCT00791700|101816386|FG001|STARTED|Overall Study||31||
48604849|NCT00791700|101816387|FG002|STARTED|Overall Study||13||
48604850|NCT00791700|101816388|FG003|STARTED|Overall Study||43||
48604851|NCT00791700|101816385|FG000|COMPLETED|Overall Study||10||
48604852|NCT00791700|101816386|FG001|COMPLETED|Overall Study||20||
48604853|NCT00791700|101816387|FG002|COMPLETED|Overall Study||7||
48604854|NCT00791700|101816388|FG003|COMPLETED|Overall Study||13||
48604855|NCT00791700|101816385|FG000|NOT COMPLETED|Overall Study||6||
48604856|NCT00791700|101816386|FG001|NOT COMPLETED|Overall Study||11||
48188532|NCT05233085|100783268|FG002|COMPLETED|Overall Study||9||
48302894|NCT00974090|101070003|FG000|NOT COMPLETED|Period 1: Double Blind Period||3||
48604857|NCT00791700|101816387|FG002|NOT COMPLETED|Overall Study||6||
48604858|NCT00791700|101816388|FG003|NOT COMPLETED|Overall Study||30||
48604859|NCT01447719|101816389|FG000|STARTED|Overall Study||152||
48604860|NCT01447719|101816389|FG000|Valid AV-45 Scan Acquired|Overall Study||147||
48604861|NCT01447719|101816389|FG000|Deceased <2 Years After AV-45 Scan|Overall Study||66||
48604862|NCT01447719|101816389|FG000|COMPLETED|Overall Study||59||
48604863|NCT01447719|101816389|FG000|NOT COMPLETED|Overall Study||93||
48604864|NCT01908582|101816390|FG000|STARTED|Period 1||26||
48604865|NCT01908582|101816390|FG000|Received at Least One Dose of Study Drug|Period 1||26||
48604866|NCT01908582|101816390|FG000|COMPLETED|Period 1||26||
48604867|NCT01908582|101816390|FG000|NOT COMPLETED|Period 1||0||
48604868|NCT01908582|101816390|FG000|STARTED|Period 2||26||
48604869|NCT01908582|101816390|FG000|COMPLETED|Period 2||24||
48604870|NCT01908582|101816390|FG000|NOT COMPLETED|Period 2||2||
48604871|NCT00508157|101816391|FG000|STARTED|Overall Study||26||
48604872|NCT00508157|101816392|FG001|STARTED|Overall Study||26||
48604873|NCT00508157|101816391|FG000|Randomized Sample|Overall Study||26||
48604874|NCT00508157|101816392|FG001|Randomized Sample|Overall Study||26||
48604875|NCT00508157|101816391|FG000|Safety Sample|Overall Study||26||
48604876|NCT00508157|101816392|FG001|Safety Sample|Overall Study||25||
48604877|NCT00508157|101816391|FG000|COMPLETED|Overall Study||24||
48604878|NCT00508157|101816392|FG001|COMPLETED|Overall Study||23||
48604879|NCT00508157|101816391|FG000|NOT COMPLETED|Overall Study||2||
48604880|NCT00508157|101816392|FG001|NOT COMPLETED|Overall Study||3||
48604881|NCT03251482|101816393|FG000|STARTED|Overall Study||39||
48604882|NCT03251482|101816394|FG001|STARTED|Overall Study||41||
48604883|NCT03251482|101816395|FG002|STARTED|Overall Study||43||
48604884|NCT03251482|101816396|FG003|STARTED|Overall Study||122||
48604885|NCT03251482|101816397|FG004|STARTED|Overall Study||63||
48604886|NCT03251482|101816393|FG000|Treated|Overall Study||38||
48604887|NCT03251482|101816394|FG001|Treated|Overall Study||40||
48604888|NCT03251482|101816395|FG002|Treated|Overall Study||42||
48604889|NCT03251482|101816396|FG003|Treated|Overall Study||122||
48604890|NCT03251482|101816397|FG004|Treated|Overall Study||63||
48604891|NCT03251482|101816393|FG000|COMPLETED|Overall Study||39||
48604892|NCT03251482|101816394|FG001|COMPLETED|Overall Study||40||
48604893|NCT03251482|101816395|FG002|COMPLETED|Overall Study||43||
48604894|NCT03251482|101816396|FG003|COMPLETED|Overall Study||122||
48604895|NCT03251482|101816397|FG004|COMPLETED|Overall Study||63||
48604896|NCT03251482|101816393|FG000|NOT COMPLETED|Overall Study||0||
48604897|NCT03251482|101816394|FG001|NOT COMPLETED|Overall Study||1||
48604898|NCT03251482|101816395|FG002|NOT COMPLETED|Overall Study||0||
48604899|NCT03251482|101816396|FG003|NOT COMPLETED|Overall Study||0||
48604900|NCT03251482|101816397|FG004|NOT COMPLETED|Overall Study||0||
48604901|NCT00080483|101816398|FG000|STARTED|Overall Study||17||
48604902|NCT00080483|101816399|FG001|STARTED|Overall Study||18||
48604903|NCT00080483|101816398|FG000|COMPLETED|Overall Study||15||
48604904|NCT00080483|101816399|FG001|COMPLETED|Overall Study||16||
48604905|NCT00080483|101816398|FG000|NOT COMPLETED|Overall Study||2||
48604906|NCT00080483|101816399|FG001|NOT COMPLETED|Overall Study||2||
48604907|NCT01358578|101816400|FG000|STARTED|Induction Period||327||
48604908|NCT01358578|101816401|FG001|STARTED|Induction Period||327||
48604909|NCT01358578|101816402|FG002|STARTED|Induction Period||326||
48604910|NCT01358578|101816403|FG003|STARTED|Induction Period||326||
48604911|NCT01358578|101816404|FG004|STARTED|Induction Period||0||
48604912|NCT01358578|101816405|FG005|STARTED|Induction Period||0||
48604913|NCT01358578|101816400|FG000|COMPLETED|Induction Period||315||
48604914|NCT01358578|101816401|FG001|COMPLETED|Induction Period||312||
48604915|NCT01358578|101816402|FG002|COMPLETED|Induction Period||301||
48604916|NCT01358578|101816403|FG003|COMPLETED|Induction Period||305||
48604917|NCT01358578|101816404|FG004|COMPLETED|Induction Period||0||
48604918|NCT01358578|101816405|FG005|COMPLETED|Induction Period||0||
48604919|NCT01358578|101816400|FG000|NOT COMPLETED|Induction Period||12||
48604920|NCT01358578|101816401|FG001|NOT COMPLETED|Induction Period||15||
48604921|NCT01358578|101816402|FG002|NOT COMPLETED|Induction Period||25||
48604922|NCT01358578|101816403|FG003|NOT COMPLETED|Induction Period||21||
48604923|NCT01358578|101816404|FG004|NOT COMPLETED|Induction Period||0||
48604924|NCT01358578|101816405|FG005|NOT COMPLETED|Induction Period||0||
48604925|NCT01358578|101816400|FG000|STARTED|Maintenance Period||315||
48604926|NCT01358578|101816401|FG001|STARTED|Maintenance Period||312||
48604927|NCT01358578|101816402|FG002|STARTED|Maintenance Period||17||
48604928|NCT01358578|101816403|FG003|STARTED|Maintenance Period||305||
48604929|NCT01358578|101816404|FG004|STARTED|Maintenance Period||142||
48604930|NCT01358578|101816405|FG005|STARTED|Maintenance Period||142||
48604931|NCT01358578|101816400|FG000|COMPLETED|Maintenance Period||276||
48604932|NCT01358578|101816401|FG001|COMPLETED|Maintenance Period||290||
48604933|NCT01358578|101816402|FG002|COMPLETED|Maintenance Period||15||
48604934|NCT01358578|101816403|FG003|COMPLETED|Maintenance Period||263||
48604935|NCT01358578|101816404|FG004|COMPLETED|Maintenance Period||125||
48604936|NCT01358578|101816405|FG005|COMPLETED|Maintenance Period||131||
48604937|NCT01358578|101816400|FG000|NOT COMPLETED|Maintenance Period||39||
48604938|NCT01358578|101816401|FG001|NOT COMPLETED|Maintenance Period||22||
48604939|NCT01358578|101816402|FG002|NOT COMPLETED|Maintenance Period||2||
48604940|NCT01358578|101816403|FG003|NOT COMPLETED|Maintenance Period||42||
48604941|NCT01358578|101816404|FG004|NOT COMPLETED|Maintenance Period||17||
48604942|NCT01358578|101816405|FG005|NOT COMPLETED|Maintenance Period||11||
48604943|NCT01358578|101816400|FG000|STARTED|Follow-up Period||148||
48604944|NCT01358578|101816401|FG001|STARTED|Follow-up Period||125||
48604945|NCT01358578|101816402|FG002|STARTED|Follow-up Period||26||
48604946|NCT01358578|101816403|FG003|STARTED|Follow-up Period||279||
48604947|NCT01358578|101816404|FG004|STARTED|Follow-up Period||0||
48604948|NCT01358578|101816405|FG005|STARTED|Follow-up Period||0||
48604949|NCT01358578|101816400|FG000|COMPLETED|Follow-up Period||138||
48604950|NCT01358578|101816401|FG001|COMPLETED|Follow-up Period||119||
48604951|NCT01358578|101816402|FG002|COMPLETED|Follow-up Period||21||
48604952|NCT01358578|101816403|FG003|COMPLETED|Follow-up Period||260||
48604953|NCT01358578|101816404|FG004|COMPLETED|Follow-up Period||0||
48604954|NCT01358578|101816405|FG005|COMPLETED|Follow-up Period||0||
48604955|NCT01358578|101816400|FG000|NOT COMPLETED|Follow-up Period||10||
48604956|NCT01358578|101816401|FG001|NOT COMPLETED|Follow-up Period||6||
48604957|NCT01358578|101816402|FG002|NOT COMPLETED|Follow-up Period||5||
48604958|NCT01358578|101816403|FG003|NOT COMPLETED|Follow-up Period||19||
48604959|NCT01358578|101816404|FG004|NOT COMPLETED|Follow-up Period||0||
48604960|NCT01358578|101816405|FG005|NOT COMPLETED|Follow-up Period||0||
48604961|NCT03141034|101816406|FG000|STARTED|Overall Study||40||
48604962|NCT03141034|101816406|FG000|COMPLETED|Overall Study||40||
48604963|NCT03141034|101816406|FG000|NOT COMPLETED|Overall Study||0||
48604964|NCT00802672|101816407|FG000|STARTED|Overall Study||224||
48715581|NCT01036529|102088818|FG001|COMPLETED|Overall Study||0||
48715582|NCT01036529|102088817|FG000|NOT COMPLETED|Overall Study||13||
48715583|NCT01036529|102088818|FG001|NOT COMPLETED|Overall Study||15||
48715584|NCT01071356|102088819|FG000|STARTED|Overall Study||111||
48715585|NCT01071356|102088820|FG001|STARTED|Overall Study||106||
48715586|NCT01071356|102088819|FG000|COMPLETED|Overall Study||104||
48715587|NCT01071356|102088820|FG001|COMPLETED|Overall Study||97||
48715588|NCT01071356|102088819|FG000|NOT COMPLETED|Overall Study||7||
48715589|NCT01071356|102088820|FG001|NOT COMPLETED|Overall Study||9||
48715590|NCT03785587|102088821|FG000|STARTED|Overall Study||21||
48604965|NCT00802672|101816408|FG001|STARTED|Overall Study||226||
48604966|NCT00802672|101816409|FG002|STARTED|Overall Study||111||
48604967|NCT00802672|101816407|FG000|COMPLETED|Overall Study||156||
48604968|NCT00802672|101816408|FG001|COMPLETED|Overall Study||174||
48604969|NCT00802672|101816409|FG002|COMPLETED|Overall Study||77||
48604970|NCT00802672|101816407|FG000|NOT COMPLETED|Overall Study||68||
48604971|NCT00802672|101816408|FG001|NOT COMPLETED|Overall Study||52||
48604972|NCT00802672|101816409|FG002|NOT COMPLETED|Overall Study||34||
48604973|NCT02770846|101816410|FG000|STARTED|Overall Study||25||
48604974|NCT02770846|101816411|FG001|STARTED|Overall Study||25||
48604975|NCT02770846|101816410|FG000|COMPLETED|Overall Study||25||
48604976|NCT02770846|101816411|FG001|COMPLETED|Overall Study||25||
48604977|NCT02770846|101816410|FG000|NOT COMPLETED|Overall Study||0||
48604978|NCT02770846|101816411|FG001|NOT COMPLETED|Overall Study||0||
48604979|NCT02322333|101816412|FG000|STARTED|Overall Study||80||
48604980|NCT02322333|101816413|FG001|STARTED|Overall Study||77||
48604981|NCT02322333|101816412|FG000|COMPLETED|Overall Study||63||
48715591|NCT03785587|102088821|FG000|COMPLETED|Overall Study||16||
48715592|NCT03785587|102088821|FG000|NOT COMPLETED|Overall Study||5||
48715593|NCT00350623|102088822|FG000|STARTED|Overall Study||71||
48715594|NCT00350623|102088823|FG001|STARTED|Overall Study||71||
48715595|NCT00350623|102088824|FG002|STARTED|Overall Study||68||
48715596|NCT00350623|102088822|FG000|COMPLETED|Overall Study||63||
48715597|NCT00350623|102088823|FG001|COMPLETED|Overall Study||67||
48715598|NCT00350623|102088824|FG002|COMPLETED|Overall Study||62||
48715599|NCT00350623|102088822|FG000|NOT COMPLETED|Overall Study||8||
48715600|NCT00350623|102088823|FG001|NOT COMPLETED|Overall Study||4||
48604982|NCT02322333|101816413|FG001|COMPLETED|Overall Study||61||
48604983|NCT02322333|101816412|FG000|NOT COMPLETED|Overall Study||17||
48604984|NCT02322333|101816413|FG001|NOT COMPLETED|Overall Study||16||
48604985|NCT04677387|101816414|FG000|STARTED|Overall Study||25||
48604986|NCT04677387|101816415|FG001|STARTED|Overall Study||23||
48604987|NCT04677387|101816414|FG000|Baseline Survey|Overall Study||25||
48604988|NCT04677387|101816415|FG001|Baseline Survey|Overall Study||23||
48604989|NCT04677387|101816414|FG000|Immediate Post-training Survey|Overall Study||18||
48604990|NCT04677387|101816415|FG001|Immediate Post-training Survey|Overall Study||19||
48604991|NCT04677387|101816414|FG000|1-month Follow-up Simulated Patient Data|Overall Study||17||
48604992|NCT04677387|101816415|FG001|1-month Follow-up Simulated Patient Data|Overall Study||16||
48604993|NCT04677387|101816414|FG000|3-month Follow-up Survey|Overall Study||17||
48604994|NCT04677387|101816415|FG001|3-month Follow-up Survey|Overall Study||18||
48604995|NCT04677387|101816414|FG000|3-month Follow-up Dispensing Data|Overall Study||19||
48715601|NCT00350623|102088824|FG002|NOT COMPLETED|Overall Study||6||
48604996|NCT04677387|101816415|FG001|3-month Follow-up Dispensing Data|Overall Study||20||
48604997|NCT04677387|101816414|FG000|COMPLETED|Overall Study||17||
48604998|NCT04677387|101816415|FG001|COMPLETED|Overall Study||18||
48604999|NCT04677387|101816414|FG000|NOT COMPLETED|Overall Study||8||
48605000|NCT04677387|101816415|FG001|NOT COMPLETED|Overall Study||5||
48605001|NCT02226120|101816416|FG000|STARTED|Overall Study||1980|All enrolled patients who received at least one dose of study medication (Safety Analysis Set (SAF))|
48605002|NCT02226120|101816416|FG000|COMPLETED|Overall Study||1660|Completed open-label treatment|
48605003|NCT02226120|101816416|FG000|NOT COMPLETED|Overall Study||320||
48605004|NCT03469999|101816417|FG000|STARTED|Overall Study||12||
48605005|NCT03469999|101816417|FG000|COMPLETED|Overall Study||10||
48605006|NCT03469999|101816417|FG000|NOT COMPLETED|Overall Study||2||
48605007|NCT02437188|101816418|FG000|STARTED|Overall Study||44||
48605008|NCT02437188|101816419|FG001|STARTED|Overall Study||44||
48605009|NCT02437188|101816418|FG000|COMPLETED|Overall Study||40||
48605010|NCT02437188|101816419|FG001|COMPLETED|Overall Study||35||
48605011|NCT02437188|101816418|FG000|NOT COMPLETED|Overall Study||4||
48605012|NCT02437188|101816419|FG001|NOT COMPLETED|Overall Study||9||
48605013|NCT02356107|101816420|FG000|STARTED|Overall Study||15||
48605014|NCT02356107|101816420|FG000|COMPLETED|Overall Study||12||
48605015|NCT02356107|101816420|FG000|NOT COMPLETED|Overall Study||3||
48605016|NCT03853291|101816421|FG000|STARTED|Overall Study||18||
48605017|NCT03853291|101816422|FG001|STARTED|Overall Study||16||
48605018|NCT03853291|101816423|FG002|STARTED|Overall Study||18||
48605019|NCT03853291|101816424|FG003|STARTED|Overall Study||16||
48605020|NCT03853291|101816425|FG004|STARTED|Overall Study||6||
48605021|NCT03853291|101816426|FG005|STARTED|Overall Study||11||
48605022|NCT03853291|101816421|FG000|COMPLETED|Overall Study||16||
48605023|NCT03853291|101816422|FG001|COMPLETED|Overall Study||13||
48605024|NCT03853291|101816423|FG002|COMPLETED|Overall Study||18||
48605025|NCT03853291|101816424|FG003|COMPLETED|Overall Study||16||
48605026|NCT03853291|101816425|FG004|COMPLETED|Overall Study||6||
48605027|NCT03853291|101816426|FG005|COMPLETED|Overall Study||11||
48605028|NCT03853291|101816421|FG000|NOT COMPLETED|Overall Study||2||
48605029|NCT03853291|101816422|FG001|NOT COMPLETED|Overall Study||3||
48605030|NCT03853291|101816423|FG002|NOT COMPLETED|Overall Study||0||
48605031|NCT03853291|101816424|FG003|NOT COMPLETED|Overall Study||0||
48605032|NCT03853291|101816425|FG004|NOT COMPLETED|Overall Study||0||
48605033|NCT03853291|101816426|FG005|NOT COMPLETED|Overall Study||0||
48605034|NCT01121536|101816427|FG000|STARTED|Overall Study||867||
48605035|NCT01121536|101816427|FG000|Safety Population|Overall Study||863||
48605036|NCT01121536|101816427|FG000|Full Analysis Population|Overall Study||859||
48605037|NCT01121536|101816427|FG000|COMPLETED|Overall Study||506||
48605038|NCT01121536|101816427|FG000|NOT COMPLETED|Overall Study||361||
48605039|NCT02315664|101816428|FG000|STARTED|Overall Study||30||
48605040|NCT02315664|101816429|FG001|STARTED|Overall Study||31||
48605041|NCT02315664|101816428|FG000|COMPLETED|Overall Study||29||
48605042|NCT02315664|101816429|FG001|COMPLETED|Overall Study||27||
48605043|NCT02315664|101816428|FG000|NOT COMPLETED|Overall Study||1||
48605044|NCT02315664|101816429|FG001|NOT COMPLETED|Overall Study||4||
48605045|NCT01483599|101816430|FG000|STARTED|Controlled Period (CP) (up to Week 16)||42||
48605046|NCT01483599|101816431|FG001|STARTED|Controlled Period (CP) (up to Week 16)||41||
48605047|NCT01483599|101816432|FG002|STARTED|Controlled Period (CP) (up to Week 16)||41||
48605048|NCT01483599|101816433|FG003|STARTED|Controlled Period (CP) (up to Week 16)||42||
48605049|NCT01483599|101816434|FG004|STARTED|Controlled Period (CP) (up to Week 16)||42||
48605050|NCT01483599|101816435|FG005|STARTED|Controlled Period (CP) (up to Week 16)||42||
48605051|NCT01483599|101816436|FG006|STARTED|Controlled Period (CP) (up to Week 16)||43||
48605052|NCT01483599|101816437|FG007|STARTED|Controlled Period (CP) (up to Week 16)||0||
48605053|NCT01483599|101816438|FG008|STARTED|Controlled Period (CP) (up to Week 16)||0||
48605054|NCT01483599|101816439|FG009|STARTED|Controlled Period (CP) (up to Week 16)||0||
48605055|NCT01483599|101816440|FG010|STARTED|Controlled Period (CP) (up to Week 16)||0||
48605056|NCT01483599|101816441|FG011|STARTED|Controlled Period (CP) (up to Week 16)||0||
48605057|NCT01483599|101816442|FG012|STARTED|Controlled Period (CP) (up to Week 16)||0||
48605058|NCT01483599|101816443|FG013|STARTED|Controlled Period (CP) (up to Week 16)||0||
48605059|NCT01483599|101816430|FG000|Treated|Controlled Period (CP) (up to Week 16)||42||
48605060|NCT01483599|101816431|FG001|Treated|Controlled Period (CP) (up to Week 16)||41||
48605061|NCT01483599|101816432|FG002|Treated|Controlled Period (CP) (up to Week 16)||41||
48605062|NCT01483599|101816433|FG003|Treated|Controlled Period (CP) (up to Week 16)||42||
48605063|NCT01483599|101816434|FG004|Treated|Controlled Period (CP) (up to Week 16)||42||
48605064|NCT01483599|101816435|FG005|Treated|Controlled Period (CP) (up to Week 16)||41||
48605065|NCT01483599|101816436|FG006|Treated|Controlled Period (CP) (up to Week 16)||43||
48605066|NCT01483599|101816437|FG007|Treated|Controlled Period (CP) (up to Week 16)||0||
48605067|NCT01483599|101816438|FG008|Treated|Controlled Period (CP) (up to Week 16)||0||
48605068|NCT01483599|101816439|FG009|Treated|Controlled Period (CP) (up to Week 16)||0||
48605069|NCT01483599|101816440|FG010|Treated|Controlled Period (CP) (up to Week 16)||0||
48605070|NCT01483599|101816441|FG011|Treated|Controlled Period (CP) (up to Week 16)||0||
48605071|NCT01483599|101816442|FG012|Treated|Controlled Period (CP) (up to Week 16)||0||
48605072|NCT01483599|101816443|FG013|Treated|Controlled Period (CP) (up to Week 16)||0||
48605073|NCT01483599|101816430|FG000|COMPLETED|Controlled Period (CP) (up to Week 16)||39||
48605074|NCT01483599|101816431|FG001|COMPLETED|Controlled Period (CP) (up to Week 16)||38||
48605075|NCT01483599|101816432|FG002|COMPLETED|Controlled Period (CP) (up to Week 16)||41||
48605076|NCT01483599|101816433|FG003|COMPLETED|Controlled Period (CP) (up to Week 16)||39||
48605077|NCT01483599|101816434|FG004|COMPLETED|Controlled Period (CP) (up to Week 16)||40||
48605078|NCT01483599|101816435|FG005|COMPLETED|Controlled Period (CP) (up to Week 16)||38||
48605079|NCT01483599|101816436|FG006|COMPLETED|Controlled Period (CP) (up to Week 16)||39||
48148208|NCT03982186|100685177|FG001|Follow up Phase 2:|Overall Study||17|Included participants who met NA treatment completion criteria at Week 44 and stopped NA at Week 48|
48148209|NCT03982186|100685178|FG002|Follow up Phase 2:|Overall Study||15|Included participants who met NA treatment completion criteria at Week 44 and stopped NA at Week 48|
48148210|NCT03982186|100685179|FG003|Follow up Phase 2:|Overall Study||5|Included participants who met NA treatment completion criteria at Week 44 and stopped NA at Week 48|
48148211|NCT03982186|100685180|FG004|Follow up Phase 2:|Overall Study||0|Included participants who met NA treatment completion criteria at Week 44 and stopped NA at Week 48|
48148212|NCT03982186|100685181|FG005|Follow up Phase 2:|Overall Study||1|Included participants who met NA treatment completion criteria at Week 44 and stopped NA at Week 48|
48302895|NCT00974090|101070004|FG001|NOT COMPLETED|Period 1: Double Blind Period||1||
48302896|NCT00974090|101070003|FG000|STARTED|Period 2: Open-label Period||95||
48605080|NCT01483599|101816437|FG007|COMPLETED|Controlled Period (CP) (up to Week 16)||0||
48605081|NCT01483599|101816438|FG008|COMPLETED|Controlled Period (CP) (up to Week 16)||0||
48605082|NCT01483599|101816439|FG009|COMPLETED|Controlled Period (CP) (up to Week 16)||0||
48605083|NCT01483599|101816440|FG010|COMPLETED|Controlled Period (CP) (up to Week 16)||0||
48605084|NCT01483599|101816441|FG011|COMPLETED|Controlled Period (CP) (up to Week 16)||0||
48605085|NCT01483599|101816442|FG012|COMPLETED|Controlled Period (CP) (up to Week 16)||0||
48605086|NCT01483599|101816443|FG013|COMPLETED|Controlled Period (CP) (up to Week 16)||0||
48605087|NCT01483599|101816430|FG000|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3||
48148213|NCT03982186|100685176|FG000|Follow up Phase 3:|Overall Study||3|Included participants who met NA treatment completion criteria after Week 44 and stopped NA during follow-up|
48148214|NCT03982186|100685177|FG001|Follow up Phase 3:|Overall Study||8|Included participants who met NA treatment completion criteria after Week 44 and stopped NA during follow-up|
48148215|NCT03982186|100685178|FG002|Follow up Phase 3:|Overall Study||5|Included participants who met NA treatment completion criteria after Week 44 and stopped NA during follow-up|
48148216|NCT03982186|100685179|FG003|Follow up Phase 3:|Overall Study||0|Included participants who met NA treatment completion criteria after Week 44 and stopped NA during follow-up|
48148217|NCT03982186|100685180|FG004|Follow up Phase 3:|Overall Study||0|Included participants who met NA treatment completion criteria after Week 44 and stopped NA during follow-up|
48302897|NCT00974090|101070004|FG001|STARTED|Period 2: Open-label Period||95||
48302898|NCT00974090|101070003|FG000|COMPLETED|Period 2: Open-label Period||87||
48302899|NCT00974090|101070004|FG001|COMPLETED|Period 2: Open-label Period||85||
48302900|NCT00974090|101070003|FG000|NOT COMPLETED|Period 2: Open-label Period||8||
48605088|NCT01483599|101816431|FG001|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3||
48605089|NCT01483599|101816432|FG002|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0||
48605090|NCT01483599|101816433|FG003|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3||
48605091|NCT01483599|101816434|FG004|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||2||
48605092|NCT01483599|101816435|FG005|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4||
48605093|NCT01483599|101816436|FG006|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4||
48605094|NCT01483599|101816437|FG007|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0||
48605095|NCT01483599|101816438|FG008|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0||
48605096|NCT01483599|101816439|FG009|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0||
48605097|NCT01483599|101816440|FG010|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0||
48148218|NCT03982186|100685181|FG005|Follow up Phase 3:|Overall Study||0|Included participants who met NA treatment completion criteria after Week 44 and stopped NA during follow-up|
48148219|NCT03982186|100685176|FG000|Extended Follow up|Overall Study||3|Included participants who completed NA treatment during the follow-up phase|
48148220|NCT03982186|100685177|FG001|Extended Follow up|Overall Study||7|Included participants who completed NA treatment during the follow-up phase|
48715602|NCT01752400|102091709|FG000|STARTED|Overall Study||6||
48715603|NCT01752400|102091709|FG000|COMPLETED|Overall Study||6||
48715604|NCT01752400|102091709|FG000|NOT COMPLETED|Overall Study||0||
48715605|NCT00392808|102091710|FG000|STARTED|Overall Study||87||
48715606|NCT00392808|102091711|FG001|STARTED|Overall Study||89||
48715607|NCT00392808|102091712|FG002|STARTED|Overall Study||109||
48148221|NCT03982186|100685178|FG002|Extended Follow up|Overall Study||5|Included participants who completed NA treatment during the follow-up phase|
48148222|NCT03982186|100685179|FG003|Extended Follow up|Overall Study||0|Included participants who completed NA treatment during the follow-up phase|
48148223|NCT03982186|100685180|FG004|Extended Follow up|Overall Study||0|Included participants who completed NA treatment during the follow-up phase|
48148224|NCT03982186|100685181|FG005|Extended Follow up|Overall Study||0|Included participants who completed NA treatment during the follow-up phase|
48148225|NCT03982186|100685176|FG000|Treated|Overall Study||95||
48148226|NCT03982186|100685177|FG001|Treated|Overall Study||96||
48148227|NCT03982186|100685178|FG002|Treated|Overall Study||93||
48148228|NCT03982186|100685179|FG003|Treated|Overall Study||94||
48148229|NCT03982186|100685180|FG004|Treated|Overall Study||48||
48148230|NCT03982186|100685181|FG005|Treated|Overall Study||45||
48715608|NCT00392808|102091713|FG003|STARTED|Overall Study||104||
48715609|NCT00392808|102091710|FG000|COMPLETED|Overall Study||81||
48715610|NCT00392808|102091711|FG001|COMPLETED|Overall Study||86||
48715611|NCT00392808|102091712|FG002|COMPLETED|Overall Study||107||
48715612|NCT00392808|102091713|FG003|COMPLETED|Overall Study||100||
48148231|NCT03982186|100685176|FG000|COMPLETED|Overall Study||92||
48148232|NCT03982186|100685177|FG001|COMPLETED|Overall Study||90||
48148233|NCT03982186|100685178|FG002|COMPLETED|Overall Study||90||
48148234|NCT03982186|100685179|FG003|COMPLETED|Overall Study||85||
48148235|NCT03982186|100685180|FG004|COMPLETED|Overall Study||45||
48148236|NCT03982186|100685181|FG005|COMPLETED|Overall Study||45||
48148237|NCT03982186|100685176|FG000|NOT COMPLETED|Overall Study||3||
48148238|NCT03982186|100685177|FG001|NOT COMPLETED|Overall Study||6||
48148239|NCT03982186|100685178|FG002|NOT COMPLETED|Overall Study||3||
48148240|NCT03982186|100685179|FG003|NOT COMPLETED|Overall Study||9||
48148241|NCT03982186|100685180|FG004|NOT COMPLETED|Overall Study||3||
48148242|NCT03982186|100685181|FG005|NOT COMPLETED|Overall Study||0||
48148243|NCT03076970|100685182|FG000|STARTED|Period 1||7||
48148244|NCT03076970|100685183|FG001|STARTED|Period 1||7||
48148245|NCT03076970|100685184|FG002|STARTED|Period 1||7||
48148246|NCT03076970|100685185|FG003|STARTED|Period 1||7||
48148247|NCT03076970|100685186|FG004|STARTED|Period 1||7||
48148248|NCT03076970|100685187|FG005|STARTED|Period 1||7||
48148249|NCT03076970|100685182|FG000|Received at Least 1 Dose of Study Drug|Period 1||7||
48148250|NCT03076970|100685183|FG001|Received at Least 1 Dose of Study Drug|Period 1||7||
48148251|NCT03076970|100685184|FG002|Received at Least 1 Dose of Study Drug|Period 1||7||
48148252|NCT03076970|100685185|FG003|Received at Least 1 Dose of Study Drug|Period 1||7||
48148253|NCT03076970|100685186|FG004|Received at Least 1 Dose of Study Drug|Period 1||7||
48148254|NCT03076970|100685187|FG005|Received at Least 1 Dose of Study Drug|Period 1||7||
48148255|NCT03076970|100685182|FG000|COMPLETED|Period 1||7||
48148256|NCT03076970|100685183|FG001|COMPLETED|Period 1||7||
48148257|NCT03076970|100685184|FG002|COMPLETED|Period 1||7||
48148258|NCT03076970|100685185|FG003|COMPLETED|Period 1||7||
48148259|NCT03076970|100685186|FG004|COMPLETED|Period 1||7||
48148260|NCT03076970|100685187|FG005|COMPLETED|Period 1||7||
48148261|NCT03076970|100685182|FG000|NOT COMPLETED|Period 1||0||
48148262|NCT03076970|100685183|FG001|NOT COMPLETED|Period 1||0||
48148263|NCT03076970|100685184|FG002|NOT COMPLETED|Period 1||0||
48148264|NCT03076970|100685185|FG003|NOT COMPLETED|Period 1||0||
48148265|NCT03076970|100685186|FG004|NOT COMPLETED|Period 1||0||
48148266|NCT03076970|100685187|FG005|NOT COMPLETED|Period 1||0||
48605098|NCT01483599|101816441|FG011|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0||
48715613|NCT00392808|102091710|FG000|NOT COMPLETED|Overall Study||6||
48715614|NCT00392808|102091711|FG001|NOT COMPLETED|Overall Study||3||
48715615|NCT00392808|102091712|FG002|NOT COMPLETED|Overall Study||2||
48715616|NCT00392808|102091713|FG003|NOT COMPLETED|Overall Study||4||
48148267|NCT03076970|100685182|FG000|STARTED|Washout Period 1||7||
48148268|NCT03076970|100685183|FG001|STARTED|Washout Period 1||7||
48715617|NCT01100567|102091714|FG000|STARTED|Overall Study||50||
48715618|NCT01100567|102091715|FG001|STARTED|Overall Study||51||
48715619|NCT01100567|102091714|FG000|COMPLETED|Overall Study||38||
48715620|NCT01100567|102091715|FG001|COMPLETED|Overall Study||35||
48302901|NCT00974090|101070004|FG001|NOT COMPLETED|Period 2: Open-label Period||10||
48302902|NCT03435003|101070005|FG000|STARTED|Overall Study||41||
48302903|NCT03435003|101070006|FG001|STARTED|Overall Study||42||
48302904|NCT03435003|101070005|FG000|COMPLETED|Overall Study||41||
48302905|NCT03435003|101070006|FG001|COMPLETED|Overall Study||42||
48302906|NCT03435003|101070005|FG000|NOT COMPLETED|Overall Study||0||
48302907|NCT03435003|101070006|FG001|NOT COMPLETED|Overall Study||0||
48302908|NCT01399190|101070007|FG000|STARTED|Overall Study||68||
48302909|NCT01399190|101070007|FG000|Included in Final Analysis|Overall Study||63||
48302910|NCT01399190|101070007|FG000|Evaluable for Primary Endpoint Analysis|Overall Study||60||
48302911|NCT01399190|101070007|FG000|COMPLETED|Overall Study||48||
48148269|NCT03076970|100685184|FG002|STARTED|Washout Period 1||7||
48148270|NCT03076970|100685185|FG003|STARTED|Washout Period 1||7||
48302912|NCT01399190|101070007|FG000|NOT COMPLETED|Overall Study||20||
48302913|NCT01736085|101070008|FG000|STARTED|Overall Study||529||
48302914|NCT01736085|101070009|FG001|STARTED|Overall Study||530||
48302915|NCT01736085|101070010|FG002|STARTED|Overall Study||793||
48302916|NCT01736085|101070011|FG003|STARTED|Overall Study||530||
48302917|NCT01736085|101070012|FG004|STARTED|Overall Study||530||
48605099|NCT01483599|101816442|FG012|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0||
48605100|NCT01483599|101816443|FG013|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0||
48605101|NCT01483599|101816430|FG000|STARTED|After Controlled Period(Week 16-Week 40)||0||
48148271|NCT03076970|100685186|FG004|STARTED|Washout Period 1||7||
48148272|NCT03076970|100685187|FG005|STARTED|Washout Period 1||7||
48148273|NCT03076970|100685182|FG000|COMPLETED|Washout Period 1||7||
48148274|NCT03076970|100685183|FG001|COMPLETED|Washout Period 1||7||
48148275|NCT03076970|100685184|FG002|COMPLETED|Washout Period 1||7||
48148276|NCT03076970|100685185|FG003|COMPLETED|Washout Period 1||7||
48148277|NCT03076970|100685186|FG004|COMPLETED|Washout Period 1||7||
48148278|NCT03076970|100685187|FG005|COMPLETED|Washout Period 1||7||
48302918|NCT01736085|101070013|FG005|STARTED|Overall Study||794||
48302919|NCT01736085|101070008|FG000|COMPLETED|Overall Study||529||
48605102|NCT01483599|101816431|FG001|STARTED|After Controlled Period(Week 16-Week 40)||0||
48605103|NCT01483599|101816432|FG002|STARTED|After Controlled Period(Week 16-Week 40)||0||
48605104|NCT01483599|101816433|FG003|STARTED|After Controlled Period(Week 16-Week 40)||0||
48605105|NCT01483599|101816434|FG004|STARTED|After Controlled Period(Week 16-Week 40)||0||
48605106|NCT01483599|101816435|FG005|STARTED|After Controlled Period(Week 16-Week 40)||0||
48605107|NCT01483599|101816436|FG006|STARTED|After Controlled Period(Week 16-Week 40)||0||
48605108|NCT01483599|101816437|FG007|STARTED|After Controlled Period(Week 16-Week 40)||39||
48605109|NCT01483599|101816438|FG008|STARTED|After Controlled Period(Week 16-Week 40)||38||
48148279|NCT03076970|100685182|FG000|NOT COMPLETED|Washout Period 1||0||
48605110|NCT01483599|101816439|FG009|STARTED|After Controlled Period(Week 16-Week 40)||41||
48148280|NCT03076970|100685183|FG001|NOT COMPLETED|Washout Period 1||0||
48148281|NCT03076970|100685184|FG002|NOT COMPLETED|Washout Period 1||0||
48148282|NCT03076970|100685185|FG003|NOT COMPLETED|Washout Period 1||0||
48148283|NCT03076970|100685186|FG004|NOT COMPLETED|Washout Period 1||0||
48148284|NCT03076970|100685187|FG005|NOT COMPLETED|Washout Period 1||0||
48148285|NCT03076970|100685182|FG000|STARTED|Period 2||7||
48148286|NCT03076970|100685183|FG001|STARTED|Period 2||7||
48148287|NCT03076970|100685184|FG002|STARTED|Period 2||7||
48148288|NCT03076970|100685185|FG003|STARTED|Period 2||7||
48148289|NCT03076970|100685186|FG004|STARTED|Period 2||7||
48148290|NCT03076970|100685187|FG005|STARTED|Period 2||7||
48148291|NCT03076970|100685182|FG000|COMPLETED|Period 2||7||
48148292|NCT03076970|100685183|FG001|COMPLETED|Period 2||7||
48148293|NCT03076970|100685184|FG002|COMPLETED|Period 2||7||
48148294|NCT03076970|100685185|FG003|COMPLETED|Period 2||7||
48148295|NCT03076970|100685186|FG004|COMPLETED|Period 2||7||
48148296|NCT03076970|100685187|FG005|COMPLETED|Period 2||7||
48148297|NCT03076970|100685182|FG000|NOT COMPLETED|Period 2||0||
48148298|NCT03076970|100685183|FG001|NOT COMPLETED|Period 2||0||
48148299|NCT03076970|100685184|FG002|NOT COMPLETED|Period 2||0||
48148300|NCT03076970|100685185|FG003|NOT COMPLETED|Period 2||0||
48148301|NCT03076970|100685186|FG004|NOT COMPLETED|Period 2||0||
48148302|NCT03076970|100685187|FG005|NOT COMPLETED|Period 2||0||
48148303|NCT03076970|100685182|FG000|STARTED|Washout Period 2||7||
48148304|NCT03076970|100685183|FG001|STARTED|Washout Period 2||7||
48148305|NCT03076970|100685184|FG002|STARTED|Washout Period 2||7||
48148306|NCT03076970|100685185|FG003|STARTED|Washout Period 2||7||
48148307|NCT03076970|100685186|FG004|STARTED|Washout Period 2||7||
48148308|NCT03076970|100685187|FG005|STARTED|Washout Period 2||7||
48715621|NCT01100567|102091714|FG000|NOT COMPLETED|Overall Study||12||
48715622|NCT01100567|102091715|FG001|NOT COMPLETED|Overall Study||16||
48715623|NCT00283868|102091716|FG000|STARTED|Overall Study||111||
48715624|NCT00283868|102091717|FG001|STARTED|Overall Study||111||
48715625|NCT00283868|102091716|FG000|COMPLETED|Overall Study||104||
48715626|NCT00283868|102091717|FG001|COMPLETED|Overall Study||103||
48148309|NCT03076970|100685182|FG000|COMPLETED|Washout Period 2||7||
48148310|NCT03076970|100685183|FG001|COMPLETED|Washout Period 2||7||
48148311|NCT03076970|100685184|FG002|COMPLETED|Washout Period 2||7||
48148312|NCT03076970|100685185|FG003|COMPLETED|Washout Period 2||7||
48148313|NCT03076970|100685186|FG004|COMPLETED|Washout Period 2||6||
48148314|NCT03076970|100685187|FG005|COMPLETED|Washout Period 2||7||
48148315|NCT03076970|100685182|FG000|NOT COMPLETED|Washout Period 2||0||
48148316|NCT03076970|100685183|FG001|NOT COMPLETED|Washout Period 2||0||
48148317|NCT03076970|100685184|FG002|NOT COMPLETED|Washout Period 2||0||
48148318|NCT03076970|100685185|FG003|NOT COMPLETED|Washout Period 2||0||
48148319|NCT03076970|100685186|FG004|NOT COMPLETED|Washout Period 2||1||
48148320|NCT03076970|100685187|FG005|NOT COMPLETED|Washout Period 2||0||
48148321|NCT03076970|100685182|FG000|STARTED|Period 3||7||
48148322|NCT03076970|100685183|FG001|STARTED|Period 3||7||
48148323|NCT03076970|100685184|FG002|STARTED|Period 3||7||
48715627|NCT00283868|102091716|FG000|NOT COMPLETED|Overall Study||7||
48715628|NCT00283868|102091717|FG001|NOT COMPLETED|Overall Study||8||
48715629|NCT01216943|102091718|FG000|STARTED|Overall Study||126||
48715630|NCT01216943|102091718|FG000|COMPLETED|Overall Study||113||
48715631|NCT01216943|102091718|FG000|NOT COMPLETED|Overall Study||13||
48715632|NCT03109262|102091719|FG000|STARTED|Overall Study||42||
48715633|NCT03109262|102091719|FG000|COMPLETED|Overall Study||42||
48715634|NCT03109262|102091719|FG000|NOT COMPLETED|Overall Study||0||
48715635|NCT00554099|102091720|FG000|STARTED|Treatment Period (12 Weeks)||41||
48715636|NCT00554099|102091721|FG001|STARTED|Treatment Period (12 Weeks)||40||
48715637|NCT00554099|102091722|FG002|STARTED|Treatment Period (12 Weeks)||36||
48148324|NCT03076970|100685185|FG003|STARTED|Period 3||7||
48148325|NCT03076970|100685186|FG004|STARTED|Period 3||6||
48148326|NCT03076970|100685187|FG005|STARTED|Period 3||7||
48148327|NCT03076970|100685182|FG000|COMPLETED|Period 3||7||
48148328|NCT03076970|100685183|FG001|COMPLETED|Period 3||7||
48148329|NCT03076970|100685184|FG002|COMPLETED|Period 3||7||
48148330|NCT03076970|100685185|FG003|COMPLETED|Period 3||7||
48148331|NCT03076970|100685186|FG004|COMPLETED|Period 3||5||
48148332|NCT03076970|100685187|FG005|COMPLETED|Period 3||6||
48148333|NCT03076970|100685182|FG000|NOT COMPLETED|Period 3||0||
48148334|NCT03076970|100685183|FG001|NOT COMPLETED|Period 3||0||
48148335|NCT03076970|100685184|FG002|NOT COMPLETED|Period 3||0||
48148336|NCT03076970|100685185|FG003|NOT COMPLETED|Period 3||0||
48148337|NCT03076970|100685186|FG004|NOT COMPLETED|Period 3||1||
48148338|NCT03076970|100685187|FG005|NOT COMPLETED|Period 3||1||
48148339|NCT03076970|100685182|FG000|STARTED|Washout Period 3||7||
48148340|NCT03076970|100685183|FG001|STARTED|Washout Period 3||7||
48148341|NCT03076970|100685184|FG002|STARTED|Washout Period 3||7||
48715638|NCT00554099|102091720|FG000|COMPLETED|Treatment Period (12 Weeks)||29||
48715639|NCT00554099|102091721|FG001|COMPLETED|Treatment Period (12 Weeks)||32||
48148342|NCT03076970|100685185|FG003|STARTED|Washout Period 3||7||
48148343|NCT03076970|100685186|FG004|STARTED|Washout Period 3||5||
48148344|NCT03076970|100685187|FG005|STARTED|Washout Period 3||6||
48148345|NCT03076970|100685182|FG000|COMPLETED|Washout Period 3||7||
48148346|NCT03076970|100685183|FG001|COMPLETED|Washout Period 3||7||
48148347|NCT03076970|100685184|FG002|COMPLETED|Washout Period 3||7||
48148348|NCT03076970|100685185|FG003|COMPLETED|Washout Period 3||7||
48148349|NCT03076970|100685186|FG004|COMPLETED|Washout Period 3||5||
48148350|NCT03076970|100685187|FG005|COMPLETED|Washout Period 3||6||
48715640|NCT00554099|102091722|FG002|COMPLETED|Treatment Period (12 Weeks)||27||
48715641|NCT00554099|102091720|FG000|NOT COMPLETED|Treatment Period (12 Weeks)||12||
48148351|NCT03076970|100685182|FG000|NOT COMPLETED|Washout Period 3||0||
48715642|NCT00554099|102091721|FG001|NOT COMPLETED|Treatment Period (12 Weeks)||8||
48715643|NCT00554099|102091722|FG002|NOT COMPLETED|Treatment Period (12 Weeks)||9||
48148352|NCT03076970|100685183|FG001|NOT COMPLETED|Washout Period 3||0||
48148353|NCT03076970|100685184|FG002|NOT COMPLETED|Washout Period 3||0||
48148354|NCT03076970|100685185|FG003|NOT COMPLETED|Washout Period 3||0||
48148355|NCT03076970|100685186|FG004|NOT COMPLETED|Washout Period 3||0||
48148356|NCT03076970|100685187|FG005|NOT COMPLETED|Washout Period 3||0||
48148357|NCT04683926|100685188|FG000|STARTED|Intervention 1 (1 Day)||6||
48148358|NCT04683926|100685189|FG001|STARTED|Intervention 1 (1 Day)||6||
48148359|NCT04683926|100685190|FG002|STARTED|Intervention 1 (1 Day)||6||
48148360|NCT04683926|100685191|FG003|STARTED|Intervention 1 (1 Day)||6||
48148361|NCT04683926|100685188|FG000|COMPLETED|Intervention 1 (1 Day)||6||
48148362|NCT04683926|100685189|FG001|COMPLETED|Intervention 1 (1 Day)||6||
48148363|NCT04683926|100685190|FG002|COMPLETED|Intervention 1 (1 Day)||6||
48148364|NCT04683926|100685191|FG003|COMPLETED|Intervention 1 (1 Day)||6||
48148365|NCT04683926|100685188|FG000|NOT COMPLETED|Intervention 1 (1 Day)||0||
48148366|NCT04683926|100685189|FG001|NOT COMPLETED|Intervention 1 (1 Day)||0||
48148367|NCT04683926|100685190|FG002|NOT COMPLETED|Intervention 1 (1 Day)||0||
48148368|NCT04683926|100685191|FG003|NOT COMPLETED|Intervention 1 (1 Day)||0||
48148369|NCT04683926|100685188|FG000|STARTED|Washout 1 (3 Days)||6||
48148370|NCT04683926|100685189|FG001|STARTED|Washout 1 (3 Days)||6||
48148371|NCT04683926|100685190|FG002|STARTED|Washout 1 (3 Days)||6||
48148372|NCT04683926|100685191|FG003|STARTED|Washout 1 (3 Days)||6||
48148373|NCT04683926|100685188|FG000|COMPLETED|Washout 1 (3 Days)||6||
48148374|NCT04683926|100685189|FG001|COMPLETED|Washout 1 (3 Days)||6||
48148375|NCT04683926|100685190|FG002|COMPLETED|Washout 1 (3 Days)||6||
48148376|NCT04683926|100685191|FG003|COMPLETED|Washout 1 (3 Days)||6||
48148377|NCT04683926|100685188|FG000|NOT COMPLETED|Washout 1 (3 Days)||0||
48148378|NCT04683926|100685189|FG001|NOT COMPLETED|Washout 1 (3 Days)||0||
48148379|NCT04683926|100685190|FG002|NOT COMPLETED|Washout 1 (3 Days)||0||
48148380|NCT04683926|100685191|FG003|NOT COMPLETED|Washout 1 (3 Days)||0||
48148381|NCT04683926|100685188|FG000|STARTED|Intervention 2 (1 Day)||6||
48148382|NCT04683926|100685189|FG001|STARTED|Intervention 2 (1 Day)||6||
48148383|NCT04683926|100685190|FG002|STARTED|Intervention 2 (1 Day)||6||
48148384|NCT04683926|100685191|FG003|STARTED|Intervention 2 (1 Day)||6||
48148385|NCT04683926|100685188|FG000|COMPLETED|Intervention 2 (1 Day)||6||
48148386|NCT04683926|100685189|FG001|COMPLETED|Intervention 2 (1 Day)||6||
48148387|NCT04683926|100685190|FG002|COMPLETED|Intervention 2 (1 Day)||6||
48148388|NCT04683926|100685191|FG003|COMPLETED|Intervention 2 (1 Day)||5||
48148389|NCT04683926|100685188|FG000|NOT COMPLETED|Intervention 2 (1 Day)||0||
48605111|NCT01483599|101816440|FG010|STARTED|After Controlled Period(Week 16-Week 40)||39||
48605112|NCT01483599|101816441|FG011|STARTED|After Controlled Period(Week 16-Week 40)||40||
48605113|NCT01483599|101816442|FG012|STARTED|After Controlled Period(Week 16-Week 40)||38||
48605114|NCT01483599|101816443|FG013|STARTED|After Controlled Period(Week 16-Week 40)||39||
48605115|NCT01483599|101816430|FG000|COMPLETED|After Controlled Period(Week 16-Week 40)||0||
48148390|NCT04683926|100685189|FG001|NOT COMPLETED|Intervention 2 (1 Day)||0||
48148391|NCT04683926|100685190|FG002|NOT COMPLETED|Intervention 2 (1 Day)||0||
48148392|NCT04683926|100685191|FG003|NOT COMPLETED|Intervention 2 (1 Day)||1||
48148393|NCT04683926|100685188|FG000|STARTED|Washout 2 (3 Days)||6||
48148394|NCT04683926|100685189|FG001|STARTED|Washout 2 (3 Days)||6||
48148395|NCT04683926|100685190|FG002|STARTED|Washout 2 (3 Days)||6||
48148396|NCT04683926|100685191|FG003|STARTED|Washout 2 (3 Days)||5||
48148397|NCT04683926|100685188|FG000|COMPLETED|Washout 2 (3 Days)||6||
48148398|NCT04683926|100685189|FG001|COMPLETED|Washout 2 (3 Days)||6||
48148399|NCT04683926|100685190|FG002|COMPLETED|Washout 2 (3 Days)||6||
48148400|NCT04683926|100685191|FG003|COMPLETED|Washout 2 (3 Days)||5||
48148401|NCT04683926|100685188|FG000|NOT COMPLETED|Washout 2 (3 Days)||0||
48605116|NCT01483599|101816431|FG001|COMPLETED|After Controlled Period(Week 16-Week 40)||0||
48605117|NCT01483599|101816432|FG002|COMPLETED|After Controlled Period(Week 16-Week 40)||0||
48605118|NCT01483599|101816433|FG003|COMPLETED|After Controlled Period(Week 16-Week 40)||0||
48605119|NCT01483599|101816434|FG004|COMPLETED|After Controlled Period(Week 16-Week 40)||0||
48605120|NCT01483599|101816435|FG005|COMPLETED|After Controlled Period(Week 16-Week 40)||0||
48605121|NCT01483599|101816436|FG006|COMPLETED|After Controlled Period(Week 16-Week 40)||0||
48605122|NCT01483599|101816437|FG007|COMPLETED|After Controlled Period(Week 16-Week 40)||37||
48148402|NCT04683926|100685189|FG001|NOT COMPLETED|Washout 2 (3 Days)||0||
48148403|NCT04683926|100685190|FG002|NOT COMPLETED|Washout 2 (3 Days)||0||
48148404|NCT04683926|100685191|FG003|NOT COMPLETED|Washout 2 (3 Days)||0||
48148405|NCT04683926|100685188|FG000|STARTED|Intervention 3 (1 Day)||6||
48148406|NCT04683926|100685189|FG001|STARTED|Intervention 3 (1 Day)||6||
48148407|NCT04683926|100685190|FG002|STARTED|Intervention 3 (1 Day)||6||
48148408|NCT04683926|100685191|FG003|STARTED|Intervention 3 (1 Day)||5||
48148409|NCT04683926|100685188|FG000|COMPLETED|Intervention 3 (1 Day)||6||
48148410|NCT04683926|100685189|FG001|COMPLETED|Intervention 3 (1 Day)||6||
48148411|NCT04683926|100685190|FG002|COMPLETED|Intervention 3 (1 Day)||6||
48605123|NCT01483599|101816438|FG008|COMPLETED|After Controlled Period(Week 16-Week 40)||29||
48605124|NCT01483599|101816439|FG009|COMPLETED|After Controlled Period(Week 16-Week 40)||37||
48605125|NCT01483599|101816440|FG010|COMPLETED|After Controlled Period(Week 16-Week 40)||37||
48148412|NCT04683926|100685191|FG003|COMPLETED|Intervention 3 (1 Day)||5||
48605126|NCT01483599|101816441|FG011|COMPLETED|After Controlled Period(Week 16-Week 40)||39||
48605127|NCT01483599|101816442|FG012|COMPLETED|After Controlled Period(Week 16-Week 40)||35||
48605128|NCT01483599|101816443|FG013|COMPLETED|After Controlled Period(Week 16-Week 40)||32||
48605129|NCT01483599|101816430|FG000|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0||
48605130|NCT01483599|101816431|FG001|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0||
48148413|NCT04683926|100685188|FG000|NOT COMPLETED|Intervention 3 (1 Day)||0||
48148414|NCT04683926|100685189|FG001|NOT COMPLETED|Intervention 3 (1 Day)||0||
48148415|NCT04683926|100685190|FG002|NOT COMPLETED|Intervention 3 (1 Day)||0||
48148416|NCT04683926|100685191|FG003|NOT COMPLETED|Intervention 3 (1 Day)||0||
48148417|NCT04683926|100685188|FG000|STARTED|Washout 3 (3 Days)||6||
48148418|NCT04683926|100685189|FG001|STARTED|Washout 3 (3 Days)||6||
48148419|NCT04683926|100685190|FG002|STARTED|Washout 3 (3 Days)||6||
48148420|NCT04683926|100685191|FG003|STARTED|Washout 3 (3 Days)||5||
48148421|NCT04683926|100685188|FG000|COMPLETED|Washout 3 (3 Days)||6||
48148422|NCT04683926|100685189|FG001|COMPLETED|Washout 3 (3 Days)||6||
48148423|NCT04683926|100685190|FG002|COMPLETED|Washout 3 (3 Days)||6||
48148424|NCT04683926|100685191|FG003|COMPLETED|Washout 3 (3 Days)||5||
48148425|NCT04683926|100685188|FG000|NOT COMPLETED|Washout 3 (3 Days)||0||
48148426|NCT04683926|100685189|FG001|NOT COMPLETED|Washout 3 (3 Days)||0||
48148427|NCT04683926|100685190|FG002|NOT COMPLETED|Washout 3 (3 Days)||0||
48148428|NCT04683926|100685191|FG003|NOT COMPLETED|Washout 3 (3 Days)||0||
48148429|NCT04683926|100685188|FG000|STARTED|Intervention 4 (1 Day)||6||
48148430|NCT04683926|100685189|FG001|STARTED|Intervention 4 (1 Day)||6||
48148431|NCT04683926|100685190|FG002|STARTED|Intervention 4 (1 Day)||6||
48605131|NCT01483599|101816432|FG002|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0||
48605132|NCT01483599|101816433|FG003|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0||
48148432|NCT04683926|100685191|FG003|STARTED|Intervention 4 (1 Day)||5||
48148433|NCT04683926|100685188|FG000|COMPLETED|Intervention 4 (1 Day)||6||
48148434|NCT04683926|100685189|FG001|COMPLETED|Intervention 4 (1 Day)||6||
48148435|NCT04683926|100685190|FG002|COMPLETED|Intervention 4 (1 Day)||6||
48148436|NCT04683926|100685191|FG003|COMPLETED|Intervention 4 (1 Day)||5||
48148437|NCT04683926|100685188|FG000|NOT COMPLETED|Intervention 4 (1 Day)||0||
48148438|NCT04683926|100685189|FG001|NOT COMPLETED|Intervention 4 (1 Day)||0||
48148439|NCT04683926|100685190|FG002|NOT COMPLETED|Intervention 4 (1 Day)||0||
48148440|NCT04683926|100685191|FG003|NOT COMPLETED|Intervention 4 (1 Day)||0||
48148441|NCT01981564|100685192|FG000|STARTED|Overall Study||107||
48148442|NCT01981564|100685193|FG001|STARTED|Overall Study||115||
48148443|NCT01981564|100685192|FG000|COMPLETED|Overall Study||98||
48148444|NCT01981564|100685193|FG001|COMPLETED|Overall Study||106||
48148445|NCT01981564|100685192|FG000|NOT COMPLETED|Overall Study||9||
48148446|NCT01981564|100685193|FG001|NOT COMPLETED|Overall Study||9||
48148447|NCT01165775|100685194|FG000|STARTED|Overall Study||17||
48148448|NCT01165775|100685194|FG000|COMPLETED|Overall Study||15||
48148449|NCT01165775|100685194|FG000|NOT COMPLETED|Overall Study||2||
48148450|NCT04259450|100685195|FG000|STARTED|Overall Study||2||
48148451|NCT04259450|100685196|FG001|STARTED|Overall Study||6||
48148452|NCT04259450|100685197|FG002|STARTED|Overall Study||4||
48148453|NCT04259450|100685198|FG003|STARTED|Overall Study||5||
48148454|NCT04259450|100685199|FG004|STARTED|Overall Study||6||
48148455|NCT04259450|100685200|FG005|STARTED|Overall Study||6||
48148456|NCT04259450|100685201|FG006|STARTED|Overall Study||6||
48148457|NCT04259450|100685202|FG007|STARTED|Overall Study||19||
48148458|NCT04259450|100685203|FG008|STARTED|Overall Study||8||
48148459|NCT04259450|100685204|FG009|STARTED|Overall Study||23||
48148460|NCT04259450|100685195|FG000|COMPLETED|Overall Study||0||
48148461|NCT04259450|100685196|FG001|COMPLETED|Overall Study||0||
48148462|NCT04259450|100685197|FG002|COMPLETED|Overall Study||0||
48148463|NCT04259450|100685198|FG003|COMPLETED|Overall Study||0||
48148464|NCT04259450|100685199|FG004|COMPLETED|Overall Study||0||
48605133|NCT01483599|101816434|FG004|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0||
48148465|NCT04259450|100685200|FG005|COMPLETED|Overall Study||0||
48148466|NCT04259450|100685201|FG006|COMPLETED|Overall Study||1||
48148467|NCT04259450|100685202|FG007|COMPLETED|Overall Study||1||
48148468|NCT04259450|100685203|FG008|COMPLETED|Overall Study||1||
48148469|NCT04259450|100685204|FG009|COMPLETED|Overall Study||2||
48148470|NCT04259450|100685195|FG000|NOT COMPLETED|Overall Study||2||
48148471|NCT04259450|100685196|FG001|NOT COMPLETED|Overall Study||6||
48148472|NCT04259450|100685197|FG002|NOT COMPLETED|Overall Study||4||
48148473|NCT04259450|100685198|FG003|NOT COMPLETED|Overall Study||5||
48148474|NCT04259450|100685199|FG004|NOT COMPLETED|Overall Study||6||
48148475|NCT04259450|100685200|FG005|NOT COMPLETED|Overall Study||6||
48148476|NCT04259450|100685201|FG006|NOT COMPLETED|Overall Study||5||
48148477|NCT04259450|100685202|FG007|NOT COMPLETED|Overall Study||18||
48148478|NCT04259450|100685203|FG008|NOT COMPLETED|Overall Study||7||
48148479|NCT04259450|100685204|FG009|NOT COMPLETED|Overall Study||21||
48148480|NCT02937168|100685205|FG000|STARTED|PET/CT Screening Period (21 Days)||5||
48148481|NCT02937168|100685206|FG001|STARTED|PET/CT Screening Period (21 Days)||0||
48605134|NCT01483599|101816435|FG005|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0||
48605135|NCT01483599|101816436|FG006|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0||
48148482|NCT02937168|100685207|FG002|STARTED|PET/CT Screening Period (21 Days)||0||
48148483|NCT02937168|100685205|FG000|COMPLETED|PET/CT Screening Period (21 Days)||5||
48148484|NCT02937168|100685206|FG001|COMPLETED|PET/CT Screening Period (21 Days)||0||
48148485|NCT02937168|100685207|FG002|COMPLETED|PET/CT Screening Period (21 Days)||0||
48148486|NCT02937168|100685205|FG000|NOT COMPLETED|PET/CT Screening Period (21 Days)||0||
48148487|NCT02937168|100685206|FG001|NOT COMPLETED|PET/CT Screening Period (21 Days)||0||
48605136|NCT01483599|101816437|FG007|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2||
48605137|NCT01483599|101816438|FG008|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||9||
48605138|NCT01483599|101816439|FG009|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||4||
48605139|NCT01483599|101816440|FG010|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2||
48148488|NCT02937168|100685207|FG002|NOT COMPLETED|PET/CT Screening Period (21 Days)||0||
48148489|NCT02937168|100685205|FG000|STARTED|Double-Blind Treatment Period (6 Weeks)||0|No participants were recruited for Part 2.|
48148490|NCT02937168|100685206|FG001|STARTED|Double-Blind Treatment Period (6 Weeks)||0|No participants were recruited for Part 2.|
48148491|NCT02937168|100685207|FG002|STARTED|Double-Blind Treatment Period (6 Weeks)||0|No participants were recruited for Part 2.|
48148492|NCT02937168|100685205|FG000|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0||
48148493|NCT02937168|100685206|FG001|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0||
48148494|NCT02937168|100685207|FG002|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0||
48148495|NCT02937168|100685205|FG000|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0||
48148496|NCT02937168|100685206|FG001|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0||
48148497|NCT02937168|100685207|FG002|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0||
48148498|NCT02436265|100685208|FG000|STARTED|Overall Study||3||
48148499|NCT02436265|100685209|FG001|STARTED|Overall Study||4||
48148500|NCT02436265|100685208|FG000|COMPLETED|Overall Study||3||
48148501|NCT02436265|100685209|FG001|COMPLETED|Overall Study||4||
48148502|NCT02436265|100685208|FG000|NOT COMPLETED|Overall Study||0||
48148503|NCT02436265|100685209|FG001|NOT COMPLETED|Overall Study||0||
48148504|NCT03407794|100685210|FG000|STARTED|Overall Study||10||
48148505|NCT03407794|100685211|FG001|STARTED|Overall Study||11||
48148506|NCT03407794|100685212|FG002|STARTED|Overall Study||13||
48148507|NCT03407794|100685210|FG000|COMPLETED|Overall Study||10||
48148508|NCT03407794|100685211|FG001|COMPLETED|Overall Study||10||
48148509|NCT03407794|100685212|FG002|COMPLETED|Overall Study||11||
48148510|NCT03407794|100685210|FG000|NOT COMPLETED|Overall Study||0||
48148511|NCT03407794|100685211|FG001|NOT COMPLETED|Overall Study||1||
48148512|NCT03407794|100685212|FG002|NOT COMPLETED|Overall Study||2||
48148513|NCT00789438|100685213|FG000|STARTED|Overall Study||21||
48148514|NCT00789438|100685214|FG001|STARTED|Overall Study||20||
48148515|NCT00789438|100685215|FG002|STARTED|Overall Study||28||
48148516|NCT00789438|100685213|FG000|COMPLETED|Overall Study||21||
48148517|NCT00789438|100685214|FG001|COMPLETED|Overall Study||20||
48148518|NCT00789438|100685215|FG002|COMPLETED|Overall Study||28||
48148519|NCT00789438|100685213|FG000|NOT COMPLETED|Overall Study||0||
48148520|NCT00789438|100685214|FG001|NOT COMPLETED|Overall Study||0||
48148521|NCT00789438|100685215|FG002|NOT COMPLETED|Overall Study||0||
48148522|NCT04020341|100685216|FG000|STARTED|Overall Study||767|Participants randomly assigned to the study treatment were included in Intent-to-Treat (ITT) population|
48148523|NCT04020341|100685217|FG001|STARTED|Overall Study||764|Participants randomly assigned to the study treatment were included in Intent-to-Treat (ITT) population|
48148524|NCT04020341|100685216|FG000|Safety Population|Overall Study||766|Safety population included all randomized participants who receive at least 1 dose of study treatment.|
48148525|NCT04020341|100685217|FG001|Safety Population|Overall Study||760|Safety population included all randomized participants who receive at least 1 dose of study treatment.|
48148526|NCT04020341|100685216|FG000|Microbiological ITT (Micro ITT) Population|Overall Study||401|Microbiological ITT (micro-ITT) population included all participants randomly assigned to study treatment who receive at least 1 dose of study treatment and have a qualifying baseline uropathogen \[10\^5 CFU/mL\] from a quantitative bacteriological culture of a pretreatment clean catch midstream urine specimen.|
48148527|NCT04020341|100685217|FG001|Microbiological ITT (Micro ITT) Population|Overall Study||365|Microbiological ITT (micro-ITT) population included all participants randomly assigned to study treatment who receive at least 1 dose of study treatment and have a qualifying baseline uropathogen \[10\^5 CFU/mL\] from a quantitative bacteriological culture of a pretreatment clean catch midstream urine specimen.|
48148528|NCT04020341|100685216|FG000|Micro-ITT NTF-S Population|Overall Study||336|Micro-ITT NTF-S population is defined as all participants in the micro-ITT population whose baseline qualifying uropathogens \[10\^5 CFU/mL\] are all susceptible to nitrofurantoin (NTF-S).|
48148529|NCT04020341|100685217|FG001|Micro-ITT NTF-S Population|Overall Study||298|Micro-ITT NTF-S population is defined as all participants in the micro-ITT population whose baseline qualifying uropathogens \[10\^5 CFU/mL\] are all susceptible to nitrofurantoin (NTF-S).|
48188533|NCT05233085|100783269|FG003|COMPLETED|Overall Study||9||
48188534|NCT05233085|100783266|FG000|NOT COMPLETED|Overall Study||1||
48188535|NCT05233085|100783267|FG001|NOT COMPLETED|Overall Study||0||
48188536|NCT05233085|100783268|FG002|NOT COMPLETED|Overall Study||0||
48605140|NCT01483599|101816441|FG011|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||1||
48605141|NCT01483599|101816442|FG012|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||3||
48605142|NCT01483599|101816443|FG013|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||7||
48605143|NCT02985021|101816444|FG000|STARTED|Overall Study||2||
48605144|NCT02985021|101816444|FG000|COMPLETED|Overall Study||1|Achievement of complete response or 10 cycles of therapy. Patient achieved complete response. One patient did not complete therapy due to inability to comply with study procedures|
48605145|NCT02985021|101816444|FG000|NOT COMPLETED|Overall Study||1||
48605146|NCT00983541|101816445|FG000|STARTED|Overall Study||1||
48605147|NCT00983541|101816445|FG000|COMPLETED|Overall Study||1||
48605148|NCT00983541|101816445|FG000|NOT COMPLETED|Overall Study||0||
48605149|NCT02756364|101816446|FG000|STARTED|Overall Study||46|Full Analysis Set (FAS) - Randomized Participants|
48657077|NCT03648372|101943775|FG018|COMPLETED|Overall Study||4||
48302920|NCT01736085|101070009|FG001|COMPLETED|Overall Study||530||
48302921|NCT01736085|101070010|FG002|COMPLETED|Overall Study||793||
48302922|NCT01736085|101070011|FG003|COMPLETED|Overall Study||530||
48302923|NCT01736085|101070012|FG004|COMPLETED|Overall Study||530||
48302924|NCT01736085|101070013|FG005|COMPLETED|Overall Study||794||
48302925|NCT01736085|101070008|FG000|NOT COMPLETED|Overall Study||0||
48302926|NCT01736085|101070009|FG001|NOT COMPLETED|Overall Study||0||
48302927|NCT01736085|101070010|FG002|NOT COMPLETED|Overall Study||0||
48302928|NCT01736085|101070011|FG003|NOT COMPLETED|Overall Study||0||
48302929|NCT01736085|101070012|FG004|NOT COMPLETED|Overall Study||0||
48302930|NCT01736085|101070013|FG005|NOT COMPLETED|Overall Study||0||
48302931|NCT04553068|101070014|FG000|STARTED|Overall Study||943||
48302932|NCT04553068|101070015|FG001|STARTED|Overall Study||949||
48302933|NCT04553068|101070014|FG000|COMPLETED|Overall Study||792||
48302934|NCT04553068|101070015|FG001|COMPLETED|Overall Study||805||
48302935|NCT04553068|101070014|FG000|NOT COMPLETED|Overall Study||151||
48302936|NCT04553068|101070015|FG001|NOT COMPLETED|Overall Study||144||
48302937|NCT00889226|101070016|FG000|STARTED|Overall Study||83||
48302938|NCT00889226|101070017|FG001|STARTED|Overall Study||78||
48302939|NCT00889226|101070016|FG000|COMPLETED|Overall Study||58||
48302940|NCT00889226|101070017|FG001|COMPLETED|Overall Study||43||
48302941|NCT00889226|101070016|FG000|NOT COMPLETED|Overall Study||25||
48302942|NCT00889226|101070017|FG001|NOT COMPLETED|Overall Study||35||
48302943|NCT01102803|101070018|FG000|STARTED|Baseline to Post-Treatment||14||
48302944|NCT01102803|101070019|FG001|STARTED|Baseline to Post-Treatment||15||
48302945|NCT01102803|101070018|FG000|COMPLETED|Baseline to Post-Treatment||11||
48302946|NCT01102803|101070019|FG001|COMPLETED|Baseline to Post-Treatment||15||
48302947|NCT01102803|101070018|FG000|NOT COMPLETED|Baseline to Post-Treatment||3||
48302948|NCT01102803|101070019|FG001|NOT COMPLETED|Baseline to Post-Treatment||0||
48302949|NCT01102803|101070018|FG000|STARTED|Post to Follow-Up||11||
48302950|NCT01102803|101070019|FG001|STARTED|Post to Follow-Up||15||
48302951|NCT01102803|101070018|FG000|COMPLETED|Post to Follow-Up||10||
48302952|NCT01102803|101070019|FG001|COMPLETED|Post to Follow-Up||12||
48302953|NCT01102803|101070018|FG000|NOT COMPLETED|Post to Follow-Up||1||
48302954|NCT01102803|101070019|FG001|NOT COMPLETED|Post to Follow-Up||3||
48302955|NCT04880447|101070020|FG000|STARTED|Overall Study||1075||
48715644|NCT00554099|102091720|FG000|STARTED|Non-Treatment Phase (9 Months)||29||
48715645|NCT00554099|102091721|FG001|STARTED|Non-Treatment Phase (9 Months)||32||
48715646|NCT00554099|102091722|FG002|STARTED|Non-Treatment Phase (9 Months)||27||
48715647|NCT00554099|102091720|FG000|COMPLETED|Non-Treatment Phase (9 Months)||22||
48715648|NCT00554099|102091721|FG001|COMPLETED|Non-Treatment Phase (9 Months)||27||
48715649|NCT00554099|102091722|FG002|COMPLETED|Non-Treatment Phase (9 Months)||24||
48715650|NCT00554099|102091720|FG000|NOT COMPLETED|Non-Treatment Phase (9 Months)||7||
48715651|NCT00554099|102091721|FG001|NOT COMPLETED|Non-Treatment Phase (9 Months)||5||
48715652|NCT00554099|102091722|FG002|NOT COMPLETED|Non-Treatment Phase (9 Months)||3||
48715653|NCT01798641|102091723|FG000|STARTED|First Intervention (6 Weeks)||19||
48715654|NCT01798641|102091724|FG001|STARTED|First Intervention (6 Weeks)||19||
48715655|NCT01798641|102091723|FG000|COMPLETED|First Intervention (6 Weeks)||19||
48715656|NCT01798641|102091724|FG001|COMPLETED|First Intervention (6 Weeks)||19||
48715657|NCT01798641|102091723|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0||
48302956|NCT04880447|101070020|FG000|COMPLETED|Overall Study||1038||
48302957|NCT04880447|101070020|FG000|NOT COMPLETED|Overall Study||37||
48302958|NCT00583024|101070021|FG000|STARTED|Overall Study||32||
48302959|NCT00583024|101070021|FG000|COMPLETED|Overall Study||28||
48302960|NCT00583024|101070021|FG000|NOT COMPLETED|Overall Study||4||
48302961|NCT03367715|101070022|FG000|STARTED|Overall Study||10||
48302962|NCT03367715|101070022|FG000|COMPLETED|Overall Study||10||
48715658|NCT01798641|102091724|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0||
48715659|NCT01798641|102091723|FG000|STARTED|Second Intervention (6 Weeks)||19||
48715660|NCT01798641|102091724|FG001|STARTED|Second Intervention (6 Weeks)||19||
48715661|NCT01798641|102091723|FG000|COMPLETED|Second Intervention (6 Weeks)||19||
48715662|NCT01798641|102091724|FG001|COMPLETED|Second Intervention (6 Weeks)||19||
48715663|NCT01798641|102091723|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0||
48715664|NCT01798641|102091724|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0||
48715665|NCT02772978|102091725|FG000|STARTED|Overall Study||10|First participant enrolled|
48302963|NCT03367715|101070022|FG000|NOT COMPLETED|Overall Study||0||
48302964|NCT03836807|101070023|FG000|STARTED|Overall Study||35||
48302965|NCT03836807|101070024|FG001|STARTED|Overall Study||35||
48715666|NCT02772978|102091726|FG001|STARTED|Overall Study||9|First participant enrolled|
48715667|NCT02772978|102091725|FG000|COMPLETED|Overall Study||9|Last participant enrolled|
48302966|NCT03836807|101070023|FG000|Intent To Treat (ITT)|Overall Study||35||
48302967|NCT03836807|101070024|FG001|Intent To Treat (ITT)|Overall Study||35||
48302968|NCT03836807|101070023|FG000|Per Protocol (PP)|Overall Study||33||
48302969|NCT03836807|101070024|FG001|Per Protocol (PP)|Overall Study||35||
48302970|NCT03836807|101070023|FG000|Safety Population (SAF)|Overall Study||35||
48302971|NCT03836807|101070024|FG001|Safety Population (SAF)|Overall Study||35||
48302972|NCT03836807|101070023|FG000|COMPLETED|Overall Study||34||
48302973|NCT03836807|101070024|FG001|COMPLETED|Overall Study||35||
48302974|NCT03836807|101070023|FG000|NOT COMPLETED|Overall Study||1||
48302975|NCT03836807|101070024|FG001|NOT COMPLETED|Overall Study||0||
48302976|NCT03986866|101070025|FG000|STARTED|Overall Study||55||
48148530|NCT04020341|100685216|FG000|Micro-ITT NTF-S (IA Set) Population|Overall Study||320|Microbiological intent-to-treat susceptible to nitrofurantoin (micro-ITT NTF-S) (IA Set) population included participants in the micro ITT NTF-S who per the interim analysis data had the opportunity to reach their Test of Cure (TOC) visit, or had not yet reached their TOC visit, but were already known to be failures.|
48148531|NCT04020341|100685217|FG001|Micro-ITT NTF-S (IA Set) Population|Overall Study||287|Microbiological intent-to-treat susceptible to nitrofurantoin (micro-ITT NTF-S) (IA Set) population included participants in the micro ITT NTF-S who per the interim analysis data had the opportunity to reach their Test of Cure (TOC) visit, or had not yet reached their TOC visit, but were already known to be failures.|
48605150|NCT02756364|101816447|FG001|STARTED|Overall Study||47|Full Analysis Set (FAS) - Randomized Participants|
48302977|NCT03986866|101070026|FG001|STARTED|Overall Study||55||
48302978|NCT03986866|101070025|FG000|COMPLETED|Overall Study||53||
48302979|NCT03986866|101070026|FG001|COMPLETED|Overall Study||50||
48148532|NCT04020341|100685216|FG000|COMPLETED|Overall Study||734||
48148533|NCT04020341|100685217|FG001|COMPLETED|Overall Study||736||
48148534|NCT04020341|100685216|FG000|NOT COMPLETED|Overall Study||33||
48302980|NCT03986866|101070025|FG000|NOT COMPLETED|Overall Study||2||
48302981|NCT03986866|101070026|FG001|NOT COMPLETED|Overall Study||5||
48302982|NCT03049735|101070027|FG000|STARTED|Overall Study||128||
48302983|NCT03049735|101070028|FG001|STARTED|Overall Study||132||
48302984|NCT03049735|101070029|FG002|STARTED|Overall Study||128||
48302985|NCT03049735|101070027|FG000|Received at Least 1 Dose of Study Drug|Overall Study||128||
48302986|NCT03049735|101070028|FG001|Received at Least 1 Dose of Study Drug|Overall Study||132||
48302987|NCT03049735|101070029|FG002|Received at Least 1 Dose of Study Drug|Overall Study||127||
48302988|NCT03049735|101070027|FG000|COMPLETED|Overall Study||100||
48302989|NCT03049735|101070028|FG001|COMPLETED|Overall Study||103||
48302990|NCT03049735|101070029|FG002|COMPLETED|Overall Study||105||
48302991|NCT03049735|101070027|FG000|NOT COMPLETED|Overall Study||28||
48302992|NCT03049735|101070028|FG001|NOT COMPLETED|Overall Study||29||
48302993|NCT03049735|101070029|FG002|NOT COMPLETED|Overall Study||23||
48148535|NCT04020341|100685217|FG001|NOT COMPLETED|Overall Study||28||
48148536|NCT00924287|100685218|FG000|STARTED|Overall Study||1||
48148537|NCT00924287|100685218|FG000|COMPLETED|Overall Study||0||
48302994|NCT04556136|101070030|FG000|STARTED|Overall Study||53||
48302995|NCT04556136|101070031|FG001|STARTED|Overall Study||53||
48302996|NCT04556136|101070030|FG000|COMPLETED|Overall Study||43||
48302997|NCT04556136|101070031|FG001|COMPLETED|Overall Study||45||
48605151|NCT02756364|101816448|FG002|STARTED|Overall Study||48|Full Analysis Set (FAS) - Randomized Participants|
48605152|NCT02756364|101816446|FG000|Treated Participants|Overall Study||46|Safety Analysis Set|
48605153|NCT02756364|101816447|FG001|Treated Participants|Overall Study||47|Safety Analysis Set|
48605154|NCT02756364|101816448|FG002|Treated Participants|Overall Study||47|Safety Analysis Set|
48605155|NCT02756364|101816446|FG000|COMPLETED|Overall Study||0||
48605156|NCT02756364|101816447|FG001|COMPLETED|Overall Study||0||
48605157|NCT02756364|101816448|FG002|COMPLETED|Overall Study||0||
48605158|NCT02756364|101816446|FG000|NOT COMPLETED|Overall Study||46||
48605159|NCT02756364|101816447|FG001|NOT COMPLETED|Overall Study||47||
48605160|NCT02756364|101816448|FG002|NOT COMPLETED|Overall Study||48||
48605161|NCT00888290|101816449|FG000|STARTED|Overall Study||20||
48148538|NCT00924287|100685218|FG000|NOT COMPLETED|Overall Study||1||
48148539|NCT04402866|100685219|FG000|STARTED|Overall Study||6||
48148540|NCT04402866|100685220|FG001|STARTED|Overall Study||6||
48148541|NCT04402866|100685221|FG002|STARTED|Overall Study||7||
48148542|NCT04402866|100685222|FG003|STARTED|Overall Study||6||
48148543|NCT04402866|100685223|FG004|STARTED|Overall Study||104||
48148544|NCT04402866|100685224|FG005|STARTED|Overall Study||106||
48302998|NCT04556136|101070030|FG000|NOT COMPLETED|Overall Study||10||
48302999|NCT04556136|101070031|FG001|NOT COMPLETED|Overall Study||8||
48605162|NCT00888290|101816449|FG000|COMPLETED|Overall Study||20||
48605163|NCT00888290|101816449|FG000|NOT COMPLETED|Overall Study||0||
48605164|NCT03167255|101816450|FG000|STARTED|Overall Study||8||
48605165|NCT03167255|101816451|FG001|STARTED|Overall Study||8||
48605166|NCT03167255|101816450|FG000|COMPLETED|Overall Study||8||
48605167|NCT03167255|101816451|FG001|COMPLETED|Overall Study||8||
48605168|NCT03167255|101816450|FG000|NOT COMPLETED|Overall Study||0||
48605169|NCT03167255|101816451|FG001|NOT COMPLETED|Overall Study||0||
48605170|NCT03884270|101819687|FG000|STARTED|Overall Study||23||
48605171|NCT03884270|101819687|FG000|COMPLETED|Overall Study||22||
48605172|NCT03884270|101819687|FG000|NOT COMPLETED|Overall Study||1||
48605173|NCT01181947|101819688|FG000|STARTED|Overall Study||100||
48605174|NCT01181947|101819688|FG000|COMPLETED|Overall Study||100||
48148545|NCT04402866|100685219|FG000|Randomized and Treated With Study Drug|Overall Study||6||
48148546|NCT04402866|100685220|FG001|Randomized and Treated With Study Drug|Overall Study||6||
48148547|NCT04402866|100685221|FG002|Randomized and Treated With Study Drug|Overall Study||7||
48148548|NCT04402866|100685222|FG003|Randomized and Treated With Study Drug|Overall Study||6||
48148549|NCT04402866|100685223|FG004|Randomized and Treated With Study Drug|Overall Study||102||
48303000|NCT00529451|101070032|FG000|STARTED|Overall Study||331||
48303001|NCT00529451|101070033|FG001|STARTED|Overall Study||323||
48303002|NCT00529451|101070034|FG002|STARTED|Overall Study||332||
48303003|NCT00529451|101070035|FG003|STARTED|Overall Study||330||
48303004|NCT00529451|101070032|FG000|COMPLETED|Overall Study||294||
48303005|NCT00529451|101070033|FG001|COMPLETED|Overall Study||275||
48303006|NCT00529451|101070034|FG002|COMPLETED|Overall Study||292||
48303007|NCT00529451|101070035|FG003|COMPLETED|Overall Study||299||
48303008|NCT00529451|101070032|FG000|NOT COMPLETED|Overall Study||37||
48303009|NCT00529451|101070033|FG001|NOT COMPLETED|Overall Study||48||
48303010|NCT00529451|101070034|FG002|NOT COMPLETED|Overall Study||40||
48303011|NCT00529451|101070035|FG003|NOT COMPLETED|Overall Study||31||
48303012|NCT00708175|101070036|FG000|STARTED|Overall Study||78||
48303013|NCT00708175|101070037|FG001|STARTED|Overall Study||78||
48303014|NCT00708175|101070036|FG000|COMPLETED|Overall Study||60||
48303015|NCT00708175|101070037|FG001|COMPLETED|Overall Study||57||
48303016|NCT00708175|101070036|FG000|NOT COMPLETED|Overall Study||18||
48303017|NCT00708175|101070037|FG001|NOT COMPLETED|Overall Study||21||
48303018|NCT01955122|101070038|FG000|STARTED|Overall Study||64||
48303019|NCT01955122|101070039|FG001|STARTED|Overall Study||62||
48303020|NCT01955122|101070038|FG000|No.Patients Enrolled|Overall Study||64||
48303021|NCT01955122|101070039|FG001|No.Patients Enrolled|Overall Study||62||
48303022|NCT01955122|101070038|FG000|No. Patients Completed Double Procedure|Overall Study||59||
48303023|NCT01955122|101070039|FG001|No. Patients Completed Double Procedure|Overall Study||57||
48303024|NCT01955122|101070038|FG000|COMPLETED|Overall Study||59||
48303025|NCT01955122|101070039|FG001|COMPLETED|Overall Study||57||
48303026|NCT01955122|101070038|FG000|NOT COMPLETED|Overall Study||5||
48303027|NCT01955122|101070039|FG001|NOT COMPLETED|Overall Study||5||
48303028|NCT01170039|101070040|FG000|STARTED|Overall Study||37||
48303029|NCT01170039|101070041|FG001|STARTED|Overall Study||39||
48303030|NCT01170039|101070040|FG000|COMPLETED|Overall Study||29||
48303031|NCT01170039|101070041|FG001|COMPLETED|Overall Study||33||
48303032|NCT01170039|101070040|FG000|NOT COMPLETED|Overall Study||8||
48303033|NCT01170039|101070041|FG001|NOT COMPLETED|Overall Study||6||
48303034|NCT03318809|101070042|FG000|STARTED|Overall Study||6||
48303035|NCT03318809|101070043|FG001|STARTED|Overall Study||6||
48303036|NCT03318809|101070042|FG000|COMPLETED|Overall Study||6||
48303037|NCT03318809|101070043|FG001|COMPLETED|Overall Study||6||
48303038|NCT03318809|101070042|FG000|NOT COMPLETED|Overall Study||0||
48303039|NCT03318809|101070043|FG001|NOT COMPLETED|Overall Study||0||
48303040|NCT01303965|101070044|FG000|STARTED|Overall Study||3||
48303041|NCT01303965|101070045|FG001|STARTED|Overall Study||11||
48303042|NCT01303965|101070044|FG000|COMPLETED|Overall Study||0||
48303043|NCT01303965|101070045|FG001|COMPLETED|Overall Study||1||
48303044|NCT01303965|101070044|FG000|NOT COMPLETED|Overall Study||3||
48303045|NCT01303965|101070045|FG001|NOT COMPLETED|Overall Study||10||
48303046|NCT01448213|101070046|FG000|STARTED|Overall Study||130||
48303047|NCT01448213|101070047|FG001|STARTED|Overall Study||134||
48303048|NCT01448213|101070046|FG000|COMPLETED|Overall Study||113||
48303049|NCT01448213|101070047|FG001|COMPLETED|Overall Study||112||
48303050|NCT01448213|101070046|FG000|NOT COMPLETED|Overall Study||17||
48303051|NCT01448213|101070047|FG001|NOT COMPLETED|Overall Study||22||
48303052|NCT02805725|101070048|FG000|STARTED|Phase I (Dose Escalation Part)||3||
48303053|NCT02805725|101070049|FG001|STARTED|Phase I (Dose Escalation Part)||3||
48303054|NCT02805725|101070050|FG002|STARTED|Phase I (Dose Escalation Part)||7||
48303055|NCT02805725|101070051|FG003|STARTED|Phase I (Dose Escalation Part)||7||
48303056|NCT02805725|101070052|FG004|STARTED|Phase I (Dose Escalation Part)||0||
48303057|NCT02805725|101070048|FG000|COMPLETED|Phase I (Dose Escalation Part)||3||
48303058|NCT02805725|101070049|FG001|COMPLETED|Phase I (Dose Escalation Part)||3||
48303059|NCT02805725|101070050|FG002|COMPLETED|Phase I (Dose Escalation Part)||5||
48303060|NCT02805725|101070051|FG003|COMPLETED|Phase I (Dose Escalation Part)||5||
48303061|NCT02805725|101070052|FG004|COMPLETED|Phase I (Dose Escalation Part)||0||
48303062|NCT02805725|101070048|FG000|NOT COMPLETED|Phase I (Dose Escalation Part)||0||
48303063|NCT02805725|101070049|FG001|NOT COMPLETED|Phase I (Dose Escalation Part)||0||
48303064|NCT02805725|101070050|FG002|NOT COMPLETED|Phase I (Dose Escalation Part)||2||
48303065|NCT02805725|101070051|FG003|NOT COMPLETED|Phase I (Dose Escalation Part)||2||
48715668|NCT02772978|102091726|FG001|COMPLETED|Overall Study||8|Last participant enrolled|
48715669|NCT02772978|102091725|FG000|NOT COMPLETED|Overall Study||1||
48715670|NCT02772978|102091726|FG001|NOT COMPLETED|Overall Study||1||
48715671|NCT00803413|102091727|FG000|STARTED|Overall Period||28||
48715672|NCT00803413|102091728|FG001|STARTED|Overall Period||32||
48148550|NCT04402866|100685224|FG005|Randomized and Treated With Study Drug|Overall Study||103||
48148551|NCT04402866|100685219|FG000|COMPLETED|Overall Study||4||
48148552|NCT04402866|100685220|FG001|COMPLETED|Overall Study||5||
48148553|NCT04402866|100685221|FG002|COMPLETED|Overall Study||6||
48715673|NCT00803413|102091729|FG002|STARTED|Overall Period||29||
48715674|NCT00803413|102091730|FG003|STARTED|Overall Period||30||
48715675|NCT00803413|102091727|FG000|COMPLETED|Overall Period||28||
48715676|NCT00803413|102091728|FG001|COMPLETED|Overall Period||32||
48715677|NCT00803413|102091729|FG002|COMPLETED|Overall Period||29||
48148554|NCT04402866|100685222|FG003|COMPLETED|Overall Study||6||
48148555|NCT04402866|100685223|FG004|COMPLETED|Overall Study||89||
48148556|NCT04402866|100685224|FG005|COMPLETED|Overall Study||92||
48148557|NCT04402866|100685219|FG000|NOT COMPLETED|Overall Study||2||
48148558|NCT04402866|100685220|FG001|NOT COMPLETED|Overall Study||1||
48148559|NCT04402866|100685221|FG002|NOT COMPLETED|Overall Study||1||
48148560|NCT04402866|100685222|FG003|NOT COMPLETED|Overall Study||0||
48148561|NCT04402866|100685223|FG004|NOT COMPLETED|Overall Study||15||
48148562|NCT04402866|100685224|FG005|NOT COMPLETED|Overall Study||14||
48148563|NCT04307004|100685225|FG000|STARTED|Randomization 1||326||
48148564|NCT04307004|100685226|FG001|STARTED|Randomization 1||328||
48148565|NCT04307004|100685227|FG002|STARTED|Randomization 1||0||
48148566|NCT04307004|100685228|FG003|STARTED|Randomization 1||0||
48148567|NCT04307004|100685225|FG000|COMPLETED|Randomization 1||301||
48148568|NCT04307004|100685226|FG001|COMPLETED|Randomization 1||302||
48148569|NCT04307004|100685227|FG002|COMPLETED|Randomization 1||0||
48148570|NCT04307004|100685228|FG003|COMPLETED|Randomization 1||0||
48148571|NCT04307004|100685225|FG000|NOT COMPLETED|Randomization 1||25||
48148572|NCT04307004|100685226|FG001|NOT COMPLETED|Randomization 1||26||
48148573|NCT04307004|100685227|FG002|NOT COMPLETED|Randomization 1||0||
48148574|NCT04307004|100685228|FG003|NOT COMPLETED|Randomization 1||0||
48148575|NCT04307004|100685225|FG000|STARTED|Randomization 2||0||
48148576|NCT04307004|100685226|FG001|STARTED|Randomization 2||0||
48148577|NCT04307004|100685227|FG002|STARTED|Randomization 2||330||
48148578|NCT04307004|100685228|FG003|STARTED|Randomization 2||324||
48148579|NCT04307004|100685225|FG000|COMPLETED|Randomization 2||0||
48715678|NCT00803413|102091730|FG003|COMPLETED|Overall Period||30||
48715679|NCT00803413|102091727|FG000|NOT COMPLETED|Overall Period||0||
48715680|NCT00803413|102091728|FG001|NOT COMPLETED|Overall Period||0||
48715681|NCT00803413|102091729|FG002|NOT COMPLETED|Overall Period||0||
48715682|NCT00803413|102091730|FG003|NOT COMPLETED|Overall Period||0||
48715683|NCT00300677|102091731|FG000|STARTED|Overall Study||12||
48715684|NCT00300677|102091731|FG000|COMPLETED|Overall Study||12||
48715685|NCT00300677|102091731|FG000|NOT COMPLETED|Overall Study||0||
48715686|NCT00369226|102091732|FG000|STARTED|Phase I (45 Days)||13||
48715687|NCT00369226|102091733|FG001|STARTED|Phase I (45 Days)||0||
48715688|NCT00369226|102091732|FG000|COMPLETED|Phase I (45 Days)||13||
48715689|NCT00369226|102091733|FG001|COMPLETED|Phase I (45 Days)||0||
48715690|NCT00369226|102091732|FG000|NOT COMPLETED|Phase I (45 Days)||0||
48715691|NCT00369226|102091733|FG001|NOT COMPLETED|Phase I (45 Days)||0||
48715692|NCT00369226|102091732|FG000|STARTED|Phase II (45 Days)||0||
48715693|NCT00369226|102091733|FG001|STARTED|Phase II (45 Days)||32||
48715694|NCT00369226|102091732|FG000|COMPLETED|Phase II (45 Days)||0||
48715695|NCT00369226|102091733|FG001|COMPLETED|Phase II (45 Days)||32||
48715696|NCT00369226|102091732|FG000|NOT COMPLETED|Phase II (45 Days)||0||
48715697|NCT00369226|102091733|FG001|NOT COMPLETED|Phase II (45 Days)||0||
48303066|NCT02805725|101070052|FG004|NOT COMPLETED|Phase I (Dose Escalation Part)||0||
48303067|NCT02805725|101070048|FG000|STARTED|Phase II||0||
48303068|NCT02805725|101070049|FG001|STARTED|Phase II||0||
48303069|NCT02805725|101070050|FG002|STARTED|Phase II||0||
48303070|NCT02805725|101070051|FG003|STARTED|Phase II||0||
48605175|NCT01181947|101819688|FG000|NOT COMPLETED|Overall Study||0||
48715698|NCT00680368|102091734|FG000|STARTED|Overall Study||112||
48715699|NCT00680368|102091734|FG000|COMPLETED|Overall Study||97||
48715700|NCT00680368|102091734|FG000|NOT COMPLETED|Overall Study||15||
48605176|NCT00073008|101819689|FG000|STARTED|Overall Study||65||
48605177|NCT00073008|101819690|FG001|STARTED|Overall Study||66||
48715701|NCT00428220|102091735|FG000|STARTED|Overall Study||223||
48715702|NCT00428220|102091735|FG000|COMPLETED|Overall Study||0||
48715703|NCT00428220|102091735|FG000|NOT COMPLETED|Overall Study||223||
48715704|NCT02365285|102091736|FG000|STARTED|Overall Study||7||
48715705|NCT02365285|102091737|FG001|STARTED|Overall Study||6||
48715706|NCT02365285|102091738|FG002|STARTED|Overall Study||7||
48715707|NCT02365285|102091739|FG003|STARTED|Overall Study||3||
48715708|NCT02365285|102091736|FG000|COMPLETED|Overall Study||7||
48715709|NCT02365285|102091737|FG001|COMPLETED|Overall Study||5||
48715710|NCT02365285|102091738|FG002|COMPLETED|Overall Study||6||
48715711|NCT02365285|102091739|FG003|COMPLETED|Overall Study||1||
48715712|NCT02365285|102091736|FG000|NOT COMPLETED|Overall Study||0||
48715713|NCT02365285|102091737|FG001|NOT COMPLETED|Overall Study||1||
48715714|NCT02365285|102091738|FG002|NOT COMPLETED|Overall Study||1||
48715715|NCT02365285|102091739|FG003|NOT COMPLETED|Overall Study||2||
48715716|NCT00623545|102091740|FG000|STARTED|Overall Study||28||
48715717|NCT00623545|102091740|FG000|COMPLETED|Overall Study||18||
48715718|NCT00623545|102091740|FG000|NOT COMPLETED|Overall Study||10||
48715719|NCT03476876|102091741|FG000|STARTED|Overall Study||19||19
48303071|NCT02805725|101070052|FG004|STARTED|Phase II||30||
48303072|NCT02805725|101070048|FG000|Interim Analysis (Stage 2 of Simon's Design)|Phase II||0||
48303073|NCT02805725|101070049|FG001|Interim Analysis (Stage 2 of Simon's Design)|Phase II||0||
48303074|NCT02805725|101070050|FG002|Interim Analysis (Stage 2 of Simon's Design)|Phase II||0||
48303075|NCT02805725|101070051|FG003|Interim Analysis (Stage 2 of Simon's Design)|Phase II||0||
48303076|NCT02805725|101070052|FG004|Interim Analysis (Stage 2 of Simon's Design)|Phase II||16||
48303077|NCT02805725|101070048|FG000|COMPLETED|Phase II||0||
48605178|NCT00073008|101819689|FG000|COMPLETED|Overall Study||3||
48303078|NCT02805725|101070049|FG001|COMPLETED|Phase II||0||
48303079|NCT02805725|101070050|FG002|COMPLETED|Phase II||0||
48303080|NCT02805725|101070051|FG003|COMPLETED|Phase II||0||
48605179|NCT00073008|101819690|FG001|COMPLETED|Overall Study||3||
48605180|NCT00073008|101819689|FG000|NOT COMPLETED|Overall Study||62||
48605181|NCT00073008|101819690|FG001|NOT COMPLETED|Overall Study||63||
48605182|NCT03162328|101819691|FG000|STARTED|Screening Period||84||
48605183|NCT03162328|101819692|FG001|STARTED|Screening Period||0||
48605184|NCT03162328|101819693|FG002|STARTED|Screening Period||0||
48605185|NCT03162328|101819691|FG000|COMPLETED|Screening Period||62||
48605186|NCT03162328|101819692|FG001|COMPLETED|Screening Period||0||
48605187|NCT03162328|101819693|FG002|COMPLETED|Screening Period||0||
48605188|NCT03162328|101819691|FG000|NOT COMPLETED|Screening Period||22||
48605189|NCT03162328|101819692|FG001|NOT COMPLETED|Screening Period||0||
48605190|NCT03162328|101819693|FG002|NOT COMPLETED|Screening Period||0||
48715720|NCT03476876|102091742|FG001|STARTED|Overall Study||15||15
48715721|NCT03476876|102091741|FG000|COMPLETED|Overall Study||9||9
48715722|NCT03476876|102091742|FG001|COMPLETED|Overall Study||7||7
48715723|NCT03476876|102091741|FG000|NOT COMPLETED|Overall Study||10||10
48303081|NCT02805725|101070052|FG004|COMPLETED|Phase II||24||
48303082|NCT02805725|101070048|FG000|NOT COMPLETED|Phase II||0||
48303083|NCT02805725|101070049|FG001|NOT COMPLETED|Phase II||0||
48605191|NCT03162328|101819691|FG000|STARTED|Study Period||0||
48605192|NCT03162328|101819692|FG001|STARTED|Study Period||30||
48715724|NCT03476876|102091742|FG001|NOT COMPLETED|Overall Study||8||8
48715725|NCT02513823|102091743|FG000|STARTED|Overall Study||27||
48605193|NCT03162328|101819693|FG002|STARTED|Study Period||32||
48605194|NCT03162328|101819691|FG000|COMPLETED|Study Period||0||
48605195|NCT03162328|101819692|FG001|COMPLETED|Study Period||30||
48605196|NCT03162328|101819693|FG002|COMPLETED|Study Period||31||
48605197|NCT03162328|101819691|FG000|NOT COMPLETED|Study Period||0||
48605198|NCT03162328|101819692|FG001|NOT COMPLETED|Study Period||0||
48605199|NCT03162328|101819693|FG002|NOT COMPLETED|Study Period||1||
48605200|NCT00845676|101819694|FG000|STARTED|Overall Study||21||
48605201|NCT00845676|101819694|FG000|COMPLETED|Overall Study||19||
48605202|NCT00845676|101819694|FG000|NOT COMPLETED|Overall Study||2||
48605203|NCT00419159|101819695|FG000|STARTED|Overall Study||99||
48605204|NCT00419159|101819696|FG001|STARTED|Overall Study||100||
48605205|NCT00419159|101819695|FG000|COMPLETED|Overall Study||0||
48605206|NCT00419159|101819696|FG001|COMPLETED|Overall Study||0||
48605207|NCT00419159|101819695|FG000|NOT COMPLETED|Overall Study||99||
48605208|NCT00419159|101819696|FG001|NOT COMPLETED|Overall Study||100||
48605209|NCT00729300|101819697|FG000|STARTED|Overall Study||26||
48605210|NCT00729300|101819698|FG001|STARTED|Overall Study||26||
48605211|NCT00729300|101819697|FG000|COMPLETED|Overall Study||17||
48605212|NCT00729300|101819698|FG001|COMPLETED|Overall Study||17||
48605213|NCT00729300|101819697|FG000|NOT COMPLETED|Overall Study||9||
48605214|NCT00729300|101819698|FG001|NOT COMPLETED|Overall Study||9||
48605215|NCT00621517|101819699|FG000|STARTED|Overall Study||29||
48605216|NCT00621517|101819700|FG001|STARTED|Overall Study||31||
48605217|NCT00621517|101819699|FG000|COMPLETED|Overall Study||22||
48605218|NCT00621517|101819700|FG001|COMPLETED|Overall Study||24||
48605219|NCT00621517|101819699|FG000|NOT COMPLETED|Overall Study||7||
48605220|NCT00621517|101819700|FG001|NOT COMPLETED|Overall Study||7||
48605221|NCT02446847|101819701|FG000|STARTED|Overall Study||8||
48605222|NCT02446847|101819702|FG001|STARTED|Overall Study||8||
48605223|NCT02446847|101819701|FG000|COMPLETED|Overall Study||8||
48605224|NCT02446847|101819702|FG001|COMPLETED|Overall Study||6||
48605225|NCT02446847|101819701|FG000|NOT COMPLETED|Overall Study||0||
48605226|NCT02446847|101819702|FG001|NOT COMPLETED|Overall Study||2||
48605227|NCT00755261|101819703|FG000|STARTED|Overall Study||6||
48605228|NCT00755261|101819703|FG000|COMPLETED|Overall Study||4||
48605229|NCT00755261|101819703|FG000|NOT COMPLETED|Overall Study||2||
48605230|NCT00538512|101819704|FG000|STARTED|Overall Study||814||
48605231|NCT00538512|101819705|FG001|STARTED|Overall Study||813||
48605232|NCT00538512|101819706|FG002|STARTED|Overall Study||325||
48605233|NCT00538512|101819704|FG000|COMPLETED|Overall Study||787||
48605234|NCT00538512|101819705|FG001|COMPLETED|Overall Study||783||
48605235|NCT00538512|101819706|FG002|COMPLETED|Overall Study||312||
48605236|NCT00538512|101819704|FG000|NOT COMPLETED|Overall Study||27||
48605237|NCT00538512|101819705|FG001|NOT COMPLETED|Overall Study||30||
48605238|NCT00538512|101819706|FG002|NOT COMPLETED|Overall Study||13||
48605239|NCT01119846|101819707|FG000|STARTED|Overall Study||13||
48605240|NCT01119846|101819708|FG001|STARTED|Overall Study||4||
48605241|NCT01119846|101819709|FG002|STARTED|Overall Study||83||
48605242|NCT01119846|101819707|FG000|COMPLETED|Overall Study||11||
48605243|NCT01119846|101819708|FG001|COMPLETED|Overall Study||4||
48605244|NCT01119846|101819709|FG002|COMPLETED|Overall Study||72||
48605245|NCT01119846|101819707|FG000|NOT COMPLETED|Overall Study||2||
48605246|NCT01119846|101819708|FG001|NOT COMPLETED|Overall Study||0||
48605247|NCT01119846|101819709|FG002|NOT COMPLETED|Overall Study||11||
48605248|NCT01601067|101819710|FG000|STARTED|Overall Study||63||
48605249|NCT01601067|101819711|FG001|STARTED|Overall Study||56||
48605250|NCT01601067|101819710|FG000|COMPLETED|Overall Study||30||
48605251|NCT01601067|101819711|FG001|COMPLETED|Overall Study||34||
48605252|NCT01601067|101819710|FG000|NOT COMPLETED|Overall Study||33||
48605253|NCT01601067|101819711|FG001|NOT COMPLETED|Overall Study||22||
48605254|NCT00048165|101819712|FG000|STARTED|Completed 6 Months Study||216||
48605255|NCT00048165|101819713|FG001|STARTED|Completed 6 Months Study||218||
48605256|NCT00048165|101819712|FG000|COMPLETED|Completed 6 Months Study||165||
48605257|NCT00048165|101819713|FG001|COMPLETED|Completed 6 Months Study||170||
48605258|NCT00048165|101819712|FG000|NOT COMPLETED|Completed 6 Months Study||51||
48605259|NCT00048165|101819713|FG001|NOT COMPLETED|Completed 6 Months Study||48||
48605260|NCT00048165|101819712|FG000|STARTED|Completed 12 Months Study||165||
48605261|NCT00048165|101819713|FG001|STARTED|Completed 12 Months Study||170||
48605262|NCT00048165|101819712|FG000|COMPLETED|Completed 12 Months Study||162||
48605263|NCT00048165|101819713|FG001|COMPLETED|Completed 12 Months Study||167||
48605264|NCT00048165|101819712|FG000|NOT COMPLETED|Completed 12 Months Study||3||
48605265|NCT00048165|101819713|FG001|NOT COMPLETED|Completed 12 Months Study||3||
48605266|NCT02918097|101819714|FG000|STARTED|Overall Study||78||
48605267|NCT02918097|101819714|FG000|COMPLETED|Overall Study||58||
48605268|NCT02918097|101819714|FG000|NOT COMPLETED|Overall Study||20||
48605269|NCT00528372|101819715|FG000|STARTED|Short-term (ST) Period (Day 1-Week 24)||75||
48605270|NCT00528372|101819716|FG001|STARTED|Short-term (ST) Period (Day 1-Week 24)||65||
48605271|NCT00528372|101819717|FG002|STARTED|Short-term (ST) Period (Day 1-Week 24)||64||
48605272|NCT00528372|101819718|FG003|STARTED|Short-term (ST) Period (Day 1-Week 24)||70||
48605273|NCT00528372|101819719|FG004|STARTED|Short-term (ST) Period (Day 1-Week 24)||67||
48605274|NCT00528372|101819720|FG005|STARTED|Short-term (ST) Period (Day 1-Week 24)||68||
48605275|NCT00528372|101819721|FG006|STARTED|Short-term (ST) Period (Day 1-Week 24)||76||
48605276|NCT00528372|101819722|FG007|STARTED|Short-term (ST) Period (Day 1-Week 24)||34||
48605277|NCT00528372|101819723|FG008|STARTED|Short-term (ST) Period (Day 1-Week 24)||39||
48605278|NCT00528372|101819715|FG000|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||63||
48605279|NCT00528372|101819716|FG001|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||60||
48605280|NCT00528372|101819717|FG002|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||52||
48605281|NCT00528372|101819718|FG003|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57||
48605282|NCT00528372|101819719|FG004|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||58||
48605283|NCT00528372|101819720|FG005|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57||
48605284|NCT00528372|101819721|FG006|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||65||
48605285|NCT00528372|101819722|FG007|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||28||
48605286|NCT00528372|101819723|FG008|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||34||
48605287|NCT00528372|101819715|FG000|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12||
48605288|NCT00528372|101819716|FG001|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5||
48605289|NCT00528372|101819717|FG002|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12||
48605290|NCT00528372|101819718|FG003|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||13||
48605291|NCT00528372|101819719|FG004|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||9||
48605292|NCT00528372|101819720|FG005|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11||
48605293|NCT00528372|101819721|FG006|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11||
48605294|NCT00528372|101819722|FG007|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||6||
48605295|NCT00528372|101819723|FG008|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5||
48605296|NCT00528372|101819715|FG000|STARTED|Long-term (LT) Period (Weeks 24-102)||62||
48605297|NCT00528372|101819716|FG001|STARTED|Long-term (LT) Period (Weeks 24-102)||59||
48605298|NCT00528372|101819717|FG002|STARTED|Long-term (LT) Period (Weeks 24-102)||51||
48605299|NCT00528372|101819718|FG003|STARTED|Long-term (LT) Period (Weeks 24-102)||56||
48605300|NCT00528372|101819719|FG004|STARTED|Long-term (LT) Period (Weeks 24-102)||58||
48605301|NCT00528372|101819720|FG005|STARTED|Long-term (LT) Period (Weeks 24-102)||57||
48605302|NCT00528372|101819721|FG006|STARTED|Long-term (LT) Period (Weeks 24-102)||65||
48605303|NCT00528372|101819722|FG007|STARTED|Long-term (LT) Period (Weeks 24-102)||28||
48605304|NCT00528372|101819723|FG008|STARTED|Long-term (LT) Period (Weeks 24-102)||33||
48605305|NCT00528372|101819715|FG000|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42||
48605306|NCT00528372|101819716|FG001|COMPLETED|Long-term (LT) Period (Weeks 24-102)||40||
48605307|NCT00528372|101819717|FG002|COMPLETED|Long-term (LT) Period (Weeks 24-102)||43||
48605308|NCT00528372|101819718|FG003|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42||
48605309|NCT00528372|101819719|FG004|COMPLETED|Long-term (LT) Period (Weeks 24-102)||37||
48605310|NCT00528372|101819720|FG005|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42||
48605311|NCT00528372|101819721|FG006|COMPLETED|Long-term (LT) Period (Weeks 24-102)||48||
48605312|NCT00528372|101819722|FG007|COMPLETED|Long-term (LT) Period (Weeks 24-102)||22||
48605313|NCT00528372|101819723|FG008|COMPLETED|Long-term (LT) Period (Weeks 24-102)||27||
48605314|NCT00528372|101819715|FG000|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||20||
48605315|NCT00528372|101819716|FG001|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||19||
48605316|NCT00528372|101819717|FG002|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||8||
48605317|NCT00528372|101819718|FG003|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||14||
48605318|NCT00528372|101819719|FG004|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||21||
48605319|NCT00528372|101819720|FG005|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||15||
48605320|NCT00528372|101819721|FG006|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||17||
48605321|NCT00528372|101819722|FG007|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6||
48605322|NCT00528372|101819723|FG008|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6||
48605323|NCT03430856|101819724|FG000|STARTED|Overall Study||31||
48605324|NCT03430856|101819725|FG001|STARTED|Overall Study||30||
48605325|NCT03430856|101819726|FG002|STARTED|Overall Study||30||
48605326|NCT03430856|101819724|FG000|Exposed|Overall Study||31||
48605327|NCT03430856|101819725|FG001|Exposed|Overall Study||30||
48605328|NCT03430856|101819726|FG002|Exposed|Overall Study||30||
48605329|NCT03430856|101819724|FG000|COMPLETED|Overall Study||29||
48605330|NCT03430856|101819725|FG001|COMPLETED|Overall Study||27||
48605331|NCT03430856|101819726|FG002|COMPLETED|Overall Study||29||
48605332|NCT03430856|101819724|FG000|NOT COMPLETED|Overall Study||2||
48605333|NCT03430856|101819725|FG001|NOT COMPLETED|Overall Study||3||
48605334|NCT03430856|101819726|FG002|NOT COMPLETED|Overall Study||1||
48605335|NCT00055497|101819727|FG000|STARTED|Overall Study||18||
48605336|NCT00055497|101819728|FG001|STARTED|Overall Study||19||
48605337|NCT00055497|101819729|FG002|STARTED|Overall Study||18||
48605338|NCT00055497|101819730|FG003|STARTED|Overall Study||221||
48605339|NCT00055497|101819727|FG000|COMPLETED|Overall Study||13||
48605340|NCT00055497|101819728|FG001|COMPLETED|Overall Study||16||
48605341|NCT00055497|101819729|FG002|COMPLETED|Overall Study||16||
48605342|NCT00055497|101819730|FG003|COMPLETED|Overall Study||131||
48605343|NCT00055497|101819727|FG000|NOT COMPLETED|Overall Study||5||
48605344|NCT00055497|101819728|FG001|NOT COMPLETED|Overall Study||3||
48605345|NCT00055497|101819729|FG002|NOT COMPLETED|Overall Study||2||
48605346|NCT00055497|101819730|FG003|NOT COMPLETED|Overall Study||90||
48605347|NCT00966355|101819731|FG000|STARTED|Overall Study||344||
48605348|NCT00966355|101819732|FG001|STARTED|Overall Study||345||
48605349|NCT00966355|101819733|FG002|STARTED|Overall Study||345||
48605350|NCT00966355|101819731|FG000|COMPLETED|Overall Study||260||
48605351|NCT00966355|101819732|FG001|COMPLETED|Overall Study||259||
48605352|NCT00966355|101819733|FG002|COMPLETED|Overall Study||261||
48605353|NCT00966355|101819731|FG000|NOT COMPLETED|Overall Study||84||
48605354|NCT00966355|101819732|FG001|NOT COMPLETED|Overall Study||86||
48605355|NCT00966355|101819733|FG002|NOT COMPLETED|Overall Study||84||
48605356|NCT00977691|101819734|FG000|STARTED|Overall Study||3||
48605357|NCT00977691|101819735|FG001|STARTED|Overall Study||8||
48605358|NCT00977691|101819736|FG002|STARTED|Overall Study||12||
48605359|NCT00977691|101819734|FG000|COMPLETED|Overall Study||3||
48605360|NCT00977691|101819735|FG001|COMPLETED|Overall Study||7||
48605361|NCT00977691|101819736|FG002|COMPLETED|Overall Study||12||
48303084|NCT02805725|101070050|FG002|NOT COMPLETED|Phase II||0||
48303085|NCT02805725|101070051|FG003|NOT COMPLETED|Phase II||0||
48303086|NCT02805725|101070052|FG004|NOT COMPLETED|Phase II||6||
48303087|NCT04195581|101070053|FG000|STARTED|Comfilcon A With All in One Light||28||
48303088|NCT04195581|101070053|FG000|COMPLETED|Comfilcon A With All in One Light||24||
48303089|NCT04195581|101070053|FG000|NOT COMPLETED|Comfilcon A With All in One Light||4||
48303090|NCT04195581|101070053|FG000|STARTED|Comfilcon A With Hy-Care||30||
48303091|NCT04195581|101070053|FG000|COMPLETED|Comfilcon A With Hy-Care||25||
48303092|NCT04195581|101070053|FG000|NOT COMPLETED|Comfilcon A With Hy-Care||5||
48303093|NCT04195581|101070053|FG000|STARTED|Comfilcon A With Refine One Step||25||
48303094|NCT04195581|101070053|FG000|COMPLETED|Comfilcon A With Refine One Step||24||
48303095|NCT04195581|101070053|FG000|NOT COMPLETED|Comfilcon A With Refine One Step||1||
48303096|NCT04195581|101070053|FG000|STARTED|Fanfilcon A With All in One Light||28||
48303097|NCT04195581|101070053|FG000|COMPLETED|Fanfilcon A With All in One Light||27||
48605362|NCT00977691|101819734|FG000|NOT COMPLETED|Overall Study||0||
48605363|NCT00977691|101819735|FG001|NOT COMPLETED|Overall Study||1||
48605364|NCT00977691|101819736|FG002|NOT COMPLETED|Overall Study||0||
48605365|NCT02187861|101819737|FG000|STARTED|Overall Study||9||
48605366|NCT02187861|101819738|FG001|STARTED|Overall Study||52||
48605367|NCT02187861|101819739|FG002|STARTED|Overall Study||51||
48303098|NCT04195581|101070053|FG000|NOT COMPLETED|Fanfilcon A With All in One Light||1||
48303099|NCT04195581|101070053|FG000|STARTED|Fanfilcon A With Hy-Care||28||
48303100|NCT04195581|101070053|FG000|COMPLETED|Fanfilcon A With Hy-Care||25||
48303101|NCT04195581|101070053|FG000|NOT COMPLETED|Fanfilcon A With Hy-Care||3||
48303102|NCT04195581|101070053|FG000|STARTED|Fanfilcon A With Refine One Step||29||
48303103|NCT04195581|101070053|FG000|COMPLETED|Fanfilcon A With Refine One Step||27||
48303104|NCT04195581|101070053|FG000|NOT COMPLETED|Fanfilcon A With Refine One Step||2||
48303105|NCT02536755|101070054|FG000|STARTED|Overall Study||31||
48303106|NCT02536755|101070054|FG000|COMPLETED|Overall Study||27||
48303107|NCT02536755|101070054|FG000|NOT COMPLETED|Overall Study||4||
48303108|NCT01176968|101070055|FG000|STARTED|Overall Study||506||
48303109|NCT01176968|101070056|FG001|STARTED|Overall Study||506||
48303110|NCT01176968|101070055|FG000|Treated|Overall Study||505||
48303111|NCT01176968|101070056|FG001|Treated|Overall Study||505||
48303112|NCT01176968|101070055|FG000|COMPLETED|Overall Study||422||
48303113|NCT01176968|101070056|FG001|COMPLETED|Overall Study||424||
48303114|NCT01176968|101070055|FG000|NOT COMPLETED|Overall Study||84||
48303115|NCT01176968|101070056|FG001|NOT COMPLETED|Overall Study||82||
48303116|NCT03982342|101070057|FG000|STARTED|Overall Study||0||
48303117|NCT03982342|101070058|FG001|STARTED|Overall Study||1||
48303118|NCT03982342|101070057|FG000|COMPLETED|Overall Study||0||
48303119|NCT03982342|101070058|FG001|COMPLETED|Overall Study||1||
48303120|NCT03982342|101070057|FG000|NOT COMPLETED|Overall Study||0||
48303121|NCT03982342|101070058|FG001|NOT COMPLETED|Overall Study||0||
48303122|NCT01557348|101070059|FG000|STARTED|Overall Study||604||
48303123|NCT01557348|101070060|FG001|STARTED|Overall Study||507||
48303124|NCT01557348|101070059|FG000|Safety Population|Overall Study||604||
48303125|NCT01557348|101070060|FG001|Safety Population|Overall Study||507||
48605368|NCT02187861|101819740|FG003|STARTED|Overall Study||51||
48605369|NCT02187861|101819737|FG000|Treated|Overall Study||9||
48605370|NCT02187861|101819738|FG001|Treated|Overall Study||52||
48605371|NCT02187861|101819739|FG002|Treated|Overall Study||49||
48303126|NCT01557348|101070059|FG000|COMPLETED|Overall Study||524||
48303127|NCT01557348|101070060|FG001|COMPLETED|Overall Study||417||
48303128|NCT01557348|101070059|FG000|NOT COMPLETED|Overall Study||80||
48303129|NCT01557348|101070060|FG001|NOT COMPLETED|Overall Study||90||
48303130|NCT02336763|101070061|FG000|STARTED|Overall Study||2||
48303131|NCT02336763|101070061|FG000|COMPLETED|Overall Study||2||
48303132|NCT02336763|101070061|FG000|NOT COMPLETED|Overall Study||0||
48303133|NCT03042780|101070062|FG000|STARTED|Overall Study||2||
48605372|NCT02187861|101819740|FG003|Treated|Overall Study||50||
48605373|NCT02187861|101819737|FG000|COMPLETED|Overall Study||3||
48605374|NCT02187861|101819738|FG001|COMPLETED|Overall Study||4||
48605375|NCT02187861|101819739|FG002|COMPLETED|Overall Study||19||
48605376|NCT02187861|101819740|FG003|COMPLETED|Overall Study||19||
48605377|NCT02187861|101819737|FG000|NOT COMPLETED|Overall Study||6||
48605378|NCT02187861|101819738|FG001|NOT COMPLETED|Overall Study||48||
48605379|NCT02187861|101819739|FG002|NOT COMPLETED|Overall Study||32||
48605380|NCT02187861|101819740|FG003|NOT COMPLETED|Overall Study||32||
48605381|NCT00632632|101819741|FG000|STARTED|Overall Study||13||
48303134|NCT03042780|101070062|FG000|COMPLETED|Overall Study||2||
48303135|NCT03042780|101070062|FG000|NOT COMPLETED|Overall Study||0||
48303136|NCT00325039|101070063|FG000|STARTED|Overall Study||298||
48303137|NCT00325039|101070064|FG001|STARTED|Overall Study||299||
48303138|NCT00325039|101070063|FG000|COMPLETED|Overall Study||280||
48303139|NCT00325039|101070064|FG001|COMPLETED|Overall Study||285||
48303140|NCT00325039|101070063|FG000|NOT COMPLETED|Overall Study||18||
48303141|NCT00325039|101070064|FG001|NOT COMPLETED|Overall Study||14||
48303142|NCT02525861|101070065|FG000|STARTED|Overall Study||18||
48303143|NCT02525861|101070066|FG001|STARTED|Overall Study||16||
48303144|NCT02525861|101070065|FG000|COMPLETED|Overall Study||17||
48605382|NCT00632632|101819742|FG001|STARTED|Overall Study||12||
48605383|NCT00632632|101819741|FG000|COMPLETED|Overall Study||13||
48605384|NCT00632632|101819742|FG001|COMPLETED|Overall Study||9||
48605385|NCT00632632|101819741|FG000|NOT COMPLETED|Overall Study||0||
48605386|NCT00632632|101819742|FG001|NOT COMPLETED|Overall Study||3||
48605387|NCT03604705|101819743|FG000|STARTED|Overall Study||21||
48605388|NCT03604705|101819743|FG000|COMPLETED|Overall Study||20||
48605389|NCT03604705|101819743|FG000|NOT COMPLETED|Overall Study||1||
48605390|NCT00076999|101819744|FG000|STARTED|Overall Study||25||
48605391|NCT00076999|101819745|FG001|STARTED|Overall Study||31||
48605392|NCT00076999|101819746|FG002|STARTED|Overall Study||19||
48605393|NCT00076999|101819747|FG003|STARTED|Overall Study||6||
48605394|NCT00076999|101819748|FG004|STARTED|Overall Study||34||
48605395|NCT00076999|101819744|FG000|COMPLETED|Overall Study||13||
48605396|NCT00076999|101819745|FG001|COMPLETED|Overall Study||7||
48605397|NCT00076999|101819746|FG002|COMPLETED|Overall Study||2||
48605398|NCT00076999|101819747|FG003|COMPLETED|Overall Study||5||
48605399|NCT00076999|101819748|FG004|COMPLETED|Overall Study||9||
48605400|NCT00076999|101819744|FG000|NOT COMPLETED|Overall Study||12||
48605401|NCT00076999|101819745|FG001|NOT COMPLETED|Overall Study||24||
48605402|NCT00076999|101819746|FG002|NOT COMPLETED|Overall Study||17||
48605403|NCT00076999|101819747|FG003|NOT COMPLETED|Overall Study||1||
48605404|NCT00076999|101819748|FG004|NOT COMPLETED|Overall Study||25||
48605405|NCT04633291|101819749|FG000|STARTED|Overall Study||11||
48605406|NCT04633291|101819750|FG001|STARTED|Overall Study||11||
48605407|NCT04633291|101819749|FG000|COMPLETED|Overall Study||11||
48605408|NCT04633291|101819750|FG001|COMPLETED|Overall Study||11||
48605409|NCT04633291|101819749|FG000|NOT COMPLETED|Overall Study||0||
48605410|NCT04633291|101819750|FG001|NOT COMPLETED|Overall Study||0||
48605411|NCT00693485|101819751|FG000|STARTED|Overall Study||25||
48605412|NCT00693485|101819752|FG001|STARTED|Overall Study||21||
48605413|NCT00693485|101819753|FG002|STARTED|Overall Study||24||
48605414|NCT00693485|101819751|FG000|COMPLETED|Overall Study||25||
48605415|NCT00693485|101819752|FG001|COMPLETED|Overall Study||19||
48605416|NCT00693485|101819753|FG002|COMPLETED|Overall Study||24||
48605417|NCT00693485|101819751|FG000|NOT COMPLETED|Overall Study||0||
48605418|NCT00693485|101819752|FG001|NOT COMPLETED|Overall Study||2||
48605419|NCT00693485|101819753|FG002|NOT COMPLETED|Overall Study||0||
48605420|NCT01754766|101819754|FG000|STARTED|Overall Study||31||
48605421|NCT01754766|101819755|FG001|STARTED|Overall Study||29||
48605422|NCT01754766|101819756|FG002|STARTED|Overall Study||30||
48605423|NCT01754766|101819754|FG000|COMPLETED|Overall Study||30||
48605424|NCT01754766|101819755|FG001|COMPLETED|Overall Study||28||
48605425|NCT01754766|101819756|FG002|COMPLETED|Overall Study||30||
48605426|NCT01754766|101819754|FG000|NOT COMPLETED|Overall Study||1||
48605427|NCT01754766|101819755|FG001|NOT COMPLETED|Overall Study||1||
48605428|NCT01754766|101819756|FG002|NOT COMPLETED|Overall Study||0||
48303145|NCT02525861|101070066|FG001|COMPLETED|Overall Study||14||
48303146|NCT02525861|101070065|FG000|NOT COMPLETED|Overall Study||1||
48303147|NCT02525861|101070066|FG001|NOT COMPLETED|Overall Study||2||
48605429|NCT02137226|101819757|FG000|STARTED|Period 1 (Initial Randomization)||324||
48605430|NCT02137226|101819758|FG001|STARTED|Period 1 (Initial Randomization)||321||
48605431|NCT02137226|101819759|FG002|STARTED|Period 1 (Initial Randomization)||0||
48605432|NCT02137226|101819760|FG003|STARTED|Period 1 (Initial Randomization)||0||
48605433|NCT02137226|101819761|FG004|STARTED|Period 1 (Initial Randomization)||0||
48605434|NCT02137226|101819757|FG000|COMPLETED|Period 1 (Initial Randomization)||304||
48605435|NCT02137226|101819758|FG001|COMPLETED|Period 1 (Initial Randomization)||305||
48605436|NCT02137226|101819759|FG002|COMPLETED|Period 1 (Initial Randomization)||0||
48605437|NCT02137226|101819760|FG003|COMPLETED|Period 1 (Initial Randomization)||0||
48605438|NCT02137226|101819761|FG004|COMPLETED|Period 1 (Initial Randomization)||0||
48303148|NCT02030405|101070067|FG000|STARTED|Overall Study||4||
48303149|NCT02030405|101070067|FG000|COMPLETED|Overall Study||2||
48303150|NCT02030405|101070067|FG000|NOT COMPLETED|Overall Study||2||
48303151|NCT00937833|101070068|FG000|STARTED|Overall Study||73||
48303152|NCT00937833|101070069|FG001|STARTED|Overall Study||77||
48605439|NCT02137226|101819757|FG000|NOT COMPLETED|Period 1 (Initial Randomization)||20||
48605440|NCT02137226|101819758|FG001|NOT COMPLETED|Period 1 (Initial Randomization)||16||
48605441|NCT02137226|101819759|FG002|NOT COMPLETED|Period 1 (Initial Randomization)||0||
48605442|NCT02137226|101819760|FG003|NOT COMPLETED|Period 1 (Initial Randomization)||0||
48605443|NCT02137226|101819761|FG004|NOT COMPLETED|Period 1 (Initial Randomization)||0||
48605444|NCT02137226|101819757|FG000|STARTED|Period 2 (Re - Randomization)||0||
48605445|NCT02137226|101819758|FG001|STARTED|Period 2 (Re - Randomization)||0||
48605446|NCT02137226|101819759|FG002|STARTED|Period 2 (Re - Randomization)||298||
48605447|NCT02137226|101819760|FG003|STARTED|Period 2 (Re - Randomization)||148||
48605448|NCT02137226|101819761|FG004|STARTED|Period 2 (Re - Randomization)||147||
48605449|NCT02137226|101819757|FG000|COMPLETED|Period 2 (Re - Randomization)||0||
48605450|NCT02137226|101819758|FG001|COMPLETED|Period 2 (Re - Randomization)||0||
48605451|NCT02137226|101819759|FG002|COMPLETED|Period 2 (Re - Randomization)||281||
48605452|NCT02137226|101819760|FG003|COMPLETED|Period 2 (Re - Randomization)||140||
48605453|NCT02137226|101819761|FG004|COMPLETED|Period 2 (Re - Randomization)||138||
48605454|NCT02137226|101819757|FG000|NOT COMPLETED|Period 2 (Re - Randomization)||0||
48605455|NCT02137226|101819758|FG001|NOT COMPLETED|Period 2 (Re - Randomization)||0||
48605456|NCT02137226|101819759|FG002|NOT COMPLETED|Period 2 (Re - Randomization)||17||
48605457|NCT02137226|101819760|FG003|NOT COMPLETED|Period 2 (Re - Randomization)||8||
48605458|NCT02137226|101819761|FG004|NOT COMPLETED|Period 2 (Re - Randomization)||9||
48605459|NCT01578499|101819762|FG000|STARTED|Overall Study||66||
48605460|NCT01578499|101819763|FG001|STARTED|Overall Study||65||
48605461|NCT01578499|101819762|FG000|Safety Population: Treated|Overall Study||66||
48303153|NCT00937833|101070068|FG000|COMPLETED|Overall Study||58||
48303154|NCT00937833|101070069|FG001|COMPLETED|Overall Study||60||
48303155|NCT00937833|101070068|FG000|NOT COMPLETED|Overall Study||15||
48303156|NCT00937833|101070069|FG001|NOT COMPLETED|Overall Study||17||
48405389|NCT03074318|101325267|FG001|NOT COMPLETED|Overall Study||5||
48605462|NCT01578499|101819763|FG001|Safety Population: Treated|Overall Study||62||
48605463|NCT01578499|101819762|FG000|Intent to Treat Population: CD30+|Overall Study||64||
48605464|NCT01578499|101819763|FG001|Intent to Treat Population: CD30+|Overall Study||64||
48605465|NCT01578499|101819762|FG000|COMPLETED|Overall Study||32||
48605466|NCT01578499|101819763|FG001|COMPLETED|Overall Study||22||
48605467|NCT01578499|101819762|FG000|NOT COMPLETED|Overall Study||34||
48605468|NCT01578499|101819763|FG001|NOT COMPLETED|Overall Study||43||
48605469|NCT00162097|101819764|FG000|STARTED|Overall Study||6||
48605470|NCT00162097|101819765|FG001|STARTED|Overall Study||2||
48605471|NCT00162097|101819766|FG002|STARTED|Overall Study||1||
48605472|NCT00162097|101819767|FG003|STARTED|Overall Study||7||
48605473|NCT00162097|101819764|FG000|COMPLETED|Overall Study||6||
48605474|NCT00162097|101819765|FG001|COMPLETED|Overall Study||2||
48605475|NCT00162097|101819766|FG002|COMPLETED|Overall Study||1||
48605476|NCT00162097|101819767|FG003|COMPLETED|Overall Study||6||
48605477|NCT00162097|101819764|FG000|NOT COMPLETED|Overall Study||0||
48605478|NCT00162097|101819765|FG001|NOT COMPLETED|Overall Study||0||
48605479|NCT00162097|101819766|FG002|NOT COMPLETED|Overall Study||0||
48605480|NCT00162097|101819767|FG003|NOT COMPLETED|Overall Study||1||
48605481|NCT00849290|101819768|FG000|STARTED|Overall Study||113||
48605482|NCT00849290|101819768|FG000|COMPLETED|Overall Study||58||
48605483|NCT00849290|101819768|FG000|NOT COMPLETED|Overall Study||55||
48605484|NCT00423358|101819769|FG000|STARTED|Overall Study||11||
48605485|NCT00423358|101819770|FG001|STARTED|Overall Study||11||
48605486|NCT00423358|101819769|FG000|COMPLETED|Overall Study||11||
48605487|NCT00423358|101819770|FG001|COMPLETED|Overall Study||11||
48605488|NCT00423358|101819769|FG000|NOT COMPLETED|Overall Study||0||
48605489|NCT00423358|101819770|FG001|NOT COMPLETED|Overall Study||0||
48605490|NCT01990768|101819771|FG000|STARTED|Intervention Started||345||
48605491|NCT01990768|101819772|FG001|STARTED|Intervention Started||345||
48605492|NCT01990768|101819773|FG002|STARTED|Intervention Started||373||
48605493|NCT01990768|101819771|FG000|COMPLETED|Intervention Started||309||
48605494|NCT01990768|101819772|FG001|COMPLETED|Intervention Started||312||
48605495|NCT01990768|101819773|FG002|COMPLETED|Intervention Started||346||
48605496|NCT01990768|101819771|FG000|NOT COMPLETED|Intervention Started||36||
48605497|NCT01990768|101819772|FG001|NOT COMPLETED|Intervention Started||33||
48605498|NCT01990768|101819773|FG002|NOT COMPLETED|Intervention Started||27||
48605499|NCT01990768|101819771|FG000|STARTED|Prehospital Study Drug Infusion||309||
48605500|NCT01990768|101819772|FG001|STARTED|Prehospital Study Drug Infusion||312||
48605501|NCT01990768|101819773|FG002|STARTED|Prehospital Study Drug Infusion||346||
48605502|NCT01990768|101819771|FG000|COMPLETED|Prehospital Study Drug Infusion||290||
48605503|NCT01990768|101819772|FG001|COMPLETED|Prehospital Study Drug Infusion||285||
48605504|NCT01990768|101819773|FG002|COMPLETED|Prehospital Study Drug Infusion||327||
48605505|NCT01990768|101819771|FG000|NOT COMPLETED|Prehospital Study Drug Infusion||19||
48605506|NCT01990768|101819772|FG001|NOT COMPLETED|Prehospital Study Drug Infusion||27||
48605507|NCT01990768|101819773|FG002|NOT COMPLETED|Prehospital Study Drug Infusion||19||
48605508|NCT01990768|101819771|FG000|STARTED|In-Hospital Study Drug Infusion||309||
48605509|NCT01990768|101819772|FG001|STARTED|In-Hospital Study Drug Infusion||312||
48605510|NCT01990768|101819773|FG002|STARTED|In-Hospital Study Drug Infusion||346||
48605511|NCT01990768|101819771|FG000|COMPLETED|In-Hospital Study Drug Infusion||214||
48605512|NCT01990768|101819772|FG001|COMPLETED|In-Hospital Study Drug Infusion||229||
48605513|NCT01990768|101819773|FG002|COMPLETED|In-Hospital Study Drug Infusion||266||
48605514|NCT01990768|101819771|FG000|NOT COMPLETED|In-Hospital Study Drug Infusion||95||
48605515|NCT01990768|101819772|FG001|NOT COMPLETED|In-Hospital Study Drug Infusion||83||
48605516|NCT01990768|101819773|FG002|NOT COMPLETED|In-Hospital Study Drug Infusion||80||
48605517|NCT01990768|101819771|FG000|STARTED|6-Month Follow-up||309||
48605518|NCT01990768|101819772|FG001|STARTED|6-Month Follow-up||312||
48605519|NCT01990768|101819773|FG002|STARTED|6-Month Follow-up||346||
48605520|NCT01990768|101819771|FG000|COMPLETED|6-Month Follow-up||270||
48605521|NCT01990768|101819772|FG001|COMPLETED|6-Month Follow-up||261||
48605522|NCT01990768|101819773|FG002|COMPLETED|6-Month Follow-up||288||
48605523|NCT01990768|101819771|FG000|NOT COMPLETED|6-Month Follow-up||39||
48605524|NCT01990768|101819772|FG001|NOT COMPLETED|6-Month Follow-up||51||
48605525|NCT01990768|101819773|FG002|NOT COMPLETED|6-Month Follow-up||58||
48605526|NCT00631163|101819774|FG000|STARTED|Number of Participants in Year 1||102||
48605527|NCT00631163|101819774|FG000|COMPLETED|Number of Participants in Year 1||68||
48605528|NCT00631163|101819774|FG000|NOT COMPLETED|Number of Participants in Year 1||34||
48605529|NCT00631163|101819774|FG000|STARTED|Number of Participants in Year 2||57||
48303157|NCT03326895|101070070|FG000|STARTED|Overall Study||168|168|
48303158|NCT03326895|101070070|FG000|COMPLETED|Overall Study||168|168|
48303159|NCT03326895|101070070|FG000|NOT COMPLETED|Overall Study||0||
48303160|NCT02092350|101070071|FG000|STARTED|Overall Study||123||
48303161|NCT02092350|101070072|FG001|STARTED|Overall Study||114||
48303162|NCT02092350|101070071|FG000|COMPLETED|Overall Study||113||
48303163|NCT02092350|101070072|FG001|COMPLETED|Overall Study||102||
48303164|NCT02092350|101070071|FG000|NOT COMPLETED|Overall Study||10||
48303165|NCT02092350|101070072|FG001|NOT COMPLETED|Overall Study||12||
48303166|NCT01184053|101070073|FG000|STARTED|Overall Study||3||
48303167|NCT01184053|101070073|FG000|COMPLETED|Overall Study||0||
48303168|NCT01184053|101070073|FG000|NOT COMPLETED|Overall Study||3||
48303169|NCT02257957|101070074|FG000|STARTED|Overall Study||15||
48303170|NCT02257957|101070075|FG001|STARTED|Overall Study||15||
48303171|NCT02257957|101070074|FG000|COMPLETED|Overall Study||15||
48303172|NCT02257957|101070075|FG001|COMPLETED|Overall Study||15||
48303173|NCT02257957|101070074|FG000|NOT COMPLETED|Overall Study||0||
48303174|NCT02257957|101070075|FG001|NOT COMPLETED|Overall Study||0||
48303175|NCT02945150|101070076|FG000|STARTED|Overall Study||8||
48303176|NCT02945150|101070076|FG000|SVR12|Overall Study||8||
48605530|NCT00631163|101819774|FG000|COMPLETED|Number of Participants in Year 2||52||
48605531|NCT00631163|101819774|FG000|NOT COMPLETED|Number of Participants in Year 2||5||
48605532|NCT00978341|101819775|FG000|STARTED|First Intervention||8||
48605533|NCT00978341|101819776|FG001|STARTED|First Intervention||7||
48605534|NCT00978341|101819775|FG000|COMPLETED|First Intervention||8||
48605535|NCT00978341|101819776|FG001|COMPLETED|First Intervention||7||
48605536|NCT00978341|101819775|FG000|NOT COMPLETED|First Intervention||0||
48605537|NCT00978341|101819776|FG001|NOT COMPLETED|First Intervention||0||
48605538|NCT00978341|101819775|FG000|STARTED|Washout Period of 2 Weeks||8||
48605539|NCT00978341|101819776|FG001|STARTED|Washout Period of 2 Weeks||7||
48605540|NCT00978341|101819775|FG000|COMPLETED|Washout Period of 2 Weeks||7||
48605541|NCT00978341|101819776|FG001|COMPLETED|Washout Period of 2 Weeks||7||
48605542|NCT00978341|101819775|FG000|NOT COMPLETED|Washout Period of 2 Weeks||1||
48303177|NCT02945150|101070076|FG000|COMPLETED|Overall Study||8||
48303178|NCT02945150|101070076|FG000|NOT COMPLETED|Overall Study||0||
48303179|NCT00592761|101070077|FG000|STARTED|First Intervention (2 Weeks)||9||
48303180|NCT00592761|101070078|FG001|STARTED|First Intervention (2 Weeks)||9||
48303181|NCT00592761|101070077|FG000|COMPLETED|First Intervention (2 Weeks)||9||
48303182|NCT00592761|101070078|FG001|COMPLETED|First Intervention (2 Weeks)||9||
48605543|NCT00978341|101819776|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0||
48605544|NCT00978341|101819775|FG000|STARTED|Second Intervention||7||
48605545|NCT00978341|101819776|FG001|STARTED|Second Intervention||7||
48605546|NCT00978341|101819775|FG000|COMPLETED|Second Intervention||7||
48605547|NCT00978341|101819776|FG001|COMPLETED|Second Intervention||7||
48605548|NCT00978341|101819775|FG000|NOT COMPLETED|Second Intervention||0||
48605549|NCT00978341|101819776|FG001|NOT COMPLETED|Second Intervention||0||
48605550|NCT00154375|101819777|FG000|STARTED|Overall Study||120||
48605551|NCT00154375|101819778|FG001|STARTED|Overall Study||120||
48605552|NCT00154375|101819777|FG000|Discontinued Study Treatment|Overall Study||111||
48605553|NCT00154375|101819778|FG001|Discontinued Study Treatment|Overall Study||104||
48605554|NCT00154375|101819777|FG000|Not Exposed to Study Treatment|Overall Study||2||
48605555|NCT00154375|101819778|FG001|Not Exposed to Study Treatment|Overall Study||2||
48605556|NCT00154375|101819777|FG000|COMPLETED|Overall Study||7||
48605557|NCT00154375|101819778|FG001|COMPLETED|Overall Study||14||
48605558|NCT00154375|101819777|FG000|NOT COMPLETED|Overall Study||113||
48605559|NCT00154375|101819778|FG001|NOT COMPLETED|Overall Study||106||
48605560|NCT02869893|101819779|FG000|STARTED|Overall Study||57||
48605561|NCT02869893|101819779|FG000|COMPLETED|Overall Study||50||
48605562|NCT02869893|101819779|FG000|NOT COMPLETED|Overall Study||7||
48605563|NCT03488563|101819780|FG000|STARTED|Overall Study||105|Number of subjects treated with study drug.|
48605564|NCT03488563|101819781|FG001|STARTED|Overall Study||104|Number of subjects treated with study drug.|
48605565|NCT03488563|101819782|FG002|STARTED|Overall Study||104|Number of subjects treated with study drug.|
48303183|NCT00592761|101070077|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0||
48303184|NCT00592761|101070078|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0||
48303185|NCT00592761|101070077|FG000|STARTED|Second Intervention (2 Weeks)||9||
48303186|NCT00592761|101070078|FG001|STARTED|Second Intervention (2 Weeks)||9||
48303187|NCT00592761|101070077|FG000|COMPLETED|Second Intervention (2 Weeks)||9||
48303188|NCT00592761|101070078|FG001|COMPLETED|Second Intervention (2 Weeks)||9||
48605566|NCT03488563|101819780|FG000|COMPLETED|Overall Study||83||
48605567|NCT03488563|101819781|FG001|COMPLETED|Overall Study||88||
48605568|NCT03488563|101819782|FG002|COMPLETED|Overall Study||81||
48605569|NCT03488563|101819780|FG000|NOT COMPLETED|Overall Study||22||
48605570|NCT03488563|101819781|FG001|NOT COMPLETED|Overall Study||16||
48605571|NCT03488563|101819782|FG002|NOT COMPLETED|Overall Study||23||
48605572|NCT01607853|101819783|FG000|STARTED|Overall Study||24||
48605573|NCT01607853|101819783|FG000|COMPLETED|Overall Study||24||
48605574|NCT01607853|101819783|FG000|NOT COMPLETED|Overall Study||0||
48605575|NCT02849171|101819784|FG000|STARTED|Overall Study||8||
48605576|NCT02849171|101819784|FG000|COMPLETED|Overall Study||6||
48605577|NCT02849171|101819784|FG000|NOT COMPLETED|Overall Study||2||
48605578|NCT02598778|101819785|FG000|STARTED|Overall Study||2||
48605579|NCT02598778|101819786|FG001|STARTED|Overall Study||4||
48605580|NCT02598778|101819787|FG002|STARTED|Overall Study||4||
48605581|NCT02598778|101819788|FG003|STARTED|Overall Study||2||
48605582|NCT02598778|101819785|FG000|COMPLETED|Overall Study||2||
48605583|NCT02598778|101819786|FG001|COMPLETED|Overall Study||4||
48605584|NCT02598778|101819787|FG002|COMPLETED|Overall Study||4||
48605585|NCT02598778|101819788|FG003|COMPLETED|Overall Study||2||
48605586|NCT02598778|101819785|FG000|NOT COMPLETED|Overall Study||0||
48605587|NCT02598778|101819786|FG001|NOT COMPLETED|Overall Study||0||
48605588|NCT02598778|101819787|FG002|NOT COMPLETED|Overall Study||0||
48605589|NCT02598778|101819788|FG003|NOT COMPLETED|Overall Study||0||
48605590|NCT00826150|101819789|FG000|STARTED|Overall Study||8||
48605591|NCT00826150|101819790|FG001|STARTED|Overall Study||3||
48605592|NCT00826150|101819791|FG002|STARTED|Overall Study||3||
48605593|NCT00826150|101819789|FG000|COMPLETED|Overall Study||2||
48605594|NCT00826150|101819790|FG001|COMPLETED|Overall Study||1||
48605595|NCT00826150|101819791|FG002|COMPLETED|Overall Study||0||
48605596|NCT00826150|101819789|FG000|NOT COMPLETED|Overall Study||6||
48605597|NCT00826150|101819790|FG001|NOT COMPLETED|Overall Study||2||
48605598|NCT00826150|101819791|FG002|NOT COMPLETED|Overall Study||3||
48605599|NCT00255840|101819792|FG000|STARTED|Overall Study||408||
48605600|NCT00255840|101819793|FG001|STARTED|Overall Study||404||
48605601|NCT00255840|101819792|FG000|COMPLETED|Overall Study||345||
48605602|NCT00255840|101819793|FG001|COMPLETED|Overall Study||334||
48605603|NCT00255840|101819792|FG000|NOT COMPLETED|Overall Study||63||
48605604|NCT00255840|101819793|FG001|NOT COMPLETED|Overall Study||70||
48605605|NCT00459368|101819794|FG000|STARTED|Overall Study||1335||
48605606|NCT00459368|101819795|FG001|STARTED|Overall Study||1363||
48605607|NCT00459368|101819794|FG000|COMPLETED|Overall Study||1040||
48605608|NCT00459368|101819795|FG001|COMPLETED|Overall Study||1034||
48605609|NCT00459368|101819794|FG000|NOT COMPLETED|Overall Study||295||
48605610|NCT00459368|101819795|FG001|NOT COMPLETED|Overall Study||329||
48605611|NCT02113007|101819796|FG000|STARTED|Overall Study||2||
48605612|NCT02113007|101819796|FG000|COMPLETED|Overall Study||0||
48303189|NCT00592761|101070077|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48303190|NCT00592761|101070078|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48303191|NCT00992511|101070079|FG000|STARTED|Overall Study||76||
48605613|NCT02113007|101819796|FG000|NOT COMPLETED|Overall Study||2||
48605614|NCT00329745|101819797|FG000|STARTED|Overall Study||4359||
48605615|NCT00329745|101819798|FG001|STARTED|Overall Study||4328||
48605616|NCT00329745|101819797|FG000|COMPLETED|Overall Study||4272||
48605617|NCT00329745|101819798|FG001|COMPLETED|Overall Study||4226||
48605618|NCT00329745|101819797|FG000|NOT COMPLETED|Overall Study||87||
48605619|NCT00329745|101819798|FG001|NOT COMPLETED|Overall Study||102||
48605620|NCT03538691|101819799|FG000|STARTED|Phase A: Acute Treatment (up to 8 Weeks)||1149||
48605621|NCT03538691|101819800|FG001|STARTED|Phase A: Acute Treatment (up to 8 Weeks)||0||
48605622|NCT03538691|101819801|FG002|STARTED|Phase A: Acute Treatment (up to 8 Weeks)||0||
48605623|NCT03538691|101819802|FG003|STARTED|Phase A: Acute Treatment (up to 8 Weeks)||0||
48605624|NCT03538691|101819799|FG000|Phase A Safety Sample|Phase A: Acute Treatment (up to 8 Weeks)||1136|The Phase A Safety Sample included all participants who received at least 1 dose of brexpiprazole in Phase A.|
48605625|NCT03538691|101819800|FG001|Phase A Safety Sample|Phase A: Acute Treatment (up to 8 Weeks)||0|The Phase A Safety Sample included all participants who received at least 1 dose of brexpiprazole in Phase A.|
48605626|NCT03538691|101819801|FG002|Phase A Safety Sample|Phase A: Acute Treatment (up to 8 Weeks)||0|The Phase A Safety Sample included all participants who received at least 1 dose of brexpiprazole in Phase A.|
48605627|NCT03538691|101819802|FG003|Phase A Safety Sample|Phase A: Acute Treatment (up to 8 Weeks)||0|The Phase A Safety Sample included all participants who received at least 1 dose of brexpiprazole in Phase A.|
48605628|NCT03538691|101819799|FG000|COMPLETED|Phase A: Acute Treatment (up to 8 Weeks)||766||
48605629|NCT03538691|101819800|FG001|COMPLETED|Phase A: Acute Treatment (up to 8 Weeks)||0||
48605630|NCT03538691|101819801|FG002|COMPLETED|Phase A: Acute Treatment (up to 8 Weeks)||0||
48605631|NCT03538691|101819802|FG003|COMPLETED|Phase A: Acute Treatment (up to 8 Weeks)||0||
48605632|NCT03538691|101819799|FG000|NOT COMPLETED|Phase A: Acute Treatment (up to 8 Weeks)||383||
48605633|NCT03538691|101819800|FG001|NOT COMPLETED|Phase A: Acute Treatment (up to 8 Weeks)||0||
48657078|NCT03648372|101943776|FG019|COMPLETED|Overall Study||2||
48605634|NCT03538691|101819801|FG002|NOT COMPLETED|Phase A: Acute Treatment (up to 8 Weeks)||0||
48605635|NCT03538691|101819802|FG003|NOT COMPLETED|Phase A: Acute Treatment (up to 8 Weeks)||0||
48605636|NCT03538691|101819799|FG000|STARTED|Phase B: Stabilization (12 Weeks)||0||
48605637|NCT03538691|101819800|FG001|STARTED|Phase B: Stabilization (12 Weeks)||766||
48605638|NCT03538691|101819801|FG002|STARTED|Phase B: Stabilization (12 Weeks)||0||
48605639|NCT03538691|101819802|FG003|STARTED|Phase B: Stabilization (12 Weeks)||0||
48605640|NCT03538691|101819799|FG000|Phase B Safety Sample|Phase B: Stabilization (12 Weeks)||0|The Phase B Safety Sample included all participants who received at least 1 dose of brexpiprazole in Phase B.|
48605641|NCT03538691|101819800|FG001|Phase B Safety Sample|Phase B: Stabilization (12 Weeks)||765|The Phase B Safety Sample included all participants who received at least 1 dose of brexpiprazole in Phase B.|
48605642|NCT03538691|101819801|FG002|Phase B Safety Sample|Phase B: Stabilization (12 Weeks)||0|The Phase B Safety Sample included all participants who received at least 1 dose of brexpiprazole in Phase B.|
48605643|NCT03538691|101819802|FG003|Phase B Safety Sample|Phase B: Stabilization (12 Weeks)||0|The Phase B Safety Sample included all participants who received at least 1 dose of brexpiprazole in Phase B.|
48605644|NCT03538691|101819799|FG000|COMPLETED|Phase B: Stabilization (12 Weeks)||0||
48605645|NCT03538691|101819800|FG001|COMPLETED|Phase B: Stabilization (12 Weeks)||489||
48605646|NCT03538691|101819801|FG002|COMPLETED|Phase B: Stabilization (12 Weeks)||0||
48605647|NCT03538691|101819802|FG003|COMPLETED|Phase B: Stabilization (12 Weeks)||0||
48605648|NCT03538691|101819799|FG000|NOT COMPLETED|Phase B: Stabilization (12 Weeks)||0||
48605649|NCT03538691|101819800|FG001|NOT COMPLETED|Phase B: Stabilization (12 Weeks)||277||
48605650|NCT03538691|101819801|FG002|NOT COMPLETED|Phase B: Stabilization (12 Weeks)||0||
48605651|NCT03538691|101819802|FG003|NOT COMPLETED|Phase B: Stabilization (12 Weeks)||0||
48605652|NCT03538691|101819799|FG000|STARTED|Phase C:Randomized Withdrawal (26 Weeks)||0||
48605653|NCT03538691|101819800|FG001|STARTED|Phase C:Randomized Withdrawal (26 Weeks)||0||
48605654|NCT03538691|101819801|FG002|STARTED|Phase C:Randomized Withdrawal (26 Weeks)||240||
48605655|NCT03538691|101819802|FG003|STARTED|Phase C:Randomized Withdrawal (26 Weeks)||249||
48605656|NCT03538691|101819799|FG000|Phase C Safety Sample|Phase C:Randomized Withdrawal (26 Weeks)||0|The Phase C Safety Sample included all participants who were randomized to double-blind treatment and received at least 1 dose of double-blind trial medication in Phase C.|
48605657|NCT03538691|101819800|FG001|Phase C Safety Sample|Phase C:Randomized Withdrawal (26 Weeks)||0|The Phase C Safety Sample included all participants who were randomized to double-blind treatment and received at least 1 dose of double-blind trial medication in Phase C.|
48605658|NCT03538691|101819801|FG002|Phase C Safety Sample|Phase C:Randomized Withdrawal (26 Weeks)||240|The Phase C Safety Sample included all participants who were randomized to double-blind treatment and received at least 1 dose of double-blind trial medication in Phase C.|
48605659|NCT03538691|101819802|FG003|Phase C Safety Sample|Phase C:Randomized Withdrawal (26 Weeks)||248|The Phase C Safety Sample included all participants who were randomized to double-blind treatment and received at least 1 dose of double-blind trial medication in Phase C.|
48605660|NCT03538691|101819799|FG000|COMPLETED|Phase C:Randomized Withdrawal (26 Weeks)||0||
48605661|NCT03538691|101819800|FG001|COMPLETED|Phase C:Randomized Withdrawal (26 Weeks)||0||
48605662|NCT03538691|101819801|FG002|COMPLETED|Phase C:Randomized Withdrawal (26 Weeks)||120||
48605663|NCT03538691|101819802|FG003|COMPLETED|Phase C:Randomized Withdrawal (26 Weeks)||131||
48605664|NCT03538691|101819799|FG000|NOT COMPLETED|Phase C:Randomized Withdrawal (26 Weeks)||0||
48605665|NCT03538691|101819800|FG001|NOT COMPLETED|Phase C:Randomized Withdrawal (26 Weeks)||0||
48605666|NCT03538691|101819801|FG002|NOT COMPLETED|Phase C:Randomized Withdrawal (26 Weeks)||120||
48605667|NCT03538691|101819802|FG003|NOT COMPLETED|Phase C:Randomized Withdrawal (26 Weeks)||118||
48605668|NCT02740335|101819803|FG000|STARTED|Overall Study||105||
48605669|NCT02740335|101819804|FG001|STARTED|Overall Study||103||
48605670|NCT02740335|101819803|FG000|COMPLETED|Overall Study||105||
48605671|NCT02740335|101819804|FG001|COMPLETED|Overall Study||103||
48605672|NCT02740335|101819803|FG000|NOT COMPLETED|Overall Study||0||
48605673|NCT02740335|101819804|FG001|NOT COMPLETED|Overall Study||0||
48605674|NCT03780972|101819805|FG000|STARTED|Overall Study||4||
48605675|NCT03780972|101819806|FG001|STARTED|Overall Study||4||
48605676|NCT03780972|101819807|FG002|STARTED|Overall Study||4||
48605677|NCT03780972|101819808|FG003|STARTED|Overall Study||2||
48605678|NCT03780972|101819805|FG000|COMPLETED|Overall Study||4||
48605679|NCT03780972|101819806|FG001|COMPLETED|Overall Study||4||
48605680|NCT03780972|101819807|FG002|COMPLETED|Overall Study||4||
48605681|NCT03780972|101819808|FG003|COMPLETED|Overall Study||2||
48605682|NCT03780972|101819805|FG000|NOT COMPLETED|Overall Study||0||
48605683|NCT03780972|101819806|FG001|NOT COMPLETED|Overall Study||0||
48605684|NCT03780972|101819807|FG002|NOT COMPLETED|Overall Study||0||
48605685|NCT03780972|101819808|FG003|NOT COMPLETED|Overall Study||0||
48605686|NCT02984644|101819809|FG000|STARTED|Overall Study||20||
48605687|NCT02984644|101819810|FG001|STARTED|Overall Study||10||
48605688|NCT02984644|101819809|FG000|COMPLETED|Overall Study||20||
48605689|NCT02984644|101819810|FG001|COMPLETED|Overall Study||10||
48605690|NCT02984644|101819809|FG000|NOT COMPLETED|Overall Study||0||
48605691|NCT02984644|101819810|FG001|NOT COMPLETED|Overall Study||0||
48605692|NCT02036541|101819811|FG000|STARTED|Overall Study||65||
48605693|NCT02036541|101819811|FG000|Completed Endpoint Visit|Overall Study||54||
48605694|NCT02036541|101819811|FG000|COMPLETED|Overall Study||49||
48605695|NCT02036541|101819811|FG000|NOT COMPLETED|Overall Study||16||
48605696|NCT03411902|101819812|FG000|STARTED|Overall Study||11||
48605697|NCT03411902|101819813|FG001|STARTED|Overall Study||13||
48605698|NCT03411902|101819812|FG000|COMPLETED|Overall Study||8||
48605699|NCT03411902|101819813|FG001|COMPLETED|Overall Study||13||
48605700|NCT03411902|101819812|FG000|NOT COMPLETED|Overall Study||3||
48605701|NCT03411902|101819813|FG001|NOT COMPLETED|Overall Study||0||
48605702|NCT00305565|101819814|FG000|STARTED|Overall Study (Safety Population)||111||
48605703|NCT00305565|101819815|FG001|STARTED|Overall Study (Safety Population)||107||
48605704|NCT00305565|101819816|FG002|STARTED|Overall Study (Safety Population)||113||
48605705|NCT00305565|101819814|FG000|COMPLETED|Overall Study (Safety Population)||97||
48605706|NCT00305565|101819815|FG001|COMPLETED|Overall Study (Safety Population)||95||
48605707|NCT00305565|101819816|FG002|COMPLETED|Overall Study (Safety Population)||106||
48605708|NCT00305565|101819814|FG000|NOT COMPLETED|Overall Study (Safety Population)||14||
48605709|NCT00305565|101819815|FG001|NOT COMPLETED|Overall Study (Safety Population)||12||
48605710|NCT00305565|101819816|FG002|NOT COMPLETED|Overall Study (Safety Population)||7||
48605711|NCT00305565|101819814|FG000|STARTED|Overall Study (ITT Population)||102||
48605712|NCT00305565|101819815|FG001|STARTED|Overall Study (ITT Population)||101||
48605713|NCT00305565|101819816|FG002|STARTED|Overall Study (ITT Population)||107||
48605714|NCT00305565|101819814|FG000|COMPLETED|Overall Study (ITT Population)||89||
48605715|NCT00305565|101819815|FG001|COMPLETED|Overall Study (ITT Population)||90||
48605716|NCT00305565|101819816|FG002|COMPLETED|Overall Study (ITT Population)||102||
48605717|NCT00305565|101819814|FG000|NOT COMPLETED|Overall Study (ITT Population)||13||
48605718|NCT00305565|101819815|FG001|NOT COMPLETED|Overall Study (ITT Population)||11||
48605719|NCT00305565|101819816|FG002|NOT COMPLETED|Overall Study (ITT Population)||5||
48605720|NCT00895934|101819817|FG000|STARTED|Dose Escalation||3||
48605721|NCT00895934|101819818|FG001|STARTED|Dose Escalation||3||
48605722|NCT00895934|101819819|FG002|STARTED|Dose Escalation||3||
48605723|NCT00895934|101819820|FG003|STARTED|Dose Escalation||6||
48605724|NCT00895934|101819817|FG000|COMPLETED|Dose Escalation||3||
48605725|NCT00895934|101819818|FG001|COMPLETED|Dose Escalation||3||
48605726|NCT00895934|101819819|FG002|COMPLETED|Dose Escalation||3||
48605727|NCT00895934|101819820|FG003|COMPLETED|Dose Escalation||6||
48605728|NCT00895934|101819817|FG000|NOT COMPLETED|Dose Escalation||0||
48605729|NCT00895934|101819818|FG001|NOT COMPLETED|Dose Escalation||0||
48605730|NCT00895934|101819819|FG002|NOT COMPLETED|Dose Escalation||0||
48605731|NCT00895934|101819820|FG003|NOT COMPLETED|Dose Escalation||0||
48605732|NCT00895934|101819817|FG000|STARTED|Efficacy of Most Tolerated Dose||0||
48605733|NCT00895934|101819818|FG001|STARTED|Efficacy of Most Tolerated Dose||0||
48605734|NCT00895934|101819819|FG002|STARTED|Efficacy of Most Tolerated Dose||0||
48605735|NCT00895934|101819820|FG003|STARTED|Efficacy of Most Tolerated Dose||37||
48605736|NCT00895934|101819817|FG000|COMPLETED|Efficacy of Most Tolerated Dose||0||
48605737|NCT00895934|101819818|FG001|COMPLETED|Efficacy of Most Tolerated Dose||0||
48605738|NCT00895934|101819819|FG002|COMPLETED|Efficacy of Most Tolerated Dose||0||
48605739|NCT00895934|101819820|FG003|COMPLETED|Efficacy of Most Tolerated Dose||37||
48605740|NCT00895934|101819817|FG000|NOT COMPLETED|Efficacy of Most Tolerated Dose||0||
48605741|NCT00895934|101819818|FG001|NOT COMPLETED|Efficacy of Most Tolerated Dose||0||
48605742|NCT00895934|101819819|FG002|NOT COMPLETED|Efficacy of Most Tolerated Dose||0||
48605743|NCT00895934|101819820|FG003|NOT COMPLETED|Efficacy of Most Tolerated Dose||0||
48605744|NCT01911793|101819821|FG000|STARTED|Overall Study||1||
48605745|NCT01911793|101819822|FG001|STARTED|Overall Study||5||
48605746|NCT01911793|101819821|FG000|COMPLETED|Overall Study||0||
48605747|NCT01911793|101819822|FG001|COMPLETED|Overall Study||0||
48605748|NCT01911793|101819821|FG000|NOT COMPLETED|Overall Study||1||
48605749|NCT01911793|101819822|FG001|NOT COMPLETED|Overall Study||5||
48605750|NCT00357890|101819823|FG000|STARTED|Overall Study||6||
48605751|NCT00357890|101819824|FG001|STARTED|Overall Study||6||
48605752|NCT00357890|101819823|FG000|COMPLETED|Overall Study||6||
48605753|NCT00357890|101819824|FG001|COMPLETED|Overall Study||6||
48605754|NCT00357890|101819823|FG000|NOT COMPLETED|Overall Study||0||
48605755|NCT00357890|101819824|FG001|NOT COMPLETED|Overall Study||0||
48605756|NCT00264290|101819825|FG000|STARTED|Intervention (8 Weeks)||16||
48605757|NCT00264290|101819826|FG001|STARTED|Intervention (8 Weeks)||14||
48605758|NCT00264290|101819825|FG000|COMPLETED|Intervention (8 Weeks)||15||
48605759|NCT00264290|101819826|FG001|COMPLETED|Intervention (8 Weeks)||14||
48148580|NCT04307004|100685226|FG001|COMPLETED|Randomization 2||0||
48148581|NCT04307004|100685227|FG002|COMPLETED|Randomization 2||302||
48148582|NCT04307004|100685228|FG003|COMPLETED|Randomization 2||301||
48148583|NCT04307004|100685225|FG000|NOT COMPLETED|Randomization 2||0||
48605760|NCT00264290|101819825|FG000|NOT COMPLETED|Intervention (8 Weeks)||1||
48605761|NCT00264290|101819826|FG001|NOT COMPLETED|Intervention (8 Weeks)||0||
48605762|NCT00264290|101819825|FG000|STARTED|Observation (4 Weeks)||15||
48605763|NCT00264290|101819826|FG001|STARTED|Observation (4 Weeks)||14||
48605764|NCT00264290|101819825|FG000|COMPLETED|Observation (4 Weeks)||15||
48605765|NCT00264290|101819826|FG001|COMPLETED|Observation (4 Weeks)||14||
48605766|NCT00264290|101819825|FG000|NOT COMPLETED|Observation (4 Weeks)||0||
48605767|NCT00264290|101819826|FG001|NOT COMPLETED|Observation (4 Weeks)||0||
48605768|NCT02669043|101819827|FG000|STARTED|Overall Study||8||
48605769|NCT02669043|101819827|FG000|COMPLETED|Overall Study||4||
48148584|NCT04307004|100685226|FG001|NOT COMPLETED|Randomization 2||0||
48148585|NCT04307004|100685227|FG002|NOT COMPLETED|Randomization 2||28||
48148586|NCT04307004|100685228|FG003|NOT COMPLETED|Randomization 2||23||
48148587|NCT02436330|100685229|FG000|STARTED|Cohort 1||14||
48148588|NCT02436330|100685230|FG001|STARTED|Cohort 1||4||
48148589|NCT02436330|100685229|FG000|COMPLETED|Cohort 1||9||
48148590|NCT02436330|100685230|FG001|COMPLETED|Cohort 1||1||
48148591|NCT02436330|100685229|FG000|NOT COMPLETED|Cohort 1||5||
48148592|NCT02436330|100685230|FG001|NOT COMPLETED|Cohort 1||3||
48148593|NCT02436330|100685229|FG000|STARTED|Cohort 2||14||
48148594|NCT02436330|100685230|FG001|STARTED|Cohort 2||10||
48148595|NCT02436330|100685229|FG000|COMPLETED|Cohort 2||10||
48148596|NCT02436330|100685230|FG001|COMPLETED|Cohort 2||7||
48148597|NCT02436330|100685229|FG000|NOT COMPLETED|Cohort 2||4||
48148598|NCT02436330|100685230|FG001|NOT COMPLETED|Cohort 2||3||
48148599|NCT02436330|100685229|FG000|STARTED|Cohort 3||12||
48148600|NCT02436330|100685230|FG001|STARTED|Cohort 3||0||
48148601|NCT02436330|100685229|FG000|COMPLETED|Cohort 3||7||
48148602|NCT02436330|100685230|FG001|COMPLETED|Cohort 3||0||
48148603|NCT02436330|100685229|FG000|NOT COMPLETED|Cohort 3||5||
48148604|NCT02436330|100685230|FG001|NOT COMPLETED|Cohort 3||0||
48148605|NCT02436330|100685229|FG000|STARTED|Cohort 4||6||
48148606|NCT02436330|100685230|FG001|STARTED|Cohort 4||0||
48148607|NCT02436330|100685229|FG000|COMPLETED|Cohort 4||4||
48148608|NCT02436330|100685230|FG001|COMPLETED|Cohort 4||0||
48148609|NCT02436330|100685229|FG000|NOT COMPLETED|Cohort 4||2||
48148610|NCT02436330|100685230|FG001|NOT COMPLETED|Cohort 4||0||
48148611|NCT02436330|100685229|FG000|STARTED|Cohort 5||10||
48148612|NCT02436330|100685230|FG001|STARTED|Cohort 5||5||
48148613|NCT02436330|100685229|FG000|COMPLETED|Cohort 5||4||
48715726|NCT02513823|102091743|FG000|COMPLETED|Overall Study||22||
48715727|NCT02513823|102091743|FG000|NOT COMPLETED|Overall Study||5||
48715728|NCT01591863|102091744|FG000|STARTED|Overall Study||38||
48715729|NCT01591863|102091744|FG000|COMPLETED|Overall Study||24||
48715730|NCT01591863|102091744|FG000|NOT COMPLETED|Overall Study||14||
48715731|NCT03322423|102091745|FG000|STARTED|Period 1||38||
48715732|NCT03322423|102091746|FG001|STARTED|Period 1||40||
48715733|NCT03322423|102091745|FG000|COMPLETED|Period 1||36||
48715734|NCT03322423|102091746|FG001|COMPLETED|Period 1||38||
48715735|NCT03322423|102091745|FG000|NOT COMPLETED|Period 1||2||
48715736|NCT03322423|102091746|FG001|NOT COMPLETED|Period 1||2||
48715737|NCT03322423|102091745|FG000|STARTED|Period 2||36||
48715738|NCT03322423|102091746|FG001|STARTED|Period 2||38||
48148614|NCT02436330|100685230|FG001|COMPLETED|Cohort 5||1||
48148615|NCT02436330|100685229|FG000|NOT COMPLETED|Cohort 5||6||
48148616|NCT02436330|100685230|FG001|NOT COMPLETED|Cohort 5||4||
48148617|NCT02436330|100685229|FG000|STARTED|Cohort 6||4||
48148618|NCT02436330|100685230|FG001|STARTED|Cohort 6||5||
48715739|NCT03322423|102091745|FG000|COMPLETED|Period 2||35||
48715740|NCT03322423|102091746|FG001|COMPLETED|Period 2||36||
48148619|NCT02436330|100685229|FG000|COMPLETED|Cohort 6||1||
48148620|NCT02436330|100685230|FG001|COMPLETED|Cohort 6||4||
48148621|NCT02436330|100685229|FG000|NOT COMPLETED|Cohort 6||3||
48148622|NCT02436330|100685230|FG001|NOT COMPLETED|Cohort 6||1||
48148623|NCT01982240|100685231|FG000|STARTED|Overall Study||452||
48148624|NCT01982240|100685232|FG001|STARTED|Overall Study||453||
48148625|NCT01982240|100685233|FG002|STARTED|Overall Study||441||
48148626|NCT01982240|100685231|FG000|COMPLETED|Overall Study||385||
48148627|NCT01982240|100685232|FG001|COMPLETED|Overall Study||384||
48148628|NCT01982240|100685233|FG002|COMPLETED|Overall Study||371||
48148629|NCT01982240|100685231|FG000|NOT COMPLETED|Overall Study||67||
48148630|NCT01982240|100685232|FG001|NOT COMPLETED|Overall Study||69||
48148631|NCT01982240|100685233|FG002|NOT COMPLETED|Overall Study||70||
48148632|NCT01596582|100685234|FG000|STARTED|Overall Study||172||
48148633|NCT01596582|100685235|FG001|STARTED|Overall Study||180||
48148634|NCT01596582|100685234|FG000|COMPLETED|Overall Study||168||
48148635|NCT01596582|100685235|FG001|COMPLETED|Overall Study||173||
48148636|NCT01596582|100685234|FG000|NOT COMPLETED|Overall Study||4||
48148637|NCT01596582|100685235|FG001|NOT COMPLETED|Overall Study||7||
48148638|NCT01559844|100688519|FG000|STARTED|Overall Study||61||
48148639|NCT01559844|100688519|FG000|COMPLETED|Overall Study||36||
48148640|NCT01559844|100688519|FG000|NOT COMPLETED|Overall Study||25||
48148641|NCT01955954|100688520|FG000|STARTED|Overall Study||69||
48148642|NCT01955954|100688520|FG000|Received Treatment|Overall Study||66||
48148643|NCT01955954|100688520|FG000|Completed Treatment|Overall Study||53||
48148644|NCT01955954|100688520|FG000|Completed Post-treatment Assessement|Overall Study||48||
48148645|NCT01955954|100688520|FG000|Completed 2-month Assessment|Overall Study||46||
48148646|NCT01955954|100688520|FG000|Completed 6-month Assessement|Overall Study||42||
48148647|NCT01955954|100688520|FG000|COMPLETED|Overall Study||33||
48148648|NCT01955954|100688520|FG000|NOT COMPLETED|Overall Study||36||
48148649|NCT02131272|100688521|FG000|STARTED|Overall Study||20||
48148650|NCT02131272|100688522|FG001|STARTED|Overall Study||22||
48148651|NCT02131272|100688521|FG000|COMPLETED|Overall Study||19||
48148652|NCT02131272|100688522|FG001|COMPLETED|Overall Study||20||
48148653|NCT02131272|100688521|FG000|NOT COMPLETED|Overall Study||1||
48148654|NCT02131272|100688522|FG001|NOT COMPLETED|Overall Study||2||
48148655|NCT02413580|100688523|FG000|STARTED|Overall Study||49||
48148656|NCT02413580|100688523|FG000|COMPLETED|Overall Study||46||
48148657|NCT02413580|100688523|FG000|NOT COMPLETED|Overall Study||3||
48148658|NCT00377403|100688524|FG000|STARTED|Overall Study||85||
48148659|NCT00377403|100688525|FG001|STARTED|Overall Study||81||
48148660|NCT00377403|100688524|FG000|Day -3 Assessment|Overall Study||81||
48148661|NCT00377403|100688525|FG001|Day -3 Assessment|Overall Study||74||
48148662|NCT00377403|100688524|FG000|Day 7 Assessment|Overall Study||80||
48148663|NCT00377403|100688525|FG001|Day 7 Assessment|Overall Study||75||
48148664|NCT00377403|100688524|FG000|Day 10 Assessment|Overall Study||81||
48148665|NCT00377403|100688525|FG001|Day 10 Assessment|Overall Study||71||
48148666|NCT00377403|100688524|FG000|Day 28 Assessment|Overall Study||82||
48148667|NCT00377403|100688525|FG001|Day 28 Assessment|Overall Study||77||
48148668|NCT00377403|100688524|FG000|COMPLETED|Overall Study||81||
48148669|NCT00377403|100688525|FG001|COMPLETED|Overall Study||74||
48148670|NCT00377403|100688524|FG000|NOT COMPLETED|Overall Study||4||
48148671|NCT00377403|100688525|FG001|NOT COMPLETED|Overall Study||7||
48148672|NCT00234052|100688526|FG000|STARTED|Treatment||51||
48148673|NCT00234052|100688526|FG000|Started Treatment|Treatment||50||
48148674|NCT00234052|100688526|FG000|Completed 6 Cycles|Treatment||33||
48148675|NCT00234052|100688526|FG000|Went Into Maintenance Phase|Treatment||30||
48148676|NCT00234052|100688526|FG000|COMPLETED|Treatment||30||
48148677|NCT00234052|100688526|FG000|NOT COMPLETED|Treatment||21||
48148678|NCT00234052|100688526|FG000|STARTED|Follow-up for 5 Years||50||
48148679|NCT00234052|100688526|FG000|COMPLETED|Follow-up for 5 Years||1||
48148680|NCT00234052|100688526|FG000|NOT COMPLETED|Follow-up for 5 Years||49||
48148681|NCT01808950|100688527|FG000|STARTED|Overall Study||1||
48148682|NCT01808950|100688528|FG001|STARTED|Overall Study||3||
48148683|NCT01808950|100688529|FG002|STARTED|Overall Study||0||
48148684|NCT01808950|100688527|FG000|COMPLETED|Overall Study||1||
48148685|NCT01808950|100688528|FG001|COMPLETED|Overall Study||3||
48148686|NCT01808950|100688529|FG002|COMPLETED|Overall Study||0||
48148687|NCT01808950|100688527|FG000|NOT COMPLETED|Overall Study||0||
48148688|NCT01808950|100688528|FG001|NOT COMPLETED|Overall Study||0||
48148689|NCT01808950|100688529|FG002|NOT COMPLETED|Overall Study||0||
48148690|NCT00781391|100688530|FG000|STARTED|Overall Study||7036||
48148691|NCT00781391|100688531|FG001|STARTED|Overall Study||7035||
48148692|NCT00781391|100688532|FG002|STARTED|Overall Study||7034||
48148693|NCT00781391|100688530|FG000|Safety Analysis Set (Received Drug)|Overall Study||7012||
48148694|NCT00781391|100688531|FG001|Safety Analysis Set (Received Drug)|Overall Study||7012||
48148695|NCT00781391|100688532|FG002|Safety Analysis Set (Received Drug)|Overall Study||7002||
48148696|NCT00781391|100688530|FG000|mITT Analysis Set (Received Drug)|Overall Study||7012||
48148697|NCT00781391|100688531|FG001|mITT Analysis Set (Received Drug)|Overall Study||7012||
48148698|NCT00781391|100688532|FG002|mITT Analysis Set (Received Drug)|Overall Study||7002||
48148699|NCT00781391|100688530|FG000|Per Protocol Analysis Set|Overall Study||6993||
48148700|NCT00781391|100688531|FG001|Per Protocol Analysis Set|Overall Study||6995||
48148701|NCT00781391|100688532|FG002|Per Protocol Analysis Set|Overall Study||6982||
48148702|NCT00781391|100688530|FG000|COMPLETED|Overall Study||6157||
48148703|NCT00781391|100688531|FG001|COMPLETED|Overall Study||6228||
48148704|NCT00781391|100688532|FG002|COMPLETED|Overall Study||6250||
48148705|NCT00781391|100688530|FG000|NOT COMPLETED|Overall Study||879||
48148706|NCT00781391|100688531|FG001|NOT COMPLETED|Overall Study||807||
48148707|NCT00781391|100688532|FG002|NOT COMPLETED|Overall Study||784||
48148708|NCT00785291|100688533|FG000|STARTED|Overall Study||283||
48148709|NCT00785291|100688534|FG001|STARTED|Overall Study||271||
48148710|NCT00785291|100688535|FG002|STARTED|Overall Study||245||
48148711|NCT00785291|100688533|FG000|COMPLETED|Overall Study||147||
48148712|NCT00785291|100688534|FG001|COMPLETED|Overall Study||122||
48148713|NCT00785291|100688535|FG002|COMPLETED|Overall Study||139||
48148714|NCT00785291|100688533|FG000|NOT COMPLETED|Overall Study||136||
48148715|NCT00785291|100688534|FG001|NOT COMPLETED|Overall Study||149||
48148716|NCT00785291|100688535|FG002|NOT COMPLETED|Overall Study||106||
48148717|NCT01760239|100688536|FG000|STARTED|Overall Study||17037||
48148718|NCT01760239|100688537|FG001|STARTED|Overall Study||14542||
48148719|NCT01760239|100688536|FG000|COMPLETED|Overall Study||296||
48148720|NCT01760239|100688537|FG001|COMPLETED|Overall Study||226||
48148721|NCT01760239|100688536|FG000|NOT COMPLETED|Overall Study||16741||
48148722|NCT01760239|100688537|FG001|NOT COMPLETED|Overall Study||14316||
48148723|NCT02565914|100688538|FG000|STARTED|Part A (Up to 96 Weeks)||1044||
48148724|NCT02565914|100688538|FG000|Safety Set|Part A (Up to 96 Weeks)||1042|Received at least 1 dose of TEZ/IVA|
48148725|NCT02565914|100688538|FG000|COMPLETED|Part A (Up to 96 Weeks)||951||
48148726|NCT02565914|100688538|FG000|NOT COMPLETED|Part A (Up to 96 Weeks)||93||
48148727|NCT02565914|100688538|FG000|STARTED|Part B (Up to 96 Weeks)||464||
48148728|NCT02565914|100688538|FG000|Safety Set|Part B (Up to 96 Weeks)||463|Received at least 1 dose of TEZ/IVA|
48148729|NCT02565914|100688538|FG000|COMPLETED|Part B (Up to 96 Weeks)||228||
48148730|NCT02565914|100688538|FG000|NOT COMPLETED|Part B (Up to 96 Weeks)||236||
48148731|NCT02565914|100688538|FG000|STARTED|Part C (Up to 192 Weeks)||204||
48148732|NCT02565914|100688538|FG000|Safety Set|Part C (Up to 192 Weeks)||204||
48148733|NCT02565914|100688538|FG000|COMPLETED|Part C (Up to 192 Weeks)||7||
48148734|NCT02565914|100688538|FG000|NOT COMPLETED|Part C (Up to 192 Weeks)||197||
48148735|NCT00477230|100688539|FG000|STARTED|Overall Study||32||
48148736|NCT00477230|100688540|FG001|STARTED|Overall Study||32||
48148737|NCT00477230|100688539|FG000|COMPLETED|Overall Study||12||
48148738|NCT00477230|100688540|FG001|COMPLETED|Overall Study||1||
48148739|NCT00477230|100688539|FG000|NOT COMPLETED|Overall Study||20||
48148740|NCT00477230|100688540|FG001|NOT COMPLETED|Overall Study||31||
48148741|NCT04208516|100688541|FG000|STARTED|Overall Study||7||
48148742|NCT04208516|100688542|FG001|STARTED|Overall Study||7||
48148743|NCT04208516|100688541|FG000|COMPLETED|Overall Study||7||
48148744|NCT04208516|100688542|FG001|COMPLETED|Overall Study||7||
48148745|NCT04208516|100688541|FG000|NOT COMPLETED|Overall Study||0||
48148746|NCT04208516|100688542|FG001|NOT COMPLETED|Overall Study||0||
48148747|NCT01292876|100688543|FG000|STARTED|Overall Study||17||
48148748|NCT01292876|100688543|FG000|COMPLETED|Overall Study||13||
48148749|NCT01292876|100688543|FG000|NOT COMPLETED|Overall Study||4||
48148750|NCT01159054|100688544|FG000|STARTED|Overall Study||22||
48148751|NCT01159054|100688544|FG000|COMPLETED|Overall Study||2||
48148752|NCT01159054|100688544|FG000|NOT COMPLETED|Overall Study||20||
48148753|NCT03185481|100688545|FG000|STARTED|Overall Study||5||
48148754|NCT03185481|100688545|FG000|COMPLETED|Overall Study||0||
48148755|NCT03185481|100688545|FG000|NOT COMPLETED|Overall Study||5||
48148756|NCT01054768|100688546|FG000|STARTED|Overall Study||17||
48148757|NCT01054768|100688547|FG001|STARTED|Overall Study||20||
48148758|NCT01054768|100688546|FG000|COMPLETED|Overall Study||9||
48148759|NCT01054768|100688547|FG001|COMPLETED|Overall Study||17||
48148760|NCT01054768|100688546|FG000|NOT COMPLETED|Overall Study||8||
48148761|NCT01054768|100688547|FG001|NOT COMPLETED|Overall Study||3||
48148762|NCT00003508|100688548|FG000|STARTED|Overall Study||8||
48148763|NCT00003508|100688548|FG000|COMPLETED|Overall Study||3||
48148764|NCT00003508|100688548|FG000|NOT COMPLETED|Overall Study||5||
48148765|NCT00363675|100688549|FG000|STARTED|Overall Study||3||
48148766|NCT00363675|100688549|FG000|Completed Testing|Overall Study||3||
48148767|NCT00363675|100688549|FG000|COMPLETED|Overall Study||3||
48148768|NCT00363675|100688549|FG000|NOT COMPLETED|Overall Study||0||
48148769|NCT01215292|100688550|FG000|STARTED|Overall Study||8||
48148770|NCT01215292|100688551|FG001|STARTED|Overall Study||8||
48148771|NCT01215292|100688552|FG002|STARTED|Overall Study||8||
48148772|NCT01215292|100688553|FG003|STARTED|Overall Study||8||
48148773|NCT01215292|100688554|FG004|STARTED|Overall Study||8||
48148774|NCT01215292|100688550|FG000|COMPLETED|Overall Study||8||
48148775|NCT01215292|100688551|FG001|COMPLETED|Overall Study||8||
48148776|NCT01215292|100688552|FG002|COMPLETED|Overall Study||8||
48148777|NCT01215292|100688553|FG003|COMPLETED|Overall Study||8||
48148778|NCT01215292|100688554|FG004|COMPLETED|Overall Study||8||
48148779|NCT01215292|100688550|FG000|NOT COMPLETED|Overall Study||0||
48148780|NCT01215292|100688551|FG001|NOT COMPLETED|Overall Study||0||
48148781|NCT01215292|100688552|FG002|NOT COMPLETED|Overall Study||0||
48148782|NCT01215292|100688553|FG003|NOT COMPLETED|Overall Study||0||
48148783|NCT01215292|100688554|FG004|NOT COMPLETED|Overall Study||0||
48148784|NCT02195986|100688555|FG000|STARTED|Overall Study||146||
48148785|NCT02195986|100688556|FG001|STARTED|Overall Study||147||
48148786|NCT02195986|100688557|FG002|STARTED|Overall Study||73||
48148787|NCT02195986|100688555|FG000|COMPLETED|Overall Study||143||
48148788|NCT02195986|100688556|FG001|COMPLETED|Overall Study||142||
48148789|NCT02195986|100688557|FG002|COMPLETED|Overall Study||71||
48148790|NCT02195986|100688555|FG000|NOT COMPLETED|Overall Study||3||
48148791|NCT02195986|100688556|FG001|NOT COMPLETED|Overall Study||5||
48148792|NCT02195986|100688557|FG002|NOT COMPLETED|Overall Study||2||
48148793|NCT01618864|100688558|FG000|STARTED|Overall Study||23||
48148794|NCT01618864|100688558|FG000|Completed 2 Weeks|Overall Study||19||
48148795|NCT01618864|100688558|FG000|COMPLETED|Overall Study||19||
48148796|NCT01618864|100688558|FG000|NOT COMPLETED|Overall Study||4||
48148797|NCT04198805|100688559|FG000|STARTED|Overall Study||34||
48148798|NCT04198805|100688560|FG001|STARTED|Overall Study||34||
48148799|NCT04198805|100688561|FG002|STARTED|Overall Study||67||
48148800|NCT04198805|100688562|FG003|STARTED|Overall Study||70||
48148801|NCT04198805|100688559|FG000|COMPLETED|Overall Study||26||
48148802|NCT04198805|100688560|FG001|COMPLETED|Overall Study||30||
48303192|NCT00992511|101070080|FG001|STARTED|Overall Study||73||
48303193|NCT00992511|101070081|FG002|STARTED|Overall Study||76||
48303194|NCT00992511|101070082|FG003|STARTED|Overall Study||75||
48303195|NCT00992511|101070079|FG000|COMPLETED|Overall Study||74||
48303196|NCT00992511|101070080|FG001|COMPLETED|Overall Study||73||
48605770|NCT02669043|101819827|FG000|NOT COMPLETED|Overall Study||4||
48605771|NCT02759835|101819828|FG000|STARTED|Overall Study||25||
48605772|NCT02759835|101819829|FG001|STARTED|Overall Study||9||
48605773|NCT02759835|101819830|FG002|STARTED|Overall Study||3||
48605774|NCT02759835|101819828|FG000|COMPLETED|Overall Study||25||
48605775|NCT02759835|101819829|FG001|COMPLETED|Overall Study||9||
48303197|NCT00992511|101070081|FG002|COMPLETED|Overall Study||74||
48605776|NCT02759835|101819830|FG002|COMPLETED|Overall Study||3||
48605777|NCT02759835|101819828|FG000|NOT COMPLETED|Overall Study||0||
48148803|NCT04198805|100688561|FG002|COMPLETED|Overall Study||61||
48148804|NCT04198805|100688562|FG003|COMPLETED|Overall Study||60||
48148805|NCT04198805|100688559|FG000|NOT COMPLETED|Overall Study||8||
48148806|NCT04198805|100688560|FG001|NOT COMPLETED|Overall Study||4||
48148807|NCT04198805|100688561|FG002|NOT COMPLETED|Overall Study||6||
48148808|NCT04198805|100688562|FG003|NOT COMPLETED|Overall Study||10||
48148809|NCT01284426|100688563|FG000|STARTED|Overall Study||94||
48148810|NCT01284426|100688563|FG000|COMPLETED|Overall Study||92||
48148811|NCT01284426|100688563|FG000|NOT COMPLETED|Overall Study||2||
48148812|NCT02123108|100688564|FG000|STARTED|Overall Study||30||
48148813|NCT02123108|100688565|FG001|STARTED|Overall Study||29||
48148814|NCT02123108|100688564|FG000|COMPLETED|Overall Study||28||
48148815|NCT02123108|100688565|FG001|COMPLETED|Overall Study||26||
48148816|NCT02123108|100688564|FG000|NOT COMPLETED|Overall Study||2||
48148817|NCT02123108|100688565|FG001|NOT COMPLETED|Overall Study||3||
48148818|NCT02481310|100688566|FG000|STARTED|Induction Treatment (6 Cycles)||1||
48148819|NCT02481310|100688567|FG001|STARTED|Induction Treatment (6 Cycles)||36||
48605778|NCT02759835|101819829|FG001|NOT COMPLETED|Overall Study||0||
48148820|NCT02481310|100688568|FG002|STARTED|Induction Treatment (6 Cycles)||1||
48148821|NCT02481310|100688566|FG000|Reached First Evaluable Response|Induction Treatment (6 Cycles)||1||
48303198|NCT00992511|101070082|FG003|COMPLETED|Overall Study||70||
48715741|NCT03322423|102091745|FG000|NOT COMPLETED|Period 2||1||
48715742|NCT03322423|102091746|FG001|NOT COMPLETED|Period 2||2||
48715743|NCT00860015|102091747|FG000|STARTED|Overall Study||12||
48715744|NCT00860015|102091747|FG000|COMPLETED|Overall Study||12||
48715745|NCT00860015|102091747|FG000|NOT COMPLETED|Overall Study||0||
48715746|NCT01667562|102091748|FG000|STARTED|Diagnostic Phase||375||
48605779|NCT02759835|101819830|FG002|NOT COMPLETED|Overall Study||0||
48605780|NCT01882803|101819831|FG000|STARTED|Overall Study||129||
48605781|NCT01882803|101819831|FG000|Received at Least 1 Dose of Study Drug|Overall Study||129||
48605782|NCT01882803|101819831|FG000|COMPLETED|Overall Study||0||
48605783|NCT01882803|101819831|FG000|NOT COMPLETED|Overall Study||129||
48605784|NCT01370616|101819832|FG000|STARTED|Overall Study||282||
48715747|NCT01667562|102091749|FG001|STARTED|Diagnostic Phase||0||
48715748|NCT01667562|102091748|FG000|COMPLETED|Diagnostic Phase||345||
48715749|NCT01667562|102091749|FG001|COMPLETED|Diagnostic Phase||0||
48715750|NCT01667562|102091748|FG000|NOT COMPLETED|Diagnostic Phase||30||
48148822|NCT02481310|100688567|FG001|Reached First Evaluable Response|Induction Treatment (6 Cycles)||34||
48148823|NCT02481310|100688568|FG002|Reached First Evaluable Response|Induction Treatment (6 Cycles)||1||
48148824|NCT02481310|100688566|FG000|Complete 6 Cycles|Induction Treatment (6 Cycles)||1||
48148825|NCT02481310|100688567|FG001|Complete 6 Cycles|Induction Treatment (6 Cycles)||30||
48148826|NCT02481310|100688568|FG002|Complete 6 Cycles|Induction Treatment (6 Cycles)||1||
48148827|NCT02481310|100688566|FG000|COMPLETED|Induction Treatment (6 Cycles)||1||
48148828|NCT02481310|100688567|FG001|COMPLETED|Induction Treatment (6 Cycles)||30||
48148829|NCT02481310|100688568|FG002|COMPLETED|Induction Treatment (6 Cycles)||1||
48148830|NCT02481310|100688566|FG000|NOT COMPLETED|Induction Treatment (6 Cycles)||0||
48148831|NCT02481310|100688567|FG001|NOT COMPLETED|Induction Treatment (6 Cycles)||6||
48148832|NCT02481310|100688568|FG002|NOT COMPLETED|Induction Treatment (6 Cycles)||0||
48605785|NCT01370616|101819833|FG001|STARTED|Overall Study||283||
48605786|NCT01370616|101819832|FG000|Treated|Overall Study||275||
48605787|NCT01370616|101819833|FG001|Treated|Overall Study||275||
48605788|NCT01370616|101819832|FG000|COMPLETED|Overall Study||220||
48605789|NCT01370616|101819833|FG001|COMPLETED|Overall Study||216||
48188537|NCT05233085|100783269|FG003|NOT COMPLETED|Overall Study||0||
48605790|NCT01370616|101819832|FG000|NOT COMPLETED|Overall Study||62||
48605791|NCT01370616|101819833|FG001|NOT COMPLETED|Overall Study||67||
48605792|NCT03658642|101819834|FG000|STARTED|Patients||2787||
48715751|NCT01667562|102091749|FG001|NOT COMPLETED|Diagnostic Phase||0||
48148833|NCT02481310|100688566|FG000|STARTED|Maintenance Treatment||1|Maintenance treatment can continue for up to one year or longer for continued clinical benefit if approved.|
48605793|NCT03658642|101819835|FG001|STARTED|Patients||2260||
48605794|NCT03658642|101819834|FG000|COMPLETED|Patients||2787||
48605795|NCT03658642|101819835|FG001|COMPLETED|Patients||2260||
48605796|NCT03658642|101819834|FG000|NOT COMPLETED|Patients||0||
48605797|NCT03658642|101819835|FG001|NOT COMPLETED|Patients||0||
48605798|NCT03658642|101819834|FG000|STARTED|Physicians||340||
48605799|NCT03658642|101819835|FG001|STARTED|Physicians||259||
48605800|NCT03658642|101819834|FG000|COMPLETED|Physicians||340||
48605801|NCT03658642|101819835|FG001|COMPLETED|Physicians||259||
48148834|NCT02481310|100688567|FG001|STARTED|Maintenance Treatment||21|Maintenance treatment can continue for up to one year or longer for continued clinical benefit if approved.|
48148835|NCT02481310|100688568|FG002|STARTED|Maintenance Treatment||1|Maintenance treatment can continue for up to one year or longer for continued clinical benefit if approved.|
48148836|NCT02481310|100688566|FG000|Started Maintenance Treatment|Maintenance Treatment||1||
48148837|NCT02481310|100688567|FG001|Started Maintenance Treatment|Maintenance Treatment||21||
48148838|NCT02481310|100688568|FG002|Started Maintenance Treatment|Maintenance Treatment||1||
48148839|NCT02481310|100688566|FG000|COMPLETED|Maintenance Treatment||1||
48148840|NCT02481310|100688567|FG001|COMPLETED|Maintenance Treatment||21||
48148841|NCT02481310|100688568|FG002|COMPLETED|Maintenance Treatment||1||
48715752|NCT01667562|102091748|FG000|STARTED|Erlotinib Phase||0||
48715753|NCT01667562|102091749|FG001|STARTED|Erlotinib Phase||30||
48715754|NCT01667562|102091748|FG000|COMPLETED|Erlotinib Phase||0||
48715755|NCT01667562|102091749|FG001|COMPLETED|Erlotinib Phase||27||
48715756|NCT01667562|102091748|FG000|NOT COMPLETED|Erlotinib Phase||0||
48715757|NCT01667562|102091749|FG001|NOT COMPLETED|Erlotinib Phase||3||
48715758|NCT01863134|102091750|FG000|STARTED|Overall Study||72||
48715759|NCT01863134|102091751|FG001|STARTED|Overall Study||68||
48715760|NCT01863134|102091750|FG000|COMPLETED|Overall Study||72||
48715761|NCT01863134|102091751|FG001|COMPLETED|Overall Study||68||
48715762|NCT01863134|102091750|FG000|NOT COMPLETED|Overall Study||0||
48715763|NCT01863134|102091751|FG001|NOT COMPLETED|Overall Study||0||
48715764|NCT04075409|102091752|FG000|STARTED|Overall Study||13||
48715765|NCT04075409|102091753|FG001|STARTED|Overall Study||13||
48715766|NCT04075409|102091754|FG002|STARTED|Overall Study||13||
48715767|NCT04075409|102091752|FG000|COMPLETED|Overall Study||13||
48715768|NCT04075409|102091753|FG001|COMPLETED|Overall Study||13||
48715769|NCT04075409|102091754|FG002|COMPLETED|Overall Study||13||
48715770|NCT04075409|102091752|FG000|NOT COMPLETED|Overall Study||0||
48715771|NCT04075409|102091753|FG001|NOT COMPLETED|Overall Study||0||
48715772|NCT04075409|102091754|FG002|NOT COMPLETED|Overall Study||0||
48715773|NCT04342689|102091755|FG000|STARTED|Overall Study||113||
48715774|NCT04342689|102091756|FG001|STARTED|Overall Study||113||
48715775|NCT04342689|102091755|FG000|COMPLETED|Overall Study||71||
48715776|NCT04342689|102091756|FG001|COMPLETED|Overall Study||68||
48715777|NCT04342689|102091755|FG000|NOT COMPLETED|Overall Study||42||
48715778|NCT04342689|102091756|FG001|NOT COMPLETED|Overall Study||45||
48715779|NCT03093636|102091757|FG000|STARTED|Overall Study||57||
48715780|NCT03093636|102091758|FG001|STARTED|Overall Study||23||
48715781|NCT03093636|102091757|FG000|COMPLETED|Overall Study||57||
48715782|NCT03093636|102091758|FG001|COMPLETED|Overall Study||23||
48715783|NCT03093636|102091757|FG000|NOT COMPLETED|Overall Study||0||
48715784|NCT03093636|102091758|FG001|NOT COMPLETED|Overall Study||0||
48715785|NCT02847858|102091759|FG000|STARTED|Overall Study||693||
48148842|NCT02481310|100688566|FG000|NOT COMPLETED|Maintenance Treatment||0||
48148843|NCT02481310|100688567|FG001|NOT COMPLETED|Maintenance Treatment||0||
48148844|NCT02481310|100688568|FG002|NOT COMPLETED|Maintenance Treatment||0||
48148845|NCT02481310|100688566|FG000|STARTED|Follow up||1|All patients that are treated with at least one dose of study drug go into the follow up period.|
48148846|NCT02481310|100688567|FG001|STARTED|Follow up||32|All patients that are treated with at least one dose of study drug go into the follow up period.|
48148847|NCT02481310|100688568|FG002|STARTED|Follow up||1|All patients that are treated with at least one dose of study drug go into the follow up period.|
48148848|NCT02481310|100688566|FG000|COMPLETED|Follow up||1||
48148849|NCT02481310|100688567|FG001|COMPLETED|Follow up||29||
48148850|NCT02481310|100688568|FG002|COMPLETED|Follow up||1||
48715786|NCT02847858|102091760|FG001|STARTED|Overall Study||667||
48715787|NCT02847858|102091759|FG000|COMPLETED|Overall Study||292||
48715788|NCT02847858|102091760|FG001|COMPLETED|Overall Study||398||
48148851|NCT02481310|100688566|FG000|NOT COMPLETED|Follow up||0||
48148852|NCT02481310|100688567|FG001|NOT COMPLETED|Follow up||3||
48148853|NCT02481310|100688568|FG002|NOT COMPLETED|Follow up||0||
48148854|NCT02366910|100688569|FG000|STARTED|Overall Study||26||
48148855|NCT02366910|100688569|FG000|COMPLETED|Overall Study||21||
48148856|NCT02366910|100688569|FG000|NOT COMPLETED|Overall Study||5||
48148857|NCT03371082|100688570|FG000|STARTED|Overall Study||287||
48148858|NCT03371082|100688571|FG001|STARTED|Overall Study||289||
48148859|NCT03371082|100688570|FG000|COMPLETED|Overall Study||258||
48148860|NCT03371082|100688571|FG001|COMPLETED|Overall Study||255||
48148861|NCT03371082|100688570|FG000|NOT COMPLETED|Overall Study||29||
48148862|NCT03371082|100688571|FG001|NOT COMPLETED|Overall Study||34||
48148863|NCT02191267|100688572|FG000|STARTED|Overall Study||20||
48148864|NCT02191267|100688573|FG001|STARTED|Overall Study||6||
48148865|NCT02191267|100688574|FG002|STARTED|Overall Study||4||
48148866|NCT02191267|100688572|FG000|COMPLETED|Overall Study||19||
48148867|NCT02191267|100688573|FG001|COMPLETED|Overall Study||6||
48148868|NCT02191267|100688574|FG002|COMPLETED|Overall Study||4||
48148869|NCT02191267|100688572|FG000|NOT COMPLETED|Overall Study||1||
48715789|NCT02847858|102091759|FG000|NOT COMPLETED|Overall Study||401||
48715790|NCT02847858|102091760|FG001|NOT COMPLETED|Overall Study||269||
48715791|NCT04240093|102091761|FG000|STARTED|Overall Study||16||
48715792|NCT04240093|102091762|FG001|STARTED|Overall Study||16||
48715793|NCT04240093|102091761|FG000|3 Month Follow-Up|Overall Study||14||
48715794|NCT04240093|102091762|FG001|3 Month Follow-Up|Overall Study||16||
48148870|NCT02191267|100688573|FG001|NOT COMPLETED|Overall Study||0||
48148871|NCT02191267|100688574|FG002|NOT COMPLETED|Overall Study||0||
48148872|NCT03687190|100688575|FG000|STARTED|Overall Study||12||
48148873|NCT03687190|100688576|FG001|STARTED|Overall Study||9||
48148874|NCT03687190|100688575|FG000|COMPLETED|Overall Study||12||
48148875|NCT03687190|100688576|FG001|COMPLETED|Overall Study||9||
48148876|NCT03687190|100688575|FG000|NOT COMPLETED|Overall Study||0||
48148877|NCT03687190|100688576|FG001|NOT COMPLETED|Overall Study||0||
48148878|NCT03432364|100688577|FG000|STARTED|Primary (ST-400 Infusion up to Week 52 )||5||
48148879|NCT03432364|100688577|FG000|COMPLETED|Primary (ST-400 Infusion up to Week 52 )||5||
48605802|NCT03658642|101819834|FG000|NOT COMPLETED|Physicians||0||
48605803|NCT03658642|101819835|FG001|NOT COMPLETED|Physicians||0||
48605804|NCT00585325|101819836|FG000|STARTED|Overall Study||10||20
48605805|NCT00585325|101819837|FG001|STARTED|Overall Study||13||21
48605806|NCT00585325|101819836|FG000|COMPLETED|Overall Study||9||14
48605807|NCT00585325|101819837|FG001|COMPLETED|Overall Study||12||18
48605808|NCT00585325|101819836|FG000|NOT COMPLETED|Overall Study||1||6
48605809|NCT00585325|101819837|FG001|NOT COMPLETED|Overall Study||1||3
48303199|NCT00992511|101070079|FG000|NOT COMPLETED|Overall Study||2||
48303200|NCT00992511|101070080|FG001|NOT COMPLETED|Overall Study||0||
48303201|NCT00992511|101070081|FG002|NOT COMPLETED|Overall Study||2||
48303202|NCT00992511|101070082|FG003|NOT COMPLETED|Overall Study||5||
48303203|NCT01672788|101070083|FG000|STARTED|Treatment Period 1 (3 Days)||9||
48303204|NCT01672788|101070084|FG001|STARTED|Treatment Period 1 (3 Days)||9||
48303205|NCT01672788|101070085|FG002|STARTED|Treatment Period 1 (3 Days)||9||
48605810|NCT02824562|101819838|FG000|STARTED|Overall Study||22||
48605811|NCT02824562|101819839|FG001|STARTED|Overall Study||22||
48148880|NCT03432364|100688577|FG000|NOT COMPLETED|Primary (ST-400 Infusion up to Week 52 )||0||
48148881|NCT03432364|100688577|FG000|STARTED|Follow Up (Weeks 52-156 Post Infusion)||5||
48148882|NCT03432364|100688577|FG000|COMPLETED|Follow Up (Weeks 52-156 Post Infusion)||4||
48303206|NCT01672788|101070086|FG003|STARTED|Treatment Period 1 (3 Days)||9||
48303207|NCT01672788|101070083|FG000|COMPLETED|Treatment Period 1 (3 Days)||9||
48605812|NCT02824562|101819838|FG000|COMPLETED|Overall Study||19||
48148883|NCT03432364|100688577|FG000|NOT COMPLETED|Follow Up (Weeks 52-156 Post Infusion)||1||
48605813|NCT02824562|101819839|FG001|COMPLETED|Overall Study||17||
48605814|NCT02824562|101819838|FG000|NOT COMPLETED|Overall Study||3||
48605815|NCT02824562|101819839|FG001|NOT COMPLETED|Overall Study||5||
48605816|NCT01608672|101819840|FG000|STARTED|Overall Study||207||
48605817|NCT01608672|101819840|FG000|COMPLETED|Overall Study||207||
48605818|NCT01608672|101819840|FG000|NOT COMPLETED|Overall Study||0||
48605819|NCT05137002|101819841|FG000|STARTED|Part I (8 Weeks)||64||
48605820|NCT05137002|101819842|FG001|STARTED|Part I (8 Weeks)||63||
48605821|NCT05137002|101819843|FG002|STARTED|Part I (8 Weeks)||62||
48605822|NCT05137002|101819844|FG003|STARTED|Part I (8 Weeks)||60||
48605823|NCT05137002|101819845|FG004|STARTED|Part I (8 Weeks)||0||
48605824|NCT05137002|101819841|FG000|COMPLETED|Part I (8 Weeks)||60||
48605825|NCT05137002|101819842|FG001|COMPLETED|Part I (8 Weeks)||55||
48605826|NCT05137002|101819843|FG002|COMPLETED|Part I (8 Weeks)||58||
48148884|NCT03538951|100688578|FG000|STARTED|Overall Study||41||
48148885|NCT03538951|100688579|FG001|STARTED|Overall Study||42||
48148886|NCT03538951|100688578|FG000|COMPLETED|Overall Study||40||
48303208|NCT01672788|101070084|FG001|COMPLETED|Treatment Period 1 (3 Days)||9||
48303209|NCT01672788|101070085|FG002|COMPLETED|Treatment Period 1 (3 Days)||9||
48303210|NCT01672788|101070086|FG003|COMPLETED|Treatment Period 1 (3 Days)||9||
48303211|NCT01672788|101070083|FG000|NOT COMPLETED|Treatment Period 1 (3 Days)||0||
48303212|NCT01672788|101070084|FG001|NOT COMPLETED|Treatment Period 1 (3 Days)||0||
48303213|NCT01672788|101070085|FG002|NOT COMPLETED|Treatment Period 1 (3 Days)||0||
48303214|NCT01672788|101070086|FG003|NOT COMPLETED|Treatment Period 1 (3 Days)||0||
48303215|NCT01672788|101070083|FG000|STARTED|Washout Period 1 (7 Days)||9||
48303216|NCT01672788|101070084|FG001|STARTED|Washout Period 1 (7 Days)||9||
48303217|NCT01672788|101070085|FG002|STARTED|Washout Period 1 (7 Days)||9||
48303218|NCT01672788|101070086|FG003|STARTED|Washout Period 1 (7 Days)||9||
48303219|NCT01672788|101070083|FG000|COMPLETED|Washout Period 1 (7 Days)||9||
48303220|NCT01672788|101070084|FG001|COMPLETED|Washout Period 1 (7 Days)||9||
48303221|NCT01672788|101070085|FG002|COMPLETED|Washout Period 1 (7 Days)||9||
48303222|NCT01672788|101070086|FG003|COMPLETED|Washout Period 1 (7 Days)||9||
48303223|NCT01672788|101070083|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48303224|NCT01672788|101070084|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48303225|NCT01672788|101070085|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48303226|NCT01672788|101070086|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48303227|NCT01672788|101070083|FG000|STARTED|Treatment Period 2 (3 Days)||9||
48303228|NCT01672788|101070084|FG001|STARTED|Treatment Period 2 (3 Days)||9||
48303229|NCT01672788|101070085|FG002|STARTED|Treatment Period 2 (3 Days)||9||
48303230|NCT01672788|101070086|FG003|STARTED|Treatment Period 2 (3 Days)||9||
48303231|NCT01672788|101070083|FG000|COMPLETED|Treatment Period 2 (3 Days)||9||
48303232|NCT01672788|101070084|FG001|COMPLETED|Treatment Period 2 (3 Days)||9||
48303233|NCT01672788|101070085|FG002|COMPLETED|Treatment Period 2 (3 Days)||9||
48148887|NCT03538951|100688579|FG001|COMPLETED|Overall Study||40||
48148888|NCT03538951|100688578|FG000|NOT COMPLETED|Overall Study||1||
48148889|NCT03538951|100688579|FG001|NOT COMPLETED|Overall Study||2||
48303234|NCT01672788|101070086|FG003|COMPLETED|Treatment Period 2 (3 Days)||9||
48303235|NCT01672788|101070083|FG000|NOT COMPLETED|Treatment Period 2 (3 Days)||0||
48303236|NCT01672788|101070084|FG001|NOT COMPLETED|Treatment Period 2 (3 Days)||0||
48303237|NCT01672788|101070085|FG002|NOT COMPLETED|Treatment Period 2 (3 Days)||0||
48303238|NCT01672788|101070086|FG003|NOT COMPLETED|Treatment Period 2 (3 Days)||0||
48303239|NCT01672788|101070083|FG000|STARTED|Washout Period 2 (7 Days)||9||
48605827|NCT05137002|101819844|FG003|COMPLETED|Part I (8 Weeks)||54||
48605828|NCT05137002|101819845|FG004|COMPLETED|Part I (8 Weeks)||0||
48605829|NCT05137002|101819841|FG000|NOT COMPLETED|Part I (8 Weeks)||4||
48605830|NCT05137002|101819842|FG001|NOT COMPLETED|Part I (8 Weeks)||8||
48605831|NCT05137002|101819843|FG002|NOT COMPLETED|Part I (8 Weeks)||4||
48148890|NCT00916032|100688580|FG000|STARTED|Overall Study||12||
48148891|NCT00916032|100688581|FG001|STARTED|Overall Study||11||
48303240|NCT01672788|101070084|FG001|STARTED|Washout Period 2 (7 Days)||9||
48303241|NCT01672788|101070085|FG002|STARTED|Washout Period 2 (7 Days)||9||
48605832|NCT05137002|101819844|FG003|NOT COMPLETED|Part I (8 Weeks)||6||
48148892|NCT00916032|100688580|FG000|COMPLETED|Overall Study||12||
48303242|NCT01672788|101070086|FG003|STARTED|Washout Period 2 (7 Days)||9||
48303243|NCT01672788|101070083|FG000|COMPLETED|Washout Period 2 (7 Days)||9||
48303244|NCT01672788|101070084|FG001|COMPLETED|Washout Period 2 (7 Days)||9||
48303245|NCT01672788|101070085|FG002|COMPLETED|Washout Period 2 (7 Days)||9||
48303246|NCT01672788|101070086|FG003|COMPLETED|Washout Period 2 (7 Days)||8||
48303247|NCT01672788|101070083|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48303248|NCT01672788|101070084|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48303249|NCT01672788|101070085|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48303250|NCT01672788|101070086|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||1||
48303251|NCT01672788|101070083|FG000|STARTED|Treatment Period 3 (3 Days)||9||
48303252|NCT01672788|101070084|FG001|STARTED|Treatment Period 3 (3 Days)||9||
48303253|NCT01672788|101070085|FG002|STARTED|Treatment Period 3 (3 Days)||9||
48303254|NCT01672788|101070086|FG003|STARTED|Treatment Period 3 (3 Days)||8||
48303255|NCT01672788|101070083|FG000|COMPLETED|Treatment Period 3 (3 Days)||9||
48303256|NCT01672788|101070084|FG001|COMPLETED|Treatment Period 3 (3 Days)||9||
48303257|NCT01672788|101070085|FG002|COMPLETED|Treatment Period 3 (3 Days)||9||
48303258|NCT01672788|101070086|FG003|COMPLETED|Treatment Period 3 (3 Days)||8||
48303259|NCT01672788|101070083|FG000|NOT COMPLETED|Treatment Period 3 (3 Days)||0||
48715795|NCT04240093|102091761|FG000|6 Month Follow Up|Overall Study||16||
48715796|NCT04240093|102091762|FG001|6 Month Follow Up|Overall Study||16||
48715797|NCT04240093|102091761|FG000|COMPLETED|Overall Study||16||
48715798|NCT04240093|102091762|FG001|COMPLETED|Overall Study||16||
48715799|NCT04240093|102091761|FG000|NOT COMPLETED|Overall Study||0||
48715800|NCT04240093|102091762|FG001|NOT COMPLETED|Overall Study||0||
48715801|NCT02818114|102091763|FG000|STARTED|Overall Study||8||
48715802|NCT02818114|102091763|FG000|COMPLETED|Overall Study||7||
48715803|NCT02818114|102091763|FG000|NOT COMPLETED|Overall Study||1||
48715804|NCT03895632|102091764|FG000|STARTED|Overall Study||25||
48715805|NCT03895632|102091764|FG000|COMPLETED|Overall Study||25||
48715806|NCT03895632|102091764|FG000|NOT COMPLETED|Overall Study||0||
48715807|NCT02654236|102091765|FG000|STARTED|Overall Study||9||
48715808|NCT02654236|102091766|FG001|STARTED|Overall Study||6||
48715809|NCT02654236|102091767|FG002|STARTED|Overall Study||15||
48715810|NCT02654236|102091765|FG000|COMPLETED|Overall Study||9||
48715811|NCT02654236|102091766|FG001|COMPLETED|Overall Study||6||
48715812|NCT02654236|102091767|FG002|COMPLETED|Overall Study||13||
48715813|NCT02654236|102091765|FG000|NOT COMPLETED|Overall Study||0||
48715814|NCT02654236|102091766|FG001|NOT COMPLETED|Overall Study||0||
48715815|NCT02654236|102091767|FG002|NOT COMPLETED|Overall Study||2||
48715816|NCT00316888|102091768|FG000|STARTED|Overall Study||28||
48303260|NCT01672788|101070084|FG001|NOT COMPLETED|Treatment Period 3 (3 Days)||0||
48303261|NCT01672788|101070085|FG002|NOT COMPLETED|Treatment Period 3 (3 Days)||0||
48303262|NCT01672788|101070086|FG003|NOT COMPLETED|Treatment Period 3 (3 Days)||0||
48303263|NCT01672788|101070083|FG000|STARTED|Washout Period 3 (7 Days)||9||
48303264|NCT01672788|101070084|FG001|STARTED|Washout Period 3 (7 Days)||9||
48303265|NCT01672788|101070085|FG002|STARTED|Washout Period 3 (7 Days)||9||
48303266|NCT01672788|101070086|FG003|STARTED|Washout Period 3 (7 Days)||8||
48715817|NCT00316888|102091769|FG001|STARTED|Overall Study||35||
48715818|NCT00316888|102091768|FG000|Eligible|Overall Study||28||
48715819|NCT00316888|102091769|FG001|Eligible|Overall Study||35||
48715820|NCT00316888|102091768|FG000|Treated|Overall Study||28||
48715821|NCT00316888|102091769|FG001|Treated|Overall Study||34||
48715822|NCT00316888|102091768|FG000|Started Induction Chemotherapy|Overall Study||28||
48715823|NCT00316888|102091769|FG001|Started Induction Chemotherapy|Overall Study||0||
48303267|NCT01672788|101070083|FG000|COMPLETED|Washout Period 3 (7 Days)||9||
48303268|NCT01672788|101070084|FG001|COMPLETED|Washout Period 3 (7 Days)||9||
48303269|NCT01672788|101070085|FG002|COMPLETED|Washout Period 3 (7 Days)||9||
48303270|NCT01672788|101070086|FG003|COMPLETED|Washout Period 3 (7 Days)||8||
48303271|NCT01672788|101070083|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48303272|NCT01672788|101070084|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48303273|NCT01672788|101070085|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48303274|NCT01672788|101070086|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48405390|NCT03074318|101325268|FG002|NOT COMPLETED|Overall Study||6||
48405391|NCT03074318|101325269|FG003|NOT COMPLETED|Overall Study||16||
48405392|NCT01789255|101325270|FG000|STARTED|Overall Study||12||
48405393|NCT01789255|101325270|FG000|COMPLETED|Overall Study||12||
48405394|NCT01789255|101325270|FG000|NOT COMPLETED|Overall Study||0||
48405395|NCT01619488|101325271|FG000|STARTED|Overall Study||57||
48303275|NCT01672788|101070083|FG000|STARTED|Treatment Period 4 (3 Days)||9||
48303276|NCT01672788|101070084|FG001|STARTED|Treatment Period 4 (3 Days)||9||
48405396|NCT01619488|101325271|FG000|COMPLETED|Overall Study||57||
48303277|NCT01672788|101070085|FG002|STARTED|Treatment Period 4 (3 Days)||9||
48303278|NCT01672788|101070086|FG003|STARTED|Treatment Period 4 (3 Days)||8||
48303279|NCT01672788|101070083|FG000|COMPLETED|Treatment Period 4 (3 Days)||9||
48303280|NCT01672788|101070084|FG001|COMPLETED|Treatment Period 4 (3 Days)||9||
48303281|NCT01672788|101070085|FG002|COMPLETED|Treatment Period 4 (3 Days)||9||
48303282|NCT01672788|101070086|FG003|COMPLETED|Treatment Period 4 (3 Days)||8||
48303283|NCT01672788|101070083|FG000|NOT COMPLETED|Treatment Period 4 (3 Days)||0||
48303284|NCT01672788|101070084|FG001|NOT COMPLETED|Treatment Period 4 (3 Days)||0||
48303285|NCT01672788|101070085|FG002|NOT COMPLETED|Treatment Period 4 (3 Days)||0||
48303286|NCT01672788|101070086|FG003|NOT COMPLETED|Treatment Period 4 (3 Days)||0||
48303287|NCT01790126|101070087|FG000|STARTED|Overall Study||30||
48303288|NCT01790126|101070088|FG001|STARTED|Overall Study||29||
48303289|NCT01790126|101070089|FG002|STARTED|Overall Study||31||
48303290|NCT01790126|101070087|FG000|Treated|Overall Study||29||
48303291|NCT01790126|101070088|FG001|Treated|Overall Study||29||
48405397|NCT01619488|101325271|FG000|NOT COMPLETED|Overall Study||0||
48405398|NCT02756845|101325272|FG000|STARTED|Overall Study||13||
48405399|NCT02756845|101325273|FG001|STARTED|Overall Study||2||
48405400|NCT02756845|101325272|FG000|Received Talimogene Laherparepvec|Overall Study||13||
48405401|NCT02756845|101325273|FG001|Received Talimogene Laherparepvec|Overall Study||2||
48405402|NCT02756845|101325272|FG000|COMPLETED|Overall Study||0||
48405403|NCT02756845|101325273|FG001|COMPLETED|Overall Study||0||
48405404|NCT02756845|101325272|FG000|NOT COMPLETED|Overall Study||13||
48303292|NCT01790126|101070089|FG002|Treated|Overall Study||31||
48303293|NCT01790126|101070087|FG000|COMPLETED|Overall Study||0||
48303294|NCT01790126|101070088|FG001|COMPLETED|Overall Study||0||
48303295|NCT01790126|101070089|FG002|COMPLETED|Overall Study||0||
48405405|NCT02756845|101325273|FG001|NOT COMPLETED|Overall Study||2||
48405406|NCT01838655|101325274|FG000|STARTED|Overall Study||5||
48605833|NCT05137002|101819845|FG004|NOT COMPLETED|Part I (8 Weeks)||0||
48605834|NCT05137002|101819841|FG000|STARTED|Part II (4 Weeks)||0||
48605835|NCT05137002|101819842|FG001|STARTED|Part II (4 Weeks)||0||
48605836|NCT05137002|101819843|FG002|STARTED|Part II (4 Weeks)||0||
48605837|NCT05137002|101819844|FG003|STARTED|Part II (4 Weeks)||0||
48605838|NCT05137002|101819845|FG004|STARTED|Part II (4 Weeks)||213||
48605839|NCT05137002|101819841|FG000|COMPLETED|Part II (4 Weeks)||0||
48605840|NCT05137002|101819842|FG001|COMPLETED|Part II (4 Weeks)||0||
48605841|NCT05137002|101819843|FG002|COMPLETED|Part II (4 Weeks)||0||
48605842|NCT05137002|101819844|FG003|COMPLETED|Part II (4 Weeks)||0||
48605843|NCT05137002|101819845|FG004|COMPLETED|Part II (4 Weeks)||201||
48605844|NCT05137002|101819841|FG000|NOT COMPLETED|Part II (4 Weeks)||0||
48303296|NCT01790126|101070087|FG000|NOT COMPLETED|Overall Study||30||
48303297|NCT01790126|101070088|FG001|NOT COMPLETED|Overall Study||29||
48303298|NCT01790126|101070089|FG002|NOT COMPLETED|Overall Study||31||
48303299|NCT01822522|101070090|FG000|STARTED|Overall Study||6||
48303300|NCT01822522|101070091|FG001|STARTED|Overall Study||7||
48303301|NCT01822522|101070092|FG002|STARTED|Overall Study||7||
48303302|NCT01822522|101070093|FG003|STARTED|Overall Study||6||
48303303|NCT01822522|101070094|FG004|STARTED|Overall Study||3||
48605845|NCT05137002|101819842|FG001|NOT COMPLETED|Part II (4 Weeks)||0||
48605846|NCT05137002|101819843|FG002|NOT COMPLETED|Part II (4 Weeks)||0||
48605847|NCT05137002|101819844|FG003|NOT COMPLETED|Part II (4 Weeks)||0||
48605848|NCT05137002|101819845|FG004|NOT COMPLETED|Part II (4 Weeks)||12||
48605849|NCT00351936|101819846|FG000|STARTED|Overall Study||15||
48605850|NCT00351936|101819846|FG000|COMPLETED|Overall Study||15||
48605851|NCT00351936|101819846|FG000|NOT COMPLETED|Overall Study||0||
48303304|NCT01822522|101070095|FG005|STARTED|Overall Study||7||
48303305|NCT01822522|101070090|FG000|COMPLETED|Overall Study||2||
48303306|NCT01822522|101070091|FG001|COMPLETED|Overall Study||6||
48605852|NCT02227368|101819847|FG000|STARTED|Overall Study||16||
48303307|NCT01822522|101070092|FG002|COMPLETED|Overall Study||3||
48605853|NCT02227368|101819848|FG001|STARTED|Overall Study||24||
48605854|NCT02227368|101819847|FG000|Sujects Who Received Treatment|Overall Study||16||
48303308|NCT01822522|101070093|FG003|COMPLETED|Overall Study||4||
48303309|NCT01822522|101070094|FG004|COMPLETED|Overall Study||3||
48605855|NCT02227368|101819848|FG001|Sujects Who Received Treatment|Overall Study||24||
48605856|NCT02227368|101819847|FG000|Sujects Who Completed Treatment|Overall Study||10||
48303310|NCT01822522|101070095|FG005|COMPLETED|Overall Study||3||
48303311|NCT01822522|101070090|FG000|NOT COMPLETED|Overall Study||4||
48303312|NCT01822522|101070091|FG001|NOT COMPLETED|Overall Study||1||
48303313|NCT01822522|101070092|FG002|NOT COMPLETED|Overall Study||4||
48303314|NCT01822522|101070093|FG003|NOT COMPLETED|Overall Study||2||
48303315|NCT01822522|101070094|FG004|NOT COMPLETED|Overall Study||0||
48303316|NCT01822522|101070095|FG005|NOT COMPLETED|Overall Study||4||
48303317|NCT01195545|101070096|FG000|STARTED|Overall Study||20||
48303318|NCT01195545|101070096|FG000|COMPLETED|Overall Study||16||
48303319|NCT01195545|101070096|FG000|NOT COMPLETED|Overall Study||4||
48303320|NCT02431650|101070097|FG000|STARTED|Overall Study||5||
48303321|NCT02431650|101070098|FG001|STARTED|Overall Study||6||
48303322|NCT02431650|101070097|FG000|COMPLETED|Overall Study||5||
48303323|NCT02431650|101070098|FG001|COMPLETED|Overall Study||6||
48303324|NCT02431650|101070097|FG000|NOT COMPLETED|Overall Study||0||
48303325|NCT02431650|101070098|FG001|NOT COMPLETED|Overall Study||0||
48303326|NCT01729156|101070099|FG000|STARTED|Overall Study||12||
48405407|NCT01838655|101325274|FG000|COMPLETED|Overall Study||5||
48303327|NCT01729156|101070100|FG001|STARTED|Overall Study||12||
48303328|NCT01729156|101070101|FG002|STARTED|Overall Study||12||
48303329|NCT01729156|101070099|FG000|COMPLETED|Overall Study||11||
48303330|NCT01729156|101070100|FG001|COMPLETED|Overall Study||12||
48303331|NCT01729156|101070101|FG002|COMPLETED|Overall Study||12||
48303332|NCT01729156|101070099|FG000|NOT COMPLETED|Overall Study||1||
48303333|NCT01729156|101070100|FG001|NOT COMPLETED|Overall Study||0||
48303334|NCT01729156|101070101|FG002|NOT COMPLETED|Overall Study||0||
48303335|NCT01854645|101070102|FG000|STARTED|Overall Study||527||
48303336|NCT01854645|101070103|FG001|STARTED|Overall Study||451||
48303337|NCT01854645|101070104|FG002|STARTED|Overall Study||452||
48303338|NCT01854645|101070105|FG003|STARTED|Overall Study||453||
48303339|NCT01854645|101070106|FG004|STARTED|Overall Study||220||
48605857|NCT02227368|101819848|FG001|Sujects Who Completed Treatment|Overall Study||17||
48605858|NCT02227368|101819847|FG000|COMPLETED|Overall Study||14||
48605859|NCT02227368|101819848|FG001|COMPLETED|Overall Study||20||
48303340|NCT01854645|101070102|FG000|COMPLETED|Overall Study||429||
48303341|NCT01854645|101070103|FG001|COMPLETED|Overall Study||345||
48303342|NCT01854645|101070104|FG002|COMPLETED|Overall Study||370||
48303343|NCT01854645|101070105|FG003|COMPLETED|Overall Study||391||
48605860|NCT02227368|101819847|FG000|NOT COMPLETED|Overall Study||2||
48605861|NCT02227368|101819848|FG001|NOT COMPLETED|Overall Study||4||
48605862|NCT03178851|101819849|FG000|STARTED|Overall Study||92||
48605863|NCT03178851|101819850|FG001|STARTED|Overall Study||11||
48605864|NCT03178851|101819851|FG002|STARTED|Overall Study||52||
48605865|NCT03178851|101819849|FG000|COMPLETED|Overall Study||0||
48303344|NCT01854645|101070106|FG004|COMPLETED|Overall Study||160||
48303345|NCT01854645|101070102|FG000|NOT COMPLETED|Overall Study||98||
48303346|NCT01854645|101070103|FG001|NOT COMPLETED|Overall Study||106||
48303347|NCT01854645|101070104|FG002|NOT COMPLETED|Overall Study||82||
48303348|NCT01854645|101070105|FG003|NOT COMPLETED|Overall Study||62||
48605866|NCT03178851|101819850|FG001|COMPLETED|Overall Study||0||
48605867|NCT03178851|101819851|FG002|COMPLETED|Overall Study||0||
48405408|NCT01838655|101325274|FG000|NOT COMPLETED|Overall Study||0||
48605868|NCT03178851|101819849|FG000|NOT COMPLETED|Overall Study||92||
48605869|NCT03178851|101819850|FG001|NOT COMPLETED|Overall Study||11||
48605870|NCT03178851|101819851|FG002|NOT COMPLETED|Overall Study||52||
48605871|NCT01796301|101819852|FG000|STARTED|Overall Study||218||
48605872|NCT01796301|101819853|FG001|STARTED|Overall Study||218||
48303349|NCT01854645|101070106|FG004|NOT COMPLETED|Overall Study||60||
48303350|NCT01772004|101070107|FG000|STARTED|Dose Escalation Phase||4||
48605873|NCT01796301|101819852|FG000|Received Treatment|Overall Study||214||
48605874|NCT01796301|101819853|FG001|Received Treatment|Overall Study||218||
48605875|NCT01796301|101819852|FG000|COMPLETED|Overall Study||200||
48605876|NCT01796301|101819853|FG001|COMPLETED|Overall Study||198||
48605877|NCT01796301|101819852|FG000|NOT COMPLETED|Overall Study||18||
48605878|NCT01796301|101819853|FG001|NOT COMPLETED|Overall Study||20||
48605879|NCT01398358|101819854|FG000|STARTED|Overall Study||218||
48605880|NCT01398358|101819855|FG001|STARTED|Overall Study||224||
48605881|NCT01398358|101819856|FG002|STARTED|Overall Study||255||
48605882|NCT01398358|101819854|FG000|COMPLETED|Overall Study||203||
48605883|NCT01398358|101819855|FG001|COMPLETED|Overall Study||201||
48605884|NCT01398358|101819856|FG002|COMPLETED|Overall Study||234||
48605885|NCT01398358|101819854|FG000|NOT COMPLETED|Overall Study||15||
48605886|NCT01398358|101819855|FG001|NOT COMPLETED|Overall Study||23||
48303351|NCT01772004|101070108|FG001|STARTED|Dose Escalation Phase||13||
48303352|NCT01772004|101070109|FG002|STARTED|Dose Escalation Phase||15||
48303353|NCT01772004|101070110|FG003|STARTED|Dose Escalation Phase||21||
48303354|NCT01772004|101070111|FG004|STARTED|Dose Escalation Phase||8||
48303355|NCT01772004|101070112|FG005|STARTED|Dose Escalation Phase||0||
48303356|NCT01772004|101070113|FG006|STARTED|Dose Escalation Phase||0||
48303357|NCT01772004|101070114|FG007|STARTED|Dose Escalation Phase||0||
48405409|NCT02996500|101325275|FG000|STARTED|Overall Study||39||
48605887|NCT01398358|101819856|FG002|NOT COMPLETED|Overall Study||21||
48605888|NCT03042910|101819857|FG000|STARTED|Overall Study||38||
48605889|NCT03042910|101819857|FG000|Treated|Overall Study||37||
48303358|NCT01772004|101070115|FG008|STARTED|Dose Escalation Phase||0||
48605890|NCT03042910|101819857|FG000|COMPLETED|Overall Study||31||
48605891|NCT03042910|101819857|FG000|NOT COMPLETED|Overall Study||7||
48605892|NCT02328937|101819858|FG000|STARTED|Period 1||7||
48605893|NCT02328937|101819859|FG001|STARTED|Period 1||6||
48605894|NCT02328937|101819860|FG002|STARTED|Period 1||7||
48605895|NCT02328937|101819861|FG003|STARTED|Period 1||6||
48605896|NCT02328937|101819862|FG004|STARTED|Period 1||6||
48605897|NCT02328937|101819863|FG005|STARTED|Period 1||6||
48605898|NCT02328937|101819858|FG000|COMPLETED|Period 1||7||
48605899|NCT02328937|101819859|FG001|COMPLETED|Period 1||6||
48605900|NCT02328937|101819860|FG002|COMPLETED|Period 1||7||
48605901|NCT02328937|101819861|FG003|COMPLETED|Period 1||5||
48605902|NCT02328937|101819862|FG004|COMPLETED|Period 1||6||
48303359|NCT01772004|101070116|FG009|STARTED|Dose Escalation Phase||0||
48605903|NCT02328937|101819863|FG005|COMPLETED|Period 1||6||
48605904|NCT02328937|101819858|FG000|NOT COMPLETED|Period 1||0||
48605905|NCT02328937|101819859|FG001|NOT COMPLETED|Period 1||0||
48605906|NCT02328937|101819860|FG002|NOT COMPLETED|Period 1||0||
48605907|NCT02328937|101819861|FG003|NOT COMPLETED|Period 1||1||
48303360|NCT01772004|101070117|FG010|STARTED|Dose Escalation Phase||0||
48303361|NCT01772004|101070118|FG011|STARTED|Dose Escalation Phase||0||
48405410|NCT02996500|101325276|FG001|STARTED|Overall Study||43||
48405411|NCT02996500|101325277|FG002|STARTED|Overall Study||39||
48405412|NCT02996500|101325278|FG003|STARTED|Overall Study||50||
48405413|NCT02996500|101325279|FG004|STARTED|Overall Study||50||
48405414|NCT02996500|101325280|FG005|STARTED|Overall Study||48||
48405415|NCT02996500|101325275|FG000|COMPLETED|Overall Study||31||
48405416|NCT02996500|101325276|FG001|COMPLETED|Overall Study||42||
48405417|NCT02996500|101325277|FG002|COMPLETED|Overall Study||29||
48405418|NCT02996500|101325278|FG003|COMPLETED|Overall Study||46||
48405419|NCT02996500|101325279|FG004|COMPLETED|Overall Study||45||
48405420|NCT02996500|101325280|FG005|COMPLETED|Overall Study||44||
48405421|NCT02996500|101325275|FG000|NOT COMPLETED|Overall Study||8||
48405422|NCT02996500|101325276|FG001|NOT COMPLETED|Overall Study||1||
48405423|NCT02996500|101325277|FG002|NOT COMPLETED|Overall Study||10||
48405424|NCT02996500|101325278|FG003|NOT COMPLETED|Overall Study||4||
48405425|NCT02996500|101325279|FG004|NOT COMPLETED|Overall Study||5||
48405426|NCT02996500|101325280|FG005|NOT COMPLETED|Overall Study||4||
48405427|NCT04350372|101325281|FG000|STARTED|Overall Study||16||
48405428|NCT04350372|101325281|FG000|COMPLETED|Overall Study||15||
48405429|NCT04350372|101325281|FG000|NOT COMPLETED|Overall Study||1||
48405430|NCT04246541|101325282|FG000|STARTED|Overall Study||25||
48405431|NCT04246541|101325283|FG001|STARTED|Overall Study||23||
48405432|NCT04246541|101325282|FG000|COMPLETED|Overall Study||22||
48405433|NCT04246541|101325283|FG001|COMPLETED|Overall Study||20||
48405434|NCT04246541|101325282|FG000|NOT COMPLETED|Overall Study||3||
48405435|NCT04246541|101325283|FG001|NOT COMPLETED|Overall Study||3||
48405436|NCT02741310|101325284|FG000|STARTED|Overall Study||12||
48405437|NCT02741310|101325285|FG001|STARTED|Overall Study||22||
48405438|NCT02741310|101325284|FG000|COMPLETED|Overall Study||10||
48405439|NCT02741310|101325285|FG001|COMPLETED|Overall Study||20||
48405440|NCT02741310|101325284|FG000|NOT COMPLETED|Overall Study||2||
48405441|NCT02741310|101325285|FG001|NOT COMPLETED|Overall Study||2||
48405442|NCT01833806|101325286|FG000|STARTED|Overall Study||32||
48405443|NCT01833806|101325286|FG000|COMPLETED|Overall Study||23||
48405444|NCT01833806|101325286|FG000|NOT COMPLETED|Overall Study||9||
48405445|NCT02150460|101325287|FG000|STARTED|Overall Study||50||
48405446|NCT02150460|101325288|FG001|STARTED|Overall Study||50||
48405447|NCT02150460|101325287|FG000|COMPLETED|Overall Study||50||
48405448|NCT02150460|101325288|FG001|COMPLETED|Overall Study||50||
48405449|NCT02150460|101325287|FG000|NOT COMPLETED|Overall Study||0||
48405450|NCT02150460|101325288|FG001|NOT COMPLETED|Overall Study||0||
48405451|NCT02667236|101325289|FG000|STARTED|Overall Study||223||
48303362|NCT01772004|101070119|FG012|STARTED|Dose Escalation Phase||0||
48405452|NCT02667236|101325290|FG001|STARTED|Overall Study||227||
48405453|NCT02667236|101325289|FG000|COMPLETED|Overall Study||220||
48405454|NCT02667236|101325290|FG001|COMPLETED|Overall Study||226||
48405455|NCT02667236|101325289|FG000|NOT COMPLETED|Overall Study||3||
48405456|NCT02667236|101325290|FG001|NOT COMPLETED|Overall Study||1||
48405457|NCT00626340|101325291|FG000|STARTED|Overall Study||18||
48405458|NCT00626340|101325291|FG000|COMPLETED|Overall Study||18||
48405459|NCT00626340|101325291|FG000|NOT COMPLETED|Overall Study||0||
48405460|NCT03655080|101325292|FG000|STARTED|Overall Study||2||
48605908|NCT02328937|101819862|FG004|NOT COMPLETED|Period 1||0||
48605909|NCT02328937|101819863|FG005|NOT COMPLETED|Period 1||0||
48605910|NCT02328937|101819858|FG000|STARTED|Period 2||7||
48605911|NCT02328937|101819859|FG001|STARTED|Period 2||6||
48605912|NCT02328937|101819860|FG002|STARTED|Period 2||7||
48605913|NCT02328937|101819861|FG003|STARTED|Period 2||5||
48605914|NCT02328937|101819862|FG004|STARTED|Period 2||6||
48605915|NCT02328937|101819863|FG005|STARTED|Period 2||6||
48303363|NCT01772004|101070120|FG013|STARTED|Dose Escalation Phase||0||
48303364|NCT01772004|101070121|FG014|STARTED|Dose Escalation Phase||0||
48303365|NCT01772004|101070122|FG015|STARTED|Dose Escalation Phase||0||
48303366|NCT01772004|101070123|FG016|STARTED|Dose Escalation Phase||0||
48303367|NCT01772004|101070124|FG017|STARTED|Dose Escalation Phase||0||
48405461|NCT03655080|101325292|FG000|COMPLETED|Overall Study||2||
48303368|NCT01772004|101070125|FG018|STARTED|Dose Escalation Phase||0||
48303369|NCT01772004|101070126|FG019|STARTED|Dose Escalation Phase||0||
48303370|NCT01772004|101070127|FG020|STARTED|Dose Escalation Phase||0||
48303371|NCT01772004|101070128|FG021|STARTED|Dose Escalation Phase||0||
48303372|NCT01772004|101070129|FG022|STARTED|Dose Escalation Phase||0||
48303373|NCT01772004|101070107|FG000|COMPLETED|Dose Escalation Phase||4||
48405462|NCT03655080|101325292|FG000|NOT COMPLETED|Overall Study||0||
48405463|NCT03128307|101325293|FG000|STARTED|Overall Study||604||
48405464|NCT03128307|101325293|FG000|COMPLETED|Overall Study||570||
48405465|NCT03128307|101325293|FG000|NOT COMPLETED|Overall Study||34||
48405466|NCT03297944|101325294|FG000|STARTED|Overall Study||15||
48405467|NCT03297944|101325294|FG000|2ALP/PLC|Overall Study||15||
48405468|NCT03297944|101325294|FG000|1ALP/PLC|Overall Study||15||
48405469|NCT03297944|101325294|FG000|0.5ALP/PLC|Overall Study||15||
48605916|NCT02328937|101819858|FG000|COMPLETED|Period 2||7||
48605917|NCT02328937|101819859|FG001|COMPLETED|Period 2||6||
48605918|NCT02328937|101819860|FG002|COMPLETED|Period 2||6||
48605919|NCT02328937|101819861|FG003|COMPLETED|Period 2||5||
48605920|NCT02328937|101819862|FG004|COMPLETED|Period 2||6||
48605921|NCT02328937|101819863|FG005|COMPLETED|Period 2||6||
48605922|NCT02328937|101819858|FG000|NOT COMPLETED|Period 2||0||
48605923|NCT02328937|101819859|FG001|NOT COMPLETED|Period 2||0||
48605924|NCT02328937|101819860|FG002|NOT COMPLETED|Period 2||1||
48715824|NCT00316888|102091768|FG000|Started Chemo+Radiation+Cetuximab|Overall Study||27||
48405470|NCT03297944|101325294|FG000|ZOL/PLC|Overall Study||15||
48605925|NCT02328937|101819861|FG003|NOT COMPLETED|Period 2||0||
48605926|NCT02328937|101819862|FG004|NOT COMPLETED|Period 2||0||
48605927|NCT02328937|101819863|FG005|NOT COMPLETED|Period 2||0||
48605928|NCT02328937|101819858|FG000|STARTED|Period 3||7||
48605929|NCT02328937|101819859|FG001|STARTED|Period 3||6||
48715825|NCT00316888|102091769|FG001|Started Chemo+Radiation+Cetuximab|Overall Study||34||
48715826|NCT00316888|102091768|FG000|COMPLETED|Overall Study||22||
48715827|NCT00316888|102091769|FG001|COMPLETED|Overall Study||27||
48605930|NCT02328937|101819860|FG002|STARTED|Period 3||6||
48605931|NCT02328937|101819861|FG003|STARTED|Period 3||5||
48605932|NCT02328937|101819862|FG004|STARTED|Period 3||6||
48605933|NCT02328937|101819863|FG005|STARTED|Period 3||6||
48605934|NCT02328937|101819858|FG000|COMPLETED|Period 3||7||
48605935|NCT02328937|101819859|FG001|COMPLETED|Period 3||6||
48715828|NCT00316888|102091768|FG000|NOT COMPLETED|Overall Study||6||
48715829|NCT00316888|102091769|FG001|NOT COMPLETED|Overall Study||8||
48605936|NCT02328937|101819860|FG002|COMPLETED|Period 3||6||
48605937|NCT02328937|101819861|FG003|COMPLETED|Period 3||5||
48605938|NCT02328937|101819862|FG004|COMPLETED|Period 3||6||
48605939|NCT02328937|101819863|FG005|COMPLETED|Period 3||6||
48605940|NCT02328937|101819858|FG000|NOT COMPLETED|Period 3||0||
48605941|NCT02328937|101819859|FG001|NOT COMPLETED|Period 3||0||
48605942|NCT02328937|101819860|FG002|NOT COMPLETED|Period 3||0||
48605943|NCT02328937|101819861|FG003|NOT COMPLETED|Period 3||0||
48605944|NCT02328937|101819862|FG004|NOT COMPLETED|Period 3||0||
48605945|NCT02328937|101819863|FG005|NOT COMPLETED|Period 3||0||
48605946|NCT01456143|101819864|FG000|STARTED|Overall Study||33||
48715830|NCT03405935|102091770|FG000|STARTED|Overall Study||86||
48715831|NCT03405935|102091770|FG000|COMPLETED|Overall Study||78||
48715832|NCT03405935|102091770|FG000|NOT COMPLETED|Overall Study||8||
48715833|NCT04172467|102091771|FG000|STARTED|Overall Study||1086||
48715834|NCT04172467|102091771|FG000|COMPLETED|Overall Study||1086||
48715835|NCT04172467|102091771|FG000|NOT COMPLETED|Overall Study||0||
48715836|NCT02130986|102091772|FG000|STARTED|Overall Study||830||
48605947|NCT01456143|101819864|FG000|COMPLETED|Overall Study||33||
48605948|NCT01456143|101819864|FG000|NOT COMPLETED|Overall Study||0||
48605949|NCT01782352|101819865|FG000|STARTED|Overall Study||6463||
48605950|NCT01782352|101819866|FG001|STARTED|Overall Study||6464||
48605951|NCT01782352|101819867|FG002|STARTED|Overall Study||6470||
48605952|NCT01782352|101819868|FG003|STARTED|Overall Study||6474||
48605953|NCT01782352|101819865|FG000|COMPLETED|Overall Study||6463||
48605954|NCT01782352|101819866|FG001|COMPLETED|Overall Study||6464||
48605955|NCT01782352|101819867|FG002|COMPLETED|Overall Study||6470||
48605956|NCT01782352|101819868|FG003|COMPLETED|Overall Study||6474||
48715837|NCT02130986|102091773|FG001|STARTED|Overall Study||834||
48715838|NCT02130986|102091772|FG000|COMPLETED|Overall Study||675||
48715839|NCT02130986|102091773|FG001|COMPLETED|Overall Study||670||
48605957|NCT01782352|101819865|FG000|NOT COMPLETED|Overall Study||0||
48605958|NCT01782352|101819866|FG001|NOT COMPLETED|Overall Study||0||
48605959|NCT01782352|101819867|FG002|NOT COMPLETED|Overall Study||0||
48605960|NCT01782352|101819868|FG003|NOT COMPLETED|Overall Study||0||
48605961|NCT01763203|101819869|FG000|STARTED|Overall Study||241||
48605962|NCT01763203|101819870|FG001|STARTED|Overall Study||246||
48605963|NCT01763203|101819869|FG000|COMPLETED|Overall Study||208||
48605964|NCT01763203|101819870|FG001|COMPLETED|Overall Study||204||
48605965|NCT01763203|101819869|FG000|NOT COMPLETED|Overall Study||33||
48715840|NCT02130986|102091772|FG000|NOT COMPLETED|Overall Study||155||
48715841|NCT02130986|102091773|FG001|NOT COMPLETED|Overall Study||164||
48405471|NCT03297944|101325294|FG000|PLC/PLC|Overall Study||15||
48605966|NCT01763203|101819870|FG001|NOT COMPLETED|Overall Study||42||
48605967|NCT03231397|101819871|FG000|STARTED|Overall Study||0||
48605968|NCT03231397|101819872|FG001|STARTED|Overall Study||1||
48605969|NCT03231397|101819873|FG002|STARTED|Overall Study||1||
48605970|NCT03231397|101819874|FG003|STARTED|Overall Study||0||
48605971|NCT03231397|101819871|FG000|COMPLETED|Overall Study||0||
48605972|NCT03231397|101819872|FG001|COMPLETED|Overall Study||1||
48605973|NCT03231397|101819873|FG002|COMPLETED|Overall Study||1||
48715842|NCT02120365|102091774|FG000|STARTED|Overall Study||4||
48715843|NCT02120365|102091775|FG001|STARTED|Overall Study||4||
48715844|NCT02120365|102091776|FG002|STARTED|Overall Study||5||
48715845|NCT02120365|102091777|FG003|STARTED|Overall Study||4||
48715846|NCT02120365|102091778|FG004|STARTED|Overall Study||3||
48715847|NCT02120365|102091779|FG005|STARTED|Overall Study||2||
48605974|NCT03231397|101819874|FG003|COMPLETED|Overall Study||0||
48605975|NCT03231397|101819871|FG000|NOT COMPLETED|Overall Study||0||
48605976|NCT03231397|101819872|FG001|NOT COMPLETED|Overall Study||0||
48605977|NCT03231397|101819873|FG002|NOT COMPLETED|Overall Study||0||
48605978|NCT03231397|101819874|FG003|NOT COMPLETED|Overall Study||0||
48715848|NCT02120365|102091774|FG000|COMPLETED|Overall Study||4||
48715849|NCT02120365|102091775|FG001|COMPLETED|Overall Study||4||
48605979|NCT01549340|101819875|FG000|STARTED|Overall Study||8790||
48605980|NCT01549340|101819875|FG000|Started AIT|Overall Study||3182||
48605981|NCT01549340|101819875|FG000|COMPLETED|Overall Study||385||
48605982|NCT01549340|101819875|FG000|NOT COMPLETED|Overall Study||8405||
48605983|NCT00645671|101819876|FG000|STARTED|Overall Study||201||
48605984|NCT00645671|101819877|FG001|STARTED|Overall Study||199||
48605985|NCT00645671|101819876|FG000|COMPLETED|Overall Study||200||
48605986|NCT00645671|101819877|FG001|COMPLETED|Overall Study||193||
48605987|NCT00645671|101819876|FG000|NOT COMPLETED|Overall Study||1||
48605988|NCT00645671|101819877|FG001|NOT COMPLETED|Overall Study||6||
48605989|NCT02022735|101819878|FG000|STARTED|Overall Study||22||
48605990|NCT02022735|101819878|FG000|COMPLETED|Overall Study||22||
48605991|NCT02022735|101819878|FG000|NOT COMPLETED|Overall Study||0||
48605992|NCT00593606|101819879|FG000|STARTED|Overall Study||124||
48605993|NCT00593606|101819879|FG000|Start of Treatment - Safety Set|Overall Study||116||
48605994|NCT00593606|101819879|FG000|Full Analysis Set|Overall Study||114||
48605995|NCT00593606|101819879|FG000|Treatment Period Completed|Overall Study||99||
48605996|NCT00593606|101819879|FG000|COMPLETED|Overall Study||97||
48605997|NCT00593606|101819879|FG000|NOT COMPLETED|Overall Study||27||
48605998|NCT02178358|101819880|FG000|STARTED|Overall Study||20||
48605999|NCT02178358|101819881|FG001|STARTED|Overall Study||74||
48606000|NCT02178358|101819882|FG002|STARTED|Overall Study||38||
48606001|NCT02178358|101819880|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20||
48606002|NCT02178358|101819881|FG001|Received at Least 1 Dose of Study Drug|Overall Study||74||
48606003|NCT02178358|101819882|FG002|Received at Least 1 Dose of Study Drug|Overall Study||38||
48606004|NCT02178358|101819880|FG000|COMPLETED|Overall Study||19||
48606005|NCT02178358|101819881|FG001|COMPLETED|Overall Study||72||
48606006|NCT02178358|101819882|FG002|COMPLETED|Overall Study||36||
48606007|NCT02178358|101819880|FG000|NOT COMPLETED|Overall Study||1||
48606008|NCT02178358|101819881|FG001|NOT COMPLETED|Overall Study||2||
48606009|NCT02178358|101819882|FG002|NOT COMPLETED|Overall Study||2||
48606010|NCT00006244|101819883|FG000|STARTED|Overall Study||36||
48606011|NCT00006244|101819883|FG000|COMPLETED|Overall Study||36||
48606012|NCT00006244|101819883|FG000|NOT COMPLETED|Overall Study||0||
48606013|NCT00691652|101819884|FG000|STARTED|Overall Study||2||
48606014|NCT00691652|101819884|FG000|COMPLETED|Overall Study||1||
48606015|NCT00691652|101819884|FG000|NOT COMPLETED|Overall Study||1||
48303374|NCT01772004|101070108|FG001|COMPLETED|Dose Escalation Phase||13||
48303375|NCT01772004|101070109|FG002|COMPLETED|Dose Escalation Phase||15||
48606016|NCT03824366|101819885|FG000|STARTED|Overall Study||20||
48606017|NCT03824366|101819885|FG000|COMPLETED|Overall Study||16||
48606018|NCT03824366|101819885|FG000|NOT COMPLETED|Overall Study||4||
48606019|NCT04096001|101819886|FG000|STARTED|Overall Study||101||
48606020|NCT04096001|101819886|FG000|COMPLETED|Overall Study||51||
48606021|NCT04096001|101819886|FG000|NOT COMPLETED|Overall Study||50||
48606022|NCT00313586|101819887|FG000|STARTED|Overall Study||75||
48606023|NCT00313586|101819888|FG001|STARTED|Overall Study||75||
48303376|NCT01772004|101070110|FG003|COMPLETED|Dose Escalation Phase||21||
48606024|NCT00313586|101819889|FG002|STARTED|Overall Study||24||
48606025|NCT00313586|101819890|FG003|STARTED|Overall Study||23||
48606026|NCT00313586|101819887|FG000|Treated|Overall Study||74||
48606027|NCT00313586|101819888|FG001|Treated|Overall Study||75||
48606028|NCT00313586|101819889|FG002|Treated|Overall Study||24||
48606029|NCT00313586|101819890|FG003|Treated|Overall Study||23||
48606030|NCT00313586|101819887|FG000|COMPLETED|Overall Study||5||
48606031|NCT00313586|101819888|FG001|COMPLETED|Overall Study||5||
48606032|NCT00313586|101819889|FG002|COMPLETED|Overall Study||0||
48606033|NCT00313586|101819890|FG003|COMPLETED|Overall Study||0||
48606034|NCT00313586|101819887|FG000|NOT COMPLETED|Overall Study||70||
48606035|NCT00313586|101819888|FG001|NOT COMPLETED|Overall Study||70||
48606036|NCT00313586|101819889|FG002|NOT COMPLETED|Overall Study||24||
48606037|NCT00313586|101819890|FG003|NOT COMPLETED|Overall Study||23||
48606038|NCT03859648|101819891|FG000|STARTED|Overall Study||8||
48606039|NCT03859648|101819891|FG000|COMPLETED|Overall Study||6||
48606040|NCT03859648|101819891|FG000|NOT COMPLETED|Overall Study||2||
48606041|NCT00564395|101819892|FG000|STARTED|First Intervention (10 Days)||9||
48606042|NCT00564395|101819893|FG001|STARTED|First Intervention (10 Days)||9||
48606043|NCT00564395|101819892|FG000|Received Intervention|First Intervention (10 Days)||7||
48606044|NCT00564395|101819893|FG001|Received Intervention|First Intervention (10 Days)||7||
48606045|NCT00564395|101819892|FG000|COMPLETED|First Intervention (10 Days)||7||
48606046|NCT00564395|101819893|FG001|COMPLETED|First Intervention (10 Days)||7||
48606047|NCT00564395|101819892|FG000|NOT COMPLETED|First Intervention (10 Days)||2||
48606048|NCT00564395|101819893|FG001|NOT COMPLETED|First Intervention (10 Days)||2||
48606049|NCT00564395|101819892|FG000|STARTED|Second Intervention (10 Days)||7||
48606050|NCT00564395|101819893|FG001|STARTED|Second Intervention (10 Days)||7||
48606051|NCT00564395|101819892|FG000|COMPLETED|Second Intervention (10 Days)||7||
48606052|NCT00564395|101819893|FG001|COMPLETED|Second Intervention (10 Days)||7||
48606053|NCT00564395|101819892|FG000|NOT COMPLETED|Second Intervention (10 Days)||0||
48606054|NCT00564395|101819893|FG001|NOT COMPLETED|Second Intervention (10 Days)||0||
48606055|NCT00048997|101819894|FG000|STARTED|Overall Study||176||
48606056|NCT00048997|101819895|FG001|STARTED|Overall Study||180||
48606057|NCT00048997|101819894|FG000|COMPLETED|Overall Study||163||
48606058|NCT00048997|101819895|FG001|COMPLETED|Overall Study||177||
48606059|NCT00048997|101819894|FG000|NOT COMPLETED|Overall Study||13||
48606060|NCT00048997|101819895|FG001|NOT COMPLETED|Overall Study||3||
48606061|NCT03041467|101819896|FG000|STARTED|Overall Study||170||
48606062|NCT03041467|101819897|FG001|STARTED|Overall Study||160||
48606063|NCT03041467|101819896|FG000|30 Days|Overall Study||159||
48606064|NCT03041467|101819897|FG001|30 Days|Overall Study||154||
48606065|NCT03041467|101819896|FG000|3 Months|Overall Study||158||
48606066|NCT03041467|101819897|FG001|3 Months|Overall Study||151||
48606067|NCT03041467|101819896|FG000|6 Months|Overall Study||145||
48715850|NCT02120365|102091776|FG002|COMPLETED|Overall Study||3||
48715851|NCT02120365|102091777|FG003|COMPLETED|Overall Study||0||
48715852|NCT02120365|102091778|FG004|COMPLETED|Overall Study||3||
48715853|NCT02120365|102091779|FG005|COMPLETED|Overall Study||0||
48715854|NCT02120365|102091774|FG000|NOT COMPLETED|Overall Study||0||
48715855|NCT02120365|102091775|FG001|NOT COMPLETED|Overall Study||0||
48715856|NCT02120365|102091776|FG002|NOT COMPLETED|Overall Study||2||
48715857|NCT02120365|102091777|FG003|NOT COMPLETED|Overall Study||4||
48715858|NCT02120365|102091778|FG004|NOT COMPLETED|Overall Study||0||
48715859|NCT02120365|102091779|FG005|NOT COMPLETED|Overall Study||2||
48715860|NCT01145053|102091780|FG000|STARTED|Overall Study||341||
48715861|NCT01145053|102091780|FG000|COMPLETED|Overall Study||248||
48715862|NCT01145053|102091780|FG000|NOT COMPLETED|Overall Study||93||
48715863|NCT00240110|102091781|FG000|STARTED|Overall Study||13||
48405472|NCT03297944|101325294|FG000|PLC/ALP|Overall Study||15||
48405473|NCT03297944|101325294|FG000|COMPLETED|Overall Study||15||
48405474|NCT03297944|101325294|FG000|NOT COMPLETED|Overall Study||0||
48405475|NCT01156363|101325295|FG000|STARTED|Overall Study||86||
48405476|NCT01156363|101325295|FG000|COMPLETED|Overall Study||64||
48405477|NCT01156363|101325295|FG000|NOT COMPLETED|Overall Study||22||
48405478|NCT02408484|101325296|FG000|STARTED|Overall Study||15||
48405479|NCT02408484|101325296|FG000|SAF Population|Overall Study||14|SAF = safety analysis population|
48405480|NCT02408484|101325296|FG000|FAS Population|Overall Study||14|FAS = full analysis population|
48405481|NCT02408484|101325296|FG000|PK Population|Overall Study||13|PK = pharmacokinetic population|
48405482|NCT02408484|101325296|FG000|firstBLEED Population|Overall Study||8|firstBLEED population = patients that have had at least one bleeding event treated with Octafibrin|
48405483|NCT02408484|101325296|FG000|BLEED Population|Overall Study||8|BLEED population = patients with all documented BEs treated with Octafibrin|
48405484|NCT02408484|101325296|FG000|SURG Population|Overall Study||3|SURG population = patients with surgical interventions with a least one infusion of Octafibrin|
48405485|NCT02408484|101325296|FG000|COMPLETED|Overall Study||11||
48405486|NCT02408484|101325296|FG000|NOT COMPLETED|Overall Study||4||
48405487|NCT01801124|101325297|FG000|STARTED|Overall Study||13||
48405488|NCT01801124|101325297|FG000|COMPLETED|Overall Study||13||
48405489|NCT01801124|101325297|FG000|NOT COMPLETED|Overall Study||0||
48405490|NCT01577628|101325298|FG000|STARTED|Overall Study||0||
48405491|NCT01577628|101325299|FG001|STARTED|Overall Study||0||
48405492|NCT01577628|101325300|FG002|STARTED|Overall Study||2||
48405493|NCT01577628|101325298|FG000|COMPLETED|Overall Study||0||
48405494|NCT01577628|101325299|FG001|COMPLETED|Overall Study||0||
48606068|NCT03041467|101819897|FG001|6 Months|Overall Study||144||
48606069|NCT03041467|101819896|FG000|9 Months|Overall Study||138||
48405495|NCT01577628|101325300|FG002|COMPLETED|Overall Study||0||
48606070|NCT03041467|101819897|FG001|9 Months|Overall Study||138||
48606071|NCT03041467|101819896|FG000|12 Months|Overall Study||131||
48606072|NCT03041467|101819897|FG001|12 Months|Overall Study||121||
48405496|NCT01577628|101325298|FG000|NOT COMPLETED|Overall Study||0||
48405497|NCT01577628|101325299|FG001|NOT COMPLETED|Overall Study||0||
48405498|NCT01577628|101325300|FG002|NOT COMPLETED|Overall Study||2||
48405499|NCT02253992|101325301|FG000|STARTED|Overall Study||6||
48405500|NCT02253992|101325302|FG001|STARTED|Overall Study||4||
48405501|NCT02253992|101325303|FG002|STARTED|Overall Study||150||
48405502|NCT02253992|101325301|FG000|COMPLETED|Overall Study||0|Completed= Continuing in the treatment period.|
48606073|NCT03041467|101819896|FG000|18 Months|Overall Study||123||
48606074|NCT03041467|101819897|FG001|18 Months|Overall Study||113||
48606075|NCT03041467|101819896|FG000|24 Months|Overall Study||110||
48715864|NCT00240110|102091782|FG001|STARTED|Overall Study||13||
48715865|NCT00240110|102091781|FG000|COMPLETED|Overall Study||7||
48715866|NCT00240110|102091782|FG001|COMPLETED|Overall Study||6||
48715867|NCT00240110|102091781|FG000|NOT COMPLETED|Overall Study||6||
48715868|NCT00240110|102091782|FG001|NOT COMPLETED|Overall Study||7||
48715869|NCT00391391|102091783|FG000|STARTED|Overall Study||98||
48606076|NCT03041467|101819897|FG001|24 Months|Overall Study||101||
48606077|NCT03041467|101819896|FG000|36 Months|Overall Study||75||
48606078|NCT03041467|101819897|FG001|36 Months|Overall Study||58||
48606079|NCT03041467|101819896|FG000|48 Months|Overall Study||54||
48606080|NCT03041467|101819897|FG001|48 Months|Overall Study||41||
48606081|NCT03041467|101819896|FG000|60 Months|Overall Study||57||
48606082|NCT03041467|101819897|FG001|60 Months|Overall Study||41||
48606083|NCT03041467|101819896|FG000|COMPLETED|Overall Study||57||
48606084|NCT03041467|101819897|FG001|COMPLETED|Overall Study||41||
48606085|NCT03041467|101819896|FG000|NOT COMPLETED|Overall Study||113||
48606086|NCT03041467|101819897|FG001|NOT COMPLETED|Overall Study||119||
48606087|NCT01709864|101819898|FG000|STARTED|Overall Study||222||
48606088|NCT01709864|101819899|FG001|STARTED|Overall Study||219||
48606089|NCT01709864|101819898|FG000|Full Analysis Set (FAS)|Overall Study||222||
48606090|NCT01709864|101819899|FG001|Full Analysis Set (FAS)|Overall Study||216||
48606091|NCT01709864|101819898|FG000|Per Protocol Set (PPS)|Overall Study||204||
48606092|NCT01709864|101819899|FG001|Per Protocol Set (PPS)|Overall Study||201||
48606093|NCT01709864|101819898|FG000|COMPLETED|Overall Study||215||
48606094|NCT01709864|101819899|FG001|COMPLETED|Overall Study||208||
48606095|NCT01709864|101819898|FG000|NOT COMPLETED|Overall Study||7||
48303377|NCT01772004|101070111|FG004|COMPLETED|Dose Escalation Phase||8||
48303378|NCT01772004|101070112|FG005|COMPLETED|Dose Escalation Phase||0||
48303379|NCT01772004|101070113|FG006|COMPLETED|Dose Escalation Phase||0||
48303380|NCT01772004|101070114|FG007|COMPLETED|Dose Escalation Phase||0||
48303381|NCT01772004|101070115|FG008|COMPLETED|Dose Escalation Phase||0||
48303382|NCT01772004|101070116|FG009|COMPLETED|Dose Escalation Phase||0||
48303383|NCT01772004|101070117|FG010|COMPLETED|Dose Escalation Phase||0||
48303384|NCT01772004|101070118|FG011|COMPLETED|Dose Escalation Phase||0||
48303385|NCT01772004|101070119|FG012|COMPLETED|Dose Escalation Phase||0||
48303386|NCT01772004|101070120|FG013|COMPLETED|Dose Escalation Phase||0||
48303387|NCT01772004|101070121|FG014|COMPLETED|Dose Escalation Phase||0||
48303388|NCT01772004|101070122|FG015|COMPLETED|Dose Escalation Phase||0||
48303389|NCT01772004|101070123|FG016|COMPLETED|Dose Escalation Phase||0||
48303390|NCT01772004|101070124|FG017|COMPLETED|Dose Escalation Phase||0||
48303391|NCT01772004|101070125|FG018|COMPLETED|Dose Escalation Phase||0||
48303392|NCT01772004|101070126|FG019|COMPLETED|Dose Escalation Phase||0||
48303393|NCT01772004|101070127|FG020|COMPLETED|Dose Escalation Phase||0||
48303394|NCT01772004|101070128|FG021|COMPLETED|Dose Escalation Phase||0||
48303395|NCT01772004|101070129|FG022|COMPLETED|Dose Escalation Phase||0||
48303396|NCT01772004|101070107|FG000|NOT COMPLETED|Dose Escalation Phase||0||
48303397|NCT01772004|101070108|FG001|NOT COMPLETED|Dose Escalation Phase||0||
48303398|NCT01772004|101070109|FG002|NOT COMPLETED|Dose Escalation Phase||0||
48303399|NCT01772004|101070110|FG003|NOT COMPLETED|Dose Escalation Phase||0||
48303400|NCT01772004|101070111|FG004|NOT COMPLETED|Dose Escalation Phase||0||
48303401|NCT01772004|101070112|FG005|NOT COMPLETED|Dose Escalation Phase||0||
48303402|NCT01772004|101070113|FG006|NOT COMPLETED|Dose Escalation Phase||0||
48303403|NCT01772004|101070114|FG007|NOT COMPLETED|Dose Escalation Phase||0||
48303404|NCT01772004|101070115|FG008|NOT COMPLETED|Dose Escalation Phase||0||
48303405|NCT01772004|101070116|FG009|NOT COMPLETED|Dose Escalation Phase||0||
48303406|NCT01772004|101070117|FG010|NOT COMPLETED|Dose Escalation Phase||0||
48303407|NCT01772004|101070118|FG011|NOT COMPLETED|Dose Escalation Phase||0||
48303408|NCT01772004|101070119|FG012|NOT COMPLETED|Dose Escalation Phase||0||
48303409|NCT01772004|101070120|FG013|NOT COMPLETED|Dose Escalation Phase||0||
48303410|NCT01772004|101070121|FG014|NOT COMPLETED|Dose Escalation Phase||0||
48303411|NCT01772004|101070122|FG015|NOT COMPLETED|Dose Escalation Phase||0||
48303412|NCT01772004|101070123|FG016|NOT COMPLETED|Dose Escalation Phase||0||
48303413|NCT01772004|101070124|FG017|NOT COMPLETED|Dose Escalation Phase||0||
48303414|NCT01772004|101070125|FG018|NOT COMPLETED|Dose Escalation Phase||0||
48303415|NCT01772004|101070126|FG019|NOT COMPLETED|Dose Escalation Phase||0||
48303416|NCT01772004|101070127|FG020|NOT COMPLETED|Dose Escalation Phase||0||
48303417|NCT01772004|101070128|FG021|NOT COMPLETED|Dose Escalation Phase||0||
48303418|NCT01772004|101070129|FG022|NOT COMPLETED|Dose Escalation Phase||0||
48303419|NCT01772004|101070107|FG000|STARTED|Dose Expansion Phase||0||
48303420|NCT01772004|101070108|FG001|STARTED|Dose Expansion Phase||0||
48303421|NCT01772004|101070109|FG002|STARTED|Dose Expansion Phase||0||
48303422|NCT01772004|101070110|FG003|STARTED|Dose Expansion Phase||0||
48303423|NCT01772004|101070111|FG004|STARTED|Dose Expansion Phase||0||
48303424|NCT01772004|101070112|FG005|STARTED|Dose Expansion Phase||184||
48303425|NCT01772004|101070113|FG006|STARTED|Dose Expansion Phase||156||
48606096|NCT01709864|101819899|FG001|NOT COMPLETED|Overall Study||11||
48606097|NCT01281956|101819900|FG000|STARTED|1st Intervention (3 Months)||5||
48606098|NCT01281956|101819901|FG001|STARTED|1st Intervention (3 Months)||5||
48606099|NCT01281956|101819900|FG000|COMPLETED|1st Intervention (3 Months)||5||
48606100|NCT01281956|101819901|FG001|COMPLETED|1st Intervention (3 Months)||5||
48606101|NCT01281956|101819900|FG000|NOT COMPLETED|1st Intervention (3 Months)||0||
48303426|NCT01772004|101070114|FG007|STARTED|Dose Expansion Phase||168||
48303427|NCT01772004|101070115|FG008|STARTED|Dose Expansion Phase||60||
48303428|NCT01772004|101070116|FG009|STARTED|Dose Expansion Phase||90||
48303429|NCT01772004|101070117|FG010|STARTED|Dose Expansion Phase||21||
48606102|NCT01281956|101819901|FG001|NOT COMPLETED|1st Intervention (3 Months)||0||
48715870|NCT00391391|102091784|FG001|STARTED|Overall Study||97||
48715871|NCT00391391|102091785|FG002|STARTED|Overall Study||161||
48148893|NCT00916032|100688581|FG001|COMPLETED|Overall Study||11||
48148894|NCT00916032|100688580|FG000|NOT COMPLETED|Overall Study||0||
48148895|NCT00916032|100688581|FG001|NOT COMPLETED|Overall Study||0||
48148896|NCT01803074|100688582|FG000|STARTED|Period 1: Part A (HIV-1 Clade B)||8||
48148897|NCT01803074|100688583|FG001|STARTED|Period 1: Part A (HIV-1 Clade B)||8||
48148898|NCT01803074|100688584|FG002|STARTED|Period 1: Part A (HIV-1 Clade B)||8||
48148899|NCT01803074|100688585|FG003|STARTED|Period 1: Part A (HIV-1 Clade B)||8||
48148900|NCT01803074|100688586|FG004|STARTED|Period 1: Part A (HIV-1 Clade B)||8||
48148901|NCT01803074|100688587|FG005|STARTED|Period 1: Part A (HIV-1 Clade B)||8||
48148902|NCT01803074|100688588|FG006|STARTED|Period 1: Part A (HIV-1 Clade B)||12||
48148903|NCT01803074|100688589|FG007|STARTED|Period 1: Part A (HIV-1 Clade B)||0||
48148904|NCT01803074|100688590|FG008|STARTED|Period 1: Part A (HIV-1 Clade B)||0||
48148905|NCT01803074|100688591|FG009|STARTED|Period 1: Part A (HIV-1 Clade B)||0||
48148906|NCT01803074|100688592|FG010|STARTED|Period 1: Part A (HIV-1 Clade B)||0||
48148907|NCT01803074|100688593|FG011|STARTED|Period 1: Part A (HIV-1 Clade B)||0||
48148908|NCT01803074|100688594|FG012|STARTED|Period 1: Part A (HIV-1 Clade B)||0||
48606103|NCT01281956|101819900|FG000|STARTED|2nd Intervention (3 Months)||5||
48606104|NCT01281956|101819901|FG001|STARTED|2nd Intervention (3 Months)||5||
48606105|NCT01281956|101819900|FG000|COMPLETED|2nd Intervention (3 Months)||4||
48606106|NCT01281956|101819901|FG001|COMPLETED|2nd Intervention (3 Months)||5||
48606107|NCT01281956|101819900|FG000|NOT COMPLETED|2nd Intervention (3 Months)||1||
48606108|NCT01281956|101819901|FG001|NOT COMPLETED|2nd Intervention (3 Months)||0||
48606109|NCT03585712|101819902|FG000|STARTED|Treatment Period 1||52||
48606110|NCT03585712|101819903|FG001|STARTED|Treatment Period 1||0||
48606111|NCT03585712|101819904|FG002|STARTED|Treatment Period 1||0||
48606112|NCT03585712|101819902|FG000|COMPLETED|Treatment Period 1||51||
48715872|NCT00391391|102091786|FG003|STARTED|Overall Study||164||
48715873|NCT00391391|102091783|FG000|COMPLETED|Overall Study||89||
48715874|NCT00391391|102091784|FG001|COMPLETED|Overall Study||87||
48715875|NCT00391391|102091785|FG002|COMPLETED|Overall Study||138||
48715876|NCT00391391|102091786|FG003|COMPLETED|Overall Study||145||
48148909|NCT01803074|100688595|FG013|STARTED|Period 1: Part A (HIV-1 Clade B)||0||
48148910|NCT01803074|100688582|FG000|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8||
48148911|NCT01803074|100688583|FG001|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8||
48606113|NCT03585712|101819903|FG001|COMPLETED|Treatment Period 1||0||
48606114|NCT03585712|101819904|FG002|COMPLETED|Treatment Period 1||0||
48606115|NCT03585712|101819902|FG000|NOT COMPLETED|Treatment Period 1||1||
48715877|NCT00391391|102091783|FG000|NOT COMPLETED|Overall Study||9||
48188700|NCT02034435|100783313|FG001|Aim 1|Overall Study||15||
48606116|NCT03585712|101819903|FG001|NOT COMPLETED|Treatment Period 1||0||
48715878|NCT00391391|102091784|FG001|NOT COMPLETED|Overall Study||10||
48715879|NCT00391391|102091785|FG002|NOT COMPLETED|Overall Study||23||
48715880|NCT00391391|102091786|FG003|NOT COMPLETED|Overall Study||19||
48606117|NCT03585712|101819904|FG002|NOT COMPLETED|Treatment Period 1||0||
48606118|NCT03585712|101819902|FG000|STARTED|Treatment Periods 2 and 3||0||
48606119|NCT03585712|101819903|FG001|STARTED|Treatment Periods 2 and 3||26||
48606120|NCT03585712|101819904|FG002|STARTED|Treatment Periods 2 and 3||25||
48606121|NCT03585712|101819902|FG000|COMPLETED|Treatment Periods 2 and 3||0||
48606122|NCT03585712|101819903|FG001|COMPLETED|Treatment Periods 2 and 3||23||
48606123|NCT03585712|101819904|FG002|COMPLETED|Treatment Periods 2 and 3||22||
48606124|NCT03585712|101819902|FG000|NOT COMPLETED|Treatment Periods 2 and 3||0||
48606125|NCT03585712|101819903|FG001|NOT COMPLETED|Treatment Periods 2 and 3||3||
48606126|NCT03585712|101819904|FG002|NOT COMPLETED|Treatment Periods 2 and 3||3||
48606127|NCT02732015|101819905|FG000|STARTED|Overall Study||9||
48606128|NCT02732015|101819906|FG001|STARTED|Overall Study||27||
48606129|NCT02732015|101819905|FG000|COMPLETED|Overall Study||9||
48606130|NCT02732015|101819906|FG001|COMPLETED|Overall Study||26||
48303430|NCT01772004|101070118|FG011|STARTED|Dose Expansion Phase||18||
48303431|NCT01772004|101070119|FG012|STARTED|Dose Expansion Phase||50||
48303432|NCT01772004|101070120|FG013|STARTED|Dose Expansion Phase||51||
48303433|NCT01772004|101070121|FG014|STARTED|Dose Expansion Phase||53||
48303434|NCT01772004|101070122|FG015|STARTED|Dose Expansion Phase||44||
48303435|NCT01772004|101070123|FG016|STARTED|Dose Expansion Phase||125||
48303436|NCT01772004|101070124|FG017|STARTED|Dose Expansion Phase||62||
48303437|NCT01772004|101070125|FG018|STARTED|Dose Expansion Phase||20||
48303438|NCT01772004|101070126|FG019|STARTED|Dose Expansion Phase||103||
48303439|NCT01772004|101070127|FG020|STARTED|Dose Expansion Phase||205||
48303440|NCT01772004|101070128|FG021|STARTED|Dose Expansion Phase||132||
48303441|NCT01772004|101070129|FG022|STARTED|Dose Expansion Phase||153||
48303442|NCT01772004|101070107|FG000|COMPLETED|Dose Expansion Phase||0||
48303443|NCT01772004|101070108|FG001|COMPLETED|Dose Expansion Phase||0||
48303444|NCT01772004|101070109|FG002|COMPLETED|Dose Expansion Phase||0||
48303445|NCT01772004|101070110|FG003|COMPLETED|Dose Expansion Phase||0||
48303446|NCT01772004|101070111|FG004|COMPLETED|Dose Expansion Phase||0||
48303447|NCT01772004|101070112|FG005|COMPLETED|Dose Expansion Phase||184||
48303448|NCT01772004|101070113|FG006|COMPLETED|Dose Expansion Phase||156||
48303449|NCT01772004|101070114|FG007|COMPLETED|Dose Expansion Phase||168||
48303450|NCT01772004|101070115|FG008|COMPLETED|Dose Expansion Phase||60||
48303451|NCT01772004|101070116|FG009|COMPLETED|Dose Expansion Phase||90||
48303452|NCT01772004|101070117|FG010|COMPLETED|Dose Expansion Phase||21||
48303453|NCT01772004|101070118|FG011|COMPLETED|Dose Expansion Phase||18||
48303454|NCT01772004|101070119|FG012|COMPLETED|Dose Expansion Phase||50||
48303455|NCT01772004|101070120|FG013|COMPLETED|Dose Expansion Phase||51||
48303456|NCT01772004|101070121|FG014|COMPLETED|Dose Expansion Phase||53||
48303457|NCT01772004|101070122|FG015|COMPLETED|Dose Expansion Phase||44||
48303458|NCT01772004|101070123|FG016|COMPLETED|Dose Expansion Phase||125||
48303459|NCT01772004|101070124|FG017|COMPLETED|Dose Expansion Phase||62||
48303460|NCT01772004|101070125|FG018|COMPLETED|Dose Expansion Phase||20||
48303461|NCT01772004|101070126|FG019|COMPLETED|Dose Expansion Phase||103||
48303462|NCT01772004|101070127|FG020|COMPLETED|Dose Expansion Phase||205||
48303463|NCT01772004|101070128|FG021|COMPLETED|Dose Expansion Phase||132||
48303464|NCT01772004|101070129|FG022|COMPLETED|Dose Expansion Phase||153||
48303465|NCT01772004|101070107|FG000|NOT COMPLETED|Dose Expansion Phase||0||
48303466|NCT01772004|101070108|FG001|NOT COMPLETED|Dose Expansion Phase||0||
48303467|NCT01772004|101070109|FG002|NOT COMPLETED|Dose Expansion Phase||0||
48303468|NCT01772004|101070110|FG003|NOT COMPLETED|Dose Expansion Phase||0||
48303469|NCT01772004|101070111|FG004|NOT COMPLETED|Dose Expansion Phase||0||
48303470|NCT01772004|101070112|FG005|NOT COMPLETED|Dose Expansion Phase||0||
48303471|NCT01772004|101070113|FG006|NOT COMPLETED|Dose Expansion Phase||0||
48606131|NCT02732015|101819905|FG000|NOT COMPLETED|Overall Study||0||
48606132|NCT02732015|101819906|FG001|NOT COMPLETED|Overall Study||1||
48606133|NCT01522131|101819907|FG000|STARTED|Overall Study||16||
48606134|NCT01522131|101819908|FG001|STARTED|Overall Study||17||
48606135|NCT01522131|101819907|FG000|COMPLETED|Overall Study||14||
48606136|NCT01522131|101819908|FG001|COMPLETED|Overall Study||17||
48303472|NCT01772004|101070114|FG007|NOT COMPLETED|Dose Expansion Phase||0||
48303473|NCT01772004|101070115|FG008|NOT COMPLETED|Dose Expansion Phase||0||
48303474|NCT01772004|101070116|FG009|NOT COMPLETED|Dose Expansion Phase||0||
48303475|NCT01772004|101070117|FG010|NOT COMPLETED|Dose Expansion Phase||0||
48303476|NCT01772004|101070118|FG011|NOT COMPLETED|Dose Expansion Phase||0||
48303477|NCT01772004|101070119|FG012|NOT COMPLETED|Dose Expansion Phase||0||
48303478|NCT01772004|101070120|FG013|NOT COMPLETED|Dose Expansion Phase||0||
48303479|NCT01772004|101070121|FG014|NOT COMPLETED|Dose Expansion Phase||0||
48303480|NCT01772004|101070122|FG015|NOT COMPLETED|Dose Expansion Phase||0||
48606137|NCT01522131|101819907|FG000|NOT COMPLETED|Overall Study||2||
48606138|NCT01522131|101819908|FG001|NOT COMPLETED|Overall Study||0||
48606139|NCT04202965|101819909|FG000|STARTED|Overall Study||16||
48405503|NCT02253992|101325302|FG001|COMPLETED|Overall Study||0|Completed= Continuing in the treatment period.|
48405504|NCT02253992|101325303|FG002|COMPLETED|Overall Study||6|Completed= Continuing in the treatment period.|
48405505|NCT02253992|101325301|FG000|NOT COMPLETED|Overall Study||6||
48405506|NCT02253992|101325302|FG001|NOT COMPLETED|Overall Study||4||
48405507|NCT02253992|101325303|FG002|NOT COMPLETED|Overall Study||144||
48405508|NCT04259346|101325304|FG000|STARTED|Overall Study||126||
48405509|NCT04259346|101325305|FG001|STARTED|Overall Study||119||
48405510|NCT04259346|101325304|FG000|Received at Least One Dose of Study Drug|Overall Study||126||
48606140|NCT04202965|101819909|FG000|COMPLETED|Overall Study||12||
48606141|NCT04202965|101819909|FG000|NOT COMPLETED|Overall Study||4||
48606142|NCT01084538|101819910|FG000|STARTED|Overall Study||181||
48606143|NCT01084538|101819910|FG000|COMPLETED|Overall Study||113||
48606144|NCT01084538|101819910|FG000|NOT COMPLETED|Overall Study||68||
48606145|NCT00627926|101819911|FG000|STARTED|Overall Study||361||
48405511|NCT04259346|101325305|FG001|Received at Least One Dose of Study Drug|Overall Study||119||
48405512|NCT04259346|101325304|FG000|COMPLETED|Overall Study||122||
48405513|NCT04259346|101325305|FG001|COMPLETED|Overall Study||115||
48405514|NCT04259346|101325304|FG000|NOT COMPLETED|Overall Study||4||
48405515|NCT04259346|101325305|FG001|NOT COMPLETED|Overall Study||4||
48405516|NCT02688153|101325306|FG000|STARTED|Overall Study||62||
48606146|NCT00627926|101819912|FG001|STARTED|Overall Study||364||
48606147|NCT00627926|101819913|FG002|STARTED|Overall Study||363||
48606148|NCT00627926|101819911|FG000|COMPLETED|Overall Study||202||
48606149|NCT00627926|101819912|FG001|COMPLETED|Overall Study||260||
48606150|NCT00627926|101819913|FG002|COMPLETED|Overall Study||268||
48606151|NCT00627926|101819911|FG000|NOT COMPLETED|Overall Study||159||
48606152|NCT00627926|101819912|FG001|NOT COMPLETED|Overall Study||104||
48606153|NCT00627926|101819913|FG002|NOT COMPLETED|Overall Study||95||
48606154|NCT02383355|101819914|FG000|STARTED|Overall Study||19||
48606155|NCT02383355|101819915|FG001|STARTED|Overall Study||21||
48606156|NCT02383355|101819914|FG000|COMPLETED|Overall Study||17||
48405517|NCT02688153|101325307|FG001|STARTED|Overall Study||58||
48405518|NCT02688153|101325306|FG000|Final Randomized Arm/Group|Overall Study||59||
48405519|NCT02688153|101325307|FG001|Final Randomized Arm/Group|Overall Study||61||
48405520|NCT02688153|101325306|FG000|COMPLETED|Overall Study||47||
48405521|NCT02688153|101325307|FG001|COMPLETED|Overall Study||51||
48405522|NCT02688153|101325306|FG000|NOT COMPLETED|Overall Study||15||
48405523|NCT02688153|101325307|FG001|NOT COMPLETED|Overall Study||7||
48405524|NCT02809118|101325308|FG000|STARTED|Overall Study||18||
48405525|NCT02809118|101325309|FG001|STARTED|Overall Study||19||
48405526|NCT02809118|101325310|FG002|STARTED|Overall Study||19||
48405527|NCT02809118|101325308|FG000|COMPLETED|Overall Study||18||
48405528|NCT02809118|101325309|FG001|COMPLETED|Overall Study||18||
48405529|NCT02809118|101325310|FG002|COMPLETED|Overall Study||18||
48405530|NCT02809118|101325308|FG000|NOT COMPLETED|Overall Study||0||
48405531|NCT02809118|101325309|FG001|NOT COMPLETED|Overall Study||1||
48405532|NCT02809118|101325310|FG002|NOT COMPLETED|Overall Study||1||
48606157|NCT02383355|101819915|FG001|COMPLETED|Overall Study||21||
48405533|NCT04973085|101325311|FG000|STARTED|First Intervention||10||
48405534|NCT04973085|101325312|FG001|STARTED|First Intervention||12||
48405535|NCT04973085|101325311|FG000|COMPLETED|First Intervention||9||
48405536|NCT04973085|101325312|FG001|COMPLETED|First Intervention||12||
48405537|NCT04973085|101325311|FG000|NOT COMPLETED|First Intervention||1||
48405538|NCT04973085|101325312|FG001|NOT COMPLETED|First Intervention||0||
48405539|NCT04973085|101325311|FG000|STARTED|Second Intervention||9||
48405540|NCT04973085|101325312|FG001|STARTED|Second Intervention||12||
48405541|NCT04973085|101325311|FG000|MRI Adjusted Protocol|Second Intervention||7|The data from the first 5 subjects was used to modify the MRI protocol to improve the accuracy of the results. All subjects who were scanned using the modified MRI protocol were analyzed.|
48405542|NCT04973085|101325312|FG001|MRI Adjusted Protocol|Second Intervention||9|The data from the first 5 subjects was used to modify the MRI protocol to improve the accuracy of the results. All subjects who were scanned using the modified MRI protocol were analyzed.|
48405543|NCT04973085|101325311|FG000|COMPLETED|Second Intervention||7||
48405544|NCT04973085|101325312|FG001|COMPLETED|Second Intervention||9||
48405545|NCT04973085|101325311|FG000|NOT COMPLETED|Second Intervention||2||
48405546|NCT04973085|101325312|FG001|NOT COMPLETED|Second Intervention||3||
48405547|NCT01236768|101325313|FG000|STARTED|Overall Study||201||
48405548|NCT01236768|101325314|FG001|STARTED|Overall Study||206||
48405549|NCT01236768|101325313|FG000|COMPLETED|Overall Study||112||
48405550|NCT01236768|101325314|FG001|COMPLETED|Overall Study||145||
48606158|NCT02383355|101819914|FG000|NOT COMPLETED|Overall Study||2||
48405551|NCT01236768|101325313|FG000|NOT COMPLETED|Overall Study||89||
48405552|NCT01236768|101325314|FG001|NOT COMPLETED|Overall Study||61||
48405553|NCT01838304|101325315|FG000|STARTED|Overall Study||20||
48606159|NCT02383355|101819915|FG001|NOT COMPLETED|Overall Study||0||
48606160|NCT00316914|101819916|FG000|STARTED|Overall Study||50||
48606161|NCT00316914|101819917|FG001|STARTED|Overall Study||52||
48606162|NCT00316914|101819916|FG000|COMPLETED|Overall Study||17||
48606163|NCT00316914|101819917|FG001|COMPLETED|Overall Study||16||
48405554|NCT01838304|101325316|FG001|STARTED|Overall Study||20||
48405555|NCT01838304|101325315|FG000|COMPLETED|Overall Study||19||
48405556|NCT01838304|101325316|FG001|COMPLETED|Overall Study||20||
48606164|NCT00316914|101819916|FG000|NOT COMPLETED|Overall Study||33||
48405557|NCT01838304|101325315|FG000|NOT COMPLETED|Overall Study||1||
48405558|NCT01838304|101325316|FG001|NOT COMPLETED|Overall Study||0||
48405559|NCT02108522|101325317|FG000|STARTED|Screening Period||82||
48405560|NCT02108522|101325317|FG000|COMPLETED|Screening Period||58||
48405561|NCT02108522|101325317|FG000|NOT COMPLETED|Screening Period||24||
48405562|NCT02108522|101325317|FG000|STARTED|Period 1: Initial Cohort||50||
48405563|NCT02108522|101325317|FG000|COMPLETED|Period 1: Initial Cohort||28||
48405564|NCT02108522|101325317|FG000|NOT COMPLETED|Period 1: Initial Cohort||22||
48405565|NCT02108522|101325317|FG000|STARTED|Period 2: Expansion Cohort||8||
48405566|NCT02108522|101325317|FG000|COMPLETED|Period 2: Expansion Cohort||2||
48405567|NCT02108522|101325317|FG000|NOT COMPLETED|Period 2: Expansion Cohort||6||
48405568|NCT01976624|101325318|FG000|STARTED|Overall Study||756||
48405569|NCT01976624|101325318|FG000|COMPLETED|Overall Study||742||
48405570|NCT01976624|101325318|FG000|NOT COMPLETED|Overall Study||14||
48715881|NCT00539617|102091787|FG000|STARTED|Pre-screening Period||7||
48715882|NCT00539617|102091787|FG000|COMPLETED|Pre-screening Period||4||
48715883|NCT00539617|102091787|FG000|NOT COMPLETED|Pre-screening Period||3||
48715884|NCT00539617|102091787|FG000|STARTED|Run-In Period||4||
48715885|NCT00539617|102091787|FG000|COMPLETED|Run-In Period||3||
48715886|NCT00539617|102091787|FG000|NOT COMPLETED|Run-In Period||1||
48715887|NCT00539617|102091787|FG000|STARTED|Treatment Period||3||
48715888|NCT00539617|102091787|FG000|COMPLETED|Treatment Period||3||
48715889|NCT00539617|102091787|FG000|NOT COMPLETED|Treatment Period||0||
48715890|NCT00969436|102091788|FG000|STARTED|Overall Study||180||
48715891|NCT00969436|102091789|FG001|STARTED|Overall Study||180||
48715892|NCT00969436|102091790|FG002|STARTED|Overall Study||90||
48715893|NCT00969436|102091788|FG000|COMPLETED|Overall Study||155||
48715894|NCT00969436|102091789|FG001|COMPLETED|Overall Study||159||
48715895|NCT00969436|102091790|FG002|COMPLETED|Overall Study||79||
48715896|NCT00969436|102091788|FG000|NOT COMPLETED|Overall Study||25||
48715897|NCT00969436|102091789|FG001|NOT COMPLETED|Overall Study||21||
48715898|NCT00969436|102091790|FG002|NOT COMPLETED|Overall Study||11||
48715899|NCT02382848|102091791|FG000|STARTED|First Intervention (3 Weeks)||3||
48715900|NCT02382848|102091792|FG001|STARTED|First Intervention (3 Weeks)||5||
48715901|NCT02382848|102091791|FG000|COMPLETED|First Intervention (3 Weeks)||3||
48715902|NCT02382848|102091792|FG001|COMPLETED|First Intervention (3 Weeks)||5||
48715903|NCT02382848|102091791|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0||
48715904|NCT02382848|102091792|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0||
48715905|NCT02382848|102091791|FG000|STARTED|Washout (1 Week)||3||
48715906|NCT02382848|102091792|FG001|STARTED|Washout (1 Week)||5||
48715907|NCT02382848|102091791|FG000|COMPLETED|Washout (1 Week)||3||
48405571|NCT01194414|101325319|FG000|STARTED|24 Weeks Double Blind Period||631||
48405572|NCT01194414|101325320|FG001|STARTED|24 Weeks Double Blind Period||631||
48405573|NCT01194414|101325321|FG002|STARTED|24 Weeks Double Blind Period||0||
48405574|NCT01194414|101325322|FG003|STARTED|24 Weeks Double Blind Period||0||
48405575|NCT01194414|101325319|FG000|Per Protocol Population|24 Weeks Double Blind Period||558||
48405576|NCT01194414|101325320|FG001|Per Protocol Population|24 Weeks Double Blind Period||537||
48405577|NCT01194414|101325321|FG002|Per Protocol Population|24 Weeks Double Blind Period||0||
48405578|NCT01194414|101325322|FG003|Per Protocol Population|24 Weeks Double Blind Period||0||
48405579|NCT01194414|101325319|FG000|COMPLETED|24 Weeks Double Blind Period||572||
48405580|NCT01194414|101325320|FG001|COMPLETED|24 Weeks Double Blind Period||564||
48405581|NCT01194414|101325321|FG002|COMPLETED|24 Weeks Double Blind Period||0||
48405582|NCT01194414|101325322|FG003|COMPLETED|24 Weeks Double Blind Period||0||
48405583|NCT01194414|101325319|FG000|NOT COMPLETED|24 Weeks Double Blind Period||59||
48405584|NCT01194414|101325320|FG001|NOT COMPLETED|24 Weeks Double Blind Period||67||
48405585|NCT01194414|101325321|FG002|NOT COMPLETED|24 Weeks Double Blind Period||0||
48405586|NCT01194414|101325322|FG003|NOT COMPLETED|24 Weeks Double Blind Period||0||
48405587|NCT01194414|101325319|FG000|STARTED|72 Weeks Open Label Extension||524||
48405588|NCT01194414|101325320|FG001|STARTED|72 Weeks Open Label Extension||377||
48405589|NCT01194414|101325321|FG002|STARTED|72 Weeks Open Label Extension||48||
48405590|NCT01194414|101325322|FG003|STARTED|72 Weeks Open Label Extension||186||
48405591|NCT01194414|101325319|FG000|COMPLETED|72 Weeks Open Label Extension||445||
48715908|NCT02382848|102091792|FG001|COMPLETED|Washout (1 Week)||5||
48715909|NCT02382848|102091791|FG000|NOT COMPLETED|Washout (1 Week)||0||
48715910|NCT02382848|102091792|FG001|NOT COMPLETED|Washout (1 Week)||0||
48715911|NCT02382848|102091791|FG000|STARTED|Second Intervention (3 Weeks)||3||
48715912|NCT02382848|102091792|FG001|STARTED|Second Intervention (3 Weeks)||5||
48715913|NCT02382848|102091791|FG000|COMPLETED|Second Intervention (3 Weeks)||3||
48715914|NCT02382848|102091792|FG001|COMPLETED|Second Intervention (3 Weeks)||5||
48715915|NCT02382848|102091791|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0||
48405592|NCT01194414|101325320|FG001|COMPLETED|72 Weeks Open Label Extension||311||
48715916|NCT02382848|102091792|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0||
48715917|NCT00581867|102091793|FG000|STARTED|First Intervention||16||
48715918|NCT00581867|102091794|FG001|STARTED|First Intervention||15||
48715919|NCT00581867|102091793|FG000|COMPLETED|First Intervention||16||
48715920|NCT00581867|102091794|FG001|COMPLETED|First Intervention||15||
48715921|NCT00581867|102091793|FG000|NOT COMPLETED|First Intervention||0||
48715922|NCT00581867|102091794|FG001|NOT COMPLETED|First Intervention||0||
48715923|NCT00581867|102091793|FG000|STARTED|Second Intervention||15||
48715924|NCT00581867|102091794|FG001|STARTED|Second Intervention||14||
48715925|NCT00581867|102091793|FG000|COMPLETED|Second Intervention||15||
48715926|NCT00581867|102091794|FG001|COMPLETED|Second Intervention||14||
48715927|NCT00581867|102091793|FG000|NOT COMPLETED|Second Intervention||0||
48606165|NCT00316914|101819917|FG001|NOT COMPLETED|Overall Study||36||
48606166|NCT01937884|101819918|FG000|STARTED|Overall Study||7||
48606167|NCT01937884|101819919|FG001|STARTED|Overall Study||11||
48606168|NCT01937884|101819918|FG000|COMPLETED|Overall Study||6||
48606169|NCT01937884|101819919|FG001|COMPLETED|Overall Study||11||
48606170|NCT01937884|101819918|FG000|NOT COMPLETED|Overall Study||1||
48606171|NCT01937884|101819919|FG001|NOT COMPLETED|Overall Study||0||
48715928|NCT00581867|102091794|FG001|NOT COMPLETED|Second Intervention||0||
48715929|NCT00613080|102091795|FG000|STARTED|Overall Study||79||
48715930|NCT00613080|102091795|FG000|COMPLETED|Overall Study||68||
48148912|NCT01803074|100688584|FG002|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8||
48148913|NCT01803074|100688585|FG003|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8||
48148914|NCT01803074|100688586|FG004|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8||
48148915|NCT01803074|100688587|FG005|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8||
48148916|NCT01803074|100688588|FG006|COMPLETED|Period 1: Part A (HIV-1 Clade B)||12||
48606172|NCT01004432|101819920|FG000|STARTED|Open-label (OL) Period (Week 0 - 16)||433||
48405593|NCT01194414|101325321|FG002|COMPLETED|72 Weeks Open Label Extension||40||
48606173|NCT01004432|101819921|FG001|STARTED|Open-label (OL) Period (Week 0 - 16)||0||
48606174|NCT01004432|101819922|FG002|STARTED|Open-label (OL) Period (Week 0 - 16)||0||
48715931|NCT00613080|102091795|FG000|NOT COMPLETED|Overall Study||11||
48715932|NCT01253265|102091796|FG000|STARTED|Overall Study||6||
48715933|NCT01253265|102091797|FG001|STARTED|Overall Study||6||
48148917|NCT01803074|100688589|FG007|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
48148918|NCT01803074|100688590|FG008|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
48148919|NCT01803074|100688591|FG009|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
48148920|NCT01803074|100688592|FG010|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
48148921|NCT01803074|100688593|FG011|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
48148922|NCT01803074|100688594|FG012|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
48148923|NCT01803074|100688595|FG013|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
48148924|NCT01803074|100688582|FG000|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
48148925|NCT01803074|100688583|FG001|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
48148926|NCT01803074|100688584|FG002|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
48148927|NCT01803074|100688585|FG003|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
48148928|NCT01803074|100688586|FG004|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
48148929|NCT01803074|100688587|FG005|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
48148930|NCT01803074|100688588|FG006|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
48148931|NCT01803074|100688589|FG007|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
48148932|NCT01803074|100688590|FG008|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
48148933|NCT01803074|100688591|FG009|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
48148934|NCT01803074|100688592|FG010|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
48148935|NCT01803074|100688593|FG011|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
48148936|NCT01803074|100688594|FG012|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
48148937|NCT01803074|100688595|FG013|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
48148938|NCT01803074|100688582|FG000|STARTED|Period 2: Part B (HIV-1 Clade B)||0||
48148939|NCT01803074|100688583|FG001|STARTED|Period 2: Part B (HIV-1 Clade B)||0||
48148940|NCT01803074|100688584|FG002|STARTED|Period 2: Part B (HIV-1 Clade B)||0||
48148941|NCT01803074|100688585|FG003|STARTED|Period 2: Part B (HIV-1 Clade B)||0||
48148942|NCT01803074|100688586|FG004|STARTED|Period 2: Part B (HIV-1 Clade B)||0||
48148943|NCT01803074|100688587|FG005|STARTED|Period 2: Part B (HIV-1 Clade B)||0||
48148944|NCT01803074|100688588|FG006|STARTED|Period 2: Part B (HIV-1 Clade B)||0||
48148945|NCT01803074|100688589|FG007|STARTED|Period 2: Part B (HIV-1 Clade B)||8||
48148946|NCT01803074|100688590|FG008|STARTED|Period 2: Part B (HIV-1 Clade B)||8||
48148947|NCT01803074|100688591|FG009|STARTED|Period 2: Part B (HIV-1 Clade B)||4||
48148948|NCT01803074|100688592|FG010|STARTED|Period 2: Part B (HIV-1 Clade B)||8||
48148949|NCT01803074|100688593|FG011|STARTED|Period 2: Part B (HIV-1 Clade B)||0||
48148950|NCT01803074|100688594|FG012|STARTED|Period 2: Part B (HIV-1 Clade B)||0||
48148951|NCT01803074|100688595|FG013|STARTED|Period 2: Part B (HIV-1 Clade B)||0||
48148952|NCT01803074|100688582|FG000|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
48148953|NCT01803074|100688583|FG001|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
48148954|NCT01803074|100688584|FG002|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
48148955|NCT01803074|100688585|FG003|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
48148956|NCT01803074|100688586|FG004|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
48148957|NCT01803074|100688587|FG005|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
48148958|NCT01803074|100688588|FG006|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
48715934|NCT01253265|102091798|FG002|STARTED|Overall Study||6||
48715935|NCT01253265|102091799|FG003|STARTED|Overall Study||6||
48715936|NCT01253265|102091800|FG004|STARTED|Overall Study||8||
48715937|NCT01253265|102091796|FG000|COMPLETED|Overall Study||5||
48715938|NCT01253265|102091797|FG001|COMPLETED|Overall Study||6||
48715939|NCT01253265|102091798|FG002|COMPLETED|Overall Study||6||
48405594|NCT01194414|101325322|FG003|COMPLETED|72 Weeks Open Label Extension||160||
48405595|NCT01194414|101325319|FG000|NOT COMPLETED|72 Weeks Open Label Extension||79||
48405596|NCT01194414|101325320|FG001|NOT COMPLETED|72 Weeks Open Label Extension||66||
48405597|NCT01194414|101325321|FG002|NOT COMPLETED|72 Weeks Open Label Extension||8||
48405598|NCT01194414|101325322|FG003|NOT COMPLETED|72 Weeks Open Label Extension||26||
48405599|NCT01775800|101325323|FG000|STARTED|Overall Study||8||
48405600|NCT01775800|101325324|FG001|STARTED|Overall Study||8||
48405601|NCT01775800|101325323|FG000|COMPLETED|Overall Study||8||
48405602|NCT01775800|101325324|FG001|COMPLETED|Overall Study||8||
48405603|NCT01775800|101325323|FG000|NOT COMPLETED|Overall Study||0||
48405604|NCT01775800|101325324|FG001|NOT COMPLETED|Overall Study||0||
48405605|NCT02933372|101325325|FG000|STARTED|Overall Study||15||
48405606|NCT02933372|101325326|FG001|STARTED|Overall Study||10||
48148959|NCT01803074|100688589|FG007|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8||
48148960|NCT01803074|100688590|FG008|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8||
48148961|NCT01803074|100688591|FG009|COMPLETED|Period 2: Part B (HIV-1 Clade B)||4||
48148962|NCT01803074|100688592|FG010|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8||
48148963|NCT01803074|100688593|FG011|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
48148964|NCT01803074|100688594|FG012|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
48148965|NCT01803074|100688595|FG013|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
48148966|NCT01803074|100688582|FG000|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
48148967|NCT01803074|100688583|FG001|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
48405607|NCT02933372|101325325|FG000|COMPLETED|Overall Study||15||
48405608|NCT02933372|101325326|FG001|COMPLETED|Overall Study||10||
48405609|NCT02933372|101325325|FG000|NOT COMPLETED|Overall Study||0||
48405610|NCT02933372|101325326|FG001|NOT COMPLETED|Overall Study||0||
48405611|NCT02019758|101325327|FG000|STARTED|Overall Study||65||
48405612|NCT02019758|101325328|FG001|STARTED|Overall Study||64||
48405613|NCT02019758|101325327|FG000|Received Intervention|Overall Study||64||
48405614|NCT02019758|101325328|FG001|Received Intervention|Overall Study||63||
48405615|NCT02019758|101325327|FG000|Did Not Receive Intervention|Overall Study||1||
48405616|NCT02019758|101325328|FG001|Did Not Receive Intervention|Overall Study||1||
48715940|NCT01253265|102091799|FG003|COMPLETED|Overall Study||6||
48715941|NCT01253265|102091800|FG004|COMPLETED|Overall Study||7||
48715942|NCT01253265|102091796|FG000|NOT COMPLETED|Overall Study||1||
48405617|NCT02019758|101325327|FG000|Lost to Follow-up|Overall Study||8||
48405618|NCT02019758|101325328|FG001|Lost to Follow-up|Overall Study||8||
48405619|NCT02019758|101325327|FG000|COMPLETED|Overall Study||56||
48715943|NCT01253265|102091797|FG001|NOT COMPLETED|Overall Study||0||
48715944|NCT01253265|102091798|FG002|NOT COMPLETED|Overall Study||0||
48715945|NCT01253265|102091799|FG003|NOT COMPLETED|Overall Study||0||
48715946|NCT01253265|102091800|FG004|NOT COMPLETED|Overall Study||1||
48148968|NCT01803074|100688584|FG002|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
48148969|NCT01803074|100688585|FG003|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
48148970|NCT01803074|100688586|FG004|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
48148971|NCT01803074|100688587|FG005|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
48148972|NCT01803074|100688588|FG006|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
48148973|NCT01803074|100688589|FG007|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
48148974|NCT01803074|100688590|FG008|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
48148975|NCT01803074|100688591|FG009|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
48148976|NCT01803074|100688592|FG010|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
48405620|NCT02019758|101325328|FG001|COMPLETED|Overall Study||55||
48715947|NCT00946322|102091801|FG000|STARTED|Pre-treatment||12||
48715948|NCT00946322|102091801|FG000|COMPLETED|Pre-treatment||11||
48148977|NCT01803074|100688593|FG011|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
48148978|NCT01803074|100688594|FG012|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
48148979|NCT01803074|100688595|FG013|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
48148980|NCT01803074|100688582|FG000|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0||
48148981|NCT01803074|100688583|FG001|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0||
48148982|NCT01803074|100688584|FG002|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0||
48148983|NCT01803074|100688585|FG003|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0||
48148984|NCT01803074|100688586|FG004|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0||
48148985|NCT01803074|100688587|FG005|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0||
48148986|NCT01803074|100688588|FG006|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0||
48148987|NCT01803074|100688589|FG007|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0||
48148988|NCT01803074|100688590|FG008|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0||
48148989|NCT01803074|100688591|FG009|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0||
48148990|NCT01803074|100688592|FG010|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0||
48148991|NCT01803074|100688593|FG011|STARTED|Period 3: Part C (HIV-1 Clade C Only)||8||
48148992|NCT01803074|100688594|FG012|STARTED|Period 3: Part C (HIV-1 Clade C Only)||7||
48148993|NCT01803074|100688595|FG013|STARTED|Period 3: Part C (HIV-1 Clade C Only)||4||
48405621|NCT02019758|101325327|FG000|NOT COMPLETED|Overall Study||9||
48405622|NCT02019758|101325328|FG001|NOT COMPLETED|Overall Study||9||
48405623|NCT04624672|101325329|FG000|STARTED|Overall Study||2||
48405624|NCT04624672|101325330|FG001|STARTED|Overall Study||1||
48715949|NCT00946322|102091801|FG000|NOT COMPLETED|Pre-treatment||1||
48303481|NCT01772004|101070123|FG016|NOT COMPLETED|Dose Expansion Phase||0||
48303482|NCT01772004|101070124|FG017|NOT COMPLETED|Dose Expansion Phase||0||
48303483|NCT01772004|101070125|FG018|NOT COMPLETED|Dose Expansion Phase||0||
48303484|NCT01772004|101070126|FG019|NOT COMPLETED|Dose Expansion Phase||0||
48303485|NCT01772004|101070127|FG020|NOT COMPLETED|Dose Expansion Phase||0||
48303486|NCT01772004|101070128|FG021|NOT COMPLETED|Dose Expansion Phase||0||
48303487|NCT01772004|101070129|FG022|NOT COMPLETED|Dose Expansion Phase||0||
48303488|NCT03620019|101070130|FG000|STARTED|Overall Study||25||
48303489|NCT03620019|101070130|FG000|COMPLETED|Overall Study||25||
48303490|NCT03620019|101070130|FG000|NOT COMPLETED|Overall Study||0||
48303491|NCT01499953|101070131|FG000|STARTED|Overall Study||236||
48303492|NCT01499953|101070132|FG001|STARTED|Overall Study||236||
48303493|NCT01499953|101070131|FG000|Participants Who Received at Least One Dose of Study Medication|Overall Study||235||
48303494|NCT01499953|101070132|FG001|Participants Who Received at Least One Dose of Study Medication|Overall Study||236||
48303495|NCT01499953|101070131|FG000|COMPLETED|Overall Study||226||
48303496|NCT01499953|101070132|FG001|COMPLETED|Overall Study||222||
48303497|NCT01499953|101070131|FG000|NOT COMPLETED|Overall Study||10||
48303498|NCT01499953|101070132|FG001|NOT COMPLETED|Overall Study||14||
48303499|NCT01641809|101070133|FG000|STARTED|Induction Phase (Day 1 to Week 24)||60||
48303500|NCT01641809|101070134|FG001|STARTED|Induction Phase (Day 1 to Week 24)||60||
48303501|NCT01641809|101070135|FG002|STARTED|Induction Phase (Day 1 to Week 24)||61||
48303502|NCT01641809|101070136|FG003|STARTED|Induction Phase (Day 1 to Week 24)||62||
48303503|NCT01641809|101070133|FG000|COMPLETED|Induction Phase (Day 1 to Week 24)||52||
48303504|NCT01641809|101070134|FG001|COMPLETED|Induction Phase (Day 1 to Week 24)||53||
48303505|NCT01641809|101070135|FG002|COMPLETED|Induction Phase (Day 1 to Week 24)||55||
48303506|NCT01641809|101070136|FG003|COMPLETED|Induction Phase (Day 1 to Week 24)||47||
48303507|NCT01641809|101070133|FG000|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||8||
48303508|NCT01641809|101070134|FG001|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||7||
48303509|NCT01641809|101070135|FG002|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||6||
48303510|NCT01641809|101070136|FG003|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||15||
48303511|NCT01641809|101070133|FG000|STARTED|Maintenance Phase (Week 24 to Week 96)||52||
48303512|NCT01641809|101070134|FG001|STARTED|Maintenance Phase (Week 24 to Week 96)||53||
48303513|NCT01641809|101070135|FG002|STARTED|Maintenance Phase (Week 24 to Week 96)||55||
48303514|NCT01641809|101070136|FG003|STARTED|Maintenance Phase (Week 24 to Week 96)||47||
48303515|NCT01641809|101070133|FG000|COMPLETED|Maintenance Phase (Week 24 to Week 96)||46||
48303516|NCT01641809|101070134|FG001|COMPLETED|Maintenance Phase (Week 24 to Week 96)||48||
48303517|NCT01641809|101070135|FG002|COMPLETED|Maintenance Phase (Week 24 to Week 96)||52||
48303518|NCT01641809|101070136|FG003|COMPLETED|Maintenance Phase (Week 24 to Week 96)||41||
48303519|NCT01641809|101070133|FG000|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||6||
48303520|NCT01641809|101070134|FG001|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||5||
48303521|NCT01641809|101070135|FG002|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||3||
48303522|NCT01641809|101070136|FG003|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||6||
48303523|NCT01641809|101070133|FG000|STARTED|Open-label (Week 96 to Week 324)||46||
48303524|NCT01641809|101070134|FG001|STARTED|Open-label (Week 96 to Week 324)||47||
48303525|NCT01641809|101070135|FG002|STARTED|Open-label (Week 96 to Week 324)||51||
48303526|NCT01641809|101070136|FG003|STARTED|Open-label (Week 96 to Week 324)||0||
48303527|NCT01641809|101070133|FG000|COMPLETED|Open-label (Week 96 to Week 324)||30||
48303528|NCT01641809|101070134|FG001|COMPLETED|Open-label (Week 96 to Week 324)||35||
48303529|NCT01641809|101070135|FG002|COMPLETED|Open-label (Week 96 to Week 324)||43||
48303530|NCT01641809|101070136|FG003|COMPLETED|Open-label (Week 96 to Week 324)||0||
48303531|NCT01641809|101070133|FG000|NOT COMPLETED|Open-label (Week 96 to Week 324)||16||
48303532|NCT01641809|101070134|FG001|NOT COMPLETED|Open-label (Week 96 to Week 324)||12||
48303533|NCT01641809|101070135|FG002|NOT COMPLETED|Open-label (Week 96 to Week 324)||8||
48303534|NCT01641809|101070136|FG003|NOT COMPLETED|Open-label (Week 96 to Week 324)||0||
48303535|NCT04399122|101070137|FG000|STARTED|Overall Study||100||
48303536|NCT04399122|101070138|FG001|STARTED|Overall Study||100||
48303537|NCT04399122|101070137|FG000|COMPLETED|Overall Study||97||
48303538|NCT04399122|101070138|FG001|COMPLETED|Overall Study||100||
48303539|NCT04399122|101070137|FG000|NOT COMPLETED|Overall Study||3||
48303540|NCT04399122|101070138|FG001|NOT COMPLETED|Overall Study||0||
48303541|NCT02540538|101070139|FG000|STARTED|Overall Study||12||
48303542|NCT02540538|101070140|FG001|STARTED|Overall Study||12||
48303543|NCT02540538|101070141|FG002|STARTED|Overall Study||10||
48303544|NCT02540538|101070139|FG000|COMPLETED|Overall Study||12||
48303545|NCT02540538|101070140|FG001|COMPLETED|Overall Study||11||
48303546|NCT02540538|101070141|FG002|COMPLETED|Overall Study||10||
48303547|NCT02540538|101070139|FG000|NOT COMPLETED|Overall Study||0||
48303548|NCT02540538|101070140|FG001|NOT COMPLETED|Overall Study||1||
48303549|NCT02540538|101070141|FG002|NOT COMPLETED|Overall Study||0||
48303550|NCT03334409|101070142|FG000|STARTED|Overall Study||2||
48303551|NCT03334409|101070143|FG001|STARTED|Overall Study||3||
48303552|NCT03334409|101070142|FG000|COMPLETED|Overall Study||1||
48303553|NCT03334409|101070143|FG001|COMPLETED|Overall Study||3||
48303554|NCT03334409|101070142|FG000|NOT COMPLETED|Overall Study||1||
48606175|NCT01004432|101819923|FG003|STARTED|Open-label (OL) Period (Week 0 - 16)||0||
48715950|NCT00946322|102091801|FG000|STARTED|Post-treatment||11||
48715951|NCT00946322|102091801|FG000|COMPLETED|Post-treatment||9||
48715952|NCT00946322|102091801|FG000|NOT COMPLETED|Post-treatment||2||
48405625|NCT04624672|101325329|FG000|COMPLETED|Overall Study||0||
48405626|NCT04624672|101325330|FG001|COMPLETED|Overall Study||0||
48405627|NCT04624672|101325329|FG000|NOT COMPLETED|Overall Study||2||
48405628|NCT04624672|101325330|FG001|NOT COMPLETED|Overall Study||1||
48405629|NCT00511108|101325331|FG000|STARTED|Overall Study||52||
48405630|NCT00511108|101325332|FG001|STARTED|Overall Study||54||
48715953|NCT00711113|102091802|FG000|STARTED|Overall Study||47||
48715954|NCT00711113|102091802|FG000|COMPLETED|Overall Study||36||
48715955|NCT00711113|102091802|FG000|NOT COMPLETED|Overall Study||11||
48715956|NCT00886119|102091803|FG000|STARTED|Period 1||24||
48715957|NCT00886119|102091804|FG001|STARTED|Period 1||22||
48715958|NCT00886119|102091803|FG000|COMPLETED|Period 1||23||
48715959|NCT00886119|102091804|FG001|COMPLETED|Period 1||22||
48715960|NCT00886119|102091803|FG000|NOT COMPLETED|Period 1||1||
48715961|NCT00886119|102091804|FG001|NOT COMPLETED|Period 1||0||
48715962|NCT00886119|102091803|FG000|STARTED|Period 2||23||
48715963|NCT00886119|102091804|FG001|STARTED|Period 2||22||
48715964|NCT00886119|102091803|FG000|COMPLETED|Period 2||23||
48715965|NCT00886119|102091804|FG001|COMPLETED|Period 2||22||
48405631|NCT00511108|101325333|FG002|STARTED|Overall Study||52||
48405632|NCT00511108|101325334|FG003|STARTED|Overall Study||53||
48405633|NCT00511108|101325331|FG000|COMPLETED|Overall Study||46||
48405634|NCT00511108|101325332|FG001|COMPLETED|Overall Study||52||
48405635|NCT00511108|101325333|FG002|COMPLETED|Overall Study||47||
48405636|NCT00511108|101325334|FG003|COMPLETED|Overall Study||48||
48405637|NCT00511108|101325331|FG000|NOT COMPLETED|Overall Study||6||
48715966|NCT00886119|102091803|FG000|NOT COMPLETED|Period 2||0||
48303555|NCT03334409|101070143|FG001|NOT COMPLETED|Overall Study||0||
48303556|NCT00859950|101070144|FG000|STARTED|Overall Study||49||
48715967|NCT00886119|102091804|FG001|NOT COMPLETED|Period 2||0||
48303557|NCT00859950|101070145|FG001|STARTED|Overall Study||21||
48303558|NCT00859950|101070144|FG000|COMPLETED|Overall Study||49||
48303559|NCT00859950|101070145|FG001|COMPLETED|Overall Study||21||
48303560|NCT00859950|101070144|FG000|NOT COMPLETED|Overall Study||0||
48303561|NCT00859950|101070145|FG001|NOT COMPLETED|Overall Study||0||
48303562|NCT02941926|101070146|FG000|STARTED|Core Phase||3246||
48303563|NCT02941926|101070146|FG000|Canadian Sub-study|Core Phase||88|Participants who participated in the Canadian sub-study|
48303564|NCT02941926|101070146|FG000|COMPLETED|Core Phase||1301||
48303565|NCT02941926|101070146|FG000|NOT COMPLETED|Core Phase||1945||
48303566|NCT02941926|101070146|FG000|STARTED|Extension Phase||413|Subjects from countries where ribociclib was not yet approved and reimbursed who were still deriving benefit at the end of the Core Phase|
48303567|NCT02941926|101070146|FG000|COMPLETED|Extension Phase||112||
48405638|NCT00511108|101325332|FG001|NOT COMPLETED|Overall Study||2||
48405639|NCT00511108|101325333|FG002|NOT COMPLETED|Overall Study||5||
48405640|NCT00511108|101325334|FG003|NOT COMPLETED|Overall Study||5||
48405641|NCT02465489|101325335|FG000|STARTED|Overall Study||20||
48405642|NCT02465489|101325335|FG000|COMPLETED|Overall Study||15||
48405643|NCT02465489|101325335|FG000|NOT COMPLETED|Overall Study||5||
48405644|NCT00887068|101325336|FG000|STARTED|Overall Study||93||
48405645|NCT00887068|101325337|FG001|STARTED|Overall Study||94||
48405646|NCT00887068|101325336|FG000|COMPLETED|Overall Study||87||
48715968|NCT00320372|102091805|FG000|STARTED|Overall Study||494||
48715969|NCT00320372|102091806|FG001|STARTED|Overall Study||301||
48715970|NCT00320372|102091805|FG000|VNS Therapy D-23 Original|Overall Study||335||
48715971|NCT00320372|102091806|FG001|VNS Therapy D-23 Original|Overall Study||0||
48715972|NCT00320372|102091805|FG000|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||159||
48715973|NCT00320372|102091806|FG001|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||0||
48715974|NCT00320372|102091805|FG000|COMPLETED|Overall Study||299||
48715975|NCT00320372|102091806|FG001|COMPLETED|Overall Study||138||
48405647|NCT00887068|101325337|FG001|COMPLETED|Overall Study||94||
48405648|NCT00887068|101325336|FG000|NOT COMPLETED|Overall Study||6||
48405649|NCT00887068|101325337|FG001|NOT COMPLETED|Overall Study||0||
48715976|NCT00320372|102091805|FG000|NOT COMPLETED|Overall Study||195||
48405650|NCT02109744|101325338|FG000|STARTED|Overall Study||26||
48405651|NCT02109744|101325339|FG001|STARTED|Overall Study||1||
48405652|NCT02109744|101325338|FG000|COMPLETED|Overall Study||24||
48405653|NCT02109744|101325339|FG001|COMPLETED|Overall Study||0||
48303568|NCT02941926|101070146|FG000|NOT COMPLETED|Extension Phase||301||
48303569|NCT01109173|101070147|FG000|STARTED|Overall Study||851||
48715977|NCT00320372|102091806|FG001|NOT COMPLETED|Overall Study||163||
48715978|NCT00711802|102091807|FG000|STARTED|Overall Study||75||
48715979|NCT00711802|102091808|FG001|STARTED|Overall Study||38||
48715980|NCT00711802|102091809|FG002|STARTED|Overall Study||75||
48715981|NCT00711802|102091810|FG003|STARTED|Overall Study||38||
48715982|NCT00711802|102091811|FG004|STARTED|Overall Study||83||
48303570|NCT01109173|101070148|FG001|STARTED|Overall Study||845||
48303571|NCT01109173|101070149|FG002|STARTED|Overall Study||211||
48303572|NCT01109173|101070150|FG003|STARTED|Overall Study||213||
48303573|NCT01109173|101070147|FG000|COMPLETED|Overall Study||763||
48303574|NCT01109173|101070148|FG001|COMPLETED|Overall Study||759||
48303575|NCT01109173|101070149|FG002|COMPLETED|Overall Study||110||
48303576|NCT01109173|101070150|FG003|COMPLETED|Overall Study||120||
48715983|NCT00711802|102091812|FG005|STARTED|Overall Study||42||
48303577|NCT01109173|101070147|FG000|NOT COMPLETED|Overall Study||88||
48303578|NCT01109173|101070148|FG001|NOT COMPLETED|Overall Study||86||
48715984|NCT00711802|102091813|FG006|STARTED|Overall Study||30||
48715985|NCT00711802|102091814|FG007|STARTED|Overall Study||15||
48715986|NCT00711802|102091807|FG000|Received at Least 1 Dose of Study Drug|Overall Study||73||
48715987|NCT00711802|102091808|FG001|Received at Least 1 Dose of Study Drug|Overall Study||37||
48715988|NCT00711802|102091809|FG002|Received at Least 1 Dose of Study Drug|Overall Study||73||
48715989|NCT00711802|102091810|FG003|Received at Least 1 Dose of Study Drug|Overall Study||38||
48715990|NCT00711802|102091811|FG004|Received at Least 1 Dose of Study Drug|Overall Study||81||
48303579|NCT01109173|101070149|FG002|NOT COMPLETED|Overall Study||101||
48303580|NCT01109173|101070150|FG003|NOT COMPLETED|Overall Study||93||
48303581|NCT00120406|101070151|FG000|STARTED|Overall Study||236||
48303582|NCT00120406|101070152|FG001|STARTED|Overall Study||238||
48303583|NCT00120406|101070151|FG000|COMPLETED|Overall Study||217||
48303584|NCT00120406|101070152|FG001|COMPLETED|Overall Study||222||
48303585|NCT00120406|101070151|FG000|NOT COMPLETED|Overall Study||19||
48303586|NCT00120406|101070152|FG001|NOT COMPLETED|Overall Study||16||
48303587|NCT01326728|101072801|FG000|STARTED|Overall Study||47||
48303588|NCT01326728|101072802|FG001|STARTED|Overall Study||9||
48303589|NCT01326728|101072801|FG000|COMPLETED|Overall Study||0||
48405654|NCT02109744|101325338|FG000|NOT COMPLETED|Overall Study||2||
48405655|NCT02109744|101325339|FG001|NOT COMPLETED|Overall Study||1||
48405656|NCT01100762|101325340|FG000|STARTED|Overall Study||10||
48405657|NCT01100762|101325340|FG000|COMPLETED|Overall Study||10||
48715991|NCT00711802|102091812|FG005|Received at Least 1 Dose of Study Drug|Overall Study||42||
48715992|NCT00711802|102091813|FG006|Received at Least 1 Dose of Study Drug|Overall Study||30||
48715993|NCT00711802|102091814|FG007|Received at Least 1 Dose of Study Drug|Overall Study||15||
48715994|NCT00711802|102091807|FG000|COMPLETED|Overall Study||73||
48303590|NCT01326728|101072802|FG001|COMPLETED|Overall Study||0||
48303591|NCT01326728|101072801|FG000|NOT COMPLETED|Overall Study||47||
48303592|NCT01326728|101072802|FG001|NOT COMPLETED|Overall Study||9||
48303593|NCT00953719|101072803|FG000|STARTED|Overall Study||169||
48303594|NCT00953719|101072804|FG001|STARTED|Overall Study||74||
48303595|NCT00953719|101072803|FG000|COMPLETED|Overall Study||150||
48303596|NCT00953719|101072804|FG001|COMPLETED|Overall Study||69||
48303597|NCT00953719|101072803|FG000|NOT COMPLETED|Overall Study||19||
48303598|NCT00953719|101072804|FG001|NOT COMPLETED|Overall Study||5||
48303599|NCT00866749|101072805|FG000|STARTED|Overall Study||120||
48303600|NCT00866749|101072805|FG000|COMPLETED|Overall Study||120||
48303601|NCT00866749|101072805|FG000|NOT COMPLETED|Overall Study||0||
48405658|NCT01100762|101325340|FG000|NOT COMPLETED|Overall Study||0||
48405659|NCT05784103|101325341|FG000|STARTED|Overall Study||20||
48303602|NCT01423812|101072806|FG000|STARTED|Overall Study||30||
48303603|NCT01423812|101072807|FG001|STARTED|Overall Study||30||
48303604|NCT01423812|101072806|FG000|COMPLETED|Overall Study||27||
48303605|NCT01423812|101072807|FG001|COMPLETED|Overall Study||26||
48303606|NCT01423812|101072806|FG000|NOT COMPLETED|Overall Study||3||
48303607|NCT01423812|101072807|FG001|NOT COMPLETED|Overall Study||4||
48715995|NCT00711802|102091808|FG001|COMPLETED|Overall Study||32||
48715996|NCT00711802|102091809|FG002|COMPLETED|Overall Study||69||
48715997|NCT00711802|102091810|FG003|COMPLETED|Overall Study||35||
48405660|NCT05784103|101325341|FG000|COMPLETED|Overall Study||20||
48405661|NCT05784103|101325341|FG000|NOT COMPLETED|Overall Study||0||
48405662|NCT00554853|101325342|FG000|STARTED|First Arm of Study||72||
48715998|NCT00711802|102091811|FG004|COMPLETED|Overall Study||69||
48715999|NCT00711802|102091812|FG005|COMPLETED|Overall Study||34||
48716000|NCT00711802|102091813|FG006|COMPLETED|Overall Study||25||
48716001|NCT00711802|102091814|FG007|COMPLETED|Overall Study||13||
48716002|NCT00711802|102091807|FG000|NOT COMPLETED|Overall Study||2||
48716003|NCT00711802|102091808|FG001|NOT COMPLETED|Overall Study||6||
48716004|NCT00711802|102091809|FG002|NOT COMPLETED|Overall Study||6||
48716005|NCT00711802|102091810|FG003|NOT COMPLETED|Overall Study||3||
48303608|NCT00597753|101072808|FG000|STARTED|Overall Study||532||
48303609|NCT00597753|101072809|FG001|STARTED|Overall Study||271||
48303610|NCT00597753|101072808|FG000|COMPLETED|Overall Study||366||
48303611|NCT00597753|101072809|FG001|COMPLETED|Overall Study||202||
48303612|NCT00597753|101072808|FG000|NOT COMPLETED|Overall Study||166||
48303613|NCT00597753|101072809|FG001|NOT COMPLETED|Overall Study||69||
48303614|NCT01436071|101072810|FG000|STARTED|Overall Study||124||
48303615|NCT01436071|101072811|FG001|STARTED|Overall Study||124||
48405663|NCT00554853|101325343|FG001|STARTED|First Arm of Study||71||
48716006|NCT00711802|102091811|FG004|NOT COMPLETED|Overall Study||14||
48716007|NCT00711802|102091812|FG005|NOT COMPLETED|Overall Study||8||
48405664|NCT00554853|101325342|FG000|COMPLETED|First Arm of Study||56||
48405665|NCT00554853|101325343|FG001|COMPLETED|First Arm of Study||64||
48405666|NCT00554853|101325342|FG000|NOT COMPLETED|First Arm of Study||16||
48405667|NCT00554853|101325343|FG001|NOT COMPLETED|First Arm of Study||7||
48405668|NCT00554853|101325342|FG000|STARTED|Washout Period (2 Weeks)||56||
48405669|NCT00554853|101325343|FG001|STARTED|Washout Period (2 Weeks)||64||
48405670|NCT00554853|101325342|FG000|COMPLETED|Washout Period (2 Weeks)||56||
48405671|NCT00554853|101325343|FG001|COMPLETED|Washout Period (2 Weeks)||57||
48716008|NCT00711802|102091813|FG006|NOT COMPLETED|Overall Study||5||
48716009|NCT00711802|102091814|FG007|NOT COMPLETED|Overall Study||2||
48716010|NCT00432744|102091815|FG000|STARTED|Months 0-6||12||
48716011|NCT00432744|102091816|FG001|STARTED|Months 0-6||12||
48303616|NCT01436071|101072810|FG000|Safety Population|Overall Study||121||
48303617|NCT01436071|101072811|FG001|Safety Population|Overall Study||121||
48303618|NCT01436071|101072810|FG000|COMPLETED|Overall Study||98||
48303619|NCT01436071|101072811|FG001|COMPLETED|Overall Study||110||
48303620|NCT01436071|101072810|FG000|NOT COMPLETED|Overall Study||26||
48303621|NCT01436071|101072811|FG001|NOT COMPLETED|Overall Study||14||
48303622|NCT02653300|101072812|FG000|STARTED|Overall Study||10||
48405672|NCT00554853|101325342|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0||
48716012|NCT00432744|102091815|FG000|COMPLETED|Months 0-6||7||
48303623|NCT02653300|101072812|FG000|COMPLETED|Overall Study||8||
48303624|NCT02653300|101072812|FG000|NOT COMPLETED|Overall Study||2||
48303625|NCT00931944|101072813|FG000|STARTED|Overall Study||74||
48303626|NCT00931944|101072813|FG000|COMPLETED|Overall Study||19||
48303627|NCT00931944|101072813|FG000|NOT COMPLETED|Overall Study||55||
48303628|NCT02445196|101072814|FG000|STARTED|Overall Study||62||
48303629|NCT02445196|101072815|FG001|STARTED|Overall Study||58||
48303630|NCT02445196|101072814|FG000|COMPLETED|Overall Study||51||
48303631|NCT02445196|101072815|FG001|COMPLETED|Overall Study||52||
48303632|NCT02445196|101072814|FG000|NOT COMPLETED|Overall Study||11||
48303633|NCT02445196|101072815|FG001|NOT COMPLETED|Overall Study||6||
48303634|NCT00993915|101072816|FG000|STARTED|Overall Study||687||
48303635|NCT00993915|101072816|FG000|COMPLETED|Overall Study||678||
48303636|NCT00993915|101072816|FG000|NOT COMPLETED|Overall Study||9||
48303637|NCT00324701|101072817|FG000|STARTED|Overall Study||120||
48303638|NCT00324701|101072818|FG001|STARTED|Overall Study||121||
48303639|NCT00324701|101072817|FG000|Week 8 Assessment|Overall Study||108||
48303640|NCT00324701|101072818|FG001|Week 8 Assessment|Overall Study||107||
48303641|NCT00324701|101072817|FG000|COMPLETED|Overall Study||100||
48303642|NCT00324701|101072818|FG001|COMPLETED|Overall Study||104||
48303643|NCT00324701|101072817|FG000|NOT COMPLETED|Overall Study||20||
48303644|NCT00324701|101072818|FG001|NOT COMPLETED|Overall Study||17||
48303645|NCT00980681|101072819|FG000|STARTED|TOF MRA||10||
48303646|NCT00980681|101072819|FG000|COMPLETED|TOF MRA||10||
48303647|NCT00980681|101072819|FG000|NOT COMPLETED|TOF MRA||0||
48303648|NCT00980681|101072819|FG000|STARTED|Dotarem MRA||10||
48303649|NCT00980681|101072819|FG000|COMPLETED|Dotarem MRA||10||
48303650|NCT00980681|101072819|FG000|NOT COMPLETED|Dotarem MRA||0||
48303651|NCT00667355|101072820|FG000|STARTED|Overall Study||41||
48303652|NCT00667355|101072820|FG000|COMPLETED|Overall Study||30||
48303653|NCT00667355|101072820|FG000|NOT COMPLETED|Overall Study||11||
48303654|NCT02075411|101072821|FG000|STARTED|Overall Study||0||
48303655|NCT02075411|101072822|FG001|STARTED|Overall Study||0||
48303656|NCT02075411|101072823|FG002|STARTED|Overall Study||0||
48303657|NCT02075411|101072824|FG003|STARTED|Overall Study||1||
48303658|NCT02075411|101072821|FG000|COMPLETED|Overall Study||0||
48303659|NCT02075411|101072822|FG001|COMPLETED|Overall Study||0||
48303660|NCT02075411|101072823|FG002|COMPLETED|Overall Study||0||
48303661|NCT02075411|101072824|FG003|COMPLETED|Overall Study||1||
48303662|NCT02075411|101072821|FG000|NOT COMPLETED|Overall Study||0||
48303663|NCT02075411|101072822|FG001|NOT COMPLETED|Overall Study||0||
48303664|NCT02075411|101072823|FG002|NOT COMPLETED|Overall Study||0||
48303665|NCT02075411|101072824|FG003|NOT COMPLETED|Overall Study||0||
48303666|NCT01859078|101072825|FG000|STARTED|Overall Study||28||
48303667|NCT01859078|101072825|FG000|COMPLETED|Overall Study||28||
48303668|NCT01859078|101072825|FG000|NOT COMPLETED|Overall Study||0||
48303669|NCT02383589|101072826|FG000|STARTED|Treatment Period||67||
48303670|NCT02383589|101072827|FG001|STARTED|Treatment Period||68||
48303671|NCT02383589|101072826|FG000|COMPLETED|Treatment Period||66|Completed the 52-week treatment period and entered safety follow up (SFU)|
48303672|NCT02383589|101072827|FG001|COMPLETED|Treatment Period||58|Completed the 52-week treatment period and entered safety follow up (SFU)|
48303673|NCT02383589|101072826|FG000|NOT COMPLETED|Treatment Period||1||
48303674|NCT02383589|101072827|FG001|NOT COMPLETED|Treatment Period||10||
48303675|NCT02383589|101072826|FG000|STARTED|Safety Follow-up (SFU)||66||
48303676|NCT02383589|101072827|FG001|STARTED|Safety Follow-up (SFU)||58||
48303677|NCT02383589|101072826|FG000|COMPLETED|Safety Follow-up (SFU)||59||
48303678|NCT02383589|101072827|FG001|COMPLETED|Safety Follow-up (SFU)||53||
48303679|NCT02383589|101072826|FG000|NOT COMPLETED|Safety Follow-up (SFU)||7||
48303680|NCT02383589|101072827|FG001|NOT COMPLETED|Safety Follow-up (SFU)||5||
48303681|NCT02202551|101072828|FG000|STARTED|Overall Study||60||
48303682|NCT02202551|101072829|FG001|STARTED|Overall Study||78||
48303683|NCT02202551|101072830|FG002|STARTED|Overall Study||24||
48303684|NCT02202551|101072831|FG003|STARTED|Overall Study||61||
48303685|NCT02202551|101072828|FG000|COMPLETED|Overall Study||35||
48303686|NCT02202551|101072829|FG001|COMPLETED|Overall Study||41||
48303687|NCT02202551|101072830|FG002|COMPLETED|Overall Study||14||
48303688|NCT02202551|101072831|FG003|COMPLETED|Overall Study||39||
48303689|NCT02202551|101072828|FG000|NOT COMPLETED|Overall Study||25||
48303690|NCT02202551|101072829|FG001|NOT COMPLETED|Overall Study||37||
48303691|NCT02202551|101072830|FG002|NOT COMPLETED|Overall Study||10||
48303692|NCT02202551|101072831|FG003|NOT COMPLETED|Overall Study||22||
48303693|NCT03716050|101072832|FG000|STARTED|Overall Study||2||
48303694|NCT03716050|101072833|FG001|STARTED|Overall Study||4||
48303695|NCT03716050|101072834|FG002|STARTED|Overall Study||1||
48303696|NCT03716050|101072835|FG003|STARTED|Overall Study||3||
48303697|NCT03716050|101072836|FG004|STARTED|Overall Study||1||
48303698|NCT03716050|101072837|FG005|STARTED|Overall Study||0||
48303699|NCT03716050|101072838|FG006|STARTED|Overall Study||4||
48303700|NCT03716050|101072839|FG007|STARTED|Overall Study||2||
48303701|NCT03716050|101072832|FG000|COMPLETED|Overall Study||2||
48303702|NCT03716050|101072833|FG001|COMPLETED|Overall Study||4||
48303703|NCT03716050|101072834|FG002|COMPLETED|Overall Study||0||
48303704|NCT03716050|101072835|FG003|COMPLETED|Overall Study||1||
48303705|NCT03716050|101072836|FG004|COMPLETED|Overall Study||1||
48303706|NCT03716050|101072837|FG005|COMPLETED|Overall Study||0||
48303707|NCT03716050|101072838|FG006|COMPLETED|Overall Study||4||
48303708|NCT03716050|101072839|FG007|COMPLETED|Overall Study||0||
48303709|NCT03716050|101072832|FG000|NOT COMPLETED|Overall Study||0||
48303710|NCT03716050|101072833|FG001|NOT COMPLETED|Overall Study||0||
48303711|NCT03716050|101072834|FG002|NOT COMPLETED|Overall Study||1||
48303712|NCT03716050|101072835|FG003|NOT COMPLETED|Overall Study||2||
48303713|NCT03716050|101072836|FG004|NOT COMPLETED|Overall Study||0||
48303714|NCT03716050|101072837|FG005|NOT COMPLETED|Overall Study||0||
48303715|NCT03716050|101072838|FG006|NOT COMPLETED|Overall Study||0||
48303716|NCT03716050|101072839|FG007|NOT COMPLETED|Overall Study||2||
48303717|NCT01233869|101072840|FG000|STARTED|Initial Treatment Period (24 Months)||58||
48303718|NCT01233869|101072841|FG001|STARTED|Initial Treatment Period (24 Months)||31||
48303719|NCT01233869|101072842|FG002|STARTED|Initial Treatment Period (24 Months)||24||
48303720|NCT01233869|101072843|FG003|STARTED|Initial Treatment Period (24 Months)||56||
48405673|NCT00554853|101325343|FG001|NOT COMPLETED|Washout Period (2 Weeks)||7||
48405674|NCT00554853|101325342|FG000|STARTED|Crossover Arm (3 Months)||56||
48405675|NCT00554853|101325343|FG001|STARTED|Crossover Arm (3 Months)||57||
48405676|NCT00554853|101325342|FG000|COMPLETED|Crossover Arm (3 Months)||53||
48405677|NCT00554853|101325343|FG001|COMPLETED|Crossover Arm (3 Months)||55||
48405678|NCT00554853|101325342|FG000|NOT COMPLETED|Crossover Arm (3 Months)||3||
48405679|NCT00554853|101325343|FG001|NOT COMPLETED|Crossover Arm (3 Months)||2||
48405680|NCT00479167|101325344|FG000|STARTED|Overall Study||1||
48405681|NCT00479167|101325344|FG000|COMPLETED|Overall Study||0||
48405682|NCT00479167|101325344|FG000|NOT COMPLETED|Overall Study||1||
48405683|NCT03190967|101325345|FG000|STARTED|Level 1 Dose Escalation||3||
48405684|NCT03190967|101325346|FG001|STARTED|Level 1 Dose Escalation||0||
48405685|NCT03190967|101325347|FG002|STARTED|Level 1 Dose Escalation||0||
48405686|NCT03190967|101325348|FG003|STARTED|Level 1 Dose Escalation||0||
48405687|NCT03190967|101325349|FG004|STARTED|Level 1 Dose Escalation||0||
48405688|NCT03190967|101325345|FG000|COMPLETED|Level 1 Dose Escalation||3||
48405689|NCT03190967|101325346|FG001|COMPLETED|Level 1 Dose Escalation||0||
48405690|NCT03190967|101325347|FG002|COMPLETED|Level 1 Dose Escalation||0||
48405691|NCT03190967|101325348|FG003|COMPLETED|Level 1 Dose Escalation||0||
48405692|NCT03190967|101325349|FG004|COMPLETED|Level 1 Dose Escalation||0||
48405693|NCT03190967|101325345|FG000|NOT COMPLETED|Level 1 Dose Escalation||0||
48405694|NCT03190967|101325346|FG001|NOT COMPLETED|Level 1 Dose Escalation||0||
48716013|NCT00432744|102091816|FG001|COMPLETED|Months 0-6||8||
48716014|NCT00432744|102091815|FG000|NOT COMPLETED|Months 0-6||5||
48716015|NCT00432744|102091816|FG001|NOT COMPLETED|Months 0-6||4||
48303721|NCT01233869|101072840|FG000|COMPLETED|Initial Treatment Period (24 Months)||34||
48303722|NCT01233869|101072841|FG001|COMPLETED|Initial Treatment Period (24 Months)||3||
48303723|NCT01233869|101072842|FG002|COMPLETED|Initial Treatment Period (24 Months)||22||
48303724|NCT01233869|101072843|FG003|COMPLETED|Initial Treatment Period (24 Months)||34||
48303725|NCT01233869|101072840|FG000|NOT COMPLETED|Initial Treatment Period (24 Months)||24||
48303726|NCT01233869|101072841|FG001|NOT COMPLETED|Initial Treatment Period (24 Months)||28||
48303727|NCT01233869|101072842|FG002|NOT COMPLETED|Initial Treatment Period (24 Months)||2||
48303728|NCT01233869|101072843|FG003|NOT COMPLETED|Initial Treatment Period (24 Months)||22||
48303729|NCT01233869|101072840|FG000|STARTED|Washout Period 30 Days||34||
48303730|NCT01233869|101072841|FG001|STARTED|Washout Period 30 Days||3||
48303731|NCT01233869|101072842|FG002|STARTED|Washout Period 30 Days||22||
48303732|NCT01233869|101072843|FG003|STARTED|Washout Period 30 Days||34||
48303733|NCT01233869|101072840|FG000|COMPLETED|Washout Period 30 Days||34||
48303734|NCT01233869|101072841|FG001|COMPLETED|Washout Period 30 Days||3||
48303735|NCT01233869|101072842|FG002|COMPLETED|Washout Period 30 Days||22||
48303736|NCT01233869|101072843|FG003|COMPLETED|Washout Period 30 Days||34||
48303737|NCT01233869|101072840|FG000|NOT COMPLETED|Washout Period 30 Days||0||
48303738|NCT01233869|101072841|FG001|NOT COMPLETED|Washout Period 30 Days||0||
48303739|NCT01233869|101072842|FG002|NOT COMPLETED|Washout Period 30 Days||0||
48303740|NCT01233869|101072843|FG003|NOT COMPLETED|Washout Period 30 Days||0||
48303741|NCT01233869|101072840|FG000|STARTED|Extended Treatment Period (46 Months)||34||
48303742|NCT01233869|101072841|FG001|STARTED|Extended Treatment Period (46 Months)||3||
48303743|NCT01233869|101072842|FG002|STARTED|Extended Treatment Period (46 Months)||22||
48405695|NCT03190967|101325347|FG002|NOT COMPLETED|Level 1 Dose Escalation||0||
48405696|NCT03190967|101325348|FG003|NOT COMPLETED|Level 1 Dose Escalation||0||
48405697|NCT03190967|101325349|FG004|NOT COMPLETED|Level 1 Dose Escalation||0||
48405698|NCT03190967|101325345|FG000|STARTED|Level 2||0||
48303744|NCT01233869|101072843|FG003|STARTED|Extended Treatment Period (46 Months)||34||
48303745|NCT01233869|101072840|FG000|COMPLETED|Extended Treatment Period (46 Months)||20||
48303746|NCT01233869|101072841|FG001|COMPLETED|Extended Treatment Period (46 Months)||0||
48303747|NCT01233869|101072842|FG002|COMPLETED|Extended Treatment Period (46 Months)||17||
48303748|NCT01233869|101072843|FG003|COMPLETED|Extended Treatment Period (46 Months)||18||
48405699|NCT03190967|101325346|FG001|STARTED|Level 2||3||
48405700|NCT03190967|101325347|FG002|STARTED|Level 2||0||
48405701|NCT03190967|101325348|FG003|STARTED|Level 2||0||
48405702|NCT03190967|101325349|FG004|STARTED|Level 2||0||
48405703|NCT03190967|101325345|FG000|COMPLETED|Level 2||0||
48716016|NCT00432744|102091815|FG000|STARTED|Months 7 - 12||7||
48716017|NCT00432744|102091816|FG001|STARTED|Months 7 - 12||8||
48405704|NCT03190967|101325346|FG001|COMPLETED|Level 2||3||
48405705|NCT03190967|101325347|FG002|COMPLETED|Level 2||0||
48405706|NCT03190967|101325348|FG003|COMPLETED|Level 2||0||
48405707|NCT03190967|101325349|FG004|COMPLETED|Level 2||0||
48405708|NCT03190967|101325345|FG000|NOT COMPLETED|Level 2||0||
48405709|NCT03190967|101325346|FG001|NOT COMPLETED|Level 2||0||
48405710|NCT03190967|101325347|FG002|NOT COMPLETED|Level 2||0||
48405711|NCT03190967|101325348|FG003|NOT COMPLETED|Level 2||0||
48716018|NCT00432744|102091815|FG000|COMPLETED|Months 7 - 12||6||
48716019|NCT00432744|102091816|FG001|COMPLETED|Months 7 - 12||7||
48716020|NCT00432744|102091815|FG000|NOT COMPLETED|Months 7 - 12||1||
48716021|NCT00432744|102091816|FG001|NOT COMPLETED|Months 7 - 12||1||
48716022|NCT02644356|102091817|FG000|STARTED|Overall Study||51||
48716023|NCT02644356|102091817|FG000|COMPLETED|Overall Study||49||
48716024|NCT02644356|102091817|FG000|NOT COMPLETED|Overall Study||2||
48716025|NCT02713529|102091818|FG000|STARTED|Overall Study||8||
48716026|NCT02713529|102091819|FG001|STARTED|Overall Study||7||
48148994|NCT01803074|100688582|FG000|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
48405712|NCT03190967|101325349|FG004|NOT COMPLETED|Level 2||0||
48405713|NCT03190967|101325345|FG000|STARTED|Level 3||0||
48405714|NCT03190967|101325346|FG001|STARTED|Level 3||0||
48405715|NCT03190967|101325347|FG002|STARTED|Level 3||6||
48405716|NCT03190967|101325348|FG003|STARTED|Level 3||0||
48405717|NCT03190967|101325349|FG004|STARTED|Level 3||0||
48405718|NCT03190967|101325345|FG000|COMPLETED|Level 3||0||
48405719|NCT03190967|101325346|FG001|COMPLETED|Level 3||0||
48405720|NCT03190967|101325347|FG002|COMPLETED|Level 3||6||
48405721|NCT03190967|101325348|FG003|COMPLETED|Level 3||0||
48405722|NCT03190967|101325349|FG004|COMPLETED|Level 3||0||
48405723|NCT03190967|101325345|FG000|NOT COMPLETED|Level 3||0||
48405724|NCT03190967|101325346|FG001|NOT COMPLETED|Level 3||0||
48405725|NCT03190967|101325347|FG002|NOT COMPLETED|Level 3||0||
48405726|NCT03190967|101325348|FG003|NOT COMPLETED|Level 3||0||
48405727|NCT03190967|101325349|FG004|NOT COMPLETED|Level 3||0||
48405728|NCT00369278|101325350|FG000|STARTED|Overall Study||63||
48405729|NCT00369278|101325351|FG001|STARTED|Overall Study||65||
48405730|NCT00369278|101325350|FG000|COMPLETED|Overall Study||39||
48405731|NCT00369278|101325351|FG001|COMPLETED|Overall Study||44||
48405732|NCT00369278|101325350|FG000|NOT COMPLETED|Overall Study||24||
48405733|NCT00369278|101325351|FG001|NOT COMPLETED|Overall Study||21||
48405734|NCT04539262|101325352|FG000|STARTED|Overall Study||12||
48405735|NCT04539262|101325353|FG001|STARTED|Overall Study||13||
48405736|NCT04539262|101325354|FG002|STARTED|Overall Study||12||
48405737|NCT04539262|101325355|FG003|STARTED|Overall Study||12||
48405738|NCT04539262|101325356|FG004|STARTED|Overall Study||12||
48405739|NCT04539262|101325357|FG005|STARTED|Overall Study||13||
48405740|NCT04539262|101325358|FG006|STARTED|Overall Study||62||
48405741|NCT04539262|101325359|FG007|STARTED|Overall Study||20||
48405742|NCT04539262|101325352|FG000|COMPLETED|Overall Study||12||
48405743|NCT04539262|101325353|FG001|COMPLETED|Overall Study||12||
48405744|NCT04539262|101325354|FG002|COMPLETED|Overall Study||11||
48405745|NCT04539262|101325355|FG003|COMPLETED|Overall Study||11||
48716027|NCT02713529|102091820|FG002|STARTED|Overall Study||42||
48716028|NCT02713529|102091821|FG003|STARTED|Overall Study||31||
48148995|NCT01803074|100688583|FG001|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
48405746|NCT04539262|101325356|FG004|COMPLETED|Overall Study||12||
48405747|NCT04539262|101325357|FG005|COMPLETED|Overall Study||13||
48405748|NCT04539262|101325358|FG006|COMPLETED|Overall Study||61||
48405749|NCT04539262|101325359|FG007|COMPLETED|Overall Study||20||
48405750|NCT04539262|101325352|FG000|NOT COMPLETED|Overall Study||0||
48405751|NCT04539262|101325353|FG001|NOT COMPLETED|Overall Study||1||
48405752|NCT04539262|101325354|FG002|NOT COMPLETED|Overall Study||1||
48405753|NCT04539262|101325355|FG003|NOT COMPLETED|Overall Study||1||
48405754|NCT04539262|101325356|FG004|NOT COMPLETED|Overall Study||0||
48405755|NCT04539262|101325357|FG005|NOT COMPLETED|Overall Study||0||
48405756|NCT04539262|101325358|FG006|NOT COMPLETED|Overall Study||1||
48405757|NCT04539262|101325359|FG007|NOT COMPLETED|Overall Study||0||
48405758|NCT01641081|101325360|FG000|STARTED|Period 1||18||
48405759|NCT01641081|101325361|FG001|STARTED|Period 1||18||
48405760|NCT01641081|101325362|FG002|STARTED|Period 1||15||
48405761|NCT01641081|101325363|FG003|STARTED|Period 1||22||
48405762|NCT01641081|101325364|FG004|STARTED|Period 1||17||
48405763|NCT01641081|101325365|FG005|STARTED|Period 1||19||
48405764|NCT01641081|101325366|FG006|STARTED|Period 1||19||
48405765|NCT01641081|101325367|FG007|STARTED|Period 1||17||
48716029|NCT02713529|102091822|FG004|STARTED|Overall Study||4||
48716030|NCT02713529|102091823|FG005|STARTED|Overall Study||19||
48716031|NCT02713529|102091824|FG006|STARTED|Overall Study||6||
48188701|NCT02034435|100783314|FG002|Aim 1|Overall Study||0||
48405766|NCT01641081|101325368|FG008|STARTED|Period 1||15||
48405767|NCT01641081|101325369|FG009|STARTED|Period 1||14||
48405768|NCT01641081|101325360|FG000|COMPLETED|Period 1||17||
48405769|NCT01641081|101325361|FG001|COMPLETED|Period 1||18||
48405770|NCT01641081|101325362|FG002|COMPLETED|Period 1||15||
48405771|NCT01641081|101325363|FG003|COMPLETED|Period 1||22||
48405772|NCT01641081|101325364|FG004|COMPLETED|Period 1||16||
48405773|NCT01641081|101325365|FG005|COMPLETED|Period 1||19||
48405774|NCT01641081|101325366|FG006|COMPLETED|Period 1||18||
48716032|NCT02713529|102091818|FG000|COMPLETED|Overall Study||1||
48405775|NCT01641081|101325367|FG007|COMPLETED|Period 1||14||
48405776|NCT01641081|101325368|FG008|COMPLETED|Period 1||15||
48405777|NCT01641081|101325369|FG009|COMPLETED|Period 1||14||
48405778|NCT01641081|101325360|FG000|NOT COMPLETED|Period 1||1||
48405779|NCT01641081|101325361|FG001|NOT COMPLETED|Period 1||0||
48405780|NCT01641081|101325362|FG002|NOT COMPLETED|Period 1||0||
48405781|NCT01641081|101325363|FG003|NOT COMPLETED|Period 1||0||
48405782|NCT01641081|101325364|FG004|NOT COMPLETED|Period 1||1||
48148996|NCT01803074|100688584|FG002|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
48148997|NCT01803074|100688585|FG003|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
48148998|NCT01803074|100688586|FG004|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
48303749|NCT01233869|101072840|FG000|NOT COMPLETED|Extended Treatment Period (46 Months)||14||
48405783|NCT01641081|101325365|FG005|NOT COMPLETED|Period 1||0||
48405784|NCT01641081|101325366|FG006|NOT COMPLETED|Period 1||1||
48405785|NCT01641081|101325367|FG007|NOT COMPLETED|Period 1||3||
48405786|NCT01641081|101325368|FG008|NOT COMPLETED|Period 1||0||
48405787|NCT01641081|101325369|FG009|NOT COMPLETED|Period 1||0||
48405788|NCT01641081|101325360|FG000|STARTED|Period 2||17||
48405789|NCT01641081|101325361|FG001|STARTED|Period 2||18||
48405790|NCT01641081|101325362|FG002|STARTED|Period 2||15||
48405791|NCT01641081|101325363|FG003|STARTED|Period 2||22||
48405792|NCT01641081|101325364|FG004|STARTED|Period 2||16||
48405793|NCT01641081|101325365|FG005|STARTED|Period 2||19||
48405794|NCT01641081|101325366|FG006|STARTED|Period 2||18||
48405795|NCT01641081|101325367|FG007|STARTED|Period 2||14||
48405796|NCT01641081|101325368|FG008|STARTED|Period 2||15||
48405797|NCT01641081|101325369|FG009|STARTED|Period 2||14||
48405798|NCT01641081|101325360|FG000|COMPLETED|Period 2||16||
48405799|NCT01641081|101325361|FG001|COMPLETED|Period 2||18||
48303750|NCT01233869|101072841|FG001|NOT COMPLETED|Extended Treatment Period (46 Months)||3||
48303751|NCT01233869|101072842|FG002|NOT COMPLETED|Extended Treatment Period (46 Months)||5||
48303752|NCT01233869|101072843|FG003|NOT COMPLETED|Extended Treatment Period (46 Months)||16||
48303753|NCT03548987|101072844|FG000|STARTED|Run-in Period (Week 0 to Week 20)||902||
48303754|NCT03548987|101072845|FG001|STARTED|Run-in Period (Week 0 to Week 20)||0||
48303755|NCT03548987|101072844|FG000|Safety Analysis Set (SAS)|Run-in Period (Week 0 to Week 20)||902||
48148999|NCT01803074|100688587|FG005|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
48149000|NCT01803074|100688588|FG006|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
48149001|NCT01803074|100688589|FG007|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
48149002|NCT01803074|100688590|FG008|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
48149003|NCT01803074|100688591|FG009|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
48149004|NCT01803074|100688592|FG010|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
48149005|NCT01803074|100688593|FG011|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||8||
48149006|NCT01803074|100688594|FG012|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||7||
48149007|NCT01803074|100688595|FG013|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||4||
48149008|NCT01803074|100688582|FG000|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
48149009|NCT01803074|100688583|FG001|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
48149010|NCT01803074|100688584|FG002|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
48149011|NCT01803074|100688585|FG003|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
48149012|NCT01803074|100688586|FG004|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
48149013|NCT01803074|100688587|FG005|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
48149014|NCT01803074|100688588|FG006|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
48149015|NCT01803074|100688589|FG007|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
48149016|NCT01803074|100688590|FG008|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
48188702|NCT02034435|100783315|FG003|Aim 1|Overall Study||0||
48405800|NCT01641081|101325362|FG002|COMPLETED|Period 2||15||
48405801|NCT01641081|101325363|FG003|COMPLETED|Period 2||21||
48405802|NCT01641081|101325364|FG004|COMPLETED|Period 2||16||
48405803|NCT01641081|101325365|FG005|COMPLETED|Period 2||18||
48405804|NCT01641081|101325366|FG006|COMPLETED|Period 2||16||
48405805|NCT01641081|101325367|FG007|COMPLETED|Period 2||14||
48303756|NCT03548987|101072845|FG001|Safety Analysis Set (SAS)|Run-in Period (Week 0 to Week 20)||0||
48303757|NCT03548987|101072844|FG000|COMPLETED|Run-in Period (Week 0 to Week 20)||803||
48303758|NCT03548987|101072845|FG001|COMPLETED|Run-in Period (Week 0 to Week 20)||0||
48303759|NCT03548987|101072844|FG000|NOT COMPLETED|Run-in Period (Week 0 to Week 20)||99||
48303760|NCT03548987|101072845|FG001|NOT COMPLETED|Run-in Period (Week 0 to Week 20)||0||
48303761|NCT03548987|101072844|FG000|STARTED|Maintenance Period (Week 20 to Week 68)||535||
48303762|NCT03548987|101072845|FG001|STARTED|Maintenance Period (Week 20 to Week 68)||268||
48303763|NCT03548987|101072844|FG000|Full Analysis Set (FAS)|Maintenance Period (Week 20 to Week 68)||535||
48303764|NCT03548987|101072845|FG001|Full Analysis Set (FAS)|Maintenance Period (Week 20 to Week 68)||268||
48303765|NCT03548987|101072844|FG000|COMPLETED|Maintenance Period (Week 20 to Week 68)||504||
48303766|NCT03548987|101072845|FG001|COMPLETED|Maintenance Period (Week 20 to Week 68)||237||
48303767|NCT03548987|101072844|FG000|NOT COMPLETED|Maintenance Period (Week 20 to Week 68)||31||
48303768|NCT03548987|101072845|FG001|NOT COMPLETED|Maintenance Period (Week 20 to Week 68)||31||
48303769|NCT04226833|101072846|FG000|STARTED|Overall Study||7||
48303770|NCT04226833|101072847|FG001|STARTED|Overall Study||12||
48303771|NCT04226833|101072848|FG002|STARTED|Overall Study||11||
48303772|NCT04226833|101072849|FG003|STARTED|Overall Study||8||
48303773|NCT04226833|101072846|FG000|COMPLETED|Overall Study||7||
48303774|NCT04226833|101072847|FG001|COMPLETED|Overall Study||12||
48303775|NCT04226833|101072848|FG002|COMPLETED|Overall Study||10||
48303776|NCT04226833|101072849|FG003|COMPLETED|Overall Study||8||
48303777|NCT04226833|101072846|FG000|NOT COMPLETED|Overall Study||0||
48303778|NCT04226833|101072847|FG001|NOT COMPLETED|Overall Study||0||
48303779|NCT04226833|101072848|FG002|NOT COMPLETED|Overall Study||1||
48303780|NCT04226833|101072849|FG003|NOT COMPLETED|Overall Study||0||
48303781|NCT00234494|101072850|FG000|STARTED|Overall Study||45||
48303782|NCT00234494|101072850|FG000|COMPLETED|Overall Study||43||
48303783|NCT00234494|101072850|FG000|NOT COMPLETED|Overall Study||2||
48303784|NCT01284062|101072851|FG000|STARTED|Overall Study||21||
48303785|NCT01284062|101072852|FG001|STARTED|Overall Study||21||
48303786|NCT01284062|101072853|FG002|STARTED|Overall Study||21||
48303787|NCT01284062|101072854|FG003|STARTED|Overall Study||21||
48303788|NCT01284062|101072851|FG000|COMPLETED|Overall Study||10||
48303789|NCT01284062|101072852|FG001|COMPLETED|Overall Study||13||
48303790|NCT01284062|101072853|FG002|COMPLETED|Overall Study||15||
48303791|NCT01284062|101072854|FG003|COMPLETED|Overall Study||7||
48303792|NCT01284062|101072851|FG000|NOT COMPLETED|Overall Study||11||
48303793|NCT01284062|101072852|FG001|NOT COMPLETED|Overall Study||8||
48303794|NCT01284062|101072853|FG002|NOT COMPLETED|Overall Study||6||
48303795|NCT01284062|101072854|FG003|NOT COMPLETED|Overall Study||14||
48303796|NCT00418951|101072855|FG000|STARTED|Overall Study||39||
48303797|NCT00418951|101072856|FG001|STARTED|Overall Study||33||
48303798|NCT00418951|101072857|FG002|STARTED|Overall Study||40||
48303799|NCT00418951|101072855|FG000|COMPLETED|Overall Study||39||
48303800|NCT00418951|101072856|FG001|COMPLETED|Overall Study||33||
48303801|NCT00418951|101072857|FG002|COMPLETED|Overall Study||40||
48303802|NCT00418951|101072855|FG000|NOT COMPLETED|Overall Study||0||
48303803|NCT00418951|101072856|FG001|NOT COMPLETED|Overall Study||0||
48303804|NCT00418951|101072857|FG002|NOT COMPLETED|Overall Study||0||
48303805|NCT01452854|101072858|FG000|STARTED|Overall Study||2||
48303806|NCT01452854|101072858|FG000|COMPLETED|Overall Study||2||
48303807|NCT01452854|101072858|FG000|NOT COMPLETED|Overall Study||0||
48303808|NCT04439071|101072859|FG000|STARTED|Overall Study||94||
48303809|NCT04439071|101072860|FG001|STARTED|Overall Study||95||
48303810|NCT04439071|101072859|FG000|Received at Least 1 Dose of Study Drug|Overall Study||92||
48303811|NCT04439071|101072860|FG001|Received at Least 1 Dose of Study Drug|Overall Study||95||
48303812|NCT04439071|101072859|FG000|COMPLETED|Overall Study||80||
48303813|NCT04439071|101072860|FG001|COMPLETED|Overall Study||77||
48303814|NCT04439071|101072859|FG000|NOT COMPLETED|Overall Study||14||
48303815|NCT04439071|101072860|FG001|NOT COMPLETED|Overall Study||18||
48303816|NCT01474863|101072861|FG000|STARTED|Overall Study||26||
48303817|NCT01474863|101072862|FG001|STARTED|Overall Study||22||
48303818|NCT01474863|101072863|FG002|STARTED|Overall Study||24||
48303819|NCT01474863|101072861|FG000|COMPLETED|Overall Study||26||
48303820|NCT01474863|101072862|FG001|COMPLETED|Overall Study||22||
48303821|NCT01474863|101072863|FG002|COMPLETED|Overall Study||24||
48303822|NCT01474863|101072861|FG000|NOT COMPLETED|Overall Study||0||
48303823|NCT01474863|101072862|FG001|NOT COMPLETED|Overall Study||0||
48303824|NCT01474863|101072863|FG002|NOT COMPLETED|Overall Study||0||
48303825|NCT01444651|101072864|FG000|STARTED|Overall Study||36||
48303826|NCT01444651|101072865|FG001|STARTED|Overall Study||37||
48303827|NCT01444651|101072864|FG000|COMPLETED|Overall Study||25||
48303828|NCT01444651|101072865|FG001|COMPLETED|Overall Study||28||
48303829|NCT01444651|101072864|FG000|NOT COMPLETED|Overall Study||11||
48303830|NCT01444651|101072865|FG001|NOT COMPLETED|Overall Study||9||
48303831|NCT03942406|101072866|FG000|STARTED|Overall Study||92||
48303832|NCT03942406|101072867|FG001|STARTED|Overall Study||92||
48303833|NCT03942406|101072868|FG002|STARTED|Overall Study||46||
48303834|NCT03942406|101072869|FG003|STARTED|Overall Study||50||
48303835|NCT03942406|101072870|FG004|STARTED|Overall Study||8||
48303836|NCT03942406|101072871|FG005|STARTED|Overall Study||8||
48303837|NCT03942406|101072872|FG006|STARTED|Overall Study||4||
48405806|NCT01641081|101325368|FG008|COMPLETED|Period 2||15||
48405807|NCT01641081|101325369|FG009|COMPLETED|Period 2||14||
48405808|NCT01641081|101325360|FG000|NOT COMPLETED|Period 2||1||
48405809|NCT01641081|101325361|FG001|NOT COMPLETED|Period 2||0||
48405810|NCT01641081|101325362|FG002|NOT COMPLETED|Period 2||0||
48405811|NCT01641081|101325363|FG003|NOT COMPLETED|Period 2||1||
48405812|NCT01641081|101325364|FG004|NOT COMPLETED|Period 2||0||
48405813|NCT01641081|101325365|FG005|NOT COMPLETED|Period 2||1||
48405814|NCT01641081|101325366|FG006|NOT COMPLETED|Period 2||2||
48405815|NCT01641081|101325367|FG007|NOT COMPLETED|Period 2||0||
48405816|NCT01641081|101325368|FG008|NOT COMPLETED|Period 2||0||
48405817|NCT01641081|101325369|FG009|NOT COMPLETED|Period 2||0||
48405818|NCT01641081|101325360|FG000|STARTED|Period 3||16||
48405819|NCT01641081|101325361|FG001|STARTED|Period 3||18||
48405820|NCT01641081|101325362|FG002|STARTED|Period 3||15||
48405821|NCT01641081|101325363|FG003|STARTED|Period 3||21||
48405822|NCT01641081|101325364|FG004|STARTED|Period 3||16||
48405823|NCT01641081|101325365|FG005|STARTED|Period 3||18||
48405824|NCT01641081|101325366|FG006|STARTED|Period 3||16||
48405825|NCT01641081|101325367|FG007|STARTED|Period 3||14||
48405826|NCT01641081|101325368|FG008|STARTED|Period 3||15||
48405827|NCT01641081|101325369|FG009|STARTED|Period 3||14||
48405828|NCT01641081|101325360|FG000|COMPLETED|Period 3||16||
48405829|NCT01641081|101325361|FG001|COMPLETED|Period 3||18||
48405830|NCT01641081|101325362|FG002|COMPLETED|Period 3||14||
48405831|NCT01641081|101325363|FG003|COMPLETED|Period 3||21||
48405832|NCT01641081|101325364|FG004|COMPLETED|Period 3||16||
48405833|NCT01641081|101325365|FG005|COMPLETED|Period 3||18||
48405834|NCT01641081|101325366|FG006|COMPLETED|Period 3||16||
48405835|NCT01641081|101325367|FG007|COMPLETED|Period 3||14||
48405836|NCT01641081|101325368|FG008|COMPLETED|Period 3||14||
48405837|NCT01641081|101325369|FG009|COMPLETED|Period 3||14||
48405838|NCT01641081|101325360|FG000|NOT COMPLETED|Period 3||0||
48405839|NCT01641081|101325361|FG001|NOT COMPLETED|Period 3||0||
48405840|NCT01641081|101325362|FG002|NOT COMPLETED|Period 3||1||
48405841|NCT01641081|101325363|FG003|NOT COMPLETED|Period 3||0||
48405842|NCT01641081|101325364|FG004|NOT COMPLETED|Period 3||0||
48405843|NCT01641081|101325365|FG005|NOT COMPLETED|Period 3||0||
48405844|NCT01641081|101325366|FG006|NOT COMPLETED|Period 3||0||
48405845|NCT01641081|101325367|FG007|NOT COMPLETED|Period 3||0||
48405846|NCT01641081|101325368|FG008|NOT COMPLETED|Period 3||1||
48405847|NCT01641081|101325369|FG009|NOT COMPLETED|Period 3||0||
48405848|NCT01641081|101325360|FG000|STARTED|Period 4||16||
48149017|NCT01803074|100688591|FG009|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
48149018|NCT01803074|100688592|FG010|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
48149019|NCT01803074|100688593|FG011|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
48149020|NCT01803074|100688594|FG012|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
48149021|NCT01803074|100688595|FG013|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
48149022|NCT03599349|100688596|FG000|STARTED|Overall Study||20||
48149023|NCT03599349|100688596|FG000|Treated|Overall Study||20||
48149024|NCT03599349|100688596|FG000|COMPLETED|Overall Study||19||
48149025|NCT03599349|100688596|FG000|NOT COMPLETED|Overall Study||1||
48149026|NCT00677352|100688597|FG000|STARTED|Treatment Phase||157||
48149027|NCT00677352|100688598|FG001|STARTED|Treatment Phase||164||
48149028|NCT00677352|100688597|FG000|COMPLETED|Treatment Phase||132||
48149029|NCT00677352|100688598|FG001|COMPLETED|Treatment Phase||122||
48149030|NCT00677352|100688597|FG000|NOT COMPLETED|Treatment Phase||25||
48149031|NCT00677352|100688598|FG001|NOT COMPLETED|Treatment Phase||42||
48149032|NCT00677352|100688597|FG000|STARTED|Tapering Phase||132||
48149033|NCT00677352|100688598|FG001|STARTED|Tapering Phase||122||
48149034|NCT00677352|100688597|FG000|COMPLETED|Tapering Phase||126||
48149035|NCT00677352|100688598|FG001|COMPLETED|Tapering Phase||112||
48149036|NCT00677352|100688597|FG000|NOT COMPLETED|Tapering Phase||6||
48149037|NCT00677352|100688598|FG001|NOT COMPLETED|Tapering Phase||10||
48149038|NCT03365882|100688599|FG000|STARTED|Randomization||26||
48149039|NCT03365882|100688600|FG001|STARTED|Randomization||28||
48149040|NCT03365882|100688599|FG000|Progressed and Crossed Over|Randomization||0||
48149041|NCT03365882|100688600|FG001|Progressed and Crossed Over|Randomization||20||
48149042|NCT03365882|100688599|FG000|COMPLETED|Randomization||0||
48149043|NCT03365882|100688600|FG001|COMPLETED|Randomization||20||
48149044|NCT03365882|100688599|FG000|NOT COMPLETED|Randomization||26||
48149045|NCT03365882|100688600|FG001|NOT COMPLETED|Randomization||8||
48149046|NCT03365882|100688599|FG000|STARTED|Crossover: Trastuzumab + Pertuzumab||0||
48149047|NCT03365882|100688600|FG001|STARTED|Crossover: Trastuzumab + Pertuzumab||20||
48149048|NCT03365882|100688599|FG000|COMPLETED|Crossover: Trastuzumab + Pertuzumab||0||
48149049|NCT03365882|100688600|FG001|COMPLETED|Crossover: Trastuzumab + Pertuzumab||0||
48405849|NCT01641081|101325361|FG001|STARTED|Period 4||18||
48405850|NCT01641081|101325362|FG002|STARTED|Period 4||14||
48405851|NCT01641081|101325363|FG003|STARTED|Period 4||21||
48405852|NCT01641081|101325364|FG004|STARTED|Period 4||16||
48405853|NCT01641081|101325365|FG005|STARTED|Period 4||18||
48405854|NCT01641081|101325366|FG006|STARTED|Period 4||16||
48405855|NCT01641081|101325367|FG007|STARTED|Period 4||14||
48405856|NCT01641081|101325368|FG008|STARTED|Period 4||14||
48405857|NCT01641081|101325369|FG009|STARTED|Period 4||14||
48405858|NCT01641081|101325360|FG000|COMPLETED|Period 4||16||
48405859|NCT01641081|101325361|FG001|COMPLETED|Period 4||17||
48405860|NCT01641081|101325362|FG002|COMPLETED|Period 4||14||
48405861|NCT01641081|101325363|FG003|COMPLETED|Period 4||20||
48405862|NCT01641081|101325364|FG004|COMPLETED|Period 4||16||
48405863|NCT01641081|101325365|FG005|COMPLETED|Period 4||18||
48405864|NCT01641081|101325366|FG006|COMPLETED|Period 4||16||
48405865|NCT01641081|101325367|FG007|COMPLETED|Period 4||14||
48405866|NCT01641081|101325368|FG008|COMPLETED|Period 4||14||
48405867|NCT01641081|101325369|FG009|COMPLETED|Period 4||14||
48405868|NCT01641081|101325360|FG000|NOT COMPLETED|Period 4||0||
48405869|NCT01641081|101325361|FG001|NOT COMPLETED|Period 4||1||
48405870|NCT01641081|101325362|FG002|NOT COMPLETED|Period 4||0||
48149050|NCT03365882|100688599|FG000|NOT COMPLETED|Crossover: Trastuzumab + Pertuzumab||0||
48149051|NCT03365882|100688600|FG001|NOT COMPLETED|Crossover: Trastuzumab + Pertuzumab||20||
48149052|NCT04205630|100688601|FG000|STARTED|Overall Study||64||
48149053|NCT04205630|100688601|FG000|Full Analysis Set (All Patients Who Received at Least 1 Dose of Study Treatment)|Overall Study||64||
48405871|NCT01641081|101325363|FG003|NOT COMPLETED|Period 4||1||
48405872|NCT01641081|101325364|FG004|NOT COMPLETED|Period 4||0||
48405873|NCT01641081|101325365|FG005|NOT COMPLETED|Period 4||0||
48149054|NCT04205630|100688601|FG000|Efficacy Analysis Set (All Patients Who Had at Least One Post-baseline Tumour Evaluation Assessment)|Overall Study||61||
48149055|NCT04205630|100688601|FG000|COMPLETED|Overall Study||0||
48149056|NCT04205630|100688601|FG000|NOT COMPLETED|Overall Study||64||
48149057|NCT03628287|100688602|FG000|STARTED|Overall Study||531||
48405874|NCT01641081|101325366|FG006|NOT COMPLETED|Period 4||0||
48405875|NCT01641081|101325367|FG007|NOT COMPLETED|Period 4||0||
48405876|NCT01641081|101325368|FG008|NOT COMPLETED|Period 4||0||
48405877|NCT01641081|101325369|FG009|NOT COMPLETED|Period 4||0||
48716033|NCT02713529|102091819|FG001|COMPLETED|Overall Study||3||
48716034|NCT02713529|102091820|FG002|COMPLETED|Overall Study||11||
48716035|NCT02713529|102091821|FG003|COMPLETED|Overall Study||2||
48716036|NCT02713529|102091822|FG004|COMPLETED|Overall Study||1||
48716037|NCT02713529|102091823|FG005|COMPLETED|Overall Study||5||
48716038|NCT02713529|102091824|FG006|COMPLETED|Overall Study||2||
48716039|NCT02713529|102091818|FG000|NOT COMPLETED|Overall Study||7||
48716040|NCT02713529|102091819|FG001|NOT COMPLETED|Overall Study||4||
48716041|NCT02713529|102091820|FG002|NOT COMPLETED|Overall Study||31||
48716042|NCT02713529|102091821|FG003|NOT COMPLETED|Overall Study||29||
48716043|NCT02713529|102091822|FG004|NOT COMPLETED|Overall Study||3||
48716044|NCT02713529|102091823|FG005|NOT COMPLETED|Overall Study||14||
48716045|NCT02713529|102091824|FG006|NOT COMPLETED|Overall Study||4||
48716046|NCT01403376|102091825|FG000|STARTED|Overall Study||41||
48716047|NCT01403376|102091826|FG001|STARTED|Overall Study||41||
48716048|NCT01403376|102091827|FG002|STARTED|Overall Study||46||
48716049|NCT01403376|102091825|FG000|COMPLETED|Overall Study||41||
48716050|NCT01403376|102091826|FG001|COMPLETED|Overall Study||41||
48716051|NCT01403376|102091827|FG002|COMPLETED|Overall Study||46||
48716052|NCT01403376|102091825|FG000|NOT COMPLETED|Overall Study||0||
48716053|NCT01403376|102091826|FG001|NOT COMPLETED|Overall Study||0||
48716054|NCT01403376|102091827|FG002|NOT COMPLETED|Overall Study||0||
48716055|NCT01838785|102091828|FG000|STARTED|Overall Study||25||
48716056|NCT01838785|102091828|FG000|COMPLETED|Overall Study||25||
48716057|NCT01838785|102091828|FG000|NOT COMPLETED|Overall Study||0||
48716058|NCT02241187|102091829|FG000|STARTED|Overall Study||2||
48716059|NCT02241187|102091829|FG000|COMPLETED|Overall Study||0||
48716060|NCT02241187|102091829|FG000|NOT COMPLETED|Overall Study||2||
48716061|NCT03558074|102091830|FG000|STARTED|Overall Study||26||
48716062|NCT03558074|102091830|FG000|COMPLETED|Overall Study||24||
48716063|NCT03558074|102091830|FG000|NOT COMPLETED|Overall Study||2||
48716064|NCT01151761|102091831|FG000|STARTED|Overall Study||2||
48716065|NCT01151761|102091831|FG000|COMPLETED|Overall Study||2||
48716066|NCT01151761|102091831|FG000|NOT COMPLETED|Overall Study||0||
48716067|NCT00186537|102091832|FG000|STARTED|Overall Study||19||
48716068|NCT00186537|102091833|FG001|STARTED|Overall Study||12||
48716069|NCT00186537|102091834|FG002|STARTED|Overall Study||16||
48716070|NCT00186537|102091832|FG000|COMPLETED|Overall Study||12||
48716071|NCT00186537|102091833|FG001|COMPLETED|Overall Study||12||
48716072|NCT00186537|102091834|FG002|COMPLETED|Overall Study||13||
48716073|NCT00186537|102091832|FG000|NOT COMPLETED|Overall Study||7||
48716074|NCT00186537|102091833|FG001|NOT COMPLETED|Overall Study||0||
48716075|NCT00186537|102091834|FG002|NOT COMPLETED|Overall Study||3||
48716076|NCT02809053|102091835|FG000|STARTED|Overall Study||157||
48716077|NCT02809053|102091836|FG001|STARTED|Overall Study||158||
48716078|NCT02809053|102091835|FG000|Completed Treatment|Overall Study||156|Received at least one infusion of study drug.|
48716079|NCT02809053|102091836|FG001|Completed Treatment|Overall Study||156|Received at least one infusion of study drug.|
48716080|NCT02809053|102091835|FG000|COMPLETED|Overall Study||150|Completed Week 28 (Primary Analysis cut-off)|
48716081|NCT02809053|102091836|FG001|COMPLETED|Overall Study||152|Completed Week 28 (Primary Analysis cut-off)|
48716082|NCT02809053|102091835|FG000|NOT COMPLETED|Overall Study||7||
48716083|NCT02809053|102091836|FG001|NOT COMPLETED|Overall Study||6||
48716084|NCT00450294|102091837|FG000|STARTED|Overall Study||10||
48716085|NCT00450294|102091837|FG000|COMPLETED|Overall Study||10||
48716086|NCT00450294|102091837|FG000|NOT COMPLETED|Overall Study||0||
48716087|NCT05714943|102091838|FG000|STARTED|Overall Study||236||
48716088|NCT05714943|102091839|FG001|STARTED|Overall Study||230||
48716089|NCT05714943|102091838|FG000|Completed Pretest|Overall Study||166||
48716090|NCT05714943|102091839|FG001|Completed Pretest|Overall Study||192||
48716091|NCT05714943|102091838|FG000|COMPLETED|Overall Study||138||
48716092|NCT05714943|102091839|FG001|COMPLETED|Overall Study||188||
48716093|NCT05714943|102091838|FG000|NOT COMPLETED|Overall Study||98||
48716094|NCT05714943|102091839|FG001|NOT COMPLETED|Overall Study||42||
48716095|NCT01522404|102091840|FG000|STARTED|First Intervention (up to Week 29)||20||
48716096|NCT01522404|102091841|FG001|STARTED|First Intervention (up to Week 29)||19||
48716097|NCT01522404|102091840|FG000|COMPLETED|First Intervention (up to Week 29)||18||
48716098|NCT01522404|102091841|FG001|COMPLETED|First Intervention (up to Week 29)||19||
48716099|NCT01522404|102091840|FG000|NOT COMPLETED|First Intervention (up to Week 29)||2||
48716100|NCT01522404|102091841|FG001|NOT COMPLETED|First Intervention (up to Week 29)||0||
48716101|NCT01522404|102091840|FG000|STARTED|Second Intervention (up to Week 58)||18||
48716102|NCT01522404|102091841|FG001|STARTED|Second Intervention (up to Week 58)||19||
48716103|NCT01522404|102091840|FG000|COMPLETED|Second Intervention (up to Week 58)||17||
48716104|NCT01522404|102091841|FG001|COMPLETED|Second Intervention (up to Week 58)||19||
48716105|NCT01522404|102091840|FG000|NOT COMPLETED|Second Intervention (up to Week 58)||1||
48767585|NCT01435382|102222771|FG000|NOT COMPLETED|Overall Study||1||
48767586|NCT01435382|102222772|FG001|NOT COMPLETED|Overall Study||2||
48149058|NCT03628287|100688603|FG001|STARTED|Overall Study||429||
48767587|NCT01435382|102222773|FG002|NOT COMPLETED|Overall Study||1||
48767588|NCT01435382|102222774|FG003|NOT COMPLETED|Overall Study||1||
48716106|NCT01522404|102091841|FG001|NOT COMPLETED|Second Intervention (up to Week 58)||0||
48716107|NCT02230683|102091842|FG000|STARTED|Overall Study||23||
48716108|NCT02230683|102091842|FG000|COMPLETED|Overall Study||22||
48716109|NCT02230683|102091842|FG000|NOT COMPLETED|Overall Study||1||
48716110|NCT03761394|102091843|FG000|STARTED|14-day Intervention & Control Period||90||
48716111|NCT03761394|102091844|FG001|STARTED|14-day Intervention & Control Period||30||
48716112|NCT03761394|102091845|FG002|STARTED|14-day Intervention & Control Period||0||
48716113|NCT03761394|102091846|FG003|STARTED|14-day Intervention & Control Period||0||
48716114|NCT03761394|102091843|FG000|COMPLETED|14-day Intervention & Control Period||87||
48716115|NCT03761394|102091844|FG001|COMPLETED|14-day Intervention & Control Period||28||
48716116|NCT03761394|102091845|FG002|COMPLETED|14-day Intervention & Control Period||0||
48716117|NCT03761394|102091846|FG003|COMPLETED|14-day Intervention & Control Period||0||
48716118|NCT03761394|102091843|FG000|NOT COMPLETED|14-day Intervention & Control Period||3||
48716119|NCT03761394|102091844|FG001|NOT COMPLETED|14-day Intervention & Control Period||2||
48716120|NCT03761394|102091845|FG002|NOT COMPLETED|14-day Intervention & Control Period||0||
48716121|NCT03761394|102091846|FG003|NOT COMPLETED|14-day Intervention & Control Period||0||
48716122|NCT03761394|102091843|FG000|STARTED|30-day Period (Extension 44 Days)||0||
48716123|NCT03761394|102091844|FG001|STARTED|30-day Period (Extension 44 Days)||0||
48716124|NCT03761394|102091845|FG002|STARTED|30-day Period (Extension 44 Days)||57||
48716125|NCT03761394|102091846|FG003|STARTED|30-day Period (Extension 44 Days)||58||
48716126|NCT03761394|102091843|FG000|COMPLETED|30-day Period (Extension 44 Days)||0||
48716127|NCT03761394|102091844|FG001|COMPLETED|30-day Period (Extension 44 Days)||0||
48716128|NCT03761394|102091845|FG002|COMPLETED|30-day Period (Extension 44 Days)||55||
48716129|NCT03761394|102091846|FG003|COMPLETED|30-day Period (Extension 44 Days)||55||
48716130|NCT03761394|102091843|FG000|NOT COMPLETED|30-day Period (Extension 44 Days)||0||
48716131|NCT03761394|102091844|FG001|NOT COMPLETED|30-day Period (Extension 44 Days)||0||
48716132|NCT03761394|102091845|FG002|NOT COMPLETED|30-day Period (Extension 44 Days)||2||
48716133|NCT03761394|102091846|FG003|NOT COMPLETED|30-day Period (Extension 44 Days)||3||
48716134|NCT02616393|102091847|FG000|STARTED|Overall Study||13||
48716135|NCT02616393|102091848|FG001|STARTED|Overall Study||20||
48716136|NCT02616393|102091849|FG002|STARTED|Overall Study||3||
48716137|NCT02616393|102091847|FG000|COMPLETED|Overall Study||0||
48716138|NCT02616393|102091848|FG001|COMPLETED|Overall Study||0||
48716139|NCT02616393|102091849|FG002|COMPLETED|Overall Study||0||
48716140|NCT02616393|102091847|FG000|NOT COMPLETED|Overall Study||13||
48716141|NCT02616393|102091848|FG001|NOT COMPLETED|Overall Study||20||
48716142|NCT02616393|102091849|FG002|NOT COMPLETED|Overall Study||3||
48716143|NCT02144155|102091850|FG000|STARTED|Overall Study||14||
48716144|NCT02144155|102091850|FG000|COMPLETED|Overall Study||14||
48716145|NCT02144155|102091850|FG000|NOT COMPLETED|Overall Study||0||
48716146|NCT04032080|102091851|FG000|STARTED|Overall Study||10||
48716147|NCT04032080|102091851|FG000|COMPLETED|Overall Study||4||
48716148|NCT04032080|102091851|FG000|NOT COMPLETED|Overall Study||6||
48716149|NCT03099148|102091852|FG000|STARTED|Period 1||7||
48716150|NCT03099148|102091853|FG001|STARTED|Period 1||7||
48716151|NCT03099148|102091854|FG002|STARTED|Period 1||7||
48716152|NCT03099148|102091855|FG003|STARTED|Period 1||8||
48716153|NCT03099148|102091852|FG000|Received at Least 1 Dose of Study Drug|Period 1||7||
48716154|NCT03099148|102091853|FG001|Received at Least 1 Dose of Study Drug|Period 1||7||
48716155|NCT03099148|102091854|FG002|Received at Least 1 Dose of Study Drug|Period 1||7||
48716156|NCT03099148|102091855|FG003|Received at Least 1 Dose of Study Drug|Period 1||8||
48716157|NCT03099148|102091852|FG000|COMPLETED|Period 1||7||
48716158|NCT03099148|102091853|FG001|COMPLETED|Period 1||7||
48716159|NCT03099148|102091854|FG002|COMPLETED|Period 1||7||
48716160|NCT03099148|102091855|FG003|COMPLETED|Period 1||8||
48716161|NCT03099148|102091852|FG000|NOT COMPLETED|Period 1||0||
48716162|NCT03099148|102091853|FG001|NOT COMPLETED|Period 1||0||
48716163|NCT03099148|102091854|FG002|NOT COMPLETED|Period 1||0||
48716164|NCT03099148|102091855|FG003|NOT COMPLETED|Period 1||0||
48716165|NCT03099148|102091852|FG000|STARTED|Wash-out||7||
48716166|NCT03099148|102091853|FG001|STARTED|Wash-out||7||
48716167|NCT03099148|102091854|FG002|STARTED|Wash-out||7||
48716168|NCT03099148|102091855|FG003|STARTED|Wash-out||8||
48716169|NCT03099148|102091852|FG000|COMPLETED|Wash-out||7||
48716170|NCT03099148|102091853|FG001|COMPLETED|Wash-out||6||
48716171|NCT03099148|102091854|FG002|COMPLETED|Wash-out||7||
48716172|NCT03099148|102091855|FG003|COMPLETED|Wash-out||8||
48716173|NCT03099148|102091852|FG000|NOT COMPLETED|Wash-out||0||
48188703|NCT02034435|100783312|FG000|Aim 2|Overall Study||0||
48716174|NCT03099148|102091853|FG001|NOT COMPLETED|Wash-out||1||
48716175|NCT03099148|102091854|FG002|NOT COMPLETED|Wash-out||0||
48716176|NCT03099148|102091855|FG003|NOT COMPLETED|Wash-out||0||
48716177|NCT03099148|102091852|FG000|STARTED|Period 2||7||
48716178|NCT03099148|102091853|FG001|STARTED|Period 2||6||
48716179|NCT03099148|102091854|FG002|STARTED|Period 2||7||
48716180|NCT03099148|102091855|FG003|STARTED|Period 2||8||
48716181|NCT03099148|102091852|FG000|COMPLETED|Period 2||7||
48716182|NCT03099148|102091853|FG001|COMPLETED|Period 2||6||
48716183|NCT03099148|102091854|FG002|COMPLETED|Period 2||7||
48716184|NCT03099148|102091855|FG003|COMPLETED|Period 2||8||
48716185|NCT03099148|102091852|FG000|NOT COMPLETED|Period 2||0||
48405878|NCT01641081|101325360|FG000|STARTED|Period 5||16||
48405879|NCT01641081|101325361|FG001|STARTED|Period 5||17||
48405880|NCT01641081|101325362|FG002|STARTED|Period 5||14||
48405881|NCT01641081|101325363|FG003|STARTED|Period 5||20||
48405882|NCT01641081|101325364|FG004|STARTED|Period 5||16||
48405883|NCT01641081|101325365|FG005|STARTED|Period 5||18||
48405884|NCT01641081|101325366|FG006|STARTED|Period 5||16||
48405885|NCT01641081|101325367|FG007|STARTED|Period 5||14||
48405886|NCT01641081|101325368|FG008|STARTED|Period 5||14||
48405887|NCT01641081|101325369|FG009|STARTED|Period 5||14||
48405888|NCT01641081|101325360|FG000|COMPLETED|Period 5||16||
48405889|NCT01641081|101325361|FG001|COMPLETED|Period 5||17||
48716186|NCT03099148|102091853|FG001|NOT COMPLETED|Period 2||0||
48716187|NCT03099148|102091854|FG002|NOT COMPLETED|Period 2||0||
48716188|NCT03099148|102091855|FG003|NOT COMPLETED|Period 2||0||
48716189|NCT03099148|102091852|FG000|STARTED|Wash-out||7||
48716190|NCT03099148|102091853|FG001|STARTED|Wash-out||6||
48716191|NCT03099148|102091854|FG002|STARTED|Wash-out||7||
48716192|NCT03099148|102091855|FG003|STARTED|Wash-out||8||
48716193|NCT03099148|102091852|FG000|COMPLETED|Wash-out||7||
48716194|NCT03099148|102091853|FG001|COMPLETED|Wash-out||5||
48716195|NCT03099148|102091854|FG002|COMPLETED|Wash-out||7||
48716196|NCT03099148|102091855|FG003|COMPLETED|Wash-out||8||
48716197|NCT03099148|102091852|FG000|NOT COMPLETED|Wash-out||0||
48716198|NCT03099148|102091853|FG001|NOT COMPLETED|Wash-out||1||
48716199|NCT03099148|102091854|FG002|NOT COMPLETED|Wash-out||0||
48716200|NCT03099148|102091855|FG003|NOT COMPLETED|Wash-out||0||
48405890|NCT01641081|101325362|FG002|COMPLETED|Period 5||12||
48405891|NCT01641081|101325363|FG003|COMPLETED|Period 5||20||
48405892|NCT01641081|101325364|FG004|COMPLETED|Period 5||16||
48405893|NCT01641081|101325365|FG005|COMPLETED|Period 5||18||
48405894|NCT01641081|101325366|FG006|COMPLETED|Period 5||16||
48405895|NCT01641081|101325367|FG007|COMPLETED|Period 5||14||
48405896|NCT01641081|101325368|FG008|COMPLETED|Period 5||14||
48405897|NCT01641081|101325369|FG009|COMPLETED|Period 5||14||
48405898|NCT01641081|101325360|FG000|NOT COMPLETED|Period 5||0||
48405899|NCT01641081|101325361|FG001|NOT COMPLETED|Period 5||0||
48405900|NCT01641081|101325362|FG002|NOT COMPLETED|Period 5||2||
48405901|NCT01641081|101325363|FG003|NOT COMPLETED|Period 5||0||
48405902|NCT01641081|101325364|FG004|NOT COMPLETED|Period 5||0||
48405903|NCT01641081|101325365|FG005|NOT COMPLETED|Period 5||0||
48405904|NCT01641081|101325366|FG006|NOT COMPLETED|Period 5||0||
48606176|NCT01004432|101819924|FG004|STARTED|Open-label (OL) Period (Week 0 - 16)||0||
48716201|NCT03099148|102091852|FG000|STARTED|Period 3||7||
48716202|NCT03099148|102091853|FG001|STARTED|Period 3||5||
48716203|NCT03099148|102091854|FG002|STARTED|Period 3||7||
48716204|NCT03099148|102091855|FG003|STARTED|Period 3||8||
48716205|NCT03099148|102091852|FG000|COMPLETED|Period 3||7||
48716206|NCT03099148|102091853|FG001|COMPLETED|Period 3||5||
48716207|NCT03099148|102091854|FG002|COMPLETED|Period 3||7||
48716208|NCT03099148|102091855|FG003|COMPLETED|Period 3||8||
48716209|NCT03099148|102091852|FG000|NOT COMPLETED|Period 3||0||
48716210|NCT03099148|102091853|FG001|NOT COMPLETED|Period 3||0||
48716211|NCT03099148|102091854|FG002|NOT COMPLETED|Period 3||0||
48716212|NCT03099148|102091855|FG003|NOT COMPLETED|Period 3||0||
48188704|NCT02034435|100783313|FG001|Aim 2|Overall Study||0||
48606177|NCT01004432|101819920|FG000|COMPLETED|Open-label (OL) Period (Week 0 - 16)||350||
48606178|NCT01004432|101819921|FG001|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0||
48606179|NCT01004432|101819922|FG002|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0||
48606180|NCT01004432|101819923|FG003|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0||
48606181|NCT01004432|101819924|FG004|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0||
48606182|NCT01004432|101819920|FG000|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||83||
48606183|NCT01004432|101819921|FG001|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0||
48606184|NCT01004432|101819922|FG002|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0||
48606185|NCT01004432|101819923|FG003|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0||
48606186|NCT01004432|101819924|FG004|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0||
48606187|NCT01004432|101819920|FG000|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0||
48606188|NCT01004432|101819921|FG001|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||75||
48606189|NCT01004432|101819922|FG002|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||91||
48716213|NCT03099148|102091852|FG000|STARTED|Wash-out||7||
48716214|NCT03099148|102091853|FG001|STARTED|Wash-out||5||
48716215|NCT03099148|102091854|FG002|STARTED|Wash-out||7||
48716216|NCT03099148|102091855|FG003|STARTED|Wash-out||8||
48716217|NCT03099148|102091852|FG000|COMPLETED|Wash-out||7||
48716218|NCT03099148|102091853|FG001|COMPLETED|Wash-out||5||
48716219|NCT03099148|102091854|FG002|COMPLETED|Wash-out||7||
48716220|NCT03099148|102091855|FG003|COMPLETED|Wash-out||8||
48716221|NCT03099148|102091852|FG000|NOT COMPLETED|Wash-out||0||
48716222|NCT03099148|102091853|FG001|NOT COMPLETED|Wash-out||0||
48405905|NCT01641081|101325367|FG007|NOT COMPLETED|Period 5||0||
48405906|NCT01641081|101325368|FG008|NOT COMPLETED|Period 5||0||
48405907|NCT01641081|101325369|FG009|NOT COMPLETED|Period 5||0||
48405908|NCT00058188|101325370|FG000|STARTED|Overall Study||0||
48405909|NCT00058188|101325371|FG001|STARTED|Overall Study||0||
48405910|NCT00058188|101325370|FG000|COMPLETED|Overall Study||0||
48716223|NCT03099148|102091854|FG002|NOT COMPLETED|Wash-out||0||
48716224|NCT03099148|102091855|FG003|NOT COMPLETED|Wash-out||0||
48716225|NCT03099148|102091852|FG000|STARTED|Period 4||7||
48716226|NCT03099148|102091853|FG001|STARTED|Period 4||5||
48716227|NCT03099148|102091854|FG002|STARTED|Period 4||7||
48716228|NCT03099148|102091855|FG003|STARTED|Period 4||8||
48716229|NCT03099148|102091852|FG000|COMPLETED|Period 4||7||
48716230|NCT03099148|102091853|FG001|COMPLETED|Period 4||5||
48716231|NCT03099148|102091854|FG002|COMPLETED|Period 4||7||
48716232|NCT03099148|102091855|FG003|COMPLETED|Period 4||8||
48716233|NCT03099148|102091852|FG000|NOT COMPLETED|Period 4||0||
48716234|NCT03099148|102091853|FG001|NOT COMPLETED|Period 4||0||
48716235|NCT03099148|102091854|FG002|NOT COMPLETED|Period 4||0||
48716236|NCT03099148|102091855|FG003|NOT COMPLETED|Period 4||0||
48716237|NCT01557959|102091856|FG000|STARTED|Overall Study||45||
48716238|NCT01557959|102091856|FG000|COMPLETED|Overall Study||45||
48716239|NCT01557959|102091856|FG000|NOT COMPLETED|Overall Study||0||
48716240|NCT03571672|102091857|FG000|STARTED|Overall Study||153||
48716241|NCT03571672|102091857|FG000|COMPLETED|Overall Study||148||
48716242|NCT03571672|102091857|FG000|NOT COMPLETED|Overall Study||5||
48716243|NCT03361189|102091858|FG000|STARTED|Overall Study||2||
48716244|NCT03361189|102091859|FG001|STARTED|Overall Study||2||
48716245|NCT03361189|102091858|FG000|Completed Test Period 1 Completed|Overall Study||1||
48716246|NCT03361189|102091859|FG001|Completed Test Period 1 Completed|Overall Study||1||
48716247|NCT03361189|102091858|FG000|Test Period 2 Begun|Overall Study||1||
48716248|NCT03361189|102091859|FG001|Test Period 2 Begun|Overall Study||1||
48716249|NCT03361189|102091858|FG000|COMPLETED|Overall Study||1||
48716250|NCT03361189|102091859|FG001|COMPLETED|Overall Study||1||
48716251|NCT03361189|102091858|FG000|NOT COMPLETED|Overall Study||1||
48716252|NCT03361189|102091859|FG001|NOT COMPLETED|Overall Study||1||
48716253|NCT00687609|102091860|FG000|STARTED|Overall Study||7||
48716254|NCT00687609|102091860|FG000|COMPLETED|Overall Study||4||
48716255|NCT00687609|102091860|FG000|NOT COMPLETED|Overall Study||3||
48716256|NCT02771626|102091861|FG000|STARTED|Overall Study||8||
48716257|NCT02771626|102091862|FG001|STARTED|Overall Study||26||
48716258|NCT02771626|102091863|FG002|STARTED|Overall Study||17||
48716259|NCT02771626|102091864|FG003|STARTED|Overall Study||9||
48716260|NCT02771626|102091865|FG004|STARTED|Overall Study||37||
48716261|NCT02771626|102091866|FG005|STARTED|Overall Study||21||
48716262|NCT02771626|102091861|FG000|COMPLETED|Overall Study||0|Study was terminated early. Participants still on study at the time of the study termination (see Reason Not Completed=Study Termination by Sponsor, below) were transferred to individual patient treatment Investigational New Drug applications (INDs) per physician and participant request.|
48716263|NCT02771626|102091862|FG001|COMPLETED|Overall Study||0|Study was terminated early. Participants still on study at the time of the study termination (see Reason Not Completed=Study Termination by Sponsor, below) were transferred to individual patient treatment Investigational New Drug applications (INDs) per physician and participant request.|
48716264|NCT02771626|102091863|FG002|COMPLETED|Overall Study||0|Study was terminated early. Participants still on study at the time of the study termination (see Reason Not Completed=Study Termination by Sponsor, below) were transferred to individual patient treatment Investigational New Drug applications (INDs) per physician and participant request.|
48716265|NCT02771626|102091864|FG003|COMPLETED|Overall Study||0|Study was terminated early. Participants still on study at the time of the study termination (see Reason Not Completed=Study Termination by Sponsor, below) were transferred to individual patient treatment Investigational New Drug applications (INDs) per physician and participant request.|
48716266|NCT02771626|102091865|FG004|COMPLETED|Overall Study||0|Study was terminated early. Participants still on study at the time of the study termination (see Reason Not Completed=Study Termination by Sponsor, below) were transferred to individual patient treatment Investigational New Drug applications (INDs) per physician and participant request.|
48716267|NCT02771626|102091866|FG005|COMPLETED|Overall Study||0|Study was terminated early. Participants still on study at the time of the study termination (see Reason Not Completed=Study Termination by Sponsor, below) were transferred to individual patient treatment Investigational New Drug applications (INDs) per physician and participant request.|
48716268|NCT02771626|102091861|FG000|NOT COMPLETED|Overall Study||8||
48716269|NCT02771626|102091862|FG001|NOT COMPLETED|Overall Study||26||
48716270|NCT02771626|102091863|FG002|NOT COMPLETED|Overall Study||17||
48716271|NCT02771626|102091864|FG003|NOT COMPLETED|Overall Study||9||
48716272|NCT02771626|102091865|FG004|NOT COMPLETED|Overall Study||37||
48716273|NCT02771626|102091866|FG005|NOT COMPLETED|Overall Study||21||
48716274|NCT00334282|102091867|FG000|STARTED|Overall Study||290||
48716275|NCT00334282|102091868|FG001|STARTED|Overall Study||145||
48716276|NCT00334282|102091867|FG000|COMPLETED|Overall Study||68||
48716277|NCT00334282|102091868|FG001|COMPLETED|Overall Study||37||
48716278|NCT00334282|102091867|FG000|NOT COMPLETED|Overall Study||222||
48149059|NCT03628287|100688602|FG000|Period 0: No Revised Program Delivery|Overall Study||83|(November 2017-March 2018, follow-up through July 2018)|
48149060|NCT03628287|100688603|FG001|Period 0: No Revised Program Delivery|Overall Study||93|(November 2017-March 2018, follow-up through July 2018)|
48149061|NCT03628287|100688602|FG000|Period 1: Revised Program Delivery Only at Sites Assigned to Early Implementation|Overall Study||286|(August-December 2018, follow-up through April 2019)|
48149062|NCT03628287|100688603|FG001|Period 1: Revised Program Delivery Only at Sites Assigned to Early Implementation|Overall Study||104|(August-December 2018, follow-up through April 2019)|
48188538|NCT02068885|100783270|FG000|STARTED|Overall Study||57|Sample size randomized|
48716279|NCT00334282|102091868|FG001|NOT COMPLETED|Overall Study||108||
48716280|NCT01853072|102091869|FG000|STARTED|Overall Study||308||
48716281|NCT01853072|102091870|FG001|STARTED|Overall Study||307||
48716282|NCT01853072|102091869|FG000|Randomized|Overall Study||308||
48716283|NCT01853072|102091870|FG001|Randomized|Overall Study||307||
48716284|NCT01853072|102091869|FG000|Treated (Safety Analysis Set)|Overall Study||301||
48716285|NCT01853072|102091870|FG001|Treated (Safety Analysis Set)|Overall Study||302||
48716286|NCT01853072|102091869|FG000|Full Analysis Set|Overall Study||298||
48716287|NCT01853072|102091870|FG001|Full Analysis Set|Overall Study||300||
48149063|NCT03628287|100688602|FG000|Period 2: Revised Program Delivery at All Sites|Overall Study||162|(May-September 2019, follow-up through January 2020)|
48149064|NCT03628287|100688603|FG001|Period 2: Revised Program Delivery at All Sites|Overall Study||232|(May-September 2019, follow-up through January 2020)|
48149065|NCT03628287|100688602|FG000|COMPLETED|Overall Study||531||
48149066|NCT03628287|100688603|FG001|COMPLETED|Overall Study||429||
48149067|NCT03628287|100688602|FG000|NOT COMPLETED|Overall Study||0||
48149068|NCT03628287|100688603|FG001|NOT COMPLETED|Overall Study||0||
48149069|NCT01146496|100688604|FG000|STARTED|Overall Study||114168||
48149070|NCT01146496|100688605|FG001|STARTED|Overall Study||109693||
48716288|NCT01853072|102091869|FG000|COMPLETED|Overall Study||296||
48716289|NCT01853072|102091870|FG001|COMPLETED|Overall Study||286||
48716290|NCT01853072|102091869|FG000|NOT COMPLETED|Overall Study||12||
48716291|NCT01853072|102091870|FG001|NOT COMPLETED|Overall Study||21||
48716292|NCT00581828|102091871|FG000|STARTED|Overall Study||19||
48716293|NCT00581828|102091871|FG000|COMPLETED|Overall Study||18||
48716294|NCT00581828|102091871|FG000|NOT COMPLETED|Overall Study||1||
48149071|NCT01146496|100688604|FG000|COMPLETED|Overall Study||114168||
48149072|NCT01146496|100688605|FG001|COMPLETED|Overall Study||109693||
48303838|NCT03942406|101072866|FG000|COMPLETED|Overall Study||81||
48606190|NCT01004432|101819923|FG003|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||184||
48606191|NCT01004432|101819924|FG004|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0||
48606192|NCT01004432|101819920|FG000|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0||
48606193|NCT01004432|101819921|FG001|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||65||
48606194|NCT01004432|101819922|FG002|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||54||
48606195|NCT01004432|101819923|FG003|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||126||
48606196|NCT01004432|101819924|FG004|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0||
48606197|NCT01004432|101819920|FG000|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0||
48606198|NCT01004432|101819921|FG001|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||10||
48606199|NCT01004432|101819922|FG002|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||37||
48606200|NCT01004432|101819923|FG003|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||58||
48606201|NCT01004432|101819924|FG004|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0||
48606202|NCT01004432|101819920|FG000|STARTED|OL Study Extension (Week 52 - 76)||0||
48606203|NCT01004432|101819921|FG001|STARTED|OL Study Extension (Week 52 - 76)||0||
48606204|NCT01004432|101819922|FG002|STARTED|OL Study Extension (Week 52 - 76)||0||
48606205|NCT01004432|101819923|FG003|STARTED|OL Study Extension (Week 52 - 76)||0||
48606206|NCT01004432|101819924|FG004|STARTED|OL Study Extension (Week 52 - 76)||212||
48606207|NCT01004432|101819920|FG000|COMPLETED|OL Study Extension (Week 52 - 76)||0||
48606208|NCT01004432|101819921|FG001|COMPLETED|OL Study Extension (Week 52 - 76)||0||
48606209|NCT01004432|101819922|FG002|COMPLETED|OL Study Extension (Week 52 - 76)||0||
48606210|NCT01004432|101819923|FG003|COMPLETED|OL Study Extension (Week 52 - 76)||0||
48606211|NCT01004432|101819924|FG004|COMPLETED|OL Study Extension (Week 52 - 76)||194||
48606212|NCT01004432|101819920|FG000|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0||
48606213|NCT01004432|101819921|FG001|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0||
48606214|NCT01004432|101819922|FG002|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0||
48606215|NCT01004432|101819923|FG003|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0||
48606216|NCT01004432|101819924|FG004|NOT COMPLETED|OL Study Extension (Week 52 - 76)||18||
48606217|NCT00624832|101819925|FG000|STARTED|Overall Study||18||
48606218|NCT00624832|101819926|FG001|STARTED|Overall Study||16||
48606219|NCT00624832|101819927|FG002|STARTED|Overall Study||10||
48606220|NCT00624832|101819928|FG003|STARTED|Overall Study||16||
48716295|NCT01920152|102091872|FG000|STARTED|Overall Study||19||20
48716296|NCT01920152|102091873|FG001|STARTED|Overall Study||15||16
48716297|NCT01920152|102091872|FG000|COMPLETED|Overall Study||18||19
48716298|NCT01920152|102091873|FG001|COMPLETED|Overall Study||13||14
48716299|NCT01920152|102091872|FG000|NOT COMPLETED|Overall Study||1||1
48716300|NCT01920152|102091873|FG001|NOT COMPLETED|Overall Study||2||2
48716301|NCT04959812|102091874|FG000|STARTED|Overall Study||28||
48716302|NCT04959812|102091875|FG001|STARTED|Overall Study||18||
48716303|NCT04959812|102091874|FG000|COMPLETED|Overall Study||20||
48716304|NCT04959812|102091875|FG001|COMPLETED|Overall Study||9||
48716305|NCT04959812|102091874|FG000|NOT COMPLETED|Overall Study||8||
48149073|NCT01146496|100688604|FG000|NOT COMPLETED|Overall Study||0||
48606221|NCT00624832|101819925|FG000|COMPLETED|Overall Study||16||
48606222|NCT00624832|101819926|FG001|COMPLETED|Overall Study||15||
48606223|NCT00624832|101819927|FG002|COMPLETED|Overall Study||10||
48716306|NCT04959812|102091875|FG001|NOT COMPLETED|Overall Study||9||
48606224|NCT00624832|101819928|FG003|COMPLETED|Overall Study||15||
48716307|NCT00489736|102091876|FG000|STARTED|Overall Study||249||
48716308|NCT00489736|102091877|FG001|STARTED|Overall Study||255||
48716309|NCT00489736|102091876|FG000|COMPLETED|Overall Study||153||
48606225|NCT00624832|101819925|FG000|NOT COMPLETED|Overall Study||2||
48716310|NCT00489736|102091877|FG001|COMPLETED|Overall Study||186||
48149074|NCT01146496|100688605|FG001|NOT COMPLETED|Overall Study||0||
48149075|NCT01844284|100688606|FG000|STARTED|Overall Study||266||
48149076|NCT01844284|100688607|FG001|STARTED|Overall Study||134||
48606226|NCT00624832|101819926|FG001|NOT COMPLETED|Overall Study||1||
48606227|NCT00624832|101819927|FG002|NOT COMPLETED|Overall Study||0||
48606228|NCT00624832|101819928|FG003|NOT COMPLETED|Overall Study||1||
48606229|NCT00456261|101819929|FG000|STARTED|Combination Therapy||55||
48606230|NCT00456261|101819930|FG001|STARTED|Combination Therapy||55||
48606231|NCT00456261|101819929|FG000|COMPLETED|Combination Therapy||3||
48606232|NCT00456261|101819930|FG001|COMPLETED|Combination Therapy||29||
48606233|NCT00456261|101819929|FG000|NOT COMPLETED|Combination Therapy||52||
48606234|NCT00456261|101819930|FG001|NOT COMPLETED|Combination Therapy||26||
48606235|NCT00456261|101819929|FG000|STARTED|Maintenance Therapy||3||
48606236|NCT00456261|101819930|FG001|STARTED|Maintenance Therapy||29||
48606237|NCT00456261|101819929|FG000|COMPLETED|Maintenance Therapy||3||
48606238|NCT00456261|101819930|FG001|COMPLETED|Maintenance Therapy||29||
48606239|NCT00456261|101819929|FG000|NOT COMPLETED|Maintenance Therapy||0||
48606240|NCT00456261|101819930|FG001|NOT COMPLETED|Maintenance Therapy||0||
48606241|NCT04348500|101819931|FG000|STARTED|Overall Study||8||
48606242|NCT04348500|101819932|FG001|STARTED|Overall Study||9||
48606243|NCT04348500|101819931|FG000|Treated|Overall Study||8||
48606244|NCT04348500|101819932|FG001|Treated|Overall Study||8||
48606245|NCT04348500|101819931|FG000|COMPLETED|Overall Study||6||
48606246|NCT04348500|101819932|FG001|COMPLETED|Overall Study||6||
48606247|NCT04348500|101819931|FG000|NOT COMPLETED|Overall Study||2||
48606248|NCT04348500|101819932|FG001|NOT COMPLETED|Overall Study||3||
48606249|NCT03188523|101819933|FG000|STARTED|Overall Study||6||
48606250|NCT03188523|101819934|FG001|STARTED|Overall Study||6||
48606251|NCT03188523|101819935|FG002|STARTED|Overall Study||0||
48606252|NCT03188523|101819936|FG003|STARTED|Overall Study||0||
48606253|NCT03188523|101819933|FG000|COMPLETED|Overall Study||6||
48606254|NCT03188523|101819934|FG001|COMPLETED|Overall Study||6||
48606255|NCT03188523|101819935|FG002|COMPLETED|Overall Study||0||
48606256|NCT03188523|101819936|FG003|COMPLETED|Overall Study||0||
48606257|NCT03188523|101819933|FG000|NOT COMPLETED|Overall Study||0||
48606258|NCT03188523|101819934|FG001|NOT COMPLETED|Overall Study||0||
48606259|NCT03188523|101819935|FG002|NOT COMPLETED|Overall Study||0||
48606260|NCT03188523|101819936|FG003|NOT COMPLETED|Overall Study||0||
48606261|NCT02065518|101819937|FG000|STARTED|Overall Study||19||
48606262|NCT02065518|101819938|FG001|STARTED|Overall Study||19||
48606263|NCT02065518|101819939|FG002|STARTED|Overall Study||20||
48606264|NCT02065518|101819940|FG003|STARTED|Overall Study||20||
48606265|NCT02065518|101819937|FG000|COMPLETED|Overall Study||13||
48606266|NCT02065518|101819938|FG001|COMPLETED|Overall Study||11||
48606267|NCT02065518|101819939|FG002|COMPLETED|Overall Study||11||
48606268|NCT02065518|101819940|FG003|COMPLETED|Overall Study||15||
48606269|NCT02065518|101819937|FG000|NOT COMPLETED|Overall Study||6||
48606270|NCT02065518|101819938|FG001|NOT COMPLETED|Overall Study||8||
48606271|NCT02065518|101819939|FG002|NOT COMPLETED|Overall Study||9||
48606272|NCT02065518|101819940|FG003|NOT COMPLETED|Overall Study||5||
48606273|NCT05459558|101819941|FG000|STARTED|Overall Study||93||
48606274|NCT05459558|101819942|FG001|STARTED|Overall Study||92||
48606275|NCT05459558|101819943|FG002|STARTED|Overall Study||94||
48606276|NCT05459558|101819941|FG000|COMPLETED|Overall Study||92||
48606277|NCT05459558|101819942|FG001|COMPLETED|Overall Study||91||
48606278|NCT05459558|101819943|FG002|COMPLETED|Overall Study||89||
48606279|NCT05459558|101819941|FG000|NOT COMPLETED|Overall Study||1||
48606280|NCT05459558|101819942|FG001|NOT COMPLETED|Overall Study||1||
48606281|NCT05459558|101819943|FG002|NOT COMPLETED|Overall Study||5||
48606282|NCT01687283|101819944|FG000|STARTED|Overall Study||158||
48606283|NCT01687283|101819945|FG001|STARTED|Overall Study||157||
48606284|NCT01687283|101819944|FG000|COMPLETED|Overall Study||123||
48606285|NCT01687283|101819945|FG001|COMPLETED|Overall Study||130||
48606286|NCT01687283|101819944|FG000|NOT COMPLETED|Overall Study||35||
48606287|NCT01687283|101819945|FG001|NOT COMPLETED|Overall Study||27||
48606288|NCT02626000|101819946|FG000|STARTED|Overall Study||36||
48606289|NCT02626000|101819946|FG000|COMPLETED|Overall Study||6||
48606290|NCT02626000|101819946|FG000|NOT COMPLETED|Overall Study||30||
48606291|NCT03060291|101819947|FG000|STARTED|Baseline||109||
48149077|NCT01844284|100688606|FG000|COMPLETED|Overall Study||254||
48606292|NCT03060291|101819948|FG001|STARTED|Baseline||108||
48606293|NCT03060291|101819949|FG002|STARTED|Baseline||105||
48606294|NCT03060291|101819947|FG000|COMPLETED|Baseline||109||
48606295|NCT03060291|101819948|FG001|COMPLETED|Baseline||108||
48606296|NCT03060291|101819949|FG002|COMPLETED|Baseline||105||
48606297|NCT03060291|101819947|FG000|NOT COMPLETED|Baseline||0||
48606298|NCT03060291|101819948|FG001|NOT COMPLETED|Baseline||0||
48606299|NCT03060291|101819949|FG002|NOT COMPLETED|Baseline||0||
48606300|NCT03060291|101819947|FG000|STARTED|3-month Follow-up||109||
48606301|NCT03060291|101819948|FG001|STARTED|3-month Follow-up||108||
48606302|NCT03060291|101819949|FG002|STARTED|3-month Follow-up||105||
48606303|NCT03060291|101819947|FG000|COMPLETED|3-month Follow-up||101||
48606304|NCT03060291|101819948|FG001|COMPLETED|3-month Follow-up||98||
48606305|NCT03060291|101819949|FG002|COMPLETED|3-month Follow-up||103||
48606306|NCT03060291|101819947|FG000|NOT COMPLETED|3-month Follow-up||8||
48606307|NCT03060291|101819948|FG001|NOT COMPLETED|3-month Follow-up||10||
48606308|NCT03060291|101819949|FG002|NOT COMPLETED|3-month Follow-up||2||
48606309|NCT03060291|101819947|FG000|STARTED|6-month Follow-up||109||
48149078|NCT01844284|100688607|FG001|COMPLETED|Overall Study||127||
48606310|NCT03060291|101819948|FG001|STARTED|6-month Follow-up||108||
48606311|NCT03060291|101819949|FG002|STARTED|6-month Follow-up||105||
48606312|NCT03060291|101819947|FG000|COMPLETED|6-month Follow-up||102|Because no families were ever lost to follow-up or withdrew from the study, all families who participated at baseline were invited to participate at each follow-up wave. Thus, there are a a few families who participated at 6-month or 12-month follow-up who did not participate at an earlier follow-up wave.|
48606313|NCT03060291|101819948|FG001|COMPLETED|6-month Follow-up||95|Because no families were ever lost to follow-up or withdrew from the study, all families who participated at baseline were invited to participate at each follow-up wave. Thus, there are a a few families who participated at 6-month or 12-month follow-up who did not participate at an earlier follow-up wave.|
48606314|NCT03060291|101819949|FG002|COMPLETED|6-month Follow-up||101|Because no families were ever lost to follow-up or withdrew from the study, all families who participated at baseline were invited to participate at each follow-up wave. Thus, there are a a few families who participated at 6-month or 12-month follow-up who did not participate at an earlier follow-up wave.|
48606315|NCT03060291|101819947|FG000|NOT COMPLETED|6-month Follow-up||7||
48606316|NCT03060291|101819948|FG001|NOT COMPLETED|6-month Follow-up||13||
48606317|NCT03060291|101819949|FG002|NOT COMPLETED|6-month Follow-up||4||
48606318|NCT03060291|101819947|FG000|STARTED|12-month Follow-up||109||
48606319|NCT03060291|101819948|FG001|STARTED|12-month Follow-up||108||
48606320|NCT03060291|101819949|FG002|STARTED|12-month Follow-up||105||
48606321|NCT03060291|101819947|FG000|COMPLETED|12-month Follow-up||102|Because no families were ever lost to follow-up or withdrew from the study, all families who participated at baseline were invited to participate at each follow-up wave. Thus, there are a a few families who participated at 6-month or 12-month follow-up who did not participate at an earlier follow-up wave.|
48606322|NCT03060291|101819948|FG001|COMPLETED|12-month Follow-up||92|Because no families were ever lost to follow-up or withdrew from the study, all families who participated at baseline were invited to participate at each follow-up wave. Thus, there are a a few families who participated at 6-month or 12-month follow-up who did not participate at an earlier follow-up wave.|
48606323|NCT03060291|101819949|FG002|COMPLETED|12-month Follow-up||99|Because no families were ever lost to follow-up or withdrew from the study, all families who participated at baseline were invited to participate at each follow-up wave. Thus, there are a a few families who participated at 6-month or 12-month follow-up who did not participate at an earlier follow-up wave.|
48606324|NCT03060291|101819947|FG000|NOT COMPLETED|12-month Follow-up||7||
48606325|NCT03060291|101819948|FG001|NOT COMPLETED|12-month Follow-up||16||
48606326|NCT03060291|101819949|FG002|NOT COMPLETED|12-month Follow-up||6||
48606327|NCT02112877|101819950|FG000|STARTED|Overall Study||30||
48606328|NCT02112877|101819951|FG001|STARTED|Overall Study||170||
48606329|NCT02112877|101819950|FG000|COMPLETED|Overall Study||28||
48606330|NCT02112877|101819951|FG001|COMPLETED|Overall Study||157||
48606331|NCT02112877|101819950|FG000|NOT COMPLETED|Overall Study||2||
48606332|NCT02112877|101819951|FG001|NOT COMPLETED|Overall Study||13||
48606333|NCT01215435|101819952|FG000|STARTED|Overall Study||122||
48606334|NCT01215435|101819953|FG001|STARTED|Overall Study||123||
48606335|NCT01215435|101819952|FG000|COMPLETED|Overall Study||103||
48606336|NCT01215435|101819953|FG001|COMPLETED|Overall Study||107||
48606337|NCT01215435|101819952|FG000|NOT COMPLETED|Overall Study||19||
48606338|NCT01215435|101819953|FG001|NOT COMPLETED|Overall Study||16||
48606339|NCT02707172|101819954|FG000|STARTED|1st Set of Experiment||28||
48606340|NCT02707172|101819954|FG000|COMPLETED|1st Set of Experiment||28||
48606341|NCT02707172|101819954|FG000|NOT COMPLETED|1st Set of Experiment||0||
48606342|NCT02707172|101819954|FG000|STARTED|Wash Out||28||
48606343|NCT02707172|101819954|FG000|COMPLETED|Wash Out||28||
48606344|NCT02707172|101819954|FG000|NOT COMPLETED|Wash Out||0||
48606345|NCT02707172|101819954|FG000|STARTED|2nd Set of Experiment||28||
48606346|NCT02707172|101819954|FG000|COMPLETED|2nd Set of Experiment||28||
48606347|NCT02707172|101819954|FG000|NOT COMPLETED|2nd Set of Experiment||0||
48606348|NCT03148067|101819955|FG000|STARTED|Overall Study||225||
48606349|NCT03148067|101819955|FG000|COMPLETED|Overall Study||221||
48606350|NCT03148067|101819955|FG000|NOT COMPLETED|Overall Study||4||
48606351|NCT01548768|101819956|FG000|STARTED|Overall Study||8||
48606352|NCT01548768|101819957|FG001|STARTED|Overall Study||4||
48606353|NCT01548768|101819958|FG002|STARTED|Overall Study||16||
48606354|NCT01548768|101819959|FG003|STARTED|Overall Study||121||
48606355|NCT01548768|101819956|FG000|COMPLETED|Overall Study||7||
48606356|NCT01548768|101819957|FG001|COMPLETED|Overall Study||2||
48606357|NCT01548768|101819958|FG002|COMPLETED|Overall Study||15||
48606358|NCT01548768|101819959|FG003|COMPLETED|Overall Study||117||
48606359|NCT01548768|101819956|FG000|NOT COMPLETED|Overall Study||1||
48606360|NCT01548768|101819957|FG001|NOT COMPLETED|Overall Study||2||
48606361|NCT01548768|101819958|FG002|NOT COMPLETED|Overall Study||1||
48606362|NCT01548768|101819959|FG003|NOT COMPLETED|Overall Study||4||
48606363|NCT03396822|101819960|FG000|STARTED|Overall Study||23||
48606364|NCT03396822|101819960|FG000|COMPLETED|Overall Study||14||
48606365|NCT03396822|101819960|FG000|NOT COMPLETED|Overall Study||9||
48606366|NCT01386944|101819961|FG000|STARTED|Overall Study||102||
48606367|NCT01386944|101819961|FG000|COMPLETED|Overall Study||46||
48149079|NCT01844284|100688606|FG000|NOT COMPLETED|Overall Study||12||
48716311|NCT00489736|102091876|FG000|NOT COMPLETED|Overall Study||96||
48716312|NCT00489736|102091877|FG001|NOT COMPLETED|Overall Study||69||
48716313|NCT03945019|102091878|FG000|STARTED|Induction Phase||396||
48716314|NCT03945019|102091879|FG001|STARTED|Induction Phase||0||
48716315|NCT03945019|102091880|FG002|STARTED|Induction Phase||0||
48716316|NCT03945019|102091878|FG000|COMPLETED|Induction Phase||343||
48716317|NCT03945019|102091879|FG001|COMPLETED|Induction Phase||0||
48716318|NCT03945019|102091880|FG002|COMPLETED|Induction Phase||0||
48716319|NCT03945019|102091878|FG000|NOT COMPLETED|Induction Phase||53||
48716320|NCT03945019|102091879|FG001|NOT COMPLETED|Induction Phase||0||
48716321|NCT03945019|102091880|FG002|NOT COMPLETED|Induction Phase||0||
48716322|NCT03945019|102091878|FG000|STARTED|Maintenance Phase||0||
48716323|NCT03945019|102091879|FG001|STARTED|Maintenance Phase||231||
48716324|NCT03945019|102091880|FG002|STARTED|Maintenance Phase||112||
48716325|NCT03945019|102091878|FG000|COMPLETED|Maintenance Phase||0||
48606368|NCT01386944|101819961|FG000|NOT COMPLETED|Overall Study||56||
48606369|NCT04186221|101819962|FG000|STARTED|Overall Study||74||
48606370|NCT04186221|101819962|FG000|COMPLETED|Overall Study||73|Completing the 30 day visit.|
48606371|NCT04186221|101819962|FG000|NOT COMPLETED|Overall Study||1||
48606372|NCT00998205|101819963|FG000|STARTED|Overall Study||16||
48606373|NCT00998205|101819963|FG000|COMPLETED|Overall Study||16||
48606374|NCT00998205|101819963|FG000|NOT COMPLETED|Overall Study||0||
48606375|NCT00272844|101819964|FG000|STARTED|Overall Study||23||
48606376|NCT00272844|101819964|FG000|COMPLETED|Overall Study||18||
48606377|NCT00272844|101819964|FG000|NOT COMPLETED|Overall Study||5||
48606378|NCT00534105|101819965|FG000|STARTED|Overall Study||47||
48606379|NCT00534105|101819966|FG001|STARTED|Overall Study||59||
48606380|NCT00534105|101819965|FG000|COMPLETED|Overall Study||24||
48606381|NCT00534105|101819966|FG001|COMPLETED|Overall Study||20||
48606382|NCT00534105|101819965|FG000|NOT COMPLETED|Overall Study||23||
48606383|NCT00534105|101819966|FG001|NOT COMPLETED|Overall Study||39||
48606384|NCT02937636|101819967|FG000|STARTED|Overall Study||63||
48716326|NCT03945019|102091879|FG001|COMPLETED|Maintenance Phase||196||
48716327|NCT03945019|102091880|FG002|COMPLETED|Maintenance Phase||87||
48716328|NCT03945019|102091878|FG000|NOT COMPLETED|Maintenance Phase||0||
48149080|NCT01844284|100688607|FG001|NOT COMPLETED|Overall Study||7||
48149081|NCT04977050|100688608|FG000|STARTED|Overall Study||169||
48149082|NCT04977050|100688609|FG001|STARTED|Overall Study||61||
48149083|NCT04977050|100688608|FG000|COMPLETED|Overall Study||169||
48149084|NCT04977050|100688609|FG001|COMPLETED|Overall Study||61||
48149085|NCT04977050|100688608|FG000|NOT COMPLETED|Overall Study||0||
48149086|NCT04977050|100688609|FG001|NOT COMPLETED|Overall Study||0||
48149087|NCT00762320|100688610|FG000|STARTED|Overall Study||8||
48716329|NCT03945019|102091879|FG001|NOT COMPLETED|Maintenance Phase||35||
48716330|NCT03945019|102091880|FG002|NOT COMPLETED|Maintenance Phase||25||
48716331|NCT03474081|102091881|FG000|STARTED|Overall Study||400||
48149088|NCT00762320|100688610|FG000|COMPLETED|Overall Study||8||
48149089|NCT00762320|100688610|FG000|NOT COMPLETED|Overall Study||0||
48149090|NCT00445679|100688611|FG000|STARTED|Overall Study||203||
48149091|NCT00445679|100688612|FG001|STARTED|Overall Study||203||
48149092|NCT00445679|100688613|FG002|STARTED|Overall Study||205||
48149093|NCT00445679|100688614|FG003|STARTED|Overall Study||196||
48149094|NCT00445679|100688611|FG000|COMPLETED|Overall Study||155||
48149095|NCT00445679|100688612|FG001|COMPLETED|Overall Study||157||
48149096|NCT00445679|100688613|FG002|COMPLETED|Overall Study||139||
48149097|NCT00445679|100688614|FG003|COMPLETED|Overall Study||149||
48716332|NCT03474081|102091882|FG001|STARTED|Overall Study||400||
48716333|NCT03474081|102091881|FG000|Received Study Treatment|Overall Study||400||
48716334|NCT03474081|102091882|FG001|Received Study Treatment|Overall Study||399||
48716335|NCT03474081|102091881|FG000|COMPLETED|Overall Study||383||
48716336|NCT03474081|102091882|FG001|COMPLETED|Overall Study||387||
48716337|NCT03474081|102091881|FG000|NOT COMPLETED|Overall Study||17||
48716338|NCT03474081|102091882|FG001|NOT COMPLETED|Overall Study||13||
48716339|NCT01852383|102091883|FG000|STARTED|Overall Study||30||
48716340|NCT01852383|102091883|FG000|COMPLETED|Overall Study||19||
48716341|NCT01852383|102091883|FG000|NOT COMPLETED|Overall Study||11||
48716342|NCT00260065|102091884|FG000|STARTED|Overall Study||99||
48716343|NCT00260065|102091884|FG000|COMPLETED|Overall Study||6||
48716344|NCT00260065|102091884|FG000|NOT COMPLETED|Overall Study||93||
48716345|NCT01304329|102091885|FG000|STARTED|First Intervention (3 Days)||3||
48716346|NCT01304329|102091886|FG001|STARTED|First Intervention (3 Days)||3||
48716347|NCT01304329|102091887|FG002|STARTED|First Intervention (3 Days)||3||
48716348|NCT01304329|102091888|FG003|STARTED|First Intervention (3 Days)||3||
48716349|NCT01304329|102091889|FG004|STARTED|First Intervention (3 Days)||3||
48149098|NCT00445679|100688611|FG000|NOT COMPLETED|Overall Study||48||
48606385|NCT02937636|101819968|FG001|STARTED|Overall Study||65||
48606386|NCT02937636|101819967|FG000|COMPLETED|Overall Study||60||
48606387|NCT02937636|101819968|FG001|COMPLETED|Overall Study||63||
48716350|NCT01304329|102091890|FG005|STARTED|First Intervention (3 Days)||3||
48149099|NCT00445679|100688612|FG001|NOT COMPLETED|Overall Study||46||
48606388|NCT02937636|101819967|FG000|NOT COMPLETED|Overall Study||3||
48716351|NCT01304329|102091885|FG000|COMPLETED|First Intervention (3 Days)||3||
48716352|NCT01304329|102091886|FG001|COMPLETED|First Intervention (3 Days)||3||
48149100|NCT00445679|100688613|FG002|NOT COMPLETED|Overall Study||66||
48149101|NCT00445679|100688614|FG003|NOT COMPLETED|Overall Study||47||
48149102|NCT02453581|100688615|FG000|STARTED|Overall Study||8||
48149103|NCT02453581|100688616|FG001|STARTED|Overall Study||8||
48149104|NCT02453581|100688617|FG002|STARTED|Overall Study||8||
48149105|NCT02453581|100688615|FG000|COMPLETED|Overall Study||8||
48149106|NCT02453581|100688616|FG001|COMPLETED|Overall Study||8||
48149107|NCT02453581|100688617|FG002|COMPLETED|Overall Study||8||
48149108|NCT02453581|100688615|FG000|NOT COMPLETED|Overall Study||0||
48149109|NCT02453581|100688616|FG001|NOT COMPLETED|Overall Study||0||
48149110|NCT02453581|100688617|FG002|NOT COMPLETED|Overall Study||0||
48149111|NCT02657031|100688618|FG000|STARTED|Overall Study||29||
48149112|NCT02657031|100688619|FG001|STARTED|Overall Study||25||
48405911|NCT00058188|101325371|FG001|COMPLETED|Overall Study||0||
48405912|NCT00058188|101325370|FG000|NOT COMPLETED|Overall Study||0||
48405913|NCT00058188|101325371|FG001|NOT COMPLETED|Overall Study||0||
48405914|NCT00633360|101325372|FG000|STARTED|Overall Study||16||
48405915|NCT00633360|101325373|FG001|STARTED|Overall Study||16||
48405916|NCT00633360|101325372|FG000|COMPLETED|Overall Study||12||
48405917|NCT00633360|101325373|FG001|COMPLETED|Overall Study||13||
48405918|NCT00633360|101325372|FG000|NOT COMPLETED|Overall Study||4||
48405919|NCT00633360|101325373|FG001|NOT COMPLETED|Overall Study||3||
48405920|NCT03003130|101325374|FG000|STARTED|Overall Study||88||
48405921|NCT03003130|101325375|FG001|STARTED|Overall Study||87||
48405922|NCT03003130|101325374|FG000|COMPLETED|Overall Study||80||
48405923|NCT03003130|101325375|FG001|COMPLETED|Overall Study||80||
48405924|NCT03003130|101325374|FG000|NOT COMPLETED|Overall Study||8||
48405925|NCT03003130|101325375|FG001|NOT COMPLETED|Overall Study||7||
48405926|NCT02910089|101325376|FG000|STARTED|Overall Study||700|1,400 randomized patients|
48405927|NCT02910089|101325377|FG001|STARTED|Overall Study||700|1,400 randomized patients|
48405928|NCT02910089|101325376|FG000|COMPLETED|Overall Study||678|38 patients (2.7%) were excluded from analysis because they lost insurance eligibility.|
48405929|NCT02910089|101325377|FG001|COMPLETED|Overall Study||684|38 patients (2.7%) were excluded from analysis because they lost insurance eligibility.|
48405930|NCT02910089|101325376|FG000|NOT COMPLETED|Overall Study||22||
48405931|NCT02910089|101325377|FG001|NOT COMPLETED|Overall Study||16||
48405932|NCT02201472|101325378|FG000|STARTED|Overall Study||2||
48405933|NCT02201472|101325378|FG000|COMPLETED|Overall Study||0||
48405934|NCT02201472|101325378|FG000|NOT COMPLETED|Overall Study||2||
48405935|NCT02665468|101325379|FG000|STARTED|Overall Study||595||
48405936|NCT02665468|101325380|FG001|STARTED|Overall Study||601||
48405937|NCT02665468|101325379|FG000|COMPLETED|Overall Study||595||
48405938|NCT02665468|101325380|FG001|COMPLETED|Overall Study||601||
48405939|NCT02665468|101325379|FG000|NOT COMPLETED|Overall Study||0||
48405940|NCT02665468|101325380|FG001|NOT COMPLETED|Overall Study||0||
48405941|NCT00633893|101325381|FG000|STARTED|Overall Study||840||
48606389|NCT02937636|101819968|FG001|NOT COMPLETED|Overall Study||2||
48606390|NCT03714776|101819969|FG000|STARTED|Overall Study||8||
48606391|NCT03714776|101819970|FG001|STARTED|Overall Study||17||
48606392|NCT03714776|101819969|FG000|Safety Set|Overall Study||8|Safety Set included all participants who were randomized and received at least 1 dose of study drug.|
48149113|NCT02657031|100688618|FG000|COMPLETED|Overall Study||28||
48149114|NCT02657031|100688619|FG001|COMPLETED|Overall Study||23||
48149115|NCT02657031|100688618|FG000|NOT COMPLETED|Overall Study||1||
48149116|NCT02657031|100688619|FG001|NOT COMPLETED|Overall Study||2||
48149117|NCT04158050|100688620|FG000|STARTED|Overall Study||42||
48149118|NCT04158050|100688621|FG001|STARTED|Overall Study||22||
48149119|NCT04158050|100688620|FG000|COMPLETED|Overall Study||33||
48149120|NCT04158050|100688621|FG001|COMPLETED|Overall Study||17||
48405942|NCT00633893|101325382|FG001|STARTED|Overall Study||813||
48405943|NCT00633893|101325383|FG002|STARTED|Overall Study||829||
48405944|NCT00633893|101325381|FG000|COMPLETED|Overall Study||726||
48405945|NCT00633893|101325382|FG001|COMPLETED|Overall Study||684||
48405946|NCT00633893|101325383|FG002|COMPLETED|Overall Study||641||
48405947|NCT00633893|101325381|FG000|NOT COMPLETED|Overall Study||114||
48405948|NCT00633893|101325382|FG001|NOT COMPLETED|Overall Study||129||
48405949|NCT00633893|101325383|FG002|NOT COMPLETED|Overall Study||188||
48405950|NCT05179057|101325384|FG000|STARTED|Overall Study||30||
48405951|NCT05179057|101325385|FG001|STARTED|Overall Study||27||
48606393|NCT03714776|101819970|FG001|Safety Set|Overall Study||17|Safety Set included all participants who were randomized and received at least 1 dose of study drug.|
48606394|NCT03714776|101819969|FG000|Full Analysis Set (FAS)|Overall Study||8|FAS included all randomized participants who received at least 1 injection of study drug and who had at least 1 post-Baseline efficacy or exploratory measurements.|
48606395|NCT03714776|101819970|FG001|Full Analysis Set (FAS)|Overall Study||17|FAS included all randomized participants who received at least 1 injection of study drug and who had at least 1 post-Baseline efficacy or exploratory measurements.|
48405952|NCT05179057|101325384|FG000|Received Primary Study Treatment|Overall Study||28||
48405953|NCT05179057|101325385|FG001|Received Primary Study Treatment|Overall Study||23||
48656912|NCT04274218|101943725|FG000|COMPLETED|Perturbation Condition 1 (15 Minutes)||5||
48656913|NCT04274218|101943726|FG001|COMPLETED|Perturbation Condition 1 (15 Minutes)||6||
48656914|NCT04274218|101943727|FG002|COMPLETED|Perturbation Condition 1 (15 Minutes)||5||
48149121|NCT04158050|100688620|FG000|NOT COMPLETED|Overall Study||9||
48149122|NCT04158050|100688621|FG001|NOT COMPLETED|Overall Study||5||
48149123|NCT01949779|100688622|FG000|STARTED|Overall Study||81||
48149124|NCT01949779|100688622|FG000|COMPLETED|Overall Study||79||
48405954|NCT05179057|101325384|FG000|Met Cross-over Eligibility Criteria|Overall Study||4||
48405955|NCT05179057|101325385|FG001|Met Cross-over Eligibility Criteria|Overall Study||5||
48606396|NCT03714776|101819969|FG000|Per Protocol Set (PPS)|Overall Study||6|PPS included all FAS participants who received at least 5 of the 7 doses of study drug, did not receive antihypertensive medications during the Treatment Period and prior to Day 43, and had no significant protocol deviations that would have been expected to affect efficacy or exploratory assessments.|
48606397|NCT03714776|101819970|FG001|Per Protocol Set (PPS)|Overall Study||15|PPS included all FAS participants who received at least 5 of the 7 doses of study drug, did not receive antihypertensive medications during the Treatment Period and prior to Day 43, and had no significant protocol deviations that would have been expected to affect efficacy or exploratory assessments.|
48606398|NCT03714776|101819969|FG000|COMPLETED|Overall Study||8||
48716353|NCT01304329|102091887|FG002|COMPLETED|First Intervention (3 Days)||3||
48716354|NCT01304329|102091888|FG003|COMPLETED|First Intervention (3 Days)||3||
48716355|NCT01304329|102091889|FG004|COMPLETED|First Intervention (3 Days)||3||
48303839|NCT03942406|101072867|FG001|COMPLETED|Overall Study||85||
48303840|NCT03942406|101072868|FG002|COMPLETED|Overall Study||41||
48303841|NCT03942406|101072869|FG003|COMPLETED|Overall Study||40||
48303842|NCT03942406|101072870|FG004|COMPLETED|Overall Study||6||
48149125|NCT01949779|100688622|FG000|NOT COMPLETED|Overall Study||2||
48149126|NCT00224874|100688623|FG000|STARTED|Overall Study||46||
48149127|NCT00224874|100688624|FG001|STARTED|Overall Study||45||
48149128|NCT00224874|100688625|FG002|STARTED|Overall Study||47||
48149129|NCT00224874|100688626|FG003|STARTED|Overall Study||42||
48149130|NCT00224874|100688623|FG000|COMPLETED|Overall Study||46||
48149131|NCT00224874|100688624|FG001|COMPLETED|Overall Study||45||
48303843|NCT03942406|101072871|FG005|COMPLETED|Overall Study||7||
48303844|NCT03942406|101072872|FG006|COMPLETED|Overall Study||4||
48303845|NCT03942406|101072866|FG000|NOT COMPLETED|Overall Study||11||
48303846|NCT03942406|101072867|FG001|NOT COMPLETED|Overall Study||7||
48303847|NCT03942406|101072868|FG002|NOT COMPLETED|Overall Study||5||
48303848|NCT03942406|101072869|FG003|NOT COMPLETED|Overall Study||10||
48303849|NCT03942406|101072870|FG004|NOT COMPLETED|Overall Study||2||
48303850|NCT03942406|101072871|FG005|NOT COMPLETED|Overall Study||1||
48716356|NCT01304329|102091890|FG005|COMPLETED|First Intervention (3 Days)||3||
48716357|NCT01304329|102091885|FG000|NOT COMPLETED|First Intervention (3 Days)||0||
48716358|NCT01304329|102091886|FG001|NOT COMPLETED|First Intervention (3 Days)||0||
48716359|NCT01304329|102091887|FG002|NOT COMPLETED|First Intervention (3 Days)||0||
48716360|NCT01304329|102091888|FG003|NOT COMPLETED|First Intervention (3 Days)||0||
48716361|NCT01304329|102091889|FG004|NOT COMPLETED|First Intervention (3 Days)||0||
48716362|NCT01304329|102091890|FG005|NOT COMPLETED|First Intervention (3 Days)||0||
48716363|NCT01304329|102091885|FG000|STARTED|Second Intervention (3 Days)||3||
48716364|NCT01304329|102091886|FG001|STARTED|Second Intervention (3 Days)||3||
48716365|NCT01304329|102091887|FG002|STARTED|Second Intervention (3 Days)||3||
48716366|NCT01304329|102091888|FG003|STARTED|Second Intervention (3 Days)||3||
48716367|NCT01304329|102091889|FG004|STARTED|Second Intervention (3 Days)||3||
48716368|NCT01304329|102091890|FG005|STARTED|Second Intervention (3 Days)||3||
48716369|NCT01304329|102091885|FG000|COMPLETED|Second Intervention (3 Days)||3||
48716370|NCT01304329|102091886|FG001|COMPLETED|Second Intervention (3 Days)||3||
48716371|NCT01304329|102091887|FG002|COMPLETED|Second Intervention (3 Days)||3||
48716372|NCT01304329|102091888|FG003|COMPLETED|Second Intervention (3 Days)||3||
48716373|NCT01304329|102091889|FG004|COMPLETED|Second Intervention (3 Days)||3||
48303851|NCT03942406|101072872|FG006|NOT COMPLETED|Overall Study||0||
48303852|NCT01717768|101072873|FG000|STARTED|Part 1 (Duration of 15 Days)||17||
48405956|NCT05179057|101325384|FG000|Received Cross-over Treatment|Overall Study||4||
48149132|NCT00224874|100688625|FG002|COMPLETED|Overall Study||46||
48405957|NCT05179057|101325385|FG001|Received Cross-over Treatment|Overall Study||5||
48405958|NCT05179057|101325384|FG000|COMPLETED|Overall Study||10||
48405959|NCT05179057|101325385|FG001|COMPLETED|Overall Study||13||
48405960|NCT05179057|101325384|FG000|NOT COMPLETED|Overall Study||20||
48303853|NCT01717768|101072874|FG001|STARTED|Part 1 (Duration of 15 Days)||17||
48303854|NCT01717768|101072875|FG002|STARTED|Part 1 (Duration of 15 Days)||0||
48303855|NCT01717768|101072876|FG003|STARTED|Part 1 (Duration of 15 Days)||0||
48303856|NCT01717768|101072877|FG004|STARTED|Part 1 (Duration of 15 Days)||0||
48405961|NCT05179057|101325385|FG001|NOT COMPLETED|Overall Study||14||
48405962|NCT03962634|101325386|FG000|STARTED|Overall Study||1||
48303857|NCT01717768|101072878|FG005|STARTED|Part 1 (Duration of 15 Days)||0||
48303858|NCT01717768|101072879|FG006|STARTED|Part 1 (Duration of 15 Days)||0||
48303859|NCT01717768|101072880|FG007|STARTED|Part 1 (Duration of 15 Days)||0||
48303860|NCT01717768|101072881|FG008|STARTED|Part 1 (Duration of 15 Days)||0||
48716374|NCT01304329|102091890|FG005|COMPLETED|Second Intervention (3 Days)||3||
48716375|NCT01304329|102091885|FG000|NOT COMPLETED|Second Intervention (3 Days)||0||
48716376|NCT01304329|102091886|FG001|NOT COMPLETED|Second Intervention (3 Days)||0||
48716377|NCT01304329|102091887|FG002|NOT COMPLETED|Second Intervention (3 Days)||0||
48716378|NCT01304329|102091888|FG003|NOT COMPLETED|Second Intervention (3 Days)||0||
48303861|NCT01717768|101072882|FG009|STARTED|Part 1 (Duration of 15 Days)||0||
48303862|NCT01717768|101072883|FG010|STARTED|Part 1 (Duration of 15 Days)||0||
48716379|NCT01304329|102091889|FG004|NOT COMPLETED|Second Intervention (3 Days)||0||
48716380|NCT01304329|102091890|FG005|NOT COMPLETED|Second Intervention (3 Days)||0||
48716381|NCT01304329|102091885|FG000|STARTED|Third Intervention (3 Days)||3||
48303863|NCT01717768|101072884|FG011|STARTED|Part 1 (Duration of 15 Days)||0||
48303864|NCT01717768|101072873|FG000|COMPLETED|Part 1 (Duration of 15 Days)||17||
48303865|NCT01717768|101072874|FG001|COMPLETED|Part 1 (Duration of 15 Days)||16||
48405963|NCT03962634|101325387|FG001|STARTED|Overall Study||2||
48405964|NCT03962634|101325386|FG000|COMPLETED|Overall Study||1||
48405965|NCT03962634|101325387|FG001|COMPLETED|Overall Study||2||
48405966|NCT03962634|101325386|FG000|NOT COMPLETED|Overall Study||0||
48405967|NCT03962634|101325387|FG001|NOT COMPLETED|Overall Study||0||
48405968|NCT03011775|101325388|FG000|STARTED|Overall Study||20||
48405969|NCT03011775|101325389|FG001|STARTED|Overall Study||23||
48405970|NCT03011775|101325388|FG000|COMPLETED|Overall Study||20||
48716382|NCT01304329|102091886|FG001|STARTED|Third Intervention (3 Days)||3||
48303866|NCT01717768|101072875|FG002|COMPLETED|Part 1 (Duration of 15 Days)||0||
48405971|NCT03011775|101325389|FG001|COMPLETED|Overall Study||23||
48405972|NCT03011775|101325388|FG000|NOT COMPLETED|Overall Study||0||
48405973|NCT03011775|101325389|FG001|NOT COMPLETED|Overall Study||0||
48405974|NCT00681291|101325390|FG000|STARTED|Overall Study||88||
48405975|NCT00681291|101325391|FG001|STARTED|Overall Study||84||
48716383|NCT01304329|102091887|FG002|STARTED|Third Intervention (3 Days)||3||
48716384|NCT01304329|102091888|FG003|STARTED|Third Intervention (3 Days)||3||
48716385|NCT01304329|102091889|FG004|STARTED|Third Intervention (3 Days)||3||
48716386|NCT01304329|102091890|FG005|STARTED|Third Intervention (3 Days)||3||
48716387|NCT01304329|102091885|FG000|COMPLETED|Third Intervention (3 Days)||3||
48716388|NCT01304329|102091886|FG001|COMPLETED|Third Intervention (3 Days)||2||
48716389|NCT01304329|102091887|FG002|COMPLETED|Third Intervention (3 Days)||3||
48716390|NCT01304329|102091888|FG003|COMPLETED|Third Intervention (3 Days)||3||
48716391|NCT01304329|102091889|FG004|COMPLETED|Third Intervention (3 Days)||3||
48716392|NCT01304329|102091890|FG005|COMPLETED|Third Intervention (3 Days)||3||
48716393|NCT01304329|102091885|FG000|NOT COMPLETED|Third Intervention (3 Days)||0||
48716394|NCT01304329|102091886|FG001|NOT COMPLETED|Third Intervention (3 Days)||1||
48716395|NCT01304329|102091887|FG002|NOT COMPLETED|Third Intervention (3 Days)||0||
48716396|NCT01304329|102091888|FG003|NOT COMPLETED|Third Intervention (3 Days)||0||
48716397|NCT01304329|102091889|FG004|NOT COMPLETED|Third Intervention (3 Days)||0||
48716398|NCT01304329|102091890|FG005|NOT COMPLETED|Third Intervention (3 Days)||0||
48716399|NCT00823212|102091891|FG000|STARTED|Overall Study||762||
48716400|NCT00823212|102091892|FG001|STARTED|Overall Study||768||
48716401|NCT00823212|102091891|FG000|COMPLETED|Overall Study||727||
48716402|NCT00823212|102091892|FG001|COMPLETED|Overall Study||735||
48716403|NCT00823212|102091891|FG000|NOT COMPLETED|Overall Study||35||
48716404|NCT00823212|102091892|FG001|NOT COMPLETED|Overall Study||33||
48716405|NCT04557787|102091893|FG000|STARTED|Overall Study||3||
48716406|NCT04557787|102091894|FG001|STARTED|Overall Study||2||
48716407|NCT04557787|102091895|FG002|STARTED|Overall Study||3||
48716408|NCT04557787|102091896|FG003|STARTED|Overall Study||2||
48716409|NCT04557787|102091897|FG004|STARTED|Overall Study||3||
48716410|NCT04557787|102091898|FG005|STARTED|Overall Study||2||
48716411|NCT04557787|102091893|FG000|COMPLETED|Overall Study||3||
48716412|NCT04557787|102091894|FG001|COMPLETED|Overall Study||2||
48716413|NCT04557787|102091895|FG002|COMPLETED|Overall Study||3||
48716414|NCT04557787|102091896|FG003|COMPLETED|Overall Study||2||
48716415|NCT04557787|102091897|FG004|COMPLETED|Overall Study||3||
48716416|NCT04557787|102091898|FG005|COMPLETED|Overall Study||2||
48716417|NCT04557787|102091893|FG000|NOT COMPLETED|Overall Study||0||
48716418|NCT04557787|102091894|FG001|NOT COMPLETED|Overall Study||0||
48716419|NCT04557787|102091895|FG002|NOT COMPLETED|Overall Study||0||
48716420|NCT04557787|102091896|FG003|NOT COMPLETED|Overall Study||0||
48716421|NCT04557787|102091897|FG004|NOT COMPLETED|Overall Study||0||
48716422|NCT04557787|102091898|FG005|NOT COMPLETED|Overall Study||0||
48303867|NCT01717768|101072876|FG003|COMPLETED|Part 1 (Duration of 15 Days)||0||
48303868|NCT01717768|101072877|FG004|COMPLETED|Part 1 (Duration of 15 Days)||0||
48303869|NCT01717768|101072878|FG005|COMPLETED|Part 1 (Duration of 15 Days)||0||
48405976|NCT00681291|101325390|FG000|COMPLETED|Overall Study||75||
48405977|NCT00681291|101325391|FG001|COMPLETED|Overall Study||57||
48405978|NCT00681291|101325390|FG000|NOT COMPLETED|Overall Study||13||
48716423|NCT01444027|102091899|FG000|STARTED|Overall Study||172||
48716424|NCT01444027|102091900|FG001|STARTED|Overall Study||171||
48606399|NCT03714776|101819970|FG001|COMPLETED|Overall Study||17||
48149133|NCT00224874|100688626|FG003|COMPLETED|Overall Study||42||
48149134|NCT00224874|100688623|FG000|NOT COMPLETED|Overall Study||0||
48149135|NCT00224874|100688624|FG001|NOT COMPLETED|Overall Study||0||
48149136|NCT00224874|100688625|FG002|NOT COMPLETED|Overall Study||1||
48149137|NCT00224874|100688626|FG003|NOT COMPLETED|Overall Study||0||
48149138|NCT01345721|100688627|FG000|STARTED|Overall Study||74||
48149139|NCT01345721|100688628|FG001|STARTED|Overall Study||66||
48149140|NCT01345721|100688629|FG002|STARTED|Overall Study||65||
48149141|NCT01345721|100688627|FG000|COMPLETED|Overall Study||74||
48149142|NCT01345721|100688628|FG001|COMPLETED|Overall Study||66||
48606400|NCT03714776|101819969|FG000|NOT COMPLETED|Overall Study||0||
48149143|NCT01345721|100688629|FG002|COMPLETED|Overall Study||65||
48606401|NCT03714776|101819970|FG001|NOT COMPLETED|Overall Study||0||
48149144|NCT01345721|100688627|FG000|NOT COMPLETED|Overall Study||0||
48149145|NCT01345721|100688628|FG001|NOT COMPLETED|Overall Study||0||
48149146|NCT01345721|100688629|FG002|NOT COMPLETED|Overall Study||0||
48149147|NCT01471054|100688630|FG000|STARTED|Overall Study||5||
48149148|NCT01471054|100688631|FG001|STARTED|Overall Study||1||
48303870|NCT01717768|101072879|FG006|COMPLETED|Part 1 (Duration of 15 Days)||0||
48303871|NCT01717768|101072880|FG007|COMPLETED|Part 1 (Duration of 15 Days)||0||
48303872|NCT01717768|101072881|FG008|COMPLETED|Part 1 (Duration of 15 Days)||0||
48303873|NCT01717768|101072882|FG009|COMPLETED|Part 1 (Duration of 15 Days)||0||
48303874|NCT01717768|101072883|FG010|COMPLETED|Part 1 (Duration of 15 Days)||0||
48303875|NCT01717768|101072884|FG011|COMPLETED|Part 1 (Duration of 15 Days)||0||
48303876|NCT01717768|101072873|FG000|NOT COMPLETED|Part 1 (Duration of 15 Days)||0||
48303877|NCT01717768|101072874|FG001|NOT COMPLETED|Part 1 (Duration of 15 Days)||1||
48303878|NCT01717768|101072875|FG002|NOT COMPLETED|Part 1 (Duration of 15 Days)||0||
48303879|NCT01717768|101072876|FG003|NOT COMPLETED|Part 1 (Duration of 15 Days)||0||
48303880|NCT01717768|101072877|FG004|NOT COMPLETED|Part 1 (Duration of 15 Days)||0||
48303881|NCT01717768|101072878|FG005|NOT COMPLETED|Part 1 (Duration of 15 Days)||0||
48303882|NCT01717768|101072879|FG006|NOT COMPLETED|Part 1 (Duration of 15 Days)||0||
48303883|NCT01717768|101072880|FG007|NOT COMPLETED|Part 1 (Duration of 15 Days)||0||
48303884|NCT01717768|101072881|FG008|NOT COMPLETED|Part 1 (Duration of 15 Days)||0||
48303885|NCT01717768|101072882|FG009|NOT COMPLETED|Part 1 (Duration of 15 Days)||0||
48716425|NCT01444027|102091901|FG002|STARTED|Overall Study||171||
48716426|NCT01444027|102091899|FG000|Received Intervention as Assigned|Overall Study||168||
48716427|NCT01444027|102091900|FG001|Received Intervention as Assigned|Overall Study||161||
48716428|NCT01444027|102091901|FG002|Received Intervention as Assigned|Overall Study||147||
48716429|NCT01444027|102091899|FG000|1 Month Follow-up|Overall Study||160||
48716430|NCT01444027|102091900|FG001|1 Month Follow-up|Overall Study||159||
48716431|NCT01444027|102091901|FG002|1 Month Follow-up|Overall Study||141||
48716432|NCT01444027|102091899|FG000|3 Month Follow-up|Overall Study||142||
48716433|NCT01444027|102091900|FG001|3 Month Follow-up|Overall Study||141||
48716434|NCT01444027|102091901|FG002|3 Month Follow-up|Overall Study||133||
48716435|NCT01444027|102091899|FG000|COMPLETED|Overall Study||142||
48716436|NCT01444027|102091900|FG001|COMPLETED|Overall Study||141||
48716437|NCT01444027|102091901|FG002|COMPLETED|Overall Study||133||
48716438|NCT01444027|102091899|FG000|NOT COMPLETED|Overall Study||30||
48716439|NCT01444027|102091900|FG001|NOT COMPLETED|Overall Study||30||
48716440|NCT01444027|102091901|FG002|NOT COMPLETED|Overall Study||38||
48716441|NCT05291936|102091902|FG000|STARTED|Period 1||36||
48716442|NCT05291936|102091903|FG001|STARTED|Period 1||37||
48716443|NCT05291936|102091902|FG000|COMPLETED|Period 1||35||
48716444|NCT05291936|102091903|FG001|COMPLETED|Period 1||36||
48716445|NCT05291936|102091902|FG000|NOT COMPLETED|Period 1||1||
48716446|NCT05291936|102091903|FG001|NOT COMPLETED|Period 1||1||
48716447|NCT05291936|102091902|FG000|STARTED|Period 2||35||
48716448|NCT05291936|102091903|FG001|STARTED|Period 2||36||
48716449|NCT05291936|102091902|FG000|COMPLETED|Period 2||34||
48716450|NCT05291936|102091903|FG001|COMPLETED|Period 2||35||
48716451|NCT05291936|102091902|FG000|NOT COMPLETED|Period 2||1||
48716452|NCT05291936|102091903|FG001|NOT COMPLETED|Period 2||1||
48716453|NCT00330928|102091904|FG000|STARTED|Overall Study||106||
48716454|NCT00330928|102091904|FG000|7 Day Phone Contact|Overall Study||99||
48716455|NCT00330928|102091904|FG000|1 Year Phone Contact|Overall Study||89||
48716456|NCT00330928|102091904|FG000|COMPLETED|Overall Study||89||
48716457|NCT00330928|102091904|FG000|NOT COMPLETED|Overall Study||17||
48716458|NCT00699218|102091905|FG000|STARTED|Overall Study||15||
48716459|NCT00699218|102091905|FG000|COMPLETED|Overall Study||15||
48716460|NCT00699218|102091905|FG000|NOT COMPLETED|Overall Study||0||
48716461|NCT00652899|102091906|FG000|STARTED|Overall Study||14||
48716462|NCT00652899|102091906|FG000|COMPLETED|Overall Study||12||
48716463|NCT00652899|102091906|FG000|NOT COMPLETED|Overall Study||2||
48716464|NCT00806442|102091907|FG000|STARTED|Overall Study||18||
48716465|NCT00806442|102091908|FG001|STARTED|Overall Study||21||
48716466|NCT00806442|102091907|FG000|First Intervention (3 Wks)|Overall Study||18||
48303886|NCT01717768|101072883|FG010|NOT COMPLETED|Part 1 (Duration of 15 Days)||0||
48303887|NCT01717768|101072884|FG011|NOT COMPLETED|Part 1 (Duration of 15 Days)||0||
48716467|NCT00806442|102091908|FG001|First Intervention (3 Wks)|Overall Study||21||
48716468|NCT00806442|102091907|FG000|Washout (3 Wks)|Overall Study||15||
48716469|NCT00806442|102091908|FG001|Washout (3 Wks)|Overall Study||14||
48716470|NCT00806442|102091907|FG000|Second Intervention (3 Wks)|Overall Study||15||
48716471|NCT00806442|102091908|FG001|Second Intervention (3 Wks)|Overall Study||14||
48716472|NCT00806442|102091907|FG000|COMPLETED|Overall Study||14||
48716473|NCT00806442|102091908|FG001|COMPLETED|Overall Study||14||
48716474|NCT00806442|102091907|FG000|NOT COMPLETED|Overall Study||4||
48716475|NCT00806442|102091908|FG001|NOT COMPLETED|Overall Study||7||
48716476|NCT01727011|102091909|FG000|STARTED|Overall Study||31||
48716477|NCT01727011|102091909|FG000|COMPLETED|Overall Study||26||
48716478|NCT01727011|102091909|FG000|NOT COMPLETED|Overall Study||5||
48716479|NCT01842581|102091910|FG000|STARTED|Overall Study||113||
48716480|NCT01842581|102091911|FG001|STARTED|Overall Study||109||
48716481|NCT01842581|102091910|FG000|Received at Least 1 Dose of Study Drug|Overall Study||113||
48716482|NCT01842581|102091911|FG001|Received at Least 1 Dose of Study Drug|Overall Study||108||
48716483|NCT01842581|102091910|FG000|COMPLETED|Overall Study||69||
48716484|NCT01842581|102091911|FG001|COMPLETED|Overall Study||79||
48716485|NCT01842581|102091910|FG000|NOT COMPLETED|Overall Study||44||
48716486|NCT01842581|102091911|FG001|NOT COMPLETED|Overall Study||30||
48716487|NCT01460719|102091912|FG000|STARTED|Overall Study||80||
48716488|NCT01460719|102091912|FG000|Vaccination 1 (Day 1)|Overall Study||80||
48716489|NCT01460719|102091912|FG000|Vaccination 2 (~Day 30)|Overall Study||78||
48716490|NCT01460719|102091912|FG000|Vaccination 3 (~Day 60)|Overall Study||78||
48716491|NCT01460719|102091912|FG000|Vaccination 4 (~Day 90)|Overall Study||78||
48716492|NCT01460719|102091912|FG000|COMPLETED|Overall Study||78||
48716493|NCT01460719|102091912|FG000|NOT COMPLETED|Overall Study||2||
48716494|NCT01519674|102091913|FG000|STARTED|Overall Study||194||
48716495|NCT01519674|102091914|FG001|STARTED|Overall Study||195||
48716496|NCT01519674|102091915|FG002|STARTED|Overall Study||193||
48716497|NCT01519674|102091913|FG000|Exposed|Overall Study||192||
48716498|NCT01519674|102091914|FG001|Exposed|Overall Study||193||
48716499|NCT01519674|102091915|FG002|Exposed|Overall Study||190||
48716500|NCT01519674|102091913|FG000|COMPLETED|Overall Study||173||
48716501|NCT01519674|102091914|FG001|COMPLETED|Overall Study||182||
48716502|NCT01519674|102091915|FG002|COMPLETED|Overall Study||181||
48716503|NCT01519674|102091913|FG000|NOT COMPLETED|Overall Study||21||
48716504|NCT01519674|102091914|FG001|NOT COMPLETED|Overall Study||13||
48716505|NCT01519674|102091915|FG002|NOT COMPLETED|Overall Study||12||
48716506|NCT03734029|102091916|FG000|STARTED|Overall Study||373||
48716507|NCT03734029|102091917|FG001|STARTED|Overall Study||184||
48716508|NCT03734029|102091916|FG000|Full Analysis Set (All Randomized Patients)|Overall Study||373||
48716509|NCT03734029|102091917|FG001|Full Analysis Set (All Randomized Patients)|Overall Study||184||
48716510|NCT03734029|102091916|FG000|Safety Analysis Set (All Randomized Patients Who Received at Least 1 Dose of Study Treatment)|Overall Study||371||
48716511|NCT03734029|102091917|FG001|Safety Analysis Set (All Randomized Patients Who Received at Least 1 Dose of Study Treatment)|Overall Study||172||
48716512|NCT03734029|102091916|FG000|COMPLETED|Overall Study||58|Ongoing as of 11 Jan 2022|
48716513|NCT03734029|102091917|FG001|COMPLETED|Overall Study||3|Ongoing as of 11 Jan 2022|
48716514|NCT03734029|102091916|FG000|NOT COMPLETED|Overall Study||315||
48716515|NCT03734029|102091917|FG001|NOT COMPLETED|Overall Study||181||
48716516|NCT03449433|102091918|FG000|STARTED|Period 1||17||
48716517|NCT03449433|102091919|FG001|STARTED|Period 1||16||
48716518|NCT03449433|102091920|FG002|STARTED|Period 1||18||
48716519|NCT03449433|102091921|FG003|STARTED|Period 1||17||
48716520|NCT03449433|102091922|FG004|STARTED|Period 1||12||
48716521|NCT03449433|102091918|FG000|Received at Least 1 Dose of Study Drug|Period 1||17||
48716522|NCT03449433|102091919|FG001|Received at Least 1 Dose of Study Drug|Period 1||16||
48716523|NCT03449433|102091920|FG002|Received at Least 1 Dose of Study Drug|Period 1||18||
48716524|NCT03449433|102091921|FG003|Received at Least 1 Dose of Study Drug|Period 1||17||
48716525|NCT03449433|102091922|FG004|Received at Least 1 Dose of Study Drug|Period 1||0||
48716526|NCT03449433|102091918|FG000|COMPLETED|Period 1||17||
48716527|NCT03449433|102091919|FG001|COMPLETED|Period 1||16||
48716528|NCT03449433|102091920|FG002|COMPLETED|Period 1||18||
48716529|NCT03449433|102091921|FG003|COMPLETED|Period 1||17||
48716530|NCT03449433|102091922|FG004|COMPLETED|Period 1||12||
48716531|NCT03449433|102091918|FG000|NOT COMPLETED|Period 1||0||
48716532|NCT03449433|102091919|FG001|NOT COMPLETED|Period 1||0||
48716533|NCT03449433|102091920|FG002|NOT COMPLETED|Period 1||0||
48716534|NCT03449433|102091921|FG003|NOT COMPLETED|Period 1||0||
48716535|NCT03449433|102091922|FG004|NOT COMPLETED|Period 1||0||
48716536|NCT03449433|102091918|FG000|STARTED|Period 2||17||
48716537|NCT03449433|102091919|FG001|STARTED|Period 2||16||
48716538|NCT03449433|102091920|FG002|STARTED|Period 2||18||
48716539|NCT03449433|102091921|FG003|STARTED|Period 2||17||
48716540|NCT03449433|102091922|FG004|STARTED|Period 2||12||
48716541|NCT03449433|102091918|FG000|Received at Least 1 Dose of Study Drug|Period 2||17||
48716542|NCT03449433|102091919|FG001|Received at Least 1 Dose of Study Drug|Period 2||16||
48716543|NCT03449433|102091920|FG002|Received at Least 1 Dose of Study Drug|Period 2||18||
48716544|NCT03449433|102091921|FG003|Received at Least 1 Dose of Study Drug|Period 2||17||
48716545|NCT03449433|102091922|FG004|Received at Least 1 Dose of Study Drug|Period 2||0||
48716546|NCT03449433|102091918|FG000|COMPLETED|Period 2||17||
48716547|NCT03449433|102091919|FG001|COMPLETED|Period 2||16||
48716548|NCT03449433|102091920|FG002|COMPLETED|Period 2||18||
48149149|NCT01471054|100688630|FG000|COMPLETED|Overall Study||1||
48149150|NCT01471054|100688631|FG001|COMPLETED|Overall Study||1||
48149151|NCT01471054|100688630|FG000|NOT COMPLETED|Overall Study||4||
48149152|NCT01471054|100688631|FG001|NOT COMPLETED|Overall Study||0||
48149153|NCT01800968|100688632|FG000|STARTED|Overall Study||154||
48149154|NCT01800968|100688633|FG001|STARTED|Overall Study||146||
48716549|NCT03449433|102091921|FG003|COMPLETED|Period 2||17||
48716550|NCT03449433|102091922|FG004|COMPLETED|Period 2||12||
48716551|NCT03449433|102091918|FG000|NOT COMPLETED|Period 2||0||
48149155|NCT01800968|100688632|FG000|COMPLETED|Overall Study||118||
48716552|NCT03449433|102091919|FG001|NOT COMPLETED|Period 2||0||
48149156|NCT01800968|100688633|FG001|COMPLETED|Overall Study||114||
48149157|NCT01800968|100688632|FG000|NOT COMPLETED|Overall Study||36||
48716553|NCT03449433|102091920|FG002|NOT COMPLETED|Period 2||0||
48716554|NCT03449433|102091921|FG003|NOT COMPLETED|Period 2||0||
48716555|NCT03449433|102091922|FG004|NOT COMPLETED|Period 2||0||
48716556|NCT03449433|102091918|FG000|STARTED|Period 3||17||
48716557|NCT03449433|102091919|FG001|STARTED|Period 3||16||
48716558|NCT03449433|102091920|FG002|STARTED|Period 3||18||
48716559|NCT03449433|102091921|FG003|STARTED|Period 3||17||
48149158|NCT01800968|100688633|FG001|NOT COMPLETED|Overall Study||32||
48149159|NCT04139564|100688634|FG000|STARTED|Overall Study||52||
48149160|NCT04139564|100688635|FG001|STARTED|Overall Study||55||
48149161|NCT04139564|100688634|FG000|COMPLETED|Overall Study||52||
48606402|NCT00741598|101819971|FG000|STARTED|Overall Study||33||
48606403|NCT00741598|101819972|FG001|STARTED|Overall Study||39||
48606404|NCT00741598|101819971|FG000|COMPLETED|Overall Study||24||
48606405|NCT00741598|101819972|FG001|COMPLETED|Overall Study||30||
48606406|NCT00741598|101819971|FG000|NOT COMPLETED|Overall Study||9||
48606407|NCT00741598|101819972|FG001|NOT COMPLETED|Overall Study||9||
48606408|NCT02688764|101819973|FG000|STARTED|Overall Study||66||
48606409|NCT02688764|101819974|FG001|STARTED|Overall Study||19||
48606410|NCT02688764|101819973|FG000|Treated in Stage 1|Overall Study||66||
48606411|NCT02688764|101819974|FG001|Treated in Stage 1|Overall Study||19||
48606412|NCT02688764|101819973|FG000|Treated in Stage 2|Overall Study||43||
48606413|NCT02688764|101819974|FG001|Treated in Stage 2|Overall Study||8||
48149162|NCT04139564|100688635|FG001|COMPLETED|Overall Study||55||
48606414|NCT02688764|101819973|FG000|COMPLETED|Overall Study||26||
48606415|NCT02688764|101819974|FG001|COMPLETED|Overall Study||2||
48606416|NCT02688764|101819973|FG000|NOT COMPLETED|Overall Study||40||
48606417|NCT02688764|101819974|FG001|NOT COMPLETED|Overall Study||17||
48606418|NCT00255164|101819975|FG000|STARTED|Overall Study||140||
48606419|NCT00255164|101819976|FG001|STARTED|Overall Study||159||
48606420|NCT00255164|101819977|FG002|STARTED|Overall Study||152||
48606421|NCT00255164|101819975|FG000|COMPLETED|Overall Study||17||
48606422|NCT00255164|101819976|FG001|COMPLETED|Overall Study||110||
48606423|NCT00255164|101819977|FG002|COMPLETED|Overall Study||103||
48606424|NCT00255164|101819975|FG000|NOT COMPLETED|Overall Study||123||
48606425|NCT00255164|101819976|FG001|NOT COMPLETED|Overall Study||49||
48606426|NCT00255164|101819977|FG002|NOT COMPLETED|Overall Study||49||
48606427|NCT04229771|101819978|FG000|STARTED|Overall Study||2||
48606428|NCT04229771|101819979|FG001|STARTED|Overall Study||0||
48606429|NCT04229771|101819978|FG000|COMPLETED|Overall Study||2||
48606430|NCT04229771|101819979|FG001|COMPLETED|Overall Study||0||
48606431|NCT04229771|101819978|FG000|NOT COMPLETED|Overall Study||0||
48606432|NCT04229771|101819979|FG001|NOT COMPLETED|Overall Study||0||
48606433|NCT01090050|101819980|FG000|STARTED|Overall Study||16||
48606434|NCT01090050|101819981|FG001|STARTED|Overall Study||12||
48606435|NCT01090050|101819980|FG000|COMPLETED|Overall Study||15||
48606436|NCT01090050|101819981|FG001|COMPLETED|Overall Study||5||
48606437|NCT01090050|101819980|FG000|NOT COMPLETED|Overall Study||1||
48606438|NCT01090050|101819981|FG001|NOT COMPLETED|Overall Study||7||
48606439|NCT01247675|101819982|FG000|STARTED|Overall Study||10||
48606440|NCT01247675|101819983|FG001|STARTED|Overall Study||10||
48606441|NCT01247675|101819984|FG002|STARTED|Overall Study||9||
48606442|NCT01247675|101819985|FG003|STARTED|Overall Study||8||
48606443|NCT01247675|101819982|FG000|COMPLETED|Overall Study||8||
48606444|NCT01247675|101819983|FG001|COMPLETED|Overall Study||8||
48606445|NCT01247675|101819984|FG002|COMPLETED|Overall Study||9||
48606446|NCT01247675|101819985|FG003|COMPLETED|Overall Study||8||
48606447|NCT01247675|101819982|FG000|NOT COMPLETED|Overall Study||2||
48606448|NCT01247675|101819983|FG001|NOT COMPLETED|Overall Study||2||
48606449|NCT01247675|101819984|FG002|NOT COMPLETED|Overall Study||0||
48606450|NCT01247675|101819985|FG003|NOT COMPLETED|Overall Study||0||
48606451|NCT03866278|101823305|FG000|STARTED|Overall Study||31||
48606452|NCT03866278|101823305|FG000|COMPLETED|Overall Study||28||
48606453|NCT03866278|101823305|FG000|NOT COMPLETED|Overall Study||3||
48606454|NCT01515696|101823306|FG000|STARTED|Overall Study||47||
48606455|NCT01515696|101823307|FG001|STARTED|Overall Study||49||
48606456|NCT01515696|101823306|FG000|COMPLETED|Overall Study||39||
48606457|NCT01515696|101823307|FG001|COMPLETED|Overall Study||39||
48606458|NCT01515696|101823306|FG000|NOT COMPLETED|Overall Study||8||
48606459|NCT01515696|101823307|FG001|NOT COMPLETED|Overall Study||10||
48606460|NCT00479115|101823308|FG000|STARTED|Overall Study||1||
48606461|NCT00479115|101823308|FG000|COMPLETED|Overall Study||1||
48606462|NCT00479115|101823308|FG000|NOT COMPLETED|Overall Study||0||
48606463|NCT04625413|101823309|FG000|STARTED|Overall Study||15||
48606464|NCT04625413|101823309|FG000|COMPLETED|Overall Study||11||
48606465|NCT04625413|101823309|FG000|NOT COMPLETED|Overall Study||4||
48606466|NCT02517021|101823310|FG000|STARTED|Overall Study||203||
48606467|NCT02517021|101823311|FG001|STARTED|Overall Study||202||
48606468|NCT02517021|101823310|FG000|COMPLETED|Overall Study||120||
48606469|NCT02517021|101823311|FG001|COMPLETED|Overall Study||117||
48606470|NCT02517021|101823310|FG000|NOT COMPLETED|Overall Study||83||
48606471|NCT02517021|101823311|FG001|NOT COMPLETED|Overall Study||85||
48606472|NCT02548949|101823312|FG000|STARTED|Overall Study||700||
48606473|NCT02548949|101823312|FG000|COMPLETED|Overall Study||700||
48606474|NCT02548949|101823312|FG000|NOT COMPLETED|Overall Study||0||
48606475|NCT01043094|101823313|FG000|STARTED|Overall Study||8||
48606476|NCT01043094|101823314|FG001|STARTED|Overall Study||8||
48606477|NCT01043094|101823313|FG000|COMPLETED|Overall Study||8||
48606478|NCT01043094|101823314|FG001|COMPLETED|Overall Study||8||
48606479|NCT01043094|101823313|FG000|NOT COMPLETED|Overall Study||0||
48606480|NCT01043094|101823314|FG001|NOT COMPLETED|Overall Study||0||
48606481|NCT00768287|101823315|FG000|STARTED|Pharmacokinetic Study||16||
48606482|NCT00768287|101823316|FG001|STARTED|Pharmacokinetic Study||16||
48606483|NCT00768287|101823317|FG002|STARTED|Pharmacokinetic Study||0||
48606484|NCT00768287|101823318|FG003|STARTED|Pharmacokinetic Study||0||
48606485|NCT00768287|101823319|FG004|STARTED|Pharmacokinetic Study||0||
48606486|NCT00768287|101823320|FG005|STARTED|Pharmacokinetic Study||0||
48606487|NCT00768287|101823315|FG000|COMPLETED|Pharmacokinetic Study||16||
48606488|NCT00768287|101823316|FG001|COMPLETED|Pharmacokinetic Study||16||
48606489|NCT00768287|101823317|FG002|COMPLETED|Pharmacokinetic Study||0||
48606490|NCT00768287|101823318|FG003|COMPLETED|Pharmacokinetic Study||0||
48606491|NCT00768287|101823319|FG004|COMPLETED|Pharmacokinetic Study||0||
48606492|NCT00768287|101823320|FG005|COMPLETED|Pharmacokinetic Study||0||
48606493|NCT00768287|101823315|FG000|NOT COMPLETED|Pharmacokinetic Study||0||
48606494|NCT00768287|101823316|FG001|NOT COMPLETED|Pharmacokinetic Study||0||
48606495|NCT00768287|101823317|FG002|NOT COMPLETED|Pharmacokinetic Study||0||
48606496|NCT00768287|101823318|FG003|NOT COMPLETED|Pharmacokinetic Study||0||
48606497|NCT00768287|101823319|FG004|NOT COMPLETED|Pharmacokinetic Study||0||
48606498|NCT00768287|101823320|FG005|NOT COMPLETED|Pharmacokinetic Study||0||
48606499|NCT00768287|101823315|FG000|STARTED|Repeat Pharmacokinetic Study||0||
48716560|NCT03449433|102091922|FG004|STARTED|Period 3||12||
48716561|NCT03449433|102091918|FG000|Received at Least 1 Dose of Study Drug|Period 3||17||
48716562|NCT03449433|102091919|FG001|Received at Least 1 Dose of Study Drug|Period 3||15||
48716563|NCT03449433|102091920|FG002|Received at Least 1 Dose of Study Drug|Period 3||18||
48716564|NCT03449433|102091921|FG003|Received at Least 1 Dose of Study Drug|Period 3||17||
48716565|NCT03449433|102091922|FG004|Received at Least 1 Dose of Study Drug|Period 3||0||
48716566|NCT03449433|102091918|FG000|COMPLETED|Period 3||17||
48716567|NCT03449433|102091919|FG001|COMPLETED|Period 3||15||
48716568|NCT03449433|102091920|FG002|COMPLETED|Period 3||18||
48716569|NCT03449433|102091921|FG003|COMPLETED|Period 3||17||
48716570|NCT03449433|102091922|FG004|COMPLETED|Period 3||12||
48716571|NCT03449433|102091918|FG000|NOT COMPLETED|Period 3||0||
48716572|NCT03449433|102091919|FG001|NOT COMPLETED|Period 3||1||
48716573|NCT03449433|102091920|FG002|NOT COMPLETED|Period 3||0||
48716574|NCT03449433|102091921|FG003|NOT COMPLETED|Period 3||0||
48716575|NCT03449433|102091922|FG004|NOT COMPLETED|Period 3||0||
48716576|NCT03449433|102091918|FG000|STARTED|Period 4||17||
48716577|NCT03449433|102091919|FG001|STARTED|Period 4||15||
48716578|NCT03449433|102091920|FG002|STARTED|Period 4||18||
48716579|NCT03449433|102091921|FG003|STARTED|Period 4||17||
48716580|NCT03449433|102091922|FG004|STARTED|Period 4||12||
48716581|NCT03449433|102091918|FG000|Received at Least 1 Dose of Study Drug|Period 4||17||
48716582|NCT03449433|102091919|FG001|Received at Least 1 Dose of Study Drug|Period 4||15||
48716583|NCT03449433|102091920|FG002|Received at Least 1 Dose of Study Drug|Period 4||18||
48716584|NCT03449433|102091921|FG003|Received at Least 1 Dose of Study Drug|Period 4||17||
48716585|NCT03449433|102091922|FG004|Received at Least 1 Dose of Study Drug|Period 4||0||
48716586|NCT03449433|102091918|FG000|COMPLETED|Period 4||17||
48716587|NCT03449433|102091919|FG001|COMPLETED|Period 4||15||
48716588|NCT03449433|102091920|FG002|COMPLETED|Period 4||18||
48716589|NCT03449433|102091921|FG003|COMPLETED|Period 4||17||
48716590|NCT03449433|102091922|FG004|COMPLETED|Period 4||12||
48716591|NCT03449433|102091918|FG000|NOT COMPLETED|Period 4||0||
48716592|NCT03449433|102091919|FG001|NOT COMPLETED|Period 4||0||
48716593|NCT03449433|102091920|FG002|NOT COMPLETED|Period 4||0||
48716594|NCT03449433|102091921|FG003|NOT COMPLETED|Period 4||0||
48716595|NCT03449433|102091922|FG004|NOT COMPLETED|Period 4||0||
48716596|NCT01005212|102091923|FG000|STARTED|Overall Study||20||
48716597|NCT01005212|102091923|FG000|COMPLETED|Overall Study||20||
48716598|NCT01005212|102091923|FG000|NOT COMPLETED|Overall Study||0||
48716599|NCT03426631|102091924|FG000|STARTED|Overall Study||7||
48716600|NCT03426631|102091925|FG001|STARTED|Overall Study||6||
48716601|NCT03426631|102091924|FG000|COMPLETED|Overall Study||7||
48716602|NCT03426631|102091925|FG001|COMPLETED|Overall Study||5||
48716603|NCT03426631|102091924|FG000|NOT COMPLETED|Overall Study||0||
48716604|NCT03426631|102091925|FG001|NOT COMPLETED|Overall Study||1||
48716605|NCT01394614|102091926|FG000|STARTED|Overall Study||8||
48716606|NCT01394614|102091927|FG001|STARTED|Overall Study||16||
48716607|NCT01394614|102091926|FG000|COMPLETED|Overall Study||8||
48716608|NCT01394614|102091927|FG001|COMPLETED|Overall Study||16||
48716609|NCT01394614|102091926|FG000|NOT COMPLETED|Overall Study||0||
48716610|NCT01394614|102091927|FG001|NOT COMPLETED|Overall Study||0||
48716611|NCT04384107|102091928|FG000|STARTED|Overall Study||347||
48716612|NCT04384107|102091929|FG001|STARTED|Overall Study||347||
48716613|NCT04384107|102091928|FG000|Dose 1|Overall Study||347||
48716614|NCT04384107|102091929|FG001|Dose 1|Overall Study||346||
48716615|NCT04384107|102091928|FG000|Dose 2|Overall Study||344||
48716616|NCT04384107|102091929|FG001|Dose 2|Overall Study||346||
48716617|NCT04384107|102091928|FG000|Dose 3|Overall Study||343||
48716618|NCT04384107|102091929|FG001|Dose 3|Overall Study||346||
48716619|NCT04384107|102091928|FG000|Dose 4|Overall Study||340||
48716620|NCT04384107|102091929|FG001|Dose 4|Overall Study||342||
48716621|NCT04384107|102091928|FG000|COMPLETED|Overall Study||338||
48716622|NCT04384107|102091929|FG001|COMPLETED|Overall Study||341||
48716623|NCT04384107|102091928|FG000|NOT COMPLETED|Overall Study||9||
48716624|NCT04384107|102091929|FG001|NOT COMPLETED|Overall Study||6||
48716625|NCT01556061|102091930|FG000|STARTED|Overall Study||25||
48716626|NCT01556061|102091931|FG001|STARTED|Overall Study||25||
48716627|NCT01556061|102091930|FG000|COMPLETED|Overall Study||25||
48716628|NCT01556061|102091931|FG001|COMPLETED|Overall Study||25||
48716629|NCT01556061|102091930|FG000|NOT COMPLETED|Overall Study||0||
48716630|NCT01556061|102091931|FG001|NOT COMPLETED|Overall Study||0||
48716631|NCT03287674|102091932|FG000|STARTED|Overall Study||7||
48716632|NCT03287674|102091932|FG000|All Treated With TILs|Overall Study||6||
48716633|NCT03287674|102091932|FG000|COMPLETED|Overall Study||6||
48716634|NCT03287674|102091932|FG000|NOT COMPLETED|Overall Study||1||
48716635|NCT01219933|102091933|FG000|STARTED|Overall Study||68||
48716636|NCT01219933|102091933|FG000|COMPLETED|Overall Study||30||
48716637|NCT01219933|102091933|FG000|NOT COMPLETED|Overall Study||38||
48716638|NCT01545050|102091934|FG000|STARTED|Overall Study||18||
48716639|NCT01545050|102091935|FG001|STARTED|Overall Study||9||
48716640|NCT01545050|102091936|FG002|STARTED|Overall Study||9||
48716641|NCT01545050|102091937|FG003|STARTED|Overall Study||18||
48716642|NCT01545050|102091938|FG004|STARTED|Overall Study||18||
48716643|NCT01545050|102091934|FG000|COMPLETED|Overall Study||11||
48716644|NCT01545050|102091935|FG001|COMPLETED|Overall Study||4||
48606500|NCT00768287|101823316|FG001|STARTED|Repeat Pharmacokinetic Study||0||
48606501|NCT00768287|101823317|FG002|STARTED|Repeat Pharmacokinetic Study||14||
48606502|NCT00768287|101823318|FG003|STARTED|Repeat Pharmacokinetic Study||0||
48606503|NCT00768287|101823319|FG004|STARTED|Repeat Pharmacokinetic Study||0||
48606504|NCT00768287|101823320|FG005|STARTED|Repeat Pharmacokinetic Study||0||
48606505|NCT00768287|101823315|FG000|COMPLETED|Repeat Pharmacokinetic Study||0||
48606506|NCT00768287|101823316|FG001|COMPLETED|Repeat Pharmacokinetic Study||0||
48606507|NCT00768287|101823317|FG002|COMPLETED|Repeat Pharmacokinetic Study||14||
48606508|NCT00768287|101823318|FG003|COMPLETED|Repeat Pharmacokinetic Study||0||
48606509|NCT00768287|101823319|FG004|COMPLETED|Repeat Pharmacokinetic Study||0||
48606510|NCT00768287|101823320|FG005|COMPLETED|Repeat Pharmacokinetic Study||0||
48606511|NCT00768287|101823315|FG000|NOT COMPLETED|Repeat Pharmacokinetic Study||0||
48606512|NCT00768287|101823316|FG001|NOT COMPLETED|Repeat Pharmacokinetic Study||0||
48606513|NCT00768287|101823317|FG002|NOT COMPLETED|Repeat Pharmacokinetic Study||0||
48606514|NCT00768287|101823318|FG003|NOT COMPLETED|Repeat Pharmacokinetic Study||0||
48606515|NCT00768287|101823319|FG004|NOT COMPLETED|Repeat Pharmacokinetic Study||0||
48606516|NCT00768287|101823320|FG005|NOT COMPLETED|Repeat Pharmacokinetic Study||0||
48606517|NCT00768287|101823315|FG000|STARTED|Treatment Study||0|29 subjects enrolled from PK study; 4 from Surgery Substudy; 35 directly into Treatment study.|
48606518|NCT00768287|101823316|FG001|STARTED|Treatment Study||0|29 subjects enrolled from PK study; 4 from Surgery Substudy; 35 directly into Treatment study.|
48606519|NCT00768287|101823317|FG002|STARTED|Treatment Study||0|29 subjects enrolled from PK study; 4 from Surgery Substudy; 35 directly into Treatment study.|
48606520|NCT00768287|101823318|FG003|STARTED|Treatment Study||58|29 subjects enrolled from PK study; 4 from Surgery Substudy; 35 directly into Treatment study.|
48606521|NCT00768287|101823319|FG004|STARTED|Treatment Study||9|29 subjects enrolled from PK study; 4 from Surgery Substudy; 35 directly into Treatment study.|
48606522|NCT00768287|101823320|FG005|STARTED|Treatment Study||0|29 subjects enrolled from PK study; 4 from Surgery Substudy; 35 directly into Treatment study.|
48606523|NCT00768287|101823315|FG000|Treated|Treatment Study||0||
48606524|NCT00768287|101823316|FG001|Treated|Treatment Study||0||
48606525|NCT00768287|101823317|FG002|Treated|Treatment Study||0||
48606526|NCT00768287|101823318|FG003|Treated|Treatment Study||61||
48606527|NCT00768287|101823319|FG004|Treated|Treatment Study||12||
48606528|NCT00768287|101823320|FG005|Treated|Treatment Study||0||
48606529|NCT00768287|101823315|FG000|COMPLETED|Treatment Study||0||
48606530|NCT00768287|101823316|FG001|COMPLETED|Treatment Study||0||
48606531|NCT00768287|101823317|FG002|COMPLETED|Treatment Study||0||
48606532|NCT00768287|101823318|FG003|COMPLETED|Treatment Study||58||
48606533|NCT00768287|101823319|FG004|COMPLETED|Treatment Study||9||
48606534|NCT00768287|101823320|FG005|COMPLETED|Treatment Study||0||
48606535|NCT00768287|101823315|FG000|NOT COMPLETED|Treatment Study||0||
48606536|NCT00768287|101823316|FG001|NOT COMPLETED|Treatment Study||0||
48606537|NCT00768287|101823317|FG002|NOT COMPLETED|Treatment Study||0||
48606538|NCT00768287|101823318|FG003|NOT COMPLETED|Treatment Study||0||
48606539|NCT00768287|101823319|FG004|NOT COMPLETED|Treatment Study||0||
48606540|NCT00768287|101823320|FG005|NOT COMPLETED|Treatment Study||0||
48606541|NCT00768287|101823315|FG000|STARTED|Surgical Sub-study||0|Four subjects came from prophylaxis, 3 from on demand, 10 enrolled directly into Surgical Substudy.|
48606542|NCT00768287|101823316|FG001|STARTED|Surgical Sub-study||0|Four subjects came from prophylaxis, 3 from on demand, 10 enrolled directly into Surgical Substudy.|
48606543|NCT00768287|101823317|FG002|STARTED|Surgical Sub-study||0|Four subjects came from prophylaxis, 3 from on demand, 10 enrolled directly into Surgical Substudy.|
48606544|NCT00768287|101823318|FG003|STARTED|Surgical Sub-study||0|Four subjects came from prophylaxis, 3 from on demand, 10 enrolled directly into Surgical Substudy.|
48606545|NCT00768287|101823319|FG004|STARTED|Surgical Sub-study||0|Four subjects came from prophylaxis, 3 from on demand, 10 enrolled directly into Surgical Substudy.|
48656915|NCT04274218|101943728|FG003|COMPLETED|Perturbation Condition 1 (15 Minutes)||4||
48303888|NCT01717768|101072873|FG000|STARTED|Part 2 (Duration of 15 Days)||0||
48303889|NCT01717768|101072874|FG001|STARTED|Part 2 (Duration of 15 Days)||0||
48303890|NCT01717768|101072875|FG002|STARTED|Part 2 (Duration of 15 Days)||17||
48303891|NCT01717768|101072876|FG003|STARTED|Part 2 (Duration of 15 Days)||0||
48303892|NCT01717768|101072877|FG004|STARTED|Part 2 (Duration of 15 Days)||0||
48303893|NCT01717768|101072878|FG005|STARTED|Part 2 (Duration of 15 Days)||0||
48303894|NCT01717768|101072879|FG006|STARTED|Part 2 (Duration of 15 Days)||0||
48303895|NCT01717768|101072880|FG007|STARTED|Part 2 (Duration of 15 Days)||0||
48303896|NCT01717768|101072881|FG008|STARTED|Part 2 (Duration of 15 Days)||0||
48606546|NCT00768287|101823320|FG005|STARTED|Surgical Sub-study||17|Four subjects came from prophylaxis, 3 from on demand, 10 enrolled directly into Surgical Substudy.|
48606547|NCT00768287|101823315|FG000|COMPLETED|Surgical Sub-study||0||
48606548|NCT00768287|101823316|FG001|COMPLETED|Surgical Sub-study||0||
48606549|NCT00768287|101823317|FG002|COMPLETED|Surgical Sub-study||0||
48606550|NCT00768287|101823318|FG003|COMPLETED|Surgical Sub-study||0||
48606551|NCT00768287|101823319|FG004|COMPLETED|Surgical Sub-study||0||
48606552|NCT00768287|101823320|FG005|COMPLETED|Surgical Sub-study||17||
48606553|NCT00768287|101823315|FG000|NOT COMPLETED|Surgical Sub-study||0||
48716645|NCT01545050|102091936|FG002|COMPLETED|Overall Study||4||
48303897|NCT01717768|101072882|FG009|STARTED|Part 2 (Duration of 15 Days)||0||
48303898|NCT01717768|101072883|FG010|STARTED|Part 2 (Duration of 15 Days)||0||
48303899|NCT01717768|101072884|FG011|STARTED|Part 2 (Duration of 15 Days)||0||
48303900|NCT01717768|101072873|FG000|COMPLETED|Part 2 (Duration of 15 Days)||0||
48303901|NCT01717768|101072874|FG001|COMPLETED|Part 2 (Duration of 15 Days)||0||
48303902|NCT01717768|101072875|FG002|COMPLETED|Part 2 (Duration of 15 Days)||17||
48303903|NCT01717768|101072876|FG003|COMPLETED|Part 2 (Duration of 15 Days)||0||
48303904|NCT01717768|101072877|FG004|COMPLETED|Part 2 (Duration of 15 Days)||0||
48303905|NCT01717768|101072878|FG005|COMPLETED|Part 2 (Duration of 15 Days)||0||
48303906|NCT01717768|101072879|FG006|COMPLETED|Part 2 (Duration of 15 Days)||0||
48303907|NCT01717768|101072880|FG007|COMPLETED|Part 2 (Duration of 15 Days)||0||
48606554|NCT00768287|101823316|FG001|NOT COMPLETED|Surgical Sub-study||0||
48606555|NCT00768287|101823317|FG002|NOT COMPLETED|Surgical Sub-study||0||
48606556|NCT00768287|101823318|FG003|NOT COMPLETED|Surgical Sub-study||0||
48606557|NCT00768287|101823319|FG004|NOT COMPLETED|Surgical Sub-study||0||
48606558|NCT00768287|101823320|FG005|NOT COMPLETED|Surgical Sub-study||0||
48606559|NCT01641471|101823321|FG000|STARTED|Overall Study||58||
48606560|NCT01641471|101823322|FG001|STARTED|Overall Study||58||
48606561|NCT01641471|101823321|FG000|COMPLETED|Overall Study||35||
48606562|NCT01641471|101823322|FG001|COMPLETED|Overall Study||31||
48606563|NCT01641471|101823321|FG000|NOT COMPLETED|Overall Study||23||
48606564|NCT01641471|101823322|FG001|NOT COMPLETED|Overall Study||27||
48606565|NCT02782377|101823323|FG000|STARTED|Overall Study||40||
48606566|NCT02782377|101823323|FG000|COMPLETED|Overall Study||35||
48606567|NCT02782377|101823323|FG000|NOT COMPLETED|Overall Study||5||
48606568|NCT02697591|101823324|FG000|STARTED|Overall Study||4||
48606569|NCT02697591|101823325|FG001|STARTED|Overall Study||4||
48606570|NCT02697591|101823326|FG002|STARTED|Overall Study||4||
48606571|NCT02697591|101823327|FG003|STARTED|Overall Study||3||
48606572|NCT02697591|101823328|FG004|STARTED|Overall Study||15||
48606573|NCT02697591|101823329|FG005|STARTED|Overall Study||18||
48606574|NCT02697591|101823330|FG006|STARTED|Overall Study||16||
48606575|NCT02697591|101823331|FG007|STARTED|Overall Study||4||
48606576|NCT02697591|101823332|FG008|STARTED|Overall Study||10||
48606577|NCT02697591|101823333|FG009|STARTED|Overall Study||22||
48606578|NCT02697591|101823324|FG000|COMPLETED|Overall Study||0||
48606579|NCT02697591|101823325|FG001|COMPLETED|Overall Study||0||
48606580|NCT02697591|101823326|FG002|COMPLETED|Overall Study||1||
48606581|NCT02697591|101823327|FG003|COMPLETED|Overall Study||0||
48606582|NCT02697591|101823328|FG004|COMPLETED|Overall Study||2||
48606583|NCT02697591|101823329|FG005|COMPLETED|Overall Study||2||
48606584|NCT02697591|101823330|FG006|COMPLETED|Overall Study||0||
48606585|NCT02697591|101823331|FG007|COMPLETED|Overall Study||1||
48716646|NCT01545050|102091937|FG003|COMPLETED|Overall Study||6||
48716647|NCT01545050|102091938|FG004|COMPLETED|Overall Study||9||
48716648|NCT01545050|102091934|FG000|NOT COMPLETED|Overall Study||7||
48716649|NCT01545050|102091935|FG001|NOT COMPLETED|Overall Study||5||
48716650|NCT01545050|102091936|FG002|NOT COMPLETED|Overall Study||5||
48303908|NCT01717768|101072881|FG008|COMPLETED|Part 2 (Duration of 15 Days)||0||
48368013|NCT03567291|101230094|FG002|Safety Set|Period I||0||
48606586|NCT02697591|101823332|FG008|COMPLETED|Overall Study||1||
48606587|NCT02697591|101823333|FG009|COMPLETED|Overall Study||2||
48606588|NCT02697591|101823324|FG000|NOT COMPLETED|Overall Study||4||
48606589|NCT02697591|101823325|FG001|NOT COMPLETED|Overall Study||4||
48606590|NCT02697591|101823326|FG002|NOT COMPLETED|Overall Study||3||
48606591|NCT02697591|101823327|FG003|NOT COMPLETED|Overall Study||3||
48606592|NCT02697591|101823328|FG004|NOT COMPLETED|Overall Study||13||
48606593|NCT02697591|101823329|FG005|NOT COMPLETED|Overall Study||16||
48606594|NCT02697591|101823330|FG006|NOT COMPLETED|Overall Study||16||
48606595|NCT02697591|101823331|FG007|NOT COMPLETED|Overall Study||3||
48606596|NCT02697591|101823332|FG008|NOT COMPLETED|Overall Study||9||
48606597|NCT02697591|101823333|FG009|NOT COMPLETED|Overall Study||20||
48606598|NCT01134393|101823334|FG000|STARTED|Overall Study||501||
48606599|NCT01134393|101823334|FG000|COMPLETED|Overall Study||449||
48606600|NCT01134393|101823334|FG000|NOT COMPLETED|Overall Study||52||
48606601|NCT01065571|101823335|FG000|STARTED|Overall Study||10||
48606602|NCT01065571|101823336|FG001|STARTED|Overall Study||5||
48606603|NCT01065571|101823335|FG000|COMPLETED|Overall Study||7||
48606604|NCT01065571|101823336|FG001|COMPLETED|Overall Study||5||
48149163|NCT04139564|100688634|FG000|NOT COMPLETED|Overall Study||0||
48149164|NCT04139564|100688635|FG001|NOT COMPLETED|Overall Study||0||
48149165|NCT04058353|100688636|FG000|STARTED|Overall Study||126||
48149166|NCT04058353|100688637|FG001|STARTED|Overall Study||132||
48606605|NCT01065571|101823335|FG000|NOT COMPLETED|Overall Study||3||
48606606|NCT01065571|101823336|FG001|NOT COMPLETED|Overall Study||0||
48606607|NCT00703326|101823337|FG000|STARTED|Overall Study||759||
48606608|NCT00703326|101823338|FG001|STARTED|Overall Study||385||
48606609|NCT00703326|101823337|FG000|Received at Least 1 Dose of Study Drug|Overall Study||752||
48606610|NCT00703326|101823338|FG001|Received at Least 1 Dose of Study Drug|Overall Study||382||
48606611|NCT00703326|101823337|FG000|COMPLETED|Overall Study||657||
48606612|NCT00703326|101823338|FG001|COMPLETED|Overall Study||347||
48606613|NCT00703326|101823337|FG000|NOT COMPLETED|Overall Study||102||
48716651|NCT01545050|102091937|FG003|NOT COMPLETED|Overall Study||12||
48716652|NCT01545050|102091938|FG004|NOT COMPLETED|Overall Study||9||
48716653|NCT02598128|102091939|FG000|STARTED|Period A: Days -7 to -1||34||
48716654|NCT02598128|102091940|FG001|STARTED|Period A: Days -7 to -1||0||
48716655|NCT02598128|102091941|FG002|STARTED|Period A: Days -7 to -1||0||
48716656|NCT02598128|102091942|FG003|STARTED|Period A: Days -7 to -1||0||
48716657|NCT02598128|102091939|FG000|COMPLETED|Period A: Days -7 to -1||33||
48716658|NCT02598128|102091940|FG001|COMPLETED|Period A: Days -7 to -1||0||
48716659|NCT02598128|102091941|FG002|COMPLETED|Period A: Days -7 to -1||0||
48716660|NCT02598128|102091942|FG003|COMPLETED|Period A: Days -7 to -1||0||
48716661|NCT02598128|102091939|FG000|NOT COMPLETED|Period A: Days -7 to -1||1||
48716662|NCT02598128|102091940|FG001|NOT COMPLETED|Period A: Days -7 to -1||0||
48716663|NCT02598128|102091941|FG002|NOT COMPLETED|Period A: Days -7 to -1||0||
48716664|NCT02598128|102091942|FG003|NOT COMPLETED|Period A: Days -7 to -1||0||
48716665|NCT02598128|102091939|FG000|STARTED|Period B: Days 1 to 11||0||
48716666|NCT02598128|102091940|FG001|STARTED|Period B: Days 1 to 11||17||
48716667|NCT02598128|102091941|FG002|STARTED|Period B: Days 1 to 11||16||
48716668|NCT02598128|102091942|FG003|STARTED|Period B: Days 1 to 11||0||
48716669|NCT02598128|102091939|FG000|COMPLETED|Period B: Days 1 to 11||0||
48149167|NCT04058353|100688636|FG000|COMPLETED|Overall Study||122||
48149168|NCT04058353|100688637|FG001|COMPLETED|Overall Study||131||
48149169|NCT04058353|100688636|FG000|NOT COMPLETED|Overall Study||4||
48149170|NCT04058353|100688637|FG001|NOT COMPLETED|Overall Study||1||
48149171|NCT04029129|100688638|FG000|STARTED|First Intervention (2 Hours)||30||
48149172|NCT04029129|100688639|FG001|STARTED|First Intervention (2 Hours)||28||
48303909|NCT01717768|101072882|FG009|COMPLETED|Part 2 (Duration of 15 Days)||0||
48303910|NCT01717768|101072883|FG010|COMPLETED|Part 2 (Duration of 15 Days)||0||
48303911|NCT01717768|101072884|FG011|COMPLETED|Part 2 (Duration of 15 Days)||0||
48303912|NCT01717768|101072873|FG000|NOT COMPLETED|Part 2 (Duration of 15 Days)||0||
48303913|NCT01717768|101072874|FG001|NOT COMPLETED|Part 2 (Duration of 15 Days)||0||
48606614|NCT00703326|101823338|FG001|NOT COMPLETED|Overall Study||38||
48303914|NCT01717768|101072875|FG002|NOT COMPLETED|Part 2 (Duration of 15 Days)||0||
48303915|NCT01717768|101072876|FG003|NOT COMPLETED|Part 2 (Duration of 15 Days)||0||
48303916|NCT01717768|101072877|FG004|NOT COMPLETED|Part 2 (Duration of 15 Days)||0||
48606615|NCT00694356|101823339|FG000|STARTED|Overall Study||3||
48606616|NCT00694356|101823340|FG001|STARTED|Overall Study||6||
48606617|NCT00694356|101823341|FG002|STARTED|Overall Study||6||
48606618|NCT00694356|101823339|FG000|COMPLETED|Overall Study||0||
48606619|NCT00694356|101823340|FG001|COMPLETED|Overall Study||0||
48606620|NCT00694356|101823341|FG002|COMPLETED|Overall Study||0||
48606621|NCT00694356|101823339|FG000|NOT COMPLETED|Overall Study||3||
48606622|NCT00694356|101823340|FG001|NOT COMPLETED|Overall Study||6||
48149173|NCT04029129|100688640|FG002|STARTED|First Intervention (2 Hours)||19||
48149174|NCT04029129|100688638|FG000|COMPLETED|First Intervention (2 Hours)||30||
48606623|NCT00694356|101823341|FG002|NOT COMPLETED|Overall Study||6||
48606624|NCT02290925|101823342|FG000|STARTED|First Period of Three Months||62||
48606625|NCT02290925|101823343|FG001|STARTED|First Period of Three Months||71||
48606626|NCT02290925|101823342|FG000|COMPLETED|First Period of Three Months||58||
48606627|NCT02290925|101823343|FG001|COMPLETED|First Period of Three Months||69||
48606628|NCT02290925|101823342|FG000|NOT COMPLETED|First Period of Three Months||4||
48716670|NCT02598128|102091940|FG001|COMPLETED|Period B: Days 1 to 11||17||
48716671|NCT02598128|102091941|FG002|COMPLETED|Period B: Days 1 to 11||16||
48149175|NCT04029129|100688639|FG001|COMPLETED|First Intervention (2 Hours)||28||
48149176|NCT04029129|100688640|FG002|COMPLETED|First Intervention (2 Hours)||19||
48149177|NCT04029129|100688638|FG000|NOT COMPLETED|First Intervention (2 Hours)||0||
48149178|NCT04029129|100688639|FG001|NOT COMPLETED|First Intervention (2 Hours)||0||
48149179|NCT04029129|100688640|FG002|NOT COMPLETED|First Intervention (2 Hours)||0||
48149180|NCT04029129|100688638|FG000|STARTED|Wash Out (1 Week)||30||
48149181|NCT04029129|100688639|FG001|STARTED|Wash Out (1 Week)||28||
48149182|NCT04029129|100688640|FG002|STARTED|Wash Out (1 Week)||19||
48149183|NCT04029129|100688638|FG000|COMPLETED|Wash Out (1 Week)||30||
48149184|NCT04029129|100688639|FG001|COMPLETED|Wash Out (1 Week)||28||
48149185|NCT04029129|100688640|FG002|COMPLETED|Wash Out (1 Week)||19||
48149186|NCT04029129|100688638|FG000|NOT COMPLETED|Wash Out (1 Week)||0||
48149187|NCT04029129|100688639|FG001|NOT COMPLETED|Wash Out (1 Week)||0||
48149188|NCT04029129|100688640|FG002|NOT COMPLETED|Wash Out (1 Week)||0||
48149189|NCT04029129|100688638|FG000|STARTED|Third Intervention (2 Hours)||30||
48149190|NCT04029129|100688639|FG001|STARTED|Third Intervention (2 Hours)||28||
48149191|NCT04029129|100688640|FG002|STARTED|Third Intervention (2 Hours)||19||
48149192|NCT04029129|100688638|FG000|COMPLETED|Third Intervention (2 Hours)||30||
48149193|NCT04029129|100688639|FG001|COMPLETED|Third Intervention (2 Hours)||28||
48149194|NCT04029129|100688640|FG002|COMPLETED|Third Intervention (2 Hours)||19||
48149195|NCT04029129|100688638|FG000|NOT COMPLETED|Third Intervention (2 Hours)||0||
48149196|NCT04029129|100688639|FG001|NOT COMPLETED|Third Intervention (2 Hours)||0||
48149197|NCT04029129|100688640|FG002|NOT COMPLETED|Third Intervention (2 Hours)||0||
48149198|NCT02495025|100688641|FG000|STARTED|Overall Study||77||
48149199|NCT02495025|100688642|FG001|STARTED|Overall Study||75||
48149200|NCT02495025|100688641|FG000|COMPLETED|Overall Study||51||
48149201|NCT02495025|100688642|FG001|COMPLETED|Overall Study||61||
48149202|NCT02495025|100688641|FG000|NOT COMPLETED|Overall Study||26||
48149203|NCT02495025|100688642|FG001|NOT COMPLETED|Overall Study||14||
48149204|NCT03148470|100688643|FG000|STARTED|Overall Study||21||
48149205|NCT03148470|100688644|FG001|STARTED|Overall Study||20||
48149206|NCT03148470|100688643|FG000|COMPLETED|Overall Study||20||
48149207|NCT03148470|100688644|FG001|COMPLETED|Overall Study||20||
48149208|NCT03148470|100688643|FG000|NOT COMPLETED|Overall Study||1||
48149209|NCT03148470|100688644|FG001|NOT COMPLETED|Overall Study||0||
48149210|NCT01298999|100688645|FG000|STARTED|Overall Study||13||
48149211|NCT01298999|100688646|FG001|STARTED|Overall Study||11||
48149212|NCT01298999|100688645|FG000|COMPLETED|Overall Study||10||
48149213|NCT01298999|100688646|FG001|COMPLETED|Overall Study||10||
48149214|NCT01298999|100688645|FG000|NOT COMPLETED|Overall Study||3||
48149215|NCT01298999|100688646|FG001|NOT COMPLETED|Overall Study||1||
48149216|NCT00316082|100688647|FG000|STARTED|Overall Study||74||
48149217|NCT00316082|100688648|FG001|STARTED|Overall Study||74||
48149218|NCT00316082|100688649|FG002|STARTED|Overall Study||71||
48149219|NCT00316082|100688650|FG003|STARTED|Overall Study||72||
48149220|NCT00316082|100688651|FG004|STARTED|Overall Study||74||
48149221|NCT00316082|100688647|FG000|Completed Study Without Being Rescued|Overall Study||25||
48149222|NCT00316082|100688648|FG001|Completed Study Without Being Rescued|Overall Study||35||
48149223|NCT00316082|100688649|FG002|Completed Study Without Being Rescued|Overall Study||29||
48149224|NCT00316082|100688650|FG003|Completed Study Without Being Rescued|Overall Study||27||
48149225|NCT00316082|100688651|FG004|Completed Study Without Being Rescued|Overall Study||31||
48149226|NCT00316082|100688647|FG000|COMPLETED|Overall Study||41||
48149227|NCT00316082|100688648|FG001|COMPLETED|Overall Study||52||
48149228|NCT00316082|100688649|FG002|COMPLETED|Overall Study||44||
48149229|NCT00316082|100688650|FG003|COMPLETED|Overall Study||46||
48149230|NCT00316082|100688651|FG004|COMPLETED|Overall Study||48||
48149231|NCT00316082|100688647|FG000|NOT COMPLETED|Overall Study||33||
48149232|NCT00316082|100688648|FG001|NOT COMPLETED|Overall Study||22||
48149233|NCT00316082|100688649|FG002|NOT COMPLETED|Overall Study||27||
48149234|NCT00316082|100688650|FG003|NOT COMPLETED|Overall Study||26||
48606629|NCT02290925|101823343|FG001|NOT COMPLETED|First Period of Three Months||2||
48606630|NCT02290925|101823342|FG000|STARTED|Second Period of 3 Months||58||
48606631|NCT02290925|101823343|FG001|STARTED|Second Period of 3 Months||69||
48606632|NCT02290925|101823342|FG000|COMPLETED|Second Period of 3 Months||57||
48606633|NCT02290925|101823343|FG001|COMPLETED|Second Period of 3 Months||65||
48606634|NCT02290925|101823342|FG000|NOT COMPLETED|Second Period of 3 Months||1||
48149235|NCT00316082|100688651|FG004|NOT COMPLETED|Overall Study||26||
48606635|NCT02290925|101823343|FG001|NOT COMPLETED|Second Period of 3 Months||4||
48606636|NCT03333486|101823344|FG000|STARTED|Overall Study||31||
48606637|NCT03333486|101823344|FG000|COMPLETED|Overall Study||29||
48606638|NCT03333486|101823344|FG000|NOT COMPLETED|Overall Study||2||
48606639|NCT02002871|101823345|FG000|STARTED|Overall Study||21||
48606640|NCT02002871|101823345|FG000|COMPLETED|Overall Study||20||
48606641|NCT02002871|101823345|FG000|NOT COMPLETED|Overall Study||1||
48606642|NCT01031004|101823346|FG000|STARTED|Overall Study||25||
48606643|NCT01031004|101823347|FG001|STARTED|Overall Study||25||
48606644|NCT01031004|101823346|FG000|COMPLETED|Overall Study||24||
48606645|NCT01031004|101823347|FG001|COMPLETED|Overall Study||24||
48606646|NCT01031004|101823346|FG000|NOT COMPLETED|Overall Study||1||
48716672|NCT02598128|102091942|FG003|COMPLETED|Period B: Days 1 to 11||0||
48716673|NCT02598128|102091939|FG000|NOT COMPLETED|Period B: Days 1 to 11||0||
48716674|NCT02598128|102091940|FG001|NOT COMPLETED|Period B: Days 1 to 11||0||
48716675|NCT02598128|102091941|FG002|NOT COMPLETED|Period B: Days 1 to 11||0||
48149236|NCT00689221|100688652|FG000|STARTED|Overall Study||272||
48149237|NCT00689221|100688653|FG001|STARTED|Overall Study||273||
48405979|NCT00681291|101325391|FG001|NOT COMPLETED|Overall Study||27||
48405980|NCT02244619|101325392|FG000|STARTED|Overall Study||249||
48405981|NCT02244619|101325393|FG001|STARTED|Overall Study||266||
48405982|NCT02244619|101325392|FG000|COMPLETED|Overall Study||241||
48405983|NCT02244619|101325393|FG001|COMPLETED|Overall Study||245||
48405984|NCT02244619|101325392|FG000|NOT COMPLETED|Overall Study||8||
48606647|NCT01031004|101823347|FG001|NOT COMPLETED|Overall Study||1||
48606648|NCT04274075|101823348|FG000|STARTED|Overall Study||3||
48149238|NCT00689221|100688652|FG000|COMPLETED|Overall Study||233||
48149239|NCT00689221|100688653|FG001|COMPLETED|Overall Study||237||
48149240|NCT00689221|100688652|FG000|NOT COMPLETED|Overall Study||39||
48149241|NCT00689221|100688653|FG001|NOT COMPLETED|Overall Study||36||
48149242|NCT01688466|100688654|FG000|STARTED|Overall Study||17||
48149243|NCT01688466|100688655|FG001|STARTED|Overall Study||17||
48149244|NCT01688466|100688654|FG000|COMPLETED|Overall Study||15||
48149245|NCT01688466|100688655|FG001|COMPLETED|Overall Study||10||
48149246|NCT01688466|100688654|FG000|NOT COMPLETED|Overall Study||2||
48149247|NCT01688466|100688655|FG001|NOT COMPLETED|Overall Study||7||
48149248|NCT00319748|100688656|FG000|STARTED|Overall Study||13||
48149249|NCT00319748|100688656|FG000|COMPLETED|Overall Study||13||
48405985|NCT02244619|101325393|FG001|NOT COMPLETED|Overall Study||21||
48606649|NCT04274075|101823349|FG001|STARTED|Overall Study||3||
48606650|NCT04274075|101823350|FG002|STARTED|Overall Study||3||
48606651|NCT04274075|101823351|FG003|STARTED|Overall Study||3||
48606652|NCT04274075|101823352|FG004|STARTED|Overall Study||3||
48606653|NCT04274075|101823353|FG005|STARTED|Overall Study||3||
48716676|NCT02598128|102091942|FG003|NOT COMPLETED|Period B: Days 1 to 11||0||
48149250|NCT00319748|100688656|FG000|NOT COMPLETED|Overall Study||0||
48149251|NCT03945188|100688657|FG000|STARTED|Overall Study||289||
48149252|NCT03945188|100688658|FG001|STARTED|Overall Study||144||
48149253|NCT03945188|100688657|FG000|COMPLETED|Overall Study||161||
48149254|NCT03945188|100688658|FG001|COMPLETED|Overall Study||46||
48149255|NCT03945188|100688657|FG000|NOT COMPLETED|Overall Study||128||
48149256|NCT03945188|100688658|FG001|NOT COMPLETED|Overall Study||98||
48149257|NCT03156660|100688659|FG000|STARTED|Overall Study||109||
48149258|NCT03156660|100688660|FG001|STARTED|Overall Study||110||
48716677|NCT02598128|102091939|FG000|STARTED|Period C: Days 12 to 20||0||
48149259|NCT03156660|100688661|FG002|STARTED|Overall Study||86||
48149260|NCT03156660|100688659|FG000|COMPLETED|Overall Study||95||
48149261|NCT03156660|100688660|FG001|COMPLETED|Overall Study||100||
48149262|NCT03156660|100688661|FG002|COMPLETED|Overall Study||78||
48149263|NCT03156660|100688659|FG000|NOT COMPLETED|Overall Study||14||
48149264|NCT03156660|100688660|FG001|NOT COMPLETED|Overall Study||10||
48149265|NCT03156660|100688661|FG002|NOT COMPLETED|Overall Study||8||
48149266|NCT02044991|100688662|FG000|STARTED|Overall Study||2||
48149267|NCT02044991|100688663|FG001|STARTED|Overall Study||0||
48149268|NCT02044991|100688662|FG000|COMPLETED|Overall Study||2||
48716678|NCT02598128|102091940|FG001|STARTED|Period C: Days 12 to 20||0||
48716679|NCT02598128|102091941|FG002|STARTED|Period C: Days 12 to 20||0||
48716680|NCT02598128|102091942|FG003|STARTED|Period C: Days 12 to 20||33||
48716681|NCT02598128|102091939|FG000|COMPLETED|Period C: Days 12 to 20||0||
48716682|NCT02598128|102091940|FG001|COMPLETED|Period C: Days 12 to 20||0||
48716683|NCT02598128|102091941|FG002|COMPLETED|Period C: Days 12 to 20||0||
48149269|NCT02044991|100688663|FG001|COMPLETED|Overall Study||0||
48149270|NCT02044991|100688662|FG000|NOT COMPLETED|Overall Study||0||
48149271|NCT02044991|100688663|FG001|NOT COMPLETED|Overall Study||0||
48149272|NCT00530855|100688664|FG000|STARTED|Overall Study||322||
48149273|NCT00530855|100688664|FG000|COMPLETED|Overall Study||210||
48149274|NCT00530855|100688664|FG000|NOT COMPLETED|Overall Study||112||
48149275|NCT00645164|100688665|FG000|STARTED|Overall Study||59||
48149276|NCT00645164|100688665|FG000|COMPLETED|Overall Study||52||
48149277|NCT00645164|100688665|FG000|NOT COMPLETED|Overall Study||7||
48149278|NCT00952822|100688666|FG000|STARTED|1st Pharmacokinetic Evaluation||9||
48149279|NCT00952822|100688667|FG001|STARTED|1st Pharmacokinetic Evaluation||18||
48149280|NCT00952822|100688668|FG002|STARTED|1st Pharmacokinetic Evaluation||11||
48149281|NCT00952822|100688669|FG003|STARTED|1st Pharmacokinetic Evaluation||4||
48149282|NCT00952822|100688666|FG000|COMPLETED|1st Pharmacokinetic Evaluation||9||
48149283|NCT00952822|100688667|FG001|COMPLETED|1st Pharmacokinetic Evaluation||17||
48149284|NCT00952822|100688668|FG002|COMPLETED|1st Pharmacokinetic Evaluation||11||
48606654|NCT04274075|101823348|FG000|Completed Treatment Period 1 (9 Days)|Overall Study||3||
48606655|NCT04274075|101823349|FG001|Completed Treatment Period 1 (9 Days)|Overall Study||3||
48606656|NCT04274075|101823350|FG002|Completed Treatment Period 1 (9 Days)|Overall Study||3||
48606657|NCT04274075|101823351|FG003|Completed Treatment Period 1 (9 Days)|Overall Study||3||
48606658|NCT04274075|101823352|FG004|Completed Treatment Period 1 (9 Days)|Overall Study||3||
48606659|NCT04274075|101823353|FG005|Completed Treatment Period 1 (9 Days)|Overall Study||3||
48606660|NCT04274075|101823348|FG000|Completed Treatment Period 2 (9 Days)|Overall Study||3||
48606661|NCT04274075|101823349|FG001|Completed Treatment Period 2 (9 Days)|Overall Study||3||
48606662|NCT04274075|101823350|FG002|Completed Treatment Period 2 (9 Days)|Overall Study||3||
48606663|NCT04274075|101823351|FG003|Completed Treatment Period 2 (9 Days)|Overall Study||3||
48606664|NCT04274075|101823352|FG004|Completed Treatment Period 2 (9 Days)|Overall Study||3||
48716684|NCT02598128|102091942|FG003|COMPLETED|Period C: Days 12 to 20||33||
48149285|NCT00952822|100688669|FG003|COMPLETED|1st Pharmacokinetic Evaluation||4||
48149286|NCT00952822|100688666|FG000|NOT COMPLETED|1st Pharmacokinetic Evaluation||0||
48149287|NCT00952822|100688667|FG001|NOT COMPLETED|1st Pharmacokinetic Evaluation||1||
48149288|NCT00952822|100688668|FG002|NOT COMPLETED|1st Pharmacokinetic Evaluation||0||
48149289|NCT00952822|100688669|FG003|NOT COMPLETED|1st Pharmacokinetic Evaluation||0||
48149290|NCT00952822|100688666|FG000|STARTED|2nd Pharmacokinetic Evaluation||9||
48716685|NCT02598128|102091939|FG000|NOT COMPLETED|Period C: Days 12 to 20||0||
48716686|NCT02598128|102091940|FG001|NOT COMPLETED|Period C: Days 12 to 20||0||
48149291|NCT00952822|100688667|FG001|STARTED|2nd Pharmacokinetic Evaluation||17||
48149292|NCT00952822|100688668|FG002|STARTED|2nd Pharmacokinetic Evaluation||11||
48149293|NCT00952822|100688669|FG003|STARTED|2nd Pharmacokinetic Evaluation||4||
48149294|NCT00952822|100688666|FG000|COMPLETED|2nd Pharmacokinetic Evaluation||9||
48716687|NCT02598128|102091941|FG002|NOT COMPLETED|Period C: Days 12 to 20||0||
48716688|NCT02598128|102091942|FG003|NOT COMPLETED|Period C: Days 12 to 20||0||
48716689|NCT02403895|102091943|FG000|STARTED|Overall Study||11||
48716690|NCT02403895|102091943|FG000|COMPLETED|Overall Study||11||
48716691|NCT02403895|102091943|FG000|NOT COMPLETED|Overall Study||0||
48716692|NCT01299571|102091944|FG000|STARTED|Overall Study||3977||
48149295|NCT00952822|100688667|FG001|COMPLETED|2nd Pharmacokinetic Evaluation||17||
48149296|NCT00952822|100688668|FG002|COMPLETED|2nd Pharmacokinetic Evaluation||10||
48149297|NCT00952822|100688669|FG003|COMPLETED|2nd Pharmacokinetic Evaluation||4||
48149298|NCT00952822|100688666|FG000|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0||
48149299|NCT00952822|100688667|FG001|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0||
48149300|NCT00952822|100688668|FG002|NOT COMPLETED|2nd Pharmacokinetic Evaluation||1||
48149301|NCT00952822|100688669|FG003|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0||
48149302|NCT01420848|100688670|FG000|STARTED|Overall Study||24||
48149303|NCT01420848|100688671|FG001|STARTED|Overall Study||25||
48149304|NCT01420848|100688672|FG002|STARTED|Overall Study||22||
48149305|NCT01420848|100688670|FG000|COMPLETED|Overall Study||24||
48149306|NCT01420848|100688671|FG001|COMPLETED|Overall Study||25||
48149307|NCT01420848|100688672|FG002|COMPLETED|Overall Study||22||
48149308|NCT01420848|100688670|FG000|NOT COMPLETED|Overall Study||0||
48149309|NCT01420848|100688671|FG001|NOT COMPLETED|Overall Study||0||
48149310|NCT01420848|100688672|FG002|NOT COMPLETED|Overall Study||0||
48149311|NCT03531320|100688673|FG000|STARTED|Overall Study||4||
48149312|NCT03531320|100688674|FG001|STARTED|Overall Study||3||
48149313|NCT03531320|100688675|FG002|STARTED|Overall Study||3||
48149314|NCT03531320|100688676|FG003|STARTED|Overall Study||6||
48149315|NCT03531320|100688677|FG004|STARTED|Overall Study||3||
48149316|NCT03531320|100688673|FG000|COMPLETED|Overall Study||3||
48149317|NCT03531320|100688674|FG001|COMPLETED|Overall Study||3||
48149318|NCT03531320|100688675|FG002|COMPLETED|Overall Study||3||
48149319|NCT03531320|100688676|FG003|COMPLETED|Overall Study||6||
48149320|NCT03531320|100688677|FG004|COMPLETED|Overall Study||3||
48149321|NCT03531320|100688673|FG000|NOT COMPLETED|Overall Study||1||
48149322|NCT03531320|100688674|FG001|NOT COMPLETED|Overall Study||0||
48149323|NCT03531320|100688675|FG002|NOT COMPLETED|Overall Study||0||
48149324|NCT03531320|100688676|FG003|NOT COMPLETED|Overall Study||0||
48149325|NCT03531320|100688677|FG004|NOT COMPLETED|Overall Study||0||
48149326|NCT00683644|100688678|FG000|STARTED|Overall Study||58||
48149327|NCT00683644|100688679|FG001|STARTED|Overall Study||58||
48149328|NCT00683644|100688678|FG000|COMPLETED|Overall Study||45||
48149329|NCT00683644|100688679|FG001|COMPLETED|Overall Study||44||
48149330|NCT00683644|100688678|FG000|NOT COMPLETED|Overall Study||13||
48149331|NCT00683644|100688679|FG001|NOT COMPLETED|Overall Study||14||
48149332|NCT02822222|100688680|FG000|STARTED|Overall Study||16|Number started means number randomized to treatment at Day 4.|
48149333|NCT02822222|100688681|FG001|STARTED|Overall Study||6|Number started means number randomized to treatment at Day 4.|
48149334|NCT02822222|100688680|FG000|COMPLETED|Overall Study||15||
48149335|NCT02822222|100688681|FG001|COMPLETED|Overall Study||6||
48149336|NCT02822222|100688680|FG000|NOT COMPLETED|Overall Study||1||
48149337|NCT02822222|100688681|FG001|NOT COMPLETED|Overall Study||0||
48149338|NCT00825266|100688682|FG000|STARTED|Overall Study||1||
48149339|NCT00825266|100688683|FG001|STARTED|Overall Study||1||
48149340|NCT00825266|100688682|FG000|COMPLETED|Overall Study||1||
48149341|NCT00825266|100688683|FG001|COMPLETED|Overall Study||1||
48149342|NCT00825266|100688682|FG000|NOT COMPLETED|Overall Study||0||
48149343|NCT00825266|100688683|FG001|NOT COMPLETED|Overall Study||0||
48149344|NCT00381966|100688684|FG000|STARTED|Overall Study||5||
48149345|NCT00381966|100688684|FG000|COMPLETED|Overall Study||5||
48149346|NCT00381966|100688684|FG000|NOT COMPLETED|Overall Study||0||
48149347|NCT02985866|100688685|FG000|STARTED|Overall Study||65||
48149348|NCT02985866|100688686|FG001|STARTED|Overall Study||62||
48606665|NCT04274075|101823353|FG005|Completed Treatment Period 2 (9 Days)|Overall Study||3||
48606666|NCT04274075|101823348|FG000|Completed Treatment Period 3 (9 Days)|Overall Study||3||
48149349|NCT02985866|100688685|FG000|COMPLETED|Overall Study||64||
48149350|NCT02985866|100688686|FG001|COMPLETED|Overall Study||61||
48149351|NCT02985866|100688685|FG000|NOT COMPLETED|Overall Study||1||
48149352|NCT02985866|100688686|FG001|NOT COMPLETED|Overall Study||1||
48149353|NCT02723864|100688687|FG000|STARTED|Overall Study||3||
48149354|NCT02723864|100688688|FG001|STARTED|Overall Study||3||
48149355|NCT02723864|100688689|FG002|STARTED|Overall Study||6||
48149356|NCT02723864|100688690|FG003|STARTED|Overall Study||7||
48149357|NCT02723864|100688691|FG004|STARTED|Overall Study||3||
48149358|NCT02723864|100688692|FG005|STARTED|Overall Study||25||
48149359|NCT02723864|100688693|FG006|STARTED|Overall Study||6||
48149360|NCT02723864|100688687|FG000|COMPLETED|Overall Study||2||
48149361|NCT02723864|100688688|FG001|COMPLETED|Overall Study||2||
48149362|NCT02723864|100688689|FG002|COMPLETED|Overall Study||5||
48149363|NCT02723864|100688690|FG003|COMPLETED|Overall Study||7||
48149364|NCT02723864|100688691|FG004|COMPLETED|Overall Study||2||
48149365|NCT02723864|100688692|FG005|COMPLETED|Overall Study||14||
48149366|NCT02723864|100688693|FG006|COMPLETED|Overall Study||4||
48149367|NCT02723864|100688687|FG000|NOT COMPLETED|Overall Study||1||
48149368|NCT02723864|100688688|FG001|NOT COMPLETED|Overall Study||1||
48149369|NCT02723864|100688689|FG002|NOT COMPLETED|Overall Study||1||
48149370|NCT02723864|100688690|FG003|NOT COMPLETED|Overall Study||0||
48149371|NCT02723864|100688691|FG004|NOT COMPLETED|Overall Study||1||
48149372|NCT02723864|100688692|FG005|NOT COMPLETED|Overall Study||11||
48149373|NCT02723864|100688693|FG006|NOT COMPLETED|Overall Study||2||
48149374|NCT02925676|100688694|FG000|STARTED|Overall Study||8||
48149375|NCT02925676|100688694|FG000|COMPLETED|Overall Study||7||
48149376|NCT02925676|100688694|FG000|NOT COMPLETED|Overall Study||1||
48149377|NCT03910413|100688695|FG000|STARTED|Overall Study||11||
48149378|NCT03910413|100688695|FG000|COMPLETED|Overall Study||6||
48149379|NCT03910413|100688695|FG000|NOT COMPLETED|Overall Study||5||
48149380|NCT01093612|100688696|FG000|STARTED|Overall Study||11||
48149381|NCT01093612|100688697|FG001|STARTED|Overall Study||7||
48149382|NCT01093612|100688696|FG000|COMPLETED|Overall Study||11||
48149383|NCT01093612|100688697|FG001|COMPLETED|Overall Study||7||
48149384|NCT01093612|100688696|FG000|NOT COMPLETED|Overall Study||0||
48149385|NCT01093612|100688697|FG001|NOT COMPLETED|Overall Study||0||
48149386|NCT04171102|100688698|FG000|STARTED|Overall Study||4||
48149387|NCT04171102|100688699|FG001|STARTED|Overall Study||5||
48149388|NCT04171102|100688700|FG002|STARTED|Overall Study||6||
48149389|NCT04171102|100688698|FG000|COMPLETED|Overall Study||4||
48149390|NCT04171102|100688699|FG001|COMPLETED|Overall Study||5||
48149391|NCT04171102|100688700|FG002|COMPLETED|Overall Study||6||
48149392|NCT04171102|100688698|FG000|NOT COMPLETED|Overall Study||0||
48149393|NCT04171102|100688699|FG001|NOT COMPLETED|Overall Study||0||
48149394|NCT04171102|100688700|FG002|NOT COMPLETED|Overall Study||0||
48149395|NCT01813474|100688701|FG000|STARTED|Overall Study||4||
48149396|NCT01813474|100688702|FG001|STARTED|Overall Study||7||
48149397|NCT01813474|100688703|FG002|STARTED|Overall Study||12||
48149398|NCT01813474|100688701|FG000|COMPLETED|Overall Study||1||
48149399|NCT01813474|100688702|FG001|COMPLETED|Overall Study||0||
48149400|NCT01813474|100688703|FG002|COMPLETED|Overall Study||1||
48149401|NCT01813474|100688701|FG000|NOT COMPLETED|Overall Study||3||
48149402|NCT01813474|100688702|FG001|NOT COMPLETED|Overall Study||7||
48149403|NCT01813474|100688703|FG002|NOT COMPLETED|Overall Study||11||
48149404|NCT01281644|100688704|FG000|STARTED|Overall Study||23||
48149405|NCT01281644|100688704|FG000|COMPLETED|Overall Study||18||
48149406|NCT01281644|100688704|FG000|NOT COMPLETED|Overall Study||5||
48149407|NCT01515748|100688705|FG000|STARTED|Overall Study||264|Randomized|
48149408|NCT01515748|100688706|FG001|STARTED|Overall Study||266|Randomized|
48149409|NCT01515748|100688705|FG000|Treated|Overall Study||195||
48149410|NCT01515748|100688706|FG001|Treated|Overall Study||241||
48149411|NCT01515748|100688705|FG000|COMPLETED|Overall Study||225||
48149412|NCT01515748|100688706|FG001|COMPLETED|Overall Study||211||
48303917|NCT01717768|101072878|FG005|NOT COMPLETED|Part 2 (Duration of 15 Days)||0||
48303918|NCT01717768|101072879|FG006|NOT COMPLETED|Part 2 (Duration of 15 Days)||0||
48303919|NCT01717768|101072880|FG007|NOT COMPLETED|Part 2 (Duration of 15 Days)||0||
48303920|NCT01717768|101072881|FG008|NOT COMPLETED|Part 2 (Duration of 15 Days)||0||
48149413|NCT01515748|100688705|FG000|NOT COMPLETED|Overall Study||39||
48149414|NCT01515748|100688706|FG001|NOT COMPLETED|Overall Study||55||
48303921|NCT01717768|101072882|FG009|NOT COMPLETED|Part 2 (Duration of 15 Days)||0||
48303922|NCT01717768|101072883|FG010|NOT COMPLETED|Part 2 (Duration of 15 Days)||0||
48303923|NCT01717768|101072884|FG011|NOT COMPLETED|Part 2 (Duration of 15 Days)||0||
48303924|NCT01717768|101072873|FG000|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
48303925|NCT01717768|101072874|FG001|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
48303926|NCT01717768|101072875|FG002|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
48303927|NCT01717768|101072876|FG003|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||4||
48405986|NCT02940860|101325394|FG000|STARTED|Overall Study||1027||
48405987|NCT02940860|101325395|FG001|STARTED|Overall Study||511||
48405988|NCT02940860|101325394|FG000|COMPLETED|Overall Study||971||
48149415|NCT02943408|100688707|FG000|STARTED|Overall Study||24||
48149416|NCT02943408|100688708|FG001|STARTED|Overall Study||24||
48149417|NCT02943408|100688707|FG000|Baseline|Overall Study||24||
48149418|NCT02943408|100688708|FG001|Baseline|Overall Study||23||
48149419|NCT02943408|100688707|FG000|Time Point 2 : 4-7 Weeks Post Baseline|Overall Study||21||
48149420|NCT02943408|100688708|FG001|Time Point 2 : 4-7 Weeks Post Baseline|Overall Study||19||
48149421|NCT02943408|100688707|FG000|Time Point 3: 3 Months Post Time Point 2|Overall Study||21||
48149422|NCT02943408|100688708|FG001|Time Point 3: 3 Months Post Time Point 2|Overall Study||22||
48149423|NCT02943408|100688707|FG000|COMPLETED|Overall Study||17||
48149424|NCT02943408|100688708|FG001|COMPLETED|Overall Study||22||
48149425|NCT02943408|100688707|FG000|NOT COMPLETED|Overall Study||7||
48149426|NCT02943408|100688708|FG001|NOT COMPLETED|Overall Study||2||
48149427|NCT00240487|100688709|FG000|STARTED|Overall Study||24||
48149428|NCT00240487|100688710|FG001|STARTED|Overall Study||28||
48149429|NCT00240487|100688709|FG000|COMPLETED|Overall Study||24||
48303928|NCT01717768|101072877|FG004|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5||
48303929|NCT01717768|101072878|FG005|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5||
48606667|NCT04274075|101823349|FG001|Completed Treatment Period 3 (9 Days)|Overall Study||3||
48303930|NCT01717768|101072879|FG006|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
48303931|NCT01717768|101072880|FG007|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
48303932|NCT01717768|101072881|FG008|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
48303933|NCT01717768|101072882|FG009|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
48303934|NCT01717768|101072883|FG010|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
48303935|NCT01717768|101072884|FG011|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
48303936|NCT01717768|101072873|FG000|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
48303937|NCT01717768|101072874|FG001|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
48303938|NCT01717768|101072875|FG002|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
48303939|NCT01717768|101072876|FG003|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||4||
48303940|NCT01717768|101072877|FG004|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5||
48303941|NCT01717768|101072878|FG005|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5||
48303942|NCT01717768|101072879|FG006|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
48303943|NCT01717768|101072880|FG007|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
48303944|NCT01717768|101072881|FG008|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
48303945|NCT01717768|101072882|FG009|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
48303946|NCT01717768|101072883|FG010|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
48303947|NCT01717768|101072884|FG011|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
48303948|NCT01717768|101072873|FG000|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
48303949|NCT01717768|101072874|FG001|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
48303950|NCT01717768|101072875|FG002|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
48303951|NCT01717768|101072876|FG003|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
48303952|NCT01717768|101072877|FG004|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
48303953|NCT01717768|101072878|FG005|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
48303954|NCT01717768|101072879|FG006|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
48303955|NCT01717768|101072880|FG007|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
48303956|NCT01717768|101072881|FG008|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
48303957|NCT01717768|101072882|FG009|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
48303958|NCT01717768|101072883|FG010|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
48303959|NCT01717768|101072884|FG011|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
48303960|NCT01717768|101072873|FG000|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
48303961|NCT01717768|101072874|FG001|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
48303962|NCT01717768|101072875|FG002|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
48303963|NCT01717768|101072876|FG003|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||4||
48303964|NCT01717768|101072877|FG004|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5||
48303965|NCT01717768|101072878|FG005|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5||
48303966|NCT01717768|101072879|FG006|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
48303967|NCT01717768|101072880|FG007|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
48303968|NCT01717768|101072881|FG008|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
48303969|NCT01717768|101072882|FG009|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
48303970|NCT01717768|101072883|FG010|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
48303971|NCT01717768|101072884|FG011|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
48303972|NCT01717768|101072873|FG000|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
48303973|NCT01717768|101072874|FG001|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
48303974|NCT01717768|101072875|FG002|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
48303975|NCT01717768|101072876|FG003|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||4||
48303976|NCT01717768|101072877|FG004|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5||
48303977|NCT01717768|101072878|FG005|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5||
48303978|NCT01717768|101072879|FG006|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
48303979|NCT01717768|101072880|FG007|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
48303980|NCT01717768|101072881|FG008|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
48303981|NCT01717768|101072882|FG009|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
48303982|NCT01717768|101072883|FG010|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
48303983|NCT01717768|101072884|FG011|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
48303984|NCT01717768|101072873|FG000|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
48303985|NCT01717768|101072874|FG001|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
48303986|NCT01717768|101072875|FG002|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
48303987|NCT01717768|101072876|FG003|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
48303988|NCT01717768|101072877|FG004|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
48303989|NCT01717768|101072878|FG005|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
48303990|NCT01717768|101072879|FG006|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
48303991|NCT01717768|101072880|FG007|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
48303992|NCT01717768|101072881|FG008|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
48303993|NCT01717768|101072882|FG009|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
48303994|NCT01717768|101072883|FG010|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
48303995|NCT01717768|101072884|FG011|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
48303996|NCT01717768|101072873|FG000|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
48303997|NCT01717768|101072874|FG001|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
48303998|NCT01717768|101072875|FG002|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
48303999|NCT01717768|101072876|FG003|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||4||
48405989|NCT02940860|101325395|FG001|COMPLETED|Overall Study||476||
48405990|NCT02940860|101325394|FG000|NOT COMPLETED|Overall Study||56||
48405991|NCT02940860|101325395|FG001|NOT COMPLETED|Overall Study||35||
48405992|NCT02972593|101325396|FG000|STARTED|Overall Study||50||
48149430|NCT00240487|100688710|FG001|COMPLETED|Overall Study||28||
48149431|NCT00240487|100688709|FG000|NOT COMPLETED|Overall Study||0||
48149432|NCT00240487|100688710|FG001|NOT COMPLETED|Overall Study||0||
48149433|NCT00852631|100688711|FG000|STARTED|Overall Study||28||
48149434|NCT00852631|100688711|FG000|COMPLETED|Overall Study||17||
48149435|NCT00852631|100688711|FG000|NOT COMPLETED|Overall Study||11||
48149436|NCT01218126|100688712|FG000|STARTED|Overall Study||153||
48304000|NCT01717768|101072877|FG004|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5||
48304001|NCT01717768|101072878|FG005|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5||
48304002|NCT01717768|101072879|FG006|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
48304003|NCT01717768|101072880|FG007|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
48149437|NCT01218126|100688713|FG001|STARTED|Overall Study||149||
48149438|NCT01218126|100688714|FG002|STARTED|Overall Study||151||
48304004|NCT01717768|101072881|FG008|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
48304005|NCT01717768|101072882|FG009|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
48304006|NCT01717768|101072883|FG010|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
48304007|NCT01717768|101072884|FG011|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
48304008|NCT01717768|101072873|FG000|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
48304009|NCT01717768|101072874|FG001|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
48304010|NCT01717768|101072875|FG002|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
48304011|NCT01717768|101072876|FG003|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||4||
48716693|NCT01299571|102091944|FG000|COMPLETED|Overall Study||3870||
48716694|NCT01299571|102091944|FG000|NOT COMPLETED|Overall Study||107||
48716695|NCT01595581|102091945|FG000|STARTED|Overall Study||7||
48716696|NCT01595581|102091946|FG001|STARTED|Overall Study||7||
48716697|NCT01595581|102091945|FG000|COMPLETED|Overall Study||6||
48716698|NCT01595581|102091946|FG001|COMPLETED|Overall Study||7||
48716699|NCT01595581|102091945|FG000|NOT COMPLETED|Overall Study||1||
48304012|NCT01717768|101072877|FG004|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5||
48304013|NCT01717768|101072878|FG005|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5||
48304014|NCT01717768|101072879|FG006|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
48304015|NCT01717768|101072880|FG007|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
48304016|NCT01717768|101072881|FG008|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
48304017|NCT01717768|101072882|FG009|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
48716700|NCT01595581|102091946|FG001|NOT COMPLETED|Overall Study||0||
48716701|NCT02360293|102091947|FG000|STARTED|Overall Study||178||
48716702|NCT02360293|102091948|FG001|STARTED|Overall Study||179||
48716703|NCT02360293|102091947|FG000|6month f/u Survey|Overall Study||110||
48716704|NCT02360293|102091948|FG001|6month f/u Survey|Overall Study||105||
48716705|NCT02360293|102091947|FG000|6month Physical Activity|Overall Study||122||
48304018|NCT01717768|101072883|FG010|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
48304019|NCT01717768|101072884|FG011|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
48304020|NCT01717768|101072873|FG000|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
48716706|NCT02360293|102091948|FG001|6month Physical Activity|Overall Study||108||
48716707|NCT02360293|102091947|FG000|12month f/u Survey|Overall Study||102||
48716708|NCT02360293|102091948|FG001|12month f/u Survey|Overall Study||83||
48716709|NCT02360293|102091947|FG000|12month Physical Activity|Overall Study||68||
48716710|NCT02360293|102091948|FG001|12month Physical Activity|Overall Study||59||
48716711|NCT02360293|102091947|FG000|COMPLETED|Overall Study||102||
48716712|NCT02360293|102091948|FG001|COMPLETED|Overall Study||83||
48716713|NCT02360293|102091947|FG000|NOT COMPLETED|Overall Study||76||
48716714|NCT02360293|102091948|FG001|NOT COMPLETED|Overall Study||96||
48716715|NCT00657150|102091949|FG000|STARTED|Overall Study||1010||
48716716|NCT00657150|102091950|FG001|STARTED|Overall Study||1003||
48716717|NCT00657150|102091949|FG000|COMPLETED|Overall Study||895||
48304021|NCT01717768|101072874|FG001|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
48304022|NCT01717768|101072875|FG002|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
48716718|NCT00657150|102091950|FG001|COMPLETED|Overall Study||910||
48716719|NCT00657150|102091949|FG000|NOT COMPLETED|Overall Study||115||
48716720|NCT00657150|102091950|FG001|NOT COMPLETED|Overall Study||93||
48716721|NCT00657150|102091949|FG000|STARTED|Treatment||1010||
48716722|NCT00657150|102091950|FG001|STARTED|Treatment||1003||
48716723|NCT00657150|102091949|FG000|COMPLETED|Treatment||903||
48716724|NCT00657150|102091950|FG001|COMPLETED|Treatment||906||
48716725|NCT00657150|102091949|FG000|NOT COMPLETED|Treatment||107||
48716726|NCT00657150|102091950|FG001|NOT COMPLETED|Treatment||97||
48716727|NCT02776033|102091951|FG000|STARTED|Overall Study||18||
48304023|NCT01717768|101072876|FG003|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
48304024|NCT01717768|101072877|FG004|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
48304025|NCT01717768|101072878|FG005|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
48304026|NCT01717768|101072879|FG006|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
48304027|NCT01717768|101072880|FG007|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
48304028|NCT01717768|101072881|FG008|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
48304029|NCT01717768|101072882|FG009|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
48304030|NCT01717768|101072883|FG010|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
48716728|NCT02776033|102091952|FG001|STARTED|Overall Study||23||
48716729|NCT02776033|102091953|FG002|STARTED|Overall Study||24||
48716730|NCT02776033|102091951|FG000|COMPLETED|Overall Study||14||
48716731|NCT02776033|102091952|FG001|COMPLETED|Overall Study||21||
48716732|NCT02776033|102091953|FG002|COMPLETED|Overall Study||22||
48716733|NCT02776033|102091951|FG000|NOT COMPLETED|Overall Study||4||
48716734|NCT02776033|102091952|FG001|NOT COMPLETED|Overall Study||2||
48304031|NCT01717768|101072884|FG011|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
48304032|NCT01717768|101072873|FG000|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0||
48304033|NCT01717768|101072874|FG001|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0||
48304034|NCT01717768|101072875|FG002|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0||
48304035|NCT01717768|101072876|FG003|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0||
48304036|NCT01717768|101072877|FG004|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0||
48304037|NCT01717768|101072878|FG005|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0||
48304038|NCT01717768|101072879|FG006|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||17||
48304039|NCT01717768|101072880|FG007|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0||
48304040|NCT01717768|101072881|FG008|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16||
48304041|NCT01717768|101072882|FG009|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0||
48304042|NCT01717768|101072883|FG010|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16||
48304043|NCT01717768|101072884|FG011|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16||
48304044|NCT01717768|101072873|FG000|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
48304045|NCT01717768|101072874|FG001|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
48304046|NCT01717768|101072875|FG002|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
48304047|NCT01717768|101072876|FG003|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
48304048|NCT01717768|101072877|FG004|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
48304049|NCT01717768|101072878|FG005|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
48304050|NCT01717768|101072879|FG006|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||17||
48304051|NCT01717768|101072880|FG007|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
48304052|NCT01717768|101072881|FG008|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16||
48304053|NCT01717768|101072882|FG009|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
48304054|NCT01717768|101072883|FG010|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16||
48304055|NCT01717768|101072884|FG011|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||15||
48304056|NCT01717768|101072873|FG000|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
48304057|NCT01717768|101072874|FG001|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
48304058|NCT01717768|101072875|FG002|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
48304059|NCT01717768|101072876|FG003|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
48304060|NCT01717768|101072877|FG004|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
48304061|NCT01717768|101072878|FG005|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
48304062|NCT01717768|101072879|FG006|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
48304063|NCT01717768|101072880|FG007|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
48304064|NCT01717768|101072881|FG008|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
48304065|NCT01717768|101072882|FG009|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
48304066|NCT01717768|101072883|FG010|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
48304067|NCT01717768|101072884|FG011|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||1||
48304068|NCT01717768|101072873|FG000|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0||
48304069|NCT01717768|101072874|FG001|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0||
48304070|NCT01717768|101072875|FG002|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0||
48304071|NCT01717768|101072876|FG003|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0||
48304072|NCT01717768|101072877|FG004|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0||
48304073|NCT01717768|101072878|FG005|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0||
48304074|NCT01717768|101072879|FG006|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0||
48304075|NCT01717768|101072880|FG007|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||17||
48304076|NCT01717768|101072881|FG008|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0||
48304077|NCT01717768|101072882|FG009|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||16||
48304078|NCT01717768|101072883|FG010|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0||
48304079|NCT01717768|101072884|FG011|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0||
48304080|NCT01717768|101072873|FG000|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
48304081|NCT01717768|101072874|FG001|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
48304082|NCT01717768|101072875|FG002|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
48304083|NCT01717768|101072876|FG003|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
48304084|NCT01717768|101072877|FG004|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
48304085|NCT01717768|101072878|FG005|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
48304086|NCT01717768|101072879|FG006|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
48304087|NCT01717768|101072880|FG007|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15||
48405993|NCT02972593|101325397|FG001|STARTED|Overall Study||50||
48405994|NCT02972593|101325396|FG000|COMPLETED|Overall Study||30||
48405995|NCT02972593|101325397|FG001|COMPLETED|Overall Study||35||
48405996|NCT02972593|101325396|FG000|NOT COMPLETED|Overall Study||20||
48405997|NCT02972593|101325397|FG001|NOT COMPLETED|Overall Study||15||
48405998|NCT00118404|101325398|FG000|STARTED|Overall Study||86||
48405999|NCT00118404|101325399|FG001|STARTED|Overall Study||86||
48406000|NCT00118404|101325400|FG002|STARTED|Overall Study||69||
48406001|NCT00118404|101325398|FG000|COMPLETED|Overall Study||62||
48406002|NCT00118404|101325399|FG001|COMPLETED|Overall Study||70||
48406003|NCT00118404|101325400|FG002|COMPLETED|Overall Study||49||
48406004|NCT00118404|101325398|FG000|NOT COMPLETED|Overall Study||24||
48406005|NCT00118404|101325399|FG001|NOT COMPLETED|Overall Study||16||
48406006|NCT00118404|101325400|FG002|NOT COMPLETED|Overall Study||20||
48406007|NCT00616772|101325401|FG000|STARTED|Overall Study||340||
48406008|NCT00616772|101325402|FG001|STARTED|Overall Study||342||
48406009|NCT00616772|101325401|FG000|Treated|Overall Study||337||
48406010|NCT00616772|101325402|FG001|Treated|Overall Study||339||
48406011|NCT00616772|101325401|FG000|COMPLETED|Overall Study||225||
48406012|NCT00616772|101325402|FG001|COMPLETED|Overall Study||240||
48406013|NCT00616772|101325401|FG000|NOT COMPLETED|Overall Study||115||
48406014|NCT00616772|101325402|FG001|NOT COMPLETED|Overall Study||102||
48406015|NCT04095793|101325403|FG000|STARTED|Overall Study||110||
48406016|NCT04095793|101325403|FG000|COMPLETED|Overall Study||0||
48406017|NCT04095793|101325403|FG000|NOT COMPLETED|Overall Study||110||
48406018|NCT02564068|101325404|FG000|STARTED|Overall Study||8||
48406019|NCT02564068|101325404|FG000|COMPLETED|Overall Study||8||
48406020|NCT02564068|101325404|FG000|NOT COMPLETED|Overall Study||0||
48406021|NCT03006926|101325405|FG000|STARTED|Overall Study||6||
48406022|NCT03006926|101325406|FG001|STARTED|Overall Study||98||
48406023|NCT03006926|101325405|FG000|Japanese Population|Overall Study||6||
48406024|NCT03006926|101325406|FG001|Japanese Population|Overall Study||16||
48406025|NCT03006926|101325405|FG000|Non-Japanese Population|Overall Study||0||
48406026|NCT03006926|101325406|FG001|Non-Japanese Population|Overall Study||82||
48406027|NCT03006926|101325405|FG000|COMPLETED|Overall Study||6||
48406028|NCT03006926|101325406|FG001|COMPLETED|Overall Study||0||
48406029|NCT03006926|101325405|FG000|NOT COMPLETED|Overall Study||0||
48406030|NCT03006926|101325406|FG001|NOT COMPLETED|Overall Study||98||
48406031|NCT01235507|101325407|FG000|STARTED|Overall Study||71||
48406032|NCT01235507|101325407|FG000|COMPLETED|Overall Study||69||
48406033|NCT01235507|101325407|FG000|NOT COMPLETED|Overall Study||2||
48406034|NCT00441012|101325408|FG000|STARTED|Overall Study||270||
48406035|NCT00441012|101325409|FG001|STARTED|Overall Study||276||
48406036|NCT00441012|101325408|FG000|Vaccination Visit 1|Overall Study||269||
48406037|NCT00441012|101325409|FG001|Vaccination Visit 1|Overall Study||276||
48406038|NCT00441012|101325408|FG000|Vaccination Visit 2|Overall Study||267||
48406039|NCT00441012|101325409|FG001|Vaccination Visit 2|Overall Study||272||
48406040|NCT00441012|101325408|FG000|Vaccination Visit 3|Overall Study||265||
48406041|NCT00441012|101325409|FG001|Vaccination Visit 3|Overall Study||269||
48406042|NCT00441012|101325408|FG000|COMPLETED|Overall Study||252||
48406043|NCT00441012|101325409|FG001|COMPLETED|Overall Study||263||
48304088|NCT01717768|101072881|FG008|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
48304089|NCT01717768|101072882|FG009|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15||
48406044|NCT00441012|101325408|FG000|NOT COMPLETED|Overall Study||18||
48406045|NCT00441012|101325409|FG001|NOT COMPLETED|Overall Study||13||
48406046|NCT04067011|101325410|FG000|STARTED|Overall Study||70||
48406047|NCT04067011|101325411|FG001|STARTED|Overall Study||71||
48406048|NCT04067011|101325412|FG002|STARTED|Overall Study||69||
48406049|NCT04067011|101325410|FG000|COMPLETED|Overall Study||51||
48406050|NCT04067011|101325411|FG001|COMPLETED|Overall Study||58||
48406051|NCT04067011|101325412|FG002|COMPLETED|Overall Study||61||
48406052|NCT04067011|101325410|FG000|NOT COMPLETED|Overall Study||19||
48716735|NCT02776033|102091953|FG002|NOT COMPLETED|Overall Study||2||
48716736|NCT04545047|102091954|FG000|STARTED|Overall Study||402||402
48716737|NCT04545047|102091955|FG001|STARTED|Overall Study||4642||10867
48716738|NCT04545047|102091954|FG000|COMPLETED|Overall Study||402||402
48716739|NCT04545047|102091955|FG001|COMPLETED|Overall Study||4642||10867
48716740|NCT04545047|102091954|FG000|NOT COMPLETED|Overall Study||0||0
48716741|NCT04545047|102091955|FG001|NOT COMPLETED|Overall Study||0||0
48716742|NCT02124772|102091956|FG000|STARTED|Overall Study||3||
48716743|NCT02124772|102091957|FG001|STARTED|Overall Study||19||
48716744|NCT02124772|102091958|FG002|STARTED|Overall Study||12||
48716745|NCT02124772|102091959|FG003|STARTED|Overall Study||16||
48716746|NCT02124772|102091960|FG004|STARTED|Overall Study||11||
48716747|NCT02124772|102091961|FG005|STARTED|Overall Study||10||
48716748|NCT02124772|102091962|FG006|STARTED|Overall Study||10||
48716749|NCT02124772|102091963|FG007|STARTED|Overall Study||10||
48716750|NCT02124772|102091964|FG008|STARTED|Overall Study||3||
48716751|NCT02124772|102091965|FG009|STARTED|Overall Study||9||
48716752|NCT02124772|102091966|FG010|STARTED|Overall Study||6||
48716753|NCT02124772|102091967|FG011|STARTED|Overall Study||20||
48716754|NCT02124772|102091968|FG012|STARTED|Overall Study||10||
48716755|NCT02124772|102091956|FG000|COMPLETED|Overall Study||0||
48716756|NCT02124772|102091957|FG001|COMPLETED|Overall Study||5||
48716757|NCT02124772|102091958|FG002|COMPLETED|Overall Study||6||
48716758|NCT02124772|102091959|FG003|COMPLETED|Overall Study||3||
48716759|NCT02124772|102091960|FG004|COMPLETED|Overall Study||2||
48716760|NCT02124772|102091961|FG005|COMPLETED|Overall Study||2||
48716761|NCT02124772|102091962|FG006|COMPLETED|Overall Study||2||
48716762|NCT02124772|102091963|FG007|COMPLETED|Overall Study||1||
48716763|NCT02124772|102091964|FG008|COMPLETED|Overall Study||2||
48716764|NCT02124772|102091965|FG009|COMPLETED|Overall Study||2||
48716765|NCT02124772|102091966|FG010|COMPLETED|Overall Study||4||
48716766|NCT02124772|102091967|FG011|COMPLETED|Overall Study||14||
48716767|NCT02124772|102091968|FG012|COMPLETED|Overall Study||8||
48716768|NCT02124772|102091956|FG000|NOT COMPLETED|Overall Study||3||
48716769|NCT02124772|102091957|FG001|NOT COMPLETED|Overall Study||14||
48716770|NCT02124772|102091958|FG002|NOT COMPLETED|Overall Study||6||
48716771|NCT02124772|102091959|FG003|NOT COMPLETED|Overall Study||13||
48716772|NCT02124772|102091960|FG004|NOT COMPLETED|Overall Study||9||
48716773|NCT02124772|102091961|FG005|NOT COMPLETED|Overall Study||8||
48716774|NCT02124772|102091962|FG006|NOT COMPLETED|Overall Study||8||
48716775|NCT02124772|102091963|FG007|NOT COMPLETED|Overall Study||9||
48716776|NCT02124772|102091964|FG008|NOT COMPLETED|Overall Study||1||
48716777|NCT02124772|102091965|FG009|NOT COMPLETED|Overall Study||7||
48716778|NCT02124772|102091966|FG010|NOT COMPLETED|Overall Study||2||
48304090|NCT01717768|101072883|FG010|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
48304091|NCT01717768|101072884|FG011|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
48304092|NCT01717768|101072873|FG000|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
48304093|NCT01717768|101072874|FG001|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
48304094|NCT01717768|101072875|FG002|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
48304095|NCT01717768|101072876|FG003|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
48304096|NCT01717768|101072877|FG004|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
48304097|NCT01717768|101072878|FG005|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
48304098|NCT01717768|101072879|FG006|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
48304099|NCT01717768|101072880|FG007|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||2||
48304100|NCT01717768|101072881|FG008|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
48304101|NCT01717768|101072882|FG009|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||1||
48304102|NCT01717768|101072883|FG010|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
48368014|NCT03567291|101230095|FG003|Safety Set|Period I||0||
48406053|NCT04067011|101325411|FG001|NOT COMPLETED|Overall Study||13||
48406054|NCT04067011|101325412|FG002|NOT COMPLETED|Overall Study||8||
48406055|NCT02152540|101325413|FG000|STARTED|Overall Study||17||
48406056|NCT02152540|101325414|FG001|STARTED|Overall Study||16||
48406057|NCT02152540|101325413|FG000|COMPLETED|Overall Study||17||
48406058|NCT02152540|101325414|FG001|COMPLETED|Overall Study||16||
48716779|NCT02124772|102091967|FG011|NOT COMPLETED|Overall Study||6||
48716780|NCT02124772|102091968|FG012|NOT COMPLETED|Overall Study||2||
48716781|NCT00831701|102091969|FG000|STARTED|Overall Study||50||
48716782|NCT00831701|102091970|FG001|STARTED|Overall Study||50||
48716783|NCT00831701|102091969|FG000|COMPLETED|Overall Study||45||
48716784|NCT00831701|102091970|FG001|COMPLETED|Overall Study||45||
48606668|NCT04274075|101823350|FG002|Completed Treatment Period 3 (9 Days)|Overall Study||3||
48606669|NCT04274075|101823351|FG003|Completed Treatment Period 3 (9 Days)|Overall Study||3||
48606670|NCT04274075|101823352|FG004|Completed Treatment Period 3 (9 Days)|Overall Study||3||
48149439|NCT01218126|100688715|FG003|STARTED|Overall Study||149||
48606671|NCT04274075|101823353|FG005|Completed Treatment Period 3 (9 Days)|Overall Study||3||
48606672|NCT04274075|101823348|FG000|Completed Follow-up Visit|Overall Study||3|The follow-up visit took place 12 to 14 days after the last dose of study drug.|
48149440|NCT01218126|100688712|FG000|COMPLETED|Overall Study||129||
48716785|NCT00831701|102091969|FG000|NOT COMPLETED|Overall Study||5||
48716786|NCT00831701|102091970|FG001|NOT COMPLETED|Overall Study||5||
48149441|NCT01218126|100688713|FG001|COMPLETED|Overall Study||127||
48149442|NCT01218126|100688714|FG002|COMPLETED|Overall Study||127||
48149443|NCT01218126|100688715|FG003|COMPLETED|Overall Study||114||
48149444|NCT01218126|100688712|FG000|NOT COMPLETED|Overall Study||24||
48149445|NCT01218126|100688713|FG001|NOT COMPLETED|Overall Study||22||
48149446|NCT01218126|100688714|FG002|NOT COMPLETED|Overall Study||24||
48149447|NCT01218126|100688715|FG003|NOT COMPLETED|Overall Study||35||
48149448|NCT02633800|100688716|FG000|STARTED|Overall Study||44||
48149449|NCT02633800|100688717|FG001|STARTED|Overall Study||43||
48149450|NCT02633800|100688716|FG000|COMPLETED|Overall Study||0||
48149451|NCT02633800|100688717|FG001|COMPLETED|Overall Study||0||
48149452|NCT02633800|100688716|FG000|NOT COMPLETED|Overall Study||44||
48149453|NCT02633800|100688717|FG001|NOT COMPLETED|Overall Study||43||
48149454|NCT04295005|100688718|FG000|STARTED|Overall Study||3285||
48149455|NCT04295005|100688719|FG001|STARTED|Overall Study||19433||
48149456|NCT04295005|100688720|FG002|STARTED|Overall Study||1747||
48149457|NCT04295005|100688718|FG000|Patients Who Started a Sitagliptin Therapy|Overall Study||0||
48149458|NCT04295005|100688719|FG001|Patients Who Started a Sitagliptin Therapy|Overall Study||18382||
48149459|NCT04295005|100688720|FG002|Patients Who Started a Sitagliptin Therapy|Overall Study||0||
48149460|NCT04295005|100688718|FG000|COMPLETED|Overall Study||3285||
48149461|NCT04295005|100688719|FG001|COMPLETED|Overall Study||19433||
48149462|NCT04295005|100688720|FG002|COMPLETED|Overall Study||1747||
48149463|NCT04295005|100688718|FG000|NOT COMPLETED|Overall Study||0||
48149464|NCT04295005|100688719|FG001|NOT COMPLETED|Overall Study||0||
48149465|NCT04295005|100688720|FG002|NOT COMPLETED|Overall Study||0||
48149466|NCT01433354|100688721|FG000|STARTED|Overall Study||119||
48149467|NCT01433354|100688721|FG000|COMPLETED|Overall Study||0||
48149468|NCT01433354|100688721|FG000|NOT COMPLETED|Overall Study||119||
48149469|NCT04434560|100688722|FG000|STARTED|Overall Study||1||
48149470|NCT04434560|100688723|FG001|STARTED|Overall Study||0||
48149471|NCT04434560|100688722|FG000|COMPLETED|Overall Study||1||
48149472|NCT04434560|100688723|FG001|COMPLETED|Overall Study||0||
48149473|NCT04434560|100688722|FG000|NOT COMPLETED|Overall Study||0||
48149474|NCT04434560|100688723|FG001|NOT COMPLETED|Overall Study||0||
48149475|NCT04535947|100688724|FG000|STARTED|Overall Study||76||
48149476|NCT04535947|100688725|FG001|STARTED|Overall Study||77||
48149477|NCT04535947|100688724|FG000|COMPLETED|Overall Study||72||
48149478|NCT04535947|100688725|FG001|COMPLETED|Overall Study||72||
48149479|NCT04535947|100688724|FG000|NOT COMPLETED|Overall Study||4||
48149480|NCT04535947|100688725|FG001|NOT COMPLETED|Overall Study||5||
48149481|NCT04843930|100688726|FG000|STARTED|Randomization||55||
48606673|NCT04274075|101823349|FG001|Completed Follow-up Visit|Overall Study||3|The follow-up visit took place 12 to 14 days after the last dose of study drug.|
48606674|NCT04274075|101823350|FG002|Completed Follow-up Visit|Overall Study||3|The follow-up visit took place 12 to 14 days after the last dose of study drug.|
48149482|NCT04843930|100688727|FG001|STARTED|Randomization||55||
48149483|NCT04843930|100688728|FG002|STARTED|Randomization||0||
48149484|NCT04843930|100688729|FG003|STARTED|Randomization||0||
48606675|NCT04274075|101823351|FG003|Completed Follow-up Visit|Overall Study||3|The follow-up visit took place 12 to 14 days after the last dose of study drug.|
48716787|NCT01102894|102091971|FG000|STARTED|Overall Study||10||
48716788|NCT01102894|102091971|FG000|COMPLETED|Overall Study||10||
48716789|NCT01102894|102091971|FG000|NOT COMPLETED|Overall Study||0||
48149485|NCT04843930|100688726|FG000|COMPLETED|Randomization||49||
48606676|NCT04274075|101823352|FG004|Completed Follow-up Visit|Overall Study||3|The follow-up visit took place 12 to 14 days after the last dose of study drug.|
48716790|NCT01739803|102091972|FG000|STARTED|Overall Study||76||
48716791|NCT01739803|102091973|FG001|STARTED|Overall Study||74||
48149486|NCT04843930|100688727|FG001|COMPLETED|Randomization||49||
48149487|NCT04843930|100688728|FG002|COMPLETED|Randomization||0||
48149488|NCT04843930|100688729|FG003|COMPLETED|Randomization||0||
48606677|NCT04274075|101823353|FG005|Completed Follow-up Visit|Overall Study||3|The follow-up visit took place 12 to 14 days after the last dose of study drug.|
48606678|NCT04274075|101823348|FG000|COMPLETED|Overall Study||3||
48606679|NCT04274075|101823349|FG001|COMPLETED|Overall Study||3||
48304103|NCT01717768|101072884|FG011|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
48304104|NCT01179672|101072885|FG000|STARTED|Overall Study||203||
48304105|NCT01179672|101072886|FG001|STARTED|Overall Study||202||
48304106|NCT01179672|101072885|FG000|Received at Least 1 Dose of Study Drug|Overall Study||202||
48304107|NCT01179672|101072886|FG001|Received at Least 1 Dose of Study Drug|Overall Study||202||
48304108|NCT01179672|101072885|FG000|Entered Taper|Overall Study||181||
48304109|NCT01179672|101072886|FG001|Entered Taper|Overall Study||177||
48304110|NCT01179672|101072885|FG000|COMPLETED|Overall Study||173||
48716792|NCT01739803|102091972|FG000|COMPLETED|Overall Study||67||
48716793|NCT01739803|102091973|FG001|COMPLETED|Overall Study||68||
48716794|NCT01739803|102091972|FG000|NOT COMPLETED|Overall Study||9||
48716795|NCT01739803|102091973|FG001|NOT COMPLETED|Overall Study||6||
48716796|NCT03369431|102091974|FG000|STARTED|Overall Study||35||
48716797|NCT03369431|102091975|FG001|STARTED|Overall Study||34||
48716798|NCT03369431|102091974|FG000|Taste Test (1 Week)|Overall Study||35||
48304111|NCT01179672|101072886|FG001|COMPLETED|Overall Study||176||
48304112|NCT01179672|101072885|FG000|NOT COMPLETED|Overall Study||30||
48304113|NCT01179672|101072886|FG001|NOT COMPLETED|Overall Study||26||
48304114|NCT00822354|101072887|FG000|STARTED|First Intervention (28 Days)||5||
48304115|NCT00822354|101072888|FG001|STARTED|First Intervention (28 Days)||5||
48716799|NCT03369431|102091975|FG001|Taste Test (1 Week)|Overall Study||34||
48716800|NCT03369431|102091974|FG000|Part 1 Treatment (12 Weeks)|Overall Study||34||
48716801|NCT03369431|102091975|FG001|Part 1 Treatment (12 Weeks)|Overall Study||34||
48304116|NCT00822354|101072887|FG000|COMPLETED|First Intervention (28 Days)||4||
48304117|NCT00822354|101072888|FG001|COMPLETED|First Intervention (28 Days)||5||
48304118|NCT00822354|101072887|FG000|NOT COMPLETED|First Intervention (28 Days)||1||
48304119|NCT00822354|101072888|FG001|NOT COMPLETED|First Intervention (28 Days)||0||
48304120|NCT00822354|101072887|FG000|STARTED|Washout (7 Days)||4||
48304121|NCT00822354|101072888|FG001|STARTED|Washout (7 Days)||5||
48304122|NCT00822354|101072887|FG000|COMPLETED|Washout (7 Days)||4||
48304123|NCT00822354|101072888|FG001|COMPLETED|Washout (7 Days)||5||
48304124|NCT00822354|101072887|FG000|NOT COMPLETED|Washout (7 Days)||0||
48304125|NCT00822354|101072888|FG001|NOT COMPLETED|Washout (7 Days)||0||
48304126|NCT00822354|101072887|FG000|STARTED|Second Intervention (28 Days)||4||
48304127|NCT00822354|101072888|FG001|STARTED|Second Intervention (28 Days)||5||
48304128|NCT00822354|101072887|FG000|COMPLETED|Second Intervention (28 Days)||3||
48304129|NCT00822354|101072888|FG001|COMPLETED|Second Intervention (28 Days)||5||
48304130|NCT00822354|101072887|FG000|NOT COMPLETED|Second Intervention (28 Days)||1||
48304131|NCT00822354|101072888|FG001|NOT COMPLETED|Second Intervention (28 Days)||0||
48304132|NCT04752475|101072889|FG000|STARTED|Overall Study||41||
48304133|NCT04752475|101072890|FG001|STARTED|Overall Study||41||
48304134|NCT04752475|101072889|FG000|COMPLETED|Overall Study||40||
48304135|NCT04752475|101072890|FG001|COMPLETED|Overall Study||40||
48304136|NCT04752475|101072889|FG000|NOT COMPLETED|Overall Study||1||
48304137|NCT04752475|101072890|FG001|NOT COMPLETED|Overall Study||1||
48304138|NCT00530868|101072891|FG000|STARTED|Overall Study||50||
48304139|NCT00530868|101072892|FG001|STARTED|Overall Study||25||
48304140|NCT00530868|101072891|FG000|COMPLETED|Overall Study||50||
48304141|NCT00530868|101072892|FG001|COMPLETED|Overall Study||25||
48304142|NCT00530868|101072891|FG000|NOT COMPLETED|Overall Study||0||
48304143|NCT00530868|101072892|FG001|NOT COMPLETED|Overall Study||0||
48304144|NCT04166383|101072893|FG000|STARTED|Drug Administration||14||
48304145|NCT04166383|101072893|FG000|COMPLETED|Drug Administration||13||
48304146|NCT04166383|101072893|FG000|NOT COMPLETED|Drug Administration||1||
48716802|NCT03369431|102091974|FG000|Washout (4 Weeks)|Overall Study||34||
48716803|NCT03369431|102091975|FG001|Washout (4 Weeks)|Overall Study||32||
48716804|NCT03369431|102091974|FG000|Part 2 Treatment (12 Weeks)|Overall Study||34||
48716805|NCT03369431|102091975|FG001|Part 2 Treatment (12 Weeks)|Overall Study||32||
48716806|NCT03369431|102091974|FG000|COMPLETED|Overall Study||31||
48716807|NCT03369431|102091975|FG001|COMPLETED|Overall Study||27||
48716808|NCT03369431|102091974|FG000|NOT COMPLETED|Overall Study||4||
48716809|NCT03369431|102091975|FG001|NOT COMPLETED|Overall Study||7||
48716810|NCT04376827|102091976|FG000|STARTED|Double Blind Period: Week 0 to Week 52||16||
48716811|NCT04376827|102091977|FG001|STARTED|Double Blind Period: Week 0 to Week 52||17||
48716812|NCT04376827|102091976|FG000|COMPLETED|Double Blind Period: Week 0 to Week 52||9||
48716813|NCT04376827|102091977|FG001|COMPLETED|Double Blind Period: Week 0 to Week 52||8||
48716814|NCT04376827|102091976|FG000|NOT COMPLETED|Double Blind Period: Week 0 to Week 52||7||
48716815|NCT04376827|102091977|FG001|NOT COMPLETED|Double Blind Period: Week 0 to Week 52||9||
48716816|NCT04376827|102091976|FG000|STARTED|LTE Phase:Week 52 to 96(LTE Termination)||4||
48304147|NCT04166383|101072893|FG000|STARTED|TAC 1 - Second Biopsy Cycle 2 Day 1||9||
48304148|NCT04166383|101072893|FG000|COMPLETED|TAC 1 - Second Biopsy Cycle 2 Day 1||7||
48304149|NCT04166383|101072893|FG000|NOT COMPLETED|TAC 1 - Second Biopsy Cycle 2 Day 1||2||
48304150|NCT04166383|101072893|FG000|STARTED|TAC 2 - Second Biopsy Cycle 4 Day 1||5||
48304151|NCT04166383|101072893|FG000|COMPLETED|TAC 2 - Second Biopsy Cycle 4 Day 1||4||
48304152|NCT04166383|101072893|FG000|NOT COMPLETED|TAC 2 - Second Biopsy Cycle 4 Day 1||1||
48304153|NCT03613662|101072894|FG000|STARTED|Overall Study||19||
48304154|NCT03613662|101072894|FG000|COMPLETED|Overall Study||19||
48304155|NCT03613662|101072894|FG000|NOT COMPLETED|Overall Study||0||
48304156|NCT02592018|101072895|FG000|STARTED|Overall Study||15||
48304157|NCT02592018|101072895|FG000|COMPLETED|Overall Study||13||
48304158|NCT02592018|101072895|FG000|NOT COMPLETED|Overall Study||2||
48304159|NCT00146328|101072896|FG000|STARTED|Overall Study||291||
48304160|NCT00146328|101072897|FG001|STARTED|Overall Study||255||
48304161|NCT00146328|101072898|FG002|STARTED|Overall Study||449||
48304162|NCT00146328|101072896|FG000|COMPLETED|Overall Study||150||
48304163|NCT00146328|101072897|FG001|COMPLETED|Overall Study||101||
48606680|NCT04274075|101823350|FG002|COMPLETED|Overall Study||3||
48606681|NCT04274075|101823351|FG003|COMPLETED|Overall Study||3||
48716817|NCT04376827|102091977|FG001|STARTED|LTE Phase:Week 52 to 96(LTE Termination)||1||
48716818|NCT04376827|102091976|FG000|COMPLETED|LTE Phase:Week 52 to 96(LTE Termination)||0||
48606682|NCT04274075|101823352|FG004|COMPLETED|Overall Study||3||
48606683|NCT04274075|101823353|FG005|COMPLETED|Overall Study||3||
48716819|NCT04376827|102091977|FG001|COMPLETED|LTE Phase:Week 52 to 96(LTE Termination)||0||
48716820|NCT04376827|102091976|FG000|NOT COMPLETED|LTE Phase:Week 52 to 96(LTE Termination)||4||
48716821|NCT04376827|102091977|FG001|NOT COMPLETED|LTE Phase:Week 52 to 96(LTE Termination)||1||
48716822|NCT01116427|102091978|FG000|STARTED|Core Phase||44||
48716823|NCT01116427|102091979|FG001|STARTED|Core Phase||21||
48716824|NCT01116427|102091978|FG000|COMPLETED|Core Phase||39||
48716825|NCT01116427|102091979|FG001|COMPLETED|Core Phase||20||
48716826|NCT01116427|102091978|FG000|NOT COMPLETED|Core Phase||5||
48716827|NCT01116427|102091979|FG001|NOT COMPLETED|Core Phase||1||
48716828|NCT01116427|102091978|FG000|STARTED|Extension Phase||38||
48716829|NCT01116427|102091979|FG001|STARTED|Extension Phase||20||
48716830|NCT01116427|102091978|FG000|COMPLETED|Extension Phase||29||
48716831|NCT01116427|102091979|FG001|COMPLETED|Extension Phase||18||
48716832|NCT01116427|102091978|FG000|NOT COMPLETED|Extension Phase||9||
48716833|NCT01116427|102091979|FG001|NOT COMPLETED|Extension Phase||2||
48716834|NCT03899064|102091980|FG000|STARTED|Overall Study||58||
48716835|NCT03899064|102091980|FG000|MC2-01 Cream, Irradiation|Overall Study||58||
48716836|NCT03899064|102091980|FG000|MC2-01 Cream, No Irradiation|Overall Study||58||
48716837|NCT03899064|102091980|FG000|MC2-01 Vehicle, Irradiation|Overall Study||58||
48716838|NCT03899064|102091980|FG000|MC2-01 Vehicle, no Irradiation|Overall Study||58||
48716839|NCT03899064|102091980|FG000|Control, Irradiation|Overall Study||58||
48716840|NCT03899064|102091980|FG000|COMPLETED|Overall Study||51||
48716841|NCT03899064|102091980|FG000|NOT COMPLETED|Overall Study||7||
48716842|NCT00892606|102091981|FG000|STARTED|Overall Study||38||
48716843|NCT00892606|102091982|FG001|STARTED|Overall Study||37||
48716844|NCT00892606|102091981|FG000|COMPLETED|Overall Study||33||
48716845|NCT00892606|102091982|FG001|COMPLETED|Overall Study||33||
48716846|NCT00892606|102091981|FG000|NOT COMPLETED|Overall Study||5||
48716847|NCT00892606|102091982|FG001|NOT COMPLETED|Overall Study||4||
48716848|NCT03987932|102091983|FG000|STARTED|Overall Study||4|Study stopped due to COVID-19|
48716849|NCT03987932|102091984|FG001|STARTED|Overall Study||3|Study stopped due to COVID-19|
48716850|NCT03987932|102091985|FG002|STARTED|Overall Study||4|Study stopped due to COVID-19|
48716851|NCT03987932|102091983|FG000|1 Month|Overall Study||4||
48716852|NCT03987932|102091984|FG001|1 Month|Overall Study||2||
48716853|NCT03987932|102091985|FG002|1 Month|Overall Study||3||
48716854|NCT03987932|102091983|FG000|3 Months|Overall Study||4||
48716855|NCT03987932|102091984|FG001|3 Months|Overall Study||2||
48716856|NCT03987932|102091985|FG002|3 Months|Overall Study||3||
48716857|NCT03987932|102091983|FG000|6 Months|Overall Study||2||
48716858|NCT03987932|102091984|FG001|6 Months|Overall Study||2||
48716859|NCT03987932|102091985|FG002|6 Months|Overall Study||2||
48716860|NCT03987932|102091983|FG000|COMPLETED|Overall Study||2|Study stopped due to COVID-19|
48716861|NCT03987932|102091984|FG001|COMPLETED|Overall Study||2|Study stopped due to COVID-19|
48716862|NCT03987932|102091985|FG002|COMPLETED|Overall Study||2|Study stopped due to COVID-19|
48716863|NCT03987932|102091983|FG000|NOT COMPLETED|Overall Study||2||
48716864|NCT03987932|102091984|FG001|NOT COMPLETED|Overall Study||1||
48716865|NCT03987932|102091985|FG002|NOT COMPLETED|Overall Study||2||
48716866|NCT02119156|102091986|FG000|STARTED|Treatment Phase (Up to 52 Weeks)||39||
48716867|NCT02119156|102091987|FG001|STARTED|Treatment Phase (Up to 52 Weeks)||29||
48716868|NCT02119156|102091988|FG002|STARTED|Treatment Phase (Up to 52 Weeks)||12||
48304164|NCT00146328|101072898|FG002|COMPLETED|Overall Study||158||
48716869|NCT02119156|102091986|FG000|COMPLETED|Treatment Phase (Up to 52 Weeks)||33||
48716870|NCT02119156|102091987|FG001|COMPLETED|Treatment Phase (Up to 52 Weeks)||27||
48716871|NCT02119156|102091988|FG002|COMPLETED|Treatment Phase (Up to 52 Weeks)||11||
48716872|NCT02119156|102091986|FG000|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||6||
48716873|NCT02119156|102091987|FG001|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||2||
48716874|NCT02119156|102091988|FG002|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||1||
48304165|NCT00146328|101072896|FG000|NOT COMPLETED|Overall Study||141||
48304166|NCT00146328|101072897|FG001|NOT COMPLETED|Overall Study||154||
48406059|NCT02152540|101325413|FG000|NOT COMPLETED|Overall Study||0||
48406060|NCT02152540|101325414|FG001|NOT COMPLETED|Overall Study||0||
48406061|NCT00513370|101325415|FG000|STARTED|Overall Study||203||
48406062|NCT00513370|101325415|FG000|COMPLETED|Overall Study||179||
48406063|NCT00513370|101325415|FG000|NOT COMPLETED|Overall Study||24||
48406064|NCT00744991|101325416|FG000|STARTED|Overall Study||25||
48406065|NCT00744991|101325416|FG000|Received at Least 1 Dose|Overall Study||25||
48406066|NCT00744991|101325416|FG000|COMPLETED|Overall Study||0||
48406067|NCT00744991|101325416|FG000|NOT COMPLETED|Overall Study||25||
48406068|NCT00839436|101325417|FG000|STARTED|Overall Study||3||
48406069|NCT00839436|101325418|FG001|STARTED|Overall Study||5||
48149489|NCT04843930|100688726|FG000|NOT COMPLETED|Randomization||6||
48149490|NCT04843930|100688727|FG001|NOT COMPLETED|Randomization||6||
48149491|NCT04843930|100688728|FG002|NOT COMPLETED|Randomization||0||
48149492|NCT04843930|100688729|FG003|NOT COMPLETED|Randomization||0||
48149493|NCT04843930|100688726|FG000|STARTED|Baseline Assessment||49||
48149494|NCT04843930|100688727|FG001|STARTED|Baseline Assessment||49||
48406070|NCT00839436|101325419|FG002|STARTED|Overall Study||1||
48406071|NCT00839436|101325417|FG000|COMPLETED|Overall Study||2||
48406072|NCT00839436|101325418|FG001|COMPLETED|Overall Study||4||
48406073|NCT00839436|101325419|FG002|COMPLETED|Overall Study||0||
48406074|NCT00839436|101325417|FG000|NOT COMPLETED|Overall Study||1||
48406075|NCT00839436|101325418|FG001|NOT COMPLETED|Overall Study||1||
48406076|NCT00839436|101325419|FG002|NOT COMPLETED|Overall Study||1||
48406077|NCT02724111|101325420|FG000|STARTED|Overall Study||45||
48406078|NCT02724111|101325421|FG001|STARTED|Overall Study||45||
48406079|NCT02724111|101325420|FG000|COMPLETED|Overall Study||43||
48149495|NCT04843930|100688728|FG002|STARTED|Baseline Assessment||0||
48149496|NCT04843930|100688729|FG003|STARTED|Baseline Assessment||0||
48149497|NCT04843930|100688726|FG000|COMPLETED|Baseline Assessment||49||
48149498|NCT04843930|100688727|FG001|COMPLETED|Baseline Assessment||49||
48149499|NCT04843930|100688728|FG002|COMPLETED|Baseline Assessment||0||
48149500|NCT04843930|100688729|FG003|COMPLETED|Baseline Assessment||0||
48149501|NCT04843930|100688726|FG000|NOT COMPLETED|Baseline Assessment||0||
48149502|NCT04843930|100688727|FG001|NOT COMPLETED|Baseline Assessment||0||
48149503|NCT04843930|100688728|FG002|NOT COMPLETED|Baseline Assessment||0||
48149504|NCT04843930|100688729|FG003|NOT COMPLETED|Baseline Assessment||0||
48149505|NCT04843930|100688726|FG000|STARTED|Week 6 Assessment||49||
48149506|NCT04843930|100688727|FG001|STARTED|Week 6 Assessment||49||
48406080|NCT02724111|101325421|FG001|COMPLETED|Overall Study||40||
48149507|NCT04843930|100688728|FG002|STARTED|Week 6 Assessment||0||
48406081|NCT02724111|101325420|FG000|NOT COMPLETED|Overall Study||2||
48406082|NCT02724111|101325421|FG001|NOT COMPLETED|Overall Study||5||
48406083|NCT01473355|101325422|FG000|STARTED|Overall Study||45||75
48406084|NCT01473355|101325422|FG000|COMPLETED|Overall Study||39||65
48716875|NCT02119156|102091986|FG000|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)||0||
48716876|NCT02119156|102091987|FG001|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)||16||
48716877|NCT02119156|102091988|FG002|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)||10||
48716878|NCT02119156|102091986|FG000|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||0||
48716879|NCT02119156|102091987|FG001|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||6||
48716880|NCT02119156|102091988|FG002|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||3||
48716881|NCT02119156|102091986|FG000|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||0||
48716882|NCT02119156|102091987|FG001|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||10||
48716883|NCT02119156|102091988|FG002|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||7||
48716884|NCT04498377|102091989|FG000|STARTED|Overall Study||1||
48716885|NCT04498377|102091990|FG001|STARTED|Overall Study||0||
48716886|NCT04498377|102091989|FG000|COMPLETED|Overall Study||1||
48716887|NCT04498377|102091990|FG001|COMPLETED|Overall Study||0||
48716888|NCT04498377|102091989|FG000|NOT COMPLETED|Overall Study||0||
48716889|NCT04498377|102091990|FG001|NOT COMPLETED|Overall Study||0||
48716890|NCT01565564|102091991|FG000|STARTED|Overall Study||344||
48716891|NCT01565564|102091992|FG001|STARTED|Overall Study||362||
48716892|NCT01565564|102091991|FG000|COMPLETED|Overall Study||339||
48716893|NCT01565564|102091992|FG001|COMPLETED|Overall Study||361||
48716894|NCT01565564|102091991|FG000|NOT COMPLETED|Overall Study||5||
48716895|NCT01565564|102091992|FG001|NOT COMPLETED|Overall Study||1||
48716896|NCT02279498|102091993|FG000|STARTED|Overall Study||65||
48716897|NCT02279498|102091994|FG001|STARTED|Overall Study||63||
48716898|NCT02279498|102091993|FG000|COMPLETED|Overall Study||47||
48716899|NCT02279498|102091994|FG001|COMPLETED|Overall Study||59||
48716900|NCT02279498|102091993|FG000|NOT COMPLETED|Overall Study||18||
48716901|NCT02279498|102091994|FG001|NOT COMPLETED|Overall Study||4||
48716902|NCT02782325|102091995|FG000|STARTED|Blinded FMT Treatment (up to 24 Weeks)||4||
48716903|NCT02782325|102091996|FG001|STARTED|Blinded FMT Treatment (up to 24 Weeks)||2||
48716904|NCT02782325|102091997|FG002|STARTED|Blinded FMT Treatment (up to 24 Weeks)||0||
48716905|NCT02782325|102091995|FG000|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0||
48716906|NCT02782325|102091996|FG001|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0||
48716907|NCT02782325|102091997|FG002|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0||
48716908|NCT02782325|102091995|FG000|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||4||
48716909|NCT02782325|102091996|FG001|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||2||
48716910|NCT02782325|102091997|FG002|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0||
48716911|NCT02782325|102091995|FG000|STARTED|Open Label FMT Period (up to 24 Weeks)||0|One patient declined participation in the open label extension arm|
48716912|NCT02782325|102091996|FG001|STARTED|Open Label FMT Period (up to 24 Weeks)||0|One patient declined participation in the open label extension arm|
48716913|NCT02782325|102091997|FG002|STARTED|Open Label FMT Period (up to 24 Weeks)||5|One patient declined participation in the open label extension arm|
48716914|NCT02782325|102091995|FG000|COMPLETED|Open Label FMT Period (up to 24 Weeks)||0||
48716915|NCT02782325|102091996|FG001|COMPLETED|Open Label FMT Period (up to 24 Weeks)||0||
48716916|NCT02782325|102091997|FG002|COMPLETED|Open Label FMT Period (up to 24 Weeks)||1||
48716917|NCT02782325|102091995|FG000|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||0||
48716918|NCT02782325|102091996|FG001|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||0||
48716919|NCT02782325|102091997|FG002|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||4||
48716920|NCT00086502|102091998|FG000|STARTED|Overall Study||175||
48716921|NCT00086502|102091999|FG001|STARTED|Overall Study||178||
48716922|NCT00086502|102091998|FG000|COMPLETED|Overall Study||149||
48716923|NCT00086502|102091999|FG001|COMPLETED|Overall Study||158||
48716924|NCT00086502|102091998|FG000|NOT COMPLETED|Overall Study||26||
48716925|NCT00086502|102091999|FG001|NOT COMPLETED|Overall Study||20||
48716926|NCT00461305|102092000|FG000|STARTED|Treatment||355||
48716927|NCT00461305|102092001|FG001|STARTED|Treatment||65||
48716928|NCT00461305|102092000|FG000|Subjects Dispensed Drugs|Treatment||350||
48716929|NCT00461305|102092001|FG001|Subjects Dispensed Drugs|Treatment||65||
48716930|NCT00461305|102092000|FG000|Subjects Received Treatment|Treatment||349||
48716931|NCT00461305|102092001|FG001|Subjects Received Treatment|Treatment||65||
48716932|NCT00461305|102092000|FG000|COMPLETED|Treatment||254||
48716933|NCT00461305|102092001|FG001|COMPLETED|Treatment||56||
48716934|NCT00461305|102092000|FG000|NOT COMPLETED|Treatment||101||
48716935|NCT00461305|102092001|FG001|NOT COMPLETED|Treatment||9||
48716936|NCT00461305|102092000|FG000|STARTED|Continued Treatment||349||
48716937|NCT00461305|102092001|FG001|STARTED|Continued Treatment||0||
48716938|NCT00461305|102092000|FG000|COMPLETED|Continued Treatment||254||
48716939|NCT00461305|102092001|FG001|COMPLETED|Continued Treatment||0||
48716940|NCT00461305|102092000|FG000|NOT COMPLETED|Continued Treatment||95||
48716941|NCT00461305|102092001|FG001|NOT COMPLETED|Continued Treatment||0||
48716942|NCT02953665|102092002|FG000|STARTED|Overall Study||42||
48716943|NCT02953665|102092003|FG001|STARTED|Overall Study||21||
48716944|NCT02953665|102092002|FG000|COMPLETED|Overall Study||33||
48716945|NCT02953665|102092003|FG001|COMPLETED|Overall Study||18||
48716946|NCT02953665|102092002|FG000|NOT COMPLETED|Overall Study||9||
48716947|NCT02953665|102092003|FG001|NOT COMPLETED|Overall Study||3||
48716948|NCT01152515|102092004|FG000|STARTED|Overall Study||25||
48716949|NCT01152515|102092005|FG001|STARTED|Overall Study||25||
48716950|NCT01152515|102092004|FG000|COMPLETED|Overall Study||25||
48606684|NCT04274075|101823348|FG000|NOT COMPLETED|Overall Study||0||
48606685|NCT04274075|101823349|FG001|NOT COMPLETED|Overall Study||0||
48606686|NCT04274075|101823350|FG002|NOT COMPLETED|Overall Study||0||
48606687|NCT04274075|101823351|FG003|NOT COMPLETED|Overall Study||0||
48606688|NCT04274075|101823352|FG004|NOT COMPLETED|Overall Study||0||
48606689|NCT04274075|101823353|FG005|NOT COMPLETED|Overall Study||0||
48606690|NCT01760447|101823354|FG000|STARTED|Weeks 0-20||62||
48606691|NCT01760447|101823355|FG001|STARTED|Weeks 0-20||62||
48606692|NCT01760447|101823356|FG002|STARTED|Weeks 0-20||47||
48606693|NCT01760447|101823357|FG003|STARTED|Weeks 0-20||51||
48606694|NCT01760447|101823354|FG000|Treated|Weeks 0-20||62||
48606695|NCT01760447|101823355|FG001|Treated|Weeks 0-20||62||
48606696|NCT01760447|101823356|FG002|Treated|Weeks 0-20||45||
48606697|NCT01760447|101823357|FG003|Treated|Weeks 0-20||51||
48606698|NCT01760447|101823354|FG000|COMPLETED|Weeks 0-20||59||
48606699|NCT01760447|101823355|FG001|COMPLETED|Weeks 0-20||62||
48606700|NCT01760447|101823356|FG002|COMPLETED|Weeks 0-20||42||
48606701|NCT01760447|101823357|FG003|COMPLETED|Weeks 0-20||47||
48606702|NCT01760447|101823354|FG000|NOT COMPLETED|Weeks 0-20||3||
48606703|NCT01760447|101823355|FG001|NOT COMPLETED|Weeks 0-20||0||
48606704|NCT01760447|101823356|FG002|NOT COMPLETED|Weeks 0-20||5||
48606705|NCT01760447|101823357|FG003|NOT COMPLETED|Weeks 0-20||4||
48606706|NCT01760447|101823354|FG000|STARTED|Weeks 20-54||28||
48606707|NCT01760447|101823355|FG001|STARTED|Weeks 20-54||30||
48606708|NCT01760447|101823356|FG002|STARTED|Weeks 20-54||42||
48606709|NCT01760447|101823357|FG003|STARTED|Weeks 20-54||47||
48606710|NCT01760447|101823354|FG000|COMPLETED|Weeks 20-54||25||
48606711|NCT01760447|101823355|FG001|COMPLETED|Weeks 20-54||28||
48606712|NCT01760447|101823356|FG002|COMPLETED|Weeks 20-54||39||
48606713|NCT01760447|101823357|FG003|COMPLETED|Weeks 20-54||43||
48606714|NCT01760447|101823354|FG000|NOT COMPLETED|Weeks 20-54||3||
48606715|NCT01760447|101823355|FG001|NOT COMPLETED|Weeks 20-54||2||
48606716|NCT01760447|101823356|FG002|NOT COMPLETED|Weeks 20-54||3||
48606717|NCT01760447|101823357|FG003|NOT COMPLETED|Weeks 20-54||4||
48606718|NCT00493311|101823358|FG000|STARTED|Overall Study||29||
48606719|NCT00493311|101823359|FG001|STARTED|Overall Study||31||
48606720|NCT00493311|101823358|FG000|COMPLETED|Overall Study||27||
48606721|NCT00493311|101823359|FG001|COMPLETED|Overall Study||29||
48606722|NCT00493311|101823358|FG000|NOT COMPLETED|Overall Study||2||
48606723|NCT00493311|101823359|FG001|NOT COMPLETED|Overall Study||2||
48606724|NCT00298363|101823360|FG000|STARTED|Overall Study||45||
48606725|NCT00298363|101823361|FG001|STARTED|Overall Study||45||
48606726|NCT00298363|101823362|FG002|STARTED|Overall Study||22||
48716951|NCT01152515|102092005|FG001|COMPLETED|Overall Study||25||
48716952|NCT01152515|102092004|FG000|NOT COMPLETED|Overall Study||0||
48606727|NCT00298363|101823360|FG000|COMPLETED|Overall Study||28||
48606728|NCT00298363|101823361|FG001|COMPLETED|Overall Study||37||
48606729|NCT00298363|101823362|FG002|COMPLETED|Overall Study||16||
48606730|NCT00298363|101823360|FG000|NOT COMPLETED|Overall Study||17||
48606731|NCT00298363|101823361|FG001|NOT COMPLETED|Overall Study||8||
48606732|NCT00298363|101823362|FG002|NOT COMPLETED|Overall Study||6||
48716953|NCT01152515|102092005|FG001|NOT COMPLETED|Overall Study||0||
48716954|NCT00386477|102092006|FG000|STARTED|Overall Study||155||
48716955|NCT00386477|102092007|FG001|STARTED|Overall Study||145||
48716956|NCT00386477|102092006|FG000|COMPLETED|Overall Study||155||
48716957|NCT00386477|102092007|FG001|COMPLETED|Overall Study||145||
48716958|NCT00386477|102092006|FG000|NOT COMPLETED|Overall Study||0||
48716959|NCT00386477|102092007|FG001|NOT COMPLETED|Overall Study||0||
48716960|NCT01638559|102092008|FG000|STARTED|Overall Study||88||
48716961|NCT01638559|102092008|FG000|COMPLETED|Overall Study||85||
48716962|NCT01638559|102092008|FG000|NOT COMPLETED|Overall Study||3||
48716963|NCT00419315|102092009|FG000|STARTED|Overall Study||85||
48716964|NCT00419315|102092010|FG001|STARTED|Overall Study||78||
48716965|NCT00419315|102092009|FG000|COMPLETED|Overall Study||85||
48716966|NCT00419315|102092010|FG001|COMPLETED|Overall Study||78||
48716967|NCT00419315|102092009|FG000|NOT COMPLETED|Overall Study||0||
48716968|NCT00419315|102092010|FG001|NOT COMPLETED|Overall Study||0||
48716969|NCT01274611|102092011|FG000|STARTED|Overall Study||20||
48716970|NCT01274611|102092011|FG000|COMPLETED|Overall Study||20||
48716971|NCT01274611|102092011|FG000|NOT COMPLETED|Overall Study||0||
48716972|NCT02920957|102092012|FG000|STARTED|First Intervention : 1 Month||46||
48716973|NCT02920957|102092013|FG001|STARTED|First Intervention : 1 Month||41||
48716974|NCT02920957|102092012|FG000|COMPLETED|First Intervention : 1 Month||42||
48716975|NCT02920957|102092013|FG001|COMPLETED|First Intervention : 1 Month||41||
48716976|NCT02920957|102092012|FG000|NOT COMPLETED|First Intervention : 1 Month||4||
48716977|NCT02920957|102092013|FG001|NOT COMPLETED|First Intervention : 1 Month||0||
48716978|NCT02920957|102092012|FG000|STARTED|Second Intervention: 1 Month||42||
48716979|NCT02920957|102092013|FG001|STARTED|Second Intervention: 1 Month||41||
48716980|NCT02920957|102092012|FG000|COMPLETED|Second Intervention: 1 Month||42||
48716981|NCT02920957|102092013|FG001|COMPLETED|Second Intervention: 1 Month||40||
48716982|NCT02920957|102092012|FG000|NOT COMPLETED|Second Intervention: 1 Month||0||
48716983|NCT02920957|102092013|FG001|NOT COMPLETED|Second Intervention: 1 Month||1||
48716984|NCT01969500|102095074|FG000|STARTED|Overall Study||25||
48716985|NCT01969500|102095075|FG001|STARTED|Overall Study||26||
48716986|NCT01969500|102095074|FG000|COMPLETED|Overall Study||24||
48716987|NCT01969500|102095075|FG001|COMPLETED|Overall Study||24||
48716988|NCT01969500|102095074|FG000|NOT COMPLETED|Overall Study||1||
48716989|NCT01969500|102095075|FG001|NOT COMPLETED|Overall Study||2||
48716990|NCT00849875|102095076|FG000|STARTED|Overall Study||48||
48304167|NCT00146328|101072898|FG002|NOT COMPLETED|Overall Study||291||
48304168|NCT03382652|101072899|FG000|STARTED|Overall Study||83||
48304169|NCT03382652|101072899|FG000|COMPLETED|Overall Study||44||
48304170|NCT03382652|101072899|FG000|NOT COMPLETED|Overall Study||39||
48304171|NCT02818920|101072900|FG000|STARTED|Overall Study||30||
48304172|NCT02818920|101072900|FG000|Completed Surgery|Overall Study||25||
48304173|NCT02818920|101072900|FG000|Received Adjuvant Therapy|Overall Study||17||
48304174|NCT02818920|101072900|FG000|COMPLETED|Overall Study||12||
48304175|NCT02818920|101072900|FG000|NOT COMPLETED|Overall Study||18||
48304176|NCT01159912|101072901|FG000|STARTED|Overall Study||115||
48304177|NCT01159912|101072902|FG001|STARTED|Overall Study||114||
48304178|NCT01159912|101072903|FG002|STARTED|Overall Study||114||
48304179|NCT01159912|101072901|FG000|COMPLETED|Overall Study||75||
48304180|NCT01159912|101072902|FG001|COMPLETED|Overall Study||92||
48304181|NCT01159912|101072903|FG002|COMPLETED|Overall Study||88||
48304182|NCT01159912|101072901|FG000|NOT COMPLETED|Overall Study||40||
48716991|NCT00849875|102095076|FG000|COMPLETED|Overall Study||1||
48716992|NCT00849875|102095076|FG000|NOT COMPLETED|Overall Study||47||
48716993|NCT01617447|102095077|FG000|STARTED|Overall Study||47||
48716994|NCT01617447|102095078|FG001|STARTED|Overall Study||45||
48716995|NCT01617447|102095077|FG000|COMPLETED|Overall Study||47||
48716996|NCT01617447|102095078|FG001|COMPLETED|Overall Study||42||
48716997|NCT01617447|102095077|FG000|NOT COMPLETED|Overall Study||0||
48716998|NCT01617447|102095078|FG001|NOT COMPLETED|Overall Study||3||
48716999|NCT02421601|102095079|FG000|STARTED|Overall Study||991||
48304183|NCT01159912|101072902|FG001|NOT COMPLETED|Overall Study||22||
48304184|NCT01159912|101072903|FG002|NOT COMPLETED|Overall Study||26||
48304185|NCT01690897|101072904|FG000|STARTED|Overall Study||70||
48304186|NCT01690897|101072905|FG001|STARTED|Overall Study||78||
48304187|NCT01690897|101072904|FG000|COMPLETED|Overall Study||55||
48304188|NCT01690897|101072905|FG001|COMPLETED|Overall Study||59||
48304189|NCT01690897|101072904|FG000|NOT COMPLETED|Overall Study||15||
48717000|NCT02421601|102095079|FG000|COMPLETED|Overall Study||909||
48304190|NCT01690897|101072905|FG001|NOT COMPLETED|Overall Study||19||
48304191|NCT01829425|101072906|FG000|STARTED|Overall Study||78||
48304192|NCT01829425|101072907|FG001|STARTED|Overall Study||74||
48304193|NCT01829425|101072906|FG000|COMPLETED|Overall Study||72||
48304194|NCT01829425|101072907|FG001|COMPLETED|Overall Study||70||
48717001|NCT02421601|102095079|FG000|NOT COMPLETED|Overall Study||82||
48717002|NCT01711866|102095080|FG000|STARTED|Overall Study||87||
48717003|NCT01711866|102095080|FG000|COMPLETED|Overall Study||79||
48717004|NCT01711866|102095080|FG000|NOT COMPLETED|Overall Study||8||
48717005|NCT02459275|102095081|FG000|STARTED|Overall Study||19||
48717006|NCT02459275|102095082|FG001|STARTED|Overall Study||17||
48717007|NCT02459275|102095081|FG000|COMPLETED|Overall Study||19||
48717008|NCT02459275|102095082|FG001|COMPLETED|Overall Study||17||
48717009|NCT02459275|102095081|FG000|NOT COMPLETED|Overall Study||0||
48717010|NCT02459275|102095082|FG001|NOT COMPLETED|Overall Study||0||
48717011|NCT00908115|102095083|FG000|STARTED|Overall Study||1258||
48717012|NCT00908115|102095083|FG000|COMPLETED|Overall Study||1244||
48717013|NCT00908115|102095083|FG000|NOT COMPLETED|Overall Study||14||
48717014|NCT00343915|102095084|FG000|STARTED|Primary Study||258||
48717015|NCT00343915|102095085|FG001|STARTED|Primary Study||126||
48717016|NCT00343915|102095084|FG000|COMPLETED|Primary Study||254||
48717017|NCT00343915|102095085|FG001|COMPLETED|Primary Study||123||
48717018|NCT00343915|102095084|FG000|NOT COMPLETED|Primary Study||4||
48717019|NCT00343915|102095085|FG001|NOT COMPLETED|Primary Study||3||
48717020|NCT00343915|102095084|FG000|STARTED|Month 30 Follow-up||179||
48717021|NCT00343915|102095085|FG001|STARTED|Month 30 Follow-up||88||
48717022|NCT00343915|102095084|FG000|COMPLETED|Month 30 Follow-up||179||
48717023|NCT00343915|102095085|FG001|COMPLETED|Month 30 Follow-up||88||
48717024|NCT00343915|102095084|FG000|NOT COMPLETED|Month 30 Follow-up||0||
48304195|NCT01829425|101072906|FG000|NOT COMPLETED|Overall Study||6||
48717025|NCT00343915|102095085|FG001|NOT COMPLETED|Month 30 Follow-up||0||
48717026|NCT00343915|102095084|FG000|STARTED|Month 42 Follow-up||174||
48717027|NCT00343915|102095085|FG001|STARTED|Month 42 Follow-up||84||
48717028|NCT00343915|102095084|FG000|COMPLETED|Month 42 Follow-up||174||
48717029|NCT00343915|102095085|FG001|COMPLETED|Month 42 Follow-up||84||
48717030|NCT00343915|102095084|FG000|NOT COMPLETED|Month 42 Follow-up||0||
48717031|NCT00343915|102095085|FG001|NOT COMPLETED|Month 42 Follow-up||0||
48717032|NCT00343915|102095084|FG000|STARTED|Month 54 Follow-up||166||
48717033|NCT00343915|102095085|FG001|STARTED|Month 54 Follow-up||79||
48717034|NCT00343915|102095084|FG000|COMPLETED|Month 54 Follow-up||166||
48149508|NCT04843930|100688729|FG003|STARTED|Week 6 Assessment||0||
48149509|NCT04843930|100688726|FG000|COMPLETED|Week 6 Assessment||44||
48149510|NCT04843930|100688727|FG001|COMPLETED|Week 6 Assessment||48||
48149511|NCT04843930|100688728|FG002|COMPLETED|Week 6 Assessment||0||
48149512|NCT04843930|100688729|FG003|COMPLETED|Week 6 Assessment||0||
48149513|NCT04843930|100688726|FG000|NOT COMPLETED|Week 6 Assessment||5||
48149514|NCT04843930|100688727|FG001|NOT COMPLETED|Week 6 Assessment||1||
48149515|NCT04843930|100688728|FG002|NOT COMPLETED|Week 6 Assessment||0||
48149516|NCT04843930|100688729|FG003|NOT COMPLETED|Week 6 Assessment||0||
48149517|NCT04843930|100688726|FG000|STARTED|Week 10 Follow-Up||44||
48149518|NCT04843930|100688727|FG001|STARTED|Week 10 Follow-Up||0||
48149519|NCT04843930|100688728|FG002|STARTED|Week 10 Follow-Up||0||
48149520|NCT04843930|100688729|FG003|STARTED|Week 10 Follow-Up||2||
48149521|NCT04843930|100688726|FG000|COMPLETED|Week 10 Follow-Up||44||
48149522|NCT04843930|100688727|FG001|COMPLETED|Week 10 Follow-Up||0||
48149523|NCT04843930|100688728|FG002|COMPLETED|Week 10 Follow-Up||0||
48149524|NCT04843930|100688729|FG003|COMPLETED|Week 10 Follow-Up||0||
48149525|NCT04843930|100688726|FG000|NOT COMPLETED|Week 10 Follow-Up||0||
48304196|NCT01829425|101072907|FG001|NOT COMPLETED|Overall Study||4||
48304197|NCT01426516|101072908|FG000|STARTED|Overall Study||12||
48304198|NCT01426516|101072909|FG001|STARTED|Overall Study||17||
48717035|NCT00343915|102095085|FG001|COMPLETED|Month 54 Follow-up||79||
48717036|NCT00343915|102095084|FG000|NOT COMPLETED|Month 54 Follow-up||0||
48717037|NCT00343915|102095085|FG001|NOT COMPLETED|Month 54 Follow-up||0||
48717038|NCT00343915|102095084|FG000|STARTED|Month 66 Follow-up||158||
48717039|NCT00343915|102095085|FG001|STARTED|Month 66 Follow-up||76||
48717040|NCT00343915|102095084|FG000|COMPLETED|Month 66 Follow-up||158||
48149526|NCT04843930|100688727|FG001|NOT COMPLETED|Week 10 Follow-Up||0||
48149527|NCT04843930|100688728|FG002|NOT COMPLETED|Week 10 Follow-Up||0||
48149528|NCT04843930|100688729|FG003|NOT COMPLETED|Week 10 Follow-Up||2||
48717041|NCT00343915|102095085|FG001|COMPLETED|Month 66 Follow-up||76||
48304199|NCT01426516|101072908|FG000|COMPLETED|Overall Study||12||
48304200|NCT01426516|101072909|FG001|COMPLETED|Overall Study||17||
48717042|NCT00343915|102095084|FG000|NOT COMPLETED|Month 66 Follow-up||0||
48717043|NCT00343915|102095085|FG001|NOT COMPLETED|Month 66 Follow-up||0||
48717044|NCT04904809|102095086|FG000|STARTED|Overall Study||36||
48717045|NCT04904809|102095086|FG000|COMPLETED|Overall Study||36||
48717046|NCT04904809|102095086|FG000|NOT COMPLETED|Overall Study||0||
48717047|NCT01366612|102095087|FG000|STARTED|Overall Study||25||
48149529|NCT04843930|100688726|FG000|STARTED|Week 16 Follow-Up||0||
48149530|NCT04843930|100688727|FG001|STARTED|Week 16 Follow-Up||0||
48149531|NCT04843930|100688728|FG002|STARTED|Week 16 Follow-Up||46||
48717048|NCT01366612|102095088|FG001|STARTED|Overall Study||22||
48717049|NCT01366612|102095087|FG000|COMPLETED|Overall Study||25||
48149532|NCT04843930|100688729|FG003|STARTED|Week 16 Follow-Up||0||
48149533|NCT04843930|100688726|FG000|COMPLETED|Week 16 Follow-Up||0||
48149534|NCT04843930|100688727|FG001|COMPLETED|Week 16 Follow-Up||0||
48149535|NCT04843930|100688728|FG002|COMPLETED|Week 16 Follow-Up||44||
48149536|NCT04843930|100688729|FG003|COMPLETED|Week 16 Follow-Up||0||
48149537|NCT04843930|100688726|FG000|NOT COMPLETED|Week 16 Follow-Up||0||
48149538|NCT04843930|100688727|FG001|NOT COMPLETED|Week 16 Follow-Up||0||
48149539|NCT04843930|100688728|FG002|NOT COMPLETED|Week 16 Follow-Up||2||
48149540|NCT04843930|100688729|FG003|NOT COMPLETED|Week 16 Follow-Up||0||
48149541|NCT00845663|100688730|FG000|STARTED|Overall Study||49||
48149542|NCT00845663|100688731|FG001|STARTED|Overall Study||49||
48149543|NCT00845663|100688730|FG000|COMPLETED|Overall Study||49||
48149544|NCT00845663|100688731|FG001|COMPLETED|Overall Study||49||
48149545|NCT00845663|100688730|FG000|NOT COMPLETED|Overall Study||0||
48149546|NCT00845663|100688731|FG001|NOT COMPLETED|Overall Study||0||
48149547|NCT00361140|100688732|FG000|STARTED|Overall Study||40||
48149548|NCT00361140|100688733|FG001|STARTED|Overall Study||29||
48149549|NCT00361140|100688734|FG002|STARTED|Overall Study||3||
48149550|NCT00361140|100688732|FG000|COMPLETED|Overall Study||40||
48149551|NCT00361140|100688733|FG001|COMPLETED|Overall Study||29||
48149552|NCT00361140|100688734|FG002|COMPLETED|Overall Study||3||
48717050|NCT01366612|102095088|FG001|COMPLETED|Overall Study||22||
48717051|NCT01366612|102095087|FG000|NOT COMPLETED|Overall Study||0||
48717052|NCT01366612|102095088|FG001|NOT COMPLETED|Overall Study||0||
48717053|NCT02677844|102095089|FG000|STARTED|Period 1||5||
48717054|NCT02677844|102095090|FG001|STARTED|Period 1||5||
48717055|NCT02677844|102095091|FG002|STARTED|Period 1||5||
48717056|NCT02677844|102095092|FG003|STARTED|Period 1||5||
48717057|NCT02677844|102095093|FG004|STARTED|Period 1||0||
48717058|NCT02677844|102095094|FG005|STARTED|Period 1||0||
48717059|NCT02677844|102095095|FG006|STARTED|Period 1||0||
48717060|NCT02677844|102095089|FG000|COMPLETED|Period 1||5||
48717061|NCT02677844|102095090|FG001|COMPLETED|Period 1||5||
48149553|NCT00361140|100688732|FG000|NOT COMPLETED|Overall Study||0||
48149554|NCT00361140|100688733|FG001|NOT COMPLETED|Overall Study||0||
48149555|NCT00361140|100688734|FG002|NOT COMPLETED|Overall Study||0||
48149556|NCT03750006|100688735|FG000|STARTED|Overall Study||42|Recruitment initiated|
48149557|NCT03750006|100688735|FG000|COMPLETED|Overall Study||23||
48149558|NCT03750006|100688735|FG000|NOT COMPLETED|Overall Study||19||
48149559|NCT00416182|100688736|FG000|STARTED|Overall Study||8||
48149560|NCT00416182|100688737|FG001|STARTED|Overall Study||8||
48149561|NCT00416182|100688736|FG000|COMPLETED|Overall Study||5||
48149562|NCT00416182|100688737|FG001|COMPLETED|Overall Study||6||
48149563|NCT00416182|100688736|FG000|NOT COMPLETED|Overall Study||3||
48149564|NCT00416182|100688737|FG001|NOT COMPLETED|Overall Study||2||
48149565|NCT01877408|100688738|FG000|STARTED|Overall Study||50||
48149566|NCT01877408|100688739|FG001|STARTED|Overall Study||100||
48149567|NCT01877408|100688738|FG000|COMPLETED|Overall Study||50||
48149568|NCT01877408|100688739|FG001|COMPLETED|Overall Study||98||
48149569|NCT01877408|100688738|FG000|NOT COMPLETED|Overall Study||0||
48149570|NCT01877408|100688739|FG001|NOT COMPLETED|Overall Study||2||
48149571|NCT01826227|100688740|FG000|STARTED|Overall Study||5||
48149572|NCT01826227|100688740|FG000|COMPLETED|Overall Study||5||
48149573|NCT01826227|100688740|FG000|NOT COMPLETED|Overall Study||0||
48149574|NCT03284788|100688741|FG000|STARTED|Overall Study||13||
48149575|NCT03284788|100688741|FG000|COMPLETED|Overall Study||11||
48149576|NCT03284788|100688741|FG000|NOT COMPLETED|Overall Study||2||
48149577|NCT01313286|100688742|FG000|STARTED|Period 1||8||
48149578|NCT01313286|100688743|FG001|STARTED|Period 1||8||
48149579|NCT01313286|100688742|FG000|COMPLETED|Period 1||6||
48149580|NCT01313286|100688743|FG001|COMPLETED|Period 1||8||
48149581|NCT01313286|100688742|FG000|NOT COMPLETED|Period 1||2||
48149582|NCT01313286|100688743|FG001|NOT COMPLETED|Period 1||0||
48149583|NCT01313286|100688742|FG000|STARTED|Period 2||6||
48406085|NCT01473355|101325422|FG000|NOT COMPLETED|Overall Study||6||10
48406086|NCT00559013|101325423|FG000|STARTED|Overall Study||38||
48717062|NCT02677844|102095091|FG002|COMPLETED|Period 1||5||
48717063|NCT02677844|102095092|FG003|COMPLETED|Period 1||5||
48717064|NCT02677844|102095093|FG004|COMPLETED|Period 1||0||
48717065|NCT02677844|102095094|FG005|COMPLETED|Period 1||0||
48717066|NCT02677844|102095095|FG006|COMPLETED|Period 1||0||
48717067|NCT02677844|102095089|FG000|NOT COMPLETED|Period 1||0||
48149584|NCT01313286|100688743|FG001|STARTED|Period 2||8||
48149585|NCT01313286|100688742|FG000|COMPLETED|Period 2||6||
48149586|NCT01313286|100688743|FG001|COMPLETED|Period 2||8||
48149587|NCT01313286|100688742|FG000|NOT COMPLETED|Period 2||0||
48149588|NCT01313286|100688743|FG001|NOT COMPLETED|Period 2||0||
48717068|NCT02677844|102095090|FG001|NOT COMPLETED|Period 1||0||
48717069|NCT02677844|102095091|FG002|NOT COMPLETED|Period 1||0||
48149589|NCT02954523|100688744|FG000|STARTED|Overall Study||3||
48149590|NCT02954523|100688745|FG001|STARTED|Overall Study||6||
48149591|NCT02954523|100688746|FG002|STARTED|Overall Study||1||
48149592|NCT02954523|100688744|FG000|COMPLETED|Overall Study||3||
48149593|NCT02954523|100688745|FG001|COMPLETED|Overall Study||6||
48149594|NCT02954523|100688746|FG002|COMPLETED|Overall Study||1||
48717070|NCT02677844|102095092|FG003|NOT COMPLETED|Period 1||0||
48717071|NCT02677844|102095093|FG004|NOT COMPLETED|Period 1||0||
48606733|NCT02173379|101823363|FG000|STARTED|Overall Study||1296||
48606734|NCT02173379|101823364|FG001|STARTED|Overall Study||1308||
48149595|NCT02954523|100688744|FG000|NOT COMPLETED|Overall Study||0||
48149596|NCT02954523|100688745|FG001|NOT COMPLETED|Overall Study||0||
48149597|NCT02954523|100688746|FG002|NOT COMPLETED|Overall Study||0||
48149598|NCT00414817|100688747|FG000|STARTED|Overall Study||7033||
48149599|NCT00414817|100688748|FG001|STARTED|Overall Study||7031||
48149600|NCT00414817|100688747|FG000|Never Started on ICS|Overall Study||1465||
48149601|NCT00414817|100688748|FG001|Never Started on ICS|Overall Study||1392||
48149602|NCT00414817|100688747|FG000|Died or Left Health Plan|Overall Study||451||
48149603|NCT00414817|100688748|FG001|Died or Left Health Plan|Overall Study||417||
48149604|NCT00414817|100688747|FG000|Adherent ICS User|Overall Study||922||
48149605|NCT00414817|100688748|FG001|Adherent ICS User|Overall Study||900||
48149606|NCT00414817|100688747|FG000|Daily Oral Steroid User|Overall Study||117||
48149607|NCT00414817|100688748|FG001|Daily Oral Steroid User|Overall Study||123||
48149608|NCT00414817|100688747|FG000|<3 Months Follow-up|Overall Study||175||
48149609|NCT00414817|100688748|FG001|<3 Months Follow-up|Overall Study||184||
48149610|NCT00414817|100688747|FG000|COMPLETED|Overall Study||3903||
48149611|NCT00414817|100688748|FG001|COMPLETED|Overall Study||4015||
48149612|NCT00414817|100688747|FG000|NOT COMPLETED|Overall Study||3130||
48149613|NCT00414817|100688748|FG001|NOT COMPLETED|Overall Study||3016||
48149614|NCT02219048|100688749|FG000|STARTED|Overall Study||26||
48149615|NCT02219048|100688750|FG001|STARTED|Overall Study||25||
48149616|NCT02219048|100688749|FG000|COMPLETED|Overall Study||5||
48149617|NCT02219048|100688750|FG001|COMPLETED|Overall Study||4||
48149618|NCT02219048|100688749|FG000|NOT COMPLETED|Overall Study||21||
48149619|NCT02219048|100688750|FG001|NOT COMPLETED|Overall Study||21||
48149620|NCT02454101|100688751|FG000|STARTED|Overall Study||150||
48149621|NCT02454101|100688752|FG001|STARTED|Overall Study||150||
48149622|NCT02454101|100688751|FG000|COMPLETED|Overall Study||145||
48149623|NCT02454101|100688752|FG001|COMPLETED|Overall Study||143||
48149624|NCT02454101|100688751|FG000|NOT COMPLETED|Overall Study||5||
48606735|NCT02173379|101823363|FG000|COMPLETED|Overall Study||1099||
48304201|NCT01426516|101072908|FG000|NOT COMPLETED|Overall Study||0||
48304202|NCT01426516|101072909|FG001|NOT COMPLETED|Overall Study||0||
48304203|NCT01949155|101072910|FG000|STARTED|Overall Study||178||
48304204|NCT01949155|101072911|FG001|STARTED|Overall Study||88||
48304205|NCT01949155|101072910|FG000|COMPLETED|Overall Study||176||
48304206|NCT01949155|101072911|FG001|COMPLETED|Overall Study||88||
48304207|NCT01949155|101072910|FG000|NOT COMPLETED|Overall Study||2||
48304208|NCT01949155|101072911|FG001|NOT COMPLETED|Overall Study||0||
48304209|NCT04376060|101072912|FG000|STARTED|Overall Study||15||
48304210|NCT04376060|101072912|FG000|COMPLETED|Overall Study||14||
48304211|NCT04376060|101072912|FG000|NOT COMPLETED|Overall Study||1||
48304212|NCT01970488|101072913|FG000|STARTED|Part 1: Through Week 16||175||
48304213|NCT01970488|101072914|FG001|STARTED|Part 1: Through Week 16||175||
48304214|NCT01970488|101072915|FG002|STARTED|Part 1: Through Week 16||0||
48304215|NCT01970488|101072916|FG003|STARTED|Part 1: Through Week 16||0||
48304216|NCT01970488|101072917|FG004|STARTED|Part 1: Through Week 16||0||
48304217|NCT01970488|101072913|FG000|Received Treatment|Part 1: Through Week 16||174||
48304218|NCT01970488|101072914|FG001|Received Treatment|Part 1: Through Week 16||173||
48717072|NCT02677844|102095094|FG005|NOT COMPLETED|Period 1||0||
48717073|NCT02677844|102095095|FG006|NOT COMPLETED|Period 1||0||
48717074|NCT02677844|102095089|FG000|STARTED|Period 2||5||
48717075|NCT02677844|102095090|FG001|STARTED|Period 2||5||
48717076|NCT02677844|102095091|FG002|STARTED|Period 2||5||
48717077|NCT02677844|102095092|FG003|STARTED|Period 2||5||
48717078|NCT02677844|102095093|FG004|STARTED|Period 2||0||
48717079|NCT02677844|102095094|FG005|STARTED|Period 2||0||
48717080|NCT02677844|102095095|FG006|STARTED|Period 2||0||
48717081|NCT02677844|102095089|FG000|COMPLETED|Period 2||5||
48717082|NCT02677844|102095090|FG001|COMPLETED|Period 2||5||
48717083|NCT02677844|102095091|FG002|COMPLETED|Period 2||5||
48717084|NCT02677844|102095092|FG003|COMPLETED|Period 2||5||
48717085|NCT02677844|102095093|FG004|COMPLETED|Period 2||0||
48717086|NCT02677844|102095094|FG005|COMPLETED|Period 2||0||
48717087|NCT02677844|102095095|FG006|COMPLETED|Period 2||0||
48717088|NCT02677844|102095089|FG000|NOT COMPLETED|Period 2||0||
48717089|NCT02677844|102095090|FG001|NOT COMPLETED|Period 2||0||
48149625|NCT02454101|100688752|FG001|NOT COMPLETED|Overall Study||7||
48149626|NCT01316510|100688753|FG000|STARTED|Overall Study||12||
48149627|NCT01316510|100688754|FG001|STARTED|Overall Study||12||
48149628|NCT01316510|100688753|FG000|COMPLETED|Overall Study||12||
48149629|NCT01316510|100688754|FG001|COMPLETED|Overall Study||12||
48149630|NCT01316510|100688753|FG000|NOT COMPLETED|Overall Study||0||
48149631|NCT01316510|100688754|FG001|NOT COMPLETED|Overall Study||0||
48149632|NCT01324271|100688755|FG000|STARTED|Overall Study||57||
48149633|NCT01324271|100688756|FG001|STARTED|Overall Study||28||
48149634|NCT01324271|100688755|FG000|COMPLETED|Overall Study||53||
48149635|NCT01324271|100688756|FG001|COMPLETED|Overall Study||28||
48149636|NCT01324271|100688755|FG000|NOT COMPLETED|Overall Study||4||
48149637|NCT01324271|100688756|FG001|NOT COMPLETED|Overall Study||0||
48149638|NCT00279201|100688757|FG000|STARTED|Initiation||1046||
48149639|NCT00279201|100688758|FG001|STARTED|Initiation||1045||
48149640|NCT00279201|100688759|FG002|STARTED|Initiation||0||
48149641|NCT00279201|100688760|FG003|STARTED|Initiation||0||
48149642|NCT00279201|100688761|FG004|STARTED|Initiation||0||
48149643|NCT00279201|100688762|FG005|STARTED|Initiation||0||
48149644|NCT00279201|100688757|FG000|COMPLETED|Initiation||918||
48149645|NCT00279201|100688758|FG001|COMPLETED|Initiation||900||
48149646|NCT00279201|100688759|FG002|COMPLETED|Initiation||0||
48149647|NCT00279201|100688760|FG003|COMPLETED|Initiation||0||
48149648|NCT00279201|100688761|FG004|COMPLETED|Initiation||0||
48149649|NCT00279201|100688762|FG005|COMPLETED|Initiation||0||
48149650|NCT00279201|100688757|FG000|NOT COMPLETED|Initiation||128||
48149651|NCT00279201|100688758|FG001|NOT COMPLETED|Initiation||145||
48149652|NCT00279201|100688759|FG002|NOT COMPLETED|Initiation||0||
48149653|NCT00279201|100688760|FG003|NOT COMPLETED|Initiation||0||
48149654|NCT00279201|100688761|FG004|NOT COMPLETED|Initiation||0||
48149655|NCT00279201|100688762|FG005|NOT COMPLETED|Initiation||0||
48717090|NCT02677844|102095091|FG002|NOT COMPLETED|Period 2||0||
48717091|NCT02677844|102095092|FG003|NOT COMPLETED|Period 2||0||
48717092|NCT02677844|102095093|FG004|NOT COMPLETED|Period 2||0||
48717093|NCT02677844|102095094|FG005|NOT COMPLETED|Period 2||0||
48717094|NCT02677844|102095095|FG006|NOT COMPLETED|Period 2||0||
48717095|NCT02677844|102095089|FG000|STARTED|Period 3||5||
48717096|NCT02677844|102095090|FG001|STARTED|Period 3||5||
48717097|NCT02677844|102095091|FG002|STARTED|Period 3||5||
48717098|NCT02677844|102095092|FG003|STARTED|Period 3||5||
48717099|NCT02677844|102095093|FG004|STARTED|Period 3||0||
48717100|NCT02677844|102095094|FG005|STARTED|Period 3||0||
48717101|NCT02677844|102095095|FG006|STARTED|Period 3||0||
48717102|NCT02677844|102095089|FG000|COMPLETED|Period 3||5||
48717103|NCT02677844|102095090|FG001|COMPLETED|Period 3||5||
48717104|NCT02677844|102095091|FG002|COMPLETED|Period 3||5||
48717105|NCT02677844|102095092|FG003|COMPLETED|Period 3||4||
48149656|NCT00279201|100688757|FG000|STARTED|Maintenance||419||
48149657|NCT00279201|100688758|FG001|STARTED|Maintenance||473||
48149658|NCT00279201|100688759|FG002|STARTED|Maintenance||0||
48149659|NCT00279201|100688760|FG003|STARTED|Maintenance||0||
48717106|NCT02677844|102095093|FG004|COMPLETED|Period 3||0||
48717107|NCT02677844|102095094|FG005|COMPLETED|Period 3||0||
48717108|NCT02677844|102095095|FG006|COMPLETED|Period 3||0||
48717109|NCT02677844|102095089|FG000|NOT COMPLETED|Period 3||0||
48717110|NCT02677844|102095090|FG001|NOT COMPLETED|Period 3||0||
48717111|NCT02677844|102095091|FG002|NOT COMPLETED|Period 3||0||
48304219|NCT01970488|101072915|FG002|Received Treatment|Part 1: Through Week 16||0||
48304220|NCT01970488|101072916|FG003|Received Treatment|Part 1: Through Week 16||0||
48304221|NCT01970488|101072917|FG004|Received Treatment|Part 1: Through Week 16||0||
48304222|NCT01970488|101072913|FG000|COMPLETED|Part 1: Through Week 16||164||
48304223|NCT01970488|101072914|FG001|COMPLETED|Part 1: Through Week 16||162||
48304224|NCT01970488|101072915|FG002|COMPLETED|Part 1: Through Week 16||0||
48304225|NCT01970488|101072916|FG003|COMPLETED|Part 1: Through Week 16||0||
48304226|NCT01970488|101072917|FG004|COMPLETED|Part 1: Through Week 16||0||
48304227|NCT01970488|101072913|FG000|NOT COMPLETED|Part 1: Through Week 16||11||
48304228|NCT01970488|101072914|FG001|NOT COMPLETED|Part 1: Through Week 16||13||
48304229|NCT01970488|101072915|FG002|NOT COMPLETED|Part 1: Through Week 16||0||
48304230|NCT01970488|101072916|FG003|NOT COMPLETED|Part 1: Through Week 16||0||
48304231|NCT01970488|101072917|FG004|NOT COMPLETED|Part 1: Through Week 16||0||
48304232|NCT01970488|101072913|FG000|STARTED|Part 2: Post Week 16||0||
48304233|NCT01970488|101072914|FG001|STARTED|Part 2: Post Week 16||0||
48304234|NCT01970488|101072915|FG002|STARTED|Part 2: Post Week 16||152||
48304235|NCT01970488|101072916|FG003|STARTED|Part 2: Post Week 16||79||
48304236|NCT01970488|101072917|FG004|STARTED|Part 2: Post Week 16||77||
48304237|NCT01970488|101072913|FG000|COMPLETED|Part 2: Post Week 16||0||
48304238|NCT01970488|101072914|FG001|COMPLETED|Part 2: Post Week 16||0||
48304239|NCT01970488|101072915|FG002|COMPLETED|Part 2: Post Week 16||135||
48304240|NCT01970488|101072916|FG003|COMPLETED|Part 2: Post Week 16||71||
48304241|NCT01970488|101072917|FG004|COMPLETED|Part 2: Post Week 16||69||
48304242|NCT01970488|101072913|FG000|NOT COMPLETED|Part 2: Post Week 16||0||
48304243|NCT01970488|101072914|FG001|NOT COMPLETED|Part 2: Post Week 16||0||
48304244|NCT01970488|101072915|FG002|NOT COMPLETED|Part 2: Post Week 16||17||
48304245|NCT01970488|101072916|FG003|NOT COMPLETED|Part 2: Post Week 16||8||
48304246|NCT01970488|101072917|FG004|NOT COMPLETED|Part 2: Post Week 16||8||
48717112|NCT02677844|102095092|FG003|NOT COMPLETED|Period 3||1||
48717113|NCT02677844|102095093|FG004|NOT COMPLETED|Period 3||0||
48717114|NCT02677844|102095094|FG005|NOT COMPLETED|Period 3||0||
48717115|NCT02677844|102095095|FG006|NOT COMPLETED|Period 3||0||
48717116|NCT02677844|102095089|FG000|STARTED|Period 4||5||
48717117|NCT02677844|102095090|FG001|STARTED|Period 4||5||
48717118|NCT02677844|102095091|FG002|STARTED|Period 4||5||
48717119|NCT02677844|102095092|FG003|STARTED|Period 4||4||
48717120|NCT02677844|102095093|FG004|STARTED|Period 4||0||
48717121|NCT02677844|102095094|FG005|STARTED|Period 4||0||
48717122|NCT02677844|102095095|FG006|STARTED|Period 4||0||
48717123|NCT02677844|102095089|FG000|COMPLETED|Period 4||5||
48717124|NCT02677844|102095090|FG001|COMPLETED|Period 4||5||
48717125|NCT02677844|102095091|FG002|COMPLETED|Period 4||5||
48717126|NCT02677844|102095092|FG003|COMPLETED|Period 4||4||
48717127|NCT02677844|102095093|FG004|COMPLETED|Period 4||0||
48717128|NCT02677844|102095094|FG005|COMPLETED|Period 4||0||
48717129|NCT02677844|102095095|FG006|COMPLETED|Period 4||0||
48717130|NCT02677844|102095089|FG000|NOT COMPLETED|Period 4||0||
48717131|NCT02677844|102095090|FG001|NOT COMPLETED|Period 4||0||
48717132|NCT02677844|102095091|FG002|NOT COMPLETED|Period 4||0||
48717133|NCT02677844|102095092|FG003|NOT COMPLETED|Period 4||0||
48717134|NCT02677844|102095093|FG004|NOT COMPLETED|Period 4||0||
48717135|NCT02677844|102095094|FG005|NOT COMPLETED|Period 4||0||
48304247|NCT02066051|101072918|FG000|STARTED|Overall Study||8||
48304248|NCT02066051|101072918|FG000|COMPLETED|Overall Study||7||
48304249|NCT02066051|101072918|FG000|NOT COMPLETED|Overall Study||1||
48304250|NCT02606461|101072919|FG000|STARTED|Period 1: Double-blinded Period||27||
48304251|NCT02606461|101072920|FG001|STARTED|Period 1: Double-blinded Period||30||
48304252|NCT02606461|101072921|FG002|STARTED|Period 1: Double-blinded Period||188||
48304253|NCT02606461|101072922|FG003|STARTED|Period 1: Double-blinded Period||97||
48304254|NCT02606461|101072923|FG004|STARTED|Period 1: Double-blinded Period||0||
48304255|NCT02606461|101072924|FG005|STARTED|Period 1: Double-blinded Period||0||
48304256|NCT02606461|101072919|FG000|Treated|Period 1: Double-blinded Period||27||
48304257|NCT02606461|101072920|FG001|Treated|Period 1: Double-blinded Period||30||
48304258|NCT02606461|101072921|FG002|Treated|Period 1: Double-blinded Period||187||
48304259|NCT02606461|101072922|FG003|Treated|Period 1: Double-blinded Period||97||
48304260|NCT02606461|101072923|FG004|Treated|Period 1: Double-blinded Period||0||
48304261|NCT02606461|101072924|FG005|Treated|Period 1: Double-blinded Period||0||
48304262|NCT02606461|101072919|FG000|COMPLETED|Period 1: Double-blinded Period||27||
48304263|NCT02606461|101072920|FG001|COMPLETED|Period 1: Double-blinded Period||30||
48304264|NCT02606461|101072921|FG002|COMPLETED|Period 1: Double-blinded Period||187||
48717136|NCT02677844|102095095|FG006|NOT COMPLETED|Period 4||0||
48717137|NCT02677844|102095089|FG000|STARTED|Period 4 (DDI)||0|Participants were mutually exclusive of cohorts, Participants in Cohort 1 \& 2 are different.|
48717138|NCT02677844|102095090|FG001|STARTED|Period 4 (DDI)||0|Participants were mutually exclusive of cohorts, Participants in Cohort 1 \& 2 are different.|
48717139|NCT02677844|102095091|FG002|STARTED|Period 4 (DDI)||0|Participants were mutually exclusive of cohorts, Participants in Cohort 1 \& 2 are different.|
48304265|NCT02606461|101072922|FG003|COMPLETED|Period 1: Double-blinded Period||97||
48304266|NCT02606461|101072923|FG004|COMPLETED|Period 1: Double-blinded Period||0||
48304267|NCT02606461|101072924|FG005|COMPLETED|Period 1: Double-blinded Period||0||
48406087|NCT00559013|101325423|FG000|COMPLETED|Overall Study||38||
48406088|NCT00559013|101325423|FG000|NOT COMPLETED|Overall Study||0||
48304268|NCT02606461|101072919|FG000|NOT COMPLETED|Period 1: Double-blinded Period||0||
48304269|NCT02606461|101072920|FG001|NOT COMPLETED|Period 1: Double-blinded Period||0||
48304270|NCT02606461|101072921|FG002|NOT COMPLETED|Period 1: Double-blinded Period||1||
48304271|NCT02606461|101072922|FG003|NOT COMPLETED|Period 1: Double-blinded Period||0||
48304272|NCT02606461|101072923|FG004|NOT COMPLETED|Period 1: Double-blinded Period||0||
48304273|NCT02606461|101072924|FG005|NOT COMPLETED|Period 1: Double-blinded Period||0||
48304274|NCT02606461|101072919|FG000|STARTED|Period 2: Open Label Period||0||
48304275|NCT02606461|101072920|FG001|STARTED|Period 2: Open Label Period||0||
48304276|NCT02606461|101072921|FG002|STARTED|Period 2: Open Label Period||0||
48304277|NCT02606461|101072922|FG003|STARTED|Period 2: Open Label Period||0||
48717140|NCT02677844|102095092|FG003|STARTED|Period 4 (DDI)||0|Participants were mutually exclusive of cohorts, Participants in Cohort 1 \& 2 are different.|
48767589|NCT04393454|102222775|FG000|STARTED|Overall Study||6||
48304278|NCT02606461|101072923|FG004|STARTED|Period 2: Open Label Period||24||
48304279|NCT02606461|101072924|FG005|STARTED|Period 2: Open Label Period||63||
48406089|NCT00741104|101325424|FG000|STARTED|Overall Study||363||
48406090|NCT00741104|101325424|FG000|COMPLETED|Overall Study||363||
48406091|NCT00741104|101325424|FG000|NOT COMPLETED|Overall Study||0||
48304280|NCT02606461|101072919|FG000|COMPLETED|Period 2: Open Label Period||0||
48304281|NCT02606461|101072920|FG001|COMPLETED|Period 2: Open Label Period||0||
48717141|NCT02677844|102095093|FG004|STARTED|Period 4 (DDI)||7|Participants were mutually exclusive of cohorts, Participants in Cohort 1 \& 2 are different.|
48717142|NCT02677844|102095094|FG005|STARTED|Period 4 (DDI)||4|Participants were mutually exclusive of cohorts, Participants in Cohort 1 \& 2 are different.|
48717143|NCT02677844|102095095|FG006|STARTED|Period 4 (DDI)||4|Participants were mutually exclusive of cohorts, Participants in Cohort 1 \& 2 are different.|
48717144|NCT02677844|102095089|FG000|COMPLETED|Period 4 (DDI)||0||
48717145|NCT02677844|102095090|FG001|COMPLETED|Period 4 (DDI)||0||
48717146|NCT02677844|102095091|FG002|COMPLETED|Period 4 (DDI)||0||
48717147|NCT02677844|102095092|FG003|COMPLETED|Period 4 (DDI)||0||
48717148|NCT02677844|102095093|FG004|COMPLETED|Period 4 (DDI)||7||
48717149|NCT02677844|102095094|FG005|COMPLETED|Period 4 (DDI)||4||
48717150|NCT02677844|102095095|FG006|COMPLETED|Period 4 (DDI)||4||
48717151|NCT02677844|102095089|FG000|NOT COMPLETED|Period 4 (DDI)||0||
48717152|NCT02677844|102095090|FG001|NOT COMPLETED|Period 4 (DDI)||0||
48717153|NCT02677844|102095091|FG002|NOT COMPLETED|Period 4 (DDI)||0||
48717154|NCT02677844|102095092|FG003|NOT COMPLETED|Period 4 (DDI)||0||
48717155|NCT02677844|102095093|FG004|NOT COMPLETED|Period 4 (DDI)||0||
48717156|NCT02677844|102095094|FG005|NOT COMPLETED|Period 4 (DDI)||0||
48717157|NCT02677844|102095095|FG006|NOT COMPLETED|Period 4 (DDI)||0||
48717158|NCT02677844|102095089|FG000|STARTED|Period 5||0||
48717159|NCT02677844|102095090|FG001|STARTED|Period 5||0||
48717160|NCT02677844|102095091|FG002|STARTED|Period 5||0||
48717161|NCT02677844|102095092|FG003|STARTED|Period 5||0||
48717162|NCT02677844|102095093|FG004|STARTED|Period 5||7||
48717163|NCT02677844|102095094|FG005|STARTED|Period 5||4||
48717164|NCT02677844|102095095|FG006|STARTED|Period 5||4||
48717165|NCT02677844|102095089|FG000|COMPLETED|Period 5||0||
48717166|NCT02677844|102095090|FG001|COMPLETED|Period 5||0||
48717167|NCT02677844|102095091|FG002|COMPLETED|Period 5||0||
48717168|NCT02677844|102095092|FG003|COMPLETED|Period 5||0||
48717169|NCT02677844|102095093|FG004|COMPLETED|Period 5||7||
48717170|NCT02677844|102095094|FG005|COMPLETED|Period 5||4||
48717171|NCT02677844|102095095|FG006|COMPLETED|Period 5||4||
48717172|NCT02677844|102095089|FG000|NOT COMPLETED|Period 5||0||
48717173|NCT02677844|102095090|FG001|NOT COMPLETED|Period 5||0||
48717174|NCT02677844|102095091|FG002|NOT COMPLETED|Period 5||0||
48717175|NCT02677844|102095092|FG003|NOT COMPLETED|Period 5||0||
48717176|NCT02677844|102095093|FG004|NOT COMPLETED|Period 5||0||
48717177|NCT02677844|102095094|FG005|NOT COMPLETED|Period 5||0||
48717178|NCT02677844|102095095|FG006|NOT COMPLETED|Period 5||0||
48717179|NCT02677844|102095089|FG000|STARTED|Period 6||0||
48717180|NCT02677844|102095090|FG001|STARTED|Period 6||0||
48717181|NCT02677844|102095091|FG002|STARTED|Period 6||0||
48717182|NCT02677844|102095092|FG003|STARTED|Period 6||0||
48717183|NCT02677844|102095093|FG004|STARTED|Period 6||7||
48717184|NCT02677844|102095094|FG005|STARTED|Period 6||4||
48717185|NCT02677844|102095095|FG006|STARTED|Period 6||4||
48717186|NCT02677844|102095089|FG000|COMPLETED|Period 6||0||
48717187|NCT02677844|102095090|FG001|COMPLETED|Period 6||0||
48717188|NCT02677844|102095091|FG002|COMPLETED|Period 6||0||
48717189|NCT02677844|102095092|FG003|COMPLETED|Period 6||0||
48717190|NCT02677844|102095093|FG004|COMPLETED|Period 6||7||
48717191|NCT02677844|102095094|FG005|COMPLETED|Period 6||4||
48717192|NCT02677844|102095095|FG006|COMPLETED|Period 6||4||
48717193|NCT02677844|102095089|FG000|NOT COMPLETED|Period 6||0||
48717194|NCT02677844|102095090|FG001|NOT COMPLETED|Period 6||0||
48717195|NCT02677844|102095091|FG002|NOT COMPLETED|Period 6||0||
48717196|NCT02677844|102095092|FG003|NOT COMPLETED|Period 6||0||
48717197|NCT02677844|102095093|FG004|NOT COMPLETED|Period 6||0||
48717198|NCT02677844|102095094|FG005|NOT COMPLETED|Period 6||0||
48717199|NCT02677844|102095095|FG006|NOT COMPLETED|Period 6||0||
48717200|NCT02677844|102095089|FG000|STARTED|Period 7||0||
48717201|NCT02677844|102095090|FG001|STARTED|Period 7||0||
48717202|NCT02677844|102095091|FG002|STARTED|Period 7||0||
48717203|NCT02677844|102095092|FG003|STARTED|Period 7||0||
48717204|NCT02677844|102095093|FG004|STARTED|Period 7||7||
48717205|NCT02677844|102095094|FG005|STARTED|Period 7||4||
48717206|NCT02677844|102095095|FG006|STARTED|Period 7||4||
48717207|NCT02677844|102095089|FG000|COMPLETED|Period 7||0||
48717208|NCT02677844|102095090|FG001|COMPLETED|Period 7||0||
48717209|NCT02677844|102095091|FG002|COMPLETED|Period 7||0||
48717210|NCT02677844|102095092|FG003|COMPLETED|Period 7||0||
48717211|NCT02677844|102095093|FG004|COMPLETED|Period 7||7||
48717212|NCT02677844|102095094|FG005|COMPLETED|Period 7||4||
48717213|NCT02677844|102095095|FG006|COMPLETED|Period 7||4||
48717214|NCT02677844|102095089|FG000|NOT COMPLETED|Period 7||0||
48717215|NCT02677844|102095090|FG001|NOT COMPLETED|Period 7||0||
48717216|NCT02677844|102095091|FG002|NOT COMPLETED|Period 7||0||
48717217|NCT02677844|102095092|FG003|NOT COMPLETED|Period 7||0||
48717218|NCT02677844|102095093|FG004|NOT COMPLETED|Period 7||0||
48717219|NCT02677844|102095094|FG005|NOT COMPLETED|Period 7||0||
48717220|NCT02677844|102095095|FG006|NOT COMPLETED|Period 7||0||
48717221|NCT03157583|102095096|FG000|STARTED|Overall Study||8||
48717222|NCT03157583|102095096|FG000|COMPLETED|Overall Study||7||
48717223|NCT03157583|102095096|FG000|NOT COMPLETED|Overall Study||1||
48717224|NCT02639338|102095097|FG000|STARTED|Overall Study||110||
48717225|NCT02639338|102095098|FG001|STARTED|Overall Study||110||
48717226|NCT02639338|102095097|FG000|COMPLETED|Overall Study||106||
48717227|NCT02639338|102095098|FG001|COMPLETED|Overall Study||105||
48717228|NCT02639338|102095097|FG000|NOT COMPLETED|Overall Study||4||
48717229|NCT02639338|102095098|FG001|NOT COMPLETED|Overall Study||5||
48717230|NCT01610596|102095099|FG000|STARTED|Overall Study||36||
48717231|NCT01610596|102095100|FG001|STARTED|Overall Study||36||
48717232|NCT01610596|102095099|FG000|COMPLETED|Overall Study||36||
48717233|NCT01610596|102095100|FG001|COMPLETED|Overall Study||35||
48717234|NCT01610596|102095099|FG000|NOT COMPLETED|Overall Study||0||
48717235|NCT01610596|102095100|FG001|NOT COMPLETED|Overall Study||1||
48717236|NCT01064687|102095101|FG000|STARTED|Overall Study||279||
48717237|NCT01064687|102095102|FG001|STARTED|Overall Study||280||
48717238|NCT01064687|102095103|FG002|STARTED|Overall Study||278||
48717239|NCT01064687|102095104|FG003|STARTED|Overall Study||141||
48717240|NCT01064687|102095101|FG000|Received at Least 1 Dose of Study Drug|Overall Study||279||
48717241|NCT01064687|102095102|FG001|Received at Least 1 Dose of Study Drug|Overall Study||280||
48717242|NCT01064687|102095103|FG002|Received at Least 1 Dose of Study Drug|Overall Study||276||
48717243|NCT01064687|102095104|FG003|Received at Least 1 Dose of Study Drug|Overall Study||141||
48717244|NCT01064687|102095101|FG000|Completed 26 Weeks|Overall Study||260||
48717245|NCT01064687|102095102|FG001|Completed 26 Weeks|Overall Study||263||
48717246|NCT01064687|102095103|FG002|Completed 26 Weeks|Overall Study||252||
48717247|NCT01064687|102095104|FG003|Completed 26 Weeks|Overall Study||124||
48717248|NCT01064687|102095101|FG000|COMPLETED|Overall Study||245||
48717249|NCT01064687|102095102|FG001|COMPLETED|Overall Study||254||
48717250|NCT01064687|102095103|FG002|COMPLETED|Overall Study||237||
48717251|NCT01064687|102095104|FG003|COMPLETED|Overall Study||124||
48149660|NCT00279201|100688761|FG004|STARTED|Maintenance||0||
48717252|NCT01064687|102095101|FG000|NOT COMPLETED|Overall Study||34||
48717253|NCT01064687|102095102|FG001|NOT COMPLETED|Overall Study||26||
48717254|NCT01064687|102095103|FG002|NOT COMPLETED|Overall Study||41||
48717255|NCT01064687|102095104|FG003|NOT COMPLETED|Overall Study||17||
48717256|NCT01655381|102095105|FG000|STARTED|Overall Study||15||
48717257|NCT01655381|102095105|FG000|COMPLETED|Overall Study||12||
48717258|NCT01655381|102095105|FG000|NOT COMPLETED|Overall Study||3||
48717259|NCT00475865|102095106|FG000|STARTED|Overall Study||41||
48717260|NCT00475865|102095107|FG001|STARTED|Overall Study||42||
48717261|NCT00475865|102095108|FG002|STARTED|Overall Study||40||
48717262|NCT00475865|102095106|FG000|Treated|Overall Study||41||
48717263|NCT00475865|102095107|FG001|Treated|Overall Study||42||
48717264|NCT00475865|102095108|FG002|Treated|Overall Study||40||
48717265|NCT00475865|102095106|FG000|COMPLETED|Overall Study||39||
48717266|NCT00475865|102095107|FG001|COMPLETED|Overall Study||37||
48717267|NCT00475865|102095108|FG002|COMPLETED|Overall Study||34||
48717268|NCT00475865|102095106|FG000|NOT COMPLETED|Overall Study||2||
48717269|NCT00475865|102095107|FG001|NOT COMPLETED|Overall Study||5||
48717270|NCT00475865|102095108|FG002|NOT COMPLETED|Overall Study||6||
48717271|NCT03037541|102095109|FG000|STARTED|Overall Study||30||
48717272|NCT03037541|102095110|FG001|STARTED|Overall Study||30||
48717273|NCT03037541|102095109|FG000|COMPLETED|Overall Study||30||
48717274|NCT03037541|102095110|FG001|COMPLETED|Overall Study||30||
48717275|NCT03037541|102095109|FG000|NOT COMPLETED|Overall Study||0||
48717276|NCT03037541|102095110|FG001|NOT COMPLETED|Overall Study||0||
48717277|NCT01231321|102095111|FG000|STARTED|Overall Study||100||
48717278|NCT01231321|102095111|FG000|COMPLETED|Overall Study||95||
48717279|NCT01231321|102095111|FG000|NOT COMPLETED|Overall Study||5||
48717280|NCT00506597|102095112|FG000|STARTED|Overall Study||33||
48717281|NCT00506597|102095112|FG000|COMPLETED|Overall Study||33||
48717282|NCT00506597|102095112|FG000|NOT COMPLETED|Overall Study||0||
48717283|NCT01189292|102095113|FG000|STARTED|Intention to Treat Analysis||76||
48717284|NCT01189292|102095114|FG001|STARTED|Intention to Treat Analysis||76||
48717285|NCT01189292|102095113|FG000|COMPLETED|Intention to Treat Analysis||76||
48717286|NCT01189292|102095114|FG001|COMPLETED|Intention to Treat Analysis||76||
48717287|NCT01189292|102095113|FG000|NOT COMPLETED|Intention to Treat Analysis||0||
48717288|NCT01189292|102095114|FG001|NOT COMPLETED|Intention to Treat Analysis||0||
48717289|NCT01189292|102095113|FG000|STARTED|Per Protocol Analysis||76||
48717290|NCT01189292|102095114|FG001|STARTED|Per Protocol Analysis||76||
48717291|NCT01189292|102095113|FG000|COMPLETED|Per Protocol Analysis||65||
48717292|NCT01189292|102095114|FG001|COMPLETED|Per Protocol Analysis||60||
48717293|NCT01189292|102095113|FG000|NOT COMPLETED|Per Protocol Analysis||11||
48717294|NCT01189292|102095114|FG001|NOT COMPLETED|Per Protocol Analysis||16||
48717295|NCT02068118|102095115|FG000|STARTED|18-month Comparative Study Period||455|"990 patients signed an informed consent, 937 returned home and started their ambulatory monitoring. These 937 patients constituted the Intent to Treat (ITT) population: 455 patients were in the Standard Care group and 482 patients in the Tele-cardiology Group."|
48717296|NCT02068118|102095116|FG001|STARTED|18-month Comparative Study Period||482|"990 patients signed an informed consent, 937 returned home and started their ambulatory monitoring. These 937 patients constituted the Intent to Treat (ITT) population: 455 patients were in the Standard Care group and 482 patients in the Tele-cardiology Group."|
48717297|NCT02068118|102095115|FG000|COMPLETED|18-month Comparative Study Period||327||
48717298|NCT02068118|102095116|FG001|COMPLETED|18-month Comparative Study Period||305||
48717299|NCT02068118|102095115|FG000|NOT COMPLETED|18-month Comparative Study Period||128||
48717300|NCT02068118|102095116|FG001|NOT COMPLETED|18-month Comparative Study Period||177||
48717301|NCT02068118|102095115|FG000|STARTED|Extension Period||7||
48717302|NCT02068118|102095116|FG001|STARTED|Extension Period||13||
48717303|NCT02068118|102095115|FG000|COMPLETED|Extension Period||5||
48717304|NCT02068118|102095116|FG001|COMPLETED|Extension Period||10||
48717305|NCT02068118|102095115|FG000|NOT COMPLETED|Extension Period||2||
48717306|NCT02068118|102095116|FG001|NOT COMPLETED|Extension Period||3||
48717307|NCT02317809|102095117|FG000|STARTED|First Intervention Period (8 Days)||17||
48717308|NCT02317809|102095118|FG001|STARTED|First Intervention Period (8 Days)||17||
48717309|NCT02317809|102095117|FG000|COMPLETED|First Intervention Period (8 Days)||14||
48717310|NCT02317809|102095118|FG001|COMPLETED|First Intervention Period (8 Days)||17||
48717311|NCT02317809|102095117|FG000|NOT COMPLETED|First Intervention Period (8 Days)||3||
48717312|NCT02317809|102095118|FG001|NOT COMPLETED|First Intervention Period (8 Days)||0||
48717313|NCT02317809|102095117|FG000|STARTED|Second Intervention Period (8 Days)||14||
48717314|NCT02317809|102095118|FG001|STARTED|Second Intervention Period (8 Days)||17||
48717315|NCT02317809|102095117|FG000|COMPLETED|Second Intervention Period (8 Days)||14||
48717316|NCT02317809|102095118|FG001|COMPLETED|Second Intervention Period (8 Days)||17||
48717317|NCT02317809|102095117|FG000|NOT COMPLETED|Second Intervention Period (8 Days)||0||
48717318|NCT02317809|102095118|FG001|NOT COMPLETED|Second Intervention Period (8 Days)||0||
48717319|NCT01483209|102095119|FG000|STARTED|Overall Study||2||
48717320|NCT01483209|102095119|FG000|COMPLETED|Overall Study||1||
48717321|NCT01483209|102095119|FG000|NOT COMPLETED|Overall Study||1||
48717322|NCT00871923|102095120|FG000|STARTED|Overall Study||44||
48717323|NCT00871923|102095120|FG000|COMPLETED|Overall Study||42||
48717324|NCT00871923|102095120|FG000|NOT COMPLETED|Overall Study||2||
48717325|NCT03242252|102095121|FG000|STARTED|Overall Study||260||
48717326|NCT03242252|102095122|FG001|STARTED|Overall Study||263||
48717327|NCT03242252|102095123|FG002|STARTED|Overall Study||264||
48304282|NCT02606461|101072921|FG002|COMPLETED|Period 2: Open Label Period||0||
48304283|NCT02606461|101072922|FG003|COMPLETED|Period 2: Open Label Period||0||
48717328|NCT03242252|102095121|FG000|COMPLETED|Overall Study||224||
48717329|NCT03242252|102095122|FG001|COMPLETED|Overall Study||240||
48717330|NCT03242252|102095123|FG002|COMPLETED|Overall Study||232||
48717331|NCT03242252|102095121|FG000|NOT COMPLETED|Overall Study||36||
48717332|NCT03242252|102095122|FG001|NOT COMPLETED|Overall Study||23||
48717333|NCT03242252|102095123|FG002|NOT COMPLETED|Overall Study||32||
48717334|NCT00276614|102095124|FG000|STARTED|Overall Study||4||
48717335|NCT00276614|102095124|FG000|COMPLETED|Overall Study||1||
48717336|NCT00276614|102095124|FG000|NOT COMPLETED|Overall Study||3||
48717337|NCT00780481|102095125|FG000|STARTED|Overall Study||13||
48717338|NCT00780481|102095125|FG000|COMPLETED|Overall Study||13||
48717339|NCT00780481|102095125|FG000|NOT COMPLETED|Overall Study||0||
48717340|NCT00424190|102095126|FG000|STARTED|Overall Study||351||
48717341|NCT00424190|102095127|FG001|STARTED|Overall Study||347||
48717342|NCT00424190|102095126|FG000|COMPLETED|Overall Study||329||
48717343|NCT00424190|102095127|FG001|COMPLETED|Overall Study||317||
48717344|NCT00424190|102095126|FG000|NOT COMPLETED|Overall Study||22||
48717345|NCT00424190|102095127|FG001|NOT COMPLETED|Overall Study||30||
48717346|NCT00907296|102095128|FG000|STARTED|Overall Study||103||
48717347|NCT00907296|102095129|FG001|STARTED|Overall Study||34||
48717348|NCT00907296|102095130|FG002|STARTED|Overall Study||34||
48717349|NCT00907296|102095131|FG003|STARTED|Overall Study||33||
48717350|NCT00907296|102095132|FG004|STARTED|Overall Study||33||
48717351|NCT00907296|102095133|FG005|STARTED|Overall Study||33||
48717352|NCT00907296|102095134|FG006|STARTED|Overall Study||33||
48717353|NCT00907296|102095135|FG007|STARTED|Overall Study||33||
48717354|NCT00907296|102095136|FG008|STARTED|Overall Study||31||
48717355|NCT00907296|102095137|FG009|STARTED|Overall Study||35||
48717356|NCT00907296|102095128|FG000|Received Treatment|Overall Study||100||
48717357|NCT00907296|102095129|FG001|Received Treatment|Overall Study||34||
48717358|NCT00907296|102095130|FG002|Received Treatment|Overall Study||34||
48717359|NCT00907296|102095131|FG003|Received Treatment|Overall Study||32||
48717360|NCT00907296|102095132|FG004|Received Treatment|Overall Study||33||
48717361|NCT00907296|102095133|FG005|Received Treatment|Overall Study||32||
48717362|NCT00907296|102095134|FG006|Received Treatment|Overall Study||31||
48717363|NCT00907296|102095135|FG007|Received Treatment|Overall Study||32||
48717364|NCT00907296|102095136|FG008|Received Treatment|Overall Study||30||
48717365|NCT00907296|102095137|FG009|Received Treatment|Overall Study||35||
48717366|NCT00907296|102095128|FG000|COMPLETED|Overall Study||83||
48717367|NCT00907296|102095129|FG001|COMPLETED|Overall Study||29||
48717368|NCT00907296|102095130|FG002|COMPLETED|Overall Study||32||
48717369|NCT00907296|102095131|FG003|COMPLETED|Overall Study||29||
48717370|NCT00907296|102095132|FG004|COMPLETED|Overall Study||32||
48717371|NCT00907296|102095133|FG005|COMPLETED|Overall Study||24||
48717372|NCT00907296|102095134|FG006|COMPLETED|Overall Study||27||
48717373|NCT00907296|102095135|FG007|COMPLETED|Overall Study||26||
48717374|NCT00907296|102095136|FG008|COMPLETED|Overall Study||27||
48717375|NCT00907296|102095137|FG009|COMPLETED|Overall Study||28||
48717376|NCT00907296|102095128|FG000|NOT COMPLETED|Overall Study||20||
48717377|NCT00907296|102095129|FG001|NOT COMPLETED|Overall Study||5||
48717378|NCT00907296|102095130|FG002|NOT COMPLETED|Overall Study||2||
48717379|NCT00907296|102095131|FG003|NOT COMPLETED|Overall Study||4||
48304284|NCT02606461|101072923|FG004|COMPLETED|Period 2: Open Label Period||24||
48304285|NCT02606461|101072924|FG005|COMPLETED|Period 2: Open Label Period||63||
48304286|NCT02606461|101072919|FG000|NOT COMPLETED|Period 2: Open Label Period||0||
48304287|NCT02606461|101072920|FG001|NOT COMPLETED|Period 2: Open Label Period||0||
48304288|NCT02606461|101072921|FG002|NOT COMPLETED|Period 2: Open Label Period||0||
48304289|NCT02606461|101072922|FG003|NOT COMPLETED|Period 2: Open Label Period||0||
48304290|NCT02606461|101072923|FG004|NOT COMPLETED|Period 2: Open Label Period||0||
48304291|NCT02606461|101072924|FG005|NOT COMPLETED|Period 2: Open Label Period||0||
48304292|NCT01494350|101072925|FG000|STARTED|Overall Study||50||
48304293|NCT01494350|101072925|FG000|COMPLETED|Overall Study||49||
48304294|NCT01494350|101072925|FG000|NOT COMPLETED|Overall Study||1||
48304295|NCT03352011|101072926|FG000|STARTED|Overall Study||28||
48304296|NCT03352011|101072927|FG001|STARTED|Overall Study||27||
48304297|NCT03352011|101072926|FG000|COMPLETED|Overall Study||21||
48304298|NCT03352011|101072927|FG001|COMPLETED|Overall Study||20||
48304299|NCT03352011|101072926|FG000|NOT COMPLETED|Overall Study||7||
48304300|NCT03352011|101072927|FG001|NOT COMPLETED|Overall Study||7||
48304301|NCT02072928|101072928|FG000|STARTED|Overall Study||55||
48304302|NCT02072928|101072928|FG000|COMPLETED|Overall Study||55||
48304303|NCT02072928|101072928|FG000|NOT COMPLETED|Overall Study||0||
48606736|NCT02173379|101823364|FG001|COMPLETED|Overall Study||1118||
48606737|NCT02173379|101823363|FG000|NOT COMPLETED|Overall Study||197||
48606738|NCT02173379|101823364|FG001|NOT COMPLETED|Overall Study||190||
48606739|NCT00551525|101823365|FG000|STARTED|Overall Study||67||
48606740|NCT00551525|101823365|FG000|COMPLETED|Overall Study||62||
48606741|NCT00551525|101823365|FG000|NOT COMPLETED|Overall Study||5||
48606742|NCT00004500|101823366|FG000|STARTED|Overall Study||38||
48606743|NCT00004500|101823367|FG001|STARTED|Overall Study||31||
48606744|NCT00004500|101823366|FG000|1 Year Follow-Up|Overall Study||24||
48606745|NCT00004500|101823367|FG001|1 Year Follow-Up|Overall Study||24||
48606746|NCT00004500|101823366|FG000|COMPLETED|Overall Study||38||
48606747|NCT00004500|101823367|FG001|COMPLETED|Overall Study||31||
48606748|NCT00004500|101823366|FG000|NOT COMPLETED|Overall Study||0||
48606749|NCT00004500|101823367|FG001|NOT COMPLETED|Overall Study||0||
48606750|NCT01118663|101823368|FG000|STARTED|Overall Study||7||
48606751|NCT01118663|101823369|FG001|STARTED|Overall Study||10||
48606752|NCT01118663|101823368|FG000|COMPLETED|Overall Study||5||
48606753|NCT01118663|101823369|FG001|COMPLETED|Overall Study||8||
48606754|NCT01118663|101823368|FG000|NOT COMPLETED|Overall Study||2||
48606755|NCT01118663|101823369|FG001|NOT COMPLETED|Overall Study||2||
48606756|NCT01308463|101823370|FG000|STARTED|Overall Study||29||
48606757|NCT01308463|101823370|FG000|6 Months|Overall Study||23||
48606758|NCT01308463|101823370|FG000|1 Year|Overall Study||21||
48606759|NCT01308463|101823370|FG000|2 Years|Overall Study||18||
48606760|NCT01308463|101823370|FG000|3 Years|Overall Study||17||
48606761|NCT01308463|101823370|FG000|4 Years|Overall Study||20||
48606762|NCT01308463|101823370|FG000|5 Years|Overall Study||20||
48606763|NCT01308463|101823370|FG000|6 Years|Overall Study||11||
48606764|NCT01308463|101823370|FG000|7 Years|Overall Study||12||
48606765|NCT01308463|101823370|FG000|8 Years|Overall Study||14||
48606766|NCT01308463|101823370|FG000|9 Years|Overall Study||11||
48606767|NCT01308463|101823370|FG000|10 Years|Overall Study||8||
48606768|NCT01308463|101823370|FG000|11 Years|Overall Study||8||
48606769|NCT01308463|101823370|FG000|12 Years|Overall Study||2||
48606770|NCT01308463|101823370|FG000|COMPLETED|Overall Study||0||
48606771|NCT01308463|101823370|FG000|NOT COMPLETED|Overall Study||29||
48606772|NCT01080976|101823371|FG000|STARTED|Overall Study||5||
48606773|NCT01080976|101823372|FG001|STARTED|Overall Study||5||
48606774|NCT01080976|101823371|FG000|COMPLETED|Overall Study||5||
48606775|NCT01080976|101823372|FG001|COMPLETED|Overall Study||5||
48606776|NCT01080976|101823371|FG000|NOT COMPLETED|Overall Study||0||
48304304|NCT03681886|101072929|FG000|STARTED|Overall Study||78||100
48304305|NCT03681886|101072929|FG000|Successful Implantation|Overall Study||76||98
48304306|NCT03681886|101072929|FG000|Failed Implantation|Overall Study||2||2
48304307|NCT03681886|101072929|FG000|Underwent Optic Exchange|Overall Study||4||4
48304308|NCT03681886|101072929|FG000|COMPLETED|Overall Study||76||98
48304309|NCT03681886|101072929|FG000|NOT COMPLETED|Overall Study||2||2
48304310|NCT03701763|101072930|FG000|STARTED|Placebo-controlled Phase||82||
48606777|NCT01080976|101823372|FG001|NOT COMPLETED|Overall Study||0||
48606778|NCT02309723|101823373|FG000|STARTED|Overall Study||129||
48606779|NCT02309723|101823374|FG001|STARTED|Overall Study||128||
48304311|NCT03701763|101072931|FG001|STARTED|Placebo-controlled Phase||163||
48606780|NCT02309723|101823375|FG002|STARTED|Overall Study||129||
48606781|NCT02309723|101823373|FG000|COMPLETED|Overall Study||105||
48606782|NCT02309723|101823374|FG001|COMPLETED|Overall Study||105||
48606783|NCT02309723|101823375|FG002|COMPLETED|Overall Study||105||
48606784|NCT02309723|101823373|FG000|NOT COMPLETED|Overall Study||24||
48606785|NCT02309723|101823374|FG001|NOT COMPLETED|Overall Study||23||
48304312|NCT03701763|101072932|FG002|STARTED|Placebo-controlled Phase||0||
48304313|NCT03701763|101072933|FG003|STARTED|Placebo-controlled Phase||0||
48304314|NCT03701763|101072930|FG000|Took at Least 1 Dose of Investigational Product (IP)|Placebo-controlled Phase||80||
48368015|NCT03567291|101230092|FG000|Intent to Treat Set|Period I||228||
48606786|NCT02309723|101823375|FG002|NOT COMPLETED|Overall Study||24||
48606787|NCT03956030|101823376|FG000|STARTED|Overall Study||4||
48606788|NCT03956030|101823377|FG001|STARTED|Overall Study||4||
48606789|NCT03956030|101823376|FG000|COMPLETED|Overall Study||1||
48606790|NCT03956030|101823377|FG001|COMPLETED|Overall Study||1||
48606791|NCT03956030|101823376|FG000|NOT COMPLETED|Overall Study||3||
48606792|NCT03956030|101823377|FG001|NOT COMPLETED|Overall Study||3||
48606793|NCT03332095|101823378|FG000|STARTED|Overall Study||10||
48606794|NCT03332095|101823379|FG001|STARTED|Overall Study||45||
48606795|NCT03332095|101823378|FG000|Received at Least One Dose of Study Treatment|Overall Study||9||
48606796|NCT03332095|101823379|FG001|Received at Least One Dose of Study Treatment|Overall Study||45||
48606797|NCT03332095|101823378|FG000|COMPLETED|Overall Study||9||
48606798|NCT03332095|101823379|FG001|COMPLETED|Overall Study||44||
48606799|NCT03332095|101823378|FG000|NOT COMPLETED|Overall Study||1||
48606800|NCT03332095|101823379|FG001|NOT COMPLETED|Overall Study||1||
48606801|NCT00045734|101823380|FG000|STARTED|Overall Study||23||
48717380|NCT00907296|102095132|FG004|NOT COMPLETED|Overall Study||1||
48149661|NCT00279201|100688762|FG005|STARTED|Maintenance||0||
48149662|NCT00279201|100688757|FG000|COMPLETED|Maintenance||188||
48149663|NCT00279201|100688758|FG001|COMPLETED|Maintenance||239||
48149664|NCT00279201|100688759|FG002|COMPLETED|Maintenance||0||
48149665|NCT00279201|100688760|FG003|COMPLETED|Maintenance||0||
48149666|NCT00279201|100688761|FG004|COMPLETED|Maintenance||0||
48149667|NCT00279201|100688762|FG005|COMPLETED|Maintenance||0||
48149668|NCT00279201|100688757|FG000|NOT COMPLETED|Maintenance||231||
48149669|NCT00279201|100688758|FG001|NOT COMPLETED|Maintenance||234||
48149670|NCT00279201|100688759|FG002|NOT COMPLETED|Maintenance||0||
48149671|NCT00279201|100688760|FG003|NOT COMPLETED|Maintenance||0||
48149672|NCT00279201|100688761|FG004|NOT COMPLETED|Maintenance||0||
48149673|NCT00279201|100688762|FG005|NOT COMPLETED|Maintenance||0||
48149674|NCT00279201|100688757|FG000|STARTED|Intensification Addendum||0||
48149675|NCT00279201|100688758|FG001|STARTED|Intensification Addendum||0||
48149676|NCT00279201|100688759|FG002|STARTED|Intensification Addendum||174||
48149677|NCT00279201|100688760|FG003|STARTED|Intensification Addendum||200||
48149678|NCT00279201|100688761|FG004|STARTED|Intensification Addendum||171||
48149679|NCT00279201|100688762|FG005|STARTED|Intensification Addendum||199||
48149680|NCT00279201|100688757|FG000|COMPLETED|Intensification Addendum||0||
48149681|NCT00279201|100688758|FG001|COMPLETED|Intensification Addendum||0||
48149682|NCT00279201|100688759|FG002|COMPLETED|Intensification Addendum||151||
48149683|NCT00279201|100688760|FG003|COMPLETED|Intensification Addendum||172||
48149684|NCT00279201|100688761|FG004|COMPLETED|Intensification Addendum||142||
48149685|NCT00279201|100688762|FG005|COMPLETED|Intensification Addendum||162||
48606802|NCT00045734|101823380|FG000|COMPLETED|Overall Study||22||
48606803|NCT00045734|101823380|FG000|NOT COMPLETED|Overall Study||1||
48606804|NCT01429441|101823381|FG000|STARTED|Overall Study||146||
48606805|NCT01429441|101823382|FG001|STARTED|Overall Study||74||
48606806|NCT01429441|101823381|FG000|COMPLETED|Overall Study||108||
48606807|NCT01429441|101823382|FG001|COMPLETED|Overall Study||51||
48606808|NCT01429441|101823381|FG000|NOT COMPLETED|Overall Study||38||
48606809|NCT01429441|101823382|FG001|NOT COMPLETED|Overall Study||23||
48606810|NCT02263729|101823383|FG000|STARTED|Overall Study||3||
48606811|NCT02263729|101823384|FG001|STARTED|Overall Study||3||
48606812|NCT02263729|101823383|FG000|Week 1 Follow-up|Overall Study||3||
48606813|NCT02263729|101823384|FG001|Week 1 Follow-up|Overall Study||3||
48606814|NCT02263729|101823383|FG000|Week 2 Follow-up|Overall Study||3||
48606815|NCT02263729|101823384|FG001|Week 2 Follow-up|Overall Study||3||
48606816|NCT02263729|101823383|FG000|Week 3 Follow-up|Overall Study||3||
48606817|NCT02263729|101823384|FG001|Week 3 Follow-up|Overall Study||3||
48606818|NCT02263729|101823383|FG000|Week 4 Follow-up|Overall Study||3||
48606819|NCT02263729|101823384|FG001|Week 4 Follow-up|Overall Study||3||
48606820|NCT02263729|101823383|FG000|Week 6 Follow-up|Overall Study||2||
48606821|NCT02263729|101823384|FG001|Week 6 Follow-up|Overall Study||3||
48606822|NCT02263729|101823383|FG000|3 Month Follow-up|Overall Study||2||
48149686|NCT00279201|100688757|FG000|NOT COMPLETED|Intensification Addendum||0||
48606823|NCT02263729|101823384|FG001|3 Month Follow-up|Overall Study||3||
48606824|NCT02263729|101823383|FG000|6 Month Follow-up|Overall Study||2||
48606825|NCT02263729|101823384|FG001|6 Month Follow-up|Overall Study||3||
48606826|NCT02263729|101823383|FG000|9 Month Follow-up|Overall Study||2||
48606827|NCT02263729|101823384|FG001|9 Month Follow-up|Overall Study||3||
48606828|NCT02263729|101823383|FG000|12 Month Follow-up|Overall Study||2||
48606829|NCT02263729|101823384|FG001|12 Month Follow-up|Overall Study||2||
48606830|NCT02263729|101823383|FG000|COMPLETED|Overall Study||2||
48606831|NCT02263729|101823384|FG001|COMPLETED|Overall Study||2||
48606832|NCT02263729|101823383|FG000|NOT COMPLETED|Overall Study||1||
48606833|NCT02263729|101823384|FG001|NOT COMPLETED|Overall Study||1||
48606834|NCT01441245|101823385|FG000|STARTED|Overall Study||30||
48606835|NCT01441245|101823386|FG001|STARTED|Overall Study||27||
48606836|NCT01441245|101823385|FG000|COMPLETED|Overall Study||30||
48606837|NCT01441245|101823386|FG001|COMPLETED|Overall Study||27||
48606838|NCT01441245|101823385|FG000|NOT COMPLETED|Overall Study||0||
48606839|NCT01441245|101823386|FG001|NOT COMPLETED|Overall Study||0||
48606840|NCT02496039|101823387|FG000|STARTED|Overall Study||5||
48606841|NCT02496039|101823387|FG000|COMPLETED|Overall Study||1||
48606842|NCT02496039|101823387|FG000|NOT COMPLETED|Overall Study||4||
48606843|NCT03297021|101823388|FG000|STARTED|Overall Study||48||
48606844|NCT03297021|101823389|FG001|STARTED|Overall Study||46||
48606845|NCT03297021|101823390|FG002|STARTED|Overall Study||47||
48606846|NCT03297021|101823388|FG000|COMPLETED|Overall Study||43||
48606847|NCT03297021|101823389|FG001|COMPLETED|Overall Study||42||
48606848|NCT03297021|101823390|FG002|COMPLETED|Overall Study||43||
48606849|NCT03297021|101823388|FG000|NOT COMPLETED|Overall Study||5||
48606850|NCT03297021|101823389|FG001|NOT COMPLETED|Overall Study||4||
48606851|NCT03297021|101823390|FG002|NOT COMPLETED|Overall Study||4||
48606852|NCT02609984|101823391|FG000|STARTED|Overall Study||45||
48606853|NCT02609984|101823392|FG001|STARTED|Overall Study||44||
48606854|NCT02609984|101823391|FG000|Treated|Overall Study||45||
48606855|NCT02609984|101823392|FG001|Treated|Overall Study||43||
48606856|NCT02609984|101823391|FG000|COMPLETED|Overall Study||1||
48606857|NCT02609984|101823392|FG001|COMPLETED|Overall Study||5||
48606858|NCT02609984|101823391|FG000|NOT COMPLETED|Overall Study||44||
48717381|NCT00907296|102095133|FG005|NOT COMPLETED|Overall Study||9||
48717382|NCT00907296|102095134|FG006|NOT COMPLETED|Overall Study||6||
48717383|NCT00907296|102095135|FG007|NOT COMPLETED|Overall Study||7||
48717384|NCT00907296|102095136|FG008|NOT COMPLETED|Overall Study||4||
48717385|NCT00907296|102095137|FG009|NOT COMPLETED|Overall Study||7||
48717386|NCT01352637|102095138|FG000|STARTED|Exposure Therapy||97||
48717387|NCT01352637|102095139|FG001|STARTED|Exposure Therapy||95||
48717388|NCT01352637|102095140|FG002|STARTED|Exposure Therapy||0||
48717389|NCT01352637|102095141|FG003|STARTED|Exposure Therapy||0||
48717390|NCT01352637|102095138|FG000|COMPLETED|Exposure Therapy||70||
48717391|NCT01352637|102095139|FG001|COMPLETED|Exposure Therapy||62||
48717392|NCT01352637|102095140|FG002|COMPLETED|Exposure Therapy||0||
48717393|NCT01352637|102095141|FG003|COMPLETED|Exposure Therapy||0||
48717394|NCT01352637|102095138|FG000|NOT COMPLETED|Exposure Therapy||27||
48717395|NCT01352637|102095139|FG001|NOT COMPLETED|Exposure Therapy||33||
48717396|NCT01352637|102095140|FG002|NOT COMPLETED|Exposure Therapy||0||
48717397|NCT01352637|102095141|FG003|NOT COMPLETED|Exposure Therapy||0||
48717398|NCT01352637|102095138|FG000|STARTED|Drug||0||
48717399|NCT01352637|102095139|FG001|STARTED|Drug||0||
48717400|NCT01352637|102095140|FG002|STARTED|Drug||95||
48717401|NCT01352637|102095141|FG003|STARTED|Drug||97||
48717402|NCT01352637|102095138|FG000|COMPLETED|Drug||0||
48717403|NCT01352637|102095139|FG001|COMPLETED|Drug||0||
48717404|NCT01352637|102095140|FG002|COMPLETED|Drug||70||
48717405|NCT01352637|102095141|FG003|COMPLETED|Drug||62||
48717406|NCT01352637|102095138|FG000|NOT COMPLETED|Drug||0||
48717407|NCT01352637|102095139|FG001|NOT COMPLETED|Drug||0||
48717408|NCT01352637|102095140|FG002|NOT COMPLETED|Drug||25||
48717409|NCT01352637|102095141|FG003|NOT COMPLETED|Drug||35||
48717410|NCT01672866|102095142|FG000|STARTED|Blinded Phase (up to 240 Weeks)||74||
48717411|NCT01672866|102095143|FG001|STARTED|Blinded Phase (up to 240 Weeks)||74||
48717412|NCT01672866|102095144|FG002|STARTED|Blinded Phase (up to 240 Weeks)||74||
48717413|NCT01672866|102095142|FG000|COMPLETED|Blinded Phase (up to 240 Weeks)||0||
48717414|NCT01672866|102095143|FG001|COMPLETED|Blinded Phase (up to 240 Weeks)||0||
48717415|NCT01672866|102095144|FG002|COMPLETED|Blinded Phase (up to 240 Weeks)||0||
48717416|NCT01672866|102095142|FG000|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74||
48606859|NCT02609984|101823392|FG001|NOT COMPLETED|Overall Study||39||
48606860|NCT02700425|101823393|FG000|STARTED|Overall Study||21||
48606861|NCT02700425|101823394|FG001|STARTED|Overall Study||20||
48606862|NCT02700425|101823393|FG000|COMPLETED|Overall Study||21||
48606863|NCT02700425|101823394|FG001|COMPLETED|Overall Study||19||
48717417|NCT01672866|102095143|FG001|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74||
48717418|NCT01672866|102095144|FG002|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74||
48717419|NCT01672866|102095142|FG000|STARTED|Open-Label Phase (up to 240 Weeks)||11||
48717420|NCT01672866|102095143|FG001|STARTED|Open-Label Phase (up to 240 Weeks)||15||
48717421|NCT01672866|102095144|FG002|STARTED|Open-Label Phase (up to 240 Weeks)||16||
48717422|NCT01672866|102095142|FG000|COMPLETED|Open-Label Phase (up to 240 Weeks)||0||
48717423|NCT01672866|102095143|FG001|COMPLETED|Open-Label Phase (up to 240 Weeks)||0||
48717424|NCT01672866|102095144|FG002|COMPLETED|Open-Label Phase (up to 240 Weeks)||0||
48717425|NCT01672866|102095142|FG000|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||11||
48717426|NCT01672866|102095143|FG001|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||15||
48717427|NCT01672866|102095144|FG002|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||16||
48717428|NCT02634606|102095145|FG000|STARTED|Overall Study||13|13 eligible participants enrolled; none were assigned to an intervention prior to termination.|
48717429|NCT02634606|102095145|FG000|COMPLETED|Overall Study||0||
48606864|NCT02700425|101823393|FG000|NOT COMPLETED|Overall Study||0||
48606865|NCT02700425|101823394|FG001|NOT COMPLETED|Overall Study||1||
48606866|NCT03782571|101823395|FG000|STARTED|Period 1||6||
48717430|NCT02634606|102095145|FG000|NOT COMPLETED|Overall Study||13||
48717431|NCT05590000|102095146|FG000|STARTED|Overall Study||25||
48717432|NCT05590000|102095146|FG000|COMPLETED|Overall Study||24||
48717433|NCT05590000|102095146|FG000|NOT COMPLETED|Overall Study||1||
48717434|NCT00748709|102095147|FG000|STARTED|Overall Study||20||
48717435|NCT00748709|102095147|FG000|COMPLETED|Overall Study||0||
48717436|NCT00748709|102095147|FG000|NOT COMPLETED|Overall Study||20||
48717437|NCT00787202|102095148|FG000|STARTED|Overall Study||49||
48606867|NCT03782571|101823396|FG001|STARTED|Period 1||6||
48606868|NCT03782571|101823397|FG002|STARTED|Period 1||6||
48606869|NCT03782571|101823398|FG003|STARTED|Period 1||7||
48606870|NCT03782571|101823395|FG000|COMPLETED|Period 1||5||
48606871|NCT03782571|101823396|FG001|COMPLETED|Period 1||6||
48606872|NCT03782571|101823397|FG002|COMPLETED|Period 1||6||
48606873|NCT03782571|101823398|FG003|COMPLETED|Period 1||7||
48606874|NCT03782571|101823395|FG000|NOT COMPLETED|Period 1||1||
48606875|NCT03782571|101823396|FG001|NOT COMPLETED|Period 1||0||
48606876|NCT03782571|101823397|FG002|NOT COMPLETED|Period 1||0||
48606877|NCT03782571|101823398|FG003|NOT COMPLETED|Period 1||0||
48606878|NCT03782571|101823395|FG000|STARTED|Period 2||5||
48606879|NCT03782571|101823396|FG001|STARTED|Period 2||6||
48606880|NCT03782571|101823397|FG002|STARTED|Period 2||6||
48606881|NCT03782571|101823398|FG003|STARTED|Period 2||7||
48606882|NCT03782571|101823395|FG000|COMPLETED|Period 2||5||
48606883|NCT03782571|101823396|FG001|COMPLETED|Period 2||6||
48606884|NCT03782571|101823397|FG002|COMPLETED|Period 2||6||
48606885|NCT03782571|101823398|FG003|COMPLETED|Period 2||7||
48606886|NCT03782571|101823395|FG000|NOT COMPLETED|Period 2||0||
48606887|NCT03782571|101823396|FG001|NOT COMPLETED|Period 2||0||
48606888|NCT03782571|101823397|FG002|NOT COMPLETED|Period 2||0||
48606889|NCT03782571|101823398|FG003|NOT COMPLETED|Period 2||0||
48606890|NCT03782571|101823395|FG000|STARTED|Period 3||5||
48606891|NCT03782571|101823396|FG001|STARTED|Period 3||6||
48606892|NCT03782571|101823397|FG002|STARTED|Period 3||6||
48606893|NCT03782571|101823398|FG003|STARTED|Period 3||7||
48606894|NCT03782571|101823395|FG000|COMPLETED|Period 3||3||
48606895|NCT03782571|101823396|FG001|COMPLETED|Period 3||6||
48606896|NCT03782571|101823397|FG002|COMPLETED|Period 3||6||
48606897|NCT03782571|101823398|FG003|COMPLETED|Period 3||7||
48606898|NCT03782571|101823395|FG000|NOT COMPLETED|Period 3||2||
48606899|NCT03782571|101823396|FG001|NOT COMPLETED|Period 3||0||
48606900|NCT03782571|101823397|FG002|NOT COMPLETED|Period 3||0||
48606901|NCT03782571|101823398|FG003|NOT COMPLETED|Period 3||0||
48606902|NCT03782571|101823395|FG000|STARTED|Period 4||3||
48606903|NCT03782571|101823396|FG001|STARTED|Period 4||6||
48606904|NCT03782571|101823397|FG002|STARTED|Period 4||6||
48606905|NCT03782571|101823398|FG003|STARTED|Period 4||7||
48606906|NCT03782571|101823395|FG000|COMPLETED|Period 4||3||
48606907|NCT03782571|101823396|FG001|COMPLETED|Period 4||6||
48606908|NCT03782571|101823397|FG002|COMPLETED|Period 4||6||
48606909|NCT03782571|101823398|FG003|COMPLETED|Period 4||7||
48606910|NCT03782571|101823395|FG000|NOT COMPLETED|Period 4||0||
48606911|NCT03782571|101823396|FG001|NOT COMPLETED|Period 4||0||
48606912|NCT03782571|101823397|FG002|NOT COMPLETED|Period 4||0||
48606913|NCT03782571|101823398|FG003|NOT COMPLETED|Period 4||0||
48606914|NCT01424241|101823399|FG000|STARTED|Overall Study||21||
48606915|NCT01424241|101823399|FG000|COMPLETED|Overall Study||18||
48606916|NCT01424241|101823399|FG000|NOT COMPLETED|Overall Study||3||
48606917|NCT00527124|101823400|FG000|STARTED|Overall Study||29||
48606918|NCT00527124|101823401|FG001|STARTED|Overall Study||28||
48717438|NCT00787202|102095149|FG001|STARTED|Overall Study||31||
48717439|NCT00787202|102095150|FG002|STARTED|Overall Study||33||
48717440|NCT00787202|102095151|FG003|STARTED|Overall Study||33||
48717441|NCT00787202|102095152|FG004|STARTED|Overall Study||49||
48717442|NCT00787202|102095148|FG000|Treated|Overall Study||48||
48717443|NCT00787202|102095149|FG001|Treated|Overall Study||31||
48717444|NCT00787202|102095150|FG002|Treated|Overall Study||33||
48717445|NCT00787202|102095151|FG003|Treated|Overall Study||33||
48717446|NCT00787202|102095152|FG004|Treated|Overall Study||49||
48717447|NCT00787202|102095148|FG000|COMPLETED|Overall Study||35||
48717448|NCT00787202|102095149|FG001|COMPLETED|Overall Study||20||
48717449|NCT00787202|102095150|FG002|COMPLETED|Overall Study||26||
48717450|NCT00787202|102095151|FG003|COMPLETED|Overall Study||31||
48717451|NCT00787202|102095152|FG004|COMPLETED|Overall Study||45||
48717452|NCT00787202|102095148|FG000|NOT COMPLETED|Overall Study||14||
48717453|NCT00787202|102095149|FG001|NOT COMPLETED|Overall Study||11||
48717454|NCT00787202|102095150|FG002|NOT COMPLETED|Overall Study||7||
48717455|NCT00787202|102095151|FG003|NOT COMPLETED|Overall Study||2||
48717456|NCT00787202|102095152|FG004|NOT COMPLETED|Overall Study||4||
48717457|NCT00316693|102095153|FG000|STARTED|Overall Study||519||
48717458|NCT00316693|102095154|FG001|STARTED|Overall Study||521||
48717459|NCT00316693|102095153|FG000|COMPLETED|Overall Study||442||
48717460|NCT00316693|102095154|FG001|COMPLETED|Overall Study||436||
48717461|NCT00316693|102095153|FG000|NOT COMPLETED|Overall Study||77||
48717462|NCT00316693|102095154|FG001|NOT COMPLETED|Overall Study||85||
48717463|NCT01048866|102095155|FG000|STARTED|Overall Study||101||
48717464|NCT01048866|102095156|FG001|STARTED|Overall Study||97||
48717465|NCT01048866|102095155|FG000|COMPLETED|Overall Study||97||
48717466|NCT01048866|102095156|FG001|COMPLETED|Overall Study||92||
48717467|NCT01048866|102095155|FG000|NOT COMPLETED|Overall Study||4||
48717468|NCT01048866|102095156|FG001|NOT COMPLETED|Overall Study||5||
48717469|NCT01541917|102095157|FG000|STARTED|Overall Study||144||
48717470|NCT01541917|102095158|FG001|STARTED|Overall Study||145||
48717471|NCT01541917|102095157|FG000|COMPLETED|Overall Study||129||
48717472|NCT01541917|102095158|FG001|COMPLETED|Overall Study||136||
48717473|NCT01541917|102095157|FG000|NOT COMPLETED|Overall Study||15||
48717474|NCT01541917|102095158|FG001|NOT COMPLETED|Overall Study||9||
48717475|NCT01275092|102095159|FG000|STARTED|Overall Study||164||
48717476|NCT01275092|102095159|FG000|COMPLETED|Overall Study||164||
48717477|NCT01275092|102095159|FG000|NOT COMPLETED|Overall Study||0||
48717478|NCT01407523|102095160|FG000|STARTED|Overall Study||16||
48717479|NCT01407523|102095160|FG000|COMPLETED|Overall Study||16||
48717480|NCT01407523|102095160|FG000|NOT COMPLETED|Overall Study||0||
48717481|NCT01009346|102095161|FG000|STARTED|Overall Study||9||
48717482|NCT01009346|102095161|FG000|COMPLETED|Overall Study||5||
48717483|NCT01009346|102095161|FG000|NOT COMPLETED|Overall Study||4||
48717484|NCT00408590|102095162|FG000|STARTED|Overall Study||3||
48717485|NCT00408590|102095163|FG001|STARTED|Overall Study||3||
48717486|NCT00408590|102095164|FG002|STARTED|Overall Study||3||
48717487|NCT00408590|102095165|FG003|STARTED|Overall Study||3||
48717488|NCT00408590|102095166|FG004|STARTED|Overall Study||3||
48717489|NCT00408590|102095167|FG005|STARTED|Overall Study||3||
48717490|NCT00408590|102095168|FG006|STARTED|Overall Study||3||
48717491|NCT00408590|102095169|FG007|STARTED|Overall Study||3||
48717492|NCT00408590|102095170|FG008|STARTED|Overall Study||13||
48717493|NCT00408590|102095162|FG000|COMPLETED|Overall Study||3||
48717494|NCT00408590|102095163|FG001|COMPLETED|Overall Study||3||
48717495|NCT00408590|102095164|FG002|COMPLETED|Overall Study||3||
48717496|NCT00408590|102095165|FG003|COMPLETED|Overall Study||3||
48717497|NCT00408590|102095166|FG004|COMPLETED|Overall Study||3||
48717498|NCT00408590|102095167|FG005|COMPLETED|Overall Study||3||
48717499|NCT00408590|102095168|FG006|COMPLETED|Overall Study||3||
48717500|NCT00408590|102095169|FG007|COMPLETED|Overall Study||3||
48717501|NCT00408590|102095170|FG008|COMPLETED|Overall Study||13||
48717502|NCT00408590|102095162|FG000|NOT COMPLETED|Overall Study||0||
48717503|NCT00408590|102095163|FG001|NOT COMPLETED|Overall Study||0||
48717504|NCT00408590|102095164|FG002|NOT COMPLETED|Overall Study||0||
48717505|NCT00408590|102095165|FG003|NOT COMPLETED|Overall Study||0||
48717506|NCT00408590|102095166|FG004|NOT COMPLETED|Overall Study||0||
48717507|NCT00408590|102095167|FG005|NOT COMPLETED|Overall Study||0||
48717508|NCT00408590|102095168|FG006|NOT COMPLETED|Overall Study||0||
48717509|NCT00408590|102095169|FG007|NOT COMPLETED|Overall Study||0||
48717510|NCT00408590|102095170|FG008|NOT COMPLETED|Overall Study||0||
48717511|NCT04728594|102095171|FG000|STARTED|Overall Study||3178|Participants who were sent an email.|
48717512|NCT04728594|102095172|FG001|STARTED|Overall Study||3198|Participants who were sent an email.|
48717513|NCT04728594|102095173|FG002|STARTED|Overall Study||3190|Participants who were sent an email.|
48717514|NCT04728594|102095171|FG000|COMPLETED|Overall Study||3178|Participants who were sent an email were also considered as those who completed the study, as inaction is a possible response to the intervention|
48717515|NCT04728594|102095172|FG001|COMPLETED|Overall Study||3198|Participants who were sent an email were also considered as those who completed the study, as inaction is a possible response to the intervention|
48717516|NCT04728594|102095173|FG002|COMPLETED|Overall Study||3190|Participants who were sent an email were also considered as those who completed the study, as inaction is a possible response to the intervention|
48717517|NCT04728594|102095171|FG000|NOT COMPLETED|Overall Study||0||
48717518|NCT04728594|102095172|FG001|NOT COMPLETED|Overall Study||0||
48717519|NCT04728594|102095173|FG002|NOT COMPLETED|Overall Study||0||
48717520|NCT03840525|102095174|FG000|STARTED|Overall Study||16||
48717521|NCT03840525|102095175|FG001|STARTED|Overall Study||16||
48717522|NCT03840525|102095176|FG002|STARTED|Overall Study||16||
48717523|NCT03840525|102095174|FG000|COMPLETED|Overall Study||13||
48717524|NCT03840525|102095175|FG001|COMPLETED|Overall Study||12||
48717525|NCT03840525|102095176|FG002|COMPLETED|Overall Study||10||
48717526|NCT03840525|102095174|FG000|NOT COMPLETED|Overall Study||3||
48717527|NCT03840525|102095175|FG001|NOT COMPLETED|Overall Study||4||
48717528|NCT03840525|102095176|FG002|NOT COMPLETED|Overall Study||6||
48717529|NCT02789410|102095177|FG000|STARTED|Overall Study||66||
48717530|NCT02789410|102095178|FG001|STARTED|Overall Study||68||
48717531|NCT02789410|102095177|FG000|COMPLETED|Overall Study||66||
48717532|NCT02789410|102095178|FG001|COMPLETED|Overall Study||68||
48717533|NCT02789410|102095177|FG000|NOT COMPLETED|Overall Study||0||
48717534|NCT02789410|102095178|FG001|NOT COMPLETED|Overall Study||0||
48717535|NCT00707746|102095179|FG000|STARTED|Treatment Period||12||
48717536|NCT00707746|102095180|FG001|STARTED|Treatment Period||22||
48717537|NCT00707746|102095179|FG000|Full Analysis Set (FAS) and Safety Set|Treatment Period||12||
48717538|NCT00707746|102095180|FG001|Full Analysis Set (FAS) and Safety Set|Treatment Period||21||
48717539|NCT00707746|102095179|FG000|COMPLETED|Treatment Period||10||
48717540|NCT00707746|102095180|FG001|COMPLETED|Treatment Period||17||
48717541|NCT00707746|102095179|FG000|NOT COMPLETED|Treatment Period||2||
48717542|NCT00707746|102095180|FG001|NOT COMPLETED|Treatment Period||5||
48717543|NCT00707746|102095179|FG000|STARTED|Follow-up Period||12||
48304315|NCT03701763|101072931|FG001|Took at Least 1 Dose of Investigational Product (IP)|Placebo-controlled Phase||163||
48304316|NCT03701763|101072932|FG002|Took at Least 1 Dose of Investigational Product (IP)|Placebo-controlled Phase||0||
48304317|NCT03701763|101072933|FG003|Took at Least 1 Dose of Investigational Product (IP)|Placebo-controlled Phase||0||
48304318|NCT03701763|101072930|FG000|COMPLETED|Placebo-controlled Phase||72||
48304319|NCT03701763|101072931|FG001|COMPLETED|Placebo-controlled Phase||149||
48304320|NCT03701763|101072932|FG002|COMPLETED|Placebo-controlled Phase||0||
48304321|NCT03701763|101072933|FG003|COMPLETED|Placebo-controlled Phase||0||
48304322|NCT03701763|101072930|FG000|NOT COMPLETED|Placebo-controlled Phase||10||
48304323|NCT03701763|101072931|FG001|NOT COMPLETED|Placebo-controlled Phase||14||
48304324|NCT03701763|101072932|FG002|NOT COMPLETED|Placebo-controlled Phase||0||
48304325|NCT03701763|101072933|FG003|NOT COMPLETED|Placebo-controlled Phase||0||
48304326|NCT03701763|101072930|FG000|STARTED|Apremilast Extension Phase||0||
48304327|NCT03701763|101072931|FG001|STARTED|Apremilast Extension Phase||0||
48304328|NCT03701763|101072932|FG002|STARTED|Apremilast Extension Phase||72||
48717544|NCT00707746|102095180|FG001|STARTED|Follow-up Period||21||
48717545|NCT00707746|102095179|FG000|COMPLETED|Follow-up Period||12||
48717546|NCT00707746|102095180|FG001|COMPLETED|Follow-up Period||21||
48304329|NCT03701763|101072933|FG003|STARTED|Apremilast Extension Phase||149||
48304330|NCT03701763|101072930|FG000|Received Apremilast 20mg BID in Either Placebo-controlled or Apremilast Extension Phases (Week 0-52)|Apremilast Extension Phase||0||
48304331|NCT03701763|101072931|FG001|Received Apremilast 20mg BID in Either Placebo-controlled or Apremilast Extension Phases (Week 0-52)|Apremilast Extension Phase||0||
48304332|NCT03701763|101072932|FG002|Received Apremilast 20mg BID in Either Placebo-controlled or Apremilast Extension Phases (Week 0-52)|Apremilast Extension Phase||36||
48304333|NCT03701763|101072933|FG003|Received Apremilast 20mg BID in Either Placebo-controlled or Apremilast Extension Phases (Week 0-52)|Apremilast Extension Phase||80||
48304334|NCT03701763|101072930|FG000|Received Apremilast 30mg BID in Either Placebo-controlled or Apremilast Extension Phases (Week 0-52)|Apremilast Extension Phase||0||
48304335|NCT03701763|101072931|FG001|Received Apremilast 30mg BID in Either Placebo-controlled or Apremilast Extension Phases (Week 0-52)|Apremilast Extension Phase||0||
48304336|NCT03701763|101072932|FG002|Received Apremilast 30mg BID in Either Placebo-controlled or Apremilast Extension Phases (Week 0-52)|Apremilast Extension Phase||36||
48304337|NCT03701763|101072933|FG003|Received Apremilast 30mg BID in Either Placebo-controlled or Apremilast Extension Phases (Week 0-52)|Apremilast Extension Phase||83||
48304338|NCT03701763|101072930|FG000|Took at Least 1 Dose of IP|Apremilast Extension Phase||0||
48368016|NCT03567291|101230093|FG001|Intent to Treat Set|Period I||0||
48717547|NCT00707746|102095179|FG000|NOT COMPLETED|Follow-up Period||0||
48717548|NCT00707746|102095180|FG001|NOT COMPLETED|Follow-up Period||0||
48717549|NCT00844805|102095181|FG000|STARTED|Treatment Phase||106||
48717550|NCT00844805|102095182|FG001|STARTED|Treatment Phase||52||
48717551|NCT00844805|102095183|FG002|STARTED|Treatment Phase||0||
48717552|NCT00844805|102095184|FG003|STARTED|Treatment Phase||0||
48717553|NCT00844805|102095181|FG000|COMPLETED|Treatment Phase||96||
48717554|NCT00844805|102095182|FG001|COMPLETED|Treatment Phase||45||
48717555|NCT00844805|102095183|FG002|COMPLETED|Treatment Phase||0||
48717556|NCT00844805|102095184|FG003|COMPLETED|Treatment Phase||0||
48717557|NCT00844805|102095181|FG000|NOT COMPLETED|Treatment Phase||10||
48717558|NCT00844805|102095182|FG001|NOT COMPLETED|Treatment Phase||7||
48717559|NCT00844805|102095183|FG002|NOT COMPLETED|Treatment Phase||0||
48717560|NCT00844805|102095184|FG003|NOT COMPLETED|Treatment Phase||0||
48717561|NCT00844805|102095181|FG000|STARTED|Follow-Up Phase||0||
48717562|NCT00844805|102095182|FG001|STARTED|Follow-Up Phase||0||
48717563|NCT00844805|102095183|FG002|STARTED|Follow-Up Phase||41||
48717564|NCT00844805|102095184|FG003|STARTED|Follow-Up Phase||41||
48717565|NCT00844805|102095181|FG000|COMPLETED|Follow-Up Phase||0||
48188705|NCT02034435|100783314|FG002|Aim 2|Overall Study||7||
48304339|NCT03701763|101072931|FG001|Took at Least 1 Dose of IP|Apremilast Extension Phase||0||
48717566|NCT00844805|102095182|FG001|COMPLETED|Follow-Up Phase||0||
48717567|NCT00844805|102095183|FG002|COMPLETED|Follow-Up Phase||32||
48717568|NCT00844805|102095184|FG003|COMPLETED|Follow-Up Phase||32||
48717569|NCT00844805|102095181|FG000|NOT COMPLETED|Follow-Up Phase||0||
48406092|NCT00606294|101325425|FG000|STARTED|Overall Study||197||
48717570|NCT00844805|102095182|FG001|NOT COMPLETED|Follow-Up Phase||0||
48717571|NCT00844805|102095183|FG002|NOT COMPLETED|Follow-Up Phase||9||
48606919|NCT00527124|101823400|FG000|COMPLETED|Overall Study||29||
48149687|NCT00279201|100688758|FG001|NOT COMPLETED|Intensification Addendum||0||
48149688|NCT00279201|100688759|FG002|NOT COMPLETED|Intensification Addendum||23||
48606920|NCT00527124|101823401|FG001|COMPLETED|Overall Study||28||
48606921|NCT00527124|101823400|FG000|NOT COMPLETED|Overall Study||0||
48606922|NCT00527124|101823401|FG001|NOT COMPLETED|Overall Study||0||
48606923|NCT00564278|101823402|FG000|STARTED|Overall Study||97||
48606924|NCT00564278|101823403|FG001|STARTED|Overall Study||98||
48606925|NCT00564278|101823402|FG000|COMPLETED|Overall Study||50||
48606926|NCT00564278|101823403|FG001|COMPLETED|Overall Study||56||
48606927|NCT00564278|101823402|FG000|NOT COMPLETED|Overall Study||47||
48606928|NCT00564278|101823403|FG001|NOT COMPLETED|Overall Study||42||
48606929|NCT00499343|101823404|FG000|STARTED|Overall Study||41||
48606930|NCT00499343|101823405|FG001|STARTED|Overall Study||43||
48606931|NCT00499343|101823404|FG000|COMPLETED|Overall Study||41||
48606932|NCT00499343|101823405|FG001|COMPLETED|Overall Study||43||
48606933|NCT00499343|101823404|FG000|NOT COMPLETED|Overall Study||0||
48606934|NCT00499343|101823405|FG001|NOT COMPLETED|Overall Study||0||
48606935|NCT01502033|101823406|FG000|STARTED|Overall Study||10||
48606936|NCT01502033|101823406|FG000|COMPLETED|Overall Study||7||
48606937|NCT01502033|101823406|FG000|NOT COMPLETED|Overall Study||3||
48606938|NCT00809094|101823407|FG000|STARTED|Overall Study||36||
48606939|NCT00809094|101823408|FG001|STARTED|Overall Study||34||
48606940|NCT00809094|101823407|FG000|COMPLETED|Overall Study||36||
48606941|NCT00809094|101823408|FG001|COMPLETED|Overall Study||33||
48606942|NCT00809094|101823407|FG000|NOT COMPLETED|Overall Study||0||
48717572|NCT00844805|102095184|FG003|NOT COMPLETED|Follow-Up Phase||9||
48717573|NCT04596085|102095185|FG000|STARTED|Overall Study||59||
48717574|NCT04596085|102095186|FG001|STARTED|Overall Study||59||
48717575|NCT04596085|102095185|FG000|COMPLETED|Overall Study||59||
48717576|NCT04596085|102095186|FG001|COMPLETED|Overall Study||59||
48717577|NCT04596085|102095185|FG000|NOT COMPLETED|Overall Study||0||
48717578|NCT04596085|102095186|FG001|NOT COMPLETED|Overall Study||0||
48717579|NCT02091284|102095187|FG000|STARTED|Overall Study||26||
48717580|NCT02091284|102095188|FG001|STARTED|Overall Study||23||
48717581|NCT02091284|102095187|FG000|COMPLETED|Overall Study||23||
48717582|NCT02091284|102095188|FG001|COMPLETED|Overall Study||22||
48717583|NCT02091284|102095187|FG000|NOT COMPLETED|Overall Study||3||
48717584|NCT02091284|102095188|FG001|NOT COMPLETED|Overall Study||1||
48717585|NCT00678535|102095189|FG000|STARTED|Overall Study||455||
48717586|NCT00678535|102095190|FG001|STARTED|Overall Study||449||
48717587|NCT00678535|102095189|FG000|COMPLETED|Overall Study||362||
48717588|NCT00678535|102095190|FG001|COMPLETED|Overall Study||351||
48717589|NCT00678535|102095189|FG000|NOT COMPLETED|Overall Study||93||
48717590|NCT00678535|102095190|FG001|NOT COMPLETED|Overall Study||98||
48717591|NCT02227836|102095191|FG000|STARTED|Overall Study||8||
48717592|NCT02227836|102095191|FG000|COMPLETED|Overall Study||8||
48717593|NCT02227836|102095191|FG000|NOT COMPLETED|Overall Study||0||
48717594|NCT01635764|102095192|FG000|STARTED|Overall Study||508||
48717595|NCT01635764|102095192|FG000|COMPLETED|Overall Study||235||
48717596|NCT01635764|102095192|FG000|NOT COMPLETED|Overall Study||273||
48717597|NCT02290938|102095193|FG000|STARTED|Overall Study||70||
48717598|NCT02290938|102095194|FG001|STARTED|Overall Study||115||
48717599|NCT02290938|102095193|FG000|COMPLETED|Overall Study||56||
48717600|NCT02290938|102095194|FG001|COMPLETED|Overall Study||72||
48717601|NCT02290938|102095193|FG000|NOT COMPLETED|Overall Study||14||
48717602|NCT02290938|102095194|FG001|NOT COMPLETED|Overall Study||43||
48717603|NCT01075971|102095195|FG000|STARTED|Overall Study||52||
48717604|NCT01075971|102095195|FG000|COMPLETED|Overall Study||52||
48606943|NCT00809094|101823408|FG001|NOT COMPLETED|Overall Study||1||
48606944|NCT03762681|101823409|FG000|STARTED|Part 1||8||
48149689|NCT00279201|100688760|FG003|NOT COMPLETED|Intensification Addendum||28||
48149690|NCT00279201|100688761|FG004|NOT COMPLETED|Intensification Addendum||29||
48149691|NCT00279201|100688762|FG005|NOT COMPLETED|Intensification Addendum||37||
48149692|NCT02258139|100688763|FG000|STARTED|Overall Study||38||
48149693|NCT02258139|100688763|FG000|COMPLETED|Overall Study||30||
48149694|NCT02258139|100688763|FG000|NOT COMPLETED|Overall Study||8||
48149695|NCT00828984|100688764|FG000|STARTED|Overall Study||28||
48149696|NCT00828984|100688765|FG001|STARTED|Overall Study||31||
48149697|NCT00828984|100688766|FG002|STARTED|Overall Study||28||
48149698|NCT00828984|100688764|FG000|Randomization|Overall Study||28||
48149699|NCT00828984|100688765|FG001|Randomization|Overall Study||31||
48149700|NCT00828984|100688766|FG002|Randomization|Overall Study||28||
48149701|NCT00828984|100688764|FG000|Treatment|Overall Study||24||
48149702|NCT00828984|100688765|FG001|Treatment|Overall Study||26||
48149703|NCT00828984|100688766|FG002|Treatment|Overall Study||24||
48149704|NCT00828984|100688764|FG000|Flexible Sigmoidoscopy|Overall Study||20||
48149705|NCT00828984|100688765|FG001|Flexible Sigmoidoscopy|Overall Study||19||
48149706|NCT00828984|100688766|FG002|Flexible Sigmoidoscopy|Overall Study||19||
48149707|NCT00828984|100688764|FG000|Post Intervention Follow-Up|Overall Study||15||
48149708|NCT00828984|100688765|FG001|Post Intervention Follow-Up|Overall Study||16||
48149709|NCT00828984|100688766|FG002|Post Intervention Follow-Up|Overall Study||19||
48149710|NCT00828984|100688764|FG000|COMPLETED|Overall Study||14||
48149711|NCT00828984|100688765|FG001|COMPLETED|Overall Study||15||
48149712|NCT00828984|100688766|FG002|COMPLETED|Overall Study||19||
48149713|NCT00828984|100688764|FG000|NOT COMPLETED|Overall Study||14||
48149714|NCT00828984|100688765|FG001|NOT COMPLETED|Overall Study||16||
48149715|NCT00828984|100688766|FG002|NOT COMPLETED|Overall Study||9||
48149716|NCT04278625|100688767|FG000|STARTED|Overall Study||15||
48149717|NCT04278625|100688768|FG001|STARTED|Overall Study||15||
48149718|NCT04278625|100688767|FG000|COMPLETED|Overall Study||15||
48149719|NCT04278625|100688768|FG001|COMPLETED|Overall Study||15||
48149720|NCT04278625|100688767|FG000|NOT COMPLETED|Overall Study||0||
48149721|NCT04278625|100688768|FG001|NOT COMPLETED|Overall Study||0||
48149722|NCT01207102|100688769|FG000|STARTED|Overall Study||10||
48149723|NCT01207102|100688769|FG000|COMPLETED|Overall Study||0||
48149724|NCT01207102|100688769|FG000|NOT COMPLETED|Overall Study||10||
48149725|NCT00886340|100688770|FG000|STARTED|Overall Study||27||
48149726|NCT00886340|100688771|FG001|STARTED|Overall Study||31||
48149727|NCT00886340|100688770|FG000|COMPLETED|Overall Study||27||
48149728|NCT00886340|100688771|FG001|COMPLETED|Overall Study||24||
48149729|NCT00886340|100688770|FG000|NOT COMPLETED|Overall Study||0||
48149730|NCT00886340|100688771|FG001|NOT COMPLETED|Overall Study||7||
48149731|NCT02821403|100688772|FG000|STARTED|"First Intervention (1 Month)"||40||
48149732|NCT02821403|100688773|FG001|STARTED|"First Intervention (1 Month)"||40||
48149733|NCT02821403|100688772|FG000|Used Clear Lens|"First Intervention (1 Month)"||13||
48149734|NCT02821403|100688773|FG001|Used Clear Lens|"First Intervention (1 Month)"||13||
48149735|NCT02821403|100688772|FG000|Used Yellow Tinted Lens|"First Intervention (1 Month)"||13||
48149736|NCT02821403|100688773|FG001|Used Yellow Tinted Lens|"First Intervention (1 Month)"||14||
48149737|NCT02821403|100688772|FG000|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||14||
48149738|NCT02821403|100688773|FG001|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||13||
48149739|NCT02821403|100688772|FG000|COMPLETED|"First Intervention (1 Month)"||40||
48149740|NCT02821403|100688773|FG001|COMPLETED|"First Intervention (1 Month)"||40||
48149741|NCT02821403|100688772|FG000|NOT COMPLETED|"First Intervention (1 Month)"||0||
48149742|NCT02821403|100688773|FG001|NOT COMPLETED|"First Intervention (1 Month)"||0||
48149743|NCT02821403|100688772|FG000|STARTED|"Second Intervention (1 Month)"||40||
48149744|NCT02821403|100688773|FG001|STARTED|"Second Intervention (1 Month)"||40||
48149745|NCT02821403|100688772|FG000|Used Clear Lens|"Second Intervention (1 Month)"||13||
48149746|NCT02821403|100688773|FG001|Used Clear Lens|"Second Intervention (1 Month)"||14||
48149747|NCT02821403|100688772|FG000|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||14||
48149748|NCT02821403|100688773|FG001|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||13||
48149749|NCT02821403|100688772|FG000|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13||
48149750|NCT02821403|100688773|FG001|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13||
48149751|NCT02821403|100688772|FG000|COMPLETED|"Second Intervention (1 Month)"||40||
48149752|NCT02821403|100688773|FG001|COMPLETED|"Second Intervention (1 Month)"||40||
48149753|NCT02821403|100688772|FG000|NOT COMPLETED|"Second Intervention (1 Month)"||0||
48149754|NCT02821403|100688773|FG001|NOT COMPLETED|"Second Intervention (1 Month)"||0||
48149755|NCT02821403|100688772|FG000|STARTED|"Third Intervention (1 Month)"||40||
48149756|NCT02821403|100688773|FG001|STARTED|"Third Intervention (1 Month)"||40||
48149757|NCT02821403|100688772|FG000|Used Clear Lens|"Third Intervention (1 Month)"||14||
48149758|NCT02821403|100688773|FG001|Used Clear Lens|"Third Intervention (1 Month)"||13||
48149759|NCT02821403|100688772|FG000|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13||
48149760|NCT02821403|100688773|FG001|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13||
48149761|NCT02821403|100688772|FG000|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||13||
48149762|NCT02821403|100688773|FG001|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||14||
48149763|NCT02821403|100688772|FG000|COMPLETED|"Third Intervention (1 Month)"||40||
48149764|NCT02821403|100688773|FG001|COMPLETED|"Third Intervention (1 Month)"||40||
48149765|NCT02821403|100688772|FG000|NOT COMPLETED|"Third Intervention (1 Month)"||0||
48149766|NCT02821403|100688773|FG001|NOT COMPLETED|"Third Intervention (1 Month)"||0||
48149767|NCT01691833|100688774|FG000|STARTED|Overall Study||50||
48149768|NCT01691833|100688775|FG001|STARTED|Overall Study||50||
48149769|NCT01691833|100688776|FG002|STARTED|Overall Study||13||
48149770|NCT01691833|100688774|FG000|COMPLETED|Overall Study||49||
48149771|NCT01691833|100688775|FG001|COMPLETED|Overall Study||49||
48149772|NCT01691833|100688776|FG002|COMPLETED|Overall Study||13||
48149773|NCT01691833|100688774|FG000|NOT COMPLETED|Overall Study||1||
48149774|NCT01691833|100688775|FG001|NOT COMPLETED|Overall Study||1||
48149775|NCT01691833|100688776|FG002|NOT COMPLETED|Overall Study||0||
48149776|NCT02279043|100688777|FG000|STARTED|Overall Study||175||
48149777|NCT02279043|100688778|FG001|STARTED|Overall Study||315||
48149778|NCT02279043|100688779|FG002|STARTED|Overall Study||140||
48149779|NCT02279043|100688777|FG000|COMPLETED|Overall Study||128||
48149780|NCT02279043|100688778|FG001|COMPLETED|Overall Study||226||
48149781|NCT02279043|100688779|FG002|COMPLETED|Overall Study||140||
48149782|NCT02279043|100688777|FG000|NOT COMPLETED|Overall Study||47||
48149783|NCT02279043|100688778|FG001|NOT COMPLETED|Overall Study||89||
48149784|NCT02279043|100688779|FG002|NOT COMPLETED|Overall Study||0||
48149785|NCT02173548|100688780|FG000|STARTED|Overall Study||21||
48149786|NCT02173548|100688781|FG001|STARTED|Overall Study||10||
48149787|NCT02173548|100688780|FG000|COMPLETED|Overall Study||20||
48149788|NCT02173548|100688781|FG001|COMPLETED|Overall Study||8||
48149789|NCT02173548|100688780|FG000|NOT COMPLETED|Overall Study||1||
48149790|NCT02173548|100688781|FG001|NOT COMPLETED|Overall Study||2||
48149791|NCT02813070|100688782|FG000|STARTED|Overall Study||28|Screened participants|
48149792|NCT02813070|100688783|FG001|STARTED|Overall Study||23|Screened participants|
48149793|NCT02813070|100688784|FG002|STARTED|Overall Study||36|Screened participants|
48149794|NCT02813070|100688782|FG000|Treated (Safety Population)|Overall Study||25||
48149795|NCT02813070|100688783|FG001|Treated (Safety Population)|Overall Study||20||
48149796|NCT02813070|100688784|FG002|Treated (Safety Population)|Overall Study||25||
48149797|NCT02813070|100688782|FG000|COMPLETED|Overall Study||25||
48149798|NCT02813070|100688783|FG001|COMPLETED|Overall Study||20||
48149799|NCT02813070|100688784|FG002|COMPLETED|Overall Study||25||
48149800|NCT02813070|100688782|FG000|NOT COMPLETED|Overall Study||3||
48149801|NCT02813070|100688783|FG001|NOT COMPLETED|Overall Study||3||
48149802|NCT02813070|100688784|FG002|NOT COMPLETED|Overall Study||11||
48149803|NCT04052204|100688785|FG000|STARTED|Overall Study||3||
48149804|NCT04052204|100688786|FG001|STARTED|Overall Study||0||
48149805|NCT04052204|100688787|FG002|STARTED|Overall Study||0||
48149806|NCT04052204|100688785|FG000|COMPLETED|Overall Study||0||
48149807|NCT04052204|100688786|FG001|COMPLETED|Overall Study||0||
48149808|NCT04052204|100688787|FG002|COMPLETED|Overall Study||0||
48149809|NCT04052204|100688785|FG000|NOT COMPLETED|Overall Study||3||
48149810|NCT04052204|100688786|FG001|NOT COMPLETED|Overall Study||0||
48149811|NCT04052204|100688787|FG002|NOT COMPLETED|Overall Study||0||
48149812|NCT04118348|100688788|FG000|STARTED|Overall Study||3416||
48149813|NCT04118348|100688789|FG001|STARTED|Overall Study||3265||
48149814|NCT04118348|100688790|FG002|STARTED|Overall Study||3441||
48149815|NCT04118348|100688791|FG003|STARTED|Overall Study||3218||
48149816|NCT04118348|100688788|FG000|COMPLETED|Overall Study||3416|Random assignment happened at the patient encounter|
48149817|NCT04118348|100688789|FG001|COMPLETED|Overall Study||3265|Random assignment happened at the patient encounter|
48149818|NCT04118348|100688790|FG002|COMPLETED|Overall Study||3441|Random assignment happened at the patient encounter|
48149819|NCT04118348|100688791|FG003|COMPLETED|Overall Study||3218|Random assignment happened at the patient encounter|
48149820|NCT04118348|100688788|FG000|NOT COMPLETED|Overall Study||0||
48149821|NCT04118348|100688789|FG001|NOT COMPLETED|Overall Study||0||
48149822|NCT04118348|100688790|FG002|NOT COMPLETED|Overall Study||0||
48149823|NCT04118348|100688791|FG003|NOT COMPLETED|Overall Study||0||
48149824|NCT02047045|100688792|FG000|STARTED|Baseline||280||
48149825|NCT02047045|100688793|FG001|STARTED|Baseline||280||
48149826|NCT02047045|100688792|FG000|COMPLETED|Baseline||277||
48149827|NCT02047045|100688793|FG001|COMPLETED|Baseline||278||
48149828|NCT02047045|100688792|FG000|NOT COMPLETED|Baseline||3||
48149829|NCT02047045|100688793|FG001|NOT COMPLETED|Baseline||2||
48149830|NCT02047045|100688792|FG000|STARTED|Treatment Period (8 Weeks )||277||
48149831|NCT02047045|100688793|FG001|STARTED|Treatment Period (8 Weeks )||278||
48149832|NCT02047045|100688792|FG000|COMPLETED|Treatment Period (8 Weeks )||266||
48149833|NCT02047045|100688793|FG001|COMPLETED|Treatment Period (8 Weeks )||263||
48149834|NCT02047045|100688792|FG000|NOT COMPLETED|Treatment Period (8 Weeks )||11||
48149835|NCT02047045|100688793|FG001|NOT COMPLETED|Treatment Period (8 Weeks )||15||
48149836|NCT02047045|100688792|FG000|STARTED|Follow-up Period (24 Weeks)||266||
48149837|NCT02047045|100688793|FG001|STARTED|Follow-up Period (24 Weeks)||263||
48149838|NCT02047045|100688792|FG000|COMPLETED|Follow-up Period (24 Weeks)||265||
48149839|NCT02047045|100688793|FG001|COMPLETED|Follow-up Period (24 Weeks)||262||
48149840|NCT02047045|100688792|FG000|NOT COMPLETED|Follow-up Period (24 Weeks)||1||
48149841|NCT02047045|100688793|FG001|NOT COMPLETED|Follow-up Period (24 Weeks)||1||
48149842|NCT03151005|100688794|FG000|STARTED|Overall Study||35||
48149843|NCT03151005|100688795|FG001|STARTED|Overall Study||35||
48149844|NCT03151005|100688794|FG000|COMPLETED|Overall Study||30||
48149845|NCT03151005|100688795|FG001|COMPLETED|Overall Study||30||
48149846|NCT03151005|100688794|FG000|NOT COMPLETED|Overall Study||5||
48149847|NCT03151005|100688795|FG001|NOT COMPLETED|Overall Study||5||
48149848|NCT02606903|100688796|FG000|STARTED|Overall Study||35||
48149849|NCT02606903|100688797|FG001|STARTED|Overall Study||36||
48149850|NCT02606903|100688796|FG000|COMPLETED|Overall Study||35||
48149851|NCT02606903|100688797|FG001|COMPLETED|Overall Study||36||
48149852|NCT02606903|100688796|FG000|NOT COMPLETED|Overall Study||0||
48149853|NCT02606903|100688797|FG001|NOT COMPLETED|Overall Study||0||
48149854|NCT01592370|100688798|FG000|STARTED|Overall Study||105|= Number of participants Treated|
48149855|NCT01592370|100688799|FG001|STARTED|Overall Study||65|= Number of participants Treated|
48149856|NCT01592370|100688800|FG002|STARTED|Overall Study||72|= Number of participants Treated|
48149857|NCT01592370|100688801|FG003|STARTED|Overall Study||6|= Number of participants Treated|
48149858|NCT01592370|100688802|FG004|STARTED|Overall Study||5|= Number of participants Treated|
48149859|NCT01592370|100688803|FG005|STARTED|Overall Study||41|= Number of participants Treated|
48149860|NCT01592370|100688804|FG006|STARTED|Overall Study||22|= Number of participants Treated|
48149861|NCT01592370|100688798|FG000|COMPLETED|Overall Study||1||
48149862|NCT01592370|100688799|FG001|COMPLETED|Overall Study||40||
48149863|NCT01592370|100688800|FG002|COMPLETED|Overall Study||0||
48149864|NCT01592370|100688801|FG003|COMPLETED|Overall Study||1||
48149865|NCT01592370|100688802|FG004|COMPLETED|Overall Study||1||
48149866|NCT01592370|100688803|FG005|COMPLETED|Overall Study||7||
48149867|NCT01592370|100688804|FG006|COMPLETED|Overall Study||6||
48149868|NCT01592370|100688798|FG000|NOT COMPLETED|Overall Study||104||
48149869|NCT01592370|100688799|FG001|NOT COMPLETED|Overall Study||25||
48149870|NCT01592370|100688800|FG002|NOT COMPLETED|Overall Study||72||
48149871|NCT01592370|100688801|FG003|NOT COMPLETED|Overall Study||5||
48149872|NCT01592370|100688802|FG004|NOT COMPLETED|Overall Study||4||
48149873|NCT01592370|100688803|FG005|NOT COMPLETED|Overall Study||34||
48149874|NCT01592370|100688804|FG006|NOT COMPLETED|Overall Study||16||
48149875|NCT01785680|100688805|FG000|STARTED|Overall Study||1100||
48149876|NCT01785680|100688806|FG001|STARTED|Overall Study||857||
48149877|NCT01785680|100688805|FG000|COMPLETED|Overall Study||1100||
48149878|NCT01785680|100688806|FG001|COMPLETED|Overall Study||857||
48149879|NCT01785680|100688805|FG000|NOT COMPLETED|Overall Study||0||
48149880|NCT01785680|100688806|FG001|NOT COMPLETED|Overall Study||0||
48149881|NCT02077166|100688807|FG000|STARTED|Overall Study||12||
48149882|NCT02077166|100688808|FG001|STARTED|Overall Study||7||
48149883|NCT02077166|100688809|FG002|STARTED|Overall Study||9||
48149884|NCT02077166|100688810|FG003|STARTED|Overall Study||9||
48149885|NCT02077166|100688811|FG004|STARTED|Overall Study||8||
48149886|NCT02077166|100688812|FG005|STARTED|Overall Study||55||
48149887|NCT02077166|100688813|FG006|STARTED|Overall Study||34||
48149888|NCT02077166|100688807|FG000|COMPLETED|Overall Study||0|"Participants remained on study until disease progression or unacceptable toxicity. Reason Not Completed rows display participants' primary reason for exiting the study."|
48149889|NCT02077166|100688808|FG001|COMPLETED|Overall Study||0|"Participants remained on study until disease progression or unacceptable toxicity. Reason Not Completed rows display participants' primary reason for exiting the study."|
48717605|NCT01075971|102095195|FG000|NOT COMPLETED|Overall Study||0||
48717606|NCT04018313|102095196|FG000|STARTED|Overall Study||15||
48717607|NCT04018313|102095197|FG001|STARTED|Overall Study||15||
48717608|NCT04018313|102095198|FG002|STARTED|Overall Study||47||
48717609|NCT04018313|102095199|FG003|STARTED|Overall Study||49||
48717610|NCT04018313|102095200|FG004|STARTED|Overall Study||50||
48717611|NCT04018313|102095196|FG000|COMPLETED|Overall Study||14||
48717612|NCT04018313|102095197|FG001|COMPLETED|Overall Study||14||
48717613|NCT04018313|102095198|FG002|COMPLETED|Overall Study||46||
48717614|NCT04018313|102095199|FG003|COMPLETED|Overall Study||47||
48717615|NCT04018313|102095200|FG004|COMPLETED|Overall Study||49||
48717616|NCT04018313|102095196|FG000|NOT COMPLETED|Overall Study||1||
48717617|NCT04018313|102095197|FG001|NOT COMPLETED|Overall Study||1||
48717618|NCT04018313|102095198|FG002|NOT COMPLETED|Overall Study||1||
48717619|NCT04018313|102095199|FG003|NOT COMPLETED|Overall Study||2||
48717620|NCT04018313|102095200|FG004|NOT COMPLETED|Overall Study||1||
48717621|NCT00046930|102095201|FG000|STARTED|Overall Study||224||
48717622|NCT00046930|102095202|FG001|STARTED|Overall Study||225||
48717623|NCT00046930|102095201|FG000|COMPLETED|Overall Study||212||
48717624|NCT00046930|102095202|FG001|COMPLETED|Overall Study||221||
48717625|NCT00046930|102095201|FG000|NOT COMPLETED|Overall Study||12||
48717626|NCT00046930|102095202|FG001|NOT COMPLETED|Overall Study||4||
48717627|NCT04524455|102095203|FG000|STARTED|Overall Study||8||
48717628|NCT04524455|102095204|FG001|STARTED|Overall Study||9||
48717629|NCT04524455|102095203|FG000|Participants Who Received Blinatumomab|Overall Study||8||
48717630|NCT04524455|102095204|FG001|Participants Who Received Blinatumomab|Overall Study||8||
48717631|NCT04524455|102095203|FG000|Participants Who Received AMG 404|Overall Study||8||
48149890|NCT02077166|100688809|FG002|COMPLETED|Overall Study||0|"Participants remained on study until disease progression or unacceptable toxicity. Reason Not Completed rows display participants' primary reason for exiting the study."|
48149891|NCT02077166|100688810|FG003|COMPLETED|Overall Study||0|"Participants remained on study until disease progression or unacceptable toxicity. Reason Not Completed rows display participants' primary reason for exiting the study."|
48149892|NCT02077166|100688811|FG004|COMPLETED|Overall Study||0|"Participants remained on study until disease progression or unacceptable toxicity. Reason Not Completed rows display participants' primary reason for exiting the study."|
48149893|NCT02077166|100688812|FG005|COMPLETED|Overall Study||0|"Participants remained on study until disease progression or unacceptable toxicity. Reason Not Completed rows display participants' primary reason for exiting the study."|
48149894|NCT02077166|100688813|FG006|COMPLETED|Overall Study||0|"Participants remained on study until disease progression or unacceptable toxicity. Reason Not Completed rows display participants' primary reason for exiting the study."|
48149895|NCT02077166|100688807|FG000|NOT COMPLETED|Overall Study||12||
48149896|NCT02077166|100688808|FG001|NOT COMPLETED|Overall Study||7||
48149897|NCT02077166|100688809|FG002|NOT COMPLETED|Overall Study||9||
48149898|NCT02077166|100688810|FG003|NOT COMPLETED|Overall Study||9||
48717632|NCT04524455|102095204|FG001|Participants Who Received AMG 404|Overall Study||8||
48717633|NCT04524455|102095203|FG000|COMPLETED|Overall Study||4||
48149899|NCT02077166|100688811|FG004|NOT COMPLETED|Overall Study||8||
48149900|NCT02077166|100688812|FG005|NOT COMPLETED|Overall Study||55||
48149901|NCT02077166|100688813|FG006|NOT COMPLETED|Overall Study||34||
48717634|NCT04524455|102095204|FG001|COMPLETED|Overall Study||3||
48717635|NCT04524455|102095203|FG000|NOT COMPLETED|Overall Study||4||
48304340|NCT03701763|101072932|FG002|Took at Least 1 Dose of IP|Apremilast Extension Phase||72||
48304341|NCT03701763|101072933|FG003|Took at Least 1 Dose of IP|Apremilast Extension Phase||149||
48304342|NCT03701763|101072930|FG000|COMPLETED|Apremilast Extension Phase||0||
48304343|NCT03701763|101072931|FG001|COMPLETED|Apremilast Extension Phase||0||
48304344|NCT03701763|101072932|FG002|COMPLETED|Apremilast Extension Phase||61||
48304345|NCT03701763|101072933|FG003|COMPLETED|Apremilast Extension Phase||125||
48304346|NCT03701763|101072930|FG000|NOT COMPLETED|Apremilast Extension Phase||0||
48304347|NCT03701763|101072931|FG001|NOT COMPLETED|Apremilast Extension Phase||0||
48304348|NCT03701763|101072932|FG002|NOT COMPLETED|Apremilast Extension Phase||11||
48304349|NCT03701763|101072933|FG003|NOT COMPLETED|Apremilast Extension Phase||24||
48304350|NCT03701763|101072930|FG000|STARTED|14-Week Observational Follow-up Phase||1||
48304351|NCT03701763|101072931|FG001|STARTED|14-Week Observational Follow-up Phase||4||
48304352|NCT03701763|101072932|FG002|STARTED|14-Week Observational Follow-up Phase||14||
48304353|NCT03701763|101072933|FG003|STARTED|14-Week Observational Follow-up Phase||26||
48304354|NCT03701763|101072930|FG000|COMPLETED|14-Week Observational Follow-up Phase||1||
48304355|NCT03701763|101072931|FG001|COMPLETED|14-Week Observational Follow-up Phase||3||
48304356|NCT03701763|101072932|FG002|COMPLETED|14-Week Observational Follow-up Phase||11||
48304357|NCT03701763|101072933|FG003|COMPLETED|14-Week Observational Follow-up Phase||23||
48304358|NCT03701763|101072930|FG000|NOT COMPLETED|14-Week Observational Follow-up Phase||0||
48304359|NCT03701763|101072931|FG001|NOT COMPLETED|14-Week Observational Follow-up Phase||1||
48304360|NCT03701763|101072932|FG002|NOT COMPLETED|14-Week Observational Follow-up Phase||3||
48304361|NCT03701763|101072933|FG003|NOT COMPLETED|14-Week Observational Follow-up Phase||3||
48304362|NCT05082116|101072934|FG000|STARTED|Overall Study||13||
48304363|NCT05082116|101072935|FG001|STARTED|Overall Study||23||
48304364|NCT05082116|101072934|FG000|Full Analysis Set|Overall Study||13||
48304365|NCT05082116|101072935|FG001|Full Analysis Set|Overall Study||23||
48304366|NCT05082116|101072934|FG000|Safety Analysis Set|Overall Study||13||
48304367|NCT05082116|101072935|FG001|Safety Analysis Set|Overall Study||23||
48304368|NCT05082116|101072934|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||4||
48304369|NCT05082116|101072935|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||11||
48304370|NCT05082116|101072934|FG000|COMPLETED|Overall Study||13||
48304371|NCT05082116|101072935|FG001|COMPLETED|Overall Study||23||
48304372|NCT05082116|101072934|FG000|NOT COMPLETED|Overall Study||0||
48304373|NCT05082116|101072935|FG001|NOT COMPLETED|Overall Study||0||
48304374|NCT00818389|101072936|FG000|STARTED|Overall Study||40||
48304375|NCT00818389|101072937|FG001|STARTED|Overall Study||44||
48304376|NCT00818389|101072936|FG000|COMPLETED|Overall Study||36||
48304377|NCT00818389|101072937|FG001|COMPLETED|Overall Study||38||
48304378|NCT00818389|101072936|FG000|NOT COMPLETED|Overall Study||4||
48304379|NCT00818389|101072937|FG001|NOT COMPLETED|Overall Study||6||
48304380|NCT00685685|101072938|FG000|STARTED|First Intervention||27||
48304381|NCT00685685|101072939|FG001|STARTED|First Intervention||27||
48304382|NCT00685685|101072938|FG000|COMPLETED|First Intervention||27||
48304383|NCT00685685|101072939|FG001|COMPLETED|First Intervention||27||
48304384|NCT00685685|101072938|FG000|NOT COMPLETED|First Intervention||0||
48304385|NCT00685685|101072939|FG001|NOT COMPLETED|First Intervention||0||
48304386|NCT00685685|101072938|FG000|STARTED|Washout Period of 7 Days||27||
48304387|NCT00685685|101072939|FG001|STARTED|Washout Period of 7 Days||27||
48304388|NCT00685685|101072938|FG000|COMPLETED|Washout Period of 7 Days||25||
48304389|NCT00685685|101072939|FG001|COMPLETED|Washout Period of 7 Days||26||
48304390|NCT00685685|101072938|FG000|NOT COMPLETED|Washout Period of 7 Days||2||
48304391|NCT00685685|101072939|FG001|NOT COMPLETED|Washout Period of 7 Days||1||
48304392|NCT00685685|101072938|FG000|STARTED|Second Intervention||25||
48304393|NCT00685685|101072939|FG001|STARTED|Second Intervention||26||
48304394|NCT00685685|101072938|FG000|COMPLETED|Second Intervention||25||
48304395|NCT00685685|101072939|FG001|COMPLETED|Second Intervention||26||
48304396|NCT00685685|101072938|FG000|NOT COMPLETED|Second Intervention||0||
48304397|NCT00685685|101072939|FG001|NOT COMPLETED|Second Intervention||0||
48304398|NCT00307125|101072940|FG000|STARTED|Screening Phase||757||
48304399|NCT00307125|101072941|FG001|STARTED|Screening Phase||0||
48304400|NCT00307125|101072942|FG002|STARTED|Screening Phase||0||
48304401|NCT00307125|101072940|FG000|COMPLETED|Screening Phase||303||
48304402|NCT00307125|101072941|FG001|COMPLETED|Screening Phase||0||
48406093|NCT00606294|101325426|FG001|STARTED|Overall Study||19||
48406094|NCT00606294|101325425|FG000|COMPLETED|Overall Study||161||
48406095|NCT00606294|101325426|FG001|COMPLETED|Overall Study||19||
48304403|NCT00307125|101072942|FG002|COMPLETED|Screening Phase||0||
48304404|NCT00307125|101072940|FG000|NOT COMPLETED|Screening Phase||454||
48304405|NCT00307125|101072941|FG001|NOT COMPLETED|Screening Phase||0||
48304406|NCT00307125|101072942|FG002|NOT COMPLETED|Screening Phase||0||
48304407|NCT00307125|101072940|FG000|STARTED|Pilot Phase||0||
48304408|NCT00307125|101072941|FG001|STARTED|Pilot Phase||15||
48304409|NCT00307125|101072942|FG002|STARTED|Pilot Phase||7||
48304410|NCT00307125|101072940|FG000|COMPLETED|Pilot Phase||0||
48304411|NCT00307125|101072941|FG001|COMPLETED|Pilot Phase||13||
48406096|NCT00606294|101325425|FG000|NOT COMPLETED|Overall Study||36||
48406097|NCT00606294|101325426|FG001|NOT COMPLETED|Overall Study||0||
48406098|NCT02143141|101325427|FG000|STARTED|Overall Study||7||
48406099|NCT02143141|101325428|FG001|STARTED|Overall Study||6||
48149902|NCT04209075|100688814|FG000|STARTED|Overall Study||4||
48149903|NCT04209075|100688815|FG001|STARTED|Overall Study||2||
48149904|NCT04209075|100688814|FG000|COMPLETED|Overall Study||4||
48149905|NCT04209075|100688815|FG001|COMPLETED|Overall Study||2||
48149906|NCT04209075|100688814|FG000|NOT COMPLETED|Overall Study||0||
48149907|NCT04209075|100688815|FG001|NOT COMPLETED|Overall Study||0||
48149908|NCT01951625|100688816|FG000|STARTED|Treatment Period||92||
48149909|NCT01951625|100688817|FG001|STARTED|Treatment Period||91||
48149910|NCT01951625|100688818|FG002|STARTED|Treatment Period||91||
48149911|NCT01951625|100688819|FG003|STARTED|Treatment Period||91||
48149912|NCT01951625|100688820|FG004|STARTED|Treatment Period||91||
48149913|NCT01951625|100688816|FG000|COMPLETED|Treatment Period||73||
48149914|NCT01951625|100688817|FG001|COMPLETED|Treatment Period||70||
48149915|NCT01951625|100688818|FG002|COMPLETED|Treatment Period||76||
48149916|NCT01951625|100688819|FG003|COMPLETED|Treatment Period||69||
48149917|NCT01951625|100688820|FG004|COMPLETED|Treatment Period||74||
48149918|NCT01951625|100688816|FG000|NOT COMPLETED|Treatment Period||19||
48149919|NCT01951625|100688817|FG001|NOT COMPLETED|Treatment Period||21||
48606945|NCT03762681|101823410|FG001|STARTED|Part 1||8||
48606946|NCT03762681|101823411|FG002|STARTED|Part 1||8||
48606947|NCT03762681|101823412|FG003|STARTED|Part 1||8||
48606948|NCT03762681|101823413|FG004|STARTED|Part 1||8||
48606949|NCT03762681|101823414|FG005|STARTED|Part 1||0||
48606950|NCT03762681|101823415|FG006|STARTED|Part 1||0||
48606951|NCT03762681|101823416|FG007|STARTED|Part 1||0||
48606952|NCT03762681|101823409|FG000|COMPLETED|Part 1||8||
48606953|NCT03762681|101823410|FG001|COMPLETED|Part 1||8||
48606954|NCT03762681|101823411|FG002|COMPLETED|Part 1||8||
48606955|NCT03762681|101823412|FG003|COMPLETED|Part 1||7||
48606956|NCT03762681|101823413|FG004|COMPLETED|Part 1||8||
48606957|NCT03762681|101823414|FG005|COMPLETED|Part 1||0||
48606958|NCT03762681|101823415|FG006|COMPLETED|Part 1||0||
48149920|NCT01951625|100688818|FG002|NOT COMPLETED|Treatment Period||15||
48149921|NCT01951625|100688819|FG003|NOT COMPLETED|Treatment Period||22||
48149922|NCT01951625|100688820|FG004|NOT COMPLETED|Treatment Period||17||
48149923|NCT01951625|100688816|FG000|STARTED|Follow Up Period||87||
48149924|NCT01951625|100688817|FG001|STARTED|Follow Up Period||88||
48606959|NCT03762681|101823416|FG007|COMPLETED|Part 1||0||
48606960|NCT03762681|101823409|FG000|NOT COMPLETED|Part 1||0||
48606961|NCT03762681|101823410|FG001|NOT COMPLETED|Part 1||0||
48606962|NCT03762681|101823411|FG002|NOT COMPLETED|Part 1||0||
48606963|NCT03762681|101823412|FG003|NOT COMPLETED|Part 1||1||
48606964|NCT03762681|101823413|FG004|NOT COMPLETED|Part 1||0||
48606965|NCT03762681|101823414|FG005|NOT COMPLETED|Part 1||0||
48606966|NCT03762681|101823415|FG006|NOT COMPLETED|Part 1||0||
48606967|NCT03762681|101823416|FG007|NOT COMPLETED|Part 1||0||
48149925|NCT01951625|100688818|FG002|STARTED|Follow Up Period||88||
48149926|NCT01951625|100688819|FG003|STARTED|Follow Up Period||87||
48149927|NCT01951625|100688820|FG004|STARTED|Follow Up Period||88||
48149928|NCT01951625|100688816|FG000|COMPLETED|Follow Up Period||79||
48149929|NCT01951625|100688817|FG001|COMPLETED|Follow Up Period||79||
48149930|NCT01951625|100688818|FG002|COMPLETED|Follow Up Period||84||
48149931|NCT01951625|100688819|FG003|COMPLETED|Follow Up Period||76||
48149932|NCT01951625|100688820|FG004|COMPLETED|Follow Up Period||78||
48149933|NCT01951625|100688816|FG000|NOT COMPLETED|Follow Up Period||8||
48149934|NCT01951625|100688817|FG001|NOT COMPLETED|Follow Up Period||9||
48149935|NCT01951625|100688818|FG002|NOT COMPLETED|Follow Up Period||4||
48149936|NCT01951625|100688819|FG003|NOT COMPLETED|Follow Up Period||11||
48149937|NCT01951625|100688820|FG004|NOT COMPLETED|Follow Up Period||10||
48149938|NCT04120233|100688821|FG000|STARTED|Overall Study||10||
48149939|NCT04120233|100688822|FG001|STARTED|Overall Study||6||
48149940|NCT04120233|100688823|FG002|STARTED|Overall Study||6||
48149941|NCT04120233|100688824|FG003|STARTED|Overall Study||6||
48149942|NCT04120233|100688825|FG004|STARTED|Overall Study||6||
48149943|NCT04120233|100688826|FG005|STARTED|Overall Study||6||
48149944|NCT04120233|100688821|FG000|COMPLETED|Overall Study||10||
48149945|NCT04120233|100688822|FG001|COMPLETED|Overall Study||6||
48149946|NCT04120233|100688823|FG002|COMPLETED|Overall Study||6||
48149947|NCT04120233|100688824|FG003|COMPLETED|Overall Study||6||
48149948|NCT04120233|100688825|FG004|COMPLETED|Overall Study||5||
48149949|NCT04120233|100688826|FG005|COMPLETED|Overall Study||6||
48149950|NCT04120233|100688821|FG000|NOT COMPLETED|Overall Study||0||
48149951|NCT04120233|100688822|FG001|NOT COMPLETED|Overall Study||0||
48149952|NCT04120233|100688823|FG002|NOT COMPLETED|Overall Study||0||
48149953|NCT04120233|100688824|FG003|NOT COMPLETED|Overall Study||0||
48606968|NCT03762681|101823409|FG000|STARTED|Part 2a||0||
48149954|NCT04120233|100688825|FG004|NOT COMPLETED|Overall Study||1||
48149955|NCT04120233|100688826|FG005|NOT COMPLETED|Overall Study||0||
48149956|NCT00500903|100688827|FG000|STARTED|Overall Study||65||
48149957|NCT00500903|100688828|FG001|STARTED|Overall Study||2||
48149958|NCT00500903|100688829|FG002|STARTED|Overall Study||20||
48149959|NCT00500903|100688827|FG000|COMPLETED|Overall Study||0||
48149960|NCT00500903|100688828|FG001|COMPLETED|Overall Study||0||
48149961|NCT00500903|100688829|FG002|COMPLETED|Overall Study||0||
48606969|NCT03762681|101823410|FG001|STARTED|Part 2a||0||
48606970|NCT03762681|101823411|FG002|STARTED|Part 2a||0||
48606971|NCT03762681|101823412|FG003|STARTED|Part 2a||0||
48606972|NCT03762681|101823413|FG004|STARTED|Part 2a||0||
48606973|NCT03762681|101823414|FG005|STARTED|Part 2a||2||
48606974|NCT03762681|101823415|FG006|STARTED|Part 2a||8||
48606975|NCT03762681|101823416|FG007|STARTED|Part 2a||5||
48606976|NCT03762681|101823409|FG000|COMPLETED|Part 2a||0||
48606977|NCT03762681|101823410|FG001|COMPLETED|Part 2a||0||
48606978|NCT03762681|101823411|FG002|COMPLETED|Part 2a||0||
48606979|NCT03762681|101823412|FG003|COMPLETED|Part 2a||0||
48606980|NCT03762681|101823413|FG004|COMPLETED|Part 2a||0||
48606981|NCT03762681|101823414|FG005|COMPLETED|Part 2a||2||
48606982|NCT03762681|101823415|FG006|COMPLETED|Part 2a||8||
48606983|NCT03762681|101823416|FG007|COMPLETED|Part 2a||4||
48606984|NCT03762681|101823409|FG000|NOT COMPLETED|Part 2a||0||
48606985|NCT03762681|101823410|FG001|NOT COMPLETED|Part 2a||0||
48606986|NCT03762681|101823411|FG002|NOT COMPLETED|Part 2a||0||
48606987|NCT03762681|101823412|FG003|NOT COMPLETED|Part 2a||0||
48606988|NCT03762681|101823413|FG004|NOT COMPLETED|Part 2a||0||
48606989|NCT03762681|101823414|FG005|NOT COMPLETED|Part 2a||0||
48606990|NCT03762681|101823415|FG006|NOT COMPLETED|Part 2a||0||
48606991|NCT03762681|101823416|FG007|NOT COMPLETED|Part 2a||1||
48606992|NCT01317004|101823417|FG000|STARTED|Overall Study||51||
48606993|NCT01317004|101823418|FG001|STARTED|Overall Study||14||
48606994|NCT01317004|101823417|FG000|Safety Set|Overall Study||50||
48606995|NCT01317004|101823418|FG001|Safety Set|Overall Study||11||
48606996|NCT01317004|101823417|FG000|COMPLETED|Overall Study||47||
48606997|NCT01317004|101823418|FG001|COMPLETED|Overall Study||5||
48606998|NCT01317004|101823417|FG000|NOT COMPLETED|Overall Study||4||
48606999|NCT01317004|101823418|FG001|NOT COMPLETED|Overall Study||9||
48607000|NCT02776670|101823419|FG000|STARTED|Overall Study||117|Randomized and treated|
48607001|NCT02776670|101823420|FG001|STARTED|Overall Study||114|Randomized and treated|
48607002|NCT02776670|101823419|FG000|Full Analysis Set (FAS)|Overall Study||117|All randomized subjects who had at least 1 post-baseline primary endpoint (ie, TFBUT) assessment.|
48607003|NCT02776670|101823420|FG001|Full Analysis Set (FAS)|Overall Study||114|All randomized subjects who had at least 1 post-baseline primary endpoint (ie, TFBUT) assessment.|
48607004|NCT02776670|101823419|FG000|Per Protocol Analysis Set (PPS)|Overall Study||115|Subjects in FAS who satisfied all inclusion/exclusion criteria and had no major protocol deviations|
48607005|NCT02776670|101823420|FG001|Per Protocol Analysis Set (PPS)|Overall Study||113|Subjects in FAS who satisfied all inclusion/exclusion criteria and had no major protocol deviations|
48607006|NCT02776670|101823419|FG000|Safety Analysis Set|Overall Study||117|All subjects exposed to post-randomization study treatment|
48607007|NCT02776670|101823420|FG001|Safety Analysis Set|Overall Study||114|All subjects exposed to post-randomization study treatment|
48656916|NCT04274218|101943725|FG000|NOT COMPLETED|Perturbation Condition 1 (15 Minutes)||0||
48149962|NCT00500903|100688827|FG000|NOT COMPLETED|Overall Study||65||
48149963|NCT00500903|100688828|FG001|NOT COMPLETED|Overall Study||2||
48149964|NCT00500903|100688829|FG002|NOT COMPLETED|Overall Study||20||
48149965|NCT01189279|100688830|FG000|STARTED|Overall Study||14||
48149966|NCT01189279|100688831|FG001|STARTED|Overall Study||14||
48607008|NCT02776670|101823419|FG000|COMPLETED|Overall Study||117|All subjects who completed the study whether on study treatment or not|
48607009|NCT02776670|101823420|FG001|COMPLETED|Overall Study||108|All subjects who completed the study whether on study treatment or not|
48607010|NCT02776670|101823419|FG000|NOT COMPLETED|Overall Study||0||
48717636|NCT04524455|102095204|FG001|NOT COMPLETED|Overall Study||6||
48717637|NCT02804750|102095205|FG000|STARTED|Period 1||17||
48717638|NCT02804750|102095206|FG001|STARTED|Period 1||18||
48717639|NCT02804750|102095205|FG000|COMPLETED|Period 1||17||
48717640|NCT02804750|102095206|FG001|COMPLETED|Period 1||15||
48717641|NCT02804750|102095205|FG000|NOT COMPLETED|Period 1||0||
48607011|NCT02776670|101823420|FG001|NOT COMPLETED|Overall Study||6||
48607012|NCT00660595|101823421|FG000|STARTED|Overall Study||19||
48607013|NCT00660595|101823422|FG001|STARTED|Overall Study||10||
48607014|NCT00660595|101823421|FG000|COMPLETED|Overall Study||1||
48607015|NCT00660595|101823422|FG001|COMPLETED|Overall Study||1||
48607016|NCT00660595|101823421|FG000|NOT COMPLETED|Overall Study||18||
48607017|NCT00660595|101823422|FG001|NOT COMPLETED|Overall Study||9||
48607018|NCT00765947|101823423|FG000|STARTED|Overall Study||256||
48607019|NCT00765947|101823423|FG000|COMPLETED|Overall Study||232||
48607020|NCT00765947|101823423|FG000|NOT COMPLETED|Overall Study||24||
48607021|NCT00069823|101823424|FG000|STARTED|Overall Study||199||
48717642|NCT02804750|102095206|FG001|NOT COMPLETED|Period 1||3||
48717643|NCT02804750|102095205|FG000|STARTED|Period 2||17||
48717644|NCT02804750|102095206|FG001|STARTED|Period 2||15||
48717645|NCT02804750|102095205|FG000|COMPLETED|Period 2||16||
48717646|NCT02804750|102095206|FG001|COMPLETED|Period 2||15||
48717647|NCT02804750|102095205|FG000|NOT COMPLETED|Period 2||1||
48717648|NCT02804750|102095206|FG001|NOT COMPLETED|Period 2||0||
48717649|NCT02804750|102095205|FG000|STARTED|Period 3||16||
48717650|NCT02804750|102095206|FG001|STARTED|Period 3||15||
48717651|NCT02804750|102095205|FG000|COMPLETED|Period 3||16||
48149967|NCT01189279|100688832|FG002|STARTED|Overall Study||14||
48607022|NCT00069823|101823425|FG001|STARTED|Overall Study||203||
48607023|NCT00069823|101823424|FG000|COMPLETED|Overall Study||193||
48149968|NCT01189279|100688830|FG000|COMPLETED|Overall Study||13||
48149969|NCT01189279|100688831|FG001|COMPLETED|Overall Study||14||
48149970|NCT01189279|100688832|FG002|COMPLETED|Overall Study||13||
48607024|NCT00069823|101823425|FG001|COMPLETED|Overall Study||200||
48607025|NCT00069823|101823424|FG000|NOT COMPLETED|Overall Study||6||
48607026|NCT00069823|101823425|FG001|NOT COMPLETED|Overall Study||3||
48607027|NCT01663857|101823426|FG000|STARTED|Overall Study||6||
48607028|NCT01663857|101823427|FG001|STARTED|Overall Study||2||
48607029|NCT01663857|101823428|FG002|STARTED|Overall Study||58||
48607030|NCT01663857|101823429|FG003|STARTED|Overall Study||52||
48717652|NCT02804750|102095206|FG001|COMPLETED|Period 3||13||
48717653|NCT02804750|102095205|FG000|NOT COMPLETED|Period 3||0||
48717654|NCT02804750|102095206|FG001|NOT COMPLETED|Period 3||2||
48717655|NCT02804750|102095205|FG000|STARTED|Period 4||0||
48717656|NCT02804750|102095206|FG001|STARTED|Period 4||12||
48717657|NCT02804750|102095205|FG000|COMPLETED|Period 4||0||
48717658|NCT02804750|102095206|FG001|COMPLETED|Period 4||7||
48717659|NCT02804750|102095205|FG000|NOT COMPLETED|Period 4||0||
48717660|NCT02804750|102095206|FG001|NOT COMPLETED|Period 4||5||
48717661|NCT03123614|102095207|FG000|STARTED|Overall Study||57||114
48717662|NCT03123614|102095208|FG001|STARTED|Overall Study||74||147
48717663|NCT03123614|102095207|FG000|COMPLETED|Overall Study||57||114
48717664|NCT03123614|102095208|FG001|COMPLETED|Overall Study||74||147
48717665|NCT03123614|102095207|FG000|NOT COMPLETED|Overall Study||0||0
48717666|NCT03123614|102095208|FG001|NOT COMPLETED|Overall Study||0||0
48717667|NCT00762996|102095209|FG000|STARTED|Period One||15||
48717668|NCT00762996|102095210|FG001|STARTED|Period One||16||
48717669|NCT00762996|102095211|FG002|STARTED|Period One||17||
48717670|NCT00762996|102095212|FG003|STARTED|Period One||17||
48717671|NCT00762996|102095209|FG000|COMPLETED|Period One||15||
48717672|NCT00762996|102095210|FG001|COMPLETED|Period One||16||
48607031|NCT01663857|101823426|FG000|Received at Least One Dose of Study Drug|Overall Study||6||
48717673|NCT00762996|102095211|FG002|COMPLETED|Period One||13||
48717674|NCT00762996|102095212|FG003|COMPLETED|Period One||16||
48717675|NCT00762996|102095209|FG000|NOT COMPLETED|Period One||0||
48717676|NCT00762996|102095210|FG001|NOT COMPLETED|Period One||0||
48717677|NCT00762996|102095211|FG002|NOT COMPLETED|Period One||4||
48717678|NCT00762996|102095212|FG003|NOT COMPLETED|Period One||1||
48717679|NCT00762996|102095209|FG000|STARTED|Period Two||15||
48717680|NCT00762996|102095210|FG001|STARTED|Period Two||16||
48717681|NCT00762996|102095211|FG002|STARTED|Period Two||13||
48717682|NCT00762996|102095212|FG003|STARTED|Period Two||16||
48717683|NCT00762996|102095209|FG000|COMPLETED|Period Two||15||
48717684|NCT00762996|102095210|FG001|COMPLETED|Period Two||16||
48717685|NCT00762996|102095211|FG002|COMPLETED|Period Two||13||
48717686|NCT00762996|102095212|FG003|COMPLETED|Period Two||16||
48717687|NCT00762996|102095209|FG000|NOT COMPLETED|Period Two||0||
48717688|NCT00762996|102095210|FG001|NOT COMPLETED|Period Two||0||
48717689|NCT00762996|102095211|FG002|NOT COMPLETED|Period Two||0||
48717690|NCT00762996|102095212|FG003|NOT COMPLETED|Period Two||0||
48607032|NCT01663857|101823427|FG001|Received at Least One Dose of Study Drug|Overall Study||2||
48717691|NCT02674425|102095213|FG000|STARTED|Overall Study||10||
48717692|NCT02674425|102095214|FG001|STARTED|Overall Study||10||
48717693|NCT02674425|102095213|FG000|COMPLETED|Overall Study||8||
48717694|NCT02674425|102095214|FG001|COMPLETED|Overall Study||8||
48717695|NCT02674425|102095213|FG000|NOT COMPLETED|Overall Study||2||
48717696|NCT02674425|102095214|FG001|NOT COMPLETED|Overall Study||2||
48607033|NCT01663857|101823428|FG002|Received at Least One Dose of Study Drug|Overall Study||58||
48607034|NCT01663857|101823429|FG003|Received at Least One Dose of Study Drug|Overall Study||52||
48607035|NCT01663857|101823426|FG000|COMPLETED|Overall Study||6||
48607036|NCT01663857|101823427|FG001|COMPLETED|Overall Study||1||
48607037|NCT01663857|101823428|FG002|COMPLETED|Overall Study||48||
48607038|NCT01663857|101823429|FG003|COMPLETED|Overall Study||48||
48607039|NCT01663857|101823426|FG000|NOT COMPLETED|Overall Study||0||
48607040|NCT01663857|101823427|FG001|NOT COMPLETED|Overall Study||1||
48607041|NCT01663857|101823428|FG002|NOT COMPLETED|Overall Study||10||
48607042|NCT01663857|101823429|FG003|NOT COMPLETED|Overall Study||4||
48607043|NCT01042392|101823430|FG000|STARTED|Period II(Randomized,Double Blinded,8wk)||257||
48607044|NCT01042392|101823431|FG001|STARTED|Period II(Randomized,Double Blinded,8wk)||0||
48149971|NCT01189279|100688830|FG000|NOT COMPLETED|Overall Study||1||
48607045|NCT01042392|101823432|FG002|STARTED|Period II(Randomized,Double Blinded,8wk)||249||
48607046|NCT01042392|101823433|FG003|STARTED|Period II(Randomized,Double Blinded,8wk)||0||
48607047|NCT01042392|101823430|FG000|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||222||
48607048|NCT01042392|101823431|FG001|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0||
48607049|NCT01042392|101823432|FG002|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||222||
48607050|NCT01042392|101823433|FG003|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0||
48607051|NCT01042392|101823430|FG000|COMPLETED|Period II(Randomized,Double Blinded,8wk)||247||
48607052|NCT01042392|101823431|FG001|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0||
48607053|NCT01042392|101823432|FG002|COMPLETED|Period II(Randomized,Double Blinded,8wk)||241||
48607054|NCT01042392|101823433|FG003|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0||
48607055|NCT01042392|101823430|FG000|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||10||
48607056|NCT01042392|101823431|FG001|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0||
48607057|NCT01042392|101823432|FG002|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||8||
48607058|NCT01042392|101823433|FG003|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0||
48607059|NCT01042392|101823430|FG000|STARTED|Period III (Unblinded,Controlled, 1 Day)||129||
48149972|NCT01189279|100688831|FG001|NOT COMPLETED|Overall Study||0||
48149973|NCT01189279|100688832|FG002|NOT COMPLETED|Overall Study||1||
48149974|NCT04570436|100688833|FG000|STARTED|Overall Study||5||
48149975|NCT04570436|100688834|FG001|STARTED|Overall Study||5||
48149976|NCT04570436|100688835|FG002|STARTED|Overall Study||6||
48149977|NCT04570436|100688836|FG003|STARTED|Overall Study||5||
48149978|NCT04570436|100688837|FG004|STARTED|Overall Study||5||
48149979|NCT04570436|100688838|FG005|STARTED|Overall Study||5||
48149980|NCT04570436|100688839|FG006|STARTED|Overall Study||6||
48149981|NCT04570436|100688840|FG007|STARTED|Overall Study||5||
48607060|NCT01042392|101823431|FG001|STARTED|Period III (Unblinded,Controlled, 1 Day)||118||
48607061|NCT01042392|101823432|FG002|STARTED|Period III (Unblinded,Controlled, 1 Day)||119||
48607062|NCT01042392|101823433|FG003|STARTED|Period III (Unblinded,Controlled, 1 Day)||122||
48607063|NCT01042392|101823430|FG000|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||98||
48607064|NCT01042392|101823431|FG001|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||73||
48607065|NCT01042392|101823432|FG002|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||93||
48607066|NCT01042392|101823433|FG003|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||82||
48607067|NCT01042392|101823430|FG000|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||127||
48607068|NCT01042392|101823431|FG001|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||117||
48607069|NCT01042392|101823432|FG002|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||115||
48607070|NCT01042392|101823433|FG003|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||121||
48607071|NCT01042392|101823430|FG000|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||2||
48607072|NCT01042392|101823431|FG001|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1||
48304412|NCT00307125|101072942|FG002|COMPLETED|Pilot Phase||6||
48304413|NCT00307125|101072940|FG000|NOT COMPLETED|Pilot Phase||0||
48304414|NCT00307125|101072941|FG001|NOT COMPLETED|Pilot Phase||2||
48304415|NCT00307125|101072942|FG002|NOT COMPLETED|Pilot Phase||1||
48304416|NCT01323621|101072943|FG000|STARTED|2-week, Single-blind Run In Period||739||
48304417|NCT01323621|101072944|FG001|STARTED|2-week, Single-blind Run In Period||0||
48304418|NCT01323621|101072945|FG002|STARTED|2-week, Single-blind Run In Period||0||
48304419|NCT01323621|101072943|FG000|COMPLETED|2-week, Single-blind Run In Period||511||
48304420|NCT01323621|101072944|FG001|COMPLETED|2-week, Single-blind Run In Period||0||
48304421|NCT01323621|101072945|FG002|COMPLETED|2-week, Single-blind Run In Period||0||
48304422|NCT01323621|101072943|FG000|NOT COMPLETED|2-week, Single-blind Run In Period||228||
48304423|NCT01323621|101072944|FG001|NOT COMPLETED|2-week, Single-blind Run In Period||0||
48607073|NCT01042392|101823432|FG002|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||4||
48607074|NCT01042392|101823433|FG003|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1||
48304424|NCT01323621|101072945|FG002|NOT COMPLETED|2-week, Single-blind Run In Period||0||
48607075|NCT01616758|101823434|FG000|STARTED|Overall Study||22||
48607076|NCT01616758|101823434|FG000|Evaluable|Overall Study||20||
48607077|NCT01616758|101823434|FG000|COMPLETED|Overall Study||0||
48607078|NCT01616758|101823434|FG000|NOT COMPLETED|Overall Study||22||
48607079|NCT03672344|101823435|FG000|STARTED|Overall Study||25||
48607080|NCT03672344|101823436|FG001|STARTED|Overall Study||29||
48607081|NCT03672344|101823435|FG000|COMPLETED|Overall Study||25||
48607082|NCT03672344|101823436|FG001|COMPLETED|Overall Study||29||
48607083|NCT03672344|101823435|FG000|NOT COMPLETED|Overall Study||0||
48607084|NCT03672344|101823436|FG001|NOT COMPLETED|Overall Study||0||
48607085|NCT02364076|101823437|FG000|STARTED|Overall Study||45||
48607086|NCT02364076|101823437|FG000|COMPLETED|Overall Study||40||
48607087|NCT02364076|101823437|FG000|NOT COMPLETED|Overall Study||5||
48607088|NCT02168777|101823438|FG000|STARTED|Overall Study||2||
48607089|NCT02168777|101823439|FG001|STARTED|Overall Study||7||
48607090|NCT02168777|101823440|FG002|STARTED|Overall Study||11||
48607091|NCT02168777|101823438|FG000|COMPLETED|Overall Study||0||
48607092|NCT02168777|101823439|FG001|COMPLETED|Overall Study||0||
48607093|NCT02168777|101823440|FG002|COMPLETED|Overall Study||0||
48304425|NCT01323621|101072943|FG000|STARTED|12-week, Double-blind Treatment Period||0||
48607094|NCT02168777|101823438|FG000|NOT COMPLETED|Overall Study||2||
48607095|NCT02168777|101823439|FG001|NOT COMPLETED|Overall Study||7||
48607096|NCT02168777|101823440|FG002|NOT COMPLETED|Overall Study||11||
48607097|NCT01662856|101823441|FG000|STARTED|Part I + Part II (Overall Study)||168||
48607098|NCT01662856|101823442|FG001|STARTED|Part I + Part II (Overall Study)||57||
48607099|NCT01662856|101823441|FG000|Completed Study up to Week 6|Part I + Part II (Overall Study)||164||
48607100|NCT01662856|101823442|FG001|Completed Study up to Week 6|Part I + Part II (Overall Study)||56||
48607101|NCT01662856|101823441|FG000|COMPLETED|Part I + Part II (Overall Study)||152||
48607102|NCT01662856|101823442|FG001|COMPLETED|Part I + Part II (Overall Study)||55||
48607103|NCT01662856|101823441|FG000|NOT COMPLETED|Part I + Part II (Overall Study)||16||
48607104|NCT01662856|101823442|FG001|NOT COMPLETED|Part I + Part II (Overall Study)||2||
48607105|NCT01662856|101823441|FG000|STARTED|Primary Part II||109||
48304426|NCT01323621|101072944|FG001|STARTED|12-week, Double-blind Treatment Period||252||
48304427|NCT01323621|101072945|FG002|STARTED|12-week, Double-blind Treatment Period||259||
48304428|NCT01323621|101072943|FG000|COMPLETED|12-week, Double-blind Treatment Period||0||
48607106|NCT01662856|101823442|FG001|STARTED|Primary Part II||57||
48607107|NCT01662856|101823441|FG000|Completed Study up to Week 6|Primary Part II||106||
48717697|NCT01355796|102095215|FG000|STARTED|Overall Study||15||
48717698|NCT01355796|102095216|FG001|STARTED|Overall Study||15||
48717699|NCT01355796|102095215|FG000|First Intervention for 14 Days|Overall Study||15||
48717700|NCT01355796|102095216|FG001|First Intervention for 14 Days|Overall Study||15||
48717701|NCT01355796|102095215|FG000|Washout Period for 7 Days|Overall Study||15||
48717702|NCT01355796|102095216|FG001|Washout Period for 7 Days|Overall Study||15||
48717703|NCT01355796|102095215|FG000|Second Intervention for 14 Days|Overall Study||15||
48717704|NCT01355796|102095216|FG001|Second Intervention for 14 Days|Overall Study||15||
48717705|NCT01355796|102095215|FG000|COMPLETED|Overall Study||15||
48717706|NCT01355796|102095216|FG001|COMPLETED|Overall Study||15||
48717707|NCT01355796|102095215|FG000|NOT COMPLETED|Overall Study||0||
48717708|NCT01355796|102095216|FG001|NOT COMPLETED|Overall Study||0||
48717709|NCT00475215|102095217|FG000|STARTED|Overall Study||44|Randomized|
48717710|NCT00475215|102095218|FG001|STARTED|Overall Study||42|Randomized|
48717711|NCT00475215|102095217|FG000|Treated|Overall Study||39||
48717712|NCT00475215|102095218|FG001|Treated|Overall Study||38||
48717713|NCT00475215|102095217|FG000|COMPLETED|Overall Study||39||
48717714|NCT00475215|102095218|FG001|COMPLETED|Overall Study||38||
48717715|NCT00475215|102095217|FG000|NOT COMPLETED|Overall Study||5||
48717716|NCT00475215|102095218|FG001|NOT COMPLETED|Overall Study||4||
48717717|NCT00712582|102095219|FG000|STARTED|Overall Study||60||
48717718|NCT00712582|102095220|FG001|STARTED|Overall Study||32||
48717719|NCT00712582|102095221|FG002|STARTED|Overall Study||4||
48717720|NCT00712582|102095219|FG000|COMPLETED|Overall Study||60||
48717721|NCT00712582|102095220|FG001|COMPLETED|Overall Study||32||
48717722|NCT00712582|102095221|FG002|COMPLETED|Overall Study||4||
48717723|NCT00712582|102095219|FG000|NOT COMPLETED|Overall Study||0||
48717724|NCT00712582|102095220|FG001|NOT COMPLETED|Overall Study||0||
48717725|NCT00712582|102095221|FG002|NOT COMPLETED|Overall Study||0||
48717726|NCT00495755|102095222|FG000|STARTED|Overall Study||13||
48717727|NCT00495755|102095222|FG000|COMPLETED|Overall Study||10||
48717728|NCT00495755|102095222|FG000|NOT COMPLETED|Overall Study||3||
48717729|NCT02723175|102095223|FG000|STARTED|Overall Study||8||
48717730|NCT02723175|102095224|FG001|STARTED|Overall Study||7||
48717731|NCT02723175|102095223|FG000|COMPLETED|Overall Study||4||
48717732|NCT02723175|102095224|FG001|COMPLETED|Overall Study||4||
48717733|NCT02723175|102095223|FG000|NOT COMPLETED|Overall Study||4||
48717734|NCT02723175|102095224|FG001|NOT COMPLETED|Overall Study||3||
48717735|NCT02089113|102095225|FG000|STARTED|Overall Study||161||
48717736|NCT02089113|102095226|FG001|STARTED|Overall Study||80||
48717737|NCT02089113|102095225|FG000|COMPLETED|Overall Study||160||
48149982|NCT04570436|100688841|FG008|STARTED|Overall Study||5||
48149983|NCT04570436|100688842|FG009|STARTED|Overall Study||5||
48149984|NCT04570436|100688833|FG000|COMPLETED|Overall Study||4||
48717738|NCT02089113|102095226|FG001|COMPLETED|Overall Study||80||
48717739|NCT02089113|102095225|FG000|NOT COMPLETED|Overall Study||1||
48717740|NCT02089113|102095226|FG001|NOT COMPLETED|Overall Study||0||
48717741|NCT01995552|102095227|FG000|STARTED|Overall Study||250|The study required to enroll 250 patients:|
48717742|NCT01995552|102095227|FG000|COMPLETED|Overall Study||233||
48717743|NCT01995552|102095227|FG000|NOT COMPLETED|Overall Study||17||
48717744|NCT01167907|102095228|FG000|STARTED|Overall Study||17||
48717745|NCT01167907|102095229|FG001|STARTED|Overall Study||15||
48717746|NCT01167907|102095228|FG000|COMPLETED|Overall Study||15||
48717747|NCT01167907|102095229|FG001|COMPLETED|Overall Study||14||
48149985|NCT04570436|100688834|FG001|COMPLETED|Overall Study||5||
48149986|NCT04570436|100688835|FG002|COMPLETED|Overall Study||5||
48149987|NCT04570436|100688836|FG003|COMPLETED|Overall Study||5||
48149988|NCT04570436|100688837|FG004|COMPLETED|Overall Study||5||
48149989|NCT04570436|100688838|FG005|COMPLETED|Overall Study||5||
48149990|NCT04570436|100688839|FG006|COMPLETED|Overall Study||6||
48149991|NCT04570436|100688840|FG007|COMPLETED|Overall Study||5||
48149992|NCT04570436|100688841|FG008|COMPLETED|Overall Study||5||
48149993|NCT04570436|100688842|FG009|COMPLETED|Overall Study||5||
48149994|NCT04570436|100688833|FG000|NOT COMPLETED|Overall Study||1||
48717748|NCT01167907|102095228|FG000|NOT COMPLETED|Overall Study||2||
48717749|NCT01167907|102095229|FG001|NOT COMPLETED|Overall Study||1||
48717750|NCT02469714|102095230|FG000|STARTED|Overall Study||55|Baseline|
48717751|NCT02469714|102095231|FG001|STARTED|Overall Study||55|Baseline|
48717752|NCT02469714|102095230|FG000|4 Month Follow-Up|Overall Study||50||
48717753|NCT02469714|102095231|FG001|4 Month Follow-Up|Overall Study||51||
48149995|NCT04570436|100688834|FG001|NOT COMPLETED|Overall Study||0||
48717754|NCT02469714|102095230|FG000|8 Month Follow-Up|Overall Study||49||
48717755|NCT02469714|102095231|FG001|8 Month Follow-Up|Overall Study||50||
48717756|NCT02469714|102095230|FG000|COMPLETED|Overall Study||47|12 Month Follow-Up|
48717757|NCT02469714|102095231|FG001|COMPLETED|Overall Study||50|12 Month Follow-Up|
48717758|NCT02469714|102095230|FG000|NOT COMPLETED|Overall Study||8||
48717759|NCT02469714|102095231|FG001|NOT COMPLETED|Overall Study||5||
48717760|NCT03435562|102095232|FG000|STARTED|Overall Study||22||
48717761|NCT03435562|102095232|FG000|COMPLETED|Overall Study||18||
48717762|NCT03435562|102095232|FG000|NOT COMPLETED|Overall Study||4||
48304429|NCT01323621|101072944|FG001|COMPLETED|12-week, Double-blind Treatment Period||237||
48304430|NCT01323621|101072945|FG002|COMPLETED|12-week, Double-blind Treatment Period||239||
48304431|NCT01323621|101072943|FG000|NOT COMPLETED|12-week, Double-blind Treatment Period||0||
48717763|NCT03550404|102095233|FG000|STARTED|Phase 1||8||
48717764|NCT03550404|102095234|FG001|STARTED|Phase 1||0||
48717765|NCT03550404|102095235|FG002|STARTED|Phase 1||0||
48717766|NCT03550404|102095233|FG000|COMPLETED|Phase 1||8||
48717767|NCT03550404|102095234|FG001|COMPLETED|Phase 1||0||
48717768|NCT03550404|102095235|FG002|COMPLETED|Phase 1||0||
48717769|NCT03550404|102095233|FG000|NOT COMPLETED|Phase 1||0||
48717770|NCT03550404|102095234|FG001|NOT COMPLETED|Phase 1||0||
48717771|NCT03550404|102095235|FG002|NOT COMPLETED|Phase 1||0||
48717772|NCT03550404|102095233|FG000|STARTED|Phase 2||8||
48717773|NCT03550404|102095234|FG001|STARTED|Phase 2||0||
48717774|NCT03550404|102095235|FG002|STARTED|Phase 2||0||
48717775|NCT03550404|102095233|FG000|COMPLETED|Phase 2||4||
48717776|NCT03550404|102095234|FG001|COMPLETED|Phase 2||0||
48717777|NCT03550404|102095235|FG002|COMPLETED|Phase 2||0||
48717778|NCT03550404|102095233|FG000|NOT COMPLETED|Phase 2||4||
48717779|NCT03550404|102095234|FG001|NOT COMPLETED|Phase 2||0||
48717780|NCT03550404|102095235|FG002|NOT COMPLETED|Phase 2||0||
48717781|NCT03052530|102095236|FG000|STARTED|Overall Study||61||
48717782|NCT03052530|102095236|FG000|COMPLETED|Overall Study||61||
48717783|NCT03052530|102095236|FG000|NOT COMPLETED|Overall Study||0||
48717784|NCT02410577|102095237|FG000|STARTED|Overall Study||2||
48717785|NCT02410577|102095237|FG000|COMPLETED|Overall Study||2||
48717786|NCT02410577|102095237|FG000|NOT COMPLETED|Overall Study||0||
48717787|NCT02522442|102095238|FG000|STARTED|Overall Study||26||
48717788|NCT02522442|102095239|FG001|STARTED|Overall Study||22||
48717789|NCT02522442|102095238|FG000|COMPLETED|Overall Study||26||
48717790|NCT02522442|102095239|FG001|COMPLETED|Overall Study||22||
48717791|NCT02522442|102095238|FG000|NOT COMPLETED|Overall Study||0||
48717792|NCT02522442|102095239|FG001|NOT COMPLETED|Overall Study||0||
48717793|NCT02575118|102095240|FG000|STARTED|Overall Study||20||
48717794|NCT02575118|102095240|FG000|COMPLETED|Overall Study||20||
48717795|NCT02575118|102095240|FG000|NOT COMPLETED|Overall Study||0||
48717796|NCT02449018|102095241|FG000|STARTED|Overall Study||64||
48717797|NCT02449018|102095242|FG001|STARTED|Overall Study||28||
48717798|NCT02449018|102095241|FG000|COMPLETED|Overall Study||52||
48717799|NCT02449018|102095242|FG001|COMPLETED|Overall Study||26||
48717800|NCT02449018|102095241|FG000|NOT COMPLETED|Overall Study||12||
48717801|NCT02449018|102095242|FG001|NOT COMPLETED|Overall Study||2||
48717802|NCT01143896|102095243|FG000|STARTED|Overall Study||156||
48717803|NCT01143896|102095244|FG001|STARTED|Overall Study||153||
48717804|NCT01143896|102095243|FG000|COMPLETED|Overall Study||114||
48717805|NCT01143896|102095244|FG001|COMPLETED|Overall Study||128||
48717806|NCT01143896|102095243|FG000|NOT COMPLETED|Overall Study||42||
48717807|NCT01143896|102095244|FG001|NOT COMPLETED|Overall Study||25||
48717808|NCT03096873|102095245|FG000|STARTED|Overall Study||20||
48717809|NCT03096873|102095246|FG001|STARTED|Overall Study||20||
48717810|NCT03096873|102095245|FG000|COMPLETED|Overall Study||20||
48717811|NCT03096873|102095246|FG001|COMPLETED|Overall Study||20||
48717812|NCT03096873|102095245|FG000|NOT COMPLETED|Overall Study||0||
48717813|NCT03096873|102095246|FG001|NOT COMPLETED|Overall Study||0||
48717814|NCT00117793|102095247|FG000|STARTED|Overall Study||17||
48717815|NCT00117793|102095247|FG000|COMPLETED|Overall Study||5||
48717816|NCT00117793|102095247|FG000|NOT COMPLETED|Overall Study||12||
48717817|NCT01973608|102095248|FG000|STARTED|Overall Study||2||
48717818|NCT01973608|102095249|FG001|STARTED|Overall Study||2||
48717819|NCT01973608|102095250|FG002|STARTED|Overall Study||6||
48304432|NCT01323621|101072944|FG001|NOT COMPLETED|12-week, Double-blind Treatment Period||15||
48304433|NCT01323621|101072945|FG002|NOT COMPLETED|12-week, Double-blind Treatment Period||20||
48406100|NCT02143141|101325427|FG000|COMPLETED|Overall Study||6||
48406101|NCT02143141|101325428|FG001|COMPLETED|Overall Study||6||
48717820|NCT01973608|102095251|FG003|STARTED|Overall Study||2||
48717821|NCT01973608|102095248|FG000|COMPLETED|Overall Study||2||
48717822|NCT01973608|102095249|FG001|COMPLETED|Overall Study||2||
48717823|NCT01973608|102095250|FG002|COMPLETED|Overall Study||6||
48717824|NCT01973608|102095251|FG003|COMPLETED|Overall Study||2||
48717825|NCT01973608|102095248|FG000|NOT COMPLETED|Overall Study||0||
48717826|NCT01973608|102095249|FG001|NOT COMPLETED|Overall Study||0||
48717827|NCT01973608|102095250|FG002|NOT COMPLETED|Overall Study||0||
48717828|NCT01973608|102095251|FG003|NOT COMPLETED|Overall Study||0||
48717829|NCT00416715|102095252|FG000|STARTED|Overall Study||100||
48717830|NCT00416715|102095252|FG000|COMPLETED|Overall Study||85||
48717831|NCT00416715|102095252|FG000|NOT COMPLETED|Overall Study||15||
48717832|NCT01319721|102095253|FG000|STARTED|Overall Study||48||
48717833|NCT01319721|102095254|FG001|STARTED|Overall Study||48||
48717834|NCT01319721|102095253|FG000|COMPLETED|Overall Study||47||
48717835|NCT01319721|102095254|FG001|COMPLETED|Overall Study||42||
48717836|NCT01319721|102095253|FG000|NOT COMPLETED|Overall Study||1||
48717837|NCT01319721|102095254|FG001|NOT COMPLETED|Overall Study||6||
48717838|NCT01902459|102095255|FG000|STARTED|Overall Study||75||
48717839|NCT01902459|102095256|FG001|STARTED|Overall Study||75||
48717840|NCT01902459|102095255|FG000|COMPLETED|Overall Study||75||
48717841|NCT01902459|102095256|FG001|COMPLETED|Overall Study||75||
48717842|NCT01902459|102095255|FG000|NOT COMPLETED|Overall Study||0||
48717843|NCT01902459|102095256|FG001|NOT COMPLETED|Overall Study||0||
48717844|NCT00509093|102095257|FG000|STARTED|Overall Study||32||
48717845|NCT00509093|102095257|FG000|COMPLETED|Overall Study||8||
48717846|NCT00509093|102095257|FG000|NOT COMPLETED|Overall Study||24||
48717847|NCT01213823|102095258|FG000|STARTED|Overall Study||69||
48717848|NCT01213823|102095259|FG001|STARTED|Overall Study||467||
48717849|NCT01213823|102095258|FG000|COMPLETED|Overall Study||69||
48717850|NCT01213823|102095259|FG001|COMPLETED|Overall Study||467||
48717851|NCT01213823|102095258|FG000|NOT COMPLETED|Overall Study||0||
48717852|NCT01213823|102095259|FG001|NOT COMPLETED|Overall Study||0||
48717853|NCT00583791|102095260|FG000|STARTED|Overall Study||91||
48717854|NCT00583791|102095260|FG000|COMPLETED|Overall Study||18||
48717855|NCT00583791|102095260|FG000|NOT COMPLETED|Overall Study||73||
48717856|NCT00181610|102095261|FG000|STARTED|Overall Study||4||
48717857|NCT00181610|102095262|FG001|STARTED|Overall Study||4||
48717858|NCT00181610|102095263|FG002|STARTED|Overall Study||3||
48717859|NCT00181610|102095261|FG000|COMPLETED|Overall Study||4||
48717860|NCT00181610|102095262|FG001|COMPLETED|Overall Study||3||
48717861|NCT00181610|102095263|FG002|COMPLETED|Overall Study||3||
48717862|NCT00181610|102095261|FG000|NOT COMPLETED|Overall Study||0||
48717863|NCT00181610|102095262|FG001|NOT COMPLETED|Overall Study||1||
48717864|NCT00181610|102095263|FG002|NOT COMPLETED|Overall Study||0||
48717865|NCT00535821|102095264|FG000|STARTED|Overall Study||2||
48717866|NCT00535821|102095265|FG001|STARTED|Overall Study||3||
48717867|NCT00535821|102095264|FG000|COMPLETED|Overall Study||2||
48717868|NCT00535821|102095265|FG001|COMPLETED|Overall Study||3||
48717869|NCT00535821|102095264|FG000|NOT COMPLETED|Overall Study||0||
48717870|NCT00535821|102095265|FG001|NOT COMPLETED|Overall Study||0||
48717871|NCT01176955|102095266|FG000|STARTED|Overall Study||10||
48717872|NCT01176955|102095267|FG001|STARTED|Overall Study||10||
48717873|NCT01176955|102095266|FG000|COMPLETED|Overall Study||7||
48717874|NCT01176955|102095267|FG001|COMPLETED|Overall Study||8||
48717875|NCT01176955|102095266|FG000|NOT COMPLETED|Overall Study||3||
48717876|NCT01176955|102095267|FG001|NOT COMPLETED|Overall Study||2||
48717877|NCT00160654|102095268|FG000|STARTED|Overall Study||251||
48717878|NCT00160654|102095268|FG000|COMPLETED|Overall Study||218||
48717879|NCT00160654|102095268|FG000|NOT COMPLETED|Overall Study||33||
48717880|NCT00343863|102095269|FG000|STARTED|Overall Study||7||
48717881|NCT00343863|102095270|FG001|STARTED|Overall Study||34||
48717882|NCT00343863|102095269|FG000|COMPLETED|Overall Study||7||
48717883|NCT00343863|102095270|FG001|COMPLETED|Overall Study||34||
48717884|NCT00343863|102095269|FG000|NOT COMPLETED|Overall Study||0||
48717885|NCT00343863|102095270|FG001|NOT COMPLETED|Overall Study||0||
48717886|NCT01022359|102095271|FG000|STARTED|Overall Study||39||
48717887|NCT01022359|102095272|FG001|STARTED|Overall Study||41||
48717888|NCT01022359|102095271|FG000|COMPLETED|Overall Study||39||
48717889|NCT01022359|102095272|FG001|COMPLETED|Overall Study||41||
48717890|NCT01022359|102095271|FG000|NOT COMPLETED|Overall Study||0||
48717891|NCT01022359|102095272|FG001|NOT COMPLETED|Overall Study||0||
48717892|NCT00499655|102095273|FG000|STARTED|Overall Study||53||
48717893|NCT00499655|102095274|FG001|STARTED|Overall Study||54||
48717894|NCT00499655|102095273|FG000|COMPLETED|Overall Study||53||
48717895|NCT00499655|102095274|FG001|COMPLETED|Overall Study||54||
48717896|NCT00499655|102095273|FG000|NOT COMPLETED|Overall Study||0||
48717897|NCT00499655|102095274|FG001|NOT COMPLETED|Overall Study||0||
48717898|NCT02559414|102095275|FG000|STARTED|Overall Study||11||
48717899|NCT02559414|102095276|FG001|STARTED|Overall Study||22||
48717900|NCT02559414|102095277|FG002|STARTED|Overall Study||22||
48717901|NCT02559414|102095275|FG000|COMPLETED|Overall Study||10||
48717902|NCT02559414|102095276|FG001|COMPLETED|Overall Study||20||
48717903|NCT02559414|102095277|FG002|COMPLETED|Overall Study||20||
48717904|NCT02559414|102095275|FG000|NOT COMPLETED|Overall Study||1||
48717905|NCT02559414|102095276|FG001|NOT COMPLETED|Overall Study||2||
48717906|NCT02559414|102095277|FG002|NOT COMPLETED|Overall Study||2||
48717907|NCT00993499|102095278|FG000|STARTED|Run-in Period (8 Days)||13||
48717908|NCT00993499|102095279|FG001|STARTED|Run-in Period (8 Days)||12||
48717909|NCT00993499|102095280|FG002|STARTED|Run-in Period (8 Days)||10||
48717910|NCT00993499|102095281|FG003|STARTED|Run-in Period (8 Days)||3||
48717911|NCT00993499|102095282|FG004|STARTED|Run-in Period (8 Days)||3||
48717912|NCT00993499|102095283|FG005|STARTED|Run-in Period (8 Days)||3||
48717913|NCT00993499|102095278|FG000|COMPLETED|Run-in Period (8 Days)||12||
48717914|NCT00993499|102095279|FG001|COMPLETED|Run-in Period (8 Days)||9||
48717915|NCT00993499|102095280|FG002|COMPLETED|Run-in Period (8 Days)||9||
48717916|NCT00993499|102095281|FG003|COMPLETED|Run-in Period (8 Days)||3||
48717917|NCT00993499|102095282|FG004|COMPLETED|Run-in Period (8 Days)||3||
48717918|NCT00993499|102095283|FG005|COMPLETED|Run-in Period (8 Days)||3||
48717919|NCT00993499|102095278|FG000|NOT COMPLETED|Run-in Period (8 Days)||1||
48717920|NCT00993499|102095279|FG001|NOT COMPLETED|Run-in Period (8 Days)||3||
48717921|NCT00993499|102095280|FG002|NOT COMPLETED|Run-in Period (8 Days)||1||
48717922|NCT00993499|102095281|FG003|NOT COMPLETED|Run-in Period (8 Days)||0||
48717923|NCT00993499|102095282|FG004|NOT COMPLETED|Run-in Period (8 Days)||0||
48717924|NCT00993499|102095283|FG005|NOT COMPLETED|Run-in Period (8 Days)||0||
48717925|NCT00993499|102095278|FG000|STARTED|Discontinued Before Starting Course 3||12||
48717926|NCT00993499|102095279|FG001|STARTED|Discontinued Before Starting Course 3||9||
48717927|NCT00993499|102095280|FG002|STARTED|Discontinued Before Starting Course 3||9||
48717928|NCT00993499|102095281|FG003|STARTED|Discontinued Before Starting Course 3||3||
48717929|NCT00993499|102095282|FG004|STARTED|Discontinued Before Starting Course 3||3||
48717930|NCT00993499|102095283|FG005|STARTED|Discontinued Before Starting Course 3||3||
48717931|NCT00993499|102095278|FG000|COMPLETED|Discontinued Before Starting Course 3||8||
48717932|NCT00993499|102095279|FG001|COMPLETED|Discontinued Before Starting Course 3||5||
48717933|NCT00993499|102095280|FG002|COMPLETED|Discontinued Before Starting Course 3||6||
48717934|NCT00993499|102095281|FG003|COMPLETED|Discontinued Before Starting Course 3||2||
48717935|NCT00993499|102095282|FG004|COMPLETED|Discontinued Before Starting Course 3||3||
48717936|NCT00993499|102095283|FG005|COMPLETED|Discontinued Before Starting Course 3||3||
48717937|NCT00993499|102095278|FG000|NOT COMPLETED|Discontinued Before Starting Course 3||4||
48717938|NCT00993499|102095279|FG001|NOT COMPLETED|Discontinued Before Starting Course 3||4||
48717939|NCT00993499|102095280|FG002|NOT COMPLETED|Discontinued Before Starting Course 3||3||
48717940|NCT00993499|102095281|FG003|NOT COMPLETED|Discontinued Before Starting Course 3||1||
48717941|NCT00993499|102095282|FG004|NOT COMPLETED|Discontinued Before Starting Course 3||0||
48717942|NCT00993499|102095283|FG005|NOT COMPLETED|Discontinued Before Starting Course 3||0||
48717943|NCT00993499|102095278|FG000|STARTED|Discontinued After Starting Course 3||12||
48717944|NCT00993499|102095279|FG001|STARTED|Discontinued After Starting Course 3||9||
48717945|NCT00993499|102095280|FG002|STARTED|Discontinued After Starting Course 3||9||
48717946|NCT00993499|102095281|FG003|STARTED|Discontinued After Starting Course 3||3||
48717947|NCT00993499|102095282|FG004|STARTED|Discontinued After Starting Course 3||3||
48717948|NCT00993499|102095283|FG005|STARTED|Discontinued After Starting Course 3||3||
48717949|NCT00993499|102095278|FG000|COMPLETED|Discontinued After Starting Course 3||4||
48717950|NCT00993499|102095279|FG001|COMPLETED|Discontinued After Starting Course 3||4||
48717951|NCT00993499|102095280|FG002|COMPLETED|Discontinued After Starting Course 3||3||
48717952|NCT00993499|102095281|FG003|COMPLETED|Discontinued After Starting Course 3||1||
48717953|NCT00993499|102095282|FG004|COMPLETED|Discontinued After Starting Course 3||0||
48717954|NCT00993499|102095283|FG005|COMPLETED|Discontinued After Starting Course 3||0||
48717955|NCT00993499|102095278|FG000|NOT COMPLETED|Discontinued After Starting Course 3||8||
48717956|NCT00993499|102095279|FG001|NOT COMPLETED|Discontinued After Starting Course 3||5||
48717957|NCT00993499|102095280|FG002|NOT COMPLETED|Discontinued After Starting Course 3||6||
48717958|NCT00993499|102095281|FG003|NOT COMPLETED|Discontinued After Starting Course 3||2||
48717959|NCT00993499|102095282|FG004|NOT COMPLETED|Discontinued After Starting Course 3||3||
48717960|NCT00993499|102095283|FG005|NOT COMPLETED|Discontinued After Starting Course 3||3||
48717961|NCT02046070|102095284|FG000|STARTED|Overall Study||36||
48717962|NCT02046070|102095285|FG001|STARTED|Overall Study||34||
48717963|NCT02046070|102095286|FG002|STARTED|Overall Study||78||
48717964|NCT02046070|102095284|FG000|COMPLETED|Overall Study||4|Completed=Completed Study Treatment|
48717965|NCT02046070|102095285|FG001|COMPLETED|Overall Study||6|Completed=Completed Study Treatment|
48717966|NCT02046070|102095286|FG002|COMPLETED|Overall Study||8|Completed=Completed Study Treatment|
48717967|NCT02046070|102095284|FG000|NOT COMPLETED|Overall Study||32||
48717968|NCT02046070|102095285|FG001|NOT COMPLETED|Overall Study||28||
48717969|NCT02046070|102095286|FG002|NOT COMPLETED|Overall Study||70||
48717970|NCT04897607|102095287|FG000|STARTED|Overall Study||17||
48717971|NCT04897607|102095288|FG001|STARTED|Overall Study||20||
48717972|NCT04897607|102095287|FG000|COMPLETED|Overall Study||11||
48717973|NCT04897607|102095288|FG001|COMPLETED|Overall Study||13||
48717974|NCT04897607|102095287|FG000|NOT COMPLETED|Overall Study||6||
48717975|NCT04897607|102095288|FG001|NOT COMPLETED|Overall Study||7||
48717976|NCT03684304|102095289|FG000|STARTED|Overall Study||19||
48717977|NCT03684304|102095290|FG001|STARTED|Overall Study||17||
48717978|NCT03684304|102095289|FG000|COMPLETED|Overall Study||0||
48717979|NCT03684304|102095290|FG001|COMPLETED|Overall Study||0||
48717980|NCT03684304|102095289|FG000|NOT COMPLETED|Overall Study||19||
48717981|NCT03684304|102095290|FG001|NOT COMPLETED|Overall Study||17||
48717982|NCT00552448|102095291|FG000|STARTED|Overall Study||20||
48717983|NCT00552448|102095292|FG001|STARTED|Overall Study||16||
48717984|NCT00552448|102095291|FG000|COMPLETED|Overall Study||19||
48717985|NCT00552448|102095292|FG001|COMPLETED|Overall Study||16||
48717986|NCT00552448|102095291|FG000|NOT COMPLETED|Overall Study||1||
48717987|NCT00552448|102095292|FG001|NOT COMPLETED|Overall Study||0||
48717988|NCT04208087|102095293|FG000|STARTED|Overall Study||8||
48717989|NCT04208087|102095294|FG001|STARTED|Overall Study||6||
48717990|NCT04208087|102095295|FG002|STARTED|Overall Study||6||
48717991|NCT04208087|102095296|FG003|STARTED|Overall Study||6||
48717992|NCT04208087|102095297|FG004|STARTED|Overall Study||7||
48717993|NCT04208087|102095293|FG000|COMPLETED|Overall Study||7||
48717994|NCT04208087|102095294|FG001|COMPLETED|Overall Study||6||
48717995|NCT04208087|102095295|FG002|COMPLETED|Overall Study||5||
48717996|NCT04208087|102095296|FG003|COMPLETED|Overall Study||6||
48717997|NCT04208087|102095297|FG004|COMPLETED|Overall Study||6||
48717998|NCT04208087|102095293|FG000|NOT COMPLETED|Overall Study||1||
48717999|NCT04208087|102095294|FG001|NOT COMPLETED|Overall Study||0||
48718000|NCT04208087|102095295|FG002|NOT COMPLETED|Overall Study||1||
48718001|NCT04208087|102095296|FG003|NOT COMPLETED|Overall Study||0||
48718002|NCT04208087|102095297|FG004|NOT COMPLETED|Overall Study||1||
48718003|NCT03283150|102095298|FG000|STARTED|Overall Study||20||
48718004|NCT03283150|102095299|FG001|STARTED|Overall Study||0||
48718005|NCT03283150|102095300|FG002|STARTED|Overall Study||0||
48718006|NCT03283150|102095298|FG000|COMPLETED|Overall Study||14||
48718007|NCT03283150|102095299|FG001|COMPLETED|Overall Study||0||
48718008|NCT03283150|102095300|FG002|COMPLETED|Overall Study||0||
48718009|NCT03283150|102095298|FG000|NOT COMPLETED|Overall Study||6||
48718010|NCT03283150|102095299|FG001|NOT COMPLETED|Overall Study||0||
48718011|NCT03283150|102095300|FG002|NOT COMPLETED|Overall Study||0||
48718012|NCT02535416|102095301|FG000|STARTED|Overall Study||4||
48718013|NCT02535416|102095302|FG001|STARTED|Overall Study||2||
48718014|NCT02535416|102095303|FG002|STARTED|Overall Study||4||
48718015|NCT02535416|102095304|FG003|STARTED|Overall Study||4||
48304434|NCT02743819|101072946|FG000|STARTED|Overall Study||70|70 patients enrolled in the study and received at least one dose of study treatment.|
48304435|NCT02743819|101072946|FG000|COMPLETED|Overall Study||62||
48304436|NCT02743819|101072946|FG000|NOT COMPLETED|Overall Study||8||
48304437|NCT03606980|101072947|FG000|STARTED|Overall Study||16||
48718016|NCT02535416|102095305|FG004|STARTED|Overall Study||4||
48718017|NCT02535416|102095306|FG005|STARTED|Overall Study||4||
48718018|NCT02535416|102095307|FG006|STARTED|Overall Study||6||
48718019|NCT02535416|102095308|FG007|STARTED|Overall Study||6||
48718020|NCT02535416|102095309|FG008|STARTED|Overall Study||6||
48718021|NCT02535416|102095301|FG000|COMPLETED|Overall Study||3||
48718022|NCT02535416|102095302|FG001|COMPLETED|Overall Study||2||
48718023|NCT02535416|102095303|FG002|COMPLETED|Overall Study||4||
48304438|NCT03606980|101072948|FG001|STARTED|Overall Study||15||
48304439|NCT03606980|101072949|FG002|STARTED|Overall Study||14||
48304440|NCT03606980|101072947|FG000|COMPLETED|Overall Study||12||
48304441|NCT03606980|101072948|FG001|COMPLETED|Overall Study||13||
48304442|NCT03606980|101072949|FG002|COMPLETED|Overall Study||7||
48304443|NCT03606980|101072947|FG000|NOT COMPLETED|Overall Study||4||
48304444|NCT03606980|101072948|FG001|NOT COMPLETED|Overall Study||2||
48304445|NCT03606980|101072949|FG002|NOT COMPLETED|Overall Study||7||
48304446|NCT01650285|101072950|FG000|STARTED|Overall Study||5||
48718024|NCT02535416|102095304|FG003|COMPLETED|Overall Study||4||
48718025|NCT02535416|102095305|FG004|COMPLETED|Overall Study||4||
48718026|NCT02535416|102095306|FG005|COMPLETED|Overall Study||4||
48718027|NCT02535416|102095307|FG006|COMPLETED|Overall Study||6||
48718028|NCT02535416|102095308|FG007|COMPLETED|Overall Study||6||
48718029|NCT02535416|102095309|FG008|COMPLETED|Overall Study||6||
48718030|NCT02535416|102095301|FG000|NOT COMPLETED|Overall Study||1||
48718031|NCT02535416|102095302|FG001|NOT COMPLETED|Overall Study||0||
48718032|NCT02535416|102095303|FG002|NOT COMPLETED|Overall Study||0||
48718033|NCT02535416|102095304|FG003|NOT COMPLETED|Overall Study||0||
48718034|NCT02535416|102095305|FG004|NOT COMPLETED|Overall Study||0||
48718035|NCT02535416|102095306|FG005|NOT COMPLETED|Overall Study||0||
48718036|NCT02535416|102095307|FG006|NOT COMPLETED|Overall Study||0||
48304447|NCT01650285|101072950|FG000|COMPLETED|Overall Study||4||
48718037|NCT02535416|102095308|FG007|NOT COMPLETED|Overall Study||0||
48718038|NCT02535416|102095309|FG008|NOT COMPLETED|Overall Study||0||
48718039|NCT00659724|102095310|FG000|STARTED|Weeks 1-2: Assessment of 180NR or 200NR||33||
48718040|NCT00659724|102095310|FG000|COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||33||
48304448|NCT01650285|101072950|FG000|NOT COMPLETED|Overall Study||1||
48718041|NCT00659724|102095310|FG000|NOT COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||0||
48718042|NCT00659724|102095310|FG000|STARTED|Weeks 3-4: Assessment of HD-C4 Big||33||
48718043|NCT00659724|102095310|FG000|COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||33||
48718044|NCT00659724|102095310|FG000|NOT COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||0||
48304449|NCT03157232|101072951|FG000|STARTED|Overall Study||18||
48718045|NCT02356887|102095311|FG000|STARTED|Overall Study||12||
48718046|NCT02356887|102095311|FG000|COMPLETED|Overall Study||10||
48718047|NCT02356887|102095311|FG000|NOT COMPLETED|Overall Study||2||
48718048|NCT00424268|102095312|FG000|STARTED|Overall Study||371||
48718049|NCT00424268|102095313|FG001|STARTED|Overall Study||372||
48718050|NCT00424268|102095312|FG000|COMPLETED|Overall Study||309||
48718051|NCT00424268|102095313|FG001|COMPLETED|Overall Study||333||
48718052|NCT00424268|102095312|FG000|NOT COMPLETED|Overall Study||62||
48718053|NCT00424268|102095313|FG001|NOT COMPLETED|Overall Study||39||
48304450|NCT03157232|101072951|FG000|COMPLETED|Overall Study||18||
48304451|NCT03157232|101072951|FG000|NOT COMPLETED|Overall Study||0||
48304452|NCT01521897|101072952|FG000|STARTED|Overall Study||1143||
48304453|NCT01521897|101072952|FG000|COMPLETED|Overall Study||1120||
48304454|NCT01521897|101072952|FG000|NOT COMPLETED|Overall Study||23||
48304455|NCT02017379|101072953|FG000|STARTED|Overall Study||0||
48718054|NCT01754194|102095314|FG000|STARTED|Overall Study||169||
48718055|NCT01754194|102095315|FG001|STARTED|Overall Study||124||
48718056|NCT01754194|102095314|FG000|COMPLETED|Overall Study||117||
48718057|NCT01754194|102095315|FG001|COMPLETED|Overall Study||97||
48718058|NCT01754194|102095314|FG000|NOT COMPLETED|Overall Study||52||
48718059|NCT01754194|102095315|FG001|NOT COMPLETED|Overall Study||27||
48718060|NCT00468845|102095316|FG000|STARTED|Overall Study||162||
48718061|NCT00468845|102095317|FG001|STARTED|Overall Study||170||
48718062|NCT00468845|102095318|FG002|STARTED|Overall Study||169||
48718063|NCT00468845|102095316|FG000|Received Treatment|Overall Study||161||
48718064|NCT00468845|102095317|FG001|Received Treatment|Overall Study||166||
48718065|NCT00468845|102095318|FG002|Received Treatment|Overall Study||167||
48718066|NCT00468845|102095316|FG000|COMPLETED|Overall Study||141||
48718067|NCT00468845|102095317|FG001|COMPLETED|Overall Study||136||
48304456|NCT02017379|101072954|FG001|STARTED|Overall Study||0||
48304457|NCT02017379|101072955|FG002|STARTED|Overall Study||0||
48304458|NCT02017379|101072953|FG000|COMPLETED|Overall Study||0||
48304459|NCT02017379|101072954|FG001|COMPLETED|Overall Study||0||
48304460|NCT02017379|101072955|FG002|COMPLETED|Overall Study||0||
48304461|NCT02017379|101072953|FG000|NOT COMPLETED|Overall Study||0||
48304462|NCT02017379|101072954|FG001|NOT COMPLETED|Overall Study||0||
48304463|NCT02017379|101072955|FG002|NOT COMPLETED|Overall Study||0||
48718068|NCT00468845|102095318|FG002|COMPLETED|Overall Study||139||
48718069|NCT00468845|102095316|FG000|NOT COMPLETED|Overall Study||21||
48718070|NCT00468845|102095317|FG001|NOT COMPLETED|Overall Study||34||
48718071|NCT00468845|102095318|FG002|NOT COMPLETED|Overall Study||30||
48718072|NCT02876328|102095319|FG000|STARTED|Overall Study||396||
48304464|NCT01667107|101072956|FG000|STARTED|Overall Study||8||
48304465|NCT01667107|101072957|FG001|STARTED|Overall Study||18||
48304466|NCT01667107|101072956|FG000|COMPLETED|Overall Study||4||
48304467|NCT01667107|101072957|FG001|COMPLETED|Overall Study||11||
48304468|NCT01667107|101072956|FG000|NOT COMPLETED|Overall Study||4||
48304469|NCT01667107|101072957|FG001|NOT COMPLETED|Overall Study||7||
48304470|NCT02311998|101072958|FG000|STARTED|Overall Study||3||
48304471|NCT02311998|101072959|FG001|STARTED|Overall Study||6||
48304472|NCT02311998|101072960|FG002|STARTED|Overall Study||9||
48304473|NCT02311998|101072961|FG003|STARTED|Overall Study||4||
48304474|NCT02311998|101072958|FG000|COMPLETED|Overall Study||3||
48304475|NCT02311998|101072959|FG001|COMPLETED|Overall Study||6||
48718073|NCT02876328|102095320|FG001|STARTED|Overall Study||221||
48718074|NCT02876328|102095321|FG002|STARTED|Overall Study||395||
48718075|NCT02876328|102095322|FG003|STARTED|Overall Study||197||
48718076|NCT02876328|102095323|FG004|STARTED|Overall Study||191||
48718077|NCT02876328|102095324|FG005|STARTED|Overall Study||403||
48718078|NCT02876328|102095325|FG006|STARTED|Overall Study||179||
48304476|NCT02311998|101072960|FG002|COMPLETED|Overall Study||9||
48304477|NCT02311998|101072961|FG003|COMPLETED|Overall Study||4||
48718079|NCT02876328|102095326|FG007|STARTED|Overall Study||407||
48718080|NCT02876328|102095327|FG008|STARTED|Overall Study||202||
48718081|NCT02876328|102095328|FG009|STARTED|Overall Study||210||
48149996|NCT04570436|100688835|FG002|NOT COMPLETED|Overall Study||1||
48304478|NCT02311998|101072958|FG000|NOT COMPLETED|Overall Study||0||
48149997|NCT04570436|100688836|FG003|NOT COMPLETED|Overall Study||0||
48149998|NCT04570436|100688837|FG004|NOT COMPLETED|Overall Study||0||
48149999|NCT04570436|100688838|FG005|NOT COMPLETED|Overall Study||0||
48150000|NCT04570436|100688839|FG006|NOT COMPLETED|Overall Study||0||
48150001|NCT04570436|100688840|FG007|NOT COMPLETED|Overall Study||0||
48150002|NCT04570436|100688841|FG008|NOT COMPLETED|Overall Study||0||
48150003|NCT04570436|100688842|FG009|NOT COMPLETED|Overall Study||0||
48150004|NCT00818961|100688843|FG000|STARTED|Overall Study||36||
48150005|NCT00818961|100688843|FG000|COMPLETED|Overall Study||36||
48150006|NCT00818961|100688843|FG000|NOT COMPLETED|Overall Study||0||
48150007|NCT02081573|100692131|FG000|STARTED|Overall Study||10||
48150008|NCT02081573|100692131|FG000|COMPLETED|Overall Study||10||
48150009|NCT02081573|100692131|FG000|NOT COMPLETED|Overall Study||0||
48150010|NCT03382782|100692132|FG000|STARTED|Cohort 1||41|The sum of number of participants who started in Cohorts 1, 2, and 3 = 234 participants initially enrolled|
48150011|NCT03382782|100692133|FG001|STARTED|Cohort 1||35|The sum of number of participants who started in Cohorts 1, 2, and 3 = 234 participants initially enrolled|
48150012|NCT03382782|100692134|FG002|STARTED|Cohort 1||30|The sum of number of participants who started in Cohorts 1, 2, and 3 = 234 participants initially enrolled|
48150013|NCT03382782|100692132|FG000|COMPLETED|Cohort 1||30|The sum of number of participants who completed Cohorts 1, 2, and 3 = 213 participants assigned to a group|
48150014|NCT03382782|100692133|FG001|COMPLETED|Cohort 1||30|The sum of number of participants who completed Cohorts 1, 2, and 3 = 213 participants assigned to a group|
48150015|NCT03382782|100692134|FG002|COMPLETED|Cohort 1||30|The sum of number of participants who completed Cohorts 1, 2, and 3 = 213 participants assigned to a group|
48607108|NCT01662856|101823442|FG001|Completed Study up to Week 6|Primary Part II||56||
48607109|NCT01662856|101823441|FG000|COMPLETED|Primary Part II||99||
48150016|NCT03382782|100692132|FG000|NOT COMPLETED|Cohort 1||11||
48150017|NCT03382782|100692133|FG001|NOT COMPLETED|Cohort 1||5||
48150018|NCT03382782|100692134|FG002|NOT COMPLETED|Cohort 1||0||
48150019|NCT03382782|100692132|FG000|STARTED|Cohort 2||24||
48150020|NCT03382782|100692133|FG001|STARTED|Cohort 2||28||
48150021|NCT03382782|100692134|FG002|STARTED|Cohort 2||27||
48150022|NCT03382782|100692132|FG000|COMPLETED|Cohort 2||23||
48150023|NCT03382782|100692133|FG001|COMPLETED|Cohort 2||27||
48150024|NCT03382782|100692134|FG002|COMPLETED|Cohort 2||27||
48150025|NCT03382782|100692132|FG000|NOT COMPLETED|Cohort 2||1||
48150026|NCT03382782|100692133|FG001|NOT COMPLETED|Cohort 2||1||
48150027|NCT03382782|100692134|FG002|NOT COMPLETED|Cohort 2||0||
48304479|NCT02311998|101072959|FG001|NOT COMPLETED|Overall Study||0||
48304480|NCT02311998|101072960|FG002|NOT COMPLETED|Overall Study||0||
48607110|NCT01662856|101823442|FG001|COMPLETED|Primary Part II||55||
48150028|NCT03382782|100692132|FG000|STARTED|Cohort 3||17||
48150029|NCT03382782|100692133|FG001|STARTED|Cohort 3||19||
48150030|NCT03382782|100692134|FG002|STARTED|Cohort 3||13||
48150031|NCT03382782|100692132|FG000|COMPLETED|Cohort 3||16||
48150032|NCT03382782|100692133|FG001|COMPLETED|Cohort 3||17||
48304481|NCT02311998|101072961|FG003|NOT COMPLETED|Overall Study||0||
48150033|NCT03382782|100692134|FG002|COMPLETED|Cohort 3||13||
48150034|NCT03382782|100692132|FG000|NOT COMPLETED|Cohort 3||1||
48150035|NCT03382782|100692133|FG001|NOT COMPLETED|Cohort 3||2||
48150036|NCT03382782|100692134|FG002|NOT COMPLETED|Cohort 3||0||
48150037|NCT02633137|100692135|FG000|STARTED|Overall Study||49||
48150038|NCT02633137|100692135|FG000|COMPLETED|Overall Study||45||
48150039|NCT02633137|100692135|FG000|NOT COMPLETED|Overall Study||4||
48150040|NCT02432105|100692136|FG000|STARTED|Overall Study||164||
48150041|NCT02432105|100692137|FG001|STARTED|Overall Study||110||
48150042|NCT02432105|100692138|FG002|STARTED|Overall Study||111||
48150043|NCT02432105|100692136|FG000|COMPLETED|Overall Study||162||
48150044|NCT02432105|100692137|FG001|COMPLETED|Overall Study||108||
48150045|NCT02432105|100692138|FG002|COMPLETED|Overall Study||108||
48150046|NCT02432105|100692136|FG000|NOT COMPLETED|Overall Study||2||
48150047|NCT02432105|100692137|FG001|NOT COMPLETED|Overall Study||2||
48150048|NCT02432105|100692138|FG002|NOT COMPLETED|Overall Study||3||
48150049|NCT00976599|100692139|FG000|STARTED|Overall Study||15||
48150050|NCT00976599|100692140|FG001|STARTED|Overall Study||14||
48150051|NCT00976599|100692139|FG000|COMPLETED|Overall Study||15||
48150052|NCT00976599|100692140|FG001|COMPLETED|Overall Study||14||
48150053|NCT00976599|100692139|FG000|NOT COMPLETED|Overall Study||0||
48150054|NCT00976599|100692140|FG001|NOT COMPLETED|Overall Study||0||
48150055|NCT03059901|100692141|FG000|STARTED|Overall Study||30||
48150056|NCT03059901|100692142|FG001|STARTED|Overall Study||30||
48150057|NCT03059901|100692141|FG000|COMPLETED|Overall Study||26||
48150058|NCT03059901|100692142|FG001|COMPLETED|Overall Study||28||
48150059|NCT03059901|100692141|FG000|NOT COMPLETED|Overall Study||4||
48150060|NCT03059901|100692142|FG001|NOT COMPLETED|Overall Study||2||
48304482|NCT00588536|101072962|FG000|STARTED|Overall Study||5||
48150061|NCT04791761|100692143|FG000|STARTED|Overall Study||21||
48150062|NCT04791761|100692144|FG001|STARTED|Overall Study||16||
48304483|NCT00588536|101072962|FG000|COMPLETED|Overall Study||5||
48304484|NCT00588536|101072962|FG000|NOT COMPLETED|Overall Study||0||
48304485|NCT01383161|101072963|FG000|STARTED|Overall Study||25||
48304486|NCT01383161|101072964|FG001|STARTED|Overall Study||21||
48150063|NCT04791761|100692145|FG002|STARTED|Overall Study||36||
48150064|NCT04791761|100692143|FG000|COMPLETED|Overall Study||13||
48150065|NCT04791761|100692144|FG001|COMPLETED|Overall Study||8||
48150066|NCT04791761|100692145|FG002|COMPLETED|Overall Study||24||
48150067|NCT04791761|100692143|FG000|NOT COMPLETED|Overall Study||8||
48150068|NCT04791761|100692144|FG001|NOT COMPLETED|Overall Study||8||
48150069|NCT04791761|100692145|FG002|NOT COMPLETED|Overall Study||12||
48150070|NCT00857207|100692146|FG000|STARTED|Overall Study||48||
48150071|NCT00857207|100692147|FG001|STARTED|Overall Study||3||
48150072|NCT00857207|100692146|FG000|COMPLETED|Overall Study||14||
48150073|NCT00857207|100692147|FG001|COMPLETED|Overall Study||3||
48150074|NCT00857207|100692146|FG000|NOT COMPLETED|Overall Study||34||
48150075|NCT00857207|100692147|FG001|NOT COMPLETED|Overall Study||0||
48150076|NCT01402141|100692148|FG000|STARTED|Overall Study||30||
48150077|NCT01402141|100692149|FG001|STARTED|Overall Study||30||
48150078|NCT01402141|100692148|FG000|COMPLETED|Overall Study||29||
48150079|NCT01402141|100692149|FG001|COMPLETED|Overall Study||28||
48150080|NCT01402141|100692148|FG000|NOT COMPLETED|Overall Study||1||
48150081|NCT01402141|100692149|FG001|NOT COMPLETED|Overall Study||2||
48150082|NCT00540124|100692150|FG000|STARTED|Overall Study||51||
48150083|NCT00540124|100692151|FG001|STARTED|Overall Study||51||
48150084|NCT00540124|100692152|FG002|STARTED|Overall Study||49||
48150085|NCT00540124|100692150|FG000|COMPLETED|Overall Study||47||
48150086|NCT00540124|100692151|FG001|COMPLETED|Overall Study||48||
48150087|NCT00540124|100692152|FG002|COMPLETED|Overall Study||48||
48150088|NCT00540124|100692150|FG000|NOT COMPLETED|Overall Study||4||
48150089|NCT00540124|100692151|FG001|NOT COMPLETED|Overall Study||3||
48150090|NCT00540124|100692152|FG002|NOT COMPLETED|Overall Study||1||
48150091|NCT01687257|100692153|FG000|STARTED|Overall Study||25||
48150092|NCT01687257|100692154|FG001|STARTED|Overall Study||4||
48150093|NCT01687257|100692155|FG002|STARTED|Overall Study||21||
48150094|NCT01687257|100692153|FG000|COMPLETED|Overall Study||17||
48150095|NCT01687257|100692154|FG001|COMPLETED|Overall Study||0||
48150096|NCT01687257|100692155|FG002|COMPLETED|Overall Study||15||
48150097|NCT01687257|100692153|FG000|NOT COMPLETED|Overall Study||8||
48150098|NCT01687257|100692154|FG001|NOT COMPLETED|Overall Study||4||
48150099|NCT01687257|100692155|FG002|NOT COMPLETED|Overall Study||6||
48150100|NCT01091155|100692156|FG000|STARTED|Overall Study||288||
48150101|NCT01091155|100692156|FG000|COMPLETED|Overall Study||279||
48150102|NCT01091155|100692156|FG000|NOT COMPLETED|Overall Study||9||
48150103|NCT02354664|100692157|FG000|STARTED|Overall Study||7||
48150104|NCT02354664|100692158|FG001|STARTED|Overall Study||7||
48150105|NCT02354664|100692157|FG000|COMPLETED|Overall Study||7||
48150106|NCT02354664|100692158|FG001|COMPLETED|Overall Study||7||
48150107|NCT02354664|100692157|FG000|NOT COMPLETED|Overall Study||0||
48150108|NCT02354664|100692158|FG001|NOT COMPLETED|Overall Study||0||
48150109|NCT02338154|100692159|FG000|STARTED|Overall Study||516||
48150110|NCT02338154|100692159|FG000|Enrolled Cohort (Intent to Treat)|Overall Study||516||
48150111|NCT02338154|100692159|FG000|INTUITY (Study Valve Cohort)|Overall Study||493||
48150112|NCT02338154|100692159|FG000|COMPLETED|Overall Study||373||
48150113|NCT02338154|100692159|FG000|NOT COMPLETED|Overall Study||143||
48150114|NCT00166296|100692160|FG000|STARTED|Overall Study||67||
48150115|NCT00166296|100692161|FG001|STARTED|Overall Study||66||
48150116|NCT00166296|100692160|FG000|ANALYZED|Overall Study||66||
48150117|NCT00166296|100692161|FG001|ANALYZED|Overall Study||63||
48150118|NCT00166296|100692160|FG000|COMPLETED|Overall Study||60||
48150119|NCT00166296|100692161|FG001|COMPLETED|Overall Study||57||
48150120|NCT00166296|100692160|FG000|NOT COMPLETED|Overall Study||7||
48150121|NCT00166296|100692161|FG001|NOT COMPLETED|Overall Study||9||
48150122|NCT01422408|100692162|FG000|STARTED|Overall Study||34||
48150123|NCT01422408|100692162|FG000|COMPLETED|Overall Study||30||
48150124|NCT01422408|100692162|FG000|NOT COMPLETED|Overall Study||4||
48150125|NCT01812655|100692163|FG000|STARTED|Overall Study||9||
48150126|NCT01812655|100692164|FG001|STARTED|Overall Study||11||
48150127|NCT01812655|100692165|FG002|STARTED|Overall Study||10||
48150128|NCT01812655|100692163|FG000|COMPLETED|Overall Study||8||
48150129|NCT01812655|100692164|FG001|COMPLETED|Overall Study||10||
48150130|NCT01812655|100692165|FG002|COMPLETED|Overall Study||10||
48150131|NCT01812655|100692163|FG000|NOT COMPLETED|Overall Study||1||
48150132|NCT01812655|100692164|FG001|NOT COMPLETED|Overall Study||1||
48150133|NCT01812655|100692165|FG002|NOT COMPLETED|Overall Study||0||
48150134|NCT00303862|100692166|FG000|STARTED|Overall Study||10||
48150135|NCT00303862|100692166|FG000|COMPLETED|Overall Study||10||
48150136|NCT00303862|100692166|FG000|NOT COMPLETED|Overall Study||0||
48304487|NCT01383161|101072963|FG000|COMPLETED|Overall Study||20||
48150137|NCT00985010|100692167|FG000|STARTED|Overall Study||4||
48304488|NCT01383161|101072964|FG001|COMPLETED|Overall Study||17||
48304489|NCT01383161|101072963|FG000|NOT COMPLETED|Overall Study||5||
48304490|NCT01383161|101072964|FG001|NOT COMPLETED|Overall Study||4||
48304491|NCT01186939|101072965|FG000|STARTED|Overall Study||40||
48304492|NCT01186939|101072965|FG000|COMPLETED|Overall Study||0||
48304493|NCT01186939|101072965|FG000|NOT COMPLETED|Overall Study||40||
48718082|NCT02876328|102095329|FG010|STARTED|Overall Study||187||
48718083|NCT02876328|102095330|FG011|STARTED|Overall Study||99||
48718084|NCT02876328|102095331|FG012|STARTED|Overall Study||177||
48718085|NCT02876328|102095332|FG013|STARTED|Overall Study||99||
48718086|NCT02876328|102095333|FG014|STARTED|Overall Study||100||
48718087|NCT02876328|102095334|FG015|STARTED|Overall Study||227||
48718088|NCT02876328|102095335|FG016|STARTED|Overall Study||107||
48718089|NCT02876328|102095336|FG017|STARTED|Overall Study||237||
48718090|NCT02876328|102095337|FG018|STARTED|Overall Study||108||
48718091|NCT02876328|102095338|FG019|STARTED|Overall Study||107||
48718092|NCT02876328|102095339|FG020|STARTED|Overall Study||324||
48718093|NCT02876328|102095340|FG021|STARTED|Overall Study||172||
48718094|NCT02876328|102095341|FG022|STARTED|Overall Study||34||
48718095|NCT02876328|102095342|FG023|STARTED|Overall Study||7||
48718096|NCT02876328|102095319|FG000|COMPLETED|Overall Study||379|For the primary outcome, Completed is defined as attending the 12 month visit.|
48718097|NCT02876328|102095320|FG001|COMPLETED|Overall Study||208|For the primary outcome, Completed is defined as attending the 12 month visit.|
48718098|NCT02876328|102095321|FG002|COMPLETED|Overall Study||378|For the primary outcome, Completed is defined as attending the 12 month visit.|
48718099|NCT02876328|102095322|FG003|COMPLETED|Overall Study||188|For the primary outcome, Completed is defined as attending the 12 month visit.|
48718100|NCT02876328|102095323|FG004|COMPLETED|Overall Study||181|For the primary outcome, Completed is defined as attending the 12 month visit.|
48718101|NCT02876328|102095324|FG005|COMPLETED|Overall Study||388|For the primary outcome, Completed is defined as attending the 12 month visit.|
48718102|NCT02876328|102095325|FG006|COMPLETED|Overall Study||175|For the primary outcome, Completed is defined as attending the 12 month visit.|
48718103|NCT02876328|102095326|FG007|COMPLETED|Overall Study||395|For the primary outcome, Completed is defined as attending the 12 month visit.|
48718104|NCT02876328|102095327|FG008|COMPLETED|Overall Study||192|For the primary outcome, Completed is defined as attending the 12 month visit.|
48718105|NCT02876328|102095328|FG009|COMPLETED|Overall Study||202|For the primary outcome, Completed is defined as attending the 12 month visit.|
48718106|NCT02876328|102095329|FG010|COMPLETED|Overall Study||182|For the primary outcome, Completed is defined as attending the 12 month visit.|
48718107|NCT02876328|102095330|FG011|COMPLETED|Overall Study||98|For the primary outcome, Completed is defined as attending the 12 month visit.|
48304494|NCT01330914|101072966|FG000|STARTED|Overall Study||55||
48304495|NCT01330914|101072966|FG000|COMPLETED|Overall Study||48||
48304496|NCT01330914|101072966|FG000|NOT COMPLETED|Overall Study||7||
48304497|NCT02876835|101072967|FG000|STARTED|Run-in Period: Placebo (Week-4 to Day 1)||1937||
48304498|NCT02876835|101072968|FG001|STARTED|Run-in Period: Placebo (Week-4 to Day 1)||1935||
48304499|NCT02876835|101072967|FG000|COMPLETED|Run-in Period: Placebo (Week-4 to Day 1)||1937||
48304500|NCT02876835|101072968|FG001|COMPLETED|Run-in Period: Placebo (Week-4 to Day 1)||1935||
48304501|NCT02876835|101072967|FG000|NOT COMPLETED|Run-in Period: Placebo (Week-4 to Day 1)||0||
48304502|NCT02876835|101072968|FG001|NOT COMPLETED|Run-in Period: Placebo (Week-4 to Day 1)||0||
48304503|NCT02876835|101072967|FG000|STARTED|Treatment Period (51.1 Month)||1937||
48304504|NCT02876835|101072968|FG001|STARTED|Treatment Period (51.1 Month)||1935||
48304505|NCT02876835|101072967|FG000|COMPLETED|Treatment Period (51.1 Month)||1873||
48304506|NCT02876835|101072968|FG001|COMPLETED|Treatment Period (51.1 Month)||1870||
48304507|NCT02876835|101072967|FG000|NOT COMPLETED|Treatment Period (51.1 Month)||64||
48304508|NCT02876835|101072968|FG001|NOT COMPLETED|Treatment Period (51.1 Month)||65||
48304509|NCT02511678|101072969|FG000|STARTED|Overall Study||73||
48304510|NCT02511678|101072969|FG000|Intent-to-Treat (ITT) Population|Overall Study||66||
48304511|NCT02511678|101072969|FG000|Participants Discontinued Pre-Treatment|Overall Study||7||
48304512|NCT02511678|101072969|FG000|Safety Population|Overall Study||65||
48304513|NCT02511678|101072969|FG000|COMPLETED|Overall Study||37||
48304514|NCT02511678|101072969|FG000|NOT COMPLETED|Overall Study||36||
48304515|NCT01310803|101072970|FG000|STARTED|Overall Study||1||
48304516|NCT01310803|101072971|FG001|STARTED|Overall Study||0||
48304517|NCT01310803|101072970|FG000|COMPLETED|Overall Study||0||
48304518|NCT01310803|101072971|FG001|COMPLETED|Overall Study||0||
48304519|NCT01310803|101072970|FG000|NOT COMPLETED|Overall Study||1||
48304520|NCT01310803|101072971|FG001|NOT COMPLETED|Overall Study||0||
48718108|NCT02876328|102095331|FG012|COMPLETED|Overall Study||172|For the primary outcome, Completed is defined as attending the 12 month visit.|
48718109|NCT02876328|102095332|FG013|COMPLETED|Overall Study||95|For the primary outcome, Completed is defined as attending the 12 month visit.|
48718110|NCT02876328|102095333|FG014|COMPLETED|Overall Study||96|For the primary outcome, Completed is defined as attending the 12 month visit.|
48718111|NCT02876328|102095334|FG015|COMPLETED|Overall Study||223|For the primary outcome, Completed is defined as attending the 12 month visit.|
48718112|NCT02876328|102095335|FG016|COMPLETED|Overall Study||102|For the primary outcome, Completed is defined as attending the 12 month visit.|
48304521|NCT00088907|101072972|FG000|STARTED|Randomized Study (Step 1)||136||
48304522|NCT00088907|101072973|FG001|STARTED|Randomized Study (Step 1)||134||
48304523|NCT00088907|101072972|FG000|Treated|Randomized Study (Step 1)||129||
48304524|NCT00088907|101072973|FG001|Treated|Randomized Study (Step 1)||124||
48368017|NCT03567291|101230094|FG002|Intent to Treat Set|Period I||0||
48304525|NCT00088907|101072972|FG000|Eligible|Randomized Study (Step 1)||117||
48304526|NCT00088907|101072973|FG001|Eligible|Randomized Study (Step 1)||122||
48304527|NCT00088907|101072972|FG000|Eligible and Treated|Randomized Study (Step 1)||117||
48304528|NCT00088907|101072973|FG001|Eligible and Treated|Randomized Study (Step 1)||122||
48304529|NCT00088907|101072972|FG000|COMPLETED|Randomized Study (Step 1)||0||
48304530|NCT00088907|101072973|FG001|COMPLETED|Randomized Study (Step 1)||0||
48304531|NCT00088907|101072972|FG000|NOT COMPLETED|Randomized Study (Step 1)||136||
48304532|NCT00088907|101072973|FG001|NOT COMPLETED|Randomized Study (Step 1)||134||
48304533|NCT00088907|101072972|FG000|STARTED|Single Gefitinib Treatment (Step 2)||24||
48304534|NCT00088907|101072973|FG001|STARTED|Single Gefitinib Treatment (Step 2)||0||
48304535|NCT00088907|101072972|FG000|Treated|Single Gefitinib Treatment (Step 2)||19||
48304536|NCT00088907|101072973|FG001|Treated|Single Gefitinib Treatment (Step 2)||0||
48304537|NCT00088907|101072972|FG000|COMPLETED|Single Gefitinib Treatment (Step 2)||0||
48304538|NCT00088907|101072973|FG001|COMPLETED|Single Gefitinib Treatment (Step 2)||0||
48304539|NCT00088907|101072972|FG000|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||24||
48304540|NCT00088907|101072973|FG001|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||0||
48304541|NCT01019980|101072974|FG000|STARTED|Overall Study||2||
48304542|NCT01019980|101072975|FG001|STARTED|Overall Study||0||
48304543|NCT01019980|101072974|FG000|Discontinued|Overall Study||2||
48304544|NCT01019980|101072975|FG001|Discontinued|Overall Study||0||
48304545|NCT01019980|101072974|FG000|COMPLETED|Overall Study||0||
48304546|NCT01019980|101072975|FG001|COMPLETED|Overall Study||0||
48304547|NCT01019980|101072974|FG000|NOT COMPLETED|Overall Study||2||
48304548|NCT01019980|101072975|FG001|NOT COMPLETED|Overall Study||0||
48304549|NCT01636414|101072976|FG000|STARTED|Overall Study||64||
48304550|NCT01636414|101072977|FG001|STARTED|Overall Study||66||
48304551|NCT01636414|101072978|FG002|STARTED|Overall Study||74||
48304552|NCT01636414|101072976|FG000|COMPLETED|Overall Study||61||
48304553|NCT01636414|101072977|FG001|COMPLETED|Overall Study||60||
48304554|NCT01636414|101072978|FG002|COMPLETED|Overall Study||65||
48304555|NCT01636414|101072976|FG000|NOT COMPLETED|Overall Study||3||
48304556|NCT01636414|101072977|FG001|NOT COMPLETED|Overall Study||6||
48304557|NCT01636414|101072978|FG002|NOT COMPLETED|Overall Study||9||
48304558|NCT01177722|101072979|FG000|STARTED|Overall Study||344||
48304559|NCT01177722|101072980|FG001|STARTED|Overall Study||344||
48304560|NCT01177722|101072981|FG002|STARTED|Overall Study||342||
48304561|NCT01177722|101072982|FG003|STARTED|Overall Study||345||
48304562|NCT01177722|101072979|FG000|COMPLETED|Overall Study||331||
48304563|NCT01177722|101072980|FG001|COMPLETED|Overall Study||334||
48304564|NCT01177722|101072981|FG002|COMPLETED|Overall Study||333||
48304565|NCT01177722|101072982|FG003|COMPLETED|Overall Study||338||
48304566|NCT01177722|101072979|FG000|NOT COMPLETED|Overall Study||13||
48304567|NCT01177722|101072980|FG001|NOT COMPLETED|Overall Study||10||
48304568|NCT01177722|101072981|FG002|NOT COMPLETED|Overall Study||9||
48304569|NCT01177722|101072982|FG003|NOT COMPLETED|Overall Study||7||
48304570|NCT01910116|101072983|FG000|STARTED|Overall Study||110||
48304571|NCT01910116|101072984|FG001|STARTED|Overall Study||110||
48304572|NCT01910116|101072983|FG000|Week 4|Overall Study||106||
48304573|NCT01910116|101072984|FG001|Week 4|Overall Study||102||
48304574|NCT01910116|101072983|FG000|Week 8|Overall Study||98||
48304575|NCT01910116|101072984|FG001|Week 8|Overall Study||99||
48304576|NCT01910116|101072983|FG000|Week 12|Overall Study||97||
48304577|NCT01910116|101072984|FG001|Week 12|Overall Study||96||
48304578|NCT01910116|101072983|FG000|Week 16|Overall Study||96||
48304579|NCT01910116|101072984|FG001|Week 16|Overall Study||94||
48304580|NCT01910116|101072983|FG000|COMPLETED|Overall Study||96||
48304581|NCT01910116|101072984|FG001|COMPLETED|Overall Study||94||
48304582|NCT01910116|101072983|FG000|NOT COMPLETED|Overall Study||14||
48304583|NCT01910116|101072984|FG001|NOT COMPLETED|Overall Study||16||
48304584|NCT00626210|101072985|FG000|STARTED|Overall Study||2||
48304585|NCT00626210|101072985|FG000|COMPLETED|Overall Study||2||
48304586|NCT00626210|101072985|FG000|NOT COMPLETED|Overall Study||0||
48304587|NCT00147290|101072986|FG000|STARTED|Overall Study||266||
48304588|NCT00147290|101072987|FG001|STARTED|Overall Study||260||
48304589|NCT00147290|101072986|FG000|COMPLETED|Overall Study||266||
48304590|NCT00147290|101072987|FG001|COMPLETED|Overall Study||260||
48304591|NCT00147290|101072986|FG000|NOT COMPLETED|Overall Study||0||
48304592|NCT00147290|101072987|FG001|NOT COMPLETED|Overall Study||0||
48304593|NCT00819260|101072988|FG000|STARTED|Overall Study||31||
48304594|NCT00819260|101072988|FG000|COMPLETED|Overall Study||31||
48304595|NCT00819260|101072988|FG000|NOT COMPLETED|Overall Study||0||
48304596|NCT00619190|101072989|FG000|STARTED|Overall Study||21||
48304597|NCT00619190|101072990|FG001|STARTED|Overall Study||9||
48304598|NCT00619190|101072989|FG000|COMPLETED|Overall Study||20||
48304599|NCT00619190|101072990|FG001|COMPLETED|Overall Study||9||
48304600|NCT00619190|101072989|FG000|NOT COMPLETED|Overall Study||1||
48304601|NCT00619190|101072990|FG001|NOT COMPLETED|Overall Study||0||
48304602|NCT00824824|101072991|FG000|STARTED|Overall Study||4||
48304603|NCT00824824|101072992|FG001|STARTED|Overall Study||3||
48304604|NCT00824824|101072991|FG000|COMPLETED|Overall Study||4||
48304605|NCT00824824|101072992|FG001|COMPLETED|Overall Study||3||
48304606|NCT00824824|101072991|FG000|NOT COMPLETED|Overall Study||0||
48304607|NCT00824824|101072992|FG001|NOT COMPLETED|Overall Study||0||
48304608|NCT03675776|101072993|FG000|STARTED|Double Blind Treatment Period||15||
48304609|NCT03675776|101072994|FG001|STARTED|Double Blind Treatment Period||17||
48304610|NCT03675776|101072995|FG002|STARTED|Double Blind Treatment Period||18||
48304611|NCT03675776|101072993|FG000|COMPLETED|Double Blind Treatment Period||9||
48304612|NCT03675776|101072994|FG001|COMPLETED|Double Blind Treatment Period||11||
48304613|NCT03675776|101072995|FG002|COMPLETED|Double Blind Treatment Period||10||
48304614|NCT03675776|101072993|FG000|NOT COMPLETED|Double Blind Treatment Period||6||
48304615|NCT03675776|101072994|FG001|NOT COMPLETED|Double Blind Treatment Period||6||
48304616|NCT03675776|101072995|FG002|NOT COMPLETED|Double Blind Treatment Period||8||
48304617|NCT03675776|101072993|FG000|STARTED|Safety Follow-up Period||6||
48304618|NCT03675776|101072994|FG001|STARTED|Safety Follow-up Period||8||
48304619|NCT03675776|101072995|FG002|STARTED|Safety Follow-up Period||7||
48304620|NCT03675776|101072993|FG000|COMPLETED|Safety Follow-up Period||6||
48304621|NCT03675776|101072994|FG001|COMPLETED|Safety Follow-up Period||8||
48304622|NCT03675776|101072995|FG002|COMPLETED|Safety Follow-up Period||7||
48304623|NCT03675776|101072993|FG000|NOT COMPLETED|Safety Follow-up Period||0||
48304624|NCT03675776|101072994|FG001|NOT COMPLETED|Safety Follow-up Period||0||
48304625|NCT03675776|101072995|FG002|NOT COMPLETED|Safety Follow-up Period||0||
48304626|NCT00146757|101072996|FG000|STARTED|Overall Study||16||
48304627|NCT00146757|101072997|FG001|STARTED|Overall Study||4||
48304628|NCT00146757|101072996|FG000|COMPLETED|Overall Study||14||
48304629|NCT00146757|101072997|FG001|COMPLETED|Overall Study||4||
48304630|NCT00146757|101072996|FG000|NOT COMPLETED|Overall Study||2||
48304631|NCT00146757|101072997|FG001|NOT COMPLETED|Overall Study||0||
48304632|NCT01674712|101072998|FG000|STARTED|Overall Study||114||
48304633|NCT01674712|101072999|FG001|STARTED|Overall Study||117||
48304634|NCT01674712|101073000|FG002|STARTED|Overall Study||115||
48304635|NCT01674712|101073001|FG003|STARTED|Overall Study||116||
48304636|NCT01674712|101073002|FG004|STARTED|Overall Study||113||
48304637|NCT01674712|101072998|FG000|Full Analysis Subject Sample|Overall Study||109||
48304638|NCT01674712|101072999|FG001|Full Analysis Subject Sample|Overall Study||114||
48304639|NCT01674712|101073000|FG002|Full Analysis Subject Sample|Overall Study||110||
48304640|NCT01674712|101073001|FG003|Full Analysis Subject Sample|Overall Study||112||
48304641|NCT01674712|101073002|FG004|Full Analysis Subject Sample|Overall Study||111||
48304642|NCT01674712|101072998|FG000|Safety Subject Sample|Overall Study||111||
48304643|NCT01674712|101072999|FG001|Safety Subject Sample|Overall Study||117||
48304644|NCT01674712|101073000|FG002|Safety Subject Sample|Overall Study||113||
48304645|NCT01674712|101073001|FG003|Safety Subject Sample|Overall Study||115||
48304646|NCT01674712|101073002|FG004|Safety Subject Sample|Overall Study||112||
48304647|NCT01674712|101072998|FG000|COMPLETED|Overall Study||104||
48304648|NCT01674712|101072999|FG001|COMPLETED|Overall Study||108||
48304649|NCT01674712|101073000|FG002|COMPLETED|Overall Study||106||
48304650|NCT01674712|101073001|FG003|COMPLETED|Overall Study||108||
48304651|NCT01674712|101073002|FG004|COMPLETED|Overall Study||102||
48304652|NCT01674712|101072998|FG000|NOT COMPLETED|Overall Study||10||
48304653|NCT01674712|101072999|FG001|NOT COMPLETED|Overall Study||9||
48304654|NCT01674712|101073000|FG002|NOT COMPLETED|Overall Study||9||
48304655|NCT01674712|101073001|FG003|NOT COMPLETED|Overall Study||8||
48304656|NCT01674712|101073002|FG004|NOT COMPLETED|Overall Study||11||
48304657|NCT01230554|101073003|FG000|STARTED|Overall Study||212||
48304658|NCT01230554|101073003|FG000|COMPLETED|Overall Study||209||
48304659|NCT01230554|101073003|FG000|NOT COMPLETED|Overall Study||3||
48304660|NCT03427125|101073004|FG000|STARTED|2 to 4 Week Washout Period||0|All patients were washed off of existing phosphate lowering medication. No patient received study drug during this period|
48304661|NCT03427125|101073005|FG001|STARTED|2 to 4 Week Washout Period||1559|All patients were washed off of existing phosphate lowering medication. No patient received study drug during this period|
48304662|NCT03427125|101073006|FG002|STARTED|2 to 4 Week Washout Period||0|All patients were washed off of existing phosphate lowering medication. No patient received study drug during this period|
48304663|NCT03427125|101073004|FG000|COMPLETED|2 to 4 Week Washout Period||0||
48304664|NCT03427125|101073005|FG001|COMPLETED|2 to 4 Week Washout Period||564||
48304665|NCT03427125|101073006|FG002|COMPLETED|2 to 4 Week Washout Period||0||
48304666|NCT03427125|101073004|FG000|NOT COMPLETED|2 to 4 Week Washout Period||0||
48304667|NCT03427125|101073005|FG001|NOT COMPLETED|2 to 4 Week Washout Period||995||
48304668|NCT03427125|101073006|FG002|NOT COMPLETED|2 to 4 Week Washout Period||0||
48304669|NCT03427125|101073004|FG000|STARTED|26-Week Treatment Period||423||
48304670|NCT03427125|101073005|FG001|STARTED|26-Week Treatment Period||0||
48304671|NCT03427125|101073006|FG002|STARTED|26-Week Treatment Period||141||
48304672|NCT03427125|101073004|FG000|COMPLETED|26-Week Treatment Period||256||
48304673|NCT03427125|101073005|FG001|COMPLETED|26-Week Treatment Period||0||
48304674|NCT03427125|101073006|FG002|COMPLETED|26-Week Treatment Period||117||
48304675|NCT03427125|101073004|FG000|NOT COMPLETED|26-Week Treatment Period||167||
48304676|NCT03427125|101073005|FG001|NOT COMPLETED|26-Week Treatment Period||0||
48304677|NCT03427125|101073006|FG002|NOT COMPLETED|26-Week Treatment Period||24||
48304678|NCT03427125|101073004|FG000|STARTED|12-Week Randomized Withdrawal Period||129||
48607111|NCT01662856|101823441|FG000|NOT COMPLETED|Primary Part II||10||
48607112|NCT01662856|101823442|FG001|NOT COMPLETED|Primary Part II||2||
48304679|NCT03427125|101073005|FG001|STARTED|12-Week Randomized Withdrawal Period||127||
48304680|NCT03427125|101073006|FG002|STARTED|12-Week Randomized Withdrawal Period||117||
48304681|NCT03427125|101073004|FG000|COMPLETED|12-Week Randomized Withdrawal Period||99||
48304682|NCT03427125|101073005|FG001|COMPLETED|12-Week Randomized Withdrawal Period||99||
48304683|NCT03427125|101073006|FG002|COMPLETED|12-Week Randomized Withdrawal Period||112||
48304684|NCT03427125|101073004|FG000|NOT COMPLETED|12-Week Randomized Withdrawal Period||30||
48304685|NCT03427125|101073005|FG001|NOT COMPLETED|12-Week Randomized Withdrawal Period||28||
48304686|NCT03427125|101073006|FG002|NOT COMPLETED|12-Week Randomized Withdrawal Period||5||
48304687|NCT03427125|101073004|FG000|STARTED|14-Week Safety Extension||222||
48304688|NCT03427125|101073005|FG001|STARTED|14-Week Safety Extension||0||
48304689|NCT03427125|101073006|FG002|STARTED|14-Week Safety Extension||112||
48304690|NCT03427125|101073004|FG000|COMPLETED|14-Week Safety Extension||205||
48304691|NCT03427125|101073005|FG001|COMPLETED|14-Week Safety Extension||0||
48304692|NCT03427125|101073006|FG002|COMPLETED|14-Week Safety Extension||109||
48304693|NCT03427125|101073004|FG000|NOT COMPLETED|14-Week Safety Extension||17||
48304694|NCT03427125|101073005|FG001|NOT COMPLETED|14-Week Safety Extension||0||
48304695|NCT03427125|101073006|FG002|NOT COMPLETED|14-Week Safety Extension||3||
48304696|NCT00129623|101073007|FG000|STARTED|Overall Study||83||
48304697|NCT00129623|101073008|FG001|STARTED|Overall Study||77||
48304698|NCT00129623|101073007|FG000|Intent-to-treat (ITT)/ Safety Population|Overall Study||83||
48304699|NCT00129623|101073008|FG001|Intent-to-treat (ITT)/ Safety Population|Overall Study||77||
48304700|NCT00129623|101073007|FG000|COMPLETED|Overall Study||73||
48304701|NCT00129623|101073008|FG001|COMPLETED|Overall Study||65||
48304702|NCT00129623|101073007|FG000|NOT COMPLETED|Overall Study||10||
48304703|NCT00129623|101073008|FG001|NOT COMPLETED|Overall Study||12||
48304704|NCT01292798|101073009|FG000|STARTED|Overall Study||43||
48304705|NCT01292798|101073009|FG000|Persistent DME After 3 Months|Overall Study||29||
48304706|NCT01292798|101073009|FG000|COMPLETED|Overall Study||43||
48304707|NCT01292798|101073009|FG000|NOT COMPLETED|Overall Study||0||
48304708|NCT01428661|101073010|FG000|STARTED|Double-Masked Phase||254||
48304709|NCT01428661|101073011|FG001|STARTED|Double-Masked Phase||253||
48304710|NCT01428661|101073012|FG002|STARTED|Double-Masked Phase||0||
48304711|NCT01428661|101073010|FG000|COMPLETED|Double-Masked Phase||197||
48304712|NCT01428661|101073011|FG001|COMPLETED|Double-Masked Phase||204||
48304713|NCT01428661|101073012|FG002|COMPLETED|Double-Masked Phase||0||
48304714|NCT01428661|101073010|FG000|NOT COMPLETED|Double-Masked Phase||57||
48304715|NCT01428661|101073011|FG001|NOT COMPLETED|Double-Masked Phase||49||
48304716|NCT01428661|101073012|FG002|NOT COMPLETED|Double-Masked Phase||0||
48304717|NCT01428661|101073010|FG000|STARTED|Open Label Extension||0||
48304718|NCT01428661|101073011|FG001|STARTED|Open Label Extension||0||
48304719|NCT01428661|101073012|FG002|STARTED|Open Label Extension||339||
48304720|NCT01428661|101073010|FG000|COMPLETED|Open Label Extension||0||
48304721|NCT01428661|101073011|FG001|COMPLETED|Open Label Extension||0||
48304722|NCT01428661|101073012|FG002|COMPLETED|Open Label Extension||19||
48304723|NCT01428661|101073010|FG000|NOT COMPLETED|Open Label Extension||0||
48304724|NCT01428661|101073011|FG001|NOT COMPLETED|Open Label Extension||0||
48607113|NCT00662311|101823443|FG000|STARTED|Overall Study||5||
48304725|NCT01428661|101073012|FG002|NOT COMPLETED|Open Label Extension||320||
48304726|NCT00984490|101073013|FG000|STARTED|Overall Study||5||
48304727|NCT00984490|101073013|FG000|COMPLETED|Overall Study||5||
48304728|NCT00984490|101073013|FG000|NOT COMPLETED|Overall Study||0||
48304729|NCT02796001|101073014|FG000|STARTED|Overall Study||20||
48304730|NCT02796001|101073015|FG001|STARTED|Overall Study||22||
48304731|NCT02796001|101073016|FG002|STARTED|Overall Study||4||
48304732|NCT02796001|101073014|FG000|COMPLETED|Overall Study||20||
48304733|NCT02796001|101073015|FG001|COMPLETED|Overall Study||22||
48304734|NCT02796001|101073016|FG002|COMPLETED|Overall Study||4||
48304735|NCT02796001|101073014|FG000|NOT COMPLETED|Overall Study||0||
48304736|NCT02796001|101073015|FG001|NOT COMPLETED|Overall Study||0||
48304737|NCT02796001|101073016|FG002|NOT COMPLETED|Overall Study||0||
48304738|NCT01817855|101073017|FG000|STARTED|Overall Study||23||
48304739|NCT01817855|101073018|FG001|STARTED|Overall Study||8||
48304740|NCT01817855|101073019|FG002|STARTED|Overall Study||11||
48304741|NCT01817855|101073020|FG003|STARTED|Overall Study||5||
48304742|NCT01817855|101073017|FG000|COMPLETED|Overall Study||23||
48607114|NCT00662311|101823444|FG001|STARTED|Overall Study||0||
48607115|NCT00662311|101823445|FG002|STARTED|Overall Study||0||
48607116|NCT00662311|101823443|FG000|COMPLETED|Overall Study||4||
48304743|NCT01817855|101073018|FG001|COMPLETED|Overall Study||6||
48304744|NCT01817855|101073019|FG002|COMPLETED|Overall Study||9||
48304745|NCT01817855|101073020|FG003|COMPLETED|Overall Study||5||
48304746|NCT01817855|101073017|FG000|NOT COMPLETED|Overall Study||0||
48304747|NCT01817855|101073018|FG001|NOT COMPLETED|Overall Study||2||
48304748|NCT01817855|101073019|FG002|NOT COMPLETED|Overall Study||2||
48304749|NCT01817855|101073020|FG003|NOT COMPLETED|Overall Study||0||
48304750|NCT01050907|101073021|FG000|STARTED|Overall Study||4||
48304751|NCT01050907|101073021|FG000|COMPLETED|Overall Study||4||
48304752|NCT01050907|101073021|FG000|NOT COMPLETED|Overall Study||0||
48304753|NCT05493852|101073022|FG000|STARTED|Overall Study||30||
48304754|NCT05493852|101073022|FG000|COMPLETED|Overall Study||30||
48718113|NCT02876328|102095336|FG017|COMPLETED|Overall Study||227|For the primary outcome, Completed is defined as attending the 12 month visit.|
48718114|NCT02876328|102095337|FG018|COMPLETED|Overall Study||106|For the primary outcome, Completed is defined as attending the 12 month visit.|
48718115|NCT02876328|102095338|FG019|COMPLETED|Overall Study||105|For the primary outcome, Completed is defined as attending the 12 month visit.|
48718116|NCT02876328|102095339|FG020|COMPLETED|Overall Study||312|For the primary outcome, Completed is defined as attending the 12 month visit.|
48718117|NCT02876328|102095340|FG021|COMPLETED|Overall Study||164|For the primary outcome, Completed is defined as attending the 12 month visit.|
48718118|NCT02876328|102095341|FG022|COMPLETED|Overall Study||33|For the primary outcome, Completed is defined as attending the 12 month visit.|
48718119|NCT02876328|102095342|FG023|COMPLETED|Overall Study||7|For the primary outcome, Completed is defined as attending the 12 month visit.|
48718120|NCT02876328|102095319|FG000|NOT COMPLETED|Overall Study||17||
48718121|NCT02876328|102095320|FG001|NOT COMPLETED|Overall Study||13||
48718122|NCT02876328|102095321|FG002|NOT COMPLETED|Overall Study||17||
48718123|NCT02876328|102095322|FG003|NOT COMPLETED|Overall Study||9||
48718124|NCT02876328|102095323|FG004|NOT COMPLETED|Overall Study||10||
48718125|NCT02876328|102095324|FG005|NOT COMPLETED|Overall Study||15||
48718126|NCT02876328|102095325|FG006|NOT COMPLETED|Overall Study||4||
48718127|NCT02876328|102095326|FG007|NOT COMPLETED|Overall Study||12||
48718128|NCT02876328|102095327|FG008|NOT COMPLETED|Overall Study||10||
48718129|NCT02876328|102095328|FG009|NOT COMPLETED|Overall Study||8||
48718130|NCT02876328|102095329|FG010|NOT COMPLETED|Overall Study||5||
48718131|NCT02876328|102095330|FG011|NOT COMPLETED|Overall Study||1||
48718132|NCT02876328|102095331|FG012|NOT COMPLETED|Overall Study||5||
48718133|NCT02876328|102095332|FG013|NOT COMPLETED|Overall Study||4||
48718134|NCT02876328|102095333|FG014|NOT COMPLETED|Overall Study||4||
48718135|NCT02876328|102095334|FG015|NOT COMPLETED|Overall Study||4||
48718136|NCT02876328|102095335|FG016|NOT COMPLETED|Overall Study||5||
48718137|NCT02876328|102095336|FG017|NOT COMPLETED|Overall Study||10||
48304755|NCT05493852|101073022|FG000|NOT COMPLETED|Overall Study||0||
48304756|NCT02322229|101073023|FG000|STARTED|Overall Study||52||
48304757|NCT02322229|101073023|FG000|COMPLETED|Overall Study||50||
48304758|NCT02322229|101073023|FG000|NOT COMPLETED|Overall Study||2||
48304759|NCT01883986|101073024|FG000|STARTED|Overall Study||20||
48304760|NCT01883986|101073025|FG001|STARTED|Overall Study||20||
48304761|NCT01883986|101073024|FG000|Did Not Complete Study|Overall Study||3||
48304762|NCT01883986|101073025|FG001|Did Not Complete Study|Overall Study||1||
48718138|NCT02876328|102095337|FG018|NOT COMPLETED|Overall Study||2||
48304763|NCT01883986|101073024|FG000|COMPLETED|Overall Study||17||
48304764|NCT01883986|101073025|FG001|COMPLETED|Overall Study||19||
48304765|NCT01883986|101073024|FG000|NOT COMPLETED|Overall Study||3||
48304766|NCT01883986|101073025|FG001|NOT COMPLETED|Overall Study||1||
48304767|NCT04321980|101073026|FG000|STARTED|Overall Study||4||
48718139|NCT02876328|102095338|FG019|NOT COMPLETED|Overall Study||2||
48718140|NCT02876328|102095339|FG020|NOT COMPLETED|Overall Study||12||
48718141|NCT02876328|102095340|FG021|NOT COMPLETED|Overall Study||8||
48150138|NCT00985010|100692168|FG001|STARTED|Overall Study||5||
48150139|NCT00985010|100692167|FG000|COMPLETED|Overall Study||4||
48150140|NCT00985010|100692168|FG001|COMPLETED|Overall Study||5||
48150141|NCT00985010|100692167|FG000|NOT COMPLETED|Overall Study||0||
48150142|NCT00985010|100692168|FG001|NOT COMPLETED|Overall Study||0||
48150143|NCT00175825|100692169|FG000|STARTED|Overall Study||54||
48150144|NCT00175825|100692170|FG001|STARTED|Overall Study||50||
48150145|NCT00175825|100692171|FG002|STARTED|Overall Study||52||
48150146|NCT00175825|100692172|FG003|STARTED|Overall Study||52||
48150147|NCT00175825|100692169|FG000|COMPLETED|Overall Study||49||
48150148|NCT00175825|100692170|FG001|COMPLETED|Overall Study||46||
48150149|NCT00175825|100692171|FG002|COMPLETED|Overall Study||51||
48150150|NCT00175825|100692172|FG003|COMPLETED|Overall Study||51||
48150151|NCT00175825|100692169|FG000|NOT COMPLETED|Overall Study||5||
48150152|NCT00175825|100692170|FG001|NOT COMPLETED|Overall Study||4||
48150153|NCT00175825|100692171|FG002|NOT COMPLETED|Overall Study||1||
48150154|NCT00175825|100692172|FG003|NOT COMPLETED|Overall Study||1||
48150155|NCT05090709|100692173|FG000|STARTED|Overall Study||10||
48150156|NCT05090709|100692174|FG001|STARTED|Overall Study||10||
48150157|NCT05090709|100692173|FG000|COMPLETED|Overall Study||10||
48150158|NCT05090709|100692174|FG001|COMPLETED|Overall Study||10||
48150159|NCT05090709|100692173|FG000|NOT COMPLETED|Overall Study||0||
48150160|NCT05090709|100692174|FG001|NOT COMPLETED|Overall Study||0||
48150161|NCT01843374|100692175|FG000|STARTED|Overall Study||189||
48150162|NCT01843374|100692176|FG001|STARTED|Overall Study||382||
48150163|NCT01843374|100692175|FG000|RANDOMIZED|Overall Study||189||
48150164|NCT01843374|100692176|FG001|RANDOMIZED|Overall Study||382||
48150165|NCT01843374|100692175|FG000|COMPLETED|Overall Study||0||
48150166|NCT01843374|100692176|FG001|COMPLETED|Overall Study||3||
48150167|NCT01843374|100692175|FG000|NOT COMPLETED|Overall Study||189||
48150168|NCT01843374|100692176|FG001|NOT COMPLETED|Overall Study||379||
48150169|NCT03489304|100692177|FG000|STARTED|Overall Study||20||
48150170|NCT03489304|100692177|FG000|COMPLETED|Overall Study||16||
48150171|NCT03489304|100692177|FG000|NOT COMPLETED|Overall Study||4||
48150172|NCT04953390|100692178|FG000|STARTED|Overall Study||19||
48150173|NCT04953390|100692178|FG000|COMPLETED|Overall Study||19||
48150174|NCT04953390|100692178|FG000|NOT COMPLETED|Overall Study||0||
48150175|NCT00746590|100692179|FG000|STARTED|Overall Study||1||
48150176|NCT00746590|100692179|FG000|COMPLETED|Overall Study||0||
48150177|NCT00746590|100692179|FG000|NOT COMPLETED|Overall Study||1||
48304768|NCT04321980|101073027|FG001|STARTED|Overall Study||4||
48304769|NCT04321980|101073026|FG000|COMPLETED|Overall Study||4||
48304770|NCT04321980|101073027|FG001|COMPLETED|Overall Study||4||
48304771|NCT04321980|101073026|FG000|NOT COMPLETED|Overall Study||0||
48304772|NCT04321980|101073027|FG001|NOT COMPLETED|Overall Study||0||
48304773|NCT03211247|101073028|FG000|STARTED|Overall Study||244||
48304774|NCT03211247|101073029|FG001|STARTED|Overall Study||118||
48304775|NCT03211247|101073030|FG002|STARTED|Overall Study||21||
48304776|NCT03211247|101073031|FG003|STARTED|Overall Study||20||
48304777|NCT03211247|101073032|FG004|STARTED|Overall Study||10||
48304778|NCT03211247|101073028|FG000|COMPLETED|Overall Study||208||
48304779|NCT03211247|101073029|FG001|COMPLETED|Overall Study||99||
48304780|NCT03211247|101073030|FG002|COMPLETED|Overall Study||17||
48304781|NCT03211247|101073031|FG003|COMPLETED|Overall Study||16||
48304782|NCT03211247|101073032|FG004|COMPLETED|Overall Study||9||
48304783|NCT03211247|101073028|FG000|NOT COMPLETED|Overall Study||36||
48304784|NCT03211247|101073029|FG001|NOT COMPLETED|Overall Study||19||
48304785|NCT03211247|101073030|FG002|NOT COMPLETED|Overall Study||4||
48304786|NCT03211247|101073031|FG003|NOT COMPLETED|Overall Study||4||
48304787|NCT03211247|101073032|FG004|NOT COMPLETED|Overall Study||1||
48304788|NCT01629784|101073033|FG000|STARTED|Overall Study||31||
48304789|NCT01629784|101073033|FG000|COMPLETED|Overall Study||25||
48304790|NCT01629784|101073033|FG000|NOT COMPLETED|Overall Study||6||
48304791|NCT03374995|101073034|FG000|STARTED|Overall Study||13||
48304792|NCT03374995|101073035|FG001|STARTED|Overall Study||12||
48304793|NCT03374995|101073034|FG000|COMPLETED|Overall Study||13||
48304794|NCT03374995|101073035|FG001|COMPLETED|Overall Study||11||
48304795|NCT03374995|101073034|FG000|NOT COMPLETED|Overall Study||0||
48304796|NCT03374995|101073035|FG001|NOT COMPLETED|Overall Study||1||
48304797|NCT02577601|101073036|FG000|STARTED|UPA Only (1 Month)||36||
48304798|NCT02577601|101073036|FG000|COMPLETED|UPA Only (1 Month)||36||
48304799|NCT02577601|101073036|FG000|NOT COMPLETED|UPA Only (1 Month)||0||
48304800|NCT02577601|101073036|FG000|STARTED|Washout (1 Month)||33||
48304801|NCT02577601|101073036|FG000|COMPLETED|Washout (1 Month)||33||
48304802|NCT02577601|101073036|FG000|NOT COMPLETED|Washout (1 Month)||0||
48304803|NCT02577601|101073036|FG000|STARTED|UPA+COC (1 Month)||33||
48304804|NCT02577601|101073036|FG000|COMPLETED|UPA+COC (1 Month)||33||
48304805|NCT02577601|101073036|FG000|NOT COMPLETED|UPA+COC (1 Month)||0||
48304806|NCT03085758|101073037|FG000|STARTED|Overall Study||72||
48304807|NCT03085758|101073038|FG001|STARTED|Overall Study||77||
48304808|NCT03085758|101073039|FG002|STARTED|Overall Study||152||
48304809|NCT03085758|101073037|FG000|COMPLETED|Overall Study||43||
48304810|NCT03085758|101073038|FG001|COMPLETED|Overall Study||49||
48304811|NCT03085758|101073039|FG002|COMPLETED|Overall Study||96||
48304812|NCT03085758|101073037|FG000|NOT COMPLETED|Overall Study||29||
48304813|NCT03085758|101073038|FG001|NOT COMPLETED|Overall Study||28||
48304814|NCT03085758|101073039|FG002|NOT COMPLETED|Overall Study||56||
48304815|NCT05111041|101073040|FG000|STARTED|Overall Study||30||
48304816|NCT05111041|101073041|FG001|STARTED|Overall Study||30||
48304817|NCT05111041|101073040|FG000|COMPLETED|Overall Study||23||
48718142|NCT02876328|102095341|FG022|NOT COMPLETED|Overall Study||1||
48150178|NCT04517396|100692180|FG000|STARTED|Overall Study||351||
48150179|NCT04517396|100692181|FG001|STARTED|Overall Study||350||
48150180|NCT04517396|100692180|FG000|COMPLETED|Overall Study||347||
48150181|NCT04517396|100692181|FG001|COMPLETED|Overall Study||347||
48150182|NCT04517396|100692180|FG000|NOT COMPLETED|Overall Study||4||
48150183|NCT04517396|100692181|FG001|NOT COMPLETED|Overall Study||3||
48150184|NCT00815295|100692182|FG000|STARTED|Overall Study||8||
48304818|NCT05111041|101073041|FG001|COMPLETED|Overall Study||23||
48304819|NCT05111041|101073040|FG000|NOT COMPLETED|Overall Study||7||
48304820|NCT05111041|101073041|FG001|NOT COMPLETED|Overall Study||7||
48304821|NCT03690141|101073042|FG000|STARTED|Overall Study||16||
48304822|NCT03690141|101073042|FG000|COMPLETED|Overall Study||0||
48304823|NCT03690141|101073042|FG000|NOT COMPLETED|Overall Study||16||
48304824|NCT01357577|101073043|FG000|STARTED|Overall Study||64||
48304825|NCT01357577|101073044|FG001|STARTED|Overall Study||65||
48304826|NCT01357577|101073043|FG000|Post-Treatment Assessment Completed|Overall Study||24||
48304827|NCT01357577|101073044|FG001|Post-Treatment Assessment Completed|Overall Study||39||
48304828|NCT01357577|101073043|FG000|COMPLETED|Overall Study||27|Completed Milestone is defined at 6-month assessment completed|
48304829|NCT01357577|101073044|FG001|COMPLETED|Overall Study||39|Completed Milestone is defined at 6-month assessment completed|
48304830|NCT01357577|101073043|FG000|NOT COMPLETED|Overall Study||37||
48304831|NCT01357577|101073044|FG001|NOT COMPLETED|Overall Study||26||
48304832|NCT03739762|101073045|FG000|STARTED|Overall Study||140||
48304833|NCT03739762|101073046|FG001|STARTED|Overall Study||143||
48304834|NCT03739762|101073045|FG000|COMPLETED|Overall Study||137||
48718143|NCT02876328|102095342|FG023|NOT COMPLETED|Overall Study||0||
48718144|NCT02525939|102095343|FG000|STARTED|Overall Study||3071||
48718145|NCT02525939|102095344|FG001|STARTED|Overall Study||3076||
48718146|NCT02525939|102095343|FG000|Took Study Medication|Overall Study||3064||
48718147|NCT02525939|102095344|FG001|Took Study Medication|Overall Study||3064||
48718148|NCT02525939|102095343|FG000|COMPLETED|Overall Study||2840||
48718149|NCT02525939|102095344|FG001|COMPLETED|Overall Study||2833||
48718150|NCT02525939|102095343|FG000|NOT COMPLETED|Overall Study||231||
48718151|NCT02525939|102095344|FG001|NOT COMPLETED|Overall Study||243||
48304835|NCT03739762|101073046|FG001|COMPLETED|Overall Study||136||
48304836|NCT03739762|101073045|FG000|NOT COMPLETED|Overall Study||3||
48304837|NCT03739762|101073046|FG001|NOT COMPLETED|Overall Study||7||
48304838|NCT00216203|101073047|FG000|STARTED|Overall Study||36||
48304839|NCT00216203|101073047|FG000|COMPLETED|Overall Study||34||
48304840|NCT00216203|101073047|FG000|NOT COMPLETED|Overall Study||2||
48304841|NCT02403622|101073048|FG000|STARTED|Overall Study||15||
48304842|NCT02403622|101073048|FG000|COMPLETED|Overall Study||13||
48304843|NCT02403622|101073048|FG000|NOT COMPLETED|Overall Study||2||
48304844|NCT00387764|101073049|FG000|STARTED|Overall Study||80||
48304845|NCT00387764|101073049|FG000|COMPLETED|Overall Study||49||
48304846|NCT00387764|101073049|FG000|NOT COMPLETED|Overall Study||31||
48304847|NCT04004429|101074755|FG000|STARTED|Overall Study||35|"The number of participants started reflects the total number in the study, i.e. both patients from part 1 and part 2.~Data from the individual parts have not been analyzed separately."|
48304848|NCT04004429|101074756|FG001|STARTED|Overall Study||36|"The number of participants started reflects the total number in the study, i.e. both patients from part 1 and part 2.~Data from the individual parts have not been analyzed separately."|
48304849|NCT04004429|101074757|FG002|STARTED|Overall Study||34|"The number of participants started reflects the total number in the study, i.e. both patients from part 1 and part 2.~Data from the individual parts have not been analyzed separately."|
48304850|NCT04004429|101074755|FG000|COMPLETED|Overall Study||33||
48304851|NCT04004429|101074756|FG001|COMPLETED|Overall Study||34||
48304852|NCT04004429|101074757|FG002|COMPLETED|Overall Study||32||
48304853|NCT04004429|101074755|FG000|NOT COMPLETED|Overall Study||2||
48304854|NCT04004429|101074756|FG001|NOT COMPLETED|Overall Study||2||
48304855|NCT04004429|101074757|FG002|NOT COMPLETED|Overall Study||2||
48718152|NCT01350115|102095345|FG000|STARTED|Core Study (All Patients)||8||
48718153|NCT01350115|102095346|FG001|STARTED|Core Study (All Patients)||2||
48718154|NCT01350115|102095345|FG000|Safety Anlysis Set|Core Study (All Patients)||8||
48718155|NCT01350115|102095346|FG001|Safety Anlysis Set|Core Study (All Patients)||2||
48718156|NCT01350115|102095345|FG000|Pharmacodynamic Set|Core Study (All Patients)||7||
48718157|NCT01350115|102095346|FG001|Pharmacodynamic Set|Core Study (All Patients)||2||
48718158|NCT01350115|102095345|FG000|COMPLETED|Core Study (All Patients)||8||
48718159|NCT01350115|102095346|FG001|COMPLETED|Core Study (All Patients)||2||
48718160|NCT01350115|102095345|FG000|NOT COMPLETED|Core Study (All Patients)||0||
48718161|NCT01350115|102095346|FG001|NOT COMPLETED|Core Study (All Patients)||0||
48718162|NCT01350115|102095345|FG000|STARTED|Long Term Follow-Up (All Patients)||8||
48718163|NCT01350115|102095346|FG001|STARTED|Long Term Follow-Up (All Patients)||2||
48718164|NCT01350115|102095345|FG000|COMPLETED|Long Term Follow-Up (All Patients)||7||
48718165|NCT01350115|102095346|FG001|COMPLETED|Long Term Follow-Up (All Patients)||0||
48718166|NCT01350115|102095345|FG000|NOT COMPLETED|Long Term Follow-Up (All Patients)||1||
48718167|NCT01350115|102095346|FG001|NOT COMPLETED|Long Term Follow-Up (All Patients)||2||
48718168|NCT03271047|102095347|FG000|STARTED|Phase 1b: Dose Finding Period||10||
48718169|NCT03271047|102095348|FG001|STARTED|Phase 1b: Dose Finding Period||11||
48718170|NCT03271047|102095349|FG002|STARTED|Phase 1b: Dose Finding Period||0||
48718171|NCT03271047|102095350|FG003|STARTED|Phase 1b: Dose Finding Period||0||
48718172|NCT03271047|102095347|FG000|COMPLETED|Phase 1b: Dose Finding Period||0||
48718173|NCT03271047|102095348|FG001|COMPLETED|Phase 1b: Dose Finding Period||0||
48718174|NCT03271047|102095349|FG002|COMPLETED|Phase 1b: Dose Finding Period||0||
48718175|NCT03271047|102095350|FG003|COMPLETED|Phase 1b: Dose Finding Period||0||
48718176|NCT03271047|102095347|FG000|NOT COMPLETED|Phase 1b: Dose Finding Period||10||
48718177|NCT03271047|102095348|FG001|NOT COMPLETED|Phase 1b: Dose Finding Period||11||
48718178|NCT03271047|102095349|FG002|NOT COMPLETED|Phase 1b: Dose Finding Period||0||
48718179|NCT03271047|102095350|FG003|NOT COMPLETED|Phase 1b: Dose Finding Period||0||
48718180|NCT03271047|102095347|FG000|STARTED|Randomized Phase 2 Period||0||
48718181|NCT03271047|102095348|FG001|STARTED|Randomized Phase 2 Period||0||
48718182|NCT03271047|102095349|FG002|STARTED|Randomized Phase 2 Period||27||
48718183|NCT03271047|102095350|FG003|STARTED|Randomized Phase 2 Period||27||
48718184|NCT03271047|102095347|FG000|COMPLETED|Randomized Phase 2 Period||0||
48718185|NCT03271047|102095348|FG001|COMPLETED|Randomized Phase 2 Period||0||
48718186|NCT03271047|102095349|FG002|COMPLETED|Randomized Phase 2 Period||0||
48718187|NCT03271047|102095350|FG003|COMPLETED|Randomized Phase 2 Period||0||
48718188|NCT03271047|102095347|FG000|NOT COMPLETED|Randomized Phase 2 Period||0||
48718189|NCT03271047|102095348|FG001|NOT COMPLETED|Randomized Phase 2 Period||0||
48718190|NCT03271047|102095349|FG002|NOT COMPLETED|Randomized Phase 2 Period||27||
48718191|NCT03271047|102095350|FG003|NOT COMPLETED|Randomized Phase 2 Period||27||
48718192|NCT03689244|102095351|FG000|STARTED|Double Blind Period (Up to 27.7 Months)||64||
48718193|NCT03689244|102095352|FG001|STARTED|Double Blind Period (Up to 27.7 Months)||64||
48718194|NCT03689244|102095353|FG002|STARTED|Double Blind Period (Up to 27.7 Months)||0||
48718195|NCT03689244|102095354|FG003|STARTED|Double Blind Period (Up to 27.7 Months)||0||
48718196|NCT03689244|102095351|FG000|COMPLETED|Double Blind Period (Up to 27.7 Months)||9||
48718197|NCT03689244|102095352|FG001|COMPLETED|Double Blind Period (Up to 27.7 Months)||6||
48718198|NCT03689244|102095353|FG002|COMPLETED|Double Blind Period (Up to 27.7 Months)||0||
48718199|NCT03689244|102095354|FG003|COMPLETED|Double Blind Period (Up to 27.7 Months)||0||
48718200|NCT03689244|102095351|FG000|NOT COMPLETED|Double Blind Period (Up to 27.7 Months)||55||
48718201|NCT03689244|102095352|FG001|NOT COMPLETED|Double Blind Period (Up to 27.7 Months)||58||
48718202|NCT03689244|102095353|FG002|NOT COMPLETED|Double Blind Period (Up to 27.7 Months)||0||
48718203|NCT03689244|102095354|FG003|NOT COMPLETED|Double Blind Period (Up to 27.7 Months)||0||
48718204|NCT03689244|102095351|FG000|STARTED|Open Label Period (Up to 20.8 Months)||0||
48718205|NCT03689244|102095352|FG001|STARTED|Open Label Period (Up to 20.8 Months)||0||
48718206|NCT03689244|102095353|FG002|STARTED|Open Label Period (Up to 20.8 Months)||9||
48718207|NCT03689244|102095354|FG003|STARTED|Open Label Period (Up to 20.8 Months)||6||
48718208|NCT03689244|102095351|FG000|COMPLETED|Open Label Period (Up to 20.8 Months)||0||
48718209|NCT03689244|102095352|FG001|COMPLETED|Open Label Period (Up to 20.8 Months)||0||
48718210|NCT03689244|102095353|FG002|COMPLETED|Open Label Period (Up to 20.8 Months)||0||
48718211|NCT03689244|102095354|FG003|COMPLETED|Open Label Period (Up to 20.8 Months)||0||
48718212|NCT03689244|102095351|FG000|NOT COMPLETED|Open Label Period (Up to 20.8 Months)||0||
48718213|NCT03689244|102095352|FG001|NOT COMPLETED|Open Label Period (Up to 20.8 Months)||0||
48718214|NCT03689244|102095353|FG002|NOT COMPLETED|Open Label Period (Up to 20.8 Months)||9||
48718215|NCT03689244|102095354|FG003|NOT COMPLETED|Open Label Period (Up to 20.8 Months)||6||
48718216|NCT01459913|102095355|FG000|STARTED|Overall Study||106||
48718217|NCT01459913|102095356|FG001|STARTED|Overall Study||52||
48718218|NCT01459913|102095357|FG002|STARTED|Overall Study||19||
48718219|NCT01459913|102095358|FG003|STARTED|Overall Study||62||
48718220|NCT01459913|102095355|FG000|COMPLETED|Overall Study||65||
48718221|NCT01459913|102095356|FG001|COMPLETED|Overall Study||32||
48718222|NCT01459913|102095357|FG002|COMPLETED|Overall Study||6||
48718223|NCT01459913|102095358|FG003|COMPLETED|Overall Study||29||
48718224|NCT01459913|102095355|FG000|NOT COMPLETED|Overall Study||41||
48718225|NCT01459913|102095356|FG001|NOT COMPLETED|Overall Study||20||
48718226|NCT01459913|102095357|FG002|NOT COMPLETED|Overall Study||13||
48718227|NCT01459913|102095358|FG003|NOT COMPLETED|Overall Study||33||
48718228|NCT03458702|102095359|FG000|STARTED|Study Condition A (Yoga or Rest)||28||
48718229|NCT03458702|102095360|FG001|STARTED|Study Condition A (Yoga or Rest)||28||
48718230|NCT03458702|102095359|FG000|COMPLETED|Study Condition A (Yoga or Rest)||24||
48718231|NCT03458702|102095360|FG001|COMPLETED|Study Condition A (Yoga or Rest)||22||
48718232|NCT03458702|102095359|FG000|NOT COMPLETED|Study Condition A (Yoga or Rest)||4||
48718233|NCT03458702|102095360|FG001|NOT COMPLETED|Study Condition A (Yoga or Rest)||6||
48718234|NCT03458702|102095359|FG000|STARTED|Study Condition B (Yoga or Rest)||24||
48718235|NCT03458702|102095360|FG001|STARTED|Study Condition B (Yoga or Rest)||22||
48718236|NCT03458702|102095359|FG000|COMPLETED|Study Condition B (Yoga or Rest)||20||
48718237|NCT03458702|102095360|FG001|COMPLETED|Study Condition B (Yoga or Rest)||20||
48718238|NCT03458702|102095359|FG000|NOT COMPLETED|Study Condition B (Yoga or Rest)||4||
48718239|NCT03458702|102095360|FG001|NOT COMPLETED|Study Condition B (Yoga or Rest)||2||
48718240|NCT03458702|102095359|FG000|STARTED|Picture Rating/Body Composition||20||
48718241|NCT03458702|102095360|FG001|STARTED|Picture Rating/Body Composition||20||
48718242|NCT03458702|102095359|FG000|COMPLETED|Picture Rating/Body Composition||20||
48718243|NCT03458702|102095360|FG001|COMPLETED|Picture Rating/Body Composition||20||
48718244|NCT03458702|102095359|FG000|NOT COMPLETED|Picture Rating/Body Composition||0||
48718245|NCT03458702|102095360|FG001|NOT COMPLETED|Picture Rating/Body Composition||0||
48718246|NCT02383433|102095361|FG000|STARTED|Overall Study||2||
48718247|NCT02383433|102095361|FG000|COMPLETED|Overall Study||0||
48718248|NCT02383433|102095361|FG000|NOT COMPLETED|Overall Study||2||
48718249|NCT02012686|102095362|FG000|STARTED|Overall Study||50||
48718250|NCT02012686|102095363|FG001|STARTED|Overall Study||50||
48718251|NCT02012686|102095362|FG000|COMPLETED|Overall Study||50||
48718252|NCT02012686|102095363|FG001|COMPLETED|Overall Study||48||
48718253|NCT02012686|102095362|FG000|NOT COMPLETED|Overall Study||0||
48718254|NCT02012686|102095363|FG001|NOT COMPLETED|Overall Study||2||
48718255|NCT00259298|102095364|FG000|STARTED|Overall Study||12||
48718256|NCT00259298|102095364|FG000|Received at Least 1 Dose of Study Drug|Overall Study||10||
48718257|NCT00259298|102095364|FG000|COMPLETED|Overall Study||9||
48718258|NCT00259298|102095364|FG000|NOT COMPLETED|Overall Study||3||
48607117|NCT00662311|101823444|FG001|COMPLETED|Overall Study||0||
48607118|NCT00662311|101823445|FG002|COMPLETED|Overall Study||0||
48607119|NCT00662311|101823443|FG000|NOT COMPLETED|Overall Study||1||
48607120|NCT00662311|101823444|FG001|NOT COMPLETED|Overall Study||0||
48607121|NCT00662311|101823445|FG002|NOT COMPLETED|Overall Study||0||
48718259|NCT02423122|102095365|FG000|STARTED|Overall Study||9||
48718260|NCT02423122|102095366|FG001|STARTED|Overall Study||7||
48718261|NCT02423122|102095365|FG000|COMPLETED|Overall Study||9||
48718262|NCT02423122|102095366|FG001|COMPLETED|Overall Study||7||
48718263|NCT02423122|102095365|FG000|NOT COMPLETED|Overall Study||0||
48718264|NCT02423122|102095366|FG001|NOT COMPLETED|Overall Study||0||
48718265|NCT03187834|102095367|FG000|STARTED|Overall Study||62||31
48718266|NCT03187834|102095368|FG001|STARTED|Overall Study||62||31
48718267|NCT03187834|102095369|FG002|STARTED|Overall Study||62||31
48607122|NCT00003896|101823446|FG000|STARTED|Overall Study||68||
48607123|NCT00003896|101823446|FG000|Eligible|Overall Study||63||
48607124|NCT00003896|101823446|FG000|COMPLETED|Overall Study||39||
48607125|NCT00003896|101823446|FG000|NOT COMPLETED|Overall Study||29||
48607126|NCT00287729|101823447|FG000|STARTED|Overall Study||171||
48607127|NCT00287729|101823448|FG001|STARTED|Overall Study||173||
48718268|NCT03187834|102095370|FG003|STARTED|Overall Study||62||31
48718269|NCT03187834|102095367|FG000|Receive Antibiotic|Overall Study||31||31
48718270|NCT03187834|102095368|FG001|Receive Antibiotic|Overall Study||31||31
48718271|NCT03187834|102095369|FG002|Receive Antibiotic|Overall Study||31||31
48718272|NCT03187834|102095370|FG003|Receive Antibiotic|Overall Study||31||31
48718273|NCT03187834|102095367|FG000|Receive Placebo|Overall Study||31||31
48718274|NCT03187834|102095368|FG001|Receive Placebo|Overall Study||31||31
48718275|NCT03187834|102095369|FG002|Receive Placebo|Overall Study||31||31
48718276|NCT03187834|102095370|FG003|Receive Placebo|Overall Study||31||31
48718277|NCT03187834|102095367|FG000|COMPLETED|Overall Study||57||30
48718278|NCT03187834|102095368|FG001|COMPLETED|Overall Study||58||31
48718279|NCT03187834|102095369|FG002|COMPLETED|Overall Study||56||31
48718280|NCT03187834|102095370|FG003|COMPLETED|Overall Study||58||31
48718281|NCT03187834|102095367|FG000|NOT COMPLETED|Overall Study||5||1
48718282|NCT03187834|102095368|FG001|NOT COMPLETED|Overall Study||4||0
48718283|NCT03187834|102095369|FG002|NOT COMPLETED|Overall Study||6||0
48718284|NCT03187834|102095370|FG003|NOT COMPLETED|Overall Study||4||0
48607128|NCT00287729|101823447|FG000|COMPLETED|Overall Study||137||
48718285|NCT01498185|102095371|FG000|STARTED|Overall Study||13||
48718286|NCT01498185|102095372|FG001|STARTED|Overall Study||13||
48718287|NCT01498185|102095373|FG002|STARTED|Overall Study||15||
48718288|NCT01498185|102095374|FG003|STARTED|Overall Study||14||
48718289|NCT01498185|102095375|FG004|STARTED|Overall Study||15||
48718290|NCT01498185|102095371|FG000|COMPLETED|Overall Study||12||
48718291|NCT01498185|102095372|FG001|COMPLETED|Overall Study||12||
48304856|NCT00616434|101074758|FG000|STARTED|Overall Study||62||
48304857|NCT00616434|101074759|FG001|STARTED|Overall Study||61||
48304858|NCT00616434|101074758|FG000|COMPLETED|Overall Study||56||
48304859|NCT00616434|101074759|FG001|COMPLETED|Overall Study||53||
48304860|NCT00616434|101074758|FG000|NOT COMPLETED|Overall Study||6||
48304861|NCT00616434|101074759|FG001|NOT COMPLETED|Overall Study||8||
48304862|NCT00119041|101074760|FG000|STARTED|Overall Study||199||
48304863|NCT00119041|101074761|FG001|STARTED|Overall Study||83||
48304864|NCT00119041|101074762|FG002|STARTED|Overall Study||22||
48304865|NCT00119041|101074760|FG000|COMPLETED|Overall Study||199||
48406102|NCT02143141|101325427|FG000|NOT COMPLETED|Overall Study||1||
48406103|NCT02143141|101325428|FG001|NOT COMPLETED|Overall Study||0||
48718292|NCT01498185|102095373|FG002|COMPLETED|Overall Study||15||
48718293|NCT01498185|102095374|FG003|COMPLETED|Overall Study||11||
48718294|NCT01498185|102095375|FG004|COMPLETED|Overall Study||12||
48406104|NCT01611311|101328347|FG000|STARTED|Overall Study||4||
48718295|NCT01498185|102095371|FG000|NOT COMPLETED|Overall Study||1||
48718296|NCT01498185|102095372|FG001|NOT COMPLETED|Overall Study||1||
48718297|NCT01498185|102095373|FG002|NOT COMPLETED|Overall Study||0||
48718298|NCT01498185|102095374|FG003|NOT COMPLETED|Overall Study||3||
48718299|NCT01498185|102095375|FG004|NOT COMPLETED|Overall Study||3||
48718300|NCT00490022|102095376|FG000|STARTED|Overall Study||16||
48718301|NCT00490022|102095377|FG001|STARTED|Overall Study||15||
48304866|NCT00119041|101074761|FG001|COMPLETED|Overall Study||83||
48304867|NCT00119041|101074762|FG002|COMPLETED|Overall Study||22||
48304868|NCT00119041|101074760|FG000|NOT COMPLETED|Overall Study||0||
48304869|NCT00119041|101074761|FG001|NOT COMPLETED|Overall Study||0||
48304870|NCT00119041|101074762|FG002|NOT COMPLETED|Overall Study||0||
48304871|NCT04881461|101074763|FG000|STARTED|Overall Study||223|Randomized and treated|
48304872|NCT04881461|101074764|FG001|STARTED|Overall Study||222|Randomized and treated|
48304873|NCT04881461|101074763|FG000|COMPLETED|Overall Study||196|Completed trial|
48304874|NCT04881461|101074764|FG001|COMPLETED|Overall Study||193|Completed trial|
48304875|NCT04881461|101074763|FG000|NOT COMPLETED|Overall Study||27||
48304876|NCT04881461|101074764|FG001|NOT COMPLETED|Overall Study||29||
48304877|NCT01133379|101074765|FG000|STARTED|Overall Study||58||
48304878|NCT01133379|101074766|FG001|STARTED|Overall Study||58||
48304879|NCT01133379|101074767|FG002|STARTED|Overall Study||58||
48406105|NCT01611311|101328348|FG001|STARTED|Overall Study||6||
48406106|NCT01611311|101328349|FG002|STARTED|Overall Study||6||
48406107|NCT01611311|101328350|FG003|STARTED|Overall Study||6||
48718302|NCT00490022|102095376|FG000|COMPLETED|Overall Study||15||
48718303|NCT00490022|102095377|FG001|COMPLETED|Overall Study||12||
48718304|NCT00490022|102095376|FG000|NOT COMPLETED|Overall Study||1||
48718305|NCT00490022|102095377|FG001|NOT COMPLETED|Overall Study||3||
48718306|NCT02231762|102095378|FG000|STARTED|Combination Phase||57||
48718307|NCT02231762|102095379|FG001|STARTED|Combination Phase||0||
48304880|NCT01133379|101074765|FG000|COMPLETED|Overall Study||57||
48304881|NCT01133379|101074766|FG001|COMPLETED|Overall Study||56||
48304882|NCT01133379|101074767|FG002|COMPLETED|Overall Study||56||
48718308|NCT02231762|102095380|FG002|STARTED|Combination Phase||0||
48718309|NCT02231762|102095381|FG003|STARTED|Combination Phase||0||
48150185|NCT00815295|100692183|FG001|STARTED|Overall Study||8||
48150186|NCT00815295|100692184|FG002|STARTED|Overall Study||12||
48150187|NCT00815295|100692182|FG000|COMPLETED|Overall Study||8||
48150188|NCT00815295|100692183|FG001|COMPLETED|Overall Study||7||
48150189|NCT00815295|100692184|FG002|COMPLETED|Overall Study||9||
48150190|NCT00815295|100692182|FG000|NOT COMPLETED|Overall Study||0||
48150191|NCT00815295|100692183|FG001|NOT COMPLETED|Overall Study||1||
48150192|NCT00815295|100692184|FG002|NOT COMPLETED|Overall Study||3||
48150193|NCT00572195|100692185|FG000|STARTED|Overall Study||230||
48150194|NCT00572195|100692185|FG000|COMPLETED|Overall Study||162||
48150195|NCT00572195|100692185|FG000|NOT COMPLETED|Overall Study||68||
48150196|NCT03595579|100692186|FG000|STARTED|Overall Study||48||
48150197|NCT03595579|100692187|FG001|STARTED|Overall Study||49||
48150198|NCT03595579|100692186|FG000|mITT Population|Overall Study||43||
48150199|NCT03595579|100692187|FG001|mITT Population|Overall Study||37||
48150200|NCT03595579|100692186|FG000|Safety Population|Overall Study||48||
48150201|NCT03595579|100692187|FG001|Safety Population|Overall Study||48||
48150202|NCT03595579|100692186|FG000|COMPLETED|Overall Study||38||
48150203|NCT03595579|100692187|FG001|COMPLETED|Overall Study||35||
48150204|NCT03595579|100692186|FG000|NOT COMPLETED|Overall Study||10||
48150205|NCT03595579|100692187|FG001|NOT COMPLETED|Overall Study||14||
48150206|NCT01235403|100692188|FG000|STARTED|Overall Study||100||
48150207|NCT01235403|100692188|FG000|COMPLETED|Overall Study||74||
48150208|NCT01235403|100692188|FG000|NOT COMPLETED|Overall Study||26||
48150209|NCT00428090|100692189|FG000|STARTED|Overall Study||165||
48150210|NCT00428090|100692190|FG001|STARTED|Overall Study||166||
48150211|NCT00428090|100692191|FG002|STARTED|Overall Study||165||
48150212|NCT00428090|100692192|FG003|STARTED|Overall Study||83||
48150213|NCT00428090|100692189|FG000|COMPLETED|Overall Study||131||
48150214|NCT00428090|100692190|FG001|COMPLETED|Overall Study||135||
48150215|NCT00428090|100692191|FG002|COMPLETED|Overall Study||127||
48150216|NCT00428090|100692192|FG003|COMPLETED|Overall Study||55||
48150217|NCT00428090|100692189|FG000|NOT COMPLETED|Overall Study||34||
48150218|NCT00428090|100692190|FG001|NOT COMPLETED|Overall Study||31||
48150219|NCT00428090|100692191|FG002|NOT COMPLETED|Overall Study||38||
48150220|NCT00428090|100692192|FG003|NOT COMPLETED|Overall Study||28||
48150221|NCT02858050|100692193|FG000|STARTED|Overall Study||20||
48150222|NCT02858050|100692194|FG001|STARTED|Overall Study||20||
48150223|NCT02858050|100692193|FG000|COMPLETED|Overall Study||20||
48150224|NCT02858050|100692194|FG001|COMPLETED|Overall Study||20||
48150225|NCT02858050|100692193|FG000|NOT COMPLETED|Overall Study||0||
48150226|NCT02858050|100692194|FG001|NOT COMPLETED|Overall Study||0||
48150227|NCT01489579|100692195|FG000|STARTED|Overall Study||56||
48150228|NCT01489579|100692196|FG001|STARTED|Overall Study||64||
48150229|NCT01489579|100692195|FG000|COMPLETED|Overall Study||47||
48150230|NCT01489579|100692196|FG001|COMPLETED|Overall Study||57||
48150231|NCT01489579|100692195|FG000|NOT COMPLETED|Overall Study||9||
48150232|NCT01489579|100692196|FG001|NOT COMPLETED|Overall Study||7||
48150233|NCT01951638|100692197|FG000|STARTED|Treatment Period||93||
48150234|NCT01951638|100692198|FG001|STARTED|Treatment Period||96||
48150235|NCT01951638|100692199|FG002|STARTED|Treatment Period||96||
48150236|NCT01951638|100692200|FG003|STARTED|Treatment Period||96||
48150237|NCT01951638|100692201|FG004|STARTED|Treatment Period||96||
48150238|NCT01951638|100692197|FG000|COMPLETED|Treatment Period||80||
48304883|NCT01133379|101074765|FG000|NOT COMPLETED|Overall Study||1||
48150239|NCT01951638|100692198|FG001|COMPLETED|Treatment Period||82||
48150240|NCT01951638|100692199|FG002|COMPLETED|Treatment Period||83||
48150241|NCT01951638|100692200|FG003|COMPLETED|Treatment Period||80||
48150242|NCT01951638|100692201|FG004|COMPLETED|Treatment Period||86||
48150243|NCT01951638|100692197|FG000|NOT COMPLETED|Treatment Period||13||
48150244|NCT01951638|100692198|FG001|NOT COMPLETED|Treatment Period||14||
48150245|NCT01951638|100692199|FG002|NOT COMPLETED|Treatment Period||13||
48150246|NCT01951638|100692200|FG003|NOT COMPLETED|Treatment Period||16||
48150247|NCT01951638|100692201|FG004|NOT COMPLETED|Treatment Period||10||
48150248|NCT01951638|100692197|FG000|STARTED|Follow-up Period||89||
48150249|NCT01951638|100692198|FG001|STARTED|Follow-up Period||95||
48150250|NCT01951638|100692199|FG002|STARTED|Follow-up Period||95||
48150251|NCT01951638|100692200|FG003|STARTED|Follow-up Period||88||
48304884|NCT01133379|101074766|FG001|NOT COMPLETED|Overall Study||2||
48304885|NCT01133379|101074767|FG002|NOT COMPLETED|Overall Study||2||
48304886|NCT02289352|101074768|FG000|STARTED|Overall Study||199||
48304887|NCT02289352|101074769|FG001|STARTED|Overall Study||199||
48304888|NCT02289352|101074770|FG002|STARTED|Overall Study||64||
48304889|NCT02289352|101074768|FG000|Safety Population|Overall Study||199|Randomized participants who received the study drug.|
48304890|NCT02289352|101074769|FG001|Safety Population|Overall Study||199|Randomized participants who received the study drug.|
48304891|NCT02289352|101074770|FG002|Safety Population|Overall Study||64|Randomized participants who received the study drug.|
48304892|NCT02289352|101074768|FG000|mITT Population|Overall Study||191|Randomized participants, at least one dose, pre and post assessments during at least one visit (2/3)|
48304893|NCT02289352|101074769|FG001|mITT Population|Overall Study||193|Randomized participants, at least one dose, pre and post assessments during at least one visit (2/3)|
48304894|NCT02289352|101074770|FG002|mITT Population|Overall Study||58|Randomized participants, at least one dose, pre and post assessments during at least one visit (2/3)|
48304895|NCT02289352|101074768|FG000|PP Population|Overall Study||173|Participants completed all visits and assessments, dose compliance, and followed restrictions.|
48304896|NCT02289352|101074769|FG001|PP Population|Overall Study||173|Participants completed all visits and assessments, dose compliance, and followed restrictions.|
48304897|NCT02289352|101074770|FG002|PP Population|Overall Study||54|Participants completed all visits and assessments, dose compliance, and followed restrictions.|
48304898|NCT02289352|101074768|FG000|COMPLETED|Overall Study||198||
48304899|NCT02289352|101074769|FG001|COMPLETED|Overall Study||198||
48304900|NCT02289352|101074770|FG002|COMPLETED|Overall Study||64||
48304901|NCT02289352|101074768|FG000|NOT COMPLETED|Overall Study||1||
48304902|NCT02289352|101074769|FG001|NOT COMPLETED|Overall Study||1||
48304903|NCT02289352|101074770|FG002|NOT COMPLETED|Overall Study||0||
48304904|NCT03144804|101074771|FG000|STARTED|Overall Study||36||
48304905|NCT03144804|101074771|FG000|COMPLETED|Overall Study||32||
48304906|NCT03144804|101074771|FG000|NOT COMPLETED|Overall Study||4||
48304907|NCT02764164|101074772|FG000|STARTED|Overall Study||1||
48304908|NCT02764164|101074772|FG000|COMPLETED|Overall Study||1||
48304909|NCT02764164|101074772|FG000|NOT COMPLETED|Overall Study||0||
48304910|NCT01807923|101074773|FG000|STARTED|Overall Study||187||
48304911|NCT01807923|101074774|FG001|STARTED|Overall Study||185||
48304912|NCT01807923|101074775|FG002|STARTED|Overall Study||187||
48304913|NCT01807923|101074773|FG000|COMPLETED|Overall Study||182||
48304914|NCT01807923|101074774|FG001|COMPLETED|Overall Study||179||
48304915|NCT01807923|101074775|FG002|COMPLETED|Overall Study||176||
48304916|NCT01807923|101074773|FG000|NOT COMPLETED|Overall Study||5||
48304917|NCT01807923|101074774|FG001|NOT COMPLETED|Overall Study||6||
48406108|NCT01611311|101328351|FG004|STARTED|Overall Study||9||
48304918|NCT01807923|101074775|FG002|NOT COMPLETED|Overall Study||11||
48304919|NCT00819286|101074776|FG000|STARTED|Overall Study||70||
48304920|NCT00819286|101074777|FG001|STARTED|Overall Study||70||
48304921|NCT00819286|101074776|FG000|COMPLETED|Overall Study||56||
48304922|NCT00819286|101074777|FG001|COMPLETED|Overall Study||45||
48304923|NCT00819286|101074776|FG000|NOT COMPLETED|Overall Study||14||
48304924|NCT00819286|101074777|FG001|NOT COMPLETED|Overall Study||25||
48304925|NCT00846885|101074778|FG000|STARTED|First Intervention||14||
48304926|NCT00846885|101074779|FG001|STARTED|First Intervention||14||
48304927|NCT00846885|101074778|FG000|COMPLETED|First Intervention||14||
48304928|NCT00846885|101074779|FG001|COMPLETED|First Intervention||14||
48304929|NCT00846885|101074778|FG000|NOT COMPLETED|First Intervention||0||
48304930|NCT00846885|101074779|FG001|NOT COMPLETED|First Intervention||0||
48304931|NCT00846885|101074778|FG000|STARTED|Washout of 7 Days||14||
48304932|NCT00846885|101074779|FG001|STARTED|Washout of 7 Days||14||
48304933|NCT00846885|101074778|FG000|COMPLETED|Washout of 7 Days||14||
48304934|NCT00846885|101074779|FG001|COMPLETED|Washout of 7 Days||14||
48304935|NCT00846885|101074778|FG000|NOT COMPLETED|Washout of 7 Days||0||
48304936|NCT00846885|101074779|FG001|NOT COMPLETED|Washout of 7 Days||0||
48304937|NCT00846885|101074778|FG000|STARTED|Second Intervention||14||
48304938|NCT00846885|101074779|FG001|STARTED|Second Intervention||14||
48304939|NCT00846885|101074778|FG000|COMPLETED|Second Intervention||14||
48304940|NCT00846885|101074779|FG001|COMPLETED|Second Intervention||14||
48304941|NCT00846885|101074778|FG000|NOT COMPLETED|Second Intervention||0||
48304942|NCT00846885|101074779|FG001|NOT COMPLETED|Second Intervention||0||
48304943|NCT01177384|101074780|FG000|STARTED|Overall Study||191||
48304944|NCT01177384|101074781|FG001|STARTED|Overall Study||190||
48304945|NCT01177384|101074780|FG000|COMPLETED|Overall Study||177||
48304946|NCT01177384|101074781|FG001|COMPLETED|Overall Study||164||
48304947|NCT01177384|101074780|FG000|NOT COMPLETED|Overall Study||14||
48304948|NCT01177384|101074781|FG001|NOT COMPLETED|Overall Study||26||
48304949|NCT03099005|101074782|FG000|STARTED|Overall Study||5||
48304950|NCT03099005|101074782|FG000|Low CBD Session|Overall Study||5||
48304951|NCT03099005|101074782|FG000|Medium CBD Session|Overall Study||5||
48304952|NCT03099005|101074782|FG000|High CBD Session|Overall Study||5||
48304953|NCT03099005|101074782|FG000|COMPLETED|Overall Study||5||
48718310|NCT02231762|102095378|FG000|COMPLETED|Combination Phase||37||
48718311|NCT02231762|102095379|FG001|COMPLETED|Combination Phase||0||
48718312|NCT02231762|102095380|FG002|COMPLETED|Combination Phase||0||
48718313|NCT02231762|102095381|FG003|COMPLETED|Combination Phase||0||
48718314|NCT02231762|102095378|FG000|NOT COMPLETED|Combination Phase||20||
48718315|NCT02231762|102095379|FG001|NOT COMPLETED|Combination Phase||0||
48718316|NCT02231762|102095380|FG002|NOT COMPLETED|Combination Phase||0||
48718317|NCT02231762|102095381|FG003|NOT COMPLETED|Combination Phase||0||
48304954|NCT03099005|101074782|FG000|NOT COMPLETED|Overall Study||0||
48304955|NCT02019420|101074783|FG000|STARTED|Overall Study||366|Randomized|
48304956|NCT02019420|101074784|FG001|STARTED|Overall Study||360|Randomized|
48304957|NCT02019420|101074783|FG000|Treated|Overall Study||361||
48304958|NCT02019420|101074784|FG001|Treated|Overall Study||357||
48304959|NCT02019420|101074783|FG000|COMPLETED|Overall Study||258||
48304960|NCT02019420|101074784|FG001|COMPLETED|Overall Study||254||
48304961|NCT02019420|101074783|FG000|NOT COMPLETED|Overall Study||108||
48304962|NCT02019420|101074784|FG001|NOT COMPLETED|Overall Study||106||
48304963|NCT04585646|101074785|FG000|STARTED|First Intervention||32||
48304964|NCT04585646|101074786|FG001|STARTED|First Intervention||32||
48304965|NCT04585646|101074785|FG000|COMPLETED|First Intervention||31||
48304966|NCT04585646|101074786|FG001|COMPLETED|First Intervention||28||
48304967|NCT04585646|101074785|FG000|NOT COMPLETED|First Intervention||1||
48304968|NCT04585646|101074786|FG001|NOT COMPLETED|First Intervention||4||
48304969|NCT04585646|101074785|FG000|STARTED|Second Intervention||31||
48304970|NCT04585646|101074786|FG001|STARTED|Second Intervention||28||
48304971|NCT04585646|101074785|FG000|COMPLETED|Second Intervention||31||
48304972|NCT04585646|101074786|FG001|COMPLETED|Second Intervention||28||
48304973|NCT04585646|101074785|FG000|NOT COMPLETED|Second Intervention||0||
48304974|NCT04585646|101074786|FG001|NOT COMPLETED|Second Intervention||0||
48718318|NCT02231762|102095378|FG000|STARTED|Maintenance Phase||0||
48718319|NCT02231762|102095379|FG001|STARTED|Maintenance Phase||11||
48718320|NCT02231762|102095380|FG002|STARTED|Maintenance Phase||14||
48718321|NCT02231762|102095381|FG003|STARTED|Maintenance Phase||12||
48718322|NCT02231762|102095378|FG000|COMPLETED|Maintenance Phase||0||
48718323|NCT02231762|102095379|FG001|COMPLETED|Maintenance Phase||8||
48718324|NCT02231762|102095380|FG002|COMPLETED|Maintenance Phase||9||
48718325|NCT02231762|102095381|FG003|COMPLETED|Maintenance Phase||7||
48718326|NCT02231762|102095378|FG000|NOT COMPLETED|Maintenance Phase||0||
48718327|NCT02231762|102095379|FG001|NOT COMPLETED|Maintenance Phase||3||
48718328|NCT02231762|102095380|FG002|NOT COMPLETED|Maintenance Phase||5||
48718329|NCT02231762|102095381|FG003|NOT COMPLETED|Maintenance Phase||5||
48718330|NCT00456599|102095382|FG000|STARTED|Overall Study||71||
48718331|NCT00456599|102095382|FG000|Completed Cycle 1|Overall Study||66||
48304975|NCT00517751|101074787|FG000|STARTED|Overall Study||162||
48304976|NCT00517751|101074787|FG000|COMPLETED|Overall Study||33||
48304977|NCT00517751|101074787|FG000|NOT COMPLETED|Overall Study||129||
48718332|NCT00456599|102095382|FG000|Initiated Cycle 2|Overall Study||61||
48718333|NCT00456599|102095382|FG000|Completed Protocol Surgery|Overall Study||48||
48718334|NCT00456599|102095382|FG000|Completed Resection|Overall Study||43||
48718335|NCT00456599|102095382|FG000|Post-Surgery Adjuvent Therapy|Overall Study||26||
48718336|NCT00456599|102095382|FG000|Completed 4th Cycle of Chemotherapy|Overall Study||24||
48718337|NCT00456599|102095382|FG000|COMPLETED|Overall Study||68||
48718338|NCT00456599|102095382|FG000|NOT COMPLETED|Overall Study||3||
48718339|NCT02636946|102095383|FG000|STARTED|Cycle 1 (Day 1 to Week 15)||72||
48718340|NCT02636946|102095384|FG001|STARTED|Cycle 1 (Day 1 to Week 15)||72||
48718341|NCT02636946|102095383|FG000|Received Treatment in Either Eye|Cycle 1 (Day 1 to Week 15)||72||
48718342|NCT02636946|102095384|FG001|Received Treatment in Either Eye|Cycle 1 (Day 1 to Week 15)||70||
48718343|NCT02636946|102095383|FG000|COMPLETED|Cycle 1 (Day 1 to Week 15)||71||
48718344|NCT02636946|102095384|FG001|COMPLETED|Cycle 1 (Day 1 to Week 15)||67||
48718345|NCT02636946|102095383|FG000|NOT COMPLETED|Cycle 1 (Day 1 to Week 15)||1||
48718346|NCT02636946|102095384|FG001|NOT COMPLETED|Cycle 1 (Day 1 to Week 15)||5||
48718347|NCT02636946|102095383|FG000|STARTED|Cycle 2 (Week 16 to Week 31)||65|Started=received administration (Sham or Bimatoprost SR) in the cycle|
48718348|NCT02636946|102095384|FG001|STARTED|Cycle 2 (Week 16 to Week 31)||62|Started=received administration (Sham or Bimatoprost SR) in the cycle|
48718349|NCT02636946|102095383|FG000|COMPLETED|Cycle 2 (Week 16 to Week 31)||63||
48718350|NCT02636946|102095384|FG001|COMPLETED|Cycle 2 (Week 16 to Week 31)||61||
48718351|NCT02636946|102095383|FG000|NOT COMPLETED|Cycle 2 (Week 16 to Week 31)||2||
48718352|NCT02636946|102095384|FG001|NOT COMPLETED|Cycle 2 (Week 16 to Week 31)||1||
48718353|NCT02636946|102095383|FG000|STARTED|Cycle 3 (Week 32 to Week 52)||17|Started=received administration (Sham or Bimatoprost SR) in the cycle|
48718354|NCT02636946|102095384|FG001|STARTED|Cycle 3 (Week 32 to Week 52)||16|Started=received administration (Sham or Bimatoprost SR) in the cycle|
48718355|NCT02636946|102095383|FG000|COMPLETED|Cycle 3 (Week 32 to Week 52)||17||
48718356|NCT02636946|102095384|FG001|COMPLETED|Cycle 3 (Week 32 to Week 52)||16||
48718357|NCT02636946|102095383|FG000|NOT COMPLETED|Cycle 3 (Week 32 to Week 52)||0||
48718358|NCT02636946|102095384|FG001|NOT COMPLETED|Cycle 3 (Week 32 to Week 52)||0||
48718359|NCT02342379|102095385|FG000|STARTED|Overall Study||35||
48718360|NCT02342379|102095385|FG000|COMPLETED|Overall Study||35||
48718361|NCT02342379|102095385|FG000|NOT COMPLETED|Overall Study||0||
48718362|NCT02250664|102095386|FG000|STARTED|Overall Study||254||
48718363|NCT02250664|102095387|FG001|STARTED|Overall Study||235||
48718364|NCT02250664|102095388|FG002|STARTED|Overall Study||286||
48718365|NCT02250664|102095386|FG000|COMPLETED|Overall Study||218||
48718366|NCT02250664|102095387|FG001|COMPLETED|Overall Study||190||
48718367|NCT02250664|102095388|FG002|COMPLETED|Overall Study||224||
48718368|NCT02250664|102095386|FG000|NOT COMPLETED|Overall Study||36||
48718369|NCT02250664|102095387|FG001|NOT COMPLETED|Overall Study||45||
48718370|NCT02250664|102095388|FG002|NOT COMPLETED|Overall Study||62||
48718371|NCT01703065|102095389|FG000|STARTED|Overall Study||9||
48718372|NCT01703065|102095390|FG001|STARTED|Overall Study||0||
48718373|NCT01703065|102095389|FG000|COMPLETED|Overall Study||8||
48718374|NCT01703065|102095390|FG001|COMPLETED|Overall Study||0||
48718375|NCT01703065|102095389|FG000|NOT COMPLETED|Overall Study||1||
48718376|NCT01703065|102095390|FG001|NOT COMPLETED|Overall Study||0||
48718377|NCT03773107|102095391|FG000|STARTED|Overall Study||5||
48718378|NCT03773107|102095392|FG001|STARTED|Overall Study||0||
48718379|NCT03773107|102095393|FG002|STARTED|Overall Study||4||
48718380|NCT03773107|102095394|FG003|STARTED|Overall Study||3||
48718381|NCT03773107|102095391|FG000|COMPLETED|Overall Study||4||
48718382|NCT03773107|102095392|FG001|COMPLETED|Overall Study||0||
48718383|NCT03773107|102095393|FG002|COMPLETED|Overall Study||4||
48718384|NCT03773107|102095394|FG003|COMPLETED|Overall Study||2||
48718385|NCT03773107|102095391|FG000|NOT COMPLETED|Overall Study||1||
48718386|NCT03773107|102095392|FG001|NOT COMPLETED|Overall Study||0||
48718387|NCT03773107|102095393|FG002|NOT COMPLETED|Overall Study||0||
48718388|NCT03773107|102095394|FG003|NOT COMPLETED|Overall Study||1||
48718389|NCT03833713|102095395|FG000|STARTED|Overall Study||110||
48718390|NCT03833713|102095396|FG001|STARTED|Overall Study||108||
48718391|NCT03833713|102095395|FG000|COMPLETED|Overall Study||110||
48718392|NCT03833713|102095396|FG001|COMPLETED|Overall Study||108||
48718393|NCT03833713|102095395|FG000|NOT COMPLETED|Overall Study||0||
48718394|NCT03833713|102095396|FG001|NOT COMPLETED|Overall Study||0||
48718395|NCT02226549|102095397|FG000|STARTED|Overall Study||23||
48718396|NCT02226549|102095398|FG001|STARTED|Overall Study||24||
48718397|NCT02226549|102095397|FG000|COMPLETED|Overall Study||22||
48718398|NCT02226549|102095398|FG001|COMPLETED|Overall Study||23||
48718399|NCT02226549|102095397|FG000|NOT COMPLETED|Overall Study||1||
48718400|NCT02226549|102095398|FG001|NOT COMPLETED|Overall Study||1||
48718401|NCT00624780|102095399|FG000|STARTED|Treatment Optimization (Up to Week 12)||154||
48718402|NCT00624780|102095400|FG001|STARTED|Treatment Optimization (Up to Week 12)||52||
48718403|NCT00624780|102095401|FG002|STARTED|Treatment Optimization (Up to Week 12)||154||
48718404|NCT00624780|102095402|FG003|STARTED|Treatment Optimization (Up to Week 12)||52||
48718405|NCT00624780|102095403|FG004|STARTED|Treatment Optimization (Up to Week 12)||153||
48718406|NCT00624780|102095404|FG005|STARTED|Treatment Optimization (Up to Week 12)||50||
48718407|NCT00624780|102095399|FG000|COMPLETED|Treatment Optimization (Up to Week 12)||121||
48718408|NCT00624780|102095400|FG001|COMPLETED|Treatment Optimization (Up to Week 12)||39||
48767590|NCT04393454|102222775|FG000|COMPLETED|Overall Study||4||
48304978|NCT05794763|101074788|FG000|STARTED|Overall Study||33||
48304979|NCT05794763|101074789|FG001|STARTED|Overall Study||36||
48304980|NCT05794763|101074788|FG000|COMPLETED|Overall Study||33||
48718409|NCT00624780|102095401|FG002|COMPLETED|Treatment Optimization (Up to Week 12)||112||
48718410|NCT00624780|102095402|FG003|COMPLETED|Treatment Optimization (Up to Week 12)||38||
48718411|NCT00624780|102095403|FG004|COMPLETED|Treatment Optimization (Up to Week 12)||114||
48718412|NCT00624780|102095404|FG005|COMPLETED|Treatment Optimization (Up to Week 12)||39||
48304981|NCT05794763|101074789|FG001|COMPLETED|Overall Study||36||
48304982|NCT05794763|101074788|FG000|NOT COMPLETED|Overall Study||0||
48304983|NCT05794763|101074789|FG001|NOT COMPLETED|Overall Study||0||
48304984|NCT05891353|101074790|FG000|STARTED|Overall Study||30||
48304985|NCT05891353|101074790|FG000|Completed Cold Water Immersion|Overall Study||30||
48304986|NCT05891353|101074790|FG000|Completed Pain Inducing Stretch|Overall Study||29||
48304987|NCT05891353|101074790|FG000|Completed Pain Free Stretch|Overall Study||30||
48304988|NCT05891353|101074790|FG000|COMPLETED|Overall Study||29||
48718413|NCT00624780|102095399|FG000|NOT COMPLETED|Treatment Optimization (Up to Week 12)||33||
48718414|NCT00624780|102095400|FG001|NOT COMPLETED|Treatment Optimization (Up to Week 12)||13||
48718415|NCT00624780|102095401|FG002|NOT COMPLETED|Treatment Optimization (Up to Week 12)||42||
48718416|NCT00624780|102095402|FG003|NOT COMPLETED|Treatment Optimization (Up to Week 12)||14||
48718417|NCT00624780|102095403|FG004|NOT COMPLETED|Treatment Optimization (Up to Week 12)||39||
48718418|NCT00624780|102095404|FG005|NOT COMPLETED|Treatment Optimization (Up to Week 12)||11||
48718419|NCT00624780|102095399|FG000|STARTED|Fixed Dosing (Week 13 to Week 24)||121||
48718420|NCT00624780|102095400|FG001|STARTED|Fixed Dosing (Week 13 to Week 24)||39||
48718421|NCT00624780|102095401|FG002|STARTED|Fixed Dosing (Week 13 to Week 24)||112||
48718422|NCT00624780|102095402|FG003|STARTED|Fixed Dosing (Week 13 to Week 24)||38||
48718423|NCT00624780|102095403|FG004|STARTED|Fixed Dosing (Week 13 to Week 24)||114||
48718424|NCT00624780|102095404|FG005|STARTED|Fixed Dosing (Week 13 to Week 24)||39||
48718425|NCT00624780|102095399|FG000|COMPLETED|Fixed Dosing (Week 13 to Week 24)||106||
48718426|NCT00624780|102095400|FG001|COMPLETED|Fixed Dosing (Week 13 to Week 24)||28||
48718427|NCT00624780|102095401|FG002|COMPLETED|Fixed Dosing (Week 13 to Week 24)||94||
48718428|NCT00624780|102095402|FG003|COMPLETED|Fixed Dosing (Week 13 to Week 24)||27||
48718429|NCT00624780|102095403|FG004|COMPLETED|Fixed Dosing (Week 13 to Week 24)||95||
48718430|NCT00624780|102095404|FG005|COMPLETED|Fixed Dosing (Week 13 to Week 24)||30||
48718431|NCT00624780|102095399|FG000|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||15||
48718432|NCT00624780|102095400|FG001|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11||
48718433|NCT00624780|102095401|FG002|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||18||
48718434|NCT00624780|102095402|FG003|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11||
48718435|NCT00624780|102095403|FG004|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||19||
48718436|NCT00624780|102095404|FG005|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||9||
48718437|NCT00624780|102095399|FG000|STARTED|Treatment Discontinuation (Week 25)||106||
48718438|NCT00624780|102095400|FG001|STARTED|Treatment Discontinuation (Week 25)||28||
48304989|NCT05891353|101074790|FG000|NOT COMPLETED|Overall Study||1||
48304990|NCT00823303|101074791|FG000|STARTED|Overall Study||54||
48304991|NCT00823303|101074792|FG001|STARTED|Overall Study||56||
48304992|NCT00823303|101074791|FG000|COMPLETED|Overall Study||45||
48304993|NCT00823303|101074792|FG001|COMPLETED|Overall Study||45||
48304994|NCT00823303|101074791|FG000|NOT COMPLETED|Overall Study||9||
48718439|NCT00624780|102095401|FG002|STARTED|Treatment Discontinuation (Week 25)||94||
48718440|NCT00624780|102095402|FG003|STARTED|Treatment Discontinuation (Week 25)||27||
48718441|NCT00624780|102095403|FG004|STARTED|Treatment Discontinuation (Week 25)||95||
48718442|NCT00624780|102095404|FG005|STARTED|Treatment Discontinuation (Week 25)||30||
48718443|NCT00624780|102095399|FG000|COMPLETED|Treatment Discontinuation (Week 25)||104||
48718444|NCT00624780|102095400|FG001|COMPLETED|Treatment Discontinuation (Week 25)||28||
48718445|NCT00624780|102095401|FG002|COMPLETED|Treatment Discontinuation (Week 25)||91||
48718446|NCT00624780|102095402|FG003|COMPLETED|Treatment Discontinuation (Week 25)||26||
48718447|NCT00624780|102095403|FG004|COMPLETED|Treatment Discontinuation (Week 25)||95||
48718448|NCT00624780|102095404|FG005|COMPLETED|Treatment Discontinuation (Week 25)||29||
48718449|NCT00624780|102095399|FG000|NOT COMPLETED|Treatment Discontinuation (Week 25)||2||
48718450|NCT00624780|102095400|FG001|NOT COMPLETED|Treatment Discontinuation (Week 25)||0||
48718451|NCT00624780|102095401|FG002|NOT COMPLETED|Treatment Discontinuation (Week 25)||3||
48718452|NCT00624780|102095402|FG003|NOT COMPLETED|Treatment Discontinuation (Week 25)||1||
48304995|NCT00823303|101074792|FG001|NOT COMPLETED|Overall Study||11||
48304996|NCT04136184|101074793|FG000|STARTED|Overall Study||24||
48304997|NCT04136184|101074794|FG001|STARTED|Overall Study||144||
48304998|NCT04136184|101074793|FG000|COMPLETED|Overall Study||1||
48304999|NCT04136184|101074794|FG001|COMPLETED|Overall Study||22||
48305000|NCT04136184|101074793|FG000|NOT COMPLETED|Overall Study||23||
48305001|NCT04136184|101074794|FG001|NOT COMPLETED|Overall Study||122||
48305002|NCT01252810|101074795|FG000|STARTED|Overall Study||142||
48305003|NCT01252810|101074796|FG001|STARTED|Overall Study||142||
48305004|NCT01252810|101074795|FG000|COMPLETED|Overall Study||128||
48305005|NCT01252810|101074796|FG001|COMPLETED|Overall Study||139||
48305006|NCT01252810|101074795|FG000|NOT COMPLETED|Overall Study||14||
48305007|NCT01252810|101074796|FG001|NOT COMPLETED|Overall Study||3||
48305008|NCT05671653|101074797|FG000|STARTED|Cohort 1 Period 1 - Treatment||16||
48305009|NCT05671653|101074798|FG001|STARTED|Cohort 1 Period 1 - Treatment||0||
48305010|NCT05671653|101074799|FG002|STARTED|Cohort 1 Period 1 - Treatment||0||
48305011|NCT05671653|101074800|FG003|STARTED|Cohort 1 Period 1 - Treatment||0||
48718453|NCT00624780|102095403|FG004|NOT COMPLETED|Treatment Discontinuation (Week 25)||0||
48718454|NCT00624780|102095404|FG005|NOT COMPLETED|Treatment Discontinuation (Week 25)||1||
48718455|NCT00624780|102095399|FG000|STARTED|Follow-up (Week 26)||104||
48718456|NCT00624780|102095400|FG001|STARTED|Follow-up (Week 26)||28||
48718457|NCT00624780|102095401|FG002|STARTED|Follow-up (Week 26)||91||
48718458|NCT00624780|102095402|FG003|STARTED|Follow-up (Week 26)||26||
48718459|NCT00624780|102095403|FG004|STARTED|Follow-up (Week 26)||95||
48718460|NCT00624780|102095404|FG005|STARTED|Follow-up (Week 26)||29||
48718461|NCT00624780|102095399|FG000|COMPLETED|Follow-up (Week 26)||102||
48718462|NCT00624780|102095400|FG001|COMPLETED|Follow-up (Week 26)||27||
48718463|NCT00624780|102095401|FG002|COMPLETED|Follow-up (Week 26)||89||
48718464|NCT00624780|102095402|FG003|COMPLETED|Follow-up (Week 26)||26||
48150252|NCT01951638|100692201|FG004|STARTED|Follow-up Period||94||
48150253|NCT01951638|100692197|FG000|COMPLETED|Follow-up Period||87||
48150254|NCT01951638|100692198|FG001|COMPLETED|Follow-up Period||86||
48150255|NCT01951638|100692199|FG002|COMPLETED|Follow-up Period||90||
48150256|NCT01951638|100692200|FG003|COMPLETED|Follow-up Period||80||
48150257|NCT01951638|100692201|FG004|COMPLETED|Follow-up Period||89||
48150258|NCT01951638|100692197|FG000|NOT COMPLETED|Follow-up Period||2||
48150259|NCT01951638|100692198|FG001|NOT COMPLETED|Follow-up Period||9||
48150260|NCT01951638|100692199|FG002|NOT COMPLETED|Follow-up Period||5||
48150261|NCT01951638|100692200|FG003|NOT COMPLETED|Follow-up Period||8||
48150262|NCT01951638|100692201|FG004|NOT COMPLETED|Follow-up Period||5||
48150263|NCT03315143|100692202|FG000|STARTED|Overall Study||5292||
48150264|NCT03315143|100692203|FG001|STARTED|Overall Study||5292||
48150265|NCT03315143|100692202|FG000|Randomized and Treated|Overall Study||5291||
48150266|NCT03315143|100692203|FG001|Randomized and Treated|Overall Study||5286||
48150267|NCT03315143|100692202|FG000|COMPLETED|Overall Study||0||
48150268|NCT03315143|100692203|FG001|COMPLETED|Overall Study||0||
48150269|NCT03315143|100692202|FG000|NOT COMPLETED|Overall Study||5292||
48150270|NCT03315143|100692203|FG001|NOT COMPLETED|Overall Study||5292||
48150271|NCT01921296|100692204|FG000|STARTED|Overall Study||2||
48150272|NCT01921296|100692204|FG000|COMPLETED|Overall Study||2||
48150273|NCT01921296|100692204|FG000|NOT COMPLETED|Overall Study||0||
48150274|NCT00774579|100692205|FG000|STARTED|Overall Study||9||
48150275|NCT00774579|100692206|FG001|STARTED|Overall Study||9||
48150276|NCT00774579|100692205|FG000|COMPLETED|Overall Study||9||
48150277|NCT00774579|100692206|FG001|COMPLETED|Overall Study||9||
48150278|NCT00774579|100692205|FG000|NOT COMPLETED|Overall Study||0||
48150279|NCT00774579|100692206|FG001|NOT COMPLETED|Overall Study||0||
48718465|NCT00624780|102095403|FG004|COMPLETED|Follow-up (Week 26)||93||
48718466|NCT00624780|102095404|FG005|COMPLETED|Follow-up (Week 26)||29||
48718467|NCT00624780|102095399|FG000|NOT COMPLETED|Follow-up (Week 26)||2||
48718468|NCT00624780|102095400|FG001|NOT COMPLETED|Follow-up (Week 26)||1||
48718469|NCT00624780|102095401|FG002|NOT COMPLETED|Follow-up (Week 26)||2||
48718470|NCT00624780|102095402|FG003|NOT COMPLETED|Follow-up (Week 26)||0||
48718471|NCT00624780|102095403|FG004|NOT COMPLETED|Follow-up (Week 26)||2||
48718472|NCT00624780|102095404|FG005|NOT COMPLETED|Follow-up (Week 26)||0||
48718473|NCT05136898|102095405|FG000|STARTED|Overall Study||8||
48718474|NCT05136898|102095405|FG000|COMPLETED|Overall Study||6||
48718475|NCT05136898|102095405|FG000|NOT COMPLETED|Overall Study||2||
48718476|NCT02080260|102095406|FG000|STARTED|Overall Study||20||
48718477|NCT02080260|102095406|FG000|COMPLETED|Overall Study||1||
48718478|NCT02080260|102095406|FG000|NOT COMPLETED|Overall Study||19||
48718479|NCT02138240|102095407|FG000|STARTED|Overall Study||34||
48150280|NCT01936857|100692207|FG000|STARTED|Overall Study||141||
48150281|NCT01936857|100692208|FG001|STARTED|Overall Study||140||
48150282|NCT01936857|100692207|FG000|COMPLETED|Overall Study||107||
48150283|NCT01936857|100692208|FG001|COMPLETED|Overall Study||115||
48305012|NCT05671653|101074801|FG004|STARTED|Cohort 1 Period 1 - Treatment||0||
48150284|NCT01936857|100692207|FG000|NOT COMPLETED|Overall Study||34||
48150285|NCT01936857|100692208|FG001|NOT COMPLETED|Overall Study||25||
48150286|NCT01944631|100692209|FG000|STARTED|Overall Study||100||
48150287|NCT01944631|100692210|FG001|STARTED|Overall Study||100||
48718480|NCT02138240|102095407|FG000|COMPLETED|Overall Study||34||
48718481|NCT02138240|102095407|FG000|NOT COMPLETED|Overall Study||0||
48718482|NCT01561963|102099112|FG000|STARTED|Overall Study||21||
48150288|NCT01944631|100692209|FG000|COMPLETED|Overall Study||96||
48718483|NCT01561963|102099112|FG000|Received Period 1 Treatment|Overall Study||21||
48718484|NCT01561963|102099112|FG000|Received Period 2 Treatment|Overall Study||20||
48718485|NCT01561963|102099112|FG000|Received Period 3 Treatment|Overall Study||20||
48718486|NCT01561963|102099112|FG000|COMPLETED|Overall Study||20||
48718487|NCT01561963|102099112|FG000|NOT COMPLETED|Overall Study||1||
48718488|NCT03131596|102099113|FG000|STARTED|Overall Study||100||
48718489|NCT03131596|102099114|FG001|STARTED|Overall Study||100||
48718490|NCT03131596|102099113|FG000|COMPLETED|Overall Study||94||
48718491|NCT03131596|102099114|FG001|COMPLETED|Overall Study||97||
48718492|NCT03131596|102099113|FG000|NOT COMPLETED|Overall Study||6||
48718493|NCT03131596|102099114|FG001|NOT COMPLETED|Overall Study||3||
48718494|NCT03559699|102099115|FG000|STARTED|Overall Study||27||
48718495|NCT03559699|102099115|FG000|COMPLETED|Overall Study||20||
48718496|NCT03559699|102099115|FG000|NOT COMPLETED|Overall Study||7||
48718497|NCT00180297|102099116|FG000|STARTED|Overall Study||107||
48718498|NCT00180297|102099117|FG001|STARTED|Overall Study||108||
48718499|NCT00180297|102099116|FG000|COMPLETED|Overall Study||61|Until 5 years follow-up|
48718500|NCT00180297|102099117|FG001|COMPLETED|Overall Study||67|Until 5 years follow-up|
48718501|NCT00180297|102099116|FG000|NOT COMPLETED|Overall Study||46||
48718502|NCT00180297|102099117|FG001|NOT COMPLETED|Overall Study||41||
48718503|NCT02117349|102099118|FG000|STARTED|Overall Study||37||
48718504|NCT02117349|102099119|FG001|STARTED|Overall Study||18||
48718505|NCT02117349|102099118|FG000|Intent-to-treat Population|Overall Study||37|All randomized participants (group based on random assignment)|
48718506|NCT02117349|102099119|FG001|Intent-to-treat Population|Overall Study||18|All randomized participants (group based on random assignment)|
48718507|NCT02117349|102099118|FG000|Safety Population|Overall Study||36|Randomized participants exposed to study drug (group based on actual treatment received)|
48718508|NCT02117349|102099119|FG001|Safety Population|Overall Study||18|Randomized participants exposed to study drug (group based on actual treatment received)|
48718509|NCT02117349|102099118|FG000|Modified Intent-to-treat (mITT)|Overall Study||36|Randomized participants who received assigned study treatment and had no major protocol violations|
48718510|NCT02117349|102099119|FG001|Modified Intent-to-treat (mITT)|Overall Study||18|Randomized participants who received assigned study treatment and had no major protocol violations|
48718511|NCT02117349|102099118|FG000|COMPLETED|Overall Study||34||
48718512|NCT02117349|102099119|FG001|COMPLETED|Overall Study||17||
48718513|NCT02117349|102099118|FG000|NOT COMPLETED|Overall Study||3||
48718514|NCT02117349|102099119|FG001|NOT COMPLETED|Overall Study||1||
48718515|NCT02981524|102099120|FG000|STARTED|Overall Study||17||
48718516|NCT02981524|102099120|FG000|COMPLETED|Overall Study||0||
48718517|NCT02981524|102099120|FG000|NOT COMPLETED|Overall Study||17||
48150289|NCT01944631|100692210|FG001|COMPLETED|Overall Study||98||
48150290|NCT01944631|100692209|FG000|NOT COMPLETED|Overall Study||4||
48150291|NCT01944631|100692210|FG001|NOT COMPLETED|Overall Study||2||
48150292|NCT03494166|100692211|FG000|STARTED|Overall Study||71||
48718518|NCT05545644|102099121|FG000|STARTED|Overall Study||18||
48718519|NCT05545644|102099122|FG001|STARTED|Overall Study||17||
48718520|NCT05545644|102099121|FG000|COMPLETED|Overall Study||14||
48718521|NCT05545644|102099122|FG001|COMPLETED|Overall Study||14||
48718522|NCT05545644|102099121|FG000|NOT COMPLETED|Overall Study||4||
48718523|NCT05545644|102099122|FG001|NOT COMPLETED|Overall Study||3||
48718524|NCT04063787|102099123|FG000|STARTED|Overall Study||46||
48718525|NCT04063787|102099123|FG000|COMPLETED|Overall Study||37||
48150293|NCT03494166|100692212|FG001|STARTED|Overall Study||204||
48150294|NCT03494166|100692213|FG002|STARTED|Overall Study||30||
48150295|NCT03494166|100692214|FG003|STARTED|Overall Study||31||
48150296|NCT03494166|100692215|FG004|STARTED|Overall Study||93||
48150297|NCT03494166|100692216|FG005|STARTED|Overall Study||17||
48150298|NCT03494166|100692211|FG000|COMPLETED|Overall Study||58||
48150299|NCT03494166|100692212|FG001|COMPLETED|Overall Study||195||
48150300|NCT03494166|100692213|FG002|COMPLETED|Overall Study||28||
48150301|NCT03494166|100692214|FG003|COMPLETED|Overall Study||23||
48150302|NCT03494166|100692215|FG004|COMPLETED|Overall Study||72||
48150303|NCT03494166|100692216|FG005|COMPLETED|Overall Study||0||
48150304|NCT03494166|100692211|FG000|NOT COMPLETED|Overall Study||13||
48150305|NCT03494166|100692212|FG001|NOT COMPLETED|Overall Study||9||
48150306|NCT03494166|100692213|FG002|NOT COMPLETED|Overall Study||2||
48150307|NCT03494166|100692214|FG003|NOT COMPLETED|Overall Study||8||
48150308|NCT03494166|100692215|FG004|NOT COMPLETED|Overall Study||21||
48150309|NCT03494166|100692216|FG005|NOT COMPLETED|Overall Study||17||
48150310|NCT02047500|100692217|FG000|STARTED|Overall Study||19||
48150311|NCT02047500|100692217|FG000|COMPLETED|Overall Study||0||
48150312|NCT02047500|100692217|FG000|NOT COMPLETED|Overall Study||19||
48150313|NCT00754338|100692218|FG000|STARTED|First Intervention for Phase1&Phase2||17||
48150314|NCT00754338|100692219|FG001|STARTED|First Intervention for Phase1&Phase2||21||
48305013|NCT05671653|101074802|FG005|STARTED|Cohort 1 Period 1 - Treatment||0||
48607129|NCT00287729|101823448|FG001|COMPLETED|Overall Study||142||
48150315|NCT00754338|100692220|FG002|STARTED|First Intervention for Phase1&Phase2||19||
48150316|NCT00754338|100692221|FG003|STARTED|First Intervention for Phase1&Phase2||19||
48150317|NCT00754338|100692218|FG000|COMPLETED|First Intervention for Phase1&Phase2||17||
48150318|NCT00754338|100692219|FG001|COMPLETED|First Intervention for Phase1&Phase2||18||
48150319|NCT00754338|100692220|FG002|COMPLETED|First Intervention for Phase1&Phase2||16||
48150320|NCT00754338|100692221|FG003|COMPLETED|First Intervention for Phase1&Phase2||19||
48150321|NCT00754338|100692218|FG000|NOT COMPLETED|First Intervention for Phase1&Phase2||0||
48150322|NCT00754338|100692219|FG001|NOT COMPLETED|First Intervention for Phase1&Phase2||3||
48150323|NCT00754338|100692220|FG002|NOT COMPLETED|First Intervention for Phase1&Phase2||3||
48150324|NCT00754338|100692221|FG003|NOT COMPLETED|First Intervention for Phase1&Phase2||0||
48150325|NCT00754338|100692218|FG000|STARTED|Second Intervention for Phase1&Phase2||17||
48150326|NCT00754338|100692219|FG001|STARTED|Second Intervention for Phase1&Phase2||18||
48150327|NCT00754338|100692220|FG002|STARTED|Second Intervention for Phase1&Phase2||16||
48150328|NCT00754338|100692221|FG003|STARTED|Second Intervention for Phase1&Phase2||19||
48150329|NCT00754338|100692218|FG000|COMPLETED|Second Intervention for Phase1&Phase2||17||
48607130|NCT00287729|101823447|FG000|NOT COMPLETED|Overall Study||34||
48607131|NCT00287729|101823448|FG001|NOT COMPLETED|Overall Study||31||
48607132|NCT01396551|101823449|FG000|STARTED|Overall Study||69||
48607133|NCT01396551|101823449|FG000|COMPLETED|Overall Study||69||
48607134|NCT01396551|101823449|FG000|NOT COMPLETED|Overall Study||0||
48607135|NCT03307837|101823450|FG000|STARTED|Overall Study||6||
48607136|NCT03307837|101823451|FG001|STARTED|Overall Study||6||
48607137|NCT03307837|101823452|FG002|STARTED|Overall Study||6||
48607138|NCT03307837|101823453|FG003|STARTED|Overall Study||6||
48607139|NCT03307837|101823454|FG004|STARTED|Overall Study||6||
48607140|NCT03307837|101823455|FG005|STARTED|Overall Study||10||
48607141|NCT03307837|101823450|FG000|COMPLETED|Overall Study||5||
48607142|NCT03307837|101823451|FG001|COMPLETED|Overall Study||5||
48607143|NCT03307837|101823452|FG002|COMPLETED|Overall Study||5||
48607144|NCT03307837|101823453|FG003|COMPLETED|Overall Study||6||
48607145|NCT03307837|101823454|FG004|COMPLETED|Overall Study||6||
48607146|NCT03307837|101823455|FG005|COMPLETED|Overall Study||8||
48607147|NCT03307837|101823450|FG000|NOT COMPLETED|Overall Study||1||
48150330|NCT00754338|100692219|FG001|COMPLETED|Second Intervention for Phase1&Phase2||17||
48150331|NCT00754338|100692220|FG002|COMPLETED|Second Intervention for Phase1&Phase2||16||
48150332|NCT00754338|100692221|FG003|COMPLETED|Second Intervention for Phase1&Phase2||18||
48150333|NCT00754338|100692218|FG000|NOT COMPLETED|Second Intervention for Phase1&Phase2||0||
48305014|NCT05671653|101074803|FG006|STARTED|Cohort 1 Period 1 - Treatment||0||
48305015|NCT05671653|101074804|FG007|STARTED|Cohort 1 Period 1 - Treatment||0||
48305016|NCT05671653|101074805|FG008|STARTED|Cohort 1 Period 1 - Treatment||0||
48305017|NCT05671653|101074806|FG009|STARTED|Cohort 1 Period 1 - Treatment||0||
48305018|NCT05671653|101074807|FG010|STARTED|Cohort 1 Period 1 - Treatment||0||
48305019|NCT05671653|101074808|FG011|STARTED|Cohort 1 Period 1 - Treatment||0||
48607148|NCT03307837|101823451|FG001|NOT COMPLETED|Overall Study||1||
48607149|NCT03307837|101823452|FG002|NOT COMPLETED|Overall Study||1||
48607150|NCT03307837|101823453|FG003|NOT COMPLETED|Overall Study||0||
48607151|NCT03307837|101823454|FG004|NOT COMPLETED|Overall Study||0||
48607152|NCT03307837|101823455|FG005|NOT COMPLETED|Overall Study||2||
48607153|NCT00572455|101823456|FG000|STARTED|Stage I (14 Days)||9||
48188706|NCT02034435|100783315|FG003|Aim 2|Overall Study||9||
48305020|NCT05671653|101074809|FG012|STARTED|Cohort 1 Period 1 - Treatment||0||
48305021|NCT05671653|101074797|FG000|COMPLETED|Cohort 1 Period 1 - Treatment||16||
48607154|NCT00572455|101823457|FG001|STARTED|Stage I (14 Days)||9||
48607155|NCT00572455|101823458|FG002|STARTED|Stage I (14 Days)||9||
48607156|NCT00572455|101823459|FG003|STARTED|Stage I (14 Days)||10||
48607157|NCT00572455|101823460|FG004|STARTED|Stage I (14 Days)||9||
48150334|NCT00754338|100692219|FG001|NOT COMPLETED|Second Intervention for Phase1&Phase2||1||
48150335|NCT00754338|100692220|FG002|NOT COMPLETED|Second Intervention for Phase1&Phase2||0||
48150336|NCT00754338|100692221|FG003|NOT COMPLETED|Second Intervention for Phase1&Phase2||1||
48150337|NCT00441701|100692222|FG000|STARTED|Overall Study||22||
48150338|NCT00441701|100692223|FG001|STARTED|Overall Study||11||
48305022|NCT05671653|101074798|FG001|COMPLETED|Cohort 1 Period 1 - Treatment||0||
48305023|NCT05671653|101074799|FG002|COMPLETED|Cohort 1 Period 1 - Treatment||0||
48305024|NCT05671653|101074800|FG003|COMPLETED|Cohort 1 Period 1 - Treatment||0||
48150339|NCT00441701|100692224|FG002|STARTED|Overall Study||22||
48150340|NCT00441701|100692225|FG003|STARTED|Overall Study||11||
48150341|NCT00441701|100692226|FG004|STARTED|Overall Study||22||
48150342|NCT00441701|100692227|FG005|STARTED|Overall Study||11||
48150343|NCT00441701|100692228|FG006|STARTED|Overall Study||0||
48150344|NCT00441701|100692229|FG007|STARTED|Overall Study||0||
48305025|NCT05671653|101074801|FG004|COMPLETED|Cohort 1 Period 1 - Treatment||0||
48305026|NCT05671653|101074802|FG005|COMPLETED|Cohort 1 Period 1 - Treatment||0||
48305027|NCT05671653|101074803|FG006|COMPLETED|Cohort 1 Period 1 - Treatment||0||
48305028|NCT05671653|101074804|FG007|COMPLETED|Cohort 1 Period 1 - Treatment||0||
48406109|NCT01611311|101328352|FG005|STARTED|Overall Study||9||
48607158|NCT00572455|101823461|FG005|STARTED|Stage I (14 Days)||9||
48607159|NCT00572455|101823462|FG006|STARTED|Stage I (14 Days)||12||
48607160|NCT00572455|101823463|FG007|STARTED|Stage I (14 Days)||0||
48607161|NCT00572455|101823464|FG008|STARTED|Stage I (14 Days)||0||
48607162|NCT00572455|101823465|FG009|STARTED|Stage I (14 Days)||0||
48607163|NCT00572455|101823466|FG010|STARTED|Stage I (14 Days)||0||
48607164|NCT00572455|101823467|FG011|STARTED|Stage I (14 Days)||0||
48607165|NCT00572455|101823468|FG012|STARTED|Stage I (14 Days)||0||
48607166|NCT00572455|101823469|FG013|STARTED|Stage I (14 Days)||0||
48607167|NCT00572455|101823456|FG000|COMPLETED|Stage I (14 Days)||9||
48607168|NCT00572455|101823457|FG001|COMPLETED|Stage I (14 Days)||9||
48607169|NCT00572455|101823458|FG002|COMPLETED|Stage I (14 Days)||9||
48607170|NCT00572455|101823459|FG003|COMPLETED|Stage I (14 Days)||10||
48607171|NCT00572455|101823460|FG004|COMPLETED|Stage I (14 Days)||8||
48607172|NCT00572455|101823461|FG005|COMPLETED|Stage I (14 Days)||6||
48607173|NCT00572455|101823462|FG006|COMPLETED|Stage I (14 Days)||12||
48607174|NCT00572455|101823463|FG007|COMPLETED|Stage I (14 Days)||0||
48607175|NCT00572455|101823464|FG008|COMPLETED|Stage I (14 Days)||0||
48607176|NCT00572455|101823465|FG009|COMPLETED|Stage I (14 Days)||0||
48607177|NCT00572455|101823466|FG010|COMPLETED|Stage I (14 Days)||0||
48607178|NCT00572455|101823467|FG011|COMPLETED|Stage I (14 Days)||0||
48607179|NCT00572455|101823468|FG012|COMPLETED|Stage I (14 Days)||0||
48607180|NCT00572455|101823469|FG013|COMPLETED|Stage I (14 Days)||0||
48607181|NCT00572455|101823456|FG000|NOT COMPLETED|Stage I (14 Days)||0||
48607182|NCT00572455|101823457|FG001|NOT COMPLETED|Stage I (14 Days)||0||
48607183|NCT00572455|101823458|FG002|NOT COMPLETED|Stage I (14 Days)||0||
48607184|NCT00572455|101823459|FG003|NOT COMPLETED|Stage I (14 Days)||0||
48607185|NCT00572455|101823460|FG004|NOT COMPLETED|Stage I (14 Days)||1||
48607186|NCT00572455|101823461|FG005|NOT COMPLETED|Stage I (14 Days)||3||
48607187|NCT00572455|101823462|FG006|NOT COMPLETED|Stage I (14 Days)||0||
48607188|NCT00572455|101823463|FG007|NOT COMPLETED|Stage I (14 Days)||0||
48607189|NCT00572455|101823464|FG008|NOT COMPLETED|Stage I (14 Days)||0||
48607190|NCT00572455|101823465|FG009|NOT COMPLETED|Stage I (14 Days)||0||
48607191|NCT00572455|101823466|FG010|NOT COMPLETED|Stage I (14 Days)||0||
48150345|NCT00441701|100692230|FG008|STARTED|Overall Study||0||
48150346|NCT00441701|100692231|FG009|STARTED|Overall Study||0||
48150347|NCT00441701|100692222|FG000|COMPLETED|Overall Study||17||
48150348|NCT00441701|100692223|FG001|COMPLETED|Overall Study||7||
48150349|NCT00441701|100692224|FG002|COMPLETED|Overall Study||18||
48150350|NCT00441701|100692225|FG003|COMPLETED|Overall Study||8||
48150351|NCT00441701|100692226|FG004|COMPLETED|Overall Study||20||
48150352|NCT00441701|100692227|FG005|COMPLETED|Overall Study||8||
48150353|NCT00441701|100692228|FG006|COMPLETED|Overall Study||0||
48150354|NCT00441701|100692229|FG007|COMPLETED|Overall Study||0||
48607192|NCT00572455|101823467|FG011|NOT COMPLETED|Stage I (14 Days)||0||
48607193|NCT00572455|101823468|FG012|NOT COMPLETED|Stage I (14 Days)||0||
48607194|NCT00572455|101823469|FG013|NOT COMPLETED|Stage I (14 Days)||0||
48607195|NCT00572455|101823456|FG000|STARTED|Stage II (28 Days)||0||
48607196|NCT00572455|101823457|FG001|STARTED|Stage II (28 Days)||0||
48607197|NCT00572455|101823458|FG002|STARTED|Stage II (28 Days)||0||
48607198|NCT00572455|101823459|FG003|STARTED|Stage II (28 Days)||0||
48607199|NCT00572455|101823460|FG004|STARTED|Stage II (28 Days)||0||
48607200|NCT00572455|101823461|FG005|STARTED|Stage II (28 Days)||0||
48607201|NCT00572455|101823462|FG006|STARTED|Stage II (28 Days)||0||
48607202|NCT00572455|101823463|FG007|STARTED|Stage II (28 Days)||35||
48718526|NCT04063787|102099123|FG000|NOT COMPLETED|Overall Study||9||
48718527|NCT02683668|102099124|FG000|STARTED|Period 1||44||
48718528|NCT02683668|102099125|FG001|STARTED|Period 1||0||
48718529|NCT02683668|102099126|FG002|STARTED|Period 1||0||
48718530|NCT02683668|102099124|FG000|COMPLETED|Period 1||44||
48718531|NCT02683668|102099125|FG001|COMPLETED|Period 1||0||
48718532|NCT02683668|102099126|FG002|COMPLETED|Period 1||0||
48718533|NCT02683668|102099124|FG000|NOT COMPLETED|Period 1||0||
48718534|NCT02683668|102099125|FG001|NOT COMPLETED|Period 1||0||
48305029|NCT05671653|101074805|FG008|COMPLETED|Cohort 1 Period 1 - Treatment||0||
48305030|NCT05671653|101074806|FG009|COMPLETED|Cohort 1 Period 1 - Treatment||0||
48305031|NCT05671653|101074807|FG010|COMPLETED|Cohort 1 Period 1 - Treatment||0||
48718535|NCT02683668|102099126|FG002|NOT COMPLETED|Period 1||0||
48718536|NCT02683668|102099124|FG000|STARTED|Period 2||0||
48718537|NCT02683668|102099125|FG001|STARTED|Period 2||44||
48718538|NCT02683668|102099126|FG002|STARTED|Period 2||0||
48718539|NCT02683668|102099124|FG000|COMPLETED|Period 2||0||
48718540|NCT02683668|102099125|FG001|COMPLETED|Period 2||43||
48718541|NCT02683668|102099126|FG002|COMPLETED|Period 2||0||
48718542|NCT02683668|102099124|FG000|NOT COMPLETED|Period 2||0||
48718543|NCT02683668|102099125|FG001|NOT COMPLETED|Period 2||1||
48718544|NCT02683668|102099126|FG002|NOT COMPLETED|Period 2||0||
48718545|NCT02683668|102099124|FG000|STARTED|Period 3||0||
48718546|NCT02683668|102099125|FG001|STARTED|Period 3||0||
48718547|NCT02683668|102099126|FG002|STARTED|Period 3||43||
48718548|NCT02683668|102099124|FG000|COMPLETED|Period 3||0||
48150355|NCT00441701|100692230|FG008|COMPLETED|Overall Study||0||
48150356|NCT00441701|100692231|FG009|COMPLETED|Overall Study||0||
48150357|NCT00441701|100692222|FG000|NOT COMPLETED|Overall Study||5||
48150358|NCT00441701|100692223|FG001|NOT COMPLETED|Overall Study||4||
48150359|NCT00441701|100692224|FG002|NOT COMPLETED|Overall Study||4||
48150360|NCT00441701|100692225|FG003|NOT COMPLETED|Overall Study||3||
48305032|NCT05671653|101074808|FG011|COMPLETED|Cohort 1 Period 1 - Treatment||0||
48305033|NCT05671653|101074809|FG012|COMPLETED|Cohort 1 Period 1 - Treatment||0||
48305034|NCT05671653|101074797|FG000|NOT COMPLETED|Cohort 1 Period 1 - Treatment||0||
48305035|NCT05671653|101074798|FG001|NOT COMPLETED|Cohort 1 Period 1 - Treatment||0||
48305036|NCT05671653|101074799|FG002|NOT COMPLETED|Cohort 1 Period 1 - Treatment||0||
48305037|NCT05671653|101074800|FG003|NOT COMPLETED|Cohort 1 Period 1 - Treatment||0||
48305038|NCT05671653|101074801|FG004|NOT COMPLETED|Cohort 1 Period 1 - Treatment||0||
48305039|NCT05671653|101074802|FG005|NOT COMPLETED|Cohort 1 Period 1 - Treatment||0||
48305040|NCT05671653|101074803|FG006|NOT COMPLETED|Cohort 1 Period 1 - Treatment||0||
48305041|NCT05671653|101074804|FG007|NOT COMPLETED|Cohort 1 Period 1 - Treatment||0||
48305042|NCT05671653|101074805|FG008|NOT COMPLETED|Cohort 1 Period 1 - Treatment||0||
48305043|NCT05671653|101074806|FG009|NOT COMPLETED|Cohort 1 Period 1 - Treatment||0||
48305044|NCT05671653|101074807|FG010|NOT COMPLETED|Cohort 1 Period 1 - Treatment||0||
48305045|NCT05671653|101074808|FG011|NOT COMPLETED|Cohort 1 Period 1 - Treatment||0||
48305046|NCT05671653|101074809|FG012|NOT COMPLETED|Cohort 1 Period 1 - Treatment||0||
48305047|NCT05671653|101074797|FG000|STARTED|Cohort 1 Period 2 - Treatment||0||
48305048|NCT05671653|101074798|FG001|STARTED|Cohort 1 Period 2 - Treatment||16||
48305049|NCT05671653|101074799|FG002|STARTED|Cohort 1 Period 2 - Treatment||0||
48305050|NCT05671653|101074800|FG003|STARTED|Cohort 1 Period 2 - Treatment||0||
48305051|NCT05671653|101074801|FG004|STARTED|Cohort 1 Period 2 - Treatment||0||
48607203|NCT00572455|101823464|FG008|STARTED|Stage II (28 Days)||36||
48607204|NCT00572455|101823465|FG009|STARTED|Stage II (28 Days)||36||
48607205|NCT00572455|101823466|FG010|STARTED|Stage II (28 Days)||36||
48607206|NCT00572455|101823467|FG011|STARTED|Stage II (28 Days)||36||
48607207|NCT00572455|101823468|FG012|STARTED|Stage II (28 Days)||36||
48607208|NCT00572455|101823469|FG013|STARTED|Stage II (28 Days)||36||
48607209|NCT00572455|101823456|FG000|Treated|Stage II (28 Days)||0||
48150361|NCT00441701|100692226|FG004|NOT COMPLETED|Overall Study||2||
48305052|NCT05671653|101074802|FG005|STARTED|Cohort 1 Period 2 - Treatment||0||
48607210|NCT00572455|101823457|FG001|Treated|Stage II (28 Days)||0||
48607211|NCT00572455|101823458|FG002|Treated|Stage II (28 Days)||0||
48607212|NCT00572455|101823459|FG003|Treated|Stage II (28 Days)||0||
48607213|NCT00572455|101823460|FG004|Treated|Stage II (28 Days)||0||
48718549|NCT02683668|102099125|FG001|COMPLETED|Period 3||0||
48718550|NCT02683668|102099126|FG002|COMPLETED|Period 3||43||
48150362|NCT00441701|100692227|FG005|NOT COMPLETED|Overall Study||3||
48150363|NCT00441701|100692228|FG006|NOT COMPLETED|Overall Study||0||
48305053|NCT05671653|101074803|FG006|STARTED|Cohort 1 Period 2 - Treatment||0||
48607214|NCT00572455|101823461|FG005|Treated|Stage II (28 Days)||0||
48718551|NCT02683668|102099124|FG000|NOT COMPLETED|Period 3||0||
48718552|NCT02683668|102099125|FG001|NOT COMPLETED|Period 3||0||
48718553|NCT02683668|102099126|FG002|NOT COMPLETED|Period 3||0||
48150364|NCT00441701|100692229|FG007|NOT COMPLETED|Overall Study||0||
48305054|NCT05671653|101074804|FG007|STARTED|Cohort 1 Period 2 - Treatment||0||
48305055|NCT05671653|101074805|FG008|STARTED|Cohort 1 Period 2 - Treatment||0||
48305056|NCT05671653|101074806|FG009|STARTED|Cohort 1 Period 2 - Treatment||0||
48305057|NCT05671653|101074807|FG010|STARTED|Cohort 1 Period 2 - Treatment||0||
48305058|NCT05671653|101074808|FG011|STARTED|Cohort 1 Period 2 - Treatment||0||
48305059|NCT05671653|101074809|FG012|STARTED|Cohort 1 Period 2 - Treatment||0||
48305060|NCT05671653|101074797|FG000|COMPLETED|Cohort 1 Period 2 - Treatment||0||
48305061|NCT05671653|101074798|FG001|COMPLETED|Cohort 1 Period 2 - Treatment||16||
48305062|NCT05671653|101074799|FG002|COMPLETED|Cohort 1 Period 2 - Treatment||0||
48305063|NCT05671653|101074800|FG003|COMPLETED|Cohort 1 Period 2 - Treatment||0||
48305064|NCT05671653|101074801|FG004|COMPLETED|Cohort 1 Period 2 - Treatment||0||
48305065|NCT05671653|101074802|FG005|COMPLETED|Cohort 1 Period 2 - Treatment||0||
48305066|NCT05671653|101074803|FG006|COMPLETED|Cohort 1 Period 2 - Treatment||0||
48305067|NCT05671653|101074804|FG007|COMPLETED|Cohort 1 Period 2 - Treatment||0||
48305068|NCT05671653|101074805|FG008|COMPLETED|Cohort 1 Period 2 - Treatment||0||
48305069|NCT05671653|101074806|FG009|COMPLETED|Cohort 1 Period 2 - Treatment||0||
48305070|NCT05671653|101074807|FG010|COMPLETED|Cohort 1 Period 2 - Treatment||0||
48305071|NCT05671653|101074808|FG011|COMPLETED|Cohort 1 Period 2 - Treatment||0||
48305072|NCT05671653|101074809|FG012|COMPLETED|Cohort 1 Period 2 - Treatment||0||
48305073|NCT05671653|101074797|FG000|NOT COMPLETED|Cohort 1 Period 2 - Treatment||0||
48305074|NCT05671653|101074798|FG001|NOT COMPLETED|Cohort 1 Period 2 - Treatment||0||
48305075|NCT05671653|101074799|FG002|NOT COMPLETED|Cohort 1 Period 2 - Treatment||0||
48305076|NCT05671653|101074800|FG003|NOT COMPLETED|Cohort 1 Period 2 - Treatment||0||
48305077|NCT05671653|101074801|FG004|NOT COMPLETED|Cohort 1 Period 2 - Treatment||0||
48305078|NCT05671653|101074802|FG005|NOT COMPLETED|Cohort 1 Period 2 - Treatment||0||
48305079|NCT05671653|101074803|FG006|NOT COMPLETED|Cohort 1 Period 2 - Treatment||0||
48305080|NCT05671653|101074804|FG007|NOT COMPLETED|Cohort 1 Period 2 - Treatment||0||
48305081|NCT05671653|101074805|FG008|NOT COMPLETED|Cohort 1 Period 2 - Treatment||0||
48305082|NCT05671653|101074806|FG009|NOT COMPLETED|Cohort 1 Period 2 - Treatment||0||
48607215|NCT00572455|101823462|FG006|Treated|Stage II (28 Days)||0||
48607216|NCT00572455|101823463|FG007|Treated|Stage II (28 Days)||35||
48607217|NCT00572455|101823464|FG008|Treated|Stage II (28 Days)||36||
48607218|NCT00572455|101823465|FG009|Treated|Stage II (28 Days)||36||
48607219|NCT00572455|101823466|FG010|Treated|Stage II (28 Days)||36||
48607220|NCT00572455|101823467|FG011|Treated|Stage II (28 Days)||36||
48607221|NCT00572455|101823468|FG012|Treated|Stage II (28 Days)||36||
48607222|NCT00572455|101823469|FG013|Treated|Stage II (28 Days)||35||
48607223|NCT00572455|101823456|FG000|COMPLETED|Stage II (28 Days)||0||
48607224|NCT00572455|101823457|FG001|COMPLETED|Stage II (28 Days)||0||
48607225|NCT00572455|101823458|FG002|COMPLETED|Stage II (28 Days)||0||
48607226|NCT00572455|101823459|FG003|COMPLETED|Stage II (28 Days)||0||
48607227|NCT00572455|101823460|FG004|COMPLETED|Stage II (28 Days)||0||
48607228|NCT00572455|101823461|FG005|COMPLETED|Stage II (28 Days)||0||
48607229|NCT00572455|101823462|FG006|COMPLETED|Stage II (28 Days)||0||
48607230|NCT00572455|101823463|FG007|COMPLETED|Stage II (28 Days)||34||
48607231|NCT00572455|101823464|FG008|COMPLETED|Stage II (28 Days)||33||
48305083|NCT05671653|101074807|FG010|NOT COMPLETED|Cohort 1 Period 2 - Treatment||0||
48305084|NCT05671653|101074808|FG011|NOT COMPLETED|Cohort 1 Period 2 - Treatment||0||
48305085|NCT05671653|101074809|FG012|NOT COMPLETED|Cohort 1 Period 2 - Treatment||0||
48305086|NCT05671653|101074797|FG000|STARTED|Cohort 1 Period 3 - Treatment||0||
48305087|NCT05671653|101074798|FG001|STARTED|Cohort 1 Period 3 - Treatment||0||
48305088|NCT05671653|101074799|FG002|STARTED|Cohort 1 Period 3 - Treatment||16||
48305089|NCT05671653|101074800|FG003|STARTED|Cohort 1 Period 3 - Treatment||0||
48305090|NCT05671653|101074801|FG004|STARTED|Cohort 1 Period 3 - Treatment||0||
48305091|NCT05671653|101074802|FG005|STARTED|Cohort 1 Period 3 - Treatment||0||
48607232|NCT00572455|101823465|FG009|COMPLETED|Stage II (28 Days)||33||
48607233|NCT00572455|101823466|FG010|COMPLETED|Stage II (28 Days)||31||
48607234|NCT00572455|101823467|FG011|COMPLETED|Stage II (28 Days)||32||
48607235|NCT00572455|101823468|FG012|COMPLETED|Stage II (28 Days)||31||
48607236|NCT00572455|101823469|FG013|COMPLETED|Stage II (28 Days)||34||
48607237|NCT00572455|101823456|FG000|NOT COMPLETED|Stage II (28 Days)||0||
48607238|NCT00572455|101823457|FG001|NOT COMPLETED|Stage II (28 Days)||0||
48607239|NCT00572455|101823458|FG002|NOT COMPLETED|Stage II (28 Days)||0||
48305092|NCT05671653|101074803|FG006|STARTED|Cohort 1 Period 3 - Treatment||0||
48305093|NCT05671653|101074804|FG007|STARTED|Cohort 1 Period 3 - Treatment||0||
48305094|NCT05671653|101074805|FG008|STARTED|Cohort 1 Period 3 - Treatment||0||
48305095|NCT05671653|101074806|FG009|STARTED|Cohort 1 Period 3 - Treatment||0||
48305096|NCT05671653|101074807|FG010|STARTED|Cohort 1 Period 3 - Treatment||0||
48305097|NCT05671653|101074808|FG011|STARTED|Cohort 1 Period 3 - Treatment||0||
48305098|NCT05671653|101074809|FG012|STARTED|Cohort 1 Period 3 - Treatment||0||
48607240|NCT00572455|101823459|FG003|NOT COMPLETED|Stage II (28 Days)||0||
48607241|NCT00572455|101823460|FG004|NOT COMPLETED|Stage II (28 Days)||0||
48607242|NCT00572455|101823461|FG005|NOT COMPLETED|Stage II (28 Days)||0||
48607243|NCT00572455|101823462|FG006|NOT COMPLETED|Stage II (28 Days)||0||
48607244|NCT00572455|101823463|FG007|NOT COMPLETED|Stage II (28 Days)||1||
48607245|NCT00572455|101823464|FG008|NOT COMPLETED|Stage II (28 Days)||3||
48607246|NCT00572455|101823465|FG009|NOT COMPLETED|Stage II (28 Days)||3||
48607247|NCT00572455|101823466|FG010|NOT COMPLETED|Stage II (28 Days)||5||
48607248|NCT00572455|101823467|FG011|NOT COMPLETED|Stage II (28 Days)||4||
48607249|NCT00572455|101823468|FG012|NOT COMPLETED|Stage II (28 Days)||5||
48607250|NCT00572455|101823469|FG013|NOT COMPLETED|Stage II (28 Days)||2||
48305099|NCT05671653|101074797|FG000|COMPLETED|Cohort 1 Period 3 - Treatment||0||
48305100|NCT05671653|101074798|FG001|COMPLETED|Cohort 1 Period 3 - Treatment||0||
48305101|NCT05671653|101074799|FG002|COMPLETED|Cohort 1 Period 3 - Treatment||16||
48305102|NCT05671653|101074800|FG003|COMPLETED|Cohort 1 Period 3 - Treatment||0||
48718554|NCT00131456|102099127|FG000|STARTED|Overall Study||52||
48718555|NCT00131456|102099128|FG001|STARTED|Overall Study||51||
48718556|NCT00131456|102099127|FG000|COMPLETED|Overall Study||33||
48718557|NCT00131456|102099128|FG001|COMPLETED|Overall Study||31||
48718558|NCT00131456|102099127|FG000|NOT COMPLETED|Overall Study||19||
48718559|NCT00131456|102099128|FG001|NOT COMPLETED|Overall Study||20||
48718560|NCT02715726|102099129|FG000|STARTED|Overall Study||208||
48718561|NCT02715726|102099130|FG001|STARTED|Overall Study||407||
48718562|NCT02715726|102099129|FG000|Treated|Overall Study||207||
48718563|NCT02715726|102099130|FG001|Treated|Overall Study||405||
48305103|NCT05671653|101074801|FG004|COMPLETED|Cohort 1 Period 3 - Treatment||0||
48305104|NCT05671653|101074802|FG005|COMPLETED|Cohort 1 Period 3 - Treatment||0||
48305105|NCT05671653|101074803|FG006|COMPLETED|Cohort 1 Period 3 - Treatment||0||
48305106|NCT05671653|101074804|FG007|COMPLETED|Cohort 1 Period 3 - Treatment||0||
48305107|NCT05671653|101074805|FG008|COMPLETED|Cohort 1 Period 3 - Treatment||0||
48305108|NCT05671653|101074806|FG009|COMPLETED|Cohort 1 Period 3 - Treatment||0||
48305109|NCT05671653|101074807|FG010|COMPLETED|Cohort 1 Period 3 - Treatment||0||
48305110|NCT05671653|101074808|FG011|COMPLETED|Cohort 1 Period 3 - Treatment||0||
48305111|NCT05671653|101074809|FG012|COMPLETED|Cohort 1 Period 3 - Treatment||0||
48305112|NCT05671653|101074797|FG000|NOT COMPLETED|Cohort 1 Period 3 - Treatment||0||
48305113|NCT05671653|101074798|FG001|NOT COMPLETED|Cohort 1 Period 3 - Treatment||0||
48305114|NCT05671653|101074799|FG002|NOT COMPLETED|Cohort 1 Period 3 - Treatment||0||
48305115|NCT05671653|101074800|FG003|NOT COMPLETED|Cohort 1 Period 3 - Treatment||0||
48305116|NCT05671653|101074801|FG004|NOT COMPLETED|Cohort 1 Period 3 - Treatment||0||
48305117|NCT05671653|101074802|FG005|NOT COMPLETED|Cohort 1 Period 3 - Treatment||0||
48305118|NCT05671653|101074803|FG006|NOT COMPLETED|Cohort 1 Period 3 - Treatment||0||
48305119|NCT05671653|101074804|FG007|NOT COMPLETED|Cohort 1 Period 3 - Treatment||0||
48305120|NCT05671653|101074805|FG008|NOT COMPLETED|Cohort 1 Period 3 - Treatment||0||
48305121|NCT05671653|101074806|FG009|NOT COMPLETED|Cohort 1 Period 3 - Treatment||0||
48305122|NCT05671653|101074807|FG010|NOT COMPLETED|Cohort 1 Period 3 - Treatment||0||
48305123|NCT05671653|101074808|FG011|NOT COMPLETED|Cohort 1 Period 3 - Treatment||0||
48305124|NCT05671653|101074809|FG012|NOT COMPLETED|Cohort 1 Period 3 - Treatment||0||
48305125|NCT05671653|101074797|FG000|STARTED|Cohort 1 Period 4 - Treatment||0||
48305126|NCT05671653|101074798|FG001|STARTED|Cohort 1 Period 4 - Treatment||0||
48607251|NCT01557868|101823470|FG000|STARTED|Overall Study||103||
48607252|NCT01557868|101823471|FG001|STARTED|Overall Study||95||
48607253|NCT01557868|101823470|FG000|COMPLETED|Overall Study||76||
48607254|NCT01557868|101823471|FG001|COMPLETED|Overall Study||65||
48607255|NCT01557868|101823470|FG000|NOT COMPLETED|Overall Study||27||
48607256|NCT01557868|101823471|FG001|NOT COMPLETED|Overall Study||30||
48607257|NCT02693717|101823472|FG000|STARTED|Overall Study||7||
48607258|NCT02693717|101823472|FG000|COMPLETED|Overall Study||7||
48607259|NCT02693717|101823472|FG000|NOT COMPLETED|Overall Study||0||
48607260|NCT02442206|101823473|FG000|STARTED|Period 1||30||
48305127|NCT05671653|101074799|FG002|STARTED|Cohort 1 Period 4 - Treatment||0||
48305128|NCT05671653|101074800|FG003|STARTED|Cohort 1 Period 4 - Treatment||16||
48305129|NCT05671653|101074801|FG004|STARTED|Cohort 1 Period 4 - Treatment||0||
48305130|NCT05671653|101074802|FG005|STARTED|Cohort 1 Period 4 - Treatment||0||
48305131|NCT05671653|101074803|FG006|STARTED|Cohort 1 Period 4 - Treatment||0||
48305132|NCT05671653|101074804|FG007|STARTED|Cohort 1 Period 4 - Treatment||0||
48305133|NCT05671653|101074805|FG008|STARTED|Cohort 1 Period 4 - Treatment||0||
48305134|NCT05671653|101074806|FG009|STARTED|Cohort 1 Period 4 - Treatment||0||
48305135|NCT05671653|101074807|FG010|STARTED|Cohort 1 Period 4 - Treatment||0||
48305136|NCT05671653|101074808|FG011|STARTED|Cohort 1 Period 4 - Treatment||0||
48718564|NCT02715726|102099129|FG000|Safety Population|Overall Study||206|1 participant of ezetimibe arm received alirocumab: counted in alirocumab arm for safety analysis.|
48718565|NCT02715726|102099130|FG001|Safety Population|Overall Study||406|1 participant of ezetimibe arm received alirocumab: counted in alirocumab arm for safety analysis.|
48718566|NCT02715726|102099129|FG000|COMPLETED|Overall Study||190||
48305137|NCT05671653|101074809|FG012|STARTED|Cohort 1 Period 4 - Treatment||0||
48305138|NCT05671653|101074797|FG000|COMPLETED|Cohort 1 Period 4 - Treatment||0||
48305139|NCT05671653|101074798|FG001|COMPLETED|Cohort 1 Period 4 - Treatment||0||
48305140|NCT05671653|101074799|FG002|COMPLETED|Cohort 1 Period 4 - Treatment||0||
48305141|NCT05671653|101074800|FG003|COMPLETED|Cohort 1 Period 4 - Treatment||16||
48305142|NCT05671653|101074801|FG004|COMPLETED|Cohort 1 Period 4 - Treatment||0||
48305143|NCT05671653|101074802|FG005|COMPLETED|Cohort 1 Period 4 - Treatment||0||
48305144|NCT05671653|101074803|FG006|COMPLETED|Cohort 1 Period 4 - Treatment||0||
48607261|NCT02442206|101823474|FG001|STARTED|Period 1||32||
48607262|NCT02442206|101823473|FG000|COMPLETED|Period 1||29||
48607263|NCT02442206|101823474|FG001|COMPLETED|Period 1||29||
48607264|NCT02442206|101823473|FG000|NOT COMPLETED|Period 1||1||
48305145|NCT05671653|101074804|FG007|COMPLETED|Cohort 1 Period 4 - Treatment||0||
48305146|NCT05671653|101074805|FG008|COMPLETED|Cohort 1 Period 4 - Treatment||0||
48305147|NCT05671653|101074806|FG009|COMPLETED|Cohort 1 Period 4 - Treatment||0||
48305148|NCT05671653|101074807|FG010|COMPLETED|Cohort 1 Period 4 - Treatment||0||
48305149|NCT05671653|101074808|FG011|COMPLETED|Cohort 1 Period 4 - Treatment||0||
48305150|NCT05671653|101074809|FG012|COMPLETED|Cohort 1 Period 4 - Treatment||0||
48305151|NCT05671653|101074797|FG000|NOT COMPLETED|Cohort 1 Period 4 - Treatment||0||
48305152|NCT05671653|101074798|FG001|NOT COMPLETED|Cohort 1 Period 4 - Treatment||0||
48607265|NCT02442206|101823474|FG001|NOT COMPLETED|Period 1||3||
48607266|NCT02442206|101823473|FG000|STARTED|Period 2||29||
48607267|NCT02442206|101823474|FG001|STARTED|Period 2||29||
48607268|NCT02442206|101823473|FG000|COMPLETED|Period 2||28||
48607269|NCT02442206|101823474|FG001|COMPLETED|Period 2||29||
48607270|NCT02442206|101823473|FG000|NOT COMPLETED|Period 2||1||
48607271|NCT02442206|101823474|FG001|NOT COMPLETED|Period 2||0||
48607272|NCT03131687|101823475|FG000|STARTED|Overall Study||51||
48607273|NCT03131687|101823476|FG001|STARTED|Overall Study||53||
48607274|NCT03131687|101823477|FG002|STARTED|Overall Study||55||
48607275|NCT03131687|101823478|FG003|STARTED|Overall Study||52||
48607276|NCT03131687|101823479|FG004|STARTED|Overall Study||53||
48607277|NCT03131687|101823480|FG005|STARTED|Overall Study||54||
48607278|NCT03131687|101823475|FG000|Received at Least One Dose of Study Drug|Overall Study||51||
48607279|NCT03131687|101823476|FG001|Received at Least One Dose of Study Drug|Overall Study||52||
48607280|NCT03131687|101823477|FG002|Received at Least One Dose of Study Drug|Overall Study||55||
48607281|NCT03131687|101823478|FG003|Received at Least One Dose of Study Drug|Overall Study||51||
48607282|NCT03131687|101823479|FG004|Received at Least One Dose of Study Drug|Overall Study||53||
48607283|NCT03131687|101823480|FG005|Received at Least One Dose of Study Drug|Overall Study||54||
48607284|NCT03131687|101823475|FG000|COMPLETED|Overall Study||45||
48607285|NCT03131687|101823476|FG001|COMPLETED|Overall Study||44||
48607286|NCT03131687|101823477|FG002|COMPLETED|Overall Study||52||
48607287|NCT03131687|101823478|FG003|COMPLETED|Overall Study||48||
48607288|NCT03131687|101823479|FG004|COMPLETED|Overall Study||45||
48607289|NCT03131687|101823480|FG005|COMPLETED|Overall Study||49||
48607290|NCT03131687|101823475|FG000|NOT COMPLETED|Overall Study||6||
48607291|NCT03131687|101823476|FG001|NOT COMPLETED|Overall Study||9||
48607292|NCT03131687|101823477|FG002|NOT COMPLETED|Overall Study||3||
48607293|NCT03131687|101823478|FG003|NOT COMPLETED|Overall Study||4||
48607294|NCT03131687|101823479|FG004|NOT COMPLETED|Overall Study||8||
48607295|NCT03131687|101823480|FG005|NOT COMPLETED|Overall Study||5||
48607296|NCT01677182|101823481|FG000|STARTED|Overall Study||184||
48607297|NCT01677182|101823482|FG001|STARTED|Overall Study||169||
48607298|NCT01677182|101823483|FG002|STARTED|Overall Study||182||
48607299|NCT01677182|101823481|FG000|COMPLETED|Overall Study||150||
48607300|NCT01677182|101823482|FG001|COMPLETED|Overall Study||141||
48607301|NCT01677182|101823483|FG002|COMPLETED|Overall Study||143||
48607302|NCT01677182|101823481|FG000|NOT COMPLETED|Overall Study||34||
48607303|NCT01677182|101823482|FG001|NOT COMPLETED|Overall Study||28||
48305153|NCT05671653|101074799|FG002|NOT COMPLETED|Cohort 1 Period 4 - Treatment||0||
48305154|NCT05671653|101074800|FG003|NOT COMPLETED|Cohort 1 Period 4 - Treatment||0||
48305155|NCT05671653|101074801|FG004|NOT COMPLETED|Cohort 1 Period 4 - Treatment||0||
48305156|NCT05671653|101074802|FG005|NOT COMPLETED|Cohort 1 Period 4 - Treatment||0||
48305157|NCT05671653|101074803|FG006|NOT COMPLETED|Cohort 1 Period 4 - Treatment||0||
48305158|NCT05671653|101074804|FG007|NOT COMPLETED|Cohort 1 Period 4 - Treatment||0||
48305159|NCT05671653|101074805|FG008|NOT COMPLETED|Cohort 1 Period 4 - Treatment||0||
48305160|NCT05671653|101074806|FG009|NOT COMPLETED|Cohort 1 Period 4 - Treatment||0||
48305161|NCT05671653|101074807|FG010|NOT COMPLETED|Cohort 1 Period 4 - Treatment||0||
48305162|NCT05671653|101074808|FG011|NOT COMPLETED|Cohort 1 Period 4 - Treatment||0||
48305163|NCT05671653|101074809|FG012|NOT COMPLETED|Cohort 1 Period 4 - Treatment||0||
48305164|NCT05671653|101074797|FG000|STARTED|Cohort 1 Period 5 - Treatment||0||
48305165|NCT05671653|101074798|FG001|STARTED|Cohort 1 Period 5 - Treatment||0||
48305166|NCT05671653|101074799|FG002|STARTED|Cohort 1 Period 5 - Treatment||0||
48305167|NCT05671653|101074800|FG003|STARTED|Cohort 1 Period 5 - Treatment||0||
48305168|NCT05671653|101074801|FG004|STARTED|Cohort 1 Period 5 - Treatment||16||
48305169|NCT05671653|101074802|FG005|STARTED|Cohort 1 Period 5 - Treatment||0||
48305170|NCT05671653|101074803|FG006|STARTED|Cohort 1 Period 5 - Treatment||0||
48305171|NCT05671653|101074804|FG007|STARTED|Cohort 1 Period 5 - Treatment||0||
48305172|NCT05671653|101074805|FG008|STARTED|Cohort 1 Period 5 - Treatment||0||
48305173|NCT05671653|101074806|FG009|STARTED|Cohort 1 Period 5 - Treatment||0||
48305174|NCT05671653|101074807|FG010|STARTED|Cohort 1 Period 5 - Treatment||0||
48305175|NCT05671653|101074808|FG011|STARTED|Cohort 1 Period 5 - Treatment||0||
48305176|NCT05671653|101074809|FG012|STARTED|Cohort 1 Period 5 - Treatment||0||
48305177|NCT05671653|101074797|FG000|COMPLETED|Cohort 1 Period 5 - Treatment||0||
48718567|NCT02715726|102099130|FG001|COMPLETED|Overall Study||380||
48718568|NCT02715726|102099129|FG000|NOT COMPLETED|Overall Study||18||
48718569|NCT02715726|102099130|FG001|NOT COMPLETED|Overall Study||27||
48718570|NCT01300351|102099131|FG000|STARTED|Overall Study||111||
48718571|NCT01300351|102099132|FG001|STARTED|Overall Study||110||
48718572|NCT01300351|102099131|FG000|Received Study Treatment|Overall Study||109||
48718573|NCT01300351|102099132|FG001|Received Study Treatment|Overall Study||110||
48718574|NCT01300351|102099131|FG000|COMPLETED|Overall Study||75||
48718575|NCT01300351|102099132|FG001|COMPLETED|Overall Study||72||
48718576|NCT01300351|102099131|FG000|NOT COMPLETED|Overall Study||36||
48718577|NCT01300351|102099132|FG001|NOT COMPLETED|Overall Study||38||
48718578|NCT00340379|102099133|FG000|STARTED|Overall Study||35||
48718579|NCT00340379|102099134|FG001|STARTED|Overall Study||37||
48718580|NCT00340379|102099133|FG000|COMPLETED|Overall Study||27||
48305178|NCT05671653|101074798|FG001|COMPLETED|Cohort 1 Period 5 - Treatment||0||
48305179|NCT05671653|101074799|FG002|COMPLETED|Cohort 1 Period 5 - Treatment||0||
48305180|NCT05671653|101074800|FG003|COMPLETED|Cohort 1 Period 5 - Treatment||0||
48305181|NCT05671653|101074801|FG004|COMPLETED|Cohort 1 Period 5 - Treatment||16||
48305182|NCT05671653|101074802|FG005|COMPLETED|Cohort 1 Period 5 - Treatment||0||
48305183|NCT05671653|101074803|FG006|COMPLETED|Cohort 1 Period 5 - Treatment||0||
48305184|NCT05671653|101074804|FG007|COMPLETED|Cohort 1 Period 5 - Treatment||0||
48305185|NCT05671653|101074805|FG008|COMPLETED|Cohort 1 Period 5 - Treatment||0||
48305186|NCT05671653|101074806|FG009|COMPLETED|Cohort 1 Period 5 - Treatment||0||
48406110|NCT01611311|101328347|FG000|COMPLETED|Overall Study||4||
48406111|NCT01611311|101328348|FG001|COMPLETED|Overall Study||6||
48718581|NCT00340379|102099134|FG001|COMPLETED|Overall Study||28||
48718582|NCT00340379|102099133|FG000|NOT COMPLETED|Overall Study||8||
48718583|NCT00340379|102099134|FG001|NOT COMPLETED|Overall Study||9||
48305187|NCT05671653|101074807|FG010|COMPLETED|Cohort 1 Period 5 - Treatment||0||
48406112|NCT01611311|101328349|FG002|COMPLETED|Overall Study||6||
48406113|NCT01611311|101328350|FG003|COMPLETED|Overall Study||6||
48406114|NCT01611311|101328351|FG004|COMPLETED|Overall Study||9||
48718584|NCT03562793|102099135|FG000|STARTED|Overall Study||124||
48718585|NCT03562793|102099136|FG001|STARTED|Overall Study||126||
48718586|NCT03562793|102099135|FG000|3 Months|Overall Study||103||
48305188|NCT05671653|101074808|FG011|COMPLETED|Cohort 1 Period 5 - Treatment||0||
48305189|NCT05671653|101074809|FG012|COMPLETED|Cohort 1 Period 5 - Treatment||0||
48305190|NCT05671653|101074797|FG000|NOT COMPLETED|Cohort 1 Period 5 - Treatment||0||
48305191|NCT05671653|101074798|FG001|NOT COMPLETED|Cohort 1 Period 5 - Treatment||0||
48406115|NCT01611311|101328352|FG005|COMPLETED|Overall Study||9||
48718587|NCT03562793|102099136|FG001|3 Months|Overall Study||120||
48718588|NCT03562793|102099135|FG000|6 Months|Overall Study||100||
48718589|NCT03562793|102099136|FG001|6 Months|Overall Study||113||
48718590|NCT03562793|102099135|FG000|COMPLETED|Overall Study||99||
48718591|NCT03562793|102099136|FG001|COMPLETED|Overall Study||104||
48718592|NCT03562793|102099135|FG000|NOT COMPLETED|Overall Study||25||
48718593|NCT03562793|102099136|FG001|NOT COMPLETED|Overall Study||22||
48718594|NCT04039867|102099137|FG000|STARTED|Overall Study||17||
48718595|NCT04039867|102099137|FG000|COMPLETED|Overall Study||17||
48718596|NCT04039867|102099137|FG000|NOT COMPLETED|Overall Study||0||
48718597|NCT01646203|102099138|FG000|STARTED|Overall Study||2||
48718598|NCT01646203|102099139|FG001|STARTED|Overall Study||5||
48718599|NCT01646203|102099140|FG002|STARTED|Overall Study||7||
48718600|NCT01646203|102099138|FG000|Received at Least One Dose of Study Drug|Overall Study||2||
48718601|NCT01646203|102099139|FG001|Received at Least One Dose of Study Drug|Overall Study||5||
48718602|NCT01646203|102099140|FG002|Received at Least One Dose of Study Drug|Overall Study||7||
48718603|NCT01646203|102099138|FG000|COMPLETED|Overall Study||0||
48718604|NCT01646203|102099139|FG001|COMPLETED|Overall Study||3||
48718605|NCT01646203|102099140|FG002|COMPLETED|Overall Study||6||
48718606|NCT01646203|102099138|FG000|NOT COMPLETED|Overall Study||2||
48718607|NCT01646203|102099139|FG001|NOT COMPLETED|Overall Study||2||
48718608|NCT01646203|102099140|FG002|NOT COMPLETED|Overall Study||1||
48718609|NCT02914561|102099141|FG000|STARTED|Induction Study (Day 1 to Week 10)||223||
48718610|NCT02914561|102099142|FG001|STARTED|Induction Study (Day 1 to Week 10)||245||
48718611|NCT02914561|102099143|FG002|STARTED|Induction Study (Day 1 to Week 10)||239||
48718612|NCT02914561|102099144|FG003|STARTED|Induction Study (Day 1 to Week 10)||204||
48718613|NCT02914561|102099145|FG004|STARTED|Induction Study (Day 1 to Week 10)||230||
48718614|NCT02914561|102099146|FG005|STARTED|Induction Study (Day 1 to Week 10)||231||
48718615|NCT02914561|102099147|FG006|STARTED|Induction Study (Day 1 to Week 10)||0||
48718616|NCT02914561|102099148|FG007|STARTED|Induction Study (Day 1 to Week 10)||0||
48718617|NCT02914561|102099149|FG008|STARTED|Induction Study (Day 1 to Week 10)||0||
48718618|NCT02914561|102099150|FG009|STARTED|Induction Study (Day 1 to Week 10)||0||
48718619|NCT02914561|102099151|FG010|STARTED|Induction Study (Day 1 to Week 10)||0||
48718620|NCT02914561|102099141|FG000|Treated|Induction Study (Day 1 to Week 10)||222||
48718621|NCT02914561|102099142|FG001|Treated|Induction Study (Day 1 to Week 10)||245||
48718622|NCT02914561|102099143|FG002|Treated|Induction Study (Day 1 to Week 10)||237||
48718623|NCT02914561|102099144|FG003|Treated|Induction Study (Day 1 to Week 10)||202||
48718624|NCT02914561|102099145|FG004|Treated|Induction Study (Day 1 to Week 10)||228||
48718625|NCT02914561|102099146|FG005|Treated|Induction Study (Day 1 to Week 10)||229||
48718626|NCT02914561|102099147|FG006|Treated|Induction Study (Day 1 to Week 10)||0||
48718627|NCT02914561|102099148|FG007|Treated|Induction Study (Day 1 to Week 10)||0||
48718628|NCT02914561|102099149|FG008|Treated|Induction Study (Day 1 to Week 10)||0||
48718629|NCT02914561|102099150|FG009|Treated|Induction Study (Day 1 to Week 10)||0||
48718630|NCT02914561|102099151|FG010|Treated|Induction Study (Day 1 to Week 10)||0||
48718631|NCT02914561|102099141|FG000|COMPLETED|Induction Study (Day 1 to Week 10)||204||
48718632|NCT02914561|102099142|FG001|COMPLETED|Induction Study (Day 1 to Week 10)||213||
48718633|NCT02914561|102099143|FG002|COMPLETED|Induction Study (Day 1 to Week 10)||212||
48718634|NCT02914561|102099144|FG003|COMPLETED|Induction Study (Day 1 to Week 10)||177||
48718635|NCT02914561|102099145|FG004|COMPLETED|Induction Study (Day 1 to Week 10)||183||
48718636|NCT02914561|102099146|FG005|COMPLETED|Induction Study (Day 1 to Week 10)||192||
48718637|NCT02914561|102099147|FG006|COMPLETED|Induction Study (Day 1 to Week 10)||0||
48718638|NCT02914561|102099148|FG007|COMPLETED|Induction Study (Day 1 to Week 10)||0||
48718639|NCT02914561|102099149|FG008|COMPLETED|Induction Study (Day 1 to Week 10)||0||
48718640|NCT02914561|102099150|FG009|COMPLETED|Induction Study (Day 1 to Week 10)||0||
48718641|NCT02914561|102099151|FG010|COMPLETED|Induction Study (Day 1 to Week 10)||0||
48718642|NCT02914561|102099141|FG000|NOT COMPLETED|Induction Study (Day 1 to Week 10)||19||
48718643|NCT02914561|102099142|FG001|NOT COMPLETED|Induction Study (Day 1 to Week 10)||32||
48718644|NCT02914561|102099143|FG002|NOT COMPLETED|Induction Study (Day 1 to Week 10)||27||
48718645|NCT02914561|102099144|FG003|NOT COMPLETED|Induction Study (Day 1 to Week 10)||27||
48150365|NCT00441701|100692230|FG008|NOT COMPLETED|Overall Study||0||
48718646|NCT02914561|102099145|FG004|NOT COMPLETED|Induction Study (Day 1 to Week 10)||47||
48305192|NCT05671653|101074799|FG002|NOT COMPLETED|Cohort 1 Period 5 - Treatment||0||
48305193|NCT05671653|101074800|FG003|NOT COMPLETED|Cohort 1 Period 5 - Treatment||0||
48305194|NCT05671653|101074801|FG004|NOT COMPLETED|Cohort 1 Period 5 - Treatment||0||
48305195|NCT05671653|101074802|FG005|NOT COMPLETED|Cohort 1 Period 5 - Treatment||0||
48305196|NCT05671653|101074803|FG006|NOT COMPLETED|Cohort 1 Period 5 - Treatment||0||
48305197|NCT05671653|101074804|FG007|NOT COMPLETED|Cohort 1 Period 5 - Treatment||0||
48406116|NCT01611311|101328347|FG000|NOT COMPLETED|Overall Study||0||
48406117|NCT01611311|101328348|FG001|NOT COMPLETED|Overall Study||0||
48718647|NCT02914561|102099146|FG005|NOT COMPLETED|Induction Study (Day 1 to Week 10)||39||
48718648|NCT02914561|102099147|FG006|NOT COMPLETED|Induction Study (Day 1 to Week 10)||0||
48718649|NCT02914561|102099148|FG007|NOT COMPLETED|Induction Study (Day 1 to Week 10)||0||
48718650|NCT02914561|102099149|FG008|NOT COMPLETED|Induction Study (Day 1 to Week 10)||0||
48718651|NCT02914561|102099150|FG009|NOT COMPLETED|Induction Study (Day 1 to Week 10)||0||
48718652|NCT02914561|102099151|FG010|NOT COMPLETED|Induction Study (Day 1 to Week 10)||0||
48718653|NCT02914561|102099141|FG000|STARTED|Maintenance Study (Weeks 11 to 58)||0||
48718654|NCT02914561|102099142|FG001|STARTED|Maintenance Study (Weeks 11 to 58)||0||
48718655|NCT02914561|102099143|FG002|STARTED|Maintenance Study (Weeks 11 to 58)||0||
48718656|NCT02914561|102099144|FG003|STARTED|Maintenance Study (Weeks 11 to 58)||0||
48718657|NCT02914561|102099145|FG004|STARTED|Maintenance Study (Weeks 11 to 58)||0||
48718658|NCT02914561|102099146|FG005|STARTED|Maintenance Study (Weeks 11 to 58)||0||
48718659|NCT02914561|102099147|FG006|STARTED|Maintenance Study (Weeks 11 to 58)||118||
48718660|NCT02914561|102099148|FG007|STARTED|Maintenance Study (Weeks 11 to 58)||56||
48718661|NCT02914561|102099149|FG008|STARTED|Maintenance Study (Weeks 11 to 58)||105||
48718662|NCT02914561|102099150|FG009|STARTED|Maintenance Study (Weeks 11 to 58)||56||
48718663|NCT02914561|102099151|FG010|STARTED|Maintenance Study (Weeks 11 to 58)||146||
48718664|NCT02914561|102099141|FG000|Treated|Maintenance Study (Weeks 11 to 58)||0||
48718665|NCT02914561|102099142|FG001|Treated|Maintenance Study (Weeks 11 to 58)||0||
48718666|NCT02914561|102099143|FG002|Treated|Maintenance Study (Weeks 11 to 58)||0||
48718667|NCT02914561|102099144|FG003|Treated|Maintenance Study (Weeks 11 to 58)||0||
48718668|NCT02914561|102099145|FG004|Treated|Maintenance Study (Weeks 11 to 58)||0||
48718669|NCT02914561|102099146|FG005|Treated|Maintenance Study (Weeks 11 to 58)||0||
48718670|NCT02914561|102099147|FG006|Treated|Maintenance Study (Weeks 11 to 58)||118||
48718671|NCT02914561|102099148|FG007|Treated|Maintenance Study (Weeks 11 to 58)||56||
48718672|NCT02914561|102099149|FG008|Treated|Maintenance Study (Weeks 11 to 58)||104||
48718673|NCT02914561|102099150|FG009|Treated|Maintenance Study (Weeks 11 to 58)||55||
48718674|NCT02914561|102099151|FG010|Treated|Maintenance Study (Weeks 11 to 58)||145||
48718675|NCT02914561|102099141|FG000|COMPLETED|Maintenance Study (Weeks 11 to 58)||0||
48718676|NCT02914561|102099142|FG001|COMPLETED|Maintenance Study (Weeks 11 to 58)||0||
48718677|NCT02914561|102099143|FG002|COMPLETED|Maintenance Study (Weeks 11 to 58)||0||
48718678|NCT02914561|102099144|FG003|COMPLETED|Maintenance Study (Weeks 11 to 58)||0||
48718679|NCT02914561|102099145|FG004|COMPLETED|Maintenance Study (Weeks 11 to 58)||0||
48718680|NCT02914561|102099146|FG005|COMPLETED|Maintenance Study (Weeks 11 to 58)||0||
48718681|NCT02914561|102099147|FG006|COMPLETED|Maintenance Study (Weeks 11 to 58)||64||
48718682|NCT02914561|102099148|FG007|COMPLETED|Maintenance Study (Weeks 11 to 58)||21||
48718683|NCT02914561|102099149|FG008|COMPLETED|Maintenance Study (Weeks 11 to 58)||45||
48718684|NCT02914561|102099150|FG009|COMPLETED|Maintenance Study (Weeks 11 to 58)||26||
48718685|NCT02914561|102099151|FG010|COMPLETED|Maintenance Study (Weeks 11 to 58)||74||
48718686|NCT02914561|102099141|FG000|NOT COMPLETED|Maintenance Study (Weeks 11 to 58)||0||
48718687|NCT02914561|102099142|FG001|NOT COMPLETED|Maintenance Study (Weeks 11 to 58)||0||
48718688|NCT02914561|102099143|FG002|NOT COMPLETED|Maintenance Study (Weeks 11 to 58)||0||
48718689|NCT02914561|102099144|FG003|NOT COMPLETED|Maintenance Study (Weeks 11 to 58)||0||
48718690|NCT02914561|102099145|FG004|NOT COMPLETED|Maintenance Study (Weeks 11 to 58)||0||
48718691|NCT02914561|102099146|FG005|NOT COMPLETED|Maintenance Study (Weeks 11 to 58)||0||
48305198|NCT05671653|101074805|FG008|NOT COMPLETED|Cohort 1 Period 5 - Treatment||0||
48718692|NCT02914561|102099147|FG006|NOT COMPLETED|Maintenance Study (Weeks 11 to 58)||54||
48718693|NCT02914561|102099148|FG007|NOT COMPLETED|Maintenance Study (Weeks 11 to 58)||35||
48718694|NCT02914561|102099149|FG008|NOT COMPLETED|Maintenance Study (Weeks 11 to 58)||60||
48718695|NCT02914561|102099150|FG009|NOT COMPLETED|Maintenance Study (Weeks 11 to 58)||30||
48718696|NCT02914561|102099151|FG010|NOT COMPLETED|Maintenance Study (Weeks 11 to 58)||72||
48718697|NCT02042534|102099152|FG000|STARTED|Overall Study||101||
48718698|NCT02042534|102099153|FG001|STARTED|Overall Study||94||
48718699|NCT02042534|102099152|FG000|COMPLETED|Overall Study||101||
48718700|NCT02042534|102099153|FG001|COMPLETED|Overall Study||94||
48718701|NCT02042534|102099152|FG000|NOT COMPLETED|Overall Study||0||
48718702|NCT02042534|102099153|FG001|NOT COMPLETED|Overall Study||0||
48718703|NCT02968914|102099154|FG000|STARTED|Overall Study||90||
48718704|NCT02968914|102099155|FG001|STARTED|Overall Study||90||
48718705|NCT02968914|102099154|FG000|COMPLETED|Overall Study||90||
48718706|NCT02968914|102099155|FG001|COMPLETED|Overall Study||90||
48718707|NCT02968914|102099154|FG000|NOT COMPLETED|Overall Study||0||
48718708|NCT02968914|102099155|FG001|NOT COMPLETED|Overall Study||0||
48718709|NCT03159104|102099156|FG000|STARTED|Overall Study||122||
48718710|NCT03159104|102099157|FG001|STARTED|Overall Study||118||
48718711|NCT03159104|102099156|FG000|COMPLETED|Overall Study||121||
48718712|NCT03159104|102099157|FG001|COMPLETED|Overall Study||116||
48718713|NCT03159104|102099156|FG000|NOT COMPLETED|Overall Study||1||
48718714|NCT03159104|102099157|FG001|NOT COMPLETED|Overall Study||2||
48718715|NCT01490294|102099158|FG000|STARTED|Overall Study||58||
48305199|NCT05671653|101074806|FG009|NOT COMPLETED|Cohort 1 Period 5 - Treatment||0||
48305200|NCT05671653|101074807|FG010|NOT COMPLETED|Cohort 1 Period 5 - Treatment||0||
48718716|NCT01490294|102099159|FG001|STARTED|Overall Study||60||
48718717|NCT01490294|102099160|FG002|STARTED|Overall Study||59||
48718718|NCT01490294|102099161|FG003|STARTED|Overall Study||55||
48718719|NCT01490294|102099158|FG000|Participant Received Treatment|Overall Study||54||
48718720|NCT01490294|102099159|FG001|Participant Received Treatment|Overall Study||60||
48718721|NCT01490294|102099160|FG002|Participant Received Treatment|Overall Study||58||
48718722|NCT01490294|102099161|FG003|Participant Received Treatment|Overall Study||54||
48718723|NCT01490294|102099158|FG000|COMPLETED|Overall Study||53||
48718724|NCT01490294|102099159|FG001|COMPLETED|Overall Study||60||
48718725|NCT01490294|102099160|FG002|COMPLETED|Overall Study||58||
48718726|NCT01490294|102099161|FG003|COMPLETED|Overall Study||54||
48718727|NCT01490294|102099158|FG000|NOT COMPLETED|Overall Study||5||
48718728|NCT01490294|102099159|FG001|NOT COMPLETED|Overall Study||0||
48718729|NCT01490294|102099160|FG002|NOT COMPLETED|Overall Study||1||
48718730|NCT01490294|102099161|FG003|NOT COMPLETED|Overall Study||1||
48718731|NCT02652416|102099162|FG000|STARTED|Overall Study||18||
48718732|NCT02652416|102099163|FG001|STARTED|Overall Study||18||
48718733|NCT02652416|102099164|FG002|STARTED|Overall Study||18||
48718734|NCT02652416|102099165|FG003|STARTED|Overall Study||18||
48718735|NCT02652416|102099162|FG000|Subjects Who Participated in MD Part|Overall Study||6|All subjects who participated in the 100 mg dose group of SRD part continued in the MD part|
48718736|NCT02652416|102099163|FG001|Subjects Who Participated in MD Part|Overall Study||0|All subjects who participated in the 100 mg dose group of SRD part continued in the MD part|
48718737|NCT02652416|102099164|FG002|Subjects Who Participated in MD Part|Overall Study||0|All subjects who participated in the 100 mg dose group of SRD part continued in the MD part|
48718738|NCT02652416|102099165|FG003|Subjects Who Participated in MD Part|Overall Study||18|All subjects who participated in the 100 mg dose group of SRD part continued in the MD part|
48718739|NCT02652416|102099162|FG000|COMPLETED|Overall Study||18||
48718740|NCT02652416|102099163|FG001|COMPLETED|Overall Study||18||
48718741|NCT02652416|102099164|FG002|COMPLETED|Overall Study||18||
48718742|NCT02652416|102099165|FG003|COMPLETED|Overall Study||18||
48718743|NCT02652416|102099162|FG000|NOT COMPLETED|Overall Study||0||
48718744|NCT02652416|102099163|FG001|NOT COMPLETED|Overall Study||0||
48718745|NCT02652416|102099164|FG002|NOT COMPLETED|Overall Study||0||
48718746|NCT02652416|102099165|FG003|NOT COMPLETED|Overall Study||0||
48718747|NCT02976103|102099166|FG000|STARTED|Overall Study||67||
48718748|NCT02976103|102099167|FG001|STARTED|Overall Study||72||
48718749|NCT02976103|102099166|FG000|COMPLETED|Overall Study||54||
48406118|NCT01611311|101328349|FG002|NOT COMPLETED|Overall Study||0||
48718750|NCT02976103|102099167|FG001|COMPLETED|Overall Study||64||
48718751|NCT02976103|102099166|FG000|NOT COMPLETED|Overall Study||13||
48718752|NCT02976103|102099167|FG001|NOT COMPLETED|Overall Study||8||
48718753|NCT00581360|102099168|FG000|STARTED|Overall Study||10||
48718754|NCT00581360|102099168|FG000|COMPLETED|Overall Study||9||
48718755|NCT00581360|102099168|FG000|NOT COMPLETED|Overall Study||1||
48718756|NCT02506660|102099169|FG000|STARTED|Overall Study||64||
48305201|NCT05671653|101074808|FG011|NOT COMPLETED|Cohort 1 Period 5 - Treatment||0||
48305202|NCT05671653|101074809|FG012|NOT COMPLETED|Cohort 1 Period 5 - Treatment||0||
48305203|NCT05671653|101074797|FG000|STARTED|Cohort 1 Period 6 - Treatment||0||
48305204|NCT05671653|101074798|FG001|STARTED|Cohort 1 Period 6 - Treatment||0||
48305205|NCT05671653|101074799|FG002|STARTED|Cohort 1 Period 6 - Treatment||0||
48305206|NCT05671653|101074800|FG003|STARTED|Cohort 1 Period 6 - Treatment||0||
48305207|NCT05671653|101074801|FG004|STARTED|Cohort 1 Period 6 - Treatment||0||
48406119|NCT01611311|101328350|FG003|NOT COMPLETED|Overall Study||0||
48305208|NCT05671653|101074802|FG005|STARTED|Cohort 1 Period 6 - Treatment||16||
48305209|NCT05671653|101074803|FG006|STARTED|Cohort 1 Period 6 - Treatment||0||
48305210|NCT05671653|101074804|FG007|STARTED|Cohort 1 Period 6 - Treatment||0||
48305211|NCT05671653|101074805|FG008|STARTED|Cohort 1 Period 6 - Treatment||0||
48305212|NCT05671653|101074806|FG009|STARTED|Cohort 1 Period 6 - Treatment||0||
48305213|NCT05671653|101074807|FG010|STARTED|Cohort 1 Period 6 - Treatment||0||
48718757|NCT02506660|102099170|FG001|STARTED|Overall Study||64||
48718758|NCT02506660|102099169|FG000|COMPLETED|Overall Study||62||
48718759|NCT02506660|102099170|FG001|COMPLETED|Overall Study||63||
48718760|NCT02506660|102099169|FG000|NOT COMPLETED|Overall Study||2||
48718761|NCT02506660|102099170|FG001|NOT COMPLETED|Overall Study||1||
48718762|NCT02066415|102099171|FG000|STARTED|Overall Study||286||
48718763|NCT02066415|102099172|FG001|STARTED|Overall Study||191||
48305214|NCT05671653|101074808|FG011|STARTED|Cohort 1 Period 6 - Treatment||0||
48305215|NCT05671653|101074809|FG012|STARTED|Cohort 1 Period 6 - Treatment||0||
48305216|NCT05671653|101074797|FG000|COMPLETED|Cohort 1 Period 6 - Treatment||0||
48305217|NCT05671653|101074798|FG001|COMPLETED|Cohort 1 Period 6 - Treatment||0||
48305218|NCT05671653|101074799|FG002|COMPLETED|Cohort 1 Period 6 - Treatment||0||
48305219|NCT05671653|101074800|FG003|COMPLETED|Cohort 1 Period 6 - Treatment||0||
48305220|NCT05671653|101074801|FG004|COMPLETED|Cohort 1 Period 6 - Treatment||0||
48305221|NCT05671653|101074802|FG005|COMPLETED|Cohort 1 Period 6 - Treatment||8||
48305222|NCT05671653|101074803|FG006|COMPLETED|Cohort 1 Period 6 - Treatment||0||
48305223|NCT05671653|101074804|FG007|COMPLETED|Cohort 1 Period 6 - Treatment||0||
48305224|NCT05671653|101074805|FG008|COMPLETED|Cohort 1 Period 6 - Treatment||0||
48305225|NCT05671653|101074806|FG009|COMPLETED|Cohort 1 Period 6 - Treatment||0||
48305226|NCT05671653|101074807|FG010|COMPLETED|Cohort 1 Period 6 - Treatment||0||
48305227|NCT05671653|101074808|FG011|COMPLETED|Cohort 1 Period 6 - Treatment||0||
48305228|NCT05671653|101074809|FG012|COMPLETED|Cohort 1 Period 6 - Treatment||0||
48305229|NCT05671653|101074797|FG000|NOT COMPLETED|Cohort 1 Period 6 - Treatment||0||
48305230|NCT05671653|101074798|FG001|NOT COMPLETED|Cohort 1 Period 6 - Treatment||0||
48305231|NCT05671653|101074799|FG002|NOT COMPLETED|Cohort 1 Period 6 - Treatment||0||
48305232|NCT05671653|101074800|FG003|NOT COMPLETED|Cohort 1 Period 6 - Treatment||0||
48305233|NCT05671653|101074801|FG004|NOT COMPLETED|Cohort 1 Period 6 - Treatment||0||
48305234|NCT05671653|101074802|FG005|NOT COMPLETED|Cohort 1 Period 6 - Treatment||8||
48305235|NCT05671653|101074803|FG006|NOT COMPLETED|Cohort 1 Period 6 - Treatment||0||
48305236|NCT05671653|101074804|FG007|NOT COMPLETED|Cohort 1 Period 6 - Treatment||0||
48305237|NCT05671653|101074805|FG008|NOT COMPLETED|Cohort 1 Period 6 - Treatment||0||
48305238|NCT05671653|101074806|FG009|NOT COMPLETED|Cohort 1 Period 6 - Treatment||0||
48305239|NCT05671653|101074807|FG010|NOT COMPLETED|Cohort 1 Period 6 - Treatment||0||
48305240|NCT05671653|101074808|FG011|NOT COMPLETED|Cohort 1 Period 6 - Treatment||0||
48305241|NCT05671653|101074809|FG012|NOT COMPLETED|Cohort 1 Period 6 - Treatment||0||
48305242|NCT05671653|101074797|FG000|STARTED|Cohort 1 Period 7 - Treatment||0||
48305243|NCT05671653|101074798|FG001|STARTED|Cohort 1 Period 7 - Treatment||0||
48305244|NCT05671653|101074799|FG002|STARTED|Cohort 1 Period 7 - Treatment||0||
48305245|NCT05671653|101074800|FG003|STARTED|Cohort 1 Period 7 - Treatment||0||
48305246|NCT05671653|101074801|FG004|STARTED|Cohort 1 Period 7 - Treatment||0||
48305247|NCT05671653|101074802|FG005|STARTED|Cohort 1 Period 7 - Treatment||0||
48305248|NCT05671653|101074803|FG006|STARTED|Cohort 1 Period 7 - Treatment||8||
48305249|NCT05671653|101074804|FG007|STARTED|Cohort 1 Period 7 - Treatment||0||
48305250|NCT05671653|101074805|FG008|STARTED|Cohort 1 Period 7 - Treatment||0||
48305251|NCT05671653|101074806|FG009|STARTED|Cohort 1 Period 7 - Treatment||0||
48305252|NCT05671653|101074807|FG010|STARTED|Cohort 1 Period 7 - Treatment||0||
48305253|NCT05671653|101074808|FG011|STARTED|Cohort 1 Period 7 - Treatment||0||
48305254|NCT05671653|101074809|FG012|STARTED|Cohort 1 Period 7 - Treatment||0||
48305255|NCT05671653|101074797|FG000|COMPLETED|Cohort 1 Period 7 - Treatment||0||
48305256|NCT05671653|101074798|FG001|COMPLETED|Cohort 1 Period 7 - Treatment||0||
48305257|NCT05671653|101074799|FG002|COMPLETED|Cohort 1 Period 7 - Treatment||0||
48718764|NCT02066415|102099173|FG002|STARTED|Overall Study||190||
48718765|NCT02066415|102099171|FG000|Received Study Drug|Overall Study||282||
48718766|NCT02066415|102099172|FG001|Received Study Drug|Overall Study||190||
48718767|NCT02066415|102099173|FG002|Received Study Drug|Overall Study||188||
48305258|NCT05671653|101074800|FG003|COMPLETED|Cohort 1 Period 7 - Treatment||0||
48305259|NCT05671653|101074801|FG004|COMPLETED|Cohort 1 Period 7 - Treatment||0||
48305260|NCT05671653|101074802|FG005|COMPLETED|Cohort 1 Period 7 - Treatment||0||
48305261|NCT05671653|101074803|FG006|COMPLETED|Cohort 1 Period 7 - Treatment||8||
48305262|NCT05671653|101074804|FG007|COMPLETED|Cohort 1 Period 7 - Treatment||0||
48305263|NCT05671653|101074805|FG008|COMPLETED|Cohort 1 Period 7 - Treatment||0||
48305264|NCT05671653|101074806|FG009|COMPLETED|Cohort 1 Period 7 - Treatment||0||
48718768|NCT02066415|102099171|FG000|COMPLETED|Overall Study||265||
48718769|NCT02066415|102099172|FG001|COMPLETED|Overall Study||184||
48718770|NCT02066415|102099173|FG002|COMPLETED|Overall Study||182||
48718771|NCT02066415|102099171|FG000|NOT COMPLETED|Overall Study||21||
48305265|NCT05671653|101074807|FG010|COMPLETED|Cohort 1 Period 7 - Treatment||0||
48305266|NCT05671653|101074808|FG011|COMPLETED|Cohort 1 Period 7 - Treatment||0||
48305267|NCT05671653|101074809|FG012|COMPLETED|Cohort 1 Period 7 - Treatment||0||
48718772|NCT02066415|102099172|FG001|NOT COMPLETED|Overall Study||7||
48718773|NCT02066415|102099173|FG002|NOT COMPLETED|Overall Study||8||
48718774|NCT01685983|102099174|FG000|STARTED|Overall Study||82||
48718775|NCT01685983|102099174|FG000|COMPLETED|Overall Study||0||
48718776|NCT01685983|102099174|FG000|NOT COMPLETED|Overall Study||82||
48718777|NCT05810714|102099175|FG000|STARTED|Overall Study||20||
48150366|NCT00441701|100692231|FG009|NOT COMPLETED|Overall Study||0||
48150367|NCT01696981|100692232|FG000|STARTED|Overall Study||77455||
48150368|NCT01696981|100692233|FG001|STARTED|Overall Study||77445||
48150369|NCT01696981|100692232|FG000|COMPLETED|Overall Study||76254||
48150370|NCT01696981|100692233|FG001|COMPLETED|Overall Study||67071||
48150371|NCT01696981|100692232|FG000|NOT COMPLETED|Overall Study||1201||
48150372|NCT01696981|100692233|FG001|NOT COMPLETED|Overall Study||10374||
48150373|NCT02034708|100692234|FG000|STARTED|First Contrast Agent Injection (1 Day)||138||
48150374|NCT02034708|100692235|FG001|STARTED|First Contrast Agent Injection (1 Day)||130||
48150375|NCT02034708|100692234|FG000|COMPLETED|First Contrast Agent Injection (1 Day)||138||
48150376|NCT02034708|100692235|FG001|COMPLETED|First Contrast Agent Injection (1 Day)||130||
48150377|NCT02034708|100692234|FG000|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0||
48150378|NCT02034708|100692235|FG001|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0||
48150379|NCT02034708|100692234|FG000|STARTED|Wash-out (From 2 Days up to 14 Days)||138||
48150380|NCT02034708|100692235|FG001|STARTED|Wash-out (From 2 Days up to 14 Days)||130||
48150381|NCT02034708|100692234|FG000|COMPLETED|Wash-out (From 2 Days up to 14 Days)||129||
48150382|NCT02034708|100692235|FG001|COMPLETED|Wash-out (From 2 Days up to 14 Days)||120||
48150383|NCT02034708|100692234|FG000|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||9||
48150384|NCT02034708|100692235|FG001|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||10||
48150385|NCT02034708|100692234|FG000|STARTED|Second Contrast Agent Injection (1 Day)||129||
48150386|NCT02034708|100692235|FG001|STARTED|Second Contrast Agent Injection (1 Day)||120||
48150387|NCT02034708|100692234|FG000|COMPLETED|Second Contrast Agent Injection (1 Day)||129||
48150388|NCT02034708|100692235|FG001|COMPLETED|Second Contrast Agent Injection (1 Day)||120||
48150389|NCT02034708|100692234|FG000|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0||
48150390|NCT02034708|100692235|FG001|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0||
48150391|NCT00689026|100692236|FG000|STARTED|Overall Study||30||
48150392|NCT00689026|100692237|FG001|STARTED|Overall Study||30||
48150393|NCT00689026|100692236|FG000|COMPLETED|Overall Study||17||
48150394|NCT00689026|100692237|FG001|COMPLETED|Overall Study||24||
48150395|NCT00689026|100692236|FG000|NOT COMPLETED|Overall Study||13||
48150396|NCT00689026|100692237|FG001|NOT COMPLETED|Overall Study||6||
48150397|NCT05276830|100692238|FG000|STARTED|Overall Study||2||
48150398|NCT05276830|100692239|FG001|STARTED|Overall Study||1||
48150399|NCT05276830|100692240|FG002|STARTED|Overall Study||2||
48150400|NCT05276830|100692238|FG000|COMPLETED|Overall Study||2||
48150401|NCT05276830|100692239|FG001|COMPLETED|Overall Study||1||
48150402|NCT05276830|100692240|FG002|COMPLETED|Overall Study||2||
48150403|NCT05276830|100692238|FG000|NOT COMPLETED|Overall Study||0||
48150404|NCT05276830|100692239|FG001|NOT COMPLETED|Overall Study||0||
48150405|NCT05276830|100692240|FG002|NOT COMPLETED|Overall Study||0||
48150406|NCT04987762|100692241|FG000|STARTED|Overall Study||103||
48150407|NCT04987762|100692241|FG000|COMPLETED|Overall Study||0||
48150408|NCT04987762|100692241|FG000|NOT COMPLETED|Overall Study||103||
48150409|NCT00511875|100692242|FG000|STARTED|Overall Study||15||
48150410|NCT00511875|100692243|FG001|STARTED|Overall Study||15||
48150411|NCT00511875|100692242|FG000|COMPLETED|Overall Study||10||
48150412|NCT00511875|100692243|FG001|COMPLETED|Overall Study||15||
48150413|NCT00511875|100692242|FG000|NOT COMPLETED|Overall Study||5||
48150414|NCT00511875|100692243|FG001|NOT COMPLETED|Overall Study||0||
48150415|NCT00799643|100692244|FG000|STARTED|Overall Study||140||
48150416|NCT00799643|100692245|FG001|STARTED|Overall Study||146||
48150417|NCT00799643|100692244|FG000|COMPLETED|Overall Study||115||
48150418|NCT00799643|100692245|FG001|COMPLETED|Overall Study||119||
48150419|NCT00799643|100692244|FG000|NOT COMPLETED|Overall Study||25||
48150420|NCT00799643|100692245|FG001|NOT COMPLETED|Overall Study||27||
48150421|NCT00569582|100692246|FG000|STARTED|Overall Study||50||
48150422|NCT00569582|100692246|FG000|COMPLETED|Overall Study||34||
48150423|NCT00569582|100692246|FG000|NOT COMPLETED|Overall Study||16||
48150424|NCT00885092|100692247|FG000|STARTED|Period 1, 7 Days||20||
48150425|NCT00885092|100692248|FG001|STARTED|Period 1, 7 Days||20||
48150426|NCT00885092|100692247|FG000|COMPLETED|Period 1, 7 Days||20||
48718778|NCT05810714|102099176|FG001|STARTED|Overall Study||42||
48305268|NCT05671653|101074797|FG000|NOT COMPLETED|Cohort 1 Period 7 - Treatment||0||
48305269|NCT05671653|101074798|FG001|NOT COMPLETED|Cohort 1 Period 7 - Treatment||0||
48305270|NCT05671653|101074799|FG002|NOT COMPLETED|Cohort 1 Period 7 - Treatment||0||
48305271|NCT05671653|101074800|FG003|NOT COMPLETED|Cohort 1 Period 7 - Treatment||0||
48305272|NCT05671653|101074801|FG004|NOT COMPLETED|Cohort 1 Period 7 - Treatment||0||
48305273|NCT05671653|101074802|FG005|NOT COMPLETED|Cohort 1 Period 7 - Treatment||0||
48305274|NCT05671653|101074803|FG006|NOT COMPLETED|Cohort 1 Period 7 - Treatment||0||
48305275|NCT05671653|101074804|FG007|NOT COMPLETED|Cohort 1 Period 7 - Treatment||0||
48305276|NCT05671653|101074805|FG008|NOT COMPLETED|Cohort 1 Period 7 - Treatment||0||
48305277|NCT05671653|101074806|FG009|NOT COMPLETED|Cohort 1 Period 7 - Treatment||0||
48305278|NCT05671653|101074807|FG010|NOT COMPLETED|Cohort 1 Period 7 - Treatment||0||
48305279|NCT05671653|101074808|FG011|NOT COMPLETED|Cohort 1 Period 7 - Treatment||0||
48305280|NCT05671653|101074809|FG012|NOT COMPLETED|Cohort 1 Period 7 - Treatment||0||
48305281|NCT05671653|101074797|FG000|STARTED|Cohort 1 Period 8 - Treatment||0||
48305282|NCT05671653|101074798|FG001|STARTED|Cohort 1 Period 8 - Treatment||0||
48305283|NCT05671653|101074799|FG002|STARTED|Cohort 1 Period 8 - Treatment||0||
48305284|NCT05671653|101074800|FG003|STARTED|Cohort 1 Period 8 - Treatment||0||
48305285|NCT05671653|101074801|FG004|STARTED|Cohort 1 Period 8 - Treatment||0||
48305286|NCT05671653|101074802|FG005|STARTED|Cohort 1 Period 8 - Treatment||0||
48305287|NCT05671653|101074803|FG006|STARTED|Cohort 1 Period 8 - Treatment||0||
48305288|NCT05671653|101074804|FG007|STARTED|Cohort 1 Period 8 - Treatment||7||
48305289|NCT05671653|101074805|FG008|STARTED|Cohort 1 Period 8 - Treatment||0||
48305290|NCT05671653|101074806|FG009|STARTED|Cohort 1 Period 8 - Treatment||0||
48305291|NCT05671653|101074807|FG010|STARTED|Cohort 1 Period 8 - Treatment||0||
48305292|NCT05671653|101074808|FG011|STARTED|Cohort 1 Period 8 - Treatment||0||
48305293|NCT05671653|101074809|FG012|STARTED|Cohort 1 Period 8 - Treatment||0||
48305294|NCT05671653|101074797|FG000|COMPLETED|Cohort 1 Period 8 - Treatment||0||
48305295|NCT05671653|101074798|FG001|COMPLETED|Cohort 1 Period 8 - Treatment||0||
48305296|NCT05671653|101074799|FG002|COMPLETED|Cohort 1 Period 8 - Treatment||0||
48305297|NCT05671653|101074800|FG003|COMPLETED|Cohort 1 Period 8 - Treatment||0||
48305298|NCT05671653|101074801|FG004|COMPLETED|Cohort 1 Period 8 - Treatment||0||
48305299|NCT05671653|101074802|FG005|COMPLETED|Cohort 1 Period 8 - Treatment||0||
48305300|NCT05671653|101074803|FG006|COMPLETED|Cohort 1 Period 8 - Treatment||0||
48305301|NCT05671653|101074804|FG007|COMPLETED|Cohort 1 Period 8 - Treatment||7||
48305302|NCT05671653|101074805|FG008|COMPLETED|Cohort 1 Period 8 - Treatment||0||
48305303|NCT05671653|101074806|FG009|COMPLETED|Cohort 1 Period 8 - Treatment||0||
48305304|NCT05671653|101074807|FG010|COMPLETED|Cohort 1 Period 8 - Treatment||0||
48305305|NCT05671653|101074808|FG011|COMPLETED|Cohort 1 Period 8 - Treatment||0||
48305306|NCT05671653|101074809|FG012|COMPLETED|Cohort 1 Period 8 - Treatment||0||
48305307|NCT05671653|101074797|FG000|NOT COMPLETED|Cohort 1 Period 8 - Treatment||0||
48305308|NCT05671653|101074798|FG001|NOT COMPLETED|Cohort 1 Period 8 - Treatment||0||
48305309|NCT05671653|101074799|FG002|NOT COMPLETED|Cohort 1 Period 8 - Treatment||0||
48305310|NCT05671653|101074800|FG003|NOT COMPLETED|Cohort 1 Period 8 - Treatment||0||
48305311|NCT05671653|101074801|FG004|NOT COMPLETED|Cohort 1 Period 8 - Treatment||0||
48305312|NCT05671653|101074802|FG005|NOT COMPLETED|Cohort 1 Period 8 - Treatment||0||
48305313|NCT05671653|101074803|FG006|NOT COMPLETED|Cohort 1 Period 8 - Treatment||0||
48305314|NCT05671653|101074804|FG007|NOT COMPLETED|Cohort 1 Period 8 - Treatment||0||
48305315|NCT05671653|101074805|FG008|NOT COMPLETED|Cohort 1 Period 8 - Treatment||0||
48305316|NCT05671653|101074806|FG009|NOT COMPLETED|Cohort 1 Period 8 - Treatment||0||
48305317|NCT05671653|101074807|FG010|NOT COMPLETED|Cohort 1 Period 8 - Treatment||0||
48305318|NCT05671653|101074808|FG011|NOT COMPLETED|Cohort 1 Period 8 - Treatment||0||
48305319|NCT05671653|101074809|FG012|NOT COMPLETED|Cohort 1 Period 8 - Treatment||0||
48305320|NCT05671653|101074797|FG000|STARTED|Cohort 1 Period 9 - Treatment||0||
48305321|NCT05671653|101074798|FG001|STARTED|Cohort 1 Period 9 - Treatment||0||
48305322|NCT05671653|101074799|FG002|STARTED|Cohort 1 Period 9 - Treatment||0||
48305323|NCT05671653|101074800|FG003|STARTED|Cohort 1 Period 9 - Treatment||0||
48305324|NCT05671653|101074801|FG004|STARTED|Cohort 1 Period 9 - Treatment||0||
48305325|NCT05671653|101074802|FG005|STARTED|Cohort 1 Period 9 - Treatment||0||
48305326|NCT05671653|101074803|FG006|STARTED|Cohort 1 Period 9 - Treatment||0||
48305327|NCT05671653|101074804|FG007|STARTED|Cohort 1 Period 9 - Treatment||0||
48305328|NCT05671653|101074805|FG008|STARTED|Cohort 1 Period 9 - Treatment||8||
48305329|NCT05671653|101074806|FG009|STARTED|Cohort 1 Period 9 - Treatment||0||
48305330|NCT05671653|101074807|FG010|STARTED|Cohort 1 Period 9 - Treatment||0||
48305331|NCT05671653|101074808|FG011|STARTED|Cohort 1 Period 9 - Treatment||0||
48305332|NCT05671653|101074809|FG012|STARTED|Cohort 1 Period 9 - Treatment||0||
48305333|NCT05671653|101074797|FG000|COMPLETED|Cohort 1 Period 9 - Treatment||0||
48305334|NCT05671653|101074798|FG001|COMPLETED|Cohort 1 Period 9 - Treatment||0||
48305335|NCT05671653|101074799|FG002|COMPLETED|Cohort 1 Period 9 - Treatment||0||
48305336|NCT05671653|101074800|FG003|COMPLETED|Cohort 1 Period 9 - Treatment||0||
48305337|NCT05671653|101074801|FG004|COMPLETED|Cohort 1 Period 9 - Treatment||0||
48305338|NCT05671653|101074802|FG005|COMPLETED|Cohort 1 Period 9 - Treatment||0||
48305339|NCT05671653|101074803|FG006|COMPLETED|Cohort 1 Period 9 - Treatment||0||
48305340|NCT05671653|101074804|FG007|COMPLETED|Cohort 1 Period 9 - Treatment||0||
48305341|NCT05671653|101074805|FG008|COMPLETED|Cohort 1 Period 9 - Treatment||7||
48305342|NCT05671653|101074806|FG009|COMPLETED|Cohort 1 Period 9 - Treatment||0||
48305343|NCT05671653|101074807|FG010|COMPLETED|Cohort 1 Period 9 - Treatment||0||
48305344|NCT05671653|101074808|FG011|COMPLETED|Cohort 1 Period 9 - Treatment||0||
48305345|NCT05671653|101074809|FG012|COMPLETED|Cohort 1 Period 9 - Treatment||0||
48305346|NCT05671653|101074797|FG000|NOT COMPLETED|Cohort 1 Period 9 - Treatment||0||
48305347|NCT05671653|101074798|FG001|NOT COMPLETED|Cohort 1 Period 9 - Treatment||0||
48305348|NCT05671653|101074799|FG002|NOT COMPLETED|Cohort 1 Period 9 - Treatment||0||
48305349|NCT05671653|101074800|FG003|NOT COMPLETED|Cohort 1 Period 9 - Treatment||0||
48305350|NCT05671653|101074801|FG004|NOT COMPLETED|Cohort 1 Period 9 - Treatment||0||
48305351|NCT05671653|101074802|FG005|NOT COMPLETED|Cohort 1 Period 9 - Treatment||0||
48305352|NCT05671653|101074803|FG006|NOT COMPLETED|Cohort 1 Period 9 - Treatment||0||
48305353|NCT05671653|101074804|FG007|NOT COMPLETED|Cohort 1 Period 9 - Treatment||0||
48305354|NCT05671653|101074805|FG008|NOT COMPLETED|Cohort 1 Period 9 - Treatment||1||
48305355|NCT05671653|101074806|FG009|NOT COMPLETED|Cohort 1 Period 9 - Treatment||0||
48305356|NCT05671653|101074807|FG010|NOT COMPLETED|Cohort 1 Period 9 - Treatment||0||
48305357|NCT05671653|101074808|FG011|NOT COMPLETED|Cohort 1 Period 9 - Treatment||0||
48305358|NCT05671653|101074809|FG012|NOT COMPLETED|Cohort 1 Period 9 - Treatment||0||
48305359|NCT05671653|101074797|FG000|STARTED|Cohort 2 Period 1 - Treatment||0||
48305360|NCT05671653|101074798|FG001|STARTED|Cohort 2 Period 1 - Treatment||0||
48305361|NCT05671653|101074799|FG002|STARTED|Cohort 2 Period 1 - Treatment||0||
48305362|NCT05671653|101074800|FG003|STARTED|Cohort 2 Period 1 - Treatment||0||
48305363|NCT05671653|101074801|FG004|STARTED|Cohort 2 Period 1 - Treatment||0||
48305364|NCT05671653|101074802|FG005|STARTED|Cohort 2 Period 1 - Treatment||0||
48305365|NCT05671653|101074803|FG006|STARTED|Cohort 2 Period 1 - Treatment||0||
48305366|NCT05671653|101074804|FG007|STARTED|Cohort 2 Period 1 - Treatment||0||
48305367|NCT05671653|101074805|FG008|STARTED|Cohort 2 Period 1 - Treatment||0||
48305368|NCT05671653|101074806|FG009|STARTED|Cohort 2 Period 1 - Treatment||16||
48305369|NCT05671653|101074807|FG010|STARTED|Cohort 2 Period 1 - Treatment||0||
48305370|NCT05671653|101074808|FG011|STARTED|Cohort 2 Period 1 - Treatment||0||
48305371|NCT05671653|101074809|FG012|STARTED|Cohort 2 Period 1 - Treatment||0||
48305372|NCT05671653|101074797|FG000|COMPLETED|Cohort 2 Period 1 - Treatment||0||
48305373|NCT05671653|101074798|FG001|COMPLETED|Cohort 2 Period 1 - Treatment||0||
48305374|NCT05671653|101074799|FG002|COMPLETED|Cohort 2 Period 1 - Treatment||0||
48305375|NCT05671653|101074800|FG003|COMPLETED|Cohort 2 Period 1 - Treatment||0||
48305376|NCT05671653|101074801|FG004|COMPLETED|Cohort 2 Period 1 - Treatment||0||
48305377|NCT05671653|101074802|FG005|COMPLETED|Cohort 2 Period 1 - Treatment||0||
48305378|NCT05671653|101074803|FG006|COMPLETED|Cohort 2 Period 1 - Treatment||0||
48305379|NCT05671653|101074804|FG007|COMPLETED|Cohort 2 Period 1 - Treatment||0||
48305380|NCT05671653|101074805|FG008|COMPLETED|Cohort 2 Period 1 - Treatment||0||
48305381|NCT05671653|101074806|FG009|COMPLETED|Cohort 2 Period 1 - Treatment||16||
48406120|NCT01611311|101328351|FG004|NOT COMPLETED|Overall Study||0||
48607304|NCT01677182|101823483|FG002|NOT COMPLETED|Overall Study||39||
48718779|NCT05810714|102099177|FG002|STARTED|Overall Study||32||
48718780|NCT05810714|102099175|FG000|COMPLETED|Overall Study||20||
48718781|NCT05810714|102099176|FG001|COMPLETED|Overall Study||42||
48718782|NCT05810714|102099177|FG002|COMPLETED|Overall Study||32||
48718783|NCT05810714|102099175|FG000|NOT COMPLETED|Overall Study||0||
48718784|NCT05810714|102099176|FG001|NOT COMPLETED|Overall Study||0||
48718785|NCT05810714|102099177|FG002|NOT COMPLETED|Overall Study||0||
48718786|NCT00459537|102099178|FG000|STARTED|Overall Study||507||
48718787|NCT00459537|102099179|FG001|STARTED|Overall Study||522||
48718788|NCT00459537|102099178|FG000|Safety Population|Overall Study||493||
48718789|NCT00459537|102099179|FG001|Safety Population|Overall Study||512||
48718790|NCT00459537|102099178|FG000|COMPLETED|Overall Study||441||
48718791|NCT00459537|102099179|FG001|COMPLETED|Overall Study||446||
48718792|NCT00459537|102099178|FG000|NOT COMPLETED|Overall Study||66||
48718793|NCT00459537|102099179|FG001|NOT COMPLETED|Overall Study||76||
48718794|NCT03263780|102099180|FG000|STARTED|Overall Study||21||
48718795|NCT03263780|102099180|FG000|COMPLETED|Overall Study||11||
48718796|NCT03263780|102099180|FG000|NOT COMPLETED|Overall Study||10||
48718797|NCT01305655|102099181|FG000|STARTED|Overall Study||47||
48718798|NCT01305655|102099181|FG000|COMPLETED|Overall Study||47||
48718799|NCT01305655|102099181|FG000|NOT COMPLETED|Overall Study||0||
48718800|NCT02528357|102099182|FG000|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||1||
48718801|NCT02528357|102099183|FG001|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||1||
48718802|NCT02528357|102099184|FG002|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||8||
48718803|NCT02528357|102099185|FG003|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||10||
48718804|NCT02528357|102099186|FG004|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||10||
48718805|NCT02528357|102099187|FG005|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||4||
48718806|NCT02528357|102099188|FG006|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||7||
48718807|NCT02528357|102099189|FG007|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||4||
48718808|NCT02528357|102099190|FG008|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48718809|NCT02528357|102099191|FG009|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48718810|NCT02528357|102099192|FG010|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48718811|NCT02528357|102099193|FG011|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48718812|NCT02528357|102099194|FG012|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48718813|NCT02528357|102099195|FG013|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48718814|NCT02528357|102099196|FG014|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48718815|NCT02528357|102099197|FG015|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48718816|NCT02528357|102099198|FG016|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48718817|NCT02528357|102099199|FG017|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48718818|NCT02528357|102099200|FG018|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48718819|NCT02528357|102099182|FG000|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||1||
48718820|NCT02528357|102099183|FG001|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48718821|NCT02528357|102099184|FG002|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||6||
48718822|NCT02528357|102099185|FG003|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||9||
48718823|NCT02528357|102099186|FG004|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||6||
48718824|NCT02528357|102099187|FG005|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2||
48718825|NCT02528357|102099188|FG006|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||5||
48718826|NCT02528357|102099189|FG007|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2||
48718827|NCT02528357|102099190|FG008|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48718828|NCT02528357|102099191|FG009|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48718829|NCT02528357|102099192|FG010|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48718830|NCT02528357|102099193|FG011|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48718831|NCT02528357|102099194|FG012|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48718832|NCT02528357|102099195|FG013|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48718833|NCT02528357|102099196|FG014|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48718834|NCT02528357|102099197|FG015|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48718835|NCT02528357|102099198|FG016|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48718836|NCT02528357|102099199|FG017|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48718837|NCT02528357|102099200|FG018|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48718838|NCT02528357|102099182|FG000|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48718839|NCT02528357|102099183|FG001|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||1||
48718840|NCT02528357|102099184|FG002|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2||
48718841|NCT02528357|102099185|FG003|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||1||
48718842|NCT02528357|102099186|FG004|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||4||
48718843|NCT02528357|102099187|FG005|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2||
48718844|NCT02528357|102099188|FG006|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2||
48718845|NCT02528357|102099189|FG007|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2||
48718846|NCT02528357|102099190|FG008|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48718847|NCT02528357|102099191|FG009|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48718848|NCT02528357|102099192|FG010|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48718849|NCT02528357|102099193|FG011|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48767591|NCT04393454|102222775|FG000|NOT COMPLETED|Overall Study||2||
48718850|NCT02528357|102099194|FG012|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48718851|NCT02528357|102099195|FG013|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48718852|NCT02528357|102099196|FG014|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48718853|NCT02528357|102099197|FG015|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48718854|NCT02528357|102099198|FG016|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48718855|NCT02528357|102099199|FG017|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48718856|NCT02528357|102099200|FG018|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
48718857|NCT02528357|102099182|FG000|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
48718858|NCT02528357|102099183|FG001|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
48718859|NCT02528357|102099184|FG002|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
48718860|NCT02528357|102099185|FG003|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
48718861|NCT02528357|102099186|FG004|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
48718862|NCT02528357|102099187|FG005|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
48718863|NCT02528357|102099188|FG006|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
48718864|NCT02528357|102099189|FG007|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
48718865|NCT02528357|102099190|FG008|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||5||
48150427|NCT00885092|100692248|FG001|COMPLETED|Period 1, 7 Days||20||
48718866|NCT02528357|102099191|FG009|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||5||
48150428|NCT00885092|100692247|FG000|NOT COMPLETED|Period 1, 7 Days||0||
48718867|NCT02528357|102099192|FG010|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||10||
48718868|NCT02528357|102099193|FG011|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||12||
48718869|NCT02528357|102099194|FG012|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||14||
48718870|NCT02528357|102099195|FG013|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||12||
48305382|NCT05671653|101074807|FG010|COMPLETED|Cohort 2 Period 1 - Treatment||0||
48305383|NCT05671653|101074808|FG011|COMPLETED|Cohort 2 Period 1 - Treatment||0||
48305384|NCT05671653|101074809|FG012|COMPLETED|Cohort 2 Period 1 - Treatment||0||
48305385|NCT05671653|101074797|FG000|NOT COMPLETED|Cohort 2 Period 1 - Treatment||0||
48305386|NCT05671653|101074798|FG001|NOT COMPLETED|Cohort 2 Period 1 - Treatment||0||
48305387|NCT05671653|101074799|FG002|NOT COMPLETED|Cohort 2 Period 1 - Treatment||0||
48305388|NCT05671653|101074800|FG003|NOT COMPLETED|Cohort 2 Period 1 - Treatment||0||
48305389|NCT05671653|101074801|FG004|NOT COMPLETED|Cohort 2 Period 1 - Treatment||0||
48305390|NCT05671653|101074802|FG005|NOT COMPLETED|Cohort 2 Period 1 - Treatment||0||
48305391|NCT05671653|101074803|FG006|NOT COMPLETED|Cohort 2 Period 1 - Treatment||0||
48305392|NCT05671653|101074804|FG007|NOT COMPLETED|Cohort 2 Period 1 - Treatment||0||
48305393|NCT05671653|101074805|FG008|NOT COMPLETED|Cohort 2 Period 1 - Treatment||0||
48607305|NCT01679028|101823484|FG000|STARTED|Overall Study||2||
48607306|NCT01679028|101823485|FG001|STARTED|Overall Study||4||
48607307|NCT01679028|101823486|FG002|STARTED|Overall Study||2||
48607308|NCT01679028|101823487|FG003|STARTED|Overall Study||4||
48607309|NCT01679028|101823488|FG004|STARTED|Overall Study||2||
48607310|NCT01679028|101823489|FG005|STARTED|Overall Study||6||
48607311|NCT01679028|101823484|FG000|COMPLETED|Overall Study||2||
48607312|NCT01679028|101823485|FG001|COMPLETED|Overall Study||4||
48607313|NCT01679028|101823486|FG002|COMPLETED|Overall Study||2||
48607314|NCT01679028|101823487|FG003|COMPLETED|Overall Study||4||
48607315|NCT01679028|101823488|FG004|COMPLETED|Overall Study||2||
48607316|NCT01679028|101823489|FG005|COMPLETED|Overall Study||6||
48607317|NCT01679028|101823484|FG000|NOT COMPLETED|Overall Study||0||
48607318|NCT01679028|101823485|FG001|NOT COMPLETED|Overall Study||0||
48607319|NCT01679028|101823486|FG002|NOT COMPLETED|Overall Study||0||
48607320|NCT01679028|101823487|FG003|NOT COMPLETED|Overall Study||0||
48607321|NCT01679028|101823488|FG004|NOT COMPLETED|Overall Study||0||
48607322|NCT01679028|101823489|FG005|NOT COMPLETED|Overall Study||0||
48607323|NCT00625183|101823490|FG000|STARTED|Overall Study||5||
48607324|NCT00625183|101823490|FG000|COMPLETED|Overall Study||4||
48607325|NCT00625183|101823490|FG000|NOT COMPLETED|Overall Study||1||
48607326|NCT02362191|101823491|FG000|STARTED|Overall Study||5||
48607327|NCT02362191|101823491|FG000|COMPLETED|Overall Study||3||
48607328|NCT02362191|101823491|FG000|NOT COMPLETED|Overall Study||2||
48607329|NCT02066727|101823492|FG000|STARTED|Overall Study||30||
48607330|NCT02066727|101823493|FG001|STARTED|Overall Study||30||
48607331|NCT02066727|101823492|FG000|COMPLETED|Overall Study||30||
48607332|NCT02066727|101823493|FG001|COMPLETED|Overall Study||30||
48607333|NCT02066727|101823492|FG000|NOT COMPLETED|Overall Study||0||
48607334|NCT02066727|101823493|FG001|NOT COMPLETED|Overall Study||0||
48607335|NCT01900847|101823494|FG000|STARTED|Overall Study||10||
48607336|NCT01900847|101823495|FG001|STARTED|Overall Study||7||
48607337|NCT01900847|101823494|FG000|COMPLETED|Overall Study||10||
48607338|NCT01900847|101823495|FG001|COMPLETED|Overall Study||7||
48607339|NCT01900847|101823494|FG000|NOT COMPLETED|Overall Study||0||
48607340|NCT01900847|101823495|FG001|NOT COMPLETED|Overall Study||0||
48607341|NCT02020135|101823496|FG000|STARTED|Overall Study||9||
48607342|NCT02020135|101823496|FG000|COMPLETED|Overall Study||0||
48607343|NCT02020135|101823496|FG000|NOT COMPLETED|Overall Study||9||
48607344|NCT01928199|101823497|FG000|STARTED|Overall Study||32||
48607345|NCT01928199|101823498|FG001|STARTED|Overall Study||29||
48607346|NCT01928199|101823497|FG000|COMPLETED|Overall Study||27||
48607347|NCT01928199|101823498|FG001|COMPLETED|Overall Study||23||
48607348|NCT01928199|101823497|FG000|NOT COMPLETED|Overall Study||5||
48607349|NCT01928199|101823498|FG001|NOT COMPLETED|Overall Study||6||
48607350|NCT02779075|101823499|FG000|STARTED|Overall Study||16||
48607351|NCT02779075|101823500|FG001|STARTED|Overall Study||13||
48607352|NCT02779075|101823499|FG000|COMPLETED|Overall Study||14||
48607353|NCT02779075|101823500|FG001|COMPLETED|Overall Study||10||
48607354|NCT02779075|101823499|FG000|NOT COMPLETED|Overall Study||2||
48607355|NCT02779075|101823500|FG001|NOT COMPLETED|Overall Study||3||
48607356|NCT01006590|101823501|FG000|STARTED|Overall Study||147||
48607357|NCT01006590|101823502|FG001|STARTED|Overall Study||139||
48607358|NCT01006590|101823501|FG000|COMPLETED|Overall Study||119||
48607359|NCT01006590|101823502|FG001|COMPLETED|Overall Study||107||
48607360|NCT01006590|101823501|FG000|NOT COMPLETED|Overall Study||28||
48607361|NCT01006590|101823502|FG001|NOT COMPLETED|Overall Study||32||
48607362|NCT03539484|101823503|FG000|STARTED|Overall Study||1||
48607363|NCT03539484|101823504|FG001|STARTED|Overall Study||1||
48607364|NCT03539484|101823505|FG002|STARTED|Overall Study||1||
48607365|NCT03539484|101823506|FG003|STARTED|Overall Study||3||
48607366|NCT03539484|101823507|FG004|STARTED|Overall Study||13||
48607367|NCT03539484|101823508|FG005|STARTED|Overall Study||5||
48607368|NCT03539484|101823509|FG006|STARTED|Overall Study||2||
48607369|NCT03539484|101823503|FG000|COMPLETED|Overall Study||0||
48607370|NCT03539484|101823504|FG001|COMPLETED|Overall Study||0||
48607371|NCT03539484|101823505|FG002|COMPLETED|Overall Study||0||
48607372|NCT03539484|101823506|FG003|COMPLETED|Overall Study||0||
48607373|NCT03539484|101823507|FG004|COMPLETED|Overall Study||0||
48607374|NCT03539484|101823508|FG005|COMPLETED|Overall Study||0||
48607375|NCT03539484|101823509|FG006|COMPLETED|Overall Study||0||
48607376|NCT03539484|101823503|FG000|NOT COMPLETED|Overall Study||1||
48607377|NCT03539484|101823504|FG001|NOT COMPLETED|Overall Study||1||
48607378|NCT03539484|101823505|FG002|NOT COMPLETED|Overall Study||1||
48607379|NCT03539484|101823506|FG003|NOT COMPLETED|Overall Study||3||
48607380|NCT03539484|101823507|FG004|NOT COMPLETED|Overall Study||13||
48607381|NCT03539484|101823508|FG005|NOT COMPLETED|Overall Study||5||
48607382|NCT03539484|101823509|FG006|NOT COMPLETED|Overall Study||2||
48607383|NCT00596453|101823510|FG000|STARTED|Overall Study||13||
48607384|NCT00596453|101823511|FG001|STARTED|Overall Study||15||
48607385|NCT00596453|101823510|FG000|COMPLETED|Overall Study||12||
48607386|NCT00596453|101823511|FG001|COMPLETED|Overall Study||12||
48607387|NCT00596453|101823510|FG000|NOT COMPLETED|Overall Study||1||
48607388|NCT00596453|101823511|FG001|NOT COMPLETED|Overall Study||3||
48607389|NCT02330172|101823512|FG000|STARTED|Overall Study||22||
48607390|NCT02330172|101823513|FG001|STARTED|Overall Study||22||
48718871|NCT02528357|102099196|FG014|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||12||
48718872|NCT02528357|102099197|FG015|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||4||
48718873|NCT02528357|102099198|FG016|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
48718874|NCT02528357|102099199|FG017|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
48718875|NCT02528357|102099200|FG018|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
48718876|NCT02528357|102099182|FG000|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
48718877|NCT02528357|102099183|FG001|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
48718878|NCT02528357|102099184|FG002|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
48718879|NCT02528357|102099185|FG003|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
48718880|NCT02528357|102099186|FG004|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
48718881|NCT02528357|102099187|FG005|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
48718882|NCT02528357|102099188|FG006|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
48718883|NCT02528357|102099189|FG007|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
48718884|NCT02528357|102099190|FG008|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||4||
48718885|NCT02528357|102099191|FG009|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||4||
48718886|NCT02528357|102099192|FG010|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||7||
48718887|NCT02528357|102099193|FG011|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||9||
48718888|NCT02528357|102099194|FG012|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||9||
48718889|NCT02528357|102099195|FG013|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||6||
48718890|NCT02528357|102099196|FG014|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||5||
48718891|NCT02528357|102099197|FG015|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||4||
48718892|NCT02528357|102099198|FG016|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
48718893|NCT02528357|102099199|FG017|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
48718894|NCT02528357|102099200|FG018|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
48718895|NCT02528357|102099182|FG000|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
48718896|NCT02528357|102099183|FG001|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
48718897|NCT02528357|102099184|FG002|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
48718898|NCT02528357|102099185|FG003|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
48718899|NCT02528357|102099186|FG004|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
48718900|NCT02528357|102099187|FG005|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
48718901|NCT02528357|102099188|FG006|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
48718902|NCT02528357|102099189|FG007|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
48305394|NCT05671653|101074806|FG009|NOT COMPLETED|Cohort 2 Period 1 - Treatment||0||
48305395|NCT05671653|101074807|FG010|NOT COMPLETED|Cohort 2 Period 1 - Treatment||0||
48718903|NCT02528357|102099190|FG008|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||1||
48718904|NCT02528357|102099191|FG009|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||1||
48718905|NCT02528357|102099192|FG010|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||3||
48718906|NCT02528357|102099193|FG011|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||3||
48718907|NCT02528357|102099194|FG012|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||5||
48718908|NCT02528357|102099195|FG013|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||6||
48718909|NCT02528357|102099196|FG014|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||7||
48718910|NCT02528357|102099197|FG015|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
48718911|NCT02528357|102099198|FG016|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
48718912|NCT02528357|102099199|FG017|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
48718913|NCT02528357|102099200|FG018|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
48718914|NCT02528357|102099182|FG000|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718915|NCT02528357|102099183|FG001|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718916|NCT02528357|102099184|FG002|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718917|NCT02528357|102099185|FG003|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718918|NCT02528357|102099186|FG004|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718919|NCT02528357|102099187|FG005|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718920|NCT02528357|102099188|FG006|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718921|NCT02528357|102099189|FG007|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48305396|NCT05671653|101074808|FG011|NOT COMPLETED|Cohort 2 Period 1 - Treatment||0||
48718922|NCT02528357|102099190|FG008|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718923|NCT02528357|102099191|FG009|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718924|NCT02528357|102099192|FG010|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718925|NCT02528357|102099193|FG011|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718926|NCT02528357|102099194|FG012|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718927|NCT02528357|102099195|FG013|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718928|NCT02528357|102099196|FG014|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718929|NCT02528357|102099197|FG015|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718930|NCT02528357|102099198|FG016|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||9||
48150429|NCT00885092|100692248|FG001|NOT COMPLETED|Period 1, 7 Days||0||
48150430|NCT00885092|100692247|FG000|STARTED|Period 2, 7 Days||20||
48305397|NCT05671653|101074809|FG012|NOT COMPLETED|Cohort 2 Period 1 - Treatment||0||
48305398|NCT05671653|101074797|FG000|STARTED|Cohort 2 Period 2||0||
48305399|NCT05671653|101074798|FG001|STARTED|Cohort 2 Period 2||0||
48305400|NCT05671653|101074799|FG002|STARTED|Cohort 2 Period 2||0||
48718931|NCT02528357|102099199|FG017|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||8||
48718932|NCT02528357|102099200|FG018|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||5||
48718933|NCT02528357|102099182|FG000|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718934|NCT02528357|102099183|FG001|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718935|NCT02528357|102099184|FG002|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718936|NCT02528357|102099185|FG003|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718937|NCT02528357|102099186|FG004|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718938|NCT02528357|102099187|FG005|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718939|NCT02528357|102099188|FG006|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718940|NCT02528357|102099189|FG007|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718941|NCT02528357|102099190|FG008|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718942|NCT02528357|102099191|FG009|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718943|NCT02528357|102099192|FG010|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718944|NCT02528357|102099193|FG011|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718945|NCT02528357|102099194|FG012|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718946|NCT02528357|102099195|FG013|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718947|NCT02528357|102099196|FG014|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718948|NCT02528357|102099197|FG015|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718949|NCT02528357|102099198|FG016|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||6||
48718950|NCT02528357|102099199|FG017|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||4||
48718951|NCT02528357|102099200|FG018|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||2||
48718952|NCT02528357|102099182|FG000|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718953|NCT02528357|102099183|FG001|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718954|NCT02528357|102099184|FG002|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718955|NCT02528357|102099185|FG003|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718956|NCT02528357|102099186|FG004|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718957|NCT02528357|102099187|FG005|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718958|NCT02528357|102099188|FG006|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718959|NCT02528357|102099189|FG007|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718960|NCT02528357|102099190|FG008|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718961|NCT02528357|102099191|FG009|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718962|NCT02528357|102099192|FG010|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718963|NCT02528357|102099193|FG011|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718964|NCT02528357|102099194|FG012|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718965|NCT02528357|102099195|FG013|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718966|NCT02528357|102099196|FG014|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718967|NCT02528357|102099197|FG015|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
48718968|NCT02528357|102099198|FG016|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||3||
48718969|NCT02528357|102099199|FG017|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||4||
48718970|NCT02528357|102099200|FG018|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||3||
48718971|NCT02641522|102099201|FG000|STARTED|Overall Study||10||
48718972|NCT02641522|102099201|FG000|COMPLETED|Overall Study||10||
48718973|NCT02641522|102099201|FG000|NOT COMPLETED|Overall Study||0||
48718974|NCT01035346|102099202|FG000|STARTED|Overall Study||7||
48718975|NCT01035346|102099203|FG001|STARTED|Overall Study||9||
48718976|NCT01035346|102099202|FG000|COMPLETED|Overall Study||7||
48718977|NCT01035346|102099203|FG001|COMPLETED|Overall Study||9||
48718978|NCT01035346|102099202|FG000|NOT COMPLETED|Overall Study||0||
48718979|NCT01035346|102099203|FG001|NOT COMPLETED|Overall Study||0||
48718980|NCT03149003|102099204|FG000|STARTED|Overall Study||4||
48718981|NCT03149003|102099205|FG001|STARTED|Overall Study||109||
48718982|NCT03149003|102099206|FG002|STARTED|Overall Study||108||
48305401|NCT05671653|101074800|FG003|STARTED|Cohort 2 Period 2||0||
48305402|NCT05671653|101074801|FG004|STARTED|Cohort 2 Period 2||0||
48305403|NCT05671653|101074802|FG005|STARTED|Cohort 2 Period 2||0||
48305404|NCT05671653|101074803|FG006|STARTED|Cohort 2 Period 2||0||
48305405|NCT05671653|101074804|FG007|STARTED|Cohort 2 Period 2||0||
48305406|NCT05671653|101074805|FG008|STARTED|Cohort 2 Period 2||0||
48305407|NCT05671653|101074806|FG009|STARTED|Cohort 2 Period 2||0||
48305408|NCT05671653|101074807|FG010|STARTED|Cohort 2 Period 2||16||
48718983|NCT03149003|102099204|FG000|COMPLETED|Overall Study||4||
48718984|NCT03149003|102099205|FG001|COMPLETED|Overall Study||108||
48718985|NCT03149003|102099206|FG002|COMPLETED|Overall Study||90||
48718986|NCT03149003|102099204|FG000|NOT COMPLETED|Overall Study||0||
48305409|NCT05671653|101074808|FG011|STARTED|Cohort 2 Period 2||0||
48305410|NCT05671653|101074809|FG012|STARTED|Cohort 2 Period 2||0||
48718987|NCT03149003|102099205|FG001|NOT COMPLETED|Overall Study||1||
48718988|NCT03149003|102099206|FG002|NOT COMPLETED|Overall Study||18||
48718989|NCT00412074|102099207|FG000|STARTED|Overall Study||199||
48718990|NCT00412074|102099208|FG001|STARTED|Overall Study||66||
48718991|NCT00412074|102099209|FG002|STARTED|Overall Study||195||
48718992|NCT00412074|102099207|FG000|COMPLETED|Overall Study||122||
48718993|NCT00412074|102099208|FG001|COMPLETED|Overall Study||44||
48718994|NCT00412074|102099209|FG002|COMPLETED|Overall Study||128||
48718995|NCT00412074|102099207|FG000|NOT COMPLETED|Overall Study||77||
48150431|NCT00885092|100692248|FG001|STARTED|Period 2, 7 Days||20||
48150432|NCT00885092|100692247|FG000|COMPLETED|Period 2, 7 Days||20||
48150433|NCT00885092|100692248|FG001|COMPLETED|Period 2, 7 Days||20||
48150434|NCT00885092|100692247|FG000|NOT COMPLETED|Period 2, 7 Days||0||
48150435|NCT00885092|100692248|FG001|NOT COMPLETED|Period 2, 7 Days||0||
48150436|NCT02396745|100692249|FG000|STARTED|Overall Study||1||
48150437|NCT02396745|100692249|FG000|COMPLETED|Overall Study||1||
48150438|NCT02396745|100692249|FG000|NOT COMPLETED|Overall Study||0||
48150439|NCT02275065|100692250|FG000|STARTED|Overall Study||5||
48150440|NCT02275065|100692251|FG001|STARTED|Overall Study||4||
48150441|NCT02275065|100692252|FG002|STARTED|Overall Study||5||
48150442|NCT02275065|100692253|FG003|STARTED|Overall Study||5||
48305411|NCT05671653|101074797|FG000|COMPLETED|Cohort 2 Period 2||0||
48305412|NCT05671653|101074798|FG001|COMPLETED|Cohort 2 Period 2||0||
48305413|NCT05671653|101074799|FG002|COMPLETED|Cohort 2 Period 2||0||
48305414|NCT05671653|101074800|FG003|COMPLETED|Cohort 2 Period 2||0||
48718996|NCT00412074|102099208|FG001|NOT COMPLETED|Overall Study||22||
48718997|NCT00412074|102099209|FG002|NOT COMPLETED|Overall Study||67||
48150443|NCT02275065|100692254|FG004|STARTED|Overall Study||4||
48150444|NCT02275065|100692250|FG000|COMPLETED|Overall Study||4||
48150445|NCT02275065|100692251|FG001|COMPLETED|Overall Study||4||
48150446|NCT02275065|100692252|FG002|COMPLETED|Overall Study||4||
48150447|NCT02275065|100692253|FG003|COMPLETED|Overall Study||4||
48150448|NCT02275065|100692254|FG004|COMPLETED|Overall Study||4||
48150449|NCT02275065|100692250|FG000|NOT COMPLETED|Overall Study||1||
48305415|NCT05671653|101074801|FG004|COMPLETED|Cohort 2 Period 2||0||
48305416|NCT05671653|101074802|FG005|COMPLETED|Cohort 2 Period 2||0||
48305417|NCT05671653|101074803|FG006|COMPLETED|Cohort 2 Period 2||0||
48305418|NCT05671653|101074804|FG007|COMPLETED|Cohort 2 Period 2||0||
48305419|NCT05671653|101074805|FG008|COMPLETED|Cohort 2 Period 2||0||
48305420|NCT05671653|101074806|FG009|COMPLETED|Cohort 2 Period 2||0||
48305421|NCT05671653|101074807|FG010|COMPLETED|Cohort 2 Period 2||11||
48305422|NCT05671653|101074808|FG011|COMPLETED|Cohort 2 Period 2||0||
48305423|NCT05671653|101074809|FG012|COMPLETED|Cohort 2 Period 2||0||
48305424|NCT05671653|101074797|FG000|NOT COMPLETED|Cohort 2 Period 2||0||
48305425|NCT05671653|101074798|FG001|NOT COMPLETED|Cohort 2 Period 2||0||
48305426|NCT05671653|101074799|FG002|NOT COMPLETED|Cohort 2 Period 2||0||
48305427|NCT05671653|101074800|FG003|NOT COMPLETED|Cohort 2 Period 2||0||
48305428|NCT05671653|101074801|FG004|NOT COMPLETED|Cohort 2 Period 2||0||
48305429|NCT05671653|101074802|FG005|NOT COMPLETED|Cohort 2 Period 2||0||
48305430|NCT05671653|101074803|FG006|NOT COMPLETED|Cohort 2 Period 2||0||
48305431|NCT05671653|101074804|FG007|NOT COMPLETED|Cohort 2 Period 2||0||
48305432|NCT05671653|101074805|FG008|NOT COMPLETED|Cohort 2 Period 2||0||
48305433|NCT05671653|101074806|FG009|NOT COMPLETED|Cohort 2 Period 2||0||
48305434|NCT05671653|101074807|FG010|NOT COMPLETED|Cohort 2 Period 2||5||
48305435|NCT05671653|101074808|FG011|NOT COMPLETED|Cohort 2 Period 2||0||
48406121|NCT01611311|101328352|FG005|NOT COMPLETED|Overall Study||0||
48607391|NCT02330172|101823512|FG000|COMPLETED|Overall Study||19||
48607392|NCT02330172|101823513|FG001|COMPLETED|Overall Study||21||
48607393|NCT02330172|101823512|FG000|NOT COMPLETED|Overall Study||3||
48607394|NCT02330172|101823513|FG001|NOT COMPLETED|Overall Study||1||
48607395|NCT01148459|101823514|FG000|STARTED|Overall Study||99||
48607396|NCT01148459|101823515|FG001|STARTED|Overall Study||101||
48607397|NCT01148459|101823514|FG000|COMPLETED|Overall Study||87||
48607398|NCT01148459|101823515|FG001|COMPLETED|Overall Study||90||
48607399|NCT01148459|101823514|FG000|NOT COMPLETED|Overall Study||12||
48607400|NCT01148459|101823515|FG001|NOT COMPLETED|Overall Study||11||
48607401|NCT01681095|101823516|FG000|STARTED|Overall Study||55||
48607402|NCT01681095|101823517|FG001|STARTED|Overall Study||55||
48607403|NCT01681095|101823516|FG000|COMPLETED|Overall Study||55||
48607404|NCT01681095|101823517|FG001|COMPLETED|Overall Study||55||
48607405|NCT01681095|101823516|FG000|NOT COMPLETED|Overall Study||0||
48607406|NCT01681095|101823517|FG001|NOT COMPLETED|Overall Study||0||
48607407|NCT03151083|101823518|FG000|STARTED|Overall Study||27||
48607408|NCT03151083|101823519|FG001|STARTED|Overall Study||20||
48607409|NCT03151083|101823520|FG002|STARTED|Overall Study||30||
48607410|NCT03151083|101823518|FG000|COMPLETED|Overall Study||25||
48607411|NCT03151083|101823519|FG001|COMPLETED|Overall Study||19||
48607412|NCT03151083|101823520|FG002|COMPLETED|Overall Study||26||
48305436|NCT05671653|101074809|FG012|NOT COMPLETED|Cohort 2 Period 2||0||
48305437|NCT05671653|101074797|FG000|STARTED|Cohort 2 Period 3 - Treatment||0||
48305438|NCT05671653|101074798|FG001|STARTED|Cohort 2 Period 3 - Treatment||0||
48305439|NCT05671653|101074799|FG002|STARTED|Cohort 2 Period 3 - Treatment||0||
48305440|NCT05671653|101074800|FG003|STARTED|Cohort 2 Period 3 - Treatment||0||
48305441|NCT05671653|101074801|FG004|STARTED|Cohort 2 Period 3 - Treatment||0||
48305442|NCT05671653|101074802|FG005|STARTED|Cohort 2 Period 3 - Treatment||0||
48305443|NCT05671653|101074803|FG006|STARTED|Cohort 2 Period 3 - Treatment||0||
48607413|NCT03151083|101823518|FG000|NOT COMPLETED|Overall Study||2||
48718998|NCT03675516|102099210|FG000|STARTED|Overall Study||6591||
48305444|NCT05671653|101074804|FG007|STARTED|Cohort 2 Period 3 - Treatment||0||
48305445|NCT05671653|101074805|FG008|STARTED|Cohort 2 Period 3 - Treatment||0||
48406122|NCT04063865|101328353|FG000|STARTED|Overall Study||6||
48607414|NCT03151083|101823519|FG001|NOT COMPLETED|Overall Study||1||
48718999|NCT03675516|102099211|FG001|STARTED|Overall Study||6591||
48719000|NCT03675516|102099210|FG000|COMPLETED|Overall Study||6591||
48719001|NCT03675516|102099211|FG001|COMPLETED|Overall Study||6591||
48719002|NCT03675516|102099210|FG000|NOT COMPLETED|Overall Study||0||
48719003|NCT03675516|102099211|FG001|NOT COMPLETED|Overall Study||0||
48719004|NCT00286221|102099212|FG000|STARTED|Overall Study||39||
48719005|NCT00286221|102099213|FG001|STARTED|Overall Study||40||
48719006|NCT00286221|102099214|FG002|STARTED|Overall Study||40||
48719007|NCT00286221|102099215|FG003|STARTED|Overall Study||40||
48719008|NCT00286221|102099212|FG000|COMPLETED|Overall Study||29||
48719009|NCT00286221|102099213|FG001|COMPLETED|Overall Study||35||
48719010|NCT00286221|102099214|FG002|COMPLETED|Overall Study||31||
48719011|NCT00286221|102099215|FG003|COMPLETED|Overall Study||34||
48719012|NCT00286221|102099212|FG000|NOT COMPLETED|Overall Study||10||
48719013|NCT00286221|102099213|FG001|NOT COMPLETED|Overall Study||5||
48719014|NCT00286221|102099214|FG002|NOT COMPLETED|Overall Study||9||
48719015|NCT00286221|102099215|FG003|NOT COMPLETED|Overall Study||6||
48719016|NCT01656629|102099216|FG000|STARTED|Overall Study||21||
48719017|NCT01656629|102099217|FG001|STARTED|Overall Study||18||
48719018|NCT01656629|102099218|FG002|STARTED|Overall Study||16||
48719019|NCT01656629|102099216|FG000|COMPLETED|Overall Study||16||
48719020|NCT01656629|102099217|FG001|COMPLETED|Overall Study||16||
48719021|NCT01656629|102099218|FG002|COMPLETED|Overall Study||14||
48719022|NCT01656629|102099216|FG000|NOT COMPLETED|Overall Study||5||
48719023|NCT01656629|102099217|FG001|NOT COMPLETED|Overall Study||2||
48719024|NCT01656629|102099218|FG002|NOT COMPLETED|Overall Study||2||
48719025|NCT04349033|102099219|FG000|STARTED|Overall Study||29||
48719026|NCT04349033|102099220|FG001|STARTED|Overall Study||34||
48719027|NCT04349033|102099221|FG002|STARTED|Overall Study||31||
48719028|NCT04349033|102099219|FG000|COMPLETED|Overall Study||26||
48719029|NCT04349033|102099220|FG001|COMPLETED|Overall Study||33||
48719030|NCT04349033|102099221|FG002|COMPLETED|Overall Study||30||
48719031|NCT04349033|102099219|FG000|NOT COMPLETED|Overall Study||3||
48719032|NCT04349033|102099220|FG001|NOT COMPLETED|Overall Study||1||
48719033|NCT04349033|102099221|FG002|NOT COMPLETED|Overall Study||1||
48719034|NCT02712424|102099222|FG000|STARTED|Overall Study||315||
48719035|NCT02712424|102099223|FG001|STARTED|Overall Study||310||
48719036|NCT02712424|102099222|FG000|COMPLETED|Overall Study||281||
48719037|NCT02712424|102099223|FG001|COMPLETED|Overall Study||278||
48719038|NCT02712424|102099222|FG000|NOT COMPLETED|Overall Study||34||
48719039|NCT02712424|102099223|FG001|NOT COMPLETED|Overall Study||32||
48719040|NCT02008357|102099224|FG000|STARTED|Double-blind (Placebo Controlled) Period||578||
48719041|NCT02008357|102099225|FG001|STARTED|Double-blind (Placebo Controlled) Period||591||
48719042|NCT02008357|102099224|FG000|COMPLETED|Double-blind (Placebo Controlled) Period||406||
48719043|NCT02008357|102099225|FG001|COMPLETED|Double-blind (Placebo Controlled) Period||424||
48719044|NCT02008357|102099224|FG000|NOT COMPLETED|Double-blind (Placebo Controlled) Period||172||
48719045|NCT02008357|102099225|FG001|NOT COMPLETED|Double-blind (Placebo Controlled) Period||167||
48719046|NCT02008357|102099224|FG000|STARTED|Open-label Extension Period||383||
48719047|NCT02008357|102099225|FG001|STARTED|Open-label Extension Period||401||
48719048|NCT02008357|102099224|FG000|COMPLETED|Open-label Extension Period||1||
48719049|NCT02008357|102099225|FG001|COMPLETED|Open-label Extension Period||1||
48719050|NCT02008357|102099224|FG000|NOT COMPLETED|Open-label Extension Period||382||
48719051|NCT02008357|102099225|FG001|NOT COMPLETED|Open-label Extension Period||400||
48719052|NCT00637572|102099226|FG000|STARTED|Overall Study||32||
48719053|NCT00637572|102099227|FG001|STARTED|Overall Study||31||
48719054|NCT00637572|102099226|FG000|COMPLETED|Overall Study||29||
48719055|NCT00637572|102099227|FG001|COMPLETED|Overall Study||24||
48719056|NCT00637572|102099226|FG000|NOT COMPLETED|Overall Study||3||
48719057|NCT00637572|102099227|FG001|NOT COMPLETED|Overall Study||7||
48719058|NCT02989805|102099228|FG000|STARTED|Overall Study||160||
48719059|NCT02989805|102099229|FG001|STARTED|Overall Study||166||
48719060|NCT02989805|102099228|FG000|COMPLETED|Overall Study||154||
48719061|NCT02989805|102099229|FG001|COMPLETED|Overall Study||162||
48719062|NCT02989805|102099228|FG000|NOT COMPLETED|Overall Study||6||
48719063|NCT02989805|102099229|FG001|NOT COMPLETED|Overall Study||4||
48719064|NCT00316524|102099230|FG000|STARTED|Overall Study||183|Vaccinated|
48719065|NCT00316524|102099231|FG001|STARTED|Overall Study||181|Vaccinated|
48719066|NCT00316524|102099232|FG002|STARTED|Overall Study||181|Vaccinated|
48719067|NCT00316524|102099233|FG003|STARTED|Overall Study||200|Vaccinated|
48719068|NCT00316524|102099230|FG000|COMPLETED|Overall Study||175|Active Trial Phase|
48719069|NCT00316524|102099231|FG001|COMPLETED|Overall Study||173|Active Trial Phase|
48719070|NCT00316524|102099232|FG002|COMPLETED|Overall Study||175|Active Trial Phase|
48719071|NCT00316524|102099233|FG003|COMPLETED|Overall Study||200|Active Trial Phase|
48719072|NCT00316524|102099230|FG000|NOT COMPLETED|Overall Study||8||
48719073|NCT00316524|102099231|FG001|NOT COMPLETED|Overall Study||8||
48719074|NCT00316524|102099232|FG002|NOT COMPLETED|Overall Study||6||
48719075|NCT00316524|102099233|FG003|NOT COMPLETED|Overall Study||0||
48719076|NCT01475162|102099234|FG000|STARTED|Overall Study||14||
48719077|NCT01475162|102099234|FG000|COMPLETED|Overall Study||0||
48719078|NCT01475162|102099234|FG000|NOT COMPLETED|Overall Study||14||
48719079|NCT02392403|102099235|FG000|STARTED|Overall Study||45||
48719080|NCT02392403|102099235|FG000|COMPLETED|Overall Study||42||
48150450|NCT02275065|100692251|FG001|NOT COMPLETED|Overall Study||0||
48150451|NCT02275065|100692252|FG002|NOT COMPLETED|Overall Study||1||
48150452|NCT02275065|100692253|FG003|NOT COMPLETED|Overall Study||1||
48150453|NCT02275065|100692254|FG004|NOT COMPLETED|Overall Study||0||
48150454|NCT00833560|100692255|FG000|STARTED|Overall Study||395||
48150455|NCT00833560|100692255|FG000|COMPLETED|Overall Study||353||
48150456|NCT00833560|100692255|FG000|NOT COMPLETED|Overall Study||42||
48150457|NCT02865720|100692256|FG000|STARTED|Overall Study||0||
48150458|NCT02865720|100692257|FG001|STARTED|Overall Study||8||
48150459|NCT02865720|100692256|FG000|COMPLETED|Overall Study||0||
48150460|NCT02865720|100692257|FG001|COMPLETED|Overall Study||8||
48150461|NCT02865720|100692256|FG000|NOT COMPLETED|Overall Study||0||
48150462|NCT02865720|100692257|FG001|NOT COMPLETED|Overall Study||0||
48150463|NCT01499082|100692258|FG000|STARTED|Overall Study||404||
48150464|NCT01499082|100692259|FG001|STARTED|Overall Study||403||
48150465|NCT01499082|100692258|FG000|Treated|Overall Study||404||
48150466|NCT01499082|100692259|FG001|Treated|Overall Study||402||
48150467|NCT01499082|100692258|FG000|Participated in Substudy|Overall Study||109||
48150468|NCT01499082|100692259|FG001|Participated in Substudy|Overall Study||0||
48150469|NCT01499082|100692258|FG000|Modified Intent-to-Treat Population|Overall Study||404||
48150470|NCT01499082|100692259|FG001|Modified Intent-to-Treat Population|Overall Study||400||
48150471|NCT01499082|100692258|FG000|COMPLETED|Overall Study||359||
48150472|NCT01499082|100692259|FG001|COMPLETED|Overall Study||355||
48150473|NCT01499082|100692258|FG000|NOT COMPLETED|Overall Study||45||
48607415|NCT03151083|101823520|FG002|NOT COMPLETED|Overall Study||4||
48607416|NCT00822328|101823521|FG000|STARTED|Overall Study||12||
48607417|NCT00822328|101823522|FG001|STARTED|Overall Study||12||
48150474|NCT01499082|100692259|FG001|NOT COMPLETED|Overall Study||48||
48607418|NCT00822328|101823521|FG000|COMPLETED|Overall Study||12||
48607419|NCT00822328|101823522|FG001|COMPLETED|Overall Study||12||
48607420|NCT00822328|101823521|FG000|NOT COMPLETED|Overall Study||0||
48607421|NCT00822328|101823522|FG001|NOT COMPLETED|Overall Study||0||
48607422|NCT00187278|101823523|FG000|STARTED|Overall Study||918||
48607423|NCT00187278|101823524|FG001|STARTED|Overall Study||915||
48607424|NCT00187278|101823523|FG000|COMPLETED|Overall Study||908||
48607425|NCT00187278|101823524|FG001|COMPLETED|Overall Study||902||
48607426|NCT00187278|101823523|FG000|NOT COMPLETED|Overall Study||10||
48607427|NCT00187278|101823524|FG001|NOT COMPLETED|Overall Study||13||
48607428|NCT03678675|101823525|FG000|STARTED|Overall Study||74||
48607429|NCT03678675|101823526|FG001|STARTED|Overall Study||74||
48607430|NCT03678675|101823525|FG000|COMPLETED|Overall Study||74||
48607431|NCT03678675|101823526|FG001|COMPLETED|Overall Study||74||
48607432|NCT03678675|101823525|FG000|NOT COMPLETED|Overall Study||0||
48607433|NCT03678675|101823526|FG001|NOT COMPLETED|Overall Study||0||
48607434|NCT01306214|101823527|FG000|STARTED|Overall Study||189||
48607435|NCT01306214|101823528|FG001|STARTED|Overall Study||187||
48607436|NCT01306214|101823529|FG002|STARTED|Overall Study||190||
48607437|NCT01306214|101823527|FG000|COMPLETED|Overall Study||161||
48607438|NCT01306214|101823528|FG001|COMPLETED|Overall Study||159||
48607439|NCT01306214|101823529|FG002|COMPLETED|Overall Study||168||
48607440|NCT01306214|101823527|FG000|NOT COMPLETED|Overall Study||28||
48607441|NCT01306214|101823528|FG001|NOT COMPLETED|Overall Study||28||
48607442|NCT01306214|101823529|FG002|NOT COMPLETED|Overall Study||22||
48607443|NCT01490840|101823530|FG000|STARTED|Phase 1||94||
48607444|NCT01490840|101823531|FG001|STARTED|Phase 1||84||
48607445|NCT01490840|101823530|FG000|Modified Full Analysis Set|Phase 1||56||
48607446|NCT01490840|101823531|FG001|Modified Full Analysis Set|Phase 1||83||
48607447|NCT01490840|101823530|FG000|COMPLETED|Phase 1||84||
48150475|NCT01032733|100692260|FG000|STARTED|Overall Study||17||
48150476|NCT01032733|100692261|FG001|STARTED|Overall Study||17||
48150477|NCT01032733|100692260|FG000|COMPLETED|Overall Study||16||
48150478|NCT01032733|100692261|FG001|COMPLETED|Overall Study||16||
48150479|NCT01032733|100692260|FG000|NOT COMPLETED|Overall Study||1||
48150480|NCT01032733|100692261|FG001|NOT COMPLETED|Overall Study||1||
48150481|NCT00566579|100692262|FG000|STARTED|Overall Study||29||
48150482|NCT00566579|100692263|FG001|STARTED|Overall Study||31||
48150483|NCT00566579|100692262|FG000|COMPLETED|Overall Study||29||
48607448|NCT01490840|101823531|FG001|COMPLETED|Phase 1||78||
48607449|NCT01490840|101823530|FG000|NOT COMPLETED|Phase 1||10||
48607450|NCT01490840|101823531|FG001|NOT COMPLETED|Phase 1||6||
48607451|NCT01490840|101823530|FG000|STARTED|Phase 2||81||
48607452|NCT01490840|101823531|FG001|STARTED|Phase 2||74||
48607453|NCT01490840|101823530|FG000|COMPLETED|Phase 2||75||
48607454|NCT01490840|101823531|FG001|COMPLETED|Phase 2||68||
48607455|NCT01490840|101823530|FG000|NOT COMPLETED|Phase 2||6||
48607456|NCT01490840|101823531|FG001|NOT COMPLETED|Phase 2||6||
48150484|NCT00566579|100692263|FG001|COMPLETED|Overall Study||31||
48150485|NCT00566579|100692262|FG000|NOT COMPLETED|Overall Study||0||
48150486|NCT00566579|100692263|FG001|NOT COMPLETED|Overall Study||0||
48150487|NCT03371940|100692264|FG000|STARTED|Overall Study||36||
48150488|NCT03371940|100692265|FG001|STARTED|Overall Study||34||
48150489|NCT03371940|100692266|FG002|STARTED|Overall Study||34||
48150490|NCT03371940|100692267|FG003|STARTED|Overall Study||36||
48150491|NCT03371940|100692264|FG000|COMPLETED|Overall Study||28||
48150492|NCT03371940|100692265|FG001|COMPLETED|Overall Study||33||
48607457|NCT03319810|101823532|FG000|STARTED|Overall Study||5||
48607458|NCT03319810|101823532|FG000|COMPLETED|Overall Study||5||
48607459|NCT03319810|101823532|FG000|NOT COMPLETED|Overall Study||0||
48607460|NCT00915603|101823533|FG000|STARTED|Overall Study||56||
48607461|NCT00915603|101823534|FG001|STARTED|Overall Study||55||
48607462|NCT00915603|101823533|FG000|COMPLETED|Overall Study||0||
48607463|NCT00915603|101823534|FG001|COMPLETED|Overall Study||0||
48607464|NCT00915603|101823533|FG000|NOT COMPLETED|Overall Study||56||
48607465|NCT00915603|101823534|FG001|NOT COMPLETED|Overall Study||55||
48607466|NCT01301079|101823535|FG000|STARTED|Overall Study||30||
48607467|NCT01301079|101823536|FG001|STARTED|Overall Study||30||
48607468|NCT01301079|101823535|FG000|COMPLETED|Overall Study||28||
48607469|NCT01301079|101823536|FG001|COMPLETED|Overall Study||28||
48607470|NCT01301079|101823535|FG000|NOT COMPLETED|Overall Study||2||
48607471|NCT01301079|101823536|FG001|NOT COMPLETED|Overall Study||2||
48719081|NCT02392403|102099235|FG000|NOT COMPLETED|Overall Study||3||
48719082|NCT00277394|102099236|FG000|STARTED|Overall Study||269||
48719083|NCT00277394|102099237|FG001|STARTED|Overall Study||270||
48150493|NCT03371940|100692266|FG002|COMPLETED|Overall Study||31||
48150494|NCT03371940|100692267|FG003|COMPLETED|Overall Study||32||
48150495|NCT03371940|100692264|FG000|NOT COMPLETED|Overall Study||8||
48150496|NCT03371940|100692265|FG001|NOT COMPLETED|Overall Study||1||
48150497|NCT03371940|100692266|FG002|NOT COMPLETED|Overall Study||3||
48150498|NCT03371940|100692267|FG003|NOT COMPLETED|Overall Study||4||
48150499|NCT01693068|100692268|FG000|STARTED|Randomization Period||64||
48719084|NCT00277394|102099236|FG000|COMPLETED|Overall Study||232||
48719085|NCT00277394|102099237|FG001|COMPLETED|Overall Study||246||
48719086|NCT00277394|102099236|FG000|NOT COMPLETED|Overall Study||37||
48719087|NCT00277394|102099237|FG001|NOT COMPLETED|Overall Study||24||
48719088|NCT01797380|102099238|FG000|STARTED|Overall Study||3||
48719089|NCT01797380|102099239|FG001|STARTED|Overall Study||2||
48719090|NCT01797380|102099238|FG000|COMPLETED|Overall Study||0||
48719091|NCT01797380|102099239|FG001|COMPLETED|Overall Study||0||
48719092|NCT01797380|102099238|FG000|NOT COMPLETED|Overall Study||3||
48719093|NCT01797380|102099239|FG001|NOT COMPLETED|Overall Study||2||
48719094|NCT01389323|102099240|FG000|STARTED|Treatment Period (up to 48 Weeks)||246||
48719095|NCT01389323|102099240|FG000|COMPLETED|Treatment Period (up to 48 Weeks)||151||
48150500|NCT01693068|100692269|FG001|STARTED|Randomization Period||130||
48607472|NCT02092649|101823537|FG000|STARTED|Overall Study||13||
48607473|NCT02092649|101823538|FG001|STARTED|Overall Study||13||
48719096|NCT01389323|102099240|FG000|NOT COMPLETED|Treatment Period (up to 48 Weeks)||95||
48719097|NCT01389323|102099240|FG000|STARTED|Follow-up Period (up to 48 Weeks)||221||
48719098|NCT01389323|102099240|FG000|COMPLETED|Follow-up Period (up to 48 Weeks)||184||
48607474|NCT02092649|101823537|FG000|COMPLETED|Overall Study||13||
48719099|NCT01389323|102099240|FG000|NOT COMPLETED|Follow-up Period (up to 48 Weeks)||37||
48305446|NCT05671653|101074806|FG009|STARTED|Cohort 2 Period 3 - Treatment||0||
48305447|NCT05671653|101074807|FG010|STARTED|Cohort 2 Period 3 - Treatment||0||
48305448|NCT05671653|101074808|FG011|STARTED|Cohort 2 Period 3 - Treatment||11||
48305449|NCT05671653|101074809|FG012|STARTED|Cohort 2 Period 3 - Treatment||0||
48305450|NCT05671653|101074797|FG000|COMPLETED|Cohort 2 Period 3 - Treatment||0||
48305451|NCT05671653|101074798|FG001|COMPLETED|Cohort 2 Period 3 - Treatment||0||
48305452|NCT05671653|101074799|FG002|COMPLETED|Cohort 2 Period 3 - Treatment||0||
48305453|NCT05671653|101074800|FG003|COMPLETED|Cohort 2 Period 3 - Treatment||0||
48305454|NCT05671653|101074801|FG004|COMPLETED|Cohort 2 Period 3 - Treatment||0||
48305455|NCT05671653|101074802|FG005|COMPLETED|Cohort 2 Period 3 - Treatment||0||
48305456|NCT05671653|101074803|FG006|COMPLETED|Cohort 2 Period 3 - Treatment||0||
48305457|NCT05671653|101074804|FG007|COMPLETED|Cohort 2 Period 3 - Treatment||0||
48305458|NCT05671653|101074805|FG008|COMPLETED|Cohort 2 Period 3 - Treatment||0||
48305459|NCT05671653|101074806|FG009|COMPLETED|Cohort 2 Period 3 - Treatment||0||
48305460|NCT05671653|101074807|FG010|COMPLETED|Cohort 2 Period 3 - Treatment||0||
48305461|NCT05671653|101074808|FG011|COMPLETED|Cohort 2 Period 3 - Treatment||10||
48305462|NCT05671653|101074809|FG012|COMPLETED|Cohort 2 Period 3 - Treatment||0||
48305463|NCT05671653|101074797|FG000|NOT COMPLETED|Cohort 2 Period 3 - Treatment||0||
48305464|NCT05671653|101074798|FG001|NOT COMPLETED|Cohort 2 Period 3 - Treatment||0||
48305465|NCT05671653|101074799|FG002|NOT COMPLETED|Cohort 2 Period 3 - Treatment||0||
48305466|NCT05671653|101074800|FG003|NOT COMPLETED|Cohort 2 Period 3 - Treatment||0||
48305467|NCT05671653|101074801|FG004|NOT COMPLETED|Cohort 2 Period 3 - Treatment||0||
48305468|NCT05671653|101074802|FG005|NOT COMPLETED|Cohort 2 Period 3 - Treatment||0||
48305469|NCT05671653|101074803|FG006|NOT COMPLETED|Cohort 2 Period 3 - Treatment||0||
48305470|NCT05671653|101074804|FG007|NOT COMPLETED|Cohort 2 Period 3 - Treatment||0||
48305471|NCT05671653|101074805|FG008|NOT COMPLETED|Cohort 2 Period 3 - Treatment||0||
48305472|NCT05671653|101074806|FG009|NOT COMPLETED|Cohort 2 Period 3 - Treatment||0||
48305473|NCT05671653|101074807|FG010|NOT COMPLETED|Cohort 2 Period 3 - Treatment||0||
48607475|NCT02092649|101823538|FG001|COMPLETED|Overall Study||13||
48607476|NCT02092649|101823537|FG000|NOT COMPLETED|Overall Study||0||
48607477|NCT02092649|101823538|FG001|NOT COMPLETED|Overall Study||0||
48607478|NCT00315614|101823539|FG000|STARTED|Overall Study||3||
48607479|NCT00315614|101823539|FG000|COMPLETED|Overall Study||3||
48607480|NCT00315614|101823539|FG000|NOT COMPLETED|Overall Study||0||
48607481|NCT01949142|101823540|FG000|STARTED|Overall Study||179||
48607482|NCT01949142|101823541|FG001|STARTED|Overall Study||87||
48607483|NCT01949142|101823540|FG000|COMPLETED|Overall Study||176||
48607484|NCT01949142|101823541|FG001|COMPLETED|Overall Study||86||
48607485|NCT01949142|101823540|FG000|NOT COMPLETED|Overall Study||3||
48607486|NCT01949142|101823541|FG001|NOT COMPLETED|Overall Study||1||
48607487|NCT01516736|101823542|FG000|STARTED|Overall Study||155|FAS/SAF full analysis set and safety analysis set|
48607488|NCT01516736|101823543|FG001|STARTED|Overall Study||153|FAS/SAF full analysis set and safety analysis set|
48607489|NCT01516736|101823542|FG000|COMPLETED|Overall Study||135|1 more patient, Neulasta arm died but been withdrawn earlier, not included in participant flow-death|
48607490|NCT01516736|101823543|FG001|COMPLETED|Overall Study||140|1 more patient, Neulasta arm died but been withdrawn earlier, not included in participant flow-death|
48607491|NCT01516736|101823542|FG000|NOT COMPLETED|Overall Study||20||
48607492|NCT01516736|101823543|FG001|NOT COMPLETED|Overall Study||13||
48607493|NCT01310582|101823544|FG000|STARTED|Overall Study||31||
48607494|NCT01310582|101823545|FG001|STARTED|Overall Study||26||
48607495|NCT01310582|101823544|FG000|COMPLETED|Overall Study||31||
48607496|NCT01310582|101823545|FG001|COMPLETED|Overall Study||26||
48607497|NCT01310582|101823544|FG000|NOT COMPLETED|Overall Study||0||
48305474|NCT05671653|101074808|FG011|NOT COMPLETED|Cohort 2 Period 3 - Treatment||1||
48305475|NCT05671653|101074809|FG012|NOT COMPLETED|Cohort 2 Period 3 - Treatment||0||
48607498|NCT01310582|101823545|FG001|NOT COMPLETED|Overall Study||0||
48607499|NCT02347072|101823546|FG000|STARTED|Overall Study||80||
48607500|NCT02347072|101823546|FG000|GFF MDI 14.4/9.6 µg|Overall Study||75||
48607501|NCT02347072|101823546|FG000|Placebo MDI|Overall Study||72||
48607502|NCT02347072|101823546|FG000|Spiriva Respimat 5 µg|Overall Study||73||
48607503|NCT02347072|101823546|FG000|COMPLETED|Overall Study||62||
48607504|NCT02347072|101823546|FG000|NOT COMPLETED|Overall Study||18||
48607505|NCT01887678|101823547|FG000|STARTED|Overall Study||119||
48607506|NCT01887678|101823548|FG001|STARTED|Overall Study||113||
48305476|NCT05671653|101074797|FG000|STARTED|Cohort 2 Period 4 - Treatment||0||
48607507|NCT01887678|101823547|FG000|COMPLETED|Overall Study||102||
48719100|NCT04214639|102099241|FG000|STARTED|Overall Study||122||
48305477|NCT05671653|101074798|FG001|STARTED|Cohort 2 Period 4 - Treatment||0||
48607508|NCT01887678|101823548|FG001|COMPLETED|Overall Study||85||
48607509|NCT01887678|101823547|FG000|NOT COMPLETED|Overall Study||17||
48607510|NCT01887678|101823548|FG001|NOT COMPLETED|Overall Study||28||
48607511|NCT01048944|101823549|FG000|STARTED|Overall Study||32||
48607512|NCT01048944|101823550|FG001|STARTED|Overall Study||38||
48607513|NCT01048944|101823551|FG002|STARTED|Overall Study||35||
48607514|NCT01048944|101823552|FG003|STARTED|Overall Study||21||
48607515|NCT01048944|101823549|FG000|COMPLETED|Overall Study||24||
48607516|NCT01048944|101823550|FG001|COMPLETED|Overall Study||28||
48607517|NCT01048944|101823551|FG002|COMPLETED|Overall Study||25||
48607518|NCT01048944|101823552|FG003|COMPLETED|Overall Study||19||
48719101|NCT04214639|102099242|FG001|STARTED|Overall Study||61||
48719102|NCT04214639|102099241|FG000|COMPLETED|Overall Study||107||
48305478|NCT05671653|101074799|FG002|STARTED|Cohort 2 Period 4 - Treatment||0||
48305479|NCT05671653|101074800|FG003|STARTED|Cohort 2 Period 4 - Treatment||0||
48305480|NCT05671653|101074801|FG004|STARTED|Cohort 2 Period 4 - Treatment||0||
48305481|NCT05671653|101074802|FG005|STARTED|Cohort 2 Period 4 - Treatment||0||
48305482|NCT05671653|101074803|FG006|STARTED|Cohort 2 Period 4 - Treatment||0||
48305483|NCT05671653|101074804|FG007|STARTED|Cohort 2 Period 4 - Treatment||0||
48305484|NCT05671653|101074805|FG008|STARTED|Cohort 2 Period 4 - Treatment||0||
48305485|NCT05671653|101074806|FG009|STARTED|Cohort 2 Period 4 - Treatment||0||
48305486|NCT05671653|101074807|FG010|STARTED|Cohort 2 Period 4 - Treatment||0||
48305487|NCT05671653|101074808|FG011|STARTED|Cohort 2 Period 4 - Treatment||0||
48305488|NCT05671653|101074809|FG012|STARTED|Cohort 2 Period 4 - Treatment||10||
48305489|NCT05671653|101074797|FG000|COMPLETED|Cohort 2 Period 4 - Treatment||0||
48305490|NCT05671653|101074798|FG001|COMPLETED|Cohort 2 Period 4 - Treatment||0||
48305491|NCT05671653|101074799|FG002|COMPLETED|Cohort 2 Period 4 - Treatment||0||
48305492|NCT05671653|101074800|FG003|COMPLETED|Cohort 2 Period 4 - Treatment||0||
48719103|NCT04214639|102099242|FG001|COMPLETED|Overall Study||55||
48719104|NCT04214639|102099241|FG000|NOT COMPLETED|Overall Study||15||
48719105|NCT04214639|102099242|FG001|NOT COMPLETED|Overall Study||6||
48305493|NCT05671653|101074801|FG004|COMPLETED|Cohort 2 Period 4 - Treatment||0||
48305494|NCT05671653|101074802|FG005|COMPLETED|Cohort 2 Period 4 - Treatment||0||
48305495|NCT05671653|101074803|FG006|COMPLETED|Cohort 2 Period 4 - Treatment||0||
48305496|NCT05671653|101074804|FG007|COMPLETED|Cohort 2 Period 4 - Treatment||0||
48305497|NCT05671653|101074805|FG008|COMPLETED|Cohort 2 Period 4 - Treatment||0||
48305498|NCT05671653|101074806|FG009|COMPLETED|Cohort 2 Period 4 - Treatment||0||
48305499|NCT05671653|101074807|FG010|COMPLETED|Cohort 2 Period 4 - Treatment||0||
48305500|NCT05671653|101074808|FG011|COMPLETED|Cohort 2 Period 4 - Treatment||0||
48305501|NCT05671653|101074809|FG012|COMPLETED|Cohort 2 Period 4 - Treatment||10||
48305502|NCT05671653|101074797|FG000|NOT COMPLETED|Cohort 2 Period 4 - Treatment||0||
48305503|NCT05671653|101074798|FG001|NOT COMPLETED|Cohort 2 Period 4 - Treatment||0||
48305504|NCT05671653|101074799|FG002|NOT COMPLETED|Cohort 2 Period 4 - Treatment||0||
48305505|NCT05671653|101074800|FG003|NOT COMPLETED|Cohort 2 Period 4 - Treatment||0||
48305506|NCT05671653|101074801|FG004|NOT COMPLETED|Cohort 2 Period 4 - Treatment||0||
48305507|NCT05671653|101074802|FG005|NOT COMPLETED|Cohort 2 Period 4 - Treatment||0||
48305508|NCT05671653|101074803|FG006|NOT COMPLETED|Cohort 2 Period 4 - Treatment||0||
48305509|NCT05671653|101074804|FG007|NOT COMPLETED|Cohort 2 Period 4 - Treatment||0||
48305510|NCT05671653|101074805|FG008|NOT COMPLETED|Cohort 2 Period 4 - Treatment||0||
48305511|NCT05671653|101074806|FG009|NOT COMPLETED|Cohort 2 Period 4 - Treatment||0||
48305512|NCT05671653|101074807|FG010|NOT COMPLETED|Cohort 2 Period 4 - Treatment||0||
48305513|NCT05671653|101074808|FG011|NOT COMPLETED|Cohort 2 Period 4 - Treatment||0||
48305514|NCT05671653|101074809|FG012|NOT COMPLETED|Cohort 2 Period 4 - Treatment||0||
48305515|NCT03876171|101074810|FG000|STARTED|Overall Study||20||
48305516|NCT03876171|101074811|FG001|STARTED|Overall Study||15||
48305517|NCT03876171|101074810|FG000|COMPLETED|Overall Study||17||
48305518|NCT03876171|101074811|FG001|COMPLETED|Overall Study||8||
48305519|NCT03876171|101074810|FG000|NOT COMPLETED|Overall Study||3||
48305520|NCT03876171|101074811|FG001|NOT COMPLETED|Overall Study||7||
48406123|NCT04063865|101328354|FG001|STARTED|Overall Study||8||
48719106|NCT00635089|102099243|FG000|STARTED|Overall Study||190||
48719107|NCT00635089|102099243|FG000|Completed >/= 16 Weeks of Study|Overall Study||181||
48719108|NCT00635089|102099243|FG000|COMPLETED|Overall Study||112||
48719109|NCT00635089|102099243|FG000|NOT COMPLETED|Overall Study||78||
48305521|NCT04555837|101074812|FG000|STARTED|Overall Study||10||
48305522|NCT04555837|101074813|FG001|STARTED|Overall Study||14||
48305523|NCT04555837|101074812|FG000|COMPLETED|Overall Study||10||
48305524|NCT04555837|101074813|FG001|COMPLETED|Overall Study||12||
48305525|NCT04555837|101074812|FG000|NOT COMPLETED|Overall Study||0||
48305526|NCT04555837|101074813|FG001|NOT COMPLETED|Overall Study||2||
48305527|NCT01572922|101074814|FG000|STARTED|Overall Study||142||
48305528|NCT01572922|101074814|FG000|COMPLETED|Overall Study||139||
48305529|NCT01572922|101074814|FG000|NOT COMPLETED|Overall Study||3||
48305530|NCT00729781|101074815|FG000|STARTED|Original Study||45||
48305531|NCT00729781|101074815|FG000|COMPLETED|Original Study||45||
48607519|NCT01048944|101823549|FG000|NOT COMPLETED|Overall Study||8||
48607520|NCT01048944|101823550|FG001|NOT COMPLETED|Overall Study||10||
48607521|NCT01048944|101823551|FG002|NOT COMPLETED|Overall Study||10||
48607522|NCT01048944|101823552|FG003|NOT COMPLETED|Overall Study||2||
48719110|NCT03561701|102099244|FG000|STARTED|Overall Study||220||
48719111|NCT03561701|102099245|FG001|STARTED|Overall Study||110||
48719112|NCT03561701|102099244|FG000|COMPLETED|Overall Study||191||
48719113|NCT03561701|102099245|FG001|COMPLETED|Overall Study||91||
48305532|NCT00729781|101074815|FG000|NOT COMPLETED|Original Study||0||
48305533|NCT00729781|101074815|FG000|STARTED|Long-term Follow-up Study||42||
48305534|NCT00729781|101074815|FG000|COMPLETED|Long-term Follow-up Study||42||
48305535|NCT00729781|101074815|FG000|NOT COMPLETED|Long-term Follow-up Study||0||
48305536|NCT03235440|101074816|FG000|STARTED|Overall Study||27||
48305537|NCT03235440|101074816|FG000|COMPLETED|Overall Study||24||
48719114|NCT03561701|102099244|FG000|NOT COMPLETED|Overall Study||29||
48719115|NCT03561701|102099245|FG001|NOT COMPLETED|Overall Study||19||
48719116|NCT01606787|102099246|FG000|STARTED|Overall Study||105||
48719117|NCT01606787|102099247|FG001|STARTED|Overall Study||105||
48719118|NCT01606787|102099246|FG000|COMPLETED|Overall Study||101||
48719119|NCT01606787|102099247|FG001|COMPLETED|Overall Study||98||
48719120|NCT01606787|102099246|FG000|NOT COMPLETED|Overall Study||4||
48719121|NCT01606787|102099247|FG001|NOT COMPLETED|Overall Study||7||
48719122|NCT03230292|102099248|FG000|STARTED|Overall Study||43||
48719123|NCT03230292|102099248|FG000|COMPLETED|Overall Study||37||
48719124|NCT03230292|102099248|FG000|NOT COMPLETED|Overall Study||6||
48719125|NCT02108691|102099249|FG000|STARTED|Overall Study||40||
48719126|NCT02108691|102099250|FG001|STARTED|Overall Study||40||
48719127|NCT02108691|102099249|FG000|COMPLETED|Overall Study||32||
48719128|NCT02108691|102099250|FG001|COMPLETED|Overall Study||31||
48719129|NCT02108691|102099249|FG000|NOT COMPLETED|Overall Study||8||
48719130|NCT02108691|102099250|FG001|NOT COMPLETED|Overall Study||9||
48719131|NCT00721175|102099251|FG000|STARTED|Overall Study||54||
48719132|NCT00721175|102099252|FG001|STARTED|Overall Study||54||
48719133|NCT00721175|102099251|FG000|COMPLETED|Overall Study||54||
48719134|NCT00721175|102099252|FG001|COMPLETED|Overall Study||54||
48719135|NCT00721175|102099251|FG000|NOT COMPLETED|Overall Study||0||
48719136|NCT00721175|102099252|FG001|NOT COMPLETED|Overall Study||0||
48719137|NCT03274804|102099253|FG000|STARTED|Overall Study||20||
48719138|NCT03274804|102099253|FG000|COMPLETED|Overall Study||20||
48719139|NCT03274804|102099253|FG000|NOT COMPLETED|Overall Study||0||
48719140|NCT00454649|102099254|FG000|STARTED|Overall Study||3||
48719141|NCT00454649|102099255|FG001|STARTED|Overall Study||5||
48719142|NCT00454649|102099256|FG002|STARTED|Overall Study||20||
48719143|NCT00454649|102099257|FG003|STARTED|Overall Study||7||
48719144|NCT00454649|102099258|FG004|STARTED|Overall Study||1||
48305538|NCT03235440|101074816|FG000|NOT COMPLETED|Overall Study||3||
48305539|NCT00403754|101074817|FG000|STARTED|Core Treatment Period 1||11||
48305540|NCT00403754|101074818|FG001|STARTED|Core Treatment Period 1||10||
48305541|NCT00403754|101074819|FG002|STARTED|Core Treatment Period 1||9||
48305542|NCT00403754|101074820|FG003|STARTED|Core Treatment Period 1||11||
48305543|NCT00403754|101074817|FG000|COMPLETED|Core Treatment Period 1||11||
48305544|NCT00403754|101074818|FG001|COMPLETED|Core Treatment Period 1||9||
48305545|NCT00403754|101074819|FG002|COMPLETED|Core Treatment Period 1||9||
48305546|NCT00403754|101074820|FG003|COMPLETED|Core Treatment Period 1||11||
48305547|NCT00403754|101074817|FG000|NOT COMPLETED|Core Treatment Period 1||0||
48305548|NCT00403754|101074818|FG001|NOT COMPLETED|Core Treatment Period 1||1||
48305549|NCT00403754|101074819|FG002|NOT COMPLETED|Core Treatment Period 1||0||
48305550|NCT00403754|101074820|FG003|NOT COMPLETED|Core Treatment Period 1||0||
48305551|NCT00403754|101074817|FG000|STARTED|Core Treatment Period 2||11||
48305552|NCT00403754|101074818|FG001|STARTED|Core Treatment Period 2||9||
48305553|NCT00403754|101074819|FG002|STARTED|Core Treatment Period 2||9||
48305554|NCT00403754|101074820|FG003|STARTED|Core Treatment Period 2||11||
48719145|NCT00454649|102099259|FG005|STARTED|Overall Study||7||
48719146|NCT00454649|102099260|FG006|STARTED|Overall Study||9||
48719147|NCT00454649|102099261|FG007|STARTED|Overall Study||19||
48719148|NCT00454649|102099262|FG008|STARTED|Overall Study||21||
48719149|NCT00454649|102099263|FG009|STARTED|Overall Study||6||
48719150|NCT00454649|102099254|FG000|COMPLETED|Overall Study||0||
48719151|NCT00454649|102099255|FG001|COMPLETED|Overall Study||1||
48719152|NCT00454649|102099256|FG002|COMPLETED|Overall Study||1||
48719153|NCT00454649|102099257|FG003|COMPLETED|Overall Study||1||
48719154|NCT00454649|102099258|FG004|COMPLETED|Overall Study||0||
48719155|NCT00454649|102099259|FG005|COMPLETED|Overall Study||0||
48719156|NCT00454649|102099260|FG006|COMPLETED|Overall Study||0||
48719157|NCT00454649|102099261|FG007|COMPLETED|Overall Study||0||
48719158|NCT00454649|102099262|FG008|COMPLETED|Overall Study||1||
48719159|NCT00454649|102099263|FG009|COMPLETED|Overall Study||1||
48719160|NCT00454649|102099254|FG000|NOT COMPLETED|Overall Study||3||
48719161|NCT00454649|102099255|FG001|NOT COMPLETED|Overall Study||4||
48719162|NCT00454649|102099256|FG002|NOT COMPLETED|Overall Study||19||
48719163|NCT00454649|102099257|FG003|NOT COMPLETED|Overall Study||6||
48719164|NCT00454649|102099258|FG004|NOT COMPLETED|Overall Study||1||
48719165|NCT00454649|102099259|FG005|NOT COMPLETED|Overall Study||7||
48719166|NCT00454649|102099260|FG006|NOT COMPLETED|Overall Study||9||
48719167|NCT00454649|102099261|FG007|NOT COMPLETED|Overall Study||19||
48719168|NCT00454649|102099262|FG008|NOT COMPLETED|Overall Study||20||
48719169|NCT00454649|102099263|FG009|NOT COMPLETED|Overall Study||5||
48719170|NCT01020903|102099264|FG000|STARTED|Overall Study||100||
48719171|NCT01020903|102099265|FG001|STARTED|Overall Study||100||
48719172|NCT01020903|102099264|FG000|COMPLETED|Overall Study||100||
48719173|NCT01020903|102099265|FG001|COMPLETED|Overall Study||100||
48719174|NCT01020903|102099264|FG000|NOT COMPLETED|Overall Study||0||
48719175|NCT01020903|102099265|FG001|NOT COMPLETED|Overall Study||0||
48719176|NCT01014455|102099266|FG000|STARTED|Overall Study||82||
48719177|NCT01014455|102099267|FG001|STARTED|Overall Study||87||
48719178|NCT01014455|102099266|FG000|COMPLETED|Overall Study||82||
48719179|NCT01014455|102099267|FG001|COMPLETED|Overall Study||87||
48719180|NCT01014455|102099266|FG000|NOT COMPLETED|Overall Study||0||
48719181|NCT01014455|102099267|FG001|NOT COMPLETED|Overall Study||0||
48719182|NCT00693472|102099268|FG000|STARTED|Part 1||19||
48719183|NCT00693472|102099269|FG001|STARTED|Part 1||13||
48719184|NCT00693472|102099270|FG002|STARTED|Part 1||0||
48719185|NCT00693472|102099271|FG003|STARTED|Part 1||0||
48719186|NCT00693472|102099268|FG000|COMPLETED|Part 1||13||
48719187|NCT00693472|102099269|FG001|COMPLETED|Part 1||9||
48719188|NCT00693472|102099270|FG002|COMPLETED|Part 1||0||
48719189|NCT00693472|102099271|FG003|COMPLETED|Part 1||0||
48719190|NCT00693472|102099268|FG000|NOT COMPLETED|Part 1||6||
48719191|NCT00693472|102099269|FG001|NOT COMPLETED|Part 1||4||
48719192|NCT00693472|102099270|FG002|NOT COMPLETED|Part 1||0||
48719193|NCT00693472|102099271|FG003|NOT COMPLETED|Part 1||0||
48719194|NCT00693472|102099268|FG000|STARTED|Part 2||0||
48719195|NCT00693472|102099269|FG001|STARTED|Part 2||0||
48719196|NCT00693472|102099270|FG002|STARTED|Part 2||8||
48719197|NCT00693472|102099271|FG003|STARTED|Part 2||6||
48719198|NCT00693472|102099268|FG000|COMPLETED|Part 2||0||
48719199|NCT00693472|102099269|FG001|COMPLETED|Part 2||0||
48719200|NCT00693472|102099270|FG002|COMPLETED|Part 2||6||
48719201|NCT00693472|102099271|FG003|COMPLETED|Part 2||4||
48719202|NCT00693472|102099268|FG000|NOT COMPLETED|Part 2||0||
48719203|NCT00693472|102099269|FG001|NOT COMPLETED|Part 2||0||
48719204|NCT00693472|102099270|FG002|NOT COMPLETED|Part 2||2||
48719205|NCT00693472|102099271|FG003|NOT COMPLETED|Part 2||2||
48305555|NCT00403754|101074817|FG000|COMPLETED|Core Treatment Period 2||11||
48305556|NCT00403754|101074818|FG001|COMPLETED|Core Treatment Period 2||9||
48305557|NCT00403754|101074819|FG002|COMPLETED|Core Treatment Period 2||8||
48719206|NCT03266172|102099272|FG000|STARTED|Part A: Period 1(2 Days)||16||
48719207|NCT03266172|102099273|FG001|STARTED|Part A: Period 1(2 Days)||0||
48719208|NCT03266172|102099274|FG002|STARTED|Part A: Period 1(2 Days)||0||
48719209|NCT03266172|102099272|FG000|COMPLETED|Part A: Period 1(2 Days)||15||
48719210|NCT03266172|102099273|FG001|COMPLETED|Part A: Period 1(2 Days)||0||
48719211|NCT03266172|102099274|FG002|COMPLETED|Part A: Period 1(2 Days)||0||
48719212|NCT03266172|102099272|FG000|NOT COMPLETED|Part A: Period 1(2 Days)||1||
48719213|NCT03266172|102099273|FG001|NOT COMPLETED|Part A: Period 1(2 Days)||0||
48719214|NCT03266172|102099274|FG002|NOT COMPLETED|Part A: Period 1(2 Days)||0||
48719215|NCT03266172|102099272|FG000|STARTED|Part A: Washout Period (7 Days)||15||
48719216|NCT03266172|102099273|FG001|STARTED|Part A: Washout Period (7 Days)||0||
48719217|NCT03266172|102099274|FG002|STARTED|Part A: Washout Period (7 Days)||0||
48719218|NCT03266172|102099272|FG000|COMPLETED|Part A: Washout Period (7 Days)||13||
48719219|NCT03266172|102099273|FG001|COMPLETED|Part A: Washout Period (7 Days)||0||
48719220|NCT03266172|102099274|FG002|COMPLETED|Part A: Washout Period (7 Days)||0||
48719221|NCT03266172|102099272|FG000|NOT COMPLETED|Part A: Washout Period (7 Days)||2||
48719222|NCT03266172|102099273|FG001|NOT COMPLETED|Part A: Washout Period (7 Days)||0||
48719223|NCT03266172|102099274|FG002|NOT COMPLETED|Part A: Washout Period (7 Days)||0||
48719224|NCT03266172|102099272|FG000|STARTED|Part A: Period 2 (2 Days)||13||
48719225|NCT03266172|102099273|FG001|STARTED|Part A: Period 2 (2 Days)||0||
48719226|NCT03266172|102099274|FG002|STARTED|Part A: Period 2 (2 Days)||0||
48305558|NCT00403754|101074820|FG003|COMPLETED|Core Treatment Period 2||11||
48719227|NCT03266172|102099272|FG000|COMPLETED|Part A: Period 2 (2 Days)||13||
48719228|NCT03266172|102099273|FG001|COMPLETED|Part A: Period 2 (2 Days)||0||
48719229|NCT03266172|102099274|FG002|COMPLETED|Part A: Period 2 (2 Days)||0||
48719230|NCT03266172|102099272|FG000|NOT COMPLETED|Part A: Period 2 (2 Days)||0||
48719231|NCT03266172|102099273|FG001|NOT COMPLETED|Part A: Period 2 (2 Days)||0||
48719232|NCT03266172|102099274|FG002|NOT COMPLETED|Part A: Period 2 (2 Days)||0||
48719233|NCT03266172|102099272|FG000|STARTED|Part A: Washout (7 Days)||13||
48719234|NCT03266172|102099273|FG001|STARTED|Part A: Washout (7 Days)||0||
48719235|NCT03266172|102099274|FG002|STARTED|Part A: Washout (7 Days)||0||
48719236|NCT03266172|102099272|FG000|COMPLETED|Part A: Washout (7 Days)||13||
48719237|NCT03266172|102099273|FG001|COMPLETED|Part A: Washout (7 Days)||0||
48719238|NCT03266172|102099274|FG002|COMPLETED|Part A: Washout (7 Days)||0||
48719239|NCT03266172|102099272|FG000|NOT COMPLETED|Part A: Washout (7 Days)||0||
48719240|NCT03266172|102099273|FG001|NOT COMPLETED|Part A: Washout (7 Days)||0||
48719241|NCT03266172|102099274|FG002|NOT COMPLETED|Part A: Washout (7 Days)||0||
48719242|NCT03266172|102099272|FG000|STARTED|Part A: Period 3 (2 Days)||16||
48719243|NCT03266172|102099273|FG001|STARTED|Part A: Period 3 (2 Days)||0||
48719244|NCT03266172|102099274|FG002|STARTED|Part A: Period 3 (2 Days)||0||
48719245|NCT03266172|102099272|FG000|COMPLETED|Part A: Period 3 (2 Days)||16||
48719246|NCT03266172|102099273|FG001|COMPLETED|Part A: Period 3 (2 Days)||0||
48719247|NCT03266172|102099274|FG002|COMPLETED|Part A: Period 3 (2 Days)||0||
48719248|NCT03266172|102099272|FG000|NOT COMPLETED|Part A: Period 3 (2 Days)||0||
48719249|NCT03266172|102099273|FG001|NOT COMPLETED|Part A: Period 3 (2 Days)||0||
48719250|NCT03266172|102099274|FG002|NOT COMPLETED|Part A: Period 3 (2 Days)||0||
48719251|NCT03266172|102099272|FG000|STARTED|Part A: Washout (7 Days)||16||
48719252|NCT03266172|102099273|FG001|STARTED|Part A: Washout (7 Days)||0||
48719253|NCT03266172|102099274|FG002|STARTED|Part A: Washout (7 Days)||0||
48719254|NCT03266172|102099272|FG000|COMPLETED|Part A: Washout (7 Days)||16||
48719255|NCT03266172|102099273|FG001|COMPLETED|Part A: Washout (7 Days)||0||
48719256|NCT03266172|102099274|FG002|COMPLETED|Part A: Washout (7 Days)||0||
48719257|NCT03266172|102099272|FG000|NOT COMPLETED|Part A: Washout (7 Days)||0||
48719258|NCT03266172|102099273|FG001|NOT COMPLETED|Part A: Washout (7 Days)||0||
48719259|NCT03266172|102099274|FG002|NOT COMPLETED|Part A: Washout (7 Days)||0||
48719260|NCT03266172|102099272|FG000|STARTED|Part A: Period 4 (2 Days)||16||
48719261|NCT03266172|102099273|FG001|STARTED|Part A: Period 4 (2 Days)||0||
48719262|NCT03266172|102099274|FG002|STARTED|Part A: Period 4 (2 Days)||0||
48719263|NCT03266172|102099272|FG000|COMPLETED|Part A: Period 4 (2 Days)||16||
48719264|NCT03266172|102099273|FG001|COMPLETED|Part A: Period 4 (2 Days)||0||
48719265|NCT03266172|102099274|FG002|COMPLETED|Part A: Period 4 (2 Days)||0||
48719266|NCT03266172|102099272|FG000|NOT COMPLETED|Part A: Period 4 (2 Days)||0||
48719267|NCT03266172|102099273|FG001|NOT COMPLETED|Part A: Period 4 (2 Days)||0||
48719268|NCT03266172|102099274|FG002|NOT COMPLETED|Part A: Period 4 (2 Days)||0||
48305559|NCT00403754|101074817|FG000|NOT COMPLETED|Core Treatment Period 2||0||
48305560|NCT00403754|101074818|FG001|NOT COMPLETED|Core Treatment Period 2||0||
48305561|NCT00403754|101074819|FG002|NOT COMPLETED|Core Treatment Period 2||1||
48305562|NCT00403754|101074820|FG003|NOT COMPLETED|Core Treatment Period 2||0||
48305563|NCT00403754|101074817|FG000|STARTED|Core Treatment Period 3||11||
48305564|NCT00403754|101074818|FG001|STARTED|Core Treatment Period 3||9||
48719269|NCT03266172|102099272|FG000|STARTED|Part B: Period 1 (4 Days)||0||
48719270|NCT03266172|102099273|FG001|STARTED|Part B: Period 1 (4 Days)||10||
48719271|NCT03266172|102099274|FG002|STARTED|Part B: Period 1 (4 Days)||0||
48719272|NCT03266172|102099272|FG000|COMPLETED|Part B: Period 1 (4 Days)||0||
48719273|NCT03266172|102099273|FG001|COMPLETED|Part B: Period 1 (4 Days)||10||
48719274|NCT03266172|102099274|FG002|COMPLETED|Part B: Period 1 (4 Days)||0||
48719275|NCT03266172|102099272|FG000|NOT COMPLETED|Part B: Period 1 (4 Days)||0||
48719276|NCT03266172|102099273|FG001|NOT COMPLETED|Part B: Period 1 (4 Days)||0||
48719277|NCT03266172|102099274|FG002|NOT COMPLETED|Part B: Period 1 (4 Days)||0||
48719278|NCT03266172|102099272|FG000|STARTED|Part B: Washout (7 Days)||0||
48719279|NCT03266172|102099273|FG001|STARTED|Part B: Washout (7 Days)||10||
48719280|NCT03266172|102099274|FG002|STARTED|Part B: Washout (7 Days)||0||
48719281|NCT03266172|102099272|FG000|COMPLETED|Part B: Washout (7 Days)||0||
48719282|NCT03266172|102099273|FG001|COMPLETED|Part B: Washout (7 Days)||10||
48719283|NCT03266172|102099274|FG002|COMPLETED|Part B: Washout (7 Days)||0||
48719284|NCT03266172|102099272|FG000|NOT COMPLETED|Part B: Washout (7 Days)||0||
48719285|NCT03266172|102099273|FG001|NOT COMPLETED|Part B: Washout (7 Days)||0||
48719286|NCT03266172|102099274|FG002|NOT COMPLETED|Part B: Washout (7 Days)||0||
48719287|NCT03266172|102099272|FG000|STARTED|Part B: Period 2 (4 Days)||0||
48719288|NCT03266172|102099273|FG001|STARTED|Part B: Period 2 (4 Days)||10||
48719289|NCT03266172|102099274|FG002|STARTED|Part B: Period 2 (4 Days)||0||
48719290|NCT03266172|102099272|FG000|COMPLETED|Part B: Period 2 (4 Days)||0||
48719291|NCT03266172|102099273|FG001|COMPLETED|Part B: Period 2 (4 Days)||10||
48719292|NCT03266172|102099274|FG002|COMPLETED|Part B: Period 2 (4 Days)||0||
48719293|NCT03266172|102099272|FG000|NOT COMPLETED|Part B: Period 2 (4 Days)||0||
48719294|NCT03266172|102099273|FG001|NOT COMPLETED|Part B: Period 2 (4 Days)||0||
48719295|NCT03266172|102099274|FG002|NOT COMPLETED|Part B: Period 2 (4 Days)||0||
48719296|NCT03266172|102099272|FG000|STARTED|Part B: Washout (7 Days)||0||
48719297|NCT03266172|102099273|FG001|STARTED|Part B: Washout (7 Days)||10||
48305565|NCT00403754|101074819|FG002|STARTED|Core Treatment Period 3||8||
48305566|NCT00403754|101074820|FG003|STARTED|Core Treatment Period 3||11||
48305567|NCT00403754|101074817|FG000|COMPLETED|Core Treatment Period 3||11||
48305568|NCT00403754|101074818|FG001|COMPLETED|Core Treatment Period 3||9||
48305569|NCT00403754|101074819|FG002|COMPLETED|Core Treatment Period 3||8||
48305570|NCT00403754|101074820|FG003|COMPLETED|Core Treatment Period 3||11||
48719298|NCT03266172|102099274|FG002|STARTED|Part B: Washout (7 Days)||0||
48719299|NCT03266172|102099272|FG000|COMPLETED|Part B: Washout (7 Days)||0||
48719300|NCT03266172|102099273|FG001|COMPLETED|Part B: Washout (7 Days)||8||
48719301|NCT03266172|102099274|FG002|COMPLETED|Part B: Washout (7 Days)||0||
48719302|NCT03266172|102099272|FG000|NOT COMPLETED|Part B: Washout (7 Days)||0||
48719303|NCT03266172|102099273|FG001|NOT COMPLETED|Part B: Washout (7 Days)||2||
48719304|NCT03266172|102099274|FG002|NOT COMPLETED|Part B: Washout (7 Days)||0||
48719305|NCT03266172|102099272|FG000|STARTED|Part B: Period 3 (4 Days)||0||
48719306|NCT03266172|102099273|FG001|STARTED|Part B: Period 3 (4 Days)||6||
48719307|NCT03266172|102099274|FG002|STARTED|Part B: Period 3 (4 Days)||0||
48719308|NCT03266172|102099272|FG000|COMPLETED|Part B: Period 3 (4 Days)||0||
48719309|NCT03266172|102099273|FG001|COMPLETED|Part B: Period 3 (4 Days)||6||
48719310|NCT03266172|102099274|FG002|COMPLETED|Part B: Period 3 (4 Days)||0||
48719311|NCT03266172|102099272|FG000|NOT COMPLETED|Part B: Period 3 (4 Days)||0||
48719312|NCT03266172|102099273|FG001|NOT COMPLETED|Part B: Period 3 (4 Days)||0||
48719313|NCT03266172|102099274|FG002|NOT COMPLETED|Part B: Period 3 (4 Days)||0||
48719314|NCT03266172|102099272|FG000|STARTED|Part C: Period 1(2 Days)||0||
48719315|NCT03266172|102099273|FG001|STARTED|Part C: Period 1(2 Days)||0||
48719316|NCT03266172|102099274|FG002|STARTED|Part C: Period 1(2 Days)||15||
48719317|NCT03266172|102099272|FG000|COMPLETED|Part C: Period 1(2 Days)||0||
48719318|NCT03266172|102099273|FG001|COMPLETED|Part C: Period 1(2 Days)||0||
48719319|NCT03266172|102099274|FG002|COMPLETED|Part C: Period 1(2 Days)||15||
48719320|NCT03266172|102099272|FG000|NOT COMPLETED|Part C: Period 1(2 Days)||0||
48719321|NCT03266172|102099273|FG001|NOT COMPLETED|Part C: Period 1(2 Days)||0||
48719322|NCT03266172|102099274|FG002|NOT COMPLETED|Part C: Period 1(2 Days)||0||
48719323|NCT03266172|102099272|FG000|STARTED|Part C Washout Period (7 Days)||0||
48719324|NCT03266172|102099273|FG001|STARTED|Part C Washout Period (7 Days)||0||
48719325|NCT03266172|102099274|FG002|STARTED|Part C Washout Period (7 Days)||15||
48719326|NCT03266172|102099272|FG000|COMPLETED|Part C Washout Period (7 Days)||0||
48719327|NCT03266172|102099273|FG001|COMPLETED|Part C Washout Period (7 Days)||0||
48719328|NCT03266172|102099274|FG002|COMPLETED|Part C Washout Period (7 Days)||15||
48719329|NCT03266172|102099272|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0||
48719330|NCT03266172|102099273|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0||
48719331|NCT03266172|102099274|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||0||
48719332|NCT03266172|102099272|FG000|STARTED|Part C Period 2(2 Days)||0||
48719333|NCT03266172|102099273|FG001|STARTED|Part C Period 2(2 Days)||0||
48719334|NCT03266172|102099274|FG002|STARTED|Part C Period 2(2 Days)||15||
48719335|NCT03266172|102099272|FG000|COMPLETED|Part C Period 2(2 Days)||0||
48305571|NCT00403754|101074817|FG000|NOT COMPLETED|Core Treatment Period 3||0||
48305572|NCT00403754|101074818|FG001|NOT COMPLETED|Core Treatment Period 3||0||
48305573|NCT00403754|101074819|FG002|NOT COMPLETED|Core Treatment Period 3||0||
48305574|NCT00403754|101074820|FG003|NOT COMPLETED|Core Treatment Period 3||0||
48305575|NCT00403754|101074817|FG000|STARTED|Core Treatment Period 4||11||
48305576|NCT00403754|101074818|FG001|STARTED|Core Treatment Period 4||9||
48305577|NCT00403754|101074819|FG002|STARTED|Core Treatment Period 4||8||
48305578|NCT00403754|101074820|FG003|STARTED|Core Treatment Period 4||11||
48607523|NCT03959488|101823553|FG000|STARTED|Season 1||616||
48719336|NCT03266172|102099273|FG001|COMPLETED|Part C Period 2(2 Days)||0||
48719337|NCT03266172|102099274|FG002|COMPLETED|Part C Period 2(2 Days)||15||
48719338|NCT03266172|102099272|FG000|NOT COMPLETED|Part C Period 2(2 Days)||0||
48719339|NCT03266172|102099273|FG001|NOT COMPLETED|Part C Period 2(2 Days)||0||
48719340|NCT03266172|102099274|FG002|NOT COMPLETED|Part C Period 2(2 Days)||0||
48719341|NCT03266172|102099272|FG000|STARTED|Part C Washout Period (7 Days)||0||
48719342|NCT03266172|102099273|FG001|STARTED|Part C Washout Period (7 Days)||0||
48719343|NCT03266172|102099274|FG002|STARTED|Part C Washout Period (7 Days)||15||
48719344|NCT03266172|102099272|FG000|COMPLETED|Part C Washout Period (7 Days)||0||
48719345|NCT03266172|102099273|FG001|COMPLETED|Part C Washout Period (7 Days)||0||
48719346|NCT03266172|102099274|FG002|COMPLETED|Part C Washout Period (7 Days)||15||
48719347|NCT03266172|102099272|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0||
48719348|NCT03266172|102099273|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0||
48719349|NCT03266172|102099274|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||0||
48719350|NCT03266172|102099272|FG000|STARTED|Part C Period 3(2 Days)||0||
48719351|NCT03266172|102099273|FG001|STARTED|Part C Period 3(2 Days)||0||
48305579|NCT00403754|101074817|FG000|COMPLETED|Core Treatment Period 4||11||
48305580|NCT00403754|101074818|FG001|COMPLETED|Core Treatment Period 4||9||
48305581|NCT00403754|101074819|FG002|COMPLETED|Core Treatment Period 4||8||
48305582|NCT00403754|101074820|FG003|COMPLETED|Core Treatment Period 4||11||
48305583|NCT00403754|101074817|FG000|NOT COMPLETED|Core Treatment Period 4||0||
48305584|NCT00403754|101074818|FG001|NOT COMPLETED|Core Treatment Period 4||0||
48305585|NCT00403754|101074819|FG002|NOT COMPLETED|Core Treatment Period 4||0||
48305586|NCT00403754|101074820|FG003|NOT COMPLETED|Core Treatment Period 4||0||
48305587|NCT00403754|101074817|FG000|STARTED|Open Label: Salmeterol||11||
48305588|NCT00403754|101074818|FG001|STARTED|Open Label: Salmeterol||9||
48719352|NCT03266172|102099274|FG002|STARTED|Part C Period 3(2 Days)||16||
48719353|NCT03266172|102099272|FG000|COMPLETED|Part C Period 3(2 Days)||0||
48719354|NCT03266172|102099273|FG001|COMPLETED|Part C Period 3(2 Days)||0||
48719355|NCT03266172|102099274|FG002|COMPLETED|Part C Period 3(2 Days)||16||
48719356|NCT03266172|102099272|FG000|NOT COMPLETED|Part C Period 3(2 Days)||0||
48719357|NCT03266172|102099273|FG001|NOT COMPLETED|Part C Period 3(2 Days)||0||
48719358|NCT03266172|102099274|FG002|NOT COMPLETED|Part C Period 3(2 Days)||0||
48719359|NCT03266172|102099272|FG000|STARTED|Part C Washout Period (7 Days)||0||
48305589|NCT00403754|101074819|FG002|STARTED|Open Label: Salmeterol||8||
48305590|NCT00403754|101074820|FG003|STARTED|Open Label: Salmeterol||11||
48719360|NCT03266172|102099273|FG001|STARTED|Part C Washout Period (7 Days)||0||
48719361|NCT03266172|102099274|FG002|STARTED|Part C Washout Period (7 Days)||16||
48607524|NCT03959488|101823554|FG001|STARTED|Season 1||309||
48607525|NCT03959488|101823555|FG002|STARTED|Season 1||0||
48607526|NCT03959488|101823556|FG003|STARTED|Season 1||0||
48607527|NCT03959488|101823557|FG004|STARTED|Season 1||0||
48607528|NCT03959488|101823553|FG000|COMPLETED|Season 1||543||
48607529|NCT03959488|101823554|FG001|COMPLETED|Season 1||263||
48607530|NCT03959488|101823555|FG002|COMPLETED|Season 1||0||
48607531|NCT03959488|101823556|FG003|COMPLETED|Season 1||0||
48607532|NCT03959488|101823557|FG004|COMPLETED|Season 1||0||
48607533|NCT03959488|101823553|FG000|NOT COMPLETED|Season 1||73||
48607534|NCT03959488|101823554|FG001|NOT COMPLETED|Season 1||46||
48607535|NCT03959488|101823555|FG002|NOT COMPLETED|Season 1||0||
48607536|NCT03959488|101823556|FG003|NOT COMPLETED|Season 1||0||
48607537|NCT03959488|101823557|FG004|NOT COMPLETED|Season 1||0||
48607538|NCT03959488|101823553|FG000|STARTED|Season 2||0|Only CHD/CLD subjects who completed Season 1 continued into Season 2 phase of the study|
48607539|NCT03959488|101823554|FG001|STARTED|Season 2||0|Only CHD/CLD subjects who completed Season 1 continued into Season 2 phase of the study|
48607540|NCT03959488|101823555|FG002|STARTED|Season 2||180|Only CHD/CLD subjects who completed Season 1 continued into Season 2 phase of the study|
48607541|NCT03959488|101823556|FG003|STARTED|Season 2||40|Only CHD/CLD subjects who completed Season 1 continued into Season 2 phase of the study|
48607542|NCT03959488|101823557|FG004|STARTED|Season 2||42|Only CHD/CLD subjects who completed Season 1 continued into Season 2 phase of the study|
48607543|NCT03959488|101823553|FG000|COMPLETED|Season 2||0||
48607544|NCT03959488|101823554|FG001|COMPLETED|Season 2||0||
48607545|NCT03959488|101823555|FG002|COMPLETED|Season 2||174||
48607546|NCT03959488|101823556|FG003|COMPLETED|Season 2||39||
48607547|NCT03959488|101823557|FG004|COMPLETED|Season 2||40||
48607548|NCT03959488|101823553|FG000|NOT COMPLETED|Season 2||0||
48607549|NCT03959488|101823554|FG001|NOT COMPLETED|Season 2||0||
48607550|NCT03959488|101823555|FG002|NOT COMPLETED|Season 2||6||
48607551|NCT03959488|101823556|FG003|NOT COMPLETED|Season 2||1||
48607552|NCT03959488|101823557|FG004|NOT COMPLETED|Season 2||2||
48607553|NCT01654263|101823558|FG000|STARTED|Overall Study||164||
48607554|NCT01654263|101823559|FG001|STARTED|Overall Study||147||
48607555|NCT01654263|101823560|FG002|STARTED|Overall Study||139||
48607556|NCT01654263|101823561|FG003|STARTED|Overall Study||145||
48607557|NCT01654263|101823562|FG004|STARTED|Overall Study||140||
48607558|NCT01654263|101823563|FG005|STARTED|Overall Study||149||
48607559|NCT01654263|101823558|FG000|COMPLETED|Overall Study||164||
48607560|NCT01654263|101823559|FG001|COMPLETED|Overall Study||147||
48607561|NCT01654263|101823560|FG002|COMPLETED|Overall Study||137||
48607562|NCT01654263|101823561|FG003|COMPLETED|Overall Study||144||
48607563|NCT01654263|101823562|FG004|COMPLETED|Overall Study||139||
48607564|NCT01654263|101823563|FG005|COMPLETED|Overall Study||148||
48607565|NCT01654263|101823558|FG000|NOT COMPLETED|Overall Study||0||
48607566|NCT01654263|101823559|FG001|NOT COMPLETED|Overall Study||0||
48607567|NCT01654263|101823560|FG002|NOT COMPLETED|Overall Study||2||
48607568|NCT01654263|101823561|FG003|NOT COMPLETED|Overall Study||1||
48607569|NCT01654263|101823562|FG004|NOT COMPLETED|Overall Study||1||
48607570|NCT01654263|101823563|FG005|NOT COMPLETED|Overall Study||1||
48607571|NCT01134263|101823564|FG000|STARTED|Overall Study||164||
48607572|NCT01134263|101823565|FG001|STARTED|Overall Study||163||
48607573|NCT01134263|101823566|FG002|STARTED|Overall Study||163||
48607574|NCT01134263|101823567|FG003|STARTED|Overall Study||168||
48607575|NCT01134263|101823568|FG004|STARTED|Overall Study||57||
48607576|NCT01134263|101823564|FG000|Received Vaccination 1|Overall Study||163||
48607577|NCT01134263|101823565|FG001|Received Vaccination 1|Overall Study||162||
48607578|NCT01134263|101823566|FG002|Received Vaccination 1|Overall Study||163||
48607579|NCT01134263|101823567|FG003|Received Vaccination 1|Overall Study||167||
48607580|NCT01134263|101823568|FG004|Received Vaccination 1|Overall Study||57||
48607581|NCT01134263|101823564|FG000|Received Vaccination 2|Overall Study||151||
48607582|NCT01134263|101823565|FG001|Received Vaccination 2|Overall Study||152||
48607583|NCT01134263|101823566|FG002|Received Vaccination 2|Overall Study||139||
48607584|NCT01134263|101823567|FG003|Received Vaccination 2|Overall Study||154||
48607585|NCT01134263|101823568|FG004|Received Vaccination 2|Overall Study||53||
48607586|NCT01134263|101823564|FG000|Received Vaccination 3|Overall Study||140||
48607587|NCT01134263|101823565|FG001|Received Vaccination 3|Overall Study||145||
48607588|NCT01134263|101823566|FG002|Received Vaccination 3|Overall Study||134||
48607589|NCT01134263|101823567|FG003|Received Vaccination 3|Overall Study||151||
48607590|NCT01134263|101823568|FG004|Received Vaccination 3|Overall Study||49||
48607591|NCT01134263|101823564|FG000|Safety Population|Overall Study||163|Safety Population:All participants who received study drug, analyzed according to treatment received|
48607592|NCT01134263|101823565|FG001|Safety Population|Overall Study||161|Safety Population:All participants who received study drug, analyzed according to treatment received|
48607593|NCT01134263|101823566|FG002|Safety Population|Overall Study||164|Safety Population:All participants who received study drug, analyzed according to treatment received|
48607594|NCT01134263|101823567|FG003|Safety Population|Overall Study||167|Safety Population:All participants who received study drug, analyzed according to treatment received|
48607595|NCT01134263|101823568|FG004|Safety Population|Overall Study||57|Safety Population:All participants who received study drug, analyzed according to treatment received|
48607596|NCT01134263|101823564|FG000|COMPLETED|Overall Study||140||
48607597|NCT01134263|101823565|FG001|COMPLETED|Overall Study||143||
48607598|NCT01134263|101823566|FG002|COMPLETED|Overall Study||134||
48719362|NCT03266172|102099272|FG000|COMPLETED|Part C Washout Period (7 Days)||0||
48719363|NCT03266172|102099273|FG001|COMPLETED|Part C Washout Period (7 Days)||0||
48719364|NCT03266172|102099274|FG002|COMPLETED|Part C Washout Period (7 Days)||16||
48719365|NCT03266172|102099272|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0||
48719366|NCT03266172|102099273|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0||
48719367|NCT03266172|102099274|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||0||
48719368|NCT03266172|102099272|FG000|STARTED|Part C Period 4(2 Days)||0||
48719369|NCT03266172|102099273|FG001|STARTED|Part C Period 4(2 Days)||0||
48719370|NCT03266172|102099274|FG002|STARTED|Part C Period 4(2 Days)||16||
48719371|NCT03266172|102099272|FG000|COMPLETED|Part C Period 4(2 Days)||0||
48719372|NCT03266172|102099273|FG001|COMPLETED|Part C Period 4(2 Days)||0||
48719373|NCT03266172|102099274|FG002|COMPLETED|Part C Period 4(2 Days)||16||
48719374|NCT03266172|102099272|FG000|NOT COMPLETED|Part C Period 4(2 Days)||0||
48719375|NCT03266172|102099273|FG001|NOT COMPLETED|Part C Period 4(2 Days)||0||
48719376|NCT03266172|102099274|FG002|NOT COMPLETED|Part C Period 4(2 Days)||0||
48719377|NCT03266172|102099272|FG000|STARTED|Part C Washout Period (7 Days)||0||
48719378|NCT03266172|102099273|FG001|STARTED|Part C Washout Period (7 Days)||0||
48719379|NCT03266172|102099274|FG002|STARTED|Part C Washout Period (7 Days)||16||
48719380|NCT03266172|102099272|FG000|COMPLETED|Part C Washout Period (7 Days)||0||
48719381|NCT03266172|102099273|FG001|COMPLETED|Part C Washout Period (7 Days)||0||
48719382|NCT03266172|102099274|FG002|COMPLETED|Part C Washout Period (7 Days)||15||
48719383|NCT03266172|102099272|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0||
48719384|NCT03266172|102099273|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0||
48719385|NCT03266172|102099274|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||1||
48719386|NCT03266172|102099272|FG000|STARTED|Part C Period 5(2 Days)||0||
48719387|NCT03266172|102099273|FG001|STARTED|Part C Period 5(2 Days)||0||
48719388|NCT03266172|102099274|FG002|STARTED|Part C Period 5(2 Days)||15||
48719389|NCT03266172|102099272|FG000|COMPLETED|Part C Period 5(2 Days)||0||
48719390|NCT03266172|102099273|FG001|COMPLETED|Part C Period 5(2 Days)||0||
48719391|NCT03266172|102099274|FG002|COMPLETED|Part C Period 5(2 Days)||15||
48719392|NCT03266172|102099272|FG000|NOT COMPLETED|Part C Period 5(2 Days)||0||
48719393|NCT03266172|102099273|FG001|NOT COMPLETED|Part C Period 5(2 Days)||0||
48719394|NCT03266172|102099274|FG002|NOT COMPLETED|Part C Period 5(2 Days)||0||
48719395|NCT03266172|102099272|FG000|STARTED|Part C Washout Period (7 Days)||0||
48719396|NCT03266172|102099273|FG001|STARTED|Part C Washout Period (7 Days)||0||
48719397|NCT03266172|102099274|FG002|STARTED|Part C Washout Period (7 Days)||15||
48719398|NCT03266172|102099272|FG000|COMPLETED|Part C Washout Period (7 Days)||0||
48719399|NCT03266172|102099273|FG001|COMPLETED|Part C Washout Period (7 Days)||0||
48719400|NCT03266172|102099274|FG002|COMPLETED|Part C Washout Period (7 Days)||14||
48719401|NCT03266172|102099272|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0||
48719402|NCT03266172|102099273|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0||
48719403|NCT03266172|102099274|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||1||
48719404|NCT03266172|102099272|FG000|STARTED|Part C Period 6(2 Days)||0||
48150501|NCT01693068|100692270|FG002|STARTED|Randomization Period||0||
48150502|NCT01693068|100692268|FG000|Treated|Randomization Period||61||
48150503|NCT01693068|100692269|FG001|Treated|Randomization Period||130||
48719405|NCT03266172|102099273|FG001|STARTED|Part C Period 6(2 Days)||0||
48719406|NCT03266172|102099274|FG002|STARTED|Part C Period 6(2 Days)||14||
48719407|NCT03266172|102099272|FG000|COMPLETED|Part C Period 6(2 Days)||0||
48719408|NCT03266172|102099273|FG001|COMPLETED|Part C Period 6(2 Days)||0||
48719409|NCT03266172|102099274|FG002|COMPLETED|Part C Period 6(2 Days)||14||
48719410|NCT03266172|102099272|FG000|NOT COMPLETED|Part C Period 6(2 Days)||0||
48719411|NCT03266172|102099273|FG001|NOT COMPLETED|Part C Period 6(2 Days)||0||
48719412|NCT03266172|102099274|FG002|NOT COMPLETED|Part C Period 6(2 Days)||0||
48719413|NCT03374202|102099275|FG000|STARTED|One Year Follow Up||3||
48719414|NCT03374202|102099276|FG001|STARTED|One Year Follow Up||3||
48719415|NCT03374202|102099277|FG002|STARTED|One Year Follow Up||4||
48719416|NCT03374202|102099275|FG000|Received Study Product|One Year Follow Up||3||
48719417|NCT03374202|102099276|FG001|Received Study Product|One Year Follow Up||3||
48719418|NCT03374202|102099277|FG002|Received Study Product|One Year Follow Up||4||
48719419|NCT03374202|102099275|FG000|COMPLETED|One Year Follow Up||3|Participants who completed one year of study visits.|
48719420|NCT03374202|102099276|FG001|COMPLETED|One Year Follow Up||3|Participants who completed one year of study visits.|
48719421|NCT03374202|102099277|FG002|COMPLETED|One Year Follow Up||4|Participants who completed one year of study visits.|
48719422|NCT03374202|102099275|FG000|NOT COMPLETED|One Year Follow Up||0||
48719423|NCT03374202|102099276|FG001|NOT COMPLETED|One Year Follow Up||0||
48719424|NCT03374202|102099277|FG002|NOT COMPLETED|One Year Follow Up||0||
48719425|NCT03374202|102099275|FG000|STARTED|Five Year Long Term Follow Up||3||
48719426|NCT03374202|102099276|FG001|STARTED|Five Year Long Term Follow Up||3||
48719427|NCT03374202|102099277|FG002|STARTED|Five Year Long Term Follow Up||4||
48150504|NCT01693068|100692270|FG002|Treated|Randomization Period||0||
48150505|NCT01693068|100692268|FG000|COMPLETED|Randomization Period||62||
48150506|NCT01693068|100692269|FG001|COMPLETED|Randomization Period||125||
48150507|NCT01693068|100692270|FG002|COMPLETED|Randomization Period||0||
48150508|NCT01693068|100692268|FG000|NOT COMPLETED|Randomization Period||2||
48150509|NCT01693068|100692269|FG001|NOT COMPLETED|Randomization Period||5||
48607599|NCT01134263|101823567|FG003|COMPLETED|Overall Study||149||
48607600|NCT01134263|101823568|FG004|COMPLETED|Overall Study||48||
48719428|NCT03374202|102099275|FG000|COMPLETED|Five Year Long Term Follow Up||2|Participants who completed 5 years of the study per protocol as of May 2023|
48719429|NCT03374202|102099276|FG001|COMPLETED|Five Year Long Term Follow Up||0|Participants who completed 5 years of the study per protocol as of May 2023|
48719430|NCT03374202|102099277|FG002|COMPLETED|Five Year Long Term Follow Up||0|Participants who completed 5 years of the study per protocol as of May 2023|
48719431|NCT03374202|102099275|FG000|NOT COMPLETED|Five Year Long Term Follow Up||1||
48719432|NCT03374202|102099276|FG001|NOT COMPLETED|Five Year Long Term Follow Up||3||
48719433|NCT03374202|102099277|FG002|NOT COMPLETED|Five Year Long Term Follow Up||4||
48719434|NCT00840060|102099278|FG000|STARTED|Overall Study||20||
48607601|NCT01134263|101823564|FG000|NOT COMPLETED|Overall Study||24||
48607602|NCT01134263|101823565|FG001|NOT COMPLETED|Overall Study||20||
48607603|NCT01134263|101823566|FG002|NOT COMPLETED|Overall Study||29||
48607604|NCT01134263|101823567|FG003|NOT COMPLETED|Overall Study||19||
48607605|NCT01134263|101823568|FG004|NOT COMPLETED|Overall Study||9||
48719435|NCT00840060|102099279|FG001|STARTED|Overall Study||20||
48719436|NCT00840060|102099278|FG000|COMPLETED|Overall Study||19||
48719437|NCT00840060|102099279|FG001|COMPLETED|Overall Study||19||
48719438|NCT00840060|102099278|FG000|NOT COMPLETED|Overall Study||1||
48719439|NCT00840060|102099279|FG001|NOT COMPLETED|Overall Study||1||
48719440|NCT01600053|102099280|FG000|STARTED|Overall Study||11||
48719441|NCT01600053|102099280|FG000|COMPLETED|Overall Study||0||
48719442|NCT01600053|102099280|FG000|NOT COMPLETED|Overall Study||11||
48719443|NCT01287195|102099281|FG000|STARTED|Overall Study||6||
48719444|NCT01287195|102099281|FG000|COMPLETED|Overall Study||4||
48719445|NCT01287195|102099281|FG000|NOT COMPLETED|Overall Study||2||
48719446|NCT02533726|102099282|FG000|STARTED|Initial Allocation||659||
48719447|NCT02533726|102099283|FG001|STARTED|Initial Allocation||653||
48719448|NCT02533726|102099282|FG000|COMPLETED|Initial Allocation||659||
48719449|NCT02533726|102099283|FG001|COMPLETED|Initial Allocation||653||
48719450|NCT02533726|102099282|FG000|NOT COMPLETED|Initial Allocation||0||
48719451|NCT02533726|102099283|FG001|NOT COMPLETED|Initial Allocation||0||
48719452|NCT02533726|102099282|FG000|STARTED|Treatment||709|54 participants allocated to Standard Care actually received Optimal Turning|
48719453|NCT02533726|102099283|FG001|STARTED|Treatment||603|54 participants allocated to Standard Care actually received Optimal Turning|
48719454|NCT02533726|102099282|FG000|Per Protocol Population|Treatment||671|Met minimum monitoring period (\>2h) and did not receive both interventions|
48719455|NCT02533726|102099283|FG001|Per Protocol Population|Treatment||555|Met minimum monitoring period (\>2h) and did not receive both interventions|
48719456|NCT02533726|102099282|FG000|COMPLETED|Treatment||709||
48719457|NCT02533726|102099283|FG001|COMPLETED|Treatment||603||
48719458|NCT02533726|102099282|FG000|NOT COMPLETED|Treatment||0||
48719459|NCT02533726|102099283|FG001|NOT COMPLETED|Treatment||0||
48719460|NCT00330668|102099284|FG000|STARTED|BID Dosing Period||114||
48719461|NCT00330668|102099284|FG000|COMPLETED|BID Dosing Period||78||
48719462|NCT00330668|102099284|FG000|NOT COMPLETED|BID Dosing Period||36||
48719463|NCT00330668|102099284|FG000|STARTED|QD Dosing Period||78||
48719464|NCT00330668|102099284|FG000|COMPLETED|QD Dosing Period||0||
48719465|NCT00330668|102099284|FG000|NOT COMPLETED|QD Dosing Period||78||
48719466|NCT03323736|102099285|FG000|STARTED|Overall Study||241||
48719467|NCT03323736|102099286|FG001|STARTED|Overall Study||59||
48719468|NCT03323736|102099287|FG002|STARTED|Overall Study||70||
48150510|NCT01693068|100692270|FG002|NOT COMPLETED|Randomization Period||0||
48150511|NCT01693068|100692268|FG000|STARTED|Cross-over (Dacarbazine To Pimasertib)||0||
48150512|NCT01693068|100692269|FG001|STARTED|Cross-over (Dacarbazine To Pimasertib)||0||
48150513|NCT01693068|100692270|FG002|STARTED|Cross-over (Dacarbazine To Pimasertib)||41||
48607606|NCT01421147|101823569|FG000|STARTED|Treatment Period||269||
48607607|NCT01421147|101823570|FG001|STARTED|Treatment Period||267||
48607608|NCT01421147|101823569|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||268||
48719469|NCT03323736|102099285|FG000|Treated|Overall Study||222||
48719470|NCT03323736|102099286|FG001|Treated|Overall Study||47||
48607609|NCT01421147|101823570|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||267||
48607610|NCT01421147|101823569|FG000|COMPLETED|Treatment Period||253||
48607611|NCT01421147|101823570|FG001|COMPLETED|Treatment Period||256||
48607612|NCT01421147|101823569|FG000|NOT COMPLETED|Treatment Period||16||
48607613|NCT01421147|101823570|FG001|NOT COMPLETED|Treatment Period||11||
48607614|NCT01421147|101823569|FG000|STARTED|Extension Period||253||
48607615|NCT01421147|101823570|FG001|STARTED|Extension Period||256||
48150514|NCT01693068|100692268|FG000|Treated|Cross-over (Dacarbazine To Pimasertib)||0||
48150515|NCT01693068|100692269|FG001|Treated|Cross-over (Dacarbazine To Pimasertib)||0||
48188707|NCT02034435|100783312|FG000|COMPLETED|Overall Study||11||
48607616|NCT01421147|101823569|FG000|COMPLETED|Extension Period||245||
48607617|NCT01421147|101823570|FG001|COMPLETED|Extension Period||245||
48150516|NCT01693068|100692270|FG002|Treated|Cross-over (Dacarbazine To Pimasertib)||41||
48150517|NCT01693068|100692268|FG000|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0||
48150518|NCT01693068|100692269|FG001|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0||
48607618|NCT01421147|101823569|FG000|NOT COMPLETED|Extension Period||8||
48607619|NCT01421147|101823570|FG001|NOT COMPLETED|Extension Period||11||
48607620|NCT02104167|101823571|FG000|STARTED|Overall Study||110||
48607621|NCT02104167|101823571|FG000|COMPLETED|Overall Study||110||
48607622|NCT02104167|101823571|FG000|NOT COMPLETED|Overall Study||0||
48607623|NCT00004088|101823572|FG000|STARTED|Overall Study||77||
48607624|NCT00004088|101823572|FG000|COMPLETED|Overall Study||68||
48607625|NCT00004088|101823572|FG000|NOT COMPLETED|Overall Study||9||
48607626|NCT02756819|101823573|FG000|STARTED|Overall Study||1945||
48607627|NCT02756819|101823573|FG000|Per-protocol Set (PPS)|Overall Study||1724||
48607628|NCT02756819|101823573|FG000|Safety Analysis Set (SAS)|Overall Study||1934||
48607629|NCT02756819|101823573|FG000|COMPLETED|Overall Study||1893||
48150519|NCT01693068|100692270|FG002|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||40||
48150520|NCT01693068|100692268|FG000|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0||
48150521|NCT01693068|100692269|FG001|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0||
48150522|NCT01693068|100692270|FG002|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||1||
48607630|NCT02756819|101823573|FG000|NOT COMPLETED|Overall Study||52||
48607631|NCT02348008|101823574|FG000|STARTED|Overall Study||3||
48607632|NCT02348008|101823575|FG001|STARTED|Overall Study||10||
48607633|NCT02348008|101823576|FG002|STARTED|Overall Study||48||
48607634|NCT02348008|101823574|FG000|COMPLETED|Overall Study||0||
48607635|NCT02348008|101823575|FG001|COMPLETED|Overall Study||0||
48150523|NCT02883062|100692271|FG000|STARTED|Overall Study||22||
48150524|NCT02883062|100692272|FG001|STARTED|Overall Study||45||
48150525|NCT02883062|100692271|FG000|COMPLETED|Overall Study||16||
48150526|NCT02883062|100692272|FG001|COMPLETED|Overall Study||45||
48150527|NCT02883062|100692271|FG000|NOT COMPLETED|Overall Study||6||
48150528|NCT02883062|100692272|FG001|NOT COMPLETED|Overall Study||0||
48150529|NCT02151266|100692273|FG000|STARTED|Overall Study||19||
48150530|NCT02151266|100692274|FG001|STARTED|Overall Study||29||
48150531|NCT02151266|100692275|FG002|STARTED|Overall Study||21||
48607636|NCT02348008|101823576|FG002|COMPLETED|Overall Study||29||
48150532|NCT02151266|100692273|FG000|COMPLETED|Overall Study||11||
48150533|NCT02151266|100692274|FG001|COMPLETED|Overall Study||14||
48150534|NCT02151266|100692275|FG002|COMPLETED|Overall Study||14||
48150535|NCT02151266|100692273|FG000|NOT COMPLETED|Overall Study||8||
48150536|NCT02151266|100692274|FG001|NOT COMPLETED|Overall Study||15||
48150537|NCT02151266|100692275|FG002|NOT COMPLETED|Overall Study||7||
48150538|NCT05159622|100692276|FG000|STARTED|Overall Study||45||
48150539|NCT05159622|100692277|FG001|STARTED|Overall Study||47||
48150540|NCT05159622|100692276|FG000|COMPLETED|Overall Study||41||
48150541|NCT05159622|100692277|FG001|COMPLETED|Overall Study||42||
48607637|NCT02348008|101823574|FG000|NOT COMPLETED|Overall Study||3||
48607638|NCT02348008|101823575|FG001|NOT COMPLETED|Overall Study||10||
48607639|NCT02348008|101823576|FG002|NOT COMPLETED|Overall Study||19||
48607640|NCT01597492|101823577|FG000|STARTED|Overall Study||34||
48607641|NCT01597492|101823578|FG001|STARTED|Overall Study||45||
48607642|NCT01597492|101823577|FG000|COMPLETED|Overall Study||28||
48607643|NCT01597492|101823578|FG001|COMPLETED|Overall Study||41||
48607644|NCT01597492|101823577|FG000|NOT COMPLETED|Overall Study||6||
48607645|NCT01597492|101823578|FG001|NOT COMPLETED|Overall Study||4||
48607646|NCT01216332|101823579|FG000|STARTED|Overall Study||34||
48607647|NCT01216332|101823580|FG001|STARTED|Overall Study||16||
48607648|NCT01216332|101823579|FG000|COMPLETED|Overall Study||30||
48607649|NCT01216332|101823580|FG001|COMPLETED|Overall Study||16||
48607650|NCT01216332|101823579|FG000|NOT COMPLETED|Overall Study||4||
48607651|NCT01216332|101823580|FG001|NOT COMPLETED|Overall Study||0||
48607652|NCT02075008|101823581|FG000|STARTED|Overall Study||270||
48607653|NCT02075008|101823581|FG000|COMPLETED|Overall Study||94||
48607654|NCT02075008|101823581|FG000|NOT COMPLETED|Overall Study||176||
48607655|NCT01716520|101823582|FG000|STARTED|Treatment Period 1 (14 Days)||31||
48607656|NCT01716520|101823583|FG001|STARTED|Treatment Period 1 (14 Days)||30||
48607657|NCT01716520|101823584|FG002|STARTED|Treatment Period 1 (14 Days)||30||
48607658|NCT01716520|101823585|FG003|STARTED|Treatment Period 1 (14 Days)||30||
48607659|NCT01716520|101823586|FG004|STARTED|Treatment Period 1 (14 Days)||31||
48607660|NCT01716520|101823587|FG005|STARTED|Treatment Period 1 (14 Days)||30||
48607661|NCT01716520|101823582|FG000|COMPLETED|Treatment Period 1 (14 Days)||29||
48607662|NCT01716520|101823583|FG001|COMPLETED|Treatment Period 1 (14 Days)||29||
48607663|NCT01716520|101823584|FG002|COMPLETED|Treatment Period 1 (14 Days)||28||
48150542|NCT05159622|100692276|FG000|NOT COMPLETED|Overall Study||4||
48150543|NCT05159622|100692277|FG001|NOT COMPLETED|Overall Study||5||
48150544|NCT00736645|100692278|FG000|STARTED|Overall Study||13||
48607664|NCT01716520|101823585|FG003|COMPLETED|Treatment Period 1 (14 Days)||29||
48607665|NCT01716520|101823586|FG004|COMPLETED|Treatment Period 1 (14 Days)||31||
48607666|NCT01716520|101823587|FG005|COMPLETED|Treatment Period 1 (14 Days)||29||
48150545|NCT00736645|100692279|FG001|STARTED|Overall Study||15||
48150546|NCT00736645|100692280|FG002|STARTED|Overall Study||14||
48150547|NCT00736645|100692281|FG003|STARTED|Overall Study||13||
48150548|NCT00736645|100692278|FG000|COMPLETED|Overall Study||13||
48150549|NCT00736645|100692279|FG001|COMPLETED|Overall Study||13||
48150550|NCT00736645|100692280|FG002|COMPLETED|Overall Study||14||
48150551|NCT00736645|100692281|FG003|COMPLETED|Overall Study||13||
48150552|NCT00736645|100692278|FG000|NOT COMPLETED|Overall Study||0||
48150553|NCT00736645|100692279|FG001|NOT COMPLETED|Overall Study||2||
48150554|NCT00736645|100692280|FG002|NOT COMPLETED|Overall Study||0||
48150555|NCT00736645|100692281|FG003|NOT COMPLETED|Overall Study||0||
48150556|NCT01552954|100692282|FG000|STARTED|Overall Study||131||
48150557|NCT01552954|100692283|FG001|STARTED|Overall Study||125||
48150558|NCT01552954|100692282|FG000|COMPLETED|Overall Study||126||
48150559|NCT01552954|100692283|FG001|COMPLETED|Overall Study||119||
48150560|NCT01552954|100692282|FG000|NOT COMPLETED|Overall Study||5||
48150561|NCT01552954|100692283|FG001|NOT COMPLETED|Overall Study||6||
48150562|NCT02276222|100692284|FG000|STARTED|Overall Study||621||
48150563|NCT02276222|100692285|FG001|STARTED|Overall Study||466||
48150564|NCT02276222|100692284|FG000|COMPLETED|Overall Study||436||
48150565|NCT02276222|100692285|FG001|COMPLETED|Overall Study||402||
48150566|NCT02276222|100692284|FG000|NOT COMPLETED|Overall Study||185||
48150567|NCT02276222|100692285|FG001|NOT COMPLETED|Overall Study||64||
48150568|NCT00633464|100692286|FG000|STARTED|Overall Study||40||
48150569|NCT00633464|100692287|FG001|STARTED|Overall Study||39||
48150570|NCT00633464|100692286|FG000|Treated|Overall Study||40||
48150571|NCT00633464|100692287|FG001|Treated|Overall Study||37||
48150572|NCT00633464|100692286|FG000|COMPLETED|Overall Study||40||
48150573|NCT00633464|100692287|FG001|COMPLETED|Overall Study||37||
48150574|NCT00633464|100692286|FG000|NOT COMPLETED|Overall Study||0||
48150575|NCT00633464|100692287|FG001|NOT COMPLETED|Overall Study||2||
48150576|NCT01621126|100692288|FG000|STARTED|Overall Study||40||
48150577|NCT01621126|100692288|FG000|COMPLETED|Overall Study||34||
48150578|NCT01621126|100692288|FG000|NOT COMPLETED|Overall Study||6||
48150579|NCT02620917|100692289|FG000|STARTED|Overall Study||6623||
48150580|NCT02620917|100692289|FG000|COMPLETED|Overall Study||6623||
48150581|NCT02620917|100692289|FG000|NOT COMPLETED|Overall Study||0||
48150582|NCT04475549|100692290|FG000|STARTED|Overall Study||8||
48150583|NCT04475549|100692290|FG000|COMPLETED|Overall Study||8||
48150584|NCT04475549|100692290|FG000|NOT COMPLETED|Overall Study||0||
48150585|NCT01610427|100692291|FG000|STARTED|Overall Study||22||
48150586|NCT01610427|100692291|FG000|COMPLETED|Overall Study||22||
48150587|NCT01610427|100692291|FG000|NOT COMPLETED|Overall Study||0||
48150588|NCT01477853|100692292|FG000|STARTED|Phase A||55||
48150589|NCT01477853|100692293|FG001|STARTED|Phase A||56||
48150590|NCT01477853|100692294|FG002|STARTED|Phase A||55||
48150591|NCT01477853|100692292|FG000|COMPLETED|Phase A||12||
48150592|NCT01477853|100692293|FG001|COMPLETED|Phase A||11||
48150593|NCT01477853|100692294|FG002|COMPLETED|Phase A||11||
48150594|NCT01477853|100692292|FG000|NOT COMPLETED|Phase A||43||
48150595|NCT01477853|100692293|FG001|NOT COMPLETED|Phase A||45||
48150596|NCT01477853|100692294|FG002|NOT COMPLETED|Phase A||44||
48150597|NCT01477853|100692292|FG000|STARTED|Phase B||12||
48150598|NCT01477853|100692293|FG001|STARTED|Phase B||11||
48150599|NCT01477853|100692294|FG002|STARTED|Phase B||11||
48150600|NCT01477853|100692292|FG000|COMPLETED|Phase B||0||
48150601|NCT01477853|100692293|FG001|COMPLETED|Phase B||0||
48150602|NCT01477853|100692294|FG002|COMPLETED|Phase B||0||
48150603|NCT01477853|100692292|FG000|NOT COMPLETED|Phase B||12||
48150604|NCT01477853|100692293|FG001|NOT COMPLETED|Phase B||11||
48150605|NCT01477853|100692294|FG002|NOT COMPLETED|Phase B||11||
48150606|NCT01274182|100692295|FG000|STARTED|Overall Study||133||
48150607|NCT01274182|100692296|FG001|STARTED|Overall Study||87||
48150608|NCT01274182|100692297|FG002|STARTED|Overall Study||92||
48150609|NCT01274182|100692295|FG000|24 Weeks|Overall Study||123||
48607667|NCT01716520|101823582|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||2||
48607668|NCT01716520|101823583|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1||
48607669|NCT01716520|101823584|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||2||
48607670|NCT01716520|101823585|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||1||
48657079|NCT03648372|101943777|FG020|COMPLETED|Overall Study||1||
48150610|NCT01274182|100692296|FG001|24 Weeks|Overall Study||83||
48150611|NCT01274182|100692297|FG002|24 Weeks|Overall Study||84||
48150612|NCT01274182|100692295|FG000|COMPLETED|Overall Study||112||
48150613|NCT01274182|100692296|FG001|COMPLETED|Overall Study||69||
48150614|NCT01274182|100692297|FG002|COMPLETED|Overall Study||80||
48150615|NCT01274182|100692295|FG000|NOT COMPLETED|Overall Study||21||
48150616|NCT01274182|100692296|FG001|NOT COMPLETED|Overall Study||18||
48150617|NCT01274182|100692297|FG002|NOT COMPLETED|Overall Study||12||
48150618|NCT04040751|100692298|FG000|STARTED|Overall Study||17||
48150619|NCT04040751|100692299|FG001|STARTED|Overall Study||6||
48150620|NCT04040751|100692300|FG002|STARTED|Overall Study||17||
48150621|NCT04040751|100692301|FG003|STARTED|Overall Study||6||
48150622|NCT04040751|100692298|FG000|COMPLETED|Overall Study||15||
48150623|NCT04040751|100692299|FG001|COMPLETED|Overall Study||6||
48150624|NCT04040751|100692300|FG002|COMPLETED|Overall Study||15||
48150625|NCT04040751|100692301|FG003|COMPLETED|Overall Study||6||
48150626|NCT04040751|100692298|FG000|NOT COMPLETED|Overall Study||2||
48607671|NCT01716520|101823586|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||0||
48607672|NCT01716520|101823587|FG005|NOT COMPLETED|Treatment Period 1 (14 Days)||1||
48150627|NCT04040751|100692299|FG001|NOT COMPLETED|Overall Study||0||
48607673|NCT01716520|101823582|FG000|STARTED|Washout Period 1 (10 to 14 Days)||29||
48607674|NCT01716520|101823583|FG001|STARTED|Washout Period 1 (10 to 14 Days)||29||
48607675|NCT01716520|101823584|FG002|STARTED|Washout Period 1 (10 to 14 Days)||28||
48607676|NCT01716520|101823585|FG003|STARTED|Washout Period 1 (10 to 14 Days)||29||
48607677|NCT01716520|101823586|FG004|STARTED|Washout Period 1 (10 to 14 Days)||31||
48607678|NCT01716520|101823587|FG005|STARTED|Washout Period 1 (10 to 14 Days)||29||
48150628|NCT04040751|100692300|FG002|NOT COMPLETED|Overall Study||2||
48150629|NCT04040751|100692301|FG003|NOT COMPLETED|Overall Study||0||
48150630|NCT00705133|100692302|FG000|STARTED|Overall Study||15||
48150631|NCT00705133|100692302|FG000|COMPLETED|Overall Study||15||
48150632|NCT00705133|100692302|FG000|NOT COMPLETED|Overall Study||0||
48150633|NCT02964416|100692303|FG000|STARTED|Overall Study||39||
48150634|NCT02964416|100692304|FG001|STARTED|Overall Study||41||
48150635|NCT02964416|100692303|FG000|COMPLETED|Overall Study||38||
48150636|NCT02964416|100692304|FG001|COMPLETED|Overall Study||41||
48607679|NCT01716520|101823582|FG000|COMPLETED|Washout Period 1 (10 to 14 Days)||29||
48607680|NCT01716520|101823583|FG001|COMPLETED|Washout Period 1 (10 to 14 Days)||28||
48607681|NCT01716520|101823584|FG002|COMPLETED|Washout Period 1 (10 to 14 Days)||27||
48607682|NCT01716520|101823585|FG003|COMPLETED|Washout Period 1 (10 to 14 Days)||29||
48607683|NCT01716520|101823586|FG004|COMPLETED|Washout Period 1 (10 to 14 Days)||31||
48607684|NCT01716520|101823587|FG005|COMPLETED|Washout Period 1 (10 to 14 Days)||27||
48150637|NCT02964416|100692303|FG000|NOT COMPLETED|Overall Study||1||
48150638|NCT02964416|100692304|FG001|NOT COMPLETED|Overall Study||0||
48150639|NCT01738984|100692305|FG000|STARTED|Overall Study||250||
48150640|NCT01738984|100692306|FG001|STARTED|Overall Study||249||
48305591|NCT00403754|101074817|FG000|COMPLETED|Open Label: Salmeterol||11||
48305592|NCT00403754|101074818|FG001|COMPLETED|Open Label: Salmeterol||9||
48607685|NCT01716520|101823582|FG000|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0||
48607686|NCT01716520|101823583|FG001|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1||
48607687|NCT01716520|101823584|FG002|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1||
48607688|NCT01716520|101823585|FG003|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0||
48607689|NCT01716520|101823586|FG004|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0||
48607690|NCT01716520|101823587|FG005|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||2||
48607691|NCT01716520|101823582|FG000|STARTED|Treatment Period 2 (14 Days)||29||
48607692|NCT01716520|101823583|FG001|STARTED|Treatment Period 2 (14 Days)||28||
48607693|NCT01716520|101823584|FG002|STARTED|Treatment Period 2 (14 Days)||27||
48607694|NCT01716520|101823585|FG003|STARTED|Treatment Period 2 (14 Days)||29||
48607695|NCT01716520|101823586|FG004|STARTED|Treatment Period 2 (14 Days)||31||
48607696|NCT01716520|101823587|FG005|STARTED|Treatment Period 2 (14 Days)||27||
48607697|NCT01716520|101823582|FG000|COMPLETED|Treatment Period 2 (14 Days)||29||
48607698|NCT01716520|101823583|FG001|COMPLETED|Treatment Period 2 (14 Days)||28||
48607699|NCT01716520|101823584|FG002|COMPLETED|Treatment Period 2 (14 Days)||27||
48607700|NCT01716520|101823585|FG003|COMPLETED|Treatment Period 2 (14 Days)||28||
48607701|NCT01716520|101823586|FG004|COMPLETED|Treatment Period 2 (14 Days)||29||
48607702|NCT01716520|101823587|FG005|COMPLETED|Treatment Period 2 (14 Days)||27||
48607703|NCT01716520|101823582|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
48607704|NCT01716520|101823583|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
48607705|NCT01716520|101823584|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
48607706|NCT01716520|101823585|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||1||
48607707|NCT01716520|101823586|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||2||
48607708|NCT01716520|101823587|FG005|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
48607709|NCT01716520|101823582|FG000|STARTED|Washout Period 2 (10 to 14 Days)||29||
48607710|NCT01716520|101823583|FG001|STARTED|Washout Period 2 (10 to 14 Days)||28||
48607711|NCT01716520|101823584|FG002|STARTED|Washout Period 2 (10 to 14 Days)||27||
48607712|NCT01716520|101823585|FG003|STARTED|Washout Period 2 (10 to 14 Days)||28||
48607713|NCT01716520|101823586|FG004|STARTED|Washout Period 2 (10 to 14 Days)||29||
48607714|NCT01716520|101823587|FG005|STARTED|Washout Period 2 (10 to 14 Days)||27||
48607715|NCT01716520|101823582|FG000|COMPLETED|Washout Period 2 (10 to 14 Days)||27||
48607716|NCT01716520|101823583|FG001|COMPLETED|Washout Period 2 (10 to 14 Days)||27||
48607717|NCT01716520|101823584|FG002|COMPLETED|Washout Period 2 (10 to 14 Days)||26||
48150641|NCT01738984|100692305|FG000|COMPLETED|Overall Study||186||
48150642|NCT01738984|100692306|FG001|COMPLETED|Overall Study||210||
48150643|NCT01738984|100692305|FG000|NOT COMPLETED|Overall Study||64||
48150644|NCT01738984|100692306|FG001|NOT COMPLETED|Overall Study||39||
48150645|NCT02709005|100692307|FG000|STARTED|Overall Study||73||
48150646|NCT02709005|100692308|FG001|STARTED|Overall Study||36||
48150647|NCT02709005|100692307|FG000|COMPLETED|Overall Study||69||
48150648|NCT02709005|100692308|FG001|COMPLETED|Overall Study||35||
48150649|NCT02709005|100692307|FG000|NOT COMPLETED|Overall Study||4||
48305593|NCT00403754|101074819|FG002|COMPLETED|Open Label: Salmeterol||8||
48305594|NCT00403754|101074820|FG003|COMPLETED|Open Label: Salmeterol||11||
48607718|NCT01716520|101823585|FG003|COMPLETED|Washout Period 2 (10 to 14 Days)||28||
48305595|NCT00403754|101074817|FG000|NOT COMPLETED|Open Label: Salmeterol||0||
48305596|NCT00403754|101074818|FG001|NOT COMPLETED|Open Label: Salmeterol||0||
48305597|NCT00403754|101074819|FG002|NOT COMPLETED|Open Label: Salmeterol||0||
48305598|NCT00403754|101074820|FG003|NOT COMPLETED|Open Label: Salmeterol||0||
48719471|NCT03323736|102099287|FG002|Treated|Overall Study||68||
48719472|NCT03323736|102099285|FG000|COMPLETED|Overall Study||222||
48150650|NCT02709005|100692308|FG001|NOT COMPLETED|Overall Study||1||
48150651|NCT04124926|100692309|FG000|STARTED|Healing Phase||514||
48150652|NCT04124926|100692310|FG001|STARTED|Healing Phase||513||
48150653|NCT04124926|100692311|FG002|STARTED|Healing Phase||0||
48150654|NCT04124926|100692312|FG003|STARTED|Healing Phase||0||
48150655|NCT04124926|100692313|FG004|STARTED|Healing Phase||0||
48150656|NCT04124926|100692309|FG000|Treated With Study Drug|Healing Phase||514||
48150657|NCT04124926|100692310|FG001|Treated With Study Drug|Healing Phase||510||
48150658|NCT04124926|100692311|FG002|Treated With Study Drug|Healing Phase||0||
48150659|NCT04124926|100692312|FG003|Treated With Study Drug|Healing Phase||0||
48150660|NCT04124926|100692313|FG004|Treated With Study Drug|Healing Phase||0||
48150661|NCT04124926|100692309|FG000|COMPLETED|Healing Phase||483||
48150662|NCT04124926|100692310|FG001|COMPLETED|Healing Phase||481||
48150663|NCT04124926|100692311|FG002|COMPLETED|Healing Phase||0||
48150664|NCT04124926|100692312|FG003|COMPLETED|Healing Phase||0||
48150665|NCT04124926|100692313|FG004|COMPLETED|Healing Phase||0||
48150666|NCT04124926|100692309|FG000|NOT COMPLETED|Healing Phase||31||
48150667|NCT04124926|100692310|FG001|NOT COMPLETED|Healing Phase||32||
48150668|NCT04124926|100692311|FG002|NOT COMPLETED|Healing Phase||0||
48150669|NCT04124926|100692312|FG003|NOT COMPLETED|Healing Phase||0||
48150670|NCT04124926|100692313|FG004|NOT COMPLETED|Healing Phase||0||
48150671|NCT04124926|100692309|FG000|STARTED|Maintenance Phase||0|Re-randomized.|
48150672|NCT04124926|100692310|FG001|STARTED|Maintenance Phase||0|Re-randomized.|
48150673|NCT04124926|100692311|FG002|STARTED|Maintenance Phase||298|Re-randomized.|
48150674|NCT04124926|100692312|FG003|STARTED|Maintenance Phase||298|Re-randomized.|
48150675|NCT04124926|100692313|FG004|STARTED|Maintenance Phase||297|Re-randomized.|
48150676|NCT04124926|100692309|FG000|Treated With Study Drug|Maintenance Phase||0||
48150677|NCT04124926|100692310|FG001|Treated With Study Drug|Maintenance Phase||0||
48150678|NCT04124926|100692311|FG002|Treated With Study Drug|Maintenance Phase||296||
48150679|NCT04124926|100692312|FG003|Treated With Study Drug|Maintenance Phase||296||
48150680|NCT04124926|100692313|FG004|Treated With Study Drug|Maintenance Phase||297||
48150681|NCT04124926|100692309|FG000|COMPLETED|Maintenance Phase||0||
48150682|NCT04124926|100692310|FG001|COMPLETED|Maintenance Phase||0||
48150683|NCT04124926|100692311|FG002|COMPLETED|Maintenance Phase||274||
48150684|NCT04124926|100692312|FG003|COMPLETED|Maintenance Phase||269||
48150685|NCT04124926|100692313|FG004|COMPLETED|Maintenance Phase||269||
48150686|NCT04124926|100692309|FG000|NOT COMPLETED|Maintenance Phase||0||
48150687|NCT04124926|100692310|FG001|NOT COMPLETED|Maintenance Phase||0||
48150688|NCT04124926|100692311|FG002|NOT COMPLETED|Maintenance Phase||24||
48150689|NCT04124926|100692312|FG003|NOT COMPLETED|Maintenance Phase||29||
48150690|NCT04124926|100692313|FG004|NOT COMPLETED|Maintenance Phase||28||
48305599|NCT03953508|101074821|FG000|STARTED|Baseline||95|The order in which phases occurred differed as a result of COVID-19 restrictions on in-person data collection. Some participants started EMA first and then began laboratory data collection when in-person data collection was allowed. Other participants started laboratory data collection first (when COVID restrictions were lifted), and then did EMA after laboratory data collection. Thus, the participant flow may appear unbalanced.|
48305600|NCT03953508|101074822|FG001|STARTED|Baseline||104|The order in which phases occurred differed as a result of COVID-19 restrictions on in-person data collection. Some participants started EMA first and then began laboratory data collection when in-person data collection was allowed. Other participants started laboratory data collection first (when COVID restrictions were lifted), and then did EMA after laboratory data collection. Thus, the participant flow may appear unbalanced.|
48719473|NCT03323736|102099286|FG001|COMPLETED|Overall Study||47||
48719474|NCT03323736|102099287|FG002|COMPLETED|Overall Study||68||
48150691|NCT01666951|100692314|FG000|STARTED|Overall Study||18||
48150692|NCT01666951|100692315|FG001|STARTED|Overall Study||18||
48150693|NCT01666951|100692314|FG000|COMPLETED|Overall Study||17||
48150694|NCT01666951|100692315|FG001|COMPLETED|Overall Study||17||
48150695|NCT01666951|100692314|FG000|NOT COMPLETED|Overall Study||1||
48150696|NCT01666951|100692315|FG001|NOT COMPLETED|Overall Study||1||
48150697|NCT02618616|100692316|FG000|STARTED|Overall Study||87||
48150698|NCT02618616|100692317|FG001|STARTED|Overall Study||42||
48150699|NCT02618616|100692316|FG000|COMPLETED|Overall Study||66||
48150700|NCT02618616|100692317|FG001|COMPLETED|Overall Study||35||
48150701|NCT02618616|100692316|FG000|NOT COMPLETED|Overall Study||21||
48150702|NCT02618616|100692317|FG001|NOT COMPLETED|Overall Study||7||
48150703|NCT00683826|100692318|FG000|STARTED|Overall Study||8||
48150704|NCT00683826|100692318|FG000|0g Leucine|Overall Study||8||
48150705|NCT00683826|100692318|FG000|8g Leucine|Overall Study||8||
48150706|NCT00683826|100692318|FG000|4g Leucine|Overall Study||7||
48719475|NCT03323736|102099285|FG000|NOT COMPLETED|Overall Study||19||
48150707|NCT00683826|100692318|FG000|COMPLETED|Overall Study||7||
48150708|NCT00683826|100692318|FG000|NOT COMPLETED|Overall Study||1||
48150709|NCT02526654|100692319|FG000|STARTED|Overall Study||79||
48150710|NCT02526654|100692320|FG001|STARTED|Overall Study||36||
48150711|NCT02526654|100692319|FG000|COMPLETED|Overall Study||79||
48150712|NCT02526654|100692320|FG001|COMPLETED|Overall Study||36||
48150713|NCT02526654|100692319|FG000|NOT COMPLETED|Overall Study||0||
48150714|NCT02526654|100692320|FG001|NOT COMPLETED|Overall Study||0||
48150715|NCT00677833|100692321|FG000|STARTED|Overall Study||55||
48150716|NCT00677833|100692322|FG001|STARTED|Overall Study||51||
48150717|NCT00677833|100692323|FG002|STARTED|Overall Study||124||
48150718|NCT00677833|100692324|FG003|STARTED|Overall Study||131||
48150719|NCT00677833|100692321|FG000|COMPLETED|Overall Study||51||
48150720|NCT00677833|100692322|FG001|COMPLETED|Overall Study||51||
48150721|NCT00677833|100692323|FG002|COMPLETED|Overall Study||122||
48607719|NCT01716520|101823586|FG004|COMPLETED|Washout Period 2 (10 to 14 Days)||29||
48607720|NCT01716520|101823587|FG005|COMPLETED|Washout Period 2 (10 to 14 Days)||25||
48607721|NCT01716520|101823582|FG000|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2||
48607722|NCT01716520|101823583|FG001|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1||
48607723|NCT01716520|101823584|FG002|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1||
48607724|NCT01716520|101823585|FG003|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0||
48150722|NCT00677833|100692324|FG003|COMPLETED|Overall Study||128||
48150723|NCT00677833|100692321|FG000|NOT COMPLETED|Overall Study||4||
48150724|NCT00677833|100692322|FG001|NOT COMPLETED|Overall Study||0||
48150725|NCT00677833|100692323|FG002|NOT COMPLETED|Overall Study||2||
48150726|NCT00677833|100692324|FG003|NOT COMPLETED|Overall Study||3||
48150727|NCT00378352|100692325|FG000|STARTED|Dose Escalation 15,000 Units||20||
48150728|NCT00378352|100692326|FG001|STARTED|Dose Escalation 15,000 Units||0||
48150729|NCT00378352|100692327|FG002|STARTED|Dose Escalation 15,000 Units||0||
48150730|NCT00378352|100692328|FG003|STARTED|Dose Escalation 15,000 Units||11||
48150731|NCT00378352|100692329|FG004|STARTED|Dose Escalation 15,000 Units||0||
48150732|NCT00378352|100692330|FG005|STARTED|Dose Escalation 15,000 Units||0||
48150733|NCT00378352|100692325|FG000|Safety Analysis|Dose Escalation 15,000 Units||19||
48150734|NCT00378352|100692326|FG001|Safety Analysis|Dose Escalation 15,000 Units||0||
48150735|NCT00378352|100692327|FG002|Safety Analysis|Dose Escalation 15,000 Units||0||
48150736|NCT00378352|100692328|FG003|Safety Analysis|Dose Escalation 15,000 Units||11||
48150737|NCT00378352|100692329|FG004|Safety Analysis|Dose Escalation 15,000 Units||0||
48150738|NCT00378352|100692330|FG005|Safety Analysis|Dose Escalation 15,000 Units||0||
48150739|NCT00378352|100692325|FG000|COMPLETED|Dose Escalation 15,000 Units||15||
48150740|NCT00378352|100692326|FG001|COMPLETED|Dose Escalation 15,000 Units||0||
48150741|NCT00378352|100692327|FG002|COMPLETED|Dose Escalation 15,000 Units||0||
48150742|NCT00378352|100692328|FG003|COMPLETED|Dose Escalation 15,000 Units||10||
48150743|NCT00378352|100692329|FG004|COMPLETED|Dose Escalation 15,000 Units||0||
48150744|NCT00378352|100692330|FG005|COMPLETED|Dose Escalation 15,000 Units||0||
48150745|NCT00378352|100692325|FG000|NOT COMPLETED|Dose Escalation 15,000 Units||5||
48150746|NCT00378352|100692326|FG001|NOT COMPLETED|Dose Escalation 15,000 Units||0||
48607725|NCT01716520|101823586|FG004|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0||
48607726|NCT01716520|101823587|FG005|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2||
48607727|NCT01716520|101823582|FG000|STARTED|Treatment Period 3 (14 Days)||27||
48607728|NCT01716520|101823583|FG001|STARTED|Treatment Period 3 (14 Days)||27||
48607729|NCT01716520|101823584|FG002|STARTED|Treatment Period 3 (14 Days)||26||
48607730|NCT01716520|101823585|FG003|STARTED|Treatment Period 3 (14 Days)||28||
48607731|NCT01716520|101823586|FG004|STARTED|Treatment Period 3 (14 Days)||29||
48607732|NCT01716520|101823587|FG005|STARTED|Treatment Period 3 (14 Days)||25||
48150747|NCT00378352|100692327|FG002|NOT COMPLETED|Dose Escalation 15,000 Units||0||
48150748|NCT00378352|100692328|FG003|NOT COMPLETED|Dose Escalation 15,000 Units||1||
48150749|NCT00378352|100692329|FG004|NOT COMPLETED|Dose Escalation 15,000 Units||0||
48150750|NCT00378352|100692330|FG005|NOT COMPLETED|Dose Escalation 15,000 Units||0||
48150751|NCT00378352|100692325|FG000|STARTED|Dose Escalation 30,000 Units||0||
48150752|NCT00378352|100692326|FG001|STARTED|Dose Escalation 30,000 Units||19||
48150753|NCT00378352|100692327|FG002|STARTED|Dose Escalation 30,000 Units||0||
48150754|NCT00378352|100692328|FG003|STARTED|Dose Escalation 30,000 Units||11||
48150755|NCT00378352|100692329|FG004|STARTED|Dose Escalation 30,000 Units||0||
48150756|NCT00378352|100692330|FG005|STARTED|Dose Escalation 30,000 Units||0||
48607733|NCT01716520|101823582|FG000|COMPLETED|Treatment Period 3 (14 Days)||27||
48607734|NCT01716520|101823583|FG001|COMPLETED|Treatment Period 3 (14 Days)||27||
48607735|NCT01716520|101823584|FG002|COMPLETED|Treatment Period 3 (14 Days)||25||
48607736|NCT01716520|101823585|FG003|COMPLETED|Treatment Period 3 (14 Days)||28||
48607737|NCT01716520|101823586|FG004|COMPLETED|Treatment Period 3 (14 Days)||29||
48150757|NCT00378352|100692325|FG000|Safety Analysis|Dose Escalation 30,000 Units||0||
48150758|NCT00378352|100692326|FG001|Safety Analysis|Dose Escalation 30,000 Units||20||
48150759|NCT00378352|100692327|FG002|Safety Analysis|Dose Escalation 30,000 Units||0||
48150760|NCT00378352|100692328|FG003|Safety Analysis|Dose Escalation 30,000 Units||11||
48150761|NCT00378352|100692329|FG004|Safety Analysis|Dose Escalation 30,000 Units||0||
48150762|NCT00378352|100692330|FG005|Safety Analysis|Dose Escalation 30,000 Units||0||
48150763|NCT00378352|100692325|FG000|COMPLETED|Dose Escalation 30,000 Units||0||
48607738|NCT01716520|101823587|FG005|COMPLETED|Treatment Period 3 (14 Days)||23||
48607739|NCT01716520|101823582|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0||
48607740|NCT01716520|101823583|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||0||
48607741|NCT01716520|101823584|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||1||
48607742|NCT01716520|101823585|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0||
48150764|NCT00378352|100692326|FG001|COMPLETED|Dose Escalation 30,000 Units||16||
48150765|NCT00378352|100692327|FG002|COMPLETED|Dose Escalation 30,000 Units||0||
48150766|NCT00378352|100692328|FG003|COMPLETED|Dose Escalation 30,000 Units||9||
48150767|NCT00378352|100692329|FG004|COMPLETED|Dose Escalation 30,000 Units||0||
48150768|NCT00378352|100692330|FG005|COMPLETED|Dose Escalation 30,000 Units||0||
48150769|NCT00378352|100692325|FG000|NOT COMPLETED|Dose Escalation 30,000 Units||0||
48150770|NCT00378352|100692326|FG001|NOT COMPLETED|Dose Escalation 30,000 Units||3||
48150771|NCT00378352|100692327|FG002|NOT COMPLETED|Dose Escalation 30,000 Units||0||
48150772|NCT00378352|100692328|FG003|NOT COMPLETED|Dose Escalation 30,000 Units||2||
48150773|NCT00378352|100692329|FG004|NOT COMPLETED|Dose Escalation 30,000 Units||0||
48150774|NCT00378352|100692330|FG005|NOT COMPLETED|Dose Escalation 30,000 Units||0||
48150775|NCT00378352|100692325|FG000|STARTED|Dose Escalation 60,000 Units||0||
48150776|NCT00378352|100692326|FG001|STARTED|Dose Escalation 60,000 Units||0||
48150777|NCT00378352|100692327|FG002|STARTED|Dose Escalation 60,000 Units||20||
48150778|NCT00378352|100692328|FG003|STARTED|Dose Escalation 60,000 Units||11||
48150779|NCT00378352|100692329|FG004|STARTED|Dose Escalation 60,000 Units||0||
48150780|NCT00378352|100692330|FG005|STARTED|Dose Escalation 60,000 Units||0||
48150781|NCT00378352|100692325|FG000|Safety Analysis|Dose Escalation 60,000 Units||0||
48150782|NCT00378352|100692326|FG001|Safety Analysis|Dose Escalation 60,000 Units||0||
48150783|NCT00378352|100692327|FG002|Safety Analysis|Dose Escalation 60,000 Units||19||
48150784|NCT00378352|100692328|FG003|Safety Analysis|Dose Escalation 60,000 Units||11||
48150785|NCT00378352|100692329|FG004|Safety Analysis|Dose Escalation 60,000 Units||0||
48150786|NCT00378352|100692330|FG005|Safety Analysis|Dose Escalation 60,000 Units||0||
48150787|NCT00378352|100692325|FG000|COMPLETED|Dose Escalation 60,000 Units||0||
48150788|NCT00378352|100692326|FG001|COMPLETED|Dose Escalation 60,000 Units||0||
48150789|NCT00378352|100692327|FG002|COMPLETED|Dose Escalation 60,000 Units||17||
48150790|NCT00378352|100692328|FG003|COMPLETED|Dose Escalation 60,000 Units||10||
48150791|NCT00378352|100692329|FG004|COMPLETED|Dose Escalation 60,000 Units||0||
48150792|NCT00378352|100692330|FG005|COMPLETED|Dose Escalation 60,000 Units||0||
48150793|NCT00378352|100692325|FG000|NOT COMPLETED|Dose Escalation 60,000 Units||0||
48150794|NCT00378352|100692326|FG001|NOT COMPLETED|Dose Escalation 60,000 Units||0||
48150795|NCT00378352|100692327|FG002|NOT COMPLETED|Dose Escalation 60,000 Units||3||
48150796|NCT00378352|100692328|FG003|NOT COMPLETED|Dose Escalation 60,000 Units||1||
48150797|NCT00378352|100692329|FG004|NOT COMPLETED|Dose Escalation 60,000 Units||0||
48150798|NCT00378352|100692330|FG005|NOT COMPLETED|Dose Escalation 60,000 Units||0||
48150799|NCT00378352|100692325|FG000|STARTED|Efficacy Phase||0||
48150800|NCT00378352|100692326|FG001|STARTED|Efficacy Phase||0||
48150801|NCT00378352|100692327|FG002|STARTED|Efficacy Phase||0||
48150802|NCT00378352|100692328|FG003|STARTED|Efficacy Phase||0||
48150803|NCT00378352|100692329|FG004|STARTED|Efficacy Phase||65||
48150804|NCT00378352|100692330|FG005|STARTED|Efficacy Phase||66||
48150805|NCT00378352|100692325|FG000|Safety Analysis|Efficacy Phase||0||
48150806|NCT00378352|100692326|FG001|Safety Analysis|Efficacy Phase||0||
48150807|NCT00378352|100692327|FG002|Safety Analysis|Efficacy Phase||0||
48150808|NCT00378352|100692328|FG003|Safety Analysis|Efficacy Phase||0||
48150809|NCT00378352|100692329|FG004|Safety Analysis|Efficacy Phase||67||
48150810|NCT00378352|100692330|FG005|Safety Analysis|Efficacy Phase||64||
48150811|NCT00378352|100692325|FG000|COMPLETED|Efficacy Phase||0||
48305601|NCT03953508|101074821|FG000|COMPLETED|Baseline||92||
48305602|NCT03953508|101074822|FG001|COMPLETED|Baseline||102||
48305603|NCT03953508|101074821|FG000|NOT COMPLETED|Baseline||3||
48305604|NCT03953508|101074822|FG001|NOT COMPLETED|Baseline||2||
48406124|NCT04063865|101328353|FG000|COMPLETED|Overall Study||0||
48607743|NCT01716520|101823586|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||0||
48607744|NCT01716520|101823587|FG005|NOT COMPLETED|Treatment Period 3 (14 Days)||2||
48607745|NCT02051335|101823588|FG000|STARTED|Period 1||7||
48607746|NCT02051335|101823589|FG001|STARTED|Period 1||7||
48607747|NCT02051335|101823590|FG002|STARTED|Period 1||7||
48607748|NCT02051335|101823591|FG003|STARTED|Period 1||6||
48607749|NCT02051335|101823588|FG000|COMPLETED|Period 1||7||
48150812|NCT00378352|100692326|FG001|COMPLETED|Efficacy Phase||0||
48150813|NCT00378352|100692327|FG002|COMPLETED|Efficacy Phase||0||
48150814|NCT00378352|100692328|FG003|COMPLETED|Efficacy Phase||0||
48150815|NCT00378352|100692329|FG004|COMPLETED|Efficacy Phase||54||
48150816|NCT00378352|100692330|FG005|COMPLETED|Efficacy Phase||59||
48150817|NCT00378352|100692325|FG000|NOT COMPLETED|Efficacy Phase||0||
48368018|NCT03567291|101230095|FG003|Intent to Treat Set|Period I||0||
48368019|NCT03567291|101230092|FG000|COMPLETED|Period I||137||
48368020|NCT03567291|101230093|FG001|COMPLETED|Period I||0||
48368021|NCT03567291|101230094|FG002|COMPLETED|Period I||0||
48406125|NCT04063865|101328354|FG001|COMPLETED|Overall Study||0||
48406126|NCT04063865|101328353|FG000|NOT COMPLETED|Overall Study||6||
48607750|NCT02051335|101823589|FG001|COMPLETED|Period 1||7||
48607751|NCT02051335|101823590|FG002|COMPLETED|Period 1||7||
48150818|NCT00378352|100692326|FG001|NOT COMPLETED|Efficacy Phase||0||
48150819|NCT00378352|100692327|FG002|NOT COMPLETED|Efficacy Phase||0||
48150820|NCT00378352|100692328|FG003|NOT COMPLETED|Efficacy Phase||0||
48150821|NCT00378352|100692329|FG004|NOT COMPLETED|Efficacy Phase||11||
48150822|NCT00378352|100692330|FG005|NOT COMPLETED|Efficacy Phase||7||
48150823|NCT03466086|100692331|FG000|STARTED|Period 1||28||
48150824|NCT03466086|100692332|FG001|STARTED|Period 1||27||
48150825|NCT03466086|100692331|FG000|COMPLETED|Period 1||26||
48150826|NCT03466086|100692332|FG001|COMPLETED|Period 1||27||
48607752|NCT02051335|101823591|FG003|COMPLETED|Period 1||6||
48607753|NCT02051335|101823588|FG000|NOT COMPLETED|Period 1||0||
48607754|NCT02051335|101823589|FG001|NOT COMPLETED|Period 1||0||
48607755|NCT02051335|101823590|FG002|NOT COMPLETED|Period 1||0||
48607756|NCT02051335|101823591|FG003|NOT COMPLETED|Period 1||0||
48607757|NCT02051335|101823588|FG000|STARTED|Period 2||7||
48607758|NCT02051335|101823589|FG001|STARTED|Period 2||7||
48607759|NCT02051335|101823590|FG002|STARTED|Period 2||7||
48607760|NCT02051335|101823591|FG003|STARTED|Period 2||4||
48719476|NCT03323736|102099286|FG001|NOT COMPLETED|Overall Study||12||
48719477|NCT03323736|102099287|FG002|NOT COMPLETED|Overall Study||2||
48719478|NCT01827332|102099288|FG000|STARTED|Overall Study||8||
48719479|NCT01827332|102099289|FG001|STARTED|Overall Study||8||
48719480|NCT01827332|102099288|FG000|COMPLETED|Overall Study||6||
48719481|NCT01827332|102099289|FG001|COMPLETED|Overall Study||7||
48150827|NCT03466086|100692331|FG000|NOT COMPLETED|Period 1||2||
48150828|NCT03466086|100692332|FG001|NOT COMPLETED|Period 1||0||
48150829|NCT03466086|100692331|FG000|STARTED|Period 2||26||
48150830|NCT03466086|100692332|FG001|STARTED|Period 2||27||
48150831|NCT03466086|100692331|FG000|COMPLETED|Period 2||26||
48150832|NCT03466086|100692332|FG001|COMPLETED|Period 2||27||
48150833|NCT03466086|100692331|FG000|NOT COMPLETED|Period 2||0||
48150834|NCT03466086|100692332|FG001|NOT COMPLETED|Period 2||0||
48150835|NCT00995072|100692333|FG000|STARTED|Overall Study||10||
48150836|NCT00995072|100692334|FG001|STARTED|Overall Study||15||
48150837|NCT00995072|100692333|FG000|COMPLETED|Overall Study||9||
48150838|NCT00995072|100692334|FG001|COMPLETED|Overall Study||12||
48150839|NCT00995072|100692333|FG000|NOT COMPLETED|Overall Study||1||
48150840|NCT00995072|100692334|FG001|NOT COMPLETED|Overall Study||3||
48150841|NCT00406133|100692335|FG000|STARTED|Phase 1 (First 26 Week Period)||165||
48150842|NCT00406133|100692336|FG001|STARTED|Phase 1 (First 26 Week Period)||157||
48150843|NCT00406133|100692337|FG002|STARTED|Phase 1 (First 26 Week Period)||67||
48150844|NCT00406133|100692338|FG003|STARTED|Phase 1 (First 26 Week Period)||62||
48150845|NCT00406133|100692335|FG000|COMPLETED|Phase 1 (First 26 Week Period)||162||
48150846|NCT00406133|100692336|FG001|COMPLETED|Phase 1 (First 26 Week Period)||155||
48150847|NCT00406133|100692337|FG002|COMPLETED|Phase 1 (First 26 Week Period)||67||
48150848|NCT00406133|100692338|FG003|COMPLETED|Phase 1 (First 26 Week Period)||60||
48150849|NCT00406133|100692335|FG000|NOT COMPLETED|Phase 1 (First 26 Week Period)||3||
48150850|NCT00406133|100692336|FG001|NOT COMPLETED|Phase 1 (First 26 Week Period)||2||
48406127|NCT04063865|101328354|FG001|NOT COMPLETED|Overall Study||8||
48719482|NCT01827332|102099288|FG000|NOT COMPLETED|Overall Study||2||
48719483|NCT01827332|102099289|FG001|NOT COMPLETED|Overall Study||1||
48719484|NCT00007644|102099290|FG000|STARTED|Overall Study||364||
48719485|NCT00007644|102099291|FG001|STARTED|Overall Study||367||
48719486|NCT00007644|102099290|FG000|COMPLETED|Overall Study||364||
48719487|NCT00007644|102099291|FG001|COMPLETED|Overall Study||367||
48719488|NCT00007644|102099290|FG000|NOT COMPLETED|Overall Study||0||
48719489|NCT00007644|102099291|FG001|NOT COMPLETED|Overall Study||0||
48719490|NCT03684694|102099292|FG000|STARTED|Phase 1||37||
48719491|NCT03684694|102099293|FG001|STARTED|Phase 1||4||
48719492|NCT03684694|102099294|FG002|STARTED|Phase 1||6||
48719493|NCT03684694|102099295|FG003|STARTED|Phase 1||0||
48719494|NCT03684694|102099296|FG004|STARTED|Phase 1||0||
48719495|NCT03684694|102099297|FG005|STARTED|Phase 1||0||
48719496|NCT03684694|102099292|FG000|COMPLETED|Phase 1||0||
48719497|NCT03684694|102099293|FG001|COMPLETED|Phase 1||1||
48150851|NCT00406133|100692337|FG002|NOT COMPLETED|Phase 1 (First 26 Week Period)||0||
48719498|NCT03684694|102099294|FG002|COMPLETED|Phase 1||1||
48719499|NCT03684694|102099295|FG003|COMPLETED|Phase 1||0||
48150852|NCT00406133|100692338|FG003|NOT COMPLETED|Phase 1 (First 26 Week Period)||2||
48150853|NCT00406133|100692335|FG000|STARTED|Phase 2 (Second 26 Week Period)||159||
48150854|NCT00406133|100692336|FG001|STARTED|Phase 2 (Second 26 Week Period)||155||
48150855|NCT00406133|100692337|FG002|STARTED|Phase 2 (Second 26 Week Period)||67||
48150856|NCT00406133|100692338|FG003|STARTED|Phase 2 (Second 26 Week Period)||60||
48150857|NCT00406133|100692335|FG000|COMPLETED|Phase 2 (Second 26 Week Period)||157||
48150858|NCT00406133|100692336|FG001|COMPLETED|Phase 2 (Second 26 Week Period)||152||
48406128|NCT00707486|101328355|FG000|STARTED|Overall Study||72||
48607761|NCT02051335|101823588|FG000|COMPLETED|Period 2||7||
48607762|NCT02051335|101823589|FG001|COMPLETED|Period 2||7||
48607763|NCT02051335|101823590|FG002|COMPLETED|Period 2||7||
48607764|NCT02051335|101823591|FG003|COMPLETED|Period 2||4||
48607765|NCT02051335|101823588|FG000|NOT COMPLETED|Period 2||0||
48719500|NCT03684694|102099296|FG004|COMPLETED|Phase 1||0||
48719501|NCT03684694|102099297|FG005|COMPLETED|Phase 1||0||
48719502|NCT03684694|102099292|FG000|NOT COMPLETED|Phase 1||37||
48719503|NCT03684694|102099293|FG001|NOT COMPLETED|Phase 1||3||
48719504|NCT03684694|102099294|FG002|NOT COMPLETED|Phase 1||5||
48719505|NCT03684694|102099295|FG003|NOT COMPLETED|Phase 1||0||
48719506|NCT03684694|102099296|FG004|NOT COMPLETED|Phase 1||0||
48150859|NCT00406133|100692337|FG002|COMPLETED|Phase 2 (Second 26 Week Period)||67||
48150860|NCT00406133|100692338|FG003|COMPLETED|Phase 2 (Second 26 Week Period)||60||
48150861|NCT00406133|100692335|FG000|NOT COMPLETED|Phase 2 (Second 26 Week Period)||2||
48150862|NCT00406133|100692336|FG001|NOT COMPLETED|Phase 2 (Second 26 Week Period)||3||
48150863|NCT00406133|100692337|FG002|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0||
48150864|NCT00406133|100692338|FG003|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0||
48150865|NCT03232983|100692339|FG000|STARTED|Period 1||7||
48150866|NCT03232983|100692340|FG001|STARTED|Period 1||7||
48150867|NCT03232983|100692341|FG002|STARTED|Period 1||7||
48305605|NCT03953508|101074821|FG000|STARTED|Ecological Momentary Assessment||65|The order in which phases occurred differed was a result of COVID-19 restrictions on data collection. For some participants, they started EMA first and then began laboratory data collection when in-person was allowed. For others, they started laboratory data collection when COVID restrictions were lifted, and then did EMA. Thus, the participant flow may appear unbalanced.|
48305606|NCT03953508|101074822|FG001|STARTED|Ecological Momentary Assessment||74|The order in which phases occurred differed was a result of COVID-19 restrictions on data collection. For some participants, they started EMA first and then began laboratory data collection when in-person was allowed. For others, they started laboratory data collection when COVID restrictions were lifted, and then did EMA. Thus, the participant flow may appear unbalanced.|
48305607|NCT03953508|101074821|FG000|COMPLETED|Ecological Momentary Assessment||63||
48305608|NCT03953508|101074822|FG001|COMPLETED|Ecological Momentary Assessment||62||
48305609|NCT03953508|101074821|FG000|NOT COMPLETED|Ecological Momentary Assessment||2||
48305610|NCT03953508|101074822|FG001|NOT COMPLETED|Ecological Momentary Assessment||12||
48305611|NCT03953508|101074821|FG000|STARTED|Laboratory Period||59|The order in which phases occurred differed was a result of COVID-19 restrictions on data collection. For some participants, they started EMA first and then began laboratory data collection when in-person was allowed. For others, they started laboratory data collection when COVID restrictions were lifted, and then did EMA. Thus, the participant flow may appear unbalanced.|
48368022|NCT03567291|101230095|FG003|COMPLETED|Period I||0||
48368023|NCT03567291|101230092|FG000|NOT COMPLETED|Period I||91||
48719507|NCT03684694|102099297|FG005|NOT COMPLETED|Phase 1||0||
48719508|NCT03684694|102099292|FG000|STARTED|Phase 2||0||
48719509|NCT03684694|102099293|FG001|STARTED|Phase 2||0||
48150868|NCT03232983|100692342|FG003|STARTED|Period 1||7||
48150869|NCT03232983|100692339|FG000|Received at Least One Dose of Study Drug|Period 1||7||
48150870|NCT03232983|100692340|FG001|Received at Least One Dose of Study Drug|Period 1||7||
48150871|NCT03232983|100692341|FG002|Received at Least One Dose of Study Drug|Period 1||7||
48150872|NCT03232983|100692342|FG003|Received at Least One Dose of Study Drug|Period 1||7||
48150873|NCT03232983|100692339|FG000|COMPLETED|Period 1||7||
48150874|NCT03232983|100692340|FG001|COMPLETED|Period 1||7||
48368024|NCT03567291|101230093|FG001|NOT COMPLETED|Period I||0||
48368025|NCT03567291|101230094|FG002|NOT COMPLETED|Period I||0||
48368026|NCT03567291|101230095|FG003|NOT COMPLETED|Period I||0||
48150875|NCT03232983|100692341|FG002|COMPLETED|Period 1||6||
48150876|NCT03232983|100692342|FG003|COMPLETED|Period 1||7||
48150877|NCT03232983|100692339|FG000|NOT COMPLETED|Period 1||0||
48150878|NCT03232983|100692340|FG001|NOT COMPLETED|Period 1||0||
48150879|NCT03232983|100692341|FG002|NOT COMPLETED|Period 1||1||
48150880|NCT03232983|100692342|FG003|NOT COMPLETED|Period 1||0||
48150881|NCT03232983|100692339|FG000|STARTED|Washout Period 1||7||
48150882|NCT03232983|100692340|FG001|STARTED|Washout Period 1||7||
48150883|NCT03232983|100692341|FG002|STARTED|Washout Period 1||6||
48150884|NCT03232983|100692342|FG003|STARTED|Washout Period 1||7||
48150885|NCT03232983|100692339|FG000|COMPLETED|Washout Period 1||7||
48150886|NCT03232983|100692340|FG001|COMPLETED|Washout Period 1||7||
48150887|NCT03232983|100692341|FG002|COMPLETED|Washout Period 1||6||
48150888|NCT03232983|100692342|FG003|COMPLETED|Washout Period 1||7||
48150889|NCT03232983|100692339|FG000|NOT COMPLETED|Washout Period 1||0||
48150890|NCT03232983|100692340|FG001|NOT COMPLETED|Washout Period 1||0||
48150891|NCT03232983|100692341|FG002|NOT COMPLETED|Washout Period 1||0||
48607766|NCT02051335|101823589|FG001|NOT COMPLETED|Period 2||0||
48607767|NCT02051335|101823590|FG002|NOT COMPLETED|Period 2||0||
48607768|NCT02051335|101823591|FG003|NOT COMPLETED|Period 2||0||
48607769|NCT02051335|101823588|FG000|STARTED|Period 3||7||
48607770|NCT02051335|101823589|FG001|STARTED|Period 3||7||
48607771|NCT02051335|101823590|FG002|STARTED|Period 3||5||
48607772|NCT02051335|101823591|FG003|STARTED|Period 3||4||
48607773|NCT02051335|101823588|FG000|COMPLETED|Period 3||7||
48607774|NCT02051335|101823589|FG001|COMPLETED|Period 3||7||
48607775|NCT02051335|101823590|FG002|COMPLETED|Period 3||5||
48607776|NCT02051335|101823591|FG003|COMPLETED|Period 3||4||
48607777|NCT02051335|101823588|FG000|NOT COMPLETED|Period 3||0||
48607778|NCT02051335|101823589|FG001|NOT COMPLETED|Period 3||0||
48607779|NCT02051335|101823590|FG002|NOT COMPLETED|Period 3||0||
48607780|NCT02051335|101823591|FG003|NOT COMPLETED|Period 3||0||
48607781|NCT02051335|101823588|FG000|STARTED|Period 4||7||
48607782|NCT02051335|101823589|FG001|STARTED|Period 4||7||
48607783|NCT02051335|101823590|FG002|STARTED|Period 4||5||
48607784|NCT02051335|101823591|FG003|STARTED|Period 4||4||
48607785|NCT02051335|101823588|FG000|COMPLETED|Period 4||7||
48150892|NCT03232983|100692342|FG003|NOT COMPLETED|Washout Period 1||0||
48150893|NCT03232983|100692339|FG000|STARTED|Period 2||7||
48150894|NCT03232983|100692340|FG001|STARTED|Period 2||7||
48607786|NCT02051335|101823589|FG001|COMPLETED|Period 4||7||
48607787|NCT02051335|101823590|FG002|COMPLETED|Period 4||5||
48607788|NCT02051335|101823591|FG003|COMPLETED|Period 4||4||
48607789|NCT02051335|101823588|FG000|NOT COMPLETED|Period 4||0||
48150895|NCT03232983|100692341|FG002|STARTED|Period 2||6||
48150896|NCT03232983|100692342|FG003|STARTED|Period 2||7||
48607790|NCT02051335|101823589|FG001|NOT COMPLETED|Period 4||0||
48607791|NCT02051335|101823590|FG002|NOT COMPLETED|Period 4||0||
48607792|NCT02051335|101823591|FG003|NOT COMPLETED|Period 4||0||
48607793|NCT01088711|101823592|FG000|STARTED|Overall Study||18||
48607794|NCT01088711|101823593|FG001|STARTED|Overall Study||6||
48607795|NCT01088711|101823594|FG002|STARTED|Overall Study||6||
48607796|NCT01088711|101823595|FG003|STARTED|Overall Study||2||
48607797|NCT01088711|101823592|FG000|COMPLETED|Overall Study||18||
48607798|NCT01088711|101823593|FG001|COMPLETED|Overall Study||6||
48607799|NCT01088711|101823594|FG002|COMPLETED|Overall Study||6||
48607800|NCT01088711|101823595|FG003|COMPLETED|Overall Study||2||
48607801|NCT01088711|101823592|FG000|NOT COMPLETED|Overall Study||0||
48607802|NCT01088711|101823593|FG001|NOT COMPLETED|Overall Study||0||
48607803|NCT01088711|101823594|FG002|NOT COMPLETED|Overall Study||0||
48607804|NCT01088711|101823595|FG003|NOT COMPLETED|Overall Study||0||
48607805|NCT00642954|101823596|FG000|STARTED|Overall Study||4||
48150897|NCT03232983|100692339|FG000|COMPLETED|Period 2||7||
48150898|NCT03232983|100692340|FG001|COMPLETED|Period 2||7||
48150899|NCT03232983|100692341|FG002|COMPLETED|Period 2||6||
48150900|NCT03232983|100692342|FG003|COMPLETED|Period 2||7||
48150901|NCT03232983|100692339|FG000|NOT COMPLETED|Period 2||0||
48150902|NCT03232983|100692340|FG001|NOT COMPLETED|Period 2||0||
48150903|NCT03232983|100692341|FG002|NOT COMPLETED|Period 2||0||
48607806|NCT00642954|101823597|FG001|STARTED|Overall Study||4||
48607807|NCT00642954|101823598|FG002|STARTED|Overall Study||3||
48607808|NCT00642954|101823599|FG003|STARTED|Overall Study||3||
48607809|NCT00642954|101823600|FG004|STARTED|Overall Study||17||
48607810|NCT00642954|101823596|FG000|COMPLETED|Overall Study||0||
48607811|NCT00642954|101823597|FG001|COMPLETED|Overall Study||0||
48607812|NCT00642954|101823598|FG002|COMPLETED|Overall Study||0||
48150904|NCT03232983|100692342|FG003|NOT COMPLETED|Period 2||0||
48150905|NCT03232983|100692339|FG000|STARTED|Washout Period 2||7||
48719510|NCT03684694|102099294|FG002|STARTED|Phase 2||0||
48150906|NCT03232983|100692340|FG001|STARTED|Washout Period 2||7||
48607813|NCT00642954|101823599|FG003|COMPLETED|Overall Study||0||
48607814|NCT00642954|101823600|FG004|COMPLETED|Overall Study||1||
48607815|NCT00642954|101823596|FG000|NOT COMPLETED|Overall Study||4||
48607816|NCT00642954|101823597|FG001|NOT COMPLETED|Overall Study||4||
48719511|NCT03684694|102099295|FG003|STARTED|Phase 2||49||
48150907|NCT03232983|100692341|FG002|STARTED|Washout Period 2||6||
48150908|NCT03232983|100692342|FG003|STARTED|Washout Period 2||7||
48150909|NCT03232983|100692339|FG000|COMPLETED|Washout Period 2||7||
48607817|NCT00642954|101823598|FG002|NOT COMPLETED|Overall Study||3||
48607818|NCT00642954|101823599|FG003|NOT COMPLETED|Overall Study||3||
48150910|NCT03232983|100692340|FG001|COMPLETED|Washout Period 2||7||
48150911|NCT03232983|100692341|FG002|COMPLETED|Washout Period 2||5||
48150912|NCT03232983|100692342|FG003|COMPLETED|Washout Period 2||6||
48150913|NCT03232983|100692339|FG000|NOT COMPLETED|Washout Period 2||0||
48150914|NCT03232983|100692340|FG001|NOT COMPLETED|Washout Period 2||0||
48150915|NCT03232983|100692341|FG002|NOT COMPLETED|Washout Period 2||1||
48150916|NCT03232983|100692342|FG003|NOT COMPLETED|Washout Period 2||1||
48150917|NCT03232983|100692339|FG000|STARTED|Period 3||7||
48150918|NCT03232983|100692340|FG001|STARTED|Period 3||7||
48150919|NCT03232983|100692341|FG002|STARTED|Period 3||5||
48150920|NCT03232983|100692342|FG003|STARTED|Period 3||6||
48150921|NCT03232983|100692339|FG000|COMPLETED|Period 3||7||
48150922|NCT03232983|100692340|FG001|COMPLETED|Period 3||7||
48150923|NCT03232983|100692341|FG002|COMPLETED|Period 3||5||
48150924|NCT03232983|100692342|FG003|COMPLETED|Period 3||6||
48150925|NCT03232983|100692339|FG000|NOT COMPLETED|Period 3||0||
48150926|NCT03232983|100692340|FG001|NOT COMPLETED|Period 3||0||
48719512|NCT03684694|102099296|FG004|STARTED|Phase 2||30||
48719513|NCT03684694|102099297|FG005|STARTED|Phase 2||10||
48719514|NCT03684694|102099292|FG000|COMPLETED|Phase 2||0||
48719515|NCT03684694|102099293|FG001|COMPLETED|Phase 2||0||
48719516|NCT03684694|102099294|FG002|COMPLETED|Phase 2||0||
48719517|NCT03684694|102099295|FG003|COMPLETED|Phase 2||0||
48150927|NCT03232983|100692341|FG002|NOT COMPLETED|Period 3||0||
48150928|NCT03232983|100692342|FG003|NOT COMPLETED|Period 3||0||
48150929|NCT03232983|100692339|FG000|STARTED|Washout Period 3||7||
48150930|NCT03232983|100692340|FG001|STARTED|Washout Period 3||7||
48150931|NCT03232983|100692341|FG002|STARTED|Washout Period 3||5||
48150932|NCT03232983|100692342|FG003|STARTED|Washout Period 3||6||
48305612|NCT03953508|101074822|FG001|STARTED|Laboratory Period||59|The order in which phases occurred differed was a result of COVID-19 restrictions on data collection. For some participants, they started EMA first and then began laboratory data collection when in-person was allowed. For others, they started laboratory data collection when COVID restrictions were lifted, and then did EMA. Thus, the participant flow may appear unbalanced.|
48305613|NCT03953508|101074821|FG000|COMPLETED|Laboratory Period||54||
48305614|NCT03953508|101074822|FG001|COMPLETED|Laboratory Period||54||
48305615|NCT03953508|101074821|FG000|NOT COMPLETED|Laboratory Period||5||
48406129|NCT00707486|101328355|FG000|COMPLETED|Overall Study||71||
48719518|NCT03684694|102099296|FG004|COMPLETED|Phase 2||0||
48719519|NCT03684694|102099297|FG005|COMPLETED|Phase 2||0||
48719520|NCT03684694|102099292|FG000|NOT COMPLETED|Phase 2||0||
48719521|NCT03684694|102099293|FG001|NOT COMPLETED|Phase 2||0||
48719522|NCT03684694|102099294|FG002|NOT COMPLETED|Phase 2||0||
48719523|NCT03684694|102099295|FG003|NOT COMPLETED|Phase 2||49||
48719524|NCT03684694|102099296|FG004|NOT COMPLETED|Phase 2||30||
48719525|NCT03684694|102099297|FG005|NOT COMPLETED|Phase 2||10||
48719526|NCT00582738|102099298|FG000|STARTED|Overall Study||21||
48719527|NCT00582738|102099299|FG001|STARTED|Overall Study||22||
48719528|NCT00582738|102099298|FG000|COMPLETED|Overall Study||12||
48719529|NCT00582738|102099299|FG001|COMPLETED|Overall Study||4||
48719530|NCT00582738|102099298|FG000|NOT COMPLETED|Overall Study||9||
48719531|NCT00582738|102099299|FG001|NOT COMPLETED|Overall Study||18||
48719532|NCT01965899|102099300|FG000|STARTED|Overall Study||151||
48719533|NCT01965899|102099300|FG000|COMPLETED|Overall Study||145||
48719534|NCT01965899|102099300|FG000|NOT COMPLETED|Overall Study||6||
48719535|NCT01395277|102099301|FG000|STARTED|Overall Study||15||
48719536|NCT01395277|102099302|FG001|STARTED|Overall Study||15||
48719537|NCT01395277|102099301|FG000|COMPLETED|Overall Study||15||
48719538|NCT01395277|102099302|FG001|COMPLETED|Overall Study||15||
48719539|NCT01395277|102099301|FG000|NOT COMPLETED|Overall Study||0||
48719540|NCT01395277|102099302|FG001|NOT COMPLETED|Overall Study||0||
48719541|NCT00709878|102099303|FG000|STARTED|Overall Study||8||
48150933|NCT03232983|100692339|FG000|COMPLETED|Washout Period 3||7||
48150934|NCT03232983|100692340|FG001|COMPLETED|Washout Period 3||7||
48150935|NCT03232983|100692341|FG002|COMPLETED|Washout Period 3||5||
48150936|NCT03232983|100692342|FG003|COMPLETED|Washout Period 3||6||
48150937|NCT03232983|100692339|FG000|NOT COMPLETED|Washout Period 3||0||
48150938|NCT03232983|100692340|FG001|NOT COMPLETED|Washout Period 3||0||
48150939|NCT03232983|100692341|FG002|NOT COMPLETED|Washout Period 3||0||
48305616|NCT03953508|101074822|FG001|NOT COMPLETED|Laboratory Period||5||
48305617|NCT03953508|101074821|FG000|STARTED|6-month Follow-up||92||
48719542|NCT00709878|102099304|FG001|STARTED|Overall Study||8||
48719543|NCT00709878|102099305|FG002|STARTED|Overall Study||8||
48719544|NCT00709878|102099306|FG003|STARTED|Overall Study||8||
48719545|NCT00709878|102099303|FG000|COMPLETED|Overall Study||8||
48719546|NCT00709878|102099304|FG001|COMPLETED|Overall Study||8||
48719547|NCT00709878|102099305|FG002|COMPLETED|Overall Study||8||
48719548|NCT00709878|102099306|FG003|COMPLETED|Overall Study||8||
48719549|NCT00709878|102099303|FG000|NOT COMPLETED|Overall Study||0||
48719550|NCT00709878|102099304|FG001|NOT COMPLETED|Overall Study||0||
48719551|NCT00709878|102099305|FG002|NOT COMPLETED|Overall Study||0||
48719552|NCT00709878|102099306|FG003|NOT COMPLETED|Overall Study||0||
48719553|NCT01114360|102099307|FG000|STARTED|Intervention 1 (4 Weeks)||18||
48719554|NCT01114360|102099308|FG001|STARTED|Intervention 1 (4 Weeks)||19||
48719555|NCT01114360|102099307|FG000|COMPLETED|Intervention 1 (4 Weeks)||18||
48719556|NCT01114360|102099308|FG001|COMPLETED|Intervention 1 (4 Weeks)||18||
48719557|NCT01114360|102099307|FG000|NOT COMPLETED|Intervention 1 (4 Weeks)||0||
48719558|NCT01114360|102099308|FG001|NOT COMPLETED|Intervention 1 (4 Weeks)||1||
48719559|NCT01114360|102099307|FG000|STARTED|Intervention 2 (4 Weeks)||18||
48719560|NCT01114360|102099308|FG001|STARTED|Intervention 2 (4 Weeks)||18||
48719561|NCT01114360|102099307|FG000|COMPLETED|Intervention 2 (4 Weeks)||18||
48719562|NCT01114360|102099308|FG001|COMPLETED|Intervention 2 (4 Weeks)||18||
48719563|NCT01114360|102099307|FG000|NOT COMPLETED|Intervention 2 (4 Weeks)||0||
48719564|NCT01114360|102099308|FG001|NOT COMPLETED|Intervention 2 (4 Weeks)||0||
48719565|NCT00262847|102099309|FG000|STARTED|Overall Study||625||
48150940|NCT03232983|100692342|FG003|NOT COMPLETED|Washout Period 3||0||
48150941|NCT03232983|100692339|FG000|STARTED|Period 4||7||
48150942|NCT03232983|100692340|FG001|STARTED|Period 4||7||
48719566|NCT00262847|102099310|FG001|STARTED|Overall Study||625||
48719567|NCT00262847|102099311|FG002|STARTED|Overall Study||623||
48719568|NCT00262847|102099309|FG000|COMPLETED|Overall Study||107||
48719569|NCT00262847|102099310|FG001|COMPLETED|Overall Study||112||
48719570|NCT00262847|102099311|FG002|COMPLETED|Overall Study||227||
48719571|NCT00262847|102099309|FG000|NOT COMPLETED|Overall Study||518||
48719572|NCT00262847|102099310|FG001|NOT COMPLETED|Overall Study||513||
48719573|NCT00262847|102099311|FG002|NOT COMPLETED|Overall Study||396||
48719574|NCT05236712|102099312|FG000|STARTED|Overall Study||8||
48719575|NCT05236712|102099313|FG001|STARTED|Overall Study||7||
48719576|NCT05236712|102099312|FG000|COMPLETED|Overall Study||8||
48719577|NCT05236712|102099313|FG001|COMPLETED|Overall Study||7||
48719578|NCT05236712|102099312|FG000|NOT COMPLETED|Overall Study||0||
48719579|NCT05236712|102099313|FG001|NOT COMPLETED|Overall Study||0||
48719580|NCT02539511|102099314|FG000|STARTED|Overall Study||23||
48719581|NCT02539511|102099315|FG001|STARTED|Overall Study||17||
48719582|NCT02539511|102099314|FG000|COMPLETED|Overall Study||17||
48719583|NCT02539511|102099315|FG001|COMPLETED|Overall Study||17||
48719584|NCT02539511|102099314|FG000|NOT COMPLETED|Overall Study||6||
48719585|NCT02539511|102099315|FG001|NOT COMPLETED|Overall Study||0||
48719586|NCT01885910|102099316|FG000|STARTED|Overall Study||32||
48719587|NCT01885910|102099316|FG000|COMPLETED|Overall Study||24||
48150943|NCT03232983|100692341|FG002|STARTED|Period 4||5||
48150944|NCT03232983|100692342|FG003|STARTED|Period 4||6||
48150945|NCT03232983|100692339|FG000|COMPLETED|Period 4||6||
48150946|NCT03232983|100692340|FG001|COMPLETED|Period 4||7||
48150947|NCT03232983|100692341|FG002|COMPLETED|Period 4||5||
48150948|NCT03232983|100692342|FG003|COMPLETED|Period 4||6||
48305618|NCT03953508|101074822|FG001|STARTED|6-month Follow-up||102||
48150949|NCT03232983|100692339|FG000|NOT COMPLETED|Period 4||1||
48150950|NCT03232983|100692340|FG001|NOT COMPLETED|Period 4||0||
48150951|NCT03232983|100692341|FG002|NOT COMPLETED|Period 4||0||
48150952|NCT03232983|100692342|FG003|NOT COMPLETED|Period 4||0||
48150953|NCT01649232|100692343|FG000|STARTED|Overall Study||30||
48150954|NCT01649232|100692344|FG001|STARTED|Overall Study||30||
48150955|NCT01649232|100692343|FG000|COMPLETED|Overall Study||28||
48150956|NCT01649232|100692344|FG001|COMPLETED|Overall Study||30||
48150957|NCT01649232|100692343|FG000|NOT COMPLETED|Overall Study||2||
48150958|NCT01649232|100692344|FG001|NOT COMPLETED|Overall Study||0||
48150959|NCT00082173|100692345|FG000|STARTED|Overall Study||74||
48150960|NCT00082173|100692346|FG001|STARTED|Overall Study||72||
48305619|NCT03953508|101074821|FG000|COMPLETED|6-month Follow-up||30||
48607819|NCT00642954|101823600|FG004|NOT COMPLETED|Overall Study||16||
48607820|NCT04970407|101823601|FG000|STARTED|Overall Study||15||
48607821|NCT04970407|101823602|FG001|STARTED|Overall Study||15||
48607822|NCT04970407|101823603|FG002|STARTED|Overall Study||15||
48607823|NCT04970407|101823601|FG000|COMPLETED|Overall Study||15||
48607824|NCT04970407|101823602|FG001|COMPLETED|Overall Study||15||
48305620|NCT03953508|101074822|FG001|COMPLETED|6-month Follow-up||32||
48305621|NCT03953508|101074821|FG000|NOT COMPLETED|6-month Follow-up||62||
48305622|NCT03953508|101074822|FG001|NOT COMPLETED|6-month Follow-up||70||
48305623|NCT03878446|101074823|FG000|STARTED|Overall Study||12||
48305624|NCT03878446|101074824|FG001|STARTED|Overall Study||13||
48305625|NCT03878446|101074825|FG002|STARTED|Overall Study||12||
48607825|NCT04970407|101823603|FG002|COMPLETED|Overall Study||15||
48607826|NCT04970407|101823601|FG000|NOT COMPLETED|Overall Study||0||
48607827|NCT04970407|101823602|FG001|NOT COMPLETED|Overall Study||0||
48607828|NCT04970407|101823603|FG002|NOT COMPLETED|Overall Study||0||
48607829|NCT04105842|101823604|FG000|STARTED|Overall Study||37||
48607830|NCT04105842|101823604|FG000|COMPLETED|Overall Study||35||
48607831|NCT04105842|101823604|FG000|NOT COMPLETED|Overall Study||2||
48607832|NCT01066663|101823605|FG000|STARTED|Overall Study||3||
48607833|NCT01066663|101823606|FG001|STARTED|Overall Study||3||
48305626|NCT03878446|101074826|FG003|STARTED|Overall Study||13||
48305627|NCT03878446|101074827|FG004|STARTED|Overall Study||12||
48305628|NCT03878446|101074823|FG000|Safety Analysis Set (SAS)|Overall Study||12|SAS included all randomized participants exposed to trial product.|
48305629|NCT03878446|101074824|FG001|Safety Analysis Set (SAS)|Overall Study||13|SAS included all randomized participants exposed to trial product.|
48305630|NCT03878446|101074825|FG002|Safety Analysis Set (SAS)|Overall Study||12|SAS included all randomized participants exposed to trial product.|
48150961|NCT00082173|100692345|FG000|COMPLETED|Overall Study||64||
48150962|NCT00082173|100692346|FG001|COMPLETED|Overall Study||61||
48150963|NCT00082173|100692345|FG000|NOT COMPLETED|Overall Study||10||
48150964|NCT00082173|100692346|FG001|NOT COMPLETED|Overall Study||11||
48150965|NCT02384759|100692347|FG000|STARTED|Overall Study||59||
48150966|NCT02384759|100692348|FG001|STARTED|Overall Study||58||
48150967|NCT02384759|100692347|FG000|COMPLETED|Overall Study||56||
48150968|NCT02384759|100692348|FG001|COMPLETED|Overall Study||56||
48150969|NCT02384759|100692347|FG000|NOT COMPLETED|Overall Study||3||
48305631|NCT03878446|101074826|FG003|Safety Analysis Set (SAS)|Overall Study||13|SAS included all randomized participants exposed to trial product.|
48305632|NCT03878446|101074827|FG004|Safety Analysis Set (SAS)|Overall Study||12|SAS included all randomized participants exposed to trial product.|
48305633|NCT03878446|101074823|FG000|Full Analysis Set (FAS)|Overall Study||12|FAS included all randomized participants exposed to the trial product.|
48305634|NCT03878446|101074824|FG001|Full Analysis Set (FAS)|Overall Study||13|FAS included all randomized participants exposed to the trial product.|
48305635|NCT03878446|101074825|FG002|Full Analysis Set (FAS)|Overall Study||12|FAS included all randomized participants exposed to the trial product.|
48305636|NCT03878446|101074826|FG003|Full Analysis Set (FAS)|Overall Study||13|FAS included all randomized participants exposed to the trial product.|
48305637|NCT03878446|101074827|FG004|Full Analysis Set (FAS)|Overall Study||12|FAS included all randomized participants exposed to the trial product.|
48305638|NCT03878446|101074823|FG000|Per Protocol Analysis Set|Overall Study||11|Participants from FAS who had not violated any inclusion/exclusion criteria and had used the randomized treatment for at least 22 weeks (for participants receiving Somapacitan) or 154 days (for participants receiving Norditropin).|
48607834|NCT01066663|101823607|FG002|STARTED|Overall Study||10||
48607835|NCT01066663|101823605|FG000|COMPLETED|Overall Study||3||
48607836|NCT01066663|101823606|FG001|COMPLETED|Overall Study||3||
48607837|NCT01066663|101823607|FG002|COMPLETED|Overall Study||9||
48607838|NCT01066663|101823605|FG000|NOT COMPLETED|Overall Study||0||
48607839|NCT01066663|101823606|FG001|NOT COMPLETED|Overall Study||0||
48607840|NCT01066663|101823607|FG002|NOT COMPLETED|Overall Study||1||
48607841|NCT01210482|101823608|FG000|STARTED|Overall Study||1050||
48607842|NCT01210482|101823608|FG000|COMPLETED|Overall Study||1001||
48607843|NCT01210482|101823608|FG000|NOT COMPLETED|Overall Study||49||
48607844|NCT00632125|101827045|FG000|STARTED|Overall Study||1695||
48607845|NCT00632125|101827045|FG000|COMPLETED|Overall Study||1393||
48607846|NCT00632125|101827045|FG000|NOT COMPLETED|Overall Study||302||
48607847|NCT01605825|101827046|FG000|STARTED|Overall Study||55||
48607848|NCT01605825|101827047|FG001|STARTED|Overall Study||28||
48607849|NCT01605825|101827046|FG000|COMPLETED|Overall Study||45||
48607850|NCT01605825|101827047|FG001|COMPLETED|Overall Study||25||
48150970|NCT02384759|100692348|FG001|NOT COMPLETED|Overall Study||2||
48150971|NCT01040260|100692349|FG000|STARTED|Overall Study||53||
48719588|NCT01885910|102099316|FG000|NOT COMPLETED|Overall Study||8||
48719589|NCT01399008|102099317|FG000|STARTED|Overall Study||35||
48719590|NCT01399008|102099318|FG001|STARTED|Overall Study||32||
48719591|NCT01399008|102099319|FG002|STARTED|Overall Study||33||
48719592|NCT01399008|102099317|FG000|COMPLETED|Overall Study||32||
48719593|NCT01399008|102099318|FG001|COMPLETED|Overall Study||27||
48719594|NCT01399008|102099319|FG002|COMPLETED|Overall Study||31||
48719595|NCT01399008|102099317|FG000|NOT COMPLETED|Overall Study||3||
48719596|NCT01399008|102099318|FG001|NOT COMPLETED|Overall Study||5||
48719597|NCT01399008|102099319|FG002|NOT COMPLETED|Overall Study||2||
48719598|NCT01719003|102099320|FG000|STARTED|Overall Study||170||
48719599|NCT01719003|102099321|FG001|STARTED|Overall Study||170||
48719600|NCT01719003|102099322|FG002|STARTED|Overall Study||171||
48719601|NCT01719003|102099323|FG003|STARTED|Overall Study||169||
48719602|NCT01719003|102099324|FG004|STARTED|Overall Study||167||
48719603|NCT01719003|102099325|FG005|STARTED|Overall Study||172||
48719604|NCT01719003|102099326|FG006|STARTED|Overall Study||170||
48719605|NCT01719003|102099327|FG007|STARTED|Overall Study||171||
48719606|NCT01719003|102099328|FG008|STARTED|Overall Study||53||
48719607|NCT01719003|102099320|FG000|COMPLETED|Overall Study||161||
48719608|NCT01719003|102099321|FG001|COMPLETED|Overall Study||153||
48719609|NCT01719003|102099322|FG002|COMPLETED|Overall Study||154||
48719610|NCT01719003|102099323|FG003|COMPLETED|Overall Study||156||
48719611|NCT01719003|102099324|FG004|COMPLETED|Overall Study||150||
48719612|NCT01719003|102099325|FG005|COMPLETED|Overall Study||160||
48719613|NCT01719003|102099326|FG006|COMPLETED|Overall Study||150||
48719614|NCT01719003|102099327|FG007|COMPLETED|Overall Study||151||
48719615|NCT01719003|102099328|FG008|COMPLETED|Overall Study||49||
48719616|NCT01719003|102099320|FG000|NOT COMPLETED|Overall Study||9||
48719617|NCT01719003|102099321|FG001|NOT COMPLETED|Overall Study||17||
48719618|NCT01719003|102099322|FG002|NOT COMPLETED|Overall Study||17||
48719619|NCT01719003|102099323|FG003|NOT COMPLETED|Overall Study||13||
48719620|NCT01719003|102099324|FG004|NOT COMPLETED|Overall Study||17||
48719621|NCT01719003|102099325|FG005|NOT COMPLETED|Overall Study||12||
48719622|NCT01719003|102099326|FG006|NOT COMPLETED|Overall Study||20||
48719623|NCT01719003|102099327|FG007|NOT COMPLETED|Overall Study||20||
48719624|NCT01719003|102099328|FG008|NOT COMPLETED|Overall Study||4||
48719625|NCT02499692|102099329|FG000|STARTED|Overall Study||103||
48719626|NCT02499692|102099329|FG000|COMPLETED|Overall Study||103||
48719627|NCT02499692|102099329|FG000|NOT COMPLETED|Overall Study||0||
48719628|NCT02258529|102099330|FG000|STARTED|Overall Study||10||
48719629|NCT02258529|102099330|FG000|COMPLETED|Overall Study||0||
48719630|NCT02258529|102099330|FG000|NOT COMPLETED|Overall Study||10||
48719631|NCT01146288|102099331|FG000|STARTED|First Intervention(1 Day)||7||
48719632|NCT01146288|102099332|FG001|STARTED|First Intervention(1 Day)||6||
48719633|NCT01146288|102099331|FG000|COMPLETED|First Intervention(1 Day)||7||
48719634|NCT01146288|102099332|FG001|COMPLETED|First Intervention(1 Day)||5||
48719635|NCT01146288|102099331|FG000|NOT COMPLETED|First Intervention(1 Day)||0||
48719636|NCT01146288|102099332|FG001|NOT COMPLETED|First Intervention(1 Day)||1||
48719637|NCT01146288|102099331|FG000|STARTED|Second Intervention (1 Day)||7||
48719638|NCT01146288|102099332|FG001|STARTED|Second Intervention (1 Day)||5||
48719639|NCT01146288|102099331|FG000|COMPLETED|Second Intervention (1 Day)||7||
48719640|NCT01146288|102099332|FG001|COMPLETED|Second Intervention (1 Day)||5||
48719641|NCT01146288|102099331|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48719642|NCT01146288|102099332|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48719643|NCT04983797|102099333|FG000|STARTED|Overall Study||31||
48719644|NCT04983797|102099333|FG000|COMPLETED|Overall Study||31||
48719645|NCT04983797|102099333|FG000|NOT COMPLETED|Overall Study||0||
48719646|NCT01915823|102099334|FG000|STARTED|Overall Study||173||
48719647|NCT01915823|102099335|FG001|STARTED|Overall Study||175||
48719648|NCT01915823|102099334|FG000|COMPLETED|Overall Study||171||
48719649|NCT01915823|102099335|FG001|COMPLETED|Overall Study||173||
48719650|NCT01915823|102099334|FG000|NOT COMPLETED|Overall Study||2||
48719651|NCT01915823|102099335|FG001|NOT COMPLETED|Overall Study||2||
48719652|NCT03529110|102099336|FG000|STARTED|Overall Study||261||
48719653|NCT03529110|102099337|FG001|STARTED|Overall Study||263||
48719654|NCT03529110|102099336|FG000|COMPLETED|Overall Study||136||
48719655|NCT03529110|102099337|FG001|COMPLETED|Overall Study||49||
48719656|NCT03529110|102099336|FG000|NOT COMPLETED|Overall Study||125||
48719657|NCT03529110|102099337|FG001|NOT COMPLETED|Overall Study||214||
48719658|NCT01122108|102099338|FG000|STARTED|Overall Study||21||
48719659|NCT01122108|102099339|FG001|STARTED|Overall Study||21||
48719660|NCT01122108|102099338|FG000|COMPLETED|Overall Study||21||
48719661|NCT01122108|102099339|FG001|COMPLETED|Overall Study||21||
48719662|NCT01122108|102099338|FG000|NOT COMPLETED|Overall Study||0||
48719663|NCT01122108|102099339|FG001|NOT COMPLETED|Overall Study||0||
48719664|NCT02530996|102099340|FG000|STARTED|First Intervention||6||
48719665|NCT02530996|102099341|FG001|STARTED|First Intervention||6||
48719666|NCT02530996|102099340|FG000|COMPLETED|First Intervention||6||
48719667|NCT02530996|102099341|FG001|COMPLETED|First Intervention||6||
48305639|NCT03878446|101074824|FG001|Per Protocol Analysis Set|Overall Study||13|Participants from FAS who had not violated any inclusion/exclusion criteria and had used the randomized treatment for at least 22 weeks (for participants receiving Somapacitan) or 154 days (for participants receiving Norditropin).|
48305640|NCT03878446|101074825|FG002|Per Protocol Analysis Set|Overall Study||12|Participants from FAS who had not violated any inclusion/exclusion criteria and had used the randomized treatment for at least 22 weeks (for participants receiving Somapacitan) or 154 days (for participants receiving Norditropin).|
48305641|NCT03878446|101074826|FG003|Per Protocol Analysis Set|Overall Study||13|Participants from FAS who had not violated any inclusion/exclusion criteria and had used the randomized treatment for at least 22 weeks (for participants receiving Somapacitan) or 154 days (for participants receiving Norditropin).|
48305642|NCT03878446|101074827|FG004|Per Protocol Analysis Set|Overall Study||12|Participants from FAS who had not violated any inclusion/exclusion criteria and had used the randomized treatment for at least 22 weeks (for participants receiving Somapacitan) or 154 days (for participants receiving Norditropin).|
48305643|NCT03878446|101074823|FG000|COMPLETED|Overall Study||11||
48305644|NCT03878446|101074824|FG001|COMPLETED|Overall Study||13||
48305645|NCT03878446|101074825|FG002|COMPLETED|Overall Study||12||
48305646|NCT03878446|101074826|FG003|COMPLETED|Overall Study||13||
48305647|NCT03878446|101074827|FG004|COMPLETED|Overall Study||12||
48305648|NCT03878446|101074823|FG000|NOT COMPLETED|Overall Study||1||
48305649|NCT03878446|101074824|FG001|NOT COMPLETED|Overall Study||0||
48305650|NCT03878446|101074825|FG002|NOT COMPLETED|Overall Study||0||
48719668|NCT02530996|102099340|FG000|NOT COMPLETED|First Intervention||0||
48719669|NCT02530996|102099341|FG001|NOT COMPLETED|First Intervention||0||
48719670|NCT02530996|102099340|FG000|STARTED|Washout (5 Days)||6||
48719671|NCT02530996|102099341|FG001|STARTED|Washout (5 Days)||6||
48719672|NCT02530996|102099340|FG000|COMPLETED|Washout (5 Days)||6||
48719673|NCT02530996|102099341|FG001|COMPLETED|Washout (5 Days)||6||
48719674|NCT02530996|102099340|FG000|NOT COMPLETED|Washout (5 Days)||0||
48719675|NCT02530996|102099341|FG001|NOT COMPLETED|Washout (5 Days)||0||
48719676|NCT02530996|102099340|FG000|STARTED|Second Intervention||6||
48719677|NCT02530996|102099341|FG001|STARTED|Second Intervention||6||
48719678|NCT02530996|102099340|FG000|COMPLETED|Second Intervention||6||
48719679|NCT02530996|102099341|FG001|COMPLETED|Second Intervention||6||
48719680|NCT02530996|102099340|FG000|NOT COMPLETED|Second Intervention||0||
48305651|NCT03878446|101074826|FG003|NOT COMPLETED|Overall Study||0||
48305652|NCT03878446|101074827|FG004|NOT COMPLETED|Overall Study||0||
48305653|NCT05120856|101074828|FG000|STARTED|Overall Study||39|Installed the app|
48305654|NCT05120856|101074829|FG001|STARTED|Overall Study||40|Installed the app|
48305655|NCT05120856|101074828|FG000|Provided Week 4 Primary Outcome Data|Overall Study||29||
48305656|NCT05120856|101074829|FG001|Provided Week 4 Primary Outcome Data|Overall Study||32||
48305657|NCT05120856|101074828|FG000|Completed Week 4 Secondary Outcome Survey|Overall Study||27||
48305658|NCT05120856|101074829|FG001|Completed Week 4 Secondary Outcome Survey|Overall Study||31||
48305659|NCT05120856|101074828|FG000|Provided Week 8 Primary Outcome Data|Overall Study||27||
48305660|NCT05120856|101074829|FG001|Provided Week 8 Primary Outcome Data|Overall Study||30||
48305661|NCT05120856|101074828|FG000|Completed Week 8 Secondary Outcome Survey|Overall Study||26||
48719681|NCT02530996|102099341|FG001|NOT COMPLETED|Second Intervention||0||
48719682|NCT00721539|102099342|FG000|STARTED|Overall Study||9||
48719683|NCT00721539|102099342|FG000|COMPLETED|Overall Study||9||
48719684|NCT00721539|102099342|FG000|NOT COMPLETED|Overall Study||0||
48719685|NCT00870194|102099343|FG000|STARTED|Overall Study||127||
48719686|NCT00870194|102099344|FG001|STARTED|Overall Study||128||
48719687|NCT00870194|102099343|FG000|Per Protocol Set|Overall Study||97||
48719688|NCT00870194|102099344|FG001|Per Protocol Set|Overall Study||111||
48719689|NCT00870194|102099343|FG000|COMPLETED|Overall Study||101||
48719690|NCT00870194|102099344|FG001|COMPLETED|Overall Study||114||
48719691|NCT00870194|102099343|FG000|NOT COMPLETED|Overall Study||26||
48719692|NCT00870194|102099344|FG001|NOT COMPLETED|Overall Study||14||
48719693|NCT01264614|102099345|FG000|STARTED|Overall Study||13||
48719694|NCT01264614|102099346|FG001|STARTED|Overall Study||9||
48719695|NCT01264614|102099345|FG000|COMPLETED|Overall Study||12||
48719696|NCT01264614|102099346|FG001|COMPLETED|Overall Study||7||
48719697|NCT01264614|102099345|FG000|NOT COMPLETED|Overall Study||1||
48719698|NCT01264614|102099346|FG001|NOT COMPLETED|Overall Study||2||
48719699|NCT01443130|102099347|FG000|STARTED|Overall Study||300||
48719700|NCT01443130|102099348|FG001|STARTED|Overall Study||300||
48719701|NCT01443130|102099349|FG002|STARTED|Overall Study||300||
48719702|NCT01443130|102099350|FG003|STARTED|Overall Study||270||
48719703|NCT01443130|102099351|FG004|STARTED|Overall Study||274||
48719704|NCT01443130|102099352|FG005|STARTED|Overall Study||259||
48719705|NCT01443130|102099347|FG000|COMPLETED|Overall Study||232||
48719706|NCT01443130|102099348|FG001|COMPLETED|Overall Study||231||
48719707|NCT01443130|102099349|FG002|COMPLETED|Overall Study||223||
48719708|NCT01443130|102099350|FG003|COMPLETED|Overall Study||231||
48719709|NCT01443130|102099351|FG004|COMPLETED|Overall Study||230||
48305662|NCT05120856|101074829|FG001|Completed Week 8 Secondary Outcome Survey|Overall Study||30||
48305663|NCT05120856|101074828|FG000|Provided Week 16 Primary Outcome Data|Overall Study||20||
48305664|NCT05120856|101074829|FG001|Provided Week 16 Primary Outcome Data|Overall Study||27||
48305665|NCT05120856|101074828|FG000|COMPLETED|Overall Study||23|Completed week 16 secondary outcomes survey|
48305666|NCT05120856|101074829|FG001|COMPLETED|Overall Study||28|Completed week 16 secondary outcomes survey|
48305667|NCT05120856|101074828|FG000|NOT COMPLETED|Overall Study||16||
48305668|NCT05120856|101074829|FG001|NOT COMPLETED|Overall Study||12||
48305669|NCT06065735|101074830|FG000|STARTED|Paroxetine 20 mg (Days 1 to 7)||38||
48305670|NCT06065735|101074831|FG001|STARTED|Paroxetine 20 mg (Days 1 to 7)||0||
48719710|NCT01443130|102099352|FG005|COMPLETED|Overall Study||225||
48719711|NCT01443130|102099347|FG000|NOT COMPLETED|Overall Study||68||
48719712|NCT01443130|102099348|FG001|NOT COMPLETED|Overall Study||69||
48719713|NCT01443130|102099349|FG002|NOT COMPLETED|Overall Study||77||
48719714|NCT01443130|102099350|FG003|NOT COMPLETED|Overall Study||39||
48719715|NCT01443130|102099351|FG004|NOT COMPLETED|Overall Study||44||
48719716|NCT01443130|102099352|FG005|NOT COMPLETED|Overall Study||34||
48719717|NCT03294629|102099353|FG000|STARTED|First Intervention (2 Weeks)||16||
48719718|NCT03294629|102099354|FG001|STARTED|First Intervention (2 Weeks)||19||
48719719|NCT03294629|102099353|FG000|COMPLETED|First Intervention (2 Weeks)||14||
48719720|NCT03294629|102099354|FG001|COMPLETED|First Intervention (2 Weeks)||15||
48719721|NCT03294629|102099353|FG000|NOT COMPLETED|First Intervention (2 Weeks)||2||
48719722|NCT03294629|102099354|FG001|NOT COMPLETED|First Intervention (2 Weeks)||4||
48719723|NCT03294629|102099353|FG000|STARTED|Second Intervention (2 Weeks)||14||
48719724|NCT03294629|102099354|FG001|STARTED|Second Intervention (2 Weeks)||15||
48719725|NCT03294629|102099353|FG000|COMPLETED|Second Intervention (2 Weeks)||12||
48719726|NCT03294629|102099354|FG001|COMPLETED|Second Intervention (2 Weeks)||13||
48719727|NCT03294629|102099353|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||2||
48719728|NCT03294629|102099354|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||2||
48719729|NCT00853840|102099355|FG000|STARTED|Period 1||9||
48719730|NCT00853840|102099356|FG001|STARTED|Period 1||9||
48719731|NCT00853840|102099355|FG000|Maraviroc (Days 1 - 4)|Period 1||9||
48719732|NCT00853840|102099356|FG001|Maraviroc (Days 1 - 4)|Period 1||9||
48719733|NCT00853840|102099355|FG000|Vardenafil or Placebo (Day 4)|Period 1||9||
48719734|NCT00853840|102099356|FG001|Vardenafil or Placebo (Day 4)|Period 1||9||
48305671|NCT06065735|101074832|FG002|STARTED|Paroxetine 20 mg (Days 1 to 7)||0||
48305672|NCT06065735|101074830|FG000|COMPLETED|Paroxetine 20 mg (Days 1 to 7)||33||
48305673|NCT06065735|101074831|FG001|COMPLETED|Paroxetine 20 mg (Days 1 to 7)||0||
48305674|NCT06065735|101074832|FG002|COMPLETED|Paroxetine 20 mg (Days 1 to 7)||0||
48305675|NCT06065735|101074830|FG000|NOT COMPLETED|Paroxetine 20 mg (Days 1 to 7)||5||
48305676|NCT06065735|101074831|FG001|NOT COMPLETED|Paroxetine 20 mg (Days 1 to 7)||0||
48305677|NCT06065735|101074832|FG002|NOT COMPLETED|Paroxetine 20 mg (Days 1 to 7)||0||
48719735|NCT00853840|102099355|FG000|COMPLETED|Period 1||9||
48719736|NCT00853840|102099356|FG001|COMPLETED|Period 1||9||
48719737|NCT00853840|102099355|FG000|NOT COMPLETED|Period 1||0||
48719738|NCT00853840|102099356|FG001|NOT COMPLETED|Period 1||0||
48719739|NCT00853840|102099355|FG000|STARTED|Period 2||9||
48719740|NCT00853840|102099356|FG001|STARTED|Period 2||9||
48719741|NCT00853840|102099355|FG000|Maraviroc (Days 1 - 3)|Period 2||9||
48719742|NCT00853840|102099356|FG001|Maraviroc (Days 1 - 3)|Period 2||9||
48719743|NCT00853840|102099355|FG000|Vardenafil or Placebo (Day 3)|Period 2||9||
48719744|NCT00853840|102099356|FG001|Vardenafil or Placebo (Day 3)|Period 2||9||
48719745|NCT00853840|102099355|FG000|COMPLETED|Period 2||9||
48719746|NCT00853840|102099356|FG001|COMPLETED|Period 2||9||
48719747|NCT00853840|102099355|FG000|NOT COMPLETED|Period 2||0||
48305678|NCT06065735|101074830|FG000|STARTED|Paroxetine 40 mg (Days 8 to 14)||0||
48305679|NCT06065735|101074831|FG001|STARTED|Paroxetine 40 mg (Days 8 to 14)||33||
48305680|NCT06065735|101074832|FG002|STARTED|Paroxetine 40 mg (Days 8 to 14)||0||
48305681|NCT06065735|101074830|FG000|COMPLETED|Paroxetine 40 mg (Days 8 to 14)||0||
48305682|NCT06065735|101074831|FG001|COMPLETED|Paroxetine 40 mg (Days 8 to 14)||32||
48305683|NCT06065735|101074832|FG002|COMPLETED|Paroxetine 40 mg (Days 8 to 14)||0||
48150972|NCT01040260|100692350|FG001|STARTED|Overall Study||50||
48150973|NCT01040260|100692349|FG000|COMPLETED|Overall Study||38||
48150974|NCT01040260|100692350|FG001|COMPLETED|Overall Study||39||
48150975|NCT01040260|100692349|FG000|NOT COMPLETED|Overall Study||15||
48607851|NCT01605825|101827046|FG000|NOT COMPLETED|Overall Study||10||
48607852|NCT01605825|101827047|FG001|NOT COMPLETED|Overall Study||3||
48607853|NCT00461097|101827048|FG000|STARTED|Overall Study||40||
48607854|NCT00461097|101827049|FG001|STARTED|Overall Study||15||
48607855|NCT00461097|101827048|FG000|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||35||
48150976|NCT01040260|100692350|FG001|NOT COMPLETED|Overall Study||11||
48150977|NCT02778100|100692351|FG000|STARTED|Period 1 (Common Cold)||18||
48150978|NCT02778100|100692352|FG001|STARTED|Period 1 (Common Cold)||18||
48150979|NCT02778100|100692351|FG000|COMPLETED|Period 1 (Common Cold)||17||
48150980|NCT02778100|100692352|FG001|COMPLETED|Period 1 (Common Cold)||18||
48150981|NCT02778100|100692351|FG000|NOT COMPLETED|Period 1 (Common Cold)||1||
48188708|NCT02034435|100783313|FG001|COMPLETED|Overall Study||13||
48607856|NCT00461097|101827049|FG001|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||13||
48607857|NCT00461097|101827048|FG000|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||34||
48607858|NCT00461097|101827049|FG001|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||1||
48607859|NCT00461097|101827048|FG000|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||16||
48607860|NCT00461097|101827049|FG001|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||0||
48607861|NCT00461097|101827048|FG000|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||7||
48607862|NCT00461097|101827049|FG001|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||0||
48607863|NCT00461097|101827048|FG000|COMPLETED|Overall Study||40||
48607864|NCT00461097|101827049|FG001|COMPLETED|Overall Study||15||
48607865|NCT00461097|101827048|FG000|NOT COMPLETED|Overall Study||0||
48607866|NCT00461097|101827049|FG001|NOT COMPLETED|Overall Study||0||
48607867|NCT03290391|101827050|FG000|STARTED|Allocation||111||
48607868|NCT03290391|101827051|FG001|STARTED|Allocation||114||
48607869|NCT03290391|101827050|FG000|COMPLETED|Allocation||111||
48719748|NCT00853840|102099356|FG001|NOT COMPLETED|Period 2||0||
48719749|NCT00499746|102099357|FG000|STARTED|Phase 1(6-9 One Day Sessions)||20||
48719750|NCT00499746|102099357|FG000|COMPLETED|Phase 1(6-9 One Day Sessions)||8||
48719751|NCT00499746|102099357|FG000|NOT COMPLETED|Phase 1(6-9 One Day Sessions)||12||
48719752|NCT00499746|102099357|FG000|STARTED|Phase 2 (6-9 One Day Sessions)||8||
48719753|NCT00499746|102099357|FG000|COMPLETED|Phase 2 (6-9 One Day Sessions)||8||
48719754|NCT00499746|102099357|FG000|NOT COMPLETED|Phase 2 (6-9 One Day Sessions)||0||
48719755|NCT00499746|102099357|FG000|STARTED|Phase 3 (9-14 One Day Sessions)||8||
48719756|NCT00499746|102099357|FG000|COMPLETED|Phase 3 (9-14 One Day Sessions)||8||
48719757|NCT00499746|102099357|FG000|NOT COMPLETED|Phase 3 (9-14 One Day Sessions)||0||
48719758|NCT02406443|102099358|FG000|STARTED|Overall Study||18||
48719759|NCT02406443|102099359|FG001|STARTED|Overall Study||18||
48719760|NCT02406443|102099358|FG000|COMPLETED|Overall Study||16||
48719761|NCT02406443|102099359|FG001|COMPLETED|Overall Study||16||
48719762|NCT02406443|102099358|FG000|NOT COMPLETED|Overall Study||2||
48719763|NCT02406443|102099359|FG001|NOT COMPLETED|Overall Study||2||
48719764|NCT01893359|102099360|FG000|STARTED|Overall Study||0||
48719765|NCT01893359|102099361|FG001|STARTED|Overall Study||2||
48719766|NCT01893359|102099362|FG002|STARTED|Overall Study||0||
48719767|NCT01893359|102099360|FG000|COMPLETED|Overall Study||0||
48719768|NCT01893359|102099361|FG001|COMPLETED|Overall Study||2||
48719769|NCT01893359|102099362|FG002|COMPLETED|Overall Study||0||
48719770|NCT01893359|102099360|FG000|NOT COMPLETED|Overall Study||0||
48719771|NCT01893359|102099361|FG001|NOT COMPLETED|Overall Study||0||
48719772|NCT01893359|102099362|FG002|NOT COMPLETED|Overall Study||0||
48719773|NCT04064346|102099363|FG000|STARTED|Pre-randomization Single-blind Period||12||
48719774|NCT04064346|102099364|FG001|STARTED|Pre-randomization Single-blind Period||0||
48719775|NCT04064346|102099365|FG002|STARTED|Pre-randomization Single-blind Period||0||
48719776|NCT04064346|102099363|FG000|Treated in Placebo Run-in|Pre-randomization Single-blind Period||12||
48719777|NCT04064346|102099364|FG001|Treated in Placebo Run-in|Pre-randomization Single-blind Period||0||
48719778|NCT04064346|102099365|FG002|Treated in Placebo Run-in|Pre-randomization Single-blind Period||0||
48719779|NCT04064346|102099363|FG000|Treated in Lixivaptan Titration Period|Pre-randomization Single-blind Period||8||
48719780|NCT04064346|102099364|FG001|Treated in Lixivaptan Titration Period|Pre-randomization Single-blind Period||0||
48719781|NCT04064346|102099365|FG002|Treated in Lixivaptan Titration Period|Pre-randomization Single-blind Period||0||
48719782|NCT04064346|102099363|FG000|COMPLETED|Pre-randomization Single-blind Period||5||
48719783|NCT04064346|102099364|FG001|COMPLETED|Pre-randomization Single-blind Period||0||
48719784|NCT04064346|102099365|FG002|COMPLETED|Pre-randomization Single-blind Period||0||
48719785|NCT04064346|102099363|FG000|NOT COMPLETED|Pre-randomization Single-blind Period||7||
48719786|NCT04064346|102099364|FG001|NOT COMPLETED|Pre-randomization Single-blind Period||0||
48719787|NCT04064346|102099365|FG002|NOT COMPLETED|Pre-randomization Single-blind Period||0||
48719788|NCT04064346|102099363|FG000|STARTED|Randomized Double-blind Period||0||
48719789|NCT04064346|102099364|FG001|STARTED|Randomized Double-blind Period||4||
48719790|NCT04064346|102099365|FG002|STARTED|Randomized Double-blind Period||1||
48767592|NCT00914316|102222776|FG000|STARTED|Phase 1||7||
48607870|NCT03290391|101827051|FG001|COMPLETED|Allocation||114||
48607871|NCT03290391|101827050|FG000|NOT COMPLETED|Allocation||0||
48607872|NCT03290391|101827051|FG001|NOT COMPLETED|Allocation||0||
48607873|NCT03290391|101827050|FG000|STARTED|Completed 6 Month Assessment||111||
48607874|NCT03290391|101827051|FG001|STARTED|Completed 6 Month Assessment||114||
48305684|NCT06065735|101074830|FG000|NOT COMPLETED|Paroxetine 40 mg (Days 8 to 14)||0||
48607875|NCT03290391|101827050|FG000|COMPLETED|Completed 6 Month Assessment||79||
48607876|NCT03290391|101827051|FG001|COMPLETED|Completed 6 Month Assessment||85||
48607877|NCT03290391|101827050|FG000|NOT COMPLETED|Completed 6 Month Assessment||32||
48607878|NCT03290391|101827051|FG001|NOT COMPLETED|Completed 6 Month Assessment||29||
48607879|NCT03290391|101827050|FG000|STARTED|Completed 12 Month Assessment||111||
48607880|NCT03290391|101827051|FG001|STARTED|Completed 12 Month Assessment||114||
48607881|NCT03290391|101827050|FG000|COMPLETED|Completed 12 Month Assessment||82||
48607882|NCT03290391|101827051|FG001|COMPLETED|Completed 12 Month Assessment||83||
48607883|NCT03290391|101827050|FG000|NOT COMPLETED|Completed 12 Month Assessment||29||
48607884|NCT03290391|101827051|FG001|NOT COMPLETED|Completed 12 Month Assessment||31||
48607885|NCT01808261|101827052|FG000|STARTED|Overall Study||68||
48607886|NCT01808261|101827053|FG001|STARTED|Overall Study||65||
48607887|NCT01808261|101827052|FG000|COMPLETED|Overall Study||32||
48607888|NCT01808261|101827053|FG001|COMPLETED|Overall Study||32||
48607889|NCT01808261|101827052|FG000|NOT COMPLETED|Overall Study||36||
48607890|NCT01808261|101827053|FG001|NOT COMPLETED|Overall Study||33||
48607891|NCT01064362|101827054|FG000|STARTED|Overall Study||1559||
48607892|NCT01064362|101827055|FG001|STARTED|Overall Study||11883||
48607893|NCT01064362|101827054|FG000|COMPLETED|Overall Study||1559||
48607894|NCT01064362|101827055|FG001|COMPLETED|Overall Study||11883||
48607895|NCT01064362|101827054|FG000|NOT COMPLETED|Overall Study||0||
48607896|NCT01064362|101827055|FG001|NOT COMPLETED|Overall Study||0||
48607897|NCT01408901|101827056|FG000|STARTED|6-Week Follow-Up||53||
48607898|NCT01408901|101827057|FG001|STARTED|6-Week Follow-Up||53||
48607899|NCT01408901|101827058|FG002|STARTED|6-Week Follow-Up||53||
48607900|NCT01408901|101827059|FG003|STARTED|6-Week Follow-Up||51||
48607901|NCT01408901|101827056|FG000|COMPLETED|6-Week Follow-Up||50||
48607902|NCT01408901|101827057|FG001|COMPLETED|6-Week Follow-Up||51||
48607903|NCT01408901|101827058|FG002|COMPLETED|6-Week Follow-Up||50||
48607904|NCT01408901|101827059|FG003|COMPLETED|6-Week Follow-Up||47||
48607905|NCT01408901|101827056|FG000|NOT COMPLETED|6-Week Follow-Up||3||
48607906|NCT01408901|101827057|FG001|NOT COMPLETED|6-Week Follow-Up||2||
48607907|NCT01408901|101827058|FG002|NOT COMPLETED|6-Week Follow-Up||3||
48607908|NCT01408901|101827059|FG003|NOT COMPLETED|6-Week Follow-Up||4||
48607909|NCT01408901|101827056|FG000|STARTED|12-Week Follow-Up (Primary Endpoint)||50||
48607910|NCT01408901|101827057|FG001|STARTED|12-Week Follow-Up (Primary Endpoint)||52||
48607911|NCT01408901|101827058|FG002|STARTED|12-Week Follow-Up (Primary Endpoint)||50||
48607912|NCT01408901|101827059|FG003|STARTED|12-Week Follow-Up (Primary Endpoint)||49||
48607913|NCT01408901|101827056|FG000|COMPLETED|12-Week Follow-Up (Primary Endpoint)||49||
48607914|NCT01408901|101827057|FG001|COMPLETED|12-Week Follow-Up (Primary Endpoint)||50||
48607915|NCT01408901|101827058|FG002|COMPLETED|12-Week Follow-Up (Primary Endpoint)||50||
48607916|NCT01408901|101827059|FG003|COMPLETED|12-Week Follow-Up (Primary Endpoint)||46||
48607917|NCT01408901|101827056|FG000|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||1||
48607918|NCT01408901|101827057|FG001|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||2||
48607919|NCT01408901|101827058|FG002|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||0||
48607920|NCT01408901|101827059|FG003|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||3||
48607921|NCT01408901|101827056|FG000|STARTED|26-Week Follow-Up||49||
48607922|NCT01408901|101827057|FG001|STARTED|26-Week Follow-Up||52||
48607923|NCT01408901|101827058|FG002|STARTED|26-Week Follow-Up||50||
48607924|NCT01408901|101827059|FG003|STARTED|26-Week Follow-Up||47||
48719791|NCT04064346|102099363|FG000|Randomized|Randomized Double-blind Period||0||
48719792|NCT04064346|102099364|FG001|Randomized|Randomized Double-blind Period||4||
48305685|NCT06065735|101074831|FG001|NOT COMPLETED|Paroxetine 40 mg (Days 8 to 14)||1||
48305686|NCT06065735|101074832|FG002|NOT COMPLETED|Paroxetine 40 mg (Days 8 to 14)||0||
48305687|NCT06065735|101074830|FG000|STARTED|Paroxetine 60 mg (Days 15 to 21)||0||
48719793|NCT04064346|102099365|FG002|Randomized|Randomized Double-blind Period||1||
48719794|NCT04064346|102099363|FG000|COMPLETED|Randomized Double-blind Period||0||
48719795|NCT04064346|102099364|FG001|COMPLETED|Randomized Double-blind Period||4||
48719796|NCT04064346|102099365|FG002|COMPLETED|Randomized Double-blind Period||1||
48719797|NCT04064346|102099363|FG000|NOT COMPLETED|Randomized Double-blind Period||0||
48719798|NCT04064346|102099364|FG001|NOT COMPLETED|Randomized Double-blind Period||0||
48719799|NCT04064346|102099365|FG002|NOT COMPLETED|Randomized Double-blind Period||0||
48719800|NCT04064346|102099363|FG000|STARTED|Follow-up Period I||0||
48719801|NCT04064346|102099364|FG001|STARTED|Follow-up Period I||3||
48719802|NCT04064346|102099365|FG002|STARTED|Follow-up Period I||1||
48719803|NCT04064346|102099363|FG000|COMPLETED|Follow-up Period I||0||
48305688|NCT06065735|101074831|FG001|STARTED|Paroxetine 60 mg (Days 15 to 21)||0||
48305689|NCT06065735|101074832|FG002|STARTED|Paroxetine 60 mg (Days 15 to 21)||32||
48305690|NCT06065735|101074830|FG000|COMPLETED|Paroxetine 60 mg (Days 15 to 21)||0||
48305691|NCT06065735|101074831|FG001|COMPLETED|Paroxetine 60 mg (Days 15 to 21)||0||
48305692|NCT06065735|101074832|FG002|COMPLETED|Paroxetine 60 mg (Days 15 to 21)||31||
48305693|NCT06065735|101074830|FG000|NOT COMPLETED|Paroxetine 60 mg (Days 15 to 21)||0||
48305694|NCT06065735|101074831|FG001|NOT COMPLETED|Paroxetine 60 mg (Days 15 to 21)||0||
48305695|NCT06065735|101074832|FG002|NOT COMPLETED|Paroxetine 60 mg (Days 15 to 21)||1||
48305696|NCT01889238|101074833|FG000|STARTED|Overall Study||118||
48305697|NCT01889238|101074833|FG000|COMPLETED|Overall Study||0||
48305698|NCT01889238|101074833|FG000|NOT COMPLETED|Overall Study||118||
48305699|NCT03039023|101074834|FG000|STARTED|Overall Study||19||
48305700|NCT03039023|101074835|FG001|STARTED|Overall Study||20||
48305701|NCT03039023|101074836|FG002|STARTED|Overall Study||17||
48305702|NCT03039023|101074837|FG003|STARTED|Overall Study||20||
48305703|NCT03039023|101074838|FG004|STARTED|Overall Study||10||
48305704|NCT03039023|101074834|FG000|COMPLETED|Overall Study||18||
48305705|NCT03039023|101074835|FG001|COMPLETED|Overall Study||20||
48305706|NCT03039023|101074836|FG002|COMPLETED|Overall Study||16||
48305707|NCT03039023|101074837|FG003|COMPLETED|Overall Study||18||
48305708|NCT03039023|101074838|FG004|COMPLETED|Overall Study||10||
48305709|NCT03039023|101074834|FG000|NOT COMPLETED|Overall Study||1||
48305710|NCT03039023|101074835|FG001|NOT COMPLETED|Overall Study||0||
48305711|NCT03039023|101074836|FG002|NOT COMPLETED|Overall Study||1||
48305712|NCT03039023|101074837|FG003|NOT COMPLETED|Overall Study||2||
48305713|NCT03039023|101074838|FG004|NOT COMPLETED|Overall Study||0||
48305714|NCT02243865|101074839|FG000|STARTED|Overall Study||44||
48305715|NCT02243865|101074840|FG001|STARTED|Overall Study||43||
48305716|NCT02243865|101074839|FG000|COMPLETED|Overall Study||40||
48305717|NCT02243865|101074840|FG001|COMPLETED|Overall Study||38||
48305718|NCT02243865|101074839|FG000|NOT COMPLETED|Overall Study||4||
48305719|NCT02243865|101074840|FG001|NOT COMPLETED|Overall Study||5||
48305720|NCT02656420|101074841|FG000|STARTED|Overall Study||55||
48305721|NCT02656420|101074842|FG001|STARTED|Overall Study||25||
48305722|NCT02656420|101074843|FG002|STARTED|Overall Study||35||
48305723|NCT02656420|101074844|FG003|STARTED|Overall Study||55||
48305724|NCT02656420|101074841|FG000|COMPLETED|Overall Study||55||
48305725|NCT02656420|101074842|FG001|COMPLETED|Overall Study||24||
48305726|NCT02656420|101074843|FG002|COMPLETED|Overall Study||35||
48305727|NCT02656420|101074844|FG003|COMPLETED|Overall Study||55||
48305728|NCT02656420|101074841|FG000|NOT COMPLETED|Overall Study||0||
48305729|NCT02656420|101074842|FG001|NOT COMPLETED|Overall Study||1||
48305730|NCT02656420|101074843|FG002|NOT COMPLETED|Overall Study||0||
48719804|NCT04064346|102099364|FG001|COMPLETED|Follow-up Period I||3||
48719805|NCT04064346|102099365|FG002|COMPLETED|Follow-up Period I||1||
48719806|NCT04064346|102099363|FG000|NOT COMPLETED|Follow-up Period I||0||
48719807|NCT04064346|102099364|FG001|NOT COMPLETED|Follow-up Period I||0||
48719808|NCT04064346|102099365|FG002|NOT COMPLETED|Follow-up Period I||0||
48719809|NCT04064346|102099363|FG000|STARTED|Re-titration Period||0||
48719810|NCT04064346|102099364|FG001|STARTED|Re-titration Period||0||
48719811|NCT04064346|102099365|FG002|STARTED|Re-titration Period||0||
48719812|NCT04064346|102099363|FG000|COMPLETED|Re-titration Period||0||
48719813|NCT04064346|102099364|FG001|COMPLETED|Re-titration Period||0||
48719814|NCT04064346|102099365|FG002|COMPLETED|Re-titration Period||0||
48719815|NCT04064346|102099363|FG000|NOT COMPLETED|Re-titration Period||0||
48719816|NCT04064346|102099364|FG001|NOT COMPLETED|Re-titration Period||0||
48719817|NCT04064346|102099365|FG002|NOT COMPLETED|Re-titration Period||0||
48719818|NCT04064346|102099363|FG000|STARTED|Maintenance Treatment Period||0||
48719819|NCT04064346|102099364|FG001|STARTED|Maintenance Treatment Period||0||
48719820|NCT04064346|102099365|FG002|STARTED|Maintenance Treatment Period||0||
48719821|NCT04064346|102099363|FG000|COMPLETED|Maintenance Treatment Period||0||
48719822|NCT04064346|102099364|FG001|COMPLETED|Maintenance Treatment Period||0||
48719823|NCT04064346|102099365|FG002|COMPLETED|Maintenance Treatment Period||0||
48719824|NCT04064346|102099363|FG000|NOT COMPLETED|Maintenance Treatment Period||0||
48719825|NCT04064346|102099364|FG001|NOT COMPLETED|Maintenance Treatment Period||0||
48719826|NCT04064346|102099365|FG002|NOT COMPLETED|Maintenance Treatment Period||0||
48719827|NCT04064346|102099363|FG000|STARTED|Follow-up Period II||0||
48719828|NCT04064346|102099364|FG001|STARTED|Follow-up Period II||0||
48719829|NCT04064346|102099365|FG002|STARTED|Follow-up Period II||0||
48719830|NCT04064346|102099363|FG000|COMPLETED|Follow-up Period II||0||
48719831|NCT04064346|102099364|FG001|COMPLETED|Follow-up Period II||0||
48719832|NCT04064346|102099365|FG002|COMPLETED|Follow-up Period II||0||
48719833|NCT04064346|102099363|FG000|NOT COMPLETED|Follow-up Period II||0||
48719834|NCT04064346|102099364|FG001|NOT COMPLETED|Follow-up Period II||0||
48719835|NCT04064346|102099365|FG002|NOT COMPLETED|Follow-up Period II||0||
48719836|NCT00500760|102099366|FG000|STARTED|Overall Study||89||
48719837|NCT00500760|102099367|FG001|STARTED|Overall Study||64||
48719838|NCT00500760|102099366|FG000|Received Treatment|Overall Study||87||
48188709|NCT02034435|100783314|FG002|COMPLETED|Overall Study||7||
48305731|NCT02656420|101074844|FG003|NOT COMPLETED|Overall Study||0||
48305732|NCT01034540|101074845|FG000|STARTED|Overall Study||11||
48305733|NCT01034540|101074846|FG001|STARTED|Overall Study||12||
48305734|NCT01034540|101074845|FG000|Completed 1st Treatment Intervention|Overall Study||11||
48305735|NCT01034540|101074846|FG001|Completed 1st Treatment Intervention|Overall Study||11||
48305736|NCT01034540|101074845|FG000|COMPLETED|Overall Study||11||
48305737|NCT01034540|101074846|FG001|COMPLETED|Overall Study||11||
48305738|NCT01034540|101074845|FG000|NOT COMPLETED|Overall Study||0||
48305739|NCT01034540|101074846|FG001|NOT COMPLETED|Overall Study||1||
48305740|NCT01286454|101074847|FG000|STARTED|Part I- First Intervention Period||2||
48305741|NCT01286454|101074848|FG001|STARTED|Part I- First Intervention Period||2||
48305742|NCT01286454|101074849|FG002|STARTED|Part I- First Intervention Period||2||
48305743|NCT01286454|101074850|FG003|STARTED|Part I- First Intervention Period||2||
48305744|NCT01286454|101074851|FG004|STARTED|Part I- First Intervention Period||2||
48305745|NCT01286454|101074852|FG005|STARTED|Part I- First Intervention Period||2||
48305746|NCT01286454|101074853|FG006|STARTED|Part I- First Intervention Period||2||
48305747|NCT01286454|101074854|FG007|STARTED|Part I- First Intervention Period||2||
48305748|NCT01286454|101074855|FG008|STARTED|Part I- First Intervention Period||2||
48305749|NCT01286454|101074856|FG009|STARTED|Part I- First Intervention Period||2||
48305750|NCT01286454|101074857|FG010|STARTED|Part I- First Intervention Period||0||
48305751|NCT01286454|101074847|FG000|COMPLETED|Part I- First Intervention Period||2||
48305752|NCT01286454|101074848|FG001|COMPLETED|Part I- First Intervention Period||2||
48305753|NCT01286454|101074849|FG002|COMPLETED|Part I- First Intervention Period||2||
48305754|NCT01286454|101074850|FG003|COMPLETED|Part I- First Intervention Period||2||
48305755|NCT01286454|101074851|FG004|COMPLETED|Part I- First Intervention Period||2||
48305756|NCT01286454|101074852|FG005|COMPLETED|Part I- First Intervention Period||2||
48305757|NCT01286454|101074853|FG006|COMPLETED|Part I- First Intervention Period||2||
48305758|NCT01286454|101074854|FG007|COMPLETED|Part I- First Intervention Period||2||
48305759|NCT01286454|101074855|FG008|COMPLETED|Part I- First Intervention Period||2||
48305760|NCT01286454|101074856|FG009|COMPLETED|Part I- First Intervention Period||2||
48305761|NCT01286454|101074857|FG010|COMPLETED|Part I- First Intervention Period||0||
48305762|NCT01286454|101074847|FG000|NOT COMPLETED|Part I- First Intervention Period||0||
48305763|NCT01286454|101074848|FG001|NOT COMPLETED|Part I- First Intervention Period||0||
48305764|NCT01286454|101074849|FG002|NOT COMPLETED|Part I- First Intervention Period||0||
48305765|NCT01286454|101074850|FG003|NOT COMPLETED|Part I- First Intervention Period||0||
48305766|NCT01286454|101074851|FG004|NOT COMPLETED|Part I- First Intervention Period||0||
48305767|NCT01286454|101074852|FG005|NOT COMPLETED|Part I- First Intervention Period||0||
48305768|NCT01286454|101074853|FG006|NOT COMPLETED|Part I- First Intervention Period||0||
48305769|NCT01286454|101074854|FG007|NOT COMPLETED|Part I- First Intervention Period||0||
48305770|NCT01286454|101074855|FG008|NOT COMPLETED|Part I- First Intervention Period||0||
48305771|NCT01286454|101074856|FG009|NOT COMPLETED|Part I- First Intervention Period||0||
48305772|NCT01286454|101074857|FG010|NOT COMPLETED|Part I- First Intervention Period||0||
48305773|NCT01286454|101074847|FG000|STARTED|Washout Period (At Least 3 Days)||2||
48305774|NCT01286454|101074848|FG001|STARTED|Washout Period (At Least 3 Days)||2||
48305775|NCT01286454|101074849|FG002|STARTED|Washout Period (At Least 3 Days)||2||
48305776|NCT01286454|101074850|FG003|STARTED|Washout Period (At Least 3 Days)||2||
48305777|NCT01286454|101074851|FG004|STARTED|Washout Period (At Least 3 Days)||2||
48305778|NCT01286454|101074852|FG005|STARTED|Washout Period (At Least 3 Days)||2||
48305779|NCT01286454|101074853|FG006|STARTED|Washout Period (At Least 3 Days)||2||
48305780|NCT01286454|101074854|FG007|STARTED|Washout Period (At Least 3 Days)||2||
48305781|NCT01286454|101074855|FG008|STARTED|Washout Period (At Least 3 Days)||2||
48305782|NCT01286454|101074856|FG009|STARTED|Washout Period (At Least 3 Days)||2||
48305783|NCT01286454|101074857|FG010|STARTED|Washout Period (At Least 3 Days)||0||
48305784|NCT01286454|101074847|FG000|COMPLETED|Washout Period (At Least 3 Days)||2||
48305785|NCT01286454|101074848|FG001|COMPLETED|Washout Period (At Least 3 Days)||2||
48305786|NCT01286454|101074849|FG002|COMPLETED|Washout Period (At Least 3 Days)||2||
48719839|NCT00500760|102099367|FG001|Received Treatment|Overall Study||63||
48719840|NCT00500760|102099366|FG000|COMPLETED|Overall Study||46||
48719841|NCT00500760|102099367|FG001|COMPLETED|Overall Study||40||
48305787|NCT01286454|101074850|FG003|COMPLETED|Washout Period (At Least 3 Days)||2||
48305788|NCT01286454|101074851|FG004|COMPLETED|Washout Period (At Least 3 Days)||2||
48305789|NCT01286454|101074852|FG005|COMPLETED|Washout Period (At Least 3 Days)||2||
48305790|NCT01286454|101074853|FG006|COMPLETED|Washout Period (At Least 3 Days)||2||
48305791|NCT01286454|101074854|FG007|COMPLETED|Washout Period (At Least 3 Days)||2||
48305792|NCT01286454|101074855|FG008|COMPLETED|Washout Period (At Least 3 Days)||2||
48305793|NCT01286454|101074856|FG009|COMPLETED|Washout Period (At Least 3 Days)||2||
48305794|NCT01286454|101074857|FG010|COMPLETED|Washout Period (At Least 3 Days)||0||
48305795|NCT01286454|101074847|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48305796|NCT01286454|101074848|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48305797|NCT01286454|101074849|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48305798|NCT01286454|101074850|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48305799|NCT01286454|101074851|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48305800|NCT01286454|101074852|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48305801|NCT01286454|101074853|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48305802|NCT01286454|101074854|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48305803|NCT01286454|101074855|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48305804|NCT01286454|101074856|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48305805|NCT01286454|101074857|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48305806|NCT01286454|101074847|FG000|STARTED|Second Intervention Period||2||
48305807|NCT01286454|101074848|FG001|STARTED|Second Intervention Period||2||
48305808|NCT01286454|101074849|FG002|STARTED|Second Intervention Period||2||
48305809|NCT01286454|101074850|FG003|STARTED|Second Intervention Period||2||
48305810|NCT01286454|101074851|FG004|STARTED|Second Intervention Period||2||
48305811|NCT01286454|101074852|FG005|STARTED|Second Intervention Period||2||
48305812|NCT01286454|101074853|FG006|STARTED|Second Intervention Period||2||
48305813|NCT01286454|101074854|FG007|STARTED|Second Intervention Period||2||
48305814|NCT01286454|101074855|FG008|STARTED|Second Intervention Period||2||
48305815|NCT01286454|101074856|FG009|STARTED|Second Intervention Period||2||
48305816|NCT01286454|101074857|FG010|STARTED|Second Intervention Period||0||
48305817|NCT01286454|101074847|FG000|COMPLETED|Second Intervention Period||2||
48305818|NCT01286454|101074848|FG001|COMPLETED|Second Intervention Period||2||
48305819|NCT01286454|101074849|FG002|COMPLETED|Second Intervention Period||2||
48305820|NCT01286454|101074850|FG003|COMPLETED|Second Intervention Period||2||
48305821|NCT01286454|101074851|FG004|COMPLETED|Second Intervention Period||2||
48305822|NCT01286454|101074852|FG005|COMPLETED|Second Intervention Period||2||
48305823|NCT01286454|101074853|FG006|COMPLETED|Second Intervention Period||2||
48305824|NCT01286454|101074854|FG007|COMPLETED|Second Intervention Period||2||
48305825|NCT01286454|101074855|FG008|COMPLETED|Second Intervention Period||2||
48305826|NCT01286454|101074856|FG009|COMPLETED|Second Intervention Period||2||
48305827|NCT01286454|101074857|FG010|COMPLETED|Second Intervention Period||0||
48305828|NCT01286454|101074847|FG000|NOT COMPLETED|Second Intervention Period||0||
48305829|NCT01286454|101074848|FG001|NOT COMPLETED|Second Intervention Period||0||
48719842|NCT00500760|102099366|FG000|NOT COMPLETED|Overall Study||43||
48719843|NCT00500760|102099367|FG001|NOT COMPLETED|Overall Study||24||
48719844|NCT03333317|102099368|FG000|STARTED|Overall Study||3||
48719845|NCT03333317|102099369|FG001|STARTED|Overall Study||1||
48719846|NCT03333317|102099370|FG002|STARTED|Overall Study||3||
48150982|NCT02778100|100692352|FG001|NOT COMPLETED|Period 1 (Common Cold)||0||
48150983|NCT02778100|100692351|FG000|STARTED|Period 2 (No Cold Symptoms)||17||
48305830|NCT01286454|101074849|FG002|NOT COMPLETED|Second Intervention Period||0||
48305831|NCT01286454|101074850|FG003|NOT COMPLETED|Second Intervention Period||0||
48305832|NCT01286454|101074851|FG004|NOT COMPLETED|Second Intervention Period||0||
48305833|NCT01286454|101074852|FG005|NOT COMPLETED|Second Intervention Period||0||
48305834|NCT01286454|101074853|FG006|NOT COMPLETED|Second Intervention Period||0||
48305835|NCT01286454|101074854|FG007|NOT COMPLETED|Second Intervention Period||0||
48305836|NCT01286454|101074855|FG008|NOT COMPLETED|Second Intervention Period||0||
48305837|NCT01286454|101074856|FG009|NOT COMPLETED|Second Intervention Period||0||
48305838|NCT01286454|101074857|FG010|NOT COMPLETED|Second Intervention Period||0||
48305839|NCT01286454|101074847|FG000|STARTED|Washout Period (At Least 3 Days)||2||
48305840|NCT01286454|101074848|FG001|STARTED|Washout Period (At Least 3 Days)||2||
48305841|NCT01286454|101074849|FG002|STARTED|Washout Period (At Least 3 Days)||2||
48305842|NCT01286454|101074850|FG003|STARTED|Washout Period (At Least 3 Days)||2||
48305843|NCT01286454|101074851|FG004|STARTED|Washout Period (At Least 3 Days)||2||
48305844|NCT01286454|101074852|FG005|STARTED|Washout Period (At Least 3 Days)||2||
48305845|NCT01286454|101074853|FG006|STARTED|Washout Period (At Least 3 Days)||2||
48719847|NCT03333317|102099368|FG000|COMPLETED|Overall Study||3||
48719848|NCT03333317|102099369|FG001|COMPLETED|Overall Study||1||
48719849|NCT03333317|102099370|FG002|COMPLETED|Overall Study||3||
48719850|NCT03333317|102099368|FG000|NOT COMPLETED|Overall Study||0||
48719851|NCT03333317|102099369|FG001|NOT COMPLETED|Overall Study||0||
48719852|NCT03333317|102099370|FG002|NOT COMPLETED|Overall Study||0||
48719853|NCT01439126|102099371|FG000|STARTED|Overall Study||68||
48719854|NCT01439126|102099372|FG001|STARTED|Overall Study||67||
48719855|NCT01439126|102099371|FG000|COMPLETED|Overall Study||37||
48719856|NCT01439126|102099372|FG001|COMPLETED|Overall Study||25||
48719857|NCT01439126|102099371|FG000|NOT COMPLETED|Overall Study||31||
48719858|NCT01439126|102099372|FG001|NOT COMPLETED|Overall Study||42||
48719859|NCT02151331|102099373|FG000|STARTED|Overall Study||77||
48719860|NCT02151331|102099374|FG001|STARTED|Overall Study||92||
48305846|NCT01286454|101074854|FG007|STARTED|Washout Period (At Least 3 Days)||2||
48305847|NCT01286454|101074855|FG008|STARTED|Washout Period (At Least 3 Days)||2||
48305848|NCT01286454|101074856|FG009|STARTED|Washout Period (At Least 3 Days)||2||
48305849|NCT01286454|101074857|FG010|STARTED|Washout Period (At Least 3 Days)||0||
48305850|NCT01286454|101074847|FG000|COMPLETED|Washout Period (At Least 3 Days)||2||
48305851|NCT01286454|101074848|FG001|COMPLETED|Washout Period (At Least 3 Days)||2||
48305852|NCT01286454|101074849|FG002|COMPLETED|Washout Period (At Least 3 Days)||2||
48305853|NCT01286454|101074850|FG003|COMPLETED|Washout Period (At Least 3 Days)||2||
48607925|NCT01408901|101827056|FG000|COMPLETED|26-Week Follow-Up||48||
48607926|NCT01408901|101827057|FG001|COMPLETED|26-Week Follow-Up||50||
48607927|NCT01408901|101827058|FG002|COMPLETED|26-Week Follow-Up||50||
48607928|NCT01408901|101827059|FG003|COMPLETED|26-Week Follow-Up||46||
48607929|NCT01408901|101827056|FG000|NOT COMPLETED|26-Week Follow-Up||1||
48607930|NCT01408901|101827057|FG001|NOT COMPLETED|26-Week Follow-Up||2||
48607931|NCT01408901|101827058|FG002|NOT COMPLETED|26-Week Follow-Up||0||
48607932|NCT01408901|101827059|FG003|NOT COMPLETED|26-Week Follow-Up||1||
48607933|NCT02020889|101827060|FG000|STARTED|Overall Study||68||
48607934|NCT02020889|101827061|FG001|STARTED|Overall Study||68||
48719861|NCT02151331|102099373|FG000|COMPLETED|Overall Study||45||
48719862|NCT02151331|102099374|FG001|COMPLETED|Overall Study||52||
48719863|NCT02151331|102099373|FG000|NOT COMPLETED|Overall Study||32||
48719864|NCT02151331|102099374|FG001|NOT COMPLETED|Overall Study||40||
48719865|NCT00952614|102099375|FG000|STARTED|Overall Study||30||
48719866|NCT00952614|102099375|FG000|Participants Started Treatment|Overall Study||30||
48719867|NCT00952614|102099375|FG000|COMPLETED|Overall Study||23||
48719868|NCT00952614|102099375|FG000|NOT COMPLETED|Overall Study||7||
48719869|NCT02308488|102099376|FG000|STARTED|Overall Study||97||
48719870|NCT02308488|102099376|FG000|COMPLETED|Overall Study||95||
48719871|NCT02308488|102099376|FG000|NOT COMPLETED|Overall Study||2||
48719872|NCT03204890|102099377|FG000|STARTED|Overall Study||12||
48305854|NCT01286454|101074851|FG004|COMPLETED|Washout Period (At Least 3 Days)||2||
48305855|NCT01286454|101074852|FG005|COMPLETED|Washout Period (At Least 3 Days)||2||
48305856|NCT01286454|101074853|FG006|COMPLETED|Washout Period (At Least 3 Days)||2||
48305857|NCT01286454|101074854|FG007|COMPLETED|Washout Period (At Least 3 Days)||2||
48305858|NCT01286454|101074855|FG008|COMPLETED|Washout Period (At Least 3 Days)||2||
48305859|NCT01286454|101074856|FG009|COMPLETED|Washout Period (At Least 3 Days)||2||
48305860|NCT01286454|101074857|FG010|COMPLETED|Washout Period (At Least 3 Days)||0||
48607935|NCT02020889|101827060|FG000|COMPLETED|Overall Study||61||
48607936|NCT02020889|101827061|FG001|COMPLETED|Overall Study||65||
48607937|NCT02020889|101827060|FG000|NOT COMPLETED|Overall Study||7||
48607938|NCT02020889|101827061|FG001|NOT COMPLETED|Overall Study||3||
48607939|NCT01342445|101827062|FG000|STARTED|Overall Study||26||
48607940|NCT01342445|101827063|FG001|STARTED|Overall Study||24||
48305861|NCT01286454|101074847|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48305862|NCT01286454|101074848|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48305863|NCT01286454|101074849|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48607941|NCT01342445|101827062|FG000|COMPLETED|Overall Study||26||
48607942|NCT01342445|101827063|FG001|COMPLETED|Overall Study||22||
48607943|NCT01342445|101827062|FG000|NOT COMPLETED|Overall Study||0||
48607944|NCT01342445|101827063|FG001|NOT COMPLETED|Overall Study||2||
48719873|NCT03204890|102099377|FG000|COMPLETED|Overall Study||11||
48719874|NCT03204890|102099377|FG000|NOT COMPLETED|Overall Study||1||
48719875|NCT00096018|102099378|FG000|STARTED|Overall Study||13||
48719876|NCT00096018|102099379|FG001|STARTED|Overall Study||30||
48719877|NCT00096018|102099378|FG000|Treated With Study Therapy|Overall Study||13||
48719878|NCT00096018|102099379|FG001|Treated With Study Therapy|Overall Study||25||
48719879|NCT00096018|102099378|FG000|COMPLETED|Overall Study||11||
48719880|NCT00096018|102099379|FG001|COMPLETED|Overall Study||16||
48719881|NCT00096018|102099378|FG000|NOT COMPLETED|Overall Study||2||
48719882|NCT00096018|102099379|FG001|NOT COMPLETED|Overall Study||14||
48719883|NCT00514020|102099380|FG000|STARTED|Overall Study||33||
48719884|NCT00514020|102099380|FG000|COMPLETED|Overall Study||5||
48719885|NCT00514020|102099380|FG000|NOT COMPLETED|Overall Study||28||
48719886|NCT03028636|102099381|FG000|STARTED|Overall Study||17||
48719887|NCT03028636|102099381|FG000|COMPLETED|Overall Study||11||
48719888|NCT03028636|102099381|FG000|NOT COMPLETED|Overall Study||6||
48719889|NCT00054691|102099382|FG000|STARTED|Overall Study||40||
48719890|NCT00054691|102099382|FG000|COMPLETED|Overall Study||37||
48719891|NCT00054691|102099382|FG000|NOT COMPLETED|Overall Study||3||
48719892|NCT02246608|102099383|FG000|STARTED|Overall Study||22||
48719893|NCT02246608|102099384|FG001|STARTED|Overall Study||21||
48719894|NCT02246608|102099383|FG000|COMPLETED|Overall Study||10||
48719895|NCT02246608|102099384|FG001|COMPLETED|Overall Study||11||
48719896|NCT02246608|102099383|FG000|NOT COMPLETED|Overall Study||12||
48719897|NCT02246608|102099384|FG001|NOT COMPLETED|Overall Study||10||
48719898|NCT00413010|102099385|FG000|STARTED|Overall Study||180||
48719899|NCT00413010|102099386|FG001|STARTED|Overall Study||176||
48719900|NCT00413010|102099385|FG000|COMPLETED|Overall Study||108||
48719901|NCT00413010|102099386|FG001|COMPLETED|Overall Study||113||
48719902|NCT00413010|102099385|FG000|NOT COMPLETED|Overall Study||72||
48719903|NCT00413010|102099386|FG001|NOT COMPLETED|Overall Study||63||
48719904|NCT03445390|102099387|FG000|STARTED|First Intervention||14||
48719905|NCT03445390|102099388|FG001|STARTED|First Intervention||13||
48719906|NCT03445390|102099387|FG000|COMPLETED|First Intervention||12||
48719907|NCT03445390|102099388|FG001|COMPLETED|First Intervention||11||
48719908|NCT03445390|102099387|FG000|NOT COMPLETED|First Intervention||2||
48719909|NCT03445390|102099388|FG001|NOT COMPLETED|First Intervention||2||
48719910|NCT03445390|102099387|FG000|STARTED|Second Intervention||12||
48719911|NCT03445390|102099388|FG001|STARTED|Second Intervention||11||
48719912|NCT03445390|102099387|FG000|COMPLETED|Second Intervention||10||
48719913|NCT03445390|102099388|FG001|COMPLETED|Second Intervention||10||
48719914|NCT03445390|102099387|FG000|NOT COMPLETED|Second Intervention||2||
48719915|NCT03445390|102099388|FG001|NOT COMPLETED|Second Intervention||1||
48719916|NCT00409344|102099389|FG000|STARTED|Overall Study||0||
48719917|NCT00409344|102099390|FG001|STARTED|Overall Study||0||
48305864|NCT01286454|101074850|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48719918|NCT00409344|102099389|FG000|COMPLETED|Overall Study||0||
48719919|NCT00409344|102099390|FG001|COMPLETED|Overall Study||0||
48719920|NCT00409344|102099389|FG000|NOT COMPLETED|Overall Study||0||
48719921|NCT00409344|102099390|FG001|NOT COMPLETED|Overall Study||0||
48719922|NCT00199888|102099391|FG000|STARTED|Overall Study||26||
48719923|NCT00199888|102099391|FG000|COMPLETED|Overall Study||25||
48719924|NCT00199888|102099391|FG000|NOT COMPLETED|Overall Study||1||
48719925|NCT00710385|102099392|FG000|STARTED|Overall Study||17||
48719926|NCT00710385|102099392|FG000|COMPLETED|Overall Study||12||
48719927|NCT00710385|102099392|FG000|NOT COMPLETED|Overall Study||5||
48719928|NCT01282294|102099393|FG000|STARTED|Overall Study||100||
48719929|NCT01282294|102099393|FG000|Intra-operative|Overall Study||99||
48719930|NCT01282294|102099393|FG000|Post-operative|Overall Study||99||
48719931|NCT01282294|102099393|FG000|6 Weeks|Overall Study||95||
48719932|NCT01282294|102099393|FG000|3 Months|Overall Study||95||
48719933|NCT01282294|102099393|FG000|6 Months|Overall Study||94||
48719934|NCT01282294|102099393|FG000|12 Months|Overall Study||86||
48719935|NCT01282294|102099393|FG000|COMPLETED|Overall Study||81||
48719936|NCT01282294|102099393|FG000|NOT COMPLETED|Overall Study||19||
48719937|NCT02210091|102099394|FG000|STARTED|Overall Study||32||
48719938|NCT02210091|102099395|FG001|STARTED|Overall Study||34||
48719939|NCT02210091|102099394|FG000|COMPLETED|Overall Study||32||
48719940|NCT02210091|102099395|FG001|COMPLETED|Overall Study||32||
48719941|NCT02210091|102099394|FG000|NOT COMPLETED|Overall Study||0||
48719942|NCT02210091|102099395|FG001|NOT COMPLETED|Overall Study||2||
48719943|NCT01968057|102099396|FG000|STARTED|Period 1 (Day 1 to Predosing Day 4)||18||
48719944|NCT01968057|102099396|FG000|Received Baricitinib|Period 1 (Day 1 to Predosing Day 4)||18||
48719945|NCT01968057|102099396|FG000|COMPLETED|Period 1 (Day 1 to Predosing Day 4)||18||
48719946|NCT01968057|102099396|FG000|NOT COMPLETED|Period 1 (Day 1 to Predosing Day 4)||0||
48719947|NCT01968057|102099396|FG000|STARTED|Period 2 (At Dosing Day 4 to Day 7)||18||
48719948|NCT01968057|102099396|FG000|Received Baricitinib + Ciclosporin|Period 2 (At Dosing Day 4 to Day 7)||18||
48719949|NCT01968057|102099396|FG000|COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||18||
48719950|NCT01968057|102099396|FG000|NOT COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||0||
48719951|NCT01751776|102099397|FG000|STARTED|Overall Study||4||
48719952|NCT01751776|102099398|FG001|STARTED|Overall Study||4||
48719953|NCT01751776|102099399|FG002|STARTED|Overall Study||8||
48719954|NCT01751776|102099400|FG003|STARTED|Overall Study||8||
48719955|NCT01751776|102099401|FG004|STARTED|Overall Study||8||
48719956|NCT01751776|102099402|FG005|STARTED|Overall Study||8||
48719957|NCT01751776|102099403|FG006|STARTED|Overall Study||23||
48719958|NCT01751776|102099404|FG007|STARTED|Overall Study||44||
48305865|NCT01286454|101074851|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48305866|NCT01286454|101074852|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48719959|NCT01751776|102099397|FG000|COMPLETED|Overall Study||4||
48719960|NCT01751776|102099398|FG001|COMPLETED|Overall Study||4||
48719961|NCT01751776|102099399|FG002|COMPLETED|Overall Study||8||
48719962|NCT01751776|102099400|FG003|COMPLETED|Overall Study||8||
48719963|NCT01751776|102099401|FG004|COMPLETED|Overall Study||8||
48719964|NCT01751776|102099402|FG005|COMPLETED|Overall Study||8||
48719965|NCT01751776|102099403|FG006|COMPLETED|Overall Study||19||
48719966|NCT01751776|102099404|FG007|COMPLETED|Overall Study||40||
48719967|NCT01751776|102099397|FG000|NOT COMPLETED|Overall Study||0||
48719968|NCT01751776|102099398|FG001|NOT COMPLETED|Overall Study||0||
48719969|NCT01751776|102099399|FG002|NOT COMPLETED|Overall Study||0||
48719970|NCT01751776|102099400|FG003|NOT COMPLETED|Overall Study||0||
48719971|NCT01751776|102099401|FG004|NOT COMPLETED|Overall Study||0||
48719972|NCT01751776|102099402|FG005|NOT COMPLETED|Overall Study||0||
48719973|NCT01751776|102099403|FG006|NOT COMPLETED|Overall Study||4||
48150984|NCT02778100|100692352|FG001|STARTED|Period 2 (No Cold Symptoms)||0||
48150985|NCT02778100|100692351|FG000|COMPLETED|Period 2 (No Cold Symptoms)||17||
48150986|NCT02778100|100692352|FG001|COMPLETED|Period 2 (No Cold Symptoms)||0||
48150987|NCT02778100|100692351|FG000|NOT COMPLETED|Period 2 (No Cold Symptoms)||0||
48150988|NCT02778100|100692352|FG001|NOT COMPLETED|Period 2 (No Cold Symptoms)||0||
48150989|NCT02690974|100692353|FG000|STARTED|Overall Study||302|All enrolled patients to whom treatment had been assigned (FAS)|
48150990|NCT02690974|100692353|FG000|COMPLETED|Overall Study||262||
48150991|NCT02690974|100692353|FG000|NOT COMPLETED|Overall Study||40||
48150992|NCT01971723|100692354|FG000|STARTED|Overall Study||16||
48150993|NCT01971723|100692355|FG001|STARTED|Overall Study||16||
48150994|NCT01971723|100692354|FG000|COMPLETED|Overall Study||14||
48150995|NCT01971723|100692355|FG001|COMPLETED|Overall Study||13||
48150996|NCT01971723|100692354|FG000|NOT COMPLETED|Overall Study||2||
48150997|NCT01971723|100692355|FG001|NOT COMPLETED|Overall Study||3||
48719974|NCT01751776|102099404|FG007|NOT COMPLETED|Overall Study||4||
48719975|NCT01806064|102099405|FG000|STARTED|Overall Study||3||
48719976|NCT01806064|102099406|FG001|STARTED|Overall Study||15||
48719977|NCT01806064|102099407|FG002|STARTED|Overall Study||5||
48719978|NCT01806064|102099408|FG003|STARTED|Overall Study||75||
48719979|NCT01806064|102099409|FG004|STARTED|Overall Study||75||
48719980|NCT01806064|102099405|FG000|COMPLETED|Overall Study||3||
48719981|NCT01806064|102099406|FG001|COMPLETED|Overall Study||15||
48719982|NCT01806064|102099407|FG002|COMPLETED|Overall Study||5||
48719983|NCT01806064|102099408|FG003|COMPLETED|Overall Study||74||
48719984|NCT01806064|102099409|FG004|COMPLETED|Overall Study||73||
48719985|NCT01806064|102099405|FG000|NOT COMPLETED|Overall Study||0||
48719986|NCT01806064|102099406|FG001|NOT COMPLETED|Overall Study||0||
48150998|NCT00671931|100692356|FG000|STARTED|Overall Study||9||
48150999|NCT00671931|100692357|FG001|STARTED|Overall Study||8||
48151000|NCT00671931|100692358|FG002|STARTED|Overall Study||9||
48151001|NCT00671931|100692359|FG003|STARTED|Overall Study||10||
48151002|NCT00671931|100692360|FG004|STARTED|Overall Study||8||
48151003|NCT00671931|100692356|FG000|COMPLETED|Overall Study||8||
48151004|NCT00671931|100692357|FG001|COMPLETED|Overall Study||8||
48151005|NCT00671931|100692358|FG002|COMPLETED|Overall Study||9||
48151006|NCT00671931|100692359|FG003|COMPLETED|Overall Study||8||
48151007|NCT00671931|100692360|FG004|COMPLETED|Overall Study||7||
48151008|NCT00671931|100692356|FG000|NOT COMPLETED|Overall Study||1||
48151009|NCT00671931|100692357|FG001|NOT COMPLETED|Overall Study||0||
48719987|NCT01806064|102099407|FG002|NOT COMPLETED|Overall Study||0||
48719988|NCT01806064|102099408|FG003|NOT COMPLETED|Overall Study||1||
48719989|NCT01806064|102099409|FG004|NOT COMPLETED|Overall Study||2||
48719990|NCT01147900|102099410|FG000|STARTED|At Year 8.5||54||
48151010|NCT00671931|100692358|FG002|NOT COMPLETED|Overall Study||0||
48151011|NCT00671931|100692359|FG003|NOT COMPLETED|Overall Study||2||
48151012|NCT00671931|100692360|FG004|NOT COMPLETED|Overall Study||1||
48151013|NCT01569438|100692361|FG000|STARTED|Overall Study||52||
48151014|NCT01569438|100692362|FG001|STARTED|Overall Study||55||
48151015|NCT01569438|100692361|FG000|Treated|Overall Study||51||
48151016|NCT01569438|100692362|FG001|Treated|Overall Study||54||
48151017|NCT01569438|100692361|FG000|Titration Set|Overall Study||38||
48151018|NCT01569438|100692362|FG001|Titration Set|Overall Study||36||
48151019|NCT01569438|100692361|FG000|COMPLETED|Overall Study||45||
48151020|NCT01569438|100692362|FG001|COMPLETED|Overall Study||33||
48719991|NCT01147900|102099411|FG001|STARTED|At Year 8.5||60||
48719992|NCT01147900|102099412|FG002|STARTED|At Year 8.5||66||
48719993|NCT01147900|102099410|FG000|COMPLETED|At Year 8.5||54||
48719994|NCT01147900|102099411|FG001|COMPLETED|At Year 8.5||60||
48719995|NCT01147900|102099412|FG002|COMPLETED|At Year 8.5||66||
48719996|NCT01147900|102099410|FG000|NOT COMPLETED|At Year 8.5||0||
48719997|NCT01147900|102099411|FG001|NOT COMPLETED|At Year 8.5||0||
48719998|NCT01147900|102099412|FG002|NOT COMPLETED|At Year 8.5||0||
48719999|NCT01147900|102099410|FG000|STARTED|At Year 10||55||
48720000|NCT01147900|102099411|FG001|STARTED|At Year 10||60||
48720001|NCT01147900|102099412|FG002|STARTED|At Year 10||62||
48720002|NCT01147900|102099410|FG000|COMPLETED|At Year 10||55||
48720003|NCT01147900|102099411|FG001|COMPLETED|At Year 10||59||
48720004|NCT01147900|102099412|FG002|COMPLETED|At Year 10||62||
48720005|NCT01147900|102099410|FG000|NOT COMPLETED|At Year 10||0||
48720006|NCT01147900|102099411|FG001|NOT COMPLETED|At Year 10||1||
48720007|NCT01147900|102099412|FG002|NOT COMPLETED|At Year 10||0||
48720008|NCT02966015|102099413|FG000|STARTED|Inclusion Visit||95||
48151021|NCT01569438|100692361|FG000|NOT COMPLETED|Overall Study||7||
48151022|NCT01569438|100692362|FG001|NOT COMPLETED|Overall Study||22||
48151023|NCT00053989|100692363|FG000|STARTED|Overall Study||41||
48151024|NCT00053989|100692363|FG000|COMPLETED|Overall Study||41||
48151025|NCT00053989|100692363|FG000|NOT COMPLETED|Overall Study||0||
48151026|NCT01256411|100692364|FG000|STARTED|Extension by Maximum Treatment||139||
48151027|NCT01256411|100692365|FG001|STARTED|Extension by Maximum Treatment||89||
48151028|NCT01256411|100692366|FG002|STARTED|Extension by Maximum Treatment||109||
48151029|NCT01256411|100692367|FG003|STARTED|Extension by Maximum Treatment||4||
48151030|NCT01256411|100692368|FG004|STARTED|Extension by Maximum Treatment||0||
48151031|NCT01256411|100692369|FG005|STARTED|Extension by Maximum Treatment||0||
48151032|NCT01256411|100692364|FG000|Down Titrated to 100 mg|Extension by Maximum Treatment||12||
48151033|NCT01256411|100692365|FG001|Down Titrated to 100 mg|Extension by Maximum Treatment||0||
48151034|NCT01256411|100692366|FG002|Down Titrated to 100 mg|Extension by Maximum Treatment||0||
48151035|NCT01256411|100692367|FG003|Down Titrated to 100 mg|Extension by Maximum Treatment||0||
48151036|NCT01256411|100692368|FG004|Down Titrated to 100 mg|Extension by Maximum Treatment||0||
48151037|NCT01256411|100692369|FG005|Down Titrated to 100 mg|Extension by Maximum Treatment||0||
48151038|NCT01256411|100692364|FG000|COMPLETED|Extension by Maximum Treatment||132||
48151039|NCT01256411|100692365|FG001|COMPLETED|Extension by Maximum Treatment||79||
48151040|NCT01256411|100692366|FG002|COMPLETED|Extension by Maximum Treatment||105||
48151041|NCT01256411|100692367|FG003|COMPLETED|Extension by Maximum Treatment||4||
48151042|NCT01256411|100692368|FG004|COMPLETED|Extension by Maximum Treatment||0||
48151043|NCT01256411|100692369|FG005|COMPLETED|Extension by Maximum Treatment||0||
48151044|NCT01256411|100692364|FG000|NOT COMPLETED|Extension by Maximum Treatment||7||
48151045|NCT01256411|100692365|FG001|NOT COMPLETED|Extension by Maximum Treatment||10||
48151046|NCT01256411|100692366|FG002|NOT COMPLETED|Extension by Maximum Treatment||4||
48151047|NCT01256411|100692367|FG003|NOT COMPLETED|Extension by Maximum Treatment||0||
48151048|NCT01256411|100692368|FG004|NOT COMPLETED|Extension by Maximum Treatment||0||
48151049|NCT01256411|100692369|FG005|NOT COMPLETED|Extension by Maximum Treatment||0||
48151050|NCT01256411|100692364|FG000|STARTED|Extension by Mono or Combination Therapy||0||
48151051|NCT01256411|100692365|FG001|STARTED|Extension by Mono or Combination Therapy||0||
48151052|NCT01256411|100692366|FG002|STARTED|Extension by Mono or Combination Therapy||0||
48151053|NCT01256411|100692367|FG003|STARTED|Extension by Mono or Combination Therapy||0||
48151054|NCT01256411|100692368|FG004|STARTED|Extension by Mono or Combination Therapy||228||
48406130|NCT00707486|101328355|FG000|NOT COMPLETED|Overall Study||1||
48406131|NCT00728728|101328356|FG000|STARTED|Overall Study||42||
48607945|NCT02872909|101827064|FG000|STARTED|Overall Study||32||
48151055|NCT01256411|100692369|FG005|STARTED|Extension by Mono or Combination Therapy||113||
48151056|NCT01256411|100692364|FG000|COMPLETED|Extension by Mono or Combination Therapy||0||
48151057|NCT01256411|100692365|FG001|COMPLETED|Extension by Mono or Combination Therapy||0||
48151058|NCT01256411|100692366|FG002|COMPLETED|Extension by Mono or Combination Therapy||0||
48151059|NCT01256411|100692367|FG003|COMPLETED|Extension by Mono or Combination Therapy||0||
48151060|NCT01256411|100692368|FG004|COMPLETED|Extension by Mono or Combination Therapy||211||
48151061|NCT01256411|100692369|FG005|COMPLETED|Extension by Mono or Combination Therapy||109||
48151062|NCT01256411|100692364|FG000|NOT COMPLETED|Extension by Mono or Combination Therapy||0||
48151063|NCT01256411|100692365|FG001|NOT COMPLETED|Extension by Mono or Combination Therapy||0||
48151064|NCT01256411|100692366|FG002|NOT COMPLETED|Extension by Mono or Combination Therapy||0||
48151065|NCT01256411|100692367|FG003|NOT COMPLETED|Extension by Mono or Combination Therapy||0||
48151066|NCT01256411|100692368|FG004|NOT COMPLETED|Extension by Mono or Combination Therapy||17||
48151067|NCT01256411|100692369|FG005|NOT COMPLETED|Extension by Mono or Combination Therapy||4||
48151068|NCT00373399|100692370|FG000|STARTED|Overall Study||5||
48151069|NCT00373399|100692371|FG001|STARTED|Overall Study||7||
48151070|NCT00373399|100692372|FG002|STARTED|Overall Study||4||
48151071|NCT00373399|100692373|FG003|STARTED|Overall Study||6||
48151072|NCT00373399|100692374|FG004|STARTED|Overall Study||7||
48151073|NCT00373399|100692375|FG005|STARTED|Overall Study||7||
48151074|NCT00373399|100692370|FG000|COMPLETED|Overall Study||5||
48151075|NCT00373399|100692371|FG001|COMPLETED|Overall Study||7||
48151076|NCT00373399|100692372|FG002|COMPLETED|Overall Study||4||
48151077|NCT00373399|100692373|FG003|COMPLETED|Overall Study||6||
48151078|NCT00373399|100692374|FG004|COMPLETED|Overall Study||7||
48151079|NCT00373399|100692375|FG005|COMPLETED|Overall Study||7||
48151080|NCT00373399|100692370|FG000|NOT COMPLETED|Overall Study||0||
48151081|NCT00373399|100692371|FG001|NOT COMPLETED|Overall Study||0||
48151082|NCT00373399|100692372|FG002|NOT COMPLETED|Overall Study||0||
48151083|NCT00373399|100692373|FG003|NOT COMPLETED|Overall Study||0||
48151084|NCT00373399|100692374|FG004|NOT COMPLETED|Overall Study||0||
48151085|NCT00373399|100692375|FG005|NOT COMPLETED|Overall Study||0||
48305867|NCT01286454|101074853|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48305868|NCT01286454|101074854|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48305869|NCT01286454|101074855|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48305870|NCT01286454|101074856|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48305871|NCT01286454|101074857|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48305872|NCT01286454|101074847|FG000|STARTED|Third Intervention Period||2||
48305873|NCT01286454|101074848|FG001|STARTED|Third Intervention Period||2||
48305874|NCT01286454|101074849|FG002|STARTED|Third Intervention Period||2||
48305875|NCT01286454|101074850|FG003|STARTED|Third Intervention Period||2||
48305876|NCT01286454|101074851|FG004|STARTED|Third Intervention Period||2||
48305877|NCT01286454|101074852|FG005|STARTED|Third Intervention Period||2||
48305878|NCT01286454|101074853|FG006|STARTED|Third Intervention Period||2||
48305879|NCT01286454|101074854|FG007|STARTED|Third Intervention Period||2||
48305880|NCT01286454|101074855|FG008|STARTED|Third Intervention Period||2||
48305881|NCT01286454|101074856|FG009|STARTED|Third Intervention Period||2||
48305882|NCT01286454|101074857|FG010|STARTED|Third Intervention Period||0||
48305883|NCT01286454|101074847|FG000|COMPLETED|Third Intervention Period||2||
48305884|NCT01286454|101074848|FG001|COMPLETED|Third Intervention Period||2||
48305885|NCT01286454|101074849|FG002|COMPLETED|Third Intervention Period||2||
48305886|NCT01286454|101074850|FG003|COMPLETED|Third Intervention Period||2||
48305887|NCT01286454|101074851|FG004|COMPLETED|Third Intervention Period||2||
48305888|NCT01286454|101074852|FG005|COMPLETED|Third Intervention Period||2||
48305889|NCT01286454|101074853|FG006|COMPLETED|Third Intervention Period||2||
48305890|NCT01286454|101074854|FG007|COMPLETED|Third Intervention Period||2||
48305891|NCT01286454|101074855|FG008|COMPLETED|Third Intervention Period||2||
48305892|NCT01286454|101074856|FG009|COMPLETED|Third Intervention Period||2||
48305893|NCT01286454|101074857|FG010|COMPLETED|Third Intervention Period||0||
48151086|NCT01362439|100692376|FG000|STARTED|Overall Study||133||
48151087|NCT01362439|100692376|FG000|COMPLETED|Overall Study||118||
48151088|NCT01362439|100692376|FG000|NOT COMPLETED|Overall Study||15||
48151089|NCT03536546|100692377|FG000|STARTED|Overall Study||104||
48151090|NCT03536546|100692378|FG001|STARTED|Overall Study||101||
48151091|NCT03536546|100692377|FG000|COMPLETED|Overall Study||90||
48151092|NCT03536546|100692378|FG001|COMPLETED|Overall Study||92||
48151093|NCT03536546|100692377|FG000|NOT COMPLETED|Overall Study||14||
48151094|NCT03536546|100692378|FG001|NOT COMPLETED|Overall Study||9||
48305894|NCT01286454|101074847|FG000|NOT COMPLETED|Third Intervention Period||0||
48305895|NCT01286454|101074848|FG001|NOT COMPLETED|Third Intervention Period||0||
48305896|NCT01286454|101074849|FG002|NOT COMPLETED|Third Intervention Period||0||
48305897|NCT01286454|101074850|FG003|NOT COMPLETED|Third Intervention Period||0||
48305898|NCT01286454|101074851|FG004|NOT COMPLETED|Third Intervention Period||0||
48305899|NCT01286454|101074852|FG005|NOT COMPLETED|Third Intervention Period||0||
48305900|NCT01286454|101074853|FG006|NOT COMPLETED|Third Intervention Period||0||
48305901|NCT01286454|101074854|FG007|NOT COMPLETED|Third Intervention Period||0||
48305902|NCT01286454|101074855|FG008|NOT COMPLETED|Third Intervention Period||0||
48305903|NCT01286454|101074856|FG009|NOT COMPLETED|Third Intervention Period||0||
48151095|NCT04549363|100692379|FG000|STARTED|Overall Study||6|All treated population|
48151096|NCT04549363|100692380|FG001|STARTED|Overall Study||3|All treated population|
48151097|NCT04549363|100692379|FG000|ICSK Population|Overall Study||6|IC or SK (ICSK) population is defined as participants from all-treated population who had a tissue sample collected using Impression Cytology (IC) or Superficial Keratectomy (SK) procedure, whether or not the specimen is evaluable.|
48151098|NCT04549363|100692380|FG001|ICSK Population|Overall Study||3|IC or SK (ICSK) population is defined as participants from all-treated population who had a tissue sample collected using Impression Cytology (IC) or Superficial Keratectomy (SK) procedure, whether or not the specimen is evaluable.|
48151099|NCT04549363|100692379|FG000|EICSK Population|Overall Study||4|Evaluable IC or SK (EICSK) population included participants from all-treated population who had an evaluable tissue sample collected using IC or SK procedure. A tissue sample specimen were determined to be evaluable by the pathologist in the pathology report.|
48305904|NCT01286454|101074857|FG010|NOT COMPLETED|Third Intervention Period||0||
48305905|NCT01286454|101074847|FG000|STARTED|Washout Period (At Least 3 Days)||2||
48305906|NCT01286454|101074848|FG001|STARTED|Washout Period (At Least 3 Days)||2||
48305907|NCT01286454|101074849|FG002|STARTED|Washout Period (At Least 3 Days)||2||
48305908|NCT01286454|101074850|FG003|STARTED|Washout Period (At Least 3 Days)||2||
48720009|NCT02966015|102099414|FG001|STARTED|Inclusion Visit||58||
48720010|NCT02966015|102099413|FG000|COMPLETED|Inclusion Visit||87||
48720011|NCT02966015|102099414|FG001|COMPLETED|Inclusion Visit||55||
48720012|NCT02966015|102099413|FG000|NOT COMPLETED|Inclusion Visit||8||
48720013|NCT02966015|102099414|FG001|NOT COMPLETED|Inclusion Visit||3||
48720014|NCT02966015|102099413|FG000|STARTED|Test Period||87||
48720015|NCT02966015|102099414|FG001|STARTED|Test Period||55||
48720016|NCT02966015|102099413|FG000|COMPLETED|Test Period||87||
48720017|NCT02966015|102099414|FG001|COMPLETED|Test Period||55||
48720018|NCT02966015|102099413|FG000|NOT COMPLETED|Test Period||0||
48720019|NCT02966015|102099414|FG001|NOT COMPLETED|Test Period||0||
48720020|NCT00279812|102099415|FG000|STARTED|Overall Study||21||
48720021|NCT00279812|102099416|FG001|STARTED|Overall Study||26||
48720022|NCT00279812|102099417|FG002|STARTED|Overall Study||24||
48720023|NCT00279812|102099418|FG003|STARTED|Overall Study||23||
48720024|NCT00279812|102099419|FG004|STARTED|Overall Study||20||
48720025|NCT00279812|102099420|FG005|STARTED|Overall Study||19||
48720026|NCT00279812|102099415|FG000|COMPLETED|Overall Study||20||
48720027|NCT00279812|102099416|FG001|COMPLETED|Overall Study||20||
48720028|NCT00279812|102099417|FG002|COMPLETED|Overall Study||21||
48720029|NCT00279812|102099418|FG003|COMPLETED|Overall Study||23||
48720030|NCT00279812|102099419|FG004|COMPLETED|Overall Study||17||
48305909|NCT01286454|101074851|FG004|STARTED|Washout Period (At Least 3 Days)||2||
48305910|NCT01286454|101074852|FG005|STARTED|Washout Period (At Least 3 Days)||2||
48305911|NCT01286454|101074853|FG006|STARTED|Washout Period (At Least 3 Days)||2||
48305912|NCT01286454|101074854|FG007|STARTED|Washout Period (At Least 3 Days)||2||
48720031|NCT00279812|102099420|FG005|COMPLETED|Overall Study||18||
48720032|NCT00279812|102099415|FG000|NOT COMPLETED|Overall Study||1||
48720033|NCT00279812|102099416|FG001|NOT COMPLETED|Overall Study||6||
48720034|NCT00279812|102099417|FG002|NOT COMPLETED|Overall Study||3||
48720035|NCT00279812|102099418|FG003|NOT COMPLETED|Overall Study||0||
48720036|NCT00279812|102099419|FG004|NOT COMPLETED|Overall Study||3||
48720037|NCT00279812|102099420|FG005|NOT COMPLETED|Overall Study||1||
48720038|NCT01399268|102099421|FG000|STARTED|Overall Study||15||
48720039|NCT01399268|102099422|FG001|STARTED|Overall Study||15||
48720040|NCT01399268|102099421|FG000|COMPLETED|Overall Study||15||
48720041|NCT01399268|102099422|FG001|COMPLETED|Overall Study||15||
48720042|NCT01399268|102099421|FG000|NOT COMPLETED|Overall Study||0||
48720043|NCT01399268|102099422|FG001|NOT COMPLETED|Overall Study||0||
48720044|NCT00025155|102099423|FG000|STARTED|Overall Study||51||
48720045|NCT00025155|102099423|FG000|COMPLETED|Overall Study||49||
48720046|NCT00025155|102099423|FG000|NOT COMPLETED|Overall Study||2||
48720047|NCT02314364|102099424|FG000|STARTED|Overall Study||27||
48720048|NCT02314364|102099424|FG000|COMPLETED|Overall Study||27||
48720049|NCT02314364|102099424|FG000|NOT COMPLETED|Overall Study||0||
48720050|NCT02248740|102099425|FG000|STARTED|Overall Study||18||
48720051|NCT02248740|102099426|FG001|STARTED|Overall Study||18||
48720052|NCT02248740|102099425|FG000|COMPLETED|Overall Study||0||
48720053|NCT02248740|102099426|FG001|COMPLETED|Overall Study||0||
48720054|NCT02248740|102099425|FG000|NOT COMPLETED|Overall Study||18||
48720055|NCT02248740|102099426|FG001|NOT COMPLETED|Overall Study||18||
48720056|NCT02469415|102099427|FG000|STARTED|Overall Study||3||
48720057|NCT02469415|102099427|FG000|COMPLETED|Overall Study||0||
48720058|NCT02469415|102099427|FG000|NOT COMPLETED|Overall Study||3||
48720059|NCT01729494|102099428|FG000|STARTED|Overall Study||107||
48720060|NCT01729494|102099429|FG001|STARTED|Overall Study||104||
48720061|NCT01729494|102099430|FG002|STARTED|Overall Study||105||
48720062|NCT01729494|102099428|FG000|COMPLETED|Overall Study||97||
48720063|NCT01729494|102099429|FG001|COMPLETED|Overall Study||93||
48720064|NCT01729494|102099430|FG002|COMPLETED|Overall Study||94||
48720065|NCT01729494|102099428|FG000|NOT COMPLETED|Overall Study||10||
48720066|NCT01729494|102099429|FG001|NOT COMPLETED|Overall Study||11||
48720067|NCT01729494|102099430|FG002|NOT COMPLETED|Overall Study||11||
48720068|NCT00930969|102099431|FG000|STARTED|Overall Study||175||
48720069|NCT00930969|102099431|FG000|COMPLETED|Overall Study||137||
48720070|NCT00930969|102099431|FG000|NOT COMPLETED|Overall Study||38||
48720071|NCT03233438|102099432|FG000|STARTED|Overall Study||48||
48720072|NCT03233438|102099433|FG001|STARTED|Overall Study||43||
48720073|NCT03233438|102099432|FG000|COMPLETED|Overall Study||42||
48720074|NCT03233438|102099433|FG001|COMPLETED|Overall Study||32||
48720075|NCT03233438|102099432|FG000|NOT COMPLETED|Overall Study||6||
48720076|NCT03233438|102099433|FG001|NOT COMPLETED|Overall Study||11||
48720077|NCT03883113|102102470|FG000|STARTED|Overall Study||87||
48720078|NCT03883113|102102471|FG001|STARTED|Overall Study||58||
48720079|NCT03883113|102102470|FG000|COMPLETED|Overall Study||71||
48720080|NCT03883113|102102471|FG001|COMPLETED|Overall Study||46||
48720081|NCT03883113|102102470|FG000|NOT COMPLETED|Overall Study||16||
48720082|NCT03883113|102102471|FG001|NOT COMPLETED|Overall Study||12||
48720083|NCT01548742|102102472|FG000|STARTED|Overall Study||58||
48720084|NCT01548742|102102473|FG001|STARTED|Overall Study||58||
48720085|NCT01548742|102102472|FG000|COMPLETED|Overall Study||45||
48720086|NCT01548742|102102473|FG001|COMPLETED|Overall Study||54||
48720087|NCT01548742|102102472|FG000|NOT COMPLETED|Overall Study||13||
48720088|NCT01548742|102102473|FG001|NOT COMPLETED|Overall Study||4||
48720089|NCT03662659|102102474|FG000|STARTED|Pre-treatment||138|Started = Randomized|
48720090|NCT03662659|102102475|FG001|STARTED|Pre-treatment||136|Started = Randomized|
48720091|NCT03662659|102102474|FG000|COMPLETED|Pre-treatment||136|Completed = Treated|
48720092|NCT03662659|102102475|FG001|COMPLETED|Pre-treatment||135|Completed = Treated|
48720093|NCT03662659|102102474|FG000|NOT COMPLETED|Pre-treatment||2||
48720094|NCT03662659|102102475|FG001|NOT COMPLETED|Pre-treatment||1||
48720095|NCT03662659|102102474|FG000|STARTED|Treatment||136|Started = Treated|
48720096|NCT03662659|102102475|FG001|STARTED|Treatment||135|Started = Treated|
48305913|NCT01286454|101074855|FG008|STARTED|Washout Period (At Least 3 Days)||2||
48305914|NCT01286454|101074856|FG009|STARTED|Washout Period (At Least 3 Days)||2||
48305915|NCT01286454|101074857|FG010|STARTED|Washout Period (At Least 3 Days)||0||
48305916|NCT01286454|101074847|FG000|COMPLETED|Washout Period (At Least 3 Days)||2||
48305917|NCT01286454|101074848|FG001|COMPLETED|Washout Period (At Least 3 Days)||2||
48305918|NCT01286454|101074849|FG002|COMPLETED|Washout Period (At Least 3 Days)||2||
48305919|NCT01286454|101074850|FG003|COMPLETED|Washout Period (At Least 3 Days)||2||
48305920|NCT01286454|101074851|FG004|COMPLETED|Washout Period (At Least 3 Days)||2||
48305921|NCT01286454|101074852|FG005|COMPLETED|Washout Period (At Least 3 Days)||2||
48305922|NCT01286454|101074853|FG006|COMPLETED|Washout Period (At Least 3 Days)||2||
48305923|NCT01286454|101074854|FG007|COMPLETED|Washout Period (At Least 3 Days)||2||
48305924|NCT01286454|101074855|FG008|COMPLETED|Washout Period (At Least 3 Days)||2||
48305925|NCT01286454|101074856|FG009|COMPLETED|Washout Period (At Least 3 Days)||2||
48305926|NCT01286454|101074857|FG010|COMPLETED|Washout Period (At Least 3 Days)||0||
48305927|NCT01286454|101074847|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48305928|NCT01286454|101074848|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48305929|NCT01286454|101074849|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48305930|NCT01286454|101074850|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48305931|NCT01286454|101074851|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48305932|NCT01286454|101074852|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48305933|NCT01286454|101074853|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48305934|NCT01286454|101074854|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48305935|NCT01286454|101074855|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48305936|NCT01286454|101074856|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48305937|NCT01286454|101074857|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48305938|NCT01286454|101074847|FG000|STARTED|Fourth Intervention Period||2||
48305939|NCT01286454|101074848|FG001|STARTED|Fourth Intervention Period||2||
48305940|NCT01286454|101074849|FG002|STARTED|Fourth Intervention Period||2||
48305941|NCT01286454|101074850|FG003|STARTED|Fourth Intervention Period||2||
48305942|NCT01286454|101074851|FG004|STARTED|Fourth Intervention Period||2||
48305943|NCT01286454|101074852|FG005|STARTED|Fourth Intervention Period||2||
48305944|NCT01286454|101074853|FG006|STARTED|Fourth Intervention Period||2||
48305945|NCT01286454|101074854|FG007|STARTED|Fourth Intervention Period||2||
48305946|NCT01286454|101074855|FG008|STARTED|Fourth Intervention Period||2||
48305947|NCT01286454|101074856|FG009|STARTED|Fourth Intervention Period||2||
48720097|NCT03662659|102102474|FG000|COMPLETED|Treatment||21|Completed = Continuing treatment|
48720098|NCT03662659|102102475|FG001|COMPLETED|Treatment||29|Completed = Continuing treatment|
48720099|NCT03662659|102102474|FG000|NOT COMPLETED|Treatment||115||
48720100|NCT03662659|102102475|FG001|NOT COMPLETED|Treatment||106||
48720101|NCT02455076|102102476|FG000|STARTED|Inpatient||47||
48720102|NCT02455076|102102477|FG001|STARTED|Inpatient||51||
48720103|NCT02455076|102102478|FG002|STARTED|Inpatient||52||
48720104|NCT02455076|102102479|FG003|STARTED|Inpatient||0||
48720105|NCT02455076|102102480|FG004|STARTED|Inpatient||0||
48720106|NCT02455076|102102476|FG000|COMPLETED|Inpatient||43||
48720107|NCT02455076|102102477|FG001|COMPLETED|Inpatient||50||
48720108|NCT02455076|102102478|FG002|COMPLETED|Inpatient||52||
48720109|NCT02455076|102102479|FG003|COMPLETED|Inpatient||0||
48720110|NCT02455076|102102480|FG004|COMPLETED|Inpatient||0||
48720111|NCT02455076|102102476|FG000|NOT COMPLETED|Inpatient||4||
48720112|NCT02455076|102102477|FG001|NOT COMPLETED|Inpatient||1||
48720113|NCT02455076|102102478|FG002|NOT COMPLETED|Inpatient||0||
48720114|NCT02455076|102102479|FG003|NOT COMPLETED|Inpatient||0||
48720115|NCT02455076|102102480|FG004|NOT COMPLETED|Inpatient||0||
48720116|NCT02455076|102102476|FG000|STARTED|Outpatient||0||
48720117|NCT02455076|102102477|FG001|STARTED|Outpatient||0||
48720118|NCT02455076|102102478|FG002|STARTED|Outpatient||0||
48720119|NCT02455076|102102479|FG003|STARTED|Outpatient||48||
48720120|NCT02455076|102102480|FG004|STARTED|Outpatient||55||
48720121|NCT02455076|102102476|FG000|COMPLETED|Outpatient||0||
48720122|NCT02455076|102102477|FG001|COMPLETED|Outpatient||0||
48720123|NCT02455076|102102478|FG002|COMPLETED|Outpatient||0||
48720124|NCT02455076|102102479|FG003|COMPLETED|Outpatient||42||
48720125|NCT02455076|102102480|FG004|COMPLETED|Outpatient||43||
48720126|NCT02455076|102102476|FG000|NOT COMPLETED|Outpatient||0||
48720127|NCT02455076|102102477|FG001|NOT COMPLETED|Outpatient||0||
48720128|NCT02455076|102102478|FG002|NOT COMPLETED|Outpatient||0||
48720129|NCT02455076|102102479|FG003|NOT COMPLETED|Outpatient||6||
48305948|NCT01286454|101074857|FG010|STARTED|Fourth Intervention Period||0||
48720130|NCT02455076|102102480|FG004|NOT COMPLETED|Outpatient||12||
48305949|NCT01286454|101074847|FG000|COMPLETED|Fourth Intervention Period||2||
48305950|NCT01286454|101074848|FG001|COMPLETED|Fourth Intervention Period||2||
48305951|NCT01286454|101074849|FG002|COMPLETED|Fourth Intervention Period||2||
48720131|NCT04375397|102102481|FG000|STARTED|Overall Study||22||
48720132|NCT04375397|102102482|FG001|STARTED|Overall Study||24||
48720133|NCT04375397|102102481|FG000|COMPLETED|Overall Study||13||
48305952|NCT01286454|101074850|FG003|COMPLETED|Fourth Intervention Period||2||
48720134|NCT04375397|102102482|FG001|COMPLETED|Overall Study||18||
48720135|NCT04375397|102102481|FG000|NOT COMPLETED|Overall Study||9||
48720136|NCT04375397|102102482|FG001|NOT COMPLETED|Overall Study||6||
48720137|NCT00130923|102102483|FG000|STARTED|Overall Study||49||
48720138|NCT00130923|102102484|FG001|STARTED|Overall Study||46||
48305953|NCT01286454|101074851|FG004|COMPLETED|Fourth Intervention Period||2||
48305954|NCT01286454|101074852|FG005|COMPLETED|Fourth Intervention Period||2||
48305955|NCT01286454|101074853|FG006|COMPLETED|Fourth Intervention Period||2||
48305956|NCT01286454|101074854|FG007|COMPLETED|Fourth Intervention Period||2||
48305957|NCT01286454|101074855|FG008|COMPLETED|Fourth Intervention Period||2||
48305958|NCT01286454|101074856|FG009|COMPLETED|Fourth Intervention Period||2||
48305959|NCT01286454|101074857|FG010|COMPLETED|Fourth Intervention Period||0||
48305960|NCT01286454|101074847|FG000|NOT COMPLETED|Fourth Intervention Period||0||
48720139|NCT00130923|102102483|FG000|COMPLETED|Overall Study||36||
48720140|NCT00130923|102102484|FG001|COMPLETED|Overall Study||32||
48720141|NCT00130923|102102483|FG000|NOT COMPLETED|Overall Study||13||
48720142|NCT00130923|102102484|FG001|NOT COMPLETED|Overall Study||14||
48720143|NCT01369680|102102485|FG000|STARTED|Overall Study||3||
48720144|NCT01369680|102102486|FG001|STARTED|Overall Study||3||
48720145|NCT01369680|102102487|FG002|STARTED|Overall Study||3||
48720146|NCT01369680|102102488|FG003|STARTED|Overall Study||3||
48720147|NCT01369680|102102485|FG000|COMPLETED|Overall Study||3||
48720148|NCT01369680|102102486|FG001|COMPLETED|Overall Study||3||
48720149|NCT01369680|102102487|FG002|COMPLETED|Overall Study||2||
48720150|NCT01369680|102102488|FG003|COMPLETED|Overall Study||1||
48720151|NCT01369680|102102485|FG000|NOT COMPLETED|Overall Study||0||
48720152|NCT01369680|102102486|FG001|NOT COMPLETED|Overall Study||0||
48720153|NCT01369680|102102487|FG002|NOT COMPLETED|Overall Study||1||
48720154|NCT01369680|102102488|FG003|NOT COMPLETED|Overall Study||2||
48720155|NCT01659255|102102489|FG000|STARTED|Overall Study||3||
48720156|NCT01659255|102102490|FG001|STARTED|Overall Study||3||
48720157|NCT01659255|102102491|FG002|STARTED|Overall Study||4||
48720158|NCT01659255|102102492|FG003|STARTED|Overall Study||3||
48720159|NCT01659255|102102493|FG004|STARTED|Overall Study||3||
48720160|NCT01659255|102102494|FG005|STARTED|Overall Study||3||
48720161|NCT01659255|102102495|FG006|STARTED|Overall Study||3||
48305961|NCT01286454|101074848|FG001|NOT COMPLETED|Fourth Intervention Period||0||
48305962|NCT01286454|101074849|FG002|NOT COMPLETED|Fourth Intervention Period||0||
48305963|NCT01286454|101074850|FG003|NOT COMPLETED|Fourth Intervention Period||0||
48305964|NCT01286454|101074851|FG004|NOT COMPLETED|Fourth Intervention Period||0||
48720162|NCT01659255|102102496|FG007|STARTED|Overall Study||3||
48720163|NCT01659255|102102497|FG008|STARTED|Overall Study||3||
48720164|NCT01659255|102102498|FG009|STARTED|Overall Study||3||
48720165|NCT01659255|102102499|FG010|STARTED|Overall Study||3||
48720166|NCT01659255|102102500|FG011|STARTED|Overall Study||5||
48720167|NCT01659255|102102501|FG012|STARTED|Overall Study||8||
48720168|NCT01659255|102102502|FG013|STARTED|Overall Study||21||
48720169|NCT01659255|102102503|FG014|STARTED|Overall Study||10||
48720170|NCT01659255|102102504|FG015|STARTED|Overall Study||9||
48720171|NCT01659255|102102505|FG016|STARTED|Overall Study||3||
48720172|NCT01659255|102102489|FG000|COMPLETED|Overall Study||1||
48720173|NCT01659255|102102490|FG001|COMPLETED|Overall Study||2||
48720174|NCT01659255|102102491|FG002|COMPLETED|Overall Study||4||
48720175|NCT01659255|102102492|FG003|COMPLETED|Overall Study||3||
48720176|NCT01659255|102102493|FG004|COMPLETED|Overall Study||3||
48720177|NCT01659255|102102494|FG005|COMPLETED|Overall Study||2||
48720178|NCT01659255|102102495|FG006|COMPLETED|Overall Study||1||
48305965|NCT01286454|101074852|FG005|NOT COMPLETED|Fourth Intervention Period||0||
48720179|NCT01659255|102102496|FG007|COMPLETED|Overall Study||1||
48720180|NCT01659255|102102497|FG008|COMPLETED|Overall Study||2||
48720181|NCT01659255|102102498|FG009|COMPLETED|Overall Study||0||
48720182|NCT01659255|102102499|FG010|COMPLETED|Overall Study||0||
48720183|NCT01659255|102102500|FG011|COMPLETED|Overall Study||1||
48305966|NCT01286454|101074853|FG006|NOT COMPLETED|Fourth Intervention Period||0||
48305967|NCT01286454|101074854|FG007|NOT COMPLETED|Fourth Intervention Period||0||
48305968|NCT01286454|101074855|FG008|NOT COMPLETED|Fourth Intervention Period||0||
48305969|NCT01286454|101074856|FG009|NOT COMPLETED|Fourth Intervention Period||0||
48305970|NCT01286454|101074857|FG010|NOT COMPLETED|Fourth Intervention Period||0||
48305971|NCT01286454|101074847|FG000|STARTED|Washout Period (At Least 3 Days)||2||
48305972|NCT01286454|101074848|FG001|STARTED|Washout Period (At Least 3 Days)||2||
48305973|NCT01286454|101074849|FG002|STARTED|Washout Period (At Least 3 Days)||2||
48305974|NCT01286454|101074850|FG003|STARTED|Washout Period (At Least 3 Days)||2||
48305975|NCT01286454|101074851|FG004|STARTED|Washout Period (At Least 3 Days)||2||
48305976|NCT01286454|101074852|FG005|STARTED|Washout Period (At Least 3 Days)||2||
48305977|NCT01286454|101074853|FG006|STARTED|Washout Period (At Least 3 Days)||2||
48305978|NCT01286454|101074854|FG007|STARTED|Washout Period (At Least 3 Days)||2||
48305979|NCT01286454|101074855|FG008|STARTED|Washout Period (At Least 3 Days)||2||
48720184|NCT01659255|102102501|FG012|COMPLETED|Overall Study||0||
48720185|NCT01659255|102102502|FG013|COMPLETED|Overall Study||3||
48720186|NCT01659255|102102503|FG014|COMPLETED|Overall Study||2||
48720187|NCT01659255|102102504|FG015|COMPLETED|Overall Study||4||
48720188|NCT01659255|102102505|FG016|COMPLETED|Overall Study||0||
48720189|NCT01659255|102102489|FG000|NOT COMPLETED|Overall Study||2||
48720190|NCT01659255|102102490|FG001|NOT COMPLETED|Overall Study||1||
48305980|NCT01286454|101074856|FG009|STARTED|Washout Period (At Least 3 Days)||2||
48305981|NCT01286454|101074857|FG010|STARTED|Washout Period (At Least 3 Days)||0||
48305982|NCT01286454|101074847|FG000|COMPLETED|Washout Period (At Least 3 Days)||2||
48305983|NCT01286454|101074848|FG001|COMPLETED|Washout Period (At Least 3 Days)||2||
48305984|NCT01286454|101074849|FG002|COMPLETED|Washout Period (At Least 3 Days)||2||
48305985|NCT01286454|101074850|FG003|COMPLETED|Washout Period (At Least 3 Days)||2||
48720191|NCT01659255|102102491|FG002|NOT COMPLETED|Overall Study||0||
48305986|NCT01286454|101074851|FG004|COMPLETED|Washout Period (At Least 3 Days)||2||
48305987|NCT01286454|101074852|FG005|COMPLETED|Washout Period (At Least 3 Days)||2||
48305988|NCT01286454|101074853|FG006|COMPLETED|Washout Period (At Least 3 Days)||2||
48305989|NCT01286454|101074854|FG007|COMPLETED|Washout Period (At Least 3 Days)||2||
48305990|NCT01286454|101074855|FG008|COMPLETED|Washout Period (At Least 3 Days)||2||
48305991|NCT01286454|101074856|FG009|COMPLETED|Washout Period (At Least 3 Days)||2||
48305992|NCT01286454|101074857|FG010|COMPLETED|Washout Period (At Least 3 Days)||0||
48720192|NCT01659255|102102492|FG003|NOT COMPLETED|Overall Study||0||
48720193|NCT01659255|102102493|FG004|NOT COMPLETED|Overall Study||0||
48720194|NCT01659255|102102494|FG005|NOT COMPLETED|Overall Study||1||
48720195|NCT01659255|102102495|FG006|NOT COMPLETED|Overall Study||2||
48720196|NCT01659255|102102496|FG007|NOT COMPLETED|Overall Study||2||
48720197|NCT01659255|102102497|FG008|NOT COMPLETED|Overall Study||1||
48720198|NCT01659255|102102498|FG009|NOT COMPLETED|Overall Study||3||
48720199|NCT01659255|102102499|FG010|NOT COMPLETED|Overall Study||3||
48151100|NCT04549363|100692380|FG001|EICSK Population|Overall Study||2|Evaluable IC or SK (EICSK) population included participants from all-treated population who had an evaluable tissue sample collected using IC or SK procedure. A tissue sample specimen were determined to be evaluable by the pathologist in the pathology report.|
48151101|NCT04549363|100692379|FG000|COMPLETED|Overall Study||6||
48151102|NCT04549363|100692380|FG001|COMPLETED|Overall Study||3||
48151103|NCT04549363|100692379|FG000|NOT COMPLETED|Overall Study||0||
48151104|NCT04549363|100692380|FG001|NOT COMPLETED|Overall Study||0||
48151105|NCT02807636|100692381|FG000|STARTED|Overall Study||400||
48151106|NCT02807636|100692382|FG001|STARTED|Overall Study||451||
48151107|NCT02807636|100692383|FG002|STARTED|Overall Study||362||
48151108|NCT02807636|100692381|FG000|COMPLETED|Overall Study||0||
48151109|NCT02807636|100692382|FG001|COMPLETED|Overall Study||0||
48151110|NCT02807636|100692383|FG002|COMPLETED|Overall Study||0||
48305993|NCT01286454|101074847|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48305994|NCT01286454|101074848|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48305995|NCT01286454|101074849|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48607946|NCT02872909|101827065|FG001|STARTED|Overall Study||18||
48720200|NCT01659255|102102500|FG011|NOT COMPLETED|Overall Study||4||
48720201|NCT01659255|102102501|FG012|NOT COMPLETED|Overall Study||8||
48720202|NCT01659255|102102502|FG013|NOT COMPLETED|Overall Study||18||
48720203|NCT01659255|102102503|FG014|NOT COMPLETED|Overall Study||8||
48720204|NCT01659255|102102504|FG015|NOT COMPLETED|Overall Study||5||
48720205|NCT01659255|102102505|FG016|NOT COMPLETED|Overall Study||3||
48720206|NCT00996346|102102506|FG000|STARTED|Overall Study||6||
48720207|NCT00996346|102102507|FG001|STARTED|Overall Study||8||
48720208|NCT00996346|102102508|FG002|STARTED|Overall Study||3||
48720209|NCT00996346|102102506|FG000|COMPLETED|Overall Study||6||
48720210|NCT00996346|102102507|FG001|COMPLETED|Overall Study||8||
48720211|NCT00996346|102102508|FG002|COMPLETED|Overall Study||3||
48720212|NCT00996346|102102506|FG000|NOT COMPLETED|Overall Study||0||
48720213|NCT00996346|102102507|FG001|NOT COMPLETED|Overall Study||0||
48720214|NCT00996346|102102508|FG002|NOT COMPLETED|Overall Study||0||
48720215|NCT01804166|102102509|FG000|STARTED|Overall Study||1||
48720216|NCT01804166|102102509|FG000|COMPLETED|Overall Study||1||
48607947|NCT02872909|101827064|FG000|COMPLETED|Overall Study||32||
48720217|NCT01804166|102102509|FG000|NOT COMPLETED|Overall Study||0||
48720218|NCT00915148|102102510|FG000|STARTED|Overall Study||110||
48720219|NCT00915148|102102510|FG000|COMPLETED|Overall Study||110||
48720220|NCT00915148|102102510|FG000|NOT COMPLETED|Overall Study||0||
48720221|NCT00975143|102102511|FG000|STARTED|Overall Study||464||
48720222|NCT00975143|102102512|FG001|STARTED|Overall Study||461||
48151111|NCT02807636|100692381|FG000|NOT COMPLETED|Overall Study||400||
48151112|NCT02807636|100692382|FG001|NOT COMPLETED|Overall Study||451||
48151113|NCT02807636|100692383|FG002|NOT COMPLETED|Overall Study||362||
48151114|NCT00553696|100692384|FG000|STARTED|Overall Study||4||
48151115|NCT00553696|100692385|FG001|STARTED|Overall Study||16||
48151116|NCT00553696|100692386|FG002|STARTED|Overall Study||6||
48151117|NCT00553696|100692387|FG003|STARTED|Overall Study||1||
48151118|NCT00553696|100692384|FG000|COMPLETED|Overall Study||0||
48151119|NCT00553696|100692385|FG001|COMPLETED|Overall Study||0||
48151120|NCT00553696|100692386|FG002|COMPLETED|Overall Study||0||
48151121|NCT00553696|100692387|FG003|COMPLETED|Overall Study||0||
48151122|NCT00553696|100692384|FG000|NOT COMPLETED|Overall Study||4||
48151123|NCT00553696|100692385|FG001|NOT COMPLETED|Overall Study||16||
48720223|NCT00975143|102102511|FG000|Completed Treatment (Week 20)|Overall Study||403||
48720224|NCT00975143|102102512|FG001|Completed Treatment (Week 20)|Overall Study||410||
48720225|NCT00975143|102102511|FG000|COMPLETED|Overall Study||394||
48720226|NCT00975143|102102512|FG001|COMPLETED|Overall Study||401||
48720227|NCT00975143|102102511|FG000|NOT COMPLETED|Overall Study||70||
48720228|NCT00975143|102102512|FG001|NOT COMPLETED|Overall Study||60||
48406132|NCT00728728|101328357|FG001|STARTED|Overall Study||46||
48151124|NCT00553696|100692386|FG002|NOT COMPLETED|Overall Study||6||
48720229|NCT01977690|102102513|FG000|STARTED|Overall Study||15||
48720230|NCT01977690|102102514|FG001|STARTED|Overall Study||15||
48720231|NCT01977690|102102513|FG000|COMPLETED|Overall Study||15||
48720232|NCT01977690|102102514|FG001|COMPLETED|Overall Study||11||
48720233|NCT01977690|102102513|FG000|NOT COMPLETED|Overall Study||0||
48720234|NCT01977690|102102514|FG001|NOT COMPLETED|Overall Study||4||
48720235|NCT02544373|102102515|FG000|STARTED|Overall Study||71||
48720236|NCT02544373|102102516|FG001|STARTED|Overall Study||40||
48720237|NCT02544373|102102515|FG000|COMPLETED|Overall Study||58||
48720238|NCT02544373|102102516|FG001|COMPLETED|Overall Study||35||
48720239|NCT02544373|102102515|FG000|NOT COMPLETED|Overall Study||13||
48720240|NCT02544373|102102516|FG001|NOT COMPLETED|Overall Study||5||
48720241|NCT00576576|102102517|FG000|STARTED|Overall Study||27||
48720242|NCT00576576|102102517|FG000|COMPLETED|Overall Study||20||
48151125|NCT00553696|100692387|FG003|NOT COMPLETED|Overall Study||1||
48151126|NCT03934736|100692388|FG000|STARTED|Overall Study||119||
48151127|NCT03934736|100692388|FG000|COMPLETED|Overall Study||86||
48151128|NCT03934736|100692388|FG000|NOT COMPLETED|Overall Study||33||
48151129|NCT04162769|100692389|FG000|STARTED|Double-blind Treatment (12-Week)||47||
48151130|NCT04162769|100692390|FG001|STARTED|Double-blind Treatment (12-Week)||47||
48151131|NCT04162769|100692391|FG002|STARTED|Double-blind Treatment (12-Week)||46||
48368027|NCT03567291|101230092|FG000|STARTED|Period II||0||
48720243|NCT00576576|102102517|FG000|NOT COMPLETED|Overall Study||7||
48720244|NCT00201123|102102518|FG000|STARTED|Overall Study||32||
48720245|NCT00201123|102102519|FG001|STARTED|Overall Study||32||
48720246|NCT00201123|102102520|FG002|STARTED|Overall Study||32||
48720247|NCT00201123|102102518|FG000|Did Not Meet Continuation Criteria|Overall Study||2||
48720248|NCT00201123|102102519|FG001|Did Not Meet Continuation Criteria|Overall Study||0||
48720249|NCT00201123|102102520|FG002|Did Not Meet Continuation Criteria|Overall Study||5||
48720250|NCT00201123|102102518|FG000|COMPLETED|Overall Study||26||
48720251|NCT00201123|102102519|FG001|COMPLETED|Overall Study||28||
48720252|NCT00201123|102102520|FG002|COMPLETED|Overall Study||23||
48720253|NCT00201123|102102518|FG000|NOT COMPLETED|Overall Study||6||
48720254|NCT00201123|102102519|FG001|NOT COMPLETED|Overall Study||4||
48720255|NCT00201123|102102520|FG002|NOT COMPLETED|Overall Study||9||
48720256|NCT00758589|102102521|FG000|STARTED|Overall Study||95||
48720257|NCT00758589|102102522|FG001|STARTED|Overall Study||90||
48720258|NCT00758589|102102523|FG002|STARTED|Overall Study||92||
48720259|NCT00758589|102102524|FG003|STARTED|Overall Study||91||
48720260|NCT00758589|102102521|FG000|COMPLETED|Overall Study||92||
48720261|NCT00758589|102102522|FG001|COMPLETED|Overall Study||87||
48720262|NCT00758589|102102523|FG002|COMPLETED|Overall Study||86||
48720263|NCT00758589|102102524|FG003|COMPLETED|Overall Study||85||
48720264|NCT00758589|102102521|FG000|NOT COMPLETED|Overall Study||3||
48720265|NCT00758589|102102522|FG001|NOT COMPLETED|Overall Study||3||
48720266|NCT00758589|102102523|FG002|NOT COMPLETED|Overall Study||6||
48720267|NCT00758589|102102524|FG003|NOT COMPLETED|Overall Study||6||
48720268|NCT05086510|102102525|FG000|STARTED|Overall Study||20||
48720269|NCT05086510|102102526|FG001|STARTED|Overall Study||20||
48151132|NCT04162769|100692392|FG003|STARTED|Double-blind Treatment (12-Week)||0||
48151133|NCT04162769|100692389|FG000|COMPLETED|Double-blind Treatment (12-Week)||34||
48720270|NCT05086510|102102525|FG000|COMPLETED|Overall Study||20||
48720271|NCT05086510|102102526|FG001|COMPLETED|Overall Study||16||
48720272|NCT05086510|102102525|FG000|NOT COMPLETED|Overall Study||0||
48720273|NCT05086510|102102526|FG001|NOT COMPLETED|Overall Study||4||
48151134|NCT04162769|100692390|FG001|COMPLETED|Double-blind Treatment (12-Week)||36||
48151135|NCT04162769|100692391|FG002|COMPLETED|Double-blind Treatment (12-Week)||37||
48151136|NCT04162769|100692392|FG003|COMPLETED|Double-blind Treatment (12-Week)||0||
48151137|NCT04162769|100692389|FG000|NOT COMPLETED|Double-blind Treatment (12-Week)||13||
48151138|NCT04162769|100692390|FG001|NOT COMPLETED|Double-blind Treatment (12-Week)||11||
48151139|NCT04162769|100692391|FG002|NOT COMPLETED|Double-blind Treatment (12-Week)||9||
48151140|NCT04162769|100692392|FG003|NOT COMPLETED|Double-blind Treatment (12-Week)||0||
48151141|NCT04162769|100692389|FG000|STARTED|OLE Period (52-Week)||0||
48151142|NCT04162769|100692390|FG001|STARTED|OLE Period (52-Week)||0||
48151143|NCT04162769|100692391|FG002|STARTED|OLE Period (52-Week)||0||
48151144|NCT04162769|100692392|FG003|STARTED|OLE Period (52-Week)||95||
48151145|NCT04162769|100692389|FG000|COMPLETED|OLE Period (52-Week)||0||
48151146|NCT04162769|100692390|FG001|COMPLETED|OLE Period (52-Week)||0||
48151147|NCT04162769|100692391|FG002|COMPLETED|OLE Period (52-Week)||0||
48720274|NCT02337725|102102527|FG000|STARTED|Overall Study||126||
48720275|NCT02337725|102102528|FG001|STARTED|Overall Study||118||
48720276|NCT02337725|102102527|FG000|COMPLETED|Overall Study||100||
48720277|NCT02337725|102102528|FG001|COMPLETED|Overall Study||110||
48720278|NCT02337725|102102527|FG000|NOT COMPLETED|Overall Study||26||
48720279|NCT02337725|102102528|FG001|NOT COMPLETED|Overall Study||8||
48720280|NCT00798317|102102529|FG000|STARTED|Overall Study||245||
48720281|NCT00798317|102102530|FG001|STARTED|Overall Study||81||
48720282|NCT00798317|102102529|FG000|COMPLETED|Overall Study||235||
48720283|NCT00798317|102102530|FG001|COMPLETED|Overall Study||74||
48151148|NCT04162769|100692392|FG003|COMPLETED|OLE Period (52-Week)||68||
48305996|NCT01286454|101074850|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48151149|NCT04162769|100692389|FG000|NOT COMPLETED|OLE Period (52-Week)||0||
48151150|NCT04162769|100692390|FG001|NOT COMPLETED|OLE Period (52-Week)||0||
48151151|NCT04162769|100692391|FG002|NOT COMPLETED|OLE Period (52-Week)||0||
48151152|NCT04162769|100692392|FG003|NOT COMPLETED|OLE Period (52-Week)||27||
48151153|NCT00338884|100692393|FG000|STARTED|Overall Study||120||
48720284|NCT00798317|102102529|FG000|NOT COMPLETED|Overall Study||10||
48720285|NCT00798317|102102530|FG001|NOT COMPLETED|Overall Study||7||
48720286|NCT03984487|102102531|FG000|STARTED|Overall Study||36||
48720287|NCT03984487|102102532|FG001|STARTED|Overall Study||37||
48607948|NCT02872909|101827065|FG001|COMPLETED|Overall Study||18||
48151154|NCT00338884|100692393|FG000|Received Treatment|Overall Study||119||
48151155|NCT00338884|100692393|FG000|COMPLETED|Overall Study||42||
48151156|NCT00338884|100692393|FG000|NOT COMPLETED|Overall Study||78||
48151157|NCT00981084|100692394|FG000|STARTED|First Intervention (One Day)||16||
48151158|NCT00981084|100692395|FG001|STARTED|First Intervention (One Day)||17||
48151159|NCT00981084|100692394|FG000|COMPLETED|First Intervention (One Day)||16||
48151160|NCT00981084|100692395|FG001|COMPLETED|First Intervention (One Day)||17||
48151161|NCT00981084|100692394|FG000|NOT COMPLETED|First Intervention (One Day)||0||
48151162|NCT00981084|100692395|FG001|NOT COMPLETED|First Intervention (One Day)||0||
48151163|NCT00981084|100692394|FG000|STARTED|Washout Period (7 Days)||16||
48151164|NCT00981084|100692395|FG001|STARTED|Washout Period (7 Days)||17||
48151165|NCT00981084|100692394|FG000|COMPLETED|Washout Period (7 Days)||16||
48151166|NCT00981084|100692395|FG001|COMPLETED|Washout Period (7 Days)||17||
48151167|NCT00981084|100692394|FG000|NOT COMPLETED|Washout Period (7 Days)||0||
48151168|NCT00981084|100692395|FG001|NOT COMPLETED|Washout Period (7 Days)||0||
48151169|NCT00981084|100692394|FG000|STARTED|Second Intervention (One Day)||16||
48151170|NCT00981084|100692395|FG001|STARTED|Second Intervention (One Day)||17||
48151171|NCT00981084|100692394|FG000|COMPLETED|Second Intervention (One Day)||16||
48151172|NCT00981084|100692395|FG001|COMPLETED|Second Intervention (One Day)||17||
48151173|NCT00981084|100692394|FG000|NOT COMPLETED|Second Intervention (One Day)||0||
48151174|NCT00981084|100692395|FG001|NOT COMPLETED|Second Intervention (One Day)||0||
48151175|NCT00981084|100692394|FG000|STARTED|Post Intervention (Data Analysis)||16||
48151176|NCT00981084|100692395|FG001|STARTED|Post Intervention (Data Analysis)||17||
48151177|NCT00981084|100692394|FG000|COMPLETED|Post Intervention (Data Analysis)||14||
48151178|NCT00981084|100692395|FG001|COMPLETED|Post Intervention (Data Analysis)||16||
48151179|NCT00981084|100692394|FG000|NOT COMPLETED|Post Intervention (Data Analysis)||2||
48151180|NCT00981084|100692395|FG001|NOT COMPLETED|Post Intervention (Data Analysis)||1||
48151181|NCT02386995|100692396|FG000|STARTED|Overall Study||30||
48151182|NCT02386995|100692396|FG000|COMPLETED|Overall Study||30||
48151183|NCT02386995|100692396|FG000|NOT COMPLETED|Overall Study||0||
48151184|NCT01685138|100692397|FG000|STARTED|Overall Study||124||
48151185|NCT01685138|100692397|FG000|Discontinued From Treatment Phase|Overall Study||124||
48151186|NCT01685138|100692397|FG000|Entered Post-treatment Efficacy f/up|Overall Study||10||
48151187|NCT01685138|100692397|FG000|Entered Survival Follow-up|Overall Study||63||
48151188|NCT01685138|100692397|FG000|Discontinued From Study|Overall Study||51||
48151189|NCT01685138|100692397|FG000|COMPLETED|Overall Study||32|Completed = discontinued from treatment phase|
48720288|NCT03984487|102102531|FG000|COMPLETED|Overall Study||31||
48720289|NCT03984487|102102532|FG001|COMPLETED|Overall Study||30||
48720290|NCT03984487|102102531|FG000|NOT COMPLETED|Overall Study||5||
48720291|NCT03984487|102102532|FG001|NOT COMPLETED|Overall Study||7||
48151190|NCT01685138|100692397|FG000|NOT COMPLETED|Overall Study||92||
48151191|NCT04102579|100692398|FG000|STARTED|Overall Study||64||
48151192|NCT04102579|100692399|FG001|STARTED|Overall Study||64||
48151193|NCT04102579|100692398|FG000|Received at Least 1 Dose of Study Drug|Overall Study||64||
48151194|NCT04102579|100692399|FG001|Received at Least 1 Dose of Study Drug|Overall Study||63||
48151195|NCT04102579|100692398|FG000|COMPLETED|Overall Study||57||
48151196|NCT04102579|100692399|FG001|COMPLETED|Overall Study||54||
48151197|NCT04102579|100692398|FG000|NOT COMPLETED|Overall Study||7||
48151198|NCT04102579|100692399|FG001|NOT COMPLETED|Overall Study||10||
48151199|NCT01050816|100692400|FG000|STARTED|Overall Study||30||
48151200|NCT01050816|100692400|FG000|COMPLETED|Overall Study||26||
48151201|NCT01050816|100692400|FG000|NOT COMPLETED|Overall Study||4||
48151202|NCT01169675|100692401|FG000|STARTED|Overall Study||20||
48151203|NCT01169675|100692402|FG001|STARTED|Overall Study||3||
48151204|NCT01169675|100692403|FG002|STARTED|Overall Study||7||
48151205|NCT01169675|100692404|FG003|STARTED|Overall Study||17||
48151206|NCT01169675|100692405|FG004|STARTED|Overall Study||6||
48151207|NCT01169675|100692401|FG000|COMPLETED|Overall Study||0||
48151208|NCT01169675|100692402|FG001|COMPLETED|Overall Study||0||
48151209|NCT01169675|100692403|FG002|COMPLETED|Overall Study||0||
48151210|NCT01169675|100692404|FG003|COMPLETED|Overall Study||0||
48151211|NCT01169675|100692405|FG004|COMPLETED|Overall Study||0||
48151212|NCT01169675|100692401|FG000|NOT COMPLETED|Overall Study||20||
48151213|NCT01169675|100692402|FG001|NOT COMPLETED|Overall Study||3||
48151214|NCT01169675|100692403|FG002|NOT COMPLETED|Overall Study||7||
48151215|NCT01169675|100692404|FG003|NOT COMPLETED|Overall Study||17||
48305997|NCT01286454|101074851|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48305998|NCT01286454|101074852|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48305999|NCT01286454|101074853|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48306000|NCT01286454|101074854|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48306001|NCT01286454|101074855|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48306002|NCT01286454|101074856|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48306003|NCT01286454|101074857|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
48306004|NCT01286454|101074847|FG000|STARTED|Fifth Intervention Period||2||
48306005|NCT01286454|101074848|FG001|STARTED|Fifth Intervention Period||2||
48306006|NCT01286454|101074849|FG002|STARTED|Fifth Intervention Period||2||
48306007|NCT01286454|101074850|FG003|STARTED|Fifth Intervention Period||2||
48306008|NCT01286454|101074851|FG004|STARTED|Fifth Intervention Period||2||
48306009|NCT01286454|101074852|FG005|STARTED|Fifth Intervention Period||2||
48306010|NCT01286454|101074853|FG006|STARTED|Fifth Intervention Period||2||
48306011|NCT01286454|101074854|FG007|STARTED|Fifth Intervention Period||2||
48306012|NCT01286454|101074855|FG008|STARTED|Fifth Intervention Period||2||
48306013|NCT01286454|101074856|FG009|STARTED|Fifth Intervention Period||2||
48306014|NCT01286454|101074857|FG010|STARTED|Fifth Intervention Period||0||
48306015|NCT01286454|101074847|FG000|COMPLETED|Fifth Intervention Period||2||
48306016|NCT01286454|101074848|FG001|COMPLETED|Fifth Intervention Period||2||
48306017|NCT01286454|101074849|FG002|COMPLETED|Fifth Intervention Period||2||
48306018|NCT01286454|101074850|FG003|COMPLETED|Fifth Intervention Period||2||
48306019|NCT01286454|101074851|FG004|COMPLETED|Fifth Intervention Period||2||
48306020|NCT01286454|101074852|FG005|COMPLETED|Fifth Intervention Period||2||
48306021|NCT01286454|101074853|FG006|COMPLETED|Fifth Intervention Period||2||
48306022|NCT01286454|101074854|FG007|COMPLETED|Fifth Intervention Period||2||
48306023|NCT01286454|101074855|FG008|COMPLETED|Fifth Intervention Period||2||
48306024|NCT01286454|101074856|FG009|COMPLETED|Fifth Intervention Period||2||
48306025|NCT01286454|101074857|FG010|COMPLETED|Fifth Intervention Period||0||
48306026|NCT01286454|101074847|FG000|NOT COMPLETED|Fifth Intervention Period||0||
48306027|NCT01286454|101074848|FG001|NOT COMPLETED|Fifth Intervention Period||0||
48306028|NCT01286454|101074849|FG002|NOT COMPLETED|Fifth Intervention Period||0||
48306029|NCT01286454|101074850|FG003|NOT COMPLETED|Fifth Intervention Period||0||
48306030|NCT01286454|101074851|FG004|NOT COMPLETED|Fifth Intervention Period||0||
48306031|NCT01286454|101074852|FG005|NOT COMPLETED|Fifth Intervention Period||0||
48306032|NCT01286454|101074853|FG006|NOT COMPLETED|Fifth Intervention Period||0||
48306033|NCT01286454|101074854|FG007|NOT COMPLETED|Fifth Intervention Period||0||
48306034|NCT01286454|101074855|FG008|NOT COMPLETED|Fifth Intervention Period||0||
48306035|NCT01286454|101074856|FG009|NOT COMPLETED|Fifth Intervention Period||0||
48306036|NCT01286454|101074857|FG010|NOT COMPLETED|Fifth Intervention Period||0||
48151216|NCT01169675|100692405|FG004|NOT COMPLETED|Overall Study||6||
48151217|NCT03880838|100692406|FG000|STARTED|Overall Study||2434||
48151218|NCT03880838|100692407|FG001|STARTED|Overall Study||2200||
48151219|NCT03880838|100692408|FG002|STARTED|Overall Study||550||
48151220|NCT03880838|100692409|FG003|STARTED|Overall Study||550||
48151221|NCT03880838|100692410|FG004|STARTED|Overall Study||550||
48151222|NCT03880838|100692411|FG005|STARTED|Overall Study||550||
48151223|NCT03880838|100692412|FG006|STARTED|Overall Study||550||
48151224|NCT03880838|100692413|FG007|STARTED|Overall Study||550||
48151225|NCT03880838|100692414|FG008|STARTED|Overall Study||550||
48151226|NCT03880838|100692415|FG009|STARTED|Overall Study||550||
48151227|NCT03880838|100692416|FG010|STARTED|Overall Study||550||
48151228|NCT03880838|100692417|FG011|STARTED|Overall Study||550||
48151229|NCT03880838|100692418|FG012|STARTED|Overall Study||550||
48151230|NCT03880838|100692419|FG013|STARTED|Overall Study||550||
48151231|NCT03880838|100692406|FG000|COMPLETED|Overall Study||2434||
48151232|NCT03880838|100692407|FG001|COMPLETED|Overall Study||2200||
48306037|NCT01286454|101074847|FG000|STARTED|Washout Period (Approximately 2 Weeks)||2||
48368028|NCT03567291|101230093|FG001|STARTED|Period II||91||
48151233|NCT03880838|100692408|FG002|COMPLETED|Overall Study||550||
48151234|NCT03880838|100692409|FG003|COMPLETED|Overall Study||550||
48720292|NCT02698371|102102533|FG000|STARTED|All Participants Flow||38|Baseline|210
48720293|NCT02698371|102102533|FG000|COMPLETED|All Participants Flow||35|Two years recall|193
48720294|NCT02698371|102102533|FG000|NOT COMPLETED|All Participants Flow||3||17
48720295|NCT02698371|102102533|FG000|STARTED|FBDC-SE (G1; Control) Arm/Group Flow||35|Baseline|35
48720296|NCT02698371|102102533|FG000|COMPLETED|FBDC-SE (G1; Control) Arm/Group Flow||32|Two years recall|32
48720297|NCT02698371|102102533|FG000|NOT COMPLETED|FBDC-SE (G1; Control) Arm/Group Flow||3||3
48720298|NCT02698371|102102533|FG000|STARTED|FBDC-SE-EE (G2; Control ) Arm/Group Flow||35|Baseline|35
48720299|NCT02698371|102102533|FG000|COMPLETED|FBDC-SE-EE (G2; Control ) Arm/Group Flow||32|Two years recall|32
48720300|NCT02698371|102102533|FG000|NOT COMPLETED|FBDC-SE-EE (G2; Control ) Arm/Group Flow||3||3
48720301|NCT02698371|102102533|FG000|STARTED|FBU-ER (G3) Arm/Group Flow||35|Baseline|35
48720302|NCT02698371|102102533|FG000|COMPLETED|FBU-ER (G3) Arm/Group Flow||32|Two years recall|32
48720303|NCT02698371|102102533|FG000|NOT COMPLETED|FBU-ER (G3) Arm/Group Flow||3||3
48720304|NCT02698371|102102533|FG000|STARTED|FBU-SE (G4) Arm/Group Flow||35|Baseline|35
48720305|NCT02698371|102102533|FG000|COMPLETED|FBU-SE (G4) Arm/Group Flow||32|Two years recall|32
48720306|NCT02698371|102102533|FG000|NOT COMPLETED|FBU-SE (G4) Arm/Group Flow||3||3
48720307|NCT02698371|102102533|FG000|STARTED|ADU-ER (G5) Arm/Group Flow||35|Baseline|35
48720308|NCT02698371|102102533|FG000|COMPLETED|ADU-ER (G5) Arm/Group Flow||32|Two years recall|32
48720309|NCT02698371|102102533|FG000|NOT COMPLETED|ADU-ER (G5) Arm/Group Flow||3||3
48720310|NCT02698371|102102533|FG000|STARTED|ADU-SE (G6) Arm/Group Flow||35|Baseline|35
48720311|NCT02698371|102102533|FG000|COMPLETED|ADU-SE (G6) Arm/Group Flow||33|Two years recall|33
48720312|NCT02698371|102102533|FG000|NOT COMPLETED|ADU-SE (G6) Arm/Group Flow||2||2
48720313|NCT00308074|102102534|FG000|STARTED|Overall Study||14||
48720314|NCT00308074|102102534|FG000|COMPLETED|Overall Study||13||
48720315|NCT00308074|102102534|FG000|NOT COMPLETED|Overall Study||1||
48720316|NCT02481713|102102535|FG000|STARTED|Overall Study||56||
48720317|NCT02481713|102102536|FG001|STARTED|Overall Study||58||
48720318|NCT02481713|102102535|FG000|COMPLETED|Overall Study||40||
48720319|NCT02481713|102102536|FG001|COMPLETED|Overall Study||42||
48720320|NCT02481713|102102535|FG000|NOT COMPLETED|Overall Study||16||
48720321|NCT02481713|102102536|FG001|NOT COMPLETED|Overall Study||16||
48720322|NCT00957333|102102537|FG000|STARTED|Overall Study||44||
48720323|NCT00957333|102102537|FG000|COMPLETED|Overall Study||44||
48720324|NCT00957333|102102537|FG000|NOT COMPLETED|Overall Study||0||
48720325|NCT01221194|102102538|FG000|STARTED|Overall Study||195||
48720326|NCT01221194|102102539|FG001|STARTED|Overall Study||186||
48720327|NCT01221194|102102538|FG000|COMPLETED|Overall Study||195||
48720328|NCT01221194|102102539|FG001|COMPLETED|Overall Study||186||
48720329|NCT01221194|102102538|FG000|NOT COMPLETED|Overall Study||0||
48720330|NCT01221194|102102539|FG001|NOT COMPLETED|Overall Study||0||
48720331|NCT03262116|102102540|FG000|STARTED|Overall Study||2||
48720332|NCT03262116|102102541|FG001|STARTED|Overall Study||3||
48720333|NCT03262116|102102542|FG002|STARTED|Overall Study||2||
48720334|NCT03262116|102102543|FG003|STARTED|Overall Study||2||
48720335|NCT03262116|102102544|FG004|STARTED|Overall Study||2||
48720336|NCT03262116|102102545|FG005|STARTED|Overall Study||2||
48720337|NCT03262116|102102540|FG000|COMPLETED|Overall Study||2||
48720338|NCT03262116|102102541|FG001|COMPLETED|Overall Study||1||
48720339|NCT03262116|102102542|FG002|COMPLETED|Overall Study||1||
48720340|NCT03262116|102102543|FG003|COMPLETED|Overall Study||1||
48720341|NCT03262116|102102544|FG004|COMPLETED|Overall Study||1||
48720342|NCT03262116|102102545|FG005|COMPLETED|Overall Study||0||
48720343|NCT03262116|102102540|FG000|NOT COMPLETED|Overall Study||0||
48720344|NCT03262116|102102541|FG001|NOT COMPLETED|Overall Study||2||
48720345|NCT03262116|102102542|FG002|NOT COMPLETED|Overall Study||1||
48720346|NCT03262116|102102543|FG003|NOT COMPLETED|Overall Study||1||
48720347|NCT03262116|102102544|FG004|NOT COMPLETED|Overall Study||1||
48720348|NCT03262116|102102545|FG005|NOT COMPLETED|Overall Study||2||
48720349|NCT00906958|102102546|FG000|STARTED|Overall Study||10||
48720350|NCT00906958|102102547|FG001|STARTED|Overall Study||10||
48720351|NCT00906958|102102546|FG000|COMPLETED|Overall Study||10||
48720352|NCT00906958|102102547|FG001|COMPLETED|Overall Study||10||
48720353|NCT00906958|102102546|FG000|NOT COMPLETED|Overall Study||0||
48720354|NCT00906958|102102547|FG001|NOT COMPLETED|Overall Study||0||
48720355|NCT01930890|102102548|FG000|STARTED|Overall Study||14||
48720356|NCT01930890|102102549|FG001|STARTED|Overall Study||33||
48720357|NCT01930890|102102550|FG002|STARTED|Overall Study||13||
48720358|NCT01930890|102102551|FG003|STARTED|Overall Study||27||
48720359|NCT01930890|102102548|FG000|COMPLETED|Overall Study||0||
48720360|NCT01930890|102102549|FG001|COMPLETED|Overall Study||0||
48720361|NCT01930890|102102550|FG002|COMPLETED|Overall Study||0||
48720362|NCT01930890|102102551|FG003|COMPLETED|Overall Study||0||
48720363|NCT01930890|102102548|FG000|NOT COMPLETED|Overall Study||14||
48720364|NCT01930890|102102549|FG001|NOT COMPLETED|Overall Study||33||
48720365|NCT01930890|102102550|FG002|NOT COMPLETED|Overall Study||13||
48720366|NCT01930890|102102551|FG003|NOT COMPLETED|Overall Study||27||
48720367|NCT02049138|102102552|FG000|STARTED|Overall Study||306||
48720368|NCT02049138|102102553|FG001|STARTED|Overall Study||149||
48720369|NCT02049138|102102554|FG002|STARTED|Overall Study||38||
48720370|NCT02049138|102102552|FG000|Enrolled in Vaccine Sub-study|Overall Study||76||
48767593|NCT00914316|102222777|FG001|STARTED|Phase 1||6||
48306038|NCT01286454|101074848|FG001|STARTED|Washout Period (Approximately 2 Weeks)||2||
48306039|NCT01286454|101074849|FG002|STARTED|Washout Period (Approximately 2 Weeks)||2||
48306040|NCT01286454|101074850|FG003|STARTED|Washout Period (Approximately 2 Weeks)||2||
48306041|NCT01286454|101074851|FG004|STARTED|Washout Period (Approximately 2 Weeks)||2||
48306042|NCT01286454|101074852|FG005|STARTED|Washout Period (Approximately 2 Weeks)||2||
48306043|NCT01286454|101074853|FG006|STARTED|Washout Period (Approximately 2 Weeks)||2||
48306044|NCT01286454|101074854|FG007|STARTED|Washout Period (Approximately 2 Weeks)||2||
48306045|NCT01286454|101074855|FG008|STARTED|Washout Period (Approximately 2 Weeks)||2||
48306046|NCT01286454|101074856|FG009|STARTED|Washout Period (Approximately 2 Weeks)||2||
48306047|NCT01286454|101074857|FG010|STARTED|Washout Period (Approximately 2 Weeks)||0||
48306048|NCT01286454|101074847|FG000|COMPLETED|Washout Period (Approximately 2 Weeks)||2||
48306049|NCT01286454|101074848|FG001|COMPLETED|Washout Period (Approximately 2 Weeks)||2||
48306050|NCT01286454|101074849|FG002|COMPLETED|Washout Period (Approximately 2 Weeks)||2||
48306051|NCT01286454|101074850|FG003|COMPLETED|Washout Period (Approximately 2 Weeks)||2||
48306052|NCT01286454|101074851|FG004|COMPLETED|Washout Period (Approximately 2 Weeks)||2||
48306053|NCT01286454|101074852|FG005|COMPLETED|Washout Period (Approximately 2 Weeks)||2||
48306054|NCT01286454|101074853|FG006|COMPLETED|Washout Period (Approximately 2 Weeks)||2||
48306055|NCT01286454|101074854|FG007|COMPLETED|Washout Period (Approximately 2 Weeks)||2||
48607949|NCT02872909|101827064|FG000|NOT COMPLETED|Overall Study||0||
48607950|NCT02872909|101827065|FG001|NOT COMPLETED|Overall Study||0||
48607951|NCT01491841|101827066|FG000|STARTED|Overall Study||33||
48607952|NCT01491841|101827066|FG000|COMPLETED|Overall Study||22||
48607953|NCT01491841|101827066|FG000|NOT COMPLETED|Overall Study||11||
48607954|NCT01884545|101827067|FG000|STARTED|Overall Study||50||
48607955|NCT01884545|101827068|FG001|STARTED|Overall Study||49||
48607956|NCT01884545|101827069|FG002|STARTED|Overall Study||49||
48607957|NCT01884545|101827070|FG003|STARTED|Overall Study||52||
48607958|NCT01884545|101827067|FG000|COMPLETED|Overall Study||37||
48607959|NCT01884545|101827068|FG001|COMPLETED|Overall Study||31||
48607960|NCT01884545|101827069|FG002|COMPLETED|Overall Study||35||
48720371|NCT02049138|102102553|FG001|Enrolled in Vaccine Sub-study|Overall Study||24||
48720372|NCT02049138|102102554|FG002|Enrolled in Vaccine Sub-study|Overall Study||11||
48720373|NCT02049138|102102552|FG000|COMPLETED|Overall Study||142||
48720374|NCT02049138|102102553|FG001|COMPLETED|Overall Study||51||
48607961|NCT01884545|101827070|FG003|COMPLETED|Overall Study||43||
48607962|NCT01884545|101827067|FG000|NOT COMPLETED|Overall Study||13||
48607963|NCT01884545|101827068|FG001|NOT COMPLETED|Overall Study||18||
48720375|NCT02049138|102102554|FG002|COMPLETED|Overall Study||30||
48306056|NCT01286454|101074855|FG008|COMPLETED|Washout Period (Approximately 2 Weeks)||2||
48306057|NCT01286454|101074856|FG009|COMPLETED|Washout Period (Approximately 2 Weeks)||2||
48306058|NCT01286454|101074857|FG010|COMPLETED|Washout Period (Approximately 2 Weeks)||0||
48306059|NCT01286454|101074847|FG000|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0||
48306060|NCT01286454|101074848|FG001|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0||
48306061|NCT01286454|101074849|FG002|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0||
48306062|NCT01286454|101074850|FG003|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0||
48306063|NCT01286454|101074851|FG004|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0||
48306064|NCT01286454|101074852|FG005|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0||
48306065|NCT01286454|101074853|FG006|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0||
48306066|NCT01286454|101074854|FG007|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0||
48306067|NCT01286454|101074855|FG008|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0||
48306068|NCT01286454|101074856|FG009|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0||
48607964|NCT01884545|101827069|FG002|NOT COMPLETED|Overall Study||14||
48720376|NCT02049138|102102552|FG000|NOT COMPLETED|Overall Study||164||
48720377|NCT02049138|102102553|FG001|NOT COMPLETED|Overall Study||98||
48720378|NCT02049138|102102554|FG002|NOT COMPLETED|Overall Study||8||
48720379|NCT02454153|102102555|FG000|STARTED|Overall Study||92||
48720380|NCT02454153|102102556|FG001|STARTED|Overall Study||92||
48720381|NCT02454153|102102555|FG000|COMPLETED|Overall Study||92||
48720382|NCT02454153|102102556|FG001|COMPLETED|Overall Study||92||
48720383|NCT02454153|102102555|FG000|NOT COMPLETED|Overall Study||0||
48720384|NCT02454153|102102556|FG001|NOT COMPLETED|Overall Study||0||
48720385|NCT01008462|102102557|FG000|STARTED|Overall Study||16||
48720386|NCT01008462|102102557|FG000|COMPLETED|Overall Study||16||
48720387|NCT01008462|102102557|FG000|NOT COMPLETED|Overall Study||0||
48720388|NCT01347255|102102558|FG000|STARTED|Overall Study||24||
48720389|NCT01347255|102102558|FG000|COMPLETED|Overall Study||24||
48720390|NCT01347255|102102558|FG000|NOT COMPLETED|Overall Study||0||
48720391|NCT01330966|102102559|FG000|STARTED|Overall Study||47||
48720392|NCT01330966|102102559|FG000|COMPLETED|Overall Study||42||
48720393|NCT01330966|102102559|FG000|NOT COMPLETED|Overall Study||5||
48720394|NCT02017522|102102560|FG000|STARTED|Overall Study||3||
48720395|NCT02017522|102102560|FG000|Scan|Overall Study||2||
48720396|NCT02017522|102102560|FG000|COMPLETED|Overall Study||2||
48720397|NCT02017522|102102560|FG000|NOT COMPLETED|Overall Study||1||
48720398|NCT00940485|102102561|FG000|STARTED|Overall Study||97||
48720399|NCT00940485|102102562|FG001|STARTED|Overall Study||100||
48720400|NCT00940485|102102561|FG000|COMPLETED|Overall Study||82||
48720401|NCT00940485|102102562|FG001|COMPLETED|Overall Study||93||
48720402|NCT00940485|102102561|FG000|NOT COMPLETED|Overall Study||15||
48720403|NCT00940485|102102562|FG001|NOT COMPLETED|Overall Study||7||
48720404|NCT02759315|102102563|FG000|STARTED|Overall Study||69||
48720405|NCT02759315|102102564|FG001|STARTED|Overall Study||29||
48720406|NCT02759315|102102565|FG002|STARTED|Overall Study||39||
48720407|NCT02759315|102102566|FG003|STARTED|Overall Study||20||
48720408|NCT02759315|102102567|FG004|STARTED|Overall Study||3||
48306069|NCT01286454|101074857|FG010|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0||
48306070|NCT01286454|101074847|FG000|STARTED|Part II- Sixth Intervention Period||0||
48306071|NCT01286454|101074848|FG001|STARTED|Part II- Sixth Intervention Period||0||
48306072|NCT01286454|101074849|FG002|STARTED|Part II- Sixth Intervention Period||0||
48306073|NCT01286454|101074850|FG003|STARTED|Part II- Sixth Intervention Period||0||
48306074|NCT01286454|101074851|FG004|STARTED|Part II- Sixth Intervention Period||0||
48306075|NCT01286454|101074852|FG005|STARTED|Part II- Sixth Intervention Period||0||
48720409|NCT02759315|102102563|FG000|COMPLETED|Overall Study||65||
48720410|NCT02759315|102102564|FG001|COMPLETED|Overall Study||28||
48720411|NCT02759315|102102565|FG002|COMPLETED|Overall Study||29||
48720412|NCT02759315|102102566|FG003|COMPLETED|Overall Study||19||
48720413|NCT02759315|102102567|FG004|COMPLETED|Overall Study||2||
48720414|NCT02759315|102102563|FG000|NOT COMPLETED|Overall Study||4||
48306076|NCT01286454|101074853|FG006|STARTED|Part II- Sixth Intervention Period||0||
48306077|NCT01286454|101074854|FG007|STARTED|Part II- Sixth Intervention Period||0||
48306078|NCT01286454|101074855|FG008|STARTED|Part II- Sixth Intervention Period||0||
48306079|NCT01286454|101074856|FG009|STARTED|Part II- Sixth Intervention Period||0||
48306080|NCT01286454|101074857|FG010|STARTED|Part II- Sixth Intervention Period||20||
48306081|NCT01286454|101074847|FG000|COMPLETED|Part II- Sixth Intervention Period||0||
48306082|NCT01286454|101074848|FG001|COMPLETED|Part II- Sixth Intervention Period||0||
48306083|NCT01286454|101074849|FG002|COMPLETED|Part II- Sixth Intervention Period||0||
48306084|NCT01286454|101074850|FG003|COMPLETED|Part II- Sixth Intervention Period||0||
48306085|NCT01286454|101074851|FG004|COMPLETED|Part II- Sixth Intervention Period||0||
48720415|NCT02759315|102102564|FG001|NOT COMPLETED|Overall Study||1||
48720416|NCT02759315|102102565|FG002|NOT COMPLETED|Overall Study||10||
48720417|NCT02759315|102102566|FG003|NOT COMPLETED|Overall Study||1||
48720418|NCT02759315|102102567|FG004|NOT COMPLETED|Overall Study||1||
48720419|NCT02191605|102102568|FG000|STARTED|Overall Study||15||
48720420|NCT02191605|102102569|FG001|STARTED|Overall Study||15||
48720421|NCT02191605|102102570|FG002|STARTED|Overall Study||15||
48720422|NCT02191605|102102571|FG003|STARTED|Overall Study||8||
48720423|NCT02191605|102102572|FG004|STARTED|Overall Study||7||
48720424|NCT02191605|102102568|FG000|Completed Intervention Portion|Overall Study||15||
48720425|NCT02191605|102102569|FG001|Completed Intervention Portion|Overall Study||15||
48720426|NCT02191605|102102570|FG002|Completed Intervention Portion|Overall Study||15||
48720427|NCT02191605|102102571|FG003|Completed Intervention Portion|Overall Study||8||
48720428|NCT02191605|102102572|FG004|Completed Intervention Portion|Overall Study||7||
48720429|NCT02191605|102102568|FG000|COMPLETED|Overall Study||6|Completed postpartum follow-up|
48720430|NCT02191605|102102569|FG001|COMPLETED|Overall Study||11|Completed postpartum follow-up|
48720431|NCT02191605|102102570|FG002|COMPLETED|Overall Study||8|Completed postpartum follow-up|
48720432|NCT02191605|102102571|FG003|COMPLETED|Overall Study||5|Completed postpartum follow-up|
48720433|NCT02191605|102102572|FG004|COMPLETED|Overall Study||3|Completed postpartum follow-up|
48720434|NCT02191605|102102568|FG000|NOT COMPLETED|Overall Study||9||
48720435|NCT02191605|102102569|FG001|NOT COMPLETED|Overall Study||4||
48720436|NCT02191605|102102570|FG002|NOT COMPLETED|Overall Study||7||
48720437|NCT02191605|102102571|FG003|NOT COMPLETED|Overall Study||3||
48306086|NCT01286454|101074852|FG005|COMPLETED|Part II- Sixth Intervention Period||0||
48306087|NCT01286454|101074853|FG006|COMPLETED|Part II- Sixth Intervention Period||0||
48306088|NCT01286454|101074854|FG007|COMPLETED|Part II- Sixth Intervention Period||0||
48306089|NCT01286454|101074855|FG008|COMPLETED|Part II- Sixth Intervention Period||0||
48306090|NCT01286454|101074856|FG009|COMPLETED|Part II- Sixth Intervention Period||0||
48306091|NCT01286454|101074857|FG010|COMPLETED|Part II- Sixth Intervention Period||20||
48306092|NCT01286454|101074847|FG000|NOT COMPLETED|Part II- Sixth Intervention Period||0||
48306093|NCT01286454|101074848|FG001|NOT COMPLETED|Part II- Sixth Intervention Period||0||
48306094|NCT01286454|101074849|FG002|NOT COMPLETED|Part II- Sixth Intervention Period||0||
48306095|NCT01286454|101074850|FG003|NOT COMPLETED|Part II- Sixth Intervention Period||0||
48306096|NCT01286454|101074851|FG004|NOT COMPLETED|Part II- Sixth Intervention Period||0||
48306097|NCT01286454|101074852|FG005|NOT COMPLETED|Part II- Sixth Intervention Period||0||
48306098|NCT01286454|101074853|FG006|NOT COMPLETED|Part II- Sixth Intervention Period||0||
48306099|NCT01286454|101074854|FG007|NOT COMPLETED|Part II- Sixth Intervention Period||0||
48306100|NCT01286454|101074855|FG008|NOT COMPLETED|Part II- Sixth Intervention Period||0||
48306101|NCT01286454|101074856|FG009|NOT COMPLETED|Part II- Sixth Intervention Period||0||
48306102|NCT01286454|101074857|FG010|NOT COMPLETED|Part II- Sixth Intervention Period||0||
48306103|NCT05323084|101074858|FG000|STARTED|Period 1||5||
48306104|NCT05323084|101074859|FG001|STARTED|Period 1||5||
48306105|NCT05323084|101074858|FG000|COMPLETED|Period 1||5||
48306106|NCT05323084|101074859|FG001|COMPLETED|Period 1||5||
48306107|NCT05323084|101074858|FG000|NOT COMPLETED|Period 1||0||
48306108|NCT05323084|101074859|FG001|NOT COMPLETED|Period 1||0||
48306109|NCT05323084|101074858|FG000|STARTED|Period 2 - Washout||5||
48306110|NCT05323084|101074859|FG001|STARTED|Period 2 - Washout||5||
48306111|NCT05323084|101074858|FG000|COMPLETED|Period 2 - Washout||5||
48306112|NCT05323084|101074859|FG001|COMPLETED|Period 2 - Washout||4||
48306113|NCT05323084|101074858|FG000|NOT COMPLETED|Period 2 - Washout||0||
48306114|NCT05323084|101074859|FG001|NOT COMPLETED|Period 2 - Washout||1||
48306115|NCT05323084|101074858|FG000|STARTED|Period 3||5||
48306116|NCT05323084|101074859|FG001|STARTED|Period 3||4||
48306117|NCT05323084|101074858|FG000|COMPLETED|Period 3||5||
48306118|NCT05323084|101074859|FG001|COMPLETED|Period 3||4||
48306119|NCT05323084|101074858|FG000|NOT COMPLETED|Period 3||0||
48306120|NCT05323084|101074859|FG001|NOT COMPLETED|Period 3||0||
48306121|NCT05591274|101074860|FG000|STARTED|Overall Study||40||
48306122|NCT05591274|101074861|FG001|STARTED|Overall Study||40||
48306123|NCT05591274|101074862|FG002|STARTED|Overall Study||40||
48306124|NCT05591274|101074860|FG000|COMPLETED|Overall Study||40||
48306125|NCT05591274|101074861|FG001|COMPLETED|Overall Study||40||
48306126|NCT05591274|101074862|FG002|COMPLETED|Overall Study||40||
48306127|NCT05591274|101074860|FG000|NOT COMPLETED|Overall Study||0||
48306128|NCT05591274|101074861|FG001|NOT COMPLETED|Overall Study||0||
48306129|NCT05591274|101074862|FG002|NOT COMPLETED|Overall Study||0||
48306130|NCT02754882|101074863|FG000|STARTED|Overall Study||384||
48306131|NCT02754882|101074864|FG001|STARTED|Overall Study||379||
48306132|NCT02754882|101074863|FG000|COMPLETED|Overall Study||38||
48306133|NCT02754882|101074864|FG001|COMPLETED|Overall Study||35||
48306134|NCT02754882|101074863|FG000|NOT COMPLETED|Overall Study||346||
48306135|NCT02754882|101074864|FG001|NOT COMPLETED|Overall Study||344||
48306136|NCT01668719|101074865|FG000|STARTED|Phase I||6||
48306137|NCT01668719|101074866|FG001|STARTED|Phase I||0||
48306138|NCT01668719|101074867|FG002|STARTED|Phase I||0||
48306139|NCT01668719|101074865|FG000|COMPLETED|Phase I||0||
48306140|NCT01668719|101074866|FG001|COMPLETED|Phase I||0||
48306141|NCT01668719|101074867|FG002|COMPLETED|Phase I||0||
48306142|NCT01668719|101074865|FG000|NOT COMPLETED|Phase I||6||
48306143|NCT01668719|101074866|FG001|NOT COMPLETED|Phase I||0||
48306144|NCT01668719|101074867|FG002|NOT COMPLETED|Phase I||0||
48306145|NCT01668719|101074865|FG000|STARTED|Phase II||0||
48306146|NCT01668719|101074866|FG001|STARTED|Phase II||52||
48306147|NCT01668719|101074867|FG002|STARTED|Phase II||48||
48306148|NCT01668719|101074865|FG000|COMPLETED|Phase II||0||
48306149|NCT01668719|101074866|FG001|COMPLETED|Phase II||0||
48306150|NCT01668719|101074867|FG002|COMPLETED|Phase II||0||
48306151|NCT01668719|101074865|FG000|NOT COMPLETED|Phase II||0||
48306152|NCT01668719|101074866|FG001|NOT COMPLETED|Phase II||52||
48306153|NCT01668719|101074867|FG002|NOT COMPLETED|Phase II||48||
48306154|NCT00757003|101074868|FG000|STARTED|Overall Study||100||
48306155|NCT00757003|101074868|FG000|COMPLETED|Overall Study||51||
48306156|NCT00757003|101074868|FG000|NOT COMPLETED|Overall Study||49||
48406133|NCT00728728|101328356|FG000|COMPLETED|Overall Study||38||
48406134|NCT00728728|101328357|FG001|COMPLETED|Overall Study||34||
48406135|NCT00728728|101328356|FG000|NOT COMPLETED|Overall Study||4||
48306157|NCT04640961|101074869|FG000|STARTED|Overall Study||25||
48306158|NCT04640961|101074869|FG000|COMPLETED|Overall Study||25||
48306159|NCT04640961|101074869|FG000|NOT COMPLETED|Overall Study||0||
48306160|NCT03272763|101074870|FG000|STARTED|Overall Study||38||
48306161|NCT03272763|101074870|FG000|COMPLETED|Overall Study||38||
48306162|NCT03272763|101074870|FG000|NOT COMPLETED|Overall Study||0||
48306163|NCT01365585|101074871|FG000|STARTED|Overall Study||227||
48306164|NCT01365585|101074871|FG000|COMPLETED|Overall Study||227||
48306165|NCT01365585|101074871|FG000|NOT COMPLETED|Overall Study||0||
48306166|NCT04663737|101074872|FG000|STARTED|Overall Study||10||
48306167|NCT04663737|101074873|FG001|STARTED|Overall Study||10||
48306168|NCT04663737|101074872|FG000|COMPLETED|Overall Study||8||
48306169|NCT04663737|101074873|FG001|COMPLETED|Overall Study||10||
48306170|NCT04663737|101074872|FG000|NOT COMPLETED|Overall Study||2||
48306171|NCT04663737|101074873|FG001|NOT COMPLETED|Overall Study||0||
48306172|NCT04104321|101074874|FG000|STARTED|Overall Study||157|157 subjects were randomized to receive Aramchol in either ARMOR Placebo part and/or the ARCON comprise the ARCON-Intent-To-Treat (ARCONITT) cohort|
48306173|NCT04104321|101074874|FG000|Subjects Randomized to the OL Part, Received Aramchol and Had Baseline and Post-baseline Biopsy|Overall Study||51|51 subjects had Baseline and post-baseline liver biopsy|
48306174|NCT04104321|101074874|FG000|COMPLETED|Overall Study||154||
48306175|NCT04104321|101074874|FG000|NOT COMPLETED|Overall Study||3||
48306176|NCT01207596|101074875|FG000|STARTED|Overall Study||30||
48306177|NCT01207596|101074875|FG000|COMPLETED|Overall Study||21||
48306178|NCT01207596|101074875|FG000|NOT COMPLETED|Overall Study||9||
48306179|NCT00504153|101074876|FG000|STARTED|Overall Study||19||
48406136|NCT00728728|101328357|FG001|NOT COMPLETED|Overall Study||12||
48306180|NCT00504153|101074876|FG000|COMPLETED|Overall Study||13||
48306181|NCT00504153|101074876|FG000|NOT COMPLETED|Overall Study||6||
48306182|NCT01025492|101074877|FG000|STARTED|Overall Study||24||
48306183|NCT01025492|101074877|FG000|COMPLETED|Overall Study||24||
48306184|NCT01025492|101074877|FG000|NOT COMPLETED|Overall Study||0||
48306185|NCT02374398|101074878|FG000|STARTED|Overall Study||31||
48306186|NCT02374398|101074879|FG001|STARTED|Overall Study||32||
48306187|NCT02374398|101074880|FG002|STARTED|Overall Study||32||
48306188|NCT02374398|101074881|FG003|STARTED|Overall Study||32||
48306189|NCT02374398|101074878|FG000|COMPLETED|Overall Study||29||
48306190|NCT02374398|101074879|FG001|COMPLETED|Overall Study||31||
48306191|NCT02374398|101074880|FG002|COMPLETED|Overall Study||29||
48306192|NCT02374398|101074881|FG003|COMPLETED|Overall Study||32||
48306193|NCT02374398|101074878|FG000|NOT COMPLETED|Overall Study||2||
48306194|NCT02374398|101074879|FG001|NOT COMPLETED|Overall Study||1||
48306195|NCT02374398|101074880|FG002|NOT COMPLETED|Overall Study||3||
48306196|NCT02374398|101074881|FG003|NOT COMPLETED|Overall Study||0||
48607965|NCT01884545|101827070|FG003|NOT COMPLETED|Overall Study||9||
48607966|NCT01220726|101827071|FG000|STARTED|Overall Study||15||
48607967|NCT01220726|101827072|FG001|STARTED|Overall Study||15||
48607968|NCT01220726|101827071|FG000|COMPLETED|Overall Study||15||
48607969|NCT01220726|101827072|FG001|COMPLETED|Overall Study||13||
48607970|NCT01220726|101827071|FG000|NOT COMPLETED|Overall Study||0||
48607971|NCT01220726|101827072|FG001|NOT COMPLETED|Overall Study||2||
48607972|NCT01709409|101827073|FG000|STARTED|Overall Study||43||
48607973|NCT01709409|101827074|FG001|STARTED|Overall Study||45||
48607974|NCT01709409|101827073|FG000|COMPLETED|Overall Study||42||
48607975|NCT01709409|101827074|FG001|COMPLETED|Overall Study||45||
48607976|NCT01709409|101827073|FG000|NOT COMPLETED|Overall Study||1||
48607977|NCT01709409|101827074|FG001|NOT COMPLETED|Overall Study||0||
48607978|NCT01087203|101827075|FG000|STARTED|Overall Study||35||
48607979|NCT01087203|101827076|FG001|STARTED|Overall Study||38||
48607980|NCT01087203|101827075|FG000|COMPLETED|Overall Study||3||
48607981|NCT01087203|101827076|FG001|COMPLETED|Overall Study||3||
48607982|NCT01087203|101827075|FG000|NOT COMPLETED|Overall Study||32||
48607983|NCT01087203|101827076|FG001|NOT COMPLETED|Overall Study||35||
48607984|NCT01299896|101827077|FG000|STARTED|Overall Study||319||
48607985|NCT01299896|101827078|FG001|STARTED|Overall Study||314||
48607986|NCT01299896|101827077|FG000|COMPLETED|Overall Study||318||
48306197|NCT01748942|101074882|FG000|STARTED|Overall Study||39||
48306198|NCT01748942|101074883|FG001|STARTED|Overall Study||37||
48306199|NCT01748942|101074882|FG000|COMPLETED|Overall Study||35||
48306200|NCT01748942|101074883|FG001|COMPLETED|Overall Study||33||
48306201|NCT01748942|101074882|FG000|NOT COMPLETED|Overall Study||4||
48306202|NCT01748942|101074883|FG001|NOT COMPLETED|Overall Study||4||
48306203|NCT01294150|101074884|FG000|STARTED|Overall Study||140||
48306204|NCT01294150|101074885|FG001|STARTED|Overall Study||66||
48306205|NCT01294150|101074884|FG000|COMPLETED|Overall Study||138||
48306206|NCT01294150|101074885|FG001|COMPLETED|Overall Study||64||
48306207|NCT01294150|101074884|FG000|NOT COMPLETED|Overall Study||2||
48306208|NCT01294150|101074885|FG001|NOT COMPLETED|Overall Study||2||
48306209|NCT02868970|101074886|FG000|STARTED|Overall Study||0||23
48306210|NCT02868970|101074887|FG001|STARTED|Overall Study||0||25
48306211|NCT02868970|101074886|FG000|COMPLETED|Overall Study||0||23
48306212|NCT02868970|101074887|FG001|COMPLETED|Overall Study||0||21
48306213|NCT02868970|101074886|FG000|NOT COMPLETED|Overall Study||0||0
48306214|NCT02868970|101074887|FG001|NOT COMPLETED|Overall Study||0||4
48306215|NCT05085665|101074888|FG000|STARTED|Overall Study||41||
48306216|NCT05085665|101074888|FG000|COMPLETED|Overall Study||39||
48306217|NCT05085665|101074888|FG000|NOT COMPLETED|Overall Study||2||
48306218|NCT00450216|101074889|FG000|STARTED|Overall Study||607||
48306219|NCT00450216|101074890|FG001|STARTED|Overall Study||299||
48306220|NCT00450216|101074889|FG000|COMPLETED|Overall Study||433||
48306221|NCT00450216|101074890|FG001|COMPLETED|Overall Study||170||
48306222|NCT00450216|101074889|FG000|NOT COMPLETED|Overall Study||174||
48306223|NCT00450216|101074890|FG001|NOT COMPLETED|Overall Study||129||
48306224|NCT05228730|101074891|FG000|STARTED|Overall Study||4||
48306225|NCT05228730|101074892|FG001|STARTED|Overall Study||1||
48306226|NCT05228730|101074893|FG002|STARTED|Overall Study||4||
48306227|NCT05228730|101074894|FG003|STARTED|Overall Study||4||
48306228|NCT05228730|101074891|FG000|COMPLETED|Overall Study||4||
48306229|NCT05228730|101074892|FG001|COMPLETED|Overall Study||1||
48306230|NCT05228730|101074893|FG002|COMPLETED|Overall Study||4||
48306231|NCT05228730|101074894|FG003|COMPLETED|Overall Study||4||
48607987|NCT01299896|101827078|FG001|COMPLETED|Overall Study||296||
48607988|NCT01299896|101827077|FG000|NOT COMPLETED|Overall Study||1||
48607989|NCT01299896|101827078|FG001|NOT COMPLETED|Overall Study||18||
48607990|NCT03173456|101827079|FG000|STARTED|Baseline||120||
48607991|NCT03173456|101827080|FG001|STARTED|Baseline||120||
48306232|NCT05228730|101074891|FG000|NOT COMPLETED|Overall Study||0||
48306233|NCT05228730|101074892|FG001|NOT COMPLETED|Overall Study||0||
48306234|NCT05228730|101074893|FG002|NOT COMPLETED|Overall Study||0||
48306235|NCT05228730|101074894|FG003|NOT COMPLETED|Overall Study||0||
48306236|NCT05103228|101074895|FG000|STARTED|Overall Study||98||
48607992|NCT03173456|101827081|FG002|STARTED|Baseline||120||
48607993|NCT03173456|101827082|FG003|STARTED|Baseline||120||
48720438|NCT02191605|102102572|FG004|NOT COMPLETED|Overall Study||4||
48720439|NCT02642965|102102573|FG000|STARTED|Overall Study||38||
48720440|NCT02642965|102102573|FG000|COMPLETED|Overall Study||25||
48720441|NCT02642965|102102573|FG000|NOT COMPLETED|Overall Study||13||
48720442|NCT01325714|102102574|FG000|STARTED|Overall Study||101||
48720443|NCT01325714|102102575|FG001|STARTED|Overall Study||102||
48720444|NCT01325714|102102574|FG000|3 Month Assessment|Overall Study||82||
48720445|NCT01325714|102102575|FG001|3 Month Assessment|Overall Study||86||
48720446|NCT01325714|102102574|FG000|6 Month Asessment|Overall Study||75||
48720447|NCT01325714|102102575|FG001|6 Month Asessment|Overall Study||82||
48720448|NCT01325714|102102574|FG000|12 Month Assessment|Overall Study||67||
48720449|NCT01325714|102102575|FG001|12 Month Assessment|Overall Study||71||
48720450|NCT01325714|102102574|FG000|COMPLETED|Overall Study||67||
48720451|NCT01325714|102102575|FG001|COMPLETED|Overall Study||71||
48720452|NCT01325714|102102574|FG000|NOT COMPLETED|Overall Study||34||
48720453|NCT01325714|102102575|FG001|NOT COMPLETED|Overall Study||31||
48720454|NCT03869333|102102576|FG000|STARTED|Overall Study||14||
48720455|NCT03869333|102102577|FG001|STARTED|Overall Study||16||
48720456|NCT03869333|102102578|FG002|STARTED|Overall Study||16||
48720457|NCT03869333|102102579|FG003|STARTED|Overall Study||12||
48720458|NCT03869333|102102576|FG000|Received First Dose|Overall Study||14||
48720459|NCT03869333|102102577|FG001|Received First Dose|Overall Study||16||
48720460|NCT03869333|102102578|FG002|Received First Dose|Overall Study||16||
48720461|NCT03869333|102102579|FG003|Received First Dose|Overall Study||12||
48720462|NCT03869333|102102576|FG000|Received Second Dose|Overall Study||13||
48720463|NCT03869333|102102577|FG001|Received Second Dose|Overall Study||15||
48720464|NCT03869333|102102578|FG002|Received Second Dose|Overall Study||16||
48720465|NCT03869333|102102579|FG003|Received Second Dose|Overall Study||12||
48720466|NCT03869333|102102576|FG000|Received Third Dose|Overall Study||13||
48720467|NCT03869333|102102577|FG001|Received Third Dose|Overall Study||15||
48720468|NCT03869333|102102578|FG002|Received Third Dose|Overall Study||16||
48720469|NCT03869333|102102579|FG003|Received Third Dose|Overall Study||11||
48720470|NCT03869333|102102576|FG000|COMPLETED|Overall Study||12|Completed Day 71 visit|
48720471|NCT03869333|102102577|FG001|COMPLETED|Overall Study||15|Completed Day 71 visit|
48720472|NCT03869333|102102578|FG002|COMPLETED|Overall Study||16|Completed Day 71 visit|
48720473|NCT03869333|102102579|FG003|COMPLETED|Overall Study||12|Completed Day 71 visit|
48720474|NCT03869333|102102576|FG000|NOT COMPLETED|Overall Study||2||
48720475|NCT03869333|102102577|FG001|NOT COMPLETED|Overall Study||1||
48720476|NCT03869333|102102578|FG002|NOT COMPLETED|Overall Study||0||
48720477|NCT03869333|102102579|FG003|NOT COMPLETED|Overall Study||0||
48720478|NCT02428413|102102580|FG000|STARTED|Overall Study||64||
48720479|NCT02428413|102102581|FG001|STARTED|Overall Study||61||
48720480|NCT02428413|102102580|FG000|COMPLETED|Overall Study||56||
48720481|NCT02428413|102102581|FG001|COMPLETED|Overall Study||52||
48720482|NCT02428413|102102580|FG000|NOT COMPLETED|Overall Study||8||
48720483|NCT02428413|102102581|FG001|NOT COMPLETED|Overall Study||9||
48720484|NCT00921310|102102582|FG000|STARTED|Overall Study||2||
48720485|NCT00921310|102102583|FG001|STARTED|Overall Study||6||
48720486|NCT00921310|102102584|FG002|STARTED|Overall Study||4||
48720487|NCT00921310|102102582|FG000|COMPLETED|Overall Study||2||
48720488|NCT00921310|102102583|FG001|COMPLETED|Overall Study||6||
48720489|NCT00921310|102102584|FG002|COMPLETED|Overall Study||4||
48720490|NCT00921310|102102582|FG000|NOT COMPLETED|Overall Study||0||
48720491|NCT00921310|102102583|FG001|NOT COMPLETED|Overall Study||0||
48720492|NCT00921310|102102584|FG002|NOT COMPLETED|Overall Study||0||
48720493|NCT02282904|102102585|FG000|STARTED|Overall Study||7||
48720494|NCT02282904|102102585|FG000|COMPLETED|Overall Study||7||
48720495|NCT02282904|102102585|FG000|NOT COMPLETED|Overall Study||0||
48720496|NCT00624416|102102586|FG000|STARTED|Overall Study||10||
48720497|NCT00624416|102102586|FG000|COMPLETED|Overall Study||10||
48720498|NCT00624416|102102586|FG000|NOT COMPLETED|Overall Study||0||
48720499|NCT00343382|102102587|FG000|STARTED|Overall Study||64||
48720500|NCT00343382|102102588|FG001|STARTED|Overall Study||65||
48720501|NCT00343382|102102589|FG002|STARTED|Overall Study||66||
48720502|NCT00343382|102102587|FG000|COMPLETED|Overall Study||60||
48720503|NCT00343382|102102588|FG001|COMPLETED|Overall Study||51||
48720504|NCT00343382|102102589|FG002|COMPLETED|Overall Study||49||
48720505|NCT00343382|102102587|FG000|NOT COMPLETED|Overall Study||4||
48720506|NCT00343382|102102588|FG001|NOT COMPLETED|Overall Study||14||
48720507|NCT00343382|102102589|FG002|NOT COMPLETED|Overall Study||17||
48720508|NCT00267150|102102590|FG000|STARTED|Overall Study||31||
48720509|NCT00267150|102102590|FG000|COMPLETED|Overall Study||30||
48720510|NCT00267150|102102590|FG000|NOT COMPLETED|Overall Study||1||
48720511|NCT02855944|102102591|FG000|STARTED|Period 1: Treatment||233||
48720512|NCT02855944|102102592|FG001|STARTED|Period 1: Treatment||116||
48720513|NCT02855944|102102591|FG000|COMPLETED|Period 1: Treatment||218||
48720514|NCT02855944|102102592|FG001|COMPLETED|Period 1: Treatment||113||
48720515|NCT02855944|102102591|FG000|NOT COMPLETED|Period 1: Treatment||15||
48720516|NCT02855944|102102592|FG001|NOT COMPLETED|Period 1: Treatment||3||
48720517|NCT02855944|102102591|FG000|STARTED|Period 2: Crossover to Rucaparib||0||
48720518|NCT02855944|102102592|FG001|STARTED|Period 2: Crossover to Rucaparib||80||
48720519|NCT02855944|102102591|FG000|COMPLETED|Period 2: Crossover to Rucaparib||0||
48720520|NCT02855944|102102592|FG001|COMPLETED|Period 2: Crossover to Rucaparib||75||
48720521|NCT02855944|102102591|FG000|NOT COMPLETED|Period 2: Crossover to Rucaparib||0||
48720522|NCT02855944|102102592|FG001|NOT COMPLETED|Period 2: Crossover to Rucaparib||5||
48720523|NCT03973905|102102593|FG000|STARTED|Overall Study||107||
48720524|NCT03973905|102102594|FG001|STARTED|Overall Study||183||
48720525|NCT03973905|102102593|FG000|COMPLETED|Overall Study||107||
48720526|NCT03973905|102102594|FG001|COMPLETED|Overall Study||183||
48720527|NCT03973905|102102593|FG000|NOT COMPLETED|Overall Study||0||
48720528|NCT03973905|102102594|FG001|NOT COMPLETED|Overall Study||0||
48720529|NCT00664326|102102595|FG000|STARTED|Overall Study||49||
48720530|NCT00664326|102102595|FG000|COMPLETED|Overall Study||1||
48720531|NCT00664326|102102595|FG000|NOT COMPLETED|Overall Study||48||
48720532|NCT00780273|102102596|FG000|STARTED|Overall Study||19||
48720533|NCT00780273|102102596|FG000|COMPLETED|Overall Study||17||
48720534|NCT00780273|102102596|FG000|NOT COMPLETED|Overall Study||2||
48720535|NCT02621073|102102597|FG000|STARTED|Overall Study||4||
48720536|NCT02621073|102102598|FG001|STARTED|Overall Study||3||
48720537|NCT02621073|102102597|FG000|COMPLETED|Overall Study||1||
48720538|NCT02621073|102102598|FG001|COMPLETED|Overall Study||0||
48720539|NCT02621073|102102597|FG000|NOT COMPLETED|Overall Study||3||
48720540|NCT02621073|102102598|FG001|NOT COMPLETED|Overall Study||3||
48720541|NCT03689712|102102599|FG000|STARTED|Overall Study||270||
48720542|NCT03689712|102102600|FG001|STARTED|Overall Study||185||
48720543|NCT03689712|102102599|FG000|Intent to Treat Population|Overall Study||241|Intent-to-Treat (ITT) population includes all randomized subjects who received at least one dose of GC4419/Placebo, with the exception of the 28 subjects whose treatment course was discontinued during the Sponsor's voluntary suspension of dosing.|
48720544|NCT03689712|102102600|FG001|Intent to Treat Population|Overall Study||166|Intent-to-Treat (ITT) population includes all randomized subjects who received at least one dose of GC4419/Placebo, with the exception of the 28 subjects whose treatment course was discontinued during the Sponsor's voluntary suspension of dosing.|
48720545|NCT03689712|102102599|FG000|COMPLETED|Overall Study||105||
48720546|NCT03689712|102102600|FG001|COMPLETED|Overall Study||74||
48720547|NCT03689712|102102599|FG000|NOT COMPLETED|Overall Study||165||
48720548|NCT03689712|102102600|FG001|NOT COMPLETED|Overall Study||111||
48720549|NCT01732913|102102601|FG000|STARTED|Overall Study||198||
48720550|NCT01732913|102102602|FG001|STARTED|Overall Study||97||
48720551|NCT01732913|102102601|FG000|COMPLETED|Overall Study||42|Completed = reached primary efficacy endpoint of progressive disease or death|
48306237|NCT05103228|101074896|FG001|STARTED|Overall Study||92||
48306238|NCT05103228|101074895|FG000|COMPLETED|Overall Study||94||
48306239|NCT05103228|101074896|FG001|COMPLETED|Overall Study||91||
48306240|NCT05103228|101074895|FG000|NOT COMPLETED|Overall Study||4||
48720552|NCT01732913|102102602|FG001|COMPLETED|Overall Study||28|Completed = reached primary efficacy endpoint of progressive disease or death|
48720553|NCT01732913|102102601|FG000|NOT COMPLETED|Overall Study||156||
48720554|NCT01732913|102102602|FG001|NOT COMPLETED|Overall Study||69||
48720555|NCT02704689|102102603|FG000|STARTED|Overall Study||9||
48720556|NCT02704689|102102603|FG000|COMPLETED|Overall Study||6||
48720557|NCT02704689|102102603|FG000|NOT COMPLETED|Overall Study||3||
48720558|NCT02107157|102102604|FG000|STARTED|Overall Study||11||
48720559|NCT02107157|102102605|FG001|STARTED|Overall Study||12||
48720560|NCT02107157|102102606|FG002|STARTED|Overall Study||4||
48720561|NCT02107157|102102604|FG000|COMPLETED|Overall Study||6||
48720562|NCT02107157|102102605|FG001|COMPLETED|Overall Study||11||
48720563|NCT02107157|102102606|FG002|COMPLETED|Overall Study||4||
48720564|NCT02107157|102102604|FG000|NOT COMPLETED|Overall Study||5||
48720565|NCT02107157|102102605|FG001|NOT COMPLETED|Overall Study||1||
48720566|NCT02107157|102102606|FG002|NOT COMPLETED|Overall Study||0||
48720567|NCT00509171|102102607|FG000|STARTED|Overall Study||11||
48720568|NCT00509171|102102608|FG001|STARTED|Overall Study||11||
48720569|NCT00509171|102102607|FG000|COMPLETED|Overall Study||11||
48720570|NCT00509171|102102608|FG001|COMPLETED|Overall Study||11||
48720571|NCT00509171|102102607|FG000|NOT COMPLETED|Overall Study||0||
48720572|NCT00509171|102102608|FG001|NOT COMPLETED|Overall Study||0||
48720573|NCT03022981|102102609|FG000|STARTED|Overall Study||102||
48720574|NCT03022981|102102610|FG001|STARTED|Overall Study||73||
48720575|NCT03022981|102102611|FG002|STARTED|Overall Study||41||
48720576|NCT03022981|102102609|FG000|Participated in PK Lead-in (PKL) Phase|Overall Study||17||
48720577|NCT03022981|102102610|FG001|Participated in PK Lead-in (PKL) Phase|Overall Study||20||
48720578|NCT03022981|102102611|FG002|Participated in PK Lead-in (PKL) Phase|Overall Study||19||
48720579|NCT03022981|102102609|FG000|COMPLETED|Overall Study||96||
48720580|NCT03022981|102102610|FG001|COMPLETED|Overall Study||69||
48720581|NCT03022981|102102611|FG002|COMPLETED|Overall Study||35||
48720582|NCT03022981|102102609|FG000|NOT COMPLETED|Overall Study||6||
48720583|NCT03022981|102102610|FG001|NOT COMPLETED|Overall Study||4||
48720584|NCT03022981|102102611|FG002|NOT COMPLETED|Overall Study||6||
48720585|NCT02717130|102102612|FG000|STARTED|Overall Study||8||
48720586|NCT02717130|102102612|FG000|COMPLETED|Overall Study||1||
48306241|NCT05103228|101074896|FG001|NOT COMPLETED|Overall Study||1||
48720587|NCT02717130|102102612|FG000|NOT COMPLETED|Overall Study||7||
48720588|NCT02435706|102102613|FG000|STARTED|Overall Study||18||
48306242|NCT04047797|101074897|FG000|STARTED|Overall Study||3||
48306243|NCT04047797|101074897|FG000|COMPLETED|Overall Study||2||
48720589|NCT02435706|102102614|FG001|STARTED|Overall Study||21||
48720590|NCT02435706|102102613|FG000|COMPLETED|Overall Study||16||
48720591|NCT02435706|102102614|FG001|COMPLETED|Overall Study||20||
48720592|NCT02435706|102102613|FG000|NOT COMPLETED|Overall Study||2||
48720593|NCT02435706|102102614|FG001|NOT COMPLETED|Overall Study||1||
48720594|NCT00566254|102102615|FG000|STARTED|Overall Study||100||
48720595|NCT00566254|102102616|FG001|STARTED|Overall Study||107||
48720596|NCT00566254|102102615|FG000|COMPLETED|Overall Study||90||
48720597|NCT00566254|102102616|FG001|COMPLETED|Overall Study||93||
48720598|NCT00566254|102102615|FG000|NOT COMPLETED|Overall Study||10||
48720599|NCT00566254|102102616|FG001|NOT COMPLETED|Overall Study||14||
48720600|NCT00587847|102102617|FG000|STARTED|Overall Study||12||
48720601|NCT00587847|102102617|FG000|COMPLETED|Overall Study||5||
48720602|NCT00587847|102102617|FG000|NOT COMPLETED|Overall Study||7||
48720603|NCT01896271|102102618|FG000|STARTED|Overall Study||30||
48720604|NCT01896271|102102618|FG000|COMPLETED|Overall Study||20||
48720605|NCT01896271|102102618|FG000|NOT COMPLETED|Overall Study||10||
48720606|NCT01264419|102102619|FG000|STARTED|Overall Study||75||
48720607|NCT01264419|102102619|FG000|COMPLETED|Overall Study||72||
48720608|NCT01264419|102102619|FG000|NOT COMPLETED|Overall Study||3||
48720609|NCT00491608|102102620|FG000|STARTED|Overall Study||209||
48720610|NCT00491608|102102620|FG000|COMPLETED|Overall Study||206||
48720611|NCT00491608|102102620|FG000|NOT COMPLETED|Overall Study||3||
48720612|NCT00491374|102102621|FG000|STARTED|Overall Study||0||
48720613|NCT00491374|102102622|FG001|STARTED|Overall Study||0||
48720614|NCT00491374|102102621|FG000|COMPLETED|Overall Study||0||
48720615|NCT00491374|102102622|FG001|COMPLETED|Overall Study||0||
48720616|NCT00491374|102102621|FG000|NOT COMPLETED|Overall Study||0||
48720617|NCT00491374|102102622|FG001|NOT COMPLETED|Overall Study||0||
48720618|NCT02102399|102102623|FG000|STARTED|Overall Study||20||
48720619|NCT02102399|102102624|FG001|STARTED|Overall Study||21||
48720620|NCT02102399|102102623|FG000|COMPLETED|Overall Study||14||
48720621|NCT02102399|102102624|FG001|COMPLETED|Overall Study||17||
48720622|NCT02102399|102102623|FG000|NOT COMPLETED|Overall Study||6||
48720623|NCT02102399|102102624|FG001|NOT COMPLETED|Overall Study||4||
48720624|NCT02713867|102102625|FG000|STARTED|Randomization||180|= Participants Randomized|
48720625|NCT02713867|102102626|FG001|STARTED|Randomization||183|= Participants Randomized|
48720626|NCT02713867|102102625|FG000|COMPLETED|Randomization||178|= Participants Treated|
48720627|NCT02713867|102102626|FG001|COMPLETED|Randomization||180|= Participants Treated|
48720628|NCT02713867|102102625|FG000|NOT COMPLETED|Randomization||2||
48720629|NCT02713867|102102626|FG001|NOT COMPLETED|Randomization||3||
48720630|NCT02713867|102102625|FG000|STARTED|Treatment Period||178|= Started Treatment|
48720631|NCT02713867|102102626|FG001|STARTED|Treatment Period||180|= Started Treatment|
48720632|NCT02713867|102102625|FG000|COMPLETED|Treatment Period||0|= Continuing Treatment Period|
48720633|NCT02713867|102102626|FG001|COMPLETED|Treatment Period||0|= Continuing Treatment Period|
48720634|NCT02713867|102102625|FG000|NOT COMPLETED|Treatment Period||178||
48720635|NCT02713867|102102626|FG001|NOT COMPLETED|Treatment Period||180||
48720636|NCT03688555|102102627|FG000|STARTED|Run-in Period||10||
48720637|NCT03688555|102102628|FG001|STARTED|Run-in Period||0||
48720638|NCT03688555|102102629|FG002|STARTED|Run-in Period||0||
48720639|NCT03688555|102102627|FG000|COMPLETED|Run-in Period||10||
48720640|NCT03688555|102102628|FG001|COMPLETED|Run-in Period||0||
48720641|NCT03688555|102102629|FG002|COMPLETED|Run-in Period||0||
48720642|NCT03688555|102102627|FG000|NOT COMPLETED|Run-in Period||0||
48720643|NCT03688555|102102628|FG001|NOT COMPLETED|Run-in Period||0||
48720644|NCT03688555|102102629|FG002|NOT COMPLETED|Run-in Period||0||
48720645|NCT03688555|102102627|FG000|STARTED|Treatment Period||0||
48720646|NCT03688555|102102628|FG001|STARTED|Treatment Period||7||
48720647|NCT03688555|102102629|FG002|STARTED|Treatment Period||3||
48720648|NCT03688555|102102627|FG000|COMPLETED|Treatment Period||0||
48720649|NCT03688555|102102628|FG001|COMPLETED|Treatment Period||7||
48720650|NCT03688555|102102629|FG002|COMPLETED|Treatment Period||2||
48720651|NCT03688555|102102627|FG000|NOT COMPLETED|Treatment Period||0||
48720652|NCT03688555|102102628|FG001|NOT COMPLETED|Treatment Period||0||
48720653|NCT03688555|102102629|FG002|NOT COMPLETED|Treatment Period||1||
48720654|NCT00121641|102102630|FG000|STARTED|24-week Short-term Treatment Period||102||
48720655|NCT00121641|102102631|FG001|STARTED|24-week Short-term Treatment Period||106||
48720656|NCT00121641|102102632|FG002|STARTED|24-week Short-term Treatment Period||98||
48720657|NCT00121641|102102633|FG003|STARTED|24-week Short-term Treatment Period||95||
48720658|NCT00121641|102102634|FG004|STARTED|24-week Short-term Treatment Period||66||
48720659|NCT00121641|102102630|FG000|COMPLETED|24-week Short-term Treatment Period||73||
48720660|NCT00121641|102102631|FG001|COMPLETED|24-week Short-term Treatment Period||68||
48720661|NCT00121641|102102632|FG002|COMPLETED|24-week Short-term Treatment Period||69||
48720662|NCT00121641|102102633|FG003|COMPLETED|24-week Short-term Treatment Period||55||
48720663|NCT00121641|102102634|FG004|COMPLETED|24-week Short-term Treatment Period||25||
48720664|NCT00121641|102102630|FG000|NOT COMPLETED|24-week Short-term Treatment Period||29||
48720665|NCT00121641|102102631|FG001|NOT COMPLETED|24-week Short-term Treatment Period||38||
48720666|NCT00121641|102102632|FG002|NOT COMPLETED|24-week Short-term Treatment Period||29||
48720667|NCT00121641|102102633|FG003|NOT COMPLETED|24-week Short-term Treatment Period||40||
48720668|NCT00121641|102102634|FG004|NOT COMPLETED|24-week Short-term Treatment Period||41||
48720669|NCT00121641|102102630|FG000|STARTED|48-month Short Term + Long Term Period||102||
48720670|NCT00121641|102102631|FG001|STARTED|48-month Short Term + Long Term Period||106||
48720671|NCT00121641|102102632|FG002|STARTED|48-month Short Term + Long Term Period||98||
48720672|NCT00121641|102102633|FG003|STARTED|48-month Short Term + Long Term Period||95||
48720673|NCT00121641|102102634|FG004|STARTED|48-month Short Term + Long Term Period||66||
48720674|NCT00121641|102102630|FG000|COMPLETED|48-month Short Term + Long Term Period||23||
48720675|NCT00121641|102102631|FG001|COMPLETED|48-month Short Term + Long Term Period||24||
48720676|NCT00121641|102102632|FG002|COMPLETED|48-month Short Term + Long Term Period||28||
48720677|NCT00121641|102102633|FG003|COMPLETED|48-month Short Term + Long Term Period||24||
48720678|NCT00121641|102102634|FG004|COMPLETED|48-month Short Term + Long Term Period||8||
48720679|NCT00121641|102102630|FG000|NOT COMPLETED|48-month Short Term + Long Term Period||79||
48720680|NCT00121641|102102631|FG001|NOT COMPLETED|48-month Short Term + Long Term Period||82||
48306244|NCT04047797|101074897|FG000|NOT COMPLETED|Overall Study||1||
48306245|NCT00450658|101074898|FG000|STARTED|Overall Study||415||
48306246|NCT00450658|101074899|FG001|STARTED|Overall Study||212||
48306247|NCT00450658|101074898|FG000|COMPLETED|Overall Study||272||
48306248|NCT00450658|101074899|FG001|COMPLETED|Overall Study||122||
48306249|NCT00450658|101074898|FG000|NOT COMPLETED|Overall Study||143||
48306250|NCT00450658|101074899|FG001|NOT COMPLETED|Overall Study||90||
48720681|NCT00121641|102102632|FG002|NOT COMPLETED|48-month Short Term + Long Term Period||70||
48720682|NCT00121641|102102633|FG003|NOT COMPLETED|48-month Short Term + Long Term Period||71||
48720683|NCT00121641|102102634|FG004|NOT COMPLETED|48-month Short Term + Long Term Period||58||
48720684|NCT03779503|102102635|FG000|STARTED|First Intervention||28||
48720685|NCT03779503|102102636|FG001|STARTED|First Intervention||27||
48720686|NCT03779503|102102635|FG000|COMPLETED|First Intervention||27||
48720687|NCT03779503|102102636|FG001|COMPLETED|First Intervention||26||
48720688|NCT03779503|102102635|FG000|NOT COMPLETED|First Intervention||1||
48720689|NCT03779503|102102636|FG001|NOT COMPLETED|First Intervention||1||
48720690|NCT03779503|102102635|FG000|STARTED|Second Intervention||27||
48720691|NCT03779503|102102636|FG001|STARTED|Second Intervention||26||
48720692|NCT03779503|102102635|FG000|COMPLETED|Second Intervention||27||
48720693|NCT03779503|102102636|FG001|COMPLETED|Second Intervention||26||
48720694|NCT03779503|102102635|FG000|NOT COMPLETED|Second Intervention||0||
48720695|NCT03779503|102102636|FG001|NOT COMPLETED|Second Intervention||0||
48720696|NCT02262754|102102637|FG000|STARTED|Overall Study||74||
48306251|NCT03914742|101074900|FG000|STARTED|Overall Study||7||
48306252|NCT03914742|101074901|FG001|STARTED|Overall Study||15||
48306253|NCT03914742|101074902|FG002|STARTED|Overall Study||24||
48306254|NCT03914742|101074903|FG003|STARTED|Overall Study||10||
48306255|NCT03914742|101074904|FG004|STARTED|Overall Study||10||
48306256|NCT03914742|101074900|FG000|COMPLETED|Overall Study||7||
48306257|NCT03914742|101074901|FG001|COMPLETED|Overall Study||15||
48306258|NCT03914742|101074902|FG002|COMPLETED|Overall Study||24||
48306259|NCT03914742|101074903|FG003|COMPLETED|Overall Study||10||
48306260|NCT03914742|101074904|FG004|COMPLETED|Overall Study||10||
48306261|NCT03914742|101074900|FG000|NOT COMPLETED|Overall Study||0||
48306262|NCT03914742|101074901|FG001|NOT COMPLETED|Overall Study||0||
48306263|NCT03914742|101074902|FG002|NOT COMPLETED|Overall Study||0||
48720697|NCT02262754|102102638|FG001|STARTED|Overall Study||74||
48720698|NCT02262754|102102639|FG002|STARTED|Overall Study||74||
48720699|NCT02262754|102102637|FG000|COMPLETED|Overall Study||58||
48720700|NCT02262754|102102638|FG001|COMPLETED|Overall Study||65||
48720701|NCT02262754|102102639|FG002|COMPLETED|Overall Study||65||
48720702|NCT02262754|102102637|FG000|NOT COMPLETED|Overall Study||16||
48720703|NCT02262754|102102638|FG001|NOT COMPLETED|Overall Study||9||
48720704|NCT02262754|102102639|FG002|NOT COMPLETED|Overall Study||9||
48306264|NCT03914742|101074903|FG003|NOT COMPLETED|Overall Study||0||
48306265|NCT03914742|101074904|FG004|NOT COMPLETED|Overall Study||0||
48306266|NCT05315947|101074905|FG000|STARTED|Overall Study||12||
48306267|NCT05315947|101074906|FG001|STARTED|Overall Study||12||
48306268|NCT05315947|101074905|FG000|COMPLETED|Overall Study||12||
48151235|NCT03880838|100692410|FG004|COMPLETED|Overall Study||550||
48151236|NCT03880838|100692411|FG005|COMPLETED|Overall Study||550||
48151237|NCT03880838|100692412|FG006|COMPLETED|Overall Study||550||
48151238|NCT03880838|100692413|FG007|COMPLETED|Overall Study||550||
48151239|NCT03880838|100692414|FG008|COMPLETED|Overall Study||550||
48151240|NCT03880838|100692415|FG009|COMPLETED|Overall Study||550||
48151241|NCT03880838|100692416|FG010|COMPLETED|Overall Study||550||
48151242|NCT03880838|100692417|FG011|COMPLETED|Overall Study||550||
48151243|NCT03880838|100692418|FG012|COMPLETED|Overall Study||550||
48151244|NCT03880838|100692419|FG013|COMPLETED|Overall Study||550||
48151245|NCT03880838|100692406|FG000|NOT COMPLETED|Overall Study||0||
48151246|NCT03880838|100692407|FG001|NOT COMPLETED|Overall Study||0||
48306269|NCT05315947|101074906|FG001|COMPLETED|Overall Study||12||
48306270|NCT05315947|101074905|FG000|NOT COMPLETED|Overall Study||0||
48306271|NCT05315947|101074906|FG001|NOT COMPLETED|Overall Study||0||
48306272|NCT05908344|101074907|FG000|STARTED|Overall Study||5||
48306273|NCT05908344|101074908|FG001|STARTED|Overall Study||5||
48306274|NCT05908344|101074907|FG000|Started Phase 1|Overall Study||5||
48306275|NCT05908344|101074908|FG001|Started Phase 1|Overall Study||5||
48151247|NCT03880838|100692408|FG002|NOT COMPLETED|Overall Study||0||
48151248|NCT03880838|100692409|FG003|NOT COMPLETED|Overall Study||0||
48151249|NCT03880838|100692410|FG004|NOT COMPLETED|Overall Study||0||
48151250|NCT03880838|100692411|FG005|NOT COMPLETED|Overall Study||0||
48151251|NCT03880838|100692412|FG006|NOT COMPLETED|Overall Study||0||
48151252|NCT03880838|100692413|FG007|NOT COMPLETED|Overall Study||0||
48151253|NCT03880838|100692414|FG008|NOT COMPLETED|Overall Study||0||
48151254|NCT03880838|100692415|FG009|NOT COMPLETED|Overall Study||0||
48151255|NCT03880838|100692416|FG010|NOT COMPLETED|Overall Study||0||
48151256|NCT03880838|100692417|FG011|NOT COMPLETED|Overall Study||0||
48151257|NCT03880838|100692418|FG012|NOT COMPLETED|Overall Study||0||
48151258|NCT03880838|100692419|FG013|NOT COMPLETED|Overall Study||0||
48151259|NCT00587964|100692420|FG000|STARTED|Overall Study||51||
48151260|NCT00587964|100692420|FG000|COMPLETED|Overall Study||39||
48151261|NCT00587964|100692420|FG000|NOT COMPLETED|Overall Study||12||
48306276|NCT05908344|101074907|FG000|Started Phase 2|Overall Study||5||
48306277|NCT05908344|101074908|FG001|Started Phase 2|Overall Study||5||
48306278|NCT05908344|101074907|FG000|COMPLETED|Overall Study||5||
48306279|NCT05908344|101074908|FG001|COMPLETED|Overall Study||5||
48306280|NCT05908344|101074907|FG000|NOT COMPLETED|Overall Study||0||
48306281|NCT05908344|101074908|FG001|NOT COMPLETED|Overall Study||0||
48720705|NCT02322190|102102640|FG000|STARTED|Overall Study||5||
48720706|NCT02322190|102102641|FG001|STARTED|Overall Study||0||
48720707|NCT02322190|102102640|FG000|COMPLETED|Overall Study||4||
48720708|NCT02322190|102102641|FG001|COMPLETED|Overall Study||0||
48720709|NCT02322190|102102640|FG000|NOT COMPLETED|Overall Study||1||
48720710|NCT02322190|102102641|FG001|NOT COMPLETED|Overall Study||0||
48720711|NCT00167661|102102642|FG000|STARTED|Overall Study||33||
48720712|NCT00167661|102102642|FG000|COMPLETED|Overall Study||33||
48720713|NCT00167661|102102642|FG000|NOT COMPLETED|Overall Study||0||
48720714|NCT01554514|102102643|FG000|STARTED|Overall Study||19||
48720715|NCT01554514|102102643|FG000|COMPLETED|Overall Study||17||
48720716|NCT01554514|102102643|FG000|NOT COMPLETED|Overall Study||2||
48720717|NCT00065806|102102644|FG000|STARTED|Overall Study||113||
48720718|NCT00065806|102102645|FG001|STARTED|Overall Study||108||
48720719|NCT00065806|102102644|FG000|COMPLETED|Overall Study||93||
48720720|NCT00065806|102102645|FG001|COMPLETED|Overall Study||89||
48720721|NCT00065806|102102644|FG000|NOT COMPLETED|Overall Study||20||
48151262|NCT04385368|100692421|FG000|STARTED|Overall Study||45||
48151263|NCT04385368|100692422|FG001|STARTED|Overall Study||44||
48151264|NCT04385368|100692421|FG000|COMPLETED|Overall Study||33||
48151265|NCT04385368|100692422|FG001|COMPLETED|Overall Study||36||
48151266|NCT04385368|100692421|FG000|NOT COMPLETED|Overall Study||12||
48151267|NCT04385368|100692422|FG001|NOT COMPLETED|Overall Study||8||
48151268|NCT02182973|100692423|FG000|STARTED|Overall Study||12||
48151269|NCT02182973|100692424|FG001|STARTED|Overall Study||9||
48151270|NCT02182973|100692423|FG000|COMPLETED|Overall Study||9||
48151271|NCT02182973|100692424|FG001|COMPLETED|Overall Study||9||
48151272|NCT02182973|100692423|FG000|NOT COMPLETED|Overall Study||3||
48151273|NCT02182973|100692424|FG001|NOT COMPLETED|Overall Study||0||
48720722|NCT00065806|102102645|FG001|NOT COMPLETED|Overall Study||19||
48720723|NCT04872998|102102646|FG000|STARTED|Overall Study||14||
48720724|NCT04872998|102102646|FG000|COMPLETED|Overall Study||14||
48151274|NCT03238300|100692425|FG000|STARTED|Baseline (Before Intervention)||18||
48151275|NCT03238300|100692426|FG001|STARTED|Baseline (Before Intervention)||17||
48306282|NCT04640298|101074909|FG000|STARTED|Overall Study||25||
48720725|NCT04872998|102102646|FG000|NOT COMPLETED|Overall Study||0||
48720726|NCT02718040|102102647|FG000|STARTED|Overall Study||30||
48720727|NCT02718040|102102647|FG000|COMPLETED|Overall Study||30||
48306283|NCT04640298|101074909|FG000|COMPLETED|Overall Study||25||
48306284|NCT04640298|101074909|FG000|NOT COMPLETED|Overall Study||0||
48306285|NCT05495971|101074910|FG000|STARTED|Overall Study||24||
48306286|NCT05495971|101074910|FG000|COMPLETED|Overall Study||24||
48306287|NCT05495971|101074910|FG000|NOT COMPLETED|Overall Study||0||
48720728|NCT02718040|102102647|FG000|NOT COMPLETED|Overall Study||0||
48720729|NCT02198794|102102648|FG000|STARTED|Part A: Open-Label (158 Weeks)||337||
48720730|NCT02198794|102102649|FG001|STARTED|Part A: Open-Label (158 Weeks)||0||
48720731|NCT02198794|102102650|FG002|STARTED|Part A: Open-Label (158 Weeks)||0||
48720732|NCT02198794|102102651|FG003|STARTED|Part A: Open-Label (158 Weeks)||0||
48720733|NCT02198794|102102648|FG000|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||337||
48720734|NCT02198794|102102649|FG001|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||0||
48720735|NCT02198794|102102650|FG002|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||0||
48720736|NCT02198794|102102651|FG003|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||0||
48720737|NCT02198794|102102648|FG000|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||337|All participants who enrolled in the study, regardless of whether or not received study drug.|
48720738|NCT02198794|102102649|FG001|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||0|All participants who enrolled in the study, regardless of whether or not received study drug.|
48720739|NCT02198794|102102650|FG002|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||0|All participants who enrolled in the study, regardless of whether or not received study drug.|
48720740|NCT02198794|102102651|FG003|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||0|All participants who enrolled in the study, regardless of whether or not received study drug.|
48720741|NCT02198794|102102648|FG000|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||195||
48720742|NCT02198794|102102649|FG001|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||0||
48720743|NCT02198794|102102650|FG002|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||0||
48720744|NCT02198794|102102651|FG003|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||0||
48720745|NCT02198794|102102648|FG000|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||142||
48720746|NCT02198794|102102649|FG001|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||0||
48720747|NCT02198794|102102650|FG002|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||0||
48720748|NCT02198794|102102651|FG003|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||0||
48720749|NCT02198794|102102648|FG000|COMPLETED|Part A: Open-Label (158 Weeks)||32|"Participants who are noted as Completed for Part A: completed the study in Part A (Week 158) plus continued in Part B."|
48720750|NCT02198794|102102649|FG001|COMPLETED|Part A: Open-Label (158 Weeks)||0|"Participants who are noted as Completed for Part A: completed the study in Part A (Week 158) plus continued in Part B."|
48720751|NCT02198794|102102650|FG002|COMPLETED|Part A: Open-Label (158 Weeks)||0|"Participants who are noted as Completed for Part A: completed the study in Part A (Week 158) plus continued in Part B."|
48720752|NCT02198794|102102651|FG003|COMPLETED|Part A: Open-Label (158 Weeks)||0|"Participants who are noted as Completed for Part A: completed the study in Part A (Week 158) plus continued in Part B."|
48720753|NCT02198794|102102648|FG000|NOT COMPLETED|Part A: Open-Label (158 Weeks)||305||
48720754|NCT02198794|102102649|FG001|NOT COMPLETED|Part A: Open-Label (158 Weeks)||0||
48720755|NCT02198794|102102650|FG002|NOT COMPLETED|Part A: Open-Label (158 Weeks)||0||
48720756|NCT02198794|102102651|FG003|NOT COMPLETED|Part A: Open-Label (158 Weeks)||0||
48720757|NCT02198794|102102648|FG000|STARTED|Part B: Randomized (13 Weeks)||0|Randomized withdrawal ITT population|
48720758|NCT02198794|102102649|FG001|STARTED|Part B: Randomized (13 Weeks)||71|Randomized withdrawal ITT population|
48720759|NCT02198794|102102650|FG002|STARTED|Part B: Randomized (13 Weeks)||71|Randomized withdrawal ITT population|
48767594|NCT00914316|102222778|FG002|STARTED|Phase 1||8||
48306288|NCT00233363|101074911|FG000|STARTED|Overall Study||53||
48306289|NCT00233363|101074912|FG001|STARTED|Overall Study||51||
48306290|NCT00233363|101074911|FG000|COMPLETED|Overall Study||50||
48306291|NCT00233363|101074912|FG001|COMPLETED|Overall Study||46||
48306292|NCT00233363|101074911|FG000|NOT COMPLETED|Overall Study||3||
48306293|NCT00233363|101074912|FG001|NOT COMPLETED|Overall Study||5||
48306294|NCT05090995|101074913|FG000|STARTED|Overall Study||30||
48306295|NCT05090995|101074914|FG001|STARTED|Overall Study||30||
48306296|NCT05090995|101074913|FG000|Completed Week 6|Overall Study||30||
48306297|NCT05090995|101074914|FG001|Completed Week 6|Overall Study||30||
48306298|NCT05090995|101074913|FG000|Completed Week 10|Overall Study||30||
48306299|NCT05090995|101074914|FG001|Completed Week 10|Overall Study||29||
48306300|NCT05090995|101074913|FG000|COMPLETED|Overall Study||30||
48306301|NCT05090995|101074914|FG001|COMPLETED|Overall Study||29||
48306302|NCT05090995|101074913|FG000|NOT COMPLETED|Overall Study||0||
48306303|NCT05090995|101074914|FG001|NOT COMPLETED|Overall Study||1||
48306304|NCT02909985|101074915|FG000|STARTED|Overall Study||21||
48306305|NCT02909985|101074915|FG000|COMPLETED|Overall Study||21||
48306306|NCT02909985|101074915|FG000|NOT COMPLETED|Overall Study||0||
48306307|NCT05406752|101074916|FG000|STARTED|Overall Study||32||
48306308|NCT05406752|101074916|FG000|COMPLETED|Overall Study||32||
48306309|NCT05406752|101074916|FG000|NOT COMPLETED|Overall Study||0||
48720760|NCT02198794|102102651|FG003|STARTED|Part B: Randomized (13 Weeks)||0|Randomized withdrawal ITT population|
48720761|NCT02198794|102102648|FG000|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||0||
48720762|NCT02198794|102102649|FG001|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||63||
48720763|NCT02198794|102102650|FG002|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||65||
48720764|NCT02198794|102102651|FG003|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||0||
48720765|NCT02198794|102102648|FG000|COMPLETED|Part B: Randomized (13 Weeks)||0||
48720766|NCT02198794|102102649|FG001|COMPLETED|Part B: Randomized (13 Weeks)||66||
48720767|NCT02198794|102102650|FG002|COMPLETED|Part B: Randomized (13 Weeks)||68||
48720768|NCT02198794|102102651|FG003|COMPLETED|Part B: Randomized (13 Weeks)||0||
48720769|NCT02198794|102102648|FG000|NOT COMPLETED|Part B: Randomized (13 Weeks)||0||
48720770|NCT02198794|102102649|FG001|NOT COMPLETED|Part B: Randomized (13 Weeks)||5||
48720771|NCT02198794|102102650|FG002|NOT COMPLETED|Part B: Randomized (13 Weeks)||3||
48720772|NCT02198794|102102651|FG003|NOT COMPLETED|Part B: Randomized (13 Weeks)||0||
48720773|NCT02198794|102102648|FG000|STARTED|Part C: Safety Assessment (52 Weeks)||0||
48720774|NCT02198794|102102649|FG001|STARTED|Part C: Safety Assessment (52 Weeks)||0||
48720775|NCT02198794|102102650|FG002|STARTED|Part C: Safety Assessment (52 Weeks)||0||
48720776|NCT02198794|102102651|FG003|STARTED|Part C: Safety Assessment (52 Weeks)||80||
48720777|NCT02198794|102102648|FG000|COMPLETED|Part C: Safety Assessment (52 Weeks)||0||
48720778|NCT02198794|102102649|FG001|COMPLETED|Part C: Safety Assessment (52 Weeks)||0||
48720779|NCT02198794|102102650|FG002|COMPLETED|Part C: Safety Assessment (52 Weeks)||0||
48720780|NCT02198794|102102651|FG003|COMPLETED|Part C: Safety Assessment (52 Weeks)||73||
48306310|NCT03531788|101074917|FG000|STARTED|Overall Study||12||
48306311|NCT03531788|101074918|FG001|STARTED|Overall Study||6||
48720781|NCT02198794|102102648|FG000|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||0||
48720782|NCT02198794|102102649|FG001|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||0||
48720783|NCT02198794|102102650|FG002|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||0||
48306312|NCT03531788|101074917|FG000|COMPLETED|Overall Study||11||
48306313|NCT03531788|101074918|FG001|COMPLETED|Overall Study||6||
48306314|NCT03531788|101074917|FG000|NOT COMPLETED|Overall Study||1||
48306315|NCT03531788|101074918|FG001|NOT COMPLETED|Overall Study||0||
48720784|NCT02198794|102102651|FG003|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||7||
48720785|NCT01722292|102102652|FG000|STARTED|Overall Study||6||
48720786|NCT01722292|102102653|FG001|STARTED|Overall Study||6||
48720787|NCT01722292|102102654|FG002|STARTED|Overall Study||14||
48720788|NCT01722292|102102652|FG000|Received at Least One Dose of Study Drug|Overall Study||6||
48720789|NCT01722292|102102653|FG001|Received at Least One Dose of Study Drug|Overall Study||6||
48720790|NCT01722292|102102654|FG002|Received at Least One Dose of Study Drug|Overall Study||14||
48720791|NCT01722292|102102652|FG000|COMPLETED|Overall Study||6||
48720792|NCT01722292|102102653|FG001|COMPLETED|Overall Study||6||
48720793|NCT01722292|102102654|FG002|COMPLETED|Overall Study||14||
48720794|NCT01722292|102102652|FG000|NOT COMPLETED|Overall Study||0||
48720795|NCT01722292|102102653|FG001|NOT COMPLETED|Overall Study||0||
48720796|NCT01722292|102102654|FG002|NOT COMPLETED|Overall Study||0||
48720797|NCT00471887|102102655|FG000|STARTED|Overall Study||32||
48720798|NCT00471887|102102655|FG000|COMPLETED|Overall Study||23||
48720799|NCT00471887|102102655|FG000|NOT COMPLETED|Overall Study||9||
48720800|NCT00869401|102102656|FG000|STARTED|Overall Study||3||
48720801|NCT00869401|102102657|FG001|STARTED|Overall Study||3||
48720802|NCT00869401|102102658|FG002|STARTED|Overall Study||7||
48720803|NCT00869401|102102659|FG003|STARTED|Overall Study||138||
48720804|NCT00869401|102102660|FG004|STARTED|Overall Study||66||
48720805|NCT00869401|102102656|FG000|COMPLETED|Overall Study||3||
48720806|NCT00869401|102102657|FG001|COMPLETED|Overall Study||3||
48720807|NCT00869401|102102658|FG002|COMPLETED|Overall Study||7||
48720808|NCT00869401|102102659|FG003|COMPLETED|Overall Study||133||
48720809|NCT00869401|102102660|FG004|COMPLETED|Overall Study||63||
48720810|NCT00869401|102102656|FG000|NOT COMPLETED|Overall Study||0||
48720811|NCT00869401|102102657|FG001|NOT COMPLETED|Overall Study||0||
48720812|NCT00869401|102102658|FG002|NOT COMPLETED|Overall Study||0||
48306316|NCT01563185|101074919|FG000|STARTED|Overall Study||12||
48720813|NCT00869401|102102659|FG003|NOT COMPLETED|Overall Study||5||
48720814|NCT00869401|102102660|FG004|NOT COMPLETED|Overall Study||3||
48720815|NCT01777945|102102661|FG000|STARTED|Overall Study||46||
48720816|NCT01777945|102102661|FG000|Evaluable Participants|Overall Study||45||
48720817|NCT01777945|102102661|FG000|COMPLETED|Overall Study||46||
48720818|NCT01777945|102102661|FG000|NOT COMPLETED|Overall Study||0||
48720819|NCT00527332|102102662|FG000|STARTED|Overall Study||91||
48720820|NCT00527332|102102663|FG001|STARTED|Overall Study||89||
48720821|NCT00527332|102102662|FG000|COMPLETED|Overall Study||82||
48720822|NCT00527332|102102663|FG001|COMPLETED|Overall Study||80||
48720823|NCT00527332|102102662|FG000|NOT COMPLETED|Overall Study||9||
48720824|NCT00527332|102102663|FG001|NOT COMPLETED|Overall Study||9||
48306317|NCT01563185|101074919|FG000|COMPLETED|Overall Study||10||
48720825|NCT02198235|102102664|FG000|STARTED|Overall Study||30||
48720826|NCT02198235|102102665|FG001|STARTED|Overall Study||30||
48306318|NCT01563185|101074919|FG000|NOT COMPLETED|Overall Study||2||
48306319|NCT01287364|101074920|FG000|STARTED|Overall Study||94||
48151276|NCT03238300|100692425|FG000|COMPLETED|Baseline (Before Intervention)||18||
48151277|NCT03238300|100692426|FG001|COMPLETED|Baseline (Before Intervention)||16||
48720827|NCT02198235|102102666|FG002|STARTED|Overall Study||30||
48720828|NCT02198235|102102664|FG000|COMPLETED|Overall Study||27||
48720829|NCT02198235|102102665|FG001|COMPLETED|Overall Study||28||
48720830|NCT02198235|102102666|FG002|COMPLETED|Overall Study||28||
48720831|NCT02198235|102102664|FG000|NOT COMPLETED|Overall Study||3||
48720832|NCT02198235|102102665|FG001|NOT COMPLETED|Overall Study||2||
48720833|NCT02198235|102102666|FG002|NOT COMPLETED|Overall Study||2||
48720834|NCT01943552|102102667|FG000|STARTED|Overall Study||96||
48720835|NCT01943552|102102668|FG001|STARTED|Overall Study||94||
48720836|NCT01943552|102102667|FG000|COMPLETED|Overall Study||71||
48720837|NCT01943552|102102668|FG001|COMPLETED|Overall Study||69||
48720838|NCT01943552|102102667|FG000|NOT COMPLETED|Overall Study||25||
48720839|NCT01943552|102102668|FG001|NOT COMPLETED|Overall Study||25||
48720840|NCT03199391|102102669|FG000|STARTED|Overall Study||71||
48720841|NCT03199391|102102669|FG000|COMPLETED|Overall Study||55||
48720842|NCT03199391|102102669|FG000|NOT COMPLETED|Overall Study||16||
48720843|NCT00549770|102102670|FG000|STARTED|Overall Study||156||
48720844|NCT00549770|102102671|FG001|STARTED|Overall Study||169||
48720845|NCT00549770|102102672|FG002|STARTED|Overall Study||172||
48720846|NCT00549770|102102673|FG003|STARTED|Overall Study||163||
48720847|NCT00549770|102102674|FG004|STARTED|Overall Study||166||
48720848|NCT00549770|102102675|FG005|STARTED|Overall Study||164||
48720849|NCT00549770|102102676|FG006|STARTED|Overall Study||165||
48720850|NCT00549770|102102677|FG007|STARTED|Overall Study||173||
48720851|NCT00549770|102102670|FG000|Intent-to-treat Population|Overall Study||154||
48720852|NCT00549770|102102671|FG001|Intent-to-treat Population|Overall Study||168||
48720853|NCT00549770|102102672|FG002|Intent-to-treat Population|Overall Study||170||
48720854|NCT00549770|102102673|FG003|Intent-to-treat Population|Overall Study||163||
48720855|NCT00549770|102102674|FG004|Intent-to-treat Population|Overall Study||163||
48720856|NCT00549770|102102675|FG005|Intent-to-treat Population|Overall Study||163||
48720857|NCT00549770|102102676|FG006|Intent-to-treat Population|Overall Study||164||
48720858|NCT00549770|102102677|FG007|Intent-to-treat Population|Overall Study||172||
48720859|NCT00549770|102102670|FG000|Ambulatory Blood Pressure Monitoring|Overall Study||48||
48720860|NCT00549770|102102671|FG001|Ambulatory Blood Pressure Monitoring|Overall Study||61||
48720861|NCT00549770|102102672|FG002|Ambulatory Blood Pressure Monitoring|Overall Study||53||
48720862|NCT00549770|102102673|FG003|Ambulatory Blood Pressure Monitoring|Overall Study||55||
48720863|NCT00549770|102102674|FG004|Ambulatory Blood Pressure Monitoring|Overall Study||49||
48720864|NCT00549770|102102675|FG005|Ambulatory Blood Pressure Monitoring|Overall Study||54||
48720865|NCT00549770|102102676|FG006|Ambulatory Blood Pressure Monitoring|Overall Study||50||
48720866|NCT00549770|102102677|FG007|Ambulatory Blood Pressure Monitoring|Overall Study||57||
48720867|NCT00549770|102102670|FG000|COMPLETED|Overall Study||149||
48720868|NCT00549770|102102671|FG001|COMPLETED|Overall Study||158||
48720869|NCT00549770|102102672|FG002|COMPLETED|Overall Study||162||
48720870|NCT00549770|102102673|FG003|COMPLETED|Overall Study||147||
48720871|NCT00549770|102102674|FG004|COMPLETED|Overall Study||149||
48720872|NCT00549770|102102675|FG005|COMPLETED|Overall Study||151||
48720873|NCT00549770|102102676|FG006|COMPLETED|Overall Study||151||
48720874|NCT00549770|102102677|FG007|COMPLETED|Overall Study||148||
48720875|NCT00549770|102102670|FG000|NOT COMPLETED|Overall Study||7||
48720876|NCT00549770|102102671|FG001|NOT COMPLETED|Overall Study||11||
48720877|NCT00549770|102102672|FG002|NOT COMPLETED|Overall Study||10||
48720878|NCT00549770|102102673|FG003|NOT COMPLETED|Overall Study||16||
48720879|NCT00549770|102102674|FG004|NOT COMPLETED|Overall Study||17||
48720880|NCT00549770|102102675|FG005|NOT COMPLETED|Overall Study||13||
48720881|NCT00549770|102102676|FG006|NOT COMPLETED|Overall Study||14||
48720882|NCT00549770|102102677|FG007|NOT COMPLETED|Overall Study||25||
48720883|NCT02440789|102102678|FG000|STARTED|Overall Study||32||
48720884|NCT02440789|102102678|FG000|Initiated Sirolimus|Overall Study||30|2 participants withdrew consent prior to initiating Sirolimus|
48720885|NCT02440789|102102678|FG000|Completed 20 Weeks of Sirolimus|Overall Study||16|14 participants completed less than 20 weeks of Sirolimus|
48720886|NCT02440789|102102678|FG000|COMPLETED|Overall Study||28||
48720887|NCT02440789|102102678|FG000|NOT COMPLETED|Overall Study||4||
48720888|NCT04109976|102102679|FG000|STARTED|Overall Study||107||
48720889|NCT04109976|102102680|FG001|STARTED|Overall Study||107||
48720890|NCT04109976|102102679|FG000|COMPLETED|Overall Study||106||
48720891|NCT04109976|102102680|FG001|COMPLETED|Overall Study||107||
48720892|NCT04109976|102102679|FG000|NOT COMPLETED|Overall Study||1||
48720893|NCT04109976|102102680|FG001|NOT COMPLETED|Overall Study||0||
48720894|NCT01839656|102102681|FG000|STARTED|Overall Study||5||
48720895|NCT01839656|102102682|FG001|STARTED|Overall Study||16||
48720896|NCT01839656|102102681|FG000|Completed Loading Dose Period|Overall Study||4||
48720897|NCT01839656|102102682|FG001|Completed Loading Dose Period|Overall Study||15||
48720898|NCT01839656|102102681|FG000|COMPLETED|Overall Study||2||
48151278|NCT03238300|100692425|FG000|NOT COMPLETED|Baseline (Before Intervention)||0||
48151279|NCT03238300|100692426|FG001|NOT COMPLETED|Baseline (Before Intervention)||1||
48720899|NCT01839656|102102682|FG001|COMPLETED|Overall Study||0||
48720900|NCT01839656|102102681|FG000|NOT COMPLETED|Overall Study||3||
48720901|NCT01839656|102102682|FG001|NOT COMPLETED|Overall Study||16||
48151280|NCT03238300|100692425|FG000|STARTED|First Intervention (10-Days)||18||
48151281|NCT03238300|100692426|FG001|STARTED|First Intervention (10-Days)||16||
48151282|NCT03238300|100692425|FG000|COMPLETED|First Intervention (10-Days)||18||
48151283|NCT03238300|100692426|FG001|COMPLETED|First Intervention (10-Days)||16||
48151284|NCT03238300|100692425|FG000|NOT COMPLETED|First Intervention (10-Days)||0||
48151285|NCT03238300|100692426|FG001|NOT COMPLETED|First Intervention (10-Days)||0||
48151286|NCT03238300|100692425|FG000|STARTED|Washout Period (11-Days)||18||
48151287|NCT03238300|100692426|FG001|STARTED|Washout Period (11-Days)||16||
48151288|NCT03238300|100692425|FG000|COMPLETED|Washout Period (11-Days)||17||
48151289|NCT03238300|100692426|FG001|COMPLETED|Washout Period (11-Days)||16||
48151290|NCT03238300|100692425|FG000|NOT COMPLETED|Washout Period (11-Days)||1||
48151291|NCT03238300|100692426|FG001|NOT COMPLETED|Washout Period (11-Days)||0||
48151292|NCT03238300|100692425|FG000|STARTED|Second Intervention (10-Days)||17||
48151293|NCT03238300|100692426|FG001|STARTED|Second Intervention (10-Days)||16||
48151294|NCT03238300|100692425|FG000|COMPLETED|Second Intervention (10-Days)||15||
48151295|NCT03238300|100692426|FG001|COMPLETED|Second Intervention (10-Days)||16||
48151296|NCT03238300|100692425|FG000|NOT COMPLETED|Second Intervention (10-Days)||2||
48151297|NCT03238300|100692426|FG001|NOT COMPLETED|Second Intervention (10-Days)||0||
48151298|NCT02163733|100692427|FG000|STARTED|Part A: Day 1-9 (1st Intervention)||18||
48151299|NCT02163733|100692428|FG001|STARTED|Part A: Day 1-9 (1st Intervention)||20||
48151300|NCT02163733|100692429|FG002|STARTED|Part A: Day 1-9 (1st Intervention)||0||
48151301|NCT02163733|100692427|FG000|COMPLETED|Part A: Day 1-9 (1st Intervention)||18||
48151302|NCT02163733|100692428|FG001|COMPLETED|Part A: Day 1-9 (1st Intervention)||20||
48151303|NCT02163733|100692429|FG002|COMPLETED|Part A: Day 1-9 (1st Intervention)||0||
48151304|NCT02163733|100692427|FG000|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0||
48151305|NCT02163733|100692428|FG001|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0||
48151306|NCT02163733|100692429|FG002|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0||
48151307|NCT02163733|100692427|FG000|STARTED|Part A: Day 10-15 (2nd Intervention)||18||
48151308|NCT02163733|100692428|FG001|STARTED|Part A: Day 10-15 (2nd Intervention)||20||
48151309|NCT02163733|100692429|FG002|STARTED|Part A: Day 10-15 (2nd Intervention)||0||
48151310|NCT02163733|100692427|FG000|COMPLETED|Part A: Day 10-15 (2nd Intervention)||18||
48151311|NCT02163733|100692428|FG001|COMPLETED|Part A: Day 10-15 (2nd Intervention)||20||
48151312|NCT02163733|100692429|FG002|COMPLETED|Part A: Day 10-15 (2nd Intervention)||0||
48151313|NCT02163733|100692427|FG000|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0||
48151314|NCT02163733|100692428|FG001|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0||
48151315|NCT02163733|100692429|FG002|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0||
48151316|NCT02163733|100692427|FG000|STARTED|Part B: Day 15 to End Part B (AZD9291)||0||
48151317|NCT02163733|100692428|FG001|STARTED|Part B: Day 15 to End Part B (AZD9291)||0||
48151318|NCT02163733|100692429|FG002|STARTED|Part B: Day 15 to End Part B (AZD9291)||38||
48151319|NCT02163733|100692427|FG000|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0||
48151320|NCT02163733|100692428|FG001|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0||
48151321|NCT02163733|100692429|FG002|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||14||
48151322|NCT02163733|100692427|FG000|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0||
48151323|NCT02163733|100692428|FG001|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0||
48151324|NCT02163733|100692429|FG002|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||24||
48151325|NCT03289234|100692430|FG000|STARTED|Overall Study||8||
48151326|NCT03289234|100692431|FG001|STARTED|Overall Study||6||
48151327|NCT03289234|100692432|FG002|STARTED|Overall Study||8||
48151328|NCT03289234|100692430|FG000|COMPLETED|Overall Study||8||
48151329|NCT03289234|100692431|FG001|COMPLETED|Overall Study||6||
48151330|NCT03289234|100692432|FG002|COMPLETED|Overall Study||8||
48151331|NCT03289234|100692430|FG000|NOT COMPLETED|Overall Study||0||
48151332|NCT03289234|100692431|FG001|NOT COMPLETED|Overall Study||0||
48151333|NCT03289234|100692432|FG002|NOT COMPLETED|Overall Study||0||
48151334|NCT01466985|100692433|FG000|STARTED|Overall Study||6||
48151335|NCT01466985|100692434|FG001|STARTED|Overall Study||6||
48151336|NCT01466985|100692435|FG002|STARTED|Overall Study||6||
48151337|NCT01466985|100692433|FG000|COMPLETED|Overall Study||6||
48151338|NCT01466985|100692434|FG001|COMPLETED|Overall Study||6||
48151339|NCT01466985|100692435|FG002|COMPLETED|Overall Study||6||
48151340|NCT01466985|100692433|FG000|NOT COMPLETED|Overall Study||0||
48151341|NCT01466985|100692434|FG001|NOT COMPLETED|Overall Study||0||
48151342|NCT01466985|100692435|FG002|NOT COMPLETED|Overall Study||0||
48151343|NCT02362048|100692436|FG000|STARTED|Overall Study||37||
48151344|NCT02362048|100692437|FG001|STARTED|Overall Study||40||
48151345|NCT02362048|100692436|FG000|Enrolled|Overall Study||37||
48151346|NCT02362048|100692437|FG001|Enrolled|Overall Study||40||
48151347|NCT02362048|100692436|FG000|Received Study Medication|Overall Study||35||
48151348|NCT02362048|100692437|FG001|Received Study Medication|Overall Study||38||
48151349|NCT02362048|100692436|FG000|Discontinued Study|Overall Study||37||
48151350|NCT02362048|100692437|FG001|Discontinued Study|Overall Study||40||
48151351|NCT02362048|100692436|FG000|COMPLETED|Overall Study||0||
48151352|NCT02362048|100692437|FG001|COMPLETED|Overall Study||0||
48151353|NCT02362048|100692436|FG000|NOT COMPLETED|Overall Study||37||
48151354|NCT02362048|100692437|FG001|NOT COMPLETED|Overall Study||40||
48151355|NCT02471651|100692438|FG000|STARTED|Overall Study||20||
48720902|NCT03619135|102102683|FG000|STARTED|Overall Study||50||
48720903|NCT03619135|102102684|FG001|STARTED|Overall Study||50||
48720904|NCT03619135|102102683|FG000|COMPLETED|Overall Study||50||
48720905|NCT03619135|102102684|FG001|COMPLETED|Overall Study||50||
48720906|NCT03619135|102102683|FG000|NOT COMPLETED|Overall Study||0||
48720907|NCT03619135|102102684|FG001|NOT COMPLETED|Overall Study||0||
48720908|NCT03480009|102102685|FG000|STARTED|Overall Study||62||
48720909|NCT03480009|102102686|FG001|STARTED|Overall Study||62||
48720910|NCT03480009|102102687|FG002|STARTED|Overall Study||16||
48720911|NCT03480009|102102688|FG003|STARTED|Overall Study||16||
48720912|NCT03480009|102102685|FG000|COMPLETED|Overall Study||58||
48720913|NCT03480009|102102686|FG001|COMPLETED|Overall Study||57||
48720914|NCT03480009|102102687|FG002|COMPLETED|Overall Study||12||
48720915|NCT03480009|102102688|FG003|COMPLETED|Overall Study||16||
48720916|NCT03480009|102102685|FG000|NOT COMPLETED|Overall Study||4||
48720917|NCT03480009|102102686|FG001|NOT COMPLETED|Overall Study||5||
48720918|NCT03480009|102102687|FG002|NOT COMPLETED|Overall Study||4||
48720919|NCT03480009|102102688|FG003|NOT COMPLETED|Overall Study||0||
48720920|NCT01401699|102102689|FG000|STARTED|Overall Study||109||
48720921|NCT01401699|102102689|FG000|COMPLETED|Overall Study||109||
48720922|NCT01401699|102102689|FG000|NOT COMPLETED|Overall Study||0||
48720923|NCT01848847|102102690|FG000|STARTED|Overall Study||51||
48720924|NCT01848847|102102691|FG001|STARTED|Overall Study||51||
48720925|NCT01848847|102102690|FG000|COMPLETED|Overall Study||49||
48720926|NCT01848847|102102691|FG001|COMPLETED|Overall Study||48||
48720927|NCT01848847|102102690|FG000|NOT COMPLETED|Overall Study||2||
48720928|NCT01848847|102102691|FG001|NOT COMPLETED|Overall Study||3||
48720929|NCT01447121|102102692|FG000|STARTED|Overall Study||118||
48720930|NCT01447121|102102692|FG000|COMPLETED|Overall Study||118||
48720931|NCT01447121|102102692|FG000|NOT COMPLETED|Overall Study||0||
48720932|NCT04754230|102102693|FG000|STARTED|Overall Study||19||
48720933|NCT04754230|102102694|FG001|STARTED|Overall Study||21||
48720934|NCT04754230|102102693|FG000|COMPLETED|Overall Study||19||
48720935|NCT04754230|102102694|FG001|COMPLETED|Overall Study||21||
48720936|NCT04754230|102102693|FG000|NOT COMPLETED|Overall Study||0||
48720937|NCT04754230|102102694|FG001|NOT COMPLETED|Overall Study||0||
48720938|NCT03412604|102102695|FG000|STARTED|Overall Study||5||
48720939|NCT03412604|102102695|FG000|COMPLETED|Overall Study||4||
48720940|NCT03412604|102102695|FG000|NOT COMPLETED|Overall Study||1||
48720941|NCT00434356|102102696|FG000|STARTED|Overall Study||23||
48720942|NCT00434356|102102697|FG001|STARTED|Overall Study||23||
48720943|NCT00434356|102102696|FG000|COMPLETED|Overall Study||0||
48720944|NCT00434356|102102697|FG001|COMPLETED|Overall Study||0||
48720945|NCT00434356|102102696|FG000|NOT COMPLETED|Overall Study||23||
48720946|NCT00434356|102102697|FG001|NOT COMPLETED|Overall Study||23||
48720947|NCT02925741|102102698|FG000|STARTED|Overall Study||1637||
48720948|NCT02925741|102102699|FG001|STARTED|Overall Study||1706||
48720949|NCT02925741|102102698|FG000|COMPLETED|Overall Study||1626||
48720950|NCT02925741|102102699|FG001|COMPLETED|Overall Study||1706||
48720951|NCT02925741|102102698|FG000|NOT COMPLETED|Overall Study||11||
48720952|NCT02925741|102102699|FG001|NOT COMPLETED|Overall Study||0||
48720953|NCT00387647|102102700|FG000|STARTED|Overall Study||24||
48720954|NCT00387647|102102700|FG000|COMPLETED|Overall Study||6||
48720955|NCT00387647|102102700|FG000|NOT COMPLETED|Overall Study||18||
48720956|NCT00864851|102102701|FG000|STARTED|Overall Study||20||
48720957|NCT00864851|102102702|FG001|STARTED|Overall Study||19||
48720958|NCT00864851|102102703|FG002|STARTED|Overall Study||5||
48720959|NCT00864851|102102701|FG000|COMPLETED|Overall Study||17||
48720960|NCT00864851|102102702|FG001|COMPLETED|Overall Study||18||
48720961|NCT00864851|102102703|FG002|COMPLETED|Overall Study||5||
48720962|NCT00864851|102102701|FG000|NOT COMPLETED|Overall Study||3||
48720963|NCT00864851|102102702|FG001|NOT COMPLETED|Overall Study||1||
48720964|NCT00864851|102102703|FG002|NOT COMPLETED|Overall Study||0||
48720965|NCT01716104|102102704|FG000|STARTED|Overall Study||125||
48720966|NCT01716104|102102705|FG001|STARTED|Overall Study||124||
48720967|NCT01716104|102102704|FG000|COMPLETED|Overall Study||119||
48720968|NCT01716104|102102705|FG001|COMPLETED|Overall Study||117||
48151356|NCT02471651|100692439|FG001|STARTED|Overall Study||20||
48151357|NCT02471651|100692438|FG000|COMPLETED|Overall Study||15||
48306320|NCT01287364|101074921|FG001|STARTED|Overall Study||91||
48720969|NCT01716104|102102704|FG000|NOT COMPLETED|Overall Study||6||
48720970|NCT01716104|102102705|FG001|NOT COMPLETED|Overall Study||7||
48720971|NCT02212678|102102706|FG000|STARTED|Overall Study||8||
48720972|NCT02212678|102102706|FG000|COMPLETED|Overall Study||7||
48720973|NCT02212678|102102706|FG000|NOT COMPLETED|Overall Study||1||
48720974|NCT01462877|102102707|FG000|STARTED|Overall Study||506||
48720975|NCT01462877|102102707|FG000|Safety Set|Overall Study||492||
48720976|NCT01462877|102102707|FG000|Full Analysis Set|Overall Study||468||
48720977|NCT01462877|102102707|FG000|Per-protocol Set|Overall Study||364||
48720978|NCT01462877|102102707|FG000|COMPLETED|Overall Study||435||
48720979|NCT01462877|102102707|FG000|NOT COMPLETED|Overall Study||71||
48720980|NCT03119389|102102708|FG000|STARTED|Overall Study||6791||7
48151358|NCT02471651|100692439|FG001|COMPLETED|Overall Study||15||
48151359|NCT02471651|100692438|FG000|NOT COMPLETED|Overall Study||5||
48151360|NCT02471651|100692439|FG001|NOT COMPLETED|Overall Study||5||
48151361|NCT01723722|100692440|FG000|STARTED|Overall Study||20||
48151362|NCT01723722|100692441|FG001|STARTED|Overall Study||20||
48151363|NCT01723722|100692440|FG000|COMPLETED|Overall Study||20||
48151364|NCT01723722|100692441|FG001|COMPLETED|Overall Study||20||
48151365|NCT01723722|100692440|FG000|NOT COMPLETED|Overall Study||0||
48151366|NCT01723722|100692441|FG001|NOT COMPLETED|Overall Study||0||
48151367|NCT00522301|100692442|FG000|STARTED|Overall Study||6||
48151368|NCT00522301|100692442|FG000|COMPLETED|Overall Study||0||
48151369|NCT00522301|100692442|FG000|NOT COMPLETED|Overall Study||6||
48151370|NCT01096992|100692443|FG000|STARTED|Overall Study||6||
48151371|NCT01096992|100692444|FG001|STARTED|Overall Study||3||
48151372|NCT01096992|100692445|FG002|STARTED|Overall Study||6||
48151373|NCT01096992|100692446|FG003|STARTED|Overall Study||6||
48151374|NCT01096992|100692447|FG004|STARTED|Overall Study||30||
48151375|NCT01096992|100692443|FG000|COMPLETED|Overall Study||6||
48151376|NCT01096992|100692444|FG001|COMPLETED|Overall Study||3||
48151377|NCT01096992|100692445|FG002|COMPLETED|Overall Study||6||
48151378|NCT01096992|100692446|FG003|COMPLETED|Overall Study||6||
48151379|NCT01096992|100692447|FG004|COMPLETED|Overall Study||30||
48151380|NCT01096992|100692443|FG000|NOT COMPLETED|Overall Study||0||
48151381|NCT01096992|100692444|FG001|NOT COMPLETED|Overall Study||0||
48151382|NCT01096992|100692445|FG002|NOT COMPLETED|Overall Study||0||
48151383|NCT01096992|100692446|FG003|NOT COMPLETED|Overall Study||0||
48151384|NCT01096992|100692447|FG004|NOT COMPLETED|Overall Study||0||
48151385|NCT01123382|100692448|FG000|STARTED|Overall Study||13||
48151386|NCT01123382|100692449|FG001|STARTED|Overall Study||12||
48151387|NCT01123382|100692448|FG000|Received Intervention|Overall Study||12||
48151388|NCT01123382|100692449|FG001|Received Intervention|Overall Study||10||
48151389|NCT01123382|100692448|FG000|COMPLETED|Overall Study||11||
48151390|NCT01123382|100692449|FG001|COMPLETED|Overall Study||6||
48151391|NCT01123382|100692448|FG000|NOT COMPLETED|Overall Study||2||
48151392|NCT01123382|100692449|FG001|NOT COMPLETED|Overall Study||6||
48151393|NCT04225988|100692450|FG000|STARTED|Overall Study||10||
48151394|NCT04225988|100692451|FG001|STARTED|Overall Study||10||
48151395|NCT04225988|100692450|FG000|COMPLETED|Overall Study||8||
48151396|NCT04225988|100692451|FG001|COMPLETED|Overall Study||10||
48151397|NCT04225988|100692450|FG000|NOT COMPLETED|Overall Study||2||
48151398|NCT04225988|100692451|FG001|NOT COMPLETED|Overall Study||0||
48151399|NCT02671032|100692452|FG000|STARTED|Overall Study||12||
48720981|NCT03119389|102102709|FG001|STARTED|Overall Study||7627||6
48720982|NCT03119389|102102708|FG000|COMPLETED|Overall Study||6791||7
48720983|NCT03119389|102102709|FG001|COMPLETED|Overall Study||7627||6
48720984|NCT03119389|102102708|FG000|NOT COMPLETED|Overall Study||0||0
48720985|NCT03119389|102102709|FG001|NOT COMPLETED|Overall Study||0||0
48720986|NCT02299076|102102710|FG000|STARTED|Overall Study||230||
48151400|NCT02671032|100692452|FG000|COMPLETED|Overall Study||12||
48151401|NCT02671032|100692452|FG000|NOT COMPLETED|Overall Study||0||
48151402|NCT00504426|100692453|FG000|STARTED|Overall Study||32||
48151403|NCT00504426|100692454|FG001|STARTED|Overall Study||23||
48151404|NCT00504426|100692455|FG002|STARTED|Overall Study||22||
48151405|NCT00504426|100692456|FG003|STARTED|Overall Study||24||
48306321|NCT01287364|101074920|FG000|COMPLETED|Overall Study||85||
48306322|NCT01287364|101074921|FG001|COMPLETED|Overall Study||81||
48306323|NCT01287364|101074920|FG000|NOT COMPLETED|Overall Study||9||
48306324|NCT01287364|101074921|FG001|NOT COMPLETED|Overall Study||10||
48306325|NCT01701674|101074922|FG000|STARTED|Overall Study||13||
48306326|NCT01701674|101074922|FG000|COMPLETED|Overall Study||12||
48306327|NCT01701674|101074922|FG000|NOT COMPLETED|Overall Study||1||
48306328|NCT01205438|101074923|FG000|STARTED|Overall Study||372||
48306329|NCT01205438|101074924|FG001|STARTED|Overall Study||376||
48306330|NCT01205438|101074925|FG002|STARTED|Overall Study||376||
48306331|NCT01205438|101074923|FG000|Received At Least One Dose of Study Drug|Overall Study||371||
48306332|NCT01205438|101074924|FG001|Received At Least One Dose of Study Drug|Overall Study||374||
48306333|NCT01205438|101074925|FG002|Received At Least One Dose of Study Drug|Overall Study||376||
48306334|NCT01205438|101074923|FG000|Participated in Follow Up|Overall Study||72||
48306335|NCT01205438|101074924|FG001|Participated in Follow Up|Overall Study||78||
48306336|NCT01205438|101074925|FG002|Participated in Follow Up|Overall Study||66||
48720987|NCT02299076|102102711|FG001|STARTED|Overall Study||226||
48720988|NCT02299076|102102710|FG000|COMPLETED|Overall Study||210||
48720989|NCT02299076|102102711|FG001|COMPLETED|Overall Study||212||
48720990|NCT02299076|102102710|FG000|NOT COMPLETED|Overall Study||20||
48720991|NCT02299076|102102711|FG001|NOT COMPLETED|Overall Study||14||
48720992|NCT01969721|102102712|FG000|STARTED|Overall Study||58||
48720993|NCT01969721|102102713|FG001|STARTED|Overall Study||69||
48720994|NCT01969721|102102714|FG002|STARTED|Overall Study||50||
48720995|NCT01969721|102102715|FG003|STARTED|Overall Study||52||
48720996|NCT01969721|102102712|FG000|COMPLETED|Overall Study||54||
48720997|NCT01969721|102102713|FG001|COMPLETED|Overall Study||57||
48720998|NCT01969721|102102714|FG002|COMPLETED|Overall Study||45||
48720999|NCT01969721|102102715|FG003|COMPLETED|Overall Study||46||
48721000|NCT01969721|102102712|FG000|NOT COMPLETED|Overall Study||4||
48721001|NCT01969721|102102713|FG001|NOT COMPLETED|Overall Study||12||
48721002|NCT01969721|102102714|FG002|NOT COMPLETED|Overall Study||5||
48721003|NCT01969721|102102715|FG003|NOT COMPLETED|Overall Study||6||
48721004|NCT03002311|102102716|FG000|STARTED|Overall Study||147||
48721005|NCT03002311|102102717|FG001|STARTED|Overall Study||180||
48721006|NCT03002311|102102716|FG000|COMPLETED|Overall Study||128||
48721007|NCT03002311|102102717|FG001|COMPLETED|Overall Study||150||
48721008|NCT03002311|102102716|FG000|NOT COMPLETED|Overall Study||19||
48721009|NCT03002311|102102717|FG001|NOT COMPLETED|Overall Study||30||
48721010|NCT00140842|102102718|FG000|STARTED|Overall Study||15||
48721011|NCT00140842|102102719|FG001|STARTED|Overall Study||15||
48721012|NCT00140842|102102718|FG000|COMPLETED|Overall Study||15||
48721013|NCT00140842|102102719|FG001|COMPLETED|Overall Study||15||
48721014|NCT00140842|102102718|FG000|NOT COMPLETED|Overall Study||0||
48721015|NCT00140842|102102719|FG001|NOT COMPLETED|Overall Study||0||
48721016|NCT01198509|102102720|FG000|STARTED|Overall Study||5||
48721017|NCT01198509|102102721|FG001|STARTED|Overall Study||10||
48721018|NCT01198509|102102722|FG002|STARTED|Overall Study||19||
48721019|NCT01198509|102102723|FG003|STARTED|Overall Study||66||
48721020|NCT01198509|102102724|FG004|STARTED|Overall Study||20||
48151406|NCT00504426|100692453|FG000|COMPLETED|Overall Study||29||
48151407|NCT00504426|100692454|FG001|COMPLETED|Overall Study||22||
48151408|NCT00504426|100692455|FG002|COMPLETED|Overall Study||18||
48151409|NCT00504426|100692456|FG003|COMPLETED|Overall Study||24||
48151410|NCT00504426|100692453|FG000|NOT COMPLETED|Overall Study||3||
48306337|NCT01205438|101074923|FG000|COMPLETED|Overall Study||295||
48306338|NCT01205438|101074924|FG001|COMPLETED|Overall Study||289||
48306339|NCT01205438|101074925|FG002|COMPLETED|Overall Study||288||
48306340|NCT01205438|101074923|FG000|NOT COMPLETED|Overall Study||77||
48306341|NCT01205438|101074924|FG001|NOT COMPLETED|Overall Study||87||
48306342|NCT01205438|101074925|FG002|NOT COMPLETED|Overall Study||88||
48306343|NCT03078595|101074926|FG000|STARTED|Overall Study||24||
48306344|NCT03078595|101074927|FG001|STARTED|Overall Study||24||
48306345|NCT03078595|101074926|FG000|COMPLETED|Overall Study||24||
48306346|NCT03078595|101074927|FG001|COMPLETED|Overall Study||24||
48721021|NCT01198509|102102725|FG005|STARTED|Overall Study||58||
48721022|NCT01198509|102102720|FG000|COMPLETED|Overall Study||4||
48721023|NCT01198509|102102721|FG001|COMPLETED|Overall Study||10||
48721024|NCT01198509|102102722|FG002|COMPLETED|Overall Study||19||
48721025|NCT01198509|102102723|FG003|COMPLETED|Overall Study||66||
48721026|NCT01198509|102102724|FG004|COMPLETED|Overall Study||20||
48721027|NCT01198509|102102725|FG005|COMPLETED|Overall Study||58||
48151411|NCT00504426|100692454|FG001|NOT COMPLETED|Overall Study||1||
48306347|NCT03078595|101074926|FG000|NOT COMPLETED|Overall Study||0||
48306348|NCT03078595|101074927|FG001|NOT COMPLETED|Overall Study||0||
48306349|NCT03519867|101074928|FG000|STARTED|Overall Study||6||
48306350|NCT03519867|101074929|FG001|STARTED|Overall Study||7||
48306351|NCT03519867|101074930|FG002|STARTED|Overall Study||6||
48306352|NCT03519867|101074931|FG003|STARTED|Overall Study||4||
48306353|NCT03519867|101074932|FG004|STARTED|Overall Study||5||
48306354|NCT03519867|101074933|FG005|STARTED|Overall Study||5||
48306355|NCT03519867|101074934|FG006|STARTED|Overall Study||4||
48306356|NCT03519867|101074935|FG007|STARTED|Overall Study||5||
48306357|NCT03519867|101074936|FG008|STARTED|Overall Study||4||
48306358|NCT03519867|101074937|FG009|STARTED|Overall Study||4||
48306359|NCT03519867|101074928|FG000|Treated|Overall Study||5||
48306360|NCT03519867|101074929|FG001|Treated|Overall Study||6||
48721028|NCT01198509|102102720|FG000|NOT COMPLETED|Overall Study||1||
48721029|NCT01198509|102102721|FG001|NOT COMPLETED|Overall Study||0||
48721030|NCT01198509|102102722|FG002|NOT COMPLETED|Overall Study||0||
48721031|NCT01198509|102102723|FG003|NOT COMPLETED|Overall Study||0||
48721032|NCT01198509|102102724|FG004|NOT COMPLETED|Overall Study||0||
48721033|NCT01198509|102102725|FG005|NOT COMPLETED|Overall Study||0||
48721034|NCT02030288|102102726|FG000|STARTED|Overall Study||89||
48721035|NCT02030288|102102727|FG001|STARTED|Overall Study||89||
48721036|NCT02030288|102102726|FG000|COMPLETED|Overall Study||89||
48721037|NCT02030288|102102727|FG001|COMPLETED|Overall Study||89||
48721038|NCT02030288|102102726|FG000|NOT COMPLETED|Overall Study||0||
48721039|NCT02030288|102102727|FG001|NOT COMPLETED|Overall Study||0||
48721040|NCT01800318|102102728|FG000|STARTED|Overall Study||39||
48721041|NCT01800318|102102729|FG001|STARTED|Overall Study||42||
48721042|NCT01800318|102102730|FG002|STARTED|Overall Study||41||
48721043|NCT01800318|102102731|FG003|STARTED|Overall Study||40||
48721044|NCT01800318|102102728|FG000|COMPLETED|Overall Study||37||
48721045|NCT01800318|102102729|FG001|COMPLETED|Overall Study||37||
48721046|NCT01800318|102102730|FG002|COMPLETED|Overall Study||40||
48721047|NCT01800318|102102731|FG003|COMPLETED|Overall Study||39||
48721048|NCT01800318|102102728|FG000|NOT COMPLETED|Overall Study||2||
48721049|NCT01800318|102102729|FG001|NOT COMPLETED|Overall Study||5||
48721050|NCT01800318|102102730|FG002|NOT COMPLETED|Overall Study||1||
48721051|NCT01800318|102102731|FG003|NOT COMPLETED|Overall Study||1||
48721052|NCT02900170|102102732|FG000|STARTED|Overall Study||8||
48721053|NCT02900170|102102732|FG000|COMPLETED|Overall Study||0||
48721054|NCT02900170|102102732|FG000|NOT COMPLETED|Overall Study||8||
48721055|NCT01410812|102102733|FG000|STARTED|Overall Study||75||
48721056|NCT01410812|102102734|FG001|STARTED|Overall Study||75||
48721057|NCT01410812|102102735|FG002|STARTED|Overall Study||76||
48721058|NCT01410812|102102733|FG000|COMPLETED|Overall Study||75||
48721059|NCT01410812|102102734|FG001|COMPLETED|Overall Study||75||
48721060|NCT01410812|102102735|FG002|COMPLETED|Overall Study||76||
48721061|NCT01410812|102102733|FG000|NOT COMPLETED|Overall Study||0||
48721062|NCT01410812|102102734|FG001|NOT COMPLETED|Overall Study||0||
48721063|NCT01410812|102102735|FG002|NOT COMPLETED|Overall Study||0||
48721064|NCT02096263|102102736|FG000|STARTED|Overall Study||195||
48721065|NCT02096263|102102737|FG001|STARTED|Overall Study||194||
48721066|NCT02096263|102102738|FG002|STARTED|Overall Study||196||
48721067|NCT02096263|102102736|FG000|COMPLETED|Overall Study||161||
48721068|NCT02096263|102102737|FG001|COMPLETED|Overall Study||158||
48721069|NCT02096263|102102738|FG002|COMPLETED|Overall Study||157||
48721070|NCT02096263|102102736|FG000|NOT COMPLETED|Overall Study||34||
48721071|NCT02096263|102102737|FG001|NOT COMPLETED|Overall Study||36||
48721072|NCT02096263|102102738|FG002|NOT COMPLETED|Overall Study||39||
48721073|NCT02684188|102102739|FG000|STARTED|Overall Study||77||
48721074|NCT02684188|102102740|FG001|STARTED|Overall Study||50||
48721075|NCT02684188|102102739|FG000|COMPLETED|Overall Study||75||
48721076|NCT02684188|102102740|FG001|COMPLETED|Overall Study||47||
48721077|NCT02684188|102102739|FG000|NOT COMPLETED|Overall Study||2||
48721078|NCT02684188|102102740|FG001|NOT COMPLETED|Overall Study||3||
48721079|NCT01727791|102102741|FG000|STARTED|Overall Study||10||
48721080|NCT01727791|102102741|FG000|COMPLETED|Overall Study||10||
48721081|NCT01727791|102102741|FG000|NOT COMPLETED|Overall Study||0||
48721082|NCT03847909|102102742|FG000|STARTED|Overall Study||23||
48721083|NCT03847909|102102743|FG001|STARTED|Overall Study||12||
48721084|NCT03847909|102102742|FG000|Safety Population|Overall Study||23||
48721085|NCT03847909|102102743|FG001|Safety Population|Overall Study||12||
48721086|NCT03847909|102102742|FG000|Intent to Treat (ITT) Population|Overall Study||23||
48306361|NCT03519867|101074930|FG002|Treated|Overall Study||5||
48306362|NCT03519867|101074931|FG003|Treated|Overall Study||3||
48306363|NCT03519867|101074932|FG004|Treated|Overall Study||5||
48721087|NCT03847909|102102743|FG001|Intent to Treat (ITT) Population|Overall Study||12||
48721088|NCT03847909|102102742|FG000|Modified ITT (MITT) Population|Overall Study||22||
48721089|NCT03847909|102102743|FG001|Modified ITT (MITT) Population|Overall Study||12||
48721090|NCT03847909|102102742|FG000|COMPLETED|Overall Study||22||
48721091|NCT03847909|102102743|FG001|COMPLETED|Overall Study||11||
48721092|NCT03847909|102102742|FG000|NOT COMPLETED|Overall Study||1||
48306364|NCT03519867|101074933|FG005|Treated|Overall Study||4||
48306365|NCT03519867|101074934|FG006|Treated|Overall Study||4||
48306366|NCT03519867|101074935|FG007|Treated|Overall Study||4||
48306367|NCT03519867|101074936|FG008|Treated|Overall Study||3||
48306368|NCT03519867|101074937|FG009|Treated|Overall Study||4||
48306369|NCT03519867|101074928|FG000|COMPLETED|Overall Study||3||
48306370|NCT03519867|101074929|FG001|COMPLETED|Overall Study||4||
48306371|NCT03519867|101074930|FG002|COMPLETED|Overall Study||5||
48306372|NCT03519867|101074931|FG003|COMPLETED|Overall Study||3||
48306373|NCT03519867|101074932|FG004|COMPLETED|Overall Study||5||
48151412|NCT00504426|100692455|FG002|NOT COMPLETED|Overall Study||4||
48151413|NCT00504426|100692456|FG003|NOT COMPLETED|Overall Study||0||
48151414|NCT00538590|100692457|FG000|STARTED|Overall Study||10||
48151415|NCT00538590|100692458|FG001|STARTED|Overall Study||10||
48151416|NCT00538590|100692457|FG000|COMPLETED|Overall Study||9||
48151417|NCT00538590|100692458|FG001|COMPLETED|Overall Study||10||
48151418|NCT00538590|100692457|FG000|NOT COMPLETED|Overall Study||1||
48151419|NCT00538590|100692458|FG001|NOT COMPLETED|Overall Study||0||
48151420|NCT02110901|100692459|FG000|STARTED|Overall Study||209||
48151421|NCT02110901|100692460|FG001|STARTED|Overall Study||102||
48151422|NCT02110901|100692459|FG000|COMPLETED|Overall Study||179||
48306374|NCT03519867|101074933|FG005|COMPLETED|Overall Study||2||
48306375|NCT03519867|101074934|FG006|COMPLETED|Overall Study||3||
48306376|NCT03519867|101074935|FG007|COMPLETED|Overall Study||4||
48306377|NCT03519867|101074936|FG008|COMPLETED|Overall Study||3||
48151423|NCT02110901|100692460|FG001|COMPLETED|Overall Study||88||
48151424|NCT02110901|100692459|FG000|NOT COMPLETED|Overall Study||30||
48151425|NCT02110901|100692460|FG001|NOT COMPLETED|Overall Study||14||
48151426|NCT01533493|100692461|FG000|STARTED|Overall Study||12||
48151427|NCT01533493|100692462|FG001|STARTED|Overall Study||14||
48151428|NCT01533493|100692461|FG000|COMPLETED|Overall Study||7||
48151429|NCT01533493|100692462|FG001|COMPLETED|Overall Study||11||
48151430|NCT01533493|100692461|FG000|NOT COMPLETED|Overall Study||5||
48151431|NCT01533493|100692462|FG001|NOT COMPLETED|Overall Study||3||
48151432|NCT00696410|100692463|FG000|STARTED|Overall Study||38||
48151433|NCT00696410|100692464|FG001|STARTED|Overall Study||10||
48151434|NCT00696410|100692463|FG000|COMPLETED|Overall Study||25||
48151435|NCT00696410|100692464|FG001|COMPLETED|Overall Study||10||
48151436|NCT00696410|100692463|FG000|NOT COMPLETED|Overall Study||13||
48151437|NCT00696410|100692464|FG001|NOT COMPLETED|Overall Study||0||
48151438|NCT03086330|100692465|FG000|STARTED|Overall Study||151||
48151439|NCT03086330|100692466|FG001|STARTED|Overall Study||151||
48151440|NCT03086330|100692465|FG000|Exposed|Overall Study||150||
48151441|NCT03086330|100692466|FG001|Exposed|Overall Study||151||
48151442|NCT03086330|100692465|FG000|COMPLETED|Overall Study||147||
48151443|NCT03086330|100692466|FG001|COMPLETED|Overall Study||147||
48151444|NCT03086330|100692465|FG000|NOT COMPLETED|Overall Study||4||
48151445|NCT03086330|100692466|FG001|NOT COMPLETED|Overall Study||4||
48151446|NCT03703466|100692467|FG000|STARTED|Overall Study||24||
48151447|NCT03703466|100692468|FG001|STARTED|Overall Study||24||
48151448|NCT03703466|100692469|FG002|STARTED|Overall Study||24||
48151449|NCT03703466|100692467|FG000|Received at Least One Dose of Study Drug|Overall Study||24||
48151450|NCT03703466|100692468|FG001|Received at Least One Dose of Study Drug|Overall Study||23||
48151451|NCT03703466|100692469|FG002|Received at Least One Dose of Study Drug|Overall Study||24||
48151452|NCT03703466|100692467|FG000|COMPLETED|Overall Study||20|Study completers are participants who completed 3 cycles of study treatment (28-day cycle)|
48151453|NCT03703466|100692468|FG001|COMPLETED|Overall Study||18|Study completers are participants who completed 3 cycles of study treatment (28-day cycle)|
48151454|NCT03703466|100692469|FG002|COMPLETED|Overall Study||22|Study completers are participants who completed 3 cycles of study treatment (28-day cycle)|
48151455|NCT03703466|100692467|FG000|NOT COMPLETED|Overall Study||4||
48151456|NCT03703466|100692468|FG001|NOT COMPLETED|Overall Study||6||
48151457|NCT03703466|100692469|FG002|NOT COMPLETED|Overall Study||2||
48151458|NCT00696384|100692470|FG000|STARTED|Open Label Phase||418||
48151459|NCT00696384|100692471|FG001|STARTED|Open Label Phase||0||
48151460|NCT00696384|100692472|FG002|STARTED|Open Label Phase||0||
48151461|NCT00696384|100692470|FG000|COMPLETED|Open Label Phase||299||
48151462|NCT00696384|100692471|FG001|COMPLETED|Open Label Phase||0||
48151463|NCT00696384|100692472|FG002|COMPLETED|Open Label Phase||0||
48151464|NCT00696384|100692470|FG000|NOT COMPLETED|Open Label Phase||119||
48151465|NCT00696384|100692471|FG001|NOT COMPLETED|Open Label Phase||0||
48151466|NCT00696384|100692472|FG002|NOT COMPLETED|Open Label Phase||0||
48151467|NCT00696384|100692470|FG000|STARTED|Double Blind Phase||0||
48151468|NCT00696384|100692471|FG001|STARTED|Double Blind Phase||148||
48151469|NCT00696384|100692472|FG002|STARTED|Double Blind Phase||151||
48151470|NCT00696384|100692470|FG000|COMPLETED|Double Blind Phase||0||
48151471|NCT00696384|100692471|FG001|COMPLETED|Double Blind Phase||137||
48151472|NCT00696384|100692472|FG002|COMPLETED|Double Blind Phase||145||
48151473|NCT00696384|100692470|FG000|NOT COMPLETED|Double Blind Phase||0||
48151474|NCT00696384|100692471|FG001|NOT COMPLETED|Double Blind Phase||11||
48151475|NCT00696384|100692472|FG002|NOT COMPLETED|Double Blind Phase||6||
48151476|NCT03030222|100692473|FG000|STARTED|Overall Study||33||
48151477|NCT03030222|100692474|FG001|STARTED|Overall Study||32||
48306378|NCT03519867|101074937|FG009|COMPLETED|Overall Study||4||
48721093|NCT03847909|102102743|FG001|NOT COMPLETED|Overall Study||1||
48721094|NCT00530920|102102744|FG000|STARTED|Overall Study||30||
48721095|NCT00530920|102102745|FG001|STARTED|Overall Study||27||
48721096|NCT00530920|102102746|FG002|STARTED|Overall Study||28||
48721097|NCT00530920|102102744|FG000|COMPLETED|Overall Study||30||
48306379|NCT03519867|101074928|FG000|NOT COMPLETED|Overall Study||3||
48306380|NCT03519867|101074929|FG001|NOT COMPLETED|Overall Study||3||
48306381|NCT03519867|101074930|FG002|NOT COMPLETED|Overall Study||1||
48306382|NCT03519867|101074931|FG003|NOT COMPLETED|Overall Study||1||
48306383|NCT03519867|101074932|FG004|NOT COMPLETED|Overall Study||0||
48306384|NCT03519867|101074933|FG005|NOT COMPLETED|Overall Study||3||
48306385|NCT03519867|101074934|FG006|NOT COMPLETED|Overall Study||1||
48306386|NCT03519867|101074935|FG007|NOT COMPLETED|Overall Study||1||
48306387|NCT03519867|101074936|FG008|NOT COMPLETED|Overall Study||1||
48306388|NCT03519867|101074937|FG009|NOT COMPLETED|Overall Study||0||
48306389|NCT01028222|101074938|FG000|STARTED|Overall Study||42||
48306390|NCT01028222|101074939|FG001|STARTED|Overall Study||13||
48306391|NCT01028222|101074938|FG000|Cross Over From DTIC to Nilotinib|Overall Study||0||
48306392|NCT01028222|101074939|FG001|Cross Over From DTIC to Nilotinib|Overall Study||10||
48306393|NCT01028222|101074938|FG000|COMPLETED|Overall Study||4||
48306394|NCT01028222|101074939|FG001|COMPLETED|Overall Study||0||
48306395|NCT01028222|101074938|FG000|NOT COMPLETED|Overall Study||38||
48306396|NCT01028222|101074939|FG001|NOT COMPLETED|Overall Study||13||
48306397|NCT00607880|101074940|FG000|STARTED|Overall Study||50||
48306398|NCT00607880|101074941|FG001|STARTED|Overall Study||50||
48306399|NCT00607880|101074940|FG000|COMPLETED|Overall Study||49||
48306400|NCT00607880|101074941|FG001|COMPLETED|Overall Study||50||
48306401|NCT00607880|101074940|FG000|NOT COMPLETED|Overall Study||1||
48306402|NCT00607880|101074941|FG001|NOT COMPLETED|Overall Study||0||
48306403|NCT00239226|101074942|FG000|STARTED|Overall Study||30||
48306404|NCT00239226|101074943|FG001|STARTED|Overall Study||18||
48306405|NCT00239226|101074944|FG002|STARTED|Overall Study||37||
48306406|NCT00239226|101074945|FG003|STARTED|Overall Study||17||
48306407|NCT00239226|101074942|FG000|COMPLETED|Overall Study||29||
48306408|NCT00239226|101074943|FG001|COMPLETED|Overall Study||18||
48306409|NCT00239226|101074944|FG002|COMPLETED|Overall Study||36||
48306410|NCT00239226|101074945|FG003|COMPLETED|Overall Study||14||
48306411|NCT00239226|101074942|FG000|NOT COMPLETED|Overall Study||1||
48306412|NCT00239226|101074943|FG001|NOT COMPLETED|Overall Study||0||
48306413|NCT00239226|101074944|FG002|NOT COMPLETED|Overall Study||1||
48306414|NCT00239226|101074945|FG003|NOT COMPLETED|Overall Study||3||
48306415|NCT04723147|101074946|FG000|STARTED|First Intervention||10||
48306416|NCT04723147|101074947|FG001|STARTED|First Intervention||9||
48306417|NCT04723147|101074946|FG000|COMPLETED|First Intervention||10||
48306418|NCT04723147|101074947|FG001|COMPLETED|First Intervention||9||
48306419|NCT04723147|101074946|FG000|NOT COMPLETED|First Intervention||0||
48306420|NCT04723147|101074947|FG001|NOT COMPLETED|First Intervention||0||
48306421|NCT04723147|101074946|FG000|STARTED|Second Intervention||10||
48306422|NCT04723147|101074947|FG001|STARTED|Second Intervention||8||
48306423|NCT04723147|101074946|FG000|COMPLETED|Second Intervention||10||
48306424|NCT04723147|101074947|FG001|COMPLETED|Second Intervention||8||
48306425|NCT04723147|101074946|FG000|NOT COMPLETED|Second Intervention||0||
48306426|NCT04723147|101074947|FG001|NOT COMPLETED|Second Intervention||0||
48306427|NCT00132496|101074948|FG000|STARTED|Overall Study||54||
48306428|NCT00132496|101074949|FG001|STARTED|Overall Study||57||
48306429|NCT00132496|101074948|FG000|COMPLETED|Overall Study||52||
48306430|NCT00132496|101074949|FG001|COMPLETED|Overall Study||55||
48721098|NCT00530920|102102745|FG001|COMPLETED|Overall Study||25||
48721099|NCT00530920|102102746|FG002|COMPLETED|Overall Study||24||
48721100|NCT00530920|102102744|FG000|NOT COMPLETED|Overall Study||0||
48721101|NCT00530920|102102745|FG001|NOT COMPLETED|Overall Study||2||
48721102|NCT00530920|102102746|FG002|NOT COMPLETED|Overall Study||4||
48721103|NCT03442296|102102747|FG000|STARTED|3 Month Follow-up||78||
48721104|NCT03442296|102102748|FG001|STARTED|3 Month Follow-up||73||
48721105|NCT03442296|102102747|FG000|COMPLETED|3 Month Follow-up||73||
48721106|NCT03442296|102102748|FG001|COMPLETED|3 Month Follow-up||70||
48721107|NCT03442296|102102747|FG000|NOT COMPLETED|3 Month Follow-up||5||
48721108|NCT03442296|102102748|FG001|NOT COMPLETED|3 Month Follow-up||3||
48721109|NCT03442296|102102747|FG000|STARTED|12 Month Follow-up||58||
48721110|NCT03442296|102102748|FG001|STARTED|12 Month Follow-up||52||
48306431|NCT00132496|101074948|FG000|NOT COMPLETED|Overall Study||2||
48306432|NCT00132496|101074949|FG001|NOT COMPLETED|Overall Study||2||
48306433|NCT00458341|101077411|FG000|STARTED|Cycle 1||15|Cycle 1: from first dose of PTC124 through day before first dosing date in Cycle 2.|
48306434|NCT00458341|101077412|FG001|STARTED|Cycle 1||15|Cycle 1: from first dose of PTC124 through day before first dosing date in Cycle 2.|
48306435|NCT00458341|101077411|FG000|Received at Least 1 Dose of Study Drug|Cycle 1||15||
48306436|NCT00458341|101077412|FG001|Received at Least 1 Dose of Study Drug|Cycle 1||15||
48306437|NCT00458341|101077411|FG000|COMPLETED|Cycle 1||14||
48306438|NCT00458341|101077412|FG001|COMPLETED|Cycle 1||15||
48721111|NCT03442296|102102747|FG000|COMPLETED|12 Month Follow-up||57||
48721112|NCT03442296|102102748|FG001|COMPLETED|12 Month Follow-up||51||
48721113|NCT03442296|102102747|FG000|NOT COMPLETED|12 Month Follow-up||1||
48721114|NCT03442296|102102748|FG001|NOT COMPLETED|12 Month Follow-up||1||
48721115|NCT00673881|102102749|FG000|STARTED|Overall Study||25||
48721116|NCT00673881|102102749|FG000|COMPLETED|Overall Study||24||
48721117|NCT00673881|102102749|FG000|NOT COMPLETED|Overall Study||1||
48721118|NCT00167388|102102750|FG000|STARTED|Overall Study||5||
48721119|NCT00167388|102102751|FG001|STARTED|Overall Study||5||
48721120|NCT00167388|102102752|FG002|STARTED|Overall Study||6||
48721121|NCT00167388|102102753|FG003|STARTED|Overall Study||6||
48721122|NCT00167388|102102750|FG000|Completed Doppler Study|Overall Study||5||
48721123|NCT00167388|102102751|FG001|Completed Doppler Study|Overall Study||5||
48721124|NCT00167388|102102752|FG002|Completed Doppler Study|Overall Study||6||
48151478|NCT03030222|100692473|FG000|COMPLETED|Overall Study||33||
48306439|NCT00458341|101077411|FG000|NOT COMPLETED|Cycle 1||1||
48306440|NCT00458341|101077412|FG001|NOT COMPLETED|Cycle 1||0||
48306441|NCT00458341|101077411|FG000|STARTED|Cycle 2||15|Cycle 2: first dosing date after 2-week rest period in Cycle 1 through end-of-study follow-up.|
48306442|NCT00458341|101077412|FG001|STARTED|Cycle 2||15|Cycle 2: first dosing date after 2-week rest period in Cycle 1 through end-of-study follow-up.|
48306443|NCT00458341|101077411|FG000|Received at Least 1 Dose of Study Drug|Cycle 2||15||
48306444|NCT00458341|101077412|FG001|Received at Least 1 Dose of Study Drug|Cycle 2||15||
48306445|NCT00458341|101077411|FG000|COMPLETED|Cycle 2||15||
48306446|NCT00458341|101077412|FG001|COMPLETED|Cycle 2||15||
48306447|NCT00458341|101077411|FG000|NOT COMPLETED|Cycle 2||0||
48721125|NCT00167388|102102753|FG003|Completed Doppler Study|Overall Study||6||
48721126|NCT00167388|102102750|FG000|COMPLETED|Overall Study||5||
48721127|NCT00167388|102102751|FG001|COMPLETED|Overall Study||5||
48721128|NCT00167388|102102752|FG002|COMPLETED|Overall Study||6||
48721129|NCT00167388|102102753|FG003|COMPLETED|Overall Study||6||
48721130|NCT00167388|102102750|FG000|NOT COMPLETED|Overall Study||0||
48721131|NCT00167388|102102751|FG001|NOT COMPLETED|Overall Study||0||
48721132|NCT00167388|102102752|FG002|NOT COMPLETED|Overall Study||0||
48721133|NCT00167388|102102753|FG003|NOT COMPLETED|Overall Study||0||
48721134|NCT03842683|102102754|FG000|STARTED|Overall Study||472||
48721135|NCT03842683|102102754|FG000|COMPLETED|Overall Study||472||
48721136|NCT03842683|102102754|FG000|NOT COMPLETED|Overall Study||0||
48721137|NCT05059977|102102755|FG000|STARTED|Overall Study||8||
48721138|NCT05059977|102102756|FG001|STARTED|Overall Study||8||
48721139|NCT05059977|102102757|FG002|STARTED|Overall Study||8||
48721140|NCT05059977|102102755|FG000|COMPLETED|Overall Study||8||
48721141|NCT05059977|102102756|FG001|COMPLETED|Overall Study||8||
48721142|NCT05059977|102102757|FG002|COMPLETED|Overall Study||7||
48721143|NCT05059977|102102755|FG000|NOT COMPLETED|Overall Study||0||
48721144|NCT05059977|102102756|FG001|NOT COMPLETED|Overall Study||0||
48721145|NCT05059977|102102757|FG002|NOT COMPLETED|Overall Study||1||
48721146|NCT02391961|102102758|FG000|STARTED|First Intervention (4 Weeks)||10||
48306448|NCT00458341|101077412|FG001|NOT COMPLETED|Cycle 2||0||
48306449|NCT04683731|101077413|FG000|STARTED|Overall Study||294||
48306450|NCT04683731|101077414|FG001|STARTED|Overall Study||265||
48306451|NCT04683731|101077415|FG002|STARTED|Overall Study||262||
48306452|NCT04683731|101077416|FG003|STARTED|Overall Study||290||
48306453|NCT04683731|101077413|FG000|COMPLETED|Overall Study||290||
48306454|NCT04683731|101077414|FG001|COMPLETED|Overall Study||262||
48306455|NCT04683731|101077415|FG002|COMPLETED|Overall Study||247||
48306456|NCT04683731|101077416|FG003|COMPLETED|Overall Study||285||
48306457|NCT04683731|101077413|FG000|NOT COMPLETED|Overall Study||4||
48306458|NCT04683731|101077414|FG001|NOT COMPLETED|Overall Study||3||
48306459|NCT04683731|101077415|FG002|NOT COMPLETED|Overall Study||15||
48306460|NCT04683731|101077416|FG003|NOT COMPLETED|Overall Study||5||
48721147|NCT02391961|102102759|FG001|STARTED|First Intervention (4 Weeks)||9||
48721148|NCT02391961|102102758|FG000|COMPLETED|First Intervention (4 Weeks)||8||
48721149|NCT02391961|102102759|FG001|COMPLETED|First Intervention (4 Weeks)||9||
48721150|NCT02391961|102102758|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2||
48721151|NCT02391961|102102759|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0||
48721152|NCT02391961|102102758|FG000|STARTED|Washout (2 Weeks)||8||
48721153|NCT02391961|102102759|FG001|STARTED|Washout (2 Weeks)||9||
48721154|NCT02391961|102102758|FG000|COMPLETED|Washout (2 Weeks)||7||
48721155|NCT02391961|102102759|FG001|COMPLETED|Washout (2 Weeks)||8||
48721156|NCT02391961|102102758|FG000|NOT COMPLETED|Washout (2 Weeks)||1||
48721157|NCT02391961|102102759|FG001|NOT COMPLETED|Washout (2 Weeks)||1||
48721158|NCT02391961|102102758|FG000|STARTED|Second Intervention (4 Weeks)||7||
48721159|NCT02391961|102102759|FG001|STARTED|Second Intervention (4 Weeks)||8||
48721160|NCT02391961|102102758|FG000|COMPLETED|Second Intervention (4 Weeks)||6||
48721161|NCT02391961|102102759|FG001|COMPLETED|Second Intervention (4 Weeks)||7||
48721162|NCT02391961|102102758|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1||
48151479|NCT03030222|100692474|FG001|COMPLETED|Overall Study||32||
48721163|NCT02391961|102102759|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1||
48721164|NCT02565810|102102760|FG000|STARTED|Overall Study||49||
48721165|NCT02565810|102102760|FG000|COMPLETED|Overall Study||48||
48721166|NCT02565810|102102760|FG000|NOT COMPLETED|Overall Study||1||
48306461|NCT05505045|101077417|FG000|STARTED|Overall Study||23||
48306462|NCT05505045|101077418|FG001|STARTED|Overall Study||22||
48306463|NCT05505045|101077417|FG000|COMPLETED|Overall Study||21||
48306464|NCT05505045|101077418|FG001|COMPLETED|Overall Study||21||
48306465|NCT05505045|101077417|FG000|NOT COMPLETED|Overall Study||2||
48306466|NCT05505045|101077418|FG001|NOT COMPLETED|Overall Study||1||
48306467|NCT03952338|101077419|FG000|STARTED|Overall Study||143||
48306468|NCT03952338|101077420|FG001|STARTED|Overall Study||142||
48306469|NCT03952338|101077419|FG000|COMPLETED|Overall Study||130||
48306470|NCT03952338|101077420|FG001|COMPLETED|Overall Study||124||
48306471|NCT03952338|101077419|FG000|NOT COMPLETED|Overall Study||13||
48306472|NCT03952338|101077420|FG001|NOT COMPLETED|Overall Study||18||
48306473|NCT04622046|101077421|FG000|STARTED|Intervention Period||25||
48306474|NCT04622046|101077421|FG000|Received at Least 1 Dose of Study Drug|Intervention Period||25||
48306475|NCT04622046|101077421|FG000|COMPLETED|Intervention Period||22||
48306476|NCT04622046|101077421|FG000|NOT COMPLETED|Intervention Period||3||
48607994|NCT03173456|101827083|FG004|STARTED|Baseline||120||
48607995|NCT03173456|101827079|FG000|COMPLETED|Baseline||120||
48607996|NCT03173456|101827080|FG001|COMPLETED|Baseline||119||
48607997|NCT03173456|101827081|FG002|COMPLETED|Baseline||120||
48607998|NCT03173456|101827082|FG003|COMPLETED|Baseline||120||
48607999|NCT03173456|101827083|FG004|COMPLETED|Baseline||118||
48608000|NCT03173456|101827079|FG000|NOT COMPLETED|Baseline||0||
48608001|NCT03173456|101827080|FG001|NOT COMPLETED|Baseline||1||
48306477|NCT04622046|101077421|FG000|STARTED|Extension Period||21||
48306478|NCT04622046|101077421|FG000|COMPLETED|Extension Period||0||
48306479|NCT04622046|101077421|FG000|NOT COMPLETED|Extension Period||21||
48306480|NCT02811549|101077422|FG000|STARTED|Overall Study||24||
48608002|NCT03173456|101827081|FG002|NOT COMPLETED|Baseline||0||
48608003|NCT03173456|101827082|FG003|NOT COMPLETED|Baseline||0||
48608004|NCT03173456|101827083|FG004|NOT COMPLETED|Baseline||2||
48151480|NCT03030222|100692473|FG000|NOT COMPLETED|Overall Study||0||
48608005|NCT03173456|101827079|FG000|STARTED|2 Hour Follow-up||120||
48608006|NCT03173456|101827080|FG001|STARTED|2 Hour Follow-up||119||
48608007|NCT03173456|101827081|FG002|STARTED|2 Hour Follow-up||120||
48608008|NCT03173456|101827082|FG003|STARTED|2 Hour Follow-up||120||
48608009|NCT03173456|101827083|FG004|STARTED|2 Hour Follow-up||118||
48608010|NCT03173456|101827079|FG000|COMPLETED|2 Hour Follow-up||120||
48608011|NCT03173456|101827080|FG001|COMPLETED|2 Hour Follow-up||118||
48608012|NCT03173456|101827081|FG002|COMPLETED|2 Hour Follow-up||119||
48608013|NCT03173456|101827082|FG003|COMPLETED|2 Hour Follow-up||119||
48608014|NCT03173456|101827083|FG004|COMPLETED|2 Hour Follow-up||116||
48608015|NCT03173456|101827079|FG000|NOT COMPLETED|2 Hour Follow-up||0||
48608016|NCT03173456|101827080|FG001|NOT COMPLETED|2 Hour Follow-up||1||
48608017|NCT03173456|101827081|FG002|NOT COMPLETED|2 Hour Follow-up||1||
48608018|NCT03173456|101827082|FG003|NOT COMPLETED|2 Hour Follow-up||1||
48608019|NCT03173456|101827083|FG004|NOT COMPLETED|2 Hour Follow-up||2||
48608020|NCT04474054|101827084|FG000|STARTED|Overall Study||15||
48608021|NCT04474054|101827084|FG000|COMPLETED|Overall Study||15||
48608022|NCT04474054|101827084|FG000|NOT COMPLETED|Overall Study||0||
48151481|NCT03030222|100692474|FG001|NOT COMPLETED|Overall Study||0||
48306481|NCT02811549|101077422|FG000|COMPLETED|Overall Study||14||
48608023|NCT00948922|101827085|FG000|STARTED|Overall Study||34||
48608024|NCT00948922|101827086|FG001|STARTED|Overall Study||51||
48608025|NCT00948922|101827087|FG002|STARTED|Overall Study||39||
48608026|NCT00948922|101827085|FG000|COMPLETED|Overall Study||26||
48608027|NCT00948922|101827086|FG001|COMPLETED|Overall Study||37||
48306482|NCT02811549|101077422|FG000|NOT COMPLETED|Overall Study||10||
48306483|NCT04995419|101077423|FG000|STARTED|Overall Study||40||
48306484|NCT04995419|101077423|FG000|COMPLETED|Overall Study||0||
48608028|NCT00948922|101827087|FG002|COMPLETED|Overall Study||38||
48608029|NCT00948922|101827085|FG000|NOT COMPLETED|Overall Study||8||
48721167|NCT04033068|102102761|FG000|STARTED|Overall Study||14||
48721168|NCT04033068|102102762|FG001|STARTED|Overall Study||14||
48721169|NCT04033068|102102763|FG002|STARTED|Overall Study||12||
48721170|NCT04033068|102102764|FG003|STARTED|Overall Study||8||
48721171|NCT04033068|102102761|FG000|First Dose|Overall Study||14||
48721172|NCT04033068|102102762|FG001|First Dose|Overall Study||14||
48721173|NCT04033068|102102763|FG002|First Dose|Overall Study||12||
48721174|NCT04033068|102102764|FG003|First Dose|Overall Study||8||
48721175|NCT04033068|102102761|FG000|Second Dose|Overall Study||14||
48721176|NCT04033068|102102762|FG001|Second Dose|Overall Study||14||
48721177|NCT04033068|102102763|FG002|Second Dose|Overall Study||11||
48721178|NCT04033068|102102764|FG003|Second Dose|Overall Study||7||
48721179|NCT04033068|102102761|FG000|COMPLETED|Overall Study||14||
48721180|NCT04033068|102102762|FG001|COMPLETED|Overall Study||13||
48721181|NCT04033068|102102763|FG002|COMPLETED|Overall Study||11||
48721182|NCT04033068|102102764|FG003|COMPLETED|Overall Study||7||
48721183|NCT04033068|102102761|FG000|NOT COMPLETED|Overall Study||0||
48721184|NCT04033068|102102762|FG001|NOT COMPLETED|Overall Study||1||
48721185|NCT04033068|102102763|FG002|NOT COMPLETED|Overall Study||1||
48721186|NCT04033068|102102764|FG003|NOT COMPLETED|Overall Study||1||
48721187|NCT01291277|102102765|FG000|STARTED|Overall Study||45||
48721188|NCT01291277|102102766|FG001|STARTED|Overall Study||45||
48721189|NCT01291277|102102765|FG000|COMPLETED|Overall Study||40||
48721190|NCT01291277|102102766|FG001|COMPLETED|Overall Study||42||
48721191|NCT01291277|102102765|FG000|NOT COMPLETED|Overall Study||5||
48721192|NCT01291277|102102766|FG001|NOT COMPLETED|Overall Study||3||
48721193|NCT00007020|102102767|FG000|STARTED|Overall Study||85||
48721194|NCT00007020|102102767|FG000|COMPLETED|Overall Study||41||
48721195|NCT00007020|102102767|FG000|NOT COMPLETED|Overall Study||44||
48721196|NCT00548717|102105350|FG000|STARTED|Overall Study||13||
48721197|NCT00548717|102105351|FG001|STARTED|Overall Study||2||
48721198|NCT00548717|102105350|FG000|COMPLETED|Overall Study||4||
48721199|NCT00548717|102105351|FG001|COMPLETED|Overall Study||0||
48721200|NCT00548717|102105350|FG000|NOT COMPLETED|Overall Study||9||
48721201|NCT00548717|102105351|FG001|NOT COMPLETED|Overall Study||2||
48721202|NCT01263015|102105352|FG000|STARTED|Double-blind Phase: 96 Weeks Duration||414||
48721203|NCT01263015|102105353|FG001|STARTED|Double-blind Phase: 96 Weeks Duration||419||
48721204|NCT01263015|102105352|FG000|COMPLETED|Double-blind Phase: 96 Weeks Duration||342||
48721205|NCT01263015|102105353|FG001|COMPLETED|Double-blind Phase: 96 Weeks Duration||310||
48721206|NCT01263015|102105352|FG000|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||72||
48721207|NCT01263015|102105353|FG001|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||109||
48721208|NCT01263015|102105352|FG000|STARTED|Open-label Phase: 48 Weeks Duration||341||
48721209|NCT01263015|102105353|FG001|STARTED|Open-label Phase: 48 Weeks Duration||309||
48721210|NCT01263015|102105352|FG000|COMPLETED|Open-label Phase: 48 Weeks Duration||317||
48721211|NCT01263015|102105353|FG001|COMPLETED|Open-label Phase: 48 Weeks Duration||278||
48721212|NCT01263015|102105352|FG000|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||24||
48721213|NCT01263015|102105353|FG001|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||31||
48721214|NCT00924404|102105354|FG000|STARTED|Overall Study||27||
48721215|NCT00924404|102105355|FG001|STARTED|Overall Study||26||
48721216|NCT00924404|102105354|FG000|COMPLETED|Overall Study||21||
48721217|NCT00924404|102105355|FG001|COMPLETED|Overall Study||22||
48721218|NCT00924404|102105354|FG000|NOT COMPLETED|Overall Study||6||
48721219|NCT00924404|102105355|FG001|NOT COMPLETED|Overall Study||4||
48721220|NCT00689793|102105356|FG000|STARTED|Overall Study||78||
48721221|NCT00689793|102105357|FG001|STARTED|Overall Study||76||
48721222|NCT00689793|102105356|FG000|COMPLETED|Overall Study||74||
48721223|NCT00689793|102105357|FG001|COMPLETED|Overall Study||71||
48721224|NCT00689793|102105356|FG000|NOT COMPLETED|Overall Study||4||
48721225|NCT00689793|102105357|FG001|NOT COMPLETED|Overall Study||5||
48721226|NCT01497613|102105358|FG000|STARTED|Overall Study||150||
48721227|NCT01497613|102105359|FG001|STARTED|Overall Study||150||
48721228|NCT01497613|102105358|FG000|COMPLETED|Overall Study||113||
48721229|NCT01497613|102105359|FG001|COMPLETED|Overall Study||131||
48721230|NCT01497613|102105358|FG000|NOT COMPLETED|Overall Study||37||
48721231|NCT01497613|102105359|FG001|NOT COMPLETED|Overall Study||19||
48721232|NCT00889200|102105360|FG000|STARTED|Overall Study||12||
48721233|NCT00889200|102105360|FG000|COMPLETED|Overall Study||12||
48721234|NCT00889200|102105360|FG000|NOT COMPLETED|Overall Study||0||
48721235|NCT00612508|102105361|FG000|STARTED|Overall Study||7||
48721236|NCT00612508|102105362|FG001|STARTED|Overall Study||7||
48721237|NCT00612508|102105361|FG000|COMPLETED|Overall Study||4||
48721238|NCT00612508|102105362|FG001|COMPLETED|Overall Study||3||
48721239|NCT00612508|102105361|FG000|NOT COMPLETED|Overall Study||3||
48721240|NCT00612508|102105362|FG001|NOT COMPLETED|Overall Study||4||
48721241|NCT02404649|102105363|FG000|STARTED|Overall Study||17||
48721242|NCT02404649|102105364|FG001|STARTED|Overall Study||16||
48721243|NCT02404649|102105363|FG000|COMPLETED|Overall Study||16||
48721244|NCT02404649|102105364|FG001|COMPLETED|Overall Study||14||
48721245|NCT02404649|102105363|FG000|NOT COMPLETED|Overall Study||1||
48721246|NCT02404649|102105364|FG001|NOT COMPLETED|Overall Study||2||
48721247|NCT02210832|102105365|FG000|STARTED|Overall Study||91||
48721248|NCT02210832|102105366|FG001|STARTED|Overall Study||85||
48721249|NCT02210832|102105367|FG002|STARTED|Overall Study||81||
48721250|NCT02210832|102105365|FG000|COMPLETED|Overall Study||62|Defined as completed week-48 postpartum assessment.|
48721251|NCT02210832|102105366|FG001|COMPLETED|Overall Study||49|Defined as completed week-48 postpartum assessment.|
48767595|NCT00914316|102222779|FG003|STARTED|Phase 1||8||
48721252|NCT02210832|102105367|FG002|COMPLETED|Overall Study||63|Defined as completed week-48 postpartum assessment.|
48721253|NCT02210832|102105365|FG000|NOT COMPLETED|Overall Study||29||
48721254|NCT02210832|102105366|FG001|NOT COMPLETED|Overall Study||36||
48721255|NCT02210832|102105367|FG002|NOT COMPLETED|Overall Study||18||
48721256|NCT00897390|102105368|FG000|STARTED|Overall Study||24||
48721257|NCT00897390|102105368|FG000|COMPLETED|Overall Study||18||
48721258|NCT00897390|102105368|FG000|NOT COMPLETED|Overall Study||6||
48721259|NCT01378429|102105369|FG000|STARTED|Overall Study||42||
48721260|NCT01378429|102105370|FG001|STARTED|Overall Study||47||
48721261|NCT01378429|102105369|FG000|COMPLETED|Overall Study||41||
48721262|NCT01378429|102105370|FG001|COMPLETED|Overall Study||47||
48721263|NCT01378429|102105369|FG000|NOT COMPLETED|Overall Study||1||
48721264|NCT01378429|102105370|FG001|NOT COMPLETED|Overall Study||0||
48721265|NCT00552760|102105371|FG000|STARTED|Overall Study||42||
48721266|NCT00552760|102105372|FG001|STARTED|Overall Study||41||
48721267|NCT00552760|102105371|FG000|COMPLETED|Overall Study||16||
48721268|NCT00552760|102105372|FG001|COMPLETED|Overall Study||8||
48721269|NCT00552760|102105371|FG000|NOT COMPLETED|Overall Study||26||
48721270|NCT00552760|102105372|FG001|NOT COMPLETED|Overall Study||33||
48721271|NCT02903394|102105373|FG000|STARTED|Overall Study||5||
48721272|NCT02903394|102105374|FG001|STARTED|Overall Study||50||
48306485|NCT04995419|101077423|FG000|NOT COMPLETED|Overall Study||40||
48721273|NCT02903394|102105373|FG000|COMPLETED|Overall Study||5||
48721274|NCT02903394|102105374|FG001|COMPLETED|Overall Study||50||
48721275|NCT02903394|102105373|FG000|NOT COMPLETED|Overall Study||0||
48721276|NCT02903394|102105374|FG001|NOT COMPLETED|Overall Study||0||
48721277|NCT02266875|102105375|FG000|STARTED|Overall Study||40||
48721278|NCT02266875|102105376|FG001|STARTED|Overall Study||30||
48151482|NCT04918784|100692475|FG000|STARTED|Overall Study||25||
48151483|NCT04918784|100692476|FG001|STARTED|Overall Study||21||
48151484|NCT04918784|100692475|FG000|COMPLETED|Overall Study||19||
48151485|NCT04918784|100692476|FG001|COMPLETED|Overall Study||18||
48151486|NCT04918784|100692475|FG000|NOT COMPLETED|Overall Study||6||
48151487|NCT04918784|100692476|FG001|NOT COMPLETED|Overall Study||3||
48151488|NCT01132326|100692477|FG000|STARTED|Overall Study||350||
48151489|NCT01132326|100692477|FG000|COMPLETED|Overall Study||132||
48151490|NCT01132326|100692477|FG000|NOT COMPLETED|Overall Study||218||
48721279|NCT02266875|102105375|FG000|COMPLETED|Overall Study||29||
48721280|NCT02266875|102105376|FG001|COMPLETED|Overall Study||30||
48721281|NCT02266875|102105375|FG000|NOT COMPLETED|Overall Study||11||
48721282|NCT02266875|102105376|FG001|NOT COMPLETED|Overall Study||0||
48721283|NCT00885482|102105377|FG000|STARTED|Overall Study||40||
48721284|NCT00885482|102105377|FG000|COMPLETED|Overall Study||36||
48721285|NCT00885482|102105377|FG000|NOT COMPLETED|Overall Study||4||
48721286|NCT01742065|102105378|FG000|STARTED|Overall Study||20059||13
48721287|NCT01742065|102105379|FG001|STARTED|Overall Study||21134||13
48721288|NCT01742065|102105378|FG000|COMPLETED|Overall Study||20059||13
48721289|NCT01742065|102105379|FG001|COMPLETED|Overall Study||21134||13
48721290|NCT01742065|102105378|FG000|NOT COMPLETED|Overall Study||0||0
48721291|NCT01742065|102105379|FG001|NOT COMPLETED|Overall Study||0||0
48721292|NCT02925728|102105380|FG000|STARTED|Overall Study||22||
48151491|NCT05361655|100692478|FG000|STARTED|Overall Study||1324||
48151492|NCT05361655|100692479|FG001|STARTED|Overall Study||1564||
48151493|NCT05361655|100692478|FG000|COMPLETED|Overall Study||1324||
48151494|NCT05361655|100692479|FG001|COMPLETED|Overall Study||1564||
48151495|NCT05361655|100692478|FG000|NOT COMPLETED|Overall Study||0||
48151496|NCT05361655|100692479|FG001|NOT COMPLETED|Overall Study||0||
48151497|NCT00976352|100695803|FG000|STARTED|Overall Study||3||
48151498|NCT00976352|100695804|FG001|STARTED|Overall Study||10||
48151499|NCT00976352|100695803|FG000|COMPLETED|Overall Study||3||
48721293|NCT02925728|102105381|FG001|STARTED|Overall Study||25||
48721294|NCT02925728|102105380|FG000|COMPLETED|Overall Study||17||
48721295|NCT02925728|102105381|FG001|COMPLETED|Overall Study||20||
48721296|NCT02925728|102105380|FG000|NOT COMPLETED|Overall Study||5||
48721297|NCT02925728|102105381|FG001|NOT COMPLETED|Overall Study||5||
48151500|NCT00976352|100695804|FG001|COMPLETED|Overall Study||6||
48151501|NCT00976352|100695803|FG000|NOT COMPLETED|Overall Study||0||
48406137|NCT01060124|101328358|FG000|STARTED|Overall Study||103||
48406138|NCT01060124|101328358|FG000|COMPLETED|Overall Study||66||
48406139|NCT01060124|101328358|FG000|NOT COMPLETED|Overall Study||37||
48406140|NCT01229410|101328359|FG000|STARTED|Overall Study||12||
48406141|NCT01229410|101328360|FG001|STARTED|Overall Study||12||
48406142|NCT01229410|101328359|FG000|COMPLETED|Overall Study||7||
48721298|NCT04957758|102105382|FG000|STARTED|Overall Study||53||
48721299|NCT04957758|102105383|FG001|STARTED|Overall Study||60||
48721300|NCT04957758|102105382|FG000|COMPLETED|Overall Study||48||
48306486|NCT02901925|101077424|FG000|STARTED|Overall Study||3||
48306487|NCT02901925|101077425|FG001|STARTED|Overall Study||3||
48306488|NCT02901925|101077426|FG002|STARTED|Overall Study||6||
48721301|NCT04957758|102105383|FG001|COMPLETED|Overall Study||55||
48306489|NCT02901925|101077424|FG000|COMPLETED|Overall Study||3||
48306490|NCT02901925|101077425|FG001|COMPLETED|Overall Study||3||
48306491|NCT02901925|101077426|FG002|COMPLETED|Overall Study||6||
48306492|NCT02901925|101077424|FG000|NOT COMPLETED|Overall Study||0||
48306493|NCT02901925|101077425|FG001|NOT COMPLETED|Overall Study||0||
48306494|NCT02901925|101077426|FG002|NOT COMPLETED|Overall Study||0||
48306495|NCT04275297|101077427|FG000|STARTED|Overall Study||52||
48306496|NCT04275297|101077428|FG001|STARTED|Overall Study||26||
48306497|NCT04275297|101077427|FG000|Completed Optional In-person Assessment Including Quantitative Sensory Testing|Overall Study||29||
48306498|NCT04275297|101077428|FG001|Completed Optional In-person Assessment Including Quantitative Sensory Testing|Overall Study||11||
48306499|NCT04275297|101077427|FG000|COMPLETED|Overall Study||51||
48306500|NCT04275297|101077428|FG001|COMPLETED|Overall Study||25||
48306501|NCT04275297|101077427|FG000|NOT COMPLETED|Overall Study||1||
48306502|NCT04275297|101077428|FG001|NOT COMPLETED|Overall Study||1||
48406143|NCT01229410|101328360|FG001|COMPLETED|Overall Study||9||
48406144|NCT01229410|101328359|FG000|NOT COMPLETED|Overall Study||5||
48721302|NCT04957758|102105382|FG000|NOT COMPLETED|Overall Study||5||
48721303|NCT04957758|102105383|FG001|NOT COMPLETED|Overall Study||5||
48721304|NCT02986802|102105384|FG000|STARTED|Overall Study||1360||
48721305|NCT02986802|102105385|FG001|STARTED|Overall Study||2839||
48721306|NCT02986802|102105386|FG002|STARTED|Overall Study||1873||
48721307|NCT02986802|102105387|FG003|STARTED|Overall Study||83060||
48721308|NCT02986802|102105384|FG000|COMPLETED|Overall Study||1360||
48306503|NCT01005745|101077429|FG000|STARTED|Overall Study||19||
48406145|NCT01229410|101328360|FG001|NOT COMPLETED|Overall Study||3||
48721309|NCT02986802|102105385|FG001|COMPLETED|Overall Study||2839||
48721310|NCT02986802|102105386|FG002|COMPLETED|Overall Study||1873||
48406146|NCT03597789|101328361|FG000|STARTED|Overall Study||45||
48306504|NCT01005745|101077429|FG000|COMPLETED|Overall Study||13||
48306505|NCT01005745|101077429|FG000|NOT COMPLETED|Overall Study||6||
48306506|NCT03219320|101077430|FG000|STARTED|Overall Study||75||
48306507|NCT03219320|101077431|FG001|STARTED|Overall Study||77||
48306508|NCT03219320|101077432|FG002|STARTED|Overall Study||77||
48721311|NCT02986802|102105387|FG003|COMPLETED|Overall Study||83060||
48721312|NCT02986802|102105384|FG000|NOT COMPLETED|Overall Study||0||
48721313|NCT02986802|102105385|FG001|NOT COMPLETED|Overall Study||0||
48721314|NCT02986802|102105386|FG002|NOT COMPLETED|Overall Study||0||
48721315|NCT02986802|102105387|FG003|NOT COMPLETED|Overall Study||0||
48721316|NCT00896649|102105388|FG000|STARTED|Overall Study||193||
48721317|NCT00896649|102105388|FG000|COMPLETED|Overall Study||188||
48721318|NCT00896649|102105388|FG000|NOT COMPLETED|Overall Study||5||
48721319|NCT00203021|102105389|FG000|STARTED|Overall Study||107||
48721320|NCT00203021|102105390|FG001|STARTED|Overall Study||101||
48721321|NCT00203021|102105389|FG000|Received at Least 1 Dose of Study Drug|Overall Study||107||
48721322|NCT00203021|102105390|FG001|Received at Least 1 Dose of Study Drug|Overall Study||101||
48721323|NCT00203021|102105389|FG000|COMPLETED|Overall Study||28||
48721324|NCT00203021|102105390|FG001|COMPLETED|Overall Study||24||
48721325|NCT00203021|102105389|FG000|NOT COMPLETED|Overall Study||79||
48721326|NCT00203021|102105390|FG001|NOT COMPLETED|Overall Study||77||
48721327|NCT04232215|102105391|FG000|STARTED|First Intervention (8 Weeks)||28||
48721328|NCT04232215|102105392|FG001|STARTED|First Intervention (8 Weeks)||27||
48721329|NCT04232215|102105391|FG000|COMPLETED|First Intervention (8 Weeks)||28||
48306509|NCT03219320|101077433|FG003|STARTED|Overall Study||72||
48721330|NCT04232215|102105392|FG001|COMPLETED|First Intervention (8 Weeks)||25||
48721331|NCT04232215|102105391|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0||
48721332|NCT04232215|102105392|FG001|NOT COMPLETED|First Intervention (8 Weeks)||2||
48721333|NCT04232215|102105391|FG000|STARTED|Second Intervention (8 Weeks)||28||
48721334|NCT04232215|102105392|FG001|STARTED|Second Intervention (8 Weeks)||25||
48721335|NCT04232215|102105391|FG000|COMPLETED|Second Intervention (8 Weeks)||28||
48721336|NCT04232215|102105392|FG001|COMPLETED|Second Intervention (8 Weeks)||1||
48721337|NCT04232215|102105391|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0||
48721338|NCT04232215|102105392|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||24||
48721339|NCT02851823|102105393|FG000|STARTED|Overall Study||25||
48721340|NCT02851823|102105393|FG000|1 Month|Overall Study||25|1 month after therapy|
48721341|NCT02851823|102105393|FG000|3 Months|Overall Study||25|3 months after therapy|
48721342|NCT02851823|102105393|FG000|COMPLETED|Overall Study||25||
48721343|NCT02851823|102105393|FG000|NOT COMPLETED|Overall Study||0||
48721344|NCT00997620|102105394|FG000|STARTED|Overall Study||19||
48721345|NCT00997620|102105395|FG001|STARTED|Overall Study||21||
48721346|NCT00997620|102105394|FG000|COMPLETED|Overall Study||19||
48721347|NCT00997620|102105395|FG001|COMPLETED|Overall Study||21||
48721348|NCT00997620|102105394|FG000|NOT COMPLETED|Overall Study||0||
48721349|NCT00997620|102105395|FG001|NOT COMPLETED|Overall Study||0||
48721350|NCT01058941|102105396|FG000|STARTED|Overall Study||34||
48721351|NCT01058941|102105397|FG001|STARTED|Overall Study||33||
48721352|NCT01058941|102105396|FG000|COMPLETED|Overall Study||25||
48721353|NCT01058941|102105397|FG001|COMPLETED|Overall Study||22||
48306510|NCT03219320|101077430|FG000|COMPLETED|Overall Study||73||
48306511|NCT03219320|101077431|FG001|COMPLETED|Overall Study||74||
48306512|NCT03219320|101077432|FG002|COMPLETED|Overall Study||72||
48306513|NCT03219320|101077433|FG003|COMPLETED|Overall Study||69||
48306514|NCT03219320|101077430|FG000|NOT COMPLETED|Overall Study||2||
48721354|NCT01058941|102105396|FG000|NOT COMPLETED|Overall Study||9||
48721355|NCT01058941|102105397|FG001|NOT COMPLETED|Overall Study||11||
48721356|NCT00651625|102105398|FG000|STARTED|Overall Study||219||
48721357|NCT00651625|102105399|FG001|STARTED|Overall Study||218||
48721358|NCT00651625|102105398|FG000|COMPLETED|Overall Study||219||
48721359|NCT00651625|102105399|FG001|COMPLETED|Overall Study||218||
48721360|NCT00651625|102105398|FG000|NOT COMPLETED|Overall Study||0||
48721361|NCT00651625|102105399|FG001|NOT COMPLETED|Overall Study||0||
48721362|NCT01511809|102105400|FG000|STARTED|Overall Study||58||
48721363|NCT01511809|102105401|FG001|STARTED|Overall Study||59||
48721364|NCT01511809|102105400|FG000|COMPLETED|Overall Study||51||
48721365|NCT01511809|102105401|FG001|COMPLETED|Overall Study||52||
48721366|NCT01511809|102105400|FG000|NOT COMPLETED|Overall Study||7||
48721367|NCT01511809|102105401|FG001|NOT COMPLETED|Overall Study||7||
48721368|NCT02177838|102105402|FG000|STARTED|Overall Study||8||
48721369|NCT02177838|102105402|FG000|COMPLETED|Overall Study||5||
48721370|NCT02177838|102105402|FG000|NOT COMPLETED|Overall Study||3||
48721371|NCT00685373|102105403|FG000|STARTED|Overall Study||166||
48721372|NCT00685373|102105403|FG000|COMPLETED|Overall Study||151||
48721373|NCT00685373|102105403|FG000|NOT COMPLETED|Overall Study||15||
48721374|NCT05219669|102105404|FG000|STARTED|Period 1 (1 Day)||4||
48721375|NCT05219669|102105405|FG001|STARTED|Period 1 (1 Day)||4||
48721376|NCT05219669|102105406|FG002|STARTED|Period 1 (1 Day)||4||
48721377|NCT05219669|102105407|FG003|STARTED|Period 1 (1 Day)||4||
48721378|NCT05219669|102105408|FG004|STARTED|Period 1 (1 Day)||4||
48721379|NCT05219669|102105409|FG005|STARTED|Period 1 (1 Day)||4||
48721380|NCT05219669|102105404|FG000|COMPLETED|Period 1 (1 Day)||4||
48721381|NCT05219669|102105405|FG001|COMPLETED|Period 1 (1 Day)||4||
48721382|NCT05219669|102105406|FG002|COMPLETED|Period 1 (1 Day)||3||
48721383|NCT05219669|102105407|FG003|COMPLETED|Period 1 (1 Day)||4||
48721384|NCT05219669|102105408|FG004|COMPLETED|Period 1 (1 Day)||4||
48721385|NCT05219669|102105409|FG005|COMPLETED|Period 1 (1 Day)||4||
48721386|NCT05219669|102105404|FG000|NOT COMPLETED|Period 1 (1 Day)||0||
48721387|NCT05219669|102105405|FG001|NOT COMPLETED|Period 1 (1 Day)||0||
48306515|NCT03219320|101077431|FG001|NOT COMPLETED|Overall Study||3||
48306516|NCT03219320|101077432|FG002|NOT COMPLETED|Overall Study||5||
48306517|NCT03219320|101077433|FG003|NOT COMPLETED|Overall Study||3||
48306518|NCT03781323|101077434|FG000|STARTED|Overall Study||12||
48306519|NCT03781323|101077434|FG000|COMPLETED|Overall Study||11||
48306520|NCT03781323|101077434|FG000|NOT COMPLETED|Overall Study||1||
48306521|NCT00813319|101077435|FG000|STARTED|Overall Study||108||
48306522|NCT00813319|101077436|FG001|STARTED|Overall Study||108||
48721388|NCT05219669|102105406|FG002|NOT COMPLETED|Period 1 (1 Day)||1||
48721389|NCT05219669|102105407|FG003|NOT COMPLETED|Period 1 (1 Day)||0||
48721390|NCT05219669|102105408|FG004|NOT COMPLETED|Period 1 (1 Day)||0||
48721391|NCT05219669|102105409|FG005|NOT COMPLETED|Period 1 (1 Day)||0||
48721392|NCT05219669|102105404|FG000|STARTED|Washout (6 Days)||4||
48721393|NCT05219669|102105405|FG001|STARTED|Washout (6 Days)||4||
48721394|NCT05219669|102105406|FG002|STARTED|Washout (6 Days)||3||
48721395|NCT05219669|102105407|FG003|STARTED|Washout (6 Days)||4||
48721396|NCT05219669|102105408|FG004|STARTED|Washout (6 Days)||4||
48721397|NCT05219669|102105409|FG005|STARTED|Washout (6 Days)||4||
48721398|NCT05219669|102105404|FG000|COMPLETED|Washout (6 Days)||4||
48721399|NCT05219669|102105405|FG001|COMPLETED|Washout (6 Days)||4||
48721400|NCT05219669|102105406|FG002|COMPLETED|Washout (6 Days)||3||
48721401|NCT05219669|102105407|FG003|COMPLETED|Washout (6 Days)||4||
48721402|NCT05219669|102105408|FG004|COMPLETED|Washout (6 Days)||4||
48721403|NCT05219669|102105409|FG005|COMPLETED|Washout (6 Days)||4||
48721404|NCT05219669|102105404|FG000|NOT COMPLETED|Washout (6 Days)||0||
48721405|NCT05219669|102105405|FG001|NOT COMPLETED|Washout (6 Days)||0||
48721406|NCT05219669|102105406|FG002|NOT COMPLETED|Washout (6 Days)||0||
48721407|NCT05219669|102105407|FG003|NOT COMPLETED|Washout (6 Days)||0||
48721408|NCT05219669|102105408|FG004|NOT COMPLETED|Washout (6 Days)||0||
48721409|NCT05219669|102105409|FG005|NOT COMPLETED|Washout (6 Days)||0||
48721410|NCT05219669|102105404|FG000|STARTED|Period 2 (1 Day)||4||
48721411|NCT05219669|102105405|FG001|STARTED|Period 2 (1 Day)||4||
48721412|NCT05219669|102105406|FG002|STARTED|Period 2 (1 Day)||3||
48721413|NCT05219669|102105407|FG003|STARTED|Period 2 (1 Day)||4||
48721414|NCT05219669|102105408|FG004|STARTED|Period 2 (1 Day)||4||
48721415|NCT05219669|102105409|FG005|STARTED|Period 2 (1 Day)||4||
48306523|NCT00813319|101077435|FG000|COMPLETED|Overall Study||108||
48306524|NCT00813319|101077436|FG001|COMPLETED|Overall Study||108||
48721416|NCT05219669|102105404|FG000|COMPLETED|Period 2 (1 Day)||4||
48721417|NCT05219669|102105405|FG001|COMPLETED|Period 2 (1 Day)||4||
48721418|NCT05219669|102105406|FG002|COMPLETED|Period 2 (1 Day)||3||
48721419|NCT05219669|102105407|FG003|COMPLETED|Period 2 (1 Day)||4||
48721420|NCT05219669|102105408|FG004|COMPLETED|Period 2 (1 Day)||4||
48721421|NCT05219669|102105409|FG005|COMPLETED|Period 2 (1 Day)||4||
48721422|NCT05219669|102105404|FG000|NOT COMPLETED|Period 2 (1 Day)||0||
48306525|NCT00813319|101077435|FG000|NOT COMPLETED|Overall Study||0||
48306526|NCT00813319|101077436|FG001|NOT COMPLETED|Overall Study||0||
48306527|NCT00108069|101077437|FG000|STARTED|Overall Study||30||
48306528|NCT00108069|101077438|FG001|STARTED|Overall Study||13||
48721423|NCT05219669|102105405|FG001|NOT COMPLETED|Period 2 (1 Day)||0||
48721424|NCT05219669|102105406|FG002|NOT COMPLETED|Period 2 (1 Day)||0||
48721425|NCT05219669|102105407|FG003|NOT COMPLETED|Period 2 (1 Day)||0||
48721426|NCT05219669|102105408|FG004|NOT COMPLETED|Period 2 (1 Day)||0||
48721427|NCT05219669|102105409|FG005|NOT COMPLETED|Period 2 (1 Day)||0||
48721428|NCT05219669|102105404|FG000|STARTED|Washout (6 Days)||4||
48306529|NCT00108069|101077437|FG000|COMPLETED|Overall Study||0||
48721429|NCT05219669|102105405|FG001|STARTED|Washout (6 Days)||4||
48721430|NCT05219669|102105406|FG002|STARTED|Washout (6 Days)||3||
48721431|NCT05219669|102105407|FG003|STARTED|Washout (6 Days)||4||
48721432|NCT05219669|102105408|FG004|STARTED|Washout (6 Days)||4||
48721433|NCT05219669|102105409|FG005|STARTED|Washout (6 Days)||4||
48721434|NCT05219669|102105404|FG000|COMPLETED|Washout (6 Days)||4||
48721435|NCT05219669|102105405|FG001|COMPLETED|Washout (6 Days)||4||
48721436|NCT05219669|102105406|FG002|COMPLETED|Washout (6 Days)||3||
48721437|NCT05219669|102105407|FG003|COMPLETED|Washout (6 Days)||4||
48721438|NCT05219669|102105408|FG004|COMPLETED|Washout (6 Days)||4||
48721439|NCT05219669|102105409|FG005|COMPLETED|Washout (6 Days)||4||
48721440|NCT05219669|102105404|FG000|NOT COMPLETED|Washout (6 Days)||0||
48721441|NCT05219669|102105405|FG001|NOT COMPLETED|Washout (6 Days)||0||
48721442|NCT05219669|102105406|FG002|NOT COMPLETED|Washout (6 Days)||0||
48721443|NCT05219669|102105407|FG003|NOT COMPLETED|Washout (6 Days)||0||
48721444|NCT05219669|102105408|FG004|NOT COMPLETED|Washout (6 Days)||0||
48721445|NCT05219669|102105409|FG005|NOT COMPLETED|Washout (6 Days)||0||
48721446|NCT05219669|102105404|FG000|STARTED|Period 3 (1 Day)||4||
48721447|NCT05219669|102105405|FG001|STARTED|Period 3 (1 Day)||4||
48721448|NCT05219669|102105406|FG002|STARTED|Period 3 (1 Day)||3||
48721449|NCT05219669|102105407|FG003|STARTED|Period 3 (1 Day)||4||
48721450|NCT05219669|102105408|FG004|STARTED|Period 3 (1 Day)||4||
48721451|NCT05219669|102105409|FG005|STARTED|Period 3 (1 Day)||4||
48721452|NCT05219669|102105404|FG000|COMPLETED|Period 3 (1 Day)||4||
48721453|NCT05219669|102105405|FG001|COMPLETED|Period 3 (1 Day)||4||
48721454|NCT05219669|102105406|FG002|COMPLETED|Period 3 (1 Day)||3||
48721455|NCT05219669|102105407|FG003|COMPLETED|Period 3 (1 Day)||4||
48721456|NCT05219669|102105408|FG004|COMPLETED|Period 3 (1 Day)||4||
48721457|NCT05219669|102105409|FG005|COMPLETED|Period 3 (1 Day)||4||
48306530|NCT00108069|101077438|FG001|COMPLETED|Overall Study||0||
48306531|NCT00108069|101077437|FG000|NOT COMPLETED|Overall Study||30||
48306532|NCT00108069|101077438|FG001|NOT COMPLETED|Overall Study||13||
48306533|NCT02979925|101077439|FG000|STARTED|Overall Study||28||
48306534|NCT02979925|101077440|FG001|STARTED|Overall Study||29||
48306535|NCT02979925|101077439|FG000|COMPLETED|Overall Study||28||
48721458|NCT05219669|102105404|FG000|NOT COMPLETED|Period 3 (1 Day)||0||
48721459|NCT05219669|102105405|FG001|NOT COMPLETED|Period 3 (1 Day)||0||
48721460|NCT05219669|102105406|FG002|NOT COMPLETED|Period 3 (1 Day)||0||
48151502|NCT00976352|100695804|FG001|NOT COMPLETED|Overall Study||4||
48151503|NCT04839965|100695805|FG000|STARTED|Overall Study||21||
48151504|NCT04839965|100695806|FG001|STARTED|Overall Study||15||
48151505|NCT04839965|100695805|FG000|COMPLETED|Overall Study||14||
48151506|NCT04839965|100695806|FG001|COMPLETED|Overall Study||9||
48151507|NCT04839965|100695805|FG000|NOT COMPLETED|Overall Study||7||
48306536|NCT02979925|101077440|FG001|COMPLETED|Overall Study||23||
48306537|NCT02979925|101077439|FG000|NOT COMPLETED|Overall Study||0||
48306538|NCT02979925|101077440|FG001|NOT COMPLETED|Overall Study||6||
48306539|NCT02708095|101077441|FG000|STARTED|Overall Study||105||
48306540|NCT02708095|101077442|FG001|STARTED|Overall Study||105||
48306541|NCT02708095|101077443|FG002|STARTED|Overall Study||104||
48306542|NCT02708095|101077441|FG000|Received at Least 1 Dose of Study Drug|Overall Study||105||
48306543|NCT02708095|101077442|FG001|Received at Least 1 Dose of Study Drug|Overall Study||105||
48306544|NCT02708095|101077443|FG002|Received at Least 1 Dose of Study Drug|Overall Study||104||
48306545|NCT02708095|101077441|FG000|COMPLETED|Overall Study||83||
48306546|NCT02708095|101077442|FG001|COMPLETED|Overall Study||86||
48306547|NCT02708095|101077443|FG002|COMPLETED|Overall Study||86||
48721461|NCT05219669|102105407|FG003|NOT COMPLETED|Period 3 (1 Day)||0||
48721462|NCT05219669|102105408|FG004|NOT COMPLETED|Period 3 (1 Day)||0||
48721463|NCT05219669|102105409|FG005|NOT COMPLETED|Period 3 (1 Day)||0||
48721464|NCT00324233|102105410|FG000|STARTED|First Period||18||
48721465|NCT00324233|102105411|FG001|STARTED|First Period||18||
48721466|NCT00324233|102105410|FG000|COMPLETED|First Period||17||
48721467|NCT00324233|102105411|FG001|COMPLETED|First Period||18||
48721468|NCT00324233|102105410|FG000|NOT COMPLETED|First Period||1||
48721469|NCT00324233|102105411|FG001|NOT COMPLETED|First Period||0||
48721470|NCT00324233|102105410|FG000|STARTED|Second Period||17||
48721471|NCT00324233|102105411|FG001|STARTED|Second Period||18||
48151508|NCT04839965|100695806|FG001|NOT COMPLETED|Overall Study||6||
48151509|NCT00238433|100695807|FG000|STARTED|Overall Study||37||
48151510|NCT00238433|100695807|FG000|COMPLETED|Overall Study||34||
48151511|NCT00238433|100695807|FG000|NOT COMPLETED|Overall Study||3||
48151512|NCT02332720|100695808|FG000|STARTED|Part A and Part B||21||
48151513|NCT02332720|100695809|FG001|STARTED|Part A and Part B||21||
48151514|NCT02332720|100695810|FG002|STARTED|Part A and Part B||22||
48151515|NCT02332720|100695811|FG003|STARTED|Part A and Part B||22||
48721472|NCT00324233|102105410|FG000|COMPLETED|Second Period||12||
48151516|NCT02332720|100695812|FG004|STARTED|Part A and Part B||16||
48151517|NCT02332720|100695813|FG005|STARTED|Part A and Part B||36||
48151518|NCT02332720|100695814|FG006|STARTED|Part A and Part B||37||
48721473|NCT00324233|102105411|FG001|COMPLETED|Second Period||11||
48721474|NCT00324233|102105410|FG000|NOT COMPLETED|Second Period||5||
48721475|NCT00324233|102105411|FG001|NOT COMPLETED|Second Period||7||
48608030|NCT00948922|101827086|FG001|NOT COMPLETED|Overall Study||14||
48306548|NCT02708095|101077441|FG000|NOT COMPLETED|Overall Study||22||
48608031|NCT00948922|101827087|FG002|NOT COMPLETED|Overall Study||1||
48608032|NCT03852498|101827088|FG000|STARTED|Overall Study||35||
48608033|NCT03852498|101827088|FG000|COMPLETED|Overall Study||35||
48608034|NCT03852498|101827088|FG000|NOT COMPLETED|Overall Study||0||
48608035|NCT02906579|101827089|FG000|STARTED|Overall Study||11||
48608036|NCT02906579|101827089|FG000|Completed Cycle 1 (Placebo)|Overall Study||11||
48608037|NCT02906579|101827089|FG000|Completed Cycle 2 (10 mg IW-1973)|Overall Study||11||
48608038|NCT02906579|101827089|FG000|Completed Cycle 3 (20 mg IW-1973)|Overall Study||11||
48608039|NCT02906579|101827089|FG000|Completed Cycle 4 (30 mg IW-1973)|Overall Study||10||
48608040|NCT02906579|101827089|FG000|Completed Cycle 5 (40 mg IW-1973)|Overall Study||9||
48608041|NCT02906579|101827089|FG000|Completed Cycle 6 (50 mg IW-1973)|Overall Study||9||
48608042|NCT02906579|101827089|FG000|COMPLETED|Overall Study||9||
48608043|NCT02906579|101827089|FG000|NOT COMPLETED|Overall Study||2||
48608044|NCT04074330|101827090|FG000|STARTED|Dose Escalation (up to 19.36 Months)||3||
48608045|NCT04074330|101827091|FG001|STARTED|Dose Escalation (up to 19.36 Months)||4||
48608046|NCT04074330|101827092|FG002|STARTED|Dose Escalation (up to 19.36 Months)||3||
48608047|NCT04074330|101827093|FG003|STARTED|Dose Escalation (up to 19.36 Months)||7||
48608048|NCT04074330|101827094|FG004|STARTED|Dose Escalation (up to 19.36 Months)||8||
48608049|NCT04074330|101827095|FG005|STARTED|Dose Escalation (up to 19.36 Months)||6||
48608050|NCT04074330|101827096|FG006|STARTED|Dose Escalation (up to 19.36 Months)||1||
48608051|NCT04074330|101827097|FG007|STARTED|Dose Escalation (up to 19.36 Months)||3||
48608052|NCT04074330|101827098|FG008|STARTED|Dose Escalation (up to 19.36 Months)||0||
48608053|NCT04074330|101827099|FG009|STARTED|Dose Escalation (up to 19.36 Months)||0||
48608054|NCT04074330|101827090|FG000|COMPLETED|Dose Escalation (up to 19.36 Months)||0||
48608055|NCT04074330|101827091|FG001|COMPLETED|Dose Escalation (up to 19.36 Months)||0||
48608056|NCT04074330|101827092|FG002|COMPLETED|Dose Escalation (up to 19.36 Months)||0||
48608057|NCT04074330|101827093|FG003|COMPLETED|Dose Escalation (up to 19.36 Months)||0||
48608058|NCT04074330|101827094|FG004|COMPLETED|Dose Escalation (up to 19.36 Months)||0||
48608059|NCT04074330|101827095|FG005|COMPLETED|Dose Escalation (up to 19.36 Months)||0||
48608060|NCT04074330|101827096|FG006|COMPLETED|Dose Escalation (up to 19.36 Months)||0||
48608061|NCT04074330|101827097|FG007|COMPLETED|Dose Escalation (up to 19.36 Months)||0||
48608062|NCT04074330|101827098|FG008|COMPLETED|Dose Escalation (up to 19.36 Months)||0||
48608063|NCT04074330|101827099|FG009|COMPLETED|Dose Escalation (up to 19.36 Months)||0||
48608064|NCT04074330|101827090|FG000|NOT COMPLETED|Dose Escalation (up to 19.36 Months)||3||
48608065|NCT04074330|101827091|FG001|NOT COMPLETED|Dose Escalation (up to 19.36 Months)||4||
48608066|NCT04074330|101827092|FG002|NOT COMPLETED|Dose Escalation (up to 19.36 Months)||3||
48608067|NCT04074330|101827093|FG003|NOT COMPLETED|Dose Escalation (up to 19.36 Months)||7||
48608068|NCT04074330|101827094|FG004|NOT COMPLETED|Dose Escalation (up to 19.36 Months)||8||
48608069|NCT04074330|101827095|FG005|NOT COMPLETED|Dose Escalation (up to 19.36 Months)||6||
48608070|NCT04074330|101827096|FG006|NOT COMPLETED|Dose Escalation (up to 19.36 Months)||1||
48608071|NCT04074330|101827097|FG007|NOT COMPLETED|Dose Escalation (up to 19.36 Months)||3||
48608072|NCT04074330|101827098|FG008|NOT COMPLETED|Dose Escalation (up to 19.36 Months)||0||
48608073|NCT04074330|101827099|FG009|NOT COMPLETED|Dose Escalation (up to 19.36 Months)||0||
48608074|NCT04074330|101827090|FG000|STARTED|Dose Expansion (up to 42 Months)||0||
48608075|NCT04074330|101827091|FG001|STARTED|Dose Expansion (up to 42 Months)||0||
48608076|NCT04074330|101827092|FG002|STARTED|Dose Expansion (up to 42 Months)||0||
48608077|NCT04074330|101827093|FG003|STARTED|Dose Expansion (up to 42 Months)||0||
48608078|NCT04074330|101827094|FG004|STARTED|Dose Expansion (up to 42 Months)||0||
48608079|NCT04074330|101827095|FG005|STARTED|Dose Expansion (up to 42 Months)||0||
48608080|NCT04074330|101827096|FG006|STARTED|Dose Expansion (up to 42 Months)||0||
48608081|NCT04074330|101827097|FG007|STARTED|Dose Expansion (up to 42 Months)||0||
48608082|NCT04074330|101827098|FG008|STARTED|Dose Expansion (up to 42 Months)||2||
48608083|NCT04074330|101827099|FG009|STARTED|Dose Expansion (up to 42 Months)||1||
48608084|NCT04074330|101827090|FG000|COMPLETED|Dose Expansion (up to 42 Months)||0||
48608085|NCT04074330|101827091|FG001|COMPLETED|Dose Expansion (up to 42 Months)||0||
48608086|NCT04074330|101827092|FG002|COMPLETED|Dose Expansion (up to 42 Months)||0||
48608087|NCT04074330|101827093|FG003|COMPLETED|Dose Expansion (up to 42 Months)||0||
48608088|NCT04074330|101827094|FG004|COMPLETED|Dose Expansion (up to 42 Months)||0||
48608089|NCT04074330|101827095|FG005|COMPLETED|Dose Expansion (up to 42 Months)||0||
48608090|NCT04074330|101827096|FG006|COMPLETED|Dose Expansion (up to 42 Months)||0||
48608091|NCT04074330|101827097|FG007|COMPLETED|Dose Expansion (up to 42 Months)||0||
48608092|NCT04074330|101827098|FG008|COMPLETED|Dose Expansion (up to 42 Months)||0||
48721476|NCT02434328|102105412|FG000|STARTED|Overall Study||372|All randomized subjects|
48721477|NCT02434328|102105413|FG001|STARTED|Overall Study||371|All randomized subjects|
48721478|NCT02434328|102105412|FG000|Randomized and Treated|Overall Study||370||
48721479|NCT02434328|102105413|FG001|Randomized and Treated|Overall Study||369||
48721480|NCT02434328|102105412|FG000|COMPLETED|Overall Study||342||
48306549|NCT02708095|101077442|FG001|NOT COMPLETED|Overall Study||19||
48306550|NCT02708095|101077443|FG002|NOT COMPLETED|Overall Study||18||
48306551|NCT00935272|101077444|FG000|STARTED|Overall Study||135||
48306552|NCT00935272|101077445|FG001|STARTED|Overall Study||45||
48306553|NCT00935272|101077444|FG000|COMPLETED|Overall Study||116||
48306554|NCT00935272|101077445|FG001|COMPLETED|Overall Study||39||
48151519|NCT02332720|100695815|FG007|STARTED|Part A and Part B||35||
48151520|NCT02332720|100695816|FG008|STARTED|Part A and Part B||15||
48151521|NCT02332720|100695817|FG009|STARTED|Part A and Part B||14||
48151522|NCT02332720|100695818|FG010|STARTED|Part A and Part B||14||
48151523|NCT02332720|100695819|FG011|STARTED|Part A and Part B||15||
48151524|NCT02332720|100695820|FG012|STARTED|Part A and Part B||16||
48151525|NCT02332720|100695821|FG013|STARTED|Part A and Part B||13||
48151526|NCT02332720|100695822|FG014|STARTED|Part A and Part B||16||
48151527|NCT02332720|100695823|FG015|STARTED|Part A and Part B||14||
48151528|NCT02332720|100695824|FG016|STARTED|Part A and Part B||15||
48151529|NCT02332720|100695825|FG017|STARTED|Part A and Part B||14||
48151530|NCT02332720|100695826|FG018|STARTED|Part A and Part B||21||
48306555|NCT00935272|101077444|FG000|NOT COMPLETED|Overall Study||19||
48306556|NCT00935272|101077445|FG001|NOT COMPLETED|Overall Study||6||
48306557|NCT00995007|101077446|FG000|STARTED|Overall Study||56||
48406147|NCT03597789|101328361|FG000|COMPLETED|Overall Study||10||
48406148|NCT03597789|101328361|FG000|NOT COMPLETED|Overall Study||35||
48406149|NCT00486889|101328362|FG000|STARTED|Overall Study||12||
48406150|NCT00486889|101328362|FG000|COMPLETED|Overall Study||1||
48721481|NCT02434328|102105413|FG001|COMPLETED|Overall Study||329||
48721482|NCT02434328|102105412|FG000|NOT COMPLETED|Overall Study||30||
48721483|NCT02434328|102105413|FG001|NOT COMPLETED|Overall Study||42||
48721484|NCT02006069|102105414|FG000|STARTED|Overall Study||510||
48721485|NCT02006069|102105415|FG001|STARTED|Overall Study||558||
48721486|NCT02006069|102105414|FG000|COMPLETED|Overall Study||271||
48721487|NCT02006069|102105415|FG001|COMPLETED|Overall Study||555||
48721488|NCT02006069|102105414|FG000|NOT COMPLETED|Overall Study||239||
48721489|NCT02006069|102105415|FG001|NOT COMPLETED|Overall Study||3||
48721490|NCT02504931|102105416|FG000|STARTED|Overall Study||26||
48151531|NCT02332720|100695827|FG019|STARTED|Part A and Part B||25||
48151532|NCT02332720|100695828|FG020|STARTED|Part A and Part B||7||
48151533|NCT02332720|100695829|FG021|STARTED|Part A and Part B||0||
48151534|NCT02332720|100695830|FG022|STARTED|Part A and Part B||4||
48151535|NCT02332720|100695808|FG000|Treated|Part A and Part B||21||
48151536|NCT02332720|100695809|FG001|Treated|Part A and Part B||21||
48151537|NCT02332720|100695810|FG002|Treated|Part A and Part B||22||
48151538|NCT02332720|100695811|FG003|Treated|Part A and Part B||22||
48151539|NCT02332720|100695812|FG004|Treated|Part A and Part B||16||
48151540|NCT02332720|100695813|FG005|Treated|Part A and Part B||36||
48151541|NCT02332720|100695814|FG006|Treated|Part A and Part B||37||
48151542|NCT02332720|100695815|FG007|Treated|Part A and Part B||35||
48151543|NCT02332720|100695816|FG008|Treated|Part A and Part B||15||
48151544|NCT02332720|100695817|FG009|Treated|Part A and Part B||14||
48151545|NCT02332720|100695818|FG010|Treated|Part A and Part B||14||
48151546|NCT02332720|100695819|FG011|Treated|Part A and Part B||15||
48151547|NCT02332720|100695820|FG012|Treated|Part A and Part B||16||
48151548|NCT02332720|100695821|FG013|Treated|Part A and Part B||13||
48151549|NCT02332720|100695822|FG014|Treated|Part A and Part B||16||
48151550|NCT02332720|100695823|FG015|Treated|Part A and Part B||14||
48306558|NCT00995007|101077447|FG001|STARTED|Overall Study||56||
48306559|NCT00995007|101077446|FG000|Crossover to Vandetanib|Overall Study||42||
48306560|NCT00995007|101077447|FG001|Crossover to Vandetanib|Overall Study||0||
48306561|NCT00995007|101077446|FG000|COMPLETED|Overall Study||39||
48306562|NCT00995007|101077447|FG001|COMPLETED|Overall Study||54||
48306563|NCT00995007|101077446|FG000|NOT COMPLETED|Overall Study||17||
48406151|NCT00486889|101328362|FG000|NOT COMPLETED|Overall Study||11||
48151551|NCT02332720|100695824|FG016|Treated|Part A and Part B||15||
48721491|NCT02504931|102105417|FG001|STARTED|Overall Study||23||
48151552|NCT02332720|100695825|FG017|Treated|Part A and Part B||14||
48151553|NCT02332720|100695826|FG018|Treated|Part A and Part B||20||
48151554|NCT02332720|100695827|FG019|Treated|Part A and Part B||25||
48151555|NCT02332720|100695828|FG020|Treated|Part A and Part B||7||
48151556|NCT02332720|100695829|FG021|Treated|Part A and Part B||0||
48608093|NCT04074330|101827099|FG009|COMPLETED|Dose Expansion (up to 42 Months)||0||
48608094|NCT04074330|101827090|FG000|NOT COMPLETED|Dose Expansion (up to 42 Months)||0||
48608095|NCT04074330|101827091|FG001|NOT COMPLETED|Dose Expansion (up to 42 Months)||0||
48608096|NCT04074330|101827092|FG002|NOT COMPLETED|Dose Expansion (up to 42 Months)||0||
48608097|NCT04074330|101827093|FG003|NOT COMPLETED|Dose Expansion (up to 42 Months)||0||
48608098|NCT04074330|101827094|FG004|NOT COMPLETED|Dose Expansion (up to 42 Months)||0||
48608099|NCT04074330|101827095|FG005|NOT COMPLETED|Dose Expansion (up to 42 Months)||0||
48608100|NCT04074330|101827096|FG006|NOT COMPLETED|Dose Expansion (up to 42 Months)||0||
48608101|NCT04074330|101827097|FG007|NOT COMPLETED|Dose Expansion (up to 42 Months)||0||
48608102|NCT04074330|101827098|FG008|NOT COMPLETED|Dose Expansion (up to 42 Months)||2||
48608103|NCT04074330|101827099|FG009|NOT COMPLETED|Dose Expansion (up to 42 Months)||1||
48608104|NCT04336475|101827100|FG000|STARTED|Overall Study||30||
48608105|NCT04336475|101827101|FG001|STARTED|Overall Study||30||
48608106|NCT04336475|101827100|FG000|COMPLETED|Overall Study||28||
48608107|NCT04336475|101827101|FG001|COMPLETED|Overall Study||28||
48608108|NCT04336475|101827100|FG000|NOT COMPLETED|Overall Study||2||
48608109|NCT04336475|101827101|FG001|NOT COMPLETED|Overall Study||2||
48608110|NCT02081014|101827102|FG000|STARTED|Overall Study||2||
48608111|NCT02081014|101827103|FG001|STARTED|Overall Study||2||
48608112|NCT02081014|101827104|FG002|STARTED|Overall Study||2||
48608113|NCT02081014|101827105|FG003|STARTED|Overall Study||2||
48608114|NCT02081014|101827106|FG004|STARTED|Overall Study||2||
48608115|NCT02081014|101827107|FG005|STARTED|Overall Study||2||
48608116|NCT02081014|101827102|FG000|COMPLETED|Overall Study||2||
48151557|NCT02332720|100695830|FG022|Treated|Part A and Part B||4||
48151558|NCT02332720|100695808|FG000|COMPLETED|Part A and Part B||20||
48151559|NCT02332720|100695809|FG001|COMPLETED|Part A and Part B||21||
48151560|NCT02332720|100695810|FG002|COMPLETED|Part A and Part B||22||
48151561|NCT02332720|100695811|FG003|COMPLETED|Part A and Part B||22||
48151562|NCT02332720|100695812|FG004|COMPLETED|Part A and Part B||16||
48151563|NCT02332720|100695813|FG005|COMPLETED|Part A and Part B||33||
48151564|NCT02332720|100695814|FG006|COMPLETED|Part A and Part B||36||
48151565|NCT02332720|100695815|FG007|COMPLETED|Part A and Part B||34||
48151566|NCT02332720|100695816|FG008|COMPLETED|Part A and Part B||15||
48151567|NCT02332720|100695817|FG009|COMPLETED|Part A and Part B||14||
48151568|NCT02332720|100695818|FG010|COMPLETED|Part A and Part B||14||
48151569|NCT02332720|100695819|FG011|COMPLETED|Part A and Part B||15||
48151570|NCT02332720|100695820|FG012|COMPLETED|Part A and Part B||16||
48151571|NCT02332720|100695821|FG013|COMPLETED|Part A and Part B||13||
48608117|NCT02081014|101827103|FG001|COMPLETED|Overall Study||2||
48608118|NCT02081014|101827104|FG002|COMPLETED|Overall Study||2||
48608119|NCT02081014|101827105|FG003|COMPLETED|Overall Study||2||
48608120|NCT02081014|101827106|FG004|COMPLETED|Overall Study||2||
48608121|NCT02081014|101827107|FG005|COMPLETED|Overall Study||2||
48608122|NCT02081014|101827102|FG000|NOT COMPLETED|Overall Study||0||
48608123|NCT02081014|101827103|FG001|NOT COMPLETED|Overall Study||0||
48608124|NCT02081014|101827104|FG002|NOT COMPLETED|Overall Study||0||
48608125|NCT02081014|101827105|FG003|NOT COMPLETED|Overall Study||0||
48608126|NCT02081014|101827106|FG004|NOT COMPLETED|Overall Study||0||
48608127|NCT02081014|101827107|FG005|NOT COMPLETED|Overall Study||0||
48151572|NCT02332720|100695822|FG014|COMPLETED|Part A and Part B||16||
48151573|NCT02332720|100695823|FG015|COMPLETED|Part A and Part B||13||
48151574|NCT02332720|100695824|FG016|COMPLETED|Part A and Part B||15||
48151575|NCT02332720|100695825|FG017|COMPLETED|Part A and Part B||13||
48151576|NCT02332720|100695826|FG018|COMPLETED|Part A and Part B||20||
48151577|NCT02332720|100695827|FG019|COMPLETED|Part A and Part B||24||
48151578|NCT02332720|100695828|FG020|COMPLETED|Part A and Part B||7||
48151579|NCT02332720|100695829|FG021|COMPLETED|Part A and Part B||0||
48151580|NCT02332720|100695830|FG022|COMPLETED|Part A and Part B||4||
48151581|NCT02332720|100695808|FG000|NOT COMPLETED|Part A and Part B||1||
48151582|NCT02332720|100695809|FG001|NOT COMPLETED|Part A and Part B||0||
48151583|NCT02332720|100695810|FG002|NOT COMPLETED|Part A and Part B||0||
48151584|NCT02332720|100695811|FG003|NOT COMPLETED|Part A and Part B||0||
48151585|NCT02332720|100695812|FG004|NOT COMPLETED|Part A and Part B||0||
48151586|NCT02332720|100695813|FG005|NOT COMPLETED|Part A and Part B||3||
48151587|NCT02332720|100695814|FG006|NOT COMPLETED|Part A and Part B||1||
48151588|NCT02332720|100695815|FG007|NOT COMPLETED|Part A and Part B||1||
48151589|NCT02332720|100695816|FG008|NOT COMPLETED|Part A and Part B||0||
48151590|NCT02332720|100695817|FG009|NOT COMPLETED|Part A and Part B||0||
48151591|NCT02332720|100695818|FG010|NOT COMPLETED|Part A and Part B||0||
48608128|NCT01509664|101827108|FG000|STARTED|Overall Study||49||
48608129|NCT01509664|101827109|FG001|STARTED|Overall Study||49||
48608130|NCT01509664|101827108|FG000|T2 Follow-up|Overall Study||45||
48608131|NCT01509664|101827109|FG001|T2 Follow-up|Overall Study||38||
48608132|NCT01509664|101827108|FG000|T3 Follow-up|Overall Study||40||
48151592|NCT02332720|100695819|FG011|NOT COMPLETED|Part A and Part B||0||
48608133|NCT01509664|101827109|FG001|T3 Follow-up|Overall Study||33||
48608134|NCT01509664|101827108|FG000|COMPLETED|Overall Study||34||
48608135|NCT01509664|101827109|FG001|COMPLETED|Overall Study||28||
48608136|NCT01509664|101827108|FG000|NOT COMPLETED|Overall Study||15||
48608137|NCT01509664|101827109|FG001|NOT COMPLETED|Overall Study||21||
48608138|NCT02082769|101827110|FG000|STARTED|Overall Study||168||
48306564|NCT00995007|101077447|FG001|NOT COMPLETED|Overall Study||2||
48721492|NCT02504931|102105416|FG000|COMPLETED|Overall Study||14||
48721493|NCT02504931|102105417|FG001|COMPLETED|Overall Study||13||
48721494|NCT02504931|102105416|FG000|NOT COMPLETED|Overall Study||12||
48721495|NCT02504931|102105417|FG001|NOT COMPLETED|Overall Study||10||
48721496|NCT01030874|102105418|FG000|STARTED|Overall Study||178||
48721497|NCT01030874|102105419|FG001|STARTED|Overall Study||178||
48721498|NCT01030874|102105418|FG000|COMPLETED|Overall Study||160||
48721499|NCT01030874|102105419|FG001|COMPLETED|Overall Study||162||
48721500|NCT01030874|102105418|FG000|NOT COMPLETED|Overall Study||18||
48151593|NCT02332720|100695820|FG012|NOT COMPLETED|Part A and Part B||0||
48151594|NCT02332720|100695821|FG013|NOT COMPLETED|Part A and Part B||0||
48151595|NCT02332720|100695822|FG014|NOT COMPLETED|Part A and Part B||0||
48151596|NCT02332720|100695823|FG015|NOT COMPLETED|Part A and Part B||1||
48151597|NCT02332720|100695824|FG016|NOT COMPLETED|Part A and Part B||0||
48151598|NCT02332720|100695825|FG017|NOT COMPLETED|Part A and Part B||1||
48608139|NCT02082769|101827111|FG001|STARTED|Overall Study||168||
48608140|NCT02082769|101827112|FG002|STARTED|Overall Study||168||
48608141|NCT02082769|101827110|FG000|COMPLETED|Overall Study||144||
48608142|NCT02082769|101827111|FG001|COMPLETED|Overall Study||141||
48608143|NCT02082769|101827112|FG002|COMPLETED|Overall Study||132||
48608144|NCT02082769|101827110|FG000|NOT COMPLETED|Overall Study||24||
48608145|NCT02082769|101827111|FG001|NOT COMPLETED|Overall Study||27||
48721501|NCT01030874|102105419|FG001|NOT COMPLETED|Overall Study||16||
48721502|NCT01927055|102105420|FG000|STARTED|Open-label||61||
48721503|NCT01927055|102105421|FG001|STARTED|Open-label||0||
48721504|NCT01927055|102105422|FG002|STARTED|Open-label||0||
48721505|NCT01927055|102105420|FG000|COMPLETED|Open-label||45||
48721506|NCT01927055|102105421|FG001|COMPLETED|Open-label||0||
48721507|NCT01927055|102105422|FG002|COMPLETED|Open-label||0||
48721508|NCT01927055|102105420|FG000|NOT COMPLETED|Open-label||16||
48721509|NCT01927055|102105421|FG001|NOT COMPLETED|Open-label||0||
48721510|NCT01927055|102105422|FG002|NOT COMPLETED|Open-label||0||
48721511|NCT01927055|102105420|FG000|STARTED|Double-Blind||0||
48721512|NCT01927055|102105421|FG001|STARTED|Double-Blind||22||
48721513|NCT01927055|102105422|FG002|STARTED|Double-Blind||23||
48721514|NCT01927055|102105420|FG000|COMPLETED|Double-Blind||0||
48721515|NCT01927055|102105421|FG001|COMPLETED|Double-Blind||11||
48721516|NCT01927055|102105422|FG002|COMPLETED|Double-Blind||10||
48721517|NCT01927055|102105420|FG000|NOT COMPLETED|Double-Blind||0||
48721518|NCT01927055|102105421|FG001|NOT COMPLETED|Double-Blind||11||
48721519|NCT01927055|102105422|FG002|NOT COMPLETED|Double-Blind||13||
48721520|NCT03298841|102105423|FG000|STARTED|Overall Study||25||
48721521|NCT03298841|102105424|FG001|STARTED|Overall Study||25||
48721522|NCT03298841|102105423|FG000|COMPLETED|Overall Study||25||
48721523|NCT03298841|102105424|FG001|COMPLETED|Overall Study||25||
48721524|NCT03298841|102105423|FG000|NOT COMPLETED|Overall Study||0||
48721525|NCT03298841|102105424|FG001|NOT COMPLETED|Overall Study||0||
48721526|NCT02981966|102105425|FG000|STARTED|Overall Study||13||
48721527|NCT02981966|102105426|FG001|STARTED|Overall Study||7||
48721528|NCT02981966|102105427|FG002|STARTED|Overall Study||8||
48721529|NCT02981966|102105428|FG003|STARTED|Overall Study||4||
48721530|NCT02981966|102105425|FG000|COMPLETED|Overall Study||13||
48721531|NCT02981966|102105426|FG001|COMPLETED|Overall Study||7||
48151599|NCT02332720|100695826|FG018|NOT COMPLETED|Part A and Part B||1||
48151600|NCT02332720|100695827|FG019|NOT COMPLETED|Part A and Part B||1||
48151601|NCT02332720|100695828|FG020|NOT COMPLETED|Part A and Part B||0||
48151602|NCT02332720|100695829|FG021|NOT COMPLETED|Part A and Part B||0||
48151603|NCT02332720|100695830|FG022|NOT COMPLETED|Part A and Part B||0||
48151604|NCT02332720|100695808|FG000|STARTED|Part C||2||
48151605|NCT02332720|100695809|FG001|STARTED|Part C||1||
48151606|NCT02332720|100695810|FG002|STARTED|Part C||3||
48151607|NCT02332720|100695811|FG003|STARTED|Part C||2||
48151608|NCT02332720|100695812|FG004|STARTED|Part C||0||
48151609|NCT02332720|100695813|FG005|STARTED|Part C||0||
48151610|NCT02332720|100695814|FG006|STARTED|Part C||0||
48151611|NCT02332720|100695815|FG007|STARTED|Part C||0||
48151612|NCT02332720|100695816|FG008|STARTED|Part C||0||
48151613|NCT02332720|100695817|FG009|STARTED|Part C||0||
48721532|NCT02981966|102105427|FG002|COMPLETED|Overall Study||8||
48721533|NCT02981966|102105428|FG003|COMPLETED|Overall Study||4||
48721534|NCT02981966|102105425|FG000|NOT COMPLETED|Overall Study||0||
48721535|NCT02981966|102105426|FG001|NOT COMPLETED|Overall Study||0||
48721536|NCT02981966|102105427|FG002|NOT COMPLETED|Overall Study||0||
48721537|NCT02981966|102105428|FG003|NOT COMPLETED|Overall Study||0||
48721538|NCT00440310|102105429|FG000|STARTED|Overall Study||244||
48151614|NCT02332720|100695818|FG010|STARTED|Part C||0||
48151615|NCT02332720|100695819|FG011|STARTED|Part C||0||
48151616|NCT02332720|100695820|FG012|STARTED|Part C||0||
48721539|NCT00440310|102105430|FG001|STARTED|Overall Study||239||
48721540|NCT00440310|102105429|FG000|Treated|Overall Study||222||
48721541|NCT00440310|102105430|FG001|Treated|Overall Study||232||
48721542|NCT00440310|102105429|FG000|COMPLETED|Overall Study||216||
48721543|NCT00440310|102105430|FG001|COMPLETED|Overall Study||209||
48721544|NCT00440310|102105429|FG000|NOT COMPLETED|Overall Study||28||
48721545|NCT00440310|102105430|FG001|NOT COMPLETED|Overall Study||30||
48721546|NCT00619489|102105431|FG000|STARTED|Overall Study||37||
48151617|NCT02332720|100695821|FG013|STARTED|Part C||0||
48721547|NCT00619489|102105432|FG001|STARTED|Overall Study||35||
48151618|NCT02332720|100695822|FG014|STARTED|Part C||0||
48151619|NCT02332720|100695823|FG015|STARTED|Part C||0||
48151620|NCT02332720|100695824|FG016|STARTED|Part C||0||
48151621|NCT02332720|100695825|FG017|STARTED|Part C||0||
48151622|NCT02332720|100695826|FG018|STARTED|Part C||0||
48151623|NCT02332720|100695827|FG019|STARTED|Part C||0||
48151624|NCT02332720|100695828|FG020|STARTED|Part C||0||
48151625|NCT02332720|100695829|FG021|STARTED|Part C||0||
48151626|NCT02332720|100695830|FG022|STARTED|Part C||0||
48151627|NCT02332720|100695808|FG000|COMPLETED|Part C||2||
48151628|NCT02332720|100695809|FG001|COMPLETED|Part C||1||
48151629|NCT02332720|100695810|FG002|COMPLETED|Part C||3||
48151630|NCT02332720|100695811|FG003|COMPLETED|Part C||2||
48608146|NCT02082769|101827112|FG002|NOT COMPLETED|Overall Study||36||
48608147|NCT03083808|101827113|FG000|STARTED|Overall Study||35||
48608148|NCT03083808|101827113|FG000|COMPLETED|Overall Study||35||
48608149|NCT03083808|101827113|FG000|NOT COMPLETED|Overall Study||0||
48608150|NCT02472262|101827114|FG000|STARTED|Overall Study||117||
48608151|NCT02472262|101827115|FG001|STARTED|Overall Study||120||
48608152|NCT02472262|101827116|FG002|STARTED|Overall Study||118||
48608153|NCT02472262|101827114|FG000|COMPLETED|Overall Study||99||
48608154|NCT02472262|101827115|FG001|COMPLETED|Overall Study||99||
48608155|NCT02472262|101827116|FG002|COMPLETED|Overall Study||93||
48608156|NCT02472262|101827114|FG000|NOT COMPLETED|Overall Study||18||
48608157|NCT02472262|101827115|FG001|NOT COMPLETED|Overall Study||21||
48608158|NCT02472262|101827116|FG002|NOT COMPLETED|Overall Study||25||
48608159|NCT01887288|101827117|FG000|STARTED|Overall Study||16||
48608160|NCT01887288|101827117|FG000|COMPLETED|Overall Study||0||
48721548|NCT00619489|102105431|FG000|COMPLETED|Overall Study||14||
48721549|NCT00619489|102105432|FG001|COMPLETED|Overall Study||1||
48721550|NCT00619489|102105431|FG000|NOT COMPLETED|Overall Study||23||
48721551|NCT00619489|102105432|FG001|NOT COMPLETED|Overall Study||34||
48721552|NCT01300455|102105433|FG000|STARTED|Period 1||13||
48721553|NCT01300455|102105434|FG001|STARTED|Period 1||13||
48608161|NCT01887288|101827117|FG000|NOT COMPLETED|Overall Study||16||
48721554|NCT01300455|102105433|FG000|COMPLETED|Period 1||13||
48721555|NCT01300455|102105434|FG001|COMPLETED|Period 1||13||
48306565|NCT00075088|101077448|FG000|STARTED|Overall Study||403||
48306566|NCT00075088|101077449|FG001|STARTED|Overall Study||391||
48306567|NCT00075088|101077448|FG000|COMPLETED|Overall Study||403||
48306568|NCT00075088|101077449|FG001|COMPLETED|Overall Study||391||
48306569|NCT00075088|101077448|FG000|NOT COMPLETED|Overall Study||0||
48306570|NCT00075088|101077449|FG001|NOT COMPLETED|Overall Study||0||
48306571|NCT02060383|101077450|FG000|STARTED|Core Phase||38|Entered Core Phase of Study|
48306572|NCT02060383|101077451|FG001|STARTED|Core Phase||43|Entered Core Phase of Study|
48306573|NCT02060383|101077452|FG002|STARTED|Core Phase||19|Entered Core Phase of Study|
48306574|NCT02060383|101077453|FG003|STARTED|Core Phase||46|Entered Core Phase of Study|
48306575|NCT02060383|101077454|FG004|STARTED|Core Phase||103|Entered Core Phase of Study|
48306576|NCT02060383|101077450|FG000|Completed Core/Entered Extension|Core Phase||17||
48306577|NCT02060383|101077451|FG001|Completed Core/Entered Extension|Core Phase||17||
48608162|NCT01183416|101827118|FG000|STARTED|Overall Study||4||
48608163|NCT01183416|101827118|FG000|COMPLETED|Overall Study||4||
48608164|NCT01183416|101827118|FG000|NOT COMPLETED|Overall Study||0||
48608165|NCT03846544|101827119|FG000|STARTED|Overall Study||24||
48721556|NCT01300455|102105433|FG000|NOT COMPLETED|Period 1||0||
48721557|NCT01300455|102105434|FG001|NOT COMPLETED|Period 1||0||
48721558|NCT01300455|102105433|FG000|STARTED|Washout||13||
48721559|NCT01300455|102105434|FG001|STARTED|Washout||13||
48608166|NCT03846544|101827120|FG001|STARTED|Overall Study||24||
48608167|NCT03846544|101827119|FG000|COMPLETED|Overall Study||23||
48608168|NCT03846544|101827120|FG001|COMPLETED|Overall Study||23||
48608169|NCT03846544|101827119|FG000|NOT COMPLETED|Overall Study||1||
48306578|NCT02060383|101077452|FG002|Completed Core/Entered Extension|Core Phase||10||
48306579|NCT02060383|101077453|FG003|Completed Core/Entered Extension|Core Phase||21||
48306580|NCT02060383|101077454|FG004|Completed Core/Entered Extension|Core Phase||53||
48306581|NCT02060383|101077450|FG000|Completed Core/Did Not Enter Extension|Core Phase||18||
48721560|NCT01300455|102105433|FG000|COMPLETED|Washout||12||
48721561|NCT01300455|102105434|FG001|COMPLETED|Washout||13||
48721562|NCT01300455|102105433|FG000|NOT COMPLETED|Washout||1||
48306582|NCT02060383|101077451|FG001|Completed Core/Did Not Enter Extension|Core Phase||20||
48306583|NCT02060383|101077452|FG002|Completed Core/Did Not Enter Extension|Core Phase||9||
48306584|NCT02060383|101077453|FG003|Completed Core/Did Not Enter Extension|Core Phase||18||
48306585|NCT02060383|101077454|FG004|Completed Core/Did Not Enter Extension|Core Phase||42||
48306586|NCT02060383|101077450|FG000|COMPLETED|Core Phase||35||
48306587|NCT02060383|101077451|FG001|COMPLETED|Core Phase||37||
48306588|NCT02060383|101077452|FG002|COMPLETED|Core Phase||19||
48306589|NCT02060383|101077453|FG003|COMPLETED|Core Phase||39||
48608170|NCT03846544|101827120|FG001|NOT COMPLETED|Overall Study||1||
48608171|NCT01225926|101827121|FG000|STARTED|Overall Study||12||
48608172|NCT01225926|101827122|FG001|STARTED|Overall Study||12||
48608173|NCT01225926|101827121|FG000|COMPLETED|Overall Study||12||
48608174|NCT01225926|101827122|FG001|COMPLETED|Overall Study||12||
48608175|NCT01225926|101827121|FG000|NOT COMPLETED|Overall Study||0||
48608176|NCT01225926|101827122|FG001|NOT COMPLETED|Overall Study||0||
48608177|NCT00828061|101827123|FG000|STARTED|Period 1||4||
48608178|NCT00828061|101827124|FG001|STARTED|Period 1||3||
48608179|NCT00828061|101827125|FG002|STARTED|Period 1||3||
48608180|NCT00828061|101827126|FG003|STARTED|Period 1||3||
48608181|NCT00828061|101827127|FG004|STARTED|Period 1||3||
48608182|NCT00828061|101827128|FG005|STARTED|Period 1||3||
48608183|NCT00828061|101827123|FG000|COMPLETED|Period 1||4||
48608184|NCT00828061|101827124|FG001|COMPLETED|Period 1||3||
48608185|NCT00828061|101827125|FG002|COMPLETED|Period 1||3||
48608186|NCT00828061|101827126|FG003|COMPLETED|Period 1||3||
48608187|NCT00828061|101827127|FG004|COMPLETED|Period 1||3||
48608188|NCT00828061|101827128|FG005|COMPLETED|Period 1||3||
48608189|NCT00828061|101827123|FG000|NOT COMPLETED|Period 1||0||
48608190|NCT00828061|101827124|FG001|NOT COMPLETED|Period 1||0||
48608191|NCT00828061|101827125|FG002|NOT COMPLETED|Period 1||0||
48608192|NCT00828061|101827126|FG003|NOT COMPLETED|Period 1||0||
48608193|NCT00828061|101827127|FG004|NOT COMPLETED|Period 1||0||
48608194|NCT00828061|101827128|FG005|NOT COMPLETED|Period 1||0||
48608195|NCT00828061|101827123|FG000|STARTED|Period 2||4||
48608196|NCT00828061|101827124|FG001|STARTED|Period 2||3||
48608197|NCT00828061|101827125|FG002|STARTED|Period 2||3||
48608198|NCT00828061|101827126|FG003|STARTED|Period 2||3||
48608199|NCT00828061|101827127|FG004|STARTED|Period 2||3||
48608200|NCT00828061|101827128|FG005|STARTED|Period 2||3||
48608201|NCT00828061|101827123|FG000|COMPLETED|Period 2||4||
48608202|NCT00828061|101827124|FG001|COMPLETED|Period 2||3||
48608203|NCT00828061|101827125|FG002|COMPLETED|Period 2||3||
48608204|NCT00828061|101827126|FG003|COMPLETED|Period 2||3||
48608205|NCT00828061|101827127|FG004|COMPLETED|Period 2||3||
48608206|NCT00828061|101827128|FG005|COMPLETED|Period 2||3||
48721563|NCT01300455|102105434|FG001|NOT COMPLETED|Washout||0||
48721564|NCT01300455|102105433|FG000|STARTED|Period 2||12||
48721565|NCT01300455|102105434|FG001|STARTED|Period 2||13||
48721566|NCT01300455|102105433|FG000|COMPLETED|Period 2||12||
48721567|NCT01300455|102105434|FG001|COMPLETED|Period 2||13||
48306590|NCT02060383|101077454|FG004|COMPLETED|Core Phase||95||
48306591|NCT02060383|101077450|FG000|NOT COMPLETED|Core Phase||3||
48306592|NCT02060383|101077451|FG001|NOT COMPLETED|Core Phase||6||
48306593|NCT02060383|101077452|FG002|NOT COMPLETED|Core Phase||0||
48306594|NCT02060383|101077453|FG003|NOT COMPLETED|Core Phase||7||
48306595|NCT02060383|101077454|FG004|NOT COMPLETED|Core Phase||8||
48306596|NCT02060383|101077450|FG000|STARTED|Extension Phase||17|Entered the Extension phase from the Core phase|
48608207|NCT00828061|101827123|FG000|NOT COMPLETED|Period 2||0||
48608208|NCT00828061|101827124|FG001|NOT COMPLETED|Period 2||0||
48608209|NCT00828061|101827125|FG002|NOT COMPLETED|Period 2||0||
48608210|NCT00828061|101827126|FG003|NOT COMPLETED|Period 2||0||
48608211|NCT00828061|101827127|FG004|NOT COMPLETED|Period 2||0||
48608212|NCT00828061|101827128|FG005|NOT COMPLETED|Period 2||0||
48608213|NCT00828061|101827123|FG000|STARTED|Period 3||4||
48608214|NCT00828061|101827124|FG001|STARTED|Period 3||3||
48608215|NCT00828061|101827125|FG002|STARTED|Period 3||3||
48608216|NCT00828061|101827126|FG003|STARTED|Period 3||3||
48608217|NCT00828061|101827127|FG004|STARTED|Period 3||3||
48608218|NCT00828061|101827128|FG005|STARTED|Period 3||3||
48608219|NCT00828061|101827123|FG000|COMPLETED|Period 3||4||
48608220|NCT00828061|101827124|FG001|COMPLETED|Period 3||3||
48608221|NCT00828061|101827125|FG002|COMPLETED|Period 3||3||
48608222|NCT00828061|101827126|FG003|COMPLETED|Period 3||3||
48608223|NCT00828061|101827127|FG004|COMPLETED|Period 3||3||
48721568|NCT01300455|102105433|FG000|NOT COMPLETED|Period 2||0||
48721569|NCT01300455|102105434|FG001|NOT COMPLETED|Period 2||0||
48608224|NCT00828061|101827128|FG005|COMPLETED|Period 3||3||
48608225|NCT00828061|101827123|FG000|NOT COMPLETED|Period 3||0||
48608226|NCT00828061|101827124|FG001|NOT COMPLETED|Period 3||0||
48608227|NCT00828061|101827125|FG002|NOT COMPLETED|Period 3||0||
48608228|NCT00828061|101827126|FG003|NOT COMPLETED|Period 3||0||
48608229|NCT00828061|101827127|FG004|NOT COMPLETED|Period 3||0||
48608230|NCT00828061|101827128|FG005|NOT COMPLETED|Period 3||0||
48608231|NCT02098395|101827129|FG000|STARTED|Overall Study||212||
48608232|NCT02098395|101827130|FG001|STARTED|Overall Study||209||
48608233|NCT02098395|101827131|FG002|STARTED|Overall Study||207||
48608234|NCT02098395|101827132|FG003|STARTED|Overall Study||207||
48608235|NCT02098395|101827129|FG000|Exposed|Overall Study||211||
48608236|NCT02098395|101827130|FG001|Exposed|Overall Study||209||
48608237|NCT02098395|101827131|FG002|Exposed|Overall Study||206||
48608238|NCT02098395|101827132|FG003|Exposed|Overall Study||206||
48608239|NCT02098395|101827129|FG000|COMPLETED|Overall Study||186||
48608240|NCT02098395|101827130|FG001|COMPLETED|Overall Study||177||
48608241|NCT02098395|101827131|FG002|COMPLETED|Overall Study||165||
48608242|NCT02098395|101827132|FG003|COMPLETED|Overall Study||180||
48608243|NCT02098395|101827129|FG000|NOT COMPLETED|Overall Study||26||
48608244|NCT02098395|101827130|FG001|NOT COMPLETED|Overall Study||32||
48608245|NCT02098395|101827131|FG002|NOT COMPLETED|Overall Study||42||
48608246|NCT02098395|101827132|FG003|NOT COMPLETED|Overall Study||27||
48608247|NCT01815502|101827133|FG000|STARTED|Overall Study||10||
48608248|NCT01815502|101827134|FG001|STARTED|Overall Study||10||
48608249|NCT01815502|101827133|FG000|COMPLETED|Overall Study||10||
48608250|NCT01815502|101827134|FG001|COMPLETED|Overall Study||10||
48608251|NCT01815502|101827133|FG000|NOT COMPLETED|Overall Study||0||
48608252|NCT01815502|101827134|FG001|NOT COMPLETED|Overall Study||0||
48608253|NCT02190721|101827135|FG000|STARTED|Overall Study||2||
48608254|NCT02190721|101827136|FG001|STARTED|Overall Study||30||
48608255|NCT02190721|101827137|FG002|STARTED|Overall Study||18||
48608256|NCT02190721|101827135|FG000|Completed Treatment|Overall Study||2||
48608257|NCT02190721|101827136|FG001|Completed Treatment|Overall Study||30||
48608258|NCT02190721|101827137|FG002|Completed Treatment|Overall Study||18||
48608259|NCT02190721|101827135|FG000|Completed 30 Day Follow-up|Overall Study||2||
48608260|NCT02190721|101827136|FG001|Completed 30 Day Follow-up|Overall Study||29||
48608261|NCT02190721|101827137|FG002|Completed 30 Day Follow-up|Overall Study||18||
48608262|NCT02190721|101827135|FG000|Completed 90 Day Follow-up|Overall Study||2||
48608263|NCT02190721|101827136|FG001|Completed 90 Day Follow-up|Overall Study||29||
48608264|NCT02190721|101827137|FG002|Completed 90 Day Follow-up|Overall Study||18||
48608265|NCT02190721|101827135|FG000|COMPLETED|Overall Study||2||
48608266|NCT02190721|101827136|FG001|COMPLETED|Overall Study||29||
48608267|NCT02190721|101827137|FG002|COMPLETED|Overall Study||18||
48608268|NCT02190721|101827135|FG000|NOT COMPLETED|Overall Study||0||
48608269|NCT02190721|101827136|FG001|NOT COMPLETED|Overall Study||1||
48608270|NCT02190721|101827137|FG002|NOT COMPLETED|Overall Study||0||
48608271|NCT01737879|101827138|FG000|STARTED|Overall Study||41||
48608272|NCT01737879|101827138|FG000|Received Peginesatide|Overall Study||34||
48608273|NCT01737879|101827138|FG000|Transitioned to Epoetin Alfa|Overall Study||0||
48608274|NCT01737879|101827138|FG000|COMPLETED|Overall Study||0||
48721570|NCT00042666|102105435|FG000|STARTED|Overall Study||55||
48721571|NCT00042666|102105435|FG000|Received at Least 1 Dose of Study Drug|Overall Study||55||
48721572|NCT00042666|102105435|FG000|Completed at Least 1 Cycle of Study Drug|Overall Study||42||
48721573|NCT00042666|102105435|FG000|COMPLETED|Overall Study||1||
48721574|NCT00042666|102105435|FG000|NOT COMPLETED|Overall Study||54||
48721575|NCT00915655|102105436|FG000|STARTED|Overall Study||12||
48721576|NCT00915655|102105436|FG000|COMPLETED|Overall Study||12||
48721577|NCT00915655|102105436|FG000|NOT COMPLETED|Overall Study||0||
48721578|NCT03028987|102105437|FG000|STARTED|Overall Study||5||
48721579|NCT03028987|102105438|FG001|STARTED|Overall Study||5||
48721580|NCT03028987|102105437|FG000|COMPLETED|Overall Study||5||
48721581|NCT03028987|102105438|FG001|COMPLETED|Overall Study||5||
48151631|NCT02332720|100695812|FG004|COMPLETED|Part C||0||
48608275|NCT01737879|101827138|FG000|NOT COMPLETED|Overall Study||41||
48608276|NCT00699400|101827139|FG000|STARTED|Overall Study||42||
48608277|NCT00699400|101827140|FG001|STARTED|Overall Study||3||
48608278|NCT00699400|101827141|FG002|STARTED|Overall Study||138||
48608279|NCT00699400|101827142|FG003|STARTED|Overall Study||6||
48608280|NCT00699400|101827143|FG004|STARTED|Overall Study||4||
48608281|NCT00699400|101827144|FG005|STARTED|Overall Study||11||
48608282|NCT00699400|101827139|FG000|COMPLETED|Overall Study||42||
48608283|NCT00699400|101827140|FG001|COMPLETED|Overall Study||3||
48608284|NCT00699400|101827141|FG002|COMPLETED|Overall Study||138||
48608285|NCT00699400|101827142|FG003|COMPLETED|Overall Study||6||
48608286|NCT00699400|101827143|FG004|COMPLETED|Overall Study||4||
48721582|NCT03028987|102105437|FG000|NOT COMPLETED|Overall Study||0||
48721583|NCT03028987|102105438|FG001|NOT COMPLETED|Overall Study||0||
48721584|NCT00574548|102105439|FG000|STARTED|Overall Study||482||
48721585|NCT00574548|102105440|FG001|STARTED|Overall Study||238||
48721586|NCT00574548|102105439|FG000|Received Vaccination 1 (Vax 1)|Overall Study||478||
48721587|NCT00574548|102105440|FG001|Received Vaccination 1 (Vax 1)|Overall Study||237||
48721588|NCT00574548|102105439|FG000|Completed Vax 1 (6 Month Contact)|Overall Study||468||
48721589|NCT00574548|102105440|FG001|Completed Vax 1 (6 Month Contact)|Overall Study||234||
48721590|NCT00574548|102105439|FG000|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||7||
48721591|NCT00574548|102105440|FG001|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||3||
48721592|NCT00574548|102105439|FG000|Withdrawn Before Vax 2|Overall Study||41||
48721593|NCT00574548|102105440|FG001|Withdrawn Before Vax 2|Overall Study||11||
48721594|NCT00574548|102105439|FG000|Received Vax 2|Overall Study||427||
48721595|NCT00574548|102105440|FG001|Received Vax 2|Overall Study||223||
48721596|NCT00574548|102105439|FG000|Completed Vax 2 (6 Month Contact)|Overall Study||421||
48721597|NCT00574548|102105440|FG001|Completed Vax 2 (6 Month Contact)|Overall Study||222||
48721598|NCT00574548|102105439|FG000|COMPLETED|Overall Study||421||
48721599|NCT00574548|102105440|FG001|COMPLETED|Overall Study||222||
48721600|NCT00574548|102105439|FG000|NOT COMPLETED|Overall Study||61||
48721601|NCT00574548|102105440|FG001|NOT COMPLETED|Overall Study||16||
48721602|NCT01751139|102105441|FG000|STARTED|Overall Study||3300||
48721603|NCT01751139|102105441|FG000|COMPLETED|Overall Study||1033||
48721604|NCT01751139|102105441|FG000|NOT COMPLETED|Overall Study||2267||
48721605|NCT01424228|102105442|FG000|STARTED|Overall Study||182||
48721606|NCT01424228|102105443|FG001|STARTED|Overall Study||182||
48721607|NCT01424228|102105442|FG000|COMPLETED|Overall Study||126||
48721608|NCT01424228|102105443|FG001|COMPLETED|Overall Study||135||
48721609|NCT01424228|102105442|FG000|NOT COMPLETED|Overall Study||56||
48721610|NCT01424228|102105443|FG001|NOT COMPLETED|Overall Study||47||
48721611|NCT01062061|102105444|FG000|STARTED|Overall Study||754||
48721612|NCT01062061|102105444|FG000|COMPLETED|Overall Study||727||
48721613|NCT01062061|102105444|FG000|NOT COMPLETED|Overall Study||27||
48721614|NCT03597061|102105445|FG000|STARTED|Overall Study||17||
48721615|NCT03597061|102105446|FG001|STARTED|Overall Study||17||
48721616|NCT03597061|102105445|FG000|COMPLETED|Overall Study||16||
48721617|NCT03597061|102105446|FG001|COMPLETED|Overall Study||16||
48721618|NCT03597061|102105445|FG000|NOT COMPLETED|Overall Study||1||
48721619|NCT03597061|102105446|FG001|NOT COMPLETED|Overall Study||1||
48721620|NCT00430937|102105447|FG000|STARTED|Overall Study||97||
48721621|NCT00430937|102105448|FG001|STARTED|Overall Study||92||
48721622|NCT00430937|102105447|FG000|COMPLETED|Overall Study||70||
48721623|NCT00430937|102105448|FG001|COMPLETED|Overall Study||64||
48721624|NCT00430937|102105447|FG000|NOT COMPLETED|Overall Study||27||
48721625|NCT00430937|102105448|FG001|NOT COMPLETED|Overall Study||28||
48721626|NCT00428207|102105449|FG000|STARTED|Overall Study||2||
48721627|NCT00428207|102105450|FG001|STARTED|Overall Study||2||
48721628|NCT00428207|102105449|FG000|COMPLETED|Overall Study||2||
48721629|NCT00428207|102105450|FG001|COMPLETED|Overall Study||2||
48721630|NCT00428207|102105449|FG000|NOT COMPLETED|Overall Study||0||
48608287|NCT00699400|101827144|FG005|COMPLETED|Overall Study||0||
48608288|NCT00699400|101827139|FG000|NOT COMPLETED|Overall Study||0||
48608289|NCT00699400|101827140|FG001|NOT COMPLETED|Overall Study||0||
48151632|NCT02332720|100695813|FG005|COMPLETED|Part C||0||
48306597|NCT02060383|101077451|FG001|STARTED|Extension Phase||17|Entered the Extension phase from the Core phase|
48306598|NCT02060383|101077452|FG002|STARTED|Extension Phase||10|Entered the Extension phase from the Core phase|
48306599|NCT02060383|101077453|FG003|STARTED|Extension Phase||21|Entered the Extension phase from the Core phase|
48306600|NCT02060383|101077454|FG004|STARTED|Extension Phase||53|Entered the Extension phase from the Core phase|
48306601|NCT02060383|101077450|FG000|COMPLETED|Extension Phase||14|Completed the Extension phase|
48306602|NCT02060383|101077451|FG001|COMPLETED|Extension Phase||14|Completed the Extension phase|
48306603|NCT02060383|101077452|FG002|COMPLETED|Extension Phase||7|Completed the Extension phase|
48306604|NCT02060383|101077453|FG003|COMPLETED|Extension Phase||19|Completed the Extension phase|
48306605|NCT02060383|101077454|FG004|COMPLETED|Extension Phase||46|Completed the Extension phase|
48306606|NCT02060383|101077450|FG000|NOT COMPLETED|Extension Phase||3||
48306607|NCT02060383|101077451|FG001|NOT COMPLETED|Extension Phase||3||
48306608|NCT02060383|101077452|FG002|NOT COMPLETED|Extension Phase||3||
48306609|NCT02060383|101077453|FG003|NOT COMPLETED|Extension Phase||2||
48306610|NCT02060383|101077454|FG004|NOT COMPLETED|Extension Phase||7||
48608290|NCT00699400|101827141|FG002|NOT COMPLETED|Overall Study||0||
48608291|NCT00699400|101827142|FG003|NOT COMPLETED|Overall Study||0||
48608292|NCT00699400|101827143|FG004|NOT COMPLETED|Overall Study||0||
48608293|NCT00699400|101827144|FG005|NOT COMPLETED|Overall Study||11||
48608294|NCT03282591|101827145|FG000|STARTED|Overall Study||92||
48608295|NCT03282591|101827146|FG001|STARTED|Overall Study||93||
48608296|NCT03282591|101827145|FG000|COMPLETED|Overall Study||88||
48608297|NCT03282591|101827146|FG001|COMPLETED|Overall Study||89||
48608298|NCT03282591|101827145|FG000|NOT COMPLETED|Overall Study||4||
48151633|NCT02332720|100695814|FG006|COMPLETED|Part C||0||
48306611|NCT02303704|101077455|FG000|STARTED|Overall Study||220||
48306612|NCT02303704|101077456|FG001|STARTED|Overall Study||228||
48306613|NCT02303704|101077455|FG000|COMPLETED|Overall Study||215||
48306614|NCT02303704|101077456|FG001|COMPLETED|Overall Study||219||
48306615|NCT02303704|101077455|FG000|NOT COMPLETED|Overall Study||5||
48306616|NCT02303704|101077456|FG001|NOT COMPLETED|Overall Study||9||
48306617|NCT01438151|101077457|FG000|STARTED|Overall Study||11||
48306618|NCT01438151|101077457|FG000|COMPLETED|Overall Study||3||
48306619|NCT01438151|101077457|FG000|NOT COMPLETED|Overall Study||8||
48306620|NCT03044886|101077458|FG000|STARTED|Overall Study||120||
48306621|NCT03044886|101077459|FG001|STARTED|Overall Study||120||
48306622|NCT03044886|101077460|FG002|STARTED|Overall Study||120||
48306623|NCT03044886|101077458|FG000|COMPLETED|Overall Study||105||
48608299|NCT03282591|101827146|FG001|NOT COMPLETED|Overall Study||4||
48608300|NCT01449864|101827147|FG000|STARTED|Overall Study||22||
48608301|NCT01449864|101827147|FG000|COMPLETED|Overall Study||17||
48608302|NCT01449864|101827147|FG000|NOT COMPLETED|Overall Study||5||
48608303|NCT01408719|101827148|FG000|STARTED|First Intervention (35 Days)||2||
48608304|NCT01408719|101827149|FG001|STARTED|First Intervention (35 Days)||3||
48608305|NCT01408719|101827150|FG002|STARTED|First Intervention (35 Days)||2||
48608306|NCT01408719|101827151|FG003|STARTED|First Intervention (35 Days)||2||
48608307|NCT01408719|101827152|FG004|STARTED|First Intervention (35 Days)||4||
48608308|NCT01408719|101827153|FG005|STARTED|First Intervention (35 Days)||3||
48151634|NCT02332720|100695815|FG007|COMPLETED|Part C||0||
48151635|NCT02332720|100695816|FG008|COMPLETED|Part C||0||
48608309|NCT01408719|101827154|FG006|STARTED|First Intervention (35 Days)||2||
48608310|NCT01408719|101827155|FG007|STARTED|First Intervention (35 Days)||3||
48608311|NCT01408719|101827156|FG008|STARTED|First Intervention (35 Days)||2||
48608312|NCT01408719|101827157|FG009|STARTED|First Intervention (35 Days)||1||
48608313|NCT01408719|101827158|FG010|STARTED|First Intervention (35 Days)||2||
48721631|NCT00428207|102105450|FG001|NOT COMPLETED|Overall Study||0||
48721632|NCT04807387|102105451|FG000|STARTED|Overall Study||2||
48721633|NCT04807387|102105452|FG001|STARTED|Overall Study||4||
48721634|NCT04807387|102105451|FG000|COMPLETED|Overall Study||2||
48721635|NCT04807387|102105452|FG001|COMPLETED|Overall Study||4||
48721636|NCT04807387|102105451|FG000|NOT COMPLETED|Overall Study||0||
48721637|NCT04807387|102105452|FG001|NOT COMPLETED|Overall Study||0||
48721638|NCT03385330|102105453|FG000|STARTED|Overall Study||28||
48721639|NCT03385330|102105454|FG001|STARTED|Overall Study||22||
48721640|NCT03385330|102105453|FG000|COMPLETED|Overall Study||23||
48721641|NCT03385330|102105454|FG001|COMPLETED|Overall Study||19||
48721642|NCT03385330|102105453|FG000|NOT COMPLETED|Overall Study||5||
48721643|NCT03385330|102105454|FG001|NOT COMPLETED|Overall Study||3||
48721644|NCT01985763|102105455|FG000|STARTED|Overall Study||13||
48721645|NCT01985763|102105455|FG000|COMPLETED|Overall Study||13||
48721646|NCT01985763|102105455|FG000|NOT COMPLETED|Overall Study||0||
48721647|NCT02066129|102105456|FG000|STARTED|Overall Study||127||
48721648|NCT02066129|102105457|FG001|STARTED|Overall Study||127||
48721649|NCT02066129|102105456|FG000|COMPLETED|Overall Study||98||
48721650|NCT02066129|102105457|FG001|COMPLETED|Overall Study||94||
48721651|NCT02066129|102105456|FG000|NOT COMPLETED|Overall Study||29||
48721652|NCT02066129|102105457|FG001|NOT COMPLETED|Overall Study||33||
48721653|NCT00629798|102105458|FG000|STARTED|Overall Study||64||
48721654|NCT00629798|102105458|FG000|COMPLETED|Overall Study||60||
48721655|NCT00629798|102105458|FG000|NOT COMPLETED|Overall Study||4||
48721656|NCT01086852|102105459|FG000|STARTED|Overall Study||4||
48721657|NCT01086852|102105459|FG000|COMPLETED|Overall Study||4||
48721658|NCT01086852|102105459|FG000|NOT COMPLETED|Overall Study||0||
48721659|NCT04971941|102105460|FG000|STARTED|Overall Study||15||
48721660|NCT04971941|102105461|FG001|STARTED|Overall Study||15||
48721661|NCT04971941|102105462|FG002|STARTED|Overall Study||15||
48721662|NCT04971941|102105463|FG003|STARTED|Overall Study||15||
48721663|NCT04971941|102105460|FG000|COMPLETED|Overall Study||15||
48721664|NCT04971941|102105461|FG001|COMPLETED|Overall Study||15||
48721665|NCT04971941|102105462|FG002|COMPLETED|Overall Study||15||
48721666|NCT04971941|102105463|FG003|COMPLETED|Overall Study||15||
48721667|NCT04971941|102105460|FG000|NOT COMPLETED|Overall Study||0||
48721668|NCT04971941|102105461|FG001|NOT COMPLETED|Overall Study||0||
48721669|NCT04971941|102105462|FG002|NOT COMPLETED|Overall Study||0||
48721670|NCT04971941|102105463|FG003|NOT COMPLETED|Overall Study||0||
48721671|NCT01624090|102105464|FG000|STARTED|Overall Study||2||
48721672|NCT01624090|102105465|FG001|STARTED|Overall Study||2||
48721673|NCT01624090|102105466|FG002|STARTED|Overall Study||10||
48721674|NCT01624090|102105467|FG003|STARTED|Overall Study||2||
48721675|NCT01624090|102105464|FG000|COMPLETED|Overall Study||2||
48721676|NCT01624090|102105465|FG001|COMPLETED|Overall Study||0||
48721677|NCT01624090|102105466|FG002|COMPLETED|Overall Study||3||
48721678|NCT01624090|102105467|FG003|COMPLETED|Overall Study||2||
48721679|NCT01624090|102105464|FG000|NOT COMPLETED|Overall Study||0||
48721680|NCT01624090|102105465|FG001|NOT COMPLETED|Overall Study||2||
48721681|NCT01624090|102105466|FG002|NOT COMPLETED|Overall Study||7||
48721682|NCT01624090|102105467|FG003|NOT COMPLETED|Overall Study||0||
48721683|NCT01455220|102105468|FG000|STARTED|Overall Study||45||
48721684|NCT01455220|102105468|FG000|COMPLETED|Overall Study||15||
48721685|NCT01455220|102105468|FG000|NOT COMPLETED|Overall Study||30||
48721686|NCT00896441|102105469|FG000|STARTED|Overall Study||17||
48721687|NCT00896441|102105470|FG001|STARTED|Overall Study||9||
48721688|NCT00896441|102105469|FG000|COMPLETED|Overall Study||15||
48721689|NCT00896441|102105470|FG001|COMPLETED|Overall Study||9||
48721690|NCT00896441|102105469|FG000|NOT COMPLETED|Overall Study||2||
48721691|NCT00896441|102105470|FG001|NOT COMPLETED|Overall Study||0||
48721692|NCT00847015|102105471|FG000|STARTED|Overall Study||18||
48721693|NCT00847015|102105471|FG000|COMPLETED|Overall Study||15||
48721694|NCT00847015|102105471|FG000|NOT COMPLETED|Overall Study||3||
48721695|NCT04468074|102105472|FG000|STARTED|Overall Study||31||
48721696|NCT04468074|102105473|FG001|STARTED|Overall Study||30||
48721697|NCT04468074|102105472|FG000|COMPLETED|Overall Study||30||
48721698|NCT04468074|102105473|FG001|COMPLETED|Overall Study||30||
48721699|NCT04468074|102105472|FG000|NOT COMPLETED|Overall Study||1||
48721700|NCT04468074|102105473|FG001|NOT COMPLETED|Overall Study||0||
48721701|NCT01944345|102105474|FG000|STARTED|Overall Study||69||
48721702|NCT01944345|102105474|FG000|COMPLETED|Overall Study||69||
48721703|NCT01944345|102105474|FG000|NOT COMPLETED|Overall Study||0||
48721704|NCT04394715|102105475|FG000|STARTED|Overall Study||1179||
48721705|NCT04394715|102105476|FG001|STARTED|Overall Study||1417||
48721706|NCT04394715|102105475|FG000|Participants Enrolled|Overall Study||1130||
48721707|NCT04394715|102105476|FG001|Participants Enrolled|Overall Study||1370||
48721708|NCT04394715|102105475|FG000|Providers Enrolled|Overall Study||49||
48721709|NCT04394715|102105476|FG001|Providers Enrolled|Overall Study||47||
48721710|NCT04394715|102105475|FG000|COMPLETED|Overall Study||1179||
48306624|NCT03044886|101077459|FG001|COMPLETED|Overall Study||110||
48306625|NCT03044886|101077460|FG002|COMPLETED|Overall Study||108||
48306626|NCT03044886|101077458|FG000|NOT COMPLETED|Overall Study||15||
48306627|NCT03044886|101077459|FG001|NOT COMPLETED|Overall Study||10||
48306628|NCT03044886|101077460|FG002|NOT COMPLETED|Overall Study||12||
48721711|NCT04394715|102105476|FG001|COMPLETED|Overall Study||1417||
48721712|NCT04394715|102105475|FG000|NOT COMPLETED|Overall Study||0||
48721713|NCT04394715|102105476|FG001|NOT COMPLETED|Overall Study||0||
48721714|NCT02963701|102105477|FG000|STARTED|Period 1 (Including Washout) (2 Days)||28||
48721715|NCT02963701|102105478|FG001|STARTED|Period 1 (Including Washout) (2 Days)||28||
48721716|NCT02963701|102105477|FG000|COMPLETED|Period 1 (Including Washout) (2 Days)||27||
48721717|NCT02963701|102105478|FG001|COMPLETED|Period 1 (Including Washout) (2 Days)||28||
48721718|NCT02963701|102105477|FG000|NOT COMPLETED|Period 1 (Including Washout) (2 Days)||1||
48721719|NCT02963701|102105478|FG001|NOT COMPLETED|Period 1 (Including Washout) (2 Days)||0||
48721720|NCT02963701|102105477|FG000|STARTED|Period 2 (2 Days)||27||
48721721|NCT02963701|102105478|FG001|STARTED|Period 2 (2 Days)||28||
48721722|NCT02963701|102105477|FG000|COMPLETED|Period 2 (2 Days)||27||
48721723|NCT02963701|102105478|FG001|COMPLETED|Period 2 (2 Days)||28||
48721724|NCT02963701|102105477|FG000|NOT COMPLETED|Period 2 (2 Days)||0||
48721725|NCT02963701|102105478|FG001|NOT COMPLETED|Period 2 (2 Days)||0||
48721726|NCT01294163|102105479|FG000|STARTED|Overall Study||178||
48721727|NCT01294163|102105480|FG001|STARTED|Overall Study||165||
48721728|NCT01294163|102105481|FG002|STARTED|Overall Study||166||
48721729|NCT01294163|102105479|FG000|COMPLETED|Overall Study||177||
48721730|NCT01294163|102105480|FG001|COMPLETED|Overall Study||165||
48721731|NCT01294163|102105481|FG002|COMPLETED|Overall Study||163||
48721732|NCT01294163|102105479|FG000|NOT COMPLETED|Overall Study||1||
48721733|NCT01294163|102105480|FG001|NOT COMPLETED|Overall Study||0||
48721734|NCT01294163|102105481|FG002|NOT COMPLETED|Overall Study||3||
48721735|NCT01422824|102105482|FG000|STARTED|Overall Study||185||
48721736|NCT01422824|102105482|FG000|Treated|Overall Study||184||
48721737|NCT01422824|102105482|FG000|COMPLETED|Overall Study||147||
48721738|NCT01422824|102105482|FG000|NOT COMPLETED|Overall Study||38||
48721739|NCT00483002|102105483|FG000|STARTED|Overall Study||3719||
48721740|NCT00483002|102105483|FG000|COMPLETED|Overall Study||1165||
48306629|NCT01892306|101077461|FG000|STARTED|Overall Study||13||
48721741|NCT00483002|102105483|FG000|NOT COMPLETED|Overall Study||2554||
48721742|NCT04969198|102105484|FG000|STARTED|Overall Study||232||
48721743|NCT04969198|102105484|FG000|Number Participants for 2 Weeks Pre-quit Timepoint Analysis|Overall Study||218||
48721744|NCT04969198|102105484|FG000|Number Participants for 1 Week Pre-quit Timepoint Analysis|Overall Study||208||
48721745|NCT04969198|102105484|FG000|Number Participants for 1-3 Days Pre-quit Timepoint Analysis|Overall Study||199||
48306630|NCT01892306|101077462|FG001|STARTED|Overall Study||16||
48306631|NCT01892306|101077461|FG000|COMPLETED|Overall Study||8||
48306632|NCT01892306|101077462|FG001|COMPLETED|Overall Study||10||
48406152|NCT02253394|101328363|FG000|STARTED|Overall Study||0|First ambrisentan 5 or 10 mg QD + Spiro 50 mg QD (90 d), then washout (21 d), then +placebo (90 d)|
48721746|NCT04969198|102105484|FG000|Number Participants for 1-2 Days Post-quit Timepoint Analysis|Overall Study||198||
48721747|NCT04969198|102105484|FG000|Number Participants for 1 Week Post-quit Timepoint Analysis|Overall Study||195||
48721748|NCT04969198|102105484|FG000|Number Participants for 2 Weeks Post-quit Timepoint Analysis|Overall Study||186||
48721749|NCT04969198|102105484|FG000|Number Participants for 9 Weeks Post-quit Timepoint Analysis|Overall Study||176||
48721750|NCT04969198|102105484|FG000|COMPLETED|Overall Study||176||
48721751|NCT04969198|102105484|FG000|NOT COMPLETED|Overall Study||56||
48151636|NCT02332720|100695817|FG009|COMPLETED|Part C||0||
48306633|NCT01892306|101077461|FG000|NOT COMPLETED|Overall Study||5||
48721752|NCT02540291|102105485|FG000|STARTED|Overall Study||8||
48306634|NCT01892306|101077462|FG001|NOT COMPLETED|Overall Study||6||
48608314|NCT01408719|101827159|FG011|STARTED|First Intervention (35 Days)||2||
48608315|NCT01408719|101827160|FG012|STARTED|First Intervention (35 Days)||2||
48608316|NCT01408719|101827161|FG013|STARTED|First Intervention (35 Days)||5||
48608317|NCT01408719|101827162|FG014|STARTED|First Intervention (35 Days)||1||
48608318|NCT01408719|101827163|FG015|STARTED|First Intervention (35 Days)||2||
48306635|NCT02462928|101077463|FG000|STARTED|Overall Study||314||
48306636|NCT02462928|101077464|FG001|STARTED|Overall Study||313||
48306637|NCT02462928|101077465|FG002|STARTED|Overall Study||312||
48306638|NCT02462928|101077463|FG000|COMPLETED|Overall Study||224||
48306639|NCT02462928|101077464|FG001|COMPLETED|Overall Study||221||
48306640|NCT02462928|101077465|FG002|COMPLETED|Overall Study||255||
48306641|NCT02462928|101077463|FG000|NOT COMPLETED|Overall Study||90||
48306642|NCT02462928|101077464|FG001|NOT COMPLETED|Overall Study||92||
48406153|NCT02253394|101328364|FG001|STARTED|Overall Study||2|First ambrisentan 5 or 10 mg QD + Spiro 50 mg QD (90 d), then washout (21 d), then +placebo (90 d)|
48151637|NCT02332720|100695818|FG010|COMPLETED|Part C||0||
48151638|NCT02332720|100695819|FG011|COMPLETED|Part C||0||
48151639|NCT02332720|100695820|FG012|COMPLETED|Part C||0||
48151640|NCT02332720|100695821|FG013|COMPLETED|Part C||0||
48151641|NCT02332720|100695822|FG014|COMPLETED|Part C||0||
48151642|NCT02332720|100695823|FG015|COMPLETED|Part C||0||
48151643|NCT02332720|100695824|FG016|COMPLETED|Part C||0||
48151644|NCT02332720|100695825|FG017|COMPLETED|Part C||0||
48151645|NCT02332720|100695826|FG018|COMPLETED|Part C||0||
48151646|NCT02332720|100695827|FG019|COMPLETED|Part C||0||
48151647|NCT02332720|100695828|FG020|COMPLETED|Part C||0||
48151648|NCT02332720|100695829|FG021|COMPLETED|Part C||0||
48151649|NCT02332720|100695830|FG022|COMPLETED|Part C||0||
48151650|NCT02332720|100695808|FG000|NOT COMPLETED|Part C||0||
48151651|NCT02332720|100695809|FG001|NOT COMPLETED|Part C||0||
48151652|NCT02332720|100695810|FG002|NOT COMPLETED|Part C||0||
48151653|NCT02332720|100695811|FG003|NOT COMPLETED|Part C||0||
48306643|NCT02462928|101077465|FG002|NOT COMPLETED|Overall Study||57||
48608319|NCT01408719|101827164|FG016|STARTED|First Intervention (35 Days)||3||
48608320|NCT01408719|101827165|FG017|STARTED|First Intervention (35 Days)||2||
48608321|NCT01408719|101827166|FG018|STARTED|First Intervention (35 Days)||1||
48608322|NCT01408719|101827167|FG019|STARTED|First Intervention (35 Days)||1||
48608323|NCT01408719|101827148|FG000|COMPLETED|First Intervention (35 Days)||2||
48608324|NCT01408719|101827149|FG001|COMPLETED|First Intervention (35 Days)||3||
48151654|NCT02332720|100695812|FG004|NOT COMPLETED|Part C||0||
48151655|NCT02332720|100695813|FG005|NOT COMPLETED|Part C||0||
48151656|NCT02332720|100695814|FG006|NOT COMPLETED|Part C||0||
48151657|NCT02332720|100695815|FG007|NOT COMPLETED|Part C||0||
48151658|NCT02332720|100695816|FG008|NOT COMPLETED|Part C||0||
48151659|NCT02332720|100695817|FG009|NOT COMPLETED|Part C||0||
48306644|NCT04621734|101077466|FG000|STARTED|Overall Study||17||
48306645|NCT04621734|101077467|FG001|STARTED|Overall Study||18||
48306646|NCT04621734|101077466|FG000|COMPLETED|Overall Study||16||
48306647|NCT04621734|101077467|FG001|COMPLETED|Overall Study||17||
48306648|NCT04621734|101077466|FG000|NOT COMPLETED|Overall Study||1||
48306649|NCT04621734|101077467|FG001|NOT COMPLETED|Overall Study||1||
48306650|NCT01162239|101077468|FG000|STARTED|Treatment Phase||55||
48306651|NCT01162239|101077469|FG001|STARTED|Treatment Phase||54||
48151660|NCT02332720|100695818|FG010|NOT COMPLETED|Part C||0||
48151661|NCT02332720|100695819|FG011|NOT COMPLETED|Part C||0||
48151662|NCT02332720|100695820|FG012|NOT COMPLETED|Part C||0||
48306652|NCT01162239|101077470|FG002|STARTED|Treatment Phase||52||
48306653|NCT01162239|101077471|FG003|STARTED|Treatment Phase||55||
48306654|NCT01162239|101077468|FG000|Week 12|Treatment Phase||50||
48306655|NCT01162239|101077469|FG001|Week 12|Treatment Phase||51||
48608325|NCT01408719|101827150|FG002|COMPLETED|First Intervention (35 Days)||1||
48608326|NCT01408719|101827151|FG003|COMPLETED|First Intervention (35 Days)||2||
48608327|NCT01408719|101827152|FG004|COMPLETED|First Intervention (35 Days)||3||
48608328|NCT01408719|101827153|FG005|COMPLETED|First Intervention (35 Days)||3||
48608329|NCT01408719|101827154|FG006|COMPLETED|First Intervention (35 Days)||2||
48608330|NCT01408719|101827155|FG007|COMPLETED|First Intervention (35 Days)||3||
48608331|NCT01408719|101827156|FG008|COMPLETED|First Intervention (35 Days)||1||
48608332|NCT01408719|101827157|FG009|COMPLETED|First Intervention (35 Days)||1||
48608333|NCT01408719|101827158|FG010|COMPLETED|First Intervention (35 Days)||2||
48608334|NCT01408719|101827159|FG011|COMPLETED|First Intervention (35 Days)||2||
48608335|NCT01408719|101827160|FG012|COMPLETED|First Intervention (35 Days)||2||
48608336|NCT01408719|101827161|FG013|COMPLETED|First Intervention (35 Days)||4||
48608337|NCT01408719|101827162|FG014|COMPLETED|First Intervention (35 Days)||1||
48608338|NCT01408719|101827163|FG015|COMPLETED|First Intervention (35 Days)||2||
48608339|NCT01408719|101827164|FG016|COMPLETED|First Intervention (35 Days)||2||
48608340|NCT01408719|101827165|FG017|COMPLETED|First Intervention (35 Days)||2||
48608341|NCT01408719|101827166|FG018|COMPLETED|First Intervention (35 Days)||0||
48721753|NCT02540291|102105486|FG001|STARTED|Overall Study||8||
48721754|NCT02540291|102105487|FG002|STARTED|Overall Study||7||
48721755|NCT02540291|102105488|FG003|STARTED|Overall Study||7||
48721756|NCT02540291|102105485|FG000|COMPLETED|Overall Study||0||
48721757|NCT02540291|102105486|FG001|COMPLETED|Overall Study||0||
48721758|NCT02540291|102105487|FG002|COMPLETED|Overall Study||0||
48721759|NCT02540291|102105488|FG003|COMPLETED|Overall Study||0||
48721760|NCT02540291|102105485|FG000|NOT COMPLETED|Overall Study||8||
48721761|NCT02540291|102105486|FG001|NOT COMPLETED|Overall Study||8||
48721762|NCT02540291|102105487|FG002|NOT COMPLETED|Overall Study||7||
48721763|NCT02540291|102105488|FG003|NOT COMPLETED|Overall Study||7||
48721764|NCT01985360|102105489|FG000|STARTED|Overall Study||388||
48721765|NCT01985360|102105490|FG001|STARTED|Overall Study||389||
48721766|NCT01985360|102105489|FG000|COMPLETED|Overall Study||379||
48721767|NCT01985360|102105490|FG001|COMPLETED|Overall Study||386||
48721768|NCT01985360|102105489|FG000|NOT COMPLETED|Overall Study||9||
48721769|NCT01985360|102105490|FG001|NOT COMPLETED|Overall Study||3||
48721770|NCT00903331|102105491|FG000|STARTED|Overall Study||59||
48721771|NCT00903331|102105492|FG001|STARTED|Overall Study||119||
48721772|NCT00903331|102105491|FG000|COMPLETED|Overall Study||54||
48721773|NCT00903331|102105492|FG001|COMPLETED|Overall Study||101||
48721774|NCT00903331|102105491|FG000|NOT COMPLETED|Overall Study||5||
48721775|NCT00903331|102105492|FG001|NOT COMPLETED|Overall Study||18||
48721776|NCT02745535|102105493|FG000|STARTED|Overall Study||77||
48721777|NCT02745535|102105493|FG000|Sustained Virologic Repsonse|Overall Study||70||
48721778|NCT02745535|102105493|FG000|COMPLETED|Overall Study||71||
48721779|NCT02745535|102105493|FG000|NOT COMPLETED|Overall Study||6||
48721780|NCT01533922|102105494|FG000|STARTED|Overall Study||59||
48721781|NCT01533922|102105495|FG001|STARTED|Overall Study||59||
48306656|NCT01162239|101077470|FG002|Week 12|Treatment Phase||49||
48306657|NCT01162239|101077471|FG003|Week 12|Treatment Phase||53||
48306658|NCT01162239|101077468|FG000|Week 24|Treatment Phase||51||
48306659|NCT01162239|101077469|FG001|Week 24|Treatment Phase||48||
48306660|NCT01162239|101077470|FG002|Week 24|Treatment Phase||48||
48306661|NCT01162239|101077471|FG003|Week 24|Treatment Phase||50||
48306662|NCT01162239|101077468|FG000|Week 52|Treatment Phase||49||
48306663|NCT01162239|101077469|FG001|Week 52|Treatment Phase||47||
48608342|NCT01408719|101827167|FG019|COMPLETED|First Intervention (35 Days)||1||
48608343|NCT01408719|101827148|FG000|NOT COMPLETED|First Intervention (35 Days)||0||
48608344|NCT01408719|101827149|FG001|NOT COMPLETED|First Intervention (35 Days)||0||
48608345|NCT01408719|101827150|FG002|NOT COMPLETED|First Intervention (35 Days)||1||
48608346|NCT01408719|101827151|FG003|NOT COMPLETED|First Intervention (35 Days)||0||
48608347|NCT01408719|101827152|FG004|NOT COMPLETED|First Intervention (35 Days)||1||
48721782|NCT01533922|102105496|FG002|STARTED|Overall Study||60||
48721783|NCT01533922|102105497|FG003|STARTED|Overall Study||58||
48721784|NCT01533922|102105498|FG004|STARTED|Overall Study||59||
48721785|NCT01533922|102105494|FG000|Received Placebo|Overall Study||0||
48721786|NCT01533922|102105495|FG001|Received Placebo|Overall Study||49||
48151663|NCT02332720|100695821|FG013|NOT COMPLETED|Part C||0||
48721787|NCT01533922|102105496|FG002|Received Placebo|Overall Study||57||
48306664|NCT01162239|101077470|FG002|Week 52|Treatment Phase||48||
48306665|NCT01162239|101077471|FG003|Week 52|Treatment Phase||50||
48608348|NCT01408719|101827153|FG005|NOT COMPLETED|First Intervention (35 Days)||0||
48608349|NCT01408719|101827154|FG006|NOT COMPLETED|First Intervention (35 Days)||0||
48608350|NCT01408719|101827155|FG007|NOT COMPLETED|First Intervention (35 Days)||0||
48608351|NCT01408719|101827156|FG008|NOT COMPLETED|First Intervention (35 Days)||1||
48608352|NCT01408719|101827157|FG009|NOT COMPLETED|First Intervention (35 Days)||0||
48608353|NCT01408719|101827158|FG010|NOT COMPLETED|First Intervention (35 Days)||0||
48608354|NCT01408719|101827159|FG011|NOT COMPLETED|First Intervention (35 Days)||0||
48151664|NCT02332720|100695822|FG014|NOT COMPLETED|Part C||0||
48151665|NCT02332720|100695823|FG015|NOT COMPLETED|Part C||0||
48151666|NCT02332720|100695824|FG016|NOT COMPLETED|Part C||0||
48151667|NCT02332720|100695825|FG017|NOT COMPLETED|Part C||0||
48151668|NCT02332720|100695826|FG018|NOT COMPLETED|Part C||0||
48151669|NCT02332720|100695827|FG019|NOT COMPLETED|Part C||0||
48151670|NCT02332720|100695828|FG020|NOT COMPLETED|Part C||0||
48151671|NCT02332720|100695829|FG021|NOT COMPLETED|Part C||0||
48151672|NCT02332720|100695830|FG022|NOT COMPLETED|Part C||0||
48151673|NCT03124979|100695831|FG000|STARTED|Overall Study||13||
48151674|NCT03124979|100695831|FG000|COMPLETED|Overall Study||13||
48151675|NCT03124979|100695831|FG000|NOT COMPLETED|Overall Study||0||
48151676|NCT03338894|100695832|FG000|STARTED|Overall Study||78||
48151677|NCT03338894|100695832|FG000|COMPLETED|Overall Study||56||
48151678|NCT03338894|100695832|FG000|NOT COMPLETED|Overall Study||22||
48151679|NCT03905330|100695833|FG000|STARTED|Overall Study||47||
48608355|NCT01408719|101827160|FG012|NOT COMPLETED|First Intervention (35 Days)||0||
48608356|NCT01408719|101827161|FG013|NOT COMPLETED|First Intervention (35 Days)||1||
48608357|NCT01408719|101827162|FG014|NOT COMPLETED|First Intervention (35 Days)||0||
48608358|NCT01408719|101827163|FG015|NOT COMPLETED|First Intervention (35 Days)||0||
48608359|NCT01408719|101827164|FG016|NOT COMPLETED|First Intervention (35 Days)||1||
48608360|NCT01408719|101827165|FG017|NOT COMPLETED|First Intervention (35 Days)||0||
48608361|NCT01408719|101827166|FG018|NOT COMPLETED|First Intervention (35 Days)||1||
48608362|NCT01408719|101827167|FG019|NOT COMPLETED|First Intervention (35 Days)||0||
48608363|NCT01408719|101827148|FG000|STARTED|Washout Period (28 Days)||2||
48608364|NCT01408719|101827149|FG001|STARTED|Washout Period (28 Days)||3||
48608365|NCT01408719|101827150|FG002|STARTED|Washout Period (28 Days)||1||
48608366|NCT01408719|101827151|FG003|STARTED|Washout Period (28 Days)||2||
48608367|NCT01408719|101827152|FG004|STARTED|Washout Period (28 Days)||3||
48608368|NCT01408719|101827153|FG005|STARTED|Washout Period (28 Days)||3||
48608369|NCT01408719|101827154|FG006|STARTED|Washout Period (28 Days)||2||
48608370|NCT01408719|101827155|FG007|STARTED|Washout Period (28 Days)||3||
48608371|NCT01408719|101827156|FG008|STARTED|Washout Period (28 Days)||1||
48608372|NCT01408719|101827157|FG009|STARTED|Washout Period (28 Days)||1||
48608373|NCT01408719|101827158|FG010|STARTED|Washout Period (28 Days)||2||
48151680|NCT03905330|100695834|FG001|STARTED|Overall Study||46||
48406154|NCT02253394|101328363|FG000|COMPLETED|Overall Study||0||
48151681|NCT03905330|100695833|FG000|Dosed 150 ug/kg BID|Overall Study||47|150 ug/kg BID planned for 1 week|
48151682|NCT03905330|100695834|FG001|Dosed 150 ug/kg BID|Overall Study||0|150 ug/kg BID planned for 1 week|
48151683|NCT03905330|100695833|FG000|Dosed 300 ug/kg BID|Overall Study||46|300 ug/kg BID planned for 1 week|
48151684|NCT03905330|100695834|FG001|Dosed 300 ug/kg BID|Overall Study||0|300 ug/kg BID planned for 1 week|
48151685|NCT03905330|100695833|FG000|Dosed 450 ug/kg BID|Overall Study||45|450 ug/kg BID planned for 1 week|
48151686|NCT03905330|100695834|FG001|Dosed 450 ug/kg BID|Overall Study||0|450 ug/kg BID planned for 1 week|
48151687|NCT03905330|100695833|FG000|Dosed 600 ug/kg BID|Overall Study||45|600 ug/kg BID planned for 23 weeks|
48151688|NCT03905330|100695834|FG001|Dosed 600 ug/kg BID|Overall Study||0|600 ug/kg BID planned for 23 weeks|
48151689|NCT03905330|100695833|FG000|COMPLETED|Overall Study||44||
48151690|NCT03905330|100695834|FG001|COMPLETED|Overall Study||42||
48151691|NCT03905330|100695833|FG000|NOT COMPLETED|Overall Study||3||
48406155|NCT02253394|101328364|FG001|COMPLETED|Overall Study||2||
48608374|NCT01408719|101827159|FG011|STARTED|Washout Period (28 Days)||2||
48608375|NCT01408719|101827160|FG012|STARTED|Washout Period (28 Days)||2||
48608376|NCT01408719|101827161|FG013|STARTED|Washout Period (28 Days)||4||
48608377|NCT01408719|101827162|FG014|STARTED|Washout Period (28 Days)||1||
48608378|NCT01408719|101827163|FG015|STARTED|Washout Period (28 Days)||2||
48608379|NCT01408719|101827164|FG016|STARTED|Washout Period (28 Days)||2||
48608380|NCT01408719|101827165|FG017|STARTED|Washout Period (28 Days)||2||
48608381|NCT01408719|101827166|FG018|STARTED|Washout Period (28 Days)||0||
48608382|NCT01408719|101827167|FG019|STARTED|Washout Period (28 Days)||1||
48608383|NCT01408719|101827148|FG000|COMPLETED|Washout Period (28 Days)||2||
48608384|NCT01408719|101827149|FG001|COMPLETED|Washout Period (28 Days)||3||
48608385|NCT01408719|101827150|FG002|COMPLETED|Washout Period (28 Days)||1||
48608386|NCT01408719|101827151|FG003|COMPLETED|Washout Period (28 Days)||2||
48151692|NCT03905330|100695834|FG001|NOT COMPLETED|Overall Study||4||
48151693|NCT01514448|100695835|FG000|STARTED|Overall Study||16||
48151694|NCT01514448|100695836|FG001|STARTED|Overall Study||13||
48151695|NCT01514448|100695835|FG000|Full Analysis Set (FAS)|Overall Study||12||
48151696|NCT01514448|100695836|FG001|Full Analysis Set (FAS)|Overall Study||13||
48151697|NCT01514448|100695835|FG000|COMPLETED|Overall Study||4||
48151698|NCT01514448|100695836|FG001|COMPLETED|Overall Study||5||
48151699|NCT01514448|100695835|FG000|NOT COMPLETED|Overall Study||12||
48151700|NCT01514448|100695836|FG001|NOT COMPLETED|Overall Study||8||
48151701|NCT00365391|100695837|FG000|STARTED|Overall Study||27||
48151702|NCT00365391|100695837|FG000|COMPLETED|Overall Study||27||
48151703|NCT00365391|100695837|FG000|NOT COMPLETED|Overall Study||0||
48721788|NCT01533922|102105497|FG003|Received Placebo|Overall Study||57||
48721789|NCT01533922|102105498|FG004|Received Placebo|Overall Study||59||
48721790|NCT01533922|102105494|FG000|Received Olo 5|Overall Study||51||
48721791|NCT01533922|102105495|FG001|Received Olo 5|Overall Study||52||
48721792|NCT01533922|102105496|FG002|Received Olo 5|Overall Study||57||
48721793|NCT01533922|102105497|FG003|Received Olo 5|Overall Study||57||
48721794|NCT01533922|102105498|FG004|Received Olo 5|Overall Study||0||
48151704|NCT01024608|100695838|FG000|STARTED|Overall Study||169||
48151705|NCT01024608|100695839|FG001|STARTED|Overall Study||171||
48151706|NCT01024608|100695838|FG000|Intent to Treat Population|Overall Study||167||
48151707|NCT01024608|100695839|FG001|Intent to Treat Population|Overall Study||171||
48151708|NCT01024608|100695838|FG000|Safety Population|Overall Study||167||
48151709|NCT01024608|100695839|FG001|Safety Population|Overall Study||171||
48151710|NCT01024608|100695838|FG000|COMPLETED|Overall Study||165||
48151711|NCT01024608|100695839|FG001|COMPLETED|Overall Study||167||
48151712|NCT01024608|100695838|FG000|NOT COMPLETED|Overall Study||4||
48151713|NCT01024608|100695839|FG001|NOT COMPLETED|Overall Study||4||
48151714|NCT01002872|100695840|FG000|STARTED|Overall Study||10||
48151715|NCT01002872|100695841|FG001|STARTED|Overall Study||9||
48151716|NCT01002872|100695840|FG000|COMPLETED|Overall Study||10||
48151717|NCT01002872|100695841|FG001|COMPLETED|Overall Study||9||
48151718|NCT01002872|100695840|FG000|NOT COMPLETED|Overall Study||0||
48151719|NCT01002872|100695841|FG001|NOT COMPLETED|Overall Study||0||
48151720|NCT04721925|100695842|FG000|STARTED|2-Month Assessment||52||
48151721|NCT04721925|100695843|FG001|STARTED|2-Month Assessment||50||
48151722|NCT04721925|100695842|FG000|COMPLETED|2-Month Assessment||47|Completed 2 Month Assessment|
48151723|NCT04721925|100695843|FG001|COMPLETED|2-Month Assessment||47|Completed 2 Month Assessment|
48151724|NCT04721925|100695842|FG000|NOT COMPLETED|2-Month Assessment||5||
48151725|NCT04721925|100695843|FG001|NOT COMPLETED|2-Month Assessment||3||
48151726|NCT04721925|100695842|FG000|STARTED|4-Month Assessment||52||
48151727|NCT04721925|100695843|FG001|STARTED|4-Month Assessment||50||
48151728|NCT04721925|100695842|FG000|COMPLETED|4-Month Assessment||49|Completed 4-Month Assessment|
48151729|NCT04721925|100695843|FG001|COMPLETED|4-Month Assessment||44|Completed 4-Month Assessment|
48151730|NCT04721925|100695842|FG000|NOT COMPLETED|4-Month Assessment||3||
48151731|NCT04721925|100695843|FG001|NOT COMPLETED|4-Month Assessment||6||
48151732|NCT03645759|100695844|FG000|STARTED|Overall Study||19||
48151733|NCT03645759|100695845|FG001|STARTED|Overall Study||19||
48151734|NCT03645759|100695844|FG000|COMPLETED|Overall Study||16||
48151735|NCT03645759|100695845|FG001|COMPLETED|Overall Study||17||
48151736|NCT03645759|100695844|FG000|NOT COMPLETED|Overall Study||3||
48151737|NCT03645759|100695845|FG001|NOT COMPLETED|Overall Study||2||
48151738|NCT00136955|100695846|FG000|STARTED|Overall Study||41||
48151739|NCT00136955|100695846|FG000|COMPLETED|Overall Study||18||
48151740|NCT00136955|100695846|FG000|NOT COMPLETED|Overall Study||23||
48151741|NCT00746122|100695847|FG000|STARTED|Overall Study||297||
48151742|NCT00746122|100695848|FG001|STARTED|Overall Study||316||
48151743|NCT00746122|100695847|FG000|COMPLETED|Overall Study||297||
48151744|NCT00746122|100695848|FG001|COMPLETED|Overall Study||316||
48151745|NCT00746122|100695847|FG000|NOT COMPLETED|Overall Study||0||
48151746|NCT00746122|100695848|FG001|NOT COMPLETED|Overall Study||0||
48151747|NCT01811212|100695849|FG000|STARTED|Overall Study||25||
48151748|NCT01811212|100695849|FG000|COMPLETED|Overall Study||25||
48151749|NCT01811212|100695849|FG000|NOT COMPLETED|Overall Study||0||
48151750|NCT02120027|100695850|FG000|STARTED|Overall Study||277||
48721795|NCT01533922|102105494|FG000|Received Tio 5|Overall Study||54||
48721796|NCT01533922|102105495|FG001|Received Tio 5|Overall Study||58||
48721797|NCT01533922|102105496|FG002|Received Tio 5|Overall Study||59||
48721798|NCT01533922|102105497|FG003|Received Tio 5|Overall Study||1||
48721799|NCT01533922|102105498|FG004|Received Tio 5|Overall Study||54||
48306666|NCT01162239|101077468|FG000|COMPLETED|Treatment Phase||49|Treatment regimens were completed at 52 weeks|
48151751|NCT02120027|100695851|FG001|STARTED|Overall Study||279||
48151752|NCT02120027|100695850|FG000|COMPLETED|Overall Study||161||
48151753|NCT02120027|100695851|FG001|COMPLETED|Overall Study||160||
48151754|NCT02120027|100695850|FG000|NOT COMPLETED|Overall Study||116||
48151755|NCT02120027|100695851|FG001|NOT COMPLETED|Overall Study||119||
48151756|NCT02038894|100695852|FG000|STARTED|Overall Study||60||
48151757|NCT02038894|100695853|FG001|STARTED|Overall Study||58||
48151758|NCT02038894|100695854|FG002|STARTED|Overall Study||61||
48151759|NCT02038894|100695852|FG000|COMPLETED|Overall Study||60||
48151760|NCT02038894|100695853|FG001|COMPLETED|Overall Study||58||
48151761|NCT02038894|100695854|FG002|COMPLETED|Overall Study||61||
48151762|NCT02038894|100695852|FG000|NOT COMPLETED|Overall Study||0||
48151763|NCT02038894|100695853|FG001|NOT COMPLETED|Overall Study||0||
48721800|NCT01533922|102105494|FG000|Received Tio+Olo 2.5/5|Overall Study||59||
48721801|NCT01533922|102105495|FG001|Received Tio+Olo 2.5/5|Overall Study||0||
48151764|NCT02038894|100695854|FG002|NOT COMPLETED|Overall Study||0||
48151765|NCT01143688|100695855|FG000|STARTED|Overall Study||39||
48721802|NCT01533922|102105496|FG002|Received Tio+Olo 2.5/5|Overall Study||52||
48151766|NCT01143688|100695855|FG000|COMPLETED|Overall Study||39||
48151767|NCT01143688|100695855|FG000|NOT COMPLETED|Overall Study||0||
48151768|NCT04512066|100695856|FG000|STARTED|Double-blind Treatment Period||73||
48151769|NCT04512066|100695857|FG001|STARTED|Double-blind Treatment Period||71||
48151770|NCT04512066|100695858|FG002|STARTED|Double-blind Treatment Period||69||
48151771|NCT04512066|100695859|FG003|STARTED|Double-blind Treatment Period||74||
48151772|NCT04512066|100695860|FG004|STARTED|Double-blind Treatment Period||0||
48151773|NCT04512066|100695861|FG005|STARTED|Double-blind Treatment Period||0||
48151774|NCT04512066|100695856|FG000|COMPLETED|Double-blind Treatment Period||56||
48151775|NCT04512066|100695857|FG001|COMPLETED|Double-blind Treatment Period||55||
48151776|NCT04512066|100695858|FG002|COMPLETED|Double-blind Treatment Period||53||
48151777|NCT04512066|100695859|FG003|COMPLETED|Double-blind Treatment Period||60||
48151778|NCT04512066|100695860|FG004|COMPLETED|Double-blind Treatment Period||0||
48151779|NCT04512066|100695861|FG005|COMPLETED|Double-blind Treatment Period||0||
48151780|NCT04512066|100695856|FG000|NOT COMPLETED|Double-blind Treatment Period||17||
48151781|NCT04512066|100695857|FG001|NOT COMPLETED|Double-blind Treatment Period||16||
48151782|NCT04512066|100695858|FG002|NOT COMPLETED|Double-blind Treatment Period||16||
48151783|NCT04512066|100695859|FG003|NOT COMPLETED|Double-blind Treatment Period||14||
48151784|NCT04512066|100695860|FG004|NOT COMPLETED|Double-blind Treatment Period||0||
48151785|NCT04512066|100695861|FG005|NOT COMPLETED|Double-blind Treatment Period||0||
48151786|NCT04512066|100695856|FG000|STARTED|Extension Period||0||
48151787|NCT04512066|100695857|FG001|STARTED|Extension Period||44||
48151788|NCT04512066|100695858|FG002|STARTED|Extension Period||46||
48721803|NCT01533922|102105497|FG003|Received Tio+Olo 2.5/5|Overall Study||55||
48721804|NCT01533922|102105498|FG004|Received Tio+Olo 2.5/5|Overall Study||56||
48721805|NCT01533922|102105494|FG000|Received Tio+Olo 5/5|Overall Study||58||
48721806|NCT01533922|102105495|FG001|Received Tio+Olo 5/5|Overall Study||59||
48721807|NCT01533922|102105496|FG002|Received Tio+Olo 5/5|Overall Study||0||
48721808|NCT01533922|102105497|FG003|Received Tio+Olo 5/5|Overall Study||53||
48721809|NCT01533922|102105498|FG004|Received Tio+Olo 5/5|Overall Study||56||
48721810|NCT01533922|102105494|FG000|COMPLETED|Overall Study||49||
48151789|NCT04512066|100695859|FG003|STARTED|Extension Period||56||
48151790|NCT04512066|100695860|FG004|STARTED|Extension Period||25||
48151791|NCT04512066|100695861|FG005|STARTED|Extension Period||26||
48151792|NCT04512066|100695856|FG000|COMPLETED|Extension Period||0||
48151793|NCT04512066|100695857|FG001|COMPLETED|Extension Period||30||
48151794|NCT04512066|100695858|FG002|COMPLETED|Extension Period||26||
48151795|NCT04512066|100695859|FG003|COMPLETED|Extension Period||38||
48151796|NCT04512066|100695860|FG004|COMPLETED|Extension Period||9||
48151797|NCT04512066|100695861|FG005|COMPLETED|Extension Period||12||
48151798|NCT04512066|100695856|FG000|NOT COMPLETED|Extension Period||0||
48151799|NCT04512066|100695857|FG001|NOT COMPLETED|Extension Period||14||
48151800|NCT04512066|100695858|FG002|NOT COMPLETED|Extension Period||20||
48151801|NCT04512066|100695859|FG003|NOT COMPLETED|Extension Period||18||
48151802|NCT04512066|100695860|FG004|NOT COMPLETED|Extension Period||16||
48151803|NCT04512066|100695861|FG005|NOT COMPLETED|Extension Period||14||
48151804|NCT01059630|100695862|FG000|STARTED|Overall Study||209||
48306667|NCT01162239|101077469|FG001|COMPLETED|Treatment Phase||47|Treatment regimens were completed at 52 weeks|
48306668|NCT01162239|101077470|FG002|COMPLETED|Treatment Phase||48|Treatment regimens were completed at 52 weeks|
48306669|NCT01162239|101077471|FG003|COMPLETED|Treatment Phase||50|Treatment regimens were completed at 52 weeks|
48306670|NCT01162239|101077468|FG000|NOT COMPLETED|Treatment Phase||6||
48306671|NCT01162239|101077469|FG001|NOT COMPLETED|Treatment Phase||7||
48306672|NCT01162239|101077470|FG002|NOT COMPLETED|Treatment Phase||4||
48306673|NCT01162239|101077471|FG003|NOT COMPLETED|Treatment Phase||5||
48306674|NCT01162239|101077468|FG000|STARTED|Extended Follow-up||47|Week 64|
48306675|NCT01162239|101077469|FG001|STARTED|Extended Follow-up||45|Week 64|
48306676|NCT01162239|101077470|FG002|STARTED|Extended Follow-up||45|Week 64|
48306677|NCT01162239|101077471|FG003|STARTED|Extended Follow-up||47|Week 64|
48306678|NCT01162239|101077468|FG000|COMPLETED|Extended Follow-up||39|Week 104|
48306679|NCT01162239|101077469|FG001|COMPLETED|Extended Follow-up||32|Week 104|
48721811|NCT01533922|102105495|FG001|COMPLETED|Overall Study||47||
48721812|NCT01533922|102105496|FG002|COMPLETED|Overall Study||50||
48721813|NCT01533922|102105497|FG003|COMPLETED|Overall Study||53||
48721814|NCT01533922|102105498|FG004|COMPLETED|Overall Study||53||
48721815|NCT01533922|102105494|FG000|NOT COMPLETED|Overall Study||10||
48721816|NCT01533922|102105495|FG001|NOT COMPLETED|Overall Study||12||
48721817|NCT01533922|102105496|FG002|NOT COMPLETED|Overall Study||10||
48151805|NCT01059630|100695863|FG001|STARTED|Overall Study||204||
48151806|NCT01059630|100695862|FG000|COMPLETED|Overall Study||82||
48151807|NCT01059630|100695863|FG001|COMPLETED|Overall Study||101||
48151808|NCT01059630|100695862|FG000|NOT COMPLETED|Overall Study||127||
48151809|NCT01059630|100695863|FG001|NOT COMPLETED|Overall Study||103||
48151810|NCT04870710|100695864|FG000|STARTED|Overall Study||6||
48151811|NCT04870710|100695864|FG000|Transcranial Direct Current Stimulation (tDCS) Baseline Assessment|Overall Study||6||
48151812|NCT04870710|100695864|FG000|Transcranial Direct Current Stimulation (tDCS) Five Day Follow-up Assessment|Overall Study||6||
48151813|NCT04870710|100695864|FG000|Transcranial Direct Current Stimulation (tDCS) 1 Month Follow-up Assessment|Overall Study||5||
48188710|NCT02034435|100783315|FG003|COMPLETED|Overall Study||8||
48151814|NCT04870710|100695864|FG000|Transcranial Alternating Current Stimulation (tACS) Baseline Assessment|Overall Study||4||
48151815|NCT04870710|100695864|FG000|Transcranial Alternating Current Stimulation (tACS) 5 Day Follow up Assessment|Overall Study||4||
48151816|NCT04870710|100695864|FG000|Transcranial Alternating Current Stimulation (tACS) 1 Month Follow up Assessment|Overall Study||3||
48306680|NCT01162239|101077470|FG002|COMPLETED|Extended Follow-up||37|Week 104|
48306681|NCT01162239|101077471|FG003|COMPLETED|Extended Follow-up||41|Week 104|
48306682|NCT01162239|101077468|FG000|NOT COMPLETED|Extended Follow-up||8||
48306683|NCT01162239|101077469|FG001|NOT COMPLETED|Extended Follow-up||13||
48306684|NCT01162239|101077470|FG002|NOT COMPLETED|Extended Follow-up||8||
48306685|NCT01162239|101077471|FG003|NOT COMPLETED|Extended Follow-up||6||
48306686|NCT01211535|101077472|FG000|STARTED|Overall Study||52||
48306687|NCT01211535|101077473|FG001|STARTED|Overall Study||52||
48306688|NCT01211535|101077472|FG000|COMPLETED|Overall Study||52||
48306689|NCT01211535|101077473|FG001|COMPLETED|Overall Study||51||
48306690|NCT01211535|101077472|FG000|NOT COMPLETED|Overall Study||0||
48306691|NCT01211535|101077473|FG001|NOT COMPLETED|Overall Study||1||
48306692|NCT00908583|101077474|FG000|STARTED|Phase 1||20||
48306693|NCT00908583|101077474|FG000|COMPLETED|Phase 1||15||
48306694|NCT00908583|101077474|FG000|NOT COMPLETED|Phase 1||5||
48306695|NCT00908583|101077474|FG000|STARTED|Phase 2||12||
48306696|NCT00908583|101077474|FG000|COMPLETED|Phase 2||10||
48306697|NCT00908583|101077474|FG000|NOT COMPLETED|Phase 2||2||
48306698|NCT00908583|101077474|FG000|STARTED|Phase 3||10||
48151817|NCT04870710|100695864|FG000|COMPLETED|Overall Study||3||
48151818|NCT04870710|100695864|FG000|NOT COMPLETED|Overall Study||3||
48151819|NCT00724152|100695865|FG000|STARTED|Two-arm Study Period||14||
48151820|NCT00724152|100695866|FG001|STARTED|Two-arm Study Period||11||
48151821|NCT00724152|100695867|FG002|STARTED|Two-arm Study Period||0||
48151822|NCT00724152|100695865|FG000|COMPLETED|Two-arm Study Period||11||
48151823|NCT00724152|100695866|FG001|COMPLETED|Two-arm Study Period||9||
48151824|NCT00724152|100695867|FG002|COMPLETED|Two-arm Study Period||0||
48306699|NCT00908583|101077474|FG000|COMPLETED|Phase 3||8||
48406156|NCT02253394|101328363|FG000|NOT COMPLETED|Overall Study||0||
48151825|NCT00724152|100695865|FG000|NOT COMPLETED|Two-arm Study Period||3||
48151826|NCT00724152|100695866|FG001|NOT COMPLETED|Two-arm Study Period||2||
48306700|NCT00908583|101077474|FG000|NOT COMPLETED|Phase 3||2||
48306701|NCT00908583|101077474|FG000|STARTED|Phase 4||5||
48306702|NCT00908583|101077474|FG000|COMPLETED|Phase 4||3||
48306703|NCT00908583|101077474|FG000|NOT COMPLETED|Phase 4||2||
48306704|NCT00908583|101077474|FG000|STARTED|Phase 5||5||
48306705|NCT00908583|101077474|FG000|COMPLETED|Phase 5||2||
48306706|NCT00908583|101077474|FG000|NOT COMPLETED|Phase 5||3||
48306707|NCT04411953|101077475|FG000|STARTED|Treatment Period 1 (8 Days)||16||
48306708|NCT04411953|101077476|FG001|STARTED|Treatment Period 1 (8 Days)||16||
48306709|NCT04411953|101077475|FG000|COMPLETED|Treatment Period 1 (8 Days)||16||
48306710|NCT04411953|101077476|FG001|COMPLETED|Treatment Period 1 (8 Days)||16||
48306711|NCT04411953|101077475|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
48306712|NCT04411953|101077476|FG001|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
48406157|NCT02253394|101328364|FG001|NOT COMPLETED|Overall Study||0||
48151827|NCT00724152|100695867|FG002|NOT COMPLETED|Two-arm Study Period||0||
48151828|NCT00724152|100695865|FG000|STARTED|Three-arm Study Period (+Standard Care)||4||
48151829|NCT00724152|100695866|FG001|STARTED|Three-arm Study Period (+Standard Care)||2||
48151830|NCT00724152|100695867|FG002|STARTED|Three-arm Study Period (+Standard Care)||2||
48151831|NCT00724152|100695865|FG000|COMPLETED|Three-arm Study Period (+Standard Care)||3||
48151832|NCT00724152|100695866|FG001|COMPLETED|Three-arm Study Period (+Standard Care)||0||
48151833|NCT00724152|100695867|FG002|COMPLETED|Three-arm Study Period (+Standard Care)||1||
48151834|NCT00724152|100695865|FG000|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1||
48151835|NCT00724152|100695866|FG001|NOT COMPLETED|Three-arm Study Period (+Standard Care)||2||
48608387|NCT01408719|101827152|FG004|COMPLETED|Washout Period (28 Days)||3||
48608388|NCT01408719|101827153|FG005|COMPLETED|Washout Period (28 Days)||3||
48608389|NCT01408719|101827154|FG006|COMPLETED|Washout Period (28 Days)||2||
48721818|NCT01533922|102105497|FG003|NOT COMPLETED|Overall Study||5||
48721819|NCT01533922|102105498|FG004|NOT COMPLETED|Overall Study||6||
48721820|NCT01455194|102105499|FG000|STARTED|Overall Study||153||
48721821|NCT01455194|102105500|FG001|STARTED|Overall Study||120||
48721822|NCT01455194|102105501|FG002|STARTED|Overall Study||122||
48721823|NCT01455194|102105502|FG003|STARTED|Overall Study||125||
48721824|NCT01455194|102105499|FG000|COMPLETED|Overall Study||0||
48721825|NCT01455194|102105500|FG001|COMPLETED|Overall Study||89||
48721826|NCT01455194|102105501|FG002|COMPLETED|Overall Study||92||
48721827|NCT01455194|102105502|FG003|COMPLETED|Overall Study||97||
48721828|NCT01455194|102105499|FG000|NOT COMPLETED|Overall Study||153||
48721829|NCT01455194|102105500|FG001|NOT COMPLETED|Overall Study||31||
48721830|NCT01455194|102105501|FG002|NOT COMPLETED|Overall Study||30||
48721831|NCT01455194|102105502|FG003|NOT COMPLETED|Overall Study||28||
48721832|NCT02014584|102105503|FG000|STARTED|Double-Blind Period (24 Weeks)||59||
48721833|NCT02014584|102105504|FG001|STARTED|Double-Blind Period (24 Weeks)||58||
48721834|NCT02014584|102105505|FG002|STARTED|Double-Blind Period (24 Weeks)||0||
48721835|NCT02014584|102105506|FG003|STARTED|Double-Blind Period (24 Weeks)||0||
48721836|NCT02014584|102105507|FG004|STARTED|Double-Blind Period (24 Weeks)||0||
48721837|NCT02014584|102105508|FG005|STARTED|Double-Blind Period (24 Weeks)||0||
48721838|NCT02014584|102105503|FG000|COMPLETED|Double-Blind Period (24 Weeks)||57||
48721839|NCT02014584|102105504|FG001|COMPLETED|Double-Blind Period (24 Weeks)||52||
48721840|NCT02014584|102105505|FG002|COMPLETED|Double-Blind Period (24 Weeks)||0||
48721841|NCT02014584|102105506|FG003|COMPLETED|Double-Blind Period (24 Weeks)||0||
48721842|NCT02014584|102105507|FG004|COMPLETED|Double-Blind Period (24 Weeks)||0||
48721843|NCT02014584|102105508|FG005|COMPLETED|Double-Blind Period (24 Weeks)||0||
48721844|NCT02014584|102105503|FG000|NOT COMPLETED|Double-Blind Period (24 Weeks)||2||
48721845|NCT02014584|102105504|FG001|NOT COMPLETED|Double-Blind Period (24 Weeks)||6||
48721846|NCT02014584|102105505|FG002|NOT COMPLETED|Double-Blind Period (24 Weeks)||0||
48721847|NCT02014584|102105506|FG003|NOT COMPLETED|Double-Blind Period (24 Weeks)||0||
48721848|NCT02014584|102105507|FG004|NOT COMPLETED|Double-Blind Period (24 Weeks)||0||
48721849|NCT02014584|102105508|FG005|NOT COMPLETED|Double-Blind Period (24 Weeks)||0||
48721850|NCT02014584|102105503|FG000|STARTED|Open-Label Period (24 Weeks)||0||
48721851|NCT02014584|102105504|FG001|STARTED|Open-Label Period (24 Weeks)||0||
48721852|NCT02014584|102105505|FG002|STARTED|Open-Label Period (24 Weeks)||49||
48721853|NCT02014584|102105506|FG003|STARTED|Open-Label Period (24 Weeks)||48||
48721854|NCT02014584|102105507|FG004|STARTED|Open-Label Period (24 Weeks)||0||
48721855|NCT02014584|102105508|FG005|STARTED|Open-Label Period (24 Weeks)||0||
48721856|NCT02014584|102105503|FG000|COMPLETED|Open-Label Period (24 Weeks)||0||
48721857|NCT02014584|102105504|FG001|COMPLETED|Open-Label Period (24 Weeks)||0||
48721858|NCT02014584|102105505|FG002|COMPLETED|Open-Label Period (24 Weeks)||44||
48721859|NCT02014584|102105506|FG003|COMPLETED|Open-Label Period (24 Weeks)||47||
48151836|NCT00724152|100695867|FG002|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1||
48608390|NCT01408719|101827155|FG007|COMPLETED|Washout Period (28 Days)||3||
48608391|NCT01408719|101827156|FG008|COMPLETED|Washout Period (28 Days)||1||
48608392|NCT01408719|101827157|FG009|COMPLETED|Washout Period (28 Days)||1||
48721860|NCT02014584|102105507|FG004|COMPLETED|Open-Label Period (24 Weeks)||0||
48721861|NCT02014584|102105508|FG005|COMPLETED|Open-Label Period (24 Weeks)||0||
48721862|NCT02014584|102105503|FG000|NOT COMPLETED|Open-Label Period (24 Weeks)||0||
48721863|NCT02014584|102105504|FG001|NOT COMPLETED|Open-Label Period (24 Weeks)||0||
48721864|NCT02014584|102105505|FG002|NOT COMPLETED|Open-Label Period (24 Weeks)||5||
48721865|NCT02014584|102105506|FG003|NOT COMPLETED|Open-Label Period (24 Weeks)||1||
48721866|NCT02014584|102105507|FG004|NOT COMPLETED|Open-Label Period (24 Weeks)||0||
48721867|NCT02014584|102105508|FG005|NOT COMPLETED|Open-Label Period (24 Weeks)||0||
48721868|NCT02014584|102105503|FG000|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0||
48721869|NCT02014584|102105504|FG001|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0||
48721870|NCT02014584|102105505|FG002|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0||
48721871|NCT02014584|102105506|FG003|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0||
48151837|NCT01907191|100695868|FG000|STARTED|Overall Study||13||
48151838|NCT01907191|100695869|FG001|STARTED|Overall Study||10||
48151839|NCT01907191|100695868|FG000|COMPLETED|Overall Study||13||
48608393|NCT01408719|101827158|FG010|COMPLETED|Washout Period (28 Days)||2||
48608394|NCT01408719|101827159|FG011|COMPLETED|Washout Period (28 Days)||2||
48151840|NCT01907191|100695869|FG001|COMPLETED|Overall Study||10||
48151841|NCT01907191|100695868|FG000|NOT COMPLETED|Overall Study||0||
48608395|NCT01408719|101827160|FG012|COMPLETED|Washout Period (28 Days)||2||
48608396|NCT01408719|101827161|FG013|COMPLETED|Washout Period (28 Days)||4||
48608397|NCT01408719|101827162|FG014|COMPLETED|Washout Period (28 Days)||1||
48608398|NCT01408719|101827163|FG015|COMPLETED|Washout Period (28 Days)||2||
48608399|NCT01408719|101827164|FG016|COMPLETED|Washout Period (28 Days)||2||
48608400|NCT01408719|101827165|FG017|COMPLETED|Washout Period (28 Days)||2||
48608401|NCT01408719|101827166|FG018|COMPLETED|Washout Period (28 Days)||0||
48608402|NCT01408719|101827167|FG019|COMPLETED|Washout Period (28 Days)||1||
48608403|NCT01408719|101827148|FG000|NOT COMPLETED|Washout Period (28 Days)||0||
48608404|NCT01408719|101827149|FG001|NOT COMPLETED|Washout Period (28 Days)||0||
48608405|NCT01408719|101827150|FG002|NOT COMPLETED|Washout Period (28 Days)||0||
48608406|NCT01408719|101827151|FG003|NOT COMPLETED|Washout Period (28 Days)||0||
48608407|NCT01408719|101827152|FG004|NOT COMPLETED|Washout Period (28 Days)||0||
48608408|NCT01408719|101827153|FG005|NOT COMPLETED|Washout Period (28 Days)||0||
48608409|NCT01408719|101827154|FG006|NOT COMPLETED|Washout Period (28 Days)||0||
48608410|NCT01408719|101827155|FG007|NOT COMPLETED|Washout Period (28 Days)||0||
48608411|NCT01408719|101827156|FG008|NOT COMPLETED|Washout Period (28 Days)||0||
48608412|NCT01408719|101827157|FG009|NOT COMPLETED|Washout Period (28 Days)||0||
48608413|NCT01408719|101827158|FG010|NOT COMPLETED|Washout Period (28 Days)||0||
48608414|NCT01408719|101827159|FG011|NOT COMPLETED|Washout Period (28 Days)||0||
48608415|NCT01408719|101827160|FG012|NOT COMPLETED|Washout Period (28 Days)||0||
48608416|NCT01408719|101827161|FG013|NOT COMPLETED|Washout Period (28 Days)||0||
48608417|NCT01408719|101827162|FG014|NOT COMPLETED|Washout Period (28 Days)||0||
48608418|NCT01408719|101827163|FG015|NOT COMPLETED|Washout Period (28 Days)||0||
48608419|NCT01408719|101827164|FG016|NOT COMPLETED|Washout Period (28 Days)||0||
48608420|NCT01408719|101827165|FG017|NOT COMPLETED|Washout Period (28 Days)||0||
48608421|NCT01408719|101827166|FG018|NOT COMPLETED|Washout Period (28 Days)||0||
48608422|NCT01408719|101827167|FG019|NOT COMPLETED|Washout Period (28 Days)||0||
48608423|NCT01408719|101827148|FG000|STARTED|Second Intervention (35 Days)||2||
48608424|NCT01408719|101827149|FG001|STARTED|Second Intervention (35 Days)||3||
48608425|NCT01408719|101827150|FG002|STARTED|Second Intervention (35 Days)||1||
48608426|NCT01408719|101827151|FG003|STARTED|Second Intervention (35 Days)||2||
48608427|NCT01408719|101827152|FG004|STARTED|Second Intervention (35 Days)||3||
48608428|NCT01408719|101827153|FG005|STARTED|Second Intervention (35 Days)||3||
48608429|NCT01408719|101827154|FG006|STARTED|Second Intervention (35 Days)||2||
48608430|NCT01408719|101827155|FG007|STARTED|Second Intervention (35 Days)||3||
48608431|NCT01408719|101827156|FG008|STARTED|Second Intervention (35 Days)||1||
48608432|NCT01408719|101827157|FG009|STARTED|Second Intervention (35 Days)||1||
48608433|NCT01408719|101827158|FG010|STARTED|Second Intervention (35 Days)||2||
48608434|NCT01408719|101827159|FG011|STARTED|Second Intervention (35 Days)||2||
48608435|NCT01408719|101827160|FG012|STARTED|Second Intervention (35 Days)||2||
48608436|NCT01408719|101827161|FG013|STARTED|Second Intervention (35 Days)||4||
48608437|NCT01408719|101827162|FG014|STARTED|Second Intervention (35 Days)||1||
48608438|NCT01408719|101827163|FG015|STARTED|Second Intervention (35 Days)||2||
48608439|NCT01408719|101827164|FG016|STARTED|Second Intervention (35 Days)||2||
48608440|NCT01408719|101827165|FG017|STARTED|Second Intervention (35 Days)||2||
48608441|NCT01408719|101827166|FG018|STARTED|Second Intervention (35 Days)||0||
48608442|NCT01408719|101827167|FG019|STARTED|Second Intervention (35 Days)||1||
48608443|NCT01408719|101827148|FG000|COMPLETED|Second Intervention (35 Days)||2||
48608444|NCT01408719|101827149|FG001|COMPLETED|Second Intervention (35 Days)||3||
48608445|NCT01408719|101827150|FG002|COMPLETED|Second Intervention (35 Days)||1||
48608446|NCT01408719|101827151|FG003|COMPLETED|Second Intervention (35 Days)||2||
48608447|NCT01408719|101827152|FG004|COMPLETED|Second Intervention (35 Days)||3||
48608448|NCT01408719|101827153|FG005|COMPLETED|Second Intervention (35 Days)||3||
48151842|NCT01907191|100695869|FG001|NOT COMPLETED|Overall Study||0||
48151843|NCT02080468|100695870|FG000|STARTED|Overall Study||16||
48151844|NCT02080468|100695871|FG001|STARTED|Overall Study||16||
48608449|NCT01408719|101827154|FG006|COMPLETED|Second Intervention (35 Days)||2||
48608450|NCT01408719|101827155|FG007|COMPLETED|Second Intervention (35 Days)||3||
48608451|NCT01408719|101827156|FG008|COMPLETED|Second Intervention (35 Days)||1||
48608452|NCT01408719|101827157|FG009|COMPLETED|Second Intervention (35 Days)||1||
48608453|NCT01408719|101827158|FG010|COMPLETED|Second Intervention (35 Days)||2||
48608454|NCT01408719|101827159|FG011|COMPLETED|Second Intervention (35 Days)||2||
48608455|NCT01408719|101827160|FG012|COMPLETED|Second Intervention (35 Days)||2||
48608456|NCT01408719|101827161|FG013|COMPLETED|Second Intervention (35 Days)||3||
48608457|NCT01408719|101827162|FG014|COMPLETED|Second Intervention (35 Days)||1||
48608458|NCT01408719|101827163|FG015|COMPLETED|Second Intervention (35 Days)||2||
48608459|NCT01408719|101827164|FG016|COMPLETED|Second Intervention (35 Days)||2||
48608460|NCT01408719|101827165|FG017|COMPLETED|Second Intervention (35 Days)||2||
48608461|NCT01408719|101827166|FG018|COMPLETED|Second Intervention (35 Days)||0||
48608462|NCT01408719|101827167|FG019|COMPLETED|Second Intervention (35 Days)||1||
48608463|NCT01408719|101827148|FG000|NOT COMPLETED|Second Intervention (35 Days)||0||
48608464|NCT01408719|101827149|FG001|NOT COMPLETED|Second Intervention (35 Days)||0||
48151845|NCT02080468|100695870|FG000|COMPLETED|Overall Study||14||
48608465|NCT01408719|101827150|FG002|NOT COMPLETED|Second Intervention (35 Days)||0||
48608466|NCT01408719|101827151|FG003|NOT COMPLETED|Second Intervention (35 Days)||0||
48608467|NCT01408719|101827152|FG004|NOT COMPLETED|Second Intervention (35 Days)||0||
48608468|NCT01408719|101827153|FG005|NOT COMPLETED|Second Intervention (35 Days)||0||
48608469|NCT01408719|101827154|FG006|NOT COMPLETED|Second Intervention (35 Days)||0||
48608470|NCT01408719|101827155|FG007|NOT COMPLETED|Second Intervention (35 Days)||0||
48608471|NCT01408719|101827156|FG008|NOT COMPLETED|Second Intervention (35 Days)||0||
48608472|NCT01408719|101827157|FG009|NOT COMPLETED|Second Intervention (35 Days)||0||
48608473|NCT01408719|101827158|FG010|NOT COMPLETED|Second Intervention (35 Days)||0||
48608474|NCT01408719|101827159|FG011|NOT COMPLETED|Second Intervention (35 Days)||0||
48608475|NCT01408719|101827160|FG012|NOT COMPLETED|Second Intervention (35 Days)||0||
48608476|NCT01408719|101827161|FG013|NOT COMPLETED|Second Intervention (35 Days)||1||
48608477|NCT01408719|101827162|FG014|NOT COMPLETED|Second Intervention (35 Days)||0||
48608478|NCT01408719|101827163|FG015|NOT COMPLETED|Second Intervention (35 Days)||0||
48608479|NCT01408719|101827164|FG016|NOT COMPLETED|Second Intervention (35 Days)||0||
48608480|NCT01408719|101827165|FG017|NOT COMPLETED|Second Intervention (35 Days)||0||
48608481|NCT01408719|101827166|FG018|NOT COMPLETED|Second Intervention (35 Days)||0||
48306713|NCT04411953|101077475|FG000|STARTED|Washout Period (14 Days)||16||
48306714|NCT04411953|101077476|FG001|STARTED|Washout Period (14 Days)||16||
48306715|NCT04411953|101077475|FG000|COMPLETED|Washout Period (14 Days)||16||
48306716|NCT04411953|101077476|FG001|COMPLETED|Washout Period (14 Days)||15||
48306717|NCT04411953|101077475|FG000|NOT COMPLETED|Washout Period (14 Days)||0||
48306718|NCT04411953|101077476|FG001|NOT COMPLETED|Washout Period (14 Days)||1||
48721872|NCT02014584|102105507|FG004|STARTED|Target Follow-up (F/U) Period (24 Weeks)||3||
48721873|NCT02014584|102105508|FG005|STARTED|Target Follow-up (F/U) Period (24 Weeks)||2||
48721874|NCT02014584|102105503|FG000|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0||
48721875|NCT02014584|102105504|FG001|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0||
48721876|NCT02014584|102105505|FG002|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0||
48721877|NCT02014584|102105506|FG003|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0||
48721878|NCT02014584|102105507|FG004|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2||
48721879|NCT02014584|102105508|FG005|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2||
48721880|NCT02014584|102105503|FG000|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0||
48721881|NCT02014584|102105504|FG001|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0||
48721882|NCT02014584|102105505|FG002|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0||
48721883|NCT02014584|102105506|FG003|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0||
48721884|NCT02014584|102105507|FG004|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||1||
48721885|NCT02014584|102105508|FG005|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0||
48721886|NCT02004977|102105509|FG000|STARTED|Overall Study||463||
48721887|NCT02004977|102105510|FG001|STARTED|Overall Study||441||
48721888|NCT02004977|102105509|FG000|COMPLETED|Overall Study||409||
48721889|NCT02004977|102105510|FG001|COMPLETED|Overall Study||436||
48721890|NCT02004977|102105509|FG000|NOT COMPLETED|Overall Study||54||
48721891|NCT02004977|102105510|FG001|NOT COMPLETED|Overall Study||5||
48721892|NCT02378207|102105511|FG000|STARTED|Overall Study||24||
48721893|NCT02378207|102105512|FG001|STARTED|Overall Study||24||
48721894|NCT02378207|102105513|FG002|STARTED|Overall Study||24||
48721895|NCT02378207|102105514|FG003|STARTED|Overall Study||12||
48721896|NCT02378207|102105511|FG000|COMPLETED|Overall Study||24||
48721897|NCT02378207|102105512|FG001|COMPLETED|Overall Study||21||
48721898|NCT02378207|102105513|FG002|COMPLETED|Overall Study||22||
48721899|NCT02378207|102105514|FG003|COMPLETED|Overall Study||11||
48721900|NCT02378207|102105511|FG000|NOT COMPLETED|Overall Study||0||
48721901|NCT02378207|102105512|FG001|NOT COMPLETED|Overall Study||3||
48721902|NCT02378207|102105513|FG002|NOT COMPLETED|Overall Study||2||
48721903|NCT02378207|102105514|FG003|NOT COMPLETED|Overall Study||1||
48721904|NCT01994993|102105515|FG000|STARTED|Overall Study||63||
48721905|NCT01994993|102105516|FG001|STARTED|Overall Study||47||
48721906|NCT01994993|102105517|FG002|STARTED|Overall Study||70||
48721907|NCT01994993|102105518|FG003|STARTED|Overall Study||55||
48721908|NCT01994993|102105519|FG004|STARTED|Overall Study||24||
48721909|NCT01994993|102105515|FG000|COMPLETED|Overall Study||28||
48721910|NCT01994993|102105516|FG001|COMPLETED|Overall Study||12||
48721911|NCT01994993|102105517|FG002|COMPLETED|Overall Study||23||
48721912|NCT01994993|102105518|FG003|COMPLETED|Overall Study||9||
48721913|NCT01994993|102105519|FG004|COMPLETED|Overall Study||22||
48721914|NCT01994993|102105515|FG000|NOT COMPLETED|Overall Study||35||
48721915|NCT01994993|102105516|FG001|NOT COMPLETED|Overall Study||35||
48721916|NCT01994993|102105517|FG002|NOT COMPLETED|Overall Study||47||
48721917|NCT01994993|102105518|FG003|NOT COMPLETED|Overall Study||46||
48721918|NCT01994993|102105519|FG004|NOT COMPLETED|Overall Study||2||
48721919|NCT00031460|102105520|FG000|STARTED|Overall Study||24||
48721920|NCT00031460|102105521|FG001|STARTED|Overall Study||22||
48721921|NCT00031460|102105520|FG000|COMPLETED|Overall Study||15||
48721922|NCT00031460|102105521|FG001|COMPLETED|Overall Study||8||
48721923|NCT00031460|102105520|FG000|NOT COMPLETED|Overall Study||9||
48721924|NCT00031460|102105521|FG001|NOT COMPLETED|Overall Study||14||
48721925|NCT03769311|102105522|FG000|STARTED|Overall Study||15||
48306719|NCT04411953|101077475|FG000|STARTED|Treatment Period 2 (8 Days)||16||
48306720|NCT04411953|101077476|FG001|STARTED|Treatment Period 2 (8 Days)||15||
48306721|NCT04411953|101077475|FG000|COMPLETED|Treatment Period 2 (8 Days)||16||
48306722|NCT04411953|101077476|FG001|COMPLETED|Treatment Period 2 (8 Days)||15||
48306723|NCT04411953|101077475|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
48306724|NCT04411953|101077476|FG001|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
48721926|NCT03769311|102105522|FG000|COMPLETED|Overall Study||14||
48721927|NCT03769311|102105522|FG000|NOT COMPLETED|Overall Study||1||
48721928|NCT01038713|102105523|FG000|STARTED|Overall Study||26||
48721929|NCT01038713|102105524|FG001|STARTED|Overall Study||20||
48721930|NCT01038713|102105525|FG002|STARTED|Overall Study||17||
48721931|NCT01038713|102105523|FG000|COMPLETED|Overall Study||21||
48721932|NCT01038713|102105524|FG001|COMPLETED|Overall Study||17||
48721933|NCT01038713|102105525|FG002|COMPLETED|Overall Study||16||
48721934|NCT01038713|102105523|FG000|NOT COMPLETED|Overall Study||5||
48721935|NCT01038713|102105524|FG001|NOT COMPLETED|Overall Study||3||
48721936|NCT01038713|102105525|FG002|NOT COMPLETED|Overall Study||1||
48721937|NCT03755661|102105526|FG000|STARTED|Overall Study||12||
48721938|NCT03755661|102105527|FG001|STARTED|Overall Study||12||
48721939|NCT03755661|102105526|FG000|COMPLETED|Overall Study||11||
48721940|NCT03755661|102105527|FG001|COMPLETED|Overall Study||12||
48721941|NCT03755661|102105526|FG000|NOT COMPLETED|Overall Study||1||
48721942|NCT03755661|102105527|FG001|NOT COMPLETED|Overall Study||0||
48721943|NCT00162266|102105528|FG000|STARTED|Double-Blind Period||115||
48721944|NCT00162266|102105529|FG001|STARTED|Double-Blind Period||105||
48306725|NCT01610687|101077477|FG000|STARTED|Overall Study||137||
48306726|NCT01610687|101077477|FG000|COMPLETED|Overall Study||70||
48306727|NCT01610687|101077477|FG000|NOT COMPLETED|Overall Study||67||
48306728|NCT00024167|101077478|FG000|STARTED|Overall Study||65||
48306729|NCT00024167|101077479|FG001|STARTED|Overall Study||62||
48306730|NCT00024167|101077478|FG000|Induction Treatment Option 1 Completed|Overall Study||22||
48306731|NCT00024167|101077479|FG001|Induction Treatment Option 1 Completed|Overall Study||21||
48306732|NCT00024167|101077478|FG000|Induction Treatment Option 2 Completed|Overall Study||43||
48306733|NCT00024167|101077479|FG001|Induction Treatment Option 2 Completed|Overall Study||41||
48306734|NCT00024167|101077478|FG000|COMPLETED|Overall Study||12||
48306735|NCT00024167|101077479|FG001|COMPLETED|Overall Study||15||
48306736|NCT00024167|101077478|FG000|NOT COMPLETED|Overall Study||53||
48306737|NCT00024167|101077479|FG001|NOT COMPLETED|Overall Study||47||
48306738|NCT01561495|101077480|FG000|STARTED|Overall Study||1||
48306739|NCT01561495|101077480|FG000|COMPLETED|Overall Study||1||
48306740|NCT01561495|101077480|FG000|NOT COMPLETED|Overall Study||0||
48306741|NCT03599557|101077481|FG000|STARTED|Baseline Period (12 Months)||50569||24
48306742|NCT03599557|101077482|FG001|STARTED|Baseline Period (12 Months)||53869||24
48306743|NCT03599557|101077481|FG000|COMPLETED|Baseline Period (12 Months)||50569||24
48306744|NCT03599557|101077482|FG001|COMPLETED|Baseline Period (12 Months)||53869||24
48306745|NCT03599557|101077481|FG000|NOT COMPLETED|Baseline Period (12 Months)||0||0
48306746|NCT03599557|101077482|FG001|NOT COMPLETED|Baseline Period (12 Months)||0||0
48306747|NCT03599557|101077481|FG000|STARTED|Communication Intervention (6 Months)||29206||24
48306748|NCT03599557|101077482|FG001|STARTED|Communication Intervention (6 Months)||33914||24
48306749|NCT03599557|101077481|FG000|COMPLETED|Communication Intervention (6 Months)||29206||24
48306750|NCT03599557|101077482|FG001|COMPLETED|Communication Intervention (6 Months)||33914||24
48306751|NCT03599557|101077481|FG000|NOT COMPLETED|Communication Intervention (6 Months)||0||0
48306752|NCT03599557|101077482|FG001|NOT COMPLETED|Communication Intervention (6 Months)||0||0
48306753|NCT00891319|101077483|FG000|STARTED|Overall Study||40||
48306754|NCT00891319|101077484|FG001|STARTED|Overall Study||40||
48306755|NCT00891319|101077483|FG000|COMPLETED|Overall Study||32||
48721945|NCT00162266|102105530|FG002|STARTED|Double-Blind Period||119||
48721946|NCT00162266|102105531|FG003|STARTED|Double-Blind Period||0||
48721947|NCT00162266|102105528|FG000|Completed Day 1 to Day 181|Double-Blind Period||98||
48306756|NCT00891319|101077484|FG001|COMPLETED|Overall Study||40||
48306757|NCT00891319|101077483|FG000|NOT COMPLETED|Overall Study||8||
48306758|NCT00891319|101077484|FG001|NOT COMPLETED|Overall Study||0||
48306759|NCT00000125|101077485|FG000|STARTED|Overall Study||819||
48306760|NCT00000125|101077486|FG001|STARTED|Overall Study||817||
48721948|NCT00162266|102105529|FG001|Completed Day 1 to Day 181|Double-Blind Period||80||
48306761|NCT00000125|101077485|FG000|Completed OHTS Phase I, June 2002|Overall Study||706||
48306762|NCT00000125|101077486|FG001|Completed OHTS Phase I, June 2002|Overall Study||702||
48306763|NCT00000125|101077485|FG000|COMPLETED|Overall Study||580||
48306764|NCT00000125|101077486|FG001|COMPLETED|Overall Study||579||
48721949|NCT00162266|102105530|FG002|Completed Day 1 to Day 181|Double-Blind Period||78||
48721950|NCT00162266|102105531|FG003|Completed Day 1 to Day 181|Double-Blind Period||0||
48608482|NCT01408719|101827167|FG019|NOT COMPLETED|Second Intervention (35 Days)||0||
48608483|NCT01408719|101827148|FG000|STARTED|Washout Period (28 Days)||2||
48608484|NCT01408719|101827149|FG001|STARTED|Washout Period (28 Days)||3||
48608485|NCT01408719|101827150|FG002|STARTED|Washout Period (28 Days)||1||
48608486|NCT01408719|101827151|FG003|STARTED|Washout Period (28 Days)||2||
48608487|NCT01408719|101827152|FG004|STARTED|Washout Period (28 Days)||3||
48608488|NCT01408719|101827153|FG005|STARTED|Washout Period (28 Days)||3||
48608489|NCT01408719|101827154|FG006|STARTED|Washout Period (28 Days)||2||
48608490|NCT01408719|101827155|FG007|STARTED|Washout Period (28 Days)||3||
48608491|NCT01408719|101827156|FG008|STARTED|Washout Period (28 Days)||1||
48608492|NCT01408719|101827157|FG009|STARTED|Washout Period (28 Days)||1||
48608493|NCT01408719|101827158|FG010|STARTED|Washout Period (28 Days)||2||
48608494|NCT01408719|101827159|FG011|STARTED|Washout Period (28 Days)||2||
48608495|NCT01408719|101827160|FG012|STARTED|Washout Period (28 Days)||2||
48608496|NCT01408719|101827161|FG013|STARTED|Washout Period (28 Days)||3||
48306765|NCT00000125|101077485|FG000|NOT COMPLETED|Overall Study||239||
48306766|NCT00000125|101077486|FG001|NOT COMPLETED|Overall Study||238||
48306767|NCT04578886|101077487|FG000|STARTED|Overall Study||50||
48306768|NCT04578886|101077488|FG001|STARTED|Overall Study||50||
48306769|NCT04578886|101077487|FG000|COMPLETED|Overall Study||50||
48306770|NCT04578886|101077488|FG001|COMPLETED|Overall Study||50||
48306771|NCT04578886|101077487|FG000|NOT COMPLETED|Overall Study||0||
48306772|NCT04578886|101077488|FG001|NOT COMPLETED|Overall Study||0||
48306773|NCT00846651|101077489|FG000|STARTED|Overall Study||41||
48306774|NCT00846651|101077490|FG001|STARTED|Overall Study||41||
48306775|NCT00846651|101077489|FG000|COMPLETED|Overall Study||37||
48306776|NCT00846651|101077490|FG001|COMPLETED|Overall Study||37||
48306777|NCT00846651|101077489|FG000|NOT COMPLETED|Overall Study||4||
48306778|NCT00846651|101077490|FG001|NOT COMPLETED|Overall Study||4||
48306779|NCT01591317|101077491|FG000|STARTED|Overall Study||10||
48306780|NCT01591317|101077492|FG001|STARTED|Overall Study||10||
48306781|NCT01591317|101077493|FG002|STARTED|Overall Study||10||
48306782|NCT01591317|101077491|FG000|COMPLETED|Overall Study||10||
48306783|NCT01591317|101077492|FG001|COMPLETED|Overall Study||10||
48306784|NCT01591317|101077493|FG002|COMPLETED|Overall Study||10||
48306785|NCT01591317|101077491|FG000|NOT COMPLETED|Overall Study||0||
48306786|NCT01591317|101077492|FG001|NOT COMPLETED|Overall Study||0||
48306787|NCT01591317|101077493|FG002|NOT COMPLETED|Overall Study||0||
48608497|NCT01408719|101827162|FG014|STARTED|Washout Period (28 Days)||1||
48608498|NCT01408719|101827163|FG015|STARTED|Washout Period (28 Days)||1||
48608499|NCT01408719|101827164|FG016|STARTED|Washout Period (28 Days)||2||
48608500|NCT01408719|101827165|FG017|STARTED|Washout Period (28 Days)||2||
48608501|NCT01408719|101827166|FG018|STARTED|Washout Period (28 Days)||0||
48608502|NCT01408719|101827167|FG019|STARTED|Washout Period (28 Days)||1||
48608503|NCT01408719|101827148|FG000|COMPLETED|Washout Period (28 Days)||2||
48608504|NCT01408719|101827149|FG001|COMPLETED|Washout Period (28 Days)||3||
48608505|NCT01408719|101827150|FG002|COMPLETED|Washout Period (28 Days)||1||
48608506|NCT01408719|101827151|FG003|COMPLETED|Washout Period (28 Days)||2||
48608507|NCT01408719|101827152|FG004|COMPLETED|Washout Period (28 Days)||3||
48608508|NCT01408719|101827153|FG005|COMPLETED|Washout Period (28 Days)||3||
48608509|NCT01408719|101827154|FG006|COMPLETED|Washout Period (28 Days)||2||
48608510|NCT01408719|101827155|FG007|COMPLETED|Washout Period (28 Days)||3||
48608511|NCT01408719|101827156|FG008|COMPLETED|Washout Period (28 Days)||1||
48608512|NCT01408719|101827157|FG009|COMPLETED|Washout Period (28 Days)||1||
48608513|NCT01408719|101827158|FG010|COMPLETED|Washout Period (28 Days)||2||
48608514|NCT01408719|101827159|FG011|COMPLETED|Washout Period (28 Days)||2||
48608515|NCT01408719|101827160|FG012|COMPLETED|Washout Period (28 Days)||2||
48306788|NCT04640974|101077494|FG000|STARTED|Overall Study||25||
48306789|NCT04640974|101077494|FG000|COMPLETED|Overall Study||25||
48306790|NCT04640974|101077494|FG000|NOT COMPLETED|Overall Study||0||
48306791|NCT00857532|101077495|FG000|STARTED|Overall Study||31||
48306792|NCT00857532|101077495|FG000|COMPLETED|Overall Study||31||
48306793|NCT00857532|101077495|FG000|NOT COMPLETED|Overall Study||0||
48306794|NCT01122576|101077496|FG000|STARTED|Pre-Cataract Surgery||26||
48306795|NCT01122576|101077497|FG001|STARTED|Pre-Cataract Surgery||26||
48306796|NCT01122576|101077498|FG002|STARTED|Pre-Cataract Surgery||26||
48306797|NCT01122576|101077496|FG000|COMPLETED|Pre-Cataract Surgery||26||
48306798|NCT01122576|101077497|FG001|COMPLETED|Pre-Cataract Surgery||25||
48306799|NCT01122576|101077498|FG002|COMPLETED|Pre-Cataract Surgery||24||
48608516|NCT01408719|101827161|FG013|COMPLETED|Washout Period (28 Days)||3||
48608517|NCT01408719|101827162|FG014|COMPLETED|Washout Period (28 Days)||1||
48608518|NCT01408719|101827163|FG015|COMPLETED|Washout Period (28 Days)||1||
48608519|NCT01408719|101827164|FG016|COMPLETED|Washout Period (28 Days)||2||
48608520|NCT01408719|101827165|FG017|COMPLETED|Washout Period (28 Days)||2||
48608521|NCT01408719|101827166|FG018|COMPLETED|Washout Period (28 Days)||0||
48608522|NCT01408719|101827167|FG019|COMPLETED|Washout Period (28 Days)||1||
48306800|NCT01122576|101077496|FG000|NOT COMPLETED|Pre-Cataract Surgery||0||
48306801|NCT01122576|101077497|FG001|NOT COMPLETED|Pre-Cataract Surgery||1||
48306802|NCT01122576|101077498|FG002|NOT COMPLETED|Pre-Cataract Surgery||2||
48306803|NCT01122576|101077496|FG000|STARTED|Post-Cataract Surgery||26||
48306804|NCT01122576|101077497|FG001|STARTED|Post-Cataract Surgery||25||
48608523|NCT01408719|101827148|FG000|NOT COMPLETED|Washout Period (28 Days)||0||
48608524|NCT01408719|101827149|FG001|NOT COMPLETED|Washout Period (28 Days)||0||
48608525|NCT01408719|101827150|FG002|NOT COMPLETED|Washout Period (28 Days)||0||
48608526|NCT01408719|101827151|FG003|NOT COMPLETED|Washout Period (28 Days)||0||
48608527|NCT01408719|101827152|FG004|NOT COMPLETED|Washout Period (28 Days)||0||
48608528|NCT01408719|101827153|FG005|NOT COMPLETED|Washout Period (28 Days)||0||
48608529|NCT01408719|101827154|FG006|NOT COMPLETED|Washout Period (28 Days)||0||
48608530|NCT01408719|101827155|FG007|NOT COMPLETED|Washout Period (28 Days)||0||
48608531|NCT01408719|101827156|FG008|NOT COMPLETED|Washout Period (28 Days)||0||
48608532|NCT01408719|101827157|FG009|NOT COMPLETED|Washout Period (28 Days)||0||
48608533|NCT01408719|101827158|FG010|NOT COMPLETED|Washout Period (28 Days)||0||
48608534|NCT01408719|101827159|FG011|NOT COMPLETED|Washout Period (28 Days)||0||
48608535|NCT01408719|101827160|FG012|NOT COMPLETED|Washout Period (28 Days)||0||
48608536|NCT01408719|101827161|FG013|NOT COMPLETED|Washout Period (28 Days)||0||
48608537|NCT01408719|101827162|FG014|NOT COMPLETED|Washout Period (28 Days)||0||
48608538|NCT01408719|101827163|FG015|NOT COMPLETED|Washout Period (28 Days)||0||
48608539|NCT01408719|101827164|FG016|NOT COMPLETED|Washout Period (28 Days)||0||
48608540|NCT01408719|101827165|FG017|NOT COMPLETED|Washout Period (28 Days)||0||
48608541|NCT01408719|101827166|FG018|NOT COMPLETED|Washout Period (28 Days)||0||
48608542|NCT01408719|101827167|FG019|NOT COMPLETED|Washout Period (28 Days)||0||
48608543|NCT01408719|101827148|FG000|STARTED|Third Intervention (35 Days)||2||
48608544|NCT01408719|101827149|FG001|STARTED|Third Intervention (35 Days)||3||
48608545|NCT01408719|101827150|FG002|STARTED|Third Intervention (35 Days)||1||
48608546|NCT01408719|101827151|FG003|STARTED|Third Intervention (35 Days)||2||
48608547|NCT01408719|101827152|FG004|STARTED|Third Intervention (35 Days)||3||
48608548|NCT01408719|101827153|FG005|STARTED|Third Intervention (35 Days)||3||
48608549|NCT01408719|101827154|FG006|STARTED|Third Intervention (35 Days)||2||
48608550|NCT01408719|101827155|FG007|STARTED|Third Intervention (35 Days)||3||
48608551|NCT01408719|101827156|FG008|STARTED|Third Intervention (35 Days)||1||
48608552|NCT01408719|101827157|FG009|STARTED|Third Intervention (35 Days)||1||
48608553|NCT01408719|101827158|FG010|STARTED|Third Intervention (35 Days)||2||
48608554|NCT01408719|101827159|FG011|STARTED|Third Intervention (35 Days)||2||
48608555|NCT01408719|101827160|FG012|STARTED|Third Intervention (35 Days)||2||
48608556|NCT01408719|101827161|FG013|STARTED|Third Intervention (35 Days)||3||
48608557|NCT01408719|101827162|FG014|STARTED|Third Intervention (35 Days)||1||
48608558|NCT01408719|101827163|FG015|STARTED|Third Intervention (35 Days)||1||
48608559|NCT01408719|101827164|FG016|STARTED|Third Intervention (35 Days)||2||
48608560|NCT01408719|101827165|FG017|STARTED|Third Intervention (35 Days)||2||
48608561|NCT01408719|101827166|FG018|STARTED|Third Intervention (35 Days)||0||
48608562|NCT01408719|101827167|FG019|STARTED|Third Intervention (35 Days)||1||
48608563|NCT01408719|101827148|FG000|COMPLETED|Third Intervention (35 Days)||2||
48608564|NCT01408719|101827149|FG001|COMPLETED|Third Intervention (35 Days)||3||
48608565|NCT01408719|101827150|FG002|COMPLETED|Third Intervention (35 Days)||1||
48608566|NCT01408719|101827151|FG003|COMPLETED|Third Intervention (35 Days)||2||
48608567|NCT01408719|101827152|FG004|COMPLETED|Third Intervention (35 Days)||3||
48608568|NCT01408719|101827153|FG005|COMPLETED|Third Intervention (35 Days)||3||
48608569|NCT01408719|101827154|FG006|COMPLETED|Third Intervention (35 Days)||2||
48608570|NCT01408719|101827155|FG007|COMPLETED|Third Intervention (35 Days)||2||
48608571|NCT01408719|101827156|FG008|COMPLETED|Third Intervention (35 Days)||1||
48608572|NCT01408719|101827157|FG009|COMPLETED|Third Intervention (35 Days)||1||
48608573|NCT01408719|101827158|FG010|COMPLETED|Third Intervention (35 Days)||2||
48608574|NCT01408719|101827159|FG011|COMPLETED|Third Intervention (35 Days)||2||
48608575|NCT01408719|101827160|FG012|COMPLETED|Third Intervention (35 Days)||2||
48608576|NCT01408719|101827161|FG013|COMPLETED|Third Intervention (35 Days)||3||
48608577|NCT01408719|101827162|FG014|COMPLETED|Third Intervention (35 Days)||1||
48608578|NCT01408719|101827163|FG015|COMPLETED|Third Intervention (35 Days)||1||
48608579|NCT01408719|101827164|FG016|COMPLETED|Third Intervention (35 Days)||2||
48608580|NCT01408719|101827165|FG017|COMPLETED|Third Intervention (35 Days)||2||
48608581|NCT01408719|101827166|FG018|COMPLETED|Third Intervention (35 Days)||0||
48608582|NCT01408719|101827167|FG019|COMPLETED|Third Intervention (35 Days)||1||
48608583|NCT01408719|101827148|FG000|NOT COMPLETED|Third Intervention (35 Days)||0||
48608584|NCT01408719|101827149|FG001|NOT COMPLETED|Third Intervention (35 Days)||0||
48608585|NCT01408719|101827150|FG002|NOT COMPLETED|Third Intervention (35 Days)||0||
48608586|NCT01408719|101827151|FG003|NOT COMPLETED|Third Intervention (35 Days)||0||
48608587|NCT01408719|101827152|FG004|NOT COMPLETED|Third Intervention (35 Days)||0||
48608588|NCT01408719|101827153|FG005|NOT COMPLETED|Third Intervention (35 Days)||0||
48608589|NCT01408719|101827154|FG006|NOT COMPLETED|Third Intervention (35 Days)||0||
48608590|NCT01408719|101827155|FG007|NOT COMPLETED|Third Intervention (35 Days)||1||
48608591|NCT01408719|101827156|FG008|NOT COMPLETED|Third Intervention (35 Days)||0||
48608592|NCT01408719|101827157|FG009|NOT COMPLETED|Third Intervention (35 Days)||0||
48608593|NCT01408719|101827158|FG010|NOT COMPLETED|Third Intervention (35 Days)||0||
48608594|NCT01408719|101827159|FG011|NOT COMPLETED|Third Intervention (35 Days)||0||
48608595|NCT01408719|101827160|FG012|NOT COMPLETED|Third Intervention (35 Days)||0||
48608596|NCT01408719|101827161|FG013|NOT COMPLETED|Third Intervention (35 Days)||0||
48608597|NCT01408719|101827162|FG014|NOT COMPLETED|Third Intervention (35 Days)||0||
48608598|NCT01408719|101827163|FG015|NOT COMPLETED|Third Intervention (35 Days)||0||
48608599|NCT01408719|101827164|FG016|NOT COMPLETED|Third Intervention (35 Days)||0||
48608600|NCT01408719|101827165|FG017|NOT COMPLETED|Third Intervention (35 Days)||0||
48608601|NCT01408719|101827166|FG018|NOT COMPLETED|Third Intervention (35 Days)||0||
48608602|NCT01408719|101827167|FG019|NOT COMPLETED|Third Intervention (35 Days)||0||
48608603|NCT01408719|101827148|FG000|STARTED|Washout Period (28 Days)||2||
48608604|NCT01408719|101827149|FG001|STARTED|Washout Period (28 Days)||3||
48608605|NCT01408719|101827150|FG002|STARTED|Washout Period (28 Days)||1||
48608606|NCT01408719|101827151|FG003|STARTED|Washout Period (28 Days)||2||
48608607|NCT01408719|101827152|FG004|STARTED|Washout Period (28 Days)||3||
48608608|NCT01408719|101827153|FG005|STARTED|Washout Period (28 Days)||3||
48608609|NCT01408719|101827154|FG006|STARTED|Washout Period (28 Days)||2||
48608610|NCT01408719|101827155|FG007|STARTED|Washout Period (28 Days)||2||
48608611|NCT01408719|101827156|FG008|STARTED|Washout Period (28 Days)||1||
48608612|NCT01408719|101827157|FG009|STARTED|Washout Period (28 Days)||1||
48608613|NCT01408719|101827158|FG010|STARTED|Washout Period (28 Days)||2||
48608614|NCT01408719|101827159|FG011|STARTED|Washout Period (28 Days)||2||
48608615|NCT01408719|101827160|FG012|STARTED|Washout Period (28 Days)||1||
48608616|NCT01408719|101827161|FG013|STARTED|Washout Period (28 Days)||3||
48608617|NCT01408719|101827162|FG014|STARTED|Washout Period (28 Days)||1||
48608618|NCT01408719|101827163|FG015|STARTED|Washout Period (28 Days)||1||
48608619|NCT01408719|101827164|FG016|STARTED|Washout Period (28 Days)||2||
48608620|NCT01408719|101827165|FG017|STARTED|Washout Period (28 Days)||2||
48608621|NCT01408719|101827166|FG018|STARTED|Washout Period (28 Days)||0||
48608622|NCT01408719|101827167|FG019|STARTED|Washout Period (28 Days)||1||
48306805|NCT01122576|101077498|FG002|STARTED|Post-Cataract Surgery||24||
48306806|NCT01122576|101077496|FG000|COMPLETED|Post-Cataract Surgery||26||
48306807|NCT01122576|101077497|FG001|COMPLETED|Post-Cataract Surgery||25||
48306808|NCT01122576|101077498|FG002|COMPLETED|Post-Cataract Surgery||22||
48306809|NCT01122576|101077496|FG000|NOT COMPLETED|Post-Cataract Surgery||0||
48306810|NCT01122576|101077497|FG001|NOT COMPLETED|Post-Cataract Surgery||0||
48306811|NCT01122576|101077498|FG002|NOT COMPLETED|Post-Cataract Surgery||2||
48306812|NCT03289910|101077499|FG000|STARTED|Overall Study||16||
48608623|NCT01408719|101827148|FG000|COMPLETED|Washout Period (28 Days)||2||
48608624|NCT01408719|101827149|FG001|COMPLETED|Washout Period (28 Days)||3||
48306813|NCT03289910|101077500|FG001|STARTED|Overall Study||9||
48306814|NCT03289910|101077499|FG000|COMPLETED|Overall Study||16||
48306815|NCT03289910|101077500|FG001|COMPLETED|Overall Study||9||
48406158|NCT02092168|101328365|FG000|STARTED|Overall Study||12||
48406159|NCT02092168|101328366|FG001|STARTED|Overall Study||12||
48608625|NCT01408719|101827150|FG002|COMPLETED|Washout Period (28 Days)||1||
48608626|NCT01408719|101827151|FG003|COMPLETED|Washout Period (28 Days)||2||
48608627|NCT01408719|101827152|FG004|COMPLETED|Washout Period (28 Days)||3||
48608628|NCT01408719|101827153|FG005|COMPLETED|Washout Period (28 Days)||3||
48608629|NCT01408719|101827154|FG006|COMPLETED|Washout Period (28 Days)||2||
48608630|NCT01408719|101827155|FG007|COMPLETED|Washout Period (28 Days)||2||
48608631|NCT01408719|101827156|FG008|COMPLETED|Washout Period (28 Days)||1||
48608632|NCT01408719|101827157|FG009|COMPLETED|Washout Period (28 Days)||1||
48608633|NCT01408719|101827158|FG010|COMPLETED|Washout Period (28 Days)||2||
48608634|NCT01408719|101827159|FG011|COMPLETED|Washout Period (28 Days)||2||
48608635|NCT01408719|101827160|FG012|COMPLETED|Washout Period (28 Days)||1||
48608636|NCT01408719|101827161|FG013|COMPLETED|Washout Period (28 Days)||3||
48608637|NCT01408719|101827162|FG014|COMPLETED|Washout Period (28 Days)||1||
48608638|NCT01408719|101827163|FG015|COMPLETED|Washout Period (28 Days)||1||
48608639|NCT01408719|101827164|FG016|COMPLETED|Washout Period (28 Days)||2||
48608640|NCT01408719|101827165|FG017|COMPLETED|Washout Period (28 Days)||2||
48608641|NCT01408719|101827166|FG018|COMPLETED|Washout Period (28 Days)||0||
48306816|NCT03289910|101077499|FG000|NOT COMPLETED|Overall Study||0||
48306817|NCT03289910|101077500|FG001|NOT COMPLETED|Overall Study||0||
48306818|NCT05715528|101077501|FG000|STARTED|Overall Study||1005||
48306819|NCT05715528|101077502|FG001|STARTED|Overall Study||1006||
48306820|NCT05715528|101077501|FG000|COMPLETED|Overall Study||977||
48306821|NCT05715528|101077502|FG001|COMPLETED|Overall Study||963||
48306822|NCT05715528|101077501|FG000|NOT COMPLETED|Overall Study||28||
48306823|NCT05715528|101077502|FG001|NOT COMPLETED|Overall Study||43||
48306824|NCT00659529|101077503|FG000|STARTED|Overall Study||36||
48306825|NCT00659529|101077503|FG000|Received at Least One Dose of Study Drug|Overall Study||27||
48608642|NCT01408719|101827167|FG019|COMPLETED|Washout Period (28 Days)||1||
48608643|NCT01408719|101827148|FG000|NOT COMPLETED|Washout Period (28 Days)||0||
48721951|NCT00162266|102105528|FG000|COMPLETED|Double-Blind Period||90||
48721952|NCT00162266|102105529|FG001|COMPLETED|Double-Blind Period||74||
48721953|NCT00162266|102105530|FG002|COMPLETED|Double-Blind Period||71||
48721954|NCT00162266|102105531|FG003|COMPLETED|Double-Blind Period||0||
48721955|NCT00162266|102105528|FG000|NOT COMPLETED|Double-Blind Period||25||
48721956|NCT00162266|102105529|FG001|NOT COMPLETED|Double-Blind Period||31||
48721957|NCT00162266|102105530|FG002|NOT COMPLETED|Double-Blind Period||48||
48721958|NCT00162266|102105531|FG003|NOT COMPLETED|Double-Blind Period||0||
48721959|NCT00162266|102105528|FG000|STARTED|Open-Label Period||0||
48721960|NCT00162266|102105529|FG001|STARTED|Open-Label Period||0||
48721961|NCT00162266|102105530|FG002|STARTED|Open-Label Period||0||
48721962|NCT00162266|102105531|FG003|STARTED|Open-Label Period||219||
48721963|NCT00162266|102105528|FG000|COMPLETED|Open-Label Period||0||
48721964|NCT00162266|102105529|FG001|COMPLETED|Open-Label Period||0||
48721965|NCT00162266|102105530|FG002|COMPLETED|Open-Label Period||0||
48721966|NCT00162266|102105531|FG003|COMPLETED|Open-Label Period||82||
48721967|NCT00162266|102105528|FG000|NOT COMPLETED|Open-Label Period||0||
48406160|NCT02092168|101328365|FG000|COMPLETED|Overall Study||12||
48608644|NCT01408719|101827149|FG001|NOT COMPLETED|Washout Period (28 Days)||0||
48608645|NCT01408719|101827150|FG002|NOT COMPLETED|Washout Period (28 Days)||0||
48608646|NCT01408719|101827151|FG003|NOT COMPLETED|Washout Period (28 Days)||0||
48608647|NCT01408719|101827152|FG004|NOT COMPLETED|Washout Period (28 Days)||0||
48608648|NCT01408719|101827153|FG005|NOT COMPLETED|Washout Period (28 Days)||0||
48608649|NCT01408719|101827154|FG006|NOT COMPLETED|Washout Period (28 Days)||0||
48608650|NCT01408719|101827155|FG007|NOT COMPLETED|Washout Period (28 Days)||0||
48608651|NCT01408719|101827156|FG008|NOT COMPLETED|Washout Period (28 Days)||0||
48608652|NCT01408719|101827157|FG009|NOT COMPLETED|Washout Period (28 Days)||0||
48608653|NCT01408719|101827158|FG010|NOT COMPLETED|Washout Period (28 Days)||0||
48608654|NCT01408719|101827159|FG011|NOT COMPLETED|Washout Period (28 Days)||0||
48608655|NCT01408719|101827160|FG012|NOT COMPLETED|Washout Period (28 Days)||0||
48721968|NCT00162266|102105529|FG001|NOT COMPLETED|Open-Label Period||0||
48721969|NCT00162266|102105530|FG002|NOT COMPLETED|Open-Label Period||0||
48721970|NCT00162266|102105531|FG003|NOT COMPLETED|Open-Label Period||137||
48721971|NCT04122170|102105532|FG000|STARTED|Overall Study||156||
48721972|NCT04122170|102105533|FG001|STARTED|Overall Study||51||
48721973|NCT04122170|102105532|FG000|COMPLETED|Overall Study||150||
48721974|NCT04122170|102105533|FG001|COMPLETED|Overall Study||50||
48721975|NCT04122170|102105532|FG000|NOT COMPLETED|Overall Study||6||
48721976|NCT04122170|102105533|FG001|NOT COMPLETED|Overall Study||1||
48721977|NCT01364740|102105534|FG000|STARTED|Overall Study||10||
48721978|NCT01364740|102105534|FG000|COMPLETED|Overall Study||10||
48721979|NCT01364740|102105534|FG000|NOT COMPLETED|Overall Study||0||
48721980|NCT00628147|102105535|FG000|STARTED|Overall Study||142||
48721981|NCT00628147|102105536|FG001|STARTED|Overall Study||142||
48721982|NCT00628147|102105535|FG000|COMPLETED|Overall Study||135||
48721983|NCT00628147|102105536|FG001|COMPLETED|Overall Study||141||
48608656|NCT01408719|101827161|FG013|NOT COMPLETED|Washout Period (28 Days)||0||
48608657|NCT01408719|101827162|FG014|NOT COMPLETED|Washout Period (28 Days)||0||
48721984|NCT00628147|102105535|FG000|NOT COMPLETED|Overall Study||7||
48721985|NCT00628147|102105536|FG001|NOT COMPLETED|Overall Study||1||
48721986|NCT02758301|102105537|FG000|STARTED|Overall Study||104||
48721987|NCT02758301|102105538|FG001|STARTED|Overall Study||8||
48721988|NCT02758301|102105537|FG000|COMPLETED|Overall Study||70||
48721989|NCT02758301|102105538|FG001|COMPLETED|Overall Study||0||
48721990|NCT02758301|102105537|FG000|NOT COMPLETED|Overall Study||34||
48721991|NCT02758301|102105538|FG001|NOT COMPLETED|Overall Study||8||
48721992|NCT00249613|102105539|FG000|STARTED|Baseline||152||
48721993|NCT00249613|102105540|FG001|STARTED|Baseline||139||
48306826|NCT00659529|101077503|FG000|COMPLETED|Overall Study||20||
48306827|NCT00659529|101077503|FG000|NOT COMPLETED|Overall Study||16||
48721994|NCT00249613|102105539|FG000|COMPLETED|Baseline||152||
48306828|NCT00404066|101077504|FG000|STARTED|Overall Study||21||
48608658|NCT01408719|101827163|FG015|NOT COMPLETED|Washout Period (28 Days)||0||
48608659|NCT01408719|101827164|FG016|NOT COMPLETED|Washout Period (28 Days)||0||
48608660|NCT01408719|101827165|FG017|NOT COMPLETED|Washout Period (28 Days)||0||
48608661|NCT01408719|101827166|FG018|NOT COMPLETED|Washout Period (28 Days)||0||
48608662|NCT01408719|101827167|FG019|NOT COMPLETED|Washout Period (28 Days)||0||
48608663|NCT01408719|101827148|FG000|STARTED|Fourth Intervention (35 Days)||2||
48608664|NCT01408719|101827149|FG001|STARTED|Fourth Intervention (35 Days)||3||
48608665|NCT01408719|101827150|FG002|STARTED|Fourth Intervention (35 Days)||1||
48608666|NCT01408719|101827151|FG003|STARTED|Fourth Intervention (35 Days)||2||
48608667|NCT01408719|101827152|FG004|STARTED|Fourth Intervention (35 Days)||3||
48608668|NCT01408719|101827153|FG005|STARTED|Fourth Intervention (35 Days)||3||
48608669|NCT01408719|101827154|FG006|STARTED|Fourth Intervention (35 Days)||2||
48608670|NCT01408719|101827155|FG007|STARTED|Fourth Intervention (35 Days)||2||
48608671|NCT01408719|101827156|FG008|STARTED|Fourth Intervention (35 Days)||1||
48608672|NCT01408719|101827157|FG009|STARTED|Fourth Intervention (35 Days)||1||
48608673|NCT01408719|101827158|FG010|STARTED|Fourth Intervention (35 Days)||2||
48608674|NCT01408719|101827159|FG011|STARTED|Fourth Intervention (35 Days)||2||
48721995|NCT00249613|102105540|FG001|COMPLETED|Baseline||139||
48721996|NCT00249613|102105539|FG000|NOT COMPLETED|Baseline||0||
48721997|NCT00249613|102105540|FG001|NOT COMPLETED|Baseline||0||
48721998|NCT00249613|102105539|FG000|STARTED|12 Month Follow-up||152||
48721999|NCT00249613|102105540|FG001|STARTED|12 Month Follow-up||139||
48722000|NCT00249613|102105539|FG000|COMPLETED|12 Month Follow-up||135||
48722001|NCT00249613|102105540|FG001|COMPLETED|12 Month Follow-up||124||
48722002|NCT00249613|102105539|FG000|NOT COMPLETED|12 Month Follow-up||17||
48722003|NCT00249613|102105540|FG001|NOT COMPLETED|12 Month Follow-up||15||
48722004|NCT00453973|102105541|FG000|STARTED|Overall Study||51||
48722005|NCT00453973|102105542|FG001|STARTED|Overall Study||63||
48722006|NCT00453973|102105541|FG000|COMPLETED|Overall Study||0||
48722007|NCT00453973|102105542|FG001|COMPLETED|Overall Study||15||
48722008|NCT00453973|102105541|FG000|NOT COMPLETED|Overall Study||51||
48722009|NCT00453973|102105542|FG001|NOT COMPLETED|Overall Study||48||
48722010|NCT00778895|102105543|FG000|STARTED|Active Phase||164||
48608675|NCT01408719|101827160|FG012|STARTED|Fourth Intervention (35 Days)||1||
48608676|NCT01408719|101827161|FG013|STARTED|Fourth Intervention (35 Days)||3||
48608677|NCT01408719|101827162|FG014|STARTED|Fourth Intervention (35 Days)||1||
48608678|NCT01408719|101827163|FG015|STARTED|Fourth Intervention (35 Days)||1||
48608679|NCT01408719|101827164|FG016|STARTED|Fourth Intervention (35 Days)||2||
48608680|NCT01408719|101827165|FG017|STARTED|Fourth Intervention (35 Days)||2||
48608681|NCT01408719|101827166|FG018|STARTED|Fourth Intervention (35 Days)||0||
48608682|NCT01408719|101827167|FG019|STARTED|Fourth Intervention (35 Days)||1||
48608683|NCT01408719|101827148|FG000|COMPLETED|Fourth Intervention (35 Days)||2||
48608684|NCT01408719|101827149|FG001|COMPLETED|Fourth Intervention (35 Days)||3||
48608685|NCT01408719|101827150|FG002|COMPLETED|Fourth Intervention (35 Days)||1||
48608686|NCT01408719|101827151|FG003|COMPLETED|Fourth Intervention (35 Days)||2||
48608687|NCT01408719|101827152|FG004|COMPLETED|Fourth Intervention (35 Days)||3||
48608688|NCT01408719|101827153|FG005|COMPLETED|Fourth Intervention (35 Days)||3||
48608689|NCT01408719|101827154|FG006|COMPLETED|Fourth Intervention (35 Days)||2||
48608690|NCT01408719|101827155|FG007|COMPLETED|Fourth Intervention (35 Days)||2||
48608691|NCT01408719|101827156|FG008|COMPLETED|Fourth Intervention (35 Days)||1||
48608692|NCT01408719|101827157|FG009|COMPLETED|Fourth Intervention (35 Days)||1||
48722011|NCT00778895|102105544|FG001|STARTED|Active Phase||167||
48722012|NCT00778895|102105545|FG002|STARTED|Active Phase||43||
48722013|NCT00778895|102105543|FG000|COMPLETED|Active Phase||157||
48722014|NCT00778895|102105544|FG001|COMPLETED|Active Phase||161||
48722015|NCT00778895|102105545|FG002|COMPLETED|Active Phase||43||
48722016|NCT00778895|102105543|FG000|NOT COMPLETED|Active Phase||7||
48722017|NCT00778895|102105544|FG001|NOT COMPLETED|Active Phase||6||
48722018|NCT00778895|102105545|FG002|NOT COMPLETED|Active Phase||0||
48722019|NCT00778895|102105543|FG000|STARTED|ESFU Phase||164||
48722020|NCT00778895|102105544|FG001|STARTED|ESFU Phase||167||
48306829|NCT00404066|101077504|FG000|COMPLETED|Overall Study||18||
48306830|NCT00404066|101077504|FG000|NOT COMPLETED|Overall Study||3||
48306831|NCT02287376|101077505|FG000|STARTED|Overall Study||25||
48306832|NCT02287376|101077505|FG000|COMPLETED|Overall Study||25||
48306833|NCT02287376|101077505|FG000|NOT COMPLETED|Overall Study||0||
48306834|NCT00351416|101077506|FG000|STARTED|Overall Study||6||
48306835|NCT00351416|101077507|FG001|STARTED|Overall Study||9||
48306836|NCT00351416|101077506|FG000|COMPLETED|Overall Study||6||
48306837|NCT00351416|101077507|FG001|COMPLETED|Overall Study||9||
48306838|NCT00351416|101077506|FG000|NOT COMPLETED|Overall Study||0||
48306839|NCT00351416|101077507|FG001|NOT COMPLETED|Overall Study||0||
48306840|NCT02566577|101077508|FG000|STARTED|Overall Study||9||
48306841|NCT02566577|101077509|FG001|STARTED|Overall Study||6||
48306842|NCT02566577|101077508|FG000|COMPLETED|Overall Study||6||
48306843|NCT02566577|101077509|FG001|COMPLETED|Overall Study||4||
48608693|NCT01408719|101827158|FG010|COMPLETED|Fourth Intervention (35 Days)||2||
48608694|NCT01408719|101827159|FG011|COMPLETED|Fourth Intervention (35 Days)||2||
48608695|NCT01408719|101827160|FG012|COMPLETED|Fourth Intervention (35 Days)||1||
48608696|NCT01408719|101827161|FG013|COMPLETED|Fourth Intervention (35 Days)||3||
48608697|NCT01408719|101827162|FG014|COMPLETED|Fourth Intervention (35 Days)||1||
48608698|NCT01408719|101827163|FG015|COMPLETED|Fourth Intervention (35 Days)||1||
48608699|NCT01408719|101827164|FG016|COMPLETED|Fourth Intervention (35 Days)||2||
48608700|NCT01408719|101827165|FG017|COMPLETED|Fourth Intervention (35 Days)||2||
48608701|NCT01408719|101827166|FG018|COMPLETED|Fourth Intervention (35 Days)||0||
48608702|NCT01408719|101827167|FG019|COMPLETED|Fourth Intervention (35 Days)||1||
48608703|NCT01408719|101827148|FG000|NOT COMPLETED|Fourth Intervention (35 Days)||0||
48608704|NCT01408719|101827149|FG001|NOT COMPLETED|Fourth Intervention (35 Days)||0||
48608705|NCT01408719|101827150|FG002|NOT COMPLETED|Fourth Intervention (35 Days)||0||
48608706|NCT01408719|101827151|FG003|NOT COMPLETED|Fourth Intervention (35 Days)||0||
48608707|NCT01408719|101827152|FG004|NOT COMPLETED|Fourth Intervention (35 Days)||0||
48608708|NCT01408719|101827153|FG005|NOT COMPLETED|Fourth Intervention (35 Days)||0||
48608709|NCT01408719|101827154|FG006|NOT COMPLETED|Fourth Intervention (35 Days)||0||
48608710|NCT01408719|101827155|FG007|NOT COMPLETED|Fourth Intervention (35 Days)||0||
48608711|NCT01408719|101827156|FG008|NOT COMPLETED|Fourth Intervention (35 Days)||0||
48608712|NCT01408719|101827157|FG009|NOT COMPLETED|Fourth Intervention (35 Days)||0||
48722021|NCT00778895|102105545|FG002|STARTED|ESFU Phase||43||
48722022|NCT00778895|102105543|FG000|COMPLETED|ESFU Phase||153||
48722023|NCT00778895|102105544|FG001|COMPLETED|ESFU Phase||155||
48722024|NCT00778895|102105545|FG002|COMPLETED|ESFU Phase||41||
48722025|NCT00778895|102105543|FG000|NOT COMPLETED|ESFU Phase||11||
48722026|NCT00778895|102105544|FG001|NOT COMPLETED|ESFU Phase||12||
48722027|NCT00778895|102105545|FG002|NOT COMPLETED|ESFU Phase||2||
48722028|NCT02648217|102105546|FG000|STARTED|Overall Study||131||
48722029|NCT02648217|102105547|FG001|STARTED|Overall Study||132||
48722030|NCT02648217|102105546|FG000|Exposed|Overall Study||130||
48722031|NCT02648217|102105547|FG001|Exposed|Overall Study||132||
48722032|NCT02648217|102105546|FG000|COMPLETED|Overall Study||121||
48722033|NCT02648217|102105547|FG001|COMPLETED|Overall Study||127||
48722034|NCT02648217|102105546|FG000|NOT COMPLETED|Overall Study||10||
48722035|NCT02648217|102105547|FG001|NOT COMPLETED|Overall Study||5||
48722036|NCT04054999|102105548|FG000|STARTED|Overall Study||9||
48722037|NCT04054999|102105549|FG001|STARTED|Overall Study||10||
48722038|NCT04054999|102105548|FG000|COMPLETED|Overall Study||9||
48722039|NCT04054999|102105549|FG001|COMPLETED|Overall Study||10||
48722040|NCT04054999|102105548|FG000|NOT COMPLETED|Overall Study||0||
48722041|NCT04054999|102105549|FG001|NOT COMPLETED|Overall Study||0||
48722042|NCT02270255|102105550|FG000|STARTED|Overall Study||22||
48722043|NCT02270255|102105551|FG001|STARTED|Overall Study||22||
48722044|NCT02270255|102105550|FG000|Complete Data at Discharge PACU|Overall Study||22||
48722045|NCT02270255|102105551|FG001|Complete Data at Discharge PACU|Overall Study||22||
48722046|NCT02270255|102105550|FG000|Complete Data From Home Survey|Overall Study||21||
48722047|NCT02270255|102105551|FG001|Complete Data From Home Survey|Overall Study||22||
48722048|NCT02270255|102105550|FG000|COMPLETED|Overall Study||21||
48722049|NCT02270255|102105551|FG001|COMPLETED|Overall Study||22||
48722050|NCT02270255|102105550|FG000|NOT COMPLETED|Overall Study||1||
48722051|NCT02270255|102105551|FG001|NOT COMPLETED|Overall Study||0||
48722052|NCT02495454|102105552|FG000|STARTED|Overall Study||34||
48722053|NCT02495454|102105552|FG000|COMPLETED|Overall Study||33||
48722054|NCT02495454|102105552|FG000|NOT COMPLETED|Overall Study||1||
48722055|NCT04496453|102105553|FG000|STARTED|Overall Study||17||
48722056|NCT04496453|102105553|FG000|COMPLETED|Overall Study||11||
48306844|NCT02566577|101077508|FG000|NOT COMPLETED|Overall Study||3||
48306845|NCT02566577|101077509|FG001|NOT COMPLETED|Overall Study||2||
48306846|NCT01235793|101077510|FG000|STARTED|Overall Study||11||
48306847|NCT01235793|101077510|FG000|COMPLETED|Overall Study||5||
48306848|NCT01235793|101077510|FG000|NOT COMPLETED|Overall Study||6||
48306849|NCT02378220|101077511|FG000|STARTED|Overall Study||53|Patients were enrolled from Feb 2015 to Dec 2015 with follow-up ending in Feb 2016.|
48406161|NCT02092168|101328366|FG001|COMPLETED|Overall Study||12||
48657080|NCT03648372|101943757|FG000|NOT COMPLETED|Overall Study||4||
48722057|NCT04496453|102105553|FG000|NOT COMPLETED|Overall Study||6||
48722058|NCT00845065|102105554|FG000|STARTED|Overall Study||67||
48722059|NCT00845065|102105555|FG001|STARTED|Overall Study||134||
48722060|NCT00845065|102105554|FG000|COMPLETED|Overall Study||20||
48722061|NCT00845065|102105555|FG001|COMPLETED|Overall Study||79||
48722062|NCT00845065|102105554|FG000|NOT COMPLETED|Overall Study||47||
48722063|NCT00845065|102105555|FG001|NOT COMPLETED|Overall Study||55||
48722064|NCT01283542|102105556|FG000|STARTED|Main Phase||20||
48722065|NCT01283542|102105556|FG000|Full Analysis Set (FAS)|Main Phase||20|received at least 1 dose of study medication|
48722066|NCT01283542|102105556|FG000|Safety Analysis Set|Main Phase||20|rec'd at least 1 dose of drug + 1 at least one post-BL safety assessment|
48306850|NCT02378220|101077512|FG001|STARTED|Overall Study||57|Patients were enrolled from Feb 2015 to Dec 2015 with follow-up ending in Feb 2016.|
48306851|NCT02378220|101077511|FG000|COMPLETED|Overall Study||47||
48306852|NCT02378220|101077512|FG001|COMPLETED|Overall Study||56||
48306853|NCT02378220|101077511|FG000|NOT COMPLETED|Overall Study||6||
48306854|NCT02378220|101077512|FG001|NOT COMPLETED|Overall Study||1||
48306855|NCT00388505|101077513|FG000|STARTED|Overall Study||308||
48306856|NCT00388505|101077514|FG001|STARTED|Overall Study||209||
48306857|NCT00388505|101077513|FG000|COMPLETED|Overall Study||225||
48306858|NCT00388505|101077514|FG001|COMPLETED|Overall Study||171||
48306859|NCT00388505|101077513|FG000|NOT COMPLETED|Overall Study||83||
48306860|NCT00388505|101077514|FG001|NOT COMPLETED|Overall Study||38||
48306861|NCT02354781|101077515|FG000|STARTED|Overall Study||3||
48306862|NCT02354781|101077515|FG000|COMPLETED|Overall Study||3||
48306863|NCT02354781|101077515|FG000|NOT COMPLETED|Overall Study||0||
48306864|NCT05075395|101077516|FG000|STARTED|Overall Study||19||
48306865|NCT05075395|101077516|FG000|COMPLETED|Overall Study||19||
48608713|NCT01408719|101827158|FG010|NOT COMPLETED|Fourth Intervention (35 Days)||0||
48608714|NCT01408719|101827159|FG011|NOT COMPLETED|Fourth Intervention (35 Days)||0||
48608715|NCT01408719|101827160|FG012|NOT COMPLETED|Fourth Intervention (35 Days)||0||
48608716|NCT01408719|101827161|FG013|NOT COMPLETED|Fourth Intervention (35 Days)||0||
48608717|NCT01408719|101827162|FG014|NOT COMPLETED|Fourth Intervention (35 Days)||0||
48608718|NCT01408719|101827163|FG015|NOT COMPLETED|Fourth Intervention (35 Days)||0||
48608719|NCT01408719|101827164|FG016|NOT COMPLETED|Fourth Intervention (35 Days)||0||
48608720|NCT01408719|101827165|FG017|NOT COMPLETED|Fourth Intervention (35 Days)||0||
48306866|NCT05075395|101077516|FG000|NOT COMPLETED|Overall Study||0||
48608721|NCT01408719|101827166|FG018|NOT COMPLETED|Fourth Intervention (35 Days)||0||
48608722|NCT01408719|101827167|FG019|NOT COMPLETED|Fourth Intervention (35 Days)||0||
48608723|NCT06236113|101827168|FG000|STARTED|Overall Study||25||
48608724|NCT06236113|101827169|FG001|STARTED|Overall Study||25||
48608725|NCT06236113|101827168|FG000|COMPLETED|Overall Study||25||
48608726|NCT06236113|101827169|FG001|COMPLETED|Overall Study||25||
48608727|NCT06236113|101827168|FG000|NOT COMPLETED|Overall Study||0||
48608728|NCT06236113|101827169|FG001|NOT COMPLETED|Overall Study||0||
48608729|NCT03715452|101827170|FG000|STARTED|Overall Study||114||
48608730|NCT03715452|101827170|FG000|COMPLETED|Overall Study||114||
48608731|NCT03715452|101827170|FG000|NOT COMPLETED|Overall Study||0||
48608732|NCT00777062|101827171|FG000|STARTED|Overall Study||39||
48608733|NCT00777062|101827172|FG001|STARTED|Overall Study||41||
48608734|NCT00777062|101827171|FG000|COMPLETED|Overall Study||36||
48608735|NCT00777062|101827172|FG001|COMPLETED|Overall Study||36||
48608736|NCT00777062|101827171|FG000|NOT COMPLETED|Overall Study||3||
48608737|NCT00777062|101827172|FG001|NOT COMPLETED|Overall Study||5||
48608738|NCT01648920|101827173|FG000|STARTED|Overall Study||50||
48608739|NCT01648920|101827173|FG000|COMPLETED|Overall Study||50||
48608740|NCT01648920|101827173|FG000|NOT COMPLETED|Overall Study||0||
48608741|NCT00460746|101827174|FG000|STARTED|Overall Study||10||
48608742|NCT00460746|101827174|FG000|COMPLETED|Overall Study||8||
48608743|NCT00460746|101827174|FG000|NOT COMPLETED|Overall Study||2||
48608744|NCT00807612|101827175|FG000|STARTED|Overall Study||15||
48608745|NCT00807612|101827175|FG000|COMPLETED|Overall Study||1||
48608746|NCT00807612|101827175|FG000|NOT COMPLETED|Overall Study||14||
48608747|NCT01404949|101827176|FG000|STARTED|Overall Study||17||
48608748|NCT01404949|101827176|FG000|COMPLETED|Overall Study||16||
48608749|NCT01404949|101827176|FG000|NOT COMPLETED|Overall Study||1||
48608750|NCT03117361|101827177|FG000|STARTED|Overall Study||10||
48608751|NCT03117361|101827177|FG000|COMPLETED|Overall Study||0||
48608752|NCT03117361|101827177|FG000|NOT COMPLETED|Overall Study||10||
48608753|NCT02501161|101827178|FG000|STARTED|Overall Study||506||
48608754|NCT02501161|101827179|FG001|STARTED|Overall Study||506||
48608755|NCT02501161|101827178|FG000|Exposed|Overall Study||506||
48608756|NCT02501161|101827179|FG001|Exposed|Overall Study||504||
48608757|NCT02501161|101827178|FG000|COMPLETED|Overall Study||484||
48608758|NCT02501161|101827179|FG001|COMPLETED|Overall Study||481||
48306867|NCT04042740|101077517|FG000|STARTED|Step 1 (4-week G/P + 24-week Follow-up)||45||
48306868|NCT04042740|101077517|FG000|Initiated Study Treatment|Step 1 (4-week G/P + 24-week Follow-up)||45||
48608759|NCT02501161|101827178|FG000|NOT COMPLETED|Overall Study||22||
48608760|NCT02501161|101827179|FG001|NOT COMPLETED|Overall Study||25||
48608761|NCT00582426|101827180|FG000|STARTED|Overall Study||68||
48608762|NCT00582426|101827181|FG001|STARTED|Overall Study||71||
48608763|NCT00582426|101827180|FG000|COMPLETED|Overall Study||48||
48608764|NCT00582426|101827181|FG001|COMPLETED|Overall Study||58||
48608765|NCT00582426|101827180|FG000|NOT COMPLETED|Overall Study||20||
48608766|NCT00582426|101827181|FG001|NOT COMPLETED|Overall Study||13||
48608767|NCT02757625|101827182|FG000|STARTED|Overall Study||14||
48608768|NCT02757625|101827183|FG001|STARTED|Overall Study||18||
48608769|NCT02757625|101827184|FG002|STARTED|Overall Study||19||
48608770|NCT02757625|101827185|FG003|STARTED|Overall Study||12||
48306869|NCT04042740|101077517|FG000|Completed 16 Weeks|Step 1 (4-week G/P + 24-week Follow-up)||44||
48306870|NCT04042740|101077517|FG000|COMPLETED|Step 1 (4-week G/P + 24-week Follow-up)||42||
48306871|NCT04042740|101077517|FG000|NOT COMPLETED|Step 1 (4-week G/P + 24-week Follow-up)||3||
48306872|NCT04042740|101077517|FG000|STARTED|Step 2 (HCV Re-treatment)||4||
48608771|NCT02757625|101827182|FG000|COMPLETED|Overall Study||14||
48608772|NCT02757625|101827183|FG001|COMPLETED|Overall Study||18||
48306873|NCT04042740|101077517|FG000|COMPLETED|Step 2 (HCV Re-treatment)||3||
48306874|NCT04042740|101077517|FG000|NOT COMPLETED|Step 2 (HCV Re-treatment)||1||
48306875|NCT01708291|101077518|FG000|STARTED|Overall Study||21||
48306876|NCT01708291|101077519|FG001|STARTED|Overall Study||21||
48306877|NCT01708291|101077518|FG000|COMPLETED|Overall Study||19||
48306878|NCT01708291|101077519|FG001|COMPLETED|Overall Study||20||
48306879|NCT01708291|101077518|FG000|NOT COMPLETED|Overall Study||2||
48608773|NCT02757625|101827184|FG002|COMPLETED|Overall Study||17||
48608774|NCT02757625|101827185|FG003|COMPLETED|Overall Study||12||
48608775|NCT02757625|101827182|FG000|NOT COMPLETED|Overall Study||0||
48608776|NCT02757625|101827183|FG001|NOT COMPLETED|Overall Study||0||
48608777|NCT02757625|101827184|FG002|NOT COMPLETED|Overall Study||2||
48608778|NCT02757625|101827185|FG003|NOT COMPLETED|Overall Study||0||
48608779|NCT01831427|101827186|FG000|STARTED|Overall Study||5||
48608780|NCT01831427|101827187|FG001|STARTED|Overall Study||5||
48608781|NCT01831427|101827188|FG002|STARTED|Overall Study||5||
48608782|NCT01831427|101827189|FG003|STARTED|Overall Study||5||
48608783|NCT01831427|101827190|FG004|STARTED|Overall Study||4||
48608784|NCT01831427|101827191|FG005|STARTED|Overall Study||8||
48608785|NCT01831427|101827192|FG006|STARTED|Overall Study||8||
48608786|NCT01831427|101827193|FG007|STARTED|Overall Study||8||
48608787|NCT01831427|101827194|FG008|STARTED|Overall Study||8||
48608788|NCT01831427|101827195|FG009|STARTED|Overall Study||10||
48608789|NCT01831427|101827196|FG010|STARTED|Overall Study||8||
48608790|NCT01831427|101827186|FG000|COMPLETED|Overall Study||5||
48608791|NCT01831427|101827187|FG001|COMPLETED|Overall Study||4||
48608792|NCT01831427|101827188|FG002|COMPLETED|Overall Study||5||
48608793|NCT01831427|101827189|FG003|COMPLETED|Overall Study||4||
48151846|NCT02080468|100695871|FG001|COMPLETED|Overall Study||14||
48151847|NCT02080468|100695870|FG000|NOT COMPLETED|Overall Study||2||
48151848|NCT02080468|100695871|FG001|NOT COMPLETED|Overall Study||2||
48151849|NCT01866943|100695872|FG000|STARTED|Overall Study||19||
48151850|NCT01866943|100695873|FG001|STARTED|Overall Study||22||
48151851|NCT01866943|100695872|FG000|COMPLETED|Overall Study||0||
48151852|NCT01866943|100695873|FG001|COMPLETED|Overall Study||0||
48151853|NCT01866943|100695872|FG000|NOT COMPLETED|Overall Study||19||
48151854|NCT01866943|100695873|FG001|NOT COMPLETED|Overall Study||22||
48151855|NCT02879812|100695874|FG000|STARTED|Overall Study||28246||334
48151856|NCT02879812|100695875|FG001|STARTED|Overall Study||28086||321
48151857|NCT02879812|100695874|FG000|COMPLETED|Overall Study||22153||313
48151858|NCT02879812|100695875|FG001|COMPLETED|Overall Study||21029||302
48151859|NCT02879812|100695874|FG000|NOT COMPLETED|Overall Study||6093||21
48151860|NCT02879812|100695875|FG001|NOT COMPLETED|Overall Study||7057||19
48151861|NCT02314624|100695876|FG000|STARTED|Overall Study||80||
48151862|NCT02314624|100695877|FG001|STARTED|Overall Study||62||
48151863|NCT02314624|100695876|FG000|COMPLETED|Overall Study||49||
48151864|NCT02314624|100695877|FG001|COMPLETED|Overall Study||36||
48151865|NCT02314624|100695876|FG000|NOT COMPLETED|Overall Study||31||
48151866|NCT02314624|100695877|FG001|NOT COMPLETED|Overall Study||26||
48151867|NCT01137474|100695878|FG000|STARTED|Overall Study||311||
48151868|NCT01137474|100695879|FG001|STARTED|Overall Study||166||
48151869|NCT01137474|100695880|FG002|STARTED|Overall Study||165||
48151870|NCT01137474|100695881|FG003|STARTED|Overall Study||302||
48151871|NCT01137474|100695878|FG000|Received Treatment|Overall Study||311||
48151872|NCT01137474|100695879|FG001|Received Treatment|Overall Study||166||
48151873|NCT01137474|100695880|FG002|Received Treatment|Overall Study||165||
48151874|NCT01137474|100695881|FG003|Received Treatment|Overall Study||302||
48151875|NCT01137474|100695878|FG000|COMPLETED|Overall Study||287||
48151876|NCT01137474|100695879|FG001|COMPLETED|Overall Study||154||
48151877|NCT01137474|100695880|FG002|COMPLETED|Overall Study||158||
48151878|NCT01137474|100695881|FG003|COMPLETED|Overall Study||281||
48151879|NCT01137474|100695878|FG000|NOT COMPLETED|Overall Study||24||
48151880|NCT01137474|100695879|FG001|NOT COMPLETED|Overall Study||12||
48151881|NCT01137474|100695880|FG002|NOT COMPLETED|Overall Study||7||
48151882|NCT01137474|100695881|FG003|NOT COMPLETED|Overall Study||21||
48151883|NCT01984684|100695882|FG000|STARTED|Overall Study||423||
48151884|NCT01984684|100695883|FG001|STARTED|Overall Study||427||
48151885|NCT01984684|100695882|FG000|COMPLETED|Overall Study||366||
48151886|NCT01984684|100695883|FG001|COMPLETED|Overall Study||368||
48151887|NCT01984684|100695882|FG000|NOT COMPLETED|Overall Study||57||
48151888|NCT01984684|100695883|FG001|NOT COMPLETED|Overall Study||59||
48306880|NCT01708291|101077519|FG001|NOT COMPLETED|Overall Study||1||
48608794|NCT01831427|101827190|FG004|COMPLETED|Overall Study||4||
48608795|NCT01831427|101827191|FG005|COMPLETED|Overall Study||7||
48608796|NCT01831427|101827192|FG006|COMPLETED|Overall Study||6||
48608797|NCT01831427|101827193|FG007|COMPLETED|Overall Study||7||
48608798|NCT01831427|101827194|FG008|COMPLETED|Overall Study||8||
48151889|NCT03017079|100695884|FG000|STARTED|Overall Study||20||
48151890|NCT03017079|100695885|FG001|STARTED|Overall Study||20||
48151891|NCT03017079|100695884|FG000|COMPLETED|Overall Study||14|Death:defined as death within 3 days of enrollment|
48151892|NCT03017079|100695885|FG001|COMPLETED|Overall Study||14|Death:defined as death within 3 days of enrollment|
48306881|NCT00448435|101077520|FG000|STARTED|Treatment Period I - 4 Weeks||26||
48306882|NCT00448435|101077521|FG001|STARTED|Treatment Period I - 4 Weeks||25||
48608799|NCT01831427|101827195|FG009|COMPLETED|Overall Study||9||
48406162|NCT02092168|101328365|FG000|NOT COMPLETED|Overall Study||0||
48406163|NCT02092168|101328366|FG001|NOT COMPLETED|Overall Study||0||
48406164|NCT01780324|101328367|FG000|STARTED|Overall Study||41||
48306883|NCT00448435|101077520|FG000|COMPLETED|Treatment Period I - 4 Weeks||26||
48306884|NCT00448435|101077521|FG001|COMPLETED|Treatment Period I - 4 Weeks||25||
48306885|NCT00448435|101077520|FG000|NOT COMPLETED|Treatment Period I - 4 Weeks||0||
48306886|NCT00448435|101077521|FG001|NOT COMPLETED|Treatment Period I - 4 Weeks||0||
48406165|NCT01780324|101328368|FG001|STARTED|Overall Study||39||
48406166|NCT01780324|101328367|FG000|COMPLETED|Overall Study||40||
48406167|NCT01780324|101328368|FG001|COMPLETED|Overall Study||33||
48406168|NCT01780324|101328367|FG000|NOT COMPLETED|Overall Study||1||
48406169|NCT01780324|101328368|FG001|NOT COMPLETED|Overall Study||6||
48406170|NCT01957085|101328369|FG000|STARTED|Overall Study||366||
48406171|NCT01957085|101328369|FG000|COMPLETED|Overall Study||366||
48608800|NCT01831427|101827196|FG010|COMPLETED|Overall Study||5||
48608801|NCT01831427|101827186|FG000|NOT COMPLETED|Overall Study||0||
48608802|NCT01831427|101827187|FG001|NOT COMPLETED|Overall Study||1||
48608803|NCT01831427|101827188|FG002|NOT COMPLETED|Overall Study||0||
48608804|NCT01831427|101827189|FG003|NOT COMPLETED|Overall Study||1||
48608805|NCT01831427|101827190|FG004|NOT COMPLETED|Overall Study||0||
48608806|NCT01831427|101827191|FG005|NOT COMPLETED|Overall Study||1||
48608807|NCT01831427|101827192|FG006|NOT COMPLETED|Overall Study||2||
48608808|NCT01831427|101827193|FG007|NOT COMPLETED|Overall Study||1||
48608809|NCT01831427|101827194|FG008|NOT COMPLETED|Overall Study||0||
48608810|NCT01831427|101827195|FG009|NOT COMPLETED|Overall Study||1||
48608811|NCT01831427|101827196|FG010|NOT COMPLETED|Overall Study||3||
48608812|NCT00178646|101827197|FG000|STARTED|Overall Study||12||
48608813|NCT00178646|101827198|FG001|STARTED|Overall Study||9||
48608814|NCT00178646|101827199|FG002|STARTED|Overall Study||11||
48608815|NCT00178646|101827197|FG000|COMPLETED|Overall Study||12||
48608816|NCT00178646|101827198|FG001|COMPLETED|Overall Study||8||
48608817|NCT00178646|101827199|FG002|COMPLETED|Overall Study||10||
48608818|NCT00178646|101827197|FG000|NOT COMPLETED|Overall Study||0||
48608819|NCT00178646|101827198|FG001|NOT COMPLETED|Overall Study||1||
48608820|NCT00178646|101827199|FG002|NOT COMPLETED|Overall Study||1||
48608821|NCT00551174|101827200|FG000|STARTED|Overall Study||381||
48608822|NCT00551174|101827201|FG001|STARTED|Overall Study||400||
48306887|NCT00448435|101077520|FG000|STARTED|Washout Period - 2 Weeks||26||
48406172|NCT01957085|101328369|FG000|NOT COMPLETED|Overall Study||0||
48406173|NCT02044822|101328370|FG000|STARTED|Overall Study||102||
48406174|NCT02044822|101328370|FG000|COMPLETED|Overall Study||9||
48406175|NCT02044822|101328370|FG000|NOT COMPLETED|Overall Study||93||
48406176|NCT00446797|101328371|FG000|STARTED|Overall Study||141||
48406177|NCT00446797|101328372|FG001|STARTED|Overall Study||137||
48406178|NCT00446797|101328371|FG000|COMPLETED|Overall Study||133||
48406179|NCT00446797|101328372|FG001|COMPLETED|Overall Study||125||
48608823|NCT00551174|101827200|FG000|COMPLETED|Overall Study||362||
48608824|NCT00551174|101827201|FG001|COMPLETED|Overall Study||394||
48608825|NCT00551174|101827200|FG000|NOT COMPLETED|Overall Study||19||
48608826|NCT00551174|101827201|FG001|NOT COMPLETED|Overall Study||6||
48608827|NCT00805129|101827202|FG000|STARTED|Overall Study||46||
48608828|NCT00805129|101827202|FG000|COMPLETED|Overall Study||45||
48608829|NCT00805129|101827202|FG000|NOT COMPLETED|Overall Study||1||
48608830|NCT03442088|101827203|FG000|STARTED|Overall Study||28||
48608831|NCT03442088|101827203|FG000|COMPLETED|Overall Study||23||
48608832|NCT03442088|101827203|FG000|NOT COMPLETED|Overall Study||5||
48608833|NCT02497404|101827204|FG000|STARTED|Overall Study||40||
48608834|NCT02497404|101827204|FG000|COMPLETED|Overall Study||39||
48608835|NCT02497404|101827204|FG000|NOT COMPLETED|Overall Study||1||
48306888|NCT00448435|101077521|FG001|STARTED|Washout Period - 2 Weeks||25||
48306889|NCT00448435|101077520|FG000|COMPLETED|Washout Period - 2 Weeks||25||
48306890|NCT00448435|101077521|FG001|COMPLETED|Washout Period - 2 Weeks||25||
48306891|NCT00448435|101077520|FG000|NOT COMPLETED|Washout Period - 2 Weeks||1||
48306892|NCT00448435|101077521|FG001|NOT COMPLETED|Washout Period - 2 Weeks||0||
48306893|NCT00448435|101077520|FG000|STARTED|Treatment Period II - 4 Weeks||25||
48306894|NCT00448435|101077521|FG001|STARTED|Treatment Period II - 4 Weeks||25||
48406180|NCT00446797|101328371|FG000|NOT COMPLETED|Overall Study||8||
48406181|NCT00446797|101328372|FG001|NOT COMPLETED|Overall Study||12||
48406182|NCT01600105|101328373|FG000|STARTED|Total Participants||255||
48406183|NCT01600105|101328374|FG001|STARTED|Total Participants||21||
48608836|NCT05446142|101827205|FG000|STARTED|Period 1||3||
48608837|NCT05446142|101827206|FG001|STARTED|Period 1||3||
48406184|NCT01600105|101328373|FG000|COMPLETED|Total Participants||214||
48406185|NCT01600105|101328374|FG001|COMPLETED|Total Participants||11||
48406186|NCT01600105|101328373|FG000|NOT COMPLETED|Total Participants||41||
48608838|NCT05446142|101827207|FG002|STARTED|Period 1||3||
48306895|NCT00448435|101077520|FG000|COMPLETED|Treatment Period II - 4 Weeks||25||
48306896|NCT00448435|101077521|FG001|COMPLETED|Treatment Period II - 4 Weeks||25||
48306897|NCT00448435|101077520|FG000|NOT COMPLETED|Treatment Period II - 4 Weeks||0||
48306898|NCT00448435|101077521|FG001|NOT COMPLETED|Treatment Period II - 4 Weeks||0||
48306899|NCT00448435|101077520|FG000|STARTED|Extension Period - 20 Weeks||50||
48306900|NCT00448435|101077521|FG001|STARTED|Extension Period - 20 Weeks||0||
48306901|NCT00448435|101077520|FG000|COMPLETED|Extension Period - 20 Weeks||50||
48306902|NCT00448435|101077521|FG001|COMPLETED|Extension Period - 20 Weeks||0||
48306903|NCT00448435|101077520|FG000|NOT COMPLETED|Extension Period - 20 Weeks||0||
48306904|NCT00448435|101077521|FG001|NOT COMPLETED|Extension Period - 20 Weeks||0||
48306905|NCT01717287|101077522|FG000|STARTED|Overall Study||4||
48306906|NCT01717287|101077523|FG001|STARTED|Overall Study||28||
48306907|NCT01717287|101077522|FG000|COMPLETED|Overall Study||4||
48306908|NCT01717287|101077523|FG001|COMPLETED|Overall Study||25||
48306909|NCT01717287|101077522|FG000|NOT COMPLETED|Overall Study||0||
48306910|NCT01717287|101077523|FG001|NOT COMPLETED|Overall Study||3||
48306911|NCT04633174|101077524|FG000|STARTED|Overall Study||1||2
48306912|NCT04633174|101077524|FG000|COMPLETED|Overall Study||1||2
48306913|NCT04633174|101077524|FG000|NOT COMPLETED|Overall Study||0||0
48306914|NCT01292447|101077525|FG000|STARTED|Overall Study||75||
48306915|NCT01292447|101077526|FG001|STARTED|Overall Study||75||
48306916|NCT01292447|101077525|FG000|COMPLETED|Overall Study||73||
48306917|NCT01292447|101077526|FG001|COMPLETED|Overall Study||72||
48306918|NCT01292447|101077525|FG000|NOT COMPLETED|Overall Study||2||
48306919|NCT01292447|101077526|FG001|NOT COMPLETED|Overall Study||3||
48306920|NCT03794583|101077527|FG000|STARTED|Overall Study||41||
48306921|NCT03794583|101077527|FG000|Received At Least 1 Dose of Study Drug|Overall Study||41||
48306922|NCT03794583|101077527|FG000|COMPLETED|Overall Study||0||
48306923|NCT03794583|101077527|FG000|NOT COMPLETED|Overall Study||41||
48306924|NCT05368961|101077528|FG000|STARTED|Overall Study||74||
48306925|NCT05368961|101077529|FG001|STARTED|Overall Study||63||
48306926|NCT05368961|101077528|FG000|COMPLETED|Overall Study||47||
48306927|NCT05368961|101077529|FG001|COMPLETED|Overall Study||52||
48306928|NCT05368961|101077528|FG000|NOT COMPLETED|Overall Study||27||
48306929|NCT05368961|101077529|FG001|NOT COMPLETED|Overall Study||11||
48306930|NCT00763971|101077530|FG000|STARTED|Overall Study||113||
48306931|NCT00763971|101077531|FG001|STARTED|Overall Study||112||
48306932|NCT00763971|101077532|FG002|STARTED|Overall Study||111||
48306933|NCT00763971|101077530|FG000|COMPLETED|Overall Study||80||
48306934|NCT00763971|101077531|FG001|COMPLETED|Overall Study||74||
48306935|NCT00763971|101077532|FG002|COMPLETED|Overall Study||42||
48306936|NCT00763971|101077530|FG000|NOT COMPLETED|Overall Study||33||
48306937|NCT00763971|101077531|FG001|NOT COMPLETED|Overall Study||38||
48306938|NCT00763971|101077532|FG002|NOT COMPLETED|Overall Study||69||
48306939|NCT02459769|101077533|FG000|STARTED|Overall Study||34||
48306940|NCT02459769|101077534|FG001|STARTED|Overall Study||32||
48306941|NCT02459769|101077535|FG002|STARTED|Overall Study||34||
48306942|NCT02459769|101077536|FG003|STARTED|Overall Study||33||
48306943|NCT02459769|101077533|FG000|COMPLETED|Overall Study||26||
48306944|NCT02459769|101077534|FG001|COMPLETED|Overall Study||28||
48306945|NCT02459769|101077535|FG002|COMPLETED|Overall Study||25||
48306946|NCT02459769|101077536|FG003|COMPLETED|Overall Study||28||
48306947|NCT02459769|101077533|FG000|NOT COMPLETED|Overall Study||8||
48306948|NCT02459769|101077534|FG001|NOT COMPLETED|Overall Study||4||
48306949|NCT02459769|101077535|FG002|NOT COMPLETED|Overall Study||9||
48306950|NCT02459769|101077536|FG003|NOT COMPLETED|Overall Study||5||
48306951|NCT00324753|101077537|FG000|STARTED|Overall Study||190||
48306952|NCT00324753|101077538|FG001|STARTED|Overall Study||264||
48306953|NCT00324753|101077537|FG000|COMPLETED|Overall Study||190||
48306954|NCT00324753|101077538|FG001|COMPLETED|Overall Study||264||
48306955|NCT00324753|101077537|FG000|NOT COMPLETED|Overall Study||0||
48306956|NCT00324753|101077538|FG001|NOT COMPLETED|Overall Study||0||
48306957|NCT01777412|101077539|FG000|STARTED|Overall Study||10||
48306958|NCT01777412|101077539|FG000|COMPLETED|Overall Study||10||
48306959|NCT01777412|101077539|FG000|NOT COMPLETED|Overall Study||0||
48306960|NCT03746951|101077540|FG000|STARTED|Overall Study||8||
48306961|NCT03746951|101077541|FG001|STARTED|Overall Study||7||
48306962|NCT03746951|101077540|FG000|COMPLETED|Overall Study||8||
48306963|NCT03746951|101077541|FG001|COMPLETED|Overall Study||7||
48306964|NCT03746951|101077540|FG000|NOT COMPLETED|Overall Study||0||
48306965|NCT03746951|101077541|FG001|NOT COMPLETED|Overall Study||0||
48306966|NCT02393677|101077542|FG000|STARTED|Overall Study||40||
48306967|NCT02393677|101077543|FG001|STARTED|Overall Study||40||
48306968|NCT02393677|101077542|FG000|COMPLETED|Overall Study||40||
48306969|NCT02393677|101077543|FG001|COMPLETED|Overall Study||40||
48306970|NCT02393677|101077542|FG000|NOT COMPLETED|Overall Study||0||
48306971|NCT02393677|101077543|FG001|NOT COMPLETED|Overall Study||0||
48306972|NCT02966223|101077544|FG000|STARTED|Overall Study||20||
48306973|NCT02966223|101077544|FG000|COMPLETED|Overall Study||5||
48306974|NCT02966223|101077544|FG000|NOT COMPLETED|Overall Study||15||
48306975|NCT00467389|101077545|FG000|STARTED|Overall Study||6||
48306976|NCT00467389|101077546|FG001|STARTED|Overall Study||6||
48306977|NCT00467389|101077545|FG000|COMPLETED|Overall Study||6||
48306978|NCT00467389|101077546|FG001|COMPLETED|Overall Study||6||
48306979|NCT00467389|101077545|FG000|NOT COMPLETED|Overall Study||0||
48608839|NCT05446142|101827208|FG003|STARTED|Period 1||3||
48608840|NCT05446142|101827209|FG004|STARTED|Period 1||3||
48608841|NCT05446142|101827210|FG005|STARTED|Period 1||3||
48608842|NCT05446142|101827205|FG000|COMPLETED|Period 1||3||
48608843|NCT05446142|101827206|FG001|COMPLETED|Period 1||3||
48608844|NCT05446142|101827207|FG002|COMPLETED|Period 1||3||
48608845|NCT05446142|101827208|FG003|COMPLETED|Period 1||3||
48608846|NCT05446142|101827209|FG004|COMPLETED|Period 1||3||
48608847|NCT05446142|101827210|FG005|COMPLETED|Period 1||3||
48608848|NCT05446142|101827205|FG000|NOT COMPLETED|Period 1||0||
48608849|NCT05446142|101827206|FG001|NOT COMPLETED|Period 1||0||
48608850|NCT05446142|101827207|FG002|NOT COMPLETED|Period 1||0||
48608851|NCT05446142|101827208|FG003|NOT COMPLETED|Period 1||0||
48608852|NCT05446142|101827209|FG004|NOT COMPLETED|Period 1||0||
48608853|NCT05446142|101827210|FG005|NOT COMPLETED|Period 1||0||
48608854|NCT05446142|101827205|FG000|STARTED|Period 2||3||
48608855|NCT05446142|101827206|FG001|STARTED|Period 2||3||
48608856|NCT05446142|101827207|FG002|STARTED|Period 2||3||
48722067|NCT01283542|102105556|FG000|COMPLETED|Main Phase||13||
48722068|NCT01283542|102105556|FG000|NOT COMPLETED|Main Phase||7||
48722069|NCT01283542|102105556|FG000|STARTED|Extension Phase||13||
48722070|NCT01283542|102105556|FG000|Full Analysis Set (FAS)|Extension Phase||13|received at least 1 dose of study drug|
48722071|NCT01283542|102105556|FG000|Safety Analysis Set|Extension Phase||13|rec'd at least 1 dose of drug + 1 at least one post-BL safety assessment|
48722072|NCT01283542|102105556|FG000|COMPLETED|Extension Phase||10||
48722073|NCT01283542|102105556|FG000|NOT COMPLETED|Extension Phase||3||
48722074|NCT03135210|102105557|FG000|STARTED|Overall Study||2||
48722075|NCT03135210|102105558|FG001|STARTED|Overall Study||2||
48722076|NCT03135210|102105557|FG000|COMPLETED|Overall Study||2||
48722077|NCT03135210|102105558|FG001|COMPLETED|Overall Study||1||
48722078|NCT03135210|102105557|FG000|NOT COMPLETED|Overall Study||0||
48151893|NCT03017079|100695884|FG000|NOT COMPLETED|Overall Study||6||
48151894|NCT03017079|100695885|FG001|NOT COMPLETED|Overall Study||6||
48151895|NCT01030861|100695886|FG000|STARTED|Overall Study||44||
48151896|NCT01030861|100695887|FG001|STARTED|Overall Study||32||
48151897|NCT01030861|100695886|FG000|COMPLETED|Overall Study||44||
48151898|NCT01030861|100695887|FG001|COMPLETED|Overall Study||32||
48151899|NCT01030861|100695886|FG000|NOT COMPLETED|Overall Study||0||
48151900|NCT01030861|100695887|FG001|NOT COMPLETED|Overall Study||0||
48151901|NCT04465357|100695888|FG000|STARTED|Overall Study||55||
48151902|NCT04465357|100695888|FG000|COMPLETED|Overall Study||42||
48151903|NCT04465357|100695888|FG000|NOT COMPLETED|Overall Study||13||
48151904|NCT03508843|100695889|FG000|STARTED|Overall Study||150||
48151905|NCT03508843|100695889|FG000|COMPLETED|Overall Study||147||
48151906|NCT03508843|100695889|FG000|NOT COMPLETED|Overall Study||3||
48151907|NCT02586025|100695890|FG000|STARTED|Neoadjuvant Treatment||219|Intent-to-Treat (ITT) Population|
48151908|NCT02586025|100695891|FG001|STARTED|Neoadjuvant Treatment||110|Intent-to-Treat (ITT) Population|
48151909|NCT02586025|100695890|FG000|Received at Least One Dose of Study Treatment|Neoadjuvant Treatment||218|Safety Evaluable Population|
48151910|NCT02586025|100695891|FG001|Received at Least One Dose of Study Treatment|Neoadjuvant Treatment||110|Safety Evaluable Population|
48151911|NCT02586025|100695890|FG000|Completed Neoadjuvant Treatment|Neoadjuvant Treatment||214||
48151912|NCT02586025|100695891|FG001|Completed Neoadjuvant Treatment|Neoadjuvant Treatment||108||
48151913|NCT02586025|100695890|FG000|Underwent Surgery|Neoadjuvant Treatment||210||
48151914|NCT02586025|100695891|FG001|Underwent Surgery|Neoadjuvant Treatment||105||
48151915|NCT02586025|100695890|FG000|COMPLETED|Neoadjuvant Treatment||208||
48151916|NCT02586025|100695891|FG001|COMPLETED|Neoadjuvant Treatment||103||
48151917|NCT02586025|100695890|FG000|NOT COMPLETED|Neoadjuvant Treatment||11||
48151918|NCT02586025|100695891|FG001|NOT COMPLETED|Neoadjuvant Treatment||7||
48151919|NCT02586025|100695890|FG000|STARTED|Adjuvant Treatment||208||
48151920|NCT02586025|100695891|FG001|STARTED|Adjuvant Treatment||103||
48151921|NCT02586025|100695890|FG000|Started Adjuvant FEC Treatment|Adjuvant Treatment||208||
48608857|NCT05446142|101827208|FG003|STARTED|Period 2||3||
48608858|NCT05446142|101827209|FG004|STARTED|Period 2||3||
48722079|NCT03135210|102105558|FG001|NOT COMPLETED|Overall Study||1||
48722080|NCT02652468|102105559|FG000|STARTED|Overall Study||11||
48722081|NCT02652468|102105559|FG000|COMPLETED|Overall Study||11||
48722082|NCT02652468|102105559|FG000|NOT COMPLETED|Overall Study||0||
48722083|NCT02048371|102105560|FG000|STARTED|Overall Study||24||
48151922|NCT02586025|100695891|FG001|Started Adjuvant FEC Treatment|Adjuvant Treatment||103||
48151923|NCT02586025|100695890|FG000|Started Adjuvant Anti-HER2 Treatment|Adjuvant Treatment||204||
48608859|NCT05446142|101827210|FG005|STARTED|Period 2||3||
48608860|NCT05446142|101827205|FG000|COMPLETED|Period 2||2||
48608861|NCT05446142|101827206|FG001|COMPLETED|Period 2||3||
48608862|NCT05446142|101827207|FG002|COMPLETED|Period 2||3||
48608863|NCT05446142|101827208|FG003|COMPLETED|Period 2||3||
48722084|NCT02048371|102105561|FG001|STARTED|Overall Study||9||
48151924|NCT02586025|100695891|FG001|Started Adjuvant Anti-HER2 Treatment|Adjuvant Treatment||99||
48188711|NCT02034435|100783312|FG000|NOT COMPLETED|Overall Study||2||
48608864|NCT05446142|101827209|FG004|COMPLETED|Period 2||3||
48608865|NCT05446142|101827210|FG005|COMPLETED|Period 2||3||
48608866|NCT05446142|101827205|FG000|NOT COMPLETED|Period 2||1||
48722085|NCT02048371|102105562|FG002|STARTED|Overall Study||15||
48608867|NCT05446142|101827206|FG001|NOT COMPLETED|Period 2||0||
48151925|NCT02586025|100695890|FG000|COMPLETED|Adjuvant Treatment||198|Completed Adjuvant anti-HER2 Treatment|
48151926|NCT02586025|100695891|FG001|COMPLETED|Adjuvant Treatment||94|Completed Adjuvant anti-HER2 Treatment|
48151927|NCT02586025|100695890|FG000|NOT COMPLETED|Adjuvant Treatment||10||
48151928|NCT02586025|100695891|FG001|NOT COMPLETED|Adjuvant Treatment||9||
48151929|NCT02586025|100695890|FG000|STARTED|Treatment-Free Follow-Up||208|Includes those who had discontinued from neoadjuvant and/or adjuvant treatment but remained in follow-up.|
48151930|NCT02586025|100695891|FG001|STARTED|Treatment-Free Follow-Up||104|Includes those who had discontinued from neoadjuvant and/or adjuvant treatment but remained in follow-up.|
48151931|NCT02586025|100695890|FG000|COMPLETED|Treatment-Free Follow-Up||175||
48608868|NCT05446142|101827207|FG002|NOT COMPLETED|Period 2||0||
48608869|NCT05446142|101827208|FG003|NOT COMPLETED|Period 2||0||
48608870|NCT05446142|101827209|FG004|NOT COMPLETED|Period 2||0||
48151932|NCT02586025|100695891|FG001|COMPLETED|Treatment-Free Follow-Up||82||
48151933|NCT02586025|100695890|FG000|NOT COMPLETED|Treatment-Free Follow-Up||33||
48151934|NCT02586025|100695891|FG001|NOT COMPLETED|Treatment-Free Follow-Up||22||
48151935|NCT01353222|100695892|FG000|STARTED|Overall Study||70||
48151936|NCT01353222|100695893|FG001|STARTED|Overall Study||72||
48151937|NCT01353222|100695892|FG000|DN24-02 Arm ≥1 Leukapheresis|Overall Study||67|Safety population for the DN24-02 arm.|
48151938|NCT01353222|100695893|FG001|DN24-02 Arm ≥1 Leukapheresis|Overall Study||0|Safety population for the DN24-02 arm.|
48151939|NCT01353222|100695892|FG000|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||0|Safety population for the Standard of Care arm.|
48151940|NCT01353222|100695893|FG001|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||72|Safety population for the Standard of Care arm.|
48151941|NCT01353222|100695892|FG000|COMPLETED|Overall Study||0||
48151942|NCT01353222|100695893|FG001|COMPLETED|Overall Study||0||
48151943|NCT01353222|100695892|FG000|NOT COMPLETED|Overall Study||70||
48151944|NCT01353222|100695893|FG001|NOT COMPLETED|Overall Study||72||
48151945|NCT02440633|100695894|FG000|STARTED|Overall Study||8||
48151946|NCT02440633|100695894|FG000|COMPLETED|Overall Study||8||
48151947|NCT02440633|100695894|FG000|NOT COMPLETED|Overall Study||0||
48151948|NCT01615328|100695895|FG000|STARTED|Overall Study||42||
48151949|NCT01615328|100695896|FG001|STARTED|Overall Study||43||
48151950|NCT01615328|100695895|FG000|COMPLETED|Overall Study||39||
48151951|NCT01615328|100695896|FG001|COMPLETED|Overall Study||38||
48151952|NCT01615328|100695895|FG000|NOT COMPLETED|Overall Study||3||
48151953|NCT01615328|100695896|FG001|NOT COMPLETED|Overall Study||5||
48151954|NCT00330174|100695897|FG000|STARTED|Overall Study||45||
48151955|NCT00330174|100695898|FG001|STARTED|Overall Study||45||
48151956|NCT00330174|100695897|FG000|COMPLETED|Overall Study||23||
48151957|NCT00330174|100695898|FG001|COMPLETED|Overall Study||26||
48151958|NCT00330174|100695897|FG000|NOT COMPLETED|Overall Study||22||
48608871|NCT05446142|101827210|FG005|NOT COMPLETED|Period 2||0||
48608872|NCT05446142|101827205|FG000|STARTED|Period 3||2||
48608873|NCT05446142|101827206|FG001|STARTED|Period 3||3||
48608874|NCT05446142|101827207|FG002|STARTED|Period 3||3||
48608875|NCT05446142|101827208|FG003|STARTED|Period 3||3||
48608876|NCT05446142|101827209|FG004|STARTED|Period 3||3||
48151959|NCT00330174|100695898|FG001|NOT COMPLETED|Overall Study||19||
48151960|NCT01410474|100695899|FG000|STARTED|Overall Study||173||
48151961|NCT01410474|100695900|FG001|STARTED|Overall Study||168||
48151962|NCT01410474|100695899|FG000|COMPLETED|Overall Study||173||
48151963|NCT01410474|100695900|FG001|COMPLETED|Overall Study||167||
48151964|NCT01410474|100695899|FG000|NOT COMPLETED|Overall Study||0||
48151965|NCT01410474|100695900|FG001|NOT COMPLETED|Overall Study||1||
48151966|NCT02954354|100695901|FG000|STARTED|Overall Study||612||
48151967|NCT02954354|100695902|FG001|STARTED|Overall Study||310||
48151968|NCT02954354|100695903|FG002|STARTED|Overall Study||514||
48151969|NCT02954354|100695901|FG000|Received Study Drug|Overall Study||610||
48151970|NCT02954354|100695902|FG001|Received Study Drug|Overall Study||309||
48151971|NCT02954354|100695903|FG002|Received Study Drug|Overall Study||513||
48608877|NCT05446142|101827210|FG005|STARTED|Period 3||3||
48608878|NCT05446142|101827205|FG000|COMPLETED|Period 3||2||
48608879|NCT05446142|101827206|FG001|COMPLETED|Period 3||3||
48608880|NCT05446142|101827207|FG002|COMPLETED|Period 3||3||
48151972|NCT02954354|100695901|FG000|Intention to Treat Infected Population|Overall Study||456||
48151973|NCT02954354|100695902|FG001|Intention to Treat Infected Population|Overall Study||231||
48151974|NCT02954354|100695903|FG002|Intention to Treat Infected Population|Overall Study||377||
48151975|NCT02954354|100695901|FG000|COMPLETED|Overall Study||578||
48151976|NCT02954354|100695902|FG001|COMPLETED|Overall Study||290||
48151977|NCT02954354|100695903|FG002|COMPLETED|Overall Study||498||
48151978|NCT02954354|100695901|FG000|NOT COMPLETED|Overall Study||34||
48151979|NCT02954354|100695902|FG001|NOT COMPLETED|Overall Study||20||
48151980|NCT02954354|100695903|FG002|NOT COMPLETED|Overall Study||16||
48151981|NCT03294330|100695904|FG000|STARTED|Overall Study||35||
48151982|NCT03294330|100695904|FG000|COMPLETED|Overall Study||35||
48151983|NCT03294330|100695904|FG000|NOT COMPLETED|Overall Study||0||
48151984|NCT02255357|100695905|FG000|STARTED|Overall Study||14||
48151985|NCT02255357|100695906|FG001|STARTED|Overall Study||29||
48151986|NCT02255357|100695905|FG000|COMPLETED|Overall Study||4||
48151987|NCT02255357|100695906|FG001|COMPLETED|Overall Study||5||
48151988|NCT02255357|100695905|FG000|NOT COMPLETED|Overall Study||10||
48151989|NCT02255357|100695906|FG001|NOT COMPLETED|Overall Study||24||
48608881|NCT05446142|101827208|FG003|COMPLETED|Period 3||3||
48151990|NCT00077064|100695907|FG000|STARTED|Overall Study||17||
48151991|NCT00077064|100695908|FG001|STARTED|Overall Study||16||
48151992|NCT00077064|100695907|FG000|COMPLETED|Overall Study||17||
48151993|NCT00077064|100695908|FG001|COMPLETED|Overall Study||10||
48151994|NCT00077064|100695907|FG000|NOT COMPLETED|Overall Study||0||
48151995|NCT00077064|100695908|FG001|NOT COMPLETED|Overall Study||6||
48151996|NCT03298451|100695909|FG000|STARTED|Overall Study||389|Randomized|
48151997|NCT03298451|100695910|FG001|STARTED|Overall Study||393|Randomized|
48151998|NCT03298451|100695911|FG002|STARTED|Overall Study||153|Randomized|
48151999|NCT03298451|100695912|FG003|STARTED|Overall Study||389|Randomized|
48152000|NCT03298451|100695909|FG000|Received Treatment|Overall Study||386|One participant in T300+D and one in T75+D arm didn't receive Treme and were analyzed under the Durva mono arm in the safety analysis set|
48152001|NCT03298451|100695910|FG001|Received Treatment|Overall Study||389|One participant in T300+D and one in T75+D arm didn't receive Treme and were analyzed under the Durva mono arm in the safety analysis set|
48152002|NCT03298451|100695911|FG002|Received Treatment|Overall Study||153|One participant in T300+D and one in T75+D arm didn't receive Treme and were analyzed under the Durva mono arm in the safety analysis set|
48152003|NCT03298451|100695912|FG003|Received Treatment|Overall Study||374|One participant in T300+D and one in T75+D arm didn't receive Treme and were analyzed under the Durva mono arm in the safety analysis set|
48152004|NCT03298451|100695909|FG000|COMPLETED|Overall Study||104|Completed final analysis and ongoing in long-term follow-up|
48152005|NCT03298451|100695910|FG001|COMPLETED|Overall Study||125|Completed final analysis and ongoing in long-term follow-up|
48152006|NCT03298451|100695911|FG002|COMPLETED|Overall Study||30|Completed final analysis and ongoing in long-term follow-up|
48152007|NCT03298451|100695912|FG003|COMPLETED|Overall Study||82|Completed final analysis and ongoing in long-term follow-up|
48152008|NCT03298451|100695909|FG000|NOT COMPLETED|Overall Study||285||
48152009|NCT03298451|100695910|FG001|NOT COMPLETED|Overall Study||268||
48152010|NCT03298451|100695911|FG002|NOT COMPLETED|Overall Study||123||
48152011|NCT03298451|100695912|FG003|NOT COMPLETED|Overall Study||307||
48152012|NCT00541450|100695913|FG000|STARTED|Phase A||244||
48152013|NCT00541450|100695914|FG001|STARTED|Phase A||248||
48152014|NCT00541450|100695913|FG000|COMPLETED|Phase A||224||
48152015|NCT00541450|100695914|FG001|COMPLETED|Phase A||231||
48152016|NCT00541450|100695913|FG000|NOT COMPLETED|Phase A||20||
48152017|NCT00541450|100695914|FG001|NOT COMPLETED|Phase A||17||
48152018|NCT00541450|100695913|FG000|STARTED|Phase B||224||
48152019|NCT00541450|100695914|FG001|STARTED|Phase B||231||
48152020|NCT00541450|100695913|FG000|COMPLETED|Phase B||187||
48152021|NCT00541450|100695914|FG001|COMPLETED|Phase B||200||
48152022|NCT00541450|100695913|FG000|NOT COMPLETED|Phase B||37||
48152023|NCT00541450|100695914|FG001|NOT COMPLETED|Phase B||31||
48152024|NCT00464815|100695915|FG000|STARTED|Overall Study||768||
48152025|NCT00464815|100695916|FG001|STARTED|Overall Study||257||
48152026|NCT00464815|100695915|FG000|COMPLETED|Overall Study||762||
48152027|NCT00464815|100695916|FG001|COMPLETED|Overall Study||254||
48152028|NCT00464815|100695915|FG000|NOT COMPLETED|Overall Study||6||
48152029|NCT00464815|100695916|FG001|NOT COMPLETED|Overall Study||3||
48152030|NCT01181726|100695917|FG000|STARTED|First Intervention||20||
48152031|NCT01181726|100695918|FG001|STARTED|First Intervention||20||
48152032|NCT01181726|100695917|FG000|COMPLETED|First Intervention||19||
48152033|NCT01181726|100695918|FG001|COMPLETED|First Intervention||20||
48152034|NCT01181726|100695917|FG000|NOT COMPLETED|First Intervention||1||
48152035|NCT01181726|100695918|FG001|NOT COMPLETED|First Intervention||0||
48152036|NCT01181726|100695917|FG000|STARTED|Washout of 28 Days||19||
48152037|NCT01181726|100695918|FG001|STARTED|Washout of 28 Days||20||
48152038|NCT01181726|100695917|FG000|COMPLETED|Washout of 28 Days||19||
48152039|NCT01181726|100695918|FG001|COMPLETED|Washout of 28 Days||20||
48152040|NCT01181726|100695917|FG000|NOT COMPLETED|Washout of 28 Days||0||
48152041|NCT01181726|100695918|FG001|NOT COMPLETED|Washout of 28 Days||0||
48152042|NCT01181726|100695917|FG000|STARTED|Second Intervention||19||
48152043|NCT01181726|100695918|FG001|STARTED|Second Intervention||20||
48152044|NCT01181726|100695917|FG000|COMPLETED|Second Intervention||19||
48152045|NCT01181726|100695918|FG001|COMPLETED|Second Intervention||20||
48152046|NCT01181726|100695917|FG000|NOT COMPLETED|Second Intervention||0||
48152047|NCT01181726|100695918|FG001|NOT COMPLETED|Second Intervention||0||
48152048|NCT00993655|100695919|FG000|STARTED|Overall Study||101||
48152049|NCT00993655|100695920|FG001|STARTED|Overall Study||72||
48152050|NCT00993655|100695921|FG002|STARTED|Overall Study||102||
48152051|NCT00993655|100695919|FG000|COMPLETED|Overall Study||101||
48152052|NCT00993655|100695920|FG001|COMPLETED|Overall Study||72||
48152053|NCT00993655|100695921|FG002|COMPLETED|Overall Study||102||
48152054|NCT00993655|100695919|FG000|NOT COMPLETED|Overall Study||0||
48152055|NCT00993655|100695920|FG001|NOT COMPLETED|Overall Study||0||
48152056|NCT00993655|100695921|FG002|NOT COMPLETED|Overall Study||0||
48152057|NCT00385580|100695922|FG000|STARTED|Overall Study||48||
48152058|NCT00385580|100695923|FG001|STARTED|Overall Study||47||
48152059|NCT00385580|100695922|FG000|COMPLETED|Overall Study||48||
48152060|NCT00385580|100695923|FG001|COMPLETED|Overall Study||47||
48152061|NCT00385580|100695922|FG000|NOT COMPLETED|Overall Study||0||
48152062|NCT00385580|100695923|FG001|NOT COMPLETED|Overall Study||0||
48152063|NCT00941993|100695924|FG000|STARTED|Overall Study||109||
48152064|NCT00941993|100695924|FG000|COMPLETED|Overall Study||109||
48306980|NCT00467389|101077546|FG001|NOT COMPLETED|Overall Study||0||
48306981|NCT02247765|101077547|FG000|STARTED|Overall Study||18||
48306982|NCT02247765|101077547|FG000|COMPLETED|Overall Study||18||
48306983|NCT02247765|101077547|FG000|NOT COMPLETED|Overall Study||0||
48306984|NCT01843972|101077548|FG000|STARTED|Overall Study||13||
48306985|NCT01843972|101077549|FG001|STARTED|Overall Study||6||
48306986|NCT01843972|101077550|FG002|STARTED|Overall Study||5||
48406187|NCT01600105|101328374|FG001|NOT COMPLETED|Total Participants||10||
48608882|NCT05446142|101827209|FG004|COMPLETED|Period 3||3||
48152065|NCT00941993|100695924|FG000|NOT COMPLETED|Overall Study||0||
48152066|NCT02306759|100695925|FG000|STARTED|Overall Study||30||
48152067|NCT02306759|100695926|FG001|STARTED|Overall Study||30||
48152068|NCT02306759|100695925|FG000|COMPLETED|Overall Study||30||
48152069|NCT02306759|100695926|FG001|COMPLETED|Overall Study||30||
48152070|NCT02306759|100695925|FG000|NOT COMPLETED|Overall Study||0||
48152071|NCT02306759|100695926|FG001|NOT COMPLETED|Overall Study||0||
48152072|NCT01843192|100695927|FG000|STARTED|Overall Study||26||
48152073|NCT01843192|100695928|FG001|STARTED|Overall Study||34||
48152074|NCT01843192|100695929|FG002|STARTED|Overall Study||11||
48152075|NCT01843192|100695927|FG000|COMPLETED|Overall Study||24||
48152076|NCT01843192|100695928|FG001|COMPLETED|Overall Study||28||
48152077|NCT01843192|100695929|FG002|COMPLETED|Overall Study||9||
48152078|NCT01843192|100695927|FG000|NOT COMPLETED|Overall Study||2||
48152079|NCT01843192|100695928|FG001|NOT COMPLETED|Overall Study||6||
48152080|NCT01843192|100695929|FG002|NOT COMPLETED|Overall Study||2||
48152081|NCT00654901|100695930|FG000|STARTED|Overall Study||254||
48152082|NCT00654901|100695931|FG001|STARTED|Overall Study||262||
48152083|NCT00654901|100695932|FG002|STARTED|Overall Study||252||
48152084|NCT00654901|100695933|FG003|STARTED|Overall Study||113||
48152085|NCT00654901|100695930|FG000|COMPLETED|Overall Study||250||
48152086|NCT00654901|100695931|FG001|COMPLETED|Overall Study||262||
48152087|NCT00654901|100695932|FG002|COMPLETED|Overall Study||250||
48152088|NCT00654901|100695933|FG003|COMPLETED|Overall Study||113||
48152089|NCT00654901|100695930|FG000|NOT COMPLETED|Overall Study||4||
48152090|NCT00654901|100695931|FG001|NOT COMPLETED|Overall Study||0||
48152091|NCT00654901|100695932|FG002|NOT COMPLETED|Overall Study||2||
48152092|NCT00654901|100695933|FG003|NOT COMPLETED|Overall Study||0||
48152093|NCT03802864|100695934|FG000|STARTED|Overall Study||25||
48152094|NCT03802864|100695935|FG001|STARTED|Overall Study||25||
48152095|NCT03802864|100695934|FG000|COMPLETED|Overall Study||25||
48306987|NCT01843972|101077551|FG003|STARTED|Overall Study||6||
48152096|NCT03802864|100695935|FG001|COMPLETED|Overall Study||25||
48152097|NCT03802864|100695934|FG000|NOT COMPLETED|Overall Study||0||
48306988|NCT01843972|101077552|FG004|STARTED|Overall Study||6||
48306989|NCT01843972|101077553|FG005|STARTED|Overall Study||6||
48306990|NCT01843972|101077554|FG006|STARTED|Overall Study||5||
48306991|NCT01843972|101077555|FG007|STARTED|Overall Study||5||
48306992|NCT01843972|101077556|FG008|STARTED|Overall Study||17||
48152098|NCT03802864|100695935|FG001|NOT COMPLETED|Overall Study||0||
48152099|NCT00811382|100695936|FG000|STARTED|Overall Study||88||
48152100|NCT00811382|100695937|FG001|STARTED|Overall Study||75||
48152101|NCT00811382|100695936|FG000|COMPLETED|Overall Study||88||
48152102|NCT00811382|100695937|FG001|COMPLETED|Overall Study||75||
48152103|NCT00811382|100695936|FG000|NOT COMPLETED|Overall Study||0||
48152104|NCT00811382|100695937|FG001|NOT COMPLETED|Overall Study||0||
48152105|NCT04557930|100695938|FG000|STARTED|Pre-intervention||39|Physician participants who agreed to enroll in the trial|8
48306993|NCT01843972|101077557|FG009|STARTED|Overall Study||12||
48306994|NCT01843972|101077548|FG000|COMPLETED|Overall Study||13||
48406188|NCT01600105|101328373|FG000|STARTED|Sub Study I||19||
48152106|NCT04557930|100695939|FG001|STARTED|Pre-intervention||30|Physician participants who agreed to enroll in the trial|7
48152107|NCT04557930|100695940|FG002|STARTED|Pre-intervention||25|Physician participants who agreed to enroll in the trial|6
48152108|NCT04557930|100695941|FG003|STARTED|Pre-intervention||41|Physician participants who agreed to enroll in the trial|7
48152109|NCT04557930|100695942|FG004|STARTED|Pre-intervention||28|Physician participants who agreed to enroll in the trial|7
48152110|NCT04557930|100695938|FG000|Patient Participants Treated by Enrolled Physician Participants|Pre-intervention||3203||8
48152111|NCT04557930|100695939|FG001|Patient Participants Treated by Enrolled Physician Participants|Pre-intervention||2677||7
48152112|NCT04557930|100695940|FG002|Patient Participants Treated by Enrolled Physician Participants|Pre-intervention||3303||6
48152113|NCT04557930|100695941|FG003|Patient Participants Treated by Enrolled Physician Participants|Pre-intervention||4976||7
48152114|NCT04557930|100695942|FG004|Patient Participants Treated by Enrolled Physician Participants|Pre-intervention||6615||7
48152115|NCT04557930|100695938|FG000|COMPLETED|Pre-intervention||39|Physician participants who completed study tasks|8
48152116|NCT04557930|100695939|FG001|COMPLETED|Pre-intervention||30|Physician participants who completed study tasks|7
48152117|NCT04557930|100695940|FG002|COMPLETED|Pre-intervention||25|Physician participants who completed study tasks|6
48152118|NCT04557930|100695941|FG003|COMPLETED|Pre-intervention||41|Physician participants who completed study tasks|7
48152119|NCT04557930|100695942|FG004|COMPLETED|Pre-intervention||28|Physician participants who completed study tasks|7
48152120|NCT04557930|100695938|FG000|NOT COMPLETED|Pre-intervention||0||0
48152121|NCT04557930|100695939|FG001|NOT COMPLETED|Pre-intervention||0||0
48306995|NCT01843972|101077549|FG001|COMPLETED|Overall Study||6||
48306996|NCT01843972|101077550|FG002|COMPLETED|Overall Study||5||
48306997|NCT01843972|101077551|FG003|COMPLETED|Overall Study||6||
48306998|NCT01843972|101077552|FG004|COMPLETED|Overall Study||5||
48306999|NCT01843972|101077553|FG005|COMPLETED|Overall Study||6||
48307000|NCT01843972|101077554|FG006|COMPLETED|Overall Study||5||
48307001|NCT01843972|101077555|FG007|COMPLETED|Overall Study||5||
48307002|NCT01843972|101077556|FG008|COMPLETED|Overall Study||17||
48307003|NCT01843972|101077557|FG009|COMPLETED|Overall Study||12||
48307004|NCT01843972|101077548|FG000|NOT COMPLETED|Overall Study||0||
48307005|NCT01843972|101077549|FG001|NOT COMPLETED|Overall Study||0||
48307006|NCT01843972|101077550|FG002|NOT COMPLETED|Overall Study||0||
48307007|NCT01843972|101077551|FG003|NOT COMPLETED|Overall Study||0||
48307008|NCT01843972|101077552|FG004|NOT COMPLETED|Overall Study||1||
48307009|NCT01843972|101077553|FG005|NOT COMPLETED|Overall Study||0||
48307010|NCT01843972|101077554|FG006|NOT COMPLETED|Overall Study||0||
48307011|NCT01843972|101077555|FG007|NOT COMPLETED|Overall Study||0||
48307012|NCT01843972|101077556|FG008|NOT COMPLETED|Overall Study||0||
48307013|NCT01843972|101077557|FG009|NOT COMPLETED|Overall Study||0||
48307014|NCT01130051|101077558|FG000|STARTED|Period 1||8||
48307015|NCT01130051|101077559|FG001|STARTED|Period 1||8||
48307016|NCT01130051|101077558|FG000|COMPLETED|Period 1||8||
48307017|NCT01130051|101077559|FG001|COMPLETED|Period 1||8||
48307018|NCT01130051|101077558|FG000|NOT COMPLETED|Period 1||0||
48307019|NCT01130051|101077559|FG001|NOT COMPLETED|Period 1||0||
48307020|NCT01130051|101077558|FG000|STARTED|Washout Period of 14 Days||8||
48152122|NCT04557930|100695940|FG002|NOT COMPLETED|Pre-intervention||0||0
48152123|NCT04557930|100695941|FG003|NOT COMPLETED|Pre-intervention||0||0
48152124|NCT04557930|100695942|FG004|NOT COMPLETED|Pre-intervention||0||0
48152125|NCT04557930|100695938|FG000|STARTED|Post-intervention||39||8
48152126|NCT04557930|100695939|FG001|STARTED|Post-intervention||30||7
48152127|NCT04557930|100695940|FG002|STARTED|Post-intervention||25||6
48152128|NCT04557930|100695941|FG003|STARTED|Post-intervention||41||7
48152129|NCT04557930|100695942|FG004|STARTED|Post-intervention||28||7
48152130|NCT04557930|100695938|FG000|Patient Participants Treated by Enrolled Physicians|Post-intervention||8076||8
48152131|NCT04557930|100695939|FG001|Patient Participants Treated by Enrolled Physicians|Post-intervention||4691||7
48152132|NCT04557930|100695940|FG002|Patient Participants Treated by Enrolled Physicians|Post-intervention||3706||6
48152133|NCT04557930|100695941|FG003|Patient Participants Treated by Enrolled Physicians|Post-intervention||3949||7
48152134|NCT04557930|100695942|FG004|Patient Participants Treated by Enrolled Physicians|Post-intervention||3030||7
48152135|NCT04557930|100695938|FG000|COMPLETED|Post-intervention||39|We used an intention to treat analysis, so all physician participants enrolled in the trial were deemed to have 'completed' the intervention. There was loss to follow up in only 1 step (Step 2). Two physicians here did not complete all study tasks.|8
48152136|NCT04557930|100695939|FG001|COMPLETED|Post-intervention||30|We used an intention to treat analysis, so all physician participants enrolled in the trial were deemed to have 'completed' the intervention. There was loss to follow up in only 1 step (Step 2). Two physicians here did not complete all study tasks.|7
48152137|NCT04557930|100695940|FG002|COMPLETED|Post-intervention||25|We used an intention to treat analysis, so all physician participants enrolled in the trial were deemed to have 'completed' the intervention. There was loss to follow up in only 1 step (Step 2). Two physicians here did not complete all study tasks.|6
48152138|NCT04557930|100695941|FG003|COMPLETED|Post-intervention||41|We used an intention to treat analysis, so all physician participants enrolled in the trial were deemed to have 'completed' the intervention. There was loss to follow up in only 1 step (Step 2). Two physicians here did not complete all study tasks.|7
48152139|NCT04557930|100695942|FG004|COMPLETED|Post-intervention||28|We used an intention to treat analysis, so all physician participants enrolled in the trial were deemed to have 'completed' the intervention. There was loss to follow up in only 1 step (Step 2). Two physicians here did not complete all study tasks.|7
48152140|NCT04557930|100695938|FG000|NOT COMPLETED|Post-intervention||0||0
48152141|NCT04557930|100695939|FG001|NOT COMPLETED|Post-intervention||0||0
48152142|NCT04557930|100695940|FG002|NOT COMPLETED|Post-intervention||0||0
48152143|NCT04557930|100695941|FG003|NOT COMPLETED|Post-intervention||0||0
48152144|NCT04557930|100695942|FG004|NOT COMPLETED|Post-intervention||0||0
48152145|NCT03210155|100695943|FG000|STARTED|Overall Study||0||
48152146|NCT03210155|100695944|FG001|STARTED|Overall Study||1||
48152147|NCT03210155|100695943|FG000|COMPLETED|Overall Study||0||
48152148|NCT03210155|100695944|FG001|COMPLETED|Overall Study||1||
48152149|NCT03210155|100695943|FG000|NOT COMPLETED|Overall Study||0||
48152150|NCT03210155|100695944|FG001|NOT COMPLETED|Overall Study||0||
48152151|NCT01194570|100695945|FG000|STARTED|Overall Study||244||
48152152|NCT01194570|100695946|FG001|STARTED|Overall Study||488||
48152153|NCT01194570|100695945|FG000|COMPLETED|Overall Study||89||
48152154|NCT01194570|100695946|FG001|COMPLETED|Overall Study||218||
48152155|NCT01194570|100695945|FG000|NOT COMPLETED|Overall Study||155||
48152156|NCT01194570|100695946|FG001|NOT COMPLETED|Overall Study||270||
48406189|NCT01600105|101328374|FG001|STARTED|Sub Study I||21||
48406190|NCT01600105|101328373|FG000|COMPLETED|Sub Study I||19||
48406191|NCT01600105|101328374|FG001|COMPLETED|Sub Study I||11||
48406192|NCT01600105|101328373|FG000|NOT COMPLETED|Sub Study I||0||
48406193|NCT01600105|101328374|FG001|NOT COMPLETED|Sub Study I||10||
48152157|NCT01345630|100695947|FG000|STARTED|Overall Study||396||
48307021|NCT01130051|101077559|FG001|STARTED|Washout Period of 14 Days||8||
48307022|NCT01130051|101077558|FG000|COMPLETED|Washout Period of 14 Days||7||
48152158|NCT01345630|100695948|FG001|STARTED|Overall Study||401||
48152159|NCT01345630|100695947|FG000|COMPLETED|Overall Study||35||
48307023|NCT01130051|101077559|FG001|COMPLETED|Washout Period of 14 Days||6||
48307024|NCT01130051|101077558|FG000|NOT COMPLETED|Washout Period of 14 Days||1||
48307025|NCT01130051|101077559|FG001|NOT COMPLETED|Washout Period of 14 Days||2||
48307026|NCT01130051|101077558|FG000|STARTED|Period 2||7||
48307027|NCT01130051|101077559|FG001|STARTED|Period 2||6||
48307028|NCT01130051|101077558|FG000|COMPLETED|Period 2||7||
48307029|NCT01130051|101077559|FG001|COMPLETED|Period 2||6||
48406194|NCT01600105|101328373|FG000|STARTED|Sub Study II||65||
48406195|NCT01600105|101328374|FG001|STARTED|Sub Study II||0||
48152160|NCT01345630|100695948|FG001|COMPLETED|Overall Study||42||
48152161|NCT01345630|100695947|FG000|NOT COMPLETED|Overall Study||361||
48152162|NCT01345630|100695948|FG001|NOT COMPLETED|Overall Study||359||
48152163|NCT00800839|100695949|FG000|STARTED|Overall Study||56||
48152164|NCT00800839|100695949|FG000|COMPLETED|Overall Study||49||
48152165|NCT00800839|100695949|FG000|NOT COMPLETED|Overall Study||7||
48152166|NCT00765843|100695950|FG000|STARTED|Overall Study||26||
48307030|NCT01130051|101077558|FG000|NOT COMPLETED|Period 2||0||
48307031|NCT01130051|101077559|FG001|NOT COMPLETED|Period 2||0||
48307032|NCT00749879|101077560|FG000|STARTED|Overall Study||12||
48406196|NCT01600105|101328373|FG000|COMPLETED|Sub Study II||60||
48406197|NCT01600105|101328374|FG001|COMPLETED|Sub Study II||0||
48406198|NCT01600105|101328373|FG000|NOT COMPLETED|Sub Study II||5||
48406199|NCT01600105|101328374|FG001|NOT COMPLETED|Sub Study II||0||
48406200|NCT01600105|101328373|FG000|STARTED|Sub Study III||39||
48406201|NCT01600105|101328374|FG001|STARTED|Sub Study III||0||
48406202|NCT01600105|101328373|FG000|COMPLETED|Sub Study III||34||
48406203|NCT01600105|101328374|FG001|COMPLETED|Sub Study III||0||
48406204|NCT01600105|101328373|FG000|NOT COMPLETED|Sub Study III||5||
48406205|NCT01600105|101328374|FG001|NOT COMPLETED|Sub Study III||0||
48406206|NCT01600105|101328373|FG000|STARTED|Sub Study IV||41||
48406207|NCT01600105|101328374|FG001|STARTED|Sub Study IV||8||
48406208|NCT01600105|101328373|FG000|COMPLETED|Sub Study IV||41||
48406209|NCT01600105|101328374|FG001|COMPLETED|Sub Study IV||8||
48406210|NCT01600105|101328373|FG000|NOT COMPLETED|Sub Study IV||0||
48406211|NCT01600105|101328374|FG001|NOT COMPLETED|Sub Study IV||0||
48406212|NCT01600105|101328373|FG000|STARTED|Sub Study V||52||
48406213|NCT01600105|101328374|FG001|STARTED|Sub Study V||0||
48406214|NCT01600105|101328373|FG000|COMPLETED|Sub Study V||50||
48406215|NCT01600105|101328374|FG001|COMPLETED|Sub Study V||0||
48406216|NCT01600105|101328373|FG000|NOT COMPLETED|Sub Study V||2||
48406217|NCT01600105|101328374|FG001|NOT COMPLETED|Sub Study V||0||
48406218|NCT04005755|101328375|FG000|STARTED|Overall Study||232||
48406219|NCT04005755|101328375|FG000|COMPLETED|Overall Study||215||
48406220|NCT04005755|101328375|FG000|NOT COMPLETED|Overall Study||17||
48406221|NCT00460525|101328376|FG000|STARTED|Overall Study||201||
48406222|NCT00460525|101328377|FG001|STARTED|Overall Study||199||
48406223|NCT00460525|101328376|FG000|COMPLETED|Overall Study||190||
48406224|NCT00460525|101328377|FG001|COMPLETED|Overall Study||194||
48406225|NCT00460525|101328376|FG000|NOT COMPLETED|Overall Study||11||
48406226|NCT00460525|101328377|FG001|NOT COMPLETED|Overall Study||5||
48406227|NCT02635867|101328378|FG000|STARTED|Overall Study||25||30
48406228|NCT02635867|101328379|FG001|STARTED|Overall Study||27||30
48406229|NCT02635867|101328380|FG002|STARTED|Overall Study||27||30
48406230|NCT02635867|101328381|FG003|STARTED|Overall Study||10||10
48406231|NCT02635867|101328382|FG004|STARTED|Overall Study||9||9
48406232|NCT02635867|101328378|FG000|COMPLETED|Overall Study||21||25
48152167|NCT00765843|100695951|FG001|STARTED|Overall Study||25||
48608883|NCT05446142|101827210|FG005|COMPLETED|Period 3||3||
48608884|NCT05446142|101827205|FG000|NOT COMPLETED|Period 3||0||
48608885|NCT05446142|101827206|FG001|NOT COMPLETED|Period 3||0||
48608886|NCT05446142|101827207|FG002|NOT COMPLETED|Period 3||0||
48608887|NCT05446142|101827208|FG003|NOT COMPLETED|Period 3||0||
48608888|NCT05446142|101827209|FG004|NOT COMPLETED|Period 3||0||
48608889|NCT05446142|101827210|FG005|NOT COMPLETED|Period 3||0||
48608890|NCT05446142|101827205|FG000|STARTED|Period 4||2||
48722086|NCT02048371|102105563|FG003|STARTED|Overall Study||22||
48722087|NCT02048371|102105564|FG004|STARTED|Overall Study||9||
48722088|NCT02048371|102105565|FG005|STARTED|Overall Study||11||
48722089|NCT02048371|102105566|FG006|STARTED|Overall Study||30||
48722090|NCT02048371|102105567|FG007|STARTED|Overall Study||10||
48722091|NCT02048371|102105568|FG008|STARTED|Overall Study||1||
48722092|NCT02048371|102105560|FG000|COMPLETED|Overall Study||17||
48722093|NCT02048371|102105561|FG001|COMPLETED|Overall Study||1||
48722094|NCT02048371|102105562|FG002|COMPLETED|Overall Study||9||
48722095|NCT02048371|102105563|FG003|COMPLETED|Overall Study||11||
48722096|NCT02048371|102105564|FG004|COMPLETED|Overall Study||3||
48722097|NCT02048371|102105565|FG005|COMPLETED|Overall Study||8||
48722098|NCT02048371|102105566|FG006|COMPLETED|Overall Study||22||
48722099|NCT02048371|102105567|FG007|COMPLETED|Overall Study||6||
48722100|NCT02048371|102105568|FG008|COMPLETED|Overall Study||1||
48722101|NCT02048371|102105560|FG000|NOT COMPLETED|Overall Study||7||
48722102|NCT02048371|102105561|FG001|NOT COMPLETED|Overall Study||8||
48722103|NCT02048371|102105562|FG002|NOT COMPLETED|Overall Study||6||
48722104|NCT02048371|102105563|FG003|NOT COMPLETED|Overall Study||11||
48722105|NCT02048371|102105564|FG004|NOT COMPLETED|Overall Study||6||
48722106|NCT02048371|102105565|FG005|NOT COMPLETED|Overall Study||3||
48722107|NCT02048371|102105566|FG006|NOT COMPLETED|Overall Study||8||
48722108|NCT02048371|102105567|FG007|NOT COMPLETED|Overall Study||4||
48722109|NCT02048371|102105568|FG008|NOT COMPLETED|Overall Study||0||
48722110|NCT05986617|102105569|FG000|STARTED|Overall Study||30||
48722111|NCT05986617|102105570|FG001|STARTED|Overall Study||30||
48722112|NCT05986617|102105569|FG000|COMPLETED|Overall Study||1||
48722113|NCT05986617|102105570|FG001|COMPLETED|Overall Study||5||
48722114|NCT05986617|102105569|FG000|NOT COMPLETED|Overall Study||29||
48722115|NCT05986617|102105570|FG001|NOT COMPLETED|Overall Study||25||
48722116|NCT00290498|102105571|FG000|STARTED|Overall Study||49||
48722117|NCT00290498|102105572|FG001|STARTED|Overall Study||10||
48722118|NCT00290498|102105571|FG000|COMPLETED|Overall Study||41||
48722119|NCT00290498|102105572|FG001|COMPLETED|Overall Study||10||
48722120|NCT00290498|102105571|FG000|NOT COMPLETED|Overall Study||8||
48722121|NCT00290498|102105572|FG001|NOT COMPLETED|Overall Study||0||
48722122|NCT00084656|102105573|FG000|STARTED|Overall Study||25||
48722123|NCT00084656|102105574|FG001|STARTED|Overall Study||25||
48722124|NCT00084656|102105575|FG002|STARTED|Overall Study||26||
48722125|NCT00084656|102105573|FG000|COMPLETED|Overall Study||0||
48722126|NCT00084656|102105574|FG001|COMPLETED|Overall Study||0||
48608891|NCT05446142|101827206|FG001|STARTED|Period 4||3||
48608892|NCT05446142|101827207|FG002|STARTED|Period 4||3||
48608893|NCT05446142|101827208|FG003|STARTED|Period 4||3||
48608894|NCT05446142|101827209|FG004|STARTED|Period 4||3||
48722127|NCT00084656|102105575|FG002|COMPLETED|Overall Study||0||
48722128|NCT00084656|102105573|FG000|NOT COMPLETED|Overall Study||25||
48722129|NCT00084656|102105574|FG001|NOT COMPLETED|Overall Study||25||
48722130|NCT00084656|102105575|FG002|NOT COMPLETED|Overall Study||26||
48722131|NCT00716742|102105576|FG000|STARTED|Baseline||364||
48722132|NCT00716742|102105577|FG001|STARTED|Baseline||370||
48722133|NCT00716742|102105578|FG002|STARTED|Baseline||365||
48152168|NCT00765843|100695952|FG002|STARTED|Overall Study||26||
48608895|NCT05446142|101827210|FG005|STARTED|Period 4||3||
48722134|NCT00716742|102105576|FG000|COMPLETED|Baseline||347||
48722135|NCT00716742|102105577|FG001|COMPLETED|Baseline||356||
48722136|NCT00716742|102105578|FG002|COMPLETED|Baseline||352||
48722137|NCT00716742|102105576|FG000|NOT COMPLETED|Baseline||17||
48722138|NCT00716742|102105577|FG001|NOT COMPLETED|Baseline||14||
48722139|NCT00716742|102105578|FG002|NOT COMPLETED|Baseline||13||
48722140|NCT00716742|102105576|FG000|STARTED|1 Year Follow-up||347||
48722141|NCT00716742|102105577|FG001|STARTED|1 Year Follow-up||356||
48722142|NCT00716742|102105578|FG002|STARTED|1 Year Follow-up||352||
48722143|NCT00716742|102105576|FG000|COMPLETED|1 Year Follow-up||160||
48722144|NCT00716742|102105577|FG001|COMPLETED|1 Year Follow-up||163||
48722145|NCT00716742|102105578|FG002|COMPLETED|1 Year Follow-up||152||
48722146|NCT00716742|102105576|FG000|NOT COMPLETED|1 Year Follow-up||187||
48608896|NCT05446142|101827205|FG000|COMPLETED|Period 4||2||
48722147|NCT00716742|102105577|FG001|NOT COMPLETED|1 Year Follow-up||193||
48722148|NCT00716742|102105578|FG002|NOT COMPLETED|1 Year Follow-up||200||
48307033|NCT00749879|101077560|FG000|COMPLETED|Overall Study||12||
48307034|NCT00749879|101077560|FG000|NOT COMPLETED|Overall Study||0||
48307035|NCT01614821|101077561|FG000|STARTED|Overall Study||63||
48307036|NCT01614821|101077561|FG000|COMPLETED|Overall Study||63||
48307037|NCT01614821|101077561|FG000|NOT COMPLETED|Overall Study||0||
48307038|NCT04906616|101077562|FG000|STARTED|Overall Study||78||
48307039|NCT04906616|101077563|FG001|STARTED|Overall Study||78||
48307040|NCT04906616|101077562|FG000|COMPLETED|Overall Study||75||
48307041|NCT04906616|101077563|FG001|COMPLETED|Overall Study||76||
48307042|NCT04906616|101077562|FG000|NOT COMPLETED|Overall Study||3||
48307043|NCT04906616|101077563|FG001|NOT COMPLETED|Overall Study||2||
48307044|NCT00727649|101077564|FG000|STARTED|First Intervention (4-weeks)||37||
48307045|NCT00727649|101077565|FG001|STARTED|First Intervention (4-weeks)||43||
48307046|NCT00727649|101077564|FG000|COMPLETED|First Intervention (4-weeks)||34||
48406233|NCT02635867|101328379|FG001|COMPLETED|Overall Study||24||27
48406234|NCT02635867|101328380|FG002|COMPLETED|Overall Study||24||27
48406235|NCT02635867|101328381|FG003|COMPLETED|Overall Study||6||6
48406236|NCT02635867|101328382|FG004|COMPLETED|Overall Study||8||8
48406237|NCT02635867|101328378|FG000|NOT COMPLETED|Overall Study||4||5
48406238|NCT02635867|101328379|FG001|NOT COMPLETED|Overall Study||3||3
48406239|NCT02635867|101328380|FG002|NOT COMPLETED|Overall Study||3||3
48406240|NCT02635867|101328381|FG003|NOT COMPLETED|Overall Study||4||4
48722149|NCT00716742|102105576|FG000|STARTED|2 Year Follow-up||160||
48722150|NCT00716742|102105577|FG001|STARTED|2 Year Follow-up||163||
48722151|NCT00716742|102105578|FG002|STARTED|2 Year Follow-up||152||
48722152|NCT00716742|102105576|FG000|COMPLETED|2 Year Follow-up||56||
48722153|NCT00716742|102105577|FG001|COMPLETED|2 Year Follow-up||67||
48722154|NCT00716742|102105578|FG002|COMPLETED|2 Year Follow-up||50||
48722155|NCT00716742|102105576|FG000|NOT COMPLETED|2 Year Follow-up||104||
48722156|NCT00716742|102105577|FG001|NOT COMPLETED|2 Year Follow-up||96||
48722157|NCT00716742|102105578|FG002|NOT COMPLETED|2 Year Follow-up||102||
48722158|NCT00716742|102105576|FG000|STARTED|3 Year Follow-up||56||
48722159|NCT00716742|102105577|FG001|STARTED|3 Year Follow-up||67||
48722160|NCT00716742|102105578|FG002|STARTED|3 Year Follow-up||50||
48722161|NCT00716742|102105576|FG000|COMPLETED|3 Year Follow-up||26||
48722162|NCT00716742|102105577|FG001|COMPLETED|3 Year Follow-up||35||
48722163|NCT00716742|102105578|FG002|COMPLETED|3 Year Follow-up||29||
48722164|NCT00716742|102105576|FG000|NOT COMPLETED|3 Year Follow-up||30||
48722165|NCT00716742|102105577|FG001|NOT COMPLETED|3 Year Follow-up||32||
48722166|NCT00716742|102105578|FG002|NOT COMPLETED|3 Year Follow-up||21||
48722167|NCT01264770|102105579|FG000|STARTED|Overall Study||54||
48722168|NCT01264770|102105580|FG001|STARTED|Overall Study||48||
48722169|NCT01264770|102105581|FG002|STARTED|Overall Study||57||
48722170|NCT01264770|102105582|FG003|STARTED|Overall Study||54||
48722171|NCT01264770|102105583|FG004|STARTED|Overall Study||27||
48722172|NCT01264770|102105584|FG005|STARTED|Overall Study||25||
48722173|NCT01264770|102105579|FG000|Randomised But Did Not Receive Treatment|Overall Study||2||
48722174|NCT01264770|102105580|FG001|Randomised But Did Not Receive Treatment|Overall Study||5||
48722175|NCT01264770|102105581|FG002|Randomised But Did Not Receive Treatment|Overall Study||2||
48722176|NCT01264770|102105582|FG003|Randomised But Did Not Receive Treatment|Overall Study||3||
48722177|NCT01264770|102105583|FG004|Randomised But Did Not Receive Treatment|Overall Study||2||
48722178|NCT01264770|102105584|FG005|Randomised But Did Not Receive Treatment|Overall Study||0||
48722179|NCT01264770|102105579|FG000|COMPLETED|Overall Study||36||
48722180|NCT01264770|102105580|FG001|COMPLETED|Overall Study||38||
48722181|NCT01264770|102105581|FG002|COMPLETED|Overall Study||41||
48722182|NCT01264770|102105582|FG003|COMPLETED|Overall Study||48||
48722183|NCT01264770|102105583|FG004|COMPLETED|Overall Study||19||
48722184|NCT01264770|102105584|FG005|COMPLETED|Overall Study||19||
48722185|NCT01264770|102105579|FG000|NOT COMPLETED|Overall Study||18||
48722186|NCT01264770|102105580|FG001|NOT COMPLETED|Overall Study||10||
48722187|NCT01264770|102105581|FG002|NOT COMPLETED|Overall Study||16||
48722188|NCT01264770|102105582|FG003|NOT COMPLETED|Overall Study||6||
48307047|NCT00727649|101077565|FG001|COMPLETED|First Intervention (4-weeks)||40||
48307048|NCT00727649|101077564|FG000|NOT COMPLETED|First Intervention (4-weeks)||3||
48307049|NCT00727649|101077565|FG001|NOT COMPLETED|First Intervention (4-weeks)||3||
48307050|NCT00727649|101077564|FG000|STARTED|Wash-out (2-weeks)||34||
48307051|NCT00727649|101077565|FG001|STARTED|Wash-out (2-weeks)||40||
48307052|NCT00727649|101077564|FG000|COMPLETED|Wash-out (2-weeks)||30||
48406241|NCT02635867|101328382|FG004|NOT COMPLETED|Overall Study||1||1
48406242|NCT01974440|101328383|FG000|STARTED|Overall Study||201||
48406243|NCT01974440|101328384|FG001|STARTED|Overall Study||202||
48406244|NCT01974440|101328383|FG000|Safety Analysis Set|Overall Study||199||
48406245|NCT01974440|101328384|FG001|Safety Analysis Set|Overall Study||201||
48406246|NCT01974440|101328383|FG000|Participants With Marginal Zone Lymphoma (MZL)|Overall Study||28||
48406247|NCT01974440|101328384|FG001|Participants With Marginal Zone Lymphoma (MZL)|Overall Study||28||
48722189|NCT01264770|102105583|FG004|NOT COMPLETED|Overall Study||8||
48307053|NCT00727649|101077565|FG001|COMPLETED|Wash-out (2-weeks)||37||
48307054|NCT00727649|101077564|FG000|NOT COMPLETED|Wash-out (2-weeks)||4||
48307055|NCT00727649|101077565|FG001|NOT COMPLETED|Wash-out (2-weeks)||3||
48406248|NCT01974440|101328383|FG000|Participants With Follicular Lymphoma (FL)|Overall Study||173||
48406249|NCT01974440|101328384|FG001|Participants With Follicular Lymphoma (FL)|Overall Study||174||
48406250|NCT01974440|101328383|FG000|COMPLETED|Overall Study||61||
48406251|NCT01974440|101328384|FG001|COMPLETED|Overall Study||65||
48406252|NCT01974440|101328383|FG000|NOT COMPLETED|Overall Study||140||
48406253|NCT01974440|101328384|FG001|NOT COMPLETED|Overall Study||137||
48406254|NCT02289833|101328385|FG000|STARTED|Overall Study||29||
48406255|NCT02289833|101328386|FG001|STARTED|Overall Study||20||
48406256|NCT02289833|101328385|FG000|COMPLETED|Overall Study||2||
48406257|NCT02289833|101328386|FG001|COMPLETED|Overall Study||3||
48406258|NCT02289833|101328385|FG000|NOT COMPLETED|Overall Study||27||
48406259|NCT02289833|101328386|FG001|NOT COMPLETED|Overall Study||17||
48406260|NCT00176878|101328387|FG000|STARTED|Overall Study||10||
48406261|NCT00176878|101328387|FG000|COMPLETED|Overall Study||10||
48406262|NCT00176878|101328387|FG000|NOT COMPLETED|Overall Study||0||
48307056|NCT00727649|101077564|FG000|STARTED|Second Intervention (4-weeks)||30||
48406263|NCT03050307|101328388|FG000|STARTED|Overall Study||115||
48406264|NCT03050307|101328389|FG001|STARTED|Overall Study||119||
48406265|NCT03050307|101328388|FG000|COMPLETED|Overall Study||107||
48406266|NCT03050307|101328389|FG001|COMPLETED|Overall Study||110||
48608897|NCT05446142|101827206|FG001|COMPLETED|Period 4||3||
48608898|NCT05446142|101827207|FG002|COMPLETED|Period 4||3||
48608899|NCT05446142|101827208|FG003|COMPLETED|Period 4||3||
48608900|NCT05446142|101827209|FG004|COMPLETED|Period 4||3||
48608901|NCT05446142|101827210|FG005|COMPLETED|Period 4||3||
48608902|NCT05446142|101827205|FG000|NOT COMPLETED|Period 4||0||
48608903|NCT05446142|101827206|FG001|NOT COMPLETED|Period 4||0||
48608904|NCT05446142|101827207|FG002|NOT COMPLETED|Period 4||0||
48608905|NCT05446142|101827208|FG003|NOT COMPLETED|Period 4||0||
48608906|NCT05446142|101827209|FG004|NOT COMPLETED|Period 4||0||
48608907|NCT05446142|101827210|FG005|NOT COMPLETED|Period 4||0||
48608908|NCT02634801|101827211|FG000|STARTED|Treatment Period (Weeks 0 to 24)||54||
48608909|NCT02634801|101827212|FG001|STARTED|Treatment Period (Weeks 0 to 24)||54||
48307057|NCT00727649|101077565|FG001|STARTED|Second Intervention (4-weeks)||37||
48307058|NCT00727649|101077564|FG000|COMPLETED|Second Intervention (4-weeks)||29||
48307059|NCT00727649|101077565|FG001|COMPLETED|Second Intervention (4-weeks)||34||
48307060|NCT00727649|101077564|FG000|NOT COMPLETED|Second Intervention (4-weeks)||1||
48307061|NCT00727649|101077565|FG001|NOT COMPLETED|Second Intervention (4-weeks)||3||
48307062|NCT00390611|101077566|FG000|STARTED|6 Cycles of Study Treatment||43||
48307063|NCT00390611|101077567|FG001|STARTED|6 Cycles of Study Treatment||42||
48307064|NCT00390611|101077566|FG000|COMPLETED|6 Cycles of Study Treatment||34||
48307065|NCT00390611|101077567|FG001|COMPLETED|6 Cycles of Study Treatment||37||
48307066|NCT00390611|101077566|FG000|NOT COMPLETED|6 Cycles of Study Treatment||9||
48307067|NCT00390611|101077567|FG001|NOT COMPLETED|6 Cycles of Study Treatment||5||
48406267|NCT03050307|101328388|FG000|NOT COMPLETED|Overall Study||8||
48307068|NCT00390611|101077566|FG000|STARTED|Maintenance Sorafenib to Month 12||23||
48307069|NCT00390611|101077567|FG001|STARTED|Maintenance Sorafenib to Month 12||0||
48307070|NCT00390611|101077566|FG000|COMPLETED|Maintenance Sorafenib to Month 12||13||
48307071|NCT00390611|101077567|FG001|COMPLETED|Maintenance Sorafenib to Month 12||0||
48307072|NCT00390611|101077566|FG000|NOT COMPLETED|Maintenance Sorafenib to Month 12||10||
48406268|NCT03050307|101328389|FG001|NOT COMPLETED|Overall Study||9||
48406269|NCT00564265|101328390|FG000|STARTED|Overall Study||24||
48406270|NCT00564265|101328390|FG000|COMPLETED|Overall Study||24||
48608910|NCT02634801|101827213|FG002|STARTED|Treatment Period (Weeks 0 to 24)||54||
48608911|NCT02634801|101827211|FG000|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||54||
48608912|NCT02634801|101827212|FG001|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||52||
48608913|NCT02634801|101827213|FG002|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||52||
48307073|NCT00390611|101077567|FG001|NOT COMPLETED|Maintenance Sorafenib to Month 12||0||
48406271|NCT00564265|101328390|FG000|NOT COMPLETED|Overall Study||0||
48406272|NCT01849562|101328391|FG000|STARTED|Overall Study||10||
48406273|NCT01849562|101328392|FG001|STARTED|Overall Study||10||
48406274|NCT01849562|101328393|FG002|STARTED|Overall Study||10||
48406275|NCT01849562|101328391|FG000|COMPLETED|Overall Study||8||
48406276|NCT01849562|101328392|FG001|COMPLETED|Overall Study||10||
48406277|NCT01849562|101328393|FG002|COMPLETED|Overall Study||10||
48406278|NCT01849562|101328391|FG000|NOT COMPLETED|Overall Study||2||
48406279|NCT01849562|101328392|FG001|NOT COMPLETED|Overall Study||0||
48406280|NCT01849562|101328393|FG002|NOT COMPLETED|Overall Study||0||
48406281|NCT00981292|101328394|FG000|STARTED|Day 1||7||
48406282|NCT00981292|101328395|FG001|STARTED|Day 1||4||
48406283|NCT00981292|101328396|FG002|STARTED|Day 1||6||
48406284|NCT00981292|101328397|FG003|STARTED|Day 1||4||
48406285|NCT00981292|101328398|FG004|STARTED|Day 1||4||
48406286|NCT00981292|101328399|FG005|STARTED|Day 1||7||
48406287|NCT00981292|101328394|FG000|COMPLETED|Day 1||6||
48406288|NCT00981292|101328395|FG001|COMPLETED|Day 1||4||
48406289|NCT00981292|101328396|FG002|COMPLETED|Day 1||6||
48406290|NCT00981292|101328397|FG003|COMPLETED|Day 1||4||
48406291|NCT00981292|101328398|FG004|COMPLETED|Day 1||4||
48406292|NCT00981292|101328399|FG005|COMPLETED|Day 1||5||
48406293|NCT00981292|101328394|FG000|NOT COMPLETED|Day 1||1||
48406294|NCT00981292|101328395|FG001|NOT COMPLETED|Day 1||0||
48406295|NCT00981292|101328396|FG002|NOT COMPLETED|Day 1||0||
48406296|NCT00981292|101328397|FG003|NOT COMPLETED|Day 1||0||
48406297|NCT00981292|101328398|FG004|NOT COMPLETED|Day 1||0||
48406298|NCT00981292|101328399|FG005|NOT COMPLETED|Day 1||2||
48406299|NCT00981292|101328394|FG000|STARTED|Day 2||6||
48406300|NCT00981292|101328395|FG001|STARTED|Day 2||4||
48406301|NCT00981292|101328396|FG002|STARTED|Day 2||6||
48406302|NCT00981292|101328397|FG003|STARTED|Day 2||4||
48406303|NCT00981292|101328398|FG004|STARTED|Day 2||4||
48406304|NCT00981292|101328399|FG005|STARTED|Day 2||5||
48406305|NCT00981292|101328394|FG000|COMPLETED|Day 2||4||
48406306|NCT00981292|101328395|FG001|COMPLETED|Day 2||4||
48406307|NCT00981292|101328396|FG002|COMPLETED|Day 2||6||
48406308|NCT00981292|101328397|FG003|COMPLETED|Day 2||4||
48406309|NCT00981292|101328398|FG004|COMPLETED|Day 2||4||
48406310|NCT00981292|101328399|FG005|COMPLETED|Day 2||5||
48406311|NCT00981292|101328394|FG000|NOT COMPLETED|Day 2||2||
48406312|NCT00981292|101328395|FG001|NOT COMPLETED|Day 2||0||
48406313|NCT00981292|101328396|FG002|NOT COMPLETED|Day 2||0||
48406314|NCT00981292|101328397|FG003|NOT COMPLETED|Day 2||0||
48406315|NCT00981292|101328398|FG004|NOT COMPLETED|Day 2||0||
48406316|NCT00981292|101328399|FG005|NOT COMPLETED|Day 2||0||
48406317|NCT00981292|101328394|FG000|STARTED|Day 3||4||
48722190|NCT01264770|102105584|FG005|NOT COMPLETED|Overall Study||6||
48722191|NCT03238924|102105585|FG000|STARTED|Overall Study||8||
48722192|NCT03238924|102105586|FG001|STARTED|Overall Study||9||
48722193|NCT03238924|102105585|FG000|COMPLETED|Overall Study||6||
48722194|NCT03238924|102105586|FG001|COMPLETED|Overall Study||7||
48722195|NCT03238924|102105585|FG000|NOT COMPLETED|Overall Study||2||
48722196|NCT03238924|102105586|FG001|NOT COMPLETED|Overall Study||2||
48722197|NCT01987583|102105587|FG000|STARTED|Overall Study||40||
48722198|NCT01987583|102105588|FG001|STARTED|Overall Study||40||
48722199|NCT01987583|102105587|FG000|COMPLETED|Overall Study||37||
48722200|NCT01987583|102105588|FG001|COMPLETED|Overall Study||38||
48722201|NCT01987583|102105587|FG000|NOT COMPLETED|Overall Study||3||
48722202|NCT01987583|102105588|FG001|NOT COMPLETED|Overall Study||2||
48307074|NCT00955487|101077568|FG000|STARTED|Overall Study||10||
48307075|NCT00955487|101077569|FG001|STARTED|Overall Study||9||
48307076|NCT00955487|101077570|FG002|STARTED|Overall Study||17||
48307077|NCT00955487|101077571|FG003|STARTED|Overall Study||21||
48307078|NCT00955487|101077572|FG004|STARTED|Overall Study||32||
48307079|NCT00955487|101077573|FG005|STARTED|Overall Study||35||
48307080|NCT00955487|101077568|FG000|COMPLETED|Overall Study||10||
48307081|NCT00955487|101077569|FG001|COMPLETED|Overall Study||9||
48307082|NCT00955487|101077570|FG002|COMPLETED|Overall Study||17||
48307083|NCT00955487|101077571|FG003|COMPLETED|Overall Study||21||
48307084|NCT00955487|101077572|FG004|COMPLETED|Overall Study||32||
48307085|NCT00955487|101077573|FG005|COMPLETED|Overall Study||35||
48307086|NCT00955487|101077568|FG000|NOT COMPLETED|Overall Study||0||
48307087|NCT00955487|101077569|FG001|NOT COMPLETED|Overall Study||0||
48307088|NCT00955487|101077570|FG002|NOT COMPLETED|Overall Study||0||
48307089|NCT00955487|101077571|FG003|NOT COMPLETED|Overall Study||0||
48307090|NCT00955487|101077572|FG004|NOT COMPLETED|Overall Study||0||
48307091|NCT00955487|101077573|FG005|NOT COMPLETED|Overall Study||0||
48307092|NCT01660451|101077574|FG000|STARTED|Overall Study||33||
48307093|NCT01660451|101077575|FG001|STARTED|Overall Study||51||
48307094|NCT01660451|101077576|FG002|STARTED|Overall Study||142||
48307095|NCT01660451|101077574|FG000|COMPLETED|Overall Study||0||
48307096|NCT01660451|101077575|FG001|COMPLETED|Overall Study||0||
48307097|NCT01660451|101077576|FG002|COMPLETED|Overall Study||0||
48307098|NCT01660451|101077574|FG000|NOT COMPLETED|Overall Study||33||
48307099|NCT01660451|101077575|FG001|NOT COMPLETED|Overall Study||51||
48307100|NCT01660451|101077576|FG002|NOT COMPLETED|Overall Study||142||
48307101|NCT03829241|101077577|FG000|STARTED|Randomization Phase (Week 1 to Week 8)||202||
48307102|NCT03829241|101077578|FG001|STARTED|Randomization Phase (Week 1 to Week 8)||200||
48307103|NCT03829241|101077577|FG000|Treated|Randomization Phase (Week 1 to Week 8)||199||
48307104|NCT03829241|101077578|FG001|Treated|Randomization Phase (Week 1 to Week 8)||191||
48307105|NCT03829241|101077577|FG000|Modified Intent-to- Treat (mITT) Participants|Randomization Phase (Week 1 to Week 8)||198|Modified intent-to-treat (mITT) participants in the randomization phase included randomized participants who received at least 1 dose of blinded study drug and provided a non-missing baseline assessment and at least 1 non-missing post-baseline efficacy assessment.|
48307106|NCT03829241|101077578|FG001|Modified Intent-to- Treat (mITT) Participants|Randomization Phase (Week 1 to Week 8)||187|Modified intent-to-treat (mITT) participants in the randomization phase included randomized participants who received at least 1 dose of blinded study drug and provided a non-missing baseline assessment and at least 1 non-missing post-baseline efficacy assessment.|
48307107|NCT03829241|101077577|FG000|COMPLETED|Randomization Phase (Week 1 to Week 8)||171||
48307108|NCT03829241|101077578|FG001|COMPLETED|Randomization Phase (Week 1 to Week 8)||158||
48307109|NCT03829241|101077577|FG000|NOT COMPLETED|Randomization Phase (Week 1 to Week 8)||31||
48307110|NCT03829241|101077578|FG001|NOT COMPLETED|Randomization Phase (Week 1 to Week 8)||42||
48307111|NCT03829241|101077577|FG000|STARTED|Extension Phase (Week 9 up to Week 48)||159|Participants who continued into the extension phase|
48368029|NCT03567291|101230094|FG002|STARTED|Period II||46||
48722203|NCT00109577|102105589|FG000|STARTED|Overall Study||20||
48722204|NCT00109577|102105590|FG001|STARTED|Overall Study||20||
48722205|NCT00109577|102105589|FG000|COMPLETED|Overall Study||17||
48307112|NCT03829241|101077578|FG001|STARTED|Extension Phase (Week 9 up to Week 48)||154|Participants who continued into the extension phase|
48307113|NCT03829241|101077577|FG000|Treated|Extension Phase (Week 9 up to Week 48)||153||
48307114|NCT03829241|101077578|FG001|Treated|Extension Phase (Week 9 up to Week 48)||149||
48307115|NCT03829241|101077577|FG000|COMPLETED|Extension Phase (Week 9 up to Week 48)||0||
48307116|NCT03829241|101077578|FG001|COMPLETED|Extension Phase (Week 9 up to Week 48)||0||
48307117|NCT03829241|101077577|FG000|NOT COMPLETED|Extension Phase (Week 9 up to Week 48)||159||
48307118|NCT03829241|101077578|FG001|NOT COMPLETED|Extension Phase (Week 9 up to Week 48)||154||
48307119|NCT00631189|101077579|FG000|STARTED|Initial Phase||668||
48307120|NCT00631189|101077580|FG001|STARTED|Initial Phase||0||
48307121|NCT00631189|101077581|FG002|STARTED|Initial Phase||0||
48307122|NCT00631189|101077582|FG003|STARTED|Initial Phase||0||
48307123|NCT00631189|101077579|FG000|COMPLETED|Initial Phase||317||
48307124|NCT00631189|101077580|FG001|COMPLETED|Initial Phase||0||
48307125|NCT00631189|101077581|FG002|COMPLETED|Initial Phase||0||
48307126|NCT00631189|101077582|FG003|COMPLETED|Initial Phase||0||
48307127|NCT00631189|101077579|FG000|NOT COMPLETED|Initial Phase||351||
48307128|NCT00631189|101077580|FG001|NOT COMPLETED|Initial Phase||0||
48307129|NCT00631189|101077581|FG002|NOT COMPLETED|Initial Phase||0||
48307130|NCT00631189|101077582|FG003|NOT COMPLETED|Initial Phase||0||
48307131|NCT00631189|101077579|FG000|STARTED|Treatment Phase||0||
48307132|NCT00631189|101077580|FG001|STARTED|Treatment Phase||104||
48307133|NCT00631189|101077581|FG002|STARTED|Treatment Phase||103||
48307134|NCT00631189|101077582|FG003|STARTED|Treatment Phase||110||
48307135|NCT00631189|101077579|FG000|COMPLETED|Treatment Phase||0||
48307136|NCT00631189|101077580|FG001|COMPLETED|Treatment Phase||97||
48307137|NCT00631189|101077581|FG002|COMPLETED|Treatment Phase||92||
48307138|NCT00631189|101077582|FG003|COMPLETED|Treatment Phase||103||
48307139|NCT00631189|101077579|FG000|NOT COMPLETED|Treatment Phase||0||
48307140|NCT00631189|101077580|FG001|NOT COMPLETED|Treatment Phase||7||
48307141|NCT00631189|101077581|FG002|NOT COMPLETED|Treatment Phase||11||
48307142|NCT00631189|101077582|FG003|NOT COMPLETED|Treatment Phase||7||
48307143|NCT00890929|101077583|FG000|STARTED|Overall Study||45||
48307144|NCT00890929|101077583|FG000|Consented & Enrolled|Overall Study||45||
48307145|NCT00890929|101077583|FG000|Initiated Treatment|Overall Study||43||
48307146|NCT00890929|101077583|FG000|COMPLETED|Overall Study||39||
48307147|NCT00890929|101077583|FG000|NOT COMPLETED|Overall Study||6||
48307148|NCT00717054|101077584|FG000|STARTED|Overall Study||58||
48307149|NCT00717054|101077585|FG001|STARTED|Overall Study||57||
48307150|NCT00717054|101077584|FG000|COMPLETED|Overall Study||58||
48307151|NCT00717054|101077585|FG001|COMPLETED|Overall Study||57||
48307152|NCT00717054|101077584|FG000|NOT COMPLETED|Overall Study||0||
48307153|NCT00717054|101077585|FG001|NOT COMPLETED|Overall Study||0||
48307154|NCT01506960|101077586|FG000|STARTED|Overall Study||64||
48722206|NCT00109577|102105590|FG001|COMPLETED|Overall Study||17||
48722207|NCT00109577|102105589|FG000|NOT COMPLETED|Overall Study||3||
48722208|NCT00109577|102105590|FG001|NOT COMPLETED|Overall Study||3||
48722209|NCT02445573|102105591|FG000|STARTED|Overall Study||40||
48722210|NCT02445573|102105592|FG001|STARTED|Overall Study||40||
48722211|NCT02445573|102105591|FG000|COMPLETED|Overall Study||39||
48152169|NCT00765843|100695950|FG000|COMPLETED|Overall Study||25||
48152170|NCT00765843|100695951|FG001|COMPLETED|Overall Study||21||
48152171|NCT00765843|100695952|FG002|COMPLETED|Overall Study||23||
48152172|NCT00765843|100695950|FG000|NOT COMPLETED|Overall Study||1||
48152173|NCT00765843|100695951|FG001|NOT COMPLETED|Overall Study||4||
48722212|NCT02445573|102105592|FG001|COMPLETED|Overall Study||38||
48152174|NCT00765843|100695952|FG002|NOT COMPLETED|Overall Study||3||
48152175|NCT00762450|100695953|FG000|STARTED|1st Treatment Period||2||
48152176|NCT00762450|100695954|FG001|STARTED|1st Treatment Period||2||
48152177|NCT00762450|100695955|FG002|STARTED|1st Treatment Period||2||
48152178|NCT00762450|100695953|FG000|COMPLETED|1st Treatment Period||2||
48152179|NCT00762450|100695954|FG001|COMPLETED|1st Treatment Period||2||
48152180|NCT00762450|100695955|FG002|COMPLETED|1st Treatment Period||2||
48152181|NCT00762450|100695953|FG000|NOT COMPLETED|1st Treatment Period||0||
48152182|NCT00762450|100695954|FG001|NOT COMPLETED|1st Treatment Period||0||
48152183|NCT00762450|100695955|FG002|NOT COMPLETED|1st Treatment Period||0||
48152184|NCT00762450|100695953|FG000|STARTED|Washout After 1st Treatment Period||2||
48152185|NCT00762450|100695954|FG001|STARTED|Washout After 1st Treatment Period||2||
48152186|NCT00762450|100695955|FG002|STARTED|Washout After 1st Treatment Period||2||
48152187|NCT00762450|100695953|FG000|COMPLETED|Washout After 1st Treatment Period||2||
48152188|NCT00762450|100695954|FG001|COMPLETED|Washout After 1st Treatment Period||2||
48152189|NCT00762450|100695955|FG002|COMPLETED|Washout After 1st Treatment Period||2||
48152190|NCT00762450|100695953|FG000|NOT COMPLETED|Washout After 1st Treatment Period||0||
48152191|NCT00762450|100695954|FG001|NOT COMPLETED|Washout After 1st Treatment Period||0||
48152192|NCT00762450|100695955|FG002|NOT COMPLETED|Washout After 1st Treatment Period||0||
48152193|NCT00762450|100695953|FG000|STARTED|2nd Treatment Period||2||
48152194|NCT00762450|100695954|FG001|STARTED|2nd Treatment Period||2||
48152195|NCT00762450|100695955|FG002|STARTED|2nd Treatment Period||2||
48152196|NCT00762450|100695953|FG000|COMPLETED|2nd Treatment Period||2||
48152197|NCT00762450|100695954|FG001|COMPLETED|2nd Treatment Period||2||
48152198|NCT00762450|100695955|FG002|COMPLETED|2nd Treatment Period||2||
48152199|NCT00762450|100695953|FG000|NOT COMPLETED|2nd Treatment Period||0||
48152200|NCT00762450|100695954|FG001|NOT COMPLETED|2nd Treatment Period||0||
48152201|NCT00762450|100695955|FG002|NOT COMPLETED|2nd Treatment Period||0||
48152202|NCT00762450|100695953|FG000|STARTED|Washout After 2nd Treatment Period||2||
48152203|NCT00762450|100695954|FG001|STARTED|Washout After 2nd Treatment Period||2||
48152204|NCT00762450|100695955|FG002|STARTED|Washout After 2nd Treatment Period||2||
48152205|NCT00762450|100695953|FG000|COMPLETED|Washout After 2nd Treatment Period||2||
48152206|NCT00762450|100695954|FG001|COMPLETED|Washout After 2nd Treatment Period||2||
48152207|NCT00762450|100695955|FG002|COMPLETED|Washout After 2nd Treatment Period||2||
48152208|NCT00762450|100695953|FG000|NOT COMPLETED|Washout After 2nd Treatment Period||0||
48152209|NCT00762450|100695954|FG001|NOT COMPLETED|Washout After 2nd Treatment Period||0||
48152210|NCT00762450|100695955|FG002|NOT COMPLETED|Washout After 2nd Treatment Period||0||
48722213|NCT02445573|102105591|FG000|NOT COMPLETED|Overall Study||1||
48722214|NCT02445573|102105592|FG001|NOT COMPLETED|Overall Study||2||
48152211|NCT00762450|100695953|FG000|STARTED|3rd Treatment Period||2||
48152212|NCT00762450|100695954|FG001|STARTED|3rd Treatment Period||2||
48152213|NCT00762450|100695955|FG002|STARTED|3rd Treatment Period||2||
48152214|NCT00762450|100695953|FG000|COMPLETED|3rd Treatment Period||2||
48722215|NCT02905006|102105593|FG000|STARTED|Overall Study||42||
48722216|NCT02905006|102105594|FG001|STARTED|Overall Study||39||
48722217|NCT02905006|102105595|FG002|STARTED|Overall Study||43||
48722218|NCT02905006|102105596|FG003|STARTED|Overall Study||40||
48722219|NCT02905006|102105597|FG004|STARTED|Overall Study||43||
48722220|NCT02905006|102105598|FG005|STARTED|Overall Study||43||
48152215|NCT00762450|100695954|FG001|COMPLETED|3rd Treatment Period||2||
48152216|NCT00762450|100695955|FG002|COMPLETED|3rd Treatment Period||2||
48152217|NCT00762450|100695953|FG000|NOT COMPLETED|3rd Treatment Period||0||
48152218|NCT00762450|100695954|FG001|NOT COMPLETED|3rd Treatment Period||0||
48152219|NCT00762450|100695955|FG002|NOT COMPLETED|3rd Treatment Period||0||
48152220|NCT04475432|100695956|FG000|STARTED|Overall Study||212||
48152221|NCT04475432|100695957|FG001|STARTED|Overall Study||209||
48152222|NCT04475432|100695956|FG000|COMPLETED|Overall Study||208||
48152223|NCT04475432|100695957|FG001|COMPLETED|Overall Study||203||
48152224|NCT04475432|100695956|FG000|NOT COMPLETED|Overall Study||4||
48152225|NCT04475432|100695957|FG001|NOT COMPLETED|Overall Study||6||
48152226|NCT00542880|100695958|FG000|STARTED|Period 1||217||
48152227|NCT00542880|100695959|FG001|STARTED|Period 1||225||
48152228|NCT00542880|100695958|FG000|COMPLETED|Period 1||211||
48722221|NCT02905006|102105593|FG000|Completed Treatment Period|Overall Study||37||
48722222|NCT02905006|102105594|FG001|Completed Treatment Period|Overall Study||36||
48722223|NCT02905006|102105595|FG002|Completed Treatment Period|Overall Study||38||
48722224|NCT02905006|102105596|FG003|Completed Treatment Period|Overall Study||34||
48722225|NCT02905006|102105597|FG004|Completed Treatment Period|Overall Study||40||
48722226|NCT02905006|102105598|FG005|Completed Treatment Period|Overall Study||39||
48722227|NCT02905006|102105593|FG000|Enrolled in Extension Study (PS0011)|Overall Study||38||
48722228|NCT02905006|102105594|FG001|Enrolled in Extension Study (PS0011)|Overall Study||35||
48722229|NCT02905006|102105595|FG002|Enrolled in Extension Study (PS0011)|Overall Study||39||
48722230|NCT02905006|102105596|FG003|Enrolled in Extension Study (PS0011)|Overall Study||38||
48307155|NCT01506960|101077586|FG000|COMPLETED|Overall Study||17||
48307156|NCT01506960|101077586|FG000|NOT COMPLETED|Overall Study||47||
48307157|NCT00894686|101077587|FG000|STARTED|Overall Study||179||
48307158|NCT00894686|101077587|FG000|COMPLETED|Overall Study||123||
48307159|NCT00894686|101077587|FG000|NOT COMPLETED|Overall Study||56||
48307160|NCT02888665|101077588|FG000|STARTED|Overall Study||3||
48307161|NCT02888665|101077589|FG001|STARTED|Overall Study||3||
48307162|NCT02888665|101077590|FG002|STARTED|Overall Study||31||
48307163|NCT02888665|101077588|FG000|COMPLETED|Overall Study||3||
48307164|NCT02888665|101077589|FG001|COMPLETED|Overall Study||3||
48307165|NCT02888665|101077590|FG002|COMPLETED|Overall Study||31||
48307166|NCT02888665|101077588|FG000|NOT COMPLETED|Overall Study||0||
48307167|NCT02888665|101077589|FG001|NOT COMPLETED|Overall Study||0||
48307168|NCT02888665|101077590|FG002|NOT COMPLETED|Overall Study||0||
48307169|NCT00232583|101077591|FG000|STARTED|Overall Study||29||
48307170|NCT00232583|101077592|FG001|STARTED|Overall Study||29||
48307171|NCT00232583|101077591|FG000|COMPLETED|Overall Study||19||
48307172|NCT00232583|101077592|FG001|COMPLETED|Overall Study||16||
48307173|NCT00232583|101077591|FG000|NOT COMPLETED|Overall Study||10||
48307174|NCT00232583|101077592|FG001|NOT COMPLETED|Overall Study||13||
48307175|NCT00419120|101077593|FG000|STARTED|Primary Study Period||10||
48307176|NCT00419120|101077593|FG000|COMPLETED|Primary Study Period||10||
48307177|NCT00419120|101077593|FG000|NOT COMPLETED|Primary Study Period||0||
48307178|NCT00419120|101077593|FG000|STARTED|Long Term Follow up Period||10||
48307179|NCT00419120|101077593|FG000|COMPLETED|Long Term Follow up Period||0||
48307180|NCT00419120|101077593|FG000|NOT COMPLETED|Long Term Follow up Period||10||
48307181|NCT02308007|101077594|FG000|STARTED|Overall Study||159||
48307182|NCT02308007|101077595|FG001|STARTED|Overall Study||159||
48307183|NCT02308007|101077596|FG002|STARTED|Overall Study||157||
48307184|NCT02308007|101077594|FG000|COMPLETED|Overall Study||83||
48307185|NCT02308007|101077595|FG001|COMPLETED|Overall Study||84||
48307186|NCT02308007|101077596|FG002|COMPLETED|Overall Study||82||
48608914|NCT02634801|101827211|FG000|COMPLETED|Treatment Period (Weeks 0 to 24)||50||
48608915|NCT02634801|101827212|FG001|COMPLETED|Treatment Period (Weeks 0 to 24)||23||
48608916|NCT02634801|101827213|FG002|COMPLETED|Treatment Period (Weeks 0 to 24)||49||
48608917|NCT02634801|101827211|FG000|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||4||
48608918|NCT02634801|101827212|FG001|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||31||
48608919|NCT02634801|101827213|FG002|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||5||
48608920|NCT02634801|101827211|FG000|STARTED|Extension Period (Weeks 24 to 36)||48||
48608921|NCT02634801|101827212|FG001|STARTED|Extension Period (Weeks 24 to 36)||19||
48608922|NCT02634801|101827213|FG002|STARTED|Extension Period (Weeks 24 to 36)||31||
48608923|NCT02634801|101827211|FG000|COMPLETED|Extension Period (Weeks 24 to 36)||45||
48608924|NCT02634801|101827212|FG001|COMPLETED|Extension Period (Weeks 24 to 36)||18||
48608925|NCT02634801|101827213|FG002|COMPLETED|Extension Period (Weeks 24 to 36)||29||
48608926|NCT02634801|101827211|FG000|NOT COMPLETED|Extension Period (Weeks 24 to 36)||3||
48608927|NCT02634801|101827212|FG001|NOT COMPLETED|Extension Period (Weeks 24 to 36)||1||
48608928|NCT02634801|101827213|FG002|NOT COMPLETED|Extension Period (Weeks 24 to 36)||2||
48722231|NCT02905006|102105597|FG004|Enrolled in Extension Study (PS0011)|Overall Study||42||
48307187|NCT02308007|101077594|FG000|NOT COMPLETED|Overall Study||76||
48307188|NCT02308007|101077595|FG001|NOT COMPLETED|Overall Study||75||
48307189|NCT02308007|101077596|FG002|NOT COMPLETED|Overall Study||75||
48307190|NCT00369785|101077597|FG000|STARTED|Overall Study||99||
48307191|NCT00369785|101077598|FG001|STARTED|Overall Study||99||
48307192|NCT00369785|101077597|FG000|COMPLETED|Overall Study||72||
48307193|NCT00369785|101077598|FG001|COMPLETED|Overall Study||74||
48608929|NCT02634801|101827211|FG000|STARTED|Follow-up Period||41||
48608930|NCT02634801|101827212|FG001|STARTED|Follow-up Period||26||
48608931|NCT02634801|101827213|FG002|STARTED|Follow-up Period||46||
48608932|NCT02634801|101827211|FG000|COMPLETED|Follow-up Period||36||
48722232|NCT02905006|102105598|FG005|Enrolled in Extension Study (PS0011)|Overall Study||40||
48722233|NCT02905006|102105593|FG000|Entered Safety Follow-up Period|Overall Study||4||
48722234|NCT02905006|102105594|FG001|Entered Safety Follow-up Period|Overall Study||4||
48722235|NCT02905006|102105595|FG002|Entered Safety Follow-up Period|Overall Study||4||
48307194|NCT00369785|101077597|FG000|NOT COMPLETED|Overall Study||27||
48307195|NCT00369785|101077598|FG001|NOT COMPLETED|Overall Study||25||
48307196|NCT03684642|101077599|FG000|STARTED|Overall Study||303||
48307197|NCT03684642|101077600|FG001|STARTED|Overall Study||302||
48307198|NCT03684642|101077601|FG002|STARTED|Overall Study||303||
48307199|NCT03684642|101077599|FG000|Treated|Overall Study||303||
48307200|NCT03684642|101077600|FG001|Treated|Overall Study||302||
48307201|NCT03684642|101077601|FG002|Treated|Overall Study||302||
48368030|NCT03567291|101230095|FG003|STARTED|Period II||0||
48368031|NCT03567291|101230092|FG000|COMPLETED|Period II||0||
48608933|NCT02634801|101827212|FG001|COMPLETED|Follow-up Period||18||
48608934|NCT02634801|101827213|FG002|COMPLETED|Follow-up Period||38||
48608935|NCT02634801|101827211|FG000|NOT COMPLETED|Follow-up Period||5||
48608936|NCT02634801|101827212|FG001|NOT COMPLETED|Follow-up Period||8||
48608937|NCT02634801|101827213|FG002|NOT COMPLETED|Follow-up Period||8||
48608938|NCT01829997|101827214|FG000|STARTED|Overall Study||22||
48608939|NCT01829997|101827214|FG000|COMPLETED|Overall Study||16||
48608940|NCT01829997|101827214|FG000|NOT COMPLETED|Overall Study||6||
48608941|NCT00103662|101827215|FG000|STARTED|Overall Study||148||
48608942|NCT00103662|101827216|FG001|STARTED|Overall Study||154||
48608943|NCT00103662|101827215|FG000|COMPLETED|Overall Study||129||
48608944|NCT00103662|101827216|FG001|COMPLETED|Overall Study||121||
48608945|NCT00103662|101827215|FG000|NOT COMPLETED|Overall Study||19||
48307202|NCT03684642|101077599|FG000|Safety Population|Overall Study||313|Participants who received at least 1 dose or part of a dose of the Investigational Medicinal Product (IMP), analyzed according to the treatment actually received.|
48307203|NCT03684642|101077600|FG001|Safety Population|Overall Study||292|Participants who received at least 1 dose or part of a dose of the Investigational Medicinal Product (IMP), analyzed according to the treatment actually received.|
48307204|NCT03684642|101077601|FG002|Safety Population|Overall Study||302|Participants who received at least 1 dose or part of a dose of the Investigational Medicinal Product (IMP), analyzed according to the treatment actually received.|
48307205|NCT03684642|101077599|FG000|COMPLETED|Overall Study||200||
48307206|NCT03684642|101077600|FG001|COMPLETED|Overall Study||169||
48307207|NCT03684642|101077601|FG002|COMPLETED|Overall Study||197||
48307208|NCT03684642|101077599|FG000|NOT COMPLETED|Overall Study||103||
48307209|NCT03684642|101077600|FG001|NOT COMPLETED|Overall Study||133||
48307210|NCT03684642|101077601|FG002|NOT COMPLETED|Overall Study||106||
48307211|NCT01383096|101077602|FG000|STARTED|First Intervention (8 Days)||19||
48307212|NCT01383096|101077603|FG001|STARTED|First Intervention (8 Days)||17||
48307213|NCT01383096|101077604|FG002|STARTED|First Intervention (8 Days)||16||
48307214|NCT01383096|101077602|FG000|COMPLETED|First Intervention (8 Days)||19||
48307215|NCT01383096|101077603|FG001|COMPLETED|First Intervention (8 Days)||17||
48307216|NCT01383096|101077604|FG002|COMPLETED|First Intervention (8 Days)||16||
48307217|NCT01383096|101077602|FG000|NOT COMPLETED|First Intervention (8 Days)||0||
48307218|NCT01383096|101077603|FG001|NOT COMPLETED|First Intervention (8 Days)||0||
48307219|NCT01383096|101077604|FG002|NOT COMPLETED|First Intervention (8 Days)||0||
48307220|NCT01383096|101077602|FG000|STARTED|Second Intervention (8 Days)||19||
48307221|NCT01383096|101077603|FG001|STARTED|Second Intervention (8 Days)||17||
48307222|NCT01383096|101077604|FG002|STARTED|Second Intervention (8 Days)||16||
48307223|NCT01383096|101077602|FG000|COMPLETED|Second Intervention (8 Days)||19||
48307224|NCT01383096|101077603|FG001|COMPLETED|Second Intervention (8 Days)||16||
48307225|NCT01383096|101077604|FG002|COMPLETED|Second Intervention (8 Days)||14||
48307226|NCT01383096|101077602|FG000|NOT COMPLETED|Second Intervention (8 Days)||0||
48307227|NCT01383096|101077603|FG001|NOT COMPLETED|Second Intervention (8 Days)||1||
48307228|NCT01383096|101077604|FG002|NOT COMPLETED|Second Intervention (8 Days)||2||
48307229|NCT01383096|101077602|FG000|STARTED|Third Intervention (8 Days)||19||
48307230|NCT01383096|101077603|FG001|STARTED|Third Intervention (8 Days)||16||
48307231|NCT01383096|101077604|FG002|STARTED|Third Intervention (8 Days)||0||
48307232|NCT01383096|101077602|FG000|COMPLETED|Third Intervention (8 Days)||15||
48307233|NCT01383096|101077603|FG001|COMPLETED|Third Intervention (8 Days)||12||
48307234|NCT01383096|101077604|FG002|COMPLETED|Third Intervention (8 Days)||0||
48307235|NCT01383096|101077602|FG000|NOT COMPLETED|Third Intervention (8 Days)||4||
48307236|NCT01383096|101077603|FG001|NOT COMPLETED|Third Intervention (8 Days)||4||
48307237|NCT01383096|101077604|FG002|NOT COMPLETED|Third Intervention (8 Days)||0||
48307238|NCT01383096|101077602|FG000|STARTED|Fourth Intervention (8 Days)||15||
48307239|NCT01383096|101077603|FG001|STARTED|Fourth Intervention (8 Days)||12||
48307240|NCT01383096|101077604|FG002|STARTED|Fourth Intervention (8 Days)||0||
48307241|NCT01383096|101077602|FG000|COMPLETED|Fourth Intervention (8 Days)||13||
48307242|NCT01383096|101077603|FG001|COMPLETED|Fourth Intervention (8 Days)||12||
48307243|NCT01383096|101077604|FG002|COMPLETED|Fourth Intervention (8 Days)||0||
48307244|NCT01383096|101077602|FG000|NOT COMPLETED|Fourth Intervention (8 Days)||2||
48307245|NCT01383096|101077603|FG001|NOT COMPLETED|Fourth Intervention (8 Days)||0||
48307246|NCT01383096|101077604|FG002|NOT COMPLETED|Fourth Intervention (8 Days)||0||
48307247|NCT01383096|101077602|FG000|STARTED|Fifth Intervention (8 Days)||13||
48307248|NCT01383096|101077603|FG001|STARTED|Fifth Intervention (8 Days)||0||
48307249|NCT01383096|101077604|FG002|STARTED|Fifth Intervention (8 Days)||0||
48307250|NCT01383096|101077602|FG000|COMPLETED|Fifth Intervention (8 Days)||11||
48307251|NCT01383096|101077603|FG001|COMPLETED|Fifth Intervention (8 Days)||0||
48307252|NCT01383096|101077604|FG002|COMPLETED|Fifth Intervention (8 Days)||0||
48307253|NCT01383096|101077602|FG000|NOT COMPLETED|Fifth Intervention (8 Days)||2||
48307254|NCT01383096|101077603|FG001|NOT COMPLETED|Fifth Intervention (8 Days)||0||
48307255|NCT01383096|101077604|FG002|NOT COMPLETED|Fifth Intervention (8 Days)||0||
48307256|NCT04695392|101077605|FG000|STARTED|Overall Study||20||
48307257|NCT04695392|101077606|FG001|STARTED|Overall Study||36||
48307258|NCT04695392|101077605|FG000|COMPLETED|Overall Study||20||
48307259|NCT04695392|101077606|FG001|COMPLETED|Overall Study||34||
48307260|NCT04695392|101077605|FG000|NOT COMPLETED|Overall Study||0||
48307261|NCT04695392|101077606|FG001|NOT COMPLETED|Overall Study||2||
48307262|NCT03308942|101077607|FG000|STARTED|Stage 1 (Up to a Maximum of 45 Months)||17||
48307263|NCT03308942|101077608|FG001|STARTED|Stage 1 (Up to a Maximum of 45 Months)||21||
48307264|NCT03308942|101077609|FG002|STARTED|Stage 1 (Up to a Maximum of 45 Months)||3||
48307265|NCT03308942|101077610|FG003|STARTED|Stage 1 (Up to a Maximum of 45 Months)||0||
48307266|NCT03308942|101077611|FG004|STARTED|Stage 1 (Up to a Maximum of 45 Months)||0||
48307267|NCT03308942|101077607|FG000|COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||0||
48307268|NCT03308942|101077608|FG001|COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||0||
48307269|NCT03308942|101077609|FG002|COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||0||
48307270|NCT03308942|101077610|FG003|COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||0||
48307271|NCT03308942|101077611|FG004|COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||0||
48307272|NCT03308942|101077607|FG000|NOT COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||17||
48307273|NCT03308942|101077608|FG001|NOT COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||21||
48307274|NCT03308942|101077609|FG002|NOT COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||3||
48307275|NCT03308942|101077610|FG003|NOT COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||0||
48307276|NCT03308942|101077611|FG004|NOT COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||0||
48307277|NCT03308942|101077607|FG000|STARTED|Stage 2 (Up to a Maximum of 29 Months)||0||
48307278|NCT03308942|101077608|FG001|STARTED|Stage 2 (Up to a Maximum of 29 Months)||0||
48307279|NCT03308942|101077609|FG002|STARTED|Stage 2 (Up to a Maximum of 29 Months)||0||
48307280|NCT03308942|101077610|FG003|STARTED|Stage 2 (Up to a Maximum of 29 Months)||12||
48307281|NCT03308942|101077611|FG004|STARTED|Stage 2 (Up to a Maximum of 29 Months)||0||
48307282|NCT03308942|101077607|FG000|COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0||
48307283|NCT03308942|101077608|FG001|COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0||
48307284|NCT03308942|101077609|FG002|COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0||
48307285|NCT03308942|101077610|FG003|COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0||
48307286|NCT03308942|101077611|FG004|COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0||
48307287|NCT03308942|101077607|FG000|NOT COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0||
48307288|NCT03308942|101077608|FG001|NOT COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0||
48307289|NCT03308942|101077609|FG002|NOT COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0||
48307290|NCT03308942|101077610|FG003|NOT COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||12||
48608946|NCT00103662|101827216|FG001|NOT COMPLETED|Overall Study||33||
48608947|NCT04508647|101827217|FG000|STARTED|Cycle 1: Baseline to 8 Weeks||4||
48608948|NCT04508647|101827218|FG001|STARTED|Cycle 1: Baseline to 8 Weeks||0||
48608949|NCT04508647|101827217|FG000|COMPLETED|Cycle 1: Baseline to 8 Weeks||4||
48608950|NCT04508647|101827218|FG001|COMPLETED|Cycle 1: Baseline to 8 Weeks||0||
48608951|NCT04508647|101827217|FG000|NOT COMPLETED|Cycle 1: Baseline to 8 Weeks||0||
48307291|NCT03308942|101077611|FG004|NOT COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0||
48608952|NCT04508647|101827218|FG001|NOT COMPLETED|Cycle 1: Baseline to 8 Weeks||0||
48608953|NCT04508647|101827217|FG000|STARTED|Cycle 2: 8 Weeks to 12 Months||2||
48608954|NCT04508647|101827218|FG001|STARTED|Cycle 2: 8 Weeks to 12 Months||2||
48608955|NCT04508647|101827217|FG000|COMPLETED|Cycle 2: 8 Weeks to 12 Months||2||
48307292|NCT03627767|101077612|FG000|STARTED|Open-label (OL) Run-in Period (12 Weeks)||1235||
48307293|NCT03627767|101077613|FG001|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0||
48307294|NCT03627767|101077614|FG002|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0||
48307295|NCT03627767|101077615|FG003|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0||
48307296|NCT03627767|101077616|FG004|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0||
48307297|NCT03627767|101077612|FG000|Treated|Open-label (OL) Run-in Period (12 Weeks)||1233||
48307298|NCT03627767|101077613|FG001|Treated|Open-label (OL) Run-in Period (12 Weeks)||0||
48307299|NCT03627767|101077614|FG002|Treated|Open-label (OL) Run-in Period (12 Weeks)||0||
48307300|NCT03627767|101077615|FG003|Treated|Open-label (OL) Run-in Period (12 Weeks)||0||
48406318|NCT00981292|101328395|FG001|STARTED|Day 3||4||
48406319|NCT00981292|101328396|FG002|STARTED|Day 3||6||
48608956|NCT04508647|101827218|FG001|COMPLETED|Cycle 2: 8 Weeks to 12 Months||2||
48608957|NCT04508647|101827217|FG000|NOT COMPLETED|Cycle 2: 8 Weeks to 12 Months||0||
48608958|NCT04508647|101827218|FG001|NOT COMPLETED|Cycle 2: 8 Weeks to 12 Months||0||
48608959|NCT01963091|101827219|FG000|STARTED|Overall Study||17||
48608960|NCT01963091|101827220|FG001|STARTED|Overall Study||16||
48152229|NCT00542880|100695959|FG001|COMPLETED|Period 1||213||
48307301|NCT03627767|101077616|FG004|Treated|Open-label (OL) Run-in Period (12 Weeks)||0||
48307302|NCT03627767|101077612|FG000|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||798||
48307303|NCT03627767|101077613|FG001|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0||
48307304|NCT03627767|101077614|FG002|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0||
48307305|NCT03627767|101077615|FG003|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0||
48608961|NCT01963091|101827219|FG000|COMPLETED|Overall Study||17||
48608962|NCT01963091|101827220|FG001|COMPLETED|Overall Study||16||
48608963|NCT01963091|101827219|FG000|NOT COMPLETED|Overall Study||0||
48608964|NCT01963091|101827220|FG001|NOT COMPLETED|Overall Study||0||
48608965|NCT02781818|101827221|FG000|STARTED|Overall Study||20||24
48608966|NCT02781818|101827222|FG001|STARTED|Overall Study||18||22
48608967|NCT02781818|101827223|FG002|STARTED|Overall Study||17||21
48608968|NCT02781818|101827221|FG000|COMPLETED|Overall Study||16||18
48608969|NCT02781818|101827222|FG001|COMPLETED|Overall Study||16||20
48608970|NCT02781818|101827223|FG002|COMPLETED|Overall Study||16||20
48608971|NCT02781818|101827221|FG000|NOT COMPLETED|Overall Study||4||6
48608972|NCT02781818|101827222|FG001|NOT COMPLETED|Overall Study||2||2
48608973|NCT02781818|101827223|FG002|NOT COMPLETED|Overall Study||1||1
48608974|NCT02370056|101827224|FG000|STARTED|Overall Study||27||
48608975|NCT02370056|101827225|FG001|STARTED|Overall Study||26||
48608976|NCT02370056|101827224|FG000|COMPLETED|Overall Study||27||
48608977|NCT02370056|101827225|FG001|COMPLETED|Overall Study||26||
48608978|NCT02370056|101827224|FG000|NOT COMPLETED|Overall Study||0||
48608979|NCT02370056|101827225|FG001|NOT COMPLETED|Overall Study||0||
48608980|NCT04676724|101827226|FG000|STARTED|Overall Study||55||
48608981|NCT04676724|101827227|FG001|STARTED|Overall Study||53||
48608982|NCT04676724|101827226|FG000|COMPLETED|Overall Study||49||
48608983|NCT04676724|101827227|FG001|COMPLETED|Overall Study||50||
48608984|NCT04676724|101827226|FG000|NOT COMPLETED|Overall Study||6||
48608985|NCT04676724|101827227|FG001|NOT COMPLETED|Overall Study||3||
48608986|NCT00497055|101827228|FG000|STARTED|Overall Study||45||
48608987|NCT00497055|101827229|FG001|STARTED|Overall Study||45||
48608988|NCT00497055|101827228|FG000|COMPLETED|Overall Study||35||
48608989|NCT00497055|101827229|FG001|COMPLETED|Overall Study||40||
48608990|NCT00497055|101827228|FG000|NOT COMPLETED|Overall Study||10||
48608991|NCT00497055|101827229|FG001|NOT COMPLETED|Overall Study||5||
48608992|NCT05886907|101827230|FG000|STARTED|First Wear Period (Approx. 2 Days)||5||
48608993|NCT05886907|101827231|FG001|STARTED|First Wear Period (Approx. 2 Days)||4||
48608994|NCT05886907|101827230|FG000|COMPLETED|First Wear Period (Approx. 2 Days)||5||
48608995|NCT05886907|101827231|FG001|COMPLETED|First Wear Period (Approx. 2 Days)||4||
48608996|NCT05886907|101827230|FG000|NOT COMPLETED|First Wear Period (Approx. 2 Days)||0||
48608997|NCT05886907|101827231|FG001|NOT COMPLETED|First Wear Period (Approx. 2 Days)||0||
48608998|NCT05886907|101827230|FG000|STARTED|Second Wear Period (Approx. 2 Days)||5||
48608999|NCT05886907|101827231|FG001|STARTED|Second Wear Period (Approx. 2 Days)||4||
48609000|NCT05886907|101827230|FG000|COMPLETED|Second Wear Period (Approx. 2 Days)||5||
48307306|NCT03627767|101077616|FG004|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0||
48307307|NCT03627767|101077612|FG000|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||437||
48307308|NCT03627767|101077613|FG001|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0||
48307309|NCT03627767|101077614|FG002|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0||
48307310|NCT03627767|101077615|FG003|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0||
48307311|NCT03627767|101077616|FG004|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0||
48609001|NCT05886907|101827231|FG001|COMPLETED|Second Wear Period (Approx. 2 Days)||4||
48609002|NCT05886907|101827230|FG000|NOT COMPLETED|Second Wear Period (Approx. 2 Days)||0||
48609003|NCT05886907|101827231|FG001|NOT COMPLETED|Second Wear Period (Approx. 2 Days)||0||
48609004|NCT01121263|101827232|FG000|STARTED|Overall Study||200||
48609005|NCT01121263|101827233|FG001|STARTED|Overall Study||98||
48609006|NCT01121263|101827232|FG000|COMPLETED|Overall Study||175||
48609007|NCT01121263|101827233|FG001|COMPLETED|Overall Study||83||
48609008|NCT01121263|101827232|FG000|NOT COMPLETED|Overall Study||25||
48609009|NCT01121263|101827233|FG001|NOT COMPLETED|Overall Study||15||
48609010|NCT01784926|101827234|FG000|STARTED|Overall Study||54||
48609011|NCT01784926|101827235|FG001|STARTED|Overall Study||50||
48609012|NCT01784926|101827234|FG000|COMPLETED|Overall Study||43||
48609013|NCT01784926|101827235|FG001|COMPLETED|Overall Study||42||
48609014|NCT01784926|101827234|FG000|NOT COMPLETED|Overall Study||11||
48609015|NCT01784926|101827235|FG001|NOT COMPLETED|Overall Study||8||
48609016|NCT01466075|101827236|FG000|STARTED|Overall Study||207||
48609017|NCT01466075|101827236|FG000|COMPLETED|Overall Study||207||
48767596|NCT00914316|102222776|FG000|COMPLETED|Phase 1||2||
48307312|NCT03627767|101077612|FG000|STARTED|Double-blind Treatment Period (40 Weeks)||0||
48609018|NCT01466075|101827236|FG000|NOT COMPLETED|Overall Study||0||
48609019|NCT05114564|101827237|FG000|STARTED|First Intervention||34||
48609020|NCT05114564|101827238|FG001|STARTED|First Intervention||32||
48609021|NCT05114564|101827237|FG000|COMPLETED|First Intervention||33||
48609022|NCT05114564|101827238|FG001|COMPLETED|First Intervention||31||
48609023|NCT05114564|101827237|FG000|NOT COMPLETED|First Intervention||1||
48609024|NCT05114564|101827238|FG001|NOT COMPLETED|First Intervention||1||
48609025|NCT05114564|101827237|FG000|STARTED|Second Intervention||33||
48609026|NCT05114564|101827238|FG001|STARTED|Second Intervention||31||
48722236|NCT02905006|102105596|FG003|Entered Safety Follow-up Period|Overall Study||2||
48722237|NCT02905006|102105597|FG004|Entered Safety Follow-up Period|Overall Study||1||
48722238|NCT02905006|102105598|FG005|Entered Safety Follow-up Period|Overall Study||3||
48722239|NCT02905006|102105593|FG000|COMPLETED|Overall Study||37||
48722240|NCT02905006|102105594|FG001|COMPLETED|Overall Study||36||
48722241|NCT02905006|102105595|FG002|COMPLETED|Overall Study||38||
48722242|NCT02905006|102105596|FG003|COMPLETED|Overall Study||34||
48722243|NCT02905006|102105597|FG004|COMPLETED|Overall Study||40||
48307313|NCT03627767|101077613|FG001|STARTED|Double-blind Treatment Period (40 Weeks)||267||
48307314|NCT03627767|101077614|FG002|STARTED|Double-blind Treatment Period (40 Weeks)||265||
48307315|NCT03627767|101077615|FG003|STARTED|Double-blind Treatment Period (40 Weeks)||266||
48307316|NCT03627767|101077616|FG004|STARTED|Double-blind Treatment Period (40 Weeks)||0||
48307317|NCT03627767|101077612|FG000|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||0||
48307318|NCT03627767|101077613|FG001|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||208||
48307319|NCT03627767|101077614|FG002|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||109||
48307320|NCT03627767|101077615|FG003|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||44||
48307321|NCT03627767|101077616|FG004|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||0||
48307322|NCT03627767|101077612|FG000|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0||
48307323|NCT03627767|101077613|FG001|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||201||
48609027|NCT05114564|101827237|FG000|COMPLETED|Second Intervention||33||
48609028|NCT05114564|101827238|FG001|COMPLETED|Second Intervention||31||
48609029|NCT05114564|101827237|FG000|NOT COMPLETED|Second Intervention||0||
48609030|NCT05114564|101827238|FG001|NOT COMPLETED|Second Intervention||0||
48609031|NCT01238341|101827239|FG000|STARTED|Overall Study||7||
48609032|NCT01238341|101827239|FG000|COMPLETED|Overall Study||7||
48609033|NCT01238341|101827239|FG000|NOT COMPLETED|Overall Study||0||
48609034|NCT02784288|101827240|FG000|STARTED|Overall Study||34||
48406320|NCT00981292|101328397|FG003|STARTED|Day 3||4||
48406321|NCT00981292|101328398|FG004|STARTED|Day 3||4||
48406322|NCT00981292|101328399|FG005|STARTED|Day 3||5||
48406323|NCT00981292|101328394|FG000|COMPLETED|Day 3||4||
48406324|NCT00981292|101328395|FG001|COMPLETED|Day 3||4||
48406325|NCT00981292|101328396|FG002|COMPLETED|Day 3||6||
48406326|NCT00981292|101328397|FG003|COMPLETED|Day 3||4||
48406327|NCT00981292|101328398|FG004|COMPLETED|Day 3||4||
48406328|NCT00981292|101328399|FG005|COMPLETED|Day 3||4||
48406329|NCT00981292|101328394|FG000|NOT COMPLETED|Day 3||0||
48406330|NCT00981292|101328395|FG001|NOT COMPLETED|Day 3||0||
48406331|NCT00981292|101328396|FG002|NOT COMPLETED|Day 3||0||
48406332|NCT00981292|101328397|FG003|NOT COMPLETED|Day 3||0||
48406333|NCT00981292|101328398|FG004|NOT COMPLETED|Day 3||0||
48406334|NCT00981292|101328399|FG005|NOT COMPLETED|Day 3||1||
48406335|NCT01462045|101328400|FG000|STARTED|Overall Study||11||
48406336|NCT01462045|101328401|FG001|STARTED|Overall Study||11||
48406337|NCT01462045|101328402|FG002|STARTED|Overall Study||7||
48406338|NCT01462045|101328400|FG000|COMPLETED|Overall Study||11||
48406339|NCT01462045|101328401|FG001|COMPLETED|Overall Study||10||
48609035|NCT02784288|101827240|FG000|COMPLETED|Overall Study||33||
48609036|NCT02784288|101827240|FG000|NOT COMPLETED|Overall Study||1||
48609037|NCT02683239|101827241|FG000|STARTED|Overall Study||1260||
48609038|NCT02683239|101827242|FG001|STARTED|Overall Study||971||
48609039|NCT02683239|101827243|FG002|STARTED|Overall Study||975||
48609040|NCT02683239|101827244|FG003|STARTED|Overall Study||214||
48609041|NCT02683239|101827245|FG004|STARTED|Overall Study||1680||
48609042|NCT02683239|101827246|FG005|STARTED|Overall Study||116||
48609043|NCT02683239|101827247|FG006|STARTED|Overall Study||115||
48609044|NCT02683239|101827241|FG000|COMPLETED|Overall Study||800||
48722244|NCT02905006|102105598|FG005|COMPLETED|Overall Study||39||
48722245|NCT02905006|102105593|FG000|NOT COMPLETED|Overall Study||5||
48722246|NCT02905006|102105594|FG001|NOT COMPLETED|Overall Study||3||
48722247|NCT02905006|102105595|FG002|NOT COMPLETED|Overall Study||5||
48722248|NCT02905006|102105596|FG003|NOT COMPLETED|Overall Study||6||
48722249|NCT02905006|102105597|FG004|NOT COMPLETED|Overall Study||3||
48722250|NCT02905006|102105598|FG005|NOT COMPLETED|Overall Study||4||
48722251|NCT00521222|102105599|FG000|STARTED|Overall Study||15||
48722252|NCT00521222|102105600|FG001|STARTED|Overall Study||18||
48722253|NCT00521222|102105601|FG002|STARTED|Overall Study||16||
48722254|NCT00521222|102105602|FG003|STARTED|Overall Study||18||
48722255|NCT00521222|102105599|FG000|COMPLETED|Overall Study||15||
48722256|NCT00521222|102105600|FG001|COMPLETED|Overall Study||17||
48609045|NCT02683239|101827242|FG001|COMPLETED|Overall Study||738||
48609046|NCT02683239|101827243|FG002|COMPLETED|Overall Study||756||
48609047|NCT02683239|101827244|FG003|COMPLETED|Overall Study||94||
48609048|NCT02683239|101827245|FG004|COMPLETED|Overall Study||935||
48609049|NCT02683239|101827246|FG005|COMPLETED|Overall Study||56||
48609050|NCT02683239|101827247|FG006|COMPLETED|Overall Study||44||
48609051|NCT02683239|101827241|FG000|NOT COMPLETED|Overall Study||460||
48722257|NCT00521222|102105601|FG002|COMPLETED|Overall Study||13||
48722258|NCT00521222|102105602|FG003|COMPLETED|Overall Study||16||
48722259|NCT00521222|102105599|FG000|NOT COMPLETED|Overall Study||0||
48722260|NCT00521222|102105600|FG001|NOT COMPLETED|Overall Study||1||
48722261|NCT00521222|102105601|FG002|NOT COMPLETED|Overall Study||3||
48722262|NCT00521222|102105602|FG003|NOT COMPLETED|Overall Study||2||
48722263|NCT02208349|102105603|FG000|STARTED|Initial 6 Months||16||3
48722264|NCT02208349|102105604|FG001|STARTED|Initial 6 Months||9||3
48722265|NCT02208349|102105603|FG000|COMPLETED|Initial 6 Months||16||3
48722266|NCT02208349|102105604|FG001|COMPLETED|Initial 6 Months||9||3
48722267|NCT02208349|102105603|FG000|NOT COMPLETED|Initial 6 Months||0||0
48722268|NCT02208349|102105604|FG001|NOT COMPLETED|Initial 6 Months||0||0
48722269|NCT02208349|102105603|FG000|STARTED|Second 6 Months||11||3
48722270|NCT02208349|102105604|FG001|STARTED|Second 6 Months||7||3
48722271|NCT02208349|102105603|FG000|COMPLETED|Second 6 Months||11||3
48722272|NCT02208349|102105604|FG001|COMPLETED|Second 6 Months||7||3
48722273|NCT02208349|102105603|FG000|NOT COMPLETED|Second 6 Months||0||0
48609052|NCT02683239|101827242|FG001|NOT COMPLETED|Overall Study||233||
48609053|NCT02683239|101827243|FG002|NOT COMPLETED|Overall Study||219||
48609054|NCT02683239|101827244|FG003|NOT COMPLETED|Overall Study||120||
48609055|NCT02683239|101827245|FG004|NOT COMPLETED|Overall Study||745||
48609056|NCT02683239|101827246|FG005|NOT COMPLETED|Overall Study||60||
48609057|NCT02683239|101827247|FG006|NOT COMPLETED|Overall Study||71||
48609058|NCT00368459|101827248|FG000|STARTED|Overall Study||21||
48609059|NCT00368459|101827249|FG001|STARTED|Overall Study||21||
48609060|NCT00368459|101827248|FG000|COMPLETED|Overall Study||19||
48609061|NCT00368459|101827249|FG001|COMPLETED|Overall Study||20||
48609062|NCT00368459|101827248|FG000|NOT COMPLETED|Overall Study||2||
48609063|NCT00368459|101827249|FG001|NOT COMPLETED|Overall Study||1||
48609064|NCT00385827|101827250|FG000|STARTED|Part 1||9||
48609065|NCT00385827|101827251|FG001|STARTED|Part 1||0||
48609066|NCT00385827|101827252|FG002|STARTED|Part 1||0||
48609067|NCT00385827|101827250|FG000|Treated|Part 1||9||
48609068|NCT00385827|101827251|FG001|Treated|Part 1||0||
48609069|NCT00385827|101827252|FG002|Treated|Part 1||0||
48609070|NCT00385827|101827250|FG000|COMPLETED|Part 1||0||
48609071|NCT00385827|101827251|FG001|COMPLETED|Part 1||0||
48609072|NCT00385827|101827252|FG002|COMPLETED|Part 1||0||
48609073|NCT00385827|101827250|FG000|NOT COMPLETED|Part 1||9||
48609074|NCT00385827|101827251|FG001|NOT COMPLETED|Part 1||0||
48722274|NCT02208349|102105604|FG001|NOT COMPLETED|Second 6 Months||0||0
48609075|NCT00385827|101827252|FG002|NOT COMPLETED|Part 1||0||
48609076|NCT00385827|101827250|FG000|STARTED|Part 2||0||
48609077|NCT00385827|101827251|FG001|STARTED|Part 2||49||
48609078|NCT00385827|101827252|FG002|STARTED|Part 2||48||
48609079|NCT00385827|101827250|FG000|Treated|Part 2||0||
48609080|NCT00385827|101827251|FG001|Treated|Part 2||47||
48609081|NCT00385827|101827252|FG002|Treated|Part 2||46||
48609082|NCT00385827|101827250|FG000|COMPLETED|Part 2||0||
48609083|NCT00385827|101827251|FG001|COMPLETED|Part 2||16||
48609084|NCT00385827|101827252|FG002|COMPLETED|Part 2||0||
48722275|NCT02208349|102105603|FG000|STARTED|Third 6 Month||6||3
48722276|NCT02208349|102105604|FG001|STARTED|Third 6 Month||3||3
48722277|NCT02208349|102105603|FG000|COMPLETED|Third 6 Month||6||3
48722278|NCT02208349|102105604|FG001|COMPLETED|Third 6 Month||3||3
48722279|NCT02208349|102105603|FG000|NOT COMPLETED|Third 6 Month||0||0
48609085|NCT00385827|101827250|FG000|NOT COMPLETED|Part 2||0||
48609086|NCT00385827|101827251|FG001|NOT COMPLETED|Part 2||33||
48609087|NCT00385827|101827252|FG002|NOT COMPLETED|Part 2||48||
48609088|NCT03743025|101827253|FG000|STARTED|Overall Study||14||
48609089|NCT03743025|101827254|FG001|STARTED|Overall Study||14||
48609090|NCT03743025|101827253|FG000|COMPLETED|Overall Study||12||
48609091|NCT03743025|101827254|FG001|COMPLETED|Overall Study||13||
48609092|NCT03743025|101827253|FG000|NOT COMPLETED|Overall Study||2||
48609093|NCT03743025|101827254|FG001|NOT COMPLETED|Overall Study||1||
48609094|NCT02651337|101827255|FG000|STARTED|Overall Study||5||
48609095|NCT02651337|101827255|FG000|COMPLETED|Overall Study||4||
48609096|NCT02651337|101827255|FG000|NOT COMPLETED|Overall Study||1||
48609097|NCT02144077|101827256|FG000|STARTED|Overall Study||138||
48609098|NCT02144077|101827257|FG001|STARTED|Overall Study||143||
48609099|NCT02144077|101827256|FG000|COMPLETED|Overall Study||128|5 patients did not complete due to AE. In 3 of them these AEs were unrelated to study treatment.|
48609100|NCT02144077|101827257|FG001|COMPLETED|Overall Study||132|5 patients did not complete due to AE. In 3 of them these AEs were unrelated to study treatment.|
48609101|NCT02144077|101827256|FG000|NOT COMPLETED|Overall Study||10||
48722280|NCT02208349|102105604|FG001|NOT COMPLETED|Third 6 Month||0||0
48722281|NCT02208349|102105603|FG000|STARTED|Fourth 6 Month||14||3
48722282|NCT02208349|102105604|FG001|STARTED|Fourth 6 Month||2||3
48722283|NCT02208349|102105603|FG000|COMPLETED|Fourth 6 Month||14||3
48609102|NCT02144077|101827257|FG001|NOT COMPLETED|Overall Study||11||
48609103|NCT02401035|101827258|FG000|STARTED|Overall Study||3||
48609104|NCT02401035|101827259|FG001|STARTED|Overall Study||16||
48609105|NCT02401035|101827258|FG000|Treated|Overall Study||2||
48609106|NCT02401035|101827259|FG001|Treated|Overall Study||16||
48609107|NCT02401035|101827258|FG000|COMPLETED|Overall Study||2||
48609108|NCT02401035|101827259|FG001|COMPLETED|Overall Study||16||
48609109|NCT02401035|101827258|FG000|NOT COMPLETED|Overall Study||1||
48609110|NCT02401035|101827259|FG001|NOT COMPLETED|Overall Study||0||
48609111|NCT02830074|101827260|FG000|STARTED|Overall Study||32||
48609112|NCT02830074|101827261|FG001|STARTED|Overall Study||31||
48609113|NCT02830074|101827260|FG000|COMPLETED|Overall Study||32||
48609114|NCT02830074|101827261|FG001|COMPLETED|Overall Study||31||
48609115|NCT02830074|101827260|FG000|NOT COMPLETED|Overall Study||0||
48609116|NCT02830074|101827261|FG001|NOT COMPLETED|Overall Study||0||
48609117|NCT04987931|101827262|FG000|STARTED|Overall Study||84||
48609118|NCT04987931|101827262|FG000|COMPLETED|Overall Study||84||
48609119|NCT04987931|101827262|FG000|NOT COMPLETED|Overall Study||0||
48609120|NCT00734656|101827263|FG000|STARTED|Lab Session 1||24||
48609121|NCT00734656|101827264|FG001|STARTED|Lab Session 1||23||
48609122|NCT00734656|101827265|FG002|STARTED|Lab Session 1||26||
48609123|NCT00734656|101827266|FG003|STARTED|Lab Session 1||21||
48609124|NCT00734656|101827263|FG000|COMPLETED|Lab Session 1||22||
48609125|NCT00734656|101827264|FG001|COMPLETED|Lab Session 1||23||
48609126|NCT00734656|101827265|FG002|COMPLETED|Lab Session 1||26||
48609127|NCT00734656|101827266|FG003|COMPLETED|Lab Session 1||21||
48609128|NCT00734656|101827263|FG000|NOT COMPLETED|Lab Session 1||2||
48609129|NCT00734656|101827264|FG001|NOT COMPLETED|Lab Session 1||0||
48609130|NCT00734656|101827265|FG002|NOT COMPLETED|Lab Session 1||0||
48609131|NCT00734656|101827266|FG003|NOT COMPLETED|Lab Session 1||0||
48609132|NCT00734656|101827263|FG000|STARTED|Washout 1||22||
48609133|NCT00734656|101827264|FG001|STARTED|Washout 1||23||
48609134|NCT00734656|101827265|FG002|STARTED|Washout 1||26||
48609135|NCT00734656|101827266|FG003|STARTED|Washout 1||21||
48609136|NCT00734656|101827263|FG000|COMPLETED|Washout 1||21||
48609137|NCT00734656|101827264|FG001|COMPLETED|Washout 1||18||
48609138|NCT00734656|101827265|FG002|COMPLETED|Washout 1||24||
48609139|NCT00734656|101827266|FG003|COMPLETED|Washout 1||18||
48609140|NCT00734656|101827263|FG000|NOT COMPLETED|Washout 1||1||
48609141|NCT00734656|101827264|FG001|NOT COMPLETED|Washout 1||5||
48609142|NCT00734656|101827265|FG002|NOT COMPLETED|Washout 1||2||
48609143|NCT00734656|101827266|FG003|NOT COMPLETED|Washout 1||3||
48609144|NCT00734656|101827263|FG000|STARTED|Lab Session 2||19||
48609145|NCT00734656|101827264|FG001|STARTED|Lab Session 2||21||
48609146|NCT00734656|101827265|FG002|STARTED|Lab Session 2||21||
48609147|NCT00734656|101827266|FG003|STARTED|Lab Session 2||20||
48609148|NCT00734656|101827263|FG000|COMPLETED|Lab Session 2||18||
48609149|NCT00734656|101827264|FG001|COMPLETED|Lab Session 2||21||
48609150|NCT00734656|101827265|FG002|COMPLETED|Lab Session 2||21||
48609151|NCT00734656|101827266|FG003|COMPLETED|Lab Session 2||19||
48609152|NCT00734656|101827263|FG000|NOT COMPLETED|Lab Session 2||1||
48609153|NCT00734656|101827264|FG001|NOT COMPLETED|Lab Session 2||0||
48609154|NCT00734656|101827265|FG002|NOT COMPLETED|Lab Session 2||0||
48609155|NCT00734656|101827266|FG003|NOT COMPLETED|Lab Session 2||1||
48609156|NCT00734656|101827263|FG000|STARTED|Washout 2||18||
48609157|NCT00734656|101827264|FG001|STARTED|Washout 2||21||
48609158|NCT00734656|101827265|FG002|STARTED|Washout 2||21||
48609159|NCT00734656|101827266|FG003|STARTED|Washout 2||19||
48609160|NCT00734656|101827263|FG000|COMPLETED|Washout 2||17||
48609161|NCT00734656|101827264|FG001|COMPLETED|Washout 2||20||
48609162|NCT00734656|101827265|FG002|COMPLETED|Washout 2||20||
48609163|NCT00734656|101827266|FG003|COMPLETED|Washout 2||19||
48609164|NCT00734656|101827263|FG000|NOT COMPLETED|Washout 2||1||
48609165|NCT00734656|101827264|FG001|NOT COMPLETED|Washout 2||1||
48609166|NCT00734656|101827265|FG002|NOT COMPLETED|Washout 2||1||
48609167|NCT00734656|101827266|FG003|NOT COMPLETED|Washout 2||0||
48609168|NCT00734656|101827263|FG000|STARTED|Lab Session 3||18||
48609169|NCT00734656|101827264|FG001|STARTED|Lab Session 3||19||
48609170|NCT00734656|101827265|FG002|STARTED|Lab Session 3||20||
48609171|NCT00734656|101827266|FG003|STARTED|Lab Session 3||19||
48609172|NCT00734656|101827263|FG000|COMPLETED|Lab Session 3||18||
48609173|NCT00734656|101827264|FG001|COMPLETED|Lab Session 3||19||
48609174|NCT00734656|101827265|FG002|COMPLETED|Lab Session 3||20||
48609175|NCT00734656|101827266|FG003|COMPLETED|Lab Session 3||19||
48609176|NCT00734656|101827263|FG000|NOT COMPLETED|Lab Session 3||0||
48609177|NCT00734656|101827264|FG001|NOT COMPLETED|Lab Session 3||0||
48609178|NCT00734656|101827265|FG002|NOT COMPLETED|Lab Session 3||0||
48609179|NCT00734656|101827266|FG003|NOT COMPLETED|Lab Session 3||0||
48609180|NCT00734656|101827263|FG000|STARTED|Washout 3||18||
48609181|NCT00734656|101827264|FG001|STARTED|Washout 3||19||
48609182|NCT00734656|101827265|FG002|STARTED|Washout 3||20||
48609183|NCT00734656|101827266|FG003|STARTED|Washout 3||19||
48609184|NCT00734656|101827263|FG000|COMPLETED|Washout 3||17||
48609185|NCT00734656|101827264|FG001|COMPLETED|Washout 3||19||
48609186|NCT00734656|101827265|FG002|COMPLETED|Washout 3||20||
48609187|NCT00734656|101827266|FG003|COMPLETED|Washout 3||18||
48609188|NCT00734656|101827263|FG000|NOT COMPLETED|Washout 3||1||
48609189|NCT00734656|101827264|FG001|NOT COMPLETED|Washout 3||0||
48722284|NCT02208349|102105604|FG001|COMPLETED|Fourth 6 Month||2||3
48609190|NCT00734656|101827265|FG002|NOT COMPLETED|Washout 3||0||
48609191|NCT00734656|101827266|FG003|NOT COMPLETED|Washout 3||1||
48609192|NCT00734656|101827263|FG000|STARTED|Lab Session 4||20||
48609193|NCT00734656|101827264|FG001|STARTED|Lab Session 4||18||
48609194|NCT00734656|101827265|FG002|STARTED|Lab Session 4||16||
48152230|NCT00542880|100695958|FG000|NOT COMPLETED|Period 1||6||
48152231|NCT00542880|100695959|FG001|NOT COMPLETED|Period 1||12||
48307324|NCT03627767|101077614|FG002|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||99||
48307325|NCT03627767|101077615|FG003|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||41||
48307326|NCT03627767|101077616|FG004|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0||
48307327|NCT03627767|101077612|FG000|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0||
48307328|NCT03627767|101077613|FG001|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||43||
48307329|NCT03627767|101077614|FG002|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||134||
48307330|NCT03627767|101077615|FG003|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||187||
48307331|NCT03627767|101077616|FG004|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0||
48307332|NCT03627767|101077612|FG000|COMPLETED|Double-blind Treatment Period (40 Weeks)||0||
48307333|NCT03627767|101077613|FG001|COMPLETED|Double-blind Treatment Period (40 Weeks)||251||
48307334|NCT03627767|101077614|FG002|COMPLETED|Double-blind Treatment Period (40 Weeks)||243||
48307335|NCT03627767|101077615|FG003|COMPLETED|Double-blind Treatment Period (40 Weeks)||231||
48307336|NCT03627767|101077616|FG004|COMPLETED|Double-blind Treatment Period (40 Weeks)||0||
48307337|NCT03627767|101077612|FG000|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||0||
48307338|NCT03627767|101077613|FG001|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||16||
48307339|NCT03627767|101077614|FG002|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||22||
48307340|NCT03627767|101077615|FG003|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||35||
48307341|NCT03627767|101077616|FG004|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||0||
48307342|NCT03627767|101077612|FG000|STARTED|Open-label Rescue Period (12 Weeks)||0||
48307343|NCT03627767|101077613|FG001|STARTED|Open-label Rescue Period (12 Weeks)||0||
48152232|NCT00542880|100695958|FG000|STARTED|Period 2||211||
48152233|NCT00542880|100695959|FG001|STARTED|Period 2||213||
48152234|NCT00542880|100695958|FG000|COMPLETED|Period 2||204||
48152235|NCT00542880|100695959|FG001|COMPLETED|Period 2||203||
48307344|NCT03627767|101077614|FG002|STARTED|Open-label Rescue Period (12 Weeks)||0||
48609195|NCT00734656|101827266|FG003|STARTED|Lab Session 4||20||
48609196|NCT00734656|101827263|FG000|COMPLETED|Lab Session 4||20||
48609197|NCT00734656|101827264|FG001|COMPLETED|Lab Session 4||18||
48609198|NCT00734656|101827265|FG002|COMPLETED|Lab Session 4||16||
48152236|NCT00542880|100695958|FG000|NOT COMPLETED|Period 2||7||
48152237|NCT00542880|100695959|FG001|NOT COMPLETED|Period 2||10||
48609199|NCT00734656|101827266|FG003|COMPLETED|Lab Session 4||19||
48609200|NCT00734656|101827263|FG000|NOT COMPLETED|Lab Session 4||0||
48609201|NCT00734656|101827264|FG001|NOT COMPLETED|Lab Session 4||0||
48609202|NCT00734656|101827265|FG002|NOT COMPLETED|Lab Session 4||0||
48609203|NCT00734656|101827266|FG003|NOT COMPLETED|Lab Session 4||1||
48609204|NCT01861002|101827267|FG000|STARTED|Overall Study||15||
48609205|NCT01861002|101827267|FG000|COMPLETED|Overall Study||14||
48609206|NCT01861002|101827267|FG000|NOT COMPLETED|Overall Study||1||
48609207|NCT04218279|101827268|FG000|STARTED|Overall Study||316||16
48609208|NCT04218279|101827269|FG001|STARTED|Overall Study||362||20
48609209|NCT04218279|101827268|FG000|COMPLETED|Overall Study||211||15
48609210|NCT04218279|101827269|FG001|COMPLETED|Overall Study||225||20
48609211|NCT04218279|101827268|FG000|NOT COMPLETED|Overall Study||105||1
48609212|NCT04218279|101827269|FG001|NOT COMPLETED|Overall Study||137||0
48609213|NCT02815267|101827270|FG000|STARTED|Double-Blind Phase||307||
48609214|NCT02815267|101827271|FG001|STARTED|Double-Blind Phase||159||
48609215|NCT02815267|101827270|FG000|COMPLETED|Double-Blind Phase||274||
48609216|NCT02815267|101827271|FG001|COMPLETED|Double-Blind Phase||128||
48152238|NCT00542880|100695958|FG000|STARTED|Period 3||204||
48152239|NCT00542880|100695959|FG001|STARTED|Period 3||203||
48609217|NCT02815267|101827270|FG000|NOT COMPLETED|Double-Blind Phase||33||
48609218|NCT02815267|101827271|FG001|NOT COMPLETED|Double-Blind Phase||31||
48609219|NCT02815267|101827270|FG000|STARTED|Open-Label Phase||193||
48609220|NCT02815267|101827271|FG001|STARTED|Open-Label Phase||91||
48609221|NCT02815267|101827270|FG000|COMPLETED|Open-Label Phase||122||
48152240|NCT00542880|100695958|FG000|COMPLETED|Period 3||204||
48307345|NCT03627767|101077615|FG003|STARTED|Open-label Rescue Period (12 Weeks)||0||
48307346|NCT03627767|101077616|FG004|STARTED|Open-label Rescue Period (12 Weeks)||361||
48307347|NCT03627767|101077612|FG000|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0||
48307348|NCT03627767|101077613|FG001|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0||
48307349|NCT03627767|101077614|FG002|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0||
48307350|NCT03627767|101077615|FG003|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0||
48307351|NCT03627767|101077616|FG004|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||351||
48307352|NCT03627767|101077612|FG000|COMPLETED|Open-label Rescue Period (12 Weeks)||0||
48307353|NCT03627767|101077613|FG001|COMPLETED|Open-label Rescue Period (12 Weeks)||0||
48307354|NCT03627767|101077614|FG002|COMPLETED|Open-label Rescue Period (12 Weeks)||0||
48307355|NCT03627767|101077615|FG003|COMPLETED|Open-label Rescue Period (12 Weeks)||0||
48307356|NCT03627767|101077616|FG004|COMPLETED|Open-label Rescue Period (12 Weeks)||341||
48307357|NCT03627767|101077612|FG000|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0||
48307358|NCT03627767|101077613|FG001|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0||
48307359|NCT03627767|101077614|FG002|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0||
48307360|NCT03627767|101077615|FG003|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0||
48307361|NCT03627767|101077616|FG004|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||20||
48307362|NCT01472380|101077617|FG000|STARTED|Efavirenz Alone||30||
48307363|NCT01472380|101077617|FG000|COMPLETED|Efavirenz Alone||29||
48307364|NCT01472380|101077617|FG000|NOT COMPLETED|Efavirenz Alone||1||
48307365|NCT01472380|101077617|FG000|STARTED|Fenofibric Acid (FFA) Alone||29||
48307366|NCT01472380|101077617|FG000|COMPLETED|Fenofibric Acid (FFA) Alone||29||
48307367|NCT01472380|101077617|FG000|NOT COMPLETED|Fenofibric Acid (FFA) Alone||0||
48307368|NCT01472380|101077617|FG000|STARTED|1 Day Period Between Dosing||29||
48307369|NCT01472380|101077617|FG000|COMPLETED|1 Day Period Between Dosing||28||
48307370|NCT01472380|101077617|FG000|NOT COMPLETED|1 Day Period Between Dosing||1||
48307371|NCT01472380|101077617|FG000|STARTED|Efavirenz and FFA||28||
48307372|NCT01472380|101077617|FG000|COMPLETED|Efavirenz and FFA||28||
48307373|NCT01472380|101077617|FG000|NOT COMPLETED|Efavirenz and FFA||0||
48307374|NCT01754857|101077618|FG000|STARTED|Overall Study||36||
48307375|NCT01754857|101077618|FG000|COMPLETED|Overall Study||17||
48307376|NCT01754857|101077618|FG000|NOT COMPLETED|Overall Study||19||
48307377|NCT03574441|101077619|FG000|STARTED|Overall Study||31||
48307378|NCT03574441|101077620|FG001|STARTED|Overall Study||30||
48307379|NCT03574441|101077621|FG002|STARTED|Overall Study||30||
48307380|NCT03574441|101077619|FG000|COMPLETED|Overall Study||31||
48307381|NCT03574441|101077620|FG001|COMPLETED|Overall Study||30||
48307382|NCT03574441|101077621|FG002|COMPLETED|Overall Study||30||
48307383|NCT03574441|101077619|FG000|NOT COMPLETED|Overall Study||0||
48307384|NCT03574441|101077620|FG001|NOT COMPLETED|Overall Study||0||
48307385|NCT03574441|101077621|FG002|NOT COMPLETED|Overall Study||0||
48307386|NCT00800683|101077622|FG000|STARTED|Overall Study||65||
48307387|NCT00800683|101077623|FG001|STARTED|Overall Study||68||
48307388|NCT00800683|101077622|FG000|COMPLETED|Overall Study||48||
48307389|NCT00800683|101077623|FG001|COMPLETED|Overall Study||49||
48307390|NCT00800683|101077622|FG000|NOT COMPLETED|Overall Study||17||
48307391|NCT00800683|101077623|FG001|NOT COMPLETED|Overall Study||19||
48307392|NCT00521053|101077624|FG000|STARTED|Treatment Phase||80||
48307393|NCT00521053|101077624|FG000|Received 1 Cycle of PV-10|Treatment Phase||35||
48307394|NCT00521053|101077624|FG000|Received 2 Cycles of PV-10|Treatment Phase||26||
48307395|NCT00521053|101077624|FG000|Received 3 Cycles of PV-10|Treatment Phase||16||
48307396|NCT00521053|101077624|FG000|Received 4 Cycles of PV-10|Treatment Phase||3||
48307397|NCT00521053|101077624|FG000|COMPLETED|Treatment Phase||80||
48307398|NCT00521053|101077624|FG000|NOT COMPLETED|Treatment Phase||0||
48307399|NCT00521053|101077624|FG000|STARTED|Observation Phase||80||
48307400|NCT00521053|101077624|FG000|COMPLETED|Observation Phase||12||
48307401|NCT00521053|101077624|FG000|NOT COMPLETED|Observation Phase||68||
48307402|NCT00420017|101077625|FG000|STARTED|Overall Study||40||
48307403|NCT00420017|101077626|FG001|STARTED|Overall Study||40||
48307404|NCT00420017|101077625|FG000|COMPLETED|Overall Study||38||
48307405|NCT00420017|101077626|FG001|COMPLETED|Overall Study||40||
48307406|NCT00420017|101077625|FG000|NOT COMPLETED|Overall Study||2||
48307407|NCT00420017|101077626|FG001|NOT COMPLETED|Overall Study||0||
48307408|NCT00916149|101077627|FG000|STARTED|Overall Study||16||
48307409|NCT00916149|101077628|FG001|STARTED|Overall Study||10||
48307410|NCT00916149|101077629|FG002|STARTED|Overall Study||5||
48307411|NCT00916149|101077627|FG000|COMPLETED|Overall Study||12||
48307412|NCT00916149|101077628|FG001|COMPLETED|Overall Study||8||
48307413|NCT00916149|101077629|FG002|COMPLETED|Overall Study||5||
48307414|NCT00916149|101077627|FG000|NOT COMPLETED|Overall Study||4||
48609222|NCT02815267|101827271|FG001|COMPLETED|Open-Label Phase||50||
48609223|NCT02815267|101827270|FG000|NOT COMPLETED|Open-Label Phase||71||
48609224|NCT02815267|101827271|FG001|NOT COMPLETED|Open-Label Phase||41||
48609225|NCT02432209|101827272|FG000|STARTED|Overall Study||188||
48609226|NCT02432209|101827273|FG001|STARTED|Overall Study||191||
48722285|NCT02208349|102105603|FG000|NOT COMPLETED|Fourth 6 Month||0||0
48722286|NCT02208349|102105604|FG001|NOT COMPLETED|Fourth 6 Month||0||0
48152241|NCT00542880|100695959|FG001|COMPLETED|Period 3||201||
48722287|NCT02208349|102105603|FG000|STARTED|Fifth 6 Month||7||3
48722288|NCT02208349|102105604|FG001|STARTED|Fifth 6 Month||2||3
48722289|NCT02208349|102105603|FG000|COMPLETED|Fifth 6 Month||7||3
48722290|NCT02208349|102105604|FG001|COMPLETED|Fifth 6 Month||2||3
48722291|NCT02208349|102105603|FG000|NOT COMPLETED|Fifth 6 Month||0||0
48152242|NCT00542880|100695958|FG000|NOT COMPLETED|Period 3||0||
48152243|NCT00542880|100695959|FG001|NOT COMPLETED|Period 3||2||
48152244|NCT03260868|100695960|FG000|STARTED|Overall Study||8|Randomized population|
48152245|NCT03260868|100695961|FG001|STARTED|Overall Study||7|Randomized population|
48152246|NCT03260868|100695960|FG000|Safety Population|Overall Study||8|Treated|
48722292|NCT02208349|102105604|FG001|NOT COMPLETED|Fifth 6 Month||0||0
48722293|NCT02208349|102105603|FG000|STARTED|Sixth 6 Month||3||3
48722294|NCT02208349|102105604|FG001|STARTED|Sixth 6 Month||2||3
48722295|NCT02208349|102105603|FG000|COMPLETED|Sixth 6 Month||3||3
48722296|NCT02208349|102105604|FG001|COMPLETED|Sixth 6 Month||2||3
48722297|NCT02208349|102105603|FG000|NOT COMPLETED|Sixth 6 Month||0||0
48722298|NCT02208349|102105604|FG001|NOT COMPLETED|Sixth 6 Month||0||0
48722299|NCT02726945|102105605|FG000|STARTED|Overall Study||13||
48722300|NCT02726945|102105606|FG001|STARTED|Overall Study||13||
48152247|NCT03260868|100695961|FG001|Safety Population|Overall Study||6|Treated|
48152248|NCT03260868|100695960|FG000|COMPLETED|Overall Study||5||
48152249|NCT03260868|100695961|FG001|COMPLETED|Overall Study||4||
48152250|NCT03260868|100695960|FG000|NOT COMPLETED|Overall Study||3||
48152251|NCT03260868|100695961|FG001|NOT COMPLETED|Overall Study||3||
48152252|NCT03063294|100695962|FG000|STARTED|Overall Study||2463|"The terminology of started applies only to primary care clinics here (only clinics were followed longitudinally). At each clinic, a cross-sectional survey of participants took place at baseline (N=2484), and then a separate cross-sectional survey with a new sample of participants took place at follow-up (N=2481). Since it is incorrect to use the terminology of started with respect to participants, we provide the total (baseline plus follow-up) participant sample size (2484+2481=4965)."|6
48152253|NCT03063294|100695963|FG001|STARTED|Overall Study||2502|"The terminology of started applies only to primary care clinics here (only clinics were followed longitudinally). At each clinic, a cross-sectional survey of participants took place at baseline (N=2484), and then a separate cross-sectional survey with a new sample of participants took place at follow-up (N=2481). Since it is incorrect to use the terminology of started with respect to participants, we provide the total (baseline plus follow-up) participant sample size (2484+2481=4965)."|6
48152254|NCT03063294|100695962|FG000|COMPLETED|Overall Study||2463|"The terminology of completed applies only to primary care clinics here (only clinics were followed longitudinally). At each clinic, a cross-sectional survey of participants took place at baseline (N=2484), and then a separate cross-sectional survey with a new sample of participants took place at follow-up (N=2481). Since it is incorrect to use the terminology of completed with respect to participants, we provide the total (baseline plus follow-up) participant sample size (2484+2481=4965)."|6
48188539|NCT02068885|100783271|FG001|STARTED|Overall Study||53|Sample size randomized|
48188540|NCT02068885|100783272|FG002|STARTED|Overall Study||54|Sample size randomized|
48188541|NCT02068885|100783270|FG000|Provided Data at Midpoint Test Phase|Overall Study||56||
48188542|NCT02068885|100783271|FG001|Provided Data at Midpoint Test Phase|Overall Study||50||
48609227|NCT02432209|101827272|FG000|COMPLETED|Overall Study||157||
48609228|NCT02432209|101827273|FG001|COMPLETED|Overall Study||151||
48722301|NCT02726945|102105607|FG002|STARTED|Overall Study||13||
48722302|NCT02726945|102105605|FG000|COMPLETED|Overall Study||13||
48609229|NCT02432209|101827272|FG000|NOT COMPLETED|Overall Study||31||
48609230|NCT02432209|101827273|FG001|NOT COMPLETED|Overall Study||40||
48609231|NCT01310127|101827274|FG000|STARTED|Overall Study||12||
48609232|NCT01310127|101827275|FG001|STARTED|Overall Study||11||
48609233|NCT01310127|101827274|FG000|COMPLETED|Overall Study||10||
48609234|NCT01310127|101827275|FG001|COMPLETED|Overall Study||10||
48722303|NCT02726945|102105606|FG001|COMPLETED|Overall Study||12||
48722304|NCT02726945|102105607|FG002|COMPLETED|Overall Study||12||
48722305|NCT02726945|102105605|FG000|NOT COMPLETED|Overall Study||0||
48722306|NCT02726945|102105606|FG001|NOT COMPLETED|Overall Study||1||
48722307|NCT02726945|102105607|FG002|NOT COMPLETED|Overall Study||1||
48722308|NCT01266317|102105608|FG000|STARTED|Overall Study||9||
48722309|NCT01266317|102105608|FG000|COMPLETED|Overall Study||7||
48722310|NCT01266317|102105608|FG000|NOT COMPLETED|Overall Study||2||
48722311|NCT01581619|102105609|FG000|STARTED|Overall Study||54||
48722312|NCT01581619|102105609|FG000|COMPLETED|Overall Study||52||
48722313|NCT01581619|102105609|FG000|NOT COMPLETED|Overall Study||2||
48722314|NCT03001778|102105610|FG000|STARTED|Overall Study||21||
48722315|NCT03001778|102105611|FG001|STARTED|Overall Study||46||
48722316|NCT03001778|102105610|FG000|COMPLETED|Overall Study||21||
48722317|NCT03001778|102105611|FG001|COMPLETED|Overall Study||46||
48722318|NCT03001778|102105610|FG000|NOT COMPLETED|Overall Study||0||
48722319|NCT03001778|102105611|FG001|NOT COMPLETED|Overall Study||0||
48722320|NCT04350307|102105612|FG000|STARTED|Overall Study||84||
48722321|NCT04350307|102105613|FG001|STARTED|Overall Study||78||
48152255|NCT03063294|100695963|FG001|COMPLETED|Overall Study||2502|"The terminology of completed applies only to primary care clinics here (only clinics were followed longitudinally). At each clinic, a cross-sectional survey of participants took place at baseline (N=2484), and then a separate cross-sectional survey with a new sample of participants took place at follow-up (N=2481). Since it is incorrect to use the terminology of completed with respect to participants, we provide the total (baseline plus follow-up) participant sample size (2484+2481=4965)."|6
48152256|NCT03063294|100695962|FG000|NOT COMPLETED|Overall Study||0||0
48152257|NCT03063294|100695963|FG001|NOT COMPLETED|Overall Study||0||0
48152258|NCT00526630|100695964|FG000|STARTED|First Intervention Period - 12 Weeks||12||
48152259|NCT00526630|100695965|FG001|STARTED|First Intervention Period - 12 Weeks||11||
48152260|NCT00526630|100695964|FG000|COMPLETED|First Intervention Period - 12 Weeks||12||
48307415|NCT00916149|101077628|FG001|NOT COMPLETED|Overall Study||2||
48307416|NCT00916149|101077629|FG002|NOT COMPLETED|Overall Study||0||
48307417|NCT01098812|101077630|FG000|STARTED|Overall Study||95||
48307418|NCT01098812|101077631|FG001|STARTED|Overall Study||102||
48307419|NCT01098812|101077632|FG002|STARTED|Overall Study||72||
48609235|NCT01310127|101827274|FG000|NOT COMPLETED|Overall Study||2||
48609236|NCT01310127|101827275|FG001|NOT COMPLETED|Overall Study||1||
48609237|NCT03883477|101827276|FG000|STARTED|Overall Study||13||
48307420|NCT01098812|101077630|FG000|COMPLETED|Overall Study||93||
48307421|NCT01098812|101077631|FG001|COMPLETED|Overall Study||101||
48307422|NCT01098812|101077632|FG002|COMPLETED|Overall Study||71||
48307423|NCT01098812|101077630|FG000|NOT COMPLETED|Overall Study||2||
48609238|NCT03883477|101827277|FG001|STARTED|Overall Study||13||
48609239|NCT03883477|101827276|FG000|COMPLETED|Overall Study||12||
48609240|NCT03883477|101827277|FG001|COMPLETED|Overall Study||12||
48609241|NCT03883477|101827276|FG000|NOT COMPLETED|Overall Study||1||
48307424|NCT01098812|101077631|FG001|NOT COMPLETED|Overall Study||1||
48307425|NCT01098812|101077632|FG002|NOT COMPLETED|Overall Study||1||
48307426|NCT01103245|101077633|FG000|STARTED|Overall Study||13||
48609242|NCT03883477|101827277|FG001|NOT COMPLETED|Overall Study||1||
48609243|NCT01150903|101827278|FG000|STARTED|Overall Study||24708||
48609244|NCT01150903|101827279|FG001|STARTED|Overall Study||74124||
48609245|NCT01150903|101827278|FG000|COMPLETED|Overall Study||24708||
48609246|NCT01150903|101827279|FG001|COMPLETED|Overall Study||74124||
48609247|NCT01150903|101827278|FG000|NOT COMPLETED|Overall Study||0||
48307427|NCT01103245|101077634|FG001|STARTED|Overall Study||7||
48307428|NCT01103245|101077635|FG002|STARTED|Overall Study||12||
48307429|NCT01103245|101077636|FG003|STARTED|Overall Study||6||
48307430|NCT01103245|101077633|FG000|COMPLETED|Overall Study||10||
48307431|NCT01103245|101077634|FG001|COMPLETED|Overall Study||5||
48307432|NCT01103245|101077635|FG002|COMPLETED|Overall Study||8||
48307433|NCT01103245|101077636|FG003|COMPLETED|Overall Study||6||
48307434|NCT01103245|101077633|FG000|NOT COMPLETED|Overall Study||3||
48307435|NCT01103245|101077634|FG001|NOT COMPLETED|Overall Study||2||
48307436|NCT01103245|101077635|FG002|NOT COMPLETED|Overall Study||4||
48307437|NCT01103245|101077636|FG003|NOT COMPLETED|Overall Study||0||
48307438|NCT01210690|101077637|FG000|STARTED|Overall Study||101||
48307439|NCT01210690|101077637|FG000|COMPLETED|Overall Study||75||
48307440|NCT01210690|101077637|FG000|NOT COMPLETED|Overall Study||26||
48307441|NCT01368809|101077638|FG000|STARTED|Overall Study||50||
48307442|NCT01368809|101077639|FG001|STARTED|Overall Study||50||
48307443|NCT01368809|101077638|FG000|COMPLETED|Overall Study||50||
48307444|NCT01368809|101077639|FG001|COMPLETED|Overall Study||50||
48307445|NCT01368809|101077638|FG000|NOT COMPLETED|Overall Study||0||
48609248|NCT01150903|101827279|FG001|NOT COMPLETED|Overall Study||0||
48609249|NCT04560868|101827280|FG000|STARTED|Overall Study||29||
48722322|NCT04350307|102105612|FG000|COMPLETED|Overall Study||84||
48722323|NCT04350307|102105613|FG001|COMPLETED|Overall Study||78||
48722324|NCT04350307|102105612|FG000|NOT COMPLETED|Overall Study||0||
48722325|NCT04350307|102105613|FG001|NOT COMPLETED|Overall Study||0||
48722326|NCT02456857|102105614|FG000|STARTED|Overall Study||17||
48722327|NCT02456857|102105614|FG000|COMPLETED|Overall Study||13||
48307446|NCT01368809|101077639|FG001|NOT COMPLETED|Overall Study||0||
48307447|NCT02367066|101077640|FG000|STARTED|Overall Study||10||
48307448|NCT02367066|101077641|FG001|STARTED|Overall Study||10||
48307449|NCT02367066|101077640|FG000|COMPLETED|Overall Study||10||
48307450|NCT02367066|101077641|FG001|COMPLETED|Overall Study||10||
48307451|NCT02367066|101077640|FG000|NOT COMPLETED|Overall Study||0||
48307452|NCT02367066|101077641|FG001|NOT COMPLETED|Overall Study||0||
48307453|NCT02208297|101077642|FG000|STARTED|Overall Study||163||
48307454|NCT02208297|101077643|FG001|STARTED|Overall Study||163||
48307455|NCT02208297|101077642|FG000|COMPLETED|Overall Study||141||
48307456|NCT02208297|101077643|FG001|COMPLETED|Overall Study||107||
48307457|NCT02208297|101077642|FG000|NOT COMPLETED|Overall Study||22||
48307458|NCT02208297|101077643|FG001|NOT COMPLETED|Overall Study||56||
48609250|NCT04560868|101827281|FG001|STARTED|Overall Study||28||
48609251|NCT04560868|101827280|FG000|Completed 1-month Self-report Survey|Overall Study||28||
48609252|NCT04560868|101827281|FG001|Completed 1-month Self-report Survey|Overall Study||21||
48609253|NCT04560868|101827280|FG000|Completed 3-month Self-report Survey|Overall Study||26||
48609254|NCT04560868|101827281|FG001|Completed 3-month Self-report Survey|Overall Study||21||
48722328|NCT02456857|102105614|FG000|NOT COMPLETED|Overall Study||4||
48722329|NCT00129961|102105615|FG000|STARTED|Overall Study||39||
48722330|NCT00129961|102105616|FG001|STARTED|Overall Study||47||
48307459|NCT01560923|101077644|FG000|STARTED|Overall Study||24||
48307460|NCT01560923|101077645|FG001|STARTED|Overall Study||22||
48307461|NCT01560923|101077644|FG000|COMPLETED|Overall Study||24||
48609255|NCT04560868|101827280|FG000|Completed App Utilization Period|Overall Study||29||
48609256|NCT04560868|101827281|FG001|Completed App Utilization Period|Overall Study||28||
48609257|NCT04560868|101827280|FG000|COMPLETED|Overall Study||29||
48609258|NCT04560868|101827281|FG001|COMPLETED|Overall Study||28||
48609259|NCT04560868|101827280|FG000|NOT COMPLETED|Overall Study||0||
48609260|NCT04560868|101827281|FG001|NOT COMPLETED|Overall Study||0||
48609261|NCT01888653|101827282|FG000|STARTED|Overall Study||24||
48609262|NCT01888653|101827283|FG001|STARTED|Overall Study||26||
48609263|NCT01888653|101827282|FG000|COMPLETED|Overall Study||24||
48609264|NCT01888653|101827283|FG001|COMPLETED|Overall Study||26||
48722331|NCT00129961|102105615|FG000|COMPLETED|Overall Study||20||
48722332|NCT00129961|102105616|FG001|COMPLETED|Overall Study||24||
48722333|NCT00129961|102105615|FG000|NOT COMPLETED|Overall Study||19||
48722334|NCT00129961|102105616|FG001|NOT COMPLETED|Overall Study||23||
48722335|NCT00428844|102105617|FG000|STARTED|Completed Study Drug Treatment||25||
48722336|NCT00428844|102105618|FG001|STARTED|Completed Study Drug Treatment||24||
48722337|NCT00428844|102105619|FG002|STARTED|Completed Study Drug Treatment||26||
48722338|NCT00428844|102105617|FG000|Received First Dose|Completed Study Drug Treatment||25||
48722339|NCT00428844|102105618|FG001|Received First Dose|Completed Study Drug Treatment||24||
48722340|NCT00428844|102105619|FG002|Received First Dose|Completed Study Drug Treatment||25||
48722341|NCT00428844|102105617|FG000|COMPLETED|Completed Study Drug Treatment||23||
48722342|NCT00428844|102105618|FG001|COMPLETED|Completed Study Drug Treatment||18||
48722343|NCT00428844|102105619|FG002|COMPLETED|Completed Study Drug Treatment||19||
48722344|NCT00428844|102105617|FG000|NOT COMPLETED|Completed Study Drug Treatment||2||
48722345|NCT00428844|102105618|FG001|NOT COMPLETED|Completed Study Drug Treatment||6||
48722346|NCT00428844|102105619|FG002|NOT COMPLETED|Completed Study Drug Treatment||7||
48722347|NCT00428844|102105617|FG000|STARTED|Completed Test of Cure (TOC) Visit||23||
48609265|NCT01888653|101827282|FG000|NOT COMPLETED|Overall Study||0||
48609266|NCT01888653|101827283|FG001|NOT COMPLETED|Overall Study||0||
48609267|NCT03374488|101827284|FG000|STARTED|Overall Study||42||
48609268|NCT03374488|101827285|FG001|STARTED|Overall Study||42||
48609269|NCT03374488|101827284|FG000|Intention-to-Treat (ITT)|Overall Study||42||
48609270|NCT03374488|101827285|FG001|Intention-to-Treat (ITT)|Overall Study||42||
48609271|NCT03374488|101827284|FG000|All Participants as Treated (APaT)|Overall Study||42||
48609272|NCT03374488|101827285|FG001|All Participants as Treated (APaT)|Overall Study||41||
48609273|NCT03374488|101827284|FG000|COMPLETED|Overall Study||23|Refers to participants that discontinued study with amendment 4, and didn't require follow-up.|
48609274|NCT03374488|101827285|FG001|COMPLETED|Overall Study||28|Refers to participants that discontinued study with amendment 4, and didn't require follow-up.|
48609275|NCT03374488|101827284|FG000|NOT COMPLETED|Overall Study||19||
48609276|NCT03374488|101827285|FG001|NOT COMPLETED|Overall Study||14||
48609277|NCT01761643|101827286|FG000|STARTED|Overall Study||198||
48609278|NCT01761643|101827287|FG001|STARTED|Overall Study||200||
48609279|NCT01761643|101827286|FG000|COMPLETED|Overall Study||166||
48609280|NCT01761643|101827287|FG001|COMPLETED|Overall Study||158||
48609281|NCT01761643|101827286|FG000|NOT COMPLETED|Overall Study||32||
48609282|NCT01761643|101827287|FG001|NOT COMPLETED|Overall Study||42||
48609283|NCT02081001|101827288|FG000|STARTED|Overall Study||2||
48609284|NCT02081001|101827289|FG001|STARTED|Overall Study||1||
48609285|NCT02081001|101827290|FG002|STARTED|Overall Study||2||
48609286|NCT02081001|101827291|FG003|STARTED|Overall Study||1||
48609287|NCT02081001|101827292|FG004|STARTED|Overall Study||3||
48609288|NCT02081001|101827293|FG005|STARTED|Overall Study||1||
48609289|NCT02081001|101827294|FG006|STARTED|Overall Study||2||
48609290|NCT02081001|101827295|FG007|STARTED|Overall Study||1||
48722348|NCT00428844|102105618|FG001|STARTED|Completed Test of Cure (TOC) Visit||18||
48609291|NCT02081001|101827296|FG008|STARTED|Overall Study||2||
48609292|NCT02081001|101827297|FG009|STARTED|Overall Study||1||
48609293|NCT02081001|101827298|FG010|STARTED|Overall Study||2||
48609294|NCT02081001|101827299|FG011|STARTED|Overall Study||1||
48609295|NCT02081001|101827288|FG000|COMPLETED|Overall Study||2||
48609296|NCT02081001|101827289|FG001|COMPLETED|Overall Study||1||
48609297|NCT02081001|101827290|FG002|COMPLETED|Overall Study||2||
48609298|NCT02081001|101827291|FG003|COMPLETED|Overall Study||1||
48609299|NCT02081001|101827292|FG004|COMPLETED|Overall Study||2||
48609300|NCT02081001|101827293|FG005|COMPLETED|Overall Study||1||
48609301|NCT02081001|101827294|FG006|COMPLETED|Overall Study||2||
48609302|NCT02081001|101827295|FG007|COMPLETED|Overall Study||1||
48609303|NCT02081001|101827296|FG008|COMPLETED|Overall Study||2||
48609304|NCT02081001|101827297|FG009|COMPLETED|Overall Study||1||
48722349|NCT00428844|102105619|FG002|STARTED|Completed Test of Cure (TOC) Visit||19||
48722350|NCT00428844|102105617|FG000|COMPLETED|Completed Test of Cure (TOC) Visit||20||
48722351|NCT00428844|102105618|FG001|COMPLETED|Completed Test of Cure (TOC) Visit||16||
48722352|NCT00428844|102105619|FG002|COMPLETED|Completed Test of Cure (TOC) Visit||17||
48722353|NCT00428844|102105617|FG000|NOT COMPLETED|Completed Test of Cure (TOC) Visit||3||
48722354|NCT00428844|102105618|FG001|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2||
48722355|NCT00428844|102105619|FG002|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2||
48722356|NCT04030247|102105620|FG000|STARTED|Overall Study||50||
48722357|NCT04030247|102105620|FG000|COMPLETED|Overall Study||33||
48722358|NCT04030247|102105620|FG000|NOT COMPLETED|Overall Study||17||
48722359|NCT02645617|102105621|FG000|STARTED|Overall Study||12||
48722360|NCT02645617|102105621|FG000|COMPLETED|Overall Study||12||
48722361|NCT02645617|102105621|FG000|NOT COMPLETED|Overall Study||0||
48722362|NCT02265796|102105622|FG000|STARTED|Overall Study||25||
48722363|NCT02265796|102105623|FG001|STARTED|Overall Study||25||
48722364|NCT02265796|102105622|FG000|COMPLETED|Overall Study||22||
48722365|NCT02265796|102105623|FG001|COMPLETED|Overall Study||24||
48722366|NCT02265796|102105622|FG000|NOT COMPLETED|Overall Study||3||
48722367|NCT02265796|102105623|FG001|NOT COMPLETED|Overall Study||1||
48722368|NCT00820872|102105624|FG000|STARTED|Overall Study||30||
48722369|NCT00820872|102105624|FG000|COMPLETED|Overall Study||30||
48722370|NCT00820872|102105624|FG000|NOT COMPLETED|Overall Study||0||
48722371|NCT00626405|102105625|FG000|STARTED|Overall Study||43||
48722372|NCT00626405|102105626|FG001|STARTED|Overall Study||52||
48722373|NCT00626405|102105625|FG000|COMPLETED|Overall Study||42||
48722374|NCT00626405|102105626|FG001|COMPLETED|Overall Study||51||
48722375|NCT00626405|102105625|FG000|NOT COMPLETED|Overall Study||1||
48722376|NCT00626405|102105626|FG001|NOT COMPLETED|Overall Study||1||
48722377|NCT03743064|102105627|FG000|STARTED|Overall Study||154|Randomized|
48722378|NCT03743064|102105628|FG001|STARTED|Overall Study||164|Randomized|
48722379|NCT03743064|102105627|FG000|Treated|Overall Study||154||
48722380|NCT03743064|102105628|FG001|Treated|Overall Study||164||
48722381|NCT03743064|102105627|FG000|COMPLETED|Overall Study||83||
48722382|NCT03743064|102105628|FG001|COMPLETED|Overall Study||90||
48722383|NCT03743064|102105627|FG000|NOT COMPLETED|Overall Study||71||
48722384|NCT03743064|102105628|FG001|NOT COMPLETED|Overall Study||74||
48722385|NCT03848949|102105629|FG000|STARTED|Overall Study||54||
48722386|NCT03848949|102105630|FG001|STARTED|Overall Study||53||
48722387|NCT03848949|102105629|FG000|COMPLETED|Overall Study||49||
48722388|NCT03848949|102105630|FG001|COMPLETED|Overall Study||46||
48722389|NCT03848949|102105629|FG000|NOT COMPLETED|Overall Study||5||
48722390|NCT03848949|102105630|FG001|NOT COMPLETED|Overall Study||7||
48722391|NCT00303511|102105631|FG000|STARTED|Overall Study||10||
48722392|NCT00303511|102105631|FG000|COMPLETED|Overall Study||10||
48722393|NCT00303511|102105631|FG000|NOT COMPLETED|Overall Study||0||
48722394|NCT00444067|102105632|FG000|STARTED|Overall Study||74||
48722395|NCT00444067|102105633|FG001|STARTED|Overall Study||24||
48722396|NCT00444067|102105632|FG000|COMPLETED|Overall Study||74||
48722397|NCT00444067|102105633|FG001|COMPLETED|Overall Study||23||
48722398|NCT00444067|102105632|FG000|NOT COMPLETED|Overall Study||0||
48722399|NCT00444067|102105633|FG001|NOT COMPLETED|Overall Study||1||
48609305|NCT02081001|101827298|FG010|COMPLETED|Overall Study||2||
48609306|NCT02081001|101827299|FG011|COMPLETED|Overall Study||1||
48609307|NCT02081001|101827288|FG000|NOT COMPLETED|Overall Study||0||
48609308|NCT02081001|101827289|FG001|NOT COMPLETED|Overall Study||0||
48609309|NCT02081001|101827290|FG002|NOT COMPLETED|Overall Study||0||
48609310|NCT02081001|101827291|FG003|NOT COMPLETED|Overall Study||0||
48609311|NCT02081001|101827292|FG004|NOT COMPLETED|Overall Study||1||
48722400|NCT00462748|102105634|FG000|STARTED|Overall Study||261||
48722401|NCT00462748|102105635|FG001|STARTED|Overall Study||263||
48722402|NCT00462748|102105636|FG002|STARTED|Overall Study||262||
48722403|NCT00462748|102105634|FG000|COMPLETED|Overall Study||249||
48722404|NCT00462748|102105635|FG001|COMPLETED|Overall Study||252||
48722405|NCT00462748|102105636|FG002|COMPLETED|Overall Study||251||
48609312|NCT02081001|101827293|FG005|NOT COMPLETED|Overall Study||0||
48609313|NCT02081001|101827294|FG006|NOT COMPLETED|Overall Study||0||
48722406|NCT00462748|102105634|FG000|NOT COMPLETED|Overall Study||12||
48722407|NCT00462748|102105635|FG001|NOT COMPLETED|Overall Study||11||
48722408|NCT00462748|102105636|FG002|NOT COMPLETED|Overall Study||11||
48722409|NCT03046225|102105637|FG000|STARTED|Overall Study||13||
48406340|NCT01462045|101328402|FG002|COMPLETED|Overall Study||7||
48406341|NCT01462045|101328400|FG000|NOT COMPLETED|Overall Study||0||
48406342|NCT01462045|101328401|FG001|NOT COMPLETED|Overall Study||1||
48406343|NCT01462045|101328402|FG002|NOT COMPLETED|Overall Study||0||
48406344|NCT02692560|101328403|FG000|STARTED|Overall Study||29||
48406345|NCT02692560|101328404|FG001|STARTED|Overall Study||31||
48406346|NCT02692560|101328403|FG000|COMPLETED|Overall Study||29||
48406347|NCT02692560|101328404|FG001|COMPLETED|Overall Study||25||
48406348|NCT02692560|101328403|FG000|NOT COMPLETED|Overall Study||0||
48188712|NCT02034435|100783313|FG001|NOT COMPLETED|Overall Study||2||
48307462|NCT01560923|101077645|FG001|COMPLETED|Overall Study||22||
48307463|NCT01560923|101077644|FG000|NOT COMPLETED|Overall Study||0||
48307464|NCT01560923|101077645|FG001|NOT COMPLETED|Overall Study||0||
48307465|NCT00493220|101077646|FG000|STARTED|First Intervention||5||
48307466|NCT00493220|101077647|FG001|STARTED|First Intervention||5||
48307467|NCT00493220|101077648|FG002|STARTED|First Intervention||5||
48307468|NCT00493220|101077649|FG003|STARTED|First Intervention||5||
48307469|NCT00493220|101077650|FG004|STARTED|First Intervention||5||
48307470|NCT00493220|101077651|FG005|STARTED|First Intervention||5||
48307471|NCT00493220|101077646|FG000|COMPLETED|First Intervention||5||
48307472|NCT00493220|101077647|FG001|COMPLETED|First Intervention||5||
48307473|NCT00493220|101077648|FG002|COMPLETED|First Intervention||5||
48307474|NCT00493220|101077649|FG003|COMPLETED|First Intervention||5||
48307475|NCT00493220|101077650|FG004|COMPLETED|First Intervention||5||
48307476|NCT00493220|101077651|FG005|COMPLETED|First Intervention||5||
48307477|NCT00493220|101077646|FG000|NOT COMPLETED|First Intervention||0||
48307478|NCT00493220|101077647|FG001|NOT COMPLETED|First Intervention||0||
48307479|NCT00493220|101077648|FG002|NOT COMPLETED|First Intervention||0||
48307480|NCT00493220|101077649|FG003|NOT COMPLETED|First Intervention||0||
48307481|NCT00493220|101077650|FG004|NOT COMPLETED|First Intervention||0||
48307482|NCT00493220|101077651|FG005|NOT COMPLETED|First Intervention||0||
48307483|NCT00493220|101077646|FG000|STARTED|First 7-Day Washout & Safety Follow-up||5||
48307484|NCT00493220|101077647|FG001|STARTED|First 7-Day Washout & Safety Follow-up||5||
48307485|NCT00493220|101077648|FG002|STARTED|First 7-Day Washout & Safety Follow-up||5||
48307486|NCT00493220|101077649|FG003|STARTED|First 7-Day Washout & Safety Follow-up||5||
48307487|NCT00493220|101077650|FG004|STARTED|First 7-Day Washout & Safety Follow-up||5||
48307488|NCT00493220|101077651|FG005|STARTED|First 7-Day Washout & Safety Follow-up||5||
48307489|NCT00493220|101077646|FG000|COMPLETED|First 7-Day Washout & Safety Follow-up||5||
48307490|NCT00493220|101077647|FG001|COMPLETED|First 7-Day Washout & Safety Follow-up||5||
48307491|NCT00493220|101077648|FG002|COMPLETED|First 7-Day Washout & Safety Follow-up||5||
48307492|NCT00493220|101077649|FG003|COMPLETED|First 7-Day Washout & Safety Follow-up||5||
48307493|NCT00493220|101077650|FG004|COMPLETED|First 7-Day Washout & Safety Follow-up||5||
48307494|NCT00493220|101077651|FG005|COMPLETED|First 7-Day Washout & Safety Follow-up||5||
48307495|NCT00493220|101077646|FG000|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0||
48307496|NCT00493220|101077647|FG001|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0||
48307497|NCT00493220|101077648|FG002|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0||
48609314|NCT02081001|101827295|FG007|NOT COMPLETED|Overall Study||0||
48307498|NCT00493220|101077649|FG003|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0||
48609315|NCT02081001|101827296|FG008|NOT COMPLETED|Overall Study||0||
48609316|NCT02081001|101827297|FG009|NOT COMPLETED|Overall Study||0||
48609317|NCT02081001|101827298|FG010|NOT COMPLETED|Overall Study||0||
48307499|NCT00493220|101077650|FG004|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0||
48307500|NCT00493220|101077651|FG005|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0||
48307501|NCT00493220|101077646|FG000|STARTED|Second Intervention||5||
48307502|NCT00493220|101077647|FG001|STARTED|Second Intervention||5||
48307503|NCT00493220|101077648|FG002|STARTED|Second Intervention||5||
48307504|NCT00493220|101077649|FG003|STARTED|Second Intervention||5||
48307505|NCT00493220|101077650|FG004|STARTED|Second Intervention||5||
48609318|NCT02081001|101827299|FG011|NOT COMPLETED|Overall Study||0||
48609319|NCT01931397|101827300|FG000|STARTED|Overall Study||30||
48609320|NCT01931397|101827300|FG000|COMPLETED|Overall Study||19||
48307506|NCT00493220|101077651|FG005|STARTED|Second Intervention||5||
48307507|NCT00493220|101077646|FG000|COMPLETED|Second Intervention||5||
48307508|NCT00493220|101077647|FG001|COMPLETED|Second Intervention||5||
48307509|NCT00493220|101077648|FG002|COMPLETED|Second Intervention||5||
48307510|NCT00493220|101077649|FG003|COMPLETED|Second Intervention||5||
48307511|NCT00493220|101077650|FG004|COMPLETED|Second Intervention||5||
48307512|NCT00493220|101077651|FG005|COMPLETED|Second Intervention||5||
48609321|NCT01931397|101827300|FG000|NOT COMPLETED|Overall Study||11||
48609322|NCT03272347|101827301|FG000|STARTED|Overall Study||31||
48609323|NCT03272347|101827302|FG001|STARTED|Overall Study||30||
48609324|NCT03272347|101827303|FG002|STARTED|Overall Study||31||
48609325|NCT03272347|101827304|FG003|STARTED|Overall Study||31||
48609326|NCT03272347|101827301|FG000|Treated|Overall Study||29||
48609327|NCT03272347|101827302|FG001|Treated|Overall Study||30||
48609328|NCT03272347|101827303|FG002|Treated|Overall Study||31||
48609329|NCT03272347|101827304|FG003|Treated|Overall Study||31||
48609330|NCT03272347|101827301|FG000|COMPLETED|Overall Study||20||
48609331|NCT03272347|101827302|FG001|COMPLETED|Overall Study||24||
48722410|NCT03046225|102105638|FG001|STARTED|Overall Study||13||
48722411|NCT03046225|102105637|FG000|COMPLETED|Overall Study||13||
48722412|NCT03046225|102105638|FG001|COMPLETED|Overall Study||13||
48722413|NCT03046225|102105637|FG000|NOT COMPLETED|Overall Study||0||
48722414|NCT03046225|102105638|FG001|NOT COMPLETED|Overall Study||0||
48722415|NCT01175395|102108150|FG000|STARTED|Overall Study||10||
48722416|NCT01175395|102108150|FG000|COMPLETED|Overall Study||10||
48722417|NCT01175395|102108150|FG000|NOT COMPLETED|Overall Study||0||
48722418|NCT00295932|102108151|FG000|STARTED|Overall Study||4||
48722419|NCT00295932|102108152|FG001|STARTED|Overall Study||6||
48722420|NCT00295932|102108153|FG002|STARTED|Overall Study||3||
48722421|NCT00295932|102108154|FG003|STARTED|Overall Study||4||
48722422|NCT00295932|102108155|FG004|STARTED|Overall Study||2||
48722423|NCT00295932|102108156|FG005|STARTED|Overall Study||18||
48722424|NCT00295932|102108157|FG006|STARTED|Overall Study||3||
48722425|NCT00295932|102108158|FG007|STARTED|Overall Study||4||
48722426|NCT00295932|102108159|FG008|STARTED|Overall Study||10||
48722427|NCT00295932|102108160|FG009|STARTED|Overall Study||12||
48722428|NCT00295932|102108161|FG010|STARTED|Overall Study||13||
48722429|NCT00295932|102108151|FG000|COMPLETED|Overall Study||4||
48722430|NCT00295932|102108152|FG001|COMPLETED|Overall Study||6||
48722431|NCT00295932|102108153|FG002|COMPLETED|Overall Study||3||
48609332|NCT03272347|101827303|FG002|COMPLETED|Overall Study||19||
48609333|NCT03272347|101827304|FG003|COMPLETED|Overall Study||24||
48609334|NCT03272347|101827301|FG000|NOT COMPLETED|Overall Study||11||
48609335|NCT03272347|101827302|FG001|NOT COMPLETED|Overall Study||6||
48609336|NCT03272347|101827303|FG002|NOT COMPLETED|Overall Study||12||
48609337|NCT03272347|101827304|FG003|NOT COMPLETED|Overall Study||7||
48307513|NCT00493220|101077646|FG000|NOT COMPLETED|Second Intervention||0||
48307514|NCT00493220|101077647|FG001|NOT COMPLETED|Second Intervention||0||
48307515|NCT00493220|101077648|FG002|NOT COMPLETED|Second Intervention||0||
48307516|NCT00493220|101077649|FG003|NOT COMPLETED|Second Intervention||0||
48307517|NCT00493220|101077650|FG004|NOT COMPLETED|Second Intervention||0||
48609338|NCT00212264|101827305|FG000|STARTED|Overall Study||70||
48609339|NCT00212264|101827306|FG001|STARTED|Overall Study||70||
48609340|NCT00212264|101827307|FG002|STARTED|Overall Study||68||
48609341|NCT00212264|101827305|FG000|COMPLETED|Overall Study||58||
48722432|NCT00295932|102108154|FG003|COMPLETED|Overall Study||4||
48722433|NCT00295932|102108155|FG004|COMPLETED|Overall Study||2||
48722434|NCT00295932|102108156|FG005|COMPLETED|Overall Study||18||
48722435|NCT00295932|102108157|FG006|COMPLETED|Overall Study||3||
48722436|NCT00295932|102108158|FG007|COMPLETED|Overall Study||4||
48722437|NCT00295932|102108159|FG008|COMPLETED|Overall Study||10||
48722438|NCT00295932|102108160|FG009|COMPLETED|Overall Study||12||
48609342|NCT00212264|101827306|FG001|COMPLETED|Overall Study||54||
48609343|NCT00212264|101827307|FG002|COMPLETED|Overall Study||64||
48609344|NCT00212264|101827305|FG000|NOT COMPLETED|Overall Study||12||
48609345|NCT00212264|101827306|FG001|NOT COMPLETED|Overall Study||16||
48722439|NCT00295932|102108161|FG010|COMPLETED|Overall Study||12||
48722440|NCT00295932|102108151|FG000|NOT COMPLETED|Overall Study||0||
48722441|NCT00295932|102108152|FG001|NOT COMPLETED|Overall Study||0||
48307518|NCT00493220|101077651|FG005|NOT COMPLETED|Second Intervention||0||
48609346|NCT00212264|101827307|FG002|NOT COMPLETED|Overall Study||4||
48609347|NCT02532283|101827308|FG000|STARTED|Overall Study||64||
48609348|NCT02532283|101827309|FG001|STARTED|Overall Study||35||
48609349|NCT02532283|101827308|FG000|Full Analysis Set|Overall Study||63||
48722442|NCT00295932|102108153|FG002|NOT COMPLETED|Overall Study||0||
48307519|NCT00493220|101077646|FG000|STARTED|Second 7-Day Washout & Safety Follow-up||5||
48307520|NCT00493220|101077647|FG001|STARTED|Second 7-Day Washout & Safety Follow-up||5||
48307521|NCT00493220|101077648|FG002|STARTED|Second 7-Day Washout & Safety Follow-up||5||
48307522|NCT00493220|101077649|FG003|STARTED|Second 7-Day Washout & Safety Follow-up||5||
48307523|NCT00493220|101077650|FG004|STARTED|Second 7-Day Washout & Safety Follow-up||5||
48307524|NCT00493220|101077651|FG005|STARTED|Second 7-Day Washout & Safety Follow-up||5||
48307525|NCT00493220|101077646|FG000|COMPLETED|Second 7-Day Washout & Safety Follow-up||5||
48307526|NCT00493220|101077647|FG001|COMPLETED|Second 7-Day Washout & Safety Follow-up||5||
48307527|NCT00493220|101077648|FG002|COMPLETED|Second 7-Day Washout & Safety Follow-up||5||
48307528|NCT00493220|101077649|FG003|COMPLETED|Second 7-Day Washout & Safety Follow-up||5||
48307529|NCT00493220|101077650|FG004|COMPLETED|Second 7-Day Washout & Safety Follow-up||5||
48307530|NCT00493220|101077651|FG005|COMPLETED|Second 7-Day Washout & Safety Follow-up||5||
48307531|NCT00493220|101077646|FG000|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0||
48307532|NCT00493220|101077647|FG001|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0||
48307533|NCT00493220|101077648|FG002|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0||
48307534|NCT00493220|101077649|FG003|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0||
48307535|NCT00493220|101077650|FG004|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0||
48307536|NCT00493220|101077651|FG005|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0||
48307537|NCT00493220|101077646|FG000|STARTED|Third Intervention||5||
48307538|NCT00493220|101077647|FG001|STARTED|Third Intervention||5||
48307539|NCT00493220|101077648|FG002|STARTED|Third Intervention||5||
48307540|NCT00493220|101077649|FG003|STARTED|Third Intervention||5||
48307541|NCT00493220|101077650|FG004|STARTED|Third Intervention||5||
48307542|NCT00493220|101077651|FG005|STARTED|Third Intervention||5||
48307543|NCT00493220|101077646|FG000|COMPLETED|Third Intervention||4||
48307544|NCT00493220|101077647|FG001|COMPLETED|Third Intervention||5||
48307545|NCT00493220|101077648|FG002|COMPLETED|Third Intervention||5||
48307546|NCT00493220|101077649|FG003|COMPLETED|Third Intervention||5||
48307547|NCT00493220|101077650|FG004|COMPLETED|Third Intervention||5||
48307548|NCT00493220|101077651|FG005|COMPLETED|Third Intervention||5||
48307549|NCT00493220|101077646|FG000|NOT COMPLETED|Third Intervention||1||
48307550|NCT00493220|101077647|FG001|NOT COMPLETED|Third Intervention||0||
48307551|NCT00493220|101077648|FG002|NOT COMPLETED|Third Intervention||0||
48307552|NCT00493220|101077649|FG003|NOT COMPLETED|Third Intervention||0||
48307553|NCT00493220|101077650|FG004|NOT COMPLETED|Third Intervention||0||
48307554|NCT00493220|101077651|FG005|NOT COMPLETED|Third Intervention||0||
48307555|NCT00493220|101077646|FG000|STARTED|Final 7-Day Safety Follow-up||4||
48307556|NCT00493220|101077647|FG001|STARTED|Final 7-Day Safety Follow-up||5||
48307557|NCT00493220|101077648|FG002|STARTED|Final 7-Day Safety Follow-up||5||
48307558|NCT00493220|101077649|FG003|STARTED|Final 7-Day Safety Follow-up||5||
48307559|NCT00493220|101077650|FG004|STARTED|Final 7-Day Safety Follow-up||5||
48307560|NCT00493220|101077651|FG005|STARTED|Final 7-Day Safety Follow-up||5||
48307561|NCT00493220|101077646|FG000|COMPLETED|Final 7-Day Safety Follow-up||4||
48307562|NCT00493220|101077647|FG001|COMPLETED|Final 7-Day Safety Follow-up||5||
48307563|NCT00493220|101077648|FG002|COMPLETED|Final 7-Day Safety Follow-up||5||
48307564|NCT00493220|101077649|FG003|COMPLETED|Final 7-Day Safety Follow-up||5||
48307565|NCT00493220|101077650|FG004|COMPLETED|Final 7-Day Safety Follow-up||5||
48307566|NCT00493220|101077651|FG005|COMPLETED|Final 7-Day Safety Follow-up||5||
48307567|NCT00493220|101077646|FG000|NOT COMPLETED|Final 7-Day Safety Follow-up||0||
48307568|NCT00493220|101077647|FG001|NOT COMPLETED|Final 7-Day Safety Follow-up||0||
48307569|NCT00493220|101077648|FG002|NOT COMPLETED|Final 7-Day Safety Follow-up||0||
48307570|NCT00493220|101077649|FG003|NOT COMPLETED|Final 7-Day Safety Follow-up||0||
48307571|NCT00493220|101077650|FG004|NOT COMPLETED|Final 7-Day Safety Follow-up||0||
48307572|NCT00493220|101077651|FG005|NOT COMPLETED|Final 7-Day Safety Follow-up||0||
48307573|NCT03239483|101077652|FG000|STARTED|Overall Study||19|one participant withdrew consent and did not receive any study product|
48307574|NCT03239483|101077653|FG001|STARTED|Overall Study||9|one participant withdrew consent and did not receive any study product|
48307575|NCT03239483|101077652|FG000|COMPLETED|Overall Study||17||
48307576|NCT03239483|101077653|FG001|COMPLETED|Overall Study||9||
48307577|NCT03239483|101077652|FG000|NOT COMPLETED|Overall Study||2||
48307578|NCT03239483|101077653|FG001|NOT COMPLETED|Overall Study||0||
48307579|NCT01514136|101077654|FG000|STARTED|Test Period 1; Test A||25||
48152261|NCT00526630|100695965|FG001|COMPLETED|First Intervention Period - 12 Weeks||8||
48152262|NCT00526630|100695964|FG000|NOT COMPLETED|First Intervention Period - 12 Weeks||0||
48152263|NCT00526630|100695965|FG001|NOT COMPLETED|First Intervention Period - 12 Weeks||3||
48152264|NCT00526630|100695964|FG000|STARTED|Second Intervention Period - 12 Weeks||12||
48152265|NCT00526630|100695965|FG001|STARTED|Second Intervention Period - 12 Weeks||8||
48152266|NCT00526630|100695964|FG000|COMPLETED|Second Intervention Period - 12 Weeks||10||
48152267|NCT00526630|100695965|FG001|COMPLETED|Second Intervention Period - 12 Weeks||7||
48152268|NCT00526630|100695964|FG000|NOT COMPLETED|Second Intervention Period - 12 Weeks||2||
48152269|NCT00526630|100695965|FG001|NOT COMPLETED|Second Intervention Period - 12 Weeks||1||
48152270|NCT03384173|100695966|FG000|STARTED|Overall Study||35||
48152271|NCT03384173|100695966|FG000|COMPLETED|Overall Study||35||
48152272|NCT03384173|100695966|FG000|NOT COMPLETED|Overall Study||0||
48152273|NCT02001194|100695967|FG000|STARTED|Intervention Period (13 Weeks)||68||
48152274|NCT02001194|100695968|FG001|STARTED|Intervention Period (13 Weeks)||80||
48152275|NCT02001194|100695969|FG002|STARTED|Intervention Period (13 Weeks)||76||
48152276|NCT02001194|100695970|FG003|STARTED|Intervention Period (13 Weeks)||80||
48152277|NCT02001194|100695967|FG000|COMPLETED|Intervention Period (13 Weeks)||67||
48152278|NCT02001194|100695968|FG001|COMPLETED|Intervention Period (13 Weeks)||80||
48152279|NCT02001194|100695969|FG002|COMPLETED|Intervention Period (13 Weeks)||74||
48152280|NCT02001194|100695970|FG003|COMPLETED|Intervention Period (13 Weeks)||78||
48152281|NCT02001194|100695967|FG000|NOT COMPLETED|Intervention Period (13 Weeks)||1||
48152282|NCT02001194|100695968|FG001|NOT COMPLETED|Intervention Period (13 Weeks)||0||
48152283|NCT02001194|100695969|FG002|NOT COMPLETED|Intervention Period (13 Weeks)||2||
48152284|NCT02001194|100695970|FG003|NOT COMPLETED|Intervention Period (13 Weeks)||2||
48152285|NCT02001194|100695967|FG000|STARTED|Follow-Up Period (13 Weeks)||67||
48406349|NCT02692560|101328404|FG001|NOT COMPLETED|Overall Study||6||
48406350|NCT00954824|101328405|FG000|STARTED|Overall Study||100||
48406351|NCT00954824|101328405|FG000|COMPLETED|Overall Study||50||
48406352|NCT00954824|101328405|FG000|NOT COMPLETED|Overall Study||50||
48406353|NCT03580525|101328406|FG000|STARTED|Overall Study||23||
48406354|NCT03580525|101328406|FG000|Nicotine Saline Infusion 0.00mcg/kg/s|Overall Study||22||
48406355|NCT03580525|101328406|FG000|Nicotine Infusion 0.24mcg/kg/s|Overall Study||23||
48406356|NCT03580525|101328406|FG000|Nicotine Infusion 0.096mcg/kg/s|Overall Study||23||
48406357|NCT03580525|101328406|FG000|Nicotine Infusion 0.048mcg/kg/s|Overall Study||22||
48406358|NCT03580525|101328406|FG000|Nicotine Infusion 0.024mcg/kg/s|Overall Study||23||
48406359|NCT03580525|101328406|FG000|COMPLETED|Overall Study||22||
48406360|NCT03580525|101328406|FG000|NOT COMPLETED|Overall Study||1||
48609350|NCT02532283|101827309|FG001|Full Analysis Set|Overall Study||32||
48609351|NCT02532283|101827308|FG000|COMPLETED|Overall Study||55||
48307580|NCT01514136|101077655|FG001|STARTED|Test Period 1; Test A||0||
48307581|NCT01514136|101077656|FG002|STARTED|Test Period 1; Test A||0||
48307582|NCT01514136|101077657|FG003|STARTED|Test Period 1; Test A||0||
48307583|NCT01514136|101077658|FG004|STARTED|Test Period 1; Test A||0||
48307584|NCT01514136|101077659|FG005|STARTED|Test Period 1; Test A||0||
48307585|NCT01514136|101077660|FG006|STARTED|Test Period 1; Test A||0||
48307586|NCT01514136|101077661|FG007|STARTED|Test Period 1; Test A||0||
48307587|NCT01514136|101077654|FG000|COMPLETED|Test Period 1; Test A||22||
48307588|NCT01514136|101077655|FG001|COMPLETED|Test Period 1; Test A||0||
48307589|NCT01514136|101077656|FG002|COMPLETED|Test Period 1; Test A||0||
48307590|NCT01514136|101077657|FG003|COMPLETED|Test Period 1; Test A||0||
48307591|NCT01514136|101077658|FG004|COMPLETED|Test Period 1; Test A||0||
48307592|NCT01514136|101077659|FG005|COMPLETED|Test Period 1; Test A||0||
48307593|NCT01514136|101077660|FG006|COMPLETED|Test Period 1; Test A||0||
48307594|NCT01514136|101077661|FG007|COMPLETED|Test Period 1; Test A||0||
48307595|NCT01514136|101077654|FG000|NOT COMPLETED|Test Period 1; Test A||3||
48307596|NCT01514136|101077655|FG001|NOT COMPLETED|Test Period 1; Test A||0||
48307597|NCT01514136|101077656|FG002|NOT COMPLETED|Test Period 1; Test A||0||
48307598|NCT01514136|101077657|FG003|NOT COMPLETED|Test Period 1; Test A||0||
48307599|NCT01514136|101077658|FG004|NOT COMPLETED|Test Period 1; Test A||0||
48307600|NCT01514136|101077659|FG005|NOT COMPLETED|Test Period 1; Test A||0||
48307601|NCT01514136|101077660|FG006|NOT COMPLETED|Test Period 1; Test A||0||
48307602|NCT01514136|101077661|FG007|NOT COMPLETED|Test Period 1; Test A||0||
48307603|NCT01514136|101077654|FG000|STARTED|Test Period 1; Test B||0||
48307604|NCT01514136|101077655|FG001|STARTED|Test Period 1; Test B||24||
48307605|NCT01514136|101077656|FG002|STARTED|Test Period 1; Test B||0||
48307606|NCT01514136|101077657|FG003|STARTED|Test Period 1; Test B||0||
48307607|NCT01514136|101077658|FG004|STARTED|Test Period 1; Test B||0||
48406361|NCT04480749|101328407|FG000|STARTED|Overall Study||50||
48406362|NCT04480749|101328408|FG001|STARTED|Overall Study||50||
48406363|NCT04480749|101328407|FG000|COMPLETED|Overall Study||50||
48406364|NCT04480749|101328408|FG001|COMPLETED|Overall Study||50||
48609352|NCT02532283|101827309|FG001|COMPLETED|Overall Study||30||
48609353|NCT02532283|101827308|FG000|NOT COMPLETED|Overall Study||9||
48609354|NCT02532283|101827309|FG001|NOT COMPLETED|Overall Study||5||
48609355|NCT03134911|101827310|FG000|STARTED|Overall Study||535||
48609356|NCT03134911|101827310|FG000|COMPLETED|Overall Study||501||
48609357|NCT03134911|101827310|FG000|NOT COMPLETED|Overall Study||34||
48609358|NCT02903420|101827311|FG000|STARTED|Overall Study||28||
48188713|NCT02034435|100783314|FG002|NOT COMPLETED|Overall Study||0||
48188714|NCT02034435|100783315|FG003|NOT COMPLETED|Overall Study||1||
48609359|NCT02903420|101827311|FG000|COMPLETED|Overall Study||25||
48609360|NCT02903420|101827311|FG000|NOT COMPLETED|Overall Study||3||
48609361|NCT00547157|101827312|FG000|STARTED|Overall Study||90||
48609362|NCT00547157|101827313|FG001|STARTED|Overall Study||62||
48609363|NCT00547157|101827312|FG000|COMPLETED|Overall Study||41||
48609364|NCT00547157|101827313|FG001|COMPLETED|Overall Study||39||
48609365|NCT00547157|101827312|FG000|NOT COMPLETED|Overall Study||49||
48609366|NCT00547157|101827313|FG001|NOT COMPLETED|Overall Study||23||
48609367|NCT00070564|101827314|FG000|STARTED|Overall Study||678||
48609368|NCT00070564|101827315|FG001|STARTED|Overall Study||693||
48188715|NCT04207255|100783316|FG000|STARTED|Overall Study||27||
48188716|NCT04207255|100783317|FG001|STARTED|Overall Study||36||
48188717|NCT04207255|100783318|FG002|STARTED|Overall Study||3||
48188718|NCT04207255|100783319|FG003|STARTED|Overall Study||3||
48188719|NCT04207255|100783316|FG000|COMPLETED|Overall Study||27||
48188720|NCT04207255|100783317|FG001|COMPLETED|Overall Study||36||
48188721|NCT04207255|100783318|FG002|COMPLETED|Overall Study||3||
48188722|NCT04207255|100783319|FG003|COMPLETED|Overall Study||3||
48188723|NCT04207255|100783316|FG000|NOT COMPLETED|Overall Study||0||
48188724|NCT04207255|100783317|FG001|NOT COMPLETED|Overall Study||0||
48188725|NCT04207255|100783318|FG002|NOT COMPLETED|Overall Study||0||
48188726|NCT04207255|100783319|FG003|NOT COMPLETED|Overall Study||0||
48609369|NCT00070564|101827316|FG002|STARTED|Overall Study||697||
48609370|NCT00070564|101827317|FG003|STARTED|Overall Study||648||
48609371|NCT00070564|101827318|FG004|STARTED|Overall Study||282||
48609372|NCT00070564|101827319|FG005|STARTED|Overall Study||296||
48609373|NCT00070564|101827314|FG000|COMPLETED|Overall Study||478||
48609374|NCT00070564|101827315|FG001|COMPLETED|Overall Study||490||
48609375|NCT00070564|101827316|FG002|COMPLETED|Overall Study||526||
48609376|NCT00070564|101827317|FG003|COMPLETED|Overall Study||481||
48307608|NCT01514136|101077659|FG005|STARTED|Test Period 1; Test B||0||
48307609|NCT01514136|101077660|FG006|STARTED|Test Period 1; Test B||0||
48307610|NCT01514136|101077661|FG007|STARTED|Test Period 1; Test B||0||
48307611|NCT01514136|101077654|FG000|COMPLETED|Test Period 1; Test B||0||
48307612|NCT01514136|101077655|FG001|COMPLETED|Test Period 1; Test B||23||
48307613|NCT01514136|101077656|FG002|COMPLETED|Test Period 1; Test B||0||
48307614|NCT01514136|101077657|FG003|COMPLETED|Test Period 1; Test B||0||
48307615|NCT01514136|101077658|FG004|COMPLETED|Test Period 1; Test B||0||
48609377|NCT00070564|101827318|FG004|COMPLETED|Overall Study||203||
48609378|NCT00070564|101827319|FG005|COMPLETED|Overall Study||244||
48609379|NCT00070564|101827314|FG000|NOT COMPLETED|Overall Study||200||
48609380|NCT00070564|101827315|FG001|NOT COMPLETED|Overall Study||203||
48609381|NCT00070564|101827316|FG002|NOT COMPLETED|Overall Study||171||
48609382|NCT00070564|101827317|FG003|NOT COMPLETED|Overall Study||167||
48609383|NCT00070564|101827318|FG004|NOT COMPLETED|Overall Study||79||
48609384|NCT00070564|101827319|FG005|NOT COMPLETED|Overall Study||52||
48609385|NCT01563198|101827320|FG000|STARTED|Baseline||49733||3
48609386|NCT01563198|101827320|FG000|COMPLETED|Baseline||49733||3
48609387|NCT01563198|101827320|FG000|NOT COMPLETED|Baseline||0||0
48609388|NCT01563198|101827320|FG000|STARTED|After Training||47979||3
48609389|NCT01563198|101827320|FG000|COMPLETED|After Training||47979||3
48609390|NCT01563198|101827320|FG000|NOT COMPLETED|After Training||0||0
48609391|NCT04388176|101827321|FG000|STARTED|Overall Study||6||
48609392|NCT04388176|101827322|FG001|STARTED|Overall Study||6||
48609393|NCT04388176|101827321|FG000|COMPLETED|Overall Study||6||
48307616|NCT01514136|101077659|FG005|COMPLETED|Test Period 1; Test B||0||
48307617|NCT01514136|101077660|FG006|COMPLETED|Test Period 1; Test B||0||
48307618|NCT01514136|101077661|FG007|COMPLETED|Test Period 1; Test B||0||
48307619|NCT01514136|101077654|FG000|NOT COMPLETED|Test Period 1; Test B||0||
48307620|NCT01514136|101077655|FG001|NOT COMPLETED|Test Period 1; Test B||1||
48307621|NCT01514136|101077656|FG002|NOT COMPLETED|Test Period 1; Test B||0||
48406365|NCT04480749|101328407|FG000|NOT COMPLETED|Overall Study||0||
48406366|NCT04480749|101328408|FG001|NOT COMPLETED|Overall Study||0||
48406367|NCT02550093|101328409|FG000|STARTED|Intervention 1||10||
48406368|NCT02550093|101328410|FG001|STARTED|Intervention 1||10||
48406369|NCT02550093|101328409|FG000|COMPLETED|Intervention 1||10||
48406370|NCT02550093|101328410|FG001|COMPLETED|Intervention 1||10||
48406371|NCT02550093|101328409|FG000|NOT COMPLETED|Intervention 1||0||
48406372|NCT02550093|101328410|FG001|NOT COMPLETED|Intervention 1||0||
48406373|NCT02550093|101328409|FG000|STARTED|Wash-out Period||10||
48609394|NCT04388176|101827322|FG001|COMPLETED|Overall Study||6||
48609395|NCT04388176|101827321|FG000|NOT COMPLETED|Overall Study||0||
48609396|NCT04388176|101827322|FG001|NOT COMPLETED|Overall Study||0||
48609397|NCT02849704|101827323|FG000|STARTED|Washout Period - CP Subj on PERT - 3days||11|Subjects with a diagnosis of CP and who were taking PERT participated in this Period|
48609398|NCT02849704|101827324|FG001|STARTED|Washout Period - CP Subj on PERT - 3days||0|Subjects with a diagnosis of CP and who were taking PERT participated in this Period|
48609399|NCT02849704|101827323|FG000|COMPLETED|Washout Period - CP Subj on PERT - 3days||11||
48609400|NCT02849704|101827324|FG001|COMPLETED|Washout Period - CP Subj on PERT - 3days||0||
48609401|NCT02849704|101827323|FG000|NOT COMPLETED|Washout Period - CP Subj on PERT - 3days||0||
48609402|NCT02849704|101827324|FG001|NOT COMPLETED|Washout Period - CP Subj on PERT - 3days||0||
48609403|NCT02849704|101827323|FG000|STARTED|Baseline Assessments - All Subj - 7 Days||24||
48609404|NCT02849704|101827324|FG001|STARTED|Baseline Assessments - All Subj - 7 Days||24||
48609405|NCT02849704|101827323|FG000|COMPLETED|Baseline Assessments - All Subj - 7 Days||24||
48609406|NCT02849704|101827324|FG001|COMPLETED|Baseline Assessments - All Subj - 7 Days||24||
48609407|NCT02849704|101827323|FG000|NOT COMPLETED|Baseline Assessments - All Subj - 7 Days||0||
48609408|NCT02849704|101827324|FG001|NOT COMPLETED|Baseline Assessments - All Subj - 7 Days||0||
48609409|NCT02849704|101827323|FG000|STARTED|Assessment on PERT - CP Subj - 16 Days||24||
48609410|NCT02849704|101827324|FG001|STARTED|Assessment on PERT - CP Subj - 16 Days||0||
48609411|NCT02849704|101827323|FG000|COMPLETED|Assessment on PERT - CP Subj - 16 Days||21||
48657081|NCT03648372|101943758|FG001|NOT COMPLETED|Overall Study||3||
48406374|NCT02550093|101328410|FG001|STARTED|Wash-out Period||10||
48406375|NCT02550093|101328409|FG000|COMPLETED|Wash-out Period||10||
48406376|NCT02550093|101328410|FG001|COMPLETED|Wash-out Period||10||
48722443|NCT00295932|102108154|FG003|NOT COMPLETED|Overall Study||0||
48722444|NCT00295932|102108155|FG004|NOT COMPLETED|Overall Study||0||
48722445|NCT00295932|102108156|FG005|NOT COMPLETED|Overall Study||0||
48722446|NCT00295932|102108157|FG006|NOT COMPLETED|Overall Study||0||
48722447|NCT00295932|102108158|FG007|NOT COMPLETED|Overall Study||0||
48722448|NCT00295932|102108159|FG008|NOT COMPLETED|Overall Study||0||
48722449|NCT00295932|102108160|FG009|NOT COMPLETED|Overall Study||0||
48722450|NCT00295932|102108161|FG010|NOT COMPLETED|Overall Study||1||
48722451|NCT00795288|102108162|FG000|STARTED|Overall Study||21||
48722452|NCT00795288|102108163|FG001|STARTED|Overall Study||21||
48722453|NCT00795288|102108162|FG000|COMPLETED|Overall Study||21||
48722454|NCT00795288|102108163|FG001|COMPLETED|Overall Study||21||
48722455|NCT00795288|102108162|FG000|NOT COMPLETED|Overall Study||0||
48406377|NCT02550093|101328409|FG000|NOT COMPLETED|Wash-out Period||0||
48406378|NCT02550093|101328410|FG001|NOT COMPLETED|Wash-out Period||0||
48609412|NCT02849704|101827324|FG001|COMPLETED|Assessment on PERT - CP Subj - 16 Days||0||
48609413|NCT02849704|101827323|FG000|NOT COMPLETED|Assessment on PERT - CP Subj - 16 Days||3||
48609414|NCT02849704|101827324|FG001|NOT COMPLETED|Assessment on PERT - CP Subj - 16 Days||0||
48609415|NCT02855567|101827325|FG000|STARTED|Overall Study||54||
48609416|NCT02855567|101827326|FG001|STARTED|Overall Study||56||
48609417|NCT02855567|101827325|FG000|COMPLETED|Overall Study||54||
48609418|NCT02855567|101827326|FG001|COMPLETED|Overall Study||56||
48609419|NCT02855567|101827325|FG000|NOT COMPLETED|Overall Study||0||
48609420|NCT02855567|101827326|FG001|NOT COMPLETED|Overall Study||0||
48609421|NCT02500719|101827327|FG000|STARTED|Overall Study||14||
48609422|NCT02500719|101827328|FG001|STARTED|Overall Study||16||
48609423|NCT02500719|101827327|FG000|COMPLETED|Overall Study||11||
48609424|NCT02500719|101827328|FG001|COMPLETED|Overall Study||9||
48609425|NCT02500719|101827327|FG000|NOT COMPLETED|Overall Study||3||
48609426|NCT02500719|101827328|FG001|NOT COMPLETED|Overall Study||7||
48609427|NCT00962078|101827329|FG000|STARTED|Overall Study||35||
48609428|NCT00962078|101827330|FG001|STARTED|Overall Study||36||
48609429|NCT00962078|101827329|FG000|COMPLETED|Overall Study||30||
48609430|NCT00962078|101827330|FG001|COMPLETED|Overall Study||30||
48609431|NCT00962078|101827329|FG000|NOT COMPLETED|Overall Study||5||
48609432|NCT00962078|101827330|FG001|NOT COMPLETED|Overall Study||6||
48609433|NCT01502956|101827331|FG000|STARTED|Overall Study||192||
48609434|NCT01502956|101827332|FG001|STARTED|Overall Study||194||
48609435|NCT01502956|101827331|FG000|COMPLETED|Overall Study||168||
48609436|NCT01502956|101827332|FG001|COMPLETED|Overall Study||168||
48609437|NCT01502956|101827331|FG000|NOT COMPLETED|Overall Study||24||
48609438|NCT01502956|101827332|FG001|NOT COMPLETED|Overall Study||26||
48609439|NCT04153565|101827333|FG000|STARTED|Overall Study||19||
48609440|NCT04153565|101827333|FG000|COMPLETED|Overall Study||6||
48609441|NCT04153565|101827333|FG000|NOT COMPLETED|Overall Study||13||
48609442|NCT01639703|101827334|FG000|STARTED|Overall Study||96||
48609443|NCT01639703|101827334|FG000|COMPLETED|Overall Study||84||
48609444|NCT01639703|101827334|FG000|NOT COMPLETED|Overall Study||12||
48609445|NCT00613379|101827335|FG000|STARTED|Overall Study||10||
48609446|NCT00613379|101827336|FG001|STARTED|Overall Study||10||
48609447|NCT00613379|101827337|FG002|STARTED|Overall Study||11||
48609448|NCT00613379|101827335|FG000|COMPLETED|Overall Study||10||
48609449|NCT00613379|101827336|FG001|COMPLETED|Overall Study||10||
48722456|NCT00795288|102108163|FG001|NOT COMPLETED|Overall Study||0||
48722457|NCT00537407|102108164|FG000|STARTED|Part 1 Weeks 1-4||10||
48609450|NCT00613379|101827337|FG002|COMPLETED|Overall Study||11||
48609451|NCT00613379|101827335|FG000|NOT COMPLETED|Overall Study||0||
48609452|NCT00613379|101827336|FG001|NOT COMPLETED|Overall Study||0||
48609453|NCT00613379|101827337|FG002|NOT COMPLETED|Overall Study||0||
48609454|NCT01616160|101827338|FG000|STARTED|Overall Study||11||
48609455|NCT01616160|101827338|FG000|COMPLETED|Overall Study||9||
48609456|NCT01616160|101827338|FG000|NOT COMPLETED|Overall Study||2||
48722458|NCT00537407|102108165|FG001|STARTED|Part 1 Weeks 1-4||9||
48722459|NCT00537407|102108166|FG002|STARTED|Part 1 Weeks 1-4||11||
48722460|NCT00537407|102108167|FG003|STARTED|Part 1 Weeks 1-4||10||
48722461|NCT00537407|102108168|FG004|STARTED|Part 1 Weeks 1-4||10||
48722462|NCT00537407|102108164|FG000|COMPLETED|Part 1 Weeks 1-4||10||
48722463|NCT00537407|102108165|FG001|COMPLETED|Part 1 Weeks 1-4||9||
48188727|NCT05161715|100783320|FG000|STARTED|Overall Study||13||
48609457|NCT00573872|101827339|FG000|STARTED|Overall Study||43||
48609458|NCT00573872|101827339|FG000|COMPLETED|Overall Study||32||
48609459|NCT00573872|101827339|FG000|NOT COMPLETED|Overall Study||11||
48609460|NCT01515566|101827340|FG000|STARTED|Overall Study||10||
48609461|NCT01515566|101827341|FG001|STARTED|Overall Study||10||
48609462|NCT01515566|101827340|FG000|COMPLETED|Overall Study||10||
48609463|NCT01515566|101827341|FG001|COMPLETED|Overall Study||10||
48609464|NCT01515566|101827340|FG000|NOT COMPLETED|Overall Study||0||
48609465|NCT01515566|101827341|FG001|NOT COMPLETED|Overall Study||0||
48609466|NCT00985686|101827342|FG000|STARTED|Overall Study||18||
48609467|NCT00985686|101827343|FG001|STARTED|Overall Study||16||
48609468|NCT00985686|101827344|FG002|STARTED|Overall Study||13||
48609469|NCT00985686|101827345|FG003|STARTED|Overall Study||16||
48609470|NCT00985686|101827342|FG000|Visit 1: Baseline Data Collection|Overall Study||18||
48609471|NCT00985686|101827343|FG001|Visit 1: Baseline Data Collection|Overall Study||15||
48609472|NCT00985686|101827344|FG002|Visit 1: Baseline Data Collection|Overall Study||13||
48609473|NCT00985686|101827345|FG003|Visit 1: Baseline Data Collection|Overall Study||16||
48609474|NCT00985686|101827342|FG000|Visit 2: Data Collection at 8 Weeks|Overall Study||18||
48609475|NCT00985686|101827343|FG001|Visit 2: Data Collection at 8 Weeks|Overall Study||15||
48609476|NCT00985686|101827344|FG002|Visit 2: Data Collection at 8 Weeks|Overall Study||13||
48609477|NCT00985686|101827345|FG003|Visit 2: Data Collection at 8 Weeks|Overall Study||16||
48609478|NCT00985686|101827342|FG000|Visit 3: Data Collection at 16 Weeks|Overall Study||17||
48609479|NCT00985686|101827343|FG001|Visit 3: Data Collection at 16 Weeks|Overall Study||15||
48609480|NCT00985686|101827344|FG002|Visit 3: Data Collection at 16 Weeks|Overall Study||13||
48609481|NCT00985686|101827345|FG003|Visit 3: Data Collection at 16 Weeks|Overall Study||16||
48609482|NCT00985686|101827342|FG000|Visit 4: Data Collection at 24 Weeks|Overall Study||17||
48609483|NCT00985686|101827343|FG001|Visit 4: Data Collection at 24 Weeks|Overall Study||15||
48609484|NCT00985686|101827344|FG002|Visit 4: Data Collection at 24 Weeks|Overall Study||13||
48609485|NCT00985686|101827345|FG003|Visit 4: Data Collection at 24 Weeks|Overall Study||14||
48609486|NCT00985686|101827342|FG000|COMPLETED|Overall Study||17||
48307622|NCT01514136|101077657|FG003|NOT COMPLETED|Test Period 1; Test B||0||
48307623|NCT01514136|101077658|FG004|NOT COMPLETED|Test Period 1; Test B||0||
48307624|NCT01514136|101077659|FG005|NOT COMPLETED|Test Period 1; Test B||0||
48307625|NCT01514136|101077660|FG006|NOT COMPLETED|Test Period 1; Test B||0||
48307626|NCT01514136|101077661|FG007|NOT COMPLETED|Test Period 1; Test B||0||
48307627|NCT01514136|101077654|FG000|STARTED|Test Period 1; Test C||0||
48609487|NCT00985686|101827343|FG001|COMPLETED|Overall Study||15||
48609488|NCT00985686|101827344|FG002|COMPLETED|Overall Study||13||
48609489|NCT00985686|101827345|FG003|COMPLETED|Overall Study||14||
48609490|NCT00985686|101827342|FG000|NOT COMPLETED|Overall Study||1||
48609491|NCT00985686|101827343|FG001|NOT COMPLETED|Overall Study||1||
48609492|NCT00985686|101827344|FG002|NOT COMPLETED|Overall Study||0||
48609493|NCT00985686|101827345|FG003|NOT COMPLETED|Overall Study||2||
48609494|NCT00186485|101827346|FG000|STARTED|Overall Study||28||
48609495|NCT00186485|101827346|FG000|COMPLETED|Overall Study||25||
48609496|NCT00186485|101827346|FG000|NOT COMPLETED|Overall Study||3||
48609497|NCT03334188|101827347|FG000|STARTED|Overall Study||153||
48609498|NCT03334188|101827348|FG001|STARTED|Overall Study||153||
48609499|NCT03334188|101827347|FG000|COMPLETED|Overall Study||145||
48609500|NCT03334188|101827348|FG001|COMPLETED|Overall Study||145||
48609501|NCT03334188|101827347|FG000|NOT COMPLETED|Overall Study||8||
48609502|NCT03334188|101827348|FG001|NOT COMPLETED|Overall Study||8||
48609503|NCT01393522|101827349|FG000|STARTED|Overall Study||19||
48609504|NCT01393522|101827350|FG001|STARTED|Overall Study||18||
48609505|NCT01393522|101827349|FG000|COMPLETED|Overall Study||12||
48609506|NCT01393522|101827350|FG001|COMPLETED|Overall Study||14||
48609507|NCT01393522|101827349|FG000|NOT COMPLETED|Overall Study||7||
48609508|NCT01393522|101827350|FG001|NOT COMPLETED|Overall Study||4||
48609509|NCT04003623|101827351|FG000|STARTED|Overall Study||1||
48609510|NCT04003623|101827352|FG001|STARTED|Overall Study||0||
48609511|NCT04003623|101827351|FG000|COMPLETED|Overall Study||0||
48609512|NCT04003623|101827352|FG001|COMPLETED|Overall Study||0||
48609513|NCT04003623|101827351|FG000|NOT COMPLETED|Overall Study||1||
48609514|NCT04003623|101827352|FG001|NOT COMPLETED|Overall Study||0||
48609515|NCT01744483|101827353|FG000|STARTED|Overall Study||44||
48609516|NCT01744483|101827354|FG001|STARTED|Overall Study||35||
48609517|NCT01744483|101827355|FG002|STARTED|Overall Study||38||
48609518|NCT01744483|101827353|FG000|COMPLETED|Overall Study||15||
48609519|NCT01744483|101827354|FG001|COMPLETED|Overall Study||13||
48609520|NCT01744483|101827355|FG002|COMPLETED|Overall Study||10||
48609521|NCT01744483|101827353|FG000|NOT COMPLETED|Overall Study||29||
48609522|NCT01744483|101827354|FG001|NOT COMPLETED|Overall Study||22||
48307628|NCT01514136|101077655|FG001|STARTED|Test Period 1; Test C||0||
48307629|NCT01514136|101077656|FG002|STARTED|Test Period 1; Test C||24||
48307630|NCT01514136|101077657|FG003|STARTED|Test Period 1; Test C||0||
48307631|NCT01514136|101077658|FG004|STARTED|Test Period 1; Test C||0||
48307632|NCT01514136|101077659|FG005|STARTED|Test Period 1; Test C||0||
48307633|NCT01514136|101077660|FG006|STARTED|Test Period 1; Test C||0||
48609523|NCT01744483|101827355|FG002|NOT COMPLETED|Overall Study||28||
48609524|NCT00642603|101827356|FG000|STARTED|Overall Study||21||
48609525|NCT00642603|101827357|FG001|STARTED|Overall Study||20||
48609526|NCT00642603|101827356|FG000|Safety Population|Overall Study||19||
48609527|NCT00642603|101827357|FG001|Safety Population|Overall Study||20||
48609528|NCT00642603|101827356|FG000|COMPLETED|Overall Study||0||
48609529|NCT00642603|101827357|FG001|COMPLETED|Overall Study||2||
48609530|NCT00642603|101827356|FG000|NOT COMPLETED|Overall Study||21||
48609531|NCT00642603|101827357|FG001|NOT COMPLETED|Overall Study||18||
48609532|NCT00199849|101827358|FG000|STARTED|Overall Study||3||
48609533|NCT00199849|101827359|FG001|STARTED|Overall Study||7||
48609534|NCT00199849|101827360|FG002|STARTED|Overall Study||8||
48609535|NCT00199849|101827358|FG000|COMPLETED|Overall Study||3||
48609536|NCT00199849|101827359|FG001|COMPLETED|Overall Study||6||
48609537|NCT00199849|101827360|FG002|COMPLETED|Overall Study||6||
48609538|NCT00199849|101827358|FG000|NOT COMPLETED|Overall Study||0||
48609539|NCT00199849|101827359|FG001|NOT COMPLETED|Overall Study||1||
48609540|NCT00199849|101827360|FG002|NOT COMPLETED|Overall Study||2||
48609541|NCT02508103|101827361|FG000|STARTED|Overall Study||5||
48609542|NCT02508103|101827362|FG001|STARTED|Overall Study||5||
48609543|NCT02508103|101827361|FG000|COMPLETED|Overall Study||5||
48609544|NCT02508103|101827362|FG001|COMPLETED|Overall Study||5||
48609545|NCT02508103|101827361|FG000|NOT COMPLETED|Overall Study||0||
48609546|NCT02508103|101827362|FG001|NOT COMPLETED|Overall Study||0||
48609547|NCT02237989|101827363|FG000|STARTED|Overall Study||19||
48609548|NCT02237989|101827364|FG001|STARTED|Overall Study||20||
48609549|NCT02237989|101827363|FG000|COMPLETED|Overall Study||19||
48609550|NCT02237989|101827364|FG001|COMPLETED|Overall Study||20||
48609551|NCT02237989|101827363|FG000|NOT COMPLETED|Overall Study||0||
48609552|NCT02237989|101827364|FG001|NOT COMPLETED|Overall Study||0||
48609553|NCT02813473|101827365|FG000|STARTED|Overall Study||223||
48609554|NCT02813473|101827365|FG000|COMPLETED|Overall Study||223||
48152286|NCT02001194|100695968|FG001|STARTED|Follow-Up Period (13 Weeks)||80||
48152287|NCT02001194|100695969|FG002|STARTED|Follow-Up Period (13 Weeks)||74||
48152288|NCT02001194|100695970|FG003|STARTED|Follow-Up Period (13 Weeks)||78||
48152289|NCT02001194|100695967|FG000|COMPLETED|Follow-Up Period (13 Weeks)||64||
48152290|NCT02001194|100695968|FG001|COMPLETED|Follow-Up Period (13 Weeks)||78||
48152291|NCT02001194|100695969|FG002|COMPLETED|Follow-Up Period (13 Weeks)||73||
48152292|NCT02001194|100695970|FG003|COMPLETED|Follow-Up Period (13 Weeks)||78||
48152293|NCT02001194|100695967|FG000|NOT COMPLETED|Follow-Up Period (13 Weeks)||3||
48152294|NCT02001194|100695968|FG001|NOT COMPLETED|Follow-Up Period (13 Weeks)||2||
48152295|NCT02001194|100695969|FG002|NOT COMPLETED|Follow-Up Period (13 Weeks)||1||
48152296|NCT02001194|100695970|FG003|NOT COMPLETED|Follow-Up Period (13 Weeks)||0||
48152297|NCT03685591|100695971|FG000|STARTED|Overall Study||1||
48152298|NCT03685591|100695972|FG001|STARTED|Overall Study||1||
48152299|NCT03685591|100695973|FG002|STARTED|Overall Study||1||
48152300|NCT03685591|100695974|FG003|STARTED|Overall Study||5||
48152301|NCT03685591|100695975|FG004|STARTED|Overall Study||13||
48152302|NCT03685591|100695976|FG005|STARTED|Overall Study||17||
48152303|NCT03685591|100695977|FG006|STARTED|Overall Study||4||
48152304|NCT03685591|100695978|FG007|STARTED|Overall Study||4||
48609555|NCT02813473|101827365|FG000|NOT COMPLETED|Overall Study||0||
48609556|NCT02308228|101827366|FG000|STARTED|Overall Study||54||
48609557|NCT02308228|101827367|FG001|STARTED|Overall Study||55||
48609558|NCT02308228|101827366|FG000|COMPLETED|Overall Study||46||
48609559|NCT02308228|101827367|FG001|COMPLETED|Overall Study||48||
48609560|NCT02308228|101827366|FG000|NOT COMPLETED|Overall Study||8||
48609561|NCT02308228|101827367|FG001|NOT COMPLETED|Overall Study||7||
48609562|NCT03180957|101827368|FG000|STARTED|Overall Study||70||
48609563|NCT03180957|101827369|FG001|STARTED|Overall Study||70||
48609564|NCT03180957|101827368|FG000|COMPLETED|Overall Study||59||
48609565|NCT03180957|101827369|FG001|COMPLETED|Overall Study||54||
48609566|NCT03180957|101827368|FG000|NOT COMPLETED|Overall Study||11||
48609567|NCT03180957|101827369|FG001|NOT COMPLETED|Overall Study||16||
48609568|NCT04757805|101827370|FG000|STARTED|Overall Study||50||
48609569|NCT04757805|101827370|FG000|COMPLETED|Overall Study||50||
48609570|NCT04757805|101827370|FG000|NOT COMPLETED|Overall Study||0||
48609571|NCT00885378|101827371|FG000|STARTED|Overall Study||74||
48609572|NCT00885378|101827372|FG001|STARTED|Overall Study||86||
48609573|NCT00885378|101827371|FG000|COMPLETED|Overall Study||66||
48609574|NCT00885378|101827372|FG001|COMPLETED|Overall Study||78||
48609575|NCT00885378|101827371|FG000|NOT COMPLETED|Overall Study||8||
48609576|NCT00885378|101827372|FG001|NOT COMPLETED|Overall Study||8||
48609577|NCT04446429|101827373|FG000|STARTED|Overall Study||134||
48609578|NCT04446429|101827374|FG001|STARTED|Overall Study||134||
48609579|NCT04446429|101827373|FG000|COMPLETED|Overall Study||128||
48609580|NCT04446429|101827374|FG001|COMPLETED|Overall Study||134||
48609581|NCT04446429|101827373|FG000|NOT COMPLETED|Overall Study||6||
48609582|NCT04446429|101827374|FG001|NOT COMPLETED|Overall Study||0||
48307634|NCT01514136|101077661|FG007|STARTED|Test Period 1; Test C||0||
48307635|NCT01514136|101077654|FG000|COMPLETED|Test Period 1; Test C||0||
48307636|NCT01514136|101077655|FG001|COMPLETED|Test Period 1; Test C||0||
48307637|NCT01514136|101077656|FG002|COMPLETED|Test Period 1; Test C||24||
48307638|NCT01514136|101077657|FG003|COMPLETED|Test Period 1; Test C||0||
48609583|NCT00389467|101827375|FG000|STARTED|Overall Study||34||
48609584|NCT00389467|101827376|FG001|STARTED|Overall Study||34||
48609585|NCT00389467|101827377|FG002|STARTED|Overall Study||30||
48609586|NCT00389467|101827378|FG003|STARTED|Overall Study||20||
48152305|NCT03685591|100695979|FG008|STARTED|Overall Study||3||
48609587|NCT00389467|101827375|FG000|COMPLETED|Overall Study||34||
48609588|NCT00389467|101827376|FG001|COMPLETED|Overall Study||34||
48609589|NCT00389467|101827377|FG002|COMPLETED|Overall Study||30||
48152306|NCT03685591|100695971|FG000|COMPLETED|Overall Study||0||
48152307|NCT03685591|100695972|FG001|COMPLETED|Overall Study||0||
48152308|NCT03685591|100695973|FG002|COMPLETED|Overall Study||0||
48609590|NCT00389467|101827378|FG003|COMPLETED|Overall Study||20||
48609591|NCT00389467|101827375|FG000|NOT COMPLETED|Overall Study||0||
48609592|NCT00389467|101827376|FG001|NOT COMPLETED|Overall Study||0||
48609593|NCT00389467|101827377|FG002|NOT COMPLETED|Overall Study||0||
48609594|NCT00389467|101827378|FG003|NOT COMPLETED|Overall Study||0||
48609595|NCT05725824|101827379|FG000|STARTED|Overall Study||10||
48609596|NCT05725824|101827380|FG001|STARTED|Overall Study||10||
48609597|NCT05725824|101827381|FG002|STARTED|Overall Study||10||
48609598|NCT05725824|101827379|FG000|COMPLETED|Overall Study||10||
48609599|NCT05725824|101827380|FG001|COMPLETED|Overall Study||10||
48609600|NCT05725824|101827381|FG002|COMPLETED|Overall Study||10||
48152309|NCT03685591|100695974|FG003|COMPLETED|Overall Study||0||
48152310|NCT03685591|100695975|FG004|COMPLETED|Overall Study||0||
48152311|NCT03685591|100695976|FG005|COMPLETED|Overall Study||0||
48152312|NCT03685591|100695977|FG006|COMPLETED|Overall Study||0||
48152313|NCT03685591|100695978|FG007|COMPLETED|Overall Study||0||
48152314|NCT03685591|100695979|FG008|COMPLETED|Overall Study||0||
48152315|NCT03685591|100695971|FG000|NOT COMPLETED|Overall Study||1||
48152316|NCT03685591|100695972|FG001|NOT COMPLETED|Overall Study||1||
48152317|NCT03685591|100695973|FG002|NOT COMPLETED|Overall Study||1||
48152318|NCT03685591|100695974|FG003|NOT COMPLETED|Overall Study||5||
48152319|NCT03685591|100695975|FG004|NOT COMPLETED|Overall Study||13||
48152320|NCT03685591|100695976|FG005|NOT COMPLETED|Overall Study||17||
48152321|NCT03685591|100695977|FG006|NOT COMPLETED|Overall Study||4||
48152322|NCT03685591|100695978|FG007|NOT COMPLETED|Overall Study||4||
48152323|NCT03685591|100695979|FG008|NOT COMPLETED|Overall Study||3||
48152324|NCT01446666|100695980|FG000|STARTED|Overall Study||407||
48152325|NCT01446666|100695980|FG000|COMPLETED|Overall Study||326||
48152326|NCT01446666|100695980|FG000|NOT COMPLETED|Overall Study||81||
48152327|NCT03026790|100695981|FG000|STARTED|Overall Study||411||
48152328|NCT03026790|100695982|FG001|STARTED|Overall Study||409||
48152329|NCT03026790|100695981|FG000|COMPLETED|Overall Study||358||
48152330|NCT03026790|100695982|FG001|COMPLETED|Overall Study||363||
48152331|NCT03026790|100695981|FG000|NOT COMPLETED|Overall Study||53||
48152332|NCT03026790|100695982|FG001|NOT COMPLETED|Overall Study||46||
48152333|NCT02365519|100695983|FG000|STARTED|Vehicle Run-In||213||
48152334|NCT02365519|100695984|FG001|STARTED|Vehicle Run-In||0||
48152335|NCT02365519|100695985|FG002|STARTED|Vehicle Run-In||0||
48152336|NCT02365519|100695983|FG000|COMPLETED|Vehicle Run-In||134||
48152337|NCT02365519|100695984|FG001|COMPLETED|Vehicle Run-In||0||
48152338|NCT02365519|100695985|FG002|COMPLETED|Vehicle Run-In||0||
48152339|NCT02365519|100695983|FG000|NOT COMPLETED|Vehicle Run-In||79||
48152340|NCT02365519|100695984|FG001|NOT COMPLETED|Vehicle Run-In||0||
48152341|NCT02365519|100695985|FG002|NOT COMPLETED|Vehicle Run-In||0||
48152342|NCT02365519|100695983|FG000|STARTED|Randomized and Treated||0||
48152343|NCT02365519|100695984|FG001|STARTED|Randomized and Treated||69||
48152344|NCT02365519|100695985|FG002|STARTED|Randomized and Treated||65||
48152345|NCT02365519|100695983|FG000|COMPLETED|Randomized and Treated||0||
48152346|NCT02365519|100695984|FG001|COMPLETED|Randomized and Treated||67||
48152347|NCT02365519|100695985|FG002|COMPLETED|Randomized and Treated||64||
48152348|NCT02365519|100695983|FG000|NOT COMPLETED|Randomized and Treated||0||
48152349|NCT02365519|100695984|FG001|NOT COMPLETED|Randomized and Treated||2||
48152350|NCT02365519|100695985|FG002|NOT COMPLETED|Randomized and Treated||1||
48152351|NCT03319537|100695986|FG000|STARTED|Overall Study||9||
48152352|NCT03319537|100695987|FG001|STARTED|Overall Study||0||
48152353|NCT03319537|100695986|FG000|COMPLETED|Overall Study||9||
48152354|NCT03319537|100695987|FG001|COMPLETED|Overall Study||0||
48152355|NCT03319537|100695986|FG000|NOT COMPLETED|Overall Study||0||
48307639|NCT01514136|101077658|FG004|COMPLETED|Test Period 1; Test C||0||
48307640|NCT01514136|101077659|FG005|COMPLETED|Test Period 1; Test C||0||
48152356|NCT03319537|100695987|FG001|NOT COMPLETED|Overall Study||0||
48307641|NCT01514136|101077660|FG006|COMPLETED|Test Period 1; Test C||0||
48307642|NCT01514136|101077661|FG007|COMPLETED|Test Period 1; Test C||0||
48307643|NCT01514136|101077654|FG000|NOT COMPLETED|Test Period 1; Test C||0||
48609601|NCT05725824|101827379|FG000|NOT COMPLETED|Overall Study||0||
48609602|NCT05725824|101827380|FG001|NOT COMPLETED|Overall Study||0||
48609603|NCT05725824|101827381|FG002|NOT COMPLETED|Overall Study||0||
48609604|NCT01962948|101827382|FG000|STARTED|Overall Study||3||
48609605|NCT01962948|101827383|FG001|STARTED|Overall Study||3||
48609606|NCT01962948|101827384|FG002|STARTED|Overall Study||6||
48609607|NCT01962948|101827385|FG003|STARTED|Overall Study||0||
48609608|NCT01962948|101827382|FG000|COMPLETED|Overall Study||0||
48152357|NCT03248375|100695988|FG000|STARTED|Overall Study||29||
48152358|NCT03248375|100695988|FG000|COMPLETED|Overall Study||24||
48152359|NCT03248375|100695988|FG000|NOT COMPLETED|Overall Study||5||
48152360|NCT04241094|100695989|FG000|STARTED|Overall Study||20||
48152361|NCT04241094|100695989|FG000|Never Started Treatment|Overall Study||8|These Veteran were enrolled, but never began the COACH treatment|
48307644|NCT01514136|101077655|FG001|NOT COMPLETED|Test Period 1; Test C||0||
48307645|NCT01514136|101077656|FG002|NOT COMPLETED|Test Period 1; Test C||0||
48609609|NCT01962948|101827383|FG001|COMPLETED|Overall Study||0||
48609610|NCT01962948|101827384|FG002|COMPLETED|Overall Study||0||
48609611|NCT01962948|101827385|FG003|COMPLETED|Overall Study||0||
48152362|NCT04241094|100695989|FG000|COMPLETED|Overall Study||12||
48152363|NCT04241094|100695989|FG000|NOT COMPLETED|Overall Study||8||
48152364|NCT01782443|100695990|FG000|STARTED|Overall Study||19||
48152365|NCT01782443|100695990|FG000|COMPLETED|Overall Study||19||
48152366|NCT01782443|100695990|FG000|NOT COMPLETED|Overall Study||0||
48406379|NCT02550093|101328409|FG000|STARTED|Intervention 2||10||
48406380|NCT02550093|101328410|FG001|STARTED|Intervention 2||10||
48406381|NCT02550093|101328409|FG000|COMPLETED|Intervention 2||10||
48406382|NCT02550093|101328410|FG001|COMPLETED|Intervention 2||10||
48406383|NCT02550093|101328409|FG000|NOT COMPLETED|Intervention 2||0||
48406384|NCT02550093|101328410|FG001|NOT COMPLETED|Intervention 2||0||
48406385|NCT04847141|101328411|FG000|STARTED|Overall Study||152|Started participants were defined as participants who were also dosed.|
48406386|NCT04847141|101328412|FG001|STARTED|Overall Study||153|Started participants were defined as participants who were also dosed.|
48406387|NCT04847141|101328413|FG002|STARTED|Overall Study||156|Started participants were defined as participants who were also dosed.|
48406388|NCT04847141|101328411|FG000|COMPLETED|Overall Study||142||
48406389|NCT04847141|101328412|FG001|COMPLETED|Overall Study||143||
48406390|NCT04847141|101328413|FG002|COMPLETED|Overall Study||145||
48406391|NCT04847141|101328411|FG000|NOT COMPLETED|Overall Study||10||
48406392|NCT04847141|101328412|FG001|NOT COMPLETED|Overall Study||10||
48406393|NCT04847141|101328413|FG002|NOT COMPLETED|Overall Study||11||
48609612|NCT01962948|101827382|FG000|NOT COMPLETED|Overall Study||3||
48609613|NCT01962948|101827383|FG001|NOT COMPLETED|Overall Study||3||
48609614|NCT01962948|101827384|FG002|NOT COMPLETED|Overall Study||6||
48609615|NCT01962948|101827385|FG003|NOT COMPLETED|Overall Study||0||
48609616|NCT03292614|101827386|FG000|STARTED|Overall Study||25||
48152367|NCT01201057|100695991|FG000|STARTED|Overall Study||34||
48152368|NCT01201057|100695992|FG001|STARTED|Overall Study||33||
48152369|NCT01201057|100695993|FG002|STARTED|Overall Study||32||
48152370|NCT01201057|100695994|FG003|STARTED|Overall Study||33||
48152371|NCT01201057|100695991|FG000|COMPLETED|Overall Study||32||
48152372|NCT01201057|100695992|FG001|COMPLETED|Overall Study||29||
48152373|NCT01201057|100695993|FG002|COMPLETED|Overall Study||27||
48152374|NCT01201057|100695994|FG003|COMPLETED|Overall Study||29||
48152375|NCT01201057|100695991|FG000|NOT COMPLETED|Overall Study||2||
48152376|NCT01201057|100695992|FG001|NOT COMPLETED|Overall Study||4||
48152377|NCT01201057|100695993|FG002|NOT COMPLETED|Overall Study||5||
48152378|NCT01201057|100695994|FG003|NOT COMPLETED|Overall Study||4||
48152379|NCT05183022|100695995|FG000|STARTED|Overall Study||48||
48152380|NCT05183022|100695995|FG000|COMPLETED|Overall Study||48||
48152381|NCT05183022|100695995|FG000|NOT COMPLETED|Overall Study||0||
48152382|NCT01357616|100695996|FG000|STARTED|Overall Study||166||
48152383|NCT01357616|100695997|FG001|STARTED|Overall Study||162||
48152384|NCT01357616|100695996|FG000|COMPLETED|Overall Study||156||
48152385|NCT01357616|100695997|FG001|COMPLETED|Overall Study||153||
48152386|NCT01357616|100695996|FG000|NOT COMPLETED|Overall Study||10||
48152387|NCT01357616|100695997|FG001|NOT COMPLETED|Overall Study||9||
48152388|NCT00611858|100695998|FG000|STARTED|Overall Study||13||
48152389|NCT00611858|100695998|FG000|COMPLETED|Overall Study||9||
48152390|NCT00611858|100695998|FG000|NOT COMPLETED|Overall Study||4||
48152391|NCT01445652|100695999|FG000|STARTED|Overall Study||57||
48152392|NCT01445652|100696000|FG001|STARTED|Overall Study||53||
48152393|NCT01445652|100695999|FG000|COMPLETED|Overall Study||47||
48152394|NCT01445652|100696000|FG001|COMPLETED|Overall Study||50||
48152395|NCT01445652|100695999|FG000|NOT COMPLETED|Overall Study||10||
48152396|NCT01445652|100696000|FG001|NOT COMPLETED|Overall Study||3||
48152397|NCT03084666|100696001|FG000|STARTED|Overall Study||20||
48152398|NCT03084666|100696002|FG001|STARTED|Overall Study||20||
48152399|NCT03084666|100696001|FG000|COMPLETED|Overall Study||20||
48152400|NCT03084666|100696002|FG001|COMPLETED|Overall Study||20||
48152401|NCT03084666|100696001|FG000|NOT COMPLETED|Overall Study||0||
48152402|NCT03084666|100696002|FG001|NOT COMPLETED|Overall Study||0||
48609617|NCT03292614|101827386|FG000|COMPLETED|Overall Study||25||
48609618|NCT03292614|101827386|FG000|NOT COMPLETED|Overall Study||0||
48609619|NCT03465709|101827387|FG000|STARTED|Overall Study||17|Received at least 1 dose pegcetacoplan.|
48722464|NCT00537407|102108166|FG002|COMPLETED|Part 1 Weeks 1-4||11||
48152403|NCT02889133|100696003|FG000|STARTED|Completed Primary Outcome||39||
48152404|NCT02889133|100696004|FG001|STARTED|Completed Primary Outcome||40||
48152405|NCT02889133|100696003|FG000|COMPLETED|Completed Primary Outcome||29||
48152406|NCT02889133|100696004|FG001|COMPLETED|Completed Primary Outcome||28||
48406394|NCT02402881|101328414|FG000|STARTED|Pre-Intervention Study Period||2222||
48406395|NCT02402881|101328415|FG001|STARTED|Pre-Intervention Study Period||5657||
48722465|NCT00537407|102108167|FG003|COMPLETED|Part 1 Weeks 1-4||10||
48152407|NCT02889133|100696003|FG000|NOT COMPLETED|Completed Primary Outcome||10||
48152408|NCT02889133|100696004|FG001|NOT COMPLETED|Completed Primary Outcome||12||
48152409|NCT02889133|100696003|FG000|STARTED|Completed Secondary Outcomes||39||
48406396|NCT02402881|101328414|FG000|COMPLETED|Pre-Intervention Study Period||2222||
48406397|NCT02402881|101328415|FG001|COMPLETED|Pre-Intervention Study Period||5657||
48406398|NCT02402881|101328414|FG000|NOT COMPLETED|Pre-Intervention Study Period||0||
48307646|NCT01514136|101077657|FG003|NOT COMPLETED|Test Period 1; Test C||0||
48307647|NCT01514136|101077658|FG004|NOT COMPLETED|Test Period 1; Test C||0||
48307648|NCT01514136|101077659|FG005|NOT COMPLETED|Test Period 1; Test C||0||
48307649|NCT01514136|101077660|FG006|NOT COMPLETED|Test Period 1; Test C||0||
48307650|NCT01514136|101077661|FG007|NOT COMPLETED|Test Period 1; Test C||0||
48307651|NCT01514136|101077654|FG000|STARTED|Test Period 1; Test D||0||
48307652|NCT01514136|101077655|FG001|STARTED|Test Period 1; Test D||0||
48307653|NCT01514136|101077656|FG002|STARTED|Test Period 1; Test D||0||
48307654|NCT01514136|101077657|FG003|STARTED|Test Period 1; Test D||26||
48307655|NCT01514136|101077658|FG004|STARTED|Test Period 1; Test D||0||
48307656|NCT01514136|101077659|FG005|STARTED|Test Period 1; Test D||0||
48307657|NCT01514136|101077660|FG006|STARTED|Test Period 1; Test D||0||
48307658|NCT01514136|101077661|FG007|STARTED|Test Period 1; Test D||0||
48307659|NCT01514136|101077654|FG000|COMPLETED|Test Period 1; Test D||0||
48307660|NCT01514136|101077655|FG001|COMPLETED|Test Period 1; Test D||0||
48307661|NCT01514136|101077656|FG002|COMPLETED|Test Period 1; Test D||0||
48307662|NCT01514136|101077657|FG003|COMPLETED|Test Period 1; Test D||24||
48307663|NCT01514136|101077658|FG004|COMPLETED|Test Period 1; Test D||0||
48307664|NCT01514136|101077659|FG005|COMPLETED|Test Period 1; Test D||0||
48307665|NCT01514136|101077660|FG006|COMPLETED|Test Period 1; Test D||0||
48307666|NCT01514136|101077661|FG007|COMPLETED|Test Period 1; Test D||0||
48307667|NCT01514136|101077654|FG000|NOT COMPLETED|Test Period 1; Test D||0||
48307668|NCT01514136|101077655|FG001|NOT COMPLETED|Test Period 1; Test D||0||
48406399|NCT02402881|101328415|FG001|NOT COMPLETED|Pre-Intervention Study Period||0||
48406400|NCT02402881|101328414|FG000|STARTED|Post-Intervention Study Period||3111||
48406401|NCT02402881|101328415|FG001|STARTED|Post-Intervention Study Period||8662||
48406402|NCT02402881|101328414|FG000|COMPLETED|Post-Intervention Study Period||3111||
48406403|NCT02402881|101328415|FG001|COMPLETED|Post-Intervention Study Period||8662||
48406404|NCT02402881|101328414|FG000|NOT COMPLETED|Post-Intervention Study Period||0||
48406405|NCT02402881|101328415|FG001|NOT COMPLETED|Post-Intervention Study Period||0||
48406406|NCT01117181|101328416|FG000|STARTED|Overall Study||29||
48406407|NCT01117181|101328417|FG001|STARTED|Overall Study||31||
48406408|NCT01117181|101328416|FG000|COMPLETED|Overall Study||28||
48406409|NCT01117181|101328417|FG001|COMPLETED|Overall Study||29||
48406410|NCT01117181|101328416|FG000|NOT COMPLETED|Overall Study||1||
48406411|NCT01117181|101328417|FG001|NOT COMPLETED|Overall Study||2||
48406412|NCT03573804|101328418|FG000|STARTED|Overall Study||72||
48406413|NCT03573804|101328418|FG000|COMPLETED|Overall Study||62||
48406414|NCT03573804|101328418|FG000|NOT COMPLETED|Overall Study||10||
48406415|NCT00880100|101328419|FG000|STARTED|Baseline Phase-Usual Pancreatic Enzymes||49||
48406416|NCT00880100|101328419|FG000|COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||48||
48406417|NCT00880100|101328419|FG000|NOT COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||1||
48406418|NCT00880100|101328419|FG000|STARTED|Treatment Phase With Ultrase® MT12||48||
48406419|NCT00880100|101328419|FG000|COMPLETED|Treatment Phase With Ultrase® MT12||45||
48406420|NCT00880100|101328419|FG000|NOT COMPLETED|Treatment Phase With Ultrase® MT12||3||
48406421|NCT02147691|101328420|FG000|STARTED|Overall Study||10||
48406422|NCT02147691|101328421|FG001|STARTED|Overall Study||12||
48406423|NCT02147691|101328420|FG000|COMPLETED|Overall Study||6||
48406424|NCT02147691|101328421|FG001|COMPLETED|Overall Study||11||
48406425|NCT02147691|101328420|FG000|NOT COMPLETED|Overall Study||4||
48307669|NCT01514136|101077656|FG002|NOT COMPLETED|Test Period 1; Test D||0||
48307670|NCT01514136|101077657|FG003|NOT COMPLETED|Test Period 1; Test D||2||
48307671|NCT01514136|101077658|FG004|NOT COMPLETED|Test Period 1; Test D||0||
48406426|NCT02147691|101328421|FG001|NOT COMPLETED|Overall Study||1||
48406427|NCT01291511|101328422|FG000|STARTED|Cross-Titration and Stabilization Phase||635||
48406428|NCT01291511|101328423|FG001|STARTED|Cross-Titration and Stabilization Phase||0||
48188728|NCT05161715|100783320|FG000|COMPLETED|Overall Study||13||
48406429|NCT01291511|101328422|FG000|COMPLETED|Cross-Titration and Stabilization Phase||309||
48406430|NCT01291511|101328423|FG001|COMPLETED|Cross-Titration and Stabilization Phase||0||
48406431|NCT01291511|101328422|FG000|NOT COMPLETED|Cross-Titration and Stabilization Phase||326||
48406432|NCT01291511|101328423|FG001|NOT COMPLETED|Cross-Titration and Stabilization Phase||0||
48406433|NCT01291511|101328422|FG000|STARTED|Double-blind Relapse Prevention Phase||153||
48406434|NCT01291511|101328423|FG001|STARTED|Double-blind Relapse Prevention Phase||150||
48609620|NCT03465709|101827387|FG000|COMPLETED|Overall Study||0|Completed planned treatment phase to Visit 15.|
48609621|NCT03465709|101827387|FG000|NOT COMPLETED|Overall Study||17||
48609622|NCT00401518|101827388|FG000|STARTED|Overall Study||46||
48609623|NCT00401518|101827389|FG001|STARTED|Overall Study||227||
48609624|NCT00401518|101827390|FG002|STARTED|Overall Study||117||
48609625|NCT00401518|101827388|FG000|COMPLETED|Overall Study||40||
48609626|NCT00401518|101827389|FG001|COMPLETED|Overall Study||190||
48406435|NCT01291511|101328422|FG000|COMPLETED|Double-blind Relapse Prevention Phase||76||
48406436|NCT01291511|101328423|FG001|COMPLETED|Double-blind Relapse Prevention Phase||102||
48406437|NCT01291511|101328422|FG000|NOT COMPLETED|Double-blind Relapse Prevention Phase||77||
48406438|NCT01291511|101328423|FG001|NOT COMPLETED|Double-blind Relapse Prevention Phase||48||
48406439|NCT03531710|101328424|FG000|STARTED|Overall Study||10||
48609627|NCT00401518|101827390|FG002|COMPLETED|Overall Study||94||
48609628|NCT00401518|101827388|FG000|NOT COMPLETED|Overall Study||6||
48609629|NCT00401518|101827389|FG001|NOT COMPLETED|Overall Study||37||
48609630|NCT00401518|101827390|FG002|NOT COMPLETED|Overall Study||23||
48609631|NCT01808222|101827391|FG000|STARTED|Overall Study||25||
48609632|NCT01808222|101827391|FG000|Completed Fluciclovine PET-CT Scan|Overall Study||25||
48609633|NCT01808222|101827391|FG000|Completed mpMR Scan|Overall Study||24||
48609634|NCT01808222|101827391|FG000|COMPLETED|Overall Study||24||
48609635|NCT01808222|101827391|FG000|NOT COMPLETED|Overall Study||1||
48609636|NCT01703169|101827392|FG000|STARTED|Overall Study||13||
48609637|NCT01703169|101827392|FG000|COMPLETED|Overall Study||13||
48307672|NCT01514136|101077659|FG005|NOT COMPLETED|Test Period 1; Test D||0||
48609638|NCT01703169|101827392|FG000|NOT COMPLETED|Overall Study||0||
48609639|NCT01563913|101827393|FG000|STARTED|Overall Study||15||
48307673|NCT01514136|101077660|FG006|NOT COMPLETED|Test Period 1; Test D||0||
48406440|NCT03531710|101328425|FG001|STARTED|Overall Study||2||
48406441|NCT03531710|101328426|FG002|STARTED|Overall Study||7||
48406442|NCT03531710|101328427|FG003|STARTED|Overall Study||5||
48406443|NCT03531710|101328428|FG004|STARTED|Overall Study||8||
48406444|NCT03531710|101328429|FG005|STARTED|Overall Study||2||
48406445|NCT03531710|101328424|FG000|COMPLETED|Overall Study||8||
48406446|NCT03531710|101328425|FG001|COMPLETED|Overall Study||2||
48406447|NCT03531710|101328426|FG002|COMPLETED|Overall Study||7||
48406448|NCT03531710|101328427|FG003|COMPLETED|Overall Study||5||
48406449|NCT03531710|101328428|FG004|COMPLETED|Overall Study||8||
48406450|NCT03531710|101328429|FG005|COMPLETED|Overall Study||2||
48406451|NCT03531710|101328424|FG000|NOT COMPLETED|Overall Study||2||
48609640|NCT01563913|101827394|FG001|STARTED|Overall Study||15||
48609641|NCT01563913|101827393|FG000|COMPLETED|Overall Study||13||
48609642|NCT01563913|101827394|FG001|COMPLETED|Overall Study||15||
48609643|NCT01563913|101827393|FG000|NOT COMPLETED|Overall Study||2||
48609644|NCT01563913|101827394|FG001|NOT COMPLETED|Overall Study||0||
48609645|NCT03246061|101827395|FG000|STARTED|Overall Study||66||
48609646|NCT03246061|101827396|FG001|STARTED|Overall Study||74||
48609647|NCT03246061|101827395|FG000|Interim Analysis|Overall Study||51||
48609648|NCT03246061|101827396|FG001|Interim Analysis|Overall Study||53||
48609649|NCT03246061|101827395|FG000|COMPLETED|Overall Study||51||
48609650|NCT03246061|101827396|FG001|COMPLETED|Overall Study||53||
48609651|NCT03246061|101827395|FG000|NOT COMPLETED|Overall Study||15||
48609652|NCT03246061|101827396|FG001|NOT COMPLETED|Overall Study||21||
48609653|NCT00824655|101827397|FG000|STARTED|Infant Series (5 Months of Age)||118||
48609654|NCT00824655|101827398|FG001|STARTED|Infant Series (5 Months of Age)||0||
48609655|NCT00824655|101827397|FG000|COMPLETED|Infant Series (5 Months of Age)||118||
48609656|NCT00824655|101827398|FG001|COMPLETED|Infant Series (5 Months of Age)||0||
48609657|NCT00824655|101827397|FG000|NOT COMPLETED|Infant Series (5 Months of Age)||0||
48609658|NCT00824655|101827398|FG001|NOT COMPLETED|Infant Series (5 Months of Age)||0||
48609659|NCT00824655|101827397|FG000|STARTED|After Infant Dose (6 Months of Age)||118||
48609660|NCT00824655|101827398|FG001|STARTED|After Infant Dose (6 Months of Age)||0||
48609661|NCT00824655|101827397|FG000|COMPLETED|After Infant Dose (6 Months of Age)||118||
48609662|NCT00824655|101827398|FG001|COMPLETED|After Infant Dose (6 Months of Age)||0||
48609663|NCT00824655|101827397|FG000|NOT COMPLETED|After Infant Dose (6 Months of Age)||0||
48609664|NCT00824655|101827398|FG001|NOT COMPLETED|After Infant Dose (6 Months of Age)||0||
48609665|NCT00824655|101827397|FG000|STARTED|Toddler Dose (12 Months of Age)||118||
48609666|NCT00824655|101827398|FG001|STARTED|Toddler Dose (12 Months of Age)||116||
48609667|NCT00824655|101827397|FG000|COMPLETED|Toddler Dose (12 Months of Age)||116||
48609668|NCT00824655|101827398|FG001|COMPLETED|Toddler Dose (12 Months of Age)||116||
48609669|NCT00824655|101827397|FG000|NOT COMPLETED|Toddler Dose (12 Months of Age)||2||
48609670|NCT00824655|101827398|FG001|NOT COMPLETED|Toddler Dose (12 Months of Age)||0||
48609671|NCT01462305|101827399|FG000|STARTED|Overall Study||18||
48609672|NCT01462305|101827400|FG001|STARTED|Overall Study||17||
48609673|NCT01462305|101827399|FG000|COMPLETED|Overall Study||16||
48609674|NCT01462305|101827400|FG001|COMPLETED|Overall Study||13||
48609675|NCT01462305|101827399|FG000|NOT COMPLETED|Overall Study||2||
48609676|NCT01462305|101827400|FG001|NOT COMPLETED|Overall Study||4||
48609677|NCT02788188|101827401|FG000|STARTED|Overall Study||2||
48609678|NCT02788188|101827402|FG001|STARTED|Overall Study||2||
48609679|NCT02788188|101827403|FG002|STARTED|Overall Study||4||
48609680|NCT02788188|101827404|FG003|STARTED|Overall Study||4||
48609681|NCT02788188|101827405|FG004|STARTED|Overall Study||8||
48609682|NCT02788188|101827406|FG005|STARTED|Overall Study||8||
48406452|NCT03531710|101328425|FG001|NOT COMPLETED|Overall Study||0||
48406453|NCT03531710|101328426|FG002|NOT COMPLETED|Overall Study||0||
48609683|NCT02788188|101827407|FG006|STARTED|Overall Study||10||
48609684|NCT02788188|101827401|FG000|COMPLETED|Overall Study||2||
48609685|NCT02788188|101827402|FG001|COMPLETED|Overall Study||2||
48609686|NCT02788188|101827403|FG002|COMPLETED|Overall Study||4||
48609687|NCT02788188|101827404|FG003|COMPLETED|Overall Study||4||
48609688|NCT02788188|101827405|FG004|COMPLETED|Overall Study||8||
48609689|NCT02788188|101827406|FG005|COMPLETED|Overall Study||8||
48609690|NCT02788188|101827407|FG006|COMPLETED|Overall Study||10||
48609691|NCT02788188|101827401|FG000|NOT COMPLETED|Overall Study||0||
48609692|NCT02788188|101827402|FG001|NOT COMPLETED|Overall Study||0||
48609693|NCT02788188|101827403|FG002|NOT COMPLETED|Overall Study||0||
48609694|NCT02788188|101827404|FG003|NOT COMPLETED|Overall Study||0||
48609695|NCT02788188|101827405|FG004|NOT COMPLETED|Overall Study||0||
48609696|NCT02788188|101827406|FG005|NOT COMPLETED|Overall Study||0||
48406454|NCT03531710|101328427|FG003|NOT COMPLETED|Overall Study||0||
48406455|NCT03531710|101328428|FG004|NOT COMPLETED|Overall Study||0||
48406456|NCT03531710|101328429|FG005|NOT COMPLETED|Overall Study||0||
48406457|NCT01237223|101328430|FG000|STARTED|Single Blind(Run-in Period, 4 Weeks)||1342||
48406458|NCT01237223|101328431|FG001|STARTED|Single Blind(Run-in Period, 4 Weeks)||0||
48406459|NCT01237223|101328432|FG002|STARTED|Single Blind(Run-in Period, 4 Weeks)||0||
48406460|NCT01237223|101328433|FG003|STARTED|Single Blind(Run-in Period, 4 Weeks)||0||
48406461|NCT01237223|101328434|FG004|STARTED|Single Blind(Run-in Period, 4 Weeks)||0||
48406462|NCT01237223|101328435|FG005|STARTED|Single Blind(Run-in Period, 4 Weeks)||0||
48609697|NCT02788188|101827407|FG006|NOT COMPLETED|Overall Study||0||
48307674|NCT01514136|101077661|FG007|NOT COMPLETED|Test Period 1; Test D||0||
48307675|NCT01514136|101077654|FG000|STARTED|Test Period 2; Test A*||0||
48307676|NCT01514136|101077655|FG001|STARTED|Test Period 2; Test A*||0||
48609698|NCT01980628|101827408|FG000|STARTED|Overall Study||63||
48609699|NCT01980628|101827408|FG000|COMPLETED|Overall Study||0||
48609700|NCT01980628|101827408|FG000|NOT COMPLETED|Overall Study||63||
48609701|NCT02681458|101827409|FG000|STARTED|Overall Study||718||
48609702|NCT02681458|101827410|FG001|STARTED|Overall Study||718||
48609703|NCT02681458|101827409|FG000|COMPLETED|Overall Study||73||
48307677|NCT01514136|101077656|FG002|STARTED|Test Period 2; Test A*||0||
48307678|NCT01514136|101077657|FG003|STARTED|Test Period 2; Test A*||0||
48307679|NCT01514136|101077658|FG004|STARTED|Test Period 2; Test A*||28||
48609704|NCT02681458|101827410|FG001|COMPLETED|Overall Study||62||
48609705|NCT02681458|101827409|FG000|NOT COMPLETED|Overall Study||645||
48609706|NCT02681458|101827410|FG001|NOT COMPLETED|Overall Study||656||
48609707|NCT04999085|101830249|FG000|STARTED|Overall Study||16||
48609708|NCT04999085|101830249|FG000|COMPLETED|Overall Study||15||
48609709|NCT04999085|101830249|FG000|NOT COMPLETED|Overall Study||1||
48307680|NCT01514136|101077659|FG005|STARTED|Test Period 2; Test A*||0||
48307681|NCT01514136|101077660|FG006|STARTED|Test Period 2; Test A*||0||
48307682|NCT01514136|101077661|FG007|STARTED|Test Period 2; Test A*||0||
48307683|NCT01514136|101077654|FG000|COMPLETED|Test Period 2; Test A*||0||
48307684|NCT01514136|101077655|FG001|COMPLETED|Test Period 2; Test A*||0||
48307685|NCT01514136|101077656|FG002|COMPLETED|Test Period 2; Test A*||0||
48609710|NCT04754542|101830250|FG000|STARTED|Overall Study||31||
48609711|NCT04754542|101830251|FG001|STARTED|Overall Study||45||
48609712|NCT04754542|101830250|FG000|COMPLETED|Overall Study||30||
48609713|NCT04754542|101830251|FG001|COMPLETED|Overall Study||44||
48609714|NCT04754542|101830250|FG000|NOT COMPLETED|Overall Study||1||
48609715|NCT04754542|101830251|FG001|NOT COMPLETED|Overall Study||1||
48609716|NCT03373760|101830252|FG000|STARTED|Overall Study||58||
48609717|NCT03373760|101830252|FG000|COMPLETED|Overall Study||0||
48609718|NCT03373760|101830252|FG000|NOT COMPLETED|Overall Study||58||
48609719|NCT00571103|101830253|FG000|STARTED|Overall Study||28||
48609720|NCT00571103|101830253|FG000|COMPLETED|Overall Study||26||
48609721|NCT00571103|101830253|FG000|NOT COMPLETED|Overall Study||2||
48609722|NCT01212159|101830254|FG000|STARTED|Overall Study||26||
48609723|NCT01212159|101830255|FG001|STARTED|Overall Study||44||
48609724|NCT01212159|101830254|FG000|COMPLETED|Overall Study||14||
48609725|NCT01212159|101830255|FG001|COMPLETED|Overall Study||32||
48609726|NCT01212159|101830254|FG000|NOT COMPLETED|Overall Study||12||
48609727|NCT01212159|101830255|FG001|NOT COMPLETED|Overall Study||12||
48609728|NCT00777335|101830256|FG000|STARTED|Overall Study||2||
48609729|NCT00777335|101830257|FG001|STARTED|Overall Study||2||
48609730|NCT00777335|101830256|FG000|COMPLETED|Overall Study||2||
48609731|NCT00777335|101830257|FG001|COMPLETED|Overall Study||2||
48609732|NCT00777335|101830256|FG000|NOT COMPLETED|Overall Study||0||
48609733|NCT00777335|101830257|FG001|NOT COMPLETED|Overall Study||0||
48609734|NCT02497937|101830258|FG000|STARTED|Period 1 (Up to 7 Days)||6||
48609735|NCT02497937|101830259|FG001|STARTED|Period 1 (Up to 7 Days)||5||
48609736|NCT02497937|101830258|FG000|COMPLETED|Period 1 (Up to 7 Days)||6||
48609737|NCT02497937|101830259|FG001|COMPLETED|Period 1 (Up to 7 Days)||5||
48609738|NCT02497937|101830258|FG000|NOT COMPLETED|Period 1 (Up to 7 Days)||0||
48307686|NCT01514136|101077657|FG003|COMPLETED|Test Period 2; Test A*||0||
48307687|NCT01514136|101077658|FG004|COMPLETED|Test Period 2; Test A*||26||
48307688|NCT01514136|101077659|FG005|COMPLETED|Test Period 2; Test A*||0||
48307689|NCT01514136|101077660|FG006|COMPLETED|Test Period 2; Test A*||0||
48307690|NCT01514136|101077661|FG007|COMPLETED|Test Period 2; Test A*||0||
48307691|NCT01514136|101077654|FG000|NOT COMPLETED|Test Period 2; Test A*||0||
48609739|NCT02497937|101830259|FG001|NOT COMPLETED|Period 1 (Up to 7 Days)||0||
48609740|NCT02497937|101830258|FG000|STARTED|Washout Period (Up to 14 Days)||6||
48609741|NCT02497937|101830259|FG001|STARTED|Washout Period (Up to 14 Days)||5||
48609742|NCT02497937|101830258|FG000|COMPLETED|Washout Period (Up to 14 Days)||6||
48609743|NCT02497937|101830259|FG001|COMPLETED|Washout Period (Up to 14 Days)||5||
48609744|NCT02497937|101830258|FG000|NOT COMPLETED|Washout Period (Up to 14 Days)||0||
48609745|NCT02497937|101830259|FG001|NOT COMPLETED|Washout Period (Up to 14 Days)||0||
48609746|NCT02497937|101830258|FG000|STARTED|Period 2 (Up to 7 Days)||6||
48609747|NCT02497937|101830259|FG001|STARTED|Period 2 (Up to 7 Days)||5||
48609748|NCT02497937|101830258|FG000|COMPLETED|Period 2 (Up to 7 Days)||6||
48609749|NCT02497937|101830259|FG001|COMPLETED|Period 2 (Up to 7 Days)||5||
48609750|NCT02497937|101830258|FG000|NOT COMPLETED|Period 2 (Up to 7 Days)||0||
48609751|NCT02497937|101830259|FG001|NOT COMPLETED|Period 2 (Up to 7 Days)||0||
48609752|NCT02469168|101830260|FG000|STARTED|Overall Study||1||
48609753|NCT02469168|101830261|FG001|STARTED|Overall Study||0||
48609754|NCT02469168|101830260|FG000|COMPLETED|Overall Study||0||
48609755|NCT02469168|101830261|FG001|COMPLETED|Overall Study||0||
48609756|NCT02469168|101830260|FG000|NOT COMPLETED|Overall Study||1||
48609757|NCT02469168|101830261|FG001|NOT COMPLETED|Overall Study||0||
48307692|NCT01514136|101077655|FG001|NOT COMPLETED|Test Period 2; Test A*||0||
48307693|NCT01514136|101077656|FG002|NOT COMPLETED|Test Period 2; Test A*||0||
48307694|NCT01514136|101077657|FG003|NOT COMPLETED|Test Period 2; Test A*||0||
48609758|NCT01983826|101830262|FG000|STARTED|Overall Study||13||
48609759|NCT01983826|101830263|FG001|STARTED|Overall Study||8||
48609760|NCT01983826|101830262|FG000|COMPLETED|Overall Study||13||
48609761|NCT01983826|101830263|FG001|COMPLETED|Overall Study||8||
48609762|NCT01983826|101830262|FG000|NOT COMPLETED|Overall Study||0||
48609763|NCT01983826|101830263|FG001|NOT COMPLETED|Overall Study||0||
48609764|NCT01698268|101830264|FG000|STARTED|Overall Study||25||
48307695|NCT01514136|101077658|FG004|NOT COMPLETED|Test Period 2; Test A*||2||
48307696|NCT01514136|101077659|FG005|NOT COMPLETED|Test Period 2; Test A*||0||
48307697|NCT01514136|101077660|FG006|NOT COMPLETED|Test Period 2; Test A*||0||
48307698|NCT01514136|101077661|FG007|NOT COMPLETED|Test Period 2; Test A*||0||
48307699|NCT01514136|101077654|FG000|STARTED|Test Period 2; Test B*||0||
48307700|NCT01514136|101077655|FG001|STARTED|Test Period 2; Test B*||0||
48307701|NCT01514136|101077656|FG002|STARTED|Test Period 2; Test B*||0||
48307702|NCT01514136|101077657|FG003|STARTED|Test Period 2; Test B*||0||
48307703|NCT01514136|101077658|FG004|STARTED|Test Period 2; Test B*||0||
48307704|NCT01514136|101077659|FG005|STARTED|Test Period 2; Test B*||28||
48307705|NCT01514136|101077660|FG006|STARTED|Test Period 2; Test B*||0||
48307706|NCT01514136|101077661|FG007|STARTED|Test Period 2; Test B*||0||
48307707|NCT01514136|101077654|FG000|COMPLETED|Test Period 2; Test B*||0||
48307708|NCT01514136|101077655|FG001|COMPLETED|Test Period 2; Test B*||0||
48307709|NCT01514136|101077656|FG002|COMPLETED|Test Period 2; Test B*||0||
48307710|NCT01514136|101077657|FG003|COMPLETED|Test Period 2; Test B*||0||
48307711|NCT01514136|101077658|FG004|COMPLETED|Test Period 2; Test B*||0||
48307712|NCT01514136|101077659|FG005|COMPLETED|Test Period 2; Test B*||26||
48307713|NCT01514136|101077660|FG006|COMPLETED|Test Period 2; Test B*||0||
48307714|NCT01514136|101077661|FG007|COMPLETED|Test Period 2; Test B*||0||
48307715|NCT01514136|101077654|FG000|NOT COMPLETED|Test Period 2; Test B*||0||
48307716|NCT01514136|101077655|FG001|NOT COMPLETED|Test Period 2; Test B*||0||
48307717|NCT01514136|101077656|FG002|NOT COMPLETED|Test Period 2; Test B*||0||
48307718|NCT01514136|101077657|FG003|NOT COMPLETED|Test Period 2; Test B*||0||
48307719|NCT01514136|101077658|FG004|NOT COMPLETED|Test Period 2; Test B*||0||
48307720|NCT01514136|101077659|FG005|NOT COMPLETED|Test Period 2; Test B*||2||
48307721|NCT01514136|101077660|FG006|NOT COMPLETED|Test Period 2; Test B*||0||
48307722|NCT01514136|101077661|FG007|NOT COMPLETED|Test Period 2; Test B*||0||
48307723|NCT01514136|101077654|FG000|STARTED|Test Period 2; Test C*||0||
48307724|NCT01514136|101077655|FG001|STARTED|Test Period 2; Test C*||0||
48307725|NCT01514136|101077656|FG002|STARTED|Test Period 2; Test C*||0||
48609765|NCT01698268|101830265|FG001|STARTED|Overall Study||25||
48609766|NCT01698268|101830264|FG000|COMPLETED|Overall Study||23||
48609767|NCT01698268|101830265|FG001|COMPLETED|Overall Study||24||
48609768|NCT01698268|101830264|FG000|NOT COMPLETED|Overall Study||2||
48307726|NCT01514136|101077657|FG003|STARTED|Test Period 2; Test C*||0||
48307727|NCT01514136|101077658|FG004|STARTED|Test Period 2; Test C*||0||
48307728|NCT01514136|101077659|FG005|STARTED|Test Period 2; Test C*||0||
48307729|NCT01514136|101077660|FG006|STARTED|Test Period 2; Test C*||26||
48307730|NCT01514136|101077661|FG007|STARTED|Test Period 2; Test C*||0||
48307731|NCT01514136|101077654|FG000|COMPLETED|Test Period 2; Test C*||0||
48307732|NCT01514136|101077655|FG001|COMPLETED|Test Period 2; Test C*||0||
48307733|NCT01514136|101077656|FG002|COMPLETED|Test Period 2; Test C*||0||
48307734|NCT01514136|101077657|FG003|COMPLETED|Test Period 2; Test C*||0||
48307735|NCT01514136|101077658|FG004|COMPLETED|Test Period 2; Test C*||0||
48307736|NCT01514136|101077659|FG005|COMPLETED|Test Period 2; Test C*||0||
48307737|NCT01514136|101077660|FG006|COMPLETED|Test Period 2; Test C*||23||
48307738|NCT01514136|101077661|FG007|COMPLETED|Test Period 2; Test C*||0||
48307739|NCT01514136|101077654|FG000|NOT COMPLETED|Test Period 2; Test C*||0||
48307740|NCT01514136|101077655|FG001|NOT COMPLETED|Test Period 2; Test C*||0||
48307741|NCT01514136|101077656|FG002|NOT COMPLETED|Test Period 2; Test C*||0||
48307742|NCT01514136|101077657|FG003|NOT COMPLETED|Test Period 2; Test C*||0||
48307743|NCT01514136|101077658|FG004|NOT COMPLETED|Test Period 2; Test C*||0||
48609769|NCT01698268|101830265|FG001|NOT COMPLETED|Overall Study||1||
48609770|NCT00376532|101830266|FG000|STARTED|Overall Study||31||
48609771|NCT00376532|101830267|FG001|STARTED|Overall Study||32||
48609772|NCT00376532|101830266|FG000|COMPLETED|Overall Study||25||
48609773|NCT00376532|101830267|FG001|COMPLETED|Overall Study||26||
48609774|NCT00376532|101830266|FG000|NOT COMPLETED|Overall Study||6||
48307744|NCT01514136|101077659|FG005|NOT COMPLETED|Test Period 2; Test C*||0||
48307745|NCT01514136|101077660|FG006|NOT COMPLETED|Test Period 2; Test C*||3||
48609775|NCT00376532|101830267|FG001|NOT COMPLETED|Overall Study||6||
48609776|NCT02096276|101830268|FG000|STARTED|Overall Study||250||
48609777|NCT02096276|101830269|FG001|STARTED|Overall Study||55||
48609778|NCT02096276|101830268|FG000|COMPLETED|Overall Study||250||
48609779|NCT02096276|101830269|FG001|COMPLETED|Overall Study||55||
48609780|NCT02096276|101830268|FG000|NOT COMPLETED|Overall Study||0||
48609781|NCT02096276|101830269|FG001|NOT COMPLETED|Overall Study||0||
48609782|NCT02588586|101830270|FG000|STARTED|Overall Study||17||
48609783|NCT02588586|101830270|FG000|COMPLETED|Overall Study||15||
48609784|NCT02588586|101830270|FG000|NOT COMPLETED|Overall Study||2||
48609785|NCT00308516|101830271|FG000|STARTED|Overall Study||35||
48609786|NCT00308516|101830272|FG001|STARTED|Overall Study||31||
48609787|NCT00308516|101830271|FG000|COMPLETED|Overall Study||6||
48609788|NCT00308516|101830272|FG001|COMPLETED|Overall Study||10||
48609789|NCT00308516|101830271|FG000|NOT COMPLETED|Overall Study||29||
48609790|NCT00308516|101830272|FG001|NOT COMPLETED|Overall Study||21||
48609791|NCT05753735|101830273|FG000|STARTED|Overall Study||0||
48609792|NCT05753735|101830274|FG001|STARTED|Overall Study||3||
48609793|NCT05753735|101830273|FG000|COMPLETED|Overall Study||0||
48307746|NCT01514136|101077661|FG007|NOT COMPLETED|Test Period 2; Test C*||0||
48307747|NCT01514136|101077654|FG000|STARTED|Test Period; Test D*||0||
48609794|NCT05753735|101830274|FG001|COMPLETED|Overall Study||3||
48307748|NCT01514136|101077655|FG001|STARTED|Test Period; Test D*||0||
48307749|NCT01514136|101077656|FG002|STARTED|Test Period; Test D*||0||
48307750|NCT01514136|101077657|FG003|STARTED|Test Period; Test D*||0||
48307751|NCT01514136|101077658|FG004|STARTED|Test Period; Test D*||0||
48609795|NCT05753735|101830273|FG000|NOT COMPLETED|Overall Study||0||
48609796|NCT05753735|101830274|FG001|NOT COMPLETED|Overall Study||0||
48609797|NCT02105285|101830275|FG000|STARTED|Overall Study||78||
48609798|NCT02105285|101830276|FG001|STARTED|Overall Study||78||
48609799|NCT02105285|101830277|FG002|STARTED|Overall Study||37||
48609800|NCT02105285|101830275|FG000|COMPLETED|Overall Study||76||
48609801|NCT02105285|101830276|FG001|COMPLETED|Overall Study||76||
48609802|NCT02105285|101830277|FG002|COMPLETED|Overall Study||37||
48609803|NCT02105285|101830275|FG000|NOT COMPLETED|Overall Study||2||
48609804|NCT02105285|101830276|FG001|NOT COMPLETED|Overall Study||2||
48609805|NCT02105285|101830277|FG002|NOT COMPLETED|Overall Study||0||
48609806|NCT04585243|101830278|FG000|STARTED|Overall Study||22||
48609807|NCT04585243|101830278|FG000|COMPLETED|Overall Study||12||
48609808|NCT04585243|101830278|FG000|NOT COMPLETED|Overall Study||10||
48609809|NCT00940576|101830279|FG000|STARTED|Overall Study||8||
48609810|NCT00940576|101830280|FG001|STARTED|Overall Study||9||
48609811|NCT00940576|101830279|FG000|COMPLETED|Overall Study||8||
48609812|NCT00940576|101830280|FG001|COMPLETED|Overall Study||9||
48609813|NCT00940576|101830279|FG000|NOT COMPLETED|Overall Study||0||
48722466|NCT00537407|102108168|FG004|COMPLETED|Part 1 Weeks 1-4||10||
48722467|NCT00537407|102108164|FG000|NOT COMPLETED|Part 1 Weeks 1-4||0||
48722468|NCT00537407|102108165|FG001|NOT COMPLETED|Part 1 Weeks 1-4||0||
48722469|NCT00537407|102108166|FG002|NOT COMPLETED|Part 1 Weeks 1-4||0||
48722470|NCT00537407|102108167|FG003|NOT COMPLETED|Part 1 Weeks 1-4||0||
48722471|NCT00537407|102108168|FG004|NOT COMPLETED|Part 1 Weeks 1-4||0||
48722472|NCT00537407|102108164|FG000|STARTED|Part 2 Weeks 5-48 or 72||10||
48152410|NCT02889133|100696004|FG001|STARTED|Completed Secondary Outcomes||40||
48152411|NCT02889133|100696003|FG000|COMPLETED|Completed Secondary Outcomes||33||
48152412|NCT02889133|100696004|FG001|COMPLETED|Completed Secondary Outcomes||35||
48152413|NCT02889133|100696003|FG000|NOT COMPLETED|Completed Secondary Outcomes||6||
48152414|NCT02889133|100696004|FG001|NOT COMPLETED|Completed Secondary Outcomes||5||
48152415|NCT02080780|100696005|FG000|STARTED|Overall Study||24||
48152416|NCT02080780|100696005|FG000|COMPLETED|Overall Study||24||
48152417|NCT02080780|100696005|FG000|NOT COMPLETED|Overall Study||0||
48152418|NCT03616184|100696006|FG000|STARTED|Overall Study||47||
48152419|NCT03616184|100696006|FG000|COMPLETED|Overall Study||34||
48152420|NCT03616184|100696006|FG000|NOT COMPLETED|Overall Study||13||
48152421|NCT02342886|100696007|FG000|STARTED|Overall Study||65||
48722473|NCT00537407|102108165|FG001|STARTED|Part 2 Weeks 5-48 or 72||9||
48722474|NCT00537407|102108166|FG002|STARTED|Part 2 Weeks 5-48 or 72||11||
48722475|NCT00537407|102108167|FG003|STARTED|Part 2 Weeks 5-48 or 72||10||
48722476|NCT00537407|102108168|FG004|STARTED|Part 2 Weeks 5-48 or 72||10||
48722477|NCT00537407|102108164|FG000|COMPLETED|Part 2 Weeks 5-48 or 72||2||
48722478|NCT00537407|102108165|FG001|COMPLETED|Part 2 Weeks 5-48 or 72||1||
48152422|NCT02342886|100696008|FG001|STARTED|Overall Study||71||
48152423|NCT02342886|100696009|FG002|STARTED|Overall Study||67||
48152424|NCT02342886|100696010|FG003|STARTED|Overall Study||68||
48152425|NCT02342886|100696011|FG004|STARTED|Overall Study||13||
48722479|NCT00537407|102108166|FG002|COMPLETED|Part 2 Weeks 5-48 or 72||2||
48722480|NCT00537407|102108167|FG003|COMPLETED|Part 2 Weeks 5-48 or 72||4||
48722481|NCT00537407|102108168|FG004|COMPLETED|Part 2 Weeks 5-48 or 72||3||
48722482|NCT00537407|102108164|FG000|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8||
48152426|NCT02342886|100696007|FG000|Completed Month 12 Follow-Up|Overall Study||43||
48152427|NCT02342886|100696008|FG001|Completed Month 12 Follow-Up|Overall Study||52||
48152428|NCT02342886|100696009|FG002|Completed Month 12 Follow-Up|Overall Study||49||
48152429|NCT02342886|100696010|FG003|Completed Month 12 Follow-Up|Overall Study||57||
48152430|NCT02342886|100696011|FG004|Completed Month 12 Follow-Up|Overall Study||10||
48307752|NCT01514136|101077659|FG005|STARTED|Test Period; Test D*||0||
48609814|NCT00940576|101830280|FG001|NOT COMPLETED|Overall Study||0||
48609815|NCT02149264|101830281|FG000|STARTED|Overall Study||159||
48609816|NCT02149264|101830281|FG000|COMPLETED|Overall Study||139||
48609817|NCT02149264|101830281|FG000|NOT COMPLETED|Overall Study||20||
48609818|NCT04227405|101830282|FG000|STARTED|Enrollment - Time 1 PreTest||294||
48722483|NCT00537407|102108165|FG001|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8||
48722484|NCT00537407|102108166|FG002|NOT COMPLETED|Part 2 Weeks 5-48 or 72||9||
48722485|NCT00537407|102108167|FG003|NOT COMPLETED|Part 2 Weeks 5-48 or 72||6||
48722486|NCT00537407|102108168|FG004|NOT COMPLETED|Part 2 Weeks 5-48 or 72||7||
48722487|NCT02647346|102108169|FG000|STARTED|Overall Study||132||
48722488|NCT02647346|102108169|FG000|COMPLETED|Overall Study||129||
48609819|NCT04227405|101830283|FG001|STARTED|Enrollment - Time 1 PreTest||290||
48609820|NCT04227405|101830282|FG000|COMPLETED|Enrollment - Time 1 PreTest||268||
48609821|NCT04227405|101830283|FG001|COMPLETED|Enrollment - Time 1 PreTest||212||
48609822|NCT04227405|101830282|FG000|NOT COMPLETED|Enrollment - Time 1 PreTest||26||
48152431|NCT02342886|100696007|FG000|Completed Month 24 Follow-Up|Overall Study||40||
48152432|NCT02342886|100696008|FG001|Completed Month 24 Follow-Up|Overall Study||47||
48152433|NCT02342886|100696009|FG002|Completed Month 24 Follow-Up|Overall Study||46||
48152434|NCT02342886|100696010|FG003|Completed Month 24 Follow-Up|Overall Study||53||
48152435|NCT02342886|100696011|FG004|Completed Month 24 Follow-Up|Overall Study||10||
48152436|NCT02342886|100696007|FG000|COMPLETED|Overall Study||57|Completed Treatment|
48152437|NCT02342886|100696008|FG001|COMPLETED|Overall Study||63|Completed Treatment|
48152438|NCT02342886|100696009|FG002|COMPLETED|Overall Study||52|Completed Treatment|
48152439|NCT02342886|100696010|FG003|COMPLETED|Overall Study||59|Completed Treatment|
48152440|NCT02342886|100696011|FG004|COMPLETED|Overall Study||10|Completed Treatment|
48152441|NCT02342886|100696007|FG000|NOT COMPLETED|Overall Study||8||
48152442|NCT02342886|100696008|FG001|NOT COMPLETED|Overall Study||8||
48152443|NCT02342886|100696009|FG002|NOT COMPLETED|Overall Study||15||
48152444|NCT02342886|100696010|FG003|NOT COMPLETED|Overall Study||9||
48152445|NCT02342886|100696011|FG004|NOT COMPLETED|Overall Study||3||
48152446|NCT03751631|100696012|FG000|STARTED|Overall Study||10||20
48152447|NCT03751631|100696013|FG001|STARTED|Overall Study||11||22
48152448|NCT03751631|100696014|FG002|STARTED|Overall Study||11||22
48152449|NCT03751631|100696015|FG003|STARTED|Overall Study||11||22
48152450|NCT03751631|100696016|FG004|STARTED|Overall Study||10||20
48152451|NCT03751631|100696017|FG005|STARTED|Overall Study||11||22
48152452|NCT03751631|100696012|FG000|Received 1st Drug in Sequence|Overall Study||10||20
48152453|NCT03751631|100696013|FG001|Received 1st Drug in Sequence|Overall Study||11||22
48152454|NCT03751631|100696014|FG002|Received 1st Drug in Sequence|Overall Study||11||22
48152455|NCT03751631|100696015|FG003|Received 1st Drug in Sequence|Overall Study||11||22
48152456|NCT03751631|100696016|FG004|Received 1st Drug in Sequence|Overall Study||10||20
48152457|NCT03751631|100696017|FG005|Received 1st Drug in Sequence|Overall Study||11||22
48152458|NCT03751631|100696012|FG000|Received 2nd Drug in Sequence|Overall Study||10||20
48152459|NCT03751631|100696013|FG001|Received 2nd Drug in Sequence|Overall Study||11||22
48152460|NCT03751631|100696014|FG002|Received 2nd Drug in Sequence|Overall Study||10||20
48152461|NCT03751631|100696015|FG003|Received 2nd Drug in Sequence|Overall Study||10||20
48152462|NCT03751631|100696016|FG004|Received 2nd Drug in Sequence|Overall Study||10||20
48152463|NCT03751631|100696017|FG005|Received 2nd Drug in Sequence|Overall Study||11||22
48152464|NCT03751631|100696012|FG000|Received 3rd Drug in Sequence|Overall Study||10||20
48152465|NCT03751631|100696013|FG001|Received 3rd Drug in Sequence|Overall Study||11||22
48152466|NCT03751631|100696014|FG002|Received 3rd Drug in Sequence|Overall Study||10||20
48152467|NCT03751631|100696015|FG003|Received 3rd Drug in Sequence|Overall Study||10||20
48152468|NCT03751631|100696016|FG004|Received 3rd Drug in Sequence|Overall Study||10||20
48152469|NCT03751631|100696017|FG005|Received 3rd Drug in Sequence|Overall Study||11||22
48152470|NCT03751631|100696012|FG000|COMPLETED|Overall Study||10||20
48152471|NCT03751631|100696013|FG001|COMPLETED|Overall Study||11||22
48152472|NCT03751631|100696014|FG002|COMPLETED|Overall Study||10||20
48152473|NCT03751631|100696015|FG003|COMPLETED|Overall Study||10||20
48152474|NCT03751631|100696016|FG004|COMPLETED|Overall Study||10||20
48152475|NCT03751631|100696017|FG005|COMPLETED|Overall Study||11||22
48152476|NCT03751631|100696012|FG000|NOT COMPLETED|Overall Study||0||0
48152477|NCT03751631|100696013|FG001|NOT COMPLETED|Overall Study||0||0
48152478|NCT03751631|100696014|FG002|NOT COMPLETED|Overall Study||1||2
48152479|NCT03751631|100696015|FG003|NOT COMPLETED|Overall Study||1||2
48152480|NCT03751631|100696016|FG004|NOT COMPLETED|Overall Study||0||0
48152481|NCT03751631|100696017|FG005|NOT COMPLETED|Overall Study||0||0
48152482|NCT03509974|100696018|FG000|STARTED|Overall Study||14||
48152483|NCT03509974|100696018|FG000|COMPLETED|Overall Study||14||
48152484|NCT03509974|100696018|FG000|NOT COMPLETED|Overall Study||0||
48152485|NCT04517864|100696019|FG000|STARTED|Placebo-Controlled Phase||36||
48152486|NCT04517864|100696020|FG001|STARTED|Placebo-Controlled Phase||35||
48152487|NCT04517864|100696019|FG000|COMPLETED|Placebo-Controlled Phase||32||
48152488|NCT04517864|100696020|FG001|COMPLETED|Placebo-Controlled Phase||33||
48152489|NCT04517864|100696019|FG000|NOT COMPLETED|Placebo-Controlled Phase||4||
48152490|NCT04517864|100696020|FG001|NOT COMPLETED|Placebo-Controlled Phase||2||
48152491|NCT04517864|100696019|FG000|STARTED|Active Therapy Extension Phase||32||
48152492|NCT04517864|100696020|FG001|STARTED|Active Therapy Extension Phase||33||
48152493|NCT04517864|100696019|FG000|COMPLETED|Active Therapy Extension Phase||1||
48152494|NCT04517864|100696020|FG001|COMPLETED|Active Therapy Extension Phase||0||
48152495|NCT04517864|100696019|FG000|NOT COMPLETED|Active Therapy Extension Phase||31||
48152496|NCT04517864|100696020|FG001|NOT COMPLETED|Active Therapy Extension Phase||33||
48152497|NCT02172625|100696021|FG000|STARTED|Overall Study||19||
48152498|NCT02172625|100696022|FG001|STARTED|Overall Study||19||
48152499|NCT02172625|100696021|FG000|COMPLETED|Overall Study||19||
48152500|NCT02172625|100696022|FG001|COMPLETED|Overall Study||16||
48152501|NCT02172625|100696021|FG000|NOT COMPLETED|Overall Study||0||
48152502|NCT02172625|100696022|FG001|NOT COMPLETED|Overall Study||3||
48152503|NCT00101933|100696023|FG000|STARTED|Overall Study||54||
48152504|NCT00101933|100696024|FG001|STARTED|Overall Study||55||
48152505|NCT00101933|100696023|FG000|COMPLETED|Overall Study||54||
48152506|NCT00101933|100696024|FG001|COMPLETED|Overall Study||55||
48152507|NCT00101933|100696023|FG000|NOT COMPLETED|Overall Study||0||
48152508|NCT00101933|100696024|FG001|NOT COMPLETED|Overall Study||0||
48152509|NCT00045305|100696025|FG000|STARTED|Overall Study||17||
48152510|NCT00045305|100696025|FG000|Eligible and Treated|Overall Study||17||
48152511|NCT00045305|100696025|FG000|COMPLETED|Overall Study||3||
48152512|NCT00045305|100696025|FG000|NOT COMPLETED|Overall Study||14||
48152513|NCT02057874|100696026|FG000|STARTED|Overall Study||2||
48152514|NCT02057874|100696026|FG000|COMPLETED|Overall Study||1||
48152515|NCT02057874|100696026|FG000|NOT COMPLETED|Overall Study||1||
48152516|NCT04123067|100696027|FG000|STARTED|Overall Study||0||
48152517|NCT04123067|100696028|FG001|STARTED|Overall Study||1||
48152518|NCT04123067|100696027|FG000|COMPLETED|Overall Study||0||
48152519|NCT04123067|100696028|FG001|COMPLETED|Overall Study||0||
48152520|NCT04123067|100696027|FG000|NOT COMPLETED|Overall Study||0||
48152521|NCT04123067|100696028|FG001|NOT COMPLETED|Overall Study||1||
48152522|NCT00453986|100696029|FG000|STARTED|Overall Study||311||
48152523|NCT00453986|100696030|FG001|STARTED|Overall Study||311||
48152524|NCT00453986|100696031|FG002|STARTED|Overall Study||313||
48152525|NCT00453986|100696032|FG003|STARTED|Overall Study||312||
48152526|NCT00453986|100696033|FG004|STARTED|Overall Study||105||
48152527|NCT00453986|100696029|FG000|COMPLETED|Overall Study||305||
48152528|NCT00453986|100696030|FG001|COMPLETED|Overall Study||306||
48152529|NCT00453986|100696031|FG002|COMPLETED|Overall Study||307||
48152530|NCT00453986|100696032|FG003|COMPLETED|Overall Study||310||
48152531|NCT00453986|100696033|FG004|COMPLETED|Overall Study||105||
48152532|NCT00453986|100696029|FG000|NOT COMPLETED|Overall Study||6||
48152533|NCT00453986|100696030|FG001|NOT COMPLETED|Overall Study||5||
48152534|NCT00453986|100696031|FG002|NOT COMPLETED|Overall Study||6||
48152535|NCT00453986|100696032|FG003|NOT COMPLETED|Overall Study||2||
48152536|NCT00453986|100696033|FG004|NOT COMPLETED|Overall Study||0||
48152537|NCT01064297|100696034|FG000|STARTED|Overall Study||2567||
48152538|NCT01064297|100696035|FG001|STARTED|Overall Study||219||
48152539|NCT01064297|100696036|FG002|STARTED|Overall Study||630||
48152540|NCT01064297|100696034|FG000|COMPLETED|Overall Study||1776||
48152541|NCT01064297|100696035|FG001|COMPLETED|Overall Study||171||
48152542|NCT01064297|100696036|FG002|COMPLETED|Overall Study||497||
48152543|NCT01064297|100696034|FG000|NOT COMPLETED|Overall Study||791||
48152544|NCT01064297|100696035|FG001|NOT COMPLETED|Overall Study||48||
48152545|NCT01064297|100696036|FG002|NOT COMPLETED|Overall Study||133||
48152546|NCT00567190|100696037|FG000|STARTED|Overall Study||402|Intent-to-Treat (ITT) Population|
48152547|NCT00567190|100696038|FG001|STARTED|Overall Study||406|Intent-to-Treat (ITT) Population|
48152548|NCT00567190|100696037|FG000|Did Not Receive Any Study Treatment|Overall Study||2||
48152549|NCT00567190|100696038|FG001|Did Not Receive Any Study Treatment|Overall Study||2||
48152550|NCT00567190|100696037|FG000|Received at Least One Dose of Pertuzumab|Overall Study||399|Safety Population (Pertuzumab)|
48152551|NCT00567190|100696038|FG001|Received at Least One Dose of Pertuzumab|Overall Study||9|Safety Population (Pertuzumab)|
48152552|NCT00567190|100696037|FG000|Received at Least One Dose of Placebo|Overall Study||1|Safety Population (Placebo)|
48152553|NCT00567190|100696038|FG001|Received at Least One Dose of Placebo|Overall Study||395|Safety Population (Placebo)|
48152554|NCT00567190|100696037|FG000|Crossover From Placebo to Pertuzumab|Overall Study||0||
48152555|NCT00567190|100696038|FG001|Crossover From Placebo to Pertuzumab|Overall Study||50||
48152556|NCT00567190|100696037|FG000|COMPLETED|Overall Study||119|Alive and in Survival Follow-up at End of Study|
48152557|NCT00567190|100696038|FG001|COMPLETED|Overall Study||73|Alive and in Survival Follow-up at End of Study|
48152558|NCT00567190|100696037|FG000|NOT COMPLETED|Overall Study||283||
48152559|NCT00567190|100696038|FG001|NOT COMPLETED|Overall Study||333||
48152560|NCT04723823|100696039|FG000|STARTED|Overall Study||5||
48152561|NCT04723823|100696040|FG001|STARTED|Overall Study||3||
48307753|NCT01514136|101077660|FG006|STARTED|Test Period; Test D*||0||
48307754|NCT01514136|101077661|FG007|STARTED|Test Period; Test D*||23||
48609823|NCT04227405|101830283|FG001|NOT COMPLETED|Enrollment - Time 1 PreTest||78||
48152562|NCT04723823|100696039|FG000|COMPLETED|Overall Study||5||
48152563|NCT04723823|100696040|FG001|COMPLETED|Overall Study||3||
48152564|NCT04723823|100696039|FG000|NOT COMPLETED|Overall Study||0||
48152565|NCT04723823|100696040|FG001|NOT COMPLETED|Overall Study||0||
48152566|NCT02320292|100696041|FG000|STARTED|Overall Study||10||
48152567|NCT02320292|100696042|FG001|STARTED|Overall Study||10||
48152568|NCT02320292|100696041|FG000|COMPLETED|Overall Study||10||
48152569|NCT02320292|100696042|FG001|COMPLETED|Overall Study||10||
48307755|NCT01514136|101077654|FG000|COMPLETED|Test Period; Test D*||0||
48307756|NCT01514136|101077655|FG001|COMPLETED|Test Period; Test D*||0||
48609824|NCT04227405|101830282|FG000|STARTED|Time 1 PreTest - Time 2 PostTest||268||
48609825|NCT04227405|101830283|FG001|STARTED|Time 1 PreTest - Time 2 PostTest||212||
48609826|NCT04227405|101830282|FG000|COMPLETED|Time 1 PreTest - Time 2 PostTest||186||
48307757|NCT01514136|101077656|FG002|COMPLETED|Test Period; Test D*||0||
48307758|NCT01514136|101077657|FG003|COMPLETED|Test Period; Test D*||0||
48609827|NCT04227405|101830283|FG001|COMPLETED|Time 1 PreTest - Time 2 PostTest||144||
48152570|NCT02320292|100696041|FG000|NOT COMPLETED|Overall Study||0||
48152571|NCT02320292|100696042|FG001|NOT COMPLETED|Overall Study||0||
48152572|NCT00430248|100696043|FG000|STARTED|Overall Study||757||
48152573|NCT00430248|100696044|FG001|STARTED|Overall Study||756||
48152574|NCT00430248|100696045|FG002|STARTED|Overall Study||756||
48152575|NCT00430248|100696043|FG000|COMPLETED|Overall Study||632||
48152576|NCT00430248|100696044|FG001|COMPLETED|Overall Study||598||
48152577|NCT00430248|100696045|FG002|COMPLETED|Overall Study||621||
48307759|NCT01514136|101077658|FG004|COMPLETED|Test Period; Test D*||0||
48307760|NCT01514136|101077659|FG005|COMPLETED|Test Period; Test D*||0||
48307761|NCT01514136|101077660|FG006|COMPLETED|Test Period; Test D*||0||
48307762|NCT01514136|101077661|FG007|COMPLETED|Test Period; Test D*||23||
48307763|NCT01514136|101077654|FG000|NOT COMPLETED|Test Period; Test D*||0||
48406463|NCT01237223|101328430|FG000|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||944||
48406464|NCT01237223|101328431|FG001|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0||
48406465|NCT01237223|101328432|FG002|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0||
48406466|NCT01237223|101328433|FG003|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0||
48609828|NCT04227405|101830282|FG000|NOT COMPLETED|Time 1 PreTest - Time 2 PostTest||82||
48609829|NCT04227405|101830283|FG001|NOT COMPLETED|Time 1 PreTest - Time 2 PostTest||68||
48609830|NCT04227405|101830282|FG000|STARTED|Time 2 PostTest - Time 3 Followup||186||
48152578|NCT00430248|100696043|FG000|NOT COMPLETED|Overall Study||125||
48152579|NCT00430248|100696044|FG001|NOT COMPLETED|Overall Study||158||
48152580|NCT00430248|100696045|FG002|NOT COMPLETED|Overall Study||135||
48152581|NCT02487810|100696046|FG000|STARTED|Overall Study||98||
48152582|NCT02487810|100696047|FG001|STARTED|Overall Study||102||
48152583|NCT02487810|100696046|FG000|COMPLETED|Overall Study||97||
48152584|NCT02487810|100696047|FG001|COMPLETED|Overall Study||102||
48152585|NCT02487810|100696046|FG000|NOT COMPLETED|Overall Study||1||
48152586|NCT02487810|100696047|FG001|NOT COMPLETED|Overall Study||0||
48406467|NCT01237223|101328434|FG004|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0||
48406468|NCT01237223|101328435|FG005|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0||
48406469|NCT01237223|101328430|FG000|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||398||
48152587|NCT00558064|100696048|FG000|STARTED|Overall Study||269||
48152588|NCT00558064|100696049|FG001|STARTED|Overall Study||262||
48152589|NCT00558064|100696048|FG000|COMPLETED|Overall Study||264||
48152590|NCT00558064|100696049|FG001|COMPLETED|Overall Study||257||
48152591|NCT00558064|100696048|FG000|NOT COMPLETED|Overall Study||5||
48152592|NCT00558064|100696049|FG001|NOT COMPLETED|Overall Study||5||
48152593|NCT02119260|100696050|FG000|STARTED|Overall Study||9||
48152594|NCT02119260|100696051|FG001|STARTED|Overall Study||12||
48152595|NCT02119260|100696052|FG002|STARTED|Overall Study||8||
48152596|NCT02119260|100696053|FG003|STARTED|Overall Study||10||
48152597|NCT02119260|100696054|FG004|STARTED|Overall Study||13||
48152598|NCT02119260|100696055|FG005|STARTED|Overall Study||6||
48152599|NCT02119260|100696056|FG006|STARTED|Overall Study||2||
48152600|NCT02119260|100696050|FG000|COMPLETED|Overall Study||8||
48152601|NCT02119260|100696051|FG001|COMPLETED|Overall Study||11||
48152602|NCT02119260|100696052|FG002|COMPLETED|Overall Study||7||
48152603|NCT02119260|100696053|FG003|COMPLETED|Overall Study||10||
48152604|NCT02119260|100696054|FG004|COMPLETED|Overall Study||13||
48152605|NCT02119260|100696055|FG005|COMPLETED|Overall Study||6||
48152606|NCT02119260|100696056|FG006|COMPLETED|Overall Study||2||
48152607|NCT02119260|100696050|FG000|NOT COMPLETED|Overall Study||1||
48152608|NCT02119260|100696051|FG001|NOT COMPLETED|Overall Study||1||
48152609|NCT02119260|100696052|FG002|NOT COMPLETED|Overall Study||1||
48152610|NCT02119260|100696053|FG003|NOT COMPLETED|Overall Study||0||
48152611|NCT02119260|100696054|FG004|NOT COMPLETED|Overall Study||0||
48152612|NCT02119260|100696055|FG005|NOT COMPLETED|Overall Study||0||
48152613|NCT02119260|100696056|FG006|NOT COMPLETED|Overall Study||0||
48152614|NCT01559454|100696057|FG000|STARTED|Overall Study||9||
48152615|NCT01559454|100696058|FG001|STARTED|Overall Study||10||
48152616|NCT01559454|100696057|FG000|COMPLETED|Overall Study||6||
48152617|NCT01559454|100696058|FG001|COMPLETED|Overall Study||4||
48152618|NCT01559454|100696057|FG000|NOT COMPLETED|Overall Study||3||
48152619|NCT01559454|100696058|FG001|NOT COMPLETED|Overall Study||6||
48307764|NCT01514136|101077655|FG001|NOT COMPLETED|Test Period; Test D*||0||
48307765|NCT01514136|101077656|FG002|NOT COMPLETED|Test Period; Test D*||0||
48152620|NCT02629991|100696059|FG000|STARTED|Overall Study||11||
48152621|NCT02629991|100696060|FG001|STARTED|Overall Study||12||
48307766|NCT01514136|101077657|FG003|NOT COMPLETED|Test Period; Test D*||0||
48307767|NCT01514136|101077658|FG004|NOT COMPLETED|Test Period; Test D*||0||
48307768|NCT01514136|101077659|FG005|NOT COMPLETED|Test Period; Test D*||0||
48307769|NCT01514136|101077660|FG006|NOT COMPLETED|Test Period; Test D*||0||
48307770|NCT01514136|101077661|FG007|NOT COMPLETED|Test Period; Test D*||0||
48307771|NCT01237340|101077662|FG000|STARTED|Overall Study||59||
48307772|NCT01237340|101077662|FG000|COMPLETED|Overall Study||19||
48307773|NCT01237340|101077662|FG000|NOT COMPLETED|Overall Study||40||
48307774|NCT00407654|101077663|FG000|STARTED|Overall Study||75||
48307775|NCT00407654|101077663|FG000|COMPLETED|Overall Study||75||
48307776|NCT00407654|101077663|FG000|NOT COMPLETED|Overall Study||0||
48307777|NCT03715153|101077664|FG000|STARTED|Double-blind Period (From W0 to W26)||107||
48307778|NCT03715153|101077665|FG001|STARTED|Double-blind Period (From W0 to W26)||104||
48152622|NCT02629991|100696059|FG000|COMPLETED|Overall Study||10||
48152623|NCT02629991|100696060|FG001|COMPLETED|Overall Study||11||
48152624|NCT02629991|100696059|FG000|NOT COMPLETED|Overall Study||1||
48152625|NCT02629991|100696060|FG001|NOT COMPLETED|Overall Study||1||
48152626|NCT02450331|100696061|FG000|STARTED|Overall Study||403||
48152627|NCT02450331|100696062|FG001|STARTED|Overall Study||406||
48152628|NCT02450331|100696061|FG000|COMPLETED|Overall Study||171||
48609831|NCT04227405|101830283|FG001|STARTED|Time 2 PostTest - Time 3 Followup||144||
48609832|NCT04227405|101830282|FG000|COMPLETED|Time 2 PostTest - Time 3 Followup||118||
48609833|NCT04227405|101830283|FG001|COMPLETED|Time 2 PostTest - Time 3 Followup||96||
48609834|NCT04227405|101830282|FG000|NOT COMPLETED|Time 2 PostTest - Time 3 Followup||68||
48609835|NCT04227405|101830283|FG001|NOT COMPLETED|Time 2 PostTest - Time 3 Followup||48||
48609836|NCT00992017|101830284|FG000|STARTED|Overall Study||128||
48609837|NCT00992017|101830284|FG000|Received Both Study Vaccinations|Overall Study||124||
48609838|NCT00992017|101830284|FG000|Received Only One Study Vaccination|Overall Study||4||
48609839|NCT00992017|101830284|FG000|COMPLETED|Overall Study||118||
48406470|NCT01237223|101328431|FG001|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0||
48406471|NCT01237223|101328432|FG002|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0||
48406472|NCT01237223|101328433|FG003|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0||
48406473|NCT01237223|101328434|FG004|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0||
48406474|NCT01237223|101328435|FG005|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0||
48406475|NCT01237223|101328430|FG000|STARTED|Double Blind (Treatment Period, 8 Weeks)||153||
48609840|NCT00992017|101830284|FG000|NOT COMPLETED|Overall Study||10||
48609841|NCT04391179|101830285|FG000|STARTED|Overall Study||49||
48609842|NCT04391179|101830286|FG001|STARTED|Overall Study||50||
48609843|NCT04391179|101830285|FG000|COMPLETED|Overall Study||34||
48609844|NCT04391179|101830286|FG001|COMPLETED|Overall Study||34||
48609845|NCT04391179|101830285|FG000|NOT COMPLETED|Overall Study||15||
48609846|NCT04391179|101830286|FG001|NOT COMPLETED|Overall Study||16||
48609847|NCT00789685|101830287|FG000|STARTED|Overall Study||37||
48609848|NCT00789685|101830287|FG000|COMPLETED|Overall Study||25||
48609849|NCT00789685|101830287|FG000|NOT COMPLETED|Overall Study||12||
48609850|NCT00171158|101830288|FG000|STARTED|Core Study||260||
48609851|NCT00171158|101830288|FG000|COMPLETED|Core Study||21||
48609852|NCT00171158|101830288|FG000|NOT COMPLETED|Core Study||239||
48609853|NCT00171158|101830288|FG000|STARTED|E2 Extension||8|Participants that completed the core study entered the Extension 1 (E1) of the study, of which 13 participants discontinued the study. 8 participants entered Extension (E2).|
48609854|NCT00171158|101830288|FG000|COMPLETED|E2 Extension||1||
48609855|NCT00171158|101830288|FG000|NOT COMPLETED|E2 Extension||7||
48609856|NCT00531947|101830289|FG000|STARTED|Overall Study||156||
48609857|NCT00531947|101830290|FG001|STARTED|Overall Study||152||
48307779|NCT03715153|101077664|FG000|COMPLETED|Double-blind Period (From W0 to W26)||90||
48307780|NCT03715153|101077665|FG001|COMPLETED|Double-blind Period (From W0 to W26)||95||
48307781|NCT03715153|101077664|FG000|NOT COMPLETED|Double-blind Period (From W0 to W26)||17||
48307782|NCT03715153|101077665|FG001|NOT COMPLETED|Double-blind Period (From W0 to W26)||9||
48307783|NCT03715153|101077664|FG000|STARTED|Open-label Period (From W26 to W52)||86||
48307784|NCT03715153|101077665|FG001|STARTED|Open-label Period (From W26 to W52)||92||
48307785|NCT03715153|101077664|FG000|COMPLETED|Open-label Period (From W26 to W52)||46||
48307786|NCT03715153|101077665|FG001|COMPLETED|Open-label Period (From W26 to W52)||50||
48307787|NCT03715153|101077664|FG000|NOT COMPLETED|Open-label Period (From W26 to W52)||40||
48307788|NCT03715153|101077665|FG001|NOT COMPLETED|Open-label Period (From W26 to W52)||42||
48406476|NCT01237223|101328431|FG001|STARTED|Double Blind (Treatment Period, 8 Weeks)||157||
48406477|NCT01237223|101328432|FG002|STARTED|Double Blind (Treatment Period, 8 Weeks)||158||
48406478|NCT01237223|101328433|FG003|STARTED|Double Blind (Treatment Period, 8 Weeks)||158||
48406479|NCT01237223|101328434|FG004|STARTED|Double Blind (Treatment Period, 8 Weeks)||159||
48406480|NCT01237223|101328435|FG005|STARTED|Double Blind (Treatment Period, 8 Weeks)||159||
48406481|NCT01237223|101328430|FG000|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||120||
48307789|NCT00909181|101077666|FG000|STARTED|Overall Study||210||
48307790|NCT00909181|101077667|FG001|STARTED|Overall Study||214||
48307791|NCT00909181|101077668|FG002|STARTED|Overall Study||202||
48307792|NCT00909181|101077666|FG000|COMPLETED|Overall Study||171||
48307793|NCT00909181|101077667|FG001|COMPLETED|Overall Study||196||
48307794|NCT00909181|101077668|FG002|COMPLETED|Overall Study||169||
48307795|NCT00909181|101077666|FG000|NOT COMPLETED|Overall Study||39||
48307796|NCT00909181|101077667|FG001|NOT COMPLETED|Overall Study||18||
48307797|NCT00909181|101077668|FG002|NOT COMPLETED|Overall Study||33||
48307798|NCT00932425|101077669|FG000|STARTED|Overall Study||20||
48406482|NCT01237223|101328431|FG001|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||142||
48609858|NCT00531947|101830289|FG000|COMPLETED|Overall Study||114||
48609859|NCT00531947|101830290|FG001|COMPLETED|Overall Study||101||
48609860|NCT00531947|101830289|FG000|NOT COMPLETED|Overall Study||42||
48609861|NCT00531947|101830290|FG001|NOT COMPLETED|Overall Study||51||
48307799|NCT00932425|101077670|FG001|STARTED|Overall Study||20||
48609862|NCT04316260|101830291|FG000|STARTED|Overall Study||34||
48609863|NCT04316260|101830292|FG001|STARTED|Overall Study||17||
48609864|NCT04316260|101830291|FG000|COMPLETED|Overall Study||34||
48609865|NCT04316260|101830292|FG001|COMPLETED|Overall Study||17||
48307800|NCT00932425|101077669|FG000|COMPLETED|Overall Study||20||
48609866|NCT04316260|101830291|FG000|NOT COMPLETED|Overall Study||0||
48609867|NCT04316260|101830292|FG001|NOT COMPLETED|Overall Study||0||
48609868|NCT00314808|101830293|FG000|STARTED|Overall Study||33||
48609869|NCT00314808|101830293|FG000|COMPLETED|Overall Study||25||
48609870|NCT00314808|101830293|FG000|NOT COMPLETED|Overall Study||8||
48609871|NCT00158262|101830294|FG000|STARTED|Overall Study||21||
48609872|NCT00158262|101830295|FG001|STARTED|Overall Study||22||
48609873|NCT00158262|101830294|FG000|COMPLETED|Overall Study||20||
48609874|NCT00158262|101830295|FG001|COMPLETED|Overall Study||21||
48307801|NCT00932425|101077670|FG001|COMPLETED|Overall Study||18||
48307802|NCT00932425|101077669|FG000|NOT COMPLETED|Overall Study||0||
48307803|NCT00932425|101077670|FG001|NOT COMPLETED|Overall Study||2||
48307804|NCT03632109|101077671|FG000|STARTED|Overall Study||13||
48307805|NCT03632109|101077671|FG000|COMPLETED|Overall Study||13||
48307806|NCT03632109|101077671|FG000|NOT COMPLETED|Overall Study||0||
48307807|NCT01412554|101077672|FG000|STARTED|Overall Study||103||
48307808|NCT01412554|101077672|FG000|COMPLETED|Overall Study||103||
48307809|NCT01412554|101077672|FG000|NOT COMPLETED|Overall Study||0||
48307810|NCT00832117|101077673|FG000|STARTED|Overall Study||29||
48307811|NCT00832117|101077673|FG000|COMPLETED|Overall Study||17||
48307812|NCT00832117|101077673|FG000|NOT COMPLETED|Overall Study||12||
48609875|NCT00158262|101830294|FG000|NOT COMPLETED|Overall Study||1||
48609876|NCT00158262|101830295|FG001|NOT COMPLETED|Overall Study||1||
48609877|NCT00583011|101830296|FG000|STARTED|Overall Study||36||
48609878|NCT00583011|101830297|FG001|STARTED|Overall Study||40||
48609879|NCT00583011|101830296|FG000|COMPLETED|Overall Study||36||
48609880|NCT00583011|101830297|FG001|COMPLETED|Overall Study||40||
48609881|NCT00583011|101830296|FG000|NOT COMPLETED|Overall Study||0||
48722489|NCT02647346|102108169|FG000|NOT COMPLETED|Overall Study||3||
48722490|NCT03809910|102108170|FG000|STARTED|Period 1 (Visit 2)||20||
48722491|NCT03809910|102108171|FG001|STARTED|Period 1 (Visit 2)||19||
48722492|NCT03809910|102108170|FG000|COMPLETED|Period 1 (Visit 2)||20||
48722493|NCT03809910|102108171|FG001|COMPLETED|Period 1 (Visit 2)||19||
48722494|NCT03809910|102108170|FG000|NOT COMPLETED|Period 1 (Visit 2)||0||
48722495|NCT03809910|102108171|FG001|NOT COMPLETED|Period 1 (Visit 2)||0||
48722496|NCT03809910|102108170|FG000|STARTED|Washout Period 1 (3 Days)||20||
48722497|NCT03809910|102108171|FG001|STARTED|Washout Period 1 (3 Days)||19||
48722498|NCT03809910|102108170|FG000|COMPLETED|Washout Period 1 (3 Days)||20||
48722499|NCT03809910|102108171|FG001|COMPLETED|Washout Period 1 (3 Days)||19||
48722500|NCT03809910|102108170|FG000|NOT COMPLETED|Washout Period 1 (3 Days)||0||
48722501|NCT03809910|102108171|FG001|NOT COMPLETED|Washout Period 1 (3 Days)||0||
48722502|NCT03809910|102108170|FG000|STARTED|Period 2 (Visit 3)||20||
48307813|NCT00809523|101077674|FG000|STARTED|Overall Study||54||
48307814|NCT00809523|101077675|FG001|STARTED|Overall Study||52||
48307815|NCT00809523|101077674|FG000|COMPLETED|Overall Study||47||
48307816|NCT00809523|101077675|FG001|COMPLETED|Overall Study||48||
48307817|NCT00809523|101077674|FG000|NOT COMPLETED|Overall Study||7||
48307818|NCT00809523|101077675|FG001|NOT COMPLETED|Overall Study||4||
48307819|NCT02137122|101077676|FG000|STARTED|Overall Study||15||
48307820|NCT02137122|101077677|FG001|STARTED|Overall Study||16||
48307821|NCT02137122|101077676|FG000|COMPLETED|Overall Study||15||
48307822|NCT02137122|101077677|FG001|COMPLETED|Overall Study||14||
48609882|NCT00583011|101830297|FG001|NOT COMPLETED|Overall Study||0||
48609883|NCT00703677|101830298|FG000|STARTED|Overall Study||17||
48609884|NCT00703677|101830298|FG000|COMPLETED|Overall Study||14||
48609885|NCT00703677|101830298|FG000|NOT COMPLETED|Overall Study||3||
48307823|NCT02137122|101077676|FG000|NOT COMPLETED|Overall Study||0||
48307824|NCT02137122|101077677|FG001|NOT COMPLETED|Overall Study||2||
48307825|NCT00680823|101077678|FG000|STARTED|Overall Study||50||
48307826|NCT00680823|101077679|FG001|STARTED|Overall Study||50||
48307827|NCT00680823|101077680|FG002|STARTED|Overall Study||50||
48307828|NCT00680823|101077678|FG000|COMPLETED|Overall Study||50||
48307829|NCT00680823|101077679|FG001|COMPLETED|Overall Study||50||
48609886|NCT00435461|101830299|FG000|STARTED|Overall Study||313||
48609887|NCT00435461|101830300|FG001|STARTED|Overall Study||312||
48609888|NCT00435461|101830301|FG002|STARTED|Overall Study||311||
48609889|NCT00435461|101830299|FG000|COMPLETED|Overall Study||290||
48609890|NCT00435461|101830300|FG001|COMPLETED|Overall Study||298||
48307830|NCT00680823|101077680|FG002|COMPLETED|Overall Study||50||
48307831|NCT00680823|101077678|FG000|NOT COMPLETED|Overall Study||0||
48307832|NCT00680823|101077679|FG001|NOT COMPLETED|Overall Study||0||
48307833|NCT00680823|101077680|FG002|NOT COMPLETED|Overall Study||0||
48307834|NCT01566682|101077681|FG000|STARTED|Overall Study||420||
48307835|NCT01566682|101077681|FG000|COMPLETED|Overall Study||374||
48307836|NCT01566682|101077681|FG000|NOT COMPLETED|Overall Study||46||
48307837|NCT00578786|101077682|FG000|STARTED|Overall Study||96||
48307838|NCT00578786|101077683|FG001|STARTED|Overall Study||190||
48307839|NCT00578786|101077684|FG002|STARTED|Overall Study||97||
48307840|NCT00578786|101077682|FG000|COMPLETED|Overall Study||57||
48307841|NCT00578786|101077683|FG001|COMPLETED|Overall Study||124||
48307842|NCT00578786|101077684|FG002|COMPLETED|Overall Study||67||
48307843|NCT00578786|101077682|FG000|NOT COMPLETED|Overall Study||39||
48307844|NCT00578786|101077683|FG001|NOT COMPLETED|Overall Study||66||
48307845|NCT00578786|101077684|FG002|NOT COMPLETED|Overall Study||30||
48609891|NCT00435461|101830301|FG002|COMPLETED|Overall Study||287||
48609892|NCT00435461|101830299|FG000|NOT COMPLETED|Overall Study||23||
48609893|NCT00435461|101830300|FG001|NOT COMPLETED|Overall Study||14||
48722503|NCT03809910|102108171|FG001|STARTED|Period 2 (Visit 3)||19||
48307846|NCT03583450|101080807|FG000|STARTED|Overall Study||34||
48307847|NCT03583450|101080808|FG001|STARTED|Overall Study||37||
48307848|NCT03583450|101080807|FG000|COMPLETED|Overall Study||33||
48307849|NCT03583450|101080808|FG001|COMPLETED|Overall Study||37||
48307850|NCT03583450|101080807|FG000|NOT COMPLETED|Overall Study||1||
48307851|NCT03583450|101080808|FG001|NOT COMPLETED|Overall Study||0||
48307852|NCT03610399|101080809|FG000|STARTED|Overall Study||63|The number of total patients included in the study (254) is different from the study because, upon review of patient records, some patients had to be excluded because they had not met the inclusion criteria.|
48307853|NCT03610399|101080810|FG001|STARTED|Overall Study||96|The number of total patients included in the study (254) is different from the study because, upon review of patient records, some patients had to be excluded because they had not met the inclusion criteria.|
48307854|NCT03610399|101080811|FG002|STARTED|Overall Study||95|The number of total patients included in the study (254) is different from the study because, upon review of patient records, some patients had to be excluded because they had not met the inclusion criteria.|
48307855|NCT03610399|101080809|FG000|COMPLETED|Overall Study||53|Patient enrollment ended in October 2018, follow up ended in March 2019.|
48307856|NCT03610399|101080810|FG001|COMPLETED|Overall Study||78|Patient enrollment ended in October 2018, follow up ended in March 2019.|
48307857|NCT03610399|101080811|FG002|COMPLETED|Overall Study||79|Patient enrollment ended in October 2018, follow up ended in March 2019.|
48307858|NCT03610399|101080809|FG000|NOT COMPLETED|Overall Study||10||
48307859|NCT03610399|101080810|FG001|NOT COMPLETED|Overall Study||18||
48307860|NCT03610399|101080811|FG002|NOT COMPLETED|Overall Study||16||
48307861|NCT03000088|101080812|FG000|STARTED|Overall Study||70||
48307862|NCT03000088|101080813|FG001|STARTED|Overall Study||70||
48307863|NCT03000088|101080812|FG000|COMPLETED|Overall Study||70||
48307864|NCT03000088|101080813|FG001|COMPLETED|Overall Study||70||
48307865|NCT03000088|101080812|FG000|NOT COMPLETED|Overall Study||0||
48307866|NCT03000088|101080813|FG001|NOT COMPLETED|Overall Study||0||
48307867|NCT01681628|101080814|FG000|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128||
48307868|NCT01681628|101080815|FG001|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128||
48307869|NCT01681628|101080814|FG000|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||114||
48307870|NCT01681628|101080815|FG001|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||122||
48307871|NCT01681628|101080814|FG000|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||14||
48307872|NCT01681628|101080815|FG001|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||6||
48307873|NCT01681628|101080814|FG000|STARTED|Time 2 to Time 3 (One Week Later).||0||
48307874|NCT01681628|101080815|FG001|STARTED|Time 2 to Time 3 (One Week Later).||122||
48307875|NCT01681628|101080814|FG000|COMPLETED|Time 2 to Time 3 (One Week Later).||0||
48307876|NCT01681628|101080815|FG001|COMPLETED|Time 2 to Time 3 (One Week Later).||107||
48307877|NCT01681628|101080814|FG000|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||0||
48307878|NCT01681628|101080815|FG001|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||15||
48609894|NCT00435461|101830301|FG002|NOT COMPLETED|Overall Study||24||
48406483|NCT01237223|101328432|FG002|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||143||
48406484|NCT01237223|101328433|FG003|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||153||
48307879|NCT01681628|101080814|FG000|STARTED|19 Months Follow-up||114||
48307880|NCT01681628|101080815|FG001|STARTED|19 Months Follow-up||107||
48307881|NCT01681628|101080814|FG000|COMPLETED|19 Months Follow-up||52||
48406485|NCT01237223|101328434|FG004|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||155||
48609895|NCT00790556|101830302|FG000|STARTED|Treatment Period 1||8||
48609896|NCT00790556|101830303|FG001|STARTED|Treatment Period 1||6||
48609897|NCT00790556|101830302|FG000|COMPLETED|Treatment Period 1||6||
48609898|NCT00790556|101830303|FG001|COMPLETED|Treatment Period 1||6||
48609899|NCT00790556|101830302|FG000|NOT COMPLETED|Treatment Period 1||2||
48609900|NCT00790556|101830303|FG001|NOT COMPLETED|Treatment Period 1||0||
48609901|NCT00790556|101830302|FG000|STARTED|Washout After Period 1||6||
48609902|NCT00790556|101830303|FG001|STARTED|Washout After Period 1||6||
48609903|NCT00790556|101830302|FG000|COMPLETED|Washout After Period 1||6||
48722504|NCT03809910|102108170|FG000|COMPLETED|Period 2 (Visit 3)||20||
48307882|NCT01681628|101080815|FG001|COMPLETED|19 Months Follow-up||64||
48307883|NCT01681628|101080814|FG000|NOT COMPLETED|19 Months Follow-up||62||
48307884|NCT01681628|101080815|FG001|NOT COMPLETED|19 Months Follow-up||43||
48307885|NCT01829360|101080816|FG000|STARTED|Overall Study||8||
48440012|NCT03046966|101410010|FG001|COMPLETED|Overall Study||51||
48609904|NCT00790556|101830303|FG001|COMPLETED|Washout After Period 1||6||
48609905|NCT00790556|101830302|FG000|NOT COMPLETED|Washout After Period 1||0||
48722505|NCT03809910|102108171|FG001|COMPLETED|Period 2 (Visit 3)||19||
48722506|NCT03809910|102108170|FG000|NOT COMPLETED|Period 2 (Visit 3)||0||
48722507|NCT03809910|102108171|FG001|NOT COMPLETED|Period 2 (Visit 3)||0||
48722508|NCT03809910|102108170|FG000|STARTED|Washout Period 2 (3 Days)||20||
48722509|NCT03809910|102108171|FG001|STARTED|Washout Period 2 (3 Days)||19||
48722510|NCT03809910|102108170|FG000|COMPLETED|Washout Period 2 (3 Days)||20||
48722511|NCT03809910|102108171|FG001|COMPLETED|Washout Period 2 (3 Days)||19||
48722512|NCT03809910|102108170|FG000|NOT COMPLETED|Washout Period 2 (3 Days)||0||
48722513|NCT03809910|102108171|FG001|NOT COMPLETED|Washout Period 2 (3 Days)||0||
48722514|NCT03809910|102108170|FG000|STARTED|Period 3 (Visit 4)||20||
48307886|NCT01829360|101080817|FG001|STARTED|Overall Study||9||
48307887|NCT01829360|101080818|FG002|STARTED|Overall Study||10||
48307888|NCT01829360|101080819|FG003|STARTED|Overall Study||8||
48307889|NCT01829360|101080816|FG000|COMPLETED|Overall Study||8||
48307890|NCT01829360|101080817|FG001|COMPLETED|Overall Study||9||
48307891|NCT01829360|101080818|FG002|COMPLETED|Overall Study||9||
48307892|NCT01829360|101080819|FG003|COMPLETED|Overall Study||8||
48307893|NCT01829360|101080816|FG000|NOT COMPLETED|Overall Study||0||
48307894|NCT01829360|101080817|FG001|NOT COMPLETED|Overall Study||0||
48307895|NCT01829360|101080818|FG002|NOT COMPLETED|Overall Study||1||
48609906|NCT00790556|101830303|FG001|NOT COMPLETED|Washout After Period 1||0||
48609907|NCT00790556|101830302|FG000|STARTED|Treatment Period 2||6||
48609908|NCT00790556|101830303|FG001|STARTED|Treatment Period 2||6||
48609909|NCT00790556|101830302|FG000|COMPLETED|Treatment Period 2||6||
48609910|NCT00790556|101830303|FG001|COMPLETED|Treatment Period 2||6||
48609911|NCT00790556|101830302|FG000|NOT COMPLETED|Treatment Period 2||0||
48609912|NCT00790556|101830303|FG001|NOT COMPLETED|Treatment Period 2||0||
48609913|NCT01853748|101830304|FG000|STARTED|Allocation||384||
48609914|NCT01853748|101830305|FG001|STARTED|Allocation||128||
48609915|NCT01853748|101830304|FG000|COMPLETED|Allocation||383||
48609916|NCT01853748|101830305|FG001|COMPLETED|Allocation||114||
48609917|NCT01853748|101830304|FG000|NOT COMPLETED|Allocation||1||
48609918|NCT01853748|101830305|FG001|NOT COMPLETED|Allocation||14||
48609919|NCT01853748|101830304|FG000|STARTED|Follow-Up||383||
48609920|NCT01853748|101830305|FG001|STARTED|Follow-Up||114||
48609921|NCT01853748|101830304|FG000|COMPLETED|Follow-Up||293||
48609922|NCT01853748|101830305|FG001|COMPLETED|Follow-Up||97||
48609923|NCT01853748|101830304|FG000|NOT COMPLETED|Follow-Up||90||
48609924|NCT01853748|101830305|FG001|NOT COMPLETED|Follow-Up||17||
48609925|NCT01509612|101830306|FG000|STARTED|Overall Study||47||
48609926|NCT01509612|101830307|FG001|STARTED|Overall Study||51||
48609927|NCT01509612|101830308|FG002|STARTED|Overall Study||52||
48609928|NCT01509612|101830306|FG000|COMPLETED|Overall Study||47||
48609929|NCT01509612|101830307|FG001|COMPLETED|Overall Study||51||
48609930|NCT01509612|101830308|FG002|COMPLETED|Overall Study||52||
48609931|NCT01509612|101830306|FG000|NOT COMPLETED|Overall Study||0||
48609932|NCT01509612|101830307|FG001|NOT COMPLETED|Overall Study||0||
48609933|NCT01509612|101830308|FG002|NOT COMPLETED|Overall Study||0||
48609934|NCT02335346|101830309|FG000|STARTED|Overall Study||93||
48609935|NCT02335346|101830309|FG000|Received At Least 1 Dose of Study Drug|Overall Study||93||
48609936|NCT02335346|101830309|FG000|COMPLETED|Overall Study||81||
48609937|NCT02335346|101830309|FG000|NOT COMPLETED|Overall Study||12||
48609938|NCT04472494|101830310|FG000|STARTED|Pre-treatment||42|Started = Randomized|
48722515|NCT03809910|102108171|FG001|STARTED|Period 3 (Visit 4)||19||
48722516|NCT03809910|102108170|FG000|COMPLETED|Period 3 (Visit 4)||20||
48722517|NCT03809910|102108171|FG001|COMPLETED|Period 3 (Visit 4)||19||
48722518|NCT03809910|102108170|FG000|NOT COMPLETED|Period 3 (Visit 4)||0||
48722519|NCT03809910|102108171|FG001|NOT COMPLETED|Period 3 (Visit 4)||0||
48307896|NCT01829360|101080819|FG003|NOT COMPLETED|Overall Study||0||
48307897|NCT02939989|101080820|FG000|STARTED|Overall Study||5||
48307898|NCT02939989|101080821|FG001|STARTED|Overall Study||28||
48307899|NCT02939989|101080820|FG000|COMPLETED|Overall Study||5||
48307900|NCT02939989|101080821|FG001|COMPLETED|Overall Study||28||
48307901|NCT02939989|101080820|FG000|NOT COMPLETED|Overall Study||0||
48307902|NCT02939989|101080821|FG001|NOT COMPLETED|Overall Study||0||
48307903|NCT01049243|101080822|FG000|STARTED|Overall Study||20||
48307904|NCT01049243|101080822|FG000|COMPLETED|Overall Study||18||
48307905|NCT01049243|101080822|FG000|NOT COMPLETED|Overall Study||2||
48307906|NCT02022085|101080823|FG000|STARTED|Overall Study||54||
48307907|NCT02022085|101080823|FG000|COMPLETED|Overall Study||53||
48307908|NCT02022085|101080823|FG000|NOT COMPLETED|Overall Study||1||
48307909|NCT02786134|101080824|FG000|STARTED|Overall Study||25||
48307910|NCT02786134|101080825|FG001|STARTED|Overall Study||25||
48609939|NCT04472494|101830311|FG001|STARTED|Pre-treatment||19|Started = Randomized|
48609940|NCT04472494|101830310|FG000|COMPLETED|Pre-treatment||40|Completed = Entering treatment period|
48609941|NCT04472494|101830311|FG001|COMPLETED|Pre-treatment||19|Completed = Entering treatment period|
48609942|NCT04472494|101830310|FG000|NOT COMPLETED|Pre-treatment||2||
48609943|NCT04472494|101830311|FG001|NOT COMPLETED|Pre-treatment||0||
48609944|NCT04472494|101830310|FG000|STARTED|Treatment||40|Started = Entering treatment period|
48609945|NCT04472494|101830311|FG001|STARTED|Treatment||19|Started = Entering treatment period|
48609946|NCT04472494|101830310|FG000|COMPLETED|Treatment||34|Completed = Completed treatment period|
48609947|NCT04472494|101830311|FG001|COMPLETED|Treatment||16|Completed = Completed treatment period|
48609948|NCT04472494|101830310|FG000|NOT COMPLETED|Treatment||6||
48609949|NCT04472494|101830311|FG001|NOT COMPLETED|Treatment||3||
48609950|NCT01497067|101830312|FG000|STARTED|Overall Study||657||
48609951|NCT01497067|101830312|FG000|COMPLETED|Overall Study||575||
48609952|NCT01497067|101830312|FG000|NOT COMPLETED|Overall Study||82||
48609953|NCT03076515|101830313|FG000|STARTED|Overall Study||58||
48609954|NCT03076515|101830314|FG001|STARTED|Overall Study||62||
48609955|NCT03076515|101830313|FG000|COMPLETED|Overall Study||33||
48609956|NCT03076515|101830314|FG001|COMPLETED|Overall Study||33||
48609957|NCT03076515|101830313|FG000|NOT COMPLETED|Overall Study||25||
48609958|NCT03076515|101830314|FG001|NOT COMPLETED|Overall Study||29||
48609959|NCT03939533|101830315|FG000|STARTED|Overall Study||15||
48609960|NCT03939533|101830316|FG001|STARTED|Overall Study||15||
48609961|NCT03939533|101830317|FG002|STARTED|Overall Study||34||
48609962|NCT03939533|101830315|FG000|COMPLETED|Overall Study||12||
48609963|NCT03939533|101830316|FG001|COMPLETED|Overall Study||13||
48609964|NCT03939533|101830317|FG002|COMPLETED|Overall Study||30||
48609965|NCT03939533|101830315|FG000|NOT COMPLETED|Overall Study||3||
48609966|NCT03939533|101830316|FG001|NOT COMPLETED|Overall Study||2||
48609967|NCT03939533|101830317|FG002|NOT COMPLETED|Overall Study||4||
48609968|NCT00520039|101830318|FG000|STARTED|Overall Study||28||
48609969|NCT00520039|101830319|FG001|STARTED|Overall Study||24||
48609970|NCT00520039|101830318|FG000|COMPLETED|Overall Study||21||
48609971|NCT00520039|101830319|FG001|COMPLETED|Overall Study||19||
48609972|NCT00520039|101830318|FG000|NOT COMPLETED|Overall Study||7||
48609973|NCT00520039|101830319|FG001|NOT COMPLETED|Overall Study||5||
48609974|NCT03518086|101830320|FG000|STARTED|Overall Study||322||
48609975|NCT03518086|101830321|FG001|STARTED|Overall Study||959||
48609976|NCT03518086|101830322|FG002|STARTED|Overall Study||0||
48609977|NCT03518086|101830323|FG003|STARTED|Overall Study||0||
48609978|NCT03518086|101830320|FG000|Received at Least One Dose of Study Drug|Overall Study||321||
48609979|NCT03518086|101830321|FG001|Received at Least One Dose of Study Drug|Overall Study||958||
48609980|NCT03518086|101830322|FG002|Received at Least One Dose of Study Drug|Overall Study||0||
48609981|NCT03518086|101830323|FG003|Received at Least One Dose of Study Drug|Overall Study||0||
48609982|NCT03518086|101830320|FG000|COMPLETED|Overall Study||285||
48609983|NCT03518086|101830321|FG001|COMPLETED|Overall Study||920||
48609984|NCT03518086|101830322|FG002|COMPLETED|Overall Study||0||
48609985|NCT03518086|101830323|FG003|COMPLETED|Overall Study||0||
48609986|NCT03518086|101830320|FG000|NOT COMPLETED|Overall Study||37||
48609987|NCT03518086|101830321|FG001|NOT COMPLETED|Overall Study||39||
48609988|NCT03518086|101830322|FG002|NOT COMPLETED|Overall Study||0||
48609989|NCT03518086|101830323|FG003|NOT COMPLETED|Overall Study||0||
48609990|NCT01051440|101830324|FG000|STARTED|Overall Study||1||
48609991|NCT01051440|101830325|FG001|STARTED|Overall Study||1||
48609992|NCT01051440|101830324|FG000|COMPLETED|Overall Study||1||
48152629|NCT02450331|100696062|FG001|COMPLETED|Overall Study||178||
48152630|NCT02450331|100696061|FG000|NOT COMPLETED|Overall Study||232||
48152631|NCT02450331|100696062|FG001|NOT COMPLETED|Overall Study||228||
48609993|NCT01051440|101830325|FG001|COMPLETED|Overall Study||1||
48609994|NCT01051440|101830324|FG000|NOT COMPLETED|Overall Study||0||
48609995|NCT01051440|101830325|FG001|NOT COMPLETED|Overall Study||0||
48609996|NCT00394888|101830326|FG000|STARTED|Overall Study||108||
48609997|NCT00394888|101830327|FG001|STARTED|Overall Study||48||
48609998|NCT00394888|101830328|FG002|STARTED|Overall Study||201||
48609999|NCT00394888|101830326|FG000|COMPLETED|Overall Study||108||
48610000|NCT00394888|101830327|FG001|COMPLETED|Overall Study||48||
48610001|NCT00394888|101830328|FG002|COMPLETED|Overall Study||201||
48610002|NCT00394888|101830326|FG000|NOT COMPLETED|Overall Study||0||
48152632|NCT01235546|100696063|FG000|STARTED|Overall Study||994||
48610003|NCT00394888|101830327|FG001|NOT COMPLETED|Overall Study||0||
48610004|NCT00394888|101830328|FG002|NOT COMPLETED|Overall Study||0||
48610005|NCT01775787|101830329|FG000|STARTED|First 7-10 Days||13||
48610006|NCT01775787|101830330|FG001|STARTED|First 7-10 Days||14||
48610007|NCT01775787|101830329|FG000|COMPLETED|First 7-10 Days||12||
48610008|NCT01775787|101830330|FG001|COMPLETED|First 7-10 Days||8||
48610009|NCT01775787|101830329|FG000|NOT COMPLETED|First 7-10 Days||1||
48610010|NCT01775787|101830330|FG001|NOT COMPLETED|First 7-10 Days||6||
48610011|NCT01775787|101830329|FG000|STARTED|Second 7-10 Days||12||
48610012|NCT01775787|101830330|FG001|STARTED|Second 7-10 Days||8||
48610013|NCT01775787|101830329|FG000|COMPLETED|Second 7-10 Days||12||
48610014|NCT01775787|101830330|FG001|COMPLETED|Second 7-10 Days||6||
48610015|NCT01775787|101830329|FG000|NOT COMPLETED|Second 7-10 Days||0||
48610016|NCT01775787|101830330|FG001|NOT COMPLETED|Second 7-10 Days||2||
48610017|NCT01939223|101830331|FG000|STARTED|Overall Study||14||
48610018|NCT01939223|101830332|FG001|STARTED|Overall Study||11||
48152633|NCT01235546|100696064|FG001|STARTED|Overall Study||1019||
48610019|NCT01939223|101830331|FG000|Participants Received Treatment|Overall Study||14||
48610020|NCT01939223|101830332|FG001|Participants Received Treatment|Overall Study||11||
48610021|NCT01939223|101830331|FG000|COMPLETED|Overall Study||1||
48610022|NCT01939223|101830332|FG001|COMPLETED|Overall Study||0||
48610023|NCT01939223|101830331|FG000|NOT COMPLETED|Overall Study||13||
48610024|NCT01939223|101830332|FG001|NOT COMPLETED|Overall Study||11||
48610025|NCT03247322|101830333|FG000|STARTED|Overall Study||68||
48610026|NCT03247322|101830334|FG001|STARTED|Overall Study||68||
48610027|NCT03247322|101830333|FG000|COMPLETED|Overall Study||66||
48610028|NCT03247322|101830334|FG001|COMPLETED|Overall Study||68||
48610029|NCT03247322|101830333|FG000|NOT COMPLETED|Overall Study||2||
48610030|NCT03247322|101830334|FG001|NOT COMPLETED|Overall Study||0||
48610031|NCT02080364|101830335|FG000|STARTED|Baseline Period||197||
48610032|NCT02080364|101830336|FG001|STARTED|Baseline Period||208||
48610033|NCT02080364|101830337|FG002|STARTED|Baseline Period||247||
48307911|NCT02786134|101080824|FG000|COMPLETED|Overall Study||25||
48307912|NCT02786134|101080825|FG001|COMPLETED|Overall Study||25||
48307913|NCT02786134|101080824|FG000|NOT COMPLETED|Overall Study||0||
48307914|NCT02786134|101080825|FG001|NOT COMPLETED|Overall Study||0||
48307915|NCT00703053|101080826|FG000|STARTED|Overall Study||27||
48307916|NCT00703053|101080827|FG001|STARTED|Overall Study||26||
48307917|NCT00703053|101080828|FG002|STARTED|Overall Study||51||
48307918|NCT00703053|101080829|FG003|STARTED|Overall Study||49||
48307919|NCT00703053|101080830|FG004|STARTED|Overall Study||51||
48307920|NCT00703053|101080831|FG005|STARTED|Overall Study||49||
48307921|NCT00703053|101080832|FG006|STARTED|Overall Study||52||
48307922|NCT00703053|101080833|FG007|STARTED|Overall Study||97||
48307923|NCT00703053|101080834|FG008|STARTED|Overall Study||103||
48307924|NCT00703053|101080826|FG000|COMPLETED|Overall Study||26||
48307925|NCT00703053|101080827|FG001|COMPLETED|Overall Study||24||
48307926|NCT00703053|101080828|FG002|COMPLETED|Overall Study||48||
48307927|NCT00703053|101080829|FG003|COMPLETED|Overall Study||46||
48307928|NCT00703053|101080830|FG004|COMPLETED|Overall Study||50||
48307929|NCT00703053|101080831|FG005|COMPLETED|Overall Study||43||
48307930|NCT00703053|101080832|FG006|COMPLETED|Overall Study||45||
48307931|NCT00703053|101080833|FG007|COMPLETED|Overall Study||91||
48610034|NCT02080364|101830338|FG003|STARTED|Baseline Period||228||
48610035|NCT02080364|101830335|FG000|COMPLETED|Baseline Period||195||
48610036|NCT02080364|101830336|FG001|COMPLETED|Baseline Period||206||
48610037|NCT02080364|101830337|FG002|COMPLETED|Baseline Period||246||
48610038|NCT02080364|101830338|FG003|COMPLETED|Baseline Period||228||
48610039|NCT02080364|101830335|FG000|NOT COMPLETED|Baseline Period||2||
48610040|NCT02080364|101830336|FG001|NOT COMPLETED|Baseline Period||2||
48610041|NCT02080364|101830337|FG002|NOT COMPLETED|Baseline Period||1||
48610042|NCT02080364|101830338|FG003|NOT COMPLETED|Baseline Period||0||
48610043|NCT02080364|101830335|FG000|STARTED|Treatment Period||195||
48610044|NCT02080364|101830336|FG001|STARTED|Treatment Period||206||
48610045|NCT02080364|101830337|FG002|STARTED|Treatment Period||246||
48610046|NCT02080364|101830338|FG003|STARTED|Treatment Period||228||
48610047|NCT02080364|101830335|FG000|COMPLETED|Treatment Period||148||
48610048|NCT02080364|101830336|FG001|COMPLETED|Treatment Period||157||
48610049|NCT02080364|101830337|FG002|COMPLETED|Treatment Period||9||
48307932|NCT00703053|101080834|FG008|COMPLETED|Overall Study||102||
48307933|NCT00703053|101080826|FG000|NOT COMPLETED|Overall Study||1||
48307934|NCT00703053|101080827|FG001|NOT COMPLETED|Overall Study||2||
48307935|NCT00703053|101080828|FG002|NOT COMPLETED|Overall Study||3||
48307936|NCT00703053|101080829|FG003|NOT COMPLETED|Overall Study||3||
48307937|NCT00703053|101080830|FG004|NOT COMPLETED|Overall Study||1||
48307938|NCT00703053|101080831|FG005|NOT COMPLETED|Overall Study||6||
48307939|NCT00703053|101080832|FG006|NOT COMPLETED|Overall Study||7||
48307940|NCT00703053|101080833|FG007|NOT COMPLETED|Overall Study||6||
48307941|NCT00703053|101080834|FG008|NOT COMPLETED|Overall Study||1||
48307942|NCT03086265|101080835|FG000|STARTED|Overall Study||10||
48307943|NCT03086265|101080836|FG001|STARTED|Overall Study||10||
48307944|NCT03086265|101080835|FG000|COMPLETED|Overall Study||10||
48307945|NCT03086265|101080836|FG001|COMPLETED|Overall Study||10||
48307946|NCT03086265|101080835|FG000|NOT COMPLETED|Overall Study||0||
48307947|NCT03086265|101080836|FG001|NOT COMPLETED|Overall Study||0||
48307948|NCT04343248|101080837|FG000|STARTED|Overall Study||97||
48307949|NCT04343248|101080838|FG001|STARTED|Overall Study||93||
48307950|NCT04343248|101080837|FG000|COMPLETED|Overall Study||81||
48307951|NCT04343248|101080838|FG001|COMPLETED|Overall Study||78||
48307952|NCT04343248|101080837|FG000|NOT COMPLETED|Overall Study||16||
48307953|NCT04343248|101080838|FG001|NOT COMPLETED|Overall Study||15||
48307954|NCT02445755|101080839|FG000|STARTED|Overall Study||113||
48307955|NCT02445755|101080839|FG000|COMPLETED|Overall Study||100||
48307956|NCT02445755|101080839|FG000|NOT COMPLETED|Overall Study||13||
48307957|NCT01701999|101080840|FG000|STARTED|Overall Study||8||
48307958|NCT01701999|101080841|FG001|STARTED|Overall Study||37||
48307959|NCT01701999|101080840|FG000|COMPLETED|Overall Study||8||
48307960|NCT01701999|101080841|FG001|COMPLETED|Overall Study||37||
48307961|NCT01701999|101080840|FG000|NOT COMPLETED|Overall Study||0||
48307962|NCT01701999|101080841|FG001|NOT COMPLETED|Overall Study||0||
48307963|NCT04261504|101080842|FG000|STARTED|Overall Study||35||
48610050|NCT02080364|101830338|FG003|COMPLETED|Treatment Period||4||
48610051|NCT02080364|101830335|FG000|NOT COMPLETED|Treatment Period||47||
48307964|NCT04261504|101080843|FG001|STARTED|Overall Study||35||
48307965|NCT04261504|101080842|FG000|COMPLETED|Overall Study||30||
48307966|NCT04261504|101080843|FG001|COMPLETED|Overall Study||28||
48307967|NCT04261504|101080842|FG000|NOT COMPLETED|Overall Study||5||
48307968|NCT04261504|101080843|FG001|NOT COMPLETED|Overall Study||7||
48307969|NCT00125762|101080844|FG000|STARTED|Overall Study||907||
48307970|NCT00125762|101080844|FG000|COMPLETED|Overall Study||748||
48307971|NCT00125762|101080844|FG000|NOT COMPLETED|Overall Study||159||
48307972|NCT00911625|101080845|FG000|STARTED|Overall Study||57||
48307973|NCT00911625|101080846|FG001|STARTED|Overall Study||57||
48307974|NCT00911625|101080845|FG000|COMPLETED|Overall Study||50||
48307975|NCT00911625|101080846|FG001|COMPLETED|Overall Study||57||
48307976|NCT00911625|101080845|FG000|NOT COMPLETED|Overall Study||7||
48307977|NCT00911625|101080846|FG001|NOT COMPLETED|Overall Study||0||
48307978|NCT02615470|101080847|FG000|STARTED|Overall Study||58||30
48307979|NCT02615470|101080848|FG001|STARTED|Overall Study||62||32
48307980|NCT02615470|101080847|FG000|Completed the Baseline Surveys|Overall Study||46||27
48610052|NCT02080364|101830336|FG001|NOT COMPLETED|Treatment Period||49||
48610053|NCT02080364|101830337|FG002|NOT COMPLETED|Treatment Period||237||
48610054|NCT02080364|101830338|FG003|NOT COMPLETED|Treatment Period||224||
48610055|NCT01156805|101830339|FG000|STARTED|Overall Study||237||
48610056|NCT01156805|101830340|FG001|STARTED|Overall Study||272||
48610057|NCT01156805|101830339|FG000|COMPLETED|Overall Study||181||
48307981|NCT02615470|101080848|FG001|Completed the Baseline Surveys|Overall Study||47||25
48307982|NCT02615470|101080847|FG000|COMPLETED|Overall Study||37|Completed the 6-month survey|22
48307983|NCT02615470|101080848|FG001|COMPLETED|Overall Study||30|Completed the 6-month survey|15
48307984|NCT02615470|101080847|FG000|NOT COMPLETED|Overall Study||21||8
48307985|NCT02615470|101080848|FG001|NOT COMPLETED|Overall Study||32||17
48307986|NCT02347488|101080849|FG000|STARTED|Overall Study||30||
48307987|NCT02347488|101080849|FG000|COMPLETED|Overall Study||30||
48307988|NCT02347488|101080849|FG000|NOT COMPLETED|Overall Study||0||
48307989|NCT00860951|101080850|FG000|STARTED|Overall Study||29||
48307990|NCT00860951|101080850|FG000|COMPLETED|Overall Study||22||
48610058|NCT01156805|101830340|FG001|COMPLETED|Overall Study||216||
48610059|NCT01156805|101830339|FG000|NOT COMPLETED|Overall Study||56||
48610060|NCT01156805|101830340|FG001|NOT COMPLETED|Overall Study||56||
48610061|NCT03026283|101830341|FG000|STARTED|CCTA Diagnosis||586||
48610062|NCT03026283|101830342|FG001|STARTED|CCTA Diagnosis||0||
48610063|NCT03026283|101830343|FG002|STARTED|CCTA Diagnosis||0||
48610064|NCT03026283|101830344|FG003|STARTED|CCTA Diagnosis||0||
48610065|NCT03026283|101830345|FG004|STARTED|CCTA Diagnosis||0||
48610066|NCT03026283|101830346|FG005|STARTED|CCTA Diagnosis||0||
48610067|NCT03026283|101830347|FG006|STARTED|CCTA Diagnosis||0||
48610068|NCT03026283|101830348|FG007|STARTED|CCTA Diagnosis||0||
48610069|NCT03026283|101830341|FG000|COMPLETED|CCTA Diagnosis||572||
48610070|NCT03026283|101830342|FG001|COMPLETED|CCTA Diagnosis||0||
48610071|NCT03026283|101830343|FG002|COMPLETED|CCTA Diagnosis||0||
48610072|NCT03026283|101830344|FG003|COMPLETED|CCTA Diagnosis||0||
48610073|NCT03026283|101830345|FG004|COMPLETED|CCTA Diagnosis||0||
48610074|NCT03026283|101830346|FG005|COMPLETED|CCTA Diagnosis||0||
48610075|NCT03026283|101830347|FG006|COMPLETED|CCTA Diagnosis||0||
48610076|NCT03026283|101830348|FG007|COMPLETED|CCTA Diagnosis||0||
48610077|NCT03026283|101830341|FG000|NOT COMPLETED|CCTA Diagnosis||14||
48610078|NCT03026283|101830342|FG001|NOT COMPLETED|CCTA Diagnosis||0||
48610079|NCT03026283|101830343|FG002|NOT COMPLETED|CCTA Diagnosis||0||
48610080|NCT03026283|101830344|FG003|NOT COMPLETED|CCTA Diagnosis||0||
48610081|NCT03026283|101830345|FG004|NOT COMPLETED|CCTA Diagnosis||0||
48610082|NCT03026283|101830346|FG005|NOT COMPLETED|CCTA Diagnosis||0||
48610083|NCT03026283|101830347|FG006|NOT COMPLETED|CCTA Diagnosis||0||
48610084|NCT03026283|101830348|FG007|NOT COMPLETED|CCTA Diagnosis||0||
48610085|NCT03026283|101830341|FG000|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0|Note: Number of participants to start period is not equal to number who completed previous period.|
48610086|NCT03026283|101830342|FG001|STARTED|Optimal Medical Care/FFR-CT Diagnosis||289|Note: Number of participants to start period is not equal to number who completed previous period.|
48610087|NCT03026283|101830343|FG002|STARTED|Optimal Medical Care/FFR-CT Diagnosis||280|Note: Number of participants to start period is not equal to number who completed previous period.|
48722520|NCT00790478|102108172|FG000|STARTED|Overall Study||0||
48307991|NCT00860951|101080850|FG000|NOT COMPLETED|Overall Study||7||
48307992|NCT00430482|101080851|FG000|STARTED|Completed Treatment||41||
48307993|NCT00430482|101080852|FG001|STARTED|Completed Treatment||37||
48307994|NCT00430482|101080851|FG000|Completed ASI at Midpoint|Completed Treatment||35||
48307995|NCT00430482|101080852|FG001|Completed ASI at Midpoint|Completed Treatment||29||
48307996|NCT00430482|101080851|FG000|COMPLETED|Completed Treatment||34|Non-completion was operationalized as a failure to complete at least 12 of 15 treatment sessions.|
48610088|NCT03026283|101830344|FG003|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0|Note: Number of participants to start period is not equal to number who completed previous period.|
48610089|NCT03026283|101830345|FG004|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0|Note: Number of participants to start period is not equal to number who completed previous period.|
48722521|NCT00790478|102108173|FG001|STARTED|Overall Study||0||
48722522|NCT00790478|102108172|FG000|COMPLETED|Overall Study||0||
48722523|NCT00790478|102108173|FG001|COMPLETED|Overall Study||0||
48722524|NCT00790478|102108172|FG000|NOT COMPLETED|Overall Study||0||
48610090|NCT03026283|101830346|FG005|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0|Note: Number of participants to start period is not equal to number who completed previous period.|
48610091|NCT03026283|101830347|FG006|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0|Note: Number of participants to start period is not equal to number who completed previous period.|
48610092|NCT03026283|101830348|FG007|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0|Note: Number of participants to start period is not equal to number who completed previous period.|
48610093|NCT03026283|101830341|FG000|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0||
48610094|NCT03026283|101830342|FG001|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||286||
48610095|NCT03026283|101830343|FG002|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||265||
48610096|NCT03026283|101830344|FG003|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0||
48307997|NCT00430482|101080852|FG001|COMPLETED|Completed Treatment||26|Non-completion was operationalized as a failure to complete at least 12 of 15 treatment sessions.|
48307998|NCT00430482|101080851|FG000|NOT COMPLETED|Completed Treatment||7||
48307999|NCT00430482|101080852|FG001|NOT COMPLETED|Completed Treatment||11||
48308000|NCT00430482|101080851|FG000|STARTED|Completed 2 Follow-Up Visits||34||
48308001|NCT00430482|101080852|FG001|STARTED|Completed 2 Follow-Up Visits||26||
48308002|NCT00430482|101080851|FG000|Completed ASI at Follow-Up #1|Completed 2 Follow-Up Visits||27||
48308003|NCT00430482|101080852|FG001|Completed ASI at Follow-Up #1|Completed 2 Follow-Up Visits||20||
48308004|NCT00430482|101080851|FG000|Completed ASI at Follow-Up #2|Completed 2 Follow-Up Visits||29||
48308005|NCT00430482|101080852|FG001|Completed ASI at Follow-Up #2|Completed 2 Follow-Up Visits||20||
48308006|NCT00430482|101080851|FG000|COMPLETED|Completed 2 Follow-Up Visits||29||
48308007|NCT00430482|101080852|FG001|COMPLETED|Completed 2 Follow-Up Visits||20||
48308008|NCT00430482|101080851|FG000|NOT COMPLETED|Completed 2 Follow-Up Visits||5||
48308009|NCT00430482|101080852|FG001|NOT COMPLETED|Completed 2 Follow-Up Visits||6||
48308010|NCT01431274|101080853|FG000|STARTED|Overall Study||528||
48308011|NCT01431274|101080854|FG001|STARTED|Overall Study||525||
48308012|NCT01431274|101080855|FG002|STARTED|Overall Study||527||
48308013|NCT01431274|101080856|FG003|STARTED|Overall Study||522||
48308014|NCT01431274|101080857|FG004|STARTED|Overall Study||522||
48308015|NCT01431274|101080853|FG000|COMPLETED|Overall Study||431||
48308016|NCT01431274|101080854|FG001|COMPLETED|Overall Study||448||
48308017|NCT01431274|101080855|FG002|COMPLETED|Overall Study||455||
48308018|NCT01431274|101080856|FG003|COMPLETED|Overall Study||462||
48308019|NCT01431274|101080857|FG004|COMPLETED|Overall Study||466||
48308020|NCT01431274|101080853|FG000|NOT COMPLETED|Overall Study||97||
48308021|NCT01431274|101080854|FG001|NOT COMPLETED|Overall Study||77||
48308022|NCT01431274|101080855|FG002|NOT COMPLETED|Overall Study||72||
48308023|NCT01431274|101080856|FG003|NOT COMPLETED|Overall Study||60||
48308024|NCT01431274|101080857|FG004|NOT COMPLETED|Overall Study||56||
48308025|NCT02113579|101080858|FG000|STARTED|Overall Study||186||
48308026|NCT02113579|101080859|FG001|STARTED|Overall Study||189||
48308027|NCT02113579|101080858|FG000|COMPLETED|Overall Study||176||
48308028|NCT02113579|101080859|FG001|COMPLETED|Overall Study||185||
48308029|NCT02113579|101080858|FG000|NOT COMPLETED|Overall Study||10||
48308030|NCT02113579|101080859|FG001|NOT COMPLETED|Overall Study||4||
48308031|NCT00962390|101080860|FG000|STARTED|Overall Study||29||
48308032|NCT00962390|101080861|FG001|STARTED|Overall Study||29||
48308033|NCT00962390|101080862|FG002|STARTED|Overall Study||29||
48308034|NCT00962390|101080863|FG003|STARTED|Overall Study||29||
48308035|NCT00962390|101080860|FG000|COMPLETED|Overall Study||25||
48308036|NCT00962390|101080861|FG001|COMPLETED|Overall Study||26||
48308037|NCT00962390|101080862|FG002|COMPLETED|Overall Study||25||
48308038|NCT00962390|101080863|FG003|COMPLETED|Overall Study||28||
48610097|NCT03026283|101830345|FG004|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0||
48308039|NCT00962390|101080860|FG000|NOT COMPLETED|Overall Study||4||
48308040|NCT00962390|101080861|FG001|NOT COMPLETED|Overall Study||3||
48308041|NCT00962390|101080862|FG002|NOT COMPLETED|Overall Study||4||
48308042|NCT00962390|101080863|FG003|NOT COMPLETED|Overall Study||1||
48308043|NCT00617539|101080864|FG000|STARTED|Overall Study||30||
48308044|NCT00617539|101080864|FG000|COMPLETED|Overall Study||30||
48308045|NCT00617539|101080864|FG000|NOT COMPLETED|Overall Study||0||
48308046|NCT00789750|101080865|FG000|STARTED|Overall Study||280||
48308047|NCT00789750|101080866|FG001|STARTED|Overall Study||282||
48308048|NCT00789750|101080865|FG000|Dropped During run-in Period|Overall Study||6||
48308049|NCT00789750|101080866|FG001|Dropped During run-in Period|Overall Study||5||
48406486|NCT01237223|101328435|FG005|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||154||
48308050|NCT00789750|101080865|FG000|Safety Set|Overall Study||274||
48308051|NCT00789750|101080866|FG001|Safety Set|Overall Study||277||
48308052|NCT00789750|101080865|FG000|Intent to Treat Set|Overall Study||271||
48308053|NCT00789750|101080866|FG001|Intent to Treat Set|Overall Study||276||
48308054|NCT00789750|101080865|FG000|COMPLETED|Overall Study||221||
48406487|NCT01237223|101328430|FG000|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||33||
48308055|NCT00789750|101080866|FG001|COMPLETED|Overall Study||222||
48308056|NCT00789750|101080865|FG000|NOT COMPLETED|Overall Study||59||
48308057|NCT00789750|101080866|FG001|NOT COMPLETED|Overall Study||60||
48308058|NCT01221727|101080867|FG000|STARTED|Overall Study||21||
48308059|NCT01221727|101080868|FG001|STARTED|Overall Study||9||
48308060|NCT01221727|101080867|FG000|Treated|Overall Study||19||
48308061|NCT01221727|101080868|FG001|Treated|Overall Study||8||
48308062|NCT01221727|101080867|FG000|COMPLETED|Overall Study||18||
48308063|NCT01221727|101080868|FG001|COMPLETED|Overall Study||8||
48308064|NCT01221727|101080867|FG000|NOT COMPLETED|Overall Study||3||
48308065|NCT01221727|101080868|FG001|NOT COMPLETED|Overall Study||1||
48308066|NCT00041080|101080869|FG000|STARTED|Overall Study||69||
48308067|NCT00041080|101080870|FG001|STARTED|Overall Study||70||
48308068|NCT00041080|101080869|FG000|COMPLETED|Overall Study||39||
48722525|NCT00790478|102108173|FG001|NOT COMPLETED|Overall Study||0||
48152634|NCT01235546|100696063|FG000|COMPLETED|Overall Study||992||
48152635|NCT01235546|100696064|FG001|COMPLETED|Overall Study||1018||
48152636|NCT01235546|100696063|FG000|NOT COMPLETED|Overall Study||2||
48152637|NCT01235546|100696064|FG001|NOT COMPLETED|Overall Study||1||
48152638|NCT00119405|100696065|FG000|STARTED|Overall Study||18||
48152639|NCT00119405|100696065|FG000|COMPLETED|Overall Study||17||
48152640|NCT00119405|100696065|FG000|NOT COMPLETED|Overall Study||1||
48152641|NCT01144026|100696066|FG000|STARTED|Overall Study||10||
48152642|NCT01144026|100696067|FG001|STARTED|Overall Study||5||
48152643|NCT01144026|100696066|FG000|COMPLETED|Overall Study||10||
48152644|NCT01144026|100696067|FG001|COMPLETED|Overall Study||5||
48152645|NCT01144026|100696066|FG000|NOT COMPLETED|Overall Study||0||
48152646|NCT01144026|100696067|FG001|NOT COMPLETED|Overall Study||0||
48152647|NCT00915031|100696068|FG000|STARTED|Overall Study||714||
48152648|NCT00915031|100696069|FG001|STARTED|Overall Study||24||
48152649|NCT00915031|100696068|FG000|COMPLETED|Overall Study||714||
48152650|NCT00915031|100696069|FG001|COMPLETED|Overall Study||24||
48152651|NCT00915031|100696068|FG000|NOT COMPLETED|Overall Study||0||
48152652|NCT00915031|100696069|FG001|NOT COMPLETED|Overall Study||0||
48152653|NCT00512148|100696070|FG000|STARTED|Primay Study Period||7||
48152654|NCT00512148|100696070|FG000|COMPLETED|Primay Study Period||6||
48152655|NCT00512148|100696070|FG000|NOT COMPLETED|Primay Study Period||1||
48152656|NCT00512148|100696070|FG000|STARTED|Long Term Follow Up Period||6||
48152657|NCT00512148|100696070|FG000|COMPLETED|Long Term Follow Up Period||0||
48152658|NCT00512148|100696070|FG000|NOT COMPLETED|Long Term Follow Up Period||6||
48152659|NCT02993445|100696071|FG000|STARTED|First Intervention (5 Minutes)||6||12
48152660|NCT02993445|100696072|FG001|STARTED|First Intervention (5 Minutes)||5||10
48152661|NCT02993445|100696071|FG000|COMPLETED|First Intervention (5 Minutes)||6||12
48152662|NCT02993445|100696072|FG001|COMPLETED|First Intervention (5 Minutes)||5||10
48152663|NCT02993445|100696071|FG000|NOT COMPLETED|First Intervention (5 Minutes)||0||0
48152664|NCT02993445|100696072|FG001|NOT COMPLETED|First Intervention (5 Minutes)||0||0
48152665|NCT02993445|100696071|FG000|STARTED|Washout (2 Weeks)||6||12
48152666|NCT02993445|100696072|FG001|STARTED|Washout (2 Weeks)||5||10
48152667|NCT02993445|100696071|FG000|COMPLETED|Washout (2 Weeks)||6||12
48152668|NCT02993445|100696072|FG001|COMPLETED|Washout (2 Weeks)||5||10
48152669|NCT02993445|100696071|FG000|NOT COMPLETED|Washout (2 Weeks)||0||0
48152670|NCT02993445|100696072|FG001|NOT COMPLETED|Washout (2 Weeks)||0||0
48152671|NCT02993445|100696071|FG000|STARTED|Second Intervention (5 Mins)||6||12
48152672|NCT02993445|100696072|FG001|STARTED|Second Intervention (5 Mins)||5||10
48152673|NCT02993445|100696071|FG000|COMPLETED|Second Intervention (5 Mins)||6||12
48152674|NCT02993445|100696072|FG001|COMPLETED|Second Intervention (5 Mins)||5||10
48152675|NCT02993445|100696071|FG000|NOT COMPLETED|Second Intervention (5 Mins)||0||0
48152676|NCT02993445|100696072|FG001|NOT COMPLETED|Second Intervention (5 Mins)||0||0
48152677|NCT03214367|100696073|FG000|STARTED|Lead-in Period||1316||
48152678|NCT03214367|100696074|FG001|STARTED|Lead-in Period||0||
48152679|NCT03214367|100696075|FG002|STARTED|Lead-in Period||0||
48152680|NCT03214367|100696076|FG003|STARTED|Lead-in Period||0||
48152681|NCT03214367|100696077|FG004|STARTED|Lead-in Period||76||
48152682|NCT03214367|100696078|FG005|STARTED|Lead-in Period||0||
48152683|NCT03214367|100696079|FG006|STARTED|Lead-in Period||0||
48152684|NCT03214367|100696080|FG007|STARTED|Lead-in Period||0||
48152685|NCT03214367|100696073|FG000|COMPLETED|Lead-in Period||1222||
48152686|NCT03214367|100696074|FG001|COMPLETED|Lead-in Period||0||
48152687|NCT03214367|100696075|FG002|COMPLETED|Lead-in Period||0||
48152688|NCT03214367|100696076|FG003|COMPLETED|Lead-in Period||0||
48152689|NCT03214367|100696077|FG004|COMPLETED|Lead-in Period||74||
48152690|NCT03214367|100696078|FG005|COMPLETED|Lead-in Period||0||
48308069|NCT00041080|101080870|FG001|COMPLETED|Overall Study||60||
48308070|NCT00041080|101080869|FG000|NOT COMPLETED|Overall Study||30||
48308071|NCT00041080|101080870|FG001|NOT COMPLETED|Overall Study||10||
48308072|NCT03407651|101080871|FG000|STARTED|Period 1: Part 1a||11||
48308073|NCT03407651|101080871|FG000|COMPLETED|Period 1: Part 1a||10||
48152691|NCT03214367|100696079|FG006|COMPLETED|Lead-in Period||0||
48152692|NCT03214367|100696080|FG007|COMPLETED|Lead-in Period||0||
48152693|NCT03214367|100696073|FG000|NOT COMPLETED|Lead-in Period||94||
48152694|NCT03214367|100696074|FG001|NOT COMPLETED|Lead-in Period||0||
48152695|NCT03214367|100696075|FG002|NOT COMPLETED|Lead-in Period||0||
48152696|NCT03214367|100696076|FG003|NOT COMPLETED|Lead-in Period||0||
48152697|NCT03214367|100696077|FG004|NOT COMPLETED|Lead-in Period||2||
48152698|NCT03214367|100696078|FG005|NOT COMPLETED|Lead-in Period||0||
48152699|NCT03214367|100696079|FG006|NOT COMPLETED|Lead-in Period||0||
48152700|NCT03214367|100696080|FG007|NOT COMPLETED|Lead-in Period||0||
48152701|NCT03214367|100696073|FG000|STARTED|Treatment Period||0||
48152702|NCT03214367|100696074|FG001|STARTED|Treatment Period||442||
48152703|NCT03214367|100696075|FG002|STARTED|Treatment Period||451||
48308074|NCT03407651|101080871|FG000|NOT COMPLETED|Period 1: Part 1a||1||
48308075|NCT03407651|101080871|FG000|STARTED|Period 2: Part 1b||9|One subject completed Part 1a of the study and opted to enter into Part 2 of the study and did not enter Part 1b, making the number of subjects in Part 1b smaller than the number of subjects in Part 1a. That subject withdrew consent after 1 SC dose in Part 2 but is counted as a discontinuation in Part 1 as no additional assessments were performed and the subject did not enter Part 1b. One subject had poor IV access and skipped Part 1b of the study.|
48308076|NCT03407651|101080871|FG000|COMPLETED|Period 2: Part 1b||9||
48308077|NCT03407651|101080871|FG000|NOT COMPLETED|Period 2: Part 1b||0||
48308078|NCT03407651|101080871|FG000|STARTED|Period 3: Part 2||11||
48308079|NCT03407651|101080871|FG000|COMPLETED|Period 3: Part 2||8||
48610098|NCT03026283|101830346|FG005|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0||
48610099|NCT03026283|101830347|FG006|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0||
48610100|NCT03026283|101830348|FG007|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0||
48610101|NCT03026283|101830341|FG000|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0||
48610102|NCT03026283|101830342|FG001|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||3||
48610103|NCT03026283|101830343|FG002|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||15||
48610104|NCT03026283|101830344|FG003|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0||
48610105|NCT03026283|101830345|FG004|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0||
48610106|NCT03026283|101830346|FG005|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0||
48610107|NCT03026283|101830347|FG006|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0||
48610108|NCT03026283|101830348|FG007|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0||
48610109|NCT03026283|101830341|FG000|STARTED|Optimal Care/Stress Test/ICA||0|Participants diagnosed to receive optimal care, or recommended for stress test diagnosis or ICA|
48610110|NCT03026283|101830342|FG001|STARTED|Optimal Care/Stress Test/ICA||0|Participants diagnosed to receive optimal care, or recommended for stress test diagnosis or ICA|
48610111|NCT03026283|101830343|FG002|STARTED|Optimal Care/Stress Test/ICA||0|Participants diagnosed to receive optimal care, or recommended for stress test diagnosis or ICA|
48610112|NCT03026283|101830344|FG003|STARTED|Optimal Care/Stress Test/ICA||128|Participants diagnosed to receive optimal care, or recommended for stress test diagnosis or ICA|
48610113|NCT03026283|101830345|FG004|STARTED|Optimal Care/Stress Test/ICA||52|Participants diagnosed to receive optimal care, or recommended for stress test diagnosis or ICA|
48610114|NCT03026283|101830346|FG005|STARTED|Optimal Care/Stress Test/ICA||101|Participants diagnosed to receive optimal care, or recommended for stress test diagnosis or ICA|
48152704|NCT03214367|100696076|FG003|STARTED|Treatment Period||329||
48152705|NCT03214367|100696077|FG004|STARTED|Treatment Period||0||
48152706|NCT03214367|100696078|FG005|STARTED|Treatment Period||31||
48308080|NCT03407651|101080871|FG000|NOT COMPLETED|Period 3: Part 2||3||
48308081|NCT03155373|101080872|FG000|STARTED|Overall Study||50||
48308082|NCT03155373|101080872|FG000|COMPLETED|Overall Study||43||
48308083|NCT03155373|101080872|FG000|NOT COMPLETED|Overall Study||7||
48308084|NCT03684590|101080873|FG000|STARTED|Overall Study||49||
48308085|NCT03684590|101080874|FG001|STARTED|Overall Study||53||
48308086|NCT03684590|101080873|FG000|COMPLETED|Overall Study||49||
48308087|NCT03684590|101080874|FG001|COMPLETED|Overall Study||53||
48308088|NCT03684590|101080873|FG000|NOT COMPLETED|Overall Study||0||
48308089|NCT03684590|101080874|FG001|NOT COMPLETED|Overall Study||0||
48308090|NCT00929656|101080875|FG000|STARTED|Overall Study||13||
48152707|NCT03214367|100696079|FG006|STARTED|Treatment Period||21||
48152708|NCT03214367|100696080|FG007|STARTED|Treatment Period||22||
48152709|NCT03214367|100696073|FG000|COMPLETED|Treatment Period||0||
48610115|NCT03026283|101830347|FG006|STARTED|Optimal Care/Stress Test/ICA||0|Participants diagnosed to receive optimal care, or recommended for stress test diagnosis or ICA|
48610116|NCT03026283|101830348|FG007|STARTED|Optimal Care/Stress Test/ICA||0|Participants diagnosed to receive optimal care, or recommended for stress test diagnosis or ICA|
48610117|NCT03026283|101830341|FG000|COMPLETED|Optimal Care/Stress Test/ICA||0|Participants who followed recommendation provided after consultation with referring physician.|
48610118|NCT03026283|101830342|FG001|COMPLETED|Optimal Care/Stress Test/ICA||0|Participants who followed recommendation provided after consultation with referring physician.|
48308091|NCT00929656|101080876|FG001|STARTED|Overall Study||9||
48308092|NCT00929656|101080875|FG000|COMPLETED|Overall Study||13||
48308093|NCT00929656|101080876|FG001|COMPLETED|Overall Study||8||
48308094|NCT00929656|101080875|FG000|NOT COMPLETED|Overall Study||0||
48308095|NCT00929656|101080876|FG001|NOT COMPLETED|Overall Study||1||
48308096|NCT00713817|101080877|FG000|STARTED|Overall Study||10||
48308097|NCT00713817|101080878|FG001|STARTED|Overall Study||9||
48308098|NCT00713817|101080877|FG000|COMPLETED|Overall Study||10||
48610119|NCT03026283|101830343|FG002|COMPLETED|Optimal Care/Stress Test/ICA||0|Participants who followed recommendation provided after consultation with referring physician.|
48308099|NCT00713817|101080878|FG001|COMPLETED|Overall Study||9||
48308100|NCT00713817|101080877|FG000|NOT COMPLETED|Overall Study||0||
48308101|NCT00713817|101080878|FG001|NOT COMPLETED|Overall Study||0||
48308102|NCT01379573|101080879|FG000|STARTED|Overall Study||74||
48308103|NCT01379573|101080879|FG000|COMPLETED|Overall Study||63||
48308104|NCT01379573|101080879|FG000|NOT COMPLETED|Overall Study||11||
48308105|NCT02361944|101080880|FG000|STARTED|Overall Study||100||
48308106|NCT02361944|101080881|FG001|STARTED|Overall Study||101||
48308107|NCT02361944|101080880|FG000|COMPLETED|Overall Study||100||
48308108|NCT02361944|101080881|FG001|COMPLETED|Overall Study||100||
48308109|NCT02361944|101080880|FG000|NOT COMPLETED|Overall Study||0||
48610120|NCT03026283|101830344|FG003|COMPLETED|Optimal Care/Stress Test/ICA||108|Participants who followed recommendation provided after consultation with referring physician.|
48610121|NCT03026283|101830345|FG004|COMPLETED|Optimal Care/Stress Test/ICA||14|Participants who followed recommendation provided after consultation with referring physician.|
48610122|NCT03026283|101830346|FG005|COMPLETED|Optimal Care/Stress Test/ICA||73|Participants who followed recommendation provided after consultation with referring physician.|
48610123|NCT03026283|101830347|FG006|COMPLETED|Optimal Care/Stress Test/ICA||0|Participants who followed recommendation provided after consultation with referring physician.|
48610124|NCT03026283|101830348|FG007|COMPLETED|Optimal Care/Stress Test/ICA||0|Participants who followed recommendation provided after consultation with referring physician.|
48610125|NCT03026283|101830341|FG000|NOT COMPLETED|Optimal Care/Stress Test/ICA||0||
48610126|NCT03026283|101830342|FG001|NOT COMPLETED|Optimal Care/Stress Test/ICA||0||
48610127|NCT03026283|101830343|FG002|NOT COMPLETED|Optimal Care/Stress Test/ICA||0||
48610128|NCT03026283|101830344|FG003|NOT COMPLETED|Optimal Care/Stress Test/ICA||20||
48610129|NCT03026283|101830345|FG004|NOT COMPLETED|Optimal Care/Stress Test/ICA||38||
48610130|NCT03026283|101830346|FG005|NOT COMPLETED|Optimal Care/Stress Test/ICA||28||
48610131|NCT03026283|101830347|FG006|NOT COMPLETED|Optimal Care/Stress Test/ICA||0||
48610132|NCT03026283|101830348|FG007|NOT COMPLETED|Optimal Care/Stress Test/ICA||0||
48610133|NCT03026283|101830341|FG000|STARTED|Optimal Care/ICA Diagnostic Cath||0|Participants recommended for ICA or optimal medical care after stress testing|
48610134|NCT03026283|101830342|FG001|STARTED|Optimal Care/ICA Diagnostic Cath||0|Participants recommended for ICA or optimal medical care after stress testing|
48610135|NCT03026283|101830343|FG002|STARTED|Optimal Care/ICA Diagnostic Cath||0|Participants recommended for ICA or optimal medical care after stress testing|
48610136|NCT03026283|101830344|FG003|STARTED|Optimal Care/ICA Diagnostic Cath||0|Participants recommended for ICA or optimal medical care after stress testing|
48610137|NCT03026283|101830345|FG004|STARTED|Optimal Care/ICA Diagnostic Cath||0|Participants recommended for ICA or optimal medical care after stress testing|
48610138|NCT03026283|101830346|FG005|STARTED|Optimal Care/ICA Diagnostic Cath||0|Participants recommended for ICA or optimal medical care after stress testing|
48610139|NCT03026283|101830347|FG006|STARTED|Optimal Care/ICA Diagnostic Cath||21|Participants recommended for ICA or optimal medical care after stress testing|
48610140|NCT03026283|101830348|FG007|STARTED|Optimal Care/ICA Diagnostic Cath||0|Participants recommended for ICA or optimal medical care after stress testing|
48610141|NCT03026283|101830341|FG000|COMPLETED|Optimal Care/ICA Diagnostic Cath||0||
48610142|NCT03026283|101830342|FG001|COMPLETED|Optimal Care/ICA Diagnostic Cath||0||
48610143|NCT03026283|101830343|FG002|COMPLETED|Optimal Care/ICA Diagnostic Cath||0||
48610144|NCT03026283|101830344|FG003|COMPLETED|Optimal Care/ICA Diagnostic Cath||0||
48610145|NCT03026283|101830345|FG004|COMPLETED|Optimal Care/ICA Diagnostic Cath||0||
48610146|NCT03026283|101830346|FG005|COMPLETED|Optimal Care/ICA Diagnostic Cath||0||
48610147|NCT03026283|101830347|FG006|COMPLETED|Optimal Care/ICA Diagnostic Cath||21||
48610148|NCT03026283|101830348|FG007|COMPLETED|Optimal Care/ICA Diagnostic Cath||0||
48610149|NCT03026283|101830341|FG000|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0||
48610150|NCT03026283|101830342|FG001|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0||
48610151|NCT03026283|101830343|FG002|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0||
48610152|NCT03026283|101830344|FG003|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0||
48610153|NCT03026283|101830345|FG004|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0||
48610154|NCT03026283|101830346|FG005|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0||
48610155|NCT03026283|101830347|FG006|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0||
48610156|NCT03026283|101830348|FG007|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0||
48610157|NCT01972464|101830349|FG000|STARTED|Treatment Period (Week 1 Through Week 8)||19||
48610158|NCT01972464|101830350|FG001|STARTED|Treatment Period (Week 1 Through Week 8)||22||
48610159|NCT01972464|101830349|FG000|COMPLETED|Treatment Period (Week 1 Through Week 8)||16||
48610160|NCT01972464|101830350|FG001|COMPLETED|Treatment Period (Week 1 Through Week 8)||18||
48610161|NCT01972464|101830349|FG000|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||3||
48610162|NCT01972464|101830350|FG001|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||4||
48610163|NCT01972464|101830349|FG000|STARTED|3-Month Follow-Up (Week 20)||16||
48610164|NCT01972464|101830350|FG001|STARTED|3-Month Follow-Up (Week 20)||18||
48610165|NCT01972464|101830349|FG000|COMPLETED|3-Month Follow-Up (Week 20)||15||
48610166|NCT01972464|101830350|FG001|COMPLETED|3-Month Follow-Up (Week 20)||17||
48610167|NCT01972464|101830349|FG000|NOT COMPLETED|3-Month Follow-Up (Week 20)||1||
48610168|NCT01972464|101830350|FG001|NOT COMPLETED|3-Month Follow-Up (Week 20)||1||
48610169|NCT03972501|101830351|FG000|STARTED|Overall Study||9||
48308110|NCT02361944|101080881|FG001|NOT COMPLETED|Overall Study||1||
48308111|NCT01831921|101080882|FG000|STARTED|Overall Study||150||
48610170|NCT03972501|101830352|FG001|STARTED|Overall Study||17||
48610171|NCT03972501|101830351|FG000|COMPLETED|Overall Study||7||
48610172|NCT03972501|101830352|FG001|COMPLETED|Overall Study||7||
48610173|NCT03972501|101830351|FG000|NOT COMPLETED|Overall Study||2||
48610174|NCT03972501|101830352|FG001|NOT COMPLETED|Overall Study||10||
48610175|NCT00524771|101830353|FG000|STARTED|Overall Study||17084||
48610176|NCT00524771|101830354|FG001|STARTED|Overall Study||17016||
48610177|NCT00524771|101830353|FG000|COMPLETED|Overall Study||16864||
48308112|NCT01831921|101080883|FG001|STARTED|Overall Study||75||
48308113|NCT01831921|101080882|FG000|6 Months|Overall Study||122||
48308114|NCT01831921|101080883|FG001|6 Months|Overall Study||63||
48722526|NCT02078648|102108174|FG000|STARTED|Overall Study||46||
48722527|NCT02078648|102108175|FG001|STARTED|Overall Study||28||
48722528|NCT02078648|102108174|FG000|COMPLETED|Overall Study||0||
48722529|NCT02078648|102108175|FG001|COMPLETED|Overall Study||0||
48722530|NCT02078648|102108174|FG000|NOT COMPLETED|Overall Study||46||
48722531|NCT02078648|102108175|FG001|NOT COMPLETED|Overall Study||28||
48308115|NCT01831921|101080882|FG000|12 Months|Overall Study||120||
48308116|NCT01831921|101080883|FG001|12 Months|Overall Study||62||
48308117|NCT01831921|101080882|FG000|18 Months|Overall Study||90||
48722532|NCT01110382|102108176|FG000|STARTED|Overall Study||31||
48722533|NCT01110382|102108177|FG001|STARTED|Overall Study||10||
48722534|NCT01110382|102108176|FG000|COMPLETED|Overall Study||31||
48722535|NCT01110382|102108177|FG001|COMPLETED|Overall Study||8||
48722536|NCT01110382|102108176|FG000|NOT COMPLETED|Overall Study||0||
48722537|NCT01110382|102108177|FG001|NOT COMPLETED|Overall Study||2||
48722538|NCT02387294|102108178|FG000|STARTED|Overall Study||60||
48722539|NCT02387294|102108179|FG001|STARTED|Overall Study||60||
48722540|NCT02387294|102108178|FG000|COMPLETED|Overall Study||60||
48722541|NCT02387294|102108179|FG001|COMPLETED|Overall Study||60||
48722542|NCT02387294|102108178|FG000|NOT COMPLETED|Overall Study||0||
48722543|NCT02387294|102108179|FG001|NOT COMPLETED|Overall Study||0||
48722544|NCT03222414|102108180|FG000|STARTED|Overall Study||0||
48722545|NCT03222414|102108181|FG001|STARTED|Overall Study||1||
48722546|NCT03222414|102108180|FG000|COMPLETED|Overall Study||0||
48722547|NCT03222414|102108181|FG001|COMPLETED|Overall Study||1||
48722548|NCT03222414|102108180|FG000|NOT COMPLETED|Overall Study||0||
48722549|NCT03222414|102108181|FG001|NOT COMPLETED|Overall Study||0||
48722550|NCT01792518|102108182|FG000|STARTED|Overall Study||178||
48722551|NCT01792518|102108183|FG001|STARTED|Overall Study||182||
48722552|NCT01792518|102108182|FG000|COMPLETED|Overall Study||170||
48722553|NCT01792518|102108183|FG001|COMPLETED|Overall Study||175||
48722554|NCT01792518|102108182|FG000|NOT COMPLETED|Overall Study||8||
48722555|NCT01792518|102108183|FG001|NOT COMPLETED|Overall Study||7||
48722556|NCT01848366|102108184|FG000|STARTED|Overall Study||8||
48722557|NCT01848366|102108184|FG000|COMPLETED|Overall Study||8||
48722558|NCT01848366|102108184|FG000|NOT COMPLETED|Overall Study||0||
48722559|NCT01515046|102108185|FG000|STARTED|Overall Study||1||
48722560|NCT01515046|102108185|FG000|COMPLETED|Overall Study||1||
48722561|NCT01515046|102108185|FG000|NOT COMPLETED|Overall Study||0||
48722562|NCT00989781|102108186|FG000|STARTED|Ovarian Response to hCG||21||
48722563|NCT00989781|102108187|FG001|STARTED|Ovarian Response to hCG||20||
48722564|NCT00989781|102108186|FG000|COMPLETED|Ovarian Response to hCG||18||
48722565|NCT00989781|102108187|FG001|COMPLETED|Ovarian Response to hCG||18||
48722566|NCT00989781|102108186|FG000|NOT COMPLETED|Ovarian Response to hCG||3||
48722567|NCT00989781|102108187|FG001|NOT COMPLETED|Ovarian Response to hCG||2||
48722568|NCT00989781|102108186|FG000|STARTED|Adrenal Response ot ACTH||18||
48722569|NCT00989781|102108187|FG001|STARTED|Adrenal Response ot ACTH||18||
48722570|NCT00989781|102108186|FG000|COMPLETED|Adrenal Response ot ACTH||13||
48722571|NCT00989781|102108187|FG001|COMPLETED|Adrenal Response ot ACTH||15||
48722572|NCT00989781|102108186|FG000|NOT COMPLETED|Adrenal Response ot ACTH||5||
48722573|NCT00989781|102108187|FG001|NOT COMPLETED|Adrenal Response ot ACTH||3||
48722574|NCT01946126|102108188|FG000|STARTED|Overall Study||184||
48722575|NCT01946126|102108189|FG001|STARTED|Overall Study||275||
48722576|NCT01946126|102108188|FG000|COMPLETED|Overall Study||184||
48722577|NCT01946126|102108189|FG001|COMPLETED|Overall Study||275||
48722578|NCT01946126|102108188|FG000|NOT COMPLETED|Overall Study||0||
48722579|NCT01946126|102108189|FG001|NOT COMPLETED|Overall Study||0||
48308118|NCT01831921|101080883|FG001|18 Months|Overall Study||49||
48308119|NCT01831921|101080882|FG000|COMPLETED|Overall Study||66||
48308120|NCT01831921|101080883|FG001|COMPLETED|Overall Study||36||
48308121|NCT01831921|101080882|FG000|NOT COMPLETED|Overall Study||84||
48308122|NCT01831921|101080883|FG001|NOT COMPLETED|Overall Study||39||
48308123|NCT00385203|101080884|FG000|STARTED|Overall Study||26||
48308124|NCT00385203|101080885|FG001|STARTED|Overall Study||10||
48308125|NCT00385203|101080884|FG000|COMPLETED|Overall Study||0||
48722580|NCT01641822|102108190|FG000|STARTED|Run-in Phase||107||
48722581|NCT01641822|102108191|FG001|STARTED|Run-in Phase||0||
48722582|NCT01641822|102108192|FG002|STARTED|Run-in Phase||0||
48722583|NCT01641822|102108190|FG000|COMPLETED|Run-in Phase||93||
48722584|NCT01641822|102108191|FG001|COMPLETED|Run-in Phase||0||
48722585|NCT01641822|102108192|FG002|COMPLETED|Run-in Phase||0||
48722586|NCT01641822|102108190|FG000|NOT COMPLETED|Run-in Phase||14||
48722587|NCT01641822|102108191|FG001|NOT COMPLETED|Run-in Phase||0||
48308126|NCT00385203|101080885|FG001|COMPLETED|Overall Study||3||
48308127|NCT00385203|101080884|FG000|NOT COMPLETED|Overall Study||26||
48722588|NCT01641822|102108192|FG002|NOT COMPLETED|Run-in Phase||0||
48722589|NCT01641822|102108190|FG000|STARTED|Comparative Phase||0||
48722590|NCT01641822|102108191|FG001|STARTED|Comparative Phase||43||
48722591|NCT01641822|102108192|FG002|STARTED|Comparative Phase||47||
48308128|NCT00385203|101080885|FG001|NOT COMPLETED|Overall Study||7||
48610178|NCT00524771|101830354|FG001|COMPLETED|Overall Study||16431||
48610179|NCT00524771|101830353|FG000|NOT COMPLETED|Overall Study||220||
48610180|NCT00524771|101830354|FG001|NOT COMPLETED|Overall Study||585||
48610181|NCT02716584|101830355|FG000|STARTED|Overall Study||35||
48610182|NCT02716584|101830356|FG001|STARTED|Overall Study||18||
48610183|NCT02716584|101830355|FG000|COMPLETED|Overall Study||27||
48610184|NCT02716584|101830356|FG001|COMPLETED|Overall Study||13||
48610185|NCT02716584|101830355|FG000|NOT COMPLETED|Overall Study||8||
48610186|NCT02716584|101830356|FG001|NOT COMPLETED|Overall Study||5||
48610187|NCT01027468|101830357|FG000|STARTED|Overall Study||160||
48610188|NCT01027468|101830357|FG000|COMPLETED|Overall Study||160||
48610189|NCT01027468|101830357|FG000|NOT COMPLETED|Overall Study||0||
48610190|NCT04039204|101830358|FG000|STARTED|Overall Study||5||
48610191|NCT04039204|101830359|FG001|STARTED|Overall Study||5||
48308129|NCT00702325|101080886|FG000|STARTED|Overall Study||156||
48308130|NCT00702325|101080887|FG001|STARTED|Overall Study||155||
48308131|NCT00702325|101080886|FG000|COMPLETED|Overall Study||118||
48308132|NCT00702325|101080887|FG001|COMPLETED|Overall Study||102||
48308133|NCT00702325|101080886|FG000|NOT COMPLETED|Overall Study||38||
48308134|NCT00702325|101080887|FG001|NOT COMPLETED|Overall Study||53||
48308135|NCT03591354|101080888|FG000|STARTED|Overall Study||54||
48308136|NCT03591354|101080889|FG001|STARTED|Overall Study||55||
48308137|NCT03591354|101080890|FG002|STARTED|Overall Study||55||
48308138|NCT03591354|101080888|FG000|COMPLETED|Overall Study||54||
48308139|NCT03591354|101080889|FG001|COMPLETED|Overall Study||55||
48308140|NCT03591354|101080890|FG002|COMPLETED|Overall Study||55||
48308141|NCT03591354|101080888|FG000|NOT COMPLETED|Overall Study||0||
48308142|NCT03591354|101080889|FG001|NOT COMPLETED|Overall Study||0||
48308143|NCT03591354|101080890|FG002|NOT COMPLETED|Overall Study||0||
48308144|NCT05093322|101080891|FG000|STARTED|Overall Study||10||
48308145|NCT05093322|101080892|FG001|STARTED|Overall Study||3||
48308146|NCT05093322|101080891|FG000|COMPLETED|Overall Study||0||
48308147|NCT05093322|101080892|FG001|COMPLETED|Overall Study||0||
48610192|NCT04039204|101830358|FG000|COMPLETED|Overall Study||5||
48610193|NCT04039204|101830359|FG001|COMPLETED|Overall Study||3||
48610194|NCT04039204|101830358|FG000|NOT COMPLETED|Overall Study||0||
48610195|NCT04039204|101830359|FG001|NOT COMPLETED|Overall Study||2||
48308148|NCT05093322|101080891|FG000|NOT COMPLETED|Overall Study||10||
48308149|NCT05093322|101080892|FG001|NOT COMPLETED|Overall Study||3||
48308150|NCT02101515|101080893|FG000|STARTED|Overall Study||37||
48308151|NCT02101515|101080894|FG001|STARTED|Overall Study||41||
48308152|NCT02101515|101080893|FG000|COMPLETED|Overall Study||37||
48610196|NCT02281955|101830360|FG000|STARTED|Overall Study||114||
48610197|NCT02281955|101830360|FG000|COMPLETED|Overall Study||113||
48610198|NCT02281955|101830360|FG000|NOT COMPLETED|Overall Study||1||
48610199|NCT00177866|101830361|FG000|STARTED|Overall Study||0||
48308153|NCT02101515|101080894|FG001|COMPLETED|Overall Study||41||
48308154|NCT02101515|101080893|FG000|NOT COMPLETED|Overall Study||0||
48308155|NCT02101515|101080894|FG001|NOT COMPLETED|Overall Study||0||
48308156|NCT01886313|101080895|FG000|STARTED|Overall Study||6||
48308157|NCT01886313|101080896|FG001|STARTED|Overall Study||5||
48308158|NCT01886313|101080895|FG000|COMPLETED|Overall Study||5||
48308159|NCT01886313|101080896|FG001|COMPLETED|Overall Study||4||
48308160|NCT01886313|101080895|FG000|NOT COMPLETED|Overall Study||1||
48308161|NCT01886313|101080896|FG001|NOT COMPLETED|Overall Study||1||
48308162|NCT00314249|101080897|FG000|STARTED|Overall Study||509||
48308163|NCT00314249|101080898|FG001|STARTED|Overall Study||516||
48308164|NCT00314249|101080897|FG000|COMPLETED|Overall Study||357||
48308165|NCT00314249|101080898|FG001|COMPLETED|Overall Study||353||
48308166|NCT00314249|101080897|FG000|NOT COMPLETED|Overall Study||152||
48308167|NCT00314249|101080898|FG001|NOT COMPLETED|Overall Study||163||
48308168|NCT02334787|101080899|FG000|STARTED|Overall Study||8||
48308169|NCT02334787|101080900|FG001|STARTED|Overall Study||8||
48308170|NCT02334787|101080901|FG002|STARTED|Overall Study||8||
48308171|NCT02334787|101080902|FG003|STARTED|Overall Study||8||
48308172|NCT02334787|101080899|FG000|COMPLETED|Overall Study||8||
48610200|NCT00177866|101830362|FG001|STARTED|Overall Study||0||
48152710|NCT03214367|100696074|FG001|COMPLETED|Treatment Period||408||
48152711|NCT03214367|100696075|FG002|COMPLETED|Treatment Period||418||
48152712|NCT03214367|100696076|FG003|COMPLETED|Treatment Period||310||
48152713|NCT03214367|100696077|FG004|COMPLETED|Treatment Period||0||
48152714|NCT03214367|100696078|FG005|COMPLETED|Treatment Period||28||
48152715|NCT03214367|100696079|FG006|COMPLETED|Treatment Period||19||
48152716|NCT03214367|100696080|FG007|COMPLETED|Treatment Period||21||
48152717|NCT03214367|100696073|FG000|NOT COMPLETED|Treatment Period||0||
48152718|NCT03214367|100696074|FG001|NOT COMPLETED|Treatment Period||34||
48152719|NCT03214367|100696075|FG002|NOT COMPLETED|Treatment Period||33||
48152720|NCT03214367|100696076|FG003|NOT COMPLETED|Treatment Period||19||
48152721|NCT03214367|100696077|FG004|NOT COMPLETED|Treatment Period||0||
48152722|NCT03214367|100696078|FG005|NOT COMPLETED|Treatment Period||3||
48152723|NCT03214367|100696079|FG006|NOT COMPLETED|Treatment Period||2||
48152724|NCT03214367|100696080|FG007|NOT COMPLETED|Treatment Period||1||
48152725|NCT05340855|100696081|FG000|STARTED|Overall Study||10||
48152726|NCT05340855|100696081|FG000|COMPLETED|Overall Study||10||
48152727|NCT05340855|100696081|FG000|NOT COMPLETED|Overall Study||0||
48152728|NCT02068495|100696082|FG000|STARTED|Overall Study||3409||
48152729|NCT02068495|100696082|FG000|COMPLETED|Overall Study||3300||
48152730|NCT02068495|100696082|FG000|NOT COMPLETED|Overall Study||109||
48152731|NCT00733980|100696083|FG000|STARTED|Overall Study||74||
48152732|NCT00733980|100696084|FG001|STARTED|Overall Study||76||
48152733|NCT00733980|100696083|FG000|COMPLETED|Overall Study||52||
48152734|NCT00733980|100696084|FG001|COMPLETED|Overall Study||55||
48152735|NCT00733980|100696083|FG000|NOT COMPLETED|Overall Study||22||
48152736|NCT00733980|100696084|FG001|NOT COMPLETED|Overall Study||21||
48152737|NCT01256567|100696085|FG000|STARTED|Overall Study||7||
48152738|NCT01256567|100696085|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7||
48152739|NCT01256567|100696085|FG000|COMPLETED|Overall Study||6||
48152740|NCT01256567|100696085|FG000|NOT COMPLETED|Overall Study||1||
48152741|NCT02220894|100696086|FG000|STARTED|Overall Study||637||
48152742|NCT02220894|100696087|FG001|STARTED|Overall Study||637||
48152743|NCT02220894|100696086|FG000|Treated|Overall Study||636||
48152744|NCT02220894|100696087|FG001|Treated|Overall Study||615||
48722592|NCT01641822|102108190|FG000|Received Randomized Study Drug Treatment|Comparative Phase||0||
48722593|NCT01641822|102108191|FG001|Received Randomized Study Drug Treatment|Comparative Phase||42||
48722594|NCT01641822|102108192|FG002|Received Randomized Study Drug Treatment|Comparative Phase||46||
48152745|NCT02220894|100696086|FG000|COMPLETED|Overall Study||0||
48610201|NCT00177866|101830361|FG000|COMPLETED|Overall Study||0||
48610202|NCT00177866|101830362|FG001|COMPLETED|Overall Study||0||
48152746|NCT02220894|100696087|FG001|COMPLETED|Overall Study||0||
48152747|NCT02220894|100696086|FG000|NOT COMPLETED|Overall Study||637||
48152748|NCT02220894|100696087|FG001|NOT COMPLETED|Overall Study||637||
48152749|NCT00763958|100696088|FG000|STARTED|Overall Study||28||
48152750|NCT00763958|100696089|FG001|STARTED|Overall Study||16||
48152751|NCT00763958|100696088|FG000|COMPLETED|Overall Study||14||
48152752|NCT00763958|100696089|FG001|COMPLETED|Overall Study||5||
48610203|NCT00177866|101830361|FG000|NOT COMPLETED|Overall Study||0||
48610204|NCT00177866|101830362|FG001|NOT COMPLETED|Overall Study||0||
48610205|NCT02511132|101830363|FG000|STARTED|Overall Study||5||
48610206|NCT02511132|101830364|FG001|STARTED|Overall Study||8||
48610207|NCT02511132|101830365|FG002|STARTED|Overall Study||9||
48610208|NCT02511132|101830363|FG000|COMPLETED|Overall Study||5||
48610209|NCT02511132|101830364|FG001|COMPLETED|Overall Study||7||
48610210|NCT02511132|101830365|FG002|COMPLETED|Overall Study||9||
48610211|NCT02511132|101830363|FG000|NOT COMPLETED|Overall Study||0||
48610212|NCT02511132|101830364|FG001|NOT COMPLETED|Overall Study||1||
48610213|NCT02511132|101830365|FG002|NOT COMPLETED|Overall Study||0||
48610214|NCT04854057|101830366|FG000|STARTED|Overall Study||1||
48610215|NCT04854057|101830367|FG001|STARTED|Overall Study||2||
48610216|NCT04854057|101830366|FG000|COMPLETED|Overall Study||1||
48722595|NCT01641822|102108190|FG000|COMPLETED|Comparative Phase||0||
48152753|NCT00763958|100696088|FG000|NOT COMPLETED|Overall Study||14||
48152754|NCT00763958|100696089|FG001|NOT COMPLETED|Overall Study||11||
48152755|NCT03987841|100696090|FG000|STARTED|Overall Study||5||
48152756|NCT03987841|100696090|FG000|COMPLETED|Overall Study||5||
48152757|NCT03987841|100696090|FG000|NOT COMPLETED|Overall Study||0||
48152758|NCT03014674|100696091|FG000|STARTED|Overall Study||85||
48152759|NCT03014674|100696092|FG001|STARTED|Overall Study||79||
48152760|NCT03014674|100696093|FG002|STARTED|Overall Study||80||
48152761|NCT03014674|100696091|FG000|COMPLETED|Overall Study||84||
48610217|NCT04854057|101830367|FG001|COMPLETED|Overall Study||1||
48610218|NCT04854057|101830366|FG000|NOT COMPLETED|Overall Study||0||
48152762|NCT03014674|100696092|FG001|COMPLETED|Overall Study||79||
48152763|NCT03014674|100696093|FG002|COMPLETED|Overall Study||80||
48152764|NCT03014674|100696091|FG000|NOT COMPLETED|Overall Study||1||
48152765|NCT03014674|100696092|FG001|NOT COMPLETED|Overall Study||0||
48152766|NCT03014674|100696093|FG002|NOT COMPLETED|Overall Study||0||
48152767|NCT00755040|100696094|FG000|STARTED|Overall Study||83||
48610219|NCT04854057|101830367|FG001|NOT COMPLETED|Overall Study||1||
48610220|NCT01471444|101830368|FG000|STARTED|Overall Study||133||
48152768|NCT00755040|100696095|FG001|STARTED|Overall Study||81||
48152769|NCT00755040|100696094|FG000|COMPLETED|Overall Study||40||
48152770|NCT00755040|100696095|FG001|COMPLETED|Overall Study||47||
48152771|NCT00755040|100696094|FG000|NOT COMPLETED|Overall Study||43||
48152772|NCT00755040|100696095|FG001|NOT COMPLETED|Overall Study||34||
48152773|NCT02963974|100696096|FG000|STARTED|Overall Study||20||
48152774|NCT02963974|100696096|FG000|COMPLETED|Overall Study||19||
48152775|NCT02963974|100696096|FG000|NOT COMPLETED|Overall Study||1||
48152776|NCT00227617|100696097|FG000|STARTED|Stage 1||22||
48152777|NCT00227617|100696098|FG001|STARTED|Stage 1||12||
48152778|NCT00227617|100696099|FG002|STARTED|Stage 1||2||
48152779|NCT00227617|100696097|FG000|COMPLETED|Stage 1||22||
48610221|NCT01471444|101830369|FG001|STARTED|Overall Study||123||
48610222|NCT01471444|101830368|FG000|COMPLETED|Overall Study||130||
48406488|NCT01237223|101328431|FG001|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15||
48152780|NCT00227617|100696098|FG001|COMPLETED|Stage 1||12||
48152781|NCT00227617|100696099|FG002|COMPLETED|Stage 1||2||
48152782|NCT00227617|100696097|FG000|NOT COMPLETED|Stage 1||0||
48152783|NCT00227617|100696098|FG001|NOT COMPLETED|Stage 1||0||
48152784|NCT00227617|100696099|FG002|NOT COMPLETED|Stage 1||0||
48152785|NCT00227617|100696097|FG000|STARTED|Stage 2||0|Study was terminated due to low accrual|
48152786|NCT00227617|100696098|FG001|STARTED|Stage 2||0|Study was terminated due to low accrual|
48152787|NCT00227617|100696099|FG002|STARTED|Stage 2||0|Study was terminated due to low accrual|
48152788|NCT00227617|100696097|FG000|COMPLETED|Stage 2||0||
48152789|NCT00227617|100696098|FG001|COMPLETED|Stage 2||0||
48152790|NCT00227617|100696099|FG002|COMPLETED|Stage 2||0||
48152791|NCT00227617|100696097|FG000|NOT COMPLETED|Stage 2||0||
48152792|NCT00227617|100696098|FG001|NOT COMPLETED|Stage 2||0||
48152793|NCT00227617|100696099|FG002|NOT COMPLETED|Stage 2||0||
48152794|NCT01091948|100696100|FG000|STARTED|Overall Study||37||
48152795|NCT01091948|100696101|FG001|STARTED|Overall Study||38||
48152796|NCT01091948|100696100|FG000|COMPLETED|Overall Study||37||
48152797|NCT01091948|100696101|FG001|COMPLETED|Overall Study||38||
48152798|NCT01091948|100696100|FG000|NOT COMPLETED|Overall Study||0||
48152799|NCT01091948|100696101|FG001|NOT COMPLETED|Overall Study||0||
48152800|NCT02497287|100696102|FG000|STARTED|Induction Phase (4 Weeks)||779||
48152801|NCT02497287|100696102|FG000|COMPLETED|Induction Phase (4 Weeks)||580||
48152802|NCT02497287|100696102|FG000|NOT COMPLETED|Induction Phase (4 Weeks)||199||
48152803|NCT02497287|100696102|FG000|STARTED|Optimization/Maintenance (48 Weeks)||603||
48152804|NCT02497287|100696102|FG000|COMPLETED|Optimization/Maintenance (48 Weeks)||150||
48152805|NCT02497287|100696102|FG000|NOT COMPLETED|Optimization/Maintenance (48 Weeks)||453||
48152806|NCT02497287|100696102|FG000|STARTED|Follow-up Phase (4 Week)||357||
48152807|NCT02497287|100696102|FG000|COMPLETED|Follow-up Phase (4 Week)||326||
48152808|NCT02497287|100696102|FG000|NOT COMPLETED|Follow-up Phase (4 Week)||31||
48152809|NCT04026165|100696103|FG000|STARTED|Run-in Placebo Period||384||
48152810|NCT04026165|100696104|FG001|STARTED|Run-in Placebo Period||0||
48152811|NCT04026165|100696105|FG002|STARTED|Run-in Placebo Period||0||
48152812|NCT04026165|100696106|FG003|STARTED|Run-in Placebo Period||0||
48152813|NCT04026165|100696103|FG000|COMPLETED|Run-in Placebo Period||362||
48152814|NCT04026165|100696104|FG001|COMPLETED|Run-in Placebo Period||0||
48152815|NCT04026165|100696105|FG002|COMPLETED|Run-in Placebo Period||0||
48152816|NCT04026165|100696106|FG003|COMPLETED|Run-in Placebo Period||0||
48152817|NCT04026165|100696103|FG000|NOT COMPLETED|Run-in Placebo Period||22||
48406489|NCT01237223|101328432|FG002|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15||
48406490|NCT01237223|101328433|FG003|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5||
48406491|NCT01237223|101328434|FG004|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||4||
48406492|NCT01237223|101328435|FG005|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5||
48610223|NCT01471444|101830369|FG001|COMPLETED|Overall Study||120||
48152818|NCT04026165|100696104|FG001|NOT COMPLETED|Run-in Placebo Period||0||
48152819|NCT04026165|100696105|FG002|NOT COMPLETED|Run-in Placebo Period||0||
48152820|NCT04026165|100696106|FG003|NOT COMPLETED|Run-in Placebo Period||0||
48152821|NCT04026165|100696103|FG000|STARTED|Run-in SEL Period||0||
48152822|NCT04026165|100696104|FG001|STARTED|Run-in SEL Period||357||
48152823|NCT04026165|100696105|FG002|STARTED|Run-in SEL Period||0||
48152824|NCT04026165|100696106|FG003|STARTED|Run-in SEL Period||0||
48152825|NCT04026165|100696103|FG000|COMPLETED|Run-in SEL Period||0||
48152826|NCT04026165|100696104|FG001|COMPLETED|Run-in SEL Period||311||
48610224|NCT01471444|101830368|FG000|NOT COMPLETED|Overall Study||3||
48610225|NCT01471444|101830369|FG001|NOT COMPLETED|Overall Study||3||
48152827|NCT04026165|100696105|FG002|COMPLETED|Run-in SEL Period||0||
48152828|NCT04026165|100696106|FG003|COMPLETED|Run-in SEL Period||0||
48152829|NCT04026165|100696103|FG000|NOT COMPLETED|Run-in SEL Period||0||
48152830|NCT04026165|100696104|FG001|NOT COMPLETED|Run-in SEL Period||46||
48152831|NCT04026165|100696105|FG002|NOT COMPLETED|Run-in SEL Period||0||
48152832|NCT04026165|100696106|FG003|NOT COMPLETED|Run-in SEL Period||0||
48152833|NCT04026165|100696103|FG000|STARTED|Randomized Period||0||
48152834|NCT04026165|100696104|FG001|STARTED|Randomized Period||0||
48152835|NCT04026165|100696105|FG002|STARTED|Randomized Period||154||
48152836|NCT04026165|100696106|FG003|STARTED|Randomized Period||156||
48152837|NCT04026165|100696103|FG000|COMPLETED|Randomized Period||0||
48152838|NCT04026165|100696104|FG001|COMPLETED|Randomized Period||0||
48152839|NCT04026165|100696105|FG002|COMPLETED|Randomized Period||140||
48152840|NCT04026165|100696106|FG003|COMPLETED|Randomized Period||137||
48152841|NCT04026165|100696103|FG000|NOT COMPLETED|Randomized Period||0||
48152842|NCT04026165|100696104|FG001|NOT COMPLETED|Randomized Period||0||
48152843|NCT04026165|100696105|FG002|NOT COMPLETED|Randomized Period||14||
48152844|NCT04026165|100696106|FG003|NOT COMPLETED|Randomized Period||19||
48152845|NCT00522626|100696107|FG000|STARTED|Overall Study||19||
48152846|NCT00522626|100696107|FG000|COMPLETED|Overall Study||12||
48152847|NCT00522626|100696107|FG000|NOT COMPLETED|Overall Study||7||
48152848|NCT01814748|100696108|FG000|STARTED|Overall Study||102||
48308173|NCT02334787|101080900|FG001|COMPLETED|Overall Study||8||
48308174|NCT02334787|101080901|FG002|COMPLETED|Overall Study||8||
48406493|NCT01010776|101328436|FG000|STARTED|Main Phase||223||
48152849|NCT01814748|100696109|FG001|STARTED|Overall Study||101||
48152850|NCT01814748|100696108|FG000|COMPLETED|Overall Study||94||
48152851|NCT01814748|100696109|FG001|COMPLETED|Overall Study||94||
48152852|NCT01814748|100696108|FG000|NOT COMPLETED|Overall Study||8||
48152853|NCT01814748|100696109|FG001|NOT COMPLETED|Overall Study||7||
48152854|NCT00789815|100696110|FG000|STARTED|Overall Study||250||
48152855|NCT00789815|100696111|FG001|STARTED|Overall Study||250||
48152856|NCT00789815|100696110|FG000|COMPLETED|Overall Study||243||
48152857|NCT00789815|100696111|FG001|COMPLETED|Overall Study||249||
48152858|NCT00789815|100696110|FG000|NOT COMPLETED|Overall Study||7||
48152859|NCT00789815|100696111|FG001|NOT COMPLETED|Overall Study||1||
48152860|NCT02563496|100696112|FG000|STARTED|Overall Study||0||
48152861|NCT02563496|100696113|FG001|STARTED|Overall Study||14||
48152862|NCT02563496|100696114|FG002|STARTED|Overall Study||5||
48152863|NCT02563496|100696115|FG003|STARTED|Overall Study||22||
48152864|NCT02563496|100696116|FG004|STARTED|Overall Study||19||
48152865|NCT02563496|100696112|FG000|COMPLETED|Overall Study||0||
48152866|NCT02563496|100696113|FG001|COMPLETED|Overall Study||14||
48152867|NCT02563496|100696114|FG002|COMPLETED|Overall Study||5||
48152868|NCT02563496|100696115|FG003|COMPLETED|Overall Study||22||
48152869|NCT02563496|100696116|FG004|COMPLETED|Overall Study||19||
48152870|NCT02563496|100696112|FG000|NOT COMPLETED|Overall Study||0||
48152871|NCT02563496|100696113|FG001|NOT COMPLETED|Overall Study||0||
48152872|NCT02563496|100696114|FG002|NOT COMPLETED|Overall Study||0||
48152873|NCT02563496|100696115|FG003|NOT COMPLETED|Overall Study||0||
48152874|NCT02563496|100696116|FG004|NOT COMPLETED|Overall Study||0||
48152875|NCT01474213|100696117|FG000|STARTED|Overall Study||20||
48152876|NCT01474213|100696118|FG001|STARTED|Overall Study||20||
48152877|NCT01474213|100696117|FG000|COMPLETED|Overall Study||20||
48152878|NCT01474213|100696118|FG001|COMPLETED|Overall Study||20||
48152879|NCT01474213|100696117|FG000|NOT COMPLETED|Overall Study||0||
48152880|NCT01474213|100696118|FG001|NOT COMPLETED|Overall Study||0||
48152881|NCT00335452|100696119|FG000|STARTED|Overall Study||6312||
48152882|NCT00335452|100696120|FG001|STARTED|Overall Study||6254||
48152883|NCT00335452|100696121|FG002|STARTED|Overall Study||6267||
48152884|NCT00335452|100696122|FG003|STARTED|Overall Study||6253||
48152885|NCT00335452|100696119|FG000|TREATED WITH CLOPIDOGREL|Overall Study||6271||
48152886|NCT00335452|100696120|FG001|TREATED WITH CLOPIDOGREL|Overall Study||6218||
48152887|NCT00335452|100696121|FG002|TREATED WITH CLOPIDOGREL|Overall Study||6228||
48152888|NCT00335452|100696122|FG003|TREATED WITH CLOPIDOGREL|Overall Study||6217||
48152889|NCT00335452|100696119|FG000|TREATED WITH ASA|Overall Study||6302||
48152890|NCT00335452|100696120|FG001|TREATED WITH ASA|Overall Study||6251||
48152891|NCT00335452|100696121|FG002|TREATED WITH ASA|Overall Study||6261||
48152892|NCT00335452|100696122|FG003|TREATED WITH ASA|Overall Study||6247||
48152893|NCT00335452|100696119|FG000|COMPLETED|Overall Study||6154||
48152894|NCT00335452|100696120|FG001|COMPLETED|Overall Study||6107||
48152895|NCT00335452|100696121|FG002|COMPLETED|Overall Study||6108||
48152896|NCT00335452|100696122|FG003|COMPLETED|Overall Study||6122||
48152897|NCT00335452|100696119|FG000|NOT COMPLETED|Overall Study||158||
48152898|NCT00335452|100696120|FG001|NOT COMPLETED|Overall Study||147||
48152899|NCT00335452|100696121|FG002|NOT COMPLETED|Overall Study||159||
48152900|NCT00335452|100696122|FG003|NOT COMPLETED|Overall Study||131||
48152901|NCT05072457|100696123|FG000|STARTED|Overall Study||10||
48152902|NCT05072457|100696123|FG000|COMPLETED|Overall Study||10||
48152903|NCT05072457|100696123|FG000|NOT COMPLETED|Overall Study||0||
48308175|NCT02334787|101080902|FG003|COMPLETED|Overall Study||8||
48308176|NCT02334787|101080899|FG000|NOT COMPLETED|Overall Study||0||
48152904|NCT02623322|100696124|FG000|STARTED|Overall Study||43||
48152905|NCT02623322|100696125|FG001|STARTED|Overall Study||41||
48152906|NCT02623322|100696126|FG002|STARTED|Overall Study||40||
48152907|NCT02623322|100696124|FG000|COMPLETED|Overall Study||41||
48152908|NCT02623322|100696125|FG001|COMPLETED|Overall Study||40||
48152909|NCT02623322|100696126|FG002|COMPLETED|Overall Study||40||
48152910|NCT02623322|100696124|FG000|NOT COMPLETED|Overall Study||2||
48152911|NCT02623322|100696125|FG001|NOT COMPLETED|Overall Study||1||
48152912|NCT02623322|100696126|FG002|NOT COMPLETED|Overall Study||0||
48610226|NCT02072941|101830370|FG000|STARTED|Overall Study||219||
48610227|NCT02072941|101830371|FG001|STARTED|Overall Study||226||
48610228|NCT02072941|101830370|FG000|COMPLETED|Overall Study||181||
48610229|NCT02072941|101830371|FG001|COMPLETED|Overall Study||197||
48610230|NCT02072941|101830370|FG000|NOT COMPLETED|Overall Study||38||
48610231|NCT02072941|101830371|FG001|NOT COMPLETED|Overall Study||29||
48610232|NCT02819440|101830372|FG000|STARTED|Overall Study||61||
48610233|NCT02819440|101830373|FG001|STARTED|Overall Study||64||
48308177|NCT02334787|101080900|FG001|NOT COMPLETED|Overall Study||0||
48308178|NCT02334787|101080901|FG002|NOT COMPLETED|Overall Study||0||
48308179|NCT02334787|101080902|FG003|NOT COMPLETED|Overall Study||0||
48308180|NCT00886704|101080903|FG000|STARTED|Overall Study||40||
48308181|NCT00886704|101080904|FG001|STARTED|Overall Study||10||
48308182|NCT00886704|101080903|FG000|COMPLETED|Overall Study||40||
48610234|NCT02819440|101830372|FG000|COMPLETED|Overall Study||48||
48610235|NCT02819440|101830373|FG001|COMPLETED|Overall Study||52||
48610236|NCT02819440|101830372|FG000|NOT COMPLETED|Overall Study||13||
48610237|NCT02819440|101830373|FG001|NOT COMPLETED|Overall Study||12||
48610238|NCT04501952|101830374|FG000|STARTED|Overall Study||292||
48610239|NCT04501952|101830375|FG001|STARTED|Overall Study||292||
48610240|NCT04501952|101830374|FG000|COMPLETED|Overall Study||266||
48610241|NCT04501952|101830375|FG001|COMPLETED|Overall Study||272||
48610242|NCT04501952|101830374|FG000|NOT COMPLETED|Overall Study||26||
48610243|NCT04501952|101830375|FG001|NOT COMPLETED|Overall Study||20||
48610244|NCT03504189|101830376|FG000|STARTED|Overall Study||151||
48610245|NCT03504189|101830376|FG000|COMPLETED|Overall Study||147||
48610246|NCT03504189|101830376|FG000|NOT COMPLETED|Overall Study||4||
48610247|NCT03061188|101830377|FG000|STARTED|Completed 1st Cycle||0|The starting dose (Cohort 1) was not de-escalated.|
48610248|NCT03061188|101830378|FG001|STARTED|Completed 1st Cycle||3|The starting dose (Cohort 1) was not de-escalated.|
48722596|NCT01641822|102108191|FG001|COMPLETED|Comparative Phase||37||
48610249|NCT03061188|101830379|FG002|STARTED|Completed 1st Cycle||6|The starting dose (Cohort 1) was not de-escalated.|
48610250|NCT03061188|101830380|FG003|STARTED|Completed 1st Cycle||6|The starting dose (Cohort 1) was not de-escalated.|
48610251|NCT03061188|101830377|FG000|COMPLETED|Completed 1st Cycle||0||
48610252|NCT03061188|101830378|FG001|COMPLETED|Completed 1st Cycle||3||
48610253|NCT03061188|101830379|FG002|COMPLETED|Completed 1st Cycle||6||
48610254|NCT03061188|101830380|FG003|COMPLETED|Completed 1st Cycle||6||
48610255|NCT03061188|101830377|FG000|NOT COMPLETED|Completed 1st Cycle||0||
48610256|NCT03061188|101830378|FG001|NOT COMPLETED|Completed 1st Cycle||0||
48610257|NCT03061188|101830379|FG002|NOT COMPLETED|Completed 1st Cycle||0||
48610258|NCT03061188|101830380|FG003|NOT COMPLETED|Completed 1st Cycle||0||
48610259|NCT03061188|101830377|FG000|STARTED|Went on to Cycle 2 and Beyond||0|The starting dose (Cohort 1) was not de-escalated.|
48610260|NCT03061188|101830378|FG001|STARTED|Went on to Cycle 2 and Beyond||3|The starting dose (Cohort 1) was not de-escalated.|
48610261|NCT03061188|101830379|FG002|STARTED|Went on to Cycle 2 and Beyond||6|The starting dose (Cohort 1) was not de-escalated.|
48610262|NCT03061188|101830380|FG003|STARTED|Went on to Cycle 2 and Beyond||6|The starting dose (Cohort 1) was not de-escalated.|
48610263|NCT03061188|101830377|FG000|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||0||
48610264|NCT03061188|101830378|FG001|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||3||
48610265|NCT03061188|101830379|FG002|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||5||
48610266|NCT03061188|101830380|FG003|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||5||
48610267|NCT03061188|101830377|FG000|COMPLETED|Went on to Cycle 2 and Beyond||0||
48610268|NCT03061188|101830378|FG001|COMPLETED|Went on to Cycle 2 and Beyond||3||
48610269|NCT03061188|101830379|FG002|COMPLETED|Went on to Cycle 2 and Beyond||5||
48610270|NCT03061188|101830380|FG003|COMPLETED|Went on to Cycle 2 and Beyond||5||
48610271|NCT03061188|101830377|FG000|NOT COMPLETED|Went on to Cycle 2 and Beyond||0||
48610272|NCT03061188|101830378|FG001|NOT COMPLETED|Went on to Cycle 2 and Beyond||0||
48610273|NCT03061188|101830379|FG002|NOT COMPLETED|Went on to Cycle 2 and Beyond||1||
48610274|NCT03061188|101830380|FG003|NOT COMPLETED|Went on to Cycle 2 and Beyond||1||
48610275|NCT03061188|101830377|FG000|STARTED|On Follow-up for 3 Years||0|The starting dose (Cohort 1) was not de-escalated.|
48610276|NCT03061188|101830378|FG001|STARTED|On Follow-up for 3 Years||3|The starting dose (Cohort 1) was not de-escalated.|
48610277|NCT03061188|101830379|FG002|STARTED|On Follow-up for 3 Years||6|The starting dose (Cohort 1) was not de-escalated.|
48610278|NCT03061188|101830380|FG003|STARTED|On Follow-up for 3 Years||6|The starting dose (Cohort 1) was not de-escalated.|
48610279|NCT03061188|101830377|FG000|COMPLETED|On Follow-up for 3 Years||0||
48610280|NCT03061188|101830378|FG001|COMPLETED|On Follow-up for 3 Years||0||
48308183|NCT00886704|101080904|FG001|COMPLETED|Overall Study||10||
48308184|NCT00886704|101080903|FG000|NOT COMPLETED|Overall Study||0||
48308185|NCT00886704|101080904|FG001|NOT COMPLETED|Overall Study||0||
48308186|NCT01519934|101080905|FG000|STARTED|Overall Study||48||
48308187|NCT01519934|101080905|FG000|COMPLETED|Overall Study||45||
48308188|NCT01519934|101080905|FG000|NOT COMPLETED|Overall Study||3||
48308189|NCT00882310|101080906|FG000|STARTED|Overall Study||37||
48308190|NCT00882310|101080906|FG000|COMPLETED|Overall Study||15||
48308191|NCT00882310|101080906|FG000|NOT COMPLETED|Overall Study||22||
48308192|NCT01826851|101080907|FG000|STARTED|Overall Study||38||
48308193|NCT01826851|101080908|FG001|STARTED|Overall Study||41||
48308194|NCT01826851|101080907|FG000|COMPLETED|Overall Study||38||
48308195|NCT01826851|101080908|FG001|COMPLETED|Overall Study||41||
48308196|NCT01826851|101080907|FG000|NOT COMPLETED|Overall Study||0||
48308197|NCT01826851|101080908|FG001|NOT COMPLETED|Overall Study||0||
48308198|NCT04415658|101080909|FG000|STARTED|Initial Study Period (12 Hours)||419||
48308199|NCT04415658|101080910|FG001|STARTED|Initial Study Period (12 Hours)||419||
48308200|NCT04415658|101080909|FG000|Started Assigned Infusion|Initial Study Period (12 Hours)||411||
48308201|NCT04415658|101080910|FG001|Started Assigned Infusion|Initial Study Period (12 Hours)||384||
48308202|NCT04415658|101080909|FG000|Per-Protocol|Initial Study Period (12 Hours)||351|Received assigned intervention for at least six hours|
48308203|NCT04415658|101080910|FG001|Per-Protocol|Initial Study Period (12 Hours)||374|Received assigned intervention for at least six hours|
48308204|NCT04415658|101080909|FG000|Cross-over|Initial Study Period (12 Hours)||0|Crossed-over to other intervention within 12 hours|
48308205|NCT04415658|101080910|FG001|Cross-over|Initial Study Period (12 Hours)||3|Crossed-over to other intervention within 12 hours|
48308206|NCT04415658|101080909|FG000|Stopped Infusion Early|Initial Study Period (12 Hours)||86||
48308207|NCT04415658|101080910|FG001|Stopped Infusion Early|Initial Study Period (12 Hours)||0||
48610281|NCT03061188|101830379|FG002|COMPLETED|On Follow-up for 3 Years||1||
48610282|NCT03061188|101830380|FG003|COMPLETED|On Follow-up for 3 Years||1||
48610283|NCT03061188|101830377|FG000|NOT COMPLETED|On Follow-up for 3 Years||0||
48610284|NCT03061188|101830378|FG001|NOT COMPLETED|On Follow-up for 3 Years||3||
48610285|NCT03061188|101830379|FG002|NOT COMPLETED|On Follow-up for 3 Years||5||
48610286|NCT03061188|101830380|FG003|NOT COMPLETED|On Follow-up for 3 Years||5||
48610287|NCT00869128|101830381|FG000|STARTED|Overall Study||18||
48610288|NCT00869128|101830382|FG001|STARTED|Overall Study||18||
48610289|NCT00869128|101830381|FG000|COMPLETED|Overall Study||12||
48610290|NCT00869128|101830382|FG001|COMPLETED|Overall Study||12||
48610291|NCT00869128|101830381|FG000|NOT COMPLETED|Overall Study||6||
48610292|NCT00869128|101830382|FG001|NOT COMPLETED|Overall Study||6||
48610293|NCT02371876|101830383|FG000|STARTED|Overall Study||134||
48610294|NCT02371876|101830383|FG000|COMPLETED|Overall Study||134||
48610295|NCT02371876|101830383|FG000|NOT COMPLETED|Overall Study||0||
48610296|NCT00565604|101830384|FG000|STARTED|Overall Study||43||
48610297|NCT00565604|101830384|FG000|7 Day|Overall Study||41||
48610298|NCT00565604|101830384|FG000|2 Week|Overall Study||41||
48610299|NCT00565604|101830384|FG000|6 Week|Overall Study||39||
48610300|NCT00565604|101830384|FG000|6 Month|Overall Study||39||
48610301|NCT00565604|101830384|FG000|COMPLETED|Overall Study||39||
48610302|NCT00565604|101830384|FG000|NOT COMPLETED|Overall Study||4||
48610303|NCT01843803|101830385|FG000|STARTED|Overall Study||137||
48610304|NCT01843803|101830386|FG001|STARTED|Overall Study||139||
48610305|NCT01843803|101830385|FG000|COMPLETED|Overall Study||136||
48610306|NCT01843803|101830386|FG001|COMPLETED|Overall Study||136||
48610307|NCT01843803|101830385|FG000|NOT COMPLETED|Overall Study||1||
48610308|NCT01843803|101830386|FG001|NOT COMPLETED|Overall Study||3||
48722597|NCT01641822|102108192|FG002|COMPLETED|Comparative Phase||37||
48308208|NCT04415658|101080909|FG000|COMPLETED|Initial Study Period (12 Hours)||333|Refers to completing donor care, with organ allocation outcomes available|
48308209|NCT04415658|101080910|FG001|COMPLETED|Initial Study Period (12 Hours)||416|Refers to completing donor care, with organ allocation outcomes available|
48308210|NCT04415658|101080909|FG000|NOT COMPLETED|Initial Study Period (12 Hours)||86||
48308211|NCT04415658|101080910|FG001|NOT COMPLETED|Initial Study Period (12 Hours)||3||
48308212|NCT04415658|101080909|FG000|STARTED|Open-Label (T4 Beyond 12 Hours)||333|Total number of donors eligible to receive open-label|
48308213|NCT04415658|101080910|FG001|STARTED|Open-Label (T4 Beyond 12 Hours)||416|Total number of donors eligible to receive open-label|
48610309|NCT00460239|101830387|FG000|STARTED|Overall Study||0||
48610310|NCT00460239|101830388|FG001|STARTED|Overall Study||3||
48610311|NCT00460239|101830389|FG002|STARTED|Overall Study||1||
48308214|NCT04415658|101080909|FG000|COMPLETED|Open-Label (T4 Beyond 12 Hours)||209|number who received thyroxine infusion beyond initial 12-hour study period|
48308215|NCT04415658|101080910|FG001|COMPLETED|Open-Label (T4 Beyond 12 Hours)||50|number who received thyroxine infusion beyond initial 12-hour study period|
48308216|NCT04415658|101080909|FG000|NOT COMPLETED|Open-Label (T4 Beyond 12 Hours)||124||
48308217|NCT04415658|101080910|FG001|NOT COMPLETED|Open-Label (T4 Beyond 12 Hours)||366||
48308218|NCT02129205|101080911|FG000|STARTED|Overall Study||2||
48308219|NCT02129205|101080912|FG001|STARTED|Overall Study||2||
48308220|NCT02129205|101080913|FG002|STARTED|Overall Study||2||
48308221|NCT02129205|101080914|FG003|STARTED|Overall Study||2||
48308222|NCT02129205|101080915|FG004|STARTED|Overall Study||7||
48308223|NCT02129205|101080916|FG005|STARTED|Overall Study||11||
48308224|NCT02129205|101080917|FG006|STARTED|Overall Study||6||
48308225|NCT02129205|101080918|FG007|STARTED|Overall Study||6||
48308226|NCT02129205|101080919|FG008|STARTED|Overall Study||2||
48308227|NCT02129205|101080920|FG009|STARTED|Overall Study||0||
48722598|NCT01641822|102108190|FG000|NOT COMPLETED|Comparative Phase||0||
48722599|NCT01641822|102108191|FG001|NOT COMPLETED|Comparative Phase||6||
48722600|NCT01641822|102108192|FG002|NOT COMPLETED|Comparative Phase||10||
48722601|NCT01818492|102108193|FG000|STARTED|Overall Study||45||
48722602|NCT01818492|102108193|FG000|COMPLETED|Overall Study||35||
48722603|NCT01818492|102108193|FG000|NOT COMPLETED|Overall Study||10||
48722604|NCT02613169|102108194|FG000|STARTED|Overall Study||150||
48722605|NCT02613169|102108195|FG001|STARTED|Overall Study||150||
48308228|NCT02129205|101080911|FG000|COMPLETED|Overall Study||1||
48308229|NCT02129205|101080912|FG001|COMPLETED|Overall Study||2||
48308230|NCT02129205|101080913|FG002|COMPLETED|Overall Study||2||
48308231|NCT02129205|101080914|FG003|COMPLETED|Overall Study||2||
48308232|NCT02129205|101080915|FG004|COMPLETED|Overall Study||4||
48308233|NCT02129205|101080916|FG005|COMPLETED|Overall Study||7||
48308234|NCT02129205|101080917|FG006|COMPLETED|Overall Study||2||
48308235|NCT02129205|101080918|FG007|COMPLETED|Overall Study||4||
48308236|NCT02129205|101080919|FG008|COMPLETED|Overall Study||0||
48308237|NCT02129205|101080920|FG009|COMPLETED|Overall Study||0||
48308238|NCT02129205|101080911|FG000|NOT COMPLETED|Overall Study||1||
48308239|NCT02129205|101080912|FG001|NOT COMPLETED|Overall Study||0||
48610312|NCT00460239|101830390|FG003|STARTED|Overall Study||0||
48610313|NCT00460239|101830391|FG004|STARTED|Overall Study||1||
48610314|NCT00460239|101830392|FG005|STARTED|Overall Study||4||
48610315|NCT00460239|101830393|FG006|STARTED|Overall Study||1||
48610316|NCT00460239|101830394|FG007|STARTED|Overall Study||1||
48610317|NCT00460239|101830395|FG008|STARTED|Overall Study||1||
48610318|NCT00460239|101830387|FG000|COMPLETED|Overall Study||0||
48610319|NCT00460239|101830388|FG001|COMPLETED|Overall Study||2||
48610320|NCT00460239|101830389|FG002|COMPLETED|Overall Study||1||
48610321|NCT00460239|101830390|FG003|COMPLETED|Overall Study||0||
48610322|NCT00460239|101830391|FG004|COMPLETED|Overall Study||1||
48308240|NCT02129205|101080913|FG002|NOT COMPLETED|Overall Study||0||
48308241|NCT02129205|101080914|FG003|NOT COMPLETED|Overall Study||0||
48308242|NCT02129205|101080915|FG004|NOT COMPLETED|Overall Study||3||
48308243|NCT02129205|101080916|FG005|NOT COMPLETED|Overall Study||4||
48308244|NCT02129205|101080917|FG006|NOT COMPLETED|Overall Study||4||
48308245|NCT02129205|101080918|FG007|NOT COMPLETED|Overall Study||2||
48308246|NCT02129205|101080919|FG008|NOT COMPLETED|Overall Study||2||
48308247|NCT02129205|101080920|FG009|NOT COMPLETED|Overall Study||0||
48308248|NCT01191541|101080921|FG000|STARTED|All the Patients||30||
48308249|NCT01191541|101080922|FG001|STARTED|All the Patients||35||
48308250|NCT01191541|101080921|FG000|COMPLETED|All the Patients||30||
48308251|NCT01191541|101080922|FG001|COMPLETED|All the Patients||35||
48308252|NCT01191541|101080921|FG000|NOT COMPLETED|All the Patients||0||
48308253|NCT01191541|101080922|FG001|NOT COMPLETED|All the Patients||0||
48308254|NCT01191541|101080921|FG000|STARTED|the Randomized Patients||30||
48308255|NCT01191541|101080922|FG001|STARTED|the Randomized Patients||35||
48308256|NCT01191541|101080921|FG000|COMPLETED|the Randomized Patients||30||
48308257|NCT01191541|101080922|FG001|COMPLETED|the Randomized Patients||35||
48308258|NCT01191541|101080921|FG000|NOT COMPLETED|the Randomized Patients||0||
48308259|NCT01191541|101080922|FG001|NOT COMPLETED|the Randomized Patients||0||
48308260|NCT03319407|101080923|FG000|STARTED|Overall Study||21||
48308261|NCT03319407|101080923|FG000|COMPLETED|Overall Study||0||
48308262|NCT03319407|101080923|FG000|NOT COMPLETED|Overall Study||21||
48308263|NCT04784897|101080924|FG000|STARTED|Overall Study||60||
48308264|NCT04784897|101080925|FG001|STARTED|Overall Study||16||
48308265|NCT04784897|101080926|FG002|STARTED|Overall Study||44||
48610323|NCT00460239|101830392|FG005|COMPLETED|Overall Study||1||
48610324|NCT00460239|101830393|FG006|COMPLETED|Overall Study||1||
48308266|NCT04784897|101080924|FG000|COMPLETED|Overall Study||56||
48308267|NCT04784897|101080925|FG001|COMPLETED|Overall Study||14||
48308268|NCT04784897|101080926|FG002|COMPLETED|Overall Study||42||
48308269|NCT04784897|101080924|FG000|NOT COMPLETED|Overall Study||4||
48610325|NCT00460239|101830394|FG007|COMPLETED|Overall Study||1||
48722606|NCT02613169|102108194|FG000|COMPLETED|Overall Study||132||
48722607|NCT02613169|102108195|FG001|COMPLETED|Overall Study||133||
48722608|NCT02613169|102108194|FG000|NOT COMPLETED|Overall Study||18||
48722609|NCT02613169|102108195|FG001|NOT COMPLETED|Overall Study||17||
48722610|NCT01176565|102108196|FG000|STARTED|Overall Study||500||
48722611|NCT01176565|102108197|FG001|STARTED|Overall Study||500||
48722612|NCT01176565|102108196|FG000|COMPLETED|Overall Study||480||
48722613|NCT01176565|102108197|FG001|COMPLETED|Overall Study||481||
48722614|NCT01176565|102108196|FG000|NOT COMPLETED|Overall Study||20||
48722615|NCT01176565|102108197|FG001|NOT COMPLETED|Overall Study||19||
48722616|NCT02228096|102108198|FG000|STARTED|Overall Study||75||
48722617|NCT02228096|102108198|FG000|Enrolled Into Long-term f/u Protocol|Overall Study||31||
48722618|NCT02228096|102108198|FG000|Enrolled But Not Infused|Overall Study||11|Enrolled means all eligibility criteria were met \& apheresis was accepted by manufacturing facility|
48722619|NCT02228096|102108198|FG000|Enrolled and Infused|Overall Study||64||
48722620|NCT02228096|102108198|FG000|COMPLETED|Overall Study||4||
48308270|NCT04784897|101080925|FG001|NOT COMPLETED|Overall Study||2||
48308271|NCT04784897|101080926|FG002|NOT COMPLETED|Overall Study||2||
48308272|NCT03838198|101080927|FG000|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0||
48308273|NCT03838198|101080928|FG001|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40||
48308274|NCT03838198|101080929|FG002|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0||
48308275|NCT03838198|101080930|FG003|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40||
48308276|NCT03838198|101080927|FG000|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0||
48406494|NCT01010776|101328436|FG000|Treated|Main Phase||218||
48610326|NCT00460239|101830395|FG008|COMPLETED|Overall Study||1||
48610327|NCT00460239|101830387|FG000|NOT COMPLETED|Overall Study||0||
48610328|NCT00460239|101830388|FG001|NOT COMPLETED|Overall Study||1||
48610329|NCT00460239|101830389|FG002|NOT COMPLETED|Overall Study||0||
48610330|NCT00460239|101830390|FG003|NOT COMPLETED|Overall Study||0||
48610331|NCT00460239|101830391|FG004|NOT COMPLETED|Overall Study||0||
48610332|NCT00460239|101830392|FG005|NOT COMPLETED|Overall Study||3||
48610333|NCT00460239|101830393|FG006|NOT COMPLETED|Overall Study||0||
48610334|NCT00460239|101830394|FG007|NOT COMPLETED|Overall Study||0||
48152913|NCT00590902|100696127|FG000|STARTED|Overall Study||81||
48152914|NCT00590902|100696127|FG000|COMPLETED|Overall Study||80||
48610335|NCT00460239|101830395|FG008|NOT COMPLETED|Overall Study||0||
48610336|NCT01765569|101830396|FG000|STARTED|Period A||29||
48610337|NCT01765569|101830396|FG000|COMPLETED|Period A||29||
48152915|NCT00590902|100696127|FG000|NOT COMPLETED|Overall Study||1||
48152916|NCT05099926|100696128|FG000|STARTED|Overall Study||4||
48152917|NCT05099926|100696128|FG000|COMPLETED|Overall Study||3||
48152918|NCT05099926|100696128|FG000|NOT COMPLETED|Overall Study||1||
48152919|NCT01783418|100696129|FG000|STARTED|Overall Study||8||
48308277|NCT03838198|101080928|FG001|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40||
48610338|NCT01765569|101830396|FG000|NOT COMPLETED|Period A||0||
48610339|NCT01765569|101830396|FG000|STARTED|Period B||29||
48152920|NCT01783418|100696130|FG001|STARTED|Overall Study||6||
48308278|NCT03838198|101080929|FG002|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0||
48308279|NCT03838198|101080930|FG003|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40||
48308280|NCT03838198|101080927|FG000|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0||
48308281|NCT03838198|101080928|FG001|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0||
48308282|NCT03838198|101080929|FG002|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0||
48610340|NCT01765569|101830396|FG000|COMPLETED|Period B||28||
48610341|NCT01765569|101830396|FG000|NOT COMPLETED|Period B||1||
48610342|NCT01765569|101830396|FG000|STARTED|Period C||28||
48610343|NCT01765569|101830396|FG000|COMPLETED|Period C||27||
48610344|NCT01765569|101830396|FG000|NOT COMPLETED|Period C||1||
48610345|NCT01110967|101830397|FG000|STARTED|Overall Study||40||
48610346|NCT01110967|101830397|FG000|Surgery|Overall Study||40||
48610347|NCT01110967|101830397|FG000|1 Month Follow up|Overall Study||26||
48610348|NCT01110967|101830397|FG000|3 Months Follow up|Overall Study||28||
48610349|NCT01110967|101830397|FG000|6 Months Follow up|Overall Study||24||
48610350|NCT01110967|101830397|FG000|12 Months Follow up|Overall Study||31||
48610351|NCT01110967|101830397|FG000|COMPLETED|Overall Study||31||
48610352|NCT01110967|101830397|FG000|NOT COMPLETED|Overall Study||9||
48610353|NCT02934555|101830398|FG000|STARTED|Overall Study||23||
48610354|NCT02934555|101830399|FG001|STARTED|Overall Study||25||
48610355|NCT02934555|101830398|FG000|COMPLETED|Overall Study||21|Endpoint measurements available|
48610356|NCT02934555|101830399|FG001|COMPLETED|Overall Study||22|Endpoint measurements available|
48610357|NCT02934555|101830398|FG000|NOT COMPLETED|Overall Study||2||
48610358|NCT02934555|101830399|FG001|NOT COMPLETED|Overall Study||3||
48610359|NCT03304106|101830400|FG000|STARTED|Overall Study||44||
48610360|NCT03304106|101830401|FG001|STARTED|Overall Study||58||
48610361|NCT03304106|101830400|FG000|COMPLETED|Overall Study||31||
48610362|NCT03304106|101830401|FG001|COMPLETED|Overall Study||56||
48610363|NCT03304106|101830400|FG000|NOT COMPLETED|Overall Study||13||
48610364|NCT03304106|101830401|FG001|NOT COMPLETED|Overall Study||2||
48610365|NCT00657657|101830402|FG000|STARTED|Overall Study||29||
48610366|NCT00657657|101830402|FG000|COMPLETED|Overall Study||29||
48610367|NCT00657657|101830402|FG000|NOT COMPLETED|Overall Study||0||
48610368|NCT03159299|101830403|FG000|STARTED|Overall Study||26||
48610369|NCT03159299|101830404|FG001|STARTED|Overall Study||21||
48610370|NCT03159299|101830403|FG000|COMPLETED|Overall Study||24||
48610371|NCT03159299|101830404|FG001|COMPLETED|Overall Study||20||
48308283|NCT03838198|101080930|FG003|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0||
48308284|NCT03838198|101080927|FG000|STARTED|Phase 2: Added Booster Call or Not||18|Started here means randomized in Phase 2 to either booster call or no booster call.|
48308285|NCT03838198|101080928|FG001|STARTED|Phase 2: Added Booster Call or Not||22|Started here means randomized in Phase 2 to either booster call or no booster call.|
48308286|NCT03838198|101080929|FG002|STARTED|Phase 2: Added Booster Call or Not||18|Started here means randomized in Phase 2 to either booster call or no booster call.|
48308287|NCT03838198|101080930|FG003|STARTED|Phase 2: Added Booster Call or Not||22|Started here means randomized in Phase 2 to either booster call or no booster call.|
48308288|NCT03838198|101080927|FG000|COMPLETED|Phase 2: Added Booster Call or Not||18||
48308289|NCT03838198|101080928|FG001|COMPLETED|Phase 2: Added Booster Call or Not||0||
48308290|NCT03838198|101080929|FG002|COMPLETED|Phase 2: Added Booster Call or Not||17||
48308291|NCT03838198|101080930|FG003|COMPLETED|Phase 2: Added Booster Call or Not||0||
48308292|NCT03838198|101080927|FG000|NOT COMPLETED|Phase 2: Added Booster Call or Not||0||
48610372|NCT03159299|101830403|FG000|NOT COMPLETED|Overall Study||2||
48610373|NCT03159299|101830404|FG001|NOT COMPLETED|Overall Study||1||
48610374|NCT00391872|101830405|FG000|STARTED|Overall Study||9333||
48610375|NCT00391872|101830406|FG001|STARTED|Overall Study||9291||
48610376|NCT00391872|101830405|FG000|COMPLETED|Overall Study||9026||
48610377|NCT00391872|101830406|FG001|COMPLETED|Overall Study||9036||
48610378|NCT00391872|101830405|FG000|NOT COMPLETED|Overall Study||307||
48610379|NCT00391872|101830406|FG001|NOT COMPLETED|Overall Study||255||
48610380|NCT01888952|101830407|FG000|STARTED|Overall Study||10||
48610381|NCT01888952|101830407|FG000|COMPLETED|Overall Study||10||
48610382|NCT01888952|101830407|FG000|NOT COMPLETED|Overall Study||0||
48610383|NCT03774888|101830408|FG000|STARTED|Overall Study||8||13
48610384|NCT03774888|101830409|FG001|STARTED|Overall Study||8||16
48610385|NCT03774888|101830410|FG002|STARTED|Overall Study||8||12
48610386|NCT03774888|101830408|FG000|COMPLETED|Overall Study||8||13
48610387|NCT03774888|101830409|FG001|COMPLETED|Overall Study||8||16
48610388|NCT03774888|101830410|FG002|COMPLETED|Overall Study||8||12
48610389|NCT03774888|101830408|FG000|NOT COMPLETED|Overall Study||0||0
48610390|NCT03774888|101830409|FG001|NOT COMPLETED|Overall Study||0||0
48610391|NCT03774888|101830410|FG002|NOT COMPLETED|Overall Study||0||0
48610392|NCT04035499|101830411|FG000|STARTED|Overall Study||25||
48610393|NCT04035499|101830411|FG000|COMPLETED|Overall Study||22||
48610394|NCT04035499|101830411|FG000|NOT COMPLETED|Overall Study||3||
48610395|NCT04693078|101830412|FG000|STARTED|Overall Study||100||
48610396|NCT04693078|101830412|FG000|COMPLETED|Overall Study||100||
48610397|NCT04693078|101830412|FG000|NOT COMPLETED|Overall Study||0||
48610398|NCT00810498|101830413|FG000|STARTED|Overall Study||6||
48610399|NCT00810498|101830414|FG001|STARTED|Overall Study||5||
48610400|NCT00810498|101830413|FG000|COMPLETED|Overall Study||6||
48610401|NCT00810498|101830414|FG001|COMPLETED|Overall Study||5||
48308293|NCT03838198|101080928|FG001|NOT COMPLETED|Phase 2: Added Booster Call or Not||22||
48308294|NCT03838198|101080929|FG002|NOT COMPLETED|Phase 2: Added Booster Call or Not||1||
48308295|NCT03838198|101080930|FG003|NOT COMPLETED|Phase 2: Added Booster Call or Not||22||
48308296|NCT03838198|101080927|FG000|STARTED|1 Month Follow up Period||18||
48308297|NCT03838198|101080928|FG001|STARTED|1 Month Follow up Period||22||
48308298|NCT03838198|101080929|FG002|STARTED|1 Month Follow up Period||17||
48308299|NCT03838198|101080930|FG003|STARTED|1 Month Follow up Period||22||
48308300|NCT03838198|101080927|FG000|Adolescent Surveys Completed|1 Month Follow up Period||16||
48308301|NCT03838198|101080928|FG001|Adolescent Surveys Completed|1 Month Follow up Period||22||
48308302|NCT03838198|101080929|FG002|Adolescent Surveys Completed|1 Month Follow up Period||16||
48308303|NCT03838198|101080930|FG003|Adolescent Surveys Completed|1 Month Follow up Period||22||
48308304|NCT03838198|101080927|FG000|COMPLETED|1 Month Follow up Period||16|Completed means parent survey completed|
48308305|NCT03838198|101080928|FG001|COMPLETED|1 Month Follow up Period||22|Completed means parent survey completed|
48308306|NCT03838198|101080929|FG002|COMPLETED|1 Month Follow up Period||16|Completed means parent survey completed|
48308307|NCT03838198|101080930|FG003|COMPLETED|1 Month Follow up Period||21|Completed means parent survey completed|
48610402|NCT00810498|101830413|FG000|NOT COMPLETED|Overall Study||0||
48610403|NCT00810498|101830414|FG001|NOT COMPLETED|Overall Study||0||
48610404|NCT02697916|101830415|FG000|STARTED|Overall Study||7540||
48610405|NCT02697916|101830416|FG001|STARTED|Overall Study||7536||
48610406|NCT02697916|101830415|FG000|COMPLETED|Overall Study||6962||
48610407|NCT02697916|101830416|FG001|COMPLETED|Overall Study||6828||
48610408|NCT02697916|101830415|FG000|NOT COMPLETED|Overall Study||578||
48610409|NCT02697916|101830416|FG001|NOT COMPLETED|Overall Study||708||
48610410|NCT03107208|101830417|FG000|STARTED|Overall Study||30||
48610411|NCT03107208|101830418|FG001|STARTED|Overall Study||27||
48308308|NCT03838198|101080927|FG000|NOT COMPLETED|1 Month Follow up Period||2||
48308309|NCT03838198|101080928|FG001|NOT COMPLETED|1 Month Follow up Period||0||
48308310|NCT03838198|101080929|FG002|NOT COMPLETED|1 Month Follow up Period||1||
48308311|NCT03838198|101080930|FG003|NOT COMPLETED|1 Month Follow up Period||1||
48308312|NCT03838198|101080927|FG000|STARTED|3 Month Follow up Period||18|All participants (except the one who withdrew) were recontacted for 3 month follow up.|
48308313|NCT03838198|101080928|FG001|STARTED|3 Month Follow up Period||22|All participants (except the one who withdrew) were recontacted for 3 month follow up.|
48308314|NCT03838198|101080929|FG002|STARTED|3 Month Follow up Period||17|All participants (except the one who withdrew) were recontacted for 3 month follow up.|
48308315|NCT03838198|101080930|FG003|STARTED|3 Month Follow up Period||22|All participants (except the one who withdrew) were recontacted for 3 month follow up.|
48308316|NCT03838198|101080927|FG000|Adolescent Survey Completed|3 Month Follow up Period||16||
48308317|NCT03838198|101080928|FG001|Adolescent Survey Completed|3 Month Follow up Period||21||
48308318|NCT03838198|101080929|FG002|Adolescent Survey Completed|3 Month Follow up Period||15||
48308319|NCT03838198|101080930|FG003|Adolescent Survey Completed|3 Month Follow up Period||21||
48610412|NCT03107208|101830417|FG000|Received Intervention|Overall Study||26||
48610413|NCT03107208|101830418|FG001|Received Intervention|Overall Study||24||
48610414|NCT03107208|101830417|FG000|COMPLETED|Overall Study||26||
48610415|NCT03107208|101830418|FG001|COMPLETED|Overall Study||24||
48308320|NCT03838198|101080927|FG000|COMPLETED|3 Month Follow up Period||15|Completed means parent survey completed|
48308321|NCT03838198|101080928|FG001|COMPLETED|3 Month Follow up Period||19|Completed means parent survey completed|
48610416|NCT03107208|101830417|FG000|NOT COMPLETED|Overall Study||4||
48308322|NCT03838198|101080929|FG002|COMPLETED|3 Month Follow up Period||14|Completed means parent survey completed|
48308323|NCT03838198|101080930|FG003|COMPLETED|3 Month Follow up Period||18|Completed means parent survey completed|
48610417|NCT03107208|101830418|FG001|NOT COMPLETED|Overall Study||3||
48610418|NCT02499263|101830419|FG000|STARTED|Overall Study||146||
48610419|NCT02499263|101830419|FG000|COMPLETED|Overall Study||84||
48610420|NCT02499263|101830419|FG000|NOT COMPLETED|Overall Study||62||
48610421|NCT03085719|101830420|FG000|STARTED|Overall Study||6||
48610422|NCT03085719|101830421|FG001|STARTED|Overall Study||12||
48610423|NCT03085719|101830420|FG000|COMPLETED|Overall Study||6||
48610424|NCT03085719|101830421|FG001|COMPLETED|Overall Study||11||
48610425|NCT03085719|101830420|FG000|NOT COMPLETED|Overall Study||0||
48610426|NCT03085719|101830421|FG001|NOT COMPLETED|Overall Study||1||
48610427|NCT03665077|101830422|FG000|STARTED|Overall Study||28||
48610428|NCT03665077|101830422|FG000|3 Months Blood Draw|Overall Study||22||
48610429|NCT03665077|101830422|FG000|6 Months Blood Draw|Overall Study||24||
48610430|NCT03665077|101830422|FG000|COMPLETED|Overall Study||24||
48610431|NCT03665077|101830422|FG000|NOT COMPLETED|Overall Study||4||
48610432|NCT01472822|101830423|FG000|STARTED|Overall Study||30||
48610433|NCT01472822|101830424|FG001|STARTED|Overall Study||30||
48610434|NCT01472822|101830423|FG000|COMPLETED|Overall Study||28||
48610435|NCT01472822|101830424|FG001|COMPLETED|Overall Study||28||
48610436|NCT01472822|101830423|FG000|NOT COMPLETED|Overall Study||2||
48610437|NCT01472822|101830424|FG001|NOT COMPLETED|Overall Study||2||
48610438|NCT05612217|101830425|FG000|STARTED|Overall Study||433||
48610439|NCT05612217|101830425|FG000|COMPLETED|Overall Study||433||
48610440|NCT05612217|101830425|FG000|NOT COMPLETED|Overall Study||0||
48610441|NCT01084148|101830426|FG000|STARTED|Overall Study||118||
48610442|NCT01084148|101830427|FG001|STARTED|Overall Study||118||
48610443|NCT01084148|101830426|FG000|Treated Patients|Overall Study||118||
48610444|NCT01084148|101830427|FG001|Treated Patients|Overall Study||117||
48610445|NCT01084148|101830426|FG000|COMPLETED|Overall Study||88||
48610446|NCT01084148|101830427|FG001|COMPLETED|Overall Study||102||
48610447|NCT01084148|101830426|FG000|NOT COMPLETED|Overall Study||30||
48610448|NCT01084148|101830427|FG001|NOT COMPLETED|Overall Study||16||
48610449|NCT05464420|101830428|FG000|STARTED|Overall Study||541||
48610450|NCT05464420|101830429|FG001|STARTED|Overall Study||540||
48610451|NCT05464420|101830430|FG002|STARTED|Overall Study||541||
48610452|NCT05464420|101830431|FG003|STARTED|Overall Study||540||
48610453|NCT05464420|101830428|FG000|Vaccinated|Overall Study||539||
48610454|NCT05464420|101830429|FG001|Vaccinated|Overall Study||538||
48610455|NCT05464420|101830430|FG002|Vaccinated|Overall Study||540||
48610456|NCT05464420|101830431|FG003|Vaccinated|Overall Study||540||
48610457|NCT05464420|101830428|FG000|Safety Analysis Population|Overall Study||539|One participant initially randomized to the V116 Lot 2 arm received V116 Lot 1, one participant initially randomized to the V116 Lot 1 arm received V116 Lot 3, and one participant initially randomized to the V116 Lot 2 arm received PPSV23.|
48610458|NCT05464420|101830429|FG001|Safety Analysis Population|Overall Study||536|One participant initially randomized to the V116 Lot 2 arm received V116 Lot 1, one participant initially randomized to the V116 Lot 1 arm received V116 Lot 3, and one participant initially randomized to the V116 Lot 2 arm received PPSV23.|
48610459|NCT05464420|101830430|FG002|Safety Analysis Population|Overall Study||541|One participant initially randomized to the V116 Lot 2 arm received V116 Lot 1, one participant initially randomized to the V116 Lot 1 arm received V116 Lot 3, and one participant initially randomized to the V116 Lot 2 arm received PPSV23.|
48610460|NCT05464420|101830431|FG003|Safety Analysis Population|Overall Study||541|One participant initially randomized to the V116 Lot 2 arm received V116 Lot 1, one participant initially randomized to the V116 Lot 1 arm received V116 Lot 3, and one participant initially randomized to the V116 Lot 2 arm received PPSV23.|
48610461|NCT05464420|101830428|FG000|COMPLETED|Overall Study||521||
48610462|NCT05464420|101830429|FG001|COMPLETED|Overall Study||520||
48152921|NCT01783418|100696129|FG000|COMPLETED|Overall Study||7||
48152922|NCT01783418|100696130|FG001|COMPLETED|Overall Study||6||
48152923|NCT01783418|100696129|FG000|NOT COMPLETED|Overall Study||1||
48152924|NCT01783418|100696130|FG001|NOT COMPLETED|Overall Study||0||
48152925|NCT00455975|100696131|FG000|STARTED|Overall Study||58||
48152926|NCT00455975|100696132|FG001|STARTED|Overall Study||61||
48610463|NCT05464420|101830430|FG002|COMPLETED|Overall Study||525||
48610464|NCT05464420|101830431|FG003|COMPLETED|Overall Study||526||
48610465|NCT05464420|101830428|FG000|NOT COMPLETED|Overall Study||20||
48610466|NCT05464420|101830429|FG001|NOT COMPLETED|Overall Study||20||
48610467|NCT05464420|101830430|FG002|NOT COMPLETED|Overall Study||16||
48610468|NCT05464420|101830431|FG003|NOT COMPLETED|Overall Study||14||
48610469|NCT02447328|101830432|FG000|STARTED|Overall Study||83||
48610470|NCT02447328|101830432|FG000|COMPLETED|Overall Study||82||
48610471|NCT02447328|101830432|FG000|NOT COMPLETED|Overall Study||1||
48152927|NCT00455975|100696131|FG000|COMPLETED|Overall Study||40||
48152928|NCT00455975|100696132|FG001|COMPLETED|Overall Study||40||
48152929|NCT00455975|100696131|FG000|NOT COMPLETED|Overall Study||18||
48152930|NCT00455975|100696132|FG001|NOT COMPLETED|Overall Study||21||
48152931|NCT04274894|100696133|FG000|STARTED|Overall Study||246||
48610472|NCT04575090|101830433|FG000|STARTED|Overall Study||0||
48610473|NCT04575090|101830434|FG001|STARTED|Overall Study||7||
48610474|NCT04575090|101830435|FG002|STARTED|Overall Study||1||
48610475|NCT04575090|101830433|FG000|COMPLETED|Overall Study||0||
48610476|NCT04575090|101830434|FG001|COMPLETED|Overall Study||5||
48610477|NCT04575090|101830435|FG002|COMPLETED|Overall Study||1||
48610478|NCT04575090|101830433|FG000|NOT COMPLETED|Overall Study||0||
48610479|NCT04575090|101830434|FG001|NOT COMPLETED|Overall Study||2||
48610480|NCT04575090|101830435|FG002|NOT COMPLETED|Overall Study||0||
48610481|NCT03334422|101830436|FG000|STARTED|Overall Study||244||
48610482|NCT03334422|101830437|FG001|STARTED|Overall Study||125||
48610483|NCT03334422|101830438|FG002|STARTED|Overall Study||123||
48610484|NCT03334422|101830439|FG003|STARTED|Overall Study||123||
48610485|NCT03334422|101830436|FG000|Received at Least One Dose of Study Drug|Overall Study||244||
48610486|NCT03334422|101830437|FG001|Received at Least One Dose of Study Drug|Overall Study||124||
48610487|NCT03334422|101830438|FG002|Received at Least One Dose of Study Drug|Overall Study||123||
48610488|NCT03334422|101830439|FG003|Received at Least One Dose of Study Drug|Overall Study||123||
48610489|NCT03334422|101830436|FG000|COMPLETED|Overall Study||225||
48610490|NCT03334422|101830437|FG001|COMPLETED|Overall Study||115||
48610491|NCT03334422|101830438|FG002|COMPLETED|Overall Study||113||
48610492|NCT03334422|101830439|FG003|COMPLETED|Overall Study||117||
48610493|NCT03334422|101830436|FG000|NOT COMPLETED|Overall Study||19||
48610494|NCT03334422|101830437|FG001|NOT COMPLETED|Overall Study||10||
48152932|NCT04274894|100696133|FG000|COMPLETED|Overall Study||204||
48152933|NCT04274894|100696133|FG000|NOT COMPLETED|Overall Study||42||
48610495|NCT03334422|101830438|FG002|NOT COMPLETED|Overall Study||10||
48610496|NCT03334422|101830439|FG003|NOT COMPLETED|Overall Study||6||
48610497|NCT02095197|101830440|FG000|STARTED|Overall Study||40||
48610498|NCT02095197|101830441|FG001|STARTED|Overall Study||39||
48610499|NCT02095197|101830440|FG000|COMPLETED|Overall Study||40||
48610500|NCT02095197|101830441|FG001|COMPLETED|Overall Study||36||
48610501|NCT02095197|101830440|FG000|NOT COMPLETED|Overall Study||0||
48610502|NCT02095197|101830441|FG001|NOT COMPLETED|Overall Study||3||
48610503|NCT01189461|101830442|FG000|STARTED|Overall Study||46||
48610504|NCT01189461|101830442|FG000|COMPLETED|Overall Study||12||
48610505|NCT01189461|101830442|FG000|NOT COMPLETED|Overall Study||34||
48610506|NCT00398047|101830443|FG000|STARTED|Overall Study||3||
48610507|NCT00398047|101830443|FG000|COMPLETED|Overall Study||0||
48610508|NCT00398047|101830443|FG000|NOT COMPLETED|Overall Study||3||
48610509|NCT00519584|101830444|FG000|STARTED|Overall Study||54||
48610510|NCT00519584|101830445|FG001|STARTED|Overall Study||54||
48610511|NCT00519584|101830446|FG002|STARTED|Overall Study||54||
48610512|NCT00519584|101830447|FG003|STARTED|Overall Study||56||
48610513|NCT00519584|101830444|FG000|COMPLETED|Overall Study||54||
48610514|NCT00519584|101830445|FG001|COMPLETED|Overall Study||54||
48610515|NCT00519584|101830446|FG002|COMPLETED|Overall Study||54||
48610516|NCT00519584|101830447|FG003|COMPLETED|Overall Study||56||
48610517|NCT00519584|101830444|FG000|NOT COMPLETED|Overall Study||0||
48152934|NCT00452387|100696134|FG000|STARTED|Overall Study||22||
48152935|NCT00452387|100696134|FG000|COMPLETED|Overall Study||22||
48152936|NCT00452387|100696134|FG000|NOT COMPLETED|Overall Study||0||
48152937|NCT01410058|100696135|FG000|STARTED|Washout Day 0||13||
48152938|NCT01410058|100696136|FG001|STARTED|Washout Day 0||6||
48152939|NCT01410058|100696135|FG000|COMPLETED|Washout Day 0||13||
48152940|NCT01410058|100696136|FG001|COMPLETED|Washout Day 0||6||
48610518|NCT00519584|101830445|FG001|NOT COMPLETED|Overall Study||0||
48610519|NCT00519584|101830446|FG002|NOT COMPLETED|Overall Study||0||
48610520|NCT00519584|101830447|FG003|NOT COMPLETED|Overall Study||0||
48152941|NCT01410058|100696135|FG000|NOT COMPLETED|Washout Day 0||0||
48610521|NCT02559570|101830448|FG000|STARTED|Overall Study||41||
48610522|NCT02559570|101830449|FG001|STARTED|Overall Study||36||
48610523|NCT02559570|101830450|FG002|STARTED|Overall Study||41||
48610524|NCT02559570|101830451|FG003|STARTED|Overall Study||39||
48610525|NCT02559570|101830452|FG004|STARTED|Overall Study||16||
48308324|NCT03838198|101080927|FG000|NOT COMPLETED|3 Month Follow up Period||3||
48308325|NCT03838198|101080928|FG001|NOT COMPLETED|3 Month Follow up Period||3||
48308326|NCT03838198|101080929|FG002|NOT COMPLETED|3 Month Follow up Period||3||
48308327|NCT03838198|101080930|FG003|NOT COMPLETED|3 Month Follow up Period||4||
48610526|NCT02559570|101830448|FG000|COMPLETED|Overall Study||39|Completed = Participants who completed the Treatment period.|
48610527|NCT02559570|101830449|FG001|COMPLETED|Overall Study||34|Completed = Participants who completed the Treatment period.|
48610528|NCT02559570|101830450|FG002|COMPLETED|Overall Study||39|Completed = Participants who completed the Treatment period.|
48610529|NCT02559570|101830451|FG003|COMPLETED|Overall Study||36|Completed = Participants who completed the Treatment period.|
48610530|NCT02559570|101830452|FG004|COMPLETED|Overall Study||14|Completed = Participants who completed the Treatment period.|
48610531|NCT02559570|101830448|FG000|NOT COMPLETED|Overall Study||2||
48308328|NCT00956657|101080931|FG000|STARTED|Overall Study||18||
48308329|NCT00956657|101080932|FG001|STARTED|Overall Study||13||
48308330|NCT00956657|101080931|FG000|COMPLETED|Overall Study||18||
48308331|NCT00956657|101080932|FG001|COMPLETED|Overall Study||13||
48308332|NCT00956657|101080931|FG000|NOT COMPLETED|Overall Study||0||
48308333|NCT00956657|101080932|FG001|NOT COMPLETED|Overall Study||0||
48610532|NCT02559570|101830449|FG001|NOT COMPLETED|Overall Study||2||
48610533|NCT02559570|101830450|FG002|NOT COMPLETED|Overall Study||2||
48610534|NCT02559570|101830451|FG003|NOT COMPLETED|Overall Study||3||
48610535|NCT02559570|101830452|FG004|NOT COMPLETED|Overall Study||2||
48610536|NCT03091738|101830453|FG000|STARTED|Overall Study||10||
48610537|NCT03091738|101830453|FG000|COMPLETED|Overall Study||8||
48610538|NCT03091738|101830453|FG000|NOT COMPLETED|Overall Study||2||
48610539|NCT04060797|101830454|FG000|STARTED|Overall Study||19||
48610540|NCT04060797|101830455|FG001|STARTED|Overall Study||19||
48610541|NCT04060797|101830454|FG000|COMPLETED|Overall Study||19||
48610542|NCT04060797|101830455|FG001|COMPLETED|Overall Study||19||
48610543|NCT04060797|101830454|FG000|NOT COMPLETED|Overall Study||0||
48610544|NCT04060797|101830455|FG001|NOT COMPLETED|Overall Study||0||
48610545|NCT01850394|101830456|FG000|STARTED|Overall Study||45||
48610546|NCT01850394|101830457|FG001|STARTED|Overall Study||45||
48610547|NCT01850394|101830458|FG002|STARTED|Overall Study||45||
48610548|NCT01850394|101830456|FG000|COMPLETED|Overall Study||45||
48610549|NCT01850394|101830457|FG001|COMPLETED|Overall Study||45||
48610550|NCT01850394|101830458|FG002|COMPLETED|Overall Study||45||
48610551|NCT01850394|101830456|FG000|NOT COMPLETED|Overall Study||0||
48610552|NCT01850394|101830457|FG001|NOT COMPLETED|Overall Study||0||
48610553|NCT01850394|101830458|FG002|NOT COMPLETED|Overall Study||0||
48308334|NCT01849497|101080933|FG000|STARTED|Overall Study||75||
48610554|NCT00990509|101830459|FG000|STARTED|Overall Study||5||
48610555|NCT00990509|101830460|FG001|STARTED|Overall Study||9||
48610556|NCT00990509|101830459|FG000|COMPLETED|Overall Study||5||
48610557|NCT00990509|101830460|FG001|COMPLETED|Overall Study||8||
48610558|NCT00990509|101830459|FG000|NOT COMPLETED|Overall Study||0||
48308335|NCT01849497|101080934|FG001|STARTED|Overall Study||74||
48308336|NCT01849497|101080933|FG000|Received Treatment|Overall Study||75||
48308337|NCT01849497|101080934|FG001|Received Treatment|Overall Study||74||
48308338|NCT01849497|101080933|FG000|COMPLETED|Overall Study||74||
48308339|NCT01849497|101080934|FG001|COMPLETED|Overall Study||70||
48308340|NCT01849497|101080933|FG000|NOT COMPLETED|Overall Study||1||
48308341|NCT01849497|101080934|FG001|NOT COMPLETED|Overall Study||4||
48308342|NCT04490395|101080935|FG000|STARTED|Overall Study||19||
48308343|NCT04490395|101080936|FG001|STARTED|Overall Study||20||
48308344|NCT04490395|101080935|FG000|COMPLETED|Overall Study||19||
48308345|NCT04490395|101080936|FG001|COMPLETED|Overall Study||19||
48610559|NCT00990509|101830460|FG001|NOT COMPLETED|Overall Study||1||
48610560|NCT02686814|101830461|FG000|STARTED|Overall Study||25||
48610561|NCT02686814|101830461|FG000|COMPLETED|Overall Study||6||
48610562|NCT02686814|101830461|FG000|NOT COMPLETED|Overall Study||19||
48610563|NCT00893074|101830462|FG000|STARTED|Overall Study||24||
48610564|NCT00893074|101830462|FG000|COMPLETED|Overall Study||13||
48308346|NCT04490395|101080935|FG000|NOT COMPLETED|Overall Study||0||
48308347|NCT04490395|101080936|FG001|NOT COMPLETED|Overall Study||1||
48308348|NCT01641237|101080937|FG000|STARTED|Period I||16||
48610565|NCT00893074|101830462|FG000|NOT COMPLETED|Overall Study||11||
48308349|NCT01641237|101080938|FG001|STARTED|Period I||16||
48308350|NCT01641237|101080939|FG002|STARTED|Period I||15||
48308351|NCT01641237|101080940|FG003|STARTED|Period I||15||
48308352|NCT01641237|101080937|FG000|COMPLETED|Period I||16||
48308353|NCT01641237|101080938|FG001|COMPLETED|Period I||16||
48308354|NCT01641237|101080939|FG002|COMPLETED|Period I||15||
48308355|NCT01641237|101080940|FG003|COMPLETED|Period I||15||
48308356|NCT01641237|101080937|FG000|NOT COMPLETED|Period I||0||
48152942|NCT01410058|100696136|FG001|NOT COMPLETED|Washout Day 0||0||
48152943|NCT01410058|100696135|FG000|STARTED|Baseline Day 22||13||
48152944|NCT01410058|100696136|FG001|STARTED|Baseline Day 22||6||
48152945|NCT01410058|100696135|FG000|COMPLETED|Baseline Day 22||13||
48152946|NCT01410058|100696136|FG001|COMPLETED|Baseline Day 22||6||
48152947|NCT01410058|100696135|FG000|NOT COMPLETED|Baseline Day 22||0||
48152948|NCT01410058|100696136|FG001|NOT COMPLETED|Baseline Day 22||0||
48152949|NCT01410058|100696135|FG000|STARTED|Day 35||13||
48610566|NCT04656301|101830463|FG000|STARTED|Overall Study||12||
48610567|NCT04656301|101830463|FG000|COMPLETED|Overall Study||12||
48610568|NCT04656301|101830463|FG000|NOT COMPLETED|Overall Study||0||
48610569|NCT04727736|101830464|FG000|STARTED|Overall Study||47||
48610570|NCT04727736|101830464|FG000|COMPLETED|Overall Study||47||
48722621|NCT02228096|102108198|FG000|NOT COMPLETED|Overall Study||71||
48722622|NCT02478580|102108199|FG000|STARTED|Overall Study||34||
48722623|NCT02478580|102108200|FG001|STARTED|Overall Study||33||
48722624|NCT02478580|102108199|FG000|COMPLETED|Overall Study||34||
48152950|NCT01410058|100696136|FG001|STARTED|Day 35||6||
48152951|NCT01410058|100696135|FG000|COMPLETED|Day 35||13||
48152952|NCT01410058|100696136|FG001|COMPLETED|Day 35||6||
48722625|NCT02478580|102108200|FG001|COMPLETED|Overall Study||33||
48722626|NCT02478580|102108199|FG000|NOT COMPLETED|Overall Study||0||
48152953|NCT01410058|100696135|FG000|NOT COMPLETED|Day 35||0||
48152954|NCT01410058|100696136|FG001|NOT COMPLETED|Day 35||0||
48152955|NCT01896869|100699700|FG000|STARTED|Overall Study||41||
48152956|NCT01896869|100699701|FG001|STARTED|Overall Study||42||
48152957|NCT01896869|100699700|FG000|COMPLETED|Overall Study||40||
48152958|NCT01896869|100699701|FG001|COMPLETED|Overall Study||36||
48152959|NCT01896869|100699700|FG000|NOT COMPLETED|Overall Study||1||
48406495|NCT01010776|101328436|FG000|COMPLETED|Main Phase||174||
48406496|NCT01010776|101328436|FG000|NOT COMPLETED|Main Phase||49||
48610571|NCT04727736|101830464|FG000|NOT COMPLETED|Overall Study||0||
48722627|NCT02478580|102108200|FG001|NOT COMPLETED|Overall Study||0||
48722628|NCT03629912|102108201|FG000|STARTED|Overall Study||73||7
48722629|NCT03629912|102108202|FG001|STARTED|Overall Study||53||5
48722630|NCT03629912|102108203|FG002|STARTED|Overall Study||50||4
48722631|NCT03629912|102108204|FG003|STARTED|Overall Study||43||4
48722632|NCT03629912|102108201|FG000|COMPLETED|Overall Study||44||7
48722633|NCT03629912|102108202|FG001|COMPLETED|Overall Study||40||5
48722634|NCT03629912|102108203|FG002|COMPLETED|Overall Study||41||4
48722635|NCT03629912|102108204|FG003|COMPLETED|Overall Study||39||4
48722636|NCT03629912|102108201|FG000|NOT COMPLETED|Overall Study||29||0
48722637|NCT03629912|102108202|FG001|NOT COMPLETED|Overall Study||13||0
48722638|NCT03629912|102108203|FG002|NOT COMPLETED|Overall Study||9||0
48722639|NCT03629912|102108204|FG003|NOT COMPLETED|Overall Study||4||0
48722640|NCT03443427|102108205|FG000|STARTED|Overall Study||100||
48722641|NCT03443427|102108206|FG001|STARTED|Overall Study||100||
48722642|NCT03443427|102108205|FG000|COMPLETED|Overall Study||88||
48722643|NCT03443427|102108206|FG001|COMPLETED|Overall Study||89||
48722644|NCT03443427|102108205|FG000|NOT COMPLETED|Overall Study||12||
48152960|NCT01896869|100699701|FG001|NOT COMPLETED|Overall Study||6||
48152961|NCT02360319|100699702|FG000|STARTED|Overall Study||255||
48152962|NCT02360319|100699703|FG001|STARTED|Overall Study||234||
48152963|NCT02360319|100699702|FG000|COMPLETED|Overall Study||167||
48152964|NCT02360319|100699703|FG001|COMPLETED|Overall Study||173||
48152965|NCT02360319|100699702|FG000|NOT COMPLETED|Overall Study||88||
48152966|NCT02360319|100699703|FG001|NOT COMPLETED|Overall Study||61||
48152967|NCT01922076|100699704|FG000|STARTED|Overall Study||6||
48152968|NCT01922076|100699705|FG001|STARTED|Overall Study||6||
48152969|NCT01922076|100699706|FG002|STARTED|Overall Study||7||
48152970|NCT01922076|100699707|FG003|STARTED|Overall Study||7||
48152971|NCT01922076|100699708|FG004|STARTED|Overall Study||7||
48152972|NCT01922076|100699709|FG005|STARTED|Overall Study||6||
48610572|NCT03872843|101830465|FG000|STARTED|Overall Study||12||
48610573|NCT03872843|101830466|FG001|STARTED|Overall Study||10||
48610574|NCT03872843|101830465|FG000|COMPLETED|Overall Study||7||
48610575|NCT03872843|101830466|FG001|COMPLETED|Overall Study||3||
48610576|NCT03872843|101830465|FG000|NOT COMPLETED|Overall Study||5||
48722645|NCT03443427|102108206|FG001|NOT COMPLETED|Overall Study||11||
48722646|NCT01272869|102108207|FG000|STARTED|Period 1 (14 Days)||10||
48722647|NCT01272869|102108208|FG001|STARTED|Period 1 (14 Days)||10||
48722648|NCT01272869|102108207|FG000|COMPLETED|Period 1 (14 Days)||10||
48722649|NCT01272869|102108208|FG001|COMPLETED|Period 1 (14 Days)||10||
48722650|NCT01272869|102108207|FG000|NOT COMPLETED|Period 1 (14 Days)||0||
48152973|NCT01922076|100699710|FG006|STARTED|Overall Study||7||
48152974|NCT01922076|100699704|FG000|COMPLETED|Overall Study||6||
48152975|NCT01922076|100699705|FG001|COMPLETED|Overall Study||6||
48152976|NCT01922076|100699706|FG002|COMPLETED|Overall Study||6||
48152977|NCT01922076|100699707|FG003|COMPLETED|Overall Study||6||
48406497|NCT01010776|101328436|FG000|STARTED|In-Between Main Phase & Extension Phase||174||
48152978|NCT01922076|100699708|FG004|COMPLETED|Overall Study||6||
48722651|NCT01272869|102108208|FG001|NOT COMPLETED|Period 1 (14 Days)||0||
48152979|NCT01922076|100699709|FG005|COMPLETED|Overall Study||5||
48152980|NCT01922076|100699710|FG006|COMPLETED|Overall Study||6||
48152981|NCT01922076|100699704|FG000|NOT COMPLETED|Overall Study||0||
48152982|NCT01922076|100699705|FG001|NOT COMPLETED|Overall Study||0||
48152983|NCT01922076|100699706|FG002|NOT COMPLETED|Overall Study||1||
48152984|NCT01922076|100699707|FG003|NOT COMPLETED|Overall Study||1||
48152985|NCT01922076|100699708|FG004|NOT COMPLETED|Overall Study||1||
48152986|NCT01922076|100699709|FG005|NOT COMPLETED|Overall Study||1||
48152987|NCT01922076|100699710|FG006|NOT COMPLETED|Overall Study||1||
48152988|NCT04349280|100699711|FG000|STARTED|Main Study (Up to Approx. 95 Weeks)||25||
48152989|NCT04349280|100699712|FG001|STARTED|Main Study (Up to Approx. 95 Weeks)||0||
48152990|NCT04349280|100699711|FG000|COMPLETED|Main Study (Up to Approx. 95 Weeks)||12||
48152991|NCT04349280|100699712|FG001|COMPLETED|Main Study (Up to Approx. 95 Weeks)||0||
48152992|NCT04349280|100699711|FG000|NOT COMPLETED|Main Study (Up to Approx. 95 Weeks)||13||
48722652|NCT01272869|102108207|FG000|STARTED|Period 2 (14 Days)||10||
48722653|NCT01272869|102108208|FG001|STARTED|Period 2 (14 Days)||10||
48722654|NCT01272869|102108207|FG000|COMPLETED|Period 2 (14 Days)||9||
48722655|NCT01272869|102108208|FG001|COMPLETED|Period 2 (14 Days)||10||
48722656|NCT01272869|102108207|FG000|NOT COMPLETED|Period 2 (14 Days)||1||
48722657|NCT01272869|102108208|FG001|NOT COMPLETED|Period 2 (14 Days)||0||
48722658|NCT01581008|102108209|FG000|STARTED|Overall Study||17||
48722659|NCT01581008|102108210|FG001|STARTED|Overall Study||13||
48722660|NCT01581008|102108209|FG000|COMPLETED|Overall Study||16||
48722661|NCT01581008|102108210|FG001|COMPLETED|Overall Study||7||
48152993|NCT04349280|100699712|FG001|NOT COMPLETED|Main Study (Up to Approx. 95 Weeks)||0||
48722662|NCT01581008|102108209|FG000|NOT COMPLETED|Overall Study||1||
48722663|NCT01581008|102108210|FG001|NOT COMPLETED|Overall Study||6||
48722664|NCT03908970|102108211|FG000|STARTED|Overall Study||182||
48152994|NCT04349280|100699711|FG000|STARTED|PACT Phase (Up to Approx. 56 Weeks)||0||
48152995|NCT04349280|100699712|FG001|STARTED|PACT Phase (Up to Approx. 56 Weeks)||1||
48152996|NCT04349280|100699711|FG000|COMPLETED|PACT Phase (Up to Approx. 56 Weeks)||0||
48152997|NCT04349280|100699712|FG001|COMPLETED|PACT Phase (Up to Approx. 56 Weeks)||0||
48152998|NCT04349280|100699711|FG000|NOT COMPLETED|PACT Phase (Up to Approx. 56 Weeks)||0||
48152999|NCT04349280|100699712|FG001|NOT COMPLETED|PACT Phase (Up to Approx. 56 Weeks)||1||
48153000|NCT02403180|100699713|FG000|STARTED|Pre-Treatment Period||36||
48153001|NCT02403180|100699714|FG001|STARTED|Pre-Treatment Period||34||
48153002|NCT02403180|100699713|FG000|COMPLETED|Pre-Treatment Period||36||
48153003|NCT02403180|100699714|FG001|COMPLETED|Pre-Treatment Period||33||
48153004|NCT02403180|100699713|FG000|NOT COMPLETED|Pre-Treatment Period||0||
48153005|NCT02403180|100699714|FG001|NOT COMPLETED|Pre-Treatment Period||1||
48153006|NCT02403180|100699713|FG000|STARTED|Period 1 (5 Days)||36||
48153007|NCT02403180|100699714|FG001|STARTED|Period 1 (5 Days)||33||
48153008|NCT02403180|100699713|FG000|Randomized|Period 1 (5 Days)||36||
48153009|NCT02403180|100699714|FG001|Randomized|Period 1 (5 Days)||33||
48153010|NCT02403180|100699713|FG000|COMPLETED|Period 1 (5 Days)||36||
48722665|NCT03908970|102108212|FG001|STARTED|Overall Study||182||
48722666|NCT03908970|102108211|FG000|COMPLETED|Overall Study||165||
48722667|NCT03908970|102108212|FG001|COMPLETED|Overall Study||135||
48722668|NCT03908970|102108211|FG000|NOT COMPLETED|Overall Study||17||
48722669|NCT03908970|102108212|FG001|NOT COMPLETED|Overall Study||47||
48153011|NCT02403180|100699714|FG001|COMPLETED|Period 1 (5 Days)||33||
48153012|NCT02403180|100699713|FG000|NOT COMPLETED|Period 1 (5 Days)||0||
48153013|NCT02403180|100699714|FG001|NOT COMPLETED|Period 1 (5 Days)||0||
48153014|NCT02403180|100699713|FG000|STARTED|Period 2 (5 Days)||36||
48153015|NCT02403180|100699714|FG001|STARTED|Period 2 (5 Days)||33||
48153016|NCT02403180|100699713|FG000|COMPLETED|Period 2 (5 Days)||36||
48153017|NCT02403180|100699714|FG001|COMPLETED|Period 2 (5 Days)||32||
48153018|NCT02403180|100699713|FG000|NOT COMPLETED|Period 2 (5 Days)||0||
48153019|NCT02403180|100699714|FG001|NOT COMPLETED|Period 2 (5 Days)||1||
48153020|NCT01291498|100699715|FG000|STARTED|Overall Study||1||
48153021|NCT01291498|100699715|FG000|COMPLETED|Overall Study||0||
48153022|NCT01291498|100699715|FG000|NOT COMPLETED|Overall Study||1||
48153023|NCT00438880|100699716|FG000|STARTED|Overall Study||30||
48153024|NCT00438880|100699717|FG001|STARTED|Overall Study||8||
48153025|NCT00438880|100699716|FG000|COMPLETED|Overall Study||30||
48153026|NCT00438880|100699717|FG001|COMPLETED|Overall Study||8||
48153027|NCT00438880|100699716|FG000|NOT COMPLETED|Overall Study||0||
48153028|NCT00438880|100699717|FG001|NOT COMPLETED|Overall Study||0||
48153029|NCT05093049|100699718|FG000|STARTED|Overall Study||10||10
48610577|NCT03872843|101830466|FG001|NOT COMPLETED|Overall Study||7||
48610578|NCT01135524|101830467|FG000|STARTED|Overall Study||196||
48610579|NCT01135524|101830467|FG000|COMPLETED|Overall Study||0||
48610580|NCT01135524|101830467|FG000|NOT COMPLETED|Overall Study||196||
48610581|NCT01579669|101830468|FG000|STARTED|Overall Study||170||
48610582|NCT01579669|101830469|FG001|STARTED|Overall Study||41||
48610583|NCT01579669|101830468|FG000|COMPLETED|Overall Study||134||
48610584|NCT01579669|101830469|FG001|COMPLETED|Overall Study||41||
48610585|NCT01579669|101830468|FG000|NOT COMPLETED|Overall Study||36||
48610586|NCT01579669|101830469|FG001|NOT COMPLETED|Overall Study||0||
48610587|NCT02287688|101830470|FG000|STARTED|Overall Study||138||
48610588|NCT02287688|101830470|FG000|COMPLETED|Overall Study||138||
48610589|NCT02287688|101830470|FG000|NOT COMPLETED|Overall Study||0||
48610590|NCT02771860|101830471|FG000|STARTED|Overall Study||51||
48610591|NCT02771860|101830472|FG001|STARTED|Overall Study||49||
48610592|NCT02771860|101830471|FG000|COMPLETED|Overall Study||46||
48610593|NCT02771860|101830472|FG001|COMPLETED|Overall Study||46||
48610594|NCT02771860|101830471|FG000|NOT COMPLETED|Overall Study||5||
48610595|NCT02771860|101830472|FG001|NOT COMPLETED|Overall Study||3||
48722670|NCT03957876|102108213|FG000|STARTED|Overall Study||4||
48722671|NCT03957876|102108213|FG000|COMPLETED|Overall Study||4||
48153030|NCT05093049|100699719|FG001|STARTED|Overall Study||10||10
48153031|NCT05093049|100699718|FG000|COMPLETED|Overall Study||10|Ten subjects were enrolled in the study and treated bilaterally.|10
48153032|NCT05093049|100699719|FG001|COMPLETED|Overall Study||10|Ten subjects were enrolled in the study and treated bilaterally.|10
48153033|NCT05093049|100699718|FG000|NOT COMPLETED|Overall Study||0||0
48153034|NCT05093049|100699719|FG001|NOT COMPLETED|Overall Study||0||0
48153035|NCT00579280|100699720|FG000|STARTED|Overall Study||49||
48610596|NCT02734862|101830473|FG000|STARTED|Part A||35|"The Intent-to-Treat (ITT) population analyzed consisted of all subjects randomized to treatment. Subjects were analyzed based on the treatment group to which they were randomized.~In Part A, subjects were randomized in a 1:1:1 ratio to receive rezafungin treatment Group 1, rezafungin Treatment Group 2 (defined below), or IV caspofungin Group 3. Enrollment into Part A closed and Part B began."|
48610597|NCT02734862|101830474|FG001|STARTED|Part A||36|"The Intent-to-Treat (ITT) population analyzed consisted of all subjects randomized to treatment. Subjects were analyzed based on the treatment group to which they were randomized.~In Part A, subjects were randomized in a 1:1:1 ratio to receive rezafungin treatment Group 1, rezafungin Treatment Group 2 (defined below), or IV caspofungin Group 3. Enrollment into Part A closed and Part B began."|
48657082|NCT03648372|101943759|FG002|NOT COMPLETED|Overall Study||4||
48722672|NCT03957876|102108213|FG000|NOT COMPLETED|Overall Study||0||
48610598|NCT02734862|101830475|FG002|STARTED|Part A||36|"The Intent-to-Treat (ITT) population analyzed consisted of all subjects randomized to treatment. Subjects were analyzed based on the treatment group to which they were randomized.~In Part A, subjects were randomized in a 1:1:1 ratio to receive rezafungin treatment Group 1, rezafungin Treatment Group 2 (defined below), or IV caspofungin Group 3. Enrollment into Part A closed and Part B began."|
48610599|NCT02734862|101830473|FG000|COMPLETED|Part A||23||
48610600|NCT02734862|101830474|FG001|COMPLETED|Part A||28||
48610601|NCT02734862|101830475|FG002|COMPLETED|Part A||22||
48610602|NCT02734862|101830473|FG000|NOT COMPLETED|Part A||12||
48610603|NCT02734862|101830474|FG001|NOT COMPLETED|Part A||8||
48610604|NCT02734862|101830475|FG002|NOT COMPLETED|Part A||14||
48656917|NCT04274218|101943726|FG001|NOT COMPLETED|Perturbation Condition 1 (15 Minutes)||0||
48656918|NCT04274218|101943727|FG002|NOT COMPLETED|Perturbation Condition 1 (15 Minutes)||0||
48722673|NCT04356040|102108214|FG000|STARTED|Overall Study||305||
48722674|NCT04356040|102108215|FG001|STARTED|Overall Study||50||
48722675|NCT04356040|102108214|FG000|Device Inserted and RF Energy Delivered|Overall Study||284||
48722676|NCT04356040|102108215|FG001|Device Inserted and RF Energy Delivered|Overall Study||50||
48722677|NCT04356040|102108214|FG000|7-Day Visit|Overall Study||280||
48722678|NCT04356040|102108215|FG001|7-Day Visit|Overall Study||50||
48722679|NCT04356040|102108214|FG000|5-Week Visit|Overall Study||279||
48722680|NCT04356040|102108215|FG001|5-Week Visit|Overall Study||50||
48722681|NCT04356040|102108214|FG000|3-Month Visit|Overall Study||272||
48308357|NCT01641237|101080938|FG001|NOT COMPLETED|Period I||0||
48308358|NCT01641237|101080939|FG002|NOT COMPLETED|Period I||0||
48308359|NCT01641237|101080940|FG003|NOT COMPLETED|Period I||0||
48722682|NCT04356040|102108215|FG001|3-Month Visit|Overall Study||50||
48722683|NCT04356040|102108214|FG000|6-Month Visit|Overall Study||267||
48722684|NCT04356040|102108215|FG001|6-Month Visit|Overall Study||49||
48308360|NCT01641237|101080937|FG000|STARTED|Period II||15||
48308361|NCT01641237|101080938|FG001|STARTED|Period II||16||
48308362|NCT01641237|101080939|FG002|STARTED|Period II||16||
48308363|NCT01641237|101080940|FG003|STARTED|Period II||15||
48308364|NCT01641237|101080937|FG000|COMPLETED|Period II||14||
48308365|NCT01641237|101080938|FG001|COMPLETED|Period II||16||
48308366|NCT01641237|101080939|FG002|COMPLETED|Period II||16||
48308367|NCT01641237|101080940|FG003|COMPLETED|Period II||15||
48308368|NCT01641237|101080937|FG000|NOT COMPLETED|Period II||1||
48308369|NCT01641237|101080938|FG001|NOT COMPLETED|Period II||0||
48308370|NCT01641237|101080939|FG002|NOT COMPLETED|Period II||0||
48308371|NCT01641237|101080940|FG003|NOT COMPLETED|Period II||0||
48308372|NCT01641237|101080937|FG000|STARTED|Period III||16||
48308373|NCT01641237|101080938|FG001|STARTED|Period III||14||
48308374|NCT01641237|101080939|FG002|STARTED|Period III||15||
48308375|NCT01641237|101080940|FG003|STARTED|Period III||16||
48308376|NCT01641237|101080937|FG000|COMPLETED|Period III||15||
48308377|NCT01641237|101080938|FG001|COMPLETED|Period III||14||
48308378|NCT01641237|101080939|FG002|COMPLETED|Period III||15||
48308379|NCT01641237|101080940|FG003|COMPLETED|Period III||16||
48308380|NCT01641237|101080937|FG000|NOT COMPLETED|Period III||1||
48308381|NCT01641237|101080938|FG001|NOT COMPLETED|Period III||0||
48308382|NCT01641237|101080939|FG002|NOT COMPLETED|Period III||0||
48308383|NCT01641237|101080940|FG003|NOT COMPLETED|Period III||0||
48308384|NCT01641237|101080937|FG000|STARTED|Period IV||15||
48308385|NCT01641237|101080938|FG001|STARTED|Period IV||15||
48308386|NCT01641237|101080939|FG002|STARTED|Period IV||15||
48308387|NCT01641237|101080940|FG003|STARTED|Period IV||15||
48308388|NCT01641237|101080937|FG000|COMPLETED|Period IV||15||
48722685|NCT04356040|102108214|FG000|12-Month Visit|Overall Study||264||
48722686|NCT04356040|102108215|FG001|12-Month Visit|Overall Study||48||
48722687|NCT04356040|102108214|FG000|COMPLETED|Overall Study||268||
48722688|NCT04356040|102108215|FG001|COMPLETED|Overall Study||48||
48722689|NCT04356040|102108214|FG000|NOT COMPLETED|Overall Study||37||
48308389|NCT01641237|101080938|FG001|COMPLETED|Period IV||15||
48308390|NCT01641237|101080939|FG002|COMPLETED|Period IV||15||
48308391|NCT01641237|101080940|FG003|COMPLETED|Period IV||15||
48308392|NCT01641237|101080937|FG000|NOT COMPLETED|Period IV||0||
48308393|NCT01641237|101080938|FG001|NOT COMPLETED|Period IV||0||
48308394|NCT01641237|101080939|FG002|NOT COMPLETED|Period IV||0||
48308395|NCT01641237|101080940|FG003|NOT COMPLETED|Period IV||0||
48308396|NCT00736034|101080941|FG000|STARTED|Overall Study||18||
48308397|NCT00736034|101080941|FG000|COMPLETED|Overall Study||16||
48308398|NCT00736034|101080941|FG000|NOT COMPLETED|Overall Study||2||
48308399|NCT01335009|101080942|FG000|STARTED|Overall Study||40||
48308400|NCT01335009|101080943|FG001|STARTED|Overall Study||36||
48308401|NCT01335009|101080942|FG000|COMPLETED|Overall Study||9||
48308402|NCT01335009|101080943|FG001|COMPLETED|Overall Study||3||
48308403|NCT01335009|101080942|FG000|NOT COMPLETED|Overall Study||31||
48308404|NCT01335009|101080943|FG001|NOT COMPLETED|Overall Study||33||
48308405|NCT00455013|101080944|FG000|STARTED|Short Term Period||33||
48308406|NCT00455013|101080945|FG001|STARTED|Short Term Period||26||
48308407|NCT00455013|101080946|FG002|STARTED|Short Term Period||30||
48308408|NCT00455013|101080944|FG000|COMPLETED|Short Term Period||27||
48308409|NCT00455013|101080945|FG001|COMPLETED|Short Term Period||21||
48610605|NCT02734862|101830473|FG000|STARTED|Part B||46|"The Intent-to-Treat (ITT) population analyzed consisted of all subjects randomized to treatment. Subjects were analyzed based on the treatment group to which they were randomized.~In Part B, subjects were randomized 2:1 to receive rezafungin treatment or IV caspofungin."|
48610606|NCT02734862|101830474|FG001|STARTED|Part B||21|"The Intent-to-Treat (ITT) population analyzed consisted of all subjects randomized to treatment. Subjects were analyzed based on the treatment group to which they were randomized.~In Part B, subjects were randomized 2:1 to receive rezafungin treatment or IV caspofungin."|
48610607|NCT02734862|101830475|FG002|STARTED|Part B||33|"The Intent-to-Treat (ITT) population analyzed consisted of all subjects randomized to treatment. Subjects were analyzed based on the treatment group to which they were randomized.~In Part B, subjects were randomized 2:1 to receive rezafungin treatment or IV caspofungin."|
48610608|NCT02734862|101830473|FG000|COMPLETED|Part B||33||
48610609|NCT02734862|101830474|FG001|COMPLETED|Part B||14||
48610610|NCT02734862|101830475|FG002|COMPLETED|Part B||28||
48610611|NCT02734862|101830473|FG000|NOT COMPLETED|Part B||13||
48610612|NCT02734862|101830474|FG001|NOT COMPLETED|Part B||7||
48610613|NCT02734862|101830475|FG002|NOT COMPLETED|Part B||5||
48610614|NCT02585713|101830476|FG000|STARTED|Overall Study||150||
48610615|NCT02585713|101830477|FG001|STARTED|Overall Study||150||
48308410|NCT00455013|101080946|FG002|COMPLETED|Short Term Period||28||
48308411|NCT00455013|101080944|FG000|NOT COMPLETED|Short Term Period||6||
48308412|NCT00455013|101080945|FG001|NOT COMPLETED|Short Term Period||5||
48308413|NCT00455013|101080946|FG002|NOT COMPLETED|Short Term Period||2||
48308414|NCT00455013|101080944|FG000|STARTED|Long Term Extension (LTE)||27||
48308415|NCT00455013|101080945|FG001|STARTED|Long Term Extension (LTE)||19||
48308416|NCT00455013|101080946|FG002|STARTED|Long Term Extension (LTE)||27||
48308417|NCT00455013|101080944|FG000|COMPLETED|Long Term Extension (LTE)||25||
48308418|NCT00455013|101080945|FG001|COMPLETED|Long Term Extension (LTE)||16||
48308419|NCT00455013|101080946|FG002|COMPLETED|Long Term Extension (LTE)||20||
48308420|NCT00455013|101080944|FG000|NOT COMPLETED|Long Term Extension (LTE)||2||
48308421|NCT00455013|101080945|FG001|NOT COMPLETED|Long Term Extension (LTE)||3||
48308422|NCT00455013|101080946|FG002|NOT COMPLETED|Long Term Extension (LTE)||7||
48308423|NCT00590044|101080947|FG000|STARTED|Overall Study||38||
48308424|NCT00590044|101080948|FG001|STARTED|Overall Study||36||
48308425|NCT00590044|101080947|FG000|COMPLETED|Overall Study||34||
48308426|NCT00590044|101080948|FG001|COMPLETED|Overall Study||34||
48308427|NCT00590044|101080947|FG000|NOT COMPLETED|Overall Study||4||
48308428|NCT00590044|101080948|FG001|NOT COMPLETED|Overall Study||2||
48308429|NCT05030454|101080949|FG000|STARTED|Overall Study||10||
48308430|NCT05030454|101080949|FG000|COMPLETED|Overall Study||10||
48610616|NCT02585713|101830476|FG000|COMPLETED|Overall Study||145|Received Treatment; Primary Analysis Population|
48610617|NCT02585713|101830477|FG001|COMPLETED|Overall Study||142|Received Treatment; Primary Analysis Population|
48610618|NCT02585713|101830476|FG000|NOT COMPLETED|Overall Study||5||
48308431|NCT05030454|101080949|FG000|NOT COMPLETED|Overall Study||0||
48308432|NCT04044183|101080950|FG000|STARTED|Overall Study||10||
48308433|NCT04044183|101080951|FG001|STARTED|Overall Study||11||
48308434|NCT04044183|101080950|FG000|COMPLETED|Overall Study||8||
48308435|NCT04044183|101080951|FG001|COMPLETED|Overall Study||11||
48308436|NCT04044183|101080950|FG000|NOT COMPLETED|Overall Study||2||
48308437|NCT04044183|101080951|FG001|NOT COMPLETED|Overall Study||0||
48308438|NCT04411628|101080952|FG000|STARTED|Overall Study||7||
48308439|NCT04411628|101080953|FG001|STARTED|Overall Study||6||
48308440|NCT04411628|101080954|FG002|STARTED|Overall Study||7||
48308441|NCT04411628|101080955|FG003|STARTED|Overall Study||6||
48308442|NCT04411628|101080952|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
48308443|NCT04411628|101080953|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
48308444|NCT04411628|101080954|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
48308445|NCT04411628|101080955|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6||
48610619|NCT02585713|101830477|FG001|NOT COMPLETED|Overall Study||8||
48610620|NCT00098670|101830478|FG000|STARTED|Overall Study||102||
48610621|NCT00098670|101830478|FG000|COMPLETED|Overall Study||102||
48153036|NCT00579280|100699721|FG001|STARTED|Overall Study||49||
48153037|NCT00579280|100699722|FG002|STARTED|Overall Study||51||
48610622|NCT00098670|101830478|FG000|NOT COMPLETED|Overall Study||0||
48610623|NCT00540644|101830479|FG000|STARTED|Overall Study||48||
48610624|NCT00540644|101830480|FG001|STARTED|Overall Study||22||
48610625|NCT00540644|101830479|FG000|COMPLETED|Overall Study||39||
48610626|NCT00540644|101830480|FG001|COMPLETED|Overall Study||13||
48610627|NCT00540644|101830479|FG000|NOT COMPLETED|Overall Study||9||
48610628|NCT00540644|101830480|FG001|NOT COMPLETED|Overall Study||9||
48610629|NCT03782987|101830481|FG000|STARTED|Period 1||14|Started are treated|
48610630|NCT03782987|101830481|FG000|COMPLETED|Period 1||14||
48610631|NCT03782987|101830481|FG000|NOT COMPLETED|Period 1||0||
48610632|NCT03782987|101830481|FG000|STARTED|Washout Period||14||
48610633|NCT03782987|101830481|FG000|COMPLETED|Washout Period||14||
48610634|NCT03782987|101830481|FG000|NOT COMPLETED|Washout Period||0||
48610635|NCT03782987|101830481|FG000|STARTED|Period 2||14||
48610636|NCT03782987|101830481|FG000|COMPLETED|Period 2||14||
48610637|NCT03782987|101830481|FG000|NOT COMPLETED|Period 2||0||
48610638|NCT00791037|101830482|FG000|STARTED|Overall Study||23||
48610639|NCT00791037|101830482|FG000|Primary Outcome|Overall Study||19||
48610640|NCT00791037|101830482|FG000|Skeletal or Bone-only Disease by FDG-PET|Overall Study||1||
48610641|NCT00791037|101830482|FG000|COMPLETED|Overall Study||23||
48610642|NCT00791037|101830482|FG000|NOT COMPLETED|Overall Study||0||
48610643|NCT02306850|101830483|FG000|STARTED|Overall Study||10||
48610644|NCT02306850|101830483|FG000|COMPLETED|Overall Study||8||
48610645|NCT02306850|101830483|FG000|NOT COMPLETED|Overall Study||2||
48610646|NCT02754518|101830484|FG000|STARTED|Overall Study||40||
48610647|NCT02754518|101830484|FG000|COMPLETED|Overall Study||40||
48610648|NCT02754518|101830484|FG000|NOT COMPLETED|Overall Study||0||
48610649|NCT01093586|101830485|FG000|STARTED|Overall Study||14||
48610650|NCT01093586|101830485|FG000|COMPLETED|Overall Study||11||
48153038|NCT00579280|100699720|FG000|COMPLETED|Overall Study||47||
48153039|NCT00579280|100699721|FG001|COMPLETED|Overall Study||46||
48153040|NCT00579280|100699722|FG002|COMPLETED|Overall Study||51||
48153041|NCT00579280|100699720|FG000|NOT COMPLETED|Overall Study||2||
48153042|NCT00579280|100699721|FG001|NOT COMPLETED|Overall Study||3||
48153043|NCT00579280|100699722|FG002|NOT COMPLETED|Overall Study||0||
48153044|NCT01089374|100699723|FG000|STARTED|Overall Study||11||
48153045|NCT01089374|100699724|FG001|STARTED|Overall Study||46||
48153046|NCT01089374|100699723|FG000|COMPLETED|Overall Study||1||
48610651|NCT01093586|101830485|FG000|NOT COMPLETED|Overall Study||3||
48610652|NCT02579382|101830486|FG000|STARTED|Main Study Phase||28||
48610653|NCT02579382|101830487|FG001|STARTED|Main Study Phase||53||
48610654|NCT02579382|101830488|FG002|STARTED|Main Study Phase||56||
48610655|NCT02579382|101830489|FG003|STARTED|Main Study Phase||55||
48610656|NCT02579382|101830486|FG000|COMPLETED|Main Study Phase||28||
48610657|NCT02579382|101830487|FG001|COMPLETED|Main Study Phase||53||
48610658|NCT02579382|101830488|FG002|COMPLETED|Main Study Phase||54||
48610659|NCT02579382|101830489|FG003|COMPLETED|Main Study Phase||52||
48153047|NCT01089374|100699724|FG001|COMPLETED|Overall Study||46||
48610660|NCT02579382|101830486|FG000|NOT COMPLETED|Main Study Phase||0||
48610661|NCT02579382|101830487|FG001|NOT COMPLETED|Main Study Phase||0||
48153048|NCT01089374|100699723|FG000|NOT COMPLETED|Overall Study||10||
48610662|NCT02579382|101830488|FG002|NOT COMPLETED|Main Study Phase||2||
48610663|NCT02579382|101830489|FG003|NOT COMPLETED|Main Study Phase||3||
48610664|NCT02579382|101830486|FG000|STARTED|Optional Treatment Extension Phase(OTEP)||27||
48610665|NCT02579382|101830487|FG001|STARTED|Optional Treatment Extension Phase(OTEP)||51||
48610666|NCT02579382|101830488|FG002|STARTED|Optional Treatment Extension Phase(OTEP)||54||
48610667|NCT02579382|101830489|FG003|STARTED|Optional Treatment Extension Phase(OTEP)||49||
48610668|NCT02579382|101830486|FG000|COMPLETED|Optional Treatment Extension Phase(OTEP)||26||
48610669|NCT02579382|101830487|FG001|COMPLETED|Optional Treatment Extension Phase(OTEP)||44||
48610670|NCT02579382|101830488|FG002|COMPLETED|Optional Treatment Extension Phase(OTEP)||50||
48722690|NCT04356040|102108215|FG001|NOT COMPLETED|Overall Study||2||
48722691|NCT01972789|102108216|FG000|STARTED|Overall Study||174||
48722692|NCT01972789|102108217|FG001|STARTED|Overall Study||175||
48722693|NCT01972789|102108216|FG000|COMPLETED|Overall Study||134||
48722694|NCT01972789|102108217|FG001|COMPLETED|Overall Study||145||
48722695|NCT01972789|102108216|FG000|NOT COMPLETED|Overall Study||40||
48610671|NCT02579382|101830489|FG003|COMPLETED|Optional Treatment Extension Phase(OTEP)||44||
48610672|NCT02579382|101830486|FG000|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||1||
48610673|NCT02579382|101830487|FG001|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||7||
48610674|NCT02579382|101830488|FG002|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||4||
48610675|NCT02579382|101830489|FG003|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||5||
48610676|NCT03260790|101830490|FG000|STARTED|Overall Study||8||
48610677|NCT03260790|101830491|FG001|STARTED|Overall Study||9||
48610678|NCT03260790|101830490|FG000|COMPLETED|Overall Study||8||
48722696|NCT01972789|102108217|FG001|NOT COMPLETED|Overall Study||30||
48722697|NCT01600092|102108218|FG000|STARTED|Overall Study||513||
48722698|NCT01600092|102108219|FG001|STARTED|Overall Study||507||
48722699|NCT01600092|102108218|FG000|Received at Least 1 Vaccination|Overall Study||510||
48722700|NCT01600092|102108219|FG001|Received at Least 1 Vaccination|Overall Study||504||
48722701|NCT01600092|102108218|FG000|Received All 3 Vaccinations|Overall Study||500||
48722702|NCT01600092|102108219|FG001|Received All 3 Vaccinations|Overall Study||494||
48722703|NCT01600092|102108218|FG000|COMPLETED|Overall Study||495||
48722704|NCT01600092|102108219|FG001|COMPLETED|Overall Study||491||
48722705|NCT01600092|102108218|FG000|NOT COMPLETED|Overall Study||18||
48722706|NCT01600092|102108219|FG001|NOT COMPLETED|Overall Study||16||
48722707|NCT04023682|102108220|FG000|STARTED|Overall Study||31||
48722708|NCT04023682|102108220|FG000|COMPLETED|Overall Study||25||
48722709|NCT04023682|102108220|FG000|NOT COMPLETED|Overall Study||6||
48722710|NCT01831817|102108221|FG000|STARTED|Overall Study||35||
48722711|NCT01831817|102108222|FG001|STARTED|Overall Study||34||
48722712|NCT01831817|102108223|FG002|STARTED|Overall Study||35||
48722713|NCT01831817|102108224|FG003|STARTED|Overall Study||36||
48722714|NCT01831817|102108221|FG000|COMPLETED|Overall Study||31||
48722715|NCT01831817|102108222|FG001|COMPLETED|Overall Study||34||
48722716|NCT01831817|102108223|FG002|COMPLETED|Overall Study||35||
48722717|NCT01831817|102108224|FG003|COMPLETED|Overall Study||36||
48722718|NCT01831817|102108221|FG000|NOT COMPLETED|Overall Study||4||
48722719|NCT01831817|102108222|FG001|NOT COMPLETED|Overall Study||0||
48722720|NCT01831817|102108223|FG002|NOT COMPLETED|Overall Study||0||
48722721|NCT01831817|102108224|FG003|NOT COMPLETED|Overall Study||0||
48722722|NCT00734071|102108225|FG000|STARTED|Overall Study||152||
48722723|NCT00734071|102108226|FG001|STARTED|Overall Study||152||
48722724|NCT00734071|102108225|FG000|Treated|Overall Study||151||
48722725|NCT00734071|102108226|FG001|Treated|Overall Study||148||
48722726|NCT00734071|102108225|FG000|COMPLETED|Overall Study||114||
48722727|NCT00734071|102108226|FG001|COMPLETED|Overall Study||125||
48722728|NCT00734071|102108225|FG000|NOT COMPLETED|Overall Study||38||
48722729|NCT00734071|102108226|FG001|NOT COMPLETED|Overall Study||27||
48722730|NCT01375608|102108227|FG000|STARTED|Overall Study||10||
48722731|NCT01375608|102108227|FG000|COMPLETED|Overall Study||8||
48722732|NCT01375608|102108227|FG000|NOT COMPLETED|Overall Study||2||
48722733|NCT00895661|102108228|FG000|STARTED|Overall Study||40||
48722734|NCT00895661|102108228|FG000|COMPLETED|Overall Study||37||
48722735|NCT00895661|102108228|FG000|NOT COMPLETED|Overall Study||3||
48722736|NCT00958217|102108229|FG000|STARTED|Overall Study||61||
48722737|NCT00958217|102108230|FG001|STARTED|Overall Study||62||
48722738|NCT00958217|102108229|FG000|End of Treatment|Overall Study||56||
48722739|NCT00958217|102108230|FG001|End of Treatment|Overall Study||57||
48722740|NCT00958217|102108229|FG000|COMPLETED|Overall Study||37||
48722741|NCT00958217|102108230|FG001|COMPLETED|Overall Study||37||
48722742|NCT00958217|102108229|FG000|NOT COMPLETED|Overall Study||24||
48722743|NCT00958217|102108230|FG001|NOT COMPLETED|Overall Study||25||
48722744|NCT00576472|102108231|FG000|STARTED|Initial Screening||230||
48722745|NCT00576472|102108232|FG001|STARTED|Initial Screening||40||
48722746|NCT00576472|102108233|FG002|STARTED|Initial Screening||199||
48722747|NCT00576472|102108234|FG003|STARTED|Initial Screening||0||
48722748|NCT00576472|102108235|FG004|STARTED|Initial Screening||0||
48722749|NCT00576472|102108236|FG005|STARTED|Initial Screening||0||
48722750|NCT00576472|102108237|FG006|STARTED|Initial Screening||0||
48722751|NCT00576472|102108238|FG007|STARTED|Initial Screening||0||
48722752|NCT00576472|102108239|FG008|STARTED|Initial Screening||0||
48722753|NCT00576472|102108240|FG009|STARTED|Initial Screening||0||
48722754|NCT00576472|102108241|FG010|STARTED|Initial Screening||0||
48722755|NCT00576472|102108242|FG011|STARTED|Initial Screening||0||
48722756|NCT00576472|102108243|FG012|STARTED|Initial Screening||0||
48610679|NCT03260790|101830491|FG001|COMPLETED|Overall Study||9||
48610680|NCT03260790|101830490|FG000|NOT COMPLETED|Overall Study||0||
48610681|NCT03260790|101830491|FG001|NOT COMPLETED|Overall Study||0||
48610682|NCT02087670|101830492|FG000|STARTED|Overall Study||20||
48610683|NCT02087670|101830493|FG001|STARTED|Overall Study||22||
48610684|NCT02087670|101830492|FG000|COMPLETED|Overall Study||17||
48610685|NCT02087670|101830493|FG001|COMPLETED|Overall Study||20||
48610686|NCT02087670|101830492|FG000|NOT COMPLETED|Overall Study||3||
48610687|NCT02087670|101830493|FG001|NOT COMPLETED|Overall Study||2||
48610688|NCT03300050|101830494|FG000|STARTED|Overall Study||20||
48610689|NCT03300050|101830495|FG001|STARTED|Overall Study||15||
48610690|NCT03300050|101830496|FG002|STARTED|Overall Study||5||
48610691|NCT03300050|101830497|FG003|STARTED|Overall Study||16||
48610692|NCT03300050|101830498|FG004|STARTED|Overall Study||10||
48610693|NCT03300050|101830494|FG000|Received Treatment|Overall Study||19||
48610694|NCT03300050|101830495|FG001|Received Treatment|Overall Study||14||
48610695|NCT03300050|101830496|FG002|Received Treatment|Overall Study||3||
48610696|NCT03300050|101830497|FG003|Received Treatment|Overall Study||15||
48610697|NCT03300050|101830498|FG004|Received Treatment|Overall Study||10||
48610698|NCT03300050|101830494|FG000|Received All Scheduled Treatments|Overall Study||16||
48610699|NCT03300050|101830495|FG001|Received All Scheduled Treatments|Overall Study||13||
48610700|NCT03300050|101830496|FG002|Received All Scheduled Treatments|Overall Study||2||
48610701|NCT03300050|101830497|FG003|Received All Scheduled Treatments|Overall Study||15||
48610702|NCT03300050|101830498|FG004|Received All Scheduled Treatments|Overall Study||10||
48610703|NCT03300050|101830494|FG000|COMPLETED|Overall Study||17||
48610704|NCT03300050|101830495|FG001|COMPLETED|Overall Study||13||
48610705|NCT03300050|101830496|FG002|COMPLETED|Overall Study||2||
48610706|NCT03300050|101830497|FG003|COMPLETED|Overall Study||15||
48610707|NCT03300050|101830498|FG004|COMPLETED|Overall Study||9||
48610708|NCT03300050|101830494|FG000|NOT COMPLETED|Overall Study||3||
48610709|NCT03300050|101830495|FG001|NOT COMPLETED|Overall Study||2||
48610710|NCT03300050|101830496|FG002|NOT COMPLETED|Overall Study||3||
48610711|NCT03300050|101830497|FG003|NOT COMPLETED|Overall Study||1||
48610712|NCT03300050|101830498|FG004|NOT COMPLETED|Overall Study||1||
48610713|NCT01827592|101830499|FG000|STARTED|Overall Study||126||
48610714|NCT01827592|101830500|FG001|STARTED|Overall Study||126||
48610715|NCT01827592|101830501|FG002|STARTED|Overall Study||124||
48610716|NCT01827592|101830499|FG000|Safety Analysis Set|Overall Study||125||
48610717|NCT01827592|101830500|FG001|Safety Analysis Set|Overall Study||126||
48610718|NCT01827592|101830501|FG002|Safety Analysis Set|Overall Study||124||
48610719|NCT01827592|101830499|FG000|COMPLETED|Overall Study||52||
48610720|NCT01827592|101830500|FG001|COMPLETED|Overall Study||46||
48610721|NCT01827592|101830501|FG002|COMPLETED|Overall Study||48||
48722757|NCT00576472|102108244|FG013|STARTED|Initial Screening||0||
48722758|NCT00576472|102108245|FG014|STARTED|Initial Screening||0||
48722759|NCT00576472|102108231|FG000|COMPLETED|Initial Screening||230||
48722760|NCT00576472|102108232|FG001|COMPLETED|Initial Screening||40||
48722761|NCT00576472|102108233|FG002|COMPLETED|Initial Screening||199||
48722762|NCT00576472|102108234|FG003|COMPLETED|Initial Screening||0||
48722763|NCT00576472|102108235|FG004|COMPLETED|Initial Screening||0||
48722764|NCT00576472|102108236|FG005|COMPLETED|Initial Screening||0||
48722765|NCT00576472|102108237|FG006|COMPLETED|Initial Screening||0||
48722766|NCT00576472|102108238|FG007|COMPLETED|Initial Screening||0||
48722767|NCT00576472|102108239|FG008|COMPLETED|Initial Screening||0||
48722768|NCT00576472|102108240|FG009|COMPLETED|Initial Screening||0||
48722769|NCT00576472|102108241|FG010|COMPLETED|Initial Screening||0||
48722770|NCT00576472|102108242|FG011|COMPLETED|Initial Screening||0||
48722771|NCT00576472|102108243|FG012|COMPLETED|Initial Screening||0||
48722772|NCT00576472|102108244|FG013|COMPLETED|Initial Screening||0||
48722773|NCT00576472|102108245|FG014|COMPLETED|Initial Screening||0||
48722774|NCT00576472|102108231|FG000|NOT COMPLETED|Initial Screening||0||
48722775|NCT00576472|102108232|FG001|NOT COMPLETED|Initial Screening||0||
48722776|NCT00576472|102108233|FG002|NOT COMPLETED|Initial Screening||0||
48722777|NCT00576472|102108234|FG003|NOT COMPLETED|Initial Screening||0||
48722778|NCT00576472|102108235|FG004|NOT COMPLETED|Initial Screening||0||
48722779|NCT00576472|102108236|FG005|NOT COMPLETED|Initial Screening||0||
48722780|NCT00576472|102108237|FG006|NOT COMPLETED|Initial Screening||0||
48722781|NCT00576472|102108238|FG007|NOT COMPLETED|Initial Screening||0||
48722782|NCT00576472|102108239|FG008|NOT COMPLETED|Initial Screening||0||
48722783|NCT00576472|102108240|FG009|NOT COMPLETED|Initial Screening||0||
48722784|NCT00576472|102108241|FG010|NOT COMPLETED|Initial Screening||0||
48722785|NCT00576472|102108242|FG011|NOT COMPLETED|Initial Screening||0||
48722786|NCT00576472|102108243|FG012|NOT COMPLETED|Initial Screening||0||
48610722|NCT01827592|101830499|FG000|NOT COMPLETED|Overall Study||74||
48610723|NCT01827592|101830500|FG001|NOT COMPLETED|Overall Study||80||
48722787|NCT00576472|102108244|FG013|NOT COMPLETED|Initial Screening||0||
48610724|NCT01827592|101830501|FG002|NOT COMPLETED|Overall Study||76||
48610725|NCT04304508|101830502|FG000|STARTED|Overall Study||455|Full analysis set (FAS)|
48610726|NCT04304508|101830503|FG001|STARTED|Overall Study||450|Full analysis set (FAS)|
48722788|NCT00576472|102108245|FG014|NOT COMPLETED|Initial Screening||0||
48722789|NCT00576472|102108231|FG000|STARTED|MPH In-Lab Phase||0||
48722790|NCT00576472|102108232|FG001|STARTED|MPH In-Lab Phase||0||
48308446|NCT04411628|101080952|FG000|COMPLETED|Overall Study||6||
48308447|NCT04411628|101080953|FG001|COMPLETED|Overall Study||4||
48308448|NCT04411628|101080954|FG002|COMPLETED|Overall Study||5||
48308449|NCT04411628|101080955|FG003|COMPLETED|Overall Study||6||
48308450|NCT04411628|101080952|FG000|NOT COMPLETED|Overall Study||1||
48308451|NCT04411628|101080953|FG001|NOT COMPLETED|Overall Study||2||
48308452|NCT04411628|101080954|FG002|NOT COMPLETED|Overall Study||2||
48308453|NCT04411628|101080955|FG003|NOT COMPLETED|Overall Study||0||
48308454|NCT03312348|101080956|FG000|STARTED|Overall Study||30||
48308455|NCT03312348|101080956|FG000|COMPLETED|Overall Study||30||
48308456|NCT03312348|101080956|FG000|NOT COMPLETED|Overall Study||0||
48308457|NCT03768505|101080957|FG000|STARTED|Overall Study||169||
48308458|NCT03768505|101080957|FG000|COMPLETED|Overall Study||0||
48308459|NCT03768505|101080957|FG000|NOT COMPLETED|Overall Study||169||
48308460|NCT02053909|101080958|FG000|STARTED|Overall Study||123||
48308461|NCT02053909|101080959|FG001|STARTED|Overall Study||127||
48308462|NCT02053909|101080958|FG000|COMPLETED|Overall Study||123||
48308463|NCT02053909|101080959|FG001|COMPLETED|Overall Study||127||
48308464|NCT02053909|101080958|FG000|NOT COMPLETED|Overall Study||0||
48308465|NCT02053909|101080959|FG001|NOT COMPLETED|Overall Study||0||
48308466|NCT00210184|101080960|FG000|STARTED|Overall Study||42||
48308467|NCT00210184|101080960|FG000|COMPLETED|Overall Study||40||
48308468|NCT00210184|101080960|FG000|NOT COMPLETED|Overall Study||2||
48308469|NCT00591825|101080961|FG000|STARTED|Overall Study||14||
48308470|NCT00591825|101080962|FG001|STARTED|Overall Study||13||
48308471|NCT00591825|101080963|FG002|STARTED|Overall Study||13||
48308472|NCT00591825|101080964|FG003|STARTED|Overall Study||14||
48308473|NCT00591825|101080961|FG000|COMPLETED|Overall Study||14||
48308474|NCT00591825|101080962|FG001|COMPLETED|Overall Study||13||
48308475|NCT00591825|101080963|FG002|COMPLETED|Overall Study||13||
48308476|NCT00591825|101080964|FG003|COMPLETED|Overall Study||14||
48308477|NCT00591825|101080961|FG000|NOT COMPLETED|Overall Study||0||
48308478|NCT00591825|101080962|FG001|NOT COMPLETED|Overall Study||0||
48308479|NCT00591825|101080963|FG002|NOT COMPLETED|Overall Study||0||
48308480|NCT00591825|101080964|FG003|NOT COMPLETED|Overall Study||0||
48308481|NCT01200238|101080965|FG000|STARTED|Overall Study||7||
48308482|NCT01200238|101080966|FG001|STARTED|Overall Study||10||
48308483|NCT01200238|101080965|FG000|COMPLETED|Overall Study||0||
48308484|NCT01200238|101080966|FG001|COMPLETED|Overall Study||0||
48308485|NCT01200238|101080965|FG000|NOT COMPLETED|Overall Study||7||
48308486|NCT01200238|101080966|FG001|NOT COMPLETED|Overall Study||10||
48308487|NCT02294682|101080967|FG000|STARTED|Overall Study||53||
48308488|NCT02294682|101080968|FG001|STARTED|Overall Study||53||
48308489|NCT02294682|101080967|FG000|COMPLETED|Overall Study||52||
48308490|NCT02294682|101080968|FG001|COMPLETED|Overall Study||53||
48308491|NCT02294682|101080967|FG000|NOT COMPLETED|Overall Study||1||
48308492|NCT02294682|101080968|FG001|NOT COMPLETED|Overall Study||0||
48308493|NCT00993954|101080969|FG000|STARTED|Overall Study||145||
48308494|NCT00993954|101080970|FG001|STARTED|Overall Study||123||
48308495|NCT00993954|101080969|FG000|COMPLETED|Overall Study||124||
48308496|NCT00993954|101080970|FG001|COMPLETED|Overall Study||121||
48308497|NCT00993954|101080969|FG000|NOT COMPLETED|Overall Study||21||
48308498|NCT00993954|101080970|FG001|NOT COMPLETED|Overall Study||2||
48308499|NCT00732251|101080971|FG000|STARTED|Overall Study||8||
48308500|NCT00732251|101080971|FG000|COMPLETED|Overall Study||1||
48308501|NCT00732251|101080971|FG000|NOT COMPLETED|Overall Study||7||
48308502|NCT01105091|101080972|FG000|STARTED|Overall Study||20||
48308503|NCT01105091|101080973|FG001|STARTED|Overall Study||10||
48308504|NCT01105091|101080972|FG000|COMPLETED|Overall Study||18||
48308505|NCT01105091|101080973|FG001|COMPLETED|Overall Study||10||
48308506|NCT01105091|101080972|FG000|NOT COMPLETED|Overall Study||2||
48308507|NCT01105091|101080973|FG001|NOT COMPLETED|Overall Study||0||
48308508|NCT01493557|101080974|FG000|STARTED|Not Randomized to Management Strategies||0||
48308509|NCT01493557|101080975|FG001|STARTED|Not Randomized to Management Strategies||0||
48308510|NCT01493557|101080976|FG002|STARTED|Not Randomized to Management Strategies||950||
48308511|NCT01493557|101080974|FG000|Without Experiencing GIS|Not Randomized to Management Strategies||0||
48308512|NCT01493557|101080975|FG001|Without Experiencing GIS|Not Randomized to Management Strategies||0||
48308513|NCT01493557|101080976|FG002|Without Experiencing GIS|Not Randomized to Management Strategies||854||
48308514|NCT01493557|101080974|FG000|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0||
48308515|NCT01493557|101080975|FG001|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0||
48308516|NCT01493557|101080976|FG002|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||48||
48308517|NCT01493557|101080974|FG000|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0||
48406498|NCT01010776|101328436|FG000|COMPLETED|In-Between Main Phase & Extension Phase||159||
48406499|NCT01010776|101328436|FG000|NOT COMPLETED|In-Between Main Phase & Extension Phase||15||
48406500|NCT01010776|101328436|FG000|STARTED|Extension Phase||159||
48406501|NCT01010776|101328436|FG000|COMPLETED|Extension Phase||156||
48406502|NCT01010776|101328436|FG000|NOT COMPLETED|Extension Phase||3||
48406503|NCT00852761|101328437|FG000|STARTED|Overall Study||17||
48406504|NCT00852761|101328438|FG001|STARTED|Overall Study||17||
48406505|NCT00852761|101328437|FG000|COMPLETED|Overall Study||17||
48722791|NCT00576472|102108233|FG002|STARTED|MPH In-Lab Phase||0||
48722792|NCT00576472|102108234|FG003|STARTED|MPH In-Lab Phase||335||
48722793|NCT00576472|102108235|FG004|STARTED|MPH In-Lab Phase||67||
48722794|NCT00576472|102108236|FG005|STARTED|MPH In-Lab Phase||67||
48722795|NCT00576472|102108237|FG006|STARTED|MPH In-Lab Phase||0||
48722796|NCT00576472|102108238|FG007|STARTED|MPH In-Lab Phase||0||
48722797|NCT00576472|102108239|FG008|STARTED|MPH In-Lab Phase||0||
48722798|NCT00576472|102108240|FG009|STARTED|MPH In-Lab Phase||0||
48722799|NCT00576472|102108241|FG010|STARTED|MPH In-Lab Phase||0||
48722800|NCT00576472|102108242|FG011|STARTED|MPH In-Lab Phase||0||
48722801|NCT00576472|102108243|FG012|STARTED|MPH In-Lab Phase||0||
48722802|NCT00576472|102108244|FG013|STARTED|MPH In-Lab Phase||0||
48722803|NCT00576472|102108245|FG014|STARTED|MPH In-Lab Phase||0||
48722804|NCT00576472|102108231|FG000|COMPLETED|MPH In-Lab Phase||0||
48722805|NCT00576472|102108232|FG001|COMPLETED|MPH In-Lab Phase||0||
48722806|NCT00576472|102108233|FG002|COMPLETED|MPH In-Lab Phase||0||
48722807|NCT00576472|102108234|FG003|COMPLETED|MPH In-Lab Phase||0||
48722808|NCT00576472|102108235|FG004|COMPLETED|MPH In-Lab Phase||67||
48722809|NCT00576472|102108236|FG005|COMPLETED|MPH In-Lab Phase||67||
48722810|NCT00576472|102108237|FG006|COMPLETED|MPH In-Lab Phase||0||
48722811|NCT00576472|102108238|FG007|COMPLETED|MPH In-Lab Phase||0||
48722812|NCT00576472|102108239|FG008|COMPLETED|MPH In-Lab Phase||0||
48722813|NCT00576472|102108240|FG009|COMPLETED|MPH In-Lab Phase||0||
48722814|NCT00576472|102108241|FG010|COMPLETED|MPH In-Lab Phase||0||
48722815|NCT00576472|102108242|FG011|COMPLETED|MPH In-Lab Phase||0||
48722816|NCT00576472|102108243|FG012|COMPLETED|MPH In-Lab Phase||0||
48722817|NCT00576472|102108244|FG013|COMPLETED|MPH In-Lab Phase||0||
48722818|NCT00576472|102108245|FG014|COMPLETED|MPH In-Lab Phase||0||
48722819|NCT00576472|102108231|FG000|NOT COMPLETED|MPH In-Lab Phase||0||
48722820|NCT00576472|102108232|FG001|NOT COMPLETED|MPH In-Lab Phase||0||
48722821|NCT00576472|102108233|FG002|NOT COMPLETED|MPH In-Lab Phase||0||
48722822|NCT00576472|102108234|FG003|NOT COMPLETED|MPH In-Lab Phase||335||
48722823|NCT00576472|102108235|FG004|NOT COMPLETED|MPH In-Lab Phase||0||
48722824|NCT00576472|102108236|FG005|NOT COMPLETED|MPH In-Lab Phase||0||
48722825|NCT00576472|102108237|FG006|NOT COMPLETED|MPH In-Lab Phase||0||
48722826|NCT00576472|102108238|FG007|NOT COMPLETED|MPH In-Lab Phase||0||
48722827|NCT00576472|102108239|FG008|NOT COMPLETED|MPH In-Lab Phase||0||
48722828|NCT00576472|102108240|FG009|NOT COMPLETED|MPH In-Lab Phase||0||
48722829|NCT00576472|102108241|FG010|NOT COMPLETED|MPH In-Lab Phase||0||
48722830|NCT00576472|102108242|FG011|NOT COMPLETED|MPH In-Lab Phase||0||
48722831|NCT00576472|102108243|FG012|NOT COMPLETED|MPH In-Lab Phase||0||
48722832|NCT00576472|102108244|FG013|NOT COMPLETED|MPH In-Lab Phase||0||
48722833|NCT00576472|102108245|FG014|NOT COMPLETED|MPH In-Lab Phase||0||
48722834|NCT00576472|102108231|FG000|STARTED|MPH Cross Over Phase||0||
48722835|NCT00576472|102108232|FG001|STARTED|MPH Cross Over Phase||0||
48308518|NCT01493557|101080975|FG001|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0||
48308519|NCT01493557|101080976|FG002|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||48||
48308520|NCT01493557|101080974|FG000|COMPLETED|Not Randomized to Management Strategies||0||
48308521|NCT01493557|101080975|FG001|COMPLETED|Not Randomized to Management Strategies||0||
48406506|NCT00852761|101328438|FG001|COMPLETED|Overall Study||17||
48406507|NCT00852761|101328437|FG000|NOT COMPLETED|Overall Study||0||
48406508|NCT00852761|101328438|FG001|NOT COMPLETED|Overall Study||0||
48406509|NCT02603172|101328439|FG000|STARTED|Part A (Approximately 16 Weeks)||7||
48722836|NCT00576472|102108233|FG002|STARTED|MPH Cross Over Phase||0||
48722837|NCT00576472|102108234|FG003|STARTED|MPH Cross Over Phase||0||
48722838|NCT00576472|102108235|FG004|STARTED|MPH Cross Over Phase||0||
48722839|NCT00576472|102108236|FG005|STARTED|MPH Cross Over Phase||0||
48722840|NCT00576472|102108237|FG006|STARTED|MPH Cross Over Phase||12||
48722841|NCT00576472|102108238|FG007|STARTED|MPH Cross Over Phase||20||
48722842|NCT00576472|102108239|FG008|STARTED|MPH Cross Over Phase||18||
48722843|NCT00576472|102108240|FG009|STARTED|MPH Cross Over Phase||22||
48722844|NCT00576472|102108241|FG010|STARTED|MPH Cross Over Phase||23||
48722845|NCT00576472|102108242|FG011|STARTED|MPH Cross Over Phase||18||
48722846|NCT00576472|102108243|FG012|STARTED|MPH Cross Over Phase||21||
48722847|NCT00576472|102108244|FG013|STARTED|MPH Cross Over Phase||0||
48722848|NCT00576472|102108245|FG014|STARTED|MPH Cross Over Phase||0||
48722849|NCT00576472|102108231|FG000|COMPLETED|MPH Cross Over Phase||0||
48406510|NCT02603172|101328440|FG001|STARTED|Part A (Approximately 16 Weeks)||1||
48406511|NCT02603172|101328441|FG002|STARTED|Part A (Approximately 16 Weeks)||8||
48406512|NCT02603172|101328442|FG003|STARTED|Part A (Approximately 16 Weeks)||1||
48406513|NCT02603172|101328443|FG004|STARTED|Part A (Approximately 16 Weeks)||0||
48406514|NCT02603172|101328444|FG005|STARTED|Part A (Approximately 16 Weeks)||0||
48406515|NCT02603172|101328445|FG006|STARTED|Part A (Approximately 16 Weeks)||0||
48722850|NCT00576472|102108232|FG001|COMPLETED|MPH Cross Over Phase||0||
48722851|NCT00576472|102108233|FG002|COMPLETED|MPH Cross Over Phase||0||
48406516|NCT02603172|101328446|FG007|STARTED|Part A (Approximately 16 Weeks)||0||
48406517|NCT02603172|101328439|FG000|COMPLETED|Part A (Approximately 16 Weeks)||7||
48406518|NCT02603172|101328440|FG001|COMPLETED|Part A (Approximately 16 Weeks)||1||
48722852|NCT00576472|102108234|FG003|COMPLETED|MPH Cross Over Phase||0||
48406519|NCT02603172|101328441|FG002|COMPLETED|Part A (Approximately 16 Weeks)||7||
48406520|NCT02603172|101328442|FG003|COMPLETED|Part A (Approximately 16 Weeks)||1||
48722853|NCT00576472|102108235|FG004|COMPLETED|MPH Cross Over Phase||0||
48722854|NCT00576472|102108236|FG005|COMPLETED|MPH Cross Over Phase||0||
48610727|NCT04304508|101830504|FG002|STARTED|Overall Study||447|Full analysis set (FAS)|
48610728|NCT04304508|101830505|FG003|STARTED|Overall Study||456|Full analysis set (FAS)|
48406521|NCT02603172|101328443|FG004|COMPLETED|Part A (Approximately 16 Weeks)||0||
48406522|NCT02603172|101328444|FG005|COMPLETED|Part A (Approximately 16 Weeks)||0||
48406523|NCT02603172|101328445|FG006|COMPLETED|Part A (Approximately 16 Weeks)||0||
48406524|NCT02603172|101328446|FG007|COMPLETED|Part A (Approximately 16 Weeks)||0||
48610729|NCT04304508|101830502|FG000|Treated|Overall Study||445|Safety analysis set (SAF)|
48657083|NCT03648372|101943760|FG003|NOT COMPLETED|Overall Study||3||
48406525|NCT02603172|101328439|FG000|NOT COMPLETED|Part A (Approximately 16 Weeks)||0||
48610730|NCT04304508|101830503|FG001|Treated|Overall Study||446|Safety analysis set (SAF)|
48610731|NCT04304508|101830504|FG002|Treated|Overall Study||443|Safety analysis set (SAF)|
48610732|NCT04304508|101830505|FG003|Treated|Overall Study||452|Safety analysis set (SAF)|
48610733|NCT04304508|101830502|FG000|COMPLETED|Overall Study||335||
48610734|NCT04304508|101830503|FG001|COMPLETED|Overall Study||329||
48610735|NCT04304508|101830504|FG002|COMPLETED|Overall Study||313||
48610736|NCT04304508|101830505|FG003|COMPLETED|Overall Study||314||
48610737|NCT04304508|101830502|FG000|NOT COMPLETED|Overall Study||120||
48610738|NCT04304508|101830503|FG001|NOT COMPLETED|Overall Study||121||
48610739|NCT04304508|101830504|FG002|NOT COMPLETED|Overall Study||134||
48610740|NCT04304508|101830505|FG003|NOT COMPLETED|Overall Study||142||
48610741|NCT02484092|101830506|FG000|STARTED|Overall Study||15||
48610742|NCT02484092|101830506|FG000|COMPLETED|Overall Study||15||
48610743|NCT02484092|101830506|FG000|NOT COMPLETED|Overall Study||0||
48610744|NCT02981914|101830507|FG000|STARTED|Overall Study||12||
48610745|NCT02981914|101830507|FG000|COMPLETED|Overall Study||12||
48308522|NCT01493557|101080976|FG002|COMPLETED|Not Randomized to Management Strategies||816||
48308523|NCT01493557|101080974|FG000|NOT COMPLETED|Not Randomized to Management Strategies||0||
48308524|NCT01493557|101080975|FG001|NOT COMPLETED|Not Randomized to Management Strategies||0||
48610746|NCT02981914|101830507|FG000|NOT COMPLETED|Overall Study||0||
48610747|NCT01859949|101830508|FG000|STARTED|Overall Study||29||
48610748|NCT01859949|101830509|FG001|STARTED|Overall Study||32||
48610749|NCT01859949|101830508|FG000|COMPLETED|Overall Study||15||
48610750|NCT01859949|101830509|FG001|COMPLETED|Overall Study||15||
48610751|NCT01859949|101830508|FG000|NOT COMPLETED|Overall Study||14||
48610752|NCT01859949|101830509|FG001|NOT COMPLETED|Overall Study||17||
48308525|NCT01493557|101080976|FG002|NOT COMPLETED|Not Randomized to Management Strategies||134||
48308526|NCT01493557|101080974|FG000|STARTED|Randomized to Management Strategies||59||
48308527|NCT01493557|101080975|FG001|STARTED|Randomized to Management Strategies||58||
48308528|NCT01493557|101080976|FG002|STARTED|Randomized to Management Strategies||0||
48308529|NCT01493557|101080974|FG000|COMPLETED|Randomized to Management Strategies||44||
48308530|NCT01493557|101080975|FG001|COMPLETED|Randomized to Management Strategies||47||
48308531|NCT01493557|101080976|FG002|COMPLETED|Randomized to Management Strategies||0||
48308532|NCT01493557|101080974|FG000|NOT COMPLETED|Randomized to Management Strategies||15||
48308533|NCT01493557|101080975|FG001|NOT COMPLETED|Randomized to Management Strategies||11||
48308534|NCT01493557|101080976|FG002|NOT COMPLETED|Randomized to Management Strategies||0||
48308535|NCT01493557|101080974|FG000|STARTED|Adding the Second Strategy||14||
48610753|NCT05568797|101830510|FG000|STARTED|Overall Study||523||
48610754|NCT05568797|101830511|FG001|STARTED|Overall Study||522||
48610755|NCT05568797|101830510|FG000|COMPLETED|Overall Study||518||
48610756|NCT05568797|101830511|FG001|COMPLETED|Overall Study||499||
48610757|NCT05568797|101830510|FG000|NOT COMPLETED|Overall Study||5||
48308536|NCT01493557|101080975|FG001|STARTED|Adding the Second Strategy||15||
48308537|NCT01493557|101080976|FG002|STARTED|Adding the Second Strategy||0||
48308538|NCT01493557|101080974|FG000|COMPLETED|Adding the Second Strategy||12||
48308539|NCT01493557|101080975|FG001|COMPLETED|Adding the Second Strategy||11||
48308540|NCT01493557|101080976|FG002|COMPLETED|Adding the Second Strategy||0||
48308541|NCT01493557|101080974|FG000|NOT COMPLETED|Adding the Second Strategy||2||
48610758|NCT05568797|101830511|FG001|NOT COMPLETED|Overall Study||23||
48610759|NCT03457818|101833888|FG000|STARTED|Overall Study||4||
48610760|NCT03457818|101833889|FG001|STARTED|Overall Study||4||
48610761|NCT03457818|101833888|FG000|COMPLETED|Overall Study||0||
48610762|NCT03457818|101833889|FG001|COMPLETED|Overall Study||0||
48610763|NCT03457818|101833888|FG000|NOT COMPLETED|Overall Study||4||
48308542|NCT01493557|101080975|FG001|NOT COMPLETED|Adding the Second Strategy||4||
48308543|NCT01493557|101080976|FG002|NOT COMPLETED|Adding the Second Strategy||0||
48308544|NCT00550654|101080977|FG000|STARTED|Overall Study||1||
48308545|NCT00550654|101080977|FG000|COMPLETED|Overall Study||1||
48308546|NCT00550654|101080977|FG000|NOT COMPLETED|Overall Study||0||
48308547|NCT00851682|101080978|FG000|STARTED|Overall Study||60||
48308548|NCT00851682|101080979|FG001|STARTED|Overall Study||5||
48610764|NCT03457818|101833889|FG001|NOT COMPLETED|Overall Study||4||
48610765|NCT00760487|101833890|FG000|STARTED|Overall Study||120||
48610766|NCT00760487|101833890|FG000|COMPLETED|Overall Study||117||
48722855|NCT00576472|102108237|FG006|COMPLETED|MPH Cross Over Phase||0||
48722856|NCT00576472|102108238|FG007|COMPLETED|MPH Cross Over Phase||20||
48722857|NCT00576472|102108239|FG008|COMPLETED|MPH Cross Over Phase||16||
48722858|NCT00576472|102108240|FG009|COMPLETED|MPH Cross Over Phase||22||
48610767|NCT00760487|101833890|FG000|NOT COMPLETED|Overall Study||3||
48610768|NCT02768792|101833891|FG000|STARTED|Overall Study||38||
48610769|NCT02768792|101833891|FG000|COMPLETED|Overall Study||37||
48610770|NCT02768792|101833891|FG000|NOT COMPLETED|Overall Study||1||
48610771|NCT02164318|101833892|FG000|STARTED|Overall Study||4||
48610772|NCT02164318|101833893|FG001|STARTED|Overall Study||3||
48610773|NCT02164318|101833894|FG002|STARTED|Overall Study||1||
48610774|NCT02164318|101833895|FG003|STARTED|Overall Study||3||
48610775|NCT02164318|101833892|FG000|COMPLETED|Overall Study||4||
48610776|NCT02164318|101833893|FG001|COMPLETED|Overall Study||2||
48610777|NCT02164318|101833894|FG002|COMPLETED|Overall Study||1||
48610778|NCT02164318|101833895|FG003|COMPLETED|Overall Study||2||
48610779|NCT02164318|101833892|FG000|NOT COMPLETED|Overall Study||0||
48610780|NCT02164318|101833893|FG001|NOT COMPLETED|Overall Study||1||
48610781|NCT02164318|101833894|FG002|NOT COMPLETED|Overall Study||0||
48722859|NCT00576472|102108241|FG010|COMPLETED|MPH Cross Over Phase||22||
48722860|NCT00576472|102108242|FG011|COMPLETED|MPH Cross Over Phase||17||
48722861|NCT00576472|102108243|FG012|COMPLETED|MPH Cross Over Phase||21||
48722862|NCT00576472|102108244|FG013|COMPLETED|MPH Cross Over Phase||0||
48610782|NCT02164318|101833895|FG003|NOT COMPLETED|Overall Study||1||
48610783|NCT01409915|101833896|FG000|STARTED|Overall Study||21||
48610784|NCT01409915|101833897|FG001|STARTED|Overall Study||23||
48722863|NCT00576472|102108245|FG014|COMPLETED|MPH Cross Over Phase||0||
48610785|NCT01409915|101833896|FG000|COMPLETED|Overall Study||20||
48610786|NCT01409915|101833897|FG001|COMPLETED|Overall Study||20||
48610787|NCT01409915|101833896|FG000|NOT COMPLETED|Overall Study||1||
48610788|NCT01409915|101833897|FG001|NOT COMPLETED|Overall Study||3||
48610789|NCT00397189|101833898|FG000|STARTED|3 Weeks Period||394||
48610790|NCT00397189|101833899|FG001|STARTED|3 Weeks Period||395||
48610791|NCT00397189|101833898|FG000|COMPLETED|3 Weeks Period||373||
48610792|NCT00397189|101833899|FG001|COMPLETED|3 Weeks Period||373||
48610793|NCT00397189|101833898|FG000|NOT COMPLETED|3 Weeks Period||21||
48610794|NCT00397189|101833899|FG001|NOT COMPLETED|3 Weeks Period||22||
48722864|NCT00576472|102108231|FG000|NOT COMPLETED|MPH Cross Over Phase||0||
48722865|NCT00576472|102108232|FG001|NOT COMPLETED|MPH Cross Over Phase||0||
48722866|NCT00576472|102108233|FG002|NOT COMPLETED|MPH Cross Over Phase||0||
48722867|NCT00576472|102108234|FG003|NOT COMPLETED|MPH Cross Over Phase||0||
48610795|NCT00397189|101833898|FG000|STARTED|Extension Period||534||
48610796|NCT00397189|101833899|FG001|STARTED|Extension Period||177||
48722868|NCT00576472|102108235|FG004|NOT COMPLETED|MPH Cross Over Phase||0||
48722869|NCT00576472|102108236|FG005|NOT COMPLETED|MPH Cross Over Phase||0||
48722870|NCT00576472|102108237|FG006|NOT COMPLETED|MPH Cross Over Phase||12||
48722871|NCT00576472|102108238|FG007|NOT COMPLETED|MPH Cross Over Phase||0||
48722872|NCT00576472|102108239|FG008|NOT COMPLETED|MPH Cross Over Phase||2||
48610797|NCT00397189|101833898|FG000|COMPLETED|Extension Period||421||
48610798|NCT00397189|101833899|FG001|COMPLETED|Extension Period||134||
48722873|NCT00576472|102108240|FG009|NOT COMPLETED|MPH Cross Over Phase||0||
48722874|NCT00576472|102108241|FG010|NOT COMPLETED|MPH Cross Over Phase||1||
48610799|NCT00397189|101833898|FG000|NOT COMPLETED|Extension Period||113||
48610800|NCT00397189|101833899|FG001|NOT COMPLETED|Extension Period||43||
48610801|NCT03790865|101833900|FG000|STARTED|Overall Study||52||
48308549|NCT00851682|101080978|FG000|COMPLETED|Overall Study||55||
48308550|NCT00851682|101080979|FG001|COMPLETED|Overall Study||5||
48610802|NCT03790865|101833901|FG001|STARTED|Overall Study||52||
48610803|NCT03790865|101833902|FG002|STARTED|Overall Study||54||
48610804|NCT03790865|101833900|FG000|COMPLETED|Overall Study||52||
48610805|NCT03790865|101833901|FG001|COMPLETED|Overall Study||50||
48610806|NCT03790865|101833902|FG002|COMPLETED|Overall Study||54||
48610807|NCT03790865|101833900|FG000|NOT COMPLETED|Overall Study||0||
48610808|NCT03790865|101833901|FG001|NOT COMPLETED|Overall Study||2||
48610809|NCT03790865|101833902|FG002|NOT COMPLETED|Overall Study||0||
48610810|NCT01721447|101833903|FG000|STARTED|Overall Study||100||
48308551|NCT00851682|101080978|FG000|NOT COMPLETED|Overall Study||5||
48308552|NCT00851682|101080979|FG001|NOT COMPLETED|Overall Study||0||
48308553|NCT00068588|101080980|FG000|STARTED|Overall Study||0||
48308554|NCT00068588|101080981|FG001|STARTED|Overall Study||3||
48308555|NCT00068588|101080982|FG002|STARTED|Overall Study||21||
48308556|NCT00068588|101080980|FG000|COMPLETED|Overall Study||0||
48308557|NCT00068588|101080981|FG001|COMPLETED|Overall Study||3||
48308558|NCT00068588|101080982|FG002|COMPLETED|Overall Study||17||
48308559|NCT00068588|101080980|FG000|NOT COMPLETED|Overall Study||0||
48308560|NCT00068588|101080981|FG001|NOT COMPLETED|Overall Study||0||
48308561|NCT00068588|101080982|FG002|NOT COMPLETED|Overall Study||4||
48308562|NCT04216251|101080983|FG000|STARTED|Overall Study||81||
48308563|NCT04216251|101080983|FG000|COMPLETED|Overall Study||73||
48308564|NCT04216251|101080983|FG000|NOT COMPLETED|Overall Study||8||
48308565|NCT00726622|101080984|FG000|STARTED|Overall Study||243||
48308566|NCT00726622|101080985|FG001|STARTED|Overall Study||243||
48308567|NCT00726622|101080984|FG000|COMPLETED|Overall Study||225||
48308568|NCT00726622|101080985|FG001|COMPLETED|Overall Study||240||
48308569|NCT00726622|101080984|FG000|NOT COMPLETED|Overall Study||18||
48308570|NCT00726622|101080985|FG001|NOT COMPLETED|Overall Study||3||
48308571|NCT03808688|101080986|FG000|STARTED|Overall Study||99||
48610811|NCT01721447|101833903|FG000|COMPLETED|Overall Study||100||
48610812|NCT01721447|101833903|FG000|NOT COMPLETED|Overall Study||0||
48610813|NCT04577794|101833904|FG000|STARTED|Overall Study||21||
48610814|NCT04577794|101833905|FG001|STARTED|Overall Study||10||
48610815|NCT04577794|101833904|FG000|COMPLETED|Overall Study||20||
48610816|NCT04577794|101833905|FG001|COMPLETED|Overall Study||9||
48610817|NCT04577794|101833904|FG000|NOT COMPLETED|Overall Study||1||
48610818|NCT04577794|101833905|FG001|NOT COMPLETED|Overall Study||1||
48610819|NCT00090870|101833906|FG000|STARTED|Overall Study||10||
48610820|NCT00090870|101833906|FG000|COMPLETED|Overall Study||10||
48610821|NCT00090870|101833906|FG000|NOT COMPLETED|Overall Study||0||
48610822|NCT00321906|101833907|FG000|STARTED|Overall Study||94||
48610823|NCT00321906|101833908|FG001|STARTED|Overall Study||87||
48610824|NCT00321906|101833907|FG000|COMPLETED|Overall Study||48||
48610825|NCT00321906|101833908|FG001|COMPLETED|Overall Study||31||
48610826|NCT00321906|101833907|FG000|NOT COMPLETED|Overall Study||46||
48610827|NCT00321906|101833908|FG001|NOT COMPLETED|Overall Study||56||
48610828|NCT02049983|101833909|FG000|STARTED|Overall Study||50||
48610829|NCT02049983|101833909|FG000|COMPLETED|Overall Study||50||
48610830|NCT02049983|101833909|FG000|NOT COMPLETED|Overall Study||0||
48610831|NCT01877668|101833910|FG000|STARTED|Overall Study||107||
48610832|NCT01877668|101833911|FG001|STARTED|Overall Study||104||
48610833|NCT01877668|101833912|FG002|STARTED|Overall Study||106||
48610834|NCT01877668|101833913|FG003|STARTED|Overall Study||52||
48308572|NCT03808688|101080987|FG001|STARTED|Overall Study||161||
48308573|NCT03808688|101080986|FG000|COMPLETED|Overall Study||81||
48308574|NCT03808688|101080987|FG001|COMPLETED|Overall Study||138||
48308575|NCT03808688|101080986|FG000|NOT COMPLETED|Overall Study||18||
48308576|NCT03808688|101080987|FG001|NOT COMPLETED|Overall Study||23||
48308577|NCT00791336|101080988|FG000|STARTED|Overall Study||1||
48308578|NCT00791336|101080988|FG000|COMPLETED|Overall Study||1||
48406526|NCT02603172|101328440|FG001|NOT COMPLETED|Part A (Approximately 16 Weeks)||0||
48308579|NCT00791336|101080988|FG000|NOT COMPLETED|Overall Study||0||
48308580|NCT02973087|101080989|FG000|STARTED|Overall Study||13||
48308581|NCT02973087|101080990|FG001|STARTED|Overall Study||10||
48308582|NCT02973087|101080989|FG000|COMPLETED|Overall Study||9||
48308583|NCT02973087|101080990|FG001|COMPLETED|Overall Study||8||
48308584|NCT02973087|101080989|FG000|NOT COMPLETED|Overall Study||4||
48308585|NCT02973087|101080990|FG001|NOT COMPLETED|Overall Study||2||
48308586|NCT00789867|101080991|FG000|STARTED|Overall Study||17||
48308587|NCT00789867|101080992|FG001|STARTED|Overall Study||10||
48308588|NCT00789867|101080993|FG002|STARTED|Overall Study||8||
48610835|NCT01877668|101833914|FG004|STARTED|Overall Study||53||
48610836|NCT01877668|101833910|FG000|COMPLETED|Overall Study||96||
48610837|NCT01877668|101833911|FG001|COMPLETED|Overall Study||96||
48610838|NCT01877668|101833912|FG002|COMPLETED|Overall Study||94||
48610839|NCT01877668|101833913|FG003|COMPLETED|Overall Study||44||
48610840|NCT01877668|101833914|FG004|COMPLETED|Overall Study||43||
48610841|NCT01877668|101833910|FG000|NOT COMPLETED|Overall Study||11||
48308589|NCT00789867|101080991|FG000|COMPLETED|Overall Study||17||
48308590|NCT00789867|101080992|FG001|COMPLETED|Overall Study||10||
48308591|NCT00789867|101080993|FG002|COMPLETED|Overall Study||8||
48308592|NCT00789867|101080991|FG000|NOT COMPLETED|Overall Study||0||
48308593|NCT00789867|101080992|FG001|NOT COMPLETED|Overall Study||0||
48308594|NCT00789867|101080993|FG002|NOT COMPLETED|Overall Study||0||
48308595|NCT04029116|101080994|FG000|STARTED|Overall Study||130||
48308596|NCT04029116|101080995|FG001|STARTED|Overall Study||130||
48308597|NCT04029116|101080994|FG000|Discontinued|Overall Study||12||
48610842|NCT01877668|101833911|FG001|NOT COMPLETED|Overall Study||8||
48610843|NCT01877668|101833912|FG002|NOT COMPLETED|Overall Study||12||
48610844|NCT01877668|101833913|FG003|NOT COMPLETED|Overall Study||8||
48610845|NCT01877668|101833914|FG004|NOT COMPLETED|Overall Study||10||
48610846|NCT00587795|101833915|FG000|STARTED|Overall Study||1||
48610847|NCT00587795|101833916|FG001|STARTED|Overall Study||0||
48610848|NCT00587795|101833915|FG000|COMPLETED|Overall Study||0||
48610849|NCT00587795|101833916|FG001|COMPLETED|Overall Study||0||
48610850|NCT00587795|101833915|FG000|NOT COMPLETED|Overall Study||1||
48610851|NCT00587795|101833916|FG001|NOT COMPLETED|Overall Study||0||
48610852|NCT03339713|101833917|FG000|STARTED|Overall Study||90||
48610853|NCT03339713|101833918|FG001|STARTED|Overall Study||90||
48610854|NCT03339713|101833917|FG000|COMPLETED|Overall Study||86||
48610855|NCT03339713|101833918|FG001|COMPLETED|Overall Study||88||
48308598|NCT04029116|101080995|FG001|Discontinued|Overall Study||16||
48610856|NCT03339713|101833917|FG000|NOT COMPLETED|Overall Study||4||
48610857|NCT03339713|101833918|FG001|NOT COMPLETED|Overall Study||2||
48610858|NCT03130959|101833919|FG000|STARTED|Overall Study||23|Started = initiated treatment|
48610859|NCT03130959|101833920|FG001|STARTED|Overall Study||22|Started = initiated treatment|
48610860|NCT03130959|101833921|FG002|STARTED|Overall Study||16|Started = initiated treatment|
48610861|NCT03130959|101833922|FG003|STARTED|Overall Study||15|Started = initiated treatment|
48610862|NCT03130959|101833923|FG004|STARTED|Overall Study||15|Started = initiated treatment|
48610863|NCT03130959|101833924|FG005|STARTED|Overall Study||15|Started = initiated treatment|
48610864|NCT03130959|101833925|FG006|STARTED|Overall Study||12|Started = initiated treatment|
48610865|NCT03130959|101833926|FG007|STARTED|Overall Study||10|Started = initiated treatment|
48610866|NCT03130959|101833927|FG008|STARTED|Overall Study||19|Started = initiated treatment|
48610867|NCT03130959|101833928|FG009|STARTED|Overall Study||19|Started = initiated treatment|
48610868|NCT03130959|101833919|FG000|COMPLETED|Overall Study||0|Completed = completed treatment|
48153049|NCT01089374|100699724|FG001|NOT COMPLETED|Overall Study||0||
48153050|NCT02054806|100699725|FG000|STARTED|Overall Study||477||
48153051|NCT02054806|100699725|FG000|Treated During First Course|Overall Study||475||
48153052|NCT02054806|100699725|FG000|Treated During Second Course|Overall Study||11||
48308599|NCT04029116|101080994|FG000|COMPLETED|Overall Study||118||
48308600|NCT04029116|101080995|FG001|COMPLETED|Overall Study||114||
48308601|NCT04029116|101080994|FG000|NOT COMPLETED|Overall Study||12||
48308602|NCT04029116|101080995|FG001|NOT COMPLETED|Overall Study||16||
48610869|NCT03130959|101833920|FG001|COMPLETED|Overall Study||12|Completed = completed treatment|
48610870|NCT03130959|101833921|FG002|COMPLETED|Overall Study||0|Completed = completed treatment|
48153053|NCT02054806|100699725|FG000|COMPLETED|Overall Study||0||
48153054|NCT02054806|100699725|FG000|NOT COMPLETED|Overall Study||477||
48153055|NCT00140205|100699726|FG000|STARTED|Overall Study||5||
48153056|NCT00140205|100699727|FG001|STARTED|Overall Study||5||
48153057|NCT00140205|100699728|FG002|STARTED|Overall Study||5||
48153058|NCT00140205|100699726|FG000|COMPLETED|Overall Study||5||
48153059|NCT00140205|100699727|FG001|COMPLETED|Overall Study||5||
48153060|NCT00140205|100699728|FG002|COMPLETED|Overall Study||5||
48153061|NCT00140205|100699726|FG000|NOT COMPLETED|Overall Study||0||
48153062|NCT00140205|100699727|FG001|NOT COMPLETED|Overall Study||0||
48308603|NCT00357214|101080996|FG000|STARTED|Overall Study||43||
48308604|NCT00357214|101080997|FG001|STARTED|Overall Study||43||
48308605|NCT00357214|101080998|FG002|STARTED|Overall Study||42||
48308606|NCT00357214|101080999|FG003|STARTED|Overall Study||43||
48657084|NCT03648372|101943761|FG004|NOT COMPLETED|Overall Study||3||
48153063|NCT00140205|100699728|FG002|NOT COMPLETED|Overall Study||0||
48153064|NCT00999466|100699729|FG000|STARTED|Pilot Part||6||
48153065|NCT00999466|100699730|FG001|STARTED|Pilot Part||0||
48153066|NCT00999466|100699731|FG002|STARTED|Pilot Part||3||
48153067|NCT00999466|100699729|FG000|COMPLETED|Pilot Part||6||
48153068|NCT00999466|100699730|FG001|COMPLETED|Pilot Part||0||
48153069|NCT00999466|100699731|FG002|COMPLETED|Pilot Part||3||
48153070|NCT00999466|100699729|FG000|NOT COMPLETED|Pilot Part||0||
48153071|NCT00999466|100699730|FG001|NOT COMPLETED|Pilot Part||0||
48153072|NCT00999466|100699731|FG002|NOT COMPLETED|Pilot Part||0||
48153073|NCT00999466|100699729|FG000|STARTED|Main Part||0||
48308607|NCT00357214|101080996|FG000|COMPLETED|Overall Study||39||
48308608|NCT00357214|101080997|FG001|COMPLETED|Overall Study||39||
48308609|NCT00357214|101080998|FG002|COMPLETED|Overall Study||42||
48308610|NCT00357214|101080999|FG003|COMPLETED|Overall Study||42||
48308611|NCT00357214|101080996|FG000|NOT COMPLETED|Overall Study||4||
48153074|NCT00999466|100699730|FG001|STARTED|Main Part||26||
48153075|NCT00999466|100699731|FG002|STARTED|Main Part||25||
48308612|NCT00357214|101080997|FG001|NOT COMPLETED|Overall Study||4||
48308613|NCT00357214|101080998|FG002|NOT COMPLETED|Overall Study||0||
48308614|NCT00357214|101080999|FG003|NOT COMPLETED|Overall Study||1||
48308615|NCT00798135|101081000|FG000|STARTED|Overall Study||13||
48308616|NCT00798135|101081000|FG000|COMPLETED|Overall Study||0||
48610871|NCT03130959|101833922|FG003|COMPLETED|Overall Study||1|Completed = completed treatment|
48610872|NCT03130959|101833923|FG004|COMPLETED|Overall Study||0|Completed = completed treatment|
48610873|NCT03130959|101833924|FG005|COMPLETED|Overall Study||9|Completed = completed treatment|
48610874|NCT03130959|101833925|FG006|COMPLETED|Overall Study||0|Completed = completed treatment|
48610875|NCT03130959|101833926|FG007|COMPLETED|Overall Study||6|Completed = completed treatment|
48610876|NCT03130959|101833927|FG008|COMPLETED|Overall Study||0|Completed = completed treatment|
48610877|NCT03130959|101833928|FG009|COMPLETED|Overall Study||4|Completed = completed treatment|
48610878|NCT03130959|101833919|FG000|NOT COMPLETED|Overall Study||23||
48610879|NCT03130959|101833920|FG001|NOT COMPLETED|Overall Study||10||
48610880|NCT03130959|101833921|FG002|NOT COMPLETED|Overall Study||16||
48610881|NCT03130959|101833922|FG003|NOT COMPLETED|Overall Study||14||
48610882|NCT03130959|101833923|FG004|NOT COMPLETED|Overall Study||15||
48610883|NCT03130959|101833924|FG005|NOT COMPLETED|Overall Study||6||
48610884|NCT03130959|101833925|FG006|NOT COMPLETED|Overall Study||12||
48610885|NCT03130959|101833926|FG007|NOT COMPLETED|Overall Study||4||
48610886|NCT03130959|101833927|FG008|NOT COMPLETED|Overall Study||19||
48610887|NCT03130959|101833928|FG009|NOT COMPLETED|Overall Study||15||
48610888|NCT00705341|101833929|FG000|STARTED|Phase 1:Control Challenge||126||
48610889|NCT00705341|101833930|FG001|STARTED|Phase 1:Control Challenge||93||
48610890|NCT00705341|101833931|FG002|STARTED|Phase 1:Control Challenge||0||
48610891|NCT00705341|101833932|FG003|STARTED|Phase 1:Control Challenge||0||
48610892|NCT00705341|101833929|FG000|COMPLETED|Phase 1:Control Challenge||126||
48610893|NCT00705341|101833930|FG001|COMPLETED|Phase 1:Control Challenge||93||
48610894|NCT00705341|101833931|FG002|COMPLETED|Phase 1:Control Challenge||0||
48610895|NCT00705341|101833932|FG003|COMPLETED|Phase 1:Control Challenge||0||
48610896|NCT00705341|101833929|FG000|NOT COMPLETED|Phase 1:Control Challenge||0||
48610897|NCT00705341|101833930|FG001|NOT COMPLETED|Phase 1:Control Challenge||0||
48610898|NCT00705341|101833931|FG002|NOT COMPLETED|Phase 1:Control Challenge||0||
48610899|NCT00705341|101833932|FG003|NOT COMPLETED|Phase 1:Control Challenge||0||
48610900|NCT00705341|101833929|FG000|STARTED|Phase 2: Trial||0||
48610901|NCT00705341|101833930|FG001|STARTED|Phase 2: Trial||0||
48610902|NCT00705341|101833931|FG002|STARTED|Phase 2: Trial||30||
48610903|NCT00705341|101833932|FG003|STARTED|Phase 2: Trial||32||
48610904|NCT00705341|101833929|FG000|COMPLETED|Phase 2: Trial||0||
48610905|NCT00705341|101833930|FG001|COMPLETED|Phase 2: Trial||0||
48610906|NCT00705341|101833931|FG002|COMPLETED|Phase 2: Trial||23||
48610907|NCT00705341|101833932|FG003|COMPLETED|Phase 2: Trial||28||
48610908|NCT00705341|101833929|FG000|NOT COMPLETED|Phase 2: Trial||0||
48610909|NCT00705341|101833930|FG001|NOT COMPLETED|Phase 2: Trial||0||
48610910|NCT00705341|101833931|FG002|NOT COMPLETED|Phase 2: Trial||7||
48610911|NCT00705341|101833932|FG003|NOT COMPLETED|Phase 2: Trial||4||
48610912|NCT01960465|101833933|FG000|STARTED|Overall Study||138||
48610913|NCT01960465|101833934|FG001|STARTED|Overall Study||82||
48610914|NCT01960465|101833933|FG000|COMPLETED|Overall Study||118||
48610915|NCT01960465|101833934|FG001|COMPLETED|Overall Study||73||
48610916|NCT01960465|101833933|FG000|NOT COMPLETED|Overall Study||20||
48610917|NCT01960465|101833934|FG001|NOT COMPLETED|Overall Study||9||
48610918|NCT04676152|101833935|FG000|STARTED|Overall Study||106||
48610919|NCT04676152|101833935|FG000|COMPLETED|Overall Study||97||
48610920|NCT04676152|101833935|FG000|NOT COMPLETED|Overall Study||9||
48610921|NCT00593918|101833936|FG000|STARTED|Overall Study||17||
48610922|NCT00593918|101833937|FG001|STARTED|Overall Study||74||
48610923|NCT00593918|101833936|FG000|COMPLETED|Overall Study||12||
48610924|NCT00593918|101833937|FG001|COMPLETED|Overall Study||50||
48610925|NCT00593918|101833936|FG000|NOT COMPLETED|Overall Study||5||
48308617|NCT00798135|101081000|FG000|NOT COMPLETED|Overall Study||13||
48308618|NCT03998176|101081001|FG000|STARTED|Overall Study||43||
48308619|NCT03998176|101081001|FG000|COMPLETED|Overall Study||31||
48308620|NCT03998176|101081001|FG000|NOT COMPLETED|Overall Study||12||
48308621|NCT00533468|101081002|FG000|STARTED|Overall Study||35||
48610926|NCT00593918|101833937|FG001|NOT COMPLETED|Overall Study||24||
48610927|NCT01223937|101833938|FG000|STARTED|Overall Study||131||
48610928|NCT01223937|101833939|FG001|STARTED|Overall Study||137||
48610929|NCT01223937|101833938|FG000|Full Analysis Set (FAS)|Overall Study||128||
48610930|NCT01223937|101833939|FG001|Full Analysis Set (FAS)|Overall Study||133||
48610931|NCT01223937|101833938|FG000|Safety Analysis Set (SAS)|Overall Study||126||
48610932|NCT01223937|101833939|FG001|Safety Analysis Set (SAS)|Overall Study||135||
48610933|NCT01223937|101833938|FG000|COMPLETED|Overall Study||114||
48610934|NCT01223937|101833939|FG001|COMPLETED|Overall Study||119||
48610935|NCT01223937|101833938|FG000|NOT COMPLETED|Overall Study||17||
48610936|NCT01223937|101833939|FG001|NOT COMPLETED|Overall Study||18||
48610937|NCT01666912|101833940|FG000|STARTED|Overall Study||48||
48610938|NCT01666912|101833941|FG001|STARTED|Overall Study||48||
48308622|NCT00533468|101081003|FG001|STARTED|Overall Study||35||
48308623|NCT00533468|101081002|FG000|COMPLETED|Overall Study||28||
48610939|NCT01666912|101833940|FG000|COMPLETED|Overall Study||27||
48610940|NCT01666912|101833941|FG001|COMPLETED|Overall Study||37||
48610941|NCT01666912|101833940|FG000|NOT COMPLETED|Overall Study||21||
48610942|NCT01666912|101833941|FG001|NOT COMPLETED|Overall Study||11||
48610943|NCT00549549|101833942|FG000|STARTED|Overall Study||101||
48610944|NCT00549549|101833943|FG001|STARTED|Overall Study||99||
48610945|NCT00549549|101833944|FG002|STARTED|Overall Study||99||
48610946|NCT00549549|101833945|FG003|STARTED|Overall Study||103||
48610947|NCT00549549|101833942|FG000|Treated|Overall Study||101||
48610948|NCT00549549|101833943|FG001|Treated|Overall Study||99||
48610949|NCT00549549|101833944|FG002|Treated|Overall Study||98||
48610950|NCT00549549|101833945|FG003|Treated|Overall Study||102||
48610951|NCT00549549|101833942|FG000|COMPLETED|Overall Study||77||
48610952|NCT00549549|101833943|FG001|COMPLETED|Overall Study||77||
48610953|NCT00549549|101833944|FG002|COMPLETED|Overall Study||82||
48610954|NCT00549549|101833945|FG003|COMPLETED|Overall Study||78||
48610955|NCT00549549|101833942|FG000|NOT COMPLETED|Overall Study||24||
48610956|NCT00549549|101833943|FG001|NOT COMPLETED|Overall Study||22||
48610957|NCT00549549|101833944|FG002|NOT COMPLETED|Overall Study||17||
48610958|NCT00549549|101833945|FG003|NOT COMPLETED|Overall Study||25||
48610959|NCT01871077|101833946|FG000|STARTED|Overall Study||30||60
48610960|NCT01871077|101833946|FG000|COMPLETED|Overall Study||30||60
48610961|NCT01871077|101833946|FG000|NOT COMPLETED|Overall Study||0||0
48610962|NCT00594230|101833947|FG000|STARTED|Overall Study||16||
48610963|NCT00594230|101833948|FG001|STARTED|Overall Study||10||
48610964|NCT00594230|101833947|FG000|COMPLETED|Overall Study||1||
48610965|NCT00594230|101833948|FG001|COMPLETED|Overall Study||1||
48610966|NCT00594230|101833947|FG000|NOT COMPLETED|Overall Study||15||
48610967|NCT00594230|101833948|FG001|NOT COMPLETED|Overall Study||9||
48610968|NCT02256917|101833949|FG000|STARTED|Pharmacokinetic (PK) Evaluation Phase||58||
48610969|NCT02256917|101833949|FG000|COMPLETED|Pharmacokinetic (PK) Evaluation Phase||58||
48610970|NCT02256917|101833949|FG000|NOT COMPLETED|Pharmacokinetic (PK) Evaluation Phase||0||
48610971|NCT02256917|101833949|FG000|STARTED|Prophylactic Treatment Phase I||57||
48610972|NCT02256917|101833949|FG000|COMPLETED|Prophylactic Treatment Phase I||56||
48610973|NCT02256917|101833949|FG000|NOT COMPLETED|Prophylactic Treatment Phase I||1||
48610974|NCT02256917|101833949|FG000|STARTED|Prophylactic Treatment Phase II||56||
48610975|NCT02256917|101833949|FG000|COMPLETED|Prophylactic Treatment Phase II||52||
48610976|NCT02256917|101833949|FG000|NOT COMPLETED|Prophylactic Treatment Phase II||4||
48610977|NCT01763827|101833950|FG000|STARTED|Overall Study||77||
48610978|NCT01763827|101833951|FG001|STARTED|Overall Study||78||
48610979|NCT01763827|101833952|FG002|STARTED|Overall Study||77||
48610980|NCT01763827|101833953|FG003|STARTED|Overall Study||77||
48610981|NCT01763827|101833954|FG004|STARTED|Overall Study||153||
48610982|NCT01763827|101833955|FG005|STARTED|Overall Study||153||
48610983|NCT01763827|101833950|FG000|Received at Least 1 Dose of Study Drug|Overall Study||76||
48610984|NCT01763827|101833951|FG001|Received at Least 1 Dose of Study Drug|Overall Study||78||
48610985|NCT01763827|101833952|FG002|Received at Least 1 Dose of Study Drug|Overall Study||77||
48610986|NCT01763827|101833953|FG003|Received at Least 1 Dose of Study Drug|Overall Study||77||
48610987|NCT01763827|101833954|FG004|Received at Least 1 Dose of Study Drug|Overall Study||153||
48610988|NCT01763827|101833955|FG005|Received at Least 1 Dose of Study Drug|Overall Study||153||
48610989|NCT01763827|101833950|FG000|COMPLETED|Overall Study||74||
48610990|NCT01763827|101833951|FG001|COMPLETED|Overall Study||77||
48610991|NCT01763827|101833952|FG002|COMPLETED|Overall Study||73||
48610992|NCT01763827|101833953|FG003|COMPLETED|Overall Study||76||
48610993|NCT01763827|101833954|FG004|COMPLETED|Overall Study||147||
48610994|NCT01763827|101833955|FG005|COMPLETED|Overall Study||151||
48610995|NCT01763827|101833950|FG000|NOT COMPLETED|Overall Study||3||
48610996|NCT01763827|101833951|FG001|NOT COMPLETED|Overall Study||1||
48610997|NCT01763827|101833952|FG002|NOT COMPLETED|Overall Study||4||
48610998|NCT01763827|101833953|FG003|NOT COMPLETED|Overall Study||1||
48610999|NCT01763827|101833954|FG004|NOT COMPLETED|Overall Study||6||
48611000|NCT01763827|101833955|FG005|NOT COMPLETED|Overall Study||2||
48611001|NCT01904032|101833956|FG000|STARTED|Overall Study||64||
48611002|NCT01904032|101833957|FG001|STARTED|Overall Study||65||
48611003|NCT01904032|101833956|FG000|COMPLETED|Overall Study||57||
48611004|NCT01904032|101833957|FG001|COMPLETED|Overall Study||62||
48611005|NCT01904032|101833956|FG000|NOT COMPLETED|Overall Study||7||
48611006|NCT01904032|101833957|FG001|NOT COMPLETED|Overall Study||3||
48611007|NCT00534638|101833958|FG000|STARTED|Overall Study||14837||
48611008|NCT00534638|101833959|FG001|STARTED|Overall Study||17338||
48611009|NCT00534638|101833958|FG000|COMPLETED|Overall Study||8346||
48611010|NCT00534638|101833959|FG001|COMPLETED|Overall Study||5547||
48611011|NCT00534638|101833958|FG000|NOT COMPLETED|Overall Study||6491||
48611012|NCT00534638|101833959|FG001|NOT COMPLETED|Overall Study||11791||
48611013|NCT00184002|101833960|FG000|STARTED|Overall Study||68||
48611014|NCT00184002|101833960|FG000|COMPLETED|Overall Study||51||
48611015|NCT00184002|101833960|FG000|NOT COMPLETED|Overall Study||17||
48611016|NCT01300247|101833961|FG000|STARTED|Overall Study||21||
48611017|NCT01300247|101833962|FG001|STARTED|Overall Study||20||
48611018|NCT01300247|101833961|FG000|COMPLETED|Overall Study||17||
48611019|NCT01300247|101833962|FG001|COMPLETED|Overall Study||18||
48611020|NCT01300247|101833961|FG000|NOT COMPLETED|Overall Study||4||
48611021|NCT01300247|101833962|FG001|NOT COMPLETED|Overall Study||2||
48611022|NCT01957579|101833963|FG000|STARTED|Overall Study||3||
48611023|NCT01957579|101833964|FG001|STARTED|Overall Study||7||
48611024|NCT01957579|101833965|FG002|STARTED|Overall Study||4||
48611025|NCT01957579|101833966|FG003|STARTED|Overall Study||6||
48611026|NCT01957579|101833963|FG000|COMPLETED|Overall Study||3||
48611027|NCT01957579|101833964|FG001|COMPLETED|Overall Study||6||
48611028|NCT01957579|101833965|FG002|COMPLETED|Overall Study||2||
48611029|NCT01957579|101833966|FG003|COMPLETED|Overall Study||6||
48611030|NCT01957579|101833963|FG000|NOT COMPLETED|Overall Study||0||
48611031|NCT01957579|101833964|FG001|NOT COMPLETED|Overall Study||1||
48611032|NCT01957579|101833965|FG002|NOT COMPLETED|Overall Study||2||
48611033|NCT01957579|101833966|FG003|NOT COMPLETED|Overall Study||0||
48611034|NCT01944644|101833967|FG000|STARTED|Overall Study||34||
48611035|NCT01944644|101833968|FG001|STARTED|Overall Study||32||
48611036|NCT01944644|101833967|FG000|COMPLETED|Overall Study||34||
48611037|NCT01944644|101833968|FG001|COMPLETED|Overall Study||32||
48611038|NCT01944644|101833967|FG000|NOT COMPLETED|Overall Study||0||
48611039|NCT01944644|101833968|FG001|NOT COMPLETED|Overall Study||0||
48611040|NCT00889915|101833969|FG000|STARTED|Overall Study||37||
48611041|NCT00889915|101833970|FG001|STARTED|Overall Study||76||
48611042|NCT00889915|101833971|FG002|STARTED|Overall Study||67||
48611043|NCT00889915|101833972|FG003|STARTED|Overall Study||48||
48611044|NCT00889915|101833969|FG000|COMPLETED|Overall Study||35||
48611045|NCT00889915|101833970|FG001|COMPLETED|Overall Study||71||
48611046|NCT00889915|101833971|FG002|COMPLETED|Overall Study||54||
48611047|NCT00889915|101833972|FG003|COMPLETED|Overall Study||40||
48611048|NCT00889915|101833969|FG000|NOT COMPLETED|Overall Study||2||
48611049|NCT00889915|101833970|FG001|NOT COMPLETED|Overall Study||5||
48611050|NCT00889915|101833971|FG002|NOT COMPLETED|Overall Study||13||
48611051|NCT00889915|101833972|FG003|NOT COMPLETED|Overall Study||8||
48611052|NCT00996034|101833973|FG000|STARTED|Overall Study||14||
48611053|NCT00996034|101833973|FG000|COMPLETED|Overall Study||11||
48611054|NCT00996034|101833973|FG000|NOT COMPLETED|Overall Study||3||
48611055|NCT00227019|101833974|FG000|STARTED|Overall Study||16||
48611056|NCT00227019|101833974|FG000|COMPLETED|Overall Study||16||
48611057|NCT00227019|101833974|FG000|NOT COMPLETED|Overall Study||0||
48611058|NCT03536663|101833975|FG000|STARTED|Optiflux||23||
48611059|NCT03536663|101833975|FG000|COMPLETED|Optiflux||19||
48308624|NCT00533468|101081003|FG001|COMPLETED|Overall Study||24||
48308625|NCT00533468|101081002|FG000|NOT COMPLETED|Overall Study||7||
48308626|NCT00533468|101081003|FG001|NOT COMPLETED|Overall Study||11||
48308627|NCT03422172|101081004|FG000|STARTED|Oral lead-in Phase (4 Weeks)||48||
48308628|NCT03422172|101081004|FG000|COMPLETED|Oral lead-in Phase (4 Weeks)||47||
48308629|NCT03422172|101081004|FG000|NOT COMPLETED|Oral lead-in Phase (4 Weeks)||1||
48308630|NCT03422172|101081004|FG000|STARTED|Washout (7 Days)||47||
48308631|NCT03422172|101081004|FG000|COMPLETED|Washout (7 Days)||47||
48308632|NCT03422172|101081004|FG000|NOT COMPLETED|Washout (7 Days)||0||
48308633|NCT03422172|101081004|FG000|STARTED|Injection Phase (Week 5 to Week 41)||47||
48308634|NCT03422172|101081004|FG000|COMPLETED|Injection Phase (Week 5 to Week 41)||43||
48308635|NCT03422172|101081004|FG000|NOT COMPLETED|Injection Phase (Week 5 to Week 41)||4||
48308636|NCT03422172|101081004|FG000|STARTED|Long Term Follow-up Phase(Upto Week 89)||43||
48611060|NCT03536663|101833975|FG000|NOT COMPLETED|Optiflux||4||
48611061|NCT03536663|101833975|FG000|STARTED|Endexo||18||
48611062|NCT03536663|101833975|FG000|COMPLETED|Endexo||17||
48611063|NCT03536663|101833975|FG000|NOT COMPLETED|Endexo||1||
48611064|NCT00217581|101833976|FG000|STARTED|Overall Study||39||
48611065|NCT00217581|101833976|FG000|COMPLETED|Overall Study||38||
48611066|NCT00217581|101833976|FG000|NOT COMPLETED|Overall Study||1||
48611067|NCT02821416|101833977|FG000|STARTED|Overall Study||23||
48611068|NCT02821416|101833978|FG001|STARTED|Overall Study||23||
48611069|NCT02821416|101833977|FG000|COMPLETED|Overall Study||20||
48611070|NCT02821416|101833978|FG001|COMPLETED|Overall Study||22||
48611071|NCT02821416|101833977|FG000|NOT COMPLETED|Overall Study||3||
48611072|NCT02821416|101833978|FG001|NOT COMPLETED|Overall Study||1||
48611073|NCT01841047|101833979|FG000|STARTED|Overall Study||48||
48611074|NCT01841047|101833979|FG000|COMPLETED|Overall Study||48||
48611075|NCT01841047|101833979|FG000|NOT COMPLETED|Overall Study||0||
48611076|NCT03705286|101833980|FG000|STARTED|Overall Study||533||
48611077|NCT03705286|101833981|FG001|STARTED|Overall Study||535||
48611078|NCT03705286|101833980|FG000|COMPLETED|Overall Study||87||
48611079|NCT03705286|101833981|FG001|COMPLETED|Overall Study||70||
48611080|NCT03705286|101833980|FG000|NOT COMPLETED|Overall Study||446||
48611081|NCT03705286|101833981|FG001|NOT COMPLETED|Overall Study||465||
48611082|NCT01852513|101833982|FG000|STARTED|Overall Study||20||
48611083|NCT01852513|101833983|FG001|STARTED|Overall Study||19||
48611084|NCT01852513|101833982|FG000|COMPLETED|Overall Study||20||
48611085|NCT01852513|101833983|FG001|COMPLETED|Overall Study||19||
48611086|NCT01852513|101833982|FG000|NOT COMPLETED|Overall Study||0||
48611087|NCT01852513|101833983|FG001|NOT COMPLETED|Overall Study||0||
48308637|NCT03422172|101081004|FG000|COMPLETED|Long Term Follow-up Phase(Upto Week 89)||43||
48308638|NCT03422172|101081004|FG000|NOT COMPLETED|Long Term Follow-up Phase(Upto Week 89)||0||
48611088|NCT04283253|101833984|FG000|STARTED|Overall Study||1||
48611089|NCT04283253|101833984|FG000|COMPLETED|Overall Study||1||
48611090|NCT04283253|101833984|FG000|NOT COMPLETED|Overall Study||0||
48611091|NCT01670045|101833985|FG000|STARTED|Overall Study||43||
48611092|NCT01670045|101833985|FG000|COMPLETED|Overall Study||27||
48611093|NCT01670045|101833985|FG000|NOT COMPLETED|Overall Study||16||
48611094|NCT01787006|101833986|FG000|STARTED|Overall Study||35||
48611095|NCT01787006|101833987|FG001|STARTED|Overall Study||39||
48611096|NCT01787006|101833986|FG000|COMPLETED|Overall Study||32||
48611097|NCT01787006|101833987|FG001|COMPLETED|Overall Study||36||
48611098|NCT01787006|101833986|FG000|NOT COMPLETED|Overall Study||3||
48611099|NCT01787006|101833987|FG001|NOT COMPLETED|Overall Study||3||
48611100|NCT01990573|101833988|FG000|STARTED|Overall Study||20||
48611101|NCT01990573|101833989|FG001|STARTED|Overall Study||14||
48611102|NCT01990573|101833990|FG002|STARTED|Overall Study||17||
48611103|NCT01990573|101833988|FG000|COMPLETED|Overall Study||20||
48611104|NCT01990573|101833989|FG001|COMPLETED|Overall Study||14||
48611105|NCT01990573|101833990|FG002|COMPLETED|Overall Study||16||
48611106|NCT01990573|101833988|FG000|NOT COMPLETED|Overall Study||0||
48611107|NCT01990573|101833989|FG001|NOT COMPLETED|Overall Study||0||
48611108|NCT01990573|101833990|FG002|NOT COMPLETED|Overall Study||1||
48611109|NCT03959527|101833991|FG000|STARTED|Overall Study||621||
48611110|NCT03959527|101833992|FG001|STARTED|Overall Study||309||
48611111|NCT03959527|101833991|FG000|COMPLETED|Overall Study||571||
48611112|NCT03959527|101833992|FG001|COMPLETED|Overall Study||285||
48611113|NCT03959527|101833991|FG000|NOT COMPLETED|Overall Study||50||
48611114|NCT03959527|101833992|FG001|NOT COMPLETED|Overall Study||24||
48611115|NCT02090283|101833993|FG000|STARTED|Overall Study||17||
48611116|NCT02090283|101833994|FG001|STARTED|Overall Study||15||
48611117|NCT02090283|101833995|FG002|STARTED|Overall Study||10||
48611118|NCT02090283|101833993|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||17||
48611119|NCT02090283|101833994|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||15||
48611120|NCT02090283|101833995|FG002|Received At Least 1 Dose Of Study Drug|Overall Study||10||
48611121|NCT02090283|101833993|FG000|COMPLETED|Overall Study||0||
48611122|NCT02090283|101833994|FG001|COMPLETED|Overall Study||0||
48611123|NCT02090283|101833995|FG002|COMPLETED|Overall Study||0||
48611124|NCT02090283|101833993|FG000|NOT COMPLETED|Overall Study||17||
48722875|NCT00576472|102108242|FG011|NOT COMPLETED|MPH Cross Over Phase||1||
48722876|NCT00576472|102108243|FG012|NOT COMPLETED|MPH Cross Over Phase||0||
48722877|NCT00576472|102108244|FG013|NOT COMPLETED|MPH Cross Over Phase||0||
48308639|NCT00074581|101081005|FG000|STARTED|Overall Study||1789||
48308640|NCT00074581|101081006|FG001|STARTED|Overall Study||1767||
48308641|NCT00074581|101081005|FG000|COMPLETED|Overall Study||1545||
48308642|NCT00074581|101081006|FG001|COMPLETED|Overall Study||1541||
48308643|NCT00074581|101081005|FG000|NOT COMPLETED|Overall Study||244||
48308644|NCT00074581|101081006|FG001|NOT COMPLETED|Overall Study||226||
48308645|NCT03530917|101081007|FG000|STARTED|Overall Study||8||
48308646|NCT03530917|101081008|FG001|STARTED|Overall Study||8||
48308647|NCT03530917|101081009|FG002|STARTED|Overall Study||8||
48308648|NCT03530917|101081010|FG003|STARTED|Overall Study||8||
48308649|NCT03530917|101081011|FG004|STARTED|Overall Study||8||
48308650|NCT03530917|101081012|FG005|STARTED|Overall Study||6||
48308651|NCT03530917|101081013|FG006|STARTED|Overall Study||8||
48308652|NCT03530917|101081014|FG007|STARTED|Overall Study||16||
48308653|NCT03530917|101081007|FG000|COMPLETED|Overall Study||8||
48308654|NCT03530917|101081008|FG001|COMPLETED|Overall Study||8||
48611125|NCT02090283|101833994|FG001|NOT COMPLETED|Overall Study||15||
48611126|NCT02090283|101833995|FG002|NOT COMPLETED|Overall Study||10||
48611127|NCT01098162|101833996|FG000|STARTED|Overall Study||573||
48611128|NCT01098162|101833996|FG000|COMPLETED|Overall Study||461||
48611129|NCT01098162|101833996|FG000|NOT COMPLETED|Overall Study||112||
48611130|NCT00765817|101833997|FG000|STARTED|Overall Study||138||
48611131|NCT00765817|101833998|FG001|STARTED|Overall Study||123||
48611132|NCT00765817|101833997|FG000|COMPLETED|Overall Study||112||
48611133|NCT00765817|101833998|FG001|COMPLETED|Overall Study||101||
48611134|NCT00765817|101833997|FG000|NOT COMPLETED|Overall Study||26||
48611135|NCT00765817|101833998|FG001|NOT COMPLETED|Overall Study||22||
48611136|NCT03746405|101833999|FG000|STARTED|Overall Study||10|Seven subjects were excluded before the second visit (when rTMS occured) and therefore were not randomized in the active or the sham group|
48611137|NCT03746405|101834000|FG001|STARTED|Overall Study||8|Seven subjects were excluded before the second visit (when rTMS occured) and therefore were not randomized in the active or the sham group|
48611138|NCT03746405|101833999|FG000|COMPLETED|Overall Study||7||
48611139|NCT03746405|101834000|FG001|COMPLETED|Overall Study||6||
48611140|NCT03746405|101833999|FG000|NOT COMPLETED|Overall Study||3||
48611141|NCT03746405|101834000|FG001|NOT COMPLETED|Overall Study||2||
48611142|NCT00972283|101834001|FG000|STARTED|Main: Week 0 to 52 (NN1250-3582)||755||
48611143|NCT00972283|101834002|FG001|STARTED|Main: Week 0 to 52 (NN1250-3582)||251||
48611144|NCT00972283|101834001|FG000|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)||744||
48611145|NCT00972283|101834002|FG001|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)||248||
48722878|NCT00576472|102108245|FG014|NOT COMPLETED|MPH Cross Over Phase||0||
48722879|NCT00576472|102108231|FG000|STARTED|MPH Home Maintenance Phase||0||
48722880|NCT00576472|102108232|FG001|STARTED|MPH Home Maintenance Phase||0||
48722881|NCT00576472|102108233|FG002|STARTED|MPH Home Maintenance Phase||0||
48308655|NCT03530917|101081009|FG002|COMPLETED|Overall Study||8||
48308656|NCT03530917|101081010|FG003|COMPLETED|Overall Study||8||
48611146|NCT00972283|101834001|FG000|Exposed|Main: Week 0 to 52 (NN1250-3582)||753||
48611147|NCT00972283|101834002|FG001|Exposed|Main: Week 0 to 52 (NN1250-3582)||251||
48611148|NCT00972283|101834001|FG000|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||618||
48611149|NCT00972283|101834002|FG001|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||211||
48611150|NCT00972283|101834001|FG000|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||137||
48611151|NCT00972283|101834002|FG001|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||40||
48611152|NCT00972283|101834001|FG000|STARTED|Extension: Week 53 to 78 (NN1250-3667)||566||
48611153|NCT00972283|101834002|FG001|STARTED|Extension: Week 53 to 78 (NN1250-3667)||191||
48611154|NCT00972283|101834001|FG000|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||539||
48611155|NCT00972283|101834002|FG001|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||183||
48611156|NCT00972283|101834001|FG000|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||27||
48611157|NCT00972283|101834002|FG001|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||8||
48611158|NCT01535443|101834003|FG000|STARTED|Overall Study||35||
48611159|NCT01535443|101834003|FG000|COMPLETED|Overall Study||32||
48611160|NCT01535443|101834003|FG000|NOT COMPLETED|Overall Study||3||
48611161|NCT02748057|101834004|FG000|STARTED|Overall Study||114||
48611162|NCT02748057|101834005|FG001|STARTED|Overall Study||21||
48611163|NCT02748057|101834004|FG000|COMPLETED|Overall Study||109||
48611164|NCT02748057|101834005|FG001|COMPLETED|Overall Study||19||
48611165|NCT02748057|101834004|FG000|NOT COMPLETED|Overall Study||5||
48611166|NCT02748057|101834005|FG001|NOT COMPLETED|Overall Study||2||
48611167|NCT03138577|101834006|FG000|STARTED|Overall Study||3||
48611168|NCT03138577|101834007|FG001|STARTED|Overall Study||3||
48611169|NCT03138577|101834008|FG002|STARTED|Overall Study||3||
48611170|NCT03138577|101834009|FG003|STARTED|Overall Study||3||
48611171|NCT03138577|101834010|FG004|STARTED|Overall Study||3||
48611172|NCT03138577|101834011|FG005|STARTED|Overall Study||3||
48611173|NCT03138577|101834012|FG006|STARTED|Overall Study||3||
48611174|NCT03138577|101834006|FG000|COMPLETED|Overall Study||3||
48611175|NCT03138577|101834007|FG001|COMPLETED|Overall Study||3||
48611176|NCT03138577|101834008|FG002|COMPLETED|Overall Study||3||
48611177|NCT03138577|101834009|FG003|COMPLETED|Overall Study||3||
48611178|NCT03138577|101834010|FG004|COMPLETED|Overall Study||3||
48611179|NCT03138577|101834011|FG005|COMPLETED|Overall Study||3||
48611180|NCT03138577|101834012|FG006|COMPLETED|Overall Study||3||
48611181|NCT03138577|101834006|FG000|NOT COMPLETED|Overall Study||0||
48611182|NCT03138577|101834007|FG001|NOT COMPLETED|Overall Study||0||
48611183|NCT03138577|101834008|FG002|NOT COMPLETED|Overall Study||0||
48611184|NCT03138577|101834009|FG003|NOT COMPLETED|Overall Study||0||
48611185|NCT03138577|101834010|FG004|NOT COMPLETED|Overall Study||0||
48611186|NCT03138577|101834011|FG005|NOT COMPLETED|Overall Study||0||
48611187|NCT03138577|101834012|FG006|NOT COMPLETED|Overall Study||0||
48611188|NCT01190189|101834013|FG000|STARTED|Overall Study||137||
48611189|NCT01190189|101834013|FG000|COMPLETED|Overall Study||131||
48611190|NCT01190189|101834013|FG000|NOT COMPLETED|Overall Study||6||
48611191|NCT01533948|101834014|FG000|STARTED|Overall Study||25||
48611192|NCT01533948|101834014|FG000|COMPLETED|Overall Study||25||
48611193|NCT01533948|101834014|FG000|NOT COMPLETED|Overall Study||0||
48611194|NCT02384538|101834015|FG000|STARTED|Overall Study||67||
48611195|NCT02384538|101834016|FG001|STARTED|Overall Study||64||
48611196|NCT02384538|101834015|FG000|COMPLETED|Overall Study||61||
48611197|NCT02384538|101834016|FG001|COMPLETED|Overall Study||49||
48611198|NCT02384538|101834015|FG000|NOT COMPLETED|Overall Study||6||
48611199|NCT02384538|101834016|FG001|NOT COMPLETED|Overall Study||15||
48611200|NCT02264210|101834017|FG000|STARTED|Overall Study||63||
48611201|NCT02264210|101834018|FG001|STARTED|Overall Study||65||
48611202|NCT02264210|101834017|FG000|COMPLETED|Overall Study||63||
48611203|NCT02264210|101834018|FG001|COMPLETED|Overall Study||65||
48611204|NCT02264210|101834017|FG000|NOT COMPLETED|Overall Study||0||
48611205|NCT02264210|101834018|FG001|NOT COMPLETED|Overall Study||0||
48611206|NCT02665741|101834019|FG000|STARTED|Overall Study||42||
48611207|NCT02665741|101834020|FG001|STARTED|Overall Study||42||
48611208|NCT02665741|101834021|FG002|STARTED|Overall Study||42||
48611209|NCT02665741|101834019|FG000|COMPLETED|Overall Study||42||
48611210|NCT02665741|101834020|FG001|COMPLETED|Overall Study||42||
48611211|NCT02665741|101834021|FG002|COMPLETED|Overall Study||42||
48611212|NCT02665741|101834019|FG000|NOT COMPLETED|Overall Study||0||
48611213|NCT02665741|101834020|FG001|NOT COMPLETED|Overall Study||0||
48611214|NCT02665741|101834021|FG002|NOT COMPLETED|Overall Study||0||
48611215|NCT04877990|101834022|FG000|STARTED|Pre-treatment||26|Started=Randomized|
48611216|NCT04877990|101834023|FG001|STARTED|Pre-treatment||41|Started=Randomized|
48611217|NCT04877990|101834022|FG000|COMPLETED|Pre-treatment||24|Completed=Treated|
48611218|NCT04877990|101834023|FG001|COMPLETED|Pre-treatment||41|Completed=Treated|
48611219|NCT04877990|101834022|FG000|NOT COMPLETED|Pre-treatment||2||
48611220|NCT04877990|101834023|FG001|NOT COMPLETED|Pre-treatment||0||
48611221|NCT04877990|101834022|FG000|STARTED|Treatment||24||
48611222|NCT04877990|101834023|FG001|STARTED|Treatment||41||
48611223|NCT04877990|101834022|FG000|COMPLETED|Treatment||0||
48611224|NCT04877990|101834023|FG001|COMPLETED|Treatment||0||
48611225|NCT04877990|101834022|FG000|NOT COMPLETED|Treatment||24||
48611226|NCT04877990|101834023|FG001|NOT COMPLETED|Treatment||41||
48611227|NCT05225389|101834024|FG000|STARTED|Overall Study||8||
48611228|NCT05225389|101834024|FG000|COMPLETED|Overall Study||5||
48611229|NCT05225389|101834024|FG000|NOT COMPLETED|Overall Study||3||
48611230|NCT02638974|101834025|FG000|STARTED|Overall Study||26||
48611231|NCT02638974|101834026|FG001|STARTED|Overall Study||25||
48611232|NCT02638974|101834025|FG000|COMPLETED|Overall Study||23||
48611233|NCT02638974|101834026|FG001|COMPLETED|Overall Study||22||
48611234|NCT02638974|101834025|FG000|NOT COMPLETED|Overall Study||3||
48611235|NCT02638974|101834026|FG001|NOT COMPLETED|Overall Study||3||
48611236|NCT04727528|101834027|FG000|STARTED|Open-label Period||39|Participants entered open-label period and received treatment|
48611237|NCT04727528|101834028|FG001|STARTED|Open-label Period||0|Participants entered open-label period and received treatment|
48611238|NCT04727528|101834027|FG000|COMPLETED|Open-label Period||37||
48611239|NCT04727528|101834028|FG001|COMPLETED|Open-label Period||0||
48153076|NCT00999466|100699729|FG000|COMPLETED|Main Part||0||
48153077|NCT00999466|100699730|FG001|COMPLETED|Main Part||22||
48153078|NCT00999466|100699731|FG002|COMPLETED|Main Part||21||
48406527|NCT02603172|101328441|FG002|NOT COMPLETED|Part A (Approximately 16 Weeks)||1||
48611240|NCT04727528|101834027|FG000|NOT COMPLETED|Open-label Period||2||
48153079|NCT00999466|100699729|FG000|NOT COMPLETED|Main Part||0||
48153080|NCT00999466|100699730|FG001|NOT COMPLETED|Main Part||4||
48153081|NCT00999466|100699731|FG002|NOT COMPLETED|Main Part||4||
48153082|NCT00977665|100699732|FG000|STARTED|Overall Study||84||
48611241|NCT04727528|101834028|FG001|NOT COMPLETED|Open-label Period||0||
48153083|NCT00977665|100699733|FG001|STARTED|Overall Study||90||
48153084|NCT00977665|100699732|FG000|COMPLETED|Overall Study||63||
48153085|NCT00977665|100699733|FG001|COMPLETED|Overall Study||75||
48153086|NCT00977665|100699732|FG000|NOT COMPLETED|Overall Study||21||
48153087|NCT00977665|100699733|FG001|NOT COMPLETED|Overall Study||15||
48153088|NCT00929162|100699734|FG000|STARTED|Overall Study||59||
48153089|NCT00929162|100699735|FG001|STARTED|Overall Study||61||
48153090|NCT00929162|100699734|FG000|Patients Who Received Treatment|Overall Study||58||
48153091|NCT00929162|100699735|FG001|Patients Who Received Treatment|Overall Study||58||
48153092|NCT00929162|100699734|FG000|COMPLETED|Overall Study||11||
48153093|NCT00929162|100699735|FG001|COMPLETED|Overall Study||19||
48153094|NCT00929162|100699734|FG000|NOT COMPLETED|Overall Study||48||
48153095|NCT00929162|100699735|FG001|NOT COMPLETED|Overall Study||42||
48153096|NCT02701985|100699736|FG000|STARTED|Overall Study||37||
48153097|NCT02701985|100699737|FG001|STARTED|Overall Study||38||
48153098|NCT02701985|100699736|FG000|COMPLETED|Overall Study||34||
48153099|NCT02701985|100699737|FG001|COMPLETED|Overall Study||32||
48153100|NCT02701985|100699736|FG000|NOT COMPLETED|Overall Study||3||
48153101|NCT02701985|100699737|FG001|NOT COMPLETED|Overall Study||6||
48153102|NCT02673398|100699738|FG000|STARTED|Overall Study||25||
48153103|NCT02673398|100699738|FG000|COMPLETED|Overall Study||25||
48153104|NCT02673398|100699738|FG000|NOT COMPLETED|Overall Study||0||
48153105|NCT01349920|100699739|FG000|STARTED|Overall Study||15||
48153106|NCT01349920|100699739|FG000|COMPLETED|Overall Study||15||
48153107|NCT01349920|100699739|FG000|NOT COMPLETED|Overall Study||0||
48153108|NCT02470494|100699740|FG000|STARTED|Overall Study||46||
48153109|NCT02470494|100699740|FG000|COMPLETED|Overall Study||41||
48153110|NCT02470494|100699740|FG000|NOT COMPLETED|Overall Study||5||
48153111|NCT01155154|100699741|FG000|STARTED|Overall Study||25||
48153112|NCT01155154|100699742|FG001|STARTED|Overall Study||24||
48153113|NCT01155154|100699743|FG002|STARTED|Overall Study||24||
48153114|NCT01155154|100699741|FG000|COMPLETED|Overall Study||25||
48153115|NCT01155154|100699742|FG001|COMPLETED|Overall Study||24||
48153116|NCT01155154|100699743|FG002|COMPLETED|Overall Study||24||
48722882|NCT00576472|102108234|FG003|STARTED|MPH Home Maintenance Phase||0||
48722883|NCT00576472|102108235|FG004|STARTED|MPH Home Maintenance Phase||0||
48722884|NCT00576472|102108236|FG005|STARTED|MPH Home Maintenance Phase||0||
48722885|NCT00576472|102108237|FG006|STARTED|MPH Home Maintenance Phase||0||
48722886|NCT00576472|102108238|FG007|STARTED|MPH Home Maintenance Phase||0||
48722887|NCT00576472|102108239|FG008|STARTED|MPH Home Maintenance Phase||0||
48722888|NCT00576472|102108240|FG009|STARTED|MPH Home Maintenance Phase||0||
48722889|NCT00576472|102108241|FG010|STARTED|MPH Home Maintenance Phase||0||
48722890|NCT00576472|102108242|FG011|STARTED|MPH Home Maintenance Phase||0||
48722891|NCT00576472|102108243|FG012|STARTED|MPH Home Maintenance Phase||0||
48722892|NCT00576472|102108244|FG013|STARTED|MPH Home Maintenance Phase||27||
48153117|NCT01155154|100699741|FG000|NOT COMPLETED|Overall Study||0||
48153118|NCT01155154|100699742|FG001|NOT COMPLETED|Overall Study||0||
48153119|NCT01155154|100699743|FG002|NOT COMPLETED|Overall Study||0||
48153120|NCT01393782|100699744|FG000|STARTED|Overall Study||10||
48153121|NCT01393782|100699745|FG001|STARTED|Overall Study||10||
48153122|NCT01393782|100699744|FG000|COMPLETED|Overall Study||10||
48153123|NCT01393782|100699745|FG001|COMPLETED|Overall Study||10||
48722893|NCT00576472|102108245|FG014|STARTED|MPH Home Maintenance Phase||91||
48153124|NCT01393782|100699744|FG000|NOT COMPLETED|Overall Study||0||
48153125|NCT01393782|100699745|FG001|NOT COMPLETED|Overall Study||0||
48153126|NCT01089231|100699746|FG000|STARTED|Overall Study||10||
48153127|NCT01089231|100699747|FG001|STARTED|Overall Study||10||
48153128|NCT01089231|100699748|FG002|STARTED|Overall Study||10||
48153129|NCT01089231|100699749|FG003|STARTED|Overall Study||10||
48153130|NCT01089231|100699746|FG000|COMPLETED|Overall Study||6||
48153131|NCT01089231|100699747|FG001|COMPLETED|Overall Study||8||
48153132|NCT01089231|100699748|FG002|COMPLETED|Overall Study||8||
48153133|NCT01089231|100699749|FG003|COMPLETED|Overall Study||9||
48153134|NCT01089231|100699746|FG000|NOT COMPLETED|Overall Study||4||
48153135|NCT01089231|100699747|FG001|NOT COMPLETED|Overall Study||2||
48153136|NCT01089231|100699748|FG002|NOT COMPLETED|Overall Study||2||
48153137|NCT01089231|100699749|FG003|NOT COMPLETED|Overall Study||1||
48153138|NCT03513757|100699750|FG000|STARTED|Overall Study||22||
48153139|NCT03513757|100699751|FG001|STARTED|Overall Study||18||
48153140|NCT03513757|100699750|FG000|COMPLETED|Overall Study||22||
48153141|NCT03513757|100699751|FG001|COMPLETED|Overall Study||18||
48153142|NCT03513757|100699750|FG000|NOT COMPLETED|Overall Study||0||
48153143|NCT03513757|100699751|FG001|NOT COMPLETED|Overall Study||0||
48153144|NCT01972529|100699752|FG000|STARTED|Overall Study||48||
48153145|NCT01972529|100699753|FG001|STARTED|Overall Study||90||
48153146|NCT01972529|100699754|FG002|STARTED|Overall Study||34||
48153147|NCT01972529|100699755|FG003|STARTED|Overall Study||59||
48153148|NCT01972529|100699752|FG000|COMPLETED|Overall Study||46||
48153149|NCT01972529|100699753|FG001|COMPLETED|Overall Study||85||
48153150|NCT01972529|100699754|FG002|COMPLETED|Overall Study||32||
48153151|NCT01972529|100699755|FG003|COMPLETED|Overall Study||55||
48153152|NCT01972529|100699752|FG000|NOT COMPLETED|Overall Study||2||
48153153|NCT01972529|100699753|FG001|NOT COMPLETED|Overall Study||5||
48153154|NCT01972529|100699754|FG002|NOT COMPLETED|Overall Study||2||
48153155|NCT01972529|100699755|FG003|NOT COMPLETED|Overall Study||4||
48153156|NCT03172702|100699756|FG000|STARTED|Overall Study||150|Started the CP|
48153157|NCT03172702|100699756|FG000|Received Treatment in CP|Overall Study||150||
48153158|NCT03172702|100699756|FG000|Received Treatment in MP|Overall Study||150||
48153159|NCT03172702|100699756|FG000|COMPLETED|Overall Study||122|Completed treatment in the MP|
48153160|NCT03172702|100699756|FG000|NOT COMPLETED|Overall Study||28||
48153161|NCT00409682|100699757|FG000|STARTED|Open-label Induction Period||192||
48153162|NCT00409682|100699758|FG001|STARTED|Open-label Induction Period||0||
48153163|NCT00409682|100699759|FG002|STARTED|Open-label Induction Period||0||
48153164|NCT00409682|100699757|FG000|COMPLETED|Open-label Induction Period||188||
48153165|NCT00409682|100699758|FG001|COMPLETED|Open-label Induction Period||0||
48153166|NCT00409682|100699759|FG002|COMPLETED|Open-label Induction Period||0||
48611242|NCT04727528|101834027|FG000|STARTED|Double-blind Treatment Phase||17||
48611243|NCT04727528|101834028|FG001|STARTED|Double-blind Treatment Phase||20||
48611244|NCT04727528|101834027|FG000|COMPLETED|Double-blind Treatment Phase||16||
48611245|NCT04727528|101834028|FG001|COMPLETED|Double-blind Treatment Phase||15||
48611246|NCT04727528|101834027|FG000|NOT COMPLETED|Double-blind Treatment Phase||1||
48153167|NCT00409682|100699757|FG000|NOT COMPLETED|Open-label Induction Period||4||
48153168|NCT00409682|100699758|FG001|NOT COMPLETED|Open-label Induction Period||0||
48153169|NCT00409682|100699759|FG002|NOT COMPLETED|Open-label Induction Period||0||
48153170|NCT00409682|100699757|FG000|STARTED|EOW Double-blind Maintenance Period||0||
48153171|NCT00409682|100699758|FG001|STARTED|EOW Double-blind Maintenance Period||95||
48153172|NCT00409682|100699759|FG002|STARTED|EOW Double-blind Maintenance Period||93||
48153173|NCT00409682|100699757|FG000|COMPLETED|EOW Double-blind Maintenance Period||0||
48153174|NCT00409682|100699758|FG001|COMPLETED|EOW Double-blind Maintenance Period||58||
48153175|NCT00409682|100699759|FG002|COMPLETED|EOW Double-blind Maintenance Period||66||
48153176|NCT00409682|100699757|FG000|NOT COMPLETED|EOW Double-blind Maintenance Period||0||
48153177|NCT00409682|100699758|FG001|NOT COMPLETED|EOW Double-blind Maintenance Period||37||
48153178|NCT00409682|100699759|FG002|NOT COMPLETED|EOW Double-blind Maintenance Period||27||
48153179|NCT01494584|100699760|FG000|STARTED|Overall Study||5||
48611247|NCT04727528|101834028|FG001|NOT COMPLETED|Double-blind Treatment Phase||5||
48611248|NCT04058028|101834029|FG000|STARTED|Overall Study||62||
48611249|NCT04058028|101834030|FG001|STARTED|Overall Study||58||
48611250|NCT04058028|101834031|FG002|STARTED|Overall Study||36||
48611251|NCT04058028|101834032|FG003|STARTED|Overall Study||88||
48611252|NCT04058028|101834029|FG000|COMPLETED|Overall Study||36||
48611253|NCT04058028|101834030|FG001|COMPLETED|Overall Study||44||
48611254|NCT04058028|101834031|FG002|COMPLETED|Overall Study||28||
48153180|NCT01494584|100699760|FG000|COMPLETED|Overall Study||4||
48153181|NCT01494584|100699760|FG000|NOT COMPLETED|Overall Study||1||
48153182|NCT00441090|100699761|FG000|STARTED|Overall Study||15||
48153183|NCT00441090|100699762|FG001|STARTED|Overall Study||15||
48153184|NCT00441090|100699763|FG002|STARTED|Overall Study||14||
48153185|NCT00441090|100699764|FG003|STARTED|Overall Study||15||
48153186|NCT00441090|100699765|FG004|STARTED|Overall Study||5||
48153187|NCT00441090|100699761|FG000|COMPLETED|Overall Study||13||
48153188|NCT00441090|100699762|FG001|COMPLETED|Overall Study||14||
48153189|NCT00441090|100699763|FG002|COMPLETED|Overall Study||12||
48153190|NCT00441090|100699764|FG003|COMPLETED|Overall Study||13||
48153191|NCT00441090|100699765|FG004|COMPLETED|Overall Study||5||
48153192|NCT00441090|100699761|FG000|NOT COMPLETED|Overall Study||2||
48153193|NCT00441090|100699762|FG001|NOT COMPLETED|Overall Study||1||
48153194|NCT00441090|100699763|FG002|NOT COMPLETED|Overall Study||2||
48153195|NCT00441090|100699764|FG003|NOT COMPLETED|Overall Study||2||
48153196|NCT00441090|100699765|FG004|NOT COMPLETED|Overall Study||0||
48153197|NCT03804710|100699766|FG000|STARTED|Overall Study||75||
48153198|NCT03804710|100699767|FG001|STARTED|Overall Study||74||
48153199|NCT03804710|100699766|FG000|COMPLETED|Overall Study||73||
48153200|NCT03804710|100699767|FG001|COMPLETED|Overall Study||69||
48153201|NCT03804710|100699766|FG000|NOT COMPLETED|Overall Study||2||
48153202|NCT03804710|100699767|FG001|NOT COMPLETED|Overall Study||5||
48153203|NCT01113502|100699768|FG000|STARTED|Overall Study||4||
48153204|NCT01113502|100699769|FG001|STARTED|Overall Study||3||
48153205|NCT01113502|100699770|FG002|STARTED|Overall Study||7||
48153206|NCT01113502|100699771|FG003|STARTED|Overall Study||9||
48153207|NCT01113502|100699772|FG004|STARTED|Overall Study||21||
48611255|NCT04058028|101834032|FG003|COMPLETED|Overall Study||46||
48611256|NCT04058028|101834029|FG000|NOT COMPLETED|Overall Study||26||
48611257|NCT04058028|101834030|FG001|NOT COMPLETED|Overall Study||14||
48611258|NCT04058028|101834031|FG002|NOT COMPLETED|Overall Study||8||
48611259|NCT04058028|101834032|FG003|NOT COMPLETED|Overall Study||42||
48611260|NCT00940888|101834033|FG000|STARTED|Overall Study||1701||
48611261|NCT00940888|101834033|FG000|COMPLETED|Overall Study||866||
48611262|NCT00940888|101834033|FG000|NOT COMPLETED|Overall Study||835||
48611263|NCT04541329|101834034|FG000|STARTED|Overall Study||7||
48153208|NCT01113502|100699768|FG000|COMPLETED|Overall Study||3||
48153209|NCT01113502|100699769|FG001|COMPLETED|Overall Study||3||
48153210|NCT01113502|100699770|FG002|COMPLETED|Overall Study||3||
48153211|NCT01113502|100699771|FG003|COMPLETED|Overall Study||6||
48153212|NCT01113502|100699772|FG004|COMPLETED|Overall Study||21||
48611264|NCT04541329|101834034|FG000|COMPLETED|Overall Study||7||
48611265|NCT04541329|101834034|FG000|NOT COMPLETED|Overall Study||0||
48611266|NCT02135016|101834035|FG000|STARTED|Overall Study||15||
48611267|NCT02135016|101834036|FG001|STARTED|Overall Study||15||
48611268|NCT02135016|101834037|FG002|STARTED|Overall Study||15||
48722894|NCT00576472|102108231|FG000|COMPLETED|MPH Home Maintenance Phase||0||
48722895|NCT00576472|102108232|FG001|COMPLETED|MPH Home Maintenance Phase||0||
48722896|NCT00576472|102108233|FG002|COMPLETED|MPH Home Maintenance Phase||0||
48722897|NCT00576472|102108234|FG003|COMPLETED|MPH Home Maintenance Phase||0||
48722898|NCT00576472|102108235|FG004|COMPLETED|MPH Home Maintenance Phase||0||
48611269|NCT02135016|101834035|FG000|COMPLETED|Overall Study||15||
48611270|NCT02135016|101834036|FG001|COMPLETED|Overall Study||15||
48611271|NCT02135016|101834037|FG002|COMPLETED|Overall Study||15||
48722899|NCT00576472|102108236|FG005|COMPLETED|MPH Home Maintenance Phase||0||
48722900|NCT00576472|102108237|FG006|COMPLETED|MPH Home Maintenance Phase||0||
48153213|NCT01113502|100699768|FG000|NOT COMPLETED|Overall Study||1||
48153214|NCT01113502|100699769|FG001|NOT COMPLETED|Overall Study||0||
48153215|NCT01113502|100699770|FG002|NOT COMPLETED|Overall Study||4||
48153216|NCT01113502|100699771|FG003|NOT COMPLETED|Overall Study||3||
48153217|NCT01113502|100699772|FG004|NOT COMPLETED|Overall Study||0||
48153218|NCT01043432|100699773|FG000|STARTED|Overall Study||22||
48153219|NCT01043432|100699774|FG001|STARTED|Overall Study||51||
48153220|NCT01043432|100699775|FG002|STARTED|Overall Study||12||
48153221|NCT01043432|100699776|FG003|STARTED|Overall Study||48||
48153222|NCT01043432|100699773|FG000|COMPLETED|Overall Study||22||
48153223|NCT01043432|100699774|FG001|COMPLETED|Overall Study||51||
48153224|NCT01043432|100699775|FG002|COMPLETED|Overall Study||12||
48153225|NCT01043432|100699776|FG003|COMPLETED|Overall Study||48||
48153226|NCT01043432|100699773|FG000|NOT COMPLETED|Overall Study||0||
48153227|NCT01043432|100699774|FG001|NOT COMPLETED|Overall Study||0||
48153228|NCT01043432|100699775|FG002|NOT COMPLETED|Overall Study||0||
48153229|NCT01043432|100699776|FG003|NOT COMPLETED|Overall Study||0||
48153230|NCT03802123|100699777|FG000|STARTED|Overall Study||52||
48153231|NCT03802123|100699777|FG000|COMPLETED|Overall Study||43||
48153232|NCT03802123|100699777|FG000|NOT COMPLETED|Overall Study||9||
48153233|NCT03295318|100699778|FG000|STARTED|Overall Study||150||
48153234|NCT03295318|100699779|FG001|STARTED|Overall Study||150||
48153235|NCT03295318|100699780|FG002|STARTED|Overall Study||76||
48153236|NCT03295318|100699778|FG000|Received First Vaccination|Overall Study||149||
48153237|NCT03295318|100699779|FG001|Received First Vaccination|Overall Study||150||
48153238|NCT03295318|100699780|FG002|Received First Vaccination|Overall Study||76||
48153239|NCT03295318|100699778|FG000|Received Second Vaccination|Overall Study||144||
48153240|NCT03295318|100699779|FG001|Received Second Vaccination|Overall Study||145||
48153241|NCT03295318|100699780|FG002|Received Second Vaccination|Overall Study||73||
48153242|NCT03295318|100699778|FG000|COMPLETED|Overall Study||144||
48153243|NCT03295318|100699779|FG001|COMPLETED|Overall Study||145||
48153244|NCT03295318|100699780|FG002|COMPLETED|Overall Study||71||
48153245|NCT03295318|100699778|FG000|NOT COMPLETED|Overall Study||6||
48153246|NCT03295318|100699779|FG001|NOT COMPLETED|Overall Study||5||
48611272|NCT02135016|101834035|FG000|NOT COMPLETED|Overall Study||0||
48611273|NCT02135016|101834036|FG001|NOT COMPLETED|Overall Study||0||
48611274|NCT02135016|101834037|FG002|NOT COMPLETED|Overall Study||0||
48611275|NCT02964338|101834038|FG000|STARTED|Overall Study||84|Intent-to-Treat (ITT) Analysis Set: All randomized participants|
48611276|NCT02964338|101834039|FG001|STARTED|Overall Study||88|Intent-to-Treat (ITT) Analysis Set: All randomized participants|
48611277|NCT02964338|101834040|FG002|STARTED|Overall Study||87|Intent-to-Treat (ITT) Analysis Set: All randomized participants|
48611278|NCT02964338|101834038|FG000|Safety Analysis Set|Overall Study||83|All randomized participants who received at least 1 dose of study drug.|
48611279|NCT02964338|101834039|FG001|Safety Analysis Set|Overall Study||88|All randomized participants who received at least 1 dose of study drug.|
48153247|NCT03295318|100699780|FG002|NOT COMPLETED|Overall Study||5||
48153248|NCT02089230|100699781|FG000|STARTED|Overall Study||3||
48153249|NCT02089230|100699782|FG001|STARTED|Overall Study||4||
48153250|NCT02089230|100699783|FG002|STARTED|Overall Study||12||
48153251|NCT02089230|100699781|FG000|COMPLETED|Overall Study||3||
48153252|NCT02089230|100699782|FG001|COMPLETED|Overall Study||4||
48153253|NCT02089230|100699783|FG002|COMPLETED|Overall Study||6||
48153254|NCT02089230|100699781|FG000|NOT COMPLETED|Overall Study||0||
48153255|NCT02089230|100699782|FG001|NOT COMPLETED|Overall Study||0||
48153256|NCT02089230|100699783|FG002|NOT COMPLETED|Overall Study||6||
48153257|NCT00289887|100699784|FG000|STARTED|Overall Study||127||
48153258|NCT00289887|100699785|FG001|STARTED|Overall Study||134||
48153259|NCT00289887|100699784|FG000|COMPLETED|Overall Study||105||
48153260|NCT00289887|100699785|FG001|COMPLETED|Overall Study||105||
48153261|NCT00289887|100699784|FG000|NOT COMPLETED|Overall Study||22||
48153262|NCT00289887|100699785|FG001|NOT COMPLETED|Overall Study||29||
48153263|NCT00708916|100699786|FG000|STARTED|Overall Study||12||
48153264|NCT00708916|100699786|FG000|COMPLETED|Overall Study||8||
48308657|NCT03530917|101081011|FG004|COMPLETED|Overall Study||8||
48308658|NCT03530917|101081012|FG005|COMPLETED|Overall Study||6||
48308659|NCT03530917|101081013|FG006|COMPLETED|Overall Study||8||
48308660|NCT03530917|101081014|FG007|COMPLETED|Overall Study||16||
48308661|NCT03530917|101081007|FG000|NOT COMPLETED|Overall Study||0||
48308662|NCT03530917|101081008|FG001|NOT COMPLETED|Overall Study||0||
48308663|NCT03530917|101081009|FG002|NOT COMPLETED|Overall Study||0||
48308664|NCT03530917|101081010|FG003|NOT COMPLETED|Overall Study||0||
48308665|NCT03530917|101081011|FG004|NOT COMPLETED|Overall Study||0||
48308666|NCT03530917|101081012|FG005|NOT COMPLETED|Overall Study||0||
48308667|NCT03530917|101081013|FG006|NOT COMPLETED|Overall Study||0||
48308668|NCT03530917|101081014|FG007|NOT COMPLETED|Overall Study||0||
48308669|NCT01145495|101081015|FG000|STARTED|Overall Study||65||
48308670|NCT01145495|101081015|FG000|COMPLETED|Overall Study||51||
48308671|NCT01145495|101081015|FG000|NOT COMPLETED|Overall Study||14||
48308672|NCT00478933|101081016|FG000|STARTED|Overall Study||1223||
48611280|NCT02964338|101834040|FG002|Safety Analysis Set|Overall Study||87|All randomized participants who received at least 1 dose of study drug.|
48611281|NCT02964338|101834038|FG000|Full Analysis Set|Overall Study||81|ITT analysis set, received ≥1 dose of study drug, ≥10 days of postbaseline efficacy assessments|
48611282|NCT02964338|101834039|FG001|Full Analysis Set|Overall Study||86|ITT analysis set, received ≥1 dose of study drug, ≥10 days of postbaseline efficacy assessments|
48308673|NCT00478933|101081016|FG000|COMPLETED|Overall Study||1145||
48308674|NCT00478933|101081016|FG000|NOT COMPLETED|Overall Study||78||
48153265|NCT00708916|100699786|FG000|NOT COMPLETED|Overall Study||4||
48153266|NCT00549757|100699787|FG000|STARTED|Active Treatment Phase: Max. 50 Months||4296||
48153267|NCT00549757|100699788|FG001|STARTED|Active Treatment Phase: Max. 50 Months||4310||
48153268|NCT00549757|100699787|FG000|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4274||
48153269|NCT00549757|100699788|FG001|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4287||
48153270|NCT00549757|100699787|FG000|Safety Set|Active Treatment Phase: Max. 50 Months||4272||
48153271|NCT00549757|100699788|FG001|Safety Set|Active Treatment Phase: Max. 50 Months||4285||
48153272|NCT00549757|100699787|FG000|COMPLETED|Active Treatment Phase: Max. 50 Months||0||
48153273|NCT00549757|100699788|FG001|COMPLETED|Active Treatment Phase: Max. 50 Months||0||
48153274|NCT00549757|100699787|FG000|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4296||
48153275|NCT00549757|100699788|FG001|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4310||
48153276|NCT00549757|100699787|FG000|STARTED|Extension Period (in Average 9 Months)||3773||
48153277|NCT00549757|100699788|FG001|STARTED|Extension Period (in Average 9 Months)||3817||
48153278|NCT00549757|100699787|FG000|COMPLETED|Extension Period (in Average 9 Months)||3148||
48153279|NCT00549757|100699788|FG001|COMPLETED|Extension Period (in Average 9 Months)||3182||
48153280|NCT00549757|100699787|FG000|NOT COMPLETED|Extension Period (in Average 9 Months)||625||
48153281|NCT00549757|100699788|FG001|NOT COMPLETED|Extension Period (in Average 9 Months)||635||
48153282|NCT01733732|100699789|FG000|STARTED|Overall Study||27||
48153283|NCT01733732|100699790|FG001|STARTED|Overall Study||27||
48153284|NCT01733732|100699789|FG000|COMPLETED|Overall Study||25||
48153285|NCT01733732|100699790|FG001|COMPLETED|Overall Study||27||
48153286|NCT01733732|100699789|FG000|NOT COMPLETED|Overall Study||2||
48153287|NCT01733732|100699790|FG001|NOT COMPLETED|Overall Study||0||
48153288|NCT02027402|100699791|FG000|STARTED|Overall Study||98||
48153289|NCT02027402|100699792|FG001|STARTED|Overall Study||100||
48153290|NCT02027402|100699791|FG000|COMPLETED|Overall Study||94||
48153291|NCT02027402|100699792|FG001|COMPLETED|Overall Study||99||
48153292|NCT02027402|100699791|FG000|NOT COMPLETED|Overall Study||4||
48153293|NCT02027402|100699792|FG001|NOT COMPLETED|Overall Study||1||
48722901|NCT00576472|102108238|FG007|COMPLETED|MPH Home Maintenance Phase||0||
48722902|NCT00576472|102108239|FG008|COMPLETED|MPH Home Maintenance Phase||0||
48722903|NCT00576472|102108240|FG009|COMPLETED|MPH Home Maintenance Phase||0||
48722904|NCT00576472|102108241|FG010|COMPLETED|MPH Home Maintenance Phase||0||
48722905|NCT00576472|102108242|FG011|COMPLETED|MPH Home Maintenance Phase||0||
48722906|NCT00576472|102108243|FG012|COMPLETED|MPH Home Maintenance Phase||0||
48722907|NCT00576472|102108244|FG013|COMPLETED|MPH Home Maintenance Phase||0||
48722908|NCT00576472|102108245|FG014|COMPLETED|MPH Home Maintenance Phase||68||
48722909|NCT00576472|102108231|FG000|NOT COMPLETED|MPH Home Maintenance Phase||0||
48722910|NCT00576472|102108232|FG001|NOT COMPLETED|MPH Home Maintenance Phase||0||
48722911|NCT00576472|102108233|FG002|NOT COMPLETED|MPH Home Maintenance Phase||0||
48722912|NCT00576472|102108234|FG003|NOT COMPLETED|MPH Home Maintenance Phase||0||
48722913|NCT00576472|102108235|FG004|NOT COMPLETED|MPH Home Maintenance Phase||0||
48406528|NCT02603172|101328442|FG003|NOT COMPLETED|Part A (Approximately 16 Weeks)||0||
48406529|NCT02603172|101328443|FG004|NOT COMPLETED|Part A (Approximately 16 Weeks)||0||
48722914|NCT00576472|102108236|FG005|NOT COMPLETED|MPH Home Maintenance Phase||0||
48722915|NCT00576472|102108237|FG006|NOT COMPLETED|MPH Home Maintenance Phase||0||
48722916|NCT00576472|102108238|FG007|NOT COMPLETED|MPH Home Maintenance Phase||0||
48722917|NCT00576472|102108239|FG008|NOT COMPLETED|MPH Home Maintenance Phase||0||
48722918|NCT00576472|102108240|FG009|NOT COMPLETED|MPH Home Maintenance Phase||0||
48611283|NCT02964338|101834040|FG002|Full Analysis Set|Overall Study||87|ITT analysis set, received ≥1 dose of study drug, ≥10 days of postbaseline efficacy assessments|
48611284|NCT02964338|101834038|FG000|COMPLETED|Overall Study||67||
48611285|NCT02964338|101834039|FG001|COMPLETED|Overall Study||64||
48611286|NCT02964338|101834040|FG002|COMPLETED|Overall Study||68||
48611287|NCT02964338|101834038|FG000|NOT COMPLETED|Overall Study||17||
48611288|NCT02964338|101834039|FG001|NOT COMPLETED|Overall Study||24||
48611289|NCT02964338|101834040|FG002|NOT COMPLETED|Overall Study||19||
48611290|NCT01844817|101834041|FG000|STARTED|Enrolled and Randomized||66||
48611291|NCT01844817|101834042|FG001|STARTED|Enrolled and Randomized||66||
48611292|NCT01844817|101834041|FG000|COMPLETED|Enrolled and Randomized||64|5 patients withdrew prior to treatment.|
48611293|NCT01844817|101834042|FG001|COMPLETED|Enrolled and Randomized||63|5 patients withdrew prior to treatment.|
48611294|NCT01844817|101834041|FG000|NOT COMPLETED|Enrolled and Randomized||2||
48611295|NCT01844817|101834042|FG001|NOT COMPLETED|Enrolled and Randomized||3||
48611296|NCT01844817|101834041|FG000|STARTED|Treatment||64||
48611297|NCT01844817|101834042|FG001|STARTED|Treatment||63||
48611298|NCT01844817|101834041|FG000|COMPLETED|Treatment||0||
48611299|NCT01844817|101834042|FG001|COMPLETED|Treatment||0||
48611300|NCT01844817|101834041|FG000|NOT COMPLETED|Treatment||64||
48153294|NCT03595332|100699793|FG000|STARTED|Overall Study||92||
48153295|NCT03595332|100699794|FG001|STARTED|Overall Study||130||
48153296|NCT03595332|100699793|FG000|COMPLETED|Overall Study||76||
48153297|NCT03595332|100699794|FG001|COMPLETED|Overall Study||106||
48153298|NCT03595332|100699793|FG000|NOT COMPLETED|Overall Study||16||
48153299|NCT03595332|100699794|FG001|NOT COMPLETED|Overall Study||24||
48153300|NCT01949311|100699795|FG000|STARTED|Overall Study||2677||
48153301|NCT01949311|100699795|FG000|COMPLETED|Overall Study||1297||
48153302|NCT01949311|100699795|FG000|NOT COMPLETED|Overall Study||1380||
48153303|NCT02703350|100699796|FG000|STARTED|Period One (Part A)||5||
48153304|NCT02703350|100699797|FG001|STARTED|Period One (Part A)||5||
48153305|NCT02703350|100699798|FG002|STARTED|Period One (Part A)||5||
48153306|NCT02703350|100699799|FG003|STARTED|Period One (Part A)||5||
48153307|NCT02703350|100699800|FG004|STARTED|Period One (Part A)||5||
48153308|NCT02703350|100699801|FG005|STARTED|Period One (Part A)||5||
48153309|NCT02703350|100699802|FG006|STARTED|Period One (Part A)||0||
48153310|NCT02703350|100699803|FG007|STARTED|Period One (Part A)||0||
48153311|NCT02703350|100699796|FG000|Received Study Drug|Period One (Part A)||5||
48153312|NCT02703350|100699797|FG001|Received Study Drug|Period One (Part A)||5||
48153313|NCT02703350|100699798|FG002|Received Study Drug|Period One (Part A)||5||
48153314|NCT02703350|100699799|FG003|Received Study Drug|Period One (Part A)||5||
48153315|NCT02703350|100699800|FG004|Received Study Drug|Period One (Part A)||5||
48153316|NCT02703350|100699801|FG005|Received Study Drug|Period One (Part A)||5||
48153317|NCT02703350|100699802|FG006|Received Study Drug|Period One (Part A)||0||
48153318|NCT02703350|100699803|FG007|Received Study Drug|Period One (Part A)||0||
48153319|NCT02703350|100699796|FG000|COMPLETED|Period One (Part A)||5||
48153320|NCT02703350|100699797|FG001|COMPLETED|Period One (Part A)||5||
48153321|NCT02703350|100699798|FG002|COMPLETED|Period One (Part A)||5||
48722919|NCT00576472|102108241|FG010|NOT COMPLETED|MPH Home Maintenance Phase||0||
48722920|NCT00576472|102108242|FG011|NOT COMPLETED|MPH Home Maintenance Phase||0||
48722921|NCT00576472|102108243|FG012|NOT COMPLETED|MPH Home Maintenance Phase||0||
48722922|NCT00576472|102108244|FG013|NOT COMPLETED|MPH Home Maintenance Phase||27||
48722923|NCT00576472|102108245|FG014|NOT COMPLETED|MPH Home Maintenance Phase||23||
48722924|NCT01192828|102108246|FG000|STARTED|Overall Study||14||
48406530|NCT02603172|101328444|FG005|NOT COMPLETED|Part A (Approximately 16 Weeks)||0||
48406531|NCT02603172|101328445|FG006|NOT COMPLETED|Part A (Approximately 16 Weeks)||0||
48611301|NCT01844817|101834042|FG001|NOT COMPLETED|Treatment||63||
48611302|NCT04254081|101834043|FG000|STARTED|Overall Study||28||
48611303|NCT04254081|101834044|FG001|STARTED|Overall Study||29||
48611304|NCT04254081|101834043|FG000|COMPLETED|Overall Study||28||
48153322|NCT02703350|100699799|FG003|COMPLETED|Period One (Part A)||5||
48611305|NCT04254081|101834044|FG001|COMPLETED|Overall Study||29||
48611306|NCT04254081|101834043|FG000|NOT COMPLETED|Overall Study||0||
48611307|NCT04254081|101834044|FG001|NOT COMPLETED|Overall Study||0||
48611308|NCT01467271|101834045|FG000|STARTED|Overall Study||540||
48611309|NCT01467271|101834045|FG000|COMPLETED|Overall Study||338||
48611310|NCT01467271|101834045|FG000|NOT COMPLETED|Overall Study||202||
48611311|NCT01689441|101834046|FG000|STARTED|Overall Study||36||
48611312|NCT01689441|101834047|FG001|STARTED|Overall Study||31||
48611313|NCT01689441|101834046|FG000|COMPLETED|Overall Study||36||
48611314|NCT01689441|101834047|FG001|COMPLETED|Overall Study||31||
48611315|NCT01689441|101834046|FG000|NOT COMPLETED|Overall Study||0||
48611316|NCT01689441|101834047|FG001|NOT COMPLETED|Overall Study||0||
48611317|NCT00753298|101834048|FG000|STARTED|Overall Study||97||
48611318|NCT00753298|101834049|FG001|STARTED|Overall Study||98||
48611319|NCT00753298|101834048|FG000|COMPLETED|Overall Study||89||
48611320|NCT00753298|101834049|FG001|COMPLETED|Overall Study||94||
48611321|NCT00753298|101834048|FG000|NOT COMPLETED|Overall Study||8||
48611322|NCT00753298|101834049|FG001|NOT COMPLETED|Overall Study||4||
48611323|NCT02499120|101834050|FG000|STARTED|Overall Study||65||
48611324|NCT02499120|101834051|FG001|STARTED|Overall Study||60||
48611325|NCT02499120|101834050|FG000|Received Treatment|Overall Study||64||
48611326|NCT02499120|101834051|FG001|Received Treatment|Overall Study||60||
48611327|NCT02499120|101834050|FG000|COMPLETED|Overall Study||0||
48611328|NCT02499120|101834051|FG001|COMPLETED|Overall Study||0||
48611329|NCT02499120|101834050|FG000|NOT COMPLETED|Overall Study||65||
48611330|NCT02499120|101834051|FG001|NOT COMPLETED|Overall Study||60||
48611331|NCT02017093|101834052|FG000|STARTED|Overall Study||4||
48611332|NCT02017093|101834053|FG001|STARTED|Overall Study||3||
48722925|NCT01192828|102108246|FG000|COMPLETED|Overall Study||14||
48722926|NCT01192828|102108246|FG000|NOT COMPLETED|Overall Study||0||
48722927|NCT01075984|102108247|FG000|STARTED|Treatment Phase||10||
48153323|NCT02703350|100699800|FG004|COMPLETED|Period One (Part A)||5||
48406532|NCT02603172|101328446|FG007|NOT COMPLETED|Part A (Approximately 16 Weeks)||0||
48611333|NCT02017093|101834052|FG000|COMPLETED|Overall Study||4||
48611334|NCT02017093|101834053|FG001|COMPLETED|Overall Study||3||
48722928|NCT01075984|102108248|FG001|STARTED|Treatment Phase||11||
48611335|NCT02017093|101834052|FG000|NOT COMPLETED|Overall Study||0||
48611336|NCT02017093|101834053|FG001|NOT COMPLETED|Overall Study||0||
48611337|NCT05171270|101834054|FG000|STARTED|Overall Study||503||
48611338|NCT05171270|101834054|FG000|COMPLETED|Overall Study||503|Over-recruitment due to errors at sites|
48611339|NCT05171270|101834054|FG000|NOT COMPLETED|Overall Study||0||
48611340|NCT03214679|101834055|FG000|STARTED|Overall Study||84||
48611341|NCT03214679|101834056|FG001|STARTED|Overall Study||83||
48611342|NCT03214679|101834055|FG000|COMPLETED|Overall Study||70||
48722929|NCT01075984|102108249|FG002|STARTED|Treatment Phase||21||
48722930|NCT01075984|102108250|FG003|STARTED|Treatment Phase||24||
48722931|NCT01075984|102108251|FG004|STARTED|Treatment Phase||213||
48722932|NCT01075984|102108247|FG000|COMPLETED|Treatment Phase||10||
48153324|NCT02703350|100699801|FG005|COMPLETED|Period One (Part A)||5||
48308675|NCT03720899|101081017|FG000|STARTED|Overall Study||21||
48308676|NCT03720899|101081018|FG001|STARTED|Overall Study||24||
48308677|NCT03720899|101081017|FG000|COMPLETED|Overall Study||13||
48308678|NCT03720899|101081018|FG001|COMPLETED|Overall Study||13||
48308679|NCT03720899|101081017|FG000|NOT COMPLETED|Overall Study||8||
48308680|NCT03720899|101081018|FG001|NOT COMPLETED|Overall Study||11||
48308681|NCT01942148|101081019|FG000|STARTED|Overall Study||68||
48308682|NCT01942148|101081019|FG000|COMPLETED|Overall Study||41||
48308683|NCT01942148|101081019|FG000|NOT COMPLETED|Overall Study||27||
48308684|NCT00916539|101081020|FG000|STARTED|Overall Study||31||
48308685|NCT00916539|101081021|FG001|STARTED|Overall Study||31||
48308686|NCT00916539|101081020|FG000|COMPLETED|Overall Study||31||
48308687|NCT00916539|101081021|FG001|COMPLETED|Overall Study||31||
48722933|NCT01075984|102108248|FG001|COMPLETED|Treatment Phase||10||
48722934|NCT01075984|102108249|FG002|COMPLETED|Treatment Phase||14||
48722935|NCT01075984|102108250|FG003|COMPLETED|Treatment Phase||17||
48722936|NCT01075984|102108251|FG004|COMPLETED|Treatment Phase||153||
48722937|NCT01075984|102108247|FG000|NOT COMPLETED|Treatment Phase||0||
48722938|NCT01075984|102108248|FG001|NOT COMPLETED|Treatment Phase||1||
48722939|NCT01075984|102108249|FG002|NOT COMPLETED|Treatment Phase||7||
48722940|NCT01075984|102108250|FG003|NOT COMPLETED|Treatment Phase||7||
48722941|NCT01075984|102108251|FG004|NOT COMPLETED|Treatment Phase||60||
48722942|NCT01075984|102108247|FG000|STARTED|Follow-up Phase||10||
48722943|NCT01075984|102108248|FG001|STARTED|Follow-up Phase||10||
48722944|NCT01075984|102108249|FG002|STARTED|Follow-up Phase||20||
48722945|NCT01075984|102108250|FG003|STARTED|Follow-up Phase||21||
48722946|NCT01075984|102108251|FG004|STARTED|Follow-up Phase||212||
48722947|NCT01075984|102108247|FG000|COMPLETED|Follow-up Phase||10||
48722948|NCT01075984|102108248|FG001|COMPLETED|Follow-up Phase||10||
48722949|NCT01075984|102108249|FG002|COMPLETED|Follow-up Phase||19||
48722950|NCT01075984|102108250|FG003|COMPLETED|Follow-up Phase||19||
48722951|NCT01075984|102108251|FG004|COMPLETED|Follow-up Phase||165||
48722952|NCT01075984|102108247|FG000|NOT COMPLETED|Follow-up Phase||0||
48722953|NCT01075984|102108248|FG001|NOT COMPLETED|Follow-up Phase||0||
48722954|NCT01075984|102108249|FG002|NOT COMPLETED|Follow-up Phase||1||
48722955|NCT01075984|102108250|FG003|NOT COMPLETED|Follow-up Phase||2||
48722956|NCT01075984|102108251|FG004|NOT COMPLETED|Follow-up Phase||47||
48722957|NCT00760838|102108252|FG000|STARTED|Overall Study||54||
48722958|NCT00760838|102108253|FG001|STARTED|Overall Study||55||
48722959|NCT00760838|102108252|FG000|COMPLETED|Overall Study||49||
48722960|NCT00760838|102108253|FG001|COMPLETED|Overall Study||53||
48722961|NCT00760838|102108252|FG000|NOT COMPLETED|Overall Study||5||
48722962|NCT00760838|102108253|FG001|NOT COMPLETED|Overall Study||2||
48722963|NCT00086411|102108254|FG000|STARTED|Overall Study||70||
48722964|NCT00086411|102108255|FG001|STARTED|Overall Study||63||
48722965|NCT00086411|102108256|FG002|STARTED|Overall Study||62||
48722966|NCT00086411|102108257|FG003|STARTED|Overall Study||65||
48722967|NCT00086411|102108254|FG000|COMPLETED|Overall Study||59||
48722968|NCT00086411|102108255|FG001|COMPLETED|Overall Study||52||
48722969|NCT00086411|102108256|FG002|COMPLETED|Overall Study||49||
48722970|NCT00086411|102108257|FG003|COMPLETED|Overall Study||53||
48722971|NCT00086411|102108254|FG000|NOT COMPLETED|Overall Study||11||
48722972|NCT00086411|102108255|FG001|NOT COMPLETED|Overall Study||11||
48722973|NCT00086411|102108256|FG002|NOT COMPLETED|Overall Study||13||
48722974|NCT00086411|102108257|FG003|NOT COMPLETED|Overall Study||12||
48722975|NCT00454584|102108258|FG000|STARTED|Controlled Period||347||
48722976|NCT00454584|102108259|FG001|STARTED|Controlled Period||209||
48722977|NCT00454584|102108260|FG002|STARTED|Controlled Period||347||
48722978|NCT00454584|102108261|FG003|STARTED|Controlled Period||0||
48722979|NCT00454584|102108262|FG004|STARTED|Controlled Period||0||
48722980|NCT00454584|102108263|FG005|STARTED|Controlled Period||0||
48722981|NCT00454584|102108258|FG000|COMPLETED|Controlled Period||336||
48722982|NCT00454584|102108259|FG001|COMPLETED|Controlled Period||201||
48722983|NCT00454584|102108260|FG002|COMPLETED|Controlled Period||342||
48722984|NCT00454584|102108261|FG003|COMPLETED|Controlled Period||0||
48153325|NCT02703350|100699802|FG006|COMPLETED|Period One (Part A)||0||
48308688|NCT00916539|101081020|FG000|NOT COMPLETED|Overall Study||0||
48308689|NCT00916539|101081021|FG001|NOT COMPLETED|Overall Study||0||
48308690|NCT03123250|101081022|FG000|STARTED|Treatment||101||
48308691|NCT03123250|101081022|FG000|COMPLETED|Treatment||101||
48308692|NCT03123250|101081022|FG000|NOT COMPLETED|Treatment||0||
48308693|NCT03123250|101081022|FG000|STARTED|1 Month Follow-Up||101||
48722985|NCT00454584|102108262|FG004|COMPLETED|Controlled Period||0||
48722986|NCT00454584|102108263|FG005|COMPLETED|Controlled Period||0||
48722987|NCT00454584|102108258|FG000|NOT COMPLETED|Controlled Period||11||
48722988|NCT00454584|102108259|FG001|NOT COMPLETED|Controlled Period||8||
48722989|NCT00454584|102108260|FG002|NOT COMPLETED|Controlled Period||5||
48722990|NCT00454584|102108261|FG003|NOT COMPLETED|Controlled Period||0||
48722991|NCT00454584|102108262|FG004|NOT COMPLETED|Controlled Period||0||
48722992|NCT00454584|102108263|FG005|NOT COMPLETED|Controlled Period||0||
48722993|NCT00454584|102108258|FG000|STARTED|After Controlled Period||0||
48722994|NCT00454584|102108259|FG001|STARTED|After Controlled Period||0||
48722995|NCT00454584|102108260|FG002|STARTED|After Controlled Period||0||
48722996|NCT00454584|102108261|FG003|STARTED|After Controlled Period||336||
48722997|NCT00454584|102108262|FG004|STARTED|After Controlled Period||201||
48308694|NCT03123250|101081022|FG000|COMPLETED|1 Month Follow-Up||101||
48308695|NCT03123250|101081022|FG000|NOT COMPLETED|1 Month Follow-Up||0||
48308696|NCT03123250|101081022|FG000|STARTED|3 Months Follow-Up||99||
48308697|NCT03123250|101081022|FG000|COMPLETED|3 Months Follow-Up||99||
48308698|NCT03123250|101081022|FG000|NOT COMPLETED|3 Months Follow-Up||0||
48308699|NCT03123250|101081022|FG000|STARTED|6 Months Follow-Up||100||
48308700|NCT03123250|101081022|FG000|COMPLETED|6 Months Follow-Up||100||
48308701|NCT03123250|101081022|FG000|NOT COMPLETED|6 Months Follow-Up||0||
48308702|NCT03123250|101081022|FG000|STARTED|12 Months Follow-Up||96||
48308703|NCT03123250|101081022|FG000|COMPLETED|12 Months Follow-Up||96||
48722998|NCT00454584|102108263|FG005|STARTED|After Controlled Period||342||
48722999|NCT00454584|102108258|FG000|COMPLETED|After Controlled Period||0||
48723000|NCT00454584|102108259|FG001|COMPLETED|After Controlled Period||0||
48723001|NCT00454584|102108260|FG002|COMPLETED|After Controlled Period||0||
48723002|NCT00454584|102108261|FG003|COMPLETED|After Controlled Period||310||
48723003|NCT00454584|102108262|FG004|COMPLETED|After Controlled Period||189||
48723004|NCT00454584|102108263|FG005|COMPLETED|After Controlled Period||310||
48723005|NCT00454584|102108258|FG000|NOT COMPLETED|After Controlled Period||0||
48723006|NCT00454584|102108259|FG001|NOT COMPLETED|After Controlled Period||0||
48308704|NCT03123250|101081022|FG000|NOT COMPLETED|12 Months Follow-Up||0||
48611343|NCT03214679|101834056|FG001|COMPLETED|Overall Study||69||
48611344|NCT03214679|101834055|FG000|NOT COMPLETED|Overall Study||14||
48611345|NCT03214679|101834056|FG001|NOT COMPLETED|Overall Study||14||
48611346|NCT00905632|101834057|FG000|STARTED|Overall Study||8||
48611347|NCT00905632|101834058|FG001|STARTED|Overall Study||6||
48611348|NCT00905632|101834059|FG002|STARTED|Overall Study||7||
48611349|NCT00905632|101834060|FG003|STARTED|Overall Study||6||
48611350|NCT00905632|101834061|FG004|STARTED|Overall Study||10||
48611351|NCT00905632|101834062|FG005|STARTED|Overall Study||9||
48611352|NCT00905632|101834063|FG006|STARTED|Overall Study||11||
48611353|NCT00905632|101834057|FG000|COMPLETED|Overall Study||8||
48723007|NCT00454584|102108260|FG002|NOT COMPLETED|After Controlled Period||0||
48723008|NCT00454584|102108261|FG003|NOT COMPLETED|After Controlled Period||26||
48723009|NCT00454584|102108262|FG004|NOT COMPLETED|After Controlled Period||12||
48723010|NCT00454584|102108263|FG005|NOT COMPLETED|After Controlled Period||32||
48723011|NCT00351273|102108264|FG000|STARTED|Overall Study||15||
48723012|NCT00351273|102108265|FG001|STARTED|Overall Study||12||
48723013|NCT00351273|102108266|FG002|STARTED|Overall Study||15||
48723014|NCT00351273|102108264|FG000|COMPLETED|Overall Study||14||
48723015|NCT00351273|102108265|FG001|COMPLETED|Overall Study||10||
48723016|NCT00351273|102108266|FG002|COMPLETED|Overall Study||10||
48723017|NCT00351273|102108264|FG000|NOT COMPLETED|Overall Study||1||
48723018|NCT00351273|102108265|FG001|NOT COMPLETED|Overall Study||2||
48723019|NCT00351273|102108266|FG002|NOT COMPLETED|Overall Study||5||
48723020|NCT03959982|102108267|FG000|STARTED|Overall Study||8||
48723021|NCT03959982|102108268|FG001|STARTED|Overall Study||3||
48723022|NCT03959982|102108267|FG000|COMPLETED|Overall Study||4||
48723023|NCT03959982|102108268|FG001|COMPLETED|Overall Study||3||
48723024|NCT03959982|102108267|FG000|NOT COMPLETED|Overall Study||4||
48723025|NCT03959982|102108268|FG001|NOT COMPLETED|Overall Study||0||
48723026|NCT01274429|102108269|FG000|STARTED|Overall Study||5||
48723027|NCT01274429|102108269|FG000|COMPLETED|Overall Study||0||
48723028|NCT01274429|102108269|FG000|NOT COMPLETED|Overall Study||5||
48723029|NCT01267175|102108270|FG000|STARTED|Overall Study||31||
48723030|NCT01267175|102108270|FG000|COMPLETED|Overall Study||29||
48723031|NCT01267175|102108270|FG000|NOT COMPLETED|Overall Study||2||
48611354|NCT00905632|101834058|FG001|COMPLETED|Overall Study||6||
48611355|NCT00905632|101834059|FG002|COMPLETED|Overall Study||7||
48611356|NCT00905632|101834060|FG003|COMPLETED|Overall Study||6||
48611357|NCT00905632|101834061|FG004|COMPLETED|Overall Study||10||
48611358|NCT00905632|101834062|FG005|COMPLETED|Overall Study||8||
48308705|NCT03123250|101081022|FG000|STARTED|24 Months Follow-Up||86||
48308706|NCT03123250|101081022|FG000|COMPLETED|24 Months Follow-Up||86||
48611359|NCT00905632|101834063|FG006|COMPLETED|Overall Study||7||
48611360|NCT00905632|101834057|FG000|NOT COMPLETED|Overall Study||0||
48611361|NCT00905632|101834058|FG001|NOT COMPLETED|Overall Study||0||
48611362|NCT00905632|101834059|FG002|NOT COMPLETED|Overall Study||0||
48723032|NCT02025439|102108271|FG000|STARTED|Overall Study||2||
48723033|NCT02025439|102108272|FG001|STARTED|Overall Study||2||
48723034|NCT02025439|102108271|FG000|COMPLETED|Overall Study||2||
48723035|NCT02025439|102108272|FG001|COMPLETED|Overall Study||2||
48723036|NCT02025439|102108271|FG000|NOT COMPLETED|Overall Study||0||
48723037|NCT02025439|102108272|FG001|NOT COMPLETED|Overall Study||0||
48723038|NCT00443781|102108273|FG000|STARTED|Overall Study||62||
48723039|NCT00443781|102108273|FG000|COMPLETED|Overall Study||37||
48723040|NCT00443781|102108273|FG000|NOT COMPLETED|Overall Study||25||
48723041|NCT02700165|102108274|FG000|STARTED|Overall Study||14||
48723042|NCT02700165|102108274|FG000|COMPLETED|Overall Study||14||
48723043|NCT02700165|102108274|FG000|NOT COMPLETED|Overall Study||0||
48723044|NCT01291836|102108275|FG000|STARTED|Overall Study||930||
48723045|NCT01291836|102108276|FG001|STARTED|Overall Study||71||
48723046|NCT01291836|102108275|FG000|COMPLETED|Overall Study||930||
48308707|NCT03123250|101081022|FG000|NOT COMPLETED|24 Months Follow-Up||0||
48308708|NCT03123250|101081022|FG000|STARTED|36 Months Follow-Up||82||
48308709|NCT03123250|101081022|FG000|COMPLETED|36 Months Follow-Up||82||
48308710|NCT03123250|101081022|FG000|NOT COMPLETED|36 Months Follow-Up||0||
48308711|NCT03123250|101081022|FG000|STARTED|48 Months Follow-Up||66||
48308712|NCT03123250|101081022|FG000|COMPLETED|48 Months Follow-Up||66||
48308713|NCT03123250|101081022|FG000|NOT COMPLETED|48 Months Follow-Up||0||
48723047|NCT01291836|102108276|FG001|COMPLETED|Overall Study||71||
48723048|NCT01291836|102108275|FG000|NOT COMPLETED|Overall Study||0||
48723049|NCT01291836|102108276|FG001|NOT COMPLETED|Overall Study||0||
48308714|NCT03123250|101081022|FG000|STARTED|60 Months Follow Up||62||
48308715|NCT03123250|101081022|FG000|COMPLETED|60 Months Follow Up||60||
48308716|NCT03123250|101081022|FG000|NOT COMPLETED|60 Months Follow Up||2||
48723050|NCT04881747|102108277|FG000|STARTED|Period 1||8||
48723051|NCT04881747|102108278|FG001|STARTED|Period 1||8||
48723052|NCT04881747|102108279|FG002|STARTED|Period 1||8||
48723053|NCT04881747|102108280|FG003|STARTED|Period 1||8||
48723054|NCT04881747|102108281|FG004|STARTED|Period 1||8||
48723055|NCT04881747|102108282|FG005|STARTED|Period 1||7||
48723056|NCT04881747|102108277|FG000|Received At Least One Dose of Study Drug|Period 1||8||
48723057|NCT04881747|102108278|FG001|Received At Least One Dose of Study Drug|Period 1||8||
48723058|NCT04881747|102108279|FG002|Received At Least One Dose of Study Drug|Period 1||8||
48723059|NCT04881747|102108280|FG003|Received At Least One Dose of Study Drug|Period 1||8||
48723060|NCT04881747|102108281|FG004|Received At Least One Dose of Study Drug|Period 1||8||
48723061|NCT04881747|102108282|FG005|Received At Least One Dose of Study Drug|Period 1||7||
48723062|NCT04881747|102108277|FG000|COMPLETED|Period 1||8||
48723063|NCT04881747|102108278|FG001|COMPLETED|Period 1||8||
48723064|NCT04881747|102108279|FG002|COMPLETED|Period 1||8||
48723065|NCT04881747|102108280|FG003|COMPLETED|Period 1||8||
48723066|NCT04881747|102108281|FG004|COMPLETED|Period 1||8||
48723067|NCT04881747|102108282|FG005|COMPLETED|Period 1||7||
48723068|NCT04881747|102108277|FG000|NOT COMPLETED|Period 1||0||
48723069|NCT04881747|102108278|FG001|NOT COMPLETED|Period 1||0||
48723070|NCT04881747|102108279|FG002|NOT COMPLETED|Period 1||0||
48723071|NCT04881747|102108280|FG003|NOT COMPLETED|Period 1||0||
48723072|NCT04881747|102108281|FG004|NOT COMPLETED|Period 1||0||
48723073|NCT04881747|102108282|FG005|NOT COMPLETED|Period 1||0||
48723074|NCT04881747|102108277|FG000|STARTED|Period 1 Washout||8||
48723075|NCT04881747|102108278|FG001|STARTED|Period 1 Washout||8||
48723076|NCT04881747|102108279|FG002|STARTED|Period 1 Washout||8||
48723077|NCT04881747|102108280|FG003|STARTED|Period 1 Washout||8||
48153326|NCT02703350|100699803|FG007|COMPLETED|Period One (Part A)||0||
48153327|NCT02703350|100699796|FG000|NOT COMPLETED|Period One (Part A)||0||
48153328|NCT02703350|100699797|FG001|NOT COMPLETED|Period One (Part A)||0||
48153329|NCT02703350|100699798|FG002|NOT COMPLETED|Period One (Part A)||0||
48153330|NCT02703350|100699799|FG003|NOT COMPLETED|Period One (Part A)||0||
48153331|NCT02703350|100699800|FG004|NOT COMPLETED|Period One (Part A)||0||
48153332|NCT02703350|100699801|FG005|NOT COMPLETED|Period One (Part A)||0||
48153333|NCT02703350|100699802|FG006|NOT COMPLETED|Period One (Part A)||0||
48153334|NCT02703350|100699803|FG007|NOT COMPLETED|Period One (Part A)||0||
48723078|NCT04881747|102108281|FG004|STARTED|Period 1 Washout||8||
48723079|NCT04881747|102108282|FG005|STARTED|Period 1 Washout||7||
48723080|NCT04881747|102108277|FG000|COMPLETED|Period 1 Washout||8||
48723081|NCT04881747|102108278|FG001|COMPLETED|Period 1 Washout||8||
48723082|NCT04881747|102108279|FG002|COMPLETED|Period 1 Washout||8||
48723083|NCT04881747|102108280|FG003|COMPLETED|Period 1 Washout||8||
48153335|NCT02703350|100699796|FG000|STARTED|Period Two (Part A)||5||
48153336|NCT02703350|100699797|FG001|STARTED|Period Two (Part A)||5||
48153337|NCT02703350|100699798|FG002|STARTED|Period Two (Part A)||5||
48153338|NCT02703350|100699799|FG003|STARTED|Period Two (Part A)||5||
48153339|NCT02703350|100699800|FG004|STARTED|Period Two (Part A)||5||
48723084|NCT04881747|102108281|FG004|COMPLETED|Period 1 Washout||8||
48723085|NCT04881747|102108282|FG005|COMPLETED|Period 1 Washout||7||
48723086|NCT04881747|102108277|FG000|NOT COMPLETED|Period 1 Washout||0||
48723087|NCT04881747|102108278|FG001|NOT COMPLETED|Period 1 Washout||0||
48723088|NCT04881747|102108279|FG002|NOT COMPLETED|Period 1 Washout||0||
48723089|NCT04881747|102108280|FG003|NOT COMPLETED|Period 1 Washout||0||
48723090|NCT04881747|102108281|FG004|NOT COMPLETED|Period 1 Washout||0||
48723091|NCT04881747|102108282|FG005|NOT COMPLETED|Period 1 Washout||0||
48723092|NCT04881747|102108277|FG000|STARTED|Period 2||8||
48723093|NCT04881747|102108278|FG001|STARTED|Period 2||8||
48723094|NCT04881747|102108279|FG002|STARTED|Period 2||8||
48723095|NCT04881747|102108280|FG003|STARTED|Period 2||8||
48723096|NCT04881747|102108281|FG004|STARTED|Period 2||8||
48723097|NCT04881747|102108282|FG005|STARTED|Period 2||7||
48723098|NCT04881747|102108277|FG000|Received At Least One Dose of Study Drug|Period 2||8||
48723099|NCT04881747|102108278|FG001|Received At Least One Dose of Study Drug|Period 2||8||
48723100|NCT04881747|102108279|FG002|Received At Least One Dose of Study Drug|Period 2||8||
48153340|NCT02703350|100699801|FG005|STARTED|Period Two (Part A)||5||
48153341|NCT02703350|100699802|FG006|STARTED|Period Two (Part A)||0||
48153342|NCT02703350|100699803|FG007|STARTED|Period Two (Part A)||0||
48153343|NCT02703350|100699796|FG000|Received Study Drug|Period Two (Part A)||5||
48153344|NCT02703350|100699797|FG001|Received Study Drug|Period Two (Part A)||5||
48153345|NCT02703350|100699798|FG002|Received Study Drug|Period Two (Part A)||5||
48723101|NCT04881747|102108280|FG003|Received At Least One Dose of Study Drug|Period 2||8||
48723102|NCT04881747|102108281|FG004|Received At Least One Dose of Study Drug|Period 2||8||
48153346|NCT02703350|100699799|FG003|Received Study Drug|Period Two (Part A)||5||
48153347|NCT02703350|100699800|FG004|Received Study Drug|Period Two (Part A)||5||
48153348|NCT02703350|100699801|FG005|Received Study Drug|Period Two (Part A)||5||
48153349|NCT02703350|100699802|FG006|Received Study Drug|Period Two (Part A)||0||
48153350|NCT02703350|100699803|FG007|Received Study Drug|Period Two (Part A)||0||
48723103|NCT04881747|102108282|FG005|Received At Least One Dose of Study Drug|Period 2||7||
48153351|NCT02703350|100699796|FG000|COMPLETED|Period Two (Part A)||5||
48153352|NCT02703350|100699797|FG001|COMPLETED|Period Two (Part A)||5||
48153353|NCT02703350|100699798|FG002|COMPLETED|Period Two (Part A)||5||
48153354|NCT02703350|100699799|FG003|COMPLETED|Period Two (Part A)||5||
48723104|NCT04881747|102108277|FG000|COMPLETED|Period 2||8||
48723105|NCT04881747|102108278|FG001|COMPLETED|Period 2||8||
48153355|NCT02703350|100699800|FG004|COMPLETED|Period Two (Part A)||5||
48153356|NCT02703350|100699801|FG005|COMPLETED|Period Two (Part A)||5||
48153357|NCT02703350|100699802|FG006|COMPLETED|Period Two (Part A)||0||
48153358|NCT02703350|100699803|FG007|COMPLETED|Period Two (Part A)||0||
48153359|NCT02703350|100699796|FG000|NOT COMPLETED|Period Two (Part A)||0||
48153360|NCT02703350|100699797|FG001|NOT COMPLETED|Period Two (Part A)||0||
48153361|NCT02703350|100699798|FG002|NOT COMPLETED|Period Two (Part A)||0||
48153362|NCT02703350|100699799|FG003|NOT COMPLETED|Period Two (Part A)||0||
48153363|NCT02703350|100699800|FG004|NOT COMPLETED|Period Two (Part A)||0||
48153364|NCT02703350|100699801|FG005|NOT COMPLETED|Period Two (Part A)||0||
48153365|NCT02703350|100699802|FG006|NOT COMPLETED|Period Two (Part A)||0||
48153366|NCT02703350|100699803|FG007|NOT COMPLETED|Period Two (Part A)||0||
48153367|NCT02703350|100699796|FG000|STARTED|Period Three (Part A)||5||
48153368|NCT02703350|100699797|FG001|STARTED|Period Three (Part A)||5||
48153369|NCT02703350|100699798|FG002|STARTED|Period Three (Part A)||5||
48153370|NCT02703350|100699799|FG003|STARTED|Period Three (Part A)||5||
48153371|NCT02703350|100699800|FG004|STARTED|Period Three (Part A)||5||
48153372|NCT02703350|100699801|FG005|STARTED|Period Three (Part A)||5||
48153373|NCT02703350|100699802|FG006|STARTED|Period Three (Part A)||0||
48153374|NCT02703350|100699803|FG007|STARTED|Period Three (Part A)||0||
48153375|NCT02703350|100699796|FG000|Received Study Drug|Period Three (Part A)||5||
48153376|NCT02703350|100699797|FG001|Received Study Drug|Period Three (Part A)||5||
48153377|NCT02703350|100699798|FG002|Received Study Drug|Period Three (Part A)||5||
48153378|NCT02703350|100699799|FG003|Received Study Drug|Period Three (Part A)||5||
48153379|NCT02703350|100699800|FG004|Received Study Drug|Period Three (Part A)||5||
48153380|NCT02703350|100699801|FG005|Received Study Drug|Period Three (Part A)||5||
48153381|NCT02703350|100699802|FG006|Received Study Drug|Period Three (Part A)||0||
48153382|NCT02703350|100699803|FG007|Received Study Drug|Period Three (Part A)||0||
48611363|NCT00905632|101834060|FG003|NOT COMPLETED|Overall Study||0||
48611364|NCT00905632|101834061|FG004|NOT COMPLETED|Overall Study||0||
48611365|NCT00905632|101834062|FG005|NOT COMPLETED|Overall Study||1||
48611366|NCT00905632|101834063|FG006|NOT COMPLETED|Overall Study||4||
48611367|NCT05359952|101834064|FG000|STARTED|Overall Study||21||
48611368|NCT05359952|101834065|FG001|STARTED|Overall Study||11||
48611369|NCT05359952|101834064|FG000|COMPLETED|Overall Study||20||
48153383|NCT02703350|100699796|FG000|COMPLETED|Period Three (Part A)||5||
48153384|NCT02703350|100699797|FG001|COMPLETED|Period Three (Part A)||5||
48153385|NCT02703350|100699798|FG002|COMPLETED|Period Three (Part A)||5||
48153386|NCT02703350|100699799|FG003|COMPLETED|Period Three (Part A)||5||
48153387|NCT02703350|100699800|FG004|COMPLETED|Period Three (Part A)||5||
48153388|NCT02703350|100699801|FG005|COMPLETED|Period Three (Part A)||5||
48153389|NCT02703350|100699802|FG006|COMPLETED|Period Three (Part A)||0||
48153390|NCT02703350|100699803|FG007|COMPLETED|Period Three (Part A)||0||
48153391|NCT02703350|100699796|FG000|NOT COMPLETED|Period Three (Part A)||0||
48153392|NCT02703350|100699797|FG001|NOT COMPLETED|Period Three (Part A)||0||
48153393|NCT02703350|100699798|FG002|NOT COMPLETED|Period Three (Part A)||0||
48153394|NCT02703350|100699799|FG003|NOT COMPLETED|Period Three (Part A)||0||
48611370|NCT05359952|101834065|FG001|COMPLETED|Overall Study||11||
48153395|NCT02703350|100699800|FG004|NOT COMPLETED|Period Three (Part A)||0||
48611371|NCT05359952|101834064|FG000|NOT COMPLETED|Overall Study||1||
48153396|NCT02703350|100699801|FG005|NOT COMPLETED|Period Three (Part A)||0||
48153397|NCT02703350|100699802|FG006|NOT COMPLETED|Period Three (Part A)||0||
48153398|NCT02703350|100699803|FG007|NOT COMPLETED|Period Three (Part A)||0||
48153399|NCT02703350|100699796|FG000|STARTED|Period Four (Part A)||5||
48153400|NCT02703350|100699797|FG001|STARTED|Period Four (Part A)||5||
48153401|NCT02703350|100699798|FG002|STARTED|Period Four (Part A)||5||
48153402|NCT02703350|100699799|FG003|STARTED|Period Four (Part A)||5||
48153403|NCT02703350|100699800|FG004|STARTED|Period Four (Part A)||5||
48153404|NCT02703350|100699801|FG005|STARTED|Period Four (Part A)||5||
48153405|NCT02703350|100699802|FG006|STARTED|Period Four (Part A)||0||
48153406|NCT02703350|100699803|FG007|STARTED|Period Four (Part A)||0||
48611372|NCT05359952|101834065|FG001|NOT COMPLETED|Overall Study||0||
48611373|NCT02840474|101834066|FG000|STARTED|Overall Study||7||
48611374|NCT02840474|101834067|FG001|STARTED|Overall Study||9||
48611375|NCT02840474|101834066|FG000|Received Study Product|Overall Study||7||
48611376|NCT02840474|101834067|FG001|Received Study Product|Overall Study||9||
48611377|NCT02840474|101834066|FG000|COMPLETED|Overall Study||6||
48611378|NCT02840474|101834067|FG001|COMPLETED|Overall Study||9||
48611379|NCT02840474|101834066|FG000|NOT COMPLETED|Overall Study||1||
48611380|NCT02840474|101834067|FG001|NOT COMPLETED|Overall Study||0||
48611381|NCT00815997|101834068|FG000|STARTED|Overall Study||80||
48611382|NCT00815997|101834069|FG001|STARTED|Overall Study||80||
48611383|NCT00815997|101834068|FG000|COMPLETED|Overall Study||80||
48611384|NCT00815997|101834069|FG001|COMPLETED|Overall Study||80||
48611385|NCT00815997|101834068|FG000|NOT COMPLETED|Overall Study||0||
48611386|NCT00815997|101834069|FG001|NOT COMPLETED|Overall Study||0||
48611387|NCT01909973|101834070|FG000|STARTED|Overall Study||8||
48611388|NCT01909973|101834071|FG001|STARTED|Overall Study||7||
48611389|NCT01909973|101834070|FG000|COMPLETED|Overall Study||7||
48611390|NCT01909973|101834071|FG001|COMPLETED|Overall Study||7||
48611391|NCT01909973|101834070|FG000|NOT COMPLETED|Overall Study||1||
48611392|NCT01909973|101834071|FG001|NOT COMPLETED|Overall Study||0||
48308717|NCT02232126|101081023|FG000|STARTED|Overall Study||91||
48308718|NCT02232126|101081024|FG001|STARTED|Overall Study||90||
48308719|NCT02232126|101081023|FG000|COMPLETED|Overall Study||91||
48308720|NCT02232126|101081024|FG001|COMPLETED|Overall Study||90||
48308721|NCT02232126|101081023|FG000|NOT COMPLETED|Overall Study||0||
48308722|NCT02232126|101081024|FG001|NOT COMPLETED|Overall Study||0||
48308723|NCT00228566|101081025|FG000|STARTED|Overall Study||247||
48308724|NCT00228566|101081025|FG000|COMPLETED|Overall Study||176||
48308725|NCT00228566|101081025|FG000|NOT COMPLETED|Overall Study||71||
48611393|NCT00418028|101834072|FG000|STARTED|Overall Study||97||
48611394|NCT00418028|101834073|FG001|STARTED|Overall Study||98||
48611395|NCT00418028|101834072|FG000|COMPLETED|Overall Study||95||
48611396|NCT00418028|101834073|FG001|COMPLETED|Overall Study||97||
48611397|NCT00418028|101834072|FG000|NOT COMPLETED|Overall Study||2||
48611398|NCT00418028|101834073|FG001|NOT COMPLETED|Overall Study||1||
48611399|NCT03543176|101834074|FG000|STARTED|Overall Study||392||
48611400|NCT03543176|101834075|FG001|STARTED|Overall Study||397||
48611401|NCT03543176|101834074|FG000|COMPLETED|Overall Study||392||
48611402|NCT03543176|101834075|FG001|COMPLETED|Overall Study||397||
48611403|NCT03543176|101834074|FG000|NOT COMPLETED|Overall Study||0||
48611404|NCT03543176|101834075|FG001|NOT COMPLETED|Overall Study||0||
48611405|NCT02232061|101834076|FG000|STARTED|Overall Study||6||
48611406|NCT02232061|101834076|FG000|COMPLETED|Overall Study||4||
48611407|NCT02232061|101834076|FG000|NOT COMPLETED|Overall Study||2||
48611408|NCT02787681|101834077|FG000|STARTED|Overall Study||71||
48611409|NCT02787681|101834077|FG000|COMPLETED|Overall Study||69||
48611410|NCT02787681|101834077|FG000|NOT COMPLETED|Overall Study||2||
48611411|NCT03052920|101834078|FG000|STARTED|Overall Study||40||
48611412|NCT03052920|101834078|FG000|COMPLETED|Overall Study||39||
48611413|NCT03052920|101834078|FG000|NOT COMPLETED|Overall Study||1||
48611414|NCT03077607|101834079|FG000|STARTED|Period 1 (15 Days)||19||
48611415|NCT03077607|101834080|FG001|STARTED|Period 1 (15 Days)||17||
48611416|NCT03077607|101834079|FG000|Treated (With Any Study Drug)|Period 1 (15 Days)||19||
48611417|NCT03077607|101834080|FG001|Treated (With Any Study Drug)|Period 1 (15 Days)||17||
48611418|NCT03077607|101834079|FG000|Received Talazoparib|Period 1 (15 Days)||19||
48611419|NCT03077607|101834080|FG001|Received Talazoparib|Period 1 (15 Days)||17||
48611420|NCT03077607|101834079|FG000|COMPLETED|Period 1 (15 Days)||17||
48611421|NCT03077607|101834080|FG001|COMPLETED|Period 1 (15 Days)||17||
48611422|NCT03077607|101834079|FG000|NOT COMPLETED|Period 1 (15 Days)||2||
48611423|NCT03077607|101834080|FG001|NOT COMPLETED|Period 1 (15 Days)||0||
48611424|NCT03077607|101834079|FG000|STARTED|Period 2 (Arm A:21 Days; Arm B:23 Days)||17||
48611425|NCT03077607|101834080|FG001|STARTED|Period 2 (Arm A:21 Days; Arm B:23 Days)||17||
48611426|NCT03077607|101834079|FG000|Treated (With Any Study Drug)|Period 2 (Arm A:21 Days; Arm B:23 Days)||17||
48611427|NCT03077607|101834080|FG001|Treated (With Any Study Drug)|Period 2 (Arm A:21 Days; Arm B:23 Days)||17||
48611428|NCT03077607|101834079|FG000|Received Talazoparib|Period 2 (Arm A:21 Days; Arm B:23 Days)||15||
48611429|NCT03077607|101834080|FG001|Received Talazoparib|Period 2 (Arm A:21 Days; Arm B:23 Days)||15||
48611430|NCT03077607|101834079|FG000|COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||14||
48611431|NCT03077607|101834080|FG001|COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||15||
48611432|NCT03077607|101834079|FG000|NOT COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||3||
48611433|NCT03077607|101834080|FG001|NOT COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||2||
48611434|NCT01133704|101834081|FG000|STARTED|Overall Study||65||
48611435|NCT01133704|101834082|FG001|STARTED|Overall Study||33||
48611436|NCT01133704|101834081|FG000|COMPLETED|Overall Study||16||
48611437|NCT01133704|101834082|FG001|COMPLETED|Overall Study||7||
48611438|NCT01133704|101834081|FG000|NOT COMPLETED|Overall Study||49||
48308726|NCT03805750|101081026|FG000|STARTED|First Intervention - 4 Weeks||3||
48611439|NCT01133704|101834082|FG001|NOT COMPLETED|Overall Study||26||
48611440|NCT05227118|101834083|FG000|STARTED|Overall Study||6||
48611441|NCT05227118|101834084|FG001|STARTED|Overall Study||2||
48611442|NCT05227118|101834085|FG002|STARTED|Overall Study||16||
48611443|NCT05227118|101834086|FG003|STARTED|Overall Study||5||
48611444|NCT05227118|101834083|FG000|COMPLETED|Overall Study||6||
48611445|NCT05227118|101834084|FG001|COMPLETED|Overall Study||2||
48611446|NCT05227118|101834085|FG002|COMPLETED|Overall Study||13||
48611447|NCT05227118|101834086|FG003|COMPLETED|Overall Study||5||
48611448|NCT05227118|101834083|FG000|NOT COMPLETED|Overall Study||0||
48611449|NCT05227118|101834084|FG001|NOT COMPLETED|Overall Study||0||
48611450|NCT05227118|101834085|FG002|NOT COMPLETED|Overall Study||3||
48611451|NCT05227118|101834086|FG003|NOT COMPLETED|Overall Study||0||
48611452|NCT04668209|101834087|FG000|STARTED|Overall Study||15||
48611453|NCT04668209|101834088|FG001|STARTED|Overall Study||14||
48611454|NCT04668209|101834087|FG000|COMPLETED|Overall Study||8||
48611455|NCT04668209|101834088|FG001|COMPLETED|Overall Study||6||
48611456|NCT04668209|101834087|FG000|NOT COMPLETED|Overall Study||7||
48611457|NCT04668209|101834088|FG001|NOT COMPLETED|Overall Study||8||
48611458|NCT03372382|101834089|FG000|STARTED|Overall Study||85||
48611459|NCT03372382|101834090|FG001|STARTED|Overall Study||85||
48611460|NCT03372382|101834089|FG000|COMPLETED|Overall Study||76||
48611461|NCT03372382|101834090|FG001|COMPLETED|Overall Study||81||
48611462|NCT03372382|101834089|FG000|NOT COMPLETED|Overall Study||9||
48611463|NCT03372382|101834090|FG001|NOT COMPLETED|Overall Study||4||
48611464|NCT00950729|101834091|FG000|STARTED|Driving With Running Shoes||48||
48611465|NCT00950729|101834091|FG000|COMPLETED|Driving With Running Shoes||48||
48611466|NCT00950729|101834091|FG000|NOT COMPLETED|Driving With Running Shoes||0||
48611467|NCT00950729|101834091|FG000|STARTED|Driving With Plaster Cast||48||
48611468|NCT00950729|101834091|FG000|COMPLETED|Driving With Plaster Cast||48||
48611469|NCT00950729|101834091|FG000|NOT COMPLETED|Driving With Plaster Cast||0||
48611470|NCT00950729|101834091|FG000|STARTED|Driving With Aircast||48||
48611471|NCT00950729|101834091|FG000|COMPLETED|Driving With Aircast||48||
48611472|NCT00950729|101834091|FG000|NOT COMPLETED|Driving With Aircast||0||
48611473|NCT02716779|101834092|FG000|STARTED|Monotherapy||14||
48611474|NCT02716779|101834093|FG001|STARTED|Monotherapy||26||
48611475|NCT02716779|101834094|FG002|STARTED|Monotherapy||27||
48611476|NCT02716779|101834092|FG000|COMPLETED|Monotherapy||14||
48611477|NCT02716779|101834093|FG001|COMPLETED|Monotherapy||25||
48611478|NCT02716779|101834094|FG002|COMPLETED|Monotherapy||26||
48611479|NCT02716779|101834092|FG000|NOT COMPLETED|Monotherapy||0||
48611480|NCT02716779|101834093|FG001|NOT COMPLETED|Monotherapy||1||
48611481|NCT02716779|101834094|FG002|NOT COMPLETED|Monotherapy||1||
48611482|NCT02716779|101834092|FG000|STARTED|Combination Therapy||14||
48611483|NCT02716779|101834093|FG001|STARTED|Combination Therapy||25||
48611484|NCT02716779|101834094|FG002|STARTED|Combination Therapy||26||
48611485|NCT02716779|101834092|FG000|COMPLETED|Combination Therapy||14||
48611486|NCT02716779|101834093|FG001|COMPLETED|Combination Therapy||23||
48611487|NCT02716779|101834094|FG002|COMPLETED|Combination Therapy||25||
48611488|NCT02716779|101834092|FG000|NOT COMPLETED|Combination Therapy||0||
48611489|NCT02716779|101834093|FG001|NOT COMPLETED|Combination Therapy||2||
48611490|NCT02716779|101834094|FG002|NOT COMPLETED|Combination Therapy||1||
48611491|NCT02360488|101834095|FG000|STARTED|Overall Study||62||
48611492|NCT02360488|101834096|FG001|STARTED|Overall Study||62||
48611493|NCT02360488|101834095|FG000|COMPLETED|Overall Study||59||
48611494|NCT02360488|101834096|FG001|COMPLETED|Overall Study||55||
48611495|NCT02360488|101834095|FG000|NOT COMPLETED|Overall Study||3||
48611496|NCT02360488|101834096|FG001|NOT COMPLETED|Overall Study||7||
48611497|NCT03315455|101834097|FG000|STARTED|Overall Study||14||
48611498|NCT03315455|101834098|FG001|STARTED|Overall Study||29||
48611499|NCT03315455|101834099|FG002|STARTED|Overall Study||27||
48611500|NCT03315455|101834100|FG003|STARTED|Overall Study||15||
48611501|NCT03315455|101834097|FG000|Completed 24 Weeks in the Study|Overall Study||14||
48611502|NCT03315455|101834098|FG001|Completed 24 Weeks in the Study|Overall Study||29||
48308727|NCT03805750|101081027|FG001|STARTED|First Intervention - 4 Weeks||4||
48308728|NCT03805750|101081026|FG000|COMPLETED|First Intervention - 4 Weeks||3||
48308729|NCT03805750|101081027|FG001|COMPLETED|First Intervention - 4 Weeks||4||
48308730|NCT03805750|101081026|FG000|NOT COMPLETED|First Intervention - 4 Weeks||0||
48611503|NCT03315455|101834099|FG002|Completed 24 Weeks in the Study|Overall Study||27||
48611504|NCT03315455|101834100|FG003|Completed 24 Weeks in the Study|Overall Study||15||
48611505|NCT03315455|101834097|FG000|COMPLETED|Overall Study||1||
48611506|NCT03315455|101834098|FG001|COMPLETED|Overall Study||4||
48611507|NCT03315455|101834099|FG002|COMPLETED|Overall Study||10||
48611508|NCT03315455|101834100|FG003|COMPLETED|Overall Study||0||
48611509|NCT03315455|101834097|FG000|NOT COMPLETED|Overall Study||13||
48611510|NCT03315455|101834098|FG001|NOT COMPLETED|Overall Study||25||
48611511|NCT03315455|101834099|FG002|NOT COMPLETED|Overall Study||17||
48611512|NCT03315455|101834100|FG003|NOT COMPLETED|Overall Study||15||
48611513|NCT04441788|101834101|FG000|STARTED|Overall Study||20||
48611514|NCT04441788|101834102|FG001|STARTED|Overall Study||21||
48611515|NCT04441788|101834103|FG002|STARTED|Overall Study||19||
48611516|NCT04441788|101834101|FG000|COMPLETED|Overall Study||3||
48611517|NCT04441788|101834102|FG001|COMPLETED|Overall Study||4||
48611518|NCT04441788|101834103|FG002|COMPLETED|Overall Study||3||
48611519|NCT04441788|101834101|FG000|NOT COMPLETED|Overall Study||17||
48611520|NCT04441788|101834102|FG001|NOT COMPLETED|Overall Study||17||
48611521|NCT04441788|101834103|FG002|NOT COMPLETED|Overall Study||16||
48611522|NCT02946892|101834104|FG000|STARTED|First Intervention (12 Weeks)||11||
48611523|NCT02946892|101834105|FG001|STARTED|First Intervention (12 Weeks)||15||
48611524|NCT02946892|101834104|FG000|COMPLETED|First Intervention (12 Weeks)||11||
48611525|NCT02946892|101834105|FG001|COMPLETED|First Intervention (12 Weeks)||14||
48308731|NCT03805750|101081027|FG001|NOT COMPLETED|First Intervention - 4 Weeks||0||
48308732|NCT03805750|101081026|FG000|STARTED|Second Intervention - 4 Weeks||3||
48308733|NCT03805750|101081027|FG001|STARTED|Second Intervention - 4 Weeks||4||
48308734|NCT03805750|101081026|FG000|COMPLETED|Second Intervention - 4 Weeks||3||
48611526|NCT02946892|101834104|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0||
48611527|NCT02946892|101834105|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1||
48611528|NCT02946892|101834104|FG000|STARTED|Washout (6 Weeks)||11||
48611529|NCT02946892|101834105|FG001|STARTED|Washout (6 Weeks)||14||
48611530|NCT02946892|101834104|FG000|COMPLETED|Washout (6 Weeks)||9||
48611531|NCT02946892|101834105|FG001|COMPLETED|Washout (6 Weeks)||14||
48611532|NCT02946892|101834104|FG000|NOT COMPLETED|Washout (6 Weeks)||2||
48611533|NCT02946892|101834105|FG001|NOT COMPLETED|Washout (6 Weeks)||0||
48611534|NCT02946892|101834104|FG000|STARTED|Second Intervention||9||
48611535|NCT02946892|101834105|FG001|STARTED|Second Intervention||14||
48611536|NCT02946892|101834104|FG000|COMPLETED|Second Intervention||9||
48611537|NCT02946892|101834105|FG001|COMPLETED|Second Intervention||14||
48611538|NCT02946892|101834104|FG000|NOT COMPLETED|Second Intervention||0||
48611539|NCT02946892|101834105|FG001|NOT COMPLETED|Second Intervention||0||
48611540|NCT01951573|101834106|FG000|STARTED|Period 1, First 9 Hours of Wear||17||
48611541|NCT01951573|101834107|FG001|STARTED|Period 1, First 9 Hours of Wear||17||
48611542|NCT01951573|101834106|FG000|COMPLETED|Period 1, First 9 Hours of Wear||17||
48611543|NCT01951573|101834107|FG001|COMPLETED|Period 1, First 9 Hours of Wear||17||
48611544|NCT01951573|101834106|FG000|NOT COMPLETED|Period 1, First 9 Hours of Wear||0||
48611545|NCT01951573|101834107|FG001|NOT COMPLETED|Period 1, First 9 Hours of Wear||0||
48611546|NCT01951573|101834106|FG000|STARTED|Washout Period||17||
48611547|NCT01951573|101834107|FG001|STARTED|Washout Period||17||
48611548|NCT01951573|101834106|FG000|COMPLETED|Washout Period||17||
48611549|NCT01951573|101834107|FG001|COMPLETED|Washout Period||16||
48611550|NCT01951573|101834106|FG000|NOT COMPLETED|Washout Period||0||
48611551|NCT01951573|101834107|FG001|NOT COMPLETED|Washout Period||1||
48611552|NCT01951573|101834106|FG000|STARTED|Period 2, Second 9 Hours of Wear||17||
48611553|NCT01951573|101834107|FG001|STARTED|Period 2, Second 9 Hours of Wear||16||
48611554|NCT01951573|101834106|FG000|COMPLETED|Period 2, Second 9 Hours of Wear||17||
48611555|NCT01951573|101834107|FG001|COMPLETED|Period 2, Second 9 Hours of Wear||16||
48611556|NCT01951573|101834106|FG000|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0||
48611557|NCT01951573|101834107|FG001|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0||
48611558|NCT01369745|101834108|FG000|STARTED|Overall Study||32||
48611559|NCT01369745|101834109|FG001|STARTED|Overall Study||41||
48611560|NCT01369745|101834110|FG002|STARTED|Overall Study||18||
48611561|NCT01369745|101834111|FG003|STARTED|Overall Study||84||
48611562|NCT01369745|101834112|FG004|STARTED|Overall Study||83||
48611563|NCT01369745|101834108|FG000|COMPLETED|Overall Study||25||
48611564|NCT01369745|101834109|FG001|COMPLETED|Overall Study||28||
48611565|NCT01369745|101834110|FG002|COMPLETED|Overall Study||16||
48611566|NCT01369745|101834111|FG003|COMPLETED|Overall Study||64||
48611567|NCT01369745|101834112|FG004|COMPLETED|Overall Study||65||
48611568|NCT01369745|101834108|FG000|NOT COMPLETED|Overall Study||7||
48611569|NCT01369745|101834109|FG001|NOT COMPLETED|Overall Study||13||
48153407|NCT02703350|100699796|FG000|Received Study Drug|Period Four (Part A)||5||
48153408|NCT02703350|100699797|FG001|Received Study Drug|Period Four (Part A)||5||
48611570|NCT01369745|101834110|FG002|NOT COMPLETED|Overall Study||2||
48611571|NCT01369745|101834111|FG003|NOT COMPLETED|Overall Study||20||
48611572|NCT01369745|101834112|FG004|NOT COMPLETED|Overall Study||18||
48611573|NCT01344759|101834113|FG000|STARTED|Overall Study||30||
48611574|NCT01344759|101834114|FG001|STARTED|Overall Study||30||
48611575|NCT01344759|101834113|FG000|COMPLETED|Overall Study||30||
48611576|NCT01344759|101834114|FG001|COMPLETED|Overall Study||28||
48611577|NCT01344759|101834113|FG000|NOT COMPLETED|Overall Study||0||
48611578|NCT01344759|101834114|FG001|NOT COMPLETED|Overall Study||2||
48611579|NCT01377636|101834115|FG000|STARTED|Overall Study||20||
48611580|NCT01377636|101834115|FG000|COMPLETED|Overall Study||20||
48611581|NCT01377636|101834115|FG000|NOT COMPLETED|Overall Study||0||
48611582|NCT00271219|101834116|FG000|STARTED|Overall Study||89||
48611583|NCT00271219|101834117|FG001|STARTED|Overall Study||86||
48611584|NCT00271219|101834116|FG000|COMPLETED|Overall Study||73||
48611585|NCT00271219|101834117|FG001|COMPLETED|Overall Study||58||
48611586|NCT00271219|101834116|FG000|NOT COMPLETED|Overall Study||16||
48611587|NCT00271219|101834117|FG001|NOT COMPLETED|Overall Study||28||
48611588|NCT00060606|101834118|FG000|STARTED|Overall Study||91||
48611589|NCT00060606|101834119|FG001|STARTED|Overall Study||92||
48611590|NCT00060606|101834118|FG000|First Primary Outcome - Shunt at 12 Mont|Overall Study||91||
48611591|NCT00060606|101834119|FG001|First Primary Outcome - Shunt at 12 Mont|Overall Study||92||
48611592|NCT00060606|101834118|FG000|COMPLETED|Overall Study||91|Second primary outcome - 30 months|
48611593|NCT00060606|101834119|FG001|COMPLETED|Overall Study||91|Second primary outcome - 30 months|
48611594|NCT00060606|101834118|FG000|NOT COMPLETED|Overall Study||0||
48611595|NCT00060606|101834119|FG001|NOT COMPLETED|Overall Study||1||
48611596|NCT01537835|101834120|FG000|STARTED|Overall Study||37||
48611597|NCT01537835|101834121|FG001|STARTED|Overall Study||37||
48611598|NCT01537835|101834122|FG002|STARTED|Overall Study||35||
48611599|NCT01537835|101834120|FG000|COMPLETED|Overall Study||37||
48611600|NCT01537835|101834121|FG001|COMPLETED|Overall Study||37||
48611601|NCT01537835|101834122|FG002|COMPLETED|Overall Study||35||
48611602|NCT01537835|101834120|FG000|NOT COMPLETED|Overall Study||0||
48611603|NCT01537835|101834121|FG001|NOT COMPLETED|Overall Study||0||
48611604|NCT01537835|101834122|FG002|NOT COMPLETED|Overall Study||0||
48611605|NCT02271217|101834123|FG000|STARTED|Overall Study||126||
48611606|NCT02271217|101834124|FG001|STARTED|Overall Study||126||
48611607|NCT02271217|101834125|FG002|STARTED|Overall Study||125||
48611608|NCT02271217|101834123|FG000|COMPLETED|Overall Study||115||
48611609|NCT02271217|101834124|FG001|COMPLETED|Overall Study||113||
48611610|NCT02271217|101834125|FG002|COMPLETED|Overall Study||113||
48611611|NCT02271217|101834123|FG000|NOT COMPLETED|Overall Study||11||
48611612|NCT02271217|101834124|FG001|NOT COMPLETED|Overall Study||13||
48611613|NCT02271217|101834125|FG002|NOT COMPLETED|Overall Study||12||
48611614|NCT01768559|101834126|FG000|STARTED|Overall Study||298||
48153409|NCT02703350|100699798|FG002|Received Study Drug|Period Four (Part A)||5||
48153410|NCT02703350|100699799|FG003|Received Study Drug|Period Four (Part A)||5||
48153411|NCT02703350|100699800|FG004|Received Study Drug|Period Four (Part A)||5||
48611615|NCT01768559|101834127|FG001|STARTED|Overall Study||298||
48611616|NCT01768559|101834128|FG002|STARTED|Overall Study||298||
48611617|NCT01768559|101834126|FG000|Treated|Overall Study||298||
48611618|NCT01768559|101834127|FG001|Treated|Overall Study||298||
48611619|NCT01768559|101834128|FG002|Treated|Overall Study||297||
48611620|NCT01768559|101834126|FG000|COMPLETED|Overall Study||268||
48611621|NCT01768559|101834127|FG001|COMPLETED|Overall Study||281||
48611622|NCT01768559|101834128|FG002|COMPLETED|Overall Study||285||
48611623|NCT01768559|101834126|FG000|NOT COMPLETED|Overall Study||30||
48611624|NCT01768559|101834127|FG001|NOT COMPLETED|Overall Study||17||
48611625|NCT01768559|101834128|FG002|NOT COMPLETED|Overall Study||13||
48611626|NCT02029274|101834129|FG000|STARTED|Overall Study||5||
48153412|NCT02703350|100699801|FG005|Received Study Drug|Period Four (Part A)||5||
48153413|NCT02703350|100699802|FG006|Received Study Drug|Period Four (Part A)||0||
48153414|NCT02703350|100699803|FG007|Received Study Drug|Period Four (Part A)||0||
48153415|NCT02703350|100699796|FG000|COMPLETED|Period Four (Part A)||5||
48153416|NCT02703350|100699797|FG001|COMPLETED|Period Four (Part A)||5||
48153417|NCT02703350|100699798|FG002|COMPLETED|Period Four (Part A)||5||
48153418|NCT02703350|100699799|FG003|COMPLETED|Period Four (Part A)||5||
48153419|NCT02703350|100699800|FG004|COMPLETED|Period Four (Part A)||5||
48153420|NCT02703350|100699801|FG005|COMPLETED|Period Four (Part A)||5||
48153421|NCT02703350|100699802|FG006|COMPLETED|Period Four (Part A)||0||
48153422|NCT02703350|100699803|FG007|COMPLETED|Period Four (Part A)||0||
48153423|NCT02703350|100699796|FG000|NOT COMPLETED|Period Four (Part A)||0||
48153424|NCT02703350|100699797|FG001|NOT COMPLETED|Period Four (Part A)||0||
48153425|NCT02703350|100699798|FG002|NOT COMPLETED|Period Four (Part A)||0||
48153426|NCT02703350|100699799|FG003|NOT COMPLETED|Period Four (Part A)||0||
48153427|NCT02703350|100699800|FG004|NOT COMPLETED|Period Four (Part A)||0||
48153428|NCT02703350|100699801|FG005|NOT COMPLETED|Period Four (Part A)||0||
48153429|NCT02703350|100699802|FG006|NOT COMPLETED|Period Four (Part A)||0||
48153430|NCT02703350|100699803|FG007|NOT COMPLETED|Period Four (Part A)||0||
48153431|NCT02703350|100699796|FG000|STARTED|Period Five (Part A)||5||
48153432|NCT02703350|100699797|FG001|STARTED|Period Five (Part A)||5||
48153433|NCT02703350|100699798|FG002|STARTED|Period Five (Part A)||5||
48153434|NCT02703350|100699799|FG003|STARTED|Period Five (Part A)||5||
48153435|NCT02703350|100699800|FG004|STARTED|Period Five (Part A)||5||
48153436|NCT02703350|100699801|FG005|STARTED|Period Five (Part A)||5||
48153437|NCT02703350|100699802|FG006|STARTED|Period Five (Part A)||0||
48153438|NCT02703350|100699803|FG007|STARTED|Period Five (Part A)||0||
48153439|NCT02703350|100699796|FG000|Received Study Drug|Period Five (Part A)||5||
48153440|NCT02703350|100699797|FG001|Received Study Drug|Period Five (Part A)||5||
48153441|NCT02703350|100699798|FG002|Received Study Drug|Period Five (Part A)||5||
48153442|NCT02703350|100699799|FG003|Received Study Drug|Period Five (Part A)||5||
48153443|NCT02703350|100699800|FG004|Received Study Drug|Period Five (Part A)||5||
48153444|NCT02703350|100699801|FG005|Received Study Drug|Period Five (Part A)||5||
48153445|NCT02703350|100699802|FG006|Received Study Drug|Period Five (Part A)||0||
48153446|NCT02703350|100699803|FG007|Received Study Drug|Period Five (Part A)||0||
48153447|NCT02703350|100699796|FG000|COMPLETED|Period Five (Part A)||5||
48153448|NCT02703350|100699797|FG001|COMPLETED|Period Five (Part A)||5||
48153449|NCT02703350|100699798|FG002|COMPLETED|Period Five (Part A)||5||
48153450|NCT02703350|100699799|FG003|COMPLETED|Period Five (Part A)||5||
48153451|NCT02703350|100699800|FG004|COMPLETED|Period Five (Part A)||5||
48153452|NCT02703350|100699801|FG005|COMPLETED|Period Five (Part A)||5||
48153453|NCT02703350|100699802|FG006|COMPLETED|Period Five (Part A)||0||
48153454|NCT02703350|100699803|FG007|COMPLETED|Period Five (Part A)||0||
48153455|NCT02703350|100699796|FG000|NOT COMPLETED|Period Five (Part A)||0||
48153456|NCT02703350|100699797|FG001|NOT COMPLETED|Period Five (Part A)||0||
48153457|NCT02703350|100699798|FG002|NOT COMPLETED|Period Five (Part A)||0||
48611627|NCT02029274|101834130|FG001|STARTED|Overall Study||4||
48611628|NCT02029274|101834131|FG002|STARTED|Overall Study||4||
48153458|NCT02703350|100699799|FG003|NOT COMPLETED|Period Five (Part A)||0||
48153459|NCT02703350|100699800|FG004|NOT COMPLETED|Period Five (Part A)||0||
48153460|NCT02703350|100699801|FG005|NOT COMPLETED|Period Five (Part A)||0||
48153461|NCT02703350|100699802|FG006|NOT COMPLETED|Period Five (Part A)||0||
48153462|NCT02703350|100699803|FG007|NOT COMPLETED|Period Five (Part A)||0||
48153463|NCT02703350|100699796|FG000|STARTED|Period Six (Part A)||5||
48153464|NCT02703350|100699797|FG001|STARTED|Period Six (Part A)||5||
48153465|NCT02703350|100699798|FG002|STARTED|Period Six (Part A)||5||
48153466|NCT02703350|100699799|FG003|STARTED|Period Six (Part A)||5||
48153467|NCT02703350|100699800|FG004|STARTED|Period Six (Part A)||5||
48153468|NCT02703350|100699801|FG005|STARTED|Period Six (Part A)||5||
48153469|NCT02703350|100699802|FG006|STARTED|Period Six (Part A)||0||
48153470|NCT02703350|100699803|FG007|STARTED|Period Six (Part A)||0||
48153471|NCT02703350|100699796|FG000|Received Study Drug|Period Six (Part A)||5||
48153472|NCT02703350|100699797|FG001|Received Study Drug|Period Six (Part A)||5||
48153473|NCT02703350|100699798|FG002|Received Study Drug|Period Six (Part A)||5||
48153474|NCT02703350|100699799|FG003|Received Study Drug|Period Six (Part A)||5||
48153475|NCT02703350|100699800|FG004|Received Study Drug|Period Six (Part A)||5||
48153476|NCT02703350|100699801|FG005|Received Study Drug|Period Six (Part A)||5||
48153477|NCT02703350|100699802|FG006|Received Study Drug|Period Six (Part A)||0||
48153478|NCT02703350|100699803|FG007|Received Study Drug|Period Six (Part A)||0||
48153479|NCT02703350|100699796|FG000|COMPLETED|Period Six (Part A)||5||
48611629|NCT02029274|101834132|FG003|STARTED|Overall Study||4||
48153480|NCT02703350|100699797|FG001|COMPLETED|Period Six (Part A)||5||
48153481|NCT02703350|100699798|FG002|COMPLETED|Period Six (Part A)||5||
48153482|NCT02703350|100699799|FG003|COMPLETED|Period Six (Part A)||5||
48153483|NCT02703350|100699800|FG004|COMPLETED|Period Six (Part A)||5||
48153484|NCT02703350|100699801|FG005|COMPLETED|Period Six (Part A)||5||
48153485|NCT02703350|100699802|FG006|COMPLETED|Period Six (Part A)||0||
48153486|NCT02703350|100699803|FG007|COMPLETED|Period Six (Part A)||0||
48153487|NCT02703350|100699796|FG000|NOT COMPLETED|Period Six (Part A)||0||
48153488|NCT02703350|100699797|FG001|NOT COMPLETED|Period Six (Part A)||0||
48153489|NCT02703350|100699798|FG002|NOT COMPLETED|Period Six (Part A)||0||
48153490|NCT02703350|100699799|FG003|NOT COMPLETED|Period Six (Part A)||0||
48153491|NCT02703350|100699800|FG004|NOT COMPLETED|Period Six (Part A)||0||
48153492|NCT02703350|100699801|FG005|NOT COMPLETED|Period Six (Part A)||0||
48153493|NCT02703350|100699802|FG006|NOT COMPLETED|Period Six (Part A)||0||
48153494|NCT02703350|100699803|FG007|NOT COMPLETED|Period Six (Part A)||0||
48153495|NCT02703350|100699796|FG000|STARTED|Part B||0|Participants who completed all six periods in Part A were eligible for Part B.|
48153496|NCT02703350|100699797|FG001|STARTED|Part B||0|Participants who completed all six periods in Part A were eligible for Part B.|
48153497|NCT02703350|100699798|FG002|STARTED|Part B||0|Participants who completed all six periods in Part A were eligible for Part B.|
48153498|NCT02703350|100699799|FG003|STARTED|Part B||0|Participants who completed all six periods in Part A were eligible for Part B.|
48153499|NCT02703350|100699800|FG004|STARTED|Part B||0|Participants who completed all six periods in Part A were eligible for Part B.|
48153500|NCT02703350|100699801|FG005|STARTED|Part B||0|Participants who completed all six periods in Part A were eligible for Part B.|
48153501|NCT02703350|100699802|FG006|STARTED|Part B||15|Participants who completed all six periods in Part A were eligible for Part B.|
48153502|NCT02703350|100699803|FG007|STARTED|Part B||15|Participants who completed all six periods in Part A were eligible for Part B.|
48153503|NCT02703350|100699796|FG000|Received Study Drug|Part B||0||
48153504|NCT02703350|100699797|FG001|Received Study Drug|Part B||0||
48153505|NCT02703350|100699798|FG002|Received Study Drug|Part B||0||
48153506|NCT02703350|100699799|FG003|Received Study Drug|Part B||0||
48153507|NCT02703350|100699800|FG004|Received Study Drug|Part B||0||
48153508|NCT02703350|100699801|FG005|Received Study Drug|Part B||0||
48153509|NCT02703350|100699802|FG006|Received Study Drug|Part B||15||
48153510|NCT02703350|100699803|FG007|Received Study Drug|Part B||15||
48153511|NCT02703350|100699796|FG000|COMPLETED|Part B||0||
48153512|NCT02703350|100699797|FG001|COMPLETED|Part B||0||
48153513|NCT02703350|100699798|FG002|COMPLETED|Part B||0||
48153514|NCT02703350|100699799|FG003|COMPLETED|Part B||0||
48308735|NCT03805750|101081027|FG001|COMPLETED|Second Intervention - 4 Weeks||2||
48308736|NCT03805750|101081026|FG000|NOT COMPLETED|Second Intervention - 4 Weeks||0||
48308737|NCT03805750|101081027|FG001|NOT COMPLETED|Second Intervention - 4 Weeks||2||
48153515|NCT02703350|100699800|FG004|COMPLETED|Part B||0||
48153516|NCT02703350|100699801|FG005|COMPLETED|Part B||0||
48153517|NCT02703350|100699802|FG006|COMPLETED|Part B||15||
48153518|NCT02703350|100699803|FG007|COMPLETED|Part B||15||
48153519|NCT02703350|100699796|FG000|NOT COMPLETED|Part B||0||
48153520|NCT02703350|100699797|FG001|NOT COMPLETED|Part B||0||
48153521|NCT02703350|100699798|FG002|NOT COMPLETED|Part B||0||
48153522|NCT02703350|100699799|FG003|NOT COMPLETED|Part B||0||
48153523|NCT02703350|100699800|FG004|NOT COMPLETED|Part B||0||
48153524|NCT02703350|100699801|FG005|NOT COMPLETED|Part B||0||
48153525|NCT02703350|100699802|FG006|NOT COMPLETED|Part B||0||
48153526|NCT02703350|100699803|FG007|NOT COMPLETED|Part B||0||
48153527|NCT01826812|100699804|FG000|STARTED|Overall Study||167||
48153528|NCT01826812|100699805|FG001|STARTED|Overall Study||33||
48153529|NCT01826812|100699804|FG000|COMPLETED|Overall Study||167||
48153530|NCT01826812|100699805|FG001|COMPLETED|Overall Study||32||
48153531|NCT01826812|100699804|FG000|NOT COMPLETED|Overall Study||0||
48153532|NCT01826812|100699805|FG001|NOT COMPLETED|Overall Study||1||
48153533|NCT03255824|100699806|FG000|STARTED|Overall Study||69||
48153534|NCT03255824|100699807|FG001|STARTED|Overall Study||75||
48153535|NCT03255824|100699806|FG000|COMPLETED|Overall Study||67||
48153536|NCT03255824|100699807|FG001|COMPLETED|Overall Study||74||
48153537|NCT03255824|100699806|FG000|NOT COMPLETED|Overall Study||2||
48308738|NCT00618436|101081028|FG000|STARTED|Overall Study||34||
48153538|NCT03255824|100699807|FG001|NOT COMPLETED|Overall Study||1||
48153539|NCT01490502|100699808|FG000|STARTED|Overall Study||83||
48153540|NCT01490502|100699809|FG001|STARTED|Overall Study||89||
48153541|NCT01490502|100699808|FG000|Received Allocated Intervention|Overall Study||83||
48153542|NCT01490502|100699809|FG001|Received Allocated Intervention|Overall Study||88||
48153543|NCT01490502|100699808|FG000|Attended at Least 1 Follow-up Visit|Overall Study||82||
48153544|NCT01490502|100699809|FG001|Attended at Least 1 Follow-up Visit|Overall Study||83||
48153545|NCT01490502|100699808|FG000|COMPLETED|Overall Study||68||
48153546|NCT01490502|100699809|FG001|COMPLETED|Overall Study||72||
48153547|NCT01490502|100699808|FG000|NOT COMPLETED|Overall Study||15||
48153548|NCT01490502|100699809|FG001|NOT COMPLETED|Overall Study||17||
48153549|NCT03813238|100699810|FG000|STARTED|Overall Study||22||
48153550|NCT03813238|100699811|FG001|STARTED|Overall Study||41||
48153551|NCT03813238|100699810|FG000|Received at Least 1 Dose of Study Drug|Overall Study||22||
48188729|NCT05161715|100783320|FG000|NOT COMPLETED|Overall Study||0||
48308739|NCT00618436|101081029|FG001|STARTED|Overall Study||18||
48153552|NCT03813238|100699811|FG001|Received at Least 1 Dose of Study Drug|Overall Study||40||
48153553|NCT03813238|100699810|FG000|Modified Intent-to-treat (mITT) Analysis Set|Overall Study||21|All randomized participants with at least 1 postbaseline centrally read Movement Disorder-Childhood Rating Scale (MD-CRS) part II assessment.|
48153554|NCT03813238|100699811|FG001|Modified Intent-to-treat (mITT) Analysis Set|Overall Study||40|All randomized participants with at least 1 postbaseline centrally read Movement Disorder-Childhood Rating Scale (MD-CRS) part II assessment.|
48153555|NCT03813238|100699810|FG000|COMPLETED|Overall Study||21||
48153556|NCT03813238|100699811|FG001|COMPLETED|Overall Study||30||
48153557|NCT03813238|100699810|FG000|NOT COMPLETED|Overall Study||1||
48153558|NCT03813238|100699811|FG001|NOT COMPLETED|Overall Study||11||
48153559|NCT01648270|100699812|FG000|STARTED|Intravenous Buprenorphine||25||
48153560|NCT01648270|100699812|FG000|COMPLETED|Intravenous Buprenorphine||13||
48153561|NCT01648270|100699812|FG000|NOT COMPLETED|Intravenous Buprenorphine||12||
48153562|NCT01648270|100699812|FG000|STARTED|Sublingual Buprenorphine||13||
48153563|NCT01648270|100699812|FG000|COMPLETED|Sublingual Buprenorphine||13||
48153564|NCT01648270|100699812|FG000|NOT COMPLETED|Sublingual Buprenorphine||0||
48153565|NCT01648270|100699812|FG000|STARTED|Cyclosporine Plus IV Buprenorphine||13||
48153566|NCT01648270|100699812|FG000|COMPLETED|Cyclosporine Plus IV Buprenorphine||13||
48153567|NCT01648270|100699812|FG000|NOT COMPLETED|Cyclosporine Plus IV Buprenorphine||0||
48153568|NCT01648270|100699812|FG000|STARTED|Cyclosporine + Sublingual Buprenorphine||13||
48153569|NCT01648270|100699812|FG000|COMPLETED|Cyclosporine + Sublingual Buprenorphine||13||
48153570|NCT01648270|100699812|FG000|NOT COMPLETED|Cyclosporine + Sublingual Buprenorphine||0||
48153571|NCT00338598|100699813|FG000|STARTED|Overall Study||10||
48153572|NCT00338598|100699814|FG001|STARTED|Overall Study||10||
48153573|NCT00338598|100699813|FG000|COMPLETED|Overall Study||10||
48153574|NCT00338598|100699814|FG001|COMPLETED|Overall Study||8||
48153575|NCT00338598|100699813|FG000|NOT COMPLETED|Overall Study||0||
48153576|NCT00338598|100699814|FG001|NOT COMPLETED|Overall Study||2||
48153577|NCT04252742|100699815|FG000|STARTED|Overall Study||256||
48153578|NCT04252742|100699816|FG001|STARTED|Overall Study||256||
48153579|NCT04252742|100699815|FG000|Received Investigational Product (IP)|Overall Study||256||
48153580|NCT04252742|100699816|FG001|Received Investigational Product (IP)|Overall Study||254||
48153581|NCT04252742|100699815|FG000|COMPLETED|Overall Study||241||
48153582|NCT04252742|100699816|FG001|COMPLETED|Overall Study||244||
48153583|NCT04252742|100699815|FG000|NOT COMPLETED|Overall Study||15||
48153584|NCT04252742|100699816|FG001|NOT COMPLETED|Overall Study||12||
48153585|NCT05899686|100699817|FG000|STARTED|Overall Study||12||
48153586|NCT05899686|100699817|FG000|COMPLETED|Overall Study||11||
48153587|NCT05899686|100699817|FG000|NOT COMPLETED|Overall Study||1||
48153588|NCT01822587|100699818|FG000|STARTED|Overall Study||59|Not all participant who were started were able to complete the study.|
48153589|NCT01822587|100699819|FG001|STARTED|Overall Study||60|Not all participant who were started were able to complete the study.|
48153590|NCT01822587|100699820|FG002|STARTED|Overall Study||62|Not all participant who were started were able to complete the study.|
48153591|NCT01822587|100699818|FG000|COMPLETED|Overall Study||43||
48153592|NCT01822587|100699819|FG001|COMPLETED|Overall Study||45||
48153593|NCT01822587|100699820|FG002|COMPLETED|Overall Study||44||
48153594|NCT01822587|100699818|FG000|NOT COMPLETED|Overall Study||16||
48153595|NCT01822587|100699819|FG001|NOT COMPLETED|Overall Study||15||
48153596|NCT01822587|100699820|FG002|NOT COMPLETED|Overall Study||18||
48153597|NCT02355028|100699821|FG000|STARTED|Overall Study||47||
48153598|NCT02355028|100699822|FG001|STARTED|Overall Study||46||
48153599|NCT02355028|100699821|FG000|Treated|Overall Study||46||
48153600|NCT02355028|100699822|FG001|Treated|Overall Study||45||
48153601|NCT02355028|100699821|FG000|COMPLETED|Overall Study||36||
48153602|NCT02355028|100699822|FG001|COMPLETED|Overall Study||41||
48153603|NCT02355028|100699821|FG000|NOT COMPLETED|Overall Study||11||
48153604|NCT02355028|100699822|FG001|NOT COMPLETED|Overall Study||5||
48153605|NCT01281202|100699823|FG000|STARTED|Overall Study||103||
48153606|NCT01281202|100699824|FG001|STARTED|Overall Study||104||
48153607|NCT01281202|100699823|FG000|COMPLETED|Overall Study||75||
48153608|NCT01281202|100699824|FG001|COMPLETED|Overall Study||68||
48153609|NCT01281202|100699823|FG000|NOT COMPLETED|Overall Study||28||
48153610|NCT01281202|100699824|FG001|NOT COMPLETED|Overall Study||36||
48153611|NCT00617981|100699825|FG000|STARTED|Overall Study||354||
48153612|NCT00617981|100699826|FG001|STARTED|Overall Study||347||
48153613|NCT00617981|100699825|FG000|COMPLETED|Overall Study||244||
48153614|NCT00617981|100699826|FG001|COMPLETED|Overall Study||245||
48153615|NCT00617981|100699825|FG000|NOT COMPLETED|Overall Study||110||
48153616|NCT00617981|100699826|FG001|NOT COMPLETED|Overall Study||102||
48153617|NCT00117676|100699827|FG000|STARTED|Double-blind Period Through Week 48||254||
48153618|NCT00117676|100699828|FG001|STARTED|Double-blind Period Through Week 48||128||
48153619|NCT00117676|100699827|FG000|COMPLETED|Double-blind Period Through Week 48||244||
48153620|NCT00117676|100699828|FG001|COMPLETED|Double-blind Period Through Week 48||121||
48153621|NCT00117676|100699827|FG000|NOT COMPLETED|Double-blind Period Through Week 48||10||
48153622|NCT00117676|100699828|FG001|NOT COMPLETED|Double-blind Period Through Week 48||7||
48153623|NCT00117676|100699827|FG000|STARTED|Open-label Period: Weeks 49 - 96||235||
48153624|NCT00117676|100699828|FG001|STARTED|Open-label Period: Weeks 49 - 96||112||
48153625|NCT00117676|100699827|FG000|COMPLETED|Open-label Period: Weeks 49 - 96||225||
48153626|NCT00117676|100699828|FG001|COMPLETED|Open-label Period: Weeks 49 - 96||110||
48153627|NCT00117676|100699827|FG000|NOT COMPLETED|Open-label Period: Weeks 49 - 96||10||
48153628|NCT00117676|100699828|FG001|NOT COMPLETED|Open-label Period: Weeks 49 - 96||2||
48153629|NCT00117676|100699827|FG000|STARTED|Open-label Period: Weeks 97 - 144||225||
48153630|NCT00117676|100699828|FG001|STARTED|Open-label Period: Weeks 97 - 144||110||
48153631|NCT00117676|100699827|FG000|COMPLETED|Open-label Period: Weeks 97 - 144||219||
48153632|NCT00117676|100699828|FG001|COMPLETED|Open-label Period: Weeks 97 - 144||109||
48153633|NCT00117676|100699827|FG000|NOT COMPLETED|Open-label Period: Weeks 97 - 144||6||
48153634|NCT00117676|100699828|FG001|NOT COMPLETED|Open-label Period: Weeks 97 - 144||1||
48153635|NCT00117676|100699827|FG000|STARTED|Open-label Period: Weeks 145 - 192||219||
48153636|NCT00117676|100699828|FG001|STARTED|Open-label Period: Weeks 145 - 192||109||
48153637|NCT00117676|100699827|FG000|COMPLETED|Open-label Period: Weeks 145 - 192||209||
48153638|NCT00117676|100699828|FG001|COMPLETED|Open-label Period: Weeks 145 - 192||106||
48153639|NCT00117676|100699827|FG000|NOT COMPLETED|Open-label Period: Weeks 145 - 192||10||
48153640|NCT00117676|100699828|FG001|NOT COMPLETED|Open-label Period: Weeks 145 - 192||3||
48153641|NCT00117676|100699827|FG000|STARTED|Open-label Period: Weeks 193 - 240||209||
48153642|NCT00117676|100699828|FG001|STARTED|Open-label Period: Weeks 193 - 240||106||
48153643|NCT00117676|100699827|FG000|COMPLETED|Open-label Period: Weeks 193 - 240||202||
48153644|NCT00117676|100699828|FG001|COMPLETED|Open-label Period: Weeks 193 - 240||103||
48153645|NCT00117676|100699827|FG000|NOT COMPLETED|Open-label Period: Weeks 193 - 240||7||
48153646|NCT00117676|100699828|FG001|NOT COMPLETED|Open-label Period: Weeks 193 - 240||3||
48153647|NCT00117676|100699827|FG000|STARTED|Open-label Period: Weeks 241 - 288||202||
48153648|NCT00117676|100699828|FG001|STARTED|Open-label Period: Weeks 241 - 288||103||
48153649|NCT00117676|100699827|FG000|COMPLETED|Open-label Period: Weeks 241 - 288||192||
48153650|NCT00117676|100699828|FG001|COMPLETED|Open-label Period: Weeks 241 - 288||100||
48153651|NCT00117676|100699827|FG000|NOT COMPLETED|Open-label Period: Weeks 241 - 288||10||
48153652|NCT00117676|100699828|FG001|NOT COMPLETED|Open-label Period: Weeks 241 - 288||3||
48153653|NCT00117676|100699827|FG000|STARTED|Open-label Period: Weeks 289 - 336||192||
48153654|NCT00117676|100699828|FG001|STARTED|Open-label Period: Weeks 289 - 336||100||
48153655|NCT00117676|100699827|FG000|COMPLETED|Open-label Period: Weeks 289 - 336||183||
48153656|NCT00117676|100699828|FG001|COMPLETED|Open-label Period: Weeks 289 - 336||93||
48153657|NCT00117676|100699827|FG000|NOT COMPLETED|Open-label Period: Weeks 289 - 336||9||
48153658|NCT00117676|100699828|FG001|NOT COMPLETED|Open-label Period: Weeks 289 - 336||7||
48153659|NCT00117676|100699827|FG000|STARTED|Open-label Period: Weeks 337 - 384||183||
48153660|NCT00117676|100699828|FG001|STARTED|Open-label Period: Weeks 337 - 384||93||
48153661|NCT00117676|100699827|FG000|COMPLETED|Open-label Period: Weeks 337 - 384||176||
48153662|NCT00117676|100699828|FG001|COMPLETED|Open-label Period: Weeks 337 - 384||90||
48153663|NCT00117676|100699827|FG000|NOT COMPLETED|Open-label Period: Weeks 337 - 384||7||
48153664|NCT00117676|100699828|FG001|NOT COMPLETED|Open-label Period: Weeks 337 - 384||3||
48153665|NCT00117676|100699827|FG000|STARTED|Open-label Period: Weeks 385 - 432||82||
48153666|NCT00117676|100699828|FG001|STARTED|Open-label Period: Weeks 385 - 432||46||
48153667|NCT00117676|100699827|FG000|COMPLETED|Open-label Period: Weeks 385 - 432||82||
48153668|NCT00117676|100699828|FG001|COMPLETED|Open-label Period: Weeks 385 - 432||44||
48153669|NCT00117676|100699827|FG000|NOT COMPLETED|Open-label Period: Weeks 385 - 432||0||
48153670|NCT00117676|100699828|FG001|NOT COMPLETED|Open-label Period: Weeks 385 - 432||2||
48153671|NCT00117676|100699827|FG000|STARTED|Open-label Period: Weeks 433 - 480||82||
48153672|NCT00117676|100699828|FG001|STARTED|Open-label Period: Weeks 433 - 480||43||
48153673|NCT00117676|100699827|FG000|COMPLETED|Open-label Period: Weeks 433 - 480||80||
48153674|NCT00117676|100699828|FG001|COMPLETED|Open-label Period: Weeks 433 - 480||41||
48153675|NCT00117676|100699827|FG000|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2||
48153676|NCT00117676|100699828|FG001|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2||
48153677|NCT04924283|100699829|FG000|STARTED|Overall Study||20||
48153678|NCT04924283|100699830|FG001|STARTED|Overall Study||20||
48153679|NCT04924283|100699829|FG000|COMPLETED|Overall Study||20||
48153680|NCT04924283|100699830|FG001|COMPLETED|Overall Study||17||
48153681|NCT04924283|100699829|FG000|NOT COMPLETED|Overall Study||0||
48153682|NCT04924283|100699830|FG001|NOT COMPLETED|Overall Study||3||
48153683|NCT01833143|100699831|FG000|STARTED|Overall Study||17||
48723106|NCT04881747|102108279|FG002|COMPLETED|Period 2||8||
48723107|NCT04881747|102108280|FG003|COMPLETED|Period 2||8||
48153684|NCT01833143|100699831|FG000|COMPLETED|Overall Study||16||
48153685|NCT01833143|100699831|FG000|NOT COMPLETED|Overall Study||1||
48723108|NCT04881747|102108281|FG004|COMPLETED|Period 2||8||
48153686|NCT02753595|100699832|FG000|STARTED|Overall Study||5||
48153687|NCT02753595|100699833|FG001|STARTED|Overall Study||9||
48153688|NCT02753595|100699832|FG000|COMPLETED|Overall Study||3||
48153689|NCT02753595|100699833|FG001|COMPLETED|Overall Study||7||
48153690|NCT02753595|100699832|FG000|NOT COMPLETED|Overall Study||2||
48153691|NCT02753595|100699833|FG001|NOT COMPLETED|Overall Study||2||
48153692|NCT02548455|100699834|FG000|STARTED|Overall Study||499|484 were successful and 15 were unsuccessful.|
48153693|NCT02548455|100699834|FG000|Completed Pre-Discharge|Overall Study||484||
48723109|NCT04881747|102108282|FG005|COMPLETED|Period 2||7||
48723110|NCT04881747|102108277|FG000|NOT COMPLETED|Period 2||0||
48723111|NCT04881747|102108278|FG001|NOT COMPLETED|Period 2||0||
48723112|NCT04881747|102108279|FG002|NOT COMPLETED|Period 2||0||
48153694|NCT02548455|100699834|FG000|Completed 6-Month Follow-up|Overall Study||259||
48153695|NCT02548455|100699834|FG000|Completed 12-Month Follow-up|Overall Study||61||
48153696|NCT02548455|100699834|FG000|COMPLETED|Overall Study||259||
48153697|NCT02548455|100699834|FG000|NOT COMPLETED|Overall Study||240||
48153698|NCT03247790|100699835|FG000|STARTED|Period 1: Migraine Attack||16||
48153699|NCT03247790|100699835|FG000|Received at Least One Dose of Study Drug|Period 1: Migraine Attack||16||
48153700|NCT03247790|100699835|FG000|COMPLETED|Period 1: Migraine Attack||16||
48153701|NCT03247790|100699835|FG000|NOT COMPLETED|Period 1: Migraine Attack||0||
48153702|NCT03247790|100699835|FG000|STARTED|Period 2: Inter-ictal Period||16||
48153703|NCT03247790|100699835|FG000|COMPLETED|Period 2: Inter-ictal Period||16||
48153704|NCT03247790|100699835|FG000|NOT COMPLETED|Period 2: Inter-ictal Period||0||
48153705|NCT01620567|100699836|FG000|STARTED|Overall Study||23||
48153706|NCT01620567|100699837|FG001|STARTED|Overall Study||25||
48153707|NCT01620567|100699836|FG000|COMPLETED|Overall Study||20||
48153708|NCT01620567|100699837|FG001|COMPLETED|Overall Study||20||
48153709|NCT01620567|100699836|FG000|NOT COMPLETED|Overall Study||3||
48153710|NCT01620567|100699837|FG001|NOT COMPLETED|Overall Study||5||
48153711|NCT02969525|100699838|FG000|STARTED|Double-Blind Period||42||
48153712|NCT02969525|100699839|FG001|STARTED|Double-Blind Period||41||
48153713|NCT02969525|100699840|FG002|STARTED|Double-Blind Period||41||
48153714|NCT02969525|100699841|FG003|STARTED|Double-Blind Period||41||
48153715|NCT02969525|100699842|FG004|STARTED|Double-Blind Period||41||
48153716|NCT02969525|100699843|FG005|STARTED|Double-Blind Period||0||
48153717|NCT02969525|100699844|FG006|STARTED|Double-Blind Period||0||
48153718|NCT02969525|100699845|FG007|STARTED|Double-Blind Period||0||
48153719|NCT02969525|100699846|FG008|STARTED|Double-Blind Period||0||
48153720|NCT02969525|100699847|FG009|STARTED|Double-Blind Period||0||
48153721|NCT02969525|100699848|FG010|STARTED|Double-Blind Period||0||
48153722|NCT02969525|100699849|FG011|STARTED|Double-Blind Period||0||
48153723|NCT02969525|100699838|FG000|Completed Double-Blind Period|Double-Blind Period||42||
48153724|NCT02969525|100699839|FG001|Completed Double-Blind Period|Double-Blind Period||41||
48153725|NCT02969525|100699840|FG002|Completed Double-Blind Period|Double-Blind Period||40||
48153726|NCT02969525|100699841|FG003|Completed Double-Blind Period|Double-Blind Period||39||
48153727|NCT02969525|100699842|FG004|Completed Double-Blind Period|Double-Blind Period||41||
48153728|NCT02969525|100699843|FG005|Completed Double-Blind Period|Double-Blind Period||0||
48153729|NCT02969525|100699844|FG006|Completed Double-Blind Period|Double-Blind Period||0||
48153730|NCT02969525|100699845|FG007|Completed Double-Blind Period|Double-Blind Period||0||
48153731|NCT02969525|100699846|FG008|Completed Double-Blind Period|Double-Blind Period||0||
48153732|NCT02969525|100699847|FG009|Completed Double-Blind Period|Double-Blind Period||0||
48153733|NCT02969525|100699848|FG010|Completed Double-Blind Period|Double-Blind Period||0||
48153734|NCT02969525|100699849|FG011|Completed Double-Blind Period|Double-Blind Period||0||
48153735|NCT02969525|100699838|FG000|Completed Wk12 and Started Dose-Blind|Double-Blind Period||40||
48153736|NCT02969525|100699839|FG001|Completed Wk12 and Started Dose-Blind|Double-Blind Period||41||
48153737|NCT02969525|100699840|FG002|Completed Wk12 and Started Dose-Blind|Double-Blind Period||40||
48611630|NCT02029274|101834129|FG000|Fixed Dose Period 2|Overall Study||5||
48308740|NCT00618436|101081028|FG000|COMPLETED|Overall Study||34||
48308741|NCT00618436|101081029|FG001|COMPLETED|Overall Study||18||
48308742|NCT00618436|101081028|FG000|NOT COMPLETED|Overall Study||0||
48308743|NCT00618436|101081029|FG001|NOT COMPLETED|Overall Study||0||
48308744|NCT00356889|101081030|FG000|STARTED|Overall Study||56||
48308745|NCT00356889|101081030|FG000|COMPLETED|Overall Study||53||
48308746|NCT00356889|101081030|FG000|NOT COMPLETED|Overall Study||3||
48308747|NCT03426787|101081031|FG000|STARTED|Overall Study||70||
48308748|NCT03426787|101081031|FG000|COMPLETED|Overall Study||56||
48308749|NCT03426787|101081031|FG000|NOT COMPLETED|Overall Study||14||
48153738|NCT02969525|100699841|FG003|Completed Wk12 and Started Dose-Blind|Double-Blind Period||37||
48153739|NCT02969525|100699842|FG004|Completed Wk12 and Started Dose-Blind|Double-Blind Period||41||
48153740|NCT02969525|100699843|FG005|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0||
48153741|NCT02969525|100699844|FG006|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0||
48308750|NCT01995578|101081032|FG000|STARTED|Overall Study||32||
48308751|NCT01995578|101081032|FG000|COMPLETED|Overall Study||32||
48308752|NCT01995578|101081032|FG000|NOT COMPLETED|Overall Study||0||
48308753|NCT00525044|101081033|FG000|STARTED|Overall Study||124||
48308754|NCT00525044|101081034|FG001|STARTED|Overall Study||125||
48308755|NCT00525044|101081033|FG000|COMPLETED|Overall Study||124||
48308756|NCT00525044|101081034|FG001|COMPLETED|Overall Study||124||
48611631|NCT02029274|101834130|FG001|Fixed Dose Period 2|Overall Study||4||
48611632|NCT02029274|101834131|FG002|Fixed Dose Period 2|Overall Study||4||
48153742|NCT02969525|100699845|FG007|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0||
48153743|NCT02969525|100699846|FG008|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0||
48308757|NCT00525044|101081033|FG000|NOT COMPLETED|Overall Study||0||
48153744|NCT02969525|100699847|FG009|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0||
48153745|NCT02969525|100699848|FG010|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0||
48153746|NCT02969525|100699849|FG011|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0||
48308758|NCT00525044|101081034|FG001|NOT COMPLETED|Overall Study||1||
48308759|NCT04422990|101081035|FG000|STARTED|Overall Study||50||100
48308760|NCT04422990|101081036|FG001|STARTED|Overall Study||97||194
48611633|NCT02029274|101834132|FG003|Fixed Dose Period 2|Overall Study||4||
48611634|NCT02029274|101834129|FG000|COMPLETED|Overall Study||4||
48611635|NCT02029274|101834130|FG001|COMPLETED|Overall Study||4||
48611636|NCT02029274|101834131|FG002|COMPLETED|Overall Study||2||
48611637|NCT02029274|101834132|FG003|COMPLETED|Overall Study||2||
48611638|NCT02029274|101834129|FG000|NOT COMPLETED|Overall Study||1||
48611639|NCT02029274|101834130|FG001|NOT COMPLETED|Overall Study||0||
48611640|NCT02029274|101834131|FG002|NOT COMPLETED|Overall Study||2||
48153747|NCT02969525|100699838|FG000|COMPLETED|Double-Blind Period||40||
48153748|NCT02969525|100699839|FG001|COMPLETED|Double-Blind Period||41||
48153749|NCT02969525|100699840|FG002|COMPLETED|Double-Blind Period||40||
48153750|NCT02969525|100699841|FG003|COMPLETED|Double-Blind Period||37||
48153751|NCT02969525|100699842|FG004|COMPLETED|Double-Blind Period||41||
48611641|NCT02029274|101834132|FG003|NOT COMPLETED|Overall Study||2||
48611642|NCT03915626|101834133|FG000|STARTED|Overall Study||7|Study was intended to enroll and complete n=12 volunteers; however, funding was terminated due to pandemic.|
48611643|NCT03915626|101834133|FG000|COMPLETED|Overall Study||6||
48611644|NCT03915626|101834133|FG000|NOT COMPLETED|Overall Study||1||
48611645|NCT01601496|101834134|FG000|STARTED|Overall Study||117||
48611646|NCT01601496|101834134|FG000|COMPLETED|Overall Study||102||
48611647|NCT01601496|101834134|FG000|NOT COMPLETED|Overall Study||15||
48611648|NCT01449734|101834135|FG000|STARTED|Overall Study||215||
48611649|NCT01449734|101834135|FG000|COMPLETED|Overall Study||215||
48611650|NCT01449734|101834135|FG000|NOT COMPLETED|Overall Study||0||
48611651|NCT02714036|101834136|FG000|STARTED|Overall Study||30||
48611652|NCT02714036|101834137|FG001|STARTED|Overall Study||5||
48611653|NCT02714036|101834136|FG000|COMPLETED|Overall Study||18||
48611654|NCT02714036|101834137|FG001|COMPLETED|Overall Study||1||
48611655|NCT02714036|101834136|FG000|NOT COMPLETED|Overall Study||12||
48611656|NCT02714036|101834137|FG001|NOT COMPLETED|Overall Study||4||
48611657|NCT02937740|101834138|FG000|STARTED|BID for 90 Days, 22 mg/Day||24||
48611658|NCT02937740|101834139|FG001|STARTED|BID for 90 Days, 22 mg/Day||93||
48611659|NCT02937740|101834138|FG000|COMPLETED|BID for 90 Days, 22 mg/Day||19||
48611660|NCT02937740|101834139|FG001|COMPLETED|BID for 90 Days, 22 mg/Day||62||
48611661|NCT02937740|101834138|FG000|NOT COMPLETED|BID for 90 Days, 22 mg/Day||5||
48611662|NCT02937740|101834139|FG001|NOT COMPLETED|BID for 90 Days, 22 mg/Day||31||
48611663|NCT02937740|101834138|FG000|STARTED|Uptitrated to TID on Day 90 for 30 Days||13||
48611664|NCT02937740|101834139|FG001|STARTED|Uptitrated to TID on Day 90 for 30 Days||17||
48611665|NCT02937740|101834138|FG000|COMPLETED|Uptitrated to TID on Day 90 for 30 Days||12||
48611666|NCT02937740|101834139|FG001|COMPLETED|Uptitrated to TID on Day 90 for 30 Days||15||
48611667|NCT02937740|101834138|FG000|NOT COMPLETED|Uptitrated to TID on Day 90 for 30 Days||1||
48611668|NCT02937740|101834139|FG001|NOT COMPLETED|Uptitrated to TID on Day 90 for 30 Days||2||
48611669|NCT02155309|101834140|FG000|STARTED|Overall Study||13||
48611670|NCT02155309|101834141|FG001|STARTED|Overall Study||10||
48611671|NCT02155309|101834142|FG002|STARTED|Overall Study||13||
48611672|NCT02155309|101834140|FG000|COMPLETED|Overall Study||13||
48611673|NCT02155309|101834141|FG001|COMPLETED|Overall Study||10||
48611674|NCT02155309|101834142|FG002|COMPLETED|Overall Study||12||
48611675|NCT02155309|101834140|FG000|NOT COMPLETED|Overall Study||0||
48611676|NCT02155309|101834141|FG001|NOT COMPLETED|Overall Study||0||
48611677|NCT02155309|101834142|FG002|NOT COMPLETED|Overall Study||1||
48611678|NCT04457362|101834143|FG000|STARTED|Overall Study||20||
48611679|NCT04457362|101834143|FG000|COMPLETED|Overall Study||20||
48611680|NCT04457362|101834143|FG000|NOT COMPLETED|Overall Study||0||
48611681|NCT05027815|101834144|FG000|STARTED|Overall Study||3||
48611682|NCT05027815|101834145|FG001|STARTED|Overall Study||1||
48611683|NCT05027815|101834144|FG000|COMPLETED|Overall Study||1||
48611684|NCT05027815|101834145|FG001|COMPLETED|Overall Study||0||
48611685|NCT05027815|101834144|FG000|NOT COMPLETED|Overall Study||2||
48611686|NCT05027815|101834145|FG001|NOT COMPLETED|Overall Study||1||
48153752|NCT02969525|100699843|FG005|COMPLETED|Double-Blind Period||0||
48153753|NCT02969525|100699844|FG006|COMPLETED|Double-Blind Period||0||
48153754|NCT02969525|100699845|FG007|COMPLETED|Double-Blind Period||0||
48153755|NCT02969525|100699846|FG008|COMPLETED|Double-Blind Period||0||
48153756|NCT02969525|100699847|FG009|COMPLETED|Double-Blind Period||0||
48153757|NCT02969525|100699848|FG010|COMPLETED|Double-Blind Period||0||
48153758|NCT02969525|100699849|FG011|COMPLETED|Double-Blind Period||0||
48153759|NCT02969525|100699838|FG000|NOT COMPLETED|Double-Blind Period||2||
48611687|NCT02421419|101834146|FG000|STARTED|Overall Study||6||
48153760|NCT02969525|100699839|FG001|NOT COMPLETED|Double-Blind Period||0||
48153761|NCT02969525|100699840|FG002|NOT COMPLETED|Double-Blind Period||1||
48153762|NCT02969525|100699841|FG003|NOT COMPLETED|Double-Blind Period||4||
48153763|NCT02969525|100699842|FG004|NOT COMPLETED|Double-Blind Period||0||
48153764|NCT02969525|100699843|FG005|NOT COMPLETED|Double-Blind Period||0||
48153765|NCT02969525|100699844|FG006|NOT COMPLETED|Double-Blind Period||0||
48611688|NCT02421419|101834147|FG001|STARTED|Overall Study||11||
48611689|NCT02421419|101834148|FG002|STARTED|Overall Study||9||
48611690|NCT02421419|101834146|FG000|COMPLETED|Overall Study||6||
48611691|NCT02421419|101834147|FG001|COMPLETED|Overall Study||11||
48611692|NCT02421419|101834148|FG002|COMPLETED|Overall Study||8||
48611693|NCT02421419|101834146|FG000|NOT COMPLETED|Overall Study||0||
48611694|NCT02421419|101834147|FG001|NOT COMPLETED|Overall Study||0||
48611695|NCT02421419|101834148|FG002|NOT COMPLETED|Overall Study||1||
48611696|NCT03828214|101834149|FG000|STARTED|Overall Study||11||
48611697|NCT03828214|101834149|FG000|COMPLETED|Overall Study||11||
48611698|NCT03828214|101834149|FG000|NOT COMPLETED|Overall Study||0||
48611699|NCT01211145|101834150|FG000|STARTED|Overall Study||296||
48611700|NCT01211145|101834151|FG001|STARTED|Overall Study||115||
48611701|NCT01211145|101834152|FG002|STARTED|Overall Study||99||
48611702|NCT01211145|101834153|FG003|STARTED|Overall Study||288||
48611703|NCT01211145|101834150|FG000|COMPLETED|Overall Study||270||
48611704|NCT01211145|101834151|FG001|COMPLETED|Overall Study||98||
48611705|NCT01211145|101834152|FG002|COMPLETED|Overall Study||86||
48611706|NCT01211145|101834153|FG003|COMPLETED|Overall Study||268||
48611707|NCT01211145|101834150|FG000|NOT COMPLETED|Overall Study||26||
48611708|NCT01211145|101834151|FG001|NOT COMPLETED|Overall Study||17||
48611709|NCT01211145|101834152|FG002|NOT COMPLETED|Overall Study||13||
48723113|NCT04881747|102108280|FG003|NOT COMPLETED|Period 2||0||
48723114|NCT04881747|102108281|FG004|NOT COMPLETED|Period 2||0||
48723115|NCT04881747|102108282|FG005|NOT COMPLETED|Period 2||0||
48723116|NCT04881747|102108277|FG000|STARTED|Period 2 Washout||8||
48723117|NCT04881747|102108278|FG001|STARTED|Period 2 Washout||8||
48723118|NCT04881747|102108279|FG002|STARTED|Period 2 Washout||8||
48723119|NCT04881747|102108280|FG003|STARTED|Period 2 Washout||8||
48723120|NCT04881747|102108281|FG004|STARTED|Period 2 Washout||8||
48723121|NCT04881747|102108282|FG005|STARTED|Period 2 Washout||7||
48723122|NCT04881747|102108277|FG000|COMPLETED|Period 2 Washout||6||
48723123|NCT04881747|102108278|FG001|COMPLETED|Period 2 Washout||8||
48723124|NCT04881747|102108279|FG002|COMPLETED|Period 2 Washout||8||
48308761|NCT04422990|101081035|FG000|COMPLETED|Overall Study||47||94
48308762|NCT04422990|101081036|FG001|COMPLETED|Overall Study||96||192
48308763|NCT04422990|101081035|FG000|NOT COMPLETED|Overall Study||3||6
48308764|NCT04422990|101081036|FG001|NOT COMPLETED|Overall Study||1||2
48308765|NCT01555151|101081037|FG000|STARTED|Overall Study||188||
48308766|NCT01555151|101081038|FG001|STARTED|Overall Study||181||
48308767|NCT01555151|101081039|FG002|STARTED|Overall Study||184||
48308768|NCT01555151|101081040|FG003|STARTED|Overall Study||186||
48308769|NCT01555151|101081037|FG000|Safety Set (SAF)|Overall Study||186||
48308770|NCT01555151|101081038|FG001|Safety Set (SAF)|Overall Study||180||
48308771|NCT01555151|101081039|FG002|Safety Set (SAF)|Overall Study||183||
48308772|NCT01555151|101081040|FG003|Safety Set (SAF)|Overall Study||186||
48308773|NCT01555151|101081037|FG000|COMPLETED|Overall Study||175||
48308774|NCT01555151|101081038|FG001|COMPLETED|Overall Study||173||
48308775|NCT01555151|101081039|FG002|COMPLETED|Overall Study||178||
48308776|NCT01555151|101081040|FG003|COMPLETED|Overall Study||176||
48308777|NCT01555151|101081037|FG000|NOT COMPLETED|Overall Study||13||
48308778|NCT01555151|101081038|FG001|NOT COMPLETED|Overall Study||8||
48308779|NCT01555151|101081039|FG002|NOT COMPLETED|Overall Study||6||
48308780|NCT01555151|101081040|FG003|NOT COMPLETED|Overall Study||10||
48308781|NCT01378104|101081041|FG000|STARTED|Overall Study||92||
48611710|NCT01211145|101834153|FG003|NOT COMPLETED|Overall Study||20||
48611711|NCT01305772|101834154|FG000|STARTED|Overall Study||5||
48611712|NCT01305772|101834155|FG001|STARTED|Overall Study||1||
48611713|NCT01305772|101834154|FG000|Genomic Screening + Biopsy #1|Overall Study||5||
48611714|NCT01305772|101834155|FG001|Genomic Screening + Biopsy #1|Overall Study||1||
48611715|NCT01305772|101834154|FG000|Research PET/CT #1|Overall Study||5||
48611716|NCT01305772|101834155|FG001|Research PET/CT #1|Overall Study||1||
48611717|NCT01305772|101834154|FG000|Panitumumab Dose #1|Overall Study||5||
48611718|NCT01305772|101834155|FG001|Panitumumab Dose #1|Overall Study||1||
48611719|NCT01305772|101834154|FG000|Research PET/CT #2|Overall Study||5||
48611720|NCT01305772|101834155|FG001|Research PET/CT #2|Overall Study||1||
48611721|NCT01305772|101834154|FG000|Surgery/Biopsy #2|Overall Study||1||
48723125|NCT04881747|102108280|FG003|COMPLETED|Period 2 Washout||7||
48308782|NCT01378104|101081042|FG001|STARTED|Overall Study||86||
48308783|NCT01378104|101081041|FG000|COMPLETED|Overall Study||65||
48611722|NCT01305772|101834155|FG001|Surgery/Biopsy #2|Overall Study||1||
48723126|NCT04881747|102108281|FG004|COMPLETED|Period 2 Washout||7||
48723127|NCT04881747|102108282|FG005|COMPLETED|Period 2 Washout||7||
48723128|NCT04881747|102108277|FG000|NOT COMPLETED|Period 2 Washout||2||
48308784|NCT01378104|101081042|FG001|COMPLETED|Overall Study||60||
48308785|NCT01378104|101081041|FG000|NOT COMPLETED|Overall Study||27||
48308786|NCT01378104|101081042|FG001|NOT COMPLETED|Overall Study||26||
48308787|NCT00199914|101081043|FG000|STARTED|Overall Study||53||
48308788|NCT00199914|101081044|FG001|STARTED|Overall Study||60||
48308789|NCT00199914|101081043|FG000|COMPLETED|Overall Study||50||
48308790|NCT00199914|101081044|FG001|COMPLETED|Overall Study||54||
48308791|NCT00199914|101081043|FG000|NOT COMPLETED|Overall Study||3||
48308792|NCT00199914|101081044|FG001|NOT COMPLETED|Overall Study||6||
48308793|NCT00865904|101081045|FG000|STARTED|Overall Study||19||
48308794|NCT00865904|101081046|FG001|STARTED|Overall Study||18||
48308795|NCT00865904|101081047|FG002|STARTED|Overall Study||18||
48308796|NCT00865904|101081048|FG003|STARTED|Overall Study||18||
48308797|NCT00865904|101081049|FG004|STARTED|Overall Study||20||
48308798|NCT00865904|101081045|FG000|COMPLETED|Overall Study||17||
48308799|NCT00865904|101081046|FG001|COMPLETED|Overall Study||18||
48308800|NCT00865904|101081047|FG002|COMPLETED|Overall Study||18||
48308801|NCT00865904|101081048|FG003|COMPLETED|Overall Study||17||
48308802|NCT00865904|101081049|FG004|COMPLETED|Overall Study||19||
48308803|NCT00865904|101081045|FG000|NOT COMPLETED|Overall Study||2||
48308804|NCT00865904|101081046|FG001|NOT COMPLETED|Overall Study||0||
48308805|NCT00865904|101081047|FG002|NOT COMPLETED|Overall Study||0||
48308806|NCT00865904|101081048|FG003|NOT COMPLETED|Overall Study||1||
48308807|NCT00865904|101081049|FG004|NOT COMPLETED|Overall Study||1||
48308808|NCT01908972|101081050|FG000|STARTED|Overall Study||17||
48308809|NCT01908972|101081051|FG001|STARTED|Overall Study||17||
48308810|NCT01908972|101081050|FG000|COMPLETED|Overall Study||15||
48308811|NCT01908972|101081051|FG001|COMPLETED|Overall Study||17||
48308812|NCT01908972|101081050|FG000|NOT COMPLETED|Overall Study||2||
48308813|NCT01908972|101081051|FG001|NOT COMPLETED|Overall Study||0||
48308814|NCT03842163|101081052|FG000|STARTED|Overall Study||812||
48308815|NCT03842163|101081052|FG000|Full Analysis Set 1|Overall Study||766||
48308816|NCT03842163|101081052|FG000|Full Analysis Set 2 (Subset of FAS 1)|Overall Study||245||
48308817|NCT03842163|101081052|FG000|Full Analysis Set 3 (Subset of FAS 2)|Overall Study||208||
48308818|NCT03842163|101081052|FG000|Full Analysis Set 3.1|Overall Study||137||
48723129|NCT04881747|102108278|FG001|NOT COMPLETED|Period 2 Washout||0||
48723130|NCT04881747|102108279|FG002|NOT COMPLETED|Period 2 Washout||0||
48723131|NCT04881747|102108280|FG003|NOT COMPLETED|Period 2 Washout||1||
48723132|NCT04881747|102108281|FG004|NOT COMPLETED|Period 2 Washout||1||
48723133|NCT04881747|102108282|FG005|NOT COMPLETED|Period 2 Washout||0||
48723134|NCT04881747|102108277|FG000|STARTED|Period 3||6||
48723135|NCT04881747|102108278|FG001|STARTED|Period 3||8||
48723136|NCT04881747|102108279|FG002|STARTED|Period 3||8||
48723137|NCT04881747|102108280|FG003|STARTED|Period 3||7||
48723138|NCT04881747|102108281|FG004|STARTED|Period 3||7||
48723139|NCT04881747|102108282|FG005|STARTED|Period 3||7||
48723140|NCT04881747|102108277|FG000|Received At Least One Dose of Study Drug|Period 3||6||
48723141|NCT04881747|102108278|FG001|Received At Least One Dose of Study Drug|Period 3||8||
48723142|NCT04881747|102108279|FG002|Received At Least One Dose of Study Drug|Period 3||8||
48723143|NCT04881747|102108280|FG003|Received At Least One Dose of Study Drug|Period 3||7||
48723144|NCT04881747|102108281|FG004|Received At Least One Dose of Study Drug|Period 3||7||
48723145|NCT04881747|102108282|FG005|Received At Least One Dose of Study Drug|Period 3||7||
48723146|NCT04881747|102108277|FG000|COMPLETED|Period 3||6||
48723147|NCT04881747|102108278|FG001|COMPLETED|Period 3||8||
48723148|NCT04881747|102108279|FG002|COMPLETED|Period 3||8||
48723149|NCT04881747|102108280|FG003|COMPLETED|Period 3||7||
48723150|NCT04881747|102108281|FG004|COMPLETED|Period 3||7||
48723151|NCT04881747|102108282|FG005|COMPLETED|Period 3||7||
48723152|NCT04881747|102108277|FG000|NOT COMPLETED|Period 3||0||
48723153|NCT04881747|102108278|FG001|NOT COMPLETED|Period 3||0||
48723154|NCT04881747|102108279|FG002|NOT COMPLETED|Period 3||0||
48723155|NCT04881747|102108280|FG003|NOT COMPLETED|Period 3||0||
48723156|NCT04881747|102108281|FG004|NOT COMPLETED|Period 3||0||
48723157|NCT04881747|102108282|FG005|NOT COMPLETED|Period 3||0||
48723158|NCT01746173|102108283|FG000|STARTED|Overall Study||5||
48723159|NCT01746173|102108283|FG000|COMPLETED|Overall Study||3||
48723160|NCT01746173|102108283|FG000|NOT COMPLETED|Overall Study||2||
48723161|NCT00849108|102108284|FG000|STARTED|Cohort 1 Dose Ranging and Dose Interval||33||
48723162|NCT00849108|102108285|FG001|STARTED|Cohort 1 Dose Ranging and Dose Interval||0||
48723163|NCT00849108|102108284|FG000|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||32||
48723164|NCT00849108|102108285|FG001|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0||
48723165|NCT00849108|102108284|FG000|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||1||
48723166|NCT00849108|102108285|FG001|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0||
48723167|NCT00849108|102108284|FG000|STARTED|Cohort 2 Efficacy||0||
48723168|NCT00849108|102108285|FG001|STARTED|Cohort 2 Efficacy||143||
48723169|NCT00849108|102108284|FG000|COMPLETED|Cohort 2 Efficacy||0||
48723170|NCT00849108|102108285|FG001|COMPLETED|Cohort 2 Efficacy||133||
48723171|NCT00849108|102108284|FG000|NOT COMPLETED|Cohort 2 Efficacy||0||
48723172|NCT00849108|102108285|FG001|NOT COMPLETED|Cohort 2 Efficacy||10||
48723173|NCT01457846|102108286|FG000|STARTED|Overall Study||41||
48723174|NCT01457846|102108287|FG001|STARTED|Overall Study||30||
48723175|NCT01457846|102108286|FG000|Received Treatment|Overall Study||40||
48723176|NCT01457846|102108287|FG001|Received Treatment|Overall Study||27||
48723177|NCT01457846|102108286|FG000|Did Not Receive Treatment|Overall Study||1||
48723178|NCT01457846|102108287|FG001|Did Not Receive Treatment|Overall Study||3||
48723179|NCT01457846|102108286|FG000|Ongoing Treatment at Data Cut-off|Overall Study||1||
48723180|NCT01457846|102108287|FG001|Ongoing Treatment at Data Cut-off|Overall Study||1||
48723181|NCT01457846|102108286|FG000|COMPLETED|Overall Study||0||
48723182|NCT01457846|102108287|FG001|COMPLETED|Overall Study||0||
48723183|NCT01457846|102108286|FG000|NOT COMPLETED|Overall Study||41||
48723184|NCT01457846|102108287|FG001|NOT COMPLETED|Overall Study||30||
48723185|NCT01224444|102108288|FG000|STARTED|Overall Study||269||
48723186|NCT01224444|102108288|FG000|COMPLETED|Overall Study||269||
48723187|NCT01224444|102108288|FG000|NOT COMPLETED|Overall Study||0||
48723188|NCT02273960|102108289|FG000|STARTED|Short Term Period||5||
48723189|NCT02273960|102108290|FG001|STARTED|Short Term Period||6||
48723190|NCT02273960|102108291|FG002|STARTED|Short Term Period||5||
48723191|NCT02273960|102108292|FG003|STARTED|Short Term Period||10||
48723192|NCT02273960|102108289|FG000|COMPLETED|Short Term Period||0|Completed = Entering Long Term Extension|
48723193|NCT02273960|102108290|FG001|COMPLETED|Short Term Period||0|Completed = Entering Long Term Extension|
48723194|NCT02273960|102108291|FG002|COMPLETED|Short Term Period||1|Completed = Entering Long Term Extension|
48723195|NCT02273960|102108292|FG003|COMPLETED|Short Term Period||4|Completed = Entering Long Term Extension|
48723196|NCT02273960|102108289|FG000|NOT COMPLETED|Short Term Period||5||
48723197|NCT02273960|102108290|FG001|NOT COMPLETED|Short Term Period||6||
48723198|NCT02273960|102108291|FG002|NOT COMPLETED|Short Term Period||4||
48723199|NCT02273960|102108292|FG003|NOT COMPLETED|Short Term Period||6||
48723200|NCT02273960|102108289|FG000|STARTED|Long Term Extension||0||
48723201|NCT02273960|102108290|FG001|STARTED|Long Term Extension||0||
48723202|NCT02273960|102108291|FG002|STARTED|Long Term Extension||1||
48723203|NCT02273960|102108292|FG003|STARTED|Long Term Extension||4||
48723204|NCT02273960|102108289|FG000|COMPLETED|Long Term Extension||0||
48723205|NCT02273960|102108290|FG001|COMPLETED|Long Term Extension||0||
48723206|NCT02273960|102108291|FG002|COMPLETED|Long Term Extension||1||
48723207|NCT02273960|102108292|FG003|COMPLETED|Long Term Extension||3||
48723208|NCT02273960|102108289|FG000|NOT COMPLETED|Long Term Extension||0||
48723209|NCT02273960|102108290|FG001|NOT COMPLETED|Long Term Extension||0||
48723210|NCT02273960|102108291|FG002|NOT COMPLETED|Long Term Extension||0||
48723211|NCT02273960|102108292|FG003|NOT COMPLETED|Long Term Extension||1||
48723212|NCT02708355|102108293|FG000|STARTED|Overall Study||21||
48723213|NCT02708355|102108294|FG001|STARTED|Overall Study||22||
48723214|NCT02708355|102108295|FG002|STARTED|Overall Study||12||
48723215|NCT02708355|102108293|FG000|COMPLETED|Overall Study||20||
48723216|NCT02708355|102108294|FG001|COMPLETED|Overall Study||22||
48723217|NCT02708355|102108295|FG002|COMPLETED|Overall Study||12||
48723218|NCT02708355|102108293|FG000|NOT COMPLETED|Overall Study||1||
48723219|NCT02708355|102108294|FG001|NOT COMPLETED|Overall Study||0||
48723220|NCT02708355|102108295|FG002|NOT COMPLETED|Overall Study||0||
48723221|NCT04094584|102108296|FG000|STARTED|Overall Study||179||
48723222|NCT04094584|102108296|FG000|Screened for Eligibility|Overall Study||55|Screened for eligibility based on pre-screening result of being interested and willing to undergo screened|
48723223|NCT04094584|102108296|FG000|Enrolled and Received First Injection|Overall Study||32||
48723224|NCT04094584|102108296|FG000|COMPLETED|Overall Study||23||
48723225|NCT04094584|102108296|FG000|NOT COMPLETED|Overall Study||156||
48723226|NCT04598269|102108297|FG000|STARTED|Overall Study||25||
48723227|NCT04598269|102108298|FG001|STARTED|Overall Study||25||
48723228|NCT04598269|102108297|FG000|Received at Least 1 Dose of Study Drug|Overall Study||23||
48723229|NCT04598269|102108298|FG001|Received at Least 1 Dose of Study Drug|Overall Study||25||
48723230|NCT04598269|102108297|FG000|COMPLETED|Overall Study||21||
48723231|NCT04598269|102108298|FG001|COMPLETED|Overall Study||18||
48723232|NCT04598269|102108297|FG000|NOT COMPLETED|Overall Study||4||
48723233|NCT04598269|102108298|FG001|NOT COMPLETED|Overall Study||7||
48723234|NCT01365624|102108299|FG000|STARTED|Overall Study||15||
48723235|NCT01365624|102108300|FG001|STARTED|Overall Study||15||
48723236|NCT01365624|102108299|FG000|COMPLETED|Overall Study||15||
48723237|NCT01365624|102108300|FG001|COMPLETED|Overall Study||15||
48723238|NCT01365624|102108299|FG000|NOT COMPLETED|Overall Study||0||
48723239|NCT01365624|102108300|FG001|NOT COMPLETED|Overall Study||0||
48723240|NCT03281304|102108301|FG000|STARTED|Treatment Phase (up to 42 Months)||70||
48723241|NCT03281304|102108302|FG001|STARTED|Treatment Phase (up to 42 Months)||70||
48723242|NCT03281304|102108301|FG000|COMPLETED|Treatment Phase (up to 42 Months)||36||
48723243|NCT03281304|102108302|FG001|COMPLETED|Treatment Phase (up to 42 Months)||27||
48723244|NCT03281304|102108301|FG000|NOT COMPLETED|Treatment Phase (up to 42 Months)||34||
48723245|NCT03281304|102108302|FG001|NOT COMPLETED|Treatment Phase (up to 42 Months)||43||
48723246|NCT03281304|102108301|FG000|STARTED|Follow-up Phase (up to 4 Weeks)||63||
48723247|NCT03281304|102108302|FG001|STARTED|Follow-up Phase (up to 4 Weeks)||57||
48723248|NCT03281304|102108301|FG000|COMPLETED|Follow-up Phase (up to 4 Weeks)||61||
48723249|NCT03281304|102108302|FG001|COMPLETED|Follow-up Phase (up to 4 Weeks)||56||
48723250|NCT03281304|102108301|FG000|NOT COMPLETED|Follow-up Phase (up to 4 Weeks)||2||
48723251|NCT03281304|102108302|FG001|NOT COMPLETED|Follow-up Phase (up to 4 Weeks)||1||
48723252|NCT00558272|102108303|FG000|STARTED|Overall Study||69||
48723253|NCT00558272|102108304|FG001|STARTED|Overall Study||70||
48723254|NCT00558272|102108303|FG000|30 Days Follow-up|Overall Study||41||
48723255|NCT00558272|102108304|FG001|30 Days Follow-up|Overall Study||67||
48723256|NCT00558272|102108303|FG000|COMPLETED|Overall Study||56||
48723257|NCT00558272|102108304|FG001|COMPLETED|Overall Study||68||
48723258|NCT00558272|102108303|FG000|NOT COMPLETED|Overall Study||13||
48723259|NCT00558272|102108304|FG001|NOT COMPLETED|Overall Study||2||
48723260|NCT03101085|102108305|FG000|STARTED|Overall Study||20||
48723261|NCT03101085|102108306|FG001|STARTED|Overall Study||20||
48723262|NCT03101085|102108305|FG000|COMPLETED|Overall Study||20||
48723263|NCT03101085|102108306|FG001|COMPLETED|Overall Study||19||
48723264|NCT03101085|102108305|FG000|NOT COMPLETED|Overall Study||0||
48723265|NCT03101085|102108306|FG001|NOT COMPLETED|Overall Study||1||
48723266|NCT00257660|102108307|FG000|STARTED|Overall Study||55||
48723267|NCT00257660|102108308|FG001|STARTED|Overall Study||61||
48723268|NCT00257660|102108307|FG000|COMPLETED|Overall Study||45||
48723269|NCT00257660|102108308|FG001|COMPLETED|Overall Study||38||
48723270|NCT00257660|102108307|FG000|NOT COMPLETED|Overall Study||10||
48723271|NCT00257660|102108308|FG001|NOT COMPLETED|Overall Study||23||
48723272|NCT00590577|102108309|FG000|STARTED|Overall Study||160||
48723273|NCT00590577|102108310|FG001|STARTED|Overall Study||165||
48723274|NCT00590577|102108311|FG002|STARTED|Overall Study||163||
48723275|NCT00590577|102108312|FG003|STARTED|Overall Study||164||
48723276|NCT00590577|102108309|FG000|COMPLETED|Overall Study||83||
48723277|NCT00590577|102108310|FG001|COMPLETED|Overall Study||89||
48723278|NCT00590577|102108311|FG002|COMPLETED|Overall Study||90||
48723279|NCT00590577|102108312|FG003|COMPLETED|Overall Study||71||
48723280|NCT00590577|102108309|FG000|NOT COMPLETED|Overall Study||77||
48723281|NCT00590577|102108310|FG001|NOT COMPLETED|Overall Study||76||
48723282|NCT00590577|102108311|FG002|NOT COMPLETED|Overall Study||73||
48723283|NCT00590577|102108312|FG003|NOT COMPLETED|Overall Study||93||
48723284|NCT00118430|102108313|FG000|STARTED|Overall Study||123||
48723285|NCT00118430|102108314|FG001|STARTED|Overall Study||127||
48723286|NCT00118430|102108315|FG002|STARTED|Overall Study||250||
48723287|NCT00118430|102108313|FG000|COMPLETED|Overall Study||102||
48723288|NCT00118430|102108314|FG001|COMPLETED|Overall Study||103||
48723289|NCT00118430|102108315|FG002|COMPLETED|Overall Study||222||
48723290|NCT00118430|102108313|FG000|NOT COMPLETED|Overall Study||21||
48723291|NCT00118430|102108314|FG001|NOT COMPLETED|Overall Study||24||
48723292|NCT00118430|102108315|FG002|NOT COMPLETED|Overall Study||28||
48723293|NCT01120990|102108316|FG000|STARTED|Overall Study||51||
48723294|NCT01120990|102108316|FG000|COMPLETED|Overall Study||51||
48723295|NCT01120990|102108316|FG000|NOT COMPLETED|Overall Study||0||
48723296|NCT01966445|102108317|FG000|STARTED|Part1 (Median Exposure of 6.143 Weeks)||1||
48723297|NCT01966445|102108318|FG001|STARTED|Part1 (Median Exposure of 6.143 Weeks)||3||
48723298|NCT01966445|102108319|FG002|STARTED|Part1 (Median Exposure of 6.143 Weeks)||2||
48723299|NCT01966445|102108320|FG003|STARTED|Part1 (Median Exposure of 6.143 Weeks)||5||
48723300|NCT01966445|102108321|FG004|STARTED|Part1 (Median Exposure of 6.143 Weeks)||4||
48723301|NCT01966445|102108322|FG005|STARTED|Part1 (Median Exposure of 6.143 Weeks)||5||
48723302|NCT01966445|102108323|FG006|STARTED|Part1 (Median Exposure of 6.143 Weeks)||0||
48723303|NCT01966445|102108317|FG000|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1||
48723304|NCT01966445|102108318|FG001|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1||
48723305|NCT01966445|102108319|FG002|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1||
48723306|NCT01966445|102108320|FG003|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||2||
48723307|NCT01966445|102108321|FG004|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1||
48723308|NCT01966445|102108322|FG005|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||4||
48723309|NCT01966445|102108323|FG006|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0||
48723310|NCT01966445|102108317|FG000|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0||
48723311|NCT01966445|102108318|FG001|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||2||
48723312|NCT01966445|102108319|FG002|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1||
48723313|NCT01966445|102108320|FG003|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||3||
48723314|NCT01966445|102108321|FG004|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||3||
48723315|NCT01966445|102108322|FG005|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1||
48723316|NCT01966445|102108323|FG006|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0||
48723317|NCT01966445|102108317|FG000|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0||
48723318|NCT01966445|102108318|FG001|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0||
48723319|NCT01966445|102108319|FG002|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0||
48723320|NCT01966445|102108320|FG003|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0||
48723321|NCT01966445|102108321|FG004|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0||
48723322|NCT01966445|102108322|FG005|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0||
48723323|NCT01966445|102108323|FG006|STARTED|Part2 (Median Exposure of 7.143 Weeks)||9||
48723324|NCT01966445|102108317|FG000|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0||
48723325|NCT01966445|102108318|FG001|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0||
48723326|NCT01966445|102108319|FG002|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0||
48723327|NCT01966445|102108320|FG003|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0||
48723328|NCT01966445|102108321|FG004|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0||
48723329|NCT01966445|102108322|FG005|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0||
48723330|NCT01966445|102108323|FG006|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||4||
48723331|NCT01966445|102108317|FG000|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0||
48723332|NCT01966445|102108318|FG001|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0||
48723333|NCT01966445|102108319|FG002|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0||
48723334|NCT01966445|102108320|FG003|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0||
48723335|NCT01966445|102108321|FG004|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0||
48723336|NCT01966445|102108322|FG005|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0||
48723337|NCT01966445|102108323|FG006|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||5||
48723338|NCT04921332|102108324|FG000|STARTED|Overall Study||4||
48723339|NCT04921332|102108324|FG000|COMPLETED|Overall Study||4||
48723340|NCT04921332|102108324|FG000|NOT COMPLETED|Overall Study||0||
48723341|NCT00849862|102108325|FG000|STARTED|First Intervention||11||
48723342|NCT00849862|102108326|FG001|STARTED|First Intervention||11||
48723343|NCT00849862|102108325|FG000|COMPLETED|First Intervention||11||
48723344|NCT00849862|102108326|FG001|COMPLETED|First Intervention||11||
48723345|NCT00849862|102108325|FG000|NOT COMPLETED|First Intervention||0||
48723346|NCT00849862|102108326|FG001|NOT COMPLETED|First Intervention||0||
48723347|NCT00849862|102108325|FG000|STARTED|Washout: 7 Days||11||
48723348|NCT00849862|102108326|FG001|STARTED|Washout: 7 Days||11||
48723349|NCT00849862|102108325|FG000|COMPLETED|Washout: 7 Days||11||
48723350|NCT00849862|102108326|FG001|COMPLETED|Washout: 7 Days||11||
48723351|NCT00849862|102108325|FG000|NOT COMPLETED|Washout: 7 Days||0||
48723352|NCT00849862|102108326|FG001|NOT COMPLETED|Washout: 7 Days||0||
48723353|NCT00849862|102108325|FG000|STARTED|Second Intervention||11||
48723354|NCT00849862|102108326|FG001|STARTED|Second Intervention||11||
48723355|NCT00849862|102108325|FG000|COMPLETED|Second Intervention||11||
48723356|NCT00849862|102108326|FG001|COMPLETED|Second Intervention||11||
48723357|NCT00849862|102108325|FG000|NOT COMPLETED|Second Intervention||0||
48723358|NCT00849862|102108326|FG001|NOT COMPLETED|Second Intervention||0||
48723359|NCT03834220|102108327|FG000|STARTED|Overall Study||30||
48723360|NCT03834220|102108328|FG001|STARTED|Overall Study||4||
48723361|NCT03834220|102108329|FG002|STARTED|Overall Study||29||
48723362|NCT03834220|102108327|FG000|COMPLETED|Overall Study||0||
48723363|NCT03834220|102108328|FG001|COMPLETED|Overall Study||0||
48723364|NCT03834220|102108329|FG002|COMPLETED|Overall Study||0||
48723365|NCT03834220|102108327|FG000|NOT COMPLETED|Overall Study||30||
48723366|NCT03834220|102108328|FG001|NOT COMPLETED|Overall Study||4||
48723367|NCT03834220|102108329|FG002|NOT COMPLETED|Overall Study||29||
48723368|NCT02437084|102108330|FG000|STARTED|Overall Study||75||
48723369|NCT02437084|102108330|FG000|COMPLETED|Overall Study||72||
48723370|NCT02437084|102108330|FG000|NOT COMPLETED|Overall Study||3||
48723371|NCT02910102|102108331|FG000|STARTED|Overall Study||21||
48723372|NCT02910102|102108332|FG001|STARTED|Overall Study||17||
48308819|NCT03842163|101081052|FG000|Full Analysis Set 3.2|Overall Study||56||
48308820|NCT03842163|101081052|FG000|COMPLETED|Overall Study||766||
48308821|NCT03842163|101081052|FG000|NOT COMPLETED|Overall Study||46||
48308822|NCT00773136|101081053|FG000|STARTED|Overall Study||21||
48308823|NCT00773136|101081053|FG000|COMPLETED|Overall Study||19||
48308824|NCT00773136|101081053|FG000|NOT COMPLETED|Overall Study||2||
48308825|NCT01509079|101081054|FG000|STARTED|Overall Study||57||
48308826|NCT01509079|101081055|FG001|STARTED|Overall Study||59||
48308827|NCT01509079|101081054|FG000|COMPLETED|Overall Study||57||
48308828|NCT01509079|101081055|FG001|COMPLETED|Overall Study||56||
48308829|NCT01509079|101081054|FG000|NOT COMPLETED|Overall Study||0||
48308830|NCT01509079|101081055|FG001|NOT COMPLETED|Overall Study||3||
48308831|NCT00072358|101081056|FG000|STARTED|Overall Study||291||
48308832|NCT00072358|101081056|FG000|COMPLETED|Overall Study||291||
48308833|NCT00072358|101081056|FG000|NOT COMPLETED|Overall Study||0||
48308834|NCT00930722|101081057|FG000|STARTED|Overall Study||329||
48308835|NCT00930722|101081057|FG000|COMPLETED|Overall Study||302||
48611723|NCT01305772|101834154|FG000|RT + Panitumumab Dose #2 / #3|Overall Study||5||
48611724|NCT01305772|101834155|FG001|RT + Panitumumab Dose #2 / #3|Overall Study||1||
48611725|NCT01305772|101834154|FG000|COMPLETED|Overall Study||5||
48611726|NCT01305772|101834155|FG001|COMPLETED|Overall Study||1||
48611727|NCT01305772|101834154|FG000|NOT COMPLETED|Overall Study||0||
48611728|NCT01305772|101834155|FG001|NOT COMPLETED|Overall Study||0||
48611729|NCT01461733|101834156|FG000|STARTED|Overall Study||12||
48611730|NCT01461733|101834157|FG001|STARTED|Overall Study||12||
48611731|NCT01461733|101834156|FG000|COMPLETED|Overall Study||8||
48723373|NCT02910102|102108331|FG000|Safety Population|Overall Study||21|The Safety population included subjects who took at least 1 dose of double-blind study drug|
48723374|NCT02910102|102108332|FG001|Safety Population|Overall Study||17|The Safety population included subjects who took at least 1 dose of double-blind study drug|
48723375|NCT02910102|102108331|FG000|Intent to Treat (ITT) Population|Overall Study||21|Subjects took at least 1 dose of DB study drug and had at least 1 post-baseline assessment|
48723376|NCT02910102|102108332|FG001|Intent to Treat (ITT) Population|Overall Study||17|Subjects took at least 1 dose of DB study drug and had at least 1 post-baseline assessment|
48723377|NCT02910102|102108331|FG000|Per-Protocol Population|Overall Study||20|Subjects in the ITT population who had no major protocol violations|
48723378|NCT02910102|102108332|FG001|Per-Protocol Population|Overall Study||17|Subjects in the ITT population who had no major protocol violations|
48723379|NCT02910102|102108331|FG000|COMPLETED|Overall Study||21|Subjects in the ITT population who completed the study|
48723380|NCT02910102|102108332|FG001|COMPLETED|Overall Study||17|Subjects in the ITT population who completed the study|
48723381|NCT02910102|102108331|FG000|NOT COMPLETED|Overall Study||0||
48723382|NCT02910102|102108332|FG001|NOT COMPLETED|Overall Study||0||
48723383|NCT00881504|102108333|FG000|STARTED|Overall Study||9||
48723384|NCT00881504|102108333|FG000|COMPLETED|Overall Study||8||
48723385|NCT00881504|102108333|FG000|NOT COMPLETED|Overall Study||1||
48723386|NCT01895309|102108334|FG000|STARTED|Overall Study||299||
48723387|NCT01895309|102108335|FG001|STARTED|Overall Study||297||
48723388|NCT01895309|102108334|FG000|COMPLETED|Overall Study||259||
48308836|NCT00930722|101081057|FG000|NOT COMPLETED|Overall Study||27||
48308837|NCT01063829|101081058|FG000|STARTED|Overall Study||33||
48308838|NCT01063829|101081059|FG001|STARTED|Overall Study||31||
48308839|NCT01063829|101081060|FG002|STARTED|Overall Study||34||
48308840|NCT01063829|101081061|FG003|STARTED|Overall Study||33||
48308841|NCT01063829|101081058|FG000|COMPLETED|Overall Study||17||
48308842|NCT01063829|101081059|FG001|COMPLETED|Overall Study||21||
48308843|NCT01063829|101081060|FG002|COMPLETED|Overall Study||24||
48308844|NCT01063829|101081061|FG003|COMPLETED|Overall Study||12||
48308845|NCT01063829|101081058|FG000|NOT COMPLETED|Overall Study||16||
48308846|NCT01063829|101081059|FG001|NOT COMPLETED|Overall Study||10||
48308847|NCT01063829|101081060|FG002|NOT COMPLETED|Overall Study||10||
48308848|NCT01063829|101081061|FG003|NOT COMPLETED|Overall Study||21||
48308849|NCT01846624|101081062|FG000|STARTED|Overall Study||13||
48723389|NCT01895309|102108335|FG001|COMPLETED|Overall Study||246||
48723390|NCT01895309|102108334|FG000|NOT COMPLETED|Overall Study||40||
48723391|NCT01895309|102108335|FG001|NOT COMPLETED|Overall Study||51||
48723392|NCT01441466|102108336|FG000|STARTED|Overall Study||37||
48308850|NCT01846624|101081062|FG000|COMPLETED|Overall Study||12||
48308851|NCT01846624|101081062|FG000|NOT COMPLETED|Overall Study||1||
48611732|NCT01461733|101834157|FG001|COMPLETED|Overall Study||8||
48611733|NCT01461733|101834156|FG000|NOT COMPLETED|Overall Study||4||
48611734|NCT01461733|101834157|FG001|NOT COMPLETED|Overall Study||4||
48611735|NCT05285787|101834158|FG000|STARTED|Overall Study||18||
48611736|NCT05285787|101834158|FG000|COMPLETED|Overall Study||17||
48611737|NCT05285787|101834158|FG000|NOT COMPLETED|Overall Study||1||
48308852|NCT03492554|101081063|FG000|STARTED|Overall Study||301||
48308853|NCT03492554|101081064|FG001|STARTED|Overall Study||301||
48611738|NCT05176717|101834159|FG000|STARTED|Overall Study||1||
48611739|NCT05176717|101834160|FG001|STARTED|Overall Study||2||
48611740|NCT05176717|101834161|FG002|STARTED|Overall Study||2||
48611741|NCT05176717|101834159|FG000|COMPLETED|Overall Study||0||
48611742|NCT05176717|101834160|FG001|COMPLETED|Overall Study||0||
48723393|NCT01441466|102108337|FG001|STARTED|Overall Study||11||
48723394|NCT01441466|102108336|FG000|COMPLETED|Overall Study||37||
48723395|NCT01441466|102108337|FG001|COMPLETED|Overall Study||11||
48308854|NCT03492554|101081063|FG000|COMPLETED|Overall Study||301||
48308855|NCT03492554|101081064|FG001|COMPLETED|Overall Study||287||
48308856|NCT03492554|101081063|FG000|NOT COMPLETED|Overall Study||0||
48308857|NCT03492554|101081064|FG001|NOT COMPLETED|Overall Study||14||
48308858|NCT00445705|101081065|FG000|STARTED|Overall Study||53||
48308859|NCT00445705|101081066|FG001|STARTED|Overall Study||53||
48308860|NCT00445705|101081067|FG002|STARTED|Overall Study||52||
48308861|NCT00445705|101081068|FG003|STARTED|Overall Study||53||
48308862|NCT00445705|101081065|FG000|COMPLETED|Overall Study||44||
48308863|NCT00445705|101081066|FG001|COMPLETED|Overall Study||42||
48308864|NCT00445705|101081067|FG002|COMPLETED|Overall Study||41||
48308865|NCT00445705|101081068|FG003|COMPLETED|Overall Study||39||
48308866|NCT00445705|101081065|FG000|NOT COMPLETED|Overall Study||9||
48308867|NCT00445705|101081066|FG001|NOT COMPLETED|Overall Study||11||
48308868|NCT00445705|101081067|FG002|NOT COMPLETED|Overall Study||11||
48308869|NCT00445705|101081068|FG003|NOT COMPLETED|Overall Study||14||
48308870|NCT00888381|101081069|FG000|STARTED|Overall Study||60||
48308871|NCT00888381|101081070|FG001|STARTED|Overall Study||60||
48308872|NCT00888381|101081069|FG000|COMPLETED|Overall Study||60||
48308873|NCT00888381|101081070|FG001|COMPLETED|Overall Study||59||
48308874|NCT00888381|101081069|FG000|NOT COMPLETED|Overall Study||0||
48308875|NCT00888381|101081070|FG001|NOT COMPLETED|Overall Study||1||
48308876|NCT02982239|101081071|FG000|STARTED|Overall Study||20||
48308877|NCT02982239|101081072|FG001|STARTED|Overall Study||20||
48308878|NCT02982239|101081071|FG000|COMPLETED|Overall Study||17||
48308879|NCT02982239|101081072|FG001|COMPLETED|Overall Study||18||
48308880|NCT02982239|101081071|FG000|NOT COMPLETED|Overall Study||3||
48308881|NCT02982239|101081072|FG001|NOT COMPLETED|Overall Study||2||
48308882|NCT00303979|101081073|FG000|STARTED|Overall Study||15177||
48308883|NCT00303979|101081074|FG001|STARTED|Overall Study||9992||
48308884|NCT00303979|101081075|FG002|STARTED|Overall Study||9641||
48308885|NCT00303979|101081073|FG000|COMPLETED|Overall Study||7605||
48611743|NCT05176717|101834161|FG002|COMPLETED|Overall Study||0||
48611744|NCT05176717|101834159|FG000|NOT COMPLETED|Overall Study||1||
48611745|NCT05176717|101834160|FG001|NOT COMPLETED|Overall Study||2||
48723396|NCT01441466|102108336|FG000|NOT COMPLETED|Overall Study||0||
48723397|NCT01441466|102108337|FG001|NOT COMPLETED|Overall Study||0||
48723398|NCT00490776|102108338|FG000|STARTED|Overall Study||9||
48723399|NCT00490776|102108338|FG000|COMPLETED|Overall Study||0||
48723400|NCT00490776|102108338|FG000|NOT COMPLETED|Overall Study||9||
48723401|NCT00727558|102108339|FG000|STARTED|Overall Study||127||
48723402|NCT00727558|102108340|FG001|STARTED|Overall Study||121||
48723403|NCT00727558|102108339|FG000|COMPLETED|Overall Study||125||
48308886|NCT00303979|101081074|FG001|COMPLETED|Overall Study||9992||
48308887|NCT00303979|101081075|FG002|COMPLETED|Overall Study||9641||
48308888|NCT00303979|101081073|FG000|NOT COMPLETED|Overall Study||7572||
48308889|NCT00303979|101081074|FG001|NOT COMPLETED|Overall Study||0||
48723404|NCT00727558|102108340|FG001|COMPLETED|Overall Study||118||
48723405|NCT00727558|102108339|FG000|NOT COMPLETED|Overall Study||2||
48723406|NCT00727558|102108340|FG001|NOT COMPLETED|Overall Study||3||
48723407|NCT03664765|102108341|FG000|STARTED|Overall Study||12||
48308890|NCT00303979|101081075|FG002|NOT COMPLETED|Overall Study||0||
48308891|NCT03472924|101081076|FG000|STARTED|Overall Study||4||
48308892|NCT03472924|101081077|FG001|STARTED|Overall Study||2||
48308893|NCT03472924|101081076|FG000|COMPLETED|Overall Study||3||
48308894|NCT03472924|101081077|FG001|COMPLETED|Overall Study||2||
48308895|NCT03472924|101081076|FG000|NOT COMPLETED|Overall Study||1||
48308896|NCT03472924|101081077|FG001|NOT COMPLETED|Overall Study||0||
48308897|NCT01576172|101081078|FG000|STARTED|Overall Study||79||
48611746|NCT05176717|101834161|FG002|NOT COMPLETED|Overall Study||2||
48611747|NCT01395810|101834162|FG000|STARTED|Overall Study||18||
48723408|NCT03664765|102108342|FG001|STARTED|Overall Study||12||
48723409|NCT03664765|102108341|FG000|COMPLETED|Overall Study||8||
48611748|NCT01395810|101834163|FG001|STARTED|Overall Study||48||
48611749|NCT01395810|101834164|FG002|STARTED|Overall Study||0||
48611750|NCT01395810|101834165|FG003|STARTED|Overall Study||5||
48657085|NCT03648372|101943762|FG005|NOT COMPLETED|Overall Study||3||
48723410|NCT03664765|102108342|FG001|COMPLETED|Overall Study||10||
48308898|NCT01576172|101081079|FG001|STARTED|Overall Study||80||
48308899|NCT01576172|101081078|FG000|COMPLETED|Overall Study||74||
48308900|NCT01576172|101081079|FG001|COMPLETED|Overall Study||79||
48308901|NCT01576172|101081078|FG000|NOT COMPLETED|Overall Study||5||
48308902|NCT01576172|101081079|FG001|NOT COMPLETED|Overall Study||1||
48308903|NCT00445484|101084484|FG000|STARTED|Overall Study||11||
48308904|NCT00445484|101084485|FG001|STARTED|Overall Study||11||
48308905|NCT00445484|101084484|FG000|COMPLETED|Overall Study||7||
48308906|NCT00445484|101084485|FG001|COMPLETED|Overall Study||10||
48308907|NCT00445484|101084484|FG000|NOT COMPLETED|Overall Study||4||
48308908|NCT00445484|101084485|FG001|NOT COMPLETED|Overall Study||1||
48308909|NCT00730964|101084486|FG000|STARTED|Overall Study||1039||
48308910|NCT00730964|101084486|FG000|COMPLETED|Overall Study||1039||
48308911|NCT00730964|101084486|FG000|NOT COMPLETED|Overall Study||0||
48308912|NCT02710136|101084487|FG000|STARTED|Study Enrollment||10||
48308913|NCT02710136|101084488|FG001|STARTED|Study Enrollment||25||
48308914|NCT02710136|101084487|FG000|COMPLETED|Study Enrollment||10||
48308915|NCT02710136|101084488|FG001|COMPLETED|Study Enrollment||25||
48308916|NCT02710136|101084487|FG000|NOT COMPLETED|Study Enrollment||0||
48308917|NCT02710136|101084488|FG001|NOT COMPLETED|Study Enrollment||0||
48308918|NCT02710136|101084487|FG000|STARTED|Phase 1a[Refer to Arm/Group Description]||10||
48308919|NCT02710136|101084488|FG001|STARTED|Phase 1a[Refer to Arm/Group Description]||0||
48308920|NCT02710136|101084487|FG000|COMPLETED|Phase 1a[Refer to Arm/Group Description]||9||
48308921|NCT02710136|101084488|FG001|COMPLETED|Phase 1a[Refer to Arm/Group Description]||0||
48308922|NCT02710136|101084487|FG000|NOT COMPLETED|Phase 1a[Refer to Arm/Group Description]||1||
48308923|NCT02710136|101084488|FG001|NOT COMPLETED|Phase 1a[Refer to Arm/Group Description]||0||
48308924|NCT02710136|101084487|FG000|STARTED|Phase 1b[Refer to Arm/Group Description]||4||
48308925|NCT02710136|101084488|FG001|STARTED|Phase 1b[Refer to Arm/Group Description]||0||
48308926|NCT02710136|101084487|FG000|COMPLETED|Phase 1b[Refer to Arm/Group Description]||4||
48308927|NCT02710136|101084488|FG001|COMPLETED|Phase 1b[Refer to Arm/Group Description]||0||
48308928|NCT02710136|101084487|FG000|NOT COMPLETED|Phase 1b[Refer to Arm/Group Description]||0||
48308929|NCT02710136|101084488|FG001|NOT COMPLETED|Phase 1b[Refer to Arm/Group Description]||0||
48308930|NCT02710136|101084487|FG000|STARTED|Phase 2 [Refer to Arm/Group Description]||0||
48308931|NCT02710136|101084488|FG001|STARTED|Phase 2 [Refer to Arm/Group Description]||25||
48308932|NCT02710136|101084487|FG000|COMPLETED|Phase 2 [Refer to Arm/Group Description]||0||
48308933|NCT02710136|101084488|FG001|COMPLETED|Phase 2 [Refer to Arm/Group Description]||25||
48308934|NCT02710136|101084487|FG000|NOT COMPLETED|Phase 2 [Refer to Arm/Group Description]||0||
48308935|NCT02710136|101084488|FG001|NOT COMPLETED|Phase 2 [Refer to Arm/Group Description]||0||
48308936|NCT02464228|101084489|FG000|STARTED|Overall Study||38||
48308937|NCT02464228|101084490|FG001|STARTED|Overall Study||14||
48308938|NCT02464228|101084491|FG002|STARTED|Overall Study||11||
48308939|NCT02464228|101084492|FG003|STARTED|Overall Study||2||
48308940|NCT02464228|101084489|FG000|COMPLETED|Overall Study||2||
48308941|NCT02464228|101084490|FG001|COMPLETED|Overall Study||0||
48308942|NCT02464228|101084491|FG002|COMPLETED|Overall Study||0||
48406533|NCT02603172|101328439|FG000|STARTED|Part B (Approximately 7 Weeks)||0||
48308943|NCT02464228|101084492|FG003|COMPLETED|Overall Study||0||
48308944|NCT02464228|101084489|FG000|NOT COMPLETED|Overall Study||36||
48308945|NCT02464228|101084490|FG001|NOT COMPLETED|Overall Study||14||
48308946|NCT02464228|101084491|FG002|NOT COMPLETED|Overall Study||11||
48406534|NCT02603172|101328440|FG001|STARTED|Part B (Approximately 7 Weeks)||1||
48406535|NCT02603172|101328441|FG002|STARTED|Part B (Approximately 7 Weeks)||0||
48308947|NCT02464228|101084492|FG003|NOT COMPLETED|Overall Study||2||
48308948|NCT04085341|101084493|FG000|STARTED|Overall Study||10||
48308949|NCT04085341|101084494|FG001|STARTED|Overall Study||11||
48308950|NCT04085341|101084493|FG000|COMPLETED|Overall Study||10||
48308951|NCT04085341|101084494|FG001|COMPLETED|Overall Study||11||
48308952|NCT04085341|101084493|FG000|NOT COMPLETED|Overall Study||0||
48406536|NCT02603172|101328442|FG003|STARTED|Part B (Approximately 7 Weeks)||1||
48308953|NCT04085341|101084494|FG001|NOT COMPLETED|Overall Study||0||
48308954|NCT00418665|101084495|FG000|STARTED|Treatment Period||12||
48308955|NCT00418665|101084496|FG001|STARTED|Treatment Period||14||
48611751|NCT01395810|101834162|FG000|After Switching the Arms|Overall Study||21|Patients were free to switch between treatment arms if agreed between investigator and patient|
48611752|NCT01395810|101834163|FG001|After Switching the Arms|Overall Study||52|Patients were free to switch between treatment arms if agreed between investigator and patient|
48611753|NCT01395810|101834164|FG002|After Switching the Arms|Overall Study||2|Patients were free to switch between treatment arms if agreed between investigator and patient|
48611754|NCT01395810|101834165|FG003|After Switching the Arms|Overall Study||5|Patients were free to switch between treatment arms if agreed between investigator and patient|
48611755|NCT01395810|101834162|FG000|COMPLETED|Overall Study||16||
48611756|NCT01395810|101834163|FG001|COMPLETED|Overall Study||44||
48611757|NCT01395810|101834164|FG002|COMPLETED|Overall Study||0||
48611758|NCT01395810|101834165|FG003|COMPLETED|Overall Study||5||
48611759|NCT01395810|101834162|FG000|NOT COMPLETED|Overall Study||2||
48611760|NCT01395810|101834163|FG001|NOT COMPLETED|Overall Study||4||
48611761|NCT01395810|101834164|FG002|NOT COMPLETED|Overall Study||0||
48611762|NCT01395810|101834165|FG003|NOT COMPLETED|Overall Study||0||
48611763|NCT00905567|101834166|FG000|STARTED|Period 1||12||
48611764|NCT00905567|101834167|FG001|STARTED|Period 1||12||
48611765|NCT00905567|101834166|FG000|COMPLETED|Period 1||12||
48611766|NCT00905567|101834167|FG001|COMPLETED|Period 1||12||
48611767|NCT00905567|101834166|FG000|NOT COMPLETED|Period 1||0||
48611768|NCT00905567|101834167|FG001|NOT COMPLETED|Period 1||0||
48611769|NCT00905567|101834166|FG000|STARTED|Washout||12||
48611770|NCT00905567|101834167|FG001|STARTED|Washout||12||
48611771|NCT00905567|101834166|FG000|COMPLETED|Washout||12||
48611772|NCT00905567|101834167|FG001|COMPLETED|Washout||11||
48611773|NCT00905567|101834166|FG000|NOT COMPLETED|Washout||0||
48723411|NCT03664765|102108341|FG000|NOT COMPLETED|Overall Study||4||
48308956|NCT00418665|101084497|FG002|STARTED|Treatment Period||13||
48308957|NCT00418665|101084495|FG000|Received Study Medication|Treatment Period||11||
48308958|NCT00418665|101084496|FG001|Received Study Medication|Treatment Period||13||
48308959|NCT00418665|101084497|FG002|Received Study Medication|Treatment Period||13||
48308960|NCT00418665|101084495|FG000|COMPLETED|Treatment Period||7||
48308961|NCT00418665|101084496|FG001|COMPLETED|Treatment Period||8||
48611774|NCT00905567|101834167|FG001|NOT COMPLETED|Washout||1||
48611775|NCT00905567|101834166|FG000|STARTED|Period 2||12||
48611776|NCT00905567|101834167|FG001|STARTED|Period 2||11||
48611777|NCT00905567|101834166|FG000|COMPLETED|Period 2||12||
48611778|NCT00905567|101834167|FG001|COMPLETED|Period 2||11||
48723412|NCT03664765|102108342|FG001|NOT COMPLETED|Overall Study||2||
48723413|NCT05216627|102108343|FG000|STARTED|Overall Study||61||
48723414|NCT05216627|102108343|FG000|COMPLETED|Overall Study||61||
48723415|NCT05216627|102108343|FG000|NOT COMPLETED|Overall Study||0||
48723416|NCT00552409|102108344|FG000|STARTED|Overall Study||11||
48723417|NCT00552409|102108345|FG001|STARTED|Overall Study||11||
48723418|NCT00552409|102108344|FG000|COMPLETED|Overall Study||10||
48723419|NCT00552409|102108345|FG001|COMPLETED|Overall Study||9||
48723420|NCT00552409|102108344|FG000|NOT COMPLETED|Overall Study||1||
48723421|NCT00552409|102108345|FG001|NOT COMPLETED|Overall Study||2||
48723422|NCT00708734|102108346|FG000|STARTED|Overall Study||10||
48723423|NCT00708734|102108346|FG000|COMPLETED|Overall Study||3||
48723424|NCT00708734|102108346|FG000|NOT COMPLETED|Overall Study||7||
48723425|NCT01220180|102108347|FG000|STARTED|Overall Study||4175||
48723426|NCT01220180|102108347|FG000|Treated|Overall Study||4174||
48723427|NCT01220180|102108347|FG000|COMPLETED|Overall Study||3968||
48723428|NCT01220180|102108347|FG000|NOT COMPLETED|Overall Study||207||
48723429|NCT02760810|102108348|FG000|STARTED|Overall Study||30||
48723430|NCT02760810|102108348|FG000|COMPLETED|Overall Study||29||
48723431|NCT02760810|102108348|FG000|NOT COMPLETED|Overall Study||1||
48611779|NCT00905567|101834166|FG000|NOT COMPLETED|Period 2||0||
48611780|NCT00905567|101834167|FG001|NOT COMPLETED|Period 2||0||
48611781|NCT02028780|101834168|FG000|STARTED|Observation Phase||6||
48611782|NCT02028780|101834169|FG001|STARTED|Observation Phase||2||
48611783|NCT02028780|101834170|FG002|STARTED|Observation Phase||6||
48611784|NCT02028780|101834171|FG003|STARTED|Observation Phase||6||
48611785|NCT02028780|101834172|FG004|STARTED|Observation Phase||6||
48611786|NCT02028780|101834173|FG005|STARTED|Observation Phase||6||
48611787|NCT02028780|101834174|FG006|STARTED|Observation Phase||9||
48611788|NCT02028780|101834175|FG007|STARTED|Observation Phase||3||
48611789|NCT02028780|101834176|FG008|STARTED|Observation Phase||9||
48611790|NCT02028780|101834177|FG009|STARTED|Observation Phase||9||
48611791|NCT02028780|101834178|FG010|STARTED|Observation Phase||9||
48611792|NCT02028780|101834179|FG011|STARTED|Observation Phase||9||
48611793|NCT02028780|101834168|FG000|COMPLETED|Observation Phase||6||
48611794|NCT02028780|101834169|FG001|COMPLETED|Observation Phase||2||
48611795|NCT02028780|101834170|FG002|COMPLETED|Observation Phase||6||
48611796|NCT02028780|101834171|FG003|COMPLETED|Observation Phase||6||
48611797|NCT02028780|101834172|FG004|COMPLETED|Observation Phase||6||
48611798|NCT02028780|101834173|FG005|COMPLETED|Observation Phase||6||
48611799|NCT02028780|101834174|FG006|COMPLETED|Observation Phase||9||
48611800|NCT02028780|101834175|FG007|COMPLETED|Observation Phase||3||
48611801|NCT02028780|101834176|FG008|COMPLETED|Observation Phase||9||
48308962|NCT00418665|101084497|FG002|COMPLETED|Treatment Period||9||
48611802|NCT02028780|101834177|FG009|COMPLETED|Observation Phase||9||
48611803|NCT02028780|101834178|FG010|COMPLETED|Observation Phase||9||
48611804|NCT02028780|101834179|FG011|COMPLETED|Observation Phase||9||
48308963|NCT00418665|101084495|FG000|NOT COMPLETED|Treatment Period||5||
48308964|NCT00418665|101084496|FG001|NOT COMPLETED|Treatment Period||6||
48308965|NCT00418665|101084497|FG002|NOT COMPLETED|Treatment Period||4||
48308966|NCT00418665|101084495|FG000|STARTED|Treatment Extension||7||
48308967|NCT00418665|101084496|FG001|STARTED|Treatment Extension||8||
48308968|NCT00418665|101084497|FG002|STARTED|Treatment Extension||9||
48611805|NCT02028780|101834168|FG000|NOT COMPLETED|Observation Phase||0||
48308969|NCT00418665|101084495|FG000|COMPLETED|Treatment Extension||1||
48308970|NCT00418665|101084496|FG001|COMPLETED|Treatment Extension||4||
48308971|NCT00418665|101084497|FG002|COMPLETED|Treatment Extension||7||
48308972|NCT00418665|101084495|FG000|NOT COMPLETED|Treatment Extension||6||
48308973|NCT00418665|101084496|FG001|NOT COMPLETED|Treatment Extension||4||
48308974|NCT00418665|101084497|FG002|NOT COMPLETED|Treatment Extension||2||
48611806|NCT02028780|101834169|FG001|NOT COMPLETED|Observation Phase||0||
48611807|NCT02028780|101834170|FG002|NOT COMPLETED|Observation Phase||0||
48611808|NCT02028780|101834171|FG003|NOT COMPLETED|Observation Phase||0||
48611809|NCT02028780|101834172|FG004|NOT COMPLETED|Observation Phase||0||
48611810|NCT02028780|101834173|FG005|NOT COMPLETED|Observation Phase||0||
48611811|NCT02028780|101834174|FG006|NOT COMPLETED|Observation Phase||0||
48611812|NCT02028780|101834175|FG007|NOT COMPLETED|Observation Phase||0||
48611813|NCT02028780|101834176|FG008|NOT COMPLETED|Observation Phase||0||
48611814|NCT02028780|101834177|FG009|NOT COMPLETED|Observation Phase||0||
48611815|NCT02028780|101834178|FG010|NOT COMPLETED|Observation Phase||0||
48611816|NCT02028780|101834179|FG011|NOT COMPLETED|Observation Phase||0||
48611817|NCT02028780|101834168|FG000|STARTED|Follow up Phase||6||
48611818|NCT02028780|101834169|FG001|STARTED|Follow up Phase||2||
48611819|NCT02028780|101834170|FG002|STARTED|Follow up Phase||6||
48611820|NCT02028780|101834171|FG003|STARTED|Follow up Phase||6||
48723432|NCT02478255|102108349|FG000|STARTED|Overall Study||17||
48308975|NCT02012296|101084498|FG000|STARTED|Overall Study||33||
48308976|NCT02012296|101084499|FG001|STARTED|Overall Study||33||
48308977|NCT02012296|101084500|FG002|STARTED|Overall Study||22||
48308978|NCT02012296|101084498|FG000|COMPLETED|Overall Study||33||
48308979|NCT02012296|101084499|FG001|COMPLETED|Overall Study||32||
48308980|NCT02012296|101084500|FG002|COMPLETED|Overall Study||0||
48308981|NCT02012296|101084498|FG000|NOT COMPLETED|Overall Study||0||
48308982|NCT02012296|101084499|FG001|NOT COMPLETED|Overall Study||1||
48308983|NCT02012296|101084500|FG002|NOT COMPLETED|Overall Study||22||
48308984|NCT00509067|101084501|FG000|STARTED|Overall Study||19||
48308985|NCT00509067|101084502|FG001|STARTED|Overall Study||24||
48308986|NCT00509067|101084501|FG000|COMPLETED|Overall Study||15||
48308987|NCT00509067|101084502|FG001|COMPLETED|Overall Study||19||
48308988|NCT00509067|101084501|FG000|NOT COMPLETED|Overall Study||4||
48308989|NCT00509067|101084502|FG001|NOT COMPLETED|Overall Study||5||
48308990|NCT00915772|101084503|FG000|STARTED|Overall Study||170||
48406537|NCT02603172|101328443|FG004|STARTED|Part B (Approximately 7 Weeks)||6||
48308991|NCT00915772|101084504|FG001|STARTED|Overall Study||225||
48308992|NCT00915772|101084505|FG002|STARTED|Overall Study||171||
48406538|NCT02603172|101328444|FG005|STARTED|Part B (Approximately 7 Weeks)||0||
48406539|NCT02603172|101328445|FG006|STARTED|Part B (Approximately 7 Weeks)||0||
48406540|NCT02603172|101328446|FG007|STARTED|Part B (Approximately 7 Weeks)||0||
48406541|NCT02603172|101328439|FG000|COMPLETED|Part B (Approximately 7 Weeks)||0||
48406542|NCT02603172|101328440|FG001|COMPLETED|Part B (Approximately 7 Weeks)||1||
48406543|NCT02603172|101328441|FG002|COMPLETED|Part B (Approximately 7 Weeks)||0||
48406544|NCT02603172|101328442|FG003|COMPLETED|Part B (Approximately 7 Weeks)||1||
48406545|NCT02603172|101328443|FG004|COMPLETED|Part B (Approximately 7 Weeks)||6||
48406546|NCT02603172|101328444|FG005|COMPLETED|Part B (Approximately 7 Weeks)||0||
48406547|NCT02603172|101328445|FG006|COMPLETED|Part B (Approximately 7 Weeks)||0||
48406548|NCT02603172|101328446|FG007|COMPLETED|Part B (Approximately 7 Weeks)||0||
48406549|NCT02603172|101328439|FG000|NOT COMPLETED|Part B (Approximately 7 Weeks)||0||
48406550|NCT02603172|101328440|FG001|NOT COMPLETED|Part B (Approximately 7 Weeks)||0||
48406551|NCT02603172|101328441|FG002|NOT COMPLETED|Part B (Approximately 7 Weeks)||0||
48406552|NCT02603172|101328442|FG003|NOT COMPLETED|Part B (Approximately 7 Weeks)||0||
48406553|NCT02603172|101328443|FG004|NOT COMPLETED|Part B (Approximately 7 Weeks)||0||
48406554|NCT02603172|101328444|FG005|NOT COMPLETED|Part B (Approximately 7 Weeks)||0||
48406555|NCT02603172|101328445|FG006|NOT COMPLETED|Part B (Approximately 7 Weeks)||0||
48406556|NCT02603172|101328446|FG007|NOT COMPLETED|Part B (Approximately 7 Weeks)||0||
48406557|NCT02603172|101328439|FG000|STARTED|Part C (Approximately 13 Weeks)||0||
48406558|NCT02603172|101328440|FG001|STARTED|Part C (Approximately 13 Weeks)||0||
48611821|NCT02028780|101834172|FG004|STARTED|Follow up Phase||6||
48611822|NCT02028780|101834173|FG005|STARTED|Follow up Phase||6||
48723433|NCT02478255|102108350|FG001|STARTED|Overall Study||8||
48308993|NCT00915772|101084503|FG000|COMPLETED|Overall Study||134||
48723434|NCT02478255|102108349|FG000|COMPLETED|Overall Study||9||
48723435|NCT02478255|102108350|FG001|COMPLETED|Overall Study||8||
48723436|NCT02478255|102108349|FG000|NOT COMPLETED|Overall Study||8||
48723437|NCT02478255|102108350|FG001|NOT COMPLETED|Overall Study||0||
48723438|NCT03332160|102108351|FG000|STARTED|Overall Study||25||
48611823|NCT02028780|101834174|FG006|STARTED|Follow up Phase||9||
48611824|NCT02028780|101834175|FG007|STARTED|Follow up Phase||3||
48611825|NCT02028780|101834176|FG008|STARTED|Follow up Phase||9||
48611826|NCT02028780|101834177|FG009|STARTED|Follow up Phase||9||
48611827|NCT02028780|101834178|FG010|STARTED|Follow up Phase||9||
48611828|NCT02028780|101834179|FG011|STARTED|Follow up Phase||9||
48611829|NCT02028780|101834168|FG000|COMPLETED|Follow up Phase||6||
48611830|NCT02028780|101834169|FG001|COMPLETED|Follow up Phase||2||
48611831|NCT02028780|101834170|FG002|COMPLETED|Follow up Phase||6||
48611832|NCT02028780|101834171|FG003|COMPLETED|Follow up Phase||6||
48611833|NCT02028780|101834172|FG004|COMPLETED|Follow up Phase||6||
48611834|NCT02028780|101834173|FG005|COMPLETED|Follow up Phase||6||
48611835|NCT02028780|101834174|FG006|COMPLETED|Follow up Phase||9||
48611836|NCT02028780|101834175|FG007|COMPLETED|Follow up Phase||3||
48611837|NCT02028780|101834176|FG008|COMPLETED|Follow up Phase||9||
48611838|NCT02028780|101834177|FG009|COMPLETED|Follow up Phase||9||
48611839|NCT02028780|101834178|FG010|COMPLETED|Follow up Phase||9||
48611840|NCT02028780|101834179|FG011|COMPLETED|Follow up Phase||9||
48611841|NCT02028780|101834168|FG000|NOT COMPLETED|Follow up Phase||0||
48611842|NCT02028780|101834169|FG001|NOT COMPLETED|Follow up Phase||0||
48611843|NCT02028780|101834170|FG002|NOT COMPLETED|Follow up Phase||0||
48611844|NCT02028780|101834171|FG003|NOT COMPLETED|Follow up Phase||0||
48611845|NCT02028780|101834172|FG004|NOT COMPLETED|Follow up Phase||0||
48611846|NCT02028780|101834173|FG005|NOT COMPLETED|Follow up Phase||0||
48611847|NCT02028780|101834174|FG006|NOT COMPLETED|Follow up Phase||0||
48611848|NCT02028780|101834175|FG007|NOT COMPLETED|Follow up Phase||0||
48611849|NCT02028780|101834176|FG008|NOT COMPLETED|Follow up Phase||0||
48611850|NCT02028780|101834177|FG009|NOT COMPLETED|Follow up Phase||0||
48611851|NCT02028780|101834178|FG010|NOT COMPLETED|Follow up Phase||0||
48611852|NCT02028780|101834179|FG011|NOT COMPLETED|Follow up Phase||0||
48611853|NCT00707980|101834180|FG000|STARTED|Overall Study||836||
48723439|NCT03332160|102108352|FG001|STARTED|Overall Study||24||
48723440|NCT03332160|102108351|FG000|COMPLETED|Overall Study||24||
48723441|NCT03332160|102108352|FG001|COMPLETED|Overall Study||19||
48611854|NCT00707980|101834180|FG000|Received Treatment|Overall Study||834||
48611855|NCT00707980|101834180|FG000|COMPLETED|Overall Study||526||
48611856|NCT00707980|101834180|FG000|NOT COMPLETED|Overall Study||310||
48611857|NCT03549598|101834181|FG000|STARTED|Overall Study||15||
48611858|NCT03549598|101834181|FG000|COMPLETED|Overall Study||15||
48611859|NCT03549598|101834181|FG000|NOT COMPLETED|Overall Study||0||
48611860|NCT01153009|101834182|FG000|STARTED|Overall Study||161||
48611861|NCT01153009|101834183|FG001|STARTED|Overall Study||147||
48611862|NCT01153009|101834184|FG002|STARTED|Overall Study||154||
48611863|NCT01153009|101834185|FG003|STARTED|Overall Study||152||
48611864|NCT01153009|101834182|FG000|Treated|Overall Study||159||
48611865|NCT01153009|101834183|FG001|Treated|Overall Study||147||
48611866|NCT01153009|101834184|FG002|Treated|Overall Study||154||
48611867|NCT01153009|101834185|FG003|Treated|Overall Study||150||
48611868|NCT01153009|101834182|FG000|COMPLETED|Overall Study||129||
48611869|NCT01153009|101834183|FG001|COMPLETED|Overall Study||113||
48611870|NCT01153009|101834184|FG002|COMPLETED|Overall Study||113||
48611871|NCT01153009|101834185|FG003|COMPLETED|Overall Study||115||
48611872|NCT01153009|101834182|FG000|NOT COMPLETED|Overall Study||32||
48611873|NCT01153009|101834183|FG001|NOT COMPLETED|Overall Study||34||
48723442|NCT03332160|102108351|FG000|NOT COMPLETED|Overall Study||1||
48723443|NCT03332160|102108352|FG001|NOT COMPLETED|Overall Study||5||
48723444|NCT00110461|102108353|FG000|STARTED|30-Week, Double-blind Treatment Phase||98||
48723445|NCT00110461|102108354|FG001|STARTED|30-Week, Double-blind Treatment Phase||99||
48723446|NCT00110461|102108355|FG002|STARTED|30-Week, Double-blind Treatment Phase||99||
48723447|NCT00110461|102108353|FG000|COMPLETED|30-Week, Double-blind Treatment Phase||34||
48723448|NCT00110461|102108354|FG001|COMPLETED|30-Week, Double-blind Treatment Phase||22||
48611874|NCT01153009|101834184|FG002|NOT COMPLETED|Overall Study||41||
48611875|NCT01153009|101834185|FG003|NOT COMPLETED|Overall Study||37||
48611876|NCT04026750|101834186|FG000|STARTED|Overall Study||3||
48611877|NCT04026750|101834187|FG001|STARTED|Overall Study||2||
48611878|NCT04026750|101834186|FG000|COMPLETED|Overall Study||3||
48611879|NCT04026750|101834187|FG001|COMPLETED|Overall Study||2||
48611880|NCT04026750|101834186|FG000|NOT COMPLETED|Overall Study||0||
48611881|NCT04026750|101834187|FG001|NOT COMPLETED|Overall Study||0||
48611882|NCT01054222|101834188|FG000|STARTED|Overall Study||31||
48611883|NCT01054222|101834188|FG000|COMPLETED|Overall Study||20||
48611884|NCT01054222|101834188|FG000|NOT COMPLETED|Overall Study||11||
48611885|NCT02820870|101834189|FG000|STARTED|Before Intervention||15|Care received prior to the intervention and intended to adjust for confounding due to chance.|538
48611886|NCT02820870|101834190|FG001|STARTED|Before Intervention||28|Care received prior to the intervention and intended to adjust for confounding due to chance.|672
48611887|NCT02820870|101834189|FG000|COMPLETED|Before Intervention||15||538
48611888|NCT02820870|101834190|FG001|COMPLETED|Before Intervention||28||672
48611889|NCT02820870|101834189|FG000|NOT COMPLETED|Before Intervention||0||0
48723449|NCT00110461|102108355|FG002|COMPLETED|30-Week, Double-blind Treatment Phase||12||
48767597|NCT00914316|102222777|FG001|COMPLETED|Phase 1||4||
48611890|NCT02820870|101834190|FG001|NOT COMPLETED|Before Intervention||0||0
48611891|NCT02820870|101834189|FG000|STARTED|Intervention||15||573
48611892|NCT02820870|101834190|FG001|STARTED|Intervention||28||673
48611893|NCT02820870|101834189|FG000|COMPLETED|Intervention||15||573
48611894|NCT02820870|101834190|FG001|COMPLETED|Intervention||28||673
48611895|NCT02820870|101834189|FG000|NOT COMPLETED|Intervention||0||0
48611896|NCT02820870|101834190|FG001|NOT COMPLETED|Intervention||0||0
48611897|NCT02820870|101834189|FG000|STARTED|Post Intervention||15|These are visits after the intervention was done. It tested the effects' persistence.|603
48611898|NCT02820870|101834190|FG001|STARTED|Post Intervention||28|These are visits after the intervention was done. It tested the effects' persistence.|728
48611899|NCT02820870|101834189|FG000|COMPLETED|Post Intervention||15||603
48611900|NCT02820870|101834190|FG001|COMPLETED|Post Intervention||28||728
48611901|NCT02820870|101834189|FG000|NOT COMPLETED|Post Intervention||0||0
48611902|NCT02820870|101834190|FG001|NOT COMPLETED|Post Intervention||0||0
48611903|NCT00576524|101834191|FG000|STARTED|Overall Study||2||
48611904|NCT00576524|101834192|FG001|STARTED|Overall Study||0||
48611905|NCT00576524|101834191|FG000|COMPLETED|Overall Study||2||
48611906|NCT00576524|101834192|FG001|COMPLETED|Overall Study||0||
48611907|NCT00576524|101834191|FG000|NOT COMPLETED|Overall Study||0||
48611908|NCT00576524|101834192|FG001|NOT COMPLETED|Overall Study||0||
48611909|NCT05415462|101834193|FG000|STARTED|Overall Study||3057||
48611910|NCT05415462|101834194|FG001|STARTED|Overall Study||3045||
48611911|NCT05415462|101834193|FG000|Received Injection|Overall Study||3048||
48611912|NCT05415462|101834194|FG001|Received Injection|Overall Study||3035||
48611913|NCT05415462|101834193|FG000|COMPLETED|Overall Study||2824||
48611914|NCT05415462|101834194|FG001|COMPLETED|Overall Study||2857||
48611915|NCT05415462|101834193|FG000|NOT COMPLETED|Overall Study||233||
48611916|NCT05415462|101834194|FG001|NOT COMPLETED|Overall Study||188||
48611917|NCT00339833|101834195|FG000|STARTED|Overall Study||28||
48611918|NCT00339833|101834196|FG001|STARTED|Overall Study||26||
48611919|NCT00339833|101834195|FG000|COMPLETED|Overall Study||22||
48611920|NCT00339833|101834196|FG001|COMPLETED|Overall Study||18||
48611921|NCT00339833|101834195|FG000|NOT COMPLETED|Overall Study||6||
48611922|NCT00339833|101834196|FG001|NOT COMPLETED|Overall Study||8||
48611923|NCT00770913|101834197|FG000|STARTED|Overall Study||113||
48611924|NCT00770913|101834198|FG001|STARTED|Overall Study||111||
48611925|NCT00770913|101834199|FG002|STARTED|Overall Study||113||
48611926|NCT00770913|101834197|FG000|COMPLETED|Overall Study||102||
48611927|NCT00770913|101834198|FG001|COMPLETED|Overall Study||103||
48611928|NCT00770913|101834199|FG002|COMPLETED|Overall Study||100||
48723450|NCT00110461|102108353|FG000|NOT COMPLETED|30-Week, Double-blind Treatment Phase||64||
48723451|NCT00110461|102108354|FG001|NOT COMPLETED|30-Week, Double-blind Treatment Phase||77||
48723452|NCT00110461|102108355|FG002|NOT COMPLETED|30-Week, Double-blind Treatment Phase||87||
48723453|NCT00110461|102108353|FG000|STARTED|Acute Phase||98||
48723454|NCT00110461|102108354|FG001|STARTED|Acute Phase||99||
48723455|NCT00110461|102108355|FG002|STARTED|Acute Phase||99||
48723456|NCT00110461|102108353|FG000|COMPLETED|Acute Phase||84||
48723457|NCT00110461|102108354|FG001|COMPLETED|Acute Phase||77||
48723458|NCT00110461|102108355|FG002|COMPLETED|Acute Phase||76||
48611929|NCT00770913|101834197|FG000|NOT COMPLETED|Overall Study||11||
48611930|NCT00770913|101834198|FG001|NOT COMPLETED|Overall Study||8||
48611931|NCT00770913|101834199|FG002|NOT COMPLETED|Overall Study||13||
48611932|NCT02998151|101834200|FG000|STARTED|Overall Study||29||
48611933|NCT02998151|101834200|FG000|Placebo|Overall Study||27||
48611934|NCT02998151|101834200|FG000|Acamprosate|Overall Study||16|Acamprosate was discontinued due to undetectable serum levels after dosage.|
48611935|NCT02998151|101834200|FG000|Lovastatin|Overall Study||29||
48611936|NCT02998151|101834200|FG000|Minocycline|Overall Study||27||
48611937|NCT02998151|101834200|FG000|Baclofen|Overall Study||18|Baclofen replaced acamprosate after it was determined acamprosate was undetectable in serum after dosage.|
48611938|NCT02998151|101834200|FG000|COMPLETED|Overall Study||5|Five participants completed all 5 study arms; however, 26 completed all that were originally asked of them (4 visits, with 5 of those 26 re-enrolling to complete baclofen as well).|
48611939|NCT02998151|101834200|FG000|NOT COMPLETED|Overall Study||24||
48723459|NCT00110461|102108353|FG000|NOT COMPLETED|Acute Phase||14||
48723460|NCT00110461|102108354|FG001|NOT COMPLETED|Acute Phase||22||
48723461|NCT00110461|102108355|FG002|NOT COMPLETED|Acute Phase||23||
48723462|NCT01436266|102108356|FG000|STARTED|Overall Study||1||
48723463|NCT01436266|102108357|FG001|STARTED|Overall Study||1||
48723464|NCT01436266|102108356|FG000|COMPLETED|Overall Study||1||
48723465|NCT01436266|102108357|FG001|COMPLETED|Overall Study||1||
48723466|NCT01436266|102108356|FG000|NOT COMPLETED|Overall Study||0||
48723467|NCT01436266|102108357|FG001|NOT COMPLETED|Overall Study||0||
48723468|NCT05026853|102108358|FG000|STARTED|Overall Study||55||
48611940|NCT02131233|101834201|FG000|STARTED|Overall Study||533||
48723469|NCT05026853|102108359|FG001|STARTED|Overall Study||55||
48611941|NCT02131233|101834202|FG001|STARTED|Overall Study||269||
48723470|NCT05026853|102108358|FG000|Week 2 Follow-up|Overall Study||35||
48611942|NCT02131233|101834201|FG000|Treated|Overall Study||531||
48611943|NCT02131233|101834202|FG001|Treated|Overall Study||266||
48611944|NCT02131233|101834201|FG000|COMPLETED|Overall Study||467||
48723471|NCT05026853|102108359|FG001|Week 2 Follow-up|Overall Study||45||
48723472|NCT05026853|102108358|FG000|Week 12 Follow-up|Overall Study||30||
48611945|NCT02131233|101834202|FG001|COMPLETED|Overall Study||227||
48611946|NCT02131233|101834201|FG000|NOT COMPLETED|Overall Study||66||
48611947|NCT02131233|101834202|FG001|NOT COMPLETED|Overall Study||42||
48611948|NCT01440634|101834203|FG000|STARTED|Cross Sectional Phase||0||
48611949|NCT01440634|101834204|FG001|STARTED|Cross Sectional Phase||347||
48611950|NCT01440634|101834203|FG000|COMPLETED|Cross Sectional Phase||0||
48611951|NCT01440634|101834204|FG001|COMPLETED|Cross Sectional Phase||347||
48611952|NCT01440634|101834203|FG000|NOT COMPLETED|Cross Sectional Phase||0||
48611953|NCT01440634|101834204|FG001|NOT COMPLETED|Cross Sectional Phase||0||
48611954|NCT01440634|101834203|FG000|STARTED|Randomization Phase||30||
48611955|NCT01440634|101834204|FG001|STARTED|Randomization Phase||24||
48611956|NCT01440634|101834203|FG000|COMPLETED|Randomization Phase||24||
48611957|NCT01440634|101834204|FG001|COMPLETED|Randomization Phase||14||
48611958|NCT01440634|101834203|FG000|NOT COMPLETED|Randomization Phase||6||
48611959|NCT01440634|101834204|FG001|NOT COMPLETED|Randomization Phase||10||
48611960|NCT02693262|101834205|FG000|STARTED|Overall Study||4||
48611961|NCT02693262|101834206|FG001|STARTED|Overall Study||5||
48611962|NCT02693262|101834205|FG000|COMPLETED|Overall Study||4||
48153766|NCT02969525|100699845|FG007|NOT COMPLETED|Double-Blind Period||0||
48153767|NCT02969525|100699846|FG008|NOT COMPLETED|Double-Blind Period||0||
48153768|NCT02969525|100699847|FG009|NOT COMPLETED|Double-Blind Period||0||
48723473|NCT05026853|102108359|FG001|Week 12 Follow-up|Overall Study||39||
48723474|NCT05026853|102108358|FG000|COMPLETED|Overall Study||30||
48723475|NCT05026853|102108359|FG001|COMPLETED|Overall Study||39||
48723476|NCT05026853|102108358|FG000|NOT COMPLETED|Overall Study||25||
48723477|NCT05026853|102108359|FG001|NOT COMPLETED|Overall Study||16||
48723478|NCT00694304|102108360|FG000|STARTED|Overall Study||535||
48723479|NCT00694304|102108360|FG000|COMPLETED|Overall Study||328||
48723480|NCT00694304|102108360|FG000|NOT COMPLETED|Overall Study||207||
48723481|NCT03890367|102108361|FG000|STARTED|Overall Study||232||
48723482|NCT03890367|102108362|FG001|STARTED|Overall Study||235||
48723483|NCT03890367|102108363|FG002|STARTED|Overall Study||240||
48723484|NCT03890367|102108361|FG000|Safety Analysis Set|Overall Study||230|All participants who had received one dose of study vaccine and analyzed according to the vaccine they actually received.|
48723485|NCT03890367|102108362|FG001|Safety Analysis Set|Overall Study||232|All participants who had received one dose of study vaccine and analyzed according to the vaccine they actually received.|
48723486|NCT03890367|102108363|FG002|Safety Analysis Set|Overall Study||239|All participants who had received one dose of study vaccine and analyzed according to the vaccine they actually received.|
48723487|NCT03890367|102108361|FG000|COMPLETED|Overall Study||228||
48723488|NCT03890367|102108362|FG001|COMPLETED|Overall Study||229||
48723489|NCT03890367|102108363|FG002|COMPLETED|Overall Study||239||
48723490|NCT03890367|102108361|FG000|NOT COMPLETED|Overall Study||4||
48723491|NCT03890367|102108362|FG001|NOT COMPLETED|Overall Study||6||
48723492|NCT03890367|102108363|FG002|NOT COMPLETED|Overall Study||1||
48723493|NCT03335254|102108364|FG000|STARTED|Period 1||9||
48153769|NCT02969525|100699848|FG010|NOT COMPLETED|Double-Blind Period||0||
48153770|NCT02969525|100699849|FG011|NOT COMPLETED|Double-Blind Period||0||
48153771|NCT02969525|100699838|FG000|STARTED|Dose-Blind Period||0||
48153772|NCT02969525|100699839|FG001|STARTED|Dose-Blind Period||0||
48153773|NCT02969525|100699840|FG002|STARTED|Dose-Blind Period||0||
48153774|NCT02969525|100699841|FG003|STARTED|Dose-Blind Period||0||
48153775|NCT02969525|100699842|FG004|STARTED|Dose-Blind Period||0||
48153776|NCT02969525|100699843|FG005|STARTED|Dose-Blind Period||20||
48153777|NCT02969525|100699844|FG006|STARTED|Dose-Blind Period||20||
48611963|NCT02693262|101834206|FG001|COMPLETED|Overall Study||5||
48611964|NCT02693262|101834205|FG000|NOT COMPLETED|Overall Study||0||
48611965|NCT02693262|101834206|FG001|NOT COMPLETED|Overall Study||0||
48611966|NCT02455453|101834207|FG000|STARTED|Overall Study||47||
48723494|NCT03335254|102108365|FG001|STARTED|Period 1||0||
48723495|NCT03335254|102108366|FG002|STARTED|Period 1||0||
48723496|NCT03335254|102108367|FG003|STARTED|Period 1||0||
48723497|NCT03335254|102108368|FG004|STARTED|Period 1||0||
48723498|NCT03335254|102108369|FG005|STARTED|Period 1||0||
48723499|NCT03335254|102108370|FG006|STARTED|Period 1||0||
48153778|NCT02969525|100699845|FG007|STARTED|Dose-Blind Period||22||
48153779|NCT02969525|100699846|FG008|STARTED|Dose-Blind Period||19||
48153780|NCT02969525|100699847|FG009|STARTED|Dose-Blind Period||37||
48153781|NCT02969525|100699848|FG010|STARTED|Dose-Blind Period||40||
48153782|NCT02969525|100699849|FG011|STARTED|Dose-Blind Period||41||
48153783|NCT02969525|100699838|FG000|COMPLETED|Dose-Blind Period||0||
48153784|NCT02969525|100699839|FG001|COMPLETED|Dose-Blind Period||0||
48611967|NCT02455453|101834207|FG000|COMPLETED|Overall Study||47||
48611968|NCT02455453|101834207|FG000|NOT COMPLETED|Overall Study||0||
48723500|NCT03335254|102108371|FG007|STARTED|Period 1||0||
48723501|NCT03335254|102108372|FG008|STARTED|Period 1||0||
48723502|NCT03335254|102108373|FG009|STARTED|Period 1||0||
48153785|NCT02969525|100699840|FG002|COMPLETED|Dose-Blind Period||0||
48153786|NCT02969525|100699841|FG003|COMPLETED|Dose-Blind Period||0||
48153787|NCT02969525|100699842|FG004|COMPLETED|Dose-Blind Period||0||
48153788|NCT02969525|100699843|FG005|COMPLETED|Dose-Blind Period||20||
48153789|NCT02969525|100699844|FG006|COMPLETED|Dose-Blind Period||18||
48611969|NCT04152083|101834208|FG000|STARTED|Overall Study||241||
48611970|NCT04152083|101834209|FG001|STARTED|Overall Study||244||
48611971|NCT04152083|101834208|FG000|Received at Least 1 Dose of Study Drug|Overall Study||238||
48153790|NCT02969525|100699845|FG007|COMPLETED|Dose-Blind Period||22||
48153791|NCT02969525|100699846|FG008|COMPLETED|Dose-Blind Period||18||
48153792|NCT02969525|100699847|FG009|COMPLETED|Dose-Blind Period||34||
48153793|NCT02969525|100699848|FG010|COMPLETED|Dose-Blind Period||38||
48153794|NCT02969525|100699849|FG011|COMPLETED|Dose-Blind Period||39||
48153795|NCT02969525|100699838|FG000|NOT COMPLETED|Dose-Blind Period||0||
48153796|NCT02969525|100699839|FG001|NOT COMPLETED|Dose-Blind Period||0||
48153797|NCT02969525|100699840|FG002|NOT COMPLETED|Dose-Blind Period||0||
48153798|NCT02969525|100699841|FG003|NOT COMPLETED|Dose-Blind Period||0||
48153799|NCT02969525|100699842|FG004|NOT COMPLETED|Dose-Blind Period||0||
48308994|NCT00915772|101084504|FG001|COMPLETED|Overall Study||179||
48611972|NCT04152083|101834209|FG001|Received at Least 1 Dose of Study Drug|Overall Study||242||
48153800|NCT02969525|100699843|FG005|NOT COMPLETED|Dose-Blind Period||0||
48153801|NCT02969525|100699844|FG006|NOT COMPLETED|Dose-Blind Period||2||
48153802|NCT02969525|100699845|FG007|NOT COMPLETED|Dose-Blind Period||0||
48153803|NCT02969525|100699846|FG008|NOT COMPLETED|Dose-Blind Period||1||
48153804|NCT02969525|100699847|FG009|NOT COMPLETED|Dose-Blind Period||3||
48153805|NCT02969525|100699848|FG010|NOT COMPLETED|Dose-Blind Period||2||
48153806|NCT02969525|100699849|FG011|NOT COMPLETED|Dose-Blind Period||2||
48153807|NCT00387673|100699850|FG000|STARTED|Overall Study||0||
48153808|NCT00387673|100699851|FG001|STARTED|Overall Study||0||
48153809|NCT00387673|100699852|FG002|STARTED|Overall Study||0||
48308995|NCT00915772|101084505|FG002|COMPLETED|Overall Study||142||
48308996|NCT00915772|101084503|FG000|NOT COMPLETED|Overall Study||36||
48308997|NCT00915772|101084504|FG001|NOT COMPLETED|Overall Study||46||
48611973|NCT04152083|101834208|FG000|COMPLETED|Overall Study||235||
48611974|NCT04152083|101834209|FG001|COMPLETED|Overall Study||241||
48611975|NCT04152083|101834208|FG000|NOT COMPLETED|Overall Study||6||
48611976|NCT04152083|101834209|FG001|NOT COMPLETED|Overall Study||3||
48611977|NCT04235504|101834210|FG000|STARTED|Study Phase||41||
48611978|NCT04235504|101834211|FG001|STARTED|Study Phase||41||
48611979|NCT04235504|101834212|FG002|STARTED|Study Phase||8||
48611980|NCT04235504|101834213|FG003|STARTED|Study Phase||5||
48611981|NCT04235504|101834210|FG000|COMPLETED|Study Phase||36||
48611982|NCT04235504|101834211|FG001|COMPLETED|Study Phase||39||
48611983|NCT04235504|101834212|FG002|COMPLETED|Study Phase||8||
48611984|NCT04235504|101834213|FG003|COMPLETED|Study Phase||5||
48611985|NCT04235504|101834210|FG000|NOT COMPLETED|Study Phase||5||
48611986|NCT04235504|101834211|FG001|NOT COMPLETED|Study Phase||2||
48611987|NCT04235504|101834212|FG002|NOT COMPLETED|Study Phase||0||
48611988|NCT04235504|101834213|FG003|NOT COMPLETED|Study Phase||0||
48611989|NCT04235504|101834210|FG000|STARTED|Continuation Phase||36||
48611990|NCT04235504|101834211|FG001|STARTED|Continuation Phase||39||
48611991|NCT04235504|101834212|FG002|STARTED|Continuation Phase||8||
48611992|NCT04235504|101834213|FG003|STARTED|Continuation Phase||5||
48611993|NCT04235504|101834210|FG000|COMPLETED|Continuation Phase||35||
48611994|NCT04235504|101834211|FG001|COMPLETED|Continuation Phase||32||
48611995|NCT04235504|101834212|FG002|COMPLETED|Continuation Phase||7||
48611996|NCT04235504|101834213|FG003|COMPLETED|Continuation Phase||5||
48611997|NCT04235504|101834210|FG000|NOT COMPLETED|Continuation Phase||1||
48611998|NCT04235504|101834211|FG001|NOT COMPLETED|Continuation Phase||7||
48611999|NCT04235504|101834212|FG002|NOT COMPLETED|Continuation Phase||1||
48612000|NCT04235504|101834213|FG003|NOT COMPLETED|Continuation Phase||0||
48612001|NCT01540981|101834214|FG000|STARTED|Overall Study||6||
48612002|NCT01540981|101834215|FG001|STARTED|Overall Study||6||
48612003|NCT01540981|101834214|FG000|COMPLETED|Overall Study||5||
48612004|NCT01540981|101834215|FG001|COMPLETED|Overall Study||6||
48612005|NCT01540981|101834214|FG000|NOT COMPLETED|Overall Study||1||
48612006|NCT01540981|101834215|FG001|NOT COMPLETED|Overall Study||0||
48612007|NCT03258645|101834216|FG000|STARTED|Overall Study||1489||
48612008|NCT03258645|101834216|FG000|COMPLETED|Overall Study||1489||
48612009|NCT03258645|101834216|FG000|NOT COMPLETED|Overall Study||0||
48612010|NCT01240902|101834217|FG000|STARTED|Overall Study||500||
48153810|NCT00387673|100699850|FG000|COMPLETED|Overall Study||0||
48153811|NCT00387673|100699851|FG001|COMPLETED|Overall Study||0||
48153812|NCT00387673|100699852|FG002|COMPLETED|Overall Study||0||
48153813|NCT00387673|100699850|FG000|NOT COMPLETED|Overall Study||0||
48153814|NCT00387673|100699851|FG001|NOT COMPLETED|Overall Study||0||
48153815|NCT00387673|100699852|FG002|NOT COMPLETED|Overall Study||0||
48153816|NCT02070484|100699853|FG000|STARTED|Overall Study||3||
48153817|NCT02070484|100699854|FG001|STARTED|Overall Study||3||
48153818|NCT02070484|100699853|FG000|COMPLETED|Overall Study||2||
48153819|NCT02070484|100699854|FG001|COMPLETED|Overall Study||3||
48153820|NCT02070484|100699853|FG000|NOT COMPLETED|Overall Study||1||
48308998|NCT00915772|101084505|FG002|NOT COMPLETED|Overall Study||29||
48308999|NCT00733304|101084506|FG000|STARTED|Overall Study||19||
48153821|NCT02070484|100699854|FG001|NOT COMPLETED|Overall Study||0||
48612011|NCT01240902|101834218|FG001|STARTED|Overall Study||156||
48612012|NCT01240902|101834219|FG002|STARTED|Overall Study||395||
48612013|NCT01240902|101834220|FG003|STARTED|Overall Study||402||
48612014|NCT01240902|101834217|FG000|COMPLETED|Overall Study||289||
48612015|NCT01240902|101834218|FG001|COMPLETED|Overall Study||77||
48612016|NCT01240902|101834219|FG002|COMPLETED|Overall Study||295||
48612017|NCT01240902|101834220|FG003|COMPLETED|Overall Study||237||
48153822|NCT00772590|100699855|FG000|STARTED|Overall Study||19||
48153823|NCT00772590|100699856|FG001|STARTED|Overall Study||19||
48153824|NCT00772590|100699857|FG002|STARTED|Overall Study||18||
48153825|NCT00772590|100699858|FG003|STARTED|Overall Study||17||
48612018|NCT01240902|101834217|FG000|NOT COMPLETED|Overall Study||211||
48612019|NCT01240902|101834218|FG001|NOT COMPLETED|Overall Study||79||
48612020|NCT01240902|101834219|FG002|NOT COMPLETED|Overall Study||100||
48153826|NCT00772590|100699855|FG000|COMPLETED|Overall Study||19||
48153827|NCT00772590|100699856|FG001|COMPLETED|Overall Study||19||
48153828|NCT00772590|100699857|FG002|COMPLETED|Overall Study||18||
48153829|NCT00772590|100699858|FG003|COMPLETED|Overall Study||17||
48153830|NCT00772590|100699855|FG000|NOT COMPLETED|Overall Study||0||
48153831|NCT00772590|100699856|FG001|NOT COMPLETED|Overall Study||0||
48153832|NCT00772590|100699857|FG002|NOT COMPLETED|Overall Study||0||
48153833|NCT00772590|100699858|FG003|NOT COMPLETED|Overall Study||0||
48153834|NCT00801801|100699859|FG000|STARTED|Overall Study||5||
48153835|NCT00801801|100699859|FG000|COMPLETED|Overall Study||5||
48153836|NCT00801801|100699859|FG000|NOT COMPLETED|Overall Study||0||
48153837|NCT01735201|100699860|FG000|STARTED|Overall Study||45||
48153838|NCT01735201|100699861|FG001|STARTED|Overall Study||44||
48612021|NCT01240902|101834220|FG003|NOT COMPLETED|Overall Study||165||
48612022|NCT00652145|101834221|FG000|STARTED|Overall Study||26||
48612023|NCT00652145|101834222|FG001|STARTED|Overall Study||26||
48612024|NCT00652145|101834221|FG000|COMPLETED|Overall Study||26||
48612025|NCT00652145|101834222|FG001|COMPLETED|Overall Study||26||
48612026|NCT00652145|101834221|FG000|NOT COMPLETED|Overall Study||0||
48612027|NCT00652145|101834222|FG001|NOT COMPLETED|Overall Study||0||
48612028|NCT01121939|101838158|FG000|STARTED|Overall Study||43||
48612029|NCT01121939|101838158|FG000|COMPLETED|Overall Study||0||
48612030|NCT01121939|101838158|FG000|NOT COMPLETED|Overall Study||43||
48612031|NCT00656175|101838159|FG000|STARTED|Overall Study||18||
48612032|NCT00656175|101838160|FG001|STARTED|Overall Study||21||
48612033|NCT00656175|101838159|FG000|COMPLETED|Overall Study||17||
48612034|NCT00656175|101838160|FG001|COMPLETED|Overall Study||20||
48612035|NCT00656175|101838159|FG000|NOT COMPLETED|Overall Study||1||
48612036|NCT00656175|101838160|FG001|NOT COMPLETED|Overall Study||1||
48612037|NCT00420628|101838161|FG000|STARTED|Overall Study||72||
48612038|NCT00420628|101838162|FG001|STARTED|Overall Study||36||
48612039|NCT00420628|101838161|FG000|COMPLETED|Overall Study||63||
48612040|NCT00420628|101838162|FG001|COMPLETED|Overall Study||32||
48612041|NCT00420628|101838161|FG000|NOT COMPLETED|Overall Study||9||
48612042|NCT00420628|101838162|FG001|NOT COMPLETED|Overall Study||4||
48612043|NCT02090777|101838163|FG000|STARTED|Overall Study||4||
48612044|NCT02090777|101838163|FG000|COMPLETED|Overall Study||4||
48612045|NCT02090777|101838163|FG000|NOT COMPLETED|Overall Study||0||
48612046|NCT01351090|101838164|FG000|STARTED|Overall Study||43||
48612047|NCT01351090|101838165|FG001|STARTED|Overall Study||42||
48612048|NCT01351090|101838166|FG002|STARTED|Overall Study||42||
48612049|NCT01351090|101838164|FG000|COMPLETED|Overall Study||32||
48612050|NCT01351090|101838165|FG001|COMPLETED|Overall Study||31||
48612051|NCT01351090|101838166|FG002|COMPLETED|Overall Study||36||
48612052|NCT01351090|101838164|FG000|NOT COMPLETED|Overall Study||11||
48612053|NCT01351090|101838165|FG001|NOT COMPLETED|Overall Study||11||
48612054|NCT01351090|101838166|FG002|NOT COMPLETED|Overall Study||6||
48612055|NCT01830933|101838167|FG000|STARTED|Overall Study||823||
48612056|NCT01830933|101838168|FG001|STARTED|Overall Study||812||
48612057|NCT01830933|101838167|FG000|Completed Meet-up|Overall Study||675||
48612058|NCT01830933|101838168|FG001|Completed Meet-up|Overall Study||603||
48612059|NCT01830933|101838167|FG000|COMPLETED|Overall Study||655||
48612060|NCT01830933|101838168|FG001|COMPLETED|Overall Study||580||
48723503|NCT03335254|102108374|FG010|STARTED|Period 1||0||
48723504|NCT03335254|102108375|FG011|STARTED|Period 1||0||
48153839|NCT01735201|100699862|FG002|STARTED|Overall Study||44||
48153840|NCT01735201|100699863|FG003|STARTED|Overall Study||44||
48153841|NCT01735201|100699864|FG004|STARTED|Overall Study||45||
48153842|NCT01735201|100699865|FG005|STARTED|Overall Study||45||
48153843|NCT01735201|100699866|FG006|STARTED|Overall Study||45||
48153844|NCT01735201|100699867|FG007|STARTED|Overall Study||44||
48153845|NCT01735201|100699860|FG000|COMPLETED|Overall Study||42||
48612061|NCT01830933|101838167|FG000|NOT COMPLETED|Overall Study||168||
48612062|NCT01830933|101838168|FG001|NOT COMPLETED|Overall Study||232||
48612063|NCT00578279|101838169|FG000|STARTED|Overall Study||10||
48723505|NCT03335254|102108376|FG012|STARTED|Period 1||0||
48723506|NCT03335254|102108377|FG013|STARTED|Period 1||0||
48153846|NCT01735201|100699861|FG001|COMPLETED|Overall Study||43||
48153847|NCT01735201|100699862|FG002|COMPLETED|Overall Study||44||
48153848|NCT01735201|100699863|FG003|COMPLETED|Overall Study||42||
48153849|NCT01735201|100699864|FG004|COMPLETED|Overall Study||44||
48612064|NCT00578279|101838170|FG001|STARTED|Overall Study||10||
48612065|NCT00578279|101838169|FG000|COMPLETED|Overall Study||10||
48612066|NCT00578279|101838170|FG001|COMPLETED|Overall Study||10||
48612067|NCT00578279|101838169|FG000|NOT COMPLETED|Overall Study||0||
48612068|NCT00578279|101838170|FG001|NOT COMPLETED|Overall Study||0||
48612069|NCT04391842|101838171|FG000|STARTED|Overall Study||34||
48612070|NCT04391842|101838171|FG000|COMPLETED|Overall Study||32||
48612071|NCT04391842|101838171|FG000|NOT COMPLETED|Overall Study||2||
48612072|NCT02778152|101838172|FG000|STARTED|Overall Study||13||
48612073|NCT02778152|101838172|FG000|COMPLETED|Overall Study||13||
48612074|NCT02778152|101838172|FG000|NOT COMPLETED|Overall Study||0||
48612075|NCT00426764|101838173|FG000|STARTED|Overall Study||131||
48612076|NCT00426764|101838173|FG000|Discontinued Prior to or During Cycle 6|Overall Study||98||
48612077|NCT00426764|101838173|FG000|Discontinued at End of or After Cycle 6|Overall Study||33||
48612078|NCT00426764|101838173|FG000|COMPLETED|Overall Study||0||
48612079|NCT00426764|101838173|FG000|NOT COMPLETED|Overall Study||131||
48612080|NCT03509181|101838174|FG000|STARTED|Overall Study||34||
48612081|NCT03509181|101838175|FG001|STARTED|Overall Study||34||
48612082|NCT03509181|101838174|FG000|COMPLETED|Overall Study||27||
48612083|NCT03509181|101838175|FG001|COMPLETED|Overall Study||31||
48612084|NCT03509181|101838174|FG000|NOT COMPLETED|Overall Study||7||
48612085|NCT03509181|101838175|FG001|NOT COMPLETED|Overall Study||3||
48612086|NCT00878800|101838176|FG000|STARTED|Overall Study||3||
48612087|NCT00878800|101838177|FG001|STARTED|Overall Study||7||
48612088|NCT00878800|101838178|FG002|STARTED|Overall Study||9||
48612089|NCT00878800|101838179|FG003|STARTED|Overall Study||6||
48612090|NCT00878800|101838180|FG004|STARTED|Overall Study||16||
48612091|NCT00878800|101838176|FG000|COMPLETED|Overall Study||0||
48612092|NCT00878800|101838177|FG001|COMPLETED|Overall Study||0||
48612093|NCT00878800|101838178|FG002|COMPLETED|Overall Study||0||
48612094|NCT00878800|101838179|FG003|COMPLETED|Overall Study||0||
48612095|NCT00878800|101838180|FG004|COMPLETED|Overall Study||0||
48612096|NCT00878800|101838176|FG000|NOT COMPLETED|Overall Study||3||
48612097|NCT00878800|101838177|FG001|NOT COMPLETED|Overall Study||7||
48612098|NCT00878800|101838178|FG002|NOT COMPLETED|Overall Study||9||
48612099|NCT00878800|101838179|FG003|NOT COMPLETED|Overall Study||6||
48612100|NCT00878800|101838180|FG004|NOT COMPLETED|Overall Study||16||
48612101|NCT01383018|101838181|FG000|STARTED|Overall Study||1457||
48612102|NCT01383018|101838181|FG000|COMPLETED|Overall Study||1082||
48612103|NCT01383018|101838181|FG000|NOT COMPLETED|Overall Study||375||
48612104|NCT04162795|101838182|FG000|STARTED|Overall Study||468||
48153850|NCT01735201|100699865|FG005|COMPLETED|Overall Study||40||
48153851|NCT01735201|100699866|FG006|COMPLETED|Overall Study||42||
48153852|NCT01735201|100699867|FG007|COMPLETED|Overall Study||42||
48153853|NCT01735201|100699860|FG000|NOT COMPLETED|Overall Study||3||
48153854|NCT01735201|100699861|FG001|NOT COMPLETED|Overall Study||1||
48153855|NCT01735201|100699862|FG002|NOT COMPLETED|Overall Study||0||
48153856|NCT01735201|100699863|FG003|NOT COMPLETED|Overall Study||2||
48153857|NCT01735201|100699864|FG004|NOT COMPLETED|Overall Study||1||
48153858|NCT01735201|100699865|FG005|NOT COMPLETED|Overall Study||5||
48153859|NCT01735201|100699866|FG006|NOT COMPLETED|Overall Study||3||
48153860|NCT01735201|100699867|FG007|NOT COMPLETED|Overall Study||2||
48153861|NCT01323530|100699868|FG000|STARTED|Phase 1b (Dose Escalation Phase)||8||
48612105|NCT04162795|101838182|FG000|COMPLETED|Overall Study||442||
48612106|NCT04162795|101838182|FG000|NOT COMPLETED|Overall Study||26||
48612107|NCT03782181|101838183|FG000|STARTED|Overall Study||20||
48612108|NCT03782181|101838184|FG001|STARTED|Overall Study||20||
48612109|NCT03782181|101838183|FG000|COMPLETED|Overall Study||20||
48612110|NCT03782181|101838184|FG001|COMPLETED|Overall Study||20||
48612111|NCT03782181|101838183|FG000|NOT COMPLETED|Overall Study||0||
48612112|NCT03782181|101838184|FG001|NOT COMPLETED|Overall Study||0||
48612113|NCT00735943|101838185|FG000|STARTED|Overall Study||22||
48612114|NCT00735943|101838185|FG000|COMPLETED|Overall Study||20||
48153862|NCT01323530|100699869|FG001|STARTED|Phase 1b (Dose Escalation Phase)||6||
48612115|NCT00735943|101838185|FG000|NOT COMPLETED|Overall Study||2||
48612116|NCT01188668|101838186|FG000|STARTED|Period 1: ARIP Alone||38||
48612117|NCT01188668|101838186|FG000|COMPLETED|Period 1: ARIP Alone||36||
48612118|NCT01188668|101838186|FG000|NOT COMPLETED|Period 1: ARIP Alone||2||
48612119|NCT01188668|101838186|FG000|STARTED|Period 2: Coadministration ARIP + DVS SR||36||
48612120|NCT01188668|101838186|FG000|COMPLETED|Period 2: Coadministration ARIP + DVS SR||33||
48153863|NCT01323530|100699870|FG002|STARTED|Phase 1b (Dose Escalation Phase)||5||
48612121|NCT01188668|101838186|FG000|NOT COMPLETED|Period 2: Coadministration ARIP + DVS SR||3||
48612122|NCT03126786|101838187|FG000|STARTED|Overall Study||36||
48612123|NCT03126786|101838188|FG001|STARTED|Overall Study||35||
48612124|NCT03126786|101838187|FG000|COMPLETED|Overall Study||30||
48612125|NCT03126786|101838188|FG001|COMPLETED|Overall Study||33||
48612126|NCT03126786|101838187|FG000|NOT COMPLETED|Overall Study||6||
48612127|NCT03126786|101838188|FG001|NOT COMPLETED|Overall Study||2||
48723507|NCT03335254|102108378|FG014|STARTED|Period 1||0||
48309000|NCT00733304|101084507|FG001|STARTED|Overall Study||15||
48309001|NCT00733304|101084508|FG002|STARTED|Overall Study||8||
48309002|NCT00733304|101084506|FG000|COMPLETED|Overall Study||12||
48309003|NCT00733304|101084507|FG001|COMPLETED|Overall Study||12||
48309004|NCT00733304|101084508|FG002|COMPLETED|Overall Study||3||
48309005|NCT00733304|101084506|FG000|NOT COMPLETED|Overall Study||7||
48309006|NCT00733304|101084507|FG001|NOT COMPLETED|Overall Study||3||
48309007|NCT00733304|101084508|FG002|NOT COMPLETED|Overall Study||5||
48309008|NCT01301456|101084509|FG000|STARTED|Stage 1||15||
48723508|NCT03335254|102108379|FG015|STARTED|Period 1||0||
48723509|NCT03335254|102108380|FG016|STARTED|Period 1||0||
48723510|NCT03335254|102108381|FG017|STARTED|Period 1||0||
48723511|NCT03335254|102108382|FG018|STARTED|Period 1||0||
48309009|NCT01301456|101084510|FG001|STARTED|Stage 1||5||
48309010|NCT01301456|101084511|FG002|STARTED|Stage 1||6||
48309011|NCT01301456|101084512|FG003|STARTED|Stage 1||6||
48309012|NCT01301456|101084513|FG004|STARTED|Stage 1||7||
48309013|NCT01301456|101084514|FG005|STARTED|Stage 1||5||
48309014|NCT01301456|101084515|FG006|STARTED|Stage 1||8||
48309015|NCT01301456|101084516|FG007|STARTED|Stage 1||0||
48309016|NCT01301456|101084517|FG008|STARTED|Stage 1||0||
48309017|NCT01301456|101084518|FG009|STARTED|Stage 1||0||
48309018|NCT01301456|101084519|FG010|STARTED|Stage 1||0||
48309019|NCT01301456|101084520|FG011|STARTED|Stage 1||0||
48309020|NCT01301456|101084509|FG000|Received Treatment|Stage 1||15||
48309021|NCT01301456|101084510|FG001|Received Treatment|Stage 1||5||
48309022|NCT01301456|101084511|FG002|Received Treatment|Stage 1||6||
48309023|NCT01301456|101084512|FG003|Received Treatment|Stage 1||6||
48309024|NCT01301456|101084513|FG004|Received Treatment|Stage 1||7||
48309025|NCT01301456|101084514|FG005|Received Treatment|Stage 1||5||
48309026|NCT01301456|101084515|FG006|Received Treatment|Stage 1||7||
48309027|NCT01301456|101084516|FG007|Received Treatment|Stage 1||0||
48309028|NCT01301456|101084517|FG008|Received Treatment|Stage 1||0||
48309029|NCT01301456|101084518|FG009|Received Treatment|Stage 1||0||
48309030|NCT01301456|101084519|FG010|Received Treatment|Stage 1||0||
48309031|NCT01301456|101084520|FG011|Received Treatment|Stage 1||0||
48309032|NCT01301456|101084509|FG000|COMPLETED|Stage 1||15||
48309033|NCT01301456|101084510|FG001|COMPLETED|Stage 1||5||
48309034|NCT01301456|101084511|FG002|COMPLETED|Stage 1||5||
48309035|NCT01301456|101084512|FG003|COMPLETED|Stage 1||6||
48309036|NCT01301456|101084513|FG004|COMPLETED|Stage 1||6||
48309037|NCT01301456|101084514|FG005|COMPLETED|Stage 1||5||
48309038|NCT01301456|101084515|FG006|COMPLETED|Stage 1||7||
48309039|NCT01301456|101084516|FG007|COMPLETED|Stage 1||0||
48309040|NCT01301456|101084517|FG008|COMPLETED|Stage 1||0||
48309041|NCT01301456|101084518|FG009|COMPLETED|Stage 1||0||
48309042|NCT01301456|101084519|FG010|COMPLETED|Stage 1||0||
48309043|NCT01301456|101084520|FG011|COMPLETED|Stage 1||0||
48309044|NCT01301456|101084509|FG000|NOT COMPLETED|Stage 1||0||
48309045|NCT01301456|101084510|FG001|NOT COMPLETED|Stage 1||0||
48723512|NCT03335254|102108383|FG019|STARTED|Period 1||0||
48723513|NCT03335254|102108364|FG000|COMPLETED|Period 1||9||
48723514|NCT03335254|102108365|FG001|COMPLETED|Period 1||0||
48309046|NCT01301456|101084511|FG002|NOT COMPLETED|Stage 1||1||
48309047|NCT01301456|101084512|FG003|NOT COMPLETED|Stage 1||0||
48309048|NCT01301456|101084513|FG004|NOT COMPLETED|Stage 1||1||
48309049|NCT01301456|101084514|FG005|NOT COMPLETED|Stage 1||0||
48309050|NCT01301456|101084515|FG006|NOT COMPLETED|Stage 1||1||
48309051|NCT01301456|101084516|FG007|NOT COMPLETED|Stage 1||0||
48309052|NCT01301456|101084517|FG008|NOT COMPLETED|Stage 1||0||
48309053|NCT01301456|101084518|FG009|NOT COMPLETED|Stage 1||0||
48309054|NCT01301456|101084519|FG010|NOT COMPLETED|Stage 1||0||
48309055|NCT01301456|101084520|FG011|NOT COMPLETED|Stage 1||0||
48309056|NCT01301456|101084509|FG000|STARTED|Stage 2||0||
48309057|NCT01301456|101084510|FG001|STARTED|Stage 2||0||
48309058|NCT01301456|101084511|FG002|STARTED|Stage 2||0||
48309059|NCT01301456|101084512|FG003|STARTED|Stage 2||0||
48309060|NCT01301456|101084513|FG004|STARTED|Stage 2||0||
48309061|NCT01301456|101084514|FG005|STARTED|Stage 2||0||
48309062|NCT01301456|101084515|FG006|STARTED|Stage 2||0||
48309063|NCT01301456|101084516|FG007|STARTED|Stage 2||7||
48309064|NCT01301456|101084517|FG008|STARTED|Stage 2||5||
48309065|NCT01301456|101084518|FG009|STARTED|Stage 2||7||
48309066|NCT01301456|101084519|FG010|STARTED|Stage 2||7||
48309067|NCT01301456|101084520|FG011|STARTED|Stage 2||6||
48309068|NCT01301456|101084509|FG000|Received Treatment|Stage 2||0||
48309069|NCT01301456|101084510|FG001|Received Treatment|Stage 2||0||
48309070|NCT01301456|101084511|FG002|Received Treatment|Stage 2||0||
48309071|NCT01301456|101084512|FG003|Received Treatment|Stage 2||0||
48309072|NCT01301456|101084513|FG004|Received Treatment|Stage 2||0||
48723515|NCT03335254|102108366|FG002|COMPLETED|Period 1||0||
48723516|NCT03335254|102108367|FG003|COMPLETED|Period 1||0||
48309073|NCT01301456|101084514|FG005|Received Treatment|Stage 2||0||
48309074|NCT01301456|101084515|FG006|Received Treatment|Stage 2||0||
48309075|NCT01301456|101084516|FG007|Received Treatment|Stage 2||7||
48309076|NCT01301456|101084517|FG008|Received Treatment|Stage 2||5||
48309077|NCT01301456|101084518|FG009|Received Treatment|Stage 2||7||
48309078|NCT01301456|101084519|FG010|Received Treatment|Stage 2||7||
48309079|NCT01301456|101084520|FG011|Received Treatment|Stage 2||6||
48309080|NCT01301456|101084509|FG000|COMPLETED|Stage 2||0||
48723517|NCT03335254|102108368|FG004|COMPLETED|Period 1||0||
48723518|NCT03335254|102108369|FG005|COMPLETED|Period 1||0||
48723519|NCT03335254|102108370|FG006|COMPLETED|Period 1||0||
48723520|NCT03335254|102108371|FG007|COMPLETED|Period 1||0||
48723521|NCT03335254|102108372|FG008|COMPLETED|Period 1||0||
48723522|NCT03335254|102108373|FG009|COMPLETED|Period 1||0||
48723523|NCT03335254|102108374|FG010|COMPLETED|Period 1||0||
48723524|NCT03335254|102108375|FG011|COMPLETED|Period 1||0||
48723525|NCT03335254|102108376|FG012|COMPLETED|Period 1||0||
48723526|NCT03335254|102108377|FG013|COMPLETED|Period 1||0||
48723527|NCT03335254|102108378|FG014|COMPLETED|Period 1||0||
48723528|NCT03335254|102108379|FG015|COMPLETED|Period 1||0||
48723529|NCT03335254|102108380|FG016|COMPLETED|Period 1||0||
48723530|NCT03335254|102108381|FG017|COMPLETED|Period 1||0||
48723531|NCT03335254|102108382|FG018|COMPLETED|Period 1||0||
48723532|NCT03335254|102108383|FG019|COMPLETED|Period 1||0||
48723533|NCT03335254|102108364|FG000|NOT COMPLETED|Period 1||0||
48723534|NCT03335254|102108365|FG001|NOT COMPLETED|Period 1||0||
48723535|NCT03335254|102108366|FG002|NOT COMPLETED|Period 1||0||
48723536|NCT03335254|102108367|FG003|NOT COMPLETED|Period 1||0||
48723537|NCT03335254|102108368|FG004|NOT COMPLETED|Period 1||0||
48723538|NCT03335254|102108369|FG005|NOT COMPLETED|Period 1||0||
48723539|NCT03335254|102108370|FG006|NOT COMPLETED|Period 1||0||
48723540|NCT03335254|102108371|FG007|NOT COMPLETED|Period 1||0||
48723541|NCT03335254|102108372|FG008|NOT COMPLETED|Period 1||0||
48723542|NCT03335254|102108373|FG009|NOT COMPLETED|Period 1||0||
48723543|NCT03335254|102108374|FG010|NOT COMPLETED|Period 1||0||
48723544|NCT03335254|102108375|FG011|NOT COMPLETED|Period 1||0||
48723545|NCT03335254|102108376|FG012|NOT COMPLETED|Period 1||0||
48723546|NCT03335254|102108377|FG013|NOT COMPLETED|Period 1||0||
48723547|NCT03335254|102108378|FG014|NOT COMPLETED|Period 1||0||
48723548|NCT03335254|102108379|FG015|NOT COMPLETED|Period 1||0||
48723549|NCT03335254|102108380|FG016|NOT COMPLETED|Period 1||0||
48723550|NCT03335254|102108381|FG017|NOT COMPLETED|Period 1||0||
48723551|NCT03335254|102108382|FG018|NOT COMPLETED|Period 1||0||
48723552|NCT03335254|102108383|FG019|NOT COMPLETED|Period 1||0||
48723553|NCT03335254|102108364|FG000|STARTED|Period 2, Day 1-15||9||
48723554|NCT03335254|102108365|FG001|STARTED|Period 2, Day 1-15||0||
48723555|NCT03335254|102108366|FG002|STARTED|Period 2, Day 1-15||0||
48723556|NCT03335254|102108367|FG003|STARTED|Period 2, Day 1-15||0||
48723557|NCT03335254|102108368|FG004|STARTED|Period 2, Day 1-15||0||
48723558|NCT03335254|102108369|FG005|STARTED|Period 2, Day 1-15||0||
48723559|NCT03335254|102108370|FG006|STARTED|Period 2, Day 1-15||0||
48723560|NCT03335254|102108371|FG007|STARTED|Period 2, Day 1-15||0||
48723561|NCT03335254|102108372|FG008|STARTED|Period 2, Day 1-15||0||
48723562|NCT03335254|102108373|FG009|STARTED|Period 2, Day 1-15||0||
48723563|NCT03335254|102108374|FG010|STARTED|Period 2, Day 1-15||0||
48723564|NCT03335254|102108375|FG011|STARTED|Period 2, Day 1-15||0||
48723565|NCT03335254|102108376|FG012|STARTED|Period 2, Day 1-15||0||
48723566|NCT03335254|102108377|FG013|STARTED|Period 2, Day 1-15||0||
48723567|NCT03335254|102108378|FG014|STARTED|Period 2, Day 1-15||0||
48723568|NCT03335254|102108379|FG015|STARTED|Period 2, Day 1-15||0||
48723569|NCT03335254|102108380|FG016|STARTED|Period 2, Day 1-15||0||
48723570|NCT03335254|102108381|FG017|STARTED|Period 2, Day 1-15||0||
48723571|NCT03335254|102108382|FG018|STARTED|Period 2, Day 1-15||0||
48723572|NCT03335254|102108383|FG019|STARTED|Period 2, Day 1-15||0||
48723573|NCT03335254|102108364|FG000|COMPLETED|Period 2, Day 1-15||9||
48309081|NCT01301456|101084510|FG001|COMPLETED|Stage 2||0||
48309082|NCT01301456|101084511|FG002|COMPLETED|Stage 2||0||
48309083|NCT01301456|101084512|FG003|COMPLETED|Stage 2||0||
48309084|NCT01301456|101084513|FG004|COMPLETED|Stage 2||0||
48309085|NCT01301456|101084514|FG005|COMPLETED|Stage 2||0||
48309086|NCT01301456|101084515|FG006|COMPLETED|Stage 2||0||
48309087|NCT01301456|101084516|FG007|COMPLETED|Stage 2||7||
48309088|NCT01301456|101084517|FG008|COMPLETED|Stage 2||5||
48723574|NCT03335254|102108365|FG001|COMPLETED|Period 2, Day 1-15||0||
48723575|NCT03335254|102108366|FG002|COMPLETED|Period 2, Day 1-15||0||
48723576|NCT03335254|102108367|FG003|COMPLETED|Period 2, Day 1-15||0||
48723577|NCT03335254|102108368|FG004|COMPLETED|Period 2, Day 1-15||0||
48723578|NCT03335254|102108369|FG005|COMPLETED|Period 2, Day 1-15||0||
48723579|NCT03335254|102108370|FG006|COMPLETED|Period 2, Day 1-15||0||
48723580|NCT03335254|102108371|FG007|COMPLETED|Period 2, Day 1-15||0||
48723581|NCT03335254|102108372|FG008|COMPLETED|Period 2, Day 1-15||0||
48723582|NCT03335254|102108373|FG009|COMPLETED|Period 2, Day 1-15||0||
48723583|NCT03335254|102108374|FG010|COMPLETED|Period 2, Day 1-15||0||
48723584|NCT03335254|102108375|FG011|COMPLETED|Period 2, Day 1-15||0||
48723585|NCT03335254|102108376|FG012|COMPLETED|Period 2, Day 1-15||0||
48723586|NCT03335254|102108377|FG013|COMPLETED|Period 2, Day 1-15||0||
48723587|NCT03335254|102108378|FG014|COMPLETED|Period 2, Day 1-15||0||
48309089|NCT01301456|101084518|FG009|COMPLETED|Stage 2||7||
48309090|NCT01301456|101084519|FG010|COMPLETED|Stage 2||6||
48309091|NCT01301456|101084520|FG011|COMPLETED|Stage 2||6||
48723588|NCT03335254|102108379|FG015|COMPLETED|Period 2, Day 1-15||0||
48723589|NCT03335254|102108380|FG016|COMPLETED|Period 2, Day 1-15||0||
48723590|NCT03335254|102108381|FG017|COMPLETED|Period 2, Day 1-15||0||
48723591|NCT03335254|102108382|FG018|COMPLETED|Period 2, Day 1-15||0||
48723592|NCT03335254|102108383|FG019|COMPLETED|Period 2, Day 1-15||0||
48723593|NCT03335254|102108364|FG000|NOT COMPLETED|Period 2, Day 1-15||0||
48309092|NCT01301456|101084509|FG000|NOT COMPLETED|Stage 2||0||
48309093|NCT01301456|101084510|FG001|NOT COMPLETED|Stage 2||0||
48309094|NCT01301456|101084511|FG002|NOT COMPLETED|Stage 2||0||
48309095|NCT01301456|101084512|FG003|NOT COMPLETED|Stage 2||0||
48723594|NCT03335254|102108365|FG001|NOT COMPLETED|Period 2, Day 1-15||0||
48723595|NCT03335254|102108366|FG002|NOT COMPLETED|Period 2, Day 1-15||0||
48723596|NCT03335254|102108367|FG003|NOT COMPLETED|Period 2, Day 1-15||0||
48723597|NCT03335254|102108368|FG004|NOT COMPLETED|Period 2, Day 1-15||0||
48723598|NCT03335254|102108369|FG005|NOT COMPLETED|Period 2, Day 1-15||0||
48723599|NCT03335254|102108370|FG006|NOT COMPLETED|Period 2, Day 1-15||0||
48723600|NCT03335254|102108371|FG007|NOT COMPLETED|Period 2, Day 1-15||0||
48723601|NCT03335254|102108372|FG008|NOT COMPLETED|Period 2, Day 1-15||0||
48723602|NCT03335254|102108373|FG009|NOT COMPLETED|Period 2, Day 1-15||0||
48723603|NCT03335254|102108374|FG010|NOT COMPLETED|Period 2, Day 1-15||0||
48723604|NCT03335254|102108375|FG011|NOT COMPLETED|Period 2, Day 1-15||0||
48723605|NCT03335254|102108376|FG012|NOT COMPLETED|Period 2, Day 1-15||0||
48723606|NCT03335254|102108377|FG013|NOT COMPLETED|Period 2, Day 1-15||0||
48723607|NCT03335254|102108378|FG014|NOT COMPLETED|Period 2, Day 1-15||0||
48723608|NCT03335254|102108379|FG015|NOT COMPLETED|Period 2, Day 1-15||0||
48723609|NCT03335254|102108380|FG016|NOT COMPLETED|Period 2, Day 1-15||0||
48723610|NCT03335254|102108381|FG017|NOT COMPLETED|Period 2, Day 1-15||0||
48723611|NCT03335254|102108382|FG018|NOT COMPLETED|Period 2, Day 1-15||0||
48723612|NCT03335254|102108383|FG019|NOT COMPLETED|Period 2, Day 1-15||0||
48309096|NCT01301456|101084513|FG004|NOT COMPLETED|Stage 2||0||
48723613|NCT03335254|102108364|FG000|STARTED|Period 3, Day 16-25||9||
48723614|NCT03335254|102108365|FG001|STARTED|Period 3, Day 16-25||0||
48723615|NCT03335254|102108366|FG002|STARTED|Period 3, Day 16-25||0||
48723616|NCT03335254|102108367|FG003|STARTED|Period 3, Day 16-25||0||
48723617|NCT03335254|102108368|FG004|STARTED|Period 3, Day 16-25||0||
48723618|NCT03335254|102108369|FG005|STARTED|Period 3, Day 16-25||0||
48723619|NCT03335254|102108370|FG006|STARTED|Period 3, Day 16-25||0||
48723620|NCT03335254|102108371|FG007|STARTED|Period 3, Day 16-25||0||
48723621|NCT03335254|102108372|FG008|STARTED|Period 3, Day 16-25||0||
48723622|NCT03335254|102108373|FG009|STARTED|Period 3, Day 16-25||0||
48723623|NCT03335254|102108374|FG010|STARTED|Period 3, Day 16-25||0||
48723624|NCT03335254|102108375|FG011|STARTED|Period 3, Day 16-25||0||
48723625|NCT03335254|102108376|FG012|STARTED|Period 3, Day 16-25||0||
48723626|NCT03335254|102108377|FG013|STARTED|Period 3, Day 16-25||0||
48723627|NCT03335254|102108378|FG014|STARTED|Period 3, Day 16-25||0||
48309097|NCT01301456|101084514|FG005|NOT COMPLETED|Stage 2||0||
48309098|NCT01301456|101084515|FG006|NOT COMPLETED|Stage 2||0||
48309099|NCT01301456|101084516|FG007|NOT COMPLETED|Stage 2||0||
48309100|NCT01301456|101084517|FG008|NOT COMPLETED|Stage 2||0||
48309101|NCT01301456|101084518|FG009|NOT COMPLETED|Stage 2||0||
48309102|NCT01301456|101084519|FG010|NOT COMPLETED|Stage 2||1||
48309103|NCT01301456|101084520|FG011|NOT COMPLETED|Stage 2||0||
48309104|NCT00709111|101084521|FG000|STARTED|Overall Study||34||
48309105|NCT00709111|101084521|FG000|Week 22/24|Overall Study||33||
48723628|NCT03335254|102108379|FG015|STARTED|Period 3, Day 16-25||0||
48723629|NCT03335254|102108380|FG016|STARTED|Period 3, Day 16-25||0||
48723630|NCT03335254|102108381|FG017|STARTED|Period 3, Day 16-25||0||
48723631|NCT03335254|102108382|FG018|STARTED|Period 3, Day 16-25||0||
48723632|NCT03335254|102108383|FG019|STARTED|Period 3, Day 16-25||0||
48723633|NCT03335254|102108364|FG000|COMPLETED|Period 3, Day 16-25||9||
48309106|NCT00709111|101084521|FG000|COMPLETED|Overall Study||32||
48309107|NCT00709111|101084521|FG000|NOT COMPLETED|Overall Study||2||
48723634|NCT03335254|102108365|FG001|COMPLETED|Period 3, Day 16-25||0||
48723635|NCT03335254|102108366|FG002|COMPLETED|Period 3, Day 16-25||0||
48723636|NCT03335254|102108367|FG003|COMPLETED|Period 3, Day 16-25||0||
48723637|NCT03335254|102108368|FG004|COMPLETED|Period 3, Day 16-25||0||
48723638|NCT03335254|102108369|FG005|COMPLETED|Period 3, Day 16-25||0||
48723639|NCT03335254|102108370|FG006|COMPLETED|Period 3, Day 16-25||0||
48723640|NCT03335254|102108371|FG007|COMPLETED|Period 3, Day 16-25||0||
48723641|NCT03335254|102108372|FG008|COMPLETED|Period 3, Day 16-25||0||
48723642|NCT03335254|102108373|FG009|COMPLETED|Period 3, Day 16-25||0||
48723643|NCT03335254|102108374|FG010|COMPLETED|Period 3, Day 16-25||0||
48723644|NCT03335254|102108375|FG011|COMPLETED|Period 3, Day 16-25||0||
48723645|NCT03335254|102108376|FG012|COMPLETED|Period 3, Day 16-25||0||
48723646|NCT03335254|102108377|FG013|COMPLETED|Period 3, Day 16-25||0||
48723647|NCT03335254|102108378|FG014|COMPLETED|Period 3, Day 16-25||0||
48723648|NCT03335254|102108379|FG015|COMPLETED|Period 3, Day 16-25||0||
48723649|NCT03335254|102108380|FG016|COMPLETED|Period 3, Day 16-25||0||
48723650|NCT03335254|102108381|FG017|COMPLETED|Period 3, Day 16-25||0||
48723651|NCT03335254|102108382|FG018|COMPLETED|Period 3, Day 16-25||0||
48723652|NCT03335254|102108383|FG019|COMPLETED|Period 3, Day 16-25||0||
48723653|NCT03335254|102108364|FG000|NOT COMPLETED|Period 3, Day 16-25||0||
48723654|NCT03335254|102108365|FG001|NOT COMPLETED|Period 3, Day 16-25||0||
48723655|NCT03335254|102108366|FG002|NOT COMPLETED|Period 3, Day 16-25||0||
48723656|NCT03335254|102108367|FG003|NOT COMPLETED|Period 3, Day 16-25||0||
48723657|NCT03335254|102108368|FG004|NOT COMPLETED|Period 3, Day 16-25||0||
48723658|NCT03335254|102108369|FG005|NOT COMPLETED|Period 3, Day 16-25||0||
48723659|NCT03335254|102108370|FG006|NOT COMPLETED|Period 3, Day 16-25||0||
48723660|NCT03335254|102108371|FG007|NOT COMPLETED|Period 3, Day 16-25||0||
48723661|NCT03335254|102108372|FG008|NOT COMPLETED|Period 3, Day 16-25||0||
48309108|NCT00880555|101084522|FG000|STARTED|Overall Study||23||
48309109|NCT00880555|101084523|FG001|STARTED|Overall Study||40||
48309110|NCT00880555|101084524|FG002|STARTED|Overall Study||11||
48309111|NCT00880555|101084525|FG003|STARTED|Overall Study||2||
48309112|NCT00880555|101084526|FG004|STARTED|Overall Study||1||
48309113|NCT00880555|101084527|FG005|STARTED|Overall Study||1||
48612128|NCT00537290|101838189|FG000|STARTED|Overall Study||19||
48612129|NCT00537290|101838189|FG000|COMPLETED|Overall Study||19||
48612130|NCT00537290|101838189|FG000|NOT COMPLETED|Overall Study||0||
48612131|NCT00547248|101838190|FG000|STARTED|Overall Study||280||
48612132|NCT00547248|101838191|FG001|STARTED|Overall Study||93||
48723662|NCT03335254|102108373|FG009|NOT COMPLETED|Period 3, Day 16-25||0||
48723663|NCT03335254|102108374|FG010|NOT COMPLETED|Period 3, Day 16-25||0||
48723664|NCT03335254|102108375|FG011|NOT COMPLETED|Period 3, Day 16-25||0||
48723665|NCT03335254|102108376|FG012|NOT COMPLETED|Period 3, Day 16-25||0||
48723666|NCT03335254|102108377|FG013|NOT COMPLETED|Period 3, Day 16-25||0||
48723667|NCT03335254|102108378|FG014|NOT COMPLETED|Period 3, Day 16-25||0||
48723668|NCT03335254|102108379|FG015|NOT COMPLETED|Period 3, Day 16-25||0||
48723669|NCT03335254|102108380|FG016|NOT COMPLETED|Period 3, Day 16-25||0||
48723670|NCT03335254|102108381|FG017|NOT COMPLETED|Period 3, Day 16-25||0||
48723671|NCT03335254|102108382|FG018|NOT COMPLETED|Period 3, Day 16-25||0||
48723672|NCT03335254|102108383|FG019|NOT COMPLETED|Period 3, Day 16-25||0||
48723673|NCT03335254|102108364|FG000|STARTED|Period 3, Day 26-30||9||
48723674|NCT03335254|102108365|FG001|STARTED|Period 3, Day 26-30||0||
48723675|NCT03335254|102108366|FG002|STARTED|Period 3, Day 26-30||0||
48723676|NCT03335254|102108367|FG003|STARTED|Period 3, Day 26-30||0||
48723677|NCT03335254|102108368|FG004|STARTED|Period 3, Day 26-30||0||
48723678|NCT03335254|102108369|FG005|STARTED|Period 3, Day 26-30||0||
48723679|NCT03335254|102108370|FG006|STARTED|Period 3, Day 26-30||0||
48723680|NCT03335254|102108371|FG007|STARTED|Period 3, Day 26-30||0||
48723681|NCT03335254|102108372|FG008|STARTED|Period 3, Day 26-30||0||
48723682|NCT03335254|102108373|FG009|STARTED|Period 3, Day 26-30||0||
48723683|NCT03335254|102108374|FG010|STARTED|Period 3, Day 26-30||0||
48723684|NCT03335254|102108375|FG011|STARTED|Period 3, Day 26-30||0||
48723685|NCT03335254|102108376|FG012|STARTED|Period 3, Day 26-30||0||
48723686|NCT03335254|102108377|FG013|STARTED|Period 3, Day 26-30||0||
48723687|NCT03335254|102108378|FG014|STARTED|Period 3, Day 26-30||0||
48723688|NCT03335254|102108379|FG015|STARTED|Period 3, Day 26-30||0||
48723689|NCT03335254|102108380|FG016|STARTED|Period 3, Day 26-30||0||
48723690|NCT03335254|102108381|FG017|STARTED|Period 3, Day 26-30||0||
48723691|NCT03335254|102108382|FG018|STARTED|Period 3, Day 26-30||0||
48723692|NCT03335254|102108383|FG019|STARTED|Period 3, Day 26-30||0||
48723693|NCT03335254|102108364|FG000|COMPLETED|Period 3, Day 26-30||9||
48723694|NCT03335254|102108365|FG001|COMPLETED|Period 3, Day 26-30||0||
48723695|NCT03335254|102108366|FG002|COMPLETED|Period 3, Day 26-30||0||
48723696|NCT03335254|102108367|FG003|COMPLETED|Period 3, Day 26-30||0||
48723697|NCT03335254|102108368|FG004|COMPLETED|Period 3, Day 26-30||0||
48309114|NCT00880555|101084522|FG000|COMPLETED|Overall Study||13||
48612133|NCT00547248|101838192|FG002|STARTED|Overall Study||285||
48723698|NCT03335254|102108369|FG005|COMPLETED|Period 3, Day 26-30||0||
48723699|NCT03335254|102108370|FG006|COMPLETED|Period 3, Day 26-30||0||
48723700|NCT03335254|102108371|FG007|COMPLETED|Period 3, Day 26-30||0||
48723701|NCT03335254|102108372|FG008|COMPLETED|Period 3, Day 26-30||0||
48723702|NCT03335254|102108373|FG009|COMPLETED|Period 3, Day 26-30||0||
48723703|NCT03335254|102108374|FG010|COMPLETED|Period 3, Day 26-30||0||
48723704|NCT03335254|102108375|FG011|COMPLETED|Period 3, Day 26-30||0||
48309115|NCT00880555|101084523|FG001|COMPLETED|Overall Study||23||
48612134|NCT00547248|101838193|FG003|STARTED|Overall Study||98||
48612135|NCT00547248|101838190|FG000|COMPLETED|Overall Study||280||
48612136|NCT00547248|101838191|FG001|COMPLETED|Overall Study||93||
48612137|NCT00547248|101838192|FG002|COMPLETED|Overall Study||275||
48612138|NCT00547248|101838193|FG003|COMPLETED|Overall Study||96||
48612139|NCT00547248|101838190|FG000|NOT COMPLETED|Overall Study||0||
48612140|NCT00547248|101838191|FG001|NOT COMPLETED|Overall Study||0||
48723705|NCT03335254|102108376|FG012|COMPLETED|Period 3, Day 26-30||0||
48723706|NCT03335254|102108377|FG013|COMPLETED|Period 3, Day 26-30||0||
48723707|NCT03335254|102108378|FG014|COMPLETED|Period 3, Day 26-30||0||
48723708|NCT03335254|102108379|FG015|COMPLETED|Period 3, Day 26-30||0||
48723709|NCT03335254|102108380|FG016|COMPLETED|Period 3, Day 26-30||0||
48723710|NCT03335254|102108381|FG017|COMPLETED|Period 3, Day 26-30||0||
48723711|NCT03335254|102108382|FG018|COMPLETED|Period 3, Day 26-30||0||
48723712|NCT03335254|102108383|FG019|COMPLETED|Period 3, Day 26-30||0||
48309116|NCT00880555|101084524|FG002|COMPLETED|Overall Study||6||
48309117|NCT00880555|101084525|FG003|COMPLETED|Overall Study||0||
48309118|NCT00880555|101084526|FG004|COMPLETED|Overall Study||0||
48723713|NCT03335254|102108364|FG000|NOT COMPLETED|Period 3, Day 26-30||0||
48723714|NCT03335254|102108365|FG001|NOT COMPLETED|Period 3, Day 26-30||0||
48723715|NCT03335254|102108366|FG002|NOT COMPLETED|Period 3, Day 26-30||0||
48723716|NCT03335254|102108367|FG003|NOT COMPLETED|Period 3, Day 26-30||0||
48723717|NCT03335254|102108368|FG004|NOT COMPLETED|Period 3, Day 26-30||0||
48723718|NCT03335254|102108369|FG005|NOT COMPLETED|Period 3, Day 26-30||0||
48309119|NCT00880555|101084527|FG005|COMPLETED|Overall Study||0||
48309120|NCT00880555|101084522|FG000|NOT COMPLETED|Overall Study||10||
48309121|NCT00880555|101084523|FG001|NOT COMPLETED|Overall Study||17||
48309122|NCT00880555|101084524|FG002|NOT COMPLETED|Overall Study||5||
48309123|NCT00880555|101084525|FG003|NOT COMPLETED|Overall Study||2||
48309124|NCT00880555|101084526|FG004|NOT COMPLETED|Overall Study||1||
48723719|NCT03335254|102108370|FG006|NOT COMPLETED|Period 3, Day 26-30||0||
48309125|NCT00880555|101084527|FG005|NOT COMPLETED|Overall Study||1||
48309126|NCT00487396|101084528|FG000|STARTED|Overall Study||98||
48309127|NCT00487396|101084528|FG000|COMPLETED|Overall Study||95||
48723720|NCT03335254|102108371|FG007|NOT COMPLETED|Period 3, Day 26-30||0||
48723721|NCT03335254|102108372|FG008|NOT COMPLETED|Period 3, Day 26-30||0||
48723722|NCT03335254|102108373|FG009|NOT COMPLETED|Period 3, Day 26-30||0||
48723723|NCT03335254|102108374|FG010|NOT COMPLETED|Period 3, Day 26-30||0||
48723724|NCT03335254|102108375|FG011|NOT COMPLETED|Period 3, Day 26-30||0||
48723725|NCT03335254|102108376|FG012|NOT COMPLETED|Period 3, Day 26-30||0||
48723726|NCT03335254|102108377|FG013|NOT COMPLETED|Period 3, Day 26-30||0||
48723727|NCT03335254|102108378|FG014|NOT COMPLETED|Period 3, Day 26-30||0||
48723728|NCT03335254|102108379|FG015|NOT COMPLETED|Period 3, Day 26-30||0||
48723729|NCT03335254|102108380|FG016|NOT COMPLETED|Period 3, Day 26-30||0||
48309128|NCT00487396|101084528|FG000|NOT COMPLETED|Overall Study||3||
48309129|NCT01364623|101084529|FG000|STARTED|Single Dose||8||
48309130|NCT01364623|101084530|FG001|STARTED|Single Dose||8||
48723730|NCT03335254|102108381|FG017|NOT COMPLETED|Period 3, Day 26-30||0||
48723731|NCT03335254|102108382|FG018|NOT COMPLETED|Period 3, Day 26-30||0||
48723732|NCT03335254|102108383|FG019|NOT COMPLETED|Period 3, Day 26-30||0||
48723733|NCT00687102|102108384|FG000|STARTED|Overall Study||733||
48723734|NCT00687102|102108385|FG001|STARTED|Overall Study||765||
48723735|NCT00687102|102108384|FG000|COMPLETED|Overall Study||733||
48723736|NCT00687102|102108385|FG001|COMPLETED|Overall Study||765||
48723737|NCT00687102|102108384|FG000|NOT COMPLETED|Overall Study||0||
48723738|NCT00687102|102108385|FG001|NOT COMPLETED|Overall Study||0||
48309131|NCT01364623|101084531|FG002|STARTED|Single Dose||8||
48309132|NCT01364623|101084532|FG003|STARTED|Single Dose||0||
48309133|NCT01364623|101084529|FG000|COMPLETED|Single Dose||8||
48309134|NCT01364623|101084530|FG001|COMPLETED|Single Dose||8||
48309135|NCT01364623|101084531|FG002|COMPLETED|Single Dose||8||
48309136|NCT01364623|101084532|FG003|COMPLETED|Single Dose||0||
48723739|NCT00671437|102108386|FG000|STARTED|Overall Study||42||
48723740|NCT00671437|102108386|FG000|COMPLETED|Overall Study||27||
48309137|NCT01364623|101084529|FG000|NOT COMPLETED|Single Dose||0||
48723741|NCT00671437|102108386|FG000|NOT COMPLETED|Overall Study||15||
48309138|NCT01364623|101084530|FG001|NOT COMPLETED|Single Dose||0||
48309139|NCT01364623|101084531|FG002|NOT COMPLETED|Single Dose||0||
48723742|NCT00141115|102108387|FG000|STARTED|Overall Study||3||
48723743|NCT00141115|102108387|FG000|COMPLETED|Overall Study||2||
48723744|NCT00141115|102108387|FG000|NOT COMPLETED|Overall Study||1||
48723745|NCT02561221|102108388|FG000|STARTED|Overall Study||452||9
48723746|NCT02561221|102108389|FG001|STARTED|Overall Study||351||9
48723747|NCT02561221|102108388|FG000|Month 6|Overall Study||386||9
48723748|NCT02561221|102108389|FG001|Month 6|Overall Study||340||9
48723749|NCT02561221|102108388|FG000|Month 12|Overall Study||365||9
48723750|NCT02561221|102108389|FG001|Month 12|Overall Study||326||9
48309140|NCT01364623|101084532|FG003|NOT COMPLETED|Single Dose||0||
48309141|NCT01364623|101084529|FG000|STARTED|Multiple Dose||0||
48309142|NCT01364623|101084530|FG001|STARTED|Multiple Dose||0||
48309143|NCT01364623|101084531|FG002|STARTED|Multiple Dose||0||
48309144|NCT01364623|101084532|FG003|STARTED|Multiple Dose||8||
48309145|NCT01364623|101084529|FG000|COMPLETED|Multiple Dose||0||
48309146|NCT01364623|101084530|FG001|COMPLETED|Multiple Dose||0||
48723751|NCT02561221|102108388|FG000|Month 18|Overall Study||357||9
48723752|NCT02561221|102108389|FG001|Month 18|Overall Study||316||9
48309147|NCT01364623|101084531|FG002|COMPLETED|Multiple Dose||0||
48309148|NCT01364623|101084532|FG003|COMPLETED|Multiple Dose||8||
48309149|NCT01364623|101084529|FG000|NOT COMPLETED|Multiple Dose||0||
48309150|NCT01364623|101084530|FG001|NOT COMPLETED|Multiple Dose||0||
48723753|NCT02561221|102108388|FG000|COMPLETED|Overall Study||362||9
48723754|NCT02561221|102108389|FG001|COMPLETED|Overall Study||308||9
48723755|NCT02561221|102108388|FG000|NOT COMPLETED|Overall Study||90||0
48723756|NCT02561221|102108389|FG001|NOT COMPLETED|Overall Study||43||0
48723757|NCT01177969|102108390|FG000|STARTED|Overall Study||19||
48723758|NCT01177969|102108391|FG001|STARTED|Overall Study||14||
48309151|NCT01364623|101084531|FG002|NOT COMPLETED|Multiple Dose||0||
48309152|NCT01364623|101084532|FG003|NOT COMPLETED|Multiple Dose||0||
48723759|NCT01177969|102108390|FG000|COMPLETED|Overall Study||16||
48723760|NCT01177969|102108391|FG001|COMPLETED|Overall Study||11||
48406559|NCT02603172|101328441|FG002|STARTED|Part C (Approximately 13 Weeks)||0||
48723761|NCT01177969|102108390|FG000|NOT COMPLETED|Overall Study||3||
48723762|NCT01177969|102108391|FG001|NOT COMPLETED|Overall Study||3||
48723763|NCT03907033|102108392|FG000|STARTED|Overall Study||14||
48723764|NCT03907033|102108393|FG001|STARTED|Overall Study||14||
48723765|NCT03907033|102108392|FG000|COMPLETED|Overall Study||14||
48723766|NCT03907033|102108393|FG001|COMPLETED|Overall Study||14||
48723767|NCT03907033|102108392|FG000|NOT COMPLETED|Overall Study||0||
48723768|NCT03907033|102108393|FG001|NOT COMPLETED|Overall Study||0||
48723769|NCT00541346|102108394|FG000|STARTED|Baseline||16||
48723770|NCT00541346|102108394|FG000|COMPLETED|Baseline||16||
48723771|NCT00541346|102108394|FG000|NOT COMPLETED|Baseline||0||
48723772|NCT00541346|102108394|FG000|STARTED|Follow-up||16||
48723773|NCT00541346|102108394|FG000|COMPLETED|Follow-up||15||
48723774|NCT00541346|102108394|FG000|NOT COMPLETED|Follow-up||1||
48723775|NCT02636712|102108395|FG000|STARTED|Overall Study||10||
48723776|NCT02636712|102108395|FG000|COMPLETED|Overall Study||10||
48723777|NCT02636712|102108395|FG000|NOT COMPLETED|Overall Study||0||
48723778|NCT04046250|102108396|FG000|STARTED|Overall Study||11||
48723779|NCT04046250|102108397|FG001|STARTED|Overall Study||11||
48723780|NCT04046250|102108396|FG000|COMPLETED|Overall Study||8||
48723781|NCT04046250|102108397|FG001|COMPLETED|Overall Study||7||
48723782|NCT04046250|102108396|FG000|NOT COMPLETED|Overall Study||3||
48723783|NCT04046250|102108397|FG001|NOT COMPLETED|Overall Study||4||
48723784|NCT01549873|102108398|FG000|STARTED|Overall Study||15||
48723785|NCT01549873|102108399|FG001|STARTED|Overall Study||15||
48723786|NCT01549873|102108398|FG000|COMPLETED|Overall Study||15||
48723787|NCT01549873|102108399|FG001|COMPLETED|Overall Study||14||
48406560|NCT02603172|101328442|FG003|STARTED|Part C (Approximately 13 Weeks)||0||
48406561|NCT02603172|101328443|FG004|STARTED|Part C (Approximately 13 Weeks)||0||
48406562|NCT02603172|101328444|FG005|STARTED|Part C (Approximately 13 Weeks)||0||
48723788|NCT01549873|102108398|FG000|NOT COMPLETED|Overall Study||0||
48723789|NCT01549873|102108399|FG001|NOT COMPLETED|Overall Study||1||
48723790|NCT01302054|102108400|FG000|STARTED|Tolterodine Open-Label Run-In Phase||990||
48723791|NCT01302054|102108401|FG001|STARTED|Tolterodine Open-Label Run-In Phase||0||
48723792|NCT01302054|102108402|FG002|STARTED|Tolterodine Open-Label Run-In Phase||0||
48723793|NCT01302054|102108400|FG000|COMPLETED|Tolterodine Open-Label Run-In Phase||611||
48723794|NCT01302054|102108401|FG001|COMPLETED|Tolterodine Open-Label Run-In Phase||0||
48723795|NCT01302054|102108402|FG002|COMPLETED|Tolterodine Open-Label Run-In Phase||0||
48723796|NCT01302054|102108400|FG000|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||379||
48723797|NCT01302054|102108401|FG001|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0||
48723798|NCT01302054|102108402|FG002|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0||
48723799|NCT01302054|102108400|FG000|STARTED|Between Open-Label and Double Blind||611||
48723800|NCT01302054|102108401|FG001|STARTED|Between Open-Label and Double Blind||0||
48723801|NCT01302054|102108402|FG002|STARTED|Between Open-Label and Double Blind||0||
48723802|NCT01302054|102108400|FG000|COMPLETED|Between Open-Label and Double Blind||609||
48723803|NCT01302054|102108401|FG001|COMPLETED|Between Open-Label and Double Blind||0||
48723804|NCT01302054|102108402|FG002|COMPLETED|Between Open-Label and Double Blind||0||
48723805|NCT01302054|102108400|FG000|NOT COMPLETED|Between Open-Label and Double Blind||2||
48723806|NCT01302054|102108401|FG001|NOT COMPLETED|Between Open-Label and Double Blind||0||
48723807|NCT01302054|102108402|FG002|NOT COMPLETED|Between Open-Label and Double Blind||0||
48723808|NCT01302054|102108400|FG000|STARTED|Double-Blind Treatment Phase||0||
48723809|NCT01302054|102108401|FG001|STARTED|Double-Blind Treatment Phase||308||
48723810|NCT01302054|102108402|FG002|STARTED|Double-Blind Treatment Phase||301||
48406563|NCT02603172|101328445|FG006|STARTED|Part C (Approximately 13 Weeks)||0||
48406564|NCT02603172|101328446|FG007|STARTED|Part C (Approximately 13 Weeks)||0||
48723811|NCT01302054|102108400|FG000|COMPLETED|Double-Blind Treatment Phase||0||
48723812|NCT01302054|102108401|FG001|COMPLETED|Double-Blind Treatment Phase||281||
48723813|NCT01302054|102108402|FG002|COMPLETED|Double-Blind Treatment Phase||255||
48723814|NCT01302054|102108400|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0||
48723815|NCT01302054|102108401|FG001|NOT COMPLETED|Double-Blind Treatment Phase||27||
48723816|NCT01302054|102108402|FG002|NOT COMPLETED|Double-Blind Treatment Phase||46||
48723817|NCT00483041|102108403|FG000|STARTED|Overall Study||5||
48723818|NCT00483041|102108404|FG001|STARTED|Overall Study||6||
48723819|NCT00483041|102108403|FG000|COMPLETED|Overall Study||5||
48723820|NCT00483041|102108404|FG001|COMPLETED|Overall Study||5||
48309153|NCT01671423|101084533|FG000|STARTED|Overall Study||20||
48309154|NCT01671423|101084534|FG001|STARTED|Overall Study||20||
48309155|NCT01671423|101084533|FG000|COMPLETED|Overall Study||14||
48723821|NCT00483041|102108403|FG000|NOT COMPLETED|Overall Study||0||
48723822|NCT00483041|102108404|FG001|NOT COMPLETED|Overall Study||1||
48723823|NCT01278407|102108405|FG000|STARTED|Confirmatory Phase||46||
48723824|NCT01278407|102108406|FG001|STARTED|Confirmatory Phase||47||
48723825|NCT01278407|102108407|FG002|STARTED|Confirmatory Phase||49||
48723826|NCT01278407|102108408|FG003|STARTED|Confirmatory Phase||0||
48723827|NCT01278407|102108409|FG004|STARTED|Confirmatory Phase||0||
48723828|NCT01278407|102108405|FG000|COMPLETED|Confirmatory Phase||37||
48309156|NCT01671423|101084534|FG001|COMPLETED|Overall Study||9||
48309157|NCT01671423|101084533|FG000|NOT COMPLETED|Overall Study||6||
48309158|NCT01671423|101084534|FG001|NOT COMPLETED|Overall Study||11||
48309159|NCT01495858|101084535|FG000|STARTED|Overall Study||107||
48309160|NCT01495858|101084536|FG001|STARTED|Overall Study||106||
48309161|NCT01495858|101084537|FG002|STARTED|Overall Study||54||
48309162|NCT01495858|101084535|FG000|COMPLETED|Overall Study||107||
48309163|NCT01495858|101084536|FG001|COMPLETED|Overall Study||106||
48309164|NCT01495858|101084537|FG002|COMPLETED|Overall Study||54||
48309165|NCT01495858|101084535|FG000|NOT COMPLETED|Overall Study||0||
48309166|NCT01495858|101084536|FG001|NOT COMPLETED|Overall Study||0||
48309167|NCT01495858|101084537|FG002|NOT COMPLETED|Overall Study||0||
48309168|NCT02014740|101084538|FG000|STARTED|Overall Study||55||
48309169|NCT02014740|101084539|FG001|STARTED|Overall Study||45||
48309170|NCT02014740|101084538|FG000|COMPLETED|Overall Study||49||
48309171|NCT02014740|101084539|FG001|COMPLETED|Overall Study||40||
48309172|NCT02014740|101084538|FG000|NOT COMPLETED|Overall Study||6||
48309173|NCT02014740|101084539|FG001|NOT COMPLETED|Overall Study||5||
48309174|NCT04901481|101084540|FG000|STARTED|Overall Study||6||
48309175|NCT04901481|101084541|FG001|STARTED|Overall Study||6||
48309176|NCT04901481|101084540|FG000|COMPLETED|Overall Study||6||
48309177|NCT04901481|101084541|FG001|COMPLETED|Overall Study||6||
48309178|NCT04901481|101084540|FG000|NOT COMPLETED|Overall Study||0||
48309179|NCT04901481|101084541|FG001|NOT COMPLETED|Overall Study||0||
48309180|NCT00393796|101084542|FG000|STARTED|Double Blind Period||26||
48309181|NCT00393796|101084543|FG001|STARTED|Double Blind Period||28||
48309182|NCT00393796|101084542|FG000|COMPLETED|Double Blind Period||26||
48309183|NCT00393796|101084543|FG001|COMPLETED|Double Blind Period||28||
48309184|NCT00393796|101084542|FG000|NOT COMPLETED|Double Blind Period||0||
48309185|NCT00393796|101084543|FG001|NOT COMPLETED|Double Blind Period||0||
48309186|NCT00393796|101084542|FG000|STARTED|Open Label Period - Placebo to SUTENT||0||
48309187|NCT00393796|101084543|FG001|STARTED|Open Label Period - Placebo to SUTENT||16||
48309188|NCT00393796|101084542|FG000|COMPLETED|Open Label Period - Placebo to SUTENT||0||
48309189|NCT00393796|101084543|FG001|COMPLETED|Open Label Period - Placebo to SUTENT||16||
48309190|NCT00393796|101084542|FG000|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0||
48309191|NCT00393796|101084543|FG001|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0||
48309192|NCT02281357|101084544|FG000|STARTED|Overall Study||70||
48309193|NCT02281357|101084545|FG001|STARTED|Overall Study||70||
48309194|NCT02281357|101084544|FG000|COMPLETED|Overall Study||63|Patients who completed treatment and patients who discontinued treatment but completed the study.|
48309195|NCT02281357|101084545|FG001|COMPLETED|Overall Study||66|Patients who completed treatment and patients who discontinued treatment but completed the study.|
48309196|NCT02281357|101084544|FG000|NOT COMPLETED|Overall Study||7||
48723829|NCT01278407|102108406|FG001|COMPLETED|Confirmatory Phase||31||
48723830|NCT01278407|102108407|FG002|COMPLETED|Confirmatory Phase||43||
48309197|NCT02281357|101084545|FG001|NOT COMPLETED|Overall Study||4||
48723831|NCT01278407|102108408|FG003|COMPLETED|Confirmatory Phase||0||
48309198|NCT02906787|101084546|FG000|STARTED|Overall Study||142||
48309199|NCT02906787|101084547|FG001|STARTED|Overall Study||146||
48309200|NCT02906787|101084546|FG000|EOT|Overall Study||106||
48309201|NCT02906787|101084547|FG001|EOT|Overall Study||112||
48309202|NCT02906787|101084546|FG000|3-month Follow-up|Overall Study||106||
48309203|NCT02906787|101084547|FG001|3-month Follow-up|Overall Study||114||
48309204|NCT02906787|101084546|FG000|Enrolled in Neuroimaging Sub-study|Overall Study||31||
48309205|NCT02906787|101084547|FG001|Enrolled in Neuroimaging Sub-study|Overall Study||28||
48309206|NCT02906787|101084546|FG000|Neuroimaging Sub-study: Completed Scan 1|Overall Study||30||
48309207|NCT02906787|101084547|FG001|Neuroimaging Sub-study: Completed Scan 1|Overall Study||26||
48309208|NCT02906787|101084546|FG000|Neuroimaging Sub-study: Completed Scan 2|Overall Study||25||
48309209|NCT02906787|101084547|FG001|Neuroimaging Sub-study: Completed Scan 2|Overall Study||20||
48309210|NCT02906787|101084546|FG000|Neuroimaging Sub-study: Completed EOT|Overall Study||25||
48309211|NCT02906787|101084547|FG001|Neuroimaging Sub-study: Completed EOT|Overall Study||20||
48309212|NCT02906787|101084546|FG000|Neuroimaging Sub-study: Completed 12-Week Follow-up|Overall Study||25||
48309213|NCT02906787|101084547|FG001|Neuroimaging Sub-study: Completed 12-Week Follow-up|Overall Study||20||
48723832|NCT01278407|102108409|FG004|COMPLETED|Confirmatory Phase||0||
48723833|NCT01278407|102108405|FG000|NOT COMPLETED|Confirmatory Phase||9||
48723834|NCT01278407|102108406|FG001|NOT COMPLETED|Confirmatory Phase||16||
48723835|NCT01278407|102108407|FG002|NOT COMPLETED|Confirmatory Phase||6||
48723836|NCT01278407|102108408|FG003|NOT COMPLETED|Confirmatory Phase||0||
48723837|NCT01278407|102108409|FG004|NOT COMPLETED|Confirmatory Phase||0||
48723838|NCT01278407|102108405|FG000|STARTED|Extension Phase||0||
48723839|NCT01278407|102108406|FG001|STARTED|Extension Phase||0||
48723840|NCT01278407|102108407|FG002|STARTED|Extension Phase||0||
48723841|NCT01278407|102108408|FG003|STARTED|Extension Phase||46||
48723842|NCT01278407|102108409|FG004|STARTED|Extension Phase||96||
48723843|NCT01278407|102108405|FG000|COMPLETED|Extension Phase||0||
48723844|NCT01278407|102108406|FG001|COMPLETED|Extension Phase||0||
48723845|NCT01278407|102108407|FG002|COMPLETED|Extension Phase||0||
48723846|NCT01278407|102108408|FG003|COMPLETED|Extension Phase||34||
48309214|NCT02906787|101084546|FG000|Completed Neuroimaging Sub-study|Overall Study||25||
48309215|NCT02906787|101084547|FG001|Completed Neuroimaging Sub-study|Overall Study||20||
48309216|NCT02906787|101084546|FG000|COMPLETED|Overall Study||106||
48309217|NCT02906787|101084547|FG001|COMPLETED|Overall Study||114||
48309218|NCT02906787|101084546|FG000|NOT COMPLETED|Overall Study||36||
48309219|NCT02906787|101084547|FG001|NOT COMPLETED|Overall Study||32||
48723847|NCT01278407|102108409|FG004|COMPLETED|Extension Phase||66||
48723848|NCT01278407|102108405|FG000|NOT COMPLETED|Extension Phase||0||
48723849|NCT01278407|102108406|FG001|NOT COMPLETED|Extension Phase||0||
48723850|NCT01278407|102108407|FG002|NOT COMPLETED|Extension Phase||0||
48723851|NCT01278407|102108408|FG003|NOT COMPLETED|Extension Phase||12||
48723852|NCT01278407|102108409|FG004|NOT COMPLETED|Extension Phase||30||
48309220|NCT00941668|101084548|FG000|STARTED|Overall Study||24||
48309221|NCT00941668|101084549|FG001|STARTED|Overall Study||25||
48309222|NCT00941668|101084548|FG000|COMPLETED|Overall Study||0||
48723853|NCT00619099|102108410|FG000|STARTED|Overall Study||44||
48723854|NCT00619099|102108411|FG001|STARTED|Overall Study||23||
48723855|NCT00619099|102108410|FG000|Received at Least 2 Cycles of Treatment|Overall Study||43||
48723856|NCT00619099|102108411|FG001|Received at Least 2 Cycles of Treatment|Overall Study||22||
48723857|NCT00619099|102108410|FG000|COMPLETED|Overall Study||11||
48723858|NCT00619099|102108411|FG001|COMPLETED|Overall Study||4||
48723859|NCT00619099|102108410|FG000|NOT COMPLETED|Overall Study||33||
48723860|NCT00619099|102108411|FG001|NOT COMPLETED|Overall Study||19||
48309223|NCT00941668|101084549|FG001|COMPLETED|Overall Study||0||
48309224|NCT00941668|101084548|FG000|NOT COMPLETED|Overall Study||24||
48309225|NCT00941668|101084549|FG001|NOT COMPLETED|Overall Study||25||
48309226|NCT04060563|101084550|FG000|STARTED|Overall Study||4||
48309227|NCT04060563|101084551|FG001|STARTED|Overall Study||8||
48309228|NCT04060563|101084550|FG000|COMPLETED|Overall Study||3||
48309229|NCT04060563|101084551|FG001|COMPLETED|Overall Study||6||
48309230|NCT04060563|101084550|FG000|NOT COMPLETED|Overall Study||1||
48309231|NCT04060563|101084551|FG001|NOT COMPLETED|Overall Study||2||
48309232|NCT02088788|101084552|FG000|STARTED|Overall Study||135||
48309233|NCT02088788|101084553|FG001|STARTED|Overall Study||130||
48309234|NCT02088788|101084552|FG000|COMPLETED|Overall Study||105||
48309235|NCT02088788|101084553|FG001|COMPLETED|Overall Study||89||
48309236|NCT02088788|101084552|FG000|NOT COMPLETED|Overall Study||30||
48723861|NCT01879072|102108412|FG000|STARTED|Overall Study||1860||
48723862|NCT01879072|102108412|FG000|COMPLETED|Overall Study||1709||
48723863|NCT01879072|102108412|FG000|NOT COMPLETED|Overall Study||151||
48723864|NCT00877370|102108413|FG000|STARTED|Overall Study||8||
48723865|NCT00877370|102108413|FG000|COMPLETED|Overall Study||8||
48723866|NCT00877370|102108413|FG000|NOT COMPLETED|Overall Study||0||
48723867|NCT02147769|102108414|FG000|STARTED|Overall Study||111||
48723868|NCT02147769|102108414|FG000|COMPLETED|Overall Study||111||
48723869|NCT02147769|102108414|FG000|NOT COMPLETED|Overall Study||0||
48309237|NCT02088788|101084553|FG001|NOT COMPLETED|Overall Study||41||
48309238|NCT02150499|101084554|FG000|STARTED|Overall Study||9||
48309239|NCT02150499|101084555|FG001|STARTED|Overall Study||9||
48309240|NCT02150499|101084554|FG000|COMPLETED|Overall Study||9||
48309241|NCT02150499|101084555|FG001|COMPLETED|Overall Study||9||
48309242|NCT02150499|101084554|FG000|NOT COMPLETED|Overall Study||0||
48309243|NCT02150499|101084555|FG001|NOT COMPLETED|Overall Study||0||
48309244|NCT03329196|101084556|FG000|STARTED|Overall Study||151||
48309245|NCT03329196|101084557|FG001|STARTED|Overall Study||153||
48309246|NCT03329196|101084556|FG000|COMPLETED|Overall Study||111||
48309247|NCT03329196|101084557|FG001|COMPLETED|Overall Study||123||
48309248|NCT03329196|101084556|FG000|NOT COMPLETED|Overall Study||40||
48309249|NCT03329196|101084557|FG001|NOT COMPLETED|Overall Study||30||
48309250|NCT00698204|101084558|FG000|STARTED|Overall Study||20||
48309251|NCT00698204|101084559|FG001|STARTED|Overall Study||20||
48309252|NCT00698204|101084558|FG000|COMPLETED|Overall Study||19||
48309253|NCT00698204|101084559|FG001|COMPLETED|Overall Study||20||
48309254|NCT00698204|101084558|FG000|NOT COMPLETED|Overall Study||1||
48723870|NCT02263911|102108415|FG000|STARTED|Period 1||4||
48723871|NCT02263911|102108416|FG001|STARTED|Period 1||4||
48723872|NCT02263911|102108417|FG002|STARTED|Period 1||4||
48723873|NCT02263911|102108418|FG003|STARTED|Period 1||4||
48309255|NCT00698204|101084559|FG001|NOT COMPLETED|Overall Study||0||
48723874|NCT02263911|102108415|FG000|COMPLETED|Period 1||4||
48723875|NCT02263911|102108416|FG001|COMPLETED|Period 1||4||
48723876|NCT02263911|102108417|FG002|COMPLETED|Period 1||4||
48723877|NCT02263911|102108418|FG003|COMPLETED|Period 1||4||
48723878|NCT02263911|102108415|FG000|NOT COMPLETED|Period 1||0||
48723879|NCT02263911|102108416|FG001|NOT COMPLETED|Period 1||0||
48723880|NCT02263911|102108417|FG002|NOT COMPLETED|Period 1||0||
48723881|NCT02263911|102108418|FG003|NOT COMPLETED|Period 1||0||
48723882|NCT02263911|102108415|FG000|STARTED|Period 1 Washout||4||
48723883|NCT02263911|102108416|FG001|STARTED|Period 1 Washout||4||
48723884|NCT02263911|102108417|FG002|STARTED|Period 1 Washout||4||
48723885|NCT02263911|102108418|FG003|STARTED|Period 1 Washout||4||
48723886|NCT02263911|102108415|FG000|COMPLETED|Period 1 Washout||4||
48723887|NCT02263911|102108416|FG001|COMPLETED|Period 1 Washout||4||
48723888|NCT02263911|102108417|FG002|COMPLETED|Period 1 Washout||4||
48723889|NCT02263911|102108418|FG003|COMPLETED|Period 1 Washout||4||
48723890|NCT02263911|102108415|FG000|NOT COMPLETED|Period 1 Washout||0||
48723891|NCT02263911|102108416|FG001|NOT COMPLETED|Period 1 Washout||0||
48723892|NCT02263911|102108417|FG002|NOT COMPLETED|Period 1 Washout||0||
48723893|NCT02263911|102108418|FG003|NOT COMPLETED|Period 1 Washout||0||
48723894|NCT02263911|102108415|FG000|STARTED|Period 2||4||
48723895|NCT02263911|102108416|FG001|STARTED|Period 2||4||
48723896|NCT02263911|102108417|FG002|STARTED|Period 2||4||
48309256|NCT04458103|101084560|FG000|STARTED|Overall Study||17||
48309257|NCT04458103|101084561|FG001|STARTED|Overall Study||144||
48309258|NCT04458103|101084560|FG000|COMPLETED|Overall Study||17||
48309259|NCT04458103|101084561|FG001|COMPLETED|Overall Study||144||
48309260|NCT04458103|101084560|FG000|NOT COMPLETED|Overall Study||0||
48723897|NCT02263911|102108418|FG003|STARTED|Period 2||4||
48723898|NCT02263911|102108415|FG000|COMPLETED|Period 2||4||
48723899|NCT02263911|102108416|FG001|COMPLETED|Period 2||4||
48723900|NCT02263911|102108417|FG002|COMPLETED|Period 2||4||
48723901|NCT02263911|102108418|FG003|COMPLETED|Period 2||4||
48723902|NCT02263911|102108415|FG000|NOT COMPLETED|Period 2||0||
48723903|NCT02263911|102108416|FG001|NOT COMPLETED|Period 2||0||
48723904|NCT02263911|102108417|FG002|NOT COMPLETED|Period 2||0||
48723905|NCT02263911|102108418|FG003|NOT COMPLETED|Period 2||0||
48723906|NCT02263911|102108415|FG000|STARTED|Period 2 Washout||4||
48723907|NCT02263911|102108416|FG001|STARTED|Period 2 Washout||4||
48723908|NCT02263911|102108417|FG002|STARTED|Period 2 Washout||4||
48723909|NCT02263911|102108418|FG003|STARTED|Period 2 Washout||4||
48723910|NCT02263911|102108415|FG000|COMPLETED|Period 2 Washout||4||
48723911|NCT02263911|102108416|FG001|COMPLETED|Period 2 Washout||4||
48723912|NCT02263911|102108417|FG002|COMPLETED|Period 2 Washout||4||
48723913|NCT02263911|102108418|FG003|COMPLETED|Period 2 Washout||4||
48723914|NCT02263911|102108415|FG000|NOT COMPLETED|Period 2 Washout||0||
48723915|NCT02263911|102108416|FG001|NOT COMPLETED|Period 2 Washout||0||
48723916|NCT02263911|102108417|FG002|NOT COMPLETED|Period 2 Washout||0||
48309261|NCT04458103|101084561|FG001|NOT COMPLETED|Overall Study||0||
48723917|NCT02263911|102108418|FG003|NOT COMPLETED|Period 2 Washout||0||
48309262|NCT03189862|101084562|FG000|STARTED|Overall Study||153||
48309263|NCT03189862|101084563|FG001|STARTED|Overall Study||146||
48309264|NCT03189862|101084562|FG000|COMPLETED|Overall Study||98||
48309265|NCT03189862|101084563|FG001|COMPLETED|Overall Study||84||
48723918|NCT02263911|102108415|FG000|STARTED|Period 3||4||
48723919|NCT02263911|102108416|FG001|STARTED|Period 3||4||
48723920|NCT02263911|102108417|FG002|STARTED|Period 3||4||
48723921|NCT02263911|102108418|FG003|STARTED|Period 3||4||
48723922|NCT02263911|102108415|FG000|COMPLETED|Period 3||4||
48723923|NCT02263911|102108416|FG001|COMPLETED|Period 3||4||
48723924|NCT02263911|102108417|FG002|COMPLETED|Period 3||4||
48723925|NCT02263911|102108418|FG003|COMPLETED|Period 3||4||
48723926|NCT02263911|102108415|FG000|NOT COMPLETED|Period 3||0||
48723927|NCT02263911|102108416|FG001|NOT COMPLETED|Period 3||0||
48723928|NCT02263911|102108417|FG002|NOT COMPLETED|Period 3||0||
48723929|NCT02263911|102108418|FG003|NOT COMPLETED|Period 3||0||
48723930|NCT02263911|102108415|FG000|STARTED|Period 3 Washout||4||
48723931|NCT02263911|102108416|FG001|STARTED|Period 3 Washout||4||
48723932|NCT02263911|102108417|FG002|STARTED|Period 3 Washout||4||
48309266|NCT03189862|101084562|FG000|NOT COMPLETED|Overall Study||55||
48309267|NCT03189862|101084563|FG001|NOT COMPLETED|Overall Study||62||
48309268|NCT03694613|101084564|FG000|STARTED|Overall Study||65||
48723933|NCT02263911|102108418|FG003|STARTED|Period 3 Washout||4||
48723934|NCT02263911|102108415|FG000|COMPLETED|Period 3 Washout||4||
48723935|NCT02263911|102108416|FG001|COMPLETED|Period 3 Washout||4||
48723936|NCT02263911|102108417|FG002|COMPLETED|Period 3 Washout||4||
48723937|NCT02263911|102108418|FG003|COMPLETED|Period 3 Washout||4||
48723938|NCT02263911|102108415|FG000|NOT COMPLETED|Period 3 Washout||0||
48723939|NCT02263911|102108416|FG001|NOT COMPLETED|Period 3 Washout||0||
48723940|NCT02263911|102108417|FG002|NOT COMPLETED|Period 3 Washout||0||
48723941|NCT02263911|102108418|FG003|NOT COMPLETED|Period 3 Washout||0||
48723942|NCT02263911|102108415|FG000|STARTED|Period 4||4||
48309269|NCT03694613|101084564|FG000|COMPLETED|Overall Study||65||
48723943|NCT02263911|102108416|FG001|STARTED|Period 4||4||
48723944|NCT02263911|102108417|FG002|STARTED|Period 4||4||
48723945|NCT02263911|102108418|FG003|STARTED|Period 4||4||
48723946|NCT02263911|102108415|FG000|COMPLETED|Period 4||4||
48723947|NCT02263911|102108416|FG001|COMPLETED|Period 4||4||
48723948|NCT02263911|102108417|FG002|COMPLETED|Period 4||4||
48723949|NCT02263911|102108418|FG003|COMPLETED|Period 4||4||
48723950|NCT02263911|102108415|FG000|NOT COMPLETED|Period 4||0||
48723951|NCT02263911|102108416|FG001|NOT COMPLETED|Period 4||0||
48723952|NCT02263911|102108417|FG002|NOT COMPLETED|Period 4||0||
48723953|NCT02263911|102108418|FG003|NOT COMPLETED|Period 4||0||
48723954|NCT02263911|102108415|FG000|STARTED|Period 4 Washout||4||
48723955|NCT02263911|102108416|FG001|STARTED|Period 4 Washout||4||
48723956|NCT02263911|102108417|FG002|STARTED|Period 4 Washout||4||
48723957|NCT02263911|102108418|FG003|STARTED|Period 4 Washout||4||
48723958|NCT02263911|102108415|FG000|COMPLETED|Period 4 Washout||4||
48723959|NCT02263911|102108416|FG001|COMPLETED|Period 4 Washout||4||
48723960|NCT02263911|102108417|FG002|COMPLETED|Period 4 Washout||4||
48723961|NCT02263911|102108418|FG003|COMPLETED|Period 4 Washout||4||
48723962|NCT02263911|102108415|FG000|NOT COMPLETED|Period 4 Washout||0||
48723963|NCT02263911|102108416|FG001|NOT COMPLETED|Period 4 Washout||0||
48723964|NCT02263911|102108417|FG002|NOT COMPLETED|Period 4 Washout||0||
48723965|NCT02263911|102108418|FG003|NOT COMPLETED|Period 4 Washout||0||
48723966|NCT02263911|102108415|FG000|STARTED|Period 5||4||
48723967|NCT02263911|102108416|FG001|STARTED|Period 5||4||
48723968|NCT02263911|102108417|FG002|STARTED|Period 5||4||
48723969|NCT02263911|102108418|FG003|STARTED|Period 5||4||
48723970|NCT02263911|102108415|FG000|COMPLETED|Period 5||4||
48723971|NCT02263911|102108416|FG001|COMPLETED|Period 5||4||
48723972|NCT02263911|102108417|FG002|COMPLETED|Period 5||4||
48723973|NCT02263911|102108418|FG003|COMPLETED|Period 5||4||
48723974|NCT02263911|102108415|FG000|NOT COMPLETED|Period 5||0||
48723975|NCT02263911|102108416|FG001|NOT COMPLETED|Period 5||0||
48723976|NCT02263911|102108417|FG002|NOT COMPLETED|Period 5||0||
48153864|NCT01323530|100699871|FG003|STARTED|Phase 1b (Dose Escalation Phase)||3||
48153865|NCT01323530|100699872|FG004|STARTED|Phase 1b (Dose Escalation Phase)||6||
48153866|NCT01323530|100699873|FG005|STARTED|Phase 1b (Dose Escalation Phase)||6||
48153867|NCT01323530|100699874|FG006|STARTED|Phase 1b (Dose Escalation Phase)||0||
48153868|NCT01323530|100699868|FG000|COMPLETED|Phase 1b (Dose Escalation Phase)||5||
48153869|NCT01323530|100699869|FG001|COMPLETED|Phase 1b (Dose Escalation Phase)||4||
48153870|NCT01323530|100699870|FG002|COMPLETED|Phase 1b (Dose Escalation Phase)||4||
48153871|NCT01323530|100699871|FG003|COMPLETED|Phase 1b (Dose Escalation Phase)||3||
48723977|NCT02263911|102108418|FG003|NOT COMPLETED|Period 5||0||
48723978|NCT01424566|102108419|FG000|STARTED|Single-blind Treatment||406||
48723979|NCT01424566|102108420|FG001|STARTED|Single-blind Treatment||0||
48723980|NCT01424566|102108421|FG002|STARTED|Single-blind Treatment||0||
48723981|NCT01424566|102108419|FG000|Received at Least 1 Dose of Study Drug|Single-blind Treatment||404||
48723982|NCT01424566|102108420|FG001|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0||
48723983|NCT01424566|102108421|FG002|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0||
48723984|NCT01424566|102108419|FG000|Single-blind Safety Population|Single-blind Treatment||404||
48723985|NCT01424566|102108420|FG001|Single-blind Safety Population|Single-blind Treatment||0||
48767598|NCT00914316|102222778|FG002|COMPLETED|Phase 1||3||
48153872|NCT01323530|100699872|FG004|COMPLETED|Phase 1b (Dose Escalation Phase)||3||
48153873|NCT01323530|100699873|FG005|COMPLETED|Phase 1b (Dose Escalation Phase)||3||
48153874|NCT01323530|100699874|FG006|COMPLETED|Phase 1b (Dose Escalation Phase)||0||
48153875|NCT01323530|100699868|FG000|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||3||
48153876|NCT01323530|100699869|FG001|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||2||
48153877|NCT01323530|100699870|FG002|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||1||
48153878|NCT01323530|100699871|FG003|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||0||
48153879|NCT01323530|100699872|FG004|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||3||
48153880|NCT01323530|100699873|FG005|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||3||
48153881|NCT01323530|100699874|FG006|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||0||
48723986|NCT01424566|102108421|FG002|Single-blind Safety Population|Single-blind Treatment||0||
48723987|NCT01424566|102108419|FG000|Met Randomization Criteria|Single-blind Treatment||206||
48723988|NCT01424566|102108420|FG001|Met Randomization Criteria|Single-blind Treatment||0||
48723989|NCT01424566|102108421|FG002|Met Randomization Criteria|Single-blind Treatment||0||
48723990|NCT01424566|102108419|FG000|COMPLETED|Single-blind Treatment||206||
48723991|NCT01424566|102108420|FG001|COMPLETED|Single-blind Treatment||0||
48723992|NCT01424566|102108421|FG002|COMPLETED|Single-blind Treatment||0||
48723993|NCT01424566|102108419|FG000|NOT COMPLETED|Single-blind Treatment||200||
48723994|NCT01424566|102108420|FG001|NOT COMPLETED|Single-blind Treatment||0||
48723995|NCT01424566|102108421|FG002|NOT COMPLETED|Single-blind Treatment||0||
48723996|NCT01424566|102108419|FG000|STARTED|Double-blind Treatment||0||
48723997|NCT01424566|102108420|FG001|STARTED|Double-blind Treatment||103||
48723998|NCT01424566|102108421|FG002|STARTED|Double-blind Treatment||103||
48723999|NCT01424566|102108419|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment||0||
48724000|NCT01424566|102108420|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103||
48724001|NCT01424566|102108421|FG002|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103||
48724002|NCT01424566|102108419|FG000|Randomized Safety Population|Double-blind Treatment||0||
48724003|NCT01424566|102108420|FG001|Randomized Safety Population|Double-blind Treatment||103||
48724004|NCT01424566|102108421|FG002|Randomized Safety Population|Double-blind Treatment||103||
48724005|NCT01424566|102108419|FG000|ITT Population|Double-blind Treatment||0||
48724006|NCT01424566|102108420|FG001|ITT Population|Double-blind Treatment||103||
48724007|NCT01424566|102108421|FG002|ITT Population|Double-blind Treatment||103||
48724008|NCT01424566|102108419|FG000|COMPLETED|Double-blind Treatment||0||
48724009|NCT01424566|102108420|FG001|COMPLETED|Double-blind Treatment||78||
48724010|NCT01424566|102108421|FG002|COMPLETED|Double-blind Treatment||88||
48724011|NCT01424566|102108419|FG000|NOT COMPLETED|Double-blind Treatment||0||
48724012|NCT01424566|102108420|FG001|NOT COMPLETED|Double-blind Treatment||25||
48724013|NCT01424566|102108421|FG002|NOT COMPLETED|Double-blind Treatment||15||
48724014|NCT00772109|102108422|FG000|STARTED|Overall Study||956||
48724015|NCT00772109|102108423|FG001|STARTED|Overall Study||953||
48724016|NCT00772109|102108424|FG002|STARTED|Overall Study||955||
48724017|NCT00772109|102108425|FG003|STARTED|Overall Study||1428||
48724018|NCT00772109|102108422|FG000|COMPLETED|Overall Study||935||
48724019|NCT00772109|102108423|FG001|COMPLETED|Overall Study||934||
48724020|NCT00772109|102108424|FG002|COMPLETED|Overall Study||936||
48724021|NCT00772109|102108425|FG003|COMPLETED|Overall Study||1397||
48724022|NCT00772109|102108422|FG000|NOT COMPLETED|Overall Study||21||
48724023|NCT00772109|102108423|FG001|NOT COMPLETED|Overall Study||19||
48724024|NCT00772109|102108424|FG002|NOT COMPLETED|Overall Study||19||
48724025|NCT00772109|102108425|FG003|NOT COMPLETED|Overall Study||31||
48724026|NCT02438813|102108426|FG000|STARTED|Overall Study||1029||
48724027|NCT02438813|102108426|FG000|Received Treatment for SMF|Overall Study||676||
48724028|NCT02438813|102108426|FG000|Did Not ReceiveTreatment for SMF|Overall Study||353||
48724029|NCT02438813|102108426|FG000|COMPLETED|Overall Study||504||
48724030|NCT02438813|102108426|FG000|NOT COMPLETED|Overall Study||525||
48724031|NCT01778426|102108427|FG000|STARTED|Overall Study - Full Analysis Set (FAS)||264|Patients included in the study.|
48309270|NCT03694613|101084564|FG000|NOT COMPLETED|Overall Study||0||
48309271|NCT01627002|101084565|FG000|STARTED|Overall Study||4||
48309272|NCT01627002|101084566|FG001|STARTED|Overall Study||4||
48406565|NCT02603172|101328439|FG000|COMPLETED|Part C (Approximately 13 Weeks)||0||
48724032|NCT01778426|102108428|FG001|STARTED|Overall Study - Full Analysis Set (FAS)||138|Patients included in the study.|
48724033|NCT01778426|102108427|FG000|COMPLETED|Overall Study - Full Analysis Set (FAS)||208|Patients having completed the 2 year follow-up.|
48724034|NCT01778426|102108428|FG001|COMPLETED|Overall Study - Full Analysis Set (FAS)||113|Patients having completed the 2 year follow-up.|
48724035|NCT01778426|102108427|FG000|NOT COMPLETED|Overall Study - Full Analysis Set (FAS)||56||
48724036|NCT01778426|102108428|FG001|NOT COMPLETED|Overall Study - Full Analysis Set (FAS)||25||
48724037|NCT01778426|102108427|FG000|STARTED|Intention-To-Treat (ITT) - Completer||198|Primo-implanted patients with baseline and follow-up pain intensity data at 2 years completed.|
48724038|NCT01778426|102108428|FG001|STARTED|Intention-To-Treat (ITT) - Completer||0|Primo-implanted patients with baseline and follow-up pain intensity data at 2 years completed.|
48724039|NCT01778426|102108427|FG000|COMPLETED|Intention-To-Treat (ITT) - Completer||198|Patients having completed the 2 year follow-up.|
48724040|NCT01778426|102108428|FG001|COMPLETED|Intention-To-Treat (ITT) - Completer||0|Patients having completed the 2 year follow-up.|
48724041|NCT01778426|102108427|FG000|NOT COMPLETED|Intention-To-Treat (ITT) - Completer||0||
48724042|NCT01778426|102108428|FG001|NOT COMPLETED|Intention-To-Treat (ITT) - Completer||0||
48724043|NCT04006392|102108429|FG000|STARTED|Overall Study||11||
48724044|NCT04006392|102108430|FG001|STARTED|Overall Study||7||
48724045|NCT04006392|102108429|FG000|COMPLETED|Overall Study||11||
48724046|NCT04006392|102108430|FG001|COMPLETED|Overall Study||6||
48724047|NCT04006392|102108429|FG000|NOT COMPLETED|Overall Study||0||
48724048|NCT04006392|102108430|FG001|NOT COMPLETED|Overall Study||1||
48724049|NCT02160145|102108431|FG000|STARTED|Prerandomization Single-blind Period||1519||
48724050|NCT02160145|102108432|FG001|STARTED|Prerandomization Single-blind Period||0||
48724051|NCT02160145|102108433|FG002|STARTED|Prerandomization Single-blind Period||0||
48309273|NCT01627002|101084567|FG002|STARTED|Overall Study||4||
48309274|NCT01627002|101084568|FG003|STARTED|Overall Study||4||
48309275|NCT01627002|101084569|FG004|STARTED|Overall Study||2||
48309276|NCT01627002|101084570|FG005|STARTED|Overall Study||9||
48309277|NCT01627002|101084571|FG006|STARTED|Overall Study||10||
48309278|NCT01627002|101084572|FG007|STARTED|Overall Study||5||
48309279|NCT01627002|101084573|FG008|STARTED|Overall Study||7||
48309280|NCT01627002|101084565|FG000|COMPLETED|Overall Study||4||
48309281|NCT01627002|101084566|FG001|COMPLETED|Overall Study||4||
48309282|NCT01627002|101084567|FG002|COMPLETED|Overall Study||4||
48309283|NCT01627002|101084568|FG003|COMPLETED|Overall Study||4||
48309284|NCT01627002|101084569|FG004|COMPLETED|Overall Study||2||
48309285|NCT01627002|101084570|FG005|COMPLETED|Overall Study||9||
48309286|NCT01627002|101084571|FG006|COMPLETED|Overall Study||10||
48309287|NCT01627002|101084572|FG007|COMPLETED|Overall Study||5||
48309288|NCT01627002|101084573|FG008|COMPLETED|Overall Study||7||
48309289|NCT01627002|101084565|FG000|NOT COMPLETED|Overall Study||0||
48309290|NCT01627002|101084566|FG001|NOT COMPLETED|Overall Study||0||
48309291|NCT01627002|101084567|FG002|NOT COMPLETED|Overall Study||0||
48309292|NCT01627002|101084568|FG003|NOT COMPLETED|Overall Study||0||
48309293|NCT01627002|101084569|FG004|NOT COMPLETED|Overall Study||0||
48309294|NCT01627002|101084570|FG005|NOT COMPLETED|Overall Study||0||
48309295|NCT01627002|101084571|FG006|NOT COMPLETED|Overall Study||0||
48309296|NCT01627002|101084572|FG007|NOT COMPLETED|Overall Study||0||
48309297|NCT01627002|101084573|FG008|NOT COMPLETED|Overall Study||0||
48309298|NCT00789880|101084574|FG000|STARTED|Overall Study||16||
48309299|NCT00789880|101084575|FG001|STARTED|Overall Study||16||
48309300|NCT00789880|101084576|FG002|STARTED|Overall Study||8||
48309301|NCT00789880|101084577|FG003|STARTED|Overall Study||16||
48309302|NCT00789880|101084578|FG004|STARTED|Overall Study||18||
48309303|NCT00789880|101084579|FG005|STARTED|Overall Study||8||
48724052|NCT02160145|102108431|FG000|Treated in Placebo Run-in|Prerandomization Single-blind Period||1514||
48724053|NCT02160145|102108432|FG001|Treated in Placebo Run-in|Prerandomization Single-blind Period||0||
48724054|NCT02160145|102108433|FG002|Treated in Placebo Run-in|Prerandomization Single-blind Period||0||
48724055|NCT02160145|102108431|FG000|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||1491||
48724056|NCT02160145|102108432|FG001|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||0||
48724057|NCT02160145|102108433|FG002|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||0||
48724058|NCT02160145|102108431|FG000|Randomized|Prerandomization Single-blind Period||1370||
48724059|NCT02160145|102108432|FG001|Randomized|Prerandomization Single-blind Period||0||
48724060|NCT02160145|102108433|FG002|Randomized|Prerandomization Single-blind Period||0||
48724061|NCT02160145|102108431|FG000|COMPLETED|Prerandomization Single-blind Period||1370||
48724062|NCT02160145|102108432|FG001|COMPLETED|Prerandomization Single-blind Period||0||
48309304|NCT00789880|101084574|FG000|COMPLETED|Overall Study||15||
48309305|NCT00789880|101084575|FG001|COMPLETED|Overall Study||15||
48309306|NCT00789880|101084576|FG002|COMPLETED|Overall Study||8||
48309307|NCT00789880|101084577|FG003|COMPLETED|Overall Study||15||
48724063|NCT02160145|102108433|FG002|COMPLETED|Prerandomization Single-blind Period||0||
48724064|NCT02160145|102108431|FG000|NOT COMPLETED|Prerandomization Single-blind Period||149||
48724065|NCT02160145|102108432|FG001|NOT COMPLETED|Prerandomization Single-blind Period||0||
48724066|NCT02160145|102108433|FG002|NOT COMPLETED|Prerandomization Single-blind Period||0||
48724067|NCT02160145|102108431|FG000|STARTED|Randomized Double-blind Period||0||
48309308|NCT00789880|101084578|FG004|COMPLETED|Overall Study||15||
48309309|NCT00789880|101084579|FG005|COMPLETED|Overall Study||8||
48309310|NCT00789880|101084574|FG000|NOT COMPLETED|Overall Study||1||
48309311|NCT00789880|101084575|FG001|NOT COMPLETED|Overall Study||1||
48309312|NCT00789880|101084576|FG002|NOT COMPLETED|Overall Study||0||
48309313|NCT00789880|101084577|FG003|NOT COMPLETED|Overall Study||1||
48309314|NCT00789880|101084578|FG004|NOT COMPLETED|Overall Study||3||
48309315|NCT00789880|101084579|FG005|NOT COMPLETED|Overall Study||0||
48309316|NCT00791258|101084580|FG000|STARTED|Overall Study||999||
48309317|NCT00791258|101084580|FG000|COMPLETED|Overall Study||736||
48309318|NCT00791258|101084580|FG000|NOT COMPLETED|Overall Study||263||
48309319|NCT03497806|101084581|FG000|STARTED|Week 8||132||
48309320|NCT03497806|101084581|FG000|COMPLETED|Week 8||123||
48309321|NCT03497806|101084581|FG000|NOT COMPLETED|Week 8||9||
48309322|NCT03497806|101084581|FG000|STARTED|Week 24||123||
48309323|NCT03497806|101084581|FG000|COMPLETED|Week 24||112||
48309324|NCT03497806|101084581|FG000|NOT COMPLETED|Week 24||11||
48309325|NCT02822950|101084582|FG000|STARTED|Overall Study||10||
48309326|NCT02822950|101084582|FG000|COMPLETED|Overall Study||10||
48309327|NCT02822950|101084582|FG000|NOT COMPLETED|Overall Study||0||
48309328|NCT01132612|101084583|FG000|STARTED|Overall Study||46||
48309329|NCT01132612|101084584|FG001|STARTED|Overall Study||42||
48309330|NCT01132612|101084585|FG002|STARTED|Overall Study||187||
48309331|NCT01132612|101084583|FG000|COMPLETED|Overall Study||6||
48724068|NCT02160145|102108432|FG001|STARTED|Randomized Double-blind Period||683||
48309332|NCT01132612|101084584|FG001|COMPLETED|Overall Study||7||
48309333|NCT01132612|101084585|FG002|COMPLETED|Overall Study||17||
48309334|NCT01132612|101084583|FG000|NOT COMPLETED|Overall Study||40||
48309335|NCT01132612|101084584|FG001|NOT COMPLETED|Overall Study||35||
48309336|NCT01132612|101084585|FG002|NOT COMPLETED|Overall Study||170||
48309337|NCT00521924|101084586|FG000|STARTED|Overall Study||4||
48309338|NCT00521924|101084587|FG001|STARTED|Overall Study||4||
48309339|NCT00521924|101084586|FG000|COMPLETED|Overall Study||0||
48309340|NCT00521924|101084587|FG001|COMPLETED|Overall Study||0||
48309341|NCT00521924|101084586|FG000|NOT COMPLETED|Overall Study||4||
48309342|NCT00521924|101084587|FG001|NOT COMPLETED|Overall Study||4||
48309343|NCT04311216|101084588|FG000|STARTED|Overall Study||15||
48309344|NCT04311216|101084589|FG001|STARTED|Overall Study||15||
48309345|NCT04311216|101084588|FG000|COMPLETED|Overall Study||13||
48309346|NCT04311216|101084589|FG001|COMPLETED|Overall Study||15||
48309347|NCT04311216|101084588|FG000|NOT COMPLETED|Overall Study||2||
48309348|NCT04311216|101084589|FG001|NOT COMPLETED|Overall Study||0||
48309349|NCT00544648|101084590|FG000|STARTED|Overall Study||11||
48309350|NCT00544648|101084591|FG001|STARTED|Overall Study||2||
48309351|NCT00544648|101084590|FG000|COMPLETED|Overall Study||8||
48309352|NCT00544648|101084591|FG001|COMPLETED|Overall Study||1||
48724069|NCT02160145|102108433|FG002|STARTED|Randomized Double-blind Period||687||
48724070|NCT02160145|102108431|FG000|On-treatment Completers|Randomized Double-blind Period||0||
48724071|NCT02160145|102108432|FG001|On-treatment Completers|Randomized Double-blind Period||578||
48724072|NCT02160145|102108433|FG002|On-treatment Completers|Randomized Double-blind Period||637||
48724073|NCT02160145|102108431|FG000|Off-treatment Completers|Randomized Double-blind Period||0||
48724074|NCT02160145|102108432|FG001|Off-treatment Completers|Randomized Double-blind Period||76||
48309353|NCT00544648|101084590|FG000|NOT COMPLETED|Overall Study||3||
48309354|NCT00544648|101084591|FG001|NOT COMPLETED|Overall Study||1||
48309355|NCT01007032|101084592|FG000|STARTED|Overall Study||4||
48309356|NCT01007032|101084593|FG001|STARTED|Overall Study||7||
48309357|NCT01007032|101084594|FG002|STARTED|Overall Study||3||
48309358|NCT01007032|101084595|FG003|STARTED|Overall Study||7||
48309359|NCT01007032|101084592|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4||
48309360|NCT01007032|101084593|FG001|Received at Least 1 Dose of Study Drug|Overall Study||7||
48309361|NCT01007032|101084594|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
48309362|NCT01007032|101084595|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7||
48309363|NCT01007032|101084592|FG000|COMPLETED|Overall Study||4||
48309364|NCT01007032|101084593|FG001|COMPLETED|Overall Study||6||
48309365|NCT01007032|101084594|FG002|COMPLETED|Overall Study||2||
48309366|NCT01007032|101084595|FG003|COMPLETED|Overall Study||6||
48309367|NCT01007032|101084592|FG000|NOT COMPLETED|Overall Study||0||
48724075|NCT02160145|102108433|FG002|Off-treatment Completers|Randomized Double-blind Period||22||
48724076|NCT02160145|102108431|FG000|COMPLETED|Randomized Double-blind Period||0|Completed Month 12 Visit|
48724077|NCT02160145|102108432|FG001|COMPLETED|Randomized Double-blind Period||654|Completed Month 12 Visit|
48724078|NCT02160145|102108433|FG002|COMPLETED|Randomized Double-blind Period||659|Completed Month 12 Visit|
48724079|NCT02160145|102108431|FG000|NOT COMPLETED|Randomized Double-blind Period||0||
48724080|NCT02160145|102108432|FG001|NOT COMPLETED|Randomized Double-blind Period||29||
48724081|NCT02160145|102108433|FG002|NOT COMPLETED|Randomized Double-blind Period||28||
48724082|NCT03565237|102108434|FG000|STARTED|Overall Study||25||
48724083|NCT03565237|102108434|FG000|Safety Analysis Set (SAS)|Overall Study||25||
48724084|NCT03565237|102108434|FG000|Effectiveness Full Analysis Set (EFAS)|Overall Study||25||
48724085|NCT03565237|102108434|FG000|COMPLETED|Overall Study||23||
48724086|NCT03565237|102108434|FG000|NOT COMPLETED|Overall Study||2||
48309368|NCT01007032|101084593|FG001|NOT COMPLETED|Overall Study||1||
48309369|NCT01007032|101084594|FG002|NOT COMPLETED|Overall Study||1||
48309370|NCT01007032|101084595|FG003|NOT COMPLETED|Overall Study||1||
48309371|NCT01031550|101084596|FG000|STARTED|Overall Study||5||
48309372|NCT01031550|101084597|FG001|STARTED|Overall Study||3||
48309373|NCT01031550|101084596|FG000|COMPLETED|Overall Study||5||
48309374|NCT01031550|101084597|FG001|COMPLETED|Overall Study||3||
48309375|NCT01031550|101084596|FG000|NOT COMPLETED|Overall Study||0||
48309376|NCT01031550|101084597|FG001|NOT COMPLETED|Overall Study||0||
48309377|NCT02163187|101084598|FG000|STARTED|Overall Study||4||
48309378|NCT02163187|101084599|FG001|STARTED|Overall Study||0||
48309379|NCT02163187|101084598|FG000|Treatment|Overall Study||2||
48309380|NCT02163187|101084599|FG001|Treatment|Overall Study||0||
48309381|NCT02163187|101084598|FG000|COMPLETED|Overall Study||2||
48309382|NCT02163187|101084599|FG001|COMPLETED|Overall Study||0||
48309383|NCT02163187|101084598|FG000|NOT COMPLETED|Overall Study||2||
48309384|NCT02163187|101084599|FG001|NOT COMPLETED|Overall Study||0||
48309385|NCT01540825|101084600|FG000|STARTED|Overall Study||20||
48309386|NCT01540825|101084601|FG001|STARTED|Overall Study||6||
48309387|NCT01540825|101084602|FG002|STARTED|Overall Study||6||
48309388|NCT01540825|101084603|FG003|STARTED|Overall Study||6||
48309389|NCT01540825|101084604|FG004|STARTED|Overall Study||6||
48309390|NCT01540825|101084605|FG005|STARTED|Overall Study||6||
48309391|NCT01540825|101084606|FG006|STARTED|Overall Study||6||
48724087|NCT01814670|102108435|FG000|STARTED|Overall Study||185||
48309392|NCT01540825|101084607|FG007|STARTED|Overall Study||6||
48309393|NCT01540825|101084608|FG008|STARTED|Overall Study||6||
48309394|NCT01540825|101084609|FG009|STARTED|Overall Study||6||
48309395|NCT01540825|101084610|FG010|STARTED|Overall Study||6||
48309396|NCT01540825|101084600|FG000|COMPLETED|Overall Study||20||
48309397|NCT01540825|101084601|FG001|COMPLETED|Overall Study||6||
48309398|NCT01540825|101084602|FG002|COMPLETED|Overall Study||6||
48724088|NCT01814670|102108435|FG000|COMPLETED|Overall Study||173||
48724089|NCT01814670|102108435|FG000|NOT COMPLETED|Overall Study||12||
48724090|NCT01825941|102108436|FG000|STARTED|Overall Study||104||
48724091|NCT01825941|102108437|FG001|STARTED|Overall Study||104||
48724092|NCT01825941|102108436|FG000|COMPLETED|Overall Study||100||
48724093|NCT01825941|102108437|FG001|COMPLETED|Overall Study||103||
48724094|NCT01825941|102108436|FG000|NOT COMPLETED|Overall Study||4||
48724095|NCT01825941|102108437|FG001|NOT COMPLETED|Overall Study||1||
48724096|NCT01858753|102108438|FG000|STARTED|Overall Study||5||
48724097|NCT01858753|102108439|FG001|STARTED|Overall Study||0||
48724098|NCT01858753|102108438|FG000|COMPLETED|Overall Study||0||
48724099|NCT01858753|102108439|FG001|COMPLETED|Overall Study||0||
48724100|NCT01858753|102108438|FG000|NOT COMPLETED|Overall Study||5||
48724101|NCT01858753|102108439|FG001|NOT COMPLETED|Overall Study||0||
48724102|NCT03316950|102108440|FG000|STARTED|Initial Intervention (1 to 3 Months)||12||
48724103|NCT03316950|102108441|FG001|STARTED|Initial Intervention (1 to 3 Months)||12||
48724104|NCT03316950|102108442|FG002|STARTED|Initial Intervention (1 to 3 Months)||23||
48724105|NCT03316950|102108443|FG003|STARTED|Initial Intervention (1 to 3 Months)||0||
48724106|NCT03316950|102108440|FG000|COMPLETED|Initial Intervention (1 to 3 Months)||9||
48724107|NCT03316950|102108441|FG001|COMPLETED|Initial Intervention (1 to 3 Months)||8||
48724108|NCT03316950|102108442|FG002|COMPLETED|Initial Intervention (1 to 3 Months)||14||
48724109|NCT03316950|102108443|FG003|COMPLETED|Initial Intervention (1 to 3 Months)||0||
48724110|NCT03316950|102108440|FG000|NOT COMPLETED|Initial Intervention (1 to 3 Months)||3||
48724111|NCT03316950|102108441|FG001|NOT COMPLETED|Initial Intervention (1 to 3 Months)||4||
48724112|NCT03316950|102108442|FG002|NOT COMPLETED|Initial Intervention (1 to 3 Months)||9||
48724113|NCT03316950|102108443|FG003|NOT COMPLETED|Initial Intervention (1 to 3 Months)||0||
48724114|NCT03316950|102108440|FG000|STARTED|Dual Intervention (6 to 8 Months)||0||
48724115|NCT03316950|102108441|FG001|STARTED|Dual Intervention (6 to 8 Months)||0||
48724116|NCT03316950|102108442|FG002|STARTED|Dual Intervention (6 to 8 Months)||0||
48724117|NCT03316950|102108443|FG003|STARTED|Dual Intervention (6 to 8 Months)||14||
48724118|NCT03316950|102108440|FG000|COMPLETED|Dual Intervention (6 to 8 Months)||0||
48724119|NCT03316950|102108441|FG001|COMPLETED|Dual Intervention (6 to 8 Months)||0||
48724120|NCT03316950|102108442|FG002|COMPLETED|Dual Intervention (6 to 8 Months)||0||
48724121|NCT03316950|102108443|FG003|COMPLETED|Dual Intervention (6 to 8 Months)||14||
48724122|NCT03316950|102108440|FG000|NOT COMPLETED|Dual Intervention (6 to 8 Months)||0||
48724123|NCT03316950|102108441|FG001|NOT COMPLETED|Dual Intervention (6 to 8 Months)||0||
48724124|NCT03316950|102108442|FG002|NOT COMPLETED|Dual Intervention (6 to 8 Months)||0||
48309399|NCT01540825|101084603|FG003|COMPLETED|Overall Study||6||
48309400|NCT01540825|101084604|FG004|COMPLETED|Overall Study||6||
48724125|NCT03316950|102108443|FG003|NOT COMPLETED|Dual Intervention (6 to 8 Months)||0||
48724126|NCT01009086|102111493|FG000|STARTED|Overall Study||206||
48724127|NCT01009086|102111494|FG001|STARTED|Overall Study||205||
48724128|NCT01009086|102111495|FG002|STARTED|Overall Study||204||
48724129|NCT01009086|102111493|FG000|COMPLETED|Overall Study||162||
48724130|NCT01009086|102111494|FG001|COMPLETED|Overall Study||158||
48724131|NCT01009086|102111495|FG002|COMPLETED|Overall Study||170||
48724132|NCT01009086|102111493|FG000|NOT COMPLETED|Overall Study||44||
48724133|NCT01009086|102111494|FG001|NOT COMPLETED|Overall Study||47||
48724134|NCT01009086|102111495|FG002|NOT COMPLETED|Overall Study||34||
48724135|NCT01304407|102111496|FG000|STARTED|Overall Study||29||
48724136|NCT01304407|102111496|FG000|COMPLETED|Overall Study||29||
48724137|NCT01304407|102111496|FG000|NOT COMPLETED|Overall Study||0||
48724138|NCT00771615|102111497|FG000|STARTED|Overall Study||49||
48309401|NCT01540825|101084605|FG005|COMPLETED|Overall Study||6||
48309402|NCT01540825|101084606|FG006|COMPLETED|Overall Study||6||
48309403|NCT01540825|101084607|FG007|COMPLETED|Overall Study||6||
48309404|NCT01540825|101084608|FG008|COMPLETED|Overall Study||6||
48309405|NCT01540825|101084609|FG009|COMPLETED|Overall Study||6||
48309406|NCT01540825|101084610|FG010|COMPLETED|Overall Study||6||
48309407|NCT01540825|101084600|FG000|NOT COMPLETED|Overall Study||0||
48309408|NCT01540825|101084601|FG001|NOT COMPLETED|Overall Study||0||
48724139|NCT00771615|102111498|FG001|STARTED|Overall Study||72||
48724140|NCT00771615|102111499|FG002|STARTED|Overall Study||41||
48724141|NCT00771615|102111500|FG003|STARTED|Overall Study||60||
48724142|NCT00771615|102111501|FG004|STARTED|Overall Study||40||
48724143|NCT00771615|102111502|FG005|STARTED|Overall Study||61||
48724144|NCT00771615|102111503|FG006|STARTED|Overall Study||46||
48724145|NCT00771615|102111504|FG007|STARTED|Overall Study||59||
48724146|NCT00771615|102111505|FG008|STARTED|Overall Study||41||
48724147|NCT00771615|102111497|FG000|COMPLETED|Overall Study||48||
48724148|NCT00771615|102111498|FG001|COMPLETED|Overall Study||70||
48724149|NCT00771615|102111499|FG002|COMPLETED|Overall Study||40||
48724150|NCT00771615|102111500|FG003|COMPLETED|Overall Study||59||
48724151|NCT00771615|102111501|FG004|COMPLETED|Overall Study||40||
48724152|NCT00771615|102111502|FG005|COMPLETED|Overall Study||60||
48724153|NCT00771615|102111503|FG006|COMPLETED|Overall Study||45||
48724154|NCT00771615|102111504|FG007|COMPLETED|Overall Study||58||
48724155|NCT00771615|102111505|FG008|COMPLETED|Overall Study||41||
48724156|NCT00771615|102111497|FG000|NOT COMPLETED|Overall Study||1||
48724157|NCT00771615|102111498|FG001|NOT COMPLETED|Overall Study||2||
48724158|NCT00771615|102111499|FG002|NOT COMPLETED|Overall Study||1||
48724159|NCT00771615|102111500|FG003|NOT COMPLETED|Overall Study||1||
48724160|NCT00771615|102111501|FG004|NOT COMPLETED|Overall Study||0||
48724161|NCT00771615|102111502|FG005|NOT COMPLETED|Overall Study||1||
48724162|NCT00771615|102111503|FG006|NOT COMPLETED|Overall Study||1||
48724163|NCT00771615|102111504|FG007|NOT COMPLETED|Overall Study||1||
48724164|NCT00771615|102111505|FG008|NOT COMPLETED|Overall Study||0||
48724165|NCT00884832|102111506|FG000|STARTED|Overall Study||22||
48724166|NCT00884832|102111507|FG001|STARTED|Overall Study||22||
48724167|NCT00884832|102111506|FG000|COMPLETED|Overall Study||22||
48724168|NCT00884832|102111507|FG001|COMPLETED|Overall Study||21||
48724169|NCT00884832|102111506|FG000|NOT COMPLETED|Overall Study||0||
48724170|NCT00884832|102111507|FG001|NOT COMPLETED|Overall Study||1||
48724171|NCT03020017|102111508|FG000|STARTED|NU-0129||8||
48724172|NCT03020017|102111508|FG000|COMPLETED|NU-0129||8||
48724173|NCT03020017|102111508|FG000|NOT COMPLETED|NU-0129||0||
48309409|NCT01540825|101084602|FG002|NOT COMPLETED|Overall Study||0||
48309410|NCT01540825|101084603|FG003|NOT COMPLETED|Overall Study||0||
48612141|NCT00547248|101838192|FG002|NOT COMPLETED|Overall Study||10||
48612142|NCT00547248|101838193|FG003|NOT COMPLETED|Overall Study||2||
48612143|NCT01545141|101838194|FG000|STARTED|Overall Study||2|9 patients in Phase I. 6 patients randomized in Phase II (2 to surgery alone and 4 to 20 MU/m2)|
48612144|NCT01545141|101838195|FG001|STARTED|Overall Study||3|9 patients in Phase I. 6 patients randomized in Phase II (2 to surgery alone and 4 to 20 MU/m2)|
48153882|NCT01323530|100699868|FG000|STARTED|Phase 2 (Dose-confirmation Phase)||0||
48153883|NCT01323530|100699869|FG001|STARTED|Phase 2 (Dose-confirmation Phase)||0||
48612145|NCT01545141|101838196|FG002|STARTED|Overall Study||3|9 patients in Phase I. 6 patients randomized in Phase II (2 to surgery alone and 4 to 20 MU/m2)|
48612146|NCT01545141|101838197|FG003|STARTED|Overall Study||7|9 patients in Phase I. 6 patients randomized in Phase II (2 to surgery alone and 4 to 20 MU/m2)|
48612147|NCT01545141|101838194|FG000|COMPLETED|Overall Study||2||
48153884|NCT01323530|100699870|FG002|STARTED|Phase 2 (Dose-confirmation Phase)||0||
48309411|NCT01540825|101084604|FG004|NOT COMPLETED|Overall Study||0||
48309412|NCT01540825|101084605|FG005|NOT COMPLETED|Overall Study||0||
48309413|NCT01540825|101084606|FG006|NOT COMPLETED|Overall Study||0||
48309414|NCT01540825|101084607|FG007|NOT COMPLETED|Overall Study||0||
48309415|NCT01540825|101084608|FG008|NOT COMPLETED|Overall Study||0||
48309416|NCT01540825|101084609|FG009|NOT COMPLETED|Overall Study||0||
48309417|NCT01540825|101084610|FG010|NOT COMPLETED|Overall Study||0||
48612148|NCT01545141|101838195|FG001|COMPLETED|Overall Study||3||
48612149|NCT01545141|101838196|FG002|COMPLETED|Overall Study||3||
48612150|NCT01545141|101838197|FG003|COMPLETED|Overall Study||7||
48724174|NCT03020017|102111508|FG000|STARTED|Standard of Care Resection||8||
48724175|NCT03020017|102111508|FG000|COMPLETED|Standard of Care Resection||8||
48724176|NCT03020017|102111508|FG000|NOT COMPLETED|Standard of Care Resection||0||
48724177|NCT02841241|102111509|FG000|STARTED|Overall Study||7||
48724178|NCT02841241|102111509|FG000|COMPLETED|Overall Study||7||
48153885|NCT01323530|100699871|FG003|STARTED|Phase 2 (Dose-confirmation Phase)||0||
48153886|NCT01323530|100699872|FG004|STARTED|Phase 2 (Dose-confirmation Phase)||0||
48724179|NCT02841241|102111509|FG000|NOT COMPLETED|Overall Study||0||
48724180|NCT03908476|102111510|FG000|STARTED|Overall Study||85||
48153887|NCT01323530|100699873|FG005|STARTED|Phase 2 (Dose-confirmation Phase)||0||
48153888|NCT01323530|100699874|FG006|STARTED|Phase 2 (Dose-confirmation Phase)||42||
48153889|NCT01323530|100699868|FG000|COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
48724181|NCT03908476|102111511|FG001|STARTED|Overall Study||15||
48724182|NCT03908476|102111510|FG000|COMPLETED|Overall Study||64||
48724183|NCT03908476|102111511|FG001|COMPLETED|Overall Study||13||
48724184|NCT03908476|102111510|FG000|NOT COMPLETED|Overall Study||21||
48724185|NCT03908476|102111511|FG001|NOT COMPLETED|Overall Study||2||
48724186|NCT00300365|102111512|FG000|STARTED|Overall Study||38||
48724187|NCT00300365|102111513|FG001|STARTED|Overall Study||40||
48724188|NCT00300365|102111512|FG000|COMPLETED|Overall Study||34||
48724189|NCT00300365|102111513|FG001|COMPLETED|Overall Study||38||
48724190|NCT00300365|102111512|FG000|NOT COMPLETED|Overall Study||4||
48724191|NCT00300365|102111513|FG001|NOT COMPLETED|Overall Study||2||
48153890|NCT01323530|100699869|FG001|COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
48153891|NCT01323530|100699870|FG002|COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
48153892|NCT01323530|100699871|FG003|COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
48153893|NCT01323530|100699872|FG004|COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
48153894|NCT01323530|100699873|FG005|COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
48153895|NCT01323530|100699874|FG006|COMPLETED|Phase 2 (Dose-confirmation Phase)||25||
48153896|NCT01323530|100699868|FG000|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
48153897|NCT01323530|100699869|FG001|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
48153898|NCT01323530|100699870|FG002|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
48153899|NCT01323530|100699871|FG003|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
48153900|NCT01323530|100699872|FG004|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
48309418|NCT02170779|101084611|FG000|STARTED|Overall Study||20||
48309419|NCT02170779|101084612|FG001|STARTED|Overall Study||20||
48612151|NCT01545141|101838194|FG000|NOT COMPLETED|Overall Study||0||
48612152|NCT01545141|101838195|FG001|NOT COMPLETED|Overall Study||0||
48612153|NCT01545141|101838196|FG002|NOT COMPLETED|Overall Study||0||
48612154|NCT01545141|101838197|FG003|NOT COMPLETED|Overall Study||0||
48612155|NCT04399889|101838198|FG000|STARTED|Overall Study||10||
48612156|NCT04399889|101838199|FG001|STARTED|Overall Study||1||
48612157|NCT04399889|101838200|FG002|STARTED|Overall Study||1||
48612158|NCT04399889|101838198|FG000|COMPLETED|Overall Study||5||
48612159|NCT04399889|101838199|FG001|COMPLETED|Overall Study||0||
48612160|NCT04399889|101838200|FG002|COMPLETED|Overall Study||0||
48724192|NCT01423916|102111514|FG000|STARTED|Overall Study||74||
48724193|NCT01423916|102111515|FG001|STARTED|Overall Study||73||
48724194|NCT01423916|102111516|FG002|STARTED|Overall Study||71||
48724195|NCT01423916|102111514|FG000|COMPLETED|Overall Study||63||
48724196|NCT01423916|102111515|FG001|COMPLETED|Overall Study||53||
48724197|NCT01423916|102111516|FG002|COMPLETED|Overall Study||64||
48724198|NCT01423916|102111514|FG000|NOT COMPLETED|Overall Study||11||
48724199|NCT01423916|102111515|FG001|NOT COMPLETED|Overall Study||20||
48724200|NCT01423916|102111516|FG002|NOT COMPLETED|Overall Study||7||
48724201|NCT00701805|102111517|FG000|STARTED|Overall Study||26||
48724202|NCT00701805|102111518|FG001|STARTED|Overall Study||29||
48724203|NCT00701805|102111519|FG002|STARTED|Overall Study||23||
48612161|NCT04399889|101838198|FG000|NOT COMPLETED|Overall Study||5||
48612162|NCT04399889|101838199|FG001|NOT COMPLETED|Overall Study||1||
48612163|NCT04399889|101838200|FG002|NOT COMPLETED|Overall Study||1||
48724204|NCT00701805|102111520|FG003|STARTED|Overall Study||26||
48153901|NCT01323530|100699873|FG005|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
48153902|NCT01323530|100699874|FG006|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||17||
48153903|NCT00734630|100699875|FG000|STARTED|Overall Study||258||
48153904|NCT00734630|100699876|FG001|STARTED|Overall Study||233||
48153905|NCT00734630|100699875|FG000|COMPLETED|Overall Study||229||
48612164|NCT03868839|101838201|FG000|STARTED|Overall Study||6||
48153906|NCT00734630|100699876|FG001|COMPLETED|Overall Study||200||
48153907|NCT00734630|100699875|FG000|NOT COMPLETED|Overall Study||29||
48153908|NCT00734630|100699876|FG001|NOT COMPLETED|Overall Study||33||
48153909|NCT01267292|100699877|FG000|STARTED|Overall Study||24||
48153910|NCT01267292|100699878|FG001|STARTED|Overall Study||26||
48612165|NCT03868839|101838201|FG000|COMPLETED|Overall Study||5||
48612166|NCT03868839|101838201|FG000|NOT COMPLETED|Overall Study||1||
48612167|NCT01964989|101838202|FG000|STARTED|Overall Study||5352||
48612168|NCT01964989|101838203|FG001|STARTED|Overall Study||5292||
48724205|NCT00701805|102111517|FG000|COMPLETED|Overall Study||23||
48724206|NCT00701805|102111518|FG001|COMPLETED|Overall Study||25||
48724207|NCT00701805|102111519|FG002|COMPLETED|Overall Study||16||
48724208|NCT00701805|102111520|FG003|COMPLETED|Overall Study||22||
48724209|NCT00701805|102111517|FG000|NOT COMPLETED|Overall Study||3||
48724210|NCT00701805|102111518|FG001|NOT COMPLETED|Overall Study||4||
48612169|NCT01964989|101838202|FG000|COMPLETED|Overall Study||4568||
48612170|NCT01964989|101838203|FG001|COMPLETED|Overall Study||4545||
48612171|NCT01964989|101838202|FG000|NOT COMPLETED|Overall Study||784||
48612172|NCT01964989|101838203|FG001|NOT COMPLETED|Overall Study||747||
48612173|NCT04265261|101838204|FG000|STARTED|Overall Study||47||
48612174|NCT04265261|101838205|FG001|STARTED|Overall Study||48||
48612175|NCT04265261|101838206|FG002|STARTED|Overall Study||44||
48612176|NCT04265261|101838204|FG000|COMPLETED|Overall Study||37||
48612177|NCT04265261|101838205|FG001|COMPLETED|Overall Study||43||
48612178|NCT04265261|101838206|FG002|COMPLETED|Overall Study||36||
48612179|NCT04265261|101838204|FG000|NOT COMPLETED|Overall Study||10||
48612180|NCT04265261|101838205|FG001|NOT COMPLETED|Overall Study||5||
48612181|NCT04265261|101838206|FG002|NOT COMPLETED|Overall Study||8||
48612182|NCT04004260|101838207|FG000|STARTED|Overall Study||79||
48612183|NCT04004260|101838208|FG001|STARTED|Overall Study||79||
48612184|NCT04004260|101838207|FG000|COMPLETED|Overall Study||37||
48612185|NCT04004260|101838208|FG001|COMPLETED|Overall Study||47||
48612186|NCT04004260|101838207|FG000|NOT COMPLETED|Overall Study||42||
48612187|NCT04004260|101838208|FG001|NOT COMPLETED|Overall Study||32||
48612188|NCT00674206|101838209|FG000|STARTED|Overall Study||6||
48612189|NCT00674206|101838209|FG000|COMPLETED|Overall Study||6||
48612190|NCT00674206|101838209|FG000|NOT COMPLETED|Overall Study||0||
48612191|NCT00382785|101838210|FG000|STARTED|Overall Study||25||
48612192|NCT00382785|101838211|FG001|STARTED|Overall Study||26||
48612193|NCT00382785|101838210|FG000|COMPLETED|Overall Study||25||
48612194|NCT00382785|101838211|FG001|COMPLETED|Overall Study||26||
48612195|NCT00382785|101838210|FG000|NOT COMPLETED|Overall Study||0||
48612196|NCT00382785|101838211|FG001|NOT COMPLETED|Overall Study||0||
48612197|NCT01826981|101838212|FG000|STARTED|Overall Study||19||
48612198|NCT01826981|101838213|FG001|STARTED|Overall Study||10||
48612199|NCT01826981|101838214|FG002|STARTED|Overall Study||25||
48612200|NCT01826981|101838215|FG003|STARTED|Overall Study||26||
48612201|NCT01826981|101838216|FG004|STARTED|Overall Study||25||
48612202|NCT01826981|101838217|FG005|STARTED|Overall Study||26||
48612203|NCT01826981|101838218|FG006|STARTED|Overall Study||25||
48612204|NCT01826981|101838219|FG007|STARTED|Overall Study||51||
48612205|NCT01826981|101838220|FG008|STARTED|Overall Study||20||
48612206|NCT01826981|101838221|FG009|STARTED|Overall Study||27||
48612207|NCT01826981|101838222|FG010|STARTED|Overall Study||24||
48612208|NCT01826981|101838223|FG011|STARTED|Overall Study||27||
48612209|NCT01826981|101838224|FG012|STARTED|Overall Study||26||
48612210|NCT01826981|101838225|FG013|STARTED|Overall Study||20||
48612211|NCT01826981|101838226|FG014|STARTED|Overall Study||8||
48612212|NCT01826981|101838212|FG000|COMPLETED|Overall Study||19||
48612213|NCT01826981|101838213|FG001|COMPLETED|Overall Study||9||
48612214|NCT01826981|101838214|FG002|COMPLETED|Overall Study||25||
48612215|NCT01826981|101838215|FG003|COMPLETED|Overall Study||26||
48612216|NCT01826981|101838216|FG004|COMPLETED|Overall Study||18||
48612217|NCT01826981|101838217|FG005|COMPLETED|Overall Study||25||
48612218|NCT01826981|101838218|FG006|COMPLETED|Overall Study||24||
48612219|NCT01826981|101838219|FG007|COMPLETED|Overall Study||40||
48612220|NCT01826981|101838220|FG008|COMPLETED|Overall Study||13||
48612221|NCT01826981|101838221|FG009|COMPLETED|Overall Study||26||
48612222|NCT01826981|101838222|FG010|COMPLETED|Overall Study||22||
48612223|NCT01826981|101838223|FG011|COMPLETED|Overall Study||25||
48612224|NCT01826981|101838224|FG012|COMPLETED|Overall Study||25||
48612225|NCT01826981|101838225|FG013|COMPLETED|Overall Study||15||
48612226|NCT01826981|101838226|FG014|COMPLETED|Overall Study||8||
48612227|NCT01826981|101838212|FG000|NOT COMPLETED|Overall Study||0||
48612228|NCT01826981|101838213|FG001|NOT COMPLETED|Overall Study||1||
48612229|NCT01826981|101838214|FG002|NOT COMPLETED|Overall Study||0||
48309420|NCT02170779|101084611|FG000|COMPLETED|Overall Study||19||
48309421|NCT02170779|101084612|FG001|COMPLETED|Overall Study||19||
48309422|NCT02170779|101084611|FG000|NOT COMPLETED|Overall Study||1||
48612230|NCT01826981|101838215|FG003|NOT COMPLETED|Overall Study||0||
48612231|NCT01826981|101838216|FG004|NOT COMPLETED|Overall Study||7||
48612232|NCT01826981|101838217|FG005|NOT COMPLETED|Overall Study||1||
48724211|NCT00701805|102111519|FG002|NOT COMPLETED|Overall Study||7||
48724212|NCT00701805|102111520|FG003|NOT COMPLETED|Overall Study||4||
48612233|NCT01826981|101838218|FG006|NOT COMPLETED|Overall Study||1||
48612234|NCT01826981|101838219|FG007|NOT COMPLETED|Overall Study||11||
48612235|NCT01826981|101838220|FG008|NOT COMPLETED|Overall Study||7||
48612236|NCT01826981|101838221|FG009|NOT COMPLETED|Overall Study||1||
48612237|NCT01826981|101838222|FG010|NOT COMPLETED|Overall Study||2||
48612238|NCT01826981|101838223|FG011|NOT COMPLETED|Overall Study||2||
48612239|NCT01826981|101838224|FG012|NOT COMPLETED|Overall Study||1||
48724213|NCT00931801|102111521|FG000|STARTED|Overall Study||14||
48724214|NCT00931801|102111522|FG001|STARTED|Overall Study||15||
48612240|NCT01826981|101838225|FG013|NOT COMPLETED|Overall Study||5||
48612241|NCT01826981|101838226|FG014|NOT COMPLETED|Overall Study||0||
48612242|NCT03626701|101838227|FG000|STARTED|Overall Study||13||
48612243|NCT03626701|101838228|FG001|STARTED|Overall Study||6||
48612244|NCT03626701|101838227|FG000|COMPLETED|Overall Study||9||
48612245|NCT03626701|101838228|FG001|COMPLETED|Overall Study||5||
48612246|NCT03626701|101838227|FG000|NOT COMPLETED|Overall Study||4||
48724215|NCT00931801|102111523|FG002|STARTED|Overall Study||14||
48309423|NCT02170779|101084612|FG001|NOT COMPLETED|Overall Study||1||
48309424|NCT04823611|101084613|FG000|STARTED|Overall Study||8||
48309425|NCT04823611|101084614|FG001|STARTED|Overall Study||3||
48309426|NCT04823611|101084615|FG002|STARTED|Overall Study||22||
48309427|NCT04823611|101084616|FG003|STARTED|Overall Study||22||
48309428|NCT04823611|101084617|FG004|STARTED|Overall Study||21||
48309429|NCT04823611|101084618|FG005|STARTED|Overall Study||8||
48309430|NCT04823611|101084619|FG006|STARTED|Overall Study||3||
48309431|NCT04823611|101084613|FG000|COMPLETED|Overall Study||6|Completed treatment|
48309432|NCT04823611|101084614|FG001|COMPLETED|Overall Study||3|Completed treatment|
48309433|NCT04823611|101084615|FG002|COMPLETED|Overall Study||21|Completed treatment|
48309434|NCT04823611|101084616|FG003|COMPLETED|Overall Study||22|Completed treatment|
48309435|NCT04823611|101084617|FG004|COMPLETED|Overall Study||21|Completed treatment|
48309436|NCT04823611|101084618|FG005|COMPLETED|Overall Study||8|Completed treatment|
48309437|NCT04823611|101084619|FG006|COMPLETED|Overall Study||3|Completed treatment|
48309438|NCT04823611|101084613|FG000|NOT COMPLETED|Overall Study||2||
48309439|NCT04823611|101084614|FG001|NOT COMPLETED|Overall Study||0||
48309440|NCT04823611|101084615|FG002|NOT COMPLETED|Overall Study||1||
48309441|NCT04823611|101084616|FG003|NOT COMPLETED|Overall Study||0||
48309442|NCT04823611|101084617|FG004|NOT COMPLETED|Overall Study||0||
48309443|NCT04823611|101084618|FG005|NOT COMPLETED|Overall Study||0||
48309444|NCT04823611|101084619|FG006|NOT COMPLETED|Overall Study||0||
48309445|NCT04280445|101084620|FG000|STARTED|Overall Study||3||
48309446|NCT04280445|101084620|FG000|COMPLETED|Overall Study||3||
48309447|NCT04280445|101084620|FG000|NOT COMPLETED|Overall Study||0||
48309448|NCT04340557|101084621|FG000|STARTED|Overall Study||16||
48309449|NCT04340557|101084622|FG001|STARTED|Overall Study||15||
48309450|NCT04340557|101084621|FG000|COMPLETED|Overall Study||15||
48309451|NCT04340557|101084622|FG001|COMPLETED|Overall Study||13||
48309452|NCT04340557|101084621|FG000|NOT COMPLETED|Overall Study||1||
48309453|NCT04340557|101084622|FG001|NOT COMPLETED|Overall Study||2||
48309454|NCT01293968|101084623|FG000|STARTED|Overall Study||20||
48309455|NCT01293968|101084624|FG001|STARTED|Overall Study||17||
48309456|NCT01293968|101084623|FG000|COMPLETED|Overall Study||17||
48309457|NCT01293968|101084624|FG001|COMPLETED|Overall Study||14||
48309458|NCT01293968|101084623|FG000|NOT COMPLETED|Overall Study||3||
48309459|NCT01293968|101084624|FG001|NOT COMPLETED|Overall Study||3||
48309460|NCT03662139|101084625|FG000|STARTED|Overall Study||16||
48309461|NCT03662139|101084626|FG001|STARTED|Overall Study||16||
48309462|NCT03662139|101084625|FG000|COMPLETED|Overall Study||16||
48309463|NCT03662139|101084626|FG001|COMPLETED|Overall Study||16||
48309464|NCT03662139|101084625|FG000|NOT COMPLETED|Overall Study||0||
48309465|NCT03662139|101084626|FG001|NOT COMPLETED|Overall Study||0||
48309466|NCT00805025|101084627|FG000|STARTED|Overall Study||131||
48309467|NCT00805025|101084627|FG000|Enrolled and Treated|Overall Study||89||
48309468|NCT00805025|101084627|FG000|COMPLETED|Overall Study||82||
48309469|NCT00805025|101084627|FG000|NOT COMPLETED|Overall Study||49||
48309470|NCT02790138|101084628|FG000|STARTED|Overall Study||51||
48309471|NCT02790138|101084629|FG001|STARTED|Overall Study||51||
48309472|NCT02790138|101084628|FG000|COMPLETED|Overall Study||30||
48309473|NCT02790138|101084629|FG001|COMPLETED|Overall Study||32||
48309474|NCT02790138|101084628|FG000|NOT COMPLETED|Overall Study||21||
48309475|NCT02790138|101084629|FG001|NOT COMPLETED|Overall Study||19||
48309476|NCT00718549|101084630|FG000|STARTED|Induction Phase||128||
48309477|NCT00718549|101084631|FG001|STARTED|Induction Phase||0||
48309478|NCT00718549|101084632|FG002|STARTED|Induction Phase||0||
48309479|NCT00718549|101084630|FG000|COMPLETED|Induction Phase||66||
48309480|NCT00718549|101084631|FG001|COMPLETED|Induction Phase||0||
48309481|NCT00718549|101084632|FG002|COMPLETED|Induction Phase||0||
48309482|NCT00718549|101084630|FG000|NOT COMPLETED|Induction Phase||62||
48309483|NCT00718549|101084631|FG001|NOT COMPLETED|Induction Phase||0||
48309484|NCT00718549|101084632|FG002|NOT COMPLETED|Induction Phase||0||
48309485|NCT00718549|101084630|FG000|STARTED|Maintenance/ Observation Phase||0||
48309486|NCT00718549|101084631|FG001|STARTED|Maintenance/ Observation Phase||33||
48309487|NCT00718549|101084632|FG002|STARTED|Maintenance/ Observation Phase||33||
48309488|NCT00718549|101084630|FG000|COMPLETED|Maintenance/ Observation Phase||0||
48309489|NCT00718549|101084631|FG001|COMPLETED|Maintenance/ Observation Phase||5||
48309490|NCT00718549|101084632|FG002|COMPLETED|Maintenance/ Observation Phase||3||
48309491|NCT00718549|101084630|FG000|NOT COMPLETED|Maintenance/ Observation Phase||0||
48309492|NCT00718549|101084631|FG001|NOT COMPLETED|Maintenance/ Observation Phase||28||
48309493|NCT00718549|101084632|FG002|NOT COMPLETED|Maintenance/ Observation Phase||30||
48309494|NCT02248259|101084633|FG000|STARTED|Treatment Period 1||6||
48309495|NCT02248259|101084634|FG001|STARTED|Treatment Period 1||6||
48309496|NCT02248259|101084635|FG002|STARTED|Treatment Period 1||7||
48309497|NCT02248259|101084636|FG003|STARTED|Treatment Period 1||6||
48309498|NCT02248259|101084633|FG000|COMPLETED|Treatment Period 1||6||
48309499|NCT02248259|101084634|FG001|COMPLETED|Treatment Period 1||6||
48309500|NCT02248259|101084635|FG002|COMPLETED|Treatment Period 1||6||
48309501|NCT02248259|101084636|FG003|COMPLETED|Treatment Period 1||6||
48309502|NCT02248259|101084633|FG000|NOT COMPLETED|Treatment Period 1||0||
48309503|NCT02248259|101084634|FG001|NOT COMPLETED|Treatment Period 1||0||
48309504|NCT02248259|101084635|FG002|NOT COMPLETED|Treatment Period 1||1||
48309505|NCT02248259|101084636|FG003|NOT COMPLETED|Treatment Period 1||0||
48309506|NCT02248259|101084633|FG000|STARTED|Treatment Period 2||6||
48309507|NCT02248259|101084634|FG001|STARTED|Treatment Period 2||6||
48309508|NCT02248259|101084635|FG002|STARTED|Treatment Period 2||6||
48309509|NCT02248259|101084636|FG003|STARTED|Treatment Period 2||6||
48309510|NCT02248259|101084633|FG000|COMPLETED|Treatment Period 2||6||
48309511|NCT02248259|101084634|FG001|COMPLETED|Treatment Period 2||6||
48309512|NCT02248259|101084635|FG002|COMPLETED|Treatment Period 2||6||
48309513|NCT02248259|101084636|FG003|COMPLETED|Treatment Period 2||6||
48309514|NCT02248259|101084633|FG000|NOT COMPLETED|Treatment Period 2||0||
48309515|NCT02248259|101084634|FG001|NOT COMPLETED|Treatment Period 2||0||
48309516|NCT02248259|101084635|FG002|NOT COMPLETED|Treatment Period 2||0||
48309517|NCT02248259|101084636|FG003|NOT COMPLETED|Treatment Period 2||0||
48612247|NCT03626701|101838228|FG001|NOT COMPLETED|Overall Study||1||
48612248|NCT00410072|101838229|FG000|STARTED|Day 1 to Week 48||182||
48612249|NCT00410072|101838230|FG001|STARTED|Day 1 to Week 48||197||
48612250|NCT00410072|101838229|FG000|COMPLETED|Day 1 to Week 48||176||
48612251|NCT00410072|101838230|FG001|COMPLETED|Day 1 to Week 48||185||
48612252|NCT00410072|101838229|FG000|NOT COMPLETED|Day 1 to Week 48||6||
48612253|NCT00410072|101838230|FG001|NOT COMPLETED|Day 1 to Week 48||12||
48612254|NCT00410072|101838229|FG000|STARTED|After Week 48 to Week 96||176||
48612255|NCT00410072|101838230|FG001|STARTED|After Week 48 to Week 96||185||
48612256|NCT00410072|101838229|FG000|COMPLETED|After Week 48 to Week 96||170||
48612257|NCT00410072|101838230|FG001|COMPLETED|After Week 48 to Week 96||174||
48612258|NCT00410072|101838229|FG000|NOT COMPLETED|After Week 48 to Week 96||6||
48612259|NCT00410072|101838230|FG001|NOT COMPLETED|After Week 48 to Week 96||11||
48612260|NCT00105989|101838231|FG000|STARTED|Acute - Open Label: Week 0-10||514||
48612261|NCT00105989|101838232|FG001|STARTED|Acute - Open Label: Week 0-10||0||
48612262|NCT00105989|101838231|FG000|COMPLETED|Acute - Open Label: Week 0-10||413||
48612263|NCT00105989|101838232|FG001|COMPLETED|Acute - Open Label: Week 0-10||0||
48612264|NCT00105989|101838231|FG000|NOT COMPLETED|Acute - Open Label: Week 0-10||101||
48612265|NCT00105989|101838232|FG001|NOT COMPLETED|Acute - Open Label: Week 0-10||0||
48612266|NCT00105989|101838231|FG000|STARTED|Continuation - Open Label:Week 10-34||413||
48612267|NCT00105989|101838232|FG001|STARTED|Continuation - Open Label:Week 10-34||0||
48309518|NCT00687440|101084637|FG000|STARTED|Overall Study||27||
48309519|NCT00687440|101084637|FG000|COMPLETED|Overall Study||15||
48309520|NCT00687440|101084637|FG000|NOT COMPLETED|Overall Study||12||
48309521|NCT00832520|101084638|FG000|STARTED|Overall Study||13||
48309522|NCT00832520|101084638|FG000|COMPLETED|Overall Study||13||
48309523|NCT00832520|101084638|FG000|NOT COMPLETED|Overall Study||0||
48309524|NCT01131351|101084639|FG000|STARTED|Overall Study||5||
48309525|NCT01131351|101084640|FG001|STARTED|Overall Study||5||
48309526|NCT01131351|101084639|FG000|COMPLETED|Overall Study||5||
48309527|NCT01131351|101084640|FG001|COMPLETED|Overall Study||2||
48309528|NCT01131351|101084639|FG000|NOT COMPLETED|Overall Study||0||
48309529|NCT01131351|101084640|FG001|NOT COMPLETED|Overall Study||3||
48309530|NCT01958788|101084641|FG000|STARTED|Overall Study||7||
48309531|NCT01958788|101084641|FG000|COMPLETED|Overall Study||7||
48309532|NCT01958788|101084641|FG000|NOT COMPLETED|Overall Study||0||
48309533|NCT02000427|101084642|FG000|STARTED|Overall Study||45||
48309534|NCT02000427|101084642|FG000|COMPLETED|Overall Study||23||
48309535|NCT02000427|101084642|FG000|NOT COMPLETED|Overall Study||22||
48309536|NCT01069172|101084643|FG000|STARTED|Overall Study||30||
48309537|NCT01069172|101084644|FG001|STARTED|Overall Study||30||
48309538|NCT01069172|101084643|FG000|COMPLETED|Overall Study||29||
48309539|NCT01069172|101084644|FG001|COMPLETED|Overall Study||30||
48309540|NCT01069172|101084643|FG000|NOT COMPLETED|Overall Study||1||
48309541|NCT01069172|101084644|FG001|NOT COMPLETED|Overall Study||0||
48309542|NCT01794520|101084645|FG000|STARTED|Overall Study||6||
48309543|NCT01794520|101084646|FG001|STARTED|Overall Study||9||
48309544|NCT01794520|101084647|FG002|STARTED|Overall Study||6||
48309545|NCT01794520|101084648|FG003|STARTED|Overall Study||9||
48309546|NCT01794520|101084649|FG004|STARTED|Overall Study||36||
48309547|NCT01794520|101084650|FG005|STARTED|Overall Study||20||
48309548|NCT01794520|101084651|FG006|STARTED|Overall Study||31||
48309549|NCT01794520|101084645|FG000|COMPLETED|Overall Study||0||
48309550|NCT01794520|101084646|FG001|COMPLETED|Overall Study||0||
48309551|NCT01794520|101084647|FG002|COMPLETED|Overall Study||0||
48309552|NCT01794520|101084648|FG003|COMPLETED|Overall Study||0||
48309553|NCT01794520|101084649|FG004|COMPLETED|Overall Study||0||
48309554|NCT01794520|101084650|FG005|COMPLETED|Overall Study||0||
48309555|NCT01794520|101084651|FG006|COMPLETED|Overall Study||0||
48309556|NCT01794520|101084645|FG000|NOT COMPLETED|Overall Study||6||
48309557|NCT01794520|101084646|FG001|NOT COMPLETED|Overall Study||9||
48309558|NCT01794520|101084647|FG002|NOT COMPLETED|Overall Study||6||
48309559|NCT01794520|101084648|FG003|NOT COMPLETED|Overall Study||9||
48309560|NCT01794520|101084649|FG004|NOT COMPLETED|Overall Study||36||
48309561|NCT01794520|101084650|FG005|NOT COMPLETED|Overall Study||20||
48309562|NCT01794520|101084651|FG006|NOT COMPLETED|Overall Study||31||
48309563|NCT00495820|101084652|FG000|STARTED|Overall Study||30||
48309564|NCT00495820|101084653|FG001|STARTED|Overall Study||30||
48309565|NCT00495820|101084652|FG000|COMPLETED|Overall Study||29||
48309566|NCT00495820|101084653|FG001|COMPLETED|Overall Study||29||
48724216|NCT00931801|102111521|FG000|COMPLETED|Overall Study||13||
48724217|NCT00931801|102111522|FG001|COMPLETED|Overall Study||14||
48724218|NCT00931801|102111523|FG002|COMPLETED|Overall Study||10||
48724219|NCT00931801|102111521|FG000|NOT COMPLETED|Overall Study||1||
48724220|NCT00931801|102111522|FG001|NOT COMPLETED|Overall Study||1||
48724221|NCT00931801|102111523|FG002|NOT COMPLETED|Overall Study||4||
48724222|NCT04450329|102111524|FG000|STARTED|Main Period||224||
48724223|NCT04450329|102111525|FG001|STARTED|Main Period||225||
48724224|NCT04450329|102111526|FG002|STARTED|Main Period||0||
48724225|NCT04450329|102111527|FG003|STARTED|Main Period||0||
48724226|NCT04450329|102111524|FG000|COMPLETED|Main Period||219||
48724227|NCT04450329|102111525|FG001|COMPLETED|Main Period||219||
48724228|NCT04450329|102111526|FG002|COMPLETED|Main Period||0||
48724229|NCT04450329|102111527|FG003|COMPLETED|Main Period||0||
48724230|NCT04450329|102111524|FG000|NOT COMPLETED|Main Period||5||
48724231|NCT04450329|102111525|FG001|NOT COMPLETED|Main Period||6||
48309567|NCT00495820|101084652|FG000|NOT COMPLETED|Overall Study||1||
48309568|NCT00495820|101084653|FG001|NOT COMPLETED|Overall Study||1||
48309569|NCT04377711|101084654|FG000|STARTED|Overall Study||197||
48309570|NCT04377711|101084655|FG001|STARTED|Overall Study||203||
48309571|NCT04377711|101084654|FG000|COMPLETED|Overall Study||178||
48309572|NCT04377711|101084655|FG001|COMPLETED|Overall Study||181||
48309573|NCT04377711|101084654|FG000|NOT COMPLETED|Overall Study||19||
48309574|NCT04377711|101084655|FG001|NOT COMPLETED|Overall Study||22||
48309575|NCT00601705|101084656|FG000|STARTED|Overall Study||61||
48309576|NCT00601705|101084656|FG000|COMPLETED|Overall Study||60||
48309577|NCT00601705|101084656|FG000|NOT COMPLETED|Overall Study||1||
48309578|NCT00861913|101084657|FG000|STARTED|Overall Study||13||
48309579|NCT00861913|101084657|FG000|COMPLETED|Overall Study||13||
48309580|NCT00861913|101084657|FG000|NOT COMPLETED|Overall Study||0||
48309581|NCT01458366|101084658|FG000|STARTED|Period 1: 70mg/m^2||5||
48309582|NCT01458366|101084659|FG001|STARTED|Period 1: 70mg/m^2||0||
48309583|NCT01458366|101084660|FG002|STARTED|Period 1: 70mg/m^2||0||
48309584|NCT01458366|101084661|FG003|STARTED|Period 1: 70mg/m^2||0||
48724232|NCT04450329|102111526|FG002|NOT COMPLETED|Main Period||0||
48724233|NCT04450329|102111527|FG003|NOT COMPLETED|Main Period||0||
48724234|NCT04450329|102111524|FG000|STARTED|Transition Period||219||
48724235|NCT04450329|102111525|FG001|STARTED|Transition Period||0||
48724236|NCT04450329|102111526|FG002|STARTED|Transition Period||111||
48724237|NCT04450329|102111527|FG003|STARTED|Transition Period||108||
48724238|NCT04450329|102111524|FG000|COMPLETED|Transition Period||215||
48153911|NCT01267292|100699877|FG000|COMPLETED|Overall Study||20||
48153912|NCT01267292|100699878|FG001|COMPLETED|Overall Study||20||
48153913|NCT01267292|100699877|FG000|NOT COMPLETED|Overall Study||4||
48153914|NCT01267292|100699878|FG001|NOT COMPLETED|Overall Study||6||
48153915|NCT02003508|100699879|FG000|STARTED|Overall Study||179||
48153916|NCT02003508|100699880|FG001|STARTED|Overall Study||166||
48153917|NCT02003508|100699879|FG000|COMPLETED|Overall Study||179||
48153918|NCT02003508|100699880|FG001|COMPLETED|Overall Study||166||
48153919|NCT02003508|100699879|FG000|NOT COMPLETED|Overall Study||0||
48153920|NCT02003508|100699880|FG001|NOT COMPLETED|Overall Study||0||
48153921|NCT04026529|100699881|FG000|STARTED|Overall Study||8||
48153922|NCT04026529|100699881|FG000|COMPLETED|Overall Study||8||
48153923|NCT04026529|100699881|FG000|NOT COMPLETED|Overall Study||0||
48153924|NCT02355743|100699882|FG000|STARTED|Overall Study||8||
48153925|NCT02355743|100699882|FG000|COMPLETED|Overall Study||6||
48153926|NCT02355743|100699882|FG000|NOT COMPLETED|Overall Study||2||
48153927|NCT01946542|100699883|FG000|STARTED|Testing Visit 1||1||
48153928|NCT01946542|100699884|FG001|STARTED|Testing Visit 1||1||
48153929|NCT01946542|100699883|FG000|COMPLETED|Testing Visit 1||1||
48153930|NCT01946542|100699884|FG001|COMPLETED|Testing Visit 1||1||
48153931|NCT01946542|100699883|FG000|NOT COMPLETED|Testing Visit 1||0||
48309585|NCT01458366|101084662|FG004|STARTED|Period 1: 70mg/m^2||0||
48309586|NCT01458366|101084658|FG000|COMPLETED|Period 1: 70mg/m^2||3||
48309587|NCT01458366|101084659|FG001|COMPLETED|Period 1: 70mg/m^2||0||
48309588|NCT01458366|101084660|FG002|COMPLETED|Period 1: 70mg/m^2||0||
48309589|NCT01458366|101084661|FG003|COMPLETED|Period 1: 70mg/m^2||0||
48309590|NCT01458366|101084662|FG004|COMPLETED|Period 1: 70mg/m^2||0||
48309591|NCT01458366|101084658|FG000|NOT COMPLETED|Period 1: 70mg/m^2||2||
48309592|NCT01458366|101084659|FG001|NOT COMPLETED|Period 1: 70mg/m^2||0||
48309593|NCT01458366|101084660|FG002|NOT COMPLETED|Period 1: 70mg/m^2||0||
48309594|NCT01458366|101084661|FG003|NOT COMPLETED|Period 1: 70mg/m^2||0||
48309595|NCT01458366|101084662|FG004|NOT COMPLETED|Period 1: 70mg/m^2||0||
48309596|NCT01458366|101084658|FG000|STARTED|Period 2: 50mg/m^2||0||
48309597|NCT01458366|101084659|FG001|STARTED|Period 2: 50mg/m^2||0||
48309598|NCT01458366|101084660|FG002|STARTED|Period 2: 50mg/m^2||0||
48309599|NCT01458366|101084661|FG003|STARTED|Period 2: 50mg/m^2||0||
48309600|NCT01458366|101084662|FG004|STARTED|Period 2: 50mg/m^2||0||
48309601|NCT01458366|101084658|FG000|COMPLETED|Period 2: 50mg/m^2||0||
48309602|NCT01458366|101084659|FG001|COMPLETED|Period 2: 50mg/m^2||0||
48309603|NCT01458366|101084660|FG002|COMPLETED|Period 2: 50mg/m^2||0||
48309604|NCT01458366|101084661|FG003|COMPLETED|Period 2: 50mg/m^2||0||
48309605|NCT01458366|101084662|FG004|COMPLETED|Period 2: 50mg/m^2||0||
48309606|NCT01458366|101084658|FG000|NOT COMPLETED|Period 2: 50mg/m^2||0||
48309607|NCT01458366|101084659|FG001|NOT COMPLETED|Period 2: 50mg/m^2||0||
48309608|NCT01458366|101084660|FG002|NOT COMPLETED|Period 2: 50mg/m^2||0||
48309609|NCT01458366|101084661|FG003|NOT COMPLETED|Period 2: 50mg/m^2||0||
48309610|NCT01458366|101084662|FG004|NOT COMPLETED|Period 2: 50mg/m^2||0||
48309611|NCT01458366|101084658|FG000|STARTED|Period 3: 90mg/m^2||0||
48309612|NCT01458366|101084659|FG001|STARTED|Period 3: 90mg/m^2||0||
48309613|NCT01458366|101084660|FG002|STARTED|Period 3: 90mg/m^2||3||
48309614|NCT01458366|101084661|FG003|STARTED|Period 3: 90mg/m^2||0||
48309615|NCT01458366|101084662|FG004|STARTED|Period 3: 90mg/m^2||0||
48309616|NCT01458366|101084658|FG000|COMPLETED|Period 3: 90mg/m^2||0||
48309617|NCT01458366|101084659|FG001|COMPLETED|Period 3: 90mg/m^2||0||
48309618|NCT01458366|101084660|FG002|COMPLETED|Period 3: 90mg/m^2||3||
48309619|NCT01458366|101084661|FG003|COMPLETED|Period 3: 90mg/m^2||0||
48309620|NCT01458366|101084662|FG004|COMPLETED|Period 3: 90mg/m^2||0||
48309621|NCT01458366|101084658|FG000|NOT COMPLETED|Period 3: 90mg/m^2||0||
48309622|NCT01458366|101084659|FG001|NOT COMPLETED|Period 3: 90mg/m^2||0||
48309623|NCT01458366|101084660|FG002|NOT COMPLETED|Period 3: 90mg/m^2||0||
48309624|NCT01458366|101084661|FG003|NOT COMPLETED|Period 3: 90mg/m^2||0||
48309625|NCT01458366|101084662|FG004|NOT COMPLETED|Period 3: 90mg/m^2||0||
48309626|NCT01458366|101084658|FG000|STARTED|Period 4: 120mg/m^2||0||
48309627|NCT01458366|101084659|FG001|STARTED|Period 4: 120mg/m^2||0||
48309628|NCT01458366|101084660|FG002|STARTED|Period 4: 120mg/m^2||0||
48309629|NCT01458366|101084661|FG003|STARTED|Period 4: 120mg/m^2||3||
48309630|NCT01458366|101084662|FG004|STARTED|Period 4: 120mg/m^2||0||
48309631|NCT01458366|101084658|FG000|COMPLETED|Period 4: 120mg/m^2||0||
48309632|NCT01458366|101084659|FG001|COMPLETED|Period 4: 120mg/m^2||0||
48309633|NCT01458366|101084660|FG002|COMPLETED|Period 4: 120mg/m^2||0||
48309634|NCT01458366|101084661|FG003|COMPLETED|Period 4: 120mg/m^2||3||
48309635|NCT01458366|101084662|FG004|COMPLETED|Period 4: 120mg/m^2||0||
48309636|NCT01458366|101084658|FG000|NOT COMPLETED|Period 4: 120mg/m^2||0||
48309637|NCT01458366|101084659|FG001|NOT COMPLETED|Period 4: 120mg/m^2||0||
48309638|NCT01458366|101084660|FG002|NOT COMPLETED|Period 4: 120mg/m^2||0||
48309639|NCT01458366|101084661|FG003|NOT COMPLETED|Period 4: 120mg/m^2||0||
48309640|NCT01458366|101084662|FG004|NOT COMPLETED|Period 4: 120mg/m^2||0||
48309641|NCT01458366|101084658|FG000|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0||
48309642|NCT01458366|101084659|FG001|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0||
48309643|NCT01458366|101084660|FG002|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0||
48309644|NCT01458366|101084661|FG003|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0||
48309645|NCT01458366|101084662|FG004|STARTED|Period 5: Maximum Tolerated Dose (MTD)||27||
48309646|NCT01458366|101084658|FG000|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0||
48309647|NCT01458366|101084659|FG001|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0||
48309648|NCT01458366|101084660|FG002|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0||
48309649|NCT01458366|101084661|FG003|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0||
48309650|NCT01458366|101084662|FG004|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||26||
48309651|NCT01458366|101084658|FG000|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0||
48309652|NCT01458366|101084659|FG001|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0||
48309653|NCT01458366|101084660|FG002|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0||
48309654|NCT01458366|101084661|FG003|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0||
48309655|NCT01458366|101084662|FG004|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||1||
48309656|NCT00706550|101084663|FG000|STARTED|Overall Study||43||
48309657|NCT00706550|101084664|FG001|STARTED|Overall Study||64||
48309658|NCT00706550|101084663|FG000|COMPLETED|Overall Study||36||
48309659|NCT00706550|101084664|FG001|COMPLETED|Overall Study||36||
48309660|NCT00706550|101084663|FG000|NOT COMPLETED|Overall Study||7||
48309661|NCT00706550|101084664|FG001|NOT COMPLETED|Overall Study||28||
48309662|NCT02224599|101084665|FG000|STARTED|Overall Study||3||
48309663|NCT02224599|101084665|FG000|COMPLETED|Overall Study||1||
48309664|NCT02224599|101084665|FG000|NOT COMPLETED|Overall Study||2||
48309665|NCT01721057|101084666|FG000|STARTED|Treatment Period||228||
48309666|NCT01721057|101084667|FG001|STARTED|Treatment Period||229||
48309667|NCT01721057|101084668|FG002|STARTED|Treatment Period||227||
48309668|NCT01721057|101084669|FG003|STARTED|Treatment Period||0||
48309669|NCT01721057|101084670|FG004|STARTED|Treatment Period||0||
48309670|NCT01721057|101084671|FG005|STARTED|Treatment Period||0||
48309671|NCT01721057|101084672|FG006|STARTED|Treatment Period||0||
48309672|NCT01721057|101084666|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||228||
48309673|NCT01721057|101084667|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||229||
48309674|NCT01721057|101084668|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||227||
48309675|NCT01721057|101084669|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||0||
48309676|NCT01721057|101084670|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||0||
48309677|NCT01721057|101084671|FG005|Received at Least 1 Dose of Study Drug|Treatment Period||0||
48309678|NCT01721057|101084672|FG006|Received at Least 1 Dose of Study Drug|Treatment Period||0||
48309679|NCT01721057|101084666|FG000|Rescued|Treatment Period||55||
48309680|NCT01721057|101084667|FG001|Rescued|Treatment Period||21||
48309681|NCT01721057|101084668|FG002|Rescued|Treatment Period||15||
48309682|NCT01721057|101084669|FG003|Rescued|Treatment Period||0||
48309683|NCT01721057|101084670|FG004|Rescued|Treatment Period||0||
48309684|NCT01721057|101084671|FG005|Rescued|Treatment Period||0||
48309685|NCT01721057|101084672|FG006|Rescued|Treatment Period||0||
48309686|NCT01721057|101084666|FG000|COMPLETED|Treatment Period||200||
48309687|NCT01721057|101084667|FG001|COMPLETED|Treatment Period||210||
48309688|NCT01721057|101084668|FG002|COMPLETED|Treatment Period||204||
48309689|NCT01721057|101084669|FG003|COMPLETED|Treatment Period||0||
48309690|NCT01721057|101084670|FG004|COMPLETED|Treatment Period||0||
48309691|NCT01721057|101084671|FG005|COMPLETED|Treatment Period||0||
48309692|NCT01721057|101084672|FG006|COMPLETED|Treatment Period||0||
48309693|NCT01721057|101084666|FG000|NOT COMPLETED|Treatment Period||28||
48309694|NCT01721057|101084667|FG001|NOT COMPLETED|Treatment Period||19||
48309695|NCT01721057|101084668|FG002|NOT COMPLETED|Treatment Period||23||
48309696|NCT01721057|101084669|FG003|NOT COMPLETED|Treatment Period||0||
48309697|NCT01721057|101084670|FG004|NOT COMPLETED|Treatment Period||0||
48309698|NCT01721057|101084671|FG005|NOT COMPLETED|Treatment Period||0||
48309699|NCT01721057|101084672|FG006|NOT COMPLETED|Treatment Period||0||
48309700|NCT01721057|101084666|FG000|STARTED|Rescue Period||0||
48309701|NCT01721057|101084667|FG001|STARTED|Rescue Period||0||
48309702|NCT01721057|101084668|FG002|STARTED|Rescue Period||0||
48309703|NCT01721057|101084669|FG003|STARTED|Rescue Period||91||
48309704|NCT01721057|101084670|FG004|STARTED|Rescue Period||0||
48309705|NCT01721057|101084671|FG005|STARTED|Rescue Period||0||
48309706|NCT01721057|101084672|FG006|STARTED|Rescue Period||0||
48724239|NCT04450329|102111525|FG001|COMPLETED|Transition Period||0||
48724240|NCT04450329|102111526|FG002|COMPLETED|Transition Period||109||
48724241|NCT04450329|102111527|FG003|COMPLETED|Transition Period||101||
48724242|NCT04450329|102111524|FG000|NOT COMPLETED|Transition Period||4||
48724243|NCT04450329|102111525|FG001|NOT COMPLETED|Transition Period||0||
48724244|NCT04450329|102111526|FG002|NOT COMPLETED|Transition Period||2||
48724245|NCT04450329|102111527|FG003|NOT COMPLETED|Transition Period||7||
48724246|NCT01657760|102111528|FG000|STARTED|Overall Study||5||
48724247|NCT01657760|102111529|FG001|STARTED|Overall Study||7||
48724248|NCT01657760|102111530|FG002|STARTED|Overall Study||7||
48724249|NCT01657760|102111531|FG003|STARTED|Overall Study||7||
48724250|NCT01657760|102111528|FG000|COMPLETED|Overall Study||4||
48724251|NCT01657760|102111529|FG001|COMPLETED|Overall Study||6||
48724252|NCT01657760|102111530|FG002|COMPLETED|Overall Study||6||
48724253|NCT01657760|102111531|FG003|COMPLETED|Overall Study||4||
48724254|NCT01657760|102111528|FG000|NOT COMPLETED|Overall Study||1||
48724255|NCT01657760|102111529|FG001|NOT COMPLETED|Overall Study||1||
48724256|NCT01657760|102111530|FG002|NOT COMPLETED|Overall Study||1||
48724257|NCT01657760|102111531|FG003|NOT COMPLETED|Overall Study||3||
48724258|NCT01919216|102111532|FG000|STARTED|Overall Study||28||
48724259|NCT01919216|102111533|FG001|STARTED|Overall Study||21||
48309707|NCT01721057|101084666|FG000|COMPLETED|Rescue Period||0||
48309708|NCT01721057|101084667|FG001|COMPLETED|Rescue Period||0||
48724260|NCT01919216|102111534|FG002|STARTED|Overall Study||5||
48309709|NCT01721057|101084668|FG002|COMPLETED|Rescue Period||0||
48309710|NCT01721057|101084669|FG003|COMPLETED|Rescue Period||88||
48309711|NCT01721057|101084670|FG004|COMPLETED|Rescue Period||0||
48309712|NCT01721057|101084671|FG005|COMPLETED|Rescue Period||0||
48309713|NCT01721057|101084672|FG006|COMPLETED|Rescue Period||0||
48309714|NCT01721057|101084666|FG000|NOT COMPLETED|Rescue Period||0||
48309715|NCT01721057|101084667|FG001|NOT COMPLETED|Rescue Period||0||
48309716|NCT01721057|101084668|FG002|NOT COMPLETED|Rescue Period||0||
48309717|NCT01721057|101084669|FG003|NOT COMPLETED|Rescue Period||3||
48309718|NCT01721057|101084670|FG004|NOT COMPLETED|Rescue Period||0||
48440013|NCT03046966|101410009|FG000|NOT COMPLETED|Overall Study||0||
48309719|NCT01721057|101084671|FG005|NOT COMPLETED|Rescue Period||0||
48309720|NCT01721057|101084672|FG006|NOT COMPLETED|Rescue Period||0||
48309721|NCT01721057|101084666|FG000|STARTED|Follow Up||0||
48309722|NCT01721057|101084667|FG001|STARTED|Follow Up||0||
48724261|NCT01919216|102111532|FG000|COMPLETED|Overall Study||26||
48309723|NCT01721057|101084668|FG002|STARTED|Follow Up||0||
48309724|NCT01721057|101084669|FG003|STARTED|Follow Up||0||
48309725|NCT01721057|101084670|FG004|STARTED|Follow Up||17||
48309726|NCT01721057|101084671|FG005|STARTED|Follow Up||19||
48309727|NCT01721057|101084672|FG006|STARTED|Follow Up||22||
48309728|NCT01721057|101084666|FG000|COMPLETED|Follow Up||0||
48309729|NCT01721057|101084667|FG001|COMPLETED|Follow Up||0||
48309730|NCT01721057|101084668|FG002|COMPLETED|Follow Up||0||
48309731|NCT01721057|101084669|FG003|COMPLETED|Follow Up||0||
48309732|NCT01721057|101084670|FG004|COMPLETED|Follow Up||17||
48309733|NCT01721057|101084671|FG005|COMPLETED|Follow Up||19||
48724262|NCT01919216|102111533|FG001|COMPLETED|Overall Study||20||
48724263|NCT01919216|102111534|FG002|COMPLETED|Overall Study||4||
48724264|NCT01919216|102111532|FG000|NOT COMPLETED|Overall Study||2||
48724265|NCT01919216|102111533|FG001|NOT COMPLETED|Overall Study||1||
48724266|NCT01919216|102111534|FG002|NOT COMPLETED|Overall Study||1||
48724267|NCT02964585|102111535|FG000|STARTED|Overall Study||15||
48724268|NCT02964585|102111536|FG001|STARTED|Overall Study||14||
48724269|NCT02964585|102111535|FG000|COMPLETED|Overall Study||15||
48724270|NCT02964585|102111536|FG001|COMPLETED|Overall Study||14||
48724271|NCT02964585|102111535|FG000|NOT COMPLETED|Overall Study||0||
48724272|NCT02964585|102111536|FG001|NOT COMPLETED|Overall Study||0||
48724273|NCT01543776|102111537|FG000|STARTED|Overall Study||36||
48724274|NCT01543776|102111538|FG001|STARTED|Overall Study||36||
48724275|NCT01543776|102111537|FG000|COMPLETED|Overall Study||34||
48724276|NCT01543776|102111538|FG001|COMPLETED|Overall Study||34||
48724277|NCT01543776|102111537|FG000|NOT COMPLETED|Overall Study||2||
48724278|NCT01543776|102111538|FG001|NOT COMPLETED|Overall Study||2||
48724279|NCT00991406|102111539|FG000|STARTED|Overall Study||9||
48309734|NCT01721057|101084672|FG006|COMPLETED|Follow Up||22||
48309735|NCT01721057|101084666|FG000|NOT COMPLETED|Follow Up||0||
48724280|NCT00991406|102111539|FG000|COMPLETED|Overall Study||8||
48724281|NCT00991406|102111539|FG000|NOT COMPLETED|Overall Study||1||
48724282|NCT01704456|102111540|FG000|STARTED|Overall Study||67||
48724283|NCT01704456|102111541|FG001|STARTED|Overall Study||63||
48724284|NCT01704456|102111540|FG000|COMPLETED|Overall Study||59||
48724285|NCT01704456|102111541|FG001|COMPLETED|Overall Study||49||
48724286|NCT01704456|102111540|FG000|NOT COMPLETED|Overall Study||8||
48724287|NCT01704456|102111541|FG001|NOT COMPLETED|Overall Study||14||
48724288|NCT00569868|102111542|FG000|STARTED|Overall Study||11||
48724289|NCT00569868|102111542|FG000|COMPLETED|Overall Study||11||
48724290|NCT00569868|102111542|FG000|NOT COMPLETED|Overall Study||0||
48724291|NCT02266576|102111543|FG000|STARTED|Overall Study||102||
48724292|NCT02266576|102111544|FG001|STARTED|Overall Study||105||
48724293|NCT02266576|102111543|FG000|COMPLETED|Overall Study||85||
48724294|NCT02266576|102111544|FG001|COMPLETED|Overall Study||90||
48724295|NCT02266576|102111543|FG000|NOT COMPLETED|Overall Study||17||
48724296|NCT02266576|102111544|FG001|NOT COMPLETED|Overall Study||15||
48724297|NCT04365452|102111545|FG000|STARTED|Overall Study||20||
48724298|NCT04365452|102111545|FG000|COMPLETED|Overall Study||20||
48724299|NCT04365452|102111545|FG000|NOT COMPLETED|Overall Study||0||
48724300|NCT03688100|102111546|FG000|STARTED|Overall Study||208||
48724301|NCT03688100|102111547|FG001|STARTED|Overall Study||208||
48724302|NCT03688100|102111548|FG002|STARTED|Overall Study||35||
48724303|NCT03688100|102111549|FG003|STARTED|Overall Study||43||
48724304|NCT03688100|102111546|FG000|COMPLETED|Overall Study||132||
48724305|NCT03688100|102111547|FG001|COMPLETED|Overall Study||150||
48724306|NCT03688100|102111548|FG002|COMPLETED|Overall Study||20||
48724307|NCT03688100|102111549|FG003|COMPLETED|Overall Study||25||
48724308|NCT03688100|102111546|FG000|NOT COMPLETED|Overall Study||76||
48724309|NCT03688100|102111547|FG001|NOT COMPLETED|Overall Study||58||
48309736|NCT01721057|101084667|FG001|NOT COMPLETED|Follow Up||0||
48309737|NCT01721057|101084668|FG002|NOT COMPLETED|Follow Up||0||
48309738|NCT01721057|101084669|FG003|NOT COMPLETED|Follow Up||0||
48309739|NCT01721057|101084670|FG004|NOT COMPLETED|Follow Up||0||
48309740|NCT01721057|101084671|FG005|NOT COMPLETED|Follow Up||0||
48309741|NCT01721057|101084672|FG006|NOT COMPLETED|Follow Up||0||
48309742|NCT00786565|101084673|FG000|STARTED|Enrollment Prior to Surgery||75||
48309743|NCT00786565|101084673|FG000|COMPLETED|Enrollment Prior to Surgery||69||
48309744|NCT00786565|101084673|FG000|NOT COMPLETED|Enrollment Prior to Surgery||6||
48309745|NCT00786565|101084673|FG000|STARTED|Post Surgery||69||
48309746|NCT00786565|101084673|FG000|COMPLETED|Post Surgery||67||
48724310|NCT03688100|102111548|FG002|NOT COMPLETED|Overall Study||15||
48724311|NCT03688100|102111549|FG003|NOT COMPLETED|Overall Study||18||
48724312|NCT01067469|102111550|FG000|STARTED|Overall Study||36||
48724313|NCT01067469|102111551|FG001|STARTED|Overall Study||35||
48724314|NCT01067469|102111550|FG000|90 mg/m^2|Overall Study||0||
48724315|NCT01067469|102111551|FG001|90 mg/m^2|Overall Study||12||
48724316|NCT01067469|102111550|FG000|75 mg/m^2|Overall Study||0||
48724317|NCT01067469|102111551|FG001|75 mg/m^2|Overall Study||21||
48724318|NCT01067469|102111550|FG000|COMPLETED|Overall Study||36||
48724319|NCT01067469|102111551|FG001|COMPLETED|Overall Study||33||
48724320|NCT01067469|102111550|FG000|NOT COMPLETED|Overall Study||0||
48724321|NCT01067469|102111551|FG001|NOT COMPLETED|Overall Study||2||
48724322|NCT02477553|102111552|FG000|STARTED|Overall Study||364||
48724323|NCT02477553|102111553|FG001|STARTED|Overall Study||364||
48309747|NCT00786565|101084673|FG000|NOT COMPLETED|Post Surgery||2||
48309748|NCT00591214|101084674|FG000|STARTED|Overall Study||10||
48309749|NCT00591214|101084674|FG000|COMPLETED|Overall Study||2||
48309750|NCT00591214|101084674|FG000|NOT COMPLETED|Overall Study||8||
48309751|NCT00619255|101084675|FG000|STARTED|Overall Study||59||
48309752|NCT00619255|101084676|FG001|STARTED|Overall Study||61||
48309753|NCT00619255|101084675|FG000|COMPLETED|Overall Study||57||
48309754|NCT00619255|101084676|FG001|COMPLETED|Overall Study||61||
48309755|NCT00619255|101084675|FG000|NOT COMPLETED|Overall Study||2||
48309756|NCT00619255|101084676|FG001|NOT COMPLETED|Overall Study||0||
48309757|NCT00290186|101084677|FG000|STARTED|Overall Study||25||
48309758|NCT00290186|101084678|FG001|STARTED|Overall Study||24||
48309759|NCT00290186|101084677|FG000|Completed Baseline Assessments|Overall Study||25||
48309760|NCT00290186|101084678|FG001|Completed Baseline Assessments|Overall Study||24||
48309761|NCT00290186|101084677|FG000|Completed 8 Weeks of Treatment|Overall Study||24||
48309762|NCT00290186|101084678|FG001|Completed 8 Weeks of Treatment|Overall Study||22||
48309763|NCT00290186|101084677|FG000|Completed Post-treatment Assessments|Overall Study||24||
48309764|NCT00290186|101084678|FG001|Completed Post-treatment Assessments|Overall Study||22||
48309765|NCT00290186|101084677|FG000|Completed 3-month Followup Assessments|Overall Study||20||
48309766|NCT00290186|101084678|FG001|Completed 3-month Followup Assessments|Overall Study||21||
48724324|NCT02477553|102111552|FG000|COMPLETED|Overall Study||344||
48724325|NCT02477553|102111553|FG001|COMPLETED|Overall Study||344||
48724326|NCT02477553|102111552|FG000|NOT COMPLETED|Overall Study||20||
48724327|NCT02477553|102111553|FG001|NOT COMPLETED|Overall Study||20||
48309767|NCT00290186|101084677|FG000|Completed 6-month Followup Assessments|Overall Study||20||
48309768|NCT00290186|101084678|FG001|Completed 6-month Followup Assessments|Overall Study||19||
48309769|NCT00290186|101084677|FG000|COMPLETED|Overall Study||20||
48724328|NCT01639755|102111554|FG000|STARTED|Overall Study||19||
48724329|NCT01639755|102111554|FG000|COMPLETED|Overall Study||0||
48309770|NCT00290186|101084678|FG001|COMPLETED|Overall Study||19||
48309771|NCT00290186|101084677|FG000|NOT COMPLETED|Overall Study||5||
48309772|NCT00290186|101084678|FG001|NOT COMPLETED|Overall Study||5||
48309773|NCT00701090|101084679|FG000|STARTED|Overall Study||516||
48309774|NCT00701090|101084680|FG001|STARTED|Overall Study||519||
48309775|NCT00701090|101084679|FG000|COMPLETED|Overall Study||468||
48309776|NCT00701090|101084680|FG001|COMPLETED|Overall Study||468||
48309777|NCT00701090|101084679|FG000|NOT COMPLETED|Overall Study||48||
48309778|NCT00701090|101084680|FG001|NOT COMPLETED|Overall Study||51||
48309779|NCT01022502|101084681|FG000|STARTED|Overall Study||38||
48309780|NCT01022502|101084681|FG000|COMPLETED|Overall Study||35||
48309781|NCT01022502|101084681|FG000|NOT COMPLETED|Overall Study||3||
48309782|NCT02716675|101084682|FG000|STARTED|Overall Study||903|Enrollment is concurrent with receiving the first infusion (safety analyses)|
48309783|NCT02716675|101084683|FG001|STARTED|Overall Study||899|Enrollment is concurrent with receiving the first infusion (safety analyses)|
48309784|NCT02716675|101084684|FG002|STARTED|Overall Study||897|Enrollment is concurrent with receiving the first infusion (safety analyses)|
48309785|NCT02716675|101084682|FG000|Modified Intent-to-treat Population|Overall Study||898|Participants excluded from MITT if HIV positive at enrollment or randomized/enrolled more than once (efficacy analyses)|
48309786|NCT02716675|101084683|FG001|Modified Intent-to-treat Population|Overall Study||895|Participants excluded from MITT if HIV positive at enrollment or randomized/enrolled more than once (efficacy analyses)|
48309787|NCT02716675|101084684|FG002|Modified Intent-to-treat Population|Overall Study||894|Participants excluded from MITT if HIV positive at enrollment or randomized/enrolled more than once (efficacy analyses)|
48724330|NCT01639755|102111554|FG000|NOT COMPLETED|Overall Study||19||
48724331|NCT05098509|102111555|FG000|STARTED|Overall Study||1||
48724332|NCT05098509|102111556|FG001|STARTED|Overall Study||1||
48724333|NCT05098509|102111557|FG002|STARTED|Overall Study||2||
48724334|NCT05098509|102111558|FG003|STARTED|Overall Study||0||
48724335|NCT05098509|102111555|FG000|Received 1 Dose of Study Drug|Overall Study||1||
48309788|NCT02716675|101084682|FG000|COMPLETED|Overall Study||703||
48309789|NCT02716675|101084683|FG001|COMPLETED|Overall Study||702||
48309790|NCT02716675|101084684|FG002|COMPLETED|Overall Study||686||
48309791|NCT02716675|101084682|FG000|NOT COMPLETED|Overall Study||200||
48309792|NCT02716675|101084683|FG001|NOT COMPLETED|Overall Study||197||
48309793|NCT02716675|101084684|FG002|NOT COMPLETED|Overall Study||211||
48309794|NCT02901574|101084685|FG000|STARTED|Intervention Period 1 (up to 5 Weeks)||14||
48724336|NCT05098509|102111556|FG001|Received 1 Dose of Study Drug|Overall Study||1||
48724337|NCT05098509|102111557|FG002|Received 1 Dose of Study Drug|Overall Study||2||
48724338|NCT05098509|102111558|FG003|Received 1 Dose of Study Drug|Overall Study||0||
48724339|NCT05098509|102111555|FG000|COMPLETED|Overall Study||0||
48309795|NCT02901574|101084686|FG001|STARTED|Intervention Period 1 (up to 5 Weeks)||14||
48309796|NCT02901574|101084685|FG000|COMPLETED|Intervention Period 1 (up to 5 Weeks)||11||
48368032|NCT03567291|101230093|FG001|COMPLETED|Period II||88||
48724340|NCT05098509|102111556|FG001|COMPLETED|Overall Study||0||
48724341|NCT05098509|102111557|FG002|COMPLETED|Overall Study||0||
48724342|NCT05098509|102111558|FG003|COMPLETED|Overall Study||0||
48724343|NCT05098509|102111555|FG000|NOT COMPLETED|Overall Study||1||
48724344|NCT05098509|102111556|FG001|NOT COMPLETED|Overall Study||1||
48724345|NCT05098509|102111557|FG002|NOT COMPLETED|Overall Study||2||
48724346|NCT05098509|102111558|FG003|NOT COMPLETED|Overall Study||0||
48309797|NCT02901574|101084686|FG001|COMPLETED|Intervention Period 1 (up to 5 Weeks)||13||
48309798|NCT02901574|101084685|FG000|NOT COMPLETED|Intervention Period 1 (up to 5 Weeks)||3||
48309799|NCT02901574|101084686|FG001|NOT COMPLETED|Intervention Period 1 (up to 5 Weeks)||1||
48309800|NCT02901574|101084685|FG000|STARTED|Wash Out ( 8 Weeks)||11||
48309801|NCT02901574|101084686|FG001|STARTED|Wash Out ( 8 Weeks)||13||
48309802|NCT02901574|101084685|FG000|COMPLETED|Wash Out ( 8 Weeks)||10||
48309803|NCT02901574|101084686|FG001|COMPLETED|Wash Out ( 8 Weeks)||12||
48309804|NCT02901574|101084685|FG000|NOT COMPLETED|Wash Out ( 8 Weeks)||1||
48309805|NCT02901574|101084686|FG001|NOT COMPLETED|Wash Out ( 8 Weeks)||1||
48309806|NCT02901574|101084685|FG000|STARTED|Intervention Period 2 (up to 5 Weeks)||10||
48309807|NCT02901574|101084686|FG001|STARTED|Intervention Period 2 (up to 5 Weeks)||12||
48309808|NCT02901574|101084685|FG000|COMPLETED|Intervention Period 2 (up to 5 Weeks)||10||
48309809|NCT02901574|101084686|FG001|COMPLETED|Intervention Period 2 (up to 5 Weeks)||12||
48309810|NCT02901574|101084685|FG000|NOT COMPLETED|Intervention Period 2 (up to 5 Weeks)||0||
48309811|NCT02901574|101084686|FG001|NOT COMPLETED|Intervention Period 2 (up to 5 Weeks)||0||
48309812|NCT01358760|101084687|FG000|STARTED|Overall Study||152||
48309813|NCT01358760|101084688|FG001|STARTED|Overall Study||148||
48309814|NCT01358760|101084689|FG002|STARTED|Overall Study||150||
48309815|NCT01358760|101084687|FG000|Safety Population|Overall Study||150||
48309816|NCT01358760|101084688|FG001|Safety Population|Overall Study||143||
48309817|NCT01358760|101084689|FG002|Safety Population|Overall Study||148||
48724347|NCT00054028|102111559|FG000|STARTED|Overall Study||31||
48724348|NCT00054028|102111559|FG000|Phase I|Overall Study||9||
48724349|NCT00054028|102111559|FG000|Phase II|Overall Study||22||
48724350|NCT00054028|102111559|FG000|COMPLETED|Overall Study||31||
48724351|NCT00054028|102111559|FG000|NOT COMPLETED|Overall Study||0||
48724352|NCT04268745|102111560|FG000|STARTED|Overall Study||15||
48724353|NCT04268745|102111561|FG001|STARTED|Overall Study||15||
48724354|NCT04268745|102111560|FG000|COMPLETED|Overall Study||8||
48724355|NCT04268745|102111561|FG001|COMPLETED|Overall Study||10||
48724356|NCT04268745|102111560|FG000|NOT COMPLETED|Overall Study||7||
48724357|NCT04268745|102111561|FG001|NOT COMPLETED|Overall Study||5||
48724358|NCT00172042|102111562|FG000|STARTED|Overall Study||226||
48724359|NCT00172042|102111563|FG001|STARTED|Overall Study||211||
48724360|NCT00172042|102111562|FG000|COMPLETED|Overall Study||68||
48724361|NCT00172042|102111563|FG001|COMPLETED|Overall Study||86||
48724362|NCT00172042|102111562|FG000|NOT COMPLETED|Overall Study||158||
48724363|NCT00172042|102111563|FG001|NOT COMPLETED|Overall Study||125||
48724364|NCT00440830|102111564|FG000|STARTED|Overall Study||20||
48724365|NCT00440830|102111565|FG001|STARTED|Overall Study||8||
48724366|NCT00440830|102111566|FG002|STARTED|Overall Study||30||
48724367|NCT00440830|102111567|FG003|STARTED|Overall Study||10||
48724368|NCT00440830|102111564|FG000|COMPLETED|Overall Study||20||
48724369|NCT00440830|102111565|FG001|COMPLETED|Overall Study||8||
48724370|NCT00440830|102111566|FG002|COMPLETED|Overall Study||30||
48724371|NCT00440830|102111567|FG003|COMPLETED|Overall Study||10||
48724372|NCT00440830|102111564|FG000|NOT COMPLETED|Overall Study||0||
48309818|NCT01358760|101084687|FG000|ITT Population|Overall Study||139||
48309819|NCT01358760|101084688|FG001|ITT Population|Overall Study||134||
48309820|NCT01358760|101084689|FG002|ITT Population|Overall Study||134||
48309821|NCT01358760|101084687|FG000|COMPLETED|Overall Study||130||
48309822|NCT01358760|101084688|FG001|COMPLETED|Overall Study||128||
48309823|NCT01358760|101084689|FG002|COMPLETED|Overall Study||125||
48309824|NCT01358760|101084687|FG000|NOT COMPLETED|Overall Study||22||
48309825|NCT01358760|101084688|FG001|NOT COMPLETED|Overall Study||20||
48309826|NCT01358760|101084689|FG002|NOT COMPLETED|Overall Study||25||
48309827|NCT00594516|101084690|FG000|STARTED|Open Label (OL): Tapentadol IR||116||
48309828|NCT00594516|101084691|FG001|STARTED|Open Label (OL): Tapentadol IR||0||
48309829|NCT00594516|101084692|FG002|STARTED|Open Label (OL): Tapentadol IR||0||
48309830|NCT00594516|101084690|FG000|COMPLETED|Open Label (OL): Tapentadol IR||87||
48309831|NCT00594516|101084691|FG001|COMPLETED|Open Label (OL): Tapentadol IR||0||
48309832|NCT00594516|101084692|FG002|COMPLETED|Open Label (OL): Tapentadol IR||0||
48309833|NCT00594516|101084690|FG000|NOT COMPLETED|Open Label (OL): Tapentadol IR||29||
48309834|NCT00594516|101084691|FG001|NOT COMPLETED|Open Label (OL): Tapentadol IR||0||
48309835|NCT00594516|101084692|FG002|NOT COMPLETED|Open Label (OL): Tapentadol IR||0||
48309836|NCT00594516|101084690|FG000|STARTED|DB: Tapentadol IR to ER & ER to IR||0||
48309837|NCT00594516|101084691|FG001|STARTED|DB: Tapentadol IR to ER & ER to IR||44||
48309838|NCT00594516|101084692|FG002|STARTED|DB: Tapentadol IR to ER & ER to IR||43||
48724373|NCT00440830|102111565|FG001|NOT COMPLETED|Overall Study||0||
48724374|NCT00440830|102111566|FG002|NOT COMPLETED|Overall Study||0||
48724375|NCT00440830|102111567|FG003|NOT COMPLETED|Overall Study||0||
48724376|NCT00447122|102111568|FG000|STARTED|Overall Study||3||
48724377|NCT00447122|102111569|FG001|STARTED|Overall Study||11||
48724378|NCT00447122|102111570|FG002|STARTED|Overall Study||6||
48724379|NCT00447122|102111571|FG003|STARTED|Overall Study||5||
48724380|NCT00447122|102111568|FG000|COMPLETED|Overall Study||3||
48724381|NCT00447122|102111569|FG001|COMPLETED|Overall Study||10||
48724382|NCT00447122|102111570|FG002|COMPLETED|Overall Study||6||
48724383|NCT00447122|102111571|FG003|COMPLETED|Overall Study||5||
48724384|NCT00447122|102111568|FG000|NOT COMPLETED|Overall Study||0||
48724385|NCT00447122|102111569|FG001|NOT COMPLETED|Overall Study||1||
48309839|NCT00594516|101084690|FG000|COMPLETED|DB: Tapentadol IR to ER & ER to IR||0||
48309840|NCT00594516|101084691|FG001|COMPLETED|DB: Tapentadol IR to ER & ER to IR||37||
48309841|NCT00594516|101084692|FG002|COMPLETED|DB: Tapentadol IR to ER & ER to IR||35||
48309842|NCT00594516|101084690|FG000|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||0||
48309843|NCT00594516|101084691|FG001|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||7||
48309844|NCT00594516|101084692|FG002|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||8||
48309845|NCT01524133|101084693|FG000|STARTED|Treatment Phase||71||
48309846|NCT01524133|101084694|FG001|STARTED|Treatment Phase||69||
48309847|NCT01524133|101084695|FG002|STARTED|Treatment Phase||67||
48309848|NCT01524133|101084693|FG000|COMPLETED|Treatment Phase||52||
48309849|NCT01524133|101084694|FG001|COMPLETED|Treatment Phase||37||
48309850|NCT01524133|101084695|FG002|COMPLETED|Treatment Phase||31||
48309851|NCT01524133|101084693|FG000|NOT COMPLETED|Treatment Phase||19||
48309852|NCT01524133|101084694|FG001|NOT COMPLETED|Treatment Phase||32||
48309853|NCT01524133|101084695|FG002|NOT COMPLETED|Treatment Phase||36||
48309854|NCT01524133|101084693|FG000|STARTED|Overall Study 52 Weeks||71|Treatment occurred weeks 0-24 and naturalistic follow-up continued through to week 52.|
48309855|NCT01524133|101084694|FG001|STARTED|Overall Study 52 Weeks||69|Treatment occurred weeks 0-24 and naturalistic follow-up continued through to week 52.|
48309856|NCT01524133|101084695|FG002|STARTED|Overall Study 52 Weeks||67|Treatment occurred weeks 0-24 and naturalistic follow-up continued through to week 52.|
48309857|NCT01524133|101084693|FG000|COMPLETED|Overall Study 52 Weeks||50||
48309858|NCT01524133|101084694|FG001|COMPLETED|Overall Study 52 Weeks||49||
48309859|NCT01524133|101084695|FG002|COMPLETED|Overall Study 52 Weeks||40||
48309860|NCT01524133|101084693|FG000|NOT COMPLETED|Overall Study 52 Weeks||21||
48309861|NCT01524133|101084694|FG001|NOT COMPLETED|Overall Study 52 Weeks||20||
48309862|NCT01524133|101084695|FG002|NOT COMPLETED|Overall Study 52 Weeks||27||
48309863|NCT02194062|101084696|FG000|STARTED|Overall Study||10||
48309864|NCT02194062|101084697|FG001|STARTED|Overall Study||10||
48309865|NCT02194062|101084698|FG002|STARTED|Overall Study||12||
48309866|NCT02194062|101084696|FG000|COMPLETED|Overall Study||8||
48309867|NCT02194062|101084697|FG001|COMPLETED|Overall Study||8||
48309868|NCT02194062|101084698|FG002|COMPLETED|Overall Study||7||
48309869|NCT02194062|101084696|FG000|NOT COMPLETED|Overall Study||2||
48309870|NCT02194062|101084697|FG001|NOT COMPLETED|Overall Study||2||
48309871|NCT02194062|101084698|FG002|NOT COMPLETED|Overall Study||5||
48309872|NCT01817751|101084699|FG000|STARTED|Overall Study||47||
48309873|NCT01817751|101084699|FG000|COMPLETED|Overall Study||46||
48309874|NCT01817751|101084699|FG000|NOT COMPLETED|Overall Study||1||
48309875|NCT01279850|101084700|FG000|STARTED|Overall Study||891||
48724386|NCT00447122|102111570|FG002|NOT COMPLETED|Overall Study||0||
48724387|NCT00447122|102111571|FG003|NOT COMPLETED|Overall Study||0||
48309876|NCT01279850|101084700|FG000|COMPLETED|Overall Study||800||
48309877|NCT01279850|101084700|FG000|NOT COMPLETED|Overall Study||91||
48612268|NCT00105989|101838231|FG000|COMPLETED|Continuation - Open Label:Week 10-34||288||
48612269|NCT00105989|101838232|FG001|COMPLETED|Continuation - Open Label:Week 10-34||0||
48612270|NCT00105989|101838231|FG000|NOT COMPLETED|Continuation - Open Label:Week 10-34||125||
48612271|NCT00105989|101838232|FG001|NOT COMPLETED|Continuation - Open Label:Week 10-34||0||
48612272|NCT00105989|101838231|FG000|STARTED|Maintenance - Double-Blind:Week 34-86||146||
48612273|NCT00105989|101838232|FG001|STARTED|Maintenance - Double-Blind:Week 34-86||142||
48612274|NCT00105989|101838231|FG000|COMPLETED|Maintenance - Double-Blind:Week 34-86||96||
48612275|NCT00105989|101838232|FG001|COMPLETED|Maintenance - Double-Blind:Week 34-86||73||
48612276|NCT00105989|101838231|FG000|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||50||
48612277|NCT00105989|101838232|FG001|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||69||
48612278|NCT01523834|101838233|FG000|STARTED|Overall Study||35||
48612279|NCT01523834|101838233|FG000|Consolidation Phase|Overall Study||7||
48612280|NCT01523834|101838233|FG000|Maintenance Phase|Overall Study||6||
48724388|NCT02345330|102111572|FG000|STARTED|Overall Study||4||
48724389|NCT02345330|102111572|FG000|COMPLETED|Overall Study||1||
48612281|NCT01523834|101838233|FG000|COMPLETED|Overall Study||4||
48612282|NCT01523834|101838233|FG000|NOT COMPLETED|Overall Study||31||
48612283|NCT01473940|101838234|FG000|STARTED|Induction Therapy||3||
48612284|NCT01473940|101838235|FG001|STARTED|Induction Therapy||4||
48612285|NCT01473940|101838236|FG002|STARTED|Induction Therapy||6||
48612286|NCT01473940|101838237|FG003|STARTED|Induction Therapy||8||
48612287|NCT01473940|101838234|FG000|Started Treatment|Induction Therapy||3||
48612288|NCT01473940|101838235|FG001|Started Treatment|Induction Therapy||4||
48612289|NCT01473940|101838236|FG002|Started Treatment|Induction Therapy||6||
48724390|NCT02345330|102111572|FG000|NOT COMPLETED|Overall Study||3||
48724391|NCT03836677|102111573|FG000|STARTED|Period 1||13||
48612290|NCT01473940|101838237|FG003|Started Treatment|Induction Therapy||8||
48612291|NCT01473940|101838234|FG000|Completed Induction- 12 Weeks|Induction Therapy||3||
48612292|NCT01473940|101838235|FG001|Completed Induction- 12 Weeks|Induction Therapy||3||
48612293|NCT01473940|101838236|FG002|Completed Induction- 12 Weeks|Induction Therapy||4||
48612294|NCT01473940|101838237|FG003|Completed Induction- 12 Weeks|Induction Therapy||7||
48612295|NCT01473940|101838234|FG000|COMPLETED|Induction Therapy||3||
48612296|NCT01473940|101838235|FG001|COMPLETED|Induction Therapy||3||
48724392|NCT03836677|102111574|FG001|STARTED|Period 1||10||
48724393|NCT03836677|102111573|FG000|COMPLETED|Period 1||13||
48724394|NCT03836677|102111574|FG001|COMPLETED|Period 1||9||
48724395|NCT03836677|102111573|FG000|NOT COMPLETED|Period 1||0||
48724396|NCT03836677|102111574|FG001|NOT COMPLETED|Period 1||1||
48724397|NCT03836677|102111573|FG000|STARTED|Washout||13||
48724398|NCT03836677|102111574|FG001|STARTED|Washout||9||
48724399|NCT03836677|102111573|FG000|COMPLETED|Washout||13||
48724400|NCT03836677|102111574|FG001|COMPLETED|Washout||9||
48724401|NCT03836677|102111573|FG000|NOT COMPLETED|Washout||0||
48724402|NCT03836677|102111574|FG001|NOT COMPLETED|Washout||0||
48724403|NCT03836677|102111573|FG000|STARTED|Period 2||13||
48724404|NCT03836677|102111574|FG001|STARTED|Period 2||9||
48724405|NCT03836677|102111573|FG000|COMPLETED|Period 2||12||
48724406|NCT03836677|102111574|FG001|COMPLETED|Period 2||9||
48724407|NCT03836677|102111573|FG000|NOT COMPLETED|Period 2||1||
48724408|NCT03836677|102111574|FG001|NOT COMPLETED|Period 2||0||
48724409|NCT03496766|102111575|FG000|STARTED|Overall Study||9||
48724410|NCT03496766|102111575|FG000|COMPLETED|Overall Study||9||
48724411|NCT03496766|102111575|FG000|NOT COMPLETED|Overall Study||0||
48724412|NCT00129467|102111576|FG000|STARTED|Received Intervention||15||
48724413|NCT00129467|102111577|FG001|STARTED|Received Intervention||17||
48724414|NCT00129467|102111576|FG000|COMPLETED|Received Intervention||9||
48724415|NCT00129467|102111577|FG001|COMPLETED|Received Intervention||13||
48724416|NCT00129467|102111576|FG000|NOT COMPLETED|Received Intervention||6||
48724417|NCT00129467|102111577|FG001|NOT COMPLETED|Received Intervention||4||
48724418|NCT00129467|102111576|FG000|STARTED|Open Label for SSRI+Methylphenidate Arm||4||
48724419|NCT00129467|102111577|FG001|STARTED|Open Label for SSRI+Methylphenidate Arm||0||
48724420|NCT00129467|102111576|FG000|COMPLETED|Open Label for SSRI+Methylphenidate Arm||2||
48724421|NCT00129467|102111577|FG001|COMPLETED|Open Label for SSRI+Methylphenidate Arm||0||
48724422|NCT00129467|102111576|FG000|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||2||
48724423|NCT00129467|102111577|FG001|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||0||
48724424|NCT02713659|102111578|FG000|STARTED|Baseline||60||
48724425|NCT02713659|102111579|FG001|STARTED|Baseline||60||
48724426|NCT02713659|102111578|FG000|COMPLETED|Baseline||60||
48724427|NCT02713659|102111579|FG001|COMPLETED|Baseline||60||
48724428|NCT02713659|102111578|FG000|NOT COMPLETED|Baseline||0||
48724429|NCT02713659|102111579|FG001|NOT COMPLETED|Baseline||0||
48724430|NCT02713659|102111578|FG000|STARTED|6 Month Study Visit||60||
48724431|NCT02713659|102111579|FG001|STARTED|6 Month Study Visit||60||
48724432|NCT02713659|102111578|FG000|COMPLETED|6 Month Study Visit||53||
48724433|NCT02713659|102111579|FG001|COMPLETED|6 Month Study Visit||47||
48724434|NCT02713659|102111578|FG000|NOT COMPLETED|6 Month Study Visit||7||
48724435|NCT02713659|102111579|FG001|NOT COMPLETED|6 Month Study Visit||13||
48724436|NCT02713659|102111578|FG000|STARTED|12 Month Study Visit||57||
48724437|NCT02713659|102111579|FG001|STARTED|12 Month Study Visit||55||
48724438|NCT02713659|102111578|FG000|COMPLETED|12 Month Study Visit||54||
48724439|NCT02713659|102111579|FG001|COMPLETED|12 Month Study Visit||52||
48724440|NCT02713659|102111578|FG000|NOT COMPLETED|12 Month Study Visit||3||
48724441|NCT02713659|102111579|FG001|NOT COMPLETED|12 Month Study Visit||3||
48724442|NCT02713659|102111578|FG000|STARTED|18 Month Study Visit||58||
48724443|NCT02713659|102111579|FG001|STARTED|18 Month Study Visit||53||
48724444|NCT02713659|102111578|FG000|COMPLETED|18 Month Study Visit||50||
48724445|NCT02713659|102111579|FG001|COMPLETED|18 Month Study Visit||50||
48724446|NCT02713659|102111578|FG000|NOT COMPLETED|18 Month Study Visit||8||
48724447|NCT02713659|102111579|FG001|NOT COMPLETED|18 Month Study Visit||3||
48724448|NCT02713659|102111578|FG000|STARTED|24 Month Study Visit||57||
48724449|NCT02713659|102111579|FG001|STARTED|24 Month Study Visit||52||
48724450|NCT02713659|102111578|FG000|COMPLETED|24 Month Study Visit||49||
48724451|NCT02713659|102111579|FG001|COMPLETED|24 Month Study Visit||44||
48724452|NCT02713659|102111578|FG000|NOT COMPLETED|24 Month Study Visit||8||
48724453|NCT02713659|102111579|FG001|NOT COMPLETED|24 Month Study Visit||8||
48724454|NCT02895945|102111580|FG000|STARTED|Overall Study||7||
48724455|NCT02895945|102111581|FG001|STARTED|Overall Study||1||
48724456|NCT02895945|102111580|FG000|SAS|Overall Study||7|Safety analysis set (SAS) comprised of all participants who received any amount of BAX 802.|
48724457|NCT02895945|102111581|FG001|SAS|Overall Study||1|Safety analysis set (SAS) comprised of all participants who received any amount of BAX 802.|
48724458|NCT02895945|102111580|FG000|FAS|Overall Study||7|Full analysis set (FAS) comprised of all participants with at least one available hemostatic assessment.|
48724459|NCT02895945|102111581|FG001|FAS|Overall Study||0|Full analysis set (FAS) comprised of all participants with at least one available hemostatic assessment.|
48724460|NCT02895945|102111580|FG000|COMPLETED|Overall Study||5||
48724461|NCT02895945|102111581|FG001|COMPLETED|Overall Study||0||
48724462|NCT02895945|102111580|FG000|NOT COMPLETED|Overall Study||2||
48724463|NCT02895945|102111581|FG001|NOT COMPLETED|Overall Study||1||
48724464|NCT01147848|102111582|FG000|STARTED|Run-in Period||1564||
48724465|NCT01147848|102111583|FG001|STARTED|Run-in Period||0||
48724466|NCT01147848|102111584|FG002|STARTED|Run-in Period||0||
48724467|NCT01147848|102111582|FG000|COMPLETED|Run-in Period||806||
48724468|NCT01147848|102111583|FG001|COMPLETED|Run-in Period||0||
48724469|NCT01147848|102111584|FG002|COMPLETED|Run-in Period||0||
48724470|NCT01147848|102111582|FG000|NOT COMPLETED|Run-in Period||758||
48724471|NCT01147848|102111583|FG001|NOT COMPLETED|Run-in Period||0||
48724472|NCT01147848|102111584|FG002|NOT COMPLETED|Run-in Period||0||
48724473|NCT01147848|102111582|FG000|STARTED|Randomized Phase||0||
48724474|NCT01147848|102111583|FG001|STARTED|Randomized Phase||403||
48724475|NCT01147848|102111584|FG002|STARTED|Randomized Phase||403||
48724476|NCT01147848|102111582|FG000|COMPLETED|Randomized Phase||0||
48724477|NCT01147848|102111583|FG001|COMPLETED|Randomized Phase||358||
48724478|NCT01147848|102111584|FG002|COMPLETED|Randomized Phase||357||
48724479|NCT01147848|102111582|FG000|NOT COMPLETED|Randomized Phase||0||
48724480|NCT01147848|102111583|FG001|NOT COMPLETED|Randomized Phase||45||
48309878|NCT00381563|101084701|FG000|STARTED|Overall Study||41||
48309879|NCT00381563|101084702|FG001|STARTED|Overall Study||39||
48309880|NCT00381563|101084701|FG000|COMPLETED|Overall Study||34||
48309881|NCT00381563|101084702|FG001|COMPLETED|Overall Study||33||
48309882|NCT00381563|101084701|FG000|NOT COMPLETED|Overall Study||7||
48309883|NCT00381563|101084702|FG001|NOT COMPLETED|Overall Study||6||
48309884|NCT02568475|101084703|FG000|STARTED|Overall Study||97||
48309885|NCT02568475|101084704|FG001|STARTED|Overall Study||95||
48309886|NCT02568475|101084703|FG000|Post-test|Overall Study||85||
48309887|NCT02568475|101084704|FG001|Post-test|Overall Study||82||
48309888|NCT02568475|101084703|FG000|COMPLETED|Overall Study||46|3 month follow-up|
48724481|NCT01147848|102111584|FG002|NOT COMPLETED|Randomized Phase||46||
48724482|NCT00895453|102111585|FG000|STARTED|Overall Study||48||
48724483|NCT00895453|102111586|FG001|STARTED|Overall Study||50||
48724484|NCT00895453|102111587|FG002|STARTED|Overall Study||46||
48724485|NCT00895453|102111585|FG000|COMPLETED|Overall Study||23||
48724486|NCT00895453|102111586|FG001|COMPLETED|Overall Study||25||
48724487|NCT00895453|102111587|FG002|COMPLETED|Overall Study||23||
48724488|NCT00895453|102111585|FG000|NOT COMPLETED|Overall Study||25||
48724489|NCT00895453|102111586|FG001|NOT COMPLETED|Overall Study||25||
48724490|NCT00895453|102111587|FG002|NOT COMPLETED|Overall Study||23||
48724491|NCT00812565|102111588|FG000|STARTED|Overall Study||8||
48724492|NCT00812565|102111589|FG001|STARTED|Overall Study||7||
48724493|NCT00812565|102111590|FG002|STARTED|Overall Study||7||
48724494|NCT00812565|102111591|FG003|STARTED|Overall Study||7||
48724495|NCT00812565|102111592|FG004|STARTED|Overall Study||7||
48724496|NCT00812565|102111593|FG005|STARTED|Overall Study||7||
48724497|NCT00812565|102111594|FG006|STARTED|Overall Study||8||
48309889|NCT02568475|101084704|FG001|COMPLETED|Overall Study||52|3 month follow-up|
48724498|NCT00812565|102111595|FG007|STARTED|Overall Study||7||
48724499|NCT00812565|102111588|FG000|COMPLETED|Overall Study||5||
48724500|NCT00812565|102111589|FG001|COMPLETED|Overall Study||6||
48724501|NCT00812565|102111590|FG002|COMPLETED|Overall Study||7||
48724502|NCT00812565|102111591|FG003|COMPLETED|Overall Study||5||
48724503|NCT00812565|102111592|FG004|COMPLETED|Overall Study||6||
48724504|NCT00812565|102111593|FG005|COMPLETED|Overall Study||6||
48724505|NCT00812565|102111594|FG006|COMPLETED|Overall Study||8||
48724506|NCT00812565|102111595|FG007|COMPLETED|Overall Study||6||
48724507|NCT00812565|102111588|FG000|NOT COMPLETED|Overall Study||3||
48724508|NCT00812565|102111589|FG001|NOT COMPLETED|Overall Study||1||
48724509|NCT00812565|102111590|FG002|NOT COMPLETED|Overall Study||0||
48724510|NCT00812565|102111591|FG003|NOT COMPLETED|Overall Study||2||
48724511|NCT00812565|102111592|FG004|NOT COMPLETED|Overall Study||1||
48724512|NCT00812565|102111593|FG005|NOT COMPLETED|Overall Study||1||
48724513|NCT00812565|102111594|FG006|NOT COMPLETED|Overall Study||0||
48724514|NCT00812565|102111595|FG007|NOT COMPLETED|Overall Study||1||
48724515|NCT03134183|102111596|FG000|STARTED|Overall Study||36||
48309890|NCT02568475|101084703|FG000|NOT COMPLETED|Overall Study||51||
48309891|NCT02568475|101084704|FG001|NOT COMPLETED|Overall Study||43||
48724516|NCT03134183|102111597|FG001|STARTED|Overall Study||34||
48724517|NCT03134183|102111596|FG000|COMPLETED|Overall Study||35||
48724518|NCT03134183|102111597|FG001|COMPLETED|Overall Study||33||
48724519|NCT03134183|102111596|FG000|NOT COMPLETED|Overall Study||1||
48724520|NCT03134183|102111597|FG001|NOT COMPLETED|Overall Study||1||
48724521|NCT04311463|102111598|FG000|STARTED|Period 1 (Up to Day 3)||19||
48309892|NCT02109562|101084705|FG000|STARTED|Overall Study||116||
48309893|NCT02109562|101084706|FG001|STARTED|Overall Study||119||
48309894|NCT02109562|101084707|FG002|STARTED|Overall Study||119||
48309895|NCT02109562|101084705|FG000|Safety|Overall Study||115|Randomized and received at least one dose of study drug|
48309896|NCT02109562|101084706|FG001|Safety|Overall Study||117|Randomized and received at least one dose of study drug|
48368033|NCT03567291|101230094|FG002|COMPLETED|Period II||45||
48724522|NCT04311463|102111599|FG001|STARTED|Period 1 (Up to Day 3)||19||
48724523|NCT04311463|102111598|FG000|COMPLETED|Period 1 (Up to Day 3)||18||
48724524|NCT04311463|102111599|FG001|COMPLETED|Period 1 (Up to Day 3)||19||
48724525|NCT04311463|102111598|FG000|NOT COMPLETED|Period 1 (Up to Day 3)||1||
48724526|NCT04311463|102111599|FG001|NOT COMPLETED|Period 1 (Up to Day 3)||0||
48724527|NCT04311463|102111598|FG000|STARTED|Washout Period (Up to Day 7)||18||
48724528|NCT04311463|102111599|FG001|STARTED|Washout Period (Up to Day 7)||19||
48724529|NCT04311463|102111598|FG000|COMPLETED|Washout Period (Up to Day 7)||17||
48724530|NCT04311463|102111599|FG001|COMPLETED|Washout Period (Up to Day 7)||18||
48724531|NCT04311463|102111598|FG000|NOT COMPLETED|Washout Period (Up to Day 7)||1||
48724532|NCT04311463|102111599|FG001|NOT COMPLETED|Washout Period (Up to Day 7)||1||
48724533|NCT04311463|102111598|FG000|STARTED|Period 2 (Up to Day 3)||17||
48309897|NCT02109562|101084707|FG002|Safety|Overall Study||118|Randomized and received at least one dose of study drug|
48309898|NCT02109562|101084705|FG000|Intent to Treat (ITT)|Overall Study||111|Randomized, dosed, had a baseline and 1 or more post baseline efficacy measurements.|
48724534|NCT04311463|102111599|FG001|STARTED|Period 2 (Up to Day 3)||18||
48724535|NCT04311463|102111598|FG000|COMPLETED|Period 2 (Up to Day 3)||15||
48724536|NCT04311463|102111599|FG001|COMPLETED|Period 2 (Up to Day 3)||17||
48309899|NCT02109562|101084706|FG001|Intent to Treat (ITT)|Overall Study||114|Randomized, dosed, had a baseline and 1 or more post baseline efficacy measurements.|
48309900|NCT02109562|101084707|FG002|Intent to Treat (ITT)|Overall Study||112|Randomized, dosed, had a baseline and 1 or more post baseline efficacy measurements.|
48309901|NCT02109562|101084705|FG000|COMPLETED|Overall Study||90||
48406566|NCT02603172|101328440|FG001|COMPLETED|Part C (Approximately 13 Weeks)||0||
48406567|NCT02603172|101328441|FG002|COMPLETED|Part C (Approximately 13 Weeks)||0||
48406568|NCT02603172|101328442|FG003|COMPLETED|Part C (Approximately 13 Weeks)||0||
48724537|NCT04311463|102111598|FG000|NOT COMPLETED|Period 2 (Up to Day 3)||2||
48724538|NCT04311463|102111599|FG001|NOT COMPLETED|Period 2 (Up to Day 3)||1||
48724539|NCT04882787|102111600|FG000|STARTED|Overall Study||7||
48724540|NCT04882787|102111601|FG001|STARTED|Overall Study||7||
48724541|NCT04882787|102111600|FG000|COMPLETED|Overall Study||7||
48724542|NCT04882787|102111601|FG001|COMPLETED|Overall Study||7||
48724543|NCT04882787|102111600|FG000|NOT COMPLETED|Overall Study||0||
48724544|NCT04882787|102111601|FG001|NOT COMPLETED|Overall Study||0||
48724545|NCT02387008|102111602|FG000|STARTED|Overall Study||2||
48724546|NCT02387008|102111603|FG001|STARTED|Overall Study||0||
48724547|NCT02387008|102111604|FG002|STARTED|Overall Study||4||
48724548|NCT02387008|102111602|FG000|COMPLETED|Overall Study||2||
48724549|NCT02387008|102111603|FG001|COMPLETED|Overall Study||0||
48724550|NCT02387008|102111604|FG002|COMPLETED|Overall Study||4||
48724551|NCT02387008|102111602|FG000|NOT COMPLETED|Overall Study||0||
48724552|NCT02387008|102111603|FG001|NOT COMPLETED|Overall Study||0||
48724553|NCT02387008|102111604|FG002|NOT COMPLETED|Overall Study||0||
48724554|NCT02553538|102111605|FG000|STARTED|Overall Study||792||
48724555|NCT02553538|102111606|FG001|STARTED|Overall Study||820||
48724556|NCT02553538|102111605|FG000|COMPLETED|Overall Study||605||
48724557|NCT02553538|102111606|FG001|COMPLETED|Overall Study||764||
48724558|NCT02553538|102111605|FG000|NOT COMPLETED|Overall Study||187||
48724559|NCT02553538|102111606|FG001|NOT COMPLETED|Overall Study||56||
48724560|NCT01789606|102111607|FG000|STARTED|Overall Study||251||
48724561|NCT01789606|102111608|FG001|STARTED|Overall Study||832||
48724562|NCT01789606|102111607|FG000|COMPLETED|Overall Study||228||
48724563|NCT01789606|102111608|FG001|COMPLETED|Overall Study||382||
48724564|NCT01789606|102111607|FG000|NOT COMPLETED|Overall Study||23||
48724565|NCT01789606|102111608|FG001|NOT COMPLETED|Overall Study||450||
48724566|NCT02411929|102111609|FG000|STARTED|Period 1||8||
48724567|NCT02411929|102111609|FG000|COMPLETED|Period 1||8||
48724568|NCT02411929|102111609|FG000|NOT COMPLETED|Period 1||0||
48724569|NCT02411929|102111609|FG000|STARTED|Washout Period||8||
48724570|NCT02411929|102111609|FG000|COMPLETED|Washout Period||8||
48724571|NCT02411929|102111609|FG000|NOT COMPLETED|Washout Period||0||
48724572|NCT02411929|102111609|FG000|STARTED|Period 2||8||
48724573|NCT02411929|102111609|FG000|COMPLETED|Period 2||8||
48153932|NCT01946542|100699884|FG001|NOT COMPLETED|Testing Visit 1||0||
48153933|NCT01946542|100699883|FG000|STARTED|Testing Visit 2||1||
48309902|NCT02109562|101084706|FG001|COMPLETED|Overall Study||85||
48309903|NCT02109562|101084707|FG002|COMPLETED|Overall Study||84||
48309904|NCT02109562|101084705|FG000|NOT COMPLETED|Overall Study||26||
48309905|NCT02109562|101084706|FG001|NOT COMPLETED|Overall Study||34||
48309906|NCT02109562|101084707|FG002|NOT COMPLETED|Overall Study||35||
48724574|NCT02411929|102111609|FG000|NOT COMPLETED|Period 2||0||
48724575|NCT00547521|102111610|FG000|STARTED|Short Term Study (4 Months)||51||
48724576|NCT00547521|102111611|FG001|STARTED|Short Term Study (4 Months)||49||
48724577|NCT00547521|102111610|FG000|COMPLETED|Short Term Study (4 Months)||50||
48724578|NCT00547521|102111611|FG001|COMPLETED|Short Term Study (4 Months)||45||
48724579|NCT00547521|102111610|FG000|NOT COMPLETED|Short Term Study (4 Months)||1||
48724580|NCT00547521|102111611|FG001|NOT COMPLETED|Short Term Study (4 Months)||4||
48724581|NCT00547521|102111610|FG000|STARTED|Long Term Extension (LTE) Study||0||
48724582|NCT00547521|102111611|FG001|STARTED|Long Term Extension (LTE) Study||90||
48724583|NCT00547521|102111610|FG000|COMPLETED|Long Term Extension (LTE) Study||0||
48724584|NCT00547521|102111611|FG001|COMPLETED|Long Term Extension (LTE) Study||59||
48724585|NCT00547521|102111610|FG000|NOT COMPLETED|Long Term Extension (LTE) Study||0||
48724586|NCT00547521|102111611|FG001|NOT COMPLETED|Long Term Extension (LTE) Study||31||
48724587|NCT02219503|102111612|FG000|STARTED|Overall Study||60||
48724588|NCT02219503|102111612|FG000|COMPLETED|Overall Study||60||
48724589|NCT02219503|102111612|FG000|NOT COMPLETED|Overall Study||0||
48724590|NCT05079477|102111613|FG000|STARTED|Overall Study||108||
48724591|NCT05079477|102111614|FG001|STARTED|Overall Study||108||
48724592|NCT05079477|102111613|FG000|COMPLETED|Overall Study||94||
48724593|NCT05079477|102111614|FG001|COMPLETED|Overall Study||95||
48724594|NCT05079477|102111613|FG000|NOT COMPLETED|Overall Study||14||
48724595|NCT05079477|102111614|FG001|NOT COMPLETED|Overall Study||13||
48153934|NCT01946542|100699884|FG001|STARTED|Testing Visit 2||1||
48153935|NCT01946542|100699883|FG000|COMPLETED|Testing Visit 2||1||
48153936|NCT01946542|100699884|FG001|COMPLETED|Testing Visit 2||1||
48724596|NCT01854268|102111615|FG000|STARTED|Overall Study||25||
48724597|NCT01854268|102111615|FG000|COMPLETED|Overall Study||25||
48724598|NCT01854268|102111615|FG000|NOT COMPLETED|Overall Study||0||
48724599|NCT01438177|102111616|FG000|STARTED|Overall Study||11||
48153937|NCT01946542|100699883|FG000|NOT COMPLETED|Testing Visit 2||0||
48153938|NCT01946542|100699884|FG001|NOT COMPLETED|Testing Visit 2||0||
48724600|NCT01438177|102111616|FG000|COMPLETED|Overall Study||9||
48724601|NCT01438177|102111616|FG000|NOT COMPLETED|Overall Study||2||
48724602|NCT02607228|102111617|FG000|STARTED|Overall Study||5||
48724603|NCT02607228|102111618|FG001|STARTED|Overall Study||4||
48724604|NCT02607228|102111619|FG002|STARTED|Overall Study||3||
48724605|NCT02607228|102111620|FG003|STARTED|Overall Study||6||
48724606|NCT02607228|102111621|FG004|STARTED|Overall Study||5||
48724607|NCT02607228|102111622|FG005|STARTED|Overall Study||6||
48724608|NCT02607228|102111623|FG006|STARTED|Overall Study||2||
48724609|NCT02607228|102111617|FG000|COMPLETED|Overall Study||0||
48724610|NCT02607228|102111618|FG001|COMPLETED|Overall Study||0||
48724611|NCT02607228|102111619|FG002|COMPLETED|Overall Study||0||
48724612|NCT02607228|102111620|FG003|COMPLETED|Overall Study||0||
48724613|NCT02607228|102111621|FG004|COMPLETED|Overall Study||0||
48724614|NCT02607228|102111622|FG005|COMPLETED|Overall Study||0||
48724615|NCT02607228|102111623|FG006|COMPLETED|Overall Study||0||
48724616|NCT02607228|102111617|FG000|NOT COMPLETED|Overall Study||5||
48724617|NCT02607228|102111618|FG001|NOT COMPLETED|Overall Study||4||
48724618|NCT02607228|102111619|FG002|NOT COMPLETED|Overall Study||3||
48724619|NCT02607228|102111620|FG003|NOT COMPLETED|Overall Study||6||
48309907|NCT01363388|101084708|FG000|STARTED|Overall Study||23||
48309908|NCT01363388|101084709|FG001|STARTED|Overall Study||22||
48724620|NCT02607228|102111621|FG004|NOT COMPLETED|Overall Study||5||
48724621|NCT02607228|102111622|FG005|NOT COMPLETED|Overall Study||6||
48724622|NCT02607228|102111623|FG006|NOT COMPLETED|Overall Study||2||
48153939|NCT03848403|100699885|FG000|STARTED|Period 1 (Day 1)||24||
48309909|NCT01363388|101084710|FG002|STARTED|Overall Study||22||
48309910|NCT01363388|101084708|FG000|COMPLETED|Overall Study||18||
48309911|NCT01363388|101084709|FG001|COMPLETED|Overall Study||19||
48309912|NCT01363388|101084710|FG002|COMPLETED|Overall Study||18||
48309913|NCT01363388|101084708|FG000|NOT COMPLETED|Overall Study||5||
48309914|NCT01363388|101084709|FG001|NOT COMPLETED|Overall Study||3||
48309915|NCT01363388|101084710|FG002|NOT COMPLETED|Overall Study||4||
48309916|NCT00003042|101084711|FG000|STARTED|Overall Study||14||
48309917|NCT00003042|101084712|FG001|STARTED|Overall Study||27||
48309918|NCT00003042|101084711|FG000|COMPLETED|Overall Study||14||
48309919|NCT00003042|101084712|FG001|COMPLETED|Overall Study||27||
48724623|NCT00098306|102111624|FG000|STARTED|Double Blind||241||
48153940|NCT03848403|100699886|FG001|STARTED|Period 1 (Day 1)||24||
48309920|NCT00003042|101084711|FG000|NOT COMPLETED|Overall Study||0||
48309921|NCT00003042|101084712|FG001|NOT COMPLETED|Overall Study||0||
48724624|NCT00098306|102111625|FG001|STARTED|Double Blind||240||
48724625|NCT00098306|102111626|FG002|STARTED|Double Blind||120||
48724626|NCT00098306|102111627|FG003|STARTED|Double Blind||0||
48724627|NCT00098306|102111628|FG004|STARTED|Double Blind||0||
48724628|NCT00098306|102111629|FG005|STARTED|Double Blind||0||
48724629|NCT00098306|102111630|FG006|STARTED|Double Blind||0||
48724630|NCT00098306|102111624|FG000|Treated|Double Blind||232||
48724631|NCT00098306|102111625|FG001|Treated|Double Blind||235||
48724632|NCT00098306|102111626|FG002|Treated|Double Blind||118||
48724633|NCT00098306|102111627|FG003|Treated|Double Blind||0||
48724634|NCT00098306|102111628|FG004|Treated|Double Blind||0||
48724635|NCT00098306|102111629|FG005|Treated|Double Blind||0||
48724636|NCT00098306|102111630|FG006|Treated|Double Blind||0||
48724637|NCT00098306|102111624|FG000|COMPLETED|Double Blind||0||
48724638|NCT00098306|102111625|FG001|COMPLETED|Double Blind||0||
48724639|NCT00098306|102111626|FG002|COMPLETED|Double Blind||0||
48724640|NCT00098306|102111627|FG003|COMPLETED|Double Blind||0||
48724641|NCT00098306|102111628|FG004|COMPLETED|Double Blind||0||
48724642|NCT00098306|102111629|FG005|COMPLETED|Double Blind||0||
48724643|NCT00098306|102111630|FG006|COMPLETED|Double Blind||0||
48724644|NCT00098306|102111624|FG000|NOT COMPLETED|Double Blind||241||
48724645|NCT00098306|102111625|FG001|NOT COMPLETED|Double Blind||240||
48724646|NCT00098306|102111626|FG002|NOT COMPLETED|Double Blind||120||
48724647|NCT00098306|102111627|FG003|NOT COMPLETED|Double Blind||0||
48724648|NCT00098306|102111628|FG004|NOT COMPLETED|Double Blind||0||
48724649|NCT00098306|102111629|FG005|NOT COMPLETED|Double Blind||0||
48724650|NCT00098306|102111630|FG006|NOT COMPLETED|Double Blind||0||
48724651|NCT00098306|102111624|FG000|STARTED|Open Label||0||
48724652|NCT00098306|102111625|FG001|STARTED|Open Label||0||
48724653|NCT00098306|102111626|FG002|STARTED|Open Label||0||
48724654|NCT00098306|102111627|FG003|STARTED|Open Label||327||
48724655|NCT00098306|102111628|FG004|STARTED|Open Label||62||
48724656|NCT00098306|102111629|FG005|STARTED|Open Label||0||
48724657|NCT00098306|102111630|FG006|STARTED|Open Label||0||
48724658|NCT00098306|102111624|FG000|COMPLETED|Open Label||0||
48724659|NCT00098306|102111625|FG001|COMPLETED|Open Label||0||
48724660|NCT00098306|102111626|FG002|COMPLETED|Open Label||0||
48724661|NCT00098306|102111627|FG003|COMPLETED|Open Label||0||
48724662|NCT00098306|102111628|FG004|COMPLETED|Open Label||0||
48724663|NCT00098306|102111629|FG005|COMPLETED|Open Label||0||
48724664|NCT00098306|102111630|FG006|COMPLETED|Open Label||0||
48724665|NCT00098306|102111624|FG000|NOT COMPLETED|Open Label||0||
48724666|NCT00098306|102111625|FG001|NOT COMPLETED|Open Label||0||
48724667|NCT00098306|102111626|FG002|NOT COMPLETED|Open Label||0||
48724668|NCT00098306|102111627|FG003|NOT COMPLETED|Open Label||327||
48724669|NCT00098306|102111628|FG004|NOT COMPLETED|Open Label||62||
48724670|NCT00098306|102111629|FG005|NOT COMPLETED|Open Label||0||
48724671|NCT00098306|102111630|FG006|NOT COMPLETED|Open Label||0||
48724672|NCT00098306|102111624|FG000|STARTED|Observational Phase||0||
48724673|NCT00098306|102111625|FG001|STARTED|Observational Phase||0||
48724674|NCT00098306|102111626|FG002|STARTED|Observational Phase||0||
48724675|NCT00098306|102111627|FG003|STARTED|Observational Phase||0||
48724676|NCT00098306|102111628|FG004|STARTED|Observational Phase||0||
48724677|NCT00098306|102111629|FG005|STARTED|Observational Phase||250||
48724678|NCT00098306|102111630|FG006|STARTED|Observational Phase||81||
48724679|NCT00098306|102111624|FG000|COMPLETED|Observational Phase||0||
48724680|NCT00098306|102111625|FG001|COMPLETED|Observational Phase||0||
48724681|NCT00098306|102111626|FG002|COMPLETED|Observational Phase||0||
48724682|NCT00098306|102111627|FG003|COMPLETED|Observational Phase||0||
48724683|NCT00098306|102111628|FG004|COMPLETED|Observational Phase||0||
48724684|NCT00098306|102111629|FG005|COMPLETED|Observational Phase||204||
48724685|NCT00098306|102111630|FG006|COMPLETED|Observational Phase||55||
48724686|NCT00098306|102111624|FG000|NOT COMPLETED|Observational Phase||0||
48724687|NCT00098306|102111625|FG001|NOT COMPLETED|Observational Phase||0||
48724688|NCT00098306|102111626|FG002|NOT COMPLETED|Observational Phase||0||
48724689|NCT00098306|102111627|FG003|NOT COMPLETED|Observational Phase||0||
48724690|NCT00098306|102111628|FG004|NOT COMPLETED|Observational Phase||0||
48724691|NCT00098306|102111629|FG005|NOT COMPLETED|Observational Phase||46||
48724692|NCT00098306|102111630|FG006|NOT COMPLETED|Observational Phase||26||
48724693|NCT01270256|102111631|FG000|STARTED|Overall Study||21||
48724694|NCT01270256|102111632|FG001|STARTED|Overall Study||20||
48724695|NCT01270256|102111631|FG000|COMPLETED|Overall Study||20||
48724696|NCT01270256|102111632|FG001|COMPLETED|Overall Study||20||
48724697|NCT01270256|102111631|FG000|NOT COMPLETED|Overall Study||1||
48724698|NCT01270256|102111632|FG001|NOT COMPLETED|Overall Study||0||
48309922|NCT00545402|101084713|FG000|STARTED|Overall Study||90||
48309923|NCT00545402|101084714|FG001|STARTED|Overall Study||90||
48309924|NCT00545402|101084713|FG000|COMPLETED|Overall Study||56||
48724699|NCT01141478|102111633|FG000|STARTED|Overall Study||4||
48724700|NCT01141478|102111634|FG001|STARTED|Overall Study||4||
48724701|NCT01141478|102111633|FG000|COMPLETED|Overall Study||3||
48724702|NCT01141478|102111634|FG001|COMPLETED|Overall Study||3||
48724703|NCT01141478|102111633|FG000|NOT COMPLETED|Overall Study||1||
48724704|NCT01141478|102111634|FG001|NOT COMPLETED|Overall Study||1||
48724705|NCT03824587|102111635|FG000|STARTED|Run-in Period||0||
48724706|NCT03824587|102111636|FG001|STARTED|Run-in Period||511||
48724707|NCT03824587|102111635|FG000|COMPLETED|Run-in Period||0||
48724708|NCT03824587|102111636|FG001|COMPLETED|Run-in Period||236||
48724709|NCT03824587|102111635|FG000|NOT COMPLETED|Run-in Period||0||
48724710|NCT03824587|102111636|FG001|NOT COMPLETED|Run-in Period||275||
48724711|NCT03824587|102111635|FG000|STARTED|Treatment Period||117||
48309925|NCT00545402|101084714|FG001|COMPLETED|Overall Study||61||
48309926|NCT00545402|101084713|FG000|NOT COMPLETED|Overall Study||34||
48309927|NCT00545402|101084714|FG001|NOT COMPLETED|Overall Study||29||
48309928|NCT00580372|101084715|FG000|STARTED|Overall Study||231||
48309929|NCT00580372|101084715|FG000|COMPLETED|Overall Study||231||
48309930|NCT00580372|101084715|FG000|NOT COMPLETED|Overall Study||0||
48309931|NCT02046096|101084716|FG000|STARTED|Overall Study||149||
48309932|NCT02046096|101084717|FG001|STARTED|Overall Study||324||
48309933|NCT02046096|101084716|FG000|COMPLETED|Overall Study||105||
48309934|NCT02046096|101084717|FG001|COMPLETED|Overall Study||223||
48309935|NCT02046096|101084716|FG000|NOT COMPLETED|Overall Study||44||
48309936|NCT02046096|101084717|FG001|NOT COMPLETED|Overall Study||101||
48309937|NCT02726971|101084718|FG000|STARTED|Overall Study||70||
48309938|NCT02726971|101084719|FG001|STARTED|Overall Study||71||
48309939|NCT02726971|101084718|FG000|COMPLETED|Overall Study||59||
48309940|NCT02726971|101084719|FG001|COMPLETED|Overall Study||62||
48612297|NCT01473940|101838236|FG002|COMPLETED|Induction Therapy||4||
48612298|NCT01473940|101838237|FG003|COMPLETED|Induction Therapy||7||
48612299|NCT01473940|101838234|FG000|NOT COMPLETED|Induction Therapy||0||
48612300|NCT01473940|101838235|FG001|NOT COMPLETED|Induction Therapy||1||
48612301|NCT01473940|101838236|FG002|NOT COMPLETED|Induction Therapy||2||
48612302|NCT01473940|101838237|FG003|NOT COMPLETED|Induction Therapy||1||
48612303|NCT01473940|101838234|FG000|STARTED|Maintenance Therapy||3||
48612304|NCT01473940|101838235|FG001|STARTED|Maintenance Therapy||3||
48612305|NCT01473940|101838236|FG002|STARTED|Maintenance Therapy||4||
48612306|NCT01473940|101838237|FG003|STARTED|Maintenance Therapy||7||
48612307|NCT01473940|101838234|FG000|Evaluated for Response|Maintenance Therapy||3||
48612308|NCT01473940|101838235|FG001|Evaluated for Response|Maintenance Therapy||3||
48612309|NCT01473940|101838236|FG002|Evaluated for Response|Maintenance Therapy||4||
48612310|NCT01473940|101838237|FG003|Evaluated for Response|Maintenance Therapy||7||
48612311|NCT01473940|101838234|FG000|Went on to Start Maintenance Therapy|Maintenance Therapy||2||
48612312|NCT01473940|101838235|FG001|Went on to Start Maintenance Therapy|Maintenance Therapy||1||
48612313|NCT01473940|101838236|FG002|Went on to Start Maintenance Therapy|Maintenance Therapy||3||
48612314|NCT01473940|101838237|FG003|Went on to Start Maintenance Therapy|Maintenance Therapy||3||
48612315|NCT01473940|101838234|FG000|COMPLETED|Maintenance Therapy||2||
48612316|NCT01473940|101838235|FG001|COMPLETED|Maintenance Therapy||1||
48612317|NCT01473940|101838236|FG002|COMPLETED|Maintenance Therapy||3||
48612318|NCT01473940|101838237|FG003|COMPLETED|Maintenance Therapy||3||
48612319|NCT01473940|101838234|FG000|NOT COMPLETED|Maintenance Therapy||1||
48612320|NCT01473940|101838235|FG001|NOT COMPLETED|Maintenance Therapy||2||
48612321|NCT01473940|101838236|FG002|NOT COMPLETED|Maintenance Therapy||1||
48612322|NCT01473940|101838237|FG003|NOT COMPLETED|Maintenance Therapy||4||
48612323|NCT01473940|101838234|FG000|STARTED|Follow-up Until Death||3|All patients that receive at least one dose of study treatment go into the follow up phase.|
48612324|NCT01473940|101838235|FG001|STARTED|Follow-up Until Death||4|All patients that receive at least one dose of study treatment go into the follow up phase.|
48612325|NCT01473940|101838236|FG002|STARTED|Follow-up Until Death||5|All patients that receive at least one dose of study treatment go into the follow up phase.|
48612326|NCT01473940|101838237|FG003|STARTED|Follow-up Until Death||7|All patients that receive at least one dose of study treatment go into the follow up phase.|
48612327|NCT01473940|101838234|FG000|COMPLETED|Follow-up Until Death||3||
48612328|NCT01473940|101838235|FG001|COMPLETED|Follow-up Until Death||4||
48612329|NCT01473940|101838236|FG002|COMPLETED|Follow-up Until Death||5||
48612330|NCT01473940|101838237|FG003|COMPLETED|Follow-up Until Death||7||
48612331|NCT01473940|101838234|FG000|NOT COMPLETED|Follow-up Until Death||0||
48612332|NCT01473940|101838235|FG001|NOT COMPLETED|Follow-up Until Death||0||
48612333|NCT01473940|101838236|FG002|NOT COMPLETED|Follow-up Until Death||0||
48612334|NCT01473940|101838237|FG003|NOT COMPLETED|Follow-up Until Death||0||
48612335|NCT01254656|101838238|FG000|STARTED|Overall Study||47||
48612336|NCT01254656|101838239|FG001|STARTED|Overall Study||43||
48612337|NCT01254656|101838240|FG002|STARTED|Overall Study||18||
48612338|NCT01254656|101838238|FG000|Treated|Overall Study||47||
48612339|NCT01254656|101838239|FG001|Treated|Overall Study||43||
48612340|NCT01254656|101838240|FG002|Treated|Overall Study||18||
48612341|NCT01254656|101838238|FG000|COMPLETED|Overall Study||0||
48612342|NCT01254656|101838239|FG001|COMPLETED|Overall Study||0||
48612343|NCT01254656|101838240|FG002|COMPLETED|Overall Study||0||
48612344|NCT01254656|101838238|FG000|NOT COMPLETED|Overall Study||47||
48309941|NCT02726971|101084718|FG000|NOT COMPLETED|Overall Study||11||
48309942|NCT02726971|101084719|FG001|NOT COMPLETED|Overall Study||9||
48309943|NCT00896779|101084720|FG000|STARTED|Overall Study||8||
48309944|NCT00896779|101084721|FG001|STARTED|Overall Study||12||
48309945|NCT00896779|101084720|FG000|COMPLETED|Overall Study||8||
48612345|NCT01254656|101838239|FG001|NOT COMPLETED|Overall Study||43||
48612346|NCT01254656|101838240|FG002|NOT COMPLETED|Overall Study||18||
48612347|NCT01678664|101838241|FG000|STARTED|Overall Study||74||
48612348|NCT01678664|101838241|FG000|COMPLETED|Overall Study||74||
48612349|NCT01678664|101838241|FG000|NOT COMPLETED|Overall Study||0||
48612350|NCT02487797|101838242|FG000|STARTED|Overall Study||502||
48612351|NCT02487797|101838243|FG001|STARTED|Overall Study||501||
48309946|NCT00896779|101084721|FG001|COMPLETED|Overall Study||11||
48309947|NCT00896779|101084720|FG000|NOT COMPLETED|Overall Study||0||
48153941|NCT03848403|100699887|FG002|STARTED|Period 1 (Day 1)||22||
48153942|NCT03848403|100699885|FG000|Received Intervention|Period 1 (Day 1)||24||
48406569|NCT02603172|101328443|FG004|COMPLETED|Part C (Approximately 13 Weeks)||0||
48406570|NCT02603172|101328444|FG005|COMPLETED|Part C (Approximately 13 Weeks)||0||
48612352|NCT02487797|101838242|FG000|COMPLETED|Overall Study||502||
48612353|NCT02487797|101838243|FG001|COMPLETED|Overall Study||501||
48612354|NCT02487797|101838242|FG000|NOT COMPLETED|Overall Study||0||
48612355|NCT02487797|101838243|FG001|NOT COMPLETED|Overall Study||0||
48612356|NCT01749410|101838244|FG000|STARTED|Overall Study||33||
48612357|NCT01749410|101838244|FG000|COMPLETED|Overall Study||33||
48612358|NCT01749410|101838244|FG000|NOT COMPLETED|Overall Study||0||
48612359|NCT02163681|101838245|FG000|STARTED|Overall Study||45||
48612360|NCT02163681|101838245|FG000|COMPLETED|Overall Study||44||
48612361|NCT02163681|101838245|FG000|NOT COMPLETED|Overall Study||1||
48612362|NCT03243305|101838246|FG000|STARTED|Overall Study||1384||
48612363|NCT03243305|101838246|FG000|COMPLETED|Overall Study||449||
48612364|NCT03243305|101838246|FG000|NOT COMPLETED|Overall Study||935||
48612365|NCT01720524|101838247|FG000|STARTED|Part A||29||
48612366|NCT01720524|101838248|FG001|STARTED|Part A||30||
48612367|NCT01720524|101838247|FG000|COMPLETED|Part A||22||
48612368|NCT01720524|101838248|FG001|COMPLETED|Part A||18||
48612369|NCT01720524|101838247|FG000|NOT COMPLETED|Part A||7||
48612370|NCT01720524|101838248|FG001|NOT COMPLETED|Part A||12||
48406571|NCT02603172|101328445|FG006|COMPLETED|Part C (Approximately 13 Weeks)||0||
48612371|NCT01720524|101838247|FG000|STARTED|Part B||27||
48612372|NCT01720524|101838248|FG001|STARTED|Part B||26||
48612373|NCT01720524|101838247|FG000|COMPLETED|Part B||22||
48612374|NCT01720524|101838248|FG001|COMPLETED|Part B||17||
48612375|NCT01720524|101838247|FG000|NOT COMPLETED|Part B||5||
48612376|NCT01720524|101838248|FG001|NOT COMPLETED|Part B||9||
48612377|NCT00995722|101838249|FG000|STARTED|Double Blinded: 16 Weeks||6||
48153943|NCT03848403|100699886|FG001|Received Intervention|Period 1 (Day 1)||24||
48153944|NCT03848403|100699887|FG002|Received Intervention|Period 1 (Day 1)||22||
48153945|NCT03848403|100699885|FG000|COMPLETED|Period 1 (Day 1)||24||
48153946|NCT03848403|100699886|FG001|COMPLETED|Period 1 (Day 1)||24||
48153947|NCT03848403|100699887|FG002|COMPLETED|Period 1 (Day 1)||22||
48153948|NCT03848403|100699885|FG000|NOT COMPLETED|Period 1 (Day 1)||0||
48153949|NCT03848403|100699886|FG001|NOT COMPLETED|Period 1 (Day 1)||0||
48153950|NCT03848403|100699887|FG002|NOT COMPLETED|Period 1 (Day 1)||0||
48153951|NCT03848403|100699885|FG000|STARTED|Period 2 (Day 8)||24||
48153952|NCT03848403|100699886|FG001|STARTED|Period 2 (Day 8)||24||
48153953|NCT03848403|100699887|FG002|STARTED|Period 2 (Day 8)||22||
48153954|NCT03848403|100699885|FG000|Received at Least One Dose of Study Drug|Period 2 (Day 8)||24||
48153955|NCT03848403|100699886|FG001|Received at Least One Dose of Study Drug|Period 2 (Day 8)||24||
48153956|NCT03848403|100699887|FG002|Received at Least One Dose of Study Drug|Period 2 (Day 8)||22||
48153957|NCT03848403|100699885|FG000|COMPLETED|Period 2 (Day 8)||15||
48153958|NCT03848403|100699886|FG001|COMPLETED|Period 2 (Day 8)||15||
48153959|NCT03848403|100699887|FG002|COMPLETED|Period 2 (Day 8)||15||
48153960|NCT03848403|100699885|FG000|NOT COMPLETED|Period 2 (Day 8)||9||
48153961|NCT03848403|100699886|FG001|NOT COMPLETED|Period 2 (Day 8)||9||
48153962|NCT03848403|100699887|FG002|NOT COMPLETED|Period 2 (Day 8)||7||
48153963|NCT03848403|100699885|FG000|STARTED|Period 3 (Day 15)||15||
48153964|NCT03848403|100699886|FG001|STARTED|Period 3 (Day 15)||15||
48153965|NCT03848403|100699887|FG002|STARTED|Period 3 (Day 15)||15||
48153966|NCT03848403|100699885|FG000|COMPLETED|Period 3 (Day 15)||15||
48153967|NCT03848403|100699886|FG001|COMPLETED|Period 3 (Day 15)||15||
48153968|NCT03848403|100699887|FG002|COMPLETED|Period 3 (Day 15)||15||
48153969|NCT03848403|100699885|FG000|NOT COMPLETED|Period 3 (Day 15)||0||
48153970|NCT03848403|100699886|FG001|NOT COMPLETED|Period 3 (Day 15)||0||
48153971|NCT03848403|100699887|FG002|NOT COMPLETED|Period 3 (Day 15)||0||
48153972|NCT01559948|100699888|FG000|STARTED|Overall Study||15||
48153973|NCT01559948|100699889|FG001|STARTED|Overall Study||15||
48153974|NCT01559948|100699888|FG000|COMPLETED|Overall Study||15||
48153975|NCT01559948|100699889|FG001|COMPLETED|Overall Study||15||
48153976|NCT01559948|100699888|FG000|NOT COMPLETED|Overall Study||0||
48153977|NCT01559948|100699889|FG001|NOT COMPLETED|Overall Study||0||
48153978|NCT00765232|100699890|FG000|STARTED|Overall Study||57||
48153979|NCT00765232|100699891|FG001|STARTED|Overall Study||54||
48612378|NCT00995722|101838250|FG001|STARTED|Double Blinded: 16 Weeks||5||
48612379|NCT00995722|101838249|FG000|COMPLETED|Double Blinded: 16 Weeks||5||
48612380|NCT00995722|101838250|FG001|COMPLETED|Double Blinded: 16 Weeks||4||
48612381|NCT00995722|101838249|FG000|NOT COMPLETED|Double Blinded: 16 Weeks||1||
48612382|NCT00995722|101838250|FG001|NOT COMPLETED|Double Blinded: 16 Weeks||1||
48612383|NCT00995722|101838249|FG000|STARTED|Overall Study: 36 Weeks||5||
48612384|NCT00995722|101838250|FG001|STARTED|Overall Study: 36 Weeks||4||
48612385|NCT00995722|101838249|FG000|COMPLETED|Overall Study: 36 Weeks||3||
48612386|NCT00995722|101838250|FG001|COMPLETED|Overall Study: 36 Weeks||2||
48612387|NCT00995722|101838249|FG000|NOT COMPLETED|Overall Study: 36 Weeks||2||
48612388|NCT00995722|101838250|FG001|NOT COMPLETED|Overall Study: 36 Weeks||2||
48612389|NCT00205660|101838251|FG000|STARTED|Overall Study||14||
48612390|NCT00205660|101838252|FG001|STARTED|Overall Study||37||
48153980|NCT00765232|100699890|FG000|COMPLETED|Overall Study||57||
48153981|NCT00765232|100699891|FG001|COMPLETED|Overall Study||54||
48153982|NCT00765232|100699890|FG000|NOT COMPLETED|Overall Study||0||
48153983|NCT00765232|100699891|FG001|NOT COMPLETED|Overall Study||0||
48153984|NCT03479697|100699892|FG000|STARTED|Overall Study||2||
48153985|NCT03479697|100699893|FG001|STARTED|Overall Study||3||
48153986|NCT03479697|100699892|FG000|COMPLETED|Overall Study||2||
48153987|NCT03479697|100699893|FG001|COMPLETED|Overall Study||3||
48153988|NCT03479697|100699892|FG000|NOT COMPLETED|Overall Study||0||
48153989|NCT03479697|100699893|FG001|NOT COMPLETED|Overall Study||0||
48153990|NCT02239380|100699894|FG000|STARTED|Overall Study||26||
48153991|NCT02239380|100699894|FG000|COMPLETED|Overall Study||26||
48153992|NCT02239380|100699894|FG000|NOT COMPLETED|Overall Study||0||
48153993|NCT05288660|100699895|FG000|STARTED|Overall Study||4||
48153994|NCT05288660|100699896|FG001|STARTED|Overall Study||6||
48153995|NCT05288660|100699897|FG002|STARTED|Overall Study||4||
48153996|NCT05288660|100699895|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4||
48153997|NCT05288660|100699896|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
48153998|NCT05288660|100699897|FG002|Received at Least 1 Dose of Study Drug|Overall Study||4||
48153999|NCT05288660|100699895|FG000|COMPLETED|Overall Study||4||
48154000|NCT05288660|100699896|FG001|COMPLETED|Overall Study||6||
48154001|NCT05288660|100699897|FG002|COMPLETED|Overall Study||4||
48154002|NCT05288660|100699895|FG000|NOT COMPLETED|Overall Study||0||
48154003|NCT05288660|100699896|FG001|NOT COMPLETED|Overall Study||0||
48612391|NCT00205660|101838251|FG000|COMPLETED|Overall Study||12||
48612392|NCT00205660|101838252|FG001|COMPLETED|Overall Study||35||
48612393|NCT00205660|101838251|FG000|NOT COMPLETED|Overall Study||2||
48612394|NCT00205660|101838252|FG001|NOT COMPLETED|Overall Study||2||
48612395|NCT03252145|101838253|FG000|STARTED|Overall Study||13||
48612396|NCT03252145|101838254|FG001|STARTED|Overall Study||15||
48154004|NCT05288660|100699897|FG002|NOT COMPLETED|Overall Study||0||
48154005|NCT01982435|100699898|FG000|STARTED|Overall Study||15||
48154006|NCT01982435|100699899|FG001|STARTED|Overall Study||12||
48154007|NCT01982435|100699898|FG000|COMPLETED|Overall Study||14||
48154008|NCT01982435|100699899|FG001|COMPLETED|Overall Study||12||
48154009|NCT01982435|100699898|FG000|NOT COMPLETED|Overall Study||1||
48154010|NCT01982435|100699899|FG001|NOT COMPLETED|Overall Study||0||
48154011|NCT03574597|100699900|FG000|STARTED|Overall Study||8803||
48154012|NCT03574597|100699901|FG001|STARTED|Overall Study||8801||
48154013|NCT03574597|100699900|FG000|Full Analysis Set (FAS)|Overall Study||8803|FAS included all randomised participants. All participants were analyzed according to the treatment to which they were assigned at randomisation.|
48154014|NCT03574597|100699901|FG001|Full Analysis Set (FAS)|Overall Study||8801|FAS included all randomised participants. All participants were analyzed according to the treatment to which they were assigned at randomisation.|
48154015|NCT03574597|100699900|FG000|COMPLETED|Overall Study||8544|Participants attended follow-up visit or died during trial considered completers in the trial.|
48154016|NCT03574597|100699901|FG001|COMPLETED|Overall Study||8517|Participants attended follow-up visit or died during trial considered completers in the trial.|
48154017|NCT03574597|100699900|FG000|NOT COMPLETED|Overall Study||259||
48154018|NCT03574597|100699901|FG001|NOT COMPLETED|Overall Study||284||
48154019|NCT00187226|100699902|FG000|STARTED|Overall Study||88||
48154020|NCT00187226|100699903|FG001|STARTED|Overall Study||49||
48154021|NCT00187226|100699904|FG002|STARTED|Overall Study||28||
48154022|NCT00187226|100699905|FG003|STARTED|Overall Study||2||
48154023|NCT00187226|100699906|FG004|STARTED|Overall Study||34||
48154024|NCT00187226|100699907|FG005|STARTED|Overall Study||1||
48154025|NCT00187226|100699902|FG000|COMPLETED|Overall Study||88||
48154026|NCT00187226|100699903|FG001|COMPLETED|Overall Study||49||
48154027|NCT00187226|100699904|FG002|COMPLETED|Overall Study||28||
48154028|NCT00187226|100699905|FG003|COMPLETED|Overall Study||2||
48154029|NCT00187226|100699906|FG004|COMPLETED|Overall Study||34||
48154030|NCT00187226|100699907|FG005|COMPLETED|Overall Study||1||
48154031|NCT00187226|100699902|FG000|NOT COMPLETED|Overall Study||0||
48154032|NCT00187226|100699903|FG001|NOT COMPLETED|Overall Study||0||
48154033|NCT00187226|100699904|FG002|NOT COMPLETED|Overall Study||0||
48154034|NCT00187226|100699905|FG003|NOT COMPLETED|Overall Study||0||
48154035|NCT00187226|100699906|FG004|NOT COMPLETED|Overall Study||0||
48154036|NCT00187226|100699907|FG005|NOT COMPLETED|Overall Study||0||
48154037|NCT00168038|100699908|FG000|STARTED|Overall Study||57||
48154038|NCT00168038|100699908|FG000|COMPLETED|Overall Study||55||
48154039|NCT00168038|100699908|FG000|NOT COMPLETED|Overall Study||2||
48154040|NCT00361439|100699909|FG000|STARTED|Overall Study||8||
48154041|NCT00361439|100699910|FG001|STARTED|Overall Study||9||
48154042|NCT00361439|100699909|FG000|COMPLETED|Overall Study||8||
48154043|NCT00361439|100699910|FG001|COMPLETED|Overall Study||9||
48154044|NCT00361439|100699909|FG000|NOT COMPLETED|Overall Study||0||
48154045|NCT00361439|100699910|FG001|NOT COMPLETED|Overall Study||0||
48154046|NCT01966003|100699911|FG000|STARTED|Overall Study||328||
48154047|NCT01966003|100699912|FG001|STARTED|Overall Study||314||
48154048|NCT01966003|100699911|FG000|Received Study Drug|Overall Study||324||
48309948|NCT00896779|101084721|FG001|NOT COMPLETED|Overall Study||1||
48309949|NCT03710486|101084722|FG000|STARTED|Overall Study||185||
48309950|NCT03710486|101084723|FG001|STARTED|Overall Study||224||
48309951|NCT03710486|101084722|FG000|COMPLETED|Overall Study||172||
48309952|NCT03710486|101084723|FG001|COMPLETED|Overall Study||212||
48309953|NCT03710486|101084722|FG000|NOT COMPLETED|Overall Study||13||
48309954|NCT03710486|101084723|FG001|NOT COMPLETED|Overall Study||12||
48612397|NCT03252145|101838253|FG000|COMPLETED|Overall Study||11||
48612398|NCT03252145|101838254|FG001|COMPLETED|Overall Study||13||
48612399|NCT03252145|101838253|FG000|NOT COMPLETED|Overall Study||2||
48612400|NCT03252145|101838254|FG001|NOT COMPLETED|Overall Study||2||
48612401|NCT02477358|101838255|FG000|STARTED|Overall Study||18||36
48612402|NCT02477358|101838256|FG001|STARTED|Overall Study||18||36
48612403|NCT02477358|101838255|FG000|COMPLETED|Overall Study||18|2 teeth (1 Treatment and 1 control) were withdrawn from the study due to early removal and excluded from statistical data.|35
48657086|NCT03648372|101943763|FG006|NOT COMPLETED|Overall Study||5||
48154049|NCT01966003|100699912|FG001|Received Study Drug|Overall Study||309||
48154050|NCT01966003|100699911|FG000|COMPLETED|Overall Study||58||
48309955|NCT03974334|101084724|FG000|STARTED|Overall Study||25||
48309956|NCT03974334|101084724|FG000|COMPLETED|Overall Study||24||
48309957|NCT03974334|101084724|FG000|NOT COMPLETED|Overall Study||1||
48154051|NCT01966003|100699912|FG001|COMPLETED|Overall Study||44||
48154052|NCT01966003|100699911|FG000|NOT COMPLETED|Overall Study||270||
48154053|NCT01966003|100699912|FG001|NOT COMPLETED|Overall Study||270||
48154054|NCT02170025|100699913|FG000|STARTED|Overall Study||14||
48154055|NCT02170025|100699914|FG001|STARTED|Overall Study||7||
48154056|NCT02170025|100699913|FG000|COMPLETED|Overall Study||12||
48154057|NCT02170025|100699914|FG001|COMPLETED|Overall Study||7||
48309958|NCT00053703|101084725|FG000|STARTED|Overall Study||35||
48309959|NCT00053703|101084726|FG001|STARTED|Overall Study||41||
48154058|NCT02170025|100699913|FG000|NOT COMPLETED|Overall Study||2||
48154059|NCT02170025|100699914|FG001|NOT COMPLETED|Overall Study||0||
48154060|NCT03365154|100699915|FG000|STARTED|Overall Study||10||
48154061|NCT03365154|100699915|FG000|COMPLETED|Overall Study||10||
48154062|NCT03365154|100699915|FG000|NOT COMPLETED|Overall Study||0||
48154063|NCT05711537|100699916|FG000|STARTED|Overall Study||21||
48154064|NCT05711537|100699916|FG000|COMPLETED|Overall Study||18||
48612404|NCT02477358|101838256|FG001|COMPLETED|Overall Study||18|2 teeth (1 Treatment and 1 control) were withdrawn from the study due to early removal and excluded from statistical data.|35
48612405|NCT02477358|101838255|FG000|NOT COMPLETED|Overall Study||0||1
48612406|NCT02477358|101838256|FG001|NOT COMPLETED|Overall Study||0||1
48612407|NCT02058589|101838257|FG000|STARTED|Overall Study||132||
48612408|NCT02058589|101838258|FG001|STARTED|Overall Study||132||
48612409|NCT02058589|101838257|FG000|COMPLETED|Overall Study||130||
48612410|NCT02058589|101838258|FG001|COMPLETED|Overall Study||130||
48154065|NCT05711537|100699916|FG000|NOT COMPLETED|Overall Study||3||
48154066|NCT00072761|100699917|FG000|STARTED|Overall Study||99||
48154067|NCT00072761|100699918|FG001|STARTED|Overall Study||97||
48154068|NCT00072761|100699917|FG000|COMPLETED|Overall Study||90||
48154069|NCT00072761|100699918|FG001|COMPLETED|Overall Study||95||
48154070|NCT00072761|100699917|FG000|NOT COMPLETED|Overall Study||9||
48154071|NCT00072761|100699918|FG001|NOT COMPLETED|Overall Study||2||
48154072|NCT02231177|100699919|FG000|STARTED|Treatment Period 1 (21 Days)||8||
48154073|NCT02231177|100699920|FG001|STARTED|Treatment Period 1 (21 Days)||7||
48154074|NCT02231177|100699921|FG002|STARTED|Treatment Period 1 (21 Days)||8||
48154075|NCT02231177|100699922|FG003|STARTED|Treatment Period 1 (21 Days)||7||
48154076|NCT02231177|100699923|FG004|STARTED|Treatment Period 1 (21 Days)||8||
48154077|NCT02231177|100699924|FG005|STARTED|Treatment Period 1 (21 Days)||9||
48154078|NCT02231177|100699919|FG000|COMPLETED|Treatment Period 1 (21 Days)||8||
48154079|NCT02231177|100699920|FG001|COMPLETED|Treatment Period 1 (21 Days)||7||
48154080|NCT02231177|100699921|FG002|COMPLETED|Treatment Period 1 (21 Days)||8||
48154081|NCT02231177|100699922|FG003|COMPLETED|Treatment Period 1 (21 Days)||7||
48154082|NCT02231177|100699923|FG004|COMPLETED|Treatment Period 1 (21 Days)||8||
48154083|NCT02231177|100699924|FG005|COMPLETED|Treatment Period 1 (21 Days)||9||
48154084|NCT02231177|100699919|FG000|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
48154085|NCT02231177|100699920|FG001|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
48154086|NCT02231177|100699921|FG002|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
48309960|NCT00053703|101084727|FG002|STARTED|Overall Study||40||
48309961|NCT00053703|101084725|FG000|COMPLETED|Overall Study||17||
48309962|NCT00053703|101084726|FG001|COMPLETED|Overall Study||28||
48309963|NCT00053703|101084727|FG002|COMPLETED|Overall Study||25||
48154087|NCT02231177|100699922|FG003|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
48154088|NCT02231177|100699923|FG004|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
48154089|NCT02231177|100699924|FG005|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
48154090|NCT02231177|100699919|FG000|STARTED|Treatment Period 2 (21 Days)||8||
48154091|NCT02231177|100699920|FG001|STARTED|Treatment Period 2 (21 Days)||7||
48154092|NCT02231177|100699921|FG002|STARTED|Treatment Period 2 (21 Days)||8||
48154093|NCT02231177|100699922|FG003|STARTED|Treatment Period 2 (21 Days)||7||
48154094|NCT02231177|100699923|FG004|STARTED|Treatment Period 2 (21 Days)||8||
48154095|NCT02231177|100699924|FG005|STARTED|Treatment Period 2 (21 Days)||9||
48154096|NCT02231177|100699919|FG000|COMPLETED|Treatment Period 2 (21 Days)||8||
48154097|NCT02231177|100699920|FG001|COMPLETED|Treatment Period 2 (21 Days)||7||
48154098|NCT02231177|100699921|FG002|COMPLETED|Treatment Period 2 (21 Days)||8||
48154099|NCT02231177|100699922|FG003|COMPLETED|Treatment Period 2 (21 Days)||7||
48154100|NCT02231177|100699923|FG004|COMPLETED|Treatment Period 2 (21 Days)||8||
48154101|NCT02231177|100699924|FG005|COMPLETED|Treatment Period 2 (21 Days)||9||
48154102|NCT02231177|100699919|FG000|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
48309964|NCT00053703|101084725|FG000|NOT COMPLETED|Overall Study||18||
48612411|NCT02058589|101838257|FG000|NOT COMPLETED|Overall Study||2||
48612412|NCT02058589|101838258|FG001|NOT COMPLETED|Overall Study||2||
48612413|NCT03084302|101838259|FG000|STARTED|Overall Study||120||
48612414|NCT03084302|101838259|FG000|COMPLETED|Overall Study||105||
48154103|NCT02231177|100699920|FG001|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
48154104|NCT02231177|100699921|FG002|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
48154105|NCT02231177|100699922|FG003|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
48309965|NCT00053703|101084726|FG001|NOT COMPLETED|Overall Study||13||
48309966|NCT00053703|101084727|FG002|NOT COMPLETED|Overall Study||15||
48612415|NCT03084302|101838259|FG000|NOT COMPLETED|Overall Study||15||
48612416|NCT02091414|101838260|FG000|STARTED|Overall Study||36||
48612417|NCT02091414|101838260|FG000|COMPLETED|Overall Study||32||
48612418|NCT02091414|101838260|FG000|NOT COMPLETED|Overall Study||4||
48612419|NCT00960804|101838261|FG000|STARTED|Overall Study||7||
48612420|NCT00960804|101838262|FG001|STARTED|Overall Study||4||
48612421|NCT00960804|101838263|FG002|STARTED|Overall Study||10||
48154106|NCT02231177|100699923|FG004|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
48154107|NCT02231177|100699924|FG005|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
48154108|NCT02231177|100699919|FG000|STARTED|Treatment Period 3 (21 Days)||8||
48154109|NCT02231177|100699920|FG001|STARTED|Treatment Period 3 (21 Days)||7||
48154110|NCT02231177|100699921|FG002|STARTED|Treatment Period 3 (21 Days)||8||
48309967|NCT01643525|101084728|FG000|STARTED|Overall Study||29||
48309968|NCT01643525|101084728|FG000|COMPLETED|Overall Study||29||
48309969|NCT01643525|101084728|FG000|NOT COMPLETED|Overall Study||0||
48612422|NCT00960804|101838261|FG000|COMPLETED|Overall Study||0||
48612423|NCT00960804|101838262|FG001|COMPLETED|Overall Study||0||
48154111|NCT02231177|100699922|FG003|STARTED|Treatment Period 3 (21 Days)||7||
48612424|NCT00960804|101838263|FG002|COMPLETED|Overall Study||0||
48154112|NCT02231177|100699923|FG004|STARTED|Treatment Period 3 (21 Days)||8||
48154113|NCT02231177|100699924|FG005|STARTED|Treatment Period 3 (21 Days)||9||
48154114|NCT02231177|100699919|FG000|COMPLETED|Treatment Period 3 (21 Days)||8||
48154115|NCT02231177|100699920|FG001|COMPLETED|Treatment Period 3 (21 Days)||7||
48154116|NCT02231177|100699921|FG002|COMPLETED|Treatment Period 3 (21 Days)||8||
48154117|NCT02231177|100699922|FG003|COMPLETED|Treatment Period 3 (21 Days)||7||
48154118|NCT02231177|100699923|FG004|COMPLETED|Treatment Period 3 (21 Days)||8||
48154119|NCT02231177|100699924|FG005|COMPLETED|Treatment Period 3 (21 Days)||9||
48154120|NCT02231177|100699919|FG000|NOT COMPLETED|Treatment Period 3 (21 Days)||0||
48154121|NCT02231177|100699920|FG001|NOT COMPLETED|Treatment Period 3 (21 Days)||0||
48154122|NCT02231177|100699921|FG002|NOT COMPLETED|Treatment Period 3 (21 Days)||0||
48154123|NCT02231177|100699922|FG003|NOT COMPLETED|Treatment Period 3 (21 Days)||0||
48154124|NCT02231177|100699923|FG004|NOT COMPLETED|Treatment Period 3 (21 Days)||0||
48154125|NCT02231177|100699924|FG005|NOT COMPLETED|Treatment Period 3 (21 Days)||0||
48154126|NCT03409666|100699925|FG000|STARTED|Overall Study||25||
48612425|NCT00960804|101838261|FG000|NOT COMPLETED|Overall Study||7||
48612426|NCT00960804|101838262|FG001|NOT COMPLETED|Overall Study||4||
48612427|NCT00960804|101838263|FG002|NOT COMPLETED|Overall Study||10||
48612428|NCT01005901|101838264|FG000|STARTED|Overall Study||552||
48612429|NCT01005901|101838265|FG001|STARTED|Overall Study||270||
48612430|NCT01005901|101838264|FG000|Safety Population|Overall Study||550||
48612431|NCT01005901|101838265|FG001|Safety Population|Overall Study||267||
48154127|NCT03409666|100699926|FG001|STARTED|Overall Study||25||
48154128|NCT03409666|100699925|FG000|COMPLETED|Overall Study||25||
48154129|NCT03409666|100699926|FG001|COMPLETED|Overall Study||21||
48154130|NCT03409666|100699925|FG000|NOT COMPLETED|Overall Study||0||
48154131|NCT03409666|100699926|FG001|NOT COMPLETED|Overall Study||4||
48154132|NCT00990964|100699927|FG000|STARTED|Overall Study||2014||
48154133|NCT00990964|100699927|FG000|Attain Family Study System Attempt|Overall Study||1917||
48154134|NCT00990964|100699927|FG000|COMPLETED|Overall Study||1802||
48154135|NCT00990964|100699927|FG000|NOT COMPLETED|Overall Study||212||
48154136|NCT02157779|100699928|FG000|STARTED|Overall Study||47||
48154137|NCT02157779|100699929|FG001|STARTED|Overall Study||45||
48154138|NCT02157779|100699928|FG000|COMPLETED|Overall Study||23||
48154139|NCT02157779|100699929|FG001|COMPLETED|Overall Study||34||
48154140|NCT02157779|100699928|FG000|NOT COMPLETED|Overall Study||24||
48154141|NCT02157779|100699929|FG001|NOT COMPLETED|Overall Study||11||
48154142|NCT01756352|100699930|FG000|STARTED|Overall Study||13||
48154143|NCT01756352|100699930|FG000|COMPLETED|Overall Study||12||
48154144|NCT01756352|100699930|FG000|NOT COMPLETED|Overall Study||1||
48154145|NCT05098054|100699931|FG000|STARTED|Overall Study||1||
48154146|NCT05098054|100699932|FG001|STARTED|Overall Study||8||
48154147|NCT05098054|100699933|FG002|STARTED|Overall Study||8||
48154148|NCT05098054|100699934|FG003|STARTED|Overall Study||19||
48154149|NCT05098054|100699931|FG000|COMPLETED|Overall Study||1||
48154150|NCT05098054|100699932|FG001|COMPLETED|Overall Study||8||
48154151|NCT05098054|100699933|FG002|COMPLETED|Overall Study||8||
48154152|NCT05098054|100699934|FG003|COMPLETED|Overall Study||19||
48154153|NCT05098054|100699931|FG000|NOT COMPLETED|Overall Study||0||
48154154|NCT05098054|100699932|FG001|NOT COMPLETED|Overall Study||0||
48154155|NCT05098054|100699933|FG002|NOT COMPLETED|Overall Study||0||
48154156|NCT05098054|100699934|FG003|NOT COMPLETED|Overall Study||0||
48154157|NCT03419364|100699935|FG000|STARTED|Overall Study||11||
48154158|NCT03419364|100699936|FG001|STARTED|Overall Study||6||
48154159|NCT03419364|100699937|FG002|STARTED|Overall Study||6||
48154160|NCT03419364|100699935|FG000|Signed Consent|Overall Study||11||
48154161|NCT03419364|100699936|FG001|Signed Consent|Overall Study||6||
48154162|NCT03419364|100699937|FG002|Signed Consent|Overall Study||6||
48154163|NCT03419364|100699935|FG000|Received Intervention|Overall Study||9||
48154164|NCT03419364|100699936|FG001|Received Intervention|Overall Study||6||
48612432|NCT01005901|101838264|FG000|Full Analysis Set|Overall Study||534||
48612433|NCT01005901|101838265|FG001|Full Analysis Set|Overall Study||260||
48612434|NCT01005901|101838264|FG000|COMPLETED|Overall Study||450||
48612435|NCT01005901|101838265|FG001|COMPLETED|Overall Study||212||
48612436|NCT01005901|101838264|FG000|NOT COMPLETED|Overall Study||102||
48612437|NCT01005901|101838265|FG001|NOT COMPLETED|Overall Study||58||
48612438|NCT00401193|101838266|FG000|STARTED|Overall Study||118||
48612439|NCT00401193|101838267|FG001|STARTED|Overall Study||117||
48612440|NCT00401193|101838268|FG002|STARTED|Overall Study||69||
48612441|NCT00401193|101838266|FG000|Intent to Treat Population|Overall Study||115||
48154165|NCT03419364|100699937|FG002|Received Intervention|Overall Study||6||
48154166|NCT03419364|100699935|FG000|COMPLETED|Overall Study||9||
48154167|NCT03419364|100699936|FG001|COMPLETED|Overall Study||6||
48154168|NCT03419364|100699937|FG002|COMPLETED|Overall Study||6||
48154169|NCT03419364|100699935|FG000|NOT COMPLETED|Overall Study||2||
48154170|NCT03419364|100699936|FG001|NOT COMPLETED|Overall Study||0||
48154171|NCT03419364|100699937|FG002|NOT COMPLETED|Overall Study||0||
48154172|NCT01995487|100699938|FG000|STARTED|Overall Study||958||
48154173|NCT01995487|100699939|FG001|STARTED|Overall Study||961||
48154174|NCT01995487|100699938|FG000|COMPLETED|Overall Study||884||
48154175|NCT01995487|100699939|FG001|COMPLETED|Overall Study||878||
48154176|NCT01995487|100699938|FG000|NOT COMPLETED|Overall Study||74||
48154177|NCT01995487|100699939|FG001|NOT COMPLETED|Overall Study||83||
48154178|NCT01751126|100699940|FG000|STARTED|Period I||57||
48154179|NCT01751126|100699941|FG001|STARTED|Period I||54||
48154180|NCT01751126|100699942|FG002|STARTED|Period I||58||
48154181|NCT01751126|100699940|FG000|COMPLETED|Period I||51||
48154182|NCT01751126|100699941|FG001|COMPLETED|Period I||43||
48154183|NCT01751126|100699942|FG002|COMPLETED|Period I||49||
48154184|NCT01751126|100699940|FG000|NOT COMPLETED|Period I||6||
48154185|NCT01751126|100699941|FG001|NOT COMPLETED|Period I||11||
48154186|NCT01751126|100699942|FG002|NOT COMPLETED|Period I||9||
48154187|NCT01751126|100699940|FG000|STARTED|Period II||72||
48612442|NCT00401193|101838267|FG001|Intent to Treat Population|Overall Study||115||
48612443|NCT00401193|101838268|FG002|Intent to Treat Population|Overall Study||67||
48612444|NCT00401193|101838266|FG000|Modified Intent to Treat Population|Overall Study||112||
48612445|NCT00401193|101838267|FG001|Modified Intent to Treat Population|Overall Study||115||
48612446|NCT00401193|101838268|FG002|Modified Intent to Treat Population|Overall Study||67||
48612447|NCT00401193|101838266|FG000|COMPLETED|Overall Study||103||
48612448|NCT00401193|101838267|FG001|COMPLETED|Overall Study||106||
48612449|NCT00401193|101838268|FG002|COMPLETED|Overall Study||63||
48612450|NCT00401193|101838266|FG000|NOT COMPLETED|Overall Study||15||
48154188|NCT01751126|100699941|FG001|STARTED|Period II||70||
48154189|NCT01751126|100699942|FG002|STARTED|Period II||0||
48154190|NCT01751126|100699940|FG000|COMPLETED|Period II||72||
48154191|NCT01751126|100699941|FG001|COMPLETED|Period II||70||
48154192|NCT01751126|100699942|FG002|COMPLETED|Period II||0||
48154193|NCT01751126|100699940|FG000|NOT COMPLETED|Period II||0||
48154194|NCT01751126|100699941|FG001|NOT COMPLETED|Period II||0||
48154195|NCT01751126|100699942|FG002|NOT COMPLETED|Period II||0||
48154196|NCT01964326|100699943|FG000|STARTED|Overall Study||1311||
48154197|NCT01964326|100699943|FG000|COMPLETED|Overall Study||1014||
48154198|NCT01964326|100699943|FG000|NOT COMPLETED|Overall Study||297||
48154199|NCT03224182|100699944|FG000|STARTED|Overall Study||81||
48154200|NCT03224182|100699945|FG001|STARTED|Overall Study||37||
48154201|NCT03224182|100699944|FG000|Safety Population|Overall Study||73||
48154202|NCT03224182|100699945|FG001|Safety Population|Overall Study||36||
48154203|NCT03224182|100699944|FG000|COMPLETED|Overall Study||0||
48154204|NCT03224182|100699945|FG001|COMPLETED|Overall Study||1||
48309970|NCT00623974|101084729|FG000|STARTED|Overall Study||0||
48309971|NCT00623974|101084730|FG001|STARTED|Overall Study||0||
48309972|NCT00623974|101084731|FG002|STARTED|Overall Study||0||
48309973|NCT00623974|101084732|FG003|STARTED|Overall Study||0||
48309974|NCT00623974|101084729|FG000|COMPLETED|Overall Study||0||
48309975|NCT00623974|101084730|FG001|COMPLETED|Overall Study||0||
48309976|NCT00623974|101084731|FG002|COMPLETED|Overall Study||0||
48309977|NCT00623974|101084732|FG003|COMPLETED|Overall Study||0||
48309978|NCT00623974|101084729|FG000|NOT COMPLETED|Overall Study||0||
48309979|NCT00623974|101084730|FG001|NOT COMPLETED|Overall Study||0||
48309980|NCT00623974|101084731|FG002|NOT COMPLETED|Overall Study||0||
48309981|NCT00623974|101084732|FG003|NOT COMPLETED|Overall Study||0||
48309982|NCT02409290|101084733|FG000|STARTED|Overall Study||32||
48612451|NCT00401193|101838267|FG001|NOT COMPLETED|Overall Study||11||
48612452|NCT00401193|101838268|FG002|NOT COMPLETED|Overall Study||6||
48612453|NCT04002791|101838269|FG000|STARTED|Overall Study||127||
48612454|NCT04002791|101838270|FG001|STARTED|Overall Study||126||
48612455|NCT04002791|101838269|FG000|COMPLETED|Overall Study||127||
48612456|NCT04002791|101838270|FG001|COMPLETED|Overall Study||126||
48612457|NCT04002791|101838269|FG000|NOT COMPLETED|Overall Study||0||
48612458|NCT04002791|101838270|FG001|NOT COMPLETED|Overall Study||0||
48612459|NCT02762071|101838271|FG000|STARTED|Overall Study||54||
48612460|NCT02762071|101838272|FG001|STARTED|Overall Study||54||
48612461|NCT02762071|101838271|FG000|COMPLETED|Overall Study||54||
48154205|NCT03224182|100699944|FG000|NOT COMPLETED|Overall Study||81||
48154206|NCT03224182|100699945|FG001|NOT COMPLETED|Overall Study||36||
48154207|NCT00673309|100699946|FG000|STARTED|Overall Study||64||
48154208|NCT00673309|100699947|FG001|STARTED|Overall Study||14||
48154209|NCT00673309|100699948|FG002|STARTED|Overall Study||14||
48154210|NCT00673309|100699949|FG003|STARTED|Overall Study||25||
48154211|NCT00673309|100699950|FG004|STARTED|Overall Study||18||
48154212|NCT00673309|100699951|FG005|STARTED|Overall Study||35||
48154213|NCT00673309|100699952|FG006|STARTED|Overall Study||14||
48154214|NCT00673309|100699953|FG007|STARTED|Overall Study||13||
48154215|NCT00673309|100699954|FG008|STARTED|Overall Study||17||
48154216|NCT00673309|100699955|FG009|STARTED|Overall Study||30||
48154217|NCT00673309|100699946|FG000|COMPLETED|Overall Study||64||
48154218|NCT00673309|100699947|FG001|COMPLETED|Overall Study||14||
48154219|NCT00673309|100699948|FG002|COMPLETED|Overall Study||14||
48154220|NCT00673309|100699949|FG003|COMPLETED|Overall Study||25||
48154221|NCT00673309|100699950|FG004|COMPLETED|Overall Study||18||
48154222|NCT00673309|100699951|FG005|COMPLETED|Overall Study||35||
48309983|NCT02409290|101084734|FG001|STARTED|Overall Study||202||
48309984|NCT02409290|101084735|FG002|STARTED|Overall Study||211||
48309985|NCT02409290|101084736|FG003|STARTED|Overall Study||143||
48309986|NCT02409290|101084733|FG000|COMPLETED|Overall Study||0||
48309987|NCT02409290|101084734|FG001|COMPLETED|Overall Study||187||
48309988|NCT02409290|101084735|FG002|COMPLETED|Overall Study||196||
48309989|NCT02409290|101084736|FG003|COMPLETED|Overall Study||134||
48309990|NCT02409290|101084733|FG000|NOT COMPLETED|Overall Study||32||
48309991|NCT02409290|101084734|FG001|NOT COMPLETED|Overall Study||15||
48309992|NCT02409290|101084735|FG002|NOT COMPLETED|Overall Study||15||
48309993|NCT02409290|101084736|FG003|NOT COMPLETED|Overall Study||9||
48309994|NCT01020591|101084737|FG000|STARTED|Overall Study||15||
48309995|NCT01020591|101084738|FG001|STARTED|Overall Study||15||
48309996|NCT01020591|101084737|FG000|COMPLETED|Overall Study||15||
48612462|NCT02762071|101838272|FG001|COMPLETED|Overall Study||54||
48612463|NCT02762071|101838271|FG000|NOT COMPLETED|Overall Study||0||
48612464|NCT02762071|101838272|FG001|NOT COMPLETED|Overall Study||0||
48612465|NCT03929263|101838273|FG000|STARTED|Overall Study||24||
48612466|NCT03929263|101838273|FG000|COMPLETED|Overall Study||24||
48154223|NCT00673309|100699952|FG006|COMPLETED|Overall Study||14||
48154224|NCT00673309|100699953|FG007|COMPLETED|Overall Study||13||
48154225|NCT00673309|100699954|FG008|COMPLETED|Overall Study||17||
48154226|NCT00673309|100699955|FG009|COMPLETED|Overall Study||30||
48154227|NCT00673309|100699946|FG000|NOT COMPLETED|Overall Study||0||
48154228|NCT00673309|100699947|FG001|NOT COMPLETED|Overall Study||0||
48154229|NCT00673309|100699948|FG002|NOT COMPLETED|Overall Study||0||
48154230|NCT00673309|100699949|FG003|NOT COMPLETED|Overall Study||0||
48154231|NCT00673309|100699950|FG004|NOT COMPLETED|Overall Study||0||
48154232|NCT00673309|100699951|FG005|NOT COMPLETED|Overall Study||0||
48154233|NCT00673309|100699952|FG006|NOT COMPLETED|Overall Study||0||
48154234|NCT00673309|100699953|FG007|NOT COMPLETED|Overall Study||0||
48154235|NCT00673309|100699954|FG008|NOT COMPLETED|Overall Study||0||
48154236|NCT00673309|100699955|FG009|NOT COMPLETED|Overall Study||0||
48154237|NCT00316173|100699956|FG000|STARTED|Run-in Phase||22||
48154238|NCT00316173|100699957|FG001|STARTED|Run-in Phase||0||
48154239|NCT00316173|100699956|FG000|COMPLETED|Run-in Phase||15||
48154240|NCT00316173|100699957|FG001|COMPLETED|Run-in Phase||0||
48154241|NCT00316173|100699956|FG000|NOT COMPLETED|Run-in Phase||7||
48154242|NCT00316173|100699957|FG001|NOT COMPLETED|Run-in Phase||0||
48154243|NCT00316173|100699956|FG000|STARTED|Treatment Phase||0||
48154244|NCT00316173|100699957|FG001|STARTED|Treatment Phase||55||
48612467|NCT03929263|101838273|FG000|NOT COMPLETED|Overall Study||0||
48612468|NCT00672633|101838274|FG000|STARTED|Overall Study||12||
48612469|NCT00672633|101838275|FG001|STARTED|Overall Study||13||
48612470|NCT00672633|101838274|FG000|COMPLETED|Overall Study||12||
48612471|NCT00672633|101838275|FG001|COMPLETED|Overall Study||12||
48612472|NCT00672633|101838274|FG000|NOT COMPLETED|Overall Study||0||
48612473|NCT00672633|101838275|FG001|NOT COMPLETED|Overall Study||1||
48154245|NCT00316173|100699956|FG000|COMPLETED|Treatment Phase||0||
48154246|NCT00316173|100699957|FG001|COMPLETED|Treatment Phase||13||
48154247|NCT00316173|100699956|FG000|NOT COMPLETED|Treatment Phase||0||
48154248|NCT00316173|100699957|FG001|NOT COMPLETED|Treatment Phase||42||
48154249|NCT02062359|100699958|FG000|STARTED|Overall Study||2||
48154250|NCT02062359|100699958|FG000|COMPLETED|Overall Study||2||
48154251|NCT02062359|100699958|FG000|NOT COMPLETED|Overall Study||0||
48154252|NCT04493931|100699959|FG000|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||14||
48154253|NCT04493931|100699960|FG001|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
48154254|NCT04493931|100699961|FG002|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
48154255|NCT04493931|100699962|FG003|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
48154256|NCT04493931|100699963|FG004|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
48154257|NCT04493931|100699964|FG005|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
48154258|NCT04493931|100699965|FG006|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
48154259|NCT04493931|100699959|FG000|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||13||
48154260|NCT04493931|100699960|FG001|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
48154261|NCT04493931|100699961|FG002|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
48154262|NCT04493931|100699962|FG003|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
48309997|NCT01020591|101084738|FG001|COMPLETED|Overall Study||15||
48309998|NCT01020591|101084737|FG000|NOT COMPLETED|Overall Study||0||
48309999|NCT01020591|101084738|FG001|NOT COMPLETED|Overall Study||0||
48310000|NCT01704287|101084739|FG000|STARTED|Initial Treatment Period||180||
48310001|NCT01704287|101084740|FG001|STARTED|Initial Treatment Period||181||
48310002|NCT01704287|101084741|FG002|STARTED|Initial Treatment Period||179||
48310003|NCT01704287|101084742|FG003|STARTED|Initial Treatment Period||0||
48310004|NCT01704287|101084743|FG004|STARTED|Initial Treatment Period||0||
48612474|NCT00758498|101838276|FG000|STARTED|Overall Study||142||
48612475|NCT00758498|101838277|FG001|STARTED|Overall Study||143||
48612476|NCT00758498|101838278|FG002|STARTED|Overall Study||142||
48612477|NCT00758498|101838276|FG000|COMPLETED|Overall Study||139||
48612478|NCT00758498|101838277|FG001|COMPLETED|Overall Study||141||
48612479|NCT00758498|101838278|FG002|COMPLETED|Overall Study||137||
48612480|NCT00758498|101838276|FG000|NOT COMPLETED|Overall Study||3||
48612481|NCT00758498|101838277|FG001|NOT COMPLETED|Overall Study||2||
48612482|NCT00758498|101838278|FG002|NOT COMPLETED|Overall Study||5||
48154263|NCT04493931|100699963|FG004|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
48154264|NCT04493931|100699964|FG005|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
48154265|NCT04493931|100699965|FG006|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
48612483|NCT04392219|101838279|FG000|STARTED|Overall Study||16||
48612484|NCT04392219|101838280|FG001|STARTED|Overall Study||6||
48154266|NCT04493931|100699959|FG000|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||1||
48154267|NCT04493931|100699960|FG001|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
48154268|NCT04493931|100699961|FG002|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
48154269|NCT04493931|100699962|FG003|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
48154270|NCT04493931|100699963|FG004|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
48154271|NCT04493931|100699964|FG005|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
48154272|NCT04493931|100699965|FG006|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
48154273|NCT04493931|100699959|FG000|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||13||
48724712|NCT03824587|102111636|FG001|STARTED|Treatment Period||119||
48724713|NCT03824587|102111635|FG000|COMPLETED|Treatment Period||112||
48724714|NCT03824587|102111636|FG001|COMPLETED|Treatment Period||116||
48724715|NCT03824587|102111635|FG000|NOT COMPLETED|Treatment Period||5||
48724716|NCT03824587|102111636|FG001|NOT COMPLETED|Treatment Period||3||
48724717|NCT00955513|102111637|FG000|STARTED|Overall Study||80||
48724718|NCT00955513|102111638|FG001|STARTED|Overall Study||80||
48724719|NCT00955513|102111639|FG002|STARTED|Overall Study||82||
48724720|NCT00955513|102111637|FG000|COMPLETED|Overall Study||79||
48724721|NCT00955513|102111638|FG001|COMPLETED|Overall Study||78||
48724722|NCT00955513|102111639|FG002|COMPLETED|Overall Study||79||
48724723|NCT00955513|102111637|FG000|NOT COMPLETED|Overall Study||1||
48724724|NCT00955513|102111638|FG001|NOT COMPLETED|Overall Study||2||
48724725|NCT00955513|102111639|FG002|NOT COMPLETED|Overall Study||3||
48724726|NCT00123604|102111640|FG000|STARTED|Overall Study||19||
48724727|NCT00123604|102111641|FG001|STARTED|Overall Study||17||
48724728|NCT00123604|102111640|FG000|COMPLETED|Overall Study||18||
48724729|NCT00123604|102111641|FG001|COMPLETED|Overall Study||16||
48724730|NCT00123604|102111640|FG000|NOT COMPLETED|Overall Study||1||
48724731|NCT00123604|102111641|FG001|NOT COMPLETED|Overall Study||1||
48724732|NCT00619307|102111642|FG000|STARTED|Overall Study||60||
48724733|NCT00619307|102111643|FG001|STARTED|Overall Study||57||
48724734|NCT00619307|102111642|FG000|COMPLETED|Overall Study||56||
48724735|NCT00619307|102111643|FG001|COMPLETED|Overall Study||53||
48724736|NCT00619307|102111642|FG000|NOT COMPLETED|Overall Study||4||
48724737|NCT00619307|102111643|FG001|NOT COMPLETED|Overall Study||4||
48724738|NCT04732949|102111644|FG000|STARTED|Overall Study||309||
48724739|NCT04732949|102111645|FG001|STARTED|Overall Study||314||
48724740|NCT04732949|102111644|FG000|COMPLETED|Overall Study||233||
48154274|NCT04493931|100699960|FG001|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
48154275|NCT04493931|100699961|FG002|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
48154276|NCT04493931|100699962|FG003|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
48154277|NCT04493931|100699963|FG004|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
48154278|NCT04493931|100699964|FG005|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
48154279|NCT04493931|100699965|FG006|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
48154280|NCT04493931|100699959|FG000|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||13||
48154281|NCT04493931|100699960|FG001|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
48154282|NCT04493931|100699961|FG002|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
48154283|NCT04493931|100699962|FG003|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
48154284|NCT04493931|100699963|FG004|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
48154285|NCT04493931|100699964|FG005|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
48612485|NCT04392219|101838281|FG002|STARTED|Overall Study||6||
48612486|NCT04392219|101838282|FG003|STARTED|Overall Study||6||
48154286|NCT04493931|100699965|FG006|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
48154287|NCT04493931|100699959|FG000|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
48154288|NCT04493931|100699960|FG001|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
48154289|NCT04493931|100699961|FG002|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
48154290|NCT04493931|100699962|FG003|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
48310005|NCT01704287|101084739|FG000|Treated|Initial Treatment Period||178||
48310006|NCT01704287|101084740|FG001|Treated|Initial Treatment Period||179||
48188730|NCT01033643|100783321|FG000|STARTED|Overall Study||6||
48310007|NCT01704287|101084741|FG002|Treated|Initial Treatment Period||171||
48310008|NCT01704287|101084742|FG003|Treated|Initial Treatment Period||0||
48310009|NCT01704287|101084743|FG004|Treated|Initial Treatment Period||0||
48310010|NCT01704287|101084739|FG000|COMPLETED|Initial Treatment Period||33||
48310011|NCT01704287|101084740|FG001|COMPLETED|Initial Treatment Period||47||
48310012|NCT01704287|101084741|FG002|COMPLETED|Initial Treatment Period||6||
48310013|NCT01704287|101084742|FG003|COMPLETED|Initial Treatment Period||0||
48612487|NCT04392219|101838283|FG004|STARTED|Overall Study||6||
48612488|NCT04392219|101838284|FG005|STARTED|Overall Study||6||
48612489|NCT04392219|101838285|FG006|STARTED|Overall Study||6||
48612490|NCT04392219|101838286|FG007|STARTED|Overall Study||6||
48612491|NCT04392219|101838287|FG008|STARTED|Overall Study||6||
48612492|NCT04392219|101838288|FG009|STARTED|Overall Study||10||
48724741|NCT04732949|102111645|FG001|COMPLETED|Overall Study||231||
48724742|NCT04732949|102111644|FG000|NOT COMPLETED|Overall Study||76||
48724743|NCT04732949|102111645|FG001|NOT COMPLETED|Overall Study||83||
48724744|NCT00528996|102111646|FG000|STARTED|Overall Study||429||
48724745|NCT00528996|102111647|FG001|STARTED|Overall Study||419||
48724746|NCT00528996|102111648|FG002|STARTED|Overall Study||415||
48310014|NCT01704287|101084743|FG004|COMPLETED|Initial Treatment Period||0||
48310015|NCT01704287|101084739|FG000|NOT COMPLETED|Initial Treatment Period||147||
48310016|NCT01704287|101084740|FG001|NOT COMPLETED|Initial Treatment Period||134||
48310017|NCT01704287|101084741|FG002|NOT COMPLETED|Initial Treatment Period||173||
48310018|NCT01704287|101084742|FG003|NOT COMPLETED|Initial Treatment Period||0||
48310019|NCT01704287|101084743|FG004|NOT COMPLETED|Initial Treatment Period||0||
48310020|NCT01704287|101084739|FG000|STARTED|Switch to Pembrolizumab Treatment Period||0||
48310021|NCT01704287|101084740|FG001|STARTED|Switch to Pembrolizumab Treatment Period||0||
48310022|NCT01704287|101084741|FG002|STARTED|Switch to Pembrolizumab Treatment Period||0||
48310023|NCT01704287|101084742|FG003|STARTED|Switch to Pembrolizumab Treatment Period||53||
48310024|NCT01704287|101084743|FG004|STARTED|Switch to Pembrolizumab Treatment Period||45||
48310025|NCT01704287|101084739|FG000|COMPLETED|Switch to Pembrolizumab Treatment Period||0||
48310026|NCT01704287|101084740|FG001|COMPLETED|Switch to Pembrolizumab Treatment Period||0||
48310027|NCT01704287|101084741|FG002|COMPLETED|Switch to Pembrolizumab Treatment Period||0||
48310028|NCT01704287|101084742|FG003|COMPLETED|Switch to Pembrolizumab Treatment Period||15||
48310029|NCT01704287|101084743|FG004|COMPLETED|Switch to Pembrolizumab Treatment Period||7||
48310030|NCT01704287|101084739|FG000|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0||
48310031|NCT01704287|101084740|FG001|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0||
48310032|NCT01704287|101084741|FG002|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0||
48310033|NCT01704287|101084742|FG003|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||38||
48310034|NCT01704287|101084743|FG004|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||38||
48310035|NCT00804570|101084744|FG000|STARTED|Overall Study||187||
48310036|NCT00804570|101084745|FG001|STARTED|Overall Study||188||
48310037|NCT00804570|101084744|FG000|COMPLETED|Overall Study||115||
48724747|NCT00528996|102111649|FG003|STARTED|Overall Study||390||
48724748|NCT00528996|102111650|FG004|STARTED|Overall Study||427||
48724749|NCT00528996|102111646|FG000|COMPLETED|Overall Study||365||
48724750|NCT00528996|102111647|FG001|COMPLETED|Overall Study||395||
48724751|NCT00528996|102111648|FG002|COMPLETED|Overall Study||372||
48724752|NCT00528996|102111649|FG003|COMPLETED|Overall Study||340||
48310038|NCT00804570|101084745|FG001|COMPLETED|Overall Study||94||
48310039|NCT00804570|101084744|FG000|NOT COMPLETED|Overall Study||72||
48310040|NCT00804570|101084745|FG001|NOT COMPLETED|Overall Study||94||
48154291|NCT04493931|100699963|FG004|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
48310041|NCT01117454|101084746|FG000|STARTED|Overall Study||6||
48310042|NCT01117454|101084747|FG001|STARTED|Overall Study||8||
48310043|NCT01117454|101084746|FG000|COMPLETED|Overall Study||6||
48310044|NCT01117454|101084747|FG001|COMPLETED|Overall Study||7||
48724753|NCT00528996|102111650|FG004|COMPLETED|Overall Study||390||
48724754|NCT00528996|102111646|FG000|NOT COMPLETED|Overall Study||64||
48724755|NCT00528996|102111647|FG001|NOT COMPLETED|Overall Study||24||
48724756|NCT00528996|102111648|FG002|NOT COMPLETED|Overall Study||43||
48724757|NCT00528996|102111649|FG003|NOT COMPLETED|Overall Study||50||
48154292|NCT04493931|100699964|FG005|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
48154293|NCT04493931|100699965|FG006|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
48154294|NCT04493931|100699959|FG000|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||13||
48154295|NCT04493931|100699960|FG001|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
48154296|NCT04493931|100699961|FG002|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
48154297|NCT04493931|100699962|FG003|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
48154298|NCT04493931|100699963|FG004|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
48154299|NCT04493931|100699964|FG005|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
48154300|NCT04493931|100699965|FG006|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
48154301|NCT04493931|100699959|FG000|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||13||
48154302|NCT04493931|100699960|FG001|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
48154303|NCT04493931|100699961|FG002|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
48154304|NCT04493931|100699962|FG003|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
48154305|NCT04493931|100699963|FG004|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
48154306|NCT04493931|100699964|FG005|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
48154307|NCT04493931|100699965|FG006|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
48154308|NCT04493931|100699959|FG000|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
48154309|NCT04493931|100699960|FG001|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
48154310|NCT04493931|100699961|FG002|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
48310045|NCT01117454|101084746|FG000|NOT COMPLETED|Overall Study||0||
48310046|NCT01117454|101084747|FG001|NOT COMPLETED|Overall Study||1||
48310047|NCT02576444|101084748|FG000|STARTED|Overall Study||26||
48724758|NCT00528996|102111650|FG004|NOT COMPLETED|Overall Study||37||
48724759|NCT02937766|102111651|FG000|STARTED|Overall Study||30||
48724760|NCT02937766|102111652|FG001|STARTED|Overall Study||30||
48310048|NCT02576444|101084749|FG001|STARTED|Overall Study||16||
48310049|NCT02576444|101084750|FG002|STARTED|Overall Study||25||
48188731|NCT01033643|100783322|FG001|STARTED|Overall Study||6||
48188732|NCT01033643|100783323|FG002|STARTED|Overall Study||6||
48188733|NCT01033643|100783324|FG003|STARTED|Overall Study||4||
48188734|NCT01033643|100783325|FG004|STARTED|Overall Study||0||
48188735|NCT01033643|100783326|FG005|STARTED|Overall Study||8||
48188736|NCT01033643|100783321|FG000|COMPLETED|Overall Study||6||
48188737|NCT01033643|100783322|FG001|COMPLETED|Overall Study||3||
48154311|NCT04493931|100699962|FG003|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
48154312|NCT04493931|100699963|FG004|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
48154313|NCT04493931|100699964|FG005|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
48154314|NCT04493931|100699965|FG006|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
48154315|NCT04493931|100699959|FG000|STARTED|Cohort 1: Follow-up (Up to 7 Days)||13||
48154316|NCT04493931|100699960|FG001|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0||
48724761|NCT02937766|102111651|FG000|COMPLETED|Overall Study||23||
48724762|NCT02937766|102111652|FG001|COMPLETED|Overall Study||30||
48724763|NCT02937766|102111651|FG000|NOT COMPLETED|Overall Study||7||
48724764|NCT02937766|102111652|FG001|NOT COMPLETED|Overall Study||0||
48724765|NCT03596450|102111653|FG000|STARTED|Overall Study||644||
48724766|NCT03596450|102111654|FG001|STARTED|Overall Study||634||
48724767|NCT03596450|102111653|FG000|COMPLETED|Overall Study||463||
48724768|NCT03596450|102111654|FG001|COMPLETED|Overall Study||447||
48724769|NCT03596450|102111653|FG000|NOT COMPLETED|Overall Study||181||
48724770|NCT03596450|102111654|FG001|NOT COMPLETED|Overall Study||187||
48724771|NCT02666105|102111655|FG000|STARTED|Overall Study||6||
48724772|NCT02666105|102111655|FG000|COMPLETED|Overall Study||5||
48724773|NCT02666105|102111655|FG000|NOT COMPLETED|Overall Study||1||
48724774|NCT04684992|102111656|FG000|STARTED|Overall Study||36||
48724775|NCT04684992|102111656|FG000|COMPLETED|Overall Study||34||
48724776|NCT04684992|102111656|FG000|NOT COMPLETED|Overall Study||2||
48724777|NCT02554981|102111657|FG000|STARTED|Overall Study||51||
48724778|NCT02554981|102111657|FG000|COMPLETED|Overall Study||46||
48724779|NCT02554981|102111657|FG000|NOT COMPLETED|Overall Study||5||
48724780|NCT03320330|102111658|FG000|STARTED|Overall Study||6||
48724781|NCT03320330|102111659|FG001|STARTED|Overall Study||6||
48724782|NCT03320330|102111660|FG002|STARTED|Overall Study||14||
48724783|NCT03320330|102111658|FG000|COMPLETED|Overall Study||0||
48724784|NCT03320330|102111659|FG001|COMPLETED|Overall Study||1||
48724785|NCT03320330|102111660|FG002|COMPLETED|Overall Study||0||
48724786|NCT03320330|102111658|FG000|NOT COMPLETED|Overall Study||6||
48724787|NCT03320330|102111659|FG001|NOT COMPLETED|Overall Study||5||
48724788|NCT03320330|102111660|FG002|NOT COMPLETED|Overall Study||14||
48724789|NCT01403116|102111661|FG000|STARTED|Overall Study||161||
48724790|NCT01403116|102111662|FG001|STARTED|Overall Study||160||
48724791|NCT01403116|102111661|FG000|Randomized|Overall Study||162||
48724792|NCT01403116|102111662|FG001|Randomized|Overall Study||163||
48724793|NCT01403116|102111661|FG000|Randomized in Error/ No Treatment Recvd|Overall Study||1||
48154317|NCT04493931|100699961|FG002|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0||
48154318|NCT04493931|100699962|FG003|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0||
48154319|NCT04493931|100699963|FG004|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0||
48724794|NCT01403116|102111662|FG001|Randomized in Error/ No Treatment Recvd|Overall Study||3||
48724795|NCT01403116|102111661|FG000|COMPLETED|Overall Study||129||
48724796|NCT01403116|102111662|FG001|COMPLETED|Overall Study||133||
48724797|NCT01403116|102111661|FG000|NOT COMPLETED|Overall Study||32||
48724798|NCT01403116|102111662|FG001|NOT COMPLETED|Overall Study||27||
48724799|NCT03968848|102111663|FG000|STARTED|Overall Study||8||
48724800|NCT03968848|102111664|FG001|STARTED|Overall Study||8||
48724801|NCT03968848|102111663|FG000|COMPLETED|Overall Study||8||
48724802|NCT03968848|102111664|FG001|COMPLETED|Overall Study||8||
48724803|NCT03968848|102111663|FG000|NOT COMPLETED|Overall Study||0||
48724804|NCT03968848|102111664|FG001|NOT COMPLETED|Overall Study||0||
48724805|NCT05327361|102111665|FG000|STARTED|Overall Study||13||26
48724806|NCT05327361|102111665|FG000|Liftactiv B3|Overall Study||13||26
48724807|NCT05327361|102111665|FG000|Control Group|Overall Study||13||26
48724808|NCT05327361|102111665|FG000|COMPLETED|Overall Study||9||18
48724809|NCT05327361|102111665|FG000|NOT COMPLETED|Overall Study||4||8
48724810|NCT02733653|102111666|FG000|STARTED|Overall Study||50||
48724811|NCT02733653|102111666|FG000|COMPLETED|Overall Study||49||
48724812|NCT02733653|102111666|FG000|NOT COMPLETED|Overall Study||1||
48724813|NCT01753401|102111667|FG000|STARTED|Double-blind Period (8 Weeks)||12||
48724814|NCT01753401|102111668|FG001|STARTED|Double-blind Period (8 Weeks)||26||
48724815|NCT01753401|102111669|FG002|STARTED|Double-blind Period (8 Weeks)||0||
48724816|NCT01753401|102111670|FG003|STARTED|Double-blind Period (8 Weeks)||0||
48724817|NCT01753401|102111667|FG000|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||11||
48154320|NCT04493931|100699964|FG005|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0||
48154321|NCT04493931|100699965|FG006|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0||
48188738|NCT01033643|100783323|FG002|COMPLETED|Overall Study||6||
48724818|NCT01753401|102111668|FG001|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||25||
48724819|NCT01753401|102111669|FG002|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||0||
48724820|NCT01753401|102111670|FG003|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||0||
48724821|NCT01753401|102111667|FG000|COMPLETED|Double-blind Period (8 Weeks)||11||
48724822|NCT01753401|102111668|FG001|COMPLETED|Double-blind Period (8 Weeks)||22||
48724823|NCT01753401|102111669|FG002|COMPLETED|Double-blind Period (8 Weeks)||0||
48724824|NCT01753401|102111670|FG003|COMPLETED|Double-blind Period (8 Weeks)||0||
48724825|NCT01753401|102111667|FG000|NOT COMPLETED|Double-blind Period (8 Weeks)||1||
48724826|NCT01753401|102111668|FG001|NOT COMPLETED|Double-blind Period (8 Weeks)||4||
48724827|NCT01753401|102111669|FG002|NOT COMPLETED|Double-blind Period (8 Weeks)||0||
48724828|NCT01753401|102111670|FG003|NOT COMPLETED|Double-blind Period (8 Weeks)||0||
48724829|NCT01753401|102111667|FG000|STARTED|Open Label Period (44 Weeks)||0||
48724830|NCT01753401|102111668|FG001|STARTED|Open Label Period (44 Weeks)||0||
48724831|NCT01753401|102111669|FG002|STARTED|Open Label Period (44 Weeks)||11||
48724832|NCT01753401|102111670|FG003|STARTED|Open Label Period (44 Weeks)||22||
48724833|NCT01753401|102111667|FG000|mITT|Open Label Period (44 Weeks)||0||
48724834|NCT01753401|102111668|FG001|mITT|Open Label Period (44 Weeks)||0||
48724835|NCT01753401|102111669|FG002|mITT|Open Label Period (44 Weeks)||11||
48724836|NCT01753401|102111670|FG003|mITT|Open Label Period (44 Weeks)||22||
48724837|NCT01753401|102111667|FG000|Safety Analysis Set|Open Label Period (44 Weeks)||0||
48724838|NCT01753401|102111668|FG001|Safety Analysis Set|Open Label Period (44 Weeks)||0||
48724839|NCT01753401|102111669|FG002|Safety Analysis Set|Open Label Period (44 Weeks)||11||
48724840|NCT01753401|102111670|FG003|Safety Analysis Set|Open Label Period (44 Weeks)||22||
48724841|NCT01753401|102111667|FG000|COMPLETED|Open Label Period (44 Weeks)||0||
48310050|NCT02576444|101084751|FG003|STARTED|Overall Study||0||
48310051|NCT02576444|101084748|FG000|COMPLETED|Overall Study||25||
48310052|NCT02576444|101084749|FG001|COMPLETED|Overall Study||15||
48310053|NCT02576444|101084750|FG002|COMPLETED|Overall Study||21||
48310054|NCT02576444|101084751|FG003|COMPLETED|Overall Study||0||
48310055|NCT02576444|101084748|FG000|NOT COMPLETED|Overall Study||1||
48310056|NCT02576444|101084749|FG001|NOT COMPLETED|Overall Study||1||
48310057|NCT02576444|101084750|FG002|NOT COMPLETED|Overall Study||4||
48310058|NCT02576444|101084751|FG003|NOT COMPLETED|Overall Study||0||
48310059|NCT02357134|101084752|FG000|STARTED|Overall Study||11||
48310060|NCT02357134|101084753|FG001|STARTED|Overall Study||11||
48310061|NCT02357134|101084754|FG002|STARTED|Overall Study||12||
48310062|NCT02357134|101084755|FG003|STARTED|Overall Study||11||
48310063|NCT02357134|101084752|FG000|COMPLETED|Overall Study||10||
48310064|NCT02357134|101084753|FG001|COMPLETED|Overall Study||11||
48310065|NCT02357134|101084754|FG002|COMPLETED|Overall Study||12||
48310066|NCT02357134|101084755|FG003|COMPLETED|Overall Study||11||
48310067|NCT02357134|101084752|FG000|NOT COMPLETED|Overall Study||1||
48310068|NCT02357134|101084753|FG001|NOT COMPLETED|Overall Study||0||
48310069|NCT02357134|101084754|FG002|NOT COMPLETED|Overall Study||0||
48310070|NCT02357134|101084755|FG003|NOT COMPLETED|Overall Study||0||
48310071|NCT00058552|101084756|FG000|STARTED|Overall Study||65||
48310072|NCT00058552|101084757|FG001|STARTED|Overall Study||64||
48724842|NCT01753401|102111668|FG001|COMPLETED|Open Label Period (44 Weeks)||0||
48724843|NCT01753401|102111669|FG002|COMPLETED|Open Label Period (44 Weeks)||7||
48724844|NCT01753401|102111670|FG003|COMPLETED|Open Label Period (44 Weeks)||13||
48724845|NCT01753401|102111667|FG000|NOT COMPLETED|Open Label Period (44 Weeks)||0||
48310073|NCT00058552|101084756|FG000|COMPLETED|Overall Study||0||
48310074|NCT00058552|101084757|FG001|COMPLETED|Overall Study||2||
48310075|NCT00058552|101084756|FG000|NOT COMPLETED|Overall Study||65||
48310076|NCT00058552|101084757|FG001|NOT COMPLETED|Overall Study||62||
48310077|NCT01553188|101084758|FG000|STARTED|Overall Study||3||
48310078|NCT01553188|101084759|FG001|STARTED|Overall Study||6||
48310079|NCT01553188|101084760|FG002|STARTED|Overall Study||16||
48310080|NCT01553188|101084761|FG003|STARTED|Overall Study||11||
48310081|NCT01553188|101084758|FG000|COMPLETED|Overall Study||2||
48310082|NCT01553188|101084759|FG001|COMPLETED|Overall Study||5||
48310083|NCT01553188|101084760|FG002|COMPLETED|Overall Study||14||
48310084|NCT01553188|101084761|FG003|COMPLETED|Overall Study||11||
48406572|NCT02603172|101328446|FG007|COMPLETED|Part C (Approximately 13 Weeks)||0||
48406573|NCT02603172|101328439|FG000|NOT COMPLETED|Part C (Approximately 13 Weeks)||0||
48406574|NCT02603172|101328440|FG001|NOT COMPLETED|Part C (Approximately 13 Weeks)||0||
48724846|NCT01753401|102111668|FG001|NOT COMPLETED|Open Label Period (44 Weeks)||0||
48724847|NCT01753401|102111669|FG002|NOT COMPLETED|Open Label Period (44 Weeks)||4||
48724848|NCT01753401|102111670|FG003|NOT COMPLETED|Open Label Period (44 Weeks)||9||
48724849|NCT02305238|102111671|FG000|STARTED|Overall Study||124||
48724850|NCT02305238|102111672|FG001|STARTED|Overall Study||123||
48724851|NCT02305238|102111673|FG002|STARTED|Overall Study||8||
48724852|NCT02305238|102111671|FG000|Treated|Overall Study||124||
48724853|NCT02305238|102111672|FG001|Treated|Overall Study||123||
48724854|NCT02305238|102111673|FG002|Treated|Overall Study||7||
48724855|NCT02305238|102111671|FG000|Randomized|Overall Study||124||
48724856|NCT02305238|102111672|FG001|Randomized|Overall Study||123||
48724857|NCT02305238|102111673|FG002|Randomized|Overall Study||0||
48724858|NCT02305238|102111671|FG000|BCVA Post-randomization Assessment|Overall Study||123||
48724859|NCT02305238|102111672|FG001|BCVA Post-randomization Assessment|Overall Study||123||
48724860|NCT02305238|102111673|FG002|BCVA Post-randomization Assessment|Overall Study||0||
48724861|NCT02305238|102111671|FG000|COMPLETED|Overall Study||108|Completed Treatment (Week 96)|
48724862|NCT02305238|102111672|FG001|COMPLETED|Overall Study||104|Completed Treatment (Week 96)|
48310085|NCT01553188|101084758|FG000|NOT COMPLETED|Overall Study||1||
48310086|NCT01553188|101084759|FG001|NOT COMPLETED|Overall Study||1||
48310087|NCT01553188|101084760|FG002|NOT COMPLETED|Overall Study||2||
48310088|NCT01553188|101084761|FG003|NOT COMPLETED|Overall Study||0||
48724863|NCT02305238|102111673|FG002|COMPLETED|Overall Study||0|Completed Treatment (Week 96)|
48724864|NCT02305238|102111671|FG000|NOT COMPLETED|Overall Study||16||
48724865|NCT02305238|102111672|FG001|NOT COMPLETED|Overall Study||19||
48724866|NCT02305238|102111673|FG002|NOT COMPLETED|Overall Study||8||
48724867|NCT03514433|102111674|FG000|STARTED|Usual Care||111||
48724868|NCT03514433|102111675|FG001|STARTED|Usual Care||38||
48724869|NCT03514433|102111676|FG002|STARTED|Usual Care||177||
48724870|NCT03514433|102111677|FG003|STARTED|Usual Care||83||
48724871|NCT03514433|102111678|FG004|STARTED|Usual Care||141||
48724872|NCT03514433|102111674|FG000|COMPLETED|Usual Care||111||
48724873|NCT03514433|102111675|FG001|COMPLETED|Usual Care||38||
48724874|NCT03514433|102111676|FG002|COMPLETED|Usual Care||177||
48724875|NCT03514433|102111677|FG003|COMPLETED|Usual Care||83||
48724876|NCT03514433|102111678|FG004|COMPLETED|Usual Care||141||
48724877|NCT03514433|102111674|FG000|NOT COMPLETED|Usual Care||0||
48724878|NCT03514433|102111675|FG001|NOT COMPLETED|Usual Care||0||
48724879|NCT03514433|102111676|FG002|NOT COMPLETED|Usual Care||0||
48724880|NCT03514433|102111677|FG003|NOT COMPLETED|Usual Care||0||
48724881|NCT03514433|102111678|FG004|NOT COMPLETED|Usual Care||0||
48724882|NCT03514433|102111674|FG000|STARTED|Intervention||317||
48724883|NCT03514433|102111675|FG001|STARTED|Intervention||75||
48724884|NCT03514433|102111676|FG002|STARTED|Intervention||372||
48724885|NCT03514433|102111677|FG003|STARTED|Intervention||144||
48724886|NCT03514433|102111678|FG004|STARTED|Intervention||267||
48724887|NCT03514433|102111674|FG000|COMPLETED|Intervention||317||
48724888|NCT03514433|102111675|FG001|COMPLETED|Intervention||75||
48724889|NCT03514433|102111676|FG002|COMPLETED|Intervention||372||
48724890|NCT03514433|102111677|FG003|COMPLETED|Intervention||144||
48724891|NCT03514433|102111678|FG004|COMPLETED|Intervention||267||
48724892|NCT03514433|102111674|FG000|NOT COMPLETED|Intervention||0||
48724893|NCT03514433|102111675|FG001|NOT COMPLETED|Intervention||0||
48724894|NCT03514433|102111676|FG002|NOT COMPLETED|Intervention||0||
48724895|NCT03514433|102111677|FG003|NOT COMPLETED|Intervention||0||
48724896|NCT03514433|102111678|FG004|NOT COMPLETED|Intervention||0||
48724897|NCT00771056|102111679|FG000|STARTED|Overall Study||23||
48724898|NCT00771056|102111679|FG000|COMPLETED|Overall Study||18||
48724899|NCT00771056|102111679|FG000|NOT COMPLETED|Overall Study||5||
48724900|NCT03624127|102111680|FG000|STARTED|Pre-treatment||332|Started = Randomized|
48724901|NCT03624127|102111681|FG001|STARTED|Pre-treatment||166|Started = Randomized|
48724902|NCT03624127|102111682|FG002|STARTED|Pre-treatment||168|Started = Randomized|
48724903|NCT03624127|102111680|FG000|COMPLETED|Pre-treatment||332|Completed = Entered treatment period|
48724904|NCT03624127|102111681|FG001|COMPLETED|Pre-treatment||165|Completed = Entered treatment period|
48154322|NCT04493931|100699959|FG000|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||13||
48154323|NCT04493931|100699960|FG001|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0||
48154324|NCT04493931|100699961|FG002|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0||
48154325|NCT04493931|100699962|FG003|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0||
48154326|NCT04493931|100699963|FG004|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0||
48154327|NCT04493931|100699964|FG005|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0||
48154328|NCT04493931|100699965|FG006|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0||
48154329|NCT04493931|100699959|FG000|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0||
48724905|NCT03624127|102111682|FG002|COMPLETED|Pre-treatment||168|Completed = Entered treatment period|
48724906|NCT03624127|102111680|FG000|NOT COMPLETED|Pre-treatment||0||
48724907|NCT03624127|102111681|FG001|NOT COMPLETED|Pre-treatment||1||
48724908|NCT03624127|102111682|FG002|NOT COMPLETED|Pre-treatment||0||
48724909|NCT03624127|102111680|FG000|STARTED|Treatment Week 0 - Week 16||332||
48724910|NCT03624127|102111681|FG001|STARTED|Treatment Week 0 - Week 16||165||
48724911|NCT03624127|102111682|FG002|STARTED|Treatment Week 0 - Week 16||168||
48724912|NCT03624127|102111680|FG000|COMPLETED|Treatment Week 0 - Week 16||307||
48724913|NCT03624127|102111681|FG001|COMPLETED|Treatment Week 0 - Week 16||145||
48724914|NCT03624127|102111682|FG002|COMPLETED|Treatment Week 0 - Week 16||145||
48724915|NCT03624127|102111680|FG000|NOT COMPLETED|Treatment Week 0 - Week 16||25||
48724916|NCT03624127|102111681|FG001|NOT COMPLETED|Treatment Week 0 - Week 16||20||
48724917|NCT03624127|102111682|FG002|NOT COMPLETED|Treatment Week 0 - Week 16||23||
48724918|NCT03624127|102111680|FG000|STARTED|Treatment Week 16 - Week 24||452||
48724919|NCT03624127|102111681|FG001|STARTED|Treatment Week 16 - Week 24||0||
48154330|NCT04493931|100699960|FG001|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0||
48154331|NCT04493931|100699961|FG002|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0||
48154332|NCT04493931|100699962|FG003|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0||
48154333|NCT04493931|100699963|FG004|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0||
48188739|NCT01033643|100783324|FG003|COMPLETED|Overall Study||4||
48724920|NCT03624127|102111682|FG002|STARTED|Treatment Week 16 - Week 24||145||
48724921|NCT03624127|102111680|FG000|COMPLETED|Treatment Week 16 - Week 24||442||
48724922|NCT03624127|102111681|FG001|COMPLETED|Treatment Week 16 - Week 24||0||
48724923|NCT03624127|102111682|FG002|COMPLETED|Treatment Week 16 - Week 24||141||
48724924|NCT03624127|102111680|FG000|NOT COMPLETED|Treatment Week 16 - Week 24||10||
48724925|NCT03624127|102111681|FG001|NOT COMPLETED|Treatment Week 16 - Week 24||0||
48724926|NCT03624127|102111682|FG002|NOT COMPLETED|Treatment Week 16 - Week 24||4||
48724927|NCT03624127|102111680|FG000|STARTED|Treatment Week 24 - Week 52||496||
48724928|NCT03624127|102111681|FG001|STARTED|Treatment Week 24 - Week 52||0||
48724929|NCT03624127|102111682|FG002|STARTED|Treatment Week 24 - Week 52||87||
48724930|NCT03624127|102111680|FG000|COMPLETED|Treatment Week 24 - Week 52||444||
48724931|NCT03624127|102111681|FG001|COMPLETED|Treatment Week 24 - Week 52||0||
48724932|NCT03624127|102111682|FG002|COMPLETED|Treatment Week 24 - Week 52||83||
48724933|NCT03624127|102111680|FG000|NOT COMPLETED|Treatment Week 24 - Week 52||52||
48724934|NCT03624127|102111681|FG001|NOT COMPLETED|Treatment Week 24 - Week 52||0||
48724935|NCT03624127|102111682|FG002|NOT COMPLETED|Treatment Week 24 - Week 52||4||
48724936|NCT04405245|102111683|FG000|STARTED|Overall Study||65||
48724937|NCT04405245|102111684|FG001|STARTED|Overall Study||65||
48724938|NCT04405245|102111685|FG002|STARTED|Overall Study||64||
48724939|NCT04405245|102111683|FG000|COMPLETED|Overall Study||65||
48724940|NCT04405245|102111684|FG001|COMPLETED|Overall Study||64||
48724941|NCT04405245|102111685|FG002|COMPLETED|Overall Study||64||
48724942|NCT04405245|102111683|FG000|NOT COMPLETED|Overall Study||0||
48724943|NCT04405245|102111684|FG001|NOT COMPLETED|Overall Study||1||
48724944|NCT04405245|102111685|FG002|NOT COMPLETED|Overall Study||0||
48724945|NCT00902174|102111686|FG000|STARTED|Overall Study||103||
48724946|NCT00902174|102111687|FG001|STARTED|Overall Study||99||
48724947|NCT00902174|102111686|FG000|COMPLETED|Overall Study||69||
48724948|NCT00902174|102111687|FG001|COMPLETED|Overall Study||81||
48724949|NCT00902174|102111686|FG000|NOT COMPLETED|Overall Study||34||
48724950|NCT00902174|102111687|FG001|NOT COMPLETED|Overall Study||18||
48724951|NCT03368235|102111688|FG000|STARTED|Overall Study||11||
48724952|NCT03368235|102111689|FG001|STARTED|Overall Study||10||
48724953|NCT03368235|102111688|FG000|COMPLETED|Overall Study||11||
48724954|NCT03368235|102111689|FG001|COMPLETED|Overall Study||10||
48724955|NCT03368235|102111688|FG000|NOT COMPLETED|Overall Study||0||
48724956|NCT03368235|102111689|FG001|NOT COMPLETED|Overall Study||0||
48724957|NCT01309269|102111690|FG000|STARTED|Overall Study||1085||
48724958|NCT01309269|102111690|FG000|Treated|Overall Study||978||
48724959|NCT01309269|102111690|FG000|COMPLETED|Overall Study||245||
48724960|NCT01309269|102111690|FG000|NOT COMPLETED|Overall Study||840||
48724961|NCT01026220|102111691|FG000|STARTED|Induction||166||
48724962|NCT01026220|102111692|FG001|STARTED|Induction||0||
48724963|NCT01026220|102111693|FG002|STARTED|Induction||0||
48724964|NCT01026220|102111691|FG000|COMPLETED|Induction||141||
48724965|NCT01026220|102111692|FG001|COMPLETED|Induction||0||
48724966|NCT01026220|102111693|FG002|COMPLETED|Induction||0||
48724967|NCT01026220|102111691|FG000|NOT COMPLETED|Induction||25||
48724968|NCT01026220|102111692|FG001|NOT COMPLETED|Induction||0||
48724969|NCT01026220|102111693|FG002|NOT COMPLETED|Induction||0||
48724970|NCT01026220|102111691|FG000|STARTED|Consolidation Maintenance||0||
48724971|NCT01026220|102111692|FG001|STARTED|Consolidation Maintenance||81||
48724972|NCT01026220|102111693|FG002|STARTED|Consolidation Maintenance||80||
48724973|NCT01026220|102111691|FG000|COMPLETED|Consolidation Maintenance||0||
48724974|NCT01026220|102111692|FG001|COMPLETED|Consolidation Maintenance||75||
48724975|NCT01026220|102111693|FG002|COMPLETED|Consolidation Maintenance||66||
48724976|NCT01026220|102111691|FG000|NOT COMPLETED|Consolidation Maintenance||0||
48724977|NCT01026220|102111692|FG001|NOT COMPLETED|Consolidation Maintenance||6||
48724978|NCT01026220|102111693|FG002|NOT COMPLETED|Consolidation Maintenance||14||
48724979|NCT00915551|102111694|FG000|STARTED|Overall Study||142||
48724980|NCT00915551|102111695|FG001|STARTED|Overall Study||136||
48724981|NCT00915551|102111694|FG000|COMPLETED|Overall Study||142||
48724982|NCT00915551|102111695|FG001|COMPLETED|Overall Study||135||
48724983|NCT00915551|102111694|FG000|NOT COMPLETED|Overall Study||0||
48724984|NCT00915551|102111695|FG001|NOT COMPLETED|Overall Study||1||
48724985|NCT01983774|102111696|FG000|STARTED|Overall Study||9||
48724986|NCT01983774|102111697|FG001|STARTED|Overall Study||8||
48724987|NCT01983774|102111696|FG000|COMPLETED|Overall Study||8||
48724988|NCT01983774|102111697|FG001|COMPLETED|Overall Study||7||
48724989|NCT01983774|102111696|FG000|NOT COMPLETED|Overall Study||1||
48724990|NCT01983774|102111697|FG001|NOT COMPLETED|Overall Study||1||
48724991|NCT02953886|102111698|FG000|STARTED|Overall Study||20||
48724992|NCT02953886|102111698|FG000|COMPLETED|Overall Study||20||
48724993|NCT02953886|102111698|FG000|NOT COMPLETED|Overall Study||0||
48724994|NCT01078168|102111699|FG000|STARTED|Overall Study||11||
48724995|NCT01078168|102111700|FG001|STARTED|Overall Study||11||
48724996|NCT01078168|102111699|FG000|COMPLETED|Overall Study||11||
48724997|NCT01078168|102111700|FG001|COMPLETED|Overall Study||10||
48724998|NCT01078168|102111699|FG000|NOT COMPLETED|Overall Study||0||
48724999|NCT01078168|102111700|FG001|NOT COMPLETED|Overall Study||1||
48725000|NCT03180307|102111701|FG000|STARTED|Overall Study||134||
48725001|NCT03180307|102111702|FG001|STARTED|Overall Study||6||
48725002|NCT03180307|102111701|FG000|Safety Analysis Set|Overall Study||134|All subjects received study drug prior to randomization. A total of 150 subjects received study drug, 10 of which were not randomized to either arm. These 10 subjects withdrew to the study prior to randomization but are included in the Safety Analysis Set.|
48725003|NCT03180307|102111702|FG001|Safety Analysis Set|Overall Study||16|All subjects received study drug prior to randomization. A total of 150 subjects received study drug, 10 of which were not randomized to either arm. These 10 subjects withdrew to the study prior to randomization but are included in the Safety Analysis Set.|
48154334|NCT04493931|100699964|FG005|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0||
48154335|NCT04493931|100699965|FG006|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0||
48154336|NCT04493931|100699959|FG000|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
48154337|NCT04493931|100699960|FG001|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||17||
48725004|NCT03180307|102111701|FG000|Full Analysis Set/ Intent to Image Set|Overall Study||134||
48725005|NCT03180307|102111702|FG001|Full Analysis Set/ Intent to Image Set|Overall Study||0||
48725006|NCT03180307|102111701|FG000|Per Protocol Analysis Set|Overall Study||106||
48725007|NCT03180307|102111702|FG001|Per Protocol Analysis Set|Overall Study||0||
48725008|NCT03180307|102111701|FG000|Pharmacokinetic Analysis Set|Overall Study||122||
48725009|NCT03180307|102111702|FG001|Pharmacokinetic Analysis Set|Overall Study||6||
48725010|NCT03180307|102111701|FG000|COMPLETED|Overall Study||128||
48725011|NCT03180307|102111702|FG001|COMPLETED|Overall Study||6||
48725012|NCT03180307|102111701|FG000|NOT COMPLETED|Overall Study||6||
48725013|NCT03180307|102111702|FG001|NOT COMPLETED|Overall Study||0||
48725014|NCT01431963|102111703|FG000|STARTED|Overall Study||67||
48725015|NCT01431963|102111703|FG000|Begin Escalation Phase (EP; 6 Weeks)|Overall Study||67||
48725016|NCT01431963|102111703|FG000|Received Treatment|Overall Study||65||
48725017|NCT01431963|102111703|FG000|Complete EP (6 Weeks)|Overall Study||52||
48725018|NCT01431963|102111703|FG000|Begin Maintenance Phase (MP; 24 Weeks)|Overall Study||52||
48725019|NCT01431963|102111703|FG000|Complete MP (24 Weeks)|Overall Study||42||
48725020|NCT01431963|102111703|FG000|Begin Extension Phase (ExP; gt= 24weeks)|Overall Study||19||
48725021|NCT01431963|102111703|FG000|Complete ExP (gt= 24 Weeks)|Overall Study||19||
48725022|NCT01431963|102111703|FG000|COMPLETED|Overall Study||32||
48725023|NCT01431963|102111703|FG000|NOT COMPLETED|Overall Study||35||
48725024|NCT00988364|102111704|FG000|STARTED|Overall Study||6||
48725025|NCT00988364|102111705|FG001|STARTED|Overall Study||6||
48725026|NCT00988364|102111706|FG002|STARTED|Overall Study||6||
48725027|NCT00988364|102111707|FG003|STARTED|Overall Study||6||
48725028|NCT00988364|102111704|FG000|COMPLETED|Overall Study||6||
48725029|NCT00988364|102111705|FG001|COMPLETED|Overall Study||6||
48725030|NCT00988364|102111706|FG002|COMPLETED|Overall Study||6||
48725031|NCT00988364|102111707|FG003|COMPLETED|Overall Study||6||
48725032|NCT00988364|102111704|FG000|NOT COMPLETED|Overall Study||0||
48725033|NCT00988364|102111705|FG001|NOT COMPLETED|Overall Study||0||
48725034|NCT00988364|102111706|FG002|NOT COMPLETED|Overall Study||0||
48725035|NCT00988364|102111707|FG003|NOT COMPLETED|Overall Study||0||
48725036|NCT00559988|102111708|FG000|STARTED|Overall Study||1357||
48725037|NCT00559988|102111709|FG001|STARTED|Overall Study||1361||
48725038|NCT00559988|102111708|FG000|COMPLETED|Overall Study||1006||
48725039|NCT00559988|102111709|FG001|COMPLETED|Overall Study||1009||
48725040|NCT00559988|102111708|FG000|NOT COMPLETED|Overall Study||351||
48725041|NCT00559988|102111709|FG001|NOT COMPLETED|Overall Study||352||
48725042|NCT00551291|102111710|FG000|STARTED|Overall Study||10||
48725043|NCT00551291|102111710|FG000|COMPLETED|Overall Study||9||
48725044|NCT00551291|102111710|FG000|NOT COMPLETED|Overall Study||1||
48725045|NCT03006887|102111711|FG000|STARTED|Overall Study||6||
48725046|NCT03006887|102111711|FG000|COMPLETED|Overall Study||5||
48725047|NCT03006887|102111711|FG000|NOT COMPLETED|Overall Study||1||
48725048|NCT00932165|102111712|FG000|STARTED|Overall Study||451||
48725049|NCT00932165|102111712|FG000|COMPLETED|Overall Study||450||
48725050|NCT00932165|102111712|FG000|NOT COMPLETED|Overall Study||1||
48725051|NCT02461745|102111713|FG000|STARTED|Overall Study||130||
48725052|NCT02461745|102111714|FG001|STARTED|Overall Study||70||
48725053|NCT02461745|102111713|FG000|COMPLETED|Overall Study||116||
48725054|NCT02461745|102111714|FG001|COMPLETED|Overall Study||66||
48725055|NCT02461745|102111713|FG000|NOT COMPLETED|Overall Study||14||
48725056|NCT02461745|102111714|FG001|NOT COMPLETED|Overall Study||4||
48725057|NCT04566692|102111715|FG000|STARTED|Overall Study||27||
48725058|NCT04566692|102111716|FG001|STARTED|Overall Study||6||
48154338|NCT04493931|100699961|FG002|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
48154339|NCT04493931|100699962|FG003|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
48154340|NCT04493931|100699963|FG004|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
48154341|NCT04493931|100699964|FG005|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
48154342|NCT04493931|100699965|FG006|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
48188740|NCT01033643|100783325|FG004|COMPLETED|Overall Study||0||
48725059|NCT04566692|102111715|FG000|Safety Population|Overall Study||27|Safety population included all participants who received at least 1 dose of IGSC 20%.|
48725060|NCT04566692|102111716|FG001|Safety Population|Overall Study||6|Safety population included all participants who received at least 1 dose of IGSC 20%.|
48725061|NCT04566692|102111715|FG000|Efficacy Evaluable Population|Overall Study||27|Efficacy evaluable population included all participants who received at least 1 dose of IGSC 20%.|
48725062|NCT04566692|102111716|FG001|Efficacy Evaluable Population|Overall Study||6|Efficacy evaluable population included all participants who received at least 1 dose of IGSC 20%.|
48725063|NCT04566692|102111715|FG000|IgG Population|Overall Study||27|IgG population included all participants who received at least 1 dose of IGSC 20%.|
48725064|NCT04566692|102111716|FG001|IgG Population|Overall Study||6|IgG population included all participants who received at least 1 dose of IGSC 20%.|
48725065|NCT04566692|102111715|FG000|Pharmacokinetic (PK) Population|Overall Study||25|PK population included all the participants who had sufficient PK concentration data to have at least one of the PK parameters: area under the concentration time curve (AUC) (0-7 days), maximum concentration (Cmax), or time to reach Cmax (Tmax).|
48725066|NCT04566692|102111716|FG001|Pharmacokinetic (PK) Population|Overall Study||0|PK population included all the participants who had sufficient PK concentration data to have at least one of the PK parameters: area under the concentration time curve (AUC) (0-7 days), maximum concentration (Cmax), or time to reach Cmax (Tmax).|
48725067|NCT04566692|102111715|FG000|COMPLETED|Overall Study||24||
48725068|NCT04566692|102111716|FG001|COMPLETED|Overall Study||5||
48725069|NCT04566692|102111715|FG000|NOT COMPLETED|Overall Study||3||
48725070|NCT04566692|102111716|FG001|NOT COMPLETED|Overall Study||1||
48725071|NCT02271945|102111717|FG000|STARTED|Overall Study||5||
48725072|NCT02271945|102111718|FG001|STARTED|Overall Study||5||
48725073|NCT02271945|102111717|FG000|COMPLETED|Overall Study||0||
48725074|NCT02271945|102111718|FG001|COMPLETED|Overall Study||0||
48725075|NCT02271945|102111717|FG000|NOT COMPLETED|Overall Study||5||
48725076|NCT02271945|102111718|FG001|NOT COMPLETED|Overall Study||5||
48725077|NCT05261009|102111719|FG000|STARTED|Overall Study||76||
48725078|NCT05261009|102111720|FG001|STARTED|Overall Study||76||
48725079|NCT05261009|102111719|FG000|COMPLETED|Overall Study||75||
48725080|NCT05261009|102111720|FG001|COMPLETED|Overall Study||75||
48725081|NCT05261009|102111719|FG000|NOT COMPLETED|Overall Study||1||
48725082|NCT05261009|102111720|FG001|NOT COMPLETED|Overall Study||1||
48725083|NCT04042727|102111721|FG000|STARTED|Overall Study||6||
48725084|NCT04042727|102111722|FG001|STARTED|Overall Study||7||
48725085|NCT04042727|102111721|FG000|COMPLETED|Overall Study||6||
48725086|NCT04042727|102111722|FG001|COMPLETED|Overall Study||7||
48725087|NCT04042727|102111721|FG000|NOT COMPLETED|Overall Study||0||
48725088|NCT04042727|102111722|FG001|NOT COMPLETED|Overall Study||0||
48725089|NCT02408523|102111723|FG000|STARTED|Overall Study||121||
48725090|NCT02408523|102111724|FG001|STARTED|Overall Study||121||
48725091|NCT02408523|102111723|FG000|Completed Treatment Period|Overall Study||110||
48725092|NCT02408523|102111724|FG001|Completed Treatment Period|Overall Study||103||
48154343|NCT04493931|100699959|FG000|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
48725093|NCT02408523|102111723|FG000|Enrolled Transition Period|Overall Study||108||
48725094|NCT02408523|102111724|FG001|Enrolled Transition Period|Overall Study||101||
48725095|NCT02408523|102111723|FG000|Enrolled Taper Period|Overall Study||7||
48725096|NCT02408523|102111724|FG001|Enrolled Taper Period|Overall Study||9||
48725097|NCT02408523|102111723|FG000|Enrolled Safety Folllow-up Period|Overall Study||10||
48725098|NCT02408523|102111724|FG001|Enrolled Safety Folllow-up Period|Overall Study||11||
48725099|NCT02408523|102111723|FG000|COMPLETED|Overall Study||110||
48725100|NCT02408523|102111724|FG001|COMPLETED|Overall Study||103||
48725101|NCT02408523|102111723|FG000|NOT COMPLETED|Overall Study||11||
48725102|NCT02408523|102111724|FG001|NOT COMPLETED|Overall Study||18||
48725103|NCT00820222|102111725|FG000|STARTED|Overall Study||271||
48725104|NCT00820222|102111726|FG001|STARTED|Overall Study||269||
48725105|NCT00820222|102111725|FG000|COMPLETED|Overall Study||95||
48725106|NCT00820222|102111726|FG001|COMPLETED|Overall Study||79||
48725107|NCT00820222|102111725|FG000|NOT COMPLETED|Overall Study||176||
48725108|NCT00820222|102111726|FG001|NOT COMPLETED|Overall Study||190||
48725109|NCT00837759|102111727|FG000|STARTED|Overall Study||7||
48725110|NCT00837759|102111727|FG000|COMPLETED|Overall Study||3||
48725111|NCT00837759|102111727|FG000|NOT COMPLETED|Overall Study||4||
48725112|NCT02762331|102111728|FG000|STARTED|Overall Study||4||
48725113|NCT02762331|102111729|FG001|STARTED|Overall Study||2||
48725114|NCT02762331|102111728|FG000|COMPLETED|Overall Study||4||
48725115|NCT02762331|102111729|FG001|COMPLETED|Overall Study||2||
48725116|NCT02762331|102111728|FG000|NOT COMPLETED|Overall Study||0||
48725117|NCT02762331|102111729|FG001|NOT COMPLETED|Overall Study||0||
48725118|NCT03826199|102111730|FG000|STARTED|Overall Study||200||
48725119|NCT03826199|102111730|FG000|COMPLETED|Overall Study||200||
48725120|NCT03826199|102111730|FG000|NOT COMPLETED|Overall Study||0||
48725121|NCT01736618|102111731|FG000|STARTED|Overall Study||1766||
48154344|NCT04493931|100699960|FG001|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||17||
48154345|NCT04493931|100699961|FG002|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
48154346|NCT04493931|100699962|FG003|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
48154347|NCT04493931|100699963|FG004|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
48154348|NCT04493931|100699964|FG005|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
48154349|NCT04493931|100699965|FG006|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
48154350|NCT04493931|100699959|FG000|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
48725122|NCT01736618|102111731|FG000|COMPLETED|Overall Study||767||
48725123|NCT01736618|102111731|FG000|NOT COMPLETED|Overall Study||999||
48725124|NCT02039856|102111732|FG000|STARTED|Overall Study||2720||8
48725125|NCT02039856|102111733|FG001|STARTED|Overall Study||1180||4
48725126|NCT02039856|102111732|FG000|Baseline Started - Patients|Overall Study||2183||8
48725127|NCT02039856|102111733|FG001|Baseline Started - Patients|Overall Study||919||4
48767599|NCT00914316|102222779|FG003|COMPLETED|Phase 1||6||
48725128|NCT02039856|102111732|FG000|Baseline Completed - Patients|Overall Study||953||8
48725129|NCT02039856|102111733|FG001|Baseline Completed - Patients|Overall Study||442||4
48725130|NCT02039856|102111732|FG000|Baseline Started - Providers/Staff|Overall Study||537||8
48725131|NCT02039856|102111733|FG001|Baseline Started - Providers/Staff|Overall Study||261||4
48725132|NCT02039856|102111732|FG000|Baseline Completed -Providers/Staff|Overall Study||194||8
48725133|NCT02039856|102111733|FG001|Baseline Completed -Providers/Staff|Overall Study||94||4
48725134|NCT02039856|102111732|FG000|Total Baseline Completed|Overall Study||1147||8
48725135|NCT02039856|102111733|FG001|Total Baseline Completed|Overall Study||536||4
48725136|NCT02039856|102111732|FG000|12-month Started-patients|Overall Study||953||8
48725137|NCT02039856|102111733|FG001|12-month Started-patients|Overall Study||442||4
48725138|NCT02039856|102111732|FG000|12-month Completed- Patients|Overall Study||580||8
48725139|NCT02039856|102111733|FG001|12-month Completed- Patients|Overall Study||241||4
48725140|NCT02039856|102111732|FG000|12-month Providers/Staff|Overall Study||0||0
48725141|NCT02039856|102111733|FG001|12-month Providers/Staff|Overall Study||0||0
48725142|NCT02039856|102111732|FG000|24-month Started|Overall Study||1518||8
48725143|NCT02039856|102111733|FG001|24-month Started|Overall Study||746||4
48725144|NCT02039856|102111732|FG000|24-month Started - Patients|Overall Study||953||8
48725145|NCT02039856|102111733|FG001|24-month Started - Patients|Overall Study||442||4
48725146|NCT02039856|102111732|FG000|24-month Completed - Patients|Overall Study||519||8
48725147|NCT02039856|102111733|FG001|24-month Completed - Patients|Overall Study||222||4
48725148|NCT02039856|102111732|FG000|24-month Started Providers/Staff|Overall Study||565||8
48725149|NCT02039856|102111733|FG001|24-month Started Providers/Staff|Overall Study||304||4
48725150|NCT02039856|102111732|FG000|24-month Completed Providers/Staff|Overall Study||174||8
48725151|NCT02039856|102111733|FG001|24-month Completed Providers/Staff|Overall Study||105||4
48725152|NCT02039856|102111732|FG000|Total 24-month Completed|Overall Study||693||8
48725153|NCT02039856|102111733|FG001|Total 24-month Completed|Overall Study||327||4
48725154|NCT02039856|102111732|FG000|COMPLETED|Overall Study||693||8
48725155|NCT02039856|102111733|FG001|COMPLETED|Overall Study||327||4
48725156|NCT02039856|102111732|FG000|NOT COMPLETED|Overall Study||2027||0
48725157|NCT02039856|102111733|FG001|NOT COMPLETED|Overall Study||853||0
48725158|NCT03652675|102111734|FG000|STARTED|Overall Study||16||
48725159|NCT03652675|102111735|FG001|STARTED|Overall Study||15||
48725160|NCT03652675|102111734|FG000|COMPLETED|Overall Study||12||
48725161|NCT03652675|102111735|FG001|COMPLETED|Overall Study||11||
48725162|NCT03652675|102111734|FG000|NOT COMPLETED|Overall Study||4||
48725163|NCT03652675|102111735|FG001|NOT COMPLETED|Overall Study||4||
48725164|NCT06037408|102111736|FG000|STARTED|Overall Study||26||
48725165|NCT06037408|102111737|FG001|STARTED|Overall Study||24||
48725166|NCT06037408|102111736|FG000|COMPLETED|Overall Study||26||
48725167|NCT06037408|102111737|FG001|COMPLETED|Overall Study||24||
48725168|NCT06037408|102111736|FG000|NOT COMPLETED|Overall Study||0||
48725169|NCT06037408|102111737|FG001|NOT COMPLETED|Overall Study||0||
48725170|NCT04699461|102111738|FG000|STARTED|Overall Study||4||
48725171|NCT04699461|102111739|FG001|STARTED|Overall Study||2||
48725172|NCT04699461|102111738|FG000|COMPLETED|Overall Study||0||
48725173|NCT04699461|102111739|FG001|COMPLETED|Overall Study||0||
48725174|NCT04699461|102111738|FG000|NOT COMPLETED|Overall Study||4||
48725175|NCT04699461|102111739|FG001|NOT COMPLETED|Overall Study||2||
48725176|NCT01306656|102111740|FG000|STARTED|Overall Study||7||
48725177|NCT01306656|102111741|FG001|STARTED|Overall Study||2||
48725178|NCT01306656|102111740|FG000|COMPLETED|Overall Study||6||
48725179|NCT01306656|102111741|FG001|COMPLETED|Overall Study||2||
48725180|NCT01306656|102111740|FG000|NOT COMPLETED|Overall Study||1||
48725181|NCT01306656|102111741|FG001|NOT COMPLETED|Overall Study||0||
48725182|NCT02508324|102111742|FG000|STARTED|Overall Study||43||
48725183|NCT02508324|102111743|FG001|STARTED|Overall Study||0||
48725184|NCT02508324|102111742|FG000|COMPLETED|Overall Study||43||
48725185|NCT02508324|102111743|FG001|COMPLETED|Overall Study||0||
48725186|NCT02508324|102111742|FG000|NOT COMPLETED|Overall Study||0||
48725187|NCT02508324|102111743|FG001|NOT COMPLETED|Overall Study||0||
48725188|NCT03657095|102111744|FG000|STARTED|Overall Study||59||
48725189|NCT03657095|102111745|FG001|STARTED|Overall Study||53||
48725190|NCT03657095|102111744|FG000|Received at Least 1 Dose of Study Drug|Overall Study||59||
48725191|NCT03657095|102111745|FG001|Received at Least 1 Dose of Study Drug|Overall Study||53||
48725192|NCT03657095|102111744|FG000|COMPLETED|Overall Study||0||
48310089|NCT02448225|101084762|FG000|STARTED|Overall Study||46||
48310090|NCT02448225|101084762|FG000|COMPLETED|Overall Study||26||
48310091|NCT02448225|101084762|FG000|NOT COMPLETED|Overall Study||20||
48310092|NCT01086410|101084763|FG000|STARTED|Overall Study||58||
48725193|NCT03657095|102111745|FG001|COMPLETED|Overall Study||0||
48725194|NCT03657095|102111744|FG000|NOT COMPLETED|Overall Study||59||
48725195|NCT03657095|102111745|FG001|NOT COMPLETED|Overall Study||53||
48725196|NCT03050320|102111746|FG000|STARTED|Overall Study||21||
48725197|NCT03050320|102111747|FG001|STARTED|Overall Study||22||
48310093|NCT01086410|101084764|FG001|STARTED|Overall Study||56||
48310094|NCT01086410|101084765|FG002|STARTED|Overall Study||56||
48725198|NCT03050320|102111746|FG000|COMPLETED|Overall Study||20||
48725199|NCT03050320|102111747|FG001|COMPLETED|Overall Study||21||
48725200|NCT03050320|102111746|FG000|NOT COMPLETED|Overall Study||1||
48725201|NCT03050320|102111747|FG001|NOT COMPLETED|Overall Study||1||
48725202|NCT00079677|102111748|FG000|STARTED|Overall Study||131||
48725203|NCT00079677|102111749|FG001|STARTED|Overall Study||132||
48725204|NCT00079677|102111748|FG000|COMPLETED|Overall Study||111||
48725205|NCT00079677|102111749|FG001|COMPLETED|Overall Study||118||
48725206|NCT00079677|102111748|FG000|NOT COMPLETED|Overall Study||20||
48725207|NCT00079677|102111749|FG001|NOT COMPLETED|Overall Study||14||
48725208|NCT00370838|102111750|FG000|STARTED|Period 1 (Days 8-50)||7||
48725209|NCT00370838|102111751|FG001|STARTED|Period 1 (Days 8-50)||3||
48310095|NCT01086410|101084766|FG003|STARTED|Overall Study||15||
48725210|NCT00370838|102111750|FG000|COMPLETED|Period 1 (Days 8-50)||7||
48725211|NCT00370838|102111751|FG001|COMPLETED|Period 1 (Days 8-50)||3||
48725212|NCT00370838|102111750|FG000|NOT COMPLETED|Period 1 (Days 8-50)||0||
48725213|NCT00370838|102111751|FG001|NOT COMPLETED|Period 1 (Days 8-50)||0||
48725214|NCT00370838|102111750|FG000|STARTED|Washout (Days 51-64)||7||
48725215|NCT00370838|102111751|FG001|STARTED|Washout (Days 51-64)||3||
48725216|NCT00370838|102111750|FG000|COMPLETED|Washout (Days 51-64)||7||
48725217|NCT00370838|102111751|FG001|COMPLETED|Washout (Days 51-64)||3||
48725218|NCT00370838|102111750|FG000|NOT COMPLETED|Washout (Days 51-64)||0||
48725219|NCT00370838|102111751|FG001|NOT COMPLETED|Washout (Days 51-64)||0||
48725220|NCT00370838|102111750|FG000|STARTED|Period 2 (Days 65-107)||7||
48725221|NCT00370838|102111751|FG001|STARTED|Period 2 (Days 65-107)||3||
48725222|NCT00370838|102111750|FG000|COMPLETED|Period 2 (Days 65-107)||7||
48725223|NCT00370838|102111751|FG001|COMPLETED|Period 2 (Days 65-107)||3||
48725224|NCT00370838|102111750|FG000|NOT COMPLETED|Period 2 (Days 65-107)||0||
48725225|NCT00370838|102111751|FG001|NOT COMPLETED|Period 2 (Days 65-107)||0||
48725226|NCT00370838|102111750|FG000|STARTED|Taper||7||
48725227|NCT00370838|102111751|FG001|STARTED|Taper||3||
48725228|NCT00370838|102111750|FG000|COMPLETED|Taper||7||
48725229|NCT00370838|102111751|FG001|COMPLETED|Taper||3||
48725230|NCT00370838|102111750|FG000|NOT COMPLETED|Taper||0||
48725231|NCT00370838|102111751|FG001|NOT COMPLETED|Taper||0||
48725232|NCT02768753|102111752|FG000|STARTED|Overall Study||30||
48725233|NCT02768753|102111753|FG001|STARTED|Overall Study||30||
48725234|NCT02768753|102111752|FG000|COMPLETED|Overall Study||30||
48725235|NCT02768753|102111753|FG001|COMPLETED|Overall Study||30||
48725236|NCT02768753|102111752|FG000|NOT COMPLETED|Overall Study||0||
48725237|NCT02768753|102111753|FG001|NOT COMPLETED|Overall Study||0||
48725238|NCT03966885|102111754|FG000|STARTED|Overall Study||78||
48725239|NCT03966885|102111755|FG001|STARTED|Overall Study||82||
48725240|NCT03966885|102111754|FG000|COMPLETED|Overall Study||56||
48725241|NCT03966885|102111755|FG001|COMPLETED|Overall Study||62||
48725242|NCT03966885|102111754|FG000|NOT COMPLETED|Overall Study||22||
48725243|NCT03966885|102111755|FG001|NOT COMPLETED|Overall Study||20||
48725244|NCT01431391|102111756|FG000|STARTED|Overall Study||34||
48725245|NCT01431391|102111757|FG001|STARTED|Overall Study||34||
48725246|NCT01431391|102111756|FG000|Received ≥1 Leaukapheresis|Overall Study||34||
48725247|NCT01431391|102111757|FG001|Received ≥1 Leaukapheresis|Overall Study||34||
48725248|NCT01431391|102111756|FG000|COMPLETED|Overall Study||26||
48725249|NCT01431391|102111757|FG001|COMPLETED|Overall Study||30||
48725250|NCT01431391|102111756|FG000|NOT COMPLETED|Overall Study||8||
48725251|NCT01431391|102111757|FG001|NOT COMPLETED|Overall Study||4||
48725252|NCT01685021|102111758|FG000|STARTED|Overall Study||22||
48725253|NCT01685021|102111758|FG000|COMPLETED|Overall Study||6||
48725254|NCT01685021|102111758|FG000|NOT COMPLETED|Overall Study||16||
48725255|NCT03344172|102111759|FG000|STARTED|Overall Study||16||
48725256|NCT03344172|102111760|FG001|STARTED|Overall Study||16||
48725257|NCT03344172|102111759|FG000|COMPLETED|Overall Study||15||
48725258|NCT03344172|102111760|FG001|COMPLETED|Overall Study||16||
48725259|NCT03344172|102111759|FG000|NOT COMPLETED|Overall Study||1||
48725260|NCT03344172|102111760|FG001|NOT COMPLETED|Overall Study||0||
48725261|NCT04943432|102111761|FG000|STARTED|Overall Study||23||
48725262|NCT04943432|102111761|FG000|Received Intervention|Overall Study||19||
48725263|NCT04943432|102111761|FG000|COMPLETED|Overall Study||17||
48725264|NCT04943432|102111761|FG000|NOT COMPLETED|Overall Study||6||
48725265|NCT03045341|102111762|FG000|STARTED|Overall Study||34||
48725266|NCT03045341|102111763|FG001|STARTED|Overall Study||32||
48725267|NCT03045341|102111764|FG002|STARTED|Overall Study||35||
48725268|NCT03045341|102111765|FG003|STARTED|Overall Study||35||
48725269|NCT03045341|102111762|FG000|COMPLETED|Overall Study||29||
48725270|NCT03045341|102111763|FG001|COMPLETED|Overall Study||27||
48725271|NCT03045341|102111764|FG002|COMPLETED|Overall Study||27||
48725272|NCT03045341|102111765|FG003|COMPLETED|Overall Study||29||
48725273|NCT03045341|102111762|FG000|NOT COMPLETED|Overall Study||5||
48725274|NCT03045341|102111763|FG001|NOT COMPLETED|Overall Study||5||
48725275|NCT03045341|102111764|FG002|NOT COMPLETED|Overall Study||8||
48725276|NCT03045341|102111765|FG003|NOT COMPLETED|Overall Study||6||
48725277|NCT04439318|102111766|FG000|STARTED|Overall Study||50||
48725278|NCT04439318|102111766|FG000|Eligible|Overall Study||49||
48725279|NCT04439318|102111766|FG000|Eligible and Started Protocol Therapy|Overall Study||46|Three patients never started treatment. This is the primary analysis population.|
48725280|NCT04439318|102111766|FG000|COMPLETED|Overall Study||0||
48725281|NCT04439318|102111766|FG000|NOT COMPLETED|Overall Study||50||
48725282|NCT05501795|102111767|FG000|STARTED|Overall Study||58||
48725283|NCT05501795|102111767|FG000|COMPLETED|Overall Study||58||
48725284|NCT05501795|102111767|FG000|NOT COMPLETED|Overall Study||0||
48725285|NCT01012323|102111768|FG000|STARTED|Overall Study||51||
48725286|NCT01012323|102111768|FG000|COMPLETED|Overall Study||50||
48725287|NCT01012323|102111768|FG000|NOT COMPLETED|Overall Study||1||
48725288|NCT04474314|102111769|FG000|STARTED|Overall Study||49||
48725289|NCT04474314|102111770|FG001|STARTED|Overall Study||34||
48725290|NCT04474314|102111771|FG002|STARTED|Overall Study||32||
48725291|NCT04474314|102111769|FG000|COMPLETED|Overall Study||2||
48725292|NCT04474314|102111770|FG001|COMPLETED|Overall Study||6||
48725293|NCT04474314|102111771|FG002|COMPLETED|Overall Study||8||
48725294|NCT04474314|102111769|FG000|NOT COMPLETED|Overall Study||47||
48725295|NCT04474314|102111770|FG001|NOT COMPLETED|Overall Study||28||
48725296|NCT04474314|102111771|FG002|NOT COMPLETED|Overall Study||24||
48725297|NCT02453555|102111772|FG000|STARTED|24-week Double-blind Treatment Period||182||
48725298|NCT02453555|102111773|FG001|STARTED|24-week Double-blind Treatment Period||93||
48725299|NCT02453555|102111774|FG002|STARTED|24-week Double-blind Treatment Period||0||
48725300|NCT02453555|102111775|FG003|STARTED|24-week Double-blind Treatment Period||0||
48725301|NCT02453555|102111776|FG004|STARTED|24-week Double-blind Treatment Period||0||
48725302|NCT02453555|102111777|FG005|STARTED|24-week Double-blind Treatment Period||0||
48725303|NCT02453555|102111772|FG000|COMPLETED|24-week Double-blind Treatment Period||177||
48725304|NCT02453555|102111773|FG001|COMPLETED|24-week Double-blind Treatment Period||86||
48154351|NCT04493931|100699960|FG001|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
48154352|NCT04493931|100699961|FG002|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
48154353|NCT04493931|100699962|FG003|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
48154354|NCT04493931|100699963|FG004|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
48725305|NCT02453555|102111774|FG002|COMPLETED|24-week Double-blind Treatment Period||0||
48725306|NCT02453555|102111775|FG003|COMPLETED|24-week Double-blind Treatment Period||0||
48725307|NCT02453555|102111776|FG004|COMPLETED|24-week Double-blind Treatment Period||0||
48725308|NCT02453555|102111777|FG005|COMPLETED|24-week Double-blind Treatment Period||0||
48725309|NCT02453555|102111772|FG000|NOT COMPLETED|24-week Double-blind Treatment Period||5||
48725310|NCT02453555|102111773|FG001|NOT COMPLETED|24-week Double-blind Treatment Period||7||
48725311|NCT02453555|102111774|FG002|NOT COMPLETED|24-week Double-blind Treatment Period||0||
48725312|NCT02453555|102111775|FG003|NOT COMPLETED|24-week Double-blind Treatment Period||0||
48725313|NCT02453555|102111776|FG004|NOT COMPLETED|24-week Double-blind Treatment Period||0||
48725314|NCT02453555|102111777|FG005|NOT COMPLETED|24-week Double-blind Treatment Period||0||
48725315|NCT02453555|102111772|FG000|STARTED|Extension Period||0||
48725316|NCT02453555|102111773|FG001|STARTED|Extension Period||0||
48725317|NCT02453555|102111774|FG002|STARTED|Extension Period||126||
48725318|NCT02453555|102111775|FG003|STARTED|Extension Period||51||
48725319|NCT02453555|102111776|FG004|STARTED|Extension Period||80||
48725320|NCT02453555|102111777|FG005|STARTED|Extension Period||6||
48725321|NCT02453555|102111772|FG000|COMPLETED|Extension Period||0||
48725322|NCT02453555|102111773|FG001|COMPLETED|Extension Period||0||
48725323|NCT02453555|102111774|FG002|COMPLETED|Extension Period||123||
48725324|NCT02453555|102111775|FG003|COMPLETED|Extension Period||49||
48154355|NCT04493931|100699964|FG005|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
48725325|NCT02453555|102111776|FG004|COMPLETED|Extension Period||79||
48725326|NCT02453555|102111777|FG005|COMPLETED|Extension Period||5||
48725327|NCT02453555|102111772|FG000|NOT COMPLETED|Extension Period||0||
48154356|NCT04493931|100699965|FG006|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
48154357|NCT04493931|100699959|FG000|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
48188741|NCT01033643|100783326|FG005|COMPLETED|Overall Study||7||
48725328|NCT02453555|102111773|FG001|NOT COMPLETED|Extension Period||0||
48725329|NCT02453555|102111774|FG002|NOT COMPLETED|Extension Period||3||
48725330|NCT02453555|102111775|FG003|NOT COMPLETED|Extension Period||2||
48154358|NCT04493931|100699960|FG001|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||17||
48406575|NCT02603172|101328441|FG002|NOT COMPLETED|Part C (Approximately 13 Weeks)||0||
48725331|NCT02453555|102111776|FG004|NOT COMPLETED|Extension Period||1||
48725332|NCT02453555|102111777|FG005|NOT COMPLETED|Extension Period||1||
48725333|NCT03626545|102111778|FG000|STARTED|Overall Study||8||
48725334|NCT03626545|102111779|FG001|STARTED|Overall Study||120||
48725335|NCT03626545|102111780|FG002|STARTED|Overall Study||117||
48154359|NCT04493931|100699961|FG002|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
48154360|NCT04493931|100699962|FG003|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
48154361|NCT04493931|100699963|FG004|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
48154362|NCT04493931|100699964|FG005|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
48154363|NCT04493931|100699965|FG006|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
48154364|NCT04493931|100699959|FG000|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
48154365|NCT04493931|100699960|FG001|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||17||
48154366|NCT04493931|100699961|FG002|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
48154367|NCT04493931|100699962|FG003|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
48154368|NCT04493931|100699963|FG004|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
48154369|NCT04493931|100699964|FG005|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
48154370|NCT04493931|100699965|FG006|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
48154371|NCT04493931|100699959|FG000|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
48154372|NCT04493931|100699960|FG001|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
48154373|NCT04493931|100699961|FG002|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
48154374|NCT04493931|100699962|FG003|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
48154375|NCT04493931|100699963|FG004|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
48154376|NCT04493931|100699964|FG005|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
48154377|NCT04493931|100699965|FG006|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
48154378|NCT04493931|100699959|FG000|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0||
48154379|NCT04493931|100699960|FG001|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||17||
48154380|NCT04493931|100699961|FG002|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0||
48154381|NCT04493931|100699962|FG003|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0||
48154382|NCT04493931|100699963|FG004|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0||
48154383|NCT04493931|100699964|FG005|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0||
48154384|NCT04493931|100699965|FG006|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0||
48154385|NCT04493931|100699959|FG000|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0||
48154386|NCT04493931|100699960|FG001|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||14||
48154387|NCT04493931|100699961|FG002|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0||
48154388|NCT04493931|100699962|FG003|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0||
48154389|NCT04493931|100699963|FG004|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0||
48154390|NCT04493931|100699964|FG005|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0||
48154391|NCT04493931|100699965|FG006|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0||
48154392|NCT04493931|100699959|FG000|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0||
48154393|NCT04493931|100699960|FG001|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||3||
48154394|NCT04493931|100699961|FG002|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0||
48154395|NCT04493931|100699962|FG003|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0||
48725336|NCT03626545|102111778|FG000|Treated|Overall Study||8||
48725337|NCT03626545|102111779|FG001|Treated|Overall Study||120||
48154396|NCT04493931|100699963|FG004|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0||
48725338|NCT03626545|102111780|FG002|Treated|Overall Study||114||
48725339|NCT03626545|102111778|FG000|COMPLETED|Overall Study||0||
48725340|NCT03626545|102111779|FG001|COMPLETED|Overall Study||0||
48725341|NCT03626545|102111780|FG002|COMPLETED|Overall Study||0||
48725342|NCT03626545|102111778|FG000|NOT COMPLETED|Overall Study||8||
48154397|NCT04493931|100699964|FG005|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0||
48154398|NCT04493931|100699965|FG006|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0||
48154399|NCT04493931|100699959|FG000|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0||
48154400|NCT04493931|100699960|FG001|STARTED|Cohort 2: Follow-up (Up to 10 Days)||14||
48154401|NCT04493931|100699961|FG002|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0||
48154402|NCT04493931|100699962|FG003|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0||
48154403|NCT04493931|100699963|FG004|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0||
48154404|NCT04493931|100699964|FG005|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0||
48154405|NCT04493931|100699965|FG006|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0||
48154406|NCT04493931|100699959|FG000|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0||
48154407|NCT04493931|100699960|FG001|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||14||
48154408|NCT04493931|100699961|FG002|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0||
48154409|NCT04493931|100699962|FG003|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0||
48154410|NCT04493931|100699963|FG004|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0||
48154411|NCT04493931|100699964|FG005|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0||
48154412|NCT04493931|100699965|FG006|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0||
48725343|NCT03626545|102111779|FG001|NOT COMPLETED|Overall Study||120||
48725344|NCT03626545|102111780|FG002|NOT COMPLETED|Overall Study||117||
48767600|NCT00914316|102222776|FG000|NOT COMPLETED|Phase 1||5||
48154413|NCT04493931|100699959|FG000|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0||
48154414|NCT04493931|100699960|FG001|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0||
48154415|NCT04493931|100699961|FG002|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0||
48154416|NCT04493931|100699962|FG003|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0||
48154417|NCT04493931|100699963|FG004|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0||
48154418|NCT04493931|100699964|FG005|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0||
48154419|NCT04493931|100699965|FG006|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0||
48154420|NCT04493931|100699959|FG000|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0||
48154421|NCT04493931|100699960|FG001|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0||
48154422|NCT04493931|100699961|FG002|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||10||
48154423|NCT04493931|100699962|FG003|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||9||
48154424|NCT04493931|100699963|FG004|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0||
48154425|NCT04493931|100699964|FG005|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0||
48154426|NCT04493931|100699965|FG006|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0||
48154427|NCT04493931|100699959|FG000|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0||
48154428|NCT04493931|100699960|FG001|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0||
48154429|NCT04493931|100699961|FG002|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||9||
48154430|NCT04493931|100699962|FG003|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||9||
48154431|NCT04493931|100699963|FG004|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0||
48154432|NCT04493931|100699964|FG005|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0||
48310096|NCT01086410|101084763|FG000|COMPLETED|Overall Study||55||
48310097|NCT01086410|101084764|FG001|COMPLETED|Overall Study||54||
48310098|NCT01086410|101084765|FG002|COMPLETED|Overall Study||55||
48612493|NCT04392219|101838289|FG010|STARTED|Overall Study||14||
48612494|NCT04392219|101838290|FG011|STARTED|Overall Study||6||
48612495|NCT04392219|101838291|FG012|STARTED|Overall Study||6||
48612496|NCT04392219|101838292|FG013|STARTED|Overall Study||6||
48612497|NCT04392219|101838293|FG014|STARTED|Overall Study||6||
48612498|NCT04392219|101838294|FG015|STARTED|Overall Study||6||
48612499|NCT04392219|101838295|FG016|STARTED|Overall Study||6||
48612500|NCT04392219|101838296|FG017|STARTED|Overall Study||6||
48612501|NCT04392219|101838279|FG000|COMPLETED|Overall Study||16||
48612502|NCT04392219|101838280|FG001|COMPLETED|Overall Study||6||
48612503|NCT04392219|101838281|FG002|COMPLETED|Overall Study||6||
48612504|NCT04392219|101838282|FG003|COMPLETED|Overall Study||6||
48612505|NCT04392219|101838283|FG004|COMPLETED|Overall Study||6||
48612506|NCT04392219|101838284|FG005|COMPLETED|Overall Study||6||
48612507|NCT04392219|101838285|FG006|COMPLETED|Overall Study||6||
48612508|NCT04392219|101838286|FG007|COMPLETED|Overall Study||6||
48612509|NCT04392219|101838287|FG008|COMPLETED|Overall Study||6||
48612510|NCT04392219|101838288|FG009|COMPLETED|Overall Study||10||
48612511|NCT04392219|101838289|FG010|COMPLETED|Overall Study||14||
48612512|NCT04392219|101838290|FG011|COMPLETED|Overall Study||6||
48154433|NCT04493931|100699965|FG006|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0||
48725345|NCT03927404|102111781|FG000|STARTED|Overall Study||60|Primary outcomes are measured in their Standard of care socket system as baseline value followed by initiation of using the test socket for 16 weeks.|
48725346|NCT03927404|102111781|FG000|COMPLETED|Overall Study||59||
48725347|NCT03927404|102111781|FG000|NOT COMPLETED|Overall Study||1||
48154434|NCT04493931|100699959|FG000|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0||
48154435|NCT04493931|100699960|FG001|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0||
48154436|NCT04493931|100699961|FG002|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||1||
48154437|NCT04493931|100699962|FG003|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0||
48154438|NCT04493931|100699963|FG004|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0||
48154439|NCT04493931|100699964|FG005|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0||
48154440|NCT04493931|100699965|FG006|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0||
48154441|NCT04493931|100699959|FG000|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0||
48154442|NCT04493931|100699960|FG001|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0||
48154443|NCT04493931|100699961|FG002|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||9||
48154444|NCT04493931|100699962|FG003|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||9||
48154445|NCT04493931|100699963|FG004|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0||
48154446|NCT04493931|100699964|FG005|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0||
48154447|NCT04493931|100699965|FG006|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0||
48154448|NCT04493931|100699959|FG000|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0||
48154449|NCT04493931|100699960|FG001|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0||
48154450|NCT04493931|100699961|FG002|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||9||
48154451|NCT04493931|100699962|FG003|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||9||
48154452|NCT04493931|100699963|FG004|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0||
48154453|NCT04493931|100699964|FG005|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0||
48725348|NCT02516228|102111782|FG000|STARTED|Overall Study||6||
48725349|NCT02516228|102111782|FG000|COMPLETED|Overall Study||3||
48725350|NCT02516228|102111782|FG000|NOT COMPLETED|Overall Study||3||
48725351|NCT02032407|102114849|FG000|STARTED|Overall Study||68||
48725352|NCT02032407|102114849|FG000|COMPLETED|Overall Study||63||
48725353|NCT02032407|102114849|FG000|NOT COMPLETED|Overall Study||5||
48725354|NCT00752726|102114850|FG000|STARTED|Overall Study||65||
48725355|NCT00752726|102114851|FG001|STARTED|Overall Study||66||
48725356|NCT00752726|102114850|FG000|Safety Population|Overall Study||63||
48725357|NCT00752726|102114851|FG001|Safety Population|Overall Study||64||
48725358|NCT00752726|102114850|FG000|Intention to Treat (ITT) Population|Overall Study||62||
48725359|NCT00752726|102114851|FG001|Intention to Treat (ITT) Population|Overall Study||61||
48725360|NCT00752726|102114850|FG000|COMPLETED|Overall Study||54||
48725361|NCT00752726|102114851|FG001|COMPLETED|Overall Study||53||
48725362|NCT00752726|102114850|FG000|NOT COMPLETED|Overall Study||11||
48725363|NCT00752726|102114851|FG001|NOT COMPLETED|Overall Study||13||
48725364|NCT00418977|102114852|FG000|STARTED|Overall Study||43||
48725365|NCT00418977|102114853|FG001|STARTED|Overall Study||16||
48725366|NCT00418977|102114852|FG000|COMPLETED|Overall Study||40||
48725367|NCT00418977|102114853|FG001|COMPLETED|Overall Study||13||
48725368|NCT00418977|102114852|FG000|NOT COMPLETED|Overall Study||3||
48725369|NCT00418977|102114853|FG001|NOT COMPLETED|Overall Study||3||
48725370|NCT01229449|102114854|FG000|STARTED|Overall Study||173||
48725371|NCT01229449|102114855|FG001|STARTED|Overall Study||168||
48725372|NCT01229449|102114856|FG002|STARTED|Overall Study||169||
48725373|NCT01229449|102114857|FG003|STARTED|Overall Study||113||
48725374|NCT01229449|102114858|FG004|STARTED|Overall Study||55||
48725375|NCT01229449|102114854|FG000|COMPLETED|Overall Study||172||
48725376|NCT01229449|102114855|FG001|COMPLETED|Overall Study||164||
48725377|NCT01229449|102114856|FG002|COMPLETED|Overall Study||167||
48725378|NCT01229449|102114857|FG003|COMPLETED|Overall Study||112||
48725379|NCT01229449|102114858|FG004|COMPLETED|Overall Study||54||
48154454|NCT04493931|100699965|FG006|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0||
48154455|NCT04493931|100699959|FG000|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0||
48154456|NCT04493931|100699960|FG001|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0||
48154457|NCT04493931|100699961|FG002|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0||
48154458|NCT04493931|100699962|FG003|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0||
48154459|NCT04493931|100699963|FG004|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0||
48154460|NCT04493931|100699964|FG005|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0||
48154461|NCT04493931|100699965|FG006|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0||
48154462|NCT04493931|100699959|FG000|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0||
48154463|NCT04493931|100699960|FG001|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0||
48154464|NCT04493931|100699961|FG002|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||9||
48440014|NCT03046966|101410010|FG001|NOT COMPLETED|Overall Study||0||
48725380|NCT01229449|102114854|FG000|NOT COMPLETED|Overall Study||1||
48725381|NCT01229449|102114855|FG001|NOT COMPLETED|Overall Study||4||
48725382|NCT01229449|102114856|FG002|NOT COMPLETED|Overall Study||2||
48725383|NCT01229449|102114857|FG003|NOT COMPLETED|Overall Study||1||
48725384|NCT01229449|102114858|FG004|NOT COMPLETED|Overall Study||1||
48725385|NCT04040621|102114859|FG000|STARTED|Overall Study||4||
48725386|NCT04040621|102114859|FG000|COMPLETED|Overall Study||4||
48725387|NCT04040621|102114859|FG000|NOT COMPLETED|Overall Study||0||
48725388|NCT01620528|102114860|FG000|STARTED|Treatment Period||374||
48725389|NCT01620528|102114861|FG001|STARTED|Treatment Period||249||
48725390|NCT01620528|102114862|FG002|STARTED|Treatment Period||249||
48725391|NCT01620528|102114860|FG000|COMPLETED|Treatment Period||274||
48725392|NCT01620528|102114861|FG001|COMPLETED|Treatment Period||196||
48725393|NCT01620528|102114862|FG002|COMPLETED|Treatment Period||183||
48725394|NCT01620528|102114860|FG000|NOT COMPLETED|Treatment Period||100||
48725395|NCT01620528|102114861|FG001|NOT COMPLETED|Treatment Period||53||
48725396|NCT01620528|102114862|FG002|NOT COMPLETED|Treatment Period||66||
48725397|NCT01620528|102114860|FG000|STARTED|Post-Treatment Follow-Up Period||68||
48725398|NCT01620528|102114861|FG001|STARTED|Post-Treatment Follow-Up Period||48||
48725399|NCT01620528|102114862|FG002|STARTED|Post-Treatment Follow-Up Period||51||
48725400|NCT01620528|102114860|FG000|Completed PTFU Month 6|Post-Treatment Follow-Up Period||46|Met criteria (reported post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|
48154465|NCT04493931|100699962|FG003|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||9||
48725401|NCT01620528|102114861|FG001|Completed PTFU Month 6|Post-Treatment Follow-Up Period||26|Met criteria (reported post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|
48725402|NCT01620528|102114862|FG002|Completed PTFU Month 6|Post-Treatment Follow-Up Period||18|Met criteria (reported post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|
48725403|NCT01620528|102114860|FG000|Completed PTFU Month 12|Post-Treatment Follow-Up Period||2||
48725404|NCT01620528|102114861|FG001|Completed PTFU Month 12|Post-Treatment Follow-Up Period||5||
48725405|NCT01620528|102114862|FG002|Completed PTFU Month 12|Post-Treatment Follow-Up Period||19||
48725406|NCT01620528|102114860|FG000|COMPLETED|Post-Treatment Follow-Up Period||48||
48725407|NCT01620528|102114861|FG001|COMPLETED|Post-Treatment Follow-Up Period||31||
48725408|NCT01620528|102114862|FG002|COMPLETED|Post-Treatment Follow-Up Period||37||
48725409|NCT01620528|102114860|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||20||
48725410|NCT01620528|102114861|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||17||
48725411|NCT01620528|102114862|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||14||
48725412|NCT03301467|102114863|FG000|STARTED|Overall Study||29||
48725413|NCT03301467|102114864|FG001|STARTED|Overall Study||28||
48725414|NCT03301467|102114863|FG000|COMPLETED|Overall Study||25||
48725415|NCT03301467|102114864|FG001|COMPLETED|Overall Study||25||
48725416|NCT03301467|102114863|FG000|NOT COMPLETED|Overall Study||4||
48725417|NCT03301467|102114864|FG001|NOT COMPLETED|Overall Study||3||
48725418|NCT02942654|102114865|FG000|STARTED|Period 1||16||
48725419|NCT02942654|102114866|FG001|STARTED|Period 1||16||
48725420|NCT02942654|102114865|FG000|Received at Least 1 Dose of Study Drug|Period 1||16||
48725421|NCT02942654|102114866|FG001|Received at Least 1 Dose of Study Drug|Period 1||16||
48725422|NCT02942654|102114865|FG000|COMPLETED|Period 1||16||
48725423|NCT02942654|102114866|FG001|COMPLETED|Period 1||16||
48725424|NCT02942654|102114865|FG000|NOT COMPLETED|Period 1||0||
48725425|NCT02942654|102114866|FG001|NOT COMPLETED|Period 1||0||
48725426|NCT02942654|102114865|FG000|STARTED|Washout||16||
48154466|NCT04493931|100699963|FG004|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0||
48154467|NCT04493931|100699964|FG005|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0||
48725427|NCT02942654|102114866|FG001|STARTED|Washout||16||
48154468|NCT04493931|100699965|FG006|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0||
48725428|NCT02942654|102114865|FG000|COMPLETED|Washout||16||
48154469|NCT04493931|100699959|FG000|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0||
48154470|NCT04493931|100699960|FG001|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0||
48154471|NCT04493931|100699961|FG002|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||9||
48154472|NCT04493931|100699962|FG003|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||9||
48154473|NCT04493931|100699963|FG004|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0||
48154474|NCT04493931|100699964|FG005|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0||
48310099|NCT01086410|101084766|FG003|COMPLETED|Overall Study||13||
48310100|NCT01086410|101084763|FG000|NOT COMPLETED|Overall Study||3||
48310101|NCT01086410|101084764|FG001|NOT COMPLETED|Overall Study||2||
48310102|NCT01086410|101084765|FG002|NOT COMPLETED|Overall Study||1||
48725429|NCT02942654|102114866|FG001|COMPLETED|Washout||16||
48725430|NCT02942654|102114865|FG000|NOT COMPLETED|Washout||0||
48725431|NCT02942654|102114866|FG001|NOT COMPLETED|Washout||0||
48725432|NCT02942654|102114865|FG000|STARTED|Period 2||16||
48725433|NCT02942654|102114866|FG001|STARTED|Period 2||16||
48725434|NCT02942654|102114865|FG000|COMPLETED|Period 2||16||
48725435|NCT02942654|102114866|FG001|COMPLETED|Period 2||16||
48725436|NCT02942654|102114865|FG000|NOT COMPLETED|Period 2||0||
48310103|NCT01086410|101084766|FG003|NOT COMPLETED|Overall Study||2||
48310104|NCT02756351|101084767|FG000|STARTED|Overall Study||24||
48310105|NCT02756351|101084768|FG001|STARTED|Overall Study||24||
48310106|NCT02756351|101084767|FG000|COMPLETED|Overall Study||24||
48310107|NCT02756351|101084768|FG001|COMPLETED|Overall Study||24||
48725437|NCT02942654|102114866|FG001|NOT COMPLETED|Period 2||0||
48725438|NCT03149029|102114867|FG000|STARTED|Overall Study||16||
48725439|NCT03149029|102114868|FG001|STARTED|Overall Study||0||
48310108|NCT02756351|101084767|FG000|NOT COMPLETED|Overall Study||0||
48310109|NCT02756351|101084768|FG001|NOT COMPLETED|Overall Study||0||
48310110|NCT02774616|101084769|FG000|STARTED|Overall Study||95||
48310111|NCT02774616|101084770|FG001|STARTED|Overall Study||167||
48310112|NCT02774616|101084771|FG002|STARTED|Overall Study||16||
48310113|NCT02774616|101084769|FG000|Died|Overall Study||6||
48725440|NCT03149029|102114867|FG000|COMPLETED|Overall Study||14||
48725441|NCT03149029|102114868|FG001|COMPLETED|Overall Study||0||
48725442|NCT03149029|102114867|FG000|NOT COMPLETED|Overall Study||2||
48310114|NCT02774616|101084770|FG001|Died|Overall Study||3||
48725443|NCT03149029|102114868|FG001|NOT COMPLETED|Overall Study||0||
48725444|NCT03040115|102114869|FG000|STARTED|Overall Study||104||
48725445|NCT03040115|102114869|FG000|COMPLETED|Overall Study||104||
48725446|NCT03040115|102114869|FG000|NOT COMPLETED|Overall Study||0||
48725447|NCT00718770|102114870|FG000|STARTED|Overall Study||10||
48725448|NCT00718770|102114870|FG000|COMPLETED|Overall Study||2||
48725449|NCT00718770|102114870|FG000|NOT COMPLETED|Overall Study||8||
48725450|NCT02248636|102114871|FG000|STARTED|Overall Study||26||
48725451|NCT02248636|102114872|FG001|STARTED|Overall Study||35||
48725452|NCT02248636|102114871|FG000|COMPLETED|Overall Study||20||
48725453|NCT02248636|102114872|FG001|COMPLETED|Overall Study||32||
48154475|NCT04493931|100699965|FG006|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0||
48154476|NCT04493931|100699959|FG000|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0||
48154477|NCT04493931|100699960|FG001|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0||
48154478|NCT04493931|100699961|FG002|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0||
48154479|NCT04493931|100699962|FG003|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0||
48154480|NCT04493931|100699963|FG004|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0||
48154481|NCT04493931|100699964|FG005|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0||
48725454|NCT02248636|102114871|FG000|NOT COMPLETED|Overall Study||6||
48725455|NCT02248636|102114872|FG001|NOT COMPLETED|Overall Study||3||
48725456|NCT01727414|102114873|FG000|STARTED|Overall Study||126||
48725457|NCT01727414|102114874|FG001|STARTED|Overall Study||45||
48725458|NCT01727414|102114873|FG000|COMPLETED|Overall Study||123||
48725459|NCT01727414|102114874|FG001|COMPLETED|Overall Study||45||
48725460|NCT01727414|102114873|FG000|NOT COMPLETED|Overall Study||3||
48725461|NCT01727414|102114874|FG001|NOT COMPLETED|Overall Study||0||
48725462|NCT03459365|102114875|FG000|STARTED|Overall Study||24||30
48725463|NCT03459365|102114875|FG000|COMPLETED|Overall Study||10||11
48725464|NCT03459365|102114875|FG000|NOT COMPLETED|Overall Study||14||19
48725465|NCT04891107|102114876|FG000|STARTED|Overall Study||26||
48725466|NCT04891107|102114876|FG000|COMPLETED|Overall Study||23||
48725467|NCT04891107|102114876|FG000|NOT COMPLETED|Overall Study||3||
48725468|NCT02951429|102114877|FG000|STARTED|Overall Study||88||
48725469|NCT02951429|102114878|FG001|STARTED|Overall Study||89||
48725470|NCT02951429|102114877|FG000|COMPLETED|Overall Study||16||
48725471|NCT02951429|102114878|FG001|COMPLETED|Overall Study||6||
48725472|NCT02951429|102114877|FG000|NOT COMPLETED|Overall Study||72||
48725473|NCT02951429|102114878|FG001|NOT COMPLETED|Overall Study||83||
48725474|NCT02423980|102114879|FG000|STARTED|Overall Study||7||
48725475|NCT02423980|102114879|FG000|COMPLETED|Overall Study||7||
48725476|NCT02423980|102114879|FG000|NOT COMPLETED|Overall Study||0||
48725477|NCT01345682|102114880|FG000|STARTED|Overall Study||322||
48725478|NCT01345682|102114881|FG001|STARTED|Overall Study||161||
48725479|NCT01345682|102114880|FG000|COMPLETED|Overall Study||0||
48725480|NCT01345682|102114881|FG001|COMPLETED|Overall Study||0||
48725481|NCT01345682|102114880|FG000|NOT COMPLETED|Overall Study||322||
48725482|NCT01345682|102114881|FG001|NOT COMPLETED|Overall Study||161||
48725483|NCT03429543|102114882|FG000|STARTED|Overall Study||7||
48725484|NCT03429543|102114883|FG001|STARTED|Overall Study||19||
48725485|NCT03429543|102114884|FG002|STARTED|Overall Study||16||
48725486|NCT03429543|102114885|FG003|STARTED|Overall Study||16||
48725487|NCT03429543|102114886|FG004|STARTED|Overall Study||59||
48725488|NCT03429543|102114887|FG005|STARTED|Overall Study||45||
48725489|NCT03429543|102114888|FG006|STARTED|Overall Study||13||
48725490|NCT03429543|102114882|FG000|Treated|Overall Study||7||
48725491|NCT03429543|102114883|FG001|Treated|Overall Study||19||
48725492|NCT03429543|102114884|FG002|Treated|Overall Study||16||
48725493|NCT03429543|102114885|FG003|Treated|Overall Study||16||
48725494|NCT03429543|102114886|FG004|Treated|Overall Study||58||
48725495|NCT03429543|102114887|FG005|Treated|Overall Study||45||
48725496|NCT03429543|102114888|FG006|Treated|Overall Study||13||
48154482|NCT04493931|100699965|FG006|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0||
48154483|NCT04493931|100699959|FG000|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0||
48725497|NCT03429543|102114882|FG000|COMPLETED|Overall Study||0||
48725498|NCT03429543|102114883|FG001|COMPLETED|Overall Study||17||
48725499|NCT03429543|102114884|FG002|COMPLETED|Overall Study||15||
48725500|NCT03429543|102114885|FG003|COMPLETED|Overall Study||14||
48725501|NCT03429543|102114886|FG004|COMPLETED|Overall Study||47||
48725502|NCT03429543|102114887|FG005|COMPLETED|Overall Study||36||
48725503|NCT03429543|102114888|FG006|COMPLETED|Overall Study||12||
48725504|NCT03429543|102114882|FG000|NOT COMPLETED|Overall Study||7||
48725505|NCT03429543|102114883|FG001|NOT COMPLETED|Overall Study||2||
48725506|NCT03429543|102114884|FG002|NOT COMPLETED|Overall Study||1||
48725507|NCT03429543|102114885|FG003|NOT COMPLETED|Overall Study||2||
48725508|NCT03429543|102114886|FG004|NOT COMPLETED|Overall Study||12||
48725509|NCT03429543|102114887|FG005|NOT COMPLETED|Overall Study||9||
48725510|NCT03429543|102114888|FG006|NOT COMPLETED|Overall Study||1||
48725511|NCT01959243|102114889|FG000|STARTED|Overall Study||337||
48725512|NCT01959243|102114890|FG001|STARTED|Overall Study||170||
48725513|NCT01959243|102114889|FG000|Received at Least 1 Dose of Study Drug|Overall Study||337||
48725514|NCT01959243|102114890|FG001|Received at Least 1 Dose of Study Drug|Overall Study||170||
48725515|NCT01959243|102114889|FG000|COMPLETED|Overall Study||324||
48725516|NCT01959243|102114890|FG001|COMPLETED|Overall Study||166||
48725517|NCT01959243|102114889|FG000|NOT COMPLETED|Overall Study||13||
48725518|NCT01959243|102114890|FG001|NOT COMPLETED|Overall Study||4||
48725519|NCT01694108|102114891|FG000|STARTED|Overall Study||2129||
48310115|NCT02774616|101084771|FG002|Died|Overall Study||1||
48310116|NCT02774616|101084769|FG000|Withdrew Consent|Overall Study||3||
48310117|NCT02774616|101084770|FG001|Withdrew Consent|Overall Study||3||
48310118|NCT02774616|101084771|FG002|Withdrew Consent|Overall Study||0||
48310119|NCT02774616|101084769|FG000|Lost to FU|Overall Study||2||
48310120|NCT02774616|101084770|FG001|Lost to FU|Overall Study||0||
48310121|NCT02774616|101084771|FG002|Lost to FU|Overall Study||0||
48310122|NCT02774616|101084769|FG000|Device Explanted|Overall Study||2||
48310123|NCT02774616|101084770|FG001|Device Explanted|Overall Study||1||
48310124|NCT02774616|101084771|FG002|Device Explanted|Overall Study||1||
48310125|NCT02774616|101084769|FG000|Other|Overall Study||2||
48310126|NCT02774616|101084770|FG001|Other|Overall Study||4||
48310127|NCT02774616|101084771|FG002|Other|Overall Study||1||
48310128|NCT02774616|101084769|FG000|COMPLETED|Overall Study||80||
48310129|NCT02774616|101084770|FG001|COMPLETED|Overall Study||156||
48310130|NCT02774616|101084771|FG002|COMPLETED|Overall Study||13||
48310131|NCT02774616|101084769|FG000|NOT COMPLETED|Overall Study||15||
48310132|NCT02774616|101084770|FG001|NOT COMPLETED|Overall Study||11||
48310133|NCT02774616|101084771|FG002|NOT COMPLETED|Overall Study||3||
48310134|NCT00731055|101084772|FG000|STARTED|Overall Study||16||
48310135|NCT00731055|101084772|FG000|Received Placebo|Overall Study||16||
48310136|NCT00731055|101084772|FG000|Received Varenicline 0.5 mg|Overall Study||16||
48310137|NCT00731055|101084772|FG000|Received Varenicline 1.0 mg|Overall Study||16||
48310138|NCT00731055|101084772|FG000|Received Varenicline 2.0 mg|Overall Study||16||
48310139|NCT00731055|101084772|FG000|COMPLETED|Overall Study||16||
48310140|NCT00731055|101084772|FG000|NOT COMPLETED|Overall Study||0||
48310141|NCT02739620|101084773|FG000|STARTED|Overall Study||12||
48310142|NCT02739620|101084774|FG001|STARTED|Overall Study||10||
48310143|NCT02739620|101084773|FG000|Baseline Testing|Overall Study||12||
48310144|NCT02739620|101084774|FG001|Baseline Testing|Overall Study||10||
48406576|NCT02603172|101328442|FG003|NOT COMPLETED|Part C (Approximately 13 Weeks)||0||
48725520|NCT01694108|102114892|FG001|STARTED|Overall Study||2133||
48725521|NCT01694108|102114891|FG000|COMPLETED|Overall Study||2129||
48725522|NCT01694108|102114892|FG001|COMPLETED|Overall Study||2133||
48725523|NCT01694108|102114891|FG000|NOT COMPLETED|Overall Study||0||
48725524|NCT01694108|102114892|FG001|NOT COMPLETED|Overall Study||0||
48725525|NCT00875342|102114893|FG000|STARTED|Overall Study||20||
48725526|NCT00875342|102114894|FG001|STARTED|Overall Study||21||
48725527|NCT00875342|102114893|FG000|COMPLETED|Overall Study||16||
48725528|NCT00875342|102114894|FG001|COMPLETED|Overall Study||16||
48725529|NCT00875342|102114893|FG000|NOT COMPLETED|Overall Study||4||
48725530|NCT00875342|102114894|FG001|NOT COMPLETED|Overall Study||5||
48725531|NCT00759525|102114895|FG000|STARTED|First Intervention (14 Days)||7||
48725532|NCT00759525|102114896|FG001|STARTED|First Intervention (14 Days)||8||
48725533|NCT00759525|102114895|FG000|COMPLETED|First Intervention (14 Days)||7||
48725534|NCT00759525|102114896|FG001|COMPLETED|First Intervention (14 Days)||8||
48725535|NCT00759525|102114895|FG000|NOT COMPLETED|First Intervention (14 Days)||0||
48310145|NCT02739620|101084773|FG000|Intervention Phase|Overall Study||10||
48310146|NCT02739620|101084774|FG001|Intervention Phase|Overall Study||10||
48310147|NCT02739620|101084773|FG000|Post-intervention Testing|Overall Study||9||
48310148|NCT02739620|101084774|FG001|Post-intervention Testing|Overall Study||8||
48310149|NCT02739620|101084773|FG000|COMPLETED|Overall Study||9||
48310150|NCT02739620|101084774|FG001|COMPLETED|Overall Study||8||
48310151|NCT02739620|101084773|FG000|NOT COMPLETED|Overall Study||3||
48310152|NCT02739620|101084774|FG001|NOT COMPLETED|Overall Study||2||
48310153|NCT01727765|101084775|FG000|STARTED|Overall Study||8||
48310154|NCT01727765|101084776|FG001|STARTED|Overall Study||8||
48310155|NCT01727765|101084775|FG000|COMPLETED|Overall Study||8||
48310156|NCT01727765|101084776|FG001|COMPLETED|Overall Study||8||
48310157|NCT01727765|101084775|FG000|NOT COMPLETED|Overall Study||0||
48310158|NCT01727765|101084776|FG001|NOT COMPLETED|Overall Study||0||
48310159|NCT01974089|101084777|FG000|STARTED|Overall Study||53||
48310160|NCT01974089|101084778|FG001|STARTED|Overall Study||101||
48725536|NCT00759525|102114896|FG001|NOT COMPLETED|First Intervention (14 Days)||0||
48725537|NCT00759525|102114895|FG000|STARTED|Washout (14 Days)||7||
48725538|NCT00759525|102114896|FG001|STARTED|Washout (14 Days)||8||
48725539|NCT00759525|102114895|FG000|COMPLETED|Washout (14 Days)||7||
48725540|NCT00759525|102114896|FG001|COMPLETED|Washout (14 Days)||8||
48725541|NCT00759525|102114895|FG000|NOT COMPLETED|Washout (14 Days)||0||
48725542|NCT00759525|102114896|FG001|NOT COMPLETED|Washout (14 Days)||0||
48310161|NCT01974089|101084777|FG000|COMPLETED|Overall Study||53||
48310162|NCT01974089|101084778|FG001|COMPLETED|Overall Study||101||
48310163|NCT01974089|101084777|FG000|NOT COMPLETED|Overall Study||0||
48310164|NCT01974089|101084778|FG001|NOT COMPLETED|Overall Study||0||
48725543|NCT00759525|102114895|FG000|STARTED|Second Intervention (14 Days)||7||
48310165|NCT02218242|101084779|FG000|STARTED|Overall Study||9||
48310166|NCT02218242|101084779|FG000|COMPLETED|Overall Study||9||
48310167|NCT02218242|101084779|FG000|NOT COMPLETED|Overall Study||0||
48310168|NCT04353596|101084780|FG000|STARTED|Overall Study||109||
48310169|NCT04353596|101084781|FG001|STARTED|Overall Study||107||
48310170|NCT04353596|101084780|FG000|Per Protocol|Overall Study||104||
48310171|NCT04353596|101084781|FG001|Per Protocol|Overall Study||100||
48725544|NCT00759525|102114896|FG001|STARTED|Second Intervention (14 Days)||8||
48725545|NCT00759525|102114895|FG000|COMPLETED|Second Intervention (14 Days)||7||
48725546|NCT00759525|102114896|FG001|COMPLETED|Second Intervention (14 Days)||8||
48725547|NCT00759525|102114895|FG000|NOT COMPLETED|Second Intervention (14 Days)||0||
48725548|NCT00759525|102114896|FG001|NOT COMPLETED|Second Intervention (14 Days)||0||
48725549|NCT03249103|102114897|FG000|STARTED|Overall Study||22||
48725550|NCT03249103|102114897|FG000|COMPLETED|Overall Study||20||
48725551|NCT03249103|102114897|FG000|NOT COMPLETED|Overall Study||2||
48725552|NCT00504894|102114898|FG000|STARTED|Overall Study||20||
48725553|NCT00504894|102114899|FG001|STARTED|Overall Study||21||
48154484|NCT04493931|100699960|FG001|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0||
48154485|NCT04493931|100699961|FG002|STARTED|Cohort 3: Follow-up (Up to 10 Days)||9||
48154486|NCT04493931|100699962|FG003|STARTED|Cohort 3: Follow-up (Up to 10 Days)||9||
48154487|NCT04493931|100699963|FG004|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0||
48154488|NCT04493931|100699964|FG005|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0||
48154489|NCT04493931|100699965|FG006|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0||
48154490|NCT04493931|100699959|FG000|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0||
48154491|NCT04493931|100699960|FG001|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0||
48154492|NCT04493931|100699961|FG002|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||9||
48725554|NCT00504894|102114900|FG002|STARTED|Overall Study||19||
48725555|NCT00504894|102114898|FG000|COMPLETED|Overall Study||17||
48725556|NCT00504894|102114899|FG001|COMPLETED|Overall Study||18||
48725557|NCT00504894|102114900|FG002|COMPLETED|Overall Study||19||
48725558|NCT00504894|102114898|FG000|NOT COMPLETED|Overall Study||3||
48725559|NCT00504894|102114899|FG001|NOT COMPLETED|Overall Study||3||
48725560|NCT00504894|102114900|FG002|NOT COMPLETED|Overall Study||0||
48725561|NCT01939366|102114901|FG000|STARTED|Overall Study||66||
48725562|NCT01939366|102114902|FG001|STARTED|Overall Study||64||
48725563|NCT01939366|102114903|FG002|STARTED|Overall Study||65||
48725564|NCT01939366|102114904|FG003|STARTED|Overall Study||68||
48406577|NCT02603172|101328443|FG004|NOT COMPLETED|Part C (Approximately 13 Weeks)||0||
48406578|NCT02603172|101328444|FG005|NOT COMPLETED|Part C (Approximately 13 Weeks)||0||
48406579|NCT02603172|101328445|FG006|NOT COMPLETED|Part C (Approximately 13 Weeks)||0||
48406580|NCT02603172|101328446|FG007|NOT COMPLETED|Part C (Approximately 13 Weeks)||0||
48725565|NCT01939366|102114905|FG004|STARTED|Overall Study||66||
48725566|NCT01939366|102114901|FG000|Allocated Set Excl. Non-compliant Sites|Overall Study||64||
48725567|NCT01939366|102114902|FG001|Allocated Set Excl. Non-compliant Sites|Overall Study||61||
48725568|NCT01939366|102114903|FG002|Allocated Set Excl. Non-compliant Sites|Overall Study||63||
48725569|NCT01939366|102114904|FG003|Allocated Set Excl. Non-compliant Sites|Overall Study||65||
48725570|NCT01939366|102114905|FG004|Allocated Set Excl. Non-compliant Sites|Overall Study||63||
48725571|NCT01939366|102114901|FG000|Safety Set|Overall Study||64||
48725572|NCT01939366|102114902|FG001|Safety Set|Overall Study||61||
48725573|NCT01939366|102114903|FG002|Safety Set|Overall Study||62||
48725574|NCT01939366|102114904|FG003|Safety Set|Overall Study||65||
48725575|NCT01939366|102114905|FG004|Safety Set|Overall Study||62||
48725576|NCT01939366|102114901|FG000|Full Analysis Set|Overall Study||64||
48725577|NCT01939366|102114902|FG001|Full Analysis Set|Overall Study||60||
48725578|NCT01939366|102114903|FG002|Full Analysis Set|Overall Study||61||
48725579|NCT01939366|102114904|FG003|Full Analysis Set|Overall Study||65||
48725580|NCT01939366|102114905|FG004|Full Analysis Set|Overall Study||62||
48725581|NCT01939366|102114901|FG000|Per Protocol Set|Overall Study||58||
48725582|NCT01939366|102114902|FG001|Per Protocol Set|Overall Study||55||
48725583|NCT01939366|102114903|FG002|Per Protocol Set|Overall Study||50||
48154493|NCT04493931|100699962|FG003|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||9||
48154494|NCT04493931|100699963|FG004|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0||
48154495|NCT04493931|100699964|FG005|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0||
48154496|NCT04493931|100699965|FG006|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0||
48154497|NCT04493931|100699959|FG000|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0||
48154498|NCT04493931|100699960|FG001|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0||
48154499|NCT04493931|100699961|FG002|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0||
48154500|NCT04493931|100699962|FG003|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0||
48406581|NCT00959699|101328447|FG000|STARTED|Treatment Period||34||
48406582|NCT00959699|101328448|FG001|STARTED|Treatment Period||65||
48406583|NCT00959699|101328447|FG000|Treated|Treatment Period||34||
48725584|NCT01939366|102114904|FG003|Per Protocol Set|Overall Study||51||
48725585|NCT01939366|102114905|FG004|Per Protocol Set|Overall Study||49||
48725586|NCT01939366|102114901|FG000|COMPLETED|Overall Study||52||
48725587|NCT01939366|102114902|FG001|COMPLETED|Overall Study||41||
48725588|NCT01939366|102114903|FG002|COMPLETED|Overall Study||27||
48725589|NCT01939366|102114904|FG003|COMPLETED|Overall Study||51||
48725590|NCT01939366|102114905|FG004|COMPLETED|Overall Study||48||
48725591|NCT01939366|102114901|FG000|NOT COMPLETED|Overall Study||14||
48725592|NCT01939366|102114902|FG001|NOT COMPLETED|Overall Study||23||
48725593|NCT01939366|102114903|FG002|NOT COMPLETED|Overall Study||38||
48725594|NCT01939366|102114904|FG003|NOT COMPLETED|Overall Study||17||
48725595|NCT01939366|102114905|FG004|NOT COMPLETED|Overall Study||18||
48725596|NCT04285489|102114906|FG000|STARTED|Overall Study||130|The first subject was enrolled in May 2, 2020|
48767601|NCT00914316|102222777|FG001|NOT COMPLETED|Phase 1||2||
48406584|NCT00959699|101328448|FG001|Treated|Treatment Period||64||
48725597|NCT04285489|102114906|FG000|COMPLETED|Overall Study||130|all subjects finished the study by Jul 1, 2020.|
48725598|NCT04285489|102114906|FG000|NOT COMPLETED|Overall Study||0||
48725599|NCT01181258|102114907|FG000|STARTED|Overall Study||16||
48725600|NCT01181258|102114907|FG000|COMPLETED|Overall Study||16||
48310172|NCT04353596|101084780|FG000|COMPLETED|Overall Study||104||
48310173|NCT04353596|101084781|FG001|COMPLETED|Overall Study||100||
48310174|NCT04353596|101084780|FG000|NOT COMPLETED|Overall Study||5||
48310175|NCT04353596|101084781|FG001|NOT COMPLETED|Overall Study||7||
48310176|NCT02217436|101084782|FG000|STARTED|Overall Study||40||
48310177|NCT02217436|101084783|FG001|STARTED|Overall Study||40||
48310178|NCT02217436|101084782|FG000|COMPLETED|Overall Study||39||
48310179|NCT02217436|101084783|FG001|COMPLETED|Overall Study||38||
48310180|NCT02217436|101084782|FG000|NOT COMPLETED|Overall Study||1||
48310181|NCT02217436|101084783|FG001|NOT COMPLETED|Overall Study||2||
48310182|NCT01034592|101084784|FG000|STARTED|Overall Study||2||
48310183|NCT01034592|101084784|FG000|COMPLETED|Overall Study||2||
48310184|NCT01034592|101084784|FG000|NOT COMPLETED|Overall Study||0||
48310185|NCT01519765|101084785|FG000|STARTED|Overall Study||37||
48310186|NCT01519765|101084786|FG001|STARTED|Overall Study||36||
48310187|NCT01519765|101084785|FG000|COMPLETED|Overall Study||34||
48310188|NCT01519765|101084786|FG001|COMPLETED|Overall Study||34||
48310189|NCT01519765|101084785|FG000|NOT COMPLETED|Overall Study||3||
48310190|NCT01519765|101084786|FG001|NOT COMPLETED|Overall Study||2||
48310191|NCT01085786|101084787|FG000|STARTED|Overall Study||123||
48310192|NCT01085786|101084788|FG001|STARTED|Overall Study||117||
48310193|NCT01085786|101084787|FG000|COMPLETED|Overall Study||123||
48310194|NCT01085786|101084788|FG001|COMPLETED|Overall Study||117||
48310195|NCT01085786|101084787|FG000|NOT COMPLETED|Overall Study||0||
48310196|NCT01085786|101084788|FG001|NOT COMPLETED|Overall Study||0||
48310197|NCT01936909|101084789|FG000|STARTED|Overall Study||20||
48310198|NCT01936909|101084790|FG001|STARTED|Overall Study||20||
48310199|NCT01936909|101084791|FG002|STARTED|Overall Study||20||
48310200|NCT01936909|101084789|FG000|COMPLETED|Overall Study||10||
48310201|NCT01936909|101084790|FG001|COMPLETED|Overall Study||12||
48310202|NCT01936909|101084791|FG002|COMPLETED|Overall Study||14||
48310203|NCT01936909|101084789|FG000|NOT COMPLETED|Overall Study||10||
48310204|NCT01936909|101084790|FG001|NOT COMPLETED|Overall Study||8||
48310205|NCT01936909|101084791|FG002|NOT COMPLETED|Overall Study||6||
48310206|NCT00283049|101084792|FG000|STARTED|Overall Study||128||
48310207|NCT00283049|101084793|FG001|STARTED|Overall Study||128||
48310208|NCT00283049|101084794|FG002|STARTED|Overall Study||130||
48310209|NCT00283049|101084792|FG000|COMPLETED|Overall Study||70||
48310210|NCT00283049|101084793|FG001|COMPLETED|Overall Study||83||
48310211|NCT00283049|101084794|FG002|COMPLETED|Overall Study||76||
48310212|NCT00283049|101084792|FG000|NOT COMPLETED|Overall Study||58||
48725601|NCT01181258|102114907|FG000|NOT COMPLETED|Overall Study||0||
48310213|NCT00283049|101084793|FG001|NOT COMPLETED|Overall Study||45||
48310214|NCT00283049|101084794|FG002|NOT COMPLETED|Overall Study||54||
48310215|NCT00698451|101084795|FG000|STARTED|Overall Study||54||
48310216|NCT00698451|101084795|FG000|COMPLETED|Overall Study||15||
48310217|NCT00698451|101084795|FG000|NOT COMPLETED|Overall Study||39||
48310218|NCT00698997|101084796|FG000|STARTED|Overall Study||55||
48310219|NCT00698997|101084797|FG001|STARTED|Overall Study||63||
48310220|NCT00698997|101084796|FG000|COMPLETED|Overall Study||45||
48310221|NCT00698997|101084797|FG001|COMPLETED|Overall Study||36||
48310222|NCT00698997|101084796|FG000|NOT COMPLETED|Overall Study||10||
48310223|NCT00698997|101084797|FG001|NOT COMPLETED|Overall Study||27||
48310224|NCT02232282|101084798|FG000|STARTED|Overall Study||10||
48310225|NCT02232282|101084799|FG001|STARTED|Overall Study||12||
48310226|NCT02232282|101084798|FG000|COMPLETED|Overall Study||10||
48310227|NCT02232282|101084799|FG001|COMPLETED|Overall Study||11||
48310228|NCT02232282|101084798|FG000|NOT COMPLETED|Overall Study||0||
48310229|NCT02232282|101084799|FG001|NOT COMPLETED|Overall Study||1||
48310230|NCT01087957|101084800|FG000|STARTED|Overall Study||253||
48310231|NCT01087957|101084801|FG001|STARTED|Overall Study||242||
48310232|NCT01087957|101084800|FG000|COMPLETED|Overall Study||212||
48310233|NCT01087957|101084801|FG001|COMPLETED|Overall Study||187||
48310234|NCT01087957|101084800|FG000|NOT COMPLETED|Overall Study||41||
48310235|NCT01087957|101084801|FG001|NOT COMPLETED|Overall Study||55||
48310236|NCT01507779|101084802|FG000|STARTED|Overall Study||23||
48310237|NCT01507779|101084803|FG001|STARTED|Overall Study||25||
48725602|NCT01124955|102114908|FG000|STARTED|Overall Study||40||
48310238|NCT01507779|101084802|FG000|COMPLETED|Overall Study||23||
48310239|NCT01507779|101084803|FG001|COMPLETED|Overall Study||25||
48310240|NCT01507779|101084802|FG000|NOT COMPLETED|Overall Study||0||
48310241|NCT01507779|101084803|FG001|NOT COMPLETED|Overall Study||0||
48310242|NCT00744211|101084804|FG000|STARTED|Baseline||10||
48310243|NCT00744211|101084805|FG001|STARTED|Baseline||9||
48310244|NCT00744211|101084806|FG002|STARTED|Baseline||10||
48310245|NCT00744211|101084804|FG000|COMPLETED|Baseline||10||
48310246|NCT00744211|101084805|FG001|COMPLETED|Baseline||9||
48725603|NCT01124955|102114909|FG001|STARTED|Overall Study||40||
48310247|NCT00744211|101084806|FG002|COMPLETED|Baseline||10||
48310248|NCT00744211|101084804|FG000|NOT COMPLETED|Baseline||0||
48310249|NCT00744211|101084805|FG001|NOT COMPLETED|Baseline||0||
48310250|NCT00744211|101084806|FG002|NOT COMPLETED|Baseline||0||
48725604|NCT01124955|102114908|FG000|COMPLETED|Overall Study||40||
48725605|NCT01124955|102114909|FG001|COMPLETED|Overall Study||40||
48725606|NCT01124955|102114908|FG000|NOT COMPLETED|Overall Study||0||
48725607|NCT01124955|102114909|FG001|NOT COMPLETED|Overall Study||0||
48725608|NCT02277119|102114910|FG000|STARTED|Overall Study||58||
48725609|NCT02277119|102114911|FG001|STARTED|Overall Study||24||
48725610|NCT02277119|102114912|FG002|STARTED|Overall Study||27||
48725611|NCT02277119|102114910|FG000|COMPLETED|Overall Study||55||
48725612|NCT02277119|102114911|FG001|COMPLETED|Overall Study||20||
48725613|NCT02277119|102114912|FG002|COMPLETED|Overall Study||19||
48725614|NCT02277119|102114910|FG000|NOT COMPLETED|Overall Study||3||
48725615|NCT02277119|102114911|FG001|NOT COMPLETED|Overall Study||4||
48725616|NCT02277119|102114912|FG002|NOT COMPLETED|Overall Study||8||
48725617|NCT00958932|102114913|FG000|STARTED|Overall Study||590||
48725618|NCT00958932|102114914|FG001|STARTED|Overall Study||597||
48725619|NCT00958932|102114913|FG000|COMPLETED|Overall Study||452||
48725620|NCT00958932|102114914|FG001|COMPLETED|Overall Study||447||
48725621|NCT00958932|102114913|FG000|NOT COMPLETED|Overall Study||138||
48725622|NCT00958932|102114914|FG001|NOT COMPLETED|Overall Study||150||
48725623|NCT01174173|102114915|FG000|STARTED|Overall Study||11||
48725624|NCT01174173|102114915|FG000|COMPLETED|Overall Study||10||
48725625|NCT01174173|102114915|FG000|NOT COMPLETED|Overall Study||1||
48725626|NCT00660985|102114916|FG000|STARTED|Overall Study||26||
48725627|NCT00660985|102114917|FG001|STARTED|Overall Study||25||
48725628|NCT00660985|102114916|FG000|COMPLETED|Overall Study||25||
48725629|NCT00660985|102114917|FG001|COMPLETED|Overall Study||25||
48725630|NCT00660985|102114916|FG000|NOT COMPLETED|Overall Study||1||
48725631|NCT00660985|102114917|FG001|NOT COMPLETED|Overall Study||0||
48725632|NCT03613363|102114918|FG000|STARTED|Overall Study||20||
48725633|NCT03613363|102114918|FG000|COMPLETED|Overall Study||20||
48725634|NCT03613363|102114918|FG000|NOT COMPLETED|Overall Study||0||
48725635|NCT00084149|102114919|FG000|STARTED|Overall Study||36||
48725636|NCT00084149|102114920|FG001|STARTED|Overall Study||18||
48725637|NCT00084149|102114919|FG000|COMPLETED|Overall Study||28||
48725638|NCT00084149|102114920|FG001|COMPLETED|Overall Study||13||
48725639|NCT00084149|102114919|FG000|NOT COMPLETED|Overall Study||8||
48725640|NCT00084149|102114920|FG001|NOT COMPLETED|Overall Study||5||
48725641|NCT01274520|102114921|FG000|STARTED|Overall Study||25||
48725642|NCT01274520|102114922|FG001|STARTED|Overall Study||24||
48725643|NCT01274520|102114921|FG000|COMPLETED|Overall Study||25||
48725644|NCT01274520|102114922|FG001|COMPLETED|Overall Study||24||
48725645|NCT01274520|102114921|FG000|NOT COMPLETED|Overall Study||0||
48725646|NCT01274520|102114922|FG001|NOT COMPLETED|Overall Study||0||
48725647|NCT00383162|102114923|FG000|STARTED|Migraine Attack 1 (Period 1)||87||
48154501|NCT04493931|100699963|FG004|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0||
48154502|NCT04493931|100699964|FG005|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0||
48154503|NCT04493931|100699965|FG006|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0||
48154504|NCT04493931|100699959|FG000|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||0||
48154505|NCT04493931|100699960|FG001|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||0||
48154506|NCT04493931|100699961|FG002|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||0||
48154507|NCT04493931|100699962|FG003|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||0||
48154508|NCT04493931|100699963|FG004|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||6||
48154509|NCT04493931|100699964|FG005|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||5||
48154510|NCT04493931|100699965|FG006|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||3||
48725648|NCT00383162|102114924|FG001|STARTED|Migraine Attack 1 (Period 1)||86||
48725649|NCT00383162|102114923|FG000|COMPLETED|Migraine Attack 1 (Period 1)||67||
48725650|NCT00383162|102114924|FG001|COMPLETED|Migraine Attack 1 (Period 1)||73||
48725651|NCT00383162|102114923|FG000|NOT COMPLETED|Migraine Attack 1 (Period 1)||20||
48725652|NCT00383162|102114924|FG001|NOT COMPLETED|Migraine Attack 1 (Period 1)||13||
48725653|NCT00383162|102114923|FG000|STARTED|Migraine Attack 2 (Period 2)||67||
48725654|NCT00383162|102114924|FG001|STARTED|Migraine Attack 2 (Period 2)||73||
48725655|NCT00383162|102114923|FG000|COMPLETED|Migraine Attack 2 (Period 2)||65||
48725656|NCT00383162|102114924|FG001|COMPLETED|Migraine Attack 2 (Period 2)||66||
48725657|NCT00383162|102114923|FG000|NOT COMPLETED|Migraine Attack 2 (Period 2)||2||
48154511|NCT04493931|100699959|FG000|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0||
48154512|NCT04493931|100699960|FG001|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0||
48154513|NCT04493931|100699961|FG002|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0||
48725658|NCT00383162|102114924|FG001|NOT COMPLETED|Migraine Attack 2 (Period 2)||7||
48725659|NCT01154751|102114925|FG000|STARTED|6-month Follow-up||109||
48725660|NCT01154751|102114925|FG000|COMPLETED|6-month Follow-up||98||
48725661|NCT01154751|102114925|FG000|NOT COMPLETED|6-month Follow-up||11||
48725662|NCT01154751|102114925|FG000|STARTED|1-year Follow-up||98||
48725663|NCT01154751|102114925|FG000|COMPLETED|1-year Follow-up||93||
48725664|NCT01154751|102114925|FG000|NOT COMPLETED|1-year Follow-up||5||
48725665|NCT01154751|102114925|FG000|STARTED|2-year Follow-up||93||
48725666|NCT01154751|102114925|FG000|COMPLETED|2-year Follow-up||83||
48725667|NCT01154751|102114925|FG000|NOT COMPLETED|2-year Follow-up||10||
48725668|NCT01154751|102114925|FG000|STARTED|3-year Follow-up||83||
48725669|NCT01154751|102114925|FG000|COMPLETED|3-year Follow-up||34||
48725670|NCT01154751|102114925|FG000|NOT COMPLETED|3-year Follow-up||49||
48725671|NCT01882868|102114926|FG000|STARTED|Overall Study||62||
48725672|NCT01882868|102114926|FG000|COMPLETED|Overall Study||62||
48725673|NCT01882868|102114926|FG000|NOT COMPLETED|Overall Study||0||
48725674|NCT04079881|102114927|FG000|STARTED|Overall Study||1||
48725675|NCT04079881|102114928|FG001|STARTED|Overall Study||0||
48725676|NCT04079881|102114927|FG000|COMPLETED|Overall Study||1||
48725677|NCT04079881|102114928|FG001|COMPLETED|Overall Study||0||
48725678|NCT04079881|102114927|FG000|NOT COMPLETED|Overall Study||0||
48725679|NCT04079881|102114928|FG001|NOT COMPLETED|Overall Study||0||
48725680|NCT01304589|102114929|FG000|STARTED|Overall Study||31||
48725681|NCT01304589|102114929|FG000|COMPLETED|Overall Study||18||
48725682|NCT01304589|102114929|FG000|NOT COMPLETED|Overall Study||13||
48725683|NCT02467842|102114930|FG000|STARTED|Overall Study||752||
48725684|NCT02467842|102114931|FG001|STARTED|Overall Study||373||
48725685|NCT02467842|102114932|FG002|STARTED|Overall Study||378||
48725686|NCT02467842|102114930|FG000|COMPLETED|Overall Study||752||
48725687|NCT02467842|102114931|FG001|COMPLETED|Overall Study||373||
48725688|NCT02467842|102114932|FG002|COMPLETED|Overall Study||378||
48725689|NCT02467842|102114930|FG000|NOT COMPLETED|Overall Study||0||
48725690|NCT02467842|102114931|FG001|NOT COMPLETED|Overall Study||0||
48725691|NCT02467842|102114932|FG002|NOT COMPLETED|Overall Study||0||
48725692|NCT01092663|102114933|FG000|STARTED|Overall Study||31||
48725693|NCT01092663|102114934|FG001|STARTED|Overall Study||30||
48725694|NCT01092663|102114933|FG000|COMPLETED|Overall Study||24||
48725695|NCT01092663|102114934|FG001|COMPLETED|Overall Study||26||
48725696|NCT01092663|102114933|FG000|NOT COMPLETED|Overall Study||7||
48725697|NCT01092663|102114934|FG001|NOT COMPLETED|Overall Study||4||
48725698|NCT01331291|102114935|FG000|STARTED|Overall Study||2||
48725699|NCT01331291|102114936|FG001|STARTED|Overall Study||9||
48725700|NCT01331291|102114935|FG000|COMPLETED|Overall Study||0||
48725701|NCT01331291|102114936|FG001|COMPLETED|Overall Study||0||
48725702|NCT01331291|102114935|FG000|NOT COMPLETED|Overall Study||2||
48725703|NCT01331291|102114936|FG001|NOT COMPLETED|Overall Study||9||
48725704|NCT02326233|102114937|FG000|STARTED|Overall Study||95||
48725705|NCT02326233|102114938|FG001|STARTED|Overall Study||95||
48725706|NCT02326233|102114937|FG000|COMPLETED|Overall Study||95||
48725707|NCT02326233|102114938|FG001|COMPLETED|Overall Study||94||
48725708|NCT02326233|102114937|FG000|NOT COMPLETED|Overall Study||0||
48725709|NCT02326233|102114938|FG001|NOT COMPLETED|Overall Study||1||
48725710|NCT01599741|102114939|FG000|STARTED|Overall Study||51||
48725711|NCT01599741|102114939|FG000|Collected Dose and Image Information|Overall Study||48||
48725712|NCT01599741|102114939|FG000|COMPLETED|Overall Study||48||
48725713|NCT01599741|102114939|FG000|NOT COMPLETED|Overall Study||3||
48725714|NCT01571232|102114940|FG000|STARTED|Overall Study||10||
48725715|NCT01571232|102114941|FG001|STARTED|Overall Study||10||
48725716|NCT01571232|102114940|FG000|COMPLETED|Overall Study||9||
48725717|NCT01571232|102114941|FG001|COMPLETED|Overall Study||9||
48725718|NCT01571232|102114940|FG000|NOT COMPLETED|Overall Study||1||
48725719|NCT01571232|102114941|FG001|NOT COMPLETED|Overall Study||1||
48725720|NCT00908466|102114942|FG000|STARTED|Overall Study||15||
48725721|NCT00908466|102114943|FG001|STARTED|Overall Study||15||
48725722|NCT00908466|102114942|FG000|COMPLETED|Overall Study||14||
48725723|NCT00908466|102114943|FG001|COMPLETED|Overall Study||14||
48725724|NCT00908466|102114942|FG000|NOT COMPLETED|Overall Study||1||
48725725|NCT00908466|102114943|FG001|NOT COMPLETED|Overall Study||1||
48725726|NCT00588094|102114944|FG000|STARTED|Overall Study||20||
48725727|NCT00588094|102114944|FG000|COMPLETED|Overall Study||15||
48725728|NCT00588094|102114944|FG000|NOT COMPLETED|Overall Study||5||
48725729|NCT01181674|102114945|FG000|STARTED|Overall Study||28||
48725730|NCT01181674|102114946|FG001|STARTED|Overall Study||27||
48725731|NCT01181674|102114947|FG002|STARTED|Overall Study||28||
48725732|NCT01181674|102114945|FG000|COMPLETED|Overall Study||28||
48725733|NCT01181674|102114946|FG001|COMPLETED|Overall Study||27||
48725734|NCT01181674|102114947|FG002|COMPLETED|Overall Study||26||
48725735|NCT01181674|102114945|FG000|NOT COMPLETED|Overall Study||0||
48725736|NCT01181674|102114946|FG001|NOT COMPLETED|Overall Study||0||
48725737|NCT01181674|102114947|FG002|NOT COMPLETED|Overall Study||2||
48725738|NCT03256253|102114948|FG000|STARTED|Overall Study||18||
48725739|NCT03256253|102114948|FG000|COMPLETED|Overall Study||6||
48725740|NCT03256253|102114948|FG000|NOT COMPLETED|Overall Study||12||
48725741|NCT00450073|102114949|FG000|STARTED|Overall Study||10||
48725742|NCT00450073|102114950|FG001|STARTED|Overall Study||10||
48725743|NCT00450073|102114951|FG002|STARTED|Overall Study||10||
48725744|NCT00450073|102114949|FG000|COMPLETED|Overall Study||9||
48725745|NCT00450073|102114950|FG001|COMPLETED|Overall Study||10||
48725746|NCT00450073|102114951|FG002|COMPLETED|Overall Study||9||
48725747|NCT00450073|102114949|FG000|NOT COMPLETED|Overall Study||1||
48725748|NCT00450073|102114950|FG001|NOT COMPLETED|Overall Study||0||
48725749|NCT00450073|102114951|FG002|NOT COMPLETED|Overall Study||1||
48725750|NCT02825212|102114952|FG000|STARTED|Overall Study||10||
48725751|NCT02825212|102114952|FG000|COMPLETED|Overall Study||10||
48725752|NCT02825212|102114952|FG000|NOT COMPLETED|Overall Study||0||
48725753|NCT00737633|102114953|FG000|STARTED|Overall Study||44||
48725754|NCT00737633|102114954|FG001|STARTED|Overall Study||57||
48725755|NCT00737633|102114953|FG000|COMPLETED|Overall Study||0||
48725756|NCT00737633|102114954|FG001|COMPLETED|Overall Study||0||
48725757|NCT00737633|102114953|FG000|NOT COMPLETED|Overall Study||44||
48725758|NCT00737633|102114954|FG001|NOT COMPLETED|Overall Study||57||
48725759|NCT04836247|102114955|FG000|STARTED|Overall Study||25||
48725760|NCT04836247|102114956|FG001|STARTED|Overall Study||25||
48725761|NCT04836247|102114955|FG000|COMPLETED|Overall Study||25||
48725762|NCT04836247|102114956|FG001|COMPLETED|Overall Study||25||
48725763|NCT04836247|102114955|FG000|NOT COMPLETED|Overall Study||0||
48725764|NCT04836247|102114956|FG001|NOT COMPLETED|Overall Study||0||
48725765|NCT03544307|102114957|FG000|STARTED|Overall Study||10||
48725766|NCT03544307|102114958|FG001|STARTED|Overall Study||10||
48725767|NCT03544307|102114957|FG000|COMPLETED|Overall Study||10||
48725768|NCT03544307|102114958|FG001|COMPLETED|Overall Study||10||
48725769|NCT03544307|102114957|FG000|NOT COMPLETED|Overall Study||0||
48725770|NCT03544307|102114958|FG001|NOT COMPLETED|Overall Study||0||
48725771|NCT00094107|102114959|FG000|STARTED|Overall Study||32||
48725772|NCT00094107|102114959|FG000|COMPLETED|Overall Study||0||
48725773|NCT00094107|102114959|FG000|NOT COMPLETED|Overall Study||32||
48725774|NCT01868334|102114960|FG000|STARTED|Year 1 RCCT Study||13186||10
48725775|NCT01868334|102114961|FG001|STARTED|Year 1 RCCT Study||17185||8
48725776|NCT01868334|102114962|FG002|STARTED|Year 1 RCCT Study||19274||3
48725777|NCT01868334|102114963|FG003|STARTED|Year 1 RCCT Study||20904||3
48725778|NCT01868334|102114960|FG000|COMPLETED|Year 1 RCCT Study||13186||10
48725779|NCT01868334|102114961|FG001|COMPLETED|Year 1 RCCT Study||17185||8
48725780|NCT01868334|102114962|FG002|COMPLETED|Year 1 RCCT Study||19274||3
48725781|NCT01868334|102114963|FG003|COMPLETED|Year 1 RCCT Study||20904||3
48725782|NCT01868334|102114960|FG000|NOT COMPLETED|Year 1 RCCT Study||0||0
48725783|NCT01868334|102114961|FG001|NOT COMPLETED|Year 1 RCCT Study||0||0
48725784|NCT01868334|102114962|FG002|NOT COMPLETED|Year 1 RCCT Study||0||0
48725785|NCT01868334|102114963|FG003|NOT COMPLETED|Year 1 RCCT Study||0||0
48725786|NCT01868334|102114960|FG000|STARTED|Year 2 Pre-post Study||22324||12
48725787|NCT01868334|102114961|FG001|STARTED|Year 2 Pre-post Study||8047||6
48154514|NCT04493931|100699962|FG003|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0||
48154515|NCT04493931|100699963|FG004|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||6||
48154516|NCT04493931|100699964|FG005|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||5||
48154517|NCT04493931|100699965|FG006|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||3||
48154518|NCT04493931|100699959|FG000|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0||
48154519|NCT04493931|100699960|FG001|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0||
48154520|NCT04493931|100699961|FG002|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0||
48154521|NCT04493931|100699962|FG003|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0||
48154522|NCT04493931|100699963|FG004|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0||
48154523|NCT04493931|100699964|FG005|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0||
48154524|NCT04493931|100699965|FG006|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0||
48154525|NCT04493931|100699959|FG000|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||0||
48154526|NCT04493931|100699960|FG001|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||0||
48154527|NCT04493931|100699961|FG002|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||0||
48154528|NCT04493931|100699962|FG003|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||0||
48154529|NCT04493931|100699963|FG004|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||6||
48154530|NCT04493931|100699964|FG005|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||5||
48154531|NCT04493931|100699965|FG006|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||3||
48154532|NCT04493931|100699959|FG000|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0||
48154533|NCT04493931|100699960|FG001|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0||
48154534|NCT04493931|100699961|FG002|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0||
48154535|NCT04493931|100699962|FG003|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0||
48154536|NCT04493931|100699963|FG004|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||6||
48154537|NCT04493931|100699964|FG005|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||5||
48154538|NCT04493931|100699965|FG006|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||3||
48154539|NCT04493931|100699959|FG000|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0||
48725788|NCT01868334|102114962|FG002|STARTED|Year 2 Pre-post Study||20904||3
48725789|NCT01868334|102114963|FG003|STARTED|Year 2 Pre-post Study||19274||3
48725790|NCT01868334|102114960|FG000|COMPLETED|Year 2 Pre-post Study||22324||12
48725791|NCT01868334|102114961|FG001|COMPLETED|Year 2 Pre-post Study||8047||6
48725792|NCT01868334|102114962|FG002|COMPLETED|Year 2 Pre-post Study||20904||3
48725793|NCT01868334|102114963|FG003|COMPLETED|Year 2 Pre-post Study||19274||3
48725794|NCT01868334|102114960|FG000|NOT COMPLETED|Year 2 Pre-post Study||0||0
48725795|NCT01868334|102114961|FG001|NOT COMPLETED|Year 2 Pre-post Study||0||0
48725796|NCT01868334|102114962|FG002|NOT COMPLETED|Year 2 Pre-post Study||0||0
48725797|NCT01868334|102114963|FG003|NOT COMPLETED|Year 2 Pre-post Study||0||0
48725798|NCT04253587|102114964|FG000|STARTED|Overall Study||25||
48725799|NCT04253587|102114965|FG001|STARTED|Overall Study||25||
48725800|NCT04253587|102114964|FG000|Baseline T1|Overall Study||24||
48154540|NCT04493931|100699960|FG001|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0||
48310251|NCT00744211|101084804|FG000|STARTED|0.5 Hours After Cardiopulmonary Bypass||10||
48612513|NCT04392219|101838291|FG012|COMPLETED|Overall Study||6||
48612514|NCT04392219|101838292|FG013|COMPLETED|Overall Study||6||
48612515|NCT04392219|101838293|FG014|COMPLETED|Overall Study||6||
48310252|NCT00744211|101084805|FG001|STARTED|0.5 Hours After Cardiopulmonary Bypass||9||
48310253|NCT00744211|101084806|FG002|STARTED|0.5 Hours After Cardiopulmonary Bypass||10||
48310254|NCT00744211|101084804|FG000|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10||
48310255|NCT00744211|101084805|FG001|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||9||
48310256|NCT00744211|101084806|FG002|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10||
48310257|NCT00744211|101084804|FG000|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0||
48310258|NCT00744211|101084805|FG001|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0||
48612516|NCT04392219|101838294|FG015|COMPLETED|Overall Study||6||
48612517|NCT04392219|101838295|FG016|COMPLETED|Overall Study||6||
48612518|NCT04392219|101838296|FG017|COMPLETED|Overall Study||6||
48612519|NCT04392219|101838279|FG000|NOT COMPLETED|Overall Study||0||
48612520|NCT04392219|101838280|FG001|NOT COMPLETED|Overall Study||0||
48612521|NCT04392219|101838281|FG002|NOT COMPLETED|Overall Study||0||
48612522|NCT04392219|101838282|FG003|NOT COMPLETED|Overall Study||0||
48612523|NCT04392219|101838283|FG004|NOT COMPLETED|Overall Study||0||
48612524|NCT04392219|101838284|FG005|NOT COMPLETED|Overall Study||0||
48612525|NCT04392219|101838285|FG006|NOT COMPLETED|Overall Study||0||
48612526|NCT04392219|101838286|FG007|NOT COMPLETED|Overall Study||0||
48612527|NCT04392219|101838287|FG008|NOT COMPLETED|Overall Study||0||
48612528|NCT04392219|101838288|FG009|NOT COMPLETED|Overall Study||0||
48612529|NCT04392219|101838289|FG010|NOT COMPLETED|Overall Study||0||
48612530|NCT04392219|101838290|FG011|NOT COMPLETED|Overall Study||0||
48612531|NCT04392219|101838291|FG012|NOT COMPLETED|Overall Study||0||
48612532|NCT04392219|101838292|FG013|NOT COMPLETED|Overall Study||0||
48612533|NCT04392219|101838293|FG014|NOT COMPLETED|Overall Study||0||
48612534|NCT04392219|101838294|FG015|NOT COMPLETED|Overall Study||0||
48612535|NCT04392219|101838295|FG016|NOT COMPLETED|Overall Study||0||
48612536|NCT04392219|101838296|FG017|NOT COMPLETED|Overall Study||0||
48612537|NCT04570709|101838297|FG000|STARTED|Overall Study||20||
48612538|NCT04570709|101838298|FG001|STARTED|Overall Study||18||
48612539|NCT04570709|101838299|FG002|STARTED|Overall Study||14||
48612540|NCT04570709|101838300|FG003|STARTED|Overall Study||15||
48612541|NCT04570709|101838297|FG000|COMPLETED|Overall Study||20||
48612542|NCT04570709|101838298|FG001|COMPLETED|Overall Study||18||
48612543|NCT04570709|101838299|FG002|COMPLETED|Overall Study||14||
48612544|NCT04570709|101838300|FG003|COMPLETED|Overall Study||13||
48612545|NCT04570709|101838297|FG000|NOT COMPLETED|Overall Study||0||
48612546|NCT04570709|101838298|FG001|NOT COMPLETED|Overall Study||0||
48612547|NCT04570709|101838299|FG002|NOT COMPLETED|Overall Study||0||
48612548|NCT04570709|101838300|FG003|NOT COMPLETED|Overall Study||2||
48612549|NCT02213380|101838301|FG000|STARTED|Underwent Randomization||476||
48612550|NCT02213380|101838302|FG001|STARTED|Underwent Randomization||474||
48612551|NCT02213380|101838301|FG000|COMPLETED|Underwent Randomization||471||
48612552|NCT02213380|101838302|FG001|COMPLETED|Underwent Randomization||471||
48612553|NCT02213380|101838301|FG000|NOT COMPLETED|Underwent Randomization||5||
48612554|NCT02213380|101838302|FG001|NOT COMPLETED|Underwent Randomization||3||
48612555|NCT02213380|101838301|FG000|STARTED|Per-protocol Analysis||471||
48612556|NCT02213380|101838302|FG001|STARTED|Per-protocol Analysis||471||
48612557|NCT02213380|101838301|FG000|COMPLETED|Per-protocol Analysis||439||
48612558|NCT02213380|101838302|FG001|COMPLETED|Per-protocol Analysis||435||
48612559|NCT02213380|101838301|FG000|NOT COMPLETED|Per-protocol Analysis||32||
48612560|NCT02213380|101838302|FG001|NOT COMPLETED|Per-protocol Analysis||36||
48612561|NCT00762034|101838303|FG000|STARTED|Induction Period||472||
48612562|NCT00762034|101838304|FG001|STARTED|Induction Period||467||
48612563|NCT00762034|101838303|FG000|Received at Least 1 Dose of Study Drug|Induction Period||442||
48612564|NCT00762034|101838304|FG001|Received at Least 1 Dose of Study Drug|Induction Period||443||
48612565|NCT00762034|101838303|FG000|COMPLETED|Induction Period||294||
48612566|NCT00762034|101838304|FG001|COMPLETED|Induction Period||298||
48612567|NCT00762034|101838303|FG000|NOT COMPLETED|Induction Period||178||
48612568|NCT00762034|101838304|FG001|NOT COMPLETED|Induction Period||169||
48725801|NCT04253587|102114965|FG001|Baseline T1|Overall Study||21||
48725802|NCT04253587|102114964|FG000|Post Training T2|Overall Study||21||
48725803|NCT04253587|102114965|FG001|Post Training T2|Overall Study||21||
48154541|NCT04493931|100699961|FG002|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0||
48154542|NCT04493931|100699962|FG003|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0||
48154543|NCT04493931|100699963|FG004|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0||
48154544|NCT04493931|100699964|FG005|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0||
48154545|NCT04493931|100699965|FG006|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0||
48154546|NCT04493931|100699959|FG000|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||0||
48154547|NCT04493931|100699960|FG001|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||0||
48154548|NCT04493931|100699961|FG002|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||0||
48154549|NCT04493931|100699962|FG003|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||0||
48154550|NCT04493931|100699963|FG004|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||6||
48154551|NCT04493931|100699964|FG005|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||5||
48154552|NCT04493931|100699965|FG006|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||3||
48154553|NCT04493931|100699959|FG000|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0||
48154554|NCT04493931|100699960|FG001|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0||
48154555|NCT04493931|100699961|FG002|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0||
48154556|NCT04493931|100699962|FG003|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0||
48154557|NCT04493931|100699963|FG004|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||6||
48154558|NCT04493931|100699964|FG005|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||5||
48154559|NCT04493931|100699965|FG006|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||3||
48154560|NCT04493931|100699959|FG000|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0||
48154561|NCT04493931|100699960|FG001|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0||
48154562|NCT04493931|100699961|FG002|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0||
48154563|NCT04493931|100699962|FG003|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0||
48154564|NCT04493931|100699963|FG004|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0||
48154565|NCT04493931|100699964|FG005|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0||
48154566|NCT04493931|100699965|FG006|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0||
48154567|NCT04493931|100699959|FG000|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||0||
48154568|NCT04493931|100699960|FG001|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||0||
48154569|NCT04493931|100699961|FG002|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||0||
48154570|NCT04493931|100699962|FG003|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||0||
48154571|NCT04493931|100699963|FG004|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||6||
48154572|NCT04493931|100699964|FG005|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||5||
48154573|NCT04493931|100699965|FG006|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||3||
48154574|NCT04493931|100699959|FG000|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0||
48154575|NCT04493931|100699960|FG001|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0||
48154576|NCT04493931|100699961|FG002|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0||
48154577|NCT04493931|100699962|FG003|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0||
48154578|NCT04493931|100699963|FG004|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||6||
48154579|NCT04493931|100699964|FG005|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||5||
48310259|NCT00744211|101084806|FG002|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0||
48310260|NCT00744211|101084804|FG000|STARTED|6 Hours After Cardiopulmonary Bypass||10||
48310261|NCT00744211|101084805|FG001|STARTED|6 Hours After Cardiopulmonary Bypass||9||
48310262|NCT00744211|101084806|FG002|STARTED|6 Hours After Cardiopulmonary Bypass||10||
48310263|NCT00744211|101084804|FG000|COMPLETED|6 Hours After Cardiopulmonary Bypass||10||
48725804|NCT04253587|102114964|FG000|COMPLETED|Overall Study||21||
48725805|NCT04253587|102114965|FG001|COMPLETED|Overall Study||21||
48154580|NCT04493931|100699965|FG006|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||3||
48154581|NCT04493931|100699959|FG000|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0||
48154582|NCT04493931|100699960|FG001|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0||
48154583|NCT04493931|100699961|FG002|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0||
48154584|NCT04493931|100699962|FG003|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0||
48154585|NCT04493931|100699963|FG004|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0||
48154586|NCT04493931|100699964|FG005|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0||
48310264|NCT00744211|101084805|FG001|COMPLETED|6 Hours After Cardiopulmonary Bypass||9||
48310265|NCT00744211|101084806|FG002|COMPLETED|6 Hours After Cardiopulmonary Bypass||10||
48310266|NCT00744211|101084804|FG000|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0||
48310267|NCT00744211|101084805|FG001|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0||
48310268|NCT00744211|101084806|FG002|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0||
48725806|NCT04253587|102114964|FG000|NOT COMPLETED|Overall Study||4||
48725807|NCT04253587|102114965|FG001|NOT COMPLETED|Overall Study||4||
48725808|NCT04896593|102114966|FG000|STARTED|Overall Study||22||
48725809|NCT04896593|102114966|FG000|COMPLETED|Overall Study||17||
48725810|NCT04896593|102114966|FG000|NOT COMPLETED|Overall Study||5||
48154587|NCT04493931|100699965|FG006|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0||
48154588|NCT04493931|100699959|FG000|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||0||
48725811|NCT02092311|102114967|FG000|STARTED|Overall Study||285||
48725812|NCT02092311|102114968|FG001|STARTED|Overall Study||285||
48310269|NCT00744211|101084804|FG000|STARTED|12 Hours After Cardiopulmonary Bypass||10||
48154589|NCT04493931|100699960|FG001|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||0||
48154590|NCT04493931|100699961|FG002|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||0||
48154591|NCT04493931|100699962|FG003|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||0||
48154592|NCT04493931|100699963|FG004|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||6||
48154593|NCT04493931|100699964|FG005|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||5||
48154594|NCT04493931|100699965|FG006|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||3||
48154595|NCT04493931|100699959|FG000|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0||
48154596|NCT04493931|100699960|FG001|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0||
48154597|NCT04493931|100699961|FG002|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0||
48154598|NCT04493931|100699962|FG003|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0||
48154599|NCT04493931|100699963|FG004|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||6||
48154600|NCT04493931|100699964|FG005|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||5||
48154601|NCT04493931|100699965|FG006|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||3||
48154602|NCT04493931|100699959|FG000|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0||
48154603|NCT04493931|100699960|FG001|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0||
48310270|NCT00744211|101084805|FG001|STARTED|12 Hours After Cardiopulmonary Bypass||9||
48310271|NCT00744211|101084806|FG002|STARTED|12 Hours After Cardiopulmonary Bypass||10||
48310272|NCT00744211|101084804|FG000|COMPLETED|12 Hours After Cardiopulmonary Bypass||10||
48310273|NCT00744211|101084805|FG001|COMPLETED|12 Hours After Cardiopulmonary Bypass||9||
48310274|NCT00744211|101084806|FG002|COMPLETED|12 Hours After Cardiopulmonary Bypass||10||
48310275|NCT00744211|101084804|FG000|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0||
48310276|NCT00744211|101084805|FG001|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0||
48310277|NCT00744211|101084806|FG002|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0||
48310278|NCT00744211|101084804|FG000|STARTED|24 Hours After Cardiopulmonary Bypass||10||
48310279|NCT00744211|101084805|FG001|STARTED|24 Hours After Cardiopulmonary Bypass||9||
48310280|NCT00744211|101084806|FG002|STARTED|24 Hours After Cardiopulmonary Bypass||10||
48310281|NCT00744211|101084804|FG000|COMPLETED|24 Hours After Cardiopulmonary Bypass||10||
48310282|NCT00744211|101084805|FG001|COMPLETED|24 Hours After Cardiopulmonary Bypass||9||
48310283|NCT00744211|101084806|FG002|COMPLETED|24 Hours After Cardiopulmonary Bypass||10||
48310284|NCT00744211|101084804|FG000|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0||
48310285|NCT00744211|101084805|FG001|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0||
48310286|NCT00744211|101084806|FG002|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0||
48310287|NCT01069120|101084807|FG000|STARTED|Overall Study||27||
48310288|NCT01069120|101084807|FG000|COMPLETED|Overall Study||0||
48310289|NCT01069120|101084807|FG000|NOT COMPLETED|Overall Study||27||
48310290|NCT00117507|101084808|FG000|STARTED|Overall Study||24||
48310291|NCT00117507|101084808|FG000|COMPLETED|Overall Study||9||
48310292|NCT00117507|101084808|FG000|NOT COMPLETED|Overall Study||15||
48310293|NCT01473563|101084809|FG000|STARTED|Overall Study||52||
48310294|NCT01473563|101084809|FG000|Received at Least 1 Dose of Study Drug|Overall Study||52||
48310295|NCT01473563|101084809|FG000|COMPLETED|Overall Study||51||
48310296|NCT01473563|101084809|FG000|NOT COMPLETED|Overall Study||1||
48310297|NCT01401842|101084810|FG000|STARTED|Overall Study||298||
48310298|NCT01401842|101084811|FG001|STARTED|Overall Study||284||
48310299|NCT01401842|101084810|FG000|COMPLETED|Overall Study||230||
48310300|NCT01401842|101084811|FG001|COMPLETED|Overall Study||217||
48310301|NCT01401842|101084810|FG000|NOT COMPLETED|Overall Study||68||
48154604|NCT04493931|100699961|FG002|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0||
48154605|NCT04493931|100699962|FG003|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0||
48154606|NCT04493931|100699963|FG004|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0||
48154607|NCT04493931|100699964|FG005|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0||
48154608|NCT04493931|100699965|FG006|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0||
48154609|NCT04493931|100699959|FG000|STARTED|Cohort 4: Follow-up (Up to 7 Days)||0||
48154610|NCT04493931|100699960|FG001|STARTED|Cohort 4: Follow-up (Up to 7 Days)||0||
48154611|NCT04493931|100699961|FG002|STARTED|Cohort 4: Follow-up (Up to 7 Days)||0||
48154612|NCT04493931|100699962|FG003|STARTED|Cohort 4: Follow-up (Up to 7 Days)||0||
48154613|NCT04493931|100699963|FG004|STARTED|Cohort 4: Follow-up (Up to 7 Days)||6||
48154614|NCT04493931|100699964|FG005|STARTED|Cohort 4: Follow-up (Up to 7 Days)||5||
48154615|NCT04493931|100699965|FG006|STARTED|Cohort 4: Follow-up (Up to 7 Days)||3||
48154616|NCT04493931|100699959|FG000|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0||
48154617|NCT04493931|100699960|FG001|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0||
48154618|NCT04493931|100699961|FG002|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0||
48154619|NCT04493931|100699962|FG003|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0||
48154620|NCT04493931|100699963|FG004|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||6||
48154621|NCT04493931|100699964|FG005|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||5||
48154622|NCT04493931|100699965|FG006|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||3||
48154623|NCT04493931|100699959|FG000|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0||
48154624|NCT04493931|100699960|FG001|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0||
48154625|NCT04493931|100699961|FG002|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0||
48154626|NCT04493931|100699962|FG003|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0||
48154627|NCT04493931|100699963|FG004|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0||
48154628|NCT04493931|100699964|FG005|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0||
48154629|NCT04493931|100699965|FG006|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0||
48154630|NCT00265980|100699966|FG000|STARTED|Overall Study||22||
48154631|NCT00265980|100699966|FG000|Weight Initial|Overall Study||22||
48154632|NCT00265980|100699966|FG000|Weight -10% Placebo|Overall Study||22||
48154633|NCT00265980|100699966|FG000|Weight -10% Leptin|Overall Study||22||
48154634|NCT00265980|100699966|FG000|COMPLETED|Overall Study||22||
48154635|NCT00265980|100699966|FG000|NOT COMPLETED|Overall Study||0||
48154636|NCT01266850|100699967|FG000|STARTED|Overall Study||242||
48154637|NCT01266850|100699968|FG001|STARTED|Overall Study||248||
48154638|NCT01266850|100699969|FG002|STARTED|Overall Study||238||
48154639|NCT01266850|100699970|FG003|STARTED|Overall Study||329||
48154640|NCT01266850|100699971|FG004|STARTED|Overall Study||327||
48154641|NCT01266850|100699967|FG000|Received Second Vaccine|Overall Study||231||
48154642|NCT01266850|100699968|FG001|Received Second Vaccine|Overall Study||233||
48154643|NCT01266850|100699969|FG002|Received Second Vaccine|Overall Study||227||
48154644|NCT01266850|100699970|FG003|Received Second Vaccine|Overall Study||311||
48154645|NCT01266850|100699971|FG004|Received Second Vaccine|Overall Study||307||
48154646|NCT01266850|100699967|FG000|Received Third Vaccine|Overall Study||221||
48154647|NCT01266850|100699968|FG001|Received Third Vaccine|Overall Study||221||
48154648|NCT01266850|100699969|FG002|Received Third Vaccine|Overall Study||217||
48154649|NCT01266850|100699970|FG003|Received Third Vaccine|Overall Study||0||
48154650|NCT01266850|100699971|FG004|Received Third Vaccine|Overall Study||299||
48154651|NCT01266850|100699967|FG000|COMPLETED|Overall Study||212||
48154652|NCT01266850|100699968|FG001|COMPLETED|Overall Study||212||
48154653|NCT01266850|100699969|FG002|COMPLETED|Overall Study||214||
48154654|NCT01266850|100699970|FG003|COMPLETED|Overall Study||301||
48154655|NCT01266850|100699971|FG004|COMPLETED|Overall Study||297||
48154656|NCT01266850|100699967|FG000|NOT COMPLETED|Overall Study||30||
48154657|NCT01266850|100699968|FG001|NOT COMPLETED|Overall Study||36||
48154658|NCT01266850|100699969|FG002|NOT COMPLETED|Overall Study||24||
48154659|NCT01266850|100699970|FG003|NOT COMPLETED|Overall Study||28||
48154660|NCT01266850|100699971|FG004|NOT COMPLETED|Overall Study||30||
48154661|NCT04279314|100699972|FG000|STARTED|Overall Study||154||
48154662|NCT04279314|100699972|FG000|COMPLETED|Overall Study||84||
48154663|NCT04279314|100699972|FG000|NOT COMPLETED|Overall Study||70||
48154664|NCT01160848|100699973|FG000|STARTED|Overall Study||12||
48154665|NCT01160848|100699974|FG001|STARTED|Overall Study||8||
48154666|NCT01160848|100699973|FG000|COMPLETED|Overall Study||12||
48154667|NCT01160848|100699974|FG001|COMPLETED|Overall Study||8||
48154668|NCT01160848|100699973|FG000|NOT COMPLETED|Overall Study||0||
48154669|NCT01160848|100699974|FG001|NOT COMPLETED|Overall Study||0||
48154670|NCT02492854|100699975|FG000|STARTED|Overall Study||5||
48154671|NCT02492854|100699976|FG001|STARTED|Overall Study||3||
48154672|NCT02492854|100699975|FG000|COMPLETED|Overall Study||5||
48154673|NCT02492854|100699976|FG001|COMPLETED|Overall Study||3||
48310302|NCT01401842|101084811|FG001|NOT COMPLETED|Overall Study||67||
48310303|NCT01101438|101084812|FG000|STARTED|Overall Study||1824||
48310304|NCT01101438|101084813|FG001|STARTED|Overall Study||1825||
48154674|NCT02492854|100699975|FG000|NOT COMPLETED|Overall Study||0||
48154675|NCT02492854|100699976|FG001|NOT COMPLETED|Overall Study||0||
48154676|NCT02298361|100699977|FG000|STARTED|Overall Study||2240||
48154677|NCT02298361|100699978|FG001|STARTED|Overall Study||12784||
48310305|NCT01101438|101084812|FG000|COMPLETED|Overall Study||1816||
48310306|NCT01101438|101084813|FG001|COMPLETED|Overall Study||1816||
48154678|NCT02298361|100699979|FG002|STARTED|Overall Study||12227||
48154679|NCT02298361|100699977|FG000|COMPLETED|Overall Study||2240||
48154680|NCT02298361|100699978|FG001|COMPLETED|Overall Study||12784||
48154681|NCT02298361|100699979|FG002|COMPLETED|Overall Study||12227||
48154682|NCT02298361|100699977|FG000|NOT COMPLETED|Overall Study||0||
48154683|NCT02298361|100699978|FG001|NOT COMPLETED|Overall Study||0||
48154684|NCT02298361|100699979|FG002|NOT COMPLETED|Overall Study||0||
48310307|NCT01101438|101084812|FG000|NOT COMPLETED|Overall Study||8||
48310308|NCT01101438|101084813|FG001|NOT COMPLETED|Overall Study||9||
48310309|NCT01422356|101084814|FG000|STARTED|Overall Study||200||
48310310|NCT01422356|101084814|FG000|COMPLETED|Overall Study||169||
48310311|NCT01422356|101084814|FG000|NOT COMPLETED|Overall Study||31||
48310312|NCT01848353|101084815|FG000|STARTED|Phase 1||38||
48154685|NCT02658630|100699980|FG000|STARTED|Overall Study||46||
48154686|NCT02658630|100699980|FG000|COMPLETED|Overall Study||42||
48154687|NCT02658630|100699980|FG000|NOT COMPLETED|Overall Study||4||
48154688|NCT02606279|100699981|FG000|STARTED|Overall Study||0||
48154689|NCT02606279|100699982|FG001|STARTED|Overall Study||1||
48154690|NCT02606279|100699981|FG000|COMPLETED|Overall Study||0||
48154691|NCT02606279|100699982|FG001|COMPLETED|Overall Study||0||
48154692|NCT02606279|100699981|FG000|NOT COMPLETED|Overall Study||0||
48154693|NCT02606279|100699982|FG001|NOT COMPLETED|Overall Study||1||
48154694|NCT01705496|100699983|FG000|STARTED|Overall Study||23||
48154695|NCT01705496|100699983|FG000|COMPLETED|Overall Study||19||
48154696|NCT01705496|100699983|FG000|NOT COMPLETED|Overall Study||4||
48154697|NCT00415610|100699984|FG000|STARTED|Overall Study||18||
48154698|NCT00415610|100699985|FG001|STARTED|Overall Study||20||
48310313|NCT01848353|101084816|FG001|STARTED|Phase 1||43||
48154699|NCT00415610|100699986|FG002|STARTED|Overall Study||22||
48154700|NCT00415610|100699984|FG000|COMPLETED|Overall Study||15||
48154701|NCT00415610|100699985|FG001|COMPLETED|Overall Study||18||
48154702|NCT00415610|100699986|FG002|COMPLETED|Overall Study||17||
48154703|NCT00415610|100699984|FG000|NOT COMPLETED|Overall Study||3||
48154704|NCT00415610|100699985|FG001|NOT COMPLETED|Overall Study||2||
48154705|NCT00415610|100699986|FG002|NOT COMPLETED|Overall Study||5||
48154706|NCT01250990|100699987|FG000|STARTED|Overall Study||11||
48154707|NCT01250990|100699988|FG001|STARTED|Overall Study||11||
48154708|NCT01250990|100699987|FG000|COMPLETED|Overall Study||7||
48154709|NCT01250990|100699988|FG001|COMPLETED|Overall Study||9||
48154710|NCT01250990|100699987|FG000|NOT COMPLETED|Overall Study||4||
48154711|NCT01250990|100699988|FG001|NOT COMPLETED|Overall Study||2||
48154712|NCT04027348|100699989|FG000|STARTED|Overall Study||15||
48154713|NCT04027348|100699989|FG000|COMPLETED|Overall Study||13||
48154714|NCT04027348|100699989|FG000|NOT COMPLETED|Overall Study||2||
48154715|NCT00855062|100699990|FG000|STARTED|Step1||36||
48154716|NCT00855062|100699991|FG001|STARTED|Step1||37||
48154717|NCT00855062|100699990|FG000|COMPLETED|Step1||26||
48154718|NCT00855062|100699991|FG001|COMPLETED|Step1||26||
48154719|NCT00855062|100699990|FG000|NOT COMPLETED|Step1||10||
48154720|NCT00855062|100699991|FG001|NOT COMPLETED|Step1||11||
48154721|NCT00855062|100699990|FG000|STARTED|Step2||19||
48154722|NCT00855062|100699991|FG001|STARTED|Step2||21||
48310314|NCT01848353|101084817|FG002|STARTED|Phase 1||20||
48310315|NCT01848353|101084818|FG003|STARTED|Phase 1||19||
48310316|NCT01848353|101084815|FG000|COMPLETED|Phase 1||35||
48310317|NCT01848353|101084816|FG001|COMPLETED|Phase 1||42||
48310318|NCT01848353|101084817|FG002|COMPLETED|Phase 1||20||
48310319|NCT01848353|101084818|FG003|COMPLETED|Phase 1||19||
48310320|NCT01848353|101084815|FG000|NOT COMPLETED|Phase 1||3||
48310321|NCT01848353|101084816|FG001|NOT COMPLETED|Phase 1||1||
48310322|NCT01848353|101084817|FG002|NOT COMPLETED|Phase 1||0||
48310323|NCT01848353|101084818|FG003|NOT COMPLETED|Phase 1||0||
48310324|NCT01848353|101084815|FG000|STARTED|Phase 2||23||
48154723|NCT00855062|100699990|FG000|COMPLETED|Step2||13||
48154724|NCT00855062|100699991|FG001|COMPLETED|Step2||15||
48154725|NCT00855062|100699990|FG000|NOT COMPLETED|Step2||6||
48154726|NCT00855062|100699991|FG001|NOT COMPLETED|Step2||6||
48154727|NCT04398537|100699992|FG000|STARTED|Overall Study||112||
48154728|NCT04398537|100699993|FG001|STARTED|Overall Study||133||
48154729|NCT04398537|100699992|FG000|COMPLETED|Overall Study||102||
48154730|NCT04398537|100699993|FG001|COMPLETED|Overall Study||118||
48154731|NCT04398537|100699992|FG000|NOT COMPLETED|Overall Study||10||
48154732|NCT04398537|100699993|FG001|NOT COMPLETED|Overall Study||15||
48154733|NCT03308825|100699994|FG000|STARTED|Overall Study||59||
48154734|NCT03308825|100699995|FG001|STARTED|Overall Study||61||
48154735|NCT03308825|100699996|FG002|STARTED|Overall Study||60||
48154736|NCT03308825|100699997|FG003|STARTED|Overall Study||60||
48154737|NCT03308825|100699994|FG000|COMPLETED|Overall Study||57||
48154738|NCT03308825|100699995|FG001|COMPLETED|Overall Study||57||
48154739|NCT03308825|100699996|FG002|COMPLETED|Overall Study||59||
48154740|NCT03308825|100699997|FG003|COMPLETED|Overall Study||60||
48154741|NCT03308825|100699994|FG000|NOT COMPLETED|Overall Study||2||
48154742|NCT03308825|100699995|FG001|NOT COMPLETED|Overall Study||4||
48154743|NCT03308825|100699996|FG002|NOT COMPLETED|Overall Study||1||
48154744|NCT03308825|100699997|FG003|NOT COMPLETED|Overall Study||0||
48154745|NCT02216773|100699998|FG000|STARTED|Overall Study||28||
48154746|NCT02216773|100699999|FG001|STARTED|Overall Study||29||
48154747|NCT02216773|100699998|FG000|Underwent Procedure (PVE/RALPPS)|Overall Study||24||
48154748|NCT02216773|100699999|FG001|Underwent Procedure (PVE/RALPPS)|Overall Study||26||
48154749|NCT02216773|100699998|FG000|COMPLETED|Overall Study||16||
48154750|NCT02216773|100699999|FG001|COMPLETED|Overall Study||24||
48154751|NCT02216773|100699998|FG000|NOT COMPLETED|Overall Study||12||
48154752|NCT02216773|100699999|FG001|NOT COMPLETED|Overall Study||5||
48154753|NCT01505387|100700000|FG000|STARTED|Overall Study||25||
48154754|NCT01505387|100700001|FG001|STARTED|Overall Study||25||
48154755|NCT01505387|100700000|FG000|Treated|Overall Study||24||
48154756|NCT01505387|100700001|FG001|Treated|Overall Study||24||
48154757|NCT01505387|100700000|FG000|COMPLETED|Overall Study||23||
48154758|NCT01505387|100700001|FG001|COMPLETED|Overall Study||24||
48154759|NCT01505387|100700000|FG000|NOT COMPLETED|Overall Study||2||
48154760|NCT01505387|100700001|FG001|NOT COMPLETED|Overall Study||1||
48154761|NCT04179721|100700002|FG000|STARTED|Overall Study||22|Enrolled|
48154762|NCT04179721|100700003|FG001|STARTED|Overall Study||32|Enrolled|
48154763|NCT04179721|100700002|FG000|T1 - Baseline|Overall Study||16||
48154764|NCT04179721|100700003|FG001|T1 - Baseline|Overall Study||24||
48154765|NCT04179721|100700002|FG000|T2 - Post-Training|Overall Study||16||
48154766|NCT04179721|100700003|FG001|T2 - Post-Training|Overall Study||21||
48154767|NCT04179721|100700002|FG000|T3 - End of Intervention|Overall Study||11||
48154768|NCT04179721|100700003|FG001|T3 - End of Intervention|Overall Study||18||
48154769|NCT04179721|100700002|FG000|COMPLETED|Overall Study||11||
48154770|NCT04179721|100700003|FG001|COMPLETED|Overall Study||18||
48154771|NCT04179721|100700002|FG000|NOT COMPLETED|Overall Study||11||
48154772|NCT04179721|100700003|FG001|NOT COMPLETED|Overall Study||14||
48154773|NCT01865708|100700004|FG000|STARTED|Overall Study||10||
48310325|NCT01848353|101084816|FG001|STARTED|Phase 2||28||
48154774|NCT01865708|100700004|FG000|COMPLETED|Overall Study||10||
48154775|NCT01865708|100700004|FG000|NOT COMPLETED|Overall Study||0||
48154776|NCT02080871|100700005|FG000|STARTED|Overall Study||134||
48154777|NCT02080871|100700005|FG000|COMPLETED|Overall Study||132|Completion of the primary outcome measure (9 months). The study is in long term follow-up.|
48154778|NCT02080871|100700005|FG000|NOT COMPLETED|Overall Study||2||
48154779|NCT03020225|100700006|FG000|STARTED|Overall Study||12||
48154780|NCT03020225|100700007|FG001|STARTED|Overall Study||11||
48154781|NCT03020225|100700008|FG002|STARTED|Overall Study||13||
48154782|NCT03020225|100700006|FG000|COMPLETED|Overall Study||12||
48154783|NCT03020225|100700007|FG001|COMPLETED|Overall Study||11||
48154784|NCT03020225|100700008|FG002|COMPLETED|Overall Study||13||
48154785|NCT03020225|100700006|FG000|NOT COMPLETED|Overall Study||0||
48154786|NCT03020225|100700007|FG001|NOT COMPLETED|Overall Study||0||
48154787|NCT03020225|100700008|FG002|NOT COMPLETED|Overall Study||0||
48154788|NCT00079001|100700009|FG000|STARTED|Overall Study||323||
48154789|NCT00079001|100700010|FG001|STARTED|Overall Study||322||
48154790|NCT00079001|100700009|FG000|COMPLETED|Overall Study||323||
48154791|NCT00079001|100700010|FG001|COMPLETED|Overall Study||322||
48154792|NCT00079001|100700009|FG000|NOT COMPLETED|Overall Study||0||
48154793|NCT00079001|100700010|FG001|NOT COMPLETED|Overall Study||0||
48154794|NCT02178566|100700011|FG000|STARTED|Overall Study||0|no data available|
48154795|NCT02178566|100700012|FG001|STARTED|Overall Study||1|no data available|
48154796|NCT02178566|100700011|FG000|COMPLETED|Overall Study||0|no data available|
48612569|NCT00762034|101838303|FG000|STARTED|Maintenance Period||294||
48612570|NCT00762034|101838304|FG001|STARTED|Maintenance Period||298||
48612571|NCT00762034|101838303|FG000|Received at Least 1 Dose of Study Drug|Maintenance Period||294||
48612572|NCT00762034|101838304|FG001|Received at Least 1 Dose of Study Drug|Maintenance Period||298||
48154797|NCT02178566|100700012|FG001|COMPLETED|Overall Study||0|no data available|
48154798|NCT02178566|100700011|FG000|NOT COMPLETED|Overall Study||0||
48154799|NCT02178566|100700012|FG001|NOT COMPLETED|Overall Study||1||
48154800|NCT01572389|100703003|FG000|STARTED|Overall Study||136||
48154801|NCT01572389|100703004|FG001|STARTED|Overall Study||89||
48154802|NCT01572389|100703003|FG000|COMPLETED|Overall Study||90||
48154803|NCT01572389|100703004|FG001|COMPLETED|Overall Study||68||
48154804|NCT01572389|100703003|FG000|NOT COMPLETED|Overall Study||46||
48154805|NCT01572389|100703004|FG001|NOT COMPLETED|Overall Study||21||
48154806|NCT04510675|100703005|FG000|STARTED|Overall Study||58||
48154807|NCT04510675|100703005|FG000|COMPLETED|Overall Study||53||
48154808|NCT04510675|100703005|FG000|NOT COMPLETED|Overall Study||5||
48154809|NCT02460692|100703006|FG000|STARTED|Overall Study||44||
48154810|NCT02460692|100703007|FG001|STARTED|Overall Study||43||
48154811|NCT02460692|100703008|FG002|STARTED|Overall Study||44||
48154812|NCT02460692|100703006|FG000|COMPLETED|Overall Study||29||
48154813|NCT02460692|100703007|FG001|COMPLETED|Overall Study||26||
48154814|NCT02460692|100703008|FG002|COMPLETED|Overall Study||36||
48154815|NCT02460692|100703006|FG000|NOT COMPLETED|Overall Study||15||
48154816|NCT02460692|100703007|FG001|NOT COMPLETED|Overall Study||17||
48154817|NCT02460692|100703008|FG002|NOT COMPLETED|Overall Study||8||
48154818|NCT01648348|100703009|FG000|STARTED|Overall Study||5||
48154819|NCT01648348|100703010|FG001|STARTED|Overall Study||3||
48154820|NCT01648348|100703011|FG002|STARTED|Overall Study||4||
48154821|NCT01648348|100703012|FG003|STARTED|Overall Study||3||
48154822|NCT01648348|100703013|FG004|STARTED|Overall Study||52||
48154823|NCT01648348|100703014|FG005|STARTED|Overall Study||49||
48154824|NCT01648348|100703009|FG000|COMPLETED|Overall Study||3||
48154825|NCT01648348|100703010|FG001|COMPLETED|Overall Study||3||
48154826|NCT01648348|100703011|FG002|COMPLETED|Overall Study||3||
48154827|NCT01648348|100703012|FG003|COMPLETED|Overall Study||3||
48154828|NCT01648348|100703013|FG004|COMPLETED|Overall Study||49||
48154829|NCT01648348|100703014|FG005|COMPLETED|Overall Study||43||
48154830|NCT01648348|100703009|FG000|NOT COMPLETED|Overall Study||2||
48154831|NCT01648348|100703010|FG001|NOT COMPLETED|Overall Study||0||
48154832|NCT01648348|100703011|FG002|NOT COMPLETED|Overall Study||1||
48154833|NCT01648348|100703012|FG003|NOT COMPLETED|Overall Study||0||
48154834|NCT01648348|100703013|FG004|NOT COMPLETED|Overall Study||3||
48154835|NCT01648348|100703014|FG005|NOT COMPLETED|Overall Study||6||
48154836|NCT02573402|100703015|FG000|STARTED|Overall Study||12||
48154837|NCT02573402|100703016|FG001|STARTED|Overall Study||7||
48154838|NCT02573402|100703015|FG000|COMPLETED|Overall Study||12||
48154839|NCT02573402|100703016|FG001|COMPLETED|Overall Study||7||
48154840|NCT02573402|100703015|FG000|NOT COMPLETED|Overall Study||0||
48154841|NCT02573402|100703016|FG001|NOT COMPLETED|Overall Study||0||
48154842|NCT00677235|100703017|FG000|STARTED|Overall Study||138||
48154843|NCT00677235|100703018|FG001|STARTED|Overall Study||132||
48154844|NCT00677235|100703017|FG000|COMPLETED|Overall Study||97||
48154845|NCT00677235|100703018|FG001|COMPLETED|Overall Study||94||
48154846|NCT00677235|100703017|FG000|NOT COMPLETED|Overall Study||41||
48154847|NCT00677235|100703018|FG001|NOT COMPLETED|Overall Study||38||
48154848|NCT03420781|100703019|FG000|STARTED|Treatment Period (40 Weeks)||236||
48154849|NCT03420781|100703020|FG001|STARTED|Treatment Period (40 Weeks)||231||
48154850|NCT03420781|100703021|FG002|STARTED|Treatment Period (40 Weeks)||0||
48154851|NCT03420781|100703022|FG003|STARTED|Treatment Period (40 Weeks)||0||
48612573|NCT00762034|101838303|FG000|COMPLETED|Maintenance Period||0||
48154852|NCT03420781|100703023|FG004|STARTED|Treatment Period (40 Weeks)||0||
48154853|NCT03420781|100703019|FG000|Safety Population|Treatment Period (40 Weeks)||235|Safety Population included all participants in the Intent-to-treat (ITT) population who received ≥1 administration of study treatment.|
48154854|NCT03420781|100703020|FG001|Safety Population|Treatment Period (40 Weeks)||231|Safety Population included all participants in the Intent-to-treat (ITT) population who received ≥1 administration of study treatment.|
48154855|NCT03420781|100703021|FG002|Safety Population|Treatment Period (40 Weeks)||0|Safety Population included all participants in the Intent-to-treat (ITT) population who received ≥1 administration of study treatment.|
48154856|NCT03420781|100703022|FG003|Safety Population|Treatment Period (40 Weeks)||0|Safety Population included all participants in the Intent-to-treat (ITT) population who received ≥1 administration of study treatment.|
48154857|NCT03420781|100703023|FG004|Safety Population|Treatment Period (40 Weeks)||0|Safety Population included all participants in the Intent-to-treat (ITT) population who received ≥1 administration of study treatment.|
48154858|NCT03420781|100703019|FG000|COMPLETED|Treatment Period (40 Weeks)||92|Out of 197 participants who completed the Treatment Period, 193 entered the RW Period.|
48154859|NCT03420781|100703020|FG001|COMPLETED|Treatment Period (40 Weeks)||105|Out of 197 participants who completed the Treatment Period, 193 entered the RW Period.|
48154860|NCT03420781|100703021|FG002|COMPLETED|Treatment Period (40 Weeks)||0|Out of 197 participants who completed the Treatment Period, 193 entered the RW Period.|
48154861|NCT03420781|100703022|FG003|COMPLETED|Treatment Period (40 Weeks)||0|Out of 197 participants who completed the Treatment Period, 193 entered the RW Period.|
48154862|NCT03420781|100703023|FG004|COMPLETED|Treatment Period (40 Weeks)||0|Out of 197 participants who completed the Treatment Period, 193 entered the RW Period.|
48154863|NCT03420781|100703019|FG000|NOT COMPLETED|Treatment Period (40 Weeks)||144||
48154864|NCT03420781|100703020|FG001|NOT COMPLETED|Treatment Period (40 Weeks)||126||
48154865|NCT03420781|100703021|FG002|NOT COMPLETED|Treatment Period (40 Weeks)||0||
48154866|NCT03420781|100703022|FG003|NOT COMPLETED|Treatment Period (40 Weeks)||0||
48154867|NCT03420781|100703023|FG004|NOT COMPLETED|Treatment Period (40 Weeks)||0||
48154868|NCT03420781|100703019|FG000|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||0||
48154869|NCT03420781|100703020|FG001|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||0||
48154870|NCT03420781|100703021|FG002|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||91||
48154871|NCT03420781|100703022|FG003|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||59||
48154872|NCT03420781|100703023|FG004|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||43||
48154873|NCT03420781|100703019|FG000|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0||
48154874|NCT03420781|100703020|FG001|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0||
48154875|NCT03420781|100703021|FG002|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||85||
48154876|NCT03420781|100703022|FG003|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||54||
48154877|NCT03420781|100703023|FG004|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||38||
48154878|NCT03420781|100703019|FG000|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0||
48154879|NCT03420781|100703020|FG001|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0||
48154880|NCT03420781|100703021|FG002|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||6||
48154881|NCT03420781|100703022|FG003|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||5||
48154882|NCT03420781|100703023|FG004|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||5||
48154883|NCT02612064|100703024|FG000|STARTED|Overall Study||115||
48154884|NCT02612064|100703025|FG001|STARTED|Overall Study||115||
48154885|NCT02612064|100703024|FG000|COMPLETED|Overall Study||114||
48154886|NCT02612064|100703025|FG001|COMPLETED|Overall Study||112||
48154887|NCT02612064|100703024|FG000|NOT COMPLETED|Overall Study||1||
48154888|NCT02612064|100703025|FG001|NOT COMPLETED|Overall Study||3||
48154889|NCT02719990|100703026|FG000|STARTED|Overall Study||36||
48154890|NCT02719990|100703026|FG000|Received at Least 1 Dose of Study Drug|Overall Study||36||
48154891|NCT02719990|100703026|FG000|COMPLETED|Overall Study||0||
48154892|NCT02719990|100703026|FG000|NOT COMPLETED|Overall Study||36||
48154893|NCT00948298|100703027|FG000|STARTED|Overall Study||65||
48154894|NCT00948298|100703028|FG001|STARTED|Overall Study||65||
48154895|NCT00948298|100703027|FG000|COMPLETED|Overall Study||55||
48154896|NCT00948298|100703028|FG001|COMPLETED|Overall Study||60||
48154897|NCT00948298|100703027|FG000|NOT COMPLETED|Overall Study||10||
48154898|NCT00948298|100703028|FG001|NOT COMPLETED|Overall Study||5||
48154899|NCT01904864|100703029|FG000|STARTED|Overall Study||40||
48154900|NCT01904864|100703030|FG001|STARTED|Overall Study||40||
48154901|NCT01904864|100703029|FG000|COMPLETED|Overall Study||31||
48154902|NCT01904864|100703030|FG001|COMPLETED|Overall Study||28||
48154903|NCT01904864|100703029|FG000|NOT COMPLETED|Overall Study||9||
48154904|NCT01904864|100703030|FG001|NOT COMPLETED|Overall Study||12||
48154905|NCT00560612|100703031|FG000|STARTED|Overall Study||5||
48154906|NCT00560612|100703032|FG001|STARTED|Overall Study||7||
48154907|NCT00560612|100703031|FG000|COMPLETED|Overall Study||5||
48154908|NCT00560612|100703032|FG001|COMPLETED|Overall Study||7||
48154909|NCT00560612|100703031|FG000|NOT COMPLETED|Overall Study||0||
48154910|NCT00560612|100703032|FG001|NOT COMPLETED|Overall Study||0||
48154911|NCT02686034|100703033|FG000|STARTED|Run-In Period 1||142||
48154912|NCT02686034|100703034|FG001|STARTED|Run-In Period 1||143||
48154913|NCT02686034|100703033|FG000|COMPLETED|Run-In Period 1||122||
48154914|NCT02686034|100703034|FG001|COMPLETED|Run-In Period 1||126||
48154915|NCT02686034|100703033|FG000|NOT COMPLETED|Run-In Period 1||20||
48154916|NCT02686034|100703034|FG001|NOT COMPLETED|Run-In Period 1||17||
48154917|NCT02686034|100703033|FG000|STARTED|Randomized Controlled Period 2||122||
48154918|NCT02686034|100703034|FG001|STARTED|Randomized Controlled Period 2||126||
48154919|NCT02686034|100703033|FG000|COMPLETED|Randomized Controlled Period 2||117||
48154920|NCT02686034|100703034|FG001|COMPLETED|Randomized Controlled Period 2||122||
48154921|NCT02686034|100703033|FG000|NOT COMPLETED|Randomized Controlled Period 2||5||
48154922|NCT02686034|100703034|FG001|NOT COMPLETED|Randomized Controlled Period 2||4||
48154923|NCT02686034|100703033|FG000|STARTED|Open Label Period 3||117||
48154924|NCT02686034|100703034|FG001|STARTED|Open Label Period 3||122||
48154925|NCT02686034|100703033|FG000|COMPLETED|Open Label Period 3||117||
48154926|NCT02686034|100703034|FG001|COMPLETED|Open Label Period 3||121||
48154927|NCT02686034|100703033|FG000|NOT COMPLETED|Open Label Period 3||0||
48154928|NCT02686034|100703034|FG001|NOT COMPLETED|Open Label Period 3||1||
48154929|NCT04225533|100703035|FG000|STARTED|Overall Study||10||
48154930|NCT04225533|100703035|FG000|COMPLETED|Overall Study||10||
48154931|NCT04225533|100703035|FG000|NOT COMPLETED|Overall Study||0||
48154932|NCT01044576|100703036|FG000|STARTED|Overall Study||200||
48154933|NCT01044576|100703036|FG000|COMPLETED|Overall Study||200||
48154934|NCT01044576|100703036|FG000|NOT COMPLETED|Overall Study||0||
48154935|NCT04108000|100703037|FG000|STARTED|Overall Study||9||
48154936|NCT04108000|100703038|FG001|STARTED|Overall Study||9||
48154937|NCT04108000|100703039|FG002|STARTED|Overall Study||10||
48154938|NCT04108000|100703040|FG003|STARTED|Overall Study||10||
48154939|NCT04108000|100703037|FG000|COMPLETED|Overall Study||6||
48154940|NCT04108000|100703038|FG001|COMPLETED|Overall Study||6||
48154941|NCT04108000|100703039|FG002|COMPLETED|Overall Study||9||
48154942|NCT04108000|100703040|FG003|COMPLETED|Overall Study||9||
48154943|NCT04108000|100703037|FG000|NOT COMPLETED|Overall Study||3||
48154944|NCT04108000|100703038|FG001|NOT COMPLETED|Overall Study||3||
48154945|NCT04108000|100703039|FG002|NOT COMPLETED|Overall Study||1||
48154946|NCT04108000|100703040|FG003|NOT COMPLETED|Overall Study||1||
48154947|NCT03286751|100703041|FG000|STARTED|Period 1||7||
48154948|NCT03286751|100703042|FG001|STARTED|Period 1||7||
48154949|NCT03286751|100703043|FG002|STARTED|Period 1||7||
48154950|NCT03286751|100703044|FG003|STARTED|Period 1||7||
48154951|NCT03286751|100703045|FG004|STARTED|Period 1||7||
48154952|NCT03286751|100703046|FG005|STARTED|Period 1||7||
48154953|NCT03286751|100703041|FG000|Received at Least One Dose of Study Drug|Period 1||7||
48154954|NCT03286751|100703042|FG001|Received at Least One Dose of Study Drug|Period 1||7||
48154955|NCT03286751|100703043|FG002|Received at Least One Dose of Study Drug|Period 1||7||
48154956|NCT03286751|100703044|FG003|Received at Least One Dose of Study Drug|Period 1||7||
48154957|NCT03286751|100703045|FG004|Received at Least One Dose of Study Drug|Period 1||7||
48154958|NCT03286751|100703046|FG005|Received at Least One Dose of Study Drug|Period 1||7||
48154959|NCT03286751|100703041|FG000|COMPLETED|Period 1||7||
48154960|NCT03286751|100703042|FG001|COMPLETED|Period 1||7||
48154961|NCT03286751|100703043|FG002|COMPLETED|Period 1||7||
48154962|NCT03286751|100703044|FG003|COMPLETED|Period 1||7||
48154963|NCT03286751|100703045|FG004|COMPLETED|Period 1||7||
48154964|NCT03286751|100703046|FG005|COMPLETED|Period 1||7||
48154965|NCT03286751|100703041|FG000|NOT COMPLETED|Period 1||0||
48154966|NCT03286751|100703042|FG001|NOT COMPLETED|Period 1||0||
48154967|NCT03286751|100703043|FG002|NOT COMPLETED|Period 1||0||
48154968|NCT03286751|100703044|FG003|NOT COMPLETED|Period 1||0||
48154969|NCT03286751|100703045|FG004|NOT COMPLETED|Period 1||0||
48154970|NCT03286751|100703046|FG005|NOT COMPLETED|Period 1||0||
48154971|NCT03286751|100703041|FG000|STARTED|Washout Period 1||7||
48154972|NCT03286751|100703042|FG001|STARTED|Washout Period 1||7||
48154973|NCT03286751|100703043|FG002|STARTED|Washout Period 1||7||
48154974|NCT03286751|100703044|FG003|STARTED|Washout Period 1||7||
48154975|NCT03286751|100703045|FG004|STARTED|Washout Period 1||7||
48154976|NCT03286751|100703046|FG005|STARTED|Washout Period 1||7||
48154977|NCT03286751|100703041|FG000|COMPLETED|Washout Period 1||7||
48154978|NCT03286751|100703042|FG001|COMPLETED|Washout Period 1||7||
48154979|NCT03286751|100703043|FG002|COMPLETED|Washout Period 1||7||
48154980|NCT03286751|100703044|FG003|COMPLETED|Washout Period 1||7||
48154981|NCT03286751|100703045|FG004|COMPLETED|Washout Period 1||6||
48154982|NCT03286751|100703046|FG005|COMPLETED|Washout Period 1||7||
48154983|NCT03286751|100703041|FG000|NOT COMPLETED|Washout Period 1||0||
48154984|NCT03286751|100703042|FG001|NOT COMPLETED|Washout Period 1||0||
48154985|NCT03286751|100703043|FG002|NOT COMPLETED|Washout Period 1||0||
48154986|NCT03286751|100703044|FG003|NOT COMPLETED|Washout Period 1||0||
48154987|NCT03286751|100703045|FG004|NOT COMPLETED|Washout Period 1||1||
48154988|NCT03286751|100703046|FG005|NOT COMPLETED|Washout Period 1||0||
48154989|NCT03286751|100703041|FG000|STARTED|Period 2||7||
48154990|NCT03286751|100703042|FG001|STARTED|Period 2||7||
48154991|NCT03286751|100703043|FG002|STARTED|Period 2||7||
48154992|NCT03286751|100703044|FG003|STARTED|Period 2||7||
48154993|NCT03286751|100703045|FG004|STARTED|Period 2||6||
48154994|NCT03286751|100703046|FG005|STARTED|Period 2||7||
48154995|NCT03286751|100703041|FG000|COMPLETED|Period 2||7||
48154996|NCT03286751|100703042|FG001|COMPLETED|Period 2||7||
48154997|NCT03286751|100703043|FG002|COMPLETED|Period 2||7||
48154998|NCT03286751|100703044|FG003|COMPLETED|Period 2||7||
48154999|NCT03286751|100703045|FG004|COMPLETED|Period 2||6||
48155000|NCT03286751|100703046|FG005|COMPLETED|Period 2||7||
48155001|NCT03286751|100703041|FG000|NOT COMPLETED|Period 2||0||
48155002|NCT03286751|100703042|FG001|NOT COMPLETED|Period 2||0||
48155003|NCT03286751|100703043|FG002|NOT COMPLETED|Period 2||0||
48155004|NCT03286751|100703044|FG003|NOT COMPLETED|Period 2||0||
48155005|NCT03286751|100703045|FG004|NOT COMPLETED|Period 2||0||
48155006|NCT03286751|100703046|FG005|NOT COMPLETED|Period 2||0||
48155007|NCT03286751|100703041|FG000|STARTED|Washout Period 2||7||
48155008|NCT03286751|100703042|FG001|STARTED|Washout Period 2||7||
48155009|NCT03286751|100703043|FG002|STARTED|Washout Period 2||7||
48155010|NCT03286751|100703044|FG003|STARTED|Washout Period 2||7||
48155011|NCT03286751|100703045|FG004|STARTED|Washout Period 2||6||
48155012|NCT03286751|100703046|FG005|STARTED|Washout Period 2||7||
48155013|NCT03286751|100703041|FG000|COMPLETED|Washout Period 2||7||
48155014|NCT03286751|100703042|FG001|COMPLETED|Washout Period 2||6||
48155015|NCT03286751|100703043|FG002|COMPLETED|Washout Period 2||7||
48155016|NCT03286751|100703044|FG003|COMPLETED|Washout Period 2||7||
48155017|NCT03286751|100703045|FG004|COMPLETED|Washout Period 2||6||
48155018|NCT03286751|100703046|FG005|COMPLETED|Washout Period 2||7||
48155019|NCT03286751|100703041|FG000|NOT COMPLETED|Washout Period 2||0||
48155020|NCT03286751|100703042|FG001|NOT COMPLETED|Washout Period 2||1||
48155021|NCT03286751|100703043|FG002|NOT COMPLETED|Washout Period 2||0||
48155022|NCT03286751|100703044|FG003|NOT COMPLETED|Washout Period 2||0||
48155023|NCT03286751|100703045|FG004|NOT COMPLETED|Washout Period 2||0||
48155024|NCT03286751|100703046|FG005|NOT COMPLETED|Washout Period 2||0||
48155025|NCT03286751|100703041|FG000|STARTED|Period 3||7||
48155026|NCT03286751|100703042|FG001|STARTED|Period 3||6||
48155027|NCT03286751|100703043|FG002|STARTED|Period 3||7||
48155028|NCT03286751|100703044|FG003|STARTED|Period 3||7||
48155029|NCT03286751|100703045|FG004|STARTED|Period 3||6||
48155030|NCT03286751|100703046|FG005|STARTED|Period 3||7||
48155031|NCT03286751|100703041|FG000|COMPLETED|Period 3||7||
48155032|NCT03286751|100703042|FG001|COMPLETED|Period 3||6||
48155033|NCT03286751|100703043|FG002|COMPLETED|Period 3||7||
48155034|NCT03286751|100703044|FG003|COMPLETED|Period 3||7||
48155035|NCT03286751|100703045|FG004|COMPLETED|Period 3||6||
48155036|NCT03286751|100703046|FG005|COMPLETED|Period 3||7||
48155037|NCT03286751|100703041|FG000|NOT COMPLETED|Period 3||0||
48155038|NCT03286751|100703042|FG001|NOT COMPLETED|Period 3||0||
48155039|NCT03286751|100703043|FG002|NOT COMPLETED|Period 3||0||
48155040|NCT03286751|100703044|FG003|NOT COMPLETED|Period 3||0||
48155041|NCT03286751|100703045|FG004|NOT COMPLETED|Period 3||0||
48155042|NCT03286751|100703046|FG005|NOT COMPLETED|Period 3||0||
48155043|NCT03286751|100703041|FG000|STARTED|Washout Period 3||7||
48155044|NCT03286751|100703042|FG001|STARTED|Washout Period 3||6||
48155045|NCT03286751|100703043|FG002|STARTED|Washout Period 3||7||
48155046|NCT03286751|100703044|FG003|STARTED|Washout Period 3||7||
48155047|NCT03286751|100703045|FG004|STARTED|Washout Period 3||6||
48155048|NCT03286751|100703046|FG005|STARTED|Washout Period 3||7||
48155049|NCT03286751|100703041|FG000|COMPLETED|Washout Period 3||7||
48155050|NCT03286751|100703042|FG001|COMPLETED|Washout Period 3||6||
48155051|NCT03286751|100703043|FG002|COMPLETED|Washout Period 3||7||
48155052|NCT03286751|100703044|FG003|COMPLETED|Washout Period 3||7||
48155053|NCT03286751|100703045|FG004|COMPLETED|Washout Period 3||6||
48155054|NCT03286751|100703046|FG005|COMPLETED|Washout Period 3||7||
48155055|NCT03286751|100703041|FG000|NOT COMPLETED|Washout Period 3||0||
48155056|NCT03286751|100703042|FG001|NOT COMPLETED|Washout Period 3||0||
48155057|NCT03286751|100703043|FG002|NOT COMPLETED|Washout Period 3||0||
48310326|NCT01848353|101084817|FG002|STARTED|Phase 2||0||
48155058|NCT03286751|100703044|FG003|NOT COMPLETED|Washout Period 3||0||
48155059|NCT03286751|100703045|FG004|NOT COMPLETED|Washout Period 3||0||
48155060|NCT03286751|100703046|FG005|NOT COMPLETED|Washout Period 3||0||
48155061|NCT03286751|100703041|FG000|STARTED|Period 4||7||
48155062|NCT03286751|100703042|FG001|STARTED|Period 4||6||
48155063|NCT03286751|100703043|FG002|STARTED|Period 4||7||
48155064|NCT03286751|100703044|FG003|STARTED|Period 4||7||
48155065|NCT03286751|100703045|FG004|STARTED|Period 4||6||
48155066|NCT03286751|100703046|FG005|STARTED|Period 4||7||
48155067|NCT03286751|100703041|FG000|COMPLETED|Period 4||7||
48155068|NCT03286751|100703042|FG001|COMPLETED|Period 4||6||
48155069|NCT03286751|100703043|FG002|COMPLETED|Period 4||7||
48155070|NCT03286751|100703044|FG003|COMPLETED|Period 4||7||
48155071|NCT03286751|100703045|FG004|COMPLETED|Period 4||6||
48155072|NCT03286751|100703046|FG005|COMPLETED|Period 4||7||
48155073|NCT03286751|100703041|FG000|NOT COMPLETED|Period 4||0||
48155074|NCT03286751|100703042|FG001|NOT COMPLETED|Period 4||0||
48155075|NCT03286751|100703043|FG002|NOT COMPLETED|Period 4||0||
48155076|NCT03286751|100703044|FG003|NOT COMPLETED|Period 4||0||
48155077|NCT03286751|100703045|FG004|NOT COMPLETED|Period 4||0||
48155078|NCT03286751|100703046|FG005|NOT COMPLETED|Period 4||0||
48155079|NCT03286751|100703041|FG000|STARTED|Washout Period 4||7||
48155080|NCT03286751|100703042|FG001|STARTED|Washout Period 4||6||
48155081|NCT03286751|100703043|FG002|STARTED|Washout Period 4||7||
48155082|NCT03286751|100703044|FG003|STARTED|Washout Period 4||7||
48155083|NCT03286751|100703045|FG004|STARTED|Washout Period 4||6||
48155084|NCT03286751|100703046|FG005|STARTED|Washout Period 4||7||
48155085|NCT03286751|100703041|FG000|COMPLETED|Washout Period 4||7||
48155086|NCT03286751|100703042|FG001|COMPLETED|Washout Period 4||6||
48155087|NCT03286751|100703043|FG002|COMPLETED|Washout Period 4||7||
48155088|NCT03286751|100703044|FG003|COMPLETED|Washout Period 4||7||
48155089|NCT03286751|100703045|FG004|COMPLETED|Washout Period 4||6||
48155090|NCT03286751|100703046|FG005|COMPLETED|Washout Period 4||7||
48155091|NCT03286751|100703041|FG000|NOT COMPLETED|Washout Period 4||0||
48155092|NCT03286751|100703042|FG001|NOT COMPLETED|Washout Period 4||0||
48155093|NCT03286751|100703043|FG002|NOT COMPLETED|Washout Period 4||0||
48155094|NCT03286751|100703044|FG003|NOT COMPLETED|Washout Period 4||0||
48155095|NCT03286751|100703045|FG004|NOT COMPLETED|Washout Period 4||0||
48155096|NCT03286751|100703046|FG005|NOT COMPLETED|Washout Period 4||0||
48155097|NCT03286751|100703041|FG000|STARTED|Period 5||7||
48155098|NCT03286751|100703042|FG001|STARTED|Period 5||6||
48155099|NCT03286751|100703043|FG002|STARTED|Period 5||7||
48155100|NCT03286751|100703044|FG003|STARTED|Period 5||7||
48155101|NCT03286751|100703045|FG004|STARTED|Period 5||6||
48155102|NCT03286751|100703046|FG005|STARTED|Period 5||7||
48155103|NCT03286751|100703041|FG000|COMPLETED|Period 5||7||
48155104|NCT03286751|100703042|FG001|COMPLETED|Period 5||6||
48155105|NCT03286751|100703043|FG002|COMPLETED|Period 5||7||
48155106|NCT03286751|100703044|FG003|COMPLETED|Period 5||7||
48155107|NCT03286751|100703045|FG004|COMPLETED|Period 5||6||
48155108|NCT03286751|100703046|FG005|COMPLETED|Period 5||7||
48155109|NCT03286751|100703041|FG000|NOT COMPLETED|Period 5||0||
48155110|NCT03286751|100703042|FG001|NOT COMPLETED|Period 5||0||
48155111|NCT03286751|100703043|FG002|NOT COMPLETED|Period 5||0||
48155112|NCT03286751|100703044|FG003|NOT COMPLETED|Period 5||0||
48155113|NCT03286751|100703045|FG004|NOT COMPLETED|Period 5||0||
48155114|NCT03286751|100703046|FG005|NOT COMPLETED|Period 5||0||
48155115|NCT03286751|100703041|FG000|STARTED|Washout Period 5||7||
48155116|NCT03286751|100703042|FG001|STARTED|Washout Period 5||6||
48155117|NCT03286751|100703043|FG002|STARTED|Washout Period 5||7||
48155118|NCT03286751|100703044|FG003|STARTED|Washout Period 5||7||
48155119|NCT03286751|100703045|FG004|STARTED|Washout Period 5||6||
48155120|NCT03286751|100703046|FG005|STARTED|Washout Period 5||7||
48155121|NCT03286751|100703041|FG000|COMPLETED|Washout Period 5||7||
48155122|NCT03286751|100703042|FG001|COMPLETED|Washout Period 5||6||
48155123|NCT03286751|100703043|FG002|COMPLETED|Washout Period 5||7||
48155124|NCT03286751|100703044|FG003|COMPLETED|Washout Period 5||7||
48155125|NCT03286751|100703045|FG004|COMPLETED|Washout Period 5||5||
48155126|NCT03286751|100703046|FG005|COMPLETED|Washout Period 5||7||
48155127|NCT03286751|100703041|FG000|NOT COMPLETED|Washout Period 5||0||
48155128|NCT03286751|100703042|FG001|NOT COMPLETED|Washout Period 5||0||
48155129|NCT03286751|100703043|FG002|NOT COMPLETED|Washout Period 5||0||
48155130|NCT03286751|100703044|FG003|NOT COMPLETED|Washout Period 5||0||
48155131|NCT03286751|100703045|FG004|NOT COMPLETED|Washout Period 5||1||
48155132|NCT03286751|100703046|FG005|NOT COMPLETED|Washout Period 5||0||
48155133|NCT03286751|100703041|FG000|STARTED|Period 6||7||
48155134|NCT03286751|100703042|FG001|STARTED|Period 6||6||
48155135|NCT03286751|100703043|FG002|STARTED|Period 6||7||
48155136|NCT03286751|100703044|FG003|STARTED|Period 6||7||
48155137|NCT03286751|100703045|FG004|STARTED|Period 6||5||
48155138|NCT03286751|100703046|FG005|STARTED|Period 6||7||
48155139|NCT03286751|100703041|FG000|COMPLETED|Period 6||7||
48155140|NCT03286751|100703042|FG001|COMPLETED|Period 6||6||
48155141|NCT03286751|100703043|FG002|COMPLETED|Period 6||7||
48155142|NCT03286751|100703044|FG003|COMPLETED|Period 6||7||
48155143|NCT03286751|100703045|FG004|COMPLETED|Period 6||5||
48155144|NCT03286751|100703046|FG005|COMPLETED|Period 6||7||
48155145|NCT03286751|100703041|FG000|NOT COMPLETED|Period 6||0||
48155146|NCT03286751|100703042|FG001|NOT COMPLETED|Period 6||0||
48155147|NCT03286751|100703043|FG002|NOT COMPLETED|Period 6||0||
48155148|NCT03286751|100703044|FG003|NOT COMPLETED|Period 6||0||
48155149|NCT03286751|100703045|FG004|NOT COMPLETED|Period 6||0||
48155150|NCT03286751|100703046|FG005|NOT COMPLETED|Period 6||0||
48155151|NCT04477187|100703047|FG000|STARTED|Overall Study||15||
48155152|NCT04477187|100703047|FG000|COMPLETED|Overall Study||13||
48155153|NCT04477187|100703047|FG000|NOT COMPLETED|Overall Study||2||
48155154|NCT03610464|100703048|FG000|STARTED|Overall Study||5||
48155155|NCT03610464|100703048|FG000|COMPLETED|Overall Study||5||
48155156|NCT03610464|100703048|FG000|NOT COMPLETED|Overall Study||0||
48155157|NCT02044848|100703049|FG000|STARTED|Overall Study||2||
48155158|NCT02044848|100703050|FG001|STARTED|Overall Study||3||
48155159|NCT02044848|100703049|FG000|COMPLETED|Overall Study||0||
48155160|NCT02044848|100703050|FG001|COMPLETED|Overall Study||0||
48155161|NCT02044848|100703049|FG000|NOT COMPLETED|Overall Study||2||
48155162|NCT02044848|100703050|FG001|NOT COMPLETED|Overall Study||3||
48155163|NCT00799292|100703051|FG000|STARTED|Overall Study||29||
48155164|NCT00799292|100703052|FG001|STARTED|Overall Study||29||
48155165|NCT00799292|100703051|FG000|COMPLETED|Overall Study||29||
48155166|NCT00799292|100703052|FG001|COMPLETED|Overall Study||29||
48155167|NCT00799292|100703051|FG000|NOT COMPLETED|Overall Study||0||
48155168|NCT00799292|100703052|FG001|NOT COMPLETED|Overall Study||0||
48155169|NCT00386022|100703053|FG000|STARTED|Baseline||10||
48155170|NCT00386022|100703054|FG001|STARTED|Baseline||9||
48155171|NCT00386022|100703053|FG000|All Doses of GnRH|Baseline||10||
48155172|NCT00386022|100703054|FG001|All Doses of GnRH|Baseline||9||
48155173|NCT00386022|100703053|FG000|COMPLETED|Baseline||10||
48155174|NCT00386022|100703054|FG001|COMPLETED|Baseline||9||
48155175|NCT00386022|100703053|FG000|NOT COMPLETED|Baseline||0||
48155176|NCT00386022|100703054|FG001|NOT COMPLETED|Baseline||0||
48155177|NCT00386022|100703053|FG000|STARTED|Plus Estrogen||10||
48155178|NCT00386022|100703054|FG001|STARTED|Plus Estrogen||9||
48155179|NCT00386022|100703053|FG000|Estrogen Patch|Plus Estrogen||8||
48155180|NCT00386022|100703054|FG001|Estrogen Patch|Plus Estrogen||9||
48155181|NCT00386022|100703053|FG000|All Doses GnRH|Plus Estrogen||8||
48155182|NCT00386022|100703054|FG001|All Doses GnRH|Plus Estrogen||8||
48155183|NCT00386022|100703053|FG000|COMPLETED|Plus Estrogen||8||
48155184|NCT00386022|100703054|FG001|COMPLETED|Plus Estrogen||8||
48310327|NCT01848353|101084818|FG003|STARTED|Phase 2||0||
48310328|NCT01848353|101084815|FG000|COMPLETED|Phase 2||20||
48310329|NCT01848353|101084816|FG001|COMPLETED|Phase 2||26||
48310330|NCT01848353|101084817|FG002|COMPLETED|Phase 2||0||
48310331|NCT01848353|101084818|FG003|COMPLETED|Phase 2||0||
48310332|NCT01848353|101084815|FG000|NOT COMPLETED|Phase 2||3||
48310333|NCT01848353|101084816|FG001|NOT COMPLETED|Phase 2||2||
48310334|NCT01848353|101084817|FG002|NOT COMPLETED|Phase 2||0||
48310335|NCT01848353|101084818|FG003|NOT COMPLETED|Phase 2||0||
48310336|NCT01848353|101084815|FG000|STARTED|Phase 3||5||
48310337|NCT01848353|101084816|FG001|STARTED|Phase 3||10||
48310338|NCT01848353|101084817|FG002|STARTED|Phase 3||0||
48310339|NCT01848353|101084818|FG003|STARTED|Phase 3||0||
48310340|NCT01848353|101084815|FG000|COMPLETED|Phase 3||4||
48310341|NCT01848353|101084816|FG001|COMPLETED|Phase 3||9||
48310342|NCT01848353|101084817|FG002|COMPLETED|Phase 3||0||
48310343|NCT01848353|101084818|FG003|COMPLETED|Phase 3||0||
48155185|NCT00386022|100703053|FG000|NOT COMPLETED|Plus Estrogen||2||
48155186|NCT00386022|100703054|FG001|NOT COMPLETED|Plus Estrogen||1||
48155187|NCT02048072|100703055|FG000|STARTED|Overall Study||33||
48155188|NCT02048072|100703055|FG000|COMPLETED|Overall Study||29||
48155189|NCT02048072|100703055|FG000|NOT COMPLETED|Overall Study||4||
48155190|NCT00969501|100703056|FG000|STARTED|Overall Study||32||
48155191|NCT00969501|100703056|FG000|COMPLETED|Overall Study||27||
48155192|NCT00969501|100703056|FG000|NOT COMPLETED|Overall Study||5||
48155193|NCT00490282|100703057|FG000|STARTED|Overall Study||25||
48155194|NCT00490282|100703057|FG000|COMPLETED|Overall Study||22||
48155195|NCT00490282|100703057|FG000|NOT COMPLETED|Overall Study||3||
48155196|NCT04605978|100703058|FG000|STARTED|Overall Study||31||
48155197|NCT04605978|100703059|FG001|STARTED|Overall Study||17||
48155198|NCT04605978|100703058|FG000|COMPLETED|Overall Study||28||
48155199|NCT04605978|100703059|FG001|COMPLETED|Overall Study||15||
48155200|NCT04605978|100703058|FG000|NOT COMPLETED|Overall Study||3||
48155201|NCT04605978|100703059|FG001|NOT COMPLETED|Overall Study||2||
48155202|NCT00593567|100703060|FG000|STARTED|Overall Study||48||
48155203|NCT00593567|100703061|FG001|STARTED|Overall Study||22||
48155204|NCT00593567|100703060|FG000|COMPLETED|Overall Study||28||
48155205|NCT00593567|100703061|FG001|COMPLETED|Overall Study||12||
48155206|NCT00593567|100703060|FG000|NOT COMPLETED|Overall Study||20||
48155207|NCT00593567|100703061|FG001|NOT COMPLETED|Overall Study||10||
48155208|NCT00939484|100703062|FG000|STARTED|Overall Study||8||
48155209|NCT00939484|100703063|FG001|STARTED|Overall Study||20||
48155210|NCT00939484|100703064|FG002|STARTED|Overall Study||3||
48155211|NCT00939484|100703062|FG000|COMPLETED|Overall Study||0||
48155212|NCT00939484|100703063|FG001|COMPLETED|Overall Study||0||
48155213|NCT00939484|100703064|FG002|COMPLETED|Overall Study||0||
48155214|NCT00939484|100703062|FG000|NOT COMPLETED|Overall Study||8||
48155215|NCT00939484|100703063|FG001|NOT COMPLETED|Overall Study||20||
48155216|NCT00939484|100703064|FG002|NOT COMPLETED|Overall Study||3||
48310344|NCT01848353|101084815|FG000|NOT COMPLETED|Phase 3||1||
48310345|NCT01848353|101084816|FG001|NOT COMPLETED|Phase 3||1||
48310346|NCT01848353|101084817|FG002|NOT COMPLETED|Phase 3||0||
48310347|NCT01848353|101084818|FG003|NOT COMPLETED|Phase 3||0||
48310348|NCT01655329|101084819|FG000|STARTED|Overall Study||10||
48310349|NCT01655329|101084819|FG000|COMPLETED|Overall Study||10||
48310350|NCT01655329|101084819|FG000|NOT COMPLETED|Overall Study||0||
48310351|NCT03654976|101084820|FG000|STARTED|Overall Study||270||
48155217|NCT02579876|100703065|FG000|STARTED|Overall Study||15||
48155218|NCT02579876|100703066|FG001|STARTED|Overall Study||5||
48155219|NCT02579876|100703065|FG000|COMPLETED|Overall Study||14||
48155220|NCT02579876|100703066|FG001|COMPLETED|Overall Study||5||
48155221|NCT02579876|100703065|FG000|NOT COMPLETED|Overall Study||1||
48155222|NCT02579876|100703066|FG001|NOT COMPLETED|Overall Study||0||
48155223|NCT01798394|100703067|FG000|STARTED|Overall Study||24||
48155224|NCT01798394|100703068|FG001|STARTED|Overall Study||22||
48155225|NCT01798394|100703067|FG000|COMPLETED|Overall Study||21||
48155226|NCT01798394|100703068|FG001|COMPLETED|Overall Study||19||
48155227|NCT01798394|100703067|FG000|NOT COMPLETED|Overall Study||3||
48155228|NCT01798394|100703068|FG001|NOT COMPLETED|Overall Study||3||
48155229|NCT02953938|100703069|FG000|STARTED|Overall Study||29||
48155230|NCT02953938|100703070|FG001|STARTED|Overall Study||30||
48310352|NCT03654976|101084821|FG001|STARTED|Overall Study||263||
48155231|NCT02953938|100703069|FG000|COMPLETED|Overall Study||28|Completed Study Prior to 12 Months|
48155232|NCT02953938|100703070|FG001|COMPLETED|Overall Study||28|Completed Study Prior to 12 Months|
48155233|NCT02953938|100703069|FG000|NOT COMPLETED|Overall Study||1||
48155234|NCT02953938|100703070|FG001|NOT COMPLETED|Overall Study||2||
48155235|NCT02641392|100703071|FG000|STARTED|Overall Study||4||
48155236|NCT02641392|100703072|FG001|STARTED|Overall Study||13||
48155237|NCT02641392|100703073|FG002|STARTED|Overall Study||293||
48155238|NCT02641392|100703071|FG000|COMPLETED|Overall Study||0||
48155239|NCT02641392|100703072|FG001|COMPLETED|Overall Study||0||
48155240|NCT02641392|100703073|FG002|COMPLETED|Overall Study||0||
48155241|NCT02641392|100703071|FG000|NOT COMPLETED|Overall Study||4||
48155242|NCT02641392|100703072|FG001|NOT COMPLETED|Overall Study||13||
48155243|NCT02641392|100703073|FG002|NOT COMPLETED|Overall Study||293||
48155244|NCT00832767|100703074|FG000|STARTED|Overall Study||121||
48155245|NCT00832767|100703075|FG001|STARTED|Overall Study||81||
48155246|NCT00832767|100703074|FG000|COMPLETED|Overall Study||99||
48155247|NCT00832767|100703075|FG001|COMPLETED|Overall Study||63||
48155248|NCT00832767|100703074|FG000|NOT COMPLETED|Overall Study||22||
48155249|NCT00832767|100703075|FG001|NOT COMPLETED|Overall Study||18||
48155250|NCT01820559|100703076|FG000|STARTED|Overall Study||136||
48155251|NCT01820559|100703077|FG001|STARTED|Overall Study||135||
48155252|NCT01820559|100703078|FG002|STARTED|Overall Study||139||
48155253|NCT01820559|100703076|FG000|Randomized and Treated|Overall Study||136||
48155254|NCT01820559|100703077|FG001|Randomized and Treated|Overall Study||135||
48406585|NCT00959699|101328447|FG000|COMPLETED|Treatment Period||11||
48406586|NCT00959699|101328448|FG001|COMPLETED|Treatment Period||40||
48406587|NCT00959699|101328447|FG000|NOT COMPLETED|Treatment Period||23||
48406588|NCT00959699|101328448|FG001|NOT COMPLETED|Treatment Period||25||
48406589|NCT00959699|101328447|FG000|STARTED|Follow-up Period||33||
48406590|NCT00959699|101328448|FG001|STARTED|Follow-up Period||62||
48612574|NCT00762034|101838304|FG001|COMPLETED|Maintenance Period||0||
48612575|NCT00762034|101838303|FG000|NOT COMPLETED|Maintenance Period||294||
48612576|NCT00762034|101838304|FG001|NOT COMPLETED|Maintenance Period||298||
48612577|NCT02143024|101838305|FG000|STARTED|Overall Study||15||
48612578|NCT02143024|101838306|FG001|STARTED|Overall Study||8||
48612579|NCT02143024|101838305|FG000|Received Treatment|Overall Study||13|These people were randomized and received at least 1 session before dropping out of the study.|
48155255|NCT01820559|100703078|FG002|Randomized and Treated|Overall Study||139||
48155256|NCT01820559|100703076|FG000|Completed Tutration Period|Overall Study||130||
48155257|NCT01820559|100703077|FG001|Completed Tutration Period|Overall Study||134||
48155258|NCT01820559|100703078|FG002|Completed Tutration Period|Overall Study||131||
48155259|NCT01820559|100703076|FG000|Entered Maintenance Period|Overall Study||129||
48155260|NCT01820559|100703077|FG001|Entered Maintenance Period|Overall Study||133||
48155261|NCT01820559|100703078|FG002|Entered Maintenance Period|Overall Study||129||
48155262|NCT01820559|100703076|FG000|Completed Maintenance Period|Overall Study||122||
48155263|NCT01820559|100703077|FG001|Completed Maintenance Period|Overall Study||123||
48155264|NCT01820559|100703078|FG002|Completed Maintenance Period|Overall Study||110||
48155265|NCT01820559|100703076|FG000|COMPLETED|Overall Study||122||
48155266|NCT01820559|100703077|FG001|COMPLETED|Overall Study||122||
48155267|NCT01820559|100703078|FG002|COMPLETED|Overall Study||110||
48155268|NCT01820559|100703076|FG000|NOT COMPLETED|Overall Study||14||
48155269|NCT01820559|100703077|FG001|NOT COMPLETED|Overall Study||13||
48155270|NCT01820559|100703078|FG002|NOT COMPLETED|Overall Study||29||
48155271|NCT00716092|100703079|FG000|STARTED|Overall Study||40||
48155272|NCT00716092|100703080|FG001|STARTED|Overall Study||40||
48155273|NCT00716092|100703081|FG002|STARTED|Overall Study||41||
48406591|NCT00959699|101328447|FG000|COMPLETED|Follow-up Period||27||
48406592|NCT00959699|101328448|FG001|COMPLETED|Follow-up Period||56||
48406593|NCT00959699|101328447|FG000|NOT COMPLETED|Follow-up Period||6||
48406594|NCT00959699|101328448|FG001|NOT COMPLETED|Follow-up Period||6||
48406595|NCT00438490|101328449|FG000|STARTED|Overall Study||12||
48406596|NCT00438490|101328450|FG001|STARTED|Overall Study||9||
48406597|NCT00438490|101328449|FG000|COMPLETED|Overall Study||12||
48406598|NCT00438490|101328450|FG001|COMPLETED|Overall Study||9||
48406599|NCT00438490|101328449|FG000|NOT COMPLETED|Overall Study||0||
48406600|NCT00438490|101328450|FG001|NOT COMPLETED|Overall Study||0||
48406601|NCT01355497|101328451|FG000|STARTED|Overall Study||165||
48406602|NCT01355497|101328452|FG001|STARTED|Overall Study||165||
48406603|NCT01355497|101328451|FG000|COMPLETED|Overall Study||99||
48155274|NCT00716092|100703079|FG000|COMPLETED|Overall Study||38||
48155275|NCT00716092|100703080|FG001|COMPLETED|Overall Study||39||
48155276|NCT00716092|100703081|FG002|COMPLETED|Overall Study||41||
48155277|NCT00716092|100703079|FG000|NOT COMPLETED|Overall Study||2||
48155278|NCT00716092|100703080|FG001|NOT COMPLETED|Overall Study||1||
48155279|NCT00716092|100703081|FG002|NOT COMPLETED|Overall Study||0||
48155280|NCT03395405|100703082|FG000|STARTED|Overall Study||16||
48155281|NCT03395405|100703083|FG001|STARTED|Overall Study||15||
48155282|NCT03395405|100703082|FG000|COMPLETED|Overall Study||12||
48155283|NCT03395405|100703083|FG001|COMPLETED|Overall Study||10||
48155284|NCT03395405|100703082|FG000|NOT COMPLETED|Overall Study||4||
48155285|NCT03395405|100703083|FG001|NOT COMPLETED|Overall Study||5||
48155286|NCT01644734|100703084|FG000|STARTED|Overall Study||1282||
48155287|NCT01644734|100703084|FG000|COMPLETED|Overall Study||1016||
48155288|NCT01644734|100703084|FG000|NOT COMPLETED|Overall Study||266||
48155289|NCT00464646|100703085|FG000|STARTED|Overall Study||76||
48155290|NCT00464646|100703086|FG001|STARTED|Overall Study||29||
48155291|NCT00464646|100703085|FG000|COMPLETED|Overall Study||76||
48155292|NCT00464646|100703086|FG001|COMPLETED|Overall Study||29||
48155293|NCT00464646|100703085|FG000|NOT COMPLETED|Overall Study||0||
48155294|NCT00464646|100703086|FG001|NOT COMPLETED|Overall Study||0||
48155295|NCT05158296|100703087|FG000|STARTED|Overall Study||2||
48155296|NCT05158296|100703088|FG001|STARTED|Overall Study||3||
48155297|NCT05158296|100703089|FG002|STARTED|Overall Study||2||
48155298|NCT05158296|100703087|FG000|COMPLETED|Overall Study||0||
48155299|NCT05158296|100703088|FG001|COMPLETED|Overall Study||0||
48155300|NCT05158296|100703089|FG002|COMPLETED|Overall Study||0||
48155301|NCT05158296|100703087|FG000|NOT COMPLETED|Overall Study||2||
48155302|NCT05158296|100703088|FG001|NOT COMPLETED|Overall Study||3||
48155303|NCT05158296|100703089|FG002|NOT COMPLETED|Overall Study||2||
48155304|NCT02007434|100703090|FG000|STARTED|Overall Study||17||
48155305|NCT02007434|100703091|FG001|STARTED|Overall Study||4||
48612580|NCT02143024|101838306|FG001|Received Treatment|Overall Study||7|These people were randomized and received at least 1 session before dropping out of the study.|
48612581|NCT02143024|101838305|FG000|COMPLETED|Overall Study||13||
48612582|NCT02143024|101838306|FG001|COMPLETED|Overall Study||7||
48612583|NCT02143024|101838305|FG000|NOT COMPLETED|Overall Study||2||
48612584|NCT02143024|101838306|FG001|NOT COMPLETED|Overall Study||1||
48612585|NCT05254340|101838307|FG000|STARTED|Overall Study||29||
48612586|NCT05254340|101838307|FG000|COMPLETED|Overall Study||22||
48612587|NCT05254340|101838307|FG000|NOT COMPLETED|Overall Study||7||
48612588|NCT00096538|101838308|FG000|STARTED|Overall Study||6||
48612589|NCT00096538|101838308|FG000|COMPLETED|Overall Study||5||
48612590|NCT00096538|101838308|FG000|NOT COMPLETED|Overall Study||1||
48612591|NCT01979523|101838309|FG000|STARTED|Overall Study||21||
48612592|NCT01979523|101838310|FG001|STARTED|Overall Study||21||
48725813|NCT02092311|102114967|FG000|COMPLETED|Overall Study||285||
48725814|NCT02092311|102114968|FG001|COMPLETED|Overall Study||285||
48725815|NCT02092311|102114967|FG000|NOT COMPLETED|Overall Study||0||
48725816|NCT02092311|102114968|FG001|NOT COMPLETED|Overall Study||0||
48725817|NCT02163421|102114969|FG000|STARTED|Overall Study||12||
48725818|NCT02163421|102114970|FG001|STARTED|Overall Study||12||
48725819|NCT02163421|102114971|FG002|STARTED|Overall Study||12||
48725820|NCT02163421|102114972|FG003|STARTED|Overall Study||12||
48725821|NCT02163421|102114969|FG000|COMPLETED|Overall Study||12||
48725822|NCT02163421|102114970|FG001|COMPLETED|Overall Study||12||
48725823|NCT02163421|102114971|FG002|COMPLETED|Overall Study||12||
48155306|NCT02007434|100703092|FG002|STARTED|Overall Study||17||
48155307|NCT02007434|100703093|FG003|STARTED|Overall Study||4||
48155308|NCT02007434|100703094|FG004|STARTED|Overall Study||16||
48155309|NCT02007434|100703095|FG005|STARTED|Overall Study||4||
48155310|NCT02007434|100703096|FG006|STARTED|Overall Study||18||
48155311|NCT02007434|100703097|FG007|STARTED|Overall Study||4||
48612593|NCT01979523|101838309|FG000|COMPLETED|Overall Study||20||
48612594|NCT01979523|101838310|FG001|COMPLETED|Overall Study||21||
48725824|NCT02163421|102114972|FG003|COMPLETED|Overall Study||12||
48725825|NCT02163421|102114969|FG000|NOT COMPLETED|Overall Study||0||
48725826|NCT02163421|102114970|FG001|NOT COMPLETED|Overall Study||0||
48725827|NCT02163421|102114971|FG002|NOT COMPLETED|Overall Study||0||
48725828|NCT02163421|102114972|FG003|NOT COMPLETED|Overall Study||0||
48155312|NCT02007434|100703090|FG000|Received Treatment|Overall Study||17||
48155313|NCT02007434|100703091|FG001|Received Treatment|Overall Study||3||
48155314|NCT02007434|100703092|FG002|Received Treatment|Overall Study||17||
48155315|NCT02007434|100703093|FG003|Received Treatment|Overall Study||4||
48155316|NCT02007434|100703094|FG004|Received Treatment|Overall Study||16||
48155317|NCT02007434|100703095|FG005|Received Treatment|Overall Study||4||
48155318|NCT02007434|100703096|FG006|Received Treatment|Overall Study||18||
48155319|NCT02007434|100703097|FG007|Received Treatment|Overall Study||4||
48155320|NCT02007434|100703090|FG000|COMPLETED|Overall Study||16||
48155321|NCT02007434|100703091|FG001|COMPLETED|Overall Study||3||
48155322|NCT02007434|100703092|FG002|COMPLETED|Overall Study||16||
48155323|NCT02007434|100703093|FG003|COMPLETED|Overall Study||4||
48155324|NCT02007434|100703094|FG004|COMPLETED|Overall Study||16||
48155325|NCT02007434|100703095|FG005|COMPLETED|Overall Study||4||
48155326|NCT02007434|100703096|FG006|COMPLETED|Overall Study||18||
48155327|NCT02007434|100703097|FG007|COMPLETED|Overall Study||4||
48155328|NCT02007434|100703090|FG000|NOT COMPLETED|Overall Study||1||
48155329|NCT02007434|100703091|FG001|NOT COMPLETED|Overall Study||1||
48155330|NCT02007434|100703092|FG002|NOT COMPLETED|Overall Study||1||
48155331|NCT02007434|100703093|FG003|NOT COMPLETED|Overall Study||0||
48155332|NCT02007434|100703094|FG004|NOT COMPLETED|Overall Study||0||
48155333|NCT02007434|100703095|FG005|NOT COMPLETED|Overall Study||0||
48155334|NCT02007434|100703096|FG006|NOT COMPLETED|Overall Study||0||
48155335|NCT02007434|100703097|FG007|NOT COMPLETED|Overall Study||0||
48155336|NCT01355588|100703098|FG000|STARTED|First Intervention (Day 1)||4||
48155337|NCT01355588|100703099|FG001|STARTED|First Intervention (Day 1)||4||
48155338|NCT01355588|100703100|FG002|STARTED|First Intervention (Day 1)||4||
48155339|NCT01355588|100703101|FG003|STARTED|First Intervention (Day 1)||4||
48155340|NCT01355588|100703098|FG000|COMPLETED|First Intervention (Day 1)||4||
48155341|NCT01355588|100703099|FG001|COMPLETED|First Intervention (Day 1)||4||
48310353|NCT03654976|101084820|FG000|Completed IMP|Overall Study||239||
48310354|NCT03654976|101084821|FG001|Completed IMP|Overall Study||242||
48310355|NCT03654976|101084820|FG000|Full Analysis Set|Overall Study||264||
48310356|NCT03654976|101084821|FG001|Full Analysis Set|Overall Study||260||
48310357|NCT03654976|101084820|FG000|Safety Analysis Set|Overall Study||270||
48310358|NCT03654976|101084821|FG001|Safety Analysis Set|Overall Study||263||
48310359|NCT03654976|101084820|FG000|COMPLETED|Overall Study||241|Completed trial|
48310360|NCT03654976|101084821|FG001|COMPLETED|Overall Study||245|Completed trial|
48310361|NCT03654976|101084820|FG000|NOT COMPLETED|Overall Study||29||
48725829|NCT01353911|102114973|FG000|STARTED|Overall Study||36||
48725830|NCT01353911|102114974|FG001|STARTED|Overall Study||66||
48725831|NCT01353911|102114975|FG002|STARTED|Overall Study||68||
48725832|NCT01353911|102114976|FG003|STARTED|Overall Study||24||
48725833|NCT01353911|102114977|FG004|STARTED|Overall Study||29||
48725834|NCT01353911|102114978|FG005|STARTED|Overall Study||43||
48725835|NCT01353911|102114979|FG006|STARTED|Overall Study||36||
48725836|NCT01353911|102114980|FG007|STARTED|Overall Study||66||
48725837|NCT01353911|102114973|FG000|COMPLETED|Overall Study||28||
48725838|NCT01353911|102114974|FG001|COMPLETED|Overall Study||57||
48725839|NCT01353911|102114975|FG002|COMPLETED|Overall Study||59||
48725840|NCT01353911|102114976|FG003|COMPLETED|Overall Study||22||
48725841|NCT01353911|102114977|FG004|COMPLETED|Overall Study||23||
48725842|NCT01353911|102114978|FG005|COMPLETED|Overall Study||36||
48725843|NCT01353911|102114979|FG006|COMPLETED|Overall Study||30||
48725844|NCT01353911|102114980|FG007|COMPLETED|Overall Study||51||
48725845|NCT01353911|102114973|FG000|NOT COMPLETED|Overall Study||8||
48725846|NCT01353911|102114974|FG001|NOT COMPLETED|Overall Study||9||
48310362|NCT03654976|101084821|FG001|NOT COMPLETED|Overall Study||18||
48310363|NCT00295633|101084822|FG000|STARTED|Overall Study||195||
48310364|NCT00295633|101084823|FG001|STARTED|Overall Study||186||
48310365|NCT00295633|101084824|FG002|STARTED|Overall Study||184||
48310366|NCT00295633|101084822|FG000|Completed Study Without Being Rescued|Overall Study||88||
48310367|NCT00295633|101084823|FG001|Completed Study Without Being Rescued|Overall Study||82||
48310368|NCT00295633|101084824|FG002|Completed Study Without Being Rescued|Overall Study||51||
48310369|NCT00295633|101084822|FG000|COMPLETED|Overall Study||133||
48310370|NCT00295633|101084823|FG001|COMPLETED|Overall Study||119||
48310371|NCT00295633|101084824|FG002|COMPLETED|Overall Study||108||
48310372|NCT00295633|101084822|FG000|NOT COMPLETED|Overall Study||62||
48310373|NCT00295633|101084823|FG001|NOT COMPLETED|Overall Study||67||
48310374|NCT00295633|101084824|FG002|NOT COMPLETED|Overall Study||76||
48310375|NCT02146599|101084825|FG000|STARTED|Overall Study||301||
48310376|NCT02146599|101084825|FG000|COMPLETED|Overall Study||296||
48310377|NCT02146599|101084825|FG000|NOT COMPLETED|Overall Study||5||
48310378|NCT01010633|101084826|FG000|STARTED|Overall Study||203||
48310379|NCT01010633|101084827|FG001|STARTED|Overall Study||203||
48310380|NCT01010633|101084826|FG000|COMPLETED|Overall Study||199||
48310381|NCT01010633|101084827|FG001|COMPLETED|Overall Study||198||
48310382|NCT01010633|101084826|FG000|NOT COMPLETED|Overall Study||4||
48310383|NCT01010633|101084827|FG001|NOT COMPLETED|Overall Study||5||
48310384|NCT00578136|101084828|FG000|STARTED|Overall Study||27||
48310385|NCT00578136|101084829|FG001|STARTED|Overall Study||27||
48310386|NCT00578136|101084828|FG000|COMPLETED|Overall Study||26||
48310387|NCT00578136|101084829|FG001|COMPLETED|Overall Study||26||
48310388|NCT00578136|101084828|FG000|NOT COMPLETED|Overall Study||1||
48310389|NCT00578136|101084829|FG001|NOT COMPLETED|Overall Study||1||
48310390|NCT00938717|101084830|FG000|STARTED|Overall Study||403||
48310391|NCT00938717|101084831|FG001|STARTED|Overall Study||402||
48310392|NCT00938717|101084830|FG000|COMPLETED|Overall Study||305||
48310393|NCT00938717|101084831|FG001|COMPLETED|Overall Study||294||
48310394|NCT00938717|101084830|FG000|NOT COMPLETED|Overall Study||98||
48310395|NCT00938717|101084831|FG001|NOT COMPLETED|Overall Study||108||
48310396|NCT02596620|101084832|FG000|STARTED|Overall Study||82||
48310397|NCT02596620|101084833|FG001|STARTED|Overall Study||82||
48310398|NCT02596620|101084832|FG000|COMPLETED|Overall Study||81||
48310399|NCT02596620|101084833|FG001|COMPLETED|Overall Study||81||
48310400|NCT02596620|101084832|FG000|NOT COMPLETED|Overall Study||1||
48310401|NCT02596620|101084833|FG001|NOT COMPLETED|Overall Study||1||
48310402|NCT02463071|101084834|FG000|STARTED|Overall Study||152||
48310403|NCT02463071|101084835|FG001|STARTED|Overall Study||154||
48310404|NCT02463071|101084836|FG002|STARTED|Overall Study||77||
48310405|NCT02463071|101084834|FG000|COMPLETED|Overall Study||140||
48310406|NCT02463071|101084835|FG001|COMPLETED|Overall Study||138||
48310407|NCT02463071|101084836|FG002|COMPLETED|Overall Study||71||
48310408|NCT02463071|101084834|FG000|NOT COMPLETED|Overall Study||12||
48310409|NCT02463071|101084835|FG001|NOT COMPLETED|Overall Study||16||
48310410|NCT02463071|101084836|FG002|NOT COMPLETED|Overall Study||6||
48310411|NCT00332839|101084837|FG000|STARTED|Core (Months 0 - 12)||47||
48310412|NCT00332839|101084838|FG001|STARTED|Core (Months 0 - 12)||46||
48310413|NCT00332839|101084837|FG000|Safety Set|Core (Months 0 - 12)||47||
48310414|NCT00332839|101084838|FG001|Safety Set|Core (Months 0 - 12)||46||
48310415|NCT00332839|101084837|FG000|COMPLETED|Core (Months 0 - 12)||37||
48310416|NCT00332839|101084838|FG001|COMPLETED|Core (Months 0 - 12)||28||
48310417|NCT00332839|101084837|FG000|NOT COMPLETED|Core (Months 0 - 12)||10||
48310418|NCT00332839|101084838|FG001|NOT COMPLETED|Core (Months 0 - 12)||18||
48310419|NCT00332839|101084837|FG000|STARTED|Follow-up (Months 12 - 60)||33||
48310420|NCT00332839|101084838|FG001|STARTED|Follow-up (Months 12 - 60)||34||
48310421|NCT00332839|101084837|FG000|COMPLETED|Follow-up (Months 12 - 60)||29||
48310422|NCT00332839|101084838|FG001|COMPLETED|Follow-up (Months 12 - 60)||31||
48310423|NCT00332839|101084837|FG000|NOT COMPLETED|Follow-up (Months 12 - 60)||4||
48310424|NCT00332839|101084838|FG001|NOT COMPLETED|Follow-up (Months 12 - 60)||3||
48310425|NCT00449670|101084839|FG000|STARTED|Primary Phase (Study no.109630)||961||
48310426|NCT00449670|101084840|FG001|STARTED|Primary Phase (Study no.109630)||245||
48310427|NCT00449670|101084839|FG000|COMPLETED|Primary Phase (Study no.109630)||947||
48310428|NCT00449670|101084840|FG001|COMPLETED|Primary Phase (Study no.109630)||243||
48310429|NCT00449670|101084839|FG000|NOT COMPLETED|Primary Phase (Study no.109630)||14||
48310430|NCT00449670|101084840|FG001|NOT COMPLETED|Primary Phase (Study no.109630)||2||
48310431|NCT00449670|101084839|FG000|STARTED|Booster Phase (Study no.109873)||265||
48310432|NCT00449670|101084840|FG001|STARTED|Booster Phase (Study no.109873)||236||
48310433|NCT00449670|101084839|FG000|COMPLETED|Booster Phase (Study no.109873)||265||
48310434|NCT00449670|101084840|FG001|COMPLETED|Booster Phase (Study no.109873)||233||
48310435|NCT00449670|101084839|FG000|NOT COMPLETED|Booster Phase (Study no.109873)||0||
48310436|NCT00449670|101084840|FG001|NOT COMPLETED|Booster Phase (Study no.109873)||3||
48310437|NCT00382018|101084841|FG000|STARTED|Overall Study||276|Patients in this group were only followed for OS and PFS. Thus, no treatment status data.|
48310438|NCT00382018|101084842|FG001|STARTED|Overall Study||165|Patients in this group were only followed for OS and PFS. Thus, no treatment status data.|
48310439|NCT00382018|101084843|FG002|STARTED|Overall Study||64|Patients in this group were only followed for OS and PFS. Thus, no treatment status data.|
48310440|NCT00382018|101084844|FG003|STARTED|Overall Study||59|Patients in this group were only followed for OS and PFS. Thus, no treatment status data.|
48310441|NCT00382018|101084841|FG000|COMPLETED|Overall Study||276||
48310442|NCT00382018|101084842|FG001|COMPLETED|Overall Study||0||
48310443|NCT00382018|101084843|FG002|COMPLETED|Overall Study||0||
48310444|NCT00382018|101084844|FG003|COMPLETED|Overall Study||0||
48310445|NCT00382018|101084841|FG000|NOT COMPLETED|Overall Study||0||
48310446|NCT00382018|101084842|FG001|NOT COMPLETED|Overall Study||165||
48310447|NCT00382018|101084843|FG002|NOT COMPLETED|Overall Study||64||
48310448|NCT00382018|101084844|FG003|NOT COMPLETED|Overall Study||59||
48310449|NCT00450242|101084845|FG000|STARTED|Overall Study||7||
48310450|NCT00450242|101084846|FG001|STARTED|Overall Study||7||
48310451|NCT00450242|101084845|FG000|COMPLETED|Overall Study||4||
48310452|NCT00450242|101084846|FG001|COMPLETED|Overall Study||6||
48310453|NCT00450242|101084845|FG000|NOT COMPLETED|Overall Study||3||
48310454|NCT00450242|101084846|FG001|NOT COMPLETED|Overall Study||1||
48310455|NCT02310776|101087852|FG000|STARTED|Overall Study||501||
48310456|NCT02310776|101087852|FG000|COMPLETED|Overall Study||501||
48310457|NCT02310776|101087852|FG000|NOT COMPLETED|Overall Study||0||
48310458|NCT01806857|101087853|FG000|STARTED|Overall Study||31||
48310459|NCT01806857|101087854|FG001|STARTED|Overall Study||29||
48310460|NCT01806857|101087853|FG000|COMPLETED|Overall Study||30||
48310461|NCT01806857|101087854|FG001|COMPLETED|Overall Study||29||
48310462|NCT01806857|101087853|FG000|NOT COMPLETED|Overall Study||1||
48310463|NCT01806857|101087854|FG001|NOT COMPLETED|Overall Study||0||
48310464|NCT01488279|101087855|FG000|STARTED|Overall Study||5||
48612595|NCT01979523|101838309|FG000|NOT COMPLETED|Overall Study||1||
48612596|NCT01979523|101838310|FG001|NOT COMPLETED|Overall Study||0||
48612597|NCT02493452|101838311|FG000|STARTED|Overall Study||379||
48612598|NCT02493452|101838312|FG001|STARTED|Overall Study||377||
48310465|NCT01488279|101087856|FG001|STARTED|Overall Study||5||
48310466|NCT01488279|101087855|FG000|COMPLETED|Overall Study||5||
48310467|NCT01488279|101087856|FG001|COMPLETED|Overall Study||5||
48310468|NCT01488279|101087855|FG000|NOT COMPLETED|Overall Study||0||
48310469|NCT01488279|101087856|FG001|NOT COMPLETED|Overall Study||0||
48310470|NCT02767323|101087857|FG000|STARTED|Overall Study||83||
48310471|NCT02767323|101087858|FG001|STARTED|Overall Study||42||
48310472|NCT02767323|101087859|FG002|STARTED|Overall Study||58||
48310473|NCT02767323|101087860|FG003|STARTED|Overall Study||1||
48310474|NCT02767323|101087857|FG000|COMPLETED|Overall Study||49||
48612599|NCT02493452|101838313|FG002|STARTED|Overall Study||379||
48310475|NCT02767323|101087858|FG001|COMPLETED|Overall Study||17||
48310476|NCT02767323|101087859|FG002|COMPLETED|Overall Study||28||
48310477|NCT02767323|101087860|FG003|COMPLETED|Overall Study||1||
48612600|NCT02493452|101838311|FG000|COMPLETED|Overall Study||329||
48612601|NCT02493452|101838312|FG001|COMPLETED|Overall Study||328||
48612602|NCT02493452|101838313|FG002|COMPLETED|Overall Study||325||
48612603|NCT02493452|101838311|FG000|NOT COMPLETED|Overall Study||50||
48612604|NCT02493452|101838312|FG001|NOT COMPLETED|Overall Study||49||
48612605|NCT02493452|101838313|FG002|NOT COMPLETED|Overall Study||54||
48612606|NCT01065558|101838314|FG000|STARTED|Overall Study||5||
48612607|NCT01065558|101838314|FG000|COMPLETED|Overall Study||5||
48612608|NCT01065558|101838314|FG000|NOT COMPLETED|Overall Study||0||
48612609|NCT00910845|101838315|FG000|STARTED|Treatment Cycle 1||280||
48612610|NCT00910845|101838316|FG001|STARTED|Treatment Cycle 1||277||
48612611|NCT00910845|101838315|FG000|COMPLETED|Treatment Cycle 1||249||
48612612|NCT00910845|101838316|FG001|COMPLETED|Treatment Cycle 1||243||
48612613|NCT00910845|101838315|FG000|NOT COMPLETED|Treatment Cycle 1||31||
48612614|NCT00910845|101838316|FG001|NOT COMPLETED|Treatment Cycle 1||34||
48612615|NCT00910845|101838315|FG000|STARTED|Treatment Cycle 2||141||
48612616|NCT00910845|101838316|FG001|STARTED|Treatment Cycle 2||212||
48612617|NCT00910845|101838315|FG000|COMPLETED|Treatment Cycle 2||136||
48612618|NCT00910845|101838316|FG001|COMPLETED|Treatment Cycle 2||203||
48612619|NCT00910845|101838315|FG000|NOT COMPLETED|Treatment Cycle 2||5||
48612620|NCT00910845|101838316|FG001|NOT COMPLETED|Treatment Cycle 2||9||
48612621|NCT02603211|101838317|FG000|STARTED|Overall Study||20||
48612622|NCT02603211|101838317|FG000|COMPLETED|Overall Study||20||
48612623|NCT02603211|101838317|FG000|NOT COMPLETED|Overall Study||0||
48612624|NCT02589847|101838318|FG000|STARTED|Overall Study||162||
48612625|NCT02589847|101838319|FG001|STARTED|Overall Study||110||
48612626|NCT02589847|101838318|FG000|Safety Population|Overall Study||149||
48612627|NCT02589847|101838319|FG001|Safety Population|Overall Study||0||
48612628|NCT02589847|101838318|FG000|Full Analysis Set (FAS)|Overall Study||149||
48612629|NCT02589847|101838319|FG001|Full Analysis Set (FAS)|Overall Study||104||
48612630|NCT02589847|101838318|FG000|Evaluable|Overall Study||142||
48612631|NCT02589847|101838319|FG001|Evaluable|Overall Study||75||
48612632|NCT02589847|101838318|FG000|COMPLETED|Overall Study||107||
48612633|NCT02589847|101838319|FG001|COMPLETED|Overall Study||39||
48612634|NCT02589847|101838318|FG000|NOT COMPLETED|Overall Study||55||
48612635|NCT02589847|101838319|FG001|NOT COMPLETED|Overall Study||71||
48612636|NCT03063619|101838320|FG000|STARTED|Overall Study||78||
48612637|NCT03063619|101838321|FG001|STARTED|Overall Study||80||
48612638|NCT03063619|101838320|FG000|Baseline|Overall Study||78||
48612639|NCT03063619|101838321|FG001|Baseline|Overall Study||80||
48612640|NCT03063619|101838320|FG000|Month 12|Overall Study||67||
48612641|NCT03063619|101838321|FG001|Month 12|Overall Study||65||
48612642|NCT03063619|101838320|FG000|Month 24|Overall Study||56||
48612643|NCT03063619|101838321|FG001|Month 24|Overall Study||55||
48612644|NCT03063619|101838320|FG000|COMPLETED|Overall Study||67||
48310478|NCT02767323|101087857|FG000|NOT COMPLETED|Overall Study||34||
48310479|NCT02767323|101087858|FG001|NOT COMPLETED|Overall Study||25||
48310480|NCT02767323|101087859|FG002|NOT COMPLETED|Overall Study||30||
48310481|NCT02767323|101087860|FG003|NOT COMPLETED|Overall Study||0||
48310482|NCT02000596|101087861|FG000|STARTED|Cohort 1||2||
48310483|NCT02000596|101087862|FG001|STARTED|Cohort 1||0||
48612645|NCT03063619|101838321|FG001|COMPLETED|Overall Study||65||
48612646|NCT03063619|101838320|FG000|NOT COMPLETED|Overall Study||11||
48612647|NCT03063619|101838321|FG001|NOT COMPLETED|Overall Study||15||
48612648|NCT02273362|101838322|FG000|STARTED|Overall Study||5||
48155342|NCT01355588|100703100|FG002|COMPLETED|First Intervention (Day 1)||4||
48155343|NCT01355588|100703101|FG003|COMPLETED|First Intervention (Day 1)||4||
48155344|NCT01355588|100703098|FG000|NOT COMPLETED|First Intervention (Day 1)||0||
48155345|NCT01355588|100703099|FG001|NOT COMPLETED|First Intervention (Day 1)||0||
48155346|NCT01355588|100703100|FG002|NOT COMPLETED|First Intervention (Day 1)||0||
48155347|NCT01355588|100703101|FG003|NOT COMPLETED|First Intervention (Day 1)||0||
48155348|NCT01355588|100703098|FG000|STARTED|Washout (3-7 Days)||4||
48725847|NCT01353911|102114975|FG002|NOT COMPLETED|Overall Study||9||
48725848|NCT01353911|102114976|FG003|NOT COMPLETED|Overall Study||2||
48725849|NCT01353911|102114977|FG004|NOT COMPLETED|Overall Study||6||
48725850|NCT01353911|102114978|FG005|NOT COMPLETED|Overall Study||7||
48725851|NCT01353911|102114979|FG006|NOT COMPLETED|Overall Study||6||
48725852|NCT01353911|102114980|FG007|NOT COMPLETED|Overall Study||15||
48725853|NCT02175368|102114981|FG000|STARTED|Overall Study||28||
48725854|NCT02175368|102114981|FG000|COMPLETED|Overall Study||27||
48725855|NCT02175368|102114981|FG000|NOT COMPLETED|Overall Study||1||
48725856|NCT00375167|102114982|FG000|STARTED|Overall Study||16||
48155349|NCT01355588|100703099|FG001|STARTED|Washout (3-7 Days)||4||
48155350|NCT01355588|100703100|FG002|STARTED|Washout (3-7 Days)||4||
48155351|NCT01355588|100703101|FG003|STARTED|Washout (3-7 Days)||4||
48155352|NCT01355588|100703098|FG000|COMPLETED|Washout (3-7 Days)||4||
48406604|NCT01355497|101328452|FG001|COMPLETED|Overall Study||102||
48725857|NCT00375167|102114983|FG001|STARTED|Overall Study||17||
48725858|NCT00375167|102114982|FG000|COMPLETED|Overall Study||16||
48725859|NCT00375167|102114983|FG001|COMPLETED|Overall Study||17||
48725860|NCT00375167|102114982|FG000|NOT COMPLETED|Overall Study||0||
48725861|NCT00375167|102114983|FG001|NOT COMPLETED|Overall Study||0||
48725862|NCT03422536|102114984|FG000|STARTED|Randomized||27||
48725863|NCT03422536|102114985|FG001|STARTED|Randomized||33||
48725864|NCT03422536|102114984|FG000|COMPLETED|Randomized||26||
48725865|NCT03422536|102114985|FG001|COMPLETED|Randomized||32||
48725866|NCT03422536|102114984|FG000|NOT COMPLETED|Randomized||1||
48725867|NCT03422536|102114985|FG001|NOT COMPLETED|Randomized||1||
48725868|NCT03422536|102114984|FG000|STARTED|Allocation - Received Intervention||26||
48725869|NCT03422536|102114985|FG001|STARTED|Allocation - Received Intervention||32||
48725870|NCT03422536|102114984|FG000|COMPLETED|Allocation - Received Intervention||0||
48725871|NCT03422536|102114985|FG001|COMPLETED|Allocation - Received Intervention||1||
48725872|NCT03422536|102114984|FG000|NOT COMPLETED|Allocation - Received Intervention||26||
48725873|NCT03422536|102114985|FG001|NOT COMPLETED|Allocation - Received Intervention||31||
48725874|NCT00439374|102114986|FG000|STARTED|Overall Study||327||
48725875|NCT00439374|102114987|FG001|STARTED|Overall Study||330||
48725876|NCT00439374|102114986|FG000|COMPLETED|Overall Study||327||
48725877|NCT00439374|102114987|FG001|COMPLETED|Overall Study||330||
48725878|NCT00439374|102114986|FG000|NOT COMPLETED|Overall Study||0||
48725879|NCT00439374|102114987|FG001|NOT COMPLETED|Overall Study||0||
48725880|NCT05399290|102114988|FG000|STARTED|Overall Study||11||
48725881|NCT05399290|102114989|FG001|STARTED|Overall Study||11||
48725882|NCT05399290|102114988|FG000|COMPLETED|Overall Study||10||
48725883|NCT05399290|102114989|FG001|COMPLETED|Overall Study||10||
48725884|NCT05399290|102114988|FG000|NOT COMPLETED|Overall Study||1||
48725885|NCT05399290|102114989|FG001|NOT COMPLETED|Overall Study||1||
48725886|NCT03286283|102114990|FG000|STARTED|Overall Study||55||
48725887|NCT03286283|102114990|FG000|COMPLETED|Overall Study||55||
48725888|NCT03286283|102114990|FG000|NOT COMPLETED|Overall Study||0||
48725889|NCT01041287|102114991|FG000|STARTED|Treatment Period 1 (3 Months)||19||
48725890|NCT01041287|102114992|FG001|STARTED|Treatment Period 1 (3 Months)||19||
48725891|NCT01041287|102114991|FG000|COMPLETED|Treatment Period 1 (3 Months)||19||
48725892|NCT01041287|102114992|FG001|COMPLETED|Treatment Period 1 (3 Months)||19||
48725893|NCT01041287|102114991|FG000|NOT COMPLETED|Treatment Period 1 (3 Months)||0||
48725894|NCT01041287|102114992|FG001|NOT COMPLETED|Treatment Period 1 (3 Months)||0||
48725895|NCT01041287|102114991|FG000|STARTED|Treatment Period 2 (3 Months)||19||
48725896|NCT01041287|102114992|FG001|STARTED|Treatment Period 2 (3 Months)||19||
48725897|NCT01041287|102114991|FG000|COMPLETED|Treatment Period 2 (3 Months)||16||
48725898|NCT01041287|102114992|FG001|COMPLETED|Treatment Period 2 (3 Months)||14||
48725899|NCT01041287|102114991|FG000|NOT COMPLETED|Treatment Period 2 (3 Months)||3||
48725900|NCT01041287|102114992|FG001|NOT COMPLETED|Treatment Period 2 (3 Months)||5||
48725901|NCT02726022|102114993|FG000|STARTED|Overall Study||114||
48725902|NCT02726022|102114993|FG000|COMPLETED|Overall Study||78||
48725903|NCT02726022|102114993|FG000|NOT COMPLETED|Overall Study||36||
48725904|NCT04576897|102114994|FG000|STARTED|Overall Study||70||
48725905|NCT04576897|102114994|FG000|COMPLETED|Overall Study||33||
48155353|NCT01355588|100703099|FG001|COMPLETED|Washout (3-7 Days)||4||
48155354|NCT01355588|100703100|FG002|COMPLETED|Washout (3-7 Days)||4||
48155355|NCT01355588|100703101|FG003|COMPLETED|Washout (3-7 Days)||4||
48155356|NCT01355588|100703098|FG000|NOT COMPLETED|Washout (3-7 Days)||0||
48155357|NCT01355588|100703099|FG001|NOT COMPLETED|Washout (3-7 Days)||0||
48155358|NCT01355588|100703100|FG002|NOT COMPLETED|Washout (3-7 Days)||0||
48155359|NCT01355588|100703101|FG003|NOT COMPLETED|Washout (3-7 Days)||0||
48155360|NCT01355588|100703098|FG000|STARTED|Second Intervention (After Washout)||4||
48155361|NCT01355588|100703099|FG001|STARTED|Second Intervention (After Washout)||4||
48725906|NCT04576897|102114994|FG000|NOT COMPLETED|Overall Study||37||
48725907|NCT05320393|102114995|FG000|STARTED|Overall Study||51||
48725908|NCT05320393|102114996|FG001|STARTED|Overall Study||50||
48725909|NCT05320393|102114997|FG002|STARTED|Overall Study||53||
48725910|NCT05320393|102114995|FG000|COMPLETED|Overall Study||49||
48725911|NCT05320393|102114996|FG001|COMPLETED|Overall Study||48||
48725912|NCT05320393|102114997|FG002|COMPLETED|Overall Study||47||
48725913|NCT05320393|102114995|FG000|NOT COMPLETED|Overall Study||2||
48310484|NCT02000596|101087863|FG002|STARTED|Cohort 1||0||
48310485|NCT02000596|101087861|FG000|COMPLETED|Cohort 1||2||
48310486|NCT02000596|101087862|FG001|COMPLETED|Cohort 1||0||
48310487|NCT02000596|101087863|FG002|COMPLETED|Cohort 1||0||
48310488|NCT02000596|101087861|FG000|NOT COMPLETED|Cohort 1||0||
48310489|NCT02000596|101087862|FG001|NOT COMPLETED|Cohort 1||0||
48310490|NCT02000596|101087863|FG002|NOT COMPLETED|Cohort 1||0||
48310491|NCT02000596|101087861|FG000|STARTED|Cohort 2||0||
48310492|NCT02000596|101087862|FG001|STARTED|Cohort 2||0||
48310493|NCT02000596|101087863|FG002|STARTED|Cohort 2||2||
48310494|NCT02000596|101087861|FG000|COMPLETED|Cohort 2||0||
48310495|NCT02000596|101087862|FG001|COMPLETED|Cohort 2||0||
48310496|NCT02000596|101087863|FG002|COMPLETED|Cohort 2||2||
48310497|NCT02000596|101087861|FG000|NOT COMPLETED|Cohort 2||0||
48310498|NCT02000596|101087862|FG001|NOT COMPLETED|Cohort 2||0||
48310499|NCT02000596|101087863|FG002|NOT COMPLETED|Cohort 2||0||
48310500|NCT01937598|101087864|FG000|STARTED|Overall Study||8||
48310501|NCT01937598|101087865|FG001|STARTED|Overall Study||8||
48725914|NCT05320393|102114996|FG001|NOT COMPLETED|Overall Study||2||
48725915|NCT05320393|102114997|FG002|NOT COMPLETED|Overall Study||6||
48725916|NCT00609739|102114998|FG000|STARTED|Overall Study||1||
48725917|NCT00609739|102114998|FG000|COMPLETED|Overall Study||1||
48725918|NCT00609739|102114998|FG000|NOT COMPLETED|Overall Study||0||
48725919|NCT04268173|102114999|FG000|STARTED|Overall Study||133||
48725920|NCT04268173|102115000|FG001|STARTED|Overall Study||194||
48725921|NCT04268173|102114999|FG000|COMPLETED|Overall Study||58||
48725922|NCT04268173|102115000|FG001|COMPLETED|Overall Study||86||
48725923|NCT04268173|102114999|FG000|NOT COMPLETED|Overall Study||75||
48725924|NCT04268173|102115000|FG001|NOT COMPLETED|Overall Study||108||
48725925|NCT03052816|102115001|FG000|STARTED|Overall Study||33||
48310502|NCT01937598|101087864|FG000|COMPLETED|Overall Study||8||
48310503|NCT01937598|101087865|FG001|COMPLETED|Overall Study||8||
48310504|NCT01937598|101087864|FG000|NOT COMPLETED|Overall Study||0||
48310505|NCT01937598|101087865|FG001|NOT COMPLETED|Overall Study||0||
48310506|NCT04233164|101087866|FG000|STARTED|Overall Study||20||
48310507|NCT04233164|101087867|FG001|STARTED|Overall Study||21||
48310508|NCT04233164|101087866|FG000|COMPLETED|Overall Study||20||
48310509|NCT04233164|101087867|FG001|COMPLETED|Overall Study||20||
48310510|NCT04233164|101087866|FG000|NOT COMPLETED|Overall Study||0||
48310511|NCT04233164|101087867|FG001|NOT COMPLETED|Overall Study||1||
48310512|NCT01092143|101087868|FG000|STARTED|Overall Study||78||
48310513|NCT01092143|101087869|FG001|STARTED|Overall Study||77||
48310514|NCT01092143|101087870|FG002|STARTED|Overall Study||84||
48310515|NCT01092143|101087871|FG003|STARTED|Overall Study||79||
48310516|NCT01092143|101087872|FG004|STARTED|Overall Study||71||
48310517|NCT01092143|101087868|FG000|Treated|Overall Study||78||
48310518|NCT01092143|101087869|FG001|Treated|Overall Study||77||
48310519|NCT01092143|101087870|FG002|Treated|Overall Study||83||
48310520|NCT01092143|101087871|FG003|Treated|Overall Study||79||
48310521|NCT01092143|101087872|FG004|Treated|Overall Study||71||
48310522|NCT01092143|101087868|FG000|COMPLETED|Overall Study||63||
48725926|NCT03052816|102115002|FG001|STARTED|Overall Study||33||
48725927|NCT03052816|102115001|FG000|COMPLETED|Overall Study||30||
48725928|NCT03052816|102115002|FG001|COMPLETED|Overall Study||33||
48725929|NCT03052816|102115001|FG000|NOT COMPLETED|Overall Study||3||
48725930|NCT03052816|102115002|FG001|NOT COMPLETED|Overall Study||0||
48725931|NCT00225784|102115003|FG000|STARTED|Overall Study||37||
48725932|NCT00225784|102115003|FG000|COMPLETED|Overall Study||33||
48725933|NCT00225784|102115003|FG000|NOT COMPLETED|Overall Study||4||
48725934|NCT00844558|102115004|FG000|STARTED|Overall Study||36||
48310523|NCT01092143|101087869|FG001|COMPLETED|Overall Study||70||
48310524|NCT01092143|101087870|FG002|COMPLETED|Overall Study||80||
48310525|NCT01092143|101087871|FG003|COMPLETED|Overall Study||72||
48310526|NCT01092143|101087872|FG004|COMPLETED|Overall Study||63||
48310527|NCT01092143|101087868|FG000|NOT COMPLETED|Overall Study||15||
48310528|NCT01092143|101087869|FG001|NOT COMPLETED|Overall Study||7||
48310529|NCT01092143|101087870|FG002|NOT COMPLETED|Overall Study||4||
48310530|NCT01092143|101087871|FG003|NOT COMPLETED|Overall Study||7||
48725935|NCT00844558|102115005|FG001|STARTED|Overall Study||22||
48310531|NCT01092143|101087872|FG004|NOT COMPLETED|Overall Study||8||
48310532|NCT00078325|101087873|FG000|STARTED|Overall Study||131||
48310533|NCT00078325|101087874|FG001|STARTED|Overall Study||133||
48155362|NCT01355588|100703100|FG002|STARTED|Second Intervention (After Washout)||4||
48155363|NCT01355588|100703101|FG003|STARTED|Second Intervention (After Washout)||4||
48155364|NCT01355588|100703098|FG000|COMPLETED|Second Intervention (After Washout)||4||
48155365|NCT01355588|100703099|FG001|COMPLETED|Second Intervention (After Washout)||4||
48155366|NCT01355588|100703100|FG002|COMPLETED|Second Intervention (After Washout)||4||
48155367|NCT01355588|100703101|FG003|COMPLETED|Second Intervention (After Washout)||4||
48155368|NCT01355588|100703098|FG000|NOT COMPLETED|Second Intervention (After Washout)||0||
48155369|NCT01355588|100703099|FG001|NOT COMPLETED|Second Intervention (After Washout)||0||
48155370|NCT01355588|100703100|FG002|NOT COMPLETED|Second Intervention (After Washout)||0||
48155371|NCT01355588|100703101|FG003|NOT COMPLETED|Second Intervention (After Washout)||0||
48155372|NCT01355588|100703098|FG000|STARTED|Washout (3-7 Days)||4||
48155373|NCT01355588|100703099|FG001|STARTED|Washout (3-7 Days)||4||
48155374|NCT01355588|100703100|FG002|STARTED|Washout (3-7 Days)||4||
48155375|NCT01355588|100703101|FG003|STARTED|Washout (3-7 Days)||4||
48155376|NCT01355588|100703098|FG000|COMPLETED|Washout (3-7 Days)||4||
48155377|NCT01355588|100703099|FG001|COMPLETED|Washout (3-7 Days)||4||
48155378|NCT01355588|100703100|FG002|COMPLETED|Washout (3-7 Days)||4||
48155379|NCT01355588|100703101|FG003|COMPLETED|Washout (3-7 Days)||4||
48155380|NCT01355588|100703098|FG000|NOT COMPLETED|Washout (3-7 Days)||0||
48155381|NCT01355588|100703099|FG001|NOT COMPLETED|Washout (3-7 Days)||0||
48155382|NCT01355588|100703100|FG002|NOT COMPLETED|Washout (3-7 Days)||0||
48155383|NCT01355588|100703101|FG003|NOT COMPLETED|Washout (3-7 Days)||0||
48155384|NCT01355588|100703098|FG000|STARTED|Third Intervention (After Washout)||4||
48155385|NCT01355588|100703099|FG001|STARTED|Third Intervention (After Washout)||4||
48155386|NCT01355588|100703100|FG002|STARTED|Third Intervention (After Washout)||4||
48155387|NCT01355588|100703101|FG003|STARTED|Third Intervention (After Washout)||4||
48155388|NCT01355588|100703098|FG000|COMPLETED|Third Intervention (After Washout)||4||
48155389|NCT01355588|100703099|FG001|COMPLETED|Third Intervention (After Washout)||4||
48155390|NCT01355588|100703100|FG002|COMPLETED|Third Intervention (After Washout)||4||
48155391|NCT01355588|100703101|FG003|COMPLETED|Third Intervention (After Washout)||4||
48155392|NCT01355588|100703098|FG000|NOT COMPLETED|Third Intervention (After Washout)||0||
48155393|NCT01355588|100703099|FG001|NOT COMPLETED|Third Intervention (After Washout)||0||
48155394|NCT01355588|100703100|FG002|NOT COMPLETED|Third Intervention (After Washout)||0||
48155395|NCT01355588|100703101|FG003|NOT COMPLETED|Third Intervention (After Washout)||0||
48155396|NCT01355588|100703098|FG000|STARTED|Washout (3-7 Days)||4||
48155397|NCT01355588|100703099|FG001|STARTED|Washout (3-7 Days)||4||
48155398|NCT01355588|100703100|FG002|STARTED|Washout (3-7 Days)||4||
48155399|NCT01355588|100703101|FG003|STARTED|Washout (3-7 Days)||4||
48155400|NCT01355588|100703098|FG000|COMPLETED|Washout (3-7 Days)||4||
48155401|NCT01355588|100703099|FG001|COMPLETED|Washout (3-7 Days)||4||
48155402|NCT01355588|100703100|FG002|COMPLETED|Washout (3-7 Days)||4||
48155403|NCT01355588|100703101|FG003|COMPLETED|Washout (3-7 Days)||4||
48155404|NCT01355588|100703098|FG000|NOT COMPLETED|Washout (3-7 Days)||0||
48155405|NCT01355588|100703099|FG001|NOT COMPLETED|Washout (3-7 Days)||0||
48155406|NCT01355588|100703100|FG002|NOT COMPLETED|Washout (3-7 Days)||0||
48155407|NCT01355588|100703101|FG003|NOT COMPLETED|Washout (3-7 Days)||0||
48155408|NCT01355588|100703098|FG000|STARTED|Fourth Intervention (After Washout)||4||
48155409|NCT01355588|100703099|FG001|STARTED|Fourth Intervention (After Washout)||4||
48155410|NCT01355588|100703100|FG002|STARTED|Fourth Intervention (After Washout)||4||
48155411|NCT01355588|100703101|FG003|STARTED|Fourth Intervention (After Washout)||4||
48155412|NCT01355588|100703098|FG000|COMPLETED|Fourth Intervention (After Washout)||4||
48155413|NCT01355588|100703099|FG001|COMPLETED|Fourth Intervention (After Washout)||4||
48155414|NCT01355588|100703100|FG002|COMPLETED|Fourth Intervention (After Washout)||4||
48155415|NCT01355588|100703101|FG003|COMPLETED|Fourth Intervention (After Washout)||4||
48155416|NCT01355588|100703098|FG000|NOT COMPLETED|Fourth Intervention (After Washout)||0||
48155417|NCT01355588|100703099|FG001|NOT COMPLETED|Fourth Intervention (After Washout)||0||
48155418|NCT01355588|100703100|FG002|NOT COMPLETED|Fourth Intervention (After Washout)||0||
48155419|NCT01355588|100703101|FG003|NOT COMPLETED|Fourth Intervention (After Washout)||0||
48155420|NCT00266825|100703102|FG000|STARTED|Enrolled and Allocated Intervention||172||
48155421|NCT00266825|100703103|FG001|STARTED|Enrolled and Allocated Intervention||178||
48155422|NCT00266825|100703102|FG000|COMPLETED|Enrolled and Allocated Intervention||172||
48155423|NCT00266825|100703103|FG001|COMPLETED|Enrolled and Allocated Intervention||178||
48155424|NCT00266825|100703102|FG000|NOT COMPLETED|Enrolled and Allocated Intervention||0||
48155425|NCT00266825|100703103|FG001|NOT COMPLETED|Enrolled and Allocated Intervention||0||
48155426|NCT00266825|100703102|FG000|STARTED|Completed Follow-Up||172||
48155427|NCT00266825|100703103|FG001|STARTED|Completed Follow-Up||178||
48155428|NCT00266825|100703102|FG000|COMPLETED|Completed Follow-Up||147||
48155429|NCT00266825|100703103|FG001|COMPLETED|Completed Follow-Up||154||
48155430|NCT00266825|100703102|FG000|NOT COMPLETED|Completed Follow-Up||25||
48155431|NCT00266825|100703103|FG001|NOT COMPLETED|Completed Follow-Up||24||
48155432|NCT02436811|100703104|FG000|STARTED|Overall Study||60||
48155433|NCT02436811|100703105|FG001|STARTED|Overall Study||60||
48155434|NCT02436811|100703106|FG002|STARTED|Overall Study||60||
48155435|NCT02436811|100703104|FG000|COMPLETED|Overall Study||58||
48155436|NCT02436811|100703105|FG001|COMPLETED|Overall Study||51||
48155437|NCT02436811|100703106|FG002|COMPLETED|Overall Study||53||
48155438|NCT02436811|100703104|FG000|NOT COMPLETED|Overall Study||2||
48155439|NCT02436811|100703105|FG001|NOT COMPLETED|Overall Study||9||
48155440|NCT02436811|100703106|FG002|NOT COMPLETED|Overall Study||7||
48155441|NCT03039595|100703107|FG000|STARTED|Overall Study||150||
48155442|NCT03039595|100703107|FG000|COMPLETED|Overall Study||143||
48155443|NCT03039595|100703107|FG000|NOT COMPLETED|Overall Study||7||
48155444|NCT02063230|100703108|FG000|STARTED|Overall Study||8||
48155445|NCT02063230|100703109|FG001|STARTED|Overall Study||8||
48155446|NCT02063230|100703110|FG002|STARTED|Overall Study||8||
48155447|NCT02063230|100703111|FG003|STARTED|Overall Study||8||
48155448|NCT02063230|100703108|FG000|Received Treatment|Overall Study||8||
48155449|NCT02063230|100703109|FG001|Received Treatment|Overall Study||8||
48155450|NCT02063230|100703110|FG002|Received Treatment|Overall Study||8||
48155451|NCT02063230|100703111|FG003|Received Treatment|Overall Study||8||
48155452|NCT02063230|100703108|FG000|COMPLETED|Overall Study||8||
48155453|NCT02063230|100703109|FG001|COMPLETED|Overall Study||8||
48155454|NCT02063230|100703110|FG002|COMPLETED|Overall Study||8||
48155455|NCT02063230|100703111|FG003|COMPLETED|Overall Study||8||
48155456|NCT02063230|100703108|FG000|NOT COMPLETED|Overall Study||0||
48155457|NCT02063230|100703109|FG001|NOT COMPLETED|Overall Study||0||
48155458|NCT02063230|100703110|FG002|NOT COMPLETED|Overall Study||0||
48155459|NCT02063230|100703111|FG003|NOT COMPLETED|Overall Study||0||
48155460|NCT02510144|100703112|FG000|STARTED|Overall Study||39||
48155461|NCT02510144|100703113|FG001|STARTED|Overall Study||41||
48155462|NCT02510144|100703112|FG000|COMPLETED|Overall Study||39||
48155463|NCT02510144|100703113|FG001|COMPLETED|Overall Study||41||
48155464|NCT02510144|100703112|FG000|NOT COMPLETED|Overall Study||0||
48155465|NCT02510144|100703113|FG001|NOT COMPLETED|Overall Study||0||
48155466|NCT04493216|100703114|FG000|STARTED|Overall Study||40||
48155467|NCT04493216|100703115|FG001|STARTED|Overall Study||43||
48155468|NCT04493216|100703116|FG002|STARTED|Overall Study||42||
48155469|NCT04493216|100703117|FG003|STARTED|Overall Study||36||
48155470|NCT04493216|100703114|FG000|COMPLETED|Overall Study||0||
48155471|NCT04493216|100703115|FG001|COMPLETED|Overall Study||0||
48155472|NCT04493216|100703116|FG002|COMPLETED|Overall Study||0||
48155473|NCT04493216|100703117|FG003|COMPLETED|Overall Study||0||
48155474|NCT04493216|100703114|FG000|NOT COMPLETED|Overall Study||40||
48155475|NCT04493216|100703115|FG001|NOT COMPLETED|Overall Study||43||
48155476|NCT04493216|100703116|FG002|NOT COMPLETED|Overall Study||42||
48155477|NCT04493216|100703117|FG003|NOT COMPLETED|Overall Study||36||
48155478|NCT01525602|100703118|FG000|STARTED|Overall Study||9||
48155479|NCT01525602|100703119|FG001|STARTED|Overall Study||3||
48155480|NCT01525602|100703120|FG002|STARTED|Overall Study||3||
48155481|NCT01525602|100703121|FG003|STARTED|Overall Study||6||
48155482|NCT01525602|100703122|FG004|STARTED|Overall Study||33||
48155483|NCT01525602|100703123|FG005|STARTED|Overall Study||7||
48612649|NCT02273362|101838323|FG001|STARTED|Overall Study||6||
48612650|NCT02273362|101838324|FG002|STARTED|Overall Study||14||
48612651|NCT02273362|101838322|FG000|COMPLETED|Overall Study||5||
48612652|NCT02273362|101838323|FG001|COMPLETED|Overall Study||6||
48612653|NCT02273362|101838324|FG002|COMPLETED|Overall Study||14||
48612654|NCT02273362|101838322|FG000|NOT COMPLETED|Overall Study||0||
48612655|NCT02273362|101838323|FG001|NOT COMPLETED|Overall Study||0||
48612656|NCT02273362|101838324|FG002|NOT COMPLETED|Overall Study||0||
48612657|NCT02094326|101838325|FG000|STARTED|Overall Study||301||
48612658|NCT02094326|101838325|FG000|COMPLETED|Overall Study||301||
48612659|NCT02094326|101838325|FG000|NOT COMPLETED|Overall Study||0||
48612660|NCT04736069|101838326|FG000|STARTED|Overall Study||30||
48612661|NCT04736069|101838327|FG001|STARTED|Overall Study||30||
48612662|NCT04736069|101838326|FG000|COMPLETED|Overall Study||30||
48155484|NCT01525602|100703124|FG006|STARTED|Overall Study||6||
48155485|NCT01525602|100703125|FG007|STARTED|Overall Study||7||
48155486|NCT01525602|100703118|FG000|COMPLETED|Overall Study||0||
48155487|NCT01525602|100703119|FG001|COMPLETED|Overall Study||0||
48155488|NCT01525602|100703120|FG002|COMPLETED|Overall Study||0||
48155489|NCT01525602|100703121|FG003|COMPLETED|Overall Study||0||
48155490|NCT01525602|100703122|FG004|COMPLETED|Overall Study||0||
48155491|NCT01525602|100703123|FG005|COMPLETED|Overall Study||0||
48155492|NCT01525602|100703124|FG006|COMPLETED|Overall Study||0||
48155493|NCT01525602|100703125|FG007|COMPLETED|Overall Study||0||
48155494|NCT01525602|100703118|FG000|NOT COMPLETED|Overall Study||9||
48155495|NCT01525602|100703119|FG001|NOT COMPLETED|Overall Study||3||
48155496|NCT01525602|100703120|FG002|NOT COMPLETED|Overall Study||3||
48155497|NCT01525602|100703121|FG003|NOT COMPLETED|Overall Study||6||
48155498|NCT01525602|100703122|FG004|NOT COMPLETED|Overall Study||33||
48155499|NCT01525602|100703123|FG005|NOT COMPLETED|Overall Study||7||
48155500|NCT01525602|100703124|FG006|NOT COMPLETED|Overall Study||6||
48155501|NCT01525602|100703125|FG007|NOT COMPLETED|Overall Study||7||
48155502|NCT01197508|100703126|FG000|STARTED|Overall Study||174||
48155503|NCT01197508|100703127|FG001|STARTED|Overall Study||174||
48612663|NCT04736069|101838327|FG001|COMPLETED|Overall Study||22||
48612664|NCT04736069|101838326|FG000|NOT COMPLETED|Overall Study||0||
48155504|NCT01197508|100703128|FG002|STARTED|Overall Study||174||
48155505|NCT01197508|100703129|FG003|STARTED|Overall Study||174||
48612665|NCT04736069|101838327|FG001|NOT COMPLETED|Overall Study||8||
48612666|NCT01922258|101838328|FG000|STARTED|Overall Study||133||
48612667|NCT01922258|101838329|FG001|STARTED|Overall Study||137||
48155506|NCT01197508|100703126|FG000|Received Treatment|Overall Study||174||
48155507|NCT01197508|100703127|FG001|Received Treatment|Overall Study||174||
48155508|NCT01197508|100703128|FG002|Received Treatment|Overall Study||171||
48155509|NCT01197508|100703129|FG003|Received Treatment|Overall Study||174||
48155510|NCT01197508|100703126|FG000|COMPLETED|Overall Study||151||
48155511|NCT01197508|100703127|FG001|COMPLETED|Overall Study||144||
48155512|NCT01197508|100703128|FG002|COMPLETED|Overall Study||125||
48155513|NCT01197508|100703129|FG003|COMPLETED|Overall Study||158||
48155514|NCT01197508|100703126|FG000|NOT COMPLETED|Overall Study||23||
48155515|NCT01197508|100703127|FG001|NOT COMPLETED|Overall Study||30||
48155516|NCT01197508|100703128|FG002|NOT COMPLETED|Overall Study||49||
48155517|NCT01197508|100703129|FG003|NOT COMPLETED|Overall Study||16||
48155518|NCT02532556|100703130|FG000|STARTED|Overall Study||12||
48155519|NCT02532556|100703130|FG000|COMPLETED|Overall Study||12||
48155520|NCT02532556|100703130|FG000|NOT COMPLETED|Overall Study||0||
48155521|NCT01566331|100703131|FG000|STARTED|Overall Study||40||
48155522|NCT01566331|100703132|FG001|STARTED|Overall Study||40||
48155523|NCT01566331|100703131|FG000|COMPLETED|Overall Study||40||
48155524|NCT01566331|100703132|FG001|COMPLETED|Overall Study||40||
48155525|NCT01566331|100703131|FG000|NOT COMPLETED|Overall Study||0||
48155526|NCT01566331|100703132|FG001|NOT COMPLETED|Overall Study||0||
48155527|NCT01373931|100703133|FG000|STARTED|Lead-in Period||10||
48155528|NCT01373931|100703134|FG001|STARTED|Lead-in Period||10||
48310534|NCT00078325|101087875|FG002|STARTED|Overall Study||131||
48310535|NCT00078325|101087873|FG000|COMPLETED|Overall Study||110||
48310536|NCT00078325|101087874|FG001|COMPLETED|Overall Study||114||
48310537|NCT00078325|101087875|FG002|COMPLETED|Overall Study||120||
48310538|NCT00078325|101087873|FG000|NOT COMPLETED|Overall Study||21||
48612668|NCT01922258|101838328|FG000|COMPLETED|Overall Study||117||
48612669|NCT01922258|101838329|FG001|COMPLETED|Overall Study||121||
48612670|NCT01922258|101838328|FG000|NOT COMPLETED|Overall Study||16||
48612671|NCT01922258|101838329|FG001|NOT COMPLETED|Overall Study||16||
48155529|NCT01373931|100703133|FG000|Received at Least 1 Dose of Study Drug|Lead-in Period||8||
48155530|NCT01373931|100703134|FG001|Received at Least 1 Dose of Study Drug|Lead-in Period||10||
48155531|NCT01373931|100703133|FG000|COMPLETED|Lead-in Period||8||
48612672|NCT01218971|101838330|FG000|STARTED|Overall Study||175||
48612673|NCT01218971|101838331|FG001|STARTED|Overall Study||157||
48612674|NCT01218971|101838330|FG000|COMPLETED|Overall Study||71||
48612675|NCT01218971|101838331|FG001|COMPLETED|Overall Study||77||
48612676|NCT01218971|101838330|FG000|NOT COMPLETED|Overall Study||104||
48612677|NCT01218971|101838331|FG001|NOT COMPLETED|Overall Study||80||
48612678|NCT02609386|101838332|FG000|STARTED|Overall Study||70||
48612679|NCT02609386|101838333|FG001|STARTED|Overall Study||35||
48612680|NCT02609386|101838332|FG000|COMPLETED|Overall Study||42||
48155532|NCT01373931|100703134|FG001|COMPLETED|Lead-in Period||10||
48155533|NCT01373931|100703133|FG000|NOT COMPLETED|Lead-in Period||2||
48155534|NCT01373931|100703134|FG001|NOT COMPLETED|Lead-in Period||0||
48155535|NCT01373931|100703133|FG000|STARTED|Period 1||8||
48155536|NCT01373931|100703134|FG001|STARTED|Period 1||10||
48155537|NCT01373931|100703133|FG000|COMPLETED|Period 1||6||
48155538|NCT01373931|100703134|FG001|COMPLETED|Period 1||8||
48155539|NCT01373931|100703133|FG000|NOT COMPLETED|Period 1||2||
48155540|NCT01373931|100703134|FG001|NOT COMPLETED|Period 1||2||
48155541|NCT01373931|100703133|FG000|STARTED|Period 2||6||
48155542|NCT01373931|100703134|FG001|STARTED|Period 2||8||
48155543|NCT01373931|100703133|FG000|COMPLETED|Period 2||6||
48310539|NCT00078325|101087874|FG001|NOT COMPLETED|Overall Study||19||
48612681|NCT02609386|101838333|FG001|COMPLETED|Overall Study||18||
48612682|NCT02609386|101838332|FG000|NOT COMPLETED|Overall Study||28||
48612683|NCT02609386|101838333|FG001|NOT COMPLETED|Overall Study||17||
48612684|NCT03020550|101838334|FG000|STARTED|Overall Study||8||
48612685|NCT03020550|101838335|FG001|STARTED|Overall Study||16||
48612686|NCT03020550|101838334|FG000|COMPLETED|Overall Study||8||
48612687|NCT03020550|101838335|FG001|COMPLETED|Overall Study||16||
48612688|NCT03020550|101838334|FG000|NOT COMPLETED|Overall Study||0||
48612689|NCT03020550|101838335|FG001|NOT COMPLETED|Overall Study||0||
48612690|NCT00482170|101838336|FG000|STARTED|Overall Study||207||
48612691|NCT00482170|101838337|FG001|STARTED|Overall Study||214||
48612692|NCT00482170|101838336|FG000|Treated|Overall Study||207||
48612693|NCT00482170|101838337|FG001|Treated|Overall Study||211||
48612694|NCT00482170|101838336|FG000|COMPLETED|Overall Study||192||
48612695|NCT00482170|101838337|FG001|COMPLETED|Overall Study||194||
48612696|NCT00482170|101838336|FG000|NOT COMPLETED|Overall Study||15||
48612697|NCT00482170|101838337|FG001|NOT COMPLETED|Overall Study||20||
48155544|NCT01373931|100703134|FG001|COMPLETED|Period 2||8||
48155545|NCT01373931|100703133|FG000|NOT COMPLETED|Period 2||0||
48155546|NCT01373931|100703134|FG001|NOT COMPLETED|Period 2||0||
48155547|NCT06097676|100703135|FG000|STARTED|Overall Study||6||
48155548|NCT06097676|100703136|FG001|STARTED|Overall Study||5||
48612698|NCT01556997|101838338|FG000|STARTED|Overall Study||279||
48155549|NCT06097676|100703137|FG002|STARTED|Overall Study||5||
48155550|NCT06097676|100703138|FG003|STARTED|Overall Study||5||
48155551|NCT06097676|100703139|FG004|STARTED|Overall Study||5||
48612699|NCT01556997|101838339|FG001|STARTED|Overall Study||280||
48406605|NCT01355497|101328451|FG000|NOT COMPLETED|Overall Study||66||
48725936|NCT00844558|102115004|FG000|Received Allocated Intervention|Overall Study||33||
48725937|NCT00844558|102115005|FG001|Received Allocated Intervention|Overall Study||21||
48725938|NCT00844558|102115004|FG000|3 Month Visit|Overall Study||29||
48725939|NCT00844558|102115005|FG001|3 Month Visit|Overall Study||19||
48725940|NCT00844558|102115004|FG000|6 Month Visit|Overall Study||28||
48725941|NCT00844558|102115005|FG001|6 Month Visit|Overall Study||18||
48725942|NCT00844558|102115004|FG000|12 Month Visit|Overall Study||24||
48725943|NCT00844558|102115005|FG001|12 Month Visit|Overall Study||18||
48725944|NCT00844558|102115004|FG000|COMPLETED|Overall Study||24||
48725945|NCT00844558|102115005|FG001|COMPLETED|Overall Study||18||
48725946|NCT00844558|102115004|FG000|NOT COMPLETED|Overall Study||12||
48725947|NCT00844558|102115005|FG001|NOT COMPLETED|Overall Study||4||
48725948|NCT00454181|102115006|FG000|STARTED|Overall Study||45||
48725949|NCT00454181|102115007|FG001|STARTED|Overall Study||14||
48725950|NCT00454181|102115006|FG000|COMPLETED|Overall Study||30||
48725951|NCT00454181|102115007|FG001|COMPLETED|Overall Study||11||
48725952|NCT00454181|102115006|FG000|NOT COMPLETED|Overall Study||15||
48725953|NCT00454181|102115007|FG001|NOT COMPLETED|Overall Study||3||
48725954|NCT00678834|102115008|FG000|STARTED|Overall Study||40||
48725955|NCT00678834|102115009|FG001|STARTED|Overall Study||15||
48725956|NCT00678834|102115010|FG002|STARTED|Overall Study||25||
48725957|NCT00678834|102115008|FG000|COMPLETED|Overall Study||24||
48725958|NCT00678834|102115009|FG001|COMPLETED|Overall Study||15||
48725959|NCT00678834|102115010|FG002|COMPLETED|Overall Study||16||
48725960|NCT00678834|102115008|FG000|NOT COMPLETED|Overall Study||16||
48725961|NCT00678834|102115009|FG001|NOT COMPLETED|Overall Study||0||
48725962|NCT00678834|102115010|FG002|NOT COMPLETED|Overall Study||9||
48725963|NCT00788710|102115011|FG000|STARTED|Overall Study||144||
48725964|NCT00788710|102115012|FG001|STARTED|Overall Study||142||
48725965|NCT00788710|102115013|FG002|STARTED|Overall Study||144||
48725966|NCT00788710|102115011|FG000|COMPLETED|Overall Study||139||
48725967|NCT00788710|102115012|FG001|COMPLETED|Overall Study||134||
48725968|NCT00788710|102115013|FG002|COMPLETED|Overall Study||138||
48725969|NCT00788710|102115011|FG000|NOT COMPLETED|Overall Study||5||
48725970|NCT00788710|102115012|FG001|NOT COMPLETED|Overall Study||8||
48725971|NCT00788710|102115013|FG002|NOT COMPLETED|Overall Study||6||
48725972|NCT01276223|102115014|FG000|STARTED|Overall Study||78||
48725973|NCT01276223|102115015|FG001|STARTED|Overall Study||107||
48725974|NCT01276223|102115016|FG002|STARTED|Overall Study||104||
48725975|NCT01276223|102115014|FG000|COMPLETED|Overall Study||67||
48725976|NCT01276223|102115015|FG001|COMPLETED|Overall Study||103||
48725977|NCT01276223|102115016|FG002|COMPLETED|Overall Study||101||
48725978|NCT01276223|102115014|FG000|NOT COMPLETED|Overall Study||11||
48725979|NCT01276223|102115015|FG001|NOT COMPLETED|Overall Study||4||
48725980|NCT01276223|102115016|FG002|NOT COMPLETED|Overall Study||3||
48725981|NCT02999633|102115017|FG000|STARTED|Overall Study||14||
48725982|NCT02999633|102115017|FG000|COMPLETED|Overall Study||0||
48725983|NCT02999633|102115017|FG000|NOT COMPLETED|Overall Study||14||
48725984|NCT00671606|102115018|FG000|STARTED|Overall Study||5||
48725985|NCT00671606|102115018|FG000|COMPLETED|Overall Study||5||
48725986|NCT00671606|102115018|FG000|NOT COMPLETED|Overall Study||0||
48725987|NCT02837042|102115019|FG000|STARTED|Overall Study||6||
48725988|NCT02837042|102115019|FG000|COMPLETED|Overall Study||6||
48725989|NCT02837042|102115019|FG000|NOT COMPLETED|Overall Study||0||
48725990|NCT00852241|102115020|FG000|STARTED|Overall Study||18||
48725991|NCT00852241|102115020|FG000|COMPLETED|Overall Study||0||
48725992|NCT00852241|102115020|FG000|NOT COMPLETED|Overall Study||18||
48725993|NCT02524418|102115021|FG000|STARTED|Overall Study||88||
48725994|NCT02524418|102115021|FG000|COMPLETED|Overall Study||75||
48725995|NCT02524418|102115021|FG000|NOT COMPLETED|Overall Study||13||
48725996|NCT00908037|102115022|FG000|STARTED|Part1 (24 Week Dose-Finding Period)||5||
48725997|NCT00908037|102115023|FG001|STARTED|Part1 (24 Week Dose-Finding Period)||5||
48725998|NCT00908037|102115024|FG002|STARTED|Part1 (24 Week Dose-Finding Period)||5||
48725999|NCT00908037|102115025|FG003|STARTED|Part1 (24 Week Dose-Finding Period)||0||
48726000|NCT00908037|102115026|FG004|STARTED|Part1 (24 Week Dose-Finding Period)||0||
48726001|NCT00908037|102115027|FG005|STARTED|Part1 (24 Week Dose-Finding Period)||0||
48726002|NCT00908037|102115028|FG006|STARTED|Part1 (24 Week Dose-Finding Period)||0||
48726003|NCT00908037|102115029|FG007|STARTED|Part1 (24 Week Dose-Finding Period)||0||
48726004|NCT00908037|102115030|FG008|STARTED|Part1 (24 Week Dose-Finding Period)||0||
48726005|NCT00908037|102115031|FG009|STARTED|Part1 (24 Week Dose-Finding Period)||0||
48726006|NCT00908037|102115032|FG010|STARTED|Part1 (24 Week Dose-Finding Period)||0||
48726007|NCT00908037|102115033|FG011|STARTED|Part1 (24 Week Dose-Finding Period)||0||
48726008|NCT00908037|102115022|FG000|COMPLETED|Part1 (24 Week Dose-Finding Period)||5||
48726009|NCT00908037|102115023|FG001|COMPLETED|Part1 (24 Week Dose-Finding Period)||5||
48726010|NCT00908037|102115024|FG002|COMPLETED|Part1 (24 Week Dose-Finding Period)||5||
48726011|NCT00908037|102115025|FG003|COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
48310540|NCT00078325|101087875|FG002|NOT COMPLETED|Overall Study||11||
48310541|NCT00711425|101087876|FG000|STARTED|Overall Study||45||
48310542|NCT00711425|101087876|FG000|COMPLETED|Overall Study||41||
48310543|NCT00711425|101087876|FG000|NOT COMPLETED|Overall Study||4||
48310544|NCT02689284|101087877|FG000|STARTED|Overall Study||3||
48310545|NCT02689284|101087878|FG001|STARTED|Overall Study||92||
48310546|NCT02689284|101087877|FG000|COMPLETED|Overall Study||0||
48310547|NCT02689284|101087878|FG001|COMPLETED|Overall Study||5||
48310548|NCT02689284|101087877|FG000|NOT COMPLETED|Overall Study||3||
48310549|NCT02689284|101087878|FG001|NOT COMPLETED|Overall Study||87||
48310550|NCT04196803|101087879|FG000|STARTED|Overall Study||124||
48310551|NCT04196803|101087880|FG001|STARTED|Overall Study||126||
48310552|NCT04196803|101087879|FG000|COMPLETED|Overall Study||119||
48310553|NCT04196803|101087880|FG001|COMPLETED|Overall Study||120||
48310554|NCT04196803|101087879|FG000|NOT COMPLETED|Overall Study||5||
48310555|NCT04196803|101087880|FG001|NOT COMPLETED|Overall Study||6||
48310556|NCT05513625|101087881|FG000|STARTED|Overall Study||16||
48310557|NCT05513625|101087881|FG000|COMPLETED|Overall Study||15||
48310558|NCT05513625|101087881|FG000|NOT COMPLETED|Overall Study||1||
48310559|NCT01045798|101087882|FG000|STARTED|Overall Study||6||
48310560|NCT01045798|101087883|FG001|STARTED|Overall Study||9||
48310561|NCT01045798|101087882|FG000|COMPLETED|Overall Study||4||
48310562|NCT01045798|101087883|FG001|COMPLETED|Overall Study||5||
48310563|NCT01045798|101087882|FG000|NOT COMPLETED|Overall Study||2||
48310564|NCT01045798|101087883|FG001|NOT COMPLETED|Overall Study||4||
48310565|NCT01817907|101087884|FG000|STARTED|First Intervention||8||
48310566|NCT01817907|101087885|FG001|STARTED|First Intervention||7||
48310567|NCT01817907|101087884|FG000|COMPLETED|First Intervention||8||
48310568|NCT01817907|101087885|FG001|COMPLETED|First Intervention||7||
48310569|NCT01817907|101087884|FG000|NOT COMPLETED|First Intervention||0||
48310570|NCT01817907|101087885|FG001|NOT COMPLETED|First Intervention||0||
48310571|NCT01817907|101087884|FG000|STARTED|Washout Period||8||
48310572|NCT01817907|101087885|FG001|STARTED|Washout Period||7||
48310573|NCT01817907|101087884|FG000|COMPLETED|Washout Period||8||
48726012|NCT00908037|102115026|FG004|COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
48726013|NCT00908037|102115027|FG005|COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
48726014|NCT00908037|102115028|FG006|COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
48726015|NCT00908037|102115029|FG007|COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
48726016|NCT00908037|102115030|FG008|COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
48726017|NCT00908037|102115031|FG009|COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
48726018|NCT00908037|102115032|FG010|COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
48726019|NCT00908037|102115033|FG011|COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
48726020|NCT00908037|102115022|FG000|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
48726021|NCT00908037|102115023|FG001|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
48726022|NCT00908037|102115024|FG002|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
48726023|NCT00908037|102115025|FG003|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
48726024|NCT00908037|102115026|FG004|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
48726025|NCT00908037|102115027|FG005|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
48726026|NCT00908037|102115028|FG006|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
48726027|NCT00908037|102115029|FG007|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
48726028|NCT00908037|102115030|FG008|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
48726029|NCT00908037|102115031|FG009|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
48726030|NCT00908037|102115032|FG010|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
48310574|NCT01817907|101087885|FG001|COMPLETED|Washout Period||7||
48310575|NCT01817907|101087884|FG000|NOT COMPLETED|Washout Period||0||
48310576|NCT01817907|101087885|FG001|NOT COMPLETED|Washout Period||0||
48310577|NCT01817907|101087884|FG000|STARTED|Second Intervention||8||
48310578|NCT01817907|101087885|FG001|STARTED|Second Intervention||7||
48310579|NCT01817907|101087884|FG000|COMPLETED|Second Intervention||8||
48310580|NCT01817907|101087885|FG001|COMPLETED|Second Intervention||7||
48310581|NCT01817907|101087884|FG000|NOT COMPLETED|Second Intervention||0||
48310582|NCT01817907|101087885|FG001|NOT COMPLETED|Second Intervention||0||
48310583|NCT01202279|101087886|FG000|STARTED|Overall Study||591||
48726031|NCT00908037|102115033|FG011|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
48726032|NCT00908037|102115022|FG000|STARTED|Part 2 (7 Week Randomized Period)||0||
48726033|NCT00908037|102115023|FG001|STARTED|Part 2 (7 Week Randomized Period)||0||
48310584|NCT01202279|101087887|FG001|STARTED|Overall Study||588||
48310585|NCT01202279|101087886|FG000|COMPLETED|Overall Study||554||
48310586|NCT01202279|101087887|FG001|COMPLETED|Overall Study||561||
48310587|NCT01202279|101087886|FG000|NOT COMPLETED|Overall Study||37||
48310588|NCT01202279|101087887|FG001|NOT COMPLETED|Overall Study||27||
48310589|NCT01536951|101087888|FG000|STARTED|First Intervention and Washout Period 1||3||
48310590|NCT01536951|101087889|FG001|STARTED|First Intervention and Washout Period 1||3||
48310591|NCT01536951|101087890|FG002|STARTED|First Intervention and Washout Period 1||3||
48310592|NCT01536951|101087891|FG003|STARTED|First Intervention and Washout Period 1||8||
48310593|NCT01536951|101087892|FG004|STARTED|First Intervention and Washout Period 1||9||
48310594|NCT01536951|101087893|FG005|STARTED|First Intervention and Washout Period 1||9||
48310595|NCT01536951|101087894|FG006|STARTED|First Intervention and Washout Period 1||9||
48310596|NCT01536951|101087895|FG007|STARTED|First Intervention and Washout Period 1||9||
48310597|NCT01536951|101087896|FG008|STARTED|First Intervention and Washout Period 1||9||
48310598|NCT01536951|101087888|FG000|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3||
48310599|NCT01536951|101087889|FG001|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3||
48310600|NCT01536951|101087890|FG002|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3||
48310601|NCT01536951|101087891|FG003|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||8||
48310602|NCT01536951|101087892|FG004|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9||
48310603|NCT01536951|101087893|FG005|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9||
48310604|NCT01536951|101087894|FG006|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9||
48310605|NCT01536951|101087895|FG007|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9||
48310606|NCT01536951|101087896|FG008|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9||
48310607|NCT01536951|101087888|FG000|COMPLETED|First Intervention and Washout Period 1||3||
48310608|NCT01536951|101087889|FG001|COMPLETED|First Intervention and Washout Period 1||3||
48310609|NCT01536951|101087890|FG002|COMPLETED|First Intervention and Washout Period 1||2||
48310610|NCT01536951|101087891|FG003|COMPLETED|First Intervention and Washout Period 1||8||
48310611|NCT01536951|101087892|FG004|COMPLETED|First Intervention and Washout Period 1||9||
48310612|NCT01536951|101087893|FG005|COMPLETED|First Intervention and Washout Period 1||9||
48310613|NCT01536951|101087894|FG006|COMPLETED|First Intervention and Washout Period 1||9||
48310614|NCT01536951|101087895|FG007|COMPLETED|First Intervention and Washout Period 1||9||
48310615|NCT01536951|101087896|FG008|COMPLETED|First Intervention and Washout Period 1||9||
48310616|NCT01536951|101087888|FG000|NOT COMPLETED|First Intervention and Washout Period 1||0||
48310617|NCT01536951|101087889|FG001|NOT COMPLETED|First Intervention and Washout Period 1||0||
48310618|NCT01536951|101087890|FG002|NOT COMPLETED|First Intervention and Washout Period 1||1||
48310619|NCT01536951|101087891|FG003|NOT COMPLETED|First Intervention and Washout Period 1||0||
48310620|NCT01536951|101087892|FG004|NOT COMPLETED|First Intervention and Washout Period 1||0||
48310621|NCT01536951|101087893|FG005|NOT COMPLETED|First Intervention and Washout Period 1||0||
48310622|NCT01536951|101087894|FG006|NOT COMPLETED|First Intervention and Washout Period 1||0||
48310623|NCT01536951|101087895|FG007|NOT COMPLETED|First Intervention and Washout Period 1||0||
48368034|NCT03567291|101230095|FG003|COMPLETED|Period II||0||
48726034|NCT00908037|102115024|FG002|STARTED|Part 2 (7 Week Randomized Period)||0||
48155552|NCT06097676|100703140|FG005|STARTED|Overall Study||5||
48726035|NCT00908037|102115025|FG003|STARTED|Part 2 (7 Week Randomized Period)||8||
48726036|NCT00908037|102115026|FG004|STARTED|Part 2 (7 Week Randomized Period)||16||
48726037|NCT00908037|102115027|FG005|STARTED|Part 2 (7 Week Randomized Period)||9||
48726038|NCT00908037|102115028|FG006|STARTED|Part 2 (7 Week Randomized Period)||19||
48726039|NCT00908037|102115029|FG007|STARTED|Part 2 (7 Week Randomized Period)||5||
48726040|NCT00908037|102115030|FG008|STARTED|Part 2 (7 Week Randomized Period)||10||
48310624|NCT01536951|101087896|FG008|NOT COMPLETED|First Intervention and Washout Period 1||0||
48155553|NCT06097676|100703141|FG006|STARTED|Overall Study||5||
48155554|NCT06097676|100703142|FG007|STARTED|Overall Study||5||
48155555|NCT06097676|100703143|FG008|STARTED|Overall Study||5||
48155556|NCT06097676|100703144|FG009|STARTED|Overall Study||5||
48155557|NCT06097676|100703135|FG000|COMPLETED|Overall Study||6||
48310625|NCT01536951|101087888|FG000|STARTED|Second Intervention and Washout Period 2||3||
48310626|NCT01536951|101087889|FG001|STARTED|Second Intervention and Washout Period 2||3||
48310627|NCT01536951|101087890|FG002|STARTED|Second Intervention and Washout Period 2||2||
48310628|NCT01536951|101087891|FG003|STARTED|Second Intervention and Washout Period 2||8||
48310629|NCT01536951|101087892|FG004|STARTED|Second Intervention and Washout Period 2||9||
48310630|NCT01536951|101087893|FG005|STARTED|Second Intervention and Washout Period 2||9||
48310631|NCT01536951|101087894|FG006|STARTED|Second Intervention and Washout Period 2||9||
48310632|NCT01536951|101087895|FG007|STARTED|Second Intervention and Washout Period 2||9||
48310633|NCT01536951|101087896|FG008|STARTED|Second Intervention and Washout Period 2||9||
48726041|NCT00908037|102115031|FG009|STARTED|Part 2 (7 Week Randomized Period)||0||
48726042|NCT00908037|102115032|FG010|STARTED|Part 2 (7 Week Randomized Period)||0||
48155558|NCT06097676|100703136|FG001|COMPLETED|Overall Study||5||
48310634|NCT01536951|101087888|FG000|COMPLETED|Second Intervention and Washout Period 2||3||
48726043|NCT00908037|102115033|FG011|STARTED|Part 2 (7 Week Randomized Period)||0||
48726044|NCT00908037|102115022|FG000|COMPLETED|Part 2 (7 Week Randomized Period)||0||
48726045|NCT00908037|102115023|FG001|COMPLETED|Part 2 (7 Week Randomized Period)||0||
48726046|NCT00908037|102115024|FG002|COMPLETED|Part 2 (7 Week Randomized Period)||0||
48726047|NCT00908037|102115025|FG003|COMPLETED|Part 2 (7 Week Randomized Period)||7||
48726048|NCT00908037|102115026|FG004|COMPLETED|Part 2 (7 Week Randomized Period)||13||
48726049|NCT00908037|102115027|FG005|COMPLETED|Part 2 (7 Week Randomized Period)||9||
48726050|NCT00908037|102115028|FG006|COMPLETED|Part 2 (7 Week Randomized Period)||15||
48726051|NCT00908037|102115029|FG007|COMPLETED|Part 2 (7 Week Randomized Period)||5||
48726052|NCT00908037|102115030|FG008|COMPLETED|Part 2 (7 Week Randomized Period)||5||
48726053|NCT00908037|102115031|FG009|COMPLETED|Part 2 (7 Week Randomized Period)||0||
48726054|NCT00908037|102115032|FG010|COMPLETED|Part 2 (7 Week Randomized Period)||0||
48726055|NCT00908037|102115033|FG011|COMPLETED|Part 2 (7 Week Randomized Period)||0||
48726056|NCT00908037|102115022|FG000|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0||
48726057|NCT00908037|102115023|FG001|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0||
48726058|NCT00908037|102115024|FG002|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0||
48726059|NCT00908037|102115025|FG003|NOT COMPLETED|Part 2 (7 Week Randomized Period)||1||
48726060|NCT00908037|102115026|FG004|NOT COMPLETED|Part 2 (7 Week Randomized Period)||3||
48726061|NCT00908037|102115027|FG005|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0||
48726062|NCT00908037|102115028|FG006|NOT COMPLETED|Part 2 (7 Week Randomized Period)||4||
48726063|NCT00908037|102115029|FG007|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0||
48726064|NCT00908037|102115030|FG008|NOT COMPLETED|Part 2 (7 Week Randomized Period)||5||
48726065|NCT00908037|102115031|FG009|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0||
48726066|NCT00908037|102115032|FG010|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0||
48726067|NCT00908037|102115033|FG011|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0||
48726068|NCT00908037|102115022|FG000|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0||
48726069|NCT00908037|102115023|FG001|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0||
48726070|NCT00908037|102115024|FG002|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0||
48726071|NCT00908037|102115025|FG003|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0||
48726072|NCT00908037|102115026|FG004|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0||
48726073|NCT00908037|102115027|FG005|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0||
48726074|NCT00908037|102115028|FG006|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0||
48726075|NCT00908037|102115029|FG007|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0||
48726076|NCT00908037|102115030|FG008|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0||
48726077|NCT00908037|102115031|FG009|STARTED|Part 2/3(Eltrombopag Open-Label Period)||24||
48726078|NCT00908037|102115032|FG010|STARTED|Part 2/3(Eltrombopag Open-Label Period)||28||
48155559|NCT06097676|100703137|FG002|COMPLETED|Overall Study||5||
48155560|NCT06097676|100703138|FG003|COMPLETED|Overall Study||5||
48155561|NCT06097676|100703139|FG004|COMPLETED|Overall Study||5||
48155562|NCT06097676|100703140|FG005|COMPLETED|Overall Study||4||
48155563|NCT06097676|100703141|FG006|COMPLETED|Overall Study||5||
48155564|NCT06097676|100703142|FG007|COMPLETED|Overall Study||4||
48155565|NCT06097676|100703143|FG008|COMPLETED|Overall Study||4||
48310635|NCT01536951|101087889|FG001|COMPLETED|Second Intervention and Washout Period 2||3||
48155566|NCT06097676|100703144|FG009|COMPLETED|Overall Study||5||
48726079|NCT00908037|102115033|FG011|STARTED|Part 2/3(Eltrombopag Open-Label Period)||15||
48155567|NCT06097676|100703135|FG000|NOT COMPLETED|Overall Study||0||
48155568|NCT06097676|100703136|FG001|NOT COMPLETED|Overall Study||0||
48155569|NCT06097676|100703137|FG002|NOT COMPLETED|Overall Study||0||
48726080|NCT00908037|102115022|FG000|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
48726081|NCT00908037|102115023|FG001|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
48726082|NCT00908037|102115024|FG002|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
48726083|NCT00908037|102115025|FG003|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
48726084|NCT00908037|102115026|FG004|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
48726085|NCT00908037|102115027|FG005|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
48726086|NCT00908037|102115028|FG006|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
48726087|NCT00908037|102115029|FG007|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
48726088|NCT00908037|102115030|FG008|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
48726089|NCT00908037|102115031|FG009|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||21||
48726090|NCT00908037|102115032|FG010|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||24||
48310636|NCT01536951|101087890|FG002|COMPLETED|Second Intervention and Washout Period 2||2||
48310637|NCT01536951|101087891|FG003|COMPLETED|Second Intervention and Washout Period 2||8||
48310638|NCT01536951|101087892|FG004|COMPLETED|Second Intervention and Washout Period 2||9||
48310639|NCT01536951|101087893|FG005|COMPLETED|Second Intervention and Washout Period 2||9||
48310640|NCT01536951|101087894|FG006|COMPLETED|Second Intervention and Washout Period 2||9||
48726091|NCT00908037|102115033|FG011|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||12||
48726092|NCT00908037|102115022|FG000|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
48726093|NCT00908037|102115023|FG001|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
48726094|NCT00908037|102115024|FG002|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
48726095|NCT00908037|102115025|FG003|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
48726096|NCT00908037|102115026|FG004|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
48726097|NCT00908037|102115027|FG005|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
48726098|NCT00908037|102115028|FG006|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
48726099|NCT00908037|102115029|FG007|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
48726100|NCT00908037|102115030|FG008|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
48726101|NCT00908037|102115031|FG009|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3||
48726102|NCT00908037|102115032|FG010|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||4||
48726103|NCT00908037|102115033|FG011|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3||
48310641|NCT01536951|101087895|FG007|COMPLETED|Second Intervention and Washout Period 2||8||
48310642|NCT01536951|101087896|FG008|COMPLETED|Second Intervention and Washout Period 2||9||
48310643|NCT01536951|101087888|FG000|NOT COMPLETED|Second Intervention and Washout Period 2||0||
48310644|NCT01536951|101087889|FG001|NOT COMPLETED|Second Intervention and Washout Period 2||0||
48310645|NCT01536951|101087890|FG002|NOT COMPLETED|Second Intervention and Washout Period 2||0||
48310646|NCT01536951|101087891|FG003|NOT COMPLETED|Second Intervention and Washout Period 2||0||
48726104|NCT02973516|102115034|FG000|STARTED|Overall Study||30||
48726105|NCT02973516|102115035|FG001|STARTED|Overall Study||10||
48726106|NCT02973516|102115034|FG000|COMPLETED|Overall Study||30||
48310647|NCT01536951|101087892|FG004|NOT COMPLETED|Second Intervention and Washout Period 2||0||
48310648|NCT01536951|101087893|FG005|NOT COMPLETED|Second Intervention and Washout Period 2||0||
48310649|NCT01536951|101087894|FG006|NOT COMPLETED|Second Intervention and Washout Period 2||0||
48310650|NCT01536951|101087895|FG007|NOT COMPLETED|Second Intervention and Washout Period 2||1||
48310651|NCT01536951|101087896|FG008|NOT COMPLETED|Second Intervention and Washout Period 2||0||
48310652|NCT01536951|101087888|FG000|STARTED|Third Intervention||3||
48310653|NCT01536951|101087889|FG001|STARTED|Third Intervention||3||
48310654|NCT01536951|101087890|FG002|STARTED|Third Intervention||2||
48310655|NCT01536951|101087891|FG003|STARTED|Third Intervention||8||
48310656|NCT01536951|101087892|FG004|STARTED|Third Intervention||9||
48310657|NCT01536951|101087893|FG005|STARTED|Third Intervention||9||
48310658|NCT01536951|101087894|FG006|STARTED|Third Intervention||9||
48310659|NCT01536951|101087895|FG007|STARTED|Third Intervention||8||
48310660|NCT01536951|101087896|FG008|STARTED|Third Intervention||9||
48310661|NCT01536951|101087888|FG000|COMPLETED|Third Intervention||3||
48310662|NCT01536951|101087889|FG001|COMPLETED|Third Intervention||3||
48310663|NCT01536951|101087890|FG002|COMPLETED|Third Intervention||2||
48310664|NCT01536951|101087891|FG003|COMPLETED|Third Intervention||8||
48310665|NCT01536951|101087892|FG004|COMPLETED|Third Intervention||9||
48310666|NCT01536951|101087893|FG005|COMPLETED|Third Intervention||9||
48310667|NCT01536951|101087894|FG006|COMPLETED|Third Intervention||9||
48310668|NCT01536951|101087895|FG007|COMPLETED|Third Intervention||8||
48310669|NCT01536951|101087896|FG008|COMPLETED|Third Intervention||9||
48726107|NCT02973516|102115035|FG001|COMPLETED|Overall Study||10||
48726108|NCT02973516|102115034|FG000|NOT COMPLETED|Overall Study||0||
48726109|NCT02973516|102115035|FG001|NOT COMPLETED|Overall Study||0||
48726110|NCT02328027|102115036|FG000|STARTED|Overall Study||5||
48310670|NCT01536951|101087888|FG000|NOT COMPLETED|Third Intervention||0||
48310671|NCT01536951|101087889|FG001|NOT COMPLETED|Third Intervention||0||
48726111|NCT02328027|102115037|FG001|STARTED|Overall Study||11||
48726112|NCT02328027|102115036|FG000|COMPLETED|Overall Study||5||
48310672|NCT01536951|101087890|FG002|NOT COMPLETED|Third Intervention||0||
48310673|NCT01536951|101087891|FG003|NOT COMPLETED|Third Intervention||0||
48310674|NCT01536951|101087892|FG004|NOT COMPLETED|Third Intervention||0||
48310675|NCT01536951|101087893|FG005|NOT COMPLETED|Third Intervention||0||
48726113|NCT02328027|102115037|FG001|COMPLETED|Overall Study||10||
48726114|NCT02328027|102115036|FG000|NOT COMPLETED|Overall Study||0||
48726115|NCT02328027|102115037|FG001|NOT COMPLETED|Overall Study||1||
48726116|NCT05375214|102115038|FG000|STARTED|Overall Study||10||
48726117|NCT05375214|102115038|FG000|COMPLETED|Overall Study||10||
48726118|NCT05375214|102115038|FG000|NOT COMPLETED|Overall Study||0||
48726119|NCT04473664|102115039|FG000|STARTED|Overall Study||6||
48726120|NCT04473664|102115040|FG001|STARTED|Overall Study||6||
48726121|NCT04473664|102115039|FG000|COMPLETED|Overall Study||6||
48726122|NCT04473664|102115040|FG001|COMPLETED|Overall Study||6||
48726123|NCT04473664|102115039|FG000|NOT COMPLETED|Overall Study||0||
48726124|NCT04473664|102115040|FG001|NOT COMPLETED|Overall Study||0||
48726125|NCT02335424|102115041|FG000|STARTED|Overall Study||374||
48726126|NCT02335424|102115041|FG000|Treated|Overall Study||370||
48726127|NCT02335424|102115041|FG000|Received Second Course Treatment|Overall Study||13||
48726128|NCT02335424|102115041|FG000|COMPLETED|Overall Study||0||
48726129|NCT02335424|102115041|FG000|NOT COMPLETED|Overall Study||374||
48726130|NCT00545103|102115042|FG000|STARTED|Overall Study||148||
48726131|NCT00545103|102115043|FG001|STARTED|Overall Study||148||
48726132|NCT00545103|102115044|FG002|STARTED|Overall Study||150||
48726133|NCT00545103|102115045|FG003|STARTED|Overall Study||146||
48726134|NCT00545103|102115042|FG000|COMPLETED|Overall Study||73||
48726135|NCT00545103|102115043|FG001|COMPLETED|Overall Study||70||
48726136|NCT00545103|102115044|FG002|COMPLETED|Overall Study||74||
48726137|NCT00545103|102115045|FG003|COMPLETED|Overall Study||76||
48726138|NCT00545103|102115042|FG000|NOT COMPLETED|Overall Study||75||
48726139|NCT00545103|102115043|FG001|NOT COMPLETED|Overall Study||78||
48726140|NCT00545103|102115044|FG002|NOT COMPLETED|Overall Study||76||
48726141|NCT00545103|102115045|FG003|NOT COMPLETED|Overall Study||70||
48726142|NCT00861471|102115046|FG000|STARTED|Overall Study||12||
48726143|NCT00861471|102115046|FG000|COMPLETED|Overall Study||3||
48726144|NCT00861471|102115046|FG000|NOT COMPLETED|Overall Study||9||
48726145|NCT00498355|102115047|FG000|STARTED|Overall Study||7||
48726146|NCT00498355|102115047|FG000|COMPLETED|Overall Study||6||
48726147|NCT00498355|102115047|FG000|NOT COMPLETED|Overall Study||1||
48726148|NCT01452919|102115048|FG000|STARTED|Open-Label Treatment||123||
48726149|NCT01452919|102115049|FG001|STARTED|Open-Label Treatment||0||
48726150|NCT01452919|102115050|FG002|STARTED|Open-Label Treatment||0||
48726151|NCT01452919|102115048|FG000|Received at Least 1 Dose of Study Drug|Open-Label Treatment||123||
48726152|NCT01452919|102115049|FG001|Received at Least 1 Dose of Study Drug|Open-Label Treatment||0||
48726153|NCT01452919|102115050|FG002|Received at Least 1 Dose of Study Drug|Open-Label Treatment||0||
48726154|NCT01452919|102115048|FG000|COMPLETED|Open-Label Treatment||103||
48726155|NCT01452919|102115049|FG001|COMPLETED|Open-Label Treatment||0||
48726156|NCT01452919|102115050|FG002|COMPLETED|Open-Label Treatment||0||
48726157|NCT01452919|102115048|FG000|NOT COMPLETED|Open-Label Treatment||20||
48726158|NCT01452919|102115049|FG001|NOT COMPLETED|Open-Label Treatment||0||
48155570|NCT06097676|100703138|FG003|NOT COMPLETED|Overall Study||0||
48155571|NCT06097676|100703139|FG004|NOT COMPLETED|Overall Study||0||
48155572|NCT06097676|100703140|FG005|NOT COMPLETED|Overall Study||1||
48155573|NCT06097676|100703141|FG006|NOT COMPLETED|Overall Study||0||
48155574|NCT06097676|100703142|FG007|NOT COMPLETED|Overall Study||1||
48155575|NCT06097676|100703143|FG008|NOT COMPLETED|Overall Study||1||
48155576|NCT06097676|100703144|FG009|NOT COMPLETED|Overall Study||0||
48155577|NCT02636270|100703145|FG000|STARTED|Overall Study||3||
48155578|NCT02636270|100703146|FG001|STARTED|Overall Study||2||
48155579|NCT02636270|100703147|FG002|STARTED|Overall Study||2||
48155580|NCT02636270|100703145|FG000|COMPLETED|Overall Study||1||
48155581|NCT02636270|100703146|FG001|COMPLETED|Overall Study||2||
48155582|NCT02636270|100703147|FG002|COMPLETED|Overall Study||2||
48155583|NCT02636270|100703145|FG000|NOT COMPLETED|Overall Study||2||
48155584|NCT02636270|100703146|FG001|NOT COMPLETED|Overall Study||0||
48155585|NCT02636270|100703147|FG002|NOT COMPLETED|Overall Study||0||
48155586|NCT00116844|100703148|FG000|STARTED|Period 1: Treatment Period 1 (60 Days)||35||
48155587|NCT00116844|100703149|FG001|STARTED|Period 1: Treatment Period 1 (60 Days)||36||
48155588|NCT00116844|100703148|FG000|COMPLETED|Period 1: Treatment Period 1 (60 Days)||28||
48726159|NCT01452919|102115050|FG002|NOT COMPLETED|Open-Label Treatment||0||
48155589|NCT00116844|100703149|FG001|COMPLETED|Period 1: Treatment Period 1 (60 Days)||33||
48155590|NCT00116844|100703148|FG000|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||7||
48155591|NCT00116844|100703149|FG001|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||3||
48155592|NCT00116844|100703148|FG000|STARTED|Period 2: Washout Period (7 Days)||28||
48155593|NCT00116844|100703149|FG001|STARTED|Period 2: Washout Period (7 Days)||33||
48726160|NCT01452919|102115048|FG000|STARTED|Randomization Treatment||0||
48726161|NCT01452919|102115049|FG001|STARTED|Randomization Treatment||50||
48726162|NCT01452919|102115050|FG002|STARTED|Randomization Treatment||53||
48726163|NCT01452919|102115048|FG000|Received at Least 1 Dose of Study Drug|Randomization Treatment||0||
48726164|NCT01452919|102115049|FG001|Received at Least 1 Dose of Study Drug|Randomization Treatment||50||
48155594|NCT00116844|100703148|FG000|COMPLETED|Period 2: Washout Period (7 Days)||28||
48155595|NCT00116844|100703149|FG001|COMPLETED|Period 2: Washout Period (7 Days)||33||
48310676|NCT01536951|101087894|FG006|NOT COMPLETED|Third Intervention||0||
48310677|NCT01536951|101087895|FG007|NOT COMPLETED|Third Intervention||0||
48310678|NCT01536951|101087896|FG008|NOT COMPLETED|Third Intervention||0||
48310679|NCT00873366|101087897|FG000|STARTED|Overall Study||77||
48726165|NCT01452919|102115050|FG002|Received at Least 1 Dose of Study Drug|Randomization Treatment||53||
48726166|NCT01452919|102115048|FG000|COMPLETED|Randomization Treatment||0||
48726167|NCT01452919|102115049|FG001|COMPLETED|Randomization Treatment||47||
48726168|NCT01452919|102115050|FG002|COMPLETED|Randomization Treatment||51||
48726169|NCT01452919|102115048|FG000|NOT COMPLETED|Randomization Treatment||0||
48726170|NCT01452919|102115049|FG001|NOT COMPLETED|Randomization Treatment||3||
48726171|NCT01452919|102115050|FG002|NOT COMPLETED|Randomization Treatment||2||
48726172|NCT00828750|102115051|FG000|STARTED|Overall Study||19||
48726173|NCT00828750|102115051|FG000|COMPLETED|Overall Study||15||
48726174|NCT00828750|102115051|FG000|NOT COMPLETED|Overall Study||4||
48726175|NCT02891382|102115052|FG000|STARTED|Overall Study||18||
48726176|NCT02891382|102115053|FG001|STARTED|Overall Study||18||
48726177|NCT02891382|102115054|FG002|STARTED|Overall Study||18||
48726178|NCT02891382|102115055|FG003|STARTED|Overall Study||18||
48726179|NCT02891382|102115056|FG004|STARTED|Overall Study||18||
48726180|NCT02891382|102115052|FG000|COMPLETED|Overall Study||15||
48726181|NCT02891382|102115053|FG001|COMPLETED|Overall Study||14||
48726182|NCT02891382|102115054|FG002|COMPLETED|Overall Study||13||
48726183|NCT02891382|102115055|FG003|COMPLETED|Overall Study||15||
48726184|NCT02891382|102115056|FG004|COMPLETED|Overall Study||14||
48726185|NCT02891382|102115052|FG000|NOT COMPLETED|Overall Study||3||
48726186|NCT02891382|102115053|FG001|NOT COMPLETED|Overall Study||4||
48726187|NCT02891382|102115054|FG002|NOT COMPLETED|Overall Study||5||
48726188|NCT02891382|102115055|FG003|NOT COMPLETED|Overall Study||3||
48726189|NCT02891382|102115056|FG004|NOT COMPLETED|Overall Study||4||
48726190|NCT00666965|102115057|FG000|STARTED|Overall Study||58||
48726191|NCT00666965|102115058|FG001|STARTED|Overall Study||57||
48726192|NCT00666965|102115059|FG002|STARTED|Overall Study||58||
48726193|NCT00666965|102115060|FG003|STARTED|Overall Study||57||
48726194|NCT00666965|102115057|FG000|COMPLETED|Overall Study||55||
48726195|NCT00666965|102115058|FG001|COMPLETED|Overall Study||53||
48726196|NCT00666965|102115059|FG002|COMPLETED|Overall Study||56||
48726197|NCT00666965|102115060|FG003|COMPLETED|Overall Study||42||
48726198|NCT00666965|102115057|FG000|NOT COMPLETED|Overall Study||3||
48726199|NCT00666965|102115058|FG001|NOT COMPLETED|Overall Study||4||
48726200|NCT00666965|102115059|FG002|NOT COMPLETED|Overall Study||2||
48726201|NCT00666965|102115060|FG003|NOT COMPLETED|Overall Study||15||
48726202|NCT00620113|102115061|FG000|STARTED|Overall Study||73||
48726203|NCT00620113|102115062|FG001|STARTED|Overall Study||74||
48726204|NCT00620113|102115063|FG002|STARTED|Overall Study||71||
48726205|NCT00620113|102115064|FG003|STARTED|Overall Study||69||
48726206|NCT00620113|102115061|FG000|Efficacy/Safety Population|Overall Study||73||
48726207|NCT00620113|102115062|FG001|Efficacy/Safety Population|Overall Study||74||
48726208|NCT00620113|102115063|FG002|Efficacy/Safety Population|Overall Study||70||
48726209|NCT00620113|102115064|FG003|Efficacy/Safety Population|Overall Study||69||
48726210|NCT00620113|102115061|FG000|COMPLETED|Overall Study||60||
48726211|NCT00620113|102115062|FG001|COMPLETED|Overall Study||67||
48726212|NCT00620113|102115063|FG002|COMPLETED|Overall Study||66||
48726213|NCT00620113|102115064|FG003|COMPLETED|Overall Study||59||
48726214|NCT00620113|102115061|FG000|NOT COMPLETED|Overall Study||13||
48726215|NCT00620113|102115062|FG001|NOT COMPLETED|Overall Study||7||
48726216|NCT00620113|102115063|FG002|NOT COMPLETED|Overall Study||5||
48726217|NCT00620113|102115064|FG003|NOT COMPLETED|Overall Study||10||
48726218|NCT01211340|102115065|FG000|STARTED|Overall Study||223||
48726219|NCT01211340|102115066|FG001|STARTED|Overall Study||223||
48726220|NCT01211340|102115065|FG000|COMPLETED|Overall Study||223||
48726221|NCT01211340|102115066|FG001|COMPLETED|Overall Study||223||
48726222|NCT01211340|102115065|FG000|NOT COMPLETED|Overall Study||0||
48726223|NCT01211340|102115066|FG001|NOT COMPLETED|Overall Study||0||
48726224|NCT01571453|102115067|FG000|STARTED|Overall Study||211||
48726225|NCT01571453|102115068|FG001|STARTED|Overall Study||226||
48310680|NCT00873366|101087897|FG000|COMPLETED|Overall Study||71||
48310681|NCT00873366|101087897|FG000|NOT COMPLETED|Overall Study||6||
48310682|NCT00307333|101087898|FG000|STARTED|Overall Study||1511||
48310683|NCT00307333|101087899|FG001|STARTED|Overall Study||1492||
48310684|NCT00307333|101087898|FG000|COMPLETED|Overall Study||1500||
48310685|NCT00307333|101087899|FG001|COMPLETED|Overall Study||1489||
48726226|NCT01571453|102115067|FG000|COMPLETED|Overall Study||173||
48726227|NCT01571453|102115068|FG001|COMPLETED|Overall Study||164||
48726228|NCT01571453|102115067|FG000|NOT COMPLETED|Overall Study||38||
48726229|NCT01571453|102115068|FG001|NOT COMPLETED|Overall Study||62||
48726230|NCT01090063|102115069|FG000|STARTED|Screen||28||
48726231|NCT01090063|102115069|FG000|COMPLETED|Screen||24||
48726232|NCT01090063|102115069|FG000|NOT COMPLETED|Screen||4||
48726233|NCT01090063|102115069|FG000|STARTED|Treatment||24||
48726234|NCT01090063|102115069|FG000|COMPLETED|Treatment||20||
48726235|NCT01090063|102115069|FG000|NOT COMPLETED|Treatment||4||
48726236|NCT01772576|102115070|FG000|STARTED|Overall Study||167||
48726237|NCT01772576|102115070|FG000|COMPLETED|Overall Study||133||
48726238|NCT01772576|102115070|FG000|NOT COMPLETED|Overall Study||34||
48767602|NCT00914316|102222778|FG002|NOT COMPLETED|Phase 1||5||
48726239|NCT00395850|102115071|FG000|STARTED|Pre-randomization Baseline/Induction||118||
48726240|NCT00395850|102115072|FG001|STARTED|Pre-randomization Baseline/Induction||0||
48726241|NCT00395850|102115073|FG002|STARTED|Pre-randomization Baseline/Induction||0||
48726242|NCT00395850|102115074|FG003|STARTED|Pre-randomization Baseline/Induction||0||
48726243|NCT00395850|102115071|FG000|COMPLETED|Pre-randomization Baseline/Induction||107||
48726244|NCT00395850|102115072|FG001|COMPLETED|Pre-randomization Baseline/Induction||0||
48726245|NCT00395850|102115073|FG002|COMPLETED|Pre-randomization Baseline/Induction||0||
48726246|NCT00395850|102115074|FG003|COMPLETED|Pre-randomization Baseline/Induction||0||
48726247|NCT00395850|102115071|FG000|NOT COMPLETED|Pre-randomization Baseline/Induction||11||
48726248|NCT00395850|102115072|FG001|NOT COMPLETED|Pre-randomization Baseline/Induction||0||
48726249|NCT00395850|102115073|FG002|NOT COMPLETED|Pre-randomization Baseline/Induction||0||
48726250|NCT00395850|102115074|FG003|NOT COMPLETED|Pre-randomization Baseline/Induction||0||
48310686|NCT00307333|101087898|FG000|NOT COMPLETED|Overall Study||11||
48310687|NCT00307333|101087899|FG001|NOT COMPLETED|Overall Study||3||
48310688|NCT00454857|101087900|FG000|STARTED|Overall Study||326||
48310689|NCT00454857|101087900|FG000|Completed Retrospective Chart Review|Overall Study||324||
48310690|NCT00454857|101087900|FG000|Completed ≥1 Observational Study Visit|Overall Study||319||
48310691|NCT00454857|101087900|FG000|COMPLETED|Overall Study||272||
48310692|NCT00454857|101087900|FG000|NOT COMPLETED|Overall Study||54||
48310693|NCT03496012|101087901|FG000|STARTED|Overall Study||66||
48310694|NCT03496012|101087902|FG001|STARTED|Overall Study||34||
48310695|NCT03496012|101087903|FG002|STARTED|Overall Study||69||
48310696|NCT03496012|101087901|FG000|COMPLETED|Overall Study||62||
48310697|NCT03496012|101087902|FG001|COMPLETED|Overall Study||34||
48310698|NCT03496012|101087903|FG002|COMPLETED|Overall Study||65||
48310699|NCT03496012|101087901|FG000|NOT COMPLETED|Overall Study||4||
48310700|NCT03496012|101087902|FG001|NOT COMPLETED|Overall Study||0||
48310701|NCT03496012|101087903|FG002|NOT COMPLETED|Overall Study||4||
48726251|NCT00395850|102115071|FG000|STARTED|Randomization to Disulfiram/ Pre-admin||27||
48726252|NCT00395850|102115072|FG001|STARTED|Randomization to Disulfiram/ Pre-admin||25||
48726253|NCT00395850|102115073|FG002|STARTED|Randomization to Disulfiram/ Pre-admin||30||
48726254|NCT00395850|102115074|FG003|STARTED|Randomization to Disulfiram/ Pre-admin||25||
48726255|NCT00395850|102115071|FG000|COMPLETED|Randomization to Disulfiram/ Pre-admin||22||
48726256|NCT00395850|102115072|FG001|COMPLETED|Randomization to Disulfiram/ Pre-admin||23||
48726257|NCT00395850|102115073|FG002|COMPLETED|Randomization to Disulfiram/ Pre-admin||24||
48726258|NCT00395850|102115074|FG003|COMPLETED|Randomization to Disulfiram/ Pre-admin||21||
48726259|NCT00395850|102115071|FG000|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||5||
48155596|NCT00116844|100703148|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0||
48310702|NCT03086057|101087904|FG000|STARTED|Stage 1: PrEP Uptake||55||
48310703|NCT03086057|101087905|FG001|STARTED|Stage 1: PrEP Uptake||55||
48310704|NCT03086057|101087906|FG002|STARTED|Stage 1: PrEP Uptake||0||
48310705|NCT03086057|101087907|FG003|STARTED|Stage 1: PrEP Uptake||0||
48310706|NCT03086057|101087904|FG000|COMPLETED|Stage 1: PrEP Uptake||44||
48155597|NCT00116844|100703149|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||0||
48310707|NCT03086057|101087905|FG001|COMPLETED|Stage 1: PrEP Uptake||45||
48310708|NCT03086057|101087906|FG002|COMPLETED|Stage 1: PrEP Uptake||0||
48310709|NCT03086057|101087907|FG003|COMPLETED|Stage 1: PrEP Uptake||0||
48310710|NCT03086057|101087904|FG000|NOT COMPLETED|Stage 1: PrEP Uptake||11||
48726260|NCT00395850|102115072|FG001|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||2||
48726261|NCT00395850|102115073|FG002|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||6||
48726262|NCT00395850|102115074|FG003|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||4||
48726263|NCT00395850|102115071|FG000|STARTED|Disulfiram/Placebo Treatment||20||
48726264|NCT00395850|102115072|FG001|STARTED|Disulfiram/Placebo Treatment||23||
48726265|NCT00395850|102115073|FG002|STARTED|Disulfiram/Placebo Treatment||24||
48726266|NCT00395850|102115074|FG003|STARTED|Disulfiram/Placebo Treatment||21||
48310711|NCT03086057|101087905|FG001|NOT COMPLETED|Stage 1: PrEP Uptake||10||
48310712|NCT03086057|101087906|FG002|NOT COMPLETED|Stage 1: PrEP Uptake||0||
48310713|NCT03086057|101087907|FG003|NOT COMPLETED|Stage 1: PrEP Uptake||0||
48310714|NCT03086057|101087904|FG000|STARTED|Stage 2: PrEP Adherence||0||
48310715|NCT03086057|101087905|FG001|STARTED|Stage 2: PrEP Adherence||0||
48310716|NCT03086057|101087906|FG002|STARTED|Stage 2: PrEP Adherence||17||
48726267|NCT00395850|102115071|FG000|COMPLETED|Disulfiram/Placebo Treatment||11||
48726268|NCT00395850|102115072|FG001|COMPLETED|Disulfiram/Placebo Treatment||9||
48726269|NCT00395850|102115073|FG002|COMPLETED|Disulfiram/Placebo Treatment||5||
48726270|NCT00395850|102115074|FG003|COMPLETED|Disulfiram/Placebo Treatment||8||
48726271|NCT00395850|102115071|FG000|NOT COMPLETED|Disulfiram/Placebo Treatment||9||
48726272|NCT00395850|102115072|FG001|NOT COMPLETED|Disulfiram/Placebo Treatment||14||
48726273|NCT00395850|102115073|FG002|NOT COMPLETED|Disulfiram/Placebo Treatment||19||
48726274|NCT00395850|102115074|FG003|NOT COMPLETED|Disulfiram/Placebo Treatment||13||
48726275|NCT01623739|102115075|FG000|STARTED|Overall Study||19||
48726276|NCT01623739|102115076|FG001|STARTED|Overall Study||19||
48726277|NCT01623739|102115075|FG000|COMPLETED|Overall Study||17||
48726278|NCT01623739|102115076|FG001|COMPLETED|Overall Study||15||
48726279|NCT01623739|102115075|FG000|NOT COMPLETED|Overall Study||2||
48726280|NCT01623739|102115076|FG001|NOT COMPLETED|Overall Study||4||
48726281|NCT01555125|102115077|FG000|STARTED|Induction Period||59||
48726282|NCT01555125|102115078|FG001|STARTED|Induction Period||59||
48726283|NCT01555125|102115079|FG002|STARTED|Induction Period||0||
48726284|NCT01555125|102115080|FG003|STARTED|Induction Period||0||
48726285|NCT01555125|102115081|FG004|STARTED|Induction Period||59||
48726286|NCT01555125|102115077|FG000|COMPLETED|Induction Period||58||
48726287|NCT01555125|102115078|FG001|COMPLETED|Induction Period||56||
48726288|NCT01555125|102115079|FG002|COMPLETED|Induction Period||0||
48726289|NCT01555125|102115080|FG003|COMPLETED|Induction Period||0||
48726290|NCT01555125|102115081|FG004|COMPLETED|Induction Period||56||
48726291|NCT01555125|102115077|FG000|NOT COMPLETED|Induction Period||1||
48726292|NCT01555125|102115078|FG001|NOT COMPLETED|Induction Period||3||
48726293|NCT01555125|102115079|FG002|NOT COMPLETED|Induction Period||0||
48726294|NCT01555125|102115080|FG003|NOT COMPLETED|Induction Period||0||
48726295|NCT01555125|102115081|FG004|NOT COMPLETED|Induction Period||3||
48726296|NCT01555125|102115077|FG000|STARTED|Maintenance Period||58||
48726297|NCT01555125|102115078|FG001|STARTED|Maintenance Period||56||
48726298|NCT01555125|102115079|FG002|STARTED|Maintenance Period||29||
48726299|NCT01555125|102115080|FG003|STARTED|Maintenance Period||27||
48726300|NCT01555125|102115081|FG004|STARTED|Maintenance Period||0||
48726301|NCT01555125|102115077|FG000|COMPLETED|Maintenance Period||48||
48726302|NCT01555125|102115078|FG001|COMPLETED|Maintenance Period||52||
48726303|NCT01555125|102115079|FG002|COMPLETED|Maintenance Period||25||
48726304|NCT01555125|102115080|FG003|COMPLETED|Maintenance Period||25||
48726305|NCT01555125|102115081|FG004|COMPLETED|Maintenance Period||0||
48726306|NCT01555125|102115077|FG000|NOT COMPLETED|Maintenance Period||10||
48726307|NCT01555125|102115078|FG001|NOT COMPLETED|Maintenance Period||4||
48726308|NCT01555125|102115079|FG002|NOT COMPLETED|Maintenance Period||4||
48726309|NCT01555125|102115080|FG003|NOT COMPLETED|Maintenance Period||2||
48726310|NCT01555125|102115081|FG004|NOT COMPLETED|Maintenance Period||0||
48726311|NCT01555125|102115077|FG000|STARTED|Extension||46||
48726312|NCT01555125|102115078|FG001|STARTED|Extension||51||
48726313|NCT01555125|102115079|FG002|STARTED|Extension||23||
48726314|NCT01555125|102115080|FG003|STARTED|Extension||23||
48726315|NCT01555125|102115081|FG004|STARTED|Extension||0||
48726316|NCT01555125|102115077|FG000|COMPLETED|Extension||1||
48310717|NCT03086057|101087907|FG003|STARTED|Stage 2: PrEP Adherence||18||
48310718|NCT03086057|101087904|FG000|COMPLETED|Stage 2: PrEP Adherence||0||
48310719|NCT03086057|101087905|FG001|COMPLETED|Stage 2: PrEP Adherence||0||
48726317|NCT01555125|102115078|FG001|COMPLETED|Extension||0||
48726318|NCT01555125|102115079|FG002|COMPLETED|Extension||0||
48726319|NCT01555125|102115080|FG003|COMPLETED|Extension||1||
48726320|NCT01555125|102115081|FG004|COMPLETED|Extension||0||
48726321|NCT01555125|102115077|FG000|NOT COMPLETED|Extension||45||
48726322|NCT01555125|102115078|FG001|NOT COMPLETED|Extension||51||
48726323|NCT01555125|102115079|FG002|NOT COMPLETED|Extension||23||
48726324|NCT01555125|102115080|FG003|NOT COMPLETED|Extension||22||
48726325|NCT01555125|102115081|FG004|NOT COMPLETED|Extension||0||
48726326|NCT01555125|102115077|FG000|STARTED|Follow-Up Period||36||
48726327|NCT01555125|102115078|FG001|STARTED|Follow-Up Period||31||
48726328|NCT01555125|102115079|FG002|STARTED|Follow-Up Period||19||
48726329|NCT01555125|102115080|FG003|STARTED|Follow-Up Period||18||
48726330|NCT01555125|102115081|FG004|STARTED|Follow-Up Period||0||
48726331|NCT01555125|102115077|FG000|COMPLETED|Follow-Up Period||32||
48726332|NCT01555125|102115078|FG001|COMPLETED|Follow-Up Period||30||
48726333|NCT01555125|102115079|FG002|COMPLETED|Follow-Up Period||18||
48726334|NCT01555125|102115080|FG003|COMPLETED|Follow-Up Period||17||
48726335|NCT01555125|102115081|FG004|COMPLETED|Follow-Up Period||0||
48726336|NCT01555125|102115077|FG000|NOT COMPLETED|Follow-Up Period||4||
48726337|NCT01555125|102115078|FG001|NOT COMPLETED|Follow-Up Period||1||
48726338|NCT01555125|102115079|FG002|NOT COMPLETED|Follow-Up Period||1||
48726339|NCT01555125|102115080|FG003|NOT COMPLETED|Follow-Up Period||1||
48726340|NCT01555125|102115081|FG004|NOT COMPLETED|Follow-Up Period||0||
48726341|NCT00599638|102115082|FG000|STARTED|First Intervention Period (2 Weeks)||16||
48726342|NCT00599638|102115083|FG001|STARTED|First Intervention Period (2 Weeks)||14||
48726343|NCT00599638|102115084|FG002|STARTED|First Intervention Period (2 Weeks)||20||
48726344|NCT00599638|102115085|FG003|STARTED|First Intervention Period (2 Weeks)||22||
48726345|NCT00599638|102115082|FG000|Treated|First Intervention Period (2 Weeks)||16||
48726346|NCT00599638|102115083|FG001|Treated|First Intervention Period (2 Weeks)||13||
48726347|NCT00599638|102115084|FG002|Treated|First Intervention Period (2 Weeks)||20||
48726348|NCT00599638|102115085|FG003|Treated|First Intervention Period (2 Weeks)||21||
48726349|NCT00599638|102115082|FG000|COMPLETED|First Intervention Period (2 Weeks)||14||
48726350|NCT00599638|102115083|FG001|COMPLETED|First Intervention Period (2 Weeks)||12||
48726351|NCT00599638|102115084|FG002|COMPLETED|First Intervention Period (2 Weeks)||17||
48726352|NCT00599638|102115085|FG003|COMPLETED|First Intervention Period (2 Weeks)||17||
48726353|NCT00599638|102115082|FG000|NOT COMPLETED|First Intervention Period (2 Weeks)||2||
48726354|NCT00599638|102115083|FG001|NOT COMPLETED|First Intervention Period (2 Weeks)||2||
48726355|NCT00599638|102115084|FG002|NOT COMPLETED|First Intervention Period (2 Weeks)||3||
48726356|NCT00599638|102115085|FG003|NOT COMPLETED|First Intervention Period (2 Weeks)||5||
48726357|NCT00599638|102115082|FG000|STARTED|Washout Period (2 Weeks)||14||
48726358|NCT00599638|102115083|FG001|STARTED|Washout Period (2 Weeks)||12||
48726359|NCT00599638|102115084|FG002|STARTED|Washout Period (2 Weeks)||17||
48726360|NCT00599638|102115085|FG003|STARTED|Washout Period (2 Weeks)||17||
48726361|NCT00599638|102115082|FG000|COMPLETED|Washout Period (2 Weeks)||13||
48726362|NCT00599638|102115083|FG001|COMPLETED|Washout Period (2 Weeks)||11||
48726363|NCT00599638|102115084|FG002|COMPLETED|Washout Period (2 Weeks)||17||
48726364|NCT00599638|102115085|FG003|COMPLETED|Washout Period (2 Weeks)||14||
48726365|NCT00599638|102115082|FG000|NOT COMPLETED|Washout Period (2 Weeks)||1||
48726366|NCT00599638|102115083|FG001|NOT COMPLETED|Washout Period (2 Weeks)||1||
48726367|NCT00599638|102115084|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0||
48726368|NCT00599638|102115085|FG003|NOT COMPLETED|Washout Period (2 Weeks)||3||
48726369|NCT00599638|102115082|FG000|STARTED|Second Intervention Period (2 Weeks)||13||
48726370|NCT00599638|102115083|FG001|STARTED|Second Intervention Period (2 Weeks)||11||
48726371|NCT00599638|102115084|FG002|STARTED|Second Intervention Period (2 Weeks)||17||
48726372|NCT00599638|102115085|FG003|STARTED|Second Intervention Period (2 Weeks)||14||
48726373|NCT00599638|102115082|FG000|COMPLETED|Second Intervention Period (2 Weeks)||12||
48726374|NCT00599638|102115083|FG001|COMPLETED|Second Intervention Period (2 Weeks)||11||
48726375|NCT00599638|102115084|FG002|COMPLETED|Second Intervention Period (2 Weeks)||17||
48726376|NCT00599638|102115085|FG003|COMPLETED|Second Intervention Period (2 Weeks)||14||
48726377|NCT00599638|102115082|FG000|NOT COMPLETED|Second Intervention Period (2 Weeks)||1||
48726378|NCT00599638|102115083|FG001|NOT COMPLETED|Second Intervention Period (2 Weeks)||0||
48726379|NCT00599638|102115084|FG002|NOT COMPLETED|Second Intervention Period (2 Weeks)||0||
48726380|NCT00599638|102115085|FG003|NOT COMPLETED|Second Intervention Period (2 Weeks)||0||
48726381|NCT03157037|102115086|FG000|STARTED|Overall Study||15||
48726382|NCT03157037|102115086|FG000|COMPLETED|Overall Study||14||
48726383|NCT03157037|102115086|FG000|NOT COMPLETED|Overall Study||1||
48726384|NCT02678923|102115087|FG000|STARTED|Overall Study||59||
48726385|NCT02678923|102115088|FG001|STARTED|Overall Study||67||
48726386|NCT02678923|102115087|FG000|Received at Least 1 Dose of Study Drug|Overall Study||58|Randomized participants included in the Safety population.|
48726387|NCT02678923|102115088|FG001|Received at Least 1 Dose of Study Drug|Overall Study||64|Randomized participants included in the Safety population.|
48726388|NCT02678923|102115087|FG000|mITT Population|Overall Study||52||
48726389|NCT02678923|102115088|FG001|mITT Population|Overall Study||61||
48726390|NCT02678923|102115087|FG000|COMPLETED|Overall Study||53||
48726391|NCT02678923|102115088|FG001|COMPLETED|Overall Study||62||
48726392|NCT02678923|102115087|FG000|NOT COMPLETED|Overall Study||6||
48726393|NCT02678923|102115088|FG001|NOT COMPLETED|Overall Study||5||
48726394|NCT02178696|102115089|FG000|STARTED|First Assignment and Washout||20||
48726395|NCT02178696|102115090|FG001|STARTED|First Assignment and Washout||20||
48726396|NCT02178696|102115089|FG000|COMPLETED|First Assignment and Washout||20||
48726397|NCT02178696|102115090|FG001|COMPLETED|First Assignment and Washout||20||
48726398|NCT02178696|102115089|FG000|NOT COMPLETED|First Assignment and Washout||0||
48726399|NCT02178696|102115090|FG001|NOT COMPLETED|First Assignment and Washout||0||
48726400|NCT02178696|102115089|FG000|STARTED|Second Assignment After Crossover||20||
48726401|NCT02178696|102115090|FG001|STARTED|Second Assignment After Crossover||20||
48726402|NCT02178696|102115089|FG000|COMPLETED|Second Assignment After Crossover||20||
48726403|NCT02178696|102115090|FG001|COMPLETED|Second Assignment After Crossover||20||
48726404|NCT02178696|102115089|FG000|NOT COMPLETED|Second Assignment After Crossover||0||
48726405|NCT02178696|102115090|FG001|NOT COMPLETED|Second Assignment After Crossover||0||
48726406|NCT02178696|102115089|FG000|STARTED|Open-label Antidepressant||20||
48726407|NCT02178696|102115090|FG001|STARTED|Open-label Antidepressant||20||
48726408|NCT02178696|102115089|FG000|COMPLETED|Open-label Antidepressant||14||
48726409|NCT02178696|102115090|FG001|COMPLETED|Open-label Antidepressant||13||
48726410|NCT02178696|102115089|FG000|NOT COMPLETED|Open-label Antidepressant||6||
48726411|NCT02178696|102115090|FG001|NOT COMPLETED|Open-label Antidepressant||7||
48726412|NCT01008904|102115091|FG000|STARTED|Overall Study||29||
48726413|NCT01008904|102115091|FG000|COMPLETED|Overall Study||25||
48726414|NCT01008904|102115091|FG000|NOT COMPLETED|Overall Study||4||
48726415|NCT01504204|102115092|FG000|STARTED|Overall Study||10||
48726416|NCT01504204|102115093|FG001|STARTED|Overall Study||10||
48726417|NCT01504204|102115092|FG000|COMPLETED|Overall Study||9||
48726418|NCT01504204|102115093|FG001|COMPLETED|Overall Study||9||
48726419|NCT01504204|102115092|FG000|NOT COMPLETED|Overall Study||1||
48726420|NCT01504204|102115093|FG001|NOT COMPLETED|Overall Study||1||
48726421|NCT00488826|102115094|FG000|STARTED|Overall Study||300||
48726422|NCT00488826|102115095|FG001|STARTED|Overall Study||296||
48726423|NCT00488826|102115096|FG002|STARTED|Overall Study||204||
48726424|NCT00488826|102115094|FG000|COMPLETED|Overall Study||244||
48726425|NCT00488826|102115095|FG001|COMPLETED|Overall Study||244||
48726426|NCT00488826|102115096|FG002|COMPLETED|Overall Study||178||
48726427|NCT00488826|102115094|FG000|NOT COMPLETED|Overall Study||56||
48726428|NCT00488826|102115095|FG001|NOT COMPLETED|Overall Study||52||
48726429|NCT00488826|102115096|FG002|NOT COMPLETED|Overall Study||26||
48726430|NCT04058886|102115097|FG000|STARTED|Overall Study||57||
48726431|NCT04058886|102115097|FG000|Primary Caregivers Started|Overall Study||29||
48726432|NCT04058886|102115097|FG000|Care Partners Started|Overall Study||28||
48726433|NCT04058886|102115097|FG000|Primary Caregivers Completed|Overall Study||27||
48726434|NCT04058886|102115097|FG000|Care Partners Completed|Overall Study||25||
48726435|NCT04058886|102115097|FG000|COMPLETED|Overall Study||52||
48726436|NCT04058886|102115097|FG000|NOT COMPLETED|Overall Study||5||
48726437|NCT04274556|102115098|FG000|STARTED|Overall Study||86||
48726438|NCT04274556|102115098|FG000|COMPLETED|Overall Study||86||
48726439|NCT04274556|102115098|FG000|NOT COMPLETED|Overall Study||0||
48726440|NCT01371305|102115099|FG000|STARTED|Overall Study||6||
48310720|NCT03086057|101087906|FG002|COMPLETED|Stage 2: PrEP Adherence||11||
48310721|NCT03086057|101087907|FG003|COMPLETED|Stage 2: PrEP Adherence||16||
48310722|NCT03086057|101087904|FG000|NOT COMPLETED|Stage 2: PrEP Adherence||0||
48310723|NCT03086057|101087905|FG001|NOT COMPLETED|Stage 2: PrEP Adherence||0||
48310724|NCT03086057|101087906|FG002|NOT COMPLETED|Stage 2: PrEP Adherence||6||
48310725|NCT03086057|101087907|FG003|NOT COMPLETED|Stage 2: PrEP Adherence||2||
48310726|NCT00102960|101087908|FG000|STARTED|Overall Study||125||
48310727|NCT00102960|101087909|FG001|STARTED|Overall Study||126||
48726441|NCT01371305|102115100|FG001|STARTED|Overall Study||6||
48726442|NCT01371305|102115101|FG002|STARTED|Overall Study||6||
48726443|NCT01371305|102115102|FG003|STARTED|Overall Study||7||
48726444|NCT01371305|102115103|FG004|STARTED|Overall Study||6||
48726445|NCT01371305|102115104|FG005|STARTED|Overall Study||10||
48726446|NCT01371305|102115099|FG000|COMPLETED|Overall Study||6||
48726447|NCT01371305|102115100|FG001|COMPLETED|Overall Study||6||
48726448|NCT01371305|102115101|FG002|COMPLETED|Overall Study||6||
48726449|NCT01371305|102115102|FG003|COMPLETED|Overall Study||5||
48726450|NCT01371305|102115103|FG004|COMPLETED|Overall Study||2||
48726451|NCT01371305|102115104|FG005|COMPLETED|Overall Study||8||
48726452|NCT01371305|102115099|FG000|NOT COMPLETED|Overall Study||0||
48726453|NCT01371305|102115100|FG001|NOT COMPLETED|Overall Study||0||
48726454|NCT01371305|102115101|FG002|NOT COMPLETED|Overall Study||0||
48726455|NCT01371305|102115102|FG003|NOT COMPLETED|Overall Study||2||
48726456|NCT01371305|102115103|FG004|NOT COMPLETED|Overall Study||4||
48310728|NCT00102960|101087910|FG002|STARTED|Overall Study||126||
48310729|NCT00102960|101087908|FG000|COMPLETED|Overall Study||95||
48310730|NCT00102960|101087909|FG001|COMPLETED|Overall Study||103||
48310731|NCT00102960|101087910|FG002|COMPLETED|Overall Study||98||
48310732|NCT00102960|101087908|FG000|NOT COMPLETED|Overall Study||30||
48310733|NCT00102960|101087909|FG001|NOT COMPLETED|Overall Study||23||
48310734|NCT00102960|101087910|FG002|NOT COMPLETED|Overall Study||28||
48310735|NCT01699542|101087911|FG000|STARTED|Overall Study||9||
48310736|NCT01699542|101087912|FG001|STARTED|Overall Study||9||
48310737|NCT01699542|101087911|FG000|COMPLETED|Overall Study||9||
48310738|NCT01699542|101087912|FG001|COMPLETED|Overall Study||9||
48726457|NCT01371305|102115104|FG005|NOT COMPLETED|Overall Study||2||
48726458|NCT03194438|102115105|FG000|STARTED|Overall Study||14||
48726459|NCT03194438|102115105|FG000|COMPLETED|Overall Study||12||
48726460|NCT03194438|102115105|FG000|NOT COMPLETED|Overall Study||2||
48726461|NCT02540993|102115106|FG000|STARTED|Overall Study||2866|Randomized|
48726462|NCT02540993|102115107|FG001|STARTED|Overall Study||2868|Randomized|
48726463|NCT02540993|102115106|FG000|Included in FAS|Overall Study||2833|60 participants were prospectively excluded from the analyses because of critical GCP violations|
48726464|NCT02540993|102115107|FG001|Included in FAS|Overall Study||2841|60 participants were prospectively excluded from the analyses because of critical GCP violations|
48726465|NCT02540993|102115106|FG000|Treated|Overall Study||2827||
48726466|NCT02540993|102115107|FG001|Treated|Overall Study||2831||
48767603|NCT00914316|102222779|FG003|NOT COMPLETED|Phase 1||2||
48767604|NCT00914316|102222776|FG000|STARTED|Phase 2||2||
48726467|NCT02540993|102115106|FG000|COMPLETED|Overall Study||2824|Participants (except those with critical GCP violations) were followed up regardless of having started treatment or not, and study completion is independent of administration of study treatment. A participant included in the FAS was considered as having completed the study if there was a contact with the subject after the end-of-study (EOS) notification or if the subject died.|
48726468|NCT02540993|102115107|FG001|COMPLETED|Overall Study||2832|Participants (except those with critical GCP violations) were followed up regardless of having started treatment or not, and study completion is independent of administration of study treatment. A participant included in the FAS was considered as having completed the study if there was a contact with the subject after the end-of-study (EOS) notification or if the subject died.|
48726469|NCT02540993|102115106|FG000|NOT COMPLETED|Overall Study||42||
48726470|NCT02540993|102115107|FG001|NOT COMPLETED|Overall Study||36||
48310739|NCT01699542|101087911|FG000|NOT COMPLETED|Overall Study||0||
48310740|NCT01699542|101087912|FG001|NOT COMPLETED|Overall Study||0||
48310741|NCT01809132|101087913|FG000|STARTED|Overall Study||53||
48310742|NCT01809132|101087914|FG001|STARTED|Overall Study||50||
48310743|NCT01809132|101087915|FG002|STARTED|Overall Study||1||
48310744|NCT01809132|101087913|FG000|COMPLETED|Overall Study||53||
48726471|NCT00890682|102115108|FG000|STARTED|Overall Study||97||
48726472|NCT00890682|102115109|FG001|STARTED|Overall Study||96||
48726473|NCT00890682|102115108|FG000|COMPLETED|Overall Study||93||
48726474|NCT00890682|102115109|FG001|COMPLETED|Overall Study||94||
48726475|NCT00890682|102115108|FG000|NOT COMPLETED|Overall Study||4||
48726476|NCT00890682|102115109|FG001|NOT COMPLETED|Overall Study||2||
48726477|NCT02641067|102115110|FG000|STARTED|Overall Study||8||
48726478|NCT02641067|102115111|FG001|STARTED|Overall Study||8||
48726479|NCT02641067|102115110|FG000|COMPLETED|Overall Study||8||
48726480|NCT02641067|102115111|FG001|COMPLETED|Overall Study||8||
48726481|NCT02641067|102115110|FG000|NOT COMPLETED|Overall Study||0||
48726482|NCT02641067|102115111|FG001|NOT COMPLETED|Overall Study||0||
48726483|NCT00695864|102115112|FG000|STARTED|Placebo||14||
48726484|NCT00695864|102115112|FG000|COMPLETED|Placebo||9||
48155598|NCT00116844|100703148|FG000|STARTED|Period 1: Treatment Period 2 (60 Days)||28||
48155599|NCT00116844|100703149|FG001|STARTED|Period 1: Treatment Period 2 (60 Days)||33||
48310745|NCT01809132|101087914|FG001|COMPLETED|Overall Study||50||
48726485|NCT00695864|102115112|FG000|NOT COMPLETED|Placebo||5||
48726486|NCT00695864|102115112|FG000|STARTED|Ondansetron||14||
48726487|NCT00695864|102115112|FG000|COMPLETED|Ondansetron||9||
48726488|NCT00695864|102115112|FG000|NOT COMPLETED|Ondansetron||5||
48726489|NCT02408263|102115113|FG000|STARTED|Overall Study||25||
48726490|NCT02408263|102115114|FG001|STARTED|Overall Study||25||
48726491|NCT02408263|102115113|FG000|COMPLETED|Overall Study||25||
48726492|NCT02408263|102115114|FG001|COMPLETED|Overall Study||25||
48726493|NCT02408263|102115113|FG000|NOT COMPLETED|Overall Study||0||
48726494|NCT02408263|102115114|FG001|NOT COMPLETED|Overall Study||0||
48155600|NCT00116844|100703148|FG000|COMPLETED|Period 1: Treatment Period 2 (60 Days)||24||
48155601|NCT00116844|100703149|FG001|COMPLETED|Period 1: Treatment Period 2 (60 Days)||28||
48155602|NCT00116844|100703148|FG000|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||4||
48310746|NCT01809132|101087915|FG002|COMPLETED|Overall Study||0||
48310747|NCT01809132|101087913|FG000|NOT COMPLETED|Overall Study||0||
48310748|NCT01809132|101087914|FG001|NOT COMPLETED|Overall Study||0||
48726495|NCT03637517|102115115|FG000|STARTED|Overall Study||14||
48726496|NCT03637517|102115116|FG001|STARTED|Overall Study||14||
48726497|NCT03637517|102115117|FG002|STARTED|Overall Study||14||
48726498|NCT03637517|102115115|FG000|COMPLETED|Overall Study||14||
48726499|NCT03637517|102115116|FG001|COMPLETED|Overall Study||14||
48726500|NCT03637517|102115117|FG002|COMPLETED|Overall Study||14||
48726501|NCT03637517|102115115|FG000|NOT COMPLETED|Overall Study||0||
48310749|NCT01809132|101087915|FG002|NOT COMPLETED|Overall Study||1||
48310750|NCT01161043|101087916|FG000|STARTED|Overall Study||83||
48310751|NCT01161043|101087916|FG000|COMPLETED|Overall Study||80||
48310752|NCT01161043|101087916|FG000|NOT COMPLETED|Overall Study||3||
48726502|NCT03637517|102115116|FG001|NOT COMPLETED|Overall Study||0||
48726503|NCT03637517|102115117|FG002|NOT COMPLETED|Overall Study||0||
48726504|NCT01141491|102115118|FG000|STARTED|Overall Study||68||
48726505|NCT01141491|102115119|FG001|STARTED|Overall Study||68||
48726506|NCT01141491|102115118|FG000|COMPLETED|Overall Study||20||
48726507|NCT01141491|102115119|FG001|COMPLETED|Overall Study||21||
48726508|NCT01141491|102115118|FG000|NOT COMPLETED|Overall Study||48||
48726509|NCT01141491|102115119|FG001|NOT COMPLETED|Overall Study||47||
48726510|NCT01555489|102115120|FG000|STARTED|Overall Study||11||
48726511|NCT01555489|102115120|FG000|COMPLETED|Overall Study||11||
48726512|NCT01555489|102115120|FG000|NOT COMPLETED|Overall Study||0||
48726513|NCT00269633|102115121|FG000|STARTED|Overall Study||4||
48726514|NCT00269633|102115122|FG001|STARTED|Overall Study||5||
48726515|NCT00269633|102115121|FG000|COMPLETED|Overall Study||3||
48726516|NCT00269633|102115122|FG001|COMPLETED|Overall Study||5||
48726517|NCT00269633|102115121|FG000|NOT COMPLETED|Overall Study||1||
48726518|NCT00269633|102115122|FG001|NOT COMPLETED|Overall Study||0||
48726519|NCT02337634|102115123|FG000|STARTED|Overall Study||26||
48726520|NCT02337634|102115124|FG001|STARTED|Overall Study||17||
48726521|NCT02337634|102115123|FG000|COMPLETED|Overall Study||22||
48726522|NCT02337634|102115124|FG001|COMPLETED|Overall Study||16||
48726523|NCT02337634|102115123|FG000|NOT COMPLETED|Overall Study||4||
48726524|NCT02337634|102115124|FG001|NOT COMPLETED|Overall Study||1||
48726525|NCT00835341|102115125|FG000|STARTED|Overall Study||35||
48726526|NCT00835341|102115126|FG001|STARTED|Overall Study||58||
48726527|NCT00835341|102115125|FG000|COMPLETED|Overall Study||32||
48726528|NCT00835341|102115126|FG001|COMPLETED|Overall Study||46||
48726529|NCT00835341|102115125|FG000|NOT COMPLETED|Overall Study||3||
48726530|NCT00835341|102115126|FG001|NOT COMPLETED|Overall Study||12||
48726531|NCT02927938|102115127|FG000|STARTED|Overall Study||1|Started/enrollment date is the date that the post-induction bone marrow aspirate was obtained.|
48726532|NCT02927938|102115128|FG001|STARTED|Overall Study||6|Started/enrollment date is the date that the post-induction bone marrow aspirate was obtained.|
48726533|NCT02927938|102115129|FG002|STARTED|Overall Study||4|Started/enrollment date is the date that the post-induction bone marrow aspirate was obtained.|
48726534|NCT02927938|102115130|FG003|STARTED|Overall Study||7|Started/enrollment date is the date that the post-induction bone marrow aspirate was obtained.|
48726535|NCT02927938|102115127|FG000|COMPLETED|Overall Study||0||
48726536|NCT02927938|102115128|FG001|COMPLETED|Overall Study||0||
48726537|NCT02927938|102115129|FG002|COMPLETED|Overall Study||0||
48726538|NCT02927938|102115130|FG003|COMPLETED|Overall Study||0||
48726539|NCT02927938|102115127|FG000|NOT COMPLETED|Overall Study||1||
48726540|NCT02927938|102115128|FG001|NOT COMPLETED|Overall Study||6||
48726541|NCT02927938|102115129|FG002|NOT COMPLETED|Overall Study||4||
48726542|NCT02927938|102115130|FG003|NOT COMPLETED|Overall Study||7||
48726543|NCT03729245|102115131|FG000|STARTED|Overall Study||311||
48726544|NCT03729245|102115132|FG001|STARTED|Overall Study||312||
48726545|NCT03729245|102115131|FG000|COMPLETED|Overall Study||289||
48726546|NCT03729245|102115132|FG001|COMPLETED|Overall Study||287||
48726547|NCT03729245|102115131|FG000|NOT COMPLETED|Overall Study||22||
48726548|NCT03729245|102115132|FG001|NOT COMPLETED|Overall Study||25||
48726549|NCT03689855|102115133|FG000|STARTED|Overall Study||21||
48310753|NCT04666350|101087917|FG000|STARTED|Overall Study||42||
48310754|NCT04666350|101087917|FG000|COMPLETED|Overall Study||42||
48310755|NCT04666350|101087917|FG000|NOT COMPLETED|Overall Study||0||
48310756|NCT01732796|101087918|FG000|STARTED|Overall Study||208||
48310757|NCT01732796|101087919|FG001|STARTED|Overall Study||211||
48310758|NCT01732796|101087920|FG002|STARTED|Overall Study||51||
48310759|NCT01732796|101087918|FG000|COMPLETED|Overall Study||162||
48310760|NCT01732796|101087919|FG001|COMPLETED|Overall Study||169||
48726550|NCT03689855|102115133|FG000|COMPLETED|Overall Study||17||
48726551|NCT03689855|102115133|FG000|NOT COMPLETED|Overall Study||4||
48726552|NCT01439373|102115134|FG000|STARTED|Monotherapy (Day 1)||11||
48726553|NCT01439373|102115135|FG001|STARTED|Monotherapy (Day 1)||5||
48726554|NCT01439373|102115134|FG000|COMPLETED|Monotherapy (Day 1)||11||
48726555|NCT01439373|102115135|FG001|COMPLETED|Monotherapy (Day 1)||4||
48726556|NCT01439373|102115134|FG000|NOT COMPLETED|Monotherapy (Day 1)||0||
48726557|NCT01439373|102115135|FG001|NOT COMPLETED|Monotherapy (Day 1)||1||
48726558|NCT01439373|102115134|FG000|STARTED|Combined With PEG and RIBA (Day 2 to 28)||11||
48726559|NCT01439373|102115135|FG001|STARTED|Combined With PEG and RIBA (Day 2 to 28)||4||
48726560|NCT01439373|102115134|FG000|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||9||
48726561|NCT01439373|102115135|FG001|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||4||
48726562|NCT01439373|102115134|FG000|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||2||
48726563|NCT01439373|102115135|FG001|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||0||
48726564|NCT00881465|102115136|FG000|STARTED|Overall Study||16||
48726565|NCT00881465|102115137|FG001|STARTED|Overall Study||15||
48726566|NCT00881465|102115136|FG000|COMPLETED|Overall Study||14||
48726567|NCT00881465|102115137|FG001|COMPLETED|Overall Study||15||
48726568|NCT00881465|102115136|FG000|NOT COMPLETED|Overall Study||2||
48155603|NCT00116844|100703149|FG001|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||5||
48155604|NCT03879408|100703150|FG000|STARTED|Overall Study||35||
48155605|NCT03879408|100703151|FG001|STARTED|Overall Study||69||
48155606|NCT03879408|100703152|FG002|STARTED|Overall Study||61||
48155607|NCT03879408|100703153|FG003|STARTED|Overall Study||63||
48155608|NCT03879408|100703154|FG004|STARTED|Overall Study||62||
48155609|NCT03879408|100703150|FG000|COMPLETED|Overall Study||33||
48155610|NCT03879408|100703151|FG001|COMPLETED|Overall Study||65||
48155611|NCT03879408|100703152|FG002|COMPLETED|Overall Study||58||
48155612|NCT03879408|100703153|FG003|COMPLETED|Overall Study||62||
48155613|NCT03879408|100703154|FG004|COMPLETED|Overall Study||61||
48155614|NCT03879408|100703150|FG000|NOT COMPLETED|Overall Study||2||
48155615|NCT03879408|100703151|FG001|NOT COMPLETED|Overall Study||4||
48155616|NCT03879408|100703152|FG002|NOT COMPLETED|Overall Study||3||
48155617|NCT03879408|100703153|FG003|NOT COMPLETED|Overall Study||1||
48155618|NCT03879408|100703154|FG004|NOT COMPLETED|Overall Study||1||
48155619|NCT02055157|100703155|FG000|STARTED|Initial 6 Months||8||
48155620|NCT02055157|100703156|FG001|STARTED|Initial 6 Months||8||
48155621|NCT02055157|100703157|FG002|STARTED|Initial 6 Months||10||
48155622|NCT02055157|100703158|FG003|STARTED|Initial 6 Months||9||
48612700|NCT01556997|101838340|FG002|STARTED|Overall Study||278||
48612701|NCT01556997|101838338|FG000|COMPLETED|Overall Study||253||
48612702|NCT01556997|101838339|FG001|COMPLETED|Overall Study||252||
48612703|NCT01556997|101838340|FG002|COMPLETED|Overall Study||246||
48612704|NCT01556997|101838338|FG000|NOT COMPLETED|Overall Study||26||
48612705|NCT01556997|101838339|FG001|NOT COMPLETED|Overall Study||28||
48612706|NCT01556997|101838340|FG002|NOT COMPLETED|Overall Study||32||
48612707|NCT00716807|101838341|FG000|STARTED|Overall Study||8||
48612708|NCT00716807|101838342|FG001|STARTED|Overall Study||5||
48612709|NCT00716807|101838343|FG002|STARTED|Overall Study||18||
48612710|NCT00716807|101838344|FG003|STARTED|Overall Study||15||
48612711|NCT00716807|101838341|FG000|COMPLETED|Overall Study||8||
48726569|NCT00881465|102115137|FG001|NOT COMPLETED|Overall Study||0||
48726570|NCT02725866|102115138|FG000|STARTED|Overall Study||216||
48726571|NCT02725866|102115138|FG000|COMPLETED|Overall Study||202||
48726572|NCT02725866|102115138|FG000|NOT COMPLETED|Overall Study||14||
48726573|NCT01854281|102115139|FG000|STARTED|Overall Study||15||
48726574|NCT01854281|102115140|FG001|STARTED|Overall Study||19||
48155623|NCT02055157|100703155|FG000|COMPLETED|Initial 6 Months||7||
48310761|NCT01732796|101087920|FG002|COMPLETED|Overall Study||38||
48726575|NCT01854281|102115141|FG002|STARTED|Overall Study||5||
48726576|NCT01854281|102115142|FG003|STARTED|Overall Study||8||
48726577|NCT01854281|102115139|FG000|COMPLETED|Overall Study||15||
48612712|NCT00716807|101838342|FG001|COMPLETED|Overall Study||5||
48612713|NCT00716807|101838343|FG002|COMPLETED|Overall Study||18||
48612714|NCT00716807|101838344|FG003|COMPLETED|Overall Study||15||
48612715|NCT00716807|101838341|FG000|NOT COMPLETED|Overall Study||0||
48612716|NCT00716807|101838342|FG001|NOT COMPLETED|Overall Study||0||
48612717|NCT00716807|101838343|FG002|NOT COMPLETED|Overall Study||0||
48726578|NCT01854281|102115140|FG001|COMPLETED|Overall Study||19||
48155624|NCT02055157|100703156|FG001|COMPLETED|Initial 6 Months||7||
48612718|NCT00716807|101838344|FG003|NOT COMPLETED|Overall Study||0||
48612719|NCT02019550|101838345|FG000|STARTED|Treatment Period 1 (4 Weeks)||46||
48612720|NCT02019550|101838346|FG001|STARTED|Treatment Period 1 (4 Weeks)||51||
48612721|NCT02019550|101838345|FG000|COMPLETED|Treatment Period 1 (4 Weeks)||46||
48612722|NCT02019550|101838346|FG001|COMPLETED|Treatment Period 1 (4 Weeks)||50||
48612723|NCT02019550|101838345|FG000|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0||
48612724|NCT02019550|101838346|FG001|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1||
48612725|NCT02019550|101838345|FG000|STARTED|Treatment Period 2 (4 Weeks)||46||
48612726|NCT02019550|101838346|FG001|STARTED|Treatment Period 2 (4 Weeks)||50||
48612727|NCT02019550|101838345|FG000|COMPLETED|Treatment Period 2 (4 Weeks)||46||
48612728|NCT02019550|101838346|FG001|COMPLETED|Treatment Period 2 (4 Weeks)||50||
48612729|NCT02019550|101838345|FG000|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0||
48612730|NCT02019550|101838346|FG001|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0||
48612731|NCT03479008|101838347|FG000|STARTED|Overall Study||22||
48612732|NCT03479008|101838347|FG000|COMPLETED|Overall Study||19||
48155625|NCT02055157|100703157|FG002|COMPLETED|Initial 6 Months||10||
48155626|NCT02055157|100703158|FG003|COMPLETED|Initial 6 Months||8||
48155627|NCT02055157|100703155|FG000|NOT COMPLETED|Initial 6 Months||1||
48155628|NCT02055157|100703156|FG001|NOT COMPLETED|Initial 6 Months||1||
48155629|NCT02055157|100703157|FG002|NOT COMPLETED|Initial 6 Months||0||
48155630|NCT02055157|100703158|FG003|NOT COMPLETED|Initial 6 Months||1||
48155631|NCT02055157|100703155|FG000|STARTED|18-month Extension||7||
48155632|NCT02055157|100703156|FG001|STARTED|18-month Extension||7||
48155633|NCT02055157|100703157|FG002|STARTED|18-month Extension||10||
48155634|NCT02055157|100703158|FG003|STARTED|18-month Extension||8||
48155635|NCT02055157|100703155|FG000|COMPLETED|18-month Extension||6||
48155636|NCT02055157|100703156|FG001|COMPLETED|18-month Extension||6||
48155637|NCT02055157|100703157|FG002|COMPLETED|18-month Extension||10||
48155638|NCT02055157|100703158|FG003|COMPLETED|18-month Extension||8||
48155639|NCT02055157|100703155|FG000|NOT COMPLETED|18-month Extension||1||
48155640|NCT02055157|100703156|FG001|NOT COMPLETED|18-month Extension||1||
48155641|NCT02055157|100703157|FG002|NOT COMPLETED|18-month Extension||0||
48155642|NCT02055157|100703158|FG003|NOT COMPLETED|18-month Extension||0||
48155643|NCT00002558|100703159|FG000|STARTED|Overall Study||92||
48155644|NCT00002558|100703160|FG001|STARTED|Overall Study||16||
48155645|NCT00002558|100703159|FG000|COMPLETED|Overall Study||92||
48155646|NCT00002558|100703160|FG001|COMPLETED|Overall Study||15||
48155647|NCT00002558|100703159|FG000|NOT COMPLETED|Overall Study||0||
48155648|NCT00002558|100703160|FG001|NOT COMPLETED|Overall Study||1||
48155649|NCT03649230|100703161|FG000|STARTED|Overall Study||207||
48155650|NCT03649230|100703161|FG000|COMPLETED|Overall Study||150||
48155651|NCT03649230|100703161|FG000|NOT COMPLETED|Overall Study||57||
48155652|NCT02543658|100703162|FG000|STARTED|Overall Study||40||
48155653|NCT02543658|100703163|FG001|STARTED|Overall Study||40||
48155654|NCT02543658|100703162|FG000|COMPLETED|Overall Study||40||
48155655|NCT02543658|100703163|FG001|COMPLETED|Overall Study||36||
48155656|NCT02543658|100703162|FG000|NOT COMPLETED|Overall Study||0||
48155657|NCT02543658|100703163|FG001|NOT COMPLETED|Overall Study||4||
48155658|NCT00715650|100703164|FG000|STARTED|Intervention||47||
48155659|NCT00715650|100703165|FG001|STARTED|Intervention||45||
48155660|NCT00715650|100703164|FG000|Received Any Session|Intervention||39||
48155661|NCT00715650|100703165|FG001|Received Any Session|Intervention||38||
48155662|NCT00715650|100703164|FG000|Attended ≥ 2 Sessions|Intervention||36||
48155663|NCT00715650|100703165|FG001|Attended ≥ 2 Sessions|Intervention||33||
48155664|NCT00715650|100703164|FG000|Attended ≥ 3 Sessions|Intervention||23||
48155665|NCT00715650|100703165|FG001|Attended ≥ 3 Sessions|Intervention||17||
48155666|NCT00715650|100703164|FG000|COMPLETED|Intervention||42||
48612733|NCT03479008|101838347|FG000|NOT COMPLETED|Overall Study||3||
48612734|NCT01465230|101838348|FG000|STARTED|Overall Study||2||
48612735|NCT01465230|101838348|FG000|COMPLETED|Overall Study||0||
48612736|NCT01465230|101838348|FG000|NOT COMPLETED|Overall Study||2||
48612737|NCT01290952|101838349|FG000|STARTED|Overall Study||204||
48612738|NCT01290952|101838350|FG001|STARTED|Overall Study||207||
48612739|NCT01290952|101838349|FG000|COMPLETED|Overall Study||192||
48612740|NCT01290952|101838350|FG001|COMPLETED|Overall Study||193||
48612741|NCT01290952|101838349|FG000|NOT COMPLETED|Overall Study||12||
48612742|NCT01290952|101838350|FG001|NOT COMPLETED|Overall Study||14||
48612743|NCT01298167|101838351|FG000|STARTED|Overall Study||6||
48726579|NCT01854281|102115141|FG002|COMPLETED|Overall Study||5||
48726580|NCT01854281|102115142|FG003|COMPLETED|Overall Study||8||
48726581|NCT01854281|102115139|FG000|NOT COMPLETED|Overall Study||0||
48726582|NCT01854281|102115140|FG001|NOT COMPLETED|Overall Study||0||
48726583|NCT01854281|102115141|FG002|NOT COMPLETED|Overall Study||0||
48726584|NCT01854281|102115142|FG003|NOT COMPLETED|Overall Study||0||
48155667|NCT00715650|100703165|FG001|COMPLETED|Intervention||42||
48155668|NCT00715650|100703164|FG000|NOT COMPLETED|Intervention||5||
48726585|NCT03244826|102115143|FG000|STARTED|Overall Study||166||
48726586|NCT03244826|102115144|FG001|STARTED|Overall Study||160||
48726587|NCT03244826|102115143|FG000|COMPLETED|Overall Study||152||
48726588|NCT03244826|102115144|FG001|COMPLETED|Overall Study||150||
48726589|NCT03244826|102115143|FG000|NOT COMPLETED|Overall Study||14||
48726590|NCT03244826|102115144|FG001|NOT COMPLETED|Overall Study||10||
48726591|NCT02126839|102115145|FG000|STARTED|Overall Study||92||
48155669|NCT00715650|100703165|FG001|NOT COMPLETED|Intervention||3||
48612744|NCT01298167|101838352|FG001|STARTED|Overall Study||8||
48612745|NCT01298167|101838351|FG000|COMPLETED|Overall Study||5||
48612746|NCT01298167|101838352|FG001|COMPLETED|Overall Study||8||
48726592|NCT02126839|102115146|FG001|STARTED|Overall Study||94||
48155670|NCT00715650|100703164|FG000|STARTED|Follow-up||42||
48612747|NCT01298167|101838351|FG000|NOT COMPLETED|Overall Study||1||
48612748|NCT01298167|101838352|FG001|NOT COMPLETED|Overall Study||0||
48612749|NCT00977613|101838353|FG000|STARTED|Overall Study||50||
48612750|NCT00977613|101838353|FG000|COMPLETED|Overall Study||34||
48726593|NCT02126839|102115145|FG000|Safety Population|Overall Study||92||
48155671|NCT00715650|100703165|FG001|STARTED|Follow-up||42||
48155672|NCT00715650|100703164|FG000|Completed Month 1 Follow-up|Follow-up||40||
48155673|NCT00715650|100703165|FG001|Completed Month 1 Follow-up|Follow-up||38||
48155674|NCT00715650|100703164|FG000|Completed Month 3 Follow-up|Follow-up||35||
48155675|NCT00715650|100703165|FG001|Completed Month 3 Follow-up|Follow-up||40||
48155676|NCT00715650|100703164|FG000|Completed Month 6 Follow-up|Follow-up||29||
48155677|NCT00715650|100703165|FG001|Completed Month 6 Follow-up|Follow-up||37||
48155678|NCT00715650|100703164|FG000|COMPLETED|Follow-up||29||
48612751|NCT00977613|101838353|FG000|NOT COMPLETED|Overall Study||16||
48612752|NCT02258217|101838354|FG000|STARTED|Overall Study||30||
48612753|NCT02258217|101838354|FG000|COMPLETED|Overall Study||30||
48612754|NCT02258217|101838354|FG000|NOT COMPLETED|Overall Study||0||
48612755|NCT00848757|101838355|FG000|STARTED|Overall Study||65||
48612756|NCT00848757|101838356|FG001|STARTED|Overall Study||65||
48612757|NCT00848757|101838355|FG000|COMPLETED|Overall Study||61||
48612758|NCT00848757|101838356|FG001|COMPLETED|Overall Study||61||
48612759|NCT00848757|101838355|FG000|NOT COMPLETED|Overall Study||4||
48612760|NCT00848757|101838356|FG001|NOT COMPLETED|Overall Study||4||
48612761|NCT00136214|101838357|FG000|STARTED|Overall Study||15||
48612762|NCT00136214|101838358|FG001|STARTED|Overall Study||7||
48612763|NCT00136214|101838357|FG000|COMPLETED|Overall Study||15||
48612764|NCT00136214|101838358|FG001|COMPLETED|Overall Study||7||
48612765|NCT00136214|101838357|FG000|NOT COMPLETED|Overall Study||0||
48612766|NCT00136214|101838358|FG001|NOT COMPLETED|Overall Study||0||
48612767|NCT01073163|101838359|FG000|STARTED|Overall Study||54||
48612768|NCT01073163|101838359|FG000|Enrolled But Not Treated|Overall Study||1||
48612769|NCT01073163|101838359|FG000|Treated With <6 Cycles|Overall Study||4||
48612770|NCT01073163|101838359|FG000|Treated With >=6 Cycles|Overall Study||49||
48612771|NCT01073163|101838359|FG000|COMPLETED|Overall Study||51||
48612772|NCT01073163|101838359|FG000|NOT COMPLETED|Overall Study||3||
48612773|NCT03293394|101838360|FG000|STARTED|First Intervention (2 Weeks)||20||
48612774|NCT03293394|101838361|FG001|STARTED|First Intervention (2 Weeks)||10||
48612775|NCT03293394|101838360|FG000|COMPLETED|First Intervention (2 Weeks)||20||
48612776|NCT03293394|101838361|FG001|COMPLETED|First Intervention (2 Weeks)||10||
48612777|NCT03293394|101838360|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0||
48612778|NCT03293394|101838361|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0||
48612779|NCT03293394|101838360|FG000|STARTED|Follow-up (6 Months)||20||
48612780|NCT03293394|101838361|FG001|STARTED|Follow-up (6 Months)||10||
48612781|NCT03293394|101838360|FG000|COMPLETED|Follow-up (6 Months)||16||
48612782|NCT03293394|101838361|FG001|COMPLETED|Follow-up (6 Months)||8||
48612783|NCT03293394|101838360|FG000|NOT COMPLETED|Follow-up (6 Months)||4||
48612784|NCT03293394|101838361|FG001|NOT COMPLETED|Follow-up (6 Months)||2||
48612785|NCT00223665|101838362|FG000|STARTED|Overall Study||102||
48612786|NCT00223665|101838362|FG000|COMPLETED|Overall Study||102||
48612787|NCT00223665|101838362|FG000|NOT COMPLETED|Overall Study||0||
48612788|NCT00320788|101838363|FG000|STARTED|Overall Study||32||
48612789|NCT00320788|101838364|FG001|STARTED|Overall Study||32||
48612790|NCT00320788|101838365|FG002|STARTED|Overall Study||32||
48612791|NCT00320788|101838366|FG003|STARTED|Overall Study||32||
48612792|NCT00320788|101838367|FG004|STARTED|Overall Study||31||
48612793|NCT00320788|101838363|FG000|Participants Received Treatment (SAF)|Overall Study||32||
48612794|NCT00320788|101838364|FG001|Participants Received Treatment (SAF)|Overall Study||32||
48612795|NCT00320788|101838365|FG002|Participants Received Treatment (SAF)|Overall Study||31||
48726594|NCT02126839|102115146|FG001|Safety Population|Overall Study||93||
48155679|NCT00715650|100703165|FG001|COMPLETED|Follow-up||37||
48155680|NCT00715650|100703164|FG000|NOT COMPLETED|Follow-up||13||
48726595|NCT02126839|102115145|FG000|Full Analysis Set|Overall Study||92||
48726596|NCT02126839|102115146|FG001|Full Analysis Set|Overall Study||92||
48726597|NCT02126839|102115145|FG000|COMPLETED|Overall Study||82||
48726598|NCT02126839|102115146|FG001|COMPLETED|Overall Study||80||
48726599|NCT02126839|102115145|FG000|NOT COMPLETED|Overall Study||10||
48726600|NCT02126839|102115146|FG001|NOT COMPLETED|Overall Study||14||
48726601|NCT02936284|102115147|FG000|STARTED|Overall Study||47|Participant units are mother-infant dyads, so 47 dyads consisting of 1 mother and 1 child started in each group in the study|
48726602|NCT02936284|102115148|FG001|STARTED|Overall Study||47|Participant units are mother-infant dyads, so 47 dyads consisting of 1 mother and 1 child started in each group in the study|
48726603|NCT02936284|102115147|FG000|COMPLETED|Overall Study||37||
48155681|NCT00715650|100703165|FG001|NOT COMPLETED|Follow-up||5||
48155682|NCT01355458|100703166|FG000|STARTED|Overall Study||129||
48612796|NCT00320788|101838366|FG003|Participants Received Treatment (SAF)|Overall Study||31||
48612797|NCT00320788|101838367|FG004|Participants Received Treatment (SAF)|Overall Study||31||
48612798|NCT00320788|101838363|FG000|COMPLETED|Overall Study||26||
48612799|NCT00320788|101838364|FG001|COMPLETED|Overall Study||26||
48612800|NCT00320788|101838365|FG002|COMPLETED|Overall Study||29||
48612801|NCT00320788|101838366|FG003|COMPLETED|Overall Study||27||
48612802|NCT00320788|101838367|FG004|COMPLETED|Overall Study||26||
48612803|NCT00320788|101838363|FG000|NOT COMPLETED|Overall Study||6||
48612804|NCT00320788|101838364|FG001|NOT COMPLETED|Overall Study||6||
48612805|NCT00320788|101838365|FG002|NOT COMPLETED|Overall Study||3||
48612806|NCT00320788|101838366|FG003|NOT COMPLETED|Overall Study||5||
48612807|NCT00320788|101838367|FG004|NOT COMPLETED|Overall Study||5||
48612808|NCT01419535|101838368|FG000|STARTED|Overall Study||9||
48612809|NCT01419535|101838369|FG001|STARTED|Overall Study||10||
48612810|NCT01419535|101838368|FG000|COMPLETED|Overall Study||8||
48612811|NCT01419535|101838369|FG001|COMPLETED|Overall Study||8||
48612812|NCT01419535|101838368|FG000|NOT COMPLETED|Overall Study||1||
48612813|NCT01419535|101838369|FG001|NOT COMPLETED|Overall Study||2||
48155683|NCT01355458|100703167|FG001|STARTED|Overall Study||131||
48155684|NCT01355458|100703166|FG000|COMPLETED|Overall Study||127||
48726604|NCT02936284|102115148|FG001|COMPLETED|Overall Study||38||
48726605|NCT02936284|102115147|FG000|NOT COMPLETED|Overall Study||10||
48726606|NCT02936284|102115148|FG001|NOT COMPLETED|Overall Study||9||
48726607|NCT04544683|102115149|FG000|STARTED|Overall Study||33||
48726608|NCT04544683|102115149|FG000|1 Month Follow-up|Overall Study||30||
48726609|NCT04544683|102115149|FG000|3 Month Follow-up|Overall Study||29||
48726610|NCT04544683|102115149|FG000|6 Month Follow-up|Overall Study||26||
48726611|NCT04544683|102115149|FG000|12 Month Follow-up|Overall Study||25||
48726612|NCT04544683|102115149|FG000|COMPLETED|Overall Study||25||
48726613|NCT04544683|102115149|FG000|NOT COMPLETED|Overall Study||8||
48726614|NCT01818063|102115150|FG000|STARTED|Overall Study||5||
48726615|NCT01818063|102115151|FG001|STARTED|Overall Study||4||
48726616|NCT01818063|102115150|FG000|COMPLETED|Overall Study||5||
48726617|NCT01818063|102115151|FG001|COMPLETED|Overall Study||4||
48726618|NCT01818063|102115150|FG000|NOT COMPLETED|Overall Study||0||
48726619|NCT01818063|102115151|FG001|NOT COMPLETED|Overall Study||0||
48726620|NCT03916484|102115152|FG000|STARTED|Stage 1 Intervention (Months 1-3)||7||
48726621|NCT03916484|102115153|FG001|STARTED|Stage 1 Intervention (Months 1-3)||41||
48726622|NCT03916484|102115154|FG002|STARTED|Stage 1 Intervention (Months 1-3)||15||
48726623|NCT03916484|102115155|FG003|STARTED|Stage 1 Intervention (Months 1-3)||8||
48726624|NCT03916484|102115152|FG000|COMPLETED|Stage 1 Intervention (Months 1-3)||7||
48726625|NCT03916484|102115153|FG001|COMPLETED|Stage 1 Intervention (Months 1-3)||40||
48726626|NCT03916484|102115154|FG002|COMPLETED|Stage 1 Intervention (Months 1-3)||15||
48726627|NCT03916484|102115155|FG003|COMPLETED|Stage 1 Intervention (Months 1-3)||8||
48726628|NCT03916484|102115152|FG000|NOT COMPLETED|Stage 1 Intervention (Months 1-3)||0||
48726629|NCT03916484|102115153|FG001|NOT COMPLETED|Stage 1 Intervention (Months 1-3)||1||
48726630|NCT03916484|102115154|FG002|NOT COMPLETED|Stage 1 Intervention (Months 1-3)||0||
48155685|NCT01355458|100703167|FG001|COMPLETED|Overall Study||127||
48155686|NCT01355458|100703166|FG000|NOT COMPLETED|Overall Study||2||
48155687|NCT01355458|100703167|FG001|NOT COMPLETED|Overall Study||4||
48155688|NCT02192970|100703168|FG000|STARTED|Overall Study||101||
48155689|NCT02192970|100703169|FG001|STARTED|Overall Study||195||
48155690|NCT02192970|100703168|FG000|COMPLETED|Overall Study||95||
48155691|NCT02192970|100703169|FG001|COMPLETED|Overall Study||195||
48726631|NCT03916484|102115155|FG003|NOT COMPLETED|Stage 1 Intervention (Months 1-3)||0||
48726632|NCT03916484|102115152|FG000|STARTED|Stage 2 Intervention (Months 4-6)||7||
48726633|NCT03916484|102115153|FG001|STARTED|Stage 2 Intervention (Months 4-6)||40||
48726634|NCT03916484|102115154|FG002|STARTED|Stage 2 Intervention (Months 4-6)||15||
48726635|NCT03916484|102115155|FG003|STARTED|Stage 2 Intervention (Months 4-6)||8||
48726636|NCT03916484|102115152|FG000|COMPLETED|Stage 2 Intervention (Months 4-6)||5||
48726637|NCT03916484|102115153|FG001|COMPLETED|Stage 2 Intervention (Months 4-6)||29||
48726638|NCT03916484|102115154|FG002|COMPLETED|Stage 2 Intervention (Months 4-6)||11||
48726639|NCT03916484|102115155|FG003|COMPLETED|Stage 2 Intervention (Months 4-6)||7||
48726640|NCT03916484|102115152|FG000|NOT COMPLETED|Stage 2 Intervention (Months 4-6)||2||
48726641|NCT03916484|102115153|FG001|NOT COMPLETED|Stage 2 Intervention (Months 4-6)||11||
48726642|NCT03916484|102115154|FG002|NOT COMPLETED|Stage 2 Intervention (Months 4-6)||4||
48726643|NCT03916484|102115155|FG003|NOT COMPLETED|Stage 2 Intervention (Months 4-6)||1||
48155692|NCT02192970|100703168|FG000|NOT COMPLETED|Overall Study||6||
48155693|NCT02192970|100703169|FG001|NOT COMPLETED|Overall Study||0||
48155694|NCT00184548|100703170|FG000|STARTED|Overall Study||226||
48155695|NCT00184548|100703171|FG001|STARTED|Overall Study||255||
48155696|NCT00184548|100703172|FG002|STARTED|Overall Study||47||
48155697|NCT00184548|100703173|FG003|STARTED|Overall Study||45||
48155698|NCT00184548|100703170|FG000|Exposed|Overall Study||224||
48155699|NCT00184548|100703171|FG001|Exposed|Overall Study||250||
48155700|NCT00184548|100703172|FG002|Exposed|Overall Study||46||
48155701|NCT00184548|100703173|FG003|Exposed|Overall Study||40||
48155702|NCT00184548|100703170|FG000|COMPLETED|Overall Study||218||
48155703|NCT00184548|100703171|FG001|COMPLETED|Overall Study||242||
48155704|NCT00184548|100703172|FG002|COMPLETED|Overall Study||44||
48155705|NCT00184548|100703173|FG003|COMPLETED|Overall Study||38||
48155706|NCT00184548|100703170|FG000|NOT COMPLETED|Overall Study||8||
48155707|NCT00184548|100703171|FG001|NOT COMPLETED|Overall Study||13||
48155708|NCT00184548|100703172|FG002|NOT COMPLETED|Overall Study||3||
48155709|NCT00184548|100703173|FG003|NOT COMPLETED|Overall Study||7||
48155710|NCT02090634|100703174|FG000|STARTED|Overall Study||30||
48155711|NCT02090634|100703175|FG001|STARTED|Overall Study||28||
48155712|NCT02090634|100703174|FG000|COMPLETED|Overall Study||25||
48155713|NCT02090634|100703175|FG001|COMPLETED|Overall Study||25||
48155714|NCT02090634|100703174|FG000|NOT COMPLETED|Overall Study||5||
48155715|NCT02090634|100703175|FG001|NOT COMPLETED|Overall Study||3||
48155716|NCT02174432|100703176|FG000|STARTED|Overall Study||36||
48155717|NCT02174432|100703176|FG000|COMPLETED|Overall Study||16||
48155718|NCT02174432|100703176|FG000|NOT COMPLETED|Overall Study||20||
48155719|NCT02428296|100703177|FG000|STARTED|Overall Study||39||
48726644|NCT01140061|102115156|FG000|STARTED|Part I||7||
48726645|NCT01140061|102115157|FG001|STARTED|Part I||2||
48726646|NCT01140061|102115158|FG002|STARTED|Part I||0||
48726647|NCT01140061|102115159|FG003|STARTED|Part I||0||
48155720|NCT02428296|100703177|FG000|Treated|Overall Study||39||
48155721|NCT02428296|100703177|FG000|COMPLETED|Overall Study||30||
48612814|NCT03076996|101838370|FG000|STARTED|Overall Study||41||
48612815|NCT03076996|101838370|FG000|COMPLETED|Overall Study||35||
48612816|NCT03076996|101838370|FG000|NOT COMPLETED|Overall Study||6||
48612817|NCT04068831|101838371|FG000|STARTED|Overall Study||10||
48155722|NCT02428296|100703177|FG000|NOT COMPLETED|Overall Study||9||
48155723|NCT01188109|100703178|FG000|STARTED|Overall Study||22||
48155724|NCT01188109|100703178|FG000|COMPLETED|Overall Study||22||
48726648|NCT01140061|102115160|FG004|STARTED|Part I||0||
48726649|NCT01140061|102115161|FG005|STARTED|Part I||0||
48726650|NCT01140061|102115162|FG006|STARTED|Part I||0||
48726651|NCT01140061|102115163|FG007|STARTED|Part I||0||
48726652|NCT01140061|102115164|FG008|STARTED|Part I||0||
48726653|NCT01140061|102115165|FG009|STARTED|Part I||0||
48726654|NCT01140061|102115156|FG000|COMPLETED|Part I||6||
48726655|NCT01140061|102115157|FG001|COMPLETED|Part I||2||
48726656|NCT01140061|102115158|FG002|COMPLETED|Part I||0||
48726657|NCT01140061|102115159|FG003|COMPLETED|Part I||0||
48726658|NCT01140061|102115160|FG004|COMPLETED|Part I||0||
48155725|NCT01188109|100703178|FG000|NOT COMPLETED|Overall Study||0||
48612818|NCT04068831|101838372|FG001|STARTED|Overall Study||8||
48612819|NCT04068831|101838371|FG000|COMPLETED|Overall Study||0||
48612820|NCT04068831|101838372|FG001|COMPLETED|Overall Study||0||
48612821|NCT04068831|101838371|FG000|NOT COMPLETED|Overall Study||10||
48612822|NCT04068831|101838372|FG001|NOT COMPLETED|Overall Study||8||
48612823|NCT01272908|101838373|FG000|STARTED|Initial Treatment Period||120||
48612824|NCT01272908|101838373|FG000|COMPLETED|Initial Treatment Period||112||
48612825|NCT01272908|101838373|FG000|NOT COMPLETED|Initial Treatment Period||8||
48612826|NCT01272908|101838373|FG000|STARTED|Re-Treatment Period||77||
48612827|NCT01272908|101838373|FG000|COMPLETED|Re-Treatment Period||71||
48612828|NCT01272908|101838373|FG000|NOT COMPLETED|Re-Treatment Period||6||
48612829|NCT00952315|101838374|FG000|STARTED|Overall Study||90||
48612830|NCT00952315|101838375|FG001|STARTED|Overall Study||90||
48612831|NCT00952315|101838376|FG002|STARTED|Overall Study||90||
48612832|NCT00952315|101838374|FG000|COMPLETED|Overall Study||64||
48612833|NCT00952315|101838375|FG001|COMPLETED|Overall Study||66||
48612834|NCT00952315|101838376|FG002|COMPLETED|Overall Study||71||
48612835|NCT00952315|101838374|FG000|NOT COMPLETED|Overall Study||26||
48612836|NCT00952315|101838375|FG001|NOT COMPLETED|Overall Study||24||
48612837|NCT00952315|101838376|FG002|NOT COMPLETED|Overall Study||19||
48612838|NCT01142947|101838377|FG000|STARTED|Overall Study||362||
48726659|NCT01140061|102115161|FG005|COMPLETED|Part I||0||
48726660|NCT01140061|102115162|FG006|COMPLETED|Part I||0||
48726661|NCT01140061|102115163|FG007|COMPLETED|Part I||0||
48726662|NCT01140061|102115164|FG008|COMPLETED|Part I||0||
48726663|NCT01140061|102115165|FG009|COMPLETED|Part I||0||
48726664|NCT01140061|102115156|FG000|NOT COMPLETED|Part I||1||
48726665|NCT01140061|102115157|FG001|NOT COMPLETED|Part I||0||
48155726|NCT00939874|100703179|FG000|STARTED|Overall Study||52||
48155727|NCT00939874|100703179|FG000|Completed Week 48|Overall Study||37||
48155728|NCT00939874|100703179|FG000|COMPLETED|Overall Study||32||
48155729|NCT00939874|100703179|FG000|NOT COMPLETED|Overall Study||20||
48155730|NCT01920282|100703180|FG000|STARTED|Overall Study||15||
48155731|NCT01920282|100703181|FG001|STARTED|Overall Study||15||
48155732|NCT01920282|100703182|FG002|STARTED|Overall Study||15||
48155733|NCT01920282|100703180|FG000|COMPLETED|Overall Study||15||
48155734|NCT01920282|100703181|FG001|COMPLETED|Overall Study||15||
48155735|NCT01920282|100703182|FG002|COMPLETED|Overall Study||15||
48155736|NCT01920282|100703180|FG000|NOT COMPLETED|Overall Study||0||
48155737|NCT01920282|100703181|FG001|NOT COMPLETED|Overall Study||0||
48155738|NCT01920282|100703182|FG002|NOT COMPLETED|Overall Study||0||
48155739|NCT01299090|100703183|FG000|STARTED|Overall Study||49||
48155740|NCT01299090|100703183|FG000|COMPLETED|Overall Study||49||
48155741|NCT01299090|100703183|FG000|NOT COMPLETED|Overall Study||0||
48155742|NCT05096156|100703184|FG000|STARTED|Overall Study||30||
48155743|NCT05096156|100703184|FG000|COMPLETED|Overall Study||30||
48155744|NCT05096156|100703184|FG000|NOT COMPLETED|Overall Study||0||
48155745|NCT00118716|100703185|FG000|STARTED|Overall Study||124||
48155746|NCT00118716|100703186|FG001|STARTED|Overall Study||124||
48155747|NCT00118716|100703185|FG000|COMPLETED|Overall Study||111||
48155748|NCT00118716|100703186|FG001|COMPLETED|Overall Study||102||
48155749|NCT00118716|100703185|FG000|NOT COMPLETED|Overall Study||13||
48155750|NCT00118716|100703186|FG001|NOT COMPLETED|Overall Study||22||
48155751|NCT04259086|100703187|FG000|STARTED|Overall Study||48||
48612839|NCT01142947|101838377|FG000|COMPLETED|Overall Study||244||
48612840|NCT01142947|101838377|FG000|NOT COMPLETED|Overall Study||118||
48726666|NCT01140061|102115158|FG002|NOT COMPLETED|Part I||0||
48726667|NCT01140061|102115159|FG003|NOT COMPLETED|Part I||0||
48726668|NCT01140061|102115160|FG004|NOT COMPLETED|Part I||0||
48726669|NCT01140061|102115161|FG005|NOT COMPLETED|Part I||0||
48155752|NCT04259086|100703187|FG000|COMPLETED|Overall Study||45||
48155753|NCT04259086|100703187|FG000|NOT COMPLETED|Overall Study||3||
48155754|NCT04204200|100703188|FG000|STARTED|Overall Study||22||
48726670|NCT01140061|102115162|FG006|NOT COMPLETED|Part I||0||
48726671|NCT01140061|102115163|FG007|NOT COMPLETED|Part I||0||
48726672|NCT01140061|102115164|FG008|NOT COMPLETED|Part I||0||
48155755|NCT04204200|100703189|FG001|STARTED|Overall Study||22||
48155756|NCT04204200|100703190|FG002|STARTED|Overall Study||22||
48155757|NCT04204200|100703188|FG000|COMPLETED|Overall Study||22||
48155758|NCT04204200|100703189|FG001|COMPLETED|Overall Study||22||
48155759|NCT04204200|100703190|FG002|COMPLETED|Overall Study||22||
48155760|NCT04204200|100703188|FG000|NOT COMPLETED|Overall Study||0||
48155761|NCT04204200|100703189|FG001|NOT COMPLETED|Overall Study||0||
48155762|NCT04204200|100703190|FG002|NOT COMPLETED|Overall Study||0||
48155763|NCT01040858|100703191|FG000|STARTED|Overall Study||59||
48155764|NCT01040858|100703192|FG001|STARTED|Overall Study||69||
48155765|NCT01040858|100703191|FG000|COMPLETED|Overall Study||50||
48155766|NCT01040858|100703192|FG001|COMPLETED|Overall Study||69||
48155767|NCT01040858|100703191|FG000|NOT COMPLETED|Overall Study||9||
48155768|NCT01040858|100703192|FG001|NOT COMPLETED|Overall Study||0||
48726673|NCT01140061|102115165|FG009|NOT COMPLETED|Part I||0||
48155769|NCT02238379|100703193|FG000|STARTED|Overall Study||12||
48155770|NCT02238379|100703194|FG001|STARTED|Overall Study||14||
48155771|NCT02238379|100703193|FG000|COMPLETED|Overall Study||11||
48155772|NCT02238379|100703194|FG001|COMPLETED|Overall Study||14||
48155773|NCT02238379|100703193|FG000|NOT COMPLETED|Overall Study||1||
48155774|NCT02238379|100703194|FG001|NOT COMPLETED|Overall Study||0||
48155775|NCT01857882|100703195|FG000|STARTED|Overall Study||21||
48155776|NCT01857882|100703196|FG001|STARTED|Overall Study||20||
48155777|NCT01857882|100703195|FG000|COMPLETED|Overall Study||21||
48155778|NCT01857882|100703196|FG001|COMPLETED|Overall Study||20||
48155779|NCT01857882|100703195|FG000|NOT COMPLETED|Overall Study||0||
48155780|NCT01857882|100703196|FG001|NOT COMPLETED|Overall Study||0||
48155781|NCT00621543|100703197|FG000|STARTED|Overall Study||120||
48155782|NCT00621543|100703197|FG000|COMPLETED|Overall Study||97||
48155783|NCT00621543|100703197|FG000|NOT COMPLETED|Overall Study||23||
48155784|NCT01631630|100703198|FG000|STARTED|Overall Study||8||
48155785|NCT01631630|100703199|FG001|STARTED|Overall Study||8||
48155786|NCT01631630|100703198|FG000|COMPLETED|Overall Study||5||
48155787|NCT01631630|100703199|FG001|COMPLETED|Overall Study||8||
48155788|NCT01631630|100703198|FG000|NOT COMPLETED|Overall Study||3||
48310762|NCT01732796|101087918|FG000|NOT COMPLETED|Overall Study||46||
48310763|NCT01732796|101087919|FG001|NOT COMPLETED|Overall Study||42||
48310764|NCT01732796|101087920|FG002|NOT COMPLETED|Overall Study||13||
48310765|NCT02958007|101087921|FG000|STARTED|Overall Study||11||
48310766|NCT02958007|101087922|FG001|STARTED|Overall Study||11||
48310767|NCT02958007|101087921|FG000|COMPLETED|Overall Study||10||
48310768|NCT02958007|101087922|FG001|COMPLETED|Overall Study||8||
48310769|NCT02958007|101087921|FG000|NOT COMPLETED|Overall Study||1||
48310770|NCT02958007|101087922|FG001|NOT COMPLETED|Overall Study||3||
48310771|NCT01721876|101087923|FG000|STARTED|Overall Study||222||
48310772|NCT01721876|101087924|FG001|STARTED|Overall Study||444||
48310773|NCT01721876|101087923|FG000|Treated|Overall Study||221||
48155789|NCT01631630|100703199|FG001|NOT COMPLETED|Overall Study||0||
48155790|NCT02650219|100703200|FG000|STARTED|Overall Study||40||
48155791|NCT02650219|100703201|FG001|STARTED|Overall Study||20||
48155792|NCT02650219|100703200|FG000|COMPLETED|Overall Study||40||
48155793|NCT02650219|100703201|FG001|COMPLETED|Overall Study||20||
48155794|NCT02650219|100703200|FG000|NOT COMPLETED|Overall Study||0||
48155795|NCT02650219|100703201|FG001|NOT COMPLETED|Overall Study||0||
48155796|NCT02946918|100703202|FG000|STARTED|Overall Study||6||
48155797|NCT02946918|100703203|FG001|STARTED|Overall Study||8||
48155798|NCT02946918|100703202|FG000|COMPLETED|Overall Study||5||
48155799|NCT02946918|100703203|FG001|COMPLETED|Overall Study||5||
48155800|NCT02946918|100703202|FG000|NOT COMPLETED|Overall Study||1||
48155801|NCT02946918|100703203|FG001|NOT COMPLETED|Overall Study||3||
48155802|NCT01699022|100703204|FG000|STARTED|Overall Study||17||
48155803|NCT01699022|100703204|FG000|COMPLETED|Overall Study||14||
48155804|NCT01699022|100703204|FG000|NOT COMPLETED|Overall Study||3||
48155805|NCT00394355|100703205|FG000|STARTED|Overall Study||140||
48155806|NCT00394355|100703206|FG001|STARTED|Overall Study||137||
48155807|NCT00394355|100703207|FG002|STARTED|Overall Study||147||
48155808|NCT00394355|100703208|FG003|STARTED|Overall Study||142||
48155809|NCT00394355|100703205|FG000|COMPLETED|Overall Study||105||
48155810|NCT00394355|100703206|FG001|COMPLETED|Overall Study||103||
48155811|NCT00394355|100703207|FG002|COMPLETED|Overall Study||109||
48155812|NCT00394355|100703208|FG003|COMPLETED|Overall Study||111||
48155813|NCT00394355|100703205|FG000|NOT COMPLETED|Overall Study||35||
48155814|NCT00394355|100703206|FG001|NOT COMPLETED|Overall Study||34||
48155815|NCT00394355|100703207|FG002|NOT COMPLETED|Overall Study||38||
48155816|NCT00394355|100703208|FG003|NOT COMPLETED|Overall Study||31||
48155817|NCT03764072|100703209|FG000|STARTED|Overall Study||46||
48155818|NCT03764072|100703210|FG001|STARTED|Overall Study||42||
48310774|NCT01721876|101087924|FG001|Treated|Overall Study||440||
48310775|NCT01721876|101087923|FG000|COMPLETED|Overall Study||0||
48155819|NCT03764072|100703211|FG002|STARTED|Overall Study||44||
48155820|NCT03764072|100703212|FG003|STARTED|Overall Study||45||
48155821|NCT03764072|100703213|FG004|STARTED|Overall Study||46||
48155822|NCT03764072|100703214|FG005|STARTED|Overall Study||27||
48155823|NCT03764072|100703209|FG000|COMPLETED|Overall Study||46||
48155824|NCT03764072|100703210|FG001|COMPLETED|Overall Study||42||
48155825|NCT03764072|100703211|FG002|COMPLETED|Overall Study||43||
48155826|NCT03764072|100703212|FG003|COMPLETED|Overall Study||45||
48155827|NCT03764072|100703213|FG004|COMPLETED|Overall Study||45||
48155828|NCT03764072|100703214|FG005|COMPLETED|Overall Study||26||
48155829|NCT03764072|100703209|FG000|NOT COMPLETED|Overall Study||0||
48155830|NCT03764072|100703210|FG001|NOT COMPLETED|Overall Study||0||
48155831|NCT03764072|100703211|FG002|NOT COMPLETED|Overall Study||1||
48155832|NCT03764072|100703212|FG003|NOT COMPLETED|Overall Study||0||
48155833|NCT03764072|100703213|FG004|NOT COMPLETED|Overall Study||1||
48155834|NCT03764072|100703214|FG005|NOT COMPLETED|Overall Study||1||
48612841|NCT04403113|101838378|FG000|STARTED|Overall Study||20||
48612842|NCT04403113|101838379|FG001|STARTED|Overall Study||20||
48612843|NCT04403113|101838378|FG000|COMPLETED|Overall Study||20||
48155835|NCT00530062|100703215|FG000|STARTED|Overall Study||49||
48155836|NCT00530062|100703215|FG000|Received at Least 1 Dose of Study Drug|Overall Study||49||
48155837|NCT00530062|100703215|FG000|COMPLETED|Overall Study||49||
48155838|NCT00530062|100703215|FG000|NOT COMPLETED|Overall Study||0||
48155839|NCT03525548|100703216|FG000|STARTED|Overall Study||52||
48155840|NCT03525548|100703217|FG001|STARTED|Overall Study||55||
48155841|NCT03525548|100703216|FG000|COMPLETED|Overall Study||52||
48155842|NCT03525548|100703217|FG001|COMPLETED|Overall Study||55||
48155843|NCT03525548|100703216|FG000|NOT COMPLETED|Overall Study||0||
48155844|NCT03525548|100703217|FG001|NOT COMPLETED|Overall Study||0||
48155845|NCT04540874|100703218|FG000|STARTED|Overall Study||6||
48155846|NCT04540874|100703219|FG001|STARTED|Overall Study||2||
48155847|NCT04540874|100703218|FG000|COMPLETED|Overall Study||6||
48155848|NCT04540874|100703219|FG001|COMPLETED|Overall Study||2||
48155849|NCT04540874|100703218|FG000|NOT COMPLETED|Overall Study||0||
48155850|NCT04540874|100703219|FG001|NOT COMPLETED|Overall Study||0||
48155851|NCT03477279|100703220|FG000|STARTED|Overall Study||250||
48155852|NCT03477279|100703221|FG001|STARTED|Overall Study||250||
48155853|NCT03477279|100703222|FG002|STARTED|Overall Study||98||
48155854|NCT03477279|100703223|FG003|STARTED|Overall Study||168||
48155855|NCT03477279|100703224|FG004|STARTED|Overall Study||350||
48155856|NCT03477279|100703220|FG000|COMPLETED|Overall Study||203||
48155857|NCT03477279|100703221|FG001|COMPLETED|Overall Study||202||
48155858|NCT03477279|100703222|FG002|COMPLETED|Overall Study||98||
48612844|NCT04403113|101838379|FG001|COMPLETED|Overall Study||20||
48612845|NCT04403113|101838378|FG000|NOT COMPLETED|Overall Study||0||
48612846|NCT04403113|101838379|FG001|NOT COMPLETED|Overall Study||0||
48612847|NCT00215644|101838380|FG000|STARTED|Overall Study||36||
48612848|NCT00215644|101838381|FG001|STARTED|Overall Study||36||
48612849|NCT00215644|101838380|FG000|Treated|Overall Study||35||
48612850|NCT00215644|101838381|FG001|Treated|Overall Study||36||
48612851|NCT00215644|101838380|FG000|COMPLETED|Overall Study||0||
48612852|NCT00215644|101838381|FG001|COMPLETED|Overall Study||0||
48612853|NCT00215644|101838380|FG000|NOT COMPLETED|Overall Study||36||
48612854|NCT00215644|101838381|FG001|NOT COMPLETED|Overall Study||36||
48612855|NCT01051557|101838382|FG000|STARTED|Overall Study||4||
48612856|NCT01051557|101838383|FG001|STARTED|Overall Study||3||
48612857|NCT01051557|101838384|FG002|STARTED|Overall Study||6||
48612858|NCT01051557|101838385|FG003|STARTED|Overall Study||3||
48612859|NCT01051557|101838386|FG004|STARTED|Overall Study||8||
48612860|NCT01051557|101838387|FG005|STARTED|Overall Study||6||
48612861|NCT01051557|101838388|FG006|STARTED|Overall Study||6||
48612862|NCT01051557|101838382|FG000|COMPLETED|Overall Study||0||
48155859|NCT03477279|100703223|FG003|COMPLETED|Overall Study||136||
48155860|NCT03477279|100703224|FG004|COMPLETED|Overall Study||349||
48155861|NCT03477279|100703220|FG000|NOT COMPLETED|Overall Study||47||
48155862|NCT03477279|100703221|FG001|NOT COMPLETED|Overall Study||48||
48155863|NCT03477279|100703222|FG002|NOT COMPLETED|Overall Study||0||
48155864|NCT03477279|100703223|FG003|NOT COMPLETED|Overall Study||32||
48155865|NCT03477279|100703224|FG004|NOT COMPLETED|Overall Study||1||
48155866|NCT01786902|100703225|FG000|STARTED|Overall Study||36||
48612863|NCT01051557|101838383|FG001|COMPLETED|Overall Study||0||
48612864|NCT01051557|101838384|FG002|COMPLETED|Overall Study||0||
48612865|NCT01051557|101838385|FG003|COMPLETED|Overall Study||0||
48612866|NCT01051557|101838386|FG004|COMPLETED|Overall Study||1||
48612867|NCT01051557|101838387|FG005|COMPLETED|Overall Study||0||
48612868|NCT01051557|101838388|FG006|COMPLETED|Overall Study||0||
48612869|NCT01051557|101838382|FG000|NOT COMPLETED|Overall Study||4||
48612870|NCT01051557|101838383|FG001|NOT COMPLETED|Overall Study||3||
48612871|NCT01051557|101838384|FG002|NOT COMPLETED|Overall Study||6||
48155867|NCT01786902|100703226|FG001|STARTED|Overall Study||34||
48155868|NCT01786902|100703225|FG000|COMPLETED|Overall Study||32||
48155869|NCT01786902|100703226|FG001|COMPLETED|Overall Study||31||
48612872|NCT01051557|101838385|FG003|NOT COMPLETED|Overall Study||3||
48612873|NCT01051557|101838386|FG004|NOT COMPLETED|Overall Study||7||
48612874|NCT01051557|101838387|FG005|NOT COMPLETED|Overall Study||6||
48612875|NCT01051557|101838388|FG006|NOT COMPLETED|Overall Study||6||
48612876|NCT03974802|101838389|FG000|STARTED|Overall Study||41||
48612877|NCT03974802|101838389|FG000|COMPLETED|Overall Study||41||
48612878|NCT03974802|101838389|FG000|NOT COMPLETED|Overall Study||0||
48155870|NCT01786902|100703225|FG000|NOT COMPLETED|Overall Study||4||
48155871|NCT01786902|100703226|FG001|NOT COMPLETED|Overall Study||3||
48155872|NCT02114151|100703227|FG000|STARTED|Overall Study||103||
48155873|NCT02114151|100703227|FG000|COMPLETED|Overall Study||96||
48155874|NCT02114151|100703227|FG000|NOT COMPLETED|Overall Study||7||
48155875|NCT02124265|100703228|FG000|STARTED|Overall Study||3||
48155876|NCT02124265|100703228|FG000|COMPLETED|Overall Study||2||
48310776|NCT01721876|101087924|FG001|COMPLETED|Overall Study||0||
48310777|NCT01721876|101087923|FG000|NOT COMPLETED|Overall Study||222||
48726674|NCT01140061|102115156|FG000|STARTED|Part II||0||
48726675|NCT01140061|102115157|FG001|STARTED|Part II||0||
48726676|NCT01140061|102115158|FG002|STARTED|Part II||6||
48726677|NCT01140061|102115159|FG003|STARTED|Part II||2||
48726678|NCT01140061|102115160|FG004|STARTED|Part II||6||
48726679|NCT01140061|102115161|FG005|STARTED|Part II||2||
48726680|NCT01140061|102115162|FG006|STARTED|Part II||6||
48726681|NCT01140061|102115163|FG007|STARTED|Part II||2||
48726682|NCT01140061|102115164|FG008|STARTED|Part II||0||
48726683|NCT01140061|102115165|FG009|STARTED|Part II||0||
48726684|NCT01140061|102115156|FG000|COMPLETED|Part II||0||
48726685|NCT01140061|102115157|FG001|COMPLETED|Part II||0||
48726686|NCT01140061|102115158|FG002|COMPLETED|Part II||6||
48726687|NCT01140061|102115159|FG003|COMPLETED|Part II||2||
48726688|NCT01140061|102115160|FG004|COMPLETED|Part II||6||
48310778|NCT01721876|101087924|FG001|NOT COMPLETED|Overall Study||444||
48310779|NCT04246801|101087925|FG000|STARTED|Overall Study||140||
48310780|NCT04246801|101087926|FG001|STARTED|Overall Study||71||
48310781|NCT04246801|101087925|FG000|COMPLETED|Overall Study||135||
48310782|NCT04246801|101087926|FG001|COMPLETED|Overall Study||65||
48310783|NCT04246801|101087925|FG000|NOT COMPLETED|Overall Study||5||
48310784|NCT04246801|101087926|FG001|NOT COMPLETED|Overall Study||6||
48310785|NCT01172197|101087927|FG000|STARTED|Overall Study||7||
48310786|NCT01172197|101087928|FG001|STARTED|Overall Study||7||
48310787|NCT01172197|101087927|FG000|COMPLETED|Overall Study||7||
48612879|NCT02420262|101838390|FG000|STARTED|Overall Study||252||
48612880|NCT02420262|101838391|FG001|STARTED|Overall Study||254||
48612881|NCT02420262|101838390|FG000|Exposed|Overall Study||252||
48612882|NCT02420262|101838391|FG001|Exposed|Overall Study||253||
48726689|NCT01140061|102115161|FG005|COMPLETED|Part II||2||
48726690|NCT01140061|102115162|FG006|COMPLETED|Part II||6||
48612883|NCT02420262|101838390|FG000|COMPLETED|Overall Study||250||
48612884|NCT02420262|101838391|FG001|COMPLETED|Overall Study||249||
48612885|NCT02420262|101838390|FG000|NOT COMPLETED|Overall Study||2||
48612886|NCT02420262|101838391|FG001|NOT COMPLETED|Overall Study||5||
48612887|NCT00905424|101838392|FG000|STARTED|Overall Study||89||
48612888|NCT00905424|101838393|FG001|STARTED|Overall Study||88||
48612889|NCT00905424|101838392|FG000|COMPLETED|Overall Study||78||
48612890|NCT00905424|101838393|FG001|COMPLETED|Overall Study||79||
48726691|NCT01140061|102115163|FG007|COMPLETED|Part II||2||
48726692|NCT01140061|102115164|FG008|COMPLETED|Part II||0||
48726693|NCT01140061|102115165|FG009|COMPLETED|Part II||0||
48155877|NCT02124265|100703228|FG000|NOT COMPLETED|Overall Study||1||
48155878|NCT02390531|100703229|FG000|STARTED|Overall Study||11||
48155879|NCT02390531|100703230|FG001|STARTED|Overall Study||16||
48155880|NCT02390531|100703231|FG002|STARTED|Overall Study||24||
48155881|NCT02390531|100703232|FG003|STARTED|Overall Study||10||
48155882|NCT02390531|100703233|FG004|STARTED|Overall Study||14||
48155883|NCT02390531|100703234|FG005|STARTED|Overall Study||9||
48310788|NCT01172197|101087928|FG001|COMPLETED|Overall Study||7||
48310789|NCT01172197|101087927|FG000|NOT COMPLETED|Overall Study||0||
48310790|NCT01172197|101087928|FG001|NOT COMPLETED|Overall Study||0||
48310791|NCT01735279|101087929|FG000|STARTED|Overall Study||29||
48310792|NCT01735279|101087930|FG001|STARTED|Overall Study||29||
48310793|NCT01735279|101087929|FG000|COMPLETED|Overall Study||18||
48310794|NCT01735279|101087930|FG001|COMPLETED|Overall Study||21||
48310795|NCT01735279|101087929|FG000|NOT COMPLETED|Overall Study||11||
48310796|NCT01735279|101087930|FG001|NOT COMPLETED|Overall Study||8||
48310797|NCT03083847|101087931|FG000|STARTED|Pilot 1a||2||
48310798|NCT03083847|101087932|FG001|STARTED|Pilot 1a||0||
48310799|NCT03083847|101087933|FG002|STARTED|Pilot 1a||0||
48310800|NCT03083847|101087934|FG003|STARTED|Pilot 1a||0||
48612891|NCT00905424|101838392|FG000|NOT COMPLETED|Overall Study||11||
48612892|NCT00905424|101838393|FG001|NOT COMPLETED|Overall Study||9||
48612893|NCT02232477|101838394|FG000|STARTED|Overall Study||6||
48612894|NCT02232477|101838394|FG000|COMPLETED|Overall Study||4||
48612895|NCT02232477|101838394|FG000|NOT COMPLETED|Overall Study||2||
48155884|NCT02390531|100703235|FG006|STARTED|Overall Study||12||
48726694|NCT01140061|102115156|FG000|NOT COMPLETED|Part II||0||
48155885|NCT02390531|100703236|FG007|STARTED|Overall Study||24||
48310801|NCT03083847|101087935|FG004|STARTED|Pilot 1a||0||
48310802|NCT03083847|101087936|FG005|STARTED|Pilot 1a||0||
48310803|NCT03083847|101087937|FG006|STARTED|Pilot 1a||0||
48310804|NCT03083847|101087938|FG007|STARTED|Pilot 1a||0||
48726695|NCT01140061|102115157|FG001|NOT COMPLETED|Part II||0||
48726696|NCT01140061|102115158|FG002|NOT COMPLETED|Part II||0||
48155886|NCT02390531|100703229|FG000|COMPLETED|Overall Study||11||
48310805|NCT03083847|101087939|FG008|STARTED|Pilot 1a||0||
48612896|NCT01951118|101838395|FG000|STARTED|Overall Study||121||
48726697|NCT01140061|102115159|FG003|NOT COMPLETED|Part II||0||
48726698|NCT01140061|102115160|FG004|NOT COMPLETED|Part II||0||
48726699|NCT01140061|102115161|FG005|NOT COMPLETED|Part II||0||
48726700|NCT01140061|102115162|FG006|NOT COMPLETED|Part II||0||
48726701|NCT01140061|102115163|FG007|NOT COMPLETED|Part II||0||
48726702|NCT01140061|102115164|FG008|NOT COMPLETED|Part II||0||
48726703|NCT01140061|102115165|FG009|NOT COMPLETED|Part II||0||
48726704|NCT01140061|102115156|FG000|STARTED|Part III||0||
48726705|NCT01140061|102115157|FG001|STARTED|Part III||0||
48726706|NCT01140061|102115158|FG002|STARTED|Part III||0||
48726707|NCT01140061|102115159|FG003|STARTED|Part III||0||
48726708|NCT01140061|102115160|FG004|STARTED|Part III||0||
48726709|NCT01140061|102115161|FG005|STARTED|Part III||0||
48726710|NCT01140061|102115162|FG006|STARTED|Part III||0||
48726711|NCT01140061|102115163|FG007|STARTED|Part III||0||
48726712|NCT01140061|102115164|FG008|STARTED|Part III||7||
48726713|NCT01140061|102115165|FG009|STARTED|Part III||2||
48726714|NCT01140061|102115156|FG000|COMPLETED|Part III||0||
48726715|NCT01140061|102115157|FG001|COMPLETED|Part III||0||
48726716|NCT01140061|102115158|FG002|COMPLETED|Part III||0||
48726717|NCT01140061|102115159|FG003|COMPLETED|Part III||0||
48726718|NCT01140061|102115160|FG004|COMPLETED|Part III||0||
48726719|NCT01140061|102115161|FG005|COMPLETED|Part III||0||
48726720|NCT01140061|102115162|FG006|COMPLETED|Part III||0||
48726721|NCT01140061|102115163|FG007|COMPLETED|Part III||0||
48726722|NCT01140061|102115164|FG008|COMPLETED|Part III||7||
48726723|NCT01140061|102115165|FG009|COMPLETED|Part III||2||
48726724|NCT01140061|102115156|FG000|NOT COMPLETED|Part III||0||
48726725|NCT01140061|102115157|FG001|NOT COMPLETED|Part III||0||
48726726|NCT01140061|102115158|FG002|NOT COMPLETED|Part III||0||
48726727|NCT01140061|102115159|FG003|NOT COMPLETED|Part III||0||
48726728|NCT01140061|102115160|FG004|NOT COMPLETED|Part III||0||
48726729|NCT01140061|102115161|FG005|NOT COMPLETED|Part III||0||
48726730|NCT01140061|102115162|FG006|NOT COMPLETED|Part III||0||
48726731|NCT01140061|102115163|FG007|NOT COMPLETED|Part III||0||
48726732|NCT01140061|102115164|FG008|NOT COMPLETED|Part III||0||
48726733|NCT01140061|102115165|FG009|NOT COMPLETED|Part III||0||
48726734|NCT01140061|102115156|FG000|STARTED|Extension||0||
48726735|NCT01140061|102115157|FG001|STARTED|Extension||0||
48726736|NCT01140061|102115158|FG002|STARTED|Extension||0||
48726737|NCT01140061|102115159|FG003|STARTED|Extension||0||
48726738|NCT01140061|102115160|FG004|STARTED|Extension||0||
48726739|NCT01140061|102115161|FG005|STARTED|Extension||0||
48726740|NCT01140061|102115162|FG006|STARTED|Extension||0||
48726741|NCT01140061|102115163|FG007|STARTED|Extension||0||
48726742|NCT01140061|102115164|FG008|STARTED|Extension||7||
48726743|NCT01140061|102115165|FG009|STARTED|Extension||2||
48726744|NCT01140061|102115156|FG000|COMPLETED|Extension||0||
48726745|NCT01140061|102115157|FG001|COMPLETED|Extension||0||
48726746|NCT01140061|102115158|FG002|COMPLETED|Extension||0||
48726747|NCT01140061|102115159|FG003|COMPLETED|Extension||0||
48726748|NCT01140061|102115160|FG004|COMPLETED|Extension||0||
48726749|NCT01140061|102115161|FG005|COMPLETED|Extension||0||
48726750|NCT01140061|102115162|FG006|COMPLETED|Extension||0||
48726751|NCT01140061|102115163|FG007|COMPLETED|Extension||0||
48726752|NCT01140061|102115164|FG008|COMPLETED|Extension||7||
48726753|NCT01140061|102115165|FG009|COMPLETED|Extension||1||
48726754|NCT01140061|102115156|FG000|NOT COMPLETED|Extension||0||
48726755|NCT01140061|102115157|FG001|NOT COMPLETED|Extension||0||
48726756|NCT01140061|102115158|FG002|NOT COMPLETED|Extension||0||
48726757|NCT01140061|102115159|FG003|NOT COMPLETED|Extension||0||
48726758|NCT01140061|102115160|FG004|NOT COMPLETED|Extension||0||
48726759|NCT01140061|102115161|FG005|NOT COMPLETED|Extension||0||
48726760|NCT01140061|102115162|FG006|NOT COMPLETED|Extension||0||
48726761|NCT01140061|102115163|FG007|NOT COMPLETED|Extension||0||
48726762|NCT01140061|102115164|FG008|NOT COMPLETED|Extension||0||
48726763|NCT01140061|102115165|FG009|NOT COMPLETED|Extension||1||
48726764|NCT00084487|102118429|FG000|STARTED|Overall Study||21||
48726765|NCT00084487|102118429|FG000|COMPLETED|Overall Study||20||
48726766|NCT00084487|102118429|FG000|NOT COMPLETED|Overall Study||1||
48726767|NCT01406990|102118430|FG000|STARTED|Overall Study||15||
48726768|NCT01406990|102118430|FG000|COMPLETED|Overall Study||15||
48726769|NCT01406990|102118430|FG000|NOT COMPLETED|Overall Study||0||
48726770|NCT00400569|102118431|FG000|STARTED|Overall Study||48||
48726771|NCT00400569|102118431|FG000|COMPLETED|Overall Study||47||
48726772|NCT00400569|102118431|FG000|NOT COMPLETED|Overall Study||1||
48726773|NCT00699335|102118432|FG000|STARTED|Overall Study||5308||
48726774|NCT00699335|102118432|FG000|COMPLETED|Overall Study||5080||
48726775|NCT00699335|102118432|FG000|NOT COMPLETED|Overall Study||228||
48726776|NCT02540265|102118433|FG000|STARTED|Overall Study||20||
48726777|NCT02540265|102118434|FG001|STARTED|Overall Study||20||
48726778|NCT02540265|102118435|FG002|STARTED|Overall Study||19||
48726779|NCT02540265|102118433|FG000|Treatment Completion|Overall Study||20|Subjects receiving at least 2 study doses were considered as treatment complete|
48726780|NCT02540265|102118434|FG001|Treatment Completion|Overall Study||19|Subjects receiving at least 2 study doses were considered as treatment complete|
48726781|NCT02540265|102118435|FG002|Treatment Completion|Overall Study||18|Subjects receiving at least 2 study doses were considered as treatment complete|
48726782|NCT02540265|102118433|FG000|COMPLETED|Overall Study||20|Subjects who completed the final study followup were considered study completers|
48726783|NCT02540265|102118434|FG001|COMPLETED|Overall Study||20|Subjects who completed the final study followup were considered study completers|
48726784|NCT02540265|102118435|FG002|COMPLETED|Overall Study||18|Subjects who completed the final study followup were considered study completers|
48726785|NCT02540265|102118433|FG000|NOT COMPLETED|Overall Study||0||
48726786|NCT02540265|102118434|FG001|NOT COMPLETED|Overall Study||0||
48726787|NCT02540265|102118435|FG002|NOT COMPLETED|Overall Study||1||
48726788|NCT01369732|102118436|FG000|STARTED|Overall Study||33||
48726789|NCT01369732|102118437|FG001|STARTED|Overall Study||33||
48726790|NCT01369732|102118436|FG000|COMPLETED|Overall Study||29||
48726791|NCT01369732|102118437|FG001|COMPLETED|Overall Study||31||
48726792|NCT01369732|102118436|FG000|NOT COMPLETED|Overall Study||4||
48726793|NCT01369732|102118437|FG001|NOT COMPLETED|Overall Study||2||
48726794|NCT00148941|102118438|FG000|STARTED|Overall Study||1053||
48726795|NCT00148941|102118439|FG001|STARTED|Overall Study||1051||
48726796|NCT00148941|102118440|FG002|STARTED|Overall Study||1052||
48726797|NCT00148941|102118441|FG003|STARTED|Overall Study||1053||
48726798|NCT00148941|102118438|FG000|COMPLETED|Overall Study||1035||
48726799|NCT00148941|102118439|FG001|COMPLETED|Overall Study||1027||
48726800|NCT00148941|102118440|FG002|COMPLETED|Overall Study||1032||
48726801|NCT00148941|102118441|FG003|COMPLETED|Overall Study||1029||
48726802|NCT00148941|102118438|FG000|NOT COMPLETED|Overall Study||18||
48726803|NCT00148941|102118439|FG001|NOT COMPLETED|Overall Study||24||
48726804|NCT00148941|102118440|FG002|NOT COMPLETED|Overall Study||20||
48726805|NCT00148941|102118441|FG003|NOT COMPLETED|Overall Study||24||
48726806|NCT01990859|102118442|FG000|STARTED|Treatment (4 Doses Over 12 Weeks)||20||
48726807|NCT01990859|102118442|FG000|COMPLETED|Treatment (4 Doses Over 12 Weeks)||15||
48726808|NCT01990859|102118442|FG000|NOT COMPLETED|Treatment (4 Doses Over 12 Weeks)||5||
48726809|NCT01990859|102118442|FG000|STARTED|Week 12 to Week 24 Post Dosing Follow Up||20||
48726810|NCT01990859|102118442|FG000|COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||3||
48726811|NCT01990859|102118442|FG000|NOT COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||17||
48726812|NCT01990859|102118442|FG000|STARTED|90 Day Follow Up for All Participants||20||
48726813|NCT01990859|102118442|FG000|COMPLETED|90 Day Follow Up for All Participants||20||
48726814|NCT01990859|102118442|FG000|NOT COMPLETED|90 Day Follow Up for All Participants||0||
48726815|NCT03667690|102118443|FG000|STARTED|Overall Study||100|Subjects were randomly assigned (1:1 ratio) to receive either rezafungin for injection or caspofungin. Randomization was stratified based on diagnosis (candidemia only; invasive candidiasis) and by Acute Physiology and Chronic Health Evaluation (APACHE II) score/absolute neutrophil count (ANC) (APACHE II score ≥20 OR ANC \<500 cells/microliter; APACHE II score \<20 AND ANC ≥500 cells/microliter) at screening.|
48767605|NCT00914316|102222777|FG001|STARTED|Phase 2||4||
48767606|NCT00914316|102222778|FG002|STARTED|Phase 2||3||
48767607|NCT00914316|102222779|FG003|STARTED|Phase 2||6||
48767608|NCT00914316|102222776|FG000|COMPLETED|Phase 2||1||
48767609|NCT00914316|102222777|FG001|COMPLETED|Phase 2||4||
48767610|NCT00914316|102222778|FG002|COMPLETED|Phase 2||2||
48155887|NCT02390531|100703230|FG001|COMPLETED|Overall Study||14||
48155888|NCT02390531|100703231|FG002|COMPLETED|Overall Study||24||
48310806|NCT03083847|101087940|FG009|STARTED|Pilot 1a||0||
48310807|NCT03083847|101087931|FG000|COMPLETED|Pilot 1a||2||
48310808|NCT03083847|101087932|FG001|COMPLETED|Pilot 1a||0||
48310809|NCT03083847|101087933|FG002|COMPLETED|Pilot 1a||0||
48726816|NCT03667690|102118444|FG001|STARTED|Overall Study||99|Subjects were randomly assigned (1:1 ratio) to receive either rezafungin for injection or caspofungin. Randomization was stratified based on diagnosis (candidemia only; invasive candidiasis) and by Acute Physiology and Chronic Health Evaluation (APACHE II) score/absolute neutrophil count (ANC) (APACHE II score ≥20 OR ANC \<500 cells/microliter; APACHE II score \<20 AND ANC ≥500 cells/microliter) at screening.|
48726817|NCT03667690|102118443|FG000|Completed Study Drug Regimen Through Study Day 14|Overall Study||66|Discontinuations of study drug prior to Day 14 occurred in 34 and 28 subjects in the rezafungin for injection and caspofungin treatment groups, respectively. The primary reasons for study drug discontinuation prior to Day 14 were death and adverse events. Other reasons for study drug discontinuation prior to Day 14 were singular in nature and did not have a clear pattern for reason or relationship to treatment assignment.|
48726818|NCT03667690|102118444|FG001|Completed Study Drug Regimen Through Study Day 14|Overall Study||71|Discontinuations of study drug prior to Day 14 occurred in 34 and 28 subjects in the rezafungin for injection and caspofungin treatment groups, respectively. The primary reasons for study drug discontinuation prior to Day 14 were death and adverse events. Other reasons for study drug discontinuation prior to Day 14 were singular in nature and did not have a clear pattern for reason or relationship to treatment assignment.|
48726819|NCT03667690|102118443|FG000|COMPLETED|Overall Study||59||
48726820|NCT03667690|102118444|FG001|COMPLETED|Overall Study||59||
48726821|NCT03667690|102118443|FG000|NOT COMPLETED|Overall Study||41||
48726822|NCT03667690|102118444|FG001|NOT COMPLETED|Overall Study||40||
48726823|NCT00387036|102118445|FG000|STARTED|2-Week First Intervention||6||
48726824|NCT00387036|102118446|FG001|STARTED|2-Week First Intervention||6||
48726825|NCT00387036|102118445|FG000|COMPLETED|2-Week First Intervention||6||
48726826|NCT00387036|102118446|FG001|COMPLETED|2-Week First Intervention||6||
48726827|NCT00387036|102118445|FG000|NOT COMPLETED|2-Week First Intervention||0||
48726828|NCT00387036|102118446|FG001|NOT COMPLETED|2-Week First Intervention||0||
48726829|NCT00387036|102118445|FG000|STARTED|2-Week Placebo Washout||6||
48726830|NCT00387036|102118446|FG001|STARTED|2-Week Placebo Washout||6||
48726831|NCT00387036|102118445|FG000|COMPLETED|2-Week Placebo Washout||6||
48726832|NCT00387036|102118446|FG001|COMPLETED|2-Week Placebo Washout||6||
48726833|NCT00387036|102118445|FG000|NOT COMPLETED|2-Week Placebo Washout||0||
48726834|NCT00387036|102118446|FG001|NOT COMPLETED|2-Week Placebo Washout||0||
48726835|NCT00387036|102118445|FG000|STARTED|2-Week Crossover Second Intervention||6||
48726836|NCT00387036|102118446|FG001|STARTED|2-Week Crossover Second Intervention||6||
48726837|NCT00387036|102118445|FG000|COMPLETED|2-Week Crossover Second Intervention||6||
48726838|NCT00387036|102118446|FG001|COMPLETED|2-Week Crossover Second Intervention||6||
48726839|NCT00387036|102118445|FG000|NOT COMPLETED|2-Week Crossover Second Intervention||0||
48726840|NCT00387036|102118446|FG001|NOT COMPLETED|2-Week Crossover Second Intervention||0||
48726841|NCT04407234|102118447|FG000|STARTED|Overall Study||18||
48726842|NCT04407234|102118448|FG001|STARTED|Overall Study||18||
48726843|NCT04407234|102118447|FG000|Received at Least One Dose of Study Drug|Overall Study||18||
48726844|NCT04407234|102118448|FG001|Received at Least One Dose of Study Drug|Overall Study||18||
48726845|NCT04407234|102118447|FG000|COMPLETED|Overall Study||15||
48726846|NCT04407234|102118448|FG001|COMPLETED|Overall Study||15||
48726847|NCT04407234|102118447|FG000|NOT COMPLETED|Overall Study||3||
48726848|NCT04407234|102118448|FG001|NOT COMPLETED|Overall Study||3||
48726849|NCT00470418|102118449|FG000|STARTED|Overall Study||7||
48726850|NCT00470418|102118450|FG001|STARTED|Overall Study||3||
48726851|NCT00470418|102118449|FG000|COMPLETED|Overall Study||6||
48726852|NCT00470418|102118450|FG001|COMPLETED|Overall Study||3||
48726853|NCT00470418|102118449|FG000|NOT COMPLETED|Overall Study||1||
48726854|NCT00470418|102118450|FG001|NOT COMPLETED|Overall Study||0||
48726855|NCT00652080|102118451|FG000|STARTED|Overall Study||35||
48726856|NCT00652080|102118451|FG000|COMPLETED|Overall Study||31||
48726857|NCT00652080|102118451|FG000|NOT COMPLETED|Overall Study||4||
48726858|NCT00330681|102118452|FG000|STARTED|Overall Study||102||
48726859|NCT00330681|102118453|FG001|STARTED|Overall Study||104||
48726860|NCT00330681|102118452|FG000|COMPLETED|Overall Study||93||
48726861|NCT00330681|102118453|FG001|COMPLETED|Overall Study||90||
48726862|NCT00330681|102118452|FG000|NOT COMPLETED|Overall Study||9||
48726863|NCT00330681|102118453|FG001|NOT COMPLETED|Overall Study||14||
48726864|NCT03665688|102118454|FG000|STARTED|Overall Study||167||
48726865|NCT03665688|102118455|FG001|STARTED|Overall Study||171||
48726866|NCT03665688|102118454|FG000|COMPLETED|Overall Study||167||
48726867|NCT03665688|102118455|FG001|COMPLETED|Overall Study||171||
48726868|NCT03665688|102118454|FG000|NOT COMPLETED|Overall Study||0||
48726869|NCT03665688|102118455|FG001|NOT COMPLETED|Overall Study||0||
48726870|NCT02081599|102118456|FG000|STARTED|Period 1：Double-blind Period||71||
48726871|NCT02081599|102118457|FG001|STARTED|Period 1：Double-blind Period||77||
48726872|NCT02081599|102118456|FG000|COMPLETED|Period 1：Double-blind Period||63||
48726873|NCT02081599|102118457|FG001|COMPLETED|Period 1：Double-blind Period||75||
48726874|NCT02081599|102118456|FG000|NOT COMPLETED|Period 1：Double-blind Period||8||
48726875|NCT02081599|102118457|FG001|NOT COMPLETED|Period 1：Double-blind Period||2||
48726876|NCT02081599|102118456|FG000|STARTED|Period 2：Open-label Period||63||
48726877|NCT02081599|102118457|FG001|STARTED|Period 2：Open-label Period||75||
48310810|NCT03083847|101087934|FG003|COMPLETED|Pilot 1a||0||
48726878|NCT02081599|102118456|FG000|COMPLETED|Period 2：Open-label Period||57||
48726879|NCT02081599|102118457|FG001|COMPLETED|Period 2：Open-label Period||71||
48726880|NCT02081599|102118456|FG000|NOT COMPLETED|Period 2：Open-label Period||6||
48726881|NCT02081599|102118457|FG001|NOT COMPLETED|Period 2：Open-label Period||4||
48726882|NCT00082381|102118458|FG000|STARTED|Overall Study||283||
48726883|NCT00082381|102118459|FG001|STARTED|Overall Study||268||
48726884|NCT00082381|102118458|FG000|Received Treatment (Intent to Treat)|Overall Study||282||
48726885|NCT00082381|102118459|FG001|Received Treatment (Intent to Treat)|Overall Study||267||
48726886|NCT00082381|102118458|FG000|COMPLETED|Overall Study||228||
48726887|NCT00082381|102118459|FG001|COMPLETED|Overall Study||242||
48726888|NCT00082381|102118458|FG000|NOT COMPLETED|Overall Study||55||
48726889|NCT00082381|102118459|FG001|NOT COMPLETED|Overall Study||26||
48726890|NCT00223704|102118460|FG000|STARTED|Overall Study||38||
48726891|NCT00223704|102118461|FG001|STARTED|Overall Study||37||
48726892|NCT00223704|102118462|FG002|STARTED|Overall Study||40||
48726893|NCT00223704|102118460|FG000|COMPLETED|Overall Study||38||
48726894|NCT00223704|102118461|FG001|COMPLETED|Overall Study||37||
48726895|NCT00223704|102118462|FG002|COMPLETED|Overall Study||40||
48726896|NCT00223704|102118460|FG000|NOT COMPLETED|Overall Study||0||
48726897|NCT00223704|102118461|FG001|NOT COMPLETED|Overall Study||0||
48726898|NCT00223704|102118462|FG002|NOT COMPLETED|Overall Study||0||
48726899|NCT01898013|102118463|FG000|STARTED|Visit 3 (Randomization Visit)||45||
48726900|NCT01898013|102118464|FG001|STARTED|Visit 3 (Randomization Visit)||49||
48726901|NCT01898013|102118463|FG000|COMPLETED|Visit 3 (Randomization Visit)||45||
48726902|NCT01898013|102118464|FG001|COMPLETED|Visit 3 (Randomization Visit)||49||
48726903|NCT01898013|102118463|FG000|NOT COMPLETED|Visit 3 (Randomization Visit)||0||
48726904|NCT01898013|102118464|FG001|NOT COMPLETED|Visit 3 (Randomization Visit)||0||
48726905|NCT01898013|102118463|FG000|STARTED|Visit 4||45||
48726906|NCT01898013|102118464|FG001|STARTED|Visit 4||49||
48726907|NCT01898013|102118463|FG000|COMPLETED|Visit 4||45||
48726908|NCT01898013|102118464|FG001|COMPLETED|Visit 4||48||
48726909|NCT01898013|102118463|FG000|NOT COMPLETED|Visit 4||0||
48726910|NCT01898013|102118464|FG001|NOT COMPLETED|Visit 4||1||
48726911|NCT01898013|102118463|FG000|STARTED|Visit 5||45||
48726912|NCT01898013|102118464|FG001|STARTED|Visit 5||48||
48726913|NCT01898013|102118463|FG000|COMPLETED|Visit 5||44||
48726914|NCT01898013|102118464|FG001|COMPLETED|Visit 5||47||
48726915|NCT01898013|102118463|FG000|NOT COMPLETED|Visit 5||1||
48726916|NCT01898013|102118464|FG001|NOT COMPLETED|Visit 5||1||
48726917|NCT01898013|102118463|FG000|STARTED|Visit 6||44||
48726918|NCT01898013|102118464|FG001|STARTED|Visit 6||47||
48726919|NCT01898013|102118463|FG000|COMPLETED|Visit 6||41||
48726920|NCT01898013|102118464|FG001|COMPLETED|Visit 6||42||
48726921|NCT01898013|102118463|FG000|NOT COMPLETED|Visit 6||3||
48726922|NCT01898013|102118464|FG001|NOT COMPLETED|Visit 6||5||
48726923|NCT03517566|102118465|FG000|STARTED|Overall Study||74||
48726924|NCT03517566|102118466|FG001|STARTED|Overall Study||37||
48726925|NCT03517566|102118467|FG002|STARTED|Overall Study||36||
48726926|NCT03517566|102118468|FG003|STARTED|Overall Study||73||
48726927|NCT03517566|102118469|FG004|STARTED|Overall Study||73||
48726928|NCT03517566|102118465|FG000|COMPLETED|Overall Study||42||
48726929|NCT03517566|102118466|FG001|COMPLETED|Overall Study||16||
48726930|NCT03517566|102118467|FG002|COMPLETED|Overall Study||21||
48726931|NCT03517566|102118468|FG003|COMPLETED|Overall Study||39||
48726932|NCT03517566|102118469|FG004|COMPLETED|Overall Study||41||
48726933|NCT03517566|102118465|FG000|NOT COMPLETED|Overall Study||32||
48726934|NCT03517566|102118466|FG001|NOT COMPLETED|Overall Study||21||
48726935|NCT03517566|102118467|FG002|NOT COMPLETED|Overall Study||15||
48726936|NCT03517566|102118468|FG003|NOT COMPLETED|Overall Study||34||
48726937|NCT03517566|102118469|FG004|NOT COMPLETED|Overall Study||32||
48726938|NCT02708485|102118470|FG000|STARTED|Overall Study||3||
48726939|NCT02708485|102118471|FG001|STARTED|Overall Study||12||
48726940|NCT02708485|102118470|FG000|COMPLETED|Overall Study||0||
48726941|NCT02708485|102118471|FG001|COMPLETED|Overall Study||10||
48726942|NCT02708485|102118470|FG000|NOT COMPLETED|Overall Study||3||
48726943|NCT02708485|102118471|FG001|NOT COMPLETED|Overall Study||2||
48726944|NCT03228212|102118472|FG000|STARTED|Period 1||65||
48726945|NCT03228212|102118473|FG001|STARTED|Period 1||65||
48726946|NCT03228212|102118472|FG000|COMPLETED|Period 1||64||
48726947|NCT03228212|102118473|FG001|COMPLETED|Period 1||64||
48726948|NCT03228212|102118472|FG000|NOT COMPLETED|Period 1||1||
48726949|NCT03228212|102118473|FG001|NOT COMPLETED|Period 1||1||
48726950|NCT03228212|102118472|FG000|STARTED|Period 2||64||
48726951|NCT03228212|102118473|FG001|STARTED|Period 2||64||
48726952|NCT03228212|102118472|FG000|COMPLETED|Period 2||63||
48726953|NCT03228212|102118473|FG001|COMPLETED|Period 2||64||
48726954|NCT03228212|102118472|FG000|NOT COMPLETED|Period 2||1||
48726955|NCT03228212|102118473|FG001|NOT COMPLETED|Period 2||0||
48726956|NCT03228212|102118472|FG000|STARTED|Period 3||63||
48726957|NCT03228212|102118473|FG001|STARTED|Period 3||64||
48726958|NCT03228212|102118472|FG000|COMPLETED|Period 3||63||
48726959|NCT03228212|102118473|FG001|COMPLETED|Period 3||64||
48726960|NCT03228212|102118472|FG000|NOT COMPLETED|Period 3||0||
48726961|NCT03228212|102118473|FG001|NOT COMPLETED|Period 3||0||
48726962|NCT01079936|102118474|FG000|STARTED|Phase I: MTD||16||
48726963|NCT01079936|102118475|FG001|STARTED|Phase I: MTD||0||
48726964|NCT01079936|102118476|FG002|STARTED|Phase I: MTD||0||
48726965|NCT01079936|102118477|FG003|STARTED|Phase I: MTD||0||
48726966|NCT01079936|102118478|FG004|STARTED|Phase I: MTD||0||
48726967|NCT01079936|102118474|FG000|COMPLETED|Phase I: MTD||12||
48726968|NCT01079936|102118475|FG001|COMPLETED|Phase I: MTD||0||
48726969|NCT01079936|102118476|FG002|COMPLETED|Phase I: MTD||0||
48726970|NCT01079936|102118477|FG003|COMPLETED|Phase I: MTD||0||
48726971|NCT01079936|102118478|FG004|COMPLETED|Phase I: MTD||0||
48726972|NCT01079936|102118474|FG000|NOT COMPLETED|Phase I: MTD||4||
48726973|NCT01079936|102118475|FG001|NOT COMPLETED|Phase I: MTD||0||
48726974|NCT01079936|102118476|FG002|NOT COMPLETED|Phase I: MTD||0||
48726975|NCT01079936|102118477|FG003|NOT COMPLETED|Phase I: MTD||0||
48726976|NCT01079936|102118478|FG004|NOT COMPLETED|Phase I: MTD||0||
48726977|NCT01079936|102118474|FG000|STARTED|Phase II||0||
48726978|NCT01079936|102118475|FG001|STARTED|Phase II||3||
48726979|NCT01079936|102118476|FG002|STARTED|Phase II||6||
48726980|NCT01079936|102118477|FG003|STARTED|Phase II||24||
48726981|NCT01079936|102118478|FG004|STARTED|Phase II||26||
48726982|NCT01079936|102118474|FG000|COMPLETED|Phase II||0||
48726983|NCT01079936|102118475|FG001|COMPLETED|Phase II||3||
48726984|NCT01079936|102118476|FG002|COMPLETED|Phase II||5||
48726985|NCT01079936|102118477|FG003|COMPLETED|Phase II||24||
48726986|NCT01079936|102118478|FG004|COMPLETED|Phase II||25||
48726987|NCT01079936|102118474|FG000|NOT COMPLETED|Phase II||0||
48726988|NCT01079936|102118475|FG001|NOT COMPLETED|Phase II||0||
48726989|NCT01079936|102118476|FG002|NOT COMPLETED|Phase II||1||
48726990|NCT01079936|102118477|FG003|NOT COMPLETED|Phase II||0||
48726991|NCT01079936|102118478|FG004|NOT COMPLETED|Phase II||1||
48726992|NCT02161757|102118479|FG000|STARTED|Randomised Through Start Treatment||401||
48726993|NCT02161757|102118480|FG001|STARTED|Randomised Through Start Treatment||406||
48726994|NCT02161757|102118481|FG002|STARTED|Randomised Through Start Treatment||400||
48726995|NCT02161757|102118479|FG000|COMPLETED|Randomised Through Start Treatment||398||
48726996|NCT02161757|102118480|FG001|COMPLETED|Randomised Through Start Treatment||404||
48726997|NCT02161757|102118481|FG002|COMPLETED|Randomised Through Start Treatment||400||
48726998|NCT02161757|102118479|FG000|NOT COMPLETED|Randomised Through Start Treatment||3||
48726999|NCT02161757|102118480|FG001|NOT COMPLETED|Randomised Through Start Treatment||2||
48727000|NCT02161757|102118481|FG002|NOT COMPLETED|Randomised Through Start Treatment||0||
48727001|NCT02161757|102118479|FG000|STARTED|Treatment Through Study Completion||398||
48727002|NCT02161757|102118480|FG001|STARTED|Treatment Through Study Completion||404||
48727003|NCT02161757|102118481|FG002|STARTED|Treatment Through Study Completion||400||
48727004|NCT02161757|102118479|FG000|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||332||
48727005|NCT02161757|102118480|FG001|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||355||
48727006|NCT02161757|102118481|FG002|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||360||
48727007|NCT02161757|102118479|FG000|COMPLETED|Treatment Through Study Completion||341|Completed the study|
48727008|NCT02161757|102118480|FG001|COMPLETED|Treatment Through Study Completion||361|Completed the study|
48727009|NCT02161757|102118481|FG002|COMPLETED|Treatment Through Study Completion||361|Completed the study|
48727010|NCT02161757|102118479|FG000|NOT COMPLETED|Treatment Through Study Completion||57||
48727011|NCT02161757|102118480|FG001|NOT COMPLETED|Treatment Through Study Completion||43||
48727012|NCT02161757|102118481|FG002|NOT COMPLETED|Treatment Through Study Completion||39||
48727013|NCT00527319|102118482|FG000|STARTED|Overall Study||12||
48727014|NCT00527319|102118483|FG001|STARTED|Overall Study||12||
48727015|NCT00527319|102118484|FG002|STARTED|Overall Study||13||
48727016|NCT00527319|102118482|FG000|COMPLETED|Overall Study||6||
48727017|NCT00527319|102118483|FG001|COMPLETED|Overall Study||8||
48727018|NCT00527319|102118484|FG002|COMPLETED|Overall Study||7||
48727019|NCT00527319|102118482|FG000|NOT COMPLETED|Overall Study||6||
48727020|NCT00527319|102118483|FG001|NOT COMPLETED|Overall Study||4||
48727021|NCT00527319|102118484|FG002|NOT COMPLETED|Overall Study||6||
48727022|NCT03123328|102118485|FG000|STARTED|Overall Study||380||
48727023|NCT03123328|102118485|FG000|COMPLETED|Overall Study||351||
48727024|NCT03123328|102118485|FG000|NOT COMPLETED|Overall Study||29||
48727025|NCT00095173|102118486|FG000|STARTED|Open-Label Lead-In Phase (Period A)||190||
48727026|NCT00095173|102118487|FG001|STARTED|Open-Label Lead-In Phase (Period A)||0||
48727027|NCT00095173|102118488|FG002|STARTED|Open-Label Lead-In Phase (Period A)||0||
48727028|NCT00095173|102118489|FG003|STARTED|Open-Label Lead-In Phase (Period A)||0||
48727029|NCT00095173|102118490|FG004|STARTED|Open-Label Lead-In Phase (Period A)||0||
48727030|NCT00095173|102118491|FG005|STARTED|Open-Label Lead-In Phase (Period A)||0||
48727031|NCT00095173|102118486|FG000|COMPLETED|Open-Label Lead-In Phase (Period A)||170||
48727032|NCT00095173|102118487|FG001|COMPLETED|Open-Label Lead-In Phase (Period A)||0||
48727033|NCT00095173|102118488|FG002|COMPLETED|Open-Label Lead-In Phase (Period A)||0||
48727034|NCT00095173|102118489|FG003|COMPLETED|Open-Label Lead-In Phase (Period A)||0||
48727035|NCT00095173|102118490|FG004|COMPLETED|Open-Label Lead-In Phase (Period A)||0||
48727036|NCT00095173|102118491|FG005|COMPLETED|Open-Label Lead-In Phase (Period A)||0||
48727037|NCT00095173|102118486|FG000|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||20||
48727038|NCT00095173|102118487|FG001|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0||
48727039|NCT00095173|102118488|FG002|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0||
48727040|NCT00095173|102118489|FG003|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0||
48727041|NCT00095173|102118490|FG004|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0||
48727042|NCT00095173|102118491|FG005|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0||
48727043|NCT00095173|102118486|FG000|STARTED|Double-Blind Phase (Period B)||0||
48727044|NCT00095173|102118487|FG001|STARTED|Double-Blind Phase (Period B)||60||
48727045|NCT00095173|102118488|FG002|STARTED|Double-Blind Phase (Period B)||62||
48727046|NCT00095173|102118489|FG003|STARTED|Double-Blind Phase (Period B)||0||
48727047|NCT00095173|102118490|FG004|STARTED|Double-Blind Phase (Period B)||0||
48727048|NCT00095173|102118491|FG005|STARTED|Double-Blind Phase (Period B)||0||
48727049|NCT00095173|102118486|FG000|COMPLETED|Double-Blind Phase (Period B)||0||
48727050|NCT00095173|102118487|FG001|COMPLETED|Double-Blind Phase (Period B)||49||
48727051|NCT00095173|102118488|FG002|COMPLETED|Double-Blind Phase (Period B)||31||
48727052|NCT00095173|102118489|FG003|COMPLETED|Double-Blind Phase (Period B)||0||
48727053|NCT00095173|102118490|FG004|COMPLETED|Double-Blind Phase (Period B)||0||
48727054|NCT00095173|102118491|FG005|COMPLETED|Double-Blind Phase (Period B)||0||
48727055|NCT00095173|102118486|FG000|NOT COMPLETED|Double-Blind Phase (Period B)||0||
48727056|NCT00095173|102118487|FG001|NOT COMPLETED|Double-Blind Phase (Period B)||11||
48727057|NCT00095173|102118488|FG002|NOT COMPLETED|Double-Blind Phase (Period B)||31||
48727058|NCT00095173|102118489|FG003|NOT COMPLETED|Double-Blind Phase (Period B)||0||
48727059|NCT00095173|102118490|FG004|NOT COMPLETED|Double-Blind Phase (Period B)||0||
48727060|NCT00095173|102118491|FG005|NOT COMPLETED|Double-Blind Phase (Period B)||0||
48727061|NCT00095173|102118486|FG000|STARTED|Open-Label Extension Phase (Period C)||0||
48727062|NCT00095173|102118487|FG001|STARTED|Open-Label Extension Phase (Period C)||0||
48727063|NCT00095173|102118488|FG002|STARTED|Open-Label Extension Phase (Period C)||0||
48727064|NCT00095173|102118489|FG003|STARTED|Open-Label Extension Phase (Period C)||36||
48727065|NCT00095173|102118490|FG004|STARTED|Open-Label Extension Phase (Period C)||58||
48727066|NCT00095173|102118491|FG005|STARTED|Open-Label Extension Phase (Period C)||59||
48727067|NCT00095173|102118486|FG000|COMPLETED|Open-Label Extension Phase (Period C)||0||
48727068|NCT00095173|102118487|FG001|COMPLETED|Open-Label Extension Phase (Period C)||0||
48727069|NCT00095173|102118488|FG002|COMPLETED|Open-Label Extension Phase (Period C)||0||
48727070|NCT00095173|102118489|FG003|COMPLETED|Open-Label Extension Phase (Period C)||13||
48727071|NCT00095173|102118490|FG004|COMPLETED|Open-Label Extension Phase (Period C)||29||
48727072|NCT00095173|102118491|FG005|COMPLETED|Open-Label Extension Phase (Period C)||27||
48727073|NCT00095173|102118486|FG000|NOT COMPLETED|Open-Label Extension Phase (Period C)||0||
48727074|NCT00095173|102118487|FG001|NOT COMPLETED|Open-Label Extension Phase (Period C)||0||
48727075|NCT00095173|102118488|FG002|NOT COMPLETED|Open-Label Extension Phase (Period C)||0||
48727076|NCT00095173|102118489|FG003|NOT COMPLETED|Open-Label Extension Phase (Period C)||23||
48727077|NCT00095173|102118490|FG004|NOT COMPLETED|Open-Label Extension Phase (Period C)||29||
48727078|NCT00095173|102118491|FG005|NOT COMPLETED|Open-Label Extension Phase (Period C)||32||
48727079|NCT02484222|102118492|FG000|STARTED|Overall Study||80||
48727080|NCT02484222|102118492|FG000|COMPLETED|Overall Study||77||
48727081|NCT02484222|102118492|FG000|NOT COMPLETED|Overall Study||3||
48727082|NCT02301624|102118493|FG000|STARTED|Blind Induction Phase||56||
48727083|NCT02301624|102118494|FG001|STARTED|Blind Induction Phase||61||
48727084|NCT02301624|102118493|FG000|Received at Least 1 Dose of Study Drug|Blind Induction Phase||56||
48727085|NCT02301624|102118494|FG001|Received at Least 1 Dose of Study Drug|Blind Induction Phase||61||
48612897|NCT01951118|101838395|FG000|COMPLETED|Overall Study||94||
48612898|NCT01951118|101838395|FG000|NOT COMPLETED|Overall Study||27||
48612899|NCT03382418|101838396|FG000|STARTED|Overall Study||25||
48612900|NCT03382418|101838397|FG001|STARTED|Overall Study||15||
48612901|NCT03382418|101838398|FG002|STARTED|Overall Study||5||
48612902|NCT03382418|101838396|FG000|Month .5 Immunogenicity Cohort|Overall Study||25|HIV uninfected at Month 0.5 and specimen available for assays|
48612903|NCT03382418|101838397|FG001|Month .5 Immunogenicity Cohort|Overall Study||14|HIV uninfected at Month 0.5 and specimen available for assays|
48612904|NCT03382418|101838398|FG002|Month .5 Immunogenicity Cohort|Overall Study||5|HIV uninfected at Month 0.5 and specimen available for assays|
48612905|NCT03382418|101838396|FG000|Month 6.5 Immunogenicity Cohort|Overall Study||21|HIV uninfected at Month 6.5 and specimen available for assays|
48612906|NCT03382418|101838397|FG001|Month 6.5 Immunogenicity Cohort|Overall Study||13|HIV uninfected at Month 6.5 and specimen available for assays|
48612907|NCT03382418|101838398|FG002|Month 6.5 Immunogenicity Cohort|Overall Study||5|HIV uninfected at Month 6.5 and specimen available for assays|
48612908|NCT03382418|101838396|FG000|COMPLETED|Overall Study||22||
48612909|NCT03382418|101838397|FG001|COMPLETED|Overall Study||12||
48612910|NCT03382418|101838398|FG002|COMPLETED|Overall Study||5||
48612911|NCT03382418|101838396|FG000|NOT COMPLETED|Overall Study||3||
48612912|NCT03382418|101838397|FG001|NOT COMPLETED|Overall Study||3||
48612913|NCT03382418|101838398|FG002|NOT COMPLETED|Overall Study||0||
48612914|NCT00490919|101838399|FG000|STARTED|Open-label Run-in Period||1024||
48612915|NCT00490919|101838400|FG001|STARTED|Open-label Run-in Period||0||
48612916|NCT00490919|101838401|FG002|STARTED|Open-label Run-in Period||0||
48727086|NCT02301624|102118493|FG000|COMPLETED|Blind Induction Phase||55||
48727087|NCT02301624|102118494|FG001|COMPLETED|Blind Induction Phase||61||
48727088|NCT02301624|102118493|FG000|NOT COMPLETED|Blind Induction Phase||1||
48727089|NCT02301624|102118494|FG001|NOT COMPLETED|Blind Induction Phase||0||
48727090|NCT02301624|102118493|FG000|STARTED|Open-label Maintenance Phase||55||
48727091|NCT02301624|102118494|FG001|STARTED|Open-label Maintenance Phase||61||
48727092|NCT02301624|102118493|FG000|Received at Least 1 Dose of Study Drug|Open-label Maintenance Phase||55||
48727093|NCT02301624|102118494|FG001|Received at Least 1 Dose of Study Drug|Open-label Maintenance Phase||61||
48727094|NCT02301624|102118493|FG000|COMPLETED|Open-label Maintenance Phase||43||
48727095|NCT02301624|102118494|FG001|COMPLETED|Open-label Maintenance Phase||44||
48727096|NCT02301624|102118493|FG000|NOT COMPLETED|Open-label Maintenance Phase||12||
48727097|NCT02301624|102118494|FG001|NOT COMPLETED|Open-label Maintenance Phase||17||
48727098|NCT02022436|102118495|FG000|STARTED|Overall Study||59||
48727099|NCT02022436|102118496|FG001|STARTED|Overall Study||7||
48727100|NCT02022436|102118495|FG000|COMPLETED|Overall Study||59||
48727101|NCT02022436|102118496|FG001|COMPLETED|Overall Study||7||
48727102|NCT02022436|102118495|FG000|NOT COMPLETED|Overall Study||0||
48727103|NCT02022436|102118496|FG001|NOT COMPLETED|Overall Study||0||
48727104|NCT01183468|102118497|FG000|STARTED|Overall Study||8||
48727105|NCT01183468|102118498|FG001|STARTED|Overall Study||9||
48727106|NCT01183468|102118499|FG002|STARTED|Overall Study||0||
48727107|NCT01183468|102118500|FG003|STARTED|Overall Study||0||
48727108|NCT01183468|102118497|FG000|COMPLETED|Overall Study||5||
48727109|NCT01183468|102118498|FG001|COMPLETED|Overall Study||7||
48727110|NCT01183468|102118499|FG002|COMPLETED|Overall Study||0||
48612917|NCT00490919|101838399|FG000|COMPLETED|Open-label Run-in Period||541||
48612918|NCT00490919|101838400|FG001|COMPLETED|Open-label Run-in Period||0||
48612919|NCT00490919|101838401|FG002|COMPLETED|Open-label Run-in Period||0||
48612920|NCT00490919|101838399|FG000|NOT COMPLETED|Open-label Run-in Period||483||
48727111|NCT01183468|102118500|FG003|COMPLETED|Overall Study||0||
48727112|NCT01183468|102118497|FG000|NOT COMPLETED|Overall Study||3||
48727113|NCT01183468|102118498|FG001|NOT COMPLETED|Overall Study||2||
48727114|NCT01183468|102118499|FG002|NOT COMPLETED|Overall Study||0||
48727115|NCT01183468|102118500|FG003|NOT COMPLETED|Overall Study||0||
48727116|NCT03688620|102118501|FG000|STARTED|Overall Study||329||
48727117|NCT03688620|102118502|FG001|STARTED|Overall Study||278||
48727118|NCT03688620|102118503|FG002|STARTED|Overall Study||453||
48727119|NCT03688620|102118501|FG000|COMPLETED|Overall Study||313||
48727120|NCT03688620|102118502|FG001|COMPLETED|Overall Study||277||
48727121|NCT03688620|102118503|FG002|COMPLETED|Overall Study||445||
48727122|NCT03688620|102118501|FG000|NOT COMPLETED|Overall Study||16||
48727123|NCT03688620|102118502|FG001|NOT COMPLETED|Overall Study||1||
48727124|NCT03688620|102118503|FG002|NOT COMPLETED|Overall Study||8||
48727125|NCT01123395|102118504|FG000|STARTED|Period 1||8||
48727126|NCT01123395|102118505|FG001|STARTED|Period 1||8||
48727127|NCT01123395|102118504|FG000|COMPLETED|Period 1||8||
48727128|NCT01123395|102118505|FG001|COMPLETED|Period 1||8||
48727129|NCT01123395|102118504|FG000|NOT COMPLETED|Period 1||0||
48727130|NCT01123395|102118505|FG001|NOT COMPLETED|Period 1||0||
48727131|NCT01123395|102118504|FG000|STARTED|Washout Period of 14 Days||8||
48727132|NCT01123395|102118505|FG001|STARTED|Washout Period of 14 Days||8||
48727133|NCT01123395|102118504|FG000|COMPLETED|Washout Period of 14 Days||8||
48727134|NCT01123395|102118505|FG001|COMPLETED|Washout Period of 14 Days||7||
48727135|NCT01123395|102118504|FG000|NOT COMPLETED|Washout Period of 14 Days||0||
48727136|NCT01123395|102118505|FG001|NOT COMPLETED|Washout Period of 14 Days||1||
48727137|NCT01123395|102118504|FG000|STARTED|Period 2||8||
48727138|NCT01123395|102118505|FG001|STARTED|Period 2||7||
48727139|NCT01123395|102118504|FG000|COMPLETED|Period 2||8||
48727140|NCT01123395|102118505|FG001|COMPLETED|Period 2||7||
48727141|NCT01123395|102118504|FG000|NOT COMPLETED|Period 2||0||
48727142|NCT01123395|102118505|FG001|NOT COMPLETED|Period 2||0||
48727143|NCT00687531|102118506|FG000|STARTED|Overall Study||385||
48727144|NCT00687531|102118506|FG000|RECEIVED TREATMENT|Overall Study||281||
48727145|NCT00687531|102118506|FG000|COMPLETED|Overall Study||250||
48727146|NCT00687531|102118506|FG000|NOT COMPLETED|Overall Study||135||
48727147|NCT03221309|102118507|FG000|STARTED|Overall Study||198||
48727148|NCT03221309|102118507|FG000|Phase 1|Overall Study||100||
48727149|NCT03221309|102118507|FG000|Phase 2|Overall Study||98||
48727150|NCT03221309|102118507|FG000|COMPLETED|Overall Study||160||
48727151|NCT03221309|102118507|FG000|NOT COMPLETED|Overall Study||38||
48310811|NCT03083847|101087935|FG004|COMPLETED|Pilot 1a||0||
48310812|NCT03083847|101087936|FG005|COMPLETED|Pilot 1a||0||
48310813|NCT03083847|101087937|FG006|COMPLETED|Pilot 1a||0||
48727152|NCT04118595|102118508|FG000|STARTED|Overall Study||112||
48727153|NCT04118595|102118509|FG001|STARTED|Overall Study||107||
48727154|NCT04118595|102118510|FG002|STARTED|Overall Study||111||
48727155|NCT04118595|102118508|FG000|Completed Week 1 Within 7-day Window|Overall Study||107||
48727156|NCT04118595|102118509|FG001|Completed Week 1 Within 7-day Window|Overall Study||97||
48727157|NCT04118595|102118510|FG002|Completed Week 1 Within 7-day Window|Overall Study||108||
48727158|NCT04118595|102118508|FG000|Completed Month 1 Within 7-day Window|Overall Study||108||
48727159|NCT04118595|102118509|FG001|Completed Month 1 Within 7-day Window|Overall Study||100||
48727160|NCT04118595|102118510|FG002|Completed Month 1 Within 7-day Window|Overall Study||106||
48727161|NCT04118595|102118508|FG000|Completed Month 3 Within 7-day Window|Overall Study||103||
48727162|NCT04118595|102118509|FG001|Completed Month 3 Within 7-day Window|Overall Study||99||
48727163|NCT04118595|102118510|FG002|Completed Month 3 Within 7-day Window|Overall Study||102||
48727164|NCT04118595|102118508|FG000|Completed Month 6 Within 7-day Window|Overall Study||104||
48155889|NCT02390531|100703232|FG003|COMPLETED|Overall Study||9||
48155890|NCT02390531|100703233|FG004|COMPLETED|Overall Study||13||
48155891|NCT02390531|100703234|FG005|COMPLETED|Overall Study||9||
48155892|NCT02390531|100703235|FG006|COMPLETED|Overall Study||10||
48310814|NCT03083847|101087938|FG007|COMPLETED|Pilot 1a||0||
48310815|NCT03083847|101087939|FG008|COMPLETED|Pilot 1a||0||
48727165|NCT04118595|102118509|FG001|Completed Month 6 Within 7-day Window|Overall Study||96||
48727166|NCT04118595|102118510|FG002|Completed Month 6 Within 7-day Window|Overall Study||102||
48727167|NCT04118595|102118508|FG000|Completed Month 12 Within 7-day Window|Overall Study||101||
48727168|NCT04118595|102118509|FG001|Completed Month 12 Within 7-day Window|Overall Study||88||
48727169|NCT04118595|102118510|FG002|Completed Month 12 Within 7-day Window|Overall Study||96||
48727170|NCT04118595|102118508|FG000|COMPLETED|Overall Study||101||
48727171|NCT04118595|102118509|FG001|COMPLETED|Overall Study||88||
48727172|NCT04118595|102118510|FG002|COMPLETED|Overall Study||96||
48727173|NCT04118595|102118508|FG000|NOT COMPLETED|Overall Study||11||
48727174|NCT04118595|102118509|FG001|NOT COMPLETED|Overall Study||19||
48727175|NCT04118595|102118510|FG002|NOT COMPLETED|Overall Study||15||
48727176|NCT01183065|102118511|FG000|STARTED|Overall Study||13||
48727177|NCT01183065|102118511|FG000|COMPLETED|Overall Study||12||
48727178|NCT01183065|102118511|FG000|NOT COMPLETED|Overall Study||1||
48727179|NCT00965419|102118512|FG000|STARTED|Open Label Treatment for Responders||267||
48727180|NCT00965419|102118512|FG000|Not Lost to f/u at First Post-baseline|Open Label Treatment for Responders||264||
48727181|NCT00965419|102118512|FG000|COMPLETED|Open Label Treatment for Responders||20||
48727182|NCT00965419|102118512|FG000|NOT COMPLETED|Open Label Treatment for Responders||247||
48727183|NCT00965419|102118512|FG000|STARTED|Follow-up Phase||80|Participants who dropped out of treatment period early had the option to enter follow-up period.|
48727184|NCT00965419|102118512|FG000|COMPLETED|Follow-up Phase||18||
48155893|NCT02390531|100703236|FG007|COMPLETED|Overall Study||23||
48310816|NCT03083847|101087940|FG009|COMPLETED|Pilot 1a||0||
48310817|NCT03083847|101087931|FG000|NOT COMPLETED|Pilot 1a||0||
48310818|NCT03083847|101087932|FG001|NOT COMPLETED|Pilot 1a||0||
48310819|NCT03083847|101087933|FG002|NOT COMPLETED|Pilot 1a||0||
48310820|NCT03083847|101087934|FG003|NOT COMPLETED|Pilot 1a||0||
48310821|NCT03083847|101087935|FG004|NOT COMPLETED|Pilot 1a||0||
48310822|NCT03083847|101087936|FG005|NOT COMPLETED|Pilot 1a||0||
48310823|NCT03083847|101087937|FG006|NOT COMPLETED|Pilot 1a||0||
48310824|NCT03083847|101087938|FG007|NOT COMPLETED|Pilot 1a||0||
48310825|NCT03083847|101087939|FG008|NOT COMPLETED|Pilot 1a||0||
48310826|NCT03083847|101087940|FG009|NOT COMPLETED|Pilot 1a||0||
48310827|NCT03083847|101087931|FG000|STARTED|Pilot Ib & 5a||0||
48310828|NCT03083847|101087932|FG001|STARTED|Pilot Ib & 5a||2||
48310829|NCT03083847|101087933|FG002|STARTED|Pilot Ib & 5a||2||
48310830|NCT03083847|101087934|FG003|STARTED|Pilot Ib & 5a||0||
48310831|NCT03083847|101087935|FG004|STARTED|Pilot Ib & 5a||0||
48612921|NCT00490919|101838400|FG001|NOT COMPLETED|Open-label Run-in Period||0||
48612922|NCT00490919|101838401|FG002|NOT COMPLETED|Open-label Run-in Period||0||
48612923|NCT00490919|101838399|FG000|STARTED|Double-blind Phase||0||
48612924|NCT00490919|101838400|FG001|STARTED|Double-blind Phase||256||
48612925|NCT00490919|101838401|FG002|STARTED|Double-blind Phase||283||
48612926|NCT00490919|101838399|FG000|COMPLETED|Double-blind Phase||0||
48612927|NCT00490919|101838400|FG001|COMPLETED|Double-blind Phase||170||
48612928|NCT00490919|101838401|FG002|COMPLETED|Double-blind Phase||199||
48612929|NCT00490919|101838399|FG000|NOT COMPLETED|Double-blind Phase||0||
48612930|NCT00490919|101838400|FG001|NOT COMPLETED|Double-blind Phase||86||
48612931|NCT00490919|101838401|FG002|NOT COMPLETED|Double-blind Phase||84||
48612932|NCT01738919|101838402|FG000|STARTED|Overall Study||15||
48612933|NCT01738919|101838403|FG001|STARTED|Overall Study||17||
48612934|NCT01738919|101838402|FG000|COMPLETED|Overall Study||14||
48612935|NCT01738919|101838403|FG001|COMPLETED|Overall Study||14||
48612936|NCT01738919|101838402|FG000|NOT COMPLETED|Overall Study||1||
48612937|NCT01738919|101838403|FG001|NOT COMPLETED|Overall Study||3||
48612938|NCT03365934|101838404|FG000|STARTED|Overall Study||35||
48612939|NCT03365934|101838404|FG000|COMPLETED|Overall Study||33||
48612940|NCT03365934|101838404|FG000|NOT COMPLETED|Overall Study||2||
48612941|NCT04086121|101838405|FG000|STARTED|Overall Study||14||
48612942|NCT04086121|101838405|FG000|COMPLETED|Overall Study||0||
48612943|NCT04086121|101838405|FG000|NOT COMPLETED|Overall Study||14||
48612944|NCT02028507|101838406|FG000|STARTED|Overall Study||153||
48612945|NCT02028507|101838407|FG001|STARTED|Overall Study||143||
48612946|NCT02028507|101838408|FG002|STARTED|Overall Study||149||
48612947|NCT02028507|101838409|FG003|STARTED|Overall Study||156||
48612948|NCT02028507|101838406|FG000|COMPLETED|Overall Study||0||
48612949|NCT02028507|101838407|FG001|COMPLETED|Overall Study||0||
48612950|NCT02028507|101838408|FG002|COMPLETED|Overall Study||0||
48612951|NCT02028507|101838409|FG003|COMPLETED|Overall Study||0||
48612952|NCT02028507|101838406|FG000|NOT COMPLETED|Overall Study||153||
48612953|NCT02028507|101838407|FG001|NOT COMPLETED|Overall Study||143||
48612954|NCT02028507|101838408|FG002|NOT COMPLETED|Overall Study||149||
48612955|NCT02028507|101838409|FG003|NOT COMPLETED|Overall Study||156||
48612956|NCT00412932|101838410|FG000|STARTED|Olmesartan (Olm) 20 mg||178||
48612957|NCT00412932|101838410|FG000|COMPLETED|Olmesartan (Olm) 20 mg||171||
48612958|NCT00412932|101838410|FG000|NOT COMPLETED|Olmesartan (Olm) 20 mg||7||
48612959|NCT00412932|101838410|FG000|STARTED|Olmesartan 40 mg||169||
48612960|NCT00412932|101838410|FG000|COMPLETED|Olmesartan 40 mg||161||
48612961|NCT00412932|101838410|FG000|NOT COMPLETED|Olmesartan 40 mg||8||
48612962|NCT00412932|101838410|FG000|STARTED|Olm+Hydrochlorothiazide 12.5 mg||159||
48155894|NCT02390531|100703229|FG000|NOT COMPLETED|Overall Study||0||
48155895|NCT02390531|100703230|FG001|NOT COMPLETED|Overall Study||2||
48310832|NCT03083847|101087936|FG005|STARTED|Pilot Ib & 5a||0||
48310833|NCT03083847|101087937|FG006|STARTED|Pilot Ib & 5a||0||
48310834|NCT03083847|101087938|FG007|STARTED|Pilot Ib & 5a||0||
48310835|NCT03083847|101087939|FG008|STARTED|Pilot Ib & 5a||0||
48310836|NCT03083847|101087940|FG009|STARTED|Pilot Ib & 5a||0||
48310837|NCT03083847|101087931|FG000|COMPLETED|Pilot Ib & 5a||0||
48310838|NCT03083847|101087932|FG001|COMPLETED|Pilot Ib & 5a||2||
48310839|NCT03083847|101087933|FG002|COMPLETED|Pilot Ib & 5a||2||
48612963|NCT00412932|101838410|FG000|COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||153||
48612964|NCT00412932|101838410|FG000|NOT COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||6||
48612965|NCT00412932|101838410|FG000|STARTED|Olm+ Hydrochlorothiazide 25 mg||125||
48612966|NCT00412932|101838410|FG000|COMPLETED|Olm+ Hydrochlorothiazide 25 mg||123||
48612967|NCT00412932|101838410|FG000|NOT COMPLETED|Olm+ Hydrochlorothiazide 25 mg||2||
48612968|NCT04948827|101838411|FG000|STARTED|Overall Study||6||
48612969|NCT04948827|101838412|FG001|STARTED|Overall Study||6||
48155896|NCT02390531|100703231|FG002|NOT COMPLETED|Overall Study||0||
48612970|NCT04948827|101838413|FG002|STARTED|Overall Study||6||
48612971|NCT04948827|101838414|FG003|STARTED|Overall Study||6||
48612972|NCT04948827|101838415|FG004|STARTED|Overall Study||6||
48612973|NCT04948827|101838416|FG005|STARTED|Overall Study||10||
48612974|NCT04948827|101838417|FG006|STARTED|Overall Study||8||
48155897|NCT02390531|100703232|FG003|NOT COMPLETED|Overall Study||1||
48310840|NCT03083847|101087934|FG003|COMPLETED|Pilot Ib & 5a||0||
48727185|NCT00965419|102118512|FG000|NOT COMPLETED|Follow-up Phase||62||
48727186|NCT02387554|102118513|FG000|STARTED|Overall Study||10||
48727187|NCT02387554|102118514|FG001|STARTED|Overall Study||7||
48727188|NCT02387554|102118515|FG002|STARTED|Overall Study||8||
48155898|NCT02390531|100703233|FG004|NOT COMPLETED|Overall Study||1||
48155899|NCT02390531|100703234|FG005|NOT COMPLETED|Overall Study||0||
48155900|NCT02390531|100703235|FG006|NOT COMPLETED|Overall Study||2||
48155901|NCT02390531|100703236|FG007|NOT COMPLETED|Overall Study||1||
48155902|NCT02657317|100703237|FG000|STARTED|Overall Study||50||
48155903|NCT02657317|100703238|FG001|STARTED|Overall Study||53||
48155904|NCT02657317|100703237|FG000|COMPLETED|Overall Study||45||
48155905|NCT02657317|100703238|FG001|COMPLETED|Overall Study||50||
48155906|NCT02657317|100703237|FG000|NOT COMPLETED|Overall Study||5||
48155907|NCT02657317|100703238|FG001|NOT COMPLETED|Overall Study||3||
48155908|NCT00668902|100703239|FG000|STARTED|Overall Study||10||
48155909|NCT00668902|100703240|FG001|STARTED|Overall Study||10||
48155910|NCT00668902|100703241|FG002|STARTED|Overall Study||5||
48155911|NCT00668902|100703239|FG000|COMPLETED|Overall Study||10||
48155912|NCT00668902|100703240|FG001|COMPLETED|Overall Study||10||
48155913|NCT00668902|100703241|FG002|COMPLETED|Overall Study||5||
48155914|NCT00668902|100703239|FG000|NOT COMPLETED|Overall Study||0||
48155915|NCT00668902|100703240|FG001|NOT COMPLETED|Overall Study||0||
48155916|NCT00668902|100703241|FG002|NOT COMPLETED|Overall Study||0||
48155917|NCT02660801|100703242|FG000|STARTED|Overall Study||11||
48155918|NCT02660801|100703243|FG001|STARTED|Overall Study||15||
48155919|NCT02660801|100703242|FG000|COMPLETED|Overall Study||11||
48155920|NCT02660801|100703243|FG001|COMPLETED|Overall Study||15||
48155921|NCT02660801|100703242|FG000|NOT COMPLETED|Overall Study||0||
48155922|NCT02660801|100703243|FG001|NOT COMPLETED|Overall Study||0||
48155923|NCT02243280|100703244|FG000|STARTED|Enrolled||40||
48155924|NCT02243280|100703245|FG001|STARTED|Enrolled||39||
48155925|NCT02243280|100703246|FG002|STARTED|Enrolled||0||
48155926|NCT02243280|100703247|FG003|STARTED|Enrolled||0||
48155927|NCT02243280|100703248|FG004|STARTED|Enrolled||0||
48155928|NCT02243280|100703249|FG005|STARTED|Enrolled||27||
48155929|NCT02243280|100703250|FG006|STARTED|Enrolled||0||
48155930|NCT02243280|100703251|FG007|STARTED|Enrolled||0||
48155931|NCT02243280|100703252|FG008|STARTED|Enrolled||34||
48155932|NCT02243280|100703253|FG009|STARTED|Enrolled||0||
48155933|NCT02243280|100703254|FG010|STARTED|Enrolled||34||
48155934|NCT02243280|100703244|FG000|COMPLETED|Enrolled||40||
48155935|NCT02243280|100703245|FG001|COMPLETED|Enrolled||39||
48155936|NCT02243280|100703246|FG002|COMPLETED|Enrolled||0||
48155937|NCT02243280|100703247|FG003|COMPLETED|Enrolled||0||
48155938|NCT02243280|100703248|FG004|COMPLETED|Enrolled||0||
48155939|NCT02243280|100703249|FG005|COMPLETED|Enrolled||27||
48155940|NCT02243280|100703250|FG006|COMPLETED|Enrolled||0||
48155941|NCT02243280|100703251|FG007|COMPLETED|Enrolled||0||
48155942|NCT02243280|100703252|FG008|COMPLETED|Enrolled||34||
48155943|NCT02243280|100703253|FG009|COMPLETED|Enrolled||0||
48406606|NCT01355497|101328452|FG001|NOT COMPLETED|Overall Study||63||
48155944|NCT02243280|100703254|FG010|COMPLETED|Enrolled||34||
48155945|NCT02243280|100703244|FG000|NOT COMPLETED|Enrolled||0||
48155946|NCT02243280|100703245|FG001|NOT COMPLETED|Enrolled||0||
48155947|NCT02243280|100703246|FG002|NOT COMPLETED|Enrolled||0||
48155948|NCT02243280|100703247|FG003|NOT COMPLETED|Enrolled||0||
48406607|NCT00285649|101328453|FG000|STARTED|Overall Study||72||
48406608|NCT00285649|101328454|FG001|STARTED|Overall Study||72||
48727189|NCT02387554|102118516|FG003|STARTED|Overall Study||8||
48727190|NCT02387554|102118513|FG000|COMPLETED|Overall Study||7||
48727191|NCT02387554|102118514|FG001|COMPLETED|Overall Study||7||
48727192|NCT02387554|102118515|FG002|COMPLETED|Overall Study||6||
48727193|NCT02387554|102118516|FG003|COMPLETED|Overall Study||6||
48155949|NCT02243280|100703248|FG004|NOT COMPLETED|Enrolled||0||
48155950|NCT02243280|100703249|FG005|NOT COMPLETED|Enrolled||0||
48727194|NCT02387554|102118513|FG000|NOT COMPLETED|Overall Study||3||
48155951|NCT02243280|100703250|FG006|NOT COMPLETED|Enrolled||0||
48155952|NCT02243280|100703251|FG007|NOT COMPLETED|Enrolled||0||
48155953|NCT02243280|100703252|FG008|NOT COMPLETED|Enrolled||0||
48155954|NCT02243280|100703253|FG009|NOT COMPLETED|Enrolled||0||
48155955|NCT02243280|100703254|FG010|NOT COMPLETED|Enrolled||0||
48155956|NCT02243280|100703244|FG000|STARTED|Treated||42||
48155957|NCT02243280|100703245|FG001|STARTED|Treated||39||
48155958|NCT02243280|100703246|FG002|STARTED|Treated||0||
48155959|NCT02243280|100703247|FG003|STARTED|Treated||0||
48155960|NCT02243280|100703248|FG004|STARTED|Treated||0||
48155961|NCT02243280|100703249|FG005|STARTED|Treated||27||
48155962|NCT02243280|100703250|FG006|STARTED|Treated||0||
48155963|NCT02243280|100703251|FG007|STARTED|Treated||0||
48406609|NCT00285649|101328455|FG002|STARTED|Overall Study||48||
48406610|NCT00285649|101328453|FG000|COMPLETED|Overall Study||63||
48406611|NCT00285649|101328454|FG001|COMPLETED|Overall Study||66||
48406612|NCT00285649|101328455|FG002|COMPLETED|Overall Study||42||
48406613|NCT00285649|101328453|FG000|NOT COMPLETED|Overall Study||9||
48406614|NCT00285649|101328454|FG001|NOT COMPLETED|Overall Study||6||
48406615|NCT00285649|101328455|FG002|NOT COMPLETED|Overall Study||6||
48406616|NCT01704976|101328456|FG000|STARTED|Overall Study||14||
48406617|NCT01704976|101328457|FG001|STARTED|Overall Study||13||
48155964|NCT02243280|100703252|FG008|STARTED|Treated||32||
48155965|NCT02243280|100703253|FG009|STARTED|Treated||0||
48155966|NCT02243280|100703254|FG010|STARTED|Treated||34||
48155967|NCT02243280|100703244|FG000|Completed Treatment|Treated||42||
48155968|NCT02243280|100703245|FG001|Completed Treatment|Treated||38||
48155969|NCT02243280|100703246|FG002|Completed Treatment|Treated||0||
48155970|NCT02243280|100703247|FG003|Completed Treatment|Treated||0||
48155971|NCT02243280|100703248|FG004|Completed Treatment|Treated||0||
48155972|NCT02243280|100703249|FG005|Completed Treatment|Treated||27||
48155973|NCT02243280|100703250|FG006|Completed Treatment|Treated||0||
48155974|NCT02243280|100703251|FG007|Completed Treatment|Treated||0||
48155975|NCT02243280|100703252|FG008|Completed Treatment|Treated||32||
48155976|NCT02243280|100703253|FG009|Completed Treatment|Treated||0||
48155977|NCT02243280|100703254|FG010|Completed Treatment|Treated||33||
48155978|NCT02243280|100703244|FG000|COMPLETED|Treated||41||
48155979|NCT02243280|100703245|FG001|COMPLETED|Treated||39||
48155980|NCT02243280|100703246|FG002|COMPLETED|Treated||0||
48155981|NCT02243280|100703247|FG003|COMPLETED|Treated||0||
48155982|NCT02243280|100703248|FG004|COMPLETED|Treated||0||
48155983|NCT02243280|100703249|FG005|COMPLETED|Treated||27||
48155984|NCT02243280|100703250|FG006|COMPLETED|Treated||0||
48155985|NCT02243280|100703251|FG007|COMPLETED|Treated||0||
48155986|NCT02243280|100703252|FG008|COMPLETED|Treated||31||
48155987|NCT02243280|100703253|FG009|COMPLETED|Treated||0||
48155988|NCT02243280|100703254|FG010|COMPLETED|Treated||31||
48155989|NCT02243280|100703244|FG000|NOT COMPLETED|Treated||1||
48155990|NCT02243280|100703245|FG001|NOT COMPLETED|Treated||0||
48155991|NCT02243280|100703246|FG002|NOT COMPLETED|Treated||0||
48155992|NCT02243280|100703247|FG003|NOT COMPLETED|Treated||0||
48155993|NCT02243280|100703248|FG004|NOT COMPLETED|Treated||0||
48155994|NCT02243280|100703249|FG005|NOT COMPLETED|Treated||0||
48155995|NCT02243280|100703250|FG006|NOT COMPLETED|Treated||0||
48155996|NCT02243280|100703251|FG007|NOT COMPLETED|Treated||0||
48155997|NCT02243280|100703252|FG008|NOT COMPLETED|Treated||1||
48155998|NCT02243280|100703253|FG009|NOT COMPLETED|Treated||0||
48155999|NCT02243280|100703254|FG010|NOT COMPLETED|Treated||3||
48156000|NCT00580814|100703255|FG000|STARTED|Baseline PET Scans at Brookhaven||55||
48156001|NCT00580814|100703256|FG001|STARTED|Baseline PET Scans at Brookhaven||20||
48156002|NCT00580814|100703255|FG000|COMPLETED|Baseline PET Scans at Brookhaven||55||
48156003|NCT00580814|100703256|FG001|COMPLETED|Baseline PET Scans at Brookhaven||20||
48156004|NCT00580814|100703255|FG000|NOT COMPLETED|Baseline PET Scans at Brookhaven||0||
48156005|NCT00580814|100703256|FG001|NOT COMPLETED|Baseline PET Scans at Brookhaven||0||
48156006|NCT00580814|100703255|FG000|STARTED|One Year of Treatment or no Intervention||55||
48156007|NCT00580814|100703256|FG001|STARTED|One Year of Treatment or no Intervention||20||
48156008|NCT00580814|100703255|FG000|COMPLETED|One Year of Treatment or no Intervention||18||
48156009|NCT00580814|100703256|FG001|COMPLETED|One Year of Treatment or no Intervention||11||
48156010|NCT00580814|100703255|FG000|NOT COMPLETED|One Year of Treatment or no Intervention||37||
48156011|NCT00580814|100703256|FG001|NOT COMPLETED|One Year of Treatment or no Intervention||9||
48612975|NCT04948827|101838418|FG007|STARTED|Overall Study||8||
48612976|NCT04948827|101838419|FG008|STARTED|Overall Study||8||
48612977|NCT04948827|101838420|FG009|STARTED|Overall Study||6||
48612978|NCT04948827|101838421|FG010|STARTED|Overall Study||8||
48612979|NCT04948827|101838422|FG011|STARTED|Overall Study||8||
48156012|NCT00580814|100703255|FG000|STARTED|Repeated PET Scans||18||
48156013|NCT00580814|100703256|FG001|STARTED|Repeated PET Scans||11||
48156014|NCT00580814|100703255|FG000|COMPLETED|Repeated PET Scans||18||
48156015|NCT00580814|100703256|FG001|COMPLETED|Repeated PET Scans||11||
48156016|NCT00580814|100703255|FG000|NOT COMPLETED|Repeated PET Scans||0||
48156017|NCT00580814|100703256|FG001|NOT COMPLETED|Repeated PET Scans||0||
48156018|NCT02272725|100703257|FG000|STARTED|Overall Study||49||
48156019|NCT02272725|100703258|FG001|STARTED|Overall Study||42||
48156020|NCT02272725|100703257|FG000|COMPLETED|Overall Study||47||
48156021|NCT02272725|100703258|FG001|COMPLETED|Overall Study||42||
48156022|NCT02272725|100703257|FG000|NOT COMPLETED|Overall Study||2||
48612980|NCT04948827|101838423|FG012|STARTED|Overall Study||4||
48612981|NCT04948827|101838411|FG000|COMPLETED|Overall Study||6||
48612982|NCT04948827|101838412|FG001|COMPLETED|Overall Study||5||
48612983|NCT04948827|101838413|FG002|COMPLETED|Overall Study||6||
48612984|NCT04948827|101838414|FG003|COMPLETED|Overall Study||6||
48612985|NCT04948827|101838415|FG004|COMPLETED|Overall Study||6||
48612986|NCT04948827|101838416|FG005|COMPLETED|Overall Study||10||
48612987|NCT04948827|101838417|FG006|COMPLETED|Overall Study||7||
48612988|NCT04948827|101838418|FG007|COMPLETED|Overall Study||6||
48612989|NCT04948827|101838419|FG008|COMPLETED|Overall Study||8||
48612990|NCT04948827|101838420|FG009|COMPLETED|Overall Study||6||
48612991|NCT04948827|101838421|FG010|COMPLETED|Overall Study||6||
48156023|NCT02272725|100703258|FG001|NOT COMPLETED|Overall Study||0||
48156024|NCT00692094|100703259|FG000|STARTED|Overall Study||0||
48156025|NCT00692094|100703260|FG001|STARTED|Overall Study||0||
48156026|NCT00692094|100703261|FG002|STARTED|Overall Study||0||
48612992|NCT04948827|101838422|FG011|COMPLETED|Overall Study||8||
48612993|NCT04948827|101838423|FG012|COMPLETED|Overall Study||4||
48612994|NCT04948827|101838411|FG000|NOT COMPLETED|Overall Study||0||
48156027|NCT00692094|100703262|FG003|STARTED|Overall Study||0||
48156028|NCT00692094|100703259|FG000|COMPLETED|Overall Study||0||
48156029|NCT00692094|100703260|FG001|COMPLETED|Overall Study||0||
48156030|NCT00692094|100703261|FG002|COMPLETED|Overall Study||0||
48156031|NCT00692094|100703262|FG003|COMPLETED|Overall Study||0||
48156032|NCT00692094|100703259|FG000|NOT COMPLETED|Overall Study||0||
48156033|NCT00692094|100703260|FG001|NOT COMPLETED|Overall Study||0||
48156034|NCT00692094|100703261|FG002|NOT COMPLETED|Overall Study||0||
48156035|NCT00692094|100703262|FG003|NOT COMPLETED|Overall Study||0||
48156036|NCT01922050|100703263|FG000|STARTED|Part 1 Open-label, Dose-escalation Phase||3||
48156037|NCT01922050|100703264|FG001|STARTED|Part 1 Open-label, Dose-escalation Phase||3||
48156038|NCT01922050|100703265|FG002|STARTED|Part 1 Open-label, Dose-escalation Phase||6||
48156039|NCT01922050|100703266|FG003|STARTED|Part 1 Open-label, Dose-escalation Phase||6||
48156040|NCT01922050|100703267|FG004|STARTED|Part 1 Open-label, Dose-escalation Phase||17||
48156041|NCT01922050|100703268|FG005|STARTED|Part 1 Open-label, Dose-escalation Phase||18||
48156042|NCT01922050|100703269|FG006|STARTED|Part 1 Open-label, Dose-escalation Phase||3||
48156043|NCT01922050|100703270|FG007|STARTED|Part 1 Open-label, Dose-escalation Phase||3||
48156044|NCT01922050|100703271|FG008|STARTED|Part 1 Open-label, Dose-escalation Phase||6||
48156045|NCT01922050|100703272|FG009|STARTED|Part 1 Open-label, Dose-escalation Phase||12||
48156046|NCT01922050|100703273|FG010|STARTED|Part 1 Open-label, Dose-escalation Phase||0||
48156047|NCT01922050|100703274|FG011|STARTED|Part 1 Open-label, Dose-escalation Phase||0||
48156048|NCT01922050|100703275|FG012|STARTED|Part 1 Open-label, Dose-escalation Phase||0||
48156049|NCT01922050|100703276|FG013|STARTED|Part 1 Open-label, Dose-escalation Phase||0||
48156050|NCT01922050|100703263|FG000|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3||
48156051|NCT01922050|100703264|FG001|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3||
48156052|NCT01922050|100703265|FG002|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6||
48156053|NCT01922050|100703266|FG003|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6||
48156054|NCT01922050|100703267|FG004|COMPLETED|Part 1 Open-label, Dose-escalation Phase||17||
48156055|NCT01922050|100703268|FG005|COMPLETED|Part 1 Open-label, Dose-escalation Phase||18||
48156056|NCT01922050|100703269|FG006|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3||
48156057|NCT01922050|100703270|FG007|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3||
48156058|NCT01922050|100703271|FG008|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6||
48156059|NCT01922050|100703272|FG009|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12||
48156060|NCT01922050|100703273|FG010|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
48612995|NCT04948827|101838412|FG001|NOT COMPLETED|Overall Study||1||
48612996|NCT04948827|101838413|FG002|NOT COMPLETED|Overall Study||0||
48612997|NCT04948827|101838414|FG003|NOT COMPLETED|Overall Study||0||
48727195|NCT02387554|102118514|FG001|NOT COMPLETED|Overall Study||0||
48727196|NCT02387554|102118515|FG002|NOT COMPLETED|Overall Study||2||
48727197|NCT02387554|102118516|FG003|NOT COMPLETED|Overall Study||2||
48612998|NCT04948827|101838415|FG004|NOT COMPLETED|Overall Study||0||
48612999|NCT04948827|101838416|FG005|NOT COMPLETED|Overall Study||0||
48613000|NCT04948827|101838417|FG006|NOT COMPLETED|Overall Study||1||
48613001|NCT04948827|101838418|FG007|NOT COMPLETED|Overall Study||2||
48613002|NCT04948827|101838419|FG008|NOT COMPLETED|Overall Study||0||
48613003|NCT04948827|101838420|FG009|NOT COMPLETED|Overall Study||0||
48613004|NCT04948827|101838421|FG010|NOT COMPLETED|Overall Study||2||
48613005|NCT04948827|101838422|FG011|NOT COMPLETED|Overall Study||0||
48613006|NCT04948827|101838423|FG012|NOT COMPLETED|Overall Study||0||
48613007|NCT00168428|101838424|FG000|STARTED|Double-Blind Phase (DB)||347||
48613008|NCT00168428|101838425|FG001|STARTED|Double-Blind Phase (DB)||358||
48613009|NCT00168428|101838424|FG000|COMPLETED|Double-Blind Phase (DB)||311||
48613010|NCT00168428|101838425|FG001|COMPLETED|Double-Blind Phase (DB)||334||
48613011|NCT00168428|101838424|FG000|NOT COMPLETED|Double-Blind Phase (DB)||36||
48613012|NCT00168428|101838425|FG001|NOT COMPLETED|Double-Blind Phase (DB)||24||
48613013|NCT00168428|101838424|FG000|STARTED|Open-Label Phase (OL)||305||
48613014|NCT00168428|101838425|FG001|STARTED|Open-Label Phase (OL)||329||
48613015|NCT00168428|101838424|FG000|COMPLETED|Open-Label Phase (OL)||261||
48613016|NCT00168428|101838425|FG001|COMPLETED|Open-Label Phase (OL)||261||
48613017|NCT00168428|101838424|FG000|NOT COMPLETED|Open-Label Phase (OL)||44||
48613018|NCT00168428|101838425|FG001|NOT COMPLETED|Open-Label Phase (OL)||68||
48613019|NCT00169104|101838426|FG000|STARTED|Overall Study||13||
48613020|NCT00169104|101838427|FG001|STARTED|Overall Study||10||
48613021|NCT00169104|101838426|FG000|COMPLETED|Overall Study||11||
48613022|NCT00169104|101838427|FG001|COMPLETED|Overall Study||8||
48613023|NCT00169104|101838426|FG000|NOT COMPLETED|Overall Study||2||
48613024|NCT00169104|101838427|FG001|NOT COMPLETED|Overall Study||2||
48727198|NCT02943915|102118517|FG000|STARTED|Overall Study||14||
48727199|NCT02943915|102118518|FG001|STARTED|Overall Study||13||
48613025|NCT00618826|101838428|FG000|STARTED|Overall Study||14||
48727200|NCT02943915|102118519|FG002|STARTED|Overall Study||6||
48727201|NCT02943915|102118520|FG003|STARTED|Overall Study||12||
48613026|NCT00618826|101838428|FG000|COMPLETED|Overall Study||13||
48613027|NCT00618826|101838428|FG000|NOT COMPLETED|Overall Study||1||
48613028|NCT04957212|101838429|FG000|STARTED|Overall Study||107||
48613029|NCT04957212|101838430|FG001|STARTED|Overall Study||107||
48727202|NCT02943915|102118517|FG000|COMPLETED|Overall Study||9||
48406618|NCT01704976|101328456|FG000|COMPLETED|Overall Study||13||
48406619|NCT01704976|101328457|FG001|COMPLETED|Overall Study||11||
48613030|NCT04957212|101838429|FG000|COMPLETED|Overall Study||107||
48613031|NCT04957212|101838430|FG001|COMPLETED|Overall Study||107||
48613032|NCT04957212|101838429|FG000|NOT COMPLETED|Overall Study||0||
48613033|NCT04957212|101838430|FG001|NOT COMPLETED|Overall Study||0||
48613034|NCT02757352|101838431|FG000|STARTED|Double-Blind Period (Week 0 - Week 16)||105||
48156061|NCT01922050|100703274|FG011|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
48156062|NCT01922050|100703275|FG012|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
48156063|NCT01922050|100703276|FG013|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
48156064|NCT01922050|100703263|FG000|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
48156065|NCT01922050|100703264|FG001|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
48156066|NCT01922050|100703265|FG002|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
48156067|NCT01922050|100703266|FG003|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
48156068|NCT01922050|100703267|FG004|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
48156069|NCT01922050|100703268|FG005|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
48156070|NCT01922050|100703269|FG006|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
48156071|NCT01922050|100703270|FG007|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
48156072|NCT01922050|100703271|FG008|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
48156073|NCT01922050|100703272|FG009|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
48156074|NCT01922050|100703273|FG010|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
48156075|NCT01922050|100703274|FG011|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
48156076|NCT01922050|100703275|FG012|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
48156077|NCT01922050|100703276|FG013|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
48156078|NCT01922050|100703263|FG000|STARTED|Part 2 Double-blind Phase||0||
48156079|NCT01922050|100703264|FG001|STARTED|Part 2 Double-blind Phase||0||
48156080|NCT01922050|100703265|FG002|STARTED|Part 2 Double-blind Phase||0||
48156081|NCT01922050|100703266|FG003|STARTED|Part 2 Double-blind Phase||0||
48156082|NCT01922050|100703267|FG004|STARTED|Part 2 Double-blind Phase||0||
48156083|NCT01922050|100703268|FG005|STARTED|Part 2 Double-blind Phase||0||
48156084|NCT01922050|100703269|FG006|STARTED|Part 2 Double-blind Phase||0||
48156085|NCT01922050|100703270|FG007|STARTED|Part 2 Double-blind Phase||0||
48156086|NCT01922050|100703271|FG008|STARTED|Part 2 Double-blind Phase||0||
48156087|NCT01922050|100703272|FG009|STARTED|Part 2 Double-blind Phase||0||
48156088|NCT01922050|100703273|FG010|STARTED|Part 2 Double-blind Phase||62||
48156089|NCT01922050|100703274|FG011|STARTED|Part 2 Double-blind Phase||60||
48156090|NCT01922050|100703275|FG012|STARTED|Part 2 Double-blind Phase||62||
48156091|NCT01922050|100703276|FG013|STARTED|Part 2 Double-blind Phase||59||
48156092|NCT01922050|100703263|FG000|COMPLETED|Part 2 Double-blind Phase||0||
48156093|NCT01922050|100703264|FG001|COMPLETED|Part 2 Double-blind Phase||0||
48156094|NCT01922050|100703265|FG002|COMPLETED|Part 2 Double-blind Phase||0||
48156095|NCT01922050|100703266|FG003|COMPLETED|Part 2 Double-blind Phase||0||
48613035|NCT02757352|101838432|FG001|STARTED|Double-Blind Period (Week 0 - Week 16)||96||
48613036|NCT02757352|101838433|FG002|STARTED|Double-Blind Period (Week 0 - Week 16)||102||
48156096|NCT01922050|100703267|FG004|COMPLETED|Part 2 Double-blind Phase||0||
48156097|NCT01922050|100703268|FG005|COMPLETED|Part 2 Double-blind Phase||0||
48156098|NCT01922050|100703269|FG006|COMPLETED|Part 2 Double-blind Phase||0||
48156099|NCT01922050|100703270|FG007|COMPLETED|Part 2 Double-blind Phase||0||
48156100|NCT01922050|100703271|FG008|COMPLETED|Part 2 Double-blind Phase||0||
48156101|NCT01922050|100703272|FG009|COMPLETED|Part 2 Double-blind Phase||0||
48156102|NCT01922050|100703273|FG010|COMPLETED|Part 2 Double-blind Phase||61||
48156103|NCT01922050|100703274|FG011|COMPLETED|Part 2 Double-blind Phase||58||
48156104|NCT01922050|100703275|FG012|COMPLETED|Part 2 Double-blind Phase||62||
48156105|NCT01922050|100703276|FG013|COMPLETED|Part 2 Double-blind Phase||56||
48156106|NCT01922050|100703263|FG000|NOT COMPLETED|Part 2 Double-blind Phase||0||
48156107|NCT01922050|100703264|FG001|NOT COMPLETED|Part 2 Double-blind Phase||0||
48156108|NCT01922050|100703265|FG002|NOT COMPLETED|Part 2 Double-blind Phase||0||
48156109|NCT01922050|100703266|FG003|NOT COMPLETED|Part 2 Double-blind Phase||0||
48613037|NCT02757352|101838434|FG003|STARTED|Double-Blind Period (Week 0 - Week 16)||0||
48156110|NCT01922050|100703267|FG004|NOT COMPLETED|Part 2 Double-blind Phase||0||
48156111|NCT01922050|100703268|FG005|NOT COMPLETED|Part 2 Double-blind Phase||0||
48156112|NCT01922050|100703269|FG006|NOT COMPLETED|Part 2 Double-blind Phase||0||
48156113|NCT01922050|100703270|FG007|NOT COMPLETED|Part 2 Double-blind Phase||0||
48156114|NCT01922050|100703271|FG008|NOT COMPLETED|Part 2 Double-blind Phase||0||
48156115|NCT01922050|100703272|FG009|NOT COMPLETED|Part 2 Double-blind Phase||0||
48156116|NCT01922050|100703273|FG010|NOT COMPLETED|Part 2 Double-blind Phase||1||
48156117|NCT01922050|100703274|FG011|NOT COMPLETED|Part 2 Double-blind Phase||2||
48156118|NCT01922050|100703275|FG012|NOT COMPLETED|Part 2 Double-blind Phase||0||
48156119|NCT01922050|100703276|FG013|NOT COMPLETED|Part 2 Double-blind Phase||3||
48156120|NCT03357614|100703277|FG000|STARTED|Overall Study||697||
48406620|NCT01704976|101328456|FG000|NOT COMPLETED|Overall Study||1||
48406621|NCT01704976|101328457|FG001|NOT COMPLETED|Overall Study||2||
48406622|NCT03398824|101328458|FG000|STARTED|Overall Study||14||
48406623|NCT03398824|101328458|FG000|COMPLETED|Overall Study||12||
48406624|NCT03398824|101328458|FG000|NOT COMPLETED|Overall Study||2||
48156121|NCT03357614|100703278|FG001|STARTED|Overall Study||698||
48156122|NCT03357614|100703277|FG000|COMPLETED|Overall Study||672||
48156123|NCT03357614|100703278|FG001|COMPLETED|Overall Study||670||
48156124|NCT03357614|100703277|FG000|NOT COMPLETED|Overall Study||25||
48156125|NCT03357614|100703278|FG001|NOT COMPLETED|Overall Study||28||
48156126|NCT02052310|100703279|FG000|STARTED|Overall Study||522||
48613038|NCT02757352|101838435|FG004|STARTED|Double-Blind Period (Week 0 - Week 16)||0||
48613039|NCT02757352|101838436|FG005|STARTED|Double-Blind Period (Week 0 - Week 16)||0||
48613040|NCT02757352|101838437|FG006|STARTED|Double-Blind Period (Week 0 - Week 16)||0||
48613041|NCT02757352|101838438|FG007|STARTED|Double-Blind Period (Week 0 - Week 16)||0||
48613042|NCT02757352|101838439|FG008|STARTED|Double-Blind Period (Week 0 - Week 16)||0||
48613043|NCT02757352|101838440|FG009|STARTED|Double-Blind Period (Week 0 - Week 16)||0||
48613044|NCT02757352|101838431|FG000|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||104||
48613045|NCT02757352|101838432|FG001|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||96||
48613046|NCT02757352|101838433|FG002|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||102||
48156127|NCT02052310|100703280|FG001|STARTED|Overall Study||521||
48156128|NCT02052310|100703279|FG000|Received at Least 1 Dose of Study Drug|Overall Study||522||
48156129|NCT02052310|100703280|FG001|Received at Least 1 Dose of Study Drug|Overall Study||517||
48156130|NCT02052310|100703279|FG000|COMPLETED|Overall Study||307||
48156131|NCT02052310|100703280|FG001|COMPLETED|Overall Study||309||
48156132|NCT02052310|100703279|FG000|NOT COMPLETED|Overall Study||215||
48156133|NCT02052310|100703280|FG001|NOT COMPLETED|Overall Study||212||
48156134|NCT01287611|100703281|FG000|STARTED|Overall Study||84||
48156135|NCT01287611|100703282|FG001|STARTED|Overall Study||84||
48156136|NCT01287611|100703281|FG000|The Number of Patients Who Underwent C/S|Overall Study||84||
48156137|NCT01287611|100703282|FG001|The Number of Patients Who Underwent C/S|Overall Study||84||
48156138|NCT01287611|100703281|FG000|COMPLETED|Overall Study||51||
48156139|NCT01287611|100703282|FG001|COMPLETED|Overall Study||65||
48156140|NCT01287611|100703281|FG000|NOT COMPLETED|Overall Study||33||
48156141|NCT01287611|100703282|FG001|NOT COMPLETED|Overall Study||19||
48156142|NCT01959425|100703283|FG000|STARTED|Overall Study||32||
48156143|NCT01959425|100703284|FG001|STARTED|Overall Study||31||
48156144|NCT01959425|100703283|FG000|COMPLETED|Overall Study||20||
48156145|NCT01959425|100703284|FG001|COMPLETED|Overall Study||23||
48156146|NCT01959425|100703283|FG000|NOT COMPLETED|Overall Study||12||
48406625|NCT00126425|101328459|FG000|STARTED|Overall Study||539||
48406626|NCT00126425|101328460|FG001|STARTED|Overall Study||48||
48406627|NCT00126425|101328459|FG000|COMPLETED|Overall Study||498||
48406628|NCT00126425|101328460|FG001|COMPLETED|Overall Study||37||
48613047|NCT02757352|101838434|FG003|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0||
48613048|NCT02757352|101838435|FG004|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0||
48613049|NCT02757352|101838436|FG005|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0||
48613050|NCT02757352|101838437|FG006|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0||
48613051|NCT02757352|101838438|FG007|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0||
48613052|NCT02757352|101838439|FG008|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0||
48613053|NCT02757352|101838440|FG009|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0||
48613054|NCT02757352|101838431|FG000|COMPLETED|Double-Blind Period (Week 0 - Week 16)||97||
48613055|NCT02757352|101838432|FG001|COMPLETED|Double-Blind Period (Week 0 - Week 16)||95||
48613056|NCT02757352|101838433|FG002|COMPLETED|Double-Blind Period (Week 0 - Week 16)||98||
48613057|NCT02757352|101838434|FG003|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0||
48613058|NCT02757352|101838435|FG004|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0||
48613059|NCT02757352|101838436|FG005|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0||
48613060|NCT02757352|101838437|FG006|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0||
48613061|NCT02757352|101838438|FG007|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0||
48613062|NCT02757352|101838439|FG008|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0||
48613063|NCT02757352|101838440|FG009|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0||
48613064|NCT02757352|101838431|FG000|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||8||
48727203|NCT02943915|102118518|FG001|COMPLETED|Overall Study||10||
48156147|NCT01959425|100703284|FG001|NOT COMPLETED|Overall Study||8||
48156148|NCT03043079|100703285|FG000|STARTED|Overall Study||21|We originally wanted 25 healthy/active volunteers. We divided that up into 15 healthy and 10 active.|
48156149|NCT03043079|100703286|FG001|STARTED|Overall Study||14|We originally wanted 25 healthy/active volunteers. We divided that up into 15 healthy and 10 active.|
48156150|NCT03043079|100703287|FG002|STARTED|Overall Study||10|We originally wanted 25 healthy/active volunteers. We divided that up into 15 healthy and 10 active.|
48156151|NCT03043079|100703285|FG000|COMPLETED|Overall Study||21||
48156152|NCT03043079|100703286|FG001|COMPLETED|Overall Study||14||
48156153|NCT03043079|100703287|FG002|COMPLETED|Overall Study||10||
48156154|NCT03043079|100703285|FG000|NOT COMPLETED|Overall Study||0||
48406629|NCT00126425|101328459|FG000|NOT COMPLETED|Overall Study||41||
48406630|NCT00126425|101328460|FG001|NOT COMPLETED|Overall Study||11||
48406631|NCT02037204|101328461|FG000|STARTED|Overall Study||35||
48406632|NCT02037204|101328461|FG000|COMPLETED|Overall Study||35||
48406633|NCT02037204|101328461|FG000|NOT COMPLETED|Overall Study||0||
48406634|NCT00320190|101328462|FG000|STARTED|First 12 Months||19||
48156155|NCT03043079|100703286|FG001|NOT COMPLETED|Overall Study||0||
48156156|NCT03043079|100703287|FG002|NOT COMPLETED|Overall Study||0||
48156157|NCT03205371|100703288|FG000|STARTED|Overall Study||107||
48156158|NCT03205371|100703289|FG001|STARTED|Overall Study||53||
48156159|NCT03205371|100703290|FG002|STARTED|Overall Study||53||
48156160|NCT03205371|100703291|FG003|STARTED|Overall Study||86||
48156161|NCT03205371|100703292|FG004|STARTED|Overall Study||42||
48156162|NCT03205371|100703293|FG005|STARTED|Overall Study||42||
48156163|NCT03205371|100703294|FG006|STARTED|Overall Study||200||
48156164|NCT03205371|100703295|FG007|STARTED|Overall Study||100||
48156165|NCT03205371|100703296|FG008|STARTED|Overall Study||100||
48156166|NCT03205371|100703297|FG009|STARTED|Overall Study||200||
48156167|NCT03205371|100703298|FG010|STARTED|Overall Study||100||
48156168|NCT03205371|100703299|FG011|STARTED|Overall Study||100||
48156169|NCT03205371|100703288|FG000|Safety Analysis Set (SafAS)|Overall Study||103|SafAS: participants who received at least 1 dose of study vaccine(s) \& had any safety data available|
48156170|NCT03205371|100703289|FG001|Safety Analysis Set (SafAS)|Overall Study||52|SafAS: participants who received at least 1 dose of study vaccine(s) \& had any safety data available|
48613065|NCT02757352|101838432|FG001|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||1||
48613066|NCT02757352|101838433|FG002|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||4||
48613067|NCT02757352|101838434|FG003|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0||
48613068|NCT02757352|101838435|FG004|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0||
48613069|NCT02757352|101838436|FG005|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0||
48613070|NCT02757352|101838437|FG006|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0||
48613071|NCT02757352|101838438|FG007|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0||
48613072|NCT02757352|101838439|FG008|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0||
48613073|NCT02757352|101838440|FG009|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0||
48613074|NCT02757352|101838431|FG000|STARTED|Double-Blind Period (Week 16 - Week 52)||97||
48613075|NCT02757352|101838432|FG001|STARTED|Double-Blind Period (Week 16 - Week 52)||95||
48613076|NCT02757352|101838433|FG002|STARTED|Double-Blind Period (Week 16 - Week 52)||98||
48613077|NCT02757352|101838434|FG003|STARTED|Double-Blind Period (Week 16 - Week 52)||0||
48613078|NCT02757352|101838435|FG004|STARTED|Double-Blind Period (Week 16 - Week 52)||0||
48613079|NCT02757352|101838436|FG005|STARTED|Double-Blind Period (Week 16 - Week 52)||0||
48156171|NCT03205371|100703290|FG002|Safety Analysis Set (SafAS)|Overall Study||53|SafAS: participants who received at least 1 dose of study vaccine(s) \& had any safety data available|
48156172|NCT03205371|100703291|FG003|Safety Analysis Set (SafAS)|Overall Study||86|SafAS: participants who received at least 1 dose of study vaccine(s) \& had any safety data available|
48156173|NCT03205371|100703292|FG004|Safety Analysis Set (SafAS)|Overall Study||42|SafAS: participants who received at least 1 dose of study vaccine(s) \& had any safety data available|
48156174|NCT03205371|100703293|FG005|Safety Analysis Set (SafAS)|Overall Study||42|SafAS: participants who received at least 1 dose of study vaccine(s) \& had any safety data available|
48156175|NCT03205371|100703294|FG006|Safety Analysis Set (SafAS)|Overall Study||200|SafAS: participants who received at least 1 dose of study vaccine(s) \& had any safety data available|
48156176|NCT03205371|100703295|FG007|Safety Analysis Set (SafAS)|Overall Study||100|SafAS: participants who received at least 1 dose of study vaccine(s) \& had any safety data available|
48156177|NCT03205371|100703296|FG008|Safety Analysis Set (SafAS)|Overall Study||100|SafAS: participants who received at least 1 dose of study vaccine(s) \& had any safety data available|
48156178|NCT03205371|100703297|FG009|Safety Analysis Set (SafAS)|Overall Study||200|SafAS: participants who received at least 1 dose of study vaccine(s) \& had any safety data available|
48156179|NCT03205371|100703298|FG010|Safety Analysis Set (SafAS)|Overall Study||100|SafAS: participants who received at least 1 dose of study vaccine(s) \& had any safety data available|
48156180|NCT03205371|100703299|FG011|Safety Analysis Set (SafAS)|Overall Study||99|SafAS: participants who received at least 1 dose of study vaccine(s) \& had any safety data available|
48406635|NCT00320190|101328463|FG001|STARTED|First 12 Months||13||
48406636|NCT00320190|101328462|FG000|COMPLETED|First 12 Months||11||
48406637|NCT00320190|101328463|FG001|COMPLETED|First 12 Months||3||
48406638|NCT00320190|101328462|FG000|NOT COMPLETED|First 12 Months||8||
48406639|NCT00320190|101328463|FG001|NOT COMPLETED|First 12 Months||10||
48406640|NCT00320190|101328462|FG000|STARTED|Long-term (12-month) Extension||11||
48406641|NCT00320190|101328463|FG001|STARTED|Long-term (12-month) Extension||3||
48406642|NCT00320190|101328462|FG000|COMPLETED|Long-term (12-month) Extension||2||
48613080|NCT02757352|101838437|FG006|STARTED|Double-Blind Period (Week 16 - Week 52)||0||
48613081|NCT02757352|101838438|FG007|STARTED|Double-Blind Period (Week 16 - Week 52)||0||
48613082|NCT02757352|101838439|FG008|STARTED|Double-Blind Period (Week 16 - Week 52)||0||
48613083|NCT02757352|101838440|FG009|STARTED|Double-Blind Period (Week 16 - Week 52)||0||
48613084|NCT02757352|101838431|FG000|COMPLETED|Double-Blind Period (Week 16 - Week 52)||34||
48613085|NCT02757352|101838432|FG001|COMPLETED|Double-Blind Period (Week 16 - Week 52)||52||
48613086|NCT02757352|101838433|FG002|COMPLETED|Double-Blind Period (Week 16 - Week 52)||52||
48613087|NCT02757352|101838434|FG003|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0||
48613088|NCT02757352|101838435|FG004|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0||
48613089|NCT02757352|101838436|FG005|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0||
48613090|NCT02757352|101838437|FG006|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0||
48613091|NCT02757352|101838438|FG007|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0||
48613092|NCT02757352|101838439|FG008|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0||
48657087|NCT03648372|101943764|FG007|NOT COMPLETED|Overall Study||5||
48156181|NCT03205371|100703288|FG000|Per-protocol Analysis Set (PPAS)|Overall Study||92|PPAS: participants who received at least 1 dose of study vaccine, and had no protocol deviations.|
48156182|NCT03205371|100703289|FG001|Per-protocol Analysis Set (PPAS)|Overall Study||45|PPAS: participants who received at least 1 dose of study vaccine, and had no protocol deviations.|
48156183|NCT03205371|100703290|FG002|Per-protocol Analysis Set (PPAS)|Overall Study||50|PPAS: participants who received at least 1 dose of study vaccine, and had no protocol deviations.|
48156184|NCT03205371|100703291|FG003|Per-protocol Analysis Set (PPAS)|Overall Study||85|PPAS: participants who received at least 1 dose of study vaccine, and had no protocol deviations.|
48156185|NCT03205371|100703292|FG004|Per-protocol Analysis Set (PPAS)|Overall Study||42|PPAS: participants who received at least 1 dose of study vaccine, and had no protocol deviations.|
48156186|NCT03205371|100703293|FG005|Per-protocol Analysis Set (PPAS)|Overall Study||42|PPAS: participants who received at least 1 dose of study vaccine, and had no protocol deviations.|
48156187|NCT03205371|100703294|FG006|Per-protocol Analysis Set (PPAS)|Overall Study||155|PPAS: participants who received at least 1 dose of study vaccine, and had no protocol deviations.|
48156188|NCT03205371|100703295|FG007|Per-protocol Analysis Set (PPAS)|Overall Study||79|PPAS: participants who received at least 1 dose of study vaccine, and had no protocol deviations.|
48156189|NCT03205371|100703296|FG008|Per-protocol Analysis Set (PPAS)|Overall Study||68|PPAS: participants who received at least 1 dose of study vaccine, and had no protocol deviations.|
48156190|NCT03205371|100703297|FG009|Per-protocol Analysis Set (PPAS)|Overall Study||196|PPAS: participants who received at least 1 dose of study vaccine, and had no protocol deviations.|
48156191|NCT03205371|100703298|FG010|Per-protocol Analysis Set (PPAS)|Overall Study||96|PPAS: participants who received at least 1 dose of study vaccine, and had no protocol deviations.|
48156192|NCT03205371|100703299|FG011|Per-protocol Analysis Set (PPAS)|Overall Study||92|PPAS: participants who received at least 1 dose of study vaccine, and had no protocol deviations.|
48156193|NCT03205371|100703288|FG000|COMPLETED|Overall Study||103||
48156194|NCT03205371|100703289|FG001|COMPLETED|Overall Study||52||
48156195|NCT03205371|100703290|FG002|COMPLETED|Overall Study||53||
48156196|NCT03205371|100703291|FG003|COMPLETED|Overall Study||86||
48156197|NCT03205371|100703292|FG004|COMPLETED|Overall Study||42||
48156198|NCT03205371|100703293|FG005|COMPLETED|Overall Study||42||
48156199|NCT03205371|100703294|FG006|COMPLETED|Overall Study||190||
48156200|NCT03205371|100703295|FG007|COMPLETED|Overall Study||97||
48156201|NCT03205371|100703296|FG008|COMPLETED|Overall Study||95||
48156202|NCT03205371|100703297|FG009|COMPLETED|Overall Study||200||
48156203|NCT03205371|100703298|FG010|COMPLETED|Overall Study||100||
48156204|NCT03205371|100703299|FG011|COMPLETED|Overall Study||99||
48156205|NCT03205371|100703288|FG000|NOT COMPLETED|Overall Study||4||
48156206|NCT03205371|100703289|FG001|NOT COMPLETED|Overall Study||1||
48156207|NCT03205371|100703290|FG002|NOT COMPLETED|Overall Study||0||
48156208|NCT03205371|100703291|FG003|NOT COMPLETED|Overall Study||0||
48156209|NCT03205371|100703292|FG004|NOT COMPLETED|Overall Study||0||
48156210|NCT03205371|100703293|FG005|NOT COMPLETED|Overall Study||0||
48156211|NCT03205371|100703294|FG006|NOT COMPLETED|Overall Study||10||
48156212|NCT03205371|100703295|FG007|NOT COMPLETED|Overall Study||3||
48156213|NCT03205371|100703296|FG008|NOT COMPLETED|Overall Study||5||
48156214|NCT03205371|100703297|FG009|NOT COMPLETED|Overall Study||0||
48156215|NCT03205371|100703298|FG010|NOT COMPLETED|Overall Study||0||
48156216|NCT03205371|100703299|FG011|NOT COMPLETED|Overall Study||1||
48156217|NCT03724487|100703300|FG000|STARTED|Overall Study||30||
48156218|NCT03724487|100703301|FG001|STARTED|Overall Study||30||
48156219|NCT03724487|100703300|FG000|COMPLETED|Overall Study||30||
48156220|NCT03724487|100703301|FG001|COMPLETED|Overall Study||30||
48156221|NCT03724487|100703300|FG000|NOT COMPLETED|Overall Study||0||
48156222|NCT03724487|100703301|FG001|NOT COMPLETED|Overall Study||0||
48156223|NCT00742079|100703302|FG000|STARTED|Overall Study||11||
48156224|NCT00742079|100703303|FG001|STARTED|Overall Study||10||
48156225|NCT00742079|100703302|FG000|Baseline/Week 1 (Received Dose 1)|Overall Study||11||
48156226|NCT00742079|100703303|FG001|Baseline/Week 1 (Received Dose 1)|Overall Study||9||
48156227|NCT00742079|100703302|FG000|Week 2 (Received Dose 2)|Overall Study||11||
48156228|NCT00742079|100703303|FG001|Week 2 (Received Dose 2)|Overall Study||9||
48156229|NCT00742079|100703302|FG000|COMPLETED|Overall Study||11||
48310841|NCT03083847|101087935|FG004|COMPLETED|Pilot Ib & 5a||0||
48310842|NCT03083847|101087936|FG005|COMPLETED|Pilot Ib & 5a||0||
48310843|NCT03083847|101087937|FG006|COMPLETED|Pilot Ib & 5a||0||
48310844|NCT03083847|101087938|FG007|COMPLETED|Pilot Ib & 5a||0||
48310845|NCT03083847|101087939|FG008|COMPLETED|Pilot Ib & 5a||0||
48310846|NCT03083847|101087940|FG009|COMPLETED|Pilot Ib & 5a||0||
48613093|NCT02757352|101838440|FG009|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0||
48613094|NCT02757352|101838431|FG000|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||63||
48613095|NCT02757352|101838432|FG001|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||43||
48613096|NCT02757352|101838433|FG002|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||46||
48613097|NCT02757352|101838434|FG003|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0||
48613098|NCT02757352|101838435|FG004|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0||
48613099|NCT02757352|101838436|FG005|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0||
48613100|NCT02757352|101838437|FG006|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0||
48613101|NCT02757352|101838438|FG007|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0||
48613102|NCT02757352|101838439|FG008|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0||
48613103|NCT02757352|101838440|FG009|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0||
48613104|NCT02757352|101838431|FG000|STARTED|IR-Open Label Period (Week 16 - Week 52)||0||
48613105|NCT02757352|101838432|FG001|STARTED|IR-Open Label Period (Week 16 - Week 52)||0||
48613106|NCT02757352|101838433|FG002|STARTED|IR-Open Label Period (Week 16 - Week 52)||0||
48613107|NCT02757352|101838434|FG003|STARTED|IR-Open Label Period (Week 16 - Week 52)||62||
48613108|NCT02757352|101838435|FG004|STARTED|IR-Open Label Period (Week 16 - Week 52)||40||
48613109|NCT02757352|101838436|FG005|STARTED|IR-Open Label Period (Week 16 - Week 52)||42||
48613110|NCT02757352|101838437|FG006|STARTED|IR-Open Label Period (Week 16 - Week 52)||0||
48613111|NCT02757352|101838438|FG007|STARTED|IR-Open Label Period (Week 16 - Week 52)||0||
48613112|NCT02757352|101838439|FG008|STARTED|IR-Open Label Period (Week 16 - Week 52)||0||
48613113|NCT02757352|101838440|FG009|STARTED|IR-Open Label Period (Week 16 - Week 52)||0||
48613114|NCT02757352|101838431|FG000|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0||
48613115|NCT02757352|101838432|FG001|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0||
48613116|NCT02757352|101838433|FG002|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0||
48613117|NCT02757352|101838434|FG003|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||2||
48613118|NCT02757352|101838435|FG004|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0||
48613119|NCT02757352|101838436|FG005|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||3||
48613120|NCT02757352|101838437|FG006|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0||
48613121|NCT02757352|101838438|FG007|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0||
48613122|NCT02757352|101838439|FG008|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0||
48613123|NCT02757352|101838440|FG009|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0||
48613124|NCT02757352|101838431|FG000|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0||
48613125|NCT02757352|101838432|FG001|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0||
48613126|NCT02757352|101838433|FG002|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0||
48613127|NCT02757352|101838434|FG003|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||55||
48613128|NCT02757352|101838435|FG004|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||37||
48613129|NCT02757352|101838436|FG005|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||35||
48613130|NCT02757352|101838437|FG006|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0||
48613131|NCT02757352|101838438|FG007|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0||
48310847|NCT03083847|101087931|FG000|NOT COMPLETED|Pilot Ib & 5a||0||
48310848|NCT03083847|101087932|FG001|NOT COMPLETED|Pilot Ib & 5a||0||
48406643|NCT00320190|101328463|FG001|COMPLETED|Long-term (12-month) Extension||1||
48406644|NCT00320190|101328462|FG000|NOT COMPLETED|Long-term (12-month) Extension||9||
48406645|NCT00320190|101328463|FG001|NOT COMPLETED|Long-term (12-month) Extension||2||
48406646|NCT00588380|101328464|FG000|STARTED|Overall Study||88||
48406647|NCT00588380|101328464|FG000|COMPLETED|Overall Study||88||
48406648|NCT00588380|101328464|FG000|NOT COMPLETED|Overall Study||0||
48406649|NCT03051217|101328465|FG000|STARTED|Initial Period (Week 0 to Week 16)||26||
48406650|NCT03051217|101328466|FG001|STARTED|Initial Period (Week 0 to Week 16)||48||
48406651|NCT03051217|101328467|FG002|STARTED|Initial Period (Week 0 to Week 16)||53||
48310849|NCT03083847|101087933|FG002|NOT COMPLETED|Pilot Ib & 5a||0||
48406652|NCT03051217|101328468|FG003|STARTED|Initial Period (Week 0 to Week 16)||0||
48310850|NCT03083847|101087934|FG003|NOT COMPLETED|Pilot Ib & 5a||0||
48406653|NCT03051217|101328469|FG004|STARTED|Initial Period (Week 0 to Week 16)||0||
48406654|NCT03051217|101328470|FG005|STARTED|Initial Period (Week 0 to Week 16)||0||
48406655|NCT03051217|101328471|FG006|STARTED|Initial Period (Week 0 to Week 16)||0||
48406656|NCT03051217|101328465|FG000|COMPLETED|Initial Period (Week 0 to Week 16)||23||
48406657|NCT03051217|101328466|FG001|COMPLETED|Initial Period (Week 0 to Week 16)||46||
48406658|NCT03051217|101328467|FG002|COMPLETED|Initial Period (Week 0 to Week 16)||51||
48406659|NCT03051217|101328468|FG003|COMPLETED|Initial Period (Week 0 to Week 16)||0||
48406660|NCT03051217|101328469|FG004|COMPLETED|Initial Period (Week 0 to Week 16)||0||
48310851|NCT03083847|101087935|FG004|NOT COMPLETED|Pilot Ib & 5a||0||
48310852|NCT03083847|101087936|FG005|NOT COMPLETED|Pilot Ib & 5a||0||
48727204|NCT02943915|102118519|FG002|COMPLETED|Overall Study||6||
48727205|NCT02943915|102118520|FG003|COMPLETED|Overall Study||12||
48727206|NCT02943915|102118517|FG000|NOT COMPLETED|Overall Study||5||
48727207|NCT02943915|102118518|FG001|NOT COMPLETED|Overall Study||3||
48727208|NCT02943915|102118519|FG002|NOT COMPLETED|Overall Study||0||
48727209|NCT02943915|102118520|FG003|NOT COMPLETED|Overall Study||0||
48727210|NCT01918332|102118521|FG000|STARTED|Overall Study||43||
48727211|NCT01918332|102118522|FG001|STARTED|Overall Study||41||
48727212|NCT01918332|102118523|FG002|STARTED|Overall Study||39||
48727213|NCT01918332|102118524|FG003|STARTED|Overall Study||45||
48727214|NCT01918332|102118521|FG000|COMPLETED|Overall Study||35||
48310853|NCT03083847|101087937|FG006|NOT COMPLETED|Pilot Ib & 5a||0||
48310854|NCT03083847|101087938|FG007|NOT COMPLETED|Pilot Ib & 5a||0||
48310855|NCT03083847|101087939|FG008|NOT COMPLETED|Pilot Ib & 5a||0||
48310856|NCT03083847|101087940|FG009|NOT COMPLETED|Pilot Ib & 5a||0||
48310857|NCT03083847|101087931|FG000|STARTED|Pilot 1d & 5b||0||
48310858|NCT03083847|101087932|FG001|STARTED|Pilot 1d & 5b||0||
48310859|NCT03083847|101087933|FG002|STARTED|Pilot 1d & 5b||0||
48310860|NCT03083847|101087934|FG003|STARTED|Pilot 1d & 5b||4||
48310861|NCT03083847|101087935|FG004|STARTED|Pilot 1d & 5b||4||
48310862|NCT03083847|101087936|FG005|STARTED|Pilot 1d & 5b||0||
48310863|NCT03083847|101087937|FG006|STARTED|Pilot 1d & 5b||0||
48310864|NCT03083847|101087938|FG007|STARTED|Pilot 1d & 5b||0||
48310865|NCT03083847|101087939|FG008|STARTED|Pilot 1d & 5b||0||
48310866|NCT03083847|101087940|FG009|STARTED|Pilot 1d & 5b||0||
48310867|NCT03083847|101087931|FG000|COMPLETED|Pilot 1d & 5b||0||
48310868|NCT03083847|101087932|FG001|COMPLETED|Pilot 1d & 5b||0||
48310869|NCT03083847|101087933|FG002|COMPLETED|Pilot 1d & 5b||0||
48310870|NCT03083847|101087934|FG003|COMPLETED|Pilot 1d & 5b||4||
48310871|NCT03083847|101087935|FG004|COMPLETED|Pilot 1d & 5b||4||
48310872|NCT03083847|101087936|FG005|COMPLETED|Pilot 1d & 5b||0||
48310873|NCT03083847|101087937|FG006|COMPLETED|Pilot 1d & 5b||0||
48310874|NCT03083847|101087938|FG007|COMPLETED|Pilot 1d & 5b||0||
48310875|NCT03083847|101087939|FG008|COMPLETED|Pilot 1d & 5b||0||
48310876|NCT03083847|101087940|FG009|COMPLETED|Pilot 1d & 5b||0||
48310877|NCT03083847|101087931|FG000|NOT COMPLETED|Pilot 1d & 5b||0||
48310878|NCT03083847|101087932|FG001|NOT COMPLETED|Pilot 1d & 5b||0||
48310879|NCT03083847|101087933|FG002|NOT COMPLETED|Pilot 1d & 5b||0||
48310880|NCT03083847|101087934|FG003|NOT COMPLETED|Pilot 1d & 5b||0||
48310881|NCT03083847|101087935|FG004|NOT COMPLETED|Pilot 1d & 5b||0||
48310882|NCT03083847|101087936|FG005|NOT COMPLETED|Pilot 1d & 5b||0||
48310883|NCT03083847|101087937|FG006|NOT COMPLETED|Pilot 1d & 5b||0||
48310884|NCT03083847|101087938|FG007|NOT COMPLETED|Pilot 1d & 5b||0||
48310885|NCT03083847|101087939|FG008|NOT COMPLETED|Pilot 1d & 5b||0||
48406661|NCT03051217|101328470|FG005|COMPLETED|Initial Period (Week 0 to Week 16)||0||
48406662|NCT03051217|101328471|FG006|COMPLETED|Initial Period (Week 0 to Week 16)||0||
48727215|NCT01918332|102118522|FG001|COMPLETED|Overall Study||36||
48310886|NCT03083847|101087940|FG009|NOT COMPLETED|Pilot 1d & 5b||0||
48310887|NCT03083847|101087931|FG000|STARTED|Main||0||
48310888|NCT03083847|101087932|FG001|STARTED|Main||0||
48310889|NCT03083847|101087933|FG002|STARTED|Main||0||
48310890|NCT03083847|101087934|FG003|STARTED|Main||0||
48310891|NCT03083847|101087935|FG004|STARTED|Main||0||
48310892|NCT03083847|101087936|FG005|STARTED|Main||9||
48310893|NCT03083847|101087937|FG006|STARTED|Main||10||
48310894|NCT03083847|101087938|FG007|STARTED|Main||10||
48310895|NCT03083847|101087939|FG008|STARTED|Main||4||
48310896|NCT03083847|101087940|FG009|STARTED|Main||8||
48310897|NCT03083847|101087931|FG000|COMPLETED|Main||0||
48440015|NCT04259905|101410011|FG000|STARTED|Overall Study||10||
48727216|NCT01918332|102118523|FG002|COMPLETED|Overall Study||30||
48727217|NCT01918332|102118524|FG003|COMPLETED|Overall Study||38||
48727218|NCT01918332|102118521|FG000|NOT COMPLETED|Overall Study||8||
48727219|NCT01918332|102118522|FG001|NOT COMPLETED|Overall Study||5||
48727220|NCT01918332|102118523|FG002|NOT COMPLETED|Overall Study||9||
48727221|NCT01918332|102118524|FG003|NOT COMPLETED|Overall Study||7||
48727222|NCT03334812|102118525|FG000|STARTED|Overall Study||9||
48727223|NCT03334812|102118526|FG001|STARTED|Overall Study||5||
48727224|NCT03334812|102118527|FG002|STARTED|Overall Study||0||
48310898|NCT03083847|101087932|FG001|COMPLETED|Main||0||
48310899|NCT03083847|101087933|FG002|COMPLETED|Main||0||
48310900|NCT03083847|101087934|FG003|COMPLETED|Main||0||
48310901|NCT03083847|101087935|FG004|COMPLETED|Main||0||
48727225|NCT03334812|102118528|FG003|STARTED|Overall Study||0||
48727226|NCT03334812|102118525|FG000|COMPLETED|Overall Study||9||
48727227|NCT03334812|102118526|FG001|COMPLETED|Overall Study||5||
48310902|NCT03083847|101087936|FG005|COMPLETED|Main||8||
48310903|NCT03083847|101087937|FG006|COMPLETED|Main||9||
48310904|NCT03083847|101087938|FG007|COMPLETED|Main||6||
48310905|NCT03083847|101087939|FG008|COMPLETED|Main||4||
48310906|NCT03083847|101087940|FG009|COMPLETED|Main||8||
48310907|NCT03083847|101087931|FG000|NOT COMPLETED|Main||0||
48310908|NCT03083847|101087932|FG001|NOT COMPLETED|Main||0||
48310909|NCT03083847|101087933|FG002|NOT COMPLETED|Main||0||
48310910|NCT03083847|101087934|FG003|NOT COMPLETED|Main||0||
48727228|NCT03334812|102118527|FG002|COMPLETED|Overall Study||0||
48727229|NCT03334812|102118528|FG003|COMPLETED|Overall Study||0||
48727230|NCT03334812|102118525|FG000|NOT COMPLETED|Overall Study||0||
48727231|NCT03334812|102118526|FG001|NOT COMPLETED|Overall Study||0||
48727232|NCT03334812|102118527|FG002|NOT COMPLETED|Overall Study||0||
48727233|NCT03334812|102118528|FG003|NOT COMPLETED|Overall Study||0||
48727234|NCT02831933|102118529|FG000|STARTED|Overall Study||11||
48310911|NCT03083847|101087935|FG004|NOT COMPLETED|Main||0||
48310912|NCT03083847|101087936|FG005|NOT COMPLETED|Main||1||
48310913|NCT03083847|101087937|FG006|NOT COMPLETED|Main||1||
48727235|NCT02831933|102118529|FG000|COMPLETED|Overall Study||0||
48727236|NCT02831933|102118529|FG000|NOT COMPLETED|Overall Study||11||
48727237|NCT01374178|102118530|FG000|STARTED|Period 1 (up to 24 Hours After Dosing)||11||
48727238|NCT01374178|102118531|FG001|STARTED|Period 1 (up to 24 Hours After Dosing)||5||
48727239|NCT01374178|102118530|FG000|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||11||
48727240|NCT01374178|102118531|FG001|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||5||
48727241|NCT01374178|102118530|FG000|COMPLETED|Period 1 (up to 24 Hours After Dosing)||11||
48727242|NCT01374178|102118531|FG001|COMPLETED|Period 1 (up to 24 Hours After Dosing)||5||
48727243|NCT01374178|102118530|FG000|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0||
48727244|NCT01374178|102118531|FG001|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0||
48727245|NCT01374178|102118530|FG000|STARTED|Washout Period of at Least 7 Days||11||
48727246|NCT01374178|102118531|FG001|STARTED|Washout Period of at Least 7 Days||5||
48727247|NCT01374178|102118530|FG000|COMPLETED|Washout Period of at Least 7 Days||10||
48727248|NCT01374178|102118531|FG001|COMPLETED|Washout Period of at Least 7 Days||5||
48727249|NCT01374178|102118530|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||1||
48727250|NCT01374178|102118531|FG001|NOT COMPLETED|Washout Period of at Least 7 Days||0||
48727251|NCT01374178|102118530|FG000|STARTED|Period 2 (up to 24 Hours After Dosing)||10||
48727252|NCT01374178|102118531|FG001|STARTED|Period 2 (up to 24 Hours After Dosing)||5||
48727253|NCT01374178|102118530|FG000|COMPLETED|Period 2 (up to 24 Hours After Dosing)||8||
48727254|NCT01374178|102118531|FG001|COMPLETED|Period 2 (up to 24 Hours After Dosing)||5||
48727255|NCT01374178|102118530|FG000|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||2||
48727256|NCT01374178|102118531|FG001|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||0||
48727257|NCT02974842|102118532|FG000|STARTED|Overall Study||50||
48727258|NCT02974842|102118532|FG000|COMPLETED|Overall Study||42||
48727259|NCT02974842|102118532|FG000|NOT COMPLETED|Overall Study||8||
48727260|NCT03776461|102118533|FG000|STARTED|Overall Study||25||
48310914|NCT03083847|101087938|FG007|NOT COMPLETED|Main||4||
48310915|NCT03083847|101087939|FG008|NOT COMPLETED|Main||0||
48310916|NCT03083847|101087940|FG009|NOT COMPLETED|Main||0||
48310917|NCT02269787|101087941|FG000|STARTED|Overall Study||148||
48310918|NCT02269787|101087942|FG001|STARTED|Overall Study||150||
48310919|NCT02269787|101087941|FG000|COMPLETED|Overall Study||126||
48310920|NCT02269787|101087942|FG001|COMPLETED|Overall Study||140||
48310921|NCT02269787|101087941|FG000|NOT COMPLETED|Overall Study||22||
48310922|NCT02269787|101087942|FG001|NOT COMPLETED|Overall Study||10||
48310923|NCT02179671|101087943|FG000|STARTED|Overall Study||1||
48310924|NCT02179671|101087944|FG001|STARTED|Overall Study||1||
48310925|NCT02179671|101087945|FG002|STARTED|Overall Study||2||
48310926|NCT02179671|101087946|FG003|STARTED|Overall Study||14||
48310927|NCT02179671|101087947|FG004|STARTED|Overall Study||14||
48310928|NCT02179671|101087943|FG000|COMPLETED|Overall Study||0||
48310929|NCT02179671|101087944|FG001|COMPLETED|Overall Study||0||
48310930|NCT02179671|101087945|FG002|COMPLETED|Overall Study||1||
48310931|NCT02179671|101087946|FG003|COMPLETED|Overall Study||1||
48310932|NCT02179671|101087947|FG004|COMPLETED|Overall Study||1||
48727261|NCT03776461|102118533|FG000|COMPLETED|Overall Study||18||
48727262|NCT03776461|102118533|FG000|NOT COMPLETED|Overall Study||7||
48727263|NCT02702414|102118534|FG000|STARTED|Overall Study||105||
48727264|NCT02702414|102118535|FG001|STARTED|Overall Study||51||
48727265|NCT02702414|102118534|FG000|Treated|Overall Study||104||
48727266|NCT02702414|102118535|FG001|Treated|Overall Study||51||
48727267|NCT02702414|102118534|FG000|Received Second Course of Pembrolizumab|Overall Study||4||
48727268|NCT02702414|102118535|FG001|Received Second Course of Pembrolizumab|Overall Study||1||
48727269|NCT02702414|102118534|FG000|COMPLETED|Overall Study||0||
48727270|NCT02702414|102118535|FG001|COMPLETED|Overall Study||0||
48727271|NCT02702414|102118534|FG000|NOT COMPLETED|Overall Study||105||
48727272|NCT02702414|102118535|FG001|NOT COMPLETED|Overall Study||51||
48727273|NCT01532869|102118536|FG000|STARTED|Blinded-Treatment Period (Up to Week 24)||44||
48727274|NCT01532869|102118537|FG001|STARTED|Blinded-Treatment Period (Up to Week 24)||43||
48727275|NCT01532869|102118536|FG000|COMPLETED|Blinded-Treatment Period (Up to Week 24)||36||
48727276|NCT01532869|102118537|FG001|COMPLETED|Blinded-Treatment Period (Up to Week 24)||35||
48727277|NCT01532869|102118536|FG000|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8||
48727278|NCT01532869|102118537|FG001|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8||
48310933|NCT02179671|101087943|FG000|NOT COMPLETED|Overall Study||1||
48727279|NCT01532869|102118536|FG000|STARTED|Blinded-Treatment Period (Up to Week 48)||44||
48727280|NCT01532869|102118537|FG001|STARTED|Blinded-Treatment Period (Up to Week 48)||43||
48727281|NCT01532869|102118536|FG000|COMPLETED|Blinded-Treatment Period (Up to Week 48)||33||
48310934|NCT02179671|101087944|FG001|NOT COMPLETED|Overall Study||1||
48310935|NCT02179671|101087945|FG002|NOT COMPLETED|Overall Study||1||
48310936|NCT02179671|101087946|FG003|NOT COMPLETED|Overall Study||13||
48310937|NCT02179671|101087947|FG004|NOT COMPLETED|Overall Study||13||
48310938|NCT02321930|101087948|FG000|STARTED|Overall Study||25||
48310939|NCT02321930|101087948|FG000|COMPLETED|Overall Study||24||
48310940|NCT02321930|101087948|FG000|NOT COMPLETED|Overall Study||1||
48613132|NCT02757352|101838439|FG008|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0||
48613133|NCT02757352|101838440|FG009|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0||
48613134|NCT02757352|101838431|FG000|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0||
48613135|NCT02757352|101838432|FG001|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0||
48310941|NCT01653964|101087949|FG000|STARTED|Overall Study||82||
48310942|NCT01653964|101087949|FG000|COMPLETED|Overall Study||82||
48310943|NCT01653964|101087949|FG000|NOT COMPLETED|Overall Study||0||
48310944|NCT01861028|101087950|FG000|STARTED|Overall Study||44||
48310945|NCT01861028|101087950|FG000|COMPLETED|Overall Study||44||
48310946|NCT01861028|101087950|FG000|NOT COMPLETED|Overall Study||0||
48310947|NCT01660321|101087951|FG000|STARTED|Overall Study||26||
48310948|NCT01660321|101087951|FG000|COMPLETED|Overall Study||26||
48310949|NCT01660321|101087951|FG000|NOT COMPLETED|Overall Study||0||
48310950|NCT03520959|101087952|FG000|STARTED|Overall Study||0||
48310951|NCT03520959|101087953|FG001|STARTED|Overall Study||1||
48310952|NCT03520959|101087952|FG000|COMPLETED|Overall Study||0||
48310953|NCT03520959|101087953|FG001|COMPLETED|Overall Study||0||
48310954|NCT03520959|101087952|FG000|NOT COMPLETED|Overall Study||0||
48310955|NCT03520959|101087953|FG001|NOT COMPLETED|Overall Study||1||
48310956|NCT01996813|101087954|FG000|STARTED|Overall Study||23||
48310957|NCT01996813|101087955|FG001|STARTED|Overall Study||24||
48310958|NCT01996813|101087954|FG000|COMPLETED|Overall Study||23||
48310959|NCT01996813|101087955|FG001|COMPLETED|Overall Study||24||
48613136|NCT02757352|101838433|FG002|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0||
48613137|NCT02757352|101838434|FG003|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||7||
48613138|NCT02757352|101838435|FG004|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||3||
48613139|NCT02757352|101838436|FG005|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||7||
48613140|NCT02757352|101838437|FG006|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0||
48613141|NCT02757352|101838438|FG007|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0||
48613142|NCT02757352|101838439|FG008|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0||
48613143|NCT02757352|101838440|FG009|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0||
48613144|NCT02757352|101838431|FG000|STARTED|Follow-Up Period||0||
48613145|NCT02757352|101838432|FG001|STARTED|Follow-Up Period||0||
48727282|NCT01532869|102118537|FG001|COMPLETED|Blinded-Treatment Period (Up to Week 48)||30||
48727283|NCT01532869|102118536|FG000|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||11||
48727284|NCT01532869|102118537|FG001|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||13||
48727285|NCT01532869|102118536|FG000|STARTED|Open-label Period (Week 48 to Week 96)||31||
48727286|NCT01532869|102118537|FG001|STARTED|Open-label Period (Week 48 to Week 96)||30||
48727287|NCT01532869|102118536|FG000|COMPLETED|Open-label Period (Week 48 to Week 96)||24||
48727288|NCT01532869|102118537|FG001|COMPLETED|Open-label Period (Week 48 to Week 96)||27||
48727289|NCT01532869|102118536|FG000|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||7||
48727290|NCT01532869|102118537|FG001|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||3||
48727291|NCT00761202|102118538|FG000|STARTED|Overall Study||22||
48727292|NCT00761202|102118539|FG001|STARTED|Overall Study||28||
48613146|NCT02757352|101838433|FG002|STARTED|Follow-Up Period||0||
48613147|NCT02757352|101838434|FG003|STARTED|Follow-Up Period||0||
48613148|NCT02757352|101838435|FG004|STARTED|Follow-Up Period||0||
48727293|NCT00761202|102118538|FG000|COMPLETED|Overall Study||21||
48727294|NCT00761202|102118539|FG001|COMPLETED|Overall Study||26||
48727295|NCT00761202|102118538|FG000|NOT COMPLETED|Overall Study||1||
48727296|NCT00761202|102118539|FG001|NOT COMPLETED|Overall Study||2||
48727297|NCT04484207|102118540|FG000|STARTED|Overall Study||86||
48727298|NCT04484207|102118541|FG001|STARTED|Overall Study||44||
48727299|NCT04484207|102118542|FG002|STARTED|Overall Study||42||
48727300|NCT04484207|102118540|FG000|14-Day Follow-Up|Overall Study||69||
48727301|NCT04484207|102118541|FG001|14-Day Follow-Up|Overall Study||40||
48727302|NCT04484207|102118542|FG002|14-Day Follow-Up|Overall Study||33||
48727303|NCT04484207|102118540|FG000|30-Day Follow-Up|Overall Study||65||
48727304|NCT04484207|102118541|FG001|30-Day Follow-Up|Overall Study||34||
48727305|NCT04484207|102118542|FG002|30-Day Follow-Up|Overall Study||31||
48310960|NCT01996813|101087954|FG000|NOT COMPLETED|Overall Study||0||
48613149|NCT02757352|101838436|FG005|STARTED|Follow-Up Period||0||
48727306|NCT04484207|102118540|FG000|COMPLETED|Overall Study||65||
48310961|NCT01996813|101087955|FG001|NOT COMPLETED|Overall Study||0||
48310962|NCT03054922|101087956|FG000|STARTED|Overall Study||20||
48310963|NCT03054922|101087957|FG001|STARTED|Overall Study||19||
48310964|NCT03054922|101087958|FG002|STARTED|Overall Study||20||
48310965|NCT03054922|101087956|FG000|COMPLETED|Overall Study||20||
48613150|NCT02757352|101838437|FG006|STARTED|Follow-Up Period||3||
48613151|NCT02757352|101838438|FG007|STARTED|Follow-Up Period||5||
48613152|NCT02757352|101838439|FG008|STARTED|Follow-Up Period||28||
48727307|NCT04484207|102118541|FG001|COMPLETED|Overall Study||34||
48727308|NCT04484207|102118542|FG002|COMPLETED|Overall Study||31||
48727309|NCT04484207|102118540|FG000|NOT COMPLETED|Overall Study||21||
48727310|NCT04484207|102118541|FG001|NOT COMPLETED|Overall Study||10||
48727311|NCT04484207|102118542|FG002|NOT COMPLETED|Overall Study||11||
48727312|NCT01705106|102118543|FG000|STARTED|Overall Study||21||
48727313|NCT01705106|102118543|FG000|COMPLETED|Overall Study||21||
48727314|NCT01705106|102118543|FG000|NOT COMPLETED|Overall Study||0||
48727315|NCT00241904|102118544|FG000|STARTED|Overall Study||261||
48727316|NCT00241904|102118545|FG001|STARTED|Overall Study||264||
48727317|NCT00241904|102118544|FG000|COMPLETED|Overall Study||227||
48727318|NCT00241904|102118545|FG001|COMPLETED|Overall Study||240||
48727319|NCT00241904|102118544|FG000|NOT COMPLETED|Overall Study||34||
48727320|NCT00241904|102118545|FG001|NOT COMPLETED|Overall Study||24||
48727321|NCT01105377|102118546|FG000|STARTED|Overall Study||24||
48727322|NCT01105377|102118547|FG001|STARTED|Overall Study||23||
48727323|NCT01105377|102118546|FG000|COMPLETED|Overall Study||24||
48727324|NCT01105377|102118547|FG001|COMPLETED|Overall Study||22||
48727325|NCT01105377|102118546|FG000|NOT COMPLETED|Overall Study||0||
48727326|NCT01105377|102118547|FG001|NOT COMPLETED|Overall Study||1||
48727327|NCT02933502|102118548|FG000|STARTED|Overall Study||3||
48727328|NCT02933502|102118548|FG000|COMPLETED|Overall Study||3||
48727329|NCT02933502|102118548|FG000|NOT COMPLETED|Overall Study||0||
48727330|NCT00597493|102118549|FG000|STARTED|Overall Study||32||
48727331|NCT00597493|102118549|FG000|COMPLETED|Overall Study||32||
48727332|NCT00597493|102118549|FG000|NOT COMPLETED|Overall Study||0||
48727333|NCT03761810|102118550|FG000|STARTED|Overall Study||290||
48727334|NCT03761810|102118551|FG001|STARTED|Overall Study||144||
48727335|NCT03761810|102118550|FG000|Received at Least 1 Dose of Study Drug|Overall Study||281||
48727336|NCT03761810|102118551|FG001|Received at Least 1 Dose of Study Drug|Overall Study||138||
48727337|NCT03761810|102118550|FG000|COMPLETED|Overall Study||242||
48727338|NCT03761810|102118551|FG001|COMPLETED|Overall Study||132||
48727339|NCT03761810|102118550|FG000|NOT COMPLETED|Overall Study||48||
48727340|NCT03761810|102118551|FG001|NOT COMPLETED|Overall Study||12||
48727341|NCT02961946|102118552|FG000|STARTED|Overall Study||66||
48727342|NCT02961946|102118553|FG001|STARTED|Overall Study||66||
48727343|NCT02961946|102118554|FG002|STARTED|Overall Study||66||
48727344|NCT02961946|102118552|FG000|COMPLETED|Overall Study||66||
48727345|NCT02961946|102118553|FG001|COMPLETED|Overall Study||66||
48727346|NCT02961946|102118554|FG002|COMPLETED|Overall Study||66||
48727347|NCT02961946|102118552|FG000|NOT COMPLETED|Overall Study||0||
48727348|NCT02961946|102118553|FG001|NOT COMPLETED|Overall Study||0||
48727349|NCT02961946|102118554|FG002|NOT COMPLETED|Overall Study||0||
48727350|NCT01729208|102118555|FG000|STARTED|Baseline||70||
48727351|NCT01729208|102118556|FG001|STARTED|Baseline||74||
48727352|NCT01729208|102118555|FG000|COMPLETED|Baseline||65||
48727353|NCT01729208|102118556|FG001|COMPLETED|Baseline||70||
48727354|NCT01729208|102118555|FG000|NOT COMPLETED|Baseline||5||
48727355|NCT01729208|102118556|FG001|NOT COMPLETED|Baseline||4||
48727356|NCT01729208|102118555|FG000|STARTED|12 Months Follow-up||65||
48727357|NCT01729208|102118556|FG001|STARTED|12 Months Follow-up||70||
48727358|NCT01729208|102118555|FG000|COMPLETED|12 Months Follow-up||58||
48727359|NCT01729208|102118556|FG001|COMPLETED|12 Months Follow-up||60||
48727360|NCT01729208|102118555|FG000|NOT COMPLETED|12 Months Follow-up||7||
48727361|NCT01729208|102118556|FG001|NOT COMPLETED|12 Months Follow-up||10||
48727362|NCT01729208|102118555|FG000|STARTED|24 Months Follow-up||58||
48727363|NCT01729208|102118556|FG001|STARTED|24 Months Follow-up||60||
48727364|NCT01729208|102118555|FG000|COMPLETED|24 Months Follow-up||55||
48727365|NCT01729208|102118556|FG001|COMPLETED|24 Months Follow-up||60||
48727366|NCT01729208|102118555|FG000|NOT COMPLETED|24 Months Follow-up||3||
48727367|NCT01729208|102118556|FG001|NOT COMPLETED|24 Months Follow-up||0||
48727368|NCT01729208|102118555|FG000|STARTED|36 Months Follow-up||55||
48727369|NCT01729208|102118556|FG001|STARTED|36 Months Follow-up||60||
48727370|NCT01729208|102118555|FG000|COMPLETED|36 Months Follow-up||52||
48727371|NCT01729208|102118556|FG001|COMPLETED|36 Months Follow-up||56||
48727372|NCT01729208|102118555|FG000|NOT COMPLETED|36 Months Follow-up||3||
48727373|NCT01729208|102118556|FG001|NOT COMPLETED|36 Months Follow-up||4||
48727374|NCT02252965|102118557|FG000|STARTED|Overall Study||267||
48727375|NCT02252965|102118558|FG001|STARTED|Overall Study||265||
48727376|NCT02252965|102118557|FG000|Safety Population|Overall Study||261||
48727377|NCT02252965|102118558|FG001|Safety Population|Overall Study||264||
48727378|NCT02252965|102118557|FG000|COMPLETED|Overall Study||227||
48727379|NCT02252965|102118558|FG001|COMPLETED|Overall Study||222||
48727380|NCT02252965|102118557|FG000|NOT COMPLETED|Overall Study||40||
48727381|NCT02252965|102118558|FG001|NOT COMPLETED|Overall Study||43||
48727382|NCT03037983|102118559|FG000|STARTED|Overall Study||5||
48727383|NCT03037983|102118560|FG001|STARTED|Overall Study||4||
48727384|NCT03037983|102118559|FG000|COMPLETED|Overall Study||5||
48727385|NCT03037983|102118560|FG001|COMPLETED|Overall Study||4||
48727386|NCT03037983|102118559|FG000|NOT COMPLETED|Overall Study||0||
48727387|NCT03037983|102118560|FG001|NOT COMPLETED|Overall Study||0||
48727388|NCT01979133|102118561|FG000|STARTED|Overall Study||10||
48727389|NCT01979133|102118561|FG000|COMPLETED|Overall Study||7||
48727390|NCT01979133|102118561|FG000|NOT COMPLETED|Overall Study||3||
48727391|NCT02921087|102118562|FG000|STARTED|Overall Study||12||
48727392|NCT02921087|102118563|FG001|STARTED|Overall Study||11||
48727393|NCT02921087|102118562|FG000|COMPLETED|Overall Study||12||
48727394|NCT02921087|102118563|FG001|COMPLETED|Overall Study||10||
48727395|NCT02921087|102118562|FG000|NOT COMPLETED|Overall Study||0||
48727396|NCT02921087|102118563|FG001|NOT COMPLETED|Overall Study||1||
48727397|NCT02211313|102118564|FG000|STARTED|Overall Study||18||
48727398|NCT02211313|102118565|FG001|STARTED|Overall Study||23||
48727399|NCT02211313|102118564|FG000|COMPLETED|Overall Study||12||
48727400|NCT02211313|102118565|FG001|COMPLETED|Overall Study||20||
48727401|NCT02211313|102118564|FG000|NOT COMPLETED|Overall Study||6||
48727402|NCT02211313|102118565|FG001|NOT COMPLETED|Overall Study||3||
48727403|NCT03369236|102118566|FG000|STARTED|Double-blind Treatment Period||6||
48727404|NCT03369236|102118567|FG001|STARTED|Double-blind Treatment Period||7||
48727405|NCT03369236|102118566|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||6||
48727406|NCT03369236|102118567|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||7||
48727407|NCT03369236|102118566|FG000|COMPLETED|Double-blind Treatment Period||6||
48727408|NCT03369236|102118567|FG001|COMPLETED|Double-blind Treatment Period||6||
48727409|NCT03369236|102118566|FG000|NOT COMPLETED|Double-blind Treatment Period||0||
48727410|NCT03369236|102118567|FG001|NOT COMPLETED|Double-blind Treatment Period||1||
48727411|NCT03369236|102118566|FG000|STARTED|Open-label Extension Period||6||
48727412|NCT03369236|102118567|FG001|STARTED|Open-label Extension Period||6||
48727413|NCT03369236|102118566|FG000|Received at Least 1 Dose of Study Drug|Open-label Extension Period||6||
48727414|NCT03369236|102118567|FG001|Received at Least 1 Dose of Study Drug|Open-label Extension Period||6||
48727415|NCT03369236|102118566|FG000|COMPLETED|Open-label Extension Period||1||
48727416|NCT03369236|102118567|FG001|COMPLETED|Open-label Extension Period||0||
48727417|NCT03369236|102118566|FG000|NOT COMPLETED|Open-label Extension Period||5||
48727418|NCT03369236|102118567|FG001|NOT COMPLETED|Open-label Extension Period||6||
48727419|NCT02706197|102118568|FG000|STARTED|Overall Study||18||
48727420|NCT02706197|102118569|FG001|STARTED|Overall Study||6||
48727421|NCT02706197|102118568|FG000|COMPLETED|Overall Study||18||
48727422|NCT02706197|102118569|FG001|COMPLETED|Overall Study||6||
48727423|NCT02706197|102118568|FG000|NOT COMPLETED|Overall Study||0||
48727424|NCT02706197|102118569|FG001|NOT COMPLETED|Overall Study||0||
48727425|NCT04978818|102118570|FG000|STARTED|Overall Study||166||
48310966|NCT03054922|101087957|FG001|COMPLETED|Overall Study||19||
48310967|NCT03054922|101087958|FG002|COMPLETED|Overall Study||20||
48310968|NCT03054922|101087956|FG000|NOT COMPLETED|Overall Study||0||
48310969|NCT03054922|101087957|FG001|NOT COMPLETED|Overall Study||0||
48310970|NCT03054922|101087958|FG002|NOT COMPLETED|Overall Study||0||
48727426|NCT04978818|102118571|FG001|STARTED|Overall Study||167||
48727427|NCT04978818|102118570|FG000|COMPLETED|Overall Study||144||
48727428|NCT04978818|102118571|FG001|COMPLETED|Overall Study||152||
48727429|NCT04978818|102118570|FG000|NOT COMPLETED|Overall Study||22||
48727430|NCT04978818|102118571|FG001|NOT COMPLETED|Overall Study||15||
48727431|NCT02879578|102118572|FG000|STARTED|Overall Study||33||
48727432|NCT02879578|102118573|FG001|STARTED|Overall Study||41||
48727433|NCT02879578|102118574|FG002|STARTED|Overall Study||81||
48727434|NCT02879578|102118572|FG000|Safety Analysis Set|Overall Study||33|Safety analysis set includes all participants who received at least one dose of study drug and have any postbaseline data.|
48727435|NCT02879578|102118573|FG001|Safety Analysis Set|Overall Study||40|Safety analysis set includes all participants who received at least one dose of study drug and have any postbaseline data.|
48727436|NCT02879578|102118574|FG002|Safety Analysis Set|Overall Study||79|Safety analysis set includes all participants who received at least one dose of study drug and have any postbaseline data.|
48727437|NCT02879578|102118572|FG000|COMPLETED|Overall Study||23||
48727438|NCT02879578|102118573|FG001|COMPLETED|Overall Study||32||
48727439|NCT02879578|102118574|FG002|COMPLETED|Overall Study||49||
48727440|NCT02879578|102118572|FG000|NOT COMPLETED|Overall Study||10||
48727441|NCT02879578|102118573|FG001|NOT COMPLETED|Overall Study||9||
48310971|NCT00006392|101087959|FG000|STARTED|Overall Study||8904||
48310972|NCT00006392|101087960|FG001|STARTED|Overall Study||8910||
48310973|NCT00006392|101087961|FG002|STARTED|Overall Study||8863||
48310974|NCT00006392|101087962|FG003|STARTED|Overall Study||8856||
48310975|NCT00006392|101087959|FG000|COMPLETED|Overall Study||8737||
48310976|NCT00006392|101087960|FG001|COMPLETED|Overall Study||8752||
48310977|NCT00006392|101087961|FG002|COMPLETED|Overall Study||8703||
48310978|NCT00006392|101087962|FG003|COMPLETED|Overall Study||8696||
48727442|NCT02879578|102118574|FG002|NOT COMPLETED|Overall Study||32||
48727443|NCT02634827|102118575|FG000|STARTED|Overall Study||1||
48310979|NCT00006392|101087959|FG000|NOT COMPLETED|Overall Study||167||
48310980|NCT00006392|101087960|FG001|NOT COMPLETED|Overall Study||158||
48727444|NCT02634827|102118575|FG000|COMPLETED|Overall Study||1||
48727445|NCT02634827|102118575|FG000|NOT COMPLETED|Overall Study||0||
48727446|NCT00445770|102118576|FG000|STARTED|Overall Study||176||
48727447|NCT00445770|102118577|FG001|STARTED|Overall Study||192||
48727448|NCT00445770|102118578|FG002|STARTED|Overall Study||182||
48310981|NCT00006392|101087961|FG002|NOT COMPLETED|Overall Study||160||
48310982|NCT00006392|101087962|FG003|NOT COMPLETED|Overall Study||160||
48310983|NCT01621542|101087963|FG000|STARTED|Overall Study||5||
48310984|NCT01621542|101087964|FG001|STARTED|Overall Study||5||
48727449|NCT00445770|102118576|FG000|COMPLETED|Overall Study||123||
48727450|NCT00445770|102118577|FG001|COMPLETED|Overall Study||157||
48727451|NCT00445770|102118578|FG002|COMPLETED|Overall Study||151||
48727452|NCT00445770|102118576|FG000|NOT COMPLETED|Overall Study||53||
48727453|NCT00445770|102118577|FG001|NOT COMPLETED|Overall Study||35||
48727454|NCT00445770|102118578|FG002|NOT COMPLETED|Overall Study||31||
48310985|NCT01621542|101087965|FG002|STARTED|Overall Study||6||
48310986|NCT01621542|101087966|FG003|STARTED|Overall Study||28||
48310987|NCT01621542|101087967|FG004|STARTED|Overall Study||9||
48310988|NCT01621542|101087968|FG005|STARTED|Overall Study||9||
48310989|NCT01621542|101087963|FG000|COMPLETED|Overall Study||0||
48310990|NCT01621542|101087964|FG001|COMPLETED|Overall Study||0||
48310991|NCT01621542|101087965|FG002|COMPLETED|Overall Study||0||
48310992|NCT01621542|101087966|FG003|COMPLETED|Overall Study||0||
48310993|NCT01621542|101087967|FG004|COMPLETED|Overall Study||0||
48310994|NCT01621542|101087968|FG005|COMPLETED|Overall Study||0||
48310995|NCT01621542|101087963|FG000|NOT COMPLETED|Overall Study||5||
48310996|NCT01621542|101087964|FG001|NOT COMPLETED|Overall Study||5||
48310997|NCT01621542|101087965|FG002|NOT COMPLETED|Overall Study||6||
48310998|NCT01621542|101087966|FG003|NOT COMPLETED|Overall Study||28||
48310999|NCT01621542|101087967|FG004|NOT COMPLETED|Overall Study||9||
48311000|NCT01621542|101087968|FG005|NOT COMPLETED|Overall Study||9||
48311001|NCT00853749|101087969|FG000|STARTED|Overall Study||50||
48311002|NCT00853749|101087970|FG001|STARTED|Overall Study||39||
48311003|NCT00853749|101087969|FG000|Vaccinated|Overall Study||50||
48311004|NCT00853749|101087970|FG001|Vaccinated|Overall Study||39||
48311005|NCT00853749|101087969|FG000|COMPLETED|Overall Study||50||
48311006|NCT00853749|101087970|FG001|COMPLETED|Overall Study||38||
48311007|NCT00853749|101087969|FG000|NOT COMPLETED|Overall Study||0||
48311008|NCT00853749|101087970|FG001|NOT COMPLETED|Overall Study||1||
48311009|NCT01146704|101087971|FG000|STARTED|Overall Study||16||
48311010|NCT01146704|101087972|FG001|STARTED|Overall Study||15||
48311011|NCT01146704|101087971|FG000|COMPLETED|Overall Study||16||
48311012|NCT01146704|101087972|FG001|COMPLETED|Overall Study||15||
48311013|NCT01146704|101087971|FG000|NOT COMPLETED|Overall Study||0||
48311014|NCT01146704|101087972|FG001|NOT COMPLETED|Overall Study||0||
48311015|NCT05082376|101087973|FG000|STARTED|Overall Study||38||76
48311016|NCT05082376|101087973|FG000|Test Product (CLM Original)|Overall Study||36||36
48311017|NCT05082376|101087973|FG000|Control (No Treatment)|Overall Study||36||36
48311018|NCT05082376|101087973|FG000|COMPLETED|Overall Study||36||72
48311019|NCT05082376|101087973|FG000|NOT COMPLETED|Overall Study||2||4
48311020|NCT00073528|101087974|FG000|STARTED|Overall Study||644|All participants included in the Intent-To-Treat (ITT) population|
48311021|NCT00073528|101087975|FG001|STARTED|Overall Study||642|All participants included in the Intent-To-Treat (ITT) population|
48311022|NCT00073528|101087974|FG000|COMPLETED|Overall Study||14||
48311023|NCT00073528|101087975|FG001|COMPLETED|Overall Study||14||
48311024|NCT00073528|101087974|FG000|NOT COMPLETED|Overall Study||630||
48311025|NCT00073528|101087975|FG001|NOT COMPLETED|Overall Study||628||
48311026|NCT02902081|101087976|FG000|STARTED|Overall Study||38||
48311027|NCT02902081|101087976|FG000|COMPLETED|Overall Study||38||
48311028|NCT02902081|101087976|FG000|NOT COMPLETED|Overall Study||0||
48311029|NCT02064920|101087977|FG000|STARTED|Overall Study||6||
48311030|NCT02064920|101087978|FG001|STARTED|Overall Study||30||
48311031|NCT02064920|101087977|FG000|Treated|Overall Study||6||
48311032|NCT02064920|101087978|FG001|Treated|Overall Study||28||
48311033|NCT02064920|101087977|FG000|COMPLETED|Overall Study||5||
48311034|NCT02064920|101087978|FG001|COMPLETED|Overall Study||21||
48311035|NCT02064920|101087977|FG000|NOT COMPLETED|Overall Study||1||
48311036|NCT02064920|101087978|FG001|NOT COMPLETED|Overall Study||9||
48311037|NCT00317720|101087979|FG000|STARTED|Overall Study||40||
48311038|NCT00317720|101087980|FG001|STARTED|Overall Study||7||
48311039|NCT00317720|101087979|FG000|COMPLETED|Overall Study||40||
48311040|NCT00317720|101087980|FG001|COMPLETED|Overall Study||7||
48311041|NCT00317720|101087979|FG000|NOT COMPLETED|Overall Study||0||
48311042|NCT00317720|101087980|FG001|NOT COMPLETED|Overall Study||0||
48311043|NCT02375724|101087981|FG000|STARTED|Overall Study||135||
48311044|NCT02375724|101087982|FG001|STARTED|Overall Study||134||
48311045|NCT02375724|101087981|FG000|COMPLETED|Overall Study||129||
48311046|NCT02375724|101087982|FG001|COMPLETED|Overall Study||128||
48311047|NCT02375724|101087981|FG000|NOT COMPLETED|Overall Study||6||
48311048|NCT02375724|101087982|FG001|NOT COMPLETED|Overall Study||6||
48311049|NCT04498169|101087983|FG000|STARTED|Modified Intent-to-Treat Population||20||
48311050|NCT04498169|101087984|FG001|STARTED|Modified Intent-to-Treat Population||20||
48311051|NCT04498169|101087983|FG000|COMPLETED|Modified Intent-to-Treat Population||19||
48311052|NCT04498169|101087984|FG001|COMPLETED|Modified Intent-to-Treat Population||19||
48311053|NCT04498169|101087983|FG000|NOT COMPLETED|Modified Intent-to-Treat Population||1||
48311054|NCT04498169|101087984|FG001|NOT COMPLETED|Modified Intent-to-Treat Population||1||
48311055|NCT04498169|101087983|FG000|STARTED|Safety Population||20||
48311056|NCT04498169|101087984|FG001|STARTED|Safety Population||20||
48311057|NCT04498169|101087983|FG000|COMPLETED|Safety Population||19||
48311058|NCT04498169|101087984|FG001|COMPLETED|Safety Population||19||
48311059|NCT04498169|101087983|FG000|NOT COMPLETED|Safety Population||1||
48311060|NCT04498169|101087984|FG001|NOT COMPLETED|Safety Population||1||
48311061|NCT04498169|101087983|FG000|STARTED|Per-Protocol Population||18||
48311062|NCT04498169|101087984|FG001|STARTED|Per-Protocol Population||16||
48311063|NCT04498169|101087983|FG000|COMPLETED|Per-Protocol Population||18||
48311064|NCT04498169|101087984|FG001|COMPLETED|Per-Protocol Population||15||
48311065|NCT04498169|101087983|FG000|NOT COMPLETED|Per-Protocol Population||0||
48311066|NCT04498169|101087984|FG001|NOT COMPLETED|Per-Protocol Population||1||
48727455|NCT02748928|102118579|FG000|STARTED|Overall Study||62||
48727456|NCT02748928|102118579|FG000|COMPLETED|Overall Study||62||
48156230|NCT00742079|100703303|FG001|COMPLETED|Overall Study||9||
48156231|NCT00742079|100703302|FG000|NOT COMPLETED|Overall Study||0||
48156232|NCT00742079|100703303|FG001|NOT COMPLETED|Overall Study||1||
48156233|NCT00620750|100703304|FG000|STARTED|Overall Study||65||
48156234|NCT00620750|100703304|FG000|COMPLETED|Overall Study||40||
48156235|NCT00620750|100703304|FG000|NOT COMPLETED|Overall Study||25||
48156236|NCT01714804|100703305|FG000|STARTED|Overall Study||30||
48156237|NCT01714804|100703306|FG001|STARTED|Overall Study||30||
48156238|NCT01714804|100703305|FG000|COMPLETED|Overall Study||29||
48156239|NCT01714804|100703306|FG001|COMPLETED|Overall Study||30||
48156240|NCT01714804|100703305|FG000|NOT COMPLETED|Overall Study||1||
48156241|NCT01714804|100703306|FG001|NOT COMPLETED|Overall Study||0||
48156242|NCT01856530|100703307|FG000|STARTED|Overall Study||27||
48156243|NCT01856530|100703308|FG001|STARTED|Overall Study||27||
48156244|NCT01856530|100703307|FG000|COMPLETED|Overall Study||27||
48156245|NCT01856530|100703308|FG001|COMPLETED|Overall Study||27||
48156246|NCT01856530|100703307|FG000|NOT COMPLETED|Overall Study||0||
48156247|NCT01856530|100703308|FG001|NOT COMPLETED|Overall Study||0||
48156248|NCT03775200|100703309|FG000|STARTED|Overall Study||79||
48156249|NCT03775200|100703310|FG001|STARTED|Overall Study||75||
48156250|NCT03775200|100703311|FG002|STARTED|Overall Study||79||
48156251|NCT03775200|100703309|FG000|COMPLETED|Overall Study||74||
48156252|NCT03775200|100703310|FG001|COMPLETED|Overall Study||66||
48156253|NCT03775200|100703311|FG002|COMPLETED|Overall Study||69||
48156254|NCT03775200|100703309|FG000|NOT COMPLETED|Overall Study||5||
48156255|NCT03775200|100703310|FG001|NOT COMPLETED|Overall Study||9||
48156256|NCT03775200|100703311|FG002|NOT COMPLETED|Overall Study||10||
48156257|NCT00295022|100703312|FG000|STARTED|Overall Study||105||
48156258|NCT00295022|100703313|FG001|STARTED|Overall Study||157||
48156259|NCT00295022|100703314|FG002|STARTED|Overall Study||156||
48156260|NCT00295022|100703312|FG000|COMPLETED|Overall Study||104||
48156261|NCT00295022|100703313|FG001|COMPLETED|Overall Study||156||
48156262|NCT00295022|100703314|FG002|COMPLETED|Overall Study||151||
48156263|NCT00295022|100703312|FG000|NOT COMPLETED|Overall Study||1||
48156264|NCT00295022|100703313|FG001|NOT COMPLETED|Overall Study||1||
48156265|NCT00295022|100703314|FG002|NOT COMPLETED|Overall Study||5||
48156266|NCT00863655|100703315|FG000|STARTED|Overall Study||485||
48156267|NCT00863655|100703316|FG001|STARTED|Overall Study||239||
48156268|NCT00863655|100703315|FG000|COMPLETED|Overall Study||0||
48156269|NCT00863655|100703316|FG001|COMPLETED|Overall Study||0||
48156270|NCT00863655|100703315|FG000|NOT COMPLETED|Overall Study||485||
48156271|NCT00863655|100703316|FG001|NOT COMPLETED|Overall Study||239||
48156272|NCT02831257|100703317|FG000|STARTED|Overall Study||18||
48156273|NCT02831257|100703317|FG000|COMPLETED|Overall Study||6||
48156274|NCT02831257|100703317|FG000|NOT COMPLETED|Overall Study||12||
48156275|NCT02287584|100703318|FG000|STARTED|the Double-blind Phase||190|Subjects treated in the double-blind treatment phase|
48156276|NCT02287584|100703319|FG001|STARTED|the Double-blind Phase||196|Subjects treated in the double-blind treatment phase|
48156277|NCT02287584|100703320|FG002|STARTED|the Double-blind Phase||194|Subjects treated in the double-blind treatment phase|
48156278|NCT02287584|100703321|FG003|STARTED|the Double-blind Phase||0|Subjects treated in the double-blind treatment phase|
48156279|NCT02287584|100703322|FG004|STARTED|the Double-blind Phase||0|Subjects treated in the double-blind treatment phase|
48156280|NCT02287584|100703323|FG005|STARTED|the Double-blind Phase||0|Subjects treated in the double-blind treatment phase|
48156281|NCT02287584|100703318|FG000|COMPLETED|the Double-blind Phase||138||
48156282|NCT02287584|100703319|FG001|COMPLETED|the Double-blind Phase||149||
48156283|NCT02287584|100703320|FG002|COMPLETED|the Double-blind Phase||161||
48156284|NCT02287584|100703321|FG003|COMPLETED|the Double-blind Phase||0||
48156285|NCT02287584|100703322|FG004|COMPLETED|the Double-blind Phase||0||
48156286|NCT02287584|100703323|FG005|COMPLETED|the Double-blind Phase||0||
48156287|NCT02287584|100703318|FG000|NOT COMPLETED|the Double-blind Phase||52||
48156288|NCT02287584|100703319|FG001|NOT COMPLETED|the Double-blind Phase||47||
48156289|NCT02287584|100703320|FG002|NOT COMPLETED|the Double-blind Phase||33||
48156290|NCT02287584|100703321|FG003|NOT COMPLETED|the Double-blind Phase||0||
48156291|NCT02287584|100703322|FG004|NOT COMPLETED|the Double-blind Phase||0||
48156292|NCT02287584|100703323|FG005|NOT COMPLETED|the Double-blind Phase||0||
48156293|NCT02287584|100703318|FG000|STARTED|the Open-label Phase||0|Subjects completed the double-blind treatment phase|
48156294|NCT02287584|100703319|FG001|STARTED|the Open-label Phase||0|Subjects completed the double-blind treatment phase|
48156295|NCT02287584|100703320|FG002|STARTED|the Open-label Phase||0|Subjects completed the double-blind treatment phase|
48156296|NCT02287584|100703321|FG003|STARTED|the Open-label Phase||138|Subjects completed the double-blind treatment phase|
48727457|NCT02748928|102118579|FG000|NOT COMPLETED|Overall Study||0||
48727458|NCT02798471|102118580|FG000|STARTED|Overall Study||147||
48156297|NCT02287584|100703322|FG004|STARTED|the Open-label Phase||149|Subjects completed the double-blind treatment phase|
48311067|NCT04498169|101087983|FG000|STARTED|Study Completion||20||
48311068|NCT04498169|101087984|FG001|STARTED|Study Completion||20||
48311069|NCT04498169|101087983|FG000|COMPLETED|Study Completion||19||
48727459|NCT02798471|102118581|FG001|STARTED|Overall Study||143||
48727460|NCT02798471|102118580|FG000|Modified Intent-to-Treat Population|Overall Study||145||
48767611|NCT00914316|102222779|FG003|COMPLETED|Phase 2||6||
48727461|NCT02798471|102118581|FG001|Modified Intent-to-Treat Population|Overall Study||141||
48727462|NCT02798471|102118580|FG000|COMPLETED|Overall Study||128||
48727463|NCT02798471|102118581|FG001|COMPLETED|Overall Study||119||
48727464|NCT02798471|102118580|FG000|NOT COMPLETED|Overall Study||19||
48727465|NCT02798471|102118581|FG001|NOT COMPLETED|Overall Study||24||
48727466|NCT02476006|102118582|FG000|STARTED|Overall Study||998||
48311070|NCT04498169|101087984|FG001|COMPLETED|Study Completion||19||
48311071|NCT04498169|101087983|FG000|NOT COMPLETED|Study Completion||1||
48311072|NCT04498169|101087984|FG001|NOT COMPLETED|Study Completion||1||
48311073|NCT03057613|101087985|FG000|STARTED|Overall Study||18||
48311074|NCT03057613|101087985|FG000|COMPLETED|Overall Study||18||
48311075|NCT03057613|101087985|FG000|NOT COMPLETED|Overall Study||0||
48311076|NCT05097144|101087986|FG000|STARTED|Period 1 (One Month)||18||
48311077|NCT05097144|101087987|FG001|STARTED|Period 1 (One Month)||18||
48311078|NCT05097144|101087986|FG000|COMPLETED|Period 1 (One Month)||18||
48311079|NCT05097144|101087987|FG001|COMPLETED|Period 1 (One Month)||18||
48311080|NCT05097144|101087986|FG000|NOT COMPLETED|Period 1 (One Month)||0||
48311081|NCT05097144|101087987|FG001|NOT COMPLETED|Period 1 (One Month)||0||
48311082|NCT05097144|101087986|FG000|STARTED|Period 2 (One Month)||18||
48311083|NCT05097144|101087987|FG001|STARTED|Period 2 (One Month)||18||
48311084|NCT05097144|101087986|FG000|COMPLETED|Period 2 (One Month)||18||
48311085|NCT05097144|101087987|FG001|COMPLETED|Period 2 (One Month)||18||
48311086|NCT05097144|101087986|FG000|NOT COMPLETED|Period 2 (One Month)||0||
48311087|NCT05097144|101087987|FG001|NOT COMPLETED|Period 2 (One Month)||0||
48311088|NCT01877915|101087988|FG000|STARTED|Overall Study||2507||
48311089|NCT01877915|101087989|FG001|STARTED|Overall Study||2515||
48311090|NCT01877915|101087988|FG000|COMPLETED|Overall Study||2453||
48311091|NCT01877915|101087989|FG001|COMPLETED|Overall Study||2447||
48311092|NCT01877915|101087988|FG000|NOT COMPLETED|Overall Study||54||
48311093|NCT01877915|101087989|FG001|NOT COMPLETED|Overall Study||68||
48311094|NCT01667536|101087990|FG000|STARTED|Overall Study||105||
48727467|NCT02476006|102118582|FG000|Treated|Overall Study||994||
48727468|NCT02476006|102118582|FG000|COMPLETED|Overall Study||878||
48727469|NCT02476006|102118582|FG000|NOT COMPLETED|Overall Study||120||
48727470|NCT00392990|102118583|FG000|STARTED|Treatment on Study||20||
48727471|NCT00392990|102118584|FG001|STARTED|Treatment on Study||5||
48727472|NCT00392990|102118583|FG000|COMPLETED|Treatment on Study||17||
48727473|NCT00392990|102118584|FG001|COMPLETED|Treatment on Study||4||
48727474|NCT00392990|102118583|FG000|NOT COMPLETED|Treatment on Study||3||
48727475|NCT00392990|102118584|FG001|NOT COMPLETED|Treatment on Study||1||
48727476|NCT00392990|102118583|FG000|STARTED|Follow up for 2 Years||20|All patients that receive one dose of study drug go into the follow-up phase.|
48311095|NCT01667536|101087990|FG000|COMPLETED|Overall Study||105||
48311096|NCT01667536|101087990|FG000|NOT COMPLETED|Overall Study||0||
48311097|NCT02729740|101087991|FG000|STARTED|Overall Study||995||
48311098|NCT02729740|101087991|FG000|COMPLETED|Overall Study||864||
48311099|NCT02729740|101087991|FG000|NOT COMPLETED|Overall Study||131||
48311100|NCT02873936|101087992|FG000|STARTED|Overall Study||148||
48311101|NCT02873936|101087993|FG001|STARTED|Overall Study||153||
48311102|NCT02873936|101087994|FG002|STARTED|Overall Study||148||
48311103|NCT02873936|101087992|FG000|COMPLETED|Overall Study||135||
48311104|NCT02873936|101087993|FG001|COMPLETED|Overall Study||130||
48311105|NCT02873936|101087994|FG002|COMPLETED|Overall Study||116||
48311106|NCT02873936|101087992|FG000|NOT COMPLETED|Overall Study||13||
48311107|NCT02873936|101087993|FG001|NOT COMPLETED|Overall Study||23||
48311108|NCT02873936|101087994|FG002|NOT COMPLETED|Overall Study||32||
48311109|NCT03104075|101087995|FG000|STARTED|Overall Study||20||
48311110|NCT03104075|101087996|FG001|STARTED|Overall Study||20||
48311111|NCT03104075|101087995|FG000|COMPLETED|Overall Study||19||
48727477|NCT00392990|102118584|FG001|STARTED|Follow up for 2 Years||5|All patients that receive one dose of study drug go into the follow-up phase.|
48727478|NCT00392990|102118583|FG000|COMPLETED|Follow up for 2 Years||16||
48727479|NCT00392990|102118584|FG001|COMPLETED|Follow up for 2 Years||5||
48727480|NCT00392990|102118583|FG000|NOT COMPLETED|Follow up for 2 Years||4||
48727481|NCT00392990|102118584|FG001|NOT COMPLETED|Follow up for 2 Years||0||
48727482|NCT01786252|102118585|FG000|STARTED|Overall Study||7||
48727483|NCT01786252|102118586|FG001|STARTED|Overall Study||8||
48727484|NCT01786252|102118585|FG000|COMPLETED|Overall Study||7||
48311112|NCT03104075|101087996|FG001|COMPLETED|Overall Study||20||
48311113|NCT03104075|101087995|FG000|NOT COMPLETED|Overall Study||1||
48727485|NCT01786252|102118586|FG001|COMPLETED|Overall Study||8||
48727486|NCT01786252|102118585|FG000|NOT COMPLETED|Overall Study||0||
48311114|NCT03104075|101087996|FG001|NOT COMPLETED|Overall Study||0||
48727487|NCT01786252|102118586|FG001|NOT COMPLETED|Overall Study||0||
48311115|NCT02219321|101087997|FG000|STARTED|Overall Study||1||
48311116|NCT02219321|101087998|FG001|STARTED|Overall Study||2||
48311117|NCT02219321|101087997|FG000|COMPLETED|Overall Study||1||
48311118|NCT02219321|101087998|FG001|COMPLETED|Overall Study||2||
48311119|NCT02219321|101087997|FG000|NOT COMPLETED|Overall Study||0||
48311120|NCT02219321|101087998|FG001|NOT COMPLETED|Overall Study||0||
48727488|NCT03647267|102118587|FG000|STARTED|Overall Study||24||24
48727489|NCT03647267|102118588|FG001|STARTED|Overall Study||22||22
48727490|NCT03647267|102118587|FG000|COMPLETED|Overall Study||23||23
48727491|NCT03647267|102118588|FG001|COMPLETED|Overall Study||22||22
48311121|NCT01628107|101087999|FG000|STARTED|Overall Study||414||
48311122|NCT01628107|101087999|FG000|Treated|Overall Study||406||
48311123|NCT01628107|101087999|FG000|COMPLETED|Overall Study||295||
48311124|NCT01628107|101087999|FG000|NOT COMPLETED|Overall Study||119||
48311125|NCT04612036|101088000|FG000|STARTED|Overall Study||25||
48311126|NCT04612036|101088001|FG001|STARTED|Overall Study||25||
48311127|NCT04612036|101088002|FG002|STARTED|Overall Study||10||
48311128|NCT04612036|101088000|FG000|COMPLETED|Overall Study||25||
48311129|NCT04612036|101088001|FG001|COMPLETED|Overall Study||25||
48311130|NCT04612036|101088002|FG002|COMPLETED|Overall Study||10||
48311131|NCT04612036|101088000|FG000|NOT COMPLETED|Overall Study||0||
48311132|NCT04612036|101088001|FG001|NOT COMPLETED|Overall Study||0||
48311133|NCT04612036|101088002|FG002|NOT COMPLETED|Overall Study||0||
48311134|NCT02114268|101088003|FG000|STARTED|Overall Study||34||
48311135|NCT02114268|101088004|FG001|STARTED|Overall Study||6||
48311136|NCT02114268|101088005|FG002|STARTED|Overall Study||6||
48311137|NCT02114268|101088006|FG003|STARTED|Overall Study||6||
48311138|NCT02114268|101088007|FG004|STARTED|Overall Study||6||
48311139|NCT02114268|101088008|FG005|STARTED|Overall Study||78||
48311140|NCT02114268|101088003|FG000|COMPLETED|Overall Study||28||
48311141|NCT02114268|101088004|FG001|COMPLETED|Overall Study||5||
48311142|NCT02114268|101088005|FG002|COMPLETED|Overall Study||5||
48311143|NCT02114268|101088006|FG003|COMPLETED|Overall Study||6||
48311144|NCT02114268|101088007|FG004|COMPLETED|Overall Study||6||
48311145|NCT02114268|101088008|FG005|COMPLETED|Overall Study||75||
48311146|NCT02114268|101088003|FG000|NOT COMPLETED|Overall Study||6||
48311147|NCT02114268|101088004|FG001|NOT COMPLETED|Overall Study||1||
48311148|NCT02114268|101088005|FG002|NOT COMPLETED|Overall Study||1||
48311149|NCT02114268|101088006|FG003|NOT COMPLETED|Overall Study||0||
48311150|NCT02114268|101088007|FG004|NOT COMPLETED|Overall Study||0||
48311151|NCT02114268|101088008|FG005|NOT COMPLETED|Overall Study||3||
48311152|NCT01873417|101088009|FG000|STARTED|Overall Study||237||
48311153|NCT01873417|101088009|FG000|Safety Population|Overall Study||233||
48311154|NCT01873417|101088009|FG000|COMPLETED|Overall Study||202||
48311155|NCT01873417|101088009|FG000|NOT COMPLETED|Overall Study||35||
48311156|NCT02221349|101088010|FG000|STARTED|Overall Study||15||
48311157|NCT02221349|101088011|FG001|STARTED|Overall Study||15||
48311158|NCT02221349|101088010|FG000|COMPLETED|Overall Study||14||
48311159|NCT02221349|101088011|FG001|COMPLETED|Overall Study||15||
48311160|NCT02221349|101088010|FG000|NOT COMPLETED|Overall Study||1||
48311161|NCT02221349|101088011|FG001|NOT COMPLETED|Overall Study||0||
48311162|NCT00729378|101088012|FG000|STARTED|Baseline||430||
48311163|NCT00729378|101088013|FG001|STARTED|Baseline||309||
48311164|NCT00729378|101088012|FG000|COMPLETED|Baseline||292||
48311165|NCT00729378|101088013|FG001|COMPLETED|Baseline||217||
48311166|NCT00729378|101088012|FG000|NOT COMPLETED|Baseline||138||
48311167|NCT00729378|101088013|FG001|NOT COMPLETED|Baseline||92||
48311168|NCT00729378|101088012|FG000|STARTED|12-months||292||
48311169|NCT00729378|101088013|FG001|STARTED|12-months||217||
48311170|NCT00729378|101088012|FG000|COMPLETED|12-months||192||
48311171|NCT00729378|101088013|FG001|COMPLETED|12-months||152||
48311172|NCT00729378|101088012|FG000|NOT COMPLETED|12-months||100||
48311173|NCT00729378|101088013|FG001|NOT COMPLETED|12-months||65||
48311174|NCT00729378|101088012|FG000|STARTED|24-months||192||
48311175|NCT00729378|101088013|FG001|STARTED|24-months||152||
48311176|NCT00729378|101088012|FG000|COMPLETED|24-months||120||
48311177|NCT00729378|101088013|FG001|COMPLETED|24-months||101||
48311178|NCT00729378|101088012|FG000|NOT COMPLETED|24-months||72||
48311179|NCT00729378|101088013|FG001|NOT COMPLETED|24-months||51||
48311180|NCT00729378|101088012|FG000|STARTED|36-months||120||
48311181|NCT00729378|101088013|FG001|STARTED|36-months||101||
48311182|NCT00729378|101088012|FG000|COMPLETED|36-months||105||
48311183|NCT00729378|101088013|FG001|COMPLETED|36-months||95||
48311184|NCT00729378|101088012|FG000|NOT COMPLETED|36-months||15||
48406663|NCT03051217|101328465|FG000|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3||
48311185|NCT00729378|101088013|FG001|NOT COMPLETED|36-months||6||
48311186|NCT01033552|101088014|FG000|STARTED|Overall Study||7||
48311187|NCT01033552|101088015|FG001|STARTED|Overall Study||16||
48311188|NCT01033552|101088016|FG002|STARTED|Overall Study||2||
48311189|NCT01033552|101088017|FG003|STARTED|Overall Study||7||
48311190|NCT01033552|101088014|FG000|COMPLETED|Overall Study||7||
48311191|NCT01033552|101088015|FG001|COMPLETED|Overall Study||16||
48311192|NCT01033552|101088016|FG002|COMPLETED|Overall Study||2||
48311193|NCT01033552|101088017|FG003|COMPLETED|Overall Study||7||
48311194|NCT01033552|101088014|FG000|NOT COMPLETED|Overall Study||0||
48311195|NCT01033552|101088015|FG001|NOT COMPLETED|Overall Study||0||
48311196|NCT01033552|101088016|FG002|NOT COMPLETED|Overall Study||0||
48311197|NCT01033552|101088017|FG003|NOT COMPLETED|Overall Study||0||
48311198|NCT00585611|101088018|FG000|STARTED|Overall Study||0||
48311199|NCT00585611|101088019|FG001|STARTED|Overall Study||0||
48156298|NCT02287584|100703323|FG005|STARTED|the Open-label Phase||161|Subjects completed the double-blind treatment phase|
48311200|NCT00585611|101088018|FG000|COMPLETED|Overall Study||0||
48311201|NCT00585611|101088019|FG001|COMPLETED|Overall Study||0||
48311202|NCT00585611|101088018|FG000|NOT COMPLETED|Overall Study||0||
48311203|NCT00585611|101088019|FG001|NOT COMPLETED|Overall Study||0||
48311204|NCT02650999|101088020|FG000|STARTED|Overall Study||12||
48156299|NCT02287584|100703318|FG000|Treated|the Open-label Phase||0|Subjects treated in the open-label treatment phase|
48156300|NCT02287584|100703319|FG001|Treated|the Open-label Phase||0|Subjects treated in the open-label treatment phase|
48156301|NCT02287584|100703320|FG002|Treated|the Open-label Phase||0|Subjects treated in the open-label treatment phase|
48156302|NCT02287584|100703321|FG003|Treated|the Open-label Phase||131|Subjects treated in the open-label treatment phase|
48156303|NCT02287584|100703322|FG004|Treated|the Open-label Phase||143|Subjects treated in the open-label treatment phase|
48156304|NCT02287584|100703323|FG005|Treated|the Open-label Phase||157|Subjects treated in the open-label treatment phase|
48156305|NCT02287584|100703318|FG000|COMPLETED|the Open-label Phase||0||
48156306|NCT02287584|100703319|FG001|COMPLETED|the Open-label Phase||0||
48156307|NCT02287584|100703320|FG002|COMPLETED|the Open-label Phase||0||
48156308|NCT02287584|100703321|FG003|COMPLETED|the Open-label Phase||81||
48727492|NCT03647267|102118587|FG000|NOT COMPLETED|Overall Study||1||1
48727493|NCT03647267|102118588|FG001|NOT COMPLETED|Overall Study||0||0
48727494|NCT01019369|102118589|FG000|STARTED|Overall Study||86||
48727495|NCT01019369|102118590|FG001|STARTED|Overall Study||46||
48727496|NCT01019369|102118589|FG000|COMPLETED|Overall Study||76||
48727497|NCT01019369|102118590|FG001|COMPLETED|Overall Study||39||
48727498|NCT01019369|102118589|FG000|NOT COMPLETED|Overall Study||10||
48727499|NCT01019369|102118590|FG001|NOT COMPLETED|Overall Study||7||
48727500|NCT03098745|102118591|FG000|STARTED|Day 1||7||
48311205|NCT02650999|101088020|FG000|COMPLETED|Overall Study||12||
48311206|NCT02650999|101088020|FG000|NOT COMPLETED|Overall Study||0||
48311207|NCT02546765|101088021|FG000|STARTED|Overall Study||31||
48727501|NCT03098745|102118592|FG001|STARTED|Day 1||3||
48727502|NCT03098745|102118593|FG002|STARTED|Day 1||8||
48727503|NCT03098745|102118594|FG003|STARTED|Day 1||8||
48727504|NCT03098745|102118595|FG004|STARTED|Day 1||10||
48727505|NCT03098745|102118596|FG005|STARTED|Day 1||4||
48727506|NCT03098745|102118591|FG000|COMPLETED|Day 1||7||
48727507|NCT03098745|102118592|FG001|COMPLETED|Day 1||3||
48727508|NCT03098745|102118593|FG002|COMPLETED|Day 1||8||
48727509|NCT03098745|102118594|FG003|COMPLETED|Day 1||8||
48727510|NCT03098745|102118595|FG004|COMPLETED|Day 1||10||
48727511|NCT03098745|102118596|FG005|COMPLETED|Day 1||4||
48727512|NCT03098745|102118591|FG000|NOT COMPLETED|Day 1||0||
48156309|NCT02287584|100703322|FG004|COMPLETED|the Open-label Phase||87||
48311208|NCT02546765|101088022|FG001|STARTED|Overall Study||30||
48311209|NCT02546765|101088023|FG002|STARTED|Overall Study||30||
48311210|NCT02546765|101088024|FG003|STARTED|Overall Study||30||
48311211|NCT02546765|101088021|FG000|COMPLETED|Overall Study||31||
48311212|NCT02546765|101088022|FG001|COMPLETED|Overall Study||29||
48311213|NCT02546765|101088023|FG002|COMPLETED|Overall Study||30||
48311214|NCT02546765|101088024|FG003|COMPLETED|Overall Study||30||
48311215|NCT02546765|101088021|FG000|NOT COMPLETED|Overall Study||0||
48311216|NCT02546765|101088022|FG001|NOT COMPLETED|Overall Study||1||
48311217|NCT02546765|101088023|FG002|NOT COMPLETED|Overall Study||0||
48311218|NCT02546765|101088024|FG003|NOT COMPLETED|Overall Study||0||
48311219|NCT01984164|101088025|FG000|STARTED|Overall Study||87||
48311220|NCT01984164|101088026|FG001|STARTED|Overall Study||89||
48311221|NCT01984164|101088025|FG000|COMPLETED|Overall Study||77||
48311222|NCT01984164|101088026|FG001|COMPLETED|Overall Study||64||
48311223|NCT01984164|101088025|FG000|NOT COMPLETED|Overall Study||10||
48311224|NCT01984164|101088026|FG001|NOT COMPLETED|Overall Study||25||
48311225|NCT01368536|101088027|FG000|STARTED|Overall Study||138||
48727513|NCT03098745|102118592|FG001|NOT COMPLETED|Day 1||0||
48727514|NCT03098745|102118593|FG002|NOT COMPLETED|Day 1||0||
48727515|NCT03098745|102118594|FG003|NOT COMPLETED|Day 1||0||
48727516|NCT03098745|102118595|FG004|NOT COMPLETED|Day 1||0||
48727517|NCT03098745|102118596|FG005|NOT COMPLETED|Day 1||0||
48156310|NCT02287584|100703323|FG005|COMPLETED|the Open-label Phase||104||
48156311|NCT02287584|100703318|FG000|NOT COMPLETED|the Open-label Phase||0||
48156312|NCT02287584|100703319|FG001|NOT COMPLETED|the Open-label Phase||0||
48311226|NCT01368536|101088028|FG001|STARTED|Overall Study||137||
48311227|NCT01368536|101088029|FG002|STARTED|Overall Study||142||
48311228|NCT01368536|101088027|FG000|Full Analysis Set|Overall Study||138||
48311229|NCT01368536|101088028|FG001|Full Analysis Set|Overall Study||137||
48727518|NCT03098745|102118591|FG000|STARTED|Day 2||7||
48727519|NCT03098745|102118592|FG001|STARTED|Day 2||3||
48727520|NCT03098745|102118593|FG002|STARTED|Day 2||8||
48311230|NCT01368536|101088029|FG002|Full Analysis Set|Overall Study||141||
48727521|NCT03098745|102118594|FG003|STARTED|Day 2||8||
48727522|NCT03098745|102118595|FG004|STARTED|Day 2||10||
48727523|NCT03098745|102118596|FG005|STARTED|Day 2||4||
48727524|NCT03098745|102118591|FG000|COMPLETED|Day 2||7||
48727525|NCT03098745|102118592|FG001|COMPLETED|Day 2||3||
48727526|NCT03098745|102118593|FG002|COMPLETED|Day 2||8||
48727527|NCT03098745|102118594|FG003|COMPLETED|Day 2||8||
48727528|NCT03098745|102118595|FG004|COMPLETED|Day 2||10||
48727529|NCT03098745|102118596|FG005|COMPLETED|Day 2||4||
48156313|NCT02287584|100703320|FG002|NOT COMPLETED|the Open-label Phase||0||
48156314|NCT02287584|100703321|FG003|NOT COMPLETED|the Open-label Phase||57||
48156315|NCT02287584|100703322|FG004|NOT COMPLETED|the Open-label Phase||62||
48156316|NCT02287584|100703323|FG005|NOT COMPLETED|the Open-label Phase||57||
48156317|NCT01742364|100703324|FG000|STARTED|Overall Study||33||
48156318|NCT01742364|100703325|FG001|STARTED|Overall Study||33||
48311231|NCT01368536|101088027|FG000|COMPLETED|Overall Study||87||
48311232|NCT01368536|101088028|FG001|COMPLETED|Overall Study||78||
48311233|NCT01368536|101088029|FG002|COMPLETED|Overall Study||83||
48311234|NCT01368536|101088027|FG000|NOT COMPLETED|Overall Study||51||
48613153|NCT02757352|101838440|FG009|STARTED|Follow-Up Period||5||
48613154|NCT02757352|101838431|FG000|COMPLETED|Follow-Up Period||0||
48613155|NCT02757352|101838432|FG001|COMPLETED|Follow-Up Period||0||
48613156|NCT02757352|101838433|FG002|COMPLETED|Follow-Up Period||0||
48613157|NCT02757352|101838434|FG003|COMPLETED|Follow-Up Period||0||
48613158|NCT02757352|101838435|FG004|COMPLETED|Follow-Up Period||0||
48613159|NCT02757352|101838436|FG005|COMPLETED|Follow-Up Period||0||
48613160|NCT02757352|101838437|FG006|COMPLETED|Follow-Up Period||2||
48613161|NCT02757352|101838438|FG007|COMPLETED|Follow-Up Period||4||
48613162|NCT02757352|101838439|FG008|COMPLETED|Follow-Up Period||18||
48613163|NCT02757352|101838440|FG009|COMPLETED|Follow-Up Period||2||
48613164|NCT02757352|101838431|FG000|NOT COMPLETED|Follow-Up Period||0||
48613165|NCT02757352|101838432|FG001|NOT COMPLETED|Follow-Up Period||0||
48613166|NCT02757352|101838433|FG002|NOT COMPLETED|Follow-Up Period||0||
48613167|NCT02757352|101838434|FG003|NOT COMPLETED|Follow-Up Period||0||
48613168|NCT02757352|101838435|FG004|NOT COMPLETED|Follow-Up Period||0||
48613169|NCT02757352|101838436|FG005|NOT COMPLETED|Follow-Up Period||0||
48613170|NCT02757352|101838437|FG006|NOT COMPLETED|Follow-Up Period||1||
48613171|NCT02757352|101838438|FG007|NOT COMPLETED|Follow-Up Period||1||
48613172|NCT02757352|101838439|FG008|NOT COMPLETED|Follow-Up Period||10||
48613173|NCT02757352|101838440|FG009|NOT COMPLETED|Follow-Up Period||3||
48613174|NCT05279131|101838441|FG000|STARTED|Overall Study||105||
48613175|NCT05279131|101838441|FG000|COMPLETED|Overall Study||102||
48613176|NCT05279131|101838441|FG000|NOT COMPLETED|Overall Study||3||
48613177|NCT01435759|101838442|FG000|STARTED|Antidepressant Lead-in Phase||1197||
48613178|NCT01435759|101838443|FG001|STARTED|Antidepressant Lead-in Phase||0||
48613179|NCT01435759|101838444|FG002|STARTED|Antidepressant Lead-in Phase||0||
48613180|NCT01435759|101838445|FG003|STARTED|Antidepressant Lead-in Phase||0||
48613181|NCT01435759|101838446|FG004|STARTED|Antidepressant Lead-in Phase||0||
48613182|NCT01435759|101838447|FG005|STARTED|Antidepressant Lead-in Phase||0||
48613183|NCT01435759|101838442|FG000|COMPLETED|Antidepressant Lead-in Phase||855||
48613184|NCT01435759|101838443|FG001|COMPLETED|Antidepressant Lead-in Phase||0||
48613185|NCT01435759|101838444|FG002|COMPLETED|Antidepressant Lead-in Phase||0||
48613186|NCT01435759|101838445|FG003|COMPLETED|Antidepressant Lead-in Phase||0||
48613187|NCT01435759|101838446|FG004|COMPLETED|Antidepressant Lead-in Phase||0||
48613188|NCT01435759|101838447|FG005|COMPLETED|Antidepressant Lead-in Phase||0||
48613189|NCT01435759|101838442|FG000|NOT COMPLETED|Antidepressant Lead-in Phase||342||
48613190|NCT01435759|101838443|FG001|NOT COMPLETED|Antidepressant Lead-in Phase||0||
48613191|NCT01435759|101838444|FG002|NOT COMPLETED|Antidepressant Lead-in Phase||0||
48156319|NCT01742364|100703326|FG002|STARTED|Overall Study||15||
48156320|NCT01742364|100703327|FG003|STARTED|Overall Study||15||
48156321|NCT01742364|100703324|FG000|COMPLETED|Overall Study||33||
48156322|NCT01742364|100703325|FG001|COMPLETED|Overall Study||33||
48156323|NCT01742364|100703326|FG002|COMPLETED|Overall Study||15||
48156324|NCT01742364|100703327|FG003|COMPLETED|Overall Study||15||
48156325|NCT01742364|100703324|FG000|NOT COMPLETED|Overall Study||0||
48156326|NCT01742364|100703325|FG001|NOT COMPLETED|Overall Study||0||
48311235|NCT01368536|101088028|FG001|NOT COMPLETED|Overall Study||59||
48311236|NCT01368536|101088029|FG002|NOT COMPLETED|Overall Study||59||
48311237|NCT01088464|101088030|FG000|STARTED|Overall Study||3||
48311238|NCT01088464|101088031|FG001|STARTED|Overall Study||6||
48311239|NCT01088464|101088032|FG002|STARTED|Overall Study||6||
48311240|NCT01088464|101088030|FG000|Received Any Quantity of Study Drug|Overall Study||3||
48311241|NCT01088464|101088031|FG001|Received Any Quantity of Study Drug|Overall Study||6||
48311242|NCT01088464|101088032|FG002|Received Any Quantity of Study Drug|Overall Study||6||
48613192|NCT01435759|101838445|FG003|NOT COMPLETED|Antidepressant Lead-in Phase||0||
48613193|NCT01435759|101838446|FG004|NOT COMPLETED|Antidepressant Lead-in Phase||0||
48613194|NCT01435759|101838447|FG005|NOT COMPLETED|Antidepressant Lead-in Phase||0||
48613195|NCT01435759|101838442|FG000|STARTED|Double-blind Phase||463||
48613196|NCT01435759|101838443|FG001|STARTED|Double-blind Phase||78||
48613197|NCT01435759|101838444|FG002|STARTED|Double-blind Phase||78||
48613198|NCT01435759|101838445|FG003|STARTED|Double-blind Phase||78||
48156327|NCT01742364|100703326|FG002|NOT COMPLETED|Overall Study||0||
48613199|NCT01435759|101838446|FG004|STARTED|Double-blind Phase||78||
48613200|NCT01435759|101838447|FG005|STARTED|Double-blind Phase||80||
48613201|NCT01435759|101838442|FG000|COMPLETED|Double-blind Phase||397||
48613202|NCT01435759|101838443|FG001|COMPLETED|Double-blind Phase||71||
48613203|NCT01435759|101838444|FG002|COMPLETED|Double-blind Phase||71||
48613204|NCT01435759|101838445|FG003|COMPLETED|Double-blind Phase||69||
48613205|NCT01435759|101838446|FG004|COMPLETED|Double-blind Phase||69||
48156328|NCT01742364|100703327|FG003|NOT COMPLETED|Overall Study||0||
48156329|NCT03581084|100703328|FG000|STARTED|Overall Study||1||
48156330|NCT03581084|100703328|FG000|COMPLETED|Overall Study||1||
48156331|NCT03581084|100703328|FG000|NOT COMPLETED|Overall Study||0||
48156332|NCT04126408|100703329|FG000|STARTED|Overall Study||21||
48156333|NCT04126408|100703330|FG001|STARTED|Overall Study||19||
48156334|NCT04126408|100703329|FG000|COMPLETED|Overall Study||21||
48156335|NCT04126408|100703330|FG001|COMPLETED|Overall Study||19||
48156336|NCT04126408|100703329|FG000|NOT COMPLETED|Overall Study||0||
48156337|NCT04126408|100703330|FG001|NOT COMPLETED|Overall Study||0||
48156338|NCT04177680|100703331|FG000|STARTED|Overall Study||49||
48156339|NCT04177680|100703332|FG001|STARTED|Overall Study||51||
48156340|NCT04177680|100703331|FG000|COMPLETED|Overall Study||47||
48156341|NCT04177680|100703332|FG001|COMPLETED|Overall Study||48||
48156342|NCT04177680|100703331|FG000|NOT COMPLETED|Overall Study||2||
48156343|NCT04177680|100703332|FG001|NOT COMPLETED|Overall Study||3||
48156344|NCT00141739|100703333|FG000|STARTED|Overall Study||100||
48156345|NCT00141739|100703333|FG000|COMPLETED|Overall Study||100||
48156346|NCT00141739|100703333|FG000|NOT COMPLETED|Overall Study||0||
48156347|NCT04560166|100703334|FG000|STARTED|Overall Study||2||
48156348|NCT04560166|100703334|FG000|COMPLETED|Overall Study||2||
48156349|NCT04560166|100703334|FG000|NOT COMPLETED|Overall Study||0||
48156350|NCT01221948|100703335|FG000|STARTED|Overall Study||53||
48156351|NCT01221948|100703335|FG000|COMPLETED|Overall Study||39||
48156352|NCT01221948|100703335|FG000|NOT COMPLETED|Overall Study||14||
48156353|NCT01551199|100703336|FG000|STARTED|Overall Study||7||
48156354|NCT01551199|100703336|FG000|COMPLETED|Overall Study||2||
48156355|NCT01551199|100703336|FG000|NOT COMPLETED|Overall Study||5||
48156356|NCT03496662|100703337|FG000|STARTED|Overall Study||7||
48156357|NCT03496662|100703338|FG001|STARTED|Overall Study||8||
48156358|NCT03496662|100703339|FG002|STARTED|Overall Study||25||
48156359|NCT03496662|100703337|FG000|COMPLETED|Overall Study||5|Completion indicates the participant receiving 4 full cycles of treatment.|
48156360|NCT03496662|100703338|FG001|COMPLETED|Overall Study||8|Completion indicates the participant receiving 4 full cycles of treatment.|
48156361|NCT03496662|100703339|FG002|COMPLETED|Overall Study||16|Completion indicates the participant receiving 4 full cycles of treatment.|
48156362|NCT03496662|100703337|FG000|NOT COMPLETED|Overall Study||2||
48156363|NCT03496662|100703338|FG001|NOT COMPLETED|Overall Study||0||
48156364|NCT03496662|100703339|FG002|NOT COMPLETED|Overall Study||9||
48156365|NCT01938833|100703340|FG000|STARTED|Overall Study||9||
48156366|NCT01938833|100703340|FG000|COMPLETED|Overall Study||9||
48156367|NCT01938833|100703340|FG000|NOT COMPLETED|Overall Study||0||
48156368|NCT00089141|100703341|FG000|STARTED|Overall Study||74||
48156369|NCT00089141|100703342|FG001|STARTED|Overall Study||77||
48156370|NCT00089141|100703341|FG000|COMPLETED|Overall Study||56||
48156371|NCT00089141|100703342|FG001|COMPLETED|Overall Study||53||
48156372|NCT00089141|100703341|FG000|NOT COMPLETED|Overall Study||18||
48156373|NCT00089141|100703342|FG001|NOT COMPLETED|Overall Study||24||
48156374|NCT05095272|100703343|FG000|STARTED|Overall Study||2||
48156375|NCT05095272|100703343|FG000|COMPLETED|Overall Study||2||
48156376|NCT05095272|100703343|FG000|NOT COMPLETED|Overall Study||0||
48156377|NCT00490256|100703344|FG000|STARTED|Overall Study||7||
48613206|NCT01435759|101838447|FG005|COMPLETED|Double-blind Phase||71||
48613207|NCT01435759|101838442|FG000|NOT COMPLETED|Double-blind Phase||66||
48613208|NCT01435759|101838443|FG001|NOT COMPLETED|Double-blind Phase||7||
48613209|NCT01435759|101838444|FG002|NOT COMPLETED|Double-blind Phase||7||
48613210|NCT01435759|101838445|FG003|NOT COMPLETED|Double-blind Phase||9||
48613211|NCT01435759|101838446|FG004|NOT COMPLETED|Double-blind Phase||9||
48613212|NCT01435759|101838447|FG005|NOT COMPLETED|Double-blind Phase||9||
48613213|NCT02658669|101838448|FG000|STARTED|Overall Study||27||
48156378|NCT00490256|100703345|FG001|STARTED|Overall Study||7||
48156379|NCT00490256|100703344|FG000|Intraoperative Portion of the Study|Overall Study||7||
48156380|NCT00490256|100703345|FG001|Intraoperative Portion of the Study|Overall Study||7||
48156381|NCT00490256|100703344|FG000|COMPLETED|Overall Study||7||
48156382|NCT00490256|100703345|FG001|COMPLETED|Overall Study||7||
48156383|NCT00490256|100703344|FG000|NOT COMPLETED|Overall Study||0||
48156384|NCT00490256|100703345|FG001|NOT COMPLETED|Overall Study||0||
48156385|NCT01060553|100703346|FG000|STARTED|Overall Study||15||
48156386|NCT01060553|100703347|FG001|STARTED|Overall Study||15||
48156387|NCT01060553|100703346|FG000|COMPLETED|Overall Study||6||
48156388|NCT01060553|100703347|FG001|COMPLETED|Overall Study||5||
48156389|NCT01060553|100703346|FG000|NOT COMPLETED|Overall Study||9||
48156390|NCT01060553|100703347|FG001|NOT COMPLETED|Overall Study||10||
48156391|NCT03619590|100703348|FG000|STARTED|Overall Study||103||
48156392|NCT03619590|100703348|FG000|COMPLETED|Overall Study||103||
48156393|NCT03619590|100703348|FG000|NOT COMPLETED|Overall Study||0||
48156394|NCT01412801|100703349|FG000|STARTED|Overall Study||91||
48156395|NCT01412801|100703350|FG001|STARTED|Overall Study||89||
48156396|NCT01412801|100703351|FG002|STARTED|Overall Study||90||
48613214|NCT02658669|101838449|FG001|STARTED|Overall Study||28||
48613215|NCT02658669|101838448|FG000|COMPLETED|Overall Study||20||
48613216|NCT02658669|101838449|FG001|COMPLETED|Overall Study||23||
48613217|NCT02658669|101838448|FG000|NOT COMPLETED|Overall Study||7||
48613218|NCT02658669|101838449|FG001|NOT COMPLETED|Overall Study||5||
48156397|NCT01412801|100703352|FG003|STARTED|Overall Study||91||
48156398|NCT01412801|100703353|FG004|STARTED|Overall Study||88||
48156399|NCT01412801|100703354|FG005|STARTED|Overall Study||87||
48156400|NCT01412801|100703349|FG000|COMPLETED|Overall Study||87||
48156401|NCT01412801|100703350|FG001|COMPLETED|Overall Study||84||
48156402|NCT01412801|100703351|FG002|COMPLETED|Overall Study||83||
48156403|NCT01412801|100703352|FG003|COMPLETED|Overall Study||87||
48156404|NCT01412801|100703353|FG004|COMPLETED|Overall Study||85||
48156405|NCT01412801|100703354|FG005|COMPLETED|Overall Study||84||
48156406|NCT01412801|100703349|FG000|NOT COMPLETED|Overall Study||4||
48156407|NCT01412801|100703350|FG001|NOT COMPLETED|Overall Study||5||
48156408|NCT01412801|100703351|FG002|NOT COMPLETED|Overall Study||7||
48156409|NCT01412801|100703352|FG003|NOT COMPLETED|Overall Study||4||
48156410|NCT01412801|100703353|FG004|NOT COMPLETED|Overall Study||3||
48156411|NCT01412801|100703354|FG005|NOT COMPLETED|Overall Study||3||
48156412|NCT04044456|100703355|FG000|STARTED|Overall Study||18||
48156413|NCT04044456|100703356|FG001|STARTED|Overall Study||2||
48156414|NCT04044456|100703355|FG000|COMPLETED|Overall Study||13||
48156415|NCT04044456|100703356|FG001|COMPLETED|Overall Study||1||
48156416|NCT04044456|100703355|FG000|NOT COMPLETED|Overall Study||5||
48156417|NCT04044456|100703356|FG001|NOT COMPLETED|Overall Study||1||
48156418|NCT00834106|100703357|FG000|STARTED|Base Study (Day 1 to Month 30)||1503||
48156419|NCT00834106|100703358|FG001|STARTED|Base Study (Day 1 to Month 30)||1503||
48156420|NCT00834106|100703357|FG000|Vaccinated|Base Study (Day 1 to Month 30)||1503||
48156421|NCT00834106|100703358|FG001|Vaccinated|Base Study (Day 1 to Month 30)||1503||
48156422|NCT00834106|100703357|FG000|Completed Vaccinations|Base Study (Day 1 to Month 30)||1473||
48156423|NCT00834106|100703358|FG001|Completed Vaccinations|Base Study (Day 1 to Month 30)||1463||
48156424|NCT00834106|100703357|FG000|COMPLETED|Base Study (Day 1 to Month 30)||1401||
48156425|NCT00834106|100703358|FG001|COMPLETED|Base Study (Day 1 to Month 30)||1358||
48156426|NCT00834106|100703357|FG000|NOT COMPLETED|Base Study (Day 1 to Month 30)||102||
48156427|NCT00834106|100703358|FG001|NOT COMPLETED|Base Study (Day 1 to Month 30)||145||
48156428|NCT00834106|100703357|FG000|STARTED|Extension Study (Month 42 to Month 90)||1404||
48156429|NCT00834106|100703358|FG001|STARTED|Extension Study (Month 42 to Month 90)||1368||
48156430|NCT00834106|100703357|FG000|COMPLETED|Extension Study (Month 42 to Month 90)||1308||
48156431|NCT00834106|100703358|FG001|COMPLETED|Extension Study (Month 42 to Month 90)||1294||
48156432|NCT00834106|100703357|FG000|NOT COMPLETED|Extension Study (Month 42 to Month 90)||96||
48613219|NCT01965002|101838450|FG000|STARTED|Overall Study||5||
48156433|NCT00834106|100703358|FG001|NOT COMPLETED|Extension Study (Month 42 to Month 90)||74||
48156434|NCT02230956|100703359|FG000|STARTED|Overall Study||44||
48156435|NCT02230956|100703360|FG001|STARTED|Overall Study||43||
48156436|NCT02230956|100703361|FG002|STARTED|Overall Study||89||
48156437|NCT02230956|100703359|FG000|COMPLETED|Overall Study||39||
48156438|NCT02230956|100703360|FG001|COMPLETED|Overall Study||37||
48156439|NCT02230956|100703361|FG002|COMPLETED|Overall Study||82||
48156440|NCT02230956|100703359|FG000|NOT COMPLETED|Overall Study||5||
48156441|NCT02230956|100703360|FG001|NOT COMPLETED|Overall Study||6||
48156442|NCT02230956|100703361|FG002|NOT COMPLETED|Overall Study||7||
48613220|NCT01965002|101838450|FG000|COMPLETED|Overall Study||5||
48613221|NCT01965002|101838450|FG000|NOT COMPLETED|Overall Study||0||
48613222|NCT03108066|101838451|FG000|STARTED|Overall Study||4||
48613223|NCT03108066|101838451|FG000|COMPLETED|Overall Study||4||
48613224|NCT03108066|101838451|FG000|NOT COMPLETED|Overall Study||0||
48613225|NCT02861664|101838452|FG000|STARTED|Overall Study||67||
48613226|NCT02861664|101838453|FG001|STARTED|Overall Study||68||
48613227|NCT02861664|101838452|FG000|COMPLETED|Overall Study||67||
48613228|NCT02861664|101838453|FG001|COMPLETED|Overall Study||67||
48156443|NCT03266770|100703362|FG000|STARTED|Overall Study||24||
48156444|NCT03266770|100703362|FG000|COMPLETED|Overall Study||19||
48156445|NCT03266770|100703362|FG000|NOT COMPLETED|Overall Study||5||
48156446|NCT01127646|100703363|FG000|STARTED|Overall Study||15||
48156447|NCT01127646|100703364|FG001|STARTED|Overall Study||8||
48156448|NCT01127646|100703363|FG000|COMPLETED|Overall Study||14||
48156449|NCT01127646|100703364|FG001|COMPLETED|Overall Study||7||
48156450|NCT01127646|100703363|FG000|NOT COMPLETED|Overall Study||1||
48156451|NCT01127646|100703364|FG001|NOT COMPLETED|Overall Study||1||
48156452|NCT02255032|100703365|FG000|STARTED|Overall Study||17||
48156453|NCT02255032|100703366|FG001|STARTED|Overall Study||5||
48156454|NCT02255032|100703365|FG000|COMPLETED|Overall Study||17||
48156455|NCT02255032|100703366|FG001|COMPLETED|Overall Study||5||
48156456|NCT02255032|100703365|FG000|NOT COMPLETED|Overall Study||0||
48156457|NCT02255032|100703366|FG001|NOT COMPLETED|Overall Study||0||
48156458|NCT02274857|100703367|FG000|STARTED|Overall Study||179||
48613229|NCT02861664|101838452|FG000|NOT COMPLETED|Overall Study||0||
48156459|NCT02274857|100703368|FG001|STARTED|Overall Study||171||
48156460|NCT02274857|100703367|FG000|Completed Per Protocol|Overall Study||102|Per protocol are subjects in ITT group who completed all follow-ups with no major deviations.|
48156461|NCT02274857|100703368|FG001|Completed Per Protocol|Overall Study||114|Per protocol are subjects in ITT group who completed all follow-ups with no major deviations.|
48156462|NCT02274857|100703367|FG000|COMPLETED|Overall Study||159||
48156463|NCT02274857|100703368|FG001|COMPLETED|Overall Study||165||
48613230|NCT02861664|101838453|FG001|NOT COMPLETED|Overall Study||1||
48613231|NCT00497146|101838454|FG000|STARTED|Treatment Period||115||
48156464|NCT02274857|100703367|FG000|NOT COMPLETED|Overall Study||20||
48156465|NCT02274857|100703368|FG001|NOT COMPLETED|Overall Study||6||
48156466|NCT02583425|100703369|FG000|STARTED|Screening||27||
48156467|NCT02583425|100703369|FG000|COMPLETED|Screening||15||
48156468|NCT02583425|100703369|FG000|NOT COMPLETED|Screening||12||
48156469|NCT02583425|100703369|FG000|STARTED|Baseline||15||
48156470|NCT02583425|100703369|FG000|COMPLETED|Baseline||10||
48156471|NCT02583425|100703369|FG000|NOT COMPLETED|Baseline||5||
48406664|NCT03051217|101328466|FG001|NOT COMPLETED|Initial Period (Week 0 to Week 16)||2||
48406665|NCT03051217|101328467|FG002|NOT COMPLETED|Initial Period (Week 0 to Week 16)||2||
48613232|NCT00497146|101838455|FG001|STARTED|Treatment Period||112||
48156472|NCT02583425|100703369|FG000|STARTED|Treatment Period||10||
48156473|NCT02583425|100703369|FG000|COMPLETED|Treatment Period||9||
48613233|NCT00497146|101838454|FG000|COMPLETED|Treatment Period||88||
48613234|NCT00497146|101838455|FG001|COMPLETED|Treatment Period||91||
48613235|NCT00497146|101838454|FG000|NOT COMPLETED|Treatment Period||27||
48156474|NCT02583425|100703369|FG000|NOT COMPLETED|Treatment Period||1||
48156475|NCT00552084|100703370|FG000|STARTED|Overall Study||126||
48156476|NCT00552084|100703371|FG001|STARTED|Overall Study||64||
48156477|NCT00552084|100703370|FG000|COMPLETED|Overall Study||118||
48156478|NCT00552084|100703371|FG001|COMPLETED|Overall Study||55||
48156479|NCT00552084|100703370|FG000|NOT COMPLETED|Overall Study||8||
48156480|NCT00552084|100703371|FG001|NOT COMPLETED|Overall Study||9||
48156481|NCT03138096|100703372|FG000|STARTED|Overall Study||3||
48156482|NCT03138096|100703373|FG001|STARTED|Overall Study||3||
48156483|NCT03138096|100703374|FG002|STARTED|Overall Study||12||
48156484|NCT03138096|100703375|FG003|STARTED|Overall Study||6||
48156485|NCT03138096|100703376|FG004|STARTED|Overall Study||0||
48156486|NCT03138096|100703372|FG000|COMPLETED|Overall Study||3||
48156487|NCT03138096|100703373|FG001|COMPLETED|Overall Study||3||
48156488|NCT03138096|100703374|FG002|COMPLETED|Overall Study||12||
48156489|NCT03138096|100703375|FG003|COMPLETED|Overall Study||6||
48156490|NCT03138096|100703376|FG004|COMPLETED|Overall Study||0||
48156491|NCT03138096|100703372|FG000|NOT COMPLETED|Overall Study||0||
48156492|NCT03138096|100703373|FG001|NOT COMPLETED|Overall Study||0||
48156493|NCT03138096|100703374|FG002|NOT COMPLETED|Overall Study||0||
48156494|NCT03138096|100703375|FG003|NOT COMPLETED|Overall Study||0||
48156495|NCT03138096|100703376|FG004|NOT COMPLETED|Overall Study||0||
48156496|NCT00031486|100706737|FG000|STARTED|Overall Study||40||
48156497|NCT00031486|100706738|FG001|STARTED|Overall Study||47||
48156498|NCT00031486|100706737|FG000|COMPLETED|Overall Study||33||
48156499|NCT00031486|100706738|FG001|COMPLETED|Overall Study||35||
48156500|NCT00031486|100706737|FG000|NOT COMPLETED|Overall Study||7||
48156501|NCT00031486|100706738|FG001|NOT COMPLETED|Overall Study||12||
48156502|NCT00850889|100706739|FG000|STARTED|Overall Study||32||
48156503|NCT00850889|100706739|FG000|COMPLETED|Overall Study||32||
48156504|NCT00850889|100706739|FG000|NOT COMPLETED|Overall Study||0||
48156505|NCT00733499|100706740|FG000|STARTED|Pre-operative||102||
48156506|NCT00733499|100706741|FG001|STARTED|Pre-operative||103||
48156507|NCT00733499|100706740|FG000|COMPLETED|Pre-operative||102||
48156508|NCT00733499|100706741|FG001|COMPLETED|Pre-operative||102||
48156509|NCT00733499|100706740|FG000|NOT COMPLETED|Pre-operative||0||
48156510|NCT00733499|100706741|FG001|NOT COMPLETED|Pre-operative||1||
48156511|NCT00733499|100706740|FG000|STARTED|3 Months Follow-up||102||
48156512|NCT00733499|100706741|FG001|STARTED|3 Months Follow-up||102||
48156513|NCT00733499|100706740|FG000|COMPLETED|3 Months Follow-up||101||
48156514|NCT00733499|100706741|FG001|COMPLETED|3 Months Follow-up||100||
48156515|NCT00733499|100706740|FG000|NOT COMPLETED|3 Months Follow-up||1||
48156516|NCT00733499|100706741|FG001|NOT COMPLETED|3 Months Follow-up||2||
48156517|NCT00733499|100706740|FG000|STARTED|6 Months Follow-up||101||
48156518|NCT00733499|100706741|FG001|STARTED|6 Months Follow-up||100||
48156519|NCT00733499|100706740|FG000|COMPLETED|6 Months Follow-up||101||
48156520|NCT00733499|100706741|FG001|COMPLETED|6 Months Follow-up||97||
48156521|NCT00733499|100706740|FG000|NOT COMPLETED|6 Months Follow-up||0||
48156522|NCT00733499|100706741|FG001|NOT COMPLETED|6 Months Follow-up||3||
48156523|NCT00733499|100706740|FG000|STARTED|12 Months Follow-up||101||
48156524|NCT00733499|100706741|FG001|STARTED|12 Months Follow-up||97||
48156525|NCT00733499|100706740|FG000|COMPLETED|12 Months Follow-up||99||
48156526|NCT00733499|100706741|FG001|COMPLETED|12 Months Follow-up||96||
48156527|NCT00733499|100706740|FG000|NOT COMPLETED|12 Months Follow-up||2||
48406666|NCT03051217|101328468|FG003|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
48406667|NCT03051217|101328469|FG004|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
48156528|NCT00733499|100706741|FG001|NOT COMPLETED|12 Months Follow-up||1||
48440016|NCT04259905|101410012|FG001|STARTED|Overall Study||10||
48156529|NCT00733499|100706740|FG000|STARTED|24 Months Follow-up||99||
48156530|NCT00733499|100706741|FG001|STARTED|24 Months Follow-up||96||
48156531|NCT00733499|100706740|FG000|COMPLETED|24 Months Follow-up||99||
48156532|NCT00733499|100706741|FG001|COMPLETED|24 Months Follow-up||95||
48156533|NCT00733499|100706740|FG000|NOT COMPLETED|24 Months Follow-up||0||
48156534|NCT00733499|100706741|FG001|NOT COMPLETED|24 Months Follow-up||1||
48156535|NCT00733499|100706740|FG000|STARTED|5 Year Followup||91||
48156536|NCT00733499|100706741|FG001|STARTED|5 Year Followup||78||
48156537|NCT00733499|100706740|FG000|COMPLETED|5 Year Followup||70||
48613236|NCT00497146|101838455|FG001|NOT COMPLETED|Treatment Period||21||
48406668|NCT03051217|101328470|FG005|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
48406669|NCT03051217|101328471|FG006|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
48156538|NCT00733499|100706741|FG001|COMPLETED|5 Year Followup||53||
48156539|NCT00733499|100706740|FG000|NOT COMPLETED|5 Year Followup||21||
48156540|NCT00733499|100706741|FG001|NOT COMPLETED|5 Year Followup||25||
48156541|NCT00733499|100706740|FG000|STARTED|10 Year Followup||46||
48156542|NCT00733499|100706741|FG001|STARTED|10 Year Followup||32||
48156543|NCT00733499|100706740|FG000|COMPLETED|10 Year Followup||26||
48156544|NCT00733499|100706741|FG001|COMPLETED|10 Year Followup||13||
48156545|NCT00733499|100706740|FG000|NOT COMPLETED|10 Year Followup||20||
48156546|NCT00733499|100706741|FG001|NOT COMPLETED|10 Year Followup||19||
48156547|NCT04251884|100706742|FG000|STARTED|Overall Study||23||
48156548|NCT04251884|100706743|FG001|STARTED|Overall Study||26||
48156549|NCT04251884|100706742|FG000|COMPLETED|Overall Study||23||
48156550|NCT04251884|100706743|FG001|COMPLETED|Overall Study||26||
48156551|NCT04251884|100706742|FG000|NOT COMPLETED|Overall Study||0||
48156552|NCT04251884|100706743|FG001|NOT COMPLETED|Overall Study||0||
48156553|NCT04280653|100706744|FG000|STARTED|Overall Study||15||
48156554|NCT04280653|100706744|FG000|COMPLETED|Overall Study||15||
48156555|NCT04280653|100706744|FG000|NOT COMPLETED|Overall Study||0||
48156556|NCT01065350|100706745|FG000|STARTED|Overall Study||43||
48156557|NCT01065350|100706746|FG001|STARTED|Overall Study||42||
48156558|NCT01065350|100706745|FG000|COMPLETED|Overall Study||43||
48156559|NCT01065350|100706746|FG001|COMPLETED|Overall Study||41||
48156560|NCT01065350|100706745|FG000|NOT COMPLETED|Overall Study||0||
48156561|NCT01065350|100706746|FG001|NOT COMPLETED|Overall Study||1||
48156562|NCT03125005|100706747|FG000|STARTED|Overall Study||51||
48156563|NCT03125005|100706747|FG000|COMPLETED|Overall Study||51||
48156564|NCT03125005|100706747|FG000|NOT COMPLETED|Overall Study||0||
48156565|NCT05745142|100706748|FG000|STARTED|Overall Study||376||
48156566|NCT05745142|100706748|FG000|COMPLETED|Overall Study||376||
48156567|NCT05745142|100706748|FG000|NOT COMPLETED|Overall Study||0||
48156568|NCT02856113|100706749|FG000|STARTED|Overall Study||77||
48156569|NCT02856113|100706750|FG001|STARTED|Overall Study||75||
48156570|NCT02856113|100706749|FG000|Safety Population|Overall Study||76|Safety Population included all participants who took at least 1 dose of study medication. One participant was randomized in error and did not receive any study medication.|
48156571|NCT02856113|100706750|FG001|Safety Population|Overall Study||75|Safety Population included all participants who took at least 1 dose of study medication. One participant was randomized in error and did not receive any study medication.|
48156572|NCT02856113|100706749|FG000|COMPLETED|Overall Study||66|Data is reported for participants who completed all study visits.|
48156573|NCT02856113|100706750|FG001|COMPLETED|Overall Study||60|Data is reported for participants who completed all study visits.|
48156574|NCT02856113|100706749|FG000|NOT COMPLETED|Overall Study||11||
48156575|NCT02856113|100706750|FG001|NOT COMPLETED|Overall Study||15||
48156576|NCT01746095|100706751|FG000|STARTED|Overall Study||20||
48156577|NCT01746095|100706752|FG001|STARTED|Overall Study||20||
48156578|NCT01746095|100706753|FG002|STARTED|Overall Study||24||
48156579|NCT01746095|100706754|FG003|STARTED|Overall Study||23||
48156580|NCT01746095|100706751|FG000|COMPLETED|Overall Study||16||
48156581|NCT01746095|100706752|FG001|COMPLETED|Overall Study||16||
48156582|NCT01746095|100706753|FG002|COMPLETED|Overall Study||11||
48156583|NCT01746095|100706754|FG003|COMPLETED|Overall Study||15||
48156584|NCT01746095|100706751|FG000|NOT COMPLETED|Overall Study||4||
48156585|NCT01746095|100706752|FG001|NOT COMPLETED|Overall Study||4||
48156586|NCT01746095|100706753|FG002|NOT COMPLETED|Overall Study||13||
48156587|NCT01746095|100706754|FG003|NOT COMPLETED|Overall Study||8||
48156588|NCT01007656|100706755|FG000|STARTED|Overall Study||31||
48156589|NCT01007656|100706755|FG000|COMPLETED|Overall Study||31||
48156590|NCT01007656|100706755|FG000|NOT COMPLETED|Overall Study||0||
48156591|NCT04082884|100706756|FG000|STARTED|Overall Study||6||
48156592|NCT04082884|100706756|FG000|Completed Standard Diet|Overall Study||5||
48156593|NCT04082884|100706756|FG000|1 Week Transition to Low Carbohydrate Diet Completed|Overall Study||5||
48156594|NCT04082884|100706756|FG000|High Protein Low Carbohydrate Completed|Overall Study||5||
48156595|NCT04082884|100706756|FG000|High Fat Low Carbohydrate Completed|Overall Study||4||
48156596|NCT04082884|100706756|FG000|COMPLETED|Overall Study||5||
48156597|NCT04082884|100706756|FG000|NOT COMPLETED|Overall Study||1||
48156598|NCT02623855|100706757|FG000|STARTED|Overall Study||56||
48156599|NCT02623855|100706758|FG001|STARTED|Overall Study||100||
48156600|NCT02623855|100706757|FG000|COMPLETED|Overall Study||46||
48156601|NCT02623855|100706758|FG001|COMPLETED|Overall Study||84||
48156602|NCT02623855|100706757|FG000|NOT COMPLETED|Overall Study||10||
48156603|NCT02623855|100706758|FG001|NOT COMPLETED|Overall Study||16||
48156604|NCT04343586|100706759|FG000|STARTED|Overall Study||11||
48406670|NCT03051217|101328465|FG000|STARTED|Maintenance Period (Week 16 to Week 52)||0||
48440017|NCT04259905|101410011|FG000|COMPLETED|Overall Study||10||
48156605|NCT04343586|100706759|FG000|COMPLETED|Overall Study||10||
48156606|NCT04343586|100706759|FG000|NOT COMPLETED|Overall Study||1||
48156607|NCT01291784|100706760|FG000|STARTED|Overall Study||1||
48156608|NCT01291784|100706761|FG001|STARTED|Overall Study||1||
48156609|NCT01291784|100706762|FG002|STARTED|Overall Study||1||
48156610|NCT01291784|100706760|FG000|COMPLETED|Overall Study||1||
48156611|NCT01291784|100706761|FG001|COMPLETED|Overall Study||0||
48156612|NCT01291784|100706762|FG002|COMPLETED|Overall Study||1||
48156613|NCT01291784|100706760|FG000|NOT COMPLETED|Overall Study||0||
48156614|NCT01291784|100706761|FG001|NOT COMPLETED|Overall Study||1||
48156615|NCT01291784|100706762|FG002|NOT COMPLETED|Overall Study||0||
48156616|NCT00827541|100706763|FG000|STARTED|Overall Study||19||
48156617|NCT00827541|100706764|FG001|STARTED|Overall Study||96||
48156618|NCT00827541|100706763|FG000|COMPLETED|Overall Study||15||
48156619|NCT00827541|100706764|FG001|COMPLETED|Overall Study||85||
48156620|NCT00827541|100706763|FG000|NOT COMPLETED|Overall Study||4||
48156621|NCT00827541|100706764|FG001|NOT COMPLETED|Overall Study||11||
48156622|NCT01111123|100706765|FG000|STARTED|Open- Label Phase||55||
48156623|NCT01111123|100706766|FG001|STARTED|Open- Label Phase||0||
48156624|NCT01111123|100706765|FG000|COMPLETED|Open- Label Phase||41||
48156625|NCT01111123|100706766|FG001|COMPLETED|Open- Label Phase||0||
48156626|NCT01111123|100706765|FG000|NOT COMPLETED|Open- Label Phase||14||
48156627|NCT01111123|100706766|FG001|NOT COMPLETED|Open- Label Phase||0||
48156628|NCT01111123|100706765|FG000|STARTED|Maintenance Phase||21||
48156629|NCT01111123|100706766|FG001|STARTED|Maintenance Phase||20||
48156630|NCT01111123|100706765|FG000|COMPLETED|Maintenance Phase||21||
48156631|NCT01111123|100706766|FG001|COMPLETED|Maintenance Phase||18||
48156632|NCT01111123|100706765|FG000|NOT COMPLETED|Maintenance Phase||0||
48156633|NCT01111123|100706766|FG001|NOT COMPLETED|Maintenance Phase||2||
48156634|NCT02498834|100706767|FG000|STARTED|Overall Study||185||
48156635|NCT02498834|100706768|FG001|STARTED|Overall Study||174||
48156636|NCT02498834|100706767|FG000|COMPLETED|Overall Study||175||
48156637|NCT02498834|100706768|FG001|COMPLETED|Overall Study||164||
48156638|NCT02498834|100706767|FG000|NOT COMPLETED|Overall Study||10||
48156639|NCT02498834|100706768|FG001|NOT COMPLETED|Overall Study||10||
48156640|NCT02940574|100706769|FG000|STARTED|From Study Start to 1-month Follow-up||22||
48156641|NCT02940574|100706770|FG001|STARTED|From Study Start to 1-month Follow-up||18||
48156642|NCT02940574|100706769|FG000|COMPLETED|From Study Start to 1-month Follow-up||21||
48156643|NCT02940574|100706770|FG001|COMPLETED|From Study Start to 1-month Follow-up||18||
48156644|NCT02940574|100706769|FG000|NOT COMPLETED|From Study Start to 1-month Follow-up||1||
48156645|NCT02940574|100706770|FG001|NOT COMPLETED|From Study Start to 1-month Follow-up||0||
48156646|NCT02940574|100706769|FG000|STARTED|1-year Follow-up||21||
48156647|NCT02940574|100706770|FG001|STARTED|1-year Follow-up||18||
48156648|NCT02940574|100706769|FG000|COMPLETED|1-year Follow-up||18||
48156649|NCT02940574|100706770|FG001|COMPLETED|1-year Follow-up||14||
48156650|NCT02940574|100706769|FG000|NOT COMPLETED|1-year Follow-up||3||
48156651|NCT02940574|100706770|FG001|NOT COMPLETED|1-year Follow-up||4||
48156652|NCT02280239|100706771|FG000|STARTED|Overall Study||1||
48156653|NCT02280239|100706772|FG001|STARTED|Overall Study||5||
48156654|NCT02280239|100706771|FG000|COMPLETED|Overall Study||1||
48156655|NCT02280239|100706772|FG001|COMPLETED|Overall Study||5||
48156656|NCT02280239|100706771|FG000|NOT COMPLETED|Overall Study||0||
48156657|NCT02280239|100706772|FG001|NOT COMPLETED|Overall Study||0||
48156658|NCT02740049|100706773|FG000|STARTED|Overall Study||9||
48156659|NCT02740049|100706773|FG000|COMPLETED|Overall Study||8||
48156660|NCT02740049|100706773|FG000|NOT COMPLETED|Overall Study||1||
48156661|NCT01120249|100706774|FG000|STARTED|Overall Study||744||
48156662|NCT01120249|100706775|FG001|STARTED|Overall Study||755||
48156663|NCT01120249|100706774|FG000|COMPLETED|Overall Study||512||
48156664|NCT01120249|100706775|FG001|COMPLETED|Overall Study||343||
48156665|NCT01120249|100706774|FG000|NOT COMPLETED|Overall Study||232||
48156666|NCT01120249|100706775|FG001|NOT COMPLETED|Overall Study||412||
48156667|NCT00766675|100706776|FG000|STARTED|Overall Study||80||
48156668|NCT00766675|100706776|FG000|COMPLETED|Overall Study||40||
48156669|NCT00766675|100706776|FG000|NOT COMPLETED|Overall Study||40||
48156670|NCT01984697|100706777|FG000|STARTED|Overall Study||301||
48156671|NCT01984697|100706778|FG001|STARTED|Overall Study||301||
48156672|NCT01984697|100706779|FG002|STARTED|Overall Study||301||
48156673|NCT01984697|100706780|FG003|STARTED|Overall Study||301||
48156674|NCT01984697|100706781|FG004|STARTED|Overall Study||314||
48156675|NCT01984697|100706777|FG000|Vaccination 1|Overall Study||301||
48156676|NCT01984697|100706778|FG001|Vaccination 1|Overall Study||301||
48156677|NCT01984697|100706779|FG002|Vaccination 1|Overall Study||300||
48156678|NCT01984697|100706780|FG003|Vaccination 1|Overall Study||300||
48156679|NCT01984697|100706781|FG004|Vaccination 1|Overall Study||314||
48156680|NCT01984697|100706777|FG000|Vaccination 2|Overall Study||293||
48156681|NCT01984697|100706778|FG001|Vaccination 2|Overall Study||296||
48156682|NCT01984697|100706779|FG002|Vaccination 2|Overall Study||291||
48156683|NCT01984697|100706780|FG003|Vaccination 2|Overall Study||298||
48156684|NCT01984697|100706781|FG004|Vaccination 2|Overall Study||313||
48156685|NCT01984697|100706777|FG000|Vaccination 3|Overall Study||0||
48156686|NCT01984697|100706778|FG001|Vaccination 3|Overall Study||0||
48156687|NCT01984697|100706779|FG002|Vaccination 3|Overall Study||0||
48156688|NCT01984697|100706780|FG003|Vaccination 3|Overall Study||293||
48156689|NCT01984697|100706781|FG004|Vaccination 3|Overall Study||311||
48156690|NCT01984697|100706777|FG000|Month 36 Vaccination|Overall Study||270||
48156691|NCT01984697|100706778|FG001|Month 36 Vaccination|Overall Study||281||
48156692|NCT01984697|100706779|FG002|Month 36 Vaccination|Overall Study||280||
48156693|NCT01984697|100706780|FG003|Month 36 Vaccination|Overall Study||9||
48156694|NCT01984697|100706781|FG004|Month 36 Vaccination|Overall Study||31||
48156695|NCT01984697|100706777|FG000|COMPLETED|Overall Study||258||
48156696|NCT01984697|100706778|FG001|COMPLETED|Overall Study||270||
48156697|NCT01984697|100706779|FG002|COMPLETED|Overall Study||272||
48156698|NCT01984697|100706780|FG003|COMPLETED|Overall Study||280||
48156699|NCT01984697|100706781|FG004|COMPLETED|Overall Study||279||
48156700|NCT01984697|100706777|FG000|NOT COMPLETED|Overall Study||43||
48156701|NCT01984697|100706778|FG001|NOT COMPLETED|Overall Study||31||
48156702|NCT01984697|100706779|FG002|NOT COMPLETED|Overall Study||29||
48156703|NCT01984697|100706780|FG003|NOT COMPLETED|Overall Study||21||
48156704|NCT01984697|100706781|FG004|NOT COMPLETED|Overall Study||35||
48156705|NCT03469284|100706782|FG000|STARTED|Overall Study||16||
48156706|NCT03469284|100706783|FG001|STARTED|Overall Study||15||
48156707|NCT03469284|100706784|FG002|STARTED|Overall Study||14||
48156708|NCT03469284|100706785|FG003|STARTED|Overall Study||15||
48156709|NCT03469284|100706782|FG000|COMPLETED|Overall Study||16||
48156710|NCT03469284|100706783|FG001|COMPLETED|Overall Study||15||
48156711|NCT03469284|100706784|FG002|COMPLETED|Overall Study||14||
48156712|NCT03469284|100706785|FG003|COMPLETED|Overall Study||15||
48156713|NCT03469284|100706782|FG000|NOT COMPLETED|Overall Study||0||
48156714|NCT03469284|100706783|FG001|NOT COMPLETED|Overall Study||0||
48156715|NCT03469284|100706784|FG002|NOT COMPLETED|Overall Study||0||
48156716|NCT03469284|100706785|FG003|NOT COMPLETED|Overall Study||0||
48156717|NCT00989092|100706786|FG000|STARTED|Overall Study||228||
48156718|NCT00989092|100706787|FG001|STARTED|Overall Study||59||
48156719|NCT00989092|100706786|FG000|Treated With Darbepoetin Alfa|Overall Study||226||
48156720|NCT00989092|100706787|FG001|Treated With Darbepoetin Alfa|Overall Study||33||
48156721|NCT00989092|100706786|FG000|COMPLETED|Overall Study||138||
48156722|NCT00989092|100706787|FG001|COMPLETED|Overall Study||31||
48156723|NCT00989092|100706786|FG000|NOT COMPLETED|Overall Study||90||
48156724|NCT00989092|100706787|FG001|NOT COMPLETED|Overall Study||28||
48156725|NCT00045708|100706788|FG000|STARTED|Phase 1||21||
48156726|NCT00045708|100706789|FG001|STARTED|Phase 1||17||
48156727|NCT00045708|100706790|FG002|STARTED|Phase 1||0||
48156728|NCT00045708|100706788|FG000|COMPLETED|Phase 1||21||
48156729|NCT00045708|100706789|FG001|COMPLETED|Phase 1||16||
48156730|NCT00045708|100706790|FG002|COMPLETED|Phase 1||0||
48156731|NCT00045708|100706788|FG000|NOT COMPLETED|Phase 1||0||
48156732|NCT00045708|100706789|FG001|NOT COMPLETED|Phase 1||1||
48156733|NCT00045708|100706790|FG002|NOT COMPLETED|Phase 1||0||
48156734|NCT00045708|100706788|FG000|STARTED|Phase 2||0||
48156735|NCT00045708|100706789|FG001|STARTED|Phase 2||0||
48156736|NCT00045708|100706790|FG002|STARTED|Phase 2||19||
48156737|NCT00045708|100706788|FG000|COMPLETED|Phase 2||0||
48156738|NCT00045708|100706789|FG001|COMPLETED|Phase 2||0||
48156739|NCT00045708|100706790|FG002|COMPLETED|Phase 2||19||
48156740|NCT00045708|100706788|FG000|NOT COMPLETED|Phase 2||0||
48156741|NCT00045708|100706789|FG001|NOT COMPLETED|Phase 2||0||
48156742|NCT00045708|100706790|FG002|NOT COMPLETED|Phase 2||0||
48156743|NCT00710606|100706791|FG000|STARTED|Overall Study||20||
48156744|NCT00710606|100706792|FG001|STARTED|Overall Study||20||
48156745|NCT00710606|100706791|FG000|COMPLETED|Overall Study||20||
48156746|NCT00710606|100706792|FG001|COMPLETED|Overall Study||18||
48156747|NCT00710606|100706791|FG000|NOT COMPLETED|Overall Study||0||
48156748|NCT00710606|100706792|FG001|NOT COMPLETED|Overall Study||2||
48156749|NCT01965938|100706793|FG000|STARTED|Overall Study||21||
48156750|NCT01965938|100706794|FG001|STARTED|Overall Study||20||
48156751|NCT01965938|100706793|FG000|COMPLETED|Overall Study||20||
48156752|NCT01965938|100706794|FG001|COMPLETED|Overall Study||20||
48156753|NCT01965938|100706793|FG000|NOT COMPLETED|Overall Study||1||
48156754|NCT01965938|100706794|FG001|NOT COMPLETED|Overall Study||0||
48156755|NCT05232864|100706795|FG000|STARTED|Overall Study||16|All enrolled subjects were included in the Full Analysis Set and Safety Set|
48156756|NCT05232864|100706796|FG001|STARTED|Overall Study||15|All enrolled subjects were included in the Full Analysis Set and Safety Set|
48156757|NCT05232864|100706795|FG000|COMPLETED|Overall Study||0||
48156758|NCT05232864|100706796|FG001|COMPLETED|Overall Study||0||
48156759|NCT05232864|100706795|FG000|NOT COMPLETED|Overall Study||16||
48156760|NCT05232864|100706796|FG001|NOT COMPLETED|Overall Study||15||
48156761|NCT00691938|100706797|FG000|STARTED|Overall Study||5||
48156762|NCT00691938|100706798|FG001|STARTED|Overall Study||3||
48156763|NCT00691938|100706799|FG002|STARTED|Overall Study||6||
48156764|NCT00691938|100706800|FG003|STARTED|Overall Study||8||
48156765|NCT00691938|100706801|FG004|STARTED|Overall Study||10||
48156766|NCT00691938|100706802|FG005|STARTED|Overall Study||6||
48156767|NCT00691938|100706803|FG006|STARTED|Overall Study||14||
48156768|NCT00691938|100706797|FG000|COMPLETED|Overall Study||4||
48156769|NCT00691938|100706798|FG001|COMPLETED|Overall Study||3||
48156770|NCT00691938|100706799|FG002|COMPLETED|Overall Study||6||
48156771|NCT00691938|100706800|FG003|COMPLETED|Overall Study||8||
48156772|NCT00691938|100706801|FG004|COMPLETED|Overall Study||10||
48156773|NCT00691938|100706802|FG005|COMPLETED|Overall Study||6||
48156774|NCT00691938|100706803|FG006|COMPLETED|Overall Study||14||
48156775|NCT00691938|100706797|FG000|NOT COMPLETED|Overall Study||1||
48156776|NCT00691938|100706798|FG001|NOT COMPLETED|Overall Study||0||
48613237|NCT00497146|101838454|FG000|STARTED|Long-term Follow-up Period||65||
48613238|NCT00497146|101838455|FG001|STARTED|Long-term Follow-up Period||72||
48613239|NCT00497146|101838454|FG000|COMPLETED|Long-term Follow-up Period||50||
48613240|NCT00497146|101838455|FG001|COMPLETED|Long-term Follow-up Period||66||
48613241|NCT00497146|101838454|FG000|NOT COMPLETED|Long-term Follow-up Period||15||
48613242|NCT00497146|101838455|FG001|NOT COMPLETED|Long-term Follow-up Period||6||
48406671|NCT03051217|101328466|FG001|STARTED|Maintenance Period (Week 16 to Week 52)||0||
48156777|NCT00691938|100706799|FG002|NOT COMPLETED|Overall Study||0||
48156778|NCT00691938|100706800|FG003|NOT COMPLETED|Overall Study||0||
48156779|NCT00691938|100706801|FG004|NOT COMPLETED|Overall Study||0||
48156780|NCT00691938|100706802|FG005|NOT COMPLETED|Overall Study||0||
48156781|NCT00691938|100706803|FG006|NOT COMPLETED|Overall Study||0||
48156782|NCT01669798|100706804|FG000|STARTED|Overall Study||32||
48156783|NCT01669798|100706804|FG000|COMPLETED|Overall Study||27||
48156784|NCT01669798|100706804|FG000|NOT COMPLETED|Overall Study||5||
48156785|NCT01207570|100706805|FG000|STARTED|The First Stage (Before Crossover)||23||
48156786|NCT01207570|100706806|FG001|STARTED|The First Stage (Before Crossover)||31||
48156787|NCT01207570|100706805|FG000|COMPLETED|The First Stage (Before Crossover)||23||
48156788|NCT01207570|100706806|FG001|COMPLETED|The First Stage (Before Crossover)||31||
48156789|NCT01207570|100706805|FG000|NOT COMPLETED|The First Stage (Before Crossover)||0||
48156790|NCT01207570|100706806|FG001|NOT COMPLETED|The First Stage (Before Crossover)||0||
48156791|NCT01207570|100706805|FG000|STARTED|The Second Stage (After Crossover)||31||
48156792|NCT01207570|100706806|FG001|STARTED|The Second Stage (After Crossover)||23||
48156793|NCT01207570|100706805|FG000|COMPLETED|The Second Stage (After Crossover)||31||
48156794|NCT01207570|100706806|FG001|COMPLETED|The Second Stage (After Crossover)||23||
48156795|NCT01207570|100706805|FG000|NOT COMPLETED|The Second Stage (After Crossover)||0||
48156796|NCT01207570|100706806|FG001|NOT COMPLETED|The Second Stage (After Crossover)||0||
48156797|NCT02355067|100706807|FG000|STARTED|Overall Study||20||
48156798|NCT02355067|100706808|FG001|STARTED|Overall Study||20||
48156799|NCT02355067|100706807|FG000|COMPLETED|Overall Study||12||
48156800|NCT02355067|100706808|FG001|COMPLETED|Overall Study||12||
48156801|NCT02355067|100706807|FG000|NOT COMPLETED|Overall Study||8||
48156802|NCT02355067|100706808|FG001|NOT COMPLETED|Overall Study||8||
48311243|NCT01088464|101088030|FG000|COMPLETED|Overall Study||3||
48311244|NCT01088464|101088031|FG001|COMPLETED|Overall Study||6||
48311245|NCT01088464|101088032|FG002|COMPLETED|Overall Study||6||
48311246|NCT01088464|101088030|FG000|NOT COMPLETED|Overall Study||0||
48311247|NCT01088464|101088031|FG001|NOT COMPLETED|Overall Study||0||
48311248|NCT01088464|101088032|FG002|NOT COMPLETED|Overall Study||0||
48406672|NCT03051217|101328467|FG002|STARTED|Maintenance Period (Week 16 to Week 52)||0||
48406673|NCT03051217|101328468|FG003|STARTED|Maintenance Period (Week 16 to Week 52)||23||
48406674|NCT03051217|101328469|FG004|STARTED|Maintenance Period (Week 16 to Week 52)||51||
48406675|NCT03051217|101328470|FG005|STARTED|Maintenance Period (Week 16 to Week 52)||26||
48406676|NCT03051217|101328471|FG006|STARTED|Maintenance Period (Week 16 to Week 52)||20||
48613243|NCT00621257|101838456|FG000|STARTED|Overall Study||24||
48613244|NCT00621257|101838457|FG001|STARTED|Overall Study||24||
48613245|NCT00621257|101838458|FG002|STARTED|Overall Study||23||
48613246|NCT00621257|101838459|FG003|STARTED|Overall Study||32||
48613247|NCT00621257|101838460|FG004|STARTED|Overall Study||31||
48613248|NCT00621257|101838456|FG000|COMPLETED|Overall Study||20||
48613249|NCT00621257|101838457|FG001|COMPLETED|Overall Study||21||
48613250|NCT00621257|101838458|FG002|COMPLETED|Overall Study||20||
48613251|NCT00621257|101838459|FG003|COMPLETED|Overall Study||26||
48613252|NCT00621257|101838460|FG004|COMPLETED|Overall Study||22||
48613253|NCT00621257|101838456|FG000|NOT COMPLETED|Overall Study||4||
48613254|NCT00621257|101838457|FG001|NOT COMPLETED|Overall Study||3||
48613255|NCT00621257|101838458|FG002|NOT COMPLETED|Overall Study||3||
48156803|NCT00948974|100706809|FG000|STARTED|Overall Study||40||
48156804|NCT00948974|100706810|FG001|STARTED|Overall Study||48||
48156805|NCT00948974|100706809|FG000|COMPLETED|Overall Study||17||
48156806|NCT00948974|100706810|FG001|COMPLETED|Overall Study||28||
48156807|NCT00948974|100706809|FG000|NOT COMPLETED|Overall Study||23||
48156808|NCT00948974|100706810|FG001|NOT COMPLETED|Overall Study||20||
48156809|NCT01058304|100706811|FG000|STARTED|Overall Study||159||
48156810|NCT01058304|100706812|FG001|STARTED|Overall Study||161||
48156811|NCT01058304|100706811|FG000|COMPLETED|Overall Study||132||
48156812|NCT01058304|100706812|FG001|COMPLETED|Overall Study||128||
48156813|NCT01058304|100706811|FG000|NOT COMPLETED|Overall Study||27||
48156814|NCT01058304|100706812|FG001|NOT COMPLETED|Overall Study||33||
48156815|NCT02227875|100706813|FG000|STARTED|Overall Study||277||
48156816|NCT02227875|100706814|FG001|STARTED|Overall Study||283||
48156817|NCT02227875|100706813|FG000|COMPLETED|Overall Study||240||
48156818|NCT02227875|100706814|FG001|COMPLETED|Overall Study||250||
48311249|NCT01876251|101088033|FG000|STARTED|Overall Study||15||
48311250|NCT01876251|101088034|FG001|STARTED|Overall Study||3||
48311251|NCT01876251|101088035|FG002|STARTED|Overall Study||11||
48311252|NCT01876251|101088033|FG000|COMPLETED|Overall Study||0||
48311253|NCT01876251|101088034|FG001|COMPLETED|Overall Study||0||
48311254|NCT01876251|101088035|FG002|COMPLETED|Overall Study||0||
48613256|NCT00621257|101838459|FG003|NOT COMPLETED|Overall Study||6||
48613257|NCT00621257|101838460|FG004|NOT COMPLETED|Overall Study||9||
48311255|NCT01876251|101088033|FG000|NOT COMPLETED|Overall Study||15||
48311256|NCT01876251|101088034|FG001|NOT COMPLETED|Overall Study||3||
48311257|NCT01876251|101088035|FG002|NOT COMPLETED|Overall Study||11||
48311258|NCT04607148|101088036|FG000|STARTED|Overall Study||14||
48311259|NCT04607148|101088037|FG001|STARTED|Overall Study||70||
48311260|NCT04607148|101088038|FG002|STARTED|Overall Study||12||
48311261|NCT04607148|101088039|FG003|STARTED|Overall Study||48||
48311262|NCT04607148|101088036|FG000|COMPLETED|Overall Study||0||
48311263|NCT04607148|101088037|FG001|COMPLETED|Overall Study||0||
48311264|NCT04607148|101088038|FG002|COMPLETED|Overall Study||0||
48311265|NCT04607148|101088039|FG003|COMPLETED|Overall Study||0||
48311266|NCT04607148|101088036|FG000|NOT COMPLETED|Overall Study||14||
48311267|NCT04607148|101088037|FG001|NOT COMPLETED|Overall Study||70||
48311268|NCT04607148|101088038|FG002|NOT COMPLETED|Overall Study||12||
48311269|NCT04607148|101088039|FG003|NOT COMPLETED|Overall Study||48||
48727530|NCT03098745|102118591|FG000|NOT COMPLETED|Day 2||0||
48311270|NCT00841204|101088040|FG000|STARTED|Overall Study||25||
48727531|NCT03098745|102118592|FG001|NOT COMPLETED|Day 2||0||
48727532|NCT03098745|102118593|FG002|NOT COMPLETED|Day 2||0||
48727533|NCT03098745|102118594|FG003|NOT COMPLETED|Day 2||0||
48311271|NCT00841204|101088041|FG001|STARTED|Overall Study||25||
48311272|NCT00841204|101088040|FG000|COMPLETED|Overall Study||25||
48311273|NCT00841204|101088041|FG001|COMPLETED|Overall Study||25||
48311274|NCT00841204|101088040|FG000|NOT COMPLETED|Overall Study||0||
48311275|NCT00841204|101088041|FG001|NOT COMPLETED|Overall Study||0||
48311276|NCT00290290|101088042|FG000|STARTED|Overall Study||440||
48311277|NCT00290290|101088043|FG001|STARTED|Overall Study||409||
48311278|NCT00290290|101088042|FG000|COMPLETED|Overall Study||422||
48311279|NCT00290290|101088043|FG001|COMPLETED|Overall Study||391||
48311280|NCT00290290|101088042|FG000|NOT COMPLETED|Overall Study||18||
48311281|NCT00290290|101088043|FG001|NOT COMPLETED|Overall Study||18||
48311282|NCT01978535|101088044|FG000|STARTED|Overall Study||1||
48311283|NCT01978535|101088045|FG001|STARTED|Overall Study||2||
48727534|NCT03098745|102118595|FG004|NOT COMPLETED|Day 2||0||
48727535|NCT03098745|102118596|FG005|NOT COMPLETED|Day 2||0||
48727536|NCT03098745|102118591|FG000|STARTED|Day 3||7||
48727537|NCT03098745|102118592|FG001|STARTED|Day 3||3||
48727538|NCT03098745|102118593|FG002|STARTED|Day 3||8||
48727539|NCT03098745|102118594|FG003|STARTED|Day 3||8||
48727540|NCT03098745|102118595|FG004|STARTED|Day 3||10||
48727541|NCT03098745|102118596|FG005|STARTED|Day 3||4||
48727542|NCT03098745|102118591|FG000|COMPLETED|Day 3||7||
48727543|NCT03098745|102118592|FG001|COMPLETED|Day 3||3||
48727544|NCT03098745|102118593|FG002|COMPLETED|Day 3||8||
48727545|NCT03098745|102118594|FG003|COMPLETED|Day 3||8||
48727546|NCT03098745|102118595|FG004|COMPLETED|Day 3||10||
48727547|NCT03098745|102118596|FG005|COMPLETED|Day 3||4||
48727548|NCT03098745|102118591|FG000|NOT COMPLETED|Day 3||0||
48727549|NCT03098745|102118592|FG001|NOT COMPLETED|Day 3||0||
48727550|NCT03098745|102118593|FG002|NOT COMPLETED|Day 3||0||
48727551|NCT03098745|102118594|FG003|NOT COMPLETED|Day 3||0||
48727552|NCT03098745|102118595|FG004|NOT COMPLETED|Day 3||0||
48727553|NCT03098745|102118596|FG005|NOT COMPLETED|Day 3||0||
48727554|NCT01818284|102118597|FG000|STARTED|Overall Study||11||
48727555|NCT01818284|102118598|FG001|STARTED|Overall Study||11||
48727556|NCT01818284|102118597|FG000|COMPLETED|Overall Study||7||
48727557|NCT01818284|102118598|FG001|COMPLETED|Overall Study||5||
48727558|NCT01818284|102118597|FG000|NOT COMPLETED|Overall Study||4||
48727559|NCT01818284|102118598|FG001|NOT COMPLETED|Overall Study||6||
48727560|NCT00679172|102118599|FG000|STARTED|Overall Study||37||
48727561|NCT00679172|102118600|FG001|STARTED|Overall Study||38||
48727562|NCT00679172|102118601|FG002|STARTED|Overall Study||36||
48311284|NCT01978535|101088044|FG000|COMPLETED|Overall Study||1||
48311285|NCT01978535|101088045|FG001|COMPLETED|Overall Study||2||
48311286|NCT01978535|101088044|FG000|NOT COMPLETED|Overall Study||0||
48311287|NCT01978535|101088045|FG001|NOT COMPLETED|Overall Study||0||
48311288|NCT03770091|101088046|FG000|STARTED|Overall Study||15||
48311289|NCT03770091|101088047|FG001|STARTED|Overall Study||13||
48311290|NCT03770091|101088048|FG002|STARTED|Overall Study||12||
48311291|NCT03770091|101088046|FG000|COMPLETED|Overall Study||15||
48311292|NCT03770091|101088047|FG001|COMPLETED|Overall Study||13||
48311293|NCT03770091|101088048|FG002|COMPLETED|Overall Study||12||
48311294|NCT03770091|101088046|FG000|NOT COMPLETED|Overall Study||0||
48311295|NCT03770091|101088047|FG001|NOT COMPLETED|Overall Study||0||
48311296|NCT03770091|101088048|FG002|NOT COMPLETED|Overall Study||0||
48311297|NCT00467779|101088049|FG000|STARTED|Stage 1||4||
48727563|NCT00679172|102118602|FG003|STARTED|Overall Study||39||
48727564|NCT00679172|102118603|FG004|STARTED|Overall Study||37||
48727565|NCT00679172|102118599|FG000|COMPLETED|Overall Study||36||
48727566|NCT00679172|102118600|FG001|COMPLETED|Overall Study||37||
48727567|NCT00679172|102118601|FG002|COMPLETED|Overall Study||35||
48727568|NCT00679172|102118602|FG003|COMPLETED|Overall Study||38||
48727569|NCT00679172|102118603|FG004|COMPLETED|Overall Study||37||
48727570|NCT00679172|102118599|FG000|NOT COMPLETED|Overall Study||1||
48727571|NCT00679172|102118600|FG001|NOT COMPLETED|Overall Study||1||
48727572|NCT00679172|102118601|FG002|NOT COMPLETED|Overall Study||1||
48727573|NCT00679172|102118602|FG003|NOT COMPLETED|Overall Study||1||
48727574|NCT00679172|102118603|FG004|NOT COMPLETED|Overall Study||0||
48727575|NCT03887221|102118604|FG000|STARTED|Overall Study||12||
48727576|NCT03887221|102118605|FG001|STARTED|Overall Study||12||
48727577|NCT03887221|102118604|FG000|COMPLETED|Overall Study||11||
48727578|NCT03887221|102118605|FG001|COMPLETED|Overall Study||12||
48727579|NCT03887221|102118604|FG000|NOT COMPLETED|Overall Study||1||
48727580|NCT03887221|102118605|FG001|NOT COMPLETED|Overall Study||0||
48727581|NCT01008449|102118606|FG000|STARTED|Overall Study||200||
48727582|NCT01008449|102118607|FG001|STARTED|Overall Study||198||
48727583|NCT01008449|102118606|FG000|COMPLETED|Overall Study||171||
48727584|NCT01008449|102118607|FG001|COMPLETED|Overall Study||179||
48727585|NCT01008449|102118606|FG000|NOT COMPLETED|Overall Study||29||
48727586|NCT01008449|102118607|FG001|NOT COMPLETED|Overall Study||19||
48727587|NCT01440881|102118608|FG000|STARTED|Overall Study||14||
48727588|NCT01440881|102118609|FG001|STARTED|Overall Study||15||
48727589|NCT01440881|102118608|FG000|COMPLETED|Overall Study||14||
48727590|NCT01440881|102118609|FG001|COMPLETED|Overall Study||14||
48727591|NCT01440881|102118608|FG000|NOT COMPLETED|Overall Study||0||
48727592|NCT01440881|102118609|FG001|NOT COMPLETED|Overall Study||1||
48727593|NCT03178669|102118610|FG000|STARTED|Overall Study||40||
48727594|NCT03178669|102118611|FG001|STARTED|Overall Study||43||
48727595|NCT03178669|102118612|FG002|STARTED|Overall Study||42||
48727596|NCT03178669|102118613|FG003|STARTED|Overall Study||42||
48727597|NCT03178669|102118614|FG004|STARTED|Overall Study||44||
48727598|NCT03178669|102118610|FG000|Completed Week 6|Overall Study||35|Completed Week 6|
48406677|NCT03051217|101328465|FG000|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0||
48406678|NCT03051217|101328466|FG001|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0||
48406679|NCT03051217|101328467|FG002|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0||
48406680|NCT03051217|101328468|FG003|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||21||
48406681|NCT03051217|101328469|FG004|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||3||
48727599|NCT03178669|102118611|FG001|Completed Week 6|Overall Study||42|Completed Week 6|
48727600|NCT03178669|102118612|FG002|Completed Week 6|Overall Study||36|Completed Week 6|
48727601|NCT03178669|102118613|FG003|Completed Week 6|Overall Study||38|Completed Week 6|
48727602|NCT03178669|102118614|FG004|Completed Week 6|Overall Study||42|Completed Week 6|
48727603|NCT03178669|102118610|FG000|COMPLETED|Overall Study||35|Completed Week 10|
48727604|NCT03178669|102118611|FG001|COMPLETED|Overall Study||42|Completed Week 10|
48727605|NCT03178669|102118612|FG002|COMPLETED|Overall Study||35|Completed Week 10|
48727606|NCT03178669|102118613|FG003|COMPLETED|Overall Study||38|Completed Week 10|
48727607|NCT03178669|102118614|FG004|COMPLETED|Overall Study||40|Completed Week 10|
48727608|NCT03178669|102118610|FG000|NOT COMPLETED|Overall Study||5||
48727609|NCT03178669|102118611|FG001|NOT COMPLETED|Overall Study||1||
48727610|NCT03178669|102118612|FG002|NOT COMPLETED|Overall Study||7||
48727611|NCT03178669|102118613|FG003|NOT COMPLETED|Overall Study||4||
48406682|NCT03051217|101328470|FG005|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||7||
48406683|NCT03051217|101328471|FG006|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||3||
48727612|NCT03178669|102118614|FG004|NOT COMPLETED|Overall Study||4||
48727613|NCT01620944|102118615|FG000|STARTED|Overall Study||2||
48727614|NCT01620944|102118616|FG001|STARTED|Overall Study||1||
48727615|NCT01620944|102118615|FG000|COMPLETED|Overall Study||0||
48727616|NCT01620944|102118616|FG001|COMPLETED|Overall Study||0||
48727617|NCT01620944|102118615|FG000|NOT COMPLETED|Overall Study||2||
48727618|NCT01620944|102118616|FG001|NOT COMPLETED|Overall Study||1||
48727619|NCT04541628|102118617|FG000|STARTED|Overall Study||1||
48727620|NCT04541628|102118618|FG001|STARTED|Overall Study||1||
48727621|NCT04541628|102118619|FG002|STARTED|Overall Study||1||
48727622|NCT04541628|102118617|FG000|Received at Least One Dose of Study Drug|Overall Study||1||
48727623|NCT04541628|102118618|FG001|Received at Least One Dose of Study Drug|Overall Study||1||
48727624|NCT04541628|102118619|FG002|Received at Least One Dose of Study Drug|Overall Study||1||
48727625|NCT04541628|102118617|FG000|COMPLETED|Overall Study||0||
48727626|NCT04541628|102118618|FG001|COMPLETED|Overall Study||0||
48727627|NCT04541628|102118619|FG002|COMPLETED|Overall Study||0||
48727628|NCT04541628|102118617|FG000|NOT COMPLETED|Overall Study||1||
48727629|NCT04541628|102118618|FG001|NOT COMPLETED|Overall Study||1||
48727630|NCT04541628|102118619|FG002|NOT COMPLETED|Overall Study||1||
48727631|NCT03088813|102118620|FG000|STARTED|Part 1: Dose Evaluation (Up to Week 172)||5||
48727632|NCT03088813|102118621|FG001|STARTED|Part 1: Dose Evaluation (Up to Week 172)||25||
48727633|NCT03088813|102118622|FG002|STARTED|Part 1: Dose Evaluation (Up to Week 172)||0||
48727634|NCT03088813|102118623|FG003|STARTED|Part 1: Dose Evaluation (Up to Week 172)||0||
48727635|NCT03088813|102118620|FG000|COMPLETED|Part 1: Dose Evaluation (Up to Week 172)||5||
48727636|NCT03088813|102118621|FG001|COMPLETED|Part 1: Dose Evaluation (Up to Week 172)||24||
48727637|NCT03088813|102118622|FG002|COMPLETED|Part 1: Dose Evaluation (Up to Week 172)||0||
48727638|NCT03088813|102118623|FG003|COMPLETED|Part 1: Dose Evaluation (Up to Week 172)||0||
48406684|NCT03051217|101328465|FG000|COMPLETED|Maintenance Period (Week 16 to Week 52)||0||
48406685|NCT03051217|101328466|FG001|COMPLETED|Maintenance Period (Week 16 to Week 52)||0||
48406686|NCT03051217|101328467|FG002|COMPLETED|Maintenance Period (Week 16 to Week 52)||0||
48406687|NCT03051217|101328468|FG003|COMPLETED|Maintenance Period (Week 16 to Week 52)||20||
48727639|NCT03088813|102118620|FG000|NOT COMPLETED|Part 1: Dose Evaluation (Up to Week 172)||0||
48727640|NCT03088813|102118621|FG001|NOT COMPLETED|Part 1: Dose Evaluation (Up to Week 172)||1||
48727641|NCT03088813|102118622|FG002|NOT COMPLETED|Part 1: Dose Evaluation (Up to Week 172)||0||
48727642|NCT03088813|102118623|FG003|NOT COMPLETED|Part 1: Dose Evaluation (Up to Week 172)||0||
48727643|NCT03088813|102118620|FG000|STARTED|Part 2: Randomized Study (Upto Week 197)||0||
48727644|NCT03088813|102118621|FG001|STARTED|Part 2: Randomized Study (Upto Week 197)||0||
48727645|NCT03088813|102118622|FG002|STARTED|Part 2: Randomized Study (Upto Week 197)||229||
48727646|NCT03088813|102118623|FG003|STARTED|Part 2: Randomized Study (Upto Week 197)||232||
48727647|NCT03088813|102118620|FG000|COMPLETED|Part 2: Randomized Study (Upto Week 197)||0||
48727648|NCT03088813|102118621|FG001|COMPLETED|Part 2: Randomized Study (Upto Week 197)||0||
48311298|NCT00467779|101088050|FG001|STARTED|Stage 1||3||
48311299|NCT00467779|101088051|FG002|STARTED|Stage 1||3||
48311300|NCT00467779|101088052|FG003|STARTED|Stage 1||3||
48311301|NCT00467779|101088053|FG004|STARTED|Stage 1||3||
48311302|NCT00467779|101088054|FG005|STARTED|Stage 1||6||
48311303|NCT00467779|101088055|FG006|STARTED|Stage 1||7||
48311304|NCT00467779|101088056|FG007|STARTED|Stage 1||7||
48311305|NCT00467779|101088057|FG008|STARTED|Stage 1||0||
48311306|NCT00467779|101088058|FG009|STARTED|Stage 1||0||
48311307|NCT00467779|101088059|FG010|STARTED|Stage 1||0||
48311308|NCT00467779|101088060|FG011|STARTED|Stage 1||0||
48311309|NCT00467779|101088061|FG012|STARTED|Stage 1||0||
48311310|NCT00467779|101088062|FG013|STARTED|Stage 1||0||
48311311|NCT00467779|101088063|FG014|STARTED|Stage 1||0||
48311312|NCT00467779|101088049|FG000|COMPLETED|Stage 1||0||
48311313|NCT00467779|101088050|FG001|COMPLETED|Stage 1||0||
48406688|NCT03051217|101328469|FG004|COMPLETED|Maintenance Period (Week 16 to Week 52)||48||
48406689|NCT03051217|101328470|FG005|COMPLETED|Maintenance Period (Week 16 to Week 52)||24||
48406690|NCT03051217|101328471|FG006|COMPLETED|Maintenance Period (Week 16 to Week 52)||19||
48406691|NCT03051217|101328465|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0||
48406692|NCT03051217|101328466|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0||
48727649|NCT03088813|102118622|FG002|COMPLETED|Part 2: Randomized Study (Upto Week 197)||202||
48727650|NCT03088813|102118623|FG003|COMPLETED|Part 2: Randomized Study (Upto Week 197)||211||
48727651|NCT03088813|102118620|FG000|NOT COMPLETED|Part 2: Randomized Study (Upto Week 197)||0||
48727652|NCT03088813|102118621|FG001|NOT COMPLETED|Part 2: Randomized Study (Upto Week 197)||0||
48311314|NCT00467779|101088051|FG002|COMPLETED|Stage 1||0||
48311315|NCT00467779|101088052|FG003|COMPLETED|Stage 1||0||
48311316|NCT00467779|101088053|FG004|COMPLETED|Stage 1||0||
48311317|NCT00467779|101088054|FG005|COMPLETED|Stage 1||1||
48311318|NCT00467779|101088055|FG006|COMPLETED|Stage 1||0||
48311319|NCT00467779|101088056|FG007|COMPLETED|Stage 1||0||
48311320|NCT00467779|101088057|FG008|COMPLETED|Stage 1||0||
48311321|NCT00467779|101088058|FG009|COMPLETED|Stage 1||0||
48311322|NCT00467779|101088059|FG010|COMPLETED|Stage 1||0||
48311323|NCT00467779|101088060|FG011|COMPLETED|Stage 1||0||
48311324|NCT00467779|101088061|FG012|COMPLETED|Stage 1||0||
48311325|NCT00467779|101088062|FG013|COMPLETED|Stage 1||0||
48311326|NCT00467779|101088063|FG014|COMPLETED|Stage 1||0||
48727653|NCT03088813|102118622|FG002|NOT COMPLETED|Part 2: Randomized Study (Upto Week 197)||27||
48727654|NCT03088813|102118623|FG003|NOT COMPLETED|Part 2: Randomized Study (Upto Week 197)||21||
48727655|NCT02123576|102118624|FG000|STARTED|Overall Study||6||
48727656|NCT02123576|102118625|FG001|STARTED|Overall Study||6||
48727657|NCT02123576|102118624|FG000|COMPLETED|Overall Study||5||
48727658|NCT02123576|102118625|FG001|COMPLETED|Overall Study||6||
48311327|NCT00467779|101088049|FG000|NOT COMPLETED|Stage 1||4||
48311328|NCT00467779|101088050|FG001|NOT COMPLETED|Stage 1||3||
48311329|NCT00467779|101088051|FG002|NOT COMPLETED|Stage 1||3||
48311330|NCT00467779|101088052|FG003|NOT COMPLETED|Stage 1||3||
48311331|NCT00467779|101088053|FG004|NOT COMPLETED|Stage 1||3||
48311332|NCT00467779|101088054|FG005|NOT COMPLETED|Stage 1||5||
48311333|NCT00467779|101088055|FG006|NOT COMPLETED|Stage 1||7||
48311334|NCT00467779|101088056|FG007|NOT COMPLETED|Stage 1||7||
48311335|NCT00467779|101088057|FG008|NOT COMPLETED|Stage 1||0||
48311336|NCT00467779|101088058|FG009|NOT COMPLETED|Stage 1||0||
48311337|NCT00467779|101088059|FG010|NOT COMPLETED|Stage 1||0||
48311338|NCT00467779|101088060|FG011|NOT COMPLETED|Stage 1||0||
48311339|NCT00467779|101088061|FG012|NOT COMPLETED|Stage 1||0||
48311340|NCT00467779|101088062|FG013|NOT COMPLETED|Stage 1||0||
48311341|NCT00467779|101088063|FG014|NOT COMPLETED|Stage 1||0||
48311342|NCT00467779|101088049|FG000|STARTED|Stage 1A||0||
48311343|NCT00467779|101088050|FG001|STARTED|Stage 1A||0||
48311344|NCT00467779|101088051|FG002|STARTED|Stage 1A||0||
48311345|NCT00467779|101088052|FG003|STARTED|Stage 1A||0||
48311346|NCT00467779|101088053|FG004|STARTED|Stage 1A||0||
48311347|NCT00467779|101088054|FG005|STARTED|Stage 1A||0||
48311348|NCT00467779|101088055|FG006|STARTED|Stage 1A||0||
48311349|NCT00467779|101088056|FG007|STARTED|Stage 1A||0||
48311350|NCT00467779|101088057|FG008|STARTED|Stage 1A||0||
48311351|NCT00467779|101088058|FG009|STARTED|Stage 1A||3||
48311352|NCT00467779|101088059|FG010|STARTED|Stage 1A||3||
48311353|NCT00467779|101088060|FG011|STARTED|Stage 1A||8||
48311354|NCT00467779|101088061|FG012|STARTED|Stage 1A||6||
48311355|NCT00467779|101088062|FG013|STARTED|Stage 1A||0||
48311356|NCT00467779|101088063|FG014|STARTED|Stage 1A||0||
48311357|NCT00467779|101088049|FG000|COMPLETED|Stage 1A||0||
48311358|NCT00467779|101088050|FG001|COMPLETED|Stage 1A||0||
48311359|NCT00467779|101088051|FG002|COMPLETED|Stage 1A||0||
48311360|NCT00467779|101088052|FG003|COMPLETED|Stage 1A||0||
48311361|NCT00467779|101088053|FG004|COMPLETED|Stage 1A||0||
48727659|NCT02123576|102118624|FG000|NOT COMPLETED|Overall Study||1||
48727660|NCT02123576|102118625|FG001|NOT COMPLETED|Overall Study||0||
48727661|NCT02986854|102118626|FG000|STARTED|Overall Study||301||
48727662|NCT02986854|102118627|FG001|STARTED|Overall Study||300||
48311362|NCT00467779|101088054|FG005|COMPLETED|Stage 1A||0||
48311363|NCT00467779|101088055|FG006|COMPLETED|Stage 1A||0||
48311364|NCT00467779|101088056|FG007|COMPLETED|Stage 1A||0||
48311365|NCT00467779|101088057|FG008|COMPLETED|Stage 1A||0||
48311366|NCT00467779|101088058|FG009|COMPLETED|Stage 1A||0||
48311367|NCT00467779|101088059|FG010|COMPLETED|Stage 1A||0||
48311368|NCT00467779|101088060|FG011|COMPLETED|Stage 1A||0||
48311369|NCT00467779|101088061|FG012|COMPLETED|Stage 1A||0||
48311370|NCT00467779|101088062|FG013|COMPLETED|Stage 1A||0||
48311371|NCT00467779|101088063|FG014|COMPLETED|Stage 1A||0||
48311372|NCT00467779|101088049|FG000|NOT COMPLETED|Stage 1A||0||
48311373|NCT00467779|101088050|FG001|NOT COMPLETED|Stage 1A||0||
48311374|NCT00467779|101088051|FG002|NOT COMPLETED|Stage 1A||0||
48727663|NCT02986854|102118628|FG002|STARTED|Overall Study||100||
48727664|NCT02986854|102118626|FG000|COMPLETED|Overall Study||298||
48727665|NCT02986854|102118627|FG001|COMPLETED|Overall Study||288||
48311375|NCT00467779|101088052|FG003|NOT COMPLETED|Stage 1A||0||
48311376|NCT00467779|101088053|FG004|NOT COMPLETED|Stage 1A||0||
48311377|NCT00467779|101088054|FG005|NOT COMPLETED|Stage 1A||0||
48311378|NCT00467779|101088055|FG006|NOT COMPLETED|Stage 1A||0||
48311379|NCT00467779|101088056|FG007|NOT COMPLETED|Stage 1A||0||
48311380|NCT00467779|101088057|FG008|NOT COMPLETED|Stage 1A||0||
48311381|NCT00467779|101088058|FG009|NOT COMPLETED|Stage 1A||3||
48311382|NCT00467779|101088059|FG010|NOT COMPLETED|Stage 1A||3||
48311383|NCT00467779|101088060|FG011|NOT COMPLETED|Stage 1A||8||
48311384|NCT00467779|101088061|FG012|NOT COMPLETED|Stage 1A||6||
48311385|NCT00467779|101088062|FG013|NOT COMPLETED|Stage 1A||0||
48727666|NCT02986854|102118628|FG002|COMPLETED|Overall Study||97||
48727667|NCT02986854|102118626|FG000|NOT COMPLETED|Overall Study||3||
48727668|NCT02986854|102118627|FG001|NOT COMPLETED|Overall Study||12||
48727669|NCT02986854|102118628|FG002|NOT COMPLETED|Overall Study||3||
48727670|NCT01218399|102118629|FG000|STARTED|Overall Study||5||
48727671|NCT01218399|102118630|FG001|STARTED|Overall Study||5||
48727672|NCT01218399|102118629|FG000|COMPLETED|Overall Study||5||
48727673|NCT01218399|102118630|FG001|COMPLETED|Overall Study||5||
48727674|NCT01218399|102118629|FG000|NOT COMPLETED|Overall Study||0||
48727675|NCT01218399|102118630|FG001|NOT COMPLETED|Overall Study||0||
48727676|NCT01716455|102118631|FG000|STARTED|Overall Study||8||
48727677|NCT01716455|102118632|FG001|STARTED|Overall Study||8||
48727678|NCT01716455|102118633|FG002|STARTED|Overall Study||8||
48727679|NCT01716455|102118634|FG003|STARTED|Overall Study||8||
48727680|NCT01716455|102118635|FG004|STARTED|Overall Study||26||
48727681|NCT01716455|102118636|FG005|STARTED|Overall Study||8||
48311386|NCT00467779|101088063|FG014|NOT COMPLETED|Stage 1A||0||
48311387|NCT00467779|101088049|FG000|STARTED|Stage 2||0||
48311388|NCT00467779|101088050|FG001|STARTED|Stage 2||0||
48311389|NCT00467779|101088051|FG002|STARTED|Stage 2||0||
48311390|NCT00467779|101088052|FG003|STARTED|Stage 2||0||
48311391|NCT00467779|101088053|FG004|STARTED|Stage 2||0||
48311392|NCT00467779|101088054|FG005|STARTED|Stage 2||0||
48311393|NCT00467779|101088055|FG006|STARTED|Stage 2||0||
48311394|NCT00467779|101088056|FG007|STARTED|Stage 2||0||
48311395|NCT00467779|101088057|FG008|STARTED|Stage 2||21||
48311396|NCT00467779|101088058|FG009|STARTED|Stage 2||0||
48311397|NCT00467779|101088059|FG010|STARTED|Stage 2||0||
48311398|NCT00467779|101088060|FG011|STARTED|Stage 2||0||
48311399|NCT00467779|101088061|FG012|STARTED|Stage 2||0||
48311400|NCT00467779|101088062|FG013|STARTED|Stage 2||0||
48311401|NCT00467779|101088063|FG014|STARTED|Stage 2||0||
48311402|NCT00467779|101088049|FG000|COMPLETED|Stage 2||0||
48311403|NCT00467779|101088050|FG001|COMPLETED|Stage 2||0||
48311404|NCT00467779|101088051|FG002|COMPLETED|Stage 2||0||
48311405|NCT00467779|101088052|FG003|COMPLETED|Stage 2||0||
48311406|NCT00467779|101088053|FG004|COMPLETED|Stage 2||0||
48311407|NCT00467779|101088054|FG005|COMPLETED|Stage 2||0||
48311408|NCT00467779|101088055|FG006|COMPLETED|Stage 2||0||
48311409|NCT00467779|101088056|FG007|COMPLETED|Stage 2||0||
48311410|NCT00467779|101088057|FG008|COMPLETED|Stage 2||0||
48311411|NCT00467779|101088058|FG009|COMPLETED|Stage 2||0||
48311412|NCT00467779|101088059|FG010|COMPLETED|Stage 2||0||
48311413|NCT00467779|101088060|FG011|COMPLETED|Stage 2||0||
48311414|NCT00467779|101088061|FG012|COMPLETED|Stage 2||0||
48311415|NCT00467779|101088062|FG013|COMPLETED|Stage 2||0||
48311416|NCT00467779|101088063|FG014|COMPLETED|Stage 2||0||
48311417|NCT00467779|101088049|FG000|NOT COMPLETED|Stage 2||0||
48311418|NCT00467779|101088050|FG001|NOT COMPLETED|Stage 2||0||
48311419|NCT00467779|101088051|FG002|NOT COMPLETED|Stage 2||0||
48311420|NCT00467779|101088052|FG003|NOT COMPLETED|Stage 2||0||
48727682|NCT01716455|102118631|FG000|COMPLETED|Overall Study||8||
48727683|NCT01716455|102118632|FG001|COMPLETED|Overall Study||8||
48727684|NCT01716455|102118633|FG002|COMPLETED|Overall Study||8||
48727685|NCT01716455|102118634|FG003|COMPLETED|Overall Study||8||
48727686|NCT01716455|102118635|FG004|COMPLETED|Overall Study||26||
48727687|NCT01716455|102118636|FG005|COMPLETED|Overall Study||8||
48727688|NCT01716455|102118631|FG000|NOT COMPLETED|Overall Study||0||
48727689|NCT01716455|102118632|FG001|NOT COMPLETED|Overall Study||0||
48727690|NCT01716455|102118633|FG002|NOT COMPLETED|Overall Study||0||
48727691|NCT01716455|102118634|FG003|NOT COMPLETED|Overall Study||0||
48727692|NCT01716455|102118635|FG004|NOT COMPLETED|Overall Study||0||
48727693|NCT01716455|102118636|FG005|NOT COMPLETED|Overall Study||0||
48727694|NCT03576716|102118637|FG000|STARTED|Overall Study||10||
48727695|NCT03576716|102118638|FG001|STARTED|Overall Study||9||
48727696|NCT03576716|102118637|FG000|COMPLETED|Overall Study||10||
48727697|NCT03576716|102118638|FG001|COMPLETED|Overall Study||8||
48311421|NCT00467779|101088053|FG004|NOT COMPLETED|Stage 2||0||
48311422|NCT00467779|101088054|FG005|NOT COMPLETED|Stage 2||0||
48311423|NCT00467779|101088055|FG006|NOT COMPLETED|Stage 2||0||
48311424|NCT00467779|101088056|FG007|NOT COMPLETED|Stage 2||0||
48311425|NCT00467779|101088057|FG008|NOT COMPLETED|Stage 2||21||
48311426|NCT00467779|101088058|FG009|NOT COMPLETED|Stage 2||0||
48727698|NCT03576716|102118637|FG000|NOT COMPLETED|Overall Study||0||
48727699|NCT03576716|102118638|FG001|NOT COMPLETED|Overall Study||1||
48727700|NCT00830180|102118639|FG000|STARTED|Overall Study||41||
48727701|NCT00830180|102118639|FG000|Received Tanezumab in Parent Study A4091003|Overall Study||19||
48727702|NCT00830180|102118639|FG000|Received Placebo in Parent Study A4091003|Overall Study||22||
48727703|NCT00830180|102118639|FG000|COMPLETED|Overall Study||15||
48311427|NCT00467779|101088059|FG010|NOT COMPLETED|Stage 2||0||
48311428|NCT00467779|101088060|FG011|NOT COMPLETED|Stage 2||0||
48311429|NCT00467779|101088061|FG012|NOT COMPLETED|Stage 2||0||
48311430|NCT00467779|101088062|FG013|NOT COMPLETED|Stage 2||0||
48311431|NCT00467779|101088063|FG014|NOT COMPLETED|Stage 2||0||
48311432|NCT00467779|101088049|FG000|STARTED|Stage 2A||0||
48311433|NCT00467779|101088050|FG001|STARTED|Stage 2A||0||
48727704|NCT00830180|102118639|FG000|NOT COMPLETED|Overall Study||26||
48727705|NCT00803062|102118640|FG000|STARTED|Overall Study||114||
48727706|NCT00803062|102118641|FG001|STARTED|Overall Study||115||
48311434|NCT00467779|101088051|FG002|STARTED|Stage 2A||0||
48311435|NCT00467779|101088052|FG003|STARTED|Stage 2A||0||
48311436|NCT00467779|101088053|FG004|STARTED|Stage 2A||0||
48156819|NCT02227875|100706813|FG000|NOT COMPLETED|Overall Study||37||
48311437|NCT00467779|101088054|FG005|STARTED|Stage 2A||0||
48311438|NCT00467779|101088055|FG006|STARTED|Stage 2A||0||
48311439|NCT00467779|101088056|FG007|STARTED|Stage 2A||0||
48311440|NCT00467779|101088057|FG008|STARTED|Stage 2A||0||
48311441|NCT00467779|101088058|FG009|STARTED|Stage 2A||0||
48311442|NCT00467779|101088059|FG010|STARTED|Stage 2A||0||
48311443|NCT00467779|101088060|FG011|STARTED|Stage 2A||0||
48727707|NCT00803062|102118642|FG002|STARTED|Overall Study||111||
48727708|NCT00803062|102118643|FG003|STARTED|Overall Study||112||
48311444|NCT00467779|101088061|FG012|STARTED|Stage 2A||0||
48311445|NCT00467779|101088062|FG013|STARTED|Stage 2A||22||
48311446|NCT00467779|101088063|FG014|STARTED|Stage 2A||0||
48311447|NCT00467779|101088049|FG000|COMPLETED|Stage 2A||0||
48311448|NCT00467779|101088050|FG001|COMPLETED|Stage 2A||0||
48311449|NCT00467779|101088051|FG002|COMPLETED|Stage 2A||0||
48311450|NCT00467779|101088052|FG003|COMPLETED|Stage 2A||0||
48311451|NCT00467779|101088053|FG004|COMPLETED|Stage 2A||0||
48311452|NCT00467779|101088054|FG005|COMPLETED|Stage 2A||0||
48727709|NCT00803062|102118640|FG000|COMPLETED|Overall Study||114||
48727710|NCT00803062|102118641|FG001|COMPLETED|Overall Study||115||
48727711|NCT00803062|102118642|FG002|COMPLETED|Overall Study||111||
48727712|NCT00803062|102118643|FG003|COMPLETED|Overall Study||112||
48727713|NCT00803062|102118640|FG000|NOT COMPLETED|Overall Study||0||
48727714|NCT00803062|102118641|FG001|NOT COMPLETED|Overall Study||0||
48727715|NCT00803062|102118642|FG002|NOT COMPLETED|Overall Study||0||
48727716|NCT00803062|102118643|FG003|NOT COMPLETED|Overall Study||0||
48727717|NCT00455143|102118644|FG000|STARTED|Overall Study||27||
48727718|NCT00455143|102118644|FG000|COMPLETED|Overall Study||21||
48727719|NCT00455143|102118644|FG000|NOT COMPLETED|Overall Study||6||
48727720|NCT00534833|102118645|FG000|STARTED|Overall Study||182||
48727721|NCT00534833|102118646|FG001|STARTED|Overall Study||180||
48727722|NCT00534833|102118645|FG000|COMPLETED|Overall Study||182||
48156820|NCT02227875|100706814|FG001|NOT COMPLETED|Overall Study||33||
48156821|NCT02003352|100706815|FG000|STARTED|Overall Study||98||
48156822|NCT02003352|100706815|FG000|COMPLETED|Overall Study||98||
48156823|NCT02003352|100706815|FG000|NOT COMPLETED|Overall Study||0||
48156824|NCT00261495|100706816|FG000|STARTED|Titration Phase (Weeks 0 to 4)||254||
48156825|NCT00261495|100706817|FG001|STARTED|Titration Phase (Weeks 0 to 4)||250||
48156826|NCT00261495|100706816|FG000|COMPLETED|Titration Phase (Weeks 0 to 4)||206||
48156827|NCT00261495|100706817|FG001|COMPLETED|Titration Phase (Weeks 0 to 4)||185||
48156828|NCT00261495|100706816|FG000|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||48||
48156829|NCT00261495|100706817|FG001|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||65||
48156830|NCT00261495|100706816|FG000|STARTED|Maintenance Phase (Weeks 4 to 24)||206||
48156831|NCT00261495|100706817|FG001|STARTED|Maintenance Phase (Weeks 4 to 24)||185||
48156832|NCT00261495|100706816|FG000|COMPLETED|Maintenance Phase (Weeks 4 to 24)||140||
48156833|NCT00261495|100706817|FG001|COMPLETED|Maintenance Phase (Weeks 4 to 24)||137||
48156834|NCT00261495|100706816|FG000|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||66||
48156835|NCT00261495|100706817|FG001|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||48||
48156836|NCT00261495|100706816|FG000|STARTED|Extension Phase (Weeks 24 to 52)||60||
48156837|NCT00261495|100706817|FG001|STARTED|Extension Phase (Weeks 24 to 52)||52||
48156838|NCT00261495|100706816|FG000|COMPLETED|Extension Phase (Weeks 24 to 52)||50||
48156839|NCT00261495|100706817|FG001|COMPLETED|Extension Phase (Weeks 24 to 52)||47||
48311453|NCT00467779|101088055|FG006|COMPLETED|Stage 2A||0||
48311454|NCT00467779|101088056|FG007|COMPLETED|Stage 2A||0||
48311455|NCT00467779|101088057|FG008|COMPLETED|Stage 2A||0||
48311456|NCT00467779|101088058|FG009|COMPLETED|Stage 2A||0||
48311457|NCT00467779|101088059|FG010|COMPLETED|Stage 2A||0||
48311458|NCT00467779|101088060|FG011|COMPLETED|Stage 2A||0||
48727723|NCT00534833|102118646|FG001|COMPLETED|Overall Study||180||
48156840|NCT00261495|100706816|FG000|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||10||
48311459|NCT00467779|101088061|FG012|COMPLETED|Stage 2A||0||
48311460|NCT00467779|101088062|FG013|COMPLETED|Stage 2A||1||
48311461|NCT00467779|101088063|FG014|COMPLETED|Stage 2A||0||
48311462|NCT00467779|101088049|FG000|NOT COMPLETED|Stage 2A||0||
48311463|NCT00467779|101088050|FG001|NOT COMPLETED|Stage 2A||0||
48311464|NCT00467779|101088051|FG002|NOT COMPLETED|Stage 2A||0||
48311465|NCT00467779|101088052|FG003|NOT COMPLETED|Stage 2A||0||
48311466|NCT00467779|101088053|FG004|NOT COMPLETED|Stage 2A||0||
48311467|NCT00467779|101088054|FG005|NOT COMPLETED|Stage 2A||0||
48311468|NCT00467779|101088055|FG006|NOT COMPLETED|Stage 2A||0||
48311469|NCT00467779|101088056|FG007|NOT COMPLETED|Stage 2A||0||
48311470|NCT00467779|101088057|FG008|NOT COMPLETED|Stage 2A||0||
48311471|NCT00467779|101088058|FG009|NOT COMPLETED|Stage 2A||0||
48311472|NCT00467779|101088059|FG010|NOT COMPLETED|Stage 2A||0||
48311473|NCT00467779|101088060|FG011|NOT COMPLETED|Stage 2A||0||
48311474|NCT00467779|101088061|FG012|NOT COMPLETED|Stage 2A||0||
48727724|NCT00534833|102118645|FG000|NOT COMPLETED|Overall Study||0||
48727725|NCT00534833|102118646|FG001|NOT COMPLETED|Overall Study||0||
48311475|NCT00467779|101088062|FG013|NOT COMPLETED|Stage 2A||21||
48311476|NCT00467779|101088063|FG014|NOT COMPLETED|Stage 2A||0||
48311477|NCT00467779|101088049|FG000|STARTED|Stage 3||0||
48727726|NCT02249182|102118647|FG000|STARTED|PK Lead-In Phase||10||
48727727|NCT02249182|102118648|FG001|STARTED|PK Lead-In Phase||12||
48727728|NCT02249182|102118649|FG002|STARTED|PK Lead-In Phase||0||
48727729|NCT02249182|102118650|FG003|STARTED|PK Lead-In Phase||0||
48727730|NCT02249182|102118651|FG004|STARTED|PK Lead-In Phase||17||
48727731|NCT02249182|102118647|FG000|COMPLETED|PK Lead-In Phase||10||
48727732|NCT02249182|102118648|FG001|COMPLETED|PK Lead-In Phase||12||
48727733|NCT02249182|102118649|FG002|COMPLETED|PK Lead-In Phase||0||
48727734|NCT02249182|102118650|FG003|COMPLETED|PK Lead-In Phase||0||
48727735|NCT02249182|102118651|FG004|COMPLETED|PK Lead-In Phase||17||
48727736|NCT02249182|102118647|FG000|NOT COMPLETED|PK Lead-In Phase||0||
48727737|NCT02249182|102118648|FG001|NOT COMPLETED|PK Lead-In Phase||0||
48727738|NCT02249182|102118649|FG002|NOT COMPLETED|PK Lead-In Phase||0||
48727739|NCT02249182|102118650|FG003|NOT COMPLETED|PK Lead-In Phase||0||
48727740|NCT02249182|102118651|FG004|NOT COMPLETED|PK Lead-In Phase||0||
48727741|NCT02249182|102118647|FG000|STARTED|Treatment Phase||100||
48727742|NCT02249182|102118648|FG001|STARTED|Treatment Phase||89||
48727743|NCT02249182|102118649|FG002|STARTED|Treatment Phase||1||
48727744|NCT02249182|102118650|FG003|STARTED|Treatment Phase||2||
48727745|NCT02249182|102118651|FG004|STARTED|Treatment Phase||34||
48727746|NCT02249182|102118647|FG000|COMPLETED|Treatment Phase||96||
48727747|NCT02249182|102118648|FG001|COMPLETED|Treatment Phase||89||
48311478|NCT00467779|101088050|FG001|STARTED|Stage 3||0||
48311479|NCT00467779|101088051|FG002|STARTED|Stage 3||0||
48311480|NCT00467779|101088052|FG003|STARTED|Stage 3||0||
48311481|NCT00467779|101088053|FG004|STARTED|Stage 3||0||
48727748|NCT02249182|102118649|FG002|COMPLETED|Treatment Phase||1||
48727749|NCT02249182|102118650|FG003|COMPLETED|Treatment Phase||2||
48727750|NCT02249182|102118651|FG004|COMPLETED|Treatment Phase||34||
48727751|NCT02249182|102118647|FG000|NOT COMPLETED|Treatment Phase||4||
48727752|NCT02249182|102118648|FG001|NOT COMPLETED|Treatment Phase||0||
48727753|NCT02249182|102118649|FG002|NOT COMPLETED|Treatment Phase||0||
48727754|NCT02249182|102118650|FG003|NOT COMPLETED|Treatment Phase||0||
48727755|NCT02249182|102118651|FG004|NOT COMPLETED|Treatment Phase||0||
48727756|NCT04294147|102118652|FG000|STARTED|Overall Study||32||
48727757|NCT04294147|102118653|FG001|STARTED|Overall Study||33||
48727758|NCT04294147|102118652|FG000|Received at Least One Dose of Study Drug|Overall Study||32||
48727759|NCT04294147|102118653|FG001|Received at Least One Dose of Study Drug|Overall Study||33||
48727760|NCT04294147|102118652|FG000|COMPLETED|Overall Study||30||
48727761|NCT04294147|102118653|FG001|COMPLETED|Overall Study||33||
48727762|NCT04294147|102118652|FG000|NOT COMPLETED|Overall Study||2||
48727763|NCT04294147|102118653|FG001|NOT COMPLETED|Overall Study||0||
48727764|NCT00494507|102118654|FG000|STARTED|Double-Blind Phase||12||
48727765|NCT00494507|102118655|FG001|STARTED|Double-Blind Phase||9||
48727766|NCT00494507|102118656|FG002|STARTED|Double-Blind Phase||24||
48727767|NCT00494507|102118657|FG003|STARTED|Double-Blind Phase||20||
48727768|NCT00494507|102118654|FG000|Reached Endpoint of Acute Worsening|Double-Blind Phase||0||
48311482|NCT00467779|101088054|FG005|STARTED|Stage 3||0||
48727769|NCT00494507|102118655|FG001|Reached Endpoint of Acute Worsening|Double-Blind Phase||2||
48727770|NCT00494507|102118656|FG002|Reached Endpoint of Acute Worsening|Double-Blind Phase||0||
48727771|NCT00494507|102118657|FG003|Reached Endpoint of Acute Worsening|Double-Blind Phase||5||
48727772|NCT00494507|102118654|FG000|COMPLETED|Double-Blind Phase||9||
48727773|NCT00494507|102118655|FG001|COMPLETED|Double-Blind Phase||9||
48311483|NCT00467779|101088055|FG006|STARTED|Stage 3||0||
48311484|NCT00467779|101088056|FG007|STARTED|Stage 3||0||
48311485|NCT00467779|101088057|FG008|STARTED|Stage 3||0||
48727774|NCT00494507|102118656|FG002|COMPLETED|Double-Blind Phase||22||
48727775|NCT00494507|102118657|FG003|COMPLETED|Double-Blind Phase||19||
48727776|NCT00494507|102118654|FG000|NOT COMPLETED|Double-Blind Phase||3||
48727777|NCT00494507|102118655|FG001|NOT COMPLETED|Double-Blind Phase||0||
48727778|NCT00494507|102118656|FG002|NOT COMPLETED|Double-Blind Phase||2||
48727779|NCT00494507|102118657|FG003|NOT COMPLETED|Double-Blind Phase||1||
48311486|NCT00467779|101088058|FG009|STARTED|Stage 3||0||
48311487|NCT00467779|101088059|FG010|STARTED|Stage 3||0||
48311488|NCT00467779|101088060|FG011|STARTED|Stage 3||0||
48311489|NCT00467779|101088061|FG012|STARTED|Stage 3||0||
48311490|NCT00467779|101088062|FG013|STARTED|Stage 3||0||
48311491|NCT00467779|101088063|FG014|STARTED|Stage 3||20||
48311492|NCT00467779|101088049|FG000|COMPLETED|Stage 3||0||
48311493|NCT00467779|101088050|FG001|COMPLETED|Stage 3||0||
48311494|NCT00467779|101088051|FG002|COMPLETED|Stage 3||0||
48311495|NCT00467779|101088052|FG003|COMPLETED|Stage 3||0||
48311496|NCT00467779|101088053|FG004|COMPLETED|Stage 3||0||
48727780|NCT00494507|102118654|FG000|STARTED|Open-Label Phase||9||
48727781|NCT00494507|102118655|FG001|STARTED|Open-Label Phase||8||
48727782|NCT00494507|102118656|FG002|STARTED|Open-Label Phase||22||
48727783|NCT00494507|102118657|FG003|STARTED|Open-Label Phase||19||
48727784|NCT00494507|102118654|FG000|COMPLETED|Open-Label Phase||9||
48727785|NCT00494507|102118655|FG001|COMPLETED|Open-Label Phase||7||
48727786|NCT00494507|102118656|FG002|COMPLETED|Open-Label Phase||17||
48727787|NCT00494507|102118657|FG003|COMPLETED|Open-Label Phase||14||
48727788|NCT00494507|102118654|FG000|NOT COMPLETED|Open-Label Phase||0||
48727789|NCT00494507|102118655|FG001|NOT COMPLETED|Open-Label Phase||1||
48727790|NCT00494507|102118656|FG002|NOT COMPLETED|Open-Label Phase||5||
48727791|NCT00494507|102118657|FG003|NOT COMPLETED|Open-Label Phase||5||
48727792|NCT03253328|102118658|FG000|STARTED|Overall Study||16||
48727793|NCT03253328|102118659|FG001|STARTED|Overall Study||17||
48727794|NCT03253328|102118658|FG000|COMPLETED|Overall Study||10||
48727795|NCT03253328|102118659|FG001|COMPLETED|Overall Study||16||
48727796|NCT03253328|102118658|FG000|NOT COMPLETED|Overall Study||6||
48727797|NCT03253328|102118659|FG001|NOT COMPLETED|Overall Study||1||
48727798|NCT02687581|102118660|FG000|STARTED|Overall Study||6||
48727799|NCT02687581|102118661|FG001|STARTED|Overall Study||6||
48727800|NCT02687581|102118662|FG002|STARTED|Overall Study||2||
48727801|NCT02687581|102118663|FG003|STARTED|Overall Study||4||
48311497|NCT00467779|101088054|FG005|COMPLETED|Stage 3||0||
48311498|NCT00467779|101088055|FG006|COMPLETED|Stage 3||0||
48311499|NCT00467779|101088056|FG007|COMPLETED|Stage 3||0||
48311500|NCT00467779|101088057|FG008|COMPLETED|Stage 3||0||
48311501|NCT00467779|101088058|FG009|COMPLETED|Stage 3||0||
48311502|NCT00467779|101088059|FG010|COMPLETED|Stage 3||0||
48311503|NCT00467779|101088060|FG011|COMPLETED|Stage 3||0||
48727802|NCT02687581|102118660|FG000|COMPLETED|Overall Study||2||
48727803|NCT02687581|102118661|FG001|COMPLETED|Overall Study||4||
48727804|NCT02687581|102118662|FG002|COMPLETED|Overall Study||2||
48727805|NCT02687581|102118663|FG003|COMPLETED|Overall Study||3||
48727806|NCT02687581|102118660|FG000|NOT COMPLETED|Overall Study||4||
48727807|NCT02687581|102118661|FG001|NOT COMPLETED|Overall Study||2||
48727808|NCT02687581|102118662|FG002|NOT COMPLETED|Overall Study||0||
48727809|NCT02687581|102118663|FG003|NOT COMPLETED|Overall Study||1||
48727810|NCT02104947|102118664|FG000|STARTED|Overall Study||301||
48727811|NCT02104947|102118665|FG001|STARTED|Overall Study||202||
48727812|NCT02104947|102118664|FG000|COMPLETED|Overall Study||222||
48727813|NCT02104947|102118665|FG001|COMPLETED|Overall Study||146||
48727814|NCT02104947|102118664|FG000|NOT COMPLETED|Overall Study||79||
48727815|NCT02104947|102118665|FG001|NOT COMPLETED|Overall Study||56||
48727816|NCT03074682|102118666|FG000|STARTED|Overall Study||18||
48727817|NCT03074682|102118667|FG001|STARTED|Overall Study||18||
48727818|NCT03074682|102118668|FG002|STARTED|Overall Study||18||
48727819|NCT03074682|102118666|FG000|COMPLETED|Overall Study||18||
48727820|NCT03074682|102118667|FG001|COMPLETED|Overall Study||18||
48727821|NCT03074682|102118668|FG002|COMPLETED|Overall Study||18||
48727822|NCT03074682|102118666|FG000|NOT COMPLETED|Overall Study||0||
48727823|NCT03074682|102118667|FG001|NOT COMPLETED|Overall Study||0||
48727824|NCT03074682|102118668|FG002|NOT COMPLETED|Overall Study||0||
48727825|NCT02188849|102118669|FG000|STARTED|Overall Study||25||
48727826|NCT02188849|102118670|FG001|STARTED|Overall Study||25||
48727827|NCT02188849|102118669|FG000|COMPLETED|Overall Study||22||
48727828|NCT02188849|102118670|FG001|COMPLETED|Overall Study||17||
48727829|NCT02188849|102118669|FG000|NOT COMPLETED|Overall Study||3||
48727830|NCT02188849|102118670|FG001|NOT COMPLETED|Overall Study||8||
48311504|NCT00467779|101088061|FG012|COMPLETED|Stage 3||0||
48311505|NCT00467779|101088062|FG013|COMPLETED|Stage 3||0||
48311506|NCT00467779|101088063|FG014|COMPLETED|Stage 3||3||
48727831|NCT00375518|102118671|FG000|STARTED|Overall Study||80||
48727832|NCT00375518|102118672|FG001|STARTED|Overall Study||82||
48311507|NCT00467779|101088049|FG000|NOT COMPLETED|Stage 3||0||
48311508|NCT00467779|101088050|FG001|NOT COMPLETED|Stage 3||0||
48311509|NCT00467779|101088051|FG002|NOT COMPLETED|Stage 3||0||
48727833|NCT00375518|102118671|FG000|COMPLETED|Overall Study||72||
48727834|NCT00375518|102118672|FG001|COMPLETED|Overall Study||65||
48727835|NCT00375518|102118671|FG000|NOT COMPLETED|Overall Study||8||
48727836|NCT00375518|102118672|FG001|NOT COMPLETED|Overall Study||17||
48727837|NCT02128074|102118673|FG000|STARTED|Overall Study||32||
48311510|NCT00467779|101088052|FG003|NOT COMPLETED|Stage 3||0||
48311511|NCT00467779|101088053|FG004|NOT COMPLETED|Stage 3||0||
48311512|NCT00467779|101088054|FG005|NOT COMPLETED|Stage 3||0||
48311513|NCT00467779|101088055|FG006|NOT COMPLETED|Stage 3||0||
48311514|NCT00467779|101088056|FG007|NOT COMPLETED|Stage 3||0||
48311515|NCT00467779|101088057|FG008|NOT COMPLETED|Stage 3||0||
48311516|NCT00467779|101088058|FG009|NOT COMPLETED|Stage 3||0||
48311517|NCT00467779|101088059|FG010|NOT COMPLETED|Stage 3||0||
48727838|NCT02128074|102118673|FG000|COMPLETED|Overall Study||26||
48727839|NCT02128074|102118673|FG000|NOT COMPLETED|Overall Study||6||
48727840|NCT04384523|102118674|FG000|STARTED|Overall Study||10||
48727841|NCT04384523|102118675|FG001|STARTED|Overall Study||6||
48727842|NCT04384523|102118676|FG002|STARTED|Overall Study||6||
48727843|NCT04384523|102118677|FG003|STARTED|Overall Study||6||
48727844|NCT04384523|102118678|FG004|STARTED|Overall Study||7||
48727845|NCT04384523|102118679|FG005|STARTED|Overall Study||6||
48156841|NCT00261495|100706817|FG001|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5||
48156842|NCT00404495|100706818|FG000|STARTED|Overall Study||66||
48156843|NCT00404495|100706819|FG001|STARTED|Overall Study||17||
48156844|NCT00404495|100706818|FG000|COMPLETED|Overall Study||22||
48156845|NCT00404495|100706819|FG001|COMPLETED|Overall Study||6||
48156846|NCT00404495|100706818|FG000|NOT COMPLETED|Overall Study||44||
48156847|NCT00404495|100706819|FG001|NOT COMPLETED|Overall Study||11||
48156848|NCT02094443|100706820|FG000|STARTED|Overall Study||26||
48156849|NCT02094443|100706821|FG001|STARTED|Overall Study||26||
48156850|NCT02094443|100706820|FG000|Completed at Week 12|Overall Study||0||
48156851|NCT02094443|100706821|FG001|Completed at Week 12|Overall Study||1||
48156852|NCT02094443|100706820|FG000|Completed at Week 24|Overall Study||11||
48156853|NCT02094443|100706821|FG001|Completed at Week 24|Overall Study||8||
48156854|NCT02094443|100706820|FG000|COMPLETED|Overall Study||11||
48156855|NCT02094443|100706821|FG001|COMPLETED|Overall Study||9||
48156856|NCT02094443|100706820|FG000|NOT COMPLETED|Overall Study||15||
48156857|NCT02094443|100706821|FG001|NOT COMPLETED|Overall Study||17||
48156858|NCT00676182|100706822|FG000|STARTED|Overall Study||75||
48156859|NCT00676182|100706822|FG000|COMPLETED|Overall Study||75||
48156860|NCT00676182|100706822|FG000|NOT COMPLETED|Overall Study||0||
48156861|NCT01875185|100706823|FG000|STARTED|Overall Study||52||
48156862|NCT01875185|100706824|FG001|STARTED|Overall Study||48||
48156863|NCT01875185|100706823|FG000|COMPLETED|Overall Study||0||
48156864|NCT01875185|100706824|FG001|COMPLETED|Overall Study||0||
48156865|NCT01875185|100706823|FG000|NOT COMPLETED|Overall Study||52||
48156866|NCT01875185|100706824|FG001|NOT COMPLETED|Overall Study||48||
48156867|NCT00571961|100706825|FG000|STARTED|Overall Study||12||
48156868|NCT00571961|100706825|FG000|COMPLETED|Overall Study||12||
48156869|NCT00571961|100706825|FG000|NOT COMPLETED|Overall Study||0||
48156870|NCT02707692|100706826|FG000|STARTED|Cycle 1 (30 Days)||9||
48156871|NCT02707692|100706827|FG001|STARTED|Cycle 1 (30 Days)||9||
48156872|NCT02707692|100706828|FG002|STARTED|Cycle 1 (30 Days)||9||
48156873|NCT02707692|100706829|FG003|STARTED|Cycle 1 (30 Days)||9||
48156874|NCT02707692|100706830|FG004|STARTED|Cycle 1 (30 Days)||9||
48156875|NCT02707692|100706831|FG005|STARTED|Cycle 1 (30 Days)||9||
48156876|NCT02707692|100706826|FG000|COMPLETED|Cycle 1 (30 Days)||8||
48156877|NCT02707692|100706827|FG001|COMPLETED|Cycle 1 (30 Days)||6||
48156878|NCT02707692|100706828|FG002|COMPLETED|Cycle 1 (30 Days)||8||
48156879|NCT02707692|100706829|FG003|COMPLETED|Cycle 1 (30 Days)||9||
48156880|NCT02707692|100706830|FG004|COMPLETED|Cycle 1 (30 Days)||8||
48156881|NCT02707692|100706831|FG005|COMPLETED|Cycle 1 (30 Days)||8||
48156882|NCT02707692|100706826|FG000|NOT COMPLETED|Cycle 1 (30 Days)||1||
48156883|NCT02707692|100706827|FG001|NOT COMPLETED|Cycle 1 (30 Days)||3||
48156884|NCT02707692|100706828|FG002|NOT COMPLETED|Cycle 1 (30 Days)||1||
48156885|NCT02707692|100706829|FG003|NOT COMPLETED|Cycle 1 (30 Days)||0||
48156886|NCT02707692|100706830|FG004|NOT COMPLETED|Cycle 1 (30 Days)||1||
48156887|NCT02707692|100706831|FG005|NOT COMPLETED|Cycle 1 (30 Days)||1||
48156888|NCT02707692|100706826|FG000|STARTED|Washout Between Cycles 1 and 2 (>=6 Wks)||8||
48311518|NCT00467779|101088060|FG011|NOT COMPLETED|Stage 3||0||
48727846|NCT04384523|102118674|FG000|COMPLETED|Overall Study||9||
48727847|NCT04384523|102118675|FG001|COMPLETED|Overall Study||5||
48727848|NCT04384523|102118676|FG002|COMPLETED|Overall Study||6||
48727849|NCT04384523|102118677|FG003|COMPLETED|Overall Study||6||
48727850|NCT04384523|102118678|FG004|COMPLETED|Overall Study||7||
48727851|NCT04384523|102118679|FG005|COMPLETED|Overall Study||5||
48727852|NCT04384523|102118674|FG000|NOT COMPLETED|Overall Study||1||
48156889|NCT02707692|100706827|FG001|STARTED|Washout Between Cycles 1 and 2 (>=6 Wks)||6||
48156890|NCT02707692|100706828|FG002|STARTED|Washout Between Cycles 1 and 2 (>=6 Wks)||9||
48156891|NCT02707692|100706829|FG003|STARTED|Washout Between Cycles 1 and 2 (>=6 Wks)||9||
48156892|NCT02707692|100706830|FG004|STARTED|Washout Between Cycles 1 and 2 (>=6 Wks)||8||
48156893|NCT02707692|100706831|FG005|STARTED|Washout Between Cycles 1 and 2 (>=6 Wks)||8||
48156894|NCT02707692|100706826|FG000|COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||7||
48156895|NCT02707692|100706827|FG001|COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||6||
48156896|NCT02707692|100706828|FG002|COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||9||
48156897|NCT02707692|100706829|FG003|COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||8||
48156898|NCT02707692|100706830|FG004|COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||7||
48156899|NCT02707692|100706831|FG005|COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||8||
48156900|NCT02707692|100706826|FG000|NOT COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||1||
48156901|NCT02707692|100706827|FG001|NOT COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||0||
48156902|NCT02707692|100706828|FG002|NOT COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||0||
48156903|NCT02707692|100706829|FG003|NOT COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||1||
48727853|NCT04384523|102118675|FG001|NOT COMPLETED|Overall Study||1||
48727854|NCT04384523|102118676|FG002|NOT COMPLETED|Overall Study||0||
48156904|NCT02707692|100706830|FG004|NOT COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||1||
48156905|NCT02707692|100706831|FG005|NOT COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||0||
48156906|NCT02707692|100706826|FG000|STARTED|Cycle 2 (30 Days)||7||
48156907|NCT02707692|100706827|FG001|STARTED|Cycle 2 (30 Days)||6||
48156908|NCT02707692|100706828|FG002|STARTED|Cycle 2 (30 Days)||9||
48156909|NCT02707692|100706829|FG003|STARTED|Cycle 2 (30 Days)||8||
48727855|NCT04384523|102118677|FG003|NOT COMPLETED|Overall Study||0||
48727856|NCT04384523|102118678|FG004|NOT COMPLETED|Overall Study||0||
48727857|NCT04384523|102118679|FG005|NOT COMPLETED|Overall Study||1||
48727858|NCT01849419|102118680|FG000|STARTED|Overall Study||65||
48727859|NCT01849419|102118680|FG000|COMPLETED|Overall Study||65||
48156910|NCT02707692|100706830|FG004|STARTED|Cycle 2 (30 Days)||7||
48156911|NCT02707692|100706831|FG005|STARTED|Cycle 2 (30 Days)||8||
48156912|NCT02707692|100706826|FG000|COMPLETED|Cycle 2 (30 Days)||6||
48156913|NCT02707692|100706827|FG001|COMPLETED|Cycle 2 (30 Days)||6||
48156914|NCT02707692|100706828|FG002|COMPLETED|Cycle 2 (30 Days)||9||
48156915|NCT02707692|100706829|FG003|COMPLETED|Cycle 2 (30 Days)||7||
48156916|NCT02707692|100706830|FG004|COMPLETED|Cycle 2 (30 Days)||4||
48156917|NCT02707692|100706831|FG005|COMPLETED|Cycle 2 (30 Days)||7||
48156918|NCT02707692|100706826|FG000|NOT COMPLETED|Cycle 2 (30 Days)||1||
48156919|NCT02707692|100706827|FG001|NOT COMPLETED|Cycle 2 (30 Days)||0||
48156920|NCT02707692|100706828|FG002|NOT COMPLETED|Cycle 2 (30 Days)||0||
48156921|NCT02707692|100706829|FG003|NOT COMPLETED|Cycle 2 (30 Days)||1||
48156922|NCT02707692|100706830|FG004|NOT COMPLETED|Cycle 2 (30 Days)||3||
48727860|NCT01849419|102118680|FG000|NOT COMPLETED|Overall Study||0||
48727861|NCT01153698|102118681|FG000|STARTED|Overall Study||168||
48727862|NCT01153698|102118681|FG000|COMPLETED|Overall Study||139||
48156923|NCT02707692|100706831|FG005|NOT COMPLETED|Cycle 2 (30 Days)||1||
48156924|NCT02707692|100706826|FG000|STARTED|Washout Between Cycles 2 and 3 (>=6 Wks)||7||
48156925|NCT02707692|100706827|FG001|STARTED|Washout Between Cycles 2 and 3 (>=6 Wks)||6||
48156926|NCT02707692|100706828|FG002|STARTED|Washout Between Cycles 2 and 3 (>=6 Wks)||9||
48156927|NCT02707692|100706829|FG003|STARTED|Washout Between Cycles 2 and 3 (>=6 Wks)||7||
48156928|NCT02707692|100706830|FG004|STARTED|Washout Between Cycles 2 and 3 (>=6 Wks)||6||
48156929|NCT02707692|100706831|FG005|STARTED|Washout Between Cycles 2 and 3 (>=6 Wks)||7||
48156930|NCT02707692|100706826|FG000|COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||7||
48156931|NCT02707692|100706827|FG001|COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||6||
48156932|NCT02707692|100706828|FG002|COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||9||
48156933|NCT02707692|100706829|FG003|COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||5||
48156934|NCT02707692|100706830|FG004|COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||6||
48156935|NCT02707692|100706831|FG005|COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||6||
48156936|NCT02707692|100706826|FG000|NOT COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||0||
48727863|NCT01153698|102118681|FG000|NOT COMPLETED|Overall Study||29||
48727864|NCT01748825|102118682|FG000|STARTED|Dose Escalation||6||
48727865|NCT01748825|102118683|FG001|STARTED|Dose Escalation||4||
48727866|NCT01748825|102118684|FG002|STARTED|Dose Escalation||6||
48727867|NCT01748825|102118685|FG003|STARTED|Dose Escalation||3||
48727868|NCT01748825|102118686|FG004|STARTED|Dose Escalation||3||
48727869|NCT01748825|102118687|FG005|STARTED|Dose Escalation||6||
48727870|NCT01748825|102118688|FG006|STARTED|Dose Escalation||3||
48156937|NCT02707692|100706827|FG001|NOT COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||0||
48156938|NCT02707692|100706828|FG002|NOT COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||0||
48727871|NCT01748825|102118689|FG007|STARTED|Dose Escalation||3||
48727872|NCT01748825|102118690|FG008|STARTED|Dose Escalation||0||
48727873|NCT01748825|102118691|FG009|STARTED|Dose Escalation||0||
48727874|NCT01748825|102118682|FG000|COMPLETED|Dose Escalation||4||
48727875|NCT01748825|102118683|FG001|COMPLETED|Dose Escalation||2||
48727876|NCT01748825|102118684|FG002|COMPLETED|Dose Escalation||6||
48727877|NCT01748825|102118685|FG003|COMPLETED|Dose Escalation||2||
48727878|NCT01748825|102118686|FG004|COMPLETED|Dose Escalation||2||
48613258|NCT01431313|101838461|FG000|STARTED|Overall Study||20||
48613259|NCT01431313|101838462|FG001|STARTED|Overall Study||20||
48613260|NCT01431313|101838463|FG002|STARTED|Overall Study||8||
48613261|NCT01431313|101838461|FG000|COMPLETED|Overall Study||20||
48613262|NCT01431313|101838462|FG001|COMPLETED|Overall Study||20||
48613263|NCT01431313|101838463|FG002|COMPLETED|Overall Study||8||
48613264|NCT01431313|101838461|FG000|NOT COMPLETED|Overall Study||0||
48613265|NCT01431313|101838462|FG001|NOT COMPLETED|Overall Study||0||
48613266|NCT01431313|101838463|FG002|NOT COMPLETED|Overall Study||0||
48613267|NCT02541409|101838464|FG000|STARTED|Overall Study||25||
48613268|NCT02541409|101838465|FG001|STARTED|Overall Study||25||
48613269|NCT02541409|101838464|FG000|COMPLETED|Overall Study||22||
48613270|NCT02541409|101838465|FG001|COMPLETED|Overall Study||22||
48613271|NCT02541409|101838464|FG000|NOT COMPLETED|Overall Study||3||
48613272|NCT02541409|101838465|FG001|NOT COMPLETED|Overall Study||3||
48613273|NCT02035553|101838466|FG000|STARTED|Overall Study||91||
48613274|NCT02035553|101838467|FG001|STARTED|Overall Study||90||
48613275|NCT02035553|101838466|FG000|COMPLETED|Overall Study||73||
48613276|NCT02035553|101838467|FG001|COMPLETED|Overall Study||67||
48613277|NCT02035553|101838466|FG000|NOT COMPLETED|Overall Study||18||
48613278|NCT02035553|101838467|FG001|NOT COMPLETED|Overall Study||23||
48613279|NCT00807885|101838468|FG000|STARTED|Overall Study||10||
48613280|NCT00807885|101838469|FG001|STARTED|Overall Study||11||
48613281|NCT00807885|101838470|FG002|STARTED|Overall Study||11||
48613282|NCT00807885|101838471|FG003|STARTED|Overall Study||10||
48613283|NCT00807885|101838472|FG004|STARTED|Overall Study||12||
48613284|NCT00807885|101838473|FG005|STARTED|Overall Study||12||
48613285|NCT00807885|101838474|FG006|STARTED|Overall Study||12||
48613286|NCT00807885|101838475|FG007|STARTED|Overall Study||11||
48613287|NCT00807885|101838476|FG008|STARTED|Overall Study||11||
48613288|NCT00807885|101838468|FG000|COMPLETED|Overall Study||10||
48613289|NCT00807885|101838469|FG001|COMPLETED|Overall Study||11||
48613290|NCT00807885|101838470|FG002|COMPLETED|Overall Study||11||
48311519|NCT00467779|101088061|FG012|NOT COMPLETED|Stage 3||0||
48311520|NCT00467779|101088062|FG013|NOT COMPLETED|Stage 3||0||
48311521|NCT00467779|101088063|FG014|NOT COMPLETED|Stage 3||17||
48311522|NCT01353508|101088064|FG000|STARTED|Period 1 - First Intervention (7 Days)||8||
48613291|NCT00807885|101838471|FG003|COMPLETED|Overall Study||10||
48613292|NCT00807885|101838472|FG004|COMPLETED|Overall Study||12||
48613293|NCT00807885|101838473|FG005|COMPLETED|Overall Study||11||
48613294|NCT00807885|101838474|FG006|COMPLETED|Overall Study||12||
48613295|NCT00807885|101838475|FG007|COMPLETED|Overall Study||11||
48613296|NCT00807885|101838476|FG008|COMPLETED|Overall Study||11||
48613297|NCT00807885|101838468|FG000|NOT COMPLETED|Overall Study||0||
48613298|NCT00807885|101838469|FG001|NOT COMPLETED|Overall Study||0||
48613299|NCT00807885|101838470|FG002|NOT COMPLETED|Overall Study||0||
48613300|NCT00807885|101838471|FG003|NOT COMPLETED|Overall Study||0||
48613301|NCT00807885|101838472|FG004|NOT COMPLETED|Overall Study||0||
48613302|NCT00807885|101838473|FG005|NOT COMPLETED|Overall Study||1||
48613303|NCT00807885|101838474|FG006|NOT COMPLETED|Overall Study||0||
48613304|NCT00807885|101838475|FG007|NOT COMPLETED|Overall Study||0||
48311523|NCT01353508|101088065|FG001|STARTED|Period 1 - First Intervention (7 Days)||8||
48311524|NCT01353508|101088066|FG002|STARTED|Period 1 - First Intervention (7 Days)||8||
48311525|NCT01353508|101088067|FG003|STARTED|Period 1 - First Intervention (7 Days)||8||
48311526|NCT01353508|101088064|FG000|COMPLETED|Period 1 - First Intervention (7 Days)||8||
48311527|NCT01353508|101088065|FG001|COMPLETED|Period 1 - First Intervention (7 Days)||8||
48311528|NCT01353508|101088066|FG002|COMPLETED|Period 1 - First Intervention (7 Days)||8||
48311529|NCT01353508|101088067|FG003|COMPLETED|Period 1 - First Intervention (7 Days)||7||
48613305|NCT00807885|101838476|FG008|NOT COMPLETED|Overall Study||0||
48613306|NCT03311841|101838477|FG000|STARTED|Period 1||6||
48613307|NCT03311841|101838478|FG001|STARTED|Period 1||7||
48613308|NCT03311841|101838479|FG002|STARTED|Period 1||6||
48613309|NCT03311841|101838480|FG003|STARTED|Period 1||7||
48613310|NCT03311841|101838481|FG004|STARTED|Period 1||6||
48613311|NCT03311841|101838477|FG000|COMPLETED|Period 1||6||
48613312|NCT03311841|101838478|FG001|COMPLETED|Period 1||7||
48613313|NCT03311841|101838479|FG002|COMPLETED|Period 1||6||
48613314|NCT03311841|101838480|FG003|COMPLETED|Period 1||7||
48613315|NCT03311841|101838481|FG004|COMPLETED|Period 1||6||
48613316|NCT03311841|101838477|FG000|NOT COMPLETED|Period 1||0||
48613317|NCT03311841|101838478|FG001|NOT COMPLETED|Period 1||0||
48613318|NCT03311841|101838479|FG002|NOT COMPLETED|Period 1||0||
48613319|NCT03311841|101838480|FG003|NOT COMPLETED|Period 1||0||
48311530|NCT01353508|101088064|FG000|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0||
48613320|NCT03311841|101838481|FG004|NOT COMPLETED|Period 1||0||
48613321|NCT03311841|101838477|FG000|STARTED|14-day Wash-out||6||
48613322|NCT03311841|101838478|FG001|STARTED|14-day Wash-out||7||
48613323|NCT03311841|101838479|FG002|STARTED|14-day Wash-out||6||
48613324|NCT03311841|101838480|FG003|STARTED|14-day Wash-out||7||
48613325|NCT03311841|101838481|FG004|STARTED|14-day Wash-out||6||
48311531|NCT01353508|101088065|FG001|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0||
48613326|NCT03311841|101838477|FG000|COMPLETED|14-day Wash-out||6||
48613327|NCT03311841|101838478|FG001|COMPLETED|14-day Wash-out||6||
48613328|NCT03311841|101838479|FG002|COMPLETED|14-day Wash-out||6||
48613329|NCT03311841|101838480|FG003|COMPLETED|14-day Wash-out||6||
48613330|NCT03311841|101838481|FG004|COMPLETED|14-day Wash-out||6||
48613331|NCT03311841|101838477|FG000|NOT COMPLETED|14-day Wash-out||0||
48613332|NCT03311841|101838478|FG001|NOT COMPLETED|14-day Wash-out||1||
48613333|NCT03311841|101838479|FG002|NOT COMPLETED|14-day Wash-out||0||
48613334|NCT03311841|101838480|FG003|NOT COMPLETED|14-day Wash-out||1||
48613335|NCT03311841|101838481|FG004|NOT COMPLETED|14-day Wash-out||0||
48613336|NCT03311841|101838477|FG000|STARTED|Period 2||6||
48613337|NCT03311841|101838478|FG001|STARTED|Period 2||6||
48613338|NCT03311841|101838479|FG002|STARTED|Period 2||6||
48613339|NCT03311841|101838480|FG003|STARTED|Period 2||6||
48613340|NCT03311841|101838481|FG004|STARTED|Period 2||6||
48613341|NCT03311841|101838477|FG000|COMPLETED|Period 2||6||
48613342|NCT03311841|101838478|FG001|COMPLETED|Period 2||6||
48613343|NCT03311841|101838479|FG002|COMPLETED|Period 2||6||
48613344|NCT03311841|101838480|FG003|COMPLETED|Period 2||6||
48613345|NCT03311841|101838481|FG004|COMPLETED|Period 2||6||
48613346|NCT03311841|101838477|FG000|NOT COMPLETED|Period 2||0||
48613347|NCT03311841|101838478|FG001|NOT COMPLETED|Period 2||0||
48613348|NCT03311841|101838479|FG002|NOT COMPLETED|Period 2||0||
48613349|NCT03311841|101838480|FG003|NOT COMPLETED|Period 2||0||
48613350|NCT03311841|101838481|FG004|NOT COMPLETED|Period 2||0||
48613351|NCT00883415|101838482|FG000|STARTED|Overall Study||20||
48613352|NCT00883415|101838482|FG000|COMPLETED|Overall Study||18||
48613353|NCT00883415|101838482|FG000|NOT COMPLETED|Overall Study||2||
48613354|NCT02251821|101838483|FG000|STARTED|Overall Study||61||
48613355|NCT02251821|101838483|FG000|COMPLETED|Overall Study||61||
48613356|NCT02251821|101838483|FG000|NOT COMPLETED|Overall Study||0||
48613357|NCT03132415|101838484|FG000|STARTED|Overall Study||143||
48613358|NCT03132415|101838485|FG001|STARTED|Overall Study||142||
48613359|NCT03132415|101838484|FG000|COMPLETED|Overall Study||143||
48613360|NCT03132415|101838485|FG001|COMPLETED|Overall Study||142||
48613361|NCT03132415|101838484|FG000|NOT COMPLETED|Overall Study||0||
48613362|NCT03132415|101838485|FG001|NOT COMPLETED|Overall Study||0||
48613363|NCT03610334|101838486|FG000|STARTED|Period 1: 2.5mg (1 Day)||6||
48613364|NCT03610334|101838487|FG001|STARTED|Period 1: 2.5mg (1 Day)||2||
48613365|NCT03610334|101838488|FG002|STARTED|Period 1: 2.5mg (1 Day)||0||
48613366|NCT03610334|101838489|FG003|STARTED|Period 1: 2.5mg (1 Day)||0||
48613367|NCT03610334|101838490|FG004|STARTED|Period 1: 2.5mg (1 Day)||0||
48613368|NCT03610334|101838491|FG005|STARTED|Period 1: 2.5mg (1 Day)||0||
48613369|NCT03610334|101838492|FG006|STARTED|Period 1: 2.5mg (1 Day)||0||
48613370|NCT03610334|101838493|FG007|STARTED|Period 1: 2.5mg (1 Day)||0||
48613371|NCT03610334|101838494|FG008|STARTED|Period 1: 2.5mg (1 Day)||0||
48613372|NCT03610334|101838495|FG009|STARTED|Period 1: 2.5mg (1 Day)||0||
48613373|NCT03610334|101838496|FG010|STARTED|Period 1: 2.5mg (1 Day)||0||
48613374|NCT03610334|101838497|FG011|STARTED|Period 1: 2.5mg (1 Day)||0||
48613375|NCT03610334|101838498|FG012|STARTED|Period 1: 2.5mg (1 Day)||0||
48613376|NCT03610334|101838499|FG013|STARTED|Period 1: 2.5mg (1 Day)||0||
48613377|NCT03610334|101838500|FG014|STARTED|Period 1: 2.5mg (1 Day)||0||
48613378|NCT03610334|101838501|FG015|STARTED|Period 1: 2.5mg (1 Day)||0||
48613379|NCT03610334|101838502|FG016|STARTED|Period 1: 2.5mg (1 Day)||0||
48613380|NCT03610334|101838503|FG017|STARTED|Period 1: 2.5mg (1 Day)||0||
48613381|NCT03610334|101838486|FG000|COMPLETED|Period 1: 2.5mg (1 Day)||6||
48613382|NCT03610334|101838487|FG001|COMPLETED|Period 1: 2.5mg (1 Day)||2||
48613383|NCT03610334|101838488|FG002|COMPLETED|Period 1: 2.5mg (1 Day)||0||
48613384|NCT03610334|101838489|FG003|COMPLETED|Period 1: 2.5mg (1 Day)||0||
48613385|NCT03610334|101838490|FG004|COMPLETED|Period 1: 2.5mg (1 Day)||0||
48613386|NCT03610334|101838491|FG005|COMPLETED|Period 1: 2.5mg (1 Day)||0||
48613387|NCT03610334|101838492|FG006|COMPLETED|Period 1: 2.5mg (1 Day)||0||
48613388|NCT03610334|101838493|FG007|COMPLETED|Period 1: 2.5mg (1 Day)||0||
48613389|NCT03610334|101838494|FG008|COMPLETED|Period 1: 2.5mg (1 Day)||0||
48613390|NCT03610334|101838495|FG009|COMPLETED|Period 1: 2.5mg (1 Day)||0||
48613391|NCT03610334|101838496|FG010|COMPLETED|Period 1: 2.5mg (1 Day)||0||
48613392|NCT03610334|101838497|FG011|COMPLETED|Period 1: 2.5mg (1 Day)||0||
48613393|NCT03610334|101838498|FG012|COMPLETED|Period 1: 2.5mg (1 Day)||0||
48613394|NCT03610334|101838499|FG013|COMPLETED|Period 1: 2.5mg (1 Day)||0||
48613395|NCT03610334|101838500|FG014|COMPLETED|Period 1: 2.5mg (1 Day)||0||
48613396|NCT03610334|101838501|FG015|COMPLETED|Period 1: 2.5mg (1 Day)||0||
48613397|NCT03610334|101838502|FG016|COMPLETED|Period 1: 2.5mg (1 Day)||0||
48613398|NCT03610334|101838503|FG017|COMPLETED|Period 1: 2.5mg (1 Day)||0||
48613399|NCT03610334|101838486|FG000|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
48613400|NCT03610334|101838487|FG001|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
48613401|NCT03610334|101838488|FG002|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
48613402|NCT03610334|101838489|FG003|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
48613403|NCT03610334|101838490|FG004|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
48613404|NCT03610334|101838491|FG005|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
48613405|NCT03610334|101838492|FG006|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
48613406|NCT03610334|101838493|FG007|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
48613407|NCT03610334|101838494|FG008|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
48613408|NCT03610334|101838495|FG009|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
48613409|NCT03610334|101838496|FG010|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
48613410|NCT03610334|101838497|FG011|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
48613411|NCT03610334|101838498|FG012|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
48613412|NCT03610334|101838499|FG013|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
48613413|NCT03610334|101838500|FG014|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
48613414|NCT03610334|101838501|FG015|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
48613415|NCT03610334|101838502|FG016|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
48613416|NCT03610334|101838503|FG017|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
48613417|NCT03610334|101838486|FG000|STARTED|Period 2: 5.0mg (1 Day)||6||
48613418|NCT03610334|101838487|FG001|STARTED|Period 2: 5.0mg (1 Day)||2||
48613419|NCT03610334|101838488|FG002|STARTED|Period 2: 5.0mg (1 Day)||6||
48613420|NCT03610334|101838489|FG003|STARTED|Period 2: 5.0mg (1 Day)||2||
48613421|NCT03610334|101838490|FG004|STARTED|Period 2: 5.0mg (1 Day)||0||
48613422|NCT03610334|101838491|FG005|STARTED|Period 2: 5.0mg (1 Day)||0||
48613423|NCT03610334|101838492|FG006|STARTED|Period 2: 5.0mg (1 Day)||0||
48613424|NCT03610334|101838493|FG007|STARTED|Period 2: 5.0mg (1 Day)||0||
48613425|NCT03610334|101838494|FG008|STARTED|Period 2: 5.0mg (1 Day)||0||
48613426|NCT03610334|101838495|FG009|STARTED|Period 2: 5.0mg (1 Day)||0||
48613427|NCT03610334|101838496|FG010|STARTED|Period 2: 5.0mg (1 Day)||0||
48613428|NCT03610334|101838497|FG011|STARTED|Period 2: 5.0mg (1 Day)||0||
48613429|NCT03610334|101838498|FG012|STARTED|Period 2: 5.0mg (1 Day)||0||
48613430|NCT03610334|101838499|FG013|STARTED|Period 2: 5.0mg (1 Day)||0||
48613431|NCT03610334|101838500|FG014|STARTED|Period 2: 5.0mg (1 Day)||0||
48613432|NCT03610334|101838501|FG015|STARTED|Period 2: 5.0mg (1 Day)||0||
48613433|NCT03610334|101838502|FG016|STARTED|Period 2: 5.0mg (1 Day)||0||
48613434|NCT03610334|101838503|FG017|STARTED|Period 2: 5.0mg (1 Day)||0||
48613435|NCT03610334|101838486|FG000|COMPLETED|Period 2: 5.0mg (1 Day)||6||
48613436|NCT03610334|101838487|FG001|COMPLETED|Period 2: 5.0mg (1 Day)||2||
48613437|NCT03610334|101838488|FG002|COMPLETED|Period 2: 5.0mg (1 Day)||6||
48613438|NCT03610334|101838489|FG003|COMPLETED|Period 2: 5.0mg (1 Day)||2||
48613439|NCT03610334|101838490|FG004|COMPLETED|Period 2: 5.0mg (1 Day)||0||
48613440|NCT03610334|101838491|FG005|COMPLETED|Period 2: 5.0mg (1 Day)||0||
48613441|NCT03610334|101838492|FG006|COMPLETED|Period 2: 5.0mg (1 Day)||0||
48613442|NCT03610334|101838493|FG007|COMPLETED|Period 2: 5.0mg (1 Day)||0||
48613443|NCT03610334|101838494|FG008|COMPLETED|Period 2: 5.0mg (1 Day)||0||
48613444|NCT03610334|101838495|FG009|COMPLETED|Period 2: 5.0mg (1 Day)||0||
48613445|NCT03610334|101838496|FG010|COMPLETED|Period 2: 5.0mg (1 Day)||0||
48613446|NCT03610334|101838497|FG011|COMPLETED|Period 2: 5.0mg (1 Day)||0||
48613447|NCT03610334|101838498|FG012|COMPLETED|Period 2: 5.0mg (1 Day)||0||
48613448|NCT03610334|101838499|FG013|COMPLETED|Period 2: 5.0mg (1 Day)||0||
48613449|NCT03610334|101838500|FG014|COMPLETED|Period 2: 5.0mg (1 Day)||0||
48613450|NCT03610334|101838501|FG015|COMPLETED|Period 2: 5.0mg (1 Day)||0||
48613451|NCT03610334|101838502|FG016|COMPLETED|Period 2: 5.0mg (1 Day)||0||
48613452|NCT03610334|101838503|FG017|COMPLETED|Period 2: 5.0mg (1 Day)||0||
48613453|NCT03610334|101838486|FG000|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
48613454|NCT03610334|101838487|FG001|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
48613455|NCT03610334|101838488|FG002|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
48613456|NCT03610334|101838489|FG003|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
48613457|NCT03610334|101838490|FG004|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
48613458|NCT03610334|101838491|FG005|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
48613459|NCT03610334|101838492|FG006|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
48613460|NCT03610334|101838493|FG007|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
48613461|NCT03610334|101838494|FG008|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
48613462|NCT03610334|101838495|FG009|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
48613463|NCT03610334|101838496|FG010|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
48613464|NCT03610334|101838497|FG011|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
48613465|NCT03610334|101838498|FG012|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
48613466|NCT03610334|101838499|FG013|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
48613467|NCT03610334|101838500|FG014|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
48613468|NCT03610334|101838501|FG015|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
48613469|NCT03610334|101838502|FG016|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
48613470|NCT03610334|101838503|FG017|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
48613471|NCT03610334|101838486|FG000|STARTED|Period 3: 10.0mg (1 Day)||6||
48613472|NCT03610334|101838487|FG001|STARTED|Period 3: 10.0mg (1 Day)||2||
48613473|NCT03610334|101838488|FG002|STARTED|Period 3: 10.0mg (1 Day)||6||
48613474|NCT03610334|101838489|FG003|STARTED|Period 3: 10.0mg (1 Day)||2||
48613475|NCT03610334|101838490|FG004|STARTED|Period 3: 10.0mg (1 Day)||6||
48613476|NCT03610334|101838491|FG005|STARTED|Period 3: 10.0mg (1 Day)||2||
48613477|NCT03610334|101838492|FG006|STARTED|Period 3: 10.0mg (1 Day)||0||
48613478|NCT03610334|101838493|FG007|STARTED|Period 3: 10.0mg (1 Day)||0||
48613479|NCT03610334|101838494|FG008|STARTED|Period 3: 10.0mg (1 Day)||0||
48613480|NCT03610334|101838495|FG009|STARTED|Period 3: 10.0mg (1 Day)||0||
48613481|NCT03610334|101838496|FG010|STARTED|Period 3: 10.0mg (1 Day)||0||
48613482|NCT03610334|101838497|FG011|STARTED|Period 3: 10.0mg (1 Day)||0||
48613483|NCT03610334|101838498|FG012|STARTED|Period 3: 10.0mg (1 Day)||0||
48613484|NCT03610334|101838499|FG013|STARTED|Period 3: 10.0mg (1 Day)||0||
48613485|NCT03610334|101838500|FG014|STARTED|Period 3: 10.0mg (1 Day)||0||
48613486|NCT03610334|101838501|FG015|STARTED|Period 3: 10.0mg (1 Day)||0||
48613487|NCT03610334|101838502|FG016|STARTED|Period 3: 10.0mg (1 Day)||0||
48613488|NCT03610334|101838503|FG017|STARTED|Period 3: 10.0mg (1 Day)||0||
48613489|NCT03610334|101838486|FG000|COMPLETED|Period 3: 10.0mg (1 Day)||6||
48613490|NCT03610334|101838487|FG001|COMPLETED|Period 3: 10.0mg (1 Day)||2||
48613491|NCT03610334|101838488|FG002|COMPLETED|Period 3: 10.0mg (1 Day)||6||
48613492|NCT03610334|101838489|FG003|COMPLETED|Period 3: 10.0mg (1 Day)||2||
48613493|NCT03610334|101838490|FG004|COMPLETED|Period 3: 10.0mg (1 Day)||6||
48613494|NCT03610334|101838491|FG005|COMPLETED|Period 3: 10.0mg (1 Day)||2||
48613495|NCT03610334|101838492|FG006|COMPLETED|Period 3: 10.0mg (1 Day)||0||
48613496|NCT03610334|101838493|FG007|COMPLETED|Period 3: 10.0mg (1 Day)||0||
48613497|NCT03610334|101838494|FG008|COMPLETED|Period 3: 10.0mg (1 Day)||0||
48613498|NCT03610334|101838495|FG009|COMPLETED|Period 3: 10.0mg (1 Day)||0||
48613499|NCT03610334|101838496|FG010|COMPLETED|Period 3: 10.0mg (1 Day)||0||
48613500|NCT03610334|101838497|FG011|COMPLETED|Period 3: 10.0mg (1 Day)||0||
48613501|NCT03610334|101838498|FG012|COMPLETED|Period 3: 10.0mg (1 Day)||0||
48613502|NCT03610334|101838499|FG013|COMPLETED|Period 3: 10.0mg (1 Day)||0||
48613503|NCT03610334|101838500|FG014|COMPLETED|Period 3: 10.0mg (1 Day)||0||
48613504|NCT03610334|101838501|FG015|COMPLETED|Period 3: 10.0mg (1 Day)||0||
48613505|NCT03610334|101838502|FG016|COMPLETED|Period 3: 10.0mg (1 Day)||0||
48613506|NCT03610334|101838503|FG017|COMPLETED|Period 3: 10.0mg (1 Day)||0||
48613507|NCT03610334|101838486|FG000|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
48613508|NCT03610334|101838487|FG001|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
48613509|NCT03610334|101838488|FG002|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
48613510|NCT03610334|101838489|FG003|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
48613511|NCT03610334|101838490|FG004|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
48613512|NCT03610334|101838491|FG005|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
48613513|NCT03610334|101838492|FG006|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
48613514|NCT03610334|101838493|FG007|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
48613515|NCT03610334|101838494|FG008|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
48613516|NCT03610334|101838495|FG009|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
48613517|NCT03610334|101838496|FG010|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
48613518|NCT03610334|101838497|FG011|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
48613519|NCT03610334|101838498|FG012|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
48613520|NCT03610334|101838499|FG013|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
48613521|NCT03610334|101838500|FG014|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
48613522|NCT03610334|101838501|FG015|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
48613523|NCT03610334|101838502|FG016|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
48613524|NCT03610334|101838503|FG017|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
48613525|NCT03610334|101838486|FG000|STARTED|Period 4: 20.0mg (1 Day)||6||
48613526|NCT03610334|101838487|FG001|STARTED|Period 4: 20.0mg (1 Day)||2||
48613527|NCT03610334|101838488|FG002|STARTED|Period 4: 20.0mg (1 Day)||6||
48613528|NCT03610334|101838489|FG003|STARTED|Period 4: 20.0mg (1 Day)||2||
48613529|NCT03610334|101838490|FG004|STARTED|Period 4: 20.0mg (1 Day)||6||
48613530|NCT03610334|101838491|FG005|STARTED|Period 4: 20.0mg (1 Day)||2||
48613531|NCT03610334|101838492|FG006|STARTED|Period 4: 20.0mg (1 Day)||6||
48613532|NCT03610334|101838493|FG007|STARTED|Period 4: 20.0mg (1 Day)||2||
48613533|NCT03610334|101838494|FG008|STARTED|Period 4: 20.0mg (1 Day)||0||
48613534|NCT03610334|101838495|FG009|STARTED|Period 4: 20.0mg (1 Day)||0||
48613535|NCT03610334|101838496|FG010|STARTED|Period 4: 20.0mg (1 Day)||0||
48613536|NCT03610334|101838497|FG011|STARTED|Period 4: 20.0mg (1 Day)||0||
48613537|NCT03610334|101838498|FG012|STARTED|Period 4: 20.0mg (1 Day)||0||
48613538|NCT03610334|101838499|FG013|STARTED|Period 4: 20.0mg (1 Day)||0||
48613539|NCT03610334|101838500|FG014|STARTED|Period 4: 20.0mg (1 Day)||0||
48613540|NCT03610334|101838501|FG015|STARTED|Period 4: 20.0mg (1 Day)||0||
48613541|NCT03610334|101838502|FG016|STARTED|Period 4: 20.0mg (1 Day)||0||
48613542|NCT03610334|101838503|FG017|STARTED|Period 4: 20.0mg (1 Day)||0||
48613543|NCT03610334|101838486|FG000|COMPLETED|Period 4: 20.0mg (1 Day)||6||
48613544|NCT03610334|101838487|FG001|COMPLETED|Period 4: 20.0mg (1 Day)||2||
48613545|NCT03610334|101838488|FG002|COMPLETED|Period 4: 20.0mg (1 Day)||6||
48613546|NCT03610334|101838489|FG003|COMPLETED|Period 4: 20.0mg (1 Day)||2||
48613547|NCT03610334|101838490|FG004|COMPLETED|Period 4: 20.0mg (1 Day)||6||
48613548|NCT03610334|101838491|FG005|COMPLETED|Period 4: 20.0mg (1 Day)||2||
48613549|NCT03610334|101838492|FG006|COMPLETED|Period 4: 20.0mg (1 Day)||6||
48613550|NCT03610334|101838493|FG007|COMPLETED|Period 4: 20.0mg (1 Day)||2||
48613551|NCT03610334|101838494|FG008|COMPLETED|Period 4: 20.0mg (1 Day)||0||
48156939|NCT02707692|100706829|FG003|NOT COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||2||
48156940|NCT02707692|100706830|FG004|NOT COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||0||
48613552|NCT03610334|101838495|FG009|COMPLETED|Period 4: 20.0mg (1 Day)||0||
48613553|NCT03610334|101838496|FG010|COMPLETED|Period 4: 20.0mg (1 Day)||0||
48613554|NCT03610334|101838497|FG011|COMPLETED|Period 4: 20.0mg (1 Day)||0||
48156941|NCT02707692|100706831|FG005|NOT COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||1||
48613555|NCT03610334|101838498|FG012|COMPLETED|Period 4: 20.0mg (1 Day)||0||
48613556|NCT03610334|101838499|FG013|COMPLETED|Period 4: 20.0mg (1 Day)||0||
48613557|NCT03610334|101838500|FG014|COMPLETED|Period 4: 20.0mg (1 Day)||0||
48613558|NCT03610334|101838501|FG015|COMPLETED|Period 4: 20.0mg (1 Day)||0||
48613559|NCT03610334|101838502|FG016|COMPLETED|Period 4: 20.0mg (1 Day)||0||
48613560|NCT03610334|101838503|FG017|COMPLETED|Period 4: 20.0mg (1 Day)||0||
48613561|NCT03610334|101838486|FG000|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
48613562|NCT03610334|101838487|FG001|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
48613563|NCT03610334|101838488|FG002|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
48613564|NCT03610334|101838489|FG003|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
48613565|NCT03610334|101838490|FG004|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
48613566|NCT03610334|101838491|FG005|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
48613567|NCT03610334|101838492|FG006|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
48613568|NCT03610334|101838493|FG007|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
48613569|NCT03610334|101838494|FG008|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
48613570|NCT03610334|101838495|FG009|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
48613571|NCT03610334|101838496|FG010|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
48613572|NCT03610334|101838497|FG011|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
48613573|NCT03610334|101838498|FG012|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
48613574|NCT03610334|101838499|FG013|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
48613575|NCT03610334|101838500|FG014|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
48613576|NCT03610334|101838501|FG015|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
48613577|NCT03610334|101838502|FG016|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
48613578|NCT03610334|101838503|FG017|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
48613579|NCT03610334|101838486|FG000|STARTED|Period 5: 40.0mg (1 Day)||6||
48613580|NCT03610334|101838487|FG001|STARTED|Period 5: 40.0mg (1 Day)||2||
48613581|NCT03610334|101838488|FG002|STARTED|Period 5: 40.0mg (1 Day)||6||
48613582|NCT03610334|101838489|FG003|STARTED|Period 5: 40.0mg (1 Day)||2||
48613583|NCT03610334|101838490|FG004|STARTED|Period 5: 40.0mg (1 Day)||6||
48613584|NCT03610334|101838491|FG005|STARTED|Period 5: 40.0mg (1 Day)||2||
48613585|NCT03610334|101838492|FG006|STARTED|Period 5: 40.0mg (1 Day)||6||
48613586|NCT03610334|101838493|FG007|STARTED|Period 5: 40.0mg (1 Day)||2||
48613587|NCT03610334|101838494|FG008|STARTED|Period 5: 40.0mg (1 Day)||6||
48613588|NCT03610334|101838495|FG009|STARTED|Period 5: 40.0mg (1 Day)||2||
48613589|NCT03610334|101838496|FG010|STARTED|Period 5: 40.0mg (1 Day)||0||
48613590|NCT03610334|101838497|FG011|STARTED|Period 5: 40.0mg (1 Day)||0||
48613591|NCT03610334|101838498|FG012|STARTED|Period 5: 40.0mg (1 Day)||0||
48613592|NCT03610334|101838499|FG013|STARTED|Period 5: 40.0mg (1 Day)||0||
48613593|NCT03610334|101838500|FG014|STARTED|Period 5: 40.0mg (1 Day)||0||
48613594|NCT03610334|101838501|FG015|STARTED|Period 5: 40.0mg (1 Day)||0||
48613595|NCT03610334|101838502|FG016|STARTED|Period 5: 40.0mg (1 Day)||0||
48613596|NCT03610334|101838503|FG017|STARTED|Period 5: 40.0mg (1 Day)||0||
48613597|NCT03610334|101838486|FG000|COMPLETED|Period 5: 40.0mg (1 Day)||6||
48613598|NCT03610334|101838487|FG001|COMPLETED|Period 5: 40.0mg (1 Day)||2||
48613599|NCT03610334|101838488|FG002|COMPLETED|Period 5: 40.0mg (1 Day)||6||
48613600|NCT03610334|101838489|FG003|COMPLETED|Period 5: 40.0mg (1 Day)||2||
48613601|NCT03610334|101838490|FG004|COMPLETED|Period 5: 40.0mg (1 Day)||6||
48613602|NCT03610334|101838491|FG005|COMPLETED|Period 5: 40.0mg (1 Day)||2||
48613603|NCT03610334|101838492|FG006|COMPLETED|Period 5: 40.0mg (1 Day)||6||
48613604|NCT03610334|101838493|FG007|COMPLETED|Period 5: 40.0mg (1 Day)||2||
48613605|NCT03610334|101838494|FG008|COMPLETED|Period 5: 40.0mg (1 Day)||6||
48613606|NCT03610334|101838495|FG009|COMPLETED|Period 5: 40.0mg (1 Day)||2||
48613607|NCT03610334|101838496|FG010|COMPLETED|Period 5: 40.0mg (1 Day)||0||
48613608|NCT03610334|101838497|FG011|COMPLETED|Period 5: 40.0mg (1 Day)||0||
48613609|NCT03610334|101838498|FG012|COMPLETED|Period 5: 40.0mg (1 Day)||0||
48613610|NCT03610334|101838499|FG013|COMPLETED|Period 5: 40.0mg (1 Day)||0||
48613611|NCT03610334|101838500|FG014|COMPLETED|Period 5: 40.0mg (1 Day)||0||
48613612|NCT03610334|101838501|FG015|COMPLETED|Period 5: 40.0mg (1 Day)||0||
48613613|NCT03610334|101838502|FG016|COMPLETED|Period 5: 40.0mg (1 Day)||0||
48613614|NCT03610334|101838503|FG017|COMPLETED|Period 5: 40.0mg (1 Day)||0||
48613615|NCT03610334|101838486|FG000|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
48613616|NCT03610334|101838487|FG001|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
48613617|NCT03610334|101838488|FG002|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
48613618|NCT03610334|101838489|FG003|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
48613619|NCT03610334|101838490|FG004|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
48613620|NCT03610334|101838491|FG005|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
48613621|NCT03610334|101838492|FG006|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
48613622|NCT03610334|101838493|FG007|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
48613623|NCT03610334|101838494|FG008|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
48613624|NCT03610334|101838495|FG009|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
48613625|NCT03610334|101838496|FG010|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
48613626|NCT03610334|101838497|FG011|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
48613627|NCT03610334|101838498|FG012|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
48613628|NCT03610334|101838499|FG013|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
48613629|NCT03610334|101838500|FG014|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
48613630|NCT03610334|101838501|FG015|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
48613631|NCT03610334|101838502|FG016|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
48613632|NCT03610334|101838503|FG017|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
48613633|NCT03610334|101838486|FG000|STARTED|Period 6: 60.0mg (1 Day)||6||
48613634|NCT03610334|101838487|FG001|STARTED|Period 6: 60.0mg (1 Day)||2||
48613635|NCT03610334|101838488|FG002|STARTED|Period 6: 60.0mg (1 Day)||6||
48613636|NCT03610334|101838489|FG003|STARTED|Period 6: 60.0mg (1 Day)||2||
48613637|NCT03610334|101838490|FG004|STARTED|Period 6: 60.0mg (1 Day)||6||
48613638|NCT03610334|101838491|FG005|STARTED|Period 6: 60.0mg (1 Day)||2||
48613639|NCT03610334|101838492|FG006|STARTED|Period 6: 60.0mg (1 Day)||6||
48613640|NCT03610334|101838493|FG007|STARTED|Period 6: 60.0mg (1 Day)||2||
48613641|NCT03610334|101838494|FG008|STARTED|Period 6: 60.0mg (1 Day)||6||
48613642|NCT03610334|101838495|FG009|STARTED|Period 6: 60.0mg (1 Day)||2||
48613643|NCT03610334|101838496|FG010|STARTED|Period 6: 60.0mg (1 Day)||6||
48613644|NCT03610334|101838497|FG011|STARTED|Period 6: 60.0mg (1 Day)||2||
48613645|NCT03610334|101838498|FG012|STARTED|Period 6: 60.0mg (1 Day)||0||
48613646|NCT03610334|101838499|FG013|STARTED|Period 6: 60.0mg (1 Day)||0||
48613647|NCT03610334|101838500|FG014|STARTED|Period 6: 60.0mg (1 Day)||0||
48613648|NCT03610334|101838501|FG015|STARTED|Period 6: 60.0mg (1 Day)||0||
48613649|NCT03610334|101838502|FG016|STARTED|Period 6: 60.0mg (1 Day)||0||
48613650|NCT03610334|101838503|FG017|STARTED|Period 6: 60.0mg (1 Day)||0||
48613651|NCT03610334|101838486|FG000|COMPLETED|Period 6: 60.0mg (1 Day)||6||
48613652|NCT03610334|101838487|FG001|COMPLETED|Period 6: 60.0mg (1 Day)||2||
48613653|NCT03610334|101838488|FG002|COMPLETED|Period 6: 60.0mg (1 Day)||6||
48613654|NCT03610334|101838489|FG003|COMPLETED|Period 6: 60.0mg (1 Day)||2||
48613655|NCT03610334|101838490|FG004|COMPLETED|Period 6: 60.0mg (1 Day)||6||
48613656|NCT03610334|101838491|FG005|COMPLETED|Period 6: 60.0mg (1 Day)||2||
48613657|NCT03610334|101838492|FG006|COMPLETED|Period 6: 60.0mg (1 Day)||6||
48613658|NCT03610334|101838493|FG007|COMPLETED|Period 6: 60.0mg (1 Day)||2||
48613659|NCT03610334|101838494|FG008|COMPLETED|Period 6: 60.0mg (1 Day)||6||
48613660|NCT03610334|101838495|FG009|COMPLETED|Period 6: 60.0mg (1 Day)||2||
48613661|NCT03610334|101838496|FG010|COMPLETED|Period 6: 60.0mg (1 Day)||6||
48613662|NCT03610334|101838497|FG011|COMPLETED|Period 6: 60.0mg (1 Day)||2||
48613663|NCT03610334|101838498|FG012|COMPLETED|Period 6: 60.0mg (1 Day)||0||
48613664|NCT03610334|101838499|FG013|COMPLETED|Period 6: 60.0mg (1 Day)||0||
48613665|NCT03610334|101838500|FG014|COMPLETED|Period 6: 60.0mg (1 Day)||0||
48613666|NCT03610334|101838501|FG015|COMPLETED|Period 6: 60.0mg (1 Day)||0||
48311532|NCT01353508|101088066|FG002|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0||
48311533|NCT01353508|101088067|FG003|NOT COMPLETED|Period 1 - First Intervention (7 Days)||1||
48311534|NCT01353508|101088064|FG000|STARTED|Period 2 - Second Intervention (7 Days)||8||
48311535|NCT01353508|101088065|FG001|STARTED|Period 2 - Second Intervention (7 Days)||8||
48311536|NCT01353508|101088066|FG002|STARTED|Period 2 - Second Intervention (7 Days)||8||
48311537|NCT01353508|101088067|FG003|STARTED|Period 2 - Second Intervention (7 Days)||7||
48311538|NCT01353508|101088064|FG000|COMPLETED|Period 2 - Second Intervention (7 Days)||7||
48311539|NCT01353508|101088065|FG001|COMPLETED|Period 2 - Second Intervention (7 Days)||8||
48311540|NCT01353508|101088066|FG002|COMPLETED|Period 2 - Second Intervention (7 Days)||8||
48311541|NCT01353508|101088067|FG003|COMPLETED|Period 2 - Second Intervention (7 Days)||7||
48406693|NCT03051217|101328467|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0||
48406694|NCT03051217|101328468|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||3||
48406695|NCT03051217|101328469|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||3||
48406696|NCT03051217|101328470|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||2||
48406697|NCT03051217|101328471|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||1||
48406698|NCT02599441|101328472|FG000|STARTED|Overall Study||9|Enrolled in the study|
48406699|NCT02599441|101328472|FG000|COMPLETED|Overall Study||9|Completed the study|
48613667|NCT03610334|101838502|FG016|COMPLETED|Period 6: 60.0mg (1 Day)||0||
48613668|NCT03610334|101838503|FG017|COMPLETED|Period 6: 60.0mg (1 Day)||0||
48613669|NCT03610334|101838486|FG000|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
48613670|NCT03610334|101838487|FG001|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
48613671|NCT03610334|101838488|FG002|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
48613672|NCT03610334|101838489|FG003|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
48613673|NCT03610334|101838490|FG004|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
48613674|NCT03610334|101838491|FG005|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
48613675|NCT03610334|101838492|FG006|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
48613676|NCT03610334|101838493|FG007|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
48613677|NCT03610334|101838494|FG008|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
48613678|NCT03610334|101838495|FG009|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
48613679|NCT03610334|101838496|FG010|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
48613680|NCT03610334|101838497|FG011|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
48613681|NCT03610334|101838498|FG012|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
48613682|NCT03610334|101838499|FG013|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
48613683|NCT03610334|101838500|FG014|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
48613684|NCT03610334|101838501|FG015|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
48613685|NCT03610334|101838502|FG016|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
48613686|NCT03610334|101838503|FG017|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
48613687|NCT03610334|101838486|FG000|STARTED|Period 7: 15.0mg (Day 1 to 14)||6||
48613688|NCT03610334|101838487|FG001|STARTED|Period 7: 15.0mg (Day 1 to 14)||2||
48613689|NCT03610334|101838488|FG002|STARTED|Period 7: 15.0mg (Day 1 to 14)||6||
48613690|NCT03610334|101838489|FG003|STARTED|Period 7: 15.0mg (Day 1 to 14)||2||
48613691|NCT03610334|101838490|FG004|STARTED|Period 7: 15.0mg (Day 1 to 14)||6||
48613692|NCT03610334|101838491|FG005|STARTED|Period 7: 15.0mg (Day 1 to 14)||2||
48613693|NCT03610334|101838492|FG006|STARTED|Period 7: 15.0mg (Day 1 to 14)||6||
48613694|NCT03610334|101838493|FG007|STARTED|Period 7: 15.0mg (Day 1 to 14)||2||
48613695|NCT03610334|101838494|FG008|STARTED|Period 7: 15.0mg (Day 1 to 14)||6||
48613696|NCT03610334|101838495|FG009|STARTED|Period 7: 15.0mg (Day 1 to 14)||2||
48311542|NCT01353508|101088064|FG000|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||1||
48613697|NCT03610334|101838496|FG010|STARTED|Period 7: 15.0mg (Day 1 to 14)||6||
48613698|NCT03610334|101838497|FG011|STARTED|Period 7: 15.0mg (Day 1 to 14)||2||
48613699|NCT03610334|101838498|FG012|STARTED|Period 7: 15.0mg (Day 1 to 14)||6||
48613700|NCT03610334|101838499|FG013|STARTED|Period 7: 15.0mg (Day 1 to 14)||2||
48613701|NCT03610334|101838500|FG014|STARTED|Period 7: 15.0mg (Day 1 to 14)||0||
48613702|NCT03610334|101838501|FG015|STARTED|Period 7: 15.0mg (Day 1 to 14)||0||
48613703|NCT03610334|101838502|FG016|STARTED|Period 7: 15.0mg (Day 1 to 14)||0||
48613704|NCT03610334|101838503|FG017|STARTED|Period 7: 15.0mg (Day 1 to 14)||0||
48613705|NCT03610334|101838486|FG000|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6||
48613706|NCT03610334|101838487|FG001|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2||
48613707|NCT03610334|101838488|FG002|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6||
48613708|NCT03610334|101838489|FG003|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2||
48613709|NCT03610334|101838490|FG004|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6||
48613710|NCT03610334|101838491|FG005|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2||
48613711|NCT03610334|101838492|FG006|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6||
48613712|NCT03610334|101838493|FG007|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2||
48613713|NCT03610334|101838494|FG008|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6||
48613714|NCT03610334|101838495|FG009|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2||
48613715|NCT03610334|101838496|FG010|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6||
48613716|NCT03610334|101838497|FG011|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2||
48613717|NCT03610334|101838498|FG012|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6||
48613718|NCT03610334|101838499|FG013|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2||
48613719|NCT03610334|101838500|FG014|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
48613720|NCT03610334|101838501|FG015|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
48613721|NCT03610334|101838502|FG016|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
48613722|NCT03610334|101838503|FG017|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
48613723|NCT03610334|101838486|FG000|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
48613724|NCT03610334|101838487|FG001|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
48613725|NCT03610334|101838488|FG002|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
48613726|NCT03610334|101838489|FG003|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
48613727|NCT03610334|101838490|FG004|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
48613728|NCT03610334|101838491|FG005|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
48613729|NCT03610334|101838492|FG006|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
48613730|NCT03610334|101838493|FG007|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
48613731|NCT03610334|101838494|FG008|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
48613732|NCT03610334|101838495|FG009|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
48613733|NCT03610334|101838496|FG010|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
48613734|NCT03610334|101838497|FG011|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
48613735|NCT03610334|101838498|FG012|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
48613736|NCT03610334|101838499|FG013|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
48613737|NCT03610334|101838500|FG014|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
48613738|NCT03610334|101838501|FG015|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
48613739|NCT03610334|101838502|FG016|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
48613740|NCT03610334|101838503|FG017|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
48613741|NCT03610334|101838486|FG000|STARTED|Period 8: 30.0mg (Day 1 to 14)||6||
48613742|NCT03610334|101838487|FG001|STARTED|Period 8: 30.0mg (Day 1 to 14)||2||
48613743|NCT03610334|101838488|FG002|STARTED|Period 8: 30.0mg (Day 1 to 14)||6||
48613744|NCT03610334|101838489|FG003|STARTED|Period 8: 30.0mg (Day 1 to 14)||2||
48613745|NCT03610334|101838490|FG004|STARTED|Period 8: 30.0mg (Day 1 to 14)||6||
48727879|NCT01748825|102118687|FG005|COMPLETED|Dose Escalation||4||
48727880|NCT01748825|102118688|FG006|COMPLETED|Dose Escalation||2||
48727881|NCT01748825|102118689|FG007|COMPLETED|Dose Escalation||3||
48613746|NCT03610334|101838491|FG005|STARTED|Period 8: 30.0mg (Day 1 to 14)||2||
48613747|NCT03610334|101838492|FG006|STARTED|Period 8: 30.0mg (Day 1 to 14)||6||
48613748|NCT03610334|101838493|FG007|STARTED|Period 8: 30.0mg (Day 1 to 14)||2||
48613749|NCT03610334|101838494|FG008|STARTED|Period 8: 30.0mg (Day 1 to 14)||6||
48613750|NCT03610334|101838495|FG009|STARTED|Period 8: 30.0mg (Day 1 to 14)||2||
48613751|NCT03610334|101838496|FG010|STARTED|Period 8: 30.0mg (Day 1 to 14)||6||
48613752|NCT03610334|101838497|FG011|STARTED|Period 8: 30.0mg (Day 1 to 14)||2||
48613753|NCT03610334|101838498|FG012|STARTED|Period 8: 30.0mg (Day 1 to 14)||6||
48613754|NCT03610334|101838499|FG013|STARTED|Period 8: 30.0mg (Day 1 to 14)||2||
48613755|NCT03610334|101838500|FG014|STARTED|Period 8: 30.0mg (Day 1 to 14)||6||
48613756|NCT03610334|101838501|FG015|STARTED|Period 8: 30.0mg (Day 1 to 14)||2||
48727882|NCT01748825|102118690|FG008|COMPLETED|Dose Escalation||0||
48727883|NCT01748825|102118691|FG009|COMPLETED|Dose Escalation||0||
48727884|NCT01748825|102118682|FG000|NOT COMPLETED|Dose Escalation||2||
48613757|NCT03610334|101838502|FG016|STARTED|Period 8: 30.0mg (Day 1 to 14)||0||
48727885|NCT01748825|102118683|FG001|NOT COMPLETED|Dose Escalation||2||
48727886|NCT01748825|102118684|FG002|NOT COMPLETED|Dose Escalation||0||
48727887|NCT01748825|102118685|FG003|NOT COMPLETED|Dose Escalation||1||
48727888|NCT01748825|102118686|FG004|NOT COMPLETED|Dose Escalation||1||
48727889|NCT01748825|102118687|FG005|NOT COMPLETED|Dose Escalation||2||
48727890|NCT01748825|102118688|FG006|NOT COMPLETED|Dose Escalation||1||
48613758|NCT03610334|101838503|FG017|STARTED|Period 8: 30.0mg (Day 1 to 14)||0||
48613759|NCT03610334|101838486|FG000|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6||
48613760|NCT03610334|101838487|FG001|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2||
48613761|NCT03610334|101838488|FG002|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6||
48613762|NCT03610334|101838489|FG003|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2||
48613763|NCT03610334|101838490|FG004|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6||
48613764|NCT03610334|101838491|FG005|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2||
48613765|NCT03610334|101838492|FG006|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6||
48613766|NCT03610334|101838493|FG007|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2||
48613767|NCT03610334|101838494|FG008|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6||
48613768|NCT03610334|101838495|FG009|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2||
48613769|NCT03610334|101838496|FG010|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6||
48406700|NCT02599441|101328472|FG000|NOT COMPLETED|Overall Study||0||
48406701|NCT00959894|101328473|FG000|STARTED|Overall Study||79||
48406702|NCT00959894|101328473|FG000|COMPLETED|Overall Study||63||
48406703|NCT00959894|101328473|FG000|NOT COMPLETED|Overall Study||16||
48406704|NCT01510028|101328474|FG000|STARTED|Overall Study||6||
48406705|NCT01510028|101328475|FG001|STARTED|Overall Study||6||
48406706|NCT01510028|101328476|FG002|STARTED|Overall Study||6||
48406707|NCT01510028|101328477|FG003|STARTED|Overall Study||6||
48406708|NCT01510028|101328474|FG000|COMPLETED|Overall Study||5||
48406709|NCT01510028|101328475|FG001|COMPLETED|Overall Study||6||
48406710|NCT01510028|101328476|FG002|COMPLETED|Overall Study||6||
48613770|NCT03610334|101838497|FG011|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2||
48613771|NCT03610334|101838498|FG012|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6||
48613772|NCT03610334|101838499|FG013|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2||
48613773|NCT03610334|101838500|FG014|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6||
48613774|NCT03610334|101838501|FG015|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2||
48613775|NCT03610334|101838502|FG016|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
48613776|NCT03610334|101838503|FG017|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
48613777|NCT03610334|101838486|FG000|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
48613778|NCT03610334|101838487|FG001|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
48613779|NCT03610334|101838488|FG002|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
48613780|NCT03610334|101838489|FG003|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
48613781|NCT03610334|101838490|FG004|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
48613782|NCT03610334|101838491|FG005|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
48613783|NCT03610334|101838492|FG006|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
48613784|NCT03610334|101838493|FG007|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
48613785|NCT03610334|101838494|FG008|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
48613786|NCT03610334|101838495|FG009|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
48613787|NCT03610334|101838496|FG010|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
48613788|NCT03610334|101838497|FG011|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
48613789|NCT03610334|101838498|FG012|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
48613790|NCT03610334|101838499|FG013|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
48613791|NCT03610334|101838500|FG014|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
48613792|NCT03610334|101838501|FG015|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
48613793|NCT03610334|101838502|FG016|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
48613794|NCT03610334|101838503|FG017|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
48613795|NCT03610334|101838486|FG000|STARTED|Period 9: 50.0mg (Day 1 to 14)||6||
48613796|NCT03610334|101838487|FG001|STARTED|Period 9: 50.0mg (Day 1 to 14)||2||
48613797|NCT03610334|101838488|FG002|STARTED|Period 9: 50.0mg (Day 1 to 14)||6||
48613798|NCT03610334|101838489|FG003|STARTED|Period 9: 50.0mg (Day 1 to 14)||2||
48613799|NCT03610334|101838490|FG004|STARTED|Period 9: 50.0mg (Day 1 to 14)||6||
48613800|NCT03610334|101838491|FG005|STARTED|Period 9: 50.0mg (Day 1 to 14)||2||
48613801|NCT03610334|101838492|FG006|STARTED|Period 9: 50.0mg (Day 1 to 14)||6||
48613802|NCT03610334|101838493|FG007|STARTED|Period 9: 50.0mg (Day 1 to 14)||2||
48613803|NCT03610334|101838494|FG008|STARTED|Period 9: 50.0mg (Day 1 to 14)||6||
48406711|NCT01510028|101328477|FG003|COMPLETED|Overall Study||6||
48406712|NCT01510028|101328474|FG000|NOT COMPLETED|Overall Study||1||
48406713|NCT01510028|101328475|FG001|NOT COMPLETED|Overall Study||0||
48406714|NCT01510028|101328476|FG002|NOT COMPLETED|Overall Study||0||
48406715|NCT01510028|101328477|FG003|NOT COMPLETED|Overall Study||0||
48613804|NCT03610334|101838495|FG009|STARTED|Period 9: 50.0mg (Day 1 to 14)||2||
48613805|NCT03610334|101838496|FG010|STARTED|Period 9: 50.0mg (Day 1 to 14)||6||
48613806|NCT03610334|101838497|FG011|STARTED|Period 9: 50.0mg (Day 1 to 14)||2||
48613807|NCT03610334|101838498|FG012|STARTED|Period 9: 50.0mg (Day 1 to 14)||6||
48613808|NCT03610334|101838499|FG013|STARTED|Period 9: 50.0mg (Day 1 to 14)||2||
48613809|NCT03610334|101838500|FG014|STARTED|Period 9: 50.0mg (Day 1 to 14)||6||
48613810|NCT03610334|101838501|FG015|STARTED|Period 9: 50.0mg (Day 1 to 14)||2||
48613811|NCT03610334|101838502|FG016|STARTED|Period 9: 50.0mg (Day 1 to 14)||6||
48613812|NCT03610334|101838503|FG017|STARTED|Period 9: 50.0mg (Day 1 to 14)||2||
48406716|NCT01102140|101328478|FG000|STARTED|Overall Study||13||
48406717|NCT01102140|101328479|FG001|STARTED|Overall Study||7||
48406718|NCT01102140|101328478|FG000|COMPLETED|Overall Study||10||
48613813|NCT03610334|101838486|FG000|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6||
48613814|NCT03610334|101838487|FG001|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2||
48613815|NCT03610334|101838488|FG002|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6||
48613816|NCT03610334|101838489|FG003|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2||
48613817|NCT03610334|101838490|FG004|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6||
48613818|NCT03610334|101838491|FG005|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2||
48613819|NCT03610334|101838492|FG006|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6||
48613820|NCT03610334|101838493|FG007|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2||
48613821|NCT03610334|101838494|FG008|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6||
48613822|NCT03610334|101838495|FG009|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2||
48613823|NCT03610334|101838496|FG010|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6||
48613824|NCT03610334|101838497|FG011|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2||
48613825|NCT03610334|101838498|FG012|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6||
48613826|NCT03610334|101838499|FG013|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2||
48613827|NCT03610334|101838500|FG014|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6||
48613828|NCT03610334|101838501|FG015|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2||
48613829|NCT03610334|101838502|FG016|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6||
48613830|NCT03610334|101838503|FG017|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2||
48613831|NCT03610334|101838486|FG000|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
48613832|NCT03610334|101838487|FG001|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
48613833|NCT03610334|101838488|FG002|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
48613834|NCT03610334|101838489|FG003|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
48613835|NCT03610334|101838490|FG004|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
48613836|NCT03610334|101838491|FG005|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
48613837|NCT03610334|101838492|FG006|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
48613838|NCT03610334|101838493|FG007|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
48613839|NCT03610334|101838494|FG008|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
48613840|NCT03610334|101838495|FG009|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
48613841|NCT03610334|101838496|FG010|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
48613842|NCT03610334|101838497|FG011|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
48613843|NCT03610334|101838498|FG012|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
48613844|NCT03610334|101838499|FG013|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
48613845|NCT03610334|101838500|FG014|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
48613846|NCT03610334|101838501|FG015|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
48613847|NCT03610334|101838502|FG016|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
48613848|NCT03610334|101838503|FG017|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
48613849|NCT04547140|101838504|FG000|STARTED|Overall Study||29||
48613850|NCT04547140|101838505|FG001|STARTED|Overall Study||28||
48613851|NCT04547140|101838504|FG000|Safety Population|Overall Study||27|Safety population included all participants who received at least any amount of liquid Alpha1-PI (Human) plus SMT or placebo plus SMT.|
48613852|NCT04547140|101838505|FG001|Safety Population|Overall Study||27|Safety population included all participants who received at least any amount of liquid Alpha1-PI (Human) plus SMT or placebo plus SMT.|
48613853|NCT04547140|101838504|FG000|COMPLETED|Overall Study||19||
48613854|NCT04547140|101838505|FG001|COMPLETED|Overall Study||22||
48727891|NCT01748825|102118689|FG007|NOT COMPLETED|Dose Escalation||0||
48727892|NCT01748825|102118690|FG008|NOT COMPLETED|Dose Escalation||0||
48727893|NCT01748825|102118691|FG009|NOT COMPLETED|Dose Escalation||0||
48727894|NCT01748825|102118682|FG000|STARTED|Dose Expansion||0||
48727895|NCT01748825|102118683|FG001|STARTED|Dose Expansion||0||
48727896|NCT01748825|102118684|FG002|STARTED|Dose Expansion||0||
48727897|NCT01748825|102118685|FG003|STARTED|Dose Expansion||0||
48727898|NCT01748825|102118686|FG004|STARTED|Dose Expansion||0||
48727899|NCT01748825|102118687|FG005|STARTED|Dose Expansion||0||
48727900|NCT01748825|102118688|FG006|STARTED|Dose Expansion||0||
48156942|NCT02707692|100706826|FG000|STARTED|Cycle 3 (30 Days)||7||
48156943|NCT02707692|100706827|FG001|STARTED|Cycle 3 (30 Days)||6||
48613855|NCT04547140|101838504|FG000|NOT COMPLETED|Overall Study||10||
48613856|NCT04547140|101838505|FG001|NOT COMPLETED|Overall Study||6||
48613857|NCT00110357|101838506|FG000|STARTED|Overall Study||27||
48613858|NCT00110357|101838507|FG001|STARTED|Overall Study||19||
48613859|NCT00110357|101838506|FG000|COMPLETED|Overall Study||0||
48613860|NCT00110357|101838507|FG001|COMPLETED|Overall Study||0||
48156944|NCT02707692|100706828|FG002|STARTED|Cycle 3 (30 Days)||9||
48156945|NCT02707692|100706829|FG003|STARTED|Cycle 3 (30 Days)||5||
48156946|NCT02707692|100706830|FG004|STARTED|Cycle 3 (30 Days)||6||
48156947|NCT02707692|100706831|FG005|STARTED|Cycle 3 (30 Days)||6||
48156948|NCT02707692|100706826|FG000|COMPLETED|Cycle 3 (30 Days)||5||
48156949|NCT02707692|100706827|FG001|COMPLETED|Cycle 3 (30 Days)||5||
48156950|NCT02707692|100706828|FG002|COMPLETED|Cycle 3 (30 Days)||9||
48156951|NCT02707692|100706829|FG003|COMPLETED|Cycle 3 (30 Days)||5||
48156952|NCT02707692|100706830|FG004|COMPLETED|Cycle 3 (30 Days)||5||
48156953|NCT02707692|100706831|FG005|COMPLETED|Cycle 3 (30 Days)||5||
48156954|NCT02707692|100706826|FG000|NOT COMPLETED|Cycle 3 (30 Days)||2||
48156955|NCT02707692|100706827|FG001|NOT COMPLETED|Cycle 3 (30 Days)||1||
48156956|NCT02707692|100706828|FG002|NOT COMPLETED|Cycle 3 (30 Days)||0||
48156957|NCT02707692|100706829|FG003|NOT COMPLETED|Cycle 3 (30 Days)||0||
48156958|NCT02707692|100706830|FG004|NOT COMPLETED|Cycle 3 (30 Days)||1||
48156959|NCT02707692|100706831|FG005|NOT COMPLETED|Cycle 3 (30 Days)||1||
48156960|NCT01111838|100706832|FG000|STARTED|Overall Study||22||
48727901|NCT01748825|102118689|FG007|STARTED|Dose Expansion||0||
48311543|NCT01353508|101088065|FG001|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0||
48613861|NCT00110357|101838506|FG000|NOT COMPLETED|Overall Study||27||
48613862|NCT00110357|101838507|FG001|NOT COMPLETED|Overall Study||19||
48613863|NCT02749227|101841626|FG000|STARTED|Overall Study||4||
48613864|NCT02749227|101841626|FG000|COMPLETED|Overall Study||4||
48613865|NCT02749227|101841626|FG000|NOT COMPLETED|Overall Study||0||
48613866|NCT03557918|101841627|FG000|STARTED|Overall Study||26||
48613867|NCT03557918|101841627|FG000|COMPLETED|Overall Study||26||
48613868|NCT03557918|101841627|FG000|NOT COMPLETED|Overall Study||0||
48613869|NCT02420119|101841628|FG000|STARTED|Overall Study||53||
48613870|NCT02420119|101841628|FG000|COMPLETED|Overall Study||48||
48613871|NCT02420119|101841628|FG000|NOT COMPLETED|Overall Study||5||
48613872|NCT00872521|101841629|FG000|STARTED|Completed PAD Induction||26||
48613873|NCT00872521|101841630|FG001|STARTED|Completed PAD Induction||72||
48613874|NCT00872521|101841631|FG002|STARTED|Completed PAD Induction||9||
48613875|NCT00872521|101841629|FG000|COMPLETED|Completed PAD Induction||21||
48613876|NCT00872521|101841630|FG001|COMPLETED|Completed PAD Induction||68||
48613877|NCT00872521|101841631|FG002|COMPLETED|Completed PAD Induction||9||
48613878|NCT00872521|101841629|FG000|NOT COMPLETED|Completed PAD Induction||5||
48613879|NCT00872521|101841630|FG001|NOT COMPLETED|Completed PAD Induction||4||
48613880|NCT00872521|101841631|FG002|NOT COMPLETED|Completed PAD Induction||0||
48613881|NCT00872521|101841629|FG000|STARTED|Primary Endpoint Analysis||21||
48613882|NCT00872521|101841630|FG001|STARTED|Primary Endpoint Analysis||68||
48613883|NCT00872521|101841631|FG002|STARTED|Primary Endpoint Analysis||9||
48613884|NCT00872521|101841629|FG000|COMPLETED|Primary Endpoint Analysis||20||
48613885|NCT00872521|101841630|FG001|COMPLETED|Primary Endpoint Analysis||63||
48311544|NCT01353508|101088066|FG002|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0||
48311545|NCT01353508|101088067|FG003|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0||
48311546|NCT02616614|101088068|FG000|STARTED|Overall Study||347||
48311547|NCT02616614|101088069|FG001|STARTED|Overall Study||345||
48311548|NCT02616614|101088070|FG002|STARTED|Overall Study||170||
48311549|NCT02616614|101088068|FG000|Safety Population|Overall Study||329|Randomized participants who received the study drug|
48613886|NCT00872521|101841631|FG002|COMPLETED|Primary Endpoint Analysis||8||
48613887|NCT00872521|101841629|FG000|NOT COMPLETED|Primary Endpoint Analysis||1||
48613888|NCT00872521|101841630|FG001|NOT COMPLETED|Primary Endpoint Analysis||5||
48613889|NCT00872521|101841631|FG002|NOT COMPLETED|Primary Endpoint Analysis||1||
48613890|NCT00872521|101841629|FG000|STARTED|Completed 3-month Follow up||20||
48613891|NCT00872521|101841630|FG001|STARTED|Completed 3-month Follow up||63||
48613892|NCT00872521|101841631|FG002|STARTED|Completed 3-month Follow up||8||
48613893|NCT00872521|101841629|FG000|COMPLETED|Completed 3-month Follow up||20||
48613894|NCT00872521|101841630|FG001|COMPLETED|Completed 3-month Follow up||60||
48613895|NCT00872521|101841631|FG002|COMPLETED|Completed 3-month Follow up||8||
48613896|NCT00872521|101841629|FG000|NOT COMPLETED|Completed 3-month Follow up||0||
48613897|NCT00872521|101841630|FG001|NOT COMPLETED|Completed 3-month Follow up||3||
48613898|NCT00872521|101841631|FG002|NOT COMPLETED|Completed 3-month Follow up||0||
48613899|NCT00872521|101841629|FG000|STARTED|Secondary Endpoint Analysis||20||
48613900|NCT00872521|101841630|FG001|STARTED|Secondary Endpoint Analysis||60||
48613901|NCT00872521|101841631|FG002|STARTED|Secondary Endpoint Analysis||8||
48613902|NCT00872521|101841629|FG000|COMPLETED|Secondary Endpoint Analysis||20||
48613903|NCT00872521|101841630|FG001|COMPLETED|Secondary Endpoint Analysis||58||
48613904|NCT00872521|101841631|FG002|COMPLETED|Secondary Endpoint Analysis||7||
48613905|NCT00872521|101841629|FG000|NOT COMPLETED|Secondary Endpoint Analysis||0||
48613906|NCT00872521|101841630|FG001|NOT COMPLETED|Secondary Endpoint Analysis||2||
48613907|NCT00872521|101841631|FG002|NOT COMPLETED|Secondary Endpoint Analysis||1||
48613908|NCT01890759|101841632|FG000|STARTED|Overall Study||100||
48311550|NCT02616614|101088069|FG001|Safety Population|Overall Study||328|Randomized participants who received the study drug|
48311551|NCT02616614|101088070|FG002|Safety Population|Overall Study||161|Randomized participants who received the study drug|
48311552|NCT02616614|101088068|FG000|mITT Population|Overall Study||325|Randomized participants, received at least 1 dose of study drug and at least 1 post-baseline visit|
48311553|NCT02616614|101088069|FG001|mITT Population|Overall Study||325|Randomized participants, received at least 1 dose of study drug and at least 1 post-baseline visit|
48311554|NCT02616614|101088070|FG002|mITT Population|Overall Study||160|Randomized participants, received at least 1 dose of study drug and at least 1 post-baseline visit|
48311555|NCT02616614|101088068|FG000|PP Population|Overall Study||253|Randomized subjects, compliant with study drug, completed study|
48311556|NCT02616614|101088069|FG001|PP Population|Overall Study||255|Randomized subjects, compliant with study drug, completed study|
48311557|NCT02616614|101088070|FG002|PP Population|Overall Study||122|Randomized subjects, compliant with study drug, completed study|
48311558|NCT02616614|101088068|FG000|COMPLETED|Overall Study||282||
48311559|NCT02616614|101088069|FG001|COMPLETED|Overall Study||285||
48406719|NCT01102140|101328479|FG001|COMPLETED|Overall Study||5||
48613909|NCT01890759|101841633|FG001|STARTED|Overall Study||200||
48613910|NCT01890759|101841632|FG000|COMPLETED|Overall Study||98||
48613911|NCT01890759|101841633|FG001|COMPLETED|Overall Study||188||
48613912|NCT01890759|101841632|FG000|NOT COMPLETED|Overall Study||2||
48613913|NCT01890759|101841633|FG001|NOT COMPLETED|Overall Study||12||
48613914|NCT01462110|101841634|FG000|STARTED|Overall Study||44||
48613915|NCT01462110|101841635|FG001|STARTED|Overall Study||43||
48311560|NCT02616614|101088070|FG002|COMPLETED|Overall Study||141||
48311561|NCT02616614|101088068|FG000|NOT COMPLETED|Overall Study||65||
48311562|NCT02616614|101088069|FG001|NOT COMPLETED|Overall Study||60||
48311563|NCT02616614|101088070|FG002|NOT COMPLETED|Overall Study||29||
48311564|NCT01538628|101088071|FG000|STARTED|Overall Study||149||
48311565|NCT01538628|101088072|FG001|STARTED|Overall Study||73||
48311566|NCT01538628|101088071|FG000|COMPLETED|Overall Study||148||
48311567|NCT01538628|101088072|FG001|COMPLETED|Overall Study||71||
48311568|NCT01538628|101088071|FG000|NOT COMPLETED|Overall Study||1||
48311569|NCT01538628|101088072|FG001|NOT COMPLETED|Overall Study||2||
48311570|NCT01687179|101088073|FG000|STARTED|Overall Study||3||
48311571|NCT01687179|101088074|FG001|STARTED|Overall Study||10||
48311572|NCT01687179|101088073|FG000|COMPLETED|Overall Study||2||
48311573|NCT01687179|101088074|FG001|COMPLETED|Overall Study||6||
48311574|NCT01687179|101088073|FG000|NOT COMPLETED|Overall Study||1||
48311575|NCT01687179|101088074|FG001|NOT COMPLETED|Overall Study||4||
48311576|NCT01837069|101088075|FG000|STARTED|Overall Study||103||
48311577|NCT01837069|101088076|FG001|STARTED|Overall Study||95||
48311578|NCT01837069|101088075|FG000|COMPLETED|Overall Study||103||
48311579|NCT01837069|101088076|FG001|COMPLETED|Overall Study||95||
48311580|NCT01837069|101088075|FG000|NOT COMPLETED|Overall Study||0||
48311581|NCT01837069|101088076|FG001|NOT COMPLETED|Overall Study||0||
48311582|NCT02252536|101088077|FG000|STARTED|Overall Study||173||
48311583|NCT02252536|101088078|FG001|STARTED|Overall Study||173||
48311584|NCT02252536|101088077|FG000|COMPLETED|Overall Study||168||
48311585|NCT02252536|101088078|FG001|COMPLETED|Overall Study||170||
48311586|NCT02252536|101088077|FG000|NOT COMPLETED|Overall Study||5||
48311587|NCT02252536|101088078|FG001|NOT COMPLETED|Overall Study||3||
48311588|NCT04344301|101088079|FG000|STARTED|Overall Study||45||
48311589|NCT04344301|101088080|FG001|STARTED|Overall Study||46||
48311590|NCT04344301|101088079|FG000|COMPLETED|Overall Study||44||
48311591|NCT04344301|101088080|FG001|COMPLETED|Overall Study||45||
48311592|NCT04344301|101088079|FG000|NOT COMPLETED|Overall Study||1||
48311593|NCT04344301|101088080|FG001|NOT COMPLETED|Overall Study||1||
48311594|NCT00404820|101088081|FG000|STARTED|Overall Study||408||
48311595|NCT00404820|101088082|FG001|STARTED|Overall Study||196||
48311596|NCT00404820|101088081|FG000|Started Treatment|Overall Study||408||
48311597|NCT00404820|101088082|FG001|Started Treatment|Overall Study||194||
48311598|NCT00404820|101088081|FG000|COMPLETED|Overall Study||389||
48311599|NCT00404820|101088082|FG001|COMPLETED|Overall Study||172||
48311600|NCT00404820|101088081|FG000|NOT COMPLETED|Overall Study||19||
48311601|NCT00404820|101088082|FG001|NOT COMPLETED|Overall Study||24||
48311602|NCT00806676|101088083|FG000|STARTED|Overall Study||29||
48311603|NCT00806676|101088084|FG001|STARTED|Overall Study||9||
48311604|NCT00806676|101088085|FG002|STARTED|Overall Study||29||
48311605|NCT00806676|101088083|FG000|COMPLETED|Overall Study||25||
48311606|NCT00806676|101088084|FG001|COMPLETED|Overall Study||9||
48311607|NCT00806676|101088085|FG002|COMPLETED|Overall Study||23||
48613916|NCT01462110|101841634|FG000|COMPLETED|Overall Study||43||
48613917|NCT01462110|101841635|FG001|COMPLETED|Overall Study||43||
48613918|NCT01462110|101841634|FG000|NOT COMPLETED|Overall Study||1||
48613919|NCT01462110|101841635|FG001|NOT COMPLETED|Overall Study||0||
48613920|NCT00436826|101841636|FG000|STARTED|Double Blind Period (DBP)||124||
48613921|NCT00436826|101841637|FG001|STARTED|Double Blind Period (DBP)||48||
48613922|NCT00436826|101841638|FG002|STARTED|Double Blind Period (DBP)||0||
48613923|NCT00436826|101841639|FG003|STARTED|Double Blind Period (DBP)||0||
48613924|NCT00436826|101841640|FG004|STARTED|Double Blind Period (DBP)||0||
48613925|NCT00436826|101841641|FG005|STARTED|Double Blind Period (DBP)||0||
48311608|NCT00806676|101088083|FG000|NOT COMPLETED|Overall Study||4||
48311609|NCT00806676|101088084|FG001|NOT COMPLETED|Overall Study||0||
48311610|NCT00806676|101088085|FG002|NOT COMPLETED|Overall Study||6||
48311611|NCT03947983|101088086|FG000|STARTED|Overall Study||19||
48311612|NCT03947983|101088087|FG001|STARTED|Overall Study||19||
48311613|NCT03947983|101088086|FG000|12 Weeks|Overall Study||15||
48311614|NCT03947983|101088087|FG001|12 Weeks|Overall Study||17||
48311615|NCT03947983|101088086|FG000|COMPLETED|Overall Study||14|24 weeks|
48311616|NCT03947983|101088087|FG001|COMPLETED|Overall Study||13|24 weeks|
48311617|NCT03947983|101088086|FG000|NOT COMPLETED|Overall Study||5||
48311618|NCT03947983|101088087|FG001|NOT COMPLETED|Overall Study||6||
48311619|NCT00842231|101088088|FG000|STARTED|Overall Study||40||
48311620|NCT00842231|101088088|FG000|COMPLETED|Overall Study||40||
48311621|NCT00842231|101088088|FG000|NOT COMPLETED|Overall Study||0||
48311622|NCT00646906|101088089|FG000|STARTED|Crossover Period 1||9||
48311623|NCT00646906|101088090|FG001|STARTED|Crossover Period 1||9||
48311624|NCT00646906|101088091|FG002|STARTED|Crossover Period 1||10||
48311625|NCT00646906|101088092|FG003|STARTED|Crossover Period 1||9||
48311626|NCT00646906|101088093|FG004|STARTED|Crossover Period 1||8||
48311627|NCT00646906|101088094|FG005|STARTED|Crossover Period 1||5||
48311628|NCT00646906|101088095|FG006|STARTED|Crossover Period 1||5||
48311629|NCT00646906|101088089|FG000|COMPLETED|Crossover Period 1||8||
48311630|NCT00646906|101088090|FG001|COMPLETED|Crossover Period 1||9||
48311631|NCT00646906|101088091|FG002|COMPLETED|Crossover Period 1||10||
48311632|NCT00646906|101088092|FG003|COMPLETED|Crossover Period 1||9||
48311633|NCT00646906|101088093|FG004|COMPLETED|Crossover Period 1||8||
48311634|NCT00646906|101088094|FG005|COMPLETED|Crossover Period 1||4||
48311635|NCT00646906|101088095|FG006|COMPLETED|Crossover Period 1||5||
48311636|NCT00646906|101088089|FG000|NOT COMPLETED|Crossover Period 1||1||
48311637|NCT00646906|101088090|FG001|NOT COMPLETED|Crossover Period 1||0||
48311638|NCT00646906|101088091|FG002|NOT COMPLETED|Crossover Period 1||0||
48311639|NCT00646906|101088092|FG003|NOT COMPLETED|Crossover Period 1||0||
48311640|NCT00646906|101088093|FG004|NOT COMPLETED|Crossover Period 1||0||
48613926|NCT00436826|101841636|FG000|COMPLETED|Double Blind Period (DBP)||111||
48613927|NCT00436826|101841637|FG001|COMPLETED|Double Blind Period (DBP)||37||
48613928|NCT00436826|101841638|FG002|COMPLETED|Double Blind Period (DBP)||0||
48613929|NCT00436826|101841639|FG003|COMPLETED|Double Blind Period (DBP)||0||
48613930|NCT00436826|101841640|FG004|COMPLETED|Double Blind Period (DBP)||0||
48613931|NCT00436826|101841641|FG005|COMPLETED|Double Blind Period (DBP)||0||
48613932|NCT00436826|101841636|FG000|NOT COMPLETED|Double Blind Period (DBP)||13||
48613933|NCT00436826|101841637|FG001|NOT COMPLETED|Double Blind Period (DBP)||11||
48613934|NCT00436826|101841638|FG002|NOT COMPLETED|Double Blind Period (DBP)||0||
48613935|NCT00436826|101841639|FG003|NOT COMPLETED|Double Blind Period (DBP)||0||
48613936|NCT00436826|101841640|FG004|NOT COMPLETED|Double Blind Period (DBP)||0||
48613937|NCT00436826|101841641|FG005|NOT COMPLETED|Double Blind Period (DBP)||0||
48613938|NCT00436826|101841636|FG000|STARTED|Ext. Period (With Cladribine Treatment)||0||
48613939|NCT00436826|101841637|FG001|STARTED|Ext. Period (With Cladribine Treatment)||0||
48613940|NCT00436826|101841638|FG002|STARTED|Ext. Period (With Cladribine Treatment)||47||
48613941|NCT00436826|101841639|FG003|STARTED|Ext. Period (With Cladribine Treatment)||28||
48613942|NCT00436826|101841640|FG004|STARTED|Ext. Period (With Cladribine Treatment)||0||
48613943|NCT00436826|101841641|FG005|STARTED|Ext. Period (With Cladribine Treatment)||0||
48613944|NCT00436826|101841636|FG000|COMPLETED|Ext. Period (With Cladribine Treatment)||0||
48613945|NCT00436826|101841637|FG001|COMPLETED|Ext. Period (With Cladribine Treatment)||0||
48613946|NCT00436826|101841638|FG002|COMPLETED|Ext. Period (With Cladribine Treatment)||1||
48613947|NCT00436826|101841639|FG003|COMPLETED|Ext. Period (With Cladribine Treatment)||2||
48727902|NCT01748825|102118690|FG008|STARTED|Dose Expansion||13||
48727903|NCT01748825|102118691|FG009|STARTED|Dose Expansion||20||
48727904|NCT01748825|102118682|FG000|COMPLETED|Dose Expansion||0||
48727905|NCT01748825|102118683|FG001|COMPLETED|Dose Expansion||0||
48311641|NCT00646906|101088094|FG005|NOT COMPLETED|Crossover Period 1||1||
48311642|NCT00646906|101088095|FG006|NOT COMPLETED|Crossover Period 1||0||
48311643|NCT00646906|101088089|FG000|STARTED|Washout (>/= 14 Days)||8||
48311644|NCT00646906|101088090|FG001|STARTED|Washout (>/= 14 Days)||9||
48311645|NCT00646906|101088091|FG002|STARTED|Washout (>/= 14 Days)||10||
48311646|NCT00646906|101088092|FG003|STARTED|Washout (>/= 14 Days)||9||
48311647|NCT00646906|101088093|FG004|STARTED|Washout (>/= 14 Days)||0||
48311648|NCT00646906|101088094|FG005|STARTED|Washout (>/= 14 Days)||4||
48311649|NCT00646906|101088095|FG006|STARTED|Washout (>/= 14 Days)||5||
48311650|NCT00646906|101088089|FG000|COMPLETED|Washout (>/= 14 Days)||8||
48311651|NCT00646906|101088090|FG001|COMPLETED|Washout (>/= 14 Days)||9||
48311652|NCT00646906|101088091|FG002|COMPLETED|Washout (>/= 14 Days)||10||
48311653|NCT00646906|101088092|FG003|COMPLETED|Washout (>/= 14 Days)||9||
48311654|NCT00646906|101088093|FG004|COMPLETED|Washout (>/= 14 Days)||0||
48613948|NCT00436826|101841640|FG004|COMPLETED|Ext. Period (With Cladribine Treatment)||0||
48613949|NCT00436826|101841641|FG005|COMPLETED|Ext. Period (With Cladribine Treatment)||0||
48613950|NCT00436826|101841636|FG000|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0||
48613951|NCT00436826|101841637|FG001|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0||
48613952|NCT00436826|101841638|FG002|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||46||
48613953|NCT00436826|101841639|FG003|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||26||
48613954|NCT00436826|101841640|FG004|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0||
48613955|NCT00436826|101841641|FG005|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0||
48613956|NCT00436826|101841636|FG000|STARTED|Ext. Period (No Cladribine Treatment)||0||
48613957|NCT00436826|101841637|FG001|STARTED|Ext. Period (No Cladribine Treatment)||0||
48613958|NCT00436826|101841638|FG002|STARTED|Ext. Period (No Cladribine Treatment)||0||
48613959|NCT00436826|101841639|FG003|STARTED|Ext. Period (No Cladribine Treatment)||0||
48727906|NCT01748825|102118684|FG002|COMPLETED|Dose Expansion||0||
48727907|NCT01748825|102118685|FG003|COMPLETED|Dose Expansion||0||
48727908|NCT01748825|102118686|FG004|COMPLETED|Dose Expansion||0||
48727909|NCT01748825|102118687|FG005|COMPLETED|Dose Expansion||0||
48727910|NCT01748825|102118688|FG006|COMPLETED|Dose Expansion||0||
48727911|NCT01748825|102118689|FG007|COMPLETED|Dose Expansion||0||
48727912|NCT01748825|102118690|FG008|COMPLETED|Dose Expansion||11||
48311655|NCT00646906|101088094|FG005|COMPLETED|Washout (>/= 14 Days)||4||
48311656|NCT00646906|101088095|FG006|COMPLETED|Washout (>/= 14 Days)||5||
48311657|NCT00646906|101088089|FG000|NOT COMPLETED|Washout (>/= 14 Days)||0||
48311658|NCT00646906|101088090|FG001|NOT COMPLETED|Washout (>/= 14 Days)||0||
48311659|NCT00646906|101088091|FG002|NOT COMPLETED|Washout (>/= 14 Days)||0||
48311660|NCT00646906|101088092|FG003|NOT COMPLETED|Washout (>/= 14 Days)||0||
48727913|NCT01748825|102118691|FG009|COMPLETED|Dose Expansion||15||
48727914|NCT01748825|102118682|FG000|NOT COMPLETED|Dose Expansion||0||
48727915|NCT01748825|102118683|FG001|NOT COMPLETED|Dose Expansion||0||
48613960|NCT00436826|101841640|FG004|STARTED|Ext. Period (No Cladribine Treatment)||52||
48613961|NCT00436826|101841641|FG005|STARTED|Ext. Period (No Cladribine Treatment)||7||
48311661|NCT00646906|101088093|FG004|NOT COMPLETED|Washout (>/= 14 Days)||0||
48311662|NCT00646906|101088094|FG005|NOT COMPLETED|Washout (>/= 14 Days)||0||
48311663|NCT00646906|101088095|FG006|NOT COMPLETED|Washout (>/= 14 Days)||0||
48311664|NCT00646906|101088089|FG000|STARTED|Crossover Period 2||8||
48311665|NCT00646906|101088090|FG001|STARTED|Crossover Period 2||9||
48311666|NCT00646906|101088091|FG002|STARTED|Crossover Period 2||10||
48311667|NCT00646906|101088092|FG003|STARTED|Crossover Period 2||9||
48613962|NCT00436826|101841636|FG000|COMPLETED|Ext. Period (No Cladribine Treatment)||0||
48613963|NCT00436826|101841637|FG001|COMPLETED|Ext. Period (No Cladribine Treatment)||0||
48613964|NCT00436826|101841638|FG002|COMPLETED|Ext. Period (No Cladribine Treatment)||0||
48613965|NCT00436826|101841639|FG003|COMPLETED|Ext. Period (No Cladribine Treatment)||0||
48613966|NCT00436826|101841640|FG004|COMPLETED|Ext. Period (No Cladribine Treatment)||1||
48311668|NCT00646906|101088093|FG004|STARTED|Crossover Period 2||0||
48311669|NCT00646906|101088094|FG005|STARTED|Crossover Period 2||4||
48311670|NCT00646906|101088095|FG006|STARTED|Crossover Period 2||5||
48311671|NCT00646906|101088089|FG000|COMPLETED|Crossover Period 2||8||
48311672|NCT00646906|101088090|FG001|COMPLETED|Crossover Period 2||8||
48311673|NCT00646906|101088091|FG002|COMPLETED|Crossover Period 2||8||
48311674|NCT00646906|101088092|FG003|COMPLETED|Crossover Period 2||8||
48311675|NCT00646906|101088093|FG004|COMPLETED|Crossover Period 2||0||
48311676|NCT00646906|101088094|FG005|COMPLETED|Crossover Period 2||4||
48311677|NCT00646906|101088095|FG006|COMPLETED|Crossover Period 2||4||
48311678|NCT00646906|101088089|FG000|NOT COMPLETED|Crossover Period 2||0||
48311679|NCT00646906|101088090|FG001|NOT COMPLETED|Crossover Period 2||1||
48311680|NCT00646906|101088091|FG002|NOT COMPLETED|Crossover Period 2||2||
48311681|NCT00646906|101088092|FG003|NOT COMPLETED|Crossover Period 2||1||
48311682|NCT00646906|101088093|FG004|NOT COMPLETED|Crossover Period 2||0||
48311683|NCT00646906|101088094|FG005|NOT COMPLETED|Crossover Period 2||0||
48311684|NCT00646906|101088095|FG006|NOT COMPLETED|Crossover Period 2||1||
48311685|NCT00436618|101088096|FG000|STARTED|Overall Study||114||
48311686|NCT00436618|101088097|FG001|STARTED|Overall Study||55||
48311687|NCT00436618|101088098|FG002|STARTED|Overall Study||107||
48311688|NCT00436618|101088096|FG000|COMPLETED|Overall Study||84||
48311689|NCT00436618|101088097|FG001|COMPLETED|Overall Study||28||
48311690|NCT00436618|101088098|FG002|COMPLETED|Overall Study||46||
48311691|NCT00436618|101088096|FG000|NOT COMPLETED|Overall Study||30||
48311692|NCT00436618|101088097|FG001|NOT COMPLETED|Overall Study||27||
48311693|NCT00436618|101088098|FG002|NOT COMPLETED|Overall Study||61||
48311694|NCT02247960|101088099|FG000|STARTED|Patient Consent and Randomization||85||
48311695|NCT02247960|101088100|FG001|STARTED|Patient Consent and Randomization||90||
48311696|NCT02247960|101088099|FG000|COMPLETED|Patient Consent and Randomization||83||
48311697|NCT02247960|101088100|FG001|COMPLETED|Patient Consent and Randomization||84||
48311698|NCT02247960|101088099|FG000|NOT COMPLETED|Patient Consent and Randomization||2||
48311699|NCT02247960|101088100|FG001|NOT COMPLETED|Patient Consent and Randomization||6||
48311700|NCT02247960|101088099|FG000|STARTED|Catheter Removed||83||
48311701|NCT02247960|101088100|FG001|STARTED|Catheter Removed||84||
48613967|NCT00436826|101841641|FG005|COMPLETED|Ext. Period (No Cladribine Treatment)||0||
48613968|NCT00436826|101841636|FG000|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0||
48613969|NCT00436826|101841637|FG001|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0||
48613970|NCT00436826|101841638|FG002|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0||
48613971|NCT00436826|101841639|FG003|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0||
48613972|NCT00436826|101841640|FG004|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||51||
48613973|NCT00436826|101841641|FG005|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||7||
48613974|NCT04921800|101841642|FG000|STARTED|Overall Study||11||
48613975|NCT04921800|101841642|FG000|COMPLETED|Overall Study||11||
48613976|NCT04921800|101841642|FG000|NOT COMPLETED|Overall Study||0||
48613977|NCT02541864|101841643|FG000|STARTED|Overall Study||164||
48613978|NCT02541864|101841644|FG001|STARTED|Overall Study||166||
48613979|NCT02541864|101841643|FG000|COMPLETED|Overall Study||164||
48613980|NCT02541864|101841644|FG001|COMPLETED|Overall Study||166||
48613981|NCT02541864|101841643|FG000|NOT COMPLETED|Overall Study||0||
48613982|NCT02541864|101841644|FG001|NOT COMPLETED|Overall Study||0||
48613983|NCT02346877|101841645|FG000|STARTED|Overall Study||19||
48613984|NCT02346877|101841646|FG001|STARTED|Overall Study||0||
48613985|NCT02346877|101841645|FG000|COMPLETED|Overall Study||0||
48613986|NCT02346877|101841646|FG001|COMPLETED|Overall Study||0||
48613987|NCT02346877|101841645|FG000|NOT COMPLETED|Overall Study||19||
48613988|NCT02346877|101841646|FG001|NOT COMPLETED|Overall Study||0||
48311702|NCT02247960|101088099|FG000|COMPLETED|Catheter Removed||76||
48311703|NCT02247960|101088100|FG001|COMPLETED|Catheter Removed||74||
48311704|NCT02247960|101088099|FG000|NOT COMPLETED|Catheter Removed||7||
48311705|NCT02247960|101088100|FG001|NOT COMPLETED|Catheter Removed||10||
48311706|NCT00615472|101088101|FG000|STARTED|Overall Study||30||
48311707|NCT00615472|101088102|FG001|STARTED|Overall Study||28||
48613989|NCT03512353|101841647|FG000|STARTED|Overall Study||7||
48311708|NCT00615472|101088101|FG000|COMPLETED|Overall Study||30||
48311709|NCT00615472|101088102|FG001|COMPLETED|Overall Study||28||
48727916|NCT01748825|102118684|FG002|NOT COMPLETED|Dose Expansion||0||
48727917|NCT01748825|102118685|FG003|NOT COMPLETED|Dose Expansion||0||
48727918|NCT01748825|102118686|FG004|NOT COMPLETED|Dose Expansion||0||
48727919|NCT01748825|102118687|FG005|NOT COMPLETED|Dose Expansion||0||
48727920|NCT01748825|102118688|FG006|NOT COMPLETED|Dose Expansion||0||
48727921|NCT01748825|102118689|FG007|NOT COMPLETED|Dose Expansion||0||
48727922|NCT01748825|102118690|FG008|NOT COMPLETED|Dose Expansion||2||
48727923|NCT01748825|102118691|FG009|NOT COMPLETED|Dose Expansion||5||
48727924|NCT02690714|102118692|FG000|STARTED|Segment 1: Single-dose Day -4 to Day 0||9||
48311710|NCT00615472|101088101|FG000|NOT COMPLETED|Overall Study||0||
48311711|NCT00615472|101088102|FG001|NOT COMPLETED|Overall Study||0||
48311712|NCT00621751|101088103|FG000|STARTED|Overall Study||35||
48311713|NCT00621751|101088104|FG001|STARTED|Overall Study||35||
48311714|NCT00621751|101088103|FG000|COMPLETED|Overall Study||35||
48311715|NCT00621751|101088104|FG001|COMPLETED|Overall Study||34||
48311716|NCT00621751|101088103|FG000|NOT COMPLETED|Overall Study||0||
48311717|NCT00621751|101088104|FG001|NOT COMPLETED|Overall Study||1||
48311718|NCT02809131|101088105|FG000|STARTED|Overall Study||505||
48311719|NCT02809131|101088106|FG001|STARTED|Overall Study||505||
48311720|NCT02809131|101088105|FG000|COMPLETED|Overall Study||445||
48311721|NCT02809131|101088106|FG001|COMPLETED|Overall Study||445||
48311722|NCT02809131|101088105|FG000|NOT COMPLETED|Overall Study||60||
48311723|NCT02809131|101088106|FG001|NOT COMPLETED|Overall Study||60||
48311724|NCT01210170|101088107|FG000|STARTED|Overall Study||22||
48311725|NCT01210170|101088107|FG000|COMPLETED|Overall Study||15||
48311726|NCT01210170|101088107|FG000|NOT COMPLETED|Overall Study||7||
48311727|NCT01236105|101088108|FG000|STARTED|Overall Study||21||
48311728|NCT01236105|101088108|FG000|COMPLETED|Overall Study||21||
48311729|NCT01236105|101088108|FG000|NOT COMPLETED|Overall Study||0||
48311730|NCT01624259|101088109|FG000|STARTED|Overall Study||299||
48311731|NCT01624259|101088110|FG001|STARTED|Overall Study||300||
48311732|NCT01624259|101088109|FG000|Received at Least One Dose of Study Drug|Overall Study||299||
48311733|NCT01624259|101088110|FG001|Received at Least One Dose of Study Drug|Overall Study||300||
48311734|NCT01624259|101088109|FG000|COMPLETED|Overall Study||269||
48311735|NCT01624259|101088110|FG001|COMPLETED|Overall Study||269||
48311736|NCT01624259|101088109|FG000|NOT COMPLETED|Overall Study||30||
48311737|NCT01624259|101088110|FG001|NOT COMPLETED|Overall Study||31||
48311738|NCT04203745|101088111|FG000|STARTED|Overall Study||26||
48311739|NCT04203745|101088111|FG000|COMPLETED|Overall Study||20||
48311740|NCT04203745|101088111|FG000|NOT COMPLETED|Overall Study||6||
48311741|NCT01878526|101088112|FG000|STARTED|Overall Study||40||
48311742|NCT01878526|101088113|FG001|STARTED|Overall Study||40||
48311743|NCT01878526|101088112|FG000|COMPLETED|Overall Study||37||
48311744|NCT01878526|101088113|FG001|COMPLETED|Overall Study||38||
48311745|NCT01878526|101088112|FG000|NOT COMPLETED|Overall Study||3||
48311746|NCT01878526|101088113|FG001|NOT COMPLETED|Overall Study||2||
48311747|NCT00943579|101088114|FG000|STARTED|Overall Study||21||
48311748|NCT00943579|101088115|FG001|STARTED|Overall Study||20||
48311749|NCT00943579|101088114|FG000|COMPLETED|Overall Study||15||
48311750|NCT00943579|101088115|FG001|COMPLETED|Overall Study||15||
48311751|NCT00943579|101088114|FG000|NOT COMPLETED|Overall Study||6||
48311752|NCT00943579|101088115|FG001|NOT COMPLETED|Overall Study||5||
48727925|NCT02690714|102118692|FG000|COMPLETED|Segment 1: Single-dose Day -4 to Day 0||9||
48727926|NCT02690714|102118692|FG000|NOT COMPLETED|Segment 1: Single-dose Day -4 to Day 0||0||
48727927|NCT02690714|102118692|FG000|STARTED|Segment 2: Multi-dose Day 0 to Week 12||15||
48727928|NCT02690714|102118692|FG000|COMPLETED|Segment 2: Multi-dose Day 0 to Week 12||15||
48727929|NCT02690714|102118692|FG000|NOT COMPLETED|Segment 2: Multi-dose Day 0 to Week 12||0||
48727930|NCT02690714|102118692|FG000|STARTED|Segment 3: Extended Treatment Wks 12-48||15||
48727931|NCT02690714|102118692|FG000|COMPLETED|Segment 3: Extended Treatment Wks 12-48||15||
48311753|NCT03372928|101088116|FG000|STARTED|First Intervention (5 d Energy Deficit)||10||
48311754|NCT03372928|101088117|FG001|STARTED|First Intervention (5 d Energy Deficit)||10||
48311755|NCT03372928|101088116|FG000|COMPLETED|First Intervention (5 d Energy Deficit)||10||
48311756|NCT03372928|101088117|FG001|COMPLETED|First Intervention (5 d Energy Deficit)||10||
48727932|NCT02690714|102118692|FG000|NOT COMPLETED|Segment 3: Extended Treatment Wks 12-48||0||
48727933|NCT02690714|102118692|FG000|STARTED|Post-Wk 48: Safety Week 48 to EoS Visit||12||
48727934|NCT02690714|102118692|FG000|COMPLETED|Post-Wk 48: Safety Week 48 to EoS Visit||10||
48727935|NCT02690714|102118692|FG000|NOT COMPLETED|Post-Wk 48: Safety Week 48 to EoS Visit||2||
48727936|NCT04390841|102118693|FG000|STARTED|Overall Study||106||
48727937|NCT04390841|102118693|FG000|COMPLETED|Overall Study||104||
48727938|NCT04390841|102118693|FG000|NOT COMPLETED|Overall Study||2||
48311757|NCT03372928|101088116|FG000|NOT COMPLETED|First Intervention (5 d Energy Deficit)||0||
48311758|NCT03372928|101088117|FG001|NOT COMPLETED|First Intervention (5 d Energy Deficit)||0||
48311759|NCT03372928|101088116|FG000|STARTED|Washout (14 d)||10||
48311760|NCT03372928|101088117|FG001|STARTED|Washout (14 d)||10||
48311761|NCT03372928|101088116|FG000|COMPLETED|Washout (14 d)||10||
48311762|NCT03372928|101088117|FG001|COMPLETED|Washout (14 d)||9||
48311763|NCT03372928|101088116|FG000|NOT COMPLETED|Washout (14 d)||0||
48311764|NCT03372928|101088117|FG001|NOT COMPLETED|Washout (14 d)||1||
48311765|NCT03372928|101088116|FG000|STARTED|Second Intervention (5 d Energy Deficit)||10||
48311766|NCT03372928|101088117|FG001|STARTED|Second Intervention (5 d Energy Deficit)||9||
48311767|NCT03372928|101088116|FG000|COMPLETED|Second Intervention (5 d Energy Deficit)||10||
48311768|NCT03372928|101088117|FG001|COMPLETED|Second Intervention (5 d Energy Deficit)||9||
48311769|NCT03372928|101088116|FG000|NOT COMPLETED|Second Intervention (5 d Energy Deficit)||0||
48311770|NCT03372928|101088117|FG001|NOT COMPLETED|Second Intervention (5 d Energy Deficit)||0||
48311771|NCT03337542|101088118|FG000|STARTED|Overall Study||243||
48311772|NCT03337542|101088118|FG000|Safety Population|Overall Study||242||
48311773|NCT03337542|101088118|FG000|COMPLETED|Overall Study||222||
48311774|NCT03337542|101088118|FG000|NOT COMPLETED|Overall Study||21||
48311775|NCT04163900|101088119|FG000|STARTED|Overall Study||388||
48311776|NCT04163900|101088120|FG001|STARTED|Overall Study||385||
48311777|NCT04163900|101088119|FG000|Received Study Treatment (Safety Population)|Overall Study||383||
48311778|NCT04163900|101088120|FG001|Received Study Treatment (Safety Population)|Overall Study||378||
48311779|NCT04163900|101088119|FG000|COMPLETED|Overall Study||0||
48311780|NCT04163900|101088120|FG001|COMPLETED|Overall Study||0||
48311781|NCT04163900|101088119|FG000|NOT COMPLETED|Overall Study||388||
48311782|NCT04163900|101088120|FG001|NOT COMPLETED|Overall Study||385||
48311783|NCT01011439|101088121|FG000|STARTED|Overall Study||72||
48311784|NCT01011439|101088121|FG000|COMPLETED|Overall Study||15||
48311785|NCT01011439|101088121|FG000|NOT COMPLETED|Overall Study||57||
48311786|NCT02486653|101088122|FG000|STARTED|Overall Study||76||
48727939|NCT03270891|102118694|FG000|STARTED|Overall Study||26||
48727940|NCT03270891|102118695|FG001|STARTED|Overall Study||25||
48727941|NCT03270891|102118696|FG002|STARTED|Overall Study||24||
48727942|NCT03270891|102118694|FG000|Received Intervention|Overall Study||25||
48727943|NCT03270891|102118695|FG001|Received Intervention|Overall Study||25||
48727944|NCT03270891|102118696|FG002|Received Intervention|Overall Study||0||
48727945|NCT03270891|102118694|FG000|For Physician Arm Only; Those Physicians Who Had Patients Who Participated|Overall Study||0||
48727946|NCT03270891|102118695|FG001|For Physician Arm Only; Those Physicians Who Had Patients Who Participated|Overall Study||0||
48156961|NCT01111838|100706832|FG000|COMPLETED|Overall Study||15||
48311787|NCT02486653|101088123|FG001|STARTED|Overall Study||75||
48727947|NCT03270891|102118696|FG002|For Physician Arm Only; Those Physicians Who Had Patients Who Participated|Overall Study||17||
48727948|NCT03270891|102118694|FG000|COMPLETED|Overall Study||22||
48727949|NCT03270891|102118695|FG001|COMPLETED|Overall Study||19||
48727950|NCT03270891|102118696|FG002|COMPLETED|Overall Study||17||
48727951|NCT03270891|102118694|FG000|NOT COMPLETED|Overall Study||4||
48727952|NCT03270891|102118695|FG001|NOT COMPLETED|Overall Study||6||
48727953|NCT03270891|102118696|FG002|NOT COMPLETED|Overall Study||7||
48727954|NCT01123707|102118697|FG000|STARTED|Overall Study||44||
48727955|NCT01123707|102118698|FG001|STARTED|Overall Study||41||
48727956|NCT01123707|102118699|FG002|STARTED|Overall Study||38||
48727957|NCT01123707|102118700|FG003|STARTED|Overall Study||50||
48727958|NCT01123707|102118697|FG000|Safety Sample|Overall Study||44|Participants who received at least one dose of aripiprazole/escitalopram combination therapy.|
48727959|NCT01123707|102118698|FG001|Safety Sample|Overall Study||41|Participants who received at least one dose of aripiprazole/escitalopram combination therapy.|
48727960|NCT01123707|102118699|FG002|Safety Sample|Overall Study||36|Participants who received at least one dose of aripiprazole/escitalopram combination therapy.|
48727961|NCT01123707|102118700|FG003|Safety Sample|Overall Study||49|Participants who received at least one dose of aripiprazole/escitalopram combination therapy.|
48727962|NCT01123707|102118697|FG000|COMPLETED|Overall Study||0||
48727963|NCT01123707|102118698|FG001|COMPLETED|Overall Study||0||
48727964|NCT01123707|102118699|FG002|COMPLETED|Overall Study||0||
48727965|NCT01123707|102118700|FG003|COMPLETED|Overall Study||0||
48727966|NCT01123707|102118697|FG000|NOT COMPLETED|Overall Study||44||
48727967|NCT01123707|102118698|FG001|NOT COMPLETED|Overall Study||41||
48727968|NCT01123707|102118699|FG002|NOT COMPLETED|Overall Study||38||
48311788|NCT02486653|101088122|FG000|COMPLETED|Overall Study||70||
48311789|NCT02486653|101088123|FG001|COMPLETED|Overall Study||71||
48311790|NCT02486653|101088122|FG000|NOT COMPLETED|Overall Study||6||
48311791|NCT02486653|101088123|FG001|NOT COMPLETED|Overall Study||4||
48311792|NCT01611948|101088124|FG000|STARTED|Overall Study||32||
48311793|NCT01611948|101088125|FG001|STARTED|Overall Study||38||
48727969|NCT01123707|102118700|FG003|NOT COMPLETED|Overall Study||50||
48727970|NCT02202538|102118701|FG000|STARTED|Overall Study||53||
48311794|NCT01611948|101088124|FG000|COMPLETED|Overall Study||18||
48311795|NCT01611948|101088125|FG001|COMPLETED|Overall Study||26||
48311796|NCT01611948|101088124|FG000|NOT COMPLETED|Overall Study||14||
48311797|NCT01611948|101088125|FG001|NOT COMPLETED|Overall Study||12||
48311798|NCT03007979|101088126|FG000|STARTED|Overall Study||55||
48311799|NCT03007979|101088126|FG000|COMPLETED|Overall Study||54||
48311800|NCT03007979|101088126|FG000|NOT COMPLETED|Overall Study||1||
48311801|NCT01444742|101088127|FG000|STARTED|Overall Study||81||
48311802|NCT01444742|101088127|FG000|COMPLETED|Overall Study||80||
48311803|NCT01444742|101088127|FG000|NOT COMPLETED|Overall Study||1||
48311804|NCT03227471|101088128|FG000|STARTED|Overall Study||9||
48311805|NCT03227471|101088129|FG001|STARTED|Overall Study||30||
48311806|NCT03227471|101088130|FG002|STARTED|Overall Study||8||
48311807|NCT03227471|101088131|FG003|STARTED|Overall Study||7||
48311808|NCT03227471|101088132|FG004|STARTED|Overall Study||25||
48311809|NCT03227471|101088133|FG005|STARTED|Overall Study||6||
48311810|NCT03227471|101088134|FG006|STARTED|Overall Study||17||
48311811|NCT03227471|101088135|FG007|STARTED|Overall Study||12||
48311812|NCT03227471|101088136|FG008|STARTED|Overall Study||10||
48311813|NCT03227471|101088137|FG009|STARTED|Overall Study||22||
48311814|NCT03227471|101088138|FG010|STARTED|Overall Study||21||
48406720|NCT01102140|101328478|FG000|NOT COMPLETED|Overall Study||3||
48613990|NCT03512353|101841647|FG000|Received Treatment|Overall Study||6||
48613991|NCT03512353|101841647|FG000|COMPLETED|Overall Study||3|Study completion is defined as participants who received 12 cycles of treatment and completed the safety follow-up visit.|
48613992|NCT03512353|101841647|FG000|NOT COMPLETED|Overall Study||4||
48613993|NCT03560869|101841648|FG000|STARTED|Overall Study||14||
48613994|NCT03560869|101841649|FG001|STARTED|Overall Study||21||
48613995|NCT03560869|101841648|FG000|COMPLETED|Overall Study||7||
48613996|NCT03560869|101841649|FG001|COMPLETED|Overall Study||12||
48613997|NCT03560869|101841648|FG000|NOT COMPLETED|Overall Study||7||
48613998|NCT03560869|101841649|FG001|NOT COMPLETED|Overall Study||9||
48613999|NCT03630705|101841650|FG000|STARTED|Overall Study||200||
48614000|NCT03630705|101841651|FG001|STARTED|Overall Study||100||
48614001|NCT03630705|101841652|FG002|STARTED|Overall Study||150||
48614002|NCT03630705|101841653|FG003|STARTED|Overall Study||75||
48614003|NCT03630705|101841650|FG000|Vaccinated at the Age of 2 Months|Overall Study||200||
48614004|NCT03630705|101841651|FG001|Vaccinated at the Age of 2 Months|Overall Study||100||
48614005|NCT03630705|101841652|FG002|Vaccinated at the Age of 2 Months|Overall Study||150||
48614006|NCT03630705|101841653|FG003|Vaccinated at the Age of 2 Months|Overall Study||75||
48614007|NCT03630705|101841650|FG000|Vaccinated at the Age of 3 Months|Overall Study||0|Group 1 and 2 participants did not receive any vaccination at the age of 3 months.|
48614008|NCT03630705|101841651|FG001|Vaccinated at the Age of 3 Months|Overall Study||0|Group 1 and 2 participants did not receive any vaccination at the age of 3 months.|
48614009|NCT03630705|101841652|FG002|Vaccinated at the Age of 3 Months|Overall Study||149|Group 1 and 2 participants did not receive any vaccination at the age of 3 months.|
48614010|NCT03630705|101841653|FG003|Vaccinated at the Age of 3 Months|Overall Study||75|Group 1 and 2 participants did not receive any vaccination at the age of 3 months.|
48614011|NCT03630705|101841650|FG000|Vaccinated at the Age of 4 Months|Overall Study||195|Group 3 and 4 participants did not receive any vaccination at the age of 4 months.|
48614012|NCT03630705|101841651|FG001|Vaccinated at the Age of 4 Months|Overall Study||96|Group 3 and 4 participants did not receive any vaccination at the age of 4 months.|
48614013|NCT03630705|101841652|FG002|Vaccinated at the Age of 4 Months|Overall Study||0|Group 3 and 4 participants did not receive any vaccination at the age of 4 months.|
48614014|NCT03630705|101841653|FG003|Vaccinated at the Age of 4 Months|Overall Study||0|Group 3 and 4 participants did not receive any vaccination at the age of 4 months.|
48614015|NCT03630705|101841650|FG000|Vaccinated at the Age of 4.5 Months|Overall Study||0|Group 1 and 2 participants did not receive any vaccination at the age of 4.5 months.|
48614016|NCT03630705|101841651|FG001|Vaccinated at the Age of 4.5 Months|Overall Study||0|Group 1 and 2 participants did not receive any vaccination at the age of 4.5 months.|
48614017|NCT03630705|101841652|FG002|Vaccinated at the Age of 4.5 Months|Overall Study||149|Group 1 and 2 participants did not receive any vaccination at the age of 4.5 months.|
48614018|NCT03630705|101841653|FG003|Vaccinated at the Age of 4.5 Months|Overall Study||75|Group 1 and 2 participants did not receive any vaccination at the age of 4.5 months.|
48614019|NCT03630705|101841650|FG000|Vaccinated at the Age of 6 Months|Overall Study||194||
48614020|NCT03630705|101841651|FG001|Vaccinated at the Age of 6 Months|Overall Study||95||
48727971|NCT02202538|102118701|FG000|Screen Failure|Overall Study||2||
48727972|NCT02202538|102118701|FG000|COMPLETED|Overall Study||45||
48727973|NCT02202538|102118701|FG000|NOT COMPLETED|Overall Study||8||
48727974|NCT04787055|102118702|FG000|STARTED|Overall Study||18||
48727975|NCT04787055|102118703|FG001|STARTED|Overall Study||17||
48311815|NCT03227471|101088139|FG011|STARTED|Overall Study||7||
48311816|NCT03227471|101088140|FG012|STARTED|Overall Study||21||
48311817|NCT03227471|101088141|FG013|STARTED|Overall Study||8||
48727976|NCT04787055|102118702|FG000|COMPLETED|Overall Study||15||
48727977|NCT04787055|102118703|FG001|COMPLETED|Overall Study||11||
48727978|NCT04787055|102118702|FG000|NOT COMPLETED|Overall Study||3||
48727979|NCT04787055|102118703|FG001|NOT COMPLETED|Overall Study||6||
48727980|NCT02268994|102118704|FG000|STARTED|Overall Study||117||
48727981|NCT02268994|102118705|FG001|STARTED|Overall Study||116||
48727982|NCT02268994|102118704|FG000|COMPLETED|Overall Study||86||
48727983|NCT02268994|102118705|FG001|COMPLETED|Overall Study||81||
48727984|NCT02268994|102118704|FG000|NOT COMPLETED|Overall Study||31||
48727985|NCT02268994|102118705|FG001|NOT COMPLETED|Overall Study||35||
48727986|NCT00924508|102118706|FG000|STARTED|Overall Study||23||
48727987|NCT00924508|102118706|FG000|COMPLETED|Overall Study||20||
48727988|NCT00924508|102118706|FG000|NOT COMPLETED|Overall Study||3||
48727989|NCT02593825|102118707|FG000|STARTED|Intervention||67||
48727990|NCT02593825|102118708|FG001|STARTED|Intervention||67||
48727991|NCT02593825|102118707|FG000|COMPLETED|Intervention||57||
48727992|NCT02593825|102118708|FG001|COMPLETED|Intervention||55||
48727993|NCT02593825|102118707|FG000|NOT COMPLETED|Intervention||10||
48727994|NCT02593825|102118708|FG001|NOT COMPLETED|Intervention||12||
48727995|NCT02593825|102118707|FG000|STARTED|Follow-up||57||
48727996|NCT02593825|102118708|FG001|STARTED|Follow-up||55||
48727997|NCT02593825|102118707|FG000|COMPLETED|Follow-up||57||
48727998|NCT02593825|102118708|FG001|COMPLETED|Follow-up||55||
48727999|NCT02593825|102118707|FG000|NOT COMPLETED|Follow-up||0||
48728000|NCT02593825|102118708|FG001|NOT COMPLETED|Follow-up||0||
48728001|NCT01399866|102118709|FG000|STARTED|Overall Study||32||
48728002|NCT01399866|102118710|FG001|STARTED|Overall Study||30||
48728003|NCT01399866|102118709|FG000|COMPLETED|Overall Study||28||
48728004|NCT01399866|102118710|FG001|COMPLETED|Overall Study||28||
48728005|NCT01399866|102118709|FG000|NOT COMPLETED|Overall Study||4||
48728006|NCT01399866|102118710|FG001|NOT COMPLETED|Overall Study||2||
48728007|NCT00604890|102118711|FG000|STARTED|Overall Study||47||
48728008|NCT00604890|102118712|FG001|STARTED|Overall Study||45||
48728009|NCT00604890|102118713|FG002|STARTED|Overall Study||48||
48728010|NCT00604890|102118714|FG003|STARTED|Overall Study||46||
48728011|NCT00604890|102118711|FG000|COMPLETED|Overall Study||44||
48728012|NCT00604890|102118712|FG001|COMPLETED|Overall Study||45||
48728013|NCT00604890|102118713|FG002|COMPLETED|Overall Study||47||
48728014|NCT00604890|102118714|FG003|COMPLETED|Overall Study||42||
48728015|NCT00604890|102118711|FG000|NOT COMPLETED|Overall Study||3||
48728016|NCT00604890|102118712|FG001|NOT COMPLETED|Overall Study||0||
48728017|NCT00604890|102118713|FG002|NOT COMPLETED|Overall Study||1||
48728018|NCT00604890|102118714|FG003|NOT COMPLETED|Overall Study||4||
48728019|NCT00524017|102118715|FG000|STARTED|Overall Study||13||
48728020|NCT00524017|102118716|FG001|STARTED|Overall Study||6||
48728021|NCT00524017|102118715|FG000|COMPLETED|Overall Study||13||
48728022|NCT00524017|102118716|FG001|COMPLETED|Overall Study||5||
48728023|NCT00524017|102118715|FG000|NOT COMPLETED|Overall Study||0||
48728024|NCT00524017|102118716|FG001|NOT COMPLETED|Overall Study||1||
48728025|NCT00997594|102118717|FG000|STARTED|Overall Study||9||
48728026|NCT00997594|102118718|FG001|STARTED|Overall Study||9||
48728027|NCT00997594|102118717|FG000|Completion of Ablation Procedure|Overall Study||9||
48728028|NCT00997594|102118718|FG001|Completion of Ablation Procedure|Overall Study||9||
48728029|NCT00997594|102118717|FG000|COMPLETED|Overall Study||9||
48728030|NCT00997594|102118718|FG001|COMPLETED|Overall Study||9||
48728031|NCT00997594|102118717|FG000|NOT COMPLETED|Overall Study||0||
48728032|NCT00997594|102118718|FG001|NOT COMPLETED|Overall Study||0||
48728033|NCT00767767|102118719|FG000|STARTED|Overall Study||21||
48728034|NCT00767767|102118720|FG001|STARTED|Overall Study||20||
48728035|NCT00767767|102118721|FG002|STARTED|Overall Study||20||
48728036|NCT00767767|102118722|FG003|STARTED|Overall Study||3||
48728037|NCT00767767|102118723|FG004|STARTED|Overall Study||3||
48728038|NCT00767767|102118719|FG000|COMPLETED|Overall Study||21||
48728039|NCT00767767|102118720|FG001|COMPLETED|Overall Study||20||
48728040|NCT00767767|102118721|FG002|COMPLETED|Overall Study||20||
48728041|NCT00767767|102118722|FG003|COMPLETED|Overall Study||3||
48728042|NCT00767767|102118723|FG004|COMPLETED|Overall Study||3||
48728043|NCT00767767|102118719|FG000|NOT COMPLETED|Overall Study||0||
48728044|NCT00767767|102118720|FG001|NOT COMPLETED|Overall Study||0||
48728045|NCT00767767|102118721|FG002|NOT COMPLETED|Overall Study||0||
48728046|NCT00767767|102118722|FG003|NOT COMPLETED|Overall Study||0||
48728047|NCT00767767|102118723|FG004|NOT COMPLETED|Overall Study||0||
48728048|NCT04167137|102118724|FG000|STARTED|Overall Study||3||
48728049|NCT04167137|102118725|FG001|STARTED|Overall Study||3||
48728050|NCT04167137|102118726|FG002|STARTED|Overall Study||4||
48728051|NCT04167137|102118727|FG003|STARTED|Overall Study||5||
48728052|NCT04167137|102118728|FG004|STARTED|Overall Study||3||
48728053|NCT04167137|102118729|FG005|STARTED|Overall Study||6||
48728054|NCT04167137|102118730|FG006|STARTED|Overall Study||4||
48728055|NCT04167137|102118731|FG007|STARTED|Overall Study||4||
48728056|NCT04167137|102118724|FG000|COMPLETED|Overall Study||1|Defined as completing treatment with study drug(s) for four 21-day cycles|
48728057|NCT04167137|102118725|FG001|COMPLETED|Overall Study||1|Defined as completing treatment with study drug(s) for four 21-day cycles|
48728058|NCT04167137|102118726|FG002|COMPLETED|Overall Study||1|Defined as completing treatment with study drug(s) for four 21-day cycles|
48728059|NCT04167137|102118727|FG003|COMPLETED|Overall Study||0|Defined as completing treatment with study drug(s) for four 21-day cycles|
48728060|NCT04167137|102118728|FG004|COMPLETED|Overall Study||1|Defined as completing treatment with study drug(s) for four 21-day cycles|
48728061|NCT04167137|102118729|FG005|COMPLETED|Overall Study||0|Defined as completing treatment with study drug(s) for four 21-day cycles|
48728062|NCT04167137|102118730|FG006|COMPLETED|Overall Study||0|Defined as completing treatment with study drug(s) for four 21-day cycles|
48728063|NCT04167137|102118731|FG007|COMPLETED|Overall Study||0|Defined as completing treatment with study drug(s) for four 21-day cycles|
48728064|NCT04167137|102118724|FG000|NOT COMPLETED|Overall Study||2||
48728065|NCT04167137|102118725|FG001|NOT COMPLETED|Overall Study||2||
48728066|NCT04167137|102118726|FG002|NOT COMPLETED|Overall Study||3||
48728067|NCT04167137|102118727|FG003|NOT COMPLETED|Overall Study||5||
48728068|NCT04167137|102118728|FG004|NOT COMPLETED|Overall Study||2||
48728069|NCT04167137|102118729|FG005|NOT COMPLETED|Overall Study||6||
48728070|NCT04167137|102118730|FG006|NOT COMPLETED|Overall Study||4||
48728071|NCT04167137|102118731|FG007|NOT COMPLETED|Overall Study||4||
48728072|NCT01300572|102118732|FG000|STARTED|Overall Study||16||
48728073|NCT01300572|102118732|FG000|COMPLETED|Overall Study||15||
48728074|NCT01300572|102118732|FG000|NOT COMPLETED|Overall Study||1||
48728075|NCT02964767|102118733|FG000|STARTED|Overall Study||171||
48728076|NCT02964767|102118734|FG001|STARTED|Overall Study||48||
48728077|NCT02964767|102118733|FG000|COMPLETED|Overall Study||171||
48728078|NCT02964767|102118734|FG001|COMPLETED|Overall Study||48||
48728079|NCT02964767|102118733|FG000|NOT COMPLETED|Overall Study||0||
48728080|NCT02964767|102118734|FG001|NOT COMPLETED|Overall Study||0||
48728081|NCT00360568|102118735|FG000|STARTED|Overall Study||33||
48728082|NCT00360568|102118736|FG001|STARTED|Overall Study||29||
48728083|NCT00360568|102118735|FG000|COMPLETED|Overall Study||31||
48728084|NCT00360568|102118736|FG001|COMPLETED|Overall Study||24||
48728085|NCT00360568|102118735|FG000|NOT COMPLETED|Overall Study||2||
48728086|NCT00360568|102118736|FG001|NOT COMPLETED|Overall Study||5||
48728087|NCT04186871|102118737|FG000|STARTED|Overall Study||5||
48728088|NCT04186871|102118738|FG001|STARTED|Overall Study||15||
48728089|NCT04186871|102118739|FG002|STARTED|Overall Study||4||
48728090|NCT04186871|102118740|FG003|STARTED|Overall Study||10||
48728091|NCT04186871|102118741|FG004|STARTED|Overall Study||21||
48728092|NCT04186871|102118742|FG005|STARTED|Overall Study||64||
48728093|NCT04186871|102118737|FG000|Double Blind Period|Overall Study||5||
48728094|NCT04186871|102118738|FG001|Double Blind Period|Overall Study||15||
48728095|NCT04186871|102118739|FG002|Double Blind Period|Overall Study||4||
48728096|NCT04186871|102118740|FG003|Double Blind Period|Overall Study||10||
48728097|NCT04186871|102118741|FG004|Double Blind Period|Overall Study||21||
48728098|NCT04186871|102118742|FG005|Double Blind Period|Overall Study||64||
48728099|NCT04186871|102118737|FG000|Open Label Period|Overall Study||0|The Open Label Period was available to RA sub-study participants only.|
48728100|NCT04186871|102118738|FG001|Open Label Period|Overall Study||0|The Open Label Period was available to RA sub-study participants only.|
48728101|NCT04186871|102118739|FG002|Open Label Period|Overall Study||0|The Open Label Period was available to RA sub-study participants only.|
48728102|NCT04186871|102118740|FG003|Open Label Period|Overall Study||0|The Open Label Period was available to RA sub-study participants only.|
48728103|NCT04186871|102118741|FG004|Open Label Period|Overall Study||20|The Open Label Period was available to RA sub-study participants only.|
48728104|NCT04186871|102118742|FG005|Open Label Period|Overall Study||61|The Open Label Period was available to RA sub-study participants only.|
48728105|NCT04186871|102118737|FG000|COMPLETED|Overall Study||3||
48728106|NCT04186871|102118738|FG001|COMPLETED|Overall Study||11||
48728107|NCT04186871|102118739|FG002|COMPLETED|Overall Study||4||
48728108|NCT04186871|102118740|FG003|COMPLETED|Overall Study||9||
48728109|NCT04186871|102118741|FG004|COMPLETED|Overall Study||20||
48311818|NCT03227471|101088142|FG014|STARTED|Overall Study||22||
48311819|NCT03227471|101088128|FG000|Safety Set|Overall Study||9|Received at least 1 dose of study drug.|
48311820|NCT03227471|101088129|FG001|Safety Set|Overall Study||30|Received at least 1 dose of study drug.|
48311821|NCT03227471|101088130|FG002|Safety Set|Overall Study||8|Received at least 1 dose of study drug.|
48311822|NCT03227471|101088131|FG003|Safety Set|Overall Study||7|Received at least 1 dose of study drug.|
48311823|NCT03227471|101088132|FG004|Safety Set|Overall Study||25|Received at least 1 dose of study drug.|
48311824|NCT03227471|101088133|FG005|Safety Set|Overall Study||6|Received at least 1 dose of study drug.|
48311825|NCT03227471|101088134|FG006|Safety Set|Overall Study||17|Received at least 1 dose of study drug.|
48311826|NCT03227471|101088135|FG007|Safety Set|Overall Study||12|Received at least 1 dose of study drug.|
48311827|NCT03227471|101088136|FG008|Safety Set|Overall Study||10|Received at least 1 dose of study drug.|
48311828|NCT03227471|101088137|FG009|Safety Set|Overall Study||22|Received at least 1 dose of study drug.|
48311829|NCT03227471|101088138|FG010|Safety Set|Overall Study||21|Received at least 1 dose of study drug.|
48311830|NCT03227471|101088139|FG011|Safety Set|Overall Study||7|Received at least 1 dose of study drug.|
48311831|NCT03227471|101088140|FG012|Safety Set|Overall Study||21|Received at least 1 dose of study drug.|
48311832|NCT03227471|101088141|FG013|Safety Set|Overall Study||8|Received at least 1 dose of study drug.|
48311833|NCT03227471|101088142|FG014|Safety Set|Overall Study||21|Received at least 1 dose of study drug.|
48311834|NCT03227471|101088128|FG000|COMPLETED|Overall Study||9||
48311835|NCT03227471|101088129|FG001|COMPLETED|Overall Study||30||
48311836|NCT03227471|101088130|FG002|COMPLETED|Overall Study||8||
48311837|NCT03227471|101088131|FG003|COMPLETED|Overall Study||7||
48311838|NCT03227471|101088132|FG004|COMPLETED|Overall Study||24||
48614021|NCT03630705|101841652|FG002|Vaccinated at the Age of 6 Months|Overall Study||149||
48614022|NCT03630705|101841653|FG003|Vaccinated at the Age of 6 Months|Overall Study||75||
48614023|NCT03630705|101841650|FG000|Vaccinated at the Age of 12 Months|Overall Study||192||
48614024|NCT03630705|101841651|FG001|Vaccinated at the Age of 12 Months|Overall Study||92||
48614025|NCT03630705|101841652|FG002|Vaccinated at the Age of 12 Months|Overall Study||148||
48614026|NCT03630705|101841653|FG003|Vaccinated at the Age of 12 Months|Overall Study||75||
48614027|NCT03630705|101841650|FG000|Safety Analysis Set|Overall Study||201|Safety analysis set (SafAS) included those participants who had received at least 1 dose of the study vaccine and had any safety data available. All participants had their safety analyzed after each dose according to the vaccine they actually received at that dose.|
48614028|NCT03630705|101841651|FG001|Safety Analysis Set|Overall Study||99|Safety analysis set (SafAS) included those participants who had received at least 1 dose of the study vaccine and had any safety data available. All participants had their safety analyzed after each dose according to the vaccine they actually received at that dose.|
48614029|NCT03630705|101841652|FG002|Safety Analysis Set|Overall Study||150|Safety analysis set (SafAS) included those participants who had received at least 1 dose of the study vaccine and had any safety data available. All participants had their safety analyzed after each dose according to the vaccine they actually received at that dose.|
48614030|NCT03630705|101841653|FG003|Safety Analysis Set|Overall Study||75|Safety analysis set (SafAS) included those participants who had received at least 1 dose of the study vaccine and had any safety data available. All participants had their safety analyzed after each dose according to the vaccine they actually received at that dose.|
48614031|NCT03630705|101841650|FG000|COMPLETED|Overall Study||190||
48614032|NCT03630705|101841651|FG001|COMPLETED|Overall Study||92||
48614033|NCT03630705|101841652|FG002|COMPLETED|Overall Study||148||
48614034|NCT03630705|101841653|FG003|COMPLETED|Overall Study||75||
48614035|NCT03630705|101841650|FG000|NOT COMPLETED|Overall Study||10||
48614036|NCT03630705|101841651|FG001|NOT COMPLETED|Overall Study||8||
48614037|NCT03630705|101841652|FG002|NOT COMPLETED|Overall Study||2||
48614038|NCT03630705|101841653|FG003|NOT COMPLETED|Overall Study||0||
48614039|NCT00402727|101841654|FG000|STARTED|Overall Study||432||
48614040|NCT00402727|101841655|FG001|STARTED|Overall Study||381||
48614041|NCT00402727|101841654|FG000|Achieving End Of Treatment (EOT)|Overall Study||408||
48614042|NCT00402727|101841655|FG001|Achieving End Of Treatment (EOT)|Overall Study||355||
48614043|NCT00402727|101841654|FG000|Achieving Test Of Cure (TOC)|Overall Study||390||
48614044|NCT00402727|101841655|FG001|Achieving Test Of Cure (TOC)|Overall Study||347||
48614045|NCT00402727|101841654|FG000|COMPLETED|Overall Study||390||
48614046|NCT00402727|101841655|FG001|COMPLETED|Overall Study||347||
48614047|NCT00402727|101841654|FG000|NOT COMPLETED|Overall Study||42||
48614048|NCT00402727|101841655|FG001|NOT COMPLETED|Overall Study||34||
48614049|NCT00929344|101841656|FG000|STARTED|Overall Study||50||
48614050|NCT00929344|101841657|FG001|STARTED|Overall Study||50||
48614051|NCT00929344|101841658|FG002|STARTED|Overall Study||50||
48614052|NCT00929344|101841656|FG000|COMPLETED|Overall Study||28||
48614053|NCT00929344|101841657|FG001|COMPLETED|Overall Study||37||
48614054|NCT00929344|101841658|FG002|COMPLETED|Overall Study||29||
48614055|NCT00929344|101841656|FG000|NOT COMPLETED|Overall Study||22||
48614056|NCT00929344|101841657|FG001|NOT COMPLETED|Overall Study||13||
48614057|NCT00929344|101841658|FG002|NOT COMPLETED|Overall Study||21||
48311839|NCT03227471|101088133|FG005|COMPLETED|Overall Study||6||
48311840|NCT03227471|101088134|FG006|COMPLETED|Overall Study||17||
48311841|NCT03227471|101088135|FG007|COMPLETED|Overall Study||12||
48311842|NCT03227471|101088136|FG008|COMPLETED|Overall Study||10||
48311843|NCT03227471|101088137|FG009|COMPLETED|Overall Study||22||
48311844|NCT03227471|101088138|FG010|COMPLETED|Overall Study||21||
48311845|NCT03227471|101088139|FG011|COMPLETED|Overall Study||7||
48311846|NCT03227471|101088140|FG012|COMPLETED|Overall Study||20||
48728110|NCT04186871|102118742|FG005|COMPLETED|Overall Study||58||
48728111|NCT04186871|102118737|FG000|NOT COMPLETED|Overall Study||2||
48728112|NCT04186871|102118738|FG001|NOT COMPLETED|Overall Study||4||
48728113|NCT04186871|102118739|FG002|NOT COMPLETED|Overall Study||0||
48728114|NCT04186871|102118740|FG003|NOT COMPLETED|Overall Study||1||
48728115|NCT04186871|102118741|FG004|NOT COMPLETED|Overall Study||1||
48728116|NCT04186871|102118742|FG005|NOT COMPLETED|Overall Study||6||
48728117|NCT03294850|102118743|FG000|STARTED|Overall Study||4||
48728118|NCT03294850|102118744|FG001|STARTED|Overall Study||10||
48728119|NCT03294850|102118743|FG000|COMPLETED|Overall Study||4||
48728120|NCT03294850|102118744|FG001|COMPLETED|Overall Study||10||
48728121|NCT03294850|102118743|FG000|NOT COMPLETED|Overall Study||0||
48728122|NCT03294850|102118744|FG001|NOT COMPLETED|Overall Study||0||
48728123|NCT00961714|102118745|FG000|STARTED|Overall Study||15||
48728124|NCT00961714|102118745|FG000|COMPLETED|Overall Study||13||
48728125|NCT00961714|102118745|FG000|NOT COMPLETED|Overall Study||2||
48728126|NCT03040986|102123065|FG000|STARTED|Overall Study||6||
48728127|NCT03040986|102123066|FG001|STARTED|Overall Study||2||
48728128|NCT03040986|102123065|FG000|COMPLETED|Overall Study||0||
48728129|NCT03040986|102123066|FG001|COMPLETED|Overall Study||0||
48728130|NCT03040986|102123065|FG000|NOT COMPLETED|Overall Study||6||
48728131|NCT03040986|102123066|FG001|NOT COMPLETED|Overall Study||2||
48728132|NCT02714283|102123067|FG000|STARTED|Overall Study||83589|Treatment episode start|
48728133|NCT02714283|102123068|FG001|STARTED|Overall Study||6500|Treatment episode start|
48728134|NCT02714283|102123067|FG000|COMPLETED|Overall Study||83589|Earliest date: death, 1st outcome occurrence, study end, lost coverage, treatment stop or switch|
48728135|NCT02714283|102123068|FG001|COMPLETED|Overall Study||6500|Earliest date: death, 1st outcome occurrence, study end, lost coverage, treatment stop or switch|
48728136|NCT02714283|102123067|FG000|NOT COMPLETED|Overall Study||0||
48728137|NCT02714283|102123068|FG001|NOT COMPLETED|Overall Study||0||
48728138|NCT02859441|102123069|FG000|STARTED|Overall Study||3||
48728139|NCT02859441|102123069|FG000|COMPLETED|Overall Study||3||
48728140|NCT02859441|102123069|FG000|NOT COMPLETED|Overall Study||0||
48728141|NCT01113580|102123070|FG000|STARTED|Overall Study||60||
48728142|NCT01113580|102123071|FG001|STARTED|Overall Study||60||
48728143|NCT01113580|102123070|FG000|COMPLETED|Overall Study||59||
48311847|NCT03227471|101088141|FG013|COMPLETED|Overall Study||8||
48311848|NCT03227471|101088142|FG014|COMPLETED|Overall Study||21||
48311849|NCT03227471|101088128|FG000|NOT COMPLETED|Overall Study||0||
48311850|NCT03227471|101088129|FG001|NOT COMPLETED|Overall Study||0||
48311851|NCT03227471|101088130|FG002|NOT COMPLETED|Overall Study||0||
48311852|NCT03227471|101088131|FG003|NOT COMPLETED|Overall Study||0||
48311853|NCT03227471|101088132|FG004|NOT COMPLETED|Overall Study||1||
48311854|NCT03227471|101088133|FG005|NOT COMPLETED|Overall Study||0||
48311855|NCT03227471|101088134|FG006|NOT COMPLETED|Overall Study||0||
48311856|NCT03227471|101088135|FG007|NOT COMPLETED|Overall Study||0||
48728144|NCT01113580|102123071|FG001|COMPLETED|Overall Study||60||
48728145|NCT01113580|102123070|FG000|NOT COMPLETED|Overall Study||1||
48728146|NCT01113580|102123071|FG001|NOT COMPLETED|Overall Study||0||
48728147|NCT04517643|102123072|FG000|STARTED|Overall Study||4||
48728148|NCT04517643|102123072|FG000|COMPLETED|Overall Study||4||
48728149|NCT04517643|102123072|FG000|NOT COMPLETED|Overall Study||0||
48728150|NCT04378114|102123073|FG000|STARTED|Overall Study||102||
48728151|NCT04378114|102123073|FG000|COMPLETED|Overall Study||97||
48728152|NCT04378114|102123073|FG000|NOT COMPLETED|Overall Study||5||
48728153|NCT01707381|102123074|FG000|STARTED|Period 1||12||
48728154|NCT01707381|102123075|FG001|STARTED|Period 1||13||
48728155|NCT01707381|102123074|FG000|COMPLETED|Period 1||10||
48728156|NCT01707381|102123075|FG001|COMPLETED|Period 1||11||
48728157|NCT01707381|102123074|FG000|NOT COMPLETED|Period 1||2||
48728158|NCT01707381|102123075|FG001|NOT COMPLETED|Period 1||2||
48728159|NCT01707381|102123074|FG000|STARTED|Period 2||10||
48728160|NCT01707381|102123075|FG001|STARTED|Period 2||11||
48728161|NCT01707381|102123074|FG000|COMPLETED|Period 2||10||
48728162|NCT01707381|102123075|FG001|COMPLETED|Period 2||11||
48728163|NCT01707381|102123074|FG000|NOT COMPLETED|Period 2||0||
48728164|NCT01707381|102123075|FG001|NOT COMPLETED|Period 2||0||
48728165|NCT02409342|102123076|FG000|STARTED|Overall Study||287||
48728166|NCT02409342|102123077|FG001|STARTED|Overall Study||285||
48728167|NCT02409342|102123076|FG000|COMPLETED|Overall Study||0||
48728168|NCT02409342|102123077|FG001|COMPLETED|Overall Study||0||
48728169|NCT02409342|102123076|FG000|NOT COMPLETED|Overall Study||287||
48728170|NCT02409342|102123077|FG001|NOT COMPLETED|Overall Study||285||
48728171|NCT00554372|102123078|FG000|STARTED|Overall Study||14||
48728172|NCT00554372|102123079|FG001|STARTED|Overall Study||16||
48728173|NCT00554372|102123078|FG000|COMPLETED|Overall Study||14||
48728174|NCT00554372|102123079|FG001|COMPLETED|Overall Study||16||
48728175|NCT00554372|102123078|FG000|NOT COMPLETED|Overall Study||0||
48728176|NCT00554372|102123079|FG001|NOT COMPLETED|Overall Study||0||
48728177|NCT00789672|102123080|FG000|STARTED|Overall Study||16||
48311857|NCT03227471|101088136|FG008|NOT COMPLETED|Overall Study||0||
48311858|NCT03227471|101088137|FG009|NOT COMPLETED|Overall Study||0||
48728178|NCT00789672|102123081|FG001|STARTED|Overall Study||17||
48728179|NCT00789672|102123080|FG000|COMPLETED|Overall Study||16||
48728180|NCT00789672|102123081|FG001|COMPLETED|Overall Study||17||
48728181|NCT00789672|102123080|FG000|NOT COMPLETED|Overall Study||0||
48728182|NCT00789672|102123081|FG001|NOT COMPLETED|Overall Study||0||
48728183|NCT03615066|102123082|FG000|STARTED|Main Study||26||
48728184|NCT03615066|102123083|FG001|STARTED|Main Study||28||
48728185|NCT03615066|102123084|FG002|STARTED|Main Study||13||
48728186|NCT03615066|102123082|FG000|COMPLETED|Main Study||26||
48728187|NCT03615066|102123083|FG001|COMPLETED|Main Study||27||
48728188|NCT03615066|102123084|FG002|COMPLETED|Main Study||11||
48728189|NCT03615066|102123082|FG000|NOT COMPLETED|Main Study||0||
48728190|NCT03615066|102123083|FG001|NOT COMPLETED|Main Study||1||
48728191|NCT03615066|102123084|FG002|NOT COMPLETED|Main Study||2||
48728192|NCT03615066|102123082|FG000|STARTED|Treatment-free Follow-up (TFFU) Phase||13||
48728193|NCT03615066|102123083|FG001|STARTED|Treatment-free Follow-up (TFFU) Phase||12||
48728194|NCT03615066|102123084|FG002|STARTED|Treatment-free Follow-up (TFFU) Phase||2||
48728195|NCT03615066|102123082|FG000|COMPLETED|Treatment-free Follow-up (TFFU) Phase||11||
48728196|NCT03615066|102123083|FG001|COMPLETED|Treatment-free Follow-up (TFFU) Phase||11||
48728197|NCT03615066|102123084|FG002|COMPLETED|Treatment-free Follow-up (TFFU) Phase||2||
48728198|NCT03615066|102123082|FG000|NOT COMPLETED|Treatment-free Follow-up (TFFU) Phase||2||
48728199|NCT03615066|102123083|FG001|NOT COMPLETED|Treatment-free Follow-up (TFFU) Phase||1||
48728200|NCT03615066|102123084|FG002|NOT COMPLETED|Treatment-free Follow-up (TFFU) Phase||0||
48728201|NCT03216746|102123085|FG000|STARTED|Overall Study||72||
48728202|NCT03216746|102123086|FG001|STARTED|Overall Study||79||
48728203|NCT03216746|102123087|FG002|STARTED|Overall Study||68||
48728204|NCT03216746|102123088|FG003|STARTED|Overall Study||69||
48728205|NCT03216746|102123085|FG000|COMPLETED|Overall Study||66||
48728206|NCT03216746|102123086|FG001|COMPLETED|Overall Study||71||
48728207|NCT03216746|102123087|FG002|COMPLETED|Overall Study||63||
48728208|NCT03216746|102123088|FG003|COMPLETED|Overall Study||63||
48728209|NCT03216746|102123085|FG000|NOT COMPLETED|Overall Study||6||
48728210|NCT03216746|102123086|FG001|NOT COMPLETED|Overall Study||8||
48728211|NCT03216746|102123087|FG002|NOT COMPLETED|Overall Study||5||
48728212|NCT03216746|102123088|FG003|NOT COMPLETED|Overall Study||6||
48728213|NCT00663403|102123089|FG000|STARTED|Overall Study||8||
48728214|NCT00663403|102123089|FG000|COMPLETED|Overall Study||8||
48728215|NCT00663403|102123089|FG000|NOT COMPLETED|Overall Study||0||
48728216|NCT02593318|102123090|FG000|STARTED|Overall Study||16||
48728217|NCT02593318|102123091|FG001|STARTED|Overall Study||16||
48728218|NCT02593318|102123090|FG000|COMPLETED|Overall Study||15||
48728219|NCT02593318|102123091|FG001|COMPLETED|Overall Study||15||
48728220|NCT02593318|102123090|FG000|NOT COMPLETED|Overall Study||1||
48728221|NCT02593318|102123091|FG001|NOT COMPLETED|Overall Study||1||
48728222|NCT01052077|102123092|FG000|STARTED|Phase A||769||
48728223|NCT01052077|102123093|FG001|STARTED|Phase A||0||
48728224|NCT01052077|102123094|FG002|STARTED|Phase A||0||
48728225|NCT01052077|102123095|FG003|STARTED|Phase A||0||
48728226|NCT01052077|102123092|FG000|COMPLETED|Phase A||623||
48728227|NCT01052077|102123093|FG001|COMPLETED|Phase A||0||
48728228|NCT01052077|102123094|FG002|COMPLETED|Phase A||0||
48728229|NCT01052077|102123095|FG003|COMPLETED|Phase A||0||
48728230|NCT01052077|102123092|FG000|NOT COMPLETED|Phase A||146||
48728231|NCT01052077|102123093|FG001|NOT COMPLETED|Phase A||0||
48728232|NCT01052077|102123094|FG002|NOT COMPLETED|Phase A||0||
48728233|NCT01052077|102123095|FG003|NOT COMPLETED|Phase A||0||
48728234|NCT01052077|102123092|FG000|STARTED|Phase B||0||
48728235|NCT01052077|102123093|FG001|STARTED|Phase B||185||
48728236|NCT01052077|102123094|FG002|STARTED|Phase B||187||
48728237|NCT01052077|102123095|FG003|STARTED|Phase B||0||
48728238|NCT01052077|102123092|FG000|COMPLETED|Phase B||0||
48728239|NCT01052077|102123093|FG001|COMPLETED|Phase B||167||
48728240|NCT01052077|102123094|FG002|COMPLETED|Phase B||171||
48728241|NCT01052077|102123095|FG003|COMPLETED|Phase B||0||
48728242|NCT01052077|102123092|FG000|NOT COMPLETED|Phase B||0||
48728243|NCT01052077|102123093|FG001|NOT COMPLETED|Phase B||18||
48728244|NCT01052077|102123094|FG002|NOT COMPLETED|Phase B||16||
48728245|NCT01052077|102123095|FG003|NOT COMPLETED|Phase B||0||
48728246|NCT01052077|102123092|FG000|STARTED|Phase A+||0||
48728247|NCT01052077|102123093|FG001|STARTED|Phase A+||0||
48728248|NCT01052077|102123094|FG002|STARTED|Phase A+||0||
48728249|NCT01052077|102123095|FG003|STARTED|Phase A+||251||
48728250|NCT01052077|102123092|FG000|COMPLETED|Phase A+||0||
48728251|NCT01052077|102123093|FG001|COMPLETED|Phase A+||0||
48728252|NCT01052077|102123094|FG002|COMPLETED|Phase A+||0||
48728253|NCT01052077|102123095|FG003|COMPLETED|Phase A+||230||
48728254|NCT01052077|102123092|FG000|NOT COMPLETED|Phase A+||0||
48728255|NCT01052077|102123093|FG001|NOT COMPLETED|Phase A+||0||
48728256|NCT01052077|102123094|FG002|NOT COMPLETED|Phase A+||0||
48728257|NCT01052077|102123095|FG003|NOT COMPLETED|Phase A+||21||
48728258|NCT00328861|102123096|FG000|STARTED|Overall Study||7||
48728259|NCT00328861|102123097|FG001|STARTED|Overall Study||1||
48728260|NCT00328861|102123096|FG000|COMPLETED|Overall Study||7||
48728261|NCT00328861|102123097|FG001|COMPLETED|Overall Study||1||
48728262|NCT00328861|102123096|FG000|NOT COMPLETED|Overall Study||0||
48728263|NCT00328861|102123097|FG001|NOT COMPLETED|Overall Study||0||
48728264|NCT00527982|102123098|FG000|STARTED|Overall Study||1||
48728265|NCT00527982|102123099|FG001|STARTED|Overall Study||0||
48728266|NCT00527982|102123098|FG000|COMPLETED|Overall Study||0||
48728267|NCT00527982|102123099|FG001|COMPLETED|Overall Study||0||
48728268|NCT00527982|102123098|FG000|NOT COMPLETED|Overall Study||1||
48728269|NCT00527982|102123099|FG001|NOT COMPLETED|Overall Study||0||
48728270|NCT01406015|102123100|FG000|STARTED|Overall Study||19||
48728271|NCT01406015|102123101|FG001|STARTED|Overall Study||19||
48728272|NCT01406015|102123100|FG000|COMPLETED|Overall Study||16||
48728273|NCT01406015|102123101|FG001|COMPLETED|Overall Study||16||
48728274|NCT01406015|102123100|FG000|NOT COMPLETED|Overall Study||3||
48728275|NCT01406015|102123101|FG001|NOT COMPLETED|Overall Study||3||
48728276|NCT03521479|102123102|FG000|STARTED|Overall Study||10||
48728277|NCT03521479|102123103|FG001|STARTED|Overall Study||10||
48728278|NCT03521479|102123104|FG002|STARTED|Overall Study||10||
48728279|NCT03521479|102123105|FG003|STARTED|Overall Study||10||
48728280|NCT03521479|102123102|FG000|COMPLETED|Overall Study||10||
48728281|NCT03521479|102123103|FG001|COMPLETED|Overall Study||10||
48728282|NCT03521479|102123104|FG002|COMPLETED|Overall Study||10||
48728283|NCT03521479|102123105|FG003|COMPLETED|Overall Study||10||
48728284|NCT03521479|102123102|FG000|NOT COMPLETED|Overall Study||0||
48728285|NCT03521479|102123103|FG001|NOT COMPLETED|Overall Study||0||
48728286|NCT03521479|102123104|FG002|NOT COMPLETED|Overall Study||0||
48728287|NCT03521479|102123105|FG003|NOT COMPLETED|Overall Study||0||
48728288|NCT03995355|102123106|FG000|STARTED|Overall Study||77||
48728289|NCT03995355|102123107|FG001|STARTED|Overall Study||81||
48728290|NCT03995355|102123106|FG000|COMPLETED|Overall Study||75||
48728291|NCT03995355|102123107|FG001|COMPLETED|Overall Study||80||
48728292|NCT03995355|102123106|FG000|NOT COMPLETED|Overall Study||2||
48728293|NCT03995355|102123107|FG001|NOT COMPLETED|Overall Study||1||
48728294|NCT01895946|102123108|FG000|STARTED|Overall Study||18||
48728295|NCT01895946|102123109|FG001|STARTED|Overall Study||12||
48728296|NCT01895946|102123108|FG000|COMPLETED|Overall Study||18||
48311859|NCT03227471|101088138|FG010|NOT COMPLETED|Overall Study||0||
48311860|NCT03227471|101088139|FG011|NOT COMPLETED|Overall Study||0||
48311861|NCT03227471|101088140|FG012|NOT COMPLETED|Overall Study||1||
48311862|NCT03227471|101088141|FG013|NOT COMPLETED|Overall Study||0||
48311863|NCT03227471|101088142|FG014|NOT COMPLETED|Overall Study||1||
48311864|NCT01265615|101088143|FG000|STARTED|Overall Study||30||
48311865|NCT01265615|101088144|FG001|STARTED|Overall Study||30||
48311866|NCT01265615|101088145|FG002|STARTED|Overall Study||30||
48311867|NCT01265615|101088146|FG003|STARTED|Overall Study||30||
48311868|NCT01265615|101088143|FG000|COMPLETED|Overall Study||28||
48728297|NCT01895946|102123109|FG001|COMPLETED|Overall Study||12||
48728298|NCT01895946|102123108|FG000|NOT COMPLETED|Overall Study||0||
48728299|NCT01895946|102123109|FG001|NOT COMPLETED|Overall Study||0||
48728300|NCT01338857|102123110|FG000|STARTED|Overall Study||12||
48728301|NCT01338857|102123110|FG000|COMPLETED|Overall Study||1||
48728302|NCT01338857|102123110|FG000|NOT COMPLETED|Overall Study||11||
48728303|NCT03245398|102123111|FG000|STARTED|Overall Study||93||
48728304|NCT03245398|102123112|FG001|STARTED|Overall Study||93||
48728305|NCT03245398|102123111|FG000|COMPLETED|Overall Study||92||
48728306|NCT03245398|102123112|FG001|COMPLETED|Overall Study||93||
48728307|NCT03245398|102123111|FG000|NOT COMPLETED|Overall Study||1||
48728308|NCT03245398|102123112|FG001|NOT COMPLETED|Overall Study||0||
48728309|NCT04230213|102123113|FG000|STARTED|TP1: Week 0 (Day 1) to Week 10||445||
48728310|NCT04230213|102123114|FG001|STARTED|TP1: Week 0 (Day 1) to Week 10||0||
48728311|NCT04230213|102123115|FG002|STARTED|TP1: Week 0 (Day 1) to Week 10||0||
48728312|NCT04230213|102123113|FG000|COMPLETED|TP1: Week 0 (Day 1) to Week 10||427||
48311869|NCT01265615|101088144|FG001|COMPLETED|Overall Study||28||
48311870|NCT01265615|101088145|FG002|COMPLETED|Overall Study||26||
48311871|NCT01265615|101088146|FG003|COMPLETED|Overall Study||27||
48311872|NCT01265615|101088143|FG000|NOT COMPLETED|Overall Study||2||
48311873|NCT01265615|101088144|FG001|NOT COMPLETED|Overall Study||2||
48311874|NCT01265615|101088145|FG002|NOT COMPLETED|Overall Study||4||
48311875|NCT01265615|101088146|FG003|NOT COMPLETED|Overall Study||3||
48311876|NCT01187550|101088147|FG000|STARTED|Overall Study||183||
48728313|NCT04230213|102123114|FG001|COMPLETED|TP1: Week 0 (Day 1) to Week 10||0||
48728314|NCT04230213|102123115|FG002|COMPLETED|TP1: Week 0 (Day 1) to Week 10||0||
48728315|NCT04230213|102123113|FG000|NOT COMPLETED|TP1: Week 0 (Day 1) to Week 10||18||
48728316|NCT04230213|102123114|FG001|NOT COMPLETED|TP1: Week 0 (Day 1) to Week 10||0||
48311877|NCT01187550|101088148|FG001|STARTED|Overall Study||30||
48728317|NCT04230213|102123115|FG002|NOT COMPLETED|TP1: Week 0 (Day 1) to Week 10||0||
48728318|NCT04230213|102123113|FG000|STARTED|TP2: Week 10 to Week 16||0||
48728319|NCT04230213|102123114|FG001|STARTED|TP2: Week 10 to Week 16||213||
48728320|NCT04230213|102123115|FG002|STARTED|TP2: Week 10 to Week 16||214||
48728321|NCT04230213|102123113|FG000|COMPLETED|TP2: Week 10 to Week 16||0||
48728322|NCT04230213|102123114|FG001|COMPLETED|TP2: Week 10 to Week 16||211||
48728323|NCT04230213|102123115|FG002|COMPLETED|TP2: Week 10 to Week 16||211||
48728324|NCT04230213|102123113|FG000|NOT COMPLETED|TP2: Week 10 to Week 16||0||
48728325|NCT04230213|102123114|FG001|NOT COMPLETED|TP2: Week 10 to Week 16||2||
48728326|NCT04230213|102123115|FG002|NOT COMPLETED|TP2: Week 10 to Week 16||3||
48728327|NCT04230213|102123113|FG000|STARTED|TP3: Week 16 to Week 22||0||
48311878|NCT01187550|101088147|FG000|Treated|Overall Study||175||
48311879|NCT01187550|101088148|FG001|Treated|Overall Study||30||
48311880|NCT01187550|101088147|FG000|COMPLETED|Overall Study||169||
48311881|NCT01187550|101088148|FG001|COMPLETED|Overall Study||29||
48311882|NCT01187550|101088147|FG000|NOT COMPLETED|Overall Study||14||
48311883|NCT01187550|101088148|FG001|NOT COMPLETED|Overall Study||1||
48311884|NCT00932360|101088149|FG000|STARTED|1: Visit 1/Week1||10||
48311885|NCT00932360|101088150|FG001|STARTED|1: Visit 1/Week1||6||
48311886|NCT00932360|101088151|FG002|STARTED|1: Visit 1/Week1||3||
48311887|NCT00932360|101088152|FG003|STARTED|1: Visit 1/Week1||13||
48311888|NCT00932360|101088153|FG004|STARTED|1: Visit 1/Week1||4||
48311889|NCT00932360|101088154|FG005|STARTED|1: Visit 1/Week1||7||
48311890|NCT00932360|101088149|FG000|COMPLETED|1: Visit 1/Week1||10||
48311891|NCT00932360|101088150|FG001|COMPLETED|1: Visit 1/Week1||6||
48311892|NCT00932360|101088151|FG002|COMPLETED|1: Visit 1/Week1||3||
48311893|NCT00932360|101088152|FG003|COMPLETED|1: Visit 1/Week1||13||
48311894|NCT00932360|101088153|FG004|COMPLETED|1: Visit 1/Week1||4||
48311895|NCT00932360|101088154|FG005|COMPLETED|1: Visit 1/Week1||7||
48728328|NCT04230213|102123114|FG001|STARTED|TP3: Week 16 to Week 22||211||
48728329|NCT04230213|102123115|FG002|STARTED|TP3: Week 16 to Week 22||211||
48728330|NCT04230213|102123113|FG000|COMPLETED|TP3: Week 16 to Week 22||0||
48728331|NCT04230213|102123114|FG001|COMPLETED|TP3: Week 16 to Week 22||210||
48728332|NCT04230213|102123115|FG002|COMPLETED|TP3: Week 16 to Week 22||204||
48728333|NCT04230213|102123113|FG000|NOT COMPLETED|TP3: Week 16 to Week 22||0||
48311896|NCT00932360|101088149|FG000|NOT COMPLETED|1: Visit 1/Week1||0||
48311897|NCT00932360|101088150|FG001|NOT COMPLETED|1: Visit 1/Week1||0||
48311898|NCT00932360|101088151|FG002|NOT COMPLETED|1: Visit 1/Week1||0||
48311899|NCT00932360|101088152|FG003|NOT COMPLETED|1: Visit 1/Week1||0||
48311900|NCT00932360|101088153|FG004|NOT COMPLETED|1: Visit 1/Week1||0||
48311901|NCT00932360|101088154|FG005|NOT COMPLETED|1: Visit 1/Week1||0||
48311902|NCT00932360|101088149|FG000|STARTED|Washout (One Week)||10||
48311903|NCT00932360|101088150|FG001|STARTED|Washout (One Week)||6||
48311904|NCT00932360|101088151|FG002|STARTED|Washout (One Week)||3||
48311905|NCT00932360|101088152|FG003|STARTED|Washout (One Week)||13||
48311906|NCT00932360|101088153|FG004|STARTED|Washout (One Week)||4||
48311907|NCT00932360|101088154|FG005|STARTED|Washout (One Week)||7||
48311908|NCT00932360|101088149|FG000|COMPLETED|Washout (One Week)||10||
48311909|NCT00932360|101088150|FG001|COMPLETED|Washout (One Week)||6||
48311910|NCT00932360|101088151|FG002|COMPLETED|Washout (One Week)||3||
48311911|NCT00932360|101088152|FG003|COMPLETED|Washout (One Week)||13||
48311912|NCT00932360|101088153|FG004|COMPLETED|Washout (One Week)||2||
48311913|NCT00932360|101088154|FG005|COMPLETED|Washout (One Week)||7||
48311914|NCT00932360|101088149|FG000|NOT COMPLETED|Washout (One Week)||0||
48311915|NCT00932360|101088150|FG001|NOT COMPLETED|Washout (One Week)||0||
48311916|NCT00932360|101088151|FG002|NOT COMPLETED|Washout (One Week)||0||
48311917|NCT00932360|101088152|FG003|NOT COMPLETED|Washout (One Week)||0||
48311918|NCT00932360|101088153|FG004|NOT COMPLETED|Washout (One Week)||2||
48311919|NCT00932360|101088154|FG005|NOT COMPLETED|Washout (One Week)||0||
48311920|NCT00932360|101088149|FG000|STARTED|Visit 2/Week 2||10||
48311921|NCT00932360|101088150|FG001|STARTED|Visit 2/Week 2||6||
48311922|NCT00932360|101088151|FG002|STARTED|Visit 2/Week 2||3||
48614058|NCT00726180|101841659|FG000|STARTED|Overall Study||1||
48614059|NCT00726180|101841659|FG000|COMPLETED|Overall Study||1||
48614060|NCT00726180|101841659|FG000|NOT COMPLETED|Overall Study||0||
48614061|NCT02895295|101841660|FG000|STARTED|Overall Study||384||
48614062|NCT02895295|101841661|FG001|STARTED|Overall Study||410||
48614063|NCT02895295|101841662|FG002|STARTED|Overall Study||391||
48614064|NCT02895295|101841660|FG000|COMPLETED|Overall Study||313||
48614065|NCT02895295|101841661|FG001|COMPLETED|Overall Study||316||
48614066|NCT02895295|101841662|FG002|COMPLETED|Overall Study||299||
48614067|NCT02895295|101841660|FG000|NOT COMPLETED|Overall Study||71||
48614068|NCT02895295|101841661|FG001|NOT COMPLETED|Overall Study||94||
48614069|NCT02895295|101841662|FG002|NOT COMPLETED|Overall Study||92||
48614070|NCT03417752|101841663|FG000|STARTED|Overall Study||149||
48614071|NCT03417752|101841664|FG001|STARTED|Overall Study||175||
48614072|NCT03417752|101841665|FG002|STARTED|Overall Study||150||
48728334|NCT04230213|102123114|FG001|NOT COMPLETED|TP3: Week 16 to Week 22||1||
48728335|NCT04230213|102123115|FG002|NOT COMPLETED|TP3: Week 16 to Week 22||7||
48728336|NCT04230213|102123113|FG000|STARTED|TP4: Week 22 to Week 32||0||
48728337|NCT04230213|102123114|FG001|STARTED|TP4: Week 22 to Week 32||210||
48728338|NCT04230213|102123115|FG002|STARTED|TP4: Week 22 to Week 32||204||
48728339|NCT04230213|102123113|FG000|COMPLETED|TP4: Week 22 to Week 32||0||
48311923|NCT00932360|101088152|FG003|STARTED|Visit 2/Week 2||13||
48311924|NCT00932360|101088153|FG004|STARTED|Visit 2/Week 2||2||
48311925|NCT00932360|101088154|FG005|STARTED|Visit 2/Week 2||7||
48311926|NCT00932360|101088149|FG000|COMPLETED|Visit 2/Week 2||10||
48311927|NCT00932360|101088150|FG001|COMPLETED|Visit 2/Week 2||6||
48311928|NCT00932360|101088151|FG002|COMPLETED|Visit 2/Week 2||3||
48311929|NCT00932360|101088152|FG003|COMPLETED|Visit 2/Week 2||13||
48614073|NCT03417752|101841663|FG000|COMPLETED|Overall Study||115||
48614074|NCT03417752|101841664|FG001|COMPLETED|Overall Study||133||
48614075|NCT03417752|101841665|FG002|COMPLETED|Overall Study||110||
48614076|NCT03417752|101841663|FG000|NOT COMPLETED|Overall Study||34||
48614077|NCT03417752|101841664|FG001|NOT COMPLETED|Overall Study||42||
48614078|NCT03417752|101841665|FG002|NOT COMPLETED|Overall Study||40||
48614079|NCT00511173|101841666|FG000|STARTED|Overall Study||102||
48728340|NCT04230213|102123114|FG001|COMPLETED|TP4: Week 22 to Week 32||202||
48728341|NCT04230213|102123115|FG002|COMPLETED|TP4: Week 22 to Week 32||196||
48728342|NCT04230213|102123113|FG000|NOT COMPLETED|TP4: Week 22 to Week 32||0||
48728343|NCT04230213|102123114|FG001|NOT COMPLETED|TP4: Week 22 to Week 32||8||
48728344|NCT04230213|102123115|FG002|NOT COMPLETED|TP4: Week 22 to Week 32||8||
48728345|NCT04230213|102123113|FG000|STARTED|Follow up: Week 32 to Week 36||0||
48728346|NCT04230213|102123114|FG001|STARTED|Follow up: Week 32 to Week 36||202||
48728347|NCT04230213|102123115|FG002|STARTED|Follow up: Week 32 to Week 36||196||
48728348|NCT04230213|102123113|FG000|COMPLETED|Follow up: Week 32 to Week 36||0||
48728349|NCT04230213|102123114|FG001|COMPLETED|Follow up: Week 32 to Week 36||201||
48728350|NCT04230213|102123115|FG002|COMPLETED|Follow up: Week 32 to Week 36||194||
48728351|NCT04230213|102123113|FG000|NOT COMPLETED|Follow up: Week 32 to Week 36||0||
48728352|NCT04230213|102123114|FG001|NOT COMPLETED|Follow up: Week 32 to Week 36||1||
48728353|NCT04230213|102123115|FG002|NOT COMPLETED|Follow up: Week 32 to Week 36||2||
48728354|NCT00565136|102123116|FG000|STARTED|Overall Study||29||
48728355|NCT00565136|102123116|FG000|COMPLETED|Overall Study||26||
48728356|NCT00565136|102123116|FG000|NOT COMPLETED|Overall Study||3||
48728357|NCT01894022|102123117|FG000|STARTED|Overall Study||9||
48728358|NCT01894022|102123118|FG001|STARTED|Overall Study||10||
48728359|NCT01894022|102123117|FG000|COMPLETED|Overall Study||0||
48728360|NCT01894022|102123118|FG001|COMPLETED|Overall Study||0||
48728361|NCT01894022|102123117|FG000|NOT COMPLETED|Overall Study||9||
48728362|NCT01894022|102123118|FG001|NOT COMPLETED|Overall Study||10||
48728363|NCT03858530|102123119|FG000|STARTED|Overall Study||21||
48728364|NCT03858530|102123119|FG000|COMPLETED|Overall Study||20||
48728365|NCT03858530|102123119|FG000|NOT COMPLETED|Overall Study||1||
48728366|NCT02596945|102123120|FG000|STARTED|Overall Study||223||
48728367|NCT02596945|102123120|FG000|Treated|Overall Study||220||
48728368|NCT02596945|102123120|FG000|COMPLETED|Overall Study||167||
48728369|NCT02596945|102123120|FG000|NOT COMPLETED|Overall Study||56||
48728370|NCT02145351|102123121|FG000|STARTED|Pacemaker Implantation (4 Weeks)||0||
48728371|NCT02145351|102123122|FG001|STARTED|Pacemaker Implantation (4 Weeks)||0||
48728372|NCT02145351|102123123|FG002|STARTED|Pacemaker Implantation (4 Weeks)||32||
48728373|NCT02145351|102123121|FG000|COMPLETED|Pacemaker Implantation (4 Weeks)||0||
48728374|NCT02145351|102123122|FG001|COMPLETED|Pacemaker Implantation (4 Weeks)||0||
48728375|NCT02145351|102123123|FG002|COMPLETED|Pacemaker Implantation (4 Weeks)||32||
48311930|NCT00932360|101088153|FG004|COMPLETED|Visit 2/Week 2||2||
48311931|NCT00932360|101088154|FG005|COMPLETED|Visit 2/Week 2||7||
48311932|NCT00932360|101088149|FG000|NOT COMPLETED|Visit 2/Week 2||0||
48311933|NCT00932360|101088150|FG001|NOT COMPLETED|Visit 2/Week 2||0||
48311934|NCT00932360|101088151|FG002|NOT COMPLETED|Visit 2/Week 2||0||
48311935|NCT00932360|101088152|FG003|NOT COMPLETED|Visit 2/Week 2||0||
48311936|NCT00932360|101088153|FG004|NOT COMPLETED|Visit 2/Week 2||0||
48311937|NCT00932360|101088154|FG005|NOT COMPLETED|Visit 2/Week 2||0||
48311938|NCT00932360|101088149|FG000|STARTED|Washout (One Week)||10||
48311939|NCT00932360|101088150|FG001|STARTED|Washout (One Week)||6||
48311940|NCT00932360|101088151|FG002|STARTED|Washout (One Week)||3||
48311941|NCT00932360|101088152|FG003|STARTED|Washout (One Week)||13||
48311942|NCT00932360|101088153|FG004|STARTED|Washout (One Week)||2||
48311943|NCT00932360|101088154|FG005|STARTED|Washout (One Week)||7||
48311944|NCT00932360|101088149|FG000|COMPLETED|Washout (One Week)||10||
48311945|NCT00932360|101088150|FG001|COMPLETED|Washout (One Week)||6||
48311946|NCT00932360|101088151|FG002|COMPLETED|Washout (One Week)||3||
48311947|NCT00932360|101088152|FG003|COMPLETED|Washout (One Week)||13||
48311948|NCT00932360|101088153|FG004|COMPLETED|Washout (One Week)||2||
48311949|NCT00932360|101088154|FG005|COMPLETED|Washout (One Week)||7||
48311950|NCT00932360|101088149|FG000|NOT COMPLETED|Washout (One Week)||0||
48311951|NCT00932360|101088150|FG001|NOT COMPLETED|Washout (One Week)||0||
48406721|NCT01102140|101328479|FG001|NOT COMPLETED|Overall Study||2||
48406722|NCT01899768|101328480|FG000|STARTED|Part A||16||
48728376|NCT02145351|102123121|FG000|NOT COMPLETED|Pacemaker Implantation (4 Weeks)||0||
48311952|NCT00932360|101088151|FG002|NOT COMPLETED|Washout (One Week)||0||
48311953|NCT00932360|101088152|FG003|NOT COMPLETED|Washout (One Week)||0||
48311954|NCT00932360|101088153|FG004|NOT COMPLETED|Washout (One Week)||0||
48311955|NCT00932360|101088154|FG005|NOT COMPLETED|Washout (One Week)||0||
48406723|NCT01899768|101328480|FG000|COMPLETED|Part A||13||
48728377|NCT02145351|102123122|FG001|NOT COMPLETED|Pacemaker Implantation (4 Weeks)||0||
48728378|NCT02145351|102123123|FG002|NOT COMPLETED|Pacemaker Implantation (4 Weeks)||0||
48728379|NCT02145351|102123121|FG000|STARTED|First Intervention (4 Weeks)||15||
48728380|NCT02145351|102123122|FG001|STARTED|First Intervention (4 Weeks)||14||
48311956|NCT00932360|101088149|FG000|STARTED|Visit 3/Week 3||10||
48406724|NCT01899768|101328480|FG000|NOT COMPLETED|Part A||3||
48156962|NCT01111838|100706832|FG000|NOT COMPLETED|Overall Study||7||
48156963|NCT00605202|100706833|FG000|STARTED|First Intervention||5||
48156964|NCT00605202|100706834|FG001|STARTED|First Intervention||5||
48156965|NCT00605202|100706833|FG000|COMPLETED|First Intervention||5||
48156966|NCT00605202|100706834|FG001|COMPLETED|First Intervention||5||
48156967|NCT00605202|100706833|FG000|NOT COMPLETED|First Intervention||0||
48156968|NCT00605202|100706834|FG001|NOT COMPLETED|First Intervention||0||
48156969|NCT00605202|100706833|FG000|STARTED|Washout Period of 3 Weeks||5||
48156970|NCT00605202|100706834|FG001|STARTED|Washout Period of 3 Weeks||5||
48156971|NCT00605202|100706833|FG000|COMPLETED|Washout Period of 3 Weeks||5||
48156972|NCT00605202|100706834|FG001|COMPLETED|Washout Period of 3 Weeks||5||
48156973|NCT00605202|100706833|FG000|NOT COMPLETED|Washout Period of 3 Weeks||0||
48156974|NCT00605202|100706834|FG001|NOT COMPLETED|Washout Period of 3 Weeks||0||
48156975|NCT00605202|100706833|FG000|STARTED|Second Intervention||5||
48156976|NCT00605202|100706834|FG001|STARTED|Second Intervention||5||
48156977|NCT00605202|100706833|FG000|COMPLETED|Second Intervention||5||
48156978|NCT00605202|100706834|FG001|COMPLETED|Second Intervention||5||
48156979|NCT00605202|100706833|FG000|NOT COMPLETED|Second Intervention||0||
48156980|NCT00605202|100706834|FG001|NOT COMPLETED|Second Intervention||0||
48156981|NCT02347657|100706835|FG000|STARTED|Overall Study||259||
48156982|NCT02347657|100706836|FG001|STARTED|Overall Study||251||
48156983|NCT02347657|100706835|FG000|Treated|Overall Study||258||
48156984|NCT02347657|100706836|FG001|Treated|Overall Study||251||
48156985|NCT02347657|100706835|FG000|COMPLETED|Overall Study||241||
48156986|NCT02347657|100706836|FG001|COMPLETED|Overall Study||236||
48156987|NCT02347657|100706835|FG000|NOT COMPLETED|Overall Study||18||
48156988|NCT02347657|100706836|FG001|NOT COMPLETED|Overall Study||15||
48156989|NCT04209725|100706837|FG000|STARTED|Overall Study||1||
48156990|NCT04209725|100706837|FG000|COMPLETED|Overall Study||0||
48156991|NCT04209725|100706837|FG000|NOT COMPLETED|Overall Study||1||
48156992|NCT01061333|100706838|FG000|STARTED|Period 1: Placebo Run-in||8||
48156993|NCT01061333|100706839|FG001|STARTED|Period 1: Placebo Run-in||8||
48156994|NCT01061333|100706838|FG000|COMPLETED|Period 1: Placebo Run-in||8||
48156995|NCT01061333|100706839|FG001|COMPLETED|Period 1: Placebo Run-in||8||
48156996|NCT01061333|100706838|FG000|NOT COMPLETED|Period 1: Placebo Run-in||0||
48156997|NCT01061333|100706839|FG001|NOT COMPLETED|Period 1: Placebo Run-in||0||
48156998|NCT01061333|100706838|FG000|STARTED|Period 2: 20-day Washout||8||
48156999|NCT01061333|100706839|FG001|STARTED|Period 2: 20-day Washout||8||
48157000|NCT01061333|100706838|FG000|COMPLETED|Period 2: 20-day Washout||8||
48157001|NCT01061333|100706839|FG001|COMPLETED|Period 2: 20-day Washout||8||
48311957|NCT00932360|101088150|FG001|STARTED|Visit 3/Week 3||6||
48311958|NCT00932360|101088151|FG002|STARTED|Visit 3/Week 3||3||
48311959|NCT00932360|101088152|FG003|STARTED|Visit 3/Week 3||13||
48311960|NCT00932360|101088153|FG004|STARTED|Visit 3/Week 3||2||
48311961|NCT00932360|101088154|FG005|STARTED|Visit 3/Week 3||7||
48311962|NCT00932360|101088149|FG000|COMPLETED|Visit 3/Week 3||10||
48311963|NCT00932360|101088150|FG001|COMPLETED|Visit 3/Week 3||6||
48311964|NCT00932360|101088151|FG002|COMPLETED|Visit 3/Week 3||3||
48311965|NCT00932360|101088152|FG003|COMPLETED|Visit 3/Week 3||13||
48311966|NCT00932360|101088153|FG004|COMPLETED|Visit 3/Week 3||2||
48311967|NCT00932360|101088154|FG005|COMPLETED|Visit 3/Week 3||7||
48157002|NCT01061333|100706838|FG000|NOT COMPLETED|Period 2: 20-day Washout||0||
48157003|NCT01061333|100706839|FG001|NOT COMPLETED|Period 2: 20-day Washout||0||
48157004|NCT01061333|100706838|FG000|STARTED|Period 3: Nedocromil-Montelukast X-over||8||
48157005|NCT01061333|100706839|FG001|STARTED|Period 3: Nedocromil-Montelukast X-over||8||
48157006|NCT01061333|100706838|FG000|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8||
48157007|NCT01061333|100706839|FG001|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8||
48157008|NCT01061333|100706838|FG000|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0||
48157009|NCT01061333|100706839|FG001|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0||
48157010|NCT01061333|100706838|FG000|STARTED|Period 4: 20-day Washout||8||
48311968|NCT00932360|101088149|FG000|NOT COMPLETED|Visit 3/Week 3||0||
48311969|NCT00932360|101088150|FG001|NOT COMPLETED|Visit 3/Week 3||0||
48311970|NCT00932360|101088151|FG002|NOT COMPLETED|Visit 3/Week 3||0||
48311971|NCT00932360|101088152|FG003|NOT COMPLETED|Visit 3/Week 3||0||
48311972|NCT00932360|101088153|FG004|NOT COMPLETED|Visit 3/Week 3||0||
48311973|NCT00932360|101088154|FG005|NOT COMPLETED|Visit 3/Week 3||0||
48311974|NCT02101021|101088155|FG000|STARTED|Overall Study||7||
48311975|NCT02101021|101088156|FG001|STARTED|Overall Study||4||
48311976|NCT02101021|101088157|FG002|STARTED|Overall Study||7||
48311977|NCT02101021|101088158|FG003|STARTED|Overall Study||3||
48311978|NCT02101021|101088159|FG004|STARTED|Overall Study||4||
48311979|NCT02101021|101088155|FG000|COMPLETED|Overall Study||0||
48311980|NCT02101021|101088156|FG001|COMPLETED|Overall Study||0||
48311981|NCT02101021|101088157|FG002|COMPLETED|Overall Study||0||
48311982|NCT02101021|101088158|FG003|COMPLETED|Overall Study||0||
48311983|NCT02101021|101088159|FG004|COMPLETED|Overall Study||0||
48311984|NCT02101021|101088155|FG000|NOT COMPLETED|Overall Study||7||
48311985|NCT02101021|101088156|FG001|NOT COMPLETED|Overall Study||4||
48311986|NCT02101021|101088157|FG002|NOT COMPLETED|Overall Study||7||
48311987|NCT02101021|101088158|FG003|NOT COMPLETED|Overall Study||3||
48728381|NCT02145351|102123123|FG002|STARTED|First Intervention (4 Weeks)||0||
48728382|NCT02145351|102123121|FG000|COMPLETED|First Intervention (4 Weeks)||15||
48728383|NCT02145351|102123122|FG001|COMPLETED|First Intervention (4 Weeks)||14||
48728384|NCT02145351|102123123|FG002|COMPLETED|First Intervention (4 Weeks)||0||
48728385|NCT02145351|102123121|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0||
48728386|NCT02145351|102123122|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0||
48728387|NCT02145351|102123123|FG002|NOT COMPLETED|First Intervention (4 Weeks)||0||
48728388|NCT02145351|102123121|FG000|STARTED|Washout (4 Weeks)||15||
48728389|NCT02145351|102123122|FG001|STARTED|Washout (4 Weeks)||14||
48728390|NCT02145351|102123123|FG002|STARTED|Washout (4 Weeks)||0||
48728391|NCT02145351|102123121|FG000|COMPLETED|Washout (4 Weeks)||15||
48728392|NCT02145351|102123122|FG001|COMPLETED|Washout (4 Weeks)||14||
48728393|NCT02145351|102123123|FG002|COMPLETED|Washout (4 Weeks)||0||
48728394|NCT02145351|102123121|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
48728395|NCT02145351|102123122|FG001|NOT COMPLETED|Washout (4 Weeks)||0||
48728396|NCT02145351|102123123|FG002|NOT COMPLETED|Washout (4 Weeks)||0||
48728397|NCT02145351|102123121|FG000|STARTED|Second Intervention (4 Weeks)||15||
48728398|NCT02145351|102123122|FG001|STARTED|Second Intervention (4 Weeks)||14||
48728399|NCT02145351|102123123|FG002|STARTED|Second Intervention (4 Weeks)||0||
48728400|NCT02145351|102123121|FG000|COMPLETED|Second Intervention (4 Weeks)||15||
48728401|NCT02145351|102123122|FG001|COMPLETED|Second Intervention (4 Weeks)||14||
48728402|NCT02145351|102123123|FG002|COMPLETED|Second Intervention (4 Weeks)||0||
48728403|NCT02145351|102123121|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0||
48728404|NCT02145351|102123122|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0||
48728405|NCT02145351|102123123|FG002|NOT COMPLETED|Second Intervention (4 Weeks)||0||
48728406|NCT03262441|102123124|FG000|STARTED|Overall Study||5||
48728407|NCT03262441|102123124|FG000|COMPLETED|Overall Study||4||
48728408|NCT03262441|102123124|FG000|NOT COMPLETED|Overall Study||1||
48728409|NCT00923845|102123125|FG000|STARTED|Donor Lymphocyte Harvest||13||
48728410|NCT00923845|102123126|FG001|STARTED|Donor Lymphocyte Harvest||0||
48311988|NCT02101021|101088159|FG004|NOT COMPLETED|Overall Study||4||
48311989|NCT01409213|101088160|FG000|STARTED|Overall Study||1523||
48311990|NCT01409213|101088160|FG000|COMPLETED|Overall Study||1523||
48311991|NCT01409213|101088160|FG000|NOT COMPLETED|Overall Study||0||
48311992|NCT01128361|101088161|FG000|STARTED|Overall Study||39||
48311993|NCT01128361|101088162|FG001|STARTED|Overall Study||37||
48311994|NCT01128361|101088161|FG000|COMPLETED|Overall Study||34||
48311995|NCT01128361|101088162|FG001|COMPLETED|Overall Study||34||
48311996|NCT01128361|101088161|FG000|NOT COMPLETED|Overall Study||5||
48311997|NCT01128361|101088162|FG001|NOT COMPLETED|Overall Study||3||
48311998|NCT00699803|101088163|FG000|STARTED|Overall Study||32||
48311999|NCT00699803|101088164|FG001|STARTED|Overall Study||32||
48312000|NCT00699803|101088163|FG000|COMPLETED|Overall Study||30||
48312001|NCT00699803|101088164|FG001|COMPLETED|Overall Study||26||
48312002|NCT00699803|101088163|FG000|NOT COMPLETED|Overall Study||2||
48312003|NCT00699803|101088164|FG001|NOT COMPLETED|Overall Study||6||
48312004|NCT01490684|101088165|FG000|STARTED|Overall Study||162||
48312005|NCT01490684|101088165|FG000|COMPLETED|Overall Study||162||
48312006|NCT01490684|101088165|FG000|NOT COMPLETED|Overall Study||0||
48312007|NCT01181076|101088166|FG000|STARTED|Overall Study||59||
48312008|NCT01181076|101088167|FG001|STARTED|Overall Study||60||
48406725|NCT01899768|101328480|FG000|STARTED|Part B||13||
48406726|NCT01899768|101328480|FG000|COMPLETED|Part B||11||
48728411|NCT00923845|102123125|FG000|COMPLETED|Donor Lymphocyte Harvest||13||
48728412|NCT00923845|102123126|FG001|COMPLETED|Donor Lymphocyte Harvest||0||
48728413|NCT00923845|102123125|FG000|NOT COMPLETED|Donor Lymphocyte Harvest||0||
48728414|NCT00923845|102123126|FG001|NOT COMPLETED|Donor Lymphocyte Harvest||0||
48728415|NCT00923845|102123125|FG000|STARTED|Donor Hematopoietic Stem Cell Harvest||13||
48312009|NCT01181076|101088166|FG000|COMPLETED|Overall Study||40||
48312010|NCT01181076|101088167|FG001|COMPLETED|Overall Study||48||
48312011|NCT01181076|101088166|FG000|NOT COMPLETED|Overall Study||19||
48312012|NCT01181076|101088167|FG001|NOT COMPLETED|Overall Study||12||
48312013|NCT00955279|101088168|FG000|STARTED|Overall Study||58||
48312014|NCT00955279|101088169|FG001|STARTED|Overall Study||55||
48312015|NCT00955279|101088170|FG002|STARTED|Overall Study||60||
48312016|NCT00955279|101088168|FG000|COMPLETED|Overall Study||55||
48312017|NCT00955279|101088169|FG001|COMPLETED|Overall Study||51||
48406727|NCT01899768|101328480|FG000|NOT COMPLETED|Part B||2||
48406728|NCT01899768|101328480|FG000|STARTED|Part C||11||
48406729|NCT01899768|101328480|FG000|COMPLETED|Part C||11||
48728416|NCT00923845|102123126|FG001|STARTED|Donor Hematopoietic Stem Cell Harvest||0||
48728417|NCT00923845|102123125|FG000|COMPLETED|Donor Hematopoietic Stem Cell Harvest||13||
48312018|NCT00955279|101088170|FG002|COMPLETED|Overall Study||52||
48312019|NCT00955279|101088168|FG000|NOT COMPLETED|Overall Study||3||
48312020|NCT00955279|101088169|FG001|NOT COMPLETED|Overall Study||4||
48312021|NCT00955279|101088170|FG002|NOT COMPLETED|Overall Study||8||
48406730|NCT01899768|101328480|FG000|NOT COMPLETED|Part C||0||
48406731|NCT00392951|101328481|FG000|STARTED|Overall Study||30||
48312022|NCT00998049|101088171|FG000|STARTED|Overall Study||39||
48312023|NCT00998049|101088171|FG000|COMPLETED|Overall Study||39||
48312024|NCT00998049|101088171|FG000|NOT COMPLETED|Overall Study||0||
48312025|NCT02319668|101088172|FG000|STARTED|Overall Study||19||
48312026|NCT02319668|101088173|FG001|STARTED|Overall Study||19||
48312027|NCT02319668|101088172|FG000|COMPLETED|Overall Study||19||
48312028|NCT02319668|101088173|FG001|COMPLETED|Overall Study||17||
48312029|NCT02319668|101088172|FG000|NOT COMPLETED|Overall Study||0||
48312030|NCT02319668|101088173|FG001|NOT COMPLETED|Overall Study||2||
48312031|NCT01368042|101088174|FG000|STARTED|Overall Study||265||
48312032|NCT01368042|101088174|FG000|COMPLETED|Overall Study||235||
48312033|NCT01368042|101088174|FG000|NOT COMPLETED|Overall Study||30||
48312034|NCT00122681|101090991|FG000|STARTED|Overall Study||9325||
48312035|NCT00122681|101090992|FG001|STARTED|Overall Study||9319||
48312036|NCT00122681|101090991|FG000|COMPLETED|Overall Study||7811||
48312037|NCT00122681|101090992|FG001|COMPLETED|Overall Study||7798||
48312038|NCT00122681|101090991|FG000|NOT COMPLETED|Overall Study||1514||
48312039|NCT00122681|101090992|FG001|NOT COMPLETED|Overall Study||1521||
48312040|NCT02043548|101090993|FG000|STARTED|Overall Study||18||
48312041|NCT02043548|101090994|FG001|STARTED|Overall Study||18||
48312042|NCT02043548|101090993|FG000|COMPLETED|Overall Study||17||
48312043|NCT02043548|101090994|FG001|COMPLETED|Overall Study||17||
48312044|NCT02043548|101090993|FG000|NOT COMPLETED|Overall Study||1||
48312045|NCT02043548|101090994|FG001|NOT COMPLETED|Overall Study||1||
48312046|NCT02161575|101090995|FG000|STARTED|Overall Study||103||
48312047|NCT02161575|101090995|FG000|Full Analysis Set (FAS) Population|Overall Study||100|received an application of study treatment and had a baseline and post-baseline assessment for CSRT|
48312048|NCT02161575|101090995|FG000|Safety (SAF) Population|Overall Study||100|received an application of study treatment and and had at least one post-baseline safety assessment|
48312049|NCT02161575|101090995|FG000|COMPLETED|Overall Study||92||
48312050|NCT02161575|101090995|FG000|NOT COMPLETED|Overall Study||11||
48312051|NCT01848184|101090996|FG000|STARTED|Overall Study||126||
48312052|NCT01848184|101090996|FG000|COMPLETED|Overall Study||100||
48312053|NCT01848184|101090996|FG000|NOT COMPLETED|Overall Study||26||
48312054|NCT01932242|101090997|FG000|STARTED|Overall Study||35||
48312055|NCT01932242|101090998|FG001|STARTED|Overall Study||35||
48312056|NCT01932242|101090997|FG000|COMPLETED|Overall Study||30||
48312057|NCT01932242|101090998|FG001|COMPLETED|Overall Study||30||
48312058|NCT01932242|101090997|FG000|NOT COMPLETED|Overall Study||5||
48312059|NCT01932242|101090998|FG001|NOT COMPLETED|Overall Study||5||
48312060|NCT02589496|101090999|FG000|STARTED|Overall Study||80||
48312061|NCT02589496|101090999|FG000|COMPLETED|Overall Study||80||
48614080|NCT00511173|101841666|FG000|COMPLETED|Overall Study||102||
48614081|NCT00511173|101841666|FG000|NOT COMPLETED|Overall Study||0||
48614082|NCT02793947|101841667|FG000|STARTED|Overall Study||47||
48614083|NCT02793947|101841668|FG001|STARTED|Overall Study||55||
48614084|NCT02793947|101841667|FG000|COMPLETED|Overall Study||45||
48614085|NCT02793947|101841668|FG001|COMPLETED|Overall Study||50||
48614086|NCT02793947|101841667|FG000|NOT COMPLETED|Overall Study||2||
48614087|NCT02793947|101841668|FG001|NOT COMPLETED|Overall Study||5||
48614088|NCT00536510|101841669|FG000|STARTED|Overall Study||322||
48614089|NCT00536510|101841670|FG001|STARTED|Overall Study||324||
48312062|NCT02589496|101090999|FG000|NOT COMPLETED|Overall Study||0||
48312063|NCT03150862|101091000|FG000|STARTED|Overall Study||3||
48312064|NCT03150862|101091001|FG001|STARTED|Overall Study||8||
48312065|NCT03150862|101091002|FG002|STARTED|Overall Study||9||
48312066|NCT03150862|101091003|FG003|STARTED|Overall Study||40||
48312067|NCT03150862|101091004|FG004|STARTED|Overall Study||9||
48312068|NCT03150862|101091005|FG005|STARTED|Overall Study||9||
48312069|NCT03150862|101091006|FG006|STARTED|Overall Study||8||
48312070|NCT03150862|101091007|FG007|STARTED|Overall Study||30||
48312071|NCT03150862|101091000|FG000|COMPLETED|Overall Study||0||
48312072|NCT03150862|101091001|FG001|COMPLETED|Overall Study||0||
48312073|NCT03150862|101091002|FG002|COMPLETED|Overall Study||0||
48312074|NCT03150862|101091003|FG003|COMPLETED|Overall Study||0||
48312075|NCT03150862|101091004|FG004|COMPLETED|Overall Study||0||
48312076|NCT03150862|101091005|FG005|COMPLETED|Overall Study||0||
48312077|NCT03150862|101091006|FG006|COMPLETED|Overall Study||0||
48312078|NCT03150862|101091007|FG007|COMPLETED|Overall Study||0||
48614090|NCT00536510|101841669|FG000|COMPLETED|Overall Study||240||
48614091|NCT00536510|101841670|FG001|COMPLETED|Overall Study||295||
48614092|NCT00536510|101841669|FG000|NOT COMPLETED|Overall Study||82||
48614093|NCT00536510|101841670|FG001|NOT COMPLETED|Overall Study||29||
48614094|NCT01152996|101841671|FG000|STARTED|Overall Study||1075||
48614095|NCT01152996|101841671|FG000|Treated|Overall Study||1073||
48614096|NCT01152996|101841671|FG000|COMPLETED|Overall Study||538||
48614097|NCT01152996|101841671|FG000|NOT COMPLETED|Overall Study||537||
48614098|NCT01534416|101841672|FG000|STARTED|Overall Study||68||
48312079|NCT03150862|101091000|FG000|NOT COMPLETED|Overall Study||3||
48312080|NCT03150862|101091001|FG001|NOT COMPLETED|Overall Study||8||
48728418|NCT00923845|102123126|FG001|COMPLETED|Donor Hematopoietic Stem Cell Harvest||0||
48728419|NCT00923845|102123125|FG000|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0||
48728420|NCT00923845|102123126|FG001|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0||
48728421|NCT00923845|102123125|FG000|STARTED|Induction Therapy||0||
48728422|NCT00923845|102123126|FG001|STARTED|Induction Therapy||12||
48728423|NCT00923845|102123125|FG000|COMPLETED|Induction Therapy||0||
48728424|NCT00923845|102123126|FG001|COMPLETED|Induction Therapy||10||
48728425|NCT00923845|102123125|FG000|NOT COMPLETED|Induction Therapy||0||
48728426|NCT00923845|102123126|FG001|NOT COMPLETED|Induction Therapy||2||
48728427|NCT00923845|102123125|FG000|STARTED|Allogeneic Stem Cell Therapy||0||
48728428|NCT00923845|102123126|FG001|STARTED|Allogeneic Stem Cell Therapy||10||
48728429|NCT00923845|102123125|FG000|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||0||
48406732|NCT00392951|101328481|FG000|COMPLETED|Overall Study||30||
48406733|NCT00392951|101328481|FG000|NOT COMPLETED|Overall Study||0||
48406734|NCT03053401|101328482|FG000|STARTED|Overall Study||26||
48406735|NCT03053401|101328483|FG001|STARTED|Overall Study||26||
48406736|NCT03053401|101328482|FG000|COMPLETED|Overall Study||26||
48406737|NCT03053401|101328483|FG001|COMPLETED|Overall Study||26||
48406738|NCT03053401|101328482|FG000|NOT COMPLETED|Overall Study||0||
48406739|NCT03053401|101328483|FG001|NOT COMPLETED|Overall Study||0||
48728430|NCT00923845|102123126|FG001|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||8||
48728431|NCT00923845|102123125|FG000|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||0||
48728432|NCT00923845|102123126|FG001|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||6||
48728433|NCT00923845|102123125|FG000|COMPLETED|Allogeneic Stem Cell Therapy||0||
48728434|NCT00923845|102123126|FG001|COMPLETED|Allogeneic Stem Cell Therapy||10||
48728435|NCT00923845|102123125|FG000|NOT COMPLETED|Allogeneic Stem Cell Therapy||0||
48728436|NCT00923845|102123126|FG001|NOT COMPLETED|Allogeneic Stem Cell Therapy||0||
48406740|NCT03424044|101328484|FG000|STARTED|Dexcom Training Visit (1 Week)||4||
48406741|NCT03424044|101328485|FG001|STARTED|Dexcom Training Visit (1 Week)||3||
48406742|NCT03424044|101328486|FG002|STARTED|Dexcom Training Visit (1 Week)||3||
48406743|NCT03424044|101328487|FG003|STARTED|Dexcom Training Visit (1 Week)||3||
48728437|NCT02853435|102123127|FG000|STARTED|Part 1a, Period 1 (3 Days)||9||
48728438|NCT02853435|102123128|FG001|STARTED|Part 1a, Period 1 (3 Days)||9||
48728439|NCT02853435|102123129|FG002|STARTED|Part 1a, Period 1 (3 Days)||8||
48728440|NCT02853435|102123130|FG003|STARTED|Part 1a, Period 1 (3 Days)||0||
48728441|NCT02853435|102123131|FG004|STARTED|Part 1a, Period 1 (3 Days)||0||
48728442|NCT02853435|102123132|FG005|STARTED|Part 1a, Period 1 (3 Days)||0||
48728443|NCT02853435|102123127|FG000|COMPLETED|Part 1a, Period 1 (3 Days)||9||
48728444|NCT02853435|102123128|FG001|COMPLETED|Part 1a, Period 1 (3 Days)||9||
48728445|NCT02853435|102123129|FG002|COMPLETED|Part 1a, Period 1 (3 Days)||8||
48728446|NCT02853435|102123130|FG003|COMPLETED|Part 1a, Period 1 (3 Days)||0||
48728447|NCT02853435|102123131|FG004|COMPLETED|Part 1a, Period 1 (3 Days)||0||
48728448|NCT02853435|102123132|FG005|COMPLETED|Part 1a, Period 1 (3 Days)||0||
48728449|NCT02853435|102123127|FG000|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0||
48728450|NCT02853435|102123128|FG001|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0||
48728451|NCT02853435|102123129|FG002|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0||
48728452|NCT02853435|102123130|FG003|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0||
48728453|NCT02853435|102123131|FG004|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0||
48728454|NCT02853435|102123132|FG005|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0||
48728455|NCT02853435|102123127|FG000|STARTED|Part 1a, Washout Period 1 (3 Days)||9||
48406744|NCT03424044|101328488|FG004|STARTED|Dexcom Training Visit (1 Week)||3||
48406745|NCT03424044|101328489|FG005|STARTED|Dexcom Training Visit (1 Week)||4||
48406746|NCT03424044|101328490|FG006|STARTED|Dexcom Training Visit (1 Week)||1||
48728456|NCT02853435|102123128|FG001|STARTED|Part 1a, Washout Period 1 (3 Days)||9||
48728457|NCT02853435|102123129|FG002|STARTED|Part 1a, Washout Period 1 (3 Days)||8||
48728458|NCT02853435|102123130|FG003|STARTED|Part 1a, Washout Period 1 (3 Days)||0||
48728459|NCT02853435|102123131|FG004|STARTED|Part 1a, Washout Period 1 (3 Days)||0||
48728460|NCT02853435|102123132|FG005|STARTED|Part 1a, Washout Period 1 (3 Days)||0||
48728461|NCT02853435|102123127|FG000|COMPLETED|Part 1a, Washout Period 1 (3 Days)||9||
48406747|NCT03424044|101328491|FG007|STARTED|Dexcom Training Visit (1 Week)||1||
48728462|NCT02853435|102123128|FG001|COMPLETED|Part 1a, Washout Period 1 (3 Days)||9||
48728463|NCT02853435|102123129|FG002|COMPLETED|Part 1a, Washout Period 1 (3 Days)||8||
48728464|NCT02853435|102123130|FG003|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0||
48728465|NCT02853435|102123131|FG004|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0||
48312081|NCT03150862|101091002|FG002|NOT COMPLETED|Overall Study||9||
48312082|NCT03150862|101091003|FG003|NOT COMPLETED|Overall Study||40||
48312083|NCT03150862|101091004|FG004|NOT COMPLETED|Overall Study||9||
48312084|NCT03150862|101091005|FG005|NOT COMPLETED|Overall Study||9||
48312085|NCT03150862|101091006|FG006|NOT COMPLETED|Overall Study||8||
48312086|NCT03150862|101091007|FG007|NOT COMPLETED|Overall Study||30||
48312087|NCT03568045|101091008|FG000|STARTED|Overall Study||2||
48312088|NCT03568045|101091009|FG001|STARTED|Overall Study||9||
48312089|NCT03568045|101091010|FG002|STARTED|Overall Study||5||
48312090|NCT03568045|101091008|FG000|COMPLETED|Overall Study||2||
48312091|NCT03568045|101091009|FG001|COMPLETED|Overall Study||9||
48312092|NCT03568045|101091010|FG002|COMPLETED|Overall Study||5||
48312093|NCT03568045|101091008|FG000|NOT COMPLETED|Overall Study||0||
48312094|NCT03568045|101091009|FG001|NOT COMPLETED|Overall Study||0||
48312095|NCT03568045|101091010|FG002|NOT COMPLETED|Overall Study||0||
48312096|NCT03633526|101091011|FG000|STARTED|Overall Study||16||
48312097|NCT03633526|101091011|FG000|COMPLETED|Overall Study||16||
48312098|NCT03633526|101091011|FG000|NOT COMPLETED|Overall Study||0||
48312099|NCT00187096|101091012|FG000|STARTED|Overall Study||10||
48312100|NCT00187096|101091013|FG001|STARTED|Overall Study||3||
48312101|NCT00187096|101091014|FG002|STARTED|Overall Study||12||
48312102|NCT00187096|101091012|FG000|COMPLETED|Overall Study||10||
48312103|NCT00187096|101091013|FG001|COMPLETED|Overall Study||3||
48312104|NCT00187096|101091014|FG002|COMPLETED|Overall Study||11||
48312105|NCT00187096|101091012|FG000|NOT COMPLETED|Overall Study||0||
48406748|NCT03424044|101328492|FG008|STARTED|Dexcom Training Visit (1 Week)||1||
48406749|NCT03424044|101328484|FG000|COMPLETED|Dexcom Training Visit (1 Week)||4||
48406750|NCT03424044|101328485|FG001|COMPLETED|Dexcom Training Visit (1 Week)||3||
48406751|NCT03424044|101328486|FG002|COMPLETED|Dexcom Training Visit (1 Week)||3||
48406752|NCT03424044|101328487|FG003|COMPLETED|Dexcom Training Visit (1 Week)||3||
48728466|NCT02853435|102123132|FG005|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0||
48728467|NCT02853435|102123127|FG000|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0||
48312106|NCT00187096|101091013|FG001|NOT COMPLETED|Overall Study||0||
48312107|NCT00187096|101091014|FG002|NOT COMPLETED|Overall Study||1||
48312108|NCT04650282|101091015|FG000|STARTED|Overall Study||1||
48312109|NCT04650282|101091016|FG001|STARTED|Overall Study||1||
48312110|NCT04650282|101091015|FG000|COMPLETED|Overall Study||1||
48312111|NCT04650282|101091016|FG001|COMPLETED|Overall Study||1||
48312112|NCT04650282|101091015|FG000|NOT COMPLETED|Overall Study||0||
48312113|NCT04650282|101091016|FG001|NOT COMPLETED|Overall Study||0||
48312114|NCT02495844|101091017|FG000|STARTED|Overall Study||27||
48312115|NCT02495844|101091018|FG001|STARTED|Overall Study||28||
48312116|NCT02495844|101091017|FG000|COMPLETED|Overall Study||26||
48312117|NCT02495844|101091018|FG001|COMPLETED|Overall Study||24||
48312118|NCT02495844|101091017|FG000|NOT COMPLETED|Overall Study||1||
48312119|NCT02495844|101091018|FG001|NOT COMPLETED|Overall Study||4||
48312120|NCT03422679|101091019|FG000|STARTED|Overall Study||5|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
48312121|NCT03422679|101091020|FG001|STARTED|Overall Study||3|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
48312122|NCT03422679|101091021|FG002|STARTED|Overall Study||7|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
48312123|NCT03422679|101091022|FG003|STARTED|Overall Study||7|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
48728468|NCT02853435|102123128|FG001|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0||
48728469|NCT02853435|102123129|FG002|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0||
48728470|NCT02853435|102123130|FG003|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0||
48728471|NCT02853435|102123131|FG004|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0||
48728472|NCT02853435|102123132|FG005|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0||
48728473|NCT02853435|102123127|FG000|STARTED|Part 1a, Period 2 (3 Days)||9||
48728474|NCT02853435|102123128|FG001|STARTED|Part 1a, Period 2 (3 Days)||9||
48728475|NCT02853435|102123129|FG002|STARTED|Part 1a, Period 2 (3 Days)||8||
48312124|NCT03422679|101091023|FG004|STARTED|Overall Study||3|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
48312125|NCT03422679|101091024|FG005|STARTED|Overall Study||4|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
48312126|NCT03422679|101091025|FG006|STARTED|Overall Study||3|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
48312127|NCT03422679|101091026|FG007|STARTED|Overall Study||9|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
48312128|NCT03422679|101091027|FG008|STARTED|Overall Study||5|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
48312129|NCT03422679|101091028|FG009|STARTED|Overall Study||6|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
48312130|NCT03422679|101091029|FG010|STARTED|Overall Study||4|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
48728476|NCT02853435|102123130|FG003|STARTED|Part 1a, Period 2 (3 Days)||0||
48728477|NCT02853435|102123131|FG004|STARTED|Part 1a, Period 2 (3 Days)||0||
48728478|NCT02853435|102123132|FG005|STARTED|Part 1a, Period 2 (3 Days)||0||
48728479|NCT02853435|102123127|FG000|COMPLETED|Part 1a, Period 2 (3 Days)||9||
48728480|NCT02853435|102123128|FG001|COMPLETED|Part 1a, Period 2 (3 Days)||9||
48728481|NCT02853435|102123129|FG002|COMPLETED|Part 1a, Period 2 (3 Days)||8||
48728482|NCT02853435|102123130|FG003|COMPLETED|Part 1a, Period 2 (3 Days)||0||
48728483|NCT02853435|102123131|FG004|COMPLETED|Part 1a, Period 2 (3 Days)||0||
48728484|NCT02853435|102123132|FG005|COMPLETED|Part 1a, Period 2 (3 Days)||0||
48728485|NCT02853435|102123127|FG000|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0||
48728486|NCT02853435|102123128|FG001|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0||
48728487|NCT02853435|102123129|FG002|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0||
48728488|NCT02853435|102123130|FG003|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0||
48728489|NCT02853435|102123131|FG004|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0||
48728490|NCT02853435|102123132|FG005|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0||
48728491|NCT02853435|102123127|FG000|STARTED|Part 1a, Washout Period 2 (3 Days)||9||
48728492|NCT02853435|102123128|FG001|STARTED|Part 1a, Washout Period 2 (3 Days)||9||
48728493|NCT02853435|102123129|FG002|STARTED|Part 1a, Washout Period 2 (3 Days)||8||
48728494|NCT02853435|102123130|FG003|STARTED|Part 1a, Washout Period 2 (3 Days)||0||
48728495|NCT02853435|102123131|FG004|STARTED|Part 1a, Washout Period 2 (3 Days)||0||
48728496|NCT02853435|102123132|FG005|STARTED|Part 1a, Washout Period 2 (3 Days)||0||
48728497|NCT02853435|102123127|FG000|COMPLETED|Part 1a, Washout Period 2 (3 Days)||9||
48728498|NCT02853435|102123128|FG001|COMPLETED|Part 1a, Washout Period 2 (3 Days)||9||
48728499|NCT02853435|102123129|FG002|COMPLETED|Part 1a, Washout Period 2 (3 Days)||8||
48728500|NCT02853435|102123130|FG003|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0||
48728501|NCT02853435|102123131|FG004|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0||
48728502|NCT02853435|102123132|FG005|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0||
48728503|NCT02853435|102123127|FG000|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0||
48728504|NCT02853435|102123128|FG001|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0||
48728505|NCT02853435|102123129|FG002|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0||
48728506|NCT02853435|102123130|FG003|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0||
48728507|NCT02853435|102123131|FG004|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0||
48728508|NCT02853435|102123132|FG005|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0||
48728509|NCT02853435|102123127|FG000|STARTED|Part 1a, Period 3 (3 Days)||9||
48728510|NCT02853435|102123128|FG001|STARTED|Part 1a, Period 3 (3 Days)||9||
48728511|NCT02853435|102123129|FG002|STARTED|Part 1a, Period 3 (3 Days)||8||
48728512|NCT02853435|102123130|FG003|STARTED|Part 1a, Period 3 (3 Days)||0||
48728513|NCT02853435|102123131|FG004|STARTED|Part 1a, Period 3 (3 Days)||0||
48728514|NCT02853435|102123132|FG005|STARTED|Part 1a, Period 3 (3 Days)||0||
48728515|NCT02853435|102123127|FG000|COMPLETED|Part 1a, Period 3 (3 Days)||9||
48728516|NCT02853435|102123128|FG001|COMPLETED|Part 1a, Period 3 (3 Days)||9||
48728517|NCT02853435|102123129|FG002|COMPLETED|Part 1a, Period 3 (3 Days)||8||
48728518|NCT02853435|102123130|FG003|COMPLETED|Part 1a, Period 3 (3 Days)||0||
48728519|NCT02853435|102123131|FG004|COMPLETED|Part 1a, Period 3 (3 Days)||0||
48728520|NCT02853435|102123132|FG005|COMPLETED|Part 1a, Period 3 (3 Days)||0||
48728521|NCT02853435|102123127|FG000|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0||
48728522|NCT02853435|102123128|FG001|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0||
48728523|NCT02853435|102123129|FG002|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0||
48728524|NCT02853435|102123130|FG003|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0||
48728525|NCT02853435|102123131|FG004|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0||
48728526|NCT02853435|102123132|FG005|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0||
48728527|NCT02853435|102123127|FG000|STARTED|Part 2, Period 1 (3 Days)||0||
48312131|NCT03422679|101091030|FG011|STARTED|Overall Study||8|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
48312132|NCT03422679|101091031|FG012|STARTED|Overall Study||15|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
48312133|NCT03422679|101091019|FG000|COMPLETED|Overall Study||5|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
48312134|NCT03422679|101091020|FG001|COMPLETED|Overall Study||3|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
48312135|NCT03422679|101091021|FG002|COMPLETED|Overall Study||7|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
48312136|NCT03422679|101091022|FG003|COMPLETED|Overall Study||7|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
48312137|NCT03422679|101091023|FG004|COMPLETED|Overall Study||3|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
48312138|NCT03422679|101091024|FG005|COMPLETED|Overall Study||4|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
48406753|NCT03424044|101328488|FG004|COMPLETED|Dexcom Training Visit (1 Week)||3||
48728528|NCT02853435|102123128|FG001|STARTED|Part 2, Period 1 (3 Days)||0||
48728529|NCT02853435|102123129|FG002|STARTED|Part 2, Period 1 (3 Days)||0||
48728530|NCT02853435|102123130|FG003|STARTED|Part 2, Period 1 (3 Days)||10||
48728531|NCT02853435|102123131|FG004|STARTED|Part 2, Period 1 (3 Days)||0||
48728532|NCT02853435|102123132|FG005|STARTED|Part 2, Period 1 (3 Days)||0||
48728533|NCT02853435|102123127|FG000|COMPLETED|Part 2, Period 1 (3 Days)||0||
48728534|NCT02853435|102123128|FG001|COMPLETED|Part 2, Period 1 (3 Days)||0||
48728535|NCT02853435|102123129|FG002|COMPLETED|Part 2, Period 1 (3 Days)||0||
48728536|NCT02853435|102123130|FG003|COMPLETED|Part 2, Period 1 (3 Days)||10||
48728537|NCT02853435|102123131|FG004|COMPLETED|Part 2, Period 1 (3 Days)||0||
48728538|NCT02853435|102123132|FG005|COMPLETED|Part 2, Period 1 (3 Days)||0||
48728539|NCT02853435|102123127|FG000|NOT COMPLETED|Part 2, Period 1 (3 Days)||0||
48728540|NCT02853435|102123128|FG001|NOT COMPLETED|Part 2, Period 1 (3 Days)||0||
48728541|NCT02853435|102123129|FG002|NOT COMPLETED|Part 2, Period 1 (3 Days)||0||
48728542|NCT02853435|102123130|FG003|NOT COMPLETED|Part 2, Period 1 (3 Days)||0||
48728543|NCT02853435|102123131|FG004|NOT COMPLETED|Part 2, Period 1 (3 Days)||0||
48728544|NCT02853435|102123132|FG005|NOT COMPLETED|Part 2, Period 1 (3 Days)||0||
48728545|NCT02853435|102123127|FG000|STARTED|Part 2, Washout Period 1 (3 Days)||0||
48728546|NCT02853435|102123128|FG001|STARTED|Part 2, Washout Period 1 (3 Days)||0||
48728547|NCT02853435|102123129|FG002|STARTED|Part 2, Washout Period 1 (3 Days)||0||
48728548|NCT02853435|102123130|FG003|STARTED|Part 2, Washout Period 1 (3 Days)||10||
48728549|NCT02853435|102123131|FG004|STARTED|Part 2, Washout Period 1 (3 Days)||0||
48728550|NCT02853435|102123132|FG005|STARTED|Part 2, Washout Period 1 (3 Days)||0||
48728551|NCT02853435|102123127|FG000|COMPLETED|Part 2, Washout Period 1 (3 Days)||0||
48728552|NCT02853435|102123128|FG001|COMPLETED|Part 2, Washout Period 1 (3 Days)||0||
48728553|NCT02853435|102123129|FG002|COMPLETED|Part 2, Washout Period 1 (3 Days)||0||
48728554|NCT02853435|102123130|FG003|COMPLETED|Part 2, Washout Period 1 (3 Days)||10||
48728555|NCT02853435|102123131|FG004|COMPLETED|Part 2, Washout Period 1 (3 Days)||0||
48728556|NCT02853435|102123132|FG005|COMPLETED|Part 2, Washout Period 1 (3 Days)||0||
48728557|NCT02853435|102123127|FG000|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0||
48728558|NCT02853435|102123128|FG001|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0||
48728559|NCT02853435|102123129|FG002|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0||
48728560|NCT02853435|102123130|FG003|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0||
48728561|NCT02853435|102123131|FG004|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0||
48728562|NCT02853435|102123132|FG005|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0||
48728563|NCT02853435|102123127|FG000|STARTED|Part 2, Period 2 (3 Days)||0||
48728564|NCT02853435|102123128|FG001|STARTED|Part 2, Period 2 (3 Days)||0||
48728565|NCT02853435|102123129|FG002|STARTED|Part 2, Period 2 (3 Days)||0||
48728566|NCT02853435|102123130|FG003|STARTED|Part 2, Period 2 (3 Days)||10||
48728567|NCT02853435|102123131|FG004|STARTED|Part 2, Period 2 (3 Days)||0||
48728568|NCT02853435|102123132|FG005|STARTED|Part 2, Period 2 (3 Days)||0||
48728569|NCT02853435|102123127|FG000|COMPLETED|Part 2, Period 2 (3 Days)||0||
48728570|NCT02853435|102123128|FG001|COMPLETED|Part 2, Period 2 (3 Days)||0||
48728571|NCT02853435|102123129|FG002|COMPLETED|Part 2, Period 2 (3 Days)||0||
48728572|NCT02853435|102123130|FG003|COMPLETED|Part 2, Period 2 (3 Days)||10||
48728573|NCT02853435|102123131|FG004|COMPLETED|Part 2, Period 2 (3 Days)||0||
48728574|NCT02853435|102123132|FG005|COMPLETED|Part 2, Period 2 (3 Days)||0||
48728575|NCT02853435|102123127|FG000|NOT COMPLETED|Part 2, Period 2 (3 Days)||0||
48728576|NCT02853435|102123128|FG001|NOT COMPLETED|Part 2, Period 2 (3 Days)||0||
48728577|NCT02853435|102123129|FG002|NOT COMPLETED|Part 2, Period 2 (3 Days)||0||
48728578|NCT02853435|102123130|FG003|NOT COMPLETED|Part 2, Period 2 (3 Days)||0||
48312139|NCT03422679|101091025|FG006|COMPLETED|Overall Study||3|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
48312140|NCT03422679|101091026|FG007|COMPLETED|Overall Study||9|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
48368035|NCT03567291|101230092|FG000|NOT COMPLETED|Period II||0||
48406754|NCT03424044|101328489|FG005|COMPLETED|Dexcom Training Visit (1 Week)||4||
48312141|NCT03422679|101091027|FG008|COMPLETED|Overall Study||5|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
48312142|NCT03422679|101091028|FG009|COMPLETED|Overall Study||6|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
48312143|NCT03422679|101091029|FG010|COMPLETED|Overall Study||4|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
48312144|NCT03422679|101091030|FG011|COMPLETED|Overall Study||8|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
48312145|NCT03422679|101091031|FG012|COMPLETED|Overall Study||15|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
48312146|NCT03422679|101091019|FG000|NOT COMPLETED|Overall Study||0||
48312147|NCT03422679|101091020|FG001|NOT COMPLETED|Overall Study||0||
48312148|NCT03422679|101091021|FG002|NOT COMPLETED|Overall Study||0||
48312149|NCT03422679|101091022|FG003|NOT COMPLETED|Overall Study||0||
48312150|NCT03422679|101091023|FG004|NOT COMPLETED|Overall Study||0||
48312151|NCT03422679|101091024|FG005|NOT COMPLETED|Overall Study||0||
48312152|NCT03422679|101091025|FG006|NOT COMPLETED|Overall Study||0||
48312153|NCT03422679|101091026|FG007|NOT COMPLETED|Overall Study||0||
48312154|NCT03422679|101091027|FG008|NOT COMPLETED|Overall Study||0||
48312155|NCT03422679|101091028|FG009|NOT COMPLETED|Overall Study||0||
48728579|NCT02853435|102123131|FG004|NOT COMPLETED|Part 2, Period 2 (3 Days)||0||
48728580|NCT02853435|102123132|FG005|NOT COMPLETED|Part 2, Period 2 (3 Days)||0||
48728581|NCT02853435|102123127|FG000|STARTED|Part 3, Period 1 (3 Days)||0||
48728582|NCT02853435|102123128|FG001|STARTED|Part 3, Period 1 (3 Days)||0||
48728583|NCT02853435|102123129|FG002|STARTED|Part 3, Period 1 (3 Days)||0||
48728584|NCT02853435|102123130|FG003|STARTED|Part 3, Period 1 (3 Days)||0||
48728585|NCT02853435|102123131|FG004|STARTED|Part 3, Period 1 (3 Days)||10||
48728586|NCT02853435|102123132|FG005|STARTED|Part 3, Period 1 (3 Days)||2||
48728587|NCT02853435|102123127|FG000|COMPLETED|Part 3, Period 1 (3 Days)||0||
48728588|NCT02853435|102123128|FG001|COMPLETED|Part 3, Period 1 (3 Days)||0||
48728589|NCT02853435|102123129|FG002|COMPLETED|Part 3, Period 1 (3 Days)||0||
48728590|NCT02853435|102123130|FG003|COMPLETED|Part 3, Period 1 (3 Days)||0||
48728591|NCT02853435|102123131|FG004|COMPLETED|Part 3, Period 1 (3 Days)||10||
48728592|NCT02853435|102123132|FG005|COMPLETED|Part 3, Period 1 (3 Days)||2||
48728593|NCT02853435|102123127|FG000|NOT COMPLETED|Part 3, Period 1 (3 Days)||0||
48728594|NCT02853435|102123128|FG001|NOT COMPLETED|Part 3, Period 1 (3 Days)||0||
48728595|NCT02853435|102123129|FG002|NOT COMPLETED|Part 3, Period 1 (3 Days)||0||
48728596|NCT02853435|102123130|FG003|NOT COMPLETED|Part 3, Period 1 (3 Days)||0||
48728597|NCT02853435|102123131|FG004|NOT COMPLETED|Part 3, Period 1 (3 Days)||0||
48728598|NCT02853435|102123132|FG005|NOT COMPLETED|Part 3, Period 1 (3 Days)||0||
48312156|NCT03422679|101091029|FG010|NOT COMPLETED|Overall Study||0||
48312157|NCT03422679|101091030|FG011|NOT COMPLETED|Overall Study||0||
48312158|NCT03422679|101091031|FG012|NOT COMPLETED|Overall Study||0||
48312159|NCT01168973|101091032|FG000|STARTED|Overall Study||628||
48728599|NCT02853435|102123127|FG000|STARTED|Part 3, Washout Period 1 (3 Days)||0||
48728600|NCT02853435|102123128|FG001|STARTED|Part 3, Washout Period 1 (3 Days)||0||
48728601|NCT02853435|102123129|FG002|STARTED|Part 3, Washout Period 1 (3 Days)||0||
48728602|NCT02853435|102123130|FG003|STARTED|Part 3, Washout Period 1 (3 Days)||0||
48728603|NCT02853435|102123131|FG004|STARTED|Part 3, Washout Period 1 (3 Days)||10||
48728604|NCT02853435|102123132|FG005|STARTED|Part 3, Washout Period 1 (3 Days)||2||
48728605|NCT02853435|102123127|FG000|COMPLETED|Part 3, Washout Period 1 (3 Days)||0||
48728606|NCT02853435|102123128|FG001|COMPLETED|Part 3, Washout Period 1 (3 Days)||0||
48728607|NCT02853435|102123129|FG002|COMPLETED|Part 3, Washout Period 1 (3 Days)||0||
48728608|NCT02853435|102123130|FG003|COMPLETED|Part 3, Washout Period 1 (3 Days)||0||
48728609|NCT02853435|102123131|FG004|COMPLETED|Part 3, Washout Period 1 (3 Days)||10||
48312160|NCT01168973|101091033|FG001|STARTED|Overall Study||625||
48312161|NCT01168973|101091032|FG000|Received Any Quantity of Any Study Drug|Overall Study||624||
48157011|NCT01061333|100706839|FG001|STARTED|Period 4: 20-day Washout||8||
48312162|NCT01168973|101091033|FG001|Received Any Quantity of Any Study Drug|Overall Study||621||
48312163|NCT01168973|101091032|FG000|COMPLETED|Overall Study||15||
48728610|NCT02853435|102123132|FG005|COMPLETED|Part 3, Washout Period 1 (3 Days)||2||
48728611|NCT02853435|102123127|FG000|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0||
48728612|NCT02853435|102123128|FG001|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0||
48728613|NCT02853435|102123129|FG002|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0||
48728614|NCT02853435|102123130|FG003|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0||
48728615|NCT02853435|102123131|FG004|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0||
48728616|NCT02853435|102123132|FG005|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0||
48728617|NCT02853435|102123127|FG000|STARTED|Part 3, Period 2 (3 Days)||0||
48728618|NCT02853435|102123128|FG001|STARTED|Part 3, Period 2 (3 Days)||0||
48728619|NCT02853435|102123129|FG002|STARTED|Part 3, Period 2 (3 Days)||0||
48728620|NCT02853435|102123130|FG003|STARTED|Part 3, Period 2 (3 Days)||0||
48728621|NCT02853435|102123131|FG004|STARTED|Part 3, Period 2 (3 Days)||10||
48728622|NCT02853435|102123132|FG005|STARTED|Part 3, Period 2 (3 Days)||2||
48728623|NCT02853435|102123127|FG000|COMPLETED|Part 3, Period 2 (3 Days)||0||
48728624|NCT02853435|102123128|FG001|COMPLETED|Part 3, Period 2 (3 Days)||0||
48728625|NCT02853435|102123129|FG002|COMPLETED|Part 3, Period 2 (3 Days)||0||
48728626|NCT02853435|102123130|FG003|COMPLETED|Part 3, Period 2 (3 Days)||0||
48728627|NCT02853435|102123131|FG004|COMPLETED|Part 3, Period 2 (3 Days)||10||
48728628|NCT02853435|102123132|FG005|COMPLETED|Part 3, Period 2 (3 Days)||2||
48728629|NCT02853435|102123127|FG000|NOT COMPLETED|Part 3, Period 2 (3 Days)||0||
48728630|NCT02853435|102123128|FG001|NOT COMPLETED|Part 3, Period 2 (3 Days)||0||
48728631|NCT02853435|102123129|FG002|NOT COMPLETED|Part 3, Period 2 (3 Days)||0||
48728632|NCT02853435|102123130|FG003|NOT COMPLETED|Part 3, Period 2 (3 Days)||0||
48728633|NCT02853435|102123131|FG004|NOT COMPLETED|Part 3, Period 2 (3 Days)||0||
48728634|NCT02853435|102123132|FG005|NOT COMPLETED|Part 3, Period 2 (3 Days)||0||
48728635|NCT02853435|102123127|FG000|STARTED|Part 3, Washout Period 2 (3 Days)||0||
48728636|NCT02853435|102123128|FG001|STARTED|Part 3, Washout Period 2 (3 Days)||0||
48728637|NCT02853435|102123129|FG002|STARTED|Part 3, Washout Period 2 (3 Days)||0||
48728638|NCT02853435|102123130|FG003|STARTED|Part 3, Washout Period 2 (3 Days)||0||
48728639|NCT02853435|102123131|FG004|STARTED|Part 3, Washout Period 2 (3 Days)||10||
48728640|NCT02853435|102123132|FG005|STARTED|Part 3, Washout Period 2 (3 Days)||2||
48728641|NCT02853435|102123127|FG000|COMPLETED|Part 3, Washout Period 2 (3 Days)||0||
48728642|NCT02853435|102123128|FG001|COMPLETED|Part 3, Washout Period 2 (3 Days)||0||
48728643|NCT02853435|102123129|FG002|COMPLETED|Part 3, Washout Period 2 (3 Days)||0||
48728644|NCT02853435|102123130|FG003|COMPLETED|Part 3, Washout Period 2 (3 Days)||0||
48728645|NCT02853435|102123131|FG004|COMPLETED|Part 3, Washout Period 2 (3 Days)||9||
48728646|NCT02853435|102123132|FG005|COMPLETED|Part 3, Washout Period 2 (3 Days)||2||
48728647|NCT02853435|102123127|FG000|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0||
48728648|NCT02853435|102123128|FG001|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0||
48728649|NCT02853435|102123129|FG002|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0||
48728650|NCT02853435|102123130|FG003|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0||
48728651|NCT02853435|102123131|FG004|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||1||
48728652|NCT02853435|102123132|FG005|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0||
48728653|NCT02853435|102123127|FG000|STARTED|Part 3, Period 3 (3 Days)||0||
48728654|NCT02853435|102123128|FG001|STARTED|Part 3, Period 3 (3 Days)||0||
48728655|NCT02853435|102123129|FG002|STARTED|Part 3, Period 3 (3 Days)||0||
48728656|NCT02853435|102123130|FG003|STARTED|Part 3, Period 3 (3 Days)||0||
48728657|NCT02853435|102123131|FG004|STARTED|Part 3, Period 3 (3 Days)||9||
48728658|NCT02853435|102123132|FG005|STARTED|Part 3, Period 3 (3 Days)||2||
48728659|NCT02853435|102123127|FG000|COMPLETED|Part 3, Period 3 (3 Days)||0||
48728660|NCT02853435|102123128|FG001|COMPLETED|Part 3, Period 3 (3 Days)||0||
48728661|NCT02853435|102123129|FG002|COMPLETED|Part 3, Period 3 (3 Days)||0||
48728662|NCT02853435|102123130|FG003|COMPLETED|Part 3, Period 3 (3 Days)||0||
48728663|NCT02853435|102123131|FG004|COMPLETED|Part 3, Period 3 (3 Days)||9||
48728664|NCT02853435|102123132|FG005|COMPLETED|Part 3, Period 3 (3 Days)||2||
48728665|NCT02853435|102123127|FG000|NOT COMPLETED|Part 3, Period 3 (3 Days)||0||
48728666|NCT02853435|102123128|FG001|NOT COMPLETED|Part 3, Period 3 (3 Days)||0||
48728667|NCT02853435|102123129|FG002|NOT COMPLETED|Part 3, Period 3 (3 Days)||0||
48728668|NCT02853435|102123130|FG003|NOT COMPLETED|Part 3, Period 3 (3 Days)||0||
48728669|NCT02853435|102123131|FG004|NOT COMPLETED|Part 3, Period 3 (3 Days)||0||
48728670|NCT02853435|102123132|FG005|NOT COMPLETED|Part 3, Period 3 (3 Days)||0||
48728671|NCT00147316|102123133|FG000|STARTED|Overall Study||103||
48728672|NCT00147316|102123133|FG000|COMPLETED|Overall Study||103||
48728673|NCT00147316|102123133|FG000|NOT COMPLETED|Overall Study||0||
48728674|NCT01300260|102123134|FG000|STARTED|Period 1 of Study: First Intervention||15||
48728675|NCT01300260|102123135|FG001|STARTED|Period 1 of Study: First Intervention||17||
48728676|NCT01300260|102123134|FG000|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||15||
48728677|NCT01300260|102123135|FG001|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||17||
48728678|NCT01300260|102123134|FG000|COMPLETED|Period 1 of Study: First Intervention||14||
48728679|NCT01300260|102123135|FG001|COMPLETED|Period 1 of Study: First Intervention||16||
48728680|NCT01300260|102123134|FG000|NOT COMPLETED|Period 1 of Study: First Intervention||1||
48728681|NCT01300260|102123135|FG001|NOT COMPLETED|Period 1 of Study: First Intervention||1||
48728682|NCT01300260|102123134|FG000|STARTED|Washout Period of at Least 28 Days||14||
48728683|NCT01300260|102123135|FG001|STARTED|Washout Period of at Least 28 Days||16||
48312164|NCT01168973|101091033|FG001|COMPLETED|Overall Study||14||
48312165|NCT01168973|101091032|FG000|NOT COMPLETED|Overall Study||613||
48312166|NCT01168973|101091033|FG001|NOT COMPLETED|Overall Study||611||
48312167|NCT03713034|101091034|FG000|STARTED|Overall Study||150||
48312168|NCT03713034|101091035|FG001|STARTED|Overall Study||146||
48312169|NCT03713034|101091034|FG000|COMPLETED|Overall Study||145||
48312170|NCT03713034|101091035|FG001|COMPLETED|Overall Study||142||
48312171|NCT03713034|101091034|FG000|NOT COMPLETED|Overall Study||5||
48312172|NCT03713034|101091035|FG001|NOT COMPLETED|Overall Study||4||
48312173|NCT00516048|101091036|FG000|STARTED|Overall Study||15||
48312174|NCT00516048|101091037|FG001|STARTED|Overall Study||42||
48728684|NCT01300260|102123134|FG000|COMPLETED|Washout Period of at Least 28 Days||14||
48728685|NCT01300260|102123135|FG001|COMPLETED|Washout Period of at Least 28 Days||16||
48312175|NCT00516048|101091038|FG002|STARTED|Overall Study||1||
48312176|NCT00516048|101091036|FG000|COMPLETED|Overall Study||15||
48312177|NCT00516048|101091037|FG001|COMPLETED|Overall Study||40||
48312178|NCT00516048|101091038|FG002|COMPLETED|Overall Study||0||
48312179|NCT00516048|101091036|FG000|NOT COMPLETED|Overall Study||0||
48728686|NCT01300260|102123134|FG000|NOT COMPLETED|Washout Period of at Least 28 Days||0||
48728687|NCT01300260|102123135|FG001|NOT COMPLETED|Washout Period of at Least 28 Days||0||
48728688|NCT01300260|102123134|FG000|STARTED|Period 2 of Study: Second Intervention||14||
48728689|NCT01300260|102123135|FG001|STARTED|Period 2 of Study: Second Intervention||16||
48728690|NCT01300260|102123134|FG000|COMPLETED|Period 2 of Study: Second Intervention||14||
48728691|NCT01300260|102123135|FG001|COMPLETED|Period 2 of Study: Second Intervention||15||
48728692|NCT01300260|102123134|FG000|NOT COMPLETED|Period 2 of Study: Second Intervention||0||
48728693|NCT01300260|102123135|FG001|NOT COMPLETED|Period 2 of Study: Second Intervention||1||
48728694|NCT03203291|102123136|FG000|STARTED|Overall Study||12||
48728695|NCT03203291|102123136|FG000|COMPLETED|Overall Study||11||
48728696|NCT03203291|102123136|FG000|NOT COMPLETED|Overall Study||1||
48728697|NCT00971295|102123137|FG000|STARTED|Overall Study||10||
48728698|NCT00971295|102123138|FG001|STARTED|Overall Study||10||
48728699|NCT00971295|102123137|FG000|COMPLETED|Overall Study||10||
48728700|NCT00971295|102123138|FG001|COMPLETED|Overall Study||9||
48614099|NCT01534416|101841673|FG001|STARTED|Overall Study||64||
48614100|NCT01534416|101841672|FG000|COMPLETED|Overall Study||68||
48614101|NCT01534416|101841673|FG001|COMPLETED|Overall Study||64||
48728701|NCT00971295|102123137|FG000|NOT COMPLETED|Overall Study||0||
48728702|NCT00971295|102123138|FG001|NOT COMPLETED|Overall Study||1||
48312180|NCT00516048|101091037|FG001|NOT COMPLETED|Overall Study||2||
48312181|NCT00516048|101091038|FG002|NOT COMPLETED|Overall Study||1||
48312182|NCT03677596|101091039|FG000|STARTED|Overall Study||64||
48312183|NCT03677596|101091040|FG001|STARTED|Overall Study||38||
48728703|NCT04558359|102123139|FG000|STARTED|Overall Study||10||
48728704|NCT04558359|102123140|FG001|STARTED|Overall Study||18||
48728705|NCT04558359|102123139|FG000|COMPLETED|Overall Study||10||
48728706|NCT04558359|102123140|FG001|COMPLETED|Overall Study||18||
48728707|NCT04558359|102123139|FG000|NOT COMPLETED|Overall Study||0||
48728708|NCT04558359|102123140|FG001|NOT COMPLETED|Overall Study||0||
48728709|NCT01717326|102123141|FG000|STARTED|Overall Study||25||
48728710|NCT01717326|102123142|FG001|STARTED|Overall Study||27||
48728711|NCT01717326|102123143|FG002|STARTED|Overall Study||13||
48728712|NCT01717326|102123144|FG003|STARTED|Overall Study||30||
48728713|NCT01717326|102123145|FG004|STARTED|Overall Study||33||
48728714|NCT01717326|102123146|FG005|STARTED|Overall Study||31||
48728715|NCT01717326|102123147|FG006|STARTED|Overall Study||31||
48728716|NCT01717326|102123148|FG007|STARTED|Overall Study||29||
48728717|NCT01717326|102123149|FG008|STARTED|Overall Study||32||
48728718|NCT01717326|102123150|FG009|STARTED|Overall Study||31||
48728719|NCT01717326|102123151|FG010|STARTED|Overall Study||32||
48728720|NCT01717326|102123152|FG011|STARTED|Overall Study||33||
48728721|NCT01717326|102123153|FG012|STARTED|Overall Study||33||
48728722|NCT01717326|102123154|FG013|STARTED|Overall Study||32||
48728723|NCT01717326|102123155|FG014|STARTED|Overall Study||29||
48728724|NCT01717326|102123156|FG015|STARTED|Overall Study||30||
48728725|NCT01717326|102123157|FG016|STARTED|Overall Study||30||
48728726|NCT01717326|102123158|FG017|STARTED|Overall Study||31||
48728727|NCT01717326|102123159|FG018|STARTED|Overall Study||20||
48728728|NCT01717326|102123160|FG019|STARTED|Overall Study||21||
48728729|NCT01717326|102123141|FG000|Treated|Overall Study||25||
48728730|NCT01717326|102123142|FG001|Treated|Overall Study||28||
48188742|NCT01033643|100783321|FG000|NOT COMPLETED|Overall Study||0||
48312184|NCT03677596|101091039|FG000|COMPLETED|Overall Study||41||
48614102|NCT01534416|101841672|FG000|NOT COMPLETED|Overall Study||0||
48614103|NCT01534416|101841673|FG001|NOT COMPLETED|Overall Study||0||
48614104|NCT00856999|101841674|FG000|STARTED|Overall Study||50||
48614105|NCT00856999|101841674|FG000|COMPLETED|Overall Study||45||
48614106|NCT00856999|101841674|FG000|NOT COMPLETED|Overall Study||5||
48614107|NCT01091246|101841675|FG000|STARTED|Overall Study||1385||
48614108|NCT01091246|101841676|FG001|STARTED|Overall Study||464||
48614109|NCT01091246|101841677|FG002|STARTED|Overall Study||463||
48614110|NCT01091246|101841675|FG000|COMPLETED|Overall Study||1350||
48614111|NCT01091246|101841676|FG001|COMPLETED|Overall Study||448||
48728731|NCT01717326|102123143|FG002|Treated|Overall Study||12||
48728732|NCT01717326|102123144|FG003|Treated|Overall Study||30||
48728733|NCT01717326|102123145|FG004|Treated|Overall Study||33||
48728734|NCT01717326|102123146|FG005|Treated|Overall Study||31||
48728735|NCT01717326|102123147|FG006|Treated|Overall Study||31||
48728736|NCT01717326|102123148|FG007|Treated|Overall Study||29||
48728737|NCT01717326|102123149|FG008|Treated|Overall Study||32||
48728738|NCT01717326|102123150|FG009|Treated|Overall Study||31||
48728739|NCT01717326|102123151|FG010|Treated|Overall Study||32||
48728740|NCT01717326|102123152|FG011|Treated|Overall Study||33||
48312185|NCT03677596|101091040|FG001|COMPLETED|Overall Study||19||
48614112|NCT01091246|101841677|FG002|COMPLETED|Overall Study||450||
48614113|NCT01091246|101841675|FG000|NOT COMPLETED|Overall Study||35||
48614114|NCT01091246|101841676|FG001|NOT COMPLETED|Overall Study||16||
48614115|NCT01091246|101841677|FG002|NOT COMPLETED|Overall Study||13||
48614116|NCT03810456|101841678|FG000|STARTED|Enrolled and Randomized||99|Participants enrolled and randomized to a treatment condition.|
48614117|NCT03810456|101841679|FG001|STARTED|Enrolled and Randomized||99|Participants enrolled and randomized to a treatment condition.|
48614118|NCT03810456|101841680|FG002|STARTED|Enrolled and Randomized||67|Participants enrolled and randomized to a treatment condition.|
48728741|NCT01717326|102123153|FG012|Treated|Overall Study||33||
48728742|NCT01717326|102123154|FG013|Treated|Overall Study||32||
48728743|NCT01717326|102123155|FG014|Treated|Overall Study||29||
48728744|NCT01717326|102123156|FG015|Treated|Overall Study||30||
48728745|NCT01717326|102123157|FG016|Treated|Overall Study||30||
48728746|NCT01717326|102123158|FG017|Treated|Overall Study||31||
48728747|NCT01717326|102123159|FG018|Treated|Overall Study||20||
48728748|NCT01717326|102123160|FG019|Treated|Overall Study||21||
48728749|NCT01717326|102123141|FG000|COMPLETED|Overall Study||22||
48728750|NCT01717326|102123142|FG001|COMPLETED|Overall Study||26||
48728751|NCT01717326|102123143|FG002|COMPLETED|Overall Study||13||
48728752|NCT01717326|102123144|FG003|COMPLETED|Overall Study||28||
48728753|NCT01717326|102123145|FG004|COMPLETED|Overall Study||31||
48728754|NCT01717326|102123146|FG005|COMPLETED|Overall Study||31||
48728755|NCT01717326|102123147|FG006|COMPLETED|Overall Study||30||
48728756|NCT01717326|102123148|FG007|COMPLETED|Overall Study||29||
48728757|NCT01717326|102123149|FG008|COMPLETED|Overall Study||32||
48728758|NCT01717326|102123150|FG009|COMPLETED|Overall Study||29||
48728759|NCT01717326|102123151|FG010|COMPLETED|Overall Study||30||
48728760|NCT01717326|102123152|FG011|COMPLETED|Overall Study||33||
48728761|NCT01717326|102123153|FG012|COMPLETED|Overall Study||32||
48728762|NCT01717326|102123154|FG013|COMPLETED|Overall Study||32||
48728763|NCT01717326|102123155|FG014|COMPLETED|Overall Study||29||
48728764|NCT01717326|102123156|FG015|COMPLETED|Overall Study||27||
48728765|NCT01717326|102123157|FG016|COMPLETED|Overall Study||29||
48728766|NCT01717326|102123158|FG017|COMPLETED|Overall Study||31||
48728767|NCT01717326|102123159|FG018|COMPLETED|Overall Study||16||
48728768|NCT01717326|102123160|FG019|COMPLETED|Overall Study||15||
48728769|NCT01717326|102123141|FG000|NOT COMPLETED|Overall Study||3||
48728770|NCT01717326|102123142|FG001|NOT COMPLETED|Overall Study||1||
48728771|NCT01717326|102123143|FG002|NOT COMPLETED|Overall Study||0||
48728772|NCT01717326|102123144|FG003|NOT COMPLETED|Overall Study||2||
48728773|NCT01717326|102123145|FG004|NOT COMPLETED|Overall Study||2||
48728774|NCT01717326|102123146|FG005|NOT COMPLETED|Overall Study||0||
48728775|NCT01717326|102123147|FG006|NOT COMPLETED|Overall Study||1||
48728776|NCT01717326|102123148|FG007|NOT COMPLETED|Overall Study||0||
48728777|NCT01717326|102123149|FG008|NOT COMPLETED|Overall Study||0||
48728778|NCT01717326|102123150|FG009|NOT COMPLETED|Overall Study||2||
48728779|NCT01717326|102123151|FG010|NOT COMPLETED|Overall Study||2||
48728780|NCT01717326|102123152|FG011|NOT COMPLETED|Overall Study||0||
48728781|NCT01717326|102123153|FG012|NOT COMPLETED|Overall Study||1||
48728782|NCT01717326|102123154|FG013|NOT COMPLETED|Overall Study||0||
48728783|NCT01717326|102123155|FG014|NOT COMPLETED|Overall Study||0||
48728784|NCT01717326|102123156|FG015|NOT COMPLETED|Overall Study||3||
48728785|NCT01717326|102123157|FG016|NOT COMPLETED|Overall Study||1||
48728786|NCT01717326|102123158|FG017|NOT COMPLETED|Overall Study||0||
48728787|NCT01717326|102123159|FG018|NOT COMPLETED|Overall Study||4||
48728788|NCT01717326|102123160|FG019|NOT COMPLETED|Overall Study||6||
48728789|NCT00950742|102123161|FG000|STARTED|Overall Study||16||
48728790|NCT00950742|102123162|FG001|STARTED|Overall Study||2||
48728791|NCT00950742|102123161|FG000|COMPLETED|Overall Study||0||
48728792|NCT00950742|102123162|FG001|COMPLETED|Overall Study||0||
48728793|NCT00950742|102123161|FG000|NOT COMPLETED|Overall Study||16||
48728794|NCT00950742|102123162|FG001|NOT COMPLETED|Overall Study||2||
48728795|NCT02353728|102123163|FG000|STARTED|Overall Study||16||
48728796|NCT02353728|102123163|FG000|COMPLETED|Overall Study||15||
48728797|NCT02353728|102123163|FG000|NOT COMPLETED|Overall Study||1||
48728798|NCT05346653|102123164|FG000|STARTED|Overall Study||0||
48728799|NCT05346653|102123165|FG001|STARTED|Overall Study||0||
48728800|NCT05346653|102123164|FG000|COMPLETED|Overall Study||0||
48728801|NCT05346653|102123165|FG001|COMPLETED|Overall Study||0||
48728802|NCT05346653|102123164|FG000|NOT COMPLETED|Overall Study||0||
48728803|NCT05346653|102123165|FG001|NOT COMPLETED|Overall Study||0||
48728804|NCT01953913|102123166|FG000|STARTED|Overall Study||542||
48728805|NCT01953913|102123166|FG000|Treated|Overall Study||541||
48728806|NCT01953913|102123166|FG000|COMPLETED|Overall Study||0|Not discontinued from trial medication|
48728807|NCT01953913|102123166|FG000|NOT COMPLETED|Overall Study||542||
48728808|NCT05096312|102123167|FG000|STARTED|Overall Study||11||
48728809|NCT05096312|102123168|FG001|STARTED|Overall Study||12||
48728810|NCT05096312|102123167|FG000|COMPLETED|Overall Study||8||
48728811|NCT05096312|102123168|FG001|COMPLETED|Overall Study||8||
48728812|NCT05096312|102123167|FG000|NOT COMPLETED|Overall Study||3||
48728813|NCT05096312|102123168|FG001|NOT COMPLETED|Overall Study||4||
48728814|NCT02294734|102123169|FG000|STARTED|Overall Study||63||
48728815|NCT02294734|102123170|FG001|STARTED|Overall Study||63||
48728816|NCT02294734|102123169|FG000|COMPLETED|Overall Study||49||
48728817|NCT02294734|102123170|FG001|COMPLETED|Overall Study||55||
48728818|NCT02294734|102123169|FG000|NOT COMPLETED|Overall Study||14||
48728819|NCT02294734|102123170|FG001|NOT COMPLETED|Overall Study||8||
48728820|NCT02220712|102123171|FG000|STARTED|Overall Study||17||
48728821|NCT02220712|102123171|FG000|COMPLETED|Overall Study||13||
48728822|NCT02220712|102123171|FG000|NOT COMPLETED|Overall Study||4||
48728823|NCT04405076|102123172|FG000|STARTED|Part A (Blinded Phase)||200||
48728824|NCT04405076|102123173|FG001|STARTED|Part A (Blinded Phase)||200||
48728825|NCT04405076|102123174|FG002|STARTED|Part A (Blinded Phase)||200||
48312186|NCT03677596|101091039|FG000|NOT COMPLETED|Overall Study||23||
48312187|NCT03677596|101091040|FG001|NOT COMPLETED|Overall Study||19||
48312188|NCT00121836|101091041|FG000|STARTED|Overall Study||109||
48312189|NCT00121836|101091041|FG000|COMPLETED|Overall Study||54||
48312190|NCT00121836|101091041|FG000|NOT COMPLETED|Overall Study||55||
48406755|NCT03424044|101328490|FG006|COMPLETED|Dexcom Training Visit (1 Week)||1||
48614119|NCT03810456|101841678|FG000|COMPLETED|Enrolled and Randomized||69|Participants who started treatment.|
48614120|NCT03810456|101841679|FG001|COMPLETED|Enrolled and Randomized||79|Participants who started treatment.|
48614121|NCT03810456|101841680|FG002|COMPLETED|Enrolled and Randomized||67|Participants who started treatment.|
48614122|NCT03810456|101841678|FG000|NOT COMPLETED|Enrolled and Randomized||30||
48614123|NCT03810456|101841679|FG001|NOT COMPLETED|Enrolled and Randomized||20||
48614124|NCT03810456|101841680|FG002|NOT COMPLETED|Enrolled and Randomized||0||
48614125|NCT03810456|101841678|FG000|STARTED|Treatment||69|Participants who started treatment.|
48614126|NCT03810456|101841679|FG001|STARTED|Treatment||79|Participants who started treatment.|
48614127|NCT03810456|101841680|FG002|STARTED|Treatment||67|Participants who started treatment.|
48614128|NCT03810456|101841678|FG000|COMPLETED|Treatment||66|Participants who completed treatment.|
48614129|NCT03810456|101841679|FG001|COMPLETED|Treatment||55|Participants who completed treatment.|
48614130|NCT03810456|101841680|FG002|COMPLETED|Treatment||67|Participants who completed treatment.|
48614131|NCT03810456|101841678|FG000|NOT COMPLETED|Treatment||3||
48614132|NCT03810456|101841679|FG001|NOT COMPLETED|Treatment||24||
48614133|NCT03810456|101841680|FG002|NOT COMPLETED|Treatment||0||
48614134|NCT03810456|101841678|FG000|STARTED|1 Month Follow-Up||66|Participants who completed treatment.|
48614135|NCT03810456|101841679|FG001|STARTED|1 Month Follow-Up||55|Participants who completed treatment.|
48614136|NCT03810456|101841680|FG002|STARTED|1 Month Follow-Up||67|Participants who completed treatment.|
48614137|NCT03810456|101841678|FG000|COMPLETED|1 Month Follow-Up||57|Participants who completed 1-Month Follow-Up.|
48614138|NCT03810456|101841679|FG001|COMPLETED|1 Month Follow-Up||51|Participants who completed 1-Month Follow-Up.|
48614139|NCT03810456|101841680|FG002|COMPLETED|1 Month Follow-Up||51|Participants who completed 1-Month Follow-Up.|
48614140|NCT03810456|101841678|FG000|NOT COMPLETED|1 Month Follow-Up||9||
48614141|NCT03810456|101841679|FG001|NOT COMPLETED|1 Month Follow-Up||4||
48614142|NCT03810456|101841680|FG002|NOT COMPLETED|1 Month Follow-Up||16||
48614143|NCT03810456|101841678|FG000|STARTED|3 Month Follow-Up||66||
48614144|NCT03810456|101841679|FG001|STARTED|3 Month Follow-Up||55||
48614145|NCT03810456|101841680|FG002|STARTED|3 Month Follow-Up||67||
48614146|NCT03810456|101841678|FG000|COMPLETED|3 Month Follow-Up||54||
48614147|NCT03810456|101841679|FG001|COMPLETED|3 Month Follow-Up||44||
48614148|NCT03810456|101841680|FG002|COMPLETED|3 Month Follow-Up||53||
48614149|NCT03810456|101841678|FG000|NOT COMPLETED|3 Month Follow-Up||12||
48614150|NCT03810456|101841679|FG001|NOT COMPLETED|3 Month Follow-Up||11||
48614151|NCT03810456|101841680|FG002|NOT COMPLETED|3 Month Follow-Up||14||
48614152|NCT03810456|101841678|FG000|STARTED|6 Month Follow-Up||66||
48614153|NCT03810456|101841679|FG001|STARTED|6 Month Follow-Up||55||
48614154|NCT03810456|101841680|FG002|STARTED|6 Month Follow-Up||67||
48614155|NCT03810456|101841678|FG000|COMPLETED|6 Month Follow-Up||53||
48614156|NCT03810456|101841679|FG001|COMPLETED|6 Month Follow-Up||46||
48614157|NCT03810456|101841680|FG002|COMPLETED|6 Month Follow-Up||49||
48614158|NCT03810456|101841678|FG000|NOT COMPLETED|6 Month Follow-Up||13||
48614159|NCT03810456|101841679|FG001|NOT COMPLETED|6 Month Follow-Up||9||
48614160|NCT03810456|101841680|FG002|NOT COMPLETED|6 Month Follow-Up||18||
48614161|NCT04978337|101841681|FG000|STARTED|Overall Study||1||
48614162|NCT04978337|101841682|FG001|STARTED|Overall Study||4||
48614163|NCT04978337|101841681|FG000|COMPLETED|Overall Study||1||
48614164|NCT04978337|101841682|FG001|COMPLETED|Overall Study||3||
48614165|NCT04978337|101841681|FG000|NOT COMPLETED|Overall Study||0||
48614166|NCT04978337|101841682|FG001|NOT COMPLETED|Overall Study||1||
48614167|NCT02155985|101841683|FG000|STARTED|Overall Study||40||
48614168|NCT02155985|101841684|FG001|STARTED|Overall Study||41||
48614169|NCT02155985|101841685|FG002|STARTED|Overall Study||40||
48728826|NCT04405076|102123175|FG003|STARTED|Part A (Blinded Phase)||0||
48312191|NCT00574145|101091042|FG000|STARTED|Overall Study||22||
48312192|NCT00574145|101091043|FG001|STARTED|Overall Study||22||
48312193|NCT00574145|101091042|FG000|COMPLETED|Overall Study||20||
48406756|NCT03424044|101328491|FG007|COMPLETED|Dexcom Training Visit (1 Week)||1||
48406757|NCT03424044|101328492|FG008|COMPLETED|Dexcom Training Visit (1 Week)||1||
48614170|NCT02155985|101841683|FG000|COMPLETED|Overall Study||39||
48728827|NCT04405076|102123176|FG004|STARTED|Part A (Blinded Phase)||0||
48728828|NCT04405076|102123177|FG005|STARTED|Part A (Blinded Phase)||0||
48312194|NCT00574145|101091043|FG001|COMPLETED|Overall Study||21||
48312195|NCT00574145|101091042|FG000|NOT COMPLETED|Overall Study||2||
48614171|NCT02155985|101841684|FG001|COMPLETED|Overall Study||41||
48614172|NCT02155985|101841685|FG002|COMPLETED|Overall Study||39||
48614173|NCT02155985|101841683|FG000|NOT COMPLETED|Overall Study||1||
48614174|NCT02155985|101841684|FG001|NOT COMPLETED|Overall Study||0||
48614175|NCT02155985|101841685|FG002|NOT COMPLETED|Overall Study||1||
48614176|NCT02207400|101841686|FG000|STARTED|Overall Study||123||
48312196|NCT00574145|101091043|FG001|NOT COMPLETED|Overall Study||1||
48312197|NCT02224313|101091044|FG000|STARTED|Overall Study||10||
48406758|NCT03424044|101328484|FG000|NOT COMPLETED|Dexcom Training Visit (1 Week)||0||
48728829|NCT04405076|102123178|FG006|STARTED|Part A (Blinded Phase)||0||
48728830|NCT04405076|102123179|FG007|STARTED|Part A (Blinded Phase)||0||
48728831|NCT04405076|102123180|FG008|STARTED|Part A (Blinded Phase)||0||
48728832|NCT04405076|102123172|FG000|Received at Least 1 Dose of Study Drug During Part A|Part A (Blinded Phase)||200||
48728833|NCT04405076|102123173|FG001|Received at Least 1 Dose of Study Drug During Part A|Part A (Blinded Phase)||200||
48728834|NCT04405076|102123174|FG002|Received at Least 1 Dose of Study Drug During Part A|Part A (Blinded Phase)||200||
48728835|NCT04405076|102123175|FG003|Received at Least 1 Dose of Study Drug During Part A|Part A (Blinded Phase)||0||
48728836|NCT04405076|102123176|FG004|Received at Least 1 Dose of Study Drug During Part A|Part A (Blinded Phase)||0||
48728837|NCT04405076|102123177|FG005|Received at Least 1 Dose of Study Drug During Part A|Part A (Blinded Phase)||0||
48728838|NCT04405076|102123178|FG006|Received at Least 1 Dose of Study Drug During Part A|Part A (Blinded Phase)||0||
48728839|NCT04405076|102123179|FG007|Received at Least 1 Dose of Study Drug During Part A|Part A (Blinded Phase)||0||
48728840|NCT04405076|102123180|FG008|Received at Least 1 Dose of Study Drug During Part A|Part A (Blinded Phase)||0||
48728841|NCT04405076|102123172|FG000|COMPLETED|Part A (Blinded Phase)||188||
48728842|NCT04405076|102123173|FG001|COMPLETED|Part A (Blinded Phase)||185||
48728843|NCT04405076|102123174|FG002|COMPLETED|Part A (Blinded Phase)||182||
48728844|NCT04405076|102123175|FG003|COMPLETED|Part A (Blinded Phase)||0||
48728845|NCT04405076|102123176|FG004|COMPLETED|Part A (Blinded Phase)||0||
48728846|NCT04405076|102123177|FG005|COMPLETED|Part A (Blinded Phase)||0||
48728847|NCT04405076|102123178|FG006|COMPLETED|Part A (Blinded Phase)||0||
48728848|NCT04405076|102123179|FG007|COMPLETED|Part A (Blinded Phase)||0||
48728849|NCT04405076|102123180|FG008|COMPLETED|Part A (Blinded Phase)||0||
48728850|NCT04405076|102123172|FG000|NOT COMPLETED|Part A (Blinded Phase)||12||
48728851|NCT04405076|102123173|FG001|NOT COMPLETED|Part A (Blinded Phase)||15||
48728852|NCT04405076|102123174|FG002|NOT COMPLETED|Part A (Blinded Phase)||18||
48728853|NCT04405076|102123175|FG003|NOT COMPLETED|Part A (Blinded Phase)||0||
48728854|NCT04405076|102123176|FG004|NOT COMPLETED|Part A (Blinded Phase)||0||
48728855|NCT04405076|102123177|FG005|NOT COMPLETED|Part A (Blinded Phase)||0||
48728856|NCT04405076|102123178|FG006|NOT COMPLETED|Part A (Blinded Phase)||0||
48728857|NCT04405076|102123179|FG007|NOT COMPLETED|Part A (Blinded Phase)||0||
48728858|NCT04405076|102123180|FG008|NOT COMPLETED|Part A (Blinded Phase)||0||
48728859|NCT04405076|102123172|FG000|STARTED|Part B (Open-Label Interventional Phase)||0||
48728860|NCT04405076|102123173|FG001|STARTED|Part B (Open-Label Interventional Phase)||0||
48728861|NCT04405076|102123174|FG002|STARTED|Part B (Open-Label Interventional Phase)||0||
48728862|NCT04405076|102123175|FG003|STARTED|Part B (Open-Label Interventional Phase)||173||
48728863|NCT04405076|102123176|FG004|STARTED|Part B (Open-Label Interventional Phase)||171||
48728864|NCT04405076|102123177|FG005|STARTED|Part B (Open-Label Interventional Phase)||158||
48728865|NCT04405076|102123178|FG006|STARTED|Part B (Open-Label Interventional Phase)||0||
48728866|NCT04405076|102123179|FG007|STARTED|Part B (Open-Label Interventional Phase)||0||
48728867|NCT04405076|102123180|FG008|STARTED|Part B (Open-Label Interventional Phase)||0||
48728868|NCT04405076|102123172|FG000|Received at Least 1 Dose of Study Drug During Part B|Part B (Open-Label Interventional Phase)||0||
48728869|NCT04405076|102123173|FG001|Received at Least 1 Dose of Study Drug During Part B|Part B (Open-Label Interventional Phase)||0||
48728870|NCT04405076|102123174|FG002|Received at Least 1 Dose of Study Drug During Part B|Part B (Open-Label Interventional Phase)||0||
48728871|NCT04405076|102123175|FG003|Received at Least 1 Dose of Study Drug During Part B|Part B (Open-Label Interventional Phase)||173||
48728872|NCT04405076|102123176|FG004|Received at Least 1 Dose of Study Drug During Part B|Part B (Open-Label Interventional Phase)||171||
48728873|NCT04405076|102123177|FG005|Received at Least 1 Dose of Study Drug During Part B|Part B (Open-Label Interventional Phase)||158||
48728874|NCT04405076|102123178|FG006|Received at Least 1 Dose of Study Drug During Part B|Part B (Open-Label Interventional Phase)||0||
48728875|NCT04405076|102123179|FG007|Received at Least 1 Dose of Study Drug During Part B|Part B (Open-Label Interventional Phase)||0||
48728876|NCT04405076|102123180|FG008|Received at Least 1 Dose of Study Drug During Part B|Part B (Open-Label Interventional Phase)||0||
48728877|NCT04405076|102123172|FG000|COMPLETED|Part B (Open-Label Interventional Phase)||0||
48157012|NCT01061333|100706838|FG000|COMPLETED|Period 4: 20-day Washout||8||
48157013|NCT01061333|100706839|FG001|COMPLETED|Period 4: 20-day Washout||7||
48157014|NCT01061333|100706838|FG000|NOT COMPLETED|Period 4: 20-day Washout||0||
48157015|NCT01061333|100706839|FG001|NOT COMPLETED|Period 4: 20-day Washout||1||
48157016|NCT01061333|100706838|FG000|STARTED|Period 5: Nedocromil-Montelukast X-over||8||
48157017|NCT01061333|100706839|FG001|STARTED|Period 5: Nedocromil-Montelukast X-over||7||
48157018|NCT01061333|100706838|FG000|COMPLETED|Period 5: Nedocromil-Montelukast X-over||8||
48728878|NCT04405076|102123173|FG001|COMPLETED|Part B (Open-Label Interventional Phase)||0||
48728879|NCT04405076|102123174|FG002|COMPLETED|Part B (Open-Label Interventional Phase)||0||
48728880|NCT04405076|102123175|FG003|COMPLETED|Part B (Open-Label Interventional Phase)||161||
48728881|NCT04405076|102123176|FG004|COMPLETED|Part B (Open-Label Interventional Phase)||166||
48728882|NCT04405076|102123177|FG005|COMPLETED|Part B (Open-Label Interventional Phase)||152||
48728883|NCT04405076|102123178|FG006|COMPLETED|Part B (Open-Label Interventional Phase)||0||
48728884|NCT04405076|102123179|FG007|COMPLETED|Part B (Open-Label Interventional Phase)||0||
48728885|NCT04405076|102123180|FG008|COMPLETED|Part B (Open-Label Interventional Phase)||0||
48157019|NCT01061333|100706839|FG001|COMPLETED|Period 5: Nedocromil-Montelukast X-over||7||
48728886|NCT04405076|102123172|FG000|NOT COMPLETED|Part B (Open-Label Interventional Phase)||0||
48728887|NCT04405076|102123173|FG001|NOT COMPLETED|Part B (Open-Label Interventional Phase)||0||
48728888|NCT04405076|102123174|FG002|NOT COMPLETED|Part B (Open-Label Interventional Phase)||0||
48728889|NCT04405076|102123175|FG003|NOT COMPLETED|Part B (Open-Label Interventional Phase)||12||
48728890|NCT04405076|102123176|FG004|NOT COMPLETED|Part B (Open-Label Interventional Phase)||5||
48728891|NCT04405076|102123177|FG005|NOT COMPLETED|Part B (Open-Label Interventional Phase)||6||
48728892|NCT04405076|102123178|FG006|NOT COMPLETED|Part B (Open-Label Interventional Phase)||0||
48728893|NCT04405076|102123179|FG007|NOT COMPLETED|Part B (Open-Label Interventional Phase)||0||
48728894|NCT04405076|102123180|FG008|NOT COMPLETED|Part B (Open-Label Interventional Phase)||0||
48728895|NCT04405076|102123172|FG000|STARTED|Part C (Rollover Proof of Concept)||0||
48728896|NCT04405076|102123173|FG001|STARTED|Part C (Rollover Proof of Concept)||0||
48728897|NCT04405076|102123174|FG002|STARTED|Part C (Rollover Proof of Concept)||0||
48728898|NCT04405076|102123175|FG003|STARTED|Part C (Rollover Proof of Concept)||0||
48728899|NCT04405076|102123176|FG004|STARTED|Part C (Rollover Proof of Concept)||0||
48728900|NCT04405076|102123177|FG005|STARTED|Part C (Rollover Proof of Concept)||0||
48728901|NCT04405076|102123178|FG006|STARTED|Part C (Rollover Proof of Concept)||20||
48728902|NCT04405076|102123179|FG007|STARTED|Part C (Rollover Proof of Concept)||20||
48728903|NCT04405076|102123180|FG008|STARTED|Part C (Rollover Proof of Concept)||20||
48728904|NCT04405076|102123172|FG000|COMPLETED|Part C (Rollover Proof of Concept)||0||
48728905|NCT04405076|102123173|FG001|COMPLETED|Part C (Rollover Proof of Concept)||0||
48728906|NCT04405076|102123174|FG002|COMPLETED|Part C (Rollover Proof of Concept)||0||
48728907|NCT04405076|102123175|FG003|COMPLETED|Part C (Rollover Proof of Concept)||0||
48728908|NCT04405076|102123176|FG004|COMPLETED|Part C (Rollover Proof of Concept)||0||
48728909|NCT04405076|102123177|FG005|COMPLETED|Part C (Rollover Proof of Concept)||0||
48728910|NCT04405076|102123178|FG006|COMPLETED|Part C (Rollover Proof of Concept)||18||
48728911|NCT04405076|102123179|FG007|COMPLETED|Part C (Rollover Proof of Concept)||18||
48728912|NCT04405076|102123180|FG008|COMPLETED|Part C (Rollover Proof of Concept)||19||
48728913|NCT04405076|102123172|FG000|NOT COMPLETED|Part C (Rollover Proof of Concept)||0||
48728914|NCT04405076|102123173|FG001|NOT COMPLETED|Part C (Rollover Proof of Concept)||0||
48728915|NCT04405076|102123174|FG002|NOT COMPLETED|Part C (Rollover Proof of Concept)||0||
48728916|NCT04405076|102123175|FG003|NOT COMPLETED|Part C (Rollover Proof of Concept)||0||
48728917|NCT04405076|102123176|FG004|NOT COMPLETED|Part C (Rollover Proof of Concept)||0||
48728918|NCT04405076|102123177|FG005|NOT COMPLETED|Part C (Rollover Proof of Concept)||0||
48728919|NCT04405076|102123178|FG006|NOT COMPLETED|Part C (Rollover Proof of Concept)||2||
48728920|NCT04405076|102123179|FG007|NOT COMPLETED|Part C (Rollover Proof of Concept)||2||
48728921|NCT04405076|102123180|FG008|NOT COMPLETED|Part C (Rollover Proof of Concept)||1||
48728922|NCT00986362|102123181|FG000|STARTED|Overall Study||16||
48728923|NCT00986362|102123182|FG001|STARTED|Overall Study||8||
48728924|NCT00986362|102123181|FG000|COMPLETED|Overall Study||14||
48728925|NCT00986362|102123182|FG001|COMPLETED|Overall Study||7||
48728926|NCT00986362|102123181|FG000|NOT COMPLETED|Overall Study||2||
48728927|NCT00986362|102123182|FG001|NOT COMPLETED|Overall Study||1||
48728928|NCT01844778|102123183|FG000|STARTED|Overall Study||14||
48728929|NCT01844778|102123184|FG001|STARTED|Overall Study||28||
48728930|NCT01844778|102123185|FG002|STARTED|Overall Study||18||
48728931|NCT01844778|102123183|FG000|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||14||
48157020|NCT01061333|100706838|FG000|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0||
48157021|NCT01061333|100706839|FG001|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0||
48728932|NCT01844778|102123184|FG001|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||28||
48728933|NCT01844778|102123185|FG002|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||18||
48728934|NCT01844778|102123183|FG000|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||12||
48728935|NCT01844778|102123184|FG001|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||25||
48728936|NCT01844778|102123185|FG002|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||15||
48728937|NCT01844778|102123183|FG000|COMPLETED|Overall Study||12||
48728938|NCT01844778|102123184|FG001|COMPLETED|Overall Study||25||
48728939|NCT01844778|102123185|FG002|COMPLETED|Overall Study||14||
48728940|NCT01844778|102123183|FG000|NOT COMPLETED|Overall Study||2||
48728941|NCT01844778|102123184|FG001|NOT COMPLETED|Overall Study||3||
48728942|NCT01844778|102123185|FG002|NOT COMPLETED|Overall Study||4||
48728943|NCT03160885|102123186|FG000|STARTED|Initial Treatment Period||593||
48728944|NCT03160885|102123187|FG001|STARTED|Initial Treatment Period||201||
48728945|NCT03160885|102123188|FG002|STARTED|Initial Treatment Period||0||
48728946|NCT03160885|102123189|FG003|STARTED|Initial Treatment Period||0||
48728947|NCT03160885|102123190|FG004|STARTED|Initial Treatment Period||0||
48728948|NCT03160885|102123191|FG005|STARTED|Initial Treatment Period||0||
48157022|NCT01061333|100706838|FG000|STARTED|Period 6: 20-day Washout||8||
48728949|NCT03160885|102123192|FG006|STARTED|Initial Treatment Period||0||
48157023|NCT01061333|100706839|FG001|STARTED|Period 6: 20-day Washout||7||
48157024|NCT01061333|100706838|FG000|COMPLETED|Period 6: 20-day Washout||8||
48157025|NCT01061333|100706839|FG001|COMPLETED|Period 6: 20-day Washout||7||
48157026|NCT01061333|100706838|FG000|NOT COMPLETED|Period 6: 20-day Washout||0||
48157027|NCT01061333|100706839|FG001|NOT COMPLETED|Period 6: 20-day Washout||0||
48157028|NCT01061333|100706838|FG000|STARTED|Period 7: Mometasone||8||
48728950|NCT03160885|102123186|FG000|COMPLETED|Initial Treatment Period||558||
48728951|NCT03160885|102123187|FG001|COMPLETED|Initial Treatment Period||179||
48728952|NCT03160885|102123188|FG002|COMPLETED|Initial Treatment Period||0||
48728953|NCT03160885|102123189|FG003|COMPLETED|Initial Treatment Period||0||
48728954|NCT03160885|102123190|FG004|COMPLETED|Initial Treatment Period||0||
48728955|NCT03160885|102123191|FG005|COMPLETED|Initial Treatment Period||0||
48728956|NCT03160885|102123192|FG006|COMPLETED|Initial Treatment Period||0||
48728957|NCT03160885|102123186|FG000|NOT COMPLETED|Initial Treatment Period||35||
48728958|NCT03160885|102123187|FG001|NOT COMPLETED|Initial Treatment Period||22||
48728959|NCT03160885|102123188|FG002|NOT COMPLETED|Initial Treatment Period||0||
48728960|NCT03160885|102123189|FG003|NOT COMPLETED|Initial Treatment Period||0||
48728961|NCT03160885|102123190|FG004|NOT COMPLETED|Initial Treatment Period||0||
48728962|NCT03160885|102123191|FG005|NOT COMPLETED|Initial Treatment Period||0||
48728963|NCT03160885|102123192|FG006|NOT COMPLETED|Initial Treatment Period||0||
48728964|NCT03160885|102123186|FG000|STARTED|Open-label Treatment||0||
48728965|NCT03160885|102123187|FG001|STARTED|Open-label Treatment||0||
48728966|NCT03160885|102123188|FG002|STARTED|Open-label Treatment||0||
48728967|NCT03160885|102123189|FG003|STARTED|Open-label Treatment||0||
48728968|NCT03160885|102123190|FG004|STARTED|Open-label Treatment||0||
48728969|NCT03160885|102123191|FG005|STARTED|Open-label Treatment||0||
48728970|NCT03160885|102123192|FG006|STARTED|Open-label Treatment||560||
48728971|NCT03160885|102123186|FG000|COMPLETED|Open-label Treatment||0||
48728972|NCT03160885|102123187|FG001|COMPLETED|Open-label Treatment||0||
48728973|NCT03160885|102123188|FG002|COMPLETED|Open-label Treatment||0||
48728974|NCT03160885|102123189|FG003|COMPLETED|Open-label Treatment||0||
48728975|NCT03160885|102123190|FG004|COMPLETED|Open-label Treatment||0||
48728976|NCT03160885|102123191|FG005|COMPLETED|Open-label Treatment||0||
48728977|NCT03160885|102123192|FG006|COMPLETED|Open-label Treatment||423||
48728978|NCT03160885|102123186|FG000|NOT COMPLETED|Open-label Treatment||0||
48728979|NCT03160885|102123187|FG001|NOT COMPLETED|Open-label Treatment||0||
48728980|NCT03160885|102123188|FG002|NOT COMPLETED|Open-label Treatment||0||
48728981|NCT03160885|102123189|FG003|NOT COMPLETED|Open-label Treatment||0||
48728982|NCT03160885|102123190|FG004|NOT COMPLETED|Open-label Treatment||0||
48728983|NCT03160885|102123191|FG005|NOT COMPLETED|Open-label Treatment||0||
48728984|NCT03160885|102123192|FG006|NOT COMPLETED|Open-label Treatment||137||
48728985|NCT03160885|102123186|FG000|STARTED|Maintenance Treatment Period||0||
48728986|NCT03160885|102123187|FG001|STARTED|Maintenance Treatment Period||0||
48728987|NCT03160885|102123188|FG002|STARTED|Maintenance Treatment Period||91||
48728988|NCT03160885|102123189|FG003|STARTED|Maintenance Treatment Period||90||
48312198|NCT02224313|101091045|FG001|STARTED|Overall Study||10||
48312199|NCT02224313|101091044|FG000|COMPLETED|Overall Study||7||
48312200|NCT02224313|101091045|FG001|COMPLETED|Overall Study||9||
48312201|NCT02224313|101091044|FG000|NOT COMPLETED|Overall Study||3||
48312202|NCT02224313|101091045|FG001|NOT COMPLETED|Overall Study||1||
48312203|NCT03672370|101091046|FG000|STARTED|Overall Study||89||
48312204|NCT03672370|101091046|FG000|COMPLETED|Overall Study||42||
48312205|NCT03672370|101091046|FG000|NOT COMPLETED|Overall Study||47||
48312206|NCT03975920|101091047|FG000|STARTED|Overall Study||84||
48312207|NCT03975920|101091048|FG001|STARTED|Overall Study||87||
48312208|NCT03975920|101091047|FG000|1-Month Follow-up Survey|Overall Study||80||
48312209|NCT03975920|101091048|FG001|1-Month Follow-up Survey|Overall Study||85||
48312210|NCT03975920|101091047|FG000|3-Month Follow-up Survey|Overall Study||78||
48312211|NCT03975920|101091048|FG001|3-Month Follow-up Survey|Overall Study||84||
48312212|NCT03975920|101091047|FG000|6-Month Follow-up Survey|Overall Study||80||
48312213|NCT03975920|101091048|FG001|6-Month Follow-up Survey|Overall Study||83||
48312214|NCT03975920|101091047|FG000|COMPLETED|Overall Study||80||
48312215|NCT03975920|101091048|FG001|COMPLETED|Overall Study||83||
48312216|NCT03975920|101091047|FG000|NOT COMPLETED|Overall Study||4||
48312217|NCT03975920|101091048|FG001|NOT COMPLETED|Overall Study||4||
48312218|NCT02663271|101091049|FG000|STARTED|Overall Study||9||
48312219|NCT02663271|101091049|FG000|COMPLETED|Overall Study||3||
48312220|NCT02663271|101091049|FG000|NOT COMPLETED|Overall Study||6||
48728989|NCT03160885|102123190|FG004|STARTED|Maintenance Treatment Period||46||
48728990|NCT03160885|102123191|FG005|STARTED|Maintenance Treatment Period||31||
48728991|NCT03160885|102123192|FG006|STARTED|Maintenance Treatment Period||0||
48728992|NCT03160885|102123186|FG000|COMPLETED|Maintenance Treatment Period||0||
48728993|NCT03160885|102123187|FG001|COMPLETED|Maintenance Treatment Period||0||
48728994|NCT03160885|102123188|FG002|COMPLETED|Maintenance Treatment Period||52||
48728995|NCT03160885|102123189|FG003|COMPLETED|Maintenance Treatment Period||50||
48728996|NCT03160885|102123190|FG004|COMPLETED|Maintenance Treatment Period||15||
48728997|NCT03160885|102123191|FG005|COMPLETED|Maintenance Treatment Period||16||
48728998|NCT03160885|102123192|FG006|COMPLETED|Maintenance Treatment Period||0||
48728999|NCT03160885|102123186|FG000|NOT COMPLETED|Maintenance Treatment Period||0||
48729000|NCT03160885|102123187|FG001|NOT COMPLETED|Maintenance Treatment Period||0||
48767612|NCT00914316|102222776|FG000|NOT COMPLETED|Phase 2||1||
48312221|NCT04126083|101091050|FG000|STARTED|Overall Study||6||
48312222|NCT04126083|101091050|FG000|COMPLETED|Overall Study||5||
48312223|NCT04126083|101091050|FG000|NOT COMPLETED|Overall Study||1||
48312224|NCT00698932|101091051|FG000|STARTED|Overall Study||284||
48406759|NCT03424044|101328485|FG001|NOT COMPLETED|Dexcom Training Visit (1 Week)||0||
48406760|NCT03424044|101328486|FG002|NOT COMPLETED|Dexcom Training Visit (1 Week)||0||
48406761|NCT03424044|101328487|FG003|NOT COMPLETED|Dexcom Training Visit (1 Week)||0||
48406762|NCT03424044|101328488|FG004|NOT COMPLETED|Dexcom Training Visit (1 Week)||0||
48406763|NCT03424044|101328489|FG005|NOT COMPLETED|Dexcom Training Visit (1 Week)||0||
48406764|NCT03424044|101328490|FG006|NOT COMPLETED|Dexcom Training Visit (1 Week)||0||
48406765|NCT03424044|101328491|FG007|NOT COMPLETED|Dexcom Training Visit (1 Week)||0||
48406766|NCT03424044|101328492|FG008|NOT COMPLETED|Dexcom Training Visit (1 Week)||0||
48406767|NCT03424044|101328484|FG000|STARTED|First Rest Period (1-12 Weeks)||4||
48729001|NCT03160885|102123188|FG002|NOT COMPLETED|Maintenance Treatment Period||39||
48729002|NCT03160885|102123189|FG003|NOT COMPLETED|Maintenance Treatment Period||40||
48729003|NCT03160885|102123190|FG004|NOT COMPLETED|Maintenance Treatment Period||31||
48729004|NCT03160885|102123191|FG005|NOT COMPLETED|Maintenance Treatment Period||15||
48729005|NCT03160885|102123192|FG006|NOT COMPLETED|Maintenance Treatment Period||0||
48729006|NCT03508609|102123193|FG000|STARTED|Overall Study||20||
48729007|NCT03508609|102123193|FG000|COMPLETED|Overall Study||19||
48729008|NCT03508609|102123193|FG000|NOT COMPLETED|Overall Study||1||
48729009|NCT02777827|102123194|FG000|STARTED|Treatment Period 1||5||
48729010|NCT02777827|102123195|FG001|STARTED|Treatment Period 1||5||
48729011|NCT02777827|102123196|FG002|STARTED|Treatment Period 1||5||
48729012|NCT02777827|102123197|FG003|STARTED|Treatment Period 1||5||
48312225|NCT00698932|101091052|FG001|STARTED|Overall Study||284||
48312226|NCT00698932|101091051|FG000|COMPLETED|Overall Study||262||
48312227|NCT00698932|101091052|FG001|COMPLETED|Overall Study||248||
48729013|NCT02777827|102123198|FG004|STARTED|Treatment Period 1||4||
48729014|NCT02777827|102123199|FG005|STARTED|Treatment Period 1||6||
48729015|NCT02777827|102123194|FG000|COMPLETED|Treatment Period 1||5||
48729016|NCT02777827|102123195|FG001|COMPLETED|Treatment Period 1||5||
48729017|NCT02777827|102123196|FG002|COMPLETED|Treatment Period 1||5||
48729018|NCT02777827|102123197|FG003|COMPLETED|Treatment Period 1||5||
48729019|NCT02777827|102123198|FG004|COMPLETED|Treatment Period 1||4||
48729020|NCT02777827|102123199|FG005|COMPLETED|Treatment Period 1||6||
48729021|NCT02777827|102123194|FG000|NOT COMPLETED|Treatment Period 1||0||
48729022|NCT02777827|102123195|FG001|NOT COMPLETED|Treatment Period 1||0||
48729023|NCT02777827|102123196|FG002|NOT COMPLETED|Treatment Period 1||0||
48729024|NCT02777827|102123197|FG003|NOT COMPLETED|Treatment Period 1||0||
48729025|NCT02777827|102123198|FG004|NOT COMPLETED|Treatment Period 1||0||
48729026|NCT02777827|102123199|FG005|NOT COMPLETED|Treatment Period 1||0||
48729027|NCT02777827|102123194|FG000|STARTED|Washout Between Periods 1 and 2||5||
48729028|NCT02777827|102123195|FG001|STARTED|Washout Between Periods 1 and 2||5||
48312228|NCT00698932|101091051|FG000|NOT COMPLETED|Overall Study||22||
48312229|NCT00698932|101091052|FG001|NOT COMPLETED|Overall Study||36||
48312230|NCT00884325|101091053|FG000|STARTED|Overall Study||20||
48312231|NCT00884325|101091054|FG001|STARTED|Overall Study||20||
48312232|NCT00884325|101091053|FG000|COMPLETED|Overall Study||17||
48312233|NCT00884325|101091054|FG001|COMPLETED|Overall Study||16||
48312234|NCT00884325|101091053|FG000|NOT COMPLETED|Overall Study||3||
48312235|NCT00884325|101091054|FG001|NOT COMPLETED|Overall Study||4||
48312236|NCT02267603|101091055|FG000|STARTED|Overall Study||50||
48312237|NCT02267603|101091055|FG000|COMPLETED|Overall Study||6||
48312238|NCT02267603|101091055|FG000|NOT COMPLETED|Overall Study||44||
48312239|NCT03437564|101091056|FG000|STARTED|Overall Study||14||
48312240|NCT03437564|101091057|FG001|STARTED|Overall Study||14||
48312241|NCT03437564|101091056|FG000|COMPLETED|Overall Study||14||
48406768|NCT03424044|101328485|FG001|STARTED|First Rest Period (1-12 Weeks)||3||
48406769|NCT03424044|101328486|FG002|STARTED|First Rest Period (1-12 Weeks)||3||
48406770|NCT03424044|101328487|FG003|STARTED|First Rest Period (1-12 Weeks)||3||
48406771|NCT03424044|101328488|FG004|STARTED|First Rest Period (1-12 Weeks)||3||
48406772|NCT03424044|101328489|FG005|STARTED|First Rest Period (1-12 Weeks)||4||
48406773|NCT03424044|101328490|FG006|STARTED|First Rest Period (1-12 Weeks)||1||
48406774|NCT03424044|101328491|FG007|STARTED|First Rest Period (1-12 Weeks)||1||
48406775|NCT03424044|101328492|FG008|STARTED|First Rest Period (1-12 Weeks)||1||
48406776|NCT03424044|101328484|FG000|COMPLETED|First Rest Period (1-12 Weeks)||4||
48406777|NCT03424044|101328485|FG001|COMPLETED|First Rest Period (1-12 Weeks)||3||
48406778|NCT03424044|101328486|FG002|COMPLETED|First Rest Period (1-12 Weeks)||2||
48406779|NCT03424044|101328487|FG003|COMPLETED|First Rest Period (1-12 Weeks)||3||
48406780|NCT03424044|101328488|FG004|COMPLETED|First Rest Period (1-12 Weeks)||3||
48406781|NCT03424044|101328489|FG005|COMPLETED|First Rest Period (1-12 Weeks)||4||
48406782|NCT03424044|101328490|FG006|COMPLETED|First Rest Period (1-12 Weeks)||1||
48729029|NCT02777827|102123196|FG002|STARTED|Washout Between Periods 1 and 2||5||
48729030|NCT02777827|102123197|FG003|STARTED|Washout Between Periods 1 and 2||5||
48729031|NCT02777827|102123198|FG004|STARTED|Washout Between Periods 1 and 2||4||
48729032|NCT02777827|102123199|FG005|STARTED|Washout Between Periods 1 and 2||6||
48729033|NCT02777827|102123194|FG000|COMPLETED|Washout Between Periods 1 and 2||5||
48312242|NCT03437564|101091057|FG001|COMPLETED|Overall Study||14||
48312243|NCT03437564|101091056|FG000|NOT COMPLETED|Overall Study||0||
48312244|NCT03437564|101091057|FG001|NOT COMPLETED|Overall Study||0||
48312245|NCT04013789|101091058|FG000|STARTED|First Wear Period (1 Week)||33||
48312246|NCT04013789|101091059|FG001|STARTED|First Wear Period (1 Week)||34||
48312247|NCT04013789|101091058|FG000|COMPLETED|First Wear Period (1 Week)||33||
48312248|NCT04013789|101091059|FG001|COMPLETED|First Wear Period (1 Week)||34||
48312249|NCT04013789|101091058|FG000|NOT COMPLETED|First Wear Period (1 Week)||0||
48312250|NCT04013789|101091059|FG001|NOT COMPLETED|First Wear Period (1 Week)||0||
48312251|NCT04013789|101091058|FG000|STARTED|Second Wear Period (1 Week)||32||
48312252|NCT04013789|101091059|FG001|STARTED|Second Wear Period (1 Week)||34||
48312253|NCT04013789|101091058|FG000|COMPLETED|Second Wear Period (1 Week)||32||
48312254|NCT04013789|101091059|FG001|COMPLETED|Second Wear Period (1 Week)||34||
48406783|NCT03424044|101328491|FG007|COMPLETED|First Rest Period (1-12 Weeks)||1||
48406784|NCT03424044|101328492|FG008|COMPLETED|First Rest Period (1-12 Weeks)||1||
48729034|NCT02777827|102123195|FG001|COMPLETED|Washout Between Periods 1 and 2||5||
48312255|NCT04013789|101091058|FG000|NOT COMPLETED|Second Wear Period (1 Week)||0||
48312256|NCT04013789|101091059|FG001|NOT COMPLETED|Second Wear Period (1 Week)||0||
48312257|NCT00814671|101091060|FG000|STARTED|Overall Study||54||
48312258|NCT00814671|101091061|FG001|STARTED|Overall Study||48||
48729035|NCT02777827|102123196|FG002|COMPLETED|Washout Between Periods 1 and 2||5||
48729036|NCT02777827|102123197|FG003|COMPLETED|Washout Between Periods 1 and 2||5||
48729037|NCT02777827|102123198|FG004|COMPLETED|Washout Between Periods 1 and 2||4||
48729038|NCT02777827|102123199|FG005|COMPLETED|Washout Between Periods 1 and 2||6||
48729039|NCT02777827|102123194|FG000|NOT COMPLETED|Washout Between Periods 1 and 2||0||
48729040|NCT02777827|102123195|FG001|NOT COMPLETED|Washout Between Periods 1 and 2||0||
48729041|NCT02777827|102123196|FG002|NOT COMPLETED|Washout Between Periods 1 and 2||0||
48729042|NCT02777827|102123197|FG003|NOT COMPLETED|Washout Between Periods 1 and 2||0||
48729043|NCT02777827|102123198|FG004|NOT COMPLETED|Washout Between Periods 1 and 2||0||
48729044|NCT02777827|102123199|FG005|NOT COMPLETED|Washout Between Periods 1 and 2||0||
48729045|NCT02777827|102123194|FG000|STARTED|Treatment Period 2||5||
48729046|NCT02777827|102123195|FG001|STARTED|Treatment Period 2||5||
48729047|NCT02777827|102123196|FG002|STARTED|Treatment Period 2||5||
48729048|NCT02777827|102123197|FG003|STARTED|Treatment Period 2||5||
48729049|NCT02777827|102123198|FG004|STARTED|Treatment Period 2||4||
48729050|NCT02777827|102123199|FG005|STARTED|Treatment Period 2||6||
48729051|NCT02777827|102123194|FG000|COMPLETED|Treatment Period 2||5||
48729052|NCT02777827|102123195|FG001|COMPLETED|Treatment Period 2||5||
48729053|NCT02777827|102123196|FG002|COMPLETED|Treatment Period 2||5||
48729054|NCT02777827|102123197|FG003|COMPLETED|Treatment Period 2||5||
48729055|NCT02777827|102123198|FG004|COMPLETED|Treatment Period 2||4||
48729056|NCT02777827|102123199|FG005|COMPLETED|Treatment Period 2||6||
48729057|NCT02777827|102123194|FG000|NOT COMPLETED|Treatment Period 2||0||
48729058|NCT02777827|102123195|FG001|NOT COMPLETED|Treatment Period 2||0||
48729059|NCT02777827|102123196|FG002|NOT COMPLETED|Treatment Period 2||0||
48729060|NCT02777827|102123197|FG003|NOT COMPLETED|Treatment Period 2||0||
48729061|NCT02777827|102123198|FG004|NOT COMPLETED|Treatment Period 2||0||
48729062|NCT02777827|102123199|FG005|NOT COMPLETED|Treatment Period 2||0||
48729063|NCT02777827|102123194|FG000|STARTED|Washout Between Periods 2 and 3||5||
48729064|NCT02777827|102123195|FG001|STARTED|Washout Between Periods 2 and 3||5||
48729065|NCT02777827|102123196|FG002|STARTED|Washout Between Periods 2 and 3||5||
48729066|NCT02777827|102123197|FG003|STARTED|Washout Between Periods 2 and 3||5||
48729067|NCT02777827|102123198|FG004|STARTED|Washout Between Periods 2 and 3||4||
48312259|NCT00814671|101091062|FG002|STARTED|Overall Study||51||
48312260|NCT00814671|101091060|FG000|COMPLETED|Overall Study||47||
48312261|NCT00814671|101091061|FG001|COMPLETED|Overall Study||44||
48312262|NCT00814671|101091062|FG002|COMPLETED|Overall Study||49||
48406785|NCT03424044|101328484|FG000|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
48406786|NCT03424044|101328485|FG001|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
48729068|NCT02777827|102123199|FG005|STARTED|Washout Between Periods 2 and 3||6||
48729069|NCT02777827|102123194|FG000|COMPLETED|Washout Between Periods 2 and 3||5||
48729070|NCT02777827|102123195|FG001|COMPLETED|Washout Between Periods 2 and 3||5||
48729071|NCT02777827|102123196|FG002|COMPLETED|Washout Between Periods 2 and 3||5||
48729072|NCT02777827|102123197|FG003|COMPLETED|Washout Between Periods 2 and 3||5||
48729073|NCT02777827|102123198|FG004|COMPLETED|Washout Between Periods 2 and 3||4||
48729074|NCT02777827|102123199|FG005|COMPLETED|Washout Between Periods 2 and 3||6||
48729075|NCT02777827|102123194|FG000|NOT COMPLETED|Washout Between Periods 2 and 3||0||
48729076|NCT02777827|102123195|FG001|NOT COMPLETED|Washout Between Periods 2 and 3||0||
48729077|NCT02777827|102123196|FG002|NOT COMPLETED|Washout Between Periods 2 and 3||0||
48729078|NCT02777827|102123197|FG003|NOT COMPLETED|Washout Between Periods 2 and 3||0||
48729079|NCT02777827|102123198|FG004|NOT COMPLETED|Washout Between Periods 2 and 3||0||
48157029|NCT01061333|100706839|FG001|STARTED|Period 7: Mometasone||7||
48729080|NCT02777827|102123199|FG005|NOT COMPLETED|Washout Between Periods 2 and 3||0||
48729081|NCT02777827|102123194|FG000|STARTED|Treatment Period 3||5||
48729082|NCT02777827|102123195|FG001|STARTED|Treatment Period 3||5||
48729083|NCT02777827|102123196|FG002|STARTED|Treatment Period 3||5||
48729084|NCT02777827|102123197|FG003|STARTED|Treatment Period 3||5||
48729085|NCT02777827|102123198|FG004|STARTED|Treatment Period 3||4||
48157030|NCT01061333|100706838|FG000|COMPLETED|Period 7: Mometasone||8||
48157031|NCT01061333|100706839|FG001|COMPLETED|Period 7: Mometasone||7||
48157032|NCT01061333|100706838|FG000|NOT COMPLETED|Period 7: Mometasone||0||
48157033|NCT01061333|100706839|FG001|NOT COMPLETED|Period 7: Mometasone||0||
48157034|NCT02659787|100706840|FG000|STARTED|First Intervention (1 Day)||19||
48157035|NCT02659787|100706841|FG001|STARTED|First Intervention (1 Day)||19||
48157036|NCT02659787|100706840|FG000|COMPLETED|First Intervention (1 Day)||19||
48157037|NCT02659787|100706841|FG001|COMPLETED|First Intervention (1 Day)||19||
48157038|NCT02659787|100706840|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48157039|NCT02659787|100706841|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48157040|NCT02659787|100706840|FG000|STARTED|Washout (3 Days)||19||
48157041|NCT02659787|100706841|FG001|STARTED|Washout (3 Days)||19||
48157042|NCT02659787|100706840|FG000|COMPLETED|Washout (3 Days)||19||
48157043|NCT02659787|100706841|FG001|COMPLETED|Washout (3 Days)||19||
48157044|NCT02659787|100706840|FG000|NOT COMPLETED|Washout (3 Days)||0||
48157045|NCT02659787|100706841|FG001|NOT COMPLETED|Washout (3 Days)||0||
48157046|NCT02659787|100706840|FG000|STARTED|Second Intervention (1 Day)||19||
48157047|NCT02659787|100706841|FG001|STARTED|Second Intervention (1 Day)||19||
48157048|NCT02659787|100706840|FG000|COMPLETED|Second Intervention (1 Day)||19||
48157049|NCT02659787|100706841|FG001|COMPLETED|Second Intervention (1 Day)||19||
48157050|NCT02659787|100706840|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48157051|NCT02659787|100706841|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48157052|NCT04635579|100706842|FG000|STARTED|Overall Study||20||
48157053|NCT04635579|100706843|FG001|STARTED|Overall Study||20||
48157054|NCT04635579|100706842|FG000|COMPLETED|Overall Study||20||
48157055|NCT04635579|100706843|FG001|COMPLETED|Overall Study||20||
48157056|NCT04635579|100706842|FG000|NOT COMPLETED|Overall Study||0||
48157057|NCT04635579|100706843|FG001|NOT COMPLETED|Overall Study||0||
48157058|NCT00791843|100706844|FG000|STARTED|Overall Study||0||
48157059|NCT00791843|100706844|FG000|COMPLETED|Overall Study||0||
48157060|NCT00791843|100706844|FG000|NOT COMPLETED|Overall Study||0||
48157061|NCT04647032|100706845|FG000|STARTED|Overall Study||15||
48157062|NCT04647032|100706846|FG001|STARTED|Overall Study||15||
48157063|NCT04647032|100706845|FG000|COMPLETED|Overall Study||14||
48157064|NCT04647032|100706846|FG001|COMPLETED|Overall Study||13||
48157065|NCT04647032|100706845|FG000|NOT COMPLETED|Overall Study||1||
48157066|NCT04647032|100706846|FG001|NOT COMPLETED|Overall Study||2||
48157067|NCT03720938|100706847|FG000|STARTED|Overall Study||242||
48157068|NCT03720938|100706848|FG001|STARTED|Overall Study||676||
48157069|NCT03720938|100706847|FG000|COMPLETED|Overall Study||53||
48157070|NCT03720938|100706848|FG001|COMPLETED|Overall Study||53||
48157071|NCT03720938|100706847|FG000|NOT COMPLETED|Overall Study||189||
48157072|NCT03720938|100706848|FG001|NOT COMPLETED|Overall Study||623||
48157073|NCT02681614|100706849|FG000|STARTED|Overall Study||5||
48157074|NCT02681614|100706849|FG000|COMPLETED|Overall Study||5||
48157075|NCT02681614|100706849|FG000|NOT COMPLETED|Overall Study||0||
48157076|NCT01122381|100706850|FG000|STARTED|Overall Study||1||
48157077|NCT01122381|100706851|FG001|STARTED|Overall Study||1||
48157078|NCT01122381|100706850|FG000|COMPLETED|Overall Study||1||
48157079|NCT01122381|100706851|FG001|COMPLETED|Overall Study||0||
48157080|NCT01122381|100706850|FG000|NOT COMPLETED|Overall Study||0||
48157081|NCT01122381|100706851|FG001|NOT COMPLETED|Overall Study||1||
48157082|NCT01622010|100706852|FG000|STARTED|Overall Study||18||
48157083|NCT01622010|100706853|FG001|STARTED|Overall Study||12||
48157084|NCT01622010|100706852|FG000|COMPLETED|Overall Study||12||
48157085|NCT01622010|100706853|FG001|COMPLETED|Overall Study||8||
48157086|NCT01622010|100706852|FG000|NOT COMPLETED|Overall Study||6||
48157087|NCT01622010|100706853|FG001|NOT COMPLETED|Overall Study||4||
48157088|NCT01083654|100706854|FG000|STARTED|Overall Study||53||
48157089|NCT01083654|100706855|FG001|STARTED|Overall Study||50||
48157090|NCT01083654|100706854|FG000|COMPLETED|Overall Study||53||
48157091|NCT01083654|100706855|FG001|COMPLETED|Overall Study||50||
48729086|NCT02777827|102123199|FG005|STARTED|Treatment Period 3||6||
48157092|NCT01083654|100706854|FG000|NOT COMPLETED|Overall Study||0||
48729087|NCT02777827|102123194|FG000|COMPLETED|Treatment Period 3||5||
48729088|NCT02777827|102123195|FG001|COMPLETED|Treatment Period 3||5||
48157093|NCT01083654|100706855|FG001|NOT COMPLETED|Overall Study||0||
48157094|NCT01949870|100706856|FG000|STARTED|Overall Study||6||
48157095|NCT01949870|100706856|FG000|Received Treatment|Overall Study||4||
48157096|NCT01949870|100706856|FG000|COMPLETED|Overall Study||0||
48157097|NCT01949870|100706856|FG000|NOT COMPLETED|Overall Study||6||
48157098|NCT03995784|100706857|FG000|STARTED|Overall Study||6||
48157099|NCT03995784|100706857|FG000|COMPLETED|Overall Study||5||
48729089|NCT02777827|102123196|FG002|COMPLETED|Treatment Period 3||5||
48729090|NCT02777827|102123197|FG003|COMPLETED|Treatment Period 3||5||
48729091|NCT02777827|102123198|FG004|COMPLETED|Treatment Period 3||4||
48312263|NCT00814671|101091060|FG000|NOT COMPLETED|Overall Study||7||
48312264|NCT00814671|101091061|FG001|NOT COMPLETED|Overall Study||4||
48312265|NCT00814671|101091062|FG002|NOT COMPLETED|Overall Study||2||
48312266|NCT04296877|101091063|FG000|STARTED|Overall Study||30||
48312267|NCT04296877|101091063|FG000|COMPLETED|Overall Study||30||
48312268|NCT04296877|101091063|FG000|NOT COMPLETED|Overall Study||0||
48312269|NCT04223843|101091064|FG000|STARTED|Overall Study||55||
48312270|NCT04223843|101091065|FG001|STARTED|Overall Study||55||
48312271|NCT04223843|101091066|FG002|STARTED|Overall Study||51||
48312272|NCT04223843|101091067|FG003|STARTED|Overall Study||52||
48312273|NCT04223843|101091064|FG000|COMPLETED|Overall Study||55||
48312274|NCT04223843|101091065|FG001|COMPLETED|Overall Study||55||
48312275|NCT04223843|101091066|FG002|COMPLETED|Overall Study||51||
48312276|NCT04223843|101091067|FG003|COMPLETED|Overall Study||52||
48312277|NCT04223843|101091064|FG000|NOT COMPLETED|Overall Study||0||
48312278|NCT04223843|101091065|FG001|NOT COMPLETED|Overall Study||0||
48312279|NCT04223843|101091066|FG002|NOT COMPLETED|Overall Study||0||
48312280|NCT04223843|101091067|FG003|NOT COMPLETED|Overall Study||0||
48312281|NCT05092919|101091068|FG000|STARTED|Overall Study||95||
48312282|NCT05092919|101091068|FG000|COMPLETED|Overall Study||86||
48312283|NCT05092919|101091068|FG000|NOT COMPLETED|Overall Study||9||
48312284|NCT00474708|101091069|FG000|STARTED|Overall Study||791||
48312285|NCT00474708|101091070|FG001|STARTED|Overall Study||367||
48312286|NCT00474708|101091069|FG000|COMPLETED|Overall Study||734||
48312287|NCT00474708|101091070|FG001|COMPLETED|Overall Study||342||
48312288|NCT00474708|101091069|FG000|NOT COMPLETED|Overall Study||57||
48312289|NCT00474708|101091070|FG001|NOT COMPLETED|Overall Study||25||
48312290|NCT00309465|101091071|FG000|STARTED|Overall Study||58||
48312291|NCT00309465|101091072|FG001|STARTED|Overall Study||58||
48312292|NCT00309465|101091073|FG002|STARTED|Overall Study||58||
48312293|NCT00309465|101091074|FG003|STARTED|Overall Study||76||
48312294|NCT00309465|101091075|FG004|STARTED|Overall Study||76||
48312295|NCT00309465|101091076|FG005|STARTED|Overall Study||76||
48312296|NCT00309465|101091071|FG000|COMPLETED|Overall Study||58||
48312297|NCT00309465|101091072|FG001|COMPLETED|Overall Study||58||
48312298|NCT00309465|101091073|FG002|COMPLETED|Overall Study||58||
48312299|NCT00309465|101091074|FG003|COMPLETED|Overall Study||75||
48312300|NCT00309465|101091075|FG004|COMPLETED|Overall Study||76||
48312301|NCT00309465|101091076|FG005|COMPLETED|Overall Study||76||
48312302|NCT00309465|101091071|FG000|NOT COMPLETED|Overall Study||0||
48312303|NCT00309465|101091072|FG001|NOT COMPLETED|Overall Study||0||
48312304|NCT00309465|101091073|FG002|NOT COMPLETED|Overall Study||0||
48312305|NCT00309465|101091074|FG003|NOT COMPLETED|Overall Study||1||
48312306|NCT00309465|101091075|FG004|NOT COMPLETED|Overall Study||0||
48312307|NCT00309465|101091076|FG005|NOT COMPLETED|Overall Study||0||
48312308|NCT03221738|101091077|FG000|STARTED|Overall Study||10||
48312309|NCT03221738|101091077|FG000|COMPLETED|Overall Study||10||
48312310|NCT03221738|101091077|FG000|NOT COMPLETED|Overall Study||0||
48312311|NCT02132884|101091078|FG000|STARTED|Overall Study||0||
48312312|NCT02132884|101091079|FG001|STARTED|Overall Study||0||
48312313|NCT02132884|101091078|FG000|COMPLETED|Overall Study||0||
48312314|NCT02132884|101091079|FG001|COMPLETED|Overall Study||0||
48312315|NCT02132884|101091078|FG000|NOT COMPLETED|Overall Study||0||
48312316|NCT02132884|101091079|FG001|NOT COMPLETED|Overall Study||0||
48312317|NCT02844920|101091080|FG000|STARTED|Overall Study||37||
48312318|NCT02844920|101091080|FG000|Completed Without Evaluable Videos|Overall Study||1||
48312319|NCT02844920|101091080|FG000|Completed With Evaluable Videos|Overall Study||34||
48312320|NCT02844920|101091080|FG000|Completed, Eval. Data, Opposing Fibroids|Overall Study||6||
48312321|NCT02844920|101091080|FG000|COMPLETED|Overall Study||35||
48312322|NCT02844920|101091080|FG000|NOT COMPLETED|Overall Study||2||
48312323|NCT00713479|101091081|FG000|STARTED|First Medication Condition||6||
48312324|NCT00713479|101091082|FG001|STARTED|First Medication Condition||6||
48312325|NCT00713479|101091081|FG000|COMPLETED|First Medication Condition||2||
48312326|NCT00713479|101091082|FG001|COMPLETED|First Medication Condition||6||
48312327|NCT00713479|101091081|FG000|NOT COMPLETED|First Medication Condition||4||
48614177|NCT02207400|101841687|FG001|STARTED|Overall Study||123||
48614178|NCT02207400|101841686|FG000|COMPLETED|Overall Study||107||
48614179|NCT02207400|101841687|FG001|COMPLETED|Overall Study||109||
48614180|NCT02207400|101841686|FG000|NOT COMPLETED|Overall Study||16||
48614181|NCT02207400|101841687|FG001|NOT COMPLETED|Overall Study||14||
48312328|NCT00713479|101091082|FG001|NOT COMPLETED|First Medication Condition||0||
48312329|NCT00713479|101091081|FG000|STARTED|Washout||2||
48312330|NCT00713479|101091082|FG001|STARTED|Washout||6||
48312331|NCT00713479|101091081|FG000|COMPLETED|Washout||2||
48312332|NCT00713479|101091082|FG001|COMPLETED|Washout||6||
48312333|NCT00713479|101091081|FG000|NOT COMPLETED|Washout||0||
48312334|NCT00713479|101091082|FG001|NOT COMPLETED|Washout||0||
48312335|NCT00713479|101091081|FG000|STARTED|Next Medication Condition||2||
48312336|NCT00713479|101091082|FG001|STARTED|Next Medication Condition||6||
48312337|NCT00713479|101091081|FG000|COMPLETED|Next Medication Condition||2||
48312338|NCT00713479|101091082|FG001|COMPLETED|Next Medication Condition||6||
48312339|NCT00713479|101091081|FG000|NOT COMPLETED|Next Medication Condition||0||
48312340|NCT00713479|101091082|FG001|NOT COMPLETED|Next Medication Condition||0||
48614182|NCT03738163|101841688|FG000|STARTED|Overall Study||121||
48312341|NCT04641299|101091083|FG000|STARTED|Overall Study||30||
48312342|NCT04641299|101091084|FG001|STARTED|Overall Study||30||
48312343|NCT04641299|101091085|FG002|STARTED|Overall Study||29||
48312344|NCT04641299|101091086|FG003|STARTED|Overall Study||30||
48312345|NCT04641299|101091083|FG000|COMPLETED|Overall Study||28||
48312346|NCT04641299|101091084|FG001|COMPLETED|Overall Study||29||
48312347|NCT04641299|101091085|FG002|COMPLETED|Overall Study||27||
48312348|NCT04641299|101091086|FG003|COMPLETED|Overall Study||30||
48312349|NCT04641299|101091083|FG000|NOT COMPLETED|Overall Study||2||
48312350|NCT04641299|101091084|FG001|NOT COMPLETED|Overall Study||1||
48312351|NCT04641299|101091085|FG002|NOT COMPLETED|Overall Study||2||
48312352|NCT04641299|101091086|FG003|NOT COMPLETED|Overall Study||0||
48312353|NCT01003210|101091087|FG000|STARTED|Overall Study||105||
48312354|NCT01003210|101091088|FG001|STARTED|Overall Study||105||
48312355|NCT01003210|101091087|FG000|COMPLETED|Overall Study||104||
48312356|NCT01003210|101091088|FG001|COMPLETED|Overall Study||102||
48312357|NCT01003210|101091087|FG000|NOT COMPLETED|Overall Study||1||
48312358|NCT01003210|101091088|FG001|NOT COMPLETED|Overall Study||3||
48312359|NCT04857996|101091089|FG000|STARTED|Overall Study||33||33
48312360|NCT04857996|101091090|FG001|STARTED|Overall Study||32||32
48312361|NCT04857996|101091089|FG000|COMPLETED|Overall Study||26||26
48312362|NCT04857996|101091090|FG001|COMPLETED|Overall Study||24||24
48312363|NCT04857996|101091089|FG000|NOT COMPLETED|Overall Study||7||7
48312364|NCT04857996|101091090|FG001|NOT COMPLETED|Overall Study||8||8
48157100|NCT03995784|100706857|FG000|NOT COMPLETED|Overall Study||1||
48157101|NCT04372628|100706858|FG000|STARTED|Overall Study||4||
48157102|NCT04372628|100706859|FG001|STARTED|Overall Study||221||
48157103|NCT04372628|100706860|FG002|STARTED|Overall Study||227||
48157104|NCT04372628|100706858|FG000|COMPLETED|Overall Study||3||
48157105|NCT04372628|100706859|FG001|COMPLETED|Overall Study||216||
48157106|NCT04372628|100706860|FG002|COMPLETED|Overall Study||221||
48157107|NCT04372628|100706858|FG000|NOT COMPLETED|Overall Study||1||
48157108|NCT04372628|100706859|FG001|NOT COMPLETED|Overall Study||5||
48157109|NCT04372628|100706860|FG002|NOT COMPLETED|Overall Study||6||
48157110|NCT00779779|100706861|FG000|STARTED|Overall Study||522||
48157111|NCT00779779|100706861|FG000|COMPLETED|Overall Study||498||
48157112|NCT00779779|100706861|FG000|NOT COMPLETED|Overall Study||24||
48312365|NCT00470054|101091091|FG000|STARTED|Overall Study||44||
48312366|NCT00470054|101091091|FG000|COMPLETED|Overall Study||43||
48312367|NCT00470054|101091091|FG000|NOT COMPLETED|Overall Study||1||
48312368|NCT00311376|101091092|FG000|STARTED|Treatment Cycle 1||132||
48312369|NCT00311376|101091093|FG001|STARTED|Treatment Cycle 1||135||
48312370|NCT00311376|101091094|FG002|STARTED|Treatment Cycle 1||149||
48312371|NCT00311376|101091092|FG000|COMPLETED|Treatment Cycle 1||105||
48312372|NCT00311376|101091093|FG001|COMPLETED|Treatment Cycle 1||118||
48312373|NCT00311376|101091094|FG002|COMPLETED|Treatment Cycle 1||132||
48312374|NCT00311376|101091092|FG000|NOT COMPLETED|Treatment Cycle 1||27||
48312375|NCT00311376|101091093|FG001|NOT COMPLETED|Treatment Cycle 1||17||
48312376|NCT00311376|101091094|FG002|NOT COMPLETED|Treatment Cycle 1||17||
48312377|NCT00311376|101091092|FG000|STARTED|Treatment Cycle 2||115||
48312378|NCT00311376|101091093|FG001|STARTED|Treatment Cycle 2||125||
48729092|NCT02777827|102123199|FG005|COMPLETED|Treatment Period 3||6||
48157113|NCT01654601|100706862|FG000|STARTED|1st Administration||14||
48157114|NCT01654601|100706863|FG001|STARTED|1st Administration||14||
48312379|NCT00311376|101091094|FG002|STARTED|Treatment Cycle 2||0||
48312380|NCT00311376|101091092|FG000|COMPLETED|Treatment Cycle 2||106||
48312381|NCT00311376|101091093|FG001|COMPLETED|Treatment Cycle 2||112||
48312382|NCT00311376|101091094|FG002|COMPLETED|Treatment Cycle 2||0||
48312383|NCT00311376|101091092|FG000|NOT COMPLETED|Treatment Cycle 2||9||
48312384|NCT00311376|101091093|FG001|NOT COMPLETED|Treatment Cycle 2||13||
48312385|NCT00311376|101091094|FG002|NOT COMPLETED|Treatment Cycle 2||0||
48312386|NCT01555567|101091095|FG000|STARTED|12 Week||12||
48312387|NCT01555567|101091096|FG001|STARTED|12 Week||13||
48312388|NCT01555567|101091097|FG002|STARTED|12 Week||9||
48312389|NCT01555567|101091098|FG003|STARTED|12 Week||9||
48157115|NCT01654601|100706862|FG000|COMPLETED|1st Administration||12||
48157116|NCT01654601|100706863|FG001|COMPLETED|1st Administration||12||
48157117|NCT01654601|100706862|FG000|NOT COMPLETED|1st Administration||2||
48157118|NCT01654601|100706863|FG001|NOT COMPLETED|1st Administration||2||
48157119|NCT01654601|100706862|FG000|STARTED|2nd Administration||12||
48312390|NCT01555567|101091095|FG000|COMPLETED|12 Week||11||
48312391|NCT01555567|101091096|FG001|COMPLETED|12 Week||12||
48312392|NCT01555567|101091097|FG002|COMPLETED|12 Week||8||
48312393|NCT01555567|101091098|FG003|COMPLETED|12 Week||9||
48312394|NCT01555567|101091095|FG000|NOT COMPLETED|12 Week||1||
48312395|NCT01555567|101091096|FG001|NOT COMPLETED|12 Week||1||
48312396|NCT01555567|101091097|FG002|NOT COMPLETED|12 Week||1||
48312397|NCT01555567|101091098|FG003|NOT COMPLETED|12 Week||0||
48312398|NCT01555567|101091095|FG000|STARTED|Return to Activity||11||
48312399|NCT01555567|101091096|FG001|STARTED|Return to Activity||12||
48312400|NCT01555567|101091097|FG002|STARTED|Return to Activity||8||
48312401|NCT01555567|101091098|FG003|STARTED|Return to Activity||9||
48157120|NCT01654601|100706863|FG001|STARTED|2nd Administration||12||
48157121|NCT01654601|100706862|FG000|COMPLETED|2nd Administration||11||
48157122|NCT01654601|100706863|FG001|COMPLETED|2nd Administration||11||
48406787|NCT03424044|101328486|FG002|NOT COMPLETED|First Rest Period (1-12 Weeks)||1||
48312402|NCT01555567|101091095|FG000|COMPLETED|Return to Activity||10||
48312403|NCT01555567|101091096|FG001|COMPLETED|Return to Activity||10||
48312404|NCT01555567|101091097|FG002|COMPLETED|Return to Activity||8||
48312405|NCT01555567|101091098|FG003|COMPLETED|Return to Activity||8||
48312406|NCT01555567|101091095|FG000|NOT COMPLETED|Return to Activity||1||
48312407|NCT01555567|101091096|FG001|NOT COMPLETED|Return to Activity||2||
48406788|NCT03424044|101328487|FG003|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
48406789|NCT03424044|101328488|FG004|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
48406790|NCT03424044|101328489|FG005|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
48406791|NCT03424044|101328490|FG006|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
48406792|NCT03424044|101328491|FG007|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
48406793|NCT03424044|101328492|FG008|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
48406794|NCT03424044|101328484|FG000|STARTED|First Intervention (76 Hours)||4||
48406795|NCT03424044|101328485|FG001|STARTED|First Intervention (76 Hours)||3||
48406796|NCT03424044|101328486|FG002|STARTED|First Intervention (76 Hours)||2||
48406797|NCT03424044|101328487|FG003|STARTED|First Intervention (76 Hours)||3||
48406798|NCT03424044|101328488|FG004|STARTED|First Intervention (76 Hours)||3||
48614183|NCT03738163|101841688|FG000|COMPLETED|Overall Study||114||
48312408|NCT01555567|101091097|FG002|NOT COMPLETED|Return to Activity||0||
48312409|NCT01555567|101091098|FG003|NOT COMPLETED|Return to Activity||1||
48312410|NCT01058070|101091099|FG000|STARTED|Overall Study||44||
48312411|NCT01058070|101091099|FG000|COMPLETED|Overall Study||33||
48312412|NCT01058070|101091099|FG000|NOT COMPLETED|Overall Study||11||
48312413|NCT02822885|101091100|FG000|STARTED|Overall Study||70||
48312414|NCT02822885|101091100|FG000|COMPLETED|Overall Study||70||
48312415|NCT02822885|101091100|FG000|NOT COMPLETED|Overall Study||0||
48312416|NCT03018587|101091101|FG000|STARTED|Overall Study||23||
48312417|NCT03018587|101091101|FG000|COMPLETED|Overall Study||19||
48312418|NCT03018587|101091101|FG000|NOT COMPLETED|Overall Study||4||
48312419|NCT04018794|101091102|FG000|STARTED|Overall Study||15||
48312420|NCT04018794|101091102|FG000|COMPLETED|Overall Study||15||
48312421|NCT04018794|101091102|FG000|NOT COMPLETED|Overall Study||0||
48312422|NCT00310804|101091103|FG000|STARTED|Overall Study||1029||
48312423|NCT00310804|101091104|FG001|STARTED|Overall Study||171||
48312424|NCT00310804|101091103|FG000|COMPLETED|Overall Study||1024||
48312425|NCT00310804|101091104|FG001|COMPLETED|Overall Study||171||
48312426|NCT00310804|101091103|FG000|NOT COMPLETED|Overall Study||5||
48312427|NCT00310804|101091104|FG001|NOT COMPLETED|Overall Study||0||
48312428|NCT03442036|101091105|FG000|STARTED|Overall Study||35||
48614184|NCT03738163|101841688|FG000|NOT COMPLETED|Overall Study||7||
48729093|NCT02777827|102123194|FG000|NOT COMPLETED|Treatment Period 3||0||
48312429|NCT03442036|101091106|FG001|STARTED|Overall Study||35||
48406799|NCT03424044|101328489|FG005|STARTED|First Intervention (76 Hours)||4||
48406800|NCT03424044|101328490|FG006|STARTED|First Intervention (76 Hours)||1||
48406801|NCT03424044|101328491|FG007|STARTED|First Intervention (76 Hours)||1||
48406802|NCT03424044|101328492|FG008|STARTED|First Intervention (76 Hours)||1||
48406803|NCT03424044|101328484|FG000|COMPLETED|First Intervention (76 Hours)||4||
48406804|NCT03424044|101328485|FG001|COMPLETED|First Intervention (76 Hours)||3||
48406805|NCT03424044|101328486|FG002|COMPLETED|First Intervention (76 Hours)||2||
48406806|NCT03424044|101328487|FG003|COMPLETED|First Intervention (76 Hours)||3||
48406807|NCT03424044|101328488|FG004|COMPLETED|First Intervention (76 Hours)||2||
48614185|NCT03046953|101841689|FG000|STARTED|Overall Study||32||
48657088|NCT03648372|101943765|FG008|NOT COMPLETED|Overall Study||5||
48312430|NCT03442036|101091105|FG000|COMPLETED|Overall Study||35||
48312431|NCT03442036|101091106|FG001|COMPLETED|Overall Study||35||
48312432|NCT03442036|101091105|FG000|NOT COMPLETED|Overall Study||0||
48312433|NCT03442036|101091106|FG001|NOT COMPLETED|Overall Study||0||
48312434|NCT00068575|101091107|FG000|STARTED|Overall Study||28||
48312435|NCT00068575|101091107|FG000|COMPLETED|Overall Study||28||
48312436|NCT00068575|101091107|FG000|NOT COMPLETED|Overall Study||0||
48312437|NCT01977820|101091108|FG000|STARTED|Overall Study||1||
48312438|NCT01977820|101091109|FG001|STARTED|Overall Study||1||
48312439|NCT01977820|101091108|FG000|COMPLETED|Overall Study||0||
48312440|NCT01977820|101091109|FG001|COMPLETED|Overall Study||0||
48312441|NCT01977820|101091108|FG000|NOT COMPLETED|Overall Study||1||
48312442|NCT01977820|101091109|FG001|NOT COMPLETED|Overall Study||1||
48312443|NCT01534013|101091110|FG000|STARTED|Overall Study||8||
48312444|NCT01534013|101091111|FG001|STARTED|Overall Study||6||
48312445|NCT01534013|101091110|FG000|COMPLETED|Overall Study||6||
48312446|NCT01534013|101091111|FG001|COMPLETED|Overall Study||6||
48312447|NCT01534013|101091110|FG000|NOT COMPLETED|Overall Study||2||
48312448|NCT01534013|101091111|FG001|NOT COMPLETED|Overall Study||0||
48312449|NCT04582149|101091112|FG000|STARTED|Overall Study||30||
48312450|NCT04582149|101091112|FG000|COMPLETED|Overall Study||30||
48312451|NCT04582149|101091112|FG000|NOT COMPLETED|Overall Study||0||
48312452|NCT02247245|101091113|FG000|STARTED|Overall Study||13||
48312453|NCT02247245|101091114|FG001|STARTED|Overall Study||13||
48312454|NCT02247245|101091115|FG002|STARTED|Overall Study||7||
48312455|NCT02247245|101091116|FG003|STARTED|Overall Study||7||
48157123|NCT01654601|100706862|FG000|NOT COMPLETED|2nd Administration||1||
48157124|NCT01654601|100706863|FG001|NOT COMPLETED|2nd Administration||1||
48157125|NCT00053495|100706864|FG000|STARTED|Overall Study||51||
48157126|NCT00053495|100706865|FG001|STARTED|Overall Study||101||
48157127|NCT00053495|100706866|FG002|STARTED|Overall Study||101||
48157128|NCT00053495|100706867|FG003|STARTED|Overall Study||51||
48157129|NCT00053495|100706868|FG004|STARTED|Overall Study||49||
48157130|NCT00053495|100706864|FG000|COMPLETED|Overall Study||51||
48157131|NCT00053495|100706865|FG001|COMPLETED|Overall Study||101||
48157132|NCT00053495|100706866|FG002|COMPLETED|Overall Study||101||
48157133|NCT00053495|100706867|FG003|COMPLETED|Overall Study||51||
48157134|NCT00053495|100706868|FG004|COMPLETED|Overall Study||49||
48157135|NCT00053495|100706864|FG000|NOT COMPLETED|Overall Study||0||
48157136|NCT00053495|100706865|FG001|NOT COMPLETED|Overall Study||0||
48157137|NCT00053495|100706866|FG002|NOT COMPLETED|Overall Study||0||
48157138|NCT00053495|100706867|FG003|NOT COMPLETED|Overall Study||0||
48157139|NCT00053495|100706868|FG004|NOT COMPLETED|Overall Study||0||
48157140|NCT00982930|100706869|FG000|STARTED|Overall Study||55||
48157141|NCT00982930|100706869|FG000|COMPLETED|Overall Study||51||
48157142|NCT00982930|100706869|FG000|NOT COMPLETED|Overall Study||4||
48157143|NCT01682213|100706870|FG000|STARTED|Overall Study||23||
48157144|NCT01682213|100706870|FG000|COMPLETED|Overall Study||21||
48157145|NCT01682213|100706870|FG000|NOT COMPLETED|Overall Study||2||
48157146|NCT00454571|100706871|FG000|STARTED|Overall Study||18||
48157147|NCT00454571|100706872|FG001|STARTED|Overall Study||19||
48157148|NCT00454571|100706871|FG000|COMPLETED|Overall Study||5||
48157149|NCT00454571|100706872|FG001|COMPLETED|Overall Study||13||
48157150|NCT00454571|100706871|FG000|NOT COMPLETED|Overall Study||13||
48157151|NCT00454571|100706872|FG001|NOT COMPLETED|Overall Study||6||
48157152|NCT02459262|100706873|FG000|STARTED|Overall Study||8||
48157153|NCT02459262|100706874|FG001|STARTED|Overall Study||8||
48157154|NCT02459262|100706875|FG002|STARTED|Overall Study||8||
48157155|NCT02459262|100706876|FG003|STARTED|Overall Study||8||
48157156|NCT02459262|100706877|FG004|STARTED|Overall Study||8||
48157157|NCT02459262|100706878|FG005|STARTED|Overall Study||8||
48157158|NCT02459262|100706879|FG006|STARTED|Overall Study||12||
48157159|NCT02459262|100706880|FG007|STARTED|Overall Study||45||
48157160|NCT02459262|100706881|FG008|STARTED|Overall Study||45||
48157161|NCT02459262|100706882|FG009|STARTED|Overall Study||45||
48157162|NCT02459262|100706883|FG010|STARTED|Overall Study||45||
48157163|NCT02459262|100706873|FG000|COMPLETED|Overall Study||8||
48157164|NCT02459262|100706874|FG001|COMPLETED|Overall Study||8||
48157165|NCT02459262|100706875|FG002|COMPLETED|Overall Study||8||
48157166|NCT02459262|100706876|FG003|COMPLETED|Overall Study||8||
48157167|NCT02459262|100706877|FG004|COMPLETED|Overall Study||8||
48157168|NCT02459262|100706878|FG005|COMPLETED|Overall Study||8||
48157169|NCT02459262|100706879|FG006|COMPLETED|Overall Study||12||
48157170|NCT02459262|100706880|FG007|COMPLETED|Overall Study||45||
48157171|NCT02459262|100706881|FG008|COMPLETED|Overall Study||45||
48157172|NCT02459262|100706882|FG009|COMPLETED|Overall Study||44||
48157173|NCT02459262|100706883|FG010|COMPLETED|Overall Study||45||
48157174|NCT02459262|100706873|FG000|NOT COMPLETED|Overall Study||0||
48312456|NCT02247245|101091113|FG000|COMPLETED|Overall Study||13||
48312457|NCT02247245|101091114|FG001|COMPLETED|Overall Study||13||
48157175|NCT02459262|100706874|FG001|NOT COMPLETED|Overall Study||0||
48157176|NCT02459262|100706875|FG002|NOT COMPLETED|Overall Study||0||
48157177|NCT02459262|100706876|FG003|NOT COMPLETED|Overall Study||0||
48312458|NCT02247245|101091115|FG002|COMPLETED|Overall Study||7||
48312459|NCT02247245|101091116|FG003|COMPLETED|Overall Study||7||
48312460|NCT02247245|101091113|FG000|NOT COMPLETED|Overall Study||0||
48157178|NCT02459262|100706877|FG004|NOT COMPLETED|Overall Study||0||
48157179|NCT02459262|100706878|FG005|NOT COMPLETED|Overall Study||0||
48157180|NCT02459262|100706879|FG006|NOT COMPLETED|Overall Study||0||
48157181|NCT02459262|100706880|FG007|NOT COMPLETED|Overall Study||0||
48157182|NCT02459262|100706881|FG008|NOT COMPLETED|Overall Study||0||
48157183|NCT02459262|100706882|FG009|NOT COMPLETED|Overall Study||1||
48157184|NCT02459262|100706883|FG010|NOT COMPLETED|Overall Study||0||
48157185|NCT02914132|100706884|FG000|STARTED|Overall Study||15||
48157186|NCT02914132|100706884|FG000|COMPLETED|Overall Study||15||
48312461|NCT02247245|101091114|FG001|NOT COMPLETED|Overall Study||0||
48312462|NCT02247245|101091115|FG002|NOT COMPLETED|Overall Study||0||
48312463|NCT02247245|101091116|FG003|NOT COMPLETED|Overall Study||0||
48312464|NCT02538016|101091117|FG000|STARTED|Overall Study||4||
48312465|NCT02538016|101091117|FG000|COMPLETED|Overall Study||4||
48312466|NCT02538016|101091117|FG000|NOT COMPLETED|Overall Study||0||
48312467|NCT01484977|101091118|FG000|STARTED|Overall Study||120||
48312468|NCT01484977|101091118|FG000|COMPLETED|Overall Study||93||
48312469|NCT01484977|101091118|FG000|NOT COMPLETED|Overall Study||27||
48312470|NCT00931242|101091119|FG000|STARTED|Overall Study||10||
48312471|NCT00931242|101091120|FG001|STARTED|Overall Study||2||
48312472|NCT00931242|101091119|FG000|COMPLETED|Overall Study||5||
48312473|NCT00931242|101091120|FG001|COMPLETED|Overall Study||0||
48312474|NCT00931242|101091119|FG000|NOT COMPLETED|Overall Study||5||
48312475|NCT00931242|101091120|FG001|NOT COMPLETED|Overall Study||2||
48312476|NCT00243386|101091121|FG000|STARTED|On-Demand Regimen (Study Part 1)||73||
48312477|NCT00243386|101091122|FG001|STARTED|On-Demand Regimen (Study Part 1)||0||
48312478|NCT00243386|101091123|FG002|STARTED|On-Demand Regimen (Study Part 1)||0||
48312479|NCT00243386|101091121|FG000|COMPLETED|On-Demand Regimen (Study Part 1)||69||
48312480|NCT00243386|101091122|FG001|COMPLETED|On-Demand Regimen (Study Part 1)||0||
48312481|NCT00243386|101091123|FG002|COMPLETED|On-Demand Regimen (Study Part 1)||0||
48406808|NCT03424044|101328489|FG005|COMPLETED|First Intervention (76 Hours)||4||
48406809|NCT03424044|101328490|FG006|COMPLETED|First Intervention (76 Hours)||0||
48406810|NCT03424044|101328491|FG007|COMPLETED|First Intervention (76 Hours)||0||
48406811|NCT03424044|101328492|FG008|COMPLETED|First Intervention (76 Hours)||0||
48614186|NCT03046953|101841689|FG000|Completed Cycle 3|Overall Study||16|Patients had to reach the CT scan assessment for cycle 3 to be evaluable for the trial|
48614187|NCT03046953|101841689|FG000|Completed Cycle 6|Overall Study||10||
48614188|NCT03046953|101841689|FG000|Completed Cycle 8|Overall Study||6||
48614189|NCT03046953|101841689|FG000|COMPLETED|Overall Study||6||
48614190|NCT03046953|101841689|FG000|NOT COMPLETED|Overall Study||26||
48614191|NCT01429298|101841690|FG000|STARTED|Overall Study||175||
48614192|NCT01429298|101841691|FG001|STARTED|Overall Study||175||
48614193|NCT01429298|101841690|FG000|Given IV Opioids|Overall Study||171||
48614194|NCT01429298|101841691|FG001|Given IV Opioids|Overall Study||169||
48614195|NCT01429298|101841690|FG000|COMPLETED|Overall Study||171||
48614196|NCT01429298|101841691|FG001|COMPLETED|Overall Study||169||
48614197|NCT01429298|101841690|FG000|NOT COMPLETED|Overall Study||4||
48406812|NCT03424044|101328484|FG000|NOT COMPLETED|First Intervention (76 Hours)||0||
48614198|NCT01429298|101841691|FG001|NOT COMPLETED|Overall Study||6||
48614199|NCT05926648|101841692|FG000|STARTED|Overall Study||53||
48614200|NCT05926648|101841692|FG000|COMPLETED|Overall Study||52||
48614201|NCT05926648|101841692|FG000|NOT COMPLETED|Overall Study||1||
48614202|NCT02179047|101841693|FG000|STARTED|Overall Study||194||
48614203|NCT02179047|101841694|FG001|STARTED|Overall Study||20||
48729094|NCT02777827|102123195|FG001|NOT COMPLETED|Treatment Period 3||0||
48729095|NCT02777827|102123196|FG002|NOT COMPLETED|Treatment Period 3||0||
48312482|NCT00243386|101091121|FG000|NOT COMPLETED|On-Demand Regimen (Study Part 1)||4||
48312483|NCT00243386|101091122|FG001|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0||
48312484|NCT00243386|101091123|FG002|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0||
48312485|NCT00243386|101091121|FG000|STARTED|End of Part 1, But Prior to Prophylaxis||69||
48312486|NCT00243386|101091122|FG001|STARTED|End of Part 1, But Prior to Prophylaxis||0||
48312487|NCT00243386|101091123|FG002|STARTED|End of Part 1, But Prior to Prophylaxis||0||
48312488|NCT00243386|101091121|FG000|COMPLETED|End of Part 1, But Prior to Prophylaxis||66||
48312489|NCT00243386|101091122|FG001|COMPLETED|End of Part 1, But Prior to Prophylaxis||0||
48312490|NCT00243386|101091123|FG002|COMPLETED|End of Part 1, But Prior to Prophylaxis||0||
48312491|NCT00243386|101091121|FG000|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||3||
48312492|NCT00243386|101091122|FG001|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0||
48312493|NCT00243386|101091123|FG002|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0||
48312494|NCT00243386|101091121|FG000|STARTED|PK-Driven or Standard Prophylaxis||0||
48312495|NCT00243386|101091122|FG001|STARTED|PK-Driven or Standard Prophylaxis||34||
48312496|NCT00243386|101091123|FG002|STARTED|PK-Driven or Standard Prophylaxis||32||
48312497|NCT00243386|101091121|FG000|COMPLETED|PK-Driven or Standard Prophylaxis||0||
48406813|NCT03424044|101328485|FG001|NOT COMPLETED|First Intervention (76 Hours)||0||
48406814|NCT03424044|101328486|FG002|NOT COMPLETED|First Intervention (76 Hours)||0||
48406815|NCT03424044|101328487|FG003|NOT COMPLETED|First Intervention (76 Hours)||0||
48406816|NCT03424044|101328488|FG004|NOT COMPLETED|First Intervention (76 Hours)||1||
48406817|NCT03424044|101328489|FG005|NOT COMPLETED|First Intervention (76 Hours)||0||
48406818|NCT03424044|101328490|FG006|NOT COMPLETED|First Intervention (76 Hours)||1||
48406819|NCT03424044|101328491|FG007|NOT COMPLETED|First Intervention (76 Hours)||1||
48312498|NCT00243386|101091122|FG001|COMPLETED|PK-Driven or Standard Prophylaxis||31||
48312499|NCT00243386|101091123|FG002|COMPLETED|PK-Driven or Standard Prophylaxis||32||
48312500|NCT00243386|101091121|FG000|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0||
48312501|NCT00243386|101091122|FG001|NOT COMPLETED|PK-Driven or Standard Prophylaxis||3||
48312502|NCT00243386|101091123|FG002|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0||
48312503|NCT01177683|101091124|FG000|STARTED|Study Treatment||3||
48614204|NCT02179047|101841693|FG000|COMPLETED|Overall Study||187||
48312504|NCT01177683|101091125|FG001|STARTED|Study Treatment||3||
48312505|NCT01177683|101091126|FG002|STARTED|Study Treatment||26||
48312506|NCT01177683|101091124|FG000|COMPLETED|Study Treatment||0||
48312507|NCT01177683|101091125|FG001|COMPLETED|Study Treatment||0||
48312508|NCT01177683|101091126|FG002|COMPLETED|Study Treatment||2||
48312509|NCT01177683|101091124|FG000|NOT COMPLETED|Study Treatment||3||
48312510|NCT01177683|101091125|FG001|NOT COMPLETED|Study Treatment||3||
48312511|NCT01177683|101091126|FG002|NOT COMPLETED|Study Treatment||24||
48614205|NCT02179047|101841694|FG001|COMPLETED|Overall Study||20||
48614206|NCT02179047|101841693|FG000|NOT COMPLETED|Overall Study||7||
48614207|NCT02179047|101841694|FG001|NOT COMPLETED|Overall Study||0||
48614208|NCT00193414|101841695|FG000|STARTED|Overall Study||72||
48614209|NCT00193414|101841695|FG000|COMPLETED|Overall Study||14||
48614210|NCT00193414|101841695|FG000|NOT COMPLETED|Overall Study||58||
48614211|NCT00738426|101841696|FG000|STARTED|Overall Study||37||
48614212|NCT00738426|101841697|FG001|STARTED|Overall Study||35||
48614213|NCT00738426|101841696|FG000|COMPLETED|Overall Study||35||
48614214|NCT00738426|101841697|FG001|COMPLETED|Overall Study||32||
48312512|NCT01177683|101091124|FG000|STARTED|Follow up||3||
48312513|NCT01177683|101091125|FG001|STARTED|Follow up||3||
48312514|NCT01177683|101091126|FG002|STARTED|Follow up||24||
48312515|NCT01177683|101091124|FG000|COMPLETED|Follow up||0||
48312516|NCT01177683|101091125|FG001|COMPLETED|Follow up||0||
48312517|NCT01177683|101091126|FG002|COMPLETED|Follow up||0||
48312518|NCT01177683|101091124|FG000|NOT COMPLETED|Follow up||3||
48312519|NCT01177683|101091125|FG001|NOT COMPLETED|Follow up||3||
48312520|NCT01177683|101091126|FG002|NOT COMPLETED|Follow up||24||
48312521|NCT00922480|101091127|FG000|STARTED|Main Study||250||
48312522|NCT00922480|101091128|FG001|STARTED|Main Study||255||
48312523|NCT00922480|101091127|FG000|COMPLETED|Main Study||213||
48312524|NCT00922480|101091128|FG001|COMPLETED|Main Study||226||
48312525|NCT00922480|101091127|FG000|NOT COMPLETED|Main Study||37||
48312526|NCT00922480|101091128|FG001|NOT COMPLETED|Main Study||29||
48312527|NCT00922480|101091127|FG000|STARTED|Extension Study||73||
48312528|NCT00922480|101091128|FG001|STARTED|Extension Study||85||
48312529|NCT00922480|101091127|FG000|COMPLETED|Extension Study||68||
48312530|NCT00922480|101091128|FG001|COMPLETED|Extension Study||82||
48312531|NCT00922480|101091127|FG000|NOT COMPLETED|Extension Study||5||
48312532|NCT00922480|101091128|FG001|NOT COMPLETED|Extension Study||3||
48312533|NCT00282295|101091129|FG000|STARTED|Overall Study||446||
48312534|NCT00282295|101091130|FG001|STARTED|Overall Study||446||
48312535|NCT00282295|101091131|FG002|STARTED|Overall Study||449||
48312536|NCT00282295|101091129|FG000|COMPLETED|Overall Study||443||
48312537|NCT00282295|101091130|FG001|COMPLETED|Overall Study||429||
48312538|NCT00282295|101091131|FG002|COMPLETED|Overall Study||441||
48312539|NCT00282295|101091129|FG000|NOT COMPLETED|Overall Study||3||
48312540|NCT00282295|101091130|FG001|NOT COMPLETED|Overall Study||17||
48312541|NCT00282295|101091131|FG002|NOT COMPLETED|Overall Study||8||
48614215|NCT00738426|101841696|FG000|NOT COMPLETED|Overall Study||2||
48614216|NCT00738426|101841697|FG001|NOT COMPLETED|Overall Study||3||
48614217|NCT02989402|101841698|FG000|STARTED|Overall Study||100||
48614218|NCT02989402|101841698|FG000|COMPLETED|Overall Study||72||
48614219|NCT02989402|101841698|FG000|NOT COMPLETED|Overall Study||28||
48614220|NCT01854697|101841699|FG000|STARTED|Overall Study||69||
48614221|NCT01854697|101841700|FG001|STARTED|Overall Study||34||
48614222|NCT01854697|101841701|FG002|STARTED|Overall Study||84||
48614223|NCT01854697|101841702|FG003|STARTED|Overall Study||83||
48614224|NCT01854697|101841703|FG004|STARTED|Overall Study||41||
48312542|NCT00415506|101091132|FG000|STARTED|Overall Study||12||
48312543|NCT00415506|101091133|FG001|STARTED|Overall Study||10||
48312544|NCT00415506|101091132|FG000|COMPLETED|Overall Study||9||
48312545|NCT00415506|101091133|FG001|COMPLETED|Overall Study||9||
48312546|NCT00415506|101091132|FG000|NOT COMPLETED|Overall Study||3||
48312547|NCT00415506|101091133|FG001|NOT COMPLETED|Overall Study||1||
48312548|NCT03593850|101091134|FG000|STARTED|Primary Endpoint||29||
48312549|NCT03593850|101091135|FG001|STARTED|Primary Endpoint||23||
48312550|NCT03593850|101091134|FG000|Received Allocated Intervention and Completed Post-intervention Outcomes (Primary Endpoint)|Primary Endpoint||29||
48312551|NCT03593850|101091135|FG001|Received Allocated Intervention and Completed Post-intervention Outcomes (Primary Endpoint)|Primary Endpoint||23||
48312552|NCT03593850|101091134|FG000|COMPLETED|Primary Endpoint||29||
48312553|NCT03593850|101091135|FG001|COMPLETED|Primary Endpoint||22||
48406820|NCT03424044|101328492|FG008|NOT COMPLETED|First Intervention (76 Hours)||1||
48312554|NCT03593850|101091134|FG000|NOT COMPLETED|Primary Endpoint||0||
48406821|NCT03424044|101328484|FG000|STARTED|Second Rest Period (7-45 Days)||4||
48406822|NCT03424044|101328485|FG001|STARTED|Second Rest Period (7-45 Days)||3||
48312555|NCT03593850|101091135|FG001|NOT COMPLETED|Primary Endpoint||1||
48312556|NCT03593850|101091134|FG000|STARTED|3-6 Hours Post Intervention Outcomes||29||
48312557|NCT03593850|101091135|FG001|STARTED|3-6 Hours Post Intervention Outcomes||22||
48312558|NCT03593850|101091134|FG000|COMPLETED|3-6 Hours Post Intervention Outcomes||27|Completed and returned 3-6 hours post-intervention outcome questionnaires|
48614225|NCT01854697|101841699|FG000|COMPLETED|Overall Study||63||
48614226|NCT01854697|101841700|FG001|COMPLETED|Overall Study||31||
48614227|NCT01854697|101841701|FG002|COMPLETED|Overall Study||82||
48614228|NCT01854697|101841702|FG003|COMPLETED|Overall Study||80||
48614229|NCT01854697|101841703|FG004|COMPLETED|Overall Study||39||
48614230|NCT01854697|101841699|FG000|NOT COMPLETED|Overall Study||6||
48312559|NCT03593850|101091135|FG001|COMPLETED|3-6 Hours Post Intervention Outcomes||19|Completed and returned 3-6 hours post-intervention outcome questionnaires|
48312560|NCT03593850|101091134|FG000|NOT COMPLETED|3-6 Hours Post Intervention Outcomes||2||
48312561|NCT03593850|101091135|FG001|NOT COMPLETED|3-6 Hours Post Intervention Outcomes||3||
48312562|NCT01761279|101091136|FG000|STARTED|Overall Study||84||
48312563|NCT01761279|101091136|FG000|COMPLETED|Overall Study||84||
48312564|NCT01761279|101091136|FG000|NOT COMPLETED|Overall Study||0||
48312565|NCT00555477|101091137|FG000|STARTED|Overall Study||14||
48312566|NCT00555477|101091138|FG001|STARTED|Overall Study||45||
48312567|NCT00555477|101091137|FG000|COMPLETED|Overall Study||12||
48312568|NCT00555477|101091138|FG001|COMPLETED|Overall Study||32||
48312569|NCT00555477|101091137|FG000|NOT COMPLETED|Overall Study||2||
48312570|NCT00555477|101091138|FG001|NOT COMPLETED|Overall Study||13||
48312571|NCT04968041|101091139|FG000|STARTED|Overall Study||10||
48312572|NCT04968041|101091139|FG000|COMPLETED|Overall Study||9||
48312573|NCT04968041|101091139|FG000|NOT COMPLETED|Overall Study||1||
48312574|NCT00916279|101091140|FG000|STARTED|Overall Study||41||
48312575|NCT00916279|101091140|FG000|30 Days|Overall Study||41||
48312576|NCT00916279|101091140|FG000|6 Months|Overall Study||41||
48312577|NCT00916279|101091140|FG000|24 Months|Overall Study||37||
48312578|NCT00916279|101091140|FG000|COMPLETED|Overall Study||37||
48312579|NCT00916279|101091140|FG000|NOT COMPLETED|Overall Study||4||
48312580|NCT03511053|101091141|FG000|STARTED|Overall Study||11||
48312581|NCT03511053|101091141|FG000|COMPLETED|Overall Study||10||
48312582|NCT03511053|101091141|FG000|NOT COMPLETED|Overall Study||1||
48312583|NCT04118270|101091142|FG000|STARTED|Overall Study||37||
48312584|NCT04118270|101091143|FG001|STARTED|Overall Study||13||
48312585|NCT04118270|101091142|FG000|Completed Provider Accuracy Assessment|Overall Study||0||
48312586|NCT04118270|101091143|FG001|Completed Provider Accuracy Assessment|Overall Study||10||
48312587|NCT04118270|101091142|FG000|COMPLETED|Overall Study||37||
48312588|NCT04118270|101091143|FG001|COMPLETED|Overall Study||13||
48312589|NCT04118270|101091142|FG000|NOT COMPLETED|Overall Study||0||
48312590|NCT04118270|101091143|FG001|NOT COMPLETED|Overall Study||0||
48312591|NCT03945591|101091144|FG000|STARTED|Overall Study||21||
48312592|NCT03945591|101091144|FG000|COMPLETED|Overall Study||16||
48312593|NCT03945591|101091144|FG000|NOT COMPLETED|Overall Study||5||
48312594|NCT00353834|101091145|FG000|STARTED|Overall Study||26||
48312595|NCT00353834|101091146|FG001|STARTED|Overall Study||27||
48312596|NCT00353834|101091145|FG000|COMPLETED|Overall Study||26||
48312597|NCT00353834|101091146|FG001|COMPLETED|Overall Study||27||
48312598|NCT00353834|101091145|FG000|NOT COMPLETED|Overall Study||0||
48312599|NCT00353834|101091146|FG001|NOT COMPLETED|Overall Study||0||
48312600|NCT03302975|101091147|FG000|STARTED|Overall Study||16||
48312601|NCT03302975|101091147|FG000|COMPLETED|Overall Study||12||
48312602|NCT03302975|101091147|FG000|NOT COMPLETED|Overall Study||4||
48312603|NCT01847430|101091148|FG000|STARTED|Overall Study||302||
48312604|NCT01847430|101091148|FG000|COMPLETED|Overall Study||302||
48312605|NCT01847430|101091148|FG000|NOT COMPLETED|Overall Study||0||
48312606|NCT00993265|101091149|FG000|STARTED|Overall Study||20||
48312607|NCT00993265|101091150|FG001|STARTED|Overall Study||19||
48312608|NCT00993265|101091149|FG000|COMPLETED|Overall Study||16||
48312609|NCT00993265|101091150|FG001|COMPLETED|Overall Study||19||
48312610|NCT00993265|101091149|FG000|NOT COMPLETED|Overall Study||4||
48312611|NCT00993265|101091150|FG001|NOT COMPLETED|Overall Study||0||
48312612|NCT00688155|101091151|FG000|STARTED|Overall Study||18||
48312613|NCT00688155|101091152|FG001|STARTED|Overall Study||18||
48312614|NCT00688155|101091153|FG002|STARTED|Overall Study||19||
48312615|NCT00688155|101091154|FG003|STARTED|Overall Study||18||
48312616|NCT00688155|101091151|FG000|COMPLETED|Overall Study||16||
48312617|NCT00688155|101091152|FG001|COMPLETED|Overall Study||16||
48312618|NCT00688155|101091153|FG002|COMPLETED|Overall Study||18||
48312619|NCT00688155|101091154|FG003|COMPLETED|Overall Study||17||
48312620|NCT00688155|101091151|FG000|NOT COMPLETED|Overall Study||2||
48312621|NCT00688155|101091152|FG001|NOT COMPLETED|Overall Study||2||
48312622|NCT00688155|101091153|FG002|NOT COMPLETED|Overall Study||1||
48312623|NCT00688155|101091154|FG003|NOT COMPLETED|Overall Study||1||
48312624|NCT00685880|101091155|FG000|STARTED|Overall Study||0||
48312625|NCT00685880|101091156|FG001|STARTED|Overall Study||2||
48312626|NCT00685880|101091155|FG000|COMPLETED|Overall Study||0||
48312627|NCT00685880|101091156|FG001|COMPLETED|Overall Study||2||
48312628|NCT00685880|101091155|FG000|NOT COMPLETED|Overall Study||0||
48312629|NCT00685880|101091156|FG001|NOT COMPLETED|Overall Study||0||
48312630|NCT02632721|101091157|FG000|STARTED|Overall Study||4||
48312631|NCT02632721|101091158|FG001|STARTED|Overall Study||3||
48312632|NCT02632721|101091159|FG002|STARTED|Overall Study||9||
48312633|NCT02632721|101091160|FG003|STARTED|Overall Study||15||
48312634|NCT02632721|101091161|FG004|STARTED|Overall Study||18||
48312635|NCT02632721|101091157|FG000|COMPLETED|Overall Study||0||
48312636|NCT02632721|101091158|FG001|COMPLETED|Overall Study||0||
48312637|NCT02632721|101091159|FG002|COMPLETED|Overall Study||0||
48312638|NCT02632721|101091160|FG003|COMPLETED|Overall Study||1||
48312639|NCT02632721|101091161|FG004|COMPLETED|Overall Study||2||
48312640|NCT02632721|101091157|FG000|NOT COMPLETED|Overall Study||4||
48312641|NCT02632721|101091158|FG001|NOT COMPLETED|Overall Study||3||
48312642|NCT02632721|101091159|FG002|NOT COMPLETED|Overall Study||9||
48157187|NCT02914132|100706884|FG000|NOT COMPLETED|Overall Study||0||
48157188|NCT00514683|100706885|FG000|STARTED|Overall Study||87||
48157189|NCT00514683|100706886|FG001|STARTED|Overall Study||87||
48157190|NCT00514683|100706887|FG002|STARTED|Overall Study||86||
48157191|NCT00514683|100706888|FG003|STARTED|Overall Study||86||
48157192|NCT00514683|100706889|FG004|STARTED|Overall Study||86||
48312643|NCT02632721|101091160|FG003|NOT COMPLETED|Overall Study||14||
48312644|NCT02632721|101091161|FG004|NOT COMPLETED|Overall Study||16||
48312645|NCT00253643|101091162|FG000|STARTED|Overall Study||14||
48312646|NCT00253643|101091163|FG001|STARTED|Overall Study||15||
48312647|NCT00253643|101091164|FG002|STARTED|Overall Study||29||
48312648|NCT00253643|101091165|FG003|STARTED|Overall Study||31||
48312649|NCT00253643|101091162|FG000|COMPLETED|Overall Study||14||
48312650|NCT00253643|101091163|FG001|COMPLETED|Overall Study||15||
48312651|NCT00253643|101091164|FG002|COMPLETED|Overall Study||28||
48312652|NCT00253643|101091165|FG003|COMPLETED|Overall Study||28||
48312653|NCT00253643|101091162|FG000|NOT COMPLETED|Overall Study||0||
48312654|NCT00253643|101091163|FG001|NOT COMPLETED|Overall Study||0||
48312655|NCT00253643|101091164|FG002|NOT COMPLETED|Overall Study||1||
48312656|NCT00253643|101091165|FG003|NOT COMPLETED|Overall Study||3||
48312657|NCT01195090|101091166|FG000|STARTED|Overall Study||60||
48312658|NCT01195090|101091167|FG001|STARTED|Overall Study||60||
48312659|NCT01195090|101091166|FG000|COMPLETED|Overall Study||54||
48312660|NCT01195090|101091167|FG001|COMPLETED|Overall Study||52||
48312661|NCT01195090|101091166|FG000|NOT COMPLETED|Overall Study||6||
48312662|NCT01195090|101091167|FG001|NOT COMPLETED|Overall Study||8||
48312663|NCT03034460|101091168|FG000|STARTED|Overall Study||48||
48312664|NCT03034460|101091169|FG001|STARTED|Overall Study||22||
48312665|NCT03034460|101091168|FG000|COMPLETED|Overall Study||45||
48312666|NCT03034460|101091169|FG001|COMPLETED|Overall Study||19||
48312667|NCT03034460|101091168|FG000|NOT COMPLETED|Overall Study||3||
48312668|NCT03034460|101091169|FG001|NOT COMPLETED|Overall Study||3||
48312669|NCT04402970|101091170|FG000|STARTED|Overall Study||10||
48312670|NCT04402970|101091171|FG001|STARTED|Overall Study||20||
48312671|NCT04402970|101091170|FG000|COMPLETED|Overall Study||10||
48312672|NCT04402970|101091171|FG001|COMPLETED|Overall Study||20||
48312673|NCT04402970|101091170|FG000|NOT COMPLETED|Overall Study||0||
48312674|NCT04402970|101091171|FG001|NOT COMPLETED|Overall Study||0||
48157193|NCT00514683|100706885|FG000|COMPLETED|Overall Study||61||
48157194|NCT00514683|100706886|FG001|COMPLETED|Overall Study||62||
48312675|NCT03451084|101091172|FG000|STARTED|Overall Study||6||
48312676|NCT03451084|101091173|FG001|STARTED|Overall Study||6||
48312677|NCT03451084|101091174|FG002|STARTED|Overall Study||6||
48312678|NCT03451084|101091175|FG003|STARTED|Overall Study||6||
48312679|NCT03451084|101091172|FG000|COMPLETED|Overall Study||0||
48312680|NCT03451084|101091173|FG001|COMPLETED|Overall Study||0||
48312681|NCT03451084|101091174|FG002|COMPLETED|Overall Study||0||
48312682|NCT03451084|101091175|FG003|COMPLETED|Overall Study||0||
48312683|NCT03451084|101091172|FG000|NOT COMPLETED|Overall Study||6||
48312684|NCT03451084|101091173|FG001|NOT COMPLETED|Overall Study||6||
48312685|NCT03451084|101091174|FG002|NOT COMPLETED|Overall Study||6||
48312686|NCT03451084|101091175|FG003|NOT COMPLETED|Overall Study||6||
48312687|NCT01093625|101091176|FG000|STARTED|Baseline and Dispensed||49||
48312688|NCT01093625|101091177|FG001|STARTED|Baseline and Dispensed||49||
48312689|NCT01093625|101091176|FG000|COMPLETED|Baseline and Dispensed||47||
48312690|NCT01093625|101091177|FG001|COMPLETED|Baseline and Dispensed||49||
48312691|NCT01093625|101091176|FG000|NOT COMPLETED|Baseline and Dispensed||2||
48312692|NCT01093625|101091177|FG001|NOT COMPLETED|Baseline and Dispensed||0||
48312693|NCT01093625|101091176|FG000|STARTED|2-Week Visit||47||
48312694|NCT01093625|101091177|FG001|STARTED|2-Week Visit||49||
48312695|NCT01093625|101091176|FG000|COMPLETED|2-Week Visit||46||
48312696|NCT01093625|101091177|FG001|COMPLETED|2-Week Visit||49||
48312697|NCT01093625|101091176|FG000|NOT COMPLETED|2-Week Visit||1||
48312698|NCT01093625|101091177|FG001|NOT COMPLETED|2-Week Visit||0||
48312699|NCT01093625|101091176|FG000|STARTED|1-Month Visit||46||
48312700|NCT01093625|101091177|FG001|STARTED|1-Month Visit||49||
48312701|NCT01093625|101091176|FG000|COMPLETED|1-Month Visit||44||
48312702|NCT01093625|101091177|FG001|COMPLETED|1-Month Visit||49||
48312703|NCT01093625|101091176|FG000|NOT COMPLETED|1-Month Visit||2||
48312704|NCT01093625|101091177|FG001|NOT COMPLETED|1-Month Visit||0||
48312705|NCT01093625|101091176|FG000|STARTED|3-Month Visit||44||
48312706|NCT01093625|101091177|FG001|STARTED|3-Month Visit||49||
48312707|NCT01093625|101091176|FG000|COMPLETED|3-Month Visit||42||
48312708|NCT01093625|101091177|FG001|COMPLETED|3-Month Visit||49||
48406823|NCT03424044|101328486|FG002|STARTED|Second Rest Period (7-45 Days)||2||
48406824|NCT03424044|101328487|FG003|STARTED|Second Rest Period (7-45 Days)||3||
48406825|NCT03424044|101328488|FG004|STARTED|Second Rest Period (7-45 Days)||2||
48406826|NCT03424044|101328489|FG005|STARTED|Second Rest Period (7-45 Days)||4||
48614231|NCT01854697|101841700|FG001|NOT COMPLETED|Overall Study||3||
48614232|NCT01854697|101841701|FG002|NOT COMPLETED|Overall Study||2||
48614233|NCT01854697|101841702|FG003|NOT COMPLETED|Overall Study||3||
48614234|NCT01854697|101841703|FG004|NOT COMPLETED|Overall Study||2||
48614235|NCT02581488|101841704|FG000|STARTED|Overall Study||51||
48614236|NCT02581488|101841705|FG001|STARTED|Overall Study||51||
48614237|NCT02581488|101841704|FG000|COMPLETED|Overall Study||42||
48614238|NCT02581488|101841705|FG001|COMPLETED|Overall Study||40||
48614239|NCT02581488|101841704|FG000|NOT COMPLETED|Overall Study||9||
48614240|NCT02581488|101841705|FG001|NOT COMPLETED|Overall Study||11||
48614241|NCT03571607|101841706|FG000|STARTED|Overall Study||53||
48614242|NCT03571607|101841707|FG001|STARTED|Overall Study||153||
48614243|NCT03571607|101841706|FG000|Vaccinated|Overall Study||53||
48614244|NCT03571607|101841707|FG001|Vaccinated|Overall Study||153||
48614245|NCT03571607|101841706|FG000|COMPLETED|Overall Study||53||
48729096|NCT02777827|102123197|FG003|NOT COMPLETED|Treatment Period 3||0||
48729097|NCT02777827|102123198|FG004|NOT COMPLETED|Treatment Period 3||0||
48729098|NCT02777827|102123199|FG005|NOT COMPLETED|Treatment Period 3||0||
48729099|NCT02777827|102123194|FG000|STARTED|Washout Between Periods 3 and 4||5||
48729100|NCT02777827|102123195|FG001|STARTED|Washout Between Periods 3 and 4||5||
48729101|NCT02777827|102123196|FG002|STARTED|Washout Between Periods 3 and 4||5||
48729102|NCT02777827|102123197|FG003|STARTED|Washout Between Periods 3 and 4||5||
48729103|NCT02777827|102123198|FG004|STARTED|Washout Between Periods 3 and 4||4||
48729104|NCT02777827|102123199|FG005|STARTED|Washout Between Periods 3 and 4||6||
48729105|NCT02777827|102123194|FG000|COMPLETED|Washout Between Periods 3 and 4||5||
48729106|NCT02777827|102123195|FG001|COMPLETED|Washout Between Periods 3 and 4||5||
48729107|NCT02777827|102123196|FG002|COMPLETED|Washout Between Periods 3 and 4||4||
48729108|NCT02777827|102123197|FG003|COMPLETED|Washout Between Periods 3 and 4||5||
48729109|NCT02777827|102123198|FG004|COMPLETED|Washout Between Periods 3 and 4||4||
48729110|NCT02777827|102123199|FG005|COMPLETED|Washout Between Periods 3 and 4||6||
48729111|NCT02777827|102123194|FG000|NOT COMPLETED|Washout Between Periods 3 and 4||0||
48729112|NCT02777827|102123195|FG001|NOT COMPLETED|Washout Between Periods 3 and 4||0||
48729113|NCT02777827|102123196|FG002|NOT COMPLETED|Washout Between Periods 3 and 4||1||
48729114|NCT02777827|102123197|FG003|NOT COMPLETED|Washout Between Periods 3 and 4||0||
48729115|NCT02777827|102123198|FG004|NOT COMPLETED|Washout Between Periods 3 and 4||0||
48729116|NCT02777827|102123199|FG005|NOT COMPLETED|Washout Between Periods 3 and 4||0||
48312709|NCT01093625|101091176|FG000|NOT COMPLETED|3-Month Visit||2||
48312710|NCT01093625|101091177|FG001|NOT COMPLETED|3-Month Visit||0||
48312711|NCT01093625|101091176|FG000|STARTED|6-Month Visit||42||
48312712|NCT01093625|101091177|FG001|STARTED|6-Month Visit||49||
48312713|NCT01093625|101091176|FG000|COMPLETED|6-Month Visit||34||
48312714|NCT01093625|101091177|FG001|COMPLETED|6-Month Visit||40||
48312715|NCT01093625|101091176|FG000|NOT COMPLETED|6-Month Visit||8||
48312716|NCT01093625|101091177|FG001|NOT COMPLETED|6-Month Visit||9||
48312717|NCT01093625|101091176|FG000|STARTED|1-Year Visit||34||
48312718|NCT01093625|101091177|FG001|STARTED|1-Year Visit||40||
48312719|NCT01093625|101091176|FG000|COMPLETED|1-Year Visit||29||
48312720|NCT01093625|101091177|FG001|COMPLETED|1-Year Visit||37||
48312721|NCT01093625|101091176|FG000|NOT COMPLETED|1-Year Visit||5||
48312722|NCT01093625|101091177|FG001|NOT COMPLETED|1-Year Visit||3||
48312723|NCT02090413|101091178|FG000|STARTED|Overall Study||81||
48312724|NCT02090413|101091179|FG001|STARTED|Overall Study||80||
48312725|NCT02090413|101091180|FG002|STARTED|Overall Study||80||
48312726|NCT02090413|101091178|FG000|COMPLETED|Overall Study||62||
48312727|NCT02090413|101091179|FG001|COMPLETED|Overall Study||60||
48312728|NCT02090413|101091180|FG002|COMPLETED|Overall Study||57||
48312729|NCT02090413|101091178|FG000|NOT COMPLETED|Overall Study||19||
48312730|NCT02090413|101091179|FG001|NOT COMPLETED|Overall Study||20||
48312731|NCT02090413|101091180|FG002|NOT COMPLETED|Overall Study||23||
48312732|NCT02445625|101091181|FG000|STARTED|Overall Study||15||
48312733|NCT02445625|101091181|FG000|COMPLETED|Overall Study||15||
48312734|NCT02445625|101091181|FG000|NOT COMPLETED|Overall Study||0||
48312735|NCT01073267|101091182|FG000|STARTED|Overall Study||4||
48312736|NCT01073267|101091182|FG000|COMPLETED|Overall Study||1||
48312737|NCT01073267|101091182|FG000|NOT COMPLETED|Overall Study||3||
48312738|NCT05144113|101091183|FG000|STARTED|Overall Study||10||
48312739|NCT05144113|101091184|FG001|STARTED|Overall Study||10||
48312740|NCT05144113|101091183|FG000|COMPLETED|Overall Study||10||
48614246|NCT03571607|101841707|FG001|COMPLETED|Overall Study||153||
48729117|NCT02777827|102123194|FG000|STARTED|Treatment Period 4||5||
48729118|NCT02777827|102123195|FG001|STARTED|Treatment Period 4||5||
48729119|NCT02777827|102123196|FG002|STARTED|Treatment Period 4||4||
48729120|NCT02777827|102123197|FG003|STARTED|Treatment Period 4||5||
48729121|NCT02777827|102123198|FG004|STARTED|Treatment Period 4||4||
48729122|NCT02777827|102123199|FG005|STARTED|Treatment Period 4||6||
48729123|NCT02777827|102123194|FG000|COMPLETED|Treatment Period 4||5||
48729124|NCT02777827|102123195|FG001|COMPLETED|Treatment Period 4||5||
48729125|NCT02777827|102123196|FG002|COMPLETED|Treatment Period 4||4||
48729126|NCT02777827|102123197|FG003|COMPLETED|Treatment Period 4||5||
48729127|NCT02777827|102123198|FG004|COMPLETED|Treatment Period 4||4||
48729128|NCT02777827|102123199|FG005|COMPLETED|Treatment Period 4||6||
48729129|NCT02777827|102123194|FG000|NOT COMPLETED|Treatment Period 4||0||
48729130|NCT02777827|102123195|FG001|NOT COMPLETED|Treatment Period 4||0||
48729131|NCT02777827|102123196|FG002|NOT COMPLETED|Treatment Period 4||0||
48729132|NCT02777827|102123197|FG003|NOT COMPLETED|Treatment Period 4||0||
48729133|NCT02777827|102123198|FG004|NOT COMPLETED|Treatment Period 4||0||
48729134|NCT02777827|102123199|FG005|NOT COMPLETED|Treatment Period 4||0||
48729135|NCT02777827|102123194|FG000|STARTED|Washout Between Periods 4 and 5||5||
48729136|NCT02777827|102123195|FG001|STARTED|Washout Between Periods 4 and 5||5||
48157195|NCT00514683|100706887|FG002|COMPLETED|Overall Study||68||
48157196|NCT00514683|100706888|FG003|COMPLETED|Overall Study||72||
48157197|NCT00514683|100706889|FG004|COMPLETED|Overall Study||53||
48157198|NCT00514683|100706885|FG000|NOT COMPLETED|Overall Study||26||
48157199|NCT00514683|100706886|FG001|NOT COMPLETED|Overall Study||25||
48157200|NCT00514683|100706887|FG002|NOT COMPLETED|Overall Study||18||
48157201|NCT00514683|100706888|FG003|NOT COMPLETED|Overall Study||14||
48157202|NCT00514683|100706889|FG004|NOT COMPLETED|Overall Study||33||
48157203|NCT01666808|100706890|FG000|STARTED|Overall Study||83||
48157204|NCT01666808|100706891|FG001|STARTED|Overall Study||82||
48157205|NCT01666808|100706890|FG000|COMPLETED|Overall Study||67||
48157206|NCT01666808|100706891|FG001|COMPLETED|Overall Study||66||
48157207|NCT01666808|100706890|FG000|NOT COMPLETED|Overall Study||16||
48157208|NCT01666808|100706891|FG001|NOT COMPLETED|Overall Study||16||
48157209|NCT00995501|100706892|FG000|STARTED|Overall Study||52||
48157210|NCT00995501|100706893|FG001|STARTED|Overall Study||51||
48157211|NCT00995501|100706894|FG002|STARTED|Overall Study||47||
48157212|NCT00995501|100706895|FG003|STARTED|Overall Study||46||
48157213|NCT00995501|100706896|FG004|STARTED|Overall Study||46||
48157214|NCT00995501|100706897|FG005|STARTED|Overall Study||44||
48157215|NCT00995501|100706898|FG006|STARTED|Overall Study||49||
48157216|NCT00995501|100706899|FG007|STARTED|Overall Study||46||
48729137|NCT02777827|102123196|FG002|STARTED|Washout Between Periods 4 and 5||4||
48157217|NCT00995501|100706892|FG000|COMPLETED|Overall Study||52||
48157218|NCT00995501|100706893|FG001|COMPLETED|Overall Study||51||
48157219|NCT00995501|100706894|FG002|COMPLETED|Overall Study||47||
48729138|NCT02777827|102123197|FG003|STARTED|Washout Between Periods 4 and 5||5||
48729139|NCT02777827|102123198|FG004|STARTED|Washout Between Periods 4 and 5||4||
48729140|NCT02777827|102123199|FG005|STARTED|Washout Between Periods 4 and 5||6||
48729141|NCT02777827|102123194|FG000|COMPLETED|Washout Between Periods 4 and 5||5||
48157220|NCT00995501|100706895|FG003|COMPLETED|Overall Study||46||
48157221|NCT00995501|100706896|FG004|COMPLETED|Overall Study||46||
48157222|NCT00995501|100706897|FG005|COMPLETED|Overall Study||44||
48157223|NCT00995501|100706898|FG006|COMPLETED|Overall Study||49||
48157224|NCT00995501|100706899|FG007|COMPLETED|Overall Study||46||
48729142|NCT02777827|102123195|FG001|COMPLETED|Washout Between Periods 4 and 5||5||
48729143|NCT02777827|102123196|FG002|COMPLETED|Washout Between Periods 4 and 5||4||
48729144|NCT02777827|102123197|FG003|COMPLETED|Washout Between Periods 4 and 5||5||
48729145|NCT02777827|102123198|FG004|COMPLETED|Washout Between Periods 4 and 5||4||
48729146|NCT02777827|102123199|FG005|COMPLETED|Washout Between Periods 4 and 5||6||
48729147|NCT02777827|102123194|FG000|NOT COMPLETED|Washout Between Periods 4 and 5||0||
48729148|NCT02777827|102123195|FG001|NOT COMPLETED|Washout Between Periods 4 and 5||0||
48729149|NCT02777827|102123196|FG002|NOT COMPLETED|Washout Between Periods 4 and 5||0||
48729150|NCT02777827|102123197|FG003|NOT COMPLETED|Washout Between Periods 4 and 5||0||
48729151|NCT02777827|102123198|FG004|NOT COMPLETED|Washout Between Periods 4 and 5||0||
48729152|NCT02777827|102123199|FG005|NOT COMPLETED|Washout Between Periods 4 and 5||0||
48729153|NCT02777827|102123194|FG000|STARTED|Treatment Period 5||5||
48729154|NCT02777827|102123195|FG001|STARTED|Treatment Period 5||5||
48729155|NCT02777827|102123196|FG002|STARTED|Treatment Period 5||4||
48312741|NCT05144113|101091184|FG001|COMPLETED|Overall Study||10||
48312742|NCT05144113|101091183|FG000|NOT COMPLETED|Overall Study||0||
48312743|NCT05144113|101091184|FG001|NOT COMPLETED|Overall Study||0||
48312744|NCT03349099|101091185|FG000|STARTED|Overall Study||48||
48312745|NCT03349099|101091186|FG001|STARTED|Overall Study||47||
48729156|NCT02777827|102123197|FG003|STARTED|Treatment Period 5||5||
48729157|NCT02777827|102123198|FG004|STARTED|Treatment Period 5||4||
48729158|NCT02777827|102123199|FG005|STARTED|Treatment Period 5||6||
48729159|NCT02777827|102123194|FG000|COMPLETED|Treatment Period 5||5||
48729160|NCT02777827|102123195|FG001|COMPLETED|Treatment Period 5||5||
48729161|NCT02777827|102123196|FG002|COMPLETED|Treatment Period 5||4||
48729162|NCT02777827|102123197|FG003|COMPLETED|Treatment Period 5||5||
48729163|NCT02777827|102123198|FG004|COMPLETED|Treatment Period 5||4||
48729164|NCT02777827|102123199|FG005|COMPLETED|Treatment Period 5||6||
48729165|NCT02777827|102123194|FG000|NOT COMPLETED|Treatment Period 5||0||
48729166|NCT02777827|102123195|FG001|NOT COMPLETED|Treatment Period 5||0||
48729167|NCT02777827|102123196|FG002|NOT COMPLETED|Treatment Period 5||0||
48729168|NCT02777827|102123197|FG003|NOT COMPLETED|Treatment Period 5||0||
48729169|NCT02777827|102123198|FG004|NOT COMPLETED|Treatment Period 5||0||
48729170|NCT02777827|102123199|FG005|NOT COMPLETED|Treatment Period 5||0||
48729171|NCT02777827|102123194|FG000|STARTED|Washout Between Periods 5 and 6||5||
48729172|NCT02777827|102123195|FG001|STARTED|Washout Between Periods 5 and 6||5||
48729173|NCT02777827|102123196|FG002|STARTED|Washout Between Periods 5 and 6||4||
48312746|NCT03349099|101091185|FG000|COMPLETED|Overall Study||44||
48312747|NCT03349099|101091186|FG001|COMPLETED|Overall Study||43||
48312748|NCT03349099|101091185|FG000|NOT COMPLETED|Overall Study||4||
48312749|NCT03349099|101091186|FG001|NOT COMPLETED|Overall Study||4||
48312750|NCT02228720|101091187|FG000|STARTED|Open Label - Baseline||15||
48406827|NCT03424044|101328490|FG006|STARTED|Second Rest Period (7-45 Days)||1||
48406828|NCT03424044|101328491|FG007|STARTED|Second Rest Period (7-45 Days)||1||
48729174|NCT02777827|102123197|FG003|STARTED|Washout Between Periods 5 and 6||5||
48729175|NCT02777827|102123198|FG004|STARTED|Washout Between Periods 5 and 6||4||
48729176|NCT02777827|102123199|FG005|STARTED|Washout Between Periods 5 and 6||6||
48729177|NCT02777827|102123194|FG000|COMPLETED|Washout Between Periods 5 and 6||5||
48729178|NCT02777827|102123195|FG001|COMPLETED|Washout Between Periods 5 and 6||5||
48729179|NCT02777827|102123196|FG002|COMPLETED|Washout Between Periods 5 and 6||4||
48729180|NCT02777827|102123197|FG003|COMPLETED|Washout Between Periods 5 and 6||5||
48729181|NCT02777827|102123198|FG004|COMPLETED|Washout Between Periods 5 and 6||4||
48729182|NCT02777827|102123199|FG005|COMPLETED|Washout Between Periods 5 and 6||6||
48729183|NCT02777827|102123194|FG000|NOT COMPLETED|Washout Between Periods 5 and 6||0||
48729184|NCT02777827|102123195|FG001|NOT COMPLETED|Washout Between Periods 5 and 6||0||
48729185|NCT02777827|102123196|FG002|NOT COMPLETED|Washout Between Periods 5 and 6||0||
48729186|NCT02777827|102123197|FG003|NOT COMPLETED|Washout Between Periods 5 and 6||0||
48729187|NCT02777827|102123198|FG004|NOT COMPLETED|Washout Between Periods 5 and 6||0||
48729188|NCT02777827|102123199|FG005|NOT COMPLETED|Washout Between Periods 5 and 6||0||
48729189|NCT02777827|102123194|FG000|STARTED|Treatment Period 6||5||
48729190|NCT02777827|102123195|FG001|STARTED|Treatment Period 6||5||
48729191|NCT02777827|102123196|FG002|STARTED|Treatment Period 6||4||
48729192|NCT02777827|102123197|FG003|STARTED|Treatment Period 6||5||
48729193|NCT02777827|102123198|FG004|STARTED|Treatment Period 6||4||
48729194|NCT02777827|102123199|FG005|STARTED|Treatment Period 6||6||
48729195|NCT02777827|102123194|FG000|COMPLETED|Treatment Period 6||5||
48729196|NCT02777827|102123195|FG001|COMPLETED|Treatment Period 6||5||
48729197|NCT02777827|102123196|FG002|COMPLETED|Treatment Period 6||4||
48729198|NCT02777827|102123197|FG003|COMPLETED|Treatment Period 6||5||
48729199|NCT02777827|102123198|FG004|COMPLETED|Treatment Period 6||4||
48729200|NCT02777827|102123199|FG005|COMPLETED|Treatment Period 6||6||
48729201|NCT02777827|102123194|FG000|NOT COMPLETED|Treatment Period 6||0||
48729202|NCT02777827|102123195|FG001|NOT COMPLETED|Treatment Period 6||0||
48729203|NCT02777827|102123196|FG002|NOT COMPLETED|Treatment Period 6||0||
48729204|NCT02777827|102123197|FG003|NOT COMPLETED|Treatment Period 6||0||
48729205|NCT02777827|102123198|FG004|NOT COMPLETED|Treatment Period 6||0||
48729206|NCT02777827|102123199|FG005|NOT COMPLETED|Treatment Period 6||0||
48729207|NCT00847197|102123200|FG000|STARTED|Overall Study||116||
48729208|NCT00847197|102123201|FG001|STARTED|Overall Study||75||
48729209|NCT00847197|102123200|FG000|COMPLETED|Overall Study||92||
48729210|NCT00847197|102123201|FG001|COMPLETED|Overall Study||70||
48729211|NCT00847197|102123200|FG000|NOT COMPLETED|Overall Study||24||
48729212|NCT00847197|102123201|FG001|NOT COMPLETED|Overall Study||5||
48729213|NCT02428205|102123202|FG000|STARTED|Overall Study||5||
48729214|NCT02428205|102123203|FG001|STARTED|Overall Study||4||
48729215|NCT02428205|102123202|FG000|COMPLETED|Overall Study||3||
48729216|NCT02428205|102123203|FG001|COMPLETED|Overall Study||2||
48729217|NCT02428205|102123202|FG000|NOT COMPLETED|Overall Study||2||
48729218|NCT02428205|102123203|FG001|NOT COMPLETED|Overall Study||2||
48729219|NCT01184417|102123204|FG000|STARTED|Overall Study||51||
48729220|NCT01184417|102123205|FG001|STARTED|Overall Study||51||
48729221|NCT01184417|102123204|FG000|COMPLETED|Overall Study||51||
48729222|NCT01184417|102123205|FG001|COMPLETED|Overall Study||51||
48729223|NCT01184417|102123204|FG000|NOT COMPLETED|Overall Study||0||
48729224|NCT01184417|102123205|FG001|NOT COMPLETED|Overall Study||0||
48729225|NCT00064792|102123206|FG000|STARTED|Overall Study||13||
48729226|NCT00064792|102123207|FG001|STARTED|Overall Study||10||
48729227|NCT00064792|102123206|FG000|COMPLETED|Overall Study||8||
48729228|NCT00064792|102123207|FG001|COMPLETED|Overall Study||10||
48729229|NCT00064792|102123206|FG000|NOT COMPLETED|Overall Study||5||
48729230|NCT00064792|102123207|FG001|NOT COMPLETED|Overall Study||0||
48729231|NCT01860950|102123208|FG000|STARTED|Overall Study||14||
48729232|NCT01860950|102123209|FG001|STARTED|Overall Study||15||
48729233|NCT01860950|102123210|FG002|STARTED|Overall Study||10||
48729234|NCT01860950|102123211|FG003|STARTED|Overall Study||13||
48729235|NCT01860950|102123212|FG004|STARTED|Overall Study||14||
48729236|NCT01860950|102123213|FG005|STARTED|Overall Study||13||
48729237|NCT01860950|102123208|FG000|COMPLETED|Overall Study||14||
48729238|NCT01860950|102123209|FG001|COMPLETED|Overall Study||15||
48729239|NCT01860950|102123210|FG002|COMPLETED|Overall Study||10||
48729240|NCT01860950|102123211|FG003|COMPLETED|Overall Study||13||
48729241|NCT01860950|102123212|FG004|COMPLETED|Overall Study||14||
48729242|NCT01860950|102123213|FG005|COMPLETED|Overall Study||13||
48729243|NCT01860950|102123208|FG000|NOT COMPLETED|Overall Study||0||
48729244|NCT01860950|102123209|FG001|NOT COMPLETED|Overall Study||0||
48729245|NCT01860950|102123210|FG002|NOT COMPLETED|Overall Study||0||
48157225|NCT00995501|100706892|FG000|NOT COMPLETED|Overall Study||0||
48729246|NCT01860950|102123211|FG003|NOT COMPLETED|Overall Study||0||
48729247|NCT01860950|102123212|FG004|NOT COMPLETED|Overall Study||0||
48729248|NCT01860950|102123213|FG005|NOT COMPLETED|Overall Study||0||
48729249|NCT00705146|102123214|FG000|STARTED|Overall Study||32||
48729250|NCT00705146|102123215|FG001|STARTED|Overall Study||24||
48729251|NCT00705146|102123214|FG000|COMPLETED|Overall Study||31||
48729252|NCT00705146|102123215|FG001|COMPLETED|Overall Study||23||
48729253|NCT00705146|102123214|FG000|NOT COMPLETED|Overall Study||1||
48729254|NCT00705146|102123215|FG001|NOT COMPLETED|Overall Study||1||
48729255|NCT04783077|102123216|FG000|STARTED|Overall Study||34||
48729256|NCT04783077|102123217|FG001|STARTED|Overall Study||33||
48729257|NCT04783077|102123218|FG002|STARTED|Overall Study||30||
48729258|NCT04783077|102123219|FG003|STARTED|Overall Study||33||
48729259|NCT04783077|102123220|FG004|STARTED|Overall Study||14||
48729260|NCT04783077|102123216|FG000|COMPLETED|Overall Study||27||
48729261|NCT04783077|102123217|FG001|COMPLETED|Overall Study||30||
48729262|NCT04783077|102123218|FG002|COMPLETED|Overall Study||28||
48729263|NCT04783077|102123219|FG003|COMPLETED|Overall Study||31||
48729264|NCT04783077|102123220|FG004|COMPLETED|Overall Study||14||
48729265|NCT04783077|102123216|FG000|NOT COMPLETED|Overall Study||7||
48729266|NCT04783077|102123217|FG001|NOT COMPLETED|Overall Study||3||
48729267|NCT04783077|102123218|FG002|NOT COMPLETED|Overall Study||2||
48729268|NCT04783077|102123219|FG003|NOT COMPLETED|Overall Study||2||
48729269|NCT04783077|102123220|FG004|NOT COMPLETED|Overall Study||0||
48729270|NCT00391625|102123221|FG000|STARTED|Baseline||10||
48729271|NCT00391625|102123221|FG000|COMPLETED|Baseline||10||
48729272|NCT00391625|102123221|FG000|NOT COMPLETED|Baseline||0||
48729273|NCT00391625|102123221|FG000|STARTED|Month 14||10||
48729274|NCT00391625|102123221|FG000|COMPLETED|Month 14||9||
48729275|NCT00391625|102123221|FG000|NOT COMPLETED|Month 14||1||
48729276|NCT00391625|102123221|FG000|STARTED|Month 50||9||
48729277|NCT00391625|102123221|FG000|COMPLETED|Month 50||8||
48729278|NCT00391625|102123221|FG000|NOT COMPLETED|Month 50||1||
48729279|NCT00391625|102123221|FG000|STARTED|Month 84||8||
48729280|NCT00391625|102123221|FG000|COMPLETED|Month 84||8||
48729281|NCT00391625|102123221|FG000|NOT COMPLETED|Month 84||0||
48729282|NCT02479139|102123222|FG000|STARTED|Overall Study||27||
48729283|NCT02479139|102123223|FG001|STARTED|Overall Study||22||
48729284|NCT02479139|102123224|FG002|STARTED|Overall Study||28||
48729285|NCT02479139|102123225|FG003|STARTED|Overall Study||21||
48729286|NCT02479139|102123226|FG004|STARTED|Overall Study||22||
48729287|NCT02479139|102123227|FG005|STARTED|Overall Study||25||
48729288|NCT02479139|102123222|FG000|COMPLETED|Overall Study||19||
48729289|NCT02479139|102123223|FG001|COMPLETED|Overall Study||12||
48729290|NCT02479139|102123224|FG002|COMPLETED|Overall Study||21||
48729291|NCT02479139|102123225|FG003|COMPLETED|Overall Study||14||
48729292|NCT02479139|102123226|FG004|COMPLETED|Overall Study||17||
48729293|NCT02479139|102123227|FG005|COMPLETED|Overall Study||19||
48729294|NCT02479139|102123222|FG000|NOT COMPLETED|Overall Study||8||
48729295|NCT02479139|102123223|FG001|NOT COMPLETED|Overall Study||10||
48729296|NCT02479139|102123224|FG002|NOT COMPLETED|Overall Study||7||
48729297|NCT02479139|102123225|FG003|NOT COMPLETED|Overall Study||7||
48729298|NCT02479139|102123226|FG004|NOT COMPLETED|Overall Study||5||
48614247|NCT03571607|101841706|FG000|NOT COMPLETED|Overall Study||0||
48614248|NCT03571607|101841707|FG001|NOT COMPLETED|Overall Study||0||
48614249|NCT04878055|101841708|FG000|STARTED|Overall Study||182||
48614250|NCT04878055|101841709|FG001|STARTED|Overall Study||88||
48614251|NCT04878055|101841708|FG000|FAS Population|Overall Study||182||
48614252|NCT04878055|101841709|FG001|FAS Population|Overall Study||88||
48614253|NCT04878055|101841708|FG000|COMPLETED|Overall Study||147||
48614254|NCT04878055|101841709|FG001|COMPLETED|Overall Study||70||
48614255|NCT04878055|101841708|FG000|NOT COMPLETED|Overall Study||35||
48614256|NCT04878055|101841709|FG001|NOT COMPLETED|Overall Study||18||
48614257|NCT01004978|101841710|FG000|STARTED|Overall Study||118||
48614258|NCT01004978|101841711|FG001|STARTED|Overall Study||117||
48157226|NCT00995501|100706893|FG001|NOT COMPLETED|Overall Study||0||
48157227|NCT00995501|100706894|FG002|NOT COMPLETED|Overall Study||0||
48157228|NCT00995501|100706895|FG003|NOT COMPLETED|Overall Study||0||
48157229|NCT00995501|100706896|FG004|NOT COMPLETED|Overall Study||0||
48157230|NCT00995501|100706897|FG005|NOT COMPLETED|Overall Study||0||
48157231|NCT00995501|100706898|FG006|NOT COMPLETED|Overall Study||0||
48157232|NCT00995501|100706899|FG007|NOT COMPLETED|Overall Study||0||
48157233|NCT00658567|100706900|FG000|STARTED|Overall Study||40||
48157234|NCT00658567|100706901|FG001|STARTED|Overall Study||42||
48157235|NCT00658567|100706902|FG002|STARTED|Overall Study||41||
48157236|NCT00658567|100706900|FG000|COMPLETED|Overall Study||32||
48157237|NCT00658567|100706901|FG001|COMPLETED|Overall Study||38||
48157238|NCT00658567|100706902|FG002|COMPLETED|Overall Study||35||
48157239|NCT00658567|100706900|FG000|NOT COMPLETED|Overall Study||8||
48157240|NCT00658567|100706901|FG001|NOT COMPLETED|Overall Study||4||
48729299|NCT02479139|102123227|FG005|NOT COMPLETED|Overall Study||6||
48729300|NCT00753363|102123228|FG000|STARTED|Overall Study||59||
48729301|NCT00753363|102123229|FG001|STARTED|Overall Study||60||
48729302|NCT00753363|102123228|FG000|COMPLETED|Overall Study||19||
48729303|NCT00753363|102123229|FG001|COMPLETED|Overall Study||21||
48729304|NCT00753363|102123228|FG000|NOT COMPLETED|Overall Study||40||
48729305|NCT00753363|102123229|FG001|NOT COMPLETED|Overall Study||39||
48729306|NCT00293020|102123230|FG000|STARTED|Overall Study||244||
48729307|NCT00293020|102123230|FG000|COMPLETED|Overall Study||82||
48157241|NCT00658567|100706902|FG002|NOT COMPLETED|Overall Study||6||
48614259|NCT01004978|101841710|FG000|COMPLETED|Overall Study||0||
48729308|NCT00293020|102123230|FG000|NOT COMPLETED|Overall Study||162||
48729309|NCT02513472|102123231|FG000|STARTED|Overall Study||66||
48729310|NCT02513472|102123232|FG001|STARTED|Overall Study||101||
48157242|NCT01330433|100706903|FG000|STARTED|Overall Study||16||
48157243|NCT01330433|100706904|FG001|STARTED|Overall Study||19||
48614260|NCT01004978|101841711|FG001|COMPLETED|Overall Study||0||
48729311|NCT02513472|102123231|FG000|Phase 1b Safety run-in|Overall Study||3||
48614261|NCT01004978|101841710|FG000|NOT COMPLETED|Overall Study||118||
48729312|NCT02513472|102123232|FG001|Phase 1b Safety run-in|Overall Study||4||
48729313|NCT02513472|102123231|FG000|Phase 2|Overall Study||63||
48729314|NCT02513472|102123232|FG001|Phase 2|Overall Study||97||
48729315|NCT02513472|102123231|FG000|COMPLETED|Overall Study||0||
48729316|NCT02513472|102123232|FG001|COMPLETED|Overall Study||0||
48729317|NCT02513472|102123231|FG000|NOT COMPLETED|Overall Study||66||
48729318|NCT02513472|102123232|FG001|NOT COMPLETED|Overall Study||101||
48729319|NCT02834247|102123233|FG000|STARTED|Dose Escalation Phase||8||
48729320|NCT02834247|102123234|FG001|STARTED|Dose Escalation Phase||11||
48729321|NCT02834247|102123235|FG002|STARTED|Dose Escalation Phase||5||
48729322|NCT02834247|102123236|FG003|STARTED|Dose Escalation Phase||0||
48729323|NCT02834247|102123233|FG000|COMPLETED|Dose Escalation Phase||0||
48729324|NCT02834247|102123234|FG001|COMPLETED|Dose Escalation Phase||0||
48729325|NCT02834247|102123235|FG002|COMPLETED|Dose Escalation Phase||0||
48312751|NCT02228720|101091187|FG000|COMPLETED|Open Label - Baseline||15||
48312752|NCT02228720|101091187|FG000|NOT COMPLETED|Open Label - Baseline||0||
48312753|NCT02228720|101091187|FG000|STARTED|Open Label - Day 30||15||
48312754|NCT02228720|101091187|FG000|COMPLETED|Open Label - Day 30||14||
48312755|NCT02228720|101091187|FG000|NOT COMPLETED|Open Label - Day 30||1||
48312756|NCT02228720|101091187|FG000|STARTED|Open Label - Day 90||14||
48312757|NCT02228720|101091187|FG000|COMPLETED|Open Label - Day 90||14||
48312758|NCT02228720|101091187|FG000|NOT COMPLETED|Open Label - Day 90||0||
48312759|NCT04534491|101091188|FG000|STARTED|Overall Study||855||
48312760|NCT04534491|101091188|FG000|Treated|Overall Study||727||
48312761|NCT04534491|101091188|FG000|COMPLETED|Overall Study||703||
48312762|NCT04534491|101091188|FG000|NOT COMPLETED|Overall Study||152||
48312763|NCT03179891|101091189|FG000|STARTED|First Intervention||13||
48312764|NCT03179891|101091190|FG001|STARTED|First Intervention||22||
48312765|NCT03179891|101091189|FG000|COMPLETED|First Intervention||11||
48312766|NCT03179891|101091190|FG001|COMPLETED|First Intervention||20||
48312767|NCT03179891|101091189|FG000|NOT COMPLETED|First Intervention||2||
48312768|NCT03179891|101091190|FG001|NOT COMPLETED|First Intervention||2||
48312769|NCT03179891|101091189|FG000|STARTED|Second Intervention (After 14 Days)||11||
48312770|NCT03179891|101091190|FG001|STARTED|Second Intervention (After 14 Days)||20||
48312771|NCT03179891|101091189|FG000|COMPLETED|Second Intervention (After 14 Days)||11||
48312772|NCT03179891|101091190|FG001|COMPLETED|Second Intervention (After 14 Days)||20||
48312773|NCT03179891|101091189|FG000|NOT COMPLETED|Second Intervention (After 14 Days)||0||
48312774|NCT03179891|101091190|FG001|NOT COMPLETED|Second Intervention (After 14 Days)||0||
48312775|NCT02705807|101091191|FG000|STARTED|Overall Study||10||
48312776|NCT02705807|101091191|FG000|COMPLETED|Overall Study||10||
48312777|NCT02705807|101091191|FG000|NOT COMPLETED|Overall Study||0||
48312778|NCT00766090|101091192|FG000|STARTED|Treatment Period 1 (28 Days)||25||
48312779|NCT00766090|101091193|FG001|STARTED|Treatment Period 1 (28 Days)||27||
48312780|NCT00766090|101091194|FG002|STARTED|Treatment Period 1 (28 Days)||23||
48312781|NCT00766090|101091195|FG003|STARTED|Treatment Period 1 (28 Days)||26||
48312782|NCT00766090|101091196|FG004|STARTED|Treatment Period 1 (28 Days)||23||
48312783|NCT00766090|101091197|FG005|STARTED|Treatment Period 1 (28 Days)||23||
48312784|NCT00766090|101091198|FG006|STARTED|Treatment Period 1 (28 Days)||6||
48312785|NCT00766090|101091199|FG007|STARTED|Treatment Period 1 (28 Days)||8||
48312786|NCT00766090|101091200|FG008|STARTED|Treatment Period 1 (28 Days)||7||
48312787|NCT00766090|101091201|FG009|STARTED|Treatment Period 1 (28 Days)||8||
48312788|NCT00766090|101091202|FG010|STARTED|Treatment Period 1 (28 Days)||7||
48312789|NCT00766090|101091203|FG011|STARTED|Treatment Period 1 (28 Days)||7||
48312790|NCT00766090|101091192|FG000|COMPLETED|Treatment Period 1 (28 Days)||22||
48312791|NCT00766090|101091193|FG001|COMPLETED|Treatment Period 1 (28 Days)||27||
48312792|NCT00766090|101091194|FG002|COMPLETED|Treatment Period 1 (28 Days)||23||
48312793|NCT00766090|101091195|FG003|COMPLETED|Treatment Period 1 (28 Days)||25||
48312794|NCT00766090|101091196|FG004|COMPLETED|Treatment Period 1 (28 Days)||23||
48312795|NCT00766090|101091197|FG005|COMPLETED|Treatment Period 1 (28 Days)||23||
48312796|NCT00766090|101091198|FG006|COMPLETED|Treatment Period 1 (28 Days)||6||
48406829|NCT03424044|101328492|FG008|STARTED|Second Rest Period (7-45 Days)||1||
48406830|NCT03424044|101328484|FG000|COMPLETED|Second Rest Period (7-45 Days)||4||
48406831|NCT03424044|101328485|FG001|COMPLETED|Second Rest Period (7-45 Days)||3||
48406832|NCT03424044|101328486|FG002|COMPLETED|Second Rest Period (7-45 Days)||2||
48729326|NCT02834247|102123236|FG003|COMPLETED|Dose Escalation Phase||0||
48729327|NCT02834247|102123233|FG000|NOT COMPLETED|Dose Escalation Phase||8||
48729328|NCT02834247|102123234|FG001|NOT COMPLETED|Dose Escalation Phase||11||
48729329|NCT02834247|102123235|FG002|NOT COMPLETED|Dose Escalation Phase||5||
48729330|NCT02834247|102123236|FG003|NOT COMPLETED|Dose Escalation Phase||0||
48729331|NCT02834247|102123233|FG000|STARTED|Dose Expansion Phase||0||
48729332|NCT02834247|102123234|FG001|STARTED|Dose Expansion Phase||0||
48729333|NCT02834247|102123235|FG002|STARTED|Dose Expansion Phase||0||
48729334|NCT02834247|102123236|FG003|STARTED|Dose Expansion Phase||17||
48729335|NCT02834247|102123233|FG000|COMPLETED|Dose Expansion Phase||0||
48729336|NCT02834247|102123234|FG001|COMPLETED|Dose Expansion Phase||0||
48729337|NCT02834247|102123235|FG002|COMPLETED|Dose Expansion Phase||0||
48729338|NCT02834247|102123236|FG003|COMPLETED|Dose Expansion Phase||0||
48729339|NCT02834247|102123233|FG000|NOT COMPLETED|Dose Expansion Phase||0||
48729340|NCT02834247|102123234|FG001|NOT COMPLETED|Dose Expansion Phase||0||
48729341|NCT02834247|102123235|FG002|NOT COMPLETED|Dose Expansion Phase||0||
48729342|NCT02834247|102123236|FG003|NOT COMPLETED|Dose Expansion Phase||17||
48729343|NCT04079114|102123237|FG000|STARTED|Overall Study||166||
48729344|NCT04079114|102123237|FG000|COMPLETED|Overall Study||0||
48729345|NCT04079114|102123237|FG000|NOT COMPLETED|Overall Study||166||
48729346|NCT01868477|102123238|FG000|STARTED|Overall Study||12||
48729347|NCT01868477|102123239|FG001|STARTED|Overall Study||11||
48729348|NCT01868477|102123238|FG000|Switched to EPO+DFX|Overall Study||5|Non-responders who switched to combination therapy at 12 weeks|
48729349|NCT01868477|102123239|FG001|Switched to EPO+DFX|Overall Study||0|Non-responders who switched to combination therapy at 12 weeks|
48729350|NCT01868477|102123238|FG000|Not Switched to EPO+DFX|Overall Study||7|Responders who were not switched to combination therapy at 12 weeks|
48729351|NCT01868477|102123239|FG001|Not Switched to EPO+DFX|Overall Study||0|Responders who were not switched to combination therapy at 12 weeks|
48729352|NCT01868477|102123238|FG000|COMPLETED|Overall Study||8||
48312797|NCT00766090|101091199|FG007|COMPLETED|Treatment Period 1 (28 Days)||8||
48729353|NCT01868477|102123239|FG001|COMPLETED|Overall Study||6||
48729354|NCT01868477|102123238|FG000|NOT COMPLETED|Overall Study||4||
48729355|NCT01868477|102123239|FG001|NOT COMPLETED|Overall Study||5||
48729356|NCT02868229|102123240|FG000|STARTED|Overall Study||12||
48729357|NCT02868229|102123241|FG001|STARTED|Overall Study||16||
48729358|NCT02868229|102123242|FG002|STARTED|Overall Study||16||
48729359|NCT02868229|102123243|FG003|STARTED|Overall Study||17||
48729360|NCT02868229|102123240|FG000|Intent to Treat (ITT) Population|Overall Study||12||
48312798|NCT00766090|101091200|FG008|COMPLETED|Treatment Period 1 (28 Days)||6||
48312799|NCT00766090|101091201|FG009|COMPLETED|Treatment Period 1 (28 Days)||8||
48312800|NCT00766090|101091202|FG010|COMPLETED|Treatment Period 1 (28 Days)||7||
48729361|NCT02868229|102123241|FG001|Intent to Treat (ITT) Population|Overall Study||16||
48729362|NCT02868229|102123242|FG002|Intent to Treat (ITT) Population|Overall Study||16||
48312801|NCT00766090|101091203|FG011|COMPLETED|Treatment Period 1 (28 Days)||7||
48312802|NCT00766090|101091192|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||3||
48312803|NCT00766090|101091193|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
48312804|NCT00766090|101091194|FG002|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
48312805|NCT00766090|101091195|FG003|NOT COMPLETED|Treatment Period 1 (28 Days)||1||
48312806|NCT00766090|101091196|FG004|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
48729363|NCT02868229|102123243|FG003|Intent to Treat (ITT) Population|Overall Study||17||
48729364|NCT02868229|102123240|FG000|Pharmacodynamic (PD) Population|Overall Study||12||
48729365|NCT02868229|102123241|FG001|Pharmacodynamic (PD) Population|Overall Study||16||
48729366|NCT02868229|102123242|FG002|Pharmacodynamic (PD) Population|Overall Study||13||
48729367|NCT02868229|102123243|FG003|Pharmacodynamic (PD) Population|Overall Study||12||
48729368|NCT02868229|102123240|FG000|Pharmacokinetic (PK) Population|Overall Study||12||
48729369|NCT02868229|102123241|FG001|Pharmacokinetic (PK) Population|Overall Study||16||
48729370|NCT02868229|102123242|FG002|Pharmacokinetic (PK) Population|Overall Study||16||
48312807|NCT00766090|101091197|FG005|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
48312808|NCT00766090|101091198|FG006|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
48312809|NCT00766090|101091199|FG007|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
48312810|NCT00766090|101091200|FG008|NOT COMPLETED|Treatment Period 1 (28 Days)||1||
48312811|NCT00766090|101091201|FG009|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
48312812|NCT00766090|101091202|FG010|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
48312813|NCT00766090|101091203|FG011|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
48312814|NCT00766090|101091192|FG000|STARTED|Washout Period 1 (14 Days)||22||
48312815|NCT00766090|101091193|FG001|STARTED|Washout Period 1 (14 Days)||27||
48312816|NCT00766090|101091194|FG002|STARTED|Washout Period 1 (14 Days)||23||
48312817|NCT00766090|101091195|FG003|STARTED|Washout Period 1 (14 Days)||25||
48729371|NCT02868229|102123243|FG003|Pharmacokinetic (PK) Population|Overall Study||17||
48729372|NCT02868229|102123240|FG000|Safety Analysis Population|Overall Study||12||
48729373|NCT02868229|102123241|FG001|Safety Analysis Population|Overall Study||16||
48729374|NCT02868229|102123242|FG002|Safety Analysis Population|Overall Study||16||
48729375|NCT02868229|102123243|FG003|Safety Analysis Population|Overall Study||17||
48729376|NCT02868229|102123240|FG000|Maximum Tolerated Dose (MTD) Population|Overall Study||12||
48729377|NCT02868229|102123241|FG001|Maximum Tolerated Dose (MTD) Population|Overall Study||16||
48729378|NCT02868229|102123242|FG002|Maximum Tolerated Dose (MTD) Population|Overall Study||16||
48729379|NCT02868229|102123243|FG003|Maximum Tolerated Dose (MTD) Population|Overall Study||16||
48729380|NCT02868229|102123240|FG000|COMPLETED|Overall Study||11||
48729381|NCT02868229|102123241|FG001|COMPLETED|Overall Study||16||
48729382|NCT02868229|102123242|FG002|COMPLETED|Overall Study||15||
48729383|NCT02868229|102123243|FG003|COMPLETED|Overall Study||12||
48312818|NCT00766090|101091196|FG004|STARTED|Washout Period 1 (14 Days)||23||
48312819|NCT00766090|101091197|FG005|STARTED|Washout Period 1 (14 Days)||23||
48729384|NCT02868229|102123240|FG000|NOT COMPLETED|Overall Study||1||
48729385|NCT02868229|102123241|FG001|NOT COMPLETED|Overall Study||0||
48312820|NCT00766090|101091198|FG006|STARTED|Washout Period 1 (14 Days)||6||
48312821|NCT00766090|101091199|FG007|STARTED|Washout Period 1 (14 Days)||8||
48312822|NCT00766090|101091200|FG008|STARTED|Washout Period 1 (14 Days)||6||
48312823|NCT00766090|101091201|FG009|STARTED|Washout Period 1 (14 Days)||8||
48312824|NCT00766090|101091202|FG010|STARTED|Washout Period 1 (14 Days)||7||
48312825|NCT00766090|101091203|FG011|STARTED|Washout Period 1 (14 Days)||7||
48312826|NCT00766090|101091192|FG000|COMPLETED|Washout Period 1 (14 Days)||22||
48312827|NCT00766090|101091193|FG001|COMPLETED|Washout Period 1 (14 Days)||27||
48312828|NCT00766090|101091194|FG002|COMPLETED|Washout Period 1 (14 Days)||22||
48312829|NCT00766090|101091195|FG003|COMPLETED|Washout Period 1 (14 Days)||25||
48312830|NCT00766090|101091196|FG004|COMPLETED|Washout Period 1 (14 Days)||23||
48312831|NCT00766090|101091197|FG005|COMPLETED|Washout Period 1 (14 Days)||23||
48312832|NCT00766090|101091198|FG006|COMPLETED|Washout Period 1 (14 Days)||6||
48312833|NCT00766090|101091199|FG007|COMPLETED|Washout Period 1 (14 Days)||8||
48312834|NCT00766090|101091200|FG008|COMPLETED|Washout Period 1 (14 Days)||6||
48312835|NCT00766090|101091201|FG009|COMPLETED|Washout Period 1 (14 Days)||8||
48312836|NCT00766090|101091202|FG010|COMPLETED|Washout Period 1 (14 Days)||7||
48312837|NCT00766090|101091203|FG011|COMPLETED|Washout Period 1 (14 Days)||7||
48312838|NCT00766090|101091192|FG000|NOT COMPLETED|Washout Period 1 (14 Days)||0||
48312839|NCT00766090|101091193|FG001|NOT COMPLETED|Washout Period 1 (14 Days)||0||
48312840|NCT00766090|101091194|FG002|NOT COMPLETED|Washout Period 1 (14 Days)||1||
48312841|NCT00766090|101091195|FG003|NOT COMPLETED|Washout Period 1 (14 Days)||0||
48312842|NCT00766090|101091196|FG004|NOT COMPLETED|Washout Period 1 (14 Days)||0||
48312843|NCT00766090|101091197|FG005|NOT COMPLETED|Washout Period 1 (14 Days)||0||
48312844|NCT00766090|101091198|FG006|NOT COMPLETED|Washout Period 1 (14 Days)||0||
48312845|NCT00766090|101091199|FG007|NOT COMPLETED|Washout Period 1 (14 Days)||0||
48312846|NCT00766090|101091200|FG008|NOT COMPLETED|Washout Period 1 (14 Days)||0||
48312847|NCT00766090|101091201|FG009|NOT COMPLETED|Washout Period 1 (14 Days)||0||
48312848|NCT00766090|101091202|FG010|NOT COMPLETED|Washout Period 1 (14 Days)||0||
48312849|NCT00766090|101091203|FG011|NOT COMPLETED|Washout Period 1 (14 Days)||0||
48312850|NCT00766090|101091192|FG000|STARTED|Treatment Period 2 (28 Days)||22||
48312851|NCT00766090|101091193|FG001|STARTED|Treatment Period 2 (28 Days)||27||
48312852|NCT00766090|101091194|FG002|STARTED|Treatment Period 2 (28 Days)||22||
48312853|NCT00766090|101091195|FG003|STARTED|Treatment Period 2 (28 Days)||25||
48312854|NCT00766090|101091196|FG004|STARTED|Treatment Period 2 (28 Days)||23||
48312855|NCT00766090|101091197|FG005|STARTED|Treatment Period 2 (28 Days)||23||
48312856|NCT00766090|101091198|FG006|STARTED|Treatment Period 2 (28 Days)||6||
48312857|NCT00766090|101091199|FG007|STARTED|Treatment Period 2 (28 Days)||8||
48312858|NCT00766090|101091200|FG008|STARTED|Treatment Period 2 (28 Days)||6||
48312859|NCT00766090|101091201|FG009|STARTED|Treatment Period 2 (28 Days)||8||
48312860|NCT00766090|101091202|FG010|STARTED|Treatment Period 2 (28 Days)||7||
48312861|NCT00766090|101091203|FG011|STARTED|Treatment Period 2 (28 Days)||7||
48312862|NCT00766090|101091192|FG000|COMPLETED|Treatment Period 2 (28 Days)||22||
48312863|NCT00766090|101091193|FG001|COMPLETED|Treatment Period 2 (28 Days)||27||
48312864|NCT00766090|101091194|FG002|COMPLETED|Treatment Period 2 (28 Days)||21||
48312865|NCT00766090|101091195|FG003|COMPLETED|Treatment Period 2 (28 Days)||25||
48312866|NCT00766090|101091196|FG004|COMPLETED|Treatment Period 2 (28 Days)||21||
48312867|NCT00766090|101091197|FG005|COMPLETED|Treatment Period 2 (28 Days)||23||
48312868|NCT00766090|101091198|FG006|COMPLETED|Treatment Period 2 (28 Days)||6||
48312869|NCT00766090|101091199|FG007|COMPLETED|Treatment Period 2 (28 Days)||8||
48312870|NCT00766090|101091200|FG008|COMPLETED|Treatment Period 2 (28 Days)||6||
48312871|NCT00766090|101091201|FG009|COMPLETED|Treatment Period 2 (28 Days)||8||
48312872|NCT00766090|101091202|FG010|COMPLETED|Treatment Period 2 (28 Days)||7||
48312873|NCT00766090|101091203|FG011|COMPLETED|Treatment Period 2 (28 Days)||7||
48312874|NCT00766090|101091192|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
48312875|NCT00766090|101091193|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
48312876|NCT00766090|101091194|FG002|NOT COMPLETED|Treatment Period 2 (28 Days)||1||
48312877|NCT00766090|101091195|FG003|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
48312878|NCT00766090|101091196|FG004|NOT COMPLETED|Treatment Period 2 (28 Days)||2||
48312879|NCT00766090|101091197|FG005|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
48312880|NCT00766090|101091198|FG006|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
48312881|NCT00766090|101091199|FG007|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
48312882|NCT00766090|101091200|FG008|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
48312883|NCT00766090|101091201|FG009|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
48312884|NCT00766090|101091202|FG010|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
48312885|NCT00766090|101091203|FG011|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
48312886|NCT00766090|101091192|FG000|STARTED|Washout Period 2 (14 Days)||22||
48312887|NCT00766090|101091193|FG001|STARTED|Washout Period 2 (14 Days)||27||
48312888|NCT00766090|101091194|FG002|STARTED|Washout Period 2 (14 Days)||21||
48312889|NCT00766090|101091195|FG003|STARTED|Washout Period 2 (14 Days)||25||
48312890|NCT00766090|101091196|FG004|STARTED|Washout Period 2 (14 Days)||21||
48312891|NCT00766090|101091197|FG005|STARTED|Washout Period 2 (14 Days)||23||
48312892|NCT00766090|101091198|FG006|STARTED|Washout Period 2 (14 Days)||6||
48312893|NCT00766090|101091199|FG007|STARTED|Washout Period 2 (14 Days)||8||
48312894|NCT00766090|101091200|FG008|STARTED|Washout Period 2 (14 Days)||6||
48312895|NCT00766090|101091201|FG009|STARTED|Washout Period 2 (14 Days)||8||
48312896|NCT00766090|101091202|FG010|STARTED|Washout Period 2 (14 Days)||7||
48312897|NCT00766090|101091203|FG011|STARTED|Washout Period 2 (14 Days)||7||
48312898|NCT00766090|101091192|FG000|COMPLETED|Washout Period 2 (14 Days)||22||
48312899|NCT00766090|101091193|FG001|COMPLETED|Washout Period 2 (14 Days)||27||
48312900|NCT00766090|101091194|FG002|COMPLETED|Washout Period 2 (14 Days)||20||
48312901|NCT00766090|101091195|FG003|COMPLETED|Washout Period 2 (14 Days)||25||
48312902|NCT00766090|101091196|FG004|COMPLETED|Washout Period 2 (14 Days)||21||
48312903|NCT00766090|101091197|FG005|COMPLETED|Washout Period 2 (14 Days)||23||
48312904|NCT00766090|101091198|FG006|COMPLETED|Washout Period 2 (14 Days)||6||
48312905|NCT00766090|101091199|FG007|COMPLETED|Washout Period 2 (14 Days)||8||
48312906|NCT00766090|101091200|FG008|COMPLETED|Washout Period 2 (14 Days)||6||
48312907|NCT00766090|101091201|FG009|COMPLETED|Washout Period 2 (14 Days)||8||
48312908|NCT00766090|101091202|FG010|COMPLETED|Washout Period 2 (14 Days)||7||
48312909|NCT00766090|101091203|FG011|COMPLETED|Washout Period 2 (14 Days)||7||
48312910|NCT00766090|101091192|FG000|NOT COMPLETED|Washout Period 2 (14 Days)||0||
48312911|NCT00766090|101091193|FG001|NOT COMPLETED|Washout Period 2 (14 Days)||0||
48312912|NCT00766090|101091194|FG002|NOT COMPLETED|Washout Period 2 (14 Days)||1||
48312913|NCT00766090|101091195|FG003|NOT COMPLETED|Washout Period 2 (14 Days)||0||
48312914|NCT00766090|101091196|FG004|NOT COMPLETED|Washout Period 2 (14 Days)||0||
48312915|NCT00766090|101091197|FG005|NOT COMPLETED|Washout Period 2 (14 Days)||0||
48312916|NCT00766090|101091198|FG006|NOT COMPLETED|Washout Period 2 (14 Days)||0||
48312917|NCT00766090|101091199|FG007|NOT COMPLETED|Washout Period 2 (14 Days)||0||
48312918|NCT00766090|101091200|FG008|NOT COMPLETED|Washout Period 2 (14 Days)||0||
48312919|NCT00766090|101091201|FG009|NOT COMPLETED|Washout Period 2 (14 Days)||0||
48312920|NCT00766090|101091202|FG010|NOT COMPLETED|Washout Period 2 (14 Days)||0||
48312921|NCT00766090|101091203|FG011|NOT COMPLETED|Washout Period 2 (14 Days)||0||
48312922|NCT00766090|101091192|FG000|STARTED|Treatment Period 3 (28 Days)||22||
48312923|NCT00766090|101091193|FG001|STARTED|Treatment Period 3 (28 Days)||27||
48312924|NCT00766090|101091194|FG002|STARTED|Treatment Period 3 (28 Days)||20||
48312925|NCT00766090|101091195|FG003|STARTED|Treatment Period 3 (28 Days)||25||
48312926|NCT00766090|101091196|FG004|STARTED|Treatment Period 3 (28 Days)||21||
48312927|NCT00766090|101091197|FG005|STARTED|Treatment Period 3 (28 Days)||23||
48312928|NCT00766090|101091198|FG006|STARTED|Treatment Period 3 (28 Days)||6||
48312929|NCT00766090|101091199|FG007|STARTED|Treatment Period 3 (28 Days)||8||
48312930|NCT00766090|101091200|FG008|STARTED|Treatment Period 3 (28 Days)||6||
48312931|NCT00766090|101091201|FG009|STARTED|Treatment Period 3 (28 Days)||8||
48312932|NCT00766090|101091202|FG010|STARTED|Treatment Period 3 (28 Days)||7||
48312933|NCT00766090|101091203|FG011|STARTED|Treatment Period 3 (28 Days)||7||
48312934|NCT00766090|101091192|FG000|COMPLETED|Treatment Period 3 (28 Days)||22||
48312935|NCT00766090|101091193|FG001|COMPLETED|Treatment Period 3 (28 Days)||26||
48312936|NCT00766090|101091194|FG002|COMPLETED|Treatment Period 3 (28 Days)||20||
48312937|NCT00766090|101091195|FG003|COMPLETED|Treatment Period 3 (28 Days)||24||
48312938|NCT00766090|101091196|FG004|COMPLETED|Treatment Period 3 (28 Days)||20||
48312939|NCT00766090|101091197|FG005|COMPLETED|Treatment Period 3 (28 Days)||22||
48312940|NCT00766090|101091198|FG006|COMPLETED|Treatment Period 3 (28 Days)||6||
48312941|NCT00766090|101091199|FG007|COMPLETED|Treatment Period 3 (28 Days)||8||
48312942|NCT00766090|101091200|FG008|COMPLETED|Treatment Period 3 (28 Days)||6||
48312943|NCT00766090|101091201|FG009|COMPLETED|Treatment Period 3 (28 Days)||8||
48312944|NCT00766090|101091202|FG010|COMPLETED|Treatment Period 3 (28 Days)||7||
48312945|NCT00766090|101091203|FG011|COMPLETED|Treatment Period 3 (28 Days)||6||
48312946|NCT00766090|101091192|FG000|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
48312947|NCT00766090|101091193|FG001|NOT COMPLETED|Treatment Period 3 (28 Days)||1||
48312948|NCT00766090|101091194|FG002|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
48312949|NCT00766090|101091195|FG003|NOT COMPLETED|Treatment Period 3 (28 Days)||1||
48312950|NCT00766090|101091196|FG004|NOT COMPLETED|Treatment Period 3 (28 Days)||1||
48312951|NCT00766090|101091197|FG005|NOT COMPLETED|Treatment Period 3 (28 Days)||1||
48312952|NCT00766090|101091198|FG006|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
48312953|NCT00766090|101091199|FG007|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
48312954|NCT00766090|101091200|FG008|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
48312955|NCT00766090|101091201|FG009|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
48312956|NCT00766090|101091202|FG010|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
48312957|NCT00766090|101091203|FG011|NOT COMPLETED|Treatment Period 3 (28 Days)||1||
48312958|NCT01396226|101091204|FG000|STARTED|Overall Study||12||
48312959|NCT01396226|101091205|FG001|STARTED|Overall Study||6||
48312960|NCT01396226|101091204|FG000|Patients Who Received Treatment|Overall Study||12||
48312961|NCT01396226|101091205|FG001|Patients Who Received Treatment|Overall Study||6||
48312962|NCT01396226|101091204|FG000|Patients Who Completed Treatment|Overall Study||12||
48312963|NCT01396226|101091205|FG001|Patients Who Completed Treatment|Overall Study||6||
48312964|NCT01396226|101091204|FG000|COMPLETED|Overall Study||12||
48312965|NCT01396226|101091205|FG001|COMPLETED|Overall Study||6||
48312966|NCT01396226|101091204|FG000|NOT COMPLETED|Overall Study||0||
48312967|NCT01396226|101091205|FG001|NOT COMPLETED|Overall Study||0||
48312968|NCT02023242|101091206|FG000|STARTED|Overall Study||75||
48312969|NCT02023242|101091207|FG001|STARTED|Overall Study||77||
48312970|NCT02023242|101091206|FG000|COMPLETED|Overall Study||72||
48312971|NCT02023242|101091207|FG001|COMPLETED|Overall Study||75||
48312972|NCT02023242|101091206|FG000|NOT COMPLETED|Overall Study||3||
48312973|NCT02023242|101091207|FG001|NOT COMPLETED|Overall Study||2||
48312974|NCT01299376|101091208|FG000|STARTED|Double-blind Treatment (Weeks 1 to 8)||141||
48312975|NCT01299376|101091209|FG001|STARTED|Double-blind Treatment (Weeks 1 to 8)||145||
48312976|NCT01299376|101091208|FG000|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||134||
48312977|NCT01299376|101091209|FG001|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||133||
48312978|NCT01299376|101091208|FG000|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||7||
48312979|NCT01299376|101091209|FG001|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||12||
48312980|NCT01299376|101091208|FG000|STARTED|Extension (Weeks 9 to 52)||134||
48312981|NCT01299376|101091209|FG001|STARTED|Extension (Weeks 9 to 52)||133||
48312982|NCT01299376|101091208|FG000|COMPLETED|Extension (Weeks 9 to 52)||124||
48312983|NCT01299376|101091209|FG001|COMPLETED|Extension (Weeks 9 to 52)||118||
48312984|NCT01299376|101091208|FG000|NOT COMPLETED|Extension (Weeks 9 to 52)||10||
48312985|NCT01299376|101091209|FG001|NOT COMPLETED|Extension (Weeks 9 to 52)||15||
48312986|NCT00482703|101091210|FG000|STARTED|Overall Study||11||
48312987|NCT00482703|101091211|FG001|STARTED|Overall Study||12||
48312988|NCT00482703|101091210|FG000|COMPLETED|Overall Study||10||
48312989|NCT00482703|101091211|FG001|COMPLETED|Overall Study||12||
48312990|NCT00482703|101091210|FG000|NOT COMPLETED|Overall Study||1||
48312991|NCT00482703|101091211|FG001|NOT COMPLETED|Overall Study||0||
48312992|NCT00312221|101091212|FG000|STARTED|Open-label Run-in Period||652||
48312993|NCT00312221|101091213|FG001|STARTED|Open-label Run-in Period||0||
48312994|NCT00312221|101091214|FG002|STARTED|Open-label Run-in Period||0||
48312995|NCT00312221|101091215|FG003|STARTED|Open-label Run-in Period||0||
48312996|NCT00312221|101091212|FG000|COMPLETED|Open-label Run-in Period||418||
48312997|NCT00312221|101091213|FG001|COMPLETED|Open-label Run-in Period||0||
48312998|NCT00312221|101091214|FG002|COMPLETED|Open-label Run-in Period||0||
48312999|NCT00312221|101091215|FG003|COMPLETED|Open-label Run-in Period||0||
48313000|NCT00312221|101091212|FG000|NOT COMPLETED|Open-label Run-in Period||234||
48313001|NCT00312221|101091213|FG001|NOT COMPLETED|Open-label Run-in Period||0||
48313002|NCT00312221|101091214|FG002|NOT COMPLETED|Open-label Run-in Period||0||
48313003|NCT00312221|101091215|FG003|NOT COMPLETED|Open-label Run-in Period||0||
48313004|NCT00312221|101091212|FG000|STARTED|Double-blind Phase||0||
48313005|NCT00312221|101091213|FG001|STARTED|Double-blind Phase||136||
48313006|NCT00312221|101091214|FG002|STARTED|Double-blind Phase||149||
48313007|NCT00312221|101091215|FG003|STARTED|Double-blind Phase||133||
48313008|NCT00312221|101091212|FG000|COMPLETED|Double-blind Phase||0||
48313009|NCT00312221|101091213|FG001|COMPLETED|Double-blind Phase||77||
48313010|NCT00312221|101091214|FG002|COMPLETED|Double-blind Phase||77||
48729386|NCT02868229|102123242|FG002|NOT COMPLETED|Overall Study||1||
48729387|NCT02868229|102123243|FG003|NOT COMPLETED|Overall Study||5||
48729388|NCT01298765|102123244|FG000|STARTED|Titration Period||302||
48729389|NCT01298765|102123244|FG000|COMPLETED|Titration Period||226||
48729390|NCT01298765|102123244|FG000|NOT COMPLETED|Titration Period||76||
48729391|NCT01298765|102123244|FG000|STARTED|Long-Term Treatment Period||226||
48729392|NCT01298765|102123244|FG000|COMPLETED|Long-Term Treatment Period||127||
48313011|NCT00312221|101091215|FG003|COMPLETED|Double-blind Phase||63||
48313012|NCT00312221|101091212|FG000|NOT COMPLETED|Double-blind Phase||0||
48313013|NCT00312221|101091213|FG001|NOT COMPLETED|Double-blind Phase||59||
48313014|NCT00312221|101091214|FG002|NOT COMPLETED|Double-blind Phase||72||
48313015|NCT00312221|101091215|FG003|NOT COMPLETED|Double-blind Phase||70||
48313016|NCT01129921|101091216|FG000|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20||
48313017|NCT01129921|101091217|FG001|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20||
48313018|NCT01129921|101091216|FG000|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20||
48313019|NCT01129921|101091217|FG001|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20||
48313020|NCT01129921|101091216|FG000|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0||
48313021|NCT01129921|101091217|FG001|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0||
48313022|NCT01129921|101091216|FG000|STARTED|After Sham Cross-over to Mild, One Year||20||
48729393|NCT01298765|102123244|FG000|NOT COMPLETED|Long-Term Treatment Period||99||
48729394|NCT02540668|102123245|FG000|STARTED|Period 1 - Warfarin Single Dose||15||
48729395|NCT02540668|102123246|FG001|STARTED|Period 1 - Warfarin Single Dose||0||
48729396|NCT02540668|102123245|FG000|Received at Least One Dose of Study Drug|Period 1 - Warfarin Single Dose||15||
48729397|NCT02540668|102123246|FG001|Received at Least One Dose of Study Drug|Period 1 - Warfarin Single Dose||0||
48729398|NCT02540668|102123245|FG000|COMPLETED|Period 1 - Warfarin Single Dose||15||
48729399|NCT02540668|102123246|FG001|COMPLETED|Period 1 - Warfarin Single Dose||0||
48729400|NCT02540668|102123245|FG000|NOT COMPLETED|Period 1 - Warfarin Single Dose||0||
48729401|NCT02540668|102123246|FG001|NOT COMPLETED|Period 1 - Warfarin Single Dose||0||
48729402|NCT02540668|102123245|FG000|STARTED|Period 2 - LY3314814 and Warfarin||0||
48729403|NCT02540668|102123246|FG001|STARTED|Period 2 - LY3314814 and Warfarin||15||
48729404|NCT02540668|102123245|FG000|COMPLETED|Period 2 - LY3314814 and Warfarin||0||
48313023|NCT01129921|101091217|FG001|STARTED|After Sham Cross-over to Mild, One Year||20||
48313024|NCT01129921|101091216|FG000|COMPLETED|After Sham Cross-over to Mild, One Year||18||
48313025|NCT01129921|101091217|FG001|COMPLETED|After Sham Cross-over to Mild, One Year||13||
48313026|NCT01129921|101091216|FG000|NOT COMPLETED|After Sham Cross-over to Mild, One Year||2||
48313027|NCT01129921|101091217|FG001|NOT COMPLETED|After Sham Cross-over to Mild, One Year||7||
48313028|NCT02327052|101091218|FG000|STARTED|Overall Study||58||
48313029|NCT02327052|101091218|FG000|COMPLETED|Overall Study||58||
48313030|NCT02327052|101091218|FG000|NOT COMPLETED|Overall Study||0||
48313031|NCT00314353|101091219|FG000|STARTED|Protocol Therapy (8 Cycles)||4||
48313032|NCT00314353|101091220|FG001|STARTED|Protocol Therapy (8 Cycles)||3||
48313033|NCT00314353|101091219|FG000|COMPLETED|Protocol Therapy (8 Cycles)||2||
48313034|NCT00314353|101091220|FG001|COMPLETED|Protocol Therapy (8 Cycles)||0||
48313035|NCT00314353|101091219|FG000|NOT COMPLETED|Protocol Therapy (8 Cycles)||2||
48313036|NCT00314353|101091220|FG001|NOT COMPLETED|Protocol Therapy (8 Cycles)||3||
48313037|NCT00314353|101091219|FG000|STARTED|Follow-up||3||
48313038|NCT00314353|101091220|FG001|STARTED|Follow-up||0||
48313039|NCT00314353|101091219|FG000|COMPLETED|Follow-up||3||
48313040|NCT00314353|101091220|FG001|COMPLETED|Follow-up||0||
48313041|NCT00314353|101091219|FG000|NOT COMPLETED|Follow-up||0||
48313042|NCT00314353|101091220|FG001|NOT COMPLETED|Follow-up||0||
48313043|NCT03441334|101091221|FG000|STARTED|Overall Study||1||
48313044|NCT03441334|101091222|FG001|STARTED|Overall Study||0||
48313045|NCT03441334|101091221|FG000|COMPLETED|Overall Study||0||
48313046|NCT03441334|101091222|FG001|COMPLETED|Overall Study||0||
48313047|NCT03441334|101091221|FG000|NOT COMPLETED|Overall Study||1||
48313048|NCT03441334|101091222|FG001|NOT COMPLETED|Overall Study||0||
48313049|NCT00063570|101091223|FG000|STARTED|Overall Study||52||
48313050|NCT00063570|101091224|FG001|STARTED|Overall Study||21||
48313051|NCT00063570|101091223|FG000|COMPLETED|Overall Study||52||
48313052|NCT00063570|101091224|FG001|COMPLETED|Overall Study||21||
48313053|NCT00063570|101091223|FG000|NOT COMPLETED|Overall Study||0||
48313054|NCT00063570|101091224|FG001|NOT COMPLETED|Overall Study||0||
48729405|NCT02540668|102123246|FG001|COMPLETED|Period 2 - LY3314814 and Warfarin||14||
48729406|NCT02540668|102123245|FG000|NOT COMPLETED|Period 2 - LY3314814 and Warfarin||0||
48729407|NCT02540668|102123246|FG001|NOT COMPLETED|Period 2 - LY3314814 and Warfarin||1||
48729408|NCT03772665|102123247|FG000|STARTED|Overall Study||128||
48157244|NCT01330433|100706903|FG000|COMPLETED|Overall Study||14||
48157245|NCT01330433|100706904|FG001|COMPLETED|Overall Study||16||
48157246|NCT01330433|100706903|FG000|NOT COMPLETED|Overall Study||2||
48157247|NCT01330433|100706904|FG001|NOT COMPLETED|Overall Study||3||
48313055|NCT04366050|101091225|FG000|STARTED|Overall Study||79||
48313056|NCT04366050|101091226|FG001|STARTED|Overall Study||35||
48313057|NCT04366050|101091225|FG000|COMPLETED|Overall Study||68||
48313058|NCT04366050|101091226|FG001|COMPLETED|Overall Study||32||
48313059|NCT04366050|101091225|FG000|NOT COMPLETED|Overall Study||11||
48729409|NCT03772665|102123248|FG001|STARTED|Overall Study||66||
48729410|NCT03772665|102123247|FG000|COMPLETED|Overall Study||127||
48729411|NCT03772665|102123248|FG001|COMPLETED|Overall Study||66||
48729412|NCT03772665|102123247|FG000|NOT COMPLETED|Overall Study||1||
48729413|NCT03772665|102123248|FG001|NOT COMPLETED|Overall Study||0||
48157248|NCT03882879|100706905|FG000|STARTED|Overall Study||27||
48157249|NCT03882879|100706906|FG001|STARTED|Overall Study||25||
48157250|NCT03882879|100706905|FG000|6-month Visit|Overall Study||19||
48157251|NCT03882879|100706906|FG001|6-month Visit|Overall Study||20||
48157252|NCT03882879|100706905|FG000|COMPLETED|Overall Study||18||
48157253|NCT03882879|100706906|FG001|COMPLETED|Overall Study||12||
48157254|NCT03882879|100706905|FG000|NOT COMPLETED|Overall Study||9||
48157255|NCT03882879|100706906|FG001|NOT COMPLETED|Overall Study||13||
48157256|NCT03243422|100706907|FG000|STARTED|Overall Study||487||
48157257|NCT03243422|100706908|FG001|STARTED|Overall Study||490||
48157258|NCT03243422|100706907|FG000|COMPLETED|Overall Study||436||
48157259|NCT03243422|100706908|FG001|COMPLETED|Overall Study||440||
48157260|NCT03243422|100706907|FG000|NOT COMPLETED|Overall Study||51||
48157261|NCT03243422|100706908|FG001|NOT COMPLETED|Overall Study||50||
48157262|NCT03988166|100706909|FG000|STARTED|Overall Study||150||
48157263|NCT03988166|100706909|FG000|COMPLETED|Overall Study||147||
48157264|NCT03988166|100706909|FG000|NOT COMPLETED|Overall Study||3||
48157265|NCT01370525|100706910|FG000|STARTED|Overall Study||171||
48157266|NCT01370525|100706911|FG001|STARTED|Overall Study||169||
48313060|NCT04366050|101091226|FG001|NOT COMPLETED|Overall Study||3||
48313061|NCT01342484|101091227|FG000|STARTED|Overall Study||15||
48313062|NCT01342484|101091228|FG001|STARTED|Overall Study||10||
48313063|NCT01342484|101091229|FG002|STARTED|Overall Study||14||
48313064|NCT01342484|101091227|FG000|COMPLETED|Overall Study||13||
48313065|NCT01342484|101091228|FG001|COMPLETED|Overall Study||10||
48313066|NCT01342484|101091229|FG002|COMPLETED|Overall Study||13||
48313067|NCT01342484|101091227|FG000|NOT COMPLETED|Overall Study||2||
48313068|NCT01342484|101091228|FG001|NOT COMPLETED|Overall Study||0||
48313069|NCT01342484|101091229|FG002|NOT COMPLETED|Overall Study||1||
48313070|NCT01022996|101091230|FG000|STARTED|Overall Study||57||
48313071|NCT01022996|101091230|FG000|COMPLETED|Overall Study||0||
48313072|NCT01022996|101091230|FG000|NOT COMPLETED|Overall Study||57||
48313073|NCT00121108|101091231|FG000|STARTED|Overall Study||710||
48313074|NCT00121108|101091232|FG001|STARTED|Overall Study||1417||
48313075|NCT00121108|101091231|FG000|COMPLETED|Overall Study||589||
48313076|NCT00121108|101091232|FG001|COMPLETED|Overall Study||1192||
48313077|NCT00121108|101091231|FG000|NOT COMPLETED|Overall Study||121||
48313078|NCT00121108|101091232|FG001|NOT COMPLETED|Overall Study||225||
48729414|NCT01227005|102123249|FG000|STARTED|Overall Study||55||
48188743|NCT01033643|100783322|FG001|NOT COMPLETED|Overall Study||3||
48157267|NCT01370525|100706910|FG000|Patients Who Received Treatment|Overall Study||168||
48157268|NCT01370525|100706911|FG001|Patients Who Received Treatment|Overall Study||163||
48157269|NCT01370525|100706910|FG000|Patients Who Completed Treatment|Overall Study||163||
48157270|NCT01370525|100706911|FG001|Patients Who Completed Treatment|Overall Study||158||
48157271|NCT01370525|100706910|FG000|COMPLETED|Overall Study||163||
48157272|NCT01370525|100706911|FG001|COMPLETED|Overall Study||158||
48157273|NCT01370525|100706910|FG000|NOT COMPLETED|Overall Study||8||
48157274|NCT01370525|100706911|FG001|NOT COMPLETED|Overall Study||11||
48157275|NCT01069354|100706912|FG000|STARTED|Overall Study||102||
48157276|NCT01069354|100706912|FG000|COMPLETED|Overall Study||101||
48157277|NCT01069354|100706912|FG000|NOT COMPLETED|Overall Study||1||
48157278|NCT00252538|100706913|FG000|STARTED|Overall Study||19||
48157279|NCT00252538|100706914|FG001|STARTED|Overall Study||114||
48157280|NCT00252538|100706913|FG000|COMPLETED|Overall Study||19||
48157281|NCT00252538|100706914|FG001|COMPLETED|Overall Study||114||
48157282|NCT00252538|100706913|FG000|NOT COMPLETED|Overall Study||0||
48157283|NCT00252538|100706914|FG001|NOT COMPLETED|Overall Study||0||
48157284|NCT00941798|100706915|FG000|STARTED|Overall Study||755||
48157285|NCT00941798|100706916|FG001|STARTED|Overall Study||763||
48157286|NCT00941798|100706915|FG000|Full Analysis Set|Overall Study||749||
48157287|NCT00941798|100706916|FG001|Full Analysis Set|Overall Study||759||
48157288|NCT00941798|100706915|FG000|COMPLETED|Overall Study||561||
48157289|NCT00941798|100706916|FG001|COMPLETED|Overall Study||578||
48157290|NCT00941798|100706915|FG000|NOT COMPLETED|Overall Study||194||
48157291|NCT00941798|100706916|FG001|NOT COMPLETED|Overall Study||185||
48157292|NCT01537302|100706917|FG000|STARTED|Overall Study||100||
48157293|NCT01537302|100706917|FG000|COMPLETED|Overall Study||100||
48157294|NCT01537302|100706917|FG000|NOT COMPLETED|Overall Study||0||
48157295|NCT01870388|100706918|FG000|STARTED|Overall Study||8||
48157296|NCT01870388|100706919|FG001|STARTED|Overall Study||8||
48157297|NCT01870388|100706918|FG000|Received 1 Dose of Study Drug|Overall Study||8||
48157298|NCT01870388|100706919|FG001|Received 1 Dose of Study Drug|Overall Study||8||
48157299|NCT01870388|100706918|FG000|COMPLETED|Overall Study||8||
48157300|NCT01870388|100706919|FG001|COMPLETED|Overall Study||8||
48157301|NCT01870388|100706918|FG000|NOT COMPLETED|Overall Study||0||
48157302|NCT01870388|100706919|FG001|NOT COMPLETED|Overall Study||0||
48157303|NCT00337272|100706920|FG000|STARTED|Screening Period (Pre-randomization)||22||
48157304|NCT00337272|100706921|FG001|STARTED|Screening Period (Pre-randomization)||0||
48157305|NCT00337272|100706920|FG000|COMPLETED|Screening Period (Pre-randomization)||16||
48157306|NCT00337272|100706921|FG001|COMPLETED|Screening Period (Pre-randomization)||0||
48157307|NCT00337272|100706920|FG000|NOT COMPLETED|Screening Period (Pre-randomization)||6||
48157308|NCT00337272|100706921|FG001|NOT COMPLETED|Screening Period (Pre-randomization)||0||
48157309|NCT00337272|100706920|FG000|STARTED|Treatment Period||7||
48157310|NCT00337272|100706921|FG001|STARTED|Treatment Period||9||
48157311|NCT00337272|100706920|FG000|Randomization|Treatment Period||7||
48157312|NCT00337272|100706921|FG001|Randomization|Treatment Period||9||
48157313|NCT00337272|100706920|FG000|COMPLETED|Treatment Period||6||
48157314|NCT00337272|100706921|FG001|COMPLETED|Treatment Period||7||
48157315|NCT00337272|100706920|FG000|NOT COMPLETED|Treatment Period||1||
48157316|NCT00337272|100706921|FG001|NOT COMPLETED|Treatment Period||2||
48157317|NCT00337272|100706920|FG000|STARTED|Withdrawal Period||6||
48157318|NCT00337272|100706921|FG001|STARTED|Withdrawal Period||7||
48157319|NCT00337272|100706920|FG000|COMPLETED|Withdrawal Period||6||
48157320|NCT00337272|100706921|FG001|COMPLETED|Withdrawal Period||6||
48157321|NCT00337272|100706920|FG000|NOT COMPLETED|Withdrawal Period||0||
48157322|NCT00337272|100706921|FG001|NOT COMPLETED|Withdrawal Period||1||
48157323|NCT01701414|100706922|FG000|STARTED|Overall Study||19||
48157324|NCT01701414|100706923|FG001|STARTED|Overall Study||19||
48157325|NCT01701414|100706922|FG000|COMPLETED|Overall Study||18||
48157326|NCT01701414|100706923|FG001|COMPLETED|Overall Study||18||
48157327|NCT01701414|100706922|FG000|NOT COMPLETED|Overall Study||1||
48157328|NCT01701414|100706923|FG001|NOT COMPLETED|Overall Study||1||
48157329|NCT01078155|100706924|FG000|STARTED|Overall Study||131||
48157330|NCT01078155|100706924|FG000|COMPLETED|Overall Study||87||
48157331|NCT01078155|100706924|FG000|NOT COMPLETED|Overall Study||44||
48157332|NCT04176939|100706925|FG000|STARTED|Overall Study||68|Started = number of participants enrolled in the study (Enrolled Set)|
48157333|NCT04176939|100706925|FG000|Vaccinated|Overall Study||47|Vaccinated = number of participants included in the Exposed Set for revaccination phase|
48157334|NCT04176939|100706925|FG000|COMPLETED|Overall Study||0||
48157335|NCT04176939|100706925|FG000|NOT COMPLETED|Overall Study||68||
48157336|NCT01591382|100706926|FG000|STARTED|Overall Study||32||
48157337|NCT01591382|100706927|FG001|STARTED|Overall Study||32||
48157338|NCT01591382|100706926|FG000|COMPLETED|Overall Study||29||
48157339|NCT01591382|100706927|FG001|COMPLETED|Overall Study||30||
48157340|NCT01591382|100706926|FG000|NOT COMPLETED|Overall Study||3||
48157341|NCT01591382|100706927|FG001|NOT COMPLETED|Overall Study||2||
48157342|NCT00331344|100706928|FG000|STARTED|Phase I||3||
48157343|NCT00331344|100706929|FG001|STARTED|Phase I||3||
48157344|NCT00331344|100706930|FG002|STARTED|Phase I||3||
48157345|NCT00331344|100706931|FG003|STARTED|Phase I||6||
48157346|NCT00331344|100706932|FG004|STARTED|Phase I||6||
48157347|NCT00331344|100706933|FG005|STARTED|Phase I||5||
48157348|NCT00331344|100706934|FG006|STARTED|Phase I||4||
48157349|NCT00331344|100706935|FG007|STARTED|Phase I||6||
48157350|NCT00331344|100706936|FG008|STARTED|Phase I||0||
48157351|NCT00331344|100706928|FG000|COMPLETED|Phase I||3||
48157352|NCT00331344|100706929|FG001|COMPLETED|Phase I||3||
48157353|NCT00331344|100706930|FG002|COMPLETED|Phase I||3||
48157354|NCT00331344|100706931|FG003|COMPLETED|Phase I||5||
48157355|NCT00331344|100706932|FG004|COMPLETED|Phase I||4||
48157356|NCT00331344|100706933|FG005|COMPLETED|Phase I||3||
48157357|NCT00331344|100706934|FG006|COMPLETED|Phase I||4||
48157358|NCT00331344|100706935|FG007|COMPLETED|Phase I||5||
48157359|NCT00331344|100706936|FG008|COMPLETED|Phase I||0||
48157360|NCT00331344|100706928|FG000|NOT COMPLETED|Phase I||0||
48157361|NCT00331344|100706929|FG001|NOT COMPLETED|Phase I||0||
48157362|NCT00331344|100706930|FG002|NOT COMPLETED|Phase I||0||
48157363|NCT00331344|100706931|FG003|NOT COMPLETED|Phase I||1||
48157364|NCT00331344|100706932|FG004|NOT COMPLETED|Phase I||2||
48157365|NCT00331344|100706933|FG005|NOT COMPLETED|Phase I||2||
48157366|NCT00331344|100706934|FG006|NOT COMPLETED|Phase I||0||
48157367|NCT00331344|100706935|FG007|NOT COMPLETED|Phase I||1||
48157368|NCT00331344|100706936|FG008|NOT COMPLETED|Phase I||0||
48157369|NCT00331344|100706928|FG000|STARTED|Phase II||0||
48157370|NCT00331344|100706929|FG001|STARTED|Phase II||0||
48157371|NCT00331344|100706930|FG002|STARTED|Phase II||0||
48157372|NCT00331344|100706931|FG003|STARTED|Phase II||0||
48157373|NCT00331344|100706932|FG004|STARTED|Phase II||0||
48157374|NCT00331344|100706933|FG005|STARTED|Phase II||0||
48157375|NCT00331344|100706934|FG006|STARTED|Phase II||0||
48157376|NCT00331344|100706935|FG007|STARTED|Phase II||6||
48157377|NCT00331344|100706936|FG008|STARTED|Phase II||52||
48157378|NCT00331344|100706928|FG000|COMPLETED|Phase II||0||
48157379|NCT00331344|100706929|FG001|COMPLETED|Phase II||0||
48157380|NCT00331344|100706930|FG002|COMPLETED|Phase II||0||
48157381|NCT00331344|100706931|FG003|COMPLETED|Phase II||0||
48157382|NCT00331344|100706932|FG004|COMPLETED|Phase II||0||
48157383|NCT00331344|100706933|FG005|COMPLETED|Phase II||0||
48157384|NCT00331344|100706934|FG006|COMPLETED|Phase II||0||
48157385|NCT00331344|100706935|FG007|COMPLETED|Phase II||6||
48157386|NCT00331344|100706936|FG008|COMPLETED|Phase II||48||
48157387|NCT00331344|100706928|FG000|NOT COMPLETED|Phase II||0||
48157388|NCT00331344|100706929|FG001|NOT COMPLETED|Phase II||0||
48157389|NCT00331344|100706930|FG002|NOT COMPLETED|Phase II||0||
48157390|NCT00331344|100706931|FG003|NOT COMPLETED|Phase II||0||
48157391|NCT00331344|100706932|FG004|NOT COMPLETED|Phase II||0||
48157392|NCT00331344|100706933|FG005|NOT COMPLETED|Phase II||0||
48313079|NCT03574753|101091233|FG000|STARTED|Overall Study||23||
48313080|NCT03574753|101091233|FG000|COMPLETED|Overall Study||0||
48313081|NCT03574753|101091233|FG000|NOT COMPLETED|Overall Study||23||
48313082|NCT03341975|101091234|FG000|STARTED|Overall Study||44||
48313083|NCT03341975|101091235|FG001|STARTED|Overall Study||47||
48313084|NCT03341975|101091234|FG000|COMPLETED|Overall Study||44||
48313085|NCT03341975|101091235|FG001|COMPLETED|Overall Study||47||
48313086|NCT03341975|101091234|FG000|NOT COMPLETED|Overall Study||0||
48313087|NCT03341975|101091235|FG001|NOT COMPLETED|Overall Study||0||
48406833|NCT03424044|101328487|FG003|COMPLETED|Second Rest Period (7-45 Days)||3||
48157393|NCT00331344|100706934|FG006|NOT COMPLETED|Phase II||0||
48157394|NCT00331344|100706935|FG007|NOT COMPLETED|Phase II||0||
48157395|NCT00331344|100706936|FG008|NOT COMPLETED|Phase II||4||
48157396|NCT00991341|100706937|FG000|STARTED|Overall Study||742||
48157397|NCT00991341|100706938|FG001|STARTED|Overall Study||739||
48157398|NCT00991341|100706937|FG000|COMPLETED|Overall Study||538||
48157399|NCT00991341|100706938|FG001|COMPLETED|Overall Study||560||
48157400|NCT00991341|100706937|FG000|NOT COMPLETED|Overall Study||204||
48157401|NCT00991341|100706938|FG001|NOT COMPLETED|Overall Study||179||
48157402|NCT03467932|100706939|FG000|STARTED|Overall Study||69||
48157403|NCT03467932|100706940|FG001|STARTED|Overall Study||68||
48157404|NCT03467932|100706941|FG002|STARTED|Overall Study||69||
48157405|NCT03467932|100706942|FG003|STARTED|Overall Study||66||
48157406|NCT03467932|100706943|FG004|STARTED|Overall Study||20||
48157407|NCT03467932|100706944|FG005|STARTED|Overall Study||15||
48313088|NCT01194453|101091236|FG000|STARTED|Overall Study||144||
48313089|NCT01194453|101091237|FG001|STARTED|Overall Study||144||
48313090|NCT01194453|101091236|FG000|COMPLETED|Overall Study||127||
48157408|NCT03467932|100706945|FG006|STARTED|Overall Study||17||
48157409|NCT03467932|100706946|FG007|STARTED|Overall Study||18||
48157410|NCT03467932|100706947|FG008|STARTED|Overall Study||15||
48157411|NCT03467932|100706948|FG009|STARTED|Overall Study||16||
48157412|NCT03467932|100706939|FG000|COMPLETED|Overall Study||62||
48157413|NCT03467932|100706940|FG001|COMPLETED|Overall Study||58||
48157414|NCT03467932|100706941|FG002|COMPLETED|Overall Study||58||
48157415|NCT03467932|100706942|FG003|COMPLETED|Overall Study||56||
48157416|NCT03467932|100706943|FG004|COMPLETED|Overall Study||19||
48157417|NCT03467932|100706944|FG005|COMPLETED|Overall Study||13||
48157418|NCT03467932|100706945|FG006|COMPLETED|Overall Study||15||
48157419|NCT03467932|100706946|FG007|COMPLETED|Overall Study||16||
48157420|NCT03467932|100706947|FG008|COMPLETED|Overall Study||11||
48157421|NCT03467932|100706948|FG009|COMPLETED|Overall Study||14||
48157422|NCT03467932|100706939|FG000|NOT COMPLETED|Overall Study||7||
48157423|NCT03467932|100706940|FG001|NOT COMPLETED|Overall Study||10||
48157424|NCT03467932|100706941|FG002|NOT COMPLETED|Overall Study||11||
48157425|NCT03467932|100706942|FG003|NOT COMPLETED|Overall Study||10||
48157426|NCT03467932|100706943|FG004|NOT COMPLETED|Overall Study||1||
48157427|NCT03467932|100706944|FG005|NOT COMPLETED|Overall Study||2||
48157428|NCT03467932|100706945|FG006|NOT COMPLETED|Overall Study||2||
48157429|NCT03467932|100706946|FG007|NOT COMPLETED|Overall Study||2||
48157430|NCT03467932|100706947|FG008|NOT COMPLETED|Overall Study||4||
48157431|NCT03467932|100706948|FG009|NOT COMPLETED|Overall Study||2||
48157432|NCT05028426|100706949|FG000|STARTED|Overall Study||214||
48157433|NCT05028426|100706950|FG001|STARTED|Overall Study||132||
48157434|NCT05028426|100706951|FG002|STARTED|Overall Study||109||
48157435|NCT05028426|100706949|FG000|COMPLETED|Overall Study||214||
48157436|NCT05028426|100706950|FG001|COMPLETED|Overall Study||132||
48157437|NCT05028426|100706951|FG002|COMPLETED|Overall Study||109||
48157438|NCT05028426|100706949|FG000|NOT COMPLETED|Overall Study||0||
48157439|NCT05028426|100706950|FG001|NOT COMPLETED|Overall Study||0||
48157440|NCT05028426|100706951|FG002|NOT COMPLETED|Overall Study||0||
48157441|NCT01321554|100706952|FG000|STARTED|Randomization Phase||261||
48157442|NCT01321554|100706953|FG001|STARTED|Randomization Phase||131||
48157443|NCT01321554|100706954|FG002|STARTED|Randomization Phase||0||
48157444|NCT01321554|100706955|FG003|STARTED|Randomization Phase||0||
48313091|NCT01194453|101091237|FG001|COMPLETED|Overall Study||127||
48313092|NCT01194453|101091236|FG000|NOT COMPLETED|Overall Study||17||
48313093|NCT01194453|101091237|FG001|NOT COMPLETED|Overall Study||17||
48614262|NCT01004978|101841711|FG001|NOT COMPLETED|Overall Study||117||
48614263|NCT02710084|101841712|FG000|STARTED|First Phase - 12 Weeks||10||
48614264|NCT02710084|101841713|FG001|STARTED|First Phase - 12 Weeks||8||
48614265|NCT02710084|101841712|FG000|COMPLETED|First Phase - 12 Weeks||7||
48614266|NCT02710084|101841713|FG001|COMPLETED|First Phase - 12 Weeks||7||
48614267|NCT02710084|101841712|FG000|NOT COMPLETED|First Phase - 12 Weeks||3||
48157445|NCT01321554|100706952|FG000|COMPLETED|Randomization Phase||261||
48157446|NCT01321554|100706953|FG001|COMPLETED|Randomization Phase||131||
48157447|NCT01321554|100706954|FG002|COMPLETED|Randomization Phase||0||
48157448|NCT01321554|100706955|FG003|COMPLETED|Randomization Phase||0||
48157449|NCT01321554|100706952|FG000|NOT COMPLETED|Randomization Phase||0||
48157450|NCT01321554|100706953|FG001|NOT COMPLETED|Randomization Phase||0||
48157451|NCT01321554|100706954|FG002|NOT COMPLETED|Randomization Phase||0||
48157452|NCT01321554|100706955|FG003|NOT COMPLETED|Randomization Phase||0||
48157453|NCT01321554|100706952|FG000|STARTED|OOL Lenvatinib Treatment Period||0||
48157454|NCT01321554|100706953|FG001|STARTED|OOL Lenvatinib Treatment Period||0||
48157455|NCT01321554|100706954|FG002|STARTED|OOL Lenvatinib Treatment Period||85||
48157456|NCT01321554|100706955|FG003|STARTED|OOL Lenvatinib Treatment Period||30||
48157457|NCT01321554|100706952|FG000|COMPLETED|OOL Lenvatinib Treatment Period||0||
48157458|NCT01321554|100706953|FG001|COMPLETED|OOL Lenvatinib Treatment Period||0||
48157459|NCT01321554|100706954|FG002|COMPLETED|OOL Lenvatinib Treatment Period||85||
48157460|NCT01321554|100706955|FG003|COMPLETED|OOL Lenvatinib Treatment Period||30||
48157461|NCT01321554|100706952|FG000|NOT COMPLETED|OOL Lenvatinib Treatment Period||0||
48157462|NCT01321554|100706953|FG001|NOT COMPLETED|OOL Lenvatinib Treatment Period||0||
48157463|NCT01321554|100706954|FG002|NOT COMPLETED|OOL Lenvatinib Treatment Period||0||
48157464|NCT01321554|100706955|FG003|NOT COMPLETED|OOL Lenvatinib Treatment Period||0||
48157465|NCT03320018|100706956|FG000|STARTED|Treatment Period||6||
48157466|NCT03320018|100706957|FG001|STARTED|Treatment Period||8||
48157467|NCT03320018|100706956|FG000|COMPLETED|Treatment Period||5||
48157468|NCT03320018|100706957|FG001|COMPLETED|Treatment Period||8||
48157469|NCT03320018|100706956|FG000|NOT COMPLETED|Treatment Period||1||
48157470|NCT03320018|100706957|FG001|NOT COMPLETED|Treatment Period||0||
48157471|NCT03320018|100706956|FG000|STARTED|Day 45 Follow up||5||
48157472|NCT03320018|100706957|FG001|STARTED|Day 45 Follow up||8||
48157473|NCT03320018|100706956|FG000|COMPLETED|Day 45 Follow up||5||
48614268|NCT02710084|101841713|FG001|NOT COMPLETED|First Phase - 12 Weeks||1||
48614269|NCT02710084|101841712|FG000|STARTED|Open Label Phase: Week 12 to 24||7||
48614270|NCT02710084|101841713|FG001|STARTED|Open Label Phase: Week 12 to 24||7||
48614271|NCT02710084|101841712|FG000|COMPLETED|Open Label Phase: Week 12 to 24||7||
48614272|NCT02710084|101841713|FG001|COMPLETED|Open Label Phase: Week 12 to 24||7||
48614273|NCT02710084|101841712|FG000|NOT COMPLETED|Open Label Phase: Week 12 to 24||0||
48157474|NCT03320018|100706957|FG001|COMPLETED|Day 45 Follow up||8||
48157475|NCT03320018|100706956|FG000|NOT COMPLETED|Day 45 Follow up||0||
48157476|NCT03320018|100706957|FG001|NOT COMPLETED|Day 45 Follow up||0||
48157477|NCT03320018|100706956|FG000|STARTED|Day 90 Follow up||5||
48157478|NCT03320018|100706957|FG001|STARTED|Day 90 Follow up||8||
48157479|NCT03320018|100706956|FG000|COMPLETED|Day 90 Follow up||5||
48157480|NCT03320018|100706957|FG001|COMPLETED|Day 90 Follow up||7||
48157481|NCT03320018|100706956|FG000|NOT COMPLETED|Day 90 Follow up||0||
48157482|NCT03320018|100706957|FG001|NOT COMPLETED|Day 90 Follow up||1||
48157483|NCT00118898|100706958|FG000|STARTED|Overall Study||464||
48157484|NCT00118898|100706959|FG001|STARTED|Overall Study||465||
48157485|NCT00118898|100706960|FG002|STARTED|Overall Study||465||
48157486|NCT00118898|100706961|FG003|STARTED|Overall Study||463||
48157487|NCT00118898|100706958|FG000|Initiated Treatment|Overall Study||461||
48157488|NCT00118898|100706959|FG001|Initiated Treatment|Overall Study||461||
48157489|NCT00118898|100706960|FG002|Initiated Treatment|Overall Study||464||
48313094|NCT01839396|101091238|FG000|STARTED|Overall Study||121||
48313095|NCT01839396|101091239|FG001|STARTED|Overall Study||39||
48313096|NCT01839396|101091238|FG000|COMPLETED|Overall Study||121||
48313097|NCT01839396|101091239|FG001|COMPLETED|Overall Study||39||
48313098|NCT01839396|101091238|FG000|NOT COMPLETED|Overall Study||0||
48313099|NCT01839396|101091239|FG001|NOT COMPLETED|Overall Study||0||
48313100|NCT03000179|101091240|FG000|STARTED|Overall Study||8||
48313101|NCT03000179|101091240|FG000|COMPLETED|Overall Study||6||
48313102|NCT03000179|101091240|FG000|NOT COMPLETED|Overall Study||2||
48313103|NCT01751399|101091241|FG000|STARTED|Overall Study||12||
48313104|NCT01751399|101091242|FG001|STARTED|Overall Study||8||
48313105|NCT01751399|101091243|FG002|STARTED|Overall Study||8||
48313106|NCT01751399|101091244|FG003|STARTED|Overall Study||7||
48313107|NCT01751399|101091241|FG000|Received 1 Dose of Study Drug|Overall Study||12||
48313108|NCT01751399|101091242|FG001|Received 1 Dose of Study Drug|Overall Study||8||
48313109|NCT01751399|101091243|FG002|Received 1 Dose of Study Drug|Overall Study||8||
48313110|NCT01751399|101091244|FG003|Received 1 Dose of Study Drug|Overall Study||7||
48313111|NCT01751399|101091241|FG000|COMPLETED|Overall Study||12||
48313112|NCT01751399|101091242|FG001|COMPLETED|Overall Study||8||
48313113|NCT01751399|101091243|FG002|COMPLETED|Overall Study||8||
48313114|NCT01751399|101091244|FG003|COMPLETED|Overall Study||7||
48313115|NCT01751399|101091241|FG000|NOT COMPLETED|Overall Study||0||
48313116|NCT01751399|101091242|FG001|NOT COMPLETED|Overall Study||0||
48313117|NCT01751399|101091243|FG002|NOT COMPLETED|Overall Study||0||
48313118|NCT01751399|101091244|FG003|NOT COMPLETED|Overall Study||0||
48313119|NCT01054144|101091245|FG000|STARTED|Overall Study||27||
48313120|NCT01054144|101091245|FG000|COMPLETED|Overall Study||25||
48313121|NCT01054144|101091245|FG000|NOT COMPLETED|Overall Study||2||
48313122|NCT00362414|101091246|FG000|STARTED|Overall Study||15||
48313123|NCT00362414|101091246|FG000|COMPLETED|Overall Study||12||
48313124|NCT00362414|101091246|FG000|NOT COMPLETED|Overall Study||3||
48313125|NCT00829049|101091247|FG000|STARTED|Overall Study||77||
48313126|NCT00829049|101091248|FG001|STARTED|Overall Study||88||
48313127|NCT00829049|101091247|FG000|COMPLETED|Overall Study||60||
48313128|NCT00829049|101091248|FG001|COMPLETED|Overall Study||68||
48313129|NCT00829049|101091247|FG000|NOT COMPLETED|Overall Study||17||
48313130|NCT00829049|101091248|FG001|NOT COMPLETED|Overall Study||20||
48313131|NCT01131520|101091249|FG000|STARTED|Overall Study||180||
48313132|NCT01131520|101091250|FG001|STARTED|Overall Study||180||
48313133|NCT01131520|101091249|FG000|COMPLETED|Overall Study||179||
48313134|NCT01131520|101091250|FG001|COMPLETED|Overall Study||176||
48313135|NCT01131520|101091249|FG000|NOT COMPLETED|Overall Study||1||
48313136|NCT01131520|101091250|FG001|NOT COMPLETED|Overall Study||4||
48313137|NCT03184077|101091251|FG000|STARTED|Overall Study||166||
48313138|NCT03184077|101091252|FG001|STARTED|Overall Study||152||
48313139|NCT03184077|101091251|FG000|COMPLETED|Overall Study||145||
48313140|NCT03184077|101091252|FG001|COMPLETED|Overall Study||131||
48313141|NCT03184077|101091251|FG000|NOT COMPLETED|Overall Study||21||
48313142|NCT03184077|101091252|FG001|NOT COMPLETED|Overall Study||21||
48313143|NCT02937194|101091253|FG000|STARTED|1-year Followup||294||
48313144|NCT02937194|101091254|FG001|STARTED|1-year Followup||286||
48313145|NCT02937194|101091253|FG000|COMPLETED|1-year Followup||223||
48313146|NCT02937194|101091254|FG001|COMPLETED|1-year Followup||218||
48313147|NCT02937194|101091253|FG000|NOT COMPLETED|1-year Followup||71||
48313148|NCT02937194|101091254|FG001|NOT COMPLETED|1-year Followup||68||
48313149|NCT02937194|101091253|FG000|STARTED|2-years Followup||294||
48313150|NCT02937194|101091254|FG001|STARTED|2-years Followup||286||
48313151|NCT02937194|101091253|FG000|COMPLETED|2-years Followup||216||
48313152|NCT02937194|101091254|FG001|COMPLETED|2-years Followup||208||
48313153|NCT02937194|101091253|FG000|NOT COMPLETED|2-years Followup||78||
48313154|NCT02937194|101091254|FG001|NOT COMPLETED|2-years Followup||78||
48313155|NCT02937194|101091253|FG000|STARTED|3-years Followup||294||
48313156|NCT02937194|101091254|FG001|STARTED|3-years Followup||286||
48313157|NCT02937194|101091253|FG000|COMPLETED|3-years Followup||228||
48313158|NCT02937194|101091254|FG001|COMPLETED|3-years Followup||208||
48313159|NCT02937194|101091253|FG000|NOT COMPLETED|3-years Followup||66||
48313160|NCT02937194|101091254|FG001|NOT COMPLETED|3-years Followup||78||
48313161|NCT02941705|101091255|FG000|STARTED|Overall Study||13|We are defining 'started' as having been randomized to a treatment group. The three subjects who were screened but did not complete the study all withdrew prior to randomization. Two subjects were screen failures and one subject withdrew prior to randomization. Therefore, we have not included those individuals in the total number of subjects 'started' since they were never randomized to a treatment group.|
48368036|NCT03567291|101230093|FG001|NOT COMPLETED|Period II||3||
48368037|NCT03567291|101230094|FG002|NOT COMPLETED|Period II||1||
48368038|NCT03567291|101230095|FG003|NOT COMPLETED|Period II||0||
48368039|NCT03567291|101230092|FG000|STARTED|Period III||0||
48313162|NCT02941705|101091256|FG001|STARTED|Overall Study||13|We are defining 'started' as having been randomized to a treatment group. The three subjects who were screened but did not complete the study all withdrew prior to randomization. Two subjects were screen failures and one subject withdrew prior to randomization. Therefore, we have not included those individuals in the total number of subjects 'started' since they were never randomized to a treatment group.|
48313163|NCT02941705|101091255|FG000|COMPLETED|Overall Study||13||
48313164|NCT02941705|101091256|FG001|COMPLETED|Overall Study||13||
48313165|NCT02941705|101091255|FG000|NOT COMPLETED|Overall Study||0||
48313166|NCT02941705|101091256|FG001|NOT COMPLETED|Overall Study||0||
48313167|NCT01953575|101091257|FG000|STARTED|Overall Study||10||
48313168|NCT01953575|101091258|FG001|STARTED|Overall Study||10||
48313169|NCT01953575|101091259|FG002|STARTED|Overall Study||10||
48313170|NCT01953575|101091257|FG000|COMPLETED|Overall Study||10||
48313171|NCT01953575|101091258|FG001|COMPLETED|Overall Study||10||
48313172|NCT01953575|101091259|FG002|COMPLETED|Overall Study||10||
48313173|NCT01953575|101091257|FG000|NOT COMPLETED|Overall Study||0||
48313174|NCT01953575|101091258|FG001|NOT COMPLETED|Overall Study||0||
48313175|NCT01953575|101091259|FG002|NOT COMPLETED|Overall Study||0||
48313176|NCT02246582|101091260|FG000|STARTED|Overall Study||44||
48313177|NCT02246582|101091261|FG001|STARTED|Overall Study||45||
48313178|NCT02246582|101091260|FG000|COMPLETED|Overall Study||41||
48313179|NCT02246582|101091261|FG001|COMPLETED|Overall Study||41||
48313180|NCT02246582|101091260|FG000|NOT COMPLETED|Overall Study||3||
48313181|NCT02246582|101091261|FG001|NOT COMPLETED|Overall Study||4||
48313182|NCT01667081|101091262|FG000|STARTED|Overall Study||1909||
48313183|NCT01667081|101091263|FG001|STARTED|Overall Study||526||
48313184|NCT01667081|101091262|FG000|COMPLETED|Overall Study||132||
48313185|NCT01667081|101091263|FG001|COMPLETED|Overall Study||169||
48313186|NCT01667081|101091262|FG000|NOT COMPLETED|Overall Study||1777||
48313187|NCT01667081|101091263|FG001|NOT COMPLETED|Overall Study||357||
48313188|NCT00618410|101091264|FG000|STARTED|First Intervention||7||
48313189|NCT00618410|101091265|FG001|STARTED|First Intervention||6||
48313190|NCT00618410|101091264|FG000|COMPLETED|First Intervention||7||
48313191|NCT00618410|101091265|FG001|COMPLETED|First Intervention||6||
48313192|NCT00618410|101091264|FG000|NOT COMPLETED|First Intervention||0||
48313193|NCT00618410|101091265|FG001|NOT COMPLETED|First Intervention||0||
48313194|NCT00618410|101091264|FG000|STARTED|Washout Period (2 Weeks)||7||
48313195|NCT00618410|101091265|FG001|STARTED|Washout Period (2 Weeks)||6||
48313196|NCT00618410|101091264|FG000|COMPLETED|Washout Period (2 Weeks)||7||
48313197|NCT00618410|101091265|FG001|COMPLETED|Washout Period (2 Weeks)||5||
48313198|NCT00618410|101091264|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0||
48313199|NCT00618410|101091265|FG001|NOT COMPLETED|Washout Period (2 Weeks)||1||
48313200|NCT00618410|101091264|FG000|STARTED|Second Intervention||7||
48313201|NCT00618410|101091265|FG001|STARTED|Second Intervention||5||
48313202|NCT00618410|101091264|FG000|COMPLETED|Second Intervention||7||
48313203|NCT00618410|101091265|FG001|COMPLETED|Second Intervention||5||
48313204|NCT00618410|101091264|FG000|NOT COMPLETED|Second Intervention||0||
48313205|NCT00618410|101091265|FG001|NOT COMPLETED|Second Intervention||0||
48313206|NCT00445224|101091266|FG000|STARTED|Specific Exercises||17||
48313207|NCT00445224|101091267|FG001|STARTED|Specific Exercises||16||
48313208|NCT00445224|101091266|FG000|Baseline|Specific Exercises||17||
48313209|NCT00445224|101091267|FG001|Baseline|Specific Exercises||16||
48313210|NCT00445224|101091266|FG000|4 Weeks|Specific Exercises||14||
48313211|NCT00445224|101091267|FG001|4 Weeks|Specific Exercises||13||
48313212|NCT00445224|101091266|FG000|COMPLETED|Specific Exercises||13||
48313213|NCT00445224|101091267|FG001|COMPLETED|Specific Exercises||13||
48313214|NCT00445224|101091266|FG000|NOT COMPLETED|Specific Exercises||4||
48313215|NCT00445224|101091267|FG001|NOT COMPLETED|Specific Exercises||3||
48313216|NCT00445224|101091266|FG000|STARTED|Combined Exercises||13||
48313217|NCT00445224|101091267|FG001|STARTED|Combined Exercises||13||
48313218|NCT00445224|101091266|FG000|COMPLETED|Combined Exercises||13||
48313219|NCT00445224|101091267|FG001|COMPLETED|Combined Exercises||13||
48313220|NCT00445224|101091266|FG000|NOT COMPLETED|Combined Exercises||0||
48313221|NCT00445224|101091267|FG001|NOT COMPLETED|Combined Exercises||0||
48313222|NCT04353284|101091268|FG000|STARTED|Overall Study||35||
48313223|NCT04353284|101091269|FG001|STARTED|Overall Study||35||
48313224|NCT04353284|101091268|FG000|COMPLETED|Overall Study||33||
48313225|NCT04353284|101091269|FG001|COMPLETED|Overall Study||34||
48313226|NCT04353284|101091268|FG000|NOT COMPLETED|Overall Study||2||
48313227|NCT04353284|101091269|FG001|NOT COMPLETED|Overall Study||1||
48313228|NCT03625687|101091270|FG000|STARTED|Overall Study||16||
48313229|NCT03625687|101091270|FG000|COMPLETED|Overall Study||15||
48313230|NCT03625687|101091270|FG000|NOT COMPLETED|Overall Study||1||
48313231|NCT03823404|101091271|FG000|STARTED|Overall Study||214||
48313232|NCT03823404|101091272|FG001|STARTED|Overall Study||212||
48313233|NCT03823404|101091273|FG002|STARTED|Overall Study||217||
48313234|NCT03823404|101091271|FG000|COMPLETED|Overall Study||129||
48313235|NCT03823404|101091272|FG001|COMPLETED|Overall Study||127||
48313236|NCT03823404|101091273|FG002|COMPLETED|Overall Study||163||
48313237|NCT03823404|101091271|FG000|NOT COMPLETED|Overall Study||85||
48313238|NCT03823404|101091272|FG001|NOT COMPLETED|Overall Study||85||
48313239|NCT03823404|101091273|FG002|NOT COMPLETED|Overall Study||54||
48313240|NCT00475722|101091274|FG000|STARTED|Overall Study||61||
48313241|NCT00475722|101091275|FG001|STARTED|Overall Study||59||
48313242|NCT00475722|101091274|FG000|COMPLETED|Overall Study||46||
48313243|NCT00475722|101091275|FG001|COMPLETED|Overall Study||47||
48313244|NCT00475722|101091274|FG000|NOT COMPLETED|Overall Study||15||
48313245|NCT00475722|101091275|FG001|NOT COMPLETED|Overall Study||12||
48313246|NCT00733954|101091276|FG000|STARTED|Overall Study||124||
48313247|NCT00733954|101091277|FG001|STARTED|Overall Study||125||
48313248|NCT00733954|101091276|FG000|COMPLETED|Overall Study||116||
48313249|NCT00733954|101091277|FG001|COMPLETED|Overall Study||123||
48313250|NCT00733954|101091276|FG000|NOT COMPLETED|Overall Study||8||
48313251|NCT00733954|101091277|FG001|NOT COMPLETED|Overall Study||2||
48313252|NCT02613884|101091278|FG000|STARTED|Overall Study||26||
48313253|NCT02613884|101091278|FG000|Safety Endpoint 1|Overall Study||26|Serum Calcium Level 1-week after dose|
48313254|NCT02613884|101091278|FG000|Feasibility Questionnaire|Overall Study||26|Phone survey|
48313255|NCT02613884|101091278|FG000|Safety Endpoint 2|Overall Study||26|Serum Calcium Level at 3-month after dose|
48313256|NCT02613884|101091278|FG000|Efficacy Endpoint 1|Overall Study||25|25OHD level at 3 Months|
48313257|NCT02613884|101091278|FG000|Efficacy Timepoint 2|Overall Study||25|25OHD3 level at 6 months|
48313258|NCT02613884|101091278|FG000|Efficacy Timepoint 3|Overall Study||24|25OHD3 level at 12 months|
48313259|NCT02613884|101091278|FG000|COMPLETED|Overall Study||24||
48313260|NCT02613884|101091278|FG000|NOT COMPLETED|Overall Study||2||
48313261|NCT02525055|101091279|FG000|STARTED|Overall Study||6||
48313262|NCT02525055|101091280|FG001|STARTED|Overall Study||6||
48313263|NCT02525055|101091281|FG002|STARTED|Overall Study||6||
48313264|NCT02525055|101091282|FG003|STARTED|Overall Study||6||
48313265|NCT02525055|101091283|FG004|STARTED|Overall Study||6||
48313266|NCT02525055|101091284|FG005|STARTED|Overall Study||16||
48313267|NCT02525055|101091279|FG000|COMPLETED|Overall Study||6||
48313268|NCT02525055|101091280|FG001|COMPLETED|Overall Study||6||
48313269|NCT02525055|101091281|FG002|COMPLETED|Overall Study||6||
48313270|NCT02525055|101091282|FG003|COMPLETED|Overall Study||6||
48313271|NCT02525055|101091283|FG004|COMPLETED|Overall Study||6||
48313272|NCT02525055|101091284|FG005|COMPLETED|Overall Study||16||
48313273|NCT02525055|101091279|FG000|NOT COMPLETED|Overall Study||0||
48313274|NCT02525055|101091280|FG001|NOT COMPLETED|Overall Study||0||
48313275|NCT02525055|101091281|FG002|NOT COMPLETED|Overall Study||0||
48313276|NCT02525055|101091282|FG003|NOT COMPLETED|Overall Study||0||
48313277|NCT02525055|101091283|FG004|NOT COMPLETED|Overall Study||0||
48313278|NCT02525055|101091284|FG005|NOT COMPLETED|Overall Study||0||
48313279|NCT02016820|101091285|FG000|STARTED|Overall Study||3||
48313280|NCT02016820|101091286|FG001|STARTED|Overall Study||4||
48313281|NCT02016820|101091285|FG000|COMPLETED|Overall Study||1||
48406834|NCT03424044|101328488|FG004|COMPLETED|Second Rest Period (7-45 Days)||2||
48406835|NCT03424044|101328489|FG005|COMPLETED|Second Rest Period (7-45 Days)||4||
48406836|NCT03424044|101328490|FG006|COMPLETED|Second Rest Period (7-45 Days)||1||
48406837|NCT03424044|101328491|FG007|COMPLETED|Second Rest Period (7-45 Days)||1||
48440018|NCT04259905|101410012|FG001|COMPLETED|Overall Study||8||
48313282|NCT02016820|101091286|FG001|COMPLETED|Overall Study||0||
48313283|NCT02016820|101091285|FG000|NOT COMPLETED|Overall Study||2||
48313284|NCT02016820|101091286|FG001|NOT COMPLETED|Overall Study||4||
48313285|NCT01671111|101091287|FG000|STARTED|Overall Study||30||
48313286|NCT01671111|101091287|FG000|COMPLETED|Overall Study||0||
48313287|NCT01671111|101091287|FG000|NOT COMPLETED|Overall Study||30||
48313288|NCT01423851|101091288|FG000|STARTED|Whole Study||3||
48313289|NCT01423851|101091289|FG001|STARTED|Whole Study||3||
48313290|NCT01423851|101091290|FG002|STARTED|Whole Study||3||
48313291|NCT01423851|101091291|FG003|STARTED|Whole Study||6||
48313292|NCT01423851|101091292|FG004|STARTED|Whole Study||3||
48313293|NCT01423851|101091293|FG005|STARTED|Whole Study||3||
48313294|NCT01423851|101091294|FG006|STARTED|Whole Study||3||
48313295|NCT01423851|101091295|FG007|STARTED|Whole Study||8||
48313296|NCT01423851|101091296|FG008|STARTED|Whole Study||8||
48313297|NCT01423851|101091297|FG009|STARTED|Whole Study||8||
48313298|NCT01423851|101091298|FG010|STARTED|Whole Study||29||
48313299|NCT01423851|101091288|FG000|COMPLETED|Whole Study||0||
48313300|NCT01423851|101091289|FG001|COMPLETED|Whole Study||0||
48313301|NCT01423851|101091290|FG002|COMPLETED|Whole Study||0||
48313302|NCT01423851|101091291|FG003|COMPLETED|Whole Study||0||
48313303|NCT01423851|101091292|FG004|COMPLETED|Whole Study||0||
48313304|NCT01423851|101091293|FG005|COMPLETED|Whole Study||0||
48313305|NCT01423851|101091294|FG006|COMPLETED|Whole Study||0||
48313306|NCT01423851|101091295|FG007|COMPLETED|Whole Study||0||
48313307|NCT01423851|101091296|FG008|COMPLETED|Whole Study||0||
48313308|NCT01423851|101091297|FG009|COMPLETED|Whole Study||0||
48313309|NCT01423851|101091298|FG010|COMPLETED|Whole Study||0||
48313310|NCT01423851|101091288|FG000|NOT COMPLETED|Whole Study||3||
48313311|NCT01423851|101091289|FG001|NOT COMPLETED|Whole Study||3||
48313312|NCT01423851|101091290|FG002|NOT COMPLETED|Whole Study||3||
48313313|NCT01423851|101091291|FG003|NOT COMPLETED|Whole Study||6||
48313314|NCT01423851|101091292|FG004|NOT COMPLETED|Whole Study||3||
48313315|NCT01423851|101091293|FG005|NOT COMPLETED|Whole Study||3||
48313316|NCT01423851|101091294|FG006|NOT COMPLETED|Whole Study||3||
48313317|NCT01423851|101091295|FG007|NOT COMPLETED|Whole Study||8||
48313318|NCT01423851|101091296|FG008|NOT COMPLETED|Whole Study||8||
48313319|NCT01423851|101091297|FG009|NOT COMPLETED|Whole Study||8||
48313320|NCT01423851|101091298|FG010|NOT COMPLETED|Whole Study||29||
48313321|NCT01423851|101091288|FG000|STARTED|Dose Finding Period - Escalation||0||
48313322|NCT01423851|101091289|FG001|STARTED|Dose Finding Period - Escalation||1||
48313323|NCT01423851|101091290|FG002|STARTED|Dose Finding Period - Escalation||4||
48313324|NCT01423851|101091291|FG003|STARTED|Dose Finding Period - Escalation||4||
48313325|NCT01423851|101091292|FG004|STARTED|Dose Finding Period - Escalation||0||
48313326|NCT01423851|101091293|FG005|STARTED|Dose Finding Period - Escalation||0||
48313327|NCT01423851|101091294|FG006|STARTED|Dose Finding Period - Escalation||2||
48313328|NCT01423851|101091295|FG007|STARTED|Dose Finding Period - Escalation||0||
48313329|NCT01423851|101091296|FG008|STARTED|Dose Finding Period - Escalation||1||
48313330|NCT01423851|101091297|FG009|STARTED|Dose Finding Period - Escalation||0||
48313331|NCT01423851|101091298|FG010|STARTED|Dose Finding Period - Escalation||0||
48313332|NCT01423851|101091288|FG000|COMPLETED|Dose Finding Period - Escalation||0||
48313333|NCT01423851|101091289|FG001|COMPLETED|Dose Finding Period - Escalation||0||
48313334|NCT01423851|101091290|FG002|COMPLETED|Dose Finding Period - Escalation||0||
48313335|NCT01423851|101091291|FG003|COMPLETED|Dose Finding Period - Escalation||0||
48313336|NCT01423851|101091292|FG004|COMPLETED|Dose Finding Period - Escalation||0||
48313337|NCT01423851|101091293|FG005|COMPLETED|Dose Finding Period - Escalation||0||
48313338|NCT01423851|101091294|FG006|COMPLETED|Dose Finding Period - Escalation||0||
48313339|NCT01423851|101091295|FG007|COMPLETED|Dose Finding Period - Escalation||0||
48313340|NCT01423851|101091296|FG008|COMPLETED|Dose Finding Period - Escalation||0||
48313341|NCT01423851|101091297|FG009|COMPLETED|Dose Finding Period - Escalation||0||
48313342|NCT01423851|101091298|FG010|COMPLETED|Dose Finding Period - Escalation||0||
48313343|NCT01423851|101091288|FG000|NOT COMPLETED|Dose Finding Period - Escalation||0||
48313344|NCT01423851|101091289|FG001|NOT COMPLETED|Dose Finding Period - Escalation||1||
48313345|NCT01423851|101091290|FG002|NOT COMPLETED|Dose Finding Period - Escalation||4||
48313346|NCT01423851|101091291|FG003|NOT COMPLETED|Dose Finding Period - Escalation||4||
48313347|NCT01423851|101091292|FG004|NOT COMPLETED|Dose Finding Period - Escalation||0||
48313348|NCT01423851|101091293|FG005|NOT COMPLETED|Dose Finding Period - Escalation||0||
48313349|NCT01423851|101091294|FG006|NOT COMPLETED|Dose Finding Period - Escalation||2||
48313350|NCT01423851|101091295|FG007|NOT COMPLETED|Dose Finding Period - Escalation||0||
48313351|NCT01423851|101091296|FG008|NOT COMPLETED|Dose Finding Period - Escalation||1||
48313352|NCT01423851|101091297|FG009|NOT COMPLETED|Dose Finding Period - Escalation||0||
48313353|NCT01423851|101091298|FG010|NOT COMPLETED|Dose Finding Period - Escalation||0||
48313354|NCT01423851|101091288|FG000|STARTED|Dose Finding Period - Reduction||0||
48313355|NCT01423851|101091289|FG001|STARTED|Dose Finding Period - Reduction||0||
48313356|NCT01423851|101091290|FG002|STARTED|Dose Finding Period - Reduction||3||
48313357|NCT01423851|101091291|FG003|STARTED|Dose Finding Period - Reduction||5||
48313358|NCT01423851|101091292|FG004|STARTED|Dose Finding Period - Reduction||1||
48313359|NCT01423851|101091293|FG005|STARTED|Dose Finding Period - Reduction||2||
48313360|NCT01423851|101091294|FG006|STARTED|Dose Finding Period - Reduction||8||
48313361|NCT01423851|101091295|FG007|STARTED|Dose Finding Period - Reduction||0||
48313362|NCT01423851|101091296|FG008|STARTED|Dose Finding Period - Reduction||3||
48313363|NCT01423851|101091297|FG009|STARTED|Dose Finding Period - Reduction||0||
48313364|NCT01423851|101091298|FG010|STARTED|Dose Finding Period - Reduction||0||
48313365|NCT01423851|101091288|FG000|COMPLETED|Dose Finding Period - Reduction||0||
48313366|NCT01423851|101091289|FG001|COMPLETED|Dose Finding Period - Reduction||0||
48313367|NCT01423851|101091290|FG002|COMPLETED|Dose Finding Period - Reduction||0||
48313368|NCT01423851|101091291|FG003|COMPLETED|Dose Finding Period - Reduction||0||
48313369|NCT01423851|101091292|FG004|COMPLETED|Dose Finding Period - Reduction||0||
48313370|NCT01423851|101091293|FG005|COMPLETED|Dose Finding Period - Reduction||0||
48313371|NCT01423851|101091294|FG006|COMPLETED|Dose Finding Period - Reduction||0||
48313372|NCT01423851|101091295|FG007|COMPLETED|Dose Finding Period - Reduction||0||
48313373|NCT01423851|101091296|FG008|COMPLETED|Dose Finding Period - Reduction||0||
48313374|NCT01423851|101091297|FG009|COMPLETED|Dose Finding Period - Reduction||0||
48313375|NCT01423851|101091298|FG010|COMPLETED|Dose Finding Period - Reduction||0||
48313376|NCT01423851|101091288|FG000|NOT COMPLETED|Dose Finding Period - Reduction||0||
48313377|NCT01423851|101091289|FG001|NOT COMPLETED|Dose Finding Period - Reduction||0||
48313378|NCT01423851|101091290|FG002|NOT COMPLETED|Dose Finding Period - Reduction||3||
48313379|NCT01423851|101091291|FG003|NOT COMPLETED|Dose Finding Period - Reduction||5||
48313380|NCT01423851|101091292|FG004|NOT COMPLETED|Dose Finding Period - Reduction||1||
48313381|NCT01423851|101091293|FG005|NOT COMPLETED|Dose Finding Period - Reduction||2||
48313382|NCT01423851|101091294|FG006|NOT COMPLETED|Dose Finding Period - Reduction||8||
48313383|NCT01423851|101091295|FG007|NOT COMPLETED|Dose Finding Period - Reduction||0||
48313384|NCT01423851|101091296|FG008|NOT COMPLETED|Dose Finding Period - Reduction||3||
48313385|NCT01423851|101091297|FG009|NOT COMPLETED|Dose Finding Period - Reduction||0||
48313386|NCT01423851|101091298|FG010|NOT COMPLETED|Dose Finding Period - Reduction||0||
48313387|NCT00682448|101091299|FG000|STARTED|Overall Study||12||
48313388|NCT00682448|101091300|FG001|STARTED|Overall Study||13||
48313389|NCT00682448|101091299|FG000|COMPLETED|Overall Study||7||
48313390|NCT00682448|101091300|FG001|COMPLETED|Overall Study||7||
48313391|NCT00682448|101091299|FG000|NOT COMPLETED|Overall Study||5||
48313392|NCT00682448|101091300|FG001|NOT COMPLETED|Overall Study||6||
48313393|NCT01572675|101091301|FG000|STARTED|Overall Study||268||
48313394|NCT01572675|101091302|FG001|STARTED|Overall Study||279||
48313395|NCT01572675|101091301|FG000|COMPLETED|Overall Study||31||
48313396|NCT01572675|101091302|FG001|COMPLETED|Overall Study||56||
48313397|NCT01572675|101091301|FG000|NOT COMPLETED|Overall Study||237||
48313398|NCT01572675|101091302|FG001|NOT COMPLETED|Overall Study||223||
48313399|NCT00397033|101091303|FG000|STARTED|Overall Study||107||
48313400|NCT00397033|101091304|FG001|STARTED|Overall Study||109||
48313401|NCT00397033|101091305|FG002|STARTED|Overall Study||100||
48313402|NCT00397033|101091303|FG000|Safety Population: >= 1 Dose of Drug|Overall Study||107||
48313403|NCT00397033|101091304|FG001|Safety Population: >= 1 Dose of Drug|Overall Study||108||
48313404|NCT00397033|101091305|FG002|Safety Population: >= 1 Dose of Drug|Overall Study||98||
48313405|NCT00397033|101091303|FG000|ITT Population|Overall Study||107||
48313406|NCT00397033|101091304|FG001|ITT Population|Overall Study||105||
48313407|NCT00397033|101091305|FG002|ITT Population|Overall Study||98||
48313408|NCT00397033|101091303|FG000|COMPLETED|Overall Study||63||
48313409|NCT00397033|101091304|FG001|COMPLETED|Overall Study||72||
48313410|NCT00397033|101091305|FG002|COMPLETED|Overall Study||77||
48313411|NCT00397033|101091303|FG000|NOT COMPLETED|Overall Study||44||
48313412|NCT00397033|101091304|FG001|NOT COMPLETED|Overall Study||37||
48313413|NCT00397033|101091305|FG002|NOT COMPLETED|Overall Study||23||
48313414|NCT04556396|101091306|FG000|STARTED|Overall Study||60||
48313415|NCT04556396|101091307|FG001|STARTED|Overall Study||174||
48313416|NCT04556396|101091306|FG000|COMPLETED|Overall Study||60||
48313417|NCT04556396|101091307|FG001|COMPLETED|Overall Study||174||
48313418|NCT04556396|101091306|FG000|NOT COMPLETED|Overall Study||0||
48313419|NCT04556396|101091307|FG001|NOT COMPLETED|Overall Study||0||
48313420|NCT02535715|101091308|FG000|STARTED|Overall Study||4||
48313421|NCT02535715|101091309|FG001|STARTED|Overall Study||4||
48313422|NCT02535715|101091310|FG002|STARTED|Overall Study||3||
48313423|NCT02535715|101091308|FG000|COMPLETED|Overall Study||4||
48313424|NCT02535715|101091309|FG001|COMPLETED|Overall Study||4||
48313425|NCT02535715|101091310|FG002|COMPLETED|Overall Study||2||
48313426|NCT02535715|101091308|FG000|NOT COMPLETED|Overall Study||0||
48313427|NCT02535715|101091309|FG001|NOT COMPLETED|Overall Study||0||
48313428|NCT02535715|101091310|FG002|NOT COMPLETED|Overall Study||1||
48313429|NCT00749476|101091311|FG000|STARTED|Overall Study||1||
48313430|NCT00749476|101091311|FG000|COMPLETED|Overall Study||1||
48313431|NCT00749476|101091311|FG000|NOT COMPLETED|Overall Study||0||
48313432|NCT01372150|101091312|FG000|STARTED|Overall Study||112||
48313433|NCT01372150|101091313|FG001|STARTED|Overall Study||113||
48313434|NCT01372150|101091314|FG002|STARTED|Overall Study||115||
48313435|NCT01372150|101091312|FG000|Treated|Overall Study||112||
48313436|NCT01372150|101091313|FG001|Treated|Overall Study||112||
48729415|NCT01227005|102123250|FG001|STARTED|Overall Study||52||
48729416|NCT01227005|102123249|FG000|COMPLETED|Overall Study||50||
48729417|NCT01227005|102123250|FG001|COMPLETED|Overall Study||51||
48729418|NCT01227005|102123249|FG000|NOT COMPLETED|Overall Study||5||
48729419|NCT01227005|102123250|FG001|NOT COMPLETED|Overall Study||1||
48729420|NCT01364389|102123251|FG000|STARTED|Overall Study||5||
48729421|NCT01364389|102123252|FG001|STARTED|Overall Study||6||
48729422|NCT01364389|102123253|FG002|STARTED|Overall Study||5||
48729423|NCT01364389|102123251|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||5||
48729424|NCT01364389|102123252|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||6||
48729425|NCT01364389|102123253|FG002|Pharmacodynamic (PD) Analysis Set|Overall Study||4||
48729426|NCT01364389|102123251|FG000|COMPLETED|Overall Study||3||
48729427|NCT01364389|102123252|FG001|COMPLETED|Overall Study||5||
48729428|NCT01364389|102123253|FG002|COMPLETED|Overall Study||4||
48313437|NCT01372150|101091314|FG002|Treated|Overall Study||115||
48313438|NCT01372150|101091312|FG000|COMPLETED|Overall Study||99||
48313439|NCT01372150|101091313|FG001|COMPLETED|Overall Study||99||
48406838|NCT03424044|101328492|FG008|COMPLETED|Second Rest Period (7-45 Days)||1||
48729429|NCT01364389|102123251|FG000|NOT COMPLETED|Overall Study||2||
48729430|NCT01364389|102123252|FG001|NOT COMPLETED|Overall Study||1||
48729431|NCT01364389|102123253|FG002|NOT COMPLETED|Overall Study||1||
48729432|NCT01336023|102123254|FG000|STARTED|Week 0 to Week 26||414||
48729433|NCT01336023|102123255|FG001|STARTED|Week 0 to Week 26||834||
48729434|NCT01336023|102123256|FG002|STARTED|Week 0 to Week 26||415||
48729435|NCT01336023|102123254|FG000|Exposed|Week 0 to Week 26||413||
48729436|NCT01336023|102123255|FG001|Exposed|Week 0 to Week 26||826||
48729437|NCT01336023|102123256|FG002|Exposed|Week 0 to Week 26||413||
48729438|NCT01336023|102123254|FG000|COMPLETED|Week 0 to Week 26||366||
48729439|NCT01336023|102123255|FG001|COMPLETED|Week 0 to Week 26||736||
48729440|NCT01336023|102123256|FG002|COMPLETED|Week 0 to Week 26||342||
48729441|NCT01336023|102123254|FG000|NOT COMPLETED|Week 0 to Week 26||48||
48729442|NCT01336023|102123255|FG001|NOT COMPLETED|Week 0 to Week 26||98||
48729443|NCT01336023|102123256|FG002|NOT COMPLETED|Week 0 to Week 26||73||
48729444|NCT01336023|102123254|FG000|STARTED|Week 27 to 52||333||
48729445|NCT01336023|102123255|FG001|STARTED|Week 27 to 52||665||
48729446|NCT01336023|102123256|FG002|STARTED|Week 27 to 52||313||
48729447|NCT01336023|102123254|FG000|COMPLETED|Week 27 to 52||305||
48729448|NCT01336023|102123255|FG001|COMPLETED|Week 27 to 52||621||
48729449|NCT01336023|102123256|FG002|COMPLETED|Week 27 to 52||285||
48729450|NCT01336023|102123254|FG000|NOT COMPLETED|Week 27 to 52||28||
48729451|NCT01336023|102123255|FG001|NOT COMPLETED|Week 27 to 52||44||
48729452|NCT01336023|102123256|FG002|NOT COMPLETED|Week 27 to 52||28||
48729453|NCT01722435|102123257|FG000|STARTED|Overall Study||78||
48729454|NCT01722435|102123257|FG000|COMPLETED|Overall Study||78||
48313440|NCT01372150|101091314|FG002|COMPLETED|Overall Study||99||
48313441|NCT01372150|101091312|FG000|NOT COMPLETED|Overall Study||13||
48313442|NCT01372150|101091313|FG001|NOT COMPLETED|Overall Study||14||
48313443|NCT01372150|101091314|FG002|NOT COMPLETED|Overall Study||16||
48729455|NCT01722435|102123257|FG000|NOT COMPLETED|Overall Study||0||
48729456|NCT00527904|102123258|FG000|STARTED|Overall Study||239||
48729457|NCT00527904|102123258|FG000|COMPLETED|Overall Study||143||
48729458|NCT00527904|102123258|FG000|NOT COMPLETED|Overall Study||96||
48729459|NCT01073930|102123259|FG000|STARTED|Overall Study||307||
48729460|NCT01073930|102123260|FG001|STARTED|Overall Study||301||
48729461|NCT01073930|102123259|FG000|Safety Population (Treated)|Overall Study||305||
48729462|NCT01073930|102123260|FG001|Safety Population (Treated)|Overall Study||298||
48729463|NCT01073930|102123259|FG000|Intent to Treat Population|Overall Study||304||
48729464|NCT01073930|102123260|FG001|Intent to Treat Population|Overall Study||297||
48729465|NCT01073930|102123259|FG000|COMPLETED|Overall Study||304||
48729466|NCT01073930|102123260|FG001|COMPLETED|Overall Study||295||
48729467|NCT01073930|102123259|FG000|NOT COMPLETED|Overall Study||3||
48729468|NCT01073930|102123260|FG001|NOT COMPLETED|Overall Study||6||
48729469|NCT01135095|102123261|FG000|STARTED|Overall Study||101||
48729470|NCT01135095|102123261|FG000|COMPLETED|Overall Study||101||
48729471|NCT01135095|102123261|FG000|NOT COMPLETED|Overall Study||0||
48729472|NCT01320202|102123262|FG000|STARTED|Overall Study||152||
48729473|NCT01320202|102123263|FG001|STARTED|Overall Study||153||
48729474|NCT01320202|102123262|FG000|Comp 48 Wks in St 2|Overall Study||27||
48313444|NCT01245387|101094061|FG000|STARTED|Overall Study||1001||
48313445|NCT01245387|101094061|FG000|COMPLETED|Overall Study||188||
48313446|NCT01245387|101094061|FG000|NOT COMPLETED|Overall Study||813||
48313447|NCT04234672|101094062|FG000|STARTED|Treatment Period 1 (Day 1)||6||
48313448|NCT04234672|101094062|FG000|COMPLETED|Treatment Period 1 (Day 1)||6||
48313449|NCT04234672|101094062|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48313450|NCT04234672|101094062|FG000|STARTED|Washout Period (Day 2 to 8)||6||
48313451|NCT04234672|101094062|FG000|COMPLETED|Washout Period (Day 2 to 8)||6||
48729475|NCT01320202|102123263|FG001|Comp 48 Wks in St 2|Overall Study||27||
48729476|NCT01320202|102123262|FG000|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||69||
48729477|NCT01320202|102123263|FG001|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||82||
48729478|NCT01320202|102123262|FG000|Enrolled in St 3|Overall Study||98||
48729479|NCT01320202|102123263|FG001|Enrolled in St 3|Overall Study||109||
48313452|NCT04234672|101094062|FG000|NOT COMPLETED|Washout Period (Day 2 to 8)||0||
48313453|NCT04234672|101094062|FG000|STARTED|Treatment Period 2(Day9[Day1of Period2])||6||
48313454|NCT04234672|101094062|FG000|COMPLETED|Treatment Period 2(Day9[Day1of Period2])||6||
48313455|NCT04234672|101094062|FG000|NOT COMPLETED|Treatment Period 2(Day9[Day1of Period2])||0||
48313456|NCT03067571|101094063|FG000|STARTED|Overall Study||7||
48313457|NCT03067571|101094063|FG000|COMPLETED|Overall Study||7||
48313458|NCT03067571|101094063|FG000|NOT COMPLETED|Overall Study||0||
48313459|NCT03880032|101094064|FG000|STARTED|Overall Study||600||
48313460|NCT03880032|101094065|FG001|STARTED|Overall Study||600||
48313461|NCT03880032|101094064|FG000|COMPLETED|Overall Study||380||
48313462|NCT03880032|101094065|FG001|COMPLETED|Overall Study||375||
48313463|NCT03880032|101094064|FG000|NOT COMPLETED|Overall Study||220||
48313464|NCT03880032|101094065|FG001|NOT COMPLETED|Overall Study||225||
48313465|NCT02512809|101094066|FG000|STARTED|Overall Study||25||
48313466|NCT02512809|101094066|FG000|COMPLETED|Overall Study||25||
48313467|NCT02512809|101094066|FG000|NOT COMPLETED|Overall Study||0||
48313468|NCT00747643|101094067|FG000|STARTED|Overall Study||82||
48313469|NCT00747643|101094068|FG001|STARTED|Overall Study||81||
48313470|NCT00747643|101094067|FG000|COMPLETED|Overall Study||46||
48313471|NCT00747643|101094068|FG001|COMPLETED|Overall Study||54||
48313472|NCT00747643|101094067|FG000|NOT COMPLETED|Overall Study||36||
48313473|NCT00747643|101094068|FG001|NOT COMPLETED|Overall Study||27||
48313474|NCT04747834|101094069|FG000|STARTED|Overall Study||44||
48313475|NCT04747834|101094070|FG001|STARTED|Overall Study||56||
48313476|NCT04747834|101094069|FG000|COMPLETED|Overall Study||44||
48313477|NCT04747834|101094070|FG001|COMPLETED|Overall Study||56||
48313478|NCT04747834|101094069|FG000|NOT COMPLETED|Overall Study||0||
48313479|NCT04747834|101094070|FG001|NOT COMPLETED|Overall Study||0||
48313480|NCT01080248|101094071|FG000|STARTED|Overall Study||2||
48313481|NCT01080248|101094071|FG000|COMPLETED|Overall Study||2||
48313482|NCT01080248|101094071|FG000|NOT COMPLETED|Overall Study||0||
48313483|NCT01987960|101094072|FG000|STARTED|Period 1||417||
48406839|NCT03424044|101328484|FG000|NOT COMPLETED|Second Rest Period (7-45 Days)||0||
48406840|NCT03424044|101328485|FG001|NOT COMPLETED|Second Rest Period (7-45 Days)||0||
48406841|NCT03424044|101328486|FG002|NOT COMPLETED|Second Rest Period (7-45 Days)||0||
48406842|NCT03424044|101328487|FG003|NOT COMPLETED|Second Rest Period (7-45 Days)||0||
48406843|NCT03424044|101328488|FG004|NOT COMPLETED|Second Rest Period (7-45 Days)||0||
48406844|NCT03424044|101328489|FG005|NOT COMPLETED|Second Rest Period (7-45 Days)||0||
48406845|NCT03424044|101328490|FG006|NOT COMPLETED|Second Rest Period (7-45 Days)||0||
48406846|NCT03424044|101328491|FG007|NOT COMPLETED|Second Rest Period (7-45 Days)||0||
48614274|NCT02710084|101841713|FG001|NOT COMPLETED|Open Label Phase: Week 12 to 24||0||
48614275|NCT01968811|101841714|FG000|STARTED|Overall Study||10||
48614276|NCT01968811|101841714|FG000|COMPLETED|Overall Study||5||
48614277|NCT01968811|101841714|FG000|NOT COMPLETED|Overall Study||5||
48614278|NCT02108977|101841715|FG000|STARTED|Overall Study||18||
48614279|NCT02108977|101841716|FG001|STARTED|Overall Study||20||
48614280|NCT02108977|101841715|FG000|COMPLETED|Overall Study||8||
48614281|NCT02108977|101841716|FG001|COMPLETED|Overall Study||19||
48614282|NCT02108977|101841715|FG000|NOT COMPLETED|Overall Study||10||
48313484|NCT01987960|101094073|FG001|STARTED|Period 1||0||
48406847|NCT03424044|101328492|FG008|NOT COMPLETED|Second Rest Period (7-45 Days)||0||
48406848|NCT03424044|101328484|FG000|STARTED|Second Intervention (76 Hours)||4||
48406849|NCT03424044|101328485|FG001|STARTED|Second Intervention (76 Hours)||3||
48614283|NCT02108977|101841716|FG001|NOT COMPLETED|Overall Study||1||
48614284|NCT01128400|101841717|FG000|STARTED|Overall Study||8||
48614285|NCT01128400|101841718|FG001|STARTED|Overall Study||9||
48614286|NCT01128400|101841719|FG002|STARTED|Overall Study||23||
48614287|NCT01128400|101841717|FG000|COMPLETED|Overall Study||6||
48729480|NCT01320202|102123262|FG000|Completed St 3|Overall Study||79||
48729481|NCT01320202|102123263|FG001|Completed St 3|Overall Study||82||
48729482|NCT01320202|102123262|FG000|COMPLETED|Overall Study||96||
48729483|NCT01320202|102123263|FG001|COMPLETED|Overall Study||109||
48729484|NCT01320202|102123262|FG000|NOT COMPLETED|Overall Study||56||
48729485|NCT01320202|102123263|FG001|NOT COMPLETED|Overall Study||44||
48729486|NCT01853605|102123264|FG000|STARTED|Overall Study||1939||
48729487|NCT01853605|102123265|FG001|STARTED|Overall Study||693||
48729488|NCT01853605|102123266|FG002|STARTED|Overall Study||751||
48729489|NCT01853605|102123267|FG003|STARTED|Overall Study||428||
48313485|NCT01987960|101094074|FG002|STARTED|Period 1||0||
48313486|NCT01987960|101094075|FG003|STARTED|Period 1||0||
48313487|NCT01987960|101094072|FG000|COMPLETED|Period 1||231||
48313488|NCT01987960|101094073|FG001|COMPLETED|Period 1||0||
48313489|NCT01987960|101094074|FG002|COMPLETED|Period 1||0||
48313490|NCT01987960|101094075|FG003|COMPLETED|Period 1||0||
48313491|NCT01987960|101094072|FG000|NOT COMPLETED|Period 1||186||
48313492|NCT01987960|101094073|FG001|NOT COMPLETED|Period 1||0||
48313493|NCT01987960|101094074|FG002|NOT COMPLETED|Period 1||0||
48313494|NCT01987960|101094075|FG003|NOT COMPLETED|Period 1||0||
48313495|NCT01987960|101094072|FG000|STARTED|Period 2||0||
48313496|NCT01987960|101094073|FG001|STARTED|Period 2||17||
48313497|NCT01987960|101094074|FG002|STARTED|Period 2||23||
48313498|NCT01987960|101094075|FG003|STARTED|Period 2||0||
48313499|NCT01987960|101094072|FG000|COMPLETED|Period 2||0||
48313500|NCT01987960|101094073|FG001|COMPLETED|Period 2||12||
48313501|NCT01987960|101094074|FG002|COMPLETED|Period 2||14||
48406850|NCT03424044|101328486|FG002|STARTED|Second Intervention (76 Hours)||2||
48313502|NCT01987960|101094075|FG003|COMPLETED|Period 2||0||
48313503|NCT01987960|101094072|FG000|NOT COMPLETED|Period 2||0||
48313504|NCT01987960|101094073|FG001|NOT COMPLETED|Period 2||5||
48313505|NCT01987960|101094074|FG002|NOT COMPLETED|Period 2||9||
48313506|NCT01987960|101094075|FG003|NOT COMPLETED|Period 2||0||
48313507|NCT01987960|101094072|FG000|STARTED|Period 3||0||
48313508|NCT01987960|101094073|FG001|STARTED|Period 3||0||
48313509|NCT01987960|101094074|FG002|STARTED|Period 3||0||
48313510|NCT01987960|101094075|FG003|STARTED|Period 3||190||
48313511|NCT01987960|101094072|FG000|COMPLETED|Period 3||0||
48313512|NCT01987960|101094073|FG001|COMPLETED|Period 3||0||
48313513|NCT01987960|101094074|FG002|COMPLETED|Period 3||0||
48313514|NCT01987960|101094075|FG003|COMPLETED|Period 3||119||
48313515|NCT01987960|101094072|FG000|NOT COMPLETED|Period 3||0||
48313516|NCT01987960|101094073|FG001|NOT COMPLETED|Period 3||0||
48313517|NCT01987960|101094074|FG002|NOT COMPLETED|Period 3||0||
48313518|NCT01987960|101094075|FG003|NOT COMPLETED|Period 3||71||
48313519|NCT00054704|101094076|FG000|STARTED|Overall Study||8||
48313520|NCT00054704|101094077|FG001|STARTED|Overall Study||11||
48313521|NCT00054704|101094076|FG000|COMPLETED|Overall Study||3||
48313522|NCT00054704|101094077|FG001|COMPLETED|Overall Study||6||
48313523|NCT00054704|101094076|FG000|NOT COMPLETED|Overall Study||5||
48313524|NCT00054704|101094077|FG001|NOT COMPLETED|Overall Study||5||
48313525|NCT00785044|101094078|FG000|STARTED|Overall Study||964||
48313526|NCT00785044|101094078|FG000|Enrolled Participants|Overall Study||471||
48313527|NCT00785044|101094078|FG000|COMPLETED|Overall Study||468||
48313528|NCT00785044|101094078|FG000|NOT COMPLETED|Overall Study||496||
48614288|NCT01128400|101841718|FG001|COMPLETED|Overall Study||8||
48614289|NCT01128400|101841719|FG002|COMPLETED|Overall Study||7||
48614290|NCT01128400|101841717|FG000|NOT COMPLETED|Overall Study||2||
48614291|NCT01128400|101841718|FG001|NOT COMPLETED|Overall Study||1||
48614292|NCT01128400|101841719|FG002|NOT COMPLETED|Overall Study||16||
48614293|NCT05381454|101841720|FG000|STARTED|Overall Study||40||
48614294|NCT05381454|101841721|FG001|STARTED|Overall Study||40||
48614295|NCT05381454|101841720|FG000|COMPLETED|Overall Study||40||
48614296|NCT05381454|101841721|FG001|COMPLETED|Overall Study||40||
48614297|NCT05381454|101841720|FG000|NOT COMPLETED|Overall Study||0||
48614298|NCT05381454|101841721|FG001|NOT COMPLETED|Overall Study||0||
48313529|NCT00240981|101094079|FG000|STARTED|Overall Study||106||
48614299|NCT02849080|101841722|FG000|STARTED|Main Phase: 0 - 52 Weeks||253||
48313530|NCT00240981|101094080|FG001|STARTED|Overall Study||103||
48313531|NCT00240981|101094079|FG000|Intent to Treat Sample|Overall Study||82||
48313532|NCT00240981|101094080|FG001|Intent to Treat Sample|Overall Study||83||
48313533|NCT00240981|101094079|FG000|COMPLETED|Overall Study||68||
48313534|NCT00240981|101094080|FG001|COMPLETED|Overall Study||70||
48313535|NCT00240981|101094079|FG000|NOT COMPLETED|Overall Study||38||
48313536|NCT00240981|101094080|FG001|NOT COMPLETED|Overall Study||33||
48313537|NCT02700997|101094081|FG000|STARTED|Overall Study||17||
48406851|NCT03424044|101328487|FG003|STARTED|Second Intervention (76 Hours)||3||
48729490|NCT01853605|102123264|FG000|COMPLETED|Overall Study||1939||
48729491|NCT01853605|102123265|FG001|COMPLETED|Overall Study||693||
48729492|NCT01853605|102123266|FG002|COMPLETED|Overall Study||751||
48729493|NCT01853605|102123267|FG003|COMPLETED|Overall Study||428||
48729494|NCT01853605|102123264|FG000|NOT COMPLETED|Overall Study||0||
48157490|NCT00118898|100706961|FG003|Initiated Treatment|Overall Study||462||
48157491|NCT00118898|100706958|FG000|COMPLETED|Overall Study||343||
48157492|NCT00118898|100706959|FG001|COMPLETED|Overall Study||324||
48157493|NCT00118898|100706960|FG002|COMPLETED|Overall Study||342||
48157494|NCT00118898|100706961|FG003|COMPLETED|Overall Study||322||
48157495|NCT00118898|100706958|FG000|NOT COMPLETED|Overall Study||121||
48157496|NCT00118898|100706959|FG001|NOT COMPLETED|Overall Study||141||
48157497|NCT00118898|100706960|FG002|NOT COMPLETED|Overall Study||123||
48313538|NCT02700997|101094081|FG000|COMPLETED|Overall Study||15||
48313539|NCT02700997|101094081|FG000|NOT COMPLETED|Overall Study||2||
48313540|NCT01378858|101094082|FG000|STARTED|Overall Study||50||
48313541|NCT01378858|101094083|FG001|STARTED|Overall Study||50||
48729495|NCT01853605|102123265|FG001|NOT COMPLETED|Overall Study||0||
48729496|NCT01853605|102123266|FG002|NOT COMPLETED|Overall Study||0||
48729497|NCT01853605|102123267|FG003|NOT COMPLETED|Overall Study||0||
48729498|NCT00782483|102123268|FG000|STARTED|Overall Study||6||
48729499|NCT00782483|102123268|FG000|COMPLETED|Overall Study||0||
48729500|NCT00782483|102123268|FG000|NOT COMPLETED|Overall Study||6||
48729501|NCT02332291|102123269|FG000|STARTED|Phase 1: Blinded Escitalopram or Placebo||63||
48729502|NCT02332291|102123270|FG001|STARTED|Phase 1: Blinded Escitalopram or Placebo||32||
48729503|NCT02332291|102123269|FG000|COMPLETED|Phase 1: Blinded Escitalopram or Placebo||59||
48729504|NCT02332291|102123270|FG001|COMPLETED|Phase 1: Blinded Escitalopram or Placebo||23||
48729505|NCT02332291|102123269|FG000|NOT COMPLETED|Phase 1: Blinded Escitalopram or Placebo||4||
48729506|NCT02332291|102123270|FG001|NOT COMPLETED|Phase 1: Blinded Escitalopram or Placebo||9||
48729507|NCT02332291|102123269|FG000|STARTED|Phase 2: Open-Label Bupropion||22||
48729508|NCT02332291|102123270|FG001|STARTED|Phase 2: Open-Label Bupropion||19||
48729509|NCT02332291|102123269|FG000|COMPLETED|Phase 2: Open-Label Bupropion||19||
48729510|NCT02332291|102123270|FG001|COMPLETED|Phase 2: Open-Label Bupropion||11||
48729511|NCT02332291|102123269|FG000|NOT COMPLETED|Phase 2: Open-Label Bupropion||3||
48729512|NCT02332291|102123270|FG001|NOT COMPLETED|Phase 2: Open-Label Bupropion||8||
48729513|NCT00156390|102123271|FG000|STARTED|Overall Study||110||
48157498|NCT00118898|100706961|FG003|NOT COMPLETED|Overall Study||141||
48157499|NCT02654990|100706962|FG000|STARTED|Overall Study||82|Full analysis set (FAS): all participants to whom study treatment was assigned by randomization.|
48157500|NCT02654990|100706963|FG001|STARTED|Overall Study||83|Full analysis set (FAS): all participants to whom study treatment was assigned by randomization.|
48157501|NCT02654990|100706964|FG002|STARTED|Overall Study||83|Full analysis set (FAS): all participants to whom study treatment was assigned by randomization.|
48188543|NCT02068885|100783272|FG002|Provided Data at Midpoint Test Phase|Overall Study||48||
48313542|NCT01378858|101094082|FG000|COMPLETED|Overall Study||46||
48313543|NCT01378858|101094083|FG001|COMPLETED|Overall Study||46||
48313544|NCT01378858|101094082|FG000|NOT COMPLETED|Overall Study||4||
48313545|NCT01378858|101094083|FG001|NOT COMPLETED|Overall Study||4||
48313546|NCT02181816|101094084|FG000|STARTED|Overall Study||1090||
48313547|NCT02181816|101094084|FG000|COMPLETED|Overall Study||1031||
48313548|NCT02181816|101094084|FG000|NOT COMPLETED|Overall Study||59||
48313549|NCT00395863|101094085|FG000|STARTED|Overall Study||23||
48313550|NCT00395863|101094086|FG001|STARTED|Overall Study||23||
48313551|NCT00395863|101094085|FG000|COMPLETED|Overall Study||21||
48313552|NCT00395863|101094086|FG001|COMPLETED|Overall Study||20||
48313553|NCT00395863|101094085|FG000|NOT COMPLETED|Overall Study||2||
48313554|NCT00395863|101094086|FG001|NOT COMPLETED|Overall Study||3||
48313555|NCT01147744|101094087|FG000|STARTED|Overall Study||100||
48313556|NCT01147744|101094088|FG001|STARTED|Overall Study||99||
48313557|NCT01147744|101094089|FG002|STARTED|Overall Study||100||
48313558|NCT01147744|101094090|FG003|STARTED|Overall Study||100||
48313559|NCT01147744|101094091|FG004|STARTED|Overall Study||101||
48729514|NCT00156390|102123272|FG001|STARTED|Overall Study||77||
48313560|NCT01147744|101094092|FG005|STARTED|Overall Study||103||
48313561|NCT01147744|101094093|FG006|STARTED|Overall Study||97||
48313562|NCT01147744|101094087|FG000|COMPLETED|Overall Study||71||
48313563|NCT01147744|101094088|FG001|COMPLETED|Overall Study||76||
48313564|NCT01147744|101094089|FG002|COMPLETED|Overall Study||82||
48313565|NCT01147744|101094090|FG003|COMPLETED|Overall Study||82||
48729515|NCT00156390|102123271|FG000|COMPLETED|Overall Study||96||
48729516|NCT00156390|102123272|FG001|COMPLETED|Overall Study||69||
48729517|NCT00156390|102123271|FG000|NOT COMPLETED|Overall Study||14||
48729518|NCT00156390|102123272|FG001|NOT COMPLETED|Overall Study||8||
48729519|NCT00186901|102123273|FG000|STARTED|Overall Study||134||
48729520|NCT00186901|102123274|FG001|STARTED|Overall Study||141||
48729521|NCT00186901|102123275|FG002|STARTED|Overall Study||149||
48729522|NCT00186901|102123273|FG000|Baseline|Overall Study||134||
48729523|NCT00186901|102123274|FG001|Baseline|Overall Study||141||
48729524|NCT00186901|102123275|FG002|Baseline|Overall Study||0||
48729525|NCT00186901|102123273|FG000|12 Month Follow-up|Overall Study||117||
48729526|NCT00186901|102123274|FG001|12 Month Follow-up|Overall Study||122||
48729527|NCT00186901|102123275|FG002|12 Month Follow-up|Overall Study||0||
48313566|NCT01147744|101094091|FG004|COMPLETED|Overall Study||76||
48406852|NCT03424044|101328488|FG004|STARTED|Second Intervention (76 Hours)||2||
48406853|NCT03424044|101328489|FG005|STARTED|Second Intervention (76 Hours)||4||
48406854|NCT03424044|101328490|FG006|STARTED|Second Intervention (76 Hours)||1||
48406855|NCT03424044|101328491|FG007|STARTED|Second Intervention (76 Hours)||1||
48406856|NCT03424044|101328492|FG008|STARTED|Second Intervention (76 Hours)||1||
48406857|NCT03424044|101328484|FG000|COMPLETED|Second Intervention (76 Hours)||4||
48406858|NCT03424044|101328485|FG001|COMPLETED|Second Intervention (76 Hours)||3||
48406859|NCT03424044|101328486|FG002|COMPLETED|Second Intervention (76 Hours)||2||
48406860|NCT03424044|101328487|FG003|COMPLETED|Second Intervention (76 Hours)||3||
48313567|NCT01147744|101094092|FG005|COMPLETED|Overall Study||83||
48313568|NCT01147744|101094093|FG006|COMPLETED|Overall Study||78||
48313569|NCT01147744|101094087|FG000|NOT COMPLETED|Overall Study||29||
48313570|NCT01147744|101094088|FG001|NOT COMPLETED|Overall Study||23||
48313571|NCT01147744|101094089|FG002|NOT COMPLETED|Overall Study||18||
48313572|NCT01147744|101094090|FG003|NOT COMPLETED|Overall Study||18||
48313573|NCT01147744|101094091|FG004|NOT COMPLETED|Overall Study||25||
48313574|NCT01147744|101094092|FG005|NOT COMPLETED|Overall Study||20||
48313575|NCT01147744|101094093|FG006|NOT COMPLETED|Overall Study||19||
48313576|NCT03021499|101094094|FG000|STARTED|Overall Study||179||
48729528|NCT00186901|102123273|FG000|24 Month Follow-up|Overall Study||106||
48729529|NCT00186901|102123274|FG001|24 Month Follow-up|Overall Study||107||
48729530|NCT00186901|102123275|FG002|24 Month Follow-up|Overall Study||0||
48313577|NCT03021499|101094095|FG001|STARTED|Overall Study||178||
48313578|NCT03021499|101094094|FG000|Week 24|Overall Study||167||
48313579|NCT03021499|101094095|FG001|Week 24|Overall Study||162||
48313580|NCT03021499|101094094|FG000|Week 52|Overall Study||162||
48313581|NCT03021499|101094095|FG001|Week 52|Overall Study||147||
48313582|NCT03021499|101094094|FG000|COMPLETED|Overall Study||163||
48313583|NCT03021499|101094095|FG001|COMPLETED|Overall Study||147||
48729531|NCT00186901|102123273|FG000|COMPLETED|Overall Study||85||
48729532|NCT00186901|102123274|FG001|COMPLETED|Overall Study||96||
48313584|NCT03021499|101094094|FG000|NOT COMPLETED|Overall Study||16||
48313585|NCT03021499|101094095|FG001|NOT COMPLETED|Overall Study||31||
48313586|NCT00359138|101094096|FG000|STARTED|Overall Study||12||
48313587|NCT00359138|101094097|FG001|STARTED|Overall Study||12||
48313588|NCT00359138|101094098|FG002|STARTED|Overall Study||12||
48313589|NCT00359138|101094096|FG000|COMPLETED|Overall Study||12||
48313590|NCT00359138|101094097|FG001|COMPLETED|Overall Study||12||
48313591|NCT00359138|101094098|FG002|COMPLETED|Overall Study||12||
48313592|NCT00359138|101094096|FG000|NOT COMPLETED|Overall Study||0||
48313593|NCT00359138|101094097|FG001|NOT COMPLETED|Overall Study||0||
48313594|NCT00359138|101094098|FG002|NOT COMPLETED|Overall Study||0||
48313595|NCT01205828|101094099|FG000|STARTED|Overall Study||16||
48313596|NCT01205828|101094099|FG000|COMPLETED|Overall Study||16||
48313597|NCT01205828|101094099|FG000|NOT COMPLETED|Overall Study||0||
48313598|NCT00290199|101094100|FG000|STARTED|Overall Study||87||
48313599|NCT00290199|101094101|FG001|STARTED|Overall Study||82||
48313600|NCT00290199|101094100|FG000|COMPLETED|Overall Study||87||
48313601|NCT00290199|101094101|FG001|COMPLETED|Overall Study||82||
48313602|NCT00290199|101094100|FG000|NOT COMPLETED|Overall Study||0||
48313603|NCT00290199|101094101|FG001|NOT COMPLETED|Overall Study||0||
48313604|NCT00097773|101094102|FG000|STARTED|Overall Study||76||
48313605|NCT00097773|101094103|FG001|STARTED|Overall Study||76||
48313606|NCT00097773|101094104|FG002|STARTED|Overall Study||76||
48313607|NCT00097773|101094105|FG003|STARTED|Overall Study||76||
48313608|NCT00097773|101094102|FG000|COMPLETED|Overall Study||68||
48313609|NCT00097773|101094103|FG001|COMPLETED|Overall Study||68||
48313610|NCT00097773|101094104|FG002|COMPLETED|Overall Study||68||
48406861|NCT03424044|101328488|FG004|COMPLETED|Second Intervention (76 Hours)||2||
48406862|NCT03424044|101328489|FG005|COMPLETED|Second Intervention (76 Hours)||4||
48406863|NCT03424044|101328490|FG006|COMPLETED|Second Intervention (76 Hours)||1||
48406864|NCT03424044|101328491|FG007|COMPLETED|Second Intervention (76 Hours)||1||
48406865|NCT03424044|101328492|FG008|COMPLETED|Second Intervention (76 Hours)||1||
48406866|NCT03424044|101328484|FG000|NOT COMPLETED|Second Intervention (76 Hours)||0||
48406867|NCT03424044|101328485|FG001|NOT COMPLETED|Second Intervention (76 Hours)||0||
48406868|NCT03424044|101328486|FG002|NOT COMPLETED|Second Intervention (76 Hours)||0||
48406869|NCT03424044|101328487|FG003|NOT COMPLETED|Second Intervention (76 Hours)||0||
48406870|NCT03424044|101328488|FG004|NOT COMPLETED|Second Intervention (76 Hours)||0||
48406871|NCT03424044|101328489|FG005|NOT COMPLETED|Second Intervention (76 Hours)||0||
48729533|NCT00186901|102123275|FG002|COMPLETED|Overall Study||0||
48729534|NCT00186901|102123273|FG000|NOT COMPLETED|Overall Study||49||
48729535|NCT00186901|102123274|FG001|NOT COMPLETED|Overall Study||45||
48313611|NCT00097773|101094105|FG003|COMPLETED|Overall Study||73||
48313612|NCT00097773|101094102|FG000|NOT COMPLETED|Overall Study||8||
48313613|NCT00097773|101094103|FG001|NOT COMPLETED|Overall Study||8||
48313614|NCT00097773|101094104|FG002|NOT COMPLETED|Overall Study||8||
48313615|NCT00097773|101094105|FG003|NOT COMPLETED|Overall Study||3||
48313616|NCT03668600|101094106|FG000|STARTED|Overall Study||230||
48313617|NCT03668600|101094106|FG000|COMPLETED|Overall Study||0||
48313618|NCT03668600|101094106|FG000|NOT COMPLETED|Overall Study||230||
48313619|NCT02230254|101094107|FG000|STARTED|Overall Study||101||
48729536|NCT00186901|102123275|FG002|NOT COMPLETED|Overall Study||149||
48729537|NCT01068769|102123276|FG000|STARTED|Overall Study||34||
48729538|NCT01068769|102123276|FG000|COMPLETED|Overall Study||33||
48729539|NCT01068769|102123276|FG000|NOT COMPLETED|Overall Study||1||
48729540|NCT01161537|102123277|FG000|STARTED|Part A||8||
48729541|NCT01161537|102123277|FG000|COMPLETED|Part A||8||
48729542|NCT01161537|102123277|FG000|NOT COMPLETED|Part A||0||
48729543|NCT01161537|102123277|FG000|STARTED|Part B||9||
48729544|NCT01161537|102123277|FG000|COMPLETED|Part B||7||
48729545|NCT01161537|102123277|FG000|NOT COMPLETED|Part B||2||
48729546|NCT04649177|102123278|FG000|STARTED|Overall Study||11||
48729547|NCT04649177|102123278|FG000|COMPLETED|Overall Study||10||
48729548|NCT04649177|102123278|FG000|NOT COMPLETED|Overall Study||1||
48729549|NCT04412707|102123279|FG000|STARTED|Cycle 1||14||
48729550|NCT04412707|102123280|FG001|STARTED|Cycle 1||13||
48729551|NCT04412707|102123279|FG000|Discontinued|Cycle 1||1||
48406872|NCT03424044|101328490|FG006|NOT COMPLETED|Second Intervention (76 Hours)||0||
48406873|NCT03424044|101328491|FG007|NOT COMPLETED|Second Intervention (76 Hours)||0||
48406874|NCT03424044|101328492|FG008|NOT COMPLETED|Second Intervention (76 Hours)||0||
48406875|NCT03424044|101328484|FG000|STARTED|Third Rest Period (7-45 Days)||4||
48614300|NCT02849080|101841723|FG001|STARTED|Main Phase: 0 - 52 Weeks||251||
48614301|NCT02849080|101841724|FG002|STARTED|Main Phase: 0 - 52 Weeks||0||
48614302|NCT02849080|101841725|FG003|STARTED|Main Phase: 0 - 52 Weeks||0||
48614303|NCT02849080|101841722|FG000|Exposed|Main Phase: 0 - 52 Weeks||253||
48614304|NCT02849080|101841723|FG001|Exposed|Main Phase: 0 - 52 Weeks||250||
48614305|NCT02849080|101841724|FG002|Exposed|Main Phase: 0 - 52 Weeks||0||
48614306|NCT02849080|101841725|FG003|Exposed|Main Phase: 0 - 52 Weeks||0||
48614307|NCT02849080|101841722|FG000|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||253||
48614308|NCT02849080|101841723|FG001|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||251||
48614309|NCT02849080|101841724|FG002|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||0||
48614310|NCT02849080|101841725|FG003|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||0||
48614311|NCT02849080|101841722|FG000|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||253||
48614312|NCT02849080|101841723|FG001|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||250||
48614313|NCT02849080|101841724|FG002|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||0||
48614314|NCT02849080|101841725|FG003|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||0||
48614315|NCT02849080|101841722|FG000|COMPLETED|Main Phase: 0 - 52 Weeks||241||
48729552|NCT04412707|102123280|FG001|Discontinued|Cycle 1||5||
48729553|NCT04412707|102123279|FG000|COMPLETED|Cycle 1||13||
48729554|NCT04412707|102123280|FG001|COMPLETED|Cycle 1||8||
48729555|NCT04412707|102123279|FG000|NOT COMPLETED|Cycle 1||1||
48729556|NCT04412707|102123280|FG001|NOT COMPLETED|Cycle 1||5||
48729557|NCT04412707|102123279|FG000|STARTED|Cycle 2||13||
48729558|NCT04412707|102123280|FG001|STARTED|Cycle 2||8||
48729559|NCT04412707|102123279|FG000|Discontinued|Cycle 2||3||
48729560|NCT04412707|102123280|FG001|Discontinued|Cycle 2||1||
48729561|NCT04412707|102123279|FG000|COMPLETED|Cycle 2||10||
48729562|NCT04412707|102123280|FG001|COMPLETED|Cycle 2||7||
48729563|NCT04412707|102123279|FG000|NOT COMPLETED|Cycle 2||3||
48729564|NCT04412707|102123280|FG001|NOT COMPLETED|Cycle 2||1||
48729565|NCT04412707|102123279|FG000|STARTED|Cycle 3 to End of Study (EOS)||10||
48729566|NCT04412707|102123280|FG001|STARTED|Cycle 3 to End of Study (EOS)||7||
48729567|NCT04412707|102123279|FG000|Ongoing in Study at Data Cut|Cycle 3 to End of Study (EOS)||0||
48729568|NCT04412707|102123280|FG001|Ongoing in Study at Data Cut|Cycle 3 to End of Study (EOS)||0||
48729569|NCT04412707|102123279|FG000|Discontinued Study in Cycle 3 or Later|Cycle 3 to End of Study (EOS)||10||
48729570|NCT04412707|102123280|FG001|Discontinued Study in Cycle 3 or Later|Cycle 3 to End of Study (EOS)||7||
48729571|NCT04412707|102123279|FG000|COMPLETED|Cycle 3 to End of Study (EOS)||0||
48729572|NCT04412707|102123280|FG001|COMPLETED|Cycle 3 to End of Study (EOS)||0||
48729573|NCT04412707|102123279|FG000|NOT COMPLETED|Cycle 3 to End of Study (EOS)||10||
48729574|NCT04412707|102123280|FG001|NOT COMPLETED|Cycle 3 to End of Study (EOS)||7||
48406876|NCT03424044|101328485|FG001|STARTED|Third Rest Period (7-45 Days)||3||
48406877|NCT03424044|101328486|FG002|STARTED|Third Rest Period (7-45 Days)||2||
48406878|NCT03424044|101328487|FG003|STARTED|Third Rest Period (7-45 Days)||3||
48614316|NCT02849080|101841723|FG001|COMPLETED|Main Phase: 0 - 52 Weeks||244||
48614317|NCT02849080|101841724|FG002|COMPLETED|Main Phase: 0 - 52 Weeks||0||
48729575|NCT01776723|102123281|FG000|STARTED|Overall Study||6||
48729576|NCT01776723|102123282|FG001|STARTED|Overall Study||4||
48729577|NCT01776723|102123283|FG002|STARTED|Overall Study||5||
48729578|NCT01776723|102123284|FG003|STARTED|Overall Study||5||
48729579|NCT01776723|102123285|FG004|STARTED|Overall Study||30||
48729580|NCT01776723|102123281|FG000|COMPLETED|Overall Study||6||
48729581|NCT01776723|102123282|FG001|COMPLETED|Overall Study||4||
48729582|NCT01776723|102123283|FG002|COMPLETED|Overall Study||5||
48729583|NCT01776723|102123284|FG003|COMPLETED|Overall Study||5||
48729584|NCT01776723|102123285|FG004|COMPLETED|Overall Study||30||
48614318|NCT02849080|101841725|FG003|COMPLETED|Main Phase: 0 - 52 Weeks||0||
48729585|NCT01776723|102123281|FG000|NOT COMPLETED|Overall Study||0||
48729586|NCT01776723|102123282|FG001|NOT COMPLETED|Overall Study||0||
48729587|NCT01776723|102123283|FG002|NOT COMPLETED|Overall Study||0||
48729588|NCT01776723|102123284|FG003|NOT COMPLETED|Overall Study||0||
48729589|NCT01776723|102123285|FG004|NOT COMPLETED|Overall Study||0||
48157502|NCT02654990|100706962|FG000|Received at Least 1 Dose of Study Drug|Overall Study||79|Safety Set: all participants who received any study treatment.|
48157503|NCT02654990|100706963|FG001|Received at Least 1 Dose of Study Drug|Overall Study||82|Safety Set: all participants who received any study treatment.|
48729590|NCT00983385|102123286|FG000|STARTED|Observation Period||208||
48729591|NCT00983385|102123286|FG000|COMPLETED|Observation Period||176||
48729592|NCT00983385|102123286|FG000|NOT COMPLETED|Observation Period||32||
48729593|NCT00983385|102123286|FG000|STARTED|Titration and Optimal Dose Period||176||
48729594|NCT00983385|102123286|FG000|COMPLETED|Titration and Optimal Dose Period||140||
48729595|NCT00983385|102123286|FG000|NOT COMPLETED|Titration and Optimal Dose Period||36||
48729596|NCT00983385|102123286|FG000|STARTED|Maintenance Period||140||
48729597|NCT00983385|102123286|FG000|COMPLETED|Maintenance Period||117||
48729598|NCT00983385|102123286|FG000|NOT COMPLETED|Maintenance Period||23||
48729599|NCT01114438|102123287|FG000|STARTED|Overall Study||45||
48729600|NCT01114438|102123287|FG000|COMPLETED|Overall Study||31||
48729601|NCT01114438|102123287|FG000|NOT COMPLETED|Overall Study||14||
48729602|NCT03603106|102123288|FG000|STARTED|Overall Study||6||
48729603|NCT03603106|102123289|FG001|STARTED|Overall Study||6||
48729604|NCT03603106|102123290|FG002|STARTED|Overall Study||6||
48157504|NCT02654990|100706964|FG002|Received at Least 1 Dose of Study Drug|Overall Study||80|Safety Set: all participants who received any study treatment.|
48157505|NCT02654990|100706962|FG000|COMPLETED|Overall Study||82||
48729605|NCT03603106|102123291|FG003|STARTED|Overall Study||6||
48729606|NCT03603106|102123292|FG004|STARTED|Overall Study||6||
48729607|NCT03603106|102123293|FG005|STARTED|Overall Study||6||
48729608|NCT03603106|102123294|FG006|STARTED|Overall Study||18||
48729609|NCT03603106|102123295|FG007|STARTED|Overall Study||3||
48729610|NCT03603106|102123296|FG008|STARTED|Overall Study||3||
48729611|NCT03603106|102123297|FG009|STARTED|Overall Study||3||
48729612|NCT03603106|102123298|FG010|STARTED|Overall Study||3||
48729613|NCT03603106|102123288|FG000|COMPLETED|Overall Study||6||
48729614|NCT03603106|102123289|FG001|COMPLETED|Overall Study||6||
48729615|NCT03603106|102123290|FG002|COMPLETED|Overall Study||6||
48729616|NCT03603106|102123291|FG003|COMPLETED|Overall Study||6||
48729617|NCT03603106|102123292|FG004|COMPLETED|Overall Study||6||
48729618|NCT03603106|102123293|FG005|COMPLETED|Overall Study||6||
48729619|NCT03603106|102123294|FG006|COMPLETED|Overall Study||18||
48729620|NCT03603106|102123295|FG007|COMPLETED|Overall Study||3||
48729621|NCT03603106|102123296|FG008|COMPLETED|Overall Study||3||
48729622|NCT03603106|102123297|FG009|COMPLETED|Overall Study||3||
48729623|NCT03603106|102123298|FG010|COMPLETED|Overall Study||3||
48729624|NCT03603106|102123288|FG000|NOT COMPLETED|Overall Study||0||
48729625|NCT03603106|102123289|FG001|NOT COMPLETED|Overall Study||0||
48729626|NCT03603106|102123290|FG002|NOT COMPLETED|Overall Study||0||
48729627|NCT03603106|102123291|FG003|NOT COMPLETED|Overall Study||0||
48729628|NCT03603106|102123292|FG004|NOT COMPLETED|Overall Study||0||
48729629|NCT03603106|102123293|FG005|NOT COMPLETED|Overall Study||0||
48729630|NCT03603106|102123294|FG006|NOT COMPLETED|Overall Study||0||
48157506|NCT02654990|100706963|FG001|COMPLETED|Overall Study||83||
48157507|NCT02654990|100706964|FG002|COMPLETED|Overall Study||83||
48729631|NCT03603106|102123295|FG007|NOT COMPLETED|Overall Study||0||
48729632|NCT03603106|102123296|FG008|NOT COMPLETED|Overall Study||0||
48729633|NCT03603106|102123297|FG009|NOT COMPLETED|Overall Study||0||
48729634|NCT03603106|102123298|FG010|NOT COMPLETED|Overall Study||0||
48729635|NCT01069705|102123299|FG000|STARTED|Overall Study||49||
48729636|NCT01069705|102123299|FG000|COMPLETED|Overall Study||46||
48729637|NCT01069705|102123299|FG000|NOT COMPLETED|Overall Study||3||
48729638|NCT01948063|102123300|FG000|STARTED|Overall Study||20||
48729639|NCT01948063|102123301|FG001|STARTED|Overall Study||21||
48729640|NCT01948063|102123300|FG000|COMPLETED|Overall Study||19||
48729641|NCT01948063|102123301|FG001|COMPLETED|Overall Study||19||
48729642|NCT01948063|102123300|FG000|NOT COMPLETED|Overall Study||1||
48729643|NCT01948063|102123301|FG001|NOT COMPLETED|Overall Study||2||
48729644|NCT01463202|102123302|FG000|STARTED|Overall Study||79|27 ineligible postpartum (26 no longer eligible, 1 withdrew consent)|
48729645|NCT01463202|102123303|FG001|STARTED|Overall Study||78|27 ineligible postpartum (26 no longer eligible, 1 withdrew consent)|
48729646|NCT01463202|102123302|FG000|COMPLETED|Overall Study||79||
48729647|NCT01463202|102123303|FG001|COMPLETED|Overall Study||78||
48729648|NCT01463202|102123302|FG000|NOT COMPLETED|Overall Study||0||
48729649|NCT01463202|102123303|FG001|NOT COMPLETED|Overall Study||0||
48157508|NCT02654990|100706962|FG000|NOT COMPLETED|Overall Study||0||
48729650|NCT04038567|102123304|FG000|STARTED|Overall Study||30||
48157509|NCT02654990|100706963|FG001|NOT COMPLETED|Overall Study||0||
48157510|NCT02654990|100706964|FG002|NOT COMPLETED|Overall Study||0||
48157511|NCT00152464|100706965|FG000|STARTED|Overall Study||255||
48157512|NCT00152464|100706966|FG001|STARTED|Overall Study||255||
48157513|NCT00152464|100706965|FG000|COMPLETED|Overall Study||215||
48729651|NCT04038567|102123305|FG001|STARTED|Overall Study||31||
48729652|NCT04038567|102123306|FG002|STARTED|Overall Study||31||
48729653|NCT04038567|102123307|FG003|STARTED|Overall Study||32||
48729654|NCT04038567|102123308|FG004|STARTED|Overall Study||32||
48729655|NCT04038567|102123309|FG005|STARTED|Overall Study||31||
48729656|NCT04038567|102123310|FG006|STARTED|Overall Study||30||
48729657|NCT04038567|102123311|FG007|STARTED|Overall Study||30||
48729658|NCT04038567|102123304|FG000|COMPLETED|Overall Study||21||
48729659|NCT04038567|102123305|FG001|COMPLETED|Overall Study||23||
48729660|NCT04038567|102123306|FG002|COMPLETED|Overall Study||23||
48729661|NCT04038567|102123307|FG003|COMPLETED|Overall Study||25||
48729662|NCT04038567|102123308|FG004|COMPLETED|Overall Study||19||
48729663|NCT04038567|102123309|FG005|COMPLETED|Overall Study||24||
48729664|NCT04038567|102123310|FG006|COMPLETED|Overall Study||22||
48729665|NCT04038567|102123311|FG007|COMPLETED|Overall Study||25||
48729666|NCT04038567|102123304|FG000|NOT COMPLETED|Overall Study||9||
48729667|NCT04038567|102123305|FG001|NOT COMPLETED|Overall Study||8||
48729668|NCT04038567|102123306|FG002|NOT COMPLETED|Overall Study||8||
48729669|NCT04038567|102123307|FG003|NOT COMPLETED|Overall Study||7||
48729670|NCT04038567|102123308|FG004|NOT COMPLETED|Overall Study||13||
48729671|NCT04038567|102123309|FG005|NOT COMPLETED|Overall Study||7||
48729672|NCT04038567|102123310|FG006|NOT COMPLETED|Overall Study||8||
48729673|NCT04038567|102123311|FG007|NOT COMPLETED|Overall Study||5||
48729674|NCT01623869|102123312|FG000|STARTED|Overall Study||16||
48729675|NCT01623869|102123312|FG000|COMPLETED|Overall Study||16||
48729676|NCT01623869|102123312|FG000|NOT COMPLETED|Overall Study||0||
48729677|NCT01041521|102123313|FG000|STARTED|Overall Study||61||
48729678|NCT01041521|102123314|FG001|STARTED|Overall Study||56||
48729679|NCT01041521|102123313|FG000|COMPLETED|Overall Study||44||
48729680|NCT01041521|102123314|FG001|COMPLETED|Overall Study||40||
48729681|NCT01041521|102123313|FG000|NOT COMPLETED|Overall Study||17||
48729682|NCT01041521|102123314|FG001|NOT COMPLETED|Overall Study||16||
48729683|NCT03916081|102123315|FG000|STARTED|Overall Study||46||
48729684|NCT03916081|102123316|FG001|STARTED|Overall Study||45||
48729685|NCT03916081|102123317|FG002|STARTED|Overall Study||45||
48729686|NCT03916081|102123315|FG000|COMPLETED|Overall Study||42||
48729687|NCT03916081|102123316|FG001|COMPLETED|Overall Study||44||
48729688|NCT03916081|102123317|FG002|COMPLETED|Overall Study||42||
48729689|NCT03916081|102123315|FG000|NOT COMPLETED|Overall Study||4||
48729690|NCT03916081|102123316|FG001|NOT COMPLETED|Overall Study||1||
48729691|NCT03916081|102123317|FG002|NOT COMPLETED|Overall Study||3||
48729692|NCT03364738|102123318|FG000|STARTED|Overall Study||22||
48729693|NCT03364738|102123318|FG000|COMPLETED|Overall Study||14||
48729694|NCT03364738|102123318|FG000|NOT COMPLETED|Overall Study||8||
48729695|NCT03696589|102123319|FG000|STARTED|Overall Study||13||
48729696|NCT03696589|102123319|FG000|COMPLETED|Overall Study||12||
48729697|NCT03696589|102123319|FG000|NOT COMPLETED|Overall Study||1||
48729698|NCT03182907|102123320|FG000|STARTED|Overall Study||111||
48729699|NCT03182907|102123321|FG001|STARTED|Overall Study||37||
48729700|NCT03182907|102123320|FG000|Treated|Overall Study||107||
48729701|NCT03182907|102123321|FG001|Treated|Overall Study||36||
48729702|NCT03182907|102123320|FG000|COMPLETED|Overall Study||103||
48729703|NCT03182907|102123321|FG001|COMPLETED|Overall Study||35||
48729704|NCT03182907|102123320|FG000|NOT COMPLETED|Overall Study||8||
48729705|NCT03182907|102123321|FG001|NOT COMPLETED|Overall Study||2||
48729706|NCT01323140|102123322|FG000|STARTED|Overall Study||40||
48729707|NCT01323140|102123322|FG000|COMPLETED|Overall Study||38||
48729708|NCT01323140|102123322|FG000|NOT COMPLETED|Overall Study||2||
48729709|NCT02518191|102123323|FG000|STARTED|Overall Study||171||
48729710|NCT02518191|102123324|FG001|STARTED|Overall Study||174||
48729711|NCT02518191|102123323|FG000|COMPLETED|Overall Study||165||
48729712|NCT02518191|102123324|FG001|COMPLETED|Overall Study||165||
48729713|NCT02518191|102123323|FG000|NOT COMPLETED|Overall Study||6||
48729714|NCT02518191|102123324|FG001|NOT COMPLETED|Overall Study||9||
48729715|NCT03170193|102123325|FG000|STARTED|Overall Study||12||
48729716|NCT03170193|102123326|FG001|STARTED|Overall Study||6||
48729717|NCT03170193|102123327|FG002|STARTED|Overall Study||6||
48729718|NCT03170193|102123328|FG003|STARTED|Overall Study||6||
48729719|NCT03170193|102123329|FG004|STARTED|Overall Study||6||
48729720|NCT03170193|102123330|FG005|STARTED|Overall Study||6||
48729721|NCT03170193|102123331|FG006|STARTED|Overall Study||6||
48729722|NCT03170193|102123325|FG000|COMPLETED|Overall Study||11||
48729723|NCT03170193|102123326|FG001|COMPLETED|Overall Study||5||
48729724|NCT03170193|102123327|FG002|COMPLETED|Overall Study||6||
48729725|NCT03170193|102123328|FG003|COMPLETED|Overall Study||5||
48729726|NCT03170193|102123329|FG004|COMPLETED|Overall Study||6||
48729727|NCT03170193|102123330|FG005|COMPLETED|Overall Study||6||
48729728|NCT03170193|102123331|FG006|COMPLETED|Overall Study||6||
48729729|NCT03170193|102123325|FG000|NOT COMPLETED|Overall Study||1||
48729730|NCT03170193|102123326|FG001|NOT COMPLETED|Overall Study||1||
48729731|NCT03170193|102123327|FG002|NOT COMPLETED|Overall Study||0||
48729732|NCT03170193|102123328|FG003|NOT COMPLETED|Overall Study||1||
48729733|NCT03170193|102123329|FG004|NOT COMPLETED|Overall Study||0||
48729734|NCT03170193|102123330|FG005|NOT COMPLETED|Overall Study||0||
48729735|NCT03170193|102123331|FG006|NOT COMPLETED|Overall Study||0||
48729736|NCT00377364|102123332|FG000|STARTED|Overall Study||16||
48729737|NCT00377364|102123333|FG001|STARTED|Overall Study||14||
48729738|NCT00377364|102123332|FG000|COMPLETED|Overall Study||14||
48729739|NCT00377364|102123333|FG001|COMPLETED|Overall Study||14||
48729740|NCT00377364|102123332|FG000|NOT COMPLETED|Overall Study||2||
48729741|NCT00377364|102123333|FG001|NOT COMPLETED|Overall Study||0||
48729742|NCT05392803|102123334|FG000|STARTED|Overall Study||7||
48729743|NCT05392803|102123335|FG001|STARTED|Overall Study||7||
48729744|NCT05392803|102123334|FG000|COMPLETED|Overall Study||7||
48729745|NCT05392803|102123335|FG001|COMPLETED|Overall Study||5||
48729746|NCT05392803|102123334|FG000|NOT COMPLETED|Overall Study||0||
48729747|NCT05392803|102123335|FG001|NOT COMPLETED|Overall Study||2||
48729748|NCT03172130|102123336|FG000|STARTED|Overall Study||12||
48729749|NCT03172130|102123337|FG001|STARTED|Overall Study||10||
48729750|NCT03172130|102123336|FG000|COMPLETED|Overall Study||9||
48729751|NCT03172130|102123337|FG001|COMPLETED|Overall Study||9||
48729752|NCT03172130|102123336|FG000|NOT COMPLETED|Overall Study||3||
48729753|NCT03172130|102123337|FG001|NOT COMPLETED|Overall Study||1||
48729754|NCT01727336|102123338|FG000|STARTED|Part 1 Dalantercept Dose Escalation||6||
48729755|NCT01727336|102123339|FG001|STARTED|Part 1 Dalantercept Dose Escalation||9||
48729756|NCT01727336|102123340|FG002|STARTED|Part 1 Dalantercept Dose Escalation||14||
48729757|NCT01727336|102123341|FG003|STARTED|Part 1 Dalantercept Dose Escalation||0||
48729758|NCT01727336|102123342|FG004|STARTED|Part 1 Dalantercept Dose Escalation||0||
48729759|NCT01727336|102123343|FG005|STARTED|Part 1 Dalantercept Dose Escalation||0||
48729760|NCT01727336|102123338|FG000|COMPLETED|Part 1 Dalantercept Dose Escalation||3||
48729761|NCT01727336|102123339|FG001|COMPLETED|Part 1 Dalantercept Dose Escalation||7||
48729762|NCT01727336|102123340|FG002|COMPLETED|Part 1 Dalantercept Dose Escalation||6||
48729763|NCT01727336|102123341|FG003|COMPLETED|Part 1 Dalantercept Dose Escalation||0||
48729764|NCT01727336|102123342|FG004|COMPLETED|Part 1 Dalantercept Dose Escalation||0||
48729765|NCT01727336|102123343|FG005|COMPLETED|Part 1 Dalantercept Dose Escalation||0||
48729766|NCT01727336|102123338|FG000|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||3||
48729767|NCT01727336|102123339|FG001|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||2||
48729768|NCT01727336|102123340|FG002|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||8||
48729769|NCT01727336|102123341|FG003|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||0||
48729770|NCT01727336|102123342|FG004|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||0||
48729771|NCT01727336|102123343|FG005|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||0||
48729772|NCT01727336|102123338|FG000|STARTED|Part 2 Blinded||0||
48729773|NCT01727336|102123339|FG001|STARTED|Part 2 Blinded||0||
48729774|NCT01727336|102123340|FG002|STARTED|Part 2 Blinded||0||
48729775|NCT01727336|102123341|FG003|STARTED|Part 2 Blinded||0||
48729776|NCT01727336|102123342|FG004|STARTED|Part 2 Blinded||63||
48729777|NCT01727336|102123343|FG005|STARTED|Part 2 Blinded||68||
48729778|NCT01727336|102123338|FG000|COMPLETED|Part 2 Blinded||0||
48729779|NCT01727336|102123339|FG001|COMPLETED|Part 2 Blinded||0||
48729780|NCT01727336|102123340|FG002|COMPLETED|Part 2 Blinded||0||
48729781|NCT01727336|102123341|FG003|COMPLETED|Part 2 Blinded||0||
48729782|NCT01727336|102123342|FG004|COMPLETED|Part 2 Blinded||0||
48729783|NCT01727336|102123343|FG005|COMPLETED|Part 2 Blinded||0||
48729784|NCT01727336|102123338|FG000|NOT COMPLETED|Part 2 Blinded||0||
48729785|NCT01727336|102123339|FG001|NOT COMPLETED|Part 2 Blinded||0||
48729786|NCT01727336|102123340|FG002|NOT COMPLETED|Part 2 Blinded||0||
48729787|NCT01727336|102123341|FG003|NOT COMPLETED|Part 2 Blinded||0||
48729788|NCT01727336|102123342|FG004|NOT COMPLETED|Part 2 Blinded||63||
48729789|NCT01727336|102123343|FG005|NOT COMPLETED|Part 2 Blinded||68||
48729790|NCT02013245|102123344|FG000|STARTED|Overall Study||9||
48729791|NCT02013245|102123345|FG001|STARTED|Overall Study||9||
48729792|NCT02013245|102123346|FG002|STARTED|Overall Study||9||
48729793|NCT02013245|102123347|FG003|STARTED|Overall Study||9||
48729794|NCT02013245|102123344|FG000|COMPLETED|Overall Study||9||
48729795|NCT02013245|102123345|FG001|COMPLETED|Overall Study||8||
48729796|NCT02013245|102123346|FG002|COMPLETED|Overall Study||9||
48729797|NCT02013245|102123347|FG003|COMPLETED|Overall Study||9||
48729798|NCT02013245|102123344|FG000|NOT COMPLETED|Overall Study||0||
48729799|NCT02013245|102123345|FG001|NOT COMPLETED|Overall Study||1||
48729800|NCT02013245|102123346|FG002|NOT COMPLETED|Overall Study||0||
48729801|NCT02013245|102123347|FG003|NOT COMPLETED|Overall Study||0||
48729802|NCT01534195|102123348|FG000|STARTED|Overall Study||5||
48729803|NCT01534195|102123349|FG001|STARTED|Overall Study||6||
48729804|NCT01534195|102123348|FG000|COMPLETED|Overall Study||4||
48729805|NCT01534195|102123349|FG001|COMPLETED|Overall Study||5||
48729806|NCT01534195|102123348|FG000|NOT COMPLETED|Overall Study||1||
48729807|NCT01534195|102123349|FG001|NOT COMPLETED|Overall Study||1||
48729808|NCT02918357|102123350|FG000|STARTED|Overall Study||385||
48729809|NCT02918357|102123350|FG000|Investigational Drug Administration|Overall Study||385||
48729810|NCT02918357|102123350|FG000|PET/CT Scan|Overall Study||385||
48729811|NCT02918357|102123350|FG000|COMPLETED|Overall Study||385||
48729812|NCT02918357|102123350|FG000|NOT COMPLETED|Overall Study||0||
48729813|NCT03235089|102123351|FG000|STARTED|Overall Study||31||31
48729814|NCT03235089|102123352|FG001|STARTED|Overall Study||31||31
48729815|NCT03235089|102123351|FG000|COMPLETED|Overall Study||28||28
48729816|NCT03235089|102123352|FG001|COMPLETED|Overall Study||28||28
48729817|NCT03235089|102123351|FG000|NOT COMPLETED|Overall Study||3||3
48729818|NCT03235089|102123352|FG001|NOT COMPLETED|Overall Study||3||3
48729819|NCT01563172|102123353|FG000|STARTED|Overall Study||65||
48729820|NCT01563172|102123353|FG000|Experimental Dentifrice 0.5g/2 Min|Overall Study||59||
48729821|NCT01563172|102123353|FG000|Experimental Dentifrice 0.5g/45 Sec|Overall Study||59||
48729822|NCT01563172|102123353|FG000|Experimental Dentifrice 1.5g/ 2min|Overall Study||58||
48729823|NCT01563172|102123353|FG000|Experimental Dentifrice 1.5g/ 45 Sec|Overall Study||58||
48729824|NCT01563172|102123353|FG000|Control Dentifrice|Overall Study||60||
48729825|NCT01563172|102123353|FG000|COMPLETED|Overall Study||52||
48729826|NCT01563172|102123353|FG000|NOT COMPLETED|Overall Study||13||
48729827|NCT04369950|102123354|FG000|STARTED|Overall Study||22||
48729828|NCT04369950|102123355|FG001|STARTED|Overall Study||22||
48729829|NCT04369950|102123354|FG000|COMPLETED|Overall Study||20||
48729830|NCT04369950|102123355|FG001|COMPLETED|Overall Study||20||
48729831|NCT04369950|102123354|FG000|NOT COMPLETED|Overall Study||2||
48729832|NCT04369950|102123355|FG001|NOT COMPLETED|Overall Study||2||
48729833|NCT01912339|102123356|FG000|STARTED|Blinded (0 to 3 Months)||136||
48729834|NCT01912339|102123357|FG001|STARTED|Blinded (0 to 3 Months)||61||
48729835|NCT01912339|102123358|FG002|STARTED|Blinded (0 to 3 Months)||0||
48729836|NCT01912339|102123356|FG000|COMPLETED|Blinded (0 to 3 Months)||134||
48729837|NCT01912339|102123357|FG001|COMPLETED|Blinded (0 to 3 Months)||61||
48729838|NCT01912339|102123358|FG002|COMPLETED|Blinded (0 to 3 Months)||0||
48729839|NCT01912339|102123356|FG000|NOT COMPLETED|Blinded (0 to 3 Months)||2||
48729840|NCT01912339|102123357|FG001|NOT COMPLETED|Blinded (0 to 3 Months)||0||
48729841|NCT01912339|102123358|FG002|NOT COMPLETED|Blinded (0 to 3 Months)||0||
48729842|NCT01912339|102123356|FG000|STARTED|Unblinded (3 to 6 Months/Crossover)||134||
48729843|NCT01912339|102123357|FG001|STARTED|Unblinded (3 to 6 Months/Crossover)||61||
48729844|NCT01912339|102123358|FG002|STARTED|Unblinded (3 to 6 Months/Crossover)||0||
48729845|NCT01912339|102123356|FG000|COMPLETED|Unblinded (3 to 6 Months/Crossover)||133||
48729846|NCT01912339|102123357|FG001|COMPLETED|Unblinded (3 to 6 Months/Crossover)||61||
48729847|NCT01912339|102123358|FG002|COMPLETED|Unblinded (3 to 6 Months/Crossover)||0||
48729848|NCT01912339|102123356|FG000|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||1||
48729849|NCT01912339|102123357|FG001|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0||
48729850|NCT01912339|102123358|FG002|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0||
48729851|NCT01912339|102123356|FG000|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)||133||
48729852|NCT01912339|102123357|FG001|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)||0||
48729853|NCT01912339|102123358|FG002|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)||53||
48729854|NCT01912339|102123356|FG000|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0||
48406879|NCT03424044|101328488|FG004|STARTED|Third Rest Period (7-45 Days)||2||
48406880|NCT03424044|101328489|FG005|STARTED|Third Rest Period (7-45 Days)||4||
48406881|NCT03424044|101328490|FG006|STARTED|Third Rest Period (7-45 Days)||1||
48406882|NCT03424044|101328491|FG007|STARTED|Third Rest Period (7-45 Days)||1||
48406883|NCT03424044|101328492|FG008|STARTED|Third Rest Period (7-45 Days)||1||
48406884|NCT03424044|101328484|FG000|COMPLETED|Third Rest Period (7-45 Days)||4||
48406885|NCT03424044|101328485|FG001|COMPLETED|Third Rest Period (7-45 Days)||3||
48406886|NCT03424044|101328486|FG002|COMPLETED|Third Rest Period (7-45 Days)||2||
48729855|NCT01912339|102123357|FG001|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0||
48729856|NCT01912339|102123358|FG002|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0||
48729857|NCT01912339|102123356|FG000|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||133||
48729858|NCT01912339|102123357|FG001|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0||
48729859|NCT01912339|102123358|FG002|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||53||
48729860|NCT01704404|102123359|FG000|STARTED|Overall Study||11||
48729861|NCT01704404|102123360|FG001|STARTED|Overall Study||10||
48729862|NCT01704404|102123361|FG002|STARTED|Overall Study||10||
48729863|NCT01704404|102123362|FG003|STARTED|Overall Study||11||
48729864|NCT01704404|102123363|FG004|STARTED|Overall Study||11||
48729865|NCT01704404|102123364|FG005|STARTED|Overall Study||9||
48729866|NCT01704404|102123359|FG000|COMPLETED|Overall Study||10||
48729867|NCT01704404|102123360|FG001|COMPLETED|Overall Study||9||
48729868|NCT01704404|102123361|FG002|COMPLETED|Overall Study||9||
48313620|NCT02230254|101094107|FG000|COMPLETED|Overall Study||98||
48313621|NCT02230254|101094107|FG000|NOT COMPLETED|Overall Study||3||
48313622|NCT02899689|101094108|FG000|STARTED|Overall Study||209||
48313623|NCT02899689|101094109|FG001|STARTED|Overall Study||210||
48313624|NCT02899689|101094108|FG000|COMPLETED|Overall Study||209||
48313625|NCT02899689|101094109|FG001|COMPLETED|Overall Study||208||
48729869|NCT01704404|102123362|FG003|COMPLETED|Overall Study||8||
48729870|NCT01704404|102123363|FG004|COMPLETED|Overall Study||10||
48729871|NCT01704404|102123364|FG005|COMPLETED|Overall Study||9||
48729872|NCT01704404|102123359|FG000|NOT COMPLETED|Overall Study||1||
48729873|NCT01704404|102123360|FG001|NOT COMPLETED|Overall Study||1||
48729874|NCT01704404|102123361|FG002|NOT COMPLETED|Overall Study||1||
48729875|NCT01704404|102123362|FG003|NOT COMPLETED|Overall Study||3||
48729876|NCT01704404|102123363|FG004|NOT COMPLETED|Overall Study||1||
48313626|NCT02899689|101094108|FG000|NOT COMPLETED|Overall Study||0||
48313627|NCT02899689|101094109|FG001|NOT COMPLETED|Overall Study||2||
48313628|NCT00596947|101094110|FG000|STARTED|Overall Study||9||
48313629|NCT00596947|101094111|FG001|STARTED|Overall Study||9||
48313630|NCT00596947|101094110|FG000|COMPLETED|Overall Study||3||
48313631|NCT00596947|101094111|FG001|COMPLETED|Overall Study||6||
48313632|NCT00596947|101094110|FG000|NOT COMPLETED|Overall Study||6||
48313633|NCT00596947|101094111|FG001|NOT COMPLETED|Overall Study||3||
48729877|NCT01704404|102123364|FG005|NOT COMPLETED|Overall Study||0||
48729878|NCT00534976|102123365|FG000|STARTED|Period 1: Placebo Run-in||33||
48729879|NCT00534976|102123366|FG001|STARTED|Period 1: Placebo Run-in||33||
48729880|NCT00534976|102123365|FG000|COMPLETED|Period 1: Placebo Run-in||33||
48729881|NCT00534976|102123366|FG001|COMPLETED|Period 1: Placebo Run-in||33||
48729882|NCT00534976|102123365|FG000|NOT COMPLETED|Period 1: Placebo Run-in||0||
48729883|NCT00534976|102123366|FG001|NOT COMPLETED|Period 1: Placebo Run-in||0||
48729884|NCT00534976|102123365|FG000|STARTED|Period 2: Treatment Montelukast/ Placebo||33||
48729885|NCT00534976|102123366|FG001|STARTED|Period 2: Treatment Montelukast/ Placebo||33||
48729886|NCT00534976|102123365|FG000|COMPLETED|Period 2: Treatment Montelukast/ Placebo||33||
48729887|NCT00534976|102123366|FG001|COMPLETED|Period 2: Treatment Montelukast/ Placebo||32||
48729888|NCT00534976|102123365|FG000|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||0||
48729889|NCT00534976|102123366|FG001|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||1||
48729890|NCT00534976|102123365|FG000|STARTED|Period 3: Crossover Placebo/ Montelukast||33||
48729891|NCT00534976|102123366|FG001|STARTED|Period 3: Crossover Placebo/ Montelukast||32||
48729892|NCT00534976|102123365|FG000|COMPLETED|Period 3: Crossover Placebo/ Montelukast||31||
48729893|NCT00534976|102123366|FG001|COMPLETED|Period 3: Crossover Placebo/ Montelukast||32||
48729894|NCT00534976|102123365|FG000|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||2||
48729895|NCT00534976|102123366|FG001|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||0||
48729896|NCT02349685|102123367|FG000|STARTED|Overall Study||89||
48729897|NCT02349685|102123368|FG001|STARTED|Overall Study||89||
48729898|NCT02349685|102123369|FG002|STARTED|Overall Study||41||
48729899|NCT02349685|102123367|FG000|COMPLETED|Overall Study||84||
48729900|NCT02349685|102123368|FG001|COMPLETED|Overall Study||87||
48729901|NCT02349685|102123369|FG002|COMPLETED|Overall Study||37||
48729902|NCT02349685|102123367|FG000|NOT COMPLETED|Overall Study||5||
48729903|NCT02349685|102123368|FG001|NOT COMPLETED|Overall Study||2||
48729904|NCT02349685|102123369|FG002|NOT COMPLETED|Overall Study||4||
48729905|NCT02292706|102123370|FG000|STARTED|Overall Study||95||
48729906|NCT02292706|102123371|FG001|STARTED|Overall Study||277||
48729907|NCT02292706|102123372|FG002|STARTED|Overall Study||265||
48729908|NCT02292706|102123373|FG003|STARTED|Overall Study||374||
48729909|NCT02292706|102123374|FG004|STARTED|Overall Study||100||
48313634|NCT02528370|101094112|FG000|STARTED|Overall Study||119||
48313635|NCT02528370|101094113|FG001|STARTED|Overall Study||78||
48313636|NCT02528370|101094112|FG000|COMPLETED|Overall Study||102||
48313637|NCT02528370|101094113|FG001|COMPLETED|Overall Study||77||
48729910|NCT02292706|102123375|FG005|STARTED|Overall Study||338||
48729911|NCT02292706|102123376|FG006|STARTED|Overall Study||141||
48729912|NCT02292706|102123377|FG007|STARTED|Overall Study||19||
48729913|NCT02292706|102123370|FG000|COMPLETED|Overall Study||49||
48729914|NCT02292706|102123371|FG001|COMPLETED|Overall Study||145||
48729915|NCT02292706|102123372|FG002|COMPLETED|Overall Study||157||
48729916|NCT02292706|102123373|FG003|COMPLETED|Overall Study||201||
48729917|NCT02292706|102123374|FG004|COMPLETED|Overall Study||35||
48729918|NCT02292706|102123375|FG005|COMPLETED|Overall Study||181||
48313638|NCT02528370|101094112|FG000|NOT COMPLETED|Overall Study||17||
48313639|NCT02528370|101094113|FG001|NOT COMPLETED|Overall Study||1||
48313640|NCT00290342|101094114|FG000|STARTED|Overall Study||224||
48729919|NCT02292706|102123376|FG006|COMPLETED|Overall Study||82||
48729920|NCT02292706|102123377|FG007|COMPLETED|Overall Study||0||
48729921|NCT02292706|102123370|FG000|NOT COMPLETED|Overall Study||46||
48729922|NCT02292706|102123371|FG001|NOT COMPLETED|Overall Study||132||
48729923|NCT02292706|102123372|FG002|NOT COMPLETED|Overall Study||108||
48729924|NCT02292706|102123373|FG003|NOT COMPLETED|Overall Study||173||
48729925|NCT02292706|102123374|FG004|NOT COMPLETED|Overall Study||65||
48729926|NCT02292706|102123375|FG005|NOT COMPLETED|Overall Study||157||
48729927|NCT02292706|102123376|FG006|NOT COMPLETED|Overall Study||59||
48729928|NCT02292706|102123377|FG007|NOT COMPLETED|Overall Study||19||
48729929|NCT01204216|102123378|FG000|STARTED|Overall Study||3||
48729930|NCT01204216|102123379|FG001|STARTED|Overall Study||0||
48729931|NCT01204216|102123378|FG000|COMPLETED|Overall Study||0||
48729932|NCT01204216|102123379|FG001|COMPLETED|Overall Study||0||
48729933|NCT01204216|102123378|FG000|NOT COMPLETED|Overall Study||3||
48313641|NCT00290342|101094115|FG001|STARTED|Overall Study||228||
48313642|NCT00290342|101094114|FG000|COMPLETED|Overall Study||217||
48313643|NCT00290342|101094115|FG001|COMPLETED|Overall Study||223||
48313644|NCT00290342|101094114|FG000|NOT COMPLETED|Overall Study||7||
48313645|NCT00290342|101094115|FG001|NOT COMPLETED|Overall Study||5||
48313646|NCT01713621|101094116|FG000|STARTED|Overall Study||8||
48313647|NCT01713621|101094117|FG001|STARTED|Overall Study||17||
48313648|NCT01713621|101094116|FG000|COMPLETED|Overall Study||1||
48313649|NCT01713621|101094117|FG001|COMPLETED|Overall Study||1||
48313650|NCT01713621|101094116|FG000|NOT COMPLETED|Overall Study||7||
48313651|NCT01713621|101094117|FG001|NOT COMPLETED|Overall Study||16||
48313652|NCT02091778|101094118|FG000|STARTED|Overall Study||21||
48313653|NCT02091778|101094118|FG000|COMPLETED|Overall Study||20||
48313654|NCT02091778|101094118|FG000|NOT COMPLETED|Overall Study||1||
48313655|NCT01688596|101094119|FG000|STARTED|Overall Study||67||
48406887|NCT03424044|101328487|FG003|COMPLETED|Third Rest Period (7-45 Days)||3||
48406888|NCT03424044|101328488|FG004|COMPLETED|Third Rest Period (7-45 Days)||2||
48614319|NCT02849080|101841722|FG000|NOT COMPLETED|Main Phase: 0 - 52 Weeks||12||
48614320|NCT02849080|101841723|FG001|NOT COMPLETED|Main Phase: 0 - 52 Weeks||7||
48614321|NCT02849080|101841724|FG002|NOT COMPLETED|Main Phase: 0 - 52 Weeks||0||
48614322|NCT02849080|101841725|FG003|NOT COMPLETED|Main Phase: 0 - 52 Weeks||0||
48614323|NCT02849080|101841722|FG000|STARTED|Extension Phase: 53 - 104 Weeks||185||
48614324|NCT02849080|101841723|FG001|STARTED|Extension Phase: 53 - 104 Weeks||0||
48614325|NCT02849080|101841724|FG002|STARTED|Extension Phase: 53 - 104 Weeks||100||
48614326|NCT02849080|101841725|FG003|STARTED|Extension Phase: 53 - 104 Weeks||98||
48614327|NCT02849080|101841722|FG000|Exposed|Extension Phase: 53 - 104 Weeks||184||
48614328|NCT02849080|101841723|FG001|Exposed|Extension Phase: 53 - 104 Weeks||0||
48614329|NCT02849080|101841724|FG002|Exposed|Extension Phase: 53 - 104 Weeks||100||
48614330|NCT02849080|101841725|FG003|Exposed|Extension Phase: 53 - 104 Weeks||97||
48729934|NCT01204216|102123379|FG001|NOT COMPLETED|Overall Study||0||
48729935|NCT01100775|102123380|FG000|STARTED|Overall Study||6||
48729936|NCT01100775|102123381|FG001|STARTED|Overall Study||6||
48729937|NCT01100775|102123380|FG000|COMPLETED|Overall Study||6||
48729938|NCT01100775|102123381|FG001|COMPLETED|Overall Study||6||
48729939|NCT01100775|102123380|FG000|NOT COMPLETED|Overall Study||0||
48729940|NCT01100775|102123381|FG001|NOT COMPLETED|Overall Study||0||
48729941|NCT01620762|102123382|FG000|STARTED|Overall Study||468||
48313656|NCT01688596|101094120|FG001|STARTED|Overall Study||68||
48313657|NCT01688596|101094119|FG000|COMPLETED|Overall Study||59||
48313658|NCT01688596|101094120|FG001|COMPLETED|Overall Study||59||
48313659|NCT01688596|101094119|FG000|NOT COMPLETED|Overall Study||8||
48313660|NCT01688596|101094120|FG001|NOT COMPLETED|Overall Study||9||
48313661|NCT02743351|101094121|FG000|STARTED|Overall Study||7||
48313662|NCT02743351|101094122|FG001|STARTED|Overall Study||45||
48313663|NCT02743351|101094123|FG002|STARTED|Overall Study||44||
48313664|NCT02743351|101094121|FG000|COMPLETED|Overall Study||7|Patients who completed study through day +100|
48313665|NCT02743351|101094122|FG001|COMPLETED|Overall Study||35|Patients who completed study through day +100|
48313666|NCT02743351|101094123|FG002|COMPLETED|Overall Study||36|Patients who completed study through day +100|
48313667|NCT02743351|101094121|FG000|NOT COMPLETED|Overall Study||0||
48313668|NCT02743351|101094122|FG001|NOT COMPLETED|Overall Study||10||
48406889|NCT03424044|101328489|FG005|COMPLETED|Third Rest Period (7-45 Days)||4||
48406890|NCT03424044|101328490|FG006|COMPLETED|Third Rest Period (7-45 Days)||1||
48614331|NCT02849080|101841722|FG000|COMPLETED|Extension Phase: 53 - 104 Weeks||182||
48614332|NCT02849080|101841723|FG001|COMPLETED|Extension Phase: 53 - 104 Weeks||0||
48614333|NCT02849080|101841724|FG002|COMPLETED|Extension Phase: 53 - 104 Weeks||99||
48614334|NCT02849080|101841725|FG003|COMPLETED|Extension Phase: 53 - 104 Weeks||98||
48614335|NCT02849080|101841722|FG000|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||3||
48729942|NCT01620762|102123383|FG001|STARTED|Overall Study||470||
48729943|NCT01620762|102123384|FG002|STARTED|Overall Study||470||
48729944|NCT01620762|102123382|FG000|COMPLETED|Overall Study||420||
48729945|NCT01620762|102123383|FG001|COMPLETED|Overall Study||412||
48313669|NCT02743351|101094123|FG002|NOT COMPLETED|Overall Study||8||
48313670|NCT00268437|101094124|FG000|STARTED|Overall Study||27||
48313671|NCT00268437|101094124|FG000|COMPLETED|Overall Study||26||
48729946|NCT01620762|102123384|FG002|COMPLETED|Overall Study||417||
48729947|NCT01620762|102123382|FG000|NOT COMPLETED|Overall Study||48||
48729948|NCT01620762|102123383|FG001|NOT COMPLETED|Overall Study||58||
48729949|NCT01620762|102123384|FG002|NOT COMPLETED|Overall Study||53||
48729950|NCT01329939|102123385|FG000|STARTED|Overall Study||7||
48729951|NCT01329939|102123386|FG001|STARTED|Overall Study||5||
48729952|NCT01329939|102123387|FG002|STARTED|Overall Study||5||
48729953|NCT01329939|102123388|FG003|STARTED|Overall Study||9||
48729954|NCT01329939|102123385|FG000|COMPLETED|Overall Study||4||
48729955|NCT01329939|102123386|FG001|COMPLETED|Overall Study||4||
48729956|NCT01329939|102123387|FG002|COMPLETED|Overall Study||4||
48614336|NCT02849080|101841723|FG001|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||0||
48614337|NCT02849080|101841724|FG002|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||1||
48614338|NCT02849080|101841725|FG003|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||0||
48614339|NCT00206427|101841726|FG000|STARTED|Overall Study||49||
48614340|NCT00206427|101841726|FG000|COMPLETED|Overall Study||47||
48614341|NCT00206427|101841726|FG000|NOT COMPLETED|Overall Study||2||
48157514|NCT00152464|100706966|FG001|COMPLETED|Overall Study||219||
48157515|NCT00152464|100706965|FG000|NOT COMPLETED|Overall Study||40||
48157516|NCT00152464|100706966|FG001|NOT COMPLETED|Overall Study||36||
48157517|NCT03152084|100706967|FG000|STARTED|Overall Study||17||
48157518|NCT03152084|100706968|FG001|STARTED|Overall Study||7||
48157519|NCT03152084|100706967|FG000|COMPLETED|Overall Study||17||
48157520|NCT03152084|100706968|FG001|COMPLETED|Overall Study||7||
48157521|NCT03152084|100706967|FG000|NOT COMPLETED|Overall Study||0||
48157522|NCT03152084|100706968|FG001|NOT COMPLETED|Overall Study||0||
48157523|NCT03040713|100706969|FG000|STARTED|Overall Study||16||
48157524|NCT03040713|100706969|FG000|COMPLETED|Overall Study||13||
48614342|NCT00385918|101841727|FG000|STARTED|Feasibility & Baseline Measurement Phase||0||
48614343|NCT00385918|101841728|FG001|STARTED|Feasibility & Baseline Measurement Phase||0||
48614344|NCT00385918|101841729|FG002|STARTED|Feasibility & Baseline Measurement Phase||35||
48614345|NCT00385918|101841727|FG000|Number Eligible|Feasibility & Baseline Measurement Phase||0||
48614346|NCT00385918|101841728|FG001|Number Eligible|Feasibility & Baseline Measurement Phase||0||
48614347|NCT00385918|101841729|FG002|Number Eligible|Feasibility & Baseline Measurement Phase||27||
48614348|NCT00385918|101841727|FG000|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0||
48614349|NCT00385918|101841728|FG001|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0||
48614350|NCT00385918|101841729|FG002|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||21||
48614351|NCT00385918|101841727|FG000|COMPLETED|Feasibility & Baseline Measurement Phase||0||
48614352|NCT00385918|101841728|FG001|COMPLETED|Feasibility & Baseline Measurement Phase||0||
48614353|NCT00385918|101841729|FG002|COMPLETED|Feasibility & Baseline Measurement Phase||21||
48313672|NCT00268437|101094124|FG000|NOT COMPLETED|Overall Study||1||
48313673|NCT03292809|101094125|FG000|STARTED|Overall Study||162||
48313674|NCT03292809|101094126|FG001|STARTED|Overall Study||166||
48313675|NCT03292809|101094125|FG000|COMPLETED|Overall Study||155||
48729957|NCT01329939|102123388|FG003|COMPLETED|Overall Study||4||
48729958|NCT01329939|102123385|FG000|NOT COMPLETED|Overall Study||3||
48729959|NCT01329939|102123386|FG001|NOT COMPLETED|Overall Study||1||
48729960|NCT01329939|102123387|FG002|NOT COMPLETED|Overall Study||1||
48729961|NCT01329939|102123388|FG003|NOT COMPLETED|Overall Study||5||
48729962|NCT03208088|102123389|FG000|STARTED|Period 1||10||
48729963|NCT03208088|102123390|FG001|STARTED|Period 1||9||
48729964|NCT03208088|102123391|FG002|STARTED|Period 1||10||
48729965|NCT03208088|102123392|FG003|STARTED|Period 1||9||
48729966|NCT03208088|102123393|FG004|STARTED|Period 1||9||
48729967|NCT03208088|102123394|FG005|STARTED|Period 1||9||
48729968|NCT03208088|102123395|FG006|STARTED|Period 1||8||
48729969|NCT03208088|102123396|FG007|STARTED|Period 1||10||
48729970|NCT03208088|102123397|FG008|STARTED|Period 1||8||
48729971|NCT03208088|102123398|FG009|STARTED|Period 1||9||
48729972|NCT03208088|102123389|FG000|COMPLETED|Period 1||10||
48729973|NCT03208088|102123390|FG001|COMPLETED|Period 1||9||
48157525|NCT03040713|100706969|FG000|NOT COMPLETED|Overall Study||3||
48157526|NCT01077544|100706970|FG000|STARTED|Overall Study||8||
48157527|NCT01077544|100706971|FG001|STARTED|Overall Study||7||
48157528|NCT01077544|100706970|FG000|COMPLETED|Overall Study||5||
48313676|NCT03292809|101094126|FG001|COMPLETED|Overall Study||163||
48614354|NCT00385918|101841727|FG000|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0||
48614355|NCT00385918|101841728|FG001|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0||
48614356|NCT00385918|101841729|FG002|NOT COMPLETED|Feasibility & Baseline Measurement Phase||14||
48614357|NCT00385918|101841727|FG000|STARTED|Intervention Phase After Randomization||15||
48614358|NCT00385918|101841728|FG001|STARTED|Intervention Phase After Randomization||6||
48614359|NCT00385918|101841729|FG002|STARTED|Intervention Phase After Randomization||0||
48729974|NCT03208088|102123391|FG002|COMPLETED|Period 1||10||
48729975|NCT03208088|102123392|FG003|COMPLETED|Period 1||9||
48729976|NCT03208088|102123393|FG004|COMPLETED|Period 1||9||
48729977|NCT03208088|102123394|FG005|COMPLETED|Period 1||9||
48729978|NCT03208088|102123395|FG006|COMPLETED|Period 1||8||
48729979|NCT03208088|102123396|FG007|COMPLETED|Period 1||10||
48157529|NCT01077544|100706971|FG001|COMPLETED|Overall Study||2||
48157530|NCT01077544|100706970|FG000|NOT COMPLETED|Overall Study||3||
48729980|NCT03208088|102123397|FG008|COMPLETED|Period 1||8||
48729981|NCT03208088|102123398|FG009|COMPLETED|Period 1||9||
48729982|NCT03208088|102123389|FG000|NOT COMPLETED|Period 1||0||
48614360|NCT00385918|101841727|FG000|COMPLETED|Intervention Phase After Randomization||12||
48614361|NCT00385918|101841728|FG001|COMPLETED|Intervention Phase After Randomization||6||
48614362|NCT00385918|101841729|FG002|COMPLETED|Intervention Phase After Randomization||0||
48614363|NCT00385918|101841727|FG000|NOT COMPLETED|Intervention Phase After Randomization||3||
48729983|NCT03208088|102123390|FG001|NOT COMPLETED|Period 1||0||
48729984|NCT03208088|102123391|FG002|NOT COMPLETED|Period 1||0||
48729985|NCT03208088|102123392|FG003|NOT COMPLETED|Period 1||0||
48729986|NCT03208088|102123393|FG004|NOT COMPLETED|Period 1||0||
48729987|NCT03208088|102123394|FG005|NOT COMPLETED|Period 1||0||
48729988|NCT03208088|102123395|FG006|NOT COMPLETED|Period 1||0||
48729989|NCT03208088|102123396|FG007|NOT COMPLETED|Period 1||0||
48729990|NCT03208088|102123397|FG008|NOT COMPLETED|Period 1||0||
48729991|NCT03208088|102123398|FG009|NOT COMPLETED|Period 1||0||
48729992|NCT03208088|102123389|FG000|STARTED|Period 2||10||
48729993|NCT03208088|102123390|FG001|STARTED|Period 2||9||
48729994|NCT03208088|102123391|FG002|STARTED|Period 2||10||
48729995|NCT03208088|102123392|FG003|STARTED|Period 2||9||
48729996|NCT03208088|102123393|FG004|STARTED|Period 2||9||
48729997|NCT03208088|102123394|FG005|STARTED|Period 2||9||
48729998|NCT03208088|102123395|FG006|STARTED|Period 2||8||
48729999|NCT03208088|102123396|FG007|STARTED|Period 2||10||
48730000|NCT03208088|102123397|FG008|STARTED|Period 2||8||
48730001|NCT03208088|102123398|FG009|STARTED|Period 2||9||
48730002|NCT03208088|102123389|FG000|COMPLETED|Period 2||10||
48730003|NCT03208088|102123390|FG001|COMPLETED|Period 2||9||
48730004|NCT03208088|102123391|FG002|COMPLETED|Period 2||10||
48730005|NCT03208088|102123392|FG003|COMPLETED|Period 2||9||
48730006|NCT03208088|102123393|FG004|COMPLETED|Period 2||9||
48730007|NCT03208088|102123394|FG005|COMPLETED|Period 2||9||
48730008|NCT03208088|102123395|FG006|COMPLETED|Period 2||8||
48730009|NCT03208088|102123396|FG007|COMPLETED|Period 2||10||
48614364|NCT00385918|101841728|FG001|NOT COMPLETED|Intervention Phase After Randomization||0||
48614365|NCT00385918|101841729|FG002|NOT COMPLETED|Intervention Phase After Randomization||0||
48614366|NCT03284853|101841730|FG000|STARTED|Overall Study||218||
48614367|NCT03284853|101841731|FG001|STARTED|Overall Study||212||
48614368|NCT03284853|101841730|FG000|Intent-to-Treat Population|Overall Study||218|All randomized participants who received at least one dose of study medication.|
48614369|NCT03284853|101841731|FG001|Intent-to-Treat Population|Overall Study||212|All randomized participants who received at least one dose of study medication.|
48614370|NCT03284853|101841730|FG000|Per-Protocol Population|Overall Study||169|Subset of the ITT Population, includes participants (and their visits) who did not have major protocol violations likely to seriously affect the primary outcome of the study as judged by a masked evaluation prior to the unmasking of the study treatment.|
48614371|NCT03284853|101841731|FG001|Per-Protocol Population|Overall Study||170|Subset of the ITT Population, includes participants (and their visits) who did not have major protocol violations likely to seriously affect the primary outcome of the study as judged by a masked evaluation prior to the unmasking of the study treatment.|
48614372|NCT03284853|101841730|FG000|Safety Population|Overall Study||218|All randomized participants who received at least one dose of study medication.|
48614373|NCT03284853|101841731|FG001|Safety Population|Overall Study||212|All randomized participants who received at least one dose of study medication.|
48614374|NCT03284853|101841730|FG000|COMPLETED|Overall Study||163||
48614375|NCT03284853|101841731|FG001|COMPLETED|Overall Study||199||
48614376|NCT03284853|101841730|FG000|NOT COMPLETED|Overall Study||55||
48614377|NCT03284853|101841731|FG001|NOT COMPLETED|Overall Study||13||
48730010|NCT03208088|102123397|FG008|COMPLETED|Period 2||7||
48730011|NCT03208088|102123398|FG009|COMPLETED|Period 2||9||
48730012|NCT03208088|102123389|FG000|NOT COMPLETED|Period 2||0||
48730013|NCT03208088|102123390|FG001|NOT COMPLETED|Period 2||0||
48730014|NCT03208088|102123391|FG002|NOT COMPLETED|Period 2||0||
48730015|NCT03208088|102123392|FG003|NOT COMPLETED|Period 2||0||
48730016|NCT03208088|102123393|FG004|NOT COMPLETED|Period 2||0||
48730017|NCT03208088|102123394|FG005|NOT COMPLETED|Period 2||0||
48730018|NCT03208088|102123395|FG006|NOT COMPLETED|Period 2||0||
48730019|NCT03208088|102123396|FG007|NOT COMPLETED|Period 2||0||
48730020|NCT03208088|102123397|FG008|NOT COMPLETED|Period 2||1||
48730021|NCT03208088|102123398|FG009|NOT COMPLETED|Period 2||0||
48730022|NCT03208088|102123389|FG000|STARTED|Period 3||10||
48730023|NCT03208088|102123390|FG001|STARTED|Period 3||9||
48730024|NCT03208088|102123391|FG002|STARTED|Period 3||10||
48730025|NCT03208088|102123392|FG003|STARTED|Period 3||9||
48730026|NCT03208088|102123393|FG004|STARTED|Period 3||9||
48730027|NCT03208088|102123394|FG005|STARTED|Period 3||9||
48730028|NCT03208088|102123395|FG006|STARTED|Period 3||8||
48730029|NCT03208088|102123396|FG007|STARTED|Period 3||10||
48730030|NCT03208088|102123397|FG008|STARTED|Period 3||7||
48730031|NCT03208088|102123398|FG009|STARTED|Period 3||9||
48730032|NCT03208088|102123389|FG000|COMPLETED|Period 3||10||
48730033|NCT03208088|102123390|FG001|COMPLETED|Period 3||9||
48730034|NCT03208088|102123391|FG002|COMPLETED|Period 3||10||
48730035|NCT03208088|102123392|FG003|COMPLETED|Period 3||8||
48730036|NCT03208088|102123393|FG004|COMPLETED|Period 3||9||
48730037|NCT03208088|102123394|FG005|COMPLETED|Period 3||9||
48730038|NCT03208088|102123395|FG006|COMPLETED|Period 3||8||
48730039|NCT03208088|102123396|FG007|COMPLETED|Period 3||10||
48730040|NCT03208088|102123397|FG008|COMPLETED|Period 3||7||
48730041|NCT03208088|102123398|FG009|COMPLETED|Period 3||9||
48730042|NCT03208088|102123389|FG000|NOT COMPLETED|Period 3||0||
48313677|NCT03292809|101094125|FG000|NOT COMPLETED|Overall Study||7||
48313678|NCT03292809|101094126|FG001|NOT COMPLETED|Overall Study||3||
48313679|NCT02066311|101094127|FG000|STARTED|Overall Study||15||
48313680|NCT02066311|101094127|FG000|COMPLETED|Overall Study||10||
48313681|NCT02066311|101094127|FG000|NOT COMPLETED|Overall Study||5||
48313682|NCT00942175|101094128|FG000|STARTED|Overall Study||40||
48313683|NCT00942175|101094129|FG001|STARTED|Overall Study||40||
48313684|NCT00942175|101094130|FG002|STARTED|Overall Study||40||
48313685|NCT00942175|101094131|FG003|STARTED|Overall Study||40||
48313686|NCT00942175|101094128|FG000|COMPLETED|Overall Study||38||
48313687|NCT00942175|101094129|FG001|COMPLETED|Overall Study||36||
48313688|NCT00942175|101094130|FG002|COMPLETED|Overall Study||38||
48313689|NCT00942175|101094131|FG003|COMPLETED|Overall Study||38||
48313690|NCT00942175|101094128|FG000|NOT COMPLETED|Overall Study||2||
48313691|NCT00942175|101094129|FG001|NOT COMPLETED|Overall Study||4||
48313692|NCT00942175|101094130|FG002|NOT COMPLETED|Overall Study||2||
48313693|NCT00942175|101094131|FG003|NOT COMPLETED|Overall Study||2||
48313694|NCT01575106|101094132|FG000|STARTED|Overall Study||38||
48313695|NCT01575106|101094132|FG000|COMPLETED|Overall Study||24||
48313696|NCT01575106|101094132|FG000|NOT COMPLETED|Overall Study||14||
48313697|NCT01830855|101094133|FG000|STARTED|Overall Study||1508||
48313698|NCT01830855|101094134|FG001|STARTED|Overall Study||598||
48313699|NCT01830855|101094135|FG002|STARTED|Overall Study||587||
48313700|NCT01830855|101094136|FG003|STARTED|Overall Study||897||
48313701|NCT01830855|101094133|FG000|COMPLETED|Overall Study||1353||
48313702|NCT01830855|101094134|FG001|COMPLETED|Overall Study||537||
48313703|NCT01830855|101094135|FG002|COMPLETED|Overall Study||521||
48313704|NCT01830855|101094136|FG003|COMPLETED|Overall Study||815||
48313705|NCT01830855|101094133|FG000|NOT COMPLETED|Overall Study||155||
48313706|NCT01830855|101094134|FG001|NOT COMPLETED|Overall Study||61||
48313707|NCT01830855|101094135|FG002|NOT COMPLETED|Overall Study||66||
48313708|NCT01830855|101094136|FG003|NOT COMPLETED|Overall Study||82||
48313709|NCT03023930|101094137|FG000|STARTED|Overall Study||394||
48313710|NCT03023930|101094138|FG001|STARTED|Overall Study||362||
48313711|NCT03023930|101094139|FG002|STARTED|Overall Study||706||
48313712|NCT03023930|101094140|FG003|STARTED|Overall Study||92||
48313713|NCT03023930|101094141|FG004|STARTED|Overall Study||177||
48313714|NCT03023930|101094137|FG000|COMPLETED|Overall Study||394||
48313715|NCT03023930|101094138|FG001|COMPLETED|Overall Study||362||
48313716|NCT03023930|101094139|FG002|COMPLETED|Overall Study||706||
48313717|NCT03023930|101094140|FG003|COMPLETED|Overall Study||92||
48313718|NCT03023930|101094141|FG004|COMPLETED|Overall Study||177||
48313719|NCT03023930|101094137|FG000|NOT COMPLETED|Overall Study||0||
48313720|NCT03023930|101094138|FG001|NOT COMPLETED|Overall Study||0||
48313721|NCT03023930|101094139|FG002|NOT COMPLETED|Overall Study||0||
48313722|NCT03023930|101094140|FG003|NOT COMPLETED|Overall Study||0||
48313723|NCT03023930|101094141|FG004|NOT COMPLETED|Overall Study||0||
48313724|NCT04792567|101094142|FG000|STARTED|Overall Study||17||
48313725|NCT04792567|101094143|FG001|STARTED|Overall Study||4||
48313726|NCT04792567|101094144|FG002|STARTED|Overall Study||20||
48313727|NCT04792567|101094142|FG000|COMPLETED|Overall Study||17||
48313728|NCT04792567|101094143|FG001|COMPLETED|Overall Study||4||
48313729|NCT04792567|101094144|FG002|COMPLETED|Overall Study||20||
48313730|NCT04792567|101094142|FG000|NOT COMPLETED|Overall Study||0||
48313731|NCT04792567|101094143|FG001|NOT COMPLETED|Overall Study||0||
48313732|NCT04792567|101094144|FG002|NOT COMPLETED|Overall Study||0||
48313733|NCT01040351|101094145|FG000|STARTED|Overall Study||55||
48313734|NCT01040351|101094146|FG001|STARTED|Overall Study||55||
48313735|NCT01040351|101094145|FG000|COMPLETED|Overall Study||54||
48313736|NCT01040351|101094146|FG001|COMPLETED|Overall Study||53||
48313737|NCT01040351|101094145|FG000|NOT COMPLETED|Overall Study||1||
48313738|NCT01040351|101094146|FG001|NOT COMPLETED|Overall Study||2||
48313739|NCT01015768|101094147|FG000|STARTED|Overall Study||30||30
48313740|NCT01015768|101094148|FG001|STARTED|Overall Study||30||30
48313741|NCT01015768|101094147|FG000|COMPLETED|Overall Study||26||26
48313742|NCT01015768|101094148|FG001|COMPLETED|Overall Study||26||26
48313743|NCT01015768|101094147|FG000|NOT COMPLETED|Overall Study||4||4
48313744|NCT01015768|101094148|FG001|NOT COMPLETED|Overall Study||4||4
48313745|NCT02431897|101094149|FG000|STARTED|Overall Study||102||
48313746|NCT02431897|101094150|FG001|STARTED|Overall Study||97||
48313747|NCT02431897|101094149|FG000|COMPLETED|Overall Study||93||
48313748|NCT02431897|101094150|FG001|COMPLETED|Overall Study||93||
48313749|NCT02431897|101094149|FG000|NOT COMPLETED|Overall Study||9||
48313750|NCT02431897|101094150|FG001|NOT COMPLETED|Overall Study||4||
48313751|NCT03887533|101094151|FG000|STARTED|Overall Study||1||
48313752|NCT03887533|101094152|FG001|STARTED|Overall Study||1||
48313753|NCT03887533|101094151|FG000|COMPLETED|Overall Study||1||
48313754|NCT03887533|101094152|FG001|COMPLETED|Overall Study||1||
48313755|NCT03887533|101094151|FG000|NOT COMPLETED|Overall Study||0||
48313756|NCT03887533|101094152|FG001|NOT COMPLETED|Overall Study||0||
48313757|NCT00829179|101094153|FG000|STARTED|Overall Study||20||
48313758|NCT00829179|101094153|FG000|COMPLETED|Overall Study||19||
48313759|NCT00829179|101094153|FG000|NOT COMPLETED|Overall Study||1||
48313760|NCT02887404|101094154|FG000|STARTED|Overall Study||150||
48313761|NCT02887404|101094155|FG001|STARTED|Overall Study||149||
48313762|NCT02887404|101094154|FG000|COMPLETED|Overall Study||150||
48313763|NCT02887404|101094155|FG001|COMPLETED|Overall Study||149||
48313764|NCT02887404|101094154|FG000|NOT COMPLETED|Overall Study||0||
48313765|NCT02887404|101094155|FG001|NOT COMPLETED|Overall Study||0||
48313766|NCT01524198|101094156|FG000|STARTED|Overall Study||471||
48313767|NCT01524198|101094157|FG001|STARTED|Overall Study||474||
48313768|NCT01524198|101094156|FG000|COMPLETED|Overall Study||448||
48157531|NCT01077544|100706971|FG001|NOT COMPLETED|Overall Study||5||
48157532|NCT02803125|100706972|FG000|STARTED|Overall Study||18||
48157533|NCT02803125|100706973|FG001|STARTED|Overall Study||16||
48157534|NCT02803125|100706972|FG000|COMPLETED|Overall Study||13||
48157535|NCT02803125|100706973|FG001|COMPLETED|Overall Study||12||
48157536|NCT02803125|100706972|FG000|NOT COMPLETED|Overall Study||5||
48157537|NCT02803125|100706973|FG001|NOT COMPLETED|Overall Study||4||
48157538|NCT04186780|100706974|FG000|STARTED|Overall Study||36||
48157539|NCT04186780|100706975|FG001|STARTED|Overall Study||32||
48157540|NCT04186780|100706974|FG000|COMPLETED|Overall Study||22||
48157541|NCT04186780|100706975|FG001|COMPLETED|Overall Study||25||
48157542|NCT04186780|100706974|FG000|NOT COMPLETED|Overall Study||14||
48157543|NCT04186780|100706975|FG001|NOT COMPLETED|Overall Study||7||
48157544|NCT01077830|100706976|FG000|STARTED|Overall Study||677||
48157545|NCT01077830|100706977|FG001|STARTED|Overall Study||682||
48157546|NCT01077830|100706976|FG000|COMPLETED|Overall Study||677||
48157547|NCT01077830|100706977|FG001|COMPLETED|Overall Study||682||
48157548|NCT01077830|100706976|FG000|NOT COMPLETED|Overall Study||0||
48157549|NCT01077830|100706977|FG001|NOT COMPLETED|Overall Study||0||
48157550|NCT03445065|100706978|FG000|STARTED|Overall Study||97||
48157551|NCT03445065|100706979|FG001|STARTED|Overall Study||52||
48157552|NCT03445065|100706980|FG002|STARTED|Overall Study||62||
48157553|NCT03445065|100706981|FG003|STARTED|Overall Study||28||
48157554|NCT03445065|100706978|FG000|COMPLETED|Overall Study||90||
48157555|NCT03445065|100706979|FG001|COMPLETED|Overall Study||43||
48157556|NCT03445065|100706980|FG002|COMPLETED|Overall Study||57||
48157557|NCT03445065|100706981|FG003|COMPLETED|Overall Study||25||
48157558|NCT03445065|100706978|FG000|NOT COMPLETED|Overall Study||7||
48157559|NCT03445065|100706979|FG001|NOT COMPLETED|Overall Study||9||
48157560|NCT03445065|100706980|FG002|NOT COMPLETED|Overall Study||5||
48157561|NCT03445065|100706981|FG003|NOT COMPLETED|Overall Study||3||
48157562|NCT01738750|100706982|FG000|STARTED|Overall Study||49||
48157563|NCT01738750|100706983|FG001|STARTED|Overall Study||51||
48157564|NCT01738750|100706982|FG000|COMPLETED|Overall Study||49||
48157565|NCT01738750|100706983|FG001|COMPLETED|Overall Study||51||
48157566|NCT01738750|100706982|FG000|NOT COMPLETED|Overall Study||0||
48157567|NCT01738750|100706983|FG001|NOT COMPLETED|Overall Study||0||
48157568|NCT00674622|100706984|FG000|STARTED|Overall Study||22||
48157569|NCT00674622|100706985|FG001|STARTED|Overall Study||22||
48157570|NCT00674622|100706986|FG002|STARTED|Overall Study||22||
48157571|NCT00674622|100706984|FG000|COMPLETED|Overall Study||21||
48157572|NCT00674622|100706985|FG001|COMPLETED|Overall Study||18||
48157573|NCT00674622|100706986|FG002|COMPLETED|Overall Study||22||
48157574|NCT00674622|100706984|FG000|NOT COMPLETED|Overall Study||1||
48157575|NCT00674622|100706985|FG001|NOT COMPLETED|Overall Study||4||
48157576|NCT00674622|100706986|FG002|NOT COMPLETED|Overall Study||0||
48157577|NCT00571701|100706987|FG000|STARTED|First Intervention 12 Months||19||
48157578|NCT00571701|100706988|FG001|STARTED|First Intervention 12 Months||22||
48157579|NCT00571701|100706987|FG000|COMPLETED|First Intervention 12 Months||16||
48157580|NCT00571701|100706988|FG001|COMPLETED|First Intervention 12 Months||21||
48157581|NCT00571701|100706987|FG000|NOT COMPLETED|First Intervention 12 Months||3||
48157582|NCT00571701|100706988|FG001|NOT COMPLETED|First Intervention 12 Months||1||
48157583|NCT00571701|100706987|FG000|STARTED|Second Intervention 12 Months||16||
48157584|NCT00571701|100706988|FG001|STARTED|Second Intervention 12 Months||21||
48157585|NCT00571701|100706987|FG000|COMPLETED|Second Intervention 12 Months||13||
48157586|NCT00571701|100706988|FG001|COMPLETED|Second Intervention 12 Months||20||
48157587|NCT00571701|100706987|FG000|NOT COMPLETED|Second Intervention 12 Months||3||
48157588|NCT00571701|100706988|FG001|NOT COMPLETED|Second Intervention 12 Months||1||
48157589|NCT01159743|100706989|FG000|STARTED|Overall Study||237||
48157590|NCT01159743|100706990|FG001|STARTED|Overall Study||109||
48157591|NCT01159743|100706989|FG000|COMPLETED|Overall Study||237||
48157592|NCT01159743|100706990|FG001|COMPLETED|Overall Study||109||
48157593|NCT01159743|100706989|FG000|NOT COMPLETED|Overall Study||0||
48157594|NCT01159743|100706990|FG001|NOT COMPLETED|Overall Study||0||
48157595|NCT02281448|100706991|FG000|STARTED|Overall Study||10||
48157596|NCT02281448|100706992|FG001|STARTED|Overall Study||10||
48157597|NCT02281448|100706991|FG000|COMPLETED|Overall Study||8||
48157598|NCT02281448|100706992|FG001|COMPLETED|Overall Study||9||
48157599|NCT02281448|100706991|FG000|NOT COMPLETED|Overall Study||2||
48157600|NCT02281448|100706992|FG001|NOT COMPLETED|Overall Study||1||
48157601|NCT00539279|100706993|FG000|STARTED|Treatment||41||
48157602|NCT00539279|100706994|FG001|STARTED|Treatment||46||
48157603|NCT00539279|100706993|FG000|COMPLETED|Treatment||30||
48313769|NCT01524198|101094157|FG001|COMPLETED|Overall Study||458||
48313770|NCT01524198|101094156|FG000|NOT COMPLETED|Overall Study||23||
48313771|NCT01524198|101094157|FG001|NOT COMPLETED|Overall Study||16||
48313772|NCT01979159|101094158|FG000|STARTED|Overall Study||4||
48313773|NCT01979159|101094158|FG000|COMPLETED|Overall Study||4||
48313774|NCT01979159|101094158|FG000|NOT COMPLETED|Overall Study||0||
48313775|NCT03962738|101094159|FG000|STARTED|Overall Study||258||
48313776|NCT03962738|101094160|FG001|STARTED|Overall Study||109||
48313777|NCT03962738|101094161|FG002|STARTED|Overall Study||261||
48313778|NCT03962738|101094162|FG003|STARTED|Overall Study||218||
48313779|NCT03962738|101094159|FG000|Received At Least One Dose of Study Drug|Overall Study||214||
48313780|NCT03962738|101094160|FG001|Received At Least One Dose of Study Drug|Overall Study||87||
48313781|NCT03962738|101094161|FG002|Received At Least One Dose of Study Drug|Overall Study||208||
48313782|NCT03962738|101094162|FG003|Received At Least One Dose of Study Drug|Overall Study||182||
48313783|NCT03962738|101094159|FG000|COMPLETED|Overall Study||251||
48313784|NCT03962738|101094160|FG001|COMPLETED|Overall Study||109||
48313785|NCT03962738|101094161|FG002|COMPLETED|Overall Study||259||
48313786|NCT03962738|101094162|FG003|COMPLETED|Overall Study||217||
48313787|NCT03962738|101094159|FG000|NOT COMPLETED|Overall Study||7||
48313788|NCT03962738|101094160|FG001|NOT COMPLETED|Overall Study||0||
48313789|NCT03962738|101094161|FG002|NOT COMPLETED|Overall Study||2||
48313790|NCT03962738|101094162|FG003|NOT COMPLETED|Overall Study||1||
48313791|NCT00471705|101094163|FG000|STARTED|Overall Study||145||
48313792|NCT00471705|101094164|FG001|STARTED|Overall Study||143||
48313793|NCT00471705|101094165|FG002|STARTED|Overall Study||149||
48313794|NCT00471705|101094163|FG000|COMPLETED|Overall Study||121||
48313795|NCT00471705|101094164|FG001|COMPLETED|Overall Study||121||
48313796|NCT00471705|101094165|FG002|COMPLETED|Overall Study||134||
48313797|NCT00471705|101094163|FG000|NOT COMPLETED|Overall Study||24||
48313798|NCT00471705|101094164|FG001|NOT COMPLETED|Overall Study||22||
48313799|NCT00471705|101094165|FG002|NOT COMPLETED|Overall Study||15||
48313800|NCT01180478|101094166|FG000|STARTED|Overall Study||484||
48313801|NCT01180478|101094167|FG001|STARTED|Overall Study||481||
48313802|NCT01180478|101094166|FG000|COMPLETED|Overall Study||303||
48313803|NCT01180478|101094167|FG001|COMPLETED|Overall Study||293||
48313804|NCT01180478|101094166|FG000|NOT COMPLETED|Overall Study||181||
48313805|NCT01180478|101094167|FG001|NOT COMPLETED|Overall Study||188||
48313806|NCT04425720|101094168|FG000|STARTED|Overall Study||150||
48313807|NCT04425720|101094169|FG001|STARTED|Overall Study||150||
48313808|NCT04425720|101094168|FG000|COMPLETED|Overall Study||150||
48313809|NCT04425720|101094169|FG001|COMPLETED|Overall Study||130||
48313810|NCT04425720|101094168|FG000|NOT COMPLETED|Overall Study||0||
48313811|NCT04425720|101094169|FG001|NOT COMPLETED|Overall Study||20||
48313812|NCT04002037|101094170|FG000|STARTED|Overall Study||24||
48313813|NCT04002037|101094171|FG001|STARTED|Overall Study||43||
48313814|NCT04002037|101094172|FG002|STARTED|Overall Study||28||
48313815|NCT04002037|101094170|FG000|COMPLETED|Overall Study||24||
48313816|NCT04002037|101094171|FG001|COMPLETED|Overall Study||43||
48313817|NCT04002037|101094172|FG002|COMPLETED|Overall Study||28||
48313818|NCT04002037|101094170|FG000|NOT COMPLETED|Overall Study||0||
48157604|NCT00539279|100706994|FG001|COMPLETED|Treatment||38||
48157605|NCT00539279|100706993|FG000|NOT COMPLETED|Treatment||11||
48157606|NCT00539279|100706994|FG001|NOT COMPLETED|Treatment||8||
48157607|NCT00539279|100706993|FG000|STARTED|Post-Treatment Assessment||30||
48157608|NCT00539279|100706994|FG001|STARTED|Post-Treatment Assessment||38||
48157609|NCT00539279|100706993|FG000|COMPLETED|Post-Treatment Assessment||18||
48157610|NCT00539279|100706994|FG001|COMPLETED|Post-Treatment Assessment||29||
48157611|NCT00539279|100706993|FG000|NOT COMPLETED|Post-Treatment Assessment||12||
48157612|NCT00539279|100706994|FG001|NOT COMPLETED|Post-Treatment Assessment||9||
48157613|NCT00539279|100706993|FG000|STARTED|6-Month Follow-Up Assessment||18||
48157614|NCT00539279|100706994|FG001|STARTED|6-Month Follow-Up Assessment||29||
48157615|NCT00539279|100706993|FG000|COMPLETED|6-Month Follow-Up Assessment||17||
48157616|NCT00539279|100706994|FG001|COMPLETED|6-Month Follow-Up Assessment||22||
48157617|NCT00539279|100706993|FG000|NOT COMPLETED|6-Month Follow-Up Assessment||1||
48157618|NCT00539279|100706994|FG001|NOT COMPLETED|6-Month Follow-Up Assessment||7||
48157619|NCT03645967|100706995|FG000|STARTED|Overall Study||9891||
48157620|NCT03645967|100706995|FG000|COMPLETED|Overall Study||9891||
48157621|NCT03645967|100706995|FG000|NOT COMPLETED|Overall Study||0||
48313819|NCT04002037|101094171|FG001|NOT COMPLETED|Overall Study||0||
48313820|NCT04002037|101094172|FG002|NOT COMPLETED|Overall Study||0||
48313821|NCT02032550|101094173|FG000|STARTED|Overall Study||371||
48313822|NCT02032550|101094174|FG001|STARTED|Overall Study||372||
48313823|NCT02032550|101094173|FG000|COMPLETED|Overall Study||343||
48313824|NCT02032550|101094174|FG001|COMPLETED|Overall Study||350||
48313825|NCT02032550|101094173|FG000|NOT COMPLETED|Overall Study||28||
48313826|NCT02032550|101094174|FG001|NOT COMPLETED|Overall Study||22||
48313827|NCT01543828|101094175|FG000|STARTED|Treatment 1||20||
48313828|NCT01543828|101094176|FG001|STARTED|Treatment 1||20||
48313829|NCT01543828|101094175|FG000|COMPLETED|Treatment 1||20||
48313830|NCT01543828|101094176|FG001|COMPLETED|Treatment 1||20||
48313831|NCT01543828|101094175|FG000|NOT COMPLETED|Treatment 1||0||
48313832|NCT01543828|101094176|FG001|NOT COMPLETED|Treatment 1||0||
48730043|NCT03208088|102123390|FG001|NOT COMPLETED|Period 3||0||
48157622|NCT02073461|100706996|FG000|STARTED|Overall Study||79||
48313833|NCT01543828|101094175|FG000|STARTED|Treatment 2||20||
48313834|NCT01543828|101094176|FG001|STARTED|Treatment 2||19||
48313835|NCT01543828|101094175|FG000|COMPLETED|Treatment 2||19||
48313836|NCT01543828|101094176|FG001|COMPLETED|Treatment 2||19||
48313837|NCT01543828|101094175|FG000|NOT COMPLETED|Treatment 2||1||
48313838|NCT01543828|101094176|FG001|NOT COMPLETED|Treatment 2||0||
48313839|NCT02554903|101094177|FG000|STARTED|Overall Study||28||
48313840|NCT02554903|101094178|FG001|STARTED|Overall Study||29||
48313841|NCT02554903|101094177|FG000|COMPLETED|Overall Study||24||
48313842|NCT02554903|101094178|FG001|COMPLETED|Overall Study||24||
48313843|NCT02554903|101094177|FG000|NOT COMPLETED|Overall Study||4||
48313844|NCT02554903|101094178|FG001|NOT COMPLETED|Overall Study||5||
48313845|NCT00095875|101094179|FG000|STARTED|Overall Study||70||
48313846|NCT00095875|101094180|FG001|STARTED|Overall Study||75||
48313847|NCT00095875|101094179|FG000|COMPLETED|Overall Study||56||
48313848|NCT00095875|101094180|FG001|COMPLETED|Overall Study||66||
48614378|NCT01676012|101841732|FG000|STARTED|Overall Study||32||
48614379|NCT01676012|101841732|FG000|COMPLETED|Overall Study||29||
48614380|NCT01676012|101841732|FG000|NOT COMPLETED|Overall Study||3||
48614381|NCT01938846|101841733|FG000|STARTED|Overall Study||41|Entered/randomised|
48614382|NCT01938846|101841734|FG001|STARTED|Overall Study||25|Entered/randomised|
48614383|NCT01938846|101841735|FG002|STARTED|Overall Study||24|Entered/randomised|
48614384|NCT01938846|101841733|FG000|COMPLETED|Overall Study||0|Not discontinued from last trial medication|
48614385|NCT01938846|101841734|FG001|COMPLETED|Overall Study||0|Not discontinued from last trial medication|
48614386|NCT01938846|101841735|FG002|COMPLETED|Overall Study||0|Not discontinued from last trial medication|
48614387|NCT01938846|101841733|FG000|NOT COMPLETED|Overall Study||41||
48614388|NCT01938846|101841734|FG001|NOT COMPLETED|Overall Study||25||
48614389|NCT01938846|101841735|FG002|NOT COMPLETED|Overall Study||24||
48614390|NCT03360019|101841736|FG000|STARTED|Overall Study||10||
48614391|NCT03360019|101841737|FG001|STARTED|Overall Study||0||
48614392|NCT03360019|101841738|FG002|STARTED|Overall Study||3||
48614393|NCT03360019|101841736|FG000|COMPLETED|Overall Study||2||
48614394|NCT03360019|101841737|FG001|COMPLETED|Overall Study||0||
48614395|NCT03360019|101841738|FG002|COMPLETED|Overall Study||3||
48614396|NCT03360019|101841736|FG000|NOT COMPLETED|Overall Study||8||
48614397|NCT03360019|101841737|FG001|NOT COMPLETED|Overall Study||0||
48614398|NCT03360019|101841738|FG002|NOT COMPLETED|Overall Study||0||
48614399|NCT02372383|101841739|FG000|STARTED|First Intervention (1 Day)||10||
48730044|NCT03208088|102123391|FG002|NOT COMPLETED|Period 3||0||
48730045|NCT03208088|102123392|FG003|NOT COMPLETED|Period 3||1||
48730046|NCT03208088|102123393|FG004|NOT COMPLETED|Period 3||0||
48730047|NCT03208088|102123394|FG005|NOT COMPLETED|Period 3||0||
48730048|NCT03208088|102123395|FG006|NOT COMPLETED|Period 3||0||
48730049|NCT03208088|102123396|FG007|NOT COMPLETED|Period 3||0||
48313849|NCT00095875|101094179|FG000|NOT COMPLETED|Overall Study||14||
48313850|NCT00095875|101094180|FG001|NOT COMPLETED|Overall Study||9||
48313851|NCT01380379|101094181|FG000|STARTED|Overall Study||9||
48313852|NCT01380379|101094181|FG000|COMPLETED|Overall Study||8||
48313853|NCT01380379|101094181|FG000|NOT COMPLETED|Overall Study||1||
48313854|NCT01127659|101094182|FG000|STARTED|Overall Study||22||
48313855|NCT01127659|101094183|FG001|STARTED|Overall Study||22||
48614400|NCT02372383|101841740|FG001|STARTED|First Intervention (1 Day)||11||
48614401|NCT02372383|101841741|FG002|STARTED|First Intervention (1 Day)||10||
48614402|NCT02372383|101841739|FG000|COMPLETED|First Intervention (1 Day)||10||
48614403|NCT02372383|101841740|FG001|COMPLETED|First Intervention (1 Day)||10||
48614404|NCT02372383|101841741|FG002|COMPLETED|First Intervention (1 Day)||10||
48614405|NCT02372383|101841739|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48614406|NCT02372383|101841740|FG001|NOT COMPLETED|First Intervention (1 Day)||1||
48614407|NCT02372383|101841741|FG002|NOT COMPLETED|First Intervention (1 Day)||0||
48614408|NCT02372383|101841739|FG000|STARTED|Washout (14 Days)||10||
48614409|NCT02372383|101841740|FG001|STARTED|Washout (14 Days)||10||
48614410|NCT02372383|101841741|FG002|STARTED|Washout (14 Days)||10||
48614411|NCT02372383|101841739|FG000|COMPLETED|Washout (14 Days)||10||
48614412|NCT02372383|101841740|FG001|COMPLETED|Washout (14 Days)||10||
48730050|NCT03208088|102123397|FG008|NOT COMPLETED|Period 3||0||
48730051|NCT03208088|102123398|FG009|NOT COMPLETED|Period 3||0||
48730052|NCT03208088|102123389|FG000|STARTED|Period 4||10||
48730053|NCT03208088|102123390|FG001|STARTED|Period 4||9||
48313856|NCT01127659|101094184|FG002|STARTED|Overall Study||12||
48313857|NCT01127659|101094185|FG003|STARTED|Overall Study||10||
48313858|NCT01127659|101094186|FG004|STARTED|Overall Study||50||
48313859|NCT01127659|101094187|FG005|STARTED|Overall Study||21||
48313860|NCT01127659|101094182|FG000|COMPLETED|Overall Study||20||
48157623|NCT02073461|100706997|FG001|STARTED|Overall Study||78||
48157624|NCT02073461|100706998|FG002|STARTED|Overall Study||79||
48157625|NCT02073461|100706996|FG000|COMPLETED|Overall Study||75||
48157626|NCT02073461|100706997|FG001|COMPLETED|Overall Study||77||
48157627|NCT02073461|100706998|FG002|COMPLETED|Overall Study||78||
48157628|NCT02073461|100706996|FG000|NOT COMPLETED|Overall Study||4||
48157629|NCT02073461|100706997|FG001|NOT COMPLETED|Overall Study||1||
48157630|NCT02073461|100706998|FG002|NOT COMPLETED|Overall Study||1||
48157631|NCT04322604|100706999|FG000|STARTED|Overall Study||91||
48157632|NCT04322604|100707000|FG001|STARTED|Overall Study||90||
48157633|NCT04322604|100706999|FG000|COMPLETED|Overall Study||85||
48157634|NCT04322604|100707000|FG001|COMPLETED|Overall Study||83||
48157635|NCT04322604|100706999|FG000|NOT COMPLETED|Overall Study||6||
48157636|NCT04322604|100707000|FG001|NOT COMPLETED|Overall Study||7||
48157637|NCT01456299|100707001|FG000|STARTED|Overall Study||34||
48157638|NCT01456299|100707002|FG001|STARTED|Overall Study||34||
48730054|NCT03208088|102123391|FG002|STARTED|Period 4||10||
48730055|NCT03208088|102123392|FG003|STARTED|Period 4||8||
48730056|NCT03208088|102123393|FG004|STARTED|Period 4||9||
48730057|NCT03208088|102123394|FG005|STARTED|Period 4||9||
48730058|NCT03208088|102123395|FG006|STARTED|Period 4||8||
48730059|NCT03208088|102123396|FG007|STARTED|Period 4||10||
48157639|NCT01456299|100707003|FG002|STARTED|Overall Study||34||
48157640|NCT01456299|100707001|FG000|COMPLETED|Overall Study||34||
48157641|NCT01456299|100707002|FG001|COMPLETED|Overall Study||33||
48157642|NCT01456299|100707003|FG002|COMPLETED|Overall Study||33||
48157643|NCT01456299|100707001|FG000|NOT COMPLETED|Overall Study||0||
48157644|NCT01456299|100707002|FG001|NOT COMPLETED|Overall Study||1||
48157645|NCT01456299|100707003|FG002|NOT COMPLETED|Overall Study||1||
48157646|NCT05168579|100707004|FG000|STARTED|Overall Study||36||
48157647|NCT05168579|100707005|FG001|STARTED|Overall Study||36||
48157648|NCT05168579|100707004|FG000|COMPLETED|Overall Study||30||
48157649|NCT05168579|100707005|FG001|COMPLETED|Overall Study||21||
48157650|NCT05168579|100707004|FG000|NOT COMPLETED|Overall Study||6||
48157651|NCT05168579|100707005|FG001|NOT COMPLETED|Overall Study||15||
48157652|NCT03078816|100707006|FG000|STARTED|Overall Study||5||
48157653|NCT03078816|100707006|FG000|COMPLETED|Overall Study||4||
48157654|NCT03078816|100707006|FG000|NOT COMPLETED|Overall Study||1||
48157655|NCT04333420|100707007|FG000|STARTED|Overall Study||15||
48157656|NCT04333420|100707008|FG001|STARTED|Overall Study||15||
48157657|NCT04333420|100707009|FG002|STARTED|Overall Study||178||
48157658|NCT04333420|100707010|FG003|STARTED|Overall Study||191||
48157659|NCT04333420|100707007|FG000|Contributed to Full Analysis Set (FAS)|Overall Study||15||
48157660|NCT04333420|100707008|FG001|Contributed to Full Analysis Set (FAS)|Overall Study||15||
48157661|NCT04333420|100707009|FG002|Contributed to Full Analysis Set (FAS)|Overall Study||177||
48157662|NCT04333420|100707010|FG003|Contributed to Full Analysis Set (FAS)|Overall Study||191||
48157663|NCT04333420|100707007|FG000|Contributed to Safety Analysis Set (SAF)|Overall Study||15||
48157664|NCT04333420|100707008|FG001|Contributed to Safety Analysis Set (SAF)|Overall Study||15||
48157665|NCT04333420|100707009|FG002|Contributed to Safety Analysis Set (SAF)|Overall Study||175||
48157666|NCT04333420|100707010|FG003|Contributed to Safety Analysis Set (SAF)|Overall Study||189||
48157667|NCT04333420|100707007|FG000|COMPLETED|Overall Study||13||
48157668|NCT04333420|100707008|FG001|COMPLETED|Overall Study||11||
48157669|NCT04333420|100707009|FG002|COMPLETED|Overall Study||103||
48157670|NCT04333420|100707010|FG003|COMPLETED|Overall Study||93||
48157671|NCT04333420|100707007|FG000|NOT COMPLETED|Overall Study||2||
48157672|NCT04333420|100707008|FG001|NOT COMPLETED|Overall Study||4||
48157673|NCT04333420|100707009|FG002|NOT COMPLETED|Overall Study||75||
48313861|NCT01127659|101094183|FG001|COMPLETED|Overall Study||14||
48313862|NCT01127659|101094184|FG002|COMPLETED|Overall Study||10||
48313863|NCT01127659|101094185|FG003|COMPLETED|Overall Study||6||
48313864|NCT01127659|101094186|FG004|COMPLETED|Overall Study||50||
48313865|NCT01127659|101094187|FG005|COMPLETED|Overall Study||21||
48313866|NCT01127659|101094182|FG000|NOT COMPLETED|Overall Study||2||
48313867|NCT01127659|101094183|FG001|NOT COMPLETED|Overall Study||8||
48313868|NCT01127659|101094184|FG002|NOT COMPLETED|Overall Study||2||
48313869|NCT01127659|101094185|FG003|NOT COMPLETED|Overall Study||4||
48313870|NCT01127659|101094186|FG004|NOT COMPLETED|Overall Study||0||
48313871|NCT01127659|101094187|FG005|NOT COMPLETED|Overall Study||0||
48313872|NCT05417607|101094188|FG000|STARTED|Overall Study||26||
48313873|NCT05417607|101094189|FG001|STARTED|Overall Study||26||
48313874|NCT05417607|101094190|FG002|STARTED|Overall Study||5||
48313875|NCT05417607|101094188|FG000|COMPLETED|Overall Study||24||
48730060|NCT03208088|102123397|FG008|STARTED|Period 4||7||
48157674|NCT04333420|100707010|FG003|NOT COMPLETED|Overall Study||98||
48157675|NCT01222195|100707011|FG000|STARTED|Overall Study||1||
48157676|NCT01222195|100707011|FG000|COMPLETED|Overall Study||1||
48157677|NCT01222195|100707011|FG000|NOT COMPLETED|Overall Study||0||
48157678|NCT04236258|100707012|FG000|STARTED|Overall Study||47||
48157679|NCT04236258|100707013|FG001|STARTED|Overall Study||47||
48157680|NCT04236258|100707012|FG000|COMPLETED|Overall Study||47||
48157681|NCT04236258|100707013|FG001|COMPLETED|Overall Study||47||
48157682|NCT04236258|100707012|FG000|NOT COMPLETED|Overall Study||0||
48157683|NCT04236258|100707013|FG001|NOT COMPLETED|Overall Study||0||
48157684|NCT00844857|100707014|FG000|STARTED|Overall Study||194||
48157685|NCT00844857|100707015|FG001|STARTED|Overall Study||97||
48313876|NCT05417607|101094189|FG001|COMPLETED|Overall Study||24||
48313877|NCT05417607|101094190|FG002|COMPLETED|Overall Study||5||
48313878|NCT05417607|101094188|FG000|NOT COMPLETED|Overall Study||2||
48313879|NCT05417607|101094189|FG001|NOT COMPLETED|Overall Study||2||
48730061|NCT03208088|102123398|FG009|STARTED|Period 4||9||
48157686|NCT00844857|100707014|FG000|Population Analyzed|Overall Study||170||
48157687|NCT00844857|100707015|FG001|Population Analyzed|Overall Study||85||
48157688|NCT00844857|100707014|FG000|COMPLETED|Overall Study||116||
48157689|NCT00844857|100707015|FG001|COMPLETED|Overall Study||60||
48157690|NCT00844857|100707014|FG000|NOT COMPLETED|Overall Study||78||
48157691|NCT00844857|100707015|FG001|NOT COMPLETED|Overall Study||37||
48313880|NCT05417607|101094190|FG002|NOT COMPLETED|Overall Study||0||
48730062|NCT03208088|102123389|FG000|COMPLETED|Period 4||10||
48730063|NCT03208088|102123390|FG001|COMPLETED|Period 4||9||
48313881|NCT03620890|101094191|FG000|STARTED|Overall Study||57||
48313882|NCT03620890|101094192|FG001|STARTED|Overall Study||51||
48313883|NCT03620890|101094191|FG000|First Trimester Miscarriage|Overall Study||2||
48313884|NCT03620890|101094192|FG001|First Trimester Miscarriage|Overall Study||1||
48313885|NCT03620890|101094191|FG000|Major Fetal Anomalies (Hypoplastic Left Heart and Sacral Agenesis) With 2nd Trimester Stillbirth|Overall Study||1||
48313886|NCT03620890|101094192|FG001|Major Fetal Anomalies (Hypoplastic Left Heart and Sacral Agenesis) With 2nd Trimester Stillbirth|Overall Study||0||
48313887|NCT03620890|101094191|FG000|Major Fetal Anomaly (Holoprosencephaly) With 2nd Trimester Pregnancy Termination|Overall Study||1||
48313888|NCT03620890|101094192|FG001|Major Fetal Anomaly (Holoprosencephaly) With 2nd Trimester Pregnancy Termination|Overall Study||0||
48313889|NCT03620890|101094191|FG000|COMPLETED|Overall Study||53||
48313890|NCT03620890|101094192|FG001|COMPLETED|Overall Study||50||
48313891|NCT03620890|101094191|FG000|NOT COMPLETED|Overall Study||4||
48157692|NCT00790452|100707016|FG000|STARTED|Overall Study||1||
48157693|NCT00790452|100707017|FG001|STARTED|Overall Study||0||
48157694|NCT00790452|100707016|FG000|COMPLETED|Overall Study||0||
48157695|NCT00790452|100707017|FG001|COMPLETED|Overall Study||0||
48157696|NCT00790452|100707016|FG000|NOT COMPLETED|Overall Study||1||
48157697|NCT00790452|100707017|FG001|NOT COMPLETED|Overall Study||0||
48157698|NCT00947661|100707018|FG000|STARTED|Overall Study||289||
48157699|NCT00947661|100707019|FG001|STARTED|Overall Study||289||
48157700|NCT00947661|100707018|FG000|COMPLETED|Overall Study||276||
48157701|NCT00947661|100707019|FG001|COMPLETED|Overall Study||274||
48157702|NCT00947661|100707018|FG000|NOT COMPLETED|Overall Study||13||
48157703|NCT00947661|100707019|FG001|NOT COMPLETED|Overall Study||15||
48157704|NCT05582304|100707020|FG000|STARTED|Overall Study||9||
48157705|NCT05582304|100707021|FG001|STARTED|Overall Study||11||
48157706|NCT05582304|100707022|FG002|STARTED|Overall Study||11||
48157707|NCT05582304|100707023|FG003|STARTED|Overall Study||9||
48157708|NCT05582304|100707020|FG000|COMPLETED|Overall Study||9||
48157709|NCT05582304|100707021|FG001|COMPLETED|Overall Study||11||
48157710|NCT05582304|100707022|FG002|COMPLETED|Overall Study||11||
48157711|NCT05582304|100707023|FG003|COMPLETED|Overall Study||9||
48157712|NCT05582304|100707020|FG000|NOT COMPLETED|Overall Study||0||
48157713|NCT05582304|100707021|FG001|NOT COMPLETED|Overall Study||0||
48157714|NCT05582304|100707022|FG002|NOT COMPLETED|Overall Study||0||
48157715|NCT05582304|100707023|FG003|NOT COMPLETED|Overall Study||0||
48157716|NCT02158884|100707024|FG000|STARTED|Baseline Assessment||91||
48157717|NCT02158884|100707024|FG000|COMPLETED|Baseline Assessment||87||
48157718|NCT02158884|100707024|FG000|NOT COMPLETED|Baseline Assessment||4||
48157719|NCT02158884|100707024|FG000|STARTED|Intervention: IDEO and PT Program||87||
48157720|NCT02158884|100707024|FG000|COMPLETED|Intervention: IDEO and PT Program||81||
48157721|NCT02158884|100707024|FG000|NOT COMPLETED|Intervention: IDEO and PT Program||6||
48157722|NCT02158884|100707024|FG000|STARTED|Post Intervention (~4 Weeks)||81||
48157723|NCT02158884|100707024|FG000|COMPLETED|Post Intervention (~4 Weeks)||71||
48157724|NCT02158884|100707024|FG000|NOT COMPLETED|Post Intervention (~4 Weeks)||10||
48157725|NCT02158884|100707024|FG000|STARTED|6 Month Assessment||81|All those that completed the intervention (n = 81) were eligible to start.|
48157726|NCT02158884|100707024|FG000|COMPLETED|6 Month Assessment||61||
48157727|NCT02158884|100707024|FG000|NOT COMPLETED|6 Month Assessment||20||
48157728|NCT02158884|100707024|FG000|STARTED|12 Month Assessment||81|All those that completed the intervention (n = 81) were eligible to start.|
48157729|NCT02158884|100707024|FG000|COMPLETED|12 Month Assessment||64||
48157730|NCT02158884|100707024|FG000|NOT COMPLETED|12 Month Assessment||17||
48157731|NCT02037438|100707025|FG000|STARTED|Overall Study||920||
48157732|NCT02037438|100707026|FG001|STARTED|Overall Study||916||
48157733|NCT02037438|100707025|FG000|COMPLETED|Overall Study||574||
48157734|NCT02037438|100707026|FG001|COMPLETED|Overall Study||561||
48157735|NCT02037438|100707025|FG000|NOT COMPLETED|Overall Study||346||
48157736|NCT02037438|100707026|FG001|NOT COMPLETED|Overall Study||355||
48157737|NCT01851174|100707027|FG000|STARTED|Overall Study||15||
48157738|NCT01851174|100707027|FG000|COMPLETED|Overall Study||15||
48313892|NCT03620890|101094192|FG001|NOT COMPLETED|Overall Study||1||
48313893|NCT01771055|101094193|FG000|STARTED|Overall Study||4||
48313894|NCT01771055|101094194|FG001|STARTED|Overall Study||3||
48313895|NCT01771055|101094193|FG000|COMPLETED|Overall Study||4||
48313896|NCT01771055|101094194|FG001|COMPLETED|Overall Study||3||
48313897|NCT01771055|101094193|FG000|NOT COMPLETED|Overall Study||0||
48614413|NCT02372383|101841741|FG002|COMPLETED|Washout (14 Days)||10||
48614414|NCT02372383|101841739|FG000|NOT COMPLETED|Washout (14 Days)||0||
48157739|NCT01851174|100707027|FG000|NOT COMPLETED|Overall Study||0||
48157740|NCT01301391|100707028|FG000|STARTED|Overall Study||30||
48157741|NCT01301391|100707028|FG000|COMPLETED|Overall Study||4|Follow up for survival: up to the end of study or for no more than 2 years from end of treatment.|
48157742|NCT01301391|100707028|FG000|NOT COMPLETED|Overall Study||26||
48157743|NCT01806584|100707029|FG000|STARTED|Overall Study||14||
48157744|NCT01806584|100707030|FG001|STARTED|Overall Study||18||
48157745|NCT01806584|100707029|FG000|COMPLETED|Overall Study||0||
48157746|NCT01806584|100707030|FG001|COMPLETED|Overall Study||0||
48157747|NCT01806584|100707029|FG000|NOT COMPLETED|Overall Study||14||
48157748|NCT01806584|100707030|FG001|NOT COMPLETED|Overall Study||18||
48157749|NCT00420199|100707031|FG000|STARTED|Overall Study||27||
48157750|NCT00420199|100707032|FG001|STARTED|Overall Study||23||
48157751|NCT00420199|100707031|FG000|COMPLETED|Overall Study||26||
48157752|NCT00420199|100707032|FG001|COMPLETED|Overall Study||23||
48157753|NCT00420199|100707031|FG000|NOT COMPLETED|Overall Study||1||
48157754|NCT00420199|100707032|FG001|NOT COMPLETED|Overall Study||0||
48157755|NCT02979639|100707033|FG000|STARTED|Overall Study||401||
48157756|NCT02979639|100707033|FG000|COMPLETED|Overall Study||387||
48157757|NCT02979639|100707033|FG000|NOT COMPLETED|Overall Study||14||
48157758|NCT01624948|100707034|FG000|STARTED|Overall Study||20||
48157759|NCT01624948|100707035|FG001|STARTED|Overall Study||20||
48157760|NCT01624948|100707034|FG000|COMPLETED|Overall Study||20||
48157761|NCT01624948|100707035|FG001|COMPLETED|Overall Study||20||
48157762|NCT01624948|100707034|FG000|NOT COMPLETED|Overall Study||0||
48157763|NCT01624948|100707035|FG001|NOT COMPLETED|Overall Study||0||
48157764|NCT04111757|100707036|FG000|STARTED|Overall Study||168||333
48157765|NCT04111757|100707036|FG000|COMPLETED|Overall Study||168||316
48157766|NCT04111757|100707036|FG000|NOT COMPLETED|Overall Study||0||17
48157767|NCT02839343|100707037|FG000|STARTED|Overall Study||70||
48157768|NCT02839343|100707038|FG001|STARTED|Overall Study||56||
48157769|NCT02839343|100707037|FG000|COMPLETED|Overall Study||65||
48157770|NCT02839343|100707038|FG001|COMPLETED|Overall Study||55||
48157771|NCT02839343|100707037|FG000|NOT COMPLETED|Overall Study||5||
48157772|NCT02839343|100707038|FG001|NOT COMPLETED|Overall Study||1||
48157773|NCT04504331|100707039|FG000|STARTED|Dose Level 1 (up to 18 28-day Cycles+FU)||3||
48157774|NCT04504331|100707040|FG001|STARTED|Dose Level 1 (up to 18 28-day Cycles+FU)||0||
48157775|NCT04504331|100707041|FG002|STARTED|Dose Level 1 (up to 18 28-day Cycles+FU)||0||
48157776|NCT04504331|100707039|FG000|Completed at Least 6 Treatment Cycles|Dose Level 1 (up to 18 28-day Cycles+FU)||3||
48157777|NCT04504331|100707040|FG001|Completed at Least 6 Treatment Cycles|Dose Level 1 (up to 18 28-day Cycles+FU)||0||
48157778|NCT04504331|100707041|FG002|Completed at Least 6 Treatment Cycles|Dose Level 1 (up to 18 28-day Cycles+FU)||0||
48157779|NCT04504331|100707039|FG000|COMPLETED|Dose Level 1 (up to 18 28-day Cycles+FU)||3||
48157780|NCT04504331|100707040|FG001|COMPLETED|Dose Level 1 (up to 18 28-day Cycles+FU)||0||
48157781|NCT04504331|100707041|FG002|COMPLETED|Dose Level 1 (up to 18 28-day Cycles+FU)||0||
48157782|NCT04504331|100707039|FG000|NOT COMPLETED|Dose Level 1 (up to 18 28-day Cycles+FU)||0||
48157783|NCT04504331|100707040|FG001|NOT COMPLETED|Dose Level 1 (up to 18 28-day Cycles+FU)||0||
48157784|NCT04504331|100707041|FG002|NOT COMPLETED|Dose Level 1 (up to 18 28-day Cycles+FU)||0||
48157785|NCT04504331|100707039|FG000|STARTED|Dose Level 2 (up to 18 28-day Cycles+FU)||0||
48313898|NCT01771055|101094194|FG001|NOT COMPLETED|Overall Study||0||
48313899|NCT01523496|101094195|FG000|STARTED|Overall Study||66||
48313900|NCT01523496|101094196|FG001|STARTED|Overall Study||36||
48406891|NCT03424044|101328491|FG007|COMPLETED|Third Rest Period (7-45 Days)||1||
48157786|NCT04504331|100707040|FG001|STARTED|Dose Level 2 (up to 18 28-day Cycles+FU)||1||
48157787|NCT04504331|100707041|FG002|STARTED|Dose Level 2 (up to 18 28-day Cycles+FU)||0||
48157788|NCT04504331|100707039|FG000|Completed at Least 6 Treatment Cycles|Dose Level 2 (up to 18 28-day Cycles+FU)||0||
48157789|NCT04504331|100707040|FG001|Completed at Least 6 Treatment Cycles|Dose Level 2 (up to 18 28-day Cycles+FU)||0||
48157790|NCT04504331|100707041|FG002|Completed at Least 6 Treatment Cycles|Dose Level 2 (up to 18 28-day Cycles+FU)||0||
48157791|NCT04504331|100707039|FG000|COMPLETED|Dose Level 2 (up to 18 28-day Cycles+FU)||0||
48157792|NCT04504331|100707040|FG001|COMPLETED|Dose Level 2 (up to 18 28-day Cycles+FU)||1||
48157793|NCT04504331|100707041|FG002|COMPLETED|Dose Level 2 (up to 18 28-day Cycles+FU)||0||
48157794|NCT04504331|100707039|FG000|NOT COMPLETED|Dose Level 2 (up to 18 28-day Cycles+FU)||0||
48157795|NCT04504331|100707040|FG001|NOT COMPLETED|Dose Level 2 (up to 18 28-day Cycles+FU)||0||
48157796|NCT04504331|100707041|FG002|NOT COMPLETED|Dose Level 2 (up to 18 28-day Cycles+FU)||0||
48157797|NCT01542957|100707042|FG000|STARTED|End of Therapy||65||
48157798|NCT01542957|100707043|FG001|STARTED|End of Therapy||63||
48157799|NCT01542957|100707042|FG000|COMPLETED|End of Therapy||53||
48157800|NCT01542957|100707043|FG001|COMPLETED|End of Therapy||53||
48157801|NCT01542957|100707042|FG000|NOT COMPLETED|End of Therapy||12||
48157802|NCT01542957|100707043|FG001|NOT COMPLETED|End of Therapy||10||
48157803|NCT01542957|100707042|FG000|STARTED|3-month Follow-up||53||
48157804|NCT01542957|100707043|FG001|STARTED|3-month Follow-up||53||
48157805|NCT01542957|100707042|FG000|COMPLETED|3-month Follow-up||50||
48157806|NCT01542957|100707043|FG001|COMPLETED|3-month Follow-up||45||
48157807|NCT01542957|100707042|FG000|NOT COMPLETED|3-month Follow-up||3||
48157808|NCT01542957|100707043|FG001|NOT COMPLETED|3-month Follow-up||8||
48157809|NCT01542957|100707042|FG000|STARTED|12-month Follow-up||53||
48157810|NCT01542957|100707043|FG001|STARTED|12-month Follow-up||53||
48157811|NCT01542957|100707042|FG000|COMPLETED|12-month Follow-up||37||
48157812|NCT01542957|100707043|FG001|COMPLETED|12-month Follow-up||40||
48157813|NCT01542957|100707042|FG000|NOT COMPLETED|12-month Follow-up||16||
48157814|NCT01542957|100707043|FG001|NOT COMPLETED|12-month Follow-up||13||
48157815|NCT01119898|100707044|FG000|STARTED|Overall Study||131||
48157816|NCT01119898|100707045|FG001|STARTED|Overall Study||129||
48157817|NCT01119898|100707044|FG000|Received Study Drug (mITT)|Overall Study||130||
48157818|NCT01119898|100707045|FG001|Received Study Drug (mITT)|Overall Study||129||
48157819|NCT01119898|100707044|FG000|COMPLETED|Overall Study||123||
48157820|NCT01119898|100707045|FG001|COMPLETED|Overall Study||117||
48157821|NCT01119898|100707044|FG000|NOT COMPLETED|Overall Study||8||
48157822|NCT01119898|100707045|FG001|NOT COMPLETED|Overall Study||12||
48157823|NCT02710292|100707046|FG000|STARTED|Period 1, First 10 Days of Wear||47||
48157824|NCT02710292|100707047|FG001|STARTED|Period 1, First 10 Days of Wear||52||
48157825|NCT02710292|100707046|FG000|COMPLETED|Period 1, First 10 Days of Wear||46||
48157826|NCT02710292|100707047|FG001|COMPLETED|Period 1, First 10 Days of Wear||49||
48157827|NCT02710292|100707046|FG000|NOT COMPLETED|Period 1, First 10 Days of Wear||1||
48157828|NCT02710292|100707047|FG001|NOT COMPLETED|Period 1, First 10 Days of Wear||3||
48157829|NCT02710292|100707046|FG000|STARTED|Period 2, Second 10 Days of Wear||46||
48157830|NCT02710292|100707047|FG001|STARTED|Period 2, Second 10 Days of Wear||49||
48313901|NCT01523496|101094197|FG002|STARTED|Overall Study||58||
48313902|NCT01523496|101094198|FG003|STARTED|Overall Study||30||
48313903|NCT01523496|101094195|FG000|COMPLETED|Overall Study||56||
48313904|NCT01523496|101094196|FG001|COMPLETED|Overall Study||32||
48313905|NCT01523496|101094197|FG002|COMPLETED|Overall Study||46||
48313906|NCT01523496|101094198|FG003|COMPLETED|Overall Study||27||
48157831|NCT02710292|100707046|FG000|COMPLETED|Period 2, Second 10 Days of Wear||46||
48157832|NCT02710292|100707047|FG001|COMPLETED|Period 2, Second 10 Days of Wear||49||
48157833|NCT02710292|100707046|FG000|NOT COMPLETED|Period 2, Second 10 Days of Wear||0||
48157834|NCT02710292|100707047|FG001|NOT COMPLETED|Period 2, Second 10 Days of Wear||0||
48157835|NCT00736489|100707048|FG000|STARTED|Period 1||6||
48313907|NCT01523496|101094195|FG000|NOT COMPLETED|Overall Study||10||
48313908|NCT01523496|101094196|FG001|NOT COMPLETED|Overall Study||4||
48313909|NCT01523496|101094197|FG002|NOT COMPLETED|Overall Study||12||
48406892|NCT03424044|101328492|FG008|COMPLETED|Third Rest Period (7-45 Days)||1||
48730064|NCT03208088|102123391|FG002|COMPLETED|Period 4||10||
48730065|NCT03208088|102123392|FG003|COMPLETED|Period 4||7||
48730066|NCT03208088|102123393|FG004|COMPLETED|Period 4||9||
48730067|NCT03208088|102123394|FG005|COMPLETED|Period 4||9||
48730068|NCT03208088|102123395|FG006|COMPLETED|Period 4||8||
48730069|NCT03208088|102123396|FG007|COMPLETED|Period 4||10||
48730070|NCT03208088|102123397|FG008|COMPLETED|Period 4||7||
48730071|NCT03208088|102123398|FG009|COMPLETED|Period 4||9||
48157836|NCT00736489|100707049|FG001|STARTED|Period 1||5||
48157837|NCT00736489|100707050|FG002|STARTED|Period 1||6||
48157838|NCT00736489|100707051|FG003|STARTED|Period 1||7||
48157839|NCT00736489|100707052|FG004|STARTED|Period 1||7||
48157840|NCT00736489|100707053|FG005|STARTED|Period 1||6||
48157841|NCT00736489|100707048|FG000|COMPLETED|Period 1||5||
48157842|NCT00736489|100707049|FG001|COMPLETED|Period 1||5||
48157843|NCT00736489|100707050|FG002|COMPLETED|Period 1||6||
48157844|NCT00736489|100707051|FG003|COMPLETED|Period 1||7||
48157845|NCT00736489|100707052|FG004|COMPLETED|Period 1||7||
48313910|NCT01523496|101094198|FG003|NOT COMPLETED|Overall Study||3||
48313911|NCT00750698|101094199|FG000|STARTED|Overall Study||6||
48313912|NCT00750698|101094200|FG001|STARTED|Overall Study||2||
48313913|NCT00750698|101094199|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
48313914|NCT00750698|101094200|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2||
48313915|NCT00750698|101094199|FG000|COMPLETED|Overall Study||0||
48730072|NCT03208088|102123389|FG000|NOT COMPLETED|Period 4||0||
48730073|NCT03208088|102123390|FG001|NOT COMPLETED|Period 4||0||
48730074|NCT03208088|102123391|FG002|NOT COMPLETED|Period 4||0||
48730075|NCT03208088|102123392|FG003|NOT COMPLETED|Period 4||1||
48730076|NCT03208088|102123393|FG004|NOT COMPLETED|Period 4||0||
48313916|NCT00750698|101094200|FG001|COMPLETED|Overall Study||0||
48313917|NCT00750698|101094199|FG000|NOT COMPLETED|Overall Study||6||
48313918|NCT00750698|101094200|FG001|NOT COMPLETED|Overall Study||2||
48313919|NCT01056510|101094201|FG000|STARTED|Overall Study||178||
48313920|NCT01056510|101094202|FG001|STARTED|Overall Study||179||
48313921|NCT01056510|101094201|FG000|COMPLETED|Overall Study||124||
48313922|NCT01056510|101094202|FG001|COMPLETED|Overall Study||115||
48313923|NCT01056510|101094201|FG000|NOT COMPLETED|Overall Study||54||
48730077|NCT03208088|102123394|FG005|NOT COMPLETED|Period 4||0||
48730078|NCT03208088|102123395|FG006|NOT COMPLETED|Period 4||0||
48730079|NCT03208088|102123396|FG007|NOT COMPLETED|Period 4||0||
48157846|NCT00736489|100707053|FG005|COMPLETED|Period 1||5||
48157847|NCT00736489|100707048|FG000|NOT COMPLETED|Period 1||1||
48157848|NCT00736489|100707049|FG001|NOT COMPLETED|Period 1||0||
48157849|NCT00736489|100707050|FG002|NOT COMPLETED|Period 1||0||
48157850|NCT00736489|100707051|FG003|NOT COMPLETED|Period 1||0||
48157851|NCT00736489|100707052|FG004|NOT COMPLETED|Period 1||0||
48157852|NCT00736489|100707053|FG005|NOT COMPLETED|Period 1||1||
48157853|NCT00736489|100707048|FG000|STARTED|Period 2||5||
48157854|NCT00736489|100707049|FG001|STARTED|Period 2||5||
48157855|NCT00736489|100707050|FG002|STARTED|Period 2||6||
48157856|NCT00736489|100707051|FG003|STARTED|Period 2||7||
48157857|NCT00736489|100707052|FG004|STARTED|Period 2||7||
48730080|NCT03208088|102123397|FG008|NOT COMPLETED|Period 4||0||
48730081|NCT03208088|102123398|FG009|NOT COMPLETED|Period 4||0||
48730082|NCT03208088|102123389|FG000|STARTED|Period 5||10||
48730083|NCT03208088|102123390|FG001|STARTED|Period 5||9||
48730084|NCT03208088|102123391|FG002|STARTED|Period 5||10||
48730085|NCT03208088|102123392|FG003|STARTED|Period 5||7||
48157858|NCT00736489|100707053|FG005|STARTED|Period 2||5||
48157859|NCT00736489|100707048|FG000|COMPLETED|Period 2||5||
48157860|NCT00736489|100707049|FG001|COMPLETED|Period 2||5||
48157861|NCT00736489|100707050|FG002|COMPLETED|Period 2||6||
48157862|NCT00736489|100707051|FG003|COMPLETED|Period 2||7||
48157863|NCT00736489|100707052|FG004|COMPLETED|Period 2||7||
48157864|NCT00736489|100707053|FG005|COMPLETED|Period 2||5||
48157865|NCT00736489|100707048|FG000|NOT COMPLETED|Period 2||0||
48157866|NCT00736489|100707049|FG001|NOT COMPLETED|Period 2||0||
48157867|NCT00736489|100707050|FG002|NOT COMPLETED|Period 2||0||
48157868|NCT00736489|100707051|FG003|NOT COMPLETED|Period 2||0||
48157869|NCT00736489|100707052|FG004|NOT COMPLETED|Period 2||0||
48157870|NCT00736489|100707053|FG005|NOT COMPLETED|Period 2||0||
48157871|NCT00736489|100707048|FG000|STARTED|Period 3||5||
48157872|NCT00736489|100707049|FG001|STARTED|Period 3||5||
48313924|NCT01056510|101094202|FG001|NOT COMPLETED|Overall Study||64||
48313925|NCT04416555|101094203|FG000|STARTED|Overall Study||55||
48313926|NCT04416555|101094204|FG001|STARTED|Overall Study||58||
48313927|NCT04416555|101094203|FG000|COMPLETED|Overall Study||55||
48313928|NCT04416555|101094204|FG001|COMPLETED|Overall Study||55||
48313929|NCT04416555|101094203|FG000|NOT COMPLETED|Overall Study||0||
48313930|NCT04416555|101094204|FG001|NOT COMPLETED|Overall Study||3||
48313931|NCT00928889|101094205|FG000|STARTED|Overall Study||80||
48313932|NCT00928889|101094206|FG001|STARTED|Overall Study||80||
48313933|NCT00928889|101094205|FG000|COMPLETED|Overall Study||75||
48313934|NCT00928889|101094206|FG001|COMPLETED|Overall Study||78||
48730086|NCT03208088|102123393|FG004|STARTED|Period 5||9||
48730087|NCT03208088|102123394|FG005|STARTED|Period 5||9||
48730088|NCT03208088|102123395|FG006|STARTED|Period 5||8||
48730089|NCT03208088|102123396|FG007|STARTED|Period 5||10||
48730090|NCT03208088|102123397|FG008|STARTED|Period 5||7||
48730091|NCT03208088|102123398|FG009|STARTED|Period 5||9||
48730092|NCT03208088|102123389|FG000|COMPLETED|Period 5||10||
48730093|NCT03208088|102123390|FG001|COMPLETED|Period 5||9||
48730094|NCT03208088|102123391|FG002|COMPLETED|Period 5||10||
48730095|NCT03208088|102123392|FG003|COMPLETED|Period 5||7||
48730096|NCT03208088|102123393|FG004|COMPLETED|Period 5||9||
48730097|NCT03208088|102123394|FG005|COMPLETED|Period 5||9||
48730098|NCT03208088|102123395|FG006|COMPLETED|Period 5||8||
48730099|NCT03208088|102123396|FG007|COMPLETED|Period 5||10||
48730100|NCT03208088|102123397|FG008|COMPLETED|Period 5||7||
48730101|NCT03208088|102123398|FG009|COMPLETED|Period 5||9||
48730102|NCT03208088|102123389|FG000|NOT COMPLETED|Period 5||0||
48730103|NCT03208088|102123390|FG001|NOT COMPLETED|Period 5||0||
48730104|NCT03208088|102123391|FG002|NOT COMPLETED|Period 5||0||
48730105|NCT03208088|102123392|FG003|NOT COMPLETED|Period 5||0||
48730106|NCT03208088|102123393|FG004|NOT COMPLETED|Period 5||0||
48730107|NCT03208088|102123394|FG005|NOT COMPLETED|Period 5||0||
48730108|NCT03208088|102123395|FG006|NOT COMPLETED|Period 5||0||
48730109|NCT03208088|102123396|FG007|NOT COMPLETED|Period 5||0||
48730110|NCT03208088|102123397|FG008|NOT COMPLETED|Period 5||0||
48730111|NCT03208088|102123398|FG009|NOT COMPLETED|Period 5||0||
48730112|NCT00659230|102123399|FG000|STARTED|Overall Study||51||
48730113|NCT00659230|102123400|FG001|STARTED|Overall Study||49||
48730114|NCT00659230|102123399|FG000|COMPLETED|Overall Study||42||
48730115|NCT00659230|102123400|FG001|COMPLETED|Overall Study||37||
48730116|NCT00659230|102123399|FG000|NOT COMPLETED|Overall Study||9||
48730117|NCT00659230|102123400|FG001|NOT COMPLETED|Overall Study||12||
48730118|NCT00061633|102123401|FG000|STARTED|Overall Study||84||
48730119|NCT00061633|102123402|FG001|STARTED|Overall Study||85||
48730120|NCT00061633|102123401|FG000|COMPLETED|Overall Study||79||
48730121|NCT00061633|102123402|FG001|COMPLETED|Overall Study||74||
48730122|NCT00061633|102123401|FG000|NOT COMPLETED|Overall Study||5||
48730123|NCT00061633|102123402|FG001|NOT COMPLETED|Overall Study||11||
48730124|NCT03274518|102123403|FG000|STARTED|First Intervention||8|First intervention: online hemodiafiltration, for 30 days|
48730125|NCT03274518|102123404|FG001|STARTED|First Intervention||8|First intervention: online hemodiafiltration, for 30 days|
48730126|NCT03274518|102123403|FG000|COMPLETED|First Intervention||8||
48730127|NCT03274518|102123404|FG001|COMPLETED|First Intervention||8||
48730128|NCT03274518|102123403|FG000|NOT COMPLETED|First Intervention||0||
48313935|NCT00928889|101094205|FG000|NOT COMPLETED|Overall Study||5||
48313936|NCT00928889|101094206|FG001|NOT COMPLETED|Overall Study||2||
48730129|NCT03274518|102123404|FG001|NOT COMPLETED|First Intervention||0||
48730130|NCT03274518|102123403|FG000|STARTED|Washout Period||8|Patients returned from online Hemodiafiltration to conventional hemodialysis for 15 days.|
48730131|NCT03274518|102123404|FG001|STARTED|Washout Period||8|Patients returned from online Hemodiafiltration to conventional hemodialysis for 15 days.|
48730132|NCT03274518|102123403|FG000|COMPLETED|Washout Period||8||
48730133|NCT03274518|102123404|FG001|COMPLETED|Washout Period||8||
48730134|NCT03274518|102123403|FG000|NOT COMPLETED|Washout Period||0||
48730135|NCT03274518|102123404|FG001|NOT COMPLETED|Washout Period||0||
48730136|NCT03274518|102123403|FG000|STARTED|Second Intervention||8|Second intervention: patients from this group underwent expanded hemodialysis for 30 days.|
48730137|NCT03274518|102123404|FG001|STARTED|Second Intervention||8|Second intervention: patients from this group underwent expanded hemodialysis for 30 days.|
48730138|NCT03274518|102123403|FG000|COMPLETED|Second Intervention||8||
48730139|NCT03274518|102123404|FG001|COMPLETED|Second Intervention||8||
48730140|NCT03274518|102123403|FG000|NOT COMPLETED|Second Intervention||0||
48730141|NCT03274518|102123404|FG001|NOT COMPLETED|Second Intervention||0||
48730142|NCT01209078|102123405|FG000|STARTED|Overall Study||57||
48730143|NCT01209078|102123406|FG001|STARTED|Overall Study||27||
48730144|NCT01209078|102123405|FG000|COMPLETED|Overall Study||41||
48730145|NCT01209078|102123406|FG001|COMPLETED|Overall Study||24||
48730146|NCT01209078|102123405|FG000|NOT COMPLETED|Overall Study||16||
48730147|NCT01209078|102123406|FG001|NOT COMPLETED|Overall Study||3||
48730148|NCT00680797|102123407|FG000|STARTED|Overall Study||9||
48730149|NCT00680797|102123408|FG001|STARTED|Overall Study||8||
48730150|NCT00680797|102123409|FG002|STARTED|Overall Study||8||
48730151|NCT00680797|102123410|FG003|STARTED|Overall Study||8||
48157873|NCT00736489|100707050|FG002|STARTED|Period 3||6||
48313937|NCT01553136|101094207|FG000|STARTED|Overall Study||64||
48313938|NCT01553136|101094208|FG001|STARTED|Overall Study||67||
48313939|NCT01553136|101094207|FG000|Completed Treatment|Overall Study||55|These data reflect those that had complete alcohol timeline data.|
48313940|NCT01553136|101094208|FG001|Completed Treatment|Overall Study||52|These data reflect those that had complete alcohol timeline data.|
48313941|NCT01553136|101094207|FG000|COMPLETED|Overall Study||48|The completed participants reflect those that continued on medication.|
48313942|NCT01553136|101094208|FG001|COMPLETED|Overall Study||45|The completed participants reflect those that continued on medication.|
48730152|NCT00680797|102123407|FG000|COMPLETED|Overall Study||9||
48730153|NCT00680797|102123408|FG001|COMPLETED|Overall Study||8||
48730154|NCT00680797|102123409|FG002|COMPLETED|Overall Study||8||
48730155|NCT00680797|102123410|FG003|COMPLETED|Overall Study||8||
48730156|NCT00680797|102123407|FG000|NOT COMPLETED|Overall Study||0||
48730157|NCT00680797|102123408|FG001|NOT COMPLETED|Overall Study||0||
48730158|NCT00680797|102123409|FG002|NOT COMPLETED|Overall Study||0||
48730159|NCT00680797|102123410|FG003|NOT COMPLETED|Overall Study||0||
48730160|NCT00646399|102123411|FG000|STARTED|Overall Study||792||
48730161|NCT00646399|102123412|FG001|STARTED|Overall Study||787||
48730162|NCT00646399|102123411|FG000|COMPLETED|Overall Study||709||
48730163|NCT00646399|102123412|FG001|COMPLETED|Overall Study||713||
48730164|NCT00646399|102123411|FG000|NOT COMPLETED|Overall Study||83||
48730165|NCT00646399|102123412|FG001|NOT COMPLETED|Overall Study||74||
48730166|NCT04569357|102123413|FG000|STARTED|Overall Study||174||
48730167|NCT04569357|102123414|FG001|STARTED|Overall Study||189||
48730168|NCT04569357|102123413|FG000|COMPLETED|Overall Study||174||
48730169|NCT04569357|102123414|FG001|COMPLETED|Overall Study||189||
48157874|NCT00736489|100707051|FG003|STARTED|Period 3||7||
48730170|NCT04569357|102123413|FG000|NOT COMPLETED|Overall Study||0||
48730171|NCT04569357|102123414|FG001|NOT COMPLETED|Overall Study||0||
48730172|NCT01299116|102123415|FG000|STARTED|Overall Study||522||
48730173|NCT01299116|102123416|FG001|STARTED|Overall Study||177||
48730174|NCT01299116|102123417|FG002|STARTED|Overall Study||195||
48730175|NCT01299116|102123415|FG000|COMPLETED|Overall Study||457||
48730176|NCT01299116|102123416|FG001|COMPLETED|Overall Study||168||
48157875|NCT00736489|100707052|FG004|STARTED|Period 3||7||
48730177|NCT01299116|102123417|FG002|COMPLETED|Overall Study||184||
48730178|NCT01299116|102123415|FG000|NOT COMPLETED|Overall Study||65||
48730179|NCT01299116|102123416|FG001|NOT COMPLETED|Overall Study||9||
48730180|NCT01299116|102123417|FG002|NOT COMPLETED|Overall Study||11||
48730181|NCT00411632|102123418|FG000|STARTED|Overall Study||37||
48730182|NCT00411632|102123418|FG000|COMPLETED|Overall Study||36||
48730183|NCT00411632|102123418|FG000|NOT COMPLETED|Overall Study||1||
48730184|NCT00773747|102123419|FG000|STARTED|Overall Study||317||
48730185|NCT00773747|102123420|FG001|STARTED|Overall Study||320||
48730186|NCT00773747|102123419|FG000|Treated|Overall Study||315||
48730187|NCT00773747|102123420|FG001|Treated|Overall Study||320||
48730188|NCT00773747|102123419|FG000|COMPLETED|Overall Study||20||
48730189|NCT00773747|102123420|FG001|COMPLETED|Overall Study||24||
48730190|NCT00773747|102123419|FG000|NOT COMPLETED|Overall Study||297||
48730191|NCT00773747|102123420|FG001|NOT COMPLETED|Overall Study||296||
48730192|NCT00367835|102123421|FG000|STARTED|Overall Study||138||
48730193|NCT00367835|102123422|FG001|STARTED|Overall Study||79||
48730194|NCT00367835|102123421|FG000|COMPLETED|Overall Study||109||
48730195|NCT00367835|102123422|FG001|COMPLETED|Overall Study||48||
48730196|NCT00367835|102123421|FG000|NOT COMPLETED|Overall Study||29||
48730197|NCT00367835|102123422|FG001|NOT COMPLETED|Overall Study||31||
48730198|NCT00802893|102123423|FG000|STARTED|Overall Study||3||
48730199|NCT00802893|102123423|FG000|COMPLETED|Overall Study||0||
48730200|NCT00802893|102123423|FG000|NOT COMPLETED|Overall Study||3||
48730201|NCT02516592|102123424|FG000|STARTED|Overall Study||251||
48730202|NCT02516592|102123425|FG001|STARTED|Overall Study||251||
48730203|NCT02516592|102123424|FG000|Full Analysis Set|Overall Study||248||
48730204|NCT02516592|102123425|FG001|Full Analysis Set|Overall Study||250||
48730205|NCT02516592|102123424|FG000|COMPLETED|Overall Study||235||
48730206|NCT02516592|102123425|FG001|COMPLETED|Overall Study||238||
48730207|NCT02516592|102123424|FG000|NOT COMPLETED|Overall Study||16||
48157876|NCT00736489|100707053|FG005|STARTED|Period 3||5||
48157877|NCT00736489|100707048|FG000|COMPLETED|Period 3||5||
48157878|NCT00736489|100707049|FG001|COMPLETED|Period 3||5||
48157879|NCT00736489|100707050|FG002|COMPLETED|Period 3||6||
48157880|NCT00736489|100707051|FG003|COMPLETED|Period 3||7||
48157881|NCT00736489|100707052|FG004|COMPLETED|Period 3||7||
48157882|NCT00736489|100707053|FG005|COMPLETED|Period 3||5||
48157883|NCT00736489|100707048|FG000|NOT COMPLETED|Period 3||0||
48157884|NCT00736489|100707049|FG001|NOT COMPLETED|Period 3||0||
48157885|NCT00736489|100707050|FG002|NOT COMPLETED|Period 3||0||
48157886|NCT00736489|100707051|FG003|NOT COMPLETED|Period 3||0||
48157887|NCT00736489|100707052|FG004|NOT COMPLETED|Period 3||0||
48157888|NCT00736489|100707053|FG005|NOT COMPLETED|Period 3||0||
48157889|NCT00736489|100707048|FG000|STARTED|Period 4||5||
48157890|NCT00736489|100707049|FG001|STARTED|Period 4||5||
48730208|NCT02516592|102123425|FG001|NOT COMPLETED|Overall Study||13||
48730209|NCT03875664|102123426|FG000|STARTED|Overall Study||37||
48730210|NCT03875664|102123427|FG001|STARTED|Overall Study||35||
48730211|NCT03875664|102123426|FG000|COMPLETED|Overall Study||37||
48730212|NCT03875664|102123427|FG001|COMPLETED|Overall Study||35||
48730213|NCT03875664|102123426|FG000|NOT COMPLETED|Overall Study||0||
48730214|NCT03875664|102123427|FG001|NOT COMPLETED|Overall Study||0||
48730215|NCT00383942|102123428|FG000|STARTED|Overall Study||40||
48730216|NCT00383942|102123429|FG001|STARTED|Overall Study||40||
48730217|NCT00383942|102123428|FG000|COMPLETED|Overall Study||40||
48730218|NCT00383942|102123429|FG001|COMPLETED|Overall Study||40||
48730219|NCT00383942|102123428|FG000|NOT COMPLETED|Overall Study||0||
48730220|NCT00383942|102123429|FG001|NOT COMPLETED|Overall Study||0||
48730221|NCT01853878|102123430|FG000|STARTED|Overall Study||86||
48730222|NCT01853878|102123431|FG001|STARTED|Overall Study||47||
48730223|NCT01853878|102123430|FG000|COMPLETED|Overall Study||23||
48730224|NCT01853878|102123431|FG001|COMPLETED|Overall Study||3||
48730225|NCT01853878|102123430|FG000|NOT COMPLETED|Overall Study||63||
48730226|NCT01853878|102123431|FG001|NOT COMPLETED|Overall Study||44||
48730227|NCT00372697|102123432|FG000|STARTED|Overall Study||16||
48730228|NCT00372697|102123433|FG001|STARTED|Overall Study||12||
48730229|NCT00372697|102123432|FG000|COMPLETED|Overall Study||15||
48730230|NCT00372697|102123433|FG001|COMPLETED|Overall Study||11||
48730231|NCT00372697|102123432|FG000|NOT COMPLETED|Overall Study||1||
48730232|NCT00372697|102123433|FG001|NOT COMPLETED|Overall Study||1||
48730233|NCT02651220|102123434|FG000|STARTED|Overall Study||337||
48730234|NCT02651220|102123435|FG001|STARTED|Overall Study||335||
48730235|NCT02651220|102123436|FG002|STARTED|Overall Study||329||
48730236|NCT02651220|102123434|FG000|COMPLETED|Overall Study||314||
48730237|NCT02651220|102123435|FG001|COMPLETED|Overall Study||308||
48730238|NCT02651220|102123436|FG002|COMPLETED|Overall Study||300||
48730239|NCT02651220|102123434|FG000|NOT COMPLETED|Overall Study||23||
48157891|NCT00736489|100707050|FG002|STARTED|Period 4||6||
48157892|NCT00736489|100707051|FG003|STARTED|Period 4||7||
48157893|NCT00736489|100707052|FG004|STARTED|Period 4||7||
48157894|NCT00736489|100707053|FG005|STARTED|Period 4||5||
48157895|NCT00736489|100707048|FG000|COMPLETED|Period 4||5||
48730240|NCT02651220|102123435|FG001|NOT COMPLETED|Overall Study||27||
48730241|NCT02651220|102123436|FG002|NOT COMPLETED|Overall Study||29||
48730242|NCT03190460|102126767|FG000|STARTED|Overall Study||40||
48730243|NCT03190460|102126768|FG001|STARTED|Overall Study||20||
48730244|NCT03190460|102126767|FG000|COMPLETED|Overall Study||3||
48730245|NCT03190460|102126768|FG001|COMPLETED|Overall Study||2||
48730246|NCT03190460|102126767|FG000|NOT COMPLETED|Overall Study||37||
48730247|NCT03190460|102126768|FG001|NOT COMPLETED|Overall Study||18||
48614415|NCT02372383|101841740|FG001|NOT COMPLETED|Washout (14 Days)||0||
48614416|NCT02372383|101841741|FG002|NOT COMPLETED|Washout (14 Days)||0||
48614417|NCT02372383|101841739|FG000|STARTED|Second Intervention (1 Day)||10||
48614418|NCT02372383|101841740|FG001|STARTED|Second Intervention (1 Day)||10||
48614419|NCT02372383|101841741|FG002|STARTED|Second Intervention (1 Day)||10||
48614420|NCT02372383|101841739|FG000|COMPLETED|Second Intervention (1 Day)||10||
48614421|NCT02372383|101841740|FG001|COMPLETED|Second Intervention (1 Day)||10||
48614422|NCT02372383|101841741|FG002|COMPLETED|Second Intervention (1 Day)||10||
48614423|NCT02372383|101841739|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48614424|NCT02372383|101841740|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48614425|NCT02372383|101841741|FG002|NOT COMPLETED|Second Intervention (1 Day)||0||
48614426|NCT03758157|101841742|FG000|STARTED|Overall Study||110||
48614427|NCT03758157|101841742|FG000|COMPLETED|Overall Study||110||
48614428|NCT03758157|101841742|FG000|NOT COMPLETED|Overall Study||0||
48614429|NCT03727841|101841743|FG000|STARTED|Overall Study||3||
48614430|NCT03727841|101841744|FG001|STARTED|Overall Study||1||
48614431|NCT03727841|101841743|FG000|COMPLETED|Overall Study||0||
48614432|NCT03727841|101841744|FG001|COMPLETED|Overall Study||0||
48614433|NCT03727841|101841743|FG000|NOT COMPLETED|Overall Study||3||
48614434|NCT03727841|101841744|FG001|NOT COMPLETED|Overall Study||1||
48614435|NCT00807365|101841745|FG000|STARTED|Overall Study||5||
48614436|NCT00807365|101841745|FG000|COMPLETED|Overall Study||0||
48614437|NCT00807365|101841745|FG000|NOT COMPLETED|Overall Study||5||
48614438|NCT02824224|101841746|FG000|STARTED|Overall Study||19||
48614439|NCT02824224|101841747|FG001|STARTED|Overall Study||18||
48614440|NCT02824224|101841746|FG000|COMPLETED|Overall Study||17||
48614441|NCT02824224|101841747|FG001|COMPLETED|Overall Study||17||
48614442|NCT02824224|101841746|FG000|NOT COMPLETED|Overall Study||2||
48614443|NCT02824224|101841747|FG001|NOT COMPLETED|Overall Study||1||
48614444|NCT00357877|101841748|FG000|STARTED|Overall Study||493||
48614445|NCT00357877|101841749|FG001|STARTED|Overall Study||490||
48614446|NCT00357877|101841748|FG000|COMPLETED|Overall Study||467||
48614447|NCT00357877|101841749|FG001|COMPLETED|Overall Study||460||
48614448|NCT00357877|101841748|FG000|NOT COMPLETED|Overall Study||26||
48614449|NCT00357877|101841749|FG001|NOT COMPLETED|Overall Study||30||
48614450|NCT03570047|101841750|FG000|STARTED|Overall Study||15902||
48614451|NCT03570047|101841751|FG001|STARTED|Overall Study||22336||
48614452|NCT03570047|101841752|FG002|STARTED|Overall Study||6925||
48614453|NCT03570047|101841753|FG003|STARTED|Overall Study||16564||
48614454|NCT03570047|101841754|FG004|STARTED|Overall Study||12262||
48614455|NCT03570047|101841750|FG000|COMPLETED|Overall Study||15902||
48614456|NCT03570047|101841751|FG001|COMPLETED|Overall Study||22336||
48614457|NCT03570047|101841752|FG002|COMPLETED|Overall Study||6925||
48614458|NCT03570047|101841753|FG003|COMPLETED|Overall Study||16564||
48614459|NCT03570047|101841754|FG004|COMPLETED|Overall Study||12262||
48614460|NCT03570047|101841750|FG000|NOT COMPLETED|Overall Study||0||
48614461|NCT03570047|101841751|FG001|NOT COMPLETED|Overall Study||0||
48614462|NCT03570047|101841752|FG002|NOT COMPLETED|Overall Study||0||
48614463|NCT03570047|101841753|FG003|NOT COMPLETED|Overall Study||0||
48614464|NCT03570047|101841754|FG004|NOT COMPLETED|Overall Study||0||
48614465|NCT02532257|101841755|FG000|STARTED|Overall Study||48||
48614466|NCT02532257|101841755|FG000|Previously Untreated Follicular Lymphoma FL Grade 1-3a|Overall Study||38||
48614467|NCT02532257|101841755|FG000|Marginal Zone|Overall Study||10||
48614468|NCT02532257|101841755|FG000|COMPLETED|Overall Study||29||
48614469|NCT02532257|101841755|FG000|NOT COMPLETED|Overall Study||19||
48614470|NCT02299388|101841756|FG000|STARTED|Overall Study||6||
48614471|NCT02299388|101841757|FG001|STARTED|Overall Study||5||
48614472|NCT02299388|101841756|FG000|COMPLETED|Overall Study||6||
48614473|NCT02299388|101841757|FG001|COMPLETED|Overall Study||4||
48614474|NCT02299388|101841756|FG000|NOT COMPLETED|Overall Study||0||
48614475|NCT02299388|101841757|FG001|NOT COMPLETED|Overall Study||1||
48614476|NCT01588158|101841758|FG000|STARTED|Overall Study||4||
48614477|NCT01588158|101841759|FG001|STARTED|Overall Study||3||
48614478|NCT01588158|101841758|FG000|COMPLETED|Overall Study||4||
48614479|NCT01588158|101841759|FG001|COMPLETED|Overall Study||3||
48614480|NCT01588158|101841758|FG000|NOT COMPLETED|Overall Study||0||
48614481|NCT01588158|101841759|FG001|NOT COMPLETED|Overall Study||0||
48614482|NCT01265394|101841760|FG000|STARTED|Overall Study||218||
48614483|NCT01265394|101841760|FG000|COMPLETED|Overall Study||181||
48614484|NCT01265394|101841760|FG000|NOT COMPLETED|Overall Study||37||
48614485|NCT02370511|101841761|FG000|STARTED|Overall Study||31||
48614486|NCT02370511|101841762|FG001|STARTED|Overall Study||30||
48730248|NCT02697435|102126769|FG000|STARTED|Overall Study||25||
48730249|NCT02697435|102126770|FG001|STARTED|Overall Study||30||
48730250|NCT02697435|102126769|FG000|COMPLETED|Overall Study||24||
48730251|NCT02697435|102126770|FG001|COMPLETED|Overall Study||26||
48614487|NCT02370511|101841763|FG002|STARTED|Overall Study||30||
48614488|NCT02370511|101841761|FG000|COMPLETED|Overall Study||19||
48614489|NCT02370511|101841762|FG001|COMPLETED|Overall Study||19||
48730252|NCT02697435|102126769|FG000|NOT COMPLETED|Overall Study||1||
48730253|NCT02697435|102126770|FG001|NOT COMPLETED|Overall Study||4||
48730254|NCT00615030|102126771|FG000|STARTED|Period I||9||
48730255|NCT00615030|102126772|FG001|STARTED|Period I||8||
48730256|NCT00615030|102126773|FG002|STARTED|Period I||9||
48730257|NCT00615030|102126774|FG003|STARTED|Period I||8||
48730258|NCT00615030|102126775|FG004|STARTED|Period I||9||
48730259|NCT00615030|102126776|FG005|STARTED|Period I||6||
48313943|NCT01553136|101094207|FG000|NOT COMPLETED|Overall Study||16||
48313944|NCT01553136|101094208|FG001|NOT COMPLETED|Overall Study||22||
48313945|NCT02490475|101094209|FG000|STARTED|Period 1: First 6 Cycles||6||
48730260|NCT00615030|102126777|FG006|STARTED|Period I||7||
48730261|NCT00615030|102126778|FG007|STARTED|Period I||7||
48730262|NCT00615030|102126779|FG008|STARTED|Period I||9||
48730263|NCT00615030|102126780|FG009|STARTED|Period I||8||
48730264|NCT00615030|102126781|FG010|STARTED|Period I||8||
48730265|NCT00615030|102126782|FG011|STARTED|Period I||7||
48730266|NCT00615030|102126771|FG000|COMPLETED|Period I||8||
48730267|NCT00615030|102126772|FG001|COMPLETED|Period I||8||
48730268|NCT00615030|102126773|FG002|COMPLETED|Period I||9||
48730269|NCT00615030|102126774|FG003|COMPLETED|Period I||8||
48730270|NCT00615030|102126775|FG004|COMPLETED|Period I||8||
48730271|NCT00615030|102126776|FG005|COMPLETED|Period I||5||
48730272|NCT00615030|102126777|FG006|COMPLETED|Period I||7||
48730273|NCT00615030|102126778|FG007|COMPLETED|Period I||7||
48730274|NCT00615030|102126779|FG008|COMPLETED|Period I||8||
48730275|NCT00615030|102126780|FG009|COMPLETED|Period I||8||
48730276|NCT00615030|102126781|FG010|COMPLETED|Period I||7||
48730277|NCT00615030|102126782|FG011|COMPLETED|Period I||6||
48730278|NCT00615030|102126771|FG000|NOT COMPLETED|Period I||1||
48730279|NCT00615030|102126772|FG001|NOT COMPLETED|Period I||0||
48730280|NCT00615030|102126773|FG002|NOT COMPLETED|Period I||0||
48730281|NCT00615030|102126774|FG003|NOT COMPLETED|Period I||0||
48730282|NCT00615030|102126775|FG004|NOT COMPLETED|Period I||1||
48730283|NCT00615030|102126776|FG005|NOT COMPLETED|Period I||1||
48730284|NCT00615030|102126777|FG006|NOT COMPLETED|Period I||0||
48730285|NCT00615030|102126778|FG007|NOT COMPLETED|Period I||0||
48730286|NCT00615030|102126779|FG008|NOT COMPLETED|Period I||1||
48730287|NCT00615030|102126780|FG009|NOT COMPLETED|Period I||0||
48730288|NCT00615030|102126781|FG010|NOT COMPLETED|Period I||1||
48730289|NCT00615030|102126782|FG011|NOT COMPLETED|Period I||1||
48730290|NCT00615030|102126771|FG000|STARTED|Period II||8||
48730291|NCT00615030|102126772|FG001|STARTED|Period II||8||
48730292|NCT00615030|102126773|FG002|STARTED|Period II||9||
48730293|NCT00615030|102126774|FG003|STARTED|Period II||8||
48313946|NCT02490475|101094210|FG001|STARTED|Period 1: First 6 Cycles||2||
48313947|NCT02490475|101094211|FG002|STARTED|Period 1: First 6 Cycles||6||
48313948|NCT02490475|101094212|FG003|STARTED|Period 1: First 6 Cycles||5||
48313949|NCT02490475|101094209|FG000|COMPLETED|Period 1: First 6 Cycles||0||
48730294|NCT00615030|102126775|FG004|STARTED|Period II||8||
48730295|NCT00615030|102126776|FG005|STARTED|Period II||5||
48730296|NCT00615030|102126777|FG006|STARTED|Period II||7||
48730297|NCT00615030|102126778|FG007|STARTED|Period II||7||
48730298|NCT00615030|102126779|FG008|STARTED|Period II||8||
48730299|NCT00615030|102126780|FG009|STARTED|Period II||8||
48730300|NCT00615030|102126781|FG010|STARTED|Period II||7||
48730301|NCT00615030|102126782|FG011|STARTED|Period II||6||
48730302|NCT00615030|102126771|FG000|COMPLETED|Period II||8||
48730303|NCT00615030|102126772|FG001|COMPLETED|Period II||8||
48730304|NCT00615030|102126773|FG002|COMPLETED|Period II||8||
48730305|NCT00615030|102126774|FG003|COMPLETED|Period II||7||
48730306|NCT00615030|102126775|FG004|COMPLETED|Period II||8||
48730307|NCT00615030|102126776|FG005|COMPLETED|Period II||5||
48730308|NCT00615030|102126777|FG006|COMPLETED|Period II||6||
48730309|NCT00615030|102126778|FG007|COMPLETED|Period II||7||
48730310|NCT00615030|102126779|FG008|COMPLETED|Period II||7||
48730311|NCT00615030|102126780|FG009|COMPLETED|Period II||8||
48730312|NCT00615030|102126781|FG010|COMPLETED|Period II||7||
48730313|NCT00615030|102126782|FG011|COMPLETED|Period II||6||
48730314|NCT00615030|102126771|FG000|NOT COMPLETED|Period II||0||
48730315|NCT00615030|102126772|FG001|NOT COMPLETED|Period II||0||
48730316|NCT00615030|102126773|FG002|NOT COMPLETED|Period II||1||
48730317|NCT00615030|102126774|FG003|NOT COMPLETED|Period II||1||
48313950|NCT02490475|101094210|FG001|COMPLETED|Period 1: First 6 Cycles||0||
48313951|NCT02490475|101094211|FG002|COMPLETED|Period 1: First 6 Cycles||0||
48313952|NCT02490475|101094212|FG003|COMPLETED|Period 1: First 6 Cycles||0||
48313953|NCT02490475|101094209|FG000|NOT COMPLETED|Period 1: First 6 Cycles||6||
48313954|NCT02490475|101094210|FG001|NOT COMPLETED|Period 1: First 6 Cycles||2||
48313955|NCT02490475|101094211|FG002|NOT COMPLETED|Period 1: First 6 Cycles||6||
48313956|NCT02490475|101094212|FG003|NOT COMPLETED|Period 1: First 6 Cycles||5||
48730318|NCT00615030|102126775|FG004|NOT COMPLETED|Period II||0||
48730319|NCT00615030|102126776|FG005|NOT COMPLETED|Period II||0||
48730320|NCT00615030|102126777|FG006|NOT COMPLETED|Period II||1||
48730321|NCT00615030|102126778|FG007|NOT COMPLETED|Period II||0||
48730322|NCT00615030|102126779|FG008|NOT COMPLETED|Period II||1||
48730323|NCT00615030|102126780|FG009|NOT COMPLETED|Period II||0||
48730324|NCT00615030|102126781|FG010|NOT COMPLETED|Period II||0||
48730325|NCT00615030|102126782|FG011|NOT COMPLETED|Period II||0||
48730326|NCT00615030|102126771|FG000|STARTED|Period III||8||
48313957|NCT02490475|101094209|FG000|STARTED|Period 2: Extension Phase||1||
48313958|NCT02490475|101094210|FG001|STARTED|Period 2: Extension Phase||0||
48313959|NCT02490475|101094211|FG002|STARTED|Period 2: Extension Phase||3||
48313960|NCT02490475|101094212|FG003|STARTED|Period 2: Extension Phase||1||
48313961|NCT02490475|101094209|FG000|COMPLETED|Period 2: Extension Phase||0||
48313962|NCT02490475|101094210|FG001|COMPLETED|Period 2: Extension Phase||0||
48313963|NCT02490475|101094211|FG002|COMPLETED|Period 2: Extension Phase||0||
48313964|NCT02490475|101094212|FG003|COMPLETED|Period 2: Extension Phase||0||
48313965|NCT02490475|101094209|FG000|NOT COMPLETED|Period 2: Extension Phase||1||
48313966|NCT02490475|101094210|FG001|NOT COMPLETED|Period 2: Extension Phase||0||
48313967|NCT02490475|101094211|FG002|NOT COMPLETED|Period 2: Extension Phase||3||
48313968|NCT02490475|101094212|FG003|NOT COMPLETED|Period 2: Extension Phase||1||
48313969|NCT04267770|101094213|FG000|STARTED|Overall Study||9||
48313970|NCT04267770|101094214|FG001|STARTED|Overall Study||8||
48313971|NCT04267770|101094213|FG000|COMPLETED|Overall Study||9||
48313972|NCT04267770|101094214|FG001|COMPLETED|Overall Study||8||
48313973|NCT04267770|101094213|FG000|NOT COMPLETED|Overall Study||0||
48313974|NCT04267770|101094214|FG001|NOT COMPLETED|Overall Study||0||
48313975|NCT00770770|101094215|FG000|STARTED|Overall Study||14||
48313976|NCT00770770|101094216|FG001|STARTED|Overall Study||6||
48313977|NCT00770770|101094215|FG000|COMPLETED|Overall Study||4||
48313978|NCT00770770|101094216|FG001|COMPLETED|Overall Study||5||
48406893|NCT03424044|101328484|FG000|NOT COMPLETED|Third Rest Period (7-45 Days)||0||
48730327|NCT00615030|102126772|FG001|STARTED|Period III||8||
48730328|NCT00615030|102126773|FG002|STARTED|Period III||8||
48730329|NCT00615030|102126774|FG003|STARTED|Period III||7||
48730330|NCT00615030|102126775|FG004|STARTED|Period III||8||
48730331|NCT00615030|102126776|FG005|STARTED|Period III||5||
48730332|NCT00615030|102126777|FG006|STARTED|Period III||6||
48730333|NCT00615030|102126778|FG007|STARTED|Period III||7||
48730334|NCT00615030|102126779|FG008|STARTED|Period III||7||
48730335|NCT00615030|102126780|FG009|STARTED|Period III||8||
48730336|NCT00615030|102126781|FG010|STARTED|Period III||7||
48730337|NCT00615030|102126782|FG011|STARTED|Period III||6||
48730338|NCT00615030|102126771|FG000|COMPLETED|Period III||7||
48730339|NCT00615030|102126772|FG001|COMPLETED|Period III||8||
48730340|NCT00615030|102126773|FG002|COMPLETED|Period III||8||
48730341|NCT00615030|102126774|FG003|COMPLETED|Period III||6||
48730342|NCT00615030|102126775|FG004|COMPLETED|Period III||8||
48730343|NCT00615030|102126776|FG005|COMPLETED|Period III||5||
48730344|NCT00615030|102126777|FG006|COMPLETED|Period III||6||
48730345|NCT00615030|102126778|FG007|COMPLETED|Period III||7||
48730346|NCT00615030|102126779|FG008|COMPLETED|Period III||7||
48730347|NCT00615030|102126780|FG009|COMPLETED|Period III||8||
48730348|NCT00615030|102126781|FG010|COMPLETED|Period III||7||
48730349|NCT00615030|102126782|FG011|COMPLETED|Period III||6||
48730350|NCT00615030|102126771|FG000|NOT COMPLETED|Period III||1||
48730351|NCT00615030|102126772|FG001|NOT COMPLETED|Period III||0||
48730352|NCT00615030|102126773|FG002|NOT COMPLETED|Period III||0||
48313979|NCT00770770|101094215|FG000|NOT COMPLETED|Overall Study||10||
48313980|NCT00770770|101094216|FG001|NOT COMPLETED|Overall Study||1||
48313981|NCT01429584|101094217|FG000|STARTED|Overall Study||15||
48313982|NCT01429584|101094218|FG001|STARTED|Overall Study||15||
48313983|NCT01429584|101094217|FG000|COMPLETED|Overall Study||14||
48406894|NCT03424044|101328485|FG001|NOT COMPLETED|Third Rest Period (7-45 Days)||0||
48406895|NCT03424044|101328486|FG002|NOT COMPLETED|Third Rest Period (7-45 Days)||0||
48730353|NCT00615030|102126774|FG003|NOT COMPLETED|Period III||1||
48730354|NCT00615030|102126775|FG004|NOT COMPLETED|Period III||0||
48730355|NCT00615030|102126776|FG005|NOT COMPLETED|Period III||0||
48730356|NCT00615030|102126777|FG006|NOT COMPLETED|Period III||0||
48730357|NCT00615030|102126778|FG007|NOT COMPLETED|Period III||0||
48730358|NCT00615030|102126779|FG008|NOT COMPLETED|Period III||0||
48730359|NCT00615030|102126780|FG009|NOT COMPLETED|Period III||0||
48730360|NCT00615030|102126781|FG010|NOT COMPLETED|Period III||0||
48730361|NCT00615030|102126782|FG011|NOT COMPLETED|Period III||0||
48730362|NCT03043651|102126783|FG000|STARTED|Overall Study||48||
48730363|NCT03043651|102126783|FG000|COMPLETED|Overall Study||0||
48730364|NCT03043651|102126783|FG000|NOT COMPLETED|Overall Study||48||
48730365|NCT02106494|102126784|FG000|STARTED|Overall Study||471||
48730366|NCT02106494|102126785|FG001|STARTED|Overall Study||471||
48313984|NCT01429584|101094218|FG001|COMPLETED|Overall Study||14||
48313985|NCT01429584|101094217|FG000|NOT COMPLETED|Overall Study||1||
48313986|NCT01429584|101094218|FG001|NOT COMPLETED|Overall Study||1||
48313987|NCT03945357|101094219|FG000|STARTED|Overall Study||124||
48313988|NCT03945357|101094220|FG001|STARTED|Overall Study||126||
48313989|NCT03945357|101094219|FG000|COMPLETED|Overall Study||121||
48313990|NCT03945357|101094220|FG001|COMPLETED|Overall Study||120||
48313991|NCT03945357|101094219|FG000|NOT COMPLETED|Overall Study||3||
48313992|NCT03945357|101094220|FG001|NOT COMPLETED|Overall Study||6||
48313993|NCT03281668|101094221|FG000|STARTED|Overall Study||29||
48730367|NCT02106494|102126784|FG000|Safety Population|Overall Study||456||
48730368|NCT02106494|102126785|FG001|Safety Population|Overall Study||459||
48730369|NCT02106494|102126784|FG000|Efficacy Population|Overall Study||450||
48730370|NCT02106494|102126785|FG001|Efficacy Population|Overall Study||452||
48730371|NCT02106494|102126784|FG000|COMPLETED|Overall Study||445||
48730372|NCT02106494|102126785|FG001|COMPLETED|Overall Study||446||
48730373|NCT02106494|102126784|FG000|NOT COMPLETED|Overall Study||26||
48730374|NCT02106494|102126785|FG001|NOT COMPLETED|Overall Study||25||
48730375|NCT03052049|102126786|FG000|STARTED|Overall Study||28||
48730376|NCT03052049|102126786|FG000|COMPLETED|Overall Study||26||
48730377|NCT03052049|102126786|FG000|NOT COMPLETED|Overall Study||2||
48730378|NCT01513122|102126787|FG000|STARTED|Overall Study||102||
48730379|NCT01513122|102126788|FG001|STARTED|Overall Study||108||
48730380|NCT01513122|102126787|FG000|COMPLETED|Overall Study||91||
48730381|NCT01513122|102126788|FG001|COMPLETED|Overall Study||105||
48730382|NCT01513122|102126787|FG000|NOT COMPLETED|Overall Study||11||
48730383|NCT01513122|102126788|FG001|NOT COMPLETED|Overall Study||3||
48730384|NCT00320424|102126789|FG000|STARTED|Overall Study||48||
48730385|NCT00320424|102126789|FG000|COMPLETED|Overall Study||42||
48730386|NCT00320424|102126789|FG000|NOT COMPLETED|Overall Study||6||
48730387|NCT01962870|102126790|FG000|STARTED|Overall Study||13||
48730388|NCT01962870|102126791|FG001|STARTED|Overall Study||17||
48730389|NCT01962870|102126790|FG000|COMPLETED|Overall Study||13||
48730390|NCT01962870|102126791|FG001|COMPLETED|Overall Study||17||
48730391|NCT01962870|102126790|FG000|NOT COMPLETED|Overall Study||0||
48730392|NCT01962870|102126791|FG001|NOT COMPLETED|Overall Study||0||
48730393|NCT01805037|102126792|FG000|STARTED|Induction (4 Weeks)||0||
48730394|NCT01805037|102126793|FG001|STARTED|Induction (4 Weeks)||20||
48730395|NCT01805037|102126792|FG000|Received Dose of Study Drug|Induction (4 Weeks)||0||
48730396|NCT01805037|102126793|FG001|Received Dose of Study Drug|Induction (4 Weeks)||20||
48730397|NCT01805037|102126792|FG000|COMPLETED|Induction (4 Weeks)||0||
48730398|NCT01805037|102126793|FG001|COMPLETED|Induction (4 Weeks)||20||
48730399|NCT01805037|102126792|FG000|NOT COMPLETED|Induction (4 Weeks)||0||
48730400|NCT01805037|102126793|FG001|NOT COMPLETED|Induction (4 Weeks)||0||
48730401|NCT01805037|102126792|FG000|STARTED|Consolidation (Optional, 4 Weeks)||0||
48730402|NCT01805037|102126793|FG001|STARTED|Consolidation (Optional, 4 Weeks)||6||
48730403|NCT01805037|102126792|FG000|Received Dose of Study Drug|Consolidation (Optional, 4 Weeks)||0||
48157896|NCT00736489|100707049|FG001|COMPLETED|Period 4||5||
48730404|NCT01805037|102126793|FG001|Received Dose of Study Drug|Consolidation (Optional, 4 Weeks)||6||
48730405|NCT01805037|102126792|FG000|COMPLETED|Consolidation (Optional, 4 Weeks)||0||
48730406|NCT01805037|102126793|FG001|COMPLETED|Consolidation (Optional, 4 Weeks)||6||
48730407|NCT01805037|102126792|FG000|NOT COMPLETED|Consolidation (Optional, 4 Weeks)||0||
48730408|NCT01805037|102126793|FG001|NOT COMPLETED|Consolidation (Optional, 4 Weeks)||0||
48730409|NCT01805037|102126792|FG000|STARTED|1st Cycle of Maintenance (3 Weeks)||0||
48157897|NCT00736489|100707050|FG002|COMPLETED|Period 4||6||
48157898|NCT00736489|100707051|FG003|COMPLETED|Period 4||7||
48157899|NCT00736489|100707052|FG004|COMPLETED|Period 4||7||
48157900|NCT00736489|100707053|FG005|COMPLETED|Period 4||5||
48157901|NCT00736489|100707048|FG000|NOT COMPLETED|Period 4||0||
48157902|NCT00736489|100707049|FG001|NOT COMPLETED|Period 4||0||
48157903|NCT00736489|100707050|FG002|NOT COMPLETED|Period 4||0||
48157904|NCT00736489|100707051|FG003|NOT COMPLETED|Period 4||0||
48157905|NCT00736489|100707052|FG004|NOT COMPLETED|Period 4||0||
48157906|NCT00736489|100707053|FG005|NOT COMPLETED|Period 4||0||
48157907|NCT00736489|100707048|FG000|STARTED|Period 5||5||
48157908|NCT00736489|100707049|FG001|STARTED|Period 5||5||
48157909|NCT00736489|100707050|FG002|STARTED|Period 5||6||
48730410|NCT01805037|102126793|FG001|STARTED|1st Cycle of Maintenance (3 Weeks)||20||
48730411|NCT01805037|102126792|FG000|Received Dose of Study Drug|1st Cycle of Maintenance (3 Weeks)||0||
48730412|NCT01805037|102126793|FG001|Received Dose of Study Drug|1st Cycle of Maintenance (3 Weeks)||14||
48730413|NCT01805037|102126792|FG000|COMPLETED|1st Cycle of Maintenance (3 Weeks)||0||
48730414|NCT01805037|102126793|FG001|COMPLETED|1st Cycle of Maintenance (3 Weeks)||14||
48730415|NCT01805037|102126792|FG000|NOT COMPLETED|1st Cycle of Maintenance (3 Weeks)||0||
48730416|NCT01805037|102126793|FG001|NOT COMPLETED|1st Cycle of Maintenance (3 Weeks)||6||
48157910|NCT00736489|100707051|FG003|STARTED|Period 5||7||
48157911|NCT00736489|100707052|FG004|STARTED|Period 5||7||
48157912|NCT00736489|100707053|FG005|STARTED|Period 5||5||
48157913|NCT00736489|100707048|FG000|COMPLETED|Period 5||5||
48157914|NCT00736489|100707049|FG001|COMPLETED|Period 5||5||
48157915|NCT00736489|100707050|FG002|COMPLETED|Period 5||6||
48730417|NCT01805037|102126792|FG000|STARTED|2nd Cycle of Maintenance and Beyond||0||
48730418|NCT01805037|102126793|FG001|STARTED|2nd Cycle of Maintenance and Beyond||14||
48730419|NCT01805037|102126792|FG000|Received Dose of Study Drug|2nd Cycle of Maintenance and Beyond||0||
48730420|NCT01805037|102126793|FG001|Received Dose of Study Drug|2nd Cycle of Maintenance and Beyond||14||
48767613|NCT00914316|102222777|FG001|NOT COMPLETED|Phase 2||0||
48157916|NCT00736489|100707051|FG003|COMPLETED|Period 5||7||
48157917|NCT00736489|100707052|FG004|COMPLETED|Period 5||7||
48157918|NCT00736489|100707053|FG005|COMPLETED|Period 5||5||
48157919|NCT00736489|100707048|FG000|NOT COMPLETED|Period 5||0||
48157920|NCT00736489|100707049|FG001|NOT COMPLETED|Period 5||0||
48730421|NCT01805037|102126792|FG000|COMPLETED|2nd Cycle of Maintenance and Beyond||0|Completion = up to 1 year of maint. treatment from time of induction (1 maint. cycle = 3 weeks).|
48730422|NCT01805037|102126793|FG001|COMPLETED|2nd Cycle of Maintenance and Beyond||2|Completion = up to 1 year of maint. treatment from time of induction (1 maint. cycle = 3 weeks).|
48730423|NCT01805037|102126792|FG000|NOT COMPLETED|2nd Cycle of Maintenance and Beyond||0||
48730424|NCT01805037|102126793|FG001|NOT COMPLETED|2nd Cycle of Maintenance and Beyond||12||
48730425|NCT01805037|102126792|FG000|STARTED|Follow Up (up to 3 Years)||0||
48157921|NCT00736489|100707050|FG002|NOT COMPLETED|Period 5||0||
48157922|NCT00736489|100707051|FG003|NOT COMPLETED|Period 5||0||
48157923|NCT00736489|100707052|FG004|NOT COMPLETED|Period 5||0||
48157924|NCT00736489|100707053|FG005|NOT COMPLETED|Period 5||0||
48157925|NCT00736489|100707048|FG000|STARTED|Period 6||5||
48157926|NCT00736489|100707049|FG001|STARTED|Period 6||5||
48157927|NCT00736489|100707050|FG002|STARTED|Period 6||6||
48157928|NCT00736489|100707051|FG003|STARTED|Period 6||7||
48157929|NCT00736489|100707052|FG004|STARTED|Period 6||7||
48157930|NCT00736489|100707053|FG005|STARTED|Period 6||5||
48157931|NCT00736489|100707048|FG000|COMPLETED|Period 6||5||
48313994|NCT03281668|101094221|FG000|COMPLETED|Overall Study||21||
48313995|NCT03281668|101094221|FG000|NOT COMPLETED|Overall Study||8||
48313996|NCT01274715|101094222|FG000|STARTED|Overall Study||12||
48313997|NCT01274715|101094222|FG000|Screened Out at Baseline|Overall Study||3||
48313998|NCT01274715|101094222|FG000|COMPLETED|Overall Study||8||
48313999|NCT01274715|101094222|FG000|NOT COMPLETED|Overall Study||4||
48314000|NCT03782402|101094223|FG000|STARTED|Overall Study||6||
48314001|NCT03782402|101094224|FG001|STARTED|Overall Study||6||
48314002|NCT03782402|101094223|FG000|COMPLETED|Overall Study||6||
48314003|NCT03782402|101094224|FG001|COMPLETED|Overall Study||6||
48314004|NCT03782402|101094223|FG000|NOT COMPLETED|Overall Study||0||
48314005|NCT03782402|101094224|FG001|NOT COMPLETED|Overall Study||0||
48314006|NCT00113074|101094225|FG000|STARTED|Overall Study||49||
48314007|NCT00113074|101094226|FG001|STARTED|Overall Study||43||
48314008|NCT00113074|101094227|FG002|STARTED|Overall Study||47||
48314009|NCT00113074|101094225|FG000|COMPLETED|Overall Study||39||
48314010|NCT00113074|101094226|FG001|COMPLETED|Overall Study||33||
48314011|NCT00113074|101094227|FG002|COMPLETED|Overall Study||33||
48314012|NCT00113074|101094225|FG000|NOT COMPLETED|Overall Study||10||
48314013|NCT00113074|101094226|FG001|NOT COMPLETED|Overall Study||10||
48730426|NCT01805037|102126793|FG001|STARTED|Follow Up (up to 3 Years)||20||
48730427|NCT01805037|102126792|FG000|COMPLETED|Follow Up (up to 3 Years)||0||
48157932|NCT00736489|100707049|FG001|COMPLETED|Period 6||5||
48157933|NCT00736489|100707050|FG002|COMPLETED|Period 6||6||
48314014|NCT00113074|101094227|FG002|NOT COMPLETED|Overall Study||14||
48314015|NCT00262522|101094228|FG000|STARTED|Study Start Through 8 Weeks||167||
48314016|NCT00262522|101094229|FG001|STARTED|Study Start Through 8 Weeks||166||
48314017|NCT00262522|101094230|FG002|STARTED|Study Start Through 8 Weeks||166||
48314018|NCT00262522|101094231|FG003|STARTED|Study Start Through 8 Weeks||165||
48314019|NCT00262522|101094228|FG000|COMPLETED|Study Start Through 8 Weeks||163||
48314020|NCT00262522|101094229|FG001|COMPLETED|Study Start Through 8 Weeks||161||
48314021|NCT00262522|101094230|FG002|COMPLETED|Study Start Through 8 Weeks||155||
48314022|NCT00262522|101094231|FG003|COMPLETED|Study Start Through 8 Weeks||160||
48314023|NCT00262522|101094228|FG000|NOT COMPLETED|Study Start Through 8 Weeks||4||
48314024|NCT00262522|101094229|FG001|NOT COMPLETED|Study Start Through 8 Weeks||5||
48314025|NCT00262522|101094230|FG002|NOT COMPLETED|Study Start Through 8 Weeks||11||
48314026|NCT00262522|101094231|FG003|NOT COMPLETED|Study Start Through 8 Weeks||5||
48314027|NCT00262522|101094228|FG000|STARTED|Study Start Through 48 Weeks||333||
48406896|NCT03424044|101328487|FG003|NOT COMPLETED|Third Rest Period (7-45 Days)||0||
48730428|NCT01805037|102126793|FG001|COMPLETED|Follow Up (up to 3 Years)||14||
48157934|NCT00736489|100707051|FG003|COMPLETED|Period 6||7||
48157935|NCT00736489|100707052|FG004|COMPLETED|Period 6||7||
48157936|NCT00736489|100707053|FG005|COMPLETED|Period 6||5||
48157937|NCT00736489|100707048|FG000|NOT COMPLETED|Period 6||0||
48157938|NCT00736489|100707049|FG001|NOT COMPLETED|Period 6||0||
48157939|NCT00736489|100707050|FG002|NOT COMPLETED|Period 6||0||
48157940|NCT00736489|100707051|FG003|NOT COMPLETED|Period 6||0||
48157941|NCT00736489|100707052|FG004|NOT COMPLETED|Period 6||0||
48157942|NCT00736489|100707053|FG005|NOT COMPLETED|Period 6||0||
48157943|NCT02487498|100710937|FG000|STARTED|Period: Period 1||178||
48157944|NCT02487498|100710938|FG001|STARTED|Period: Period 1||177||
48157945|NCT02487498|100710937|FG000|COMPLETED|Period: Period 1||172||
48157946|NCT02487498|100710938|FG001|COMPLETED|Period: Period 1||166||
48157947|NCT02487498|100710937|FG000|NOT COMPLETED|Period: Period 1||6||
48157948|NCT02487498|100710938|FG001|NOT COMPLETED|Period: Period 1||11||
48157949|NCT02487498|100710937|FG000|STARTED|Period: Washout||172||
48157950|NCT02487498|100710938|FG001|STARTED|Period: Washout||166||
48157951|NCT02487498|100710937|FG000|COMPLETED|Period: Washout||170||
48157952|NCT02487498|100710938|FG001|COMPLETED|Period: Washout||159||
48157953|NCT02487498|100710937|FG000|NOT COMPLETED|Period: Washout||2||
48157954|NCT02487498|100710938|FG001|NOT COMPLETED|Period: Washout||7||
48157955|NCT02487498|100710937|FG000|STARTED|Period: Period 2||170||
48157956|NCT02487498|100710938|FG001|STARTED|Period: Period 2||159||
48157957|NCT02487498|100710937|FG000|COMPLETED|Period: Period 2||164||
48157958|NCT02487498|100710938|FG001|COMPLETED|Period: Period 2||154||
48157959|NCT02487498|100710937|FG000|NOT COMPLETED|Period: Period 2||6||
48157960|NCT02487498|100710938|FG001|NOT COMPLETED|Period: Period 2||5||
48157961|NCT01493687|100710939|FG000|STARTED|Part A Vehicle Control (12 Weeks)||451||
48157962|NCT01493687|100710940|FG001|STARTED|Part A Vehicle Control (12 Weeks)||232||
48157963|NCT01493687|100710939|FG000|COMPLETED|Part A Vehicle Control (12 Weeks)||414||
48157964|NCT01493687|100710940|FG001|COMPLETED|Part A Vehicle Control (12 Weeks)||210||
48157965|NCT01493687|100710939|FG000|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||37||
48157966|NCT01493687|100710940|FG001|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||22||
48157967|NCT01493687|100710939|FG000|STARTED|Part B Long Term Active Control 40 Weeks||412||
48157968|NCT01493687|100710940|FG001|STARTED|Part B Long Term Active Control 40 Weeks||210||
48157969|NCT01493687|100710939|FG000|COMPLETED|Part B Long Term Active Control 40 Weeks||351||
48157970|NCT01493687|100710940|FG001|COMPLETED|Part B Long Term Active Control 40 Weeks||175||
48157971|NCT01493687|100710939|FG000|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||61||
48157972|NCT01493687|100710940|FG001|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||35||
48157973|NCT01493687|100710939|FG000|STARTED|Part C Safety Follow up (4 Weeks)||350||
48157974|NCT01493687|100710940|FG001|STARTED|Part C Safety Follow up (4 Weeks)||175||
48157975|NCT01493687|100710939|FG000|COMPLETED|Part C Safety Follow up (4 Weeks)||350||
48157976|NCT01493687|100710940|FG001|COMPLETED|Part C Safety Follow up (4 Weeks)||174||
48157977|NCT01493687|100710939|FG000|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0||
48157978|NCT01493687|100710940|FG001|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||1||
48157979|NCT01059643|100710941|FG000|STARTED|Overall Study||103||
48157980|NCT01059643|100710941|FG000|Received at Least 1 Dose of Study Drug|Overall Study||103||
48730429|NCT01805037|102126792|FG000|NOT COMPLETED|Follow Up (up to 3 Years)||0||
48730430|NCT01805037|102126793|FG001|NOT COMPLETED|Follow Up (up to 3 Years)||6||
48730431|NCT00999518|102126794|FG000|STARTED|Overall Study||43||
48730432|NCT00999518|102126795|FG001|STARTED|Overall Study||42||
48730433|NCT00999518|102126796|FG002|STARTED|Overall Study||39||
48730434|NCT00999518|102126797|FG003|STARTED|Overall Study||40||
48730435|NCT00999518|102126798|FG004|STARTED|Overall Study||41||
48730436|NCT00999518|102126794|FG000|Treated|Overall Study||42||
48730437|NCT00999518|102126795|FG001|Treated|Overall Study||41||
48730438|NCT00999518|102126796|FG002|Treated|Overall Study||37||
48730439|NCT00999518|102126797|FG003|Treated|Overall Study||40||
48157981|NCT01059643|100710941|FG000|COMPLETED|Overall Study||97||
48157982|NCT01059643|100710941|FG000|NOT COMPLETED|Overall Study||6||
48157983|NCT04452292|100710942|FG000|STARTED|Overall Study||2||
48157984|NCT04452292|100710943|FG001|STARTED|Overall Study||0||
48157985|NCT04452292|100710942|FG000|COMPLETED|Overall Study||2||
48157986|NCT04452292|100710943|FG001|COMPLETED|Overall Study||0||
48157987|NCT04452292|100710942|FG000|NOT COMPLETED|Overall Study||0||
48157988|NCT04452292|100710943|FG001|NOT COMPLETED|Overall Study||0||
48157989|NCT03532308|100710944|FG000|STARTED|Overall Study||10||
48157990|NCT03532308|100710945|FG001|STARTED|Overall Study||9||
48157991|NCT03532308|100710944|FG000|Completed Assessments|Overall Study||9||
48157992|NCT03532308|100710945|FG001|Completed Assessments|Overall Study||7||
48157993|NCT03532308|100710944|FG000|COMPLETED|Overall Study||10||
48157994|NCT03532308|100710945|FG001|COMPLETED|Overall Study||8||
48157995|NCT03532308|100710944|FG000|NOT COMPLETED|Overall Study||0||
48730440|NCT00999518|102126798|FG004|Treated|Overall Study||40||
48730441|NCT00999518|102126794|FG000|COMPLETED|Overall Study||19||
48314028|NCT00262522|101094229|FG001|STARTED|Study Start Through 48 Weeks||0||
48314029|NCT00262522|101094230|FG002|STARTED|Study Start Through 48 Weeks||331||
48314030|NCT00262522|101094231|FG003|STARTED|Study Start Through 48 Weeks||0||
48314031|NCT00262522|101094228|FG000|COMPLETED|Study Start Through 48 Weeks||284||
48314032|NCT00262522|101094229|FG001|COMPLETED|Study Start Through 48 Weeks||0||
48314033|NCT00262522|101094230|FG002|COMPLETED|Study Start Through 48 Weeks||276||
48730442|NCT00999518|102126795|FG001|COMPLETED|Overall Study||17||
48730443|NCT00999518|102126796|FG002|COMPLETED|Overall Study||17||
48730444|NCT00999518|102126797|FG003|COMPLETED|Overall Study||18||
48730445|NCT00999518|102126798|FG004|COMPLETED|Overall Study||17||
48730446|NCT00999518|102126794|FG000|NOT COMPLETED|Overall Study||24||
48314034|NCT00262522|101094231|FG003|COMPLETED|Study Start Through 48 Weeks||0||
48314035|NCT00262522|101094228|FG000|NOT COMPLETED|Study Start Through 48 Weeks||49||
48314036|NCT00262522|101094229|FG001|NOT COMPLETED|Study Start Through 48 Weeks||0||
48314037|NCT00262522|101094230|FG002|NOT COMPLETED|Study Start Through 48 Weeks||55||
48314038|NCT00262522|101094231|FG003|NOT COMPLETED|Study Start Through 48 Weeks||0||
48314039|NCT00262522|101094228|FG000|STARTED|Study Start Through 96 Weeks||333||
48314040|NCT00262522|101094229|FG001|STARTED|Study Start Through 96 Weeks||0||
48314041|NCT00262522|101094230|FG002|STARTED|Study Start Through 96 Weeks||331||
48314042|NCT00262522|101094231|FG003|STARTED|Study Start Through 96 Weeks||0||
48314043|NCT00262522|101094228|FG000|COMPLETED|Study Start Through 96 Weeks||256||
48730447|NCT00999518|102126795|FG001|NOT COMPLETED|Overall Study||25||
48730448|NCT00999518|102126796|FG002|NOT COMPLETED|Overall Study||22||
48730449|NCT00999518|102126797|FG003|NOT COMPLETED|Overall Study||22||
48730450|NCT00999518|102126798|FG004|NOT COMPLETED|Overall Study||24||
48730451|NCT03771274|102126799|FG000|STARTED|Overall Study||39||
48730452|NCT03771274|102126799|FG000|COMPLETED|Overall Study||39||
48730453|NCT03771274|102126799|FG000|NOT COMPLETED|Overall Study||0||
48730454|NCT02283788|102126800|FG000|STARTED|Overall Study||17||
48730455|NCT02283788|102126801|FG001|STARTED|Overall Study||17||
48730456|NCT02283788|102126802|FG002|STARTED|Overall Study||17||
48730457|NCT02283788|102126803|FG003|STARTED|Overall Study||16||
48730458|NCT02283788|102126800|FG000|COMPLETED|Overall Study||16||
48730459|NCT02283788|102126801|FG001|COMPLETED|Overall Study||13||
48730460|NCT02283788|102126802|FG002|COMPLETED|Overall Study||12||
48730461|NCT02283788|102126803|FG003|COMPLETED|Overall Study||14||
48730462|NCT02283788|102126800|FG000|NOT COMPLETED|Overall Study||1||
48730463|NCT02283788|102126801|FG001|NOT COMPLETED|Overall Study||4||
48730464|NCT02283788|102126802|FG002|NOT COMPLETED|Overall Study||5||
48730465|NCT02283788|102126803|FG003|NOT COMPLETED|Overall Study||2||
48730466|NCT00924443|102126804|FG000|STARTED|Overall Study||69||
48730467|NCT00924443|102126804|FG000|Full Analysis Set (Received Study Drug)|Overall Study||66||
48730468|NCT00924443|102126804|FG000|COMPLETED|Overall Study||66||
48730469|NCT00924443|102126804|FG000|NOT COMPLETED|Overall Study||3||
48730470|NCT02690649|102126805|FG000|STARTED|Overall Study||80||
48730471|NCT02690649|102126806|FG001|STARTED|Overall Study||80||
48730472|NCT02690649|102126805|FG000|COMPLETED|Overall Study||79||
48730473|NCT02690649|102126806|FG001|COMPLETED|Overall Study||76||
48730474|NCT02690649|102126805|FG000|NOT COMPLETED|Overall Study||1||
48730475|NCT02690649|102126806|FG001|NOT COMPLETED|Overall Study||4||
48730476|NCT04856904|102126807|FG000|STARTED|Overall Study||121||121
48730477|NCT04856904|102126808|FG001|STARTED|Overall Study||121||121
48730478|NCT04856904|102126807|FG000|COMPLETED|Overall Study||99||99
48730479|NCT04856904|102126808|FG001|COMPLETED|Overall Study||99||99
48730480|NCT04856904|102126807|FG000|NOT COMPLETED|Overall Study||22||22
48730481|NCT04856904|102126808|FG001|NOT COMPLETED|Overall Study||22||22
48730482|NCT02409719|102126809|FG000|STARTED|Overall Study||31|Each milestone corresponds to the time of evaluation.|
48730483|NCT02409719|102126810|FG001|STARTED|Overall Study||45|Each milestone corresponds to the time of evaluation.|
48730484|NCT02409719|102126809|FG000|2 Weeks|Overall Study||28||
48730485|NCT02409719|102126810|FG001|2 Weeks|Overall Study||42||
48730486|NCT02409719|102126809|FG000|4 Weeks|Overall Study||28||
48730487|NCT02409719|102126810|FG001|4 Weeks|Overall Study||42||
48730488|NCT02409719|102126809|FG000|6 Weeks|Overall Study||28||
48730489|NCT02409719|102126810|FG001|6 Weeks|Overall Study||42||
48730490|NCT02409719|102126809|FG000|3 Months|Overall Study||28||
48730491|NCT02409719|102126810|FG001|3 Months|Overall Study||42||
48730492|NCT02409719|102126809|FG000|6 Months|Overall Study||28||
48730493|NCT02409719|102126810|FG001|6 Months|Overall Study||42||
48730494|NCT02409719|102126809|FG000|12 Months|Overall Study||28||
48730495|NCT02409719|102126810|FG001|12 Months|Overall Study||42||
48730496|NCT02409719|102126809|FG000|COMPLETED|Overall Study||28||
48730497|NCT02409719|102126810|FG001|COMPLETED|Overall Study||42||
48730498|NCT02409719|102126809|FG000|NOT COMPLETED|Overall Study||3||
48730499|NCT02409719|102126810|FG001|NOT COMPLETED|Overall Study||3||
48730500|NCT01417455|102126811|FG000|STARTED|Overall Study||16||
48730501|NCT01417455|102126812|FG001|STARTED|Overall Study||16||
48730502|NCT01417455|102126813|FG002|STARTED|Overall Study||17||
48730503|NCT01417455|102126814|FG003|STARTED|Overall Study||17||
48730504|NCT01417455|102126815|FG004|STARTED|Overall Study||30||
48730505|NCT01417455|102126816|FG005|STARTED|Overall Study||13||
48730506|NCT01417455|102126817|FG006|STARTED|Overall Study||13||
48314044|NCT00262522|101094229|FG001|COMPLETED|Study Start Through 96 Weeks||0||
48730507|NCT01417455|102126818|FG007|STARTED|Overall Study||25||
48730508|NCT01417455|102126811|FG000|COMPLETED|Overall Study||16||
48730509|NCT01417455|102126812|FG001|COMPLETED|Overall Study||16||
48730510|NCT01417455|102126813|FG002|COMPLETED|Overall Study||17||
48730511|NCT01417455|102126814|FG003|COMPLETED|Overall Study||17||
48730512|NCT01417455|102126815|FG004|COMPLETED|Overall Study||30||
48730513|NCT01417455|102126816|FG005|COMPLETED|Overall Study||13||
48730514|NCT01417455|102126817|FG006|COMPLETED|Overall Study||13||
48730515|NCT01417455|102126818|FG007|COMPLETED|Overall Study||25||
48730516|NCT01417455|102126811|FG000|NOT COMPLETED|Overall Study||0||
48730517|NCT01417455|102126812|FG001|NOT COMPLETED|Overall Study||0||
48730518|NCT01417455|102126813|FG002|NOT COMPLETED|Overall Study||0||
48730519|NCT01417455|102126814|FG003|NOT COMPLETED|Overall Study||0||
48730520|NCT01417455|102126815|FG004|NOT COMPLETED|Overall Study||0||
48730521|NCT01417455|102126816|FG005|NOT COMPLETED|Overall Study||0||
48730522|NCT01417455|102126817|FG006|NOT COMPLETED|Overall Study||0||
48730523|NCT01417455|102126818|FG007|NOT COMPLETED|Overall Study||0||
48730524|NCT00966550|102126819|FG000|STARTED|Overall Study||13||
48730525|NCT00966550|102126820|FG001|STARTED|Overall Study||12||
48730526|NCT00966550|102126819|FG000|COMPLETED|Overall Study||13||
48730527|NCT00966550|102126820|FG001|COMPLETED|Overall Study||12||
48730528|NCT00966550|102126819|FG000|NOT COMPLETED|Overall Study||0||
48730529|NCT00966550|102126820|FG001|NOT COMPLETED|Overall Study||0||
48730530|NCT03068767|102126821|FG000|STARTED|Overall Study||75||
48730531|NCT03068767|102126822|FG001|STARTED|Overall Study||74||
48730532|NCT03068767|102126821|FG000|COMPLETED|Overall Study||65||
48730533|NCT03068767|102126822|FG001|COMPLETED|Overall Study||71||
48730534|NCT03068767|102126821|FG000|NOT COMPLETED|Overall Study||10||
48730535|NCT03068767|102126822|FG001|NOT COMPLETED|Overall Study||3||
48730536|NCT01630889|102126823|FG000|STARTED|Overall Study||15||
48730537|NCT01630889|102126823|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15||
48730538|NCT01630889|102126823|FG000|COMPLETED|Overall Study||5||
48730539|NCT01630889|102126823|FG000|NOT COMPLETED|Overall Study||10||
48730540|NCT01054625|102126824|FG000|STARTED|Overall Study||8||
48730541|NCT01054625|102126825|FG001|STARTED|Overall Study||12||
48730542|NCT01054625|102126826|FG002|STARTED|Overall Study||10||
48730543|NCT01054625|102126824|FG000|COMPLETED|Overall Study||6||
48730544|NCT01054625|102126825|FG001|COMPLETED|Overall Study||9||
48730545|NCT01054625|102126826|FG002|COMPLETED|Overall Study||9||
48730546|NCT01054625|102126824|FG000|NOT COMPLETED|Overall Study||2||
48730547|NCT01054625|102126825|FG001|NOT COMPLETED|Overall Study||3||
48730548|NCT01054625|102126826|FG002|NOT COMPLETED|Overall Study||1||
48730549|NCT00692419|102126827|FG000|STARTED|Overall Study||100||
48730550|NCT00692419|102126828|FG001|STARTED|Overall Study||120||
48730551|NCT00692419|102126827|FG000|COMPLETED|Overall Study||84||
48730552|NCT00692419|102126828|FG001|COMPLETED|Overall Study||102||
48730553|NCT00692419|102126827|FG000|NOT COMPLETED|Overall Study||16||
48730554|NCT00692419|102126828|FG001|NOT COMPLETED|Overall Study||18||
48730555|NCT02673684|102126829|FG000|STARTED|Overall Study||9||
48730556|NCT02673684|102126830|FG001|STARTED|Overall Study||8||
48730557|NCT02673684|102126829|FG000|COMPLETED|Overall Study||0||
48730558|NCT02673684|102126830|FG001|COMPLETED|Overall Study||0||
48730559|NCT02673684|102126829|FG000|NOT COMPLETED|Overall Study||9||
48730560|NCT02673684|102126830|FG001|NOT COMPLETED|Overall Study||8||
48730561|NCT03997825|102126831|FG000|STARTED|Overall Study||117||
48730562|NCT03997825|102126831|FG000|COMPLETED|Overall Study||100||
48730563|NCT03997825|102126831|FG000|NOT COMPLETED|Overall Study||17||
48730564|NCT00773773|102126832|FG000|STARTED|Overall Study||58||
48730565|NCT00773773|102126832|FG000|COMPLETED|Overall Study||58||
48730566|NCT00773773|102126832|FG000|NOT COMPLETED|Overall Study||0||
48730567|NCT01078844|102126833|FG000|STARTED|Overall Study||4||
48730568|NCT01078844|102126833|FG000|COMPLETED|Overall Study||0||
48730569|NCT01078844|102126833|FG000|NOT COMPLETED|Overall Study||4||
48730570|NCT01340573|102126834|FG000|STARTED|Overall Study||3||
48730571|NCT01340573|102126834|FG000|COMPLETED|Overall Study||0||
48730572|NCT01340573|102126834|FG000|NOT COMPLETED|Overall Study||3||
48730573|NCT05532891|102126835|FG000|STARTED|Overall Study||8615||
48730574|NCT05532891|102126836|FG001|STARTED|Overall Study||2930||
48730575|NCT05532891|102126835|FG000|COMPLETED|Overall Study||8615||
48730576|NCT05532891|102126836|FG001|COMPLETED|Overall Study||2930||
48730577|NCT05532891|102126835|FG000|NOT COMPLETED|Overall Study||0||
48730578|NCT05532891|102126836|FG001|NOT COMPLETED|Overall Study||0||
48730579|NCT04003987|102126837|FG000|STARTED|Overall Study||39||
48730580|NCT04003987|102126838|FG001|STARTED|Overall Study||39||
48730581|NCT04003987|102126837|FG000|COMPLETED|Overall Study||39||
48730582|NCT04003987|102126838|FG001|COMPLETED|Overall Study||39||
48730583|NCT04003987|102126837|FG000|NOT COMPLETED|Overall Study||0||
48730584|NCT04003987|102126838|FG001|NOT COMPLETED|Overall Study||0||
48730585|NCT00662545|102126839|FG000|STARTED|Overall Study||5||
48730586|NCT00662545|102126840|FG001|STARTED|Overall Study||5||
48730587|NCT00662545|102126839|FG000|COMPLETED|Overall Study||5||
48730588|NCT00662545|102126840|FG001|COMPLETED|Overall Study||5||
48730589|NCT00662545|102126839|FG000|NOT COMPLETED|Overall Study||0||
48730590|NCT00662545|102126840|FG001|NOT COMPLETED|Overall Study||0||
48730591|NCT04583956|102126841|FG000|STARTED|Overall Study||104||
48157996|NCT03532308|100710945|FG001|NOT COMPLETED|Overall Study||1||
48157997|NCT02395133|100710946|FG000|STARTED|Overall Study||83|Full Analysis Set (FAS) included all randomized participants|
48314045|NCT00262522|101094230|FG002|COMPLETED|Study Start Through 96 Weeks||254||
48314046|NCT00262522|101094231|FG003|COMPLETED|Study Start Through 96 Weeks||0||
48314047|NCT00262522|101094228|FG000|NOT COMPLETED|Study Start Through 96 Weeks||77||
48314048|NCT00262522|101094229|FG001|NOT COMPLETED|Study Start Through 96 Weeks||0||
48314049|NCT00262522|101094230|FG002|NOT COMPLETED|Study Start Through 96 Weeks||77||
48314050|NCT00262522|101094231|FG003|NOT COMPLETED|Study Start Through 96 Weeks||0||
48730592|NCT04583956|102126842|FG001|STARTED|Overall Study||110||
48730593|NCT04583956|102126841|FG000|Included in Modified Intention-to-treat (mITT) Population|Overall Study||100||
48730594|NCT04583956|102126842|FG001|Included in Modified Intention-to-treat (mITT) Population|Overall Study||107||
48730595|NCT04583956|102126841|FG000|COMPLETED|Overall Study||83||
48730596|NCT04583956|102126842|FG001|COMPLETED|Overall Study||85||
48730597|NCT04583956|102126841|FG000|NOT COMPLETED|Overall Study||21||
48730598|NCT04583956|102126842|FG001|NOT COMPLETED|Overall Study||25||
48730599|NCT01025830|102126843|FG000|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8||
48730600|NCT01025830|102126844|FG001|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12||
48730601|NCT01025830|102126843|FG000|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8||
48730602|NCT01025830|102126844|FG001|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12||
48730603|NCT01025830|102126843|FG000|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0||
48730604|NCT01025830|102126844|FG001|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0||
48730605|NCT01025830|102126843|FG000|STARTED|Washout Period of 30 Days||8||
48730606|NCT01025830|102126844|FG001|STARTED|Washout Period of 30 Days||12||
48730607|NCT01025830|102126843|FG000|COMPLETED|Washout Period of 30 Days||8||
48730608|NCT01025830|102126844|FG001|COMPLETED|Washout Period of 30 Days||12||
48730609|NCT01025830|102126843|FG000|NOT COMPLETED|Washout Period of 30 Days||0||
48730610|NCT01025830|102126844|FG001|NOT COMPLETED|Washout Period of 30 Days||0||
48730611|NCT01025830|102126843|FG000|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8||
48730612|NCT01025830|102126844|FG001|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12||
48730613|NCT01025830|102126843|FG000|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8||
48730614|NCT01025830|102126844|FG001|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12||
48730615|NCT01025830|102126843|FG000|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0||
48730616|NCT01025830|102126844|FG001|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0||
48730617|NCT02828020|102126845|FG000|STARTED|Treatment Period||559||
48730618|NCT02828020|102126846|FG001|STARTED|Treatment Period||556||
48730619|NCT02828020|102126847|FG002|STARTED|Treatment Period||557||
48730620|NCT02828020|102126845|FG000|Safety Population: Received Study Drug|Treatment Period||485||
48730621|NCT02828020|102126846|FG001|Safety Population: Received Study Drug|Treatment Period||466||
48730622|NCT02828020|102126847|FG002|Safety Population: Received Study Drug|Treatment Period||485||
48730623|NCT02828020|102126845|FG000|COMPLETED|Treatment Period||479||
48730624|NCT02828020|102126846|FG001|COMPLETED|Treatment Period||457||
48730625|NCT02828020|102126847|FG002|COMPLETED|Treatment Period||479||
48730626|NCT02828020|102126845|FG000|NOT COMPLETED|Treatment Period||80||
48730627|NCT02828020|102126846|FG001|NOT COMPLETED|Treatment Period||99||
48730628|NCT02828020|102126847|FG002|NOT COMPLETED|Treatment Period||78||
48730629|NCT02828020|102126845|FG000|STARTED|Safety Follow-up Period||480||
48730630|NCT02828020|102126846|FG001|STARTED|Safety Follow-up Period||458||
48730631|NCT02828020|102126847|FG002|STARTED|Safety Follow-up Period||480||
48730632|NCT02828020|102126845|FG000|COMPLETED|Safety Follow-up Period||460||
48730633|NCT02828020|102126846|FG001|COMPLETED|Safety Follow-up Period||440||
48730634|NCT02828020|102126847|FG002|COMPLETED|Safety Follow-up Period||461||
48730635|NCT02828020|102126845|FG000|NOT COMPLETED|Safety Follow-up Period||20||
48730636|NCT02828020|102126846|FG001|NOT COMPLETED|Safety Follow-up Period||18||
48730637|NCT02828020|102126847|FG002|NOT COMPLETED|Safety Follow-up Period||19||
48730638|NCT01511081|102126848|FG000|STARTED|Overall Study||8||
48730639|NCT01511081|102126849|FG001|STARTED|Overall Study||9||
48730640|NCT01511081|102126848|FG000|COMPLETED|Overall Study||8||
48730641|NCT01511081|102126849|FG001|COMPLETED|Overall Study||9||
48730642|NCT01511081|102126848|FG000|NOT COMPLETED|Overall Study||0||
48314051|NCT02687542|101094232|FG000|STARTED|Overall Study||23||
48314052|NCT02687542|101094233|FG001|STARTED|Overall Study||13||
48730643|NCT01511081|102126849|FG001|NOT COMPLETED|Overall Study||0||
48730644|NCT03659136|102126850|FG000|STARTED|Overall Study||52|Randomised|
48730645|NCT03659136|102126851|FG001|STARTED|Overall Study||51|Randomised|
48730646|NCT03659136|102126850|FG000|Treated|Overall Study||50||
48730647|NCT03659136|102126851|FG001|Treated|Overall Study||51||
48767614|NCT00914316|102222778|FG002|NOT COMPLETED|Phase 2||1||
48767615|NCT00914316|102222779|FG003|NOT COMPLETED|Phase 2||0||
48767616|NCT03678493|102222780|FG000|STARTED|Overall Study||18||
48767617|NCT03678493|102222781|FG001|STARTED|Overall Study||8||
48767618|NCT03678493|102222782|FG002|STARTED|Overall Study||49||
48767619|NCT03678493|102222783|FG003|STARTED|Overall Study||25||
48767620|NCT03678493|102222780|FG000|COMPLETED|Overall Study||18||
48314053|NCT02687542|101094234|FG002|STARTED|Overall Study||15||
48767621|NCT03678493|102222781|FG001|COMPLETED|Overall Study||8||
48767622|NCT03678493|102222782|FG002|COMPLETED|Overall Study||49||
48730648|NCT03659136|102126850|FG000|On-treatment at Cut-off Date for Primary Analysis|Overall Study||9||
48730649|NCT03659136|102126851|FG001|On-treatment at Cut-off Date for Primary Analysis|Overall Study||12||
48157998|NCT02395133|100710947|FG001|STARTED|Overall Study||84|Full Analysis Set (FAS) included all randomized participants|
48157999|NCT02395133|100710948|FG002|STARTED|Overall Study||86|Full Analysis Set (FAS) included all randomized participants|
48730650|NCT03659136|102126850|FG000|COMPLETED|Overall Study||0|Completed = Number of participants on treatment at the final analysis cut-off date|
48730651|NCT03659136|102126851|FG001|COMPLETED|Overall Study||0|Completed = Number of participants on treatment at the final analysis cut-off date|
48730652|NCT03659136|102126850|FG000|NOT COMPLETED|Overall Study||52||
48158000|NCT02395133|100710949|FG003|STARTED|Overall Study||169|Full Analysis Set (FAS) included all randomized participants|
48158001|NCT02395133|100710946|FG000|COMPLETED|Overall Study||69||
48158002|NCT02395133|100710947|FG001|COMPLETED|Overall Study||75||
48158003|NCT02395133|100710948|FG002|COMPLETED|Overall Study||76||
48730653|NCT03659136|102126851|FG001|NOT COMPLETED|Overall Study||51||
48730654|NCT01278797|102126852|FG000|STARTED|Period 1||14||
48730655|NCT01278797|102126853|FG001|STARTED|Period 1||14||
48314054|NCT02687542|101094235|FG003|STARTED|Overall Study||13||
48314055|NCT02687542|101094236|FG004|STARTED|Overall Study||44||
48314056|NCT02687542|101094232|FG000|COMPLETED|Overall Study||15||
48314057|NCT02687542|101094233|FG001|COMPLETED|Overall Study||1||
48314058|NCT02687542|101094234|FG002|COMPLETED|Overall Study||1||
48314059|NCT02687542|101094235|FG003|COMPLETED|Overall Study||3||
48730656|NCT01278797|102126852|FG000|COMPLETED|Period 1||13||
48730657|NCT01278797|102126853|FG001|COMPLETED|Period 1||13||
48730658|NCT01278797|102126852|FG000|NOT COMPLETED|Period 1||1||
48730659|NCT01278797|102126853|FG001|NOT COMPLETED|Period 1||1||
48730660|NCT01278797|102126852|FG000|STARTED|Washout Period of 21 Days||13||
48730661|NCT01278797|102126853|FG001|STARTED|Washout Period of 21 Days||13||
48314060|NCT02687542|101094236|FG004|COMPLETED|Overall Study||24||
48314061|NCT02687542|101094232|FG000|NOT COMPLETED|Overall Study||8||
48314062|NCT02687542|101094233|FG001|NOT COMPLETED|Overall Study||12||
48730662|NCT01278797|102126852|FG000|COMPLETED|Washout Period of 21 Days||13||
48730663|NCT01278797|102126853|FG001|COMPLETED|Washout Period of 21 Days||13||
48730664|NCT01278797|102126852|FG000|NOT COMPLETED|Washout Period of 21 Days||0||
48158004|NCT02395133|100710949|FG003|COMPLETED|Overall Study||155||
48158005|NCT02395133|100710946|FG000|NOT COMPLETED|Overall Study||14||
48730665|NCT01278797|102126853|FG001|NOT COMPLETED|Washout Period of 21 Days||0||
48730666|NCT01278797|102126852|FG000|STARTED|Period 2||13||
48730667|NCT01278797|102126853|FG001|STARTED|Period 2||13||
48158006|NCT02395133|100710947|FG001|NOT COMPLETED|Overall Study||9||
48158007|NCT02395133|100710948|FG002|NOT COMPLETED|Overall Study||10||
48730668|NCT01278797|102126852|FG000|COMPLETED|Period 2||13||
48730669|NCT01278797|102126853|FG001|COMPLETED|Period 2||13||
48730670|NCT01278797|102126852|FG000|NOT COMPLETED|Period 2||0||
48730671|NCT01278797|102126853|FG001|NOT COMPLETED|Period 2||0||
48730672|NCT00622388|102126854|FG000|STARTED|Overall Study||81||
48730673|NCT00622388|102126854|FG000|COMPLETED|Overall Study||9||
48730674|NCT00622388|102126854|FG000|NOT COMPLETED|Overall Study||72||
48158008|NCT02395133|100710949|FG003|NOT COMPLETED|Overall Study||14||
48158009|NCT02238925|100710950|FG000|STARTED|Overall Study||26||
48158010|NCT02238925|100710950|FG000|COMPLETED|Overall Study||1||
48158011|NCT02238925|100710950|FG000|NOT COMPLETED|Overall Study||25||
48158012|NCT02296190|100710951|FG000|STARTED|Overall Study||35||
48158013|NCT02296190|100710952|FG001|STARTED|Overall Study||41||
48158014|NCT02296190|100710953|FG002|STARTED|Overall Study||35||
48158015|NCT02296190|100710954|FG003|STARTED|Overall Study||43||
48158016|NCT02296190|100710955|FG004|STARTED|Overall Study||36||
48158017|NCT02296190|100710956|FG005|STARTED|Overall Study||9||
48158018|NCT02296190|100710951|FG000|COMPLETED|Overall Study||21||
48158019|NCT02296190|100710952|FG001|COMPLETED|Overall Study||20||
48158020|NCT02296190|100710953|FG002|COMPLETED|Overall Study||23||
48158021|NCT02296190|100710954|FG003|COMPLETED|Overall Study||20||
48158022|NCT02296190|100710955|FG004|COMPLETED|Overall Study||20||
48158023|NCT02296190|100710956|FG005|COMPLETED|Overall Study||9||
48158024|NCT02296190|100710951|FG000|NOT COMPLETED|Overall Study||14||
48158025|NCT02296190|100710952|FG001|NOT COMPLETED|Overall Study||21||
48158026|NCT02296190|100710953|FG002|NOT COMPLETED|Overall Study||12||
48158027|NCT02296190|100710954|FG003|NOT COMPLETED|Overall Study||23||
48158028|NCT02296190|100710955|FG004|NOT COMPLETED|Overall Study||16||
48158029|NCT02296190|100710956|FG005|NOT COMPLETED|Overall Study||0||
48158030|NCT01472874|100710957|FG000|STARTED|Overall Study||8||
48158031|NCT01472874|100710957|FG000|COMPLETED|Overall Study||8||
48158032|NCT01472874|100710957|FG000|NOT COMPLETED|Overall Study||0||
48158033|NCT01693692|100710958|FG000|STARTED|Overall Study||130||
48314063|NCT02687542|101094234|FG002|NOT COMPLETED|Overall Study||14||
48314064|NCT02687542|101094235|FG003|NOT COMPLETED|Overall Study||10||
48314065|NCT02687542|101094236|FG004|NOT COMPLETED|Overall Study||20||
48314066|NCT04310085|101094237|FG000|STARTED|Overall Study||8||
48314067|NCT04310085|101094238|FG001|STARTED|Overall Study||8||
48314068|NCT04310085|101094237|FG000|COMPLETED|Overall Study||8||
48314069|NCT04310085|101094238|FG001|COMPLETED|Overall Study||8||
48158034|NCT01693692|100710959|FG001|STARTED|Overall Study||131||
48158035|NCT01693692|100710960|FG002|STARTED|Overall Study||131||
48158036|NCT01693692|100710958|FG000|Received Study Drug|Overall Study||128||
48158037|NCT01693692|100710959|FG001|Received Study Drug|Overall Study||127||
48158038|NCT01693692|100710960|FG002|Received Study Drug|Overall Study||128||
48314070|NCT04310085|101094237|FG000|NOT COMPLETED|Overall Study||0||
48314071|NCT04310085|101094238|FG001|NOT COMPLETED|Overall Study||0||
48314072|NCT00038727|101094239|FG000|STARTED|Overall Study||916||
48314073|NCT00038727|101094240|FG001|STARTED|Overall Study||927||
48730675|NCT03304873|102126855|FG000|STARTED|Overall Study||23||
48730676|NCT03304873|102126856|FG001|STARTED|Overall Study||24||
48730677|NCT03304873|102126855|FG000|COMPLETED|Overall Study||22||
48730678|NCT03304873|102126856|FG001|COMPLETED|Overall Study||16||
48730679|NCT03304873|102126855|FG000|NOT COMPLETED|Overall Study||1||
48730680|NCT03304873|102126856|FG001|NOT COMPLETED|Overall Study||8||
48730681|NCT00168454|102126857|FG000|STARTED|Overall Study||44||
48730682|NCT00168454|102126858|FG001|STARTED|Overall Study||57||
48730683|NCT00168454|102126859|FG002|STARTED|Overall Study||54||
48730684|NCT00168454|102126860|FG003|STARTED|Overall Study||49||
48730685|NCT00168454|102126861|FG004|STARTED|Overall Study||53||
48730686|NCT00168454|102126862|FG005|STARTED|Overall Study||56||
48730687|NCT00168454|102126857|FG000|COMPLETED|Overall Study||37||
48730688|NCT00168454|102126858|FG001|COMPLETED|Overall Study||50||
48730689|NCT00168454|102126859|FG002|COMPLETED|Overall Study||48||
48730690|NCT00168454|102126860|FG003|COMPLETED|Overall Study||40||
48730691|NCT00168454|102126861|FG004|COMPLETED|Overall Study||47||
48730692|NCT00168454|102126862|FG005|COMPLETED|Overall Study||50||
48730693|NCT00168454|102126857|FG000|NOT COMPLETED|Overall Study||7||
48730694|NCT00168454|102126858|FG001|NOT COMPLETED|Overall Study||7||
48730695|NCT00168454|102126859|FG002|NOT COMPLETED|Overall Study||6||
48730696|NCT00168454|102126860|FG003|NOT COMPLETED|Overall Study||9||
48730697|NCT00168454|102126861|FG004|NOT COMPLETED|Overall Study||6||
48730698|NCT00168454|102126862|FG005|NOT COMPLETED|Overall Study||6||
48730699|NCT02980133|102126863|FG000|STARTED|Overall Study||209||
48730700|NCT02980133|102126864|FG001|STARTED|Overall Study||211||
48730701|NCT02980133|102126865|FG002|STARTED|Overall Study||210||
48730702|NCT02980133|102126866|FG003|STARTED|Overall Study||211||
48730703|NCT02980133|102126863|FG000|Received at Least 1 Dose of Study Drug|Overall Study||209|Safety analysis set|
48730704|NCT02980133|102126864|FG001|Received at Least 1 Dose of Study Drug|Overall Study||211|Safety analysis set|
48730705|NCT02980133|102126865|FG002|Received at Least 1 Dose of Study Drug|Overall Study||208|Safety analysis set|
48730706|NCT02980133|102126866|FG003|Received at Least 1 Dose of Study Drug|Overall Study||211|Safety analysis set|
48730707|NCT02980133|102126863|FG000|COMPLETED|Overall Study||202||
48730708|NCT02980133|102126864|FG001|COMPLETED|Overall Study||206||
48730709|NCT02980133|102126865|FG002|COMPLETED|Overall Study||203||
48730710|NCT02980133|102126866|FG003|COMPLETED|Overall Study||205||
48730711|NCT02980133|102126863|FG000|NOT COMPLETED|Overall Study||7||
48730712|NCT02980133|102126864|FG001|NOT COMPLETED|Overall Study||5||
48730713|NCT02980133|102126865|FG002|NOT COMPLETED|Overall Study||7||
48730714|NCT02980133|102126866|FG003|NOT COMPLETED|Overall Study||6||
48730715|NCT02021955|102126867|FG000|STARTED|Step 0||210||30
48730716|NCT02021955|102126868|FG001|STARTED|Step 0||0||0
48730717|NCT02021955|102126867|FG000|COMPLETED|Step 0||210||30
48314074|NCT00038727|101094241|FG002|STARTED|Overall Study||936||
48314075|NCT00038727|101094239|FG000|DPPOS Phase 1 Primary|Overall Study||910||
48730718|NCT02021955|102126868|FG001|COMPLETED|Step 0||0||0
48730719|NCT02021955|102126867|FG000|NOT COMPLETED|Step 0||0||0
48730720|NCT02021955|102126868|FG001|NOT COMPLETED|Step 0||0||0
48730721|NCT02021955|102126867|FG000|STARTED|Step 1||193||29
48730722|NCT02021955|102126868|FG001|STARTED|Step 1||18||1
48158039|NCT01693692|100710958|FG000|COMPLETED|Overall Study||100||
48158040|NCT01693692|100710959|FG001|COMPLETED|Overall Study||97||
48158041|NCT01693692|100710960|FG002|COMPLETED|Overall Study||95||
48158042|NCT01693692|100710958|FG000|NOT COMPLETED|Overall Study||30||
48730723|NCT02021955|102126867|FG000|COMPLETED|Step 1||193||29
48158043|NCT01693692|100710959|FG001|NOT COMPLETED|Overall Study||34||
48158044|NCT01693692|100710960|FG002|NOT COMPLETED|Overall Study||36||
48158045|NCT01257880|100710961|FG000|STARTED|Overall Study||12||
48158046|NCT01257880|100710962|FG001|STARTED|Overall Study||19||
48158047|NCT01257880|100710961|FG000|COMPLETED|Overall Study||12||
48314076|NCT00038727|101094240|FG001|DPPOS Phase 1 Primary|Overall Study||924||
48440019|NCT04259905|101410011|FG000|NOT COMPLETED|Overall Study||0||
48730724|NCT02021955|102126868|FG001|COMPLETED|Step 1||18||1
48730725|NCT02021955|102126867|FG000|NOT COMPLETED|Step 1||0||0
48730726|NCT02021955|102126868|FG001|NOT COMPLETED|Step 1||0||0
48730727|NCT02021955|102126867|FG000|STARTED|Step 2||165||28
48158048|NCT01257880|100710962|FG001|COMPLETED|Overall Study||19||
48158049|NCT01257880|100710961|FG000|NOT COMPLETED|Overall Study||0||
48314077|NCT00038727|101094241|FG002|DPPOS Phase 1 Primary|Overall Study||932||
48314078|NCT00038727|101094239|FG000|DPPOS Phase 2 Enrolled|Overall Study||915||
48730728|NCT02021955|102126868|FG001|STARTED|Step 2||21||2
48730729|NCT02021955|102126867|FG000|COMPLETED|Step 2||165||28
48730730|NCT02021955|102126868|FG001|COMPLETED|Step 2||21||2
48730731|NCT02021955|102126867|FG000|NOT COMPLETED|Step 2||0||0
48730732|NCT02021955|102126868|FG001|NOT COMPLETED|Step 2||0||0
48730733|NCT02021955|102126867|FG000|STARTED|Step 3||175||27
48730734|NCT02021955|102126868|FG001|STARTED|Step 3||30||3
48730735|NCT02021955|102126867|FG000|COMPLETED|Step 3||175||27
48730736|NCT02021955|102126868|FG001|COMPLETED|Step 3||30||3
48730737|NCT02021955|102126867|FG000|NOT COMPLETED|Step 3||0||0
48730738|NCT02021955|102126868|FG001|NOT COMPLETED|Step 3||0||0
48730739|NCT02021955|102126867|FG000|STARTED|Step 4||173||26
48730740|NCT02021955|102126868|FG001|STARTED|Step 4||37||4
48730741|NCT02021955|102126867|FG000|COMPLETED|Step 4||173||26
48730742|NCT02021955|102126868|FG001|COMPLETED|Step 4||37||4
48158050|NCT01257880|100710962|FG001|NOT COMPLETED|Overall Study||0||
48158051|NCT01690130|100710963|FG000|STARTED|Overall Study||10||
48314079|NCT00038727|101094240|FG001|DPPOS Phase 2 Enrolled|Overall Study||926||
48314080|NCT00038727|101094241|FG002|DPPOS Phase 2 Enrolled|Overall Study||935||
48314081|NCT00038727|101094239|FG000|DPPOS Phase 2 Primary|Overall Study||751||
48730743|NCT02021955|102126867|FG000|NOT COMPLETED|Step 4||0||0
48730744|NCT02021955|102126868|FG001|NOT COMPLETED|Step 4||0||0
48730745|NCT02021955|102126867|FG000|STARTED|Step 5||174||25
48730746|NCT02021955|102126868|FG001|STARTED|Step 5||40||5
48730747|NCT02021955|102126867|FG000|COMPLETED|Step 5||174||25
48730748|NCT02021955|102126868|FG001|COMPLETED|Step 5||40||5
48730749|NCT02021955|102126867|FG000|NOT COMPLETED|Step 5||0||0
48730750|NCT02021955|102126868|FG001|NOT COMPLETED|Step 5||0||0
48730751|NCT02021955|102126867|FG000|STARTED|Step 6||158||24
48730752|NCT02021955|102126868|FG001|STARTED|Step 6||53||6
48730753|NCT02021955|102126867|FG000|COMPLETED|Step 6||158||24
48730754|NCT02021955|102126868|FG001|COMPLETED|Step 6||53||6
48730755|NCT02021955|102126867|FG000|NOT COMPLETED|Step 6||0||0
48730756|NCT02021955|102126868|FG001|NOT COMPLETED|Step 6||0||0
48730757|NCT02021955|102126867|FG000|STARTED|Step 7||157||23
48730758|NCT02021955|102126868|FG001|STARTED|Step 7||57||7
48730759|NCT02021955|102126867|FG000|COMPLETED|Step 7||157||23
48730760|NCT02021955|102126868|FG001|COMPLETED|Step 7||57||7
48730761|NCT02021955|102126867|FG000|NOT COMPLETED|Step 7||0||0
48730762|NCT02021955|102126868|FG001|NOT COMPLETED|Step 7||0||0
48730763|NCT02021955|102126867|FG000|STARTED|Step 8||144||22
48730764|NCT02021955|102126868|FG001|STARTED|Step 8||73||8
48730765|NCT02021955|102126867|FG000|COMPLETED|Step 8||144||22
48730766|NCT02021955|102126868|FG001|COMPLETED|Step 8||73||8
48730767|NCT02021955|102126867|FG000|NOT COMPLETED|Step 8||0||0
48730768|NCT02021955|102126868|FG001|NOT COMPLETED|Step 8||0||0
48730769|NCT02021955|102126867|FG000|STARTED|Step 9||139||21
48730770|NCT02021955|102126868|FG001|STARTED|Step 9||77||9
48730771|NCT02021955|102126867|FG000|COMPLETED|Step 9||139||21
48730772|NCT02021955|102126868|FG001|COMPLETED|Step 9||77||9
48730773|NCT02021955|102126867|FG000|NOT COMPLETED|Step 9||0||0
48730774|NCT02021955|102126868|FG001|NOT COMPLETED|Step 9||0||0
48730775|NCT02021955|102126867|FG000|STARTED|Step 10||135||20
48730776|NCT02021955|102126868|FG001|STARTED|Step 10||79||10
48730777|NCT02021955|102126867|FG000|COMPLETED|Step 10||135||20
48730778|NCT02021955|102126868|FG001|COMPLETED|Step 10||79||10
48730779|NCT02021955|102126867|FG000|NOT COMPLETED|Step 10||0||0
48730780|NCT02021955|102126868|FG001|NOT COMPLETED|Step 10||0||0
48730781|NCT02021955|102126867|FG000|STARTED|Step 11||126||19
48730782|NCT02021955|102126868|FG001|STARTED|Step 11||88||11
48730783|NCT02021955|102126867|FG000|COMPLETED|Step 11||126||19
48730784|NCT02021955|102126868|FG001|COMPLETED|Step 11||88||11
48730785|NCT02021955|102126867|FG000|NOT COMPLETED|Step 11||0||0
48730786|NCT02021955|102126868|FG001|NOT COMPLETED|Step 11||0||0
48730787|NCT02021955|102126867|FG000|STARTED|Step 12||123||18
48730788|NCT02021955|102126868|FG001|STARTED|Step 12||90||12
48730789|NCT02021955|102126867|FG000|COMPLETED|Step 12||123||18
48730790|NCT02021955|102126868|FG001|COMPLETED|Step 12||90||12
48730791|NCT02021955|102126867|FG000|NOT COMPLETED|Step 12||0||0
48314082|NCT00038727|101094240|FG001|DPPOS Phase 2 Primary|Overall Study||772||
48730792|NCT02021955|102126868|FG001|NOT COMPLETED|Step 12||0||0
48730793|NCT02021955|102126867|FG000|STARTED|Step 13||118||17
48730794|NCT02021955|102126868|FG001|STARTED|Step 13||96||13
48730795|NCT02021955|102126867|FG000|COMPLETED|Step 13||118||17
48158052|NCT01690130|100710964|FG001|STARTED|Overall Study||9||
48314083|NCT00038727|101094241|FG002|DPPOS Phase 2 Primary|Overall Study||780||
48314084|NCT00038727|101094239|FG000|DPPOS Phase 3 Enrolled|Overall Study||916|As of February 2016|
48158053|NCT01690130|100710963|FG000|COMPLETED|Overall Study||9||
48158054|NCT01690130|100710964|FG001|COMPLETED|Overall Study||9||
48730796|NCT02021955|102126868|FG001|COMPLETED|Step 13||96||13
48730797|NCT02021955|102126867|FG000|NOT COMPLETED|Step 13||0||0
48730798|NCT02021955|102126868|FG001|NOT COMPLETED|Step 13||0||0
48730799|NCT02021955|102126867|FG000|STARTED|Step 14||105||16
48158055|NCT01690130|100710963|FG000|NOT COMPLETED|Overall Study||1||
48730800|NCT02021955|102126868|FG001|STARTED|Step 14||95||14
48730801|NCT02021955|102126867|FG000|COMPLETED|Step 14||105||16
48730802|NCT02021955|102126868|FG001|COMPLETED|Step 14||95||14
48730803|NCT02021955|102126867|FG000|NOT COMPLETED|Step 14||0||0
48730804|NCT02021955|102126868|FG001|NOT COMPLETED|Step 14||0||0
48730805|NCT02021955|102126867|FG000|STARTED|Step 15||110||15
48730806|NCT02021955|102126868|FG001|STARTED|Step 15||102||15
48730807|NCT02021955|102126867|FG000|COMPLETED|Step 15||110||15
48730808|NCT02021955|102126868|FG001|COMPLETED|Step 15||102||15
48730809|NCT02021955|102126867|FG000|NOT COMPLETED|Step 15||0||0
48730810|NCT02021955|102126868|FG001|NOT COMPLETED|Step 15||0||0
48730811|NCT02021955|102126867|FG000|STARTED|Step 16||103||14
48730812|NCT02021955|102126868|FG001|STARTED|Step 16||114||16
48730813|NCT02021955|102126867|FG000|COMPLETED|Step 16||103||14
48314085|NCT00038727|101094240|FG001|DPPOS Phase 3 Enrolled|Overall Study||927|As of February 2016|
48730814|NCT02021955|102126868|FG001|COMPLETED|Step 16||114||16
48730815|NCT02021955|102126867|FG000|NOT COMPLETED|Step 16||0||0
48730816|NCT02021955|102126868|FG001|NOT COMPLETED|Step 16||0||0
48730817|NCT02021955|102126867|FG000|STARTED|Step 17||99||13
48730818|NCT02021955|102126868|FG001|STARTED|Step 17||121||17
48730819|NCT02021955|102126867|FG000|COMPLETED|Step 17||99||13
48730820|NCT02021955|102126868|FG001|COMPLETED|Step 17||121||17
48730821|NCT02021955|102126867|FG000|NOT COMPLETED|Step 17||0||0
48730822|NCT02021955|102126868|FG001|NOT COMPLETED|Step 17||0||0
48730823|NCT02021955|102126867|FG000|STARTED|Step 18||96||12
48730824|NCT02021955|102126868|FG001|STARTED|Step 18||124||18
48730825|NCT02021955|102126867|FG000|COMPLETED|Step 18||96||12
48730826|NCT02021955|102126868|FG001|COMPLETED|Step 18||124||18
48730827|NCT02021955|102126867|FG000|NOT COMPLETED|Step 18||0||0
48730828|NCT02021955|102126868|FG001|NOT COMPLETED|Step 18||0||0
48730829|NCT02021955|102126867|FG000|STARTED|Step 19||94||11
48730830|NCT02021955|102126868|FG001|STARTED|Step 19||126||19
48730831|NCT02021955|102126867|FG000|COMPLETED|Step 19||94||11
48730832|NCT02021955|102126868|FG001|COMPLETED|Step 19||126||19
48730833|NCT02021955|102126867|FG000|NOT COMPLETED|Step 19||0||0
48730834|NCT02021955|102126868|FG001|NOT COMPLETED|Step 19||0||0
48730835|NCT02021955|102126867|FG000|STARTED|Step 20||92||10
48730836|NCT02021955|102126868|FG001|STARTED|Step 20||128||20
48730837|NCT02021955|102126867|FG000|COMPLETED|Step 20||92||10
48314086|NCT00038727|101094241|FG002|DPPOS Phase 3 Enrolled|Overall Study||936|As of February 2016|
48314087|NCT00038727|101094239|FG000|COMPLETED|Overall Study||916||
48314088|NCT00038727|101094240|FG001|COMPLETED|Overall Study||927||
48314089|NCT00038727|101094241|FG002|COMPLETED|Overall Study||936||
48314090|NCT00038727|101094239|FG000|NOT COMPLETED|Overall Study||0||
48314091|NCT00038727|101094240|FG001|NOT COMPLETED|Overall Study||0||
48314092|NCT00038727|101094241|FG002|NOT COMPLETED|Overall Study||0||
48314093|NCT02114164|101094242|FG000|STARTED|Overall Study||50||
48314094|NCT02114164|101094243|FG001|STARTED|Overall Study||50||
48314095|NCT02114164|101094242|FG000|COMPLETED|Overall Study||50||
48314096|NCT02114164|101094243|FG001|COMPLETED|Overall Study||50||
48314097|NCT02114164|101094242|FG000|NOT COMPLETED|Overall Study||0||
48314098|NCT02114164|101094243|FG001|NOT COMPLETED|Overall Study||0||
48314099|NCT02285920|101094244|FG000|STARTED|Overall Study||51||
48314100|NCT02285920|101094245|FG001|STARTED|Overall Study||27||
48730838|NCT02021955|102126868|FG001|COMPLETED|Step 20||128||20
48730839|NCT02021955|102126867|FG000|NOT COMPLETED|Step 20||0||0
48314101|NCT02285920|101094246|FG002|STARTED|Overall Study||26||
48314102|NCT02285920|101094247|FG003|STARTED|Overall Study||25||
48314103|NCT02285920|101094244|FG000|COMPLETED|Overall Study||47||
48314104|NCT02285920|101094245|FG001|COMPLETED|Overall Study||23||
48314105|NCT02285920|101094246|FG002|COMPLETED|Overall Study||21||
48314106|NCT02285920|101094247|FG003|COMPLETED|Overall Study||24||
48314107|NCT02285920|101094244|FG000|NOT COMPLETED|Overall Study||4||
48406897|NCT03424044|101328488|FG004|NOT COMPLETED|Third Rest Period (7-45 Days)||0||
48406898|NCT03424044|101328489|FG005|NOT COMPLETED|Third Rest Period (7-45 Days)||0||
48406899|NCT03424044|101328490|FG006|NOT COMPLETED|Third Rest Period (7-45 Days)||0||
48730840|NCT02021955|102126868|FG001|NOT COMPLETED|Step 20||0||0
48730841|NCT02021955|102126867|FG000|STARTED|Step 21||88||9
48730842|NCT02021955|102126868|FG001|STARTED|Step 21||134||21
48730843|NCT02021955|102126867|FG000|COMPLETED|Step 21||88||9
48730844|NCT02021955|102126868|FG001|COMPLETED|Step 21||134||21
48730845|NCT02021955|102126867|FG000|NOT COMPLETED|Step 21||0||0
48730846|NCT02021955|102126868|FG001|NOT COMPLETED|Step 21||0||0
48730847|NCT02021955|102126867|FG000|STARTED|Step 22||89||8
48730848|NCT02021955|102126868|FG001|STARTED|Step 22||152||22
48314108|NCT02285920|101094245|FG001|NOT COMPLETED|Overall Study||4||
48314109|NCT02285920|101094246|FG002|NOT COMPLETED|Overall Study||5||
48730849|NCT02021955|102126867|FG000|COMPLETED|Step 22||89||8
48730850|NCT02021955|102126868|FG001|COMPLETED|Step 22||152||22
48730851|NCT02021955|102126867|FG000|NOT COMPLETED|Step 22||0||0
48730852|NCT02021955|102126868|FG001|NOT COMPLETED|Step 22||0||0
48314110|NCT02285920|101094247|FG003|NOT COMPLETED|Overall Study||1||
48314111|NCT02665052|101094248|FG000|STARTED|Overall Study||11||
48314112|NCT02665052|101094249|FG001|STARTED|Overall Study||9||
48406900|NCT03424044|101328491|FG007|NOT COMPLETED|Third Rest Period (7-45 Days)||0||
48406901|NCT03424044|101328492|FG008|NOT COMPLETED|Third Rest Period (7-45 Days)||0||
48730853|NCT02021955|102126867|FG000|STARTED|Step 23||69||7
48730854|NCT02021955|102126868|FG001|STARTED|Step 23||175||23
48730855|NCT02021955|102126867|FG000|COMPLETED|Step 23||69||7
48730856|NCT02021955|102126868|FG001|COMPLETED|Step 23||175||23
48730857|NCT02021955|102126867|FG000|NOT COMPLETED|Step 23||0||0
48730858|NCT02021955|102126868|FG001|NOT COMPLETED|Step 23||0||0
48730859|NCT02021955|102126867|FG000|STARTED|Step 24||62||6
48730860|NCT02021955|102126868|FG001|STARTED|Step 24||183||24
48730861|NCT02021955|102126867|FG000|COMPLETED|Step 24||62||6
48730862|NCT02021955|102126868|FG001|COMPLETED|Step 24||183||24
48730863|NCT02021955|102126867|FG000|NOT COMPLETED|Step 24||0||0
48730864|NCT02021955|102126868|FG001|NOT COMPLETED|Step 24||0||0
48730865|NCT02021955|102126867|FG000|STARTED|Step 25||37||5
48730866|NCT02021955|102126868|FG001|STARTED|Step 25||208||25
48730867|NCT02021955|102126867|FG000|COMPLETED|Step 25||37||5
48730868|NCT02021955|102126868|FG001|COMPLETED|Step 25||208||25
48730869|NCT02021955|102126867|FG000|NOT COMPLETED|Step 25||0||0
48730870|NCT02021955|102126868|FG001|NOT COMPLETED|Step 25||0||0
48730871|NCT02021955|102126867|FG000|STARTED|Step 26||30||4
48730872|NCT02021955|102126868|FG001|STARTED|Step 26||215||26
48730873|NCT02021955|102126867|FG000|COMPLETED|Step 26||30||4
48730874|NCT02021955|102126868|FG001|COMPLETED|Step 26||215||26
48730875|NCT02021955|102126867|FG000|NOT COMPLETED|Step 26||0||0
48730876|NCT02021955|102126868|FG001|NOT COMPLETED|Step 26||0||0
48730877|NCT02021955|102126867|FG000|STARTED|Step 27||25||3
48730878|NCT02021955|102126868|FG001|STARTED|Step 27||243||27
48730879|NCT02021955|102126867|FG000|COMPLETED|Step 27||25||3
48730880|NCT02021955|102126868|FG001|COMPLETED|Step 27||243||27
48158056|NCT01690130|100710964|FG001|NOT COMPLETED|Overall Study||0||
48158057|NCT02569710|100710965|FG000|STARTED|Overall Study||20||
48314113|NCT02665052|101094250|FG002|STARTED|Overall Study||9||
48314114|NCT02665052|101094251|FG003|STARTED|Overall Study||19||
48314115|NCT02665052|101094248|FG000|COMPLETED|Overall Study||8||
48314116|NCT02665052|101094249|FG001|COMPLETED|Overall Study||7||
48314117|NCT02665052|101094250|FG002|COMPLETED|Overall Study||9||
48314118|NCT02665052|101094251|FG003|COMPLETED|Overall Study||14||
48314119|NCT02665052|101094248|FG000|NOT COMPLETED|Overall Study||3||
48314120|NCT02665052|101094249|FG001|NOT COMPLETED|Overall Study||2||
48730881|NCT02021955|102126867|FG000|NOT COMPLETED|Step 27||0||0
48730882|NCT02021955|102126868|FG001|NOT COMPLETED|Step 27||0||0
48730883|NCT02021955|102126867|FG000|STARTED|Step 28||15||2
48730884|NCT02021955|102126868|FG001|STARTED|Step 28||256||28
48730885|NCT02021955|102126867|FG000|COMPLETED|Step 28||15||2
48730886|NCT02021955|102126868|FG001|COMPLETED|Step 28||256||28
48730887|NCT02021955|102126867|FG000|NOT COMPLETED|Step 28||0||0
48730888|NCT02021955|102126868|FG001|NOT COMPLETED|Step 28||0||0
48730889|NCT02021955|102126867|FG000|STARTED|Step 29||10||1
48730890|NCT02021955|102126868|FG001|STARTED|Step 29||266||29
48730891|NCT02021955|102126867|FG000|COMPLETED|Step 29||10||1
48730892|NCT02021955|102126868|FG001|COMPLETED|Step 29||266||29
48730893|NCT02021955|102126867|FG000|NOT COMPLETED|Step 29||0||0
48730894|NCT02021955|102126868|FG001|NOT COMPLETED|Step 29||0||0
48730895|NCT02021955|102126867|FG000|STARTED|Step 30||0||0
48730896|NCT02021955|102126868|FG001|STARTED|Step 30||277||30
48730897|NCT02021955|102126867|FG000|COMPLETED|Step 30||0||0
48730898|NCT02021955|102126868|FG001|COMPLETED|Step 30||277||30
48730899|NCT02021955|102126867|FG000|NOT COMPLETED|Step 30||0||0
48730900|NCT02021955|102126868|FG001|NOT COMPLETED|Step 30||0||0
48730901|NCT02703480|102126869|FG000|STARTED|Overall Study||11||11
48730902|NCT02703480|102126870|FG001|STARTED|Overall Study||11||11
48730903|NCT02703480|102126869|FG000|COMPLETED|Overall Study||10||10
48730904|NCT02703480|102126870|FG001|COMPLETED|Overall Study||10||10
48730905|NCT02703480|102126869|FG000|NOT COMPLETED|Overall Study||1||1
48158058|NCT02569710|100710966|FG001|STARTED|Overall Study||25||
48158059|NCT02569710|100710967|FG002|STARTED|Overall Study||20||
48158060|NCT02569710|100710968|FG003|STARTED|Overall Study||20||
48158061|NCT02569710|100710969|FG004|STARTED|Overall Study||8||
48158062|NCT02569710|100710970|FG005|STARTED|Overall Study||5||
48314121|NCT02665052|101094250|FG002|NOT COMPLETED|Overall Study||0||
48314122|NCT02665052|101094251|FG003|NOT COMPLETED|Overall Study||5||
48158063|NCT02569710|100710971|FG006|STARTED|Overall Study||14||
48730906|NCT02703480|102126870|FG001|NOT COMPLETED|Overall Study||1||1
48314123|NCT00113230|101094252|FG000|STARTED|Overall Study||25||
48730907|NCT02019875|102126871|FG000|STARTED|Overall Study||16||
48730908|NCT02019875|102126872|FG001|STARTED|Overall Study||18||
48730909|NCT02019875|102126873|FG002|STARTED|Overall Study||15||
48730910|NCT02019875|102126874|FG003|STARTED|Overall Study||15||
48730911|NCT02019875|102126875|FG004|STARTED|Overall Study||16||
48730912|NCT02019875|102126876|FG005|STARTED|Overall Study||12||
48730913|NCT02019875|102126871|FG000|COMPLETED|Overall Study||14||
48730914|NCT02019875|102126872|FG001|COMPLETED|Overall Study||16||
48158064|NCT02569710|100710972|FG007|STARTED|Overall Study||30||
48314124|NCT00113230|101094252|FG000|COMPLETED|Overall Study||25||
48314125|NCT00113230|101094252|FG000|NOT COMPLETED|Overall Study||0||
48314126|NCT01376778|101094253|FG000|STARTED|Overall Study||206||
48730915|NCT02019875|102126873|FG002|COMPLETED|Overall Study||15||
48730916|NCT02019875|102126874|FG003|COMPLETED|Overall Study||14||
48730917|NCT02019875|102126875|FG004|COMPLETED|Overall Study||15||
48730918|NCT02019875|102126876|FG005|COMPLETED|Overall Study||11||
48730919|NCT02019875|102126871|FG000|NOT COMPLETED|Overall Study||2||
48158065|NCT02569710|100710973|FG008|STARTED|Overall Study||15||
48158066|NCT02569710|100710974|FG009|STARTED|Overall Study||4||
48158067|NCT02569710|100710965|FG000|COMPLETED|Overall Study||19||
48158068|NCT02569710|100710966|FG001|COMPLETED|Overall Study||25||
48158069|NCT02569710|100710967|FG002|COMPLETED|Overall Study||20||
48158070|NCT02569710|100710968|FG003|COMPLETED|Overall Study||20||
48158071|NCT02569710|100710969|FG004|COMPLETED|Overall Study||7||
48158072|NCT02569710|100710970|FG005|COMPLETED|Overall Study||4||
48158073|NCT02569710|100710971|FG006|COMPLETED|Overall Study||12||
48158074|NCT02569710|100710972|FG007|COMPLETED|Overall Study||30||
48158075|NCT02569710|100710973|FG008|COMPLETED|Overall Study||14||
48614490|NCT02370511|101841763|FG002|COMPLETED|Overall Study||29||
48614491|NCT02370511|101841761|FG000|NOT COMPLETED|Overall Study||12||
48614492|NCT02370511|101841762|FG001|NOT COMPLETED|Overall Study||11||
48614493|NCT02370511|101841763|FG002|NOT COMPLETED|Overall Study||1||
48614494|NCT02576977|101841764|FG000|STARTED|Overall Study||126||
48614495|NCT02576977|101841765|FG001|STARTED|Overall Study||125||
48614496|NCT02576977|101841764|FG000|Treated|Overall Study||122||
48614497|NCT02576977|101841765|FG001|Treated|Overall Study||123||
48614498|NCT02576977|101841764|FG000|COMPLETED|Overall Study||0||
48614499|NCT02576977|101841765|FG001|COMPLETED|Overall Study||0||
48614500|NCT02576977|101841764|FG000|NOT COMPLETED|Overall Study||126||
48614501|NCT02576977|101841765|FG001|NOT COMPLETED|Overall Study||125||
48614502|NCT00673257|101841766|FG000|STARTED|Overall Study||107||
48614503|NCT00673257|101841766|FG000|COMPLETED|Overall Study||102||
48614504|NCT00673257|101841766|FG000|NOT COMPLETED|Overall Study||5||
48614505|NCT01673178|101841767|FG000|STARTED|Overall Study||22||
48158076|NCT02569710|100710974|FG009|COMPLETED|Overall Study||4||
48158077|NCT02569710|100710965|FG000|NOT COMPLETED|Overall Study||1||
48158078|NCT02569710|100710966|FG001|NOT COMPLETED|Overall Study||0||
48158079|NCT02569710|100710967|FG002|NOT COMPLETED|Overall Study||0||
48158080|NCT02569710|100710968|FG003|NOT COMPLETED|Overall Study||0||
48158081|NCT02569710|100710969|FG004|NOT COMPLETED|Overall Study||1||
48158082|NCT02569710|100710970|FG005|NOT COMPLETED|Overall Study||1||
48158083|NCT02569710|100710971|FG006|NOT COMPLETED|Overall Study||2||
48158084|NCT02569710|100710972|FG007|NOT COMPLETED|Overall Study||0||
48158085|NCT02569710|100710973|FG008|NOT COMPLETED|Overall Study||1||
48158086|NCT02569710|100710974|FG009|NOT COMPLETED|Overall Study||0||
48158087|NCT01768832|100710975|FG000|STARTED|Overall Study||41||
48158088|NCT01768832|100710976|FG001|STARTED|Overall Study||43||
48158089|NCT01768832|100710977|FG002|STARTED|Overall Study||35||
48158090|NCT01768832|100710975|FG000|COMPLETED|Overall Study||31||
48158091|NCT01768832|100710976|FG001|COMPLETED|Overall Study||39||
48158092|NCT01768832|100710977|FG002|COMPLETED|Overall Study||26||
48158093|NCT01768832|100710975|FG000|NOT COMPLETED|Overall Study||10||
48158094|NCT01768832|100710976|FG001|NOT COMPLETED|Overall Study||4||
48158095|NCT01768832|100710977|FG002|NOT COMPLETED|Overall Study||9||
48158096|NCT03403426|100710978|FG000|STARTED|Overall Study||85||
48158097|NCT03403426|100710978|FG000|COMPLETED|Overall Study||82||
48158098|NCT03403426|100710978|FG000|NOT COMPLETED|Overall Study||3||
48158099|NCT01678131|100710979|FG000|STARTED|Overall Study||10||
48158100|NCT01678131|100710980|FG001|STARTED|Overall Study||10||
48158101|NCT01678131|100710981|FG002|STARTED|Overall Study||11||
48158102|NCT01678131|100710979|FG000|COMPLETED|Overall Study||10||
48158103|NCT01678131|100710980|FG001|COMPLETED|Overall Study||9||
48158104|NCT01678131|100710981|FG002|COMPLETED|Overall Study||9||
48158105|NCT01678131|100710979|FG000|NOT COMPLETED|Overall Study||0||
48158106|NCT01678131|100710980|FG001|NOT COMPLETED|Overall Study||1||
48158107|NCT01678131|100710981|FG002|NOT COMPLETED|Overall Study||2||
48158108|NCT00985725|100710982|FG000|STARTED|Overall Study||71||
48158109|NCT00985725|100710983|FG001|STARTED|Overall Study||72||
48158110|NCT00985725|100710982|FG000|COMPLETED|Overall Study||60||
48158111|NCT00985725|100710983|FG001|COMPLETED|Overall Study||59||
48158112|NCT00985725|100710982|FG000|NOT COMPLETED|Overall Study||11||
48158113|NCT00985725|100710983|FG001|NOT COMPLETED|Overall Study||13||
48158114|NCT00387894|100710984|FG000|STARTED|Overall Study||6||
48158115|NCT00387894|100710984|FG000|COMPLETED|Overall Study||5||
48158116|NCT00387894|100710984|FG000|NOT COMPLETED|Overall Study||1||
48314127|NCT01376778|101094254|FG001|STARTED|Overall Study||193||
48614506|NCT01673178|101841768|FG001|STARTED|Overall Study||21||
48158117|NCT00615264|100710985|FG000|STARTED|Overall Study||225||
48158118|NCT00615264|100710986|FG001|STARTED|Overall Study||232||
48314128|NCT01376778|101094253|FG000|COMPLETED|Overall Study||203||
48614507|NCT01673178|101841769|FG002|STARTED|Overall Study||21||
48614508|NCT01673178|101841770|FG003|STARTED|Overall Study||22||
48614509|NCT01673178|101841771|FG004|STARTED|Overall Study||21||
48314129|NCT01376778|101094254|FG001|COMPLETED|Overall Study||191||
48614510|NCT01673178|101841767|FG000|COMPLETED|Overall Study||19||
48614511|NCT01673178|101841768|FG001|COMPLETED|Overall Study||19||
48614512|NCT01673178|101841769|FG002|COMPLETED|Overall Study||18||
48158119|NCT00615264|100710985|FG000|Received at Least One Dose (ITT)|Overall Study||225||
48158120|NCT00615264|100710986|FG001|Received at Least One Dose (ITT)|Overall Study||231||
48158121|NCT00615264|100710985|FG000|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||209||
48158122|NCT00615264|100710986|FG001|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||213||
48158123|NCT00615264|100710985|FG000|COMPLETED|Overall Study||175||
48730920|NCT02019875|102126872|FG001|NOT COMPLETED|Overall Study||2||
48730921|NCT02019875|102126873|FG002|NOT COMPLETED|Overall Study||0||
48730922|NCT02019875|102126874|FG003|NOT COMPLETED|Overall Study||1||
48730923|NCT02019875|102126875|FG004|NOT COMPLETED|Overall Study||1||
48730924|NCT02019875|102126876|FG005|NOT COMPLETED|Overall Study||1||
48730925|NCT00994643|102126877|FG000|STARTED|Overall Study||11||
48730926|NCT00994643|102126877|FG000|COMPLETED|Overall Study||10||
48730927|NCT00994643|102126877|FG000|NOT COMPLETED|Overall Study||1||
48730928|NCT04534881|102126878|FG000|STARTED|Overall Study||3||
48730929|NCT04534881|102126879|FG001|STARTED|Overall Study||2||
48730930|NCT04534881|102126878|FG000|COMPLETED|Overall Study||3||
48730931|NCT04534881|102126879|FG001|COMPLETED|Overall Study||2||
48730932|NCT04534881|102126878|FG000|NOT COMPLETED|Overall Study||0||
48730933|NCT04534881|102126879|FG001|NOT COMPLETED|Overall Study||0||
48730934|NCT00477152|102126880|FG000|STARTED|Overall Study||52||
48730935|NCT00477152|102126880|FG000|COMPLETED|Overall Study||49||
48730936|NCT00477152|102126880|FG000|NOT COMPLETED|Overall Study||3||
48730937|NCT00604045|102126881|FG000|STARTED|Overall Study||15||
48730938|NCT00604045|102126882|FG001|STARTED|Overall Study||10||
48730939|NCT00604045|102126881|FG000|COMPLETED|Overall Study||14||
48730940|NCT00604045|102126882|FG001|COMPLETED|Overall Study||9||
48314130|NCT01376778|101094253|FG000|NOT COMPLETED|Overall Study||3||
48314131|NCT01376778|101094254|FG001|NOT COMPLETED|Overall Study||2||
48314132|NCT02709694|101094255|FG000|STARTED|Overall Study||33||
48314133|NCT02709694|101094255|FG000|Any Back Pain|Overall Study||19||
48314134|NCT02709694|101094255|FG000|No Back Pain|Overall Study||14||
48314135|NCT02709694|101094255|FG000|MRI Showing Presence of Sacroiliitis|Overall Study||4||
48314136|NCT02709694|101094255|FG000|MRI Not Showing Sacroiliitis|Overall Study||29||
48314137|NCT02709694|101094255|FG000|Classified as Having Inflammatory Back Pain by the ASAS Criteria|Overall Study||6||
48314138|NCT02709694|101094255|FG000|Not Classified as Having Inflammatory Back Pain by the ASAS Criteria|Overall Study||25||
48314139|NCT02709694|101094255|FG000|Having Bone Marrow Edema Seen in MRI|Overall Study||33||
48314140|NCT02709694|101094255|FG000|Having Erosion (a Structural Lesion) Seen in MRI|Overall Study||33||
48314141|NCT02709694|101094255|FG000|Having Fat Metaplasia Seen in MRI|Overall Study||33||
48314142|NCT02709694|101094255|FG000|Having Backfill (Type of Structural Lesion) Seen in MRI|Overall Study||33||
48314143|NCT02709694|101094255|FG000|Having Ankylosis Seen in MRI|Overall Study||33||
48314144|NCT02709694|101094255|FG000|COMPLETED|Overall Study||33||
48314145|NCT02709694|101094255|FG000|NOT COMPLETED|Overall Study||0||
48314146|NCT01357655|101094256|FG000|STARTED|Overall Study||66||
48314147|NCT01357655|101094257|FG001|STARTED|Overall Study||0||
48730941|NCT00604045|102126881|FG000|NOT COMPLETED|Overall Study||1||
48730942|NCT00604045|102126882|FG001|NOT COMPLETED|Overall Study||1||
48730943|NCT01840527|102126883|FG000|STARTED|Overall Study||110||
48730944|NCT01840527|102126884|FG001|STARTED|Overall Study||110||
48730945|NCT01840527|102126883|FG000|COMPLETED|Overall Study||110||
48730946|NCT01840527|102126884|FG001|COMPLETED|Overall Study||110||
48730947|NCT01840527|102126883|FG000|NOT COMPLETED|Overall Study||0||
48730948|NCT01840527|102126884|FG001|NOT COMPLETED|Overall Study||0||
48730949|NCT00428389|102126885|FG000|STARTED|Core Phase||131||
48730950|NCT00428389|102126886|FG001|STARTED|Core Phase||131||
48730951|NCT00428389|102126885|FG000|Intent-to-treat Population|Core Phase||131||
48730952|NCT00428389|102126886|FG001|Intent-to-treat Population|Core Phase||130||
48314148|NCT01357655|101094256|FG000|COMPLETED|Overall Study||0||
48730953|NCT00428389|102126885|FG000|COMPLETED|Core Phase||120||
48730954|NCT00428389|102126886|FG001|COMPLETED|Core Phase||120||
48314149|NCT01357655|101094257|FG001|COMPLETED|Overall Study||0||
48314150|NCT01357655|101094256|FG000|NOT COMPLETED|Overall Study||66||
48314151|NCT01357655|101094257|FG001|NOT COMPLETED|Overall Study||0||
48314152|NCT02982590|101094258|FG000|STARTED|Overall Study||13||
48314153|NCT02982590|101094259|FG001|STARTED|Overall Study||14||
48314154|NCT02982590|101094258|FG000|COMPLETED|Overall Study||9||
48314155|NCT02982590|101094259|FG001|COMPLETED|Overall Study||13||
48314156|NCT02982590|101094258|FG000|NOT COMPLETED|Overall Study||4||
48730955|NCT00428389|102126885|FG000|NOT COMPLETED|Core Phase||11||
48730956|NCT00428389|102126886|FG001|NOT COMPLETED|Core Phase||11||
48730957|NCT00428389|102126885|FG000|STARTED|Extension Phase||117||
48730958|NCT00428389|102126886|FG001|STARTED|Extension Phase||117||
48730959|NCT00428389|102126885|FG000|COMPLETED|Extension Phase||85||
48730960|NCT00428389|102126886|FG001|COMPLETED|Extension Phase||91||
48730961|NCT00428389|102126885|FG000|NOT COMPLETED|Extension Phase||32||
48314157|NCT02982590|101094259|FG001|NOT COMPLETED|Overall Study||1||
48314158|NCT00528580|101094260|FG000|STARTED|Overall Study||34||
48314159|NCT00528580|101094261|FG001|STARTED|Overall Study||34||
48314160|NCT00528580|101094260|FG000|COMPLETED|Overall Study||34||
48314161|NCT00528580|101094261|FG001|COMPLETED|Overall Study||34||
48314162|NCT00528580|101094260|FG000|NOT COMPLETED|Overall Study||0||
48730962|NCT00428389|102126886|FG001|NOT COMPLETED|Extension Phase||26||
48730963|NCT03777319|102126887|FG000|STARTED|Overall Study||1||
48730964|NCT03777319|102126888|FG001|STARTED|Overall Study||1||
48730965|NCT03777319|102126887|FG000|COMPLETED|Overall Study||1||
48730966|NCT03777319|102126888|FG001|COMPLETED|Overall Study||1||
48730967|NCT03777319|102126887|FG000|NOT COMPLETED|Overall Study||0||
48730968|NCT03777319|102126888|FG001|NOT COMPLETED|Overall Study||0||
48730969|NCT05198843|102126889|FG000|STARTED|Overall Study||1||
48730970|NCT05198843|102126889|FG000|COMPLETED|Overall Study||0||
48730971|NCT05198843|102126889|FG000|NOT COMPLETED|Overall Study||1||
48730972|NCT02211456|102126890|FG000|STARTED|Overall Study||15||
48730973|NCT02211456|102126890|FG000|COMPLETED|Overall Study||15||
48730974|NCT02211456|102126890|FG000|NOT COMPLETED|Overall Study||0||
48730975|NCT00250276|102126891|FG000|STARTED|Overall Study||199||
48730976|NCT00250276|102126892|FG001|STARTED|Overall Study||198||
48730977|NCT00250276|102126893|FG002|STARTED|Overall Study||201||
48730978|NCT00250276|102126894|FG003|STARTED|Overall Study||200||
48730979|NCT00250276|102126891|FG000|COMPLETED|Overall Study||182||
48730980|NCT00250276|102126892|FG001|COMPLETED|Overall Study||177||
48730981|NCT00250276|102126893|FG002|COMPLETED|Overall Study||182||
48730982|NCT00250276|102126894|FG003|COMPLETED|Overall Study||181||
48730983|NCT00250276|102126891|FG000|NOT COMPLETED|Overall Study||17||
48730984|NCT00250276|102126892|FG001|NOT COMPLETED|Overall Study||21||
48730985|NCT00250276|102126893|FG002|NOT COMPLETED|Overall Study||19||
48730986|NCT00250276|102126894|FG003|NOT COMPLETED|Overall Study||19||
48730987|NCT02508428|102126895|FG000|STARTED|Overall Study||114||116
48730988|NCT02508428|102126896|FG001|STARTED|Overall Study||111||114
48730989|NCT02508428|102126895|FG000|COMPLETED|Overall Study||62||64
48730990|NCT02508428|102126896|FG001|COMPLETED|Overall Study||44||46
48730991|NCT02508428|102126895|FG000|NOT COMPLETED|Overall Study||52||52
48730992|NCT02508428|102126896|FG001|NOT COMPLETED|Overall Study||67||68
48730993|NCT00417963|102126897|FG000|STARTED|Overall Study||486||
48730994|NCT00417963|102126897|FG000|COMPLETED|Overall Study||445||
48730995|NCT00417963|102126897|FG000|NOT COMPLETED|Overall Study||41||
48730996|NCT02696759|102126898|FG000|STARTED|Overall Study||15||
48730997|NCT02696759|102126898|FG000|COMPLETED|Overall Study||15||
48730998|NCT02696759|102126898|FG000|NOT COMPLETED|Overall Study||0||
48730999|NCT01068158|102126899|FG000|STARTED|Overall Study||169||
48731000|NCT01068158|102126900|FG001|STARTED|Overall Study||202||
48731001|NCT01068158|102126899|FG000|COMPLETED|Overall Study||161||
48731002|NCT01068158|102126900|FG001|COMPLETED|Overall Study||198||
48731003|NCT01068158|102126899|FG000|NOT COMPLETED|Overall Study||8||
48731004|NCT01068158|102126900|FG001|NOT COMPLETED|Overall Study||4||
48731005|NCT00614484|102126901|FG000|STARTED|Overall Study||28||
48731006|NCT00614484|102126901|FG000|COMPLETED|Overall Study||28||
48731007|NCT00614484|102126901|FG000|NOT COMPLETED|Overall Study||0||
48731008|NCT00106353|102126902|FG000|STARTED|Part 1||4||
48731009|NCT00106353|102126903|FG001|STARTED|Part 1||5||
48731010|NCT00106353|102126904|FG002|STARTED|Part 1||3||
48731011|NCT00106353|102126905|FG003|STARTED|Part 1||7||
48731012|NCT00106353|102126906|FG004|STARTED|Part 1||0||
48731013|NCT00106353|102126907|FG005|STARTED|Part 1||0||
48731014|NCT00106353|102126908|FG006|STARTED|Part 1||0||
48731015|NCT00106353|102126902|FG000|COMPLETED|Part 1||0||
48731016|NCT00106353|102126903|FG001|COMPLETED|Part 1||0||
48731017|NCT00106353|102126904|FG002|COMPLETED|Part 1||0||
48731018|NCT00106353|102126905|FG003|COMPLETED|Part 1||0||
48731019|NCT00106353|102126906|FG004|COMPLETED|Part 1||0||
48158124|NCT00615264|100710986|FG001|COMPLETED|Overall Study||180||
48158125|NCT00615264|100710985|FG000|NOT COMPLETED|Overall Study||50||
48158126|NCT00615264|100710986|FG001|NOT COMPLETED|Overall Study||52||
48158127|NCT01376323|100710987|FG000|STARTED|Overall Study||20||
48158128|NCT01376323|100710988|FG001|STARTED|Overall Study||18||
48158129|NCT01376323|100710989|FG002|STARTED|Overall Study||19||
48158130|NCT01376323|100710990|FG003|STARTED|Overall Study||19||
48158131|NCT01376323|100710991|FG004|STARTED|Overall Study||18||
48158132|NCT01376323|100710987|FG000|COMPLETED|Overall Study||18||
48158133|NCT01376323|100710988|FG001|COMPLETED|Overall Study||17||
48158134|NCT01376323|100710989|FG002|COMPLETED|Overall Study||16||
48158135|NCT01376323|100710990|FG003|COMPLETED|Overall Study||14||
48158136|NCT01376323|100710991|FG004|COMPLETED|Overall Study||17||
48158137|NCT01376323|100710987|FG000|NOT COMPLETED|Overall Study||2||
48158138|NCT01376323|100710988|FG001|NOT COMPLETED|Overall Study||1||
48158139|NCT01376323|100710989|FG002|NOT COMPLETED|Overall Study||3||
48731020|NCT00106353|102126907|FG005|COMPLETED|Part 1||0||
48731021|NCT00106353|102126908|FG006|COMPLETED|Part 1||0||
48731022|NCT00106353|102126902|FG000|NOT COMPLETED|Part 1||4||
48731023|NCT00106353|102126903|FG001|NOT COMPLETED|Part 1||5||
48158140|NCT01376323|100710990|FG003|NOT COMPLETED|Overall Study||5||
48158141|NCT01376323|100710991|FG004|NOT COMPLETED|Overall Study||1||
48158142|NCT00971750|100710992|FG000|STARTED|Overall Study||253||
48158143|NCT00971750|100710992|FG000|COMPLETED|Overall Study||253||
48158144|NCT00971750|100710992|FG000|NOT COMPLETED|Overall Study||0||
48731024|NCT00106353|102126904|FG002|NOT COMPLETED|Part 1||3||
48731025|NCT00106353|102126905|FG003|NOT COMPLETED|Part 1||7||
48731026|NCT00106353|102126906|FG004|NOT COMPLETED|Part 1||0||
48731027|NCT00106353|102126907|FG005|NOT COMPLETED|Part 1||0||
48731028|NCT00106353|102126908|FG006|NOT COMPLETED|Part 1||0||
48731029|NCT00106353|102126902|FG000|STARTED|Part 2||0||
48731030|NCT00106353|102126903|FG001|STARTED|Part 2||0||
48731031|NCT00106353|102126904|FG002|STARTED|Part 2||0||
48731032|NCT00106353|102126905|FG003|STARTED|Part 2||0||
48731033|NCT00106353|102126906|FG004|STARTED|Part 2||17||
48731034|NCT00106353|102126907|FG005|STARTED|Part 2||19||
48731035|NCT00106353|102126908|FG006|STARTED|Part 2||16||
48731036|NCT00106353|102126902|FG000|COMPLETED|Part 2||0||
48731037|NCT00106353|102126903|FG001|COMPLETED|Part 2||0||
48731038|NCT00106353|102126904|FG002|COMPLETED|Part 2||0||
48731039|NCT00106353|102126905|FG003|COMPLETED|Part 2||0||
48731040|NCT00106353|102126906|FG004|COMPLETED|Part 2||1||
48731041|NCT00106353|102126907|FG005|COMPLETED|Part 2||1||
48314163|NCT00528580|101094261|FG001|NOT COMPLETED|Overall Study||0||
48314164|NCT01226459|101094262|FG000|STARTED|Overall Study||201||
48731042|NCT00106353|102126908|FG006|COMPLETED|Part 2||0||
48731043|NCT00106353|102126902|FG000|NOT COMPLETED|Part 2||0||
48731044|NCT00106353|102126903|FG001|NOT COMPLETED|Part 2||0||
48731045|NCT00106353|102126904|FG002|NOT COMPLETED|Part 2||0||
48731046|NCT00106353|102126905|FG003|NOT COMPLETED|Part 2||0||
48731047|NCT00106353|102126906|FG004|NOT COMPLETED|Part 2||16||
48731048|NCT00106353|102126907|FG005|NOT COMPLETED|Part 2||18||
48731049|NCT00106353|102126908|FG006|NOT COMPLETED|Part 2||16||
48731050|NCT00167310|102126909|FG000|STARTED|Overall Study||29||
48731051|NCT00167310|102126910|FG001|STARTED|Overall Study||28||
48731052|NCT00167310|102126909|FG000|COMPLETED|Overall Study||21||
48731053|NCT00167310|102126910|FG001|COMPLETED|Overall Study||18||
48731054|NCT00167310|102126909|FG000|NOT COMPLETED|Overall Study||8||
48731055|NCT00167310|102126910|FG001|NOT COMPLETED|Overall Study||10||
48731056|NCT01138501|102126911|FG000|STARTED|Overall Study||65||
48731057|NCT01138501|102126911|FG000|Exposed|Overall Study||63||
48731058|NCT01138501|102126911|FG000|COMPLETED|Overall Study||60||
48731059|NCT01138501|102126911|FG000|NOT COMPLETED|Overall Study||5||
48731060|NCT00811174|102126912|FG000|STARTED|Overall Study||5||
48731061|NCT00811174|102126912|FG000|COMPLETED|Overall Study||2||
48731062|NCT00811174|102126912|FG000|NOT COMPLETED|Overall Study||3||
48731063|NCT03036189|102126913|FG000|STARTED|Overall Study||104||
48731064|NCT03036189|102126914|FG001|STARTED|Overall Study||107||
48731065|NCT03036189|102126913|FG000|COMPLETED|Overall Study||69||
48731066|NCT03036189|102126914|FG001|COMPLETED|Overall Study||74||
48731067|NCT03036189|102126913|FG000|NOT COMPLETED|Overall Study||35||
48731068|NCT03036189|102126914|FG001|NOT COMPLETED|Overall Study||33||
48731069|NCT03350906|102126915|FG000|STARTED|Overall Study||30||
48731070|NCT03350906|102126916|FG001|STARTED|Overall Study||33||
48731071|NCT03350906|102126915|FG000|COMPLETED|Overall Study||30||
48731072|NCT03350906|102126916|FG001|COMPLETED|Overall Study||33||
48731073|NCT03350906|102126915|FG000|NOT COMPLETED|Overall Study||0||
48731074|NCT03350906|102126916|FG001|NOT COMPLETED|Overall Study||0||
48731075|NCT00211887|102126917|FG000|STARTED|Overall Study||499||
48731076|NCT00211887|102126918|FG001|STARTED|Overall Study||250||
48731077|NCT00211887|102126919|FG002|STARTED|Overall Study||259||
48731078|NCT00211887|102126917|FG000|COMPLETED|Overall Study||397||
48731079|NCT00211887|102126918|FG001|COMPLETED|Overall Study||194||
48731080|NCT00211887|102126919|FG002|COMPLETED|Overall Study||223||
48731081|NCT00211887|102126917|FG000|NOT COMPLETED|Overall Study||102||
48731082|NCT00211887|102126918|FG001|NOT COMPLETED|Overall Study||56||
48731083|NCT00211887|102126919|FG002|NOT COMPLETED|Overall Study||36||
48731084|NCT01730586|102126920|FG000|STARTED|Overall Study||34||
48731085|NCT01730586|102126920|FG000|COMPLETED|Overall Study||21||
48731086|NCT01730586|102126920|FG000|NOT COMPLETED|Overall Study||13||
48731087|NCT00895310|102126921|FG000|STARTED|Overall Study||30||
48731088|NCT00895310|102126921|FG000|COMPLETED|Overall Study||29||
48731089|NCT00895310|102126921|FG000|NOT COMPLETED|Overall Study||1||
48731090|NCT02280317|102126922|FG000|STARTED|Overall Study||1||
48731091|NCT02280317|102126923|FG001|STARTED|Overall Study||1||
48731092|NCT02280317|102126924|FG002|STARTED|Overall Study||3||
48731093|NCT02280317|102126925|FG003|STARTED|Overall Study||5||
48731094|NCT02280317|102126926|FG004|STARTED|Overall Study||2||
48731095|NCT02280317|102126922|FG000|COMPLETED|Overall Study||1||
48731096|NCT02280317|102126923|FG001|COMPLETED|Overall Study||1||
48731097|NCT02280317|102126924|FG002|COMPLETED|Overall Study||0||
48731098|NCT02280317|102126925|FG003|COMPLETED|Overall Study||2||
48731099|NCT02280317|102126926|FG004|COMPLETED|Overall Study||0||
48731100|NCT02280317|102126922|FG000|NOT COMPLETED|Overall Study||0||
48731101|NCT02280317|102126923|FG001|NOT COMPLETED|Overall Study||0||
48731102|NCT02280317|102126924|FG002|NOT COMPLETED|Overall Study||3||
48731103|NCT02280317|102126925|FG003|NOT COMPLETED|Overall Study||3||
48314165|NCT01226459|101094263|FG001|STARTED|Overall Study||203||
48314166|NCT01226459|101094262|FG000|COMPLETED|Overall Study||180||
48314167|NCT01226459|101094263|FG001|COMPLETED|Overall Study||171||
48314168|NCT01226459|101094262|FG000|NOT COMPLETED|Overall Study||21||
48731104|NCT02280317|102126926|FG004|NOT COMPLETED|Overall Study||2||
48731105|NCT01971008|102126927|FG000|STARTED|Overall Study||6||
48406902|NCT03424044|101328484|FG000|STARTED|Third Intervention (76 Hours)||4||
48731106|NCT01971008|102126928|FG001|STARTED|Overall Study||9||
48731107|NCT01971008|102126927|FG000|COMPLETED|Overall Study||4||
48731108|NCT01971008|102126928|FG001|COMPLETED|Overall Study||8||
48731109|NCT01971008|102126927|FG000|NOT COMPLETED|Overall Study||2||
48731110|NCT01971008|102126928|FG001|NOT COMPLETED|Overall Study||1||
48731111|NCT03878758|102126929|FG000|STARTED|Overall Study||158||
48731112|NCT03878758|102126929|FG000|COMPLETED|Overall Study||154||
48731113|NCT03878758|102126929|FG000|NOT COMPLETED|Overall Study||4||
48731114|NCT00151372|102126930|FG000|STARTED|Overall Study||67||
48731115|NCT00151372|102126931|FG001|STARTED|Overall Study||74||
48731116|NCT00151372|102126930|FG000|COMPLETED|Overall Study||38||
48731117|NCT00151372|102126931|FG001|COMPLETED|Overall Study||45||
48731118|NCT00151372|102126930|FG000|NOT COMPLETED|Overall Study||29||
48731119|NCT00151372|102126931|FG001|NOT COMPLETED|Overall Study||29||
48731120|NCT00639626|102126932|FG000|STARTED|Overall Study||0||
48731121|NCT00639626|102126932|FG000|COMPLETED|Overall Study||0||
48731122|NCT00639626|102126932|FG000|NOT COMPLETED|Overall Study||0||
48731123|NCT02020408|102126933|FG000|STARTED|Overall Study||88||
48731124|NCT02020408|102126933|FG000|COMPLETED|Overall Study||85||
48731125|NCT02020408|102126933|FG000|NOT COMPLETED|Overall Study||3||
48731126|NCT05740332|102126934|FG000|STARTED|Overall Study||46||
48731127|NCT05740332|102126934|FG000|COMPLETED|Overall Study||46||
48731128|NCT05740332|102126934|FG000|NOT COMPLETED|Overall Study||0||
48731129|NCT02421588|102126935|FG000|STARTED|Overall Study||221||
48731130|NCT02421588|102126936|FG001|STARTED|Overall Study||221||
48731131|NCT02421588|102126935|FG000|COMPLETED|Overall Study||0||
48731132|NCT02421588|102126936|FG001|COMPLETED|Overall Study||0||
48731133|NCT02421588|102126935|FG000|NOT COMPLETED|Overall Study||221||
48731134|NCT02421588|102126936|FG001|NOT COMPLETED|Overall Study||221||
48731135|NCT01368081|102126937|FG000|STARTED|Overall Study||136||
48731136|NCT01368081|102126938|FG001|STARTED|Overall Study||137||
48731137|NCT01368081|102126939|FG002|STARTED|Overall Study||63||
48731138|NCT01368081|102126940|FG003|STARTED|Overall Study||68||
48731139|NCT01368081|102126941|FG004|STARTED|Overall Study||65||
48731140|NCT01368081|102126942|FG005|STARTED|Overall Study||137||
48731141|NCT01368081|102126943|FG006|STARTED|Overall Study||136||
48731142|NCT01368081|102126944|FG007|STARTED|Overall Study||69||
48731143|NCT01368081|102126945|FG008|STARTED|Overall Study||70||
48731144|NCT01368081|102126946|FG009|STARTED|Overall Study||68||
48731145|NCT01368081|102126947|FG010|STARTED|Overall Study||71||
48731146|NCT01368081|102126948|FG011|STARTED|Overall Study||70||
48731147|NCT01368081|102126949|FG012|STARTED|Overall Study||70||
48731148|NCT01368081|102126937|FG000|COMPLETED|Overall Study||126||
48731149|NCT01368081|102126938|FG001|COMPLETED|Overall Study||128||
48731150|NCT01368081|102126939|FG002|COMPLETED|Overall Study||59||
48731151|NCT01368081|102126940|FG003|COMPLETED|Overall Study||63||
48731152|NCT01368081|102126941|FG004|COMPLETED|Overall Study||63||
48731153|NCT01368081|102126942|FG005|COMPLETED|Overall Study||127||
48731154|NCT01368081|102126943|FG006|COMPLETED|Overall Study||124||
48731155|NCT01368081|102126944|FG007|COMPLETED|Overall Study||62||
48731156|NCT01368081|102126945|FG008|COMPLETED|Overall Study||62||
48731157|NCT01368081|102126946|FG009|COMPLETED|Overall Study||58||
48731158|NCT01368081|102126947|FG010|COMPLETED|Overall Study||62||
48731159|NCT01368081|102126948|FG011|COMPLETED|Overall Study||67||
48731160|NCT01368081|102126949|FG012|COMPLETED|Overall Study||63||
48731161|NCT01368081|102126937|FG000|NOT COMPLETED|Overall Study||10||
48731162|NCT01368081|102126938|FG001|NOT COMPLETED|Overall Study||9||
48731163|NCT01368081|102126939|FG002|NOT COMPLETED|Overall Study||4||
48731164|NCT01368081|102126940|FG003|NOT COMPLETED|Overall Study||5||
48731165|NCT01368081|102126941|FG004|NOT COMPLETED|Overall Study||2||
48731166|NCT01368081|102126942|FG005|NOT COMPLETED|Overall Study||10||
48731167|NCT01368081|102126943|FG006|NOT COMPLETED|Overall Study||12||
48731168|NCT01368081|102126944|FG007|NOT COMPLETED|Overall Study||7||
48731169|NCT01368081|102126945|FG008|NOT COMPLETED|Overall Study||8||
48731170|NCT01368081|102126946|FG009|NOT COMPLETED|Overall Study||10||
48731171|NCT01368081|102126947|FG010|NOT COMPLETED|Overall Study||9||
48731172|NCT01368081|102126948|FG011|NOT COMPLETED|Overall Study||3||
48731173|NCT01368081|102126949|FG012|NOT COMPLETED|Overall Study||7||
48731174|NCT01817959|102126950|FG000|STARTED|Overall Study||29||
48731175|NCT01817959|102126951|FG001|STARTED|Overall Study||19||
48731176|NCT01817959|102126950|FG000|COMPLETED|Overall Study||25||
48158145|NCT02202746|100710993|FG000|STARTED|Overall Study||109||
48158146|NCT02202746|100710994|FG001|STARTED|Overall Study||69||
48158147|NCT02202746|100710993|FG000|COMPLETED|Overall Study||109||
48158148|NCT02202746|100710994|FG001|COMPLETED|Overall Study||69||
48158149|NCT02202746|100710993|FG000|NOT COMPLETED|Overall Study||0||
48158150|NCT02202746|100710994|FG001|NOT COMPLETED|Overall Study||0||
48731177|NCT01817959|102126951|FG001|COMPLETED|Overall Study||16||
48731178|NCT01817959|102126950|FG000|NOT COMPLETED|Overall Study||4||
48731179|NCT01817959|102126951|FG001|NOT COMPLETED|Overall Study||3||
48731180|NCT02915978|102126952|FG000|STARTED|Overall Study||15||
48731181|NCT02915978|102126953|FG001|STARTED|Overall Study||15||
48731182|NCT02915978|102126954|FG002|STARTED|Overall Study||15||
48731183|NCT02915978|102126952|FG000|COMPLETED|Overall Study||13||
48731184|NCT02915978|102126953|FG001|COMPLETED|Overall Study||14||
48731185|NCT02915978|102126954|FG002|COMPLETED|Overall Study||15||
48731186|NCT02915978|102126952|FG000|NOT COMPLETED|Overall Study||2||
48731187|NCT02915978|102126953|FG001|NOT COMPLETED|Overall Study||1||
48731188|NCT02915978|102126954|FG002|NOT COMPLETED|Overall Study||0||
48731189|NCT01307462|102126955|FG000|STARTED|Overall Study||36||
48731190|NCT01307462|102126955|FG000|COMPLETED|Overall Study||35||
48731191|NCT01307462|102126955|FG000|NOT COMPLETED|Overall Study||1||
48731192|NCT00667849|102126956|FG000|STARTED|Overall Study||250||
48731193|NCT00667849|102126957|FG001|STARTED|Overall Study||251||
48731194|NCT00667849|102126956|FG000|COMPLETED|Overall Study||142||
48731195|NCT00667849|102126957|FG001|COMPLETED|Overall Study||130||
48731196|NCT00667849|102126956|FG000|NOT COMPLETED|Overall Study||108||
48731197|NCT00667849|102126957|FG001|NOT COMPLETED|Overall Study||121||
48731198|NCT03857542|102126958|FG000|STARTED|Overall Study||215||
48731199|NCT03857542|102126959|FG001|STARTED|Overall Study||212||
48731200|NCT03857542|102126958|FG000|COMPLETED|Overall Study||209||
48731201|NCT03857542|102126959|FG001|COMPLETED|Overall Study||207||
48731202|NCT03857542|102126958|FG000|NOT COMPLETED|Overall Study||6||
48731203|NCT03857542|102126959|FG001|NOT COMPLETED|Overall Study||5||
48731204|NCT04302545|102126960|FG000|STARTED|Overall Study||107||
48731205|NCT04302545|102126961|FG001|STARTED|Overall Study||107||
48731206|NCT04302545|102126960|FG000|COMPLETED|Overall Study||104||
48731207|NCT04302545|102126961|FG001|COMPLETED|Overall Study||103||
48731208|NCT04302545|102126960|FG000|NOT COMPLETED|Overall Study||3||
48731209|NCT04302545|102126961|FG001|NOT COMPLETED|Overall Study||4||
48731210|NCT00365274|102126962|FG000|STARTED|Overall Study||6||
48731211|NCT00365274|102126962|FG000|COMPLETED|Overall Study||6||
48731212|NCT00365274|102126962|FG000|NOT COMPLETED|Overall Study||0||
48158151|NCT00674570|100710995|FG000|STARTED|Overall Study||37|5 participants dropped out between screening and randomization to group.|
48158152|NCT00674570|100710996|FG001|STARTED|Overall Study||34|5 participants dropped out between screening and randomization to group.|
48158153|NCT00674570|100710997|FG002|STARTED|Overall Study||35|5 participants dropped out between screening and randomization to group.|
48314169|NCT01226459|101094263|FG001|NOT COMPLETED|Overall Study||32||
48314170|NCT01490450|101094264|FG000|STARTED|Period 1||41||
48314171|NCT01490450|101094265|FG001|STARTED|Period 1||41||
48314172|NCT01490450|101094266|FG002|STARTED|Period 1||42||
48314173|NCT01490450|101094267|FG003|STARTED|Period 1||41||
48314174|NCT01490450|101094264|FG000|COMPLETED|Period 1||38||
48314175|NCT01490450|101094265|FG001|COMPLETED|Period 1||40||
48314176|NCT01490450|101094266|FG002|COMPLETED|Period 1||38||
48314177|NCT01490450|101094267|FG003|COMPLETED|Period 1||33||
48314178|NCT01490450|101094264|FG000|NOT COMPLETED|Period 1||3||
48314179|NCT01490450|101094265|FG001|NOT COMPLETED|Period 1||1||
48314180|NCT01490450|101094266|FG002|NOT COMPLETED|Period 1||4||
48314181|NCT01490450|101094267|FG003|NOT COMPLETED|Period 1||8||
48314182|NCT01490450|101094264|FG000|STARTED|Period 2||38||
48314183|NCT01490450|101094265|FG001|STARTED|Period 2||40||
48314184|NCT01490450|101094266|FG002|STARTED|Period 2||37||
48314185|NCT01490450|101094267|FG003|STARTED|Period 2||32||
48314186|NCT01490450|101094264|FG000|COMPLETED|Period 2||36||
48314187|NCT01490450|101094265|FG001|COMPLETED|Period 2||39||
48731213|NCT01223183|102126963|FG000|STARTED|Imaging Day 1||10||
48731214|NCT01223183|102126964|FG001|STARTED|Imaging Day 1||10||
48731215|NCT01223183|102126963|FG000|COMPLETED|Imaging Day 1||10||
48731216|NCT01223183|102126964|FG001|COMPLETED|Imaging Day 1||9||
48731217|NCT01223183|102126963|FG000|NOT COMPLETED|Imaging Day 1||0||
48731218|NCT01223183|102126964|FG001|NOT COMPLETED|Imaging Day 1||1||
48731219|NCT01223183|102126963|FG000|STARTED|Washout Period (5-24 Days)||10||
48731220|NCT01223183|102126964|FG001|STARTED|Washout Period (5-24 Days)||9||
48731221|NCT01223183|102126963|FG000|COMPLETED|Washout Period (5-24 Days)||8||
48731222|NCT01223183|102126964|FG001|COMPLETED|Washout Period (5-24 Days)||9||
48731223|NCT01223183|102126963|FG000|NOT COMPLETED|Washout Period (5-24 Days)||2||
48731224|NCT01223183|102126964|FG001|NOT COMPLETED|Washout Period (5-24 Days)||0||
48731225|NCT01223183|102126963|FG000|STARTED|Imaging Day 2||8||
48731226|NCT01223183|102126964|FG001|STARTED|Imaging Day 2||9||
48731227|NCT01223183|102126963|FG000|COMPLETED|Imaging Day 2||8||
48314188|NCT01490450|101094266|FG002|COMPLETED|Period 2||37||
48314189|NCT01490450|101094267|FG003|COMPLETED|Period 2||28||
48314190|NCT01490450|101094264|FG000|NOT COMPLETED|Period 2||2||
48314191|NCT01490450|101094265|FG001|NOT COMPLETED|Period 2||1||
48314192|NCT01490450|101094266|FG002|NOT COMPLETED|Period 2||0||
48314193|NCT01490450|101094267|FG003|NOT COMPLETED|Period 2||4||
48314194|NCT00383084|101094268|FG000|STARTED|Overall Study||46||
48314195|NCT00383084|101094269|FG001|STARTED|Overall Study||38||
48314196|NCT00383084|101094268|FG000|COMPLETED|Overall Study||34||
48314197|NCT00383084|101094269|FG001|COMPLETED|Overall Study||28||
48314198|NCT00383084|101094268|FG000|NOT COMPLETED|Overall Study||12||
48314199|NCT00383084|101094269|FG001|NOT COMPLETED|Overall Study||10||
48314200|NCT02536313|101094270|FG000|STARTED|Overall Study||24||
48314201|NCT02536313|101094271|FG001|STARTED|Overall Study||25||
48731228|NCT01223183|102126964|FG001|COMPLETED|Imaging Day 2||9||
48731229|NCT01223183|102126963|FG000|NOT COMPLETED|Imaging Day 2||0||
48731230|NCT01223183|102126964|FG001|NOT COMPLETED|Imaging Day 2||0||
48731231|NCT02413047|102126965|FG000|STARTED|Overall Study||3||
48731232|NCT02413047|102126965|FG000|Participants on Infliximab|Overall Study||2||
48731233|NCT02413047|102126965|FG000|Participants on Adalimumab|Overall Study||1||
48731234|NCT02413047|102126965|FG000|COMPLETED|Overall Study||3||
48731235|NCT02413047|102126965|FG000|NOT COMPLETED|Overall Study||0||
48731236|NCT00122369|102126966|FG000|STARTED|Overall Study||76||
48731237|NCT00122369|102126967|FG001|STARTED|Overall Study||82||
48314202|NCT02536313|101094270|FG000|COMPLETED|Overall Study||24||
48314203|NCT02536313|101094271|FG001|COMPLETED|Overall Study||24||
48314204|NCT02536313|101094270|FG000|NOT COMPLETED|Overall Study||0||
48314205|NCT02536313|101094271|FG001|NOT COMPLETED|Overall Study||1||
48731238|NCT00122369|102126968|FG002|STARTED|Overall Study||78||
48158154|NCT00674570|100710995|FG000|COMPLETED|Overall Study||37||
48158155|NCT00674570|100710996|FG001|COMPLETED|Overall Study||32||
48314206|NCT00006151|101094272|FG000|STARTED|Overall Study||30||
48314207|NCT00006151|101094273|FG001|STARTED|Overall Study||30||
48314208|NCT00006151|101094272|FG000|COMPLETED|Overall Study||17||
48314209|NCT00006151|101094273|FG001|COMPLETED|Overall Study||16||
48314210|NCT00006151|101094272|FG000|NOT COMPLETED|Overall Study||13||
48314211|NCT00006151|101094273|FG001|NOT COMPLETED|Overall Study||14||
48314212|NCT02171611|101094274|FG000|STARTED|Overall Study||5||
48314213|NCT02171611|101094275|FG001|STARTED|Overall Study||5||
48158156|NCT00674570|100710997|FG002|COMPLETED|Overall Study||35||
48158157|NCT00674570|100710995|FG000|NOT COMPLETED|Overall Study||0||
48158158|NCT00674570|100710996|FG001|NOT COMPLETED|Overall Study||2||
48158159|NCT00674570|100710997|FG002|NOT COMPLETED|Overall Study||0||
48314214|NCT02171611|101094276|FG002|STARTED|Overall Study||5||
48314215|NCT02171611|101094277|FG003|STARTED|Overall Study||5||
48314216|NCT02171611|101094278|FG004|STARTED|Overall Study||5||
48314217|NCT02171611|101094279|FG005|STARTED|Overall Study||5||
48314218|NCT02171611|101094274|FG000|COMPLETED|Overall Study||5||
48314219|NCT02171611|101094275|FG001|COMPLETED|Overall Study||5||
48314220|NCT02171611|101094276|FG002|COMPLETED|Overall Study||5||
48314221|NCT02171611|101094277|FG003|COMPLETED|Overall Study||5||
48314222|NCT02171611|101094278|FG004|COMPLETED|Overall Study||5||
48314223|NCT02171611|101094279|FG005|COMPLETED|Overall Study||5||
48314224|NCT02171611|101094274|FG000|NOT COMPLETED|Overall Study||0||
48314225|NCT02171611|101094275|FG001|NOT COMPLETED|Overall Study||0||
48314226|NCT02171611|101094276|FG002|NOT COMPLETED|Overall Study||0||
48314227|NCT02171611|101094277|FG003|NOT COMPLETED|Overall Study||0||
48314228|NCT02171611|101094278|FG004|NOT COMPLETED|Overall Study||0||
48314229|NCT02171611|101094279|FG005|NOT COMPLETED|Overall Study||0||
48314230|NCT01621230|101094280|FG000|STARTED|Overall Study||154||
48314231|NCT01621230|101094281|FG001|STARTED|Overall Study||156||
48158160|NCT04247282|100710998|FG000|STARTED|Overall Study||14||
48158161|NCT04247282|100710999|FG001|STARTED|Overall Study||6||
48314232|NCT01621230|101094280|FG000|COMPLETED|Overall Study||154||
48314233|NCT01621230|101094281|FG001|COMPLETED|Overall Study||156||
48314234|NCT01621230|101094280|FG000|NOT COMPLETED|Overall Study||0||
48314235|NCT01621230|101094281|FG001|NOT COMPLETED|Overall Study||0||
48314236|NCT01353196|101094282|FG000|STARTED|Overall Study||100||
48314237|NCT01353196|101094283|FG001|STARTED|Overall Study||70||
48314238|NCT01353196|101094282|FG000|COMPLETED|Overall Study||71||
48314239|NCT01353196|101094283|FG001|COMPLETED|Overall Study||59||
48314240|NCT01353196|101094282|FG000|NOT COMPLETED|Overall Study||29||
48314241|NCT01353196|101094283|FG001|NOT COMPLETED|Overall Study||11||
48406903|NCT03424044|101328485|FG001|STARTED|Third Intervention (76 Hours)||3||
48614513|NCT01673178|101841770|FG003|COMPLETED|Overall Study||14||
48614514|NCT01673178|101841771|FG004|COMPLETED|Overall Study||19||
48614515|NCT01673178|101841767|FG000|NOT COMPLETED|Overall Study||3||
48614516|NCT01673178|101841768|FG001|NOT COMPLETED|Overall Study||2||
48614517|NCT01673178|101841769|FG002|NOT COMPLETED|Overall Study||3||
48614518|NCT01673178|101841770|FG003|NOT COMPLETED|Overall Study||8||
48614519|NCT01673178|101841771|FG004|NOT COMPLETED|Overall Study||2||
48614520|NCT00837967|101841772|FG000|STARTED|First Intervention||13||
48614521|NCT00837967|101841773|FG001|STARTED|First Intervention||12||
48614522|NCT00837967|101841772|FG000|COMPLETED|First Intervention||13||
48614523|NCT00837967|101841773|FG001|COMPLETED|First Intervention||12||
48614524|NCT00837967|101841772|FG000|NOT COMPLETED|First Intervention||0||
48614525|NCT00837967|101841773|FG001|NOT COMPLETED|First Intervention||0||
48614526|NCT00837967|101841772|FG000|STARTED|Washout Period of 7 - 14 Days||13||
48614527|NCT00837967|101841773|FG001|STARTED|Washout Period of 7 - 14 Days||12||
48614528|NCT00837967|101841772|FG000|COMPLETED|Washout Period of 7 - 14 Days||11||
48614529|NCT00837967|101841773|FG001|COMPLETED|Washout Period of 7 - 14 Days||12||
48614530|NCT00837967|101841772|FG000|NOT COMPLETED|Washout Period of 7 - 14 Days||2||
48614531|NCT00837967|101841773|FG001|NOT COMPLETED|Washout Period of 7 - 14 Days||0||
48731239|NCT00122369|102126966|FG000|COMPLETED|Overall Study||76||
48731240|NCT00122369|102126967|FG001|COMPLETED|Overall Study||82||
48731241|NCT00122369|102126968|FG002|COMPLETED|Overall Study||78||
48731242|NCT00122369|102126966|FG000|NOT COMPLETED|Overall Study||0||
48731243|NCT00122369|102126967|FG001|NOT COMPLETED|Overall Study||0||
48731244|NCT00122369|102126968|FG002|NOT COMPLETED|Overall Study||0||
48314242|NCT00820950|101094284|FG000|STARTED|Overall Study||6||6
48314243|NCT00820950|101094285|FG001|STARTED|Overall Study||6||6
48314244|NCT00820950|101094286|FG002|STARTED|Overall Study||6||6
48614532|NCT00837967|101841772|FG000|STARTED|Second Intervention||11||
48614533|NCT00837967|101841773|FG001|STARTED|Second Intervention||12||
48614534|NCT00837967|101841772|FG000|COMPLETED|Second Intervention||11||
48614535|NCT00837967|101841773|FG001|COMPLETED|Second Intervention||12||
48314245|NCT00820950|101094287|FG003|STARTED|Overall Study||6||6
48314246|NCT00820950|101094288|FG004|STARTED|Overall Study||6||6
48314247|NCT00820950|101094289|FG005|STARTED|Overall Study||6||6
48314248|NCT00820950|101094290|FG006|STARTED|Overall Study||6||6
48314249|NCT00820950|101094291|FG007|STARTED|Overall Study||6||6
48314250|NCT00820950|101094292|FG008|STARTED|Overall Study||5||5
48314251|NCT00820950|101094293|FG009|STARTED|Overall Study||5||5
48314252|NCT00820950|101094284|FG000|COMPLETED|Overall Study||5||5
48314253|NCT00820950|101094285|FG001|COMPLETED|Overall Study||5||5
48158162|NCT04247282|100711000|FG002|STARTED|Overall Study||0||
48158163|NCT04247282|100711001|FG003|STARTED|Overall Study||1||
48158164|NCT04247282|100710998|FG000|COMPLETED|Overall Study||14||
48158165|NCT04247282|100710999|FG001|COMPLETED|Overall Study||5||
48158166|NCT04247282|100711000|FG002|COMPLETED|Overall Study||0||
48158167|NCT04247282|100711001|FG003|COMPLETED|Overall Study||0||
48158168|NCT04247282|100710998|FG000|NOT COMPLETED|Overall Study||0||
48158169|NCT04247282|100710999|FG001|NOT COMPLETED|Overall Study||1||
48314254|NCT00820950|101094286|FG002|COMPLETED|Overall Study||6||6
48314255|NCT00820950|101094287|FG003|COMPLETED|Overall Study||6||6
48314256|NCT00820950|101094288|FG004|COMPLETED|Overall Study||6||6
48314257|NCT00820950|101094289|FG005|COMPLETED|Overall Study||6||6
48314258|NCT00820950|101094290|FG006|COMPLETED|Overall Study||5||5
48314259|NCT00820950|101094291|FG007|COMPLETED|Overall Study||5||5
48314260|NCT00820950|101094292|FG008|COMPLETED|Overall Study||5||5
48314261|NCT00820950|101094293|FG009|COMPLETED|Overall Study||5||5
48731245|NCT03595527|102126969|FG000|STARTED|Overall Study||6350||
48731246|NCT03595527|102126969|FG000|Patients Screened for HIV|Overall Study||3905||
48731247|NCT03595527|102126969|FG000|Patients Screened for HCV|Overall Study||3910||
48731248|NCT03595527|102126969|FG000|COMPLETED|Overall Study||6350||
48731249|NCT03595527|102126969|FG000|NOT COMPLETED|Overall Study||0||
48731250|NCT01108523|102126970|FG000|STARTED|Overall Study||7||
48731251|NCT01108523|102126970|FG000|COMPLETED|Overall Study||3||
48731252|NCT01108523|102126970|FG000|NOT COMPLETED|Overall Study||4||
48731253|NCT01345669|102126971|FG000|STARTED|Overall Study||411||
48731254|NCT01345669|102126972|FG001|STARTED|Overall Study||206||
48731255|NCT01345669|102126971|FG000|COMPLETED|Overall Study||124||
48731256|NCT01345669|102126972|FG001|COMPLETED|Overall Study||87||
48731257|NCT01345669|102126971|FG000|NOT COMPLETED|Overall Study||287||
48731258|NCT01345669|102126972|FG001|NOT COMPLETED|Overall Study||119||
48731259|NCT00408434|102126973|FG000|STARTED|Overall Study||6||
48731260|NCT00408434|102126974|FG001|STARTED|Overall Study||3||
48731261|NCT00408434|102126975|FG002|STARTED|Overall Study||6||
48731262|NCT00408434|102126976|FG003|STARTED|Overall Study||3||
48731263|NCT00408434|102126977|FG004|STARTED|Overall Study||6||
48731264|NCT00408434|102126978|FG005|STARTED|Overall Study||3||
48731265|NCT00408434|102126979|FG006|STARTED|Overall Study||4||
48731266|NCT00408434|102126973|FG000|COMPLETED|Overall Study||0||
48731267|NCT00408434|102126974|FG001|COMPLETED|Overall Study||0||
48731268|NCT00408434|102126975|FG002|COMPLETED|Overall Study||0||
48731269|NCT00408434|102126976|FG003|COMPLETED|Overall Study||0||
48731270|NCT00408434|102126977|FG004|COMPLETED|Overall Study||0||
48731271|NCT00408434|102126978|FG005|COMPLETED|Overall Study||0||
48731272|NCT00408434|102126979|FG006|COMPLETED|Overall Study||0||
48731273|NCT00408434|102126973|FG000|NOT COMPLETED|Overall Study||6||
48731274|NCT00408434|102126974|FG001|NOT COMPLETED|Overall Study||3||
48731275|NCT00408434|102126975|FG002|NOT COMPLETED|Overall Study||6||
48731276|NCT00408434|102126976|FG003|NOT COMPLETED|Overall Study||3||
48731277|NCT00408434|102126977|FG004|NOT COMPLETED|Overall Study||6||
48731278|NCT00408434|102126978|FG005|NOT COMPLETED|Overall Study||3||
48731279|NCT00408434|102126979|FG006|NOT COMPLETED|Overall Study||4||
48731280|NCT01793883|102126980|FG000|STARTED|Overall Study||213||
48731281|NCT01793883|102126981|FG001|STARTED|Overall Study||214||
48731282|NCT01793883|102126982|FG002|STARTED|Overall Study||212||
48731283|NCT01793883|102126980|FG000|COMPLETED|Overall Study||201||
48731284|NCT01793883|102126981|FG001|COMPLETED|Overall Study||204||
48731285|NCT01793883|102126982|FG002|COMPLETED|Overall Study||204||
48731286|NCT01793883|102126980|FG000|NOT COMPLETED|Overall Study||12||
48731287|NCT01793883|102126981|FG001|NOT COMPLETED|Overall Study||10||
48731288|NCT01793883|102126982|FG002|NOT COMPLETED|Overall Study||8||
48731289|NCT01628965|102126983|FG000|STARTED|Overall Study||143||
48158170|NCT04247282|100711000|FG002|NOT COMPLETED|Overall Study||0||
48314262|NCT00820950|101094284|FG000|NOT COMPLETED|Overall Study||1||1
48314263|NCT00820950|101094285|FG001|NOT COMPLETED|Overall Study||1||1
48314264|NCT00820950|101094286|FG002|NOT COMPLETED|Overall Study||0||0
48731290|NCT01628965|102126983|FG000|COMPLETED|Overall Study||94||
48731291|NCT01628965|102126983|FG000|NOT COMPLETED|Overall Study||49||
48731292|NCT01990612|102126984|FG000|STARTED|Overall Study||3044||
48731293|NCT01990612|102126985|FG001|STARTED|Overall Study||3062||
48731294|NCT01990612|102126984|FG000|COMPLETED|Overall Study||3037||
48314265|NCT00820950|101094287|FG003|NOT COMPLETED|Overall Study||0||0
48731295|NCT01990612|102126985|FG001|COMPLETED|Overall Study||3059||
48731296|NCT01990612|102126984|FG000|NOT COMPLETED|Overall Study||7||
48731297|NCT01990612|102126985|FG001|NOT COMPLETED|Overall Study||3||
48314266|NCT00820950|101094288|FG004|NOT COMPLETED|Overall Study||0||0
48314267|NCT00820950|101094289|FG005|NOT COMPLETED|Overall Study||0||0
48314268|NCT00820950|101094290|FG006|NOT COMPLETED|Overall Study||1||1
48314269|NCT00820950|101094291|FG007|NOT COMPLETED|Overall Study||1||1
48314270|NCT00820950|101094292|FG008|NOT COMPLETED|Overall Study||0||0
48314271|NCT00820950|101094293|FG009|NOT COMPLETED|Overall Study||0||0
48314272|NCT03600142|101094294|FG000|STARTED|Overall Study||777||
48314273|NCT03600142|101094295|FG001|STARTED|Overall Study||762||
48314274|NCT03600142|101094294|FG000|COMPLETED|Overall Study||773||
48314275|NCT03600142|101094295|FG001|COMPLETED|Overall Study||758||
48314276|NCT03600142|101094294|FG000|NOT COMPLETED|Overall Study||4||
48314277|NCT03600142|101094295|FG001|NOT COMPLETED|Overall Study||4||
48731298|NCT01196416|102126986|FG000|STARTED|Overall Study||14||
48731299|NCT01196416|102126986|FG000|COMPLETED|Overall Study||12||
48731300|NCT01196416|102126986|FG000|NOT COMPLETED|Overall Study||2||
48731301|NCT00006400|102126987|FG000|STARTED|Overall Study||96||
48731302|NCT00006400|102126988|FG001|STARTED|Overall Study||97||
48731303|NCT00006400|102126987|FG000|COMPLETED|Overall Study||83||
48731304|NCT00006400|102126988|FG001|COMPLETED|Overall Study||84||
48731305|NCT00006400|102126987|FG000|NOT COMPLETED|Overall Study||13||
48731306|NCT00006400|102126988|FG001|NOT COMPLETED|Overall Study||13||
48731307|NCT02227199|102126989|FG000|STARTED|Overall Study||3||
48731308|NCT02227199|102126990|FG001|STARTED|Overall Study||3||
48731309|NCT02227199|102126991|FG002|STARTED|Overall Study||39||
48731310|NCT02227199|102126989|FG000|COMPLETED|Overall Study||3||
48731311|NCT02227199|102126990|FG001|COMPLETED|Overall Study||3||
48731312|NCT02227199|102126991|FG002|COMPLETED|Overall Study||35||
48731313|NCT02227199|102126989|FG000|NOT COMPLETED|Overall Study||0||
48731314|NCT02227199|102126990|FG001|NOT COMPLETED|Overall Study||0||
48731315|NCT02227199|102126991|FG002|NOT COMPLETED|Overall Study||4||
48731316|NCT01549977|102126992|FG000|STARTED|Overall Study||1||
48731317|NCT01549977|102126993|FG001|STARTED|Overall Study||0||
48731318|NCT01549977|102126992|FG000|COMPLETED|Overall Study||1||
48731319|NCT01549977|102126993|FG001|COMPLETED|Overall Study||0||
48731320|NCT01549977|102126992|FG000|NOT COMPLETED|Overall Study||0||
48731321|NCT01549977|102126993|FG001|NOT COMPLETED|Overall Study||0||
48731322|NCT01130896|102126994|FG000|STARTED|Overall Study||1509||
48731323|NCT01130896|102126994|FG000|COMPLETED|Overall Study||1509||
48731324|NCT01130896|102126994|FG000|NOT COMPLETED|Overall Study||0||
48731325|NCT00621140|102126995|FG000|STARTED|Overall Study||167||
48731326|NCT00621140|102126996|FG001|STARTED|Overall Study||336||
48731327|NCT00621140|102126995|FG000|COMPLETED|Overall Study||152||
48731328|NCT00621140|102126996|FG001|COMPLETED|Overall Study||318||
48731329|NCT00621140|102126995|FG000|NOT COMPLETED|Overall Study||15||
48731330|NCT00621140|102126996|FG001|NOT COMPLETED|Overall Study||18||
48731331|NCT04565951|102126997|FG000|STARTED|Overall Study||151||
48731332|NCT04565951|102126998|FG001|STARTED|Overall Study||130||
48731333|NCT04565951|102126997|FG000|Responded to Baseline Survey|Overall Study||112||
48731334|NCT04565951|102126998|FG001|Responded to Baseline Survey|Overall Study||102||
48731335|NCT04565951|102126997|FG000|COMPLETED|Overall Study||71|Responded to 6-month follow-up survey|
48731336|NCT04565951|102126998|FG001|COMPLETED|Overall Study||84|Responded to 6-month follow-up survey|
48731337|NCT04565951|102126997|FG000|NOT COMPLETED|Overall Study||80||
48731338|NCT04565951|102126998|FG001|NOT COMPLETED|Overall Study||46||
48314278|NCT04206020|101094296|FG000|STARTED|Overall Study||306||
48314279|NCT04206020|101094297|FG001|STARTED|Overall Study||304||
48314280|NCT04206020|101094296|FG000|COMPLETED|Overall Study||298||
48314281|NCT04206020|101094297|FG001|COMPLETED|Overall Study||297||
48314282|NCT04206020|101094296|FG000|NOT COMPLETED|Overall Study||8||
48314283|NCT04206020|101094297|FG001|NOT COMPLETED|Overall Study||7||
48314284|NCT03331861|101094298|FG000|STARTED|Overall Study||2||
48314285|NCT03331861|101094299|FG001|STARTED|Overall Study||2||
48731339|NCT01468350|102126999|FG000|STARTED|(PART A) Day 1, Day 3||6||
48731340|NCT01468350|102127000|FG001|STARTED|(PART A) Day 1, Day 3||5||
48731341|NCT01468350|102127001|FG002|STARTED|(PART A) Day 1, Day 3||0||
48731342|NCT01468350|102127002|FG003|STARTED|(PART A) Day 1, Day 3||0||
48731343|NCT01468350|102126999|FG000|COMPLETED|(PART A) Day 1, Day 3||6||
48731344|NCT01468350|102127000|FG001|COMPLETED|(PART A) Day 1, Day 3||5||
48731345|NCT01468350|102127001|FG002|COMPLETED|(PART A) Day 1, Day 3||0||
48731346|NCT01468350|102127002|FG003|COMPLETED|(PART A) Day 1, Day 3||0||
48731347|NCT01468350|102126999|FG000|NOT COMPLETED|(PART A) Day 1, Day 3||0||
48731348|NCT01468350|102127000|FG001|NOT COMPLETED|(PART A) Day 1, Day 3||0||
48731349|NCT01468350|102127001|FG002|NOT COMPLETED|(PART A) Day 1, Day 3||0||
48731350|NCT01468350|102127002|FG003|NOT COMPLETED|(PART A) Day 1, Day 3||0||
48731351|NCT01468350|102126999|FG000|STARTED|(PART B) Day 1, Day 15||0||
48731352|NCT01468350|102127000|FG001|STARTED|(PART B) Day 1, Day 15||0||
48731353|NCT01468350|102127001|FG002|STARTED|(PART B) Day 1, Day 15||12||
48731354|NCT01468350|102127002|FG003|STARTED|(PART B) Day 1, Day 15||12||
48731355|NCT01468350|102126999|FG000|COMPLETED|(PART B) Day 1, Day 15||0||
48731356|NCT01468350|102127000|FG001|COMPLETED|(PART B) Day 1, Day 15||0||
48314286|NCT03331861|101094298|FG000|COMPLETED|Overall Study||2||
48314287|NCT03331861|101094299|FG001|COMPLETED|Overall Study||2||
48314288|NCT03331861|101094298|FG000|NOT COMPLETED|Overall Study||0||
48731357|NCT01468350|102127001|FG002|COMPLETED|(PART B) Day 1, Day 15||12||
48731358|NCT01468350|102127002|FG003|COMPLETED|(PART B) Day 1, Day 15||12||
48731359|NCT01468350|102126999|FG000|NOT COMPLETED|(PART B) Day 1, Day 15||0||
48731360|NCT01468350|102127000|FG001|NOT COMPLETED|(PART B) Day 1, Day 15||0||
48158171|NCT04247282|100711001|FG003|NOT COMPLETED|Overall Study||1||
48158172|NCT01342458|100711002|FG000|STARTED|Overall Study||28||
48158173|NCT01342458|100711003|FG001|STARTED|Overall Study||28||
48158174|NCT01342458|100711002|FG000|COMPLETED|Overall Study||26||
48158175|NCT01342458|100711003|FG001|COMPLETED|Overall Study||24||
48314289|NCT03331861|101094299|FG001|NOT COMPLETED|Overall Study||0||
48731361|NCT01468350|102127001|FG002|NOT COMPLETED|(PART B) Day 1, Day 15||0||
48731362|NCT01468350|102127002|FG003|NOT COMPLETED|(PART B) Day 1, Day 15||0||
48731363|NCT01458015|102127003|FG000|STARTED|Overall Study||2||
48731364|NCT01458015|102127004|FG001|STARTED|Overall Study||1||
48731365|NCT01458015|102127003|FG000|COMPLETED|Overall Study||2||
48731366|NCT01458015|102127004|FG001|COMPLETED|Overall Study||0||
48731367|NCT01458015|102127003|FG000|NOT COMPLETED|Overall Study||0||
48731368|NCT01458015|102127004|FG001|NOT COMPLETED|Overall Study||1||
48731369|NCT00900029|102127005|FG000|STARTED|Overall Study||38||
48731370|NCT00900029|102127006|FG001|STARTED|Overall Study||41||
48731371|NCT00900029|102127007|FG002|STARTED|Overall Study||41||
48314290|NCT02251379|101094300|FG000|STARTED|Overall Study||77||
48731372|NCT00900029|102127008|FG003|STARTED|Overall Study||42||
48731373|NCT00900029|102127009|FG004|STARTED|Overall Study||44||
48731374|NCT00900029|102127005|FG000|COMPLETED|Overall Study||35||
48731375|NCT00900029|102127006|FG001|COMPLETED|Overall Study||37||
48731376|NCT00900029|102127007|FG002|COMPLETED|Overall Study||38||
48731377|NCT00900029|102127008|FG003|COMPLETED|Overall Study||35||
48731378|NCT00900029|102127009|FG004|COMPLETED|Overall Study||38||
48731379|NCT00900029|102127005|FG000|NOT COMPLETED|Overall Study||3||
48731380|NCT00900029|102127006|FG001|NOT COMPLETED|Overall Study||4||
48731381|NCT00900029|102127007|FG002|NOT COMPLETED|Overall Study||3||
48731382|NCT00900029|102127008|FG003|NOT COMPLETED|Overall Study||7||
48731383|NCT00900029|102127009|FG004|NOT COMPLETED|Overall Study||6||
48731384|NCT04356352|102127010|FG000|STARTED|Overall Study||13||
48731385|NCT04356352|102127011|FG001|STARTED|Overall Study||13||
48731386|NCT04356352|102127012|FG002|STARTED|Overall Study||7||
48731387|NCT04356352|102127010|FG000|COMPLETED|Overall Study||11||
48731388|NCT04356352|102127011|FG001|COMPLETED|Overall Study||10||
48731389|NCT04356352|102127012|FG002|COMPLETED|Overall Study||6||
48731390|NCT04356352|102127010|FG000|NOT COMPLETED|Overall Study||2||
48314291|NCT02251379|101094301|FG001|STARTED|Overall Study||78||
48158176|NCT01342458|100711002|FG000|NOT COMPLETED|Overall Study||2||
48314292|NCT02251379|101094300|FG000|COMPLETED|Overall Study||57||
48731391|NCT04356352|102127011|FG001|NOT COMPLETED|Overall Study||3||
48731392|NCT04356352|102127012|FG002|NOT COMPLETED|Overall Study||1||
48731393|NCT00524472|102127013|FG000|STARTED|Overall Study||709||
48731394|NCT00524472|102127014|FG001|STARTED|Overall Study||730||
48731395|NCT00524472|102127013|FG000|COMPLETED|Overall Study||709||
48731396|NCT00524472|102127014|FG001|COMPLETED|Overall Study||730||
48731397|NCT00524472|102127013|FG000|NOT COMPLETED|Overall Study||0||
48731398|NCT00524472|102127014|FG001|NOT COMPLETED|Overall Study||0||
48731399|NCT02267538|102127015|FG000|STARTED|Overall Study||142||
48731400|NCT02267538|102127016|FG001|STARTED|Overall Study||143||
48731401|NCT02267538|102127015|FG000|COMPLETED|Overall Study||142||
48731402|NCT02267538|102127016|FG001|COMPLETED|Overall Study||143||
48731403|NCT02267538|102127015|FG000|NOT COMPLETED|Overall Study||0||
48731404|NCT02267538|102127016|FG001|NOT COMPLETED|Overall Study||0||
48731405|NCT01496846|102127017|FG000|STARTED|IANB Articaine (All Participants)||28||
48731406|NCT01496846|102127018|FG001|STARTED|IANB Articaine (All Participants)||24||
48731407|NCT01496846|102127019|FG002|STARTED|IANB Articaine (All Participants)||36||
48731408|NCT01496846|102127020|FG003|STARTED|IANB Articaine (All Participants)||40||
48731409|NCT01496846|102127021|FG004|STARTED|IANB Articaine (All Participants)||35||
48731410|NCT01496846|102127022|FG005|STARTED|IANB Articaine (All Participants)||38||
48731411|NCT01496846|102127017|FG000|COMPLETED|IANB Articaine (All Participants)||27||
48731412|NCT01496846|102127018|FG001|COMPLETED|IANB Articaine (All Participants)||23||
48731413|NCT01496846|102127019|FG002|COMPLETED|IANB Articaine (All Participants)||36||
48731414|NCT01496846|102127020|FG003|COMPLETED|IANB Articaine (All Participants)||40||
48731415|NCT01496846|102127021|FG004|COMPLETED|IANB Articaine (All Participants)||35||
48731416|NCT01496846|102127022|FG005|COMPLETED|IANB Articaine (All Participants)||38||
48731417|NCT01496846|102127017|FG000|NOT COMPLETED|IANB Articaine (All Participants)||1||
48731418|NCT01496846|102127018|FG001|NOT COMPLETED|IANB Articaine (All Participants)||1||
48731419|NCT01496846|102127019|FG002|NOT COMPLETED|IANB Articaine (All Participants)||0||
48731420|NCT01496846|102127020|FG003|NOT COMPLETED|IANB Articaine (All Participants)||0||
48731421|NCT01496846|102127021|FG004|NOT COMPLETED|IANB Articaine (All Participants)||0||
48731422|NCT01496846|102127022|FG005|NOT COMPLETED|IANB Articaine (All Participants)||0||
48314293|NCT02251379|101094301|FG001|COMPLETED|Overall Study||58||
48314294|NCT02251379|101094300|FG000|NOT COMPLETED|Overall Study||20||
48731423|NCT01496846|102127017|FG000|STARTED|Supplemental Buccal Infiltration||0|Supplemental buccal anesthesia (SUP) was provided in cases of unsuccessful IANB.|
48731424|NCT01496846|102127018|FG001|STARTED|Supplemental Buccal Infiltration||0|Supplemental buccal anesthesia (SUP) was provided in cases of unsuccessful IANB.|
48731425|NCT01496846|102127019|FG002|STARTED|Supplemental Buccal Infiltration||36|Supplemental buccal anesthesia (SUP) was provided in cases of unsuccessful IANB.|
48731426|NCT01496846|102127020|FG003|STARTED|Supplemental Buccal Infiltration||40|Supplemental buccal anesthesia (SUP) was provided in cases of unsuccessful IANB.|
48731427|NCT01496846|102127021|FG004|STARTED|Supplemental Buccal Infiltration||35|Supplemental buccal anesthesia (SUP) was provided in cases of unsuccessful IANB.|
48731428|NCT01496846|102127022|FG005|STARTED|Supplemental Buccal Infiltration||38|Supplemental buccal anesthesia (SUP) was provided in cases of unsuccessful IANB.|
48731429|NCT01496846|102127017|FG000|COMPLETED|Supplemental Buccal Infiltration||0||
48731430|NCT01496846|102127018|FG001|COMPLETED|Supplemental Buccal Infiltration||0||
48731431|NCT01496846|102127019|FG002|COMPLETED|Supplemental Buccal Infiltration||36||
48731432|NCT01496846|102127020|FG003|COMPLETED|Supplemental Buccal Infiltration||40||
48731433|NCT01496846|102127021|FG004|COMPLETED|Supplemental Buccal Infiltration||35||
48731434|NCT01496846|102127022|FG005|COMPLETED|Supplemental Buccal Infiltration||38||
48731435|NCT01496846|102127017|FG000|NOT COMPLETED|Supplemental Buccal Infiltration||0||
48731436|NCT01496846|102127018|FG001|NOT COMPLETED|Supplemental Buccal Infiltration||0||
48731437|NCT01496846|102127019|FG002|NOT COMPLETED|Supplemental Buccal Infiltration||0||
48731438|NCT01496846|102127020|FG003|NOT COMPLETED|Supplemental Buccal Infiltration||0||
48731439|NCT01496846|102127021|FG004|NOT COMPLETED|Supplemental Buccal Infiltration||0||
48731440|NCT01496846|102127022|FG005|NOT COMPLETED|Supplemental Buccal Infiltration||0||
48731441|NCT01103063|102127023|FG000|STARTED|Overall Study||1446||
48731442|NCT01103063|102127024|FG001|STARTED|Overall Study||1445||
48731443|NCT01103063|102127023|FG000|COMPLETED|Overall Study||969||
48731444|NCT01103063|102127024|FG001|COMPLETED|Overall Study||1024||
48731445|NCT01103063|102127023|FG000|NOT COMPLETED|Overall Study||477||
48731446|NCT01103063|102127024|FG001|NOT COMPLETED|Overall Study||421||
48731447|NCT00799591|102127025|FG000|STARTED|Overall Study||156||
48731448|NCT00799591|102127025|FG000|COMPLETED|Overall Study||90||
48731449|NCT00799591|102127025|FG000|NOT COMPLETED|Overall Study||66||
48731450|NCT02697188|102127026|FG000|STARTED|TE Period 1 - 400 mg QD||12||
48731451|NCT02697188|102127026|FG000|COMPLETED|TE Period 1 - 400 mg QD||12||
48731452|NCT02697188|102127026|FG000|NOT COMPLETED|TE Period 1 - 400 mg QD||0||
48731453|NCT02697188|102127026|FG000|STARTED|TU Period 2 - 200 mg QD||12||
48731454|NCT02697188|102127026|FG000|COMPLETED|TU Period 2 - 200 mg QD||12||
48731455|NCT02697188|102127026|FG000|NOT COMPLETED|TU Period 2 - 200 mg QD||0||
48731456|NCT02697188|102127026|FG000|STARTED|TU Period 3 - 200 mg BID||12||
48731457|NCT02697188|102127026|FG000|COMPLETED|TU Period 3 - 200 mg BID||12||
48731458|NCT02697188|102127026|FG000|NOT COMPLETED|TU Period 3 - 200 mg BID||0||
48731459|NCT02697188|102127026|FG000|STARTED|TU Period 4 - 400 BID||12||
48731460|NCT02697188|102127026|FG000|COMPLETED|TU Period 4 - 400 BID||12||
48731461|NCT02697188|102127026|FG000|NOT COMPLETED|TU Period 4 - 400 BID||0||
48731462|NCT02697188|102127026|FG000|STARTED|TE Period 5 - 800 mg BID||12||
48731463|NCT02697188|102127026|FG000|COMPLETED|TE Period 5 - 800 mg BID||12||
48731464|NCT02697188|102127026|FG000|NOT COMPLETED|TE Period 5 - 800 mg BID||0||
48731465|NCT03937960|102127027|FG000|STARTED|Overall Study||15||
48731466|NCT03937960|102127028|FG001|STARTED|Overall Study||15||
48731467|NCT03937960|102127027|FG000|COMPLETED|Overall Study||15||
48731468|NCT03937960|102127028|FG001|COMPLETED|Overall Study||15||
48731469|NCT03937960|102127027|FG000|NOT COMPLETED|Overall Study||0||
48731470|NCT03937960|102127028|FG001|NOT COMPLETED|Overall Study||0||
48731471|NCT00901199|102127029|FG000|STARTED|Overall Study||22||
48731472|NCT00901199|102127029|FG000|COMPLETED|Overall Study||18||
48731473|NCT00901199|102127029|FG000|NOT COMPLETED|Overall Study||4||
48731474|NCT02092025|102127030|FG000|STARTED|Overall Study||3437||
48731475|NCT02092025|102127030|FG000|COMPLETED|Overall Study||3369||
48731476|NCT02092025|102127030|FG000|NOT COMPLETED|Overall Study||68||
48731477|NCT01811186|102127031|FG000|STARTED|Overall Study||132||
48731478|NCT01811186|102127032|FG001|STARTED|Overall Study||126||
48731479|NCT01811186|102127031|FG000|COMPLETED|Overall Study||61||
48731480|NCT01811186|102127032|FG001|COMPLETED|Overall Study||64||
48731481|NCT01811186|102127031|FG000|NOT COMPLETED|Overall Study||71||
48731482|NCT01811186|102127032|FG001|NOT COMPLETED|Overall Study||62||
48731483|NCT02577016|102127033|FG000|STARTED|Overall Study||70||
48731484|NCT02577016|102127034|FG001|STARTED|Overall Study||71||
48731485|NCT02577016|102127033|FG000|COMPLETED|Overall Study||68||
48731486|NCT02577016|102127034|FG001|COMPLETED|Overall Study||69||
48731487|NCT02577016|102127033|FG000|NOT COMPLETED|Overall Study||2||
48731488|NCT02577016|102127034|FG001|NOT COMPLETED|Overall Study||2||
48731489|NCT03653988|102127035|FG000|STARTED|Overall Study||17||
48731490|NCT03653988|102127036|FG001|STARTED|Overall Study||17||
48731491|NCT03653988|102127035|FG000|COMPLETED|Overall Study||17||
48731492|NCT03653988|102127036|FG001|COMPLETED|Overall Study||17||
48731493|NCT03653988|102127035|FG000|NOT COMPLETED|Overall Study||0||
48731494|NCT03653988|102127036|FG001|NOT COMPLETED|Overall Study||0||
48731495|NCT02207491|102127037|FG000|STARTED|Overall Study||202||
48731496|NCT02207491|102127038|FG001|STARTED|Overall Study||209||
48731497|NCT02207491|102127037|FG000|COMPLETED|Overall Study||171||
48731498|NCT02207491|102127038|FG001|COMPLETED|Overall Study||196||
48158177|NCT01342458|100711003|FG001|NOT COMPLETED|Overall Study||4||
48158178|NCT00085202|100711004|FG000|STARTED|Overall Study||269||
48158179|NCT00085202|100711005|FG001|STARTED|Overall Study||144||
48158180|NCT00085202|100711004|FG000|COMPLETED|Overall Study||251||
48158181|NCT00085202|100711005|FG001|COMPLETED|Overall Study||120||
48314295|NCT02251379|101094301|FG001|NOT COMPLETED|Overall Study||20||
48314296|NCT03029715|101094302|FG000|STARTED|Overall Study||50||
48314297|NCT03029715|101094303|FG001|STARTED|Overall Study||50||
48158182|NCT00085202|100711004|FG000|NOT COMPLETED|Overall Study||18||
48158183|NCT00085202|100711005|FG001|NOT COMPLETED|Overall Study||24||
48158184|NCT00855010|100711006|FG000|STARTED|Overall Study||23||
48158185|NCT00855010|100711007|FG001|STARTED|Overall Study||19||
48158186|NCT00855010|100711006|FG000|COMPLETED|Overall Study||19||
48158187|NCT00855010|100711007|FG001|COMPLETED|Overall Study||18||
48158188|NCT00855010|100711006|FG000|NOT COMPLETED|Overall Study||4||
48314298|NCT03029715|101094302|FG000|COMPLETED|Overall Study||50||
48314299|NCT03029715|101094303|FG001|COMPLETED|Overall Study||50||
48314300|NCT03029715|101094302|FG000|NOT COMPLETED|Overall Study||0||
48314301|NCT03029715|101094303|FG001|NOT COMPLETED|Overall Study||0||
48314302|NCT00003702|101094304|FG000|STARTED|Overall Study||120||
48314303|NCT00003702|101094305|FG001|STARTED|Overall Study||120||
48731499|NCT02207491|102127037|FG000|NOT COMPLETED|Overall Study||31||
48731500|NCT02207491|102127038|FG001|NOT COMPLETED|Overall Study||13||
48731501|NCT01887353|102127039|FG000|STARTED|Overall Study||4||
48731502|NCT01887353|102127040|FG001|STARTED|Overall Study||4||
48731503|NCT01887353|102127039|FG000|COMPLETED|Overall Study||0||
48731504|NCT01887353|102127040|FG001|COMPLETED|Overall Study||1||
48731505|NCT01887353|102127039|FG000|NOT COMPLETED|Overall Study||4||
48731506|NCT01887353|102127040|FG001|NOT COMPLETED|Overall Study||3||
48731507|NCT01266590|102127041|FG000|STARTED|Overall Study||30||
48731508|NCT01266590|102127041|FG000|COMPLETED|Overall Study||24||
48731509|NCT01266590|102127041|FG000|NOT COMPLETED|Overall Study||6||
48731510|NCT01846741|102127042|FG000|STARTED|Baseline Visit||22||
48731511|NCT01846741|102127042|FG000|COMPLETED|Baseline Visit||20||
48731512|NCT01846741|102127042|FG000|NOT COMPLETED|Baseline Visit||2||
48731513|NCT01846741|102127042|FG000|STARTED|Implantation to 18-Month/End of Study||20||
48731514|NCT01846741|102127042|FG000|COMPLETED|Implantation to 18-Month/End of Study||20||
48731515|NCT01846741|102127042|FG000|NOT COMPLETED|Implantation to 18-Month/End of Study||0||
48731516|NCT01673620|102127043|FG000|STARTED|Overall Study||47||
48731517|NCT01673620|102127044|FG001|STARTED|Overall Study||22||
48731518|NCT01673620|102127043|FG000|COMPLETED|Overall Study||46||
48158189|NCT00855010|100711007|FG001|NOT COMPLETED|Overall Study||1||
48158190|NCT00462280|100711008|FG000|STARTED|Overall Study||34||
48158191|NCT00462280|100711009|FG001|STARTED|Overall Study||32||
48731519|NCT01673620|102127044|FG001|COMPLETED|Overall Study||22||
48158192|NCT00462280|100711010|FG002|STARTED|Overall Study||7||
48731520|NCT01673620|102127043|FG000|NOT COMPLETED|Overall Study||1||
48314304|NCT00003702|101094304|FG000|COMPLETED|Overall Study||107||
48314305|NCT00003702|101094305|FG001|COMPLETED|Overall Study||109||
48314306|NCT00003702|101094304|FG000|NOT COMPLETED|Overall Study||13||
48314307|NCT00003702|101094305|FG001|NOT COMPLETED|Overall Study||11||
48314308|NCT00003895|101094306|FG000|STARTED|Overall Study||18||
48314309|NCT00003895|101094307|FG001|STARTED|Overall Study||18||
48731521|NCT01673620|102127044|FG001|NOT COMPLETED|Overall Study||0||
48731522|NCT03845738|102127045|FG000|STARTED|Overall Study||208|Enrolled/consented|385
48731523|NCT03845738|102127045|FG000|COMPLETED|Overall Study||208|Initiated (completed Visit 1). Included in the PP analysis.|385
48731524|NCT03845738|102127045|FG000|NOT COMPLETED|Overall Study||0||0
48158193|NCT00462280|100711011|FG003|STARTED|Overall Study||7||
48158194|NCT00462280|100711008|FG000|COMPLETED|Overall Study||24||
48158195|NCT00462280|100711009|FG001|COMPLETED|Overall Study||25||
48158196|NCT00462280|100711010|FG002|COMPLETED|Overall Study||7||
48731525|NCT00360724|102127046|FG000|STARTED|Overall Study||33||
48731526|NCT00360724|102127047|FG001|STARTED|Overall Study||32||
48731527|NCT00360724|102127046|FG000|COMPLETED|Overall Study||29||
48731528|NCT00360724|102127047|FG001|COMPLETED|Overall Study||28||
48731529|NCT00360724|102127046|FG000|NOT COMPLETED|Overall Study||4||
48731530|NCT00360724|102127047|FG001|NOT COMPLETED|Overall Study||4||
48731531|NCT04016077|102127048|FG000|STARTED|Overall Study||10||
48731532|NCT04016077|102127049|FG001|STARTED|Overall Study||8||
48731533|NCT04016077|102127048|FG000|COMPLETED|Overall Study||10||
48731534|NCT04016077|102127049|FG001|COMPLETED|Overall Study||8||
48731535|NCT04016077|102127048|FG000|NOT COMPLETED|Overall Study||0||
48731536|NCT04016077|102127049|FG001|NOT COMPLETED|Overall Study||0||
48731537|NCT02713828|102127050|FG000|STARTED|Overall Study||13||
48731538|NCT02713828|102127051|FG001|STARTED|Overall Study||0||
48731539|NCT02713828|102127050|FG000|COMPLETED|Overall Study||8||
48731540|NCT02713828|102127051|FG001|COMPLETED|Overall Study||0||
48731541|NCT02713828|102127050|FG000|NOT COMPLETED|Overall Study||5||
48731542|NCT02713828|102127051|FG001|NOT COMPLETED|Overall Study||0||
48731543|NCT03323801|102127052|FG000|STARTED|Overall Study||10||
48731544|NCT03323801|102127052|FG000|COMPLETED|Overall Study||10||
48731545|NCT03323801|102127052|FG000|NOT COMPLETED|Overall Study||0||
48731546|NCT04371666|102127053|FG000|STARTED|DB Treatment Period (52 Weeks)||49||
48731547|NCT04371666|102127054|FG001|STARTED|DB Treatment Period (52 Weeks)||49||
48731548|NCT04371666|102127053|FG000|Received at Least 1 Dose of Study Drug|DB Treatment Period (52 Weeks)||48||
48731549|NCT04371666|102127054|FG001|Received at Least 1 Dose of Study Drug|DB Treatment Period (52 Weeks)||49||
48731550|NCT04371666|102127053|FG000|COMPLETED|DB Treatment Period (52 Weeks)||44||
48731551|NCT04371666|102127054|FG001|COMPLETED|DB Treatment Period (52 Weeks)||46||
48731552|NCT04371666|102127053|FG000|NOT COMPLETED|DB Treatment Period (52 Weeks)||5||
48731553|NCT04371666|102127054|FG001|NOT COMPLETED|DB Treatment Period (52 Weeks)||3||
48731554|NCT04371666|102127053|FG000|STARTED|OLE (Maximum Exposure: 93.4 Weeks)||43||
48158197|NCT00462280|100711011|FG003|COMPLETED|Overall Study||4||
48158198|NCT00462280|100711008|FG000|NOT COMPLETED|Overall Study||10||
48158199|NCT00462280|100711009|FG001|NOT COMPLETED|Overall Study||7||
48158200|NCT00462280|100711010|FG002|NOT COMPLETED|Overall Study||0||
48731555|NCT04371666|102127054|FG001|STARTED|OLE (Maximum Exposure: 93.4 Weeks)||43||
48731556|NCT04371666|102127053|FG000|Received at Least 1 Dose of Study Drug|OLE (Maximum Exposure: 93.4 Weeks)||43||
48731557|NCT04371666|102127054|FG001|Received at Least 1 Dose of Study Drug|OLE (Maximum Exposure: 93.4 Weeks)||43||
48731558|NCT04371666|102127053|FG000|COMPLETED|OLE (Maximum Exposure: 93.4 Weeks)||0||
48731559|NCT04371666|102127054|FG001|COMPLETED|OLE (Maximum Exposure: 93.4 Weeks)||0||
48731560|NCT04371666|102127053|FG000|NOT COMPLETED|OLE (Maximum Exposure: 93.4 Weeks)||43||
48731561|NCT04371666|102127054|FG001|NOT COMPLETED|OLE (Maximum Exposure: 93.4 Weeks)||43||
48731562|NCT02241343|102127055|FG000|STARTED|Overall Study||1||
48731563|NCT02241343|102127055|FG000|COMPLETED|Overall Study||0||
48731564|NCT02241343|102127055|FG000|NOT COMPLETED|Overall Study||1||
48731565|NCT00410605|102127056|FG000|STARTED|Overall Study||39||
48731566|NCT00410605|102127056|FG000|COMPLETED|Overall Study||14||
48731567|NCT00410605|102127056|FG000|NOT COMPLETED|Overall Study||25||
48731568|NCT03691571|102127057|FG000|STARTED|Overall Study||31||
48731569|NCT03691571|102127058|FG001|STARTED|Overall Study||24||
48731570|NCT03691571|102127057|FG000|COMPLETED|Overall Study||22|Eleven patients withdrew from the study prior to completing the post-procedure EGD due to delays obtaining the EGD prior to discharge.|
48731571|NCT03691571|102127058|FG001|COMPLETED|Overall Study||22|Eleven patients withdrew from the study prior to completing the post-procedure EGD due to delays obtaining the EGD prior to discharge.|
48731572|NCT03691571|102127057|FG000|NOT COMPLETED|Overall Study||9||
48731573|NCT03691571|102127058|FG001|NOT COMPLETED|Overall Study||2||
48731574|NCT04408040|102127059|FG000|STARTED|Overall Study||0||
48158201|NCT00462280|100711011|FG003|NOT COMPLETED|Overall Study||3||
48158202|NCT00895622|100711012|FG000|STARTED|Overall Study||65||
48158203|NCT00895622|100711013|FG001|STARTED|Overall Study||56||
48731575|NCT04408040|102127060|FG001|STARTED|Overall Study||1||
48731576|NCT04408040|102127061|FG002|STARTED|Overall Study||6||
48731577|NCT04408040|102127062|FG003|STARTED|Overall Study||1||
48731578|NCT04408040|102127059|FG000|COMPLETED|Overall Study||0||
48731579|NCT04408040|102127060|FG001|COMPLETED|Overall Study||1||
48731580|NCT04408040|102127061|FG002|COMPLETED|Overall Study||6||
48731581|NCT04408040|102127062|FG003|COMPLETED|Overall Study||1||
48731582|NCT04408040|102127059|FG000|NOT COMPLETED|Overall Study||0||
48731583|NCT04408040|102127060|FG001|NOT COMPLETED|Overall Study||0||
48731584|NCT04408040|102127061|FG002|NOT COMPLETED|Overall Study||0||
48731585|NCT04408040|102127062|FG003|NOT COMPLETED|Overall Study||0||
48731586|NCT00151476|102127063|FG000|STARTED|FAP Identified Subjects||13||
48731587|NCT00151476|102127064|FG001|STARTED|FAP Identified Subjects||55||
48731588|NCT00151476|102127063|FG000|COMPLETED|FAP Identified Subjects||13||
48731589|NCT00151476|102127064|FG001|COMPLETED|FAP Identified Subjects||54||
48731590|NCT00151476|102127063|FG000|NOT COMPLETED|FAP Identified Subjects||0||
48731591|NCT00151476|102127064|FG001|NOT COMPLETED|FAP Identified Subjects||1||
48314310|NCT00003895|101094306|FG000|COMPLETED|Overall Study||11||
48314311|NCT00003895|101094307|FG001|COMPLETED|Overall Study||14||
48314312|NCT00003895|101094306|FG000|NOT COMPLETED|Overall Study||7||
48314313|NCT00003895|101094307|FG001|NOT COMPLETED|Overall Study||4||
48314314|NCT00175877|101094308|FG000|STARTED|Overall Study||846||
48314315|NCT00175877|101094308|FG000|COMPLETED|Overall Study||497||
48314316|NCT00175877|101094308|FG000|NOT COMPLETED|Overall Study||349||
48314317|NCT00847145|101094309|FG000|STARTED|Overall Study||629||
48314318|NCT00847145|101094310|FG001|STARTED|Overall Study||633||
48314319|NCT00847145|101094311|FG002|STARTED|Overall Study||285||
48314320|NCT00847145|101094312|FG003|STARTED|Overall Study||117||
48314321|NCT00847145|101094313|FG004|STARTED|Overall Study||137||
48314322|NCT00847145|101094314|FG005|STARTED|Overall Study||156||
48314323|NCT00847145|101094315|FG006|STARTED|Overall Study||152||
48314324|NCT00847145|101094316|FG007|STARTED|Overall Study||140||
48314325|NCT00847145|101094309|FG000|COMPLETED|Overall Study||623||
48314326|NCT00847145|101094310|FG001|COMPLETED|Overall Study||627||
48314327|NCT00847145|101094311|FG002|COMPLETED|Overall Study||274||
48314328|NCT00847145|101094312|FG003|COMPLETED|Overall Study||116||
48314329|NCT00847145|101094313|FG004|COMPLETED|Overall Study||131||
48314330|NCT00847145|101094314|FG005|COMPLETED|Overall Study||152||
48158204|NCT00895622|100711014|FG002|STARTED|Overall Study||57||
48158205|NCT00895622|100711012|FG000|COMPLETED|Overall Study||60||
48731592|NCT00151476|102127063|FG000|STARTED|FAP Analyzed Subjects||13||
48731593|NCT00151476|102127064|FG001|STARTED|FAP Analyzed Subjects||54||
48731594|NCT00151476|102127063|FG000|COMPLETED|FAP Analyzed Subjects||13||
48731595|NCT00151476|102127064|FG001|COMPLETED|FAP Analyzed Subjects||51||
48731596|NCT00151476|102127063|FG000|NOT COMPLETED|FAP Analyzed Subjects||0||
48731597|NCT00151476|102127064|FG001|NOT COMPLETED|FAP Analyzed Subjects||3||
48731598|NCT01931163|102127065|FG000|STARTED|Overall Study||22||
48731599|NCT01931163|102127065|FG000|COMPLETED|Overall Study||22||
48731600|NCT01931163|102127065|FG000|NOT COMPLETED|Overall Study||0||
48731601|NCT01677858|102127066|FG000|STARTED|Overall Study||3||
48731602|NCT01677858|102127067|FG001|STARTED|Overall Study||3||
48158206|NCT00895622|100711013|FG001|COMPLETED|Overall Study||52||
48158207|NCT00895622|100711014|FG002|COMPLETED|Overall Study||53||
48158208|NCT00895622|100711012|FG000|NOT COMPLETED|Overall Study||5||
48158209|NCT00895622|100711013|FG001|NOT COMPLETED|Overall Study||4||
48314331|NCT00847145|101094315|FG006|COMPLETED|Overall Study||143||
48314332|NCT00847145|101094316|FG007|COMPLETED|Overall Study||136||
48314333|NCT00847145|101094309|FG000|NOT COMPLETED|Overall Study||6||
48314334|NCT00847145|101094310|FG001|NOT COMPLETED|Overall Study||6||
48314335|NCT00847145|101094311|FG002|NOT COMPLETED|Overall Study||11||
48731603|NCT01677858|102127068|FG002|STARTED|Overall Study||15||
48731604|NCT01677858|102127069|FG003|STARTED|Overall Study||6||
48731605|NCT01677858|102127070|FG004|STARTED|Overall Study||89||
48731606|NCT01677858|102127066|FG000|COMPLETED|Overall Study||0||
48731607|NCT01677858|102127067|FG001|COMPLETED|Overall Study||1||
48731608|NCT01677858|102127068|FG002|COMPLETED|Overall Study||1||
48731609|NCT01677858|102127069|FG003|COMPLETED|Overall Study||0||
48731610|NCT01677858|102127070|FG004|COMPLETED|Overall Study||4||
48731611|NCT01677858|102127066|FG000|NOT COMPLETED|Overall Study||3||
48731612|NCT01677858|102127067|FG001|NOT COMPLETED|Overall Study||2||
48731613|NCT01677858|102127068|FG002|NOT COMPLETED|Overall Study||14||
48731614|NCT01677858|102127069|FG003|NOT COMPLETED|Overall Study||6||
48731615|NCT01677858|102127070|FG004|NOT COMPLETED|Overall Study||85||
48731616|NCT00387725|102127071|FG000|STARTED|Overall Study||21||
48731617|NCT00387725|102127072|FG001|STARTED|Overall Study||16||
48731618|NCT00387725|102127073|FG002|STARTED|Overall Study||45||
48731619|NCT00387725|102127074|FG003|STARTED|Overall Study||45||
48731620|NCT00387725|102127071|FG000|COMPLETED|Overall Study||20||
48731621|NCT00387725|102127072|FG001|COMPLETED|Overall Study||15||
48731622|NCT00387725|102127073|FG002|COMPLETED|Overall Study||43||
48731623|NCT00387725|102127074|FG003|COMPLETED|Overall Study||43||
48731624|NCT00387725|102127071|FG000|NOT COMPLETED|Overall Study||1||
48731625|NCT00387725|102127072|FG001|NOT COMPLETED|Overall Study||1||
48731626|NCT00387725|102127073|FG002|NOT COMPLETED|Overall Study||2||
48731627|NCT00387725|102127074|FG003|NOT COMPLETED|Overall Study||2||
48731628|NCT04667104|102127075|FG000|STARTED|TP 1: From Week 1 to Week 12||48||
48731629|NCT04667104|102127076|FG001|STARTED|TP 1: From Week 1 to Week 12||0||
48731630|NCT04667104|102127077|FG002|STARTED|TP 1: From Week 1 to Week 12||0||
48731631|NCT04667104|102127075|FG000|COMPLETED|TP 1: From Week 1 to Week 12||48||
48731632|NCT04667104|102127076|FG001|COMPLETED|TP 1: From Week 1 to Week 12||0||
48731633|NCT04667104|102127077|FG002|COMPLETED|TP 1: From Week 1 to Week 12||0||
48731634|NCT04667104|102127075|FG000|NOT COMPLETED|TP 1: From Week 1 to Week 12||0||
48731635|NCT04667104|102127076|FG001|NOT COMPLETED|TP 1: From Week 1 to Week 12||0||
48731636|NCT04667104|102127077|FG002|NOT COMPLETED|TP 1: From Week 1 to Week 12||0||
48731637|NCT04667104|102127075|FG000|STARTED|TP 2: From Week 12 to Week 24||0||
48731638|NCT04667104|102127076|FG001|STARTED|TP 2: From Week 12 to Week 24||48||
48731639|NCT04667104|102127077|FG002|STARTED|TP 2: From Week 12 to Week 24||0||
48731640|NCT04667104|102127075|FG000|COMPLETED|TP 2: From Week 12 to Week 24||0||
48731641|NCT04667104|102127076|FG001|COMPLETED|TP 2: From Week 12 to Week 24||48||
48731642|NCT04667104|102127077|FG002|COMPLETED|TP 2: From Week 12 to Week 24||0||
48731643|NCT04667104|102127075|FG000|NOT COMPLETED|TP 2: From Week 12 to Week 24||0||
48731644|NCT04667104|102127076|FG001|NOT COMPLETED|TP 2: From Week 12 to Week 24||0||
48731645|NCT04667104|102127077|FG002|NOT COMPLETED|TP 2: From Week 12 to Week 24||0||
48731646|NCT04667104|102127075|FG000|STARTED|FU:Week 24 to FU Week 48 (i.e.Week 72.4)||0||
48731647|NCT04667104|102127076|FG001|STARTED|FU:Week 24 to FU Week 48 (i.e.Week 72.4)||0||
48731648|NCT04667104|102127077|FG002|STARTED|FU:Week 24 to FU Week 48 (i.e.Week 72.4)||48||
48731649|NCT04667104|102127075|FG000|COMPLETED|FU:Week 24 to FU Week 48 (i.e.Week 72.4)||0||
48731650|NCT04667104|102127076|FG001|COMPLETED|FU:Week 24 to FU Week 48 (i.e.Week 72.4)||0||
48731651|NCT04667104|102127077|FG002|COMPLETED|FU:Week 24 to FU Week 48 (i.e.Week 72.4)||47||
48731652|NCT04667104|102127075|FG000|NOT COMPLETED|FU:Week 24 to FU Week 48 (i.e.Week 72.4)||0||
48731653|NCT04667104|102127076|FG001|NOT COMPLETED|FU:Week 24 to FU Week 48 (i.e.Week 72.4)||0||
48731654|NCT04667104|102127077|FG002|NOT COMPLETED|FU:Week 24 to FU Week 48 (i.e.Week 72.4)||1||
48731655|NCT00761527|102127078|FG000|STARTED|Overall Study||2980||
48731656|NCT00761527|102127078|FG000|Received One Dose of Study Medication|Overall Study||2978||
48731657|NCT00761527|102127078|FG000|COMPLETED|Overall Study||2958||
48731658|NCT00761527|102127078|FG000|NOT COMPLETED|Overall Study||22||
48731659|NCT02783599|102127079|FG000|STARTED|Overall Study||51||
48731660|NCT02783599|102127079|FG000|Received At Least One Dose of Study Drug|Overall Study||51||
48731661|NCT02783599|102127079|FG000|COMPLETED|Overall Study||11||
48731662|NCT02783599|102127079|FG000|NOT COMPLETED|Overall Study||40||
48731663|NCT02396589|102127080|FG000|STARTED|Intervention||6||
48731664|NCT02396589|102127081|FG001|STARTED|Intervention||9||
48731665|NCT02396589|102127080|FG000|COMPLETED|Intervention||5||
48731666|NCT02396589|102127081|FG001|COMPLETED|Intervention||9||
48731667|NCT02396589|102127080|FG000|NOT COMPLETED|Intervention||1||
48731668|NCT02396589|102127081|FG001|NOT COMPLETED|Intervention||0||
48731669|NCT02396589|102127080|FG000|STARTED|6 Month Follow-up||5||
48731670|NCT02396589|102127081|FG001|STARTED|6 Month Follow-up||9||
48731671|NCT02396589|102127080|FG000|COMPLETED|6 Month Follow-up||5||
48731672|NCT02396589|102127081|FG001|COMPLETED|6 Month Follow-up||8||
48731673|NCT02396589|102127080|FG000|NOT COMPLETED|6 Month Follow-up||0||
48731674|NCT02396589|102127081|FG001|NOT COMPLETED|6 Month Follow-up||1||
48731675|NCT02396589|102127080|FG000|STARTED|9 Month Follow-up||5||
48731676|NCT02396589|102127081|FG001|STARTED|9 Month Follow-up||8||
48731677|NCT02396589|102127080|FG000|COMPLETED|9 Month Follow-up||5||
48731678|NCT02396589|102127081|FG001|COMPLETED|9 Month Follow-up||7||
48731679|NCT02396589|102127080|FG000|NOT COMPLETED|9 Month Follow-up||0||
48731680|NCT02396589|102127081|FG001|NOT COMPLETED|9 Month Follow-up||1||
48731681|NCT02396589|102127080|FG000|STARTED|12 Month Follow up||5||
48731682|NCT02396589|102127081|FG001|STARTED|12 Month Follow up||7||
48731683|NCT02396589|102127080|FG000|COMPLETED|12 Month Follow up||5||
48731684|NCT02396589|102127081|FG001|COMPLETED|12 Month Follow up||5||
48731685|NCT02396589|102127080|FG000|NOT COMPLETED|12 Month Follow up||0||
48731686|NCT02396589|102127081|FG001|NOT COMPLETED|12 Month Follow up||2||
48731687|NCT02566590|102127082|FG000|STARTED|Overall Study||10||
48731688|NCT02566590|102127083|FG001|STARTED|Overall Study||10||
48731689|NCT02566590|102127082|FG000|COMPLETED|Overall Study||10||
48731690|NCT02566590|102127083|FG001|COMPLETED|Overall Study||10||
48731691|NCT02566590|102127082|FG000|NOT COMPLETED|Overall Study||0||
48731692|NCT02566590|102127083|FG001|NOT COMPLETED|Overall Study||0||
48731693|NCT00759408|102127084|FG000|STARTED|Overall Study||38||
48731694|NCT00759408|102127084|FG000|COMPLETED|Overall Study||19||
48731695|NCT00759408|102127084|FG000|NOT COMPLETED|Overall Study||19||
48731696|NCT00517361|102127085|FG000|STARTED|Overall Study||11||
48731697|NCT00517361|102127085|FG000|COMPLETED|Overall Study||0||
48731698|NCT00517361|102127085|FG000|NOT COMPLETED|Overall Study||11||
48731699|NCT04858295|102127086|FG000|STARTED|All Study Participants||23||
48731700|NCT04858295|102127087|FG001|STARTED|All Study Participants||24||
48731701|NCT04858295|102127086|FG000|Received Intervention|All Study Participants||23||
48731702|NCT04858295|102127087|FG001|Received Intervention|All Study Participants||23||
48731703|NCT04858295|102127086|FG000|COMPLETED|All Study Participants||22||
48731704|NCT04858295|102127087|FG001|COMPLETED|All Study Participants||21||
48731705|NCT04858295|102127086|FG000|NOT COMPLETED|All Study Participants||1||
48731706|NCT04858295|102127087|FG001|NOT COMPLETED|All Study Participants||3||
48731707|NCT04858295|102127086|FG000|STARTED|First Intervention (6 Weeks)||23||
48731708|NCT04858295|102127087|FG001|STARTED|First Intervention (6 Weeks)||24||
48731709|NCT04858295|102127086|FG000|Received Intervention|First Intervention (6 Weeks)||23||
48731710|NCT04858295|102127087|FG001|Received Intervention|First Intervention (6 Weeks)||23||
48731711|NCT04858295|102127086|FG000|COMPLETED|First Intervention (6 Weeks)||23||
48731712|NCT04858295|102127087|FG001|COMPLETED|First Intervention (6 Weeks)||21||
48731713|NCT04858295|102127086|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0||
48731714|NCT04858295|102127087|FG001|NOT COMPLETED|First Intervention (6 Weeks)||3||
48731715|NCT04858295|102127086|FG000|STARTED|Second Intervention (6 Weeks)||23||
48731716|NCT04858295|102127087|FG001|STARTED|Second Intervention (6 Weeks)||21||
48731717|NCT04858295|102127086|FG000|COMPLETED|Second Intervention (6 Weeks)||22||
48731718|NCT04858295|102127087|FG001|COMPLETED|Second Intervention (6 Weeks)||21||
48731719|NCT04858295|102127086|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||1||
48731720|NCT04858295|102127087|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0||
48731721|NCT04775264|102127088|FG000|STARTED|Overall Study||24||
48731722|NCT04775264|102127088|FG000|COMPLETED|Overall Study||24||
48731723|NCT04775264|102127088|FG000|NOT COMPLETED|Overall Study||0||
48731724|NCT00757822|102127089|FG000|STARTED|Overall Study||92||
48731725|NCT00757822|102127090|FG001|STARTED|Overall Study||88||
48731726|NCT00757822|102127089|FG000|Day of Surgery (DOS) Assessment|Overall Study||92||
48731727|NCT00757822|102127090|FG001|Day of Surgery (DOS) Assessment|Overall Study||88||
48731728|NCT00757822|102127089|FG000|Withdrawal by Subject-no Intervention|Overall Study||1||
48731729|NCT00757822|102127090|FG001|Withdrawal by Subject-no Intervention|Overall Study||3||
48731730|NCT00757822|102127089|FG000|DOS Withdrawn by Investigator|Overall Study||6||
48731731|NCT00757822|102127090|FG001|DOS Withdrawn by Investigator|Overall Study||11||
48731732|NCT00757822|102127089|FG000|Received Study Intervention|Overall Study||85||
48731733|NCT00757822|102127090|FG001|Received Study Intervention|Overall Study||74||
48731734|NCT00757822|102127089|FG000|DOS: Post-operative Assessments|Overall Study||85||
48731735|NCT00757822|102127090|FG001|DOS: Post-operative Assessments|Overall Study||74||
48731736|NCT00757822|102127089|FG000|24-48 hr Telephone Assessment|Overall Study||85||
48731737|NCT00757822|102127090|FG001|24-48 hr Telephone Assessment|Overall Study||74||
48731738|NCT00757822|102127089|FG000|2-6 wk Post-op Assessment|Overall Study||85||
48731739|NCT00757822|102127090|FG001|2-6 wk Post-op Assessment|Overall Study||74||
48731740|NCT00757822|102127089|FG000|Data Entry, QC Assessment|Overall Study||85||
48731741|NCT00757822|102127090|FG001|Data Entry, QC Assessment|Overall Study||74||
48731742|NCT00757822|102127089|FG000|Withdrawn-low-risk for PONV|Overall Study||12||
48731743|NCT00757822|102127090|FG001|Withdrawn-low-risk for PONV|Overall Study||9||
48731744|NCT00757822|102127089|FG000|Withdrawn-protocol Deviation|Overall Study||9||
48731745|NCT00757822|102127090|FG001|Withdrawn-protocol Deviation|Overall Study||8||
48731746|NCT00757822|102127089|FG000|Data Lock, Unblinding Analysis|Overall Study||64||
48731747|NCT00757822|102127090|FG001|Data Lock, Unblinding Analysis|Overall Study||57||
48731748|NCT00757822|102127089|FG000|COMPLETED|Overall Study||64||
48731749|NCT00757822|102127090|FG001|COMPLETED|Overall Study||57||
48731750|NCT00757822|102127089|FG000|NOT COMPLETED|Overall Study||28||
48731751|NCT00757822|102127090|FG001|NOT COMPLETED|Overall Study||31||
48731752|NCT02528786|102127091|FG000|STARTED|Overall Study||8||
48731753|NCT02528786|102127091|FG000|COMPLETED|Overall Study||8||
48731754|NCT02528786|102127091|FG000|NOT COMPLETED|Overall Study||0||
48314336|NCT00847145|101094312|FG003|NOT COMPLETED|Overall Study||1||
48314337|NCT00847145|101094313|FG004|NOT COMPLETED|Overall Study||6||
48314338|NCT00847145|101094314|FG005|NOT COMPLETED|Overall Study||4||
48731755|NCT02487030|102127092|FG000|STARTED|Overall Study||43||
48731756|NCT02487030|102127093|FG001|STARTED|Overall Study||42||
48731757|NCT02487030|102127094|FG002|STARTED|Overall Study||43||
48731758|NCT02487030|102127095|FG003|STARTED|Overall Study||42||
48731759|NCT02487030|102127096|FG004|STARTED|Overall Study||36||
48731760|NCT02487030|102127097|FG005|STARTED|Overall Study||38||
48731761|NCT02487030|102127098|FG006|STARTED|Overall Study||11||
48731762|NCT02487030|102127092|FG000|COMPLETED|Overall Study||41||
48731763|NCT02487030|102127093|FG001|COMPLETED|Overall Study||38||
48731764|NCT02487030|102127094|FG002|COMPLETED|Overall Study||41||
48731765|NCT02487030|102127095|FG003|COMPLETED|Overall Study||40||
48731766|NCT02487030|102127096|FG004|COMPLETED|Overall Study||34||
48731767|NCT02487030|102127097|FG005|COMPLETED|Overall Study||37||
48731768|NCT02487030|102127098|FG006|COMPLETED|Overall Study||11||
48731769|NCT02487030|102127092|FG000|NOT COMPLETED|Overall Study||2||
48731770|NCT02487030|102127093|FG001|NOT COMPLETED|Overall Study||4||
48731771|NCT02487030|102127094|FG002|NOT COMPLETED|Overall Study||2||
48731772|NCT02487030|102127095|FG003|NOT COMPLETED|Overall Study||2||
48731773|NCT02487030|102127096|FG004|NOT COMPLETED|Overall Study||2||
48731774|NCT02487030|102127097|FG005|NOT COMPLETED|Overall Study||1||
48731775|NCT02487030|102127098|FG006|NOT COMPLETED|Overall Study||0||
48731776|NCT01894243|102127099|FG000|STARTED|Overall Study||13|Received treatment in Part A|
48731777|NCT01894243|102127100|FG001|STARTED|Overall Study||10|Received treatment in Part A|
48731778|NCT01894243|102127101|FG002|STARTED|Overall Study||8|Received treatment in Part A|
48731779|NCT01894243|102127099|FG000|Completed Treatment in Part A|Overall Study||13||
48158210|NCT00895622|100711014|FG002|NOT COMPLETED|Overall Study||4||
48314339|NCT00847145|101094315|FG006|NOT COMPLETED|Overall Study||9||
48731780|NCT01894243|102127100|FG001|Completed Treatment in Part A|Overall Study||10||
48731781|NCT01894243|102127101|FG002|Completed Treatment in Part A|Overall Study||8||
48731782|NCT01894243|102127099|FG000|Ongoing Into Part B|Overall Study||13||
48731783|NCT01894243|102127100|FG001|Ongoing Into Part B|Overall Study||10||
48731784|NCT01894243|102127101|FG002|Ongoing Into Part B|Overall Study||8||
48158211|NCT01424930|100711015|FG000|STARTED|Overall Study||7||
48731785|NCT01894243|102127099|FG000|COMPLETED|Overall Study||0|Completed treatment in Part B|
48731786|NCT01894243|102127100|FG001|COMPLETED|Overall Study||0|Completed treatment in Part B|
48731787|NCT01894243|102127101|FG002|COMPLETED|Overall Study||0|Completed treatment in Part B|
48731788|NCT01894243|102127099|FG000|NOT COMPLETED|Overall Study||13||
48731789|NCT01894243|102127100|FG001|NOT COMPLETED|Overall Study||10||
48731790|NCT01894243|102127101|FG002|NOT COMPLETED|Overall Study||8||
48731791|NCT03077204|102127102|FG000|STARTED|Overall Study||20||
48731792|NCT03077204|102127102|FG000|COMPLETED|Overall Study||20||
48314340|NCT00847145|101094316|FG007|NOT COMPLETED|Overall Study||4||
48314341|NCT02047253|101094317|FG000|STARTED|Overall Study||28||
48314342|NCT02047253|101094317|FG000|COMPLETED|Overall Study||20||
48731793|NCT03077204|102127102|FG000|NOT COMPLETED|Overall Study||0||
48731794|NCT00605345|102127103|FG000|STARTED|Overall Study||46||
48731795|NCT00605345|102127104|FG001|STARTED|Overall Study||25||
48731796|NCT00605345|102127103|FG000|COMPLETED|Overall Study||45||
48731797|NCT00605345|102127104|FG001|COMPLETED|Overall Study||22||
48731798|NCT00605345|102127103|FG000|NOT COMPLETED|Overall Study||1||
48731799|NCT00605345|102127104|FG001|NOT COMPLETED|Overall Study||3||
48731800|NCT01279681|102127105|FG000|STARTED|Overall Study||15||
48731801|NCT01279681|102127106|FG001|STARTED|Overall Study||17||
48731802|NCT01279681|102127105|FG000|COMPLETED|Overall Study||0||
48731803|NCT01279681|102127106|FG001|COMPLETED|Overall Study||0||
48731804|NCT01279681|102127105|FG000|NOT COMPLETED|Overall Study||15||
48731805|NCT01279681|102127106|FG001|NOT COMPLETED|Overall Study||17||
48731806|NCT03319212|102127107|FG000|STARTED|Overall Study||29||
48731807|NCT03319212|102127108|FG001|STARTED|Overall Study||52||
48731808|NCT03319212|102127107|FG000|COMPLETED|Overall Study||26||
48731809|NCT03319212|102127108|FG001|COMPLETED|Overall Study||47||
48731810|NCT03319212|102127107|FG000|NOT COMPLETED|Overall Study||3||
48731811|NCT03319212|102127108|FG001|NOT COMPLETED|Overall Study||5||
48731812|NCT01114828|102127109|FG000|STARTED|Overall Study||19||
48731813|NCT01114828|102127110|FG001|STARTED|Overall Study||21||
48731814|NCT01114828|102127109|FG000|COMPLETED|Overall Study||16||
48731815|NCT01114828|102127110|FG001|COMPLETED|Overall Study||17||
48731816|NCT01114828|102127109|FG000|NOT COMPLETED|Overall Study||3||
48731817|NCT01114828|102127110|FG001|NOT COMPLETED|Overall Study||4||
48731818|NCT01743040|102127111|FG000|STARTED|Overall Study||1014||
48731819|NCT01743040|102127111|FG000|CADence Testing|Overall Study||1013||
48731820|NCT01743040|102127111|FG000|Nuclear Stress Test|Overall Study||992||
48731821|NCT01743040|102127111|FG000|CT and/or Standard Angiogram|Overall Study||785||
48731822|NCT01743040|102127111|FG000|COMPLETED|Overall Study||785||
48731823|NCT01743040|102127111|FG000|NOT COMPLETED|Overall Study||229||
48314343|NCT02047253|101094317|FG000|NOT COMPLETED|Overall Study||8||
48314344|NCT03901105|101094318|FG000|STARTED|Overall Study||205||
48314345|NCT03901105|101094318|FG000|COMPLETED|Overall Study||205||
48314346|NCT03901105|101094318|FG000|NOT COMPLETED|Overall Study||0||
48314347|NCT00729482|101094319|FG000|STARTED|Overall Study||54||
48314348|NCT00729482|101094319|FG000|COMPLETED|Overall Study||54||
48314349|NCT00729482|101094319|FG000|NOT COMPLETED|Overall Study||0||
48314350|NCT00636675|101094320|FG000|STARTED|Overall Study||951||
48314351|NCT00636675|101094321|FG001|STARTED|Overall Study||775||
48314352|NCT00636675|101094320|FG000|COMPLETED|Overall Study||811||
48314353|NCT00636675|101094321|FG001|COMPLETED|Overall Study||734||
48314354|NCT00636675|101094320|FG000|NOT COMPLETED|Overall Study||140||
48314355|NCT00636675|101094321|FG001|NOT COMPLETED|Overall Study||41||
48314356|NCT01979536|101094322|FG000|STARTED|Overall Study||68||
48314357|NCT01979536|101094323|FG001|STARTED|Overall Study||69||
48314358|NCT01979536|101094322|FG000|COMPLETED|Overall Study||66||
48314359|NCT01979536|101094323|FG001|COMPLETED|Overall Study||61||
48314360|NCT01979536|101094322|FG000|NOT COMPLETED|Overall Study||2||
48314361|NCT01979536|101094323|FG001|NOT COMPLETED|Overall Study||8||
48314362|NCT03198520|101094324|FG000|STARTED|Overall Study||46||
48314363|NCT03198520|101094324|FG000|COMPLETED|Overall Study||40||
48314364|NCT03198520|101094324|FG000|NOT COMPLETED|Overall Study||6||
48314365|NCT01670539|101094325|FG000|STARTED|Overall Study||26||
48314366|NCT01670539|101094326|FG001|STARTED|Overall Study||21||
48731824|NCT03245775|102127112|FG000|STARTED|Overall Study||66||
48314367|NCT01670539|101094325|FG000|COMPLETED|Overall Study||20||
48314368|NCT01670539|101094326|FG001|COMPLETED|Overall Study||16||
48314369|NCT01670539|101094325|FG000|NOT COMPLETED|Overall Study||6||
48314370|NCT01670539|101094326|FG001|NOT COMPLETED|Overall Study||5||
48314371|NCT01436084|101094327|FG000|STARTED|Overall Study||4||
48314372|NCT01436084|101094327|FG000|COMPLETED|Overall Study||0||
48314373|NCT01436084|101094327|FG000|NOT COMPLETED|Overall Study||4||
48314374|NCT00754793|101094328|FG000|STARTED|Overall Study||1||
48314375|NCT00754793|101094329|FG001|STARTED|Overall Study||2||
48314376|NCT00754793|101094328|FG000|COMPLETED|Overall Study||1||
48314377|NCT00754793|101094329|FG001|COMPLETED|Overall Study||1||
48314378|NCT00754793|101094328|FG000|NOT COMPLETED|Overall Study||0||
48314379|NCT00754793|101094329|FG001|NOT COMPLETED|Overall Study||1||
48731825|NCT03245775|102127113|FG001|STARTED|Overall Study||70||
48731826|NCT03245775|102127114|FG002|STARTED|Overall Study||62||
48731827|NCT03245775|102127115|FG003|STARTED|Overall Study||69||
48731828|NCT03245775|102127112|FG000|COMPLETED|Overall Study||41||
48731829|NCT03245775|102127113|FG001|COMPLETED|Overall Study||44||
48731830|NCT03245775|102127114|FG002|COMPLETED|Overall Study||46||
48158212|NCT01424930|100711016|FG001|STARTED|Overall Study||18||
48314380|NCT01490814|101094330|FG000|STARTED|Overall Study||378||
48314381|NCT01490814|101094331|FG001|STARTED|Overall Study||384||
48314382|NCT01490814|101094330|FG000|COMPLETED|Overall Study||374||
48314383|NCT01490814|101094331|FG001|COMPLETED|Overall Study||376||
48314384|NCT01490814|101094330|FG000|NOT COMPLETED|Overall Study||4||
48314385|NCT01490814|101094331|FG001|NOT COMPLETED|Overall Study||8||
48314386|NCT02354222|101094332|FG000|STARTED|Overall Study||77||
48314387|NCT02354222|101094333|FG001|STARTED|Overall Study||77||
48314388|NCT02354222|101094332|FG000|COMPLETED|Overall Study||73||
48314389|NCT02354222|101094333|FG001|COMPLETED|Overall Study||66||
48314390|NCT02354222|101094332|FG000|NOT COMPLETED|Overall Study||4||
48314391|NCT02354222|101094333|FG001|NOT COMPLETED|Overall Study||11||
48314392|NCT01537198|101094334|FG000|STARTED|Overall Study||617||
48314393|NCT01537198|101094334|FG000|COMPLETED|Overall Study||463||
48314394|NCT01537198|101094334|FG000|NOT COMPLETED|Overall Study||154||
48314395|NCT00382720|101094335|FG000|STARTED|Overall Study||79||
48314396|NCT00382720|101094336|FG001|STARTED|Overall Study||89||
48314397|NCT00382720|101094337|FG002|STARTED|Overall Study||86||
48314398|NCT00382720|101094335|FG000|Administered Non-Optimal Dose (Part I)|Overall Study||10||
48314399|NCT00382720|101094336|FG001|Administered Non-Optimal Dose (Part I)|Overall Study||11||
48314400|NCT00382720|101094337|FG002|Administered Non-Optimal Dose (Part I)|Overall Study||0||
48314401|NCT00382720|101094335|FG000|Administered Optimal Dose (Parts I & II)|Overall Study||78||
48314402|NCT00382720|101094336|FG001|Administered Optimal Dose (Parts I & II)|Overall Study||88||
48314403|NCT00382720|101094337|FG002|Administered Optimal Dose (Parts I & II)|Overall Study||82||
48314404|NCT00382720|101094335|FG000|Full Analysis Population (FAP)|Overall Study||78||
48314405|NCT00382720|101094336|FG001|Full Analysis Population (FAP)|Overall Study||88||
48314406|NCT00382720|101094337|FG002|Full Analysis Population (FAP)|Overall Study||82||
48314407|NCT00382720|101094335|FG000|COMPLETED|Overall Study||0||
48314408|NCT00382720|101094336|FG001|COMPLETED|Overall Study||0||
48314409|NCT00382720|101094337|FG002|COMPLETED|Overall Study||0||
48314410|NCT00382720|101094335|FG000|NOT COMPLETED|Overall Study||79||
48314411|NCT00382720|101094336|FG001|NOT COMPLETED|Overall Study||89||
48314412|NCT00382720|101094337|FG002|NOT COMPLETED|Overall Study||86||
48314413|NCT00257166|101094338|FG000|STARTED|Overall Study||150||
48314414|NCT00257166|101094339|FG001|STARTED|Overall Study||88||
48314415|NCT00257166|101094338|FG000|Treated|Overall Study||149||
48314416|NCT00257166|101094339|FG001|Treated|Overall Study||88||
48314417|NCT00257166|101094338|FG000|COMPLETED|Overall Study||97||
48314418|NCT00257166|101094339|FG001|COMPLETED|Overall Study||51||
48314419|NCT00257166|101094338|FG000|NOT COMPLETED|Overall Study||53||
48314420|NCT00257166|101094339|FG001|NOT COMPLETED|Overall Study||37||
48314421|NCT00424749|101094340|FG000|STARTED|Overall Study||4||
48158213|NCT01424930|100711015|FG000|Completed Food Safety Evaluation|Overall Study||6||
48158214|NCT01424930|100711016|FG001|Completed Food Safety Evaluation|Overall Study||18||
48158215|NCT01424930|100711015|FG000|COMPLETED|Overall Study||3||
48314422|NCT00424749|101094340|FG000|COMPLETED|Overall Study||3||
48314423|NCT00424749|101094340|FG000|NOT COMPLETED|Overall Study||1||
48314424|NCT01205230|101094341|FG000|STARTED|Overall Study||21||
48314425|NCT01205230|101094342|FG001|STARTED|Overall Study||13||
48314426|NCT01205230|101094341|FG000|Combination Therapy|Overall Study||21||
48314427|NCT01205230|101094342|FG001|Combination Therapy|Overall Study||13||
48314428|NCT01205230|101094341|FG000|COMPLETED|Overall Study||16||
48731831|NCT03245775|102127115|FG003|COMPLETED|Overall Study||53||
48731832|NCT03245775|102127112|FG000|NOT COMPLETED|Overall Study||25||
48731833|NCT03245775|102127113|FG001|NOT COMPLETED|Overall Study||26||
48731834|NCT03245775|102127114|FG002|NOT COMPLETED|Overall Study||16||
48731835|NCT03245775|102127115|FG003|NOT COMPLETED|Overall Study||16||
48731836|NCT02587819|102127116|FG000|STARTED|Overall Study||21||
48731837|NCT02587819|102127116|FG000|Exposed|Overall Study||21||
48731838|NCT02587819|102127116|FG000|COMPLETED|Overall Study||19||
48314429|NCT01205230|101094342|FG001|COMPLETED|Overall Study||13||
48731839|NCT02587819|102127116|FG000|NOT COMPLETED|Overall Study||2||
48731840|NCT00568126|102127117|FG000|STARTED|Overall Study||24||
48158216|NCT01424930|100711016|FG001|COMPLETED|Overall Study||4||
48158217|NCT01424930|100711015|FG000|NOT COMPLETED|Overall Study||4||
48158218|NCT01424930|100711016|FG001|NOT COMPLETED|Overall Study||14||
48158219|NCT00508261|100711017|FG000|STARTED|Overall Study||222||
48158220|NCT00508261|100711018|FG001|STARTED|Overall Study||220||
48158221|NCT00508261|100711019|FG002|STARTED|Overall Study||224||
48158222|NCT00508261|100711020|FG003|STARTED|Overall Study||127||
48158223|NCT00508261|100711017|FG000|COMPLETED|Overall Study||219||
48158224|NCT00508261|100711018|FG001|COMPLETED|Overall Study||212||
48158225|NCT00508261|100711019|FG002|COMPLETED|Overall Study||218||
48158226|NCT00508261|100711020|FG003|COMPLETED|Overall Study||126||
48158227|NCT00508261|100711017|FG000|NOT COMPLETED|Overall Study||3||
48158228|NCT00508261|100711018|FG001|NOT COMPLETED|Overall Study||8||
48158229|NCT00508261|100711019|FG002|NOT COMPLETED|Overall Study||6||
48158230|NCT00508261|100711020|FG003|NOT COMPLETED|Overall Study||1||
48158231|NCT04765735|100711021|FG000|STARTED|Overall Study||22||
48158232|NCT04765735|100711022|FG001|STARTED|Overall Study||20||
48158233|NCT04765735|100711021|FG000|COMPLETED|Overall Study||22||
48158234|NCT04765735|100711022|FG001|COMPLETED|Overall Study||20||
48158235|NCT04765735|100711021|FG000|NOT COMPLETED|Overall Study||0||
48158236|NCT04765735|100711022|FG001|NOT COMPLETED|Overall Study||0||
48158237|NCT00962247|100711023|FG000|STARTED|Usual Sedentary||61||
48158238|NCT00962247|100711023|FG000|COMPLETED|Usual Sedentary||61||
48158239|NCT00962247|100711023|FG000|NOT COMPLETED|Usual Sedentary||0||
48158240|NCT00962247|100711023|FG000|STARTED|25% Reduction of Sedentary Activity||61||
48158241|NCT00962247|100711023|FG000|COMPLETED|25% Reduction of Sedentary Activity||56||
48158242|NCT00962247|100711023|FG000|NOT COMPLETED|25% Reduction of Sedentary Activity||5||
48158243|NCT00962247|100711023|FG000|STARTED|50% Reduction of Sedentary Activity||56||
48158244|NCT00962247|100711023|FG000|COMPLETED|50% Reduction of Sedentary Activity||56||
48158245|NCT00962247|100711023|FG000|NOT COMPLETED|50% Reduction of Sedentary Activity||0||
48158246|NCT03123848|100711024|FG000|STARTED|Overall Study||8||
48158247|NCT03123848|100711024|FG000|COMPLETED|Overall Study||8||
48158248|NCT03123848|100711024|FG000|NOT COMPLETED|Overall Study||0||
48158249|NCT00429663|100711025|FG000|STARTED|Overall Study||76||
48158250|NCT00429663|100711026|FG001|STARTED|Overall Study||80||
48158251|NCT00429663|100711025|FG000|COMPLETED|Overall Study||40||
48158252|NCT00429663|100711026|FG001|COMPLETED|Overall Study||41||
48158253|NCT00429663|100711025|FG000|NOT COMPLETED|Overall Study||36||
48158254|NCT00429663|100711026|FG001|NOT COMPLETED|Overall Study||39||
48158255|NCT04149925|100711027|FG000|STARTED|Overall Study||30||
48158256|NCT04149925|100711028|FG001|STARTED|Overall Study||30||
48158257|NCT04149925|100711027|FG000|COMPLETED|Overall Study||30||
48158258|NCT04149925|100711028|FG001|COMPLETED|Overall Study||30||
48158259|NCT04149925|100711027|FG000|NOT COMPLETED|Overall Study||0||
48158260|NCT04149925|100711028|FG001|NOT COMPLETED|Overall Study||0||
48158261|NCT01133158|100711029|FG000|STARTED|Overall Study||60||
48158262|NCT01133158|100711029|FG000|COMPLETED|Overall Study||43||
48158263|NCT01133158|100711029|FG000|NOT COMPLETED|Overall Study||17||
48158264|NCT00263328|100711030|FG000|STARTED|Overall Study||18||
48158265|NCT00263328|100711031|FG001|STARTED|Overall Study||14||
48158266|NCT00263328|100711032|FG002|STARTED|Overall Study||13||
48158267|NCT00263328|100711030|FG000|COMPLETED|Overall Study||10||
48158268|NCT00263328|100711031|FG001|COMPLETED|Overall Study||12||
48158269|NCT00263328|100711032|FG002|COMPLETED|Overall Study||6||
48158270|NCT00263328|100711030|FG000|NOT COMPLETED|Overall Study||8||
48158271|NCT00263328|100711031|FG001|NOT COMPLETED|Overall Study||2||
48158272|NCT00263328|100711032|FG002|NOT COMPLETED|Overall Study||7||
48158273|NCT01242748|100711033|FG000|STARTED|Overall Study||194||
48158274|NCT01242748|100711034|FG001|STARTED|Overall Study||94||
48158275|NCT01242748|100711033|FG000|CS35/CS35A Safety Analysis Set|Overall Study||565||
48158276|NCT01242748|100711034|FG001|CS35/CS35A Safety Analysis Set|Overall Study||283||
48158277|NCT01242748|100711033|FG000|CS35/CS35A Full Analysis Set (FAS)|Overall Study||565||
48158278|NCT01242748|100711034|FG001|CS35/CS35A Full Analysis Set (FAS)|Overall Study||282||
48158279|NCT01242748|100711033|FG000|COMPLETED|Overall Study||156||
48158280|NCT01242748|100711034|FG001|COMPLETED|Overall Study||80||
48158281|NCT01242748|100711033|FG000|NOT COMPLETED|Overall Study||38||
48158282|NCT01242748|100711034|FG001|NOT COMPLETED|Overall Study||14||
48158283|NCT00304512|100711035|FG000|STARTED|Treatment Period||2||
48158284|NCT00304512|100711036|FG001|STARTED|Treatment Period||4||
48158285|NCT00304512|100711037|FG002|STARTED|Treatment Period||3||
48158286|NCT00304512|100711035|FG000|Safety Population|Treatment Period||2|Received at least 1 dose of study drug|
48158287|NCT00304512|100711036|FG001|Safety Population|Treatment Period||4|Received at least 1 dose of study drug|
48158288|NCT00304512|100711037|FG002|Safety Population|Treatment Period||3|Received at least 1 dose of study drug|
48158289|NCT00304512|100711035|FG000|Pharmacokinetic (PK) Population|Treatment Period||2|Received study drug and had at least 1 postbaseline PK parameter recorded|
48158290|NCT00304512|100711036|FG001|Pharmacokinetic (PK) Population|Treatment Period||4|Received study drug and had at least 1 postbaseline PK parameter recorded|
48158291|NCT00304512|100711037|FG002|Pharmacokinetic (PK) Population|Treatment Period||3|Received study drug and had at least 1 postbaseline PK parameter recorded|
48158292|NCT00304512|100711035|FG000|Pharmacodynamic (PD) Population|Treatment Period||2|Received study drug and had at least 1 postbaseline PD parameter recorded|
48314430|NCT01205230|101094341|FG000|NOT COMPLETED|Overall Study||5||
48314431|NCT01205230|101094342|FG001|NOT COMPLETED|Overall Study||0||
48314432|NCT01186796|101094343|FG000|STARTED|Overall Study||14||
48314433|NCT01186796|101094344|FG001|STARTED|Overall Study||16||
48158293|NCT00304512|100711036|FG001|Pharmacodynamic (PD) Population|Treatment Period||4|Received study drug and had at least 1 postbaseline PD parameter recorded|
48158294|NCT00304512|100711037|FG002|Pharmacodynamic (PD) Population|Treatment Period||3|Received study drug and had at least 1 postbaseline PD parameter recorded|
48158295|NCT00304512|100711035|FG000|COMPLETED|Treatment Period||2||
48158296|NCT00304512|100711036|FG001|COMPLETED|Treatment Period||4||
48158297|NCT00304512|100711037|FG002|COMPLETED|Treatment Period||3||
48158298|NCT00304512|100711035|FG000|NOT COMPLETED|Treatment Period||0||
48158299|NCT00304512|100711036|FG001|NOT COMPLETED|Treatment Period||0||
48158300|NCT00304512|100711037|FG002|NOT COMPLETED|Treatment Period||0||
48158301|NCT00304512|100711035|FG000|STARTED|Extension Period||2||
48158302|NCT00304512|100711036|FG001|STARTED|Extension Period||4||
48158303|NCT00304512|100711037|FG002|STARTED|Extension Period||3||
48158304|NCT00304512|100711035|FG000|COMPLETED|Extension Period||2||
48314434|NCT01186796|101094343|FG000|COMPLETED|Overall Study||10||
48314435|NCT01186796|101094344|FG001|COMPLETED|Overall Study||14||
48314436|NCT01186796|101094343|FG000|NOT COMPLETED|Overall Study||4||
48314437|NCT01186796|101094344|FG001|NOT COMPLETED|Overall Study||2||
48314438|NCT02819635|101097214|FG000|STARTED|Substudy 1 and Substudy 2, Part 1||46||
48314439|NCT02819635|101097215|FG001|STARTED|Substudy 1 and Substudy 2, Part 1||47||
48314440|NCT02819635|101097216|FG002|STARTED|Substudy 1 and Substudy 2, Part 1||49||
48314441|NCT02819635|101097217|FG003|STARTED|Substudy 1 and Substudy 2, Part 1||117||
48314442|NCT02819635|101097218|FG004|STARTED|Substudy 1 and Substudy 2, Part 1||123||
48314443|NCT02819635|101097219|FG005|STARTED|Substudy 1 and Substudy 2, Part 1||155||
48314444|NCT02819635|101097220|FG006|STARTED|Substudy 1 and Substudy 2, Part 1||319||
48314445|NCT02819635|101097221|FG007|STARTED|Substudy 1 and Substudy 2, Part 1||446||
48314446|NCT02819635|101097222|FG008|STARTED|Substudy 1 and Substudy 2, Part 1||0||
48314447|NCT02819635|101097223|FG009|STARTED|Substudy 1 and Substudy 2, Part 1||0||
48158305|NCT00304512|100711036|FG001|COMPLETED|Extension Period||4||
48158306|NCT00304512|100711037|FG002|COMPLETED|Extension Period||3||
48158307|NCT00304512|100711035|FG000|NOT COMPLETED|Extension Period||0||
48158308|NCT00304512|100711036|FG001|NOT COMPLETED|Extension Period||0||
48158309|NCT00304512|100711037|FG002|NOT COMPLETED|Extension Period||0||
48158310|NCT02010632|100711038|FG000|STARTED|First Intervention (7 Days)||16||
48158311|NCT02010632|100711039|FG001|STARTED|First Intervention (7 Days)||16||
48158312|NCT02010632|100711038|FG000|COMPLETED|First Intervention (7 Days)||16||
48158313|NCT02010632|100711039|FG001|COMPLETED|First Intervention (7 Days)||16||
48158314|NCT02010632|100711038|FG000|NOT COMPLETED|First Intervention (7 Days)||0||
48158315|NCT02010632|100711039|FG001|NOT COMPLETED|First Intervention (7 Days)||0||
48158316|NCT02010632|100711038|FG000|STARTED|Wash Out Period (14 Days)||16||
48158317|NCT02010632|100711039|FG001|STARTED|Wash Out Period (14 Days)||16||
48158318|NCT02010632|100711038|FG000|COMPLETED|Wash Out Period (14 Days)||16||
48158319|NCT02010632|100711039|FG001|COMPLETED|Wash Out Period (14 Days)||16||
48158320|NCT02010632|100711038|FG000|NOT COMPLETED|Wash Out Period (14 Days)||0||
48158321|NCT02010632|100711039|FG001|NOT COMPLETED|Wash Out Period (14 Days)||0||
48314448|NCT02819635|101097224|FG010|STARTED|Substudy 1 and Substudy 2, Part 1||0||
48314449|NCT02819635|101097225|FG011|STARTED|Substudy 1 and Substudy 2, Part 1||0||
48314450|NCT02819635|101097214|FG000|COMPLETED|Substudy 1 and Substudy 2, Part 1||41||
48314451|NCT02819635|101097215|FG001|COMPLETED|Substudy 1 and Substudy 2, Part 1||45||
48314452|NCT02819635|101097216|FG002|COMPLETED|Substudy 1 and Substudy 2, Part 1||45||
48314453|NCT02819635|101097217|FG003|COMPLETED|Substudy 1 and Substudy 2, Part 1||105||
48314454|NCT02819635|101097218|FG004|COMPLETED|Substudy 1 and Substudy 2, Part 1||113||
48314455|NCT02819635|101097219|FG005|COMPLETED|Substudy 1 and Substudy 2, Part 1||135||
48314456|NCT02819635|101097220|FG006|COMPLETED|Substudy 1 and Substudy 2, Part 1||306||
48314457|NCT02819635|101097221|FG007|COMPLETED|Substudy 1 and Substudy 2, Part 1||446||
48314458|NCT02819635|101097222|FG008|COMPLETED|Substudy 1 and Substudy 2, Part 1||0||
48314459|NCT02819635|101097223|FG009|COMPLETED|Substudy 1 and Substudy 2, Part 1||0||
48314460|NCT02819635|101097224|FG010|COMPLETED|Substudy 1 and Substudy 2, Part 1||0||
48314461|NCT02819635|101097225|FG011|COMPLETED|Substudy 1 and Substudy 2, Part 1||0||
48314462|NCT02819635|101097214|FG000|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||5||
48314463|NCT02819635|101097215|FG001|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||2||
48314464|NCT02819635|101097216|FG002|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||4||
48314465|NCT02819635|101097217|FG003|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||12||
48314466|NCT02819635|101097218|FG004|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||10||
48314467|NCT02819635|101097219|FG005|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||20||
48314468|NCT02819635|101097220|FG006|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||13||
48314469|NCT02819635|101097221|FG007|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||0||
48158322|NCT02010632|100711038|FG000|STARTED|Second Intervention (7 Days)||16||
48158323|NCT02010632|100711039|FG001|STARTED|Second Intervention (7 Days)||16||
48158324|NCT02010632|100711038|FG000|COMPLETED|Second Intervention (7 Days)||15||
48158325|NCT02010632|100711039|FG001|COMPLETED|Second Intervention (7 Days)||16||
48188744|NCT01033643|100783323|FG002|NOT COMPLETED|Overall Study||0||
48314470|NCT02819635|101097222|FG008|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||0||
48314471|NCT02819635|101097223|FG009|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||0||
48314472|NCT02819635|101097224|FG010|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||0||
48314473|NCT02819635|101097225|FG011|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||0||
48314474|NCT02819635|101097214|FG000|STARTED|Substudy 2, Part 2||0||
48314475|NCT02819635|101097215|FG001|STARTED|Substudy 2, Part 2||0||
48314476|NCT02819635|101097216|FG002|STARTED|Substudy 2, Part 2||0||
48314477|NCT02819635|101097217|FG003|STARTED|Substudy 2, Part 2||0||
48314478|NCT02819635|101097218|FG004|STARTED|Substudy 2, Part 2||0||
48314479|NCT02819635|101097219|FG005|STARTED|Substudy 2, Part 2||85||
48314480|NCT02819635|101097220|FG006|STARTED|Substudy 2, Part 2||59||
48314481|NCT02819635|101097221|FG007|STARTED|Substudy 2, Part 2||0||
48314482|NCT02819635|101097222|FG008|STARTED|Substudy 2, Part 2||0||
48314483|NCT02819635|101097223|FG009|STARTED|Substudy 2, Part 2||0||
48314484|NCT02819635|101097224|FG010|STARTED|Substudy 2, Part 2||0||
48314485|NCT02819635|101097225|FG011|STARTED|Substudy 2, Part 2||0||
48314486|NCT02819635|101097214|FG000|COMPLETED|Substudy 2, Part 2||0||
48314487|NCT02819635|101097215|FG001|COMPLETED|Substudy 2, Part 2||0||
48314488|NCT02819635|101097216|FG002|COMPLETED|Substudy 2, Part 2||0||
48314489|NCT02819635|101097217|FG003|COMPLETED|Substudy 2, Part 2||0||
48314490|NCT02819635|101097218|FG004|COMPLETED|Substudy 2, Part 2||0||
48314491|NCT02819635|101097219|FG005|COMPLETED|Substudy 2, Part 2||74||
48314492|NCT02819635|101097220|FG006|COMPLETED|Substudy 2, Part 2||47||
48314493|NCT02819635|101097221|FG007|COMPLETED|Substudy 2, Part 2||0||
48314494|NCT02819635|101097222|FG008|COMPLETED|Substudy 2, Part 2||0||
48314495|NCT02819635|101097223|FG009|COMPLETED|Substudy 2, Part 2||0||
48314496|NCT02819635|101097224|FG010|COMPLETED|Substudy 2, Part 2||0||
48314497|NCT02819635|101097225|FG011|COMPLETED|Substudy 2, Part 2||0||
48406904|NCT03424044|101328486|FG002|STARTED|Third Intervention (76 Hours)||2||
48314498|NCT02819635|101097214|FG000|NOT COMPLETED|Substudy 2, Part 2||0||
48314499|NCT02819635|101097215|FG001|NOT COMPLETED|Substudy 2, Part 2||0||
48314500|NCT02819635|101097216|FG002|NOT COMPLETED|Substudy 2, Part 2||0||
48314501|NCT02819635|101097217|FG003|NOT COMPLETED|Substudy 2, Part 2||0||
48314502|NCT02819635|101097218|FG004|NOT COMPLETED|Substudy 2, Part 2||0||
48314503|NCT02819635|101097219|FG005|NOT COMPLETED|Substudy 2, Part 2||11||
48314504|NCT02819635|101097220|FG006|NOT COMPLETED|Substudy 2, Part 2||12||
48314505|NCT02819635|101097221|FG007|NOT COMPLETED|Substudy 2, Part 2||0||
48314506|NCT02819635|101097222|FG008|NOT COMPLETED|Substudy 2, Part 2||0||
48314507|NCT02819635|101097223|FG009|NOT COMPLETED|Substudy 2, Part 2||0||
48314508|NCT02819635|101097224|FG010|NOT COMPLETED|Substudy 2, Part 2||0||
48314509|NCT02819635|101097225|FG011|NOT COMPLETED|Substudy 2, Part 2||0||
48314510|NCT02819635|101097214|FG000|STARTED|Substudy 3||0||
48314511|NCT02819635|101097215|FG001|STARTED|Substudy 3||0||
48314512|NCT02819635|101097216|FG002|STARTED|Substudy 3||0||
48314513|NCT02819635|101097217|FG003|STARTED|Substudy 3||0||
48314514|NCT02819635|101097218|FG004|STARTED|Substudy 3||0||
48314515|NCT02819635|101097219|FG005|STARTED|Substudy 3||0||
48314516|NCT02819635|101097220|FG006|STARTED|Substudy 3||0||
48314517|NCT02819635|101097221|FG007|STARTED|Substudy 3||0||
48314518|NCT02819635|101097222|FG008|STARTED|Substudy 3||386||
48314519|NCT02819635|101097223|FG009|STARTED|Substudy 3||20||
48314520|NCT02819635|101097224|FG010|STARTED|Substudy 3||324||
48314521|NCT02819635|101097225|FG011|STARTED|Substudy 3||316||
48314522|NCT02819635|101097214|FG000|COMPLETED|Substudy 3||0||
48314523|NCT02819635|101097215|FG001|COMPLETED|Substudy 3||0||
48314524|NCT02819635|101097216|FG002|COMPLETED|Substudy 3||0||
48314525|NCT02819635|101097217|FG003|COMPLETED|Substudy 3||0||
48314526|NCT02819635|101097218|FG004|COMPLETED|Substudy 3||0||
48314527|NCT02819635|101097219|FG005|COMPLETED|Substudy 3||0||
48314528|NCT02819635|101097220|FG006|COMPLETED|Substudy 3||0||
48314529|NCT02819635|101097221|FG007|COMPLETED|Substudy 3||0||
48314530|NCT02819635|101097222|FG008|COMPLETED|Substudy 3||140||
48314531|NCT02819635|101097223|FG009|COMPLETED|Substudy 3||11||
48314532|NCT02819635|101097224|FG010|COMPLETED|Substudy 3||218||
48314533|NCT02819635|101097225|FG011|COMPLETED|Substudy 3||248||
48314534|NCT02819635|101097214|FG000|NOT COMPLETED|Substudy 3||0||
48314535|NCT02819635|101097215|FG001|NOT COMPLETED|Substudy 3||0||
48314536|NCT02819635|101097216|FG002|NOT COMPLETED|Substudy 3||0||
48314537|NCT02819635|101097217|FG003|NOT COMPLETED|Substudy 3||0||
48314538|NCT02819635|101097218|FG004|NOT COMPLETED|Substudy 3||0||
48314539|NCT02819635|101097219|FG005|NOT COMPLETED|Substudy 3||0||
48314540|NCT02819635|101097220|FG006|NOT COMPLETED|Substudy 3||0||
48314541|NCT02819635|101097221|FG007|NOT COMPLETED|Substudy 3||0||
48314542|NCT02819635|101097222|FG008|NOT COMPLETED|Substudy 3||246||
48314543|NCT02819635|101097223|FG009|NOT COMPLETED|Substudy 3||9||
48314544|NCT02819635|101097224|FG010|NOT COMPLETED|Substudy 3||106||
48314545|NCT02819635|101097225|FG011|NOT COMPLETED|Substudy 3||68||
48314546|NCT01651104|101097226|FG000|STARTED|Overall Study||63||
48314547|NCT01651104|101097226|FG000|COMPLETED|Overall Study||63||
48314548|NCT01651104|101097226|FG000|NOT COMPLETED|Overall Study||0||
48314549|NCT03069352|101097227|FG000|STARTED|Overall Study||68||
48406905|NCT03424044|101328487|FG003|STARTED|Third Intervention (76 Hours)||3||
48406906|NCT03424044|101328488|FG004|STARTED|Third Intervention (76 Hours)||2||
48314550|NCT03069352|101097228|FG001|STARTED|Overall Study||143||
48314551|NCT03069352|101097227|FG000|Received Treatment|Overall Study||68||
48314552|NCT03069352|101097228|FG001|Received Treatment|Overall Study||142||
48314553|NCT03069352|101097227|FG000|COMPLETED|Overall Study||56|As of 15 August 2019|
48314554|NCT03069352|101097228|FG001|COMPLETED|Overall Study||103|As of 15 August 2019|
48314555|NCT03069352|101097227|FG000|NOT COMPLETED|Overall Study||12||
48314556|NCT03069352|101097228|FG001|NOT COMPLETED|Overall Study||40||
48314557|NCT03199040|101097229|FG000|STARTED|Overall Study||9||
48314558|NCT03199040|101097230|FG001|STARTED|Overall Study||9||
48314559|NCT03199040|101097229|FG000|COMPLETED|Overall Study||5||
48314560|NCT03199040|101097230|FG001|COMPLETED|Overall Study||7||
48314561|NCT03199040|101097229|FG000|NOT COMPLETED|Overall Study||4||
48314562|NCT03199040|101097230|FG001|NOT COMPLETED|Overall Study||2||
48314563|NCT00501007|101097231|FG000|STARTED|Overall Study||100||
48314564|NCT00501007|101097232|FG001|STARTED|Overall Study||103||
48314565|NCT00501007|101097231|FG000|COMPLETED|Overall Study||71||
48314566|NCT00501007|101097232|FG001|COMPLETED|Overall Study||78||
48314567|NCT00501007|101097231|FG000|NOT COMPLETED|Overall Study||29||
48314568|NCT00501007|101097232|FG001|NOT COMPLETED|Overall Study||25||
48314569|NCT02645760|101097233|FG000|STARTED|Overall Study||19||
48314570|NCT02645760|101097234|FG001|STARTED|Overall Study||19||
48314571|NCT02645760|101097233|FG000|COMPLETED|Overall Study||19||
48314572|NCT02645760|101097234|FG001|COMPLETED|Overall Study||19||
48314573|NCT02645760|101097233|FG000|NOT COMPLETED|Overall Study||0||
48314574|NCT02645760|101097234|FG001|NOT COMPLETED|Overall Study||0||
48314575|NCT00843518|101097235|FG000|STARTED|Period 2 (Double-blind Treatment)||63||
48314576|NCT00843518|101097236|FG001|STARTED|Period 2 (Double-blind Treatment)||69||
48314577|NCT00843518|101097235|FG000|COMPLETED|Period 2 (Double-blind Treatment)||43||
48314578|NCT00843518|101097236|FG001|COMPLETED|Period 2 (Double-blind Treatment)||49||
48314579|NCT00843518|101097235|FG000|NOT COMPLETED|Period 2 (Double-blind Treatment)||20||
48314580|NCT00843518|101097236|FG001|NOT COMPLETED|Period 2 (Double-blind Treatment)||20||
48314581|NCT00843518|101097235|FG000|STARTED|Period 3 (Single-blind Washout)||42||
48314582|NCT00843518|101097236|FG001|STARTED|Period 3 (Single-blind Washout)||49||
48314583|NCT00843518|101097235|FG000|COMPLETED|Period 3 (Single-blind Washout)||42||
48314584|NCT00843518|101097236|FG001|COMPLETED|Period 3 (Single-blind Washout)||49||
48314585|NCT00843518|101097235|FG000|NOT COMPLETED|Period 3 (Single-blind Washout)||0||
48314586|NCT00843518|101097236|FG001|NOT COMPLETED|Period 3 (Single-blind Washout)||0||
48314587|NCT05418673|101097237|FG000|STARTED|Overall Study||3||
48314588|NCT05418673|101097238|FG001|STARTED|Overall Study||4||
48314589|NCT05418673|101097237|FG000|COMPLETED|Overall Study||0||
48314590|NCT05418673|101097238|FG001|COMPLETED|Overall Study||0||
48314591|NCT05418673|101097237|FG000|NOT COMPLETED|Overall Study||3||
48314592|NCT05418673|101097238|FG001|NOT COMPLETED|Overall Study||4||
48314593|NCT01312038|101097239|FG000|STARTED|Overall Study||13||
48314594|NCT01312038|101097240|FG001|STARTED|Overall Study||12||
48314595|NCT01312038|101097239|FG000|COMPLETED|Overall Study||13||
48314596|NCT01312038|101097240|FG001|COMPLETED|Overall Study||12||
48314597|NCT01312038|101097239|FG000|NOT COMPLETED|Overall Study||0||
48314598|NCT01312038|101097240|FG001|NOT COMPLETED|Overall Study||0||
48314599|NCT05038020|101097241|FG000|STARTED|Overall Study||3||
48314600|NCT05038020|101097242|FG001|STARTED|Overall Study||0||
48314601|NCT05038020|101097241|FG000|COMPLETED|Overall Study||0||
48440020|NCT04259905|101410012|FG001|NOT COMPLETED|Overall Study||2||
48614536|NCT00837967|101841772|FG000|NOT COMPLETED|Second Intervention||0||
48614537|NCT00837967|101841773|FG001|NOT COMPLETED|Second Intervention||0||
48614538|NCT04110314|101841774|FG000|STARTED|Overall Study||71781||
48614539|NCT04110314|101841775|FG001|STARTED|Overall Study||71492||
48614540|NCT04110314|101841776|FG002|STARTED|Overall Study||72177||
48614541|NCT04110314|101841777|FG003|STARTED|Overall Study||71512||
48614542|NCT04110314|101841778|FG004|STARTED|Overall Study||71536||
48614543|NCT04110314|101841779|FG005|STARTED|Overall Study||72138||
48614544|NCT04110314|101841774|FG000|Patients Who Met Inclusion|Overall Study||36526||
48614545|NCT04110314|101841775|FG001|Patients Who Met Inclusion|Overall Study||36388||
48614546|NCT04110314|101841776|FG002|Patients Who Met Inclusion|Overall Study||36541||
48614547|NCT04110314|101841777|FG003|Patients Who Met Inclusion|Overall Study||36377||
48614548|NCT04110314|101841778|FG004|Patients Who Met Inclusion|Overall Study||36289||
48614549|NCT04110314|101841779|FG005|Patients Who Met Inclusion|Overall Study||36411||
48614550|NCT04110314|101841774|FG000|COMPLETED|Overall Study||36526||
48614551|NCT04110314|101841775|FG001|COMPLETED|Overall Study||36388||
48314602|NCT05038020|101097242|FG001|COMPLETED|Overall Study||0||
48314603|NCT05038020|101097241|FG000|NOT COMPLETED|Overall Study||3||
48314604|NCT05038020|101097242|FG001|NOT COMPLETED|Overall Study||0||
48314605|NCT01027819|101097243|FG000|STARTED|Overall Study||40||
48314606|NCT01027819|101097244|FG001|STARTED|Overall Study||40||
48314607|NCT01027819|101097243|FG000|COMPLETED|Overall Study||40||
48314608|NCT01027819|101097244|FG001|COMPLETED|Overall Study||40||
48314609|NCT01027819|101097243|FG000|NOT COMPLETED|Overall Study||0||
48314610|NCT01027819|101097244|FG001|NOT COMPLETED|Overall Study||0||
48314611|NCT05376215|101097245|FG000|STARTED|Overall Study||23||
48314612|NCT05376215|101097246|FG001|STARTED|Overall Study||21||
48314613|NCT05376215|101097245|FG000|Completed First Assigned Fitting Method|Overall Study||22||
48368040|NCT03567291|101230093|FG001|STARTED|Period III||0||
48314614|NCT05376215|101097246|FG001|Completed First Assigned Fitting Method|Overall Study||20||
48314615|NCT05376215|101097245|FG000|Completed Second Fitting Method|Overall Study||21||
48314616|NCT05376215|101097246|FG001|Completed Second Fitting Method|Overall Study||19||
48314617|NCT05376215|101097245|FG000|COMPLETED|Overall Study||21||
48314618|NCT05376215|101097246|FG001|COMPLETED|Overall Study||19||
48314619|NCT05376215|101097245|FG000|NOT COMPLETED|Overall Study||2||
48314620|NCT05376215|101097246|FG001|NOT COMPLETED|Overall Study||2||
48314621|NCT00096785|101097247|FG000|STARTED|Overall Study||35||
48314622|NCT00096785|101097248|FG001|STARTED|Overall Study||34||
48314623|NCT00096785|101097247|FG000|As-Randomized Population|Overall Study||35||
48314624|NCT00096785|101097248|FG001|As-Randomized Population|Overall Study||34||
48314625|NCT00096785|101097247|FG000|As-Treated Population|Overall Study||36||
48314626|NCT00096785|101097248|FG001|As-Treated Population|Overall Study||33||
48314627|NCT00096785|101097247|FG000|COMPLETED|Overall Study||33||
48314628|NCT00096785|101097248|FG001|COMPLETED|Overall Study||33||
48440021|NCT01266642|101410013|FG000|STARTED|Overall Study||149||
48614552|NCT04110314|101841776|FG002|COMPLETED|Overall Study||36541||
48614553|NCT04110314|101841777|FG003|COMPLETED|Overall Study||36377||
48614554|NCT04110314|101841778|FG004|COMPLETED|Overall Study||36289||
48158326|NCT02010632|100711038|FG000|NOT COMPLETED|Second Intervention (7 Days)||1||
48158327|NCT02010632|100711039|FG001|NOT COMPLETED|Second Intervention (7 Days)||0||
48158328|NCT00685945|100711040|FG000|STARTED|Control (Bradykinin Infusion)||24||
48158329|NCT00685945|100711040|FG000|COMPLETED|Control (Bradykinin Infusion)||24||
48158330|NCT00685945|100711040|FG000|NOT COMPLETED|Control (Bradykinin Infusion)||0||
48158331|NCT00685945|100711040|FG000|STARTED|L-NMMA + Bradykinin||24||
48158332|NCT00685945|100711040|FG000|COMPLETED|L-NMMA + Bradykinin||23||
48158333|NCT00685945|100711040|FG000|NOT COMPLETED|L-NMMA + Bradykinin||1||
48158334|NCT00685945|100711040|FG000|STARTED|Isosorbide + L-NMMA + Bradykinin||11||
48158335|NCT00685945|100711040|FG000|COMPLETED|Isosorbide + L-NMMA + Bradykinin||11||
48158336|NCT00685945|100711040|FG000|NOT COMPLETED|Isosorbide + L-NMMA + Bradykinin||0||
48158337|NCT00685945|100711040|FG000|STARTED|Sildenafil + L-NMMA + Bradykinin||12||
48614555|NCT04110314|101841779|FG005|COMPLETED|Overall Study||36411||
48614556|NCT04110314|101841774|FG000|NOT COMPLETED|Overall Study||35255||
48614557|NCT04110314|101841775|FG001|NOT COMPLETED|Overall Study||35104||
48158338|NCT00685945|100711040|FG000|COMPLETED|Sildenafil + L-NMMA + Bradykinin||12||
48158339|NCT00685945|100711040|FG000|NOT COMPLETED|Sildenafil + L-NMMA + Bradykinin||0||
48158340|NCT04886479|100711041|FG000|STARTED|Period 1: Habitual Device, 6-8 Hours||10||20
48158341|NCT04886479|100711042|FG001|STARTED|Period 1: Habitual Device, 6-8 Hours||3||6
48158342|NCT04886479|100711043|FG002|STARTED|Period 1: Habitual Device, 6-8 Hours||9||18
48158343|NCT04886479|100711041|FG000|COMPLETED|Period 1: Habitual Device, 6-8 Hours||10||20
48158344|NCT04886479|100711042|FG001|COMPLETED|Period 1: Habitual Device, 6-8 Hours||3||6
48158345|NCT04886479|100711043|FG002|COMPLETED|Period 1: Habitual Device, 6-8 Hours||9||18
48158346|NCT04886479|100711041|FG000|NOT COMPLETED|Period 1: Habitual Device, 6-8 Hours||0||0
48158347|NCT04886479|100711042|FG001|NOT COMPLETED|Period 1: Habitual Device, 6-8 Hours||0||0
48158348|NCT04886479|100711043|FG002|NOT COMPLETED|Period 1: Habitual Device, 6-8 Hours||0||0
48158349|NCT04886479|100711041|FG000|STARTED|Period 2: Test Lens, 3 Hours||10||10
48158350|NCT04886479|100711042|FG001|STARTED|Period 2: Test Lens, 3 Hours||3||3
48158351|NCT04886479|100711043|FG002|STARTED|Period 2: Test Lens, 3 Hours||0||0
48158352|NCT04886479|100711041|FG000|COMPLETED|Period 2: Test Lens, 3 Hours||10||10
48158353|NCT04886479|100711042|FG001|COMPLETED|Period 2: Test Lens, 3 Hours||3||3
48158354|NCT04886479|100711043|FG002|COMPLETED|Period 2: Test Lens, 3 Hours||0||0
48158355|NCT04886479|100711041|FG000|NOT COMPLETED|Period 2: Test Lens, 3 Hours||0||0
48158356|NCT04886479|100711042|FG001|NOT COMPLETED|Period 2: Test Lens, 3 Hours||0||0
48158357|NCT04886479|100711043|FG002|NOT COMPLETED|Period 2: Test Lens, 3 Hours||0||0
48158358|NCT01746043|100711044|FG000|STARTED|Overall Study||5||
48158359|NCT01746043|100711045|FG001|STARTED|Overall Study||4||
48158360|NCT01746043|100711046|FG002|STARTED|Overall Study||5||
48158361|NCT01746043|100711047|FG003|STARTED|Overall Study||5||
48614558|NCT04110314|101841776|FG002|NOT COMPLETED|Overall Study||35636||
48614559|NCT04110314|101841777|FG003|NOT COMPLETED|Overall Study||35135||
48158362|NCT01746043|100711044|FG000|COMPLETED|Overall Study||5||
48158363|NCT01746043|100711045|FG001|COMPLETED|Overall Study||4||
48158364|NCT01746043|100711046|FG002|COMPLETED|Overall Study||5||
48158365|NCT01746043|100711047|FG003|COMPLETED|Overall Study||5||
48614560|NCT04110314|101841778|FG004|NOT COMPLETED|Overall Study||35247||
48614561|NCT04110314|101841779|FG005|NOT COMPLETED|Overall Study||35727||
48614562|NCT02227784|101841780|FG000|STARTED|Double-Blind Phase||123||
48614563|NCT02227784|101841781|FG001|STARTED|Double-Blind Phase||54||
48158366|NCT01746043|100711044|FG000|NOT COMPLETED|Overall Study||0||
48158367|NCT01746043|100711045|FG001|NOT COMPLETED|Overall Study||0||
48158368|NCT01746043|100711046|FG002|NOT COMPLETED|Overall Study||0||
48314629|NCT00096785|101097247|FG000|NOT COMPLETED|Overall Study||2||
48314630|NCT00096785|101097248|FG001|NOT COMPLETED|Overall Study||1||
48314631|NCT01379469|101097249|FG000|STARTED|Overall Study||13||
48314632|NCT01379469|101097250|FG001|STARTED|Overall Study||7||
48314633|NCT01379469|101097249|FG000|COMPLETED|Overall Study||1||
48314634|NCT01379469|101097250|FG001|COMPLETED|Overall Study||3||
48614564|NCT02227784|101841782|FG002|STARTED|Double-Blind Phase||62||
48158369|NCT01746043|100711047|FG003|NOT COMPLETED|Overall Study||0||
48158370|NCT02160314|100711048|FG000|STARTED|Overall Study||73||
48158371|NCT02160314|100711049|FG001|STARTED|Overall Study||72||
48158372|NCT02160314|100711048|FG000|COMPLETED|Overall Study||72||
48158373|NCT02160314|100711049|FG001|COMPLETED|Overall Study||59||
48158374|NCT02160314|100711048|FG000|NOT COMPLETED|Overall Study||1||
48158375|NCT02160314|100711049|FG001|NOT COMPLETED|Overall Study||13||
48158376|NCT02036645|100711050|FG000|STARTED|SAD Cohorts : Study Part 1||12||
48158377|NCT02036645|100711051|FG001|STARTED|SAD Cohorts : Study Part 1||3||
48158378|NCT02036645|100711052|FG002|STARTED|SAD Cohorts : Study Part 1||6||
48158379|NCT02036645|100711053|FG003|STARTED|SAD Cohorts : Study Part 1||6||
48158380|NCT02036645|100711054|FG004|STARTED|SAD Cohorts : Study Part 1||6||
48158381|NCT02036645|100711055|FG005|STARTED|SAD Cohorts : Study Part 1||6||
48158382|NCT02036645|100711056|FG006|STARTED|SAD Cohorts : Study Part 1||6||
48158383|NCT02036645|100711057|FG007|STARTED|SAD Cohorts : Study Part 1||0||
48158384|NCT02036645|100711058|FG008|STARTED|SAD Cohorts : Study Part 1||0||
48158385|NCT02036645|100711059|FG009|STARTED|SAD Cohorts : Study Part 1||0||
48158386|NCT02036645|100711060|FG010|STARTED|SAD Cohorts : Study Part 1||0||
48158387|NCT02036645|100711061|FG011|STARTED|SAD Cohorts : Study Part 1||0||
48158388|NCT02036645|100711050|FG000|COMPLETED|SAD Cohorts : Study Part 1||12||
48158389|NCT02036645|100711051|FG001|COMPLETED|SAD Cohorts : Study Part 1||3||
48158390|NCT02036645|100711052|FG002|COMPLETED|SAD Cohorts : Study Part 1||6||
48158391|NCT02036645|100711053|FG003|COMPLETED|SAD Cohorts : Study Part 1||5||
48158392|NCT02036645|100711054|FG004|COMPLETED|SAD Cohorts : Study Part 1||6||
48158393|NCT02036645|100711055|FG005|COMPLETED|SAD Cohorts : Study Part 1||6||
48158394|NCT02036645|100711056|FG006|COMPLETED|SAD Cohorts : Study Part 1||5||
48158395|NCT02036645|100711057|FG007|COMPLETED|SAD Cohorts : Study Part 1||0||
48158396|NCT02036645|100711058|FG008|COMPLETED|SAD Cohorts : Study Part 1||0||
48158397|NCT02036645|100711059|FG009|COMPLETED|SAD Cohorts : Study Part 1||0||
48158398|NCT02036645|100711060|FG010|COMPLETED|SAD Cohorts : Study Part 1||0||
48158399|NCT02036645|100711061|FG011|COMPLETED|SAD Cohorts : Study Part 1||0||
48158400|NCT02036645|100711050|FG000|NOT COMPLETED|SAD Cohorts : Study Part 1||0||
48158401|NCT02036645|100711051|FG001|NOT COMPLETED|SAD Cohorts : Study Part 1||0||
48158402|NCT02036645|100711052|FG002|NOT COMPLETED|SAD Cohorts : Study Part 1||0||
48158403|NCT02036645|100711053|FG003|NOT COMPLETED|SAD Cohorts : Study Part 1||1||
48158404|NCT02036645|100711054|FG004|NOT COMPLETED|SAD Cohorts : Study Part 1||0||
48158405|NCT02036645|100711055|FG005|NOT COMPLETED|SAD Cohorts : Study Part 1||0||
48158406|NCT02036645|100711056|FG006|NOT COMPLETED|SAD Cohorts : Study Part 1||1||
48158407|NCT02036645|100711057|FG007|NOT COMPLETED|SAD Cohorts : Study Part 1||0||
48158408|NCT02036645|100711058|FG008|NOT COMPLETED|SAD Cohorts : Study Part 1||0||
48158409|NCT02036645|100711059|FG009|NOT COMPLETED|SAD Cohorts : Study Part 1||0||
48158410|NCT02036645|100711060|FG010|NOT COMPLETED|SAD Cohorts : Study Part 1||0||
48158411|NCT02036645|100711061|FG011|NOT COMPLETED|SAD Cohorts : Study Part 1||0||
48158412|NCT02036645|100711050|FG000|STARTED|MAD Cohorts: Study Part 2||0||
48158413|NCT02036645|100711051|FG001|STARTED|MAD Cohorts: Study Part 2||0||
48158414|NCT02036645|100711052|FG002|STARTED|MAD Cohorts: Study Part 2||0||
48158415|NCT02036645|100711053|FG003|STARTED|MAD Cohorts: Study Part 2||0||
48158416|NCT02036645|100711054|FG004|STARTED|MAD Cohorts: Study Part 2||0||
48158417|NCT02036645|100711055|FG005|STARTED|MAD Cohorts: Study Part 2||0||
48158418|NCT02036645|100711056|FG006|STARTED|MAD Cohorts: Study Part 2||0||
48158419|NCT02036645|100711057|FG007|STARTED|MAD Cohorts: Study Part 2||8||
48158420|NCT02036645|100711058|FG008|STARTED|MAD Cohorts: Study Part 2||6||
48158421|NCT02036645|100711059|FG009|STARTED|MAD Cohorts: Study Part 2||6||
48614565|NCT02227784|101841783|FG003|STARTED|Double-Blind Phase||127||
48614566|NCT02227784|101841784|FG004|STARTED|Double-Blind Phase||0||
48614567|NCT02227784|101841780|FG000|COMPLETED|Double-Blind Phase||83||
48614568|NCT02227784|101841781|FG001|COMPLETED|Double-Blind Phase||36||
48614569|NCT02227784|101841782|FG002|COMPLETED|Double-Blind Phase||41||
48614570|NCT02227784|101841783|FG003|COMPLETED|Double-Blind Phase||88||
48614571|NCT02227784|101841784|FG004|COMPLETED|Double-Blind Phase||0||
48614572|NCT02227784|101841780|FG000|NOT COMPLETED|Double-Blind Phase||40||
48614573|NCT02227784|101841781|FG001|NOT COMPLETED|Double-Blind Phase||18||
48614574|NCT02227784|101841782|FG002|NOT COMPLETED|Double-Blind Phase||21||
48158422|NCT02036645|100711060|FG010|STARTED|MAD Cohorts: Study Part 2||6||
48158423|NCT02036645|100711061|FG011|STARTED|MAD Cohorts: Study Part 2||6||
48158424|NCT02036645|100711050|FG000|COMPLETED|MAD Cohorts: Study Part 2||0||
48158425|NCT02036645|100711051|FG001|COMPLETED|MAD Cohorts: Study Part 2||0||
48158426|NCT02036645|100711052|FG002|COMPLETED|MAD Cohorts: Study Part 2||0||
48614575|NCT02227784|101841783|FG003|NOT COMPLETED|Double-Blind Phase||39||
48158427|NCT02036645|100711053|FG003|COMPLETED|MAD Cohorts: Study Part 2||0||
48158428|NCT02036645|100711054|FG004|COMPLETED|MAD Cohorts: Study Part 2||0||
48158429|NCT02036645|100711055|FG005|COMPLETED|MAD Cohorts: Study Part 2||0||
48158430|NCT02036645|100711056|FG006|COMPLETED|MAD Cohorts: Study Part 2||0||
48158431|NCT02036645|100711057|FG007|COMPLETED|MAD Cohorts: Study Part 2||8||
48158432|NCT02036645|100711058|FG008|COMPLETED|MAD Cohorts: Study Part 2||6||
48158433|NCT02036645|100711059|FG009|COMPLETED|MAD Cohorts: Study Part 2||6||
48614576|NCT02227784|101841784|FG004|NOT COMPLETED|Double-Blind Phase||0||
48614577|NCT02227784|101841780|FG000|STARTED|Open-Label Extension Phase (OLE)||0||
48614578|NCT02227784|101841781|FG001|STARTED|Open-Label Extension Phase (OLE)||0||
48614579|NCT02227784|101841782|FG002|STARTED|Open-Label Extension Phase (OLE)||0||
48614580|NCT02227784|101841783|FG003|STARTED|Open-Label Extension Phase (OLE)||0||
48614581|NCT02227784|101841784|FG004|STARTED|Open-Label Extension Phase (OLE)||248||
48614582|NCT02227784|101841780|FG000|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0||
48731841|NCT00568126|102127118|FG001|STARTED|Overall Study||21||
48158434|NCT02036645|100711060|FG010|COMPLETED|MAD Cohorts: Study Part 2||6||
48158435|NCT02036645|100711061|FG011|COMPLETED|MAD Cohorts: Study Part 2||6||
48158436|NCT02036645|100711050|FG000|NOT COMPLETED|MAD Cohorts: Study Part 2||0||
48158437|NCT02036645|100711051|FG001|NOT COMPLETED|MAD Cohorts: Study Part 2||0||
48158438|NCT02036645|100711052|FG002|NOT COMPLETED|MAD Cohorts: Study Part 2||0||
48158439|NCT02036645|100711053|FG003|NOT COMPLETED|MAD Cohorts: Study Part 2||0||
48158440|NCT02036645|100711054|FG004|NOT COMPLETED|MAD Cohorts: Study Part 2||0||
48158441|NCT02036645|100711055|FG005|NOT COMPLETED|MAD Cohorts: Study Part 2||0||
48158442|NCT02036645|100711056|FG006|NOT COMPLETED|MAD Cohorts: Study Part 2||0||
48158443|NCT02036645|100711057|FG007|NOT COMPLETED|MAD Cohorts: Study Part 2||0||
48158444|NCT02036645|100711058|FG008|NOT COMPLETED|MAD Cohorts: Study Part 2||0||
48158445|NCT02036645|100711059|FG009|NOT COMPLETED|MAD Cohorts: Study Part 2||0||
48158446|NCT02036645|100711060|FG010|NOT COMPLETED|MAD Cohorts: Study Part 2||0||
48158447|NCT02036645|100711061|FG011|NOT COMPLETED|MAD Cohorts: Study Part 2||0||
48158448|NCT00420992|100711062|FG000|STARTED|Titration Phase||547||
48158449|NCT00420992|100711063|FG001|STARTED|Titration Phase||0||
48158450|NCT00420992|100711062|FG000|COMPLETED|Titration Phase||344||
48158451|NCT00420992|100711063|FG001|COMPLETED|Titration Phase||0||
48158452|NCT00420992|100711062|FG000|NOT COMPLETED|Titration Phase||203||
48158453|NCT00420992|100711063|FG001|NOT COMPLETED|Titration Phase||0||
48158454|NCT00420992|100711062|FG000|STARTED|Maintenance Phase||171||
48158455|NCT00420992|100711063|FG001|STARTED|Maintenance Phase||173||
48158456|NCT00420992|100711062|FG000|COMPLETED|Maintenance Phase||110||
48158457|NCT00420992|100711063|FG001|COMPLETED|Maintenance Phase||98||
48158458|NCT00420992|100711062|FG000|NOT COMPLETED|Maintenance Phase||61||
48158459|NCT00420992|100711063|FG001|NOT COMPLETED|Maintenance Phase||75||
48158460|NCT02584725|100711064|FG000|STARTED|Overall Study||28||
48158461|NCT02584725|100711065|FG001|STARTED|Overall Study||28||
48158462|NCT02584725|100711066|FG002|STARTED|Overall Study||28||
48158463|NCT02584725|100711064|FG000|COMPLETED|Overall Study||28||
48158464|NCT02584725|100711065|FG001|COMPLETED|Overall Study||28||
48158465|NCT02584725|100711066|FG002|COMPLETED|Overall Study||28||
48158466|NCT02584725|100711064|FG000|NOT COMPLETED|Overall Study||0||
48158467|NCT02584725|100711065|FG001|NOT COMPLETED|Overall Study||0||
48158468|NCT02584725|100711066|FG002|NOT COMPLETED|Overall Study||0||
48158469|NCT01970787|100711067|FG000|STARTED|Overall Study||22||
48158470|NCT01970787|100711067|FG000|COMPLETED|Overall Study||21||
48158471|NCT01970787|100711067|FG000|NOT COMPLETED|Overall Study||1||
48158472|NCT01974700|100711068|FG000|STARTED|Overall Study||5||
48158473|NCT01974700|100711069|FG001|STARTED|Overall Study||3||
48158474|NCT01974700|100711068|FG000|COMPLETED|Overall Study||5||
48158475|NCT01974700|100711069|FG001|COMPLETED|Overall Study||3||
48158476|NCT01974700|100711068|FG000|NOT COMPLETED|Overall Study||0||
48158477|NCT01974700|100711069|FG001|NOT COMPLETED|Overall Study||0||
48158478|NCT00180479|100711070|FG000|STARTED|Overall Study||669||
48158479|NCT00180479|100711071|FG001|STARTED|Overall Study||333||
48158480|NCT00180479|100711070|FG000|COMPLETED|Overall Study||653||
48158481|NCT00180479|100711071|FG001|COMPLETED|Overall Study||320||
48158482|NCT00180479|100711070|FG000|NOT COMPLETED|Overall Study||16||
48158483|NCT00180479|100711071|FG001|NOT COMPLETED|Overall Study||13||
48158484|NCT00110890|100711072|FG000|STARTED|Overall Study||368||
48158485|NCT00110890|100711073|FG001|STARTED|Overall Study||184||
48158486|NCT00110890|100711072|FG000|End of Dose Optimization Phase|Overall Study||316||
48158487|NCT00110890|100711073|FG001|End of Dose Optimization Phase|Overall Study||170||
48158488|NCT00110890|100711072|FG000|End of Efficacy Assessment Phase|Overall Study||280||
48158489|NCT00110890|100711073|FG001|End of Efficacy Assessment Phase|Overall Study||150||
48158490|NCT00110890|100711072|FG000|COMPLETED|Overall Study||7||
48614583|NCT02227784|101841781|FG001|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0||
48614584|NCT02227784|101841782|FG002|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0||
48614585|NCT02227784|101841783|FG003|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0||
48614586|NCT02227784|101841784|FG004|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||247||
48614587|NCT02227784|101841780|FG000|COMPLETED|Open-Label Extension Phase (OLE)||0||
48158491|NCT00110890|100711073|FG001|COMPLETED|Overall Study||5||
48158492|NCT00110890|100711072|FG000|NOT COMPLETED|Overall Study||361||
48158493|NCT00110890|100711073|FG001|NOT COMPLETED|Overall Study||179||
48158494|NCT04425902|100711074|FG000|STARTED|Treatment Period 1 (Days 1 to 10)||20||
48158495|NCT04425902|100711074|FG000|COMPLETED|Treatment Period 1 (Days 1 to 10)||20||
48158496|NCT04425902|100711074|FG000|NOT COMPLETED|Treatment Period 1 (Days 1 to 10)||0||
48158497|NCT04425902|100711074|FG000|STARTED|Treatment Period 2 (Days 11 to 20)||20||
48158498|NCT04425902|100711074|FG000|COMPLETED|Treatment Period 2 (Days 11 to 20)||19||
48158499|NCT04425902|100711074|FG000|NOT COMPLETED|Treatment Period 2 (Days 11 to 20)||1||
48158500|NCT04425902|100711074|FG000|STARTED|Treatment Period 3 (Days 21 to 26)||19||
48158501|NCT04425902|100711074|FG000|COMPLETED|Treatment Period 3 (Days 21 to 26)||19||
48158502|NCT04425902|100711074|FG000|NOT COMPLETED|Treatment Period 3 (Days 21 to 26)||0||
48158503|NCT02901626|100711075|FG000|STARTED|Overall Study||280||
48158504|NCT02901626|100711076|FG001|STARTED|Overall Study||264||
48158505|NCT02901626|100711075|FG000|COMPLETED|Overall Study||279||
48158506|NCT02901626|100711076|FG001|COMPLETED|Overall Study||263||
48158507|NCT02901626|100711075|FG000|NOT COMPLETED|Overall Study||1||
48158508|NCT02901626|100711076|FG001|NOT COMPLETED|Overall Study||1||
48158509|NCT04524598|100711077|FG000|STARTED|Phase I - Feasibility||35||
48158510|NCT04524598|100711078|FG001|STARTED|Phase I - Feasibility||25||
48158511|NCT04524598|100711079|FG002|STARTED|Phase I - Feasibility||0||
48158512|NCT04524598|100711080|FG003|STARTED|Phase I - Feasibility||0||
48158513|NCT04524598|100711081|FG004|STARTED|Phase I - Feasibility||0||
48158514|NCT04524598|100711077|FG000|COMPLETED|Phase I - Feasibility||31||
48158515|NCT04524598|100711078|FG001|COMPLETED|Phase I - Feasibility||20||
48158516|NCT04524598|100711079|FG002|COMPLETED|Phase I - Feasibility||0||
48158517|NCT04524598|100711080|FG003|COMPLETED|Phase I - Feasibility||0||
48158518|NCT04524598|100711081|FG004|COMPLETED|Phase I - Feasibility||0||
48158519|NCT04524598|100711077|FG000|NOT COMPLETED|Phase I - Feasibility||4||
48158520|NCT04524598|100711078|FG001|NOT COMPLETED|Phase I - Feasibility||5||
48158521|NCT04524598|100711079|FG002|NOT COMPLETED|Phase I - Feasibility||0||
48158522|NCT04524598|100711080|FG003|NOT COMPLETED|Phase I - Feasibility||0||
48158523|NCT04524598|100711081|FG004|NOT COMPLETED|Phase I - Feasibility||0||
48158524|NCT04524598|100711077|FG000|STARTED|Phase II - Outcomes||0||
48158525|NCT04524598|100711078|FG001|STARTED|Phase II - Outcomes||0||
48158526|NCT04524598|100711079|FG002|STARTED|Phase II - Outcomes||80||
48158527|NCT04524598|100711080|FG003|STARTED|Phase II - Outcomes||80||
48158528|NCT04524598|100711081|FG004|STARTED|Phase II - Outcomes||0||
48158529|NCT04524598|100711077|FG000|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||0|Participants who met this threshold were included in the intention-to-treat analysis and the per protocol analyses.|
48158530|NCT04524598|100711078|FG001|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||0|Participants who met this threshold were included in the intention-to-treat analysis and the per protocol analyses.|
48158531|NCT04524598|100711079|FG002|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||63|Participants who met this threshold were included in the intention-to-treat analysis and the per protocol analyses.|
48314635|NCT01379469|101097249|FG000|NOT COMPLETED|Overall Study||12||
48314636|NCT01379469|101097250|FG001|NOT COMPLETED|Overall Study||4||
48158532|NCT04524598|100711080|FG003|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||58|Participants who met this threshold were included in the intention-to-treat analysis and the per protocol analyses.|
48158533|NCT04524598|100711081|FG004|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||0|Participants who met this threshold were included in the intention-to-treat analysis and the per protocol analyses.|
48158534|NCT04524598|100711077|FG000|COMPLETED|Phase II - Outcomes||0||
48158535|NCT04524598|100711078|FG001|COMPLETED|Phase II - Outcomes||0||
48158536|NCT04524598|100711079|FG002|COMPLETED|Phase II - Outcomes||54||
48158537|NCT04524598|100711080|FG003|COMPLETED|Phase II - Outcomes||67||
48158538|NCT04524598|100711081|FG004|COMPLETED|Phase II - Outcomes||0||
48158539|NCT04524598|100711077|FG000|NOT COMPLETED|Phase II - Outcomes||0||
48158540|NCT04524598|100711078|FG001|NOT COMPLETED|Phase II - Outcomes||0||
48158541|NCT04524598|100711079|FG002|NOT COMPLETED|Phase II - Outcomes||26||
48158542|NCT04524598|100711080|FG003|NOT COMPLETED|Phase II - Outcomes||13||
48158543|NCT04524598|100711081|FG004|NOT COMPLETED|Phase II - Outcomes||0||
48158544|NCT04524598|100711077|FG000|STARTED|Phase II - Control Extension||0||
48158545|NCT04524598|100711078|FG001|STARTED|Phase II - Control Extension||0||
48158546|NCT04524598|100711079|FG002|STARTED|Phase II - Control Extension||0||
48158547|NCT04524598|100711080|FG003|STARTED|Phase II - Control Extension||0||
48158548|NCT04524598|100711081|FG004|STARTED|Phase II - Control Extension||66||
48158549|NCT04524598|100711077|FG000|COMPLETED|Phase II - Control Extension||0||
48158550|NCT04524598|100711078|FG001|COMPLETED|Phase II - Control Extension||0||
48158551|NCT04524598|100711079|FG002|COMPLETED|Phase II - Control Extension||0||
48314637|NCT04667377|101097251|FG000|STARTED|Dose Escalation Period||78|Randomised|
48314638|NCT04667377|101097252|FG001|STARTED|Dose Escalation Period||78|Randomised|
48314639|NCT04667377|101097253|FG002|STARTED|Dose Escalation Period||77|Randomised|
48314640|NCT04667377|101097254|FG003|STARTED|Dose Escalation Period||77|Randomised|
48158552|NCT04524598|100711080|FG003|COMPLETED|Phase II - Control Extension||0||
48158553|NCT04524598|100711081|FG004|COMPLETED|Phase II - Control Extension||54||
48158554|NCT04524598|100711077|FG000|NOT COMPLETED|Phase II - Control Extension||0||
48158555|NCT04524598|100711078|FG001|NOT COMPLETED|Phase II - Control Extension||0||
48158556|NCT04524598|100711079|FG002|NOT COMPLETED|Phase II - Control Extension||0||
48158557|NCT04524598|100711080|FG003|NOT COMPLETED|Phase II - Control Extension||0||
48158558|NCT04524598|100711081|FG004|NOT COMPLETED|Phase II - Control Extension||12||
48158559|NCT02237508|100711082|FG000|STARTED|Overall Study||9||
48158560|NCT02237508|100711083|FG001|STARTED|Overall Study||9||
48158561|NCT02237508|100711084|FG002|STARTED|Overall Study||9||
48158562|NCT02237508|100711085|FG003|STARTED|Overall Study||9||
48314641|NCT04667377|101097255|FG004|STARTED|Dose Escalation Period||77|Randomised|
48314642|NCT04667377|101097251|FG000|Treated During Dose Escalation Period|Dose Escalation Period||77||
48406907|NCT03424044|101328489|FG005|STARTED|Third Intervention (76 Hours)||4||
48158563|NCT02237508|100711086|FG004|STARTED|Overall Study||9||
48158564|NCT02237508|100711087|FG005|STARTED|Overall Study||9||
48158565|NCT02237508|100711088|FG006|STARTED|Overall Study||9||
48158566|NCT02237508|100711089|FG007|STARTED|Overall Study||9||
48158567|NCT02237508|100711090|FG008|STARTED|Overall Study||9||
48158568|NCT02237508|100711091|FG009|STARTED|Overall Study||9||
48158569|NCT02237508|100711082|FG000|A|Overall Study||9||
48158570|NCT02237508|100711083|FG001|A|Overall Study||6||
48158571|NCT02237508|100711084|FG002|A|Overall Study||8||
48158572|NCT02237508|100711085|FG003|A|Overall Study||8||
48158573|NCT02237508|100711086|FG004|A|Overall Study||9||
48158574|NCT02237508|100711087|FG005|A|Overall Study||8||
48158575|NCT02237508|100711088|FG006|A|Overall Study||8||
48158576|NCT02237508|100711089|FG007|A|Overall Study||9||
48158577|NCT02237508|100711090|FG008|A|Overall Study||9||
48158578|NCT02237508|100711091|FG009|A|Overall Study||9||
48158579|NCT02237508|100711082|FG000|B1|Overall Study||9||
48158580|NCT02237508|100711083|FG001|B1|Overall Study||9||
48158581|NCT02237508|100711084|FG002|B1|Overall Study||9||
48614588|NCT02227784|101841781|FG001|COMPLETED|Open-Label Extension Phase (OLE)||0||
48614589|NCT02227784|101841782|FG002|COMPLETED|Open-Label Extension Phase (OLE)||0||
48614590|NCT02227784|101841783|FG003|COMPLETED|Open-Label Extension Phase (OLE)||0||
48614591|NCT02227784|101841784|FG004|COMPLETED|Open-Label Extension Phase (OLE)||0||
48614592|NCT02227784|101841780|FG000|NOT COMPLETED|Open-Label Extension Phase (OLE)||0||
48614593|NCT02227784|101841781|FG001|NOT COMPLETED|Open-Label Extension Phase (OLE)||0||
48614594|NCT02227784|101841782|FG002|NOT COMPLETED|Open-Label Extension Phase (OLE)||0||
48614595|NCT02227784|101841783|FG003|NOT COMPLETED|Open-Label Extension Phase (OLE)||0||
48614596|NCT02227784|101841784|FG004|NOT COMPLETED|Open-Label Extension Phase (OLE)||248||
48614597|NCT01354197|101841785|FG000|STARTED|Overall Study||4652||
48614598|NCT01354197|101841785|FG000|COMPLETED|Overall Study||4652||
48614599|NCT01354197|101841785|FG000|NOT COMPLETED|Overall Study||0||
48158582|NCT02237508|100711085|FG003|B1|Overall Study||8||
48158583|NCT02237508|100711086|FG004|B1|Overall Study||9||
48158584|NCT02237508|100711087|FG005|B1|Overall Study||9||
48158585|NCT02237508|100711088|FG006|B1|Overall Study||9||
48158586|NCT02237508|100711089|FG007|B1|Overall Study||9||
48158587|NCT02237508|100711090|FG008|B1|Overall Study||9||
48158588|NCT02237508|100711091|FG009|B1|Overall Study||9||
48158589|NCT02237508|100711082|FG000|B2|Overall Study||9||
48158590|NCT02237508|100711083|FG001|B2|Overall Study||6||
48158591|NCT02237508|100711084|FG002|B2|Overall Study||9||
48158592|NCT02237508|100711085|FG003|B2|Overall Study||9||
48158593|NCT02237508|100711086|FG004|B2|Overall Study||9||
48158594|NCT02237508|100711087|FG005|B2|Overall Study||9||
48158595|NCT02237508|100711088|FG006|B2|Overall Study||9||
48158596|NCT02237508|100711089|FG007|B2|Overall Study||9||
48158597|NCT02237508|100711090|FG008|B2|Overall Study||8||
48158598|NCT02237508|100711091|FG009|B2|Overall Study||9||
48158599|NCT02237508|100711082|FG000|C|Overall Study||9||
48158600|NCT02237508|100711083|FG001|C|Overall Study||8||
48158601|NCT02237508|100711084|FG002|C|Overall Study||9||
48158602|NCT02237508|100711085|FG003|C|Overall Study||8||
48158603|NCT02237508|100711086|FG004|C|Overall Study||9||
48158604|NCT02237508|100711087|FG005|C|Overall Study||9||
48158605|NCT02237508|100711088|FG006|C|Overall Study||9||
48158606|NCT02237508|100711089|FG007|C|Overall Study||9||
48158607|NCT02237508|100711090|FG008|C|Overall Study||9||
48158608|NCT02237508|100711091|FG009|C|Overall Study||9||
48158609|NCT02237508|100711082|FG000|D|Overall Study||9||
48158610|NCT02237508|100711083|FG001|D|Overall Study||6||
48614600|NCT00719160|101841786|FG000|STARTED|Overall Study||6||
48614601|NCT00719160|101841787|FG001|STARTED|Overall Study||6||
48614602|NCT00719160|101841786|FG000|COMPLETED|Overall Study||6||
48614603|NCT00719160|101841787|FG001|COMPLETED|Overall Study||6||
48158611|NCT02237508|100711084|FG002|D|Overall Study||9||
48158612|NCT02237508|100711085|FG003|D|Overall Study||9||
48158613|NCT02237508|100711086|FG004|D|Overall Study||9||
48158614|NCT02237508|100711087|FG005|D|Overall Study||9||
48158615|NCT02237508|100711088|FG006|D|Overall Study||9||
48158616|NCT02237508|100711089|FG007|D|Overall Study||9||
48158617|NCT02237508|100711090|FG008|D|Overall Study||8||
48158618|NCT02237508|100711091|FG009|D|Overall Study||9||
48158619|NCT02237508|100711082|FG000|COMPLETED|Overall Study||9||
48158620|NCT02237508|100711083|FG001|COMPLETED|Overall Study||6||
48158621|NCT02237508|100711084|FG002|COMPLETED|Overall Study||8||
48158622|NCT02237508|100711085|FG003|COMPLETED|Overall Study||8||
48158623|NCT02237508|100711086|FG004|COMPLETED|Overall Study||9||
48158624|NCT02237508|100711087|FG005|COMPLETED|Overall Study||8||
48158625|NCT02237508|100711088|FG006|COMPLETED|Overall Study||8||
48158626|NCT02237508|100711089|FG007|COMPLETED|Overall Study||9||
48158627|NCT02237508|100711090|FG008|COMPLETED|Overall Study||8||
48158628|NCT02237508|100711091|FG009|COMPLETED|Overall Study||9||
48158629|NCT02237508|100711082|FG000|NOT COMPLETED|Overall Study||0||
48158630|NCT02237508|100711083|FG001|NOT COMPLETED|Overall Study||3||
48614604|NCT00719160|101841786|FG000|NOT COMPLETED|Overall Study||0||
48614605|NCT00719160|101841787|FG001|NOT COMPLETED|Overall Study||0||
48614606|NCT05122624|101841788|FG000|STARTED|Overall Study||1826||6
48614607|NCT05122624|101841789|FG001|STARTED|Overall Study||1506||5
48614608|NCT05122624|101841788|FG000|COMPLETED|Overall Study||1826||6
48614609|NCT05122624|101841789|FG001|COMPLETED|Overall Study||1506||5
48158631|NCT02237508|100711084|FG002|NOT COMPLETED|Overall Study||1||
48158632|NCT02237508|100711085|FG003|NOT COMPLETED|Overall Study||1||
48158633|NCT02237508|100711086|FG004|NOT COMPLETED|Overall Study||0||
48158634|NCT02237508|100711087|FG005|NOT COMPLETED|Overall Study||1||
48158635|NCT02237508|100711088|FG006|NOT COMPLETED|Overall Study||1||
48158636|NCT02237508|100711089|FG007|NOT COMPLETED|Overall Study||0||
48158637|NCT02237508|100711090|FG008|NOT COMPLETED|Overall Study||1||
48158638|NCT02237508|100711091|FG009|NOT COMPLETED|Overall Study||0||
48158639|NCT01755143|100711092|FG000|STARTED|Overall Study||177||
48158640|NCT01755143|100711093|FG001|STARTED|Overall Study||89||
48158641|NCT01755143|100711092|FG000|COMPLETED|Overall Study||166||
48158642|NCT01755143|100711093|FG001|COMPLETED|Overall Study||86||
48158643|NCT01755143|100711092|FG000|NOT COMPLETED|Overall Study||11||
48158644|NCT01755143|100711093|FG001|NOT COMPLETED|Overall Study||3||
48158645|NCT01931735|100711094|FG000|STARTED|Randomized Phase||4||
48158646|NCT01931735|100711095|FG001|STARTED|Randomized Phase||3||
48158647|NCT01931735|100711096|FG002|STARTED|Randomized Phase||9||
48158648|NCT01931735|100711097|FG003|STARTED|Randomized Phase||0||
48158649|NCT01931735|100711094|FG000|COMPLETED|Randomized Phase||2||
48158650|NCT01931735|100711095|FG001|COMPLETED|Randomized Phase||1||
48158651|NCT01931735|100711096|FG002|COMPLETED|Randomized Phase||4||
48158652|NCT01931735|100711097|FG003|COMPLETED|Randomized Phase||0||
48158653|NCT01931735|100711094|FG000|NOT COMPLETED|Randomized Phase||2||
48158654|NCT01931735|100711095|FG001|NOT COMPLETED|Randomized Phase||2||
48158655|NCT01931735|100711096|FG002|NOT COMPLETED|Randomized Phase||5||
48158656|NCT01931735|100711097|FG003|NOT COMPLETED|Randomized Phase||0||
48158657|NCT01931735|100711094|FG000|STARTED|Observational Non-Randomized Phase||2||
48158658|NCT01931735|100711095|FG001|STARTED|Observational Non-Randomized Phase||1||
48158659|NCT01931735|100711096|FG002|STARTED|Observational Non-Randomized Phase||0||
48158660|NCT01931735|100711097|FG003|STARTED|Observational Non-Randomized Phase||11||
48158661|NCT01931735|100711094|FG000|COMPLETED|Observational Non-Randomized Phase||2||
48158662|NCT01931735|100711095|FG001|COMPLETED|Observational Non-Randomized Phase||1||
48158663|NCT01931735|100711096|FG002|COMPLETED|Observational Non-Randomized Phase||0||
48158664|NCT01931735|100711097|FG003|COMPLETED|Observational Non-Randomized Phase||9||
48158665|NCT01931735|100711094|FG000|NOT COMPLETED|Observational Non-Randomized Phase||0||
48158666|NCT01931735|100711095|FG001|NOT COMPLETED|Observational Non-Randomized Phase||0||
48158667|NCT01931735|100711096|FG002|NOT COMPLETED|Observational Non-Randomized Phase||0||
48158668|NCT01931735|100711097|FG003|NOT COMPLETED|Observational Non-Randomized Phase||2||
48158669|NCT03764449|100711098|FG000|STARTED|Overall Study||8||
48158670|NCT03764449|100711099|FG001|STARTED|Overall Study||8||
48158671|NCT03764449|100711098|FG000|COMPLETED|Overall Study||8||
48158672|NCT03764449|100711099|FG001|COMPLETED|Overall Study||8||
48158673|NCT03764449|100711098|FG000|NOT COMPLETED|Overall Study||0||
48158674|NCT03764449|100711099|FG001|NOT COMPLETED|Overall Study||0||
48158675|NCT00583622|100711100|FG000|STARTED|Overall Study||12||
48158676|NCT00583622|100711100|FG000|COMPLETED|Overall Study||12||
48158677|NCT00583622|100711100|FG000|NOT COMPLETED|Overall Study||0||
48158678|NCT00828308|100711101|FG000|STARTED|Overall Study||16||
48158679|NCT00828308|100711101|FG000|COMPLETED|Overall Study||16||
48158680|NCT00828308|100711101|FG000|NOT COMPLETED|Overall Study||0||
48314643|NCT04667377|101097252|FG001|Treated During Dose Escalation Period|Dose Escalation Period||78||
48314644|NCT04667377|101097253|FG002|Treated During Dose Escalation Period|Dose Escalation Period||77||
48314645|NCT04667377|101097254|FG003|Treated During Dose Escalation Period|Dose Escalation Period||77||
48314646|NCT04667377|101097255|FG004|Treated During Dose Escalation Period|Dose Escalation Period||77||
48314647|NCT04667377|101097251|FG000|COMPLETED|Dose Escalation Period||55|Completed = Completed trial medication|
48314648|NCT04667377|101097252|FG001|COMPLETED|Dose Escalation Period||60|Completed = Completed trial medication|
48314649|NCT04667377|101097253|FG002|COMPLETED|Dose Escalation Period||59|Completed = Completed trial medication|
48314650|NCT04667377|101097254|FG003|COMPLETED|Dose Escalation Period||55|Completed = Completed trial medication|
48158681|NCT00508404|100711102|FG000|STARTED|Overall Study||154||
48158682|NCT00508404|100711102|FG000|COMPLETED|Overall Study||112||
48158683|NCT00508404|100711102|FG000|NOT COMPLETED|Overall Study||42||
48158684|NCT00437645|100711103|FG000|STARTED|Overall Study||592||
48158685|NCT00437645|100711104|FG001|STARTED|Overall Study||591||
48158686|NCT00437645|100711103|FG000|COMPLETED|Overall Study||557||
48158687|NCT00437645|100711104|FG001|COMPLETED|Overall Study||476||
48158688|NCT00437645|100711103|FG000|NOT COMPLETED|Overall Study||35||
48158689|NCT00437645|100711104|FG001|NOT COMPLETED|Overall Study||115||
48158690|NCT01286441|100711105|FG000|STARTED|Overall Study||45||
48158691|NCT01286441|100711106|FG001|STARTED|Overall Study||44||
48158692|NCT01286441|100711107|FG002|STARTED|Overall Study||46||
48158693|NCT01286441|100711108|FG003|STARTED|Overall Study||48||
48158694|NCT01286441|100711105|FG000|COMPLETED|Overall Study||38||
48158695|NCT01286441|100711106|FG001|COMPLETED|Overall Study||37||
48158696|NCT01286441|100711107|FG002|COMPLETED|Overall Study||39||
48158697|NCT01286441|100711108|FG003|COMPLETED|Overall Study||37||
48158698|NCT01286441|100711105|FG000|NOT COMPLETED|Overall Study||7||
48158699|NCT01286441|100711106|FG001|NOT COMPLETED|Overall Study||7||
48158700|NCT01286441|100711107|FG002|NOT COMPLETED|Overall Study||7||
48368041|NCT03567291|101230094|FG002|STARTED|Period III||0||
48314651|NCT04667377|101097255|FG004|COMPLETED|Dose Escalation Period||57|Completed = Completed trial medication|
48314652|NCT04667377|101097251|FG000|NOT COMPLETED|Dose Escalation Period||23||
48314653|NCT04667377|101097252|FG001|NOT COMPLETED|Dose Escalation Period||18||
48314654|NCT04667377|101097253|FG002|NOT COMPLETED|Dose Escalation Period||18||
48314655|NCT04667377|101097254|FG003|NOT COMPLETED|Dose Escalation Period||22||
48314656|NCT04667377|101097255|FG004|NOT COMPLETED|Dose Escalation Period||20||
48314657|NCT04667377|101097251|FG000|STARTED|Maintenance Period||55||
48314658|NCT04667377|101097252|FG001|STARTED|Maintenance Period||60||
48314659|NCT04667377|101097253|FG002|STARTED|Maintenance Period||59||
48314660|NCT04667377|101097254|FG003|STARTED|Maintenance Period||55||
48314661|NCT04667377|101097255|FG004|STARTED|Maintenance Period||57||
48314662|NCT04667377|101097251|FG000|COMPLETED|Maintenance Period||47|Completed = Completed trial medication|
48314663|NCT04667377|101097252|FG001|COMPLETED|Maintenance Period||45|Completed = Completed trial medication|
48314664|NCT04667377|101097253|FG002|COMPLETED|Maintenance Period||48|Completed = Completed trial medication|
48314665|NCT04667377|101097254|FG003|COMPLETED|Maintenance Period||47|Completed = Completed trial medication|
48314666|NCT04667377|101097255|FG004|COMPLETED|Maintenance Period||46|Completed = Completed trial medication|
48314667|NCT04667377|101097251|FG000|NOT COMPLETED|Maintenance Period||8||
48314668|NCT04667377|101097252|FG001|NOT COMPLETED|Maintenance Period||15||
48314669|NCT04667377|101097253|FG002|NOT COMPLETED|Maintenance Period||11||
48314670|NCT04667377|101097254|FG003|NOT COMPLETED|Maintenance Period||8||
48314671|NCT04667377|101097255|FG004|NOT COMPLETED|Maintenance Period||11||
48314672|NCT04305275|101097256|FG000|STARTED|Overall Study||34||
48314673|NCT04305275|101097257|FG001|STARTED|Overall Study||35||
48314674|NCT04305275|101097256|FG000|Safety Set|Overall Study||34|Safety Set included all participants who were administered SAGE-324 or placebo.|
48314675|NCT04305275|101097257|FG001|Safety Set|Overall Study||35|Safety Set included all participants who were administered SAGE-324 or placebo.|
48314676|NCT04305275|101097256|FG000|Full Analysis Set|Overall Study||33|Full Analysis Set included all randomized participants who received any amount of SAGE-324 or placebo and had a baseline and at least one postbaseline efficacy assessment.|
48314677|NCT04305275|101097257|FG001|Full Analysis Set|Overall Study||34|Full Analysis Set included all randomized participants who received any amount of SAGE-324 or placebo and had a baseline and at least one postbaseline efficacy assessment.|
48314678|NCT04305275|101097256|FG000|COMPLETED|Overall Study||21||
48314679|NCT04305275|101097257|FG001|COMPLETED|Overall Study||33||
48314680|NCT04305275|101097256|FG000|NOT COMPLETED|Overall Study||13||
48314681|NCT04305275|101097257|FG001|NOT COMPLETED|Overall Study||2||
48314682|NCT00359021|101097258|FG000|STARTED|Overall Study||256||
48314683|NCT00359021|101097259|FG001|STARTED|Overall Study||247||
48314684|NCT00359021|101097258|FG000|COMPLETED|Overall Study||175||
48314685|NCT00359021|101097259|FG001|COMPLETED|Overall Study||195||
48314686|NCT00359021|101097258|FG000|NOT COMPLETED|Overall Study||81||
48314687|NCT00359021|101097259|FG001|NOT COMPLETED|Overall Study||52||
48314688|NCT03924752|101097260|FG000|STARTED|Overall Study||10||
48314689|NCT03924752|101097260|FG000|COMPLETED|Overall Study||10||
48314690|NCT03924752|101097260|FG000|NOT COMPLETED|Overall Study||0||
48314691|NCT03310450|101097261|FG000|STARTED|Overall Study||32||
48314692|NCT03310450|101097262|FG001|STARTED|Overall Study||34||
48314693|NCT03310450|101097263|FG002|STARTED|Overall Study||28||
48314694|NCT03310450|101097261|FG000|COMPLETED|Overall Study||30||
48314695|NCT03310450|101097262|FG001|COMPLETED|Overall Study||30||
48314696|NCT03310450|101097263|FG002|COMPLETED|Overall Study||28||
48314697|NCT03310450|101097261|FG000|NOT COMPLETED|Overall Study||2||
48314698|NCT03310450|101097262|FG001|NOT COMPLETED|Overall Study||4||
48314699|NCT03310450|101097263|FG002|NOT COMPLETED|Overall Study||0||
48314700|NCT02015442|101097264|FG000|STARTED|First Intervention (7 Days)||5||
48314701|NCT02015442|101097265|FG001|STARTED|First Intervention (7 Days)||4||
48314702|NCT02015442|101097264|FG000|COMPLETED|First Intervention (7 Days)||5||
48314703|NCT02015442|101097265|FG001|COMPLETED|First Intervention (7 Days)||4||
48314704|NCT02015442|101097264|FG000|NOT COMPLETED|First Intervention (7 Days)||0||
48314705|NCT02015442|101097265|FG001|NOT COMPLETED|First Intervention (7 Days)||0||
48314706|NCT02015442|101097264|FG000|STARTED|Wash-out (4 Weeks)||5||
48314707|NCT02015442|101097265|FG001|STARTED|Wash-out (4 Weeks)||4||
48314708|NCT02015442|101097264|FG000|COMPLETED|Wash-out (4 Weeks)||5||
48314709|NCT02015442|101097265|FG001|COMPLETED|Wash-out (4 Weeks)||4||
48314710|NCT02015442|101097264|FG000|NOT COMPLETED|Wash-out (4 Weeks)||0||
48314711|NCT02015442|101097265|FG001|NOT COMPLETED|Wash-out (4 Weeks)||0||
48314712|NCT02015442|101097264|FG000|STARTED|Second Intervention (7 Days)||5||
48314713|NCT02015442|101097265|FG001|STARTED|Second Intervention (7 Days)||4||
48314714|NCT02015442|101097264|FG000|COMPLETED|Second Intervention (7 Days)||5||
48314715|NCT02015442|101097265|FG001|COMPLETED|Second Intervention (7 Days)||4||
48314716|NCT02015442|101097264|FG000|NOT COMPLETED|Second Intervention (7 Days)||0||
48314717|NCT02015442|101097265|FG001|NOT COMPLETED|Second Intervention (7 Days)||0||
48314718|NCT01892163|101097266|FG000|STARTED|Overall Study||50||
48314719|NCT01892163|101097267|FG001|STARTED|Overall Study||50||
48314720|NCT01892163|101097266|FG000|COMPLETED|Overall Study||48||
48314721|NCT01892163|101097267|FG001|COMPLETED|Overall Study||49||
48314722|NCT01892163|101097266|FG000|NOT COMPLETED|Overall Study||2||
48314723|NCT01892163|101097267|FG001|NOT COMPLETED|Overall Study||1||
48314724|NCT02219282|101097268|FG000|STARTED|Overall Study||33||
48314725|NCT02219282|101097269|FG001|STARTED|Overall Study||33||
48314726|NCT02219282|101097268|FG000|COMPLETED|Overall Study||32||
48314727|NCT02219282|101097269|FG001|COMPLETED|Overall Study||32||
48314728|NCT02219282|101097268|FG000|NOT COMPLETED|Overall Study||1||
48314729|NCT02219282|101097269|FG001|NOT COMPLETED|Overall Study||1||
48314730|NCT02426476|101097270|FG000|STARTED|Overall Study||57||
48314731|NCT02426476|101097271|FG001|STARTED|Overall Study||56||
48314732|NCT02426476|101097270|FG000|COMPLETED|Overall Study||38||
48314733|NCT02426476|101097271|FG001|COMPLETED|Overall Study||39||
48314734|NCT02426476|101097270|FG000|NOT COMPLETED|Overall Study||19||
48314735|NCT02426476|101097271|FG001|NOT COMPLETED|Overall Study||17||
48314736|NCT01392677|101097272|FG000|STARTED|Overall Study||109||
48314737|NCT01392677|101097273|FG001|STARTED|Overall Study||109||
48314738|NCT01392677|101097272|FG000|COMPLETED|Overall Study||101||
48314739|NCT01392677|101097273|FG001|COMPLETED|Overall Study||101||
48314740|NCT01392677|101097272|FG000|NOT COMPLETED|Overall Study||8||
48314741|NCT01392677|101097273|FG001|NOT COMPLETED|Overall Study||8||
48314742|NCT04311697|101097274|FG000|STARTED|Overall Study||136||
48314743|NCT04311697|101097275|FG001|STARTED|Overall Study||67||
48314744|NCT04311697|101097274|FG000|COMPLETED|Overall Study||85||
48314745|NCT04311697|101097275|FG001|COMPLETED|Overall Study||35||
48314746|NCT04311697|101097274|FG000|NOT COMPLETED|Overall Study||51||
48314747|NCT04311697|101097275|FG001|NOT COMPLETED|Overall Study||32||
48314748|NCT02142738|101097276|FG000|STARTED|Overall Study||154||
48314749|NCT02142738|101097277|FG001|STARTED|Overall Study||151||
48314750|NCT02142738|101097276|FG000|Treated|Overall Study||154||
48314751|NCT02142738|101097277|FG001|Treated|Overall Study||150||
48314752|NCT02142738|101097276|FG000|Chemotherapy Switch to Pembrolizumab|Overall Study||0||
48314753|NCT02142738|101097277|FG001|Chemotherapy Switch to Pembrolizumab|Overall Study||83||
48314754|NCT02142738|101097276|FG000|Second Course Pembrolizumab|Overall Study||12||
48314755|NCT02142738|101097277|FG001|Second Course Pembrolizumab|Overall Study||1||
48314756|NCT02142738|101097276|FG000|COMPLETED|Overall Study||0||
48314757|NCT02142738|101097277|FG001|COMPLETED|Overall Study||0||
48314758|NCT02142738|101097276|FG000|NOT COMPLETED|Overall Study||154||
48314759|NCT02142738|101097277|FG001|NOT COMPLETED|Overall Study||151||
48314760|NCT04093843|101097278|FG000|STARTED|Overall Study||6||
48314761|NCT04093843|101097278|FG000|COMPLETED|Overall Study||6||
48314762|NCT04093843|101097278|FG000|NOT COMPLETED|Overall Study||0||
48314763|NCT01118273|101097279|FG000|STARTED|Overall Study||27||
48314764|NCT01118273|101097280|FG001|STARTED|Overall Study||27||
48314765|NCT01118273|101097281|FG002|STARTED|Overall Study||27||
48314766|NCT01118273|101097282|FG003|STARTED|Overall Study||27||
48314767|NCT01118273|101097283|FG004|STARTED|Overall Study||27||
48314768|NCT01118273|101097284|FG005|STARTED|Overall Study||27||
48314769|NCT01118273|101097279|FG000|COMPLETED|Overall Study||27||
48314770|NCT01118273|101097280|FG001|COMPLETED|Overall Study||27||
48314771|NCT01118273|101097281|FG002|COMPLETED|Overall Study||27||
48314772|NCT01118273|101097282|FG003|COMPLETED|Overall Study||27||
48314773|NCT01118273|101097283|FG004|COMPLETED|Overall Study||27||
48314774|NCT01118273|101097284|FG005|COMPLETED|Overall Study||27||
48314775|NCT01118273|101097279|FG000|NOT COMPLETED|Overall Study||0||
48314776|NCT01118273|101097280|FG001|NOT COMPLETED|Overall Study||0||
48314777|NCT01118273|101097281|FG002|NOT COMPLETED|Overall Study||0||
48314778|NCT01118273|101097282|FG003|NOT COMPLETED|Overall Study||0||
48314779|NCT01118273|101097283|FG004|NOT COMPLETED|Overall Study||0||
48314780|NCT01118273|101097284|FG005|NOT COMPLETED|Overall Study||0||
48314781|NCT03349775|101097285|FG000|STARTED|Overall Study||10||
48314782|NCT03349775|101097286|FG001|STARTED|Overall Study||11||
48314783|NCT03349775|101097285|FG000|COMPLETED|Overall Study||8||
48314784|NCT03349775|101097286|FG001|COMPLETED|Overall Study||7||
48314785|NCT03349775|101097285|FG000|NOT COMPLETED|Overall Study||2||
48314786|NCT03349775|101097286|FG001|NOT COMPLETED|Overall Study||4||
48314787|NCT00871845|101097287|FG000|STARTED|Overall Study||11||
48314788|NCT00871845|101097288|FG001|STARTED|Overall Study||25||
48314789|NCT00871845|101097287|FG000|COMPLETED|Overall Study||11||
48314790|NCT00871845|101097288|FG001|COMPLETED|Overall Study||25||
48314791|NCT00871845|101097287|FG000|NOT COMPLETED|Overall Study||0||
48314792|NCT00871845|101097288|FG001|NOT COMPLETED|Overall Study||0||
48314793|NCT04037748|101097289|FG000|STARTED|Treatment Period 1||36||
48314794|NCT04037748|101097290|FG001|STARTED|Treatment Period 1||36||
48314795|NCT04037748|101097289|FG000|COMPLETED|Treatment Period 1||28||
48314796|NCT04037748|101097290|FG001|COMPLETED|Treatment Period 1||30||
48314797|NCT04037748|101097289|FG000|NOT COMPLETED|Treatment Period 1||8||
48314798|NCT04037748|101097290|FG001|NOT COMPLETED|Treatment Period 1||6||
48314799|NCT04037748|101097289|FG000|STARTED|Treatment Period 2||28||
48314800|NCT04037748|101097290|FG001|STARTED|Treatment Period 2||30||
48314801|NCT04037748|101097289|FG000|COMPLETED|Treatment Period 2||26||
48314802|NCT04037748|101097290|FG001|COMPLETED|Treatment Period 2||29||
48314803|NCT04037748|101097289|FG000|NOT COMPLETED|Treatment Period 2||2||
48314804|NCT04037748|101097290|FG001|NOT COMPLETED|Treatment Period 2||1||
48314805|NCT04869345|101097291|FG000|STARTED|Overall Study||49||
48314806|NCT04869345|101097292|FG001|STARTED|Overall Study||46||
48314807|NCT04869345|101097291|FG000|Post-Intervention Week 11|Overall Study||43||
48314808|NCT04869345|101097292|FG001|Post-Intervention Week 11|Overall Study||43||
48314809|NCT04869345|101097291|FG000|1 Month Follow-Up Week 16|Overall Study||41||
48314810|NCT04869345|101097292|FG001|1 Month Follow-Up Week 16|Overall Study||43||
48314811|NCT04869345|101097291|FG000|COMPLETED|Overall Study||41||
48314812|NCT04869345|101097292|FG001|COMPLETED|Overall Study||43||
48314813|NCT04869345|101097291|FG000|NOT COMPLETED|Overall Study||8||
48314814|NCT04869345|101097292|FG001|NOT COMPLETED|Overall Study||3||
48314815|NCT00868348|101097293|FG000|STARTED|Overall Study||30||
48314816|NCT00868348|101097294|FG001|STARTED|Overall Study||30||
48314817|NCT00868348|101097293|FG000|COMPLETED|Overall Study||30||
48314818|NCT00868348|101097294|FG001|COMPLETED|Overall Study||30||
48314819|NCT00868348|101097293|FG000|NOT COMPLETED|Overall Study||0||
48314820|NCT00868348|101097294|FG001|NOT COMPLETED|Overall Study||0||
48314821|NCT01469182|101097295|FG000|STARTED|Overall Study||610||
48314822|NCT01469182|101097296|FG001|STARTED|Overall Study||304||
48314823|NCT01469182|101097295|FG000|Treated|Overall Study||609||
48314824|NCT01469182|101097296|FG001|Treated|Overall Study||304||
48314825|NCT01469182|101097295|FG000|COMPLETED|Overall Study||575||
48314826|NCT01469182|101097296|FG001|COMPLETED|Overall Study||298||
48314827|NCT01469182|101097295|FG000|NOT COMPLETED|Overall Study||35||
48314828|NCT01469182|101097296|FG001|NOT COMPLETED|Overall Study||6||
48314829|NCT04743921|101097297|FG000|STARTED|Overall Study||14||
48314830|NCT04743921|101097297|FG000|COMPLETED|Overall Study||13||
48314831|NCT04743921|101097297|FG000|NOT COMPLETED|Overall Study||1||
48314832|NCT01471015|101097298|FG000|STARTED|Overall Study||10||
48406908|NCT03424044|101328490|FG006|STARTED|Third Intervention (76 Hours)||1||
48731842|NCT00568126|102127117|FG000|COMPLETED|Overall Study||13||
48731843|NCT00568126|102127118|FG001|COMPLETED|Overall Study||12||
48731844|NCT00568126|102127117|FG000|NOT COMPLETED|Overall Study||11||
48731845|NCT00568126|102127118|FG001|NOT COMPLETED|Overall Study||9||
48731846|NCT01088399|102127119|FG000|STARTED|Overall Study||8716||
48731847|NCT01088399|102127120|FG001|STARTED|Overall Study||1655||
48314833|NCT01471015|101097299|FG001|STARTED|Overall Study||10||
48314834|NCT01471015|101097300|FG002|STARTED|Overall Study||10||
48314835|NCT01471015|101097298|FG000|COMPLETED|Overall Study||10||
48314836|NCT01471015|101097299|FG001|COMPLETED|Overall Study||9||
48314837|NCT01471015|101097300|FG002|COMPLETED|Overall Study||9||
48314838|NCT01471015|101097298|FG000|NOT COMPLETED|Overall Study||0||
48314839|NCT01471015|101097299|FG001|NOT COMPLETED|Overall Study||1||
48406909|NCT03424044|101328491|FG007|STARTED|Third Intervention (76 Hours)||1||
48731848|NCT01088399|102127121|FG002|STARTED|Overall Study||302||
48731849|NCT01088399|102127119|FG000|COMPLETED|Overall Study||1595||
48731850|NCT01088399|102127120|FG001|COMPLETED|Overall Study||308||
48731851|NCT01088399|102127121|FG002|COMPLETED|Overall Study||21||
48731852|NCT01088399|102127119|FG000|NOT COMPLETED|Overall Study||7121||
48731853|NCT01088399|102127120|FG001|NOT COMPLETED|Overall Study||1347||
48731854|NCT01088399|102127121|FG002|NOT COMPLETED|Overall Study||281||
48731855|NCT04016844|102127122|FG000|STARTED|Overall Study||4||
48314840|NCT01471015|101097300|FG002|NOT COMPLETED|Overall Study||1||
48314841|NCT00674583|101097301|FG000|STARTED|Overall Study||311||
48314842|NCT00674583|101097302|FG001|STARTED|Overall Study||103||
48314843|NCT00674583|101097301|FG000|COMPLETED|Overall Study||311||
48314844|NCT00674583|101097302|FG001|COMPLETED|Overall Study||103||
48314845|NCT00674583|101097301|FG000|NOT COMPLETED|Overall Study||0||
48314846|NCT00674583|101097302|FG001|NOT COMPLETED|Overall Study||0||
48314847|NCT00995475|101097303|FG000|STARTED|First Intervention||9||
48314848|NCT00995475|101097304|FG001|STARTED|First Intervention||9||
48314849|NCT00995475|101097303|FG000|COMPLETED|First Intervention||9||
48314850|NCT00995475|101097304|FG001|COMPLETED|First Intervention||9||
48158701|NCT01286441|100711108|FG003|NOT COMPLETED|Overall Study||11||
48158702|NCT00112580|100711109|FG000|STARTED|Overall Study||8||
48158703|NCT00112580|100711110|FG001|STARTED|Overall Study||19||
48406910|NCT03424044|101328492|FG008|STARTED|Third Intervention (76 Hours)||1||
48406911|NCT03424044|101328484|FG000|COMPLETED|Third Intervention (76 Hours)||3||
48731856|NCT04016844|102127122|FG000|COMPLETED|Overall Study||4||
48731857|NCT04016844|102127122|FG000|NOT COMPLETED|Overall Study||0||
48731858|NCT00856297|102127123|FG000|STARTED|Overall Study||131||
48731859|NCT00856297|102127124|FG001|STARTED|Overall Study||76||
48731860|NCT00856297|102127125|FG002|STARTED|Overall Study||107||
48731861|NCT00856297|102127126|FG003|STARTED|Overall Study||44||
48731862|NCT00856297|102127127|FG004|STARTED|Overall Study||31||
48731863|NCT00856297|102127123|FG000|COMPLETED|Overall Study||129||
48731864|NCT00856297|102127124|FG001|COMPLETED|Overall Study||76||
48731865|NCT00856297|102127125|FG002|COMPLETED|Overall Study||107||
48731866|NCT00856297|102127126|FG003|COMPLETED|Overall Study||44||
48158704|NCT00112580|100711109|FG000|COMPLETED|Overall Study||0||
48158705|NCT00112580|100711110|FG001|COMPLETED|Overall Study||0||
48158706|NCT00112580|100711109|FG000|NOT COMPLETED|Overall Study||8||
48158707|NCT00112580|100711110|FG001|NOT COMPLETED|Overall Study||19||
48158708|NCT02312856|100711111|FG000|STARTED|Overall Study||34|10/22/2014|
48158709|NCT02312856|100711111|FG000|COMPLETED|Overall Study||30|11/07/2015|
48158710|NCT02312856|100711111|FG000|NOT COMPLETED|Overall Study||4||
48158711|NCT02799784|100711112|FG000|STARTED|Treatment Period 1 (TP1- 8 Weeks)||117||
48158712|NCT02799784|100711113|FG001|STARTED|Treatment Period 1 (TP1- 8 Weeks)||119||
48158713|NCT02799784|100711112|FG000|COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||111||
48158714|NCT02799784|100711113|FG001|COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||118||
48158715|NCT02799784|100711112|FG000|NOT COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||6||
48158716|NCT02799784|100711113|FG001|NOT COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||1||
48731867|NCT00856297|102127127|FG004|COMPLETED|Overall Study||31||
48731868|NCT00856297|102127123|FG000|NOT COMPLETED|Overall Study||2||
48731869|NCT00856297|102127124|FG001|NOT COMPLETED|Overall Study||0||
48731870|NCT00856297|102127125|FG002|NOT COMPLETED|Overall Study||0||
48731871|NCT00856297|102127126|FG003|NOT COMPLETED|Overall Study||0||
48731872|NCT00856297|102127127|FG004|NOT COMPLETED|Overall Study||0||
48731873|NCT02815644|102127128|FG000|STARTED|Treatment Period 1 + Washout||11||
48731874|NCT02815644|102127129|FG001|STARTED|Treatment Period 1 + Washout||11||
48731875|NCT02815644|102127128|FG000|COMPLETED|Treatment Period 1 + Washout||11||
48731876|NCT02815644|102127129|FG001|COMPLETED|Treatment Period 1 + Washout||11||
48731877|NCT02815644|102127128|FG000|NOT COMPLETED|Treatment Period 1 + Washout||0||
48731878|NCT02815644|102127129|FG001|NOT COMPLETED|Treatment Period 1 + Washout||0||
48731879|NCT02815644|102127128|FG000|STARTED|Treatment Period 2||11||
48731880|NCT02815644|102127129|FG001|STARTED|Treatment Period 2||11||
48731881|NCT02815644|102127128|FG000|COMPLETED|Treatment Period 2||11||
48731882|NCT02815644|102127129|FG001|COMPLETED|Treatment Period 2||11||
48731883|NCT02815644|102127128|FG000|NOT COMPLETED|Treatment Period 2||0||
48731884|NCT02815644|102127129|FG001|NOT COMPLETED|Treatment Period 2||0||
48731885|NCT00528801|102127130|FG000|STARTED|Overall Study||160||
48731886|NCT00528801|102127131|FG001|STARTED|Overall Study||52||
48731887|NCT00528801|102127130|FG000|COMPLETED|Overall Study||133||
48158717|NCT02799784|100711112|FG000|STARTED|Washout Period (3 Weeks)||111||
48158718|NCT02799784|100711113|FG001|STARTED|Washout Period (3 Weeks)||118||
48158719|NCT02799784|100711112|FG000|COMPLETED|Washout Period (3 Weeks)||111||
48158720|NCT02799784|100711113|FG001|COMPLETED|Washout Period (3 Weeks)||118||
48314851|NCT00995475|101097303|FG000|NOT COMPLETED|First Intervention||0||
48314852|NCT00995475|101097304|FG001|NOT COMPLETED|First Intervention||0||
48314853|NCT00995475|101097303|FG000|STARTED|Wash-out Two Week||9||
48314854|NCT00995475|101097304|FG001|STARTED|Wash-out Two Week||9||
48314855|NCT00995475|101097303|FG000|COMPLETED|Wash-out Two Week||9||
48314856|NCT00995475|101097304|FG001|COMPLETED|Wash-out Two Week||9||
48314857|NCT00995475|101097303|FG000|NOT COMPLETED|Wash-out Two Week||0||
48314858|NCT00995475|101097304|FG001|NOT COMPLETED|Wash-out Two Week||0||
48314859|NCT00995475|101097303|FG000|STARTED|Second Intervention||9||
48314860|NCT00995475|101097304|FG001|STARTED|Second Intervention||9||
48158721|NCT02799784|100711112|FG000|NOT COMPLETED|Washout Period (3 Weeks)||0||
48158722|NCT02799784|100711113|FG001|NOT COMPLETED|Washout Period (3 Weeks)||0||
48158723|NCT02799784|100711112|FG000|STARTED|Treatment Period 2 (TP2 - 8 Weeks)||111||
48314861|NCT00995475|101097303|FG000|COMPLETED|Second Intervention||9||
48406912|NCT03424044|101328485|FG001|COMPLETED|Third Intervention (76 Hours)||3||
48731888|NCT00528801|102127131|FG001|COMPLETED|Overall Study||41||
48314862|NCT00995475|101097304|FG001|COMPLETED|Second Intervention||9||
48731889|NCT00528801|102127130|FG000|NOT COMPLETED|Overall Study||27||
48731890|NCT00528801|102127131|FG001|NOT COMPLETED|Overall Study||11||
48731891|NCT00238238|102129995|FG000|STARTED|Overall Study||3||
48731892|NCT00238238|102129996|FG001|STARTED|Overall Study||48||
48731893|NCT00238238|102129997|FG002|STARTED|Overall Study||46||
48731894|NCT00238238|102129995|FG000|COMPLETED|Overall Study||3||
48314863|NCT00995475|101097303|FG000|NOT COMPLETED|Second Intervention||0||
48314864|NCT00995475|101097304|FG001|NOT COMPLETED|Second Intervention||0||
48314865|NCT00702754|101097305|FG000|STARTED|MYOBLOC Treatment Session 1 (Time 0)||502||
48314866|NCT00702754|101097305|FG000|COMPLETED|MYOBLOC Treatment Session 1 (Time 0)||495||
48314867|NCT00702754|101097305|FG000|NOT COMPLETED|MYOBLOC Treatment Session 1 (Time 0)||7||
48314868|NCT00702754|101097305|FG000|STARTED|MYOBLOC Treatment Session 2 (App 12 Wks)||495||
48314869|NCT00702754|101097305|FG000|COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||475||
48314870|NCT00702754|101097305|FG000|NOT COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||20||
48314871|NCT00702754|101097305|FG000|STARTED|MYOBLOC Treatment Session 3 (App 24 Wks)||475||
48314872|NCT00702754|101097305|FG000|COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||450||
48314873|NCT00702754|101097305|FG000|NOT COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||25||
48314874|NCT00702754|101097305|FG000|STARTED|MYOBLOC Treatment Session 4 (App 36 Wks)||450||
48314875|NCT00702754|101097305|FG000|COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||428||
48314876|NCT00702754|101097305|FG000|NOT COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||22||
48314877|NCT00702754|101097305|FG000|STARTED|MYOBLOC Treatment Session 5 (App 48 Wks)||428||
48314878|NCT00702754|101097305|FG000|COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||396||
48314879|NCT00702754|101097305|FG000|NOT COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||32||
48314880|NCT00702754|101097305|FG000|STARTED|MYOBLOC Treatment Session 6 (App 60 Wks)||396||
48314881|NCT00702754|101097305|FG000|COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||377||
48314882|NCT00702754|101097305|FG000|NOT COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||19||
48314883|NCT00702754|101097305|FG000|STARTED|MYOBLOC Treatment Session 7 (App 72 Wks)||377||
48314884|NCT00702754|101097305|FG000|COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||353||
48314885|NCT00702754|101097305|FG000|NOT COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||24||
48314886|NCT00702754|101097305|FG000|STARTED|MYOBLOC Treatment Session 8 (App 84 Wks)||353||
48314887|NCT00702754|101097305|FG000|COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||329||
48314888|NCT00702754|101097305|FG000|NOT COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||24||
48314889|NCT03697720|101097306|FG000|STARTED|Overall Study||26||
48314890|NCT03697720|101097306|FG000|COMPLETED|Overall Study||19||
48314891|NCT03697720|101097306|FG000|NOT COMPLETED|Overall Study||7||
48314892|NCT00808236|101097307|FG000|STARTED|Overall Study||96||
48314893|NCT00808236|101097308|FG001|STARTED|Overall Study||104||
48314894|NCT00808236|101097307|FG000|Met Eligibility Criteria|Overall Study||84||
48314895|NCT00808236|101097308|FG001|Met Eligibility Criteria|Overall Study||101||
48314896|NCT00808236|101097307|FG000|Included in Analysis|Overall Study||83||
48314897|NCT00808236|101097308|FG001|Included in Analysis|Overall Study||99||
48314898|NCT00808236|101097307|FG000|Achieved ROSC|Overall Study||33||
48314899|NCT00808236|101097308|FG001|Achieved ROSC|Overall Study||43||
48314900|NCT00808236|101097307|FG000|Admitted to Hospital|Overall Study||30||
48314901|NCT00808236|101097308|FG001|Admitted to Hospital|Overall Study||42||
48314902|NCT00808236|101097307|FG000|COMPLETED|Overall Study||14||
48314903|NCT00808236|101097308|FG001|COMPLETED|Overall Study||13||
48314904|NCT00808236|101097307|FG000|NOT COMPLETED|Overall Study||82||
48314905|NCT00808236|101097308|FG001|NOT COMPLETED|Overall Study||91||
48314906|NCT00427349|101097309|FG000|STARTED|Overall Study||46||
48314907|NCT00427349|101097309|FG000|Eligible|Overall Study||45||
48314908|NCT00427349|101097309|FG000|Treated|Overall Study||45||
48314909|NCT00427349|101097309|FG000|Eligible and Treated|Overall Study||44||
48314910|NCT00427349|101097309|FG000|COMPLETED|Overall Study||0||
48314911|NCT00427349|101097309|FG000|NOT COMPLETED|Overall Study||46||
48314912|NCT02667275|101097310|FG000|STARTED|Overall Study||244||
48314913|NCT02667275|101097311|FG001|STARTED|Overall Study||243||
48314914|NCT02667275|101097310|FG000|COMPLETED|Overall Study||233||
48314915|NCT02667275|101097311|FG001|COMPLETED|Overall Study||228||
48314916|NCT02667275|101097310|FG000|NOT COMPLETED|Overall Study||11||
48314917|NCT02667275|101097311|FG001|NOT COMPLETED|Overall Study||15||
48314918|NCT00415857|101097312|FG000|STARTED|Overall Study||2||
48314919|NCT00415857|101097313|FG001|STARTED|Overall Study||3||
48314920|NCT00415857|101097312|FG000|COMPLETED|Overall Study||2||
48314921|NCT00415857|101097313|FG001|COMPLETED|Overall Study||3||
48314922|NCT00415857|101097312|FG000|NOT COMPLETED|Overall Study||0||
48314923|NCT00415857|101097313|FG001|NOT COMPLETED|Overall Study||0||
48314924|NCT02953639|101097314|FG000|STARTED|Overall Study||81||
48314925|NCT02953639|101097315|FG001|STARTED|Overall Study||54||
48314926|NCT02953639|101097316|FG002|STARTED|Overall Study||78||
48731895|NCT00238238|102129996|FG001|COMPLETED|Overall Study||45||
48731896|NCT00238238|102129997|FG002|COMPLETED|Overall Study||46||
48731897|NCT00238238|102129995|FG000|NOT COMPLETED|Overall Study||0||
48731898|NCT00238238|102129996|FG001|NOT COMPLETED|Overall Study||3||
48731899|NCT00238238|102129997|FG002|NOT COMPLETED|Overall Study||0||
48731900|NCT01504841|102129998|FG000|STARTED|Overall Study||20||
48731901|NCT01504841|102129999|FG001|STARTED|Overall Study||6||
48731902|NCT01504841|102130000|FG002|STARTED|Overall Study||0||
48731903|NCT01504841|102129998|FG000|COMPLETED|Overall Study||19||
48731904|NCT01504841|102129999|FG001|COMPLETED|Overall Study||5||
48314927|NCT02953639|101097314|FG000|COMPLETED|Overall Study||61||
48314928|NCT02953639|101097315|FG001|COMPLETED|Overall Study||40||
48314929|NCT02953639|101097316|FG002|COMPLETED|Overall Study||62||
48314930|NCT02953639|101097314|FG000|NOT COMPLETED|Overall Study||20||
48731905|NCT01504841|102130000|FG002|COMPLETED|Overall Study||0||
48731906|NCT01504841|102129998|FG000|NOT COMPLETED|Overall Study||1||
48731907|NCT01504841|102129999|FG001|NOT COMPLETED|Overall Study||1||
48731908|NCT01504841|102130000|FG002|NOT COMPLETED|Overall Study||0||
48731909|NCT04338971|102130001|FG000|STARTED|Overall Study||24||
48731910|NCT04338971|102130001|FG000|COMPLETED|Overall Study||17||
48731911|NCT04338971|102130001|FG000|NOT COMPLETED|Overall Study||7||
48314931|NCT02953639|101097315|FG001|NOT COMPLETED|Overall Study||14||
48314932|NCT02953639|101097316|FG002|NOT COMPLETED|Overall Study||16||
48314933|NCT00528021|101097317|FG000|STARTED|Overall Study||59||
48314934|NCT00528021|101097318|FG001|STARTED|Overall Study||59||
48314935|NCT00528021|101097319|FG002|STARTED|Overall Study||56||
48314936|NCT00528021|101097320|FG003|STARTED|Overall Study||56||
48314937|NCT00528021|101097317|FG000|COMPLETED|Overall Study||42||
48314938|NCT00528021|101097318|FG001|COMPLETED|Overall Study||46||
48314939|NCT00528021|101097319|FG002|COMPLETED|Overall Study||49||
48314940|NCT00528021|101097320|FG003|COMPLETED|Overall Study||47||
48314941|NCT00528021|101097317|FG000|NOT COMPLETED|Overall Study||17||
48314942|NCT00528021|101097318|FG001|NOT COMPLETED|Overall Study||13||
48314943|NCT00528021|101097319|FG002|NOT COMPLETED|Overall Study||7||
48314944|NCT00528021|101097320|FG003|NOT COMPLETED|Overall Study||9||
48314945|NCT01961349|101097321|FG000|STARTED|Overall Study||54||
48314946|NCT01961349|101097322|FG001|STARTED|Overall Study||107||
48314947|NCT01961349|101097323|FG002|STARTED|Overall Study||111||
48314948|NCT01961349|101097321|FG000|COMPLETED|Overall Study||51||
48731912|NCT02227394|102130002|FG000|STARTED|Overall Study||10||
48731913|NCT02227394|102130003|FG001|STARTED|Overall Study||10||
48731914|NCT02227394|102130002|FG000|COMPLETED|Overall Study||10||
48731915|NCT02227394|102130003|FG001|COMPLETED|Overall Study||10||
48314949|NCT01961349|101097322|FG001|COMPLETED|Overall Study||101||
48314950|NCT01961349|101097323|FG002|COMPLETED|Overall Study||109||
48314951|NCT01961349|101097321|FG000|NOT COMPLETED|Overall Study||3||
48314952|NCT01961349|101097322|FG001|NOT COMPLETED|Overall Study||6||
48314953|NCT01961349|101097323|FG002|NOT COMPLETED|Overall Study||2||
48314954|NCT01329679|101097324|FG000|STARTED|Overall Study||13||
48314955|NCT01329679|101097325|FG001|STARTED|Overall Study||13||
48314956|NCT01329679|101097324|FG000|COMPLETED|Overall Study||13||
48314957|NCT01329679|101097325|FG001|COMPLETED|Overall Study||13||
48314958|NCT01329679|101097324|FG000|NOT COMPLETED|Overall Study||0||
48314959|NCT01329679|101097325|FG001|NOT COMPLETED|Overall Study||0||
48314960|NCT03451786|101097326|FG000|STARTED|Overall Study||369||
48314961|NCT03451786|101097326|FG000|COMPLETED|Overall Study||310||
48314962|NCT03451786|101097326|FG000|NOT COMPLETED|Overall Study||59||
48314963|NCT01463670|101097327|FG000|STARTED|Overall Study||11||
48314964|NCT01463670|101097327|FG000|COMPLETED|Overall Study||11||
48314965|NCT01463670|101097327|FG000|NOT COMPLETED|Overall Study||0||
48314966|NCT02663453|101097328|FG000|STARTED|Overall Study||22||
48314967|NCT02663453|101097329|FG001|STARTED|Overall Study||22||
48314968|NCT02663453|101097328|FG000|COMPLETED|Overall Study||17||
48314969|NCT02663453|101097329|FG001|COMPLETED|Overall Study||18||
48314970|NCT02663453|101097328|FG000|NOT COMPLETED|Overall Study||5||
48314971|NCT02663453|101097329|FG001|NOT COMPLETED|Overall Study||4||
48314972|NCT05289570|101097330|FG000|STARTED|Overall Study||3||
48731916|NCT02227394|102130002|FG000|NOT COMPLETED|Overall Study||0||
48731917|NCT02227394|102130003|FG001|NOT COMPLETED|Overall Study||0||
48731918|NCT01099397|102130004|FG000|STARTED|Overall Study||39||
48731919|NCT01099397|102130004|FG000|COMPLETED|Overall Study||26||
48731920|NCT01099397|102130004|FG000|NOT COMPLETED|Overall Study||13||
48731921|NCT01938040|102130005|FG000|STARTED|Overall Study||28||
48731922|NCT01938040|102130006|FG001|STARTED|Overall Study||27||
48731923|NCT01938040|102130005|FG000|Plasma Analysis|Overall Study||24||
48731924|NCT01938040|102130006|FG001|Plasma Analysis|Overall Study||25||
48731925|NCT01938040|102130005|FG000|Behavior Metrics|Overall Study||28||
48731926|NCT01938040|102130006|FG001|Behavior Metrics|Overall Study||27||
48731927|NCT01938040|102130005|FG000|COMPLETED|Overall Study||28||
48731928|NCT01938040|102130006|FG001|COMPLETED|Overall Study||27||
48731929|NCT01938040|102130005|FG000|NOT COMPLETED|Overall Study||0||
48731930|NCT01938040|102130006|FG001|NOT COMPLETED|Overall Study||0||
48314973|NCT05289570|101097330|FG000|COMPLETED|Overall Study||2||
48314974|NCT05289570|101097330|FG000|NOT COMPLETED|Overall Study||1||
48731931|NCT04560075|102130007|FG000|STARTED|Overall Study||34||
48731932|NCT04560075|102130008|FG001|STARTED|Overall Study||18||
48731933|NCT04560075|102130007|FG000|COMPLETED|Overall Study||34||
48731934|NCT04560075|102130008|FG001|COMPLETED|Overall Study||18||
48731935|NCT04560075|102130007|FG000|NOT COMPLETED|Overall Study||0||
48731936|NCT04560075|102130008|FG001|NOT COMPLETED|Overall Study||0||
48731937|NCT01192412|102130009|FG000|STARTED|Overall Study||497||
48731938|NCT01192412|102130010|FG001|STARTED|Overall Study||490||
48314975|NCT02285777|101097331|FG000|STARTED|Overall Study||95||
48731939|NCT01192412|102130009|FG000|COMPLETED|Overall Study||493||
48731940|NCT01192412|102130010|FG001|COMPLETED|Overall Study||488||
48314976|NCT02285777|101097332|FG001|STARTED|Overall Study||94||
48314977|NCT02285777|101097331|FG000|COMPLETED|Overall Study||90||
48314978|NCT02285777|101097332|FG001|COMPLETED|Overall Study||91||
48314979|NCT02285777|101097331|FG000|NOT COMPLETED|Overall Study||5||
48314980|NCT02285777|101097332|FG001|NOT COMPLETED|Overall Study||3||
48314981|NCT01225731|101097333|FG000|STARTED|Part 1||42||
48314982|NCT01225731|101097334|FG001|STARTED|Part 1||92||
48314983|NCT01225731|101097335|FG002|STARTED|Part 1||89||
48314984|NCT01225731|101097336|FG003|STARTED|Part 1||86||
48314985|NCT01225731|101097337|FG004|STARTED|Part 1||46||
48314986|NCT01225731|101097338|FG005|STARTED|Part 1||0||
48314987|NCT01225731|101097339|FG006|STARTED|Part 1||0||
48314988|NCT01225731|101097340|FG007|STARTED|Part 1||0||
48314989|NCT01225731|101097341|FG008|STARTED|Part 1||0||
48314990|NCT01225731|101097342|FG009|STARTED|Part 1||0||
48314991|NCT01225731|101097343|FG010|STARTED|Part 1||0||
48314992|NCT01225731|101097344|FG011|STARTED|Part 1||0||
48314993|NCT01225731|101097345|FG012|STARTED|Part 1||0||
48314994|NCT01225731|101097333|FG000|COMPLETED|Part 1||40||
48314995|NCT01225731|101097334|FG001|COMPLETED|Part 1||87||
48314996|NCT01225731|101097335|FG002|COMPLETED|Part 1||88||
48314997|NCT01225731|101097336|FG003|COMPLETED|Part 1||84||
48314998|NCT01225731|101097337|FG004|COMPLETED|Part 1||40||
48314999|NCT01225731|101097338|FG005|COMPLETED|Part 1||0||
48315000|NCT01225731|101097339|FG006|COMPLETED|Part 1||0||
48315001|NCT01225731|101097340|FG007|COMPLETED|Part 1||0||
48315002|NCT01225731|101097341|FG008|COMPLETED|Part 1||0||
48315003|NCT01225731|101097342|FG009|COMPLETED|Part 1||0||
48315004|NCT01225731|101097343|FG010|COMPLETED|Part 1||0||
48315005|NCT01225731|101097344|FG011|COMPLETED|Part 1||0||
48315006|NCT01225731|101097345|FG012|COMPLETED|Part 1||0||
48315007|NCT01225731|101097333|FG000|NOT COMPLETED|Part 1||2||
48315008|NCT01225731|101097334|FG001|NOT COMPLETED|Part 1||5||
48315009|NCT01225731|101097335|FG002|NOT COMPLETED|Part 1||1||
48315010|NCT01225731|101097336|FG003|NOT COMPLETED|Part 1||2||
48315011|NCT01225731|101097337|FG004|NOT COMPLETED|Part 1||6||
48315012|NCT01225731|101097338|FG005|NOT COMPLETED|Part 1||0||
48315013|NCT01225731|101097339|FG006|NOT COMPLETED|Part 1||0||
48315014|NCT01225731|101097340|FG007|NOT COMPLETED|Part 1||0||
48315015|NCT01225731|101097341|FG008|NOT COMPLETED|Part 1||0||
48315016|NCT01225731|101097342|FG009|NOT COMPLETED|Part 1||0||
48315017|NCT01225731|101097343|FG010|NOT COMPLETED|Part 1||0||
48315018|NCT01225731|101097344|FG011|NOT COMPLETED|Part 1||0||
48315019|NCT01225731|101097345|FG012|NOT COMPLETED|Part 1||0||
48315020|NCT01225731|101097333|FG000|STARTED|Part 2||0||
48315021|NCT01225731|101097334|FG001|STARTED|Part 2||0||
48315022|NCT01225731|101097335|FG002|STARTED|Part 2||0||
48315023|NCT01225731|101097336|FG003|STARTED|Part 2||0||
48315024|NCT01225731|101097337|FG004|STARTED|Part 2||0||
48315025|NCT01225731|101097338|FG005|STARTED|Part 2||13||
48315026|NCT01225731|101097339|FG006|STARTED|Part 2||94||
48614610|NCT05122624|101841788|FG000|NOT COMPLETED|Overall Study||0||0
48614611|NCT05122624|101841789|FG001|NOT COMPLETED|Overall Study||0||0
48614612|NCT00810069|101841790|FG000|STARTED|Lead-in Period I||840||
48614613|NCT00810069|101841791|FG001|STARTED|Lead-in Period I||0||
48614614|NCT00810069|101841792|FG002|STARTED|Lead-in Period I||0||
48614615|NCT00810069|101841790|FG000|COMPLETED|Lead-in Period I||566||
48614616|NCT00810069|101841791|FG001|COMPLETED|Lead-in Period I||0||
48614617|NCT00810069|101841792|FG002|COMPLETED|Lead-in Period I||0||
48614618|NCT00810069|101841790|FG000|NOT COMPLETED|Lead-in Period I||274||
48614619|NCT00810069|101841791|FG001|NOT COMPLETED|Lead-in Period I||0||
48614620|NCT00810069|101841792|FG002|NOT COMPLETED|Lead-in Period I||0||
48614621|NCT00810069|101841790|FG000|STARTED|Double-Blind Period II||0||
48614622|NCT00810069|101841791|FG001|STARTED|Double-Blind Period II||282||
48614623|NCT00810069|101841792|FG002|STARTED|Double-Blind Period II||284||
48614624|NCT00810069|101841790|FG000|COMPLETED|Double-Blind Period II||0||
48614625|NCT00810069|101841791|FG001|COMPLETED|Double-Blind Period II||226||
48614626|NCT00810069|101841792|FG002|COMPLETED|Double-Blind Period II||212||
48614627|NCT00810069|101841790|FG000|NOT COMPLETED|Double-Blind Period II||0||
48614628|NCT00810069|101841791|FG001|NOT COMPLETED|Double-Blind Period II||56||
48614629|NCT00810069|101841792|FG002|NOT COMPLETED|Double-Blind Period II||72||
48614630|NCT01457417|101841793|FG000|STARTED|Overall Study||3||
48614631|NCT01457417|101841794|FG001|STARTED|Overall Study||3||
48614632|NCT01457417|101841795|FG002|STARTED|Overall Study||4||
48614633|NCT01457417|101841796|FG003|STARTED|Overall Study||3||
48614634|NCT01457417|101841797|FG004|STARTED|Overall Study||19||
48614635|NCT01457417|101841793|FG000|COMPLETED|Overall Study||3||
48614636|NCT01457417|101841794|FG001|COMPLETED|Overall Study||3||
48614637|NCT01457417|101841795|FG002|COMPLETED|Overall Study||4||
48315027|NCT01225731|101097340|FG007|STARTED|Part 2||153||
48315028|NCT01225731|101097341|FG008|STARTED|Part 2||79||
48315029|NCT01225731|101097342|FG009|STARTED|Part 2||0||
48315030|NCT01225731|101097343|FG010|STARTED|Part 2||0||
48315031|NCT01225731|101097344|FG011|STARTED|Part 2||0||
48315032|NCT01225731|101097345|FG012|STARTED|Part 2||0||
48315033|NCT01225731|101097333|FG000|COMPLETED|Part 2||0||
48315034|NCT01225731|101097334|FG001|COMPLETED|Part 2||0||
48315035|NCT01225731|101097335|FG002|COMPLETED|Part 2||0||
48315036|NCT01225731|101097336|FG003|COMPLETED|Part 2||0||
48315037|NCT01225731|101097337|FG004|COMPLETED|Part 2||0||
48315038|NCT01225731|101097338|FG005|COMPLETED|Part 2||10||
48315039|NCT01225731|101097339|FG006|COMPLETED|Part 2||86||
48315040|NCT01225731|101097340|FG007|COMPLETED|Part 2||128||
48315041|NCT01225731|101097341|FG008|COMPLETED|Part 2||68||
48614638|NCT01457417|101841796|FG003|COMPLETED|Overall Study||3||
48731941|NCT01192412|102130009|FG000|NOT COMPLETED|Overall Study||4||
48731942|NCT01192412|102130010|FG001|NOT COMPLETED|Overall Study||2||
48731943|NCT00296140|102130011|FG000|STARTED|Overall Study||33||
48731944|NCT00296140|102130012|FG001|STARTED|Overall Study||33||
48731945|NCT00296140|102130011|FG000|COMPLETED|Overall Study||30||
48731946|NCT00296140|102130012|FG001|COMPLETED|Overall Study||33||
48731947|NCT00296140|102130011|FG000|NOT COMPLETED|Overall Study||3||
48315042|NCT01225731|101097342|FG009|COMPLETED|Part 2||0||
48315043|NCT01225731|101097343|FG010|COMPLETED|Part 2||0||
48315044|NCT01225731|101097344|FG011|COMPLETED|Part 2||0||
48315045|NCT01225731|101097345|FG012|COMPLETED|Part 2||0||
48315046|NCT01225731|101097333|FG000|NOT COMPLETED|Part 2||0||
48315047|NCT01225731|101097334|FG001|NOT COMPLETED|Part 2||0||
48315048|NCT01225731|101097335|FG002|NOT COMPLETED|Part 2||0||
48315049|NCT01225731|101097336|FG003|NOT COMPLETED|Part 2||0||
48315050|NCT01225731|101097337|FG004|NOT COMPLETED|Part 2||0||
48315051|NCT01225731|101097338|FG005|NOT COMPLETED|Part 2||3||
48315052|NCT01225731|101097339|FG006|NOT COMPLETED|Part 2||8||
48315053|NCT01225731|101097340|FG007|NOT COMPLETED|Part 2||25||
48315054|NCT01225731|101097341|FG008|NOT COMPLETED|Part 2||11||
48315055|NCT01225731|101097342|FG009|NOT COMPLETED|Part 2||0||
48315056|NCT01225731|101097343|FG010|NOT COMPLETED|Part 2||0||
48731948|NCT00296140|102130012|FG001|NOT COMPLETED|Overall Study||0||
48731949|NCT01329848|102130013|FG000|STARTED|Overall Study||83||
48731950|NCT01329848|102130013|FG000|COMPLETED|Overall Study||54||
48731951|NCT01329848|102130013|FG000|NOT COMPLETED|Overall Study||29||
48731952|NCT00348309|102130014|FG000|STARTED|Overall Study||496||
48731953|NCT00348309|102130015|FG001|STARTED|Overall Study||494||
48731954|NCT00348309|102130016|FG002|STARTED|Overall Study||489||
48158724|NCT02799784|100711113|FG001|STARTED|Treatment Period 2 (TP2 - 8 Weeks)||118||
48158725|NCT02799784|100711112|FG000|COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||110||
48158726|NCT02799784|100711113|FG001|COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||115||
48158727|NCT02799784|100711112|FG000|NOT COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||1||
48315057|NCT01225731|101097344|FG011|NOT COMPLETED|Part 2||0||
48315058|NCT01225731|101097345|FG012|NOT COMPLETED|Part 2||0||
48315059|NCT01225731|101097333|FG000|STARTED|Part 3||0||
48315060|NCT01225731|101097334|FG001|STARTED|Part 3||0||
48315061|NCT01225731|101097335|FG002|STARTED|Part 3||0||
48315062|NCT01225731|101097336|FG003|STARTED|Part 3||0||
48315063|NCT01225731|101097337|FG004|STARTED|Part 3||0||
48315064|NCT01225731|101097338|FG005|STARTED|Part 3||0||
48315065|NCT01225731|101097339|FG006|STARTED|Part 3||0||
48315066|NCT01225731|101097340|FG007|STARTED|Part 3||0||
48315067|NCT01225731|101097341|FG008|STARTED|Part 3||0||
48315068|NCT01225731|101097342|FG009|STARTED|Part 3||10||
48315069|NCT01225731|101097343|FG010|STARTED|Part 3||86||
48731955|NCT00348309|102130014|FG000|COMPLETED|Overall Study||362||
48731956|NCT00348309|102130015|FG001|COMPLETED|Overall Study||396||
48731957|NCT00348309|102130016|FG002|COMPLETED|Overall Study||346||
48731958|NCT00348309|102130014|FG000|NOT COMPLETED|Overall Study||134||
48731959|NCT00348309|102130015|FG001|NOT COMPLETED|Overall Study||98||
48731960|NCT00348309|102130016|FG002|NOT COMPLETED|Overall Study||143||
48731961|NCT04724967|102130017|FG000|STARTED|Overall Study||528||
48731962|NCT04724967|102130017|FG000|COMPLETED|Overall Study||528||
48731963|NCT04724967|102130017|FG000|NOT COMPLETED|Overall Study||0||
48731964|NCT03274856|102130018|FG000|STARTED|Overall Study||10||
48731965|NCT03274856|102130019|FG001|STARTED|Overall Study||9||
48158728|NCT02799784|100711113|FG001|NOT COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||3||
48158729|NCT00321048|100711114|FG000|STARTED|Overall Study||28||
48158730|NCT00321048|100711115|FG001|STARTED|Overall Study||29||
48315070|NCT01225731|101097344|FG011|STARTED|Part 3||126||
48315071|NCT01225731|101097345|FG012|STARTED|Part 3||67||
48315072|NCT01225731|101097333|FG000|COMPLETED|Part 3||0||
48315073|NCT01225731|101097334|FG001|COMPLETED|Part 3||0||
48315074|NCT01225731|101097335|FG002|COMPLETED|Part 3||0||
48315075|NCT01225731|101097336|FG003|COMPLETED|Part 3||0||
48315076|NCT01225731|101097337|FG004|COMPLETED|Part 3||0||
48315077|NCT01225731|101097338|FG005|COMPLETED|Part 3||0||
48315078|NCT01225731|101097339|FG006|COMPLETED|Part 3||0||
48315079|NCT01225731|101097340|FG007|COMPLETED|Part 3||0||
48315080|NCT01225731|101097341|FG008|COMPLETED|Part 3||0||
48315081|NCT01225731|101097342|FG009|COMPLETED|Part 3||10||
48315082|NCT01225731|101097343|FG010|COMPLETED|Part 3||80||
48315083|NCT01225731|101097344|FG011|COMPLETED|Part 3||116||
48315084|NCT01225731|101097345|FG012|COMPLETED|Part 3||60||
48315085|NCT01225731|101097333|FG000|NOT COMPLETED|Part 3||0||
48315086|NCT01225731|101097334|FG001|NOT COMPLETED|Part 3||0||
48315087|NCT01225731|101097335|FG002|NOT COMPLETED|Part 3||0||
48315088|NCT01225731|101097336|FG003|NOT COMPLETED|Part 3||0||
48315089|NCT01225731|101097337|FG004|NOT COMPLETED|Part 3||0||
48315090|NCT01225731|101097338|FG005|NOT COMPLETED|Part 3||0||
48731966|NCT03274856|102130018|FG000|COMPLETED|Overall Study||10||
48731967|NCT03274856|102130019|FG001|COMPLETED|Overall Study||9||
48731968|NCT03274856|102130018|FG000|NOT COMPLETED|Overall Study||0||
48731969|NCT03274856|102130019|FG001|NOT COMPLETED|Overall Study||0||
48731970|NCT03129360|102130020|FG000|STARTED|Overall Study||9||
48731971|NCT03129360|102130021|FG001|STARTED|Overall Study||8||
48731972|NCT03129360|102130022|FG002|STARTED|Overall Study||8||
48614639|NCT01457417|101841797|FG004|COMPLETED|Overall Study||19||
48614640|NCT01457417|101841793|FG000|NOT COMPLETED|Overall Study||0||
48614641|NCT01457417|101841794|FG001|NOT COMPLETED|Overall Study||0||
48614642|NCT01457417|101841795|FG002|NOT COMPLETED|Overall Study||0||
48614643|NCT01457417|101841796|FG003|NOT COMPLETED|Overall Study||0||
48614644|NCT01457417|101841797|FG004|NOT COMPLETED|Overall Study||0||
48614645|NCT00130689|101841798|FG000|STARTED|Overall Study||43||
48614646|NCT00130689|101841798|FG000|Eligible|Overall Study||37||
48731973|NCT03129360|102130020|FG000|COMPLETED|Overall Study||8||
48731974|NCT03129360|102130021|FG001|COMPLETED|Overall Study||6||
48731975|NCT03129360|102130022|FG002|COMPLETED|Overall Study||7||
48731976|NCT03129360|102130020|FG000|NOT COMPLETED|Overall Study||1||
48731977|NCT03129360|102130021|FG001|NOT COMPLETED|Overall Study||2||
48731978|NCT03129360|102130022|FG002|NOT COMPLETED|Overall Study||1||
48731979|NCT02147288|102130023|FG000|STARTED|Overall Study||22||
48731980|NCT02147288|102130024|FG001|STARTED|Overall Study||24||
48315091|NCT01225731|101097339|FG006|NOT COMPLETED|Part 3||0||
48315092|NCT01225731|101097340|FG007|NOT COMPLETED|Part 3||0||
48315093|NCT01225731|101097341|FG008|NOT COMPLETED|Part 3||0||
48315094|NCT01225731|101097342|FG009|NOT COMPLETED|Part 3||0||
48315095|NCT01225731|101097343|FG010|NOT COMPLETED|Part 3||6||
48315096|NCT01225731|101097344|FG011|NOT COMPLETED|Part 3||10||
48315097|NCT01225731|101097345|FG012|NOT COMPLETED|Part 3||7||
48315098|NCT02668874|101097346|FG000|STARTED|Overall Study||104||203
48315099|NCT02668874|101097347|FG001|STARTED|Overall Study||104||203
48315100|NCT02668874|101097346|FG000|6 Months After Placement|Overall Study||59||113
48315101|NCT02668874|101097347|FG001|6 Months After Placement|Overall Study||59||113
48315102|NCT02668874|101097346|FG000|COMPLETED|Overall Study||47||82
48315103|NCT02668874|101097347|FG001|COMPLETED|Overall Study||47||82
48315104|NCT02668874|101097346|FG000|NOT COMPLETED|Overall Study||57||121
48315105|NCT02668874|101097347|FG001|NOT COMPLETED|Overall Study||57||121
48315106|NCT00827606|101097348|FG000|STARTED|Overall Study||139||
48315107|NCT00827606|101097349|FG001|STARTED|Overall Study||132||
48315108|NCT00827606|101097348|FG000|COMPLETED|Overall Study||112||
48315109|NCT00827606|101097349|FG001|COMPLETED|Overall Study||94||
48315110|NCT00827606|101097348|FG000|NOT COMPLETED|Overall Study||27||
48315111|NCT00827606|101097349|FG001|NOT COMPLETED|Overall Study||38||
48315112|NCT04251910|101097350|FG000|STARTED|Overall Study||16||
48315113|NCT04251910|101097351|FG001|STARTED|Overall Study||20||
48315114|NCT04251910|101097352|FG002|STARTED|Overall Study||4||
48315115|NCT04251910|101097353|FG003|STARTED|Overall Study||14||
48315116|NCT04251910|101097354|FG004|STARTED|Overall Study||23||
48315117|NCT04251910|101097355|FG005|STARTED|Overall Study||23||
48315118|NCT04251910|101097350|FG000|COMPLETED|Overall Study||16||
48614647|NCT00130689|101841798|FG000|Treated|Overall Study||35||
48614648|NCT00130689|101841798|FG000|COMPLETED|Overall Study||0||
48614649|NCT00130689|101841798|FG000|NOT COMPLETED|Overall Study||43||
48731981|NCT02147288|102130025|FG002|STARTED|Overall Study||0||
48731982|NCT02147288|102130026|FG003|STARTED|Overall Study||0||
48731983|NCT02147288|102130027|FG004|STARTED|Overall Study||0||
48731984|NCT02147288|102130028|FG005|STARTED|Overall Study||0||
48731985|NCT02147288|102130029|FG006|STARTED|Overall Study||0||
48315119|NCT04251910|101097351|FG001|COMPLETED|Overall Study||15||
48315120|NCT04251910|101097352|FG002|COMPLETED|Overall Study||4||
48315121|NCT04251910|101097353|FG003|COMPLETED|Overall Study||10||
48315122|NCT04251910|101097354|FG004|COMPLETED|Overall Study||22||
48315123|NCT04251910|101097355|FG005|COMPLETED|Overall Study||23||
48315124|NCT04251910|101097350|FG000|NOT COMPLETED|Overall Study||0||
48315125|NCT04251910|101097351|FG001|NOT COMPLETED|Overall Study||5||
48315126|NCT04251910|101097352|FG002|NOT COMPLETED|Overall Study||0||
48315127|NCT04251910|101097353|FG003|NOT COMPLETED|Overall Study||4||
48315128|NCT04251910|101097354|FG004|NOT COMPLETED|Overall Study||1||
48315129|NCT04251910|101097355|FG005|NOT COMPLETED|Overall Study||0||
48315130|NCT01785459|101097356|FG000|STARTED|Overall Study||11||
48315131|NCT01785459|101097357|FG001|STARTED|Overall Study||12||
48315132|NCT01785459|101097356|FG000|COMPLETED|Overall Study||11||
48315133|NCT01785459|101097357|FG001|COMPLETED|Overall Study||12||
48315134|NCT01785459|101097356|FG000|NOT COMPLETED|Overall Study||0||
48315135|NCT01785459|101097357|FG001|NOT COMPLETED|Overall Study||0||
48315136|NCT01075412|101097358|FG000|STARTED|Overall Study||4||
48315137|NCT01075412|101097359|FG001|STARTED|Overall Study||2||
48315138|NCT01075412|101097358|FG000|COMPLETED|Overall Study||4||
48315139|NCT01075412|101097359|FG001|COMPLETED|Overall Study||1||
48614650|NCT01952418|101841799|FG000|STARTED|Overall Study||910||
48614651|NCT01952418|101841800|FG001|STARTED|Overall Study||895||
48731986|NCT02147288|102130030|FG007|STARTED|Overall Study||0||
48731987|NCT02147288|102130031|FG008|STARTED|Overall Study||0||
48731988|NCT02147288|102130032|FG009|STARTED|Overall Study||0||
48315140|NCT01075412|101097358|FG000|NOT COMPLETED|Overall Study||0||
48315141|NCT01075412|101097359|FG001|NOT COMPLETED|Overall Study||1||
48315142|NCT01585272|101097360|FG000|STARTED|Overall Study||121||
48315143|NCT01585272|101097360|FG000|Safety Set|Overall Study||102||
48315144|NCT01585272|101097360|FG000|Exelon Patch 5 cm2|Overall Study||114||
48315145|NCT01585272|101097360|FG000|Exelon Patch 10 cm2|Overall Study||96||
48315146|NCT01585272|101097360|FG000|COMPLETED|Overall Study||82||
48315147|NCT01585272|101097360|FG000|NOT COMPLETED|Overall Study||39||
48315148|NCT00388973|101097361|FG000|STARTED|Overall Study||166||
48315149|NCT00388973|101097362|FG001|STARTED|Overall Study||172||
48315150|NCT00388973|101097361|FG000|Completed Study|Overall Study||110||
48315151|NCT00388973|101097362|FG001|Completed Study|Overall Study||114||
48315152|NCT00388973|101097361|FG000|COMPLETED|Overall Study||110||
48315153|NCT00388973|101097362|FG001|COMPLETED|Overall Study||114||
48315154|NCT00388973|101097361|FG000|NOT COMPLETED|Overall Study||56||
48315155|NCT00388973|101097362|FG001|NOT COMPLETED|Overall Study||58||
48315156|NCT02278562|101097363|FG000|STARTED|Overall Study||9||
48315157|NCT02278562|101097364|FG001|STARTED|Overall Study||7||
48315158|NCT02278562|101097365|FG002|STARTED|Overall Study||8||
48315159|NCT02278562|101097363|FG000|COMPLETED|Overall Study||9||
48315160|NCT02278562|101097364|FG001|COMPLETED|Overall Study||7||
48315161|NCT02278562|101097365|FG002|COMPLETED|Overall Study||8||
48315162|NCT02278562|101097363|FG000|NOT COMPLETED|Overall Study||0||
48315163|NCT02278562|101097364|FG001|NOT COMPLETED|Overall Study||0||
48315164|NCT02278562|101097365|FG002|NOT COMPLETED|Overall Study||0||
48315165|NCT01871220|101097366|FG000|STARTED|Overall Study||29||
48315166|NCT01871220|101097367|FG001|STARTED|Overall Study||32||
48315167|NCT01871220|101097366|FG000|COMPLETED|Overall Study||25||
48315168|NCT01871220|101097367|FG001|COMPLETED|Overall Study||29||
48315169|NCT01871220|101097366|FG000|NOT COMPLETED|Overall Study||4||
48315170|NCT01871220|101097367|FG001|NOT COMPLETED|Overall Study||3||
48315171|NCT02116777|101097368|FG000|STARTED|Overall Study||3||
48315172|NCT02116777|101097369|FG001|STARTED|Overall Study||3||
48315173|NCT02116777|101097370|FG002|STARTED|Overall Study||3||
48315174|NCT02116777|101097371|FG003|STARTED|Overall Study||13||
48315175|NCT02116777|101097372|FG004|STARTED|Overall Study||6||
48315176|NCT02116777|101097373|FG005|STARTED|Overall Study||3||
48315177|NCT02116777|101097374|FG006|STARTED|Overall Study||9||
48315178|NCT02116777|101097368|FG000|COMPLETED|Overall Study||0||
48315179|NCT02116777|101097369|FG001|COMPLETED|Overall Study||0||
48315180|NCT02116777|101097370|FG002|COMPLETED|Overall Study||0||
48315181|NCT02116777|101097371|FG003|COMPLETED|Overall Study||0||
48315182|NCT02116777|101097372|FG004|COMPLETED|Overall Study||0||
48315183|NCT02116777|101097373|FG005|COMPLETED|Overall Study||0||
48315184|NCT02116777|101097374|FG006|COMPLETED|Overall Study||0||
48315185|NCT02116777|101097368|FG000|NOT COMPLETED|Overall Study||3||
48315186|NCT02116777|101097369|FG001|NOT COMPLETED|Overall Study||3||
48315187|NCT02116777|101097370|FG002|NOT COMPLETED|Overall Study||3||
48315188|NCT02116777|101097371|FG003|NOT COMPLETED|Overall Study||13||
48315189|NCT02116777|101097372|FG004|NOT COMPLETED|Overall Study||6||
48315190|NCT02116777|101097373|FG005|NOT COMPLETED|Overall Study||3||
48315191|NCT02116777|101097374|FG006|NOT COMPLETED|Overall Study||9||
48614652|NCT01952418|101841799|FG000|COMPLETED|Overall Study||910||
48614653|NCT01952418|101841800|FG001|COMPLETED|Overall Study||895||
48614654|NCT01952418|101841799|FG000|NOT COMPLETED|Overall Study||0||
48614655|NCT01952418|101841800|FG001|NOT COMPLETED|Overall Study||0||
48614656|NCT04888494|101841801|FG000|STARTED|Overall Study||8||
48614657|NCT04888494|101841802|FG001|STARTED|Overall Study||8||
48614658|NCT04888494|101841801|FG000|First Intervention (5 Days)|Overall Study||5||
48614659|NCT04888494|101841802|FG001|First Intervention (5 Days)|Overall Study||5||
48614660|NCT04888494|101841801|FG000|Washout (14 Days)|Overall Study||5||
48731989|NCT02147288|102130023|FG000|COMPLETED|Overall Study||21||
48731990|NCT02147288|102130024|FG001|COMPLETED|Overall Study||22||
48731991|NCT02147288|102130025|FG002|COMPLETED|Overall Study||0||
48315192|NCT00683163|101097375|FG000|STARTED|Overall Study||22||
48315193|NCT00683163|101097376|FG001|STARTED|Overall Study||22||
48315194|NCT00683163|101097375|FG000|COMPLETED|Overall Study||22||
48315195|NCT00683163|101097376|FG001|COMPLETED|Overall Study||22||
48315196|NCT00683163|101097375|FG000|NOT COMPLETED|Overall Study||0||
48315197|NCT00683163|101097376|FG001|NOT COMPLETED|Overall Study||0||
48315198|NCT01944293|101097377|FG000|STARTED|Overall Study||7||
48315199|NCT01944293|101097378|FG001|STARTED|Overall Study||9||
48614661|NCT04888494|101841802|FG001|Washout (14 Days)|Overall Study||5||
48614662|NCT04888494|101841801|FG000|Second Intervention (5 Days)|Overall Study||5||
48614663|NCT04888494|101841802|FG001|Second Intervention (5 Days)|Overall Study||5||
48315200|NCT01944293|101097377|FG000|COMPLETED|Overall Study||7||
48315201|NCT01944293|101097378|FG001|COMPLETED|Overall Study||9||
48614664|NCT04888494|101841801|FG000|COMPLETED|Overall Study||5||
48614665|NCT04888494|101841802|FG001|COMPLETED|Overall Study||5||
48614666|NCT04888494|101841801|FG000|NOT COMPLETED|Overall Study||3||
48614667|NCT04888494|101841802|FG001|NOT COMPLETED|Overall Study||3||
48731992|NCT02147288|102130026|FG003|COMPLETED|Overall Study||0||
48731993|NCT02147288|102130027|FG004|COMPLETED|Overall Study||0||
48315202|NCT01944293|101097377|FG000|NOT COMPLETED|Overall Study||0||
48315203|NCT01944293|101097378|FG001|NOT COMPLETED|Overall Study||0||
48614668|NCT03364036|101841803|FG000|STARTED|Overall Study||270||
48614669|NCT03364036|101841803|FG000|Full Analysis Set (FAS)|Overall Study||270||
48614670|NCT03364036|101841803|FG000|COMPLETED|Overall Study||270||
48614671|NCT03364036|101841803|FG000|NOT COMPLETED|Overall Study||0||
48614672|NCT01909141|101841804|FG000|STARTED|Overall Study||50||
48614673|NCT01909141|101841805|FG001|STARTED|Overall Study||50||
48614674|NCT01909141|101841804|FG000|COMPLETED|Overall Study||50||
48614675|NCT01909141|101841805|FG001|COMPLETED|Overall Study||50||
48614676|NCT01909141|101841804|FG000|NOT COMPLETED|Overall Study||0||
48614677|NCT01909141|101841805|FG001|NOT COMPLETED|Overall Study||0||
48731994|NCT02147288|102130028|FG005|COMPLETED|Overall Study||0||
48315204|NCT01750931|101097379|FG000|STARTED|Period 1||14||
48315205|NCT01750931|101097380|FG001|STARTED|Period 1||14||
48315206|NCT01750931|101097379|FG000|COMPLETED|Period 1||14||
48315207|NCT01750931|101097380|FG001|COMPLETED|Period 1||14||
48315208|NCT01750931|101097379|FG000|NOT COMPLETED|Period 1||0||
48315209|NCT01750931|101097380|FG001|NOT COMPLETED|Period 1||0||
48315210|NCT01750931|101097379|FG000|STARTED|Wash Out||14||
48315211|NCT01750931|101097380|FG001|STARTED|Wash Out||14||
48315212|NCT01750931|101097379|FG000|COMPLETED|Wash Out||14||
48315213|NCT01750931|101097380|FG001|COMPLETED|Wash Out||14||
48315214|NCT01750931|101097379|FG000|NOT COMPLETED|Wash Out||0||
48315215|NCT01750931|101097380|FG001|NOT COMPLETED|Wash Out||0||
48315216|NCT01750931|101097379|FG000|STARTED|Period 2||14||
48315217|NCT01750931|101097380|FG001|STARTED|Period 2||14||
48315218|NCT01750931|101097379|FG000|COMPLETED|Period 2||14||
48315219|NCT01750931|101097380|FG001|COMPLETED|Period 2||14||
48315220|NCT01750931|101097379|FG000|NOT COMPLETED|Period 2||0||
48315221|NCT01750931|101097380|FG001|NOT COMPLETED|Period 2||0||
48315222|NCT01314963|101097381|FG000|STARTED|Overall Study||50||
48315223|NCT01314963|101097381|FG000|COMPLETED|Overall Study||50||
48315224|NCT01314963|101097381|FG000|NOT COMPLETED|Overall Study||0||
48315225|NCT02877693|101097382|FG000|STARTED|Overall Study||205||
48315226|NCT02877693|101097383|FG001|STARTED|Overall Study||0||
48731995|NCT02147288|102130029|FG006|COMPLETED|Overall Study||0||
48731996|NCT02147288|102130030|FG007|COMPLETED|Overall Study||0||
48731997|NCT02147288|102130031|FG008|COMPLETED|Overall Study||0||
48731998|NCT02147288|102130032|FG009|COMPLETED|Overall Study||0||
48731999|NCT02147288|102130023|FG000|NOT COMPLETED|Overall Study||1||
48315227|NCT02877693|101097382|FG000|COMPLETED|Overall Study||177||
48315228|NCT02877693|101097383|FG001|COMPLETED|Overall Study||0||
48315229|NCT02877693|101097382|FG000|NOT COMPLETED|Overall Study||28||
48315230|NCT02877693|101097383|FG001|NOT COMPLETED|Overall Study||0||
48315231|NCT04770389|101097384|FG000|STARTED|Overall Study||28||
48315232|NCT04770389|101097385|FG001|STARTED|Overall Study||27||
48315233|NCT04770389|101097386|FG002|STARTED|Overall Study||28||
48315234|NCT04770389|101097387|FG003|STARTED|Overall Study||29||
48315235|NCT04770389|101097384|FG000|COMPLETED|Overall Study||26||
48315236|NCT04770389|101097385|FG001|COMPLETED|Overall Study||22||
48315237|NCT04770389|101097386|FG002|COMPLETED|Overall Study||26||
48315238|NCT04770389|101097387|FG003|COMPLETED|Overall Study||24||
48732000|NCT02147288|102130024|FG001|NOT COMPLETED|Overall Study||2||
48315239|NCT04770389|101097384|FG000|NOT COMPLETED|Overall Study||2||
48315240|NCT04770389|101097385|FG001|NOT COMPLETED|Overall Study||5||
48315241|NCT04770389|101097386|FG002|NOT COMPLETED|Overall Study||2||
48315242|NCT04770389|101097387|FG003|NOT COMPLETED|Overall Study||5||
48315243|NCT01301950|101097388|FG000|STARTED|Overall Study||15||
48315244|NCT01301950|101097389|FG001|STARTED|Overall Study||15||
48315245|NCT01301950|101097388|FG000|COMPLETED|Overall Study||15||
48315246|NCT01301950|101097389|FG001|COMPLETED|Overall Study||14||
48315247|NCT01301950|101097388|FG000|NOT COMPLETED|Overall Study||0||
48732001|NCT02147288|102130025|FG002|NOT COMPLETED|Overall Study||0||
48732002|NCT02147288|102130026|FG003|NOT COMPLETED|Overall Study||0||
48732003|NCT02147288|102130027|FG004|NOT COMPLETED|Overall Study||0||
48732004|NCT02147288|102130028|FG005|NOT COMPLETED|Overall Study||0||
48315248|NCT01301950|101097389|FG001|NOT COMPLETED|Overall Study||1||
48315249|NCT01391286|101097390|FG000|STARTED|Overall Study||18||
48315250|NCT01391286|101097391|FG001|STARTED|Overall Study||18||
48315251|NCT01391286|101097390|FG000|COMPLETED|Overall Study||18||
48315252|NCT01391286|101097391|FG001|COMPLETED|Overall Study||18||
48315253|NCT01391286|101097390|FG000|NOT COMPLETED|Overall Study||0||
48315254|NCT01391286|101097391|FG001|NOT COMPLETED|Overall Study||0||
48315255|NCT03418129|101097392|FG000|STARTED|Overall Study||84||
48614678|NCT01100723|101841806|FG000|STARTED|Overall Study||92||
48315256|NCT03418129|101097393|FG001|STARTED|Overall Study||85||
48315257|NCT03418129|101097394|FG002|STARTED|Overall Study||85||
48315258|NCT03418129|101097392|FG000|COMPLETED|Overall Study||70||
48315259|NCT03418129|101097393|FG001|COMPLETED|Overall Study||59||
48315260|NCT03418129|101097394|FG002|COMPLETED|Overall Study||66||
48315261|NCT03418129|101097392|FG000|NOT COMPLETED|Overall Study||14||
48614679|NCT01100723|101841806|FG000|6 Month Analysis|Overall Study||85||
48614680|NCT01100723|101841806|FG000|COMPLETED|Overall Study||78||
48614681|NCT01100723|101841806|FG000|NOT COMPLETED|Overall Study||14||
48315262|NCT03418129|101097393|FG001|NOT COMPLETED|Overall Study||26||
48315263|NCT03418129|101097394|FG002|NOT COMPLETED|Overall Study||19||
48315264|NCT01210807|101097395|FG000|STARTED|Overall Study||36||
48315265|NCT01210807|101097396|FG001|STARTED|Overall Study||34||
48315266|NCT01210807|101097395|FG000|COMPLETED|Overall Study||33||
48732005|NCT02147288|102130029|FG006|NOT COMPLETED|Overall Study||0||
48732006|NCT02147288|102130030|FG007|NOT COMPLETED|Overall Study||0||
48732007|NCT02147288|102130031|FG008|NOT COMPLETED|Overall Study||0||
48732008|NCT02147288|102130032|FG009|NOT COMPLETED|Overall Study||0||
48732009|NCT02038075|102130033|FG000|STARTED|Overall Study||76||
48732010|NCT02038075|102130034|FG001|STARTED|Overall Study||76||
48732011|NCT02038075|102130033|FG000|COMPLETED|Overall Study||73||
48732012|NCT02038075|102130034|FG001|COMPLETED|Overall Study||76||
48732013|NCT02038075|102130033|FG000|NOT COMPLETED|Overall Study||3||
48732014|NCT02038075|102130034|FG001|NOT COMPLETED|Overall Study||0||
48732015|NCT03392649|102130035|FG000|STARTED|Overall Study||40||
48732016|NCT03392649|102130036|FG001|STARTED|Overall Study||41||
48732017|NCT03392649|102130035|FG000|COMPLETED|Overall Study||40||
48732018|NCT03392649|102130036|FG001|COMPLETED|Overall Study||41||
48732019|NCT03392649|102130035|FG000|NOT COMPLETED|Overall Study||0||
48732020|NCT03392649|102130036|FG001|NOT COMPLETED|Overall Study||0||
48732021|NCT03188510|102130037|FG000|STARTED|Overall Study||18||
48732022|NCT03188510|102130038|FG001|STARTED|Overall Study||18||
48732023|NCT03188510|102130039|FG002|STARTED|Overall Study||18||
48732024|NCT03188510|102130037|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18||
48732025|NCT03188510|102130038|FG001|Received at Least 1 Dose of Study Drug|Overall Study||18||
48732026|NCT03188510|102130039|FG002|Received at Least 1 Dose of Study Drug|Overall Study||18||
48732027|NCT03188510|102130037|FG000|COMPLETED|Overall Study||18||
48732028|NCT03188510|102130038|FG001|COMPLETED|Overall Study||17||
48732029|NCT03188510|102130039|FG002|COMPLETED|Overall Study||18||
48732030|NCT03188510|102130037|FG000|NOT COMPLETED|Overall Study||0||
48732031|NCT03188510|102130038|FG001|NOT COMPLETED|Overall Study||1||
48732032|NCT03188510|102130039|FG002|NOT COMPLETED|Overall Study||0||
48732033|NCT04209595|102130040|FG000|STARTED|Phase I - Maximum Tolerated Dose||0||
48732034|NCT04209595|102130041|FG001|STARTED|Phase I - Maximum Tolerated Dose||8||
48732035|NCT04209595|102130042|FG002|STARTED|Phase I - Maximum Tolerated Dose||2||
48732036|NCT04209595|102130043|FG003|STARTED|Phase I - Maximum Tolerated Dose||0||
48158731|NCT00321048|100711114|FG000|COMPLETED|Overall Study||22||
48158732|NCT00321048|100711115|FG001|COMPLETED|Overall Study||21||
48158733|NCT00321048|100711114|FG000|NOT COMPLETED|Overall Study||6||
48158734|NCT00321048|100711115|FG001|NOT COMPLETED|Overall Study||8||
48158735|NCT01621880|100711116|FG000|STARTED|Overall Study||58||
48158736|NCT01621880|100711117|FG001|STARTED|Overall Study||54||
48158737|NCT01621880|100711116|FG000|COMPLETED|Overall Study||48||
48158738|NCT01621880|100711117|FG001|COMPLETED|Overall Study||49||
48158739|NCT01621880|100711116|FG000|NOT COMPLETED|Overall Study||10||
48158740|NCT01621880|100711117|FG001|NOT COMPLETED|Overall Study||5||
48158741|NCT00431184|100711118|FG000|STARTED|1st Intervention (Day 1)||10||
48158742|NCT00431184|100711119|FG001|STARTED|1st Intervention (Day 1)||9||
48158743|NCT00431184|100711118|FG000|COMPLETED|1st Intervention (Day 1)||10||
48158744|NCT00431184|100711119|FG001|COMPLETED|1st Intervention (Day 1)||9||
48158745|NCT00431184|100711118|FG000|NOT COMPLETED|1st Intervention (Day 1)||0||
48158746|NCT00431184|100711119|FG001|NOT COMPLETED|1st Intervention (Day 1)||0||
48158747|NCT00431184|100711118|FG000|STARTED|Second Intervention (Day 2)||10||
48158748|NCT00431184|100711119|FG001|STARTED|Second Intervention (Day 2)||9||
48158749|NCT00431184|100711118|FG000|COMPLETED|Second Intervention (Day 2)||10||
48158750|NCT00431184|100711119|FG001|COMPLETED|Second Intervention (Day 2)||9||
48158751|NCT00431184|100711118|FG000|NOT COMPLETED|Second Intervention (Day 2)||0||
48158752|NCT00431184|100711119|FG001|NOT COMPLETED|Second Intervention (Day 2)||0||
48158753|NCT00652938|100711120|FG000|STARTED|Overall Study||247||
48158754|NCT00652938|100711121|FG001|STARTED|Overall Study||247||
48158755|NCT00652938|100711122|FG002|STARTED|Overall Study||247||
48158756|NCT00652938|100711120|FG000|COMPLETED|Overall Study||246||
48158757|NCT00652938|100711121|FG001|COMPLETED|Overall Study||240||
48732037|NCT04209595|102130044|FG004|STARTED|Phase I - Maximum Tolerated Dose||0||
48732038|NCT04209595|102130040|FG000|COMPLETED|Phase I - Maximum Tolerated Dose||0||
48732039|NCT04209595|102130041|FG001|COMPLETED|Phase I - Maximum Tolerated Dose||8||
48732040|NCT04209595|102130042|FG002|COMPLETED|Phase I - Maximum Tolerated Dose||2||
48732041|NCT04209595|102130043|FG003|COMPLETED|Phase I - Maximum Tolerated Dose||0||
48767623|NCT03678493|102222783|FG003|COMPLETED|Overall Study||25||
48158758|NCT00652938|100711122|FG002|COMPLETED|Overall Study||242||
48158759|NCT00652938|100711120|FG000|NOT COMPLETED|Overall Study||1||
48158760|NCT00652938|100711121|FG001|NOT COMPLETED|Overall Study||7||
48158761|NCT00652938|100711122|FG002|NOT COMPLETED|Overall Study||5||
48158762|NCT02487472|100711123|FG000|STARTED|Overall Study||101||
48158763|NCT02487472|100711123|FG000|COMPLETED|Overall Study||90||
48158764|NCT02487472|100711123|FG000|NOT COMPLETED|Overall Study||11||
48158765|NCT03928028|100711124|FG000|STARTED|Overall Study||63||21
48158766|NCT03928028|100711125|FG001|STARTED|Overall Study||57||19
48158767|NCT03928028|100711126|FG002|STARTED|Overall Study||57||19
48158768|NCT03928028|100711124|FG000|Mother|Overall Study||21||21
48158769|NCT03928028|100711125|FG001|Mother|Overall Study||19||19
48158770|NCT03928028|100711126|FG002|Mother|Overall Study||19||19
48158771|NCT03928028|100711124|FG000|Father|Overall Study||21||21
48158772|NCT03928028|100711125|FG001|Father|Overall Study||19||19
48315267|NCT01210807|101097396|FG001|COMPLETED|Overall Study||31||
48315268|NCT01210807|101097395|FG000|NOT COMPLETED|Overall Study||3||
48158773|NCT03928028|100711126|FG002|Father|Overall Study||19||19
48158774|NCT03928028|100711124|FG000|Adolescent|Overall Study||21||21
48158775|NCT03928028|100711125|FG001|Adolescent|Overall Study||19||19
48158776|NCT03928028|100711126|FG002|Adolescent|Overall Study||19||19
48158777|NCT03928028|100711124|FG000|COMPLETED|Overall Study||42||14
48158778|NCT03928028|100711125|FG001|COMPLETED|Overall Study||48||16
48158779|NCT03928028|100711126|FG002|COMPLETED|Overall Study||51||17
48158780|NCT03928028|100711124|FG000|NOT COMPLETED|Overall Study||21||7
48158781|NCT03928028|100711125|FG001|NOT COMPLETED|Overall Study||9||3
48158782|NCT03928028|100711126|FG002|NOT COMPLETED|Overall Study||6||2
48158783|NCT01224925|100711127|FG000|STARTED|Overall Study||37||
48158784|NCT01224925|100711128|FG001|STARTED|Overall Study||33||
48158785|NCT01224925|100711127|FG000|COMPLETED|Overall Study||34||
48158786|NCT01224925|100711128|FG001|COMPLETED|Overall Study||31||
48158787|NCT01224925|100711127|FG000|NOT COMPLETED|Overall Study||3||
48158788|NCT01224925|100711128|FG001|NOT COMPLETED|Overall Study||2||
48158789|NCT02404389|100711129|FG000|STARTED|Overall Study||20||
48158790|NCT02404389|100711130|FG001|STARTED|Overall Study||20||
48158791|NCT02404389|100711131|FG002|STARTED|Overall Study||11||
48158792|NCT02404389|100711132|FG003|STARTED|Overall Study||10||
48158793|NCT02404389|100711133|FG004|STARTED|Overall Study||21||
48158794|NCT02404389|100711129|FG000|COMPLETED|Overall Study||18||
48158795|NCT02404389|100711130|FG001|COMPLETED|Overall Study||20||
48158796|NCT02404389|100711131|FG002|COMPLETED|Overall Study||10||
48158797|NCT02404389|100711132|FG003|COMPLETED|Overall Study||9||
48158798|NCT02404389|100711133|FG004|COMPLETED|Overall Study||18||
48158799|NCT02404389|100711129|FG000|NOT COMPLETED|Overall Study||2||
48158800|NCT02404389|100711130|FG001|NOT COMPLETED|Overall Study||0||
48158801|NCT02404389|100711131|FG002|NOT COMPLETED|Overall Study||1||
48158802|NCT02404389|100711132|FG003|NOT COMPLETED|Overall Study||1||
48158803|NCT02404389|100711133|FG004|NOT COMPLETED|Overall Study||3||
48158804|NCT01330316|100711134|FG000|STARTED|Overall Study||43||
48158805|NCT01330316|100711135|FG001|STARTED|Overall Study||75||
48158806|NCT01330316|100711134|FG000|COMPLETED|Overall Study||41||
48158807|NCT01330316|100711135|FG001|COMPLETED|Overall Study||60||
48158808|NCT01330316|100711134|FG000|NOT COMPLETED|Overall Study||2||
48158809|NCT01330316|100711135|FG001|NOT COMPLETED|Overall Study||15||
48158810|NCT03662074|100711136|FG000|STARTED|Overall Study||14||
48158811|NCT03662074|100711136|FG000|COMPLETED|Overall Study||14||
48158812|NCT03662074|100711136|FG000|NOT COMPLETED|Overall Study||0||
48158813|NCT02127372|100711137|FG000|STARTED|Overall Study||15||
48158814|NCT02127372|100711138|FG001|STARTED|Overall Study||28||
48158815|NCT02127372|100711137|FG000|Started Study Treatment|Overall Study||15||
48158816|NCT02127372|100711138|FG001|Started Study Treatment|Overall Study||28||
48158817|NCT02127372|100711137|FG000|COMPLETED|Overall Study||14||
48158818|NCT02127372|100711138|FG001|COMPLETED|Overall Study||28||
48158819|NCT02127372|100711137|FG000|NOT COMPLETED|Overall Study||1||
48158820|NCT02127372|100711138|FG001|NOT COMPLETED|Overall Study||0||
48158821|NCT01435655|100711139|FG000|STARTED|Overall Study||10||
48158822|NCT01435655|100711139|FG000|COMPLETED|Overall Study||7||
48158823|NCT01435655|100711139|FG000|NOT COMPLETED|Overall Study||3||
48158824|NCT00806234|100711140|FG000|STARTED|Overall Study||47||
48158825|NCT00806234|100711141|FG001|STARTED|Overall Study||31||
48158826|NCT00806234|100711142|FG002|STARTED|Overall Study||49||
48158827|NCT00806234|100711140|FG000|COMPLETED|Overall Study||34||
48158828|NCT00806234|100711141|FG001|COMPLETED|Overall Study||19||
48315269|NCT01210807|101097396|FG001|NOT COMPLETED|Overall Study||3||
48158829|NCT00806234|100711142|FG002|COMPLETED|Overall Study||37||
48315270|NCT03370120|101097397|FG000|STARTED|Overall Study||406||
48315271|NCT03370120|101097397|FG000|COMPLETED|Overall Study||0||
48315272|NCT03370120|101097397|FG000|NOT COMPLETED|Overall Study||406||
48315273|NCT02153528|101097398|FG000|STARTED|Overall Study||348||
48315274|NCT02153528|101097399|FG001|STARTED|Overall Study||353||
48158830|NCT00806234|100711140|FG000|NOT COMPLETED|Overall Study||13||
48158831|NCT00806234|100711141|FG001|NOT COMPLETED|Overall Study||12||
48158832|NCT00806234|100711142|FG002|NOT COMPLETED|Overall Study||12||
48158833|NCT01916655|100711143|FG000|STARTED|Overall Study||131||
48158834|NCT01916655|100711144|FG001|STARTED|Overall Study||109||
48158835|NCT01916655|100711145|FG002|STARTED|Overall Study||120||
48158836|NCT01916655|100711143|FG000|COMPLETED|Overall Study||116||
48158837|NCT01916655|100711144|FG001|COMPLETED|Overall Study||89||
48158838|NCT01916655|100711145|FG002|COMPLETED|Overall Study||91||
48315275|NCT02153528|101097398|FG000|COMPLETED|Overall Study||348||
48158839|NCT01916655|100711143|FG000|NOT COMPLETED|Overall Study||15||
48158840|NCT01916655|100711144|FG001|NOT COMPLETED|Overall Study||20||
48158841|NCT01916655|100711145|FG002|NOT COMPLETED|Overall Study||29||
48158842|NCT01368900|100711146|FG000|STARTED|Overall Study||68||
48158843|NCT01368900|100711146|FG000|COMPLETED|Overall Study||61||
48158844|NCT01368900|100711146|FG000|NOT COMPLETED|Overall Study||7||
48158845|NCT02081950|100711147|FG000|STARTED|Treatment Period 1||14||
48158846|NCT02081950|100711147|FG000|COMPLETED|Treatment Period 1||14|The same 14 subjects received two doses of s.c. Clexane over 2 Treatment Periods (1 dose/period).|
48315276|NCT02153528|101097399|FG001|COMPLETED|Overall Study||353||
48732042|NCT04209595|102130044|FG004|COMPLETED|Phase I - Maximum Tolerated Dose||0||
48732043|NCT04209595|102130040|FG000|NOT COMPLETED|Phase I - Maximum Tolerated Dose||0||
48732044|NCT04209595|102130041|FG001|NOT COMPLETED|Phase I - Maximum Tolerated Dose||0||
48732045|NCT04209595|102130042|FG002|NOT COMPLETED|Phase I - Maximum Tolerated Dose||0||
48732046|NCT04209595|102130043|FG003|NOT COMPLETED|Phase I - Maximum Tolerated Dose||0||
48732047|NCT04209595|102130044|FG004|NOT COMPLETED|Phase I - Maximum Tolerated Dose||0||
48732048|NCT04209595|102130040|FG000|STARTED|Phase IIA - Assess Efficacy||0||
48732049|NCT04209595|102130041|FG001|STARTED|Phase IIA - Assess Efficacy||0||
48732050|NCT04209595|102130042|FG002|STARTED|Phase IIA - Assess Efficacy||0||
48732051|NCT04209595|102130043|FG003|STARTED|Phase IIA - Assess Efficacy||0||
48732052|NCT04209595|102130044|FG004|STARTED|Phase IIA - Assess Efficacy||0||
48732053|NCT04209595|102130040|FG000|COMPLETED|Phase IIA - Assess Efficacy||0||
48732054|NCT04209595|102130041|FG001|COMPLETED|Phase IIA - Assess Efficacy||0||
48732055|NCT04209595|102130042|FG002|COMPLETED|Phase IIA - Assess Efficacy||0||
48732056|NCT04209595|102130043|FG003|COMPLETED|Phase IIA - Assess Efficacy||0||
48732057|NCT04209595|102130044|FG004|COMPLETED|Phase IIA - Assess Efficacy||0||
48732058|NCT04209595|102130040|FG000|NOT COMPLETED|Phase IIA - Assess Efficacy||0||
48732059|NCT04209595|102130041|FG001|NOT COMPLETED|Phase IIA - Assess Efficacy||0||
48732060|NCT04209595|102130042|FG002|NOT COMPLETED|Phase IIA - Assess Efficacy||0||
48732061|NCT04209595|102130043|FG003|NOT COMPLETED|Phase IIA - Assess Efficacy||0||
48158847|NCT02081950|100711147|FG000|NOT COMPLETED|Treatment Period 1||0||
48158848|NCT02081950|100711147|FG000|STARTED|Treatment Period 2||14||
48158849|NCT02081950|100711147|FG000|COMPLETED|Treatment Period 2||14||
48158850|NCT02081950|100711147|FG000|NOT COMPLETED|Treatment Period 2||0||
48158851|NCT03621202|100711148|FG000|STARTED|Overall Study||66||
48158852|NCT03621202|100711148|FG000|COMPLETED|Overall Study||60||
48158853|NCT03621202|100711148|FG000|NOT COMPLETED|Overall Study||6||
48158854|NCT00584935|100711149|FG000|STARTED|Overall Study||3||
48158855|NCT00584935|100711149|FG000|COMPLETED|Overall Study||3||
48158856|NCT00584935|100711149|FG000|NOT COMPLETED|Overall Study||0||
48158857|NCT00551070|100711150|FG000|STARTED|Overall Study||52||
48158858|NCT00551070|100711150|FG000|COMPLETED|Overall Study||52||
48158859|NCT00551070|100711150|FG000|NOT COMPLETED|Overall Study||0||
48158860|NCT01538472|100711151|FG000|STARTED|Overall Study||40||
48158861|NCT01538472|100711151|FG000|COMPLETED|Overall Study||36||
48158862|NCT01538472|100711151|FG000|NOT COMPLETED|Overall Study||4||
48158863|NCT01718028|100711152|FG000|STARTED|Overall Study||25||
48158864|NCT01718028|100711153|FG001|STARTED|Overall Study||24||
48158865|NCT01718028|100711152|FG000|COMPLETED|Overall Study||25||
48158866|NCT01718028|100711153|FG001|COMPLETED|Overall Study||24||
48158867|NCT01718028|100711152|FG000|NOT COMPLETED|Overall Study||0||
48158868|NCT01718028|100711153|FG001|NOT COMPLETED|Overall Study||0||
48158869|NCT00330915|100711154|FG000|STARTED|Overall Study||37||
48158870|NCT00330915|100711154|FG000|COMPLETED|Overall Study||37||
48158871|NCT00330915|100711154|FG000|NOT COMPLETED|Overall Study||0||
48158872|NCT03168295|100711155|FG000|STARTED|Overall Study||3||
48158873|NCT03168295|100711156|FG001|STARTED|Overall Study||3||
48158874|NCT03168295|100711157|FG002|STARTED|Overall Study||4||
48158875|NCT03168295|100711158|FG003|STARTED|Overall Study||4||
48158876|NCT03168295|100711159|FG004|STARTED|Overall Study||20||
48158877|NCT03168295|100711155|FG000|COMPLETED|Overall Study||3||
48158878|NCT03168295|100711156|FG001|COMPLETED|Overall Study||3||
48158879|NCT03168295|100711157|FG002|COMPLETED|Overall Study||4||
48158880|NCT03168295|100711158|FG003|COMPLETED|Overall Study||4||
48158881|NCT03168295|100711159|FG004|COMPLETED|Overall Study||20||
48158882|NCT03168295|100711155|FG000|NOT COMPLETED|Overall Study||0||
48158883|NCT03168295|100711156|FG001|NOT COMPLETED|Overall Study||0||
48158884|NCT03168295|100711157|FG002|NOT COMPLETED|Overall Study||0||
48158885|NCT03168295|100711158|FG003|NOT COMPLETED|Overall Study||0||
48158886|NCT03168295|100711159|FG004|NOT COMPLETED|Overall Study||0||
48158887|NCT01199926|100711160|FG000|STARTED|Overall Study||17||
48158888|NCT01199926|100711161|FG001|STARTED|Overall Study||17||
48158889|NCT01199926|100711160|FG000|COMPLETED|Overall Study||10||
48158890|NCT01199926|100711161|FG001|COMPLETED|Overall Study||13||
48158891|NCT01199926|100711160|FG000|NOT COMPLETED|Overall Study||7||
48158892|NCT01199926|100711161|FG001|NOT COMPLETED|Overall Study||4||
48158893|NCT00570674|100711162|FG000|STARTED|Overall Study||6||
48158894|NCT00570674|100711163|FG001|STARTED|Overall Study||3||
48158895|NCT00570674|100711164|FG002|STARTED|Overall Study||4||
48158896|NCT00570674|100711165|FG003|STARTED|Overall Study||3||
48732062|NCT04209595|102130044|FG004|NOT COMPLETED|Phase IIA - Assess Efficacy||0||
48732063|NCT04209595|102130040|FG000|STARTED|Phase IIB - Assess Efficacy||0||
48732064|NCT04209595|102130041|FG001|STARTED|Phase IIB - Assess Efficacy||0||
48732065|NCT04209595|102130042|FG002|STARTED|Phase IIB - Assess Efficacy||0||
48732066|NCT04209595|102130043|FG003|STARTED|Phase IIB - Assess Efficacy||0||
48158897|NCT00570674|100711166|FG004|STARTED|Overall Study||3||
48158898|NCT00570674|100711167|FG005|STARTED|Overall Study||10||
48158899|NCT00570674|100711168|FG006|STARTED|Overall Study||0||
48158900|NCT00570674|100711162|FG000|Treated|Overall Study||6||
48158901|NCT00570674|100711163|FG001|Treated|Overall Study||3||
48315277|NCT02153528|101097398|FG000|NOT COMPLETED|Overall Study||0||
48315278|NCT02153528|101097399|FG001|NOT COMPLETED|Overall Study||0||
48315279|NCT01543152|101097400|FG000|STARTED|Overall Study||3||
48315280|NCT01543152|101097401|FG001|STARTED|Overall Study||6||
48315281|NCT01543152|101097402|FG002|STARTED|Overall Study||11||
48315282|NCT01543152|101097403|FG003|STARTED|Overall Study||3||
48315283|NCT01543152|101097404|FG004|STARTED|Overall Study||3||
48315284|NCT01543152|101097400|FG000|COMPLETED|Overall Study||3||
48315285|NCT01543152|101097401|FG001|COMPLETED|Overall Study||4||
48315286|NCT01543152|101097402|FG002|COMPLETED|Overall Study||11||
48315287|NCT01543152|101097403|FG003|COMPLETED|Overall Study||3||
48315288|NCT01543152|101097404|FG004|COMPLETED|Overall Study||3||
48315289|NCT01543152|101097400|FG000|NOT COMPLETED|Overall Study||0||
48315290|NCT01543152|101097401|FG001|NOT COMPLETED|Overall Study||2||
48315291|NCT01543152|101097402|FG002|NOT COMPLETED|Overall Study||0||
48315292|NCT01543152|101097403|FG003|NOT COMPLETED|Overall Study||0||
48315293|NCT01543152|101097404|FG004|NOT COMPLETED|Overall Study||0||
48315294|NCT02783443|101097405|FG000|STARTED|Overall Study||30||
48315295|NCT02783443|101097406|FG001|STARTED|Overall Study||30||
48315296|NCT02783443|101097405|FG000|COMPLETED|Overall Study||30||
48315297|NCT02783443|101097406|FG001|COMPLETED|Overall Study||30||
48315298|NCT02783443|101097405|FG000|NOT COMPLETED|Overall Study||0||
48315299|NCT02783443|101097406|FG001|NOT COMPLETED|Overall Study||0||
48315300|NCT01999569|101097407|FG000|STARTED|Control Cycle||10||
48315301|NCT01999569|101097407|FG000|COMPLETED|Control Cycle||10||
48315302|NCT01999569|101097407|FG000|NOT COMPLETED|Control Cycle||0||
48315303|NCT01999569|101097407|FG000|STARTED|Letrozole Treatment Cycle||10||
48315304|NCT01999569|101097407|FG000|COMPLETED|Letrozole Treatment Cycle||10||
48315305|NCT01999569|101097407|FG000|NOT COMPLETED|Letrozole Treatment Cycle||0||
48315306|NCT00988143|101097408|FG000|STARTED|Overall Study||220||
48315307|NCT00988143|101097409|FG001|STARTED|Overall Study||190||
48315308|NCT00988143|101097410|FG002|STARTED|Overall Study||190||
48315309|NCT00988143|101097408|FG000|COMPLETED|Overall Study||220||
48315310|NCT00988143|101097409|FG001|COMPLETED|Overall Study||190||
48315311|NCT00988143|101097410|FG002|COMPLETED|Overall Study||190||
48315312|NCT00988143|101097408|FG000|NOT COMPLETED|Overall Study||0||
48315313|NCT00988143|101097409|FG001|NOT COMPLETED|Overall Study||0||
48315314|NCT00988143|101097410|FG002|NOT COMPLETED|Overall Study||0||
48315315|NCT01496131|101097411|FG000|STARTED|Overall Study||14||
48315316|NCT01496131|101097412|FG001|STARTED|Overall Study||14||
48315317|NCT01496131|101097411|FG000|COMPLETED|Overall Study||14||
48315318|NCT01496131|101097412|FG001|COMPLETED|Overall Study||14||
48315319|NCT01496131|101097411|FG000|NOT COMPLETED|Overall Study||0||
48315320|NCT01496131|101097412|FG001|NOT COMPLETED|Overall Study||0||
48315321|NCT04474795|101097413|FG000|STARTED|Overall Study||85||
48315322|NCT04474795|101097413|FG000|Completed Pre-test|Overall Study||82||
48315323|NCT04474795|101097413|FG000|Accessed Training Module 1|Overall Study||65||
48315324|NCT04474795|101097413|FG000|Accessed Training Module 2|Overall Study||45||
48315325|NCT04474795|101097413|FG000|Accessed Training Module 3|Overall Study||41||
48315326|NCT04474795|101097413|FG000|Accessed Training Module 4|Overall Study||20||
48315327|NCT04474795|101097413|FG000|COMPLETED|Overall Study||20||
48315328|NCT04474795|101097413|FG000|NOT COMPLETED|Overall Study||65||
48315329|NCT03719690|101097414|FG000|STARTED|Overall Study||59||
48315330|NCT03719690|101097415|FG001|STARTED|Overall Study||237||
48315331|NCT03719690|101097414|FG000|Safety Analysis Set (SAS)|Overall Study||59||
48315332|NCT03719690|101097415|FG001|Safety Analysis Set (SAS)|Overall Study||0||
48315333|NCT03719690|101097414|FG000|Modified Intent-to-Treat Analysis Set (mITT)|Overall Study||59||
48315334|NCT03719690|101097415|FG001|Modified Intent-to-Treat Analysis Set (mITT)|Overall Study||0||
48315335|NCT03719690|101097414|FG000|COMPLETED|Overall Study||0||
48315336|NCT03719690|101097415|FG001|COMPLETED|Overall Study||0||
48315337|NCT03719690|101097414|FG000|NOT COMPLETED|Overall Study||59||
48315338|NCT03719690|101097415|FG001|NOT COMPLETED|Overall Study||237||
48315339|NCT02971631|101097416|FG000|STARTED|First Intervention - One Day||3||
48315340|NCT02971631|101097417|FG001|STARTED|First Intervention - One Day||2||
48315341|NCT02971631|101097416|FG000|COMPLETED|First Intervention - One Day||3||
48315342|NCT02971631|101097417|FG001|COMPLETED|First Intervention - One Day||2||
48315343|NCT02971631|101097416|FG000|NOT COMPLETED|First Intervention - One Day||0||
48315344|NCT02971631|101097417|FG001|NOT COMPLETED|First Intervention - One Day||0||
48315345|NCT02971631|101097416|FG000|STARTED|Second Intervention - One Day||3||
48315346|NCT02971631|101097417|FG001|STARTED|Second Intervention - One Day||2||
48315347|NCT02971631|101097416|FG000|COMPLETED|Second Intervention - One Day||3||
48315348|NCT02971631|101097417|FG001|COMPLETED|Second Intervention - One Day||2||
48315349|NCT02971631|101097416|FG000|NOT COMPLETED|Second Intervention - One Day||0||
48315350|NCT02971631|101097417|FG001|NOT COMPLETED|Second Intervention - One Day||0||
48315351|NCT02330978|101097418|FG000|STARTED|The First Patient Included at Study||1||
48315352|NCT02330978|101097418|FG000|COMPLETED|The First Patient Included at Study||1||
48315353|NCT02330978|101097418|FG000|NOT COMPLETED|The First Patient Included at Study||0||
48315354|NCT02330978|101097418|FG000|STARTED|The Second Patient Included at Study||1||
48315355|NCT02330978|101097418|FG000|COMPLETED|The Second Patient Included at Study||1||
48315356|NCT02330978|101097418|FG000|NOT COMPLETED|The Second Patient Included at Study||0||
48315357|NCT01033825|101097419|FG000|STARTED|Overall Study||51||
48315358|NCT01033825|101097420|FG001|STARTED|Overall Study||60||
48315359|NCT01033825|101097421|FG002|STARTED|Overall Study||57||
48315360|NCT01033825|101097422|FG003|STARTED|Overall Study||48||
48732067|NCT04209595|102130044|FG004|STARTED|Phase IIB - Assess Efficacy||0||
48732068|NCT04209595|102130040|FG000|COMPLETED|Phase IIB - Assess Efficacy||0||
48732069|NCT04209595|102130041|FG001|COMPLETED|Phase IIB - Assess Efficacy||0||
48158902|NCT00570674|100711164|FG002|Treated|Overall Study||3||
48158903|NCT00570674|100711165|FG003|Treated|Overall Study||3||
48158904|NCT00570674|100711166|FG004|Treated|Overall Study||3||
48158905|NCT00570674|100711167|FG005|Treated|Overall Study||10||
48315361|NCT01033825|101097423|FG004|STARTED|Overall Study||58||
48315362|NCT01033825|101097424|FG005|STARTED|Overall Study||18||
48315363|NCT01033825|101097425|FG006|STARTED|Overall Study||18||
48315364|NCT01033825|101097419|FG000|COMPLETED|Overall Study||48||
48315365|NCT01033825|101097420|FG001|COMPLETED|Overall Study||57||
48315366|NCT01033825|101097421|FG002|COMPLETED|Overall Study||55||
48315367|NCT01033825|101097422|FG003|COMPLETED|Overall Study||46||
48315368|NCT01033825|101097423|FG004|COMPLETED|Overall Study||56||
48315369|NCT01033825|101097424|FG005|COMPLETED|Overall Study||18||
48315370|NCT01033825|101097425|FG006|COMPLETED|Overall Study||18||
48315371|NCT01033825|101097419|FG000|NOT COMPLETED|Overall Study||3||
48315372|NCT01033825|101097420|FG001|NOT COMPLETED|Overall Study||3||
48315373|NCT01033825|101097421|FG002|NOT COMPLETED|Overall Study||2||
48315374|NCT01033825|101097422|FG003|NOT COMPLETED|Overall Study||2||
48315375|NCT01033825|101097423|FG004|NOT COMPLETED|Overall Study||2||
48158906|NCT00570674|100711168|FG006|Treated|Overall Study||0||
48158907|NCT00570674|100711162|FG000|PEG Evaluable|Overall Study||6||
48158908|NCT00570674|100711163|FG001|PEG Evaluable|Overall Study||3||
48315376|NCT01033825|101097424|FG005|NOT COMPLETED|Overall Study||0||
48315377|NCT01033825|101097425|FG006|NOT COMPLETED|Overall Study||0||
48315378|NCT00802204|101097426|FG000|STARTED|Overall Study||9||
48732070|NCT04209595|102130042|FG002|COMPLETED|Phase IIB - Assess Efficacy||0||
48158909|NCT00570674|100711164|FG002|PEG Evaluable|Overall Study||3||
48158910|NCT00570674|100711165|FG003|PEG Evaluable|Overall Study||3||
48158911|NCT00570674|100711166|FG004|PEG Evaluable|Overall Study||2||
48158912|NCT00570674|100711167|FG005|PEG Evaluable|Overall Study||10||
48158913|NCT00570674|100711168|FG006|PEG Evaluable|Overall Study||0||
48158914|NCT00570674|100711162|FG000|COMPLETED|Overall Study||6||
48158915|NCT00570674|100711163|FG001|COMPLETED|Overall Study||3||
48158916|NCT00570674|100711164|FG002|COMPLETED|Overall Study||3||
48158917|NCT00570674|100711165|FG003|COMPLETED|Overall Study||3||
48158918|NCT00570674|100711166|FG004|COMPLETED|Overall Study||3||
48315379|NCT00802204|101097427|FG001|STARTED|Overall Study||19||
48315380|NCT00802204|101097426|FG000|COMPLETED|Overall Study||8||
48315381|NCT00802204|101097427|FG001|COMPLETED|Overall Study||18||
48315382|NCT00802204|101097426|FG000|NOT COMPLETED|Overall Study||1||
48315383|NCT00802204|101097427|FG001|NOT COMPLETED|Overall Study||1||
48315384|NCT01838616|101097428|FG000|STARTED|Titration Period||130||
48315385|NCT01838616|101097429|FG001|STARTED|Titration Period||128||
48315386|NCT01838616|101097428|FG000|No Post Baseline Pain Intensity Values|Titration Period||0||
48315387|NCT01838616|101097429|FG001|No Post Baseline Pain Intensity Values|Titration Period||2||
48315388|NCT01838616|101097428|FG000|Major Protocol Deviations|Titration Period||13||
48315389|NCT01838616|101097429|FG001|Major Protocol Deviations|Titration Period||16||
48315390|NCT01838616|101097428|FG000|Switched to Pick-up Arm|Titration Period||0||
48315391|NCT01838616|101097429|FG001|Switched to Pick-up Arm|Titration Period||43||
48315392|NCT01838616|101097428|FG000|Full Analysis Set|Titration Period||130||
48315393|NCT01838616|101097429|FG001|Full Analysis Set|Titration Period||128||
48315394|NCT01838616|101097428|FG000|Per Protocol Set|Titration Period||117||
48315395|NCT01838616|101097429|FG001|Per Protocol Set|Titration Period||112||
48315396|NCT01838616|101097428|FG000|COMPLETED|Titration Period||100||
48315397|NCT01838616|101097429|FG001|COMPLETED|Titration Period||62||
48315398|NCT01838616|101097428|FG000|NOT COMPLETED|Titration Period||30||
48315399|NCT01838616|101097429|FG001|NOT COMPLETED|Titration Period||66||
48315400|NCT01838616|101097428|FG000|STARTED|Continuation Period||100||
48315401|NCT01838616|101097429|FG001|STARTED|Continuation Period||62||
48315402|NCT01838616|101097428|FG000|Switched to Pick-up Arm|Continuation Period||0||
48315403|NCT01838616|101097429|FG001|Switched to Pick-up Arm|Continuation Period||7||
48315404|NCT01838616|101097428|FG000|COMPLETED|Continuation Period||86||
48315405|NCT01838616|101097429|FG001|COMPLETED|Continuation Period||48||
48315406|NCT01838616|101097428|FG000|NOT COMPLETED|Continuation Period||14||
48315407|NCT01838616|101097429|FG001|NOT COMPLETED|Continuation Period||14||
48315408|NCT01838616|101097428|FG000|STARTED|Pick-up Arm||50||
48315409|NCT01838616|101097429|FG001|STARTED|Pick-up Arm||0||
48315410|NCT01838616|101097428|FG000|Full Analysis Set|Pick-up Arm||49||
48158919|NCT00570674|100711167|FG005|COMPLETED|Overall Study||10||
48158920|NCT00570674|100711168|FG006|COMPLETED|Overall Study||0||
48158921|NCT00570674|100711162|FG000|NOT COMPLETED|Overall Study||0||
48315411|NCT01838616|101097429|FG001|Full Analysis Set|Pick-up Arm||0||
48315412|NCT01838616|101097428|FG000|COMPLETED|Pick-up Arm||35||
48732071|NCT04209595|102130043|FG003|COMPLETED|Phase IIB - Assess Efficacy||0||
48732072|NCT04209595|102130044|FG004|COMPLETED|Phase IIB - Assess Efficacy||0||
48732073|NCT04209595|102130040|FG000|NOT COMPLETED|Phase IIB - Assess Efficacy||0||
48315413|NCT01838616|101097429|FG001|COMPLETED|Pick-up Arm||0||
48315414|NCT01838616|101097428|FG000|NOT COMPLETED|Pick-up Arm||15||
48315415|NCT01838616|101097429|FG001|NOT COMPLETED|Pick-up Arm||0||
48315416|NCT01825057|101097430|FG000|STARTED|Patient Study Flow||336||
48315417|NCT01825057|101097431|FG001|STARTED|Patient Study Flow||379||
48315418|NCT01825057|101097432|FG002|STARTED|Patient Study Flow||458||
48315419|NCT01825057|101097430|FG000|COMPLETED|Patient Study Flow||336||
48315420|NCT01825057|101097431|FG001|COMPLETED|Patient Study Flow||379||
48315421|NCT01825057|101097432|FG002|COMPLETED|Patient Study Flow||458||
48315422|NCT01825057|101097430|FG000|NOT COMPLETED|Patient Study Flow||0||
48614682|NCT00289094|101841807|FG000|STARTED|Overall Study||50||
48614683|NCT00289094|101841808|FG001|STARTED|Overall Study||49||
48614684|NCT00289094|101841807|FG000|COMPLETED|Overall Study||3||
48614685|NCT00289094|101841808|FG001|COMPLETED|Overall Study||2||
48614686|NCT00289094|101841807|FG000|NOT COMPLETED|Overall Study||47||
48614687|NCT00289094|101841808|FG001|NOT COMPLETED|Overall Study||47||
48614688|NCT00003471|101841809|FG000|STARTED|Overall Study||7||
48614689|NCT00003471|101841809|FG000|COMPLETED|Overall Study||3||
48614690|NCT00003471|101841809|FG000|NOT COMPLETED|Overall Study||4||
48614691|NCT02196857|101841810|FG000|STARTED|Overall Study||16||
48614692|NCT02196857|101841810|FG000|COMPLETED|Overall Study||16||
48614693|NCT02196857|101841810|FG000|NOT COMPLETED|Overall Study||0||
48614694|NCT02038179|101841811|FG000|STARTED|Phase 1 (4 Weeks)||52||
48614695|NCT02038179|101841812|FG001|STARTED|Phase 1 (4 Weeks)||47||
48614696|NCT02038179|101841811|FG000|COMPLETED|Phase 1 (4 Weeks)||48||
48614697|NCT02038179|101841812|FG001|COMPLETED|Phase 1 (4 Weeks)||42||
48614698|NCT02038179|101841811|FG000|NOT COMPLETED|Phase 1 (4 Weeks)||4||
48614699|NCT02038179|101841812|FG001|NOT COMPLETED|Phase 1 (4 Weeks)||5||
48315423|NCT01825057|101097431|FG001|NOT COMPLETED|Patient Study Flow||0||
48315424|NCT01825057|101097432|FG002|NOT COMPLETED|Patient Study Flow||0||
48315425|NCT01825057|101097430|FG000|STARTED|Provider Study Flow||13||
48315426|NCT01825057|101097431|FG001|STARTED|Provider Study Flow||12||
48315427|NCT01825057|101097432|FG002|STARTED|Provider Study Flow||13||
48315428|NCT01825057|101097430|FG000|COMPLETED|Provider Study Flow||13||
48315429|NCT01825057|101097431|FG001|COMPLETED|Provider Study Flow||12||
48614700|NCT02038179|101841811|FG000|STARTED|Washout (2-4 Weeks)||48||
48614701|NCT02038179|101841812|FG001|STARTED|Washout (2-4 Weeks)||42||
48614702|NCT02038179|101841811|FG000|COMPLETED|Washout (2-4 Weeks)||46||
48614703|NCT02038179|101841812|FG001|COMPLETED|Washout (2-4 Weeks)||40||
48732074|NCT04209595|102130041|FG001|NOT COMPLETED|Phase IIB - Assess Efficacy||0||
48732075|NCT04209595|102130042|FG002|NOT COMPLETED|Phase IIB - Assess Efficacy||0||
48732076|NCT04209595|102130043|FG003|NOT COMPLETED|Phase IIB - Assess Efficacy||0||
48732077|NCT04209595|102130044|FG004|NOT COMPLETED|Phase IIB - Assess Efficacy||0||
48732078|NCT01023724|102130045|FG000|STARTED|Overall Study||25||
48732079|NCT01023724|102130046|FG001|STARTED|Overall Study||25||
48732080|NCT01023724|102130045|FG000|COMPLETED|Overall Study||21||
48732081|NCT01023724|102130046|FG001|COMPLETED|Overall Study||22||
48732082|NCT01023724|102130045|FG000|NOT COMPLETED|Overall Study||4||
48732083|NCT01023724|102130046|FG001|NOT COMPLETED|Overall Study||3||
48732084|NCT03605914|102130047|FG000|STARTED|Overall Study||57||
48732085|NCT03605914|102130048|FG001|STARTED|Overall Study||43||
48732086|NCT03605914|102130047|FG000|Completed Day 1 Assessment|Overall Study||31||
48732087|NCT03605914|102130048|FG001|Completed Day 1 Assessment|Overall Study||26||
48732088|NCT03605914|102130047|FG000|Completed Day 2 Assessment|Overall Study||32||
48732089|NCT03605914|102130048|FG001|Completed Day 2 Assessment|Overall Study||27||
48732090|NCT03605914|102130047|FG000|Completed Day 3 Assessment|Overall Study||31||
48732091|NCT03605914|102130048|FG001|Completed Day 3 Assessment|Overall Study||28||
48732092|NCT03605914|102130047|FG000|Completed Day 5 Assessment|Overall Study||30||
48315430|NCT01825057|101097432|FG002|COMPLETED|Provider Study Flow||13||
48315431|NCT01825057|101097430|FG000|NOT COMPLETED|Provider Study Flow||0||
48315432|NCT01825057|101097431|FG001|NOT COMPLETED|Provider Study Flow||0||
48315433|NCT01825057|101097432|FG002|NOT COMPLETED|Provider Study Flow||0||
48315434|NCT02605187|101097433|FG000|STARTED|Overall Study||40||
48315435|NCT02605187|101097434|FG001|STARTED|Overall Study||21||
48315436|NCT02605187|101097435|FG002|STARTED|Overall Study||83||
48315437|NCT02605187|101097436|FG003|STARTED|Overall Study||16||
48315438|NCT02605187|101097433|FG000|COMPLETED|Overall Study||32||
48315439|NCT02605187|101097434|FG001|COMPLETED|Overall Study||19||
48614704|NCT02038179|101841811|FG000|NOT COMPLETED|Washout (2-4 Weeks)||2||
48614705|NCT02038179|101841812|FG001|NOT COMPLETED|Washout (2-4 Weeks)||2||
48614706|NCT02038179|101841811|FG000|STARTED|Phase 2 (4 Weeks)||46||
48614707|NCT02038179|101841812|FG001|STARTED|Phase 2 (4 Weeks)||40||
48614708|NCT02038179|101841811|FG000|COMPLETED|Phase 2 (4 Weeks)||44||
48614709|NCT02038179|101841812|FG001|COMPLETED|Phase 2 (4 Weeks)||38||
48614710|NCT02038179|101841811|FG000|NOT COMPLETED|Phase 2 (4 Weeks)||2||
48614711|NCT02038179|101841812|FG001|NOT COMPLETED|Phase 2 (4 Weeks)||2||
48614712|NCT00558012|101841813|FG000|STARTED|Overall Study||89||
48732093|NCT03605914|102130048|FG001|Completed Day 5 Assessment|Overall Study||24||
48732094|NCT03605914|102130047|FG000|COMPLETED|Overall Study||30||
48732095|NCT03605914|102130048|FG001|COMPLETED|Overall Study||24||
48315440|NCT02605187|101097435|FG002|COMPLETED|Overall Study||72||
48315441|NCT02605187|101097436|FG003|COMPLETED|Overall Study||15||
48315442|NCT02605187|101097433|FG000|NOT COMPLETED|Overall Study||8||
48315443|NCT02605187|101097434|FG001|NOT COMPLETED|Overall Study||2||
48315444|NCT02605187|101097435|FG002|NOT COMPLETED|Overall Study||11||
48315445|NCT02605187|101097436|FG003|NOT COMPLETED|Overall Study||1||
48315446|NCT02700412|101097437|FG000|STARTED|Overall Study||80||
48614713|NCT00558012|101841814|FG001|STARTED|Overall Study||92||
48614714|NCT00558012|101841813|FG000|COMPLETED|Overall Study||64||
48614715|NCT00558012|101841814|FG001|COMPLETED|Overall Study||74||
48614716|NCT00558012|101841813|FG000|NOT COMPLETED|Overall Study||25||
48614717|NCT00558012|101841814|FG001|NOT COMPLETED|Overall Study||18||
48614718|NCT01675492|101841815|FG000|STARTED|Overall Study||84|Number of patients and eyes (units) treated|149
48732096|NCT03605914|102130047|FG000|NOT COMPLETED|Overall Study||27||
48732097|NCT03605914|102130048|FG001|NOT COMPLETED|Overall Study||19||
48732098|NCT04115098|102130049|FG000|STARTED|Overall Study||5||
48732099|NCT04115098|102130050|FG001|STARTED|Overall Study||2||
48732100|NCT04115098|102130051|FG002|STARTED|Overall Study||3||
48732101|NCT04115098|102130052|FG003|STARTED|Overall Study||4||
48732102|NCT04115098|102130053|FG004|STARTED|Overall Study||5||
48732103|NCT04115098|102130054|FG005|STARTED|Overall Study||2||
48732104|NCT04115098|102130055|FG006|STARTED|Overall Study||0||
48614719|NCT01675492|101841815|FG000|COMPLETED|Overall Study||42|# subjects and eyes completed 24M visit. 149 eyes of 84 subjects completed 3M visit - approval basis|75
48614720|NCT01675492|101841815|FG000|NOT COMPLETED|Overall Study||42||74
48614721|NCT01585246|101841816|FG000|STARTED|Overall Study||3||
48614722|NCT01585246|101841817|FG001|STARTED|Overall Study||4||
48614723|NCT01585246|101841818|FG002|STARTED|Overall Study||20||
48614724|NCT01585246|101841819|FG003|STARTED|Overall Study||10||
48732105|NCT04115098|102130056|FG007|STARTED|Overall Study||7||
48732106|NCT04115098|102130057|FG008|STARTED|Overall Study||4||
48732107|NCT04115098|102130058|FG009|STARTED|Overall Study||3||
48315447|NCT02700412|101097437|FG000|COMPLETED|Overall Study||47||
48315448|NCT02700412|101097437|FG000|NOT COMPLETED|Overall Study||33||
48315449|NCT02664272|101097438|FG000|STARTED|Overall Study||40||41
48614725|NCT01585246|101841820|FG004|STARTED|Overall Study||11||
48614726|NCT01585246|101841816|FG000|COMPLETED|Overall Study||3||
48614727|NCT01585246|101841817|FG001|COMPLETED|Overall Study||3||
48614728|NCT01585246|101841818|FG002|COMPLETED|Overall Study||16||
48614729|NCT01585246|101841819|FG003|COMPLETED|Overall Study||6||
48614730|NCT01585246|101841820|FG004|COMPLETED|Overall Study||9||
48614731|NCT01585246|101841816|FG000|NOT COMPLETED|Overall Study||0||
48732108|NCT04115098|102130059|FG010|STARTED|Overall Study||4||
48732109|NCT04115098|102130060|FG011|STARTED|Overall Study||3||
48732110|NCT04115098|102130049|FG000|4-week Treatment Session 1|Overall Study||5||
48732111|NCT04115098|102130050|FG001|4-week Treatment Session 1|Overall Study||2||
48315450|NCT02664272|101097438|FG000|COMPLETED|Overall Study||38|There were 39 units that met the primary outcome and 41 units that met the secondary outcome.|39
48315451|NCT02664272|101097438|FG000|NOT COMPLETED|Overall Study||2||2
48315452|NCT01365039|101097439|FG000|STARTED|Overall Study||86||
48315453|NCT01365039|101097440|FG001|STARTED|Overall Study||87||
48315454|NCT01365039|101097439|FG000|COMPLETED|Overall Study||85||
48315455|NCT01365039|101097440|FG001|COMPLETED|Overall Study||87||
48315456|NCT01365039|101097439|FG000|NOT COMPLETED|Overall Study||1||
48315457|NCT01365039|101097440|FG001|NOT COMPLETED|Overall Study||0||
48315458|NCT00545298|101097441|FG000|STARTED|Overall Study||2||
48614732|NCT01585246|101841817|FG001|NOT COMPLETED|Overall Study||1||
48732112|NCT04115098|102130051|FG002|4-week Treatment Session 1|Overall Study||3||
48732113|NCT04115098|102130052|FG003|4-week Treatment Session 1|Overall Study||4||
48732114|NCT04115098|102130053|FG004|4-week Treatment Session 1|Overall Study||5||
48732115|NCT04115098|102130054|FG005|4-week Treatment Session 1|Overall Study||2||
48732116|NCT04115098|102130055|FG006|4-week Treatment Session 1|Overall Study||0||
48732117|NCT04115098|102130056|FG007|4-week Treatment Session 1|Overall Study||7||
48732118|NCT04115098|102130057|FG008|4-week Treatment Session 1|Overall Study||4||
48315459|NCT00545298|101097442|FG001|STARTED|Overall Study||1||
48315460|NCT00545298|101097443|FG002|STARTED|Overall Study||1||
48315461|NCT00545298|101097441|FG000|COMPLETED|Overall Study||0||
48315462|NCT00545298|101097442|FG001|COMPLETED|Overall Study||1||
48315463|NCT00545298|101097443|FG002|COMPLETED|Overall Study||0||
48614733|NCT01585246|101841818|FG002|NOT COMPLETED|Overall Study||4||
48614734|NCT01585246|101841819|FG003|NOT COMPLETED|Overall Study||4||
48614735|NCT01585246|101841820|FG004|NOT COMPLETED|Overall Study||2||
48614736|NCT02360280|101841821|FG000|STARTED|Overall Study||28||
48614737|NCT02360280|101841822|FG001|STARTED|Overall Study||30||
48732119|NCT04115098|102130058|FG009|4-week Treatment Session 1|Overall Study||3||
48732120|NCT04115098|102130059|FG010|4-week Treatment Session 1|Overall Study||4||
48732121|NCT04115098|102130060|FG011|4-week Treatment Session 1|Overall Study||3||
48732122|NCT04115098|102130049|FG000|4-week Treatment Session 2|Overall Study||4||
48315464|NCT00545298|101097441|FG000|NOT COMPLETED|Overall Study||2||
48315465|NCT00545298|101097442|FG001|NOT COMPLETED|Overall Study||0||
48315466|NCT00545298|101097443|FG002|NOT COMPLETED|Overall Study||1||
48614738|NCT02360280|101841821|FG000|COMPLETED|Overall Study||25||
48614739|NCT02360280|101841822|FG001|COMPLETED|Overall Study||29||
48732123|NCT04115098|102130050|FG001|4-week Treatment Session 2|Overall Study||2||
48732124|NCT04115098|102130051|FG002|4-week Treatment Session 2|Overall Study||3||
48732125|NCT04115098|102130052|FG003|4-week Treatment Session 2|Overall Study||4||
48732126|NCT04115098|102130053|FG004|4-week Treatment Session 2|Overall Study||4||
48732127|NCT04115098|102130054|FG005|4-week Treatment Session 2|Overall Study||2||
48732128|NCT04115098|102130055|FG006|4-week Treatment Session 2|Overall Study||0||
48732129|NCT04115098|102130056|FG007|4-week Treatment Session 2|Overall Study||6||
48732130|NCT04115098|102130057|FG008|4-week Treatment Session 2|Overall Study||3||
48732131|NCT04115098|102130058|FG009|4-week Treatment Session 2|Overall Study||3||
48732132|NCT04115098|102130059|FG010|4-week Treatment Session 2|Overall Study||4||
48732133|NCT04115098|102130060|FG011|4-week Treatment Session 2|Overall Study||3||
48732134|NCT04115098|102130049|FG000|4-week Treatment Session 3|Overall Study||3||
48315467|NCT03078075|101097444|FG000|STARTED|Overall Study||111||
48315468|NCT03078075|101097445|FG001|STARTED|Overall Study||114||
48315469|NCT03078075|101097446|FG002|STARTED|Overall Study||59||
48315470|NCT03078075|101097447|FG003|STARTED|Overall Study||10||
48315471|NCT03078075|101097448|FG004|STARTED|Overall Study||109||
48315472|NCT03078075|101097444|FG000|COMPLETED|Overall Study||106||
48315473|NCT03078075|101097445|FG001|COMPLETED|Overall Study||103||
48315474|NCT03078075|101097446|FG002|COMPLETED|Overall Study||19||
48315475|NCT03078075|101097447|FG003|COMPLETED|Overall Study||9||
48732135|NCT04115098|102130050|FG001|4-week Treatment Session 3|Overall Study||2||
48732136|NCT04115098|102130051|FG002|4-week Treatment Session 3|Overall Study||3||
48732137|NCT04115098|102130052|FG003|4-week Treatment Session 3|Overall Study||4||
48732138|NCT04115098|102130053|FG004|4-week Treatment Session 3|Overall Study||4||
48732139|NCT04115098|102130054|FG005|4-week Treatment Session 3|Overall Study||1||
48732140|NCT04115098|102130055|FG006|4-week Treatment Session 3|Overall Study||0||
48732141|NCT04115098|102130056|FG007|4-week Treatment Session 3|Overall Study||6||
48732142|NCT04115098|102130057|FG008|4-week Treatment Session 3|Overall Study||3||
48732143|NCT04115098|102130058|FG009|4-week Treatment Session 3|Overall Study||2||
48732144|NCT04115098|102130059|FG010|4-week Treatment Session 3|Overall Study||4||
48315476|NCT03078075|101097448|FG004|COMPLETED|Overall Study||78||
48315477|NCT03078075|101097444|FG000|NOT COMPLETED|Overall Study||5||
48315478|NCT03078075|101097445|FG001|NOT COMPLETED|Overall Study||11||
48315479|NCT03078075|101097446|FG002|NOT COMPLETED|Overall Study||40||
48315480|NCT03078075|101097447|FG003|NOT COMPLETED|Overall Study||1||
48732145|NCT04115098|102130060|FG011|4-week Treatment Session 3|Overall Study||2||
48732146|NCT04115098|102130049|FG000|4-week Treatment Session 4|Overall Study||3||
48732147|NCT04115098|102130050|FG001|4-week Treatment Session 4|Overall Study||2||
48732148|NCT04115098|102130051|FG002|4-week Treatment Session 4|Overall Study||3||
48732149|NCT04115098|102130052|FG003|4-week Treatment Session 4|Overall Study||4||
48732150|NCT04115098|102130053|FG004|4-week Treatment Session 4|Overall Study||3||
48732151|NCT04115098|102130054|FG005|4-week Treatment Session 4|Overall Study||1||
48732152|NCT04115098|102130055|FG006|4-week Treatment Session 4|Overall Study||0||
48732153|NCT04115098|102130056|FG007|4-week Treatment Session 4|Overall Study||6||
48732154|NCT04115098|102130057|FG008|4-week Treatment Session 4|Overall Study||2||
48732155|NCT04115098|102130058|FG009|4-week Treatment Session 4|Overall Study||2||
48732156|NCT04115098|102130059|FG010|4-week Treatment Session 4|Overall Study||4||
48732157|NCT04115098|102130060|FG011|4-week Treatment Session 4|Overall Study||2||
48732158|NCT04115098|102130049|FG000|4-week Treatment Session 5|Overall Study||2||
48732159|NCT04115098|102130050|FG001|4-week Treatment Session 5|Overall Study||2||
48732160|NCT04115098|102130051|FG002|4-week Treatment Session 5|Overall Study||3||
48732161|NCT04115098|102130052|FG003|4-week Treatment Session 5|Overall Study||4||
48732162|NCT04115098|102130053|FG004|4-week Treatment Session 5|Overall Study||3||
48732163|NCT04115098|102130054|FG005|4-week Treatment Session 5|Overall Study||1||
48732164|NCT04115098|102130055|FG006|4-week Treatment Session 5|Overall Study||0||
48732165|NCT04115098|102130056|FG007|4-week Treatment Session 5|Overall Study||6||
48732166|NCT04115098|102130057|FG008|4-week Treatment Session 5|Overall Study||2||
48732167|NCT04115098|102130058|FG009|4-week Treatment Session 5|Overall Study||1||
48732168|NCT04115098|102130059|FG010|4-week Treatment Session 5|Overall Study||4||
48732169|NCT04115098|102130060|FG011|4-week Treatment Session 5|Overall Study||2||
48732170|NCT04115098|102130049|FG000|COMPLETED|Overall Study||2||
48315481|NCT03078075|101097448|FG004|NOT COMPLETED|Overall Study||31||
48315482|NCT02437864|101097449|FG000|STARTED|Overall Study||200||
48315483|NCT02437864|101097450|FG001|STARTED|Overall Study||160||
48315484|NCT02437864|101097449|FG000|COMPLETED|Overall Study||196||
48315485|NCT02437864|101097450|FG001|COMPLETED|Overall Study||160||
48315486|NCT02437864|101097449|FG000|NOT COMPLETED|Overall Study||4||
48315487|NCT02437864|101097450|FG001|NOT COMPLETED|Overall Study||0||
48315488|NCT00710879|101097451|FG000|STARTED|Overall Study||60||
48732171|NCT04115098|102130050|FG001|COMPLETED|Overall Study||2||
48732172|NCT04115098|102130051|FG002|COMPLETED|Overall Study||3||
48732173|NCT04115098|102130052|FG003|COMPLETED|Overall Study||4||
48732174|NCT04115098|102130053|FG004|COMPLETED|Overall Study||3||
48732175|NCT04115098|102130054|FG005|COMPLETED|Overall Study||1||
48315489|NCT00710879|101097452|FG001|STARTED|Overall Study||117||
48315490|NCT00710879|101097451|FG000|COMPLETED|Overall Study||58||
48315491|NCT00710879|101097452|FG001|COMPLETED|Overall Study||113||
48315492|NCT00710879|101097451|FG000|NOT COMPLETED|Overall Study||2||
48315493|NCT00710879|101097452|FG001|NOT COMPLETED|Overall Study||4||
48315494|NCT03996876|101097453|FG000|STARTED|Overall Study||14||
48315495|NCT03996876|101097454|FG001|STARTED|Overall Study||14||
48315496|NCT03996876|101097453|FG000|COMPLETED|Overall Study||12||
48315497|NCT03996876|101097454|FG001|COMPLETED|Overall Study||10||
48315498|NCT03996876|101097453|FG000|NOT COMPLETED|Overall Study||2||
48315499|NCT03996876|101097454|FG001|NOT COMPLETED|Overall Study||4||
48315500|NCT03159091|101097455|FG000|STARTED|Overall Study||121||
48315501|NCT03159091|101097456|FG001|STARTED|Overall Study||117||
48315502|NCT03159091|101097455|FG000|COMPLETED|Overall Study||116||
48315503|NCT03159091|101097456|FG001|COMPLETED|Overall Study||113||
48315504|NCT03159091|101097455|FG000|NOT COMPLETED|Overall Study||5||
48315505|NCT03159091|101097456|FG001|NOT COMPLETED|Overall Study||4||
48315506|NCT00316355|101097457|FG000|STARTED|Overall Study||15||
48315507|NCT00316355|101097458|FG001|STARTED|Overall Study||19||
48315508|NCT00316355|101097457|FG000|Started Treatment|Overall Study||12||
48315509|NCT00316355|101097458|FG001|Started Treatment|Overall Study||18||
48315510|NCT00316355|101097457|FG000|COMPLETED|Overall Study||10||
48315511|NCT00316355|101097458|FG001|COMPLETED|Overall Study||12||
48315512|NCT00316355|101097457|FG000|NOT COMPLETED|Overall Study||5||
48315513|NCT00316355|101097458|FG001|NOT COMPLETED|Overall Study||7||
48315514|NCT03680911|101097459|FG000|STARTED|Visit 1 (Baseline)||3||
48315515|NCT03680911|101097460|FG001|STARTED|Visit 1 (Baseline)||4||
48315516|NCT03680911|101097459|FG000|COMPLETED|Visit 1 (Baseline)||3||
48315517|NCT03680911|101097460|FG001|COMPLETED|Visit 1 (Baseline)||4||
48315518|NCT03680911|101097459|FG000|NOT COMPLETED|Visit 1 (Baseline)||0||
48315519|NCT03680911|101097460|FG001|NOT COMPLETED|Visit 1 (Baseline)||0||
48315520|NCT03680911|101097459|FG000|STARTED|At Home Treatment||3||
48315521|NCT03680911|101097460|FG001|STARTED|At Home Treatment||4||
48315522|NCT03680911|101097459|FG000|COMPLETED|At Home Treatment||0||
48315523|NCT03680911|101097460|FG001|COMPLETED|At Home Treatment||1||
48315524|NCT03680911|101097459|FG000|NOT COMPLETED|At Home Treatment||3||
48732176|NCT04115098|102130055|FG006|COMPLETED|Overall Study||0||
48732177|NCT04115098|102130056|FG007|COMPLETED|Overall Study||6||
48732178|NCT04115098|102130057|FG008|COMPLETED|Overall Study||2||
48732179|NCT04115098|102130058|FG009|COMPLETED|Overall Study||1||
48732180|NCT04115098|102130059|FG010|COMPLETED|Overall Study||4||
48732181|NCT04115098|102130060|FG011|COMPLETED|Overall Study||2||
48732182|NCT04115098|102130049|FG000|NOT COMPLETED|Overall Study||3||
48732183|NCT04115098|102130050|FG001|NOT COMPLETED|Overall Study||0||
48732184|NCT04115098|102130051|FG002|NOT COMPLETED|Overall Study||0||
48732185|NCT04115098|102130052|FG003|NOT COMPLETED|Overall Study||0||
48732186|NCT04115098|102130053|FG004|NOT COMPLETED|Overall Study||2||
48732187|NCT04115098|102130054|FG005|NOT COMPLETED|Overall Study||1||
48732188|NCT04115098|102130055|FG006|NOT COMPLETED|Overall Study||0||
48732189|NCT04115098|102130056|FG007|NOT COMPLETED|Overall Study||1||
48732190|NCT04115098|102130057|FG008|NOT COMPLETED|Overall Study||2||
48732191|NCT04115098|102130058|FG009|NOT COMPLETED|Overall Study||2||
48732192|NCT04115098|102130059|FG010|NOT COMPLETED|Overall Study||0||
48732193|NCT04115098|102130060|FG011|NOT COMPLETED|Overall Study||1||
48732194|NCT01235234|102130061|FG000|STARTED|Overall Study||77||
48732195|NCT01235234|102130062|FG001|STARTED|Overall Study||78||
48732196|NCT01235234|102130063|FG002|STARTED|Overall Study||81||
48315525|NCT03680911|101097460|FG001|NOT COMPLETED|At Home Treatment||3||
48315526|NCT03680911|101097459|FG000|STARTED|Visit 2 (1 Month Follow up)||0||
48315527|NCT03680911|101097460|FG001|STARTED|Visit 2 (1 Month Follow up)||1||
48315528|NCT03680911|101097459|FG000|COMPLETED|Visit 2 (1 Month Follow up)||0||
48315529|NCT03680911|101097460|FG001|COMPLETED|Visit 2 (1 Month Follow up)||1||
48315530|NCT03680911|101097459|FG000|NOT COMPLETED|Visit 2 (1 Month Follow up)||0||
48315531|NCT03680911|101097460|FG001|NOT COMPLETED|Visit 2 (1 Month Follow up)||0||
48315532|NCT03680911|101097459|FG000|STARTED|Visit 3 (4 Month Follow up)||0||
48315533|NCT03680911|101097460|FG001|STARTED|Visit 3 (4 Month Follow up)||1||
48315534|NCT03680911|101097459|FG000|COMPLETED|Visit 3 (4 Month Follow up)||0||
48315535|NCT03680911|101097460|FG001|COMPLETED|Visit 3 (4 Month Follow up)||0||
48315536|NCT03680911|101097459|FG000|NOT COMPLETED|Visit 3 (4 Month Follow up)||0||
48315537|NCT03680911|101097460|FG001|NOT COMPLETED|Visit 3 (4 Month Follow up)||1||
48315538|NCT03700320|101097461|FG000|STARTED|Overall Study||198||
48315539|NCT03700320|101097462|FG001|STARTED|Overall Study||546||
48315540|NCT03700320|101097461|FG000|Safety Population; Received Treatment|Overall Study||196||
48315541|NCT03700320|101097462|FG001|Safety Population; Received Treatment|Overall Study||543||
48315542|NCT03700320|101097461|FG000|Entered Safety Follow-up|Overall Study||159||
48315543|NCT03700320|101097462|FG001|Entered Safety Follow-up|Overall Study||472||
48315544|NCT03700320|101097461|FG000|COMPLETED|Overall Study||136||
48315545|NCT03700320|101097462|FG001|COMPLETED|Overall Study||373||
48315546|NCT03700320|101097461|FG000|NOT COMPLETED|Overall Study||62||
48315547|NCT03700320|101097462|FG001|NOT COMPLETED|Overall Study||173||
48315548|NCT00552175|101097463|FG000|STARTED|Overall Study||167||
48315549|NCT00552175|101097464|FG001|STARTED|Overall Study||86||
48732197|NCT01235234|102130061|FG000|COMPLETED|Overall Study||75||
48732198|NCT01235234|102130062|FG001|COMPLETED|Overall Study||76||
48732199|NCT01235234|102130063|FG002|COMPLETED|Overall Study||80||
48732200|NCT01235234|102130061|FG000|NOT COMPLETED|Overall Study||2||
48315550|NCT00552175|101097465|FG002|STARTED|Overall Study||86||
48315551|NCT00552175|101097463|FG000|Full Analysis Set Population|Overall Study||167||
48315552|NCT00552175|101097464|FG001|Full Analysis Set Population|Overall Study||85||
48315553|NCT00552175|101097465|FG002|Full Analysis Set Population|Overall Study||86||
48315554|NCT00552175|101097463|FG000|COMPLETED|Overall Study||150||
48315555|NCT00552175|101097464|FG001|COMPLETED|Overall Study||73||
48315556|NCT00552175|101097465|FG002|COMPLETED|Overall Study||72||
48315557|NCT00552175|101097463|FG000|NOT COMPLETED|Overall Study||17||
48315558|NCT00552175|101097464|FG001|NOT COMPLETED|Overall Study||13||
48315559|NCT00552175|101097465|FG002|NOT COMPLETED|Overall Study||14||
48315560|NCT01994382|101097466|FG000|STARTED|Overall Study||3||
48315561|NCT01994382|101097467|FG001|STARTED|Overall Study||6||
48732201|NCT01235234|102130062|FG001|NOT COMPLETED|Overall Study||2||
48732202|NCT01235234|102130063|FG002|NOT COMPLETED|Overall Study||1||
48732203|NCT01832532|102130064|FG000|STARTED|Overall Study||23||
48732204|NCT01832532|102130065|FG001|STARTED|Overall Study||11||
48158922|NCT00570674|100711163|FG001|NOT COMPLETED|Overall Study||0||
48315562|NCT01994382|101097468|FG002|STARTED|Overall Study||7||
48315563|NCT01994382|101097469|FG003|STARTED|Overall Study||3||
48315564|NCT01994382|101097470|FG004|STARTED|Overall Study||3||
48315565|NCT01994382|101097471|FG005|STARTED|Overall Study||3||
48315566|NCT01994382|101097472|FG006|STARTED|Overall Study||4||
48315567|NCT01994382|101097473|FG007|STARTED|Overall Study||6||
48315568|NCT01994382|101097474|FG008|STARTED|Overall Study||3||
48315569|NCT01994382|101097475|FG009|STARTED|Overall Study||5||
48158923|NCT00570674|100711164|FG002|NOT COMPLETED|Overall Study||1||
48158924|NCT00570674|100711165|FG003|NOT COMPLETED|Overall Study||0||
48158925|NCT00570674|100711166|FG004|NOT COMPLETED|Overall Study||0||
48158926|NCT00570674|100711167|FG005|NOT COMPLETED|Overall Study||0||
48158927|NCT00570674|100711168|FG006|NOT COMPLETED|Overall Study||0||
48158928|NCT00946296|100711169|FG000|STARTED|Overall Study||21||
48158929|NCT00946296|100711170|FG001|STARTED|Overall Study||15||
48158930|NCT00946296|100711169|FG000|COMPLETED|Overall Study||18||
48158931|NCT00946296|100711170|FG001|COMPLETED|Overall Study||15||
48158932|NCT00946296|100711169|FG000|NOT COMPLETED|Overall Study||3||
48158933|NCT00946296|100711170|FG001|NOT COMPLETED|Overall Study||0||
48158934|NCT02634788|100711171|FG000|STARTED|Overall Study||79||
48158935|NCT02634788|100711172|FG001|STARTED|Overall Study||81||
48158936|NCT02634788|100711173|FG002|STARTED|Overall Study||80||
48158937|NCT02634788|100711174|FG003|STARTED|Overall Study||82||
48158938|NCT02634788|100711171|FG000|COMPLETED|Overall Study||75||
48158939|NCT02634788|100711172|FG001|COMPLETED|Overall Study||71||
48158940|NCT02634788|100711173|FG002|COMPLETED|Overall Study||75||
48158941|NCT02634788|100711174|FG003|COMPLETED|Overall Study||77||
48158942|NCT02634788|100711171|FG000|NOT COMPLETED|Overall Study||4||
48158943|NCT02634788|100711172|FG001|NOT COMPLETED|Overall Study||10||
48158944|NCT02634788|100711173|FG002|NOT COMPLETED|Overall Study||5||
48158945|NCT02634788|100711174|FG003|NOT COMPLETED|Overall Study||5||
48158946|NCT02228395|100711175|FG000|STARTED|First Intervention Period||3||
48158947|NCT02228395|100711176|FG001|STARTED|First Intervention Period||3||
48158948|NCT02228395|100711177|FG002|STARTED|First Intervention Period||3||
48315570|NCT01994382|101097476|FG010|STARTED|Overall Study||42||
48315571|NCT01994382|101097477|FG011|STARTED|Overall Study||12||
48315572|NCT01994382|101097478|FG012|STARTED|Overall Study||26||
48315573|NCT01994382|101097479|FG013|STARTED|Overall Study||6||
48315574|NCT01994382|101097480|FG014|STARTED|Overall Study||28||
48315575|NCT01994382|101097481|FG015|STARTED|Overall Study||65||
48315576|NCT01994382|101097482|FG016|STARTED|Overall Study||41||
48315577|NCT01994382|101097466|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3|Safety Population|
48315578|NCT01994382|101097467|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6|Safety Population|
48158949|NCT02228395|100711175|FG000|COMPLETED|First Intervention Period||2||
48158950|NCT02228395|100711176|FG001|COMPLETED|First Intervention Period||2||
48158951|NCT02228395|100711177|FG002|COMPLETED|First Intervention Period||2||
48158952|NCT02228395|100711175|FG000|NOT COMPLETED|First Intervention Period||1||
48158953|NCT02228395|100711176|FG001|NOT COMPLETED|First Intervention Period||1||
48158954|NCT02228395|100711177|FG002|NOT COMPLETED|First Intervention Period||1||
48315579|NCT01994382|101097468|FG002|Received at Least 1 Dose of Study Drug|Overall Study||7|Safety Population|
48315580|NCT01994382|101097469|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3|Safety Population|
48315581|NCT01994382|101097470|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3|Safety Population|
48315582|NCT01994382|101097471|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3|Safety Population|
48315583|NCT01994382|101097472|FG006|Received at Least 1 Dose of Study Drug|Overall Study||4|Safety Population|
48315584|NCT01994382|101097473|FG007|Received at Least 1 Dose of Study Drug|Overall Study||6|Safety Population|
48315585|NCT01994382|101097474|FG008|Received at Least 1 Dose of Study Drug|Overall Study||3|Safety Population|
48315586|NCT01994382|101097475|FG009|Received at Least 1 Dose of Study Drug|Overall Study||5|Safety Population|
48315587|NCT01994382|101097476|FG010|Received at Least 1 Dose of Study Drug|Overall Study||42|Safety Population|
48732205|NCT01832532|102130064|FG000|COMPLETED|Overall Study||18||
48732206|NCT01832532|102130065|FG001|COMPLETED|Overall Study||9||
48732207|NCT01832532|102130064|FG000|NOT COMPLETED|Overall Study||5||
48732208|NCT01832532|102130065|FG001|NOT COMPLETED|Overall Study||2||
48315588|NCT01994382|101097477|FG011|Received at Least 1 Dose of Study Drug|Overall Study||12|Safety Population|
48315589|NCT01994382|101097478|FG012|Received at Least 1 Dose of Study Drug|Overall Study||26|Safety Population|
48315590|NCT01994382|101097479|FG013|Received at Least 1 Dose of Study Drug|Overall Study||6|Safety Population|
48315591|NCT01994382|101097480|FG014|Received at Least 1 Dose of Study Drug|Overall Study||28|Safety Population|
48315592|NCT01994382|101097481|FG015|Received at Least 1 Dose of Study Drug|Overall Study||65|Safety Population|
48732209|NCT00869518|102130066|FG000|STARTED|Overall Study||6||
48732210|NCT00869518|102130067|FG001|STARTED|Overall Study||6||
48732211|NCT00869518|102130066|FG000|COMPLETED|Overall Study||5||
48732212|NCT00869518|102130067|FG001|COMPLETED|Overall Study||5||
48732213|NCT00869518|102130066|FG000|NOT COMPLETED|Overall Study||1||
48732214|NCT00869518|102130067|FG001|NOT COMPLETED|Overall Study||1||
48732215|NCT00240500|102130068|FG000|STARTED|Overall Study||17||
48732216|NCT00240500|102130069|FG001|STARTED|Overall Study||20||
48732217|NCT00240500|102130070|FG002|STARTED|Overall Study||17||
48732218|NCT00240500|102130071|FG003|STARTED|Overall Study||23||
48732219|NCT00240500|102130072|FG004|STARTED|Overall Study||29||
48732220|NCT00240500|102130073|FG005|STARTED|Overall Study||3||
48732221|NCT00240500|102130068|FG000|COMPLETED|Overall Study||16||
48732222|NCT00240500|102130069|FG001|COMPLETED|Overall Study||17||
48732223|NCT00240500|102130070|FG002|COMPLETED|Overall Study||14||
48732224|NCT00240500|102130071|FG003|COMPLETED|Overall Study||19||
48732225|NCT00240500|102130072|FG004|COMPLETED|Overall Study||26||
48158955|NCT02228395|100711175|FG000|STARTED|Washout Period (at Least 10 Days)||3||
48158956|NCT02228395|100711176|FG001|STARTED|Washout Period (at Least 10 Days)||3||
48158957|NCT02228395|100711177|FG002|STARTED|Washout Period (at Least 10 Days)||3||
48158958|NCT02228395|100711175|FG000|COMPLETED|Washout Period (at Least 10 Days)||3||
48158959|NCT02228395|100711176|FG001|COMPLETED|Washout Period (at Least 10 Days)||3||
48315593|NCT01994382|101097482|FG016|Received at Least 1 Dose of Study Drug|Overall Study||41|Safety Population|
48158960|NCT02228395|100711177|FG002|COMPLETED|Washout Period (at Least 10 Days)||3||
48158961|NCT02228395|100711175|FG000|NOT COMPLETED|Washout Period (at Least 10 Days)||0||
48158962|NCT02228395|100711176|FG001|NOT COMPLETED|Washout Period (at Least 10 Days)||0||
48315594|NCT01994382|101097466|FG000|COMPLETED|Overall Study||0||
48315595|NCT01994382|101097467|FG001|COMPLETED|Overall Study||0||
48315596|NCT01994382|101097468|FG002|COMPLETED|Overall Study||0||
48315597|NCT01994382|101097469|FG003|COMPLETED|Overall Study||0||
48315598|NCT01994382|101097470|FG004|COMPLETED|Overall Study||0||
48315599|NCT01994382|101097471|FG005|COMPLETED|Overall Study||0||
48315600|NCT01994382|101097472|FG006|COMPLETED|Overall Study||0||
48315601|NCT01994382|101097473|FG007|COMPLETED|Overall Study||0||
48614740|NCT02360280|101841821|FG000|NOT COMPLETED|Overall Study||3||
48614741|NCT02360280|101841822|FG001|NOT COMPLETED|Overall Study||1||
48614742|NCT02726789|101841823|FG000|STARTED|Overall Study||5||
48614743|NCT02726789|101841823|FG000|COMPLETED|Overall Study||5||
48614744|NCT02726789|101841823|FG000|NOT COMPLETED|Overall Study||0||
48614745|NCT03939923|101841824|FG000|STARTED|Overall Study||42||
48614746|NCT03939923|101841825|FG001|STARTED|Overall Study||42||
48614747|NCT03939923|101841824|FG000|COMPLETED|Overall Study||36||
48614748|NCT03939923|101841825|FG001|COMPLETED|Overall Study||35||
48614749|NCT03939923|101841824|FG000|NOT COMPLETED|Overall Study||6||
48732226|NCT00240500|102130073|FG005|COMPLETED|Overall Study||2||
48732227|NCT00240500|102130068|FG000|NOT COMPLETED|Overall Study||1||
48732228|NCT00240500|102130069|FG001|NOT COMPLETED|Overall Study||3||
48732229|NCT00240500|102130070|FG002|NOT COMPLETED|Overall Study||3||
48732230|NCT00240500|102130071|FG003|NOT COMPLETED|Overall Study||4||
48732231|NCT00240500|102130072|FG004|NOT COMPLETED|Overall Study||3||
48732232|NCT00240500|102130073|FG005|NOT COMPLETED|Overall Study||1||
48732233|NCT03193736|102130074|FG000|STARTED|Overall Study||26||
48732234|NCT03193736|102130074|FG000|Received Implant|Overall Study||25||
48158963|NCT02228395|100711177|FG002|NOT COMPLETED|Washout Period (at Least 10 Days)||0||
48158964|NCT02228395|100711175|FG000|STARTED|Second Intervention Period||3||
48158965|NCT02228395|100711176|FG001|STARTED|Second Intervention Period||3||
48315602|NCT01994382|101097474|FG008|COMPLETED|Overall Study||0||
48315603|NCT01994382|101097475|FG009|COMPLETED|Overall Study||0||
48315604|NCT01994382|101097476|FG010|COMPLETED|Overall Study||0||
48614750|NCT03939923|101841825|FG001|NOT COMPLETED|Overall Study||7||
48614751|NCT02472886|101841826|FG000|STARTED|Overall Study||67||
48614752|NCT02472886|101841827|FG001|STARTED|Overall Study||59||
48732235|NCT03193736|102130074|FG000|COMPLETED|Overall Study||21||
48732236|NCT03193736|102130074|FG000|NOT COMPLETED|Overall Study||5||
48732237|NCT03078855|102130075|FG000|STARTED|Overall Study||139||
48732238|NCT03078855|102130076|FG001|STARTED|Overall Study||72||
48732239|NCT03078855|102130075|FG000|COMPLETED|Overall Study||53||
48732240|NCT03078855|102130076|FG001|COMPLETED|Overall Study||32||
48732241|NCT03078855|102130075|FG000|NOT COMPLETED|Overall Study||86||
48732242|NCT03078855|102130076|FG001|NOT COMPLETED|Overall Study||40||
48732243|NCT01192568|102130077|FG000|STARTED|Double Blind Pre-Amendment 3||16||
48732244|NCT01192568|102130078|FG001|STARTED|Double Blind Pre-Amendment 3||17||
48732245|NCT01192568|102130079|FG002|STARTED|Double Blind Pre-Amendment 3||0||
48732246|NCT01192568|102130080|FG003|STARTED|Double Blind Pre-Amendment 3||0||
48732247|NCT01192568|102130077|FG000|COMPLETED|Double Blind Pre-Amendment 3||16||
48315605|NCT01994382|101097477|FG011|COMPLETED|Overall Study||0||
48315606|NCT01994382|101097478|FG012|COMPLETED|Overall Study||0||
48315607|NCT01994382|101097479|FG013|COMPLETED|Overall Study||0||
48315608|NCT01994382|101097480|FG014|COMPLETED|Overall Study||0||
48315609|NCT01994382|101097481|FG015|COMPLETED|Overall Study||0||
48315610|NCT01994382|101097482|FG016|COMPLETED|Overall Study||0||
48315611|NCT01994382|101097466|FG000|NOT COMPLETED|Overall Study||3||
48315612|NCT01994382|101097467|FG001|NOT COMPLETED|Overall Study||6||
48732248|NCT01192568|102130078|FG001|COMPLETED|Double Blind Pre-Amendment 3||17||
48732249|NCT01192568|102130079|FG002|COMPLETED|Double Blind Pre-Amendment 3||0||
48732250|NCT01192568|102130080|FG003|COMPLETED|Double Blind Pre-Amendment 3||0||
48732251|NCT01192568|102130077|FG000|NOT COMPLETED|Double Blind Pre-Amendment 3||0||
48732252|NCT01192568|102130078|FG001|NOT COMPLETED|Double Blind Pre-Amendment 3||0||
48732253|NCT01192568|102130079|FG002|NOT COMPLETED|Double Blind Pre-Amendment 3||0||
48732254|NCT01192568|102130080|FG003|NOT COMPLETED|Double Blind Pre-Amendment 3||0||
48732255|NCT01192568|102130077|FG000|STARTED|Open Label Pre-Amendment 3||0||
48732256|NCT01192568|102130078|FG001|STARTED|Open Label Pre-Amendment 3||0||
48732257|NCT01192568|102130079|FG002|STARTED|Open Label Pre-Amendment 3||33||
48732258|NCT01192568|102130080|FG003|STARTED|Open Label Pre-Amendment 3||0||
48732259|NCT01192568|102130077|FG000|COMPLETED|Open Label Pre-Amendment 3||0||
48732260|NCT01192568|102130078|FG001|COMPLETED|Open Label Pre-Amendment 3||0||
48732261|NCT01192568|102130079|FG002|COMPLETED|Open Label Pre-Amendment 3||32||
48732262|NCT01192568|102130080|FG003|COMPLETED|Open Label Pre-Amendment 3||0||
48732263|NCT01192568|102130077|FG000|NOT COMPLETED|Open Label Pre-Amendment 3||0||
48732264|NCT01192568|102130078|FG001|NOT COMPLETED|Open Label Pre-Amendment 3||0||
48732265|NCT01192568|102130079|FG002|NOT COMPLETED|Open Label Pre-Amendment 3||1||
48732266|NCT01192568|102130080|FG003|NOT COMPLETED|Open Label Pre-Amendment 3||0||
48732267|NCT01192568|102130077|FG000|STARTED|Open Label Post-Amendment 3||0||
48732268|NCT01192568|102130078|FG001|STARTED|Open Label Post-Amendment 3||0||
48732269|NCT01192568|102130079|FG002|STARTED|Open Label Post-Amendment 3||0||
48732270|NCT01192568|102130080|FG003|STARTED|Open Label Post-Amendment 3||19||
48732271|NCT01192568|102130077|FG000|COMPLETED|Open Label Post-Amendment 3||0||
48732272|NCT01192568|102130078|FG001|COMPLETED|Open Label Post-Amendment 3||0||
48732273|NCT01192568|102130079|FG002|COMPLETED|Open Label Post-Amendment 3||0||
48732274|NCT01192568|102130080|FG003|COMPLETED|Open Label Post-Amendment 3||18||
48732275|NCT01192568|102130077|FG000|NOT COMPLETED|Open Label Post-Amendment 3||0||
48732276|NCT01192568|102130078|FG001|NOT COMPLETED|Open Label Post-Amendment 3||0||
48732277|NCT01192568|102130079|FG002|NOT COMPLETED|Open Label Post-Amendment 3||0||
48732278|NCT01192568|102130080|FG003|NOT COMPLETED|Open Label Post-Amendment 3||1||
48732279|NCT02464410|102130081|FG000|STARTED|Overall Study||147||
48732280|NCT02464410|102130082|FG001|STARTED|Overall Study||152||
48732281|NCT02464410|102130081|FG000|3-month Follow-up|Overall Study||137||
48732282|NCT02464410|102130082|FG001|3-month Follow-up|Overall Study||138||
48732283|NCT02464410|102130081|FG000|6-month Follow-up|Overall Study||132||
48732284|NCT02464410|102130082|FG001|6-month Follow-up|Overall Study||140||
48732285|NCT02464410|102130081|FG000|12-month Follow-up|Overall Study||125||
48732286|NCT02464410|102130082|FG001|12-month Follow-up|Overall Study||136||
48732287|NCT02464410|102130081|FG000|COMPLETED|Overall Study||125||
48732288|NCT02464410|102130082|FG001|COMPLETED|Overall Study||136||
48732289|NCT02464410|102130081|FG000|NOT COMPLETED|Overall Study||22||
48732290|NCT02464410|102130082|FG001|NOT COMPLETED|Overall Study||16||
48732291|NCT02873338|102130083|FG000|STARTED|Overall Study||26||
48732292|NCT02873338|102130084|FG001|STARTED|Overall Study||25||
48732293|NCT02873338|102130085|FG002|STARTED|Overall Study||24||
48732294|NCT02873338|102130083|FG000|COMPLETED|Overall Study||8||
48732295|NCT02873338|102130084|FG001|COMPLETED|Overall Study||4||
48732296|NCT02873338|102130085|FG002|COMPLETED|Overall Study||6||
48732297|NCT02873338|102130083|FG000|NOT COMPLETED|Overall Study||18||
48732298|NCT02873338|102130084|FG001|NOT COMPLETED|Overall Study||21||
48732299|NCT02873338|102130085|FG002|NOT COMPLETED|Overall Study||18||
48732300|NCT02429791|102130086|FG000|STARTED|Early Switch Phase (Up to Week 52)||252||
48732301|NCT02429791|102130087|FG001|STARTED|Early Switch Phase (Up to Week 52)||256||
48732302|NCT02429791|102130086|FG000|COMPLETED|Early Switch Phase (Up to Week 52)||239||
48732303|NCT02429791|102130087|FG001|COMPLETED|Early Switch Phase (Up to Week 52)||238||
48732304|NCT02429791|102130086|FG000|NOT COMPLETED|Early Switch Phase (Up to Week 52)||13||
48732305|NCT02429791|102130087|FG001|NOT COMPLETED|Early Switch Phase (Up to Week 52)||18||
48732306|NCT02429791|102130086|FG000|STARTED|Late Switch Phase (Week 52 to Week 148)||239||
48732307|NCT02429791|102130087|FG001|STARTED|Late Switch Phase (Week 52 to Week 148)||238||
48732308|NCT02429791|102130086|FG000|COMPLETED|Late Switch Phase (Week 52 to Week 148)||214||
48315613|NCT01994382|101097468|FG002|NOT COMPLETED|Overall Study||7||
48315614|NCT01994382|101097469|FG003|NOT COMPLETED|Overall Study||3||
48732309|NCT02429791|102130087|FG001|COMPLETED|Late Switch Phase (Week 52 to Week 148)||210||
48732310|NCT02429791|102130086|FG000|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||25||
48732311|NCT02429791|102130087|FG001|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||28||
48732312|NCT02429791|102130086|FG000|STARTED|Continuation Phase(Week 148 to Week 411)||186||
48732313|NCT02429791|102130087|FG001|STARTED|Continuation Phase(Week 148 to Week 411)||183||
48732314|NCT02429791|102130086|FG000|COMPLETED|Continuation Phase(Week 148 to Week 411)||179||
48732315|NCT02429791|102130087|FG001|COMPLETED|Continuation Phase(Week 148 to Week 411)||178||
48732316|NCT02429791|102130086|FG000|NOT COMPLETED|Continuation Phase(Week 148 to Week 411)||7||
48732317|NCT02429791|102130087|FG001|NOT COMPLETED|Continuation Phase(Week 148 to Week 411)||5||
48732318|NCT03041896|102130088|FG000|STARTED|Overall Study||1486||
48732319|NCT03041896|102130089|FG001|STARTED|Overall Study||1009||
48732320|NCT03041896|102130090|FG002|STARTED|Overall Study||2299||
48732321|NCT03041896|102130091|FG003|STARTED|Overall Study||256||
48732322|NCT03041896|102130088|FG000|COMPLETED|Overall Study||1486||
48732323|NCT03041896|102130089|FG001|COMPLETED|Overall Study||1009||
48732324|NCT03041896|102130090|FG002|COMPLETED|Overall Study||2236||
48732325|NCT03041896|102130091|FG003|COMPLETED|Overall Study||253||
48732326|NCT03041896|102130088|FG000|NOT COMPLETED|Overall Study||0||
48732327|NCT03041896|102130089|FG001|NOT COMPLETED|Overall Study||0||
48315615|NCT01994382|101097470|FG004|NOT COMPLETED|Overall Study||3||
48732328|NCT03041896|102130090|FG002|NOT COMPLETED|Overall Study||63||
48732329|NCT03041896|102130091|FG003|NOT COMPLETED|Overall Study||3||
48732330|NCT04725500|102130092|FG000|STARTED|Screening||42||
48732331|NCT04725500|102130092|FG000|COMPLETED|Screening||15||
48732332|NCT04725500|102130092|FG000|NOT COMPLETED|Screening||27||
48732333|NCT04725500|102130092|FG000|STARTED|Overnight Polysomnography (PSG)||15||
48732334|NCT04725500|102130092|FG000|COMPLETED|Overnight Polysomnography (PSG)||15||
48732335|NCT04725500|102130092|FG000|NOT COMPLETED|Overnight Polysomnography (PSG)||0||
48732336|NCT04725500|102130092|FG000|STARTED|2 Week Take Home||15||
48732337|NCT04725500|102130092|FG000|COMPLETED|2 Week Take Home||10||
48732338|NCT04725500|102130092|FG000|NOT COMPLETED|2 Week Take Home||5||
48732339|NCT00764673|102130093|FG000|STARTED|Overall Study||71||
48732340|NCT00764673|102130093|FG000|COMPLETED|Overall Study||59||
48732341|NCT00764673|102130093|FG000|NOT COMPLETED|Overall Study||12||
48732342|NCT00781859|102130094|FG000|STARTED|Overall Study||219||
48732343|NCT00781859|102130095|FG001|STARTED|Overall Study||107||
48732344|NCT00781859|102130094|FG000|COMPLETED|Overall Study||200||
48732345|NCT00781859|102130095|FG001|COMPLETED|Overall Study||98||
48732346|NCT00781859|102130094|FG000|NOT COMPLETED|Overall Study||19||
48732347|NCT00781859|102130095|FG001|NOT COMPLETED|Overall Study||9||
48732348|NCT04054375|102130096|FG000|STARTED|Overall Study||20||
48732349|NCT04054375|102130096|FG000|COMPLETED|Overall Study||20||
48732350|NCT04054375|102130096|FG000|NOT COMPLETED|Overall Study||0||
48732351|NCT00077649|102130097|FG000|STARTED|Overall Study||47||
48732352|NCT00077649|102130098|FG001|STARTED|Overall Study||47||
48732353|NCT00077649|102130099|FG002|STARTED|Overall Study||47||
48732354|NCT00077649|102130100|FG003|STARTED|Overall Study||47||
48732355|NCT00077649|102130097|FG000|Completed 24 Weeks of Follow-up|Overall Study||36||
48732356|NCT00077649|102130098|FG001|Completed 24 Weeks of Follow-up|Overall Study||40||
48732357|NCT00077649|102130099|FG002|Completed 24 Weeks of Follow-up|Overall Study||36||
48732358|NCT00077649|102130100|FG003|Completed 24 Weeks of Follow-up|Overall Study||31||
48732359|NCT00077649|102130097|FG000|COMPLETED|Overall Study||33||
48732360|NCT00077649|102130098|FG001|COMPLETED|Overall Study||38||
48732361|NCT00077649|102130099|FG002|COMPLETED|Overall Study||32||
48732362|NCT00077649|102130100|FG003|COMPLETED|Overall Study||30||
48732363|NCT00077649|102130097|FG000|NOT COMPLETED|Overall Study||14||
48732364|NCT00077649|102130098|FG001|NOT COMPLETED|Overall Study||9||
48732365|NCT00077649|102130099|FG002|NOT COMPLETED|Overall Study||15||
48732366|NCT00077649|102130100|FG003|NOT COMPLETED|Overall Study||17||
48732367|NCT01022424|102130101|FG000|STARTED|Overall Study||13||
48732368|NCT01022424|102130101|FG000|COMPLETED|Overall Study||9||
48732369|NCT01022424|102130101|FG000|NOT COMPLETED|Overall Study||4||
48732370|NCT04310566|102130102|FG000|STARTED|Period 1||31||
48732371|NCT04310566|102130103|FG001|STARTED|Period 1||34||
48732372|NCT04310566|102130102|FG000|COMPLETED|Period 1||15||
48315616|NCT01994382|101097471|FG005|NOT COMPLETED|Overall Study||3||
48315617|NCT01994382|101097472|FG006|NOT COMPLETED|Overall Study||4||
48315618|NCT01994382|101097473|FG007|NOT COMPLETED|Overall Study||6||
48315619|NCT01994382|101097474|FG008|NOT COMPLETED|Overall Study||3||
48315620|NCT01994382|101097475|FG009|NOT COMPLETED|Overall Study||5||
48315621|NCT01994382|101097476|FG010|NOT COMPLETED|Overall Study||42||
48315622|NCT01994382|101097477|FG011|NOT COMPLETED|Overall Study||12||
48315623|NCT01994382|101097478|FG012|NOT COMPLETED|Overall Study||26||
48315624|NCT01994382|101097479|FG013|NOT COMPLETED|Overall Study||6||
48732373|NCT04310566|102130103|FG001|COMPLETED|Period 1||14||
48732374|NCT04310566|102130102|FG000|NOT COMPLETED|Period 1||16||
48732375|NCT04310566|102130103|FG001|NOT COMPLETED|Period 1||20||
48732376|NCT04310566|102130102|FG000|STARTED|Period 2||15||
48732377|NCT04310566|102130103|FG001|STARTED|Period 2||14||
48732378|NCT04310566|102130102|FG000|COMPLETED|Period 2||8||
48732379|NCT04310566|102130103|FG001|COMPLETED|Period 2||9||
48732380|NCT04310566|102130102|FG000|NOT COMPLETED|Period 2||7||
48732381|NCT04310566|102130103|FG001|NOT COMPLETED|Period 2||5||
48315625|NCT01994382|101097480|FG014|NOT COMPLETED|Overall Study||28||
48315626|NCT01994382|101097481|FG015|NOT COMPLETED|Overall Study||65||
48732382|NCT01985425|102130104|FG000|STARTED|Overall Study||49||
48732383|NCT01985425|102130105|FG001|STARTED|Overall Study||51||
48732384|NCT01985425|102130104|FG000|COMPLETED|Overall Study||49||
48732385|NCT01985425|102130105|FG001|COMPLETED|Overall Study||51||
48732386|NCT01985425|102130104|FG000|NOT COMPLETED|Overall Study||0||
48732387|NCT01985425|102130105|FG001|NOT COMPLETED|Overall Study||0||
48315627|NCT01994382|101097482|FG016|NOT COMPLETED|Overall Study||41||
48315628|NCT02713542|101097483|FG000|STARTED|Overall Study||60||
48315629|NCT02713542|101097484|FG001|STARTED|Overall Study||30||
48315630|NCT02713542|101097483|FG000|COMPLETED|Overall Study||42||
48315631|NCT02713542|101097484|FG001|COMPLETED|Overall Study||24||
48315632|NCT02713542|101097483|FG000|NOT COMPLETED|Overall Study||18||
48315633|NCT02713542|101097484|FG001|NOT COMPLETED|Overall Study||6||
48315634|NCT00974675|101097485|FG000|STARTED|Overall Study||8||
48614753|NCT02472886|101841828|FG002|STARTED|Overall Study||27||
48614754|NCT02472886|101841826|FG000|COMPLETED|Overall Study||67||
48614755|NCT02472886|101841827|FG001|COMPLETED|Overall Study||57||
48614756|NCT02472886|101841828|FG002|COMPLETED|Overall Study||26||
48614757|NCT02472886|101841826|FG000|NOT COMPLETED|Overall Study||0||
48614758|NCT02472886|101841827|FG001|NOT COMPLETED|Overall Study||2||
48614759|NCT02472886|101841828|FG002|NOT COMPLETED|Overall Study||1||
48614760|NCT04001803|101841829|FG000|STARTED|Intervention Phase (Up to Month 12)||115||
48614761|NCT04001803|101841829|FG000|COMPLETED|Intervention Phase (Up to Month 12)||102||
48614762|NCT04001803|101841829|FG000|NOT COMPLETED|Intervention Phase (Up to Month 12)||13||
48732388|NCT00687674|102130106|FG000|STARTED|Overall Study||13||
48732389|NCT00687674|102130106|FG000|COMPLETED|Overall Study||11||
48732390|NCT00687674|102130106|FG000|NOT COMPLETED|Overall Study||2||
48614763|NCT04001803|101841829|FG000|STARTED|Extension Phase (From Months 13 to 30)||101||
48614764|NCT04001803|101841829|FG000|COMPLETED|Extension Phase (From Months 13 to 30)||95||
48614765|NCT04001803|101841829|FG000|NOT COMPLETED|Extension Phase (From Months 13 to 30)||6||
48614766|NCT04001803|101841829|FG000|STARTED|Long-term Follow-up Phase(Up to Week 52)||10||
48614767|NCT04001803|101841829|FG000|COMPLETED|Long-term Follow-up Phase(Up to Week 52)||7||
48614768|NCT04001803|101841829|FG000|NOT COMPLETED|Long-term Follow-up Phase(Up to Week 52)||3||
48614769|NCT02030119|101841830|FG000|STARTED|Overall Study||70||
48614770|NCT02030119|101841831|FG001|STARTED|Overall Study||70||
48614771|NCT02030119|101841832|FG002|STARTED|Overall Study||71||
48614772|NCT02030119|101841833|FG003|STARTED|Overall Study||70||
48732391|NCT03029091|102130107|FG000|STARTED|Overall Study||8||
48732392|NCT03029091|102130108|FG001|STARTED|Overall Study||7||
48732393|NCT03029091|102130107|FG000|COMPLETED|Overall Study||8||
48732394|NCT03029091|102130108|FG001|COMPLETED|Overall Study||7||
48732395|NCT03029091|102130107|FG000|NOT COMPLETED|Overall Study||0||
48732396|NCT03029091|102130108|FG001|NOT COMPLETED|Overall Study||0||
48732397|NCT00880191|102130109|FG000|STARTED|Overall Study||207||
48315635|NCT00974675|101097486|FG001|STARTED|Overall Study||8||
48315636|NCT00974675|101097487|FG002|STARTED|Overall Study||3||
48315637|NCT00974675|101097488|FG003|STARTED|Overall Study||4||
48315638|NCT00974675|101097485|FG000|COMPLETED|Overall Study||6||
48315639|NCT00974675|101097486|FG001|COMPLETED|Overall Study||7||
48315640|NCT00974675|101097487|FG002|COMPLETED|Overall Study||1||
48315641|NCT00974675|101097488|FG003|COMPLETED|Overall Study||2||
48315642|NCT00974675|101097485|FG000|NOT COMPLETED|Overall Study||2||
48315643|NCT00974675|101097486|FG001|NOT COMPLETED|Overall Study||1||
48614773|NCT02030119|101841830|FG000|COMPLETED|Overall Study||67||
48614774|NCT02030119|101841831|FG001|COMPLETED|Overall Study||68||
48614775|NCT02030119|101841832|FG002|COMPLETED|Overall Study||65||
48614776|NCT02030119|101841833|FG003|COMPLETED|Overall Study||67||
48614777|NCT02030119|101841830|FG000|NOT COMPLETED|Overall Study||3||
48732398|NCT00880191|102130110|FG001|STARTED|Overall Study||206||
48732399|NCT00880191|102130109|FG000|Available for Primary Endpoint Analysis|Overall Study||207||
48732400|NCT00880191|102130110|FG001|Available for Primary Endpoint Analysis|Overall Study||206||
48732401|NCT00880191|102130109|FG000|COMPLETED|Overall Study||194||
48732402|NCT00880191|102130110|FG001|COMPLETED|Overall Study||198||
48732403|NCT00880191|102130109|FG000|NOT COMPLETED|Overall Study||13||
48732404|NCT00880191|102130110|FG001|NOT COMPLETED|Overall Study||8||
48732405|NCT04551950|102130111|FG000|STARTED|Overall Study||8||
48732406|NCT04551950|102130112|FG001|STARTED|Overall Study||9||
48732407|NCT04551950|102130113|FG002|STARTED|Overall Study||8||
48158966|NCT02228395|100711177|FG002|STARTED|Second Intervention Period||3||
48158967|NCT02228395|100711175|FG000|COMPLETED|Second Intervention Period||3||
48158968|NCT02228395|100711176|FG001|COMPLETED|Second Intervention Period||3||
48158969|NCT02228395|100711177|FG002|COMPLETED|Second Intervention Period||3||
48158970|NCT02228395|100711175|FG000|NOT COMPLETED|Second Intervention Period||0||
48315644|NCT00974675|101097487|FG002|NOT COMPLETED|Overall Study||2||
48315645|NCT00974675|101097488|FG003|NOT COMPLETED|Overall Study||2||
48315646|NCT00619970|101097489|FG000|STARTED|Overall Study||40||
48315647|NCT00619970|101097490|FG001|STARTED|Overall Study||49||
48614778|NCT02030119|101841831|FG001|NOT COMPLETED|Overall Study||2||
48732408|NCT04551950|102130111|FG000|Treated|Overall Study||8||
48732409|NCT04551950|102130112|FG001|Treated|Overall Study||9||
48315648|NCT00619970|101097491|FG002|STARTED|Overall Study||26||
48732410|NCT04551950|102130113|FG002|Treated|Overall Study||8||
48732411|NCT04551950|102130111|FG000|COMPLETED|Overall Study||8||
48315649|NCT00619970|101097489|FG000|COMPLETED|Overall Study||40||
48614779|NCT02030119|101841832|FG002|NOT COMPLETED|Overall Study||6||
48614780|NCT02030119|101841833|FG003|NOT COMPLETED|Overall Study||3||
48614781|NCT02465164|101841834|FG000|STARTED|Overall Study||16||
48614782|NCT02465164|101841835|FG001|STARTED|Overall Study||10||
48732412|NCT04551950|102130112|FG001|COMPLETED|Overall Study||9||
48732413|NCT04551950|102130113|FG002|COMPLETED|Overall Study||8||
48732414|NCT04551950|102130111|FG000|NOT COMPLETED|Overall Study||0||
48732415|NCT04551950|102130112|FG001|NOT COMPLETED|Overall Study||0||
48732416|NCT04551950|102130113|FG002|NOT COMPLETED|Overall Study||0||
48732417|NCT01564732|102130114|FG000|STARTED|Overall Study||6||
48732418|NCT01564732|102130115|FG001|STARTED|Overall Study||5||
48158971|NCT02228395|100711176|FG001|NOT COMPLETED|Second Intervention Period||0||
48158972|NCT02228395|100711177|FG002|NOT COMPLETED|Second Intervention Period||0||
48315650|NCT00619970|101097490|FG001|COMPLETED|Overall Study||46||
48315651|NCT00619970|101097491|FG002|COMPLETED|Overall Study||24||
48315652|NCT00619970|101097489|FG000|NOT COMPLETED|Overall Study||0||
48315653|NCT00619970|101097490|FG001|NOT COMPLETED|Overall Study||3||
48315654|NCT00619970|101097491|FG002|NOT COMPLETED|Overall Study||2||
48315655|NCT01242267|101097492|FG000|STARTED|Overall Study||3||
48315656|NCT01242267|101097493|FG001|STARTED|Overall Study||3||
48315657|NCT01242267|101097494|FG002|STARTED|Overall Study||3||
48315658|NCT01242267|101097495|FG003|STARTED|Overall Study||20||
48315659|NCT01242267|101097492|FG000|COMPLETED|Overall Study||3||
48614783|NCT02465164|101841834|FG000|COMPLETED|Overall Study||16||
48614784|NCT02465164|101841835|FG001|COMPLETED|Overall Study||10||
48614785|NCT02465164|101841834|FG000|NOT COMPLETED|Overall Study||0||
48614786|NCT02465164|101841835|FG001|NOT COMPLETED|Overall Study||0||
48614787|NCT03283930|101841836|FG000|STARTED|Overall Study||59||
48614788|NCT03283930|101841837|FG001|STARTED|Overall Study||62||
48614789|NCT03283930|101841836|FG000|COMPLETED|Overall Study||48||
48614790|NCT03283930|101841837|FG001|COMPLETED|Overall Study||49||
48614791|NCT03283930|101841836|FG000|NOT COMPLETED|Overall Study||11||
48614792|NCT03283930|101841837|FG001|NOT COMPLETED|Overall Study||13||
48614793|NCT01381926|101841838|FG000|STARTED|Low/High Dose of 1st Treatment (2months)||5|The number of participants started is for each segment. Crossover study. Total is not applicable.|
48614794|NCT01381926|101841839|FG001|STARTED|Low/High Dose of 1st Treatment (2months)||5|The number of participants started is for each segment. Crossover study. Total is not applicable.|
48614795|NCT01381926|101841838|FG000|COMPLETED|Low/High Dose of 1st Treatment (2months)||3||
48614796|NCT01381926|101841839|FG001|COMPLETED|Low/High Dose of 1st Treatment (2months)||4||
48614797|NCT01381926|101841838|FG000|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||2||
48614798|NCT01381926|101841839|FG001|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||1||
48614799|NCT01381926|101841838|FG000|STARTED|Low/High Dose of 2nd Treatment (2months)||3||
48614800|NCT01381926|101841839|FG001|STARTED|Low/High Dose of 2nd Treatment (2months)||4||
48614801|NCT01381926|101841838|FG000|COMPLETED|Low/High Dose of 2nd Treatment (2months)||3||
48614802|NCT01381926|101841839|FG001|COMPLETED|Low/High Dose of 2nd Treatment (2months)||4||
48614803|NCT01381926|101841838|FG000|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0||
48614804|NCT01381926|101841839|FG001|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0||
48614805|NCT00570960|101841840|FG000|STARTED|Overall Study||4||
48614806|NCT00570960|101841841|FG001|STARTED|Overall Study||4||
48614807|NCT00570960|101841840|FG000|COMPLETED|Overall Study||4||
48614808|NCT00570960|101841841|FG001|COMPLETED|Overall Study||4||
48614809|NCT00570960|101841840|FG000|NOT COMPLETED|Overall Study||0||
48614810|NCT00570960|101841841|FG001|NOT COMPLETED|Overall Study||0||
48614811|NCT04826484|101841842|FG000|STARTED|Overall Study||52||
48614812|NCT04826484|101841843|FG001|STARTED|Overall Study||52||
48614813|NCT04826484|101841842|FG000|COMPLETED|Overall Study||50||
48732419|NCT01564732|102130114|FG000|COMPLETED|Overall Study||0||
48732420|NCT01564732|102130115|FG001|COMPLETED|Overall Study||0||
48732421|NCT01564732|102130114|FG000|NOT COMPLETED|Overall Study||6||
48732422|NCT01564732|102130115|FG001|NOT COMPLETED|Overall Study||5||
48732423|NCT00418574|102130116|FG000|STARTED|Overall Study||593||
48732424|NCT00418574|102130117|FG001|STARTED|Overall Study||295||
48732425|NCT00418574|102130116|FG000|TREATED|Overall Study||592||
48732426|NCT00418574|102130117|FG001|TREATED|Overall Study||294||
48732427|NCT00418574|102130116|FG000|COMPLETED|Overall Study||545||
48732428|NCT00418574|102130117|FG001|COMPLETED|Overall Study||272||
48158973|NCT02228395|100711175|FG000|STARTED|Washout Period (at Least 10 Days)||3||
48158974|NCT02228395|100711176|FG001|STARTED|Washout Period (at Least 10 Days)||3||
48158975|NCT02228395|100711177|FG002|STARTED|Washout Period (at Least 10 Days)||3||
48158976|NCT02228395|100711175|FG000|COMPLETED|Washout Period (at Least 10 Days)||3||
48315660|NCT01242267|101097493|FG001|COMPLETED|Overall Study||3||
48315661|NCT01242267|101097494|FG002|COMPLETED|Overall Study||3||
48315662|NCT01242267|101097495|FG003|COMPLETED|Overall Study||20||
48614814|NCT04826484|101841843|FG001|COMPLETED|Overall Study||52||
48614815|NCT04826484|101841842|FG000|NOT COMPLETED|Overall Study||2||
48732429|NCT00418574|102130116|FG000|NOT COMPLETED|Overall Study||48||
48732430|NCT00418574|102130117|FG001|NOT COMPLETED|Overall Study||23||
48732431|NCT02110264|102130118|FG000|STARTED|Overall Study||53||
48315663|NCT01242267|101097492|FG000|NOT COMPLETED|Overall Study||0||
48315664|NCT01242267|101097493|FG001|NOT COMPLETED|Overall Study||0||
48732432|NCT02110264|102130119|FG001|STARTED|Overall Study||50||
48732433|NCT02110264|102130120|FG002|STARTED|Overall Study||48||
48732434|NCT02110264|102130118|FG000|COMPLETED|Overall Study||35||
48732435|NCT02110264|102130119|FG001|COMPLETED|Overall Study||38||
48732436|NCT02110264|102130120|FG002|COMPLETED|Overall Study||39||
48732437|NCT02110264|102130118|FG000|NOT COMPLETED|Overall Study||18||
48732438|NCT02110264|102130119|FG001|NOT COMPLETED|Overall Study||12||
48732439|NCT02110264|102130120|FG002|NOT COMPLETED|Overall Study||9||
48732440|NCT03405818|102130121|FG000|STARTED|Overall Study||55||
48732441|NCT03405818|102130121|FG000|COMPLETED|Overall Study||47||
48732442|NCT03405818|102130121|FG000|NOT COMPLETED|Overall Study||8||
48732443|NCT00483938|102130122|FG000|STARTED|Overall Study||41||
48732444|NCT00483938|102130123|FG001|STARTED|Overall Study||43||
48732445|NCT00483938|102130124|FG002|STARTED|Overall Study||30||
48732446|NCT00483938|102130125|FG003|STARTED|Overall Study||31||
48732447|NCT00483938|102130126|FG004|STARTED|Overall Study||25||
48732448|NCT00483938|102130127|FG005|STARTED|Overall Study||26||
48732449|NCT00483938|102130128|FG006|STARTED|Overall Study||40||
48732450|NCT00483938|102130122|FG000|COMPLETED|Overall Study||36||
48732451|NCT00483938|102130123|FG001|COMPLETED|Overall Study||24||
48732452|NCT00483938|102130124|FG002|COMPLETED|Overall Study||30||
48732453|NCT00483938|102130125|FG003|COMPLETED|Overall Study||25||
48732454|NCT00483938|102130126|FG004|COMPLETED|Overall Study||23||
48732455|NCT00483938|102130127|FG005|COMPLETED|Overall Study||18||
48732456|NCT00483938|102130128|FG006|COMPLETED|Overall Study||0||
48732457|NCT00483938|102130122|FG000|NOT COMPLETED|Overall Study||5||
48732458|NCT00483938|102130123|FG001|NOT COMPLETED|Overall Study||19||
48732459|NCT00483938|102130124|FG002|NOT COMPLETED|Overall Study||0||
48732460|NCT00483938|102130125|FG003|NOT COMPLETED|Overall Study||6||
48315665|NCT01242267|101097494|FG002|NOT COMPLETED|Overall Study||0||
48315666|NCT01242267|101097495|FG003|NOT COMPLETED|Overall Study||0||
48315667|NCT02285998|101097496|FG000|STARTED|Overall Study||4474||
48315668|NCT02285998|101097497|FG001|STARTED|Overall Study||4489||
48315669|NCT02285998|101097496|FG000|COMPLETED|Overall Study||4228||
48315670|NCT02285998|101097497|FG001|COMPLETED|Overall Study||4236||
48315671|NCT02285998|101097496|FG000|NOT COMPLETED|Overall Study||246||
48315672|NCT02285998|101097497|FG001|NOT COMPLETED|Overall Study||253||
48732461|NCT00483938|102130126|FG004|NOT COMPLETED|Overall Study||2||
48732462|NCT00483938|102130127|FG005|NOT COMPLETED|Overall Study||8||
48732463|NCT00483938|102130128|FG006|NOT COMPLETED|Overall Study||40||
48732464|NCT00588354|102130129|FG000|STARTED|Baseline to 2 Weeks||11||
48732465|NCT00588354|102130130|FG001|STARTED|Baseline to 2 Weeks||15||
48732466|NCT00588354|102130129|FG000|COMPLETED|Baseline to 2 Weeks||9||
48732467|NCT00588354|102130130|FG001|COMPLETED|Baseline to 2 Weeks||15||
48732468|NCT00588354|102130129|FG000|NOT COMPLETED|Baseline to 2 Weeks||2||
48732469|NCT00588354|102130130|FG001|NOT COMPLETED|Baseline to 2 Weeks||0||
48732470|NCT00588354|102130129|FG000|STARTED|Baseline to 4 Weeks||9||
48732471|NCT00588354|102130130|FG001|STARTED|Baseline to 4 Weeks||15||
48732472|NCT00588354|102130129|FG000|COMPLETED|Baseline to 4 Weeks||9||
48732473|NCT00588354|102130130|FG001|COMPLETED|Baseline to 4 Weeks||14||
48732474|NCT00588354|102130129|FG000|NOT COMPLETED|Baseline to 4 Weeks||0||
48732475|NCT00588354|102130130|FG001|NOT COMPLETED|Baseline to 4 Weeks||1||
48732476|NCT00989963|102130131|FG000|STARTED|Overall Study||12|Full Analysis Population: All randomized participants (per intended treatment assignment).|
48732477|NCT00989963|102130132|FG001|STARTED|Overall Study||12|Full Analysis Population: All randomized participants (per intended treatment assignment).|
48732478|NCT00989963|102130133|FG002|STARTED|Overall Study||12|Full Analysis Population: All randomized participants (per intended treatment assignment).|
48315673|NCT00589420|101097498|FG000|STARTED|Overall Study||18||
48315674|NCT00589420|101097498|FG000|COMPLETED|Overall Study||17||
48315675|NCT00589420|101097498|FG000|NOT COMPLETED|Overall Study||1||
48315676|NCT01328951|101097499|FG000|STARTED|Overall Study||321||
48315677|NCT01328951|101097500|FG001|STARTED|Overall Study||322||
48315678|NCT01328951|101097499|FG000|COMPLETED|Overall Study||0||
48315679|NCT01328951|101097500|FG001|COMPLETED|Overall Study||0||
48315680|NCT01328951|101097499|FG000|NOT COMPLETED|Overall Study||321||
48315681|NCT01328951|101097500|FG001|NOT COMPLETED|Overall Study||322||
48315682|NCT02865018|101097501|FG000|STARTED|Overall Study||16||
48315683|NCT02865018|101097501|FG000|COMPLETED|Overall Study||15||
48315684|NCT02865018|101097501|FG000|NOT COMPLETED|Overall Study||1||
48315685|NCT01846728|101097502|FG000|STARTED|Overall Study||6||
48315686|NCT01846728|101097502|FG000|COMPLETED|Overall Study||6||
48315687|NCT01846728|101097502|FG000|NOT COMPLETED|Overall Study||0||
48315688|NCT01877187|101097503|FG000|STARTED|Overall Study||39||
48315689|NCT01877187|101097503|FG000|Completed 30 Day f/u|Overall Study||35||
48315690|NCT01877187|101097503|FG000|Completed 90 Day f/u|Overall Study||20||
48732479|NCT00989963|102130131|FG000|Safety Population|Overall Study||13|Randomized participants (per actual treatment received) who received ≥1 dose of study drug.|
48732480|NCT00989963|102130132|FG001|Safety Population|Overall Study||12|Randomized participants (per actual treatment received) who received ≥1 dose of study drug.|
48732481|NCT00989963|102130133|FG002|Safety Population|Overall Study||11|Randomized participants (per actual treatment received) who received ≥1 dose of study drug.|
48732482|NCT00989963|102130131|FG000|Per-Protocol Population|Overall Study||12|Randomized participants (actual treatment received), completed study, no major protocol deviations.|
48315691|NCT01877187|101097503|FG000|COMPLETED|Overall Study||17|Completed 180 day f/u|
48315692|NCT01877187|101097503|FG000|NOT COMPLETED|Overall Study||22||
48315693|NCT00867789|101097504|FG000|STARTED|Overall Study||70||
48315694|NCT00867789|101097505|FG001|STARTED|Overall Study||70||
48315695|NCT00867789|101097504|FG000|COMPLETED|Overall Study||68||
48315696|NCT00867789|101097505|FG001|COMPLETED|Overall Study||70||
48315697|NCT00867789|101097504|FG000|NOT COMPLETED|Overall Study||2||
48315698|NCT00867789|101097505|FG001|NOT COMPLETED|Overall Study||0||
48732483|NCT00989963|102130132|FG001|Per-Protocol Population|Overall Study||11|Randomized participants (actual treatment received), completed study, no major protocol deviations.|
48732484|NCT00989963|102130133|FG002|Per-Protocol Population|Overall Study||10|Randomized participants (actual treatment received), completed study, no major protocol deviations.|
48732485|NCT00989963|102130131|FG000|COMPLETED|Overall Study||11||
48732486|NCT00989963|102130132|FG001|COMPLETED|Overall Study||11||
48732487|NCT00989963|102130133|FG002|COMPLETED|Overall Study||11||
48732488|NCT00989963|102130131|FG000|NOT COMPLETED|Overall Study||1||
48732489|NCT00989963|102130132|FG001|NOT COMPLETED|Overall Study||1||
48732490|NCT00989963|102130133|FG002|NOT COMPLETED|Overall Study||1||
48732491|NCT01023672|102130134|FG000|STARTED|Overall Study||20||
48732492|NCT01023672|102130134|FG000|COMPLETED|Overall Study||17||
48732493|NCT01023672|102130134|FG000|NOT COMPLETED|Overall Study||3||
48732494|NCT02008773|102130135|FG000|STARTED|Overall Study||40||
48732495|NCT02008773|102130136|FG001|STARTED|Overall Study||34||
48732496|NCT02008773|102130137|FG002|STARTED|Overall Study||46||
48732497|NCT02008773|102130138|FG003|STARTED|Overall Study||50||
48732498|NCT02008773|102130135|FG000|COMPLETED|Overall Study||27||
48732499|NCT02008773|102130136|FG001|COMPLETED|Overall Study||25||
48732500|NCT02008773|102130137|FG002|COMPLETED|Overall Study||32||
48732501|NCT02008773|102130138|FG003|COMPLETED|Overall Study||38||
48732502|NCT02008773|102130135|FG000|NOT COMPLETED|Overall Study||13||
48732503|NCT02008773|102130136|FG001|NOT COMPLETED|Overall Study||9||
48732504|NCT02008773|102130137|FG002|NOT COMPLETED|Overall Study||14||
48732505|NCT02008773|102130138|FG003|NOT COMPLETED|Overall Study||12||
48732506|NCT01371734|102130139|FG000|STARTED|Overall Study||120||
48315699|NCT03598647|101097506|FG000|STARTED|Exercisers vs. Non-exercisers||30||
48315700|NCT03598647|101097507|FG001|STARTED|Exercisers vs. Non-exercisers||30||
48315701|NCT03598647|101097508|FG002|STARTED|Exercisers vs. Non-exercisers||0||
48315702|NCT03598647|101097509|FG003|STARTED|Exercisers vs. Non-exercisers||0||
48315703|NCT03598647|101097506|FG000|COMPLETED|Exercisers vs. Non-exercisers||29||
48406913|NCT03424044|101328486|FG002|COMPLETED|Third Intervention (76 Hours)||2||
48732507|NCT01371734|102130140|FG001|STARTED|Overall Study||122||
48732508|NCT01371734|102130141|FG002|STARTED|Overall Study||121||
48732509|NCT01371734|102130139|FG000|COMPLETED|Overall Study||97||
48732510|NCT01371734|102130140|FG001|COMPLETED|Overall Study||103||
48732511|NCT01371734|102130141|FG002|COMPLETED|Overall Study||104||
48732512|NCT01371734|102130139|FG000|NOT COMPLETED|Overall Study||23||
48732513|NCT01371734|102130140|FG001|NOT COMPLETED|Overall Study||19||
48732514|NCT01371734|102130141|FG002|NOT COMPLETED|Overall Study||17||
48732515|NCT00801398|102130142|FG000|STARTED|Overall Study||13||
48732516|NCT00801398|102130143|FG001|STARTED|Overall Study||9||
48732517|NCT00801398|102130144|FG002|STARTED|Overall Study||11||
48732518|NCT00801398|102130145|FG003|STARTED|Overall Study||9||
48732519|NCT00801398|102130146|FG004|STARTED|Overall Study||8||
48732520|NCT00801398|102130147|FG005|STARTED|Overall Study||8||
48732521|NCT00801398|102130142|FG000|COMPLETED|Overall Study||7||
48732522|NCT00801398|102130143|FG001|COMPLETED|Overall Study||0||
48732523|NCT00801398|102130144|FG002|COMPLETED|Overall Study||4||
48732524|NCT00801398|102130145|FG003|COMPLETED|Overall Study||3||
48406914|NCT03424044|101328487|FG003|COMPLETED|Third Intervention (76 Hours)||2||
48406915|NCT03424044|101328488|FG004|COMPLETED|Third Intervention (76 Hours)||2||
48406916|NCT03424044|101328489|FG005|COMPLETED|Third Intervention (76 Hours)||4||
48406917|NCT03424044|101328490|FG006|COMPLETED|Third Intervention (76 Hours)||0||
48406918|NCT03424044|101328491|FG007|COMPLETED|Third Intervention (76 Hours)||1||
48406919|NCT03424044|101328492|FG008|COMPLETED|Third Intervention (76 Hours)||1||
48406920|NCT03424044|101328484|FG000|NOT COMPLETED|Third Intervention (76 Hours)||1||
48406921|NCT03424044|101328485|FG001|NOT COMPLETED|Third Intervention (76 Hours)||0||
48406922|NCT03424044|101328486|FG002|NOT COMPLETED|Third Intervention (76 Hours)||0||
48406923|NCT03424044|101328487|FG003|NOT COMPLETED|Third Intervention (76 Hours)||1||
48406924|NCT03424044|101328488|FG004|NOT COMPLETED|Third Intervention (76 Hours)||0||
48732525|NCT00801398|102130146|FG004|COMPLETED|Overall Study||1||
48732526|NCT00801398|102130147|FG005|COMPLETED|Overall Study||5||
48732527|NCT00801398|102130142|FG000|NOT COMPLETED|Overall Study||6||
48732528|NCT00801398|102130143|FG001|NOT COMPLETED|Overall Study||9||
48732529|NCT00801398|102130144|FG002|NOT COMPLETED|Overall Study||7||
48732530|NCT00801398|102130145|FG003|NOT COMPLETED|Overall Study||6||
48732531|NCT00801398|102130146|FG004|NOT COMPLETED|Overall Study||7||
48315704|NCT03598647|101097507|FG001|COMPLETED|Exercisers vs. Non-exercisers||30||
48315705|NCT03598647|101097508|FG002|COMPLETED|Exercisers vs. Non-exercisers||0||
48315706|NCT03598647|101097509|FG003|COMPLETED|Exercisers vs. Non-exercisers||0||
48315707|NCT03598647|101097506|FG000|NOT COMPLETED|Exercisers vs. Non-exercisers||1||
48315708|NCT03598647|101097507|FG001|NOT COMPLETED|Exercisers vs. Non-exercisers||0||
48732532|NCT00801398|102130147|FG005|NOT COMPLETED|Overall Study||3||
48732533|NCT00429169|102130148|FG000|STARTED|Overall Study||38||
48732534|NCT00429169|102130149|FG001|STARTED|Overall Study||40||
48732535|NCT00429169|102130148|FG000|COMPLETED|Overall Study||36||
48732536|NCT00429169|102130149|FG001|COMPLETED|Overall Study||38||
48732537|NCT00429169|102130148|FG000|NOT COMPLETED|Overall Study||2||
48732538|NCT00429169|102130149|FG001|NOT COMPLETED|Overall Study||2||
48315709|NCT03598647|101097508|FG002|NOT COMPLETED|Exercisers vs. Non-exercisers||0||
48315710|NCT03598647|101097509|FG003|NOT COMPLETED|Exercisers vs. Non-exercisers||0||
48315711|NCT03598647|101097506|FG000|STARTED|Interventions for Non-exercisers||0||
48315712|NCT03598647|101097507|FG001|STARTED|Interventions for Non-exercisers||0||
48315713|NCT03598647|101097508|FG002|STARTED|Interventions for Non-exercisers||14||
48315714|NCT03598647|101097509|FG003|STARTED|Interventions for Non-exercisers||16||
48732539|NCT02522325|102130150|FG000|STARTED|Overall Study||15||
48732540|NCT02522325|102130151|FG001|STARTED|Overall Study||15||
48732541|NCT02522325|102130150|FG000|COMPLETED|Overall Study||15||
48732542|NCT02522325|102130151|FG001|COMPLETED|Overall Study||14||
48732543|NCT02522325|102130150|FG000|NOT COMPLETED|Overall Study||0||
48732544|NCT02522325|102130151|FG001|NOT COMPLETED|Overall Study||1||
48732545|NCT01867086|102130152|FG000|STARTED|Overall Study||1||
48732546|NCT01867086|102130152|FG000|COMPLETED|Overall Study||0||
48732547|NCT01867086|102130152|FG000|NOT COMPLETED|Overall Study||1||
48732548|NCT03691662|102130153|FG000|STARTED|Overall Study||208||
48732549|NCT03691662|102130154|FG001|STARTED|Overall Study||209||
48732550|NCT03691662|102130153|FG000|Safety and Full Analysis Set (FAS) Participants|Overall Study||204||
48158977|NCT02228395|100711176|FG001|COMPLETED|Washout Period (at Least 10 Days)||3||
48315715|NCT03598647|101097506|FG000|COMPLETED|Interventions for Non-exercisers||0||
48732551|NCT03691662|102130154|FG001|Safety and Full Analysis Set (FAS) Participants|Overall Study||205||
48732552|NCT03691662|102130153|FG000|COMPLETED|Overall Study||187||
48732553|NCT03691662|102130154|FG001|COMPLETED|Overall Study||196||
48732554|NCT03691662|102130153|FG000|NOT COMPLETED|Overall Study||21||
48732555|NCT03691662|102130154|FG001|NOT COMPLETED|Overall Study||13||
48732556|NCT00707954|102130155|FG000|STARTED|Overall Study||12||
48732557|NCT00707954|102130156|FG001|STARTED|Overall Study||12||
48732558|NCT00707954|102130157|FG002|STARTED|Overall Study||14||
48732559|NCT00707954|102130158|FG003|STARTED|Overall Study||13||
48732560|NCT00707954|102130159|FG004|STARTED|Overall Study||10||
48732561|NCT00707954|102130155|FG000|COMPLETED|Overall Study||12||
48732562|NCT00707954|102130156|FG001|COMPLETED|Overall Study||12||
48732563|NCT00707954|102130157|FG002|COMPLETED|Overall Study||14||
48732564|NCT00707954|102130158|FG003|COMPLETED|Overall Study||13||
48732565|NCT00707954|102130159|FG004|COMPLETED|Overall Study||9||
48732566|NCT00707954|102130155|FG000|NOT COMPLETED|Overall Study||0||
48732567|NCT00707954|102130156|FG001|NOT COMPLETED|Overall Study||0||
48732568|NCT00707954|102130157|FG002|NOT COMPLETED|Overall Study||0||
48732569|NCT00707954|102130158|FG003|NOT COMPLETED|Overall Study||0||
48732570|NCT00707954|102130159|FG004|NOT COMPLETED|Overall Study||1||
48732571|NCT01895959|102130160|FG000|STARTED|Overall Study||12||
48732572|NCT01895959|102130160|FG000|COMPLETED|Overall Study||10||
48732573|NCT01895959|102130160|FG000|NOT COMPLETED|Overall Study||2||
48732574|NCT04802187|102130161|FG000|STARTED|Overall Study||0||6
48732575|NCT04802187|102130161|FG000|COMPLETED|Overall Study||0||6
48732576|NCT04802187|102130161|FG000|NOT COMPLETED|Overall Study||0||0
48732577|NCT00495625|102130162|FG000|STARTED|Overall Study||33||
48732578|NCT00495625|102130162|FG000|COMPLETED|Overall Study||23||
48732579|NCT00495625|102130162|FG000|NOT COMPLETED|Overall Study||10||
48732580|NCT01755455|102130163|FG000|STARTED|First Intervention (6 Weeks)||11||
48732581|NCT01755455|102130164|FG001|STARTED|First Intervention (6 Weeks)||11||
48732582|NCT01755455|102130163|FG000|COMPLETED|First Intervention (6 Weeks)||11||
48732583|NCT01755455|102130164|FG001|COMPLETED|First Intervention (6 Weeks)||11||
48732584|NCT01755455|102130163|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0||
48732585|NCT01755455|102130164|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0||
48315716|NCT03598647|101097507|FG001|COMPLETED|Interventions for Non-exercisers||0||
48315717|NCT03598647|101097508|FG002|COMPLETED|Interventions for Non-exercisers||14||
48732586|NCT01755455|102130163|FG000|STARTED|Washout (4 Weeks)||11||
48732587|NCT01755455|102130164|FG001|STARTED|Washout (4 Weeks)||11||
48732588|NCT01755455|102130163|FG000|COMPLETED|Washout (4 Weeks)||11||
48732589|NCT01755455|102130164|FG001|COMPLETED|Washout (4 Weeks)||11||
48732590|NCT01755455|102130163|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
48732591|NCT01755455|102130164|FG001|NOT COMPLETED|Washout (4 Weeks)||0||
48732592|NCT01755455|102130163|FG000|STARTED|Second Intervention (6 Weeks)||11||
48732593|NCT01755455|102130164|FG001|STARTED|Second Intervention (6 Weeks)||11||
48732594|NCT01755455|102130163|FG000|COMPLETED|Second Intervention (6 Weeks)||11||
48732595|NCT01755455|102130164|FG001|COMPLETED|Second Intervention (6 Weeks)||11||
48732596|NCT01755455|102130163|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0||
48732597|NCT01755455|102130164|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0||
48158978|NCT02228395|100711177|FG002|COMPLETED|Washout Period (at Least 10 Days)||3||
48315718|NCT03598647|101097509|FG003|COMPLETED|Interventions for Non-exercisers||16||
48732598|NCT00714311|102130165|FG000|STARTED|Overall Study||52||
48732599|NCT00714311|102130166|FG001|STARTED|Overall Study||52||
48732600|NCT00714311|102130165|FG000|COMPLETED|Overall Study||39||
48732601|NCT00714311|102130166|FG001|COMPLETED|Overall Study||30||
48732602|NCT00714311|102130165|FG000|NOT COMPLETED|Overall Study||13||
48732603|NCT00714311|102130166|FG001|NOT COMPLETED|Overall Study||22||
48732604|NCT04373746|102130167|FG000|STARTED|Overall Study||31||
48732605|NCT04373746|102130168|FG001|STARTED|Overall Study||51||
48732606|NCT04373746|102130167|FG000|COMPLETED|Overall Study||24||
48732607|NCT04373746|102130168|FG001|COMPLETED|Overall Study||44||
48732608|NCT04373746|102130167|FG000|NOT COMPLETED|Overall Study||7||
48732609|NCT04373746|102130168|FG001|NOT COMPLETED|Overall Study||7||
48732610|NCT01380834|102130169|FG000|STARTED|Overall Study||42||
48732611|NCT01380834|102130170|FG001|STARTED|Overall Study||42||
48732612|NCT01380834|102130169|FG000|COMPLETED|Overall Study||41||
48732613|NCT01380834|102130170|FG001|COMPLETED|Overall Study||42||
48732614|NCT01380834|102130169|FG000|NOT COMPLETED|Overall Study||1||
48732615|NCT01380834|102130170|FG001|NOT COMPLETED|Overall Study||0||
48732616|NCT04736628|102130171|FG000|STARTED|Overall Study||64|Randomised to avenciguat or placebo matching avenciguat|
48732617|NCT04736628|102130172|FG001|STARTED|Overall Study||65|Randomised to avenciguat or placebo matching avenciguat|
48732618|NCT04736628|102130173|FG002|STARTED|Overall Study||66|Randomised to avenciguat or placebo matching avenciguat|
48732619|NCT04736628|102130174|FG003|STARTED|Overall Study||66|Randomised to avenciguat or placebo matching avenciguat|
48732620|NCT04736628|102130171|FG000|Treated|Overall Study||64||
48732621|NCT04736628|102130172|FG001|Treated|Overall Study||65||
48732622|NCT04736628|102130173|FG002|Treated|Overall Study||66||
48732623|NCT04736628|102130174|FG003|Treated|Overall Study||64||
48732624|NCT04736628|102130171|FG000|COMPLETED|Overall Study||58||
48732625|NCT04736628|102130172|FG001|COMPLETED|Overall Study||60||
48732626|NCT04736628|102130173|FG002|COMPLETED|Overall Study||60||
48732627|NCT04736628|102130174|FG003|COMPLETED|Overall Study||55||
48732628|NCT04736628|102130171|FG000|NOT COMPLETED|Overall Study||6||
48732629|NCT04736628|102130172|FG001|NOT COMPLETED|Overall Study||5||
48732630|NCT04736628|102130173|FG002|NOT COMPLETED|Overall Study||6||
48732631|NCT04736628|102130174|FG003|NOT COMPLETED|Overall Study||11||
48732632|NCT02718716|102130175|FG000|STARTED|Overall Study||15||
48732633|NCT02718716|102130176|FG001|STARTED|Overall Study||15||
48732634|NCT02718716|102130177|FG002|STARTED|Overall Study||12||
48732635|NCT02718716|102130178|FG003|STARTED|Overall Study||12||
48732636|NCT02718716|102130179|FG004|STARTED|Overall Study||12||
48732637|NCT02718716|102130175|FG000|COMPLETED|Overall Study||14||
48732638|NCT02718716|102130176|FG001|COMPLETED|Overall Study||15||
48732639|NCT02718716|102130177|FG002|COMPLETED|Overall Study||12||
48732640|NCT02718716|102130178|FG003|COMPLETED|Overall Study||12||
48732641|NCT02718716|102130179|FG004|COMPLETED|Overall Study||12||
48732642|NCT02718716|102130175|FG000|NOT COMPLETED|Overall Study||1||
48732643|NCT02718716|102130176|FG001|NOT COMPLETED|Overall Study||0||
48732644|NCT02718716|102130177|FG002|NOT COMPLETED|Overall Study||0||
48732645|NCT02718716|102130178|FG003|NOT COMPLETED|Overall Study||0||
48732646|NCT02718716|102130179|FG004|NOT COMPLETED|Overall Study||0||
48732647|NCT02251938|102130180|FG000|STARTED|Overall Study||60||
48732648|NCT02251938|102130180|FG000|COMPLETED|Overall Study||43||
48732649|NCT02251938|102130180|FG000|NOT COMPLETED|Overall Study||17||
48732650|NCT02315560|102130181|FG000|STARTED|Overall Study||25||
48732651|NCT02315560|102130181|FG000|COMPLETED|Overall Study||22||
48732652|NCT02315560|102130181|FG000|NOT COMPLETED|Overall Study||3||
48732653|NCT00859937|102130182|FG000|STARTED|Overall Study||41||
48732654|NCT00859937|102130183|FG001|STARTED|Overall Study||14||
48732655|NCT00859937|102130182|FG000|COMPLETED|Overall Study||40||
48732656|NCT00859937|102130183|FG001|COMPLETED|Overall Study||14||
48732657|NCT00859937|102130182|FG000|NOT COMPLETED|Overall Study||1||
48732658|NCT00859937|102130183|FG001|NOT COMPLETED|Overall Study||0||
48732659|NCT05090852|102130184|FG000|STARTED|Overall Study||31||
48732660|NCT05090852|102130184|FG000|COMPLETED|Overall Study||26||
48732661|NCT05090852|102130184|FG000|NOT COMPLETED|Overall Study||5||
48732662|NCT03267888|102130185|FG000|STARTED|Overall Study||25||
48732663|NCT03267888|102130185|FG000|COMPLETED|Overall Study||25||
48732664|NCT03267888|102130185|FG000|NOT COMPLETED|Overall Study||0||
48732665|NCT02275156|102130186|FG000|STARTED|Overall Study||6||
48732666|NCT02275156|102130187|FG001|STARTED|Overall Study||6||
48732667|NCT02275156|102130188|FG002|STARTED|Overall Study||6||
48732668|NCT02275156|102130186|FG000|COMPLETED|Overall Study||6||
48732669|NCT02275156|102130187|FG001|COMPLETED|Overall Study||6||
48732670|NCT02275156|102130188|FG002|COMPLETED|Overall Study||6||
48732671|NCT02275156|102130186|FG000|NOT COMPLETED|Overall Study||0||
48732672|NCT02275156|102130187|FG001|NOT COMPLETED|Overall Study||0||
48732673|NCT02275156|102130188|FG002|NOT COMPLETED|Overall Study||0||
48732674|NCT00235716|102130189|FG000|STARTED|Overall Study||152||
48732675|NCT00235716|102130190|FG001|STARTED|Overall Study||155||
48732676|NCT00235716|102130191|FG002|STARTED|Overall Study||154||
48732677|NCT00235716|102130192|FG003|STARTED|Overall Study||152||
48732678|NCT00235716|102130189|FG000|COMPLETED|Overall Study||90||
48732679|NCT00235716|102130190|FG001|COMPLETED|Overall Study||88||
48732680|NCT00235716|102130191|FG002|COMPLETED|Overall Study||89||
48732681|NCT00235716|102130192|FG003|COMPLETED|Overall Study||90||
48732682|NCT00235716|102130189|FG000|NOT COMPLETED|Overall Study||62||
48732683|NCT00235716|102130190|FG001|NOT COMPLETED|Overall Study||67||
48732684|NCT00235716|102130191|FG002|NOT COMPLETED|Overall Study||65||
48732685|NCT00235716|102130192|FG003|NOT COMPLETED|Overall Study||62||
48732686|NCT04752358|102130193|FG000|STARTED|Overall Study||2||
48732687|NCT04752358|102130194|FG001|STARTED|Overall Study||1||
48732688|NCT04752358|102130193|FG000|COMPLETED|Overall Study||0||
48732689|NCT04752358|102130194|FG001|COMPLETED|Overall Study||0||
48732690|NCT04752358|102130193|FG000|NOT COMPLETED|Overall Study||2||
48732691|NCT04752358|102130194|FG001|NOT COMPLETED|Overall Study||1||
48732692|NCT03533244|102130195|FG000|STARTED|Overall Study||20||
48732693|NCT03533244|102130196|FG001|STARTED|Overall Study||22||
48732694|NCT03533244|102130197|FG002|STARTED|Overall Study||22||
48732695|NCT03533244|102130195|FG000|COMPLETED|Overall Study||18||
48732696|NCT03533244|102130196|FG001|COMPLETED|Overall Study||21||
48732697|NCT03533244|102130197|FG002|COMPLETED|Overall Study||22||
48732698|NCT03533244|102130195|FG000|NOT COMPLETED|Overall Study||2||
48732699|NCT03533244|102130196|FG001|NOT COMPLETED|Overall Study||1||
48732700|NCT03533244|102130197|FG002|NOT COMPLETED|Overall Study||0||
48732701|NCT01957410|102130198|FG000|STARTED|Open Label||13||
48732702|NCT01957410|102130198|FG000|COMPLETED|Open Label||13||
48732703|NCT01957410|102130198|FG000|NOT COMPLETED|Open Label||0||
48732704|NCT01957410|102130198|FG000|STARTED|Optional Open Label||13||
48732705|NCT01957410|102130198|FG000|COMPLETED|Optional Open Label||13||
48732706|NCT01957410|102130198|FG000|NOT COMPLETED|Optional Open Label||0||
48732707|NCT03472586|102130199|FG000|STARTED|Overall Study||14||
48732708|NCT03472586|102130199|FG000|COMPLETED|Overall Study||1||
48732709|NCT03472586|102130199|FG000|NOT COMPLETED|Overall Study||13||
48732710|NCT03301298|102130200|FG000|STARTED|Unfed Conditions||6||
48732711|NCT03301298|102130201|FG001|STARTED|Unfed Conditions||6||
48732712|NCT03301298|102130202|FG002|STARTED|Unfed Conditions||6||
48732713|NCT03301298|102130203|FG003|STARTED|Unfed Conditions||6||
48732714|NCT03301298|102130204|FG004|STARTED|Unfed Conditions||6||
48732715|NCT03301298|102130205|FG005|STARTED|Unfed Conditions||6||
48732716|NCT03301298|102130206|FG006|STARTED|Unfed Conditions||12||
48732717|NCT03301298|102130200|FG000|COMPLETED|Unfed Conditions||6||
48732718|NCT03301298|102130201|FG001|COMPLETED|Unfed Conditions||6||
48732719|NCT03301298|102130202|FG002|COMPLETED|Unfed Conditions||6||
48732720|NCT03301298|102130203|FG003|COMPLETED|Unfed Conditions||6||
48732721|NCT03301298|102130204|FG004|COMPLETED|Unfed Conditions||6||
48732722|NCT03301298|102130205|FG005|COMPLETED|Unfed Conditions||6||
48732723|NCT03301298|102130206|FG006|COMPLETED|Unfed Conditions||12||
48158979|NCT02228395|100711175|FG000|NOT COMPLETED|Washout Period (at Least 10 Days)||0||
48158980|NCT02228395|100711176|FG001|NOT COMPLETED|Washout Period (at Least 10 Days)||0||
48158981|NCT02228395|100711177|FG002|NOT COMPLETED|Washout Period (at Least 10 Days)||0||
48158982|NCT02228395|100711175|FG000|STARTED|Third Intervention Period||3||
48732724|NCT03301298|102130200|FG000|NOT COMPLETED|Unfed Conditions||0||
48732725|NCT03301298|102130201|FG001|NOT COMPLETED|Unfed Conditions||0||
48732726|NCT03301298|102130202|FG002|NOT COMPLETED|Unfed Conditions||0||
48732727|NCT03301298|102130203|FG003|NOT COMPLETED|Unfed Conditions||0||
48732728|NCT03301298|102130204|FG004|NOT COMPLETED|Unfed Conditions||0||
48732729|NCT03301298|102130205|FG005|NOT COMPLETED|Unfed Conditions||0||
48732730|NCT03301298|102130206|FG006|NOT COMPLETED|Unfed Conditions||0||
48732731|NCT03301298|102130200|FG000|STARTED|Fed Conditions||0|Only cohort 5 participated in the fed portion of the study, subject 5004 elected to discontinue.|
48732732|NCT03301298|102130201|FG001|STARTED|Fed Conditions||0|Only cohort 5 participated in the fed portion of the study, subject 5004 elected to discontinue.|
48732733|NCT03301298|102130202|FG002|STARTED|Fed Conditions||0|Only cohort 5 participated in the fed portion of the study, subject 5004 elected to discontinue.|
48732734|NCT03301298|102130203|FG003|STARTED|Fed Conditions||0|Only cohort 5 participated in the fed portion of the study, subject 5004 elected to discontinue.|
48732735|NCT03301298|102130204|FG004|STARTED|Fed Conditions||5|Only cohort 5 participated in the fed portion of the study, subject 5004 elected to discontinue.|
48732736|NCT03301298|102130205|FG005|STARTED|Fed Conditions||0|Only cohort 5 participated in the fed portion of the study, subject 5004 elected to discontinue.|
48732737|NCT03301298|102130206|FG006|STARTED|Fed Conditions||2|Only cohort 5 participated in the fed portion of the study, subject 5004 elected to discontinue.|
48732738|NCT03301298|102130200|FG000|COMPLETED|Fed Conditions||0||
48732739|NCT03301298|102130201|FG001|COMPLETED|Fed Conditions||0||
48732740|NCT03301298|102130202|FG002|COMPLETED|Fed Conditions||0||
48732741|NCT03301298|102130203|FG003|COMPLETED|Fed Conditions||0||
48732742|NCT03301298|102130204|FG004|COMPLETED|Fed Conditions||5||
48732743|NCT03301298|102130205|FG005|COMPLETED|Fed Conditions||0||
48158983|NCT02228395|100711176|FG001|STARTED|Third Intervention Period||3||
48158984|NCT02228395|100711177|FG002|STARTED|Third Intervention Period||3||
48158985|NCT02228395|100711175|FG000|COMPLETED|Third Intervention Period||3||
48158986|NCT02228395|100711176|FG001|COMPLETED|Third Intervention Period||3||
48158987|NCT02228395|100711177|FG002|COMPLETED|Third Intervention Period||3||
48158988|NCT02228395|100711175|FG000|NOT COMPLETED|Third Intervention Period||0||
48158989|NCT02228395|100711176|FG001|NOT COMPLETED|Third Intervention Period||0||
48732744|NCT03301298|102130206|FG006|COMPLETED|Fed Conditions||2||
48732745|NCT03301298|102130200|FG000|NOT COMPLETED|Fed Conditions||0||
48732746|NCT03301298|102130201|FG001|NOT COMPLETED|Fed Conditions||0||
48732747|NCT03301298|102130202|FG002|NOT COMPLETED|Fed Conditions||0||
48732748|NCT03301298|102130203|FG003|NOT COMPLETED|Fed Conditions||0||
48732749|NCT03301298|102130204|FG004|NOT COMPLETED|Fed Conditions||0||
48732750|NCT03301298|102130205|FG005|NOT COMPLETED|Fed Conditions||0||
48732751|NCT03301298|102130206|FG006|NOT COMPLETED|Fed Conditions||0||
48732752|NCT01754493|102130207|FG000|STARTED|Overall Study||17||
48732753|NCT01754493|102130207|FG000|COMPLETED|Overall Study||10||
48732754|NCT01754493|102130207|FG000|NOT COMPLETED|Overall Study||7||
48732755|NCT03915470|102130208|FG000|STARTED|Overall Study||63||
48732756|NCT03915470|102130209|FG001|STARTED|Overall Study||61||
48732757|NCT03915470|102130208|FG000|COMPLETED|Overall Study||57||
48732758|NCT03915470|102130209|FG001|COMPLETED|Overall Study||59||
48732759|NCT03915470|102130208|FG000|NOT COMPLETED|Overall Study||6||
48732760|NCT03915470|102130209|FG001|NOT COMPLETED|Overall Study||2||
48732761|NCT00398320|102130210|FG000|STARTED|Overall Study||40||
48732762|NCT00398320|102130210|FG000|COMPLETED|Overall Study||34||
48732763|NCT00398320|102130210|FG000|NOT COMPLETED|Overall Study||6||
48732764|NCT02503501|102130211|FG000|STARTED|Overall Study||19||
48732765|NCT02503501|102130212|FG001|STARTED|Overall Study||16||
48732766|NCT02503501|102130211|FG000|COMPLETED|Overall Study||18||
48732767|NCT02503501|102130212|FG001|COMPLETED|Overall Study||13||
48732768|NCT02503501|102130211|FG000|NOT COMPLETED|Overall Study||1||
48732769|NCT02503501|102130212|FG001|NOT COMPLETED|Overall Study||3||
48732770|NCT04120363|102130213|FG000|STARTED|Phase 1||16||
48732771|NCT04120363|102130214|FG001|STARTED|Phase 1||18||
48732772|NCT04120363|102130213|FG000|COMPLETED|Phase 1||16||
48732773|NCT04120363|102130214|FG001|COMPLETED|Phase 1||18||
48732774|NCT04120363|102130213|FG000|NOT COMPLETED|Phase 1||0||
48732775|NCT04120363|102130214|FG001|NOT COMPLETED|Phase 1||0||
48732776|NCT04120363|102130213|FG000|STARTED|Phase 2||16||
48732777|NCT04120363|102130214|FG001|STARTED|Phase 2||18||
48732778|NCT04120363|102130213|FG000|COMPLETED|Phase 2||16||
48732779|NCT04120363|102130214|FG001|COMPLETED|Phase 2||16||
48732780|NCT04120363|102130213|FG000|NOT COMPLETED|Phase 2||0||
48732781|NCT04120363|102130214|FG001|NOT COMPLETED|Phase 2||2||
48732782|NCT04120363|102130213|FG000|STARTED|Phase 3||16||
48732783|NCT04120363|102130214|FG001|STARTED|Phase 3||16||
48732784|NCT04120363|102130213|FG000|COMPLETED|Phase 3||16||
48732785|NCT04120363|102130214|FG001|COMPLETED|Phase 3||16||
48732786|NCT04120363|102130213|FG000|NOT COMPLETED|Phase 3||0||
48732787|NCT04120363|102130214|FG001|NOT COMPLETED|Phase 3||0||
48732788|NCT01815840|102130215|FG000|STARTED|Overall Study||116||
48732789|NCT01815840|102130216|FG001|STARTED|Overall Study||113||
48732790|NCT01815840|102130215|FG000|COMPLETED|Overall Study||57||
48732791|NCT01815840|102130216|FG001|COMPLETED|Overall Study||50||
48732792|NCT01815840|102130215|FG000|NOT COMPLETED|Overall Study||59||
48732793|NCT01815840|102130216|FG001|NOT COMPLETED|Overall Study||63||
48732794|NCT00492336|102130217|FG000|STARTED|Overall Study||28||
48732795|NCT00492336|102130218|FG001|STARTED|Overall Study||29||
48732796|NCT00492336|102130217|FG000|COMPLETED|Overall Study||26||
48732797|NCT00492336|102130218|FG001|COMPLETED|Overall Study||23||
48732798|NCT00492336|102130217|FG000|NOT COMPLETED|Overall Study||2||
48732799|NCT00492336|102130218|FG001|NOT COMPLETED|Overall Study||6||
48732800|NCT01629953|102130219|FG000|STARTED|Overall Study||65||
48732801|NCT01629953|102130220|FG001|STARTED|Overall Study||75||
48732802|NCT01629953|102130219|FG000|COMPLETED|Overall Study||52||
48732803|NCT01629953|102130220|FG001|COMPLETED|Overall Study||60||
48732804|NCT01629953|102130219|FG000|NOT COMPLETED|Overall Study||13||
48732805|NCT01629953|102130220|FG001|NOT COMPLETED|Overall Study||15||
48732806|NCT01870726|102130221|FG000|STARTED|Overall Study||5||
48732807|NCT01870726|102130222|FG001|STARTED|Overall Study||6||
48732808|NCT01870726|102130223|FG002|STARTED|Overall Study||4||
48732809|NCT01870726|102130224|FG003|STARTED|Overall Study||6||
48732810|NCT01870726|102130225|FG004|STARTED|Overall Study||7||
48732811|NCT01870726|102130226|FG005|STARTED|Overall Study||5||
48732812|NCT01870726|102130227|FG006|STARTED|Overall Study||10||
48732813|NCT01870726|102130221|FG000|COMPLETED|Overall Study||0||
48732814|NCT01870726|102130222|FG001|COMPLETED|Overall Study||0||
48732815|NCT01870726|102130223|FG002|COMPLETED|Overall Study||0||
48732816|NCT01870726|102130224|FG003|COMPLETED|Overall Study||0||
48732817|NCT01870726|102130225|FG004|COMPLETED|Overall Study||0||
48732818|NCT01870726|102130226|FG005|COMPLETED|Overall Study||0||
48732819|NCT01870726|102130227|FG006|COMPLETED|Overall Study||0||
48732820|NCT01870726|102130221|FG000|NOT COMPLETED|Overall Study||5||
48732821|NCT01870726|102130222|FG001|NOT COMPLETED|Overall Study||6||
48732822|NCT01870726|102130223|FG002|NOT COMPLETED|Overall Study||4||
48732823|NCT01870726|102130224|FG003|NOT COMPLETED|Overall Study||6||
48732824|NCT01870726|102130225|FG004|NOT COMPLETED|Overall Study||7||
48732825|NCT01870726|102130226|FG005|NOT COMPLETED|Overall Study||5||
48732826|NCT01870726|102130227|FG006|NOT COMPLETED|Overall Study||10||
48732827|NCT01092910|102130228|FG000|STARTED|Overall Study||57||
48732828|NCT01092910|102130228|FG000|4 Month Follow-up|Overall Study||54||
48732829|NCT01092910|102130228|FG000|10 Month Follow-up|Overall Study||52||
48732830|NCT01092910|102130228|FG000|COMPLETED|Overall Study||52||
48732831|NCT01092910|102130228|FG000|NOT COMPLETED|Overall Study||5||
48732832|NCT00669383|102130229|FG000|STARTED|Overall Study||44||
48732833|NCT00669383|102130230|FG001|STARTED|Overall Study||41||
48732834|NCT00669383|102130229|FG000|COMPLETED|Overall Study||44||
48732835|NCT00669383|102130230|FG001|COMPLETED|Overall Study||41||
48732836|NCT00669383|102130229|FG000|NOT COMPLETED|Overall Study||0||
48732837|NCT00669383|102130230|FG001|NOT COMPLETED|Overall Study||0||
48732838|NCT00511238|102130231|FG000|STARTED|Overall Study||46||
48732839|NCT00511238|102130232|FG001|STARTED|Overall Study||266||
48732840|NCT00511238|102130231|FG000|COMPLETED|Overall Study||4||
48732841|NCT00511238|102130232|FG001|COMPLETED|Overall Study||40||
48732842|NCT00511238|102130231|FG000|NOT COMPLETED|Overall Study||42||
48732843|NCT00511238|102130232|FG001|NOT COMPLETED|Overall Study||226||
48732844|NCT03400163|102130233|FG000|STARTED|Treatment Period||1||
48732845|NCT03400163|102130234|FG001|STARTED|Treatment Period||2||
48732846|NCT03400163|102130233|FG000|COMPLETED|Treatment Period||1||
48158990|NCT02228395|100711177|FG002|NOT COMPLETED|Third Intervention Period||0||
48158991|NCT01337674|100711178|FG000|STARTED|Treatment Period 1||6||
48158992|NCT01337674|100711179|FG001|STARTED|Treatment Period 1||7||
48158993|NCT01337674|100711180|FG002|STARTED|Treatment Period 1||6||
48158994|NCT01337674|100711181|FG003|STARTED|Treatment Period 1||7||
48158995|NCT01337674|100711178|FG000|COMPLETED|Treatment Period 1||6||
48158996|NCT01337674|100711179|FG001|COMPLETED|Treatment Period 1||6||
48158997|NCT01337674|100711180|FG002|COMPLETED|Treatment Period 1||6||
48158998|NCT01337674|100711181|FG003|COMPLETED|Treatment Period 1||6||
48158999|NCT01337674|100711178|FG000|NOT COMPLETED|Treatment Period 1||0||
48159000|NCT01337674|100711179|FG001|NOT COMPLETED|Treatment Period 1||1||
48159001|NCT01337674|100711180|FG002|NOT COMPLETED|Treatment Period 1||0||
48159002|NCT01337674|100711181|FG003|NOT COMPLETED|Treatment Period 1||1||
48159003|NCT01337674|100711178|FG000|STARTED|Two-week Washout Period||6||
48159004|NCT01337674|100711179|FG001|STARTED|Two-week Washout Period||6||
48159005|NCT01337674|100711180|FG002|STARTED|Two-week Washout Period||6||
48159006|NCT01337674|100711181|FG003|STARTED|Two-week Washout Period||6||
48159007|NCT01337674|100711178|FG000|COMPLETED|Two-week Washout Period||6||
48159008|NCT01337674|100711179|FG001|COMPLETED|Two-week Washout Period||6||
48159009|NCT01337674|100711180|FG002|COMPLETED|Two-week Washout Period||6||
48159010|NCT01337674|100711181|FG003|COMPLETED|Two-week Washout Period||6||
48159011|NCT01337674|100711178|FG000|NOT COMPLETED|Two-week Washout Period||0||
48159012|NCT01337674|100711179|FG001|NOT COMPLETED|Two-week Washout Period||0||
48159013|NCT01337674|100711180|FG002|NOT COMPLETED|Two-week Washout Period||0||
48159014|NCT01337674|100711181|FG003|NOT COMPLETED|Two-week Washout Period||0||
48159015|NCT01337674|100711178|FG000|STARTED|Treatment Period 2||6||
48159016|NCT01337674|100711179|FG001|STARTED|Treatment Period 2||6||
48159017|NCT01337674|100711180|FG002|STARTED|Treatment Period 2||6||
48159018|NCT01337674|100711181|FG003|STARTED|Treatment Period 2||6||
48159019|NCT01337674|100711178|FG000|COMPLETED|Treatment Period 2||6||
48159020|NCT01337674|100711179|FG001|COMPLETED|Treatment Period 2||6||
48159021|NCT01337674|100711180|FG002|COMPLETED|Treatment Period 2||5||
48159022|NCT01337674|100711181|FG003|COMPLETED|Treatment Period 2||6||
48159023|NCT01337674|100711178|FG000|NOT COMPLETED|Treatment Period 2||0||
48159024|NCT01337674|100711179|FG001|NOT COMPLETED|Treatment Period 2||0||
48159025|NCT01337674|100711180|FG002|NOT COMPLETED|Treatment Period 2||1||
48159026|NCT01337674|100711181|FG003|NOT COMPLETED|Treatment Period 2||0||
48159027|NCT02978443|100711182|FG000|STARTED|Overall Study||14||
48159028|NCT02978443|100711182|FG000|COMPLETED|Overall Study||0||
48159029|NCT02978443|100711182|FG000|NOT COMPLETED|Overall Study||14||
48159030|NCT02249819|100711183|FG000|STARTED|Overall Study||8||
48159031|NCT02249819|100711184|FG001|STARTED|Overall Study||7||
48159032|NCT02249819|100711183|FG000|COMPLETED|Overall Study||8||
48159033|NCT02249819|100711184|FG001|COMPLETED|Overall Study||7||
48159034|NCT02249819|100711183|FG000|NOT COMPLETED|Overall Study||0||
48732847|NCT03400163|102130234|FG001|COMPLETED|Treatment Period||2||
48732848|NCT03400163|102130233|FG000|NOT COMPLETED|Treatment Period||0||
48732849|NCT03400163|102130234|FG001|NOT COMPLETED|Treatment Period||0||
48732850|NCT03400163|102130233|FG000|STARTED|Follow-up Period||1||
48732851|NCT03400163|102130234|FG001|STARTED|Follow-up Period||2||
48159035|NCT02249819|100711184|FG001|NOT COMPLETED|Overall Study||0||
48159036|NCT00499863|100711185|FG000|STARTED|Overall Study||145||
48159037|NCT00499863|100711186|FG001|STARTED|Overall Study||72||
48159038|NCT00499863|100711185|FG000|COMPLETED|Overall Study||95||
48159039|NCT00499863|100711186|FG001|COMPLETED|Overall Study||29||
48159040|NCT00499863|100711185|FG000|NOT COMPLETED|Overall Study||50||
48159041|NCT00499863|100711186|FG001|NOT COMPLETED|Overall Study||43||
48159042|NCT02472652|100711187|FG000|STARTED|Overall Study||2||
48159043|NCT02472652|100711187|FG000|COMPLETED|Overall Study||1||
48159044|NCT02472652|100711187|FG000|NOT COMPLETED|Overall Study||1||
48159045|NCT02073097|100711188|FG000|STARTED|Overall Study||0||
48159046|NCT02073097|100711189|FG001|STARTED|Overall Study||0||
48159047|NCT02073097|100711190|FG002|STARTED|Overall Study||9||
48732852|NCT03400163|102130233|FG000|COMPLETED|Follow-up Period||1||
48159048|NCT02073097|100711191|FG003|STARTED|Overall Study||3||
48159049|NCT02073097|100711192|FG004|STARTED|Overall Study||3||
48159050|NCT02073097|100711193|FG005|STARTED|Overall Study||3||
48159051|NCT02073097|100711194|FG006|STARTED|Overall Study||6||
48159052|NCT02073097|100711195|FG007|STARTED|Overall Study||24||
48159053|NCT02073097|100711188|FG000|COMPLETED|Overall Study||0|Received at least 6 cycles of study drug.|
48732853|NCT03400163|102130234|FG001|COMPLETED|Follow-up Period||2||
48732854|NCT03400163|102130233|FG000|NOT COMPLETED|Follow-up Period||0||
48159054|NCT02073097|100711189|FG001|COMPLETED|Overall Study||0|Received at least 6 cycles of study drug.|
48159055|NCT02073097|100711190|FG002|COMPLETED|Overall Study||9|Received at least 6 cycles of study drug.|
48159056|NCT02073097|100711191|FG003|COMPLETED|Overall Study||3|Received at least 6 cycles of study drug.|
48159057|NCT02073097|100711192|FG004|COMPLETED|Overall Study||3|Received at least 6 cycles of study drug.|
48159058|NCT02073097|100711193|FG005|COMPLETED|Overall Study||3|Received at least 6 cycles of study drug.|
48159059|NCT02073097|100711194|FG006|COMPLETED|Overall Study||6|Received at least 6 cycles of study drug.|
48159060|NCT02073097|100711195|FG007|COMPLETED|Overall Study||18|Received at least 6 cycles of study drug.|
48159061|NCT02073097|100711188|FG000|NOT COMPLETED|Overall Study||0||
48159062|NCT02073097|100711189|FG001|NOT COMPLETED|Overall Study||0||
48159063|NCT02073097|100711190|FG002|NOT COMPLETED|Overall Study||0||
48159064|NCT02073097|100711191|FG003|NOT COMPLETED|Overall Study||0||
48159065|NCT02073097|100711192|FG004|NOT COMPLETED|Overall Study||0||
48159066|NCT02073097|100711193|FG005|NOT COMPLETED|Overall Study||0||
48159067|NCT02073097|100711194|FG006|NOT COMPLETED|Overall Study||0||
48159068|NCT02073097|100711195|FG007|NOT COMPLETED|Overall Study||6||
48159069|NCT01778556|100711196|FG000|STARTED|Intervention 1 (5 Days)||15||
48159070|NCT01778556|100711197|FG001|STARTED|Intervention 1 (5 Days)||10||
48159071|NCT01778556|100711196|FG000|COMPLETED|Intervention 1 (5 Days)||15||
48159072|NCT01778556|100711197|FG001|COMPLETED|Intervention 1 (5 Days)||8||
48159073|NCT01778556|100711196|FG000|NOT COMPLETED|Intervention 1 (5 Days)||0||
48159074|NCT01778556|100711197|FG001|NOT COMPLETED|Intervention 1 (5 Days)||2||
48159075|NCT01778556|100711196|FG000|STARTED|Intervention 2 (14 Days)||15||
48159076|NCT01778556|100711197|FG001|STARTED|Intervention 2 (14 Days)||8||
48159077|NCT01778556|100711196|FG000|COMPLETED|Intervention 2 (14 Days)||14||
48159078|NCT01778556|100711197|FG001|COMPLETED|Intervention 2 (14 Days)||8||
48159079|NCT01778556|100711196|FG000|NOT COMPLETED|Intervention 2 (14 Days)||1||
48159080|NCT01778556|100711197|FG001|NOT COMPLETED|Intervention 2 (14 Days)||0||
48159081|NCT01778556|100711196|FG000|STARTED|Long-term Follow-up||15||
48315719|NCT03598647|101097506|FG000|NOT COMPLETED|Interventions for Non-exercisers||0||
48315720|NCT03598647|101097507|FG001|NOT COMPLETED|Interventions for Non-exercisers||0||
48315721|NCT03598647|101097508|FG002|NOT COMPLETED|Interventions for Non-exercisers||0||
48315722|NCT03598647|101097509|FG003|NOT COMPLETED|Interventions for Non-exercisers||0||
48732855|NCT03400163|102130234|FG001|NOT COMPLETED|Follow-up Period||0||
48732856|NCT00856544|102130235|FG000|STARTED|Overall Study||318||
48732857|NCT00856544|102130236|FG001|STARTED|Overall Study||318||
48732858|NCT00856544|102130237|FG002|STARTED|Overall Study||79||
48732859|NCT00856544|102130238|FG003|STARTED|Overall Study||80||
48732860|NCT00856544|102130235|FG000|Treated|Overall Study||315||
48732861|NCT00856544|102130236|FG001|Treated|Overall Study||318||
48732862|NCT00856544|102130237|FG002|Treated|Overall Study||79||
48732863|NCT00856544|102130238|FG003|Treated|Overall Study||80||
48732864|NCT00856544|102130235|FG000|COMPLETED|Overall Study||261||
48732865|NCT00856544|102130236|FG001|COMPLETED|Overall Study||252||
48732866|NCT00856544|102130237|FG002|COMPLETED|Overall Study||71||
48732867|NCT00856544|102130238|FG003|COMPLETED|Overall Study||67||
48732868|NCT00856544|102130235|FG000|NOT COMPLETED|Overall Study||57||
48732869|NCT00856544|102130236|FG001|NOT COMPLETED|Overall Study||66||
48732870|NCT00856544|102130237|FG002|NOT COMPLETED|Overall Study||8||
48732871|NCT00856544|102130238|FG003|NOT COMPLETED|Overall Study||13||
48732872|NCT00422383|102130239|FG000|STARTED|Overall Study||134||
48732873|NCT00422383|102130240|FG001|STARTED|Overall Study||120||
48732874|NCT00422383|102130241|FG002|STARTED|Overall Study||93||
48732875|NCT00422383|102130242|FG003|STARTED|Overall Study||6||
48159082|NCT01778556|100711197|FG001|STARTED|Long-term Follow-up||0||
48159083|NCT01778556|100711196|FG000|COMPLETED|Long-term Follow-up||14||
48159084|NCT01778556|100711197|FG001|COMPLETED|Long-term Follow-up||0||
48159085|NCT01778556|100711196|FG000|NOT COMPLETED|Long-term Follow-up||1||
48159086|NCT01778556|100711197|FG001|NOT COMPLETED|Long-term Follow-up||0||
48159087|NCT00628901|100711198|FG000|STARTED|Overall Study||30||
48159088|NCT00628901|100711199|FG001|STARTED|Overall Study||30||
48159089|NCT00628901|100711198|FG000|COMPLETED|Overall Study||27||
48159090|NCT00628901|100711199|FG001|COMPLETED|Overall Study||29||
48159091|NCT00628901|100711198|FG000|NOT COMPLETED|Overall Study||3||
48732876|NCT00422383|102130243|FG004|STARTED|Overall Study||25||
48732877|NCT00422383|102130239|FG000|COMPLETED|Overall Study||119||
48159092|NCT00628901|100711199|FG001|NOT COMPLETED|Overall Study||1||
48159093|NCT01804101|100711200|FG000|STARTED|Overall Study||38||
48159094|NCT01804101|100711201|FG001|STARTED|Overall Study||10||
48159095|NCT01804101|100711200|FG000|COMPLETED|Overall Study||38||
48159096|NCT01804101|100711201|FG001|COMPLETED|Overall Study||10||
48159097|NCT01804101|100711200|FG000|NOT COMPLETED|Overall Study||0||
48159098|NCT01804101|100711201|FG001|NOT COMPLETED|Overall Study||0||
48732878|NCT00422383|102130240|FG001|COMPLETED|Overall Study||106||
48732879|NCT00422383|102130241|FG002|COMPLETED|Overall Study||89||
48188745|NCT01033643|100783324|FG003|NOT COMPLETED|Overall Study||0||
48732880|NCT00422383|102130242|FG003|COMPLETED|Overall Study||4||
48732881|NCT00422383|102130243|FG004|COMPLETED|Overall Study||22||
48732882|NCT00422383|102130239|FG000|NOT COMPLETED|Overall Study||15||
48732883|NCT00422383|102130240|FG001|NOT COMPLETED|Overall Study||14||
48732884|NCT00422383|102130241|FG002|NOT COMPLETED|Overall Study||4||
48159099|NCT01544998|100711202|FG000|STARTED|First Intervention (3 Hours)||26||
48159100|NCT01544998|100711203|FG001|STARTED|First Intervention (3 Hours)||15||
48159101|NCT01544998|100711202|FG000|COMPLETED|First Intervention (3 Hours)||26||
48159102|NCT01544998|100711203|FG001|COMPLETED|First Intervention (3 Hours)||15||
48159103|NCT01544998|100711202|FG000|NOT COMPLETED|First Intervention (3 Hours)||0||
48159104|NCT01544998|100711203|FG001|NOT COMPLETED|First Intervention (3 Hours)||0||
48159105|NCT01544998|100711202|FG000|STARTED|Washout (1 Week)||26||
48159106|NCT01544998|100711203|FG001|STARTED|Washout (1 Week)||15||
48159107|NCT01544998|100711202|FG000|COMPLETED|Washout (1 Week)||26||
48159108|NCT01544998|100711203|FG001|COMPLETED|Washout (1 Week)||15||
48159109|NCT01544998|100711202|FG000|NOT COMPLETED|Washout (1 Week)||0||
48159110|NCT01544998|100711203|FG001|NOT COMPLETED|Washout (1 Week)||0||
48159111|NCT01544998|100711202|FG000|STARTED|Second Intervention (3 Hours)||26||
48159112|NCT01544998|100711203|FG001|STARTED|Second Intervention (3 Hours)||15||
48159113|NCT01544998|100711202|FG000|COMPLETED|Second Intervention (3 Hours)||26||
48159114|NCT01544998|100711203|FG001|COMPLETED|Second Intervention (3 Hours)||15||
48159115|NCT01544998|100711202|FG000|NOT COMPLETED|Second Intervention (3 Hours)||0||
48159116|NCT01544998|100711203|FG001|NOT COMPLETED|Second Intervention (3 Hours)||0||
48159117|NCT02624739|100711204|FG000|STARTED|Overall Study||0||
48732885|NCT00422383|102130242|FG003|NOT COMPLETED|Overall Study||2||
48732886|NCT00422383|102130243|FG004|NOT COMPLETED|Overall Study||3||
48732887|NCT02024724|102130244|FG000|STARTED|Overall Study||30||
48732888|NCT02024724|102130245|FG001|STARTED|Overall Study||30||
48732889|NCT02024724|102130244|FG000|COMPLETED|Overall Study||29||
48732890|NCT02024724|102130245|FG001|COMPLETED|Overall Study||30||
48732891|NCT02024724|102130244|FG000|NOT COMPLETED|Overall Study||1||
48732892|NCT02024724|102130245|FG001|NOT COMPLETED|Overall Study||0||
48732893|NCT00615992|102130246|FG000|STARTED|Overall Study||754||
48732894|NCT00615992|102130246|FG000|COMPLETED|Overall Study||687||
48732895|NCT00615992|102130246|FG000|NOT COMPLETED|Overall Study||67||
48159118|NCT02624739|100711205|FG001|STARTED|Overall Study||0||
48159119|NCT02624739|100711204|FG000|COMPLETED|Overall Study||0||
48159120|NCT02624739|100711205|FG001|COMPLETED|Overall Study||0||
48159121|NCT02624739|100711204|FG000|NOT COMPLETED|Overall Study||0||
48159122|NCT02624739|100711205|FG001|NOT COMPLETED|Overall Study||0||
48614816|NCT04826484|101841843|FG001|NOT COMPLETED|Overall Study||0||
48614817|NCT01263717|101841844|FG000|STARTED|Overall Study||28||
48315723|NCT00254501|101097510|FG000|STARTED|Overall Study||32||
48315724|NCT00254501|101097511|FG001|STARTED|Overall Study||37||
48315725|NCT00254501|101097510|FG000|COMPLETED|Overall Study||31||
48315726|NCT00254501|101097511|FG001|COMPLETED|Overall Study||36||
48315727|NCT00254501|101097510|FG000|NOT COMPLETED|Overall Study||1||
48315728|NCT00254501|101097511|FG001|NOT COMPLETED|Overall Study||1||
48614818|NCT01263717|101841845|FG001|STARTED|Overall Study||26||
48614819|NCT01263717|101841844|FG000|Baseline Visit|Overall Study||28||
48614820|NCT01263717|101841845|FG001|Baseline Visit|Overall Study||22||
48614821|NCT01263717|101841844|FG000|COMPLETED|Overall Study||23||
48614822|NCT01263717|101841845|FG001|COMPLETED|Overall Study||20||
48614823|NCT01263717|101841844|FG000|NOT COMPLETED|Overall Study||5||
48614824|NCT01263717|101841845|FG001|NOT COMPLETED|Overall Study||6||
48614825|NCT03397121|101841846|FG000|STARTED|Overall Study||242||
48614826|NCT03397121|101841847|FG001|STARTED|Overall Study||240||
48614827|NCT03397121|101841846|FG000|COMPLETED|Overall Study||235||
48614828|NCT03397121|101841847|FG001|COMPLETED|Overall Study||231||
48732896|NCT03927144|102130247|FG000|STARTED|Core Phase||413||
48732897|NCT03927144|102130248|FG001|STARTED|Core Phase||208||
48159123|NCT02417064|100711206|FG000|STARTED|Double-blind Induction Phase (4 Weeks)||117||
48159124|NCT02417064|100711207|FG001|STARTED|Double-blind Induction Phase (4 Weeks)||116||
48159125|NCT02417064|100711208|FG002|STARTED|Double-blind Induction Phase (4 Weeks)||113||
48159126|NCT02417064|100711206|FG000|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||115||
48159127|NCT02417064|100711207|FG001|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||114||
48159128|NCT02417064|100711208|FG002|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||113||
48159129|NCT02417064|100711206|FG000|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||115||
48159130|NCT02417064|100711207|FG001|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||116||
48159131|NCT02417064|100711208|FG002|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||113||
48159132|NCT02417064|100711206|FG000|COMPLETED|Double-blind Induction Phase (4 Weeks)||111||
48159133|NCT02417064|100711207|FG001|COMPLETED|Double-blind Induction Phase (4 Weeks)||97||
48315729|NCT00219284|101097512|FG000|STARTED|Treatment Phase - 16 Weeks||180||
48614829|NCT03397121|101841846|FG000|NOT COMPLETED|Overall Study||7||
48732898|NCT03927144|102130247|FG000|COMPLETED|Core Phase||377|Completed 52 week core phase|
48732899|NCT03927144|102130248|FG001|COMPLETED|Core Phase||146|Completed 52 week core phase|
48732900|NCT03927144|102130247|FG000|NOT COMPLETED|Core Phase||36||
48159134|NCT02417064|100711208|FG002|COMPLETED|Double-blind Induction Phase (4 Weeks)||107||
48159135|NCT02417064|100711206|FG000|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6||
48315730|NCT00219284|101097513|FG001|STARTED|Treatment Phase - 16 Weeks||179||
48315731|NCT00219284|101097512|FG000|COMPLETED|Treatment Phase - 16 Weeks||136||
48614830|NCT03397121|101841847|FG001|NOT COMPLETED|Overall Study||9||
48732901|NCT03927144|102130248|FG001|NOT COMPLETED|Core Phase||62||
48315732|NCT00219284|101097513|FG001|COMPLETED|Treatment Phase - 16 Weeks||128||
48315733|NCT00219284|101097512|FG000|NOT COMPLETED|Treatment Phase - 16 Weeks||44||
48315734|NCT00219284|101097513|FG001|NOT COMPLETED|Treatment Phase - 16 Weeks||51||
48315735|NCT00219284|101097512|FG000|STARTED|Extension Phase - 8 Weeks||114||
48315736|NCT00219284|101097513|FG001|STARTED|Extension Phase - 8 Weeks||106||
48732902|NCT03927144|102130247|FG000|STARTED|Extension Phase||343||
48732903|NCT03927144|102130248|FG001|STARTED|Extension Phase||118||
48732904|NCT03927144|102130247|FG000|COMPLETED|Extension Phase||328||
48732905|NCT03927144|102130248|FG001|COMPLETED|Extension Phase||108||
48159136|NCT02417064|100711207|FG001|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||19||
48315737|NCT00219284|101097512|FG000|COMPLETED|Extension Phase - 8 Weeks||112||
48315738|NCT00219284|101097513|FG001|COMPLETED|Extension Phase - 8 Weeks||99||
48315739|NCT00219284|101097512|FG000|NOT COMPLETED|Extension Phase - 8 Weeks||2||
48315740|NCT00219284|101097513|FG001|NOT COMPLETED|Extension Phase - 8 Weeks||7||
48315741|NCT02201420|101097514|FG000|STARTED|Overall Study||5||
48315742|NCT02201420|101097514|FG000|COMPLETED|Overall Study||5||
48315743|NCT02201420|101097514|FG000|NOT COMPLETED|Overall Study||0||
48315744|NCT04544475|101097515|FG000|STARTED|Overall Study||23||
48315745|NCT04544475|101097516|FG001|STARTED|Overall Study||26||
48732906|NCT03927144|102130247|FG000|NOT COMPLETED|Extension Phase||15||
48732907|NCT03927144|102130248|FG001|NOT COMPLETED|Extension Phase||10||
48732908|NCT03043391|102130249|FG000|STARTED|Overall Study||8||
48732909|NCT03043391|102130249|FG000|COMPLETED|Overall Study||8||
48732910|NCT03043391|102130249|FG000|NOT COMPLETED|Overall Study||0||
48732911|NCT00177255|102130250|FG000|STARTED|Overall Study||39||
48159137|NCT02417064|100711208|FG002|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6||
48159138|NCT02417064|100711206|FG000|STARTED|Follow-up Phase (24 Weeks)||47||
48159139|NCT02417064|100711207|FG001|STARTED|Follow-up Phase (24 Weeks)||52||
48159140|NCT02417064|100711208|FG002|STARTED|Follow-up Phase (24 Weeks)||69||
48159141|NCT02417064|100711206|FG000|COMPLETED|Follow-up Phase (24 Weeks)||8||
48159142|NCT02417064|100711207|FG001|COMPLETED|Follow-up Phase (24 Weeks)||10||
48159143|NCT02417064|100711208|FG002|COMPLETED|Follow-up Phase (24 Weeks)||18||
48159144|NCT02417064|100711206|FG000|NOT COMPLETED|Follow-up Phase (24 Weeks)||39||
48159145|NCT02417064|100711207|FG001|NOT COMPLETED|Follow-up Phase (24 Weeks)||42||
48159146|NCT02417064|100711208|FG002|NOT COMPLETED|Follow-up Phase (24 Weeks)||51||
48159147|NCT01760889|100711209|FG000|STARTED|Overall Study||0||
48159148|NCT01760889|100711210|FG001|STARTED|Overall Study||0||
48159149|NCT01760889|100711211|FG002|STARTED|Overall Study||0||
48159150|NCT01760889|100711209|FG000|COMPLETED|Overall Study||0||
48159151|NCT01760889|100711210|FG001|COMPLETED|Overall Study||0||
48159152|NCT01760889|100711211|FG002|COMPLETED|Overall Study||0||
48159153|NCT01760889|100711209|FG000|NOT COMPLETED|Overall Study||0||
48159154|NCT01760889|100711210|FG001|NOT COMPLETED|Overall Study||0||
48159155|NCT01760889|100711211|FG002|NOT COMPLETED|Overall Study||0||
48159156|NCT04552743|100711212|FG000|STARTED|Overall Study||25||
48159157|NCT04552743|100711212|FG000|COMPLETED|Overall Study||25||
48159158|NCT04552743|100711212|FG000|NOT COMPLETED|Overall Study||0||
48159159|NCT01292070|100711213|FG000|STARTED|Overall Study||4||
48159160|NCT01292070|100711213|FG000|COMPLETED|Overall Study||4||
48159161|NCT01292070|100711213|FG000|NOT COMPLETED|Overall Study||0||
48159162|NCT03036384|100711214|FG000|STARTED|Overall Study||4||
48159163|NCT03036384|100711215|FG001|STARTED|Overall Study||4||
48159164|NCT03036384|100711216|FG002|STARTED|Overall Study||4||
48159165|NCT03036384|100711217|FG003|STARTED|Overall Study||4||
48159166|NCT03036384|100711218|FG004|STARTED|Overall Study||4||
48159167|NCT03036384|100711219|FG005|STARTED|Overall Study||4||
48159168|NCT03036384|100711220|FG006|STARTED|Overall Study||4||
48159169|NCT03036384|100711221|FG007|STARTED|Overall Study||4||
48159170|NCT03036384|100711222|FG008|STARTED|Overall Study||4||
48159171|NCT03036384|100711223|FG009|STARTED|Overall Study||4||
48159172|NCT03036384|100711214|FG000|COMPLETED|Overall Study||4||
48159173|NCT03036384|100711215|FG001|COMPLETED|Overall Study||4||
48159174|NCT03036384|100711216|FG002|COMPLETED|Overall Study||4||
48159175|NCT03036384|100711217|FG003|COMPLETED|Overall Study||4||
48159176|NCT03036384|100711218|FG004|COMPLETED|Overall Study||4||
48159177|NCT03036384|100711219|FG005|COMPLETED|Overall Study||4||
48159178|NCT03036384|100711220|FG006|COMPLETED|Overall Study||4||
48159179|NCT03036384|100711221|FG007|COMPLETED|Overall Study||4||
48159180|NCT03036384|100711222|FG008|COMPLETED|Overall Study||4||
48159181|NCT03036384|100711223|FG009|COMPLETED|Overall Study||4||
48159182|NCT03036384|100711214|FG000|NOT COMPLETED|Overall Study||0||
48159183|NCT03036384|100711215|FG001|NOT COMPLETED|Overall Study||0||
48159184|NCT03036384|100711216|FG002|NOT COMPLETED|Overall Study||0||
48159185|NCT03036384|100711217|FG003|NOT COMPLETED|Overall Study||0||
48315746|NCT04544475|101097515|FG000|COMPLETED|Overall Study||22||
48315747|NCT04544475|101097516|FG001|COMPLETED|Overall Study||23||
48732912|NCT00177255|102130250|FG000|COMPLETED|Overall Study||39||
48732913|NCT00177255|102130250|FG000|NOT COMPLETED|Overall Study||0||
48159186|NCT03036384|100711218|FG004|NOT COMPLETED|Overall Study||0||
48159187|NCT03036384|100711219|FG005|NOT COMPLETED|Overall Study||0||
48159188|NCT03036384|100711220|FG006|NOT COMPLETED|Overall Study||0||
48159189|NCT03036384|100711221|FG007|NOT COMPLETED|Overall Study||0||
48159190|NCT03036384|100711222|FG008|NOT COMPLETED|Overall Study||0||
48732914|NCT02161380|102130251|FG000|STARTED|Overall Study||9||
48732915|NCT02161380|102130252|FG001|STARTED|Overall Study||9||
48159191|NCT03036384|100711223|FG009|NOT COMPLETED|Overall Study||0||
48614831|NCT01655719|101841848|FG000|STARTED|Overall Study||1||
48614832|NCT01655719|101841848|FG000|COMPLETED|Overall Study||1||
48614833|NCT01655719|101841848|FG000|NOT COMPLETED|Overall Study||0||
48614834|NCT02258659|101841849|FG000|STARTED|Overall Study||62||
48614835|NCT02258659|101841849|FG000|COMPLETED|Overall Study||61||
48614836|NCT02258659|101841849|FG000|NOT COMPLETED|Overall Study||1||
48614837|NCT04865029|101841850|FG000|STARTED|Overall Study||5||
48614838|NCT04865029|101841851|FG001|STARTED|Overall Study||5||
48159192|NCT00662857|100711224|FG000|STARTED|TI Dosing Period 1 (1 Day)||13||
48159193|NCT00662857|100711225|FG001|STARTED|TI Dosing Period 1 (1 Day)||16||
48159194|NCT00662857|100711224|FG000|COMPLETED|TI Dosing Period 1 (1 Day)||13||
48159195|NCT00662857|100711225|FG001|COMPLETED|TI Dosing Period 1 (1 Day)||16||
48159196|NCT00662857|100711224|FG000|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0||
48614839|NCT04865029|101841850|FG000|COMPLETED|Overall Study||5||
48159197|NCT00662857|100711225|FG001|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0||
48159198|NCT00662857|100711224|FG000|STARTED|Washout 1 (3 - 14 Days)||13||
48159199|NCT00662857|100711225|FG001|STARTED|Washout 1 (3 - 14 Days)||16||
48159200|NCT00662857|100711224|FG000|COMPLETED|Washout 1 (3 - 14 Days)||13||
48159201|NCT00662857|100711225|FG001|COMPLETED|Washout 1 (3 - 14 Days)||14||
48159202|NCT00662857|100711224|FG000|NOT COMPLETED|Washout 1 (3 - 14 Days)||0||
48159203|NCT00662857|100711225|FG001|NOT COMPLETED|Washout 1 (3 - 14 Days)||2||
48159204|NCT00662857|100711224|FG000|STARTED|TI Dosing Period 2 (1 Day)||13||
48159205|NCT00662857|100711225|FG001|STARTED|TI Dosing Period 2 (1 Day)||14||
48159206|NCT00662857|100711224|FG000|COMPLETED|TI Dosing Period 2 (1 Day)||13||
48159207|NCT00662857|100711225|FG001|COMPLETED|TI Dosing Period 2 (1 Day)||14||
48159208|NCT00662857|100711224|FG000|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0||
48159209|NCT00662857|100711225|FG001|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0||
48159210|NCT00662857|100711224|FG000|STARTED|Washout 2 (3 - 14 Days)||13||
48159211|NCT00662857|100711225|FG001|STARTED|Washout 2 (3 - 14 Days)||14||
48159212|NCT00662857|100711224|FG000|COMPLETED|Washout 2 (3 - 14 Days)||12||
48159213|NCT00662857|100711225|FG001|COMPLETED|Washout 2 (3 - 14 Days)||14||
48159214|NCT00662857|100711224|FG000|NOT COMPLETED|Washout 2 (3 - 14 Days)||1||
48614840|NCT04865029|101841851|FG001|COMPLETED|Overall Study||5||
48614841|NCT04865029|101841850|FG000|NOT COMPLETED|Overall Study||0||
48614842|NCT04865029|101841851|FG001|NOT COMPLETED|Overall Study||0||
48614843|NCT05404711|101841852|FG000|STARTED|Completed Study Visit||40||
48614844|NCT05404711|101841852|FG000|COMPLETED|Completed Study Visit||39||
48159215|NCT00662857|100711225|FG001|NOT COMPLETED|Washout 2 (3 - 14 Days)||0||
48159216|NCT00662857|100711224|FG000|STARTED|Lispro Dosing Period (1 Day)||12||
48159217|NCT00662857|100711225|FG001|STARTED|Lispro Dosing Period (1 Day)||14||
48159218|NCT00662857|100711224|FG000|COMPLETED|Lispro Dosing Period (1 Day)||12||
48159219|NCT00662857|100711225|FG001|COMPLETED|Lispro Dosing Period (1 Day)||14||
48159220|NCT00662857|100711224|FG000|NOT COMPLETED|Lispro Dosing Period (1 Day)||0||
48159221|NCT00662857|100711225|FG001|NOT COMPLETED|Lispro Dosing Period (1 Day)||0||
48159222|NCT04062448|100711226|FG000|STARTED|Overall Study||16||
48159223|NCT04062448|100711226|FG000|COMPLETED|Overall Study||13||
48159224|NCT04062448|100711226|FG000|NOT COMPLETED|Overall Study||3||
48159225|NCT05056870|100711227|FG000|STARTED|Period 1||80||
48614845|NCT05404711|101841852|FG000|NOT COMPLETED|Completed Study Visit||1||
48614846|NCT05404711|101841852|FG000|STARTED|Completed 75-gram, 2-hour CGM-OGTT||39||
48159226|NCT05056870|100711228|FG001|STARTED|Period 1||81||
48159227|NCT05056870|100711227|FG000|COMPLETED|Period 1||76||
48159228|NCT05056870|100711228|FG001|COMPLETED|Period 1||77||
48159229|NCT05056870|100711227|FG000|NOT COMPLETED|Period 1||4||
48159230|NCT05056870|100711228|FG001|NOT COMPLETED|Period 1||4||
48159231|NCT05056870|100711227|FG000|STARTED|Period 2||76||
48159232|NCT05056870|100711228|FG001|STARTED|Period 2||77||
48159233|NCT05056870|100711227|FG000|COMPLETED|Period 2||74||
48159234|NCT05056870|100711228|FG001|COMPLETED|Period 2||77||
48159235|NCT05056870|100711227|FG000|NOT COMPLETED|Period 2||2||
48159236|NCT05056870|100711228|FG001|NOT COMPLETED|Period 2||0||
48159237|NCT04539821|100711229|FG000|STARTED|Overall Study||44||
48159238|NCT04539821|100711229|FG000|Engaged in CPS Care|Overall Study||21|these individuals engaged in care with the clinical pharmacists and made changes to their opioid regimen|
48159239|NCT04539821|100711229|FG000|COMPLETED|Overall Study||19||
48159240|NCT04539821|100711229|FG000|NOT COMPLETED|Overall Study||25||
48159241|NCT00834808|100711230|FG000|STARTED|Treatment Period 1 (Day 1)||9||
48614847|NCT05404711|101841852|FG000|COMPLETED|Completed 75-gram, 2-hour CGM-OGTT||35||
48614848|NCT05404711|101841852|FG000|NOT COMPLETED|Completed 75-gram, 2-hour CGM-OGTT||4||
48614849|NCT05404711|101841852|FG000|STARTED|Valid 75-gram, 2-hour CGM-OGTT||35||
48732916|NCT02161380|102130253|FG002|STARTED|Overall Study||3||
48159242|NCT00834808|100711231|FG001|STARTED|Treatment Period 1 (Day 1)||9||
48159243|NCT00834808|100711232|FG002|STARTED|Treatment Period 1 (Day 1)||9||
48159244|NCT00834808|100711230|FG000|COMPLETED|Treatment Period 1 (Day 1)||9||
48315748|NCT04544475|101097515|FG000|NOT COMPLETED|Overall Study||1||
48315749|NCT04544475|101097516|FG001|NOT COMPLETED|Overall Study||3||
48315750|NCT01648790|101097517|FG000|STARTED|Treatment 1||4||
48315751|NCT01648790|101097518|FG001|STARTED|Treatment 1||4||
48315752|NCT01648790|101097519|FG002|STARTED|Treatment 1||4||
48315753|NCT01648790|101097520|FG003|STARTED|Treatment 1||4||
48315754|NCT01648790|101097521|FG004|STARTED|Treatment 1||4||
48315755|NCT01648790|101097517|FG000|Received at Least 1 Dose of Study Drug|Treatment 1||4||
48315756|NCT01648790|101097518|FG001|Received at Least 1 Dose of Study Drug|Treatment 1||4||
48315757|NCT01648790|101097519|FG002|Received at Least 1 Dose of Study Drug|Treatment 1||4||
48315758|NCT01648790|101097520|FG003|Received at Least 1 Dose of Study Drug|Treatment 1||4||
48315759|NCT01648790|101097521|FG004|Received at Least 1 Dose of Study Drug|Treatment 1||4||
48315760|NCT01648790|101097517|FG000|COMPLETED|Treatment 1||4||
48315761|NCT01648790|101097518|FG001|COMPLETED|Treatment 1||4||
48315762|NCT01648790|101097519|FG002|COMPLETED|Treatment 1||4||
48315763|NCT01648790|101097520|FG003|COMPLETED|Treatment 1||4||
48315764|NCT01648790|101097521|FG004|COMPLETED|Treatment 1||4||
48732917|NCT02161380|102130254|FG003|STARTED|Overall Study||7||
48732918|NCT02161380|102130251|FG000|Chronic Bilateral|Overall Study||3||
48732919|NCT02161380|102130252|FG001|Chronic Bilateral|Overall Study||3||
48732920|NCT02161380|102130253|FG002|Chronic Bilateral|Overall Study||3||
48732921|NCT02161380|102130254|FG003|Chronic Bilateral|Overall Study||2||
48732922|NCT02161380|102130251|FG000|Acute Bilateral|Overall Study||3||
48732923|NCT02161380|102130252|FG001|Acute Bilateral|Overall Study||3||
48732924|NCT02161380|102130253|FG002|Acute Bilateral|Overall Study||0||
48732925|NCT02161380|102130254|FG003|Acute Bilateral|Overall Study||3||
48732926|NCT02161380|102130251|FG000|Acute Unilateral|Overall Study||3||
48732927|NCT02161380|102130252|FG001|Acute Unilateral|Overall Study||3||
48732928|NCT02161380|102130253|FG002|Acute Unilateral|Overall Study||0||
48732929|NCT02161380|102130254|FG003|Acute Unilateral|Overall Study||2||
48732930|NCT02161380|102130251|FG000|COMPLETED|Overall Study||9||
48732931|NCT02161380|102130252|FG001|COMPLETED|Overall Study||8||
48732932|NCT02161380|102130253|FG002|COMPLETED|Overall Study||3||
48732933|NCT02161380|102130254|FG003|COMPLETED|Overall Study||7||
48732934|NCT02161380|102130251|FG000|NOT COMPLETED|Overall Study||0||
48732935|NCT02161380|102130252|FG001|NOT COMPLETED|Overall Study||1||
48732936|NCT02161380|102130253|FG002|NOT COMPLETED|Overall Study||0||
48315765|NCT01648790|101097517|FG000|NOT COMPLETED|Treatment 1||0||
48315766|NCT01648790|101097518|FG001|NOT COMPLETED|Treatment 1||0||
48315767|NCT01648790|101097519|FG002|NOT COMPLETED|Treatment 1||0||
48315768|NCT01648790|101097520|FG003|NOT COMPLETED|Treatment 1||0||
48315769|NCT01648790|101097521|FG004|NOT COMPLETED|Treatment 1||0||
48315770|NCT01648790|101097517|FG000|STARTED|Treatment 2||4||
48315771|NCT01648790|101097518|FG001|STARTED|Treatment 2||4||
48315772|NCT01648790|101097519|FG002|STARTED|Treatment 2||4||
48315773|NCT01648790|101097520|FG003|STARTED|Treatment 2||4||
48315774|NCT01648790|101097521|FG004|STARTED|Treatment 2||4||
48315775|NCT01648790|101097517|FG000|COMPLETED|Treatment 2||4||
48315776|NCT01648790|101097518|FG001|COMPLETED|Treatment 2||4||
48315777|NCT01648790|101097519|FG002|COMPLETED|Treatment 2||4||
48315778|NCT01648790|101097520|FG003|COMPLETED|Treatment 2||4||
48315779|NCT01648790|101097521|FG004|COMPLETED|Treatment 2||4||
48315780|NCT01648790|101097517|FG000|NOT COMPLETED|Treatment 2||0||
48315781|NCT01648790|101097518|FG001|NOT COMPLETED|Treatment 2||0||
48315782|NCT01648790|101097519|FG002|NOT COMPLETED|Treatment 2||0||
48315783|NCT01648790|101097520|FG003|NOT COMPLETED|Treatment 2||0||
48315784|NCT01648790|101097521|FG004|NOT COMPLETED|Treatment 2||0||
48315785|NCT01648790|101097517|FG000|STARTED|Treatment 3||4||
48315786|NCT01648790|101097518|FG001|STARTED|Treatment 3||4||
48732937|NCT02161380|102130254|FG003|NOT COMPLETED|Overall Study||0||
48732938|NCT03437577|102130255|FG000|STARTED|Pre-Randomization||0||
48732939|NCT03437577|102130256|FG001|STARTED|Pre-Randomization||0||
48732940|NCT03437577|102130257|FG002|STARTED|Pre-Randomization||10||
48732941|NCT03437577|102130255|FG000|COMPLETED|Pre-Randomization||0||
48315787|NCT01648790|101097519|FG002|STARTED|Treatment 3||4||
48315788|NCT01648790|101097520|FG003|STARTED|Treatment 3||4||
48315789|NCT01648790|101097521|FG004|STARTED|Treatment 3||4||
48315790|NCT01648790|101097517|FG000|COMPLETED|Treatment 3||4||
48315791|NCT01648790|101097518|FG001|COMPLETED|Treatment 3||4||
48315792|NCT01648790|101097519|FG002|COMPLETED|Treatment 3||4||
48315793|NCT01648790|101097520|FG003|COMPLETED|Treatment 3||3||
48315794|NCT01648790|101097521|FG004|COMPLETED|Treatment 3||4||
48315795|NCT01648790|101097517|FG000|NOT COMPLETED|Treatment 3||0||
48315796|NCT01648790|101097518|FG001|NOT COMPLETED|Treatment 3||0||
48315797|NCT01648790|101097519|FG002|NOT COMPLETED|Treatment 3||0||
48315798|NCT01648790|101097520|FG003|NOT COMPLETED|Treatment 3||1||
48315799|NCT01648790|101097521|FG004|NOT COMPLETED|Treatment 3||0||
48315800|NCT01648790|101097517|FG000|STARTED|Treatment 4||4||
48315801|NCT01648790|101097518|FG001|STARTED|Treatment 4||4||
48315802|NCT01648790|101097519|FG002|STARTED|Treatment 4||4||
48732942|NCT03437577|102130256|FG001|COMPLETED|Pre-Randomization||0||
48315803|NCT01648790|101097520|FG003|STARTED|Treatment 4||3||
48732943|NCT03437577|102130257|FG002|COMPLETED|Pre-Randomization||0||
48732944|NCT03437577|102130255|FG000|NOT COMPLETED|Pre-Randomization||0||
48732945|NCT03437577|102130256|FG001|NOT COMPLETED|Pre-Randomization||0||
48315804|NCT01648790|101097521|FG004|STARTED|Treatment 4||4||
48315805|NCT01648790|101097517|FG000|COMPLETED|Treatment 4||4||
48315806|NCT01648790|101097518|FG001|COMPLETED|Treatment 4||4||
48315807|NCT01648790|101097519|FG002|COMPLETED|Treatment 4||4||
48315808|NCT01648790|101097520|FG003|COMPLETED|Treatment 4||3||
48315809|NCT01648790|101097521|FG004|COMPLETED|Treatment 4||4||
48315810|NCT01648790|101097517|FG000|NOT COMPLETED|Treatment 4||0||
48315811|NCT01648790|101097518|FG001|NOT COMPLETED|Treatment 4||0||
48315812|NCT01648790|101097519|FG002|NOT COMPLETED|Treatment 4||0||
48315813|NCT01648790|101097520|FG003|NOT COMPLETED|Treatment 4||0||
48315814|NCT01648790|101097521|FG004|NOT COMPLETED|Treatment 4||0||
48315815|NCT01648790|101097517|FG000|STARTED|Treatment 5||4||
48315816|NCT01648790|101097518|FG001|STARTED|Treatment 5||4||
48315817|NCT01648790|101097519|FG002|STARTED|Treatment 5||4||
48315818|NCT01648790|101097520|FG003|STARTED|Treatment 5||3||
48315819|NCT01648790|101097521|FG004|STARTED|Treatment 5||4||
48315820|NCT01648790|101097517|FG000|COMPLETED|Treatment 5||4||
48315821|NCT01648790|101097518|FG001|COMPLETED|Treatment 5||4||
48315822|NCT01648790|101097519|FG002|COMPLETED|Treatment 5||4||
48315823|NCT01648790|101097520|FG003|COMPLETED|Treatment 5||3||
48315824|NCT01648790|101097521|FG004|COMPLETED|Treatment 5||4||
48315825|NCT01648790|101097517|FG000|NOT COMPLETED|Treatment 5||0||
48315826|NCT01648790|101097518|FG001|NOT COMPLETED|Treatment 5||0||
48315827|NCT01648790|101097519|FG002|NOT COMPLETED|Treatment 5||0||
48315828|NCT01648790|101097520|FG003|NOT COMPLETED|Treatment 5||0||
48315829|NCT01648790|101097521|FG004|NOT COMPLETED|Treatment 5||0||
48406925|NCT03424044|101328489|FG005|NOT COMPLETED|Third Intervention (76 Hours)||0||
48406926|NCT03424044|101328490|FG006|NOT COMPLETED|Third Intervention (76 Hours)||1||
48406927|NCT03424044|101328491|FG007|NOT COMPLETED|Third Intervention (76 Hours)||0||
48406928|NCT03424044|101328492|FG008|NOT COMPLETED|Third Intervention (76 Hours)||0||
48614850|NCT05404711|101841852|FG000|COMPLETED|Valid 75-gram, 2-hour CGM-OGTT||30||
48614851|NCT05404711|101841852|FG000|NOT COMPLETED|Valid 75-gram, 2-hour CGM-OGTT||5||
48614852|NCT05404711|101841852|FG000|STARTED|Completed, Valid Lab-OGTT and CGM-OGTT||30||
48614853|NCT05404711|101841852|FG000|COMPLETED|Completed, Valid Lab-OGTT and CGM-OGTT||29||
48614854|NCT05404711|101841852|FG000|NOT COMPLETED|Completed, Valid Lab-OGTT and CGM-OGTT||1||
48406929|NCT03424044|101328484|FG000|STARTED|Optional Fourth Rest Period (7-45 Days)||0||
48406930|NCT03424044|101328485|FG001|STARTED|Optional Fourth Rest Period (7-45 Days)||0||
48406931|NCT03424044|101328486|FG002|STARTED|Optional Fourth Rest Period (7-45 Days)||0||
48406932|NCT03424044|101328487|FG003|STARTED|Optional Fourth Rest Period (7-45 Days)||0||
48406933|NCT03424044|101328488|FG004|STARTED|Optional Fourth Rest Period (7-45 Days)||0||
48614855|NCT01639144|101841853|FG000|STARTED|Overall Study||260||
48614856|NCT01639144|101841854|FG001|STARTED|Overall Study||255||
48614857|NCT01639144|101841853|FG000|COMPLETED|Overall Study||250||
48614858|NCT01639144|101841854|FG001|COMPLETED|Overall Study||250||
48614859|NCT01639144|101841853|FG000|NOT COMPLETED|Overall Study||10||
48614860|NCT01639144|101841854|FG001|NOT COMPLETED|Overall Study||5||
48315830|NCT00761306|101097522|FG000|STARTED|Overall Study||74||
48315831|NCT00761306|101097522|FG000|COMPLETED|Overall Study||54||
48315832|NCT00761306|101097522|FG000|NOT COMPLETED|Overall Study||20||
48315833|NCT05162027|101100976|FG000|STARTED|Overall Study||1||
48315834|NCT05162027|101100977|FG001|STARTED|Overall Study||1||
48315835|NCT05162027|101100976|FG000|COMPLETED|Overall Study||0||
48315836|NCT05162027|101100977|FG001|COMPLETED|Overall Study||1||
48315837|NCT05162027|101100976|FG000|NOT COMPLETED|Overall Study||1||
48315838|NCT05162027|101100977|FG001|NOT COMPLETED|Overall Study||0||
48315839|NCT03491007|101100978|FG000|STARTED|Overall Study||3||
48315840|NCT03491007|101100979|FG001|STARTED|Overall Study||2||
48315841|NCT03491007|101100978|FG000|COMPLETED|Overall Study||0||
48315842|NCT03491007|101100979|FG001|COMPLETED|Overall Study||1||
48315843|NCT03491007|101100978|FG000|NOT COMPLETED|Overall Study||3||
48315844|NCT03491007|101100979|FG001|NOT COMPLETED|Overall Study||1||
48315845|NCT01816061|101100980|FG000|STARTED|Overall Study||40||
48315846|NCT01816061|101100981|FG001|STARTED|Overall Study||51||
48315847|NCT01816061|101100980|FG000|COMPLETED|Overall Study||27||
48315848|NCT01816061|101100981|FG001|COMPLETED|Overall Study||27||
48315849|NCT01816061|101100980|FG000|NOT COMPLETED|Overall Study||13||
48315850|NCT01816061|101100981|FG001|NOT COMPLETED|Overall Study||24||
48315851|NCT01475175|101100982|FG000|STARTED|Overall Study||12||
48315852|NCT01475175|101100982|FG000|COMPLETED|Overall Study||12||
48315853|NCT01475175|101100982|FG000|NOT COMPLETED|Overall Study||0||
48315854|NCT01143727|101100983|FG000|STARTED|Overall Study||9||
48315855|NCT01143727|101100984|FG001|STARTED|Overall Study||8||
48315856|NCT01143727|101100983|FG000|COMPLETED|Overall Study||9||
48315857|NCT01143727|101100984|FG001|COMPLETED|Overall Study||8||
48315858|NCT01143727|101100983|FG000|NOT COMPLETED|Overall Study||0||
48406934|NCT03424044|101328489|FG005|STARTED|Optional Fourth Rest Period (7-45 Days)||0||
48406935|NCT03424044|101328490|FG006|STARTED|Optional Fourth Rest Period (7-45 Days)||0||
48406936|NCT03424044|101328491|FG007|STARTED|Optional Fourth Rest Period (7-45 Days)||1||
48406937|NCT03424044|101328492|FG008|STARTED|Optional Fourth Rest Period (7-45 Days)||1||
48406938|NCT03424044|101328484|FG000|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0||
48406939|NCT03424044|101328485|FG001|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0||
48406940|NCT03424044|101328486|FG002|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0||
48406941|NCT03424044|101328487|FG003|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0||
48406942|NCT03424044|101328488|FG004|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0||
48406943|NCT03424044|101328489|FG005|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0||
48406944|NCT03424044|101328490|FG006|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0||
48406945|NCT03424044|101328491|FG007|COMPLETED|Optional Fourth Rest Period (7-45 Days)||1||
48406946|NCT03424044|101328492|FG008|COMPLETED|Optional Fourth Rest Period (7-45 Days)||1||
48406947|NCT03424044|101328484|FG000|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0||
48406948|NCT03424044|101328485|FG001|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0||
48315859|NCT01143727|101100984|FG001|NOT COMPLETED|Overall Study||0||
48315860|NCT00806195|101100985|FG000|STARTED|Overall Study||4363||
48315861|NCT00806195|101100986|FG001|STARTED|Overall Study||1483||
48315862|NCT00806195|101100987|FG002|STARTED|Overall Study||1409||
48315863|NCT00806195|101100988|FG003|STARTED|Overall Study||489||
48315864|NCT00806195|101100985|FG000|COMPLETED|Overall Study||3849||
48315865|NCT00806195|101100986|FG001|COMPLETED|Overall Study||1321||
48315866|NCT00806195|101100987|FG002|COMPLETED|Overall Study||1139||
48315867|NCT00806195|101100988|FG003|COMPLETED|Overall Study||383||
48315868|NCT00806195|101100985|FG000|NOT COMPLETED|Overall Study||514||
48315869|NCT00806195|101100986|FG001|NOT COMPLETED|Overall Study||162||
48315870|NCT00806195|101100987|FG002|NOT COMPLETED|Overall Study||270||
48315871|NCT00806195|101100988|FG003|NOT COMPLETED|Overall Study||106||
48315872|NCT01793142|101100989|FG000|STARTED|Overall Study||3430||
48315873|NCT01793142|101100989|FG000|Treated|Overall Study||3423||
48315874|NCT01793142|101100989|FG000|COMPLETED|Overall Study||3423||
48315875|NCT01793142|101100989|FG000|NOT COMPLETED|Overall Study||7||
48315876|NCT02414399|101100990|FG000|STARTED|Overall Study||702||
48315877|NCT02414399|101100991|FG001|STARTED|Overall Study||696||
48315878|NCT02414399|101100990|FG000|COMPLETED|Overall Study||702||
48315879|NCT02414399|101100991|FG001|COMPLETED|Overall Study||696||
48315880|NCT02414399|101100990|FG000|NOT COMPLETED|Overall Study||0||
48315881|NCT02414399|101100991|FG001|NOT COMPLETED|Overall Study||0||
48315882|NCT04206605|101100992|FG000|STARTED|Overall Study||27||
48315883|NCT04206605|101100993|FG001|STARTED|Overall Study||50||
48315884|NCT04206605|101100992|FG000|Steady State Full Analysis Set (SS-FAS)|Overall Study||27|SS-FAS included all randomized participants who received any exposure to the investigational product during the presumed steady state period (Day 70 through Day 182).|
48315885|NCT04206605|101100993|FG001|Steady State Full Analysis Set (SS-FAS)|Overall Study||49|SS-FAS included all randomized participants who received any exposure to the investigational product during the presumed steady state period (Day 70 through Day 182).|
48315886|NCT04206605|101100992|FG000|COMPLETED|Overall Study||26||
48315887|NCT04206605|101100993|FG001|COMPLETED|Overall Study||49||
48315888|NCT04206605|101100992|FG000|NOT COMPLETED|Overall Study||1||
48315889|NCT04206605|101100993|FG001|NOT COMPLETED|Overall Study||1||
48315890|NCT01017003|101100994|FG000|STARTED|Single Dose Colchicine 0.6 mg, Day 1||13||
48315891|NCT01017003|101100994|FG000|COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||13||
48315892|NCT01017003|101100994|FG000|NOT COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||0||
48315893|NCT01017003|101100994|FG000|STARTED|14 Day Washout Period||13||
48315894|NCT01017003|101100994|FG000|COMPLETED|14 Day Washout Period||13||
48315895|NCT01017003|101100994|FG000|NOT COMPLETED|14 Day Washout Period||0||
48315896|NCT01017003|101100994|FG000|STARTED|Colchicine 0.6 mg Twice Daily x 10 Days||13||
48315897|NCT01017003|101100994|FG000|COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||13||
48159245|NCT00834808|100711231|FG001|COMPLETED|Treatment Period 1 (Day 1)||9||
48159246|NCT00834808|100711232|FG002|COMPLETED|Treatment Period 1 (Day 1)||9||
48159247|NCT00834808|100711230|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48315898|NCT01017003|101100994|FG000|NOT COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||0||
48315899|NCT01017003|101100994|FG000|STARTED|Colchicine 0.6 mg Final Dose||13||
48315900|NCT01017003|101100994|FG000|COMPLETED|Colchicine 0.6 mg Final Dose||13||
48315901|NCT01017003|101100994|FG000|NOT COMPLETED|Colchicine 0.6 mg Final Dose||0||
48315902|NCT02428855|101100995|FG000|STARTED|Overall Study||8||
48159248|NCT00834808|100711231|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48159249|NCT00834808|100711232|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48159250|NCT00834808|100711230|FG000|STARTED|Treatment Period 2 (Day 8)||9||
48159251|NCT00834808|100711231|FG001|STARTED|Treatment Period 2 (Day 8)||9||
48159252|NCT00834808|100711232|FG002|STARTED|Treatment Period 2 (Day 8)||9||
48159253|NCT00834808|100711230|FG000|COMPLETED|Treatment Period 2 (Day 8)||9||
48159254|NCT00834808|100711231|FG001|COMPLETED|Treatment Period 2 (Day 8)||9||
48159255|NCT00834808|100711232|FG002|COMPLETED|Treatment Period 2 (Day 8)||9||
48159256|NCT00834808|100711230|FG000|NOT COMPLETED|Treatment Period 2 (Day 8)||0||
48159257|NCT00834808|100711231|FG001|NOT COMPLETED|Treatment Period 2 (Day 8)||0||
48159258|NCT00834808|100711232|FG002|NOT COMPLETED|Treatment Period 2 (Day 8)||0||
48159259|NCT00834808|100711230|FG000|STARTED|Treatment Period 3 (Day 15)||9||
48159260|NCT00834808|100711231|FG001|STARTED|Treatment Period 3 (Day 15)||9||
48159261|NCT00834808|100711232|FG002|STARTED|Treatment Period 3 (Day 15)||9||
48159262|NCT00834808|100711230|FG000|COMPLETED|Treatment Period 3 (Day 15)||9||
48159263|NCT00834808|100711231|FG001|COMPLETED|Treatment Period 3 (Day 15)||9||
48159264|NCT00834808|100711232|FG002|COMPLETED|Treatment Period 3 (Day 15)||9||
48159265|NCT00834808|100711230|FG000|NOT COMPLETED|Treatment Period 3 (Day 15)||0||
48159266|NCT00834808|100711231|FG001|NOT COMPLETED|Treatment Period 3 (Day 15)||0||
48159267|NCT00834808|100711232|FG002|NOT COMPLETED|Treatment Period 3 (Day 15)||0||
48159268|NCT03002610|100711233|FG000|STARTED|Overall Study||24||
48159269|NCT03002610|100711234|FG001|STARTED|Overall Study||50||
48159270|NCT03002610|100711235|FG002|STARTED|Overall Study||34||
48159271|NCT03002610|100711233|FG000|COMPLETED|Overall Study||18||
48159272|NCT03002610|100711234|FG001|COMPLETED|Overall Study||25||
48159273|NCT03002610|100711235|FG002|COMPLETED|Overall Study||21||
48159274|NCT03002610|100711233|FG000|NOT COMPLETED|Overall Study||6||
48159275|NCT03002610|100711234|FG001|NOT COMPLETED|Overall Study||25||
48159276|NCT03002610|100711235|FG002|NOT COMPLETED|Overall Study||13||
48159277|NCT01489189|100711236|FG000|STARTED|Overall Study||191||
48159278|NCT01489189|100711237|FG001|STARTED|Overall Study||203||
48159279|NCT01489189|100711236|FG000|COMPLETED|Overall Study||160||
48159280|NCT01489189|100711237|FG001|COMPLETED|Overall Study||168||
48159281|NCT01489189|100711236|FG000|NOT COMPLETED|Overall Study||31||
48159282|NCT01489189|100711237|FG001|NOT COMPLETED|Overall Study||35||
48159283|NCT00886639|100711238|FG000|STARTED|Overall Study||127||
48159284|NCT00886639|100711238|FG000|COMPLETED|Overall Study||111||
48159285|NCT00886639|100711238|FG000|NOT COMPLETED|Overall Study||16||
48159286|NCT05120115|100711239|FG000|STARTED|Overall Study||21||
48159287|NCT05120115|100711239|FG000|no Weight|Overall Study||21||
48159288|NCT05120115|100711239|FG000|4kg and Bilateral Weight Distribution|Overall Study||21||
48159289|NCT05120115|100711239|FG000|6kg and Bilateral Weight Distriubtion|Overall Study||21||
48159290|NCT05120115|100711239|FG000|8 kg and Bilateral Weight Distriubtion|Overall Study||21||
48159291|NCT05120115|100711239|FG000|4 kg and Lumbar Weight Distriubtion|Overall Study||21||
48159292|NCT05120115|100711239|FG000|6kg and Lumbar Weight Distriubtion|Overall Study||21||
48159293|NCT05120115|100711239|FG000|8 kg and Lumbar Weight Distribution|Overall Study||21||
48315903|NCT02428855|101100995|FG000|COMPLETED|Overall Study||6||
48315904|NCT02428855|101100995|FG000|NOT COMPLETED|Overall Study||2||
48159294|NCT05120115|100711239|FG000|4kg and Unilateral Weight Distribution|Overall Study||21||
48159295|NCT05120115|100711239|FG000|6kg and Unilateral Weight Distribution|Overall Study||21||
48159296|NCT05120115|100711239|FG000|8kg and Unilateral Weight Distribution|Overall Study||21||
48159297|NCT05120115|100711239|FG000|COMPLETED|Overall Study||21||
48159298|NCT05120115|100711239|FG000|NOT COMPLETED|Overall Study||0||
48159299|NCT02207725|100711240|FG000|STARTED|Overall Study||9||
48159300|NCT02207725|100711241|FG001|STARTED|Overall Study||25||
48159301|NCT02207725|100711242|FG002|STARTED|Overall Study||9||
48315905|NCT02830776|101100996|FG000|STARTED|Overall Study||15||
48159302|NCT02207725|100711243|FG003|STARTED|Overall Study||25||
48159303|NCT02207725|100711240|FG000|COMPLETED|Overall Study||9||
48159304|NCT02207725|100711241|FG001|COMPLETED|Overall Study||24||
48159305|NCT02207725|100711242|FG002|COMPLETED|Overall Study||8||
48159306|NCT02207725|100711243|FG003|COMPLETED|Overall Study||24||
48159307|NCT02207725|100711240|FG000|NOT COMPLETED|Overall Study||0||
48315906|NCT02830776|101100996|FG000|COMPLETED|Overall Study||14||
48315907|NCT02830776|101100996|FG000|NOT COMPLETED|Overall Study||1||
48159308|NCT02207725|100711241|FG001|NOT COMPLETED|Overall Study||1||
48159309|NCT02207725|100711242|FG002|NOT COMPLETED|Overall Study||1||
48159310|NCT02207725|100711243|FG003|NOT COMPLETED|Overall Study||1||
48315908|NCT02592551|101100997|FG000|STARTED|Overall Study||9||
48315909|NCT02592551|101100998|FG001|STARTED|Overall Study||11||
48315910|NCT02592551|101100999|FG002|STARTED|Overall Study||4||
48159311|NCT01553318|100711244|FG000|STARTED|Overall Study||24||
48159312|NCT01553318|100711245|FG001|STARTED|Overall Study||27||
48159313|NCT01553318|100711244|FG000|COMPLETED|Overall Study||21||
48159314|NCT01553318|100711245|FG001|COMPLETED|Overall Study||25||
48159315|NCT01553318|100711244|FG000|NOT COMPLETED|Overall Study||3||
48159316|NCT01553318|100711245|FG001|NOT COMPLETED|Overall Study||2||
48159317|NCT01321541|100711246|FG000|STARTED|Overall Study||155||
48159318|NCT01321541|100711247|FG001|STARTED|Overall Study||157||
48159319|NCT01321541|100711246|FG000|COMPLETED|Overall Study||72||
48159320|NCT01321541|100711247|FG001|COMPLETED|Overall Study||61||
48159321|NCT01321541|100711246|FG000|NOT COMPLETED|Overall Study||83||
48159322|NCT01321541|100711247|FG001|NOT COMPLETED|Overall Study||96||
48159323|NCT03520400|100711248|FG000|STARTED|Overall Study||37||
48159324|NCT03520400|100711249|FG001|STARTED|Overall Study||14||
48159325|NCT03520400|100711248|FG000|COMPLETED|Overall Study||22||
48159326|NCT03520400|100711249|FG001|COMPLETED|Overall Study||7||
48159327|NCT03520400|100711248|FG000|NOT COMPLETED|Overall Study||15||
48159328|NCT03520400|100711249|FG001|NOT COMPLETED|Overall Study||7||
48159329|NCT03586583|100711250|FG000|STARTED|Overall Study||600||
48159330|NCT03586583|100711250|FG000|COMPLETED|Overall Study||600||
48315911|NCT02592551|101100997|FG000|COMPLETED|Overall Study||8||
48315912|NCT02592551|101100998|FG001|COMPLETED|Overall Study||8||
48732946|NCT03437577|102130257|FG002|NOT COMPLETED|Pre-Randomization||10||
48732947|NCT03437577|102130255|FG000|STARTED|Post-Randomization||3||
48732948|NCT03437577|102130256|FG001|STARTED|Post-Randomization||5||
48315913|NCT02592551|101100999|FG002|COMPLETED|Overall Study||4||
48315914|NCT02592551|101100997|FG000|NOT COMPLETED|Overall Study||1||
48315915|NCT02592551|101100998|FG001|NOT COMPLETED|Overall Study||3||
48732949|NCT03437577|102130257|FG002|STARTED|Post-Randomization||0||
48732950|NCT03437577|102130255|FG000|COMPLETED|Post-Randomization||3||
48732951|NCT03437577|102130256|FG001|COMPLETED|Post-Randomization||3||
48732952|NCT03437577|102130257|FG002|COMPLETED|Post-Randomization||0||
48732953|NCT03437577|102130255|FG000|NOT COMPLETED|Post-Randomization||0||
48732954|NCT03437577|102130256|FG001|NOT COMPLETED|Post-Randomization||2||
48732955|NCT03437577|102130257|FG002|NOT COMPLETED|Post-Randomization||0||
48732956|NCT03785964|102130258|FG000|STARTED|Overall Study||70||
48732957|NCT03785964|102130259|FG001|STARTED|Overall Study||72||
48732958|NCT03785964|102130258|FG000|Treated (Safety Population)|Overall Study||69||
48732959|NCT03785964|102130259|FG001|Treated (Safety Population)|Overall Study||72||
48732960|NCT03785964|102130258|FG000|COMPLETED|Overall Study||12|Completed participants met the study endpoint. Information for completed and not completed pertains to treatment status at the time of the primary analysis. The open-label extension is ongoing.|
48732961|NCT03785964|102130259|FG001|COMPLETED|Overall Study||35|Completed participants met the study endpoint. Information for completed and not completed pertains to treatment status at the time of the primary analysis. The open-label extension is ongoing.|
48732962|NCT03785964|102130258|FG000|NOT COMPLETED|Overall Study||58||
48732963|NCT03785964|102130259|FG001|NOT COMPLETED|Overall Study||37||
48732964|NCT04000581|102130260|FG000|STARTED|Overall Study||5||
48159331|NCT03586583|100711250|FG000|NOT COMPLETED|Overall Study||0||
48159332|NCT01392300|100711251|FG000|STARTED|Main Period (MP)||210||
48159333|NCT01392300|100711252|FG001|STARTED|Main Period (MP)||107||
48159334|NCT01392300|100711253|FG002|STARTED|Main Period (MP)||0||
48159335|NCT01392300|100711251|FG000|COMPLETED|Main Period (MP)||199||
48159336|NCT01392300|100711252|FG001|COMPLETED|Main Period (MP)||100||
48159337|NCT01392300|100711253|FG002|COMPLETED|Main Period (MP)||0||
48159338|NCT01392300|100711251|FG000|NOT COMPLETED|Main Period (MP)||11||
48159339|NCT01392300|100711252|FG001|NOT COMPLETED|Main Period (MP)||7||
48159340|NCT01392300|100711253|FG002|NOT COMPLETED|Main Period (MP)||0||
48159341|NCT01392300|100711251|FG000|STARTED|Open Label Extension (OLEX) Period||0||
48159342|NCT01392300|100711252|FG001|STARTED|Open Label Extension (OLEX) Period||0||
48159343|NCT01392300|100711253|FG002|STARTED|Open Label Extension (OLEX) Period||299||
48159344|NCT01392300|100711251|FG000|COMPLETED|Open Label Extension (OLEX) Period||0||
48159345|NCT01392300|100711252|FG001|COMPLETED|Open Label Extension (OLEX) Period||0||
48159346|NCT01392300|100711253|FG002|COMPLETED|Open Label Extension (OLEX) Period||248||
48159347|NCT01392300|100711251|FG000|NOT COMPLETED|Open Label Extension (OLEX) Period||0||
48159348|NCT01392300|100711252|FG001|NOT COMPLETED|Open Label Extension (OLEX) Period||0||
48159349|NCT01392300|100711253|FG002|NOT COMPLETED|Open Label Extension (OLEX) Period||51||
48159350|NCT01662063|100711254|FG000|STARTED|Overall Study||44||
48159351|NCT01662063|100711255|FG001|STARTED|Overall Study||173||
48159352|NCT01662063|100711256|FG002|STARTED|Overall Study||1||
48159353|NCT01662063|100711254|FG000|COMPLETED|Overall Study||39||
48159354|NCT01662063|100711255|FG001|COMPLETED|Overall Study||144||
48159355|NCT01662063|100711256|FG002|COMPLETED|Overall Study||0||
48159356|NCT01662063|100711254|FG000|NOT COMPLETED|Overall Study||5||
48159357|NCT01662063|100711255|FG001|NOT COMPLETED|Overall Study||29||
48159358|NCT01662063|100711256|FG002|NOT COMPLETED|Overall Study||1||
48159359|NCT00051168|100711257|FG000|STARTED|Overall Study||502||
48159360|NCT00051168|100711257|FG000|COMPLETED|Overall Study||367||
48159361|NCT00051168|100711257|FG000|NOT COMPLETED|Overall Study||135||
48159362|NCT00058422|100711258|FG000|STARTED|Overall Study||65||
48159363|NCT00058422|100711258|FG000|COMPLETED|Overall Study||63||
48315916|NCT02592551|101100999|FG002|NOT COMPLETED|Overall Study||0||
48732965|NCT04000581|102130261|FG001|STARTED|Overall Study||12||
48732966|NCT04000581|102130260|FG000|COMPLETED|Overall Study||5||
48732967|NCT04000581|102130261|FG001|COMPLETED|Overall Study||11||
48732968|NCT04000581|102130260|FG000|NOT COMPLETED|Overall Study||0||
48732969|NCT04000581|102130261|FG001|NOT COMPLETED|Overall Study||1||
48732970|NCT03139344|102130262|FG000|STARTED|Overall Study||28||
48732971|NCT03139344|102130263|FG001|STARTED|Overall Study||12||
48732972|NCT03139344|102130264|FG002|STARTED|Overall Study||21||
48732973|NCT03139344|102130265|FG003|STARTED|Overall Study||10||
48732974|NCT03139344|102130266|FG004|STARTED|Overall Study||18||
48732975|NCT03139344|102130262|FG000|COMPLETED|Overall Study||28||
48732976|NCT03139344|102130263|FG001|COMPLETED|Overall Study||12||
48732977|NCT03139344|102130264|FG002|COMPLETED|Overall Study||21||
48732978|NCT03139344|102130265|FG003|COMPLETED|Overall Study||10||
48732979|NCT03139344|102130266|FG004|COMPLETED|Overall Study||18||
48732980|NCT03139344|102130262|FG000|NOT COMPLETED|Overall Study||0||
48732981|NCT03139344|102130263|FG001|NOT COMPLETED|Overall Study||0||
48732982|NCT03139344|102130264|FG002|NOT COMPLETED|Overall Study||0||
48732983|NCT03139344|102130265|FG003|NOT COMPLETED|Overall Study||0||
48732984|NCT03139344|102130266|FG004|NOT COMPLETED|Overall Study||0||
48732985|NCT00604695|102130267|FG000|STARTED|Overall Study||20||
48732986|NCT00604695|102130268|FG001|STARTED|Overall Study||20||
48732987|NCT00604695|102130267|FG000|COMPLETED|Overall Study||20||
48732988|NCT00604695|102130268|FG001|COMPLETED|Overall Study||16||
48732989|NCT00604695|102130267|FG000|NOT COMPLETED|Overall Study||0||
48732990|NCT00604695|102130268|FG001|NOT COMPLETED|Overall Study||4||
48732991|NCT01007838|102130269|FG000|STARTED|Overall Study||12||
48732992|NCT01007838|102130270|FG001|STARTED|Overall Study||11||
48732993|NCT01007838|102130271|FG002|STARTED|Overall Study||5||
48732994|NCT01007838|102130272|FG003|STARTED|Overall Study||4||
48159364|NCT00058422|100711258|FG000|NOT COMPLETED|Overall Study||2||
48159365|NCT05597722|100711259|FG000|STARTED|Overall Study||6||
48159366|NCT05597722|100711260|FG001|STARTED|Overall Study||1||
48159367|NCT05597722|100711259|FG000|COMPLETED|Overall Study||0||
48159368|NCT05597722|100711260|FG001|COMPLETED|Overall Study||0||
48159369|NCT05597722|100711259|FG000|NOT COMPLETED|Overall Study||6||
48159370|NCT05597722|100711260|FG001|NOT COMPLETED|Overall Study||1||
48159371|NCT01786330|100711261|FG000|STARTED|Overall Study||30||
48159372|NCT01786330|100711262|FG001|STARTED|Overall Study||30||
48732995|NCT01007838|102130269|FG000|COMPLETED|Overall Study||9||
48159373|NCT01786330|100711261|FG000|COMPLETED|Overall Study||29||
48159374|NCT01786330|100711262|FG001|COMPLETED|Overall Study||27||
48159375|NCT01786330|100711261|FG000|NOT COMPLETED|Overall Study||1||
48315917|NCT01298752|101101000|FG000|STARTED|Overall Study||120||
48315918|NCT01298752|101101001|FG001|STARTED|Overall Study||57||
48315919|NCT01298752|101101000|FG000|COMPLETED|Overall Study||77||
48315920|NCT01298752|101101001|FG001|COMPLETED|Overall Study||31||
48315921|NCT01298752|101101000|FG000|NOT COMPLETED|Overall Study||43||
48315922|NCT01298752|101101001|FG001|NOT COMPLETED|Overall Study||26||
48315923|NCT00199836|101101002|FG000|STARTED|Overall Study||14||
48315924|NCT00199836|101101002|FG000|COMPLETED|Overall Study||8||
48315925|NCT00199836|101101002|FG000|NOT COMPLETED|Overall Study||6||
48315926|NCT04202679|101101003|FG000|STARTED|Overall Study||82||
48315927|NCT04202679|101101004|FG001|STARTED|Overall Study||78||
48315928|NCT04202679|101101003|FG000|Treated|Overall Study||82||
48315929|NCT04202679|101101004|FG001|Treated|Overall Study||77||
48315930|NCT04202679|101101003|FG000|COMPLETED|Overall Study||56||
48315931|NCT04202679|101101004|FG001|COMPLETED|Overall Study||72||
48315932|NCT04202679|101101003|FG000|NOT COMPLETED|Overall Study||26||
48315933|NCT04202679|101101004|FG001|NOT COMPLETED|Overall Study||6||
48315934|NCT03610724|101101005|FG000|STARTED|Overall Study||34||
48315935|NCT03610724|101101005|FG000|Met Eligibilty Criteria and Were Infused|Overall Study||33||
48732996|NCT01007838|102130270|FG001|COMPLETED|Overall Study||11||
48732997|NCT01007838|102130271|FG002|COMPLETED|Overall Study||5||
48732998|NCT01007838|102130272|FG003|COMPLETED|Overall Study||4||
48732999|NCT01007838|102130269|FG000|NOT COMPLETED|Overall Study||3||
48733000|NCT01007838|102130270|FG001|NOT COMPLETED|Overall Study||0||
48733001|NCT01007838|102130271|FG002|NOT COMPLETED|Overall Study||0||
48733002|NCT01007838|102130272|FG003|NOT COMPLETED|Overall Study||0||
48733003|NCT02141360|102130273|FG000|STARTED|Overall Study||11||
48733004|NCT02141360|102130274|FG001|STARTED|Overall Study||6||
48733005|NCT02141360|102130275|FG002|STARTED|Overall Study||6||
48733006|NCT02141360|102130273|FG000|COMPLETED|Overall Study||4||
48733007|NCT02141360|102130274|FG001|COMPLETED|Overall Study||6||
48159376|NCT01786330|100711262|FG001|NOT COMPLETED|Overall Study||3||
48159377|NCT04080752|100711263|FG000|STARTED|Overall Study||112||
48159378|NCT04080752|100711264|FG001|STARTED|Overall Study||110||
48159379|NCT04080752|100711263|FG000|COMPLETED|Overall Study||99||
48315936|NCT03610724|101101005|FG000|Met Eligibilty Criteria But Was Not Infused*|Overall Study||1|\*Patient died prior to infusion|
48315937|NCT03610724|101101005|FG000|Completed Treatment & Primary Follow-up Phase|Overall Study||14||
48733008|NCT02141360|102130275|FG002|COMPLETED|Overall Study||6||
48733009|NCT02141360|102130273|FG000|NOT COMPLETED|Overall Study||7||
48733010|NCT02141360|102130274|FG001|NOT COMPLETED|Overall Study||0||
48733011|NCT02141360|102130275|FG002|NOT COMPLETED|Overall Study||0||
48159380|NCT04080752|100711264|FG001|COMPLETED|Overall Study||104||
48159381|NCT04080752|100711263|FG000|NOT COMPLETED|Overall Study||13||
48159382|NCT04080752|100711264|FG001|NOT COMPLETED|Overall Study||6||
48159383|NCT04710927|100711265|FG000|STARTED|Overall Study||18||21
48159384|NCT04710927|100711266|FG001|STARTED|Overall Study||19||21
48159385|NCT04710927|100711267|FG002|STARTED|Overall Study||20||21
48159386|NCT04710927|100711265|FG000|6 Months|Overall Study||15||18
48159387|NCT04710927|100711266|FG001|6 Months|Overall Study||16||17
48159388|NCT04710927|100711267|FG002|6 Months|Overall Study||16||17
48159389|NCT04710927|100711265|FG000|12 Months|Overall Study||11||13
48159390|NCT04710927|100711266|FG001|12 Months|Overall Study||13||15
48733012|NCT00866814|102130276|FG000|STARTED|Overall Study||119||
48733013|NCT00866814|102130276|FG000|COMPLETED|Overall Study||99||
48733014|NCT00866814|102130276|FG000|NOT COMPLETED|Overall Study||20||
48159391|NCT04710927|100711267|FG002|12 Months|Overall Study||15||16
48159392|NCT04710927|100711265|FG000|COMPLETED|Overall Study||11||13
48315938|NCT03610724|101101005|FG000|Discont. Treatment & Primary Follow-up Phase|Overall Study||19||
48315939|NCT03610724|101101005|FG000|COMPLETED|Overall Study||14||
48315940|NCT03610724|101101005|FG000|NOT COMPLETED|Overall Study||20||
48733015|NCT00384332|102130277|FG000|STARTED|Overall Study||13||
48733016|NCT00384332|102130278|FG001|STARTED|Overall Study||10||
48733017|NCT00384332|102130277|FG000|COMPLETED|Overall Study||9||
48733018|NCT00384332|102130278|FG001|COMPLETED|Overall Study||10||
48733019|NCT00384332|102130277|FG000|NOT COMPLETED|Overall Study||4||
48733020|NCT00384332|102130278|FG001|NOT COMPLETED|Overall Study||0||
48733021|NCT04072887|102130279|FG000|STARTED|Overall Study||99|All randomized participants|
48733022|NCT04072887|102130280|FG001|STARTED|Overall Study||250|All randomized participants|
48733023|NCT04072887|102130281|FG002|STARTED|Overall Study||124|All randomized participants|
48733024|NCT04072887|102130282|FG003|STARTED|Overall Study||126|All randomized participants|
48733025|NCT04072887|102130283|FG004|STARTED|Overall Study||124|All randomized participants|
48733026|NCT04072887|102130284|FG005|STARTED|Overall Study||251|All randomized participants|
48733027|NCT04072887|102130279|FG000|Pharmacokinetic (PK) Set|Overall Study||99|All randomized participants who have at least one evaluable concentration data sample|
48733028|NCT04072887|102130280|FG001|Pharmacokinetic (PK) Set|Overall Study||250|All randomized participants who have at least one evaluable concentration data sample|
48733029|NCT04072887|102130281|FG002|Pharmacokinetic (PK) Set|Overall Study||123|All randomized participants who have at least one evaluable concentration data sample|
48733030|NCT04072887|102130282|FG003|Pharmacokinetic (PK) Set|Overall Study||126|All randomized participants who have at least one evaluable concentration data sample|
48733031|NCT04072887|102130283|FG004|Pharmacokinetic (PK) Set|Overall Study||124|All randomized participants who have at least one evaluable concentration data sample|
48733032|NCT04072887|102130284|FG005|Pharmacokinetic (PK) Set|Overall Study||0|All randomized participants who have at least one evaluable concentration data sample|
48733033|NCT04072887|102130279|FG000|Serial Pharmacokinetic (PK) Set|Overall Study||14|The Serial PK set includes the participants who consented to participate in the PK serial subgroup|
48733034|NCT04072887|102130280|FG001|Serial Pharmacokinetic (PK) Set|Overall Study||21|The Serial PK set includes the participants who consented to participate in the PK serial subgroup|
48733035|NCT04072887|102130281|FG002|Serial Pharmacokinetic (PK) Set|Overall Study||14|The Serial PK set includes the participants who consented to participate in the PK serial subgroup|
48733036|NCT04072887|102130282|FG003|Serial Pharmacokinetic (PK) Set|Overall Study||13|The Serial PK set includes the participants who consented to participate in the PK serial subgroup|
48733037|NCT04072887|102130283|FG004|Serial Pharmacokinetic (PK) Set|Overall Study||14|The Serial PK set includes the participants who consented to participate in the PK serial subgroup|
48159393|NCT04710927|100711266|FG001|COMPLETED|Overall Study||13||15
48159394|NCT04710927|100711267|FG002|COMPLETED|Overall Study||15||16
48159395|NCT04710927|100711265|FG000|NOT COMPLETED|Overall Study||7||8
48159396|NCT04710927|100711266|FG001|NOT COMPLETED|Overall Study||6||6
48159397|NCT04710927|100711267|FG002|NOT COMPLETED|Overall Study||5||5
48159398|NCT03576768|100711268|FG000|STARTED|Overall Study||13||
48159399|NCT03576768|100711269|FG001|STARTED|Overall Study||12||
48159400|NCT03576768|100711270|FG002|STARTED|Overall Study||0||
48159401|NCT03576768|100711271|FG003|STARTED|Overall Study||0||
48159402|NCT03576768|100711268|FG000|COMPLETED|Overall Study||10||
48159403|NCT03576768|100711269|FG001|COMPLETED|Overall Study||9||
48159404|NCT03576768|100711270|FG002|COMPLETED|Overall Study||0||
48159405|NCT03576768|100711271|FG003|COMPLETED|Overall Study||0||
48159406|NCT03576768|100711268|FG000|NOT COMPLETED|Overall Study||3||
48159407|NCT03576768|100711269|FG001|NOT COMPLETED|Overall Study||3||
48159408|NCT03576768|100711270|FG002|NOT COMPLETED|Overall Study||0||
48159409|NCT03576768|100711271|FG003|NOT COMPLETED|Overall Study||0||
48159410|NCT00521144|100711272|FG000|STARTED|Overall Study||6||
48159411|NCT00521144|100711273|FG001|STARTED|Overall Study||5||
48159412|NCT00521144|100711274|FG002|STARTED|Overall Study||3||
48159413|NCT00521144|100711275|FG003|STARTED|Overall Study||1||
48159414|NCT00521144|100711276|FG004|STARTED|Overall Study||7||
48159415|NCT00521144|100711272|FG000|COMPLETED|Overall Study||2||
48159416|NCT00521144|100711273|FG001|COMPLETED|Overall Study||2||
48159417|NCT00521144|100711274|FG002|COMPLETED|Overall Study||1||
48159418|NCT00521144|100711275|FG003|COMPLETED|Overall Study||0||
48159419|NCT00521144|100711276|FG004|COMPLETED|Overall Study||0||
48733038|NCT04072887|102130284|FG005|Serial Pharmacokinetic (PK) Set|Overall Study||0|The Serial PK set includes the participants who consented to participate in the PK serial subgroup|
48733039|NCT04072887|102130279|FG000|COMPLETED|Overall Study||91||
48733040|NCT04072887|102130280|FG001|COMPLETED|Overall Study||233||
48733041|NCT04072887|102130281|FG002|COMPLETED|Overall Study||122||
48733042|NCT04072887|102130282|FG003|COMPLETED|Overall Study||117||
48315941|NCT00715026|101101006|FG000|STARTED|Overall Study||31||
48315942|NCT00715026|101101006|FG000|Subjects That Received Surgery|Overall Study||25||
48315943|NCT00715026|101101006|FG000|COMPLETED|Overall Study||21||
48315944|NCT00715026|101101006|FG000|NOT COMPLETED|Overall Study||10||
48315945|NCT01651351|101101007|FG000|STARTED|Overall Study||15||
48315946|NCT01651351|101101008|FG001|STARTED|Overall Study||15||
48315947|NCT01651351|101101007|FG000|COMPLETED|Overall Study||15||
48733043|NCT04072887|102130283|FG004|COMPLETED|Overall Study||118||
48733044|NCT04072887|102130284|FG005|COMPLETED|Overall Study||236||
48733045|NCT04072887|102130279|FG000|NOT COMPLETED|Overall Study||8||
48733046|NCT04072887|102130280|FG001|NOT COMPLETED|Overall Study||17||
48733047|NCT04072887|102130281|FG002|NOT COMPLETED|Overall Study||2||
48733048|NCT04072887|102130282|FG003|NOT COMPLETED|Overall Study||9||
48733049|NCT04072887|102130283|FG004|NOT COMPLETED|Overall Study||6||
48733050|NCT04072887|102130284|FG005|NOT COMPLETED|Overall Study||15||
48733051|NCT01943591|102130285|FG000|STARTED|Overall Study||104||
48733052|NCT01943591|102130286|FG001|STARTED|Overall Study||106||
48733053|NCT01943591|102130285|FG000|COMPLETED|Overall Study||99||
48733054|NCT01943591|102130286|FG001|COMPLETED|Overall Study||95||
48733055|NCT01943591|102130285|FG000|NOT COMPLETED|Overall Study||5||
48733056|NCT01943591|102130286|FG001|NOT COMPLETED|Overall Study||11||
48733057|NCT04680975|102130287|FG000|STARTED|Overall Study||10||
48733058|NCT04680975|102130287|FG000|COMPLETED|Overall Study||4||
48733059|NCT04680975|102130287|FG000|NOT COMPLETED|Overall Study||6||
48733060|NCT02146001|102130288|FG000|STARTED|Overall Study||19||
48733061|NCT02146001|102130289|FG001|STARTED|Overall Study||19||
48733062|NCT02146001|102130288|FG000|COMPLETED|Overall Study||19||
48733063|NCT02146001|102130289|FG001|COMPLETED|Overall Study||19||
48733064|NCT02146001|102130288|FG000|NOT COMPLETED|Overall Study||0||
48733065|NCT02146001|102130289|FG001|NOT COMPLETED|Overall Study||0||
48733066|NCT01408459|102130290|FG000|STARTED|Overall Study||22||
48733067|NCT01408459|102130291|FG001|STARTED|Overall Study||15||
48733068|NCT01408459|102130290|FG000|COMPLETED|Overall Study||21||
48733069|NCT01408459|102130291|FG001|COMPLETED|Overall Study||14||
48733070|NCT01408459|102130290|FG000|NOT COMPLETED|Overall Study||1||
48733071|NCT01408459|102130291|FG001|NOT COMPLETED|Overall Study||1||
48733072|NCT01439594|102130292|FG000|STARTED|Overall Study||17||
48733073|NCT01439594|102130292|FG000|COMPLETED|Overall Study||17||
48733074|NCT01439594|102130292|FG000|NOT COMPLETED|Overall Study||0||
48733075|NCT00474617|102130293|FG000|STARTED|Overall Study||56||
48733076|NCT00474617|102130294|FG001|STARTED|Overall Study||64||
48733077|NCT00474617|102130295|FG002|STARTED|Overall Study||42||
48733078|NCT00474617|102130293|FG000|Treated|Overall Study||48||
48733079|NCT00474617|102130294|FG001|Treated|Overall Study||62||
48733080|NCT00474617|102130295|FG002|Treated|Overall Study||40||
48733081|NCT00474617|102130293|FG000|COMPLETED|Overall Study||48||
48733082|NCT00474617|102130294|FG001|COMPLETED|Overall Study||61||
48733083|NCT00474617|102130295|FG002|COMPLETED|Overall Study||40||
48733084|NCT00474617|102130293|FG000|NOT COMPLETED|Overall Study||8||
48733085|NCT00474617|102130294|FG001|NOT COMPLETED|Overall Study||3||
48733086|NCT00474617|102130295|FG002|NOT COMPLETED|Overall Study||2||
48733087|NCT00486824|102130296|FG000|STARTED|Overall Study||5||
48733088|NCT00486824|102130297|FG001|STARTED|Overall Study||5||
48733089|NCT00486824|102130296|FG000|COMPLETED|Overall Study||3||
48733090|NCT00486824|102130297|FG001|COMPLETED|Overall Study||3||
48733091|NCT00486824|102130296|FG000|NOT COMPLETED|Overall Study||2||
48315948|NCT01651351|101101008|FG001|COMPLETED|Overall Study||15||
48315949|NCT01651351|101101007|FG000|NOT COMPLETED|Overall Study||0||
48315950|NCT01651351|101101008|FG001|NOT COMPLETED|Overall Study||0||
48315951|NCT04912245|101101009|FG000|STARTED|Overall Study||107||
48315952|NCT04912245|101101010|FG001|STARTED|Overall Study||45||
48315953|NCT04912245|101101009|FG000|COMPLETED|Overall Study||81|Caregivers Completed|
48440022|NCT01266642|101410014|FG001|STARTED|Overall Study||138||
48733092|NCT00486824|102130297|FG001|NOT COMPLETED|Overall Study||2||
48733093|NCT01971385|102130298|FG000|STARTED|Overall Study||17||
48733094|NCT01971385|102130299|FG001|STARTED|Overall Study||18||
48733095|NCT01971385|102130300|FG002|STARTED|Overall Study||19||
48733096|NCT01971385|102130298|FG000|COMPLETED|Overall Study||14||
48733097|NCT01971385|102130299|FG001|COMPLETED|Overall Study||13||
48733098|NCT01971385|102130300|FG002|COMPLETED|Overall Study||15||
48733099|NCT01971385|102130298|FG000|NOT COMPLETED|Overall Study||3||
48733100|NCT01971385|102130299|FG001|NOT COMPLETED|Overall Study||5||
48315954|NCT04912245|101101010|FG001|COMPLETED|Overall Study||30|Caregivers Completed|
48315955|NCT04912245|101101009|FG000|NOT COMPLETED|Overall Study||26||
48315956|NCT04912245|101101010|FG001|NOT COMPLETED|Overall Study||15||
48733101|NCT01971385|102130300|FG002|NOT COMPLETED|Overall Study||4||
48733102|NCT04677504|102130301|FG000|STARTED|Overall Study||83||
48733103|NCT04677504|102130302|FG001|STARTED|Overall Study||79||
48733104|NCT04677504|102130301|FG000|COMPLETED|Overall Study||0||
48733105|NCT04677504|102130302|FG001|COMPLETED|Overall Study||0||
48733106|NCT04677504|102130301|FG000|NOT COMPLETED|Overall Study||83||
48733107|NCT04677504|102130302|FG001|NOT COMPLETED|Overall Study||79||
48733108|NCT00516165|102130303|FG000|STARTED|Overall Study||28||
48733109|NCT00516165|102130303|FG000|COMPLETED|Overall Study||28||
48733110|NCT00516165|102130303|FG000|NOT COMPLETED|Overall Study||0||
48733111|NCT01549925|102130304|FG000|STARTED|Overall Study||25||
48733112|NCT01549925|102130305|FG001|STARTED|Overall Study||25||
48733113|NCT01549925|102130304|FG000|COMPLETED|Overall Study||25||
48733114|NCT01549925|102130305|FG001|COMPLETED|Overall Study||25||
48733115|NCT01549925|102130304|FG000|NOT COMPLETED|Overall Study||0||
48733116|NCT01549925|102130305|FG001|NOT COMPLETED|Overall Study||0||
48733117|NCT01546688|102130306|FG000|STARTED|Overall Study||18||
48733118|NCT01546688|102130307|FG001|STARTED|Overall Study||33||
48733119|NCT01546688|102130306|FG000|COMPLETED|Overall Study||15||
48733120|NCT01546688|102130307|FG001|COMPLETED|Overall Study||28||
48733121|NCT01546688|102130306|FG000|NOT COMPLETED|Overall Study||3||
48733122|NCT01546688|102130307|FG001|NOT COMPLETED|Overall Study||5||
48733123|NCT04698993|102130308|FG000|STARTED|Overall Study||275||
48733124|NCT04698993|102130309|FG001|STARTED|Overall Study||113||
48733125|NCT04698993|102130308|FG000|COMPLETED|Overall Study||272||
48733126|NCT04698993|102130309|FG001|COMPLETED|Overall Study||106||
48733127|NCT04698993|102130308|FG000|NOT COMPLETED|Overall Study||3||
48733128|NCT04698993|102130309|FG001|NOT COMPLETED|Overall Study||7||
48733129|NCT01240200|102130310|FG000|STARTED|12-week Crossover Phase - Period 1||25||
48315957|NCT01840579|101101011|FG000|STARTED|Overall Study||3||
48733130|NCT01240200|102130311|FG001|STARTED|12-week Crossover Phase - Period 1||24||
48733131|NCT01240200|102130310|FG000|COMPLETED|12-week Crossover Phase - Period 1||23||
48733132|NCT01240200|102130311|FG001|COMPLETED|12-week Crossover Phase - Period 1||23||
48733133|NCT01240200|102130310|FG000|NOT COMPLETED|12-week Crossover Phase - Period 1||2||
48733134|NCT01240200|102130311|FG001|NOT COMPLETED|12-week Crossover Phase - Period 1||1||
48733135|NCT01240200|102130310|FG000|STARTED|12-week Crossover Phase - Period 2||23||
48733136|NCT01240200|102130311|FG001|STARTED|12-week Crossover Phase - Period 2||23||
48733137|NCT01240200|102130310|FG000|COMPLETED|12-week Crossover Phase - Period 2||23||
48733138|NCT01240200|102130311|FG001|COMPLETED|12-week Crossover Phase - Period 2||23||
48733139|NCT01240200|102130310|FG000|NOT COMPLETED|12-week Crossover Phase - Period 2||0||
48733140|NCT01240200|102130311|FG001|NOT COMPLETED|12-week Crossover Phase - Period 2||0||
48733141|NCT04260347|102130312|FG000|STARTED|Overall Study||993||
48733142|NCT04260347|102130313|FG001|STARTED|Overall Study||662||
48733143|NCT04260347|102130312|FG000|Propensity Score-matched Population|Overall Study||614||
48733144|NCT04260347|102130313|FG001|Propensity Score-matched Population|Overall Study||614||
48733145|NCT04260347|102130312|FG000|COMPLETED|Overall Study||993||
48733146|NCT04260347|102130313|FG001|COMPLETED|Overall Study||662||
48733147|NCT04260347|102130312|FG000|NOT COMPLETED|Overall Study||0||
48733148|NCT04260347|102130313|FG001|NOT COMPLETED|Overall Study||0||
48733149|NCT01122849|102130314|FG000|STARTED|Overall Study||20||
48733150|NCT01122849|102130315|FG001|STARTED|Overall Study||21||
48733151|NCT01122849|102130316|FG002|STARTED|Overall Study||20||
48733152|NCT01122849|102130314|FG000|COMPLETED|Overall Study||20||
48733153|NCT01122849|102130315|FG001|COMPLETED|Overall Study||21||
48733154|NCT01122849|102130316|FG002|COMPLETED|Overall Study||20||
48733155|NCT01122849|102130314|FG000|NOT COMPLETED|Overall Study||0||
48733156|NCT01122849|102130315|FG001|NOT COMPLETED|Overall Study||0||
48733157|NCT01122849|102130316|FG002|NOT COMPLETED|Overall Study||0||
48733158|NCT05169424|102130317|FG000|STARTED|Overall Study||3996||
48733159|NCT05169424|102130318|FG001|STARTED|Overall Study||5121||
48733160|NCT05169424|102130317|FG000|Propensity Score Matching|Overall Study||2951||
48733161|NCT05169424|102130318|FG001|Propensity Score Matching|Overall Study||2951||
48733162|NCT05169424|102130317|FG000|COMPLETED|Overall Study||3996||
48733163|NCT05169424|102130318|FG001|COMPLETED|Overall Study||5121||
48733164|NCT05169424|102130317|FG000|NOT COMPLETED|Overall Study||0||
48733165|NCT05169424|102130318|FG001|NOT COMPLETED|Overall Study||0||
48733166|NCT02395614|102133645|FG000|STARTED|Overall Study||88||
48733167|NCT02395614|102133645|FG000|Chlorhexidine Irrigation|Overall Study||88||
48733168|NCT02395614|102133645|FG000|Triple Antibiotic Irrigation|Overall Study||88||
48733169|NCT02395614|102133645|FG000|COMPLETED|Overall Study||88||
48733170|NCT02395614|102133645|FG000|NOT COMPLETED|Overall Study||0||
48733171|NCT03100058|102133646|FG000|STARTED|Epoch 3 (24 Weeks of Treatment)||38||
48733172|NCT03100058|102133647|FG001|STARTED|Epoch 3 (24 Weeks of Treatment)||38||
48733173|NCT03100058|102133648|FG002|STARTED|Epoch 3 (24 Weeks of Treatment)||38||
48733174|NCT03100058|102133649|FG003|STARTED|Epoch 3 (24 Weeks of Treatment)||77||
48733175|NCT03100058|102133650|FG004|STARTED|Epoch 3 (24 Weeks of Treatment)||38||
48733176|NCT03100058|102133651|FG005|STARTED|Epoch 3 (24 Weeks of Treatment)||39||
48733177|NCT03100058|102133652|FG006|STARTED|Epoch 3 (24 Weeks of Treatment)||38||
48733178|NCT03100058|102133653|FG007|STARTED|Epoch 3 (24 Weeks of Treatment)||76||
48733179|NCT03100058|102133654|FG008|STARTED|Epoch 3 (24 Weeks of Treatment)||78||
48733180|NCT03100058|102133655|FG009|STARTED|Epoch 3 (24 Weeks of Treatment)||0||
48733181|NCT03100058|102133656|FG010|STARTED|Epoch 3 (24 Weeks of Treatment)||0||
48733182|NCT03100058|102133657|FG011|STARTED|Epoch 3 (24 Weeks of Treatment)||0||
48733183|NCT03100058|102133658|FG012|STARTED|Epoch 3 (24 Weeks of Treatment)||0||
48733184|NCT03100058|102133646|FG000|COMPLETED|Epoch 3 (24 Weeks of Treatment)||35||
48733185|NCT03100058|102133647|FG001|COMPLETED|Epoch 3 (24 Weeks of Treatment)||31||
48733186|NCT03100058|102133648|FG002|COMPLETED|Epoch 3 (24 Weeks of Treatment)||29||
48733187|NCT03100058|102133649|FG003|COMPLETED|Epoch 3 (24 Weeks of Treatment)||63||
48733188|NCT03100058|102133650|FG004|COMPLETED|Epoch 3 (24 Weeks of Treatment)||36||
48733189|NCT03100058|102133651|FG005|COMPLETED|Epoch 3 (24 Weeks of Treatment)||37||
48733190|NCT03100058|102133652|FG006|COMPLETED|Epoch 3 (24 Weeks of Treatment)||30||
48733191|NCT03100058|102133653|FG007|COMPLETED|Epoch 3 (24 Weeks of Treatment)||60||
48733192|NCT03100058|102133654|FG008|COMPLETED|Epoch 3 (24 Weeks of Treatment)||73||
48733193|NCT03100058|102133655|FG009|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0||
48733194|NCT03100058|102133656|FG010|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0||
48733195|NCT03100058|102133657|FG011|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0||
48733196|NCT03100058|102133658|FG012|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0||
48733197|NCT03100058|102133646|FG000|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||3||
48733198|NCT03100058|102133647|FG001|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||7||
48733199|NCT03100058|102133648|FG002|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||9||
48733200|NCT03100058|102133649|FG003|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||14||
48733201|NCT03100058|102133650|FG004|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||2||
48733202|NCT03100058|102133651|FG005|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||2||
48733203|NCT03100058|102133652|FG006|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||8||
48733204|NCT03100058|102133653|FG007|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||16||
48733205|NCT03100058|102133654|FG008|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||5||
48733206|NCT03100058|102133655|FG009|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0||
48733207|NCT03100058|102133656|FG010|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0||
48733208|NCT03100058|102133657|FG011|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0||
48733209|NCT03100058|102133658|FG012|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0||
48733210|NCT03100058|102133646|FG000|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0||
48733211|NCT03100058|102133647|FG001|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0||
48733212|NCT03100058|102133648|FG002|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0||
48733213|NCT03100058|102133649|FG003|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0||
48733214|NCT03100058|102133650|FG004|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0||
48733215|NCT03100058|102133651|FG005|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0||
48733216|NCT03100058|102133652|FG006|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0||
48733217|NCT03100058|102133653|FG007|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0||
48733218|NCT03100058|102133654|FG008|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0||
48733219|NCT03100058|102133655|FG009|STARTED|Epoch 4 (Last 24 Weeks of the Study)||158||
48733220|NCT03100058|102133656|FG010|STARTED|Epoch 4 (Last 24 Weeks of the Study)||163||
48733221|NCT03100058|102133657|FG011|STARTED|Epoch 4 (Last 24 Weeks of the Study)||39||
48733222|NCT03100058|102133658|FG012|STARTED|Epoch 4 (Last 24 Weeks of the Study)||34||
48733223|NCT03100058|102133646|FG000|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
48733224|NCT03100058|102133647|FG001|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
48733225|NCT03100058|102133648|FG002|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
48733226|NCT03100058|102133649|FG003|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
48733227|NCT03100058|102133650|FG004|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
48733228|NCT03100058|102133651|FG005|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
48733229|NCT03100058|102133652|FG006|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
48733230|NCT03100058|102133653|FG007|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
48733231|NCT03100058|102133654|FG008|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
48733232|NCT03100058|102133655|FG009|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||153||
48733233|NCT03100058|102133656|FG010|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||148||
48733234|NCT03100058|102133657|FG011|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||36||
48733235|NCT03100058|102133658|FG012|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||30||
48733236|NCT03100058|102133646|FG000|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
48733237|NCT03100058|102133647|FG001|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
48733238|NCT03100058|102133648|FG002|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
48733239|NCT03100058|102133649|FG003|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
48733240|NCT03100058|102133650|FG004|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
48733241|NCT03100058|102133651|FG005|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
48733242|NCT03100058|102133652|FG006|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
48733243|NCT03100058|102133653|FG007|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
48733244|NCT03100058|102133654|FG008|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
48733245|NCT03100058|102133655|FG009|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||5||
48733246|NCT03100058|102133656|FG010|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||15||
48733247|NCT03100058|102133657|FG011|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||3||
48733248|NCT03100058|102133658|FG012|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||4||
48733249|NCT00448747|102133659|FG000|STARTED|Overall Study||53|Safety Analysis Set: all subjects enrolled; one subject included who had not received AEZS-130.|
48767624|NCT03678493|102222780|FG000|NOT COMPLETED|Overall Study||0||
48733250|NCT00448747|102133660|FG001|STARTED|Overall Study||48|Safety Analysis Set: all subjects enrolled; one subject included who had not received AEZS-130.|
48733251|NCT00448747|102133659|FG000|Received First Drug Administration|Overall Study||53||
48733252|NCT00448747|102133660|FG001|Received First Drug Administration|Overall Study||48||
48733253|NCT00448747|102133659|FG000|Received Second Drug Administration|Overall Study||42||
48733254|NCT00448747|102133660|FG001|Received Second Drug Administration|Overall Study||10||
48733255|NCT00448747|102133659|FG000|Received AEZS-130|Overall Study||52||
48733256|NCT00448747|102133660|FG001|Received AEZS-130|Overall Study||48||
48733257|NCT00448747|102133659|FG000|Received L-ARG-GHRH|Overall Study||43||
48733258|NCT00448747|102133660|FG001|Received L-ARG-GHRH|Overall Study||10||
48733259|NCT00448747|102133659|FG000|Received L-ARG-GHRH and AEZS-130|Overall Study||42||
48733260|NCT00448747|102133660|FG001|Received L-ARG-GHRH and AEZS-130|Overall Study||10||
48733261|NCT00448747|102133659|FG000|Per Protocol Population (PPS)|Overall Study||50||
48733262|NCT00448747|102133660|FG001|Per Protocol Population (PPS)|Overall Study||48||
48733263|NCT00448747|102133659|FG000|COMPLETED|Overall Study||52|modified Intention-to-treat (mITT) population|
48733264|NCT00448747|102133660|FG001|COMPLETED|Overall Study||48|modified Intention-to-treat (mITT) population|
48733265|NCT00448747|102133659|FG000|NOT COMPLETED|Overall Study||1||
48733266|NCT00448747|102133660|FG001|NOT COMPLETED|Overall Study||0||
48733267|NCT04440813|102133661|FG000|STARTED|Overall Study||69||
48733268|NCT04440813|102133662|FG001|STARTED|Overall Study||67||
48733269|NCT04440813|102133661|FG000|COMPLETED|Overall Study||64||
48159420|NCT00521144|100711272|FG000|NOT COMPLETED|Overall Study||4||
48159421|NCT00521144|100711273|FG001|NOT COMPLETED|Overall Study||3||
48159422|NCT00521144|100711274|FG002|NOT COMPLETED|Overall Study||2||
48733270|NCT04440813|102133662|FG001|COMPLETED|Overall Study||62||
48733271|NCT04440813|102133661|FG000|NOT COMPLETED|Overall Study||5||
48315958|NCT01840579|101101012|FG001|STARTED|Overall Study||7||
48315959|NCT01840579|101101013|FG002|STARTED|Overall Study||6||
48315960|NCT01840579|101101014|FG003|STARTED|Overall Study||6||
48315961|NCT01840579|101101015|FG004|STARTED|Overall Study||8||
48315962|NCT01840579|101101016|FG005|STARTED|Overall Study||6||
48315963|NCT01840579|101101017|FG006|STARTED|Overall Study||6||
48315964|NCT01840579|101101018|FG007|STARTED|Overall Study||6||
48315965|NCT01840579|101101019|FG008|STARTED|Overall Study||6||
48315966|NCT01840579|101101020|FG009|STARTED|Overall Study||3||
48733272|NCT04440813|102133662|FG001|NOT COMPLETED|Overall Study||5||
48733273|NCT03781778|102133663|FG000|STARTED|Overall Study||4||
48733274|NCT03781778|102133664|FG001|STARTED|Overall Study||6||
48733275|NCT03781778|102133663|FG000|Started Intervention|Overall Study||3||
48733276|NCT03781778|102133664|FG001|Started Intervention|Overall Study||4||
48733277|NCT03781778|102133663|FG000|COMPLETED|Overall Study||2||
48159423|NCT00521144|100711275|FG003|NOT COMPLETED|Overall Study||1||
48159424|NCT00521144|100711276|FG004|NOT COMPLETED|Overall Study||7||
48159425|NCT00071721|100711277|FG000|STARTED|Overall Study||153||
48159426|NCT00071721|100711278|FG001|STARTED|Overall Study||160||
48159427|NCT00071721|100711277|FG000|COMPLETED|Overall Study||81||
48159428|NCT00071721|100711278|FG001|COMPLETED|Overall Study||69||
48159429|NCT00071721|100711277|FG000|NOT COMPLETED|Overall Study||72||
48159430|NCT00071721|100711278|FG001|NOT COMPLETED|Overall Study||91||
48159431|NCT00944047|100711279|FG000|STARTED|Overall Study||32||
48159432|NCT00944047|100711279|FG000|COMPLETED|Overall Study||27||
48159433|NCT00944047|100711279|FG000|NOT COMPLETED|Overall Study||5||
48159434|NCT00105235|100711280|FG000|STARTED|Overall Study||27||
48159435|NCT00105235|100711280|FG000|COMPLETED|Overall Study||20||
48159436|NCT00105235|100711280|FG000|NOT COMPLETED|Overall Study||7||
48159437|NCT01224158|100711281|FG000|STARTED|Overall Study||76||
48315967|NCT01840579|101101011|FG000|COMPLETED|Overall Study||0||
48315968|NCT01840579|101101012|FG001|COMPLETED|Overall Study||0||
48315969|NCT01840579|101101013|FG002|COMPLETED|Overall Study||4||
48315970|NCT01840579|101101014|FG003|COMPLETED|Overall Study||3||
48315971|NCT01840579|101101015|FG004|COMPLETED|Overall Study||4||
48315972|NCT01840579|101101016|FG005|COMPLETED|Overall Study||2||
48315973|NCT01840579|101101017|FG006|COMPLETED|Overall Study||4||
48315974|NCT01840579|101101018|FG007|COMPLETED|Overall Study||3||
48315975|NCT01840579|101101019|FG008|COMPLETED|Overall Study||3||
48315976|NCT01840579|101101020|FG009|COMPLETED|Overall Study||0||
48733278|NCT03781778|102133664|FG001|COMPLETED|Overall Study||4||
48733279|NCT03781778|102133663|FG000|NOT COMPLETED|Overall Study||2||
48733280|NCT03781778|102133664|FG001|NOT COMPLETED|Overall Study||2||
48733281|NCT00416455|102133665|FG000|STARTED|Overall Study||169||
48733282|NCT00416455|102133666|FG001|STARTED|Overall Study||215||
48733283|NCT00416455|102133665|FG000|COMPLETED|Overall Study||153||
48159438|NCT01224158|100711282|FG001|STARTED|Overall Study||77||
48315977|NCT01840579|101101011|FG000|NOT COMPLETED|Overall Study||3||
48315978|NCT01840579|101101012|FG001|NOT COMPLETED|Overall Study||7||
48733284|NCT00416455|102133666|FG001|COMPLETED|Overall Study||207||
48733285|NCT00416455|102133665|FG000|NOT COMPLETED|Overall Study||16||
48733286|NCT00416455|102133666|FG001|NOT COMPLETED|Overall Study||8||
48733287|NCT03401671|102133667|FG000|STARTED|Overall Study||16||
48315979|NCT01840579|101101013|FG002|NOT COMPLETED|Overall Study||2||
48315980|NCT01840579|101101014|FG003|NOT COMPLETED|Overall Study||3||
48315981|NCT01840579|101101015|FG004|NOT COMPLETED|Overall Study||4||
48733288|NCT03401671|102133668|FG001|STARTED|Overall Study||16||
48159439|NCT01224158|100711281|FG000|COMPLETED|Overall Study||75||
48159440|NCT01224158|100711282|FG001|COMPLETED|Overall Study||77||
48159441|NCT01224158|100711281|FG000|NOT COMPLETED|Overall Study||1||
48315982|NCT01840579|101101016|FG005|NOT COMPLETED|Overall Study||4||
48315983|NCT01840579|101101017|FG006|NOT COMPLETED|Overall Study||2||
48733289|NCT03401671|102133667|FG000|COMPLETED|Overall Study||16||
48733290|NCT03401671|102133668|FG001|COMPLETED|Overall Study||16||
48733291|NCT03401671|102133667|FG000|NOT COMPLETED|Overall Study||0||
48733292|NCT03401671|102133668|FG001|NOT COMPLETED|Overall Study||0||
48733293|NCT00112125|102133669|FG000|STARTED|Overall Study||213||
48733294|NCT00112125|102133670|FG001|STARTED|Overall Study||215||
48733295|NCT00112125|102133669|FG000|COMPLETED|Overall Study||189||
48733296|NCT00112125|102133670|FG001|COMPLETED|Overall Study||193||
48733297|NCT00112125|102133669|FG000|NOT COMPLETED|Overall Study||24||
48733298|NCT00112125|102133670|FG001|NOT COMPLETED|Overall Study||22||
48733299|NCT03214406|102133671|FG000|STARTED|Overall Study||88||
48733300|NCT03214406|102133672|FG001|STARTED|Overall Study||93||
48733301|NCT03214406|102133671|FG000|COMPLETED|Overall Study||78||
48733302|NCT03214406|102133672|FG001|COMPLETED|Overall Study||78||
48733303|NCT03214406|102133671|FG000|NOT COMPLETED|Overall Study||10||
48733304|NCT03214406|102133672|FG001|NOT COMPLETED|Overall Study||15||
48733305|NCT01098305|102133673|FG000|STARTED|Overall Study||119||
48733306|NCT01098305|102133674|FG001|STARTED|Overall Study||118||
48733307|NCT01098305|102133673|FG000|COMPLETED|Overall Study||88||
48733308|NCT01098305|102133674|FG001|COMPLETED|Overall Study||85||
48733309|NCT01098305|102133673|FG000|NOT COMPLETED|Overall Study||31||
48733310|NCT01098305|102133674|FG001|NOT COMPLETED|Overall Study||33||
48733311|NCT00195663|102133675|FG000|STARTED|2-year Double-blind Treatment Period||257||
48733312|NCT00195663|102133676|FG001|STARTED|2-year Double-blind Treatment Period||274||
48733313|NCT00195663|102133677|FG002|STARTED|2-year Double-blind Treatment Period||268||
48733314|NCT00195663|102133675|FG000|COMPLETED|2-year Double-blind Treatment Period||164||
48733315|NCT00195663|102133676|FG001|COMPLETED|2-year Double-blind Treatment Period||166||
48733316|NCT00195663|102133677|FG002|COMPLETED|2-year Double-blind Treatment Period||196||
48733317|NCT00195663|102133675|FG000|NOT COMPLETED|2-year Double-blind Treatment Period||93||
48733318|NCT00195663|102133676|FG001|NOT COMPLETED|2-year Double-blind Treatment Period||108||
48733319|NCT00195663|102133677|FG002|NOT COMPLETED|2-year Double-blind Treatment Period||72||
48733320|NCT00195663|102133675|FG000|STARTED|Open-Label Extension Period||155||
48733321|NCT00195663|102133676|FG001|STARTED|Open-Label Extension Period||159||
48733322|NCT00195663|102133677|FG002|STARTED|Open-Label Extension Period||183||
48733323|NCT00195663|102133675|FG000|COMPLETED|Open-Label Extension Period||79||
48733324|NCT00195663|102133676|FG001|COMPLETED|Open-Label Extension Period||85||
48733325|NCT00195663|102133677|FG002|COMPLETED|Open-Label Extension Period||86||
48733326|NCT00195663|102133675|FG000|NOT COMPLETED|Open-Label Extension Period||76||
48733327|NCT00195663|102133676|FG001|NOT COMPLETED|Open-Label Extension Period||74||
48733328|NCT00195663|102133677|FG002|NOT COMPLETED|Open-Label Extension Period||97||
48733329|NCT03197376|102133678|FG000|STARTED|Primary and Booster Phase||502||
48733330|NCT03197376|102133679|FG001|STARTED|Primary and Booster Phase||501||
48733331|NCT03197376|102133680|FG002|STARTED|Primary and Booster Phase||500||
48733332|NCT03197376|102133681|FG003|STARTED|Primary and Booster Phase||747||
48733333|NCT03197376|102133678|FG000|Vaccinated-Dose 1|Primary and Booster Phase||502||
48733334|NCT03197376|102133679|FG001|Vaccinated-Dose 1|Primary and Booster Phase||501||
48733335|NCT03197376|102133680|FG002|Vaccinated-Dose 1|Primary and Booster Phase||500||
48733336|NCT03197376|102133681|FG003|Vaccinated-Dose 1|Primary and Booster Phase||747||
48733337|NCT03197376|102133678|FG000|Vaccinated-Dose 2|Primary and Booster Phase||495||
48733338|NCT03197376|102133679|FG001|Vaccinated-Dose 2|Primary and Booster Phase||495||
48159442|NCT01224158|100711282|FG001|NOT COMPLETED|Overall Study||0||
48159443|NCT02173054|100711283|FG000|STARTED|Overall Study||40||
48159444|NCT02173054|100711284|FG001|STARTED|Overall Study||40||
48159445|NCT02173054|100711285|FG002|STARTED|Overall Study||40||
48315984|NCT01840579|101101018|FG007|NOT COMPLETED|Overall Study||3||
48315985|NCT01840579|101101019|FG008|NOT COMPLETED|Overall Study||3||
48315986|NCT01840579|101101020|FG009|NOT COMPLETED|Overall Study||3||
48733339|NCT03197376|102133680|FG002|Vaccinated-Dose 2|Primary and Booster Phase||491||
48733340|NCT03197376|102133681|FG003|Vaccinated-Dose 2|Primary and Booster Phase||738||
48159446|NCT02173054|100711283|FG000|COMPLETED|Overall Study||39||
48315987|NCT04341441|101101021|FG000|STARTED|Overall Study||197||
48733341|NCT03197376|102133678|FG000|Vaccinated-Dose 3|Primary and Booster Phase||492||
48733342|NCT03197376|102133679|FG001|Vaccinated-Dose 3|Primary and Booster Phase||493||
48733343|NCT03197376|102133680|FG002|Vaccinated-Dose 3|Primary and Booster Phase||490||
48733344|NCT03197376|102133681|FG003|Vaccinated-Dose 3|Primary and Booster Phase||731||
48159447|NCT02173054|100711284|FG001|COMPLETED|Overall Study||40||
48159448|NCT02173054|100711285|FG002|COMPLETED|Overall Study||39||
48159449|NCT02173054|100711283|FG000|NOT COMPLETED|Overall Study||1||
48159450|NCT02173054|100711284|FG001|NOT COMPLETED|Overall Study||0||
48159451|NCT02173054|100711285|FG002|NOT COMPLETED|Overall Study||1||
48159452|NCT00800202|100711286|FG000|STARTED|Overall Study||67||
48315988|NCT04341441|101101022|FG001|STARTED|Overall Study||201||
48315989|NCT04341441|101101023|FG002|STARTED|Overall Study||200||
48733345|NCT03197376|102133678|FG000|Primary Reactogenicity Cohort|Primary and Booster Phase||251||
48733346|NCT03197376|102133679|FG001|Primary Reactogenicity Cohort|Primary and Booster Phase||243||
48733347|NCT03197376|102133680|FG002|Primary Reactogenicity Cohort|Primary and Booster Phase||257||
48733348|NCT03197376|102133681|FG003|Primary Reactogenicity Cohort|Primary and Booster Phase||364||
48733349|NCT03197376|102133678|FG000|Booster Cohort|Primary and Booster Phase||150||
48733350|NCT03197376|102133679|FG001|Booster Cohort|Primary and Booster Phase||151||
48733351|NCT03197376|102133680|FG002|Booster Cohort|Primary and Booster Phase||150||
48733352|NCT03197376|102133681|FG003|Booster Cohort|Primary and Booster Phase||224||
48733353|NCT03197376|102133678|FG000|Received Booster Vaccine|Primary and Booster Phase||145||
48733354|NCT03197376|102133679|FG001|Received Booster Vaccine|Primary and Booster Phase||144||
48733355|NCT03197376|102133680|FG002|Received Booster Vaccine|Primary and Booster Phase||139||
48733356|NCT03197376|102133681|FG003|Received Booster Vaccine|Primary and Booster Phase||213||
48733357|NCT03197376|102133678|FG000|COMPLETED|Primary and Booster Phase||487|Completed main phase of study excluding immune persistence phase|
48733358|NCT03197376|102133679|FG001|COMPLETED|Primary and Booster Phase||488|Completed main phase of study excluding immune persistence phase|
48733359|NCT03197376|102133680|FG002|COMPLETED|Primary and Booster Phase||480|Completed main phase of study excluding immune persistence phase|
48733360|NCT03197376|102133681|FG003|COMPLETED|Primary and Booster Phase||722|Completed main phase of study excluding immune persistence phase|
48733361|NCT03197376|102133678|FG000|NOT COMPLETED|Primary and Booster Phase||15||
48733362|NCT03197376|102133679|FG001|NOT COMPLETED|Primary and Booster Phase||13||
48733363|NCT03197376|102133680|FG002|NOT COMPLETED|Primary and Booster Phase||20||
48733364|NCT03197376|102133681|FG003|NOT COMPLETED|Primary and Booster Phase||25||
48733365|NCT03197376|102133678|FG000|STARTED|Immune Persistence Phase||132||
48733366|NCT03197376|102133679|FG001|STARTED|Immune Persistence Phase||133||
48733367|NCT03197376|102133680|FG002|STARTED|Immune Persistence Phase||128||
48733368|NCT03197376|102133681|FG003|STARTED|Immune Persistence Phase||195||
48733369|NCT03197376|102133678|FG000|COMPLETED|Immune Persistence Phase||127||
48733370|NCT03197376|102133679|FG001|COMPLETED|Immune Persistence Phase||129||
48733371|NCT03197376|102133680|FG002|COMPLETED|Immune Persistence Phase||123||
48733372|NCT03197376|102133681|FG003|COMPLETED|Immune Persistence Phase||190||
48733373|NCT03197376|102133678|FG000|NOT COMPLETED|Immune Persistence Phase||5||
48733374|NCT03197376|102133679|FG001|NOT COMPLETED|Immune Persistence Phase||4||
48733375|NCT03197376|102133680|FG002|NOT COMPLETED|Immune Persistence Phase||5||
48733376|NCT03197376|102133681|FG003|NOT COMPLETED|Immune Persistence Phase||5||
48733377|NCT00870545|102133682|FG000|STARTED|Overall Study||86||
48733378|NCT00870545|102133682|FG000|COMPLETED|Overall Study||69||
48733379|NCT00870545|102133682|FG000|NOT COMPLETED|Overall Study||17||
48733380|NCT00842543|102133683|FG000|STARTED|Overall Study||13||
48733381|NCT00842543|102133684|FG001|STARTED|Overall Study||5||
48733382|NCT00842543|102133685|FG002|STARTED|Overall Study||13||
48733383|NCT00842543|102133686|FG003|STARTED|Overall Study||8||
48733384|NCT00842543|102133683|FG000|COMPLETED|Overall Study||11||
48733385|NCT00842543|102133684|FG001|COMPLETED|Overall Study||5||
48733386|NCT00842543|102133685|FG002|COMPLETED|Overall Study||10||
48733387|NCT00842543|102133686|FG003|COMPLETED|Overall Study||4||
48733388|NCT00842543|102133683|FG000|NOT COMPLETED|Overall Study||2||
48733389|NCT00842543|102133684|FG001|NOT COMPLETED|Overall Study||0||
48733390|NCT00842543|102133685|FG002|NOT COMPLETED|Overall Study||3||
48733391|NCT00842543|102133686|FG003|NOT COMPLETED|Overall Study||4||
48733392|NCT02669121|102133687|FG000|STARTED|Overall Study||2377||
48733393|NCT02669121|102133688|FG001|STARTED|Overall Study||2371||
48733394|NCT02669121|102133687|FG000|Treated (Safety Analysis Set)|Overall Study||2357|All participants who received trial vaccination (NoV or placebo).|
48733395|NCT02669121|102133688|FG001|Treated (Safety Analysis Set)|Overall Study||2355|All participants who received trial vaccination (NoV or placebo).|
48733396|NCT02669121|102133687|FG000|COMPLETED|Overall Study||2087||
48733397|NCT02669121|102133688|FG001|COMPLETED|Overall Study||2089||
48733398|NCT02669121|102133687|FG000|NOT COMPLETED|Overall Study||290||
48733399|NCT02669121|102133688|FG001|NOT COMPLETED|Overall Study||282||
48733400|NCT01059994|102133689|FG000|STARTED|Overall Study||3||
48733401|NCT01059994|102133690|FG001|STARTED|Overall Study||2||
48733402|NCT01059994|102133691|FG002|STARTED|Overall Study||3||
48733403|NCT01059994|102133692|FG003|STARTED|Overall Study||4||
48733404|NCT01059994|102133689|FG000|COMPLETED|Overall Study||3||
48733405|NCT01059994|102133690|FG001|COMPLETED|Overall Study||2||
48315990|NCT04341441|101101024|FG003|STARTED|Overall Study||26||
48315991|NCT04341441|101101021|FG000|COMPLETED|Overall Study||188||
48315992|NCT04341441|101101022|FG001|COMPLETED|Overall Study||199||
48406949|NCT03424044|101328486|FG002|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0||
48315993|NCT04341441|101101023|FG002|COMPLETED|Overall Study||191||
48315994|NCT04341441|101101024|FG003|COMPLETED|Overall Study||26||
48614861|NCT02998996|101841855|FG000|STARTED|Overall Study||36||
48614862|NCT02998996|101841856|FG001|STARTED|Overall Study||35||
48614863|NCT02998996|101841857|FG002|STARTED|Overall Study||36||
48614864|NCT02998996|101841858|FG003|STARTED|Overall Study||18||
48614865|NCT02998996|101841859|FG004|STARTED|Overall Study||18||
48614866|NCT02998996|101841860|FG005|STARTED|Overall Study||19||
48614867|NCT02998996|101841855|FG000|COMPLETED|Overall Study||36||
48614868|NCT02998996|101841856|FG001|COMPLETED|Overall Study||34||
48614869|NCT02998996|101841857|FG002|COMPLETED|Overall Study||35||
48614870|NCT02998996|101841858|FG003|COMPLETED|Overall Study||18||
48614871|NCT02998996|101841859|FG004|COMPLETED|Overall Study||17||
48614872|NCT02998996|101841860|FG005|COMPLETED|Overall Study||19||
48614873|NCT02998996|101841855|FG000|NOT COMPLETED|Overall Study||0||
48614874|NCT02998996|101841856|FG001|NOT COMPLETED|Overall Study||1||
48614875|NCT02998996|101841857|FG002|NOT COMPLETED|Overall Study||1||
48614876|NCT02998996|101841858|FG003|NOT COMPLETED|Overall Study||0||
48614877|NCT02998996|101841859|FG004|NOT COMPLETED|Overall Study||1||
48614878|NCT02998996|101841860|FG005|NOT COMPLETED|Overall Study||0||
48614879|NCT01673984|101841861|FG000|STARTED|Overall Study||14||
48614880|NCT01673984|101841862|FG001|STARTED|Overall Study||7||
48614881|NCT01673984|101841861|FG000|COMPLETED|Overall Study||4||
48614882|NCT01673984|101841862|FG001|COMPLETED|Overall Study||1||
48614883|NCT01673984|101841861|FG000|NOT COMPLETED|Overall Study||10||
48614884|NCT01673984|101841862|FG001|NOT COMPLETED|Overall Study||6||
48614885|NCT01267929|101841863|FG000|STARTED|Overall Study||15||
48614886|NCT01267929|101841864|FG001|STARTED|Overall Study||15||
48614887|NCT01267929|101841863|FG000|COMPLETED|Overall Study||15||
48614888|NCT01267929|101841864|FG001|COMPLETED|Overall Study||15||
48614889|NCT01267929|101841863|FG000|NOT COMPLETED|Overall Study||0||
48614890|NCT01267929|101841864|FG001|NOT COMPLETED|Overall Study||0||
48614891|NCT03280056|101841865|FG000|STARTED|Overall Study||95||
48614892|NCT03280056|101841866|FG001|STARTED|Overall Study||94||
48614893|NCT03280056|101841865|FG000|COMPLETED|Overall Study||71||
48614894|NCT03280056|101841866|FG001|COMPLETED|Overall Study||73||
48614895|NCT03280056|101841865|FG000|NOT COMPLETED|Overall Study||24||
48614896|NCT03280056|101841866|FG001|NOT COMPLETED|Overall Study||21||
48614897|NCT04147247|101841867|FG000|STARTED|Overall Study||3||
48614898|NCT04147247|101841868|FG001|STARTED|Overall Study||4||
48614899|NCT04147247|101841869|FG002|STARTED|Overall Study||5||
48614900|NCT04147247|101841870|FG003|STARTED|Overall Study||4||
48614901|NCT04147247|101841871|FG004|STARTED|Overall Study||5||
48614902|NCT04147247|101841867|FG000|COMPLETED|Overall Study||0||
48614903|NCT04147247|101841868|FG001|COMPLETED|Overall Study||0||
48614904|NCT04147247|101841869|FG002|COMPLETED|Overall Study||0||
48614905|NCT04147247|101841870|FG003|COMPLETED|Overall Study||0||
48614906|NCT04147247|101841871|FG004|COMPLETED|Overall Study||0||
48614907|NCT04147247|101841867|FG000|NOT COMPLETED|Overall Study||3||
48614908|NCT04147247|101841868|FG001|NOT COMPLETED|Overall Study||4||
48614909|NCT04147247|101841869|FG002|NOT COMPLETED|Overall Study||5||
48614910|NCT04147247|101841870|FG003|NOT COMPLETED|Overall Study||4||
48614911|NCT04147247|101841871|FG004|NOT COMPLETED|Overall Study||5||
48614912|NCT02324361|101841872|FG000|STARTED|Overall Study||24||
48614913|NCT02324361|101841873|FG001|STARTED|Overall Study||24||
48614914|NCT02324361|101841872|FG000|COMPLETED|Overall Study||19||
48614915|NCT02324361|101841873|FG001|COMPLETED|Overall Study||22||
48614916|NCT02324361|101841872|FG000|NOT COMPLETED|Overall Study||5||
48614917|NCT02324361|101841873|FG001|NOT COMPLETED|Overall Study||2||
48614918|NCT02959918|101841874|FG000|STARTED|Overall Study||3||
48614919|NCT02959918|101841875|FG001|STARTED|Overall Study||3||
48614920|NCT02959918|101841876|FG002|STARTED|Overall Study||9||
48614921|NCT02959918|101841877|FG003|STARTED|Overall Study||10||
48614922|NCT02959918|101841878|FG004|STARTED|Overall Study||6||
48614923|NCT02959918|101841879|FG005|STARTED|Overall Study||11||
48614924|NCT02959918|101841880|FG006|STARTED|Overall Study||11||
48614925|NCT02959918|101841881|FG007|STARTED|Overall Study||12||
48614926|NCT02959918|101841882|FG008|STARTED|Overall Study||14||
48614927|NCT02959918|101841883|FG009|STARTED|Overall Study||13||
48614928|NCT02959918|101841884|FG010|STARTED|Overall Study||14||
48614929|NCT02959918|101841885|FG011|STARTED|Overall Study||23||
48614930|NCT02959918|101841886|FG012|STARTED|Overall Study||11||
48614931|NCT02959918|101841887|FG013|STARTED|Overall Study||12||
48614932|NCT02959918|101841874|FG000|COMPLETED|Overall Study||0||
48614933|NCT02959918|101841875|FG001|COMPLETED|Overall Study||0||
48614934|NCT02959918|101841876|FG002|COMPLETED|Overall Study||1||
48614935|NCT02959918|101841877|FG003|COMPLETED|Overall Study||1||
48614936|NCT02959918|101841878|FG004|COMPLETED|Overall Study||1||
48614937|NCT02959918|101841879|FG005|COMPLETED|Overall Study||5||
48614938|NCT02959918|101841880|FG006|COMPLETED|Overall Study||6||
48614939|NCT02959918|101841881|FG007|COMPLETED|Overall Study||6||
48614940|NCT02959918|101841882|FG008|COMPLETED|Overall Study||7||
48614941|NCT02959918|101841883|FG009|COMPLETED|Overall Study||7||
48614942|NCT02959918|101841884|FG010|COMPLETED|Overall Study||8||
48614943|NCT02959918|101841885|FG011|COMPLETED|Overall Study||11||
48614944|NCT02959918|101841886|FG012|COMPLETED|Overall Study||4||
48614945|NCT02959918|101841887|FG013|COMPLETED|Overall Study||6||
48614946|NCT02959918|101841874|FG000|NOT COMPLETED|Overall Study||3||
48733406|NCT01059994|102133691|FG002|COMPLETED|Overall Study||3||
48733407|NCT01059994|102133692|FG003|COMPLETED|Overall Study||3||
48733408|NCT01059994|102133689|FG000|NOT COMPLETED|Overall Study||0||
48733409|NCT01059994|102133690|FG001|NOT COMPLETED|Overall Study||0||
48733410|NCT01059994|102133691|FG002|NOT COMPLETED|Overall Study||0||
48733411|NCT01059994|102133692|FG003|NOT COMPLETED|Overall Study||1||
48733412|NCT01611194|102133693|FG000|STARTED|Overall Study||36||
48733413|NCT01611194|102133694|FG001|STARTED|Overall Study||35||
48733414|NCT01611194|102133693|FG000|COMPLETED|Overall Study||36||
48733415|NCT01611194|102133694|FG001|COMPLETED|Overall Study||32||
48733416|NCT01611194|102133693|FG000|NOT COMPLETED|Overall Study||0||
48733417|NCT01611194|102133694|FG001|NOT COMPLETED|Overall Study||3||
48733418|NCT03517228|102133695|FG000|STARTED|Overall Study||28||
48733419|NCT03517228|102133695|FG000|COMPLETED|Overall Study||18||
48733420|NCT03517228|102133695|FG000|NOT COMPLETED|Overall Study||10||
48733421|NCT01240135|102133696|FG000|STARTED|Period One, 14 Days of Wear||44||
48733422|NCT01240135|102133697|FG001|STARTED|Period One, 14 Days of Wear||45||
48733423|NCT01240135|102133696|FG000|COMPLETED|Period One, 14 Days of Wear||44||
48733424|NCT01240135|102133697|FG001|COMPLETED|Period One, 14 Days of Wear||45||
48733425|NCT01240135|102133696|FG000|NOT COMPLETED|Period One, 14 Days of Wear||0||
48733426|NCT01240135|102133697|FG001|NOT COMPLETED|Period One, 14 Days of Wear||0||
48733427|NCT01240135|102133696|FG000|STARTED|Period Two, 14 Days of Wear||44||
48733428|NCT01240135|102133697|FG001|STARTED|Period Two, 14 Days of Wear||45||
48733429|NCT01240135|102133696|FG000|COMPLETED|Period Two, 14 Days of Wear||43||
48733430|NCT01240135|102133697|FG001|COMPLETED|Period Two, 14 Days of Wear||43||
48733431|NCT01240135|102133696|FG000|NOT COMPLETED|Period Two, 14 Days of Wear||1||
48733432|NCT01240135|102133697|FG001|NOT COMPLETED|Period Two, 14 Days of Wear||2||
48733433|NCT00520910|102133698|FG000|STARTED|Overall Study||5||
48733434|NCT00520910|102133699|FG001|STARTED|Overall Study||5||
48733435|NCT00520910|102133698|FG000|COMPLETED|Overall Study||5||
48733436|NCT00520910|102133699|FG001|COMPLETED|Overall Study||5||
48733437|NCT00520910|102133698|FG000|NOT COMPLETED|Overall Study||0||
48733438|NCT00520910|102133699|FG001|NOT COMPLETED|Overall Study||0||
48733439|NCT02560012|102133700|FG000|STARTED|Overall Study||3||
48733440|NCT02560012|102133700|FG000|COMPLETED|Overall Study||1||
48733441|NCT02560012|102133700|FG000|NOT COMPLETED|Overall Study||2||
48733442|NCT02006979|102133701|FG000|STARTED|Overall Study||14||
48733443|NCT02006979|102133702|FG001|STARTED|Overall Study||13||
48315995|NCT04341441|101101021|FG000|NOT COMPLETED|Overall Study||9||
48315996|NCT04341441|101101022|FG001|NOT COMPLETED|Overall Study||2||
48315997|NCT04341441|101101023|FG002|NOT COMPLETED|Overall Study||9||
48315998|NCT04341441|101101024|FG003|NOT COMPLETED|Overall Study||0||
48315999|NCT01850485|101101025|FG000|STARTED|Overall Study||9||
48614947|NCT02959918|101841875|FG001|NOT COMPLETED|Overall Study||3||
48614948|NCT02959918|101841876|FG002|NOT COMPLETED|Overall Study||8||
48614949|NCT02959918|101841877|FG003|NOT COMPLETED|Overall Study||9||
48614950|NCT02959918|101841878|FG004|NOT COMPLETED|Overall Study||5||
48614951|NCT02959918|101841879|FG005|NOT COMPLETED|Overall Study||6||
48614952|NCT02959918|101841880|FG006|NOT COMPLETED|Overall Study||5||
48316000|NCT01850485|101101026|FG001|STARTED|Overall Study||13||
48316001|NCT01850485|101101025|FG000|COMPLETED|Overall Study||9||
48316002|NCT01850485|101101026|FG001|COMPLETED|Overall Study||13||
48614953|NCT02959918|101841881|FG007|NOT COMPLETED|Overall Study||6||
48614954|NCT02959918|101841882|FG008|NOT COMPLETED|Overall Study||7||
48614955|NCT02959918|101841883|FG009|NOT COMPLETED|Overall Study||6||
48614956|NCT02959918|101841884|FG010|NOT COMPLETED|Overall Study||6||
48733444|NCT02006979|102133701|FG000|COMPLETED|Overall Study||13||
48316003|NCT01850485|101101025|FG000|NOT COMPLETED|Overall Study||0||
48316004|NCT01850485|101101026|FG001|NOT COMPLETED|Overall Study||0||
48316005|NCT00577642|101101027|FG000|STARTED|Overall Study||29||
48316006|NCT00577642|101101027|FG000|COMPLETED|Overall Study||28||
48316007|NCT00577642|101101027|FG000|NOT COMPLETED|Overall Study||1||
48316008|NCT03335163|101101028|FG000|STARTED|Overall Study||48||
48316009|NCT03335163|101101028|FG000|Completed Visit 2|Overall Study||32||
48614957|NCT02959918|101841885|FG011|NOT COMPLETED|Overall Study||12||
48316010|NCT03335163|101101028|FG000|Completed Visit 3|Overall Study||31||
48614958|NCT02959918|101841886|FG012|NOT COMPLETED|Overall Study||7||
48733445|NCT02006979|102133702|FG001|COMPLETED|Overall Study||11||
48733446|NCT02006979|102133701|FG000|NOT COMPLETED|Overall Study||1||
48733447|NCT02006979|102133702|FG001|NOT COMPLETED|Overall Study||2||
48733448|NCT00555217|102133703|FG000|STARTED|Overall Study||724||
48733449|NCT00555217|102133704|FG001|STARTED|Overall Study||724||
48733450|NCT00555217|102133703|FG000|COMPLETED|Overall Study||649||
48733451|NCT00555217|102133704|FG001|COMPLETED|Overall Study||656||
48733452|NCT00555217|102133703|FG000|NOT COMPLETED|Overall Study||75||
48733453|NCT00555217|102133704|FG001|NOT COMPLETED|Overall Study||68||
48733454|NCT00793325|102133705|FG000|STARTED|Overall Study||909||
48733455|NCT00793325|102133705|FG000|COMPLETED|Overall Study||890||
48733456|NCT00793325|102133705|FG000|NOT COMPLETED|Overall Study||19||
48733457|NCT00793169|102133706|FG000|STARTED|Overall Study||19||
48614959|NCT02959918|101841887|FG013|NOT COMPLETED|Overall Study||6||
48614960|NCT03677869|101841888|FG000|STARTED|Overall Study||35||
48733458|NCT00793169|102133706|FG000|COMPLETED|Overall Study||19||
48316011|NCT03335163|101101028|FG000|COMPLETED|Overall Study||27|Visit 4 completed|
48316012|NCT03335163|101101028|FG000|NOT COMPLETED|Overall Study||21||
48733459|NCT00793169|102133706|FG000|NOT COMPLETED|Overall Study||0||
48733460|NCT03202134|102133707|FG000|STARTED|Overall Study||55||
48733461|NCT03202134|102133708|FG001|STARTED|Overall Study||149||
48733462|NCT03202134|102133707|FG000|COMPLETED|Overall Study||55||
48733463|NCT03202134|102133708|FG001|COMPLETED|Overall Study||149||
48733464|NCT03202134|102133707|FG000|NOT COMPLETED|Overall Study||0||
48733465|NCT03202134|102133708|FG001|NOT COMPLETED|Overall Study||0||
48733466|NCT03722524|102133709|FG000|STARTED|Overall Study||1247||
48733467|NCT03722524|102133709|FG000|COMPLETED|Overall Study||1148||
48733468|NCT03722524|102133709|FG000|NOT COMPLETED|Overall Study||99||
48733469|NCT02473367|102133710|FG000|STARTED|Period 1||20||
48733470|NCT02473367|102133710|FG000|COMPLETED|Period 1||20||
48733471|NCT02473367|102133710|FG000|NOT COMPLETED|Period 1||0||
48733472|NCT02473367|102133710|FG000|STARTED|Wait 1||20||
48733473|NCT02473367|102133710|FG000|COMPLETED|Wait 1||19||
48733474|NCT02473367|102133710|FG000|NOT COMPLETED|Wait 1||1||
48733475|NCT02473367|102133710|FG000|STARTED|Period 2||19||
48733476|NCT02473367|102133710|FG000|COMPLETED|Period 2||19||
48733477|NCT02473367|102133710|FG000|NOT COMPLETED|Period 2||0||
48733478|NCT02473367|102133710|FG000|STARTED|Wait 2||19||
48733479|NCT02473367|102133710|FG000|COMPLETED|Wait 2||19||
48733480|NCT02473367|102133710|FG000|NOT COMPLETED|Wait 2||0||
48733481|NCT02473367|102133710|FG000|STARTED|Period 3||19||
48733482|NCT02473367|102133710|FG000|COMPLETED|Period 3||19||
48733483|NCT02473367|102133710|FG000|NOT COMPLETED|Period 3||0||
48733484|NCT02473367|102133710|FG000|STARTED|Wait 3||19||
48733485|NCT02473367|102133710|FG000|COMPLETED|Wait 3||19||
48733486|NCT02473367|102133710|FG000|NOT COMPLETED|Wait 3||0||
48733487|NCT02473367|102133710|FG000|STARTED|Period 4||19||
48733488|NCT02473367|102133710|FG000|COMPLETED|Period 4||18||
48733489|NCT02473367|102133710|FG000|NOT COMPLETED|Period 4||1||
48733490|NCT00245037|102133711|FG000|STARTED|Overall Study||147||
48733491|NCT00245037|102133711|FG000|COMPLETED|Overall Study||130||
48733492|NCT00245037|102133711|FG000|NOT COMPLETED|Overall Study||17||
48733493|NCT01604291|102133712|FG000|STARTED|Overall Study||311||
48733494|NCT01604291|102133713|FG001|STARTED|Overall Study||443||
48733495|NCT01604291|102133714|FG002|STARTED|Overall Study||193||
48733496|NCT01604291|102133715|FG003|STARTED|Overall Study||44||
48733497|NCT01604291|102133712|FG000|COMPLETED|Overall Study||311||
48733498|NCT01604291|102133713|FG001|COMPLETED|Overall Study||443||
48733499|NCT01604291|102133714|FG002|COMPLETED|Overall Study||193||
48733500|NCT01604291|102133715|FG003|COMPLETED|Overall Study||44||
48733501|NCT01604291|102133712|FG000|NOT COMPLETED|Overall Study||0||
48733502|NCT01604291|102133713|FG001|NOT COMPLETED|Overall Study||0||
48159453|NCT00800202|100711287|FG001|STARTED|Overall Study||24||
48159454|NCT00800202|100711286|FG000|COMPLETED|Overall Study||0||
48159455|NCT00800202|100711287|FG001|COMPLETED|Overall Study||0||
48159456|NCT00800202|100711286|FG000|NOT COMPLETED|Overall Study||67||
48159457|NCT00800202|100711287|FG001|NOT COMPLETED|Overall Study||24||
48159458|NCT04810221|100715630|FG000|STARTED|Overall Study||16||
48159459|NCT04810221|100715630|FG000|COMPLETED|Overall Study||13||
48159460|NCT04810221|100715630|FG000|NOT COMPLETED|Overall Study||3||
48159461|NCT02489110|100715631|FG000|STARTED|Overall Study||75||
48159462|NCT02489110|100715632|FG001|STARTED|Overall Study||75||
48159463|NCT02489110|100715631|FG000|COMPLETED|Overall Study||48||
48159464|NCT02489110|100715632|FG001|COMPLETED|Overall Study||50||
48159465|NCT02489110|100715631|FG000|NOT COMPLETED|Overall Study||27||
48159466|NCT02489110|100715632|FG001|NOT COMPLETED|Overall Study||25||
48159467|NCT00682643|100715633|FG000|STARTED|Overall Study||182||
48159468|NCT00682643|100715634|FG001|STARTED|Overall Study||368||
48159469|NCT00682643|100715633|FG000|COMPLETED|Overall Study||104||
48159470|NCT00682643|100715634|FG001|COMPLETED|Overall Study||199||
48159471|NCT00682643|100715633|FG000|NOT COMPLETED|Overall Study||78||
48316013|NCT01858532|101101029|FG000|STARTED|Overall Study||1325||
48316014|NCT01858532|101101030|FG001|STARTED|Overall Study||1323||
48316015|NCT01858532|101101031|FG002|STARTED|Overall Study||509||
48733503|NCT01604291|102133714|FG002|NOT COMPLETED|Overall Study||0||
48733504|NCT01604291|102133715|FG003|NOT COMPLETED|Overall Study||0||
48733505|NCT04039217|102133716|FG000|STARTED|Overall Study||20||
48733506|NCT04039217|102133716|FG000|Started Study Arm A.1|Overall Study||4||
48733507|NCT04039217|102133716|FG000|Completed Study Arm A.1|Overall Study||4||
48733508|NCT04039217|102133716|FG000|Started Study Arm A.2|Overall Study||4||
48733509|NCT04039217|102133716|FG000|Completed Study Arm A.2|Overall Study||4||
48733510|NCT04039217|102133716|FG000|Started Study Arm A.3|Overall Study||4||
48733511|NCT04039217|102133716|FG000|Completed Study Arm A.3|Overall Study||4||
48733512|NCT04039217|102133716|FG000|Started Study Arm B.1|Overall Study||4||
48733513|NCT04039217|102133716|FG000|Completed Study Arm B.1|Overall Study||4||
48159472|NCT00682643|100715634|FG001|NOT COMPLETED|Overall Study||169||
48159473|NCT00859651|100715635|FG000|STARTED|Overall Study||18||
48159474|NCT00859651|100715636|FG001|STARTED|Overall Study||22||
48159475|NCT00859651|100715635|FG000|COMPLETED|Overall Study||18||
48733514|NCT04039217|102133716|FG000|Started Study Arm B.2|Overall Study||4||
48733515|NCT04039217|102133716|FG000|Completed Study Arm B.2|Overall Study||4||
48733516|NCT04039217|102133716|FG000|Started Study Arm C.1|Overall Study||5||
48733517|NCT04039217|102133716|FG000|Completed Study Arm C.1|Overall Study||4||
48733518|NCT04039217|102133716|FG000|Started Study Arm C.2|Overall Study||0||
48159476|NCT00859651|100715636|FG001|COMPLETED|Overall Study||22||
48159477|NCT00859651|100715635|FG000|NOT COMPLETED|Overall Study||0||
48159478|NCT00859651|100715636|FG001|NOT COMPLETED|Overall Study||0||
48159479|NCT04899245|100715637|FG000|STARTED|Overall Study||41||
48159480|NCT04899245|100715638|FG001|STARTED|Overall Study||47||
48316016|NCT01858532|101101032|FG003|STARTED|Overall Study||511||
48316017|NCT01858532|101101029|FG000|COMPLETED|Overall Study||1144||
48316018|NCT01858532|101101030|FG001|COMPLETED|Overall Study||1131||
48614961|NCT03677869|101841888|FG000|COMPLETED|Overall Study||34||
48614962|NCT03677869|101841888|FG000|NOT COMPLETED|Overall Study||1||
48614963|NCT00534248|101841889|FG000|STARTED|Overall Study||11211||
48159481|NCT04899245|100715639|FG002|STARTED|Overall Study||24||
48159482|NCT04899245|100715637|FG000|COMPLETED|Overall Study||17||
48159483|NCT04899245|100715638|FG001|COMPLETED|Overall Study||19||
48159484|NCT04899245|100715639|FG002|COMPLETED|Overall Study||21||
48159485|NCT04899245|100715637|FG000|NOT COMPLETED|Overall Study||24||
48159486|NCT04899245|100715638|FG001|NOT COMPLETED|Overall Study||28||
48159487|NCT04899245|100715639|FG002|NOT COMPLETED|Overall Study||3||
48159488|NCT02316769|100715640|FG000|STARTED|Overall Study||33||
48159489|NCT02316769|100715641|FG001|STARTED|Overall Study||33||
48159490|NCT02316769|100715640|FG000|COMPLETED|Overall Study||31||
48159491|NCT02316769|100715641|FG001|COMPLETED|Overall Study||33||
48159492|NCT02316769|100715640|FG000|NOT COMPLETED|Overall Study||2||
48159493|NCT02316769|100715641|FG001|NOT COMPLETED|Overall Study||0||
48159494|NCT03988634|100715642|FG000|STARTED|Double-Blind||234|Randomized|
48159495|NCT03988634|100715643|FG001|STARTED|Double-Blind||233|Randomized|
48159496|NCT03988634|100715644|FG002|STARTED|Double-Blind||0|Randomized|
48316019|NCT01858532|101101031|FG002|COMPLETED|Overall Study||411||
48614964|NCT00534248|101841890|FG001|STARTED|Overall Study||11228||
48614965|NCT00534248|101841889|FG000|VACCINATED|Overall Study||11186||
48614966|NCT00534248|101841890|FG001|VACCINATED|Overall Study||11210||
48614967|NCT00534248|101841889|FG000|COMPLETED|Overall Study||10550||
48614968|NCT00534248|101841890|FG001|COMPLETED|Overall Study||10555||
48614969|NCT00534248|101841889|FG000|NOT COMPLETED|Overall Study||661||
48733519|NCT04039217|102133716|FG000|Completed Study Arm C.2|Overall Study||0||
48733520|NCT04039217|102133716|FG000|COMPLETED|Overall Study||19||
48733521|NCT04039217|102133716|FG000|NOT COMPLETED|Overall Study||1||
48733522|NCT02465203|102133717|FG000|STARTED|Overall Study||56||
48733523|NCT02465203|102133718|FG001|STARTED|Overall Study||36||
48733524|NCT02465203|102133719|FG002|STARTED|Overall Study||13||
48733525|NCT02465203|102133717|FG000|COMPLETED|Overall Study||0||
48733526|NCT02465203|102133718|FG001|COMPLETED|Overall Study||0||
48733527|NCT02465203|102133719|FG002|COMPLETED|Overall Study||0||
48733528|NCT02465203|102133717|FG000|NOT COMPLETED|Overall Study||56||
48733529|NCT02465203|102133718|FG001|NOT COMPLETED|Overall Study||36||
48733530|NCT02465203|102133719|FG002|NOT COMPLETED|Overall Study||13||
48733531|NCT02682992|102133720|FG000|STARTED|Overall Study||47||
48733532|NCT02682992|102133720|FG000|COMPLETED|Overall Study||47||
48733533|NCT02682992|102133720|FG000|NOT COMPLETED|Overall Study||0||
48159497|NCT03988634|100715642|FG000|Treated Patients|Double-Blind||233||
48159498|NCT03988634|100715643|FG001|Treated Patients|Double-Blind||233||
48316020|NCT01858532|101101032|FG003|COMPLETED|Overall Study||418||
48316021|NCT01858532|101101029|FG000|NOT COMPLETED|Overall Study||181||
48316022|NCT01858532|101101030|FG001|NOT COMPLETED|Overall Study||192||
48614970|NCT00534248|101841890|FG001|NOT COMPLETED|Overall Study||673||
48316023|NCT01858532|101101031|FG002|NOT COMPLETED|Overall Study||98||
48614971|NCT02983045|101841891|FG000|STARTED|Overall Study||4||
48733534|NCT02119663|102133721|FG000|STARTED|Overall Study||43||
48733535|NCT02119663|102133722|FG001|STARTED|Overall Study||43||
48733536|NCT02119663|102133721|FG000|COMPLETED|Overall Study||3||
48159499|NCT03988634|100715644|FG002|Treated Patients|Double-Blind||0||
48159500|NCT03988634|100715642|FG000|COMPLETED|Double-Blind||173||
48159501|NCT03988634|100715643|FG001|COMPLETED|Double-Blind||182||
48159502|NCT03988634|100715644|FG002|COMPLETED|Double-Blind||0||
48614972|NCT02983045|101841892|FG001|STARTED|Overall Study||3||
48316024|NCT01858532|101101032|FG003|NOT COMPLETED|Overall Study||93||
48316025|NCT02475070|101101033|FG000|STARTED|Overall Study||17||
48614973|NCT02983045|101841893|FG002|STARTED|Overall Study||3||
48614974|NCT02983045|101841894|FG003|STARTED|Overall Study||25||
48614975|NCT02983045|101841895|FG004|STARTED|Overall Study||3||
48614976|NCT02983045|101841896|FG005|STARTED|Overall Study||476||
48614977|NCT02983045|101841897|FG006|STARTED|Overall Study||10||
48614978|NCT02983045|101841898|FG007|STARTED|Overall Study||8||
48614979|NCT02983045|101841899|FG008|STARTED|Overall Study||6||
48614980|NCT02983045|101841900|FG009|STARTED|Overall Study||19||
48614981|NCT02983045|101841891|FG000|COMPLETED|Overall Study||4||
48614982|NCT02983045|101841892|FG001|COMPLETED|Overall Study||2||
48614983|NCT02983045|101841893|FG002|COMPLETED|Overall Study||3||
48614984|NCT02983045|101841894|FG003|COMPLETED|Overall Study||20||
48614985|NCT02983045|101841895|FG004|COMPLETED|Overall Study||3||
48614986|NCT02983045|101841896|FG005|COMPLETED|Overall Study||394||
48614987|NCT02983045|101841897|FG006|COMPLETED|Overall Study||10||
48614988|NCT02983045|101841898|FG007|COMPLETED|Overall Study||8||
48614989|NCT02983045|101841899|FG008|COMPLETED|Overall Study||6||
48614990|NCT02983045|101841900|FG009|COMPLETED|Overall Study||17||
48614991|NCT02983045|101841891|FG000|NOT COMPLETED|Overall Study||0||
48614992|NCT02983045|101841892|FG001|NOT COMPLETED|Overall Study||1||
48614993|NCT02983045|101841893|FG002|NOT COMPLETED|Overall Study||0||
48733537|NCT02119663|102133722|FG001|COMPLETED|Overall Study||2||
48733538|NCT02119663|102133721|FG000|NOT COMPLETED|Overall Study||40||
48733539|NCT02119663|102133722|FG001|NOT COMPLETED|Overall Study||41||
48316026|NCT02475070|101101034|FG001|STARTED|Overall Study||11||
48316027|NCT02475070|101101033|FG000|COMPLETED|Overall Study||17||
48316028|NCT02475070|101101034|FG001|COMPLETED|Overall Study||11||
48316029|NCT02475070|101101033|FG000|NOT COMPLETED|Overall Study||0||
48316030|NCT02475070|101101034|FG001|NOT COMPLETED|Overall Study||0||
48316031|NCT03497585|101101035|FG000|STARTED|Overall Study||112||
48316032|NCT03497585|101101035|FG000|COMPLETED|Overall Study||57||
48316033|NCT03497585|101101035|FG000|NOT COMPLETED|Overall Study||55||
48316034|NCT00496730|101101036|FG000|STARTED|Overall Study||130||
48316035|NCT00496730|101101037|FG001|STARTED|Overall Study||126||
48316036|NCT00496730|101101036|FG000|COMPLETED|Overall Study||124||
48316037|NCT00496730|101101037|FG001|COMPLETED|Overall Study||121||
48733540|NCT00042991|102133723|FG000|STARTED|Overall Study||6||
48733541|NCT00042991|102133724|FG001|STARTED|Overall Study||43||
48733542|NCT00042991|102133725|FG002|STARTED|Overall Study||7||
48733543|NCT00042991|102133726|FG003|STARTED|Overall Study||2||
48733544|NCT00042991|102133727|FG004|STARTED|Overall Study||3||
48733545|NCT00042991|102133728|FG005|STARTED|Overall Study||5||
48733546|NCT00042991|102133729|FG006|STARTED|Overall Study||3||
48733547|NCT00042991|102133723|FG000|Phase-I Trial|Overall Study||6||
48733548|NCT00042991|102133724|FG001|Phase-I Trial|Overall Study||7||
48733549|NCT00042991|102133725|FG002|Phase-I Trial|Overall Study||7||
48733550|NCT00042991|102133726|FG003|Phase-I Trial|Overall Study||2||
48733551|NCT00042991|102133727|FG004|Phase-I Trial|Overall Study||3||
48733552|NCT00042991|102133728|FG005|Phase-I Trial|Overall Study||5||
48316038|NCT00496730|101101036|FG000|NOT COMPLETED|Overall Study||6||
48316039|NCT00496730|101101037|FG001|NOT COMPLETED|Overall Study||5||
48316040|NCT01500759|101101038|FG000|STARTED|Overall Study||3686||
48316041|NCT01500759|101101039|FG001|STARTED|Overall Study||3190||
48316042|NCT01500759|101101038|FG000|COMPLETED|Overall Study||3686||
48406950|NCT03424044|101328487|FG003|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0||
48406951|NCT03424044|101328488|FG004|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0||
48406952|NCT03424044|101328489|FG005|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0||
48614994|NCT02983045|101841894|FG003|NOT COMPLETED|Overall Study||5||
48614995|NCT02983045|101841895|FG004|NOT COMPLETED|Overall Study||0||
48614996|NCT02983045|101841896|FG005|NOT COMPLETED|Overall Study||82||
48614997|NCT02983045|101841897|FG006|NOT COMPLETED|Overall Study||0||
48614998|NCT02983045|101841898|FG007|NOT COMPLETED|Overall Study||0||
48733553|NCT00042991|102133729|FG006|Phase-I Trial|Overall Study||3||
48733554|NCT00042991|102133723|FG000|Phase-II Trial|Overall Study||0||
48733555|NCT00042991|102133724|FG001|Phase-II Trial|Overall Study||36||
48733556|NCT00042991|102133725|FG002|Phase-II Trial|Overall Study||0||
48733557|NCT00042991|102133726|FG003|Phase-II Trial|Overall Study||0||
48614999|NCT02983045|101841899|FG008|NOT COMPLETED|Overall Study||0||
48316043|NCT01500759|101101039|FG001|COMPLETED|Overall Study||3190||
48316044|NCT01500759|101101038|FG000|NOT COMPLETED|Overall Study||0||
48615000|NCT02983045|101841900|FG009|NOT COMPLETED|Overall Study||2||
48615001|NCT00766597|101841901|FG000|STARTED|Overall Study||9||
48733558|NCT00042991|102133727|FG004|Phase-II Trial|Overall Study||0||
48733559|NCT00042991|102133728|FG005|Phase-II Trial|Overall Study||0||
48733560|NCT00042991|102133729|FG006|Phase-II Trial|Overall Study||0||
48733561|NCT00042991|102133723|FG000|COMPLETED|Overall Study||0||
48316045|NCT01500759|101101039|FG001|NOT COMPLETED|Overall Study||0||
48316046|NCT04640272|101101040|FG000|STARTED|Overall Study||22||
48615002|NCT00766597|101841901|FG000|With CCR5-tropic Virus|Overall Study||4||
48657089|NCT03648372|101943766|FG009|NOT COMPLETED|Overall Study||5||
48615003|NCT00766597|101841901|FG000|Without CCR5-tropic Virus|Overall Study||5||
48615004|NCT00766597|101841901|FG000|Completed Week 24|Overall Study||1||
48159503|NCT03988634|100715642|FG000|NOT COMPLETED|Double-Blind||61||
48159504|NCT03988634|100715643|FG001|NOT COMPLETED|Double-Blind||51||
48159505|NCT03988634|100715644|FG002|NOT COMPLETED|Double-Blind||0||
48159506|NCT03988634|100715642|FG000|STARTED|Open-Label||0|Started open label phase under Protocol Version 00|
48316047|NCT04640272|101101040|FG000|COMPLETED|Overall Study||21||
48316048|NCT04640272|101101040|FG000|NOT COMPLETED|Overall Study||1||
48316049|NCT01330134|101101041|FG000|STARTED|Overall Study||244||
48159507|NCT03988634|100715643|FG001|STARTED|Open-Label||0|Started open label phase under Protocol Version 00|
48159508|NCT03988634|100715644|FG002|STARTED|Open-Label||50|Started open label phase under Protocol Version 00|
48159509|NCT03988634|100715642|FG000|COMPLETED|Open-Label||0||
48159510|NCT03988634|100715643|FG001|COMPLETED|Open-Label||0||
48159511|NCT03988634|100715644|FG002|COMPLETED|Open-Label||41||
48159512|NCT03988634|100715642|FG000|NOT COMPLETED|Open-Label||0||
48159513|NCT03988634|100715643|FG001|NOT COMPLETED|Open-Label||0||
48159514|NCT03988634|100715644|FG002|NOT COMPLETED|Open-Label||9||
48159515|NCT02260401|100715645|FG000|STARTED|Overall Study||80||
48159516|NCT02260401|100715646|FG001|STARTED|Overall Study||85||
48159517|NCT02260401|100715645|FG000|COMPLETED|Overall Study||75||
48159518|NCT02260401|100715646|FG001|COMPLETED|Overall Study||73||
48159519|NCT02260401|100715645|FG000|NOT COMPLETED|Overall Study||5||
48159520|NCT02260401|100715646|FG001|NOT COMPLETED|Overall Study||12||
48159521|NCT04676425|100715647|FG000|STARTED|Overall Study||7||
48159522|NCT04676425|100715648|FG001|STARTED|Overall Study||7||
48159523|NCT04676425|100715647|FG000|COMPLETED|Overall Study||7||
48159524|NCT04676425|100715648|FG001|COMPLETED|Overall Study||7||
48316050|NCT01330134|101101042|FG001|STARTED|Overall Study||237||
48316051|NCT01330134|101101041|FG000|COMPLETED|Overall Study||244||
48316052|NCT01330134|101101042|FG001|COMPLETED|Overall Study||237||
48316053|NCT01330134|101101041|FG000|NOT COMPLETED|Overall Study||0||
48615005|NCT00766597|101841901|FG000|Completed Week 48|Overall Study||0||
48615006|NCT00766597|101841901|FG000|COMPLETED|Overall Study||0||
48615007|NCT00766597|101841901|FG000|NOT COMPLETED|Overall Study||9||
48615008|NCT04710004|101841902|FG000|STARTED|Overall Study||1||
48615009|NCT04710004|101841902|FG000|COMPLETED|Overall Study||0||
48615010|NCT04710004|101841902|FG000|NOT COMPLETED|Overall Study||1||
48615011|NCT00527826|101841903|FG000|STARTED|Overall Study||108||
48615012|NCT00527826|101841904|FG001|STARTED|Overall Study||106||
48615013|NCT00527826|101841903|FG000|COMPLETED|Overall Study||87||
48615014|NCT00527826|101841904|FG001|COMPLETED|Overall Study||80||
48615015|NCT00527826|101841903|FG000|NOT COMPLETED|Overall Study||21||
48615016|NCT00527826|101841904|FG001|NOT COMPLETED|Overall Study||26||
48615017|NCT01421641|101841905|FG000|STARTED|Overall Study||37||
48615018|NCT01421641|101841906|FG001|STARTED|Overall Study||37||
48615019|NCT01421641|101841905|FG000|COMPLETED|Overall Study||35||
48615020|NCT01421641|101841906|FG001|COMPLETED|Overall Study||35||
48615021|NCT01421641|101841905|FG000|NOT COMPLETED|Overall Study||2||
48159525|NCT04676425|100715647|FG000|NOT COMPLETED|Overall Study||0||
48159526|NCT04676425|100715648|FG001|NOT COMPLETED|Overall Study||0||
48159527|NCT02835339|100715649|FG000|STARTED|Overall Study||31||
48159528|NCT02835339|100715650|FG001|STARTED|Overall Study||35||
48159529|NCT02835339|100715649|FG000|COMPLETED|Overall Study||18||
48159530|NCT02835339|100715650|FG001|COMPLETED|Overall Study||19||
48159531|NCT02835339|100715649|FG000|NOT COMPLETED|Overall Study||13||
48159532|NCT02835339|100715650|FG001|NOT COMPLETED|Overall Study||16||
48159533|NCT05178121|100715651|FG000|STARTED|Overall Study||18||
48159534|NCT05178121|100715651|FG000|Completed Training|Overall Study||15||
48159535|NCT05178121|100715651|FG000|Completed Post-Training Survey|Overall Study||14||
48159536|NCT05178121|100715651|FG000|Completed Post-Training Role-Play|Overall Study||14||
48159537|NCT05178121|100715651|FG000|Completed 6-Month Role-Play|Overall Study||10||
48159538|NCT05178121|100715651|FG000|COMPLETED|Overall Study||13|Completed 6-Month Follow-up Survey|
48159539|NCT05178121|100715651|FG000|NOT COMPLETED|Overall Study||5||
48159540|NCT01987817|100715652|FG000|STARTED|Overall Study||29||
48159541|NCT01987817|100715653|FG001|STARTED|Overall Study||27||
48159542|NCT01987817|100715652|FG000|COMPLETED|Overall Study||23||
48159543|NCT01987817|100715653|FG001|COMPLETED|Overall Study||26||
48159544|NCT01987817|100715652|FG000|NOT COMPLETED|Overall Study||6||
48159545|NCT01987817|100715653|FG001|NOT COMPLETED|Overall Study||1||
48159546|NCT00817999|100715654|FG000|STARTED|Grapefruit Juice||15||
48159547|NCT00817999|100715655|FG001|STARTED|Grapefruit Juice||17||
48159548|NCT00817999|100715654|FG000|COMPLETED|Grapefruit Juice||15||
48159549|NCT00817999|100715655|FG001|COMPLETED|Grapefruit Juice||17||
48159550|NCT00817999|100715654|FG000|NOT COMPLETED|Grapefruit Juice||0||
48159551|NCT00817999|100715655|FG001|NOT COMPLETED|Grapefruit Juice||0||
48159552|NCT00817999|100715654|FG000|STARTED|No Grapefruit Juice||15||
48159553|NCT00817999|100715655|FG001|STARTED|No Grapefruit Juice||17||
48159554|NCT00817999|100715654|FG000|COMPLETED|No Grapefruit Juice||15||
48316054|NCT01330134|101101042|FG001|NOT COMPLETED|Overall Study||0||
48316055|NCT00912028|101101043|FG000|STARTED|Overall Study||35||
48615022|NCT01421641|101841906|FG001|NOT COMPLETED|Overall Study||2||
48615023|NCT02600611|101841907|FG000|STARTED|Overall Study||300||
48615024|NCT02600611|101841908|FG001|STARTED|Overall Study||300||
48316056|NCT00912028|101101044|FG001|STARTED|Overall Study||3||
48316057|NCT00912028|101101045|FG002|STARTED|Overall Study||13||
48316058|NCT00912028|101101046|FG003|STARTED|Overall Study||17||
48316059|NCT00912028|101101047|FG004|STARTED|Overall Study||3||
48316060|NCT00912028|101101043|FG000|COMPLETED|Overall Study||30||
48316061|NCT00912028|101101044|FG001|COMPLETED|Overall Study||0||
48316062|NCT00912028|101101045|FG002|COMPLETED|Overall Study||13||
48316063|NCT00912028|101101046|FG003|COMPLETED|Overall Study||16||
48316064|NCT00912028|101101047|FG004|COMPLETED|Overall Study||0||
48316065|NCT00912028|101101043|FG000|NOT COMPLETED|Overall Study||5||
48316066|NCT00912028|101101044|FG001|NOT COMPLETED|Overall Study||3||
48316067|NCT00912028|101101045|FG002|NOT COMPLETED|Overall Study||0||
48316068|NCT00912028|101101046|FG003|NOT COMPLETED|Overall Study||1||
48316069|NCT00912028|101101047|FG004|NOT COMPLETED|Overall Study||3||
48316070|NCT03118232|101101048|FG000|STARTED|Overall Study||7388||14
48316071|NCT03118232|101101049|FG001|STARTED|Overall Study||6564||14
48316072|NCT03118232|101101048|FG000|COMPLETED|Overall Study||7388||14
48316073|NCT03118232|101101049|FG001|COMPLETED|Overall Study||6564||14
48316074|NCT03118232|101101048|FG000|NOT COMPLETED|Overall Study||0||0
48316075|NCT03118232|101101049|FG001|NOT COMPLETED|Overall Study||0||0
48316076|NCT01875783|101101050|FG000|STARTED|Overall Study||385||
48316077|NCT01875783|101101050|FG000|COMPLETED|Overall Study||385||
48316078|NCT01875783|101101050|FG000|NOT COMPLETED|Overall Study||0||
48316079|NCT04688775|101101051|FG000|STARTED|Placebo-controlled Period||113||
48316080|NCT04688775|101101052|FG001|STARTED|Placebo-controlled Period||118||
48316081|NCT04688775|101101053|FG002|STARTED|Placebo-controlled Period||0||
48316082|NCT04688775|101101054|FG003|STARTED|Placebo-controlled Period||0||
48316083|NCT04688775|101101051|FG000|Received at Least 1 Dose of Study Drug|Placebo-controlled Period||112||
48316084|NCT04688775|101101052|FG001|Received at Least 1 Dose of Study Drug|Placebo-controlled Period||117||
48316085|NCT04688775|101101053|FG002|Received at Least 1 Dose of Study Drug|Placebo-controlled Period||0||
48316086|NCT04688775|101101054|FG003|Received at Least 1 Dose of Study Drug|Placebo-controlled Period||0||
48316087|NCT04688775|101101051|FG000|COMPLETED|Placebo-controlled Period||108||
48316088|NCT04688775|101101052|FG001|COMPLETED|Placebo-controlled Period||107||
48316089|NCT04688775|101101053|FG002|COMPLETED|Placebo-controlled Period||0||
48316090|NCT04688775|101101054|FG003|COMPLETED|Placebo-controlled Period||0||
48316091|NCT04688775|101101051|FG000|NOT COMPLETED|Placebo-controlled Period||5||
48316092|NCT04688775|101101052|FG001|NOT COMPLETED|Placebo-controlled Period||11||
48316093|NCT04688775|101101053|FG002|NOT COMPLETED|Placebo-controlled Period||0||
48316094|NCT04688775|101101054|FG003|NOT COMPLETED|Placebo-controlled Period||0||
48316095|NCT04688775|101101051|FG000|STARTED|Delayed Start Period||0||
48316096|NCT04688775|101101052|FG001|STARTED|Delayed Start Period||0||
48316097|NCT04688775|101101053|FG002|STARTED|Delayed Start Period||107||
48316098|NCT04688775|101101054|FG003|STARTED|Delayed Start Period||108||
48316099|NCT04688775|101101051|FG000|Received at Least 1 Dose of Study Drug|Delayed Start Period||0||
48316100|NCT04688775|101101052|FG001|Received at Least 1 Dose of Study Drug|Delayed Start Period||0||
48316101|NCT04688775|101101053|FG002|Received at Least 1 Dose of Study Drug|Delayed Start Period||107||
48316102|NCT04688775|101101054|FG003|Received at Least 1 Dose of Study Drug|Delayed Start Period||108||
48316103|NCT04688775|101101051|FG000|COMPLETED|Delayed Start Period||0||
48316104|NCT04688775|101101052|FG001|COMPLETED|Delayed Start Period||0||
48316105|NCT04688775|101101053|FG002|COMPLETED|Delayed Start Period||101||
48316106|NCT04688775|101101054|FG003|COMPLETED|Delayed Start Period||100||
48316107|NCT04688775|101101051|FG000|NOT COMPLETED|Delayed Start Period||0||
48316108|NCT04688775|101101052|FG001|NOT COMPLETED|Delayed Start Period||0||
48316109|NCT04688775|101101053|FG002|NOT COMPLETED|Delayed Start Period||6||
48316110|NCT04688775|101101054|FG003|NOT COMPLETED|Delayed Start Period||8||
48316111|NCT00833053|101101055|FG000|STARTED|Overall Study||19||
48316112|NCT00833053|101101056|FG001|STARTED|Overall Study||20||
48316113|NCT00833053|101101055|FG000|COMPLETED|Overall Study||10||
48316114|NCT00833053|101101056|FG001|COMPLETED|Overall Study||17||
48316115|NCT00833053|101101055|FG000|NOT COMPLETED|Overall Study||9||
48316116|NCT00833053|101101056|FG001|NOT COMPLETED|Overall Study||3||
48316117|NCT03070470|101101057|FG000|STARTED|Overall Study||10||
48316118|NCT03070470|101101058|FG001|STARTED|Overall Study||10||
48316119|NCT03070470|101101059|FG002|STARTED|Overall Study||10||
48316120|NCT03070470|101101060|FG003|STARTED|Overall Study||10||
48316121|NCT03070470|101101061|FG004|STARTED|Overall Study||10||
48316122|NCT03070470|101101062|FG005|STARTED|Overall Study||10||
48316123|NCT03070470|101101057|FG000|COMPLETED|Overall Study||10||
48316124|NCT03070470|101101058|FG001|COMPLETED|Overall Study||9||
48316125|NCT03070470|101101059|FG002|COMPLETED|Overall Study||10||
48316126|NCT03070470|101101060|FG003|COMPLETED|Overall Study||10||
48316127|NCT03070470|101101061|FG004|COMPLETED|Overall Study||10||
48316128|NCT03070470|101101062|FG005|COMPLETED|Overall Study||8||
48316129|NCT03070470|101101057|FG000|NOT COMPLETED|Overall Study||0||
48316130|NCT03070470|101101058|FG001|NOT COMPLETED|Overall Study||1||
48316131|NCT03070470|101101059|FG002|NOT COMPLETED|Overall Study||0||
48316132|NCT03070470|101101060|FG003|NOT COMPLETED|Overall Study||0||
48316133|NCT03070470|101101061|FG004|NOT COMPLETED|Overall Study||0||
48316134|NCT03070470|101101062|FG005|NOT COMPLETED|Overall Study||2||
48316135|NCT02518997|101101063|FG000|STARTED|Overall Study||18||
48316136|NCT02518997|101101063|FG000|COMPLETED|Overall Study||18||
48316137|NCT02518997|101101063|FG000|NOT COMPLETED|Overall Study||0||
48316138|NCT03807349|101101064|FG000|STARTED|Overall Study||12||
48316139|NCT03807349|101101064|FG000|COMPLETED|Overall Study||3||
48316140|NCT03807349|101101064|FG000|NOT COMPLETED|Overall Study||9||
48316141|NCT02631525|101101065|FG000|STARTED|Overall Study||20||
48316142|NCT02631525|101101066|FG001|STARTED|Overall Study||20||
48316143|NCT02631525|101101065|FG000|COMPLETED|Overall Study||20||
48316144|NCT02631525|101101066|FG001|COMPLETED|Overall Study||20||
48316145|NCT02631525|101101065|FG000|NOT COMPLETED|Overall Study||0||
48316146|NCT02631525|101101066|FG001|NOT COMPLETED|Overall Study||0||
48316147|NCT03044249|101101067|FG000|STARTED|Overall Study||42||
48316148|NCT03044249|101101068|FG001|STARTED|Overall Study||39||
48316149|NCT03044249|101101067|FG000|Received at Least One Dose of Study Drug|Overall Study||42||
48316150|NCT03044249|101101068|FG001|Received at Least One Dose of Study Drug|Overall Study||39||
48316151|NCT03044249|101101067|FG000|COMPLETED|Overall Study||32||
48615025|NCT02600611|101841907|FG000|COMPLETED|Overall Study||298||
48615026|NCT02600611|101841908|FG001|COMPLETED|Overall Study||300||
48615027|NCT02600611|101841907|FG000|NOT COMPLETED|Overall Study||2||
48316152|NCT03044249|101101068|FG001|COMPLETED|Overall Study||25||
48316153|NCT03044249|101101067|FG000|NOT COMPLETED|Overall Study||10||
48316154|NCT03044249|101101068|FG001|NOT COMPLETED|Overall Study||14||
48733562|NCT00042991|102133724|FG001|COMPLETED|Overall Study||3||
48733563|NCT00042991|102133725|FG002|COMPLETED|Overall Study||1||
48733564|NCT00042991|102133726|FG003|COMPLETED|Overall Study||0||
48733565|NCT00042991|102133727|FG004|COMPLETED|Overall Study||0||
48733566|NCT00042991|102133728|FG005|COMPLETED|Overall Study||0||
48733567|NCT00042991|102133729|FG006|COMPLETED|Overall Study||1||
48316155|NCT02625233|101101069|FG000|STARTED|Overall Study||49||
48316156|NCT02625233|101101070|FG001|STARTED|Overall Study||56||
48316157|NCT02625233|101101069|FG000|COMPLETED|Overall Study||47||
48316158|NCT02625233|101101070|FG001|COMPLETED|Overall Study||56||
48316159|NCT02625233|101101069|FG000|NOT COMPLETED|Overall Study||2||
48316160|NCT02625233|101101070|FG001|NOT COMPLETED|Overall Study||0||
48316161|NCT00974246|101101071|FG000|STARTED|Overall Study||27||
48316162|NCT00974246|101101071|FG000|COMPLETED|Overall Study||27||
48316163|NCT00974246|101101071|FG000|NOT COMPLETED|Overall Study||0||
48316164|NCT03693625|101101072|FG000|STARTED|Overall Study||23||
48316165|NCT03693625|101101073|FG001|STARTED|Overall Study||8||
48316166|NCT03693625|101101072|FG000|COMPLETED|Overall Study||0||
48316167|NCT03693625|101101073|FG001|COMPLETED|Overall Study||0||
48316168|NCT03693625|101101072|FG000|NOT COMPLETED|Overall Study||23||
48316169|NCT03693625|101101073|FG001|NOT COMPLETED|Overall Study||8||
48316170|NCT03196076|101101074|FG000|STARTED|Overall Study||5||
48316171|NCT03196076|101101075|FG001|STARTED|Overall Study||20||
48316172|NCT03196076|101101076|FG002|STARTED|Overall Study||0||
48316173|NCT03196076|101101074|FG000|COMPLETED|Overall Study||5||
48316174|NCT03196076|101101075|FG001|COMPLETED|Overall Study||20||
48316175|NCT03196076|101101076|FG002|COMPLETED|Overall Study||0||
48316176|NCT03196076|101101074|FG000|NOT COMPLETED|Overall Study||0||
48316177|NCT03196076|101101075|FG001|NOT COMPLETED|Overall Study||0||
48316178|NCT03196076|101101076|FG002|NOT COMPLETED|Overall Study||0||
48316179|NCT03471975|101101077|FG000|STARTED|Overall Study||17||
48316180|NCT03471975|101101078|FG001|STARTED|Overall Study||20||
48316181|NCT03471975|101101077|FG000|COMPLETED|Overall Study||17||
48316182|NCT03471975|101101078|FG001|COMPLETED|Overall Study||20||
48316183|NCT03471975|101101077|FG000|NOT COMPLETED|Overall Study||0||
48316184|NCT03471975|101101078|FG001|NOT COMPLETED|Overall Study||0||
48615028|NCT02600611|101841908|FG001|NOT COMPLETED|Overall Study||0||
48615029|NCT03735407|101841909|FG000|STARTED|Overall Study||40||
48615030|NCT03735407|101841909|FG000|COMPLETED|Overall Study||40||
48615031|NCT03735407|101841909|FG000|NOT COMPLETED|Overall Study||0||
48615032|NCT04167189|101841910|FG000|STARTED|Overall Study||28||
48615033|NCT04167189|101841910|FG000|COMPLETED|Overall Study||28||
48733568|NCT00042991|102133723|FG000|NOT COMPLETED|Overall Study||6||
48733569|NCT00042991|102133724|FG001|NOT COMPLETED|Overall Study||40||
48733570|NCT00042991|102133725|FG002|NOT COMPLETED|Overall Study||6||
48733571|NCT00042991|102133726|FG003|NOT COMPLETED|Overall Study||2||
48316185|NCT02997735|101101079|FG000|STARTED|Overall Study||233||
48316186|NCT02997735|101101080|FG001|STARTED|Overall Study||251||
48316187|NCT02997735|101101079|FG000|COMPLETED|Overall Study||233||
48316188|NCT02997735|101101080|FG001|COMPLETED|Overall Study||251||
48316189|NCT02997735|101101079|FG000|NOT COMPLETED|Overall Study||0||
48316190|NCT02997735|101101080|FG001|NOT COMPLETED|Overall Study||0||
48316191|NCT01063075|101101081|FG000|STARTED|Overall Study||2||
48316192|NCT01063075|101101082|FG001|STARTED|Overall Study||3||
48615034|NCT04167189|101841910|FG000|NOT COMPLETED|Overall Study||0||
48615035|NCT03974282|101841911|FG000|STARTED|Overall Study||18||
48615036|NCT03974282|101841912|FG001|STARTED|Overall Study||18||
48615037|NCT03974282|101841911|FG000|COMPLETED|Overall Study||18||
48733572|NCT00042991|102133727|FG004|NOT COMPLETED|Overall Study||3||
48733573|NCT00042991|102133728|FG005|NOT COMPLETED|Overall Study||5||
48316193|NCT01063075|101101083|FG002|STARTED|Overall Study||14||
48316194|NCT01063075|101101084|FG003|STARTED|Overall Study||15||
48316195|NCT01063075|101101081|FG000|COMPLETED|Overall Study||1||
48316196|NCT01063075|101101082|FG001|COMPLETED|Overall Study||1||
48316197|NCT01063075|101101083|FG002|COMPLETED|Overall Study||9||
48316198|NCT01063075|101101084|FG003|COMPLETED|Overall Study||14||
48316199|NCT01063075|101101081|FG000|NOT COMPLETED|Overall Study||1||
48316200|NCT01063075|101101082|FG001|NOT COMPLETED|Overall Study||2||
48316201|NCT01063075|101101083|FG002|NOT COMPLETED|Overall Study||5||
48316202|NCT01063075|101101084|FG003|NOT COMPLETED|Overall Study||1||
48316203|NCT01439555|101101085|FG000|STARTED|Overall Study||11||
48316204|NCT01439555|101101085|FG000|COMPLETED|Overall Study||10||
48316205|NCT01439555|101101085|FG000|NOT COMPLETED|Overall Study||1||
48316206|NCT00631020|101101086|FG000|STARTED|Overall Study||34||
48316207|NCT00631020|101101086|FG000|COMPLETED|Overall Study||26||
48316208|NCT00631020|101101086|FG000|NOT COMPLETED|Overall Study||8||
48316209|NCT02533063|101101087|FG000|STARTED|Intervention 1 (8 Weeks)||16||
48316210|NCT02533063|101101088|FG001|STARTED|Intervention 1 (8 Weeks)||16||
48316211|NCT02533063|101101087|FG000|COMPLETED|Intervention 1 (8 Weeks)||14||
48316212|NCT02533063|101101088|FG001|COMPLETED|Intervention 1 (8 Weeks)||11||
48316213|NCT02533063|101101087|FG000|NOT COMPLETED|Intervention 1 (8 Weeks)||2||
48316214|NCT02533063|101101088|FG001|NOT COMPLETED|Intervention 1 (8 Weeks)||5||
48316215|NCT02533063|101101087|FG000|STARTED|Washout (4 Weeks)||14||
48316216|NCT02533063|101101088|FG001|STARTED|Washout (4 Weeks)||11||
48316217|NCT02533063|101101087|FG000|COMPLETED|Washout (4 Weeks)||14||
48316218|NCT02533063|101101088|FG001|COMPLETED|Washout (4 Weeks)||11||
48733574|NCT00042991|102133729|FG006|NOT COMPLETED|Overall Study||2||
48733575|NCT01835223|102133730|FG000|STARTED|Overall Study||30||
48733576|NCT01835223|102133731|FG001|STARTED|Overall Study||3||
48733577|NCT01835223|102133730|FG000|COMPLETED|Overall Study||21||
48733578|NCT01835223|102133731|FG001|COMPLETED|Overall Study||2||
48733579|NCT01835223|102133730|FG000|NOT COMPLETED|Overall Study||9||
48733580|NCT01835223|102133731|FG001|NOT COMPLETED|Overall Study||1||
48733581|NCT00650845|102133732|FG000|STARTED|Overall Study||75||
48733582|NCT00650845|102133733|FG001|STARTED|Overall Study||57||
48733583|NCT00650845|102133732|FG000|COMPLETED|Overall Study||70||
48733584|NCT00650845|102133733|FG001|COMPLETED|Overall Study||44||
48733585|NCT00650845|102133732|FG000|NOT COMPLETED|Overall Study||5||
48733586|NCT00650845|102133733|FG001|NOT COMPLETED|Overall Study||13||
48733587|NCT02397057|102133734|FG000|STARTED|Overall Study||105||
48733588|NCT02397057|102133735|FG001|STARTED|Overall Study||104||
48733589|NCT02397057|102133734|FG000|COMPLETED|Overall Study||94||
48733590|NCT02397057|102133735|FG001|COMPLETED|Overall Study||91||
48733591|NCT02397057|102133734|FG000|NOT COMPLETED|Overall Study||11||
48733592|NCT02397057|102133735|FG001|NOT COMPLETED|Overall Study||13||
48733593|NCT00306527|102133736|FG000|STARTED|Overall Study||533||
48733594|NCT00306527|102133737|FG001|STARTED|Overall Study||534||
48733595|NCT00306527|102133738|FG002|STARTED|Overall Study||572||
48316219|NCT02533063|101101087|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
48316220|NCT02533063|101101088|FG001|NOT COMPLETED|Washout (4 Weeks)||0||
48316221|NCT02533063|101101087|FG000|STARTED|Intervention 2 (8 Weeks)||14||
48316222|NCT02533063|101101088|FG001|STARTED|Intervention 2 (8 Weeks)||11||
48316223|NCT02533063|101101087|FG000|COMPLETED|Intervention 2 (8 Weeks)||14||
48316224|NCT02533063|101101088|FG001|COMPLETED|Intervention 2 (8 Weeks)||11||
48316225|NCT02533063|101101087|FG000|NOT COMPLETED|Intervention 2 (8 Weeks)||0||
48316226|NCT02533063|101101088|FG001|NOT COMPLETED|Intervention 2 (8 Weeks)||0||
48316227|NCT00530270|101101089|FG000|STARTED|Overall Study||6||
48316228|NCT00530270|101101090|FG001|STARTED|Overall Study||6||
48316229|NCT00530270|101101089|FG000|COMPLETED|Overall Study||5||
48316230|NCT00530270|101101090|FG001|COMPLETED|Overall Study||6||
48316231|NCT00530270|101101089|FG000|NOT COMPLETED|Overall Study||1||
48316232|NCT00530270|101101090|FG001|NOT COMPLETED|Overall Study||0||
48316233|NCT02446314|101101091|FG000|STARTED|Zero to Twelve Weeks.||30||
48316234|NCT02446314|101101092|FG001|STARTED|Zero to Twelve Weeks.||30||
48316235|NCT02446314|101101093|FG002|STARTED|Zero to Twelve Weeks.||31||
48316236|NCT02446314|101101094|FG003|STARTED|Zero to Twelve Weeks.||31||
48316237|NCT02446314|101101091|FG000|COMPLETED|Zero to Twelve Weeks.||27||
48316238|NCT02446314|101101092|FG001|COMPLETED|Zero to Twelve Weeks.||29||
48316239|NCT02446314|101101093|FG002|COMPLETED|Zero to Twelve Weeks.||31||
48316240|NCT02446314|101101094|FG003|COMPLETED|Zero to Twelve Weeks.||29||
48316241|NCT02446314|101101091|FG000|NOT COMPLETED|Zero to Twelve Weeks.||3||
48733596|NCT00306527|102133739|FG003|STARTED|Overall Study||596||
48733597|NCT00306527|102133736|FG000|COMPLETED|Overall Study||527||
48733598|NCT00306527|102133737|FG001|COMPLETED|Overall Study||527||
48733599|NCT00306527|102133738|FG002|COMPLETED|Overall Study||567||
48733600|NCT00306527|102133739|FG003|COMPLETED|Overall Study||590||
48733601|NCT00306527|102133736|FG000|NOT COMPLETED|Overall Study||6||
48733602|NCT00306527|102133737|FG001|NOT COMPLETED|Overall Study||7||
48733603|NCT00306527|102133738|FG002|NOT COMPLETED|Overall Study||5||
48733604|NCT00306527|102133739|FG003|NOT COMPLETED|Overall Study||6||
48733605|NCT00857857|102133740|FG000|STARTED|Overall Study||24||
48733606|NCT00857857|102133740|FG000|COMPLETED|Overall Study||24||
48733607|NCT00857857|102133740|FG000|NOT COMPLETED|Overall Study||0||
48733608|NCT02679170|102133741|FG000|STARTED|ALK Incidence Sub-study||572||
48733609|NCT02679170|102133742|FG001|STARTED|ALK Incidence Sub-study||0||
48316242|NCT02446314|101101092|FG001|NOT COMPLETED|Zero to Twelve Weeks.||1||
48316243|NCT02446314|101101093|FG002|NOT COMPLETED|Zero to Twelve Weeks.||0||
48316244|NCT02446314|101101094|FG003|NOT COMPLETED|Zero to Twelve Weeks.||2||
48316245|NCT02446314|101101091|FG000|STARTED|Thirteen to Twenty Four Weeks||27||
48316246|NCT02446314|101101092|FG001|STARTED|Thirteen to Twenty Four Weeks||29||
48316247|NCT02446314|101101093|FG002|STARTED|Thirteen to Twenty Four Weeks||31||
48316248|NCT02446314|101101094|FG003|STARTED|Thirteen to Twenty Four Weeks||29||
48316249|NCT02446314|101101091|FG000|COMPLETED|Thirteen to Twenty Four Weeks||27||
48316250|NCT02446314|101101092|FG001|COMPLETED|Thirteen to Twenty Four Weeks||28||
48406953|NCT03424044|101328490|FG006|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0||
48406954|NCT03424044|101328491|FG007|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0||
48406955|NCT03424044|101328492|FG008|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0||
48406956|NCT03424044|101328484|FG000|STARTED|Fourth Intervention Repeat Visit (76 hr)||0||
48406957|NCT03424044|101328485|FG001|STARTED|Fourth Intervention Repeat Visit (76 hr)||0||
48406958|NCT03424044|101328486|FG002|STARTED|Fourth Intervention Repeat Visit (76 hr)||0||
48406959|NCT03424044|101328487|FG003|STARTED|Fourth Intervention Repeat Visit (76 hr)||0||
48406960|NCT03424044|101328488|FG004|STARTED|Fourth Intervention Repeat Visit (76 hr)||0||
48406961|NCT03424044|101328489|FG005|STARTED|Fourth Intervention Repeat Visit (76 hr)||0||
48406962|NCT03424044|101328490|FG006|STARTED|Fourth Intervention Repeat Visit (76 hr)||0||
48406963|NCT03424044|101328491|FG007|STARTED|Fourth Intervention Repeat Visit (76 hr)||1||
48406964|NCT03424044|101328492|FG008|STARTED|Fourth Intervention Repeat Visit (76 hr)||1||
48615038|NCT03974282|101841912|FG001|COMPLETED|Overall Study||18||
48615039|NCT03974282|101841911|FG000|NOT COMPLETED|Overall Study||0||
48615040|NCT03974282|101841912|FG001|NOT COMPLETED|Overall Study||0||
48316251|NCT02446314|101101093|FG002|COMPLETED|Thirteen to Twenty Four Weeks||29||
48316252|NCT02446314|101101094|FG003|COMPLETED|Thirteen to Twenty Four Weeks||28||
48316253|NCT02446314|101101091|FG000|NOT COMPLETED|Thirteen to Twenty Four Weeks||0||
48316254|NCT02446314|101101092|FG001|NOT COMPLETED|Thirteen to Twenty Four Weeks||1||
48316255|NCT02446314|101101093|FG002|NOT COMPLETED|Thirteen to Twenty Four Weeks||2||
48316256|NCT02446314|101101094|FG003|NOT COMPLETED|Thirteen to Twenty Four Weeks||1||
48316257|NCT02777268|101101095|FG000|STARTED|Overall Study||16||
48316258|NCT02777268|101101095|FG000|COMPLETED|Overall Study||16||
48316259|NCT02777268|101101095|FG000|NOT COMPLETED|Overall Study||0||
48316260|NCT00986544|101101096|FG000|STARTED|Overall Study||53||
48316261|NCT00986544|101101097|FG001|STARTED|Overall Study||53||
48316262|NCT00986544|101101096|FG000|COMPLETED|Overall Study||53||
48316263|NCT00986544|101101097|FG001|COMPLETED|Overall Study||53||
48406965|NCT03424044|101328484|FG000|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0||
48406966|NCT03424044|101328485|FG001|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0||
48406967|NCT03424044|101328486|FG002|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0||
48406968|NCT03424044|101328487|FG003|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0||
48440023|NCT01266642|101410013|FG000|COMPLETED|Overall Study||149||
48615041|NCT00196105|101841913|FG000|STARTED|Overall Study||64||
48615042|NCT00196105|101841914|FG001|STARTED|Overall Study||88||
48615043|NCT00196105|101841915|FG002|STARTED|Overall Study||89||
48615044|NCT00196105|101841913|FG000|COMPLETED|Overall Study||60||
48615045|NCT00196105|101841914|FG001|COMPLETED|Overall Study||83||
48615046|NCT00196105|101841915|FG002|COMPLETED|Overall Study||82||
48615047|NCT00196105|101841913|FG000|NOT COMPLETED|Overall Study||4||
48615048|NCT00196105|101841914|FG001|NOT COMPLETED|Overall Study||5||
48615049|NCT00196105|101841915|FG002|NOT COMPLETED|Overall Study||7||
48615050|NCT00697593|101841916|FG000|STARTED|Overall Study||70||
48615051|NCT00697593|101841916|FG000|COMPLETED|Overall Study||51||
48615052|NCT00697593|101841916|FG000|NOT COMPLETED|Overall Study||19||
48615053|NCT00685360|101841917|FG000|STARTED|Overall Study||161||
48615054|NCT00685360|101841918|FG001|STARTED|Overall Study||160||
48316264|NCT00986544|101101096|FG000|NOT COMPLETED|Overall Study||0||
48316265|NCT00986544|101101097|FG001|NOT COMPLETED|Overall Study||0||
48316266|NCT03215771|101101098|FG000|STARTED|Overall Study||16||
48316267|NCT03215771|101101098|FG000|Stroke Subjects|Overall Study||8||
48316268|NCT03215771|101101098|FG000|TBI Subjects|Overall Study||8||
48316269|NCT03215771|101101098|FG000|COMPLETED|Overall Study||13||
48316270|NCT03215771|101101098|FG000|NOT COMPLETED|Overall Study||3||
48316271|NCT00677820|101101099|FG000|STARTED|Overall Study||240||
48316272|NCT00677820|101101100|FG001|STARTED|Overall Study||60||
48316273|NCT00677820|101101099|FG000|COMPLETED|Overall Study||239||
48316274|NCT00677820|101101100|FG001|COMPLETED|Overall Study||60||
48316275|NCT00677820|101101099|FG000|NOT COMPLETED|Overall Study||1||
48316276|NCT00677820|101101100|FG001|NOT COMPLETED|Overall Study||0||
48316277|NCT01071538|101101101|FG000|STARTED|Overall Study||15||
48316278|NCT01071538|101101101|FG000|COMPLETED|Overall Study||13||
48316279|NCT01071538|101101101|FG000|NOT COMPLETED|Overall Study||2||
48316280|NCT02122198|101101102|FG000|STARTED|Overall Study||5||
48316281|NCT02122198|101101103|FG001|STARTED|Overall Study||12||
48316282|NCT02122198|101101102|FG000|COMPLETED|Overall Study||3||
48615055|NCT00685360|101841919|FG002|STARTED|Overall Study||160||
48656919|NCT04274218|101943728|FG003|NOT COMPLETED|Perturbation Condition 1 (15 Minutes)||0||
48656920|NCT04274218|101943725|FG000|STARTED|Perturbation Condition 1 (15 Minutes)||5||
48316283|NCT02122198|101101103|FG001|COMPLETED|Overall Study||10||
48406969|NCT03424044|101328488|FG004|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0||
48316284|NCT02122198|101101102|FG000|NOT COMPLETED|Overall Study||2||
48316285|NCT02122198|101101103|FG001|NOT COMPLETED|Overall Study||2||
48316286|NCT04207801|101101104|FG000|STARTED|Overall Study||30||
48316287|NCT04207801|101101105|FG001|STARTED|Overall Study||30||
48316288|NCT04207801|101101106|FG002|STARTED|Overall Study||30||
48316289|NCT04207801|101101104|FG000|COMPLETED|Overall Study||26||
48316290|NCT04207801|101101105|FG001|COMPLETED|Overall Study||26||
48316291|NCT04207801|101101106|FG002|COMPLETED|Overall Study||23||
48316292|NCT04207801|101101104|FG000|NOT COMPLETED|Overall Study||4||
48316293|NCT04207801|101101105|FG001|NOT COMPLETED|Overall Study||4||
48316294|NCT04207801|101101106|FG002|NOT COMPLETED|Overall Study||7||
48316295|NCT04066491|101101107|FG000|STARTED|Overall Study||12||
48316296|NCT04066491|101101108|FG001|STARTED|Overall Study||149||
48316297|NCT04066491|101101109|FG002|STARTED|Overall Study||148||
48316298|NCT04066491|101101107|FG000|Treated|Overall Study||12||
48316299|NCT04066491|101101108|FG001|Treated|Overall Study||149||
48406970|NCT03424044|101328489|FG005|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0||
48406971|NCT03424044|101328490|FG006|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0||
48406972|NCT03424044|101328491|FG007|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||1||
48406973|NCT03424044|101328492|FG008|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||1||
48406974|NCT03424044|101328484|FG000|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0||
48406975|NCT03424044|101328485|FG001|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0||
48406976|NCT03424044|101328486|FG002|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0||
48406977|NCT03424044|101328487|FG003|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0||
48406978|NCT03424044|101328488|FG004|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0||
48406979|NCT03424044|101328489|FG005|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0||
48406980|NCT03424044|101328490|FG006|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0||
48406981|NCT03424044|101328491|FG007|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0||
48406982|NCT03424044|101328492|FG008|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0||
48406983|NCT01319045|101328493|FG000|STARTED|Overall Study||5||
48406984|NCT01319045|101328493|FG000|COMPLETED|Overall Study||3||
48406985|NCT01319045|101328493|FG000|NOT COMPLETED|Overall Study||2||
48406986|NCT01948518|101328494|FG000|STARTED|Overall Study||15||
48406987|NCT01948518|101328494|FG000|COMPLETED|Overall Study||15||
48406988|NCT01948518|101328494|FG000|NOT COMPLETED|Overall Study||0||
48733610|NCT02679170|102133743|FG002|STARTED|ALK Incidence Sub-study||0||
48733611|NCT02679170|102133741|FG000|Full Analysis Set|ALK Incidence Sub-study||559||
48733612|NCT02679170|102133742|FG001|Full Analysis Set|ALK Incidence Sub-study||0||
48733613|NCT02679170|102133743|FG002|Full Analysis Set|ALK Incidence Sub-study||0||
48733614|NCT02679170|102133741|FG000|Safety Analysis Set|ALK Incidence Sub-study||0||
48733615|NCT02679170|102133742|FG001|Safety Analysis Set|ALK Incidence Sub-study||0||
48733616|NCT02679170|102133743|FG002|Safety Analysis Set|ALK Incidence Sub-study||0||
48733617|NCT02679170|102133741|FG000|COMPLETED|ALK Incidence Sub-study||572||
48733618|NCT02679170|102133742|FG001|COMPLETED|ALK Incidence Sub-study||0||
48733619|NCT02679170|102133743|FG002|COMPLETED|ALK Incidence Sub-study||0||
48733620|NCT02679170|102133741|FG000|NOT COMPLETED|ALK Incidence Sub-study||0||
48733621|NCT02679170|102133742|FG001|NOT COMPLETED|ALK Incidence Sub-study||0||
48733622|NCT02679170|102133743|FG002|NOT COMPLETED|ALK Incidence Sub-study||0||
48733623|NCT02679170|102133741|FG000|STARTED|ALK Treatment Sub-study||0||
48733624|NCT02679170|102133742|FG001|STARTED|ALK Treatment Sub-study||91||
48316300|NCT04066491|101101109|FG002|Treated|Overall Study||146||
48316301|NCT04066491|101101107|FG000|COMPLETED|Overall Study||12||
48316302|NCT04066491|101101108|FG001|COMPLETED|Overall Study||149||
48316303|NCT04066491|101101109|FG002|COMPLETED|Overall Study||146||
48316304|NCT04066491|101101107|FG000|NOT COMPLETED|Overall Study||0||
48316305|NCT04066491|101101108|FG001|NOT COMPLETED|Overall Study||0||
48316306|NCT04066491|101101109|FG002|NOT COMPLETED|Overall Study||2||
48316307|NCT00609986|101101110|FG000|STARTED|Overall Study||52||
48316308|NCT00609986|101101111|FG001|STARTED|Overall Study||52||
48316309|NCT00609986|101101110|FG000|Received Transplant|Overall Study||44||
48316310|NCT00609986|101101111|FG001|Received Transplant|Overall Study||49||
48316311|NCT00609986|101101110|FG000|COMPLETED|Overall Study||44||
48316312|NCT00609986|101101111|FG001|COMPLETED|Overall Study||49||
48316313|NCT00609986|101101110|FG000|NOT COMPLETED|Overall Study||8||
48316314|NCT00609986|101101111|FG001|NOT COMPLETED|Overall Study||3||
48316315|NCT03831971|101101112|FG000|STARTED|Overall Study||12||
48316316|NCT03831971|101101112|FG000|COMPLETED|Overall Study||12||
48406989|NCT03924427|101328495|FG000|STARTED|Overall Study||74||
48733625|NCT02679170|102133743|FG002|STARTED|ALK Treatment Sub-study||0||
48316317|NCT03831971|101101112|FG000|NOT COMPLETED|Overall Study||0||
48316318|NCT02347098|101101113|FG000|STARTED|Overall Study||63||
48316319|NCT02347098|101101114|FG001|STARTED|Overall Study||66||
48316320|NCT02347098|101101113|FG000|COMPLETED|Overall Study||56||
48316321|NCT02347098|101101114|FG001|COMPLETED|Overall Study||58||
48316322|NCT02347098|101101113|FG000|NOT COMPLETED|Overall Study||7||
48316323|NCT02347098|101101114|FG001|NOT COMPLETED|Overall Study||8||
48733626|NCT02679170|102133741|FG000|Full Analysis Set|ALK Treatment Sub-study||0||
48733627|NCT02679170|102133742|FG001|Full Analysis Set|ALK Treatment Sub-study||91||
48733628|NCT02679170|102133743|FG002|Full Analysis Set|ALK Treatment Sub-study||0||
48733629|NCT02679170|102133741|FG000|Safety Analysis Set|ALK Treatment Sub-study||0||
48733630|NCT02679170|102133742|FG001|Safety Analysis Set|ALK Treatment Sub-study||91||
48733631|NCT02679170|102133743|FG002|Safety Analysis Set|ALK Treatment Sub-study||0||
48733632|NCT02679170|102133741|FG000|COMPLETED|ALK Treatment Sub-study||0||
48733633|NCT02679170|102133742|FG001|COMPLETED|ALK Treatment Sub-study||91||
48733634|NCT02679170|102133743|FG002|COMPLETED|ALK Treatment Sub-study||0||
48733635|NCT02679170|102133741|FG000|NOT COMPLETED|ALK Treatment Sub-study||0||
48733636|NCT02679170|102133742|FG001|NOT COMPLETED|ALK Treatment Sub-study||0||
48733637|NCT02679170|102133743|FG002|NOT COMPLETED|ALK Treatment Sub-study||0||
48733638|NCT02679170|102133741|FG000|STARTED|ROS1 Treatment Sub-study||0||
48733639|NCT02679170|102133742|FG001|STARTED|ROS1 Treatment Sub-study||0||
48733640|NCT02679170|102133743|FG002|STARTED|ROS1 Treatment Sub-study||50||
48733641|NCT02679170|102133741|FG000|Full Analysis Set|ROS1 Treatment Sub-study||0||
48406990|NCT03924427|101328495|FG000|COMPLETED|Overall Study||68||
48406991|NCT03924427|101328495|FG000|NOT COMPLETED|Overall Study||6||
48733642|NCT02679170|102133742|FG001|Full Analysis Set|ROS1 Treatment Sub-study||0||
48733643|NCT02679170|102133743|FG002|Full Analysis Set|ROS1 Treatment Sub-study||50||
48733644|NCT02679170|102133741|FG000|Safety Analysis Set|ROS1 Treatment Sub-study||0||
48733645|NCT02679170|102133742|FG001|Safety Analysis Set|ROS1 Treatment Sub-study||0||
48733646|NCT02679170|102133743|FG002|Safety Analysis Set|ROS1 Treatment Sub-study||50||
48733647|NCT02679170|102133741|FG000|COMPLETED|ROS1 Treatment Sub-study||0||
48733648|NCT02679170|102133742|FG001|COMPLETED|ROS1 Treatment Sub-study||0||
48733649|NCT02679170|102133743|FG002|COMPLETED|ROS1 Treatment Sub-study||50||
48733650|NCT02679170|102133741|FG000|NOT COMPLETED|ROS1 Treatment Sub-study||0||
48733651|NCT02679170|102133742|FG001|NOT COMPLETED|ROS1 Treatment Sub-study||0||
48733652|NCT02679170|102133743|FG002|NOT COMPLETED|ROS1 Treatment Sub-study||0||
48733653|NCT02942485|102133744|FG000|STARTED|Overall Study||7||
48406992|NCT01843205|101328496|FG000|STARTED|First Treatment (11 Days)||5||
48406993|NCT01843205|101328497|FG001|STARTED|First Treatment (11 Days)||4||
48406994|NCT01843205|101328496|FG000|COMPLETED|First Treatment (11 Days)||4||
48406995|NCT01843205|101328497|FG001|COMPLETED|First Treatment (11 Days)||4||
48406996|NCT01843205|101328496|FG000|NOT COMPLETED|First Treatment (11 Days)||1||
48406997|NCT01843205|101328497|FG001|NOT COMPLETED|First Treatment (11 Days)||0||
48406998|NCT01843205|101328496|FG000|STARTED|Second Treatment (11 Days)||4||
48406999|NCT01843205|101328497|FG001|STARTED|Second Treatment (11 Days)||4||
48407000|NCT01843205|101328496|FG000|COMPLETED|Second Treatment (11 Days)||4||
48407001|NCT01843205|101328497|FG001|COMPLETED|Second Treatment (11 Days)||4||
48407002|NCT01843205|101328496|FG000|NOT COMPLETED|Second Treatment (11 Days)||0||
48407003|NCT01843205|101328497|FG001|NOT COMPLETED|Second Treatment (11 Days)||0||
48407004|NCT02858713|101328498|FG000|STARTED|Overall Study||68||
48407005|NCT02858713|101328499|FG001|STARTED|Overall Study||66||
48407006|NCT02858713|101328498|FG000|COMPLETED|Overall Study||61||
48407007|NCT02858713|101328499|FG001|COMPLETED|Overall Study||61||
48407008|NCT02858713|101328498|FG000|NOT COMPLETED|Overall Study||7||
48407009|NCT02858713|101328499|FG001|NOT COMPLETED|Overall Study||5||
48407010|NCT03552289|101328500|FG000|STARTED|Overall Study||102||120
48407011|NCT03552289|101328501|FG001|STARTED|Overall Study||109||130
48407012|NCT03552289|101328500|FG000|COMPLETED|Overall Study||101||119
48407013|NCT03552289|101328501|FG001|COMPLETED|Overall Study||106||125
48407014|NCT03552289|101328500|FG000|NOT COMPLETED|Overall Study||1||1
48407015|NCT03552289|101328501|FG001|NOT COMPLETED|Overall Study||3||5
48407016|NCT05116683|101328502|FG000|STARTED|Overall Study||4||
48407017|NCT05116683|101328502|FG000|COMPLETED|Overall Study||0||
48407018|NCT05116683|101328502|FG000|NOT COMPLETED|Overall Study||4||
48407019|NCT01047436|101328503|FG000|STARTED|Overall Study||16||
48407020|NCT01047436|101328504|FG001|STARTED|Overall Study||15||
48407021|NCT01047436|101328503|FG000|COMPLETED|Overall Study||15||
48407022|NCT01047436|101328504|FG001|COMPLETED|Overall Study||15||
48407023|NCT01047436|101328503|FG000|NOT COMPLETED|Overall Study||1||
48407024|NCT01047436|101328504|FG001|NOT COMPLETED|Overall Study||0||
48407025|NCT00117572|101328505|FG000|STARTED|Overall Study||144||
48407026|NCT00117572|101328506|FG001|STARTED|Overall Study||141||
48407027|NCT00117572|101328505|FG000|COMPLETED|Overall Study||138||
48733654|NCT02942485|102133745|FG001|STARTED|Overall Study||1||
48733655|NCT02942485|102133744|FG000|COMPLETED|Overall Study||6||
48733656|NCT02942485|102133745|FG001|COMPLETED|Overall Study||1||
48733657|NCT02942485|102133744|FG000|NOT COMPLETED|Overall Study||1||
48407028|NCT00117572|101328506|FG001|COMPLETED|Overall Study||135||
48407029|NCT00117572|101328505|FG000|NOT COMPLETED|Overall Study||6||
48407030|NCT00117572|101328506|FG001|NOT COMPLETED|Overall Study||6||
48407031|NCT01347840|101328507|FG000|STARTED|Overall Study||1||
48407032|NCT01347840|101328507|FG000|COMPLETED|Overall Study||0||
48407033|NCT01347840|101328507|FG000|NOT COMPLETED|Overall Study||1||
48407034|NCT02903966|101328508|FG000|STARTED|Part A (Day 1 to 43)||12||
48407035|NCT02903966|101328509|FG001|STARTED|Part A (Day 1 to 43)||24||
48407036|NCT02903966|101328508|FG000|COMPLETED|Part A (Day 1 to 43)||11||
48407037|NCT02903966|101328509|FG001|COMPLETED|Part A (Day 1 to 43)||24||
48733658|NCT02942485|102133745|FG001|NOT COMPLETED|Overall Study||0||
48733659|NCT02106403|102133746|FG000|STARTED|Visit 1, Treatment Period 1||8||
48316324|NCT02651584|101101115|FG000|STARTED|Overall Study||215||
48316325|NCT02651584|101101116|FG001|STARTED|Overall Study||213||
48316326|NCT02651584|101101115|FG000|COMPLETED|Overall Study||126||
48733660|NCT02106403|102133747|FG001|STARTED|Visit 1, Treatment Period 1||8||
48733661|NCT02106403|102133748|FG002|STARTED|Visit 1, Treatment Period 1||9||
48733662|NCT02106403|102133749|FG003|STARTED|Visit 1, Treatment Period 1||8||
48733663|NCT02106403|102133750|FG004|STARTED|Visit 1, Treatment Period 1||8||
48733664|NCT02106403|102133751|FG005|STARTED|Visit 1, Treatment Period 1||9||
48733665|NCT02106403|102133746|FG000|COMPLETED|Visit 1, Treatment Period 1||8||
48733666|NCT02106403|102133747|FG001|COMPLETED|Visit 1, Treatment Period 1||8||
48733667|NCT02106403|102133748|FG002|COMPLETED|Visit 1, Treatment Period 1||9||
48733668|NCT02106403|102133749|FG003|COMPLETED|Visit 1, Treatment Period 1||8||
48733669|NCT02106403|102133750|FG004|COMPLETED|Visit 1, Treatment Period 1||8||
48733670|NCT02106403|102133751|FG005|COMPLETED|Visit 1, Treatment Period 1||9||
48733671|NCT02106403|102133746|FG000|NOT COMPLETED|Visit 1, Treatment Period 1||0||
48733672|NCT02106403|102133747|FG001|NOT COMPLETED|Visit 1, Treatment Period 1||0||
48733673|NCT02106403|102133748|FG002|NOT COMPLETED|Visit 1, Treatment Period 1||0||
48733674|NCT02106403|102133749|FG003|NOT COMPLETED|Visit 1, Treatment Period 1||0||
48316327|NCT02651584|101101116|FG001|COMPLETED|Overall Study||121||
48316328|NCT02651584|101101115|FG000|NOT COMPLETED|Overall Study||89||
48316329|NCT02651584|101101116|FG001|NOT COMPLETED|Overall Study||92||
48316330|NCT04673292|101101117|FG000|STARTED|Overall Study||277||277
48733675|NCT02106403|102133750|FG004|NOT COMPLETED|Visit 1, Treatment Period 1||0||
48733676|NCT02106403|102133751|FG005|NOT COMPLETED|Visit 1, Treatment Period 1||0||
48733677|NCT02106403|102133746|FG000|STARTED|Visit 1, Treatment Period 2||8||
48733678|NCT02106403|102133747|FG001|STARTED|Visit 1, Treatment Period 2||8||
48733679|NCT02106403|102133748|FG002|STARTED|Visit 1, Treatment Period 2||9||
48733680|NCT02106403|102133749|FG003|STARTED|Visit 1, Treatment Period 2||8||
48733681|NCT02106403|102133750|FG004|STARTED|Visit 1, Treatment Period 2||8||
48733682|NCT02106403|102133751|FG005|STARTED|Visit 1, Treatment Period 2||9||
48733683|NCT02106403|102133746|FG000|COMPLETED|Visit 1, Treatment Period 2||8||
48733684|NCT02106403|102133747|FG001|COMPLETED|Visit 1, Treatment Period 2||8||
48733685|NCT02106403|102133748|FG002|COMPLETED|Visit 1, Treatment Period 2||9||
48733686|NCT02106403|102133749|FG003|COMPLETED|Visit 1, Treatment Period 2||8||
48733687|NCT02106403|102133750|FG004|COMPLETED|Visit 1, Treatment Period 2||8||
48733688|NCT02106403|102133751|FG005|COMPLETED|Visit 1, Treatment Period 2||9||
48733689|NCT02106403|102133746|FG000|NOT COMPLETED|Visit 1, Treatment Period 2||0||
48733690|NCT02106403|102133747|FG001|NOT COMPLETED|Visit 1, Treatment Period 2||0||
48733691|NCT02106403|102133748|FG002|NOT COMPLETED|Visit 1, Treatment Period 2||0||
48733692|NCT02106403|102133749|FG003|NOT COMPLETED|Visit 1, Treatment Period 2||0||
48733693|NCT02106403|102133750|FG004|NOT COMPLETED|Visit 1, Treatment Period 2||0||
48733694|NCT02106403|102133751|FG005|NOT COMPLETED|Visit 1, Treatment Period 2||0||
48733695|NCT02106403|102133746|FG000|STARTED|Visit 1, Treatment Period 3||8||
48733696|NCT02106403|102133747|FG001|STARTED|Visit 1, Treatment Period 3||8||
48733697|NCT02106403|102133748|FG002|STARTED|Visit 1, Treatment Period 3||9||
48733698|NCT02106403|102133749|FG003|STARTED|Visit 1, Treatment Period 3||8||
48733699|NCT02106403|102133750|FG004|STARTED|Visit 1, Treatment Period 3||8||
48733700|NCT02106403|102133751|FG005|STARTED|Visit 1, Treatment Period 3||9||
48733701|NCT02106403|102133746|FG000|COMPLETED|Visit 1, Treatment Period 3||8||
48733702|NCT02106403|102133747|FG001|COMPLETED|Visit 1, Treatment Period 3||8||
48733703|NCT02106403|102133748|FG002|COMPLETED|Visit 1, Treatment Period 3||9||
48316331|NCT04673292|101101118|FG001|STARTED|Overall Study||273||273
48316332|NCT04673292|101101119|FG002|STARTED|Overall Study||281||281
48316333|NCT04673292|101101117|FG000|COMPLETED|Overall Study||277||277
48316334|NCT04673292|101101118|FG001|COMPLETED|Overall Study||273||273
48316335|NCT04673292|101101119|FG002|COMPLETED|Overall Study||281||281
48316336|NCT04673292|101101117|FG000|NOT COMPLETED|Overall Study||0||0
48316337|NCT04673292|101101118|FG001|NOT COMPLETED|Overall Study||0||0
48316338|NCT04673292|101101119|FG002|NOT COMPLETED|Overall Study||0||0
48733704|NCT02106403|102133749|FG003|COMPLETED|Visit 1, Treatment Period 3||8||
48733705|NCT02106403|102133750|FG004|COMPLETED|Visit 1, Treatment Period 3||8||
48733706|NCT02106403|102133751|FG005|COMPLETED|Visit 1, Treatment Period 3||9||
48733707|NCT02106403|102133746|FG000|NOT COMPLETED|Visit 1, Treatment Period 3||0||
48733708|NCT02106403|102133747|FG001|NOT COMPLETED|Visit 1, Treatment Period 3||0||
48733709|NCT02106403|102133748|FG002|NOT COMPLETED|Visit 1, Treatment Period 3||0||
48733710|NCT02106403|102133749|FG003|NOT COMPLETED|Visit 1, Treatment Period 3||0||
48733711|NCT02106403|102133750|FG004|NOT COMPLETED|Visit 1, Treatment Period 3||0||
48733712|NCT02106403|102133751|FG005|NOT COMPLETED|Visit 1, Treatment Period 3||0||
48733713|NCT02106403|102133746|FG000|STARTED|Follow-Up Visit 2||8||
48733714|NCT02106403|102133747|FG001|STARTED|Follow-Up Visit 2||8||
48316339|NCT00111800|101101120|FG000|STARTED|Period 1: Main Phase (12 Weeks)||64||
48316340|NCT00111800|101101121|FG001|STARTED|Period 1: Main Phase (12 Weeks)||61||
48316341|NCT00111800|101101122|FG002|STARTED|Period 1: Main Phase (12 Weeks)||63||
48316342|NCT00111800|101101123|FG003|STARTED|Period 1: Main Phase (12 Weeks)||66||
48733715|NCT02106403|102133748|FG002|STARTED|Follow-Up Visit 2||9||
48733716|NCT02106403|102133749|FG003|STARTED|Follow-Up Visit 2||8||
48733717|NCT02106403|102133750|FG004|STARTED|Follow-Up Visit 2||8||
48733718|NCT02106403|102133751|FG005|STARTED|Follow-Up Visit 2||9||
48733719|NCT02106403|102133746|FG000|COMPLETED|Follow-Up Visit 2||8||
48733720|NCT02106403|102133747|FG001|COMPLETED|Follow-Up Visit 2||8||
48733721|NCT02106403|102133748|FG002|COMPLETED|Follow-Up Visit 2||9||
48733722|NCT02106403|102133749|FG003|COMPLETED|Follow-Up Visit 2||8||
48733723|NCT02106403|102133750|FG004|COMPLETED|Follow-Up Visit 2||8||
48733724|NCT02106403|102133751|FG005|COMPLETED|Follow-Up Visit 2||9||
48733725|NCT02106403|102133746|FG000|NOT COMPLETED|Follow-Up Visit 2||0||
48733726|NCT02106403|102133747|FG001|NOT COMPLETED|Follow-Up Visit 2||0||
48733727|NCT02106403|102133748|FG002|NOT COMPLETED|Follow-Up Visit 2||0||
48733728|NCT02106403|102133749|FG003|NOT COMPLETED|Follow-Up Visit 2||0||
48733729|NCT02106403|102133750|FG004|NOT COMPLETED|Follow-Up Visit 2||0||
48733730|NCT02106403|102133751|FG005|NOT COMPLETED|Follow-Up Visit 2||0||
48733731|NCT02106403|102133746|FG000|STARTED|Follow-Up Visit 3||8||
48733732|NCT02106403|102133747|FG001|STARTED|Follow-Up Visit 3||8||
48733733|NCT02106403|102133748|FG002|STARTED|Follow-Up Visit 3||9||
48733734|NCT02106403|102133749|FG003|STARTED|Follow-Up Visit 3||8||
48733735|NCT02106403|102133750|FG004|STARTED|Follow-Up Visit 3||8||
48733736|NCT02106403|102133751|FG005|STARTED|Follow-Up Visit 3||9||
48733737|NCT02106403|102133746|FG000|COMPLETED|Follow-Up Visit 3||8||
48733738|NCT02106403|102133747|FG001|COMPLETED|Follow-Up Visit 3||8||
48733739|NCT02106403|102133748|FG002|COMPLETED|Follow-Up Visit 3||9||
48316343|NCT00111800|101101124|FG004|STARTED|Period 1: Main Phase (12 Weeks)||60||
48316344|NCT00111800|101101125|FG005|STARTED|Period 1: Main Phase (12 Weeks)||61||
48316345|NCT00111800|101101120|FG000|COMPLETED|Period 1: Main Phase (12 Weeks)||49||
48316346|NCT00111800|101101121|FG001|COMPLETED|Period 1: Main Phase (12 Weeks)||47||
48316347|NCT00111800|101101122|FG002|COMPLETED|Period 1: Main Phase (12 Weeks)||54||
48733740|NCT02106403|102133749|FG003|COMPLETED|Follow-Up Visit 3||8||
48733741|NCT02106403|102133750|FG004|COMPLETED|Follow-Up Visit 3||8||
48733742|NCT02106403|102133751|FG005|COMPLETED|Follow-Up Visit 3||8||
48733743|NCT02106403|102133746|FG000|NOT COMPLETED|Follow-Up Visit 3||0||
48733744|NCT02106403|102133747|FG001|NOT COMPLETED|Follow-Up Visit 3||0||
48733745|NCT02106403|102133748|FG002|NOT COMPLETED|Follow-Up Visit 3||0||
48316348|NCT00111800|101101123|FG003|COMPLETED|Period 1: Main Phase (12 Weeks)||60||
48316349|NCT00111800|101101124|FG004|COMPLETED|Period 1: Main Phase (12 Weeks)||55||
48316350|NCT00111800|101101125|FG005|COMPLETED|Period 1: Main Phase (12 Weeks)||56||
48316351|NCT00111800|101101120|FG000|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||15||
48316352|NCT00111800|101101121|FG001|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||14||
48316353|NCT00111800|101101122|FG002|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||9||
48733746|NCT02106403|102133749|FG003|NOT COMPLETED|Follow-Up Visit 3||0||
48733747|NCT02106403|102133750|FG004|NOT COMPLETED|Follow-Up Visit 3||0||
48733748|NCT02106403|102133751|FG005|NOT COMPLETED|Follow-Up Visit 3||1||
48733749|NCT00555672|102133752|FG000|STARTED|Overall Study||24||
48733750|NCT00555672|102133753|FG001|STARTED|Overall Study||10||
48733751|NCT00555672|102133752|FG000|COMPLETED|Overall Study||0||
48733752|NCT00555672|102133753|FG001|COMPLETED|Overall Study||0||
48733753|NCT00555672|102133752|FG000|NOT COMPLETED|Overall Study||24||
48733754|NCT00555672|102133753|FG001|NOT COMPLETED|Overall Study||10||
48733755|NCT00892775|102133754|FG000|STARTED|Overall Study||332||
48733756|NCT00892775|102133755|FG001|STARTED|Overall Study||166||
48733757|NCT00892775|102133754|FG000|COMPLETED|Overall Study||327||
48733758|NCT00892775|102133755|FG001|COMPLETED|Overall Study||165||
48733759|NCT00892775|102133754|FG000|NOT COMPLETED|Overall Study||5||
48733760|NCT00892775|102133755|FG001|NOT COMPLETED|Overall Study||1||
48733761|NCT00988091|102133756|FG000|STARTED|Double-blind Period||298||
48733762|NCT00988091|102133757|FG001|STARTED|Double-blind Period||298||
48733763|NCT00988091|102133756|FG000|Intent to Treat Population|Double-blind Period||294||
48733764|NCT00988091|102133757|FG001|Intent to Treat Population|Double-blind Period||295||
48733765|NCT00988091|102133756|FG000|COMPLETED|Double-blind Period||255||
48733766|NCT00988091|102133757|FG001|COMPLETED|Double-blind Period||251||
48733767|NCT00988091|102133756|FG000|NOT COMPLETED|Double-blind Period||43||
48733768|NCT00988091|102133757|FG001|NOT COMPLETED|Double-blind Period||47||
48733769|NCT00988091|102133756|FG000|STARTED|Open-label Period||229||
48733770|NCT00988091|102133757|FG001|STARTED|Open-label Period||225||
48733771|NCT00988091|102133756|FG000|COMPLETED|Open-label Period||208||
48733772|NCT00988091|102133757|FG001|COMPLETED|Open-label Period||192||
48733773|NCT00988091|102133756|FG000|NOT COMPLETED|Open-label Period||21||
48733774|NCT00988091|102133757|FG001|NOT COMPLETED|Open-label Period||33||
48316354|NCT00111800|101101123|FG003|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||6||
48316355|NCT00111800|101101124|FG004|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5||
48316356|NCT00111800|101101125|FG005|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5||
48733775|NCT00118742|102133758|FG000|STARTED|Overall Study||145||
48733776|NCT00118742|102133759|FG001|STARTED|Overall Study||148||
48733777|NCT00118742|102133758|FG000|COMPLETED|Overall Study||96||
48733778|NCT00118742|102133759|FG001|COMPLETED|Overall Study||82||
48733779|NCT00118742|102133758|FG000|NOT COMPLETED|Overall Study||49||
48733780|NCT00118742|102133759|FG001|NOT COMPLETED|Overall Study||66||
48733781|NCT03268941|102133760|FG000|STARTED|Part 1 (Days 1 to 9)||12||
48733782|NCT03268941|102133761|FG001|STARTED|Part 1 (Days 1 to 9)||14||
48733783|NCT03268941|102133762|FG002|STARTED|Part 1 (Days 1 to 9)||12||
48733784|NCT03268941|102133763|FG003|STARTED|Part 1 (Days 1 to 9)||13||
48733785|NCT03268941|102133764|FG004|STARTED|Part 1 (Days 1 to 9)||0||
48733786|NCT03268941|102133765|FG005|STARTED|Part 1 (Days 1 to 9)||0||
48733787|NCT03268941|102133766|FG006|STARTED|Part 1 (Days 1 to 9)||0||
48733788|NCT03268941|102133760|FG000|COMPLETED|Part 1 (Days 1 to 9)||11||
48733789|NCT03268941|102133761|FG001|COMPLETED|Part 1 (Days 1 to 9)||14||
48733790|NCT03268941|102133762|FG002|COMPLETED|Part 1 (Days 1 to 9)||12||
48733791|NCT03268941|102133763|FG003|COMPLETED|Part 1 (Days 1 to 9)||11||
48733792|NCT03268941|102133764|FG004|COMPLETED|Part 1 (Days 1 to 9)||0||
48733793|NCT03268941|102133765|FG005|COMPLETED|Part 1 (Days 1 to 9)||0||
48733794|NCT03268941|102133766|FG006|COMPLETED|Part 1 (Days 1 to 9)||0||
48733795|NCT03268941|102133760|FG000|NOT COMPLETED|Part 1 (Days 1 to 9)||1||
48733796|NCT03268941|102133761|FG001|NOT COMPLETED|Part 1 (Days 1 to 9)||0||
48733797|NCT03268941|102133762|FG002|NOT COMPLETED|Part 1 (Days 1 to 9)||0||
48733798|NCT03268941|102133763|FG003|NOT COMPLETED|Part 1 (Days 1 to 9)||2||
48733799|NCT03268941|102133764|FG004|NOT COMPLETED|Part 1 (Days 1 to 9)||0||
48733800|NCT03268941|102133765|FG005|NOT COMPLETED|Part 1 (Days 1 to 9)||0||
48733801|NCT03268941|102133766|FG006|NOT COMPLETED|Part 1 (Days 1 to 9)||0||
48733802|NCT03268941|102133760|FG000|STARTED|Part 2: Days 17 to 25||0||
48733803|NCT03268941|102133761|FG001|STARTED|Part 2: Days 17 to 25||0||
48733804|NCT03268941|102133762|FG002|STARTED|Part 2: Days 17 to 25||0||
48733805|NCT03268941|102133763|FG003|STARTED|Part 2: Days 17 to 25||0||
48733806|NCT03268941|102133764|FG004|STARTED|Part 2: Days 17 to 25||6||
48733807|NCT03268941|102133765|FG005|STARTED|Part 2: Days 17 to 25||0||
48733808|NCT03268941|102133766|FG006|STARTED|Part 2: Days 17 to 25||15||
48733809|NCT03268941|102133760|FG000|Treated|Part 2: Days 17 to 25||0||
48733810|NCT03268941|102133761|FG001|Treated|Part 2: Days 17 to 25||0||
48733811|NCT03268941|102133762|FG002|Treated|Part 2: Days 17 to 25||0||
48733812|NCT03268941|102133763|FG003|Treated|Part 2: Days 17 to 25||0||
48733813|NCT03268941|102133764|FG004|Treated|Part 2: Days 17 to 25||6||
48733814|NCT03268941|102133765|FG005|Treated|Part 2: Days 17 to 25||0||
48733815|NCT03268941|102133766|FG006|Treated|Part 2: Days 17 to 25||13||
48733816|NCT03268941|102133760|FG000|COMPLETED|Part 2: Days 17 to 25||0||
48733817|NCT03268941|102133761|FG001|COMPLETED|Part 2: Days 17 to 25||0||
48733818|NCT03268941|102133762|FG002|COMPLETED|Part 2: Days 17 to 25||0||
48733819|NCT03268941|102133763|FG003|COMPLETED|Part 2: Days 17 to 25||0||
48733820|NCT03268941|102133764|FG004|COMPLETED|Part 2: Days 17 to 25||6||
48733821|NCT03268941|102133765|FG005|COMPLETED|Part 2: Days 17 to 25||0||
48733822|NCT03268941|102133766|FG006|COMPLETED|Part 2: Days 17 to 25||13||
48733823|NCT03268941|102133760|FG000|NOT COMPLETED|Part 2: Days 17 to 25||0||
48733824|NCT03268941|102133761|FG001|NOT COMPLETED|Part 2: Days 17 to 25||0||
48733825|NCT03268941|102133762|FG002|NOT COMPLETED|Part 2: Days 17 to 25||0||
48733826|NCT03268941|102133763|FG003|NOT COMPLETED|Part 2: Days 17 to 25||0||
48733827|NCT03268941|102133764|FG004|NOT COMPLETED|Part 2: Days 17 to 25||0||
48733828|NCT03268941|102133765|FG005|NOT COMPLETED|Part 2: Days 17 to 25||0||
48733829|NCT03268941|102133766|FG006|NOT COMPLETED|Part 2: Days 17 to 25||2||
48733830|NCT03268941|102133760|FG000|STARTED|Part 2: Period 2: Fasted (Day 25)||0||
48733831|NCT03268941|102133761|FG001|STARTED|Part 2: Period 2: Fasted (Day 25)||0||
48733832|NCT03268941|102133762|FG002|STARTED|Part 2: Period 2: Fasted (Day 25)||0||
48733833|NCT03268941|102133763|FG003|STARTED|Part 2: Period 2: Fasted (Day 25)||0||
48733834|NCT03268941|102133764|FG004|STARTED|Part 2: Period 2: Fasted (Day 25)||0||
48733835|NCT03268941|102133765|FG005|STARTED|Part 2: Period 2: Fasted (Day 25)||6||
48733836|NCT03268941|102133766|FG006|STARTED|Part 2: Period 2: Fasted (Day 25)||0||
48733837|NCT03268941|102133760|FG000|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0||
48733838|NCT03268941|102133761|FG001|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0||
48733839|NCT03268941|102133762|FG002|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0||
48733840|NCT03268941|102133763|FG003|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0||
48733841|NCT03268941|102133764|FG004|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0||
48733842|NCT03268941|102133765|FG005|COMPLETED|Part 2: Period 2: Fasted (Day 25)||6||
48733843|NCT03268941|102133766|FG006|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0||
48733844|NCT03268941|102133760|FG000|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0||
48733845|NCT03268941|102133761|FG001|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0||
48733846|NCT03268941|102133762|FG002|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0||
48733847|NCT03268941|102133763|FG003|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0||
48733848|NCT03268941|102133764|FG004|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0||
48733849|NCT03268941|102133765|FG005|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0||
48733850|NCT03268941|102133766|FG006|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0||
48733851|NCT01802710|102133767|FG000|STARTED|From T0 to T1||76||
48733852|NCT01802710|102133768|FG001|STARTED|From T0 to T1||82||
48733853|NCT01802710|102133767|FG000|COMPLETED|From T0 to T1||60||
48733854|NCT01802710|102133768|FG001|COMPLETED|From T0 to T1||72||
48733855|NCT01802710|102133767|FG000|NOT COMPLETED|From T0 to T1||16||
48733856|NCT01802710|102133768|FG001|NOT COMPLETED|From T0 to T1||10||
48733857|NCT01802710|102133767|FG000|STARTED|From T1 to T2||60||
48733858|NCT01802710|102133768|FG001|STARTED|From T1 to T2||72||
48733859|NCT01802710|102133767|FG000|COMPLETED|From T1 to T2||58||
48733860|NCT01802710|102133768|FG001|COMPLETED|From T1 to T2||70||
48733861|NCT01802710|102133767|FG000|NOT COMPLETED|From T1 to T2||2||
48733862|NCT01802710|102133768|FG001|NOT COMPLETED|From T1 to T2||2||
48733863|NCT04146935|102133769|FG000|STARTED|Overall Study||10||
48733864|NCT04146935|102133769|FG000|COMPLETED|Overall Study||10||
48733865|NCT04146935|102133769|FG000|NOT COMPLETED|Overall Study||0||
48733866|NCT00465647|102133770|FG000|STARTED|Overall Study||39||
48733867|NCT00465647|102133771|FG001|STARTED|Overall Study||23||
48733868|NCT00465647|102133772|FG002|STARTED|Overall Study||29||
48733869|NCT00465647|102133773|FG003|STARTED|Overall Study||25||
48733870|NCT00465647|102133770|FG000|COMPLETED|Overall Study||26||
48733871|NCT00465647|102133771|FG001|COMPLETED|Overall Study||15||
48733872|NCT00465647|102133772|FG002|COMPLETED|Overall Study||18||
48733873|NCT00465647|102133773|FG003|COMPLETED|Overall Study||12||
48733874|NCT00465647|102133770|FG000|NOT COMPLETED|Overall Study||13||
48733875|NCT00465647|102133771|FG001|NOT COMPLETED|Overall Study||8||
48733876|NCT00465647|102133772|FG002|NOT COMPLETED|Overall Study||11||
48615056|NCT00685360|101841917|FG000|Modified Intent-to-Treat (MITT)|Overall Study||141|MITT Population included all participants who had sputum cultures positive for multidrug resistant tuberculosis (MDR TB) at baseline (Day -1 and/or Day 1) using the mycobacteria growth indicator tube (MGIT) system.|
48615057|NCT00685360|101841918|FG001|Modified Intent-to-Treat (MITT)|Overall Study||136|MITT Population included all participants who had sputum cultures positive for multidrug resistant tuberculosis (MDR TB) at baseline (Day -1 and/or Day 1) using the mycobacteria growth indicator tube (MGIT) system.|
48615058|NCT00685360|101841919|FG002|Modified Intent-to-Treat (MITT)|Overall Study||125|MITT Population included all participants who had sputum cultures positive for multidrug resistant tuberculosis (MDR TB) at baseline (Day -1 and/or Day 1) using the mycobacteria growth indicator tube (MGIT) system.|
48615059|NCT00685360|101841917|FG000|MITT (Solid Culture)|Overall Study||119|MITT (Solid Culture) Population included all participants who had sputum cultures positive for MDR TB at baseline (Day -1 and/or Day 1) using solid culture medium.|
48615060|NCT00685360|101841918|FG001|MITT (Solid Culture)|Overall Study||115|MITT (Solid Culture) Population included all participants who had sputum cultures positive for MDR TB at baseline (Day -1 and/or Day 1) using solid culture medium.|
48657090|NCT03648372|101943767|FG010|NOT COMPLETED|Overall Study||6||
48733877|NCT00465647|102133773|FG003|NOT COMPLETED|Overall Study||13||
48733878|NCT01045694|102133774|FG000|STARTED|Overall Study||8||
48733879|NCT01045694|102133774|FG000|COMPLETED|Overall Study||6||
48733880|NCT01045694|102133774|FG000|NOT COMPLETED|Overall Study||2||
48733881|NCT01137370|102133775|FG000|STARTED|Overall Study||116||
48733882|NCT01137370|102133776|FG001|STARTED|Overall Study||87||
48733883|NCT01137370|102133775|FG000|COMPLETED|Overall Study||116||
48733884|NCT01137370|102133776|FG001|COMPLETED|Overall Study||87||
48733885|NCT01137370|102133775|FG000|NOT COMPLETED|Overall Study||0||
48733886|NCT01137370|102133776|FG001|NOT COMPLETED|Overall Study||0||
48733887|NCT02504580|102133777|FG000|STARTED|Overall Study||19||
48733888|NCT02504580|102133778|FG001|STARTED|Overall Study||17||
48733889|NCT02504580|102133779|FG002|STARTED|Overall Study||16||
48733890|NCT02504580|102133780|FG003|STARTED|Overall Study||20||
48733891|NCT02504580|102133781|FG004|STARTED|Overall Study||17||
48733892|NCT02504580|102133782|FG005|STARTED|Overall Study||18||
48733893|NCT02504580|102133783|FG006|STARTED|Overall Study||40||
48733894|NCT02504580|102133784|FG007|STARTED|Overall Study||131||
48733895|NCT02504580|102133785|FG008|STARTED|Overall Study||52||
48733896|NCT02504580|102133786|FG009|STARTED|Overall Study||18||
48733897|NCT02504580|102133787|FG010|STARTED|Overall Study||32||
48733898|NCT02504580|102133788|FG011|STARTED|Overall Study||83||
48733899|NCT02504580|102133777|FG000|COMPLETED|Overall Study||18||
48733900|NCT02504580|102133778|FG001|COMPLETED|Overall Study||16||
48733901|NCT02504580|102133779|FG002|COMPLETED|Overall Study||16||
48733902|NCT02504580|102133780|FG003|COMPLETED|Overall Study||18||
48733903|NCT02504580|102133781|FG004|COMPLETED|Overall Study||16||
48733904|NCT02504580|102133782|FG005|COMPLETED|Overall Study||17||
48316357|NCT00111800|101101120|FG000|STARTED|Period 2: Extension Phase (12 Weeks)||48||
48316358|NCT00111800|101101121|FG001|STARTED|Period 2: Extension Phase (12 Weeks)||47||
48733905|NCT02504580|102133783|FG006|COMPLETED|Overall Study||39||
48733906|NCT02504580|102133784|FG007|COMPLETED|Overall Study||129||
48733907|NCT02504580|102133785|FG008|COMPLETED|Overall Study||52||
48733908|NCT02504580|102133786|FG009|COMPLETED|Overall Study||18||
48733909|NCT02504580|102133787|FG010|COMPLETED|Overall Study||32||
48733910|NCT02504580|102133788|FG011|COMPLETED|Overall Study||81||
48733911|NCT02504580|102133777|FG000|NOT COMPLETED|Overall Study||1||
48733912|NCT02504580|102133778|FG001|NOT COMPLETED|Overall Study||1||
48733913|NCT02504580|102133779|FG002|NOT COMPLETED|Overall Study||0||
48733914|NCT02504580|102133780|FG003|NOT COMPLETED|Overall Study||2||
48733915|NCT02504580|102133781|FG004|NOT COMPLETED|Overall Study||1||
48733916|NCT02504580|102133782|FG005|NOT COMPLETED|Overall Study||1||
48316359|NCT00111800|101101122|FG002|STARTED|Period 2: Extension Phase (12 Weeks)||54||
48316360|NCT00111800|101101123|FG003|STARTED|Period 2: Extension Phase (12 Weeks)||59||
48316361|NCT00111800|101101124|FG004|STARTED|Period 2: Extension Phase (12 Weeks)||55||
48316362|NCT00111800|101101125|FG005|STARTED|Period 2: Extension Phase (12 Weeks)||55||
48316363|NCT00111800|101101120|FG000|COMPLETED|Period 2: Extension Phase (12 Weeks)||46||
48368042|NCT03567291|101230095|FG003|STARTED|Period III||133||
48733917|NCT02504580|102133783|FG006|NOT COMPLETED|Overall Study||1||
48733918|NCT02504580|102133784|FG007|NOT COMPLETED|Overall Study||2||
48733919|NCT02504580|102133785|FG008|NOT COMPLETED|Overall Study||0||
48316364|NCT00111800|101101121|FG001|COMPLETED|Period 2: Extension Phase (12 Weeks)||40||
48733920|NCT02504580|102133786|FG009|NOT COMPLETED|Overall Study||0||
48733921|NCT02504580|102133787|FG010|NOT COMPLETED|Overall Study||0||
48733922|NCT02504580|102133788|FG011|NOT COMPLETED|Overall Study||2||
48733923|NCT00680459|102133789|FG000|STARTED|Overall Study||7||
48733924|NCT00680459|102133790|FG001|STARTED|Overall Study||6||
48733925|NCT00680459|102133789|FG000|COMPLETED|Overall Study||7||
48316365|NCT00111800|101101122|FG002|COMPLETED|Period 2: Extension Phase (12 Weeks)||47||
48316366|NCT00111800|101101123|FG003|COMPLETED|Period 2: Extension Phase (12 Weeks)||54||
48316367|NCT00111800|101101124|FG004|COMPLETED|Period 2: Extension Phase (12 Weeks)||51||
48316368|NCT00111800|101101125|FG005|COMPLETED|Period 2: Extension Phase (12 Weeks)||53||
48407038|NCT02903966|101328508|FG000|NOT COMPLETED|Part A (Day 1 to 43)||1||
48407039|NCT02903966|101328509|FG001|NOT COMPLETED|Part A (Day 1 to 43)||0||
48656921|NCT04274218|101943726|FG001|STARTED|Perturbation Condition 1 (15 Minutes)||6||
48733926|NCT00680459|102133790|FG001|COMPLETED|Overall Study||6||
48733927|NCT00680459|102133789|FG000|NOT COMPLETED|Overall Study||0||
48733928|NCT00680459|102133790|FG001|NOT COMPLETED|Overall Study||0||
48733929|NCT03152591|102133791|FG000|STARTED|Overall Study||15|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
48733930|NCT03152591|102133792|FG001|STARTED|Overall Study||14|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
48733931|NCT03152591|102133791|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||14|At least one dose of study drug and one evaluable PK concentration measurement|
48733932|NCT03152591|102133792|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||0|At least one dose of study drug and one evaluable PK concentration measurement|
48733933|NCT03152591|102133791|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||15|At least one dose of study drug and one evaluable PD assessment|
48733934|NCT03152591|102133792|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||14|At least one dose of study drug and one evaluable PD assessment|
48733935|NCT03152591|102133791|FG000|COMPLETED|Overall Study||15||
48733936|NCT03152591|102133792|FG001|COMPLETED|Overall Study||14||
48733937|NCT03152591|102133791|FG000|NOT COMPLETED|Overall Study||0||
48733938|NCT03152591|102133792|FG001|NOT COMPLETED|Overall Study||0||
48733939|NCT01857297|102133793|FG000|STARTED|Overall Study||60||
48733940|NCT01857297|102133794|FG001|STARTED|Overall Study||60||
48733941|NCT01857297|102133793|FG000|COMPLETED|Overall Study||60||
48733942|NCT01857297|102133794|FG001|COMPLETED|Overall Study||60||
48733943|NCT01857297|102133793|FG000|NOT COMPLETED|Overall Study||0||
48733944|NCT01857297|102133794|FG001|NOT COMPLETED|Overall Study||0||
48733945|NCT04331002|102133795|FG000|STARTED|Overall Study||1||
48733946|NCT04331002|102133796|FG001|STARTED|Overall Study||0||
48733947|NCT04331002|102133795|FG000|COMPLETED|Overall Study||1||
48733948|NCT04331002|102133796|FG001|COMPLETED|Overall Study||0||
48733949|NCT04331002|102133795|FG000|NOT COMPLETED|Overall Study||0||
48733950|NCT04331002|102133796|FG001|NOT COMPLETED|Overall Study||0||
48733951|NCT01280695|102133797|FG000|STARTED|Overall Study||26||
48733952|NCT01280695|102133798|FG001|STARTED|Overall Study||25||
48733953|NCT01280695|102133799|FG002|STARTED|Overall Study||26||
48316369|NCT00111800|101101120|FG000|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2||
48316370|NCT00111800|101101121|FG001|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7||
48316371|NCT00111800|101101122|FG002|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7||
48316372|NCT00111800|101101123|FG003|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||5||
48407040|NCT02903966|101328508|FG000|STARTED|Part B (Day 44 to 112)||11||
48407041|NCT02903966|101328509|FG001|STARTED|Part B (Day 44 to 112)||24||
48407042|NCT02903966|101328508|FG000|COMPLETED|Part B (Day 44 to 112)||11||
48656922|NCT04274218|101943727|FG002|STARTED|Perturbation Condition 1 (15 Minutes)||5||
48656923|NCT04274218|101943728|FG003|STARTED|Perturbation Condition 1 (15 Minutes)||4||
48656924|NCT04274218|101943725|FG000|COMPLETED|Perturbation Condition 1 (15 Minutes)||5||
48656925|NCT04274218|101943726|FG001|COMPLETED|Perturbation Condition 1 (15 Minutes)||6||
48656926|NCT04274218|101943727|FG002|COMPLETED|Perturbation Condition 1 (15 Minutes)||5||
48656927|NCT04274218|101943728|FG003|COMPLETED|Perturbation Condition 1 (15 Minutes)||4||
48656928|NCT04274218|101943725|FG000|NOT COMPLETED|Perturbation Condition 1 (15 Minutes)||0||
48656929|NCT04274218|101943726|FG001|NOT COMPLETED|Perturbation Condition 1 (15 Minutes)||0||
48656930|NCT04274218|101943727|FG002|NOT COMPLETED|Perturbation Condition 1 (15 Minutes)||0||
48656931|NCT04274218|101943728|FG003|NOT COMPLETED|Perturbation Condition 1 (15 Minutes)||0||
48656932|NCT01368185|101943729|FG000|STARTED|Overall Study||1705||
48656933|NCT01368185|101943729|FG000|COMPLETED|Overall Study||1705||
48656934|NCT01368185|101943729|FG000|NOT COMPLETED|Overall Study||0||
48656935|NCT03382873|101943730|FG000|STARTED|Overall Study||86||
48656936|NCT03382873|101943731|FG001|STARTED|Overall Study||122||
48656937|NCT03382873|101943730|FG000|Completed 4-months|Overall Study||80||
48656938|NCT03382873|101943731|FG001|Completed 4-months|Overall Study||111||
48656939|NCT03382873|101943730|FG000|Randomized at 5-months|Overall Study||94||
48656940|NCT03382873|101943731|FG001|Randomized at 5-months|Overall Study||96||
48656941|NCT03382873|101943730|FG000|Completed 12-months|Overall Study||87||
48656942|NCT03382873|101943731|FG001|Completed 12-months|Overall Study||88||
48656943|NCT03382873|101943730|FG000|Completed 18-months|Overall Study||55||
48656944|NCT03382873|101943731|FG001|Completed 18-months|Overall Study||60||
48733954|NCT01280695|102133800|FG003|STARTED|Overall Study||26||
48733955|NCT01280695|102133801|FG004|STARTED|Overall Study||26||
48733956|NCT01280695|102133797|FG000|COMPLETED|Overall Study||26||
48733957|NCT01280695|102133798|FG001|COMPLETED|Overall Study||24||
48733958|NCT01280695|102133799|FG002|COMPLETED|Overall Study||21||
48733959|NCT01280695|102133800|FG003|COMPLETED|Overall Study||22||
48733960|NCT01280695|102133801|FG004|COMPLETED|Overall Study||24||
48733961|NCT01280695|102133797|FG000|NOT COMPLETED|Overall Study||0||
48733962|NCT01280695|102133798|FG001|NOT COMPLETED|Overall Study||1||
48733963|NCT01280695|102133799|FG002|NOT COMPLETED|Overall Study||5||
48733964|NCT01280695|102133800|FG003|NOT COMPLETED|Overall Study||4||
48733965|NCT01280695|102133801|FG004|NOT COMPLETED|Overall Study||2||
48733966|NCT01792115|102133802|FG000|STARTED|Overall Study||7||
48733967|NCT01792115|102133803|FG001|STARTED|Overall Study||7||
48733968|NCT01792115|102133804|FG002|STARTED|Overall Study||8||
48733969|NCT01792115|102133802|FG000|COMPLETED|Overall Study||7||
48733970|NCT01792115|102133803|FG001|COMPLETED|Overall Study||6||
48733971|NCT01792115|102133804|FG002|COMPLETED|Overall Study||8||
48733972|NCT01792115|102133802|FG000|NOT COMPLETED|Overall Study||0||
48733973|NCT01792115|102133803|FG001|NOT COMPLETED|Overall Study||1||
48733974|NCT01792115|102133804|FG002|NOT COMPLETED|Overall Study||0||
48733975|NCT01445080|102133805|FG000|STARTED|Overall Study||7||
48733976|NCT01445080|102133806|FG001|STARTED|Overall Study||5||
48733977|NCT01445080|102133807|FG002|STARTED|Overall Study||12||
48733978|NCT01445080|102133808|FG003|STARTED|Overall Study||8||
48733979|NCT01445080|102133809|FG004|STARTED|Overall Study||4||
48733980|NCT01445080|102133810|FG005|STARTED|Overall Study||9||
48733981|NCT01445080|102133811|FG006|STARTED|Overall Study||2||
48733982|NCT01445080|102133812|FG007|STARTED|Overall Study||5||
48733983|NCT01445080|102133813|FG008|STARTED|Overall Study||18||
48733984|NCT01445080|102133805|FG000|COMPLETED|Overall Study||0||
48733985|NCT01445080|102133806|FG001|COMPLETED|Overall Study||0||
48733986|NCT01445080|102133807|FG002|COMPLETED|Overall Study||0||
48733987|NCT01445080|102133808|FG003|COMPLETED|Overall Study||0||
48733988|NCT01445080|102133809|FG004|COMPLETED|Overall Study||0||
48733989|NCT01445080|102133810|FG005|COMPLETED|Overall Study||0||
48733990|NCT01445080|102133811|FG006|COMPLETED|Overall Study||0||
48733991|NCT01445080|102133812|FG007|COMPLETED|Overall Study||0||
48733992|NCT01445080|102133813|FG008|COMPLETED|Overall Study||0||
48733993|NCT01445080|102133805|FG000|NOT COMPLETED|Overall Study||7||
48733994|NCT01445080|102133806|FG001|NOT COMPLETED|Overall Study||5||
48733995|NCT01445080|102133807|FG002|NOT COMPLETED|Overall Study||12||
48733996|NCT01445080|102133808|FG003|NOT COMPLETED|Overall Study||8||
48733997|NCT01445080|102133809|FG004|NOT COMPLETED|Overall Study||4||
48733998|NCT01445080|102133810|FG005|NOT COMPLETED|Overall Study||9||
48733999|NCT01445080|102133811|FG006|NOT COMPLETED|Overall Study||2||
48734000|NCT01445080|102133812|FG007|NOT COMPLETED|Overall Study||5||
48734001|NCT01445080|102133813|FG008|NOT COMPLETED|Overall Study||18||
48734002|NCT00231413|102133814|FG000|STARTED|Overall Study||88||
48734003|NCT00231413|102133815|FG001|STARTED|Overall Study||50||
48734004|NCT00231413|102133816|FG002|STARTED|Overall Study||49||
48734005|NCT00231413|102133817|FG003|STARTED|Overall Study||48||
48734006|NCT00231413|102133818|FG004|STARTED|Overall Study||48||
48734007|NCT00231413|102133819|FG005|STARTED|Overall Study||50||
48734008|NCT00231413|102133820|FG006|STARTED|Overall Study||50||
48734009|NCT00231413|102133814|FG000|COMPLETED|Overall Study||80||
48734010|NCT00231413|102133815|FG001|COMPLETED|Overall Study||45||
48734011|NCT00231413|102133816|FG002|COMPLETED|Overall Study||42||
48734012|NCT00231413|102133817|FG003|COMPLETED|Overall Study||45||
48734013|NCT00231413|102133818|FG004|COMPLETED|Overall Study||45||
48734014|NCT00231413|102133819|FG005|COMPLETED|Overall Study||45||
48734015|NCT00231413|102133820|FG006|COMPLETED|Overall Study||46||
48734016|NCT00231413|102133814|FG000|NOT COMPLETED|Overall Study||8||
48734017|NCT00231413|102133815|FG001|NOT COMPLETED|Overall Study||5||
48734018|NCT00231413|102133816|FG002|NOT COMPLETED|Overall Study||7||
48734019|NCT00231413|102133817|FG003|NOT COMPLETED|Overall Study||3||
48734020|NCT00231413|102133818|FG004|NOT COMPLETED|Overall Study||3||
48734021|NCT00231413|102133819|FG005|NOT COMPLETED|Overall Study||5||
48734022|NCT00231413|102133820|FG006|NOT COMPLETED|Overall Study||4||
48734023|NCT05513053|102133821|FG000|STARTED|Overall Study||648||
48734024|NCT05513053|102133822|FG001|STARTED|Overall Study||660||
48734025|NCT05513053|102133821|FG000|COMPLETED|Overall Study||629||
48734026|NCT05513053|102133822|FG001|COMPLETED|Overall Study||635||
48734027|NCT05513053|102133821|FG000|NOT COMPLETED|Overall Study||19||
48734028|NCT05513053|102133822|FG001|NOT COMPLETED|Overall Study||25||
48734029|NCT00874848|102133823|FG000|STARTED|Overall Study||59||
48734030|NCT00874848|102133824|FG001|STARTED|Overall Study||29||
48734031|NCT00874848|102133823|FG000|Discontinued|Overall Study||59||
48734032|NCT00874848|102133824|FG001|Discontinued|Overall Study||28||
48734033|NCT00874848|102133823|FG000|COMPLETED|Overall Study||0||
48734034|NCT00874848|102133824|FG001|COMPLETED|Overall Study||1||
48734035|NCT00874848|102133823|FG000|NOT COMPLETED|Overall Study||59||
48734036|NCT00874848|102133824|FG001|NOT COMPLETED|Overall Study||28||
48734037|NCT00950248|102133825|FG000|STARTED|Year 1: Baseline||85||
48734038|NCT00950248|102133826|FG001|STARTED|Year 1: Baseline||0||
48734039|NCT00950248|102133827|FG002|STARTED|Year 1: Baseline||0||
48734040|NCT00950248|102133825|FG000|COMPLETED|Year 1: Baseline||77||
48734041|NCT00950248|102133826|FG001|COMPLETED|Year 1: Baseline||0||
48734042|NCT00950248|102133827|FG002|COMPLETED|Year 1: Baseline||0||
48734043|NCT00950248|102133825|FG000|NOT COMPLETED|Year 1: Baseline||8||
48734044|NCT00950248|102133826|FG001|NOT COMPLETED|Year 1: Baseline||0||
48734045|NCT00950248|102133827|FG002|NOT COMPLETED|Year 1: Baseline||0||
48734046|NCT00950248|102133825|FG000|STARTED|Year 2&3 Treatment Randomization||0||
48734047|NCT00950248|102133826|FG001|STARTED|Year 2&3 Treatment Randomization||39||
48734048|NCT00950248|102133827|FG002|STARTED|Year 2&3 Treatment Randomization||38||
48734049|NCT00950248|102133825|FG000|COMPLETED|Year 2&3 Treatment Randomization||0||
48734050|NCT00950248|102133826|FG001|COMPLETED|Year 2&3 Treatment Randomization||33||
48734051|NCT00950248|102133827|FG002|COMPLETED|Year 2&3 Treatment Randomization||33||
48734052|NCT00950248|102133825|FG000|NOT COMPLETED|Year 2&3 Treatment Randomization||0||
48734053|NCT00950248|102133826|FG001|NOT COMPLETED|Year 2&3 Treatment Randomization||6||
48734054|NCT00950248|102133827|FG002|NOT COMPLETED|Year 2&3 Treatment Randomization||5||
48734055|NCT00746694|102133828|FG000|STARTED|Overall Study||154||
48734056|NCT00746694|102133828|FG000|COMPLETED|Overall Study||154||
48734057|NCT00746694|102133828|FG000|NOT COMPLETED|Overall Study||0||
48734058|NCT02485704|102133829|FG000|STARTED|Overall Study||154||
48734059|NCT02485704|102133830|FG001|STARTED|Overall Study||126||
48734060|NCT02485704|102133829|FG000|COMPLETED|Overall Study||149||
48734061|NCT02485704|102133830|FG001|COMPLETED|Overall Study||118||
48734062|NCT02485704|102133829|FG000|NOT COMPLETED|Overall Study||5||
48734063|NCT02485704|102133830|FG001|NOT COMPLETED|Overall Study||8||
48316373|NCT00111800|101101124|FG004|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||4||
48734064|NCT05546229|102133831|FG000|STARTED|Overall Study||3||
48734065|NCT05546229|102133832|FG001|STARTED|Overall Study||6||
48734066|NCT05546229|102133833|FG002|STARTED|Overall Study||2||
48734067|NCT05546229|102133831|FG000|COMPLETED|Overall Study||3||
48734068|NCT05546229|102133832|FG001|COMPLETED|Overall Study||6||
48734069|NCT05546229|102133833|FG002|COMPLETED|Overall Study||2||
48734070|NCT05546229|102133831|FG000|NOT COMPLETED|Overall Study||0||
48734071|NCT05546229|102133832|FG001|NOT COMPLETED|Overall Study||0||
48734072|NCT05546229|102133833|FG002|NOT COMPLETED|Overall Study||0||
48734073|NCT00310817|102133834|FG000|STARTED|Overall Study||207||
48734074|NCT00310817|102133835|FG001|STARTED|Overall Study||206||
48734075|NCT00310817|102133836|FG002|STARTED|Overall Study||128||
48734076|NCT00310817|102133837|FG003|STARTED|Overall Study||82||
48734077|NCT00310817|102133834|FG000|COMPLETED|Overall Study||196||
48734078|NCT00310817|102133835|FG001|COMPLETED|Overall Study||198||
48734079|NCT00310817|102133836|FG002|COMPLETED|Overall Study||120||
48734080|NCT00310817|102133837|FG003|COMPLETED|Overall Study||74||
48734081|NCT00310817|102133834|FG000|NOT COMPLETED|Overall Study||11||
48734082|NCT00310817|102133835|FG001|NOT COMPLETED|Overall Study||8||
48734083|NCT00310817|102133836|FG002|NOT COMPLETED|Overall Study||8||
48734084|NCT00310817|102133837|FG003|NOT COMPLETED|Overall Study||8||
48734085|NCT01153724|102133838|FG000|STARTED|Treatment Period 1||35||
48734086|NCT01153724|102133838|FG000|COMPLETED|Treatment Period 1||34||
48734087|NCT01153724|102133838|FG000|NOT COMPLETED|Treatment Period 1||1||
48734088|NCT01153724|102133838|FG000|STARTED|Treatment Period 2||34||
48734089|NCT01153724|102133838|FG000|COMPLETED|Treatment Period 2||32||
48734090|NCT01153724|102133838|FG000|NOT COMPLETED|Treatment Period 2||2||
48734091|NCT01387464|102133839|FG000|STARTED|Overall Study||30||
48734092|NCT01387464|102133840|FG001|STARTED|Overall Study||30||
48734093|NCT01387464|102133839|FG000|Safety Population|Overall Study||30||
48734094|NCT01387464|102133840|FG001|Safety Population|Overall Study||29||
48734095|NCT01387464|102133839|FG000|Per-Protocol Population|Overall Study||29||
48734096|NCT01387464|102133840|FG001|Per-Protocol Population|Overall Study||29||
48734097|NCT01387464|102133839|FG000|COMPLETED|Overall Study||29||
48734098|NCT01387464|102133840|FG001|COMPLETED|Overall Study||29||
48734099|NCT01387464|102133839|FG000|NOT COMPLETED|Overall Study||1||
48734100|NCT01387464|102133840|FG001|NOT COMPLETED|Overall Study||1||
48734101|NCT03559933|102133841|FG000|STARTED|Overall Study||12|Date of first treatment for first treated patient (P01).|
48734102|NCT03559933|102133841|FG000|COMPLETED|Overall Study||12|Date of follow-up visit for last treated patient (P12).|
48734103|NCT03559933|102133841|FG000|NOT COMPLETED|Overall Study||0||
48159555|NCT00817999|100715655|FG001|COMPLETED|No Grapefruit Juice||17||
48316374|NCT00111800|101101125|FG005|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2||
48316375|NCT04331795|101101126|FG000|STARTED|Overall Study||12||
48316376|NCT04331795|101101127|FG001|STARTED|Overall Study||20||
48734104|NCT06359080|102133842|FG000|STARTED|Overall Study||25||
48734105|NCT06359080|102133842|FG000|COMPLETED|Overall Study||22||
48734106|NCT06359080|102133842|FG000|NOT COMPLETED|Overall Study||3||
48734107|NCT02069392|102133843|FG000|STARTED|Overall Study||14||
48734108|NCT02069392|102133844|FG001|STARTED|Overall Study||17||
48734109|NCT02069392|102133843|FG000|COMPLETED|Overall Study||10||
48734110|NCT02069392|102133844|FG001|COMPLETED|Overall Study||15||
48734111|NCT02069392|102133843|FG000|NOT COMPLETED|Overall Study||4||
48734112|NCT02069392|102133844|FG001|NOT COMPLETED|Overall Study||2||
48734113|NCT01248741|102133845|FG000|STARTED|Overall Study||20||
48734114|NCT01248741|102133845|FG000|COMPLETED|Overall Study||20||
48734115|NCT01248741|102133845|FG000|NOT COMPLETED|Overall Study||0||
48159556|NCT00817999|100715654|FG000|NOT COMPLETED|No Grapefruit Juice||0||
48159557|NCT00817999|100715655|FG001|NOT COMPLETED|No Grapefruit Juice||0||
48159558|NCT01114204|100715656|FG000|STARTED|Overall Study||406||
48159559|NCT01114204|100715657|FG001|STARTED|Overall Study||199||
48159560|NCT01114204|100715656|FG000|Received at Least 1 Dose of Study Drug|Overall Study||406||
48159561|NCT01114204|100715657|FG001|Received at Least 1 Dose of Study Drug|Overall Study||199||
48734116|NCT01657292|102133846|FG000|STARTED|Overall Study||61||
48734117|NCT01657292|102133846|FG000|COMPLETED|Overall Study||51||
48734118|NCT01657292|102133846|FG000|NOT COMPLETED|Overall Study||10||
48734119|NCT01561053|102133847|FG000|STARTED|Overall Study||86||
48734120|NCT01561053|102133848|FG001|STARTED|Overall Study||92||
48734121|NCT01561053|102133849|FG002|STARTED|Overall Study||82||
48734122|NCT01561053|102133850|FG003|STARTED|Overall Study||87||
48734123|NCT01561053|102133847|FG000|Patients With Baseline MMSE:18-21|Overall Study||47||
48734124|NCT01561053|102133848|FG001|Patients With Baseline MMSE:18-21|Overall Study||40||
48734125|NCT01561053|102133849|FG002|Patients With Baseline MMSE:18-21|Overall Study||47||
48734126|NCT01561053|102133850|FG003|Patients With Baseline MMSE:18-21|Overall Study||42||
48734127|NCT01561053|102133847|FG000|Patients With Baseline MMSE:22-26|Overall Study||39||
48734128|NCT01561053|102133848|FG001|Patients With Baseline MMSE:22-26|Overall Study||52||
48734129|NCT01561053|102133849|FG002|Patients With Baseline MMSE:22-26|Overall Study||35||
48734130|NCT01561053|102133850|FG003|Patients With Baseline MMSE:22-26|Overall Study||45||
48734131|NCT01561053|102133847|FG000|Randomized Not Treated|Overall Study||8||
48734132|NCT01561053|102133848|FG001|Randomized Not Treated|Overall Study||6||
48734133|NCT01561053|102133849|FG002|Randomized Not Treated|Overall Study||4||
48734134|NCT01561053|102133850|FG003|Randomized Not Treated|Overall Study||7||
48734135|NCT01561053|102133847|FG000|Evaluable Subjects|Overall Study||78||
48734136|NCT01561053|102133848|FG001|Evaluable Subjects|Overall Study||86||
48734137|NCT01561053|102133849|FG002|Evaluable Subjects|Overall Study||78||
48734138|NCT01561053|102133850|FG003|Evaluable Subjects|Overall Study||80||
48734139|NCT01561053|102133847|FG000|COMPLETED|Overall Study||51||
48734140|NCT01561053|102133848|FG001|COMPLETED|Overall Study||56||
48734141|NCT01561053|102133849|FG002|COMPLETED|Overall Study||61||
48734142|NCT01561053|102133850|FG003|COMPLETED|Overall Study||64||
48734143|NCT01561053|102133847|FG000|NOT COMPLETED|Overall Study||35||
48734144|NCT01561053|102133848|FG001|NOT COMPLETED|Overall Study||36||
48734145|NCT01561053|102133849|FG002|NOT COMPLETED|Overall Study||21||
48734146|NCT01561053|102133850|FG003|NOT COMPLETED|Overall Study||23||
48734147|NCT01635881|102133851|FG000|STARTED|Overall Study||60||
48159562|NCT01114204|100715656|FG000|COMPLETED|Overall Study||385|Completed is defined as had study drug and Week 5 visit.|
48159563|NCT01114204|100715657|FG001|COMPLETED|Overall Study||191|Completed is defined as had study drug and Week 5 visit.|
48734148|NCT01635881|102133851|FG000|COMPLETED|Overall Study||60||
48734149|NCT01635881|102133851|FG000|NOT COMPLETED|Overall Study||0||
48734150|NCT00635882|102133852|FG000|STARTED|Overall Study||20||
48734151|NCT00635882|102133853|FG001|STARTED|Overall Study||17||
48734152|NCT00635882|102133854|FG002|STARTED|Overall Study||12||
48734153|NCT00635882|102133855|FG003|STARTED|Overall Study||15||
48734154|NCT00635882|102133856|FG004|STARTED|Overall Study||16||
48734155|NCT00635882|102133857|FG005|STARTED|Overall Study||13||
48734156|NCT00635882|102133852|FG000|COMPLETED|Overall Study||19||
48734157|NCT00635882|102133853|FG001|COMPLETED|Overall Study||17||
48734158|NCT00635882|102133854|FG002|COMPLETED|Overall Study||12||
48734159|NCT00635882|102133855|FG003|COMPLETED|Overall Study||15||
48734160|NCT00635882|102133856|FG004|COMPLETED|Overall Study||16||
48734161|NCT00635882|102133857|FG005|COMPLETED|Overall Study||13||
48734162|NCT00635882|102133852|FG000|NOT COMPLETED|Overall Study||1||
48734163|NCT00635882|102133853|FG001|NOT COMPLETED|Overall Study||0||
48734164|NCT00635882|102133854|FG002|NOT COMPLETED|Overall Study||0||
48734165|NCT00635882|102133855|FG003|NOT COMPLETED|Overall Study||0||
48734166|NCT00635882|102133856|FG004|NOT COMPLETED|Overall Study||0||
48734167|NCT00635882|102133857|FG005|NOT COMPLETED|Overall Study||0||
48734168|NCT00119366|102133858|FG000|STARTED|Overall Study||1||
48734169|NCT00119366|102133859|FG001|STARTED|Overall Study||2||
48734170|NCT00119366|102133860|FG002|STARTED|Overall Study||3||
48734171|NCT00119366|102133861|FG003|STARTED|Overall Study||2||
48734172|NCT00119366|102133862|FG004|STARTED|Overall Study||8||
48734173|NCT00119366|102133858|FG000|COMPLETED|Overall Study||1||
48734174|NCT00119366|102133859|FG001|COMPLETED|Overall Study||2||
48734175|NCT00119366|102133860|FG002|COMPLETED|Overall Study||3||
48734176|NCT00119366|102133861|FG003|COMPLETED|Overall Study||2||
48159564|NCT01114204|100715656|FG000|NOT COMPLETED|Overall Study||21||
48734177|NCT00119366|102133862|FG004|COMPLETED|Overall Study||8||
48734178|NCT00119366|102133858|FG000|NOT COMPLETED|Overall Study||0||
48734179|NCT00119366|102133859|FG001|NOT COMPLETED|Overall Study||0||
48734180|NCT00119366|102133860|FG002|NOT COMPLETED|Overall Study||0||
48159565|NCT01114204|100715657|FG001|NOT COMPLETED|Overall Study||8||
48159566|NCT02569437|100715658|FG000|STARTED|Overall Study||24||
48159567|NCT02569437|100715659|FG001|STARTED|Overall Study||25||
48159568|NCT02569437|100715658|FG000|COMPLETED|Overall Study||12||
48159569|NCT02569437|100715659|FG001|COMPLETED|Overall Study||11||
48159570|NCT02569437|100715658|FG000|NOT COMPLETED|Overall Study||12||
48159571|NCT02569437|100715659|FG001|NOT COMPLETED|Overall Study||14||
48734181|NCT00119366|102133861|FG003|NOT COMPLETED|Overall Study||0||
48734182|NCT00119366|102133862|FG004|NOT COMPLETED|Overall Study||0||
48734183|NCT02176161|102133863|FG000|STARTED|Overall Study||15||
48734184|NCT02176161|102133864|FG001|STARTED|Overall Study||18||
48734185|NCT02176161|102133865|FG002|STARTED|Overall Study||26||
48734186|NCT02176161|102133863|FG000|COMPLETED|Overall Study||15||
48734187|NCT02176161|102133864|FG001|COMPLETED|Overall Study||18||
48734188|NCT02176161|102133865|FG002|COMPLETED|Overall Study||26||
48734189|NCT02176161|102133863|FG000|NOT COMPLETED|Overall Study||0||
48734190|NCT02176161|102133864|FG001|NOT COMPLETED|Overall Study||0||
48734191|NCT02176161|102133865|FG002|NOT COMPLETED|Overall Study||0||
48734192|NCT00193180|102133866|FG000|STARTED|Overall Study||37||
48734193|NCT00193180|102133866|FG000|COMPLETED|Overall Study||27||
48734194|NCT00193180|102133866|FG000|NOT COMPLETED|Overall Study||10||
48734195|NCT00699660|102133867|FG000|STARTED|Overall Study||190||
48159572|NCT03270514|100715660|FG000|STARTED|Overall Study||29||
48159573|NCT03270514|100715661|FG001|STARTED|Overall Study||31||
48316377|NCT04331795|101101126|FG000|COMPLETED|Overall Study||12||
48316378|NCT04331795|101101127|FG001|COMPLETED|Overall Study||20||
48316379|NCT04331795|101101126|FG000|NOT COMPLETED|Overall Study||0||
48316380|NCT04331795|101101127|FG001|NOT COMPLETED|Overall Study||0||
48316381|NCT03124771|101101128|FG000|STARTED|Overall Study||132||
48316382|NCT03124771|101101128|FG000|COMPLETED|Overall Study||132||
48316383|NCT03124771|101101128|FG000|NOT COMPLETED|Overall Study||0||
48316384|NCT04649255|101101129|FG000|STARTED|Overall Study||113||
48316385|NCT04649255|101101129|FG000|COMPLETED|Overall Study||103||
48316386|NCT04649255|101101129|FG000|NOT COMPLETED|Overall Study||10||
48316387|NCT02348775|101101130|FG000|STARTED|Overall Study||8||
48734196|NCT00699660|102133868|FG001|STARTED|Overall Study||216||
48734197|NCT00699660|102133867|FG000|COMPLETED|Overall Study||176||
48734198|NCT00699660|102133868|FG001|COMPLETED|Overall Study||208||
48734199|NCT00699660|102133867|FG000|NOT COMPLETED|Overall Study||14||
48734200|NCT00699660|102133868|FG001|NOT COMPLETED|Overall Study||8||
48734201|NCT02109809|102133869|FG000|STARTED|Overall Study||4||
48734202|NCT02109809|102133869|FG000|COMPLETED|Overall Study||1||
48734203|NCT02109809|102133869|FG000|NOT COMPLETED|Overall Study||3||
48734204|NCT01128192|102133870|FG000|STARTED|Overall Study||19||
48734205|NCT01128192|102133871|FG001|STARTED|Overall Study||19||
48734206|NCT01128192|102133872|FG002|STARTED|Overall Study||7||
48734207|NCT01128192|102133870|FG000|COMPLETED|Overall Study||19||
48734208|NCT01128192|102133871|FG001|COMPLETED|Overall Study||19||
48734209|NCT01128192|102133872|FG002|COMPLETED|Overall Study||7||
48734210|NCT01128192|102133870|FG000|NOT COMPLETED|Overall Study||0||
48734211|NCT01128192|102133871|FG001|NOT COMPLETED|Overall Study||0||
48734212|NCT01128192|102133872|FG002|NOT COMPLETED|Overall Study||0||
48734213|NCT02649894|102133873|FG000|STARTED|Overall Study||81||
48734214|NCT02649894|102133874|FG001|STARTED|Overall Study||38||
48734215|NCT02649894|102133873|FG000|Device Inserted|Overall Study||77||
48734216|NCT02649894|102133874|FG001|Device Inserted|Overall Study||37||
48734217|NCT02649894|102133873|FG000|Completed Day 30|Overall Study||56||
48734218|NCT02649894|102133874|FG001|Completed Day 30|Overall Study||35||
48734219|NCT02649894|102133873|FG000|COMPLETED|Overall Study||37|Day 90|
48734220|NCT02649894|102133874|FG001|COMPLETED|Overall Study||27|Day 90|
48316388|NCT02348775|101101131|FG001|STARTED|Overall Study||8||
48316389|NCT02348775|101101130|FG000|COMPLETED|Overall Study||8||
48316390|NCT02348775|101101131|FG001|COMPLETED|Overall Study||8||
48316391|NCT02348775|101101130|FG000|NOT COMPLETED|Overall Study||0||
48316392|NCT02348775|101101131|FG001|NOT COMPLETED|Overall Study||0||
48316393|NCT02231164|101101132|FG000|STARTED|Overall Study||6||
48316394|NCT02231164|101101133|FG001|STARTED|Overall Study||6||
48316395|NCT02231164|101101132|FG000|COMPLETED|Overall Study||0||
48316396|NCT02231164|101101133|FG001|COMPLETED|Overall Study||0||
48316397|NCT02231164|101101132|FG000|NOT COMPLETED|Overall Study||6||
48316398|NCT02231164|101101133|FG001|NOT COMPLETED|Overall Study||6||
48316399|NCT02152085|101101134|FG000|STARTED|Overall Study||14||
48316400|NCT02152085|101101135|FG001|STARTED|Overall Study||15||
48316401|NCT02152085|101101134|FG000|COMPLETED|Overall Study||13||
48316402|NCT02152085|101101135|FG001|COMPLETED|Overall Study||14||
48316403|NCT02152085|101101134|FG000|NOT COMPLETED|Overall Study||1||
48316404|NCT02152085|101101135|FG001|NOT COMPLETED|Overall Study||1||
48316405|NCT02230384|101101136|FG000|STARTED|Phase 1||30||
48316406|NCT02230384|101101137|FG001|STARTED|Phase 1||32||
48316407|NCT02230384|101101136|FG000|COMPLETED|Phase 1||29||
48734221|NCT02649894|102133873|FG000|NOT COMPLETED|Overall Study||44||
48734222|NCT02649894|102133874|FG001|NOT COMPLETED|Overall Study||11||
48734223|NCT00947115|102133875|FG000|STARTED|Overall Study||159||
48734224|NCT00947115|102133876|FG001|STARTED|Overall Study||194||
48734225|NCT00947115|102133877|FG002|STARTED|Overall Study||171||
48734226|NCT00947115|102133875|FG000|COMPLETED|Overall Study||142||
48159574|NCT03270514|100715660|FG000|COMPLETED|Overall Study||29||
48159575|NCT03270514|100715661|FG001|COMPLETED|Overall Study||31||
48159576|NCT03270514|100715660|FG000|NOT COMPLETED|Overall Study||0||
48316408|NCT02230384|101101137|FG001|COMPLETED|Phase 1||31||
48734227|NCT00947115|102133876|FG001|COMPLETED|Overall Study||172||
48734228|NCT00947115|102133877|FG002|COMPLETED|Overall Study||156||
48734229|NCT00947115|102133875|FG000|NOT COMPLETED|Overall Study||17||
48734230|NCT00947115|102133876|FG001|NOT COMPLETED|Overall Study||22||
48734231|NCT00947115|102133877|FG002|NOT COMPLETED|Overall Study||15||
48316409|NCT02230384|101101136|FG000|NOT COMPLETED|Phase 1||1||
48316410|NCT02230384|101101137|FG001|NOT COMPLETED|Phase 1||1||
48316411|NCT02230384|101101136|FG000|STARTED|Phase 1 Wash Out||29||
48316412|NCT02230384|101101137|FG001|STARTED|Phase 1 Wash Out||31||
48316413|NCT02230384|101101136|FG000|COMPLETED|Phase 1 Wash Out||29||
48316414|NCT02230384|101101137|FG001|COMPLETED|Phase 1 Wash Out||31||
48316415|NCT02230384|101101136|FG000|NOT COMPLETED|Phase 1 Wash Out||0||
48316416|NCT02230384|101101137|FG001|NOT COMPLETED|Phase 1 Wash Out||0||
48316417|NCT02230384|101101136|FG000|STARTED|Phase 2 - Switch||29||
48316418|NCT02230384|101101137|FG001|STARTED|Phase 2 - Switch||31||
48316419|NCT02230384|101101136|FG000|COMPLETED|Phase 2 - Switch||26||
48316420|NCT02230384|101101137|FG001|COMPLETED|Phase 2 - Switch||30||
48316421|NCT02230384|101101136|FG000|NOT COMPLETED|Phase 2 - Switch||3||
48316422|NCT02230384|101101137|FG001|NOT COMPLETED|Phase 2 - Switch||1||
48316423|NCT02230384|101101136|FG000|STARTED|Phase 2 Wash Out||26||
48615061|NCT00685360|101841919|FG002|MITT (Solid Culture)|Overall Study||113|MITT (Solid Culture) Population included all participants who had sputum cultures positive for MDR TB at baseline (Day -1 and/or Day 1) using solid culture medium.|
48615062|NCT00685360|101841917|FG000|COMPLETED|Overall Study||143||
48615063|NCT00685360|101841918|FG001|COMPLETED|Overall Study||146||
48615064|NCT00685360|101841919|FG002|COMPLETED|Overall Study||145||
48615065|NCT00685360|101841917|FG000|NOT COMPLETED|Overall Study||18||
48615066|NCT00685360|101841918|FG001|NOT COMPLETED|Overall Study||14||
48615067|NCT00685360|101841919|FG002|NOT COMPLETED|Overall Study||15||
48615068|NCT05117112|101844818|FG000|STARTED|Overall Study||9||
48615069|NCT05117112|101844819|FG001|STARTED|Overall Study||11||
48615070|NCT05117112|101844820|FG002|STARTED|Overall Study||10||
48615071|NCT05117112|101844818|FG000|COMPLETED|Overall Study||9||
48615072|NCT05117112|101844819|FG001|COMPLETED|Overall Study||10||
48615073|NCT05117112|101844820|FG002|COMPLETED|Overall Study||10||
48615074|NCT05117112|101844818|FG000|NOT COMPLETED|Overall Study||0||
48734232|NCT03775512|102133878|FG000|STARTED|Overall Study||191||
48734233|NCT03775512|102133879|FG001|STARTED|Overall Study||92||
48159577|NCT03270514|100715661|FG001|NOT COMPLETED|Overall Study||0||
48159578|NCT01279343|100715662|FG000|STARTED|Overall Study||59||
48159579|NCT01279343|100715663|FG001|STARTED|Overall Study||64||
48159580|NCT01279343|100715662|FG000|COMPLETED|Overall Study||57||
48159581|NCT01279343|100715663|FG001|COMPLETED|Overall Study||58||
48159582|NCT01279343|100715662|FG000|NOT COMPLETED|Overall Study||2||
48159583|NCT01279343|100715663|FG001|NOT COMPLETED|Overall Study||6||
48159584|NCT04999644|100715664|FG000|STARTED|Overall Study||21||
48159585|NCT04999644|100715664|FG000|COMPLETED|Overall Study||21||
48159586|NCT04999644|100715664|FG000|NOT COMPLETED|Overall Study||0||
48159587|NCT03642938|100715665|FG000|STARTED|Overall Study||10||
48159588|NCT03642938|100715666|FG001|STARTED|Overall Study||10||
48159589|NCT03642938|100715667|FG002|STARTED|Overall Study||10||
48159590|NCT03642938|100715668|FG003|STARTED|Overall Study||11||
48159591|NCT03642938|100715665|FG000|COMPLETED|Overall Study||10||
48734234|NCT03775512|102133878|FG000|Treated|Overall Study||177||
48734235|NCT03775512|102133879|FG001|Treated|Overall Study||87||
48159592|NCT03642938|100715666|FG001|COMPLETED|Overall Study||10||
48159593|NCT03642938|100715667|FG002|COMPLETED|Overall Study||10||
48159594|NCT03642938|100715668|FG003|COMPLETED|Overall Study||10||
48159595|NCT03642938|100715665|FG000|NOT COMPLETED|Overall Study||0||
48159596|NCT03642938|100715666|FG001|NOT COMPLETED|Overall Study||0||
48159597|NCT03642938|100715667|FG002|NOT COMPLETED|Overall Study||0||
48159598|NCT03642938|100715668|FG003|NOT COMPLETED|Overall Study||1||
48159599|NCT04098406|100715669|FG000|STARTED|Overall Study||22||
48159600|NCT04098406|100715670|FG001|STARTED|Overall Study||23||
48159601|NCT04098406|100715669|FG000|COMPLETED|Overall Study||19||
48159602|NCT04098406|100715670|FG001|COMPLETED|Overall Study||22||
48159603|NCT04098406|100715669|FG000|NOT COMPLETED|Overall Study||3||
48159604|NCT04098406|100715670|FG001|NOT COMPLETED|Overall Study||1||
48159605|NCT03587142|100715671|FG000|STARTED|Overall Study||47||
48159606|NCT03587142|100715672|FG001|STARTED|Overall Study||49||
48159607|NCT03587142|100715671|FG000|COMPLETED|Overall Study||39||
48159608|NCT03587142|100715672|FG001|COMPLETED|Overall Study||39||
48159609|NCT03587142|100715671|FG000|NOT COMPLETED|Overall Study||8||
48159610|NCT03587142|100715672|FG001|NOT COMPLETED|Overall Study||10||
48159611|NCT01892345|100715673|FG000|STARTED|Overall Study||96||
48159612|NCT01892345|100715674|FG001|STARTED|Overall Study||47||
48316424|NCT02230384|101101137|FG001|STARTED|Phase 2 Wash Out||30||
48316425|NCT02230384|101101136|FG000|COMPLETED|Phase 2 Wash Out||26||
48316426|NCT02230384|101101137|FG001|COMPLETED|Phase 2 Wash Out||30||
48316427|NCT02230384|101101136|FG000|NOT COMPLETED|Phase 2 Wash Out||0||
48316428|NCT02230384|101101137|FG001|NOT COMPLETED|Phase 2 Wash Out||0||
48316429|NCT02997904|101101138|FG000|STARTED|Overall Study||51||
48159613|NCT01892345|100715673|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||96|Full Analysis Set (FAS)|
48159614|NCT01892345|100715674|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||47|Full Analysis Set (FAS)|
48159615|NCT01892345|100715673|FG000|COMPLETED|Overall Study||80||
48159616|NCT01892345|100715674|FG001|COMPLETED|Overall Study||44||
48316430|NCT02997904|101101139|FG001|STARTED|Overall Study||49||
48316431|NCT02997904|101101138|FG000|COMPLETED|Overall Study||51||
48316432|NCT02997904|101101139|FG001|COMPLETED|Overall Study||49||
48316433|NCT02997904|101101138|FG000|NOT COMPLETED|Overall Study||0||
48316434|NCT02997904|101101139|FG001|NOT COMPLETED|Overall Study||0||
48316435|NCT01835015|101101140|FG000|STARTED|Overall Study||6||
48316436|NCT01835015|101101141|FG001|STARTED|Overall Study||6||
48316437|NCT01835015|101101142|FG002|STARTED|Overall Study||7||
48316438|NCT01835015|101101143|FG003|STARTED|Overall Study||6||
48316439|NCT01835015|101101144|FG004|STARTED|Overall Study||6||
48316440|NCT01835015|101101140|FG000|COMPLETED|Overall Study||6||
48316441|NCT01835015|101101141|FG001|COMPLETED|Overall Study||6||
48615075|NCT05117112|101844819|FG001|NOT COMPLETED|Overall Study||1||
48615076|NCT05117112|101844820|FG002|NOT COMPLETED|Overall Study||0||
48615077|NCT03143101|101844821|FG000|STARTED|Overall Study||67||
48615078|NCT03143101|101844822|FG001|STARTED|Overall Study||66||
48615079|NCT03143101|101844823|FG002|STARTED|Overall Study||67||
48159617|NCT01892345|100715673|FG000|NOT COMPLETED|Overall Study||16||
48159618|NCT01892345|100715674|FG001|NOT COMPLETED|Overall Study||3||
48159619|NCT00659490|100715675|FG000|STARTED|Overall Study||61||
48159620|NCT00659490|100715676|FG001|STARTED|Overall Study||59||
48159621|NCT00659490|100715677|FG002|STARTED|Overall Study||31||
48316442|NCT01835015|101101142|FG002|COMPLETED|Overall Study||6||
48316443|NCT01835015|101101143|FG003|COMPLETED|Overall Study||6||
48316444|NCT01835015|101101144|FG004|COMPLETED|Overall Study||6||
48316445|NCT01835015|101101140|FG000|NOT COMPLETED|Overall Study||0||
48316446|NCT01835015|101101141|FG001|NOT COMPLETED|Overall Study||0||
48316447|NCT01835015|101101142|FG002|NOT COMPLETED|Overall Study||1||
48316448|NCT01835015|101101143|FG003|NOT COMPLETED|Overall Study||0||
48316449|NCT01835015|101101144|FG004|NOT COMPLETED|Overall Study||0||
48316450|NCT00763750|101101145|FG000|STARTED|Overall Study||25||
48316451|NCT00763750|101101145|FG000|COMPLETED|Overall Study||25||
48316452|NCT00763750|101101145|FG000|NOT COMPLETED|Overall Study||0||
48316453|NCT01252745|101101146|FG000|STARTED|Overall Study||8||
48316454|NCT01252745|101101147|FG001|STARTED|Overall Study||7||
48316455|NCT01252745|101101148|FG002|STARTED|Overall Study||7||
48316456|NCT01252745|101101146|FG000|COMPLETED|Overall Study||8||
48316457|NCT01252745|101101147|FG001|COMPLETED|Overall Study||7||
48316458|NCT01252745|101101148|FG002|COMPLETED|Overall Study||7||
48316459|NCT01252745|101101146|FG000|NOT COMPLETED|Overall Study||0||
48316460|NCT01252745|101101147|FG001|NOT COMPLETED|Overall Study||0||
48316461|NCT01252745|101101148|FG002|NOT COMPLETED|Overall Study||0||
48316462|NCT02340338|101101149|FG000|STARTED|Overall Study||2||
48316463|NCT02340338|101101150|FG001|STARTED|Overall Study||2||
48316464|NCT02340338|101101151|FG002|STARTED|Overall Study||3||
48316465|NCT02340338|101101152|FG003|STARTED|Overall Study||9||
48615080|NCT03143101|101844821|FG000|COMPLETED|Overall Study||65||
48615081|NCT03143101|101844822|FG001|COMPLETED|Overall Study||63||
48615082|NCT03143101|101844823|FG002|COMPLETED|Overall Study||67||
48615083|NCT03143101|101844821|FG000|NOT COMPLETED|Overall Study||2||
48615084|NCT03143101|101844822|FG001|NOT COMPLETED|Overall Study||3||
48615085|NCT03143101|101844823|FG002|NOT COMPLETED|Overall Study||0||
48615086|NCT02223351|101844824|FG000|STARTED|Overall Study||24||
48316466|NCT02340338|101101153|FG004|STARTED|Overall Study||9||
48316467|NCT02340338|101101154|FG005|STARTED|Overall Study||9||
48615087|NCT02223351|101844825|FG001|STARTED|Overall Study||24||
48316468|NCT02340338|101101155|FG006|STARTED|Overall Study||12||
48316469|NCT02340338|101101149|FG000|COMPLETED|Overall Study||2||
48407043|NCT02903966|101328509|FG001|COMPLETED|Part B (Day 44 to 112)||22||
48615088|NCT02223351|101844824|FG000|First Intervention (8 Days)|Overall Study||24||
48615089|NCT02223351|101844825|FG001|First Intervention (8 Days)|Overall Study||24||
48615090|NCT02223351|101844824|FG000|Wasout (2weeks)|Overall Study||24||
48615091|NCT02223351|101844825|FG001|Wasout (2weeks)|Overall Study||24||
48159622|NCT00659490|100715675|FG000|COMPLETED|Overall Study||59||
48159623|NCT00659490|100715676|FG001|COMPLETED|Overall Study||59||
48159624|NCT00659490|100715677|FG002|COMPLETED|Overall Study||30||
48316470|NCT02340338|101101150|FG001|COMPLETED|Overall Study||2||
48316471|NCT02340338|101101151|FG002|COMPLETED|Overall Study||3||
48316472|NCT02340338|101101152|FG003|COMPLETED|Overall Study||9||
48316473|NCT02340338|101101153|FG004|COMPLETED|Overall Study||9||
48316474|NCT02340338|101101154|FG005|COMPLETED|Overall Study||9||
48316475|NCT02340338|101101155|FG006|COMPLETED|Overall Study||12||
48316476|NCT02340338|101101149|FG000|NOT COMPLETED|Overall Study||0||
48316477|NCT02340338|101101150|FG001|NOT COMPLETED|Overall Study||0||
48316478|NCT02340338|101101151|FG002|NOT COMPLETED|Overall Study||0||
48316479|NCT02340338|101101152|FG003|NOT COMPLETED|Overall Study||0||
48407044|NCT02903966|101328508|FG000|NOT COMPLETED|Part B (Day 44 to 112)||0||
48615092|NCT02223351|101844824|FG000|Second Intervention (8 Days)|Overall Study||24||
48316480|NCT02340338|101101153|FG004|NOT COMPLETED|Overall Study||0||
48316481|NCT02340338|101101154|FG005|NOT COMPLETED|Overall Study||0||
48316482|NCT02340338|101101155|FG006|NOT COMPLETED|Overall Study||0||
48316483|NCT02969187|101101156|FG000|STARTED|Overall Study||63||
48316484|NCT02969187|101101157|FG001|STARTED|Overall Study||63||
48316485|NCT02969187|101101156|FG000|COMPLETED|Overall Study||51||
48316486|NCT02969187|101101157|FG001|COMPLETED|Overall Study||50||
48316487|NCT02969187|101101156|FG000|NOT COMPLETED|Overall Study||12||
48316488|NCT02969187|101101157|FG001|NOT COMPLETED|Overall Study||13||
48316489|NCT02553265|101101158|FG000|STARTED|Enrollment||9||
48316490|NCT02553265|101101159|FG001|STARTED|Enrollment||7||
48316491|NCT02553265|101101160|FG002|STARTED|Enrollment||6||
48316492|NCT02553265|101101158|FG000|COMPLETED|Enrollment||9||
48316493|NCT02553265|101101159|FG001|COMPLETED|Enrollment||7||
48316494|NCT02553265|101101160|FG002|COMPLETED|Enrollment||5||
48316495|NCT02553265|101101158|FG000|NOT COMPLETED|Enrollment||0||
48316496|NCT02553265|101101159|FG001|NOT COMPLETED|Enrollment||0||
48316497|NCT02553265|101101160|FG002|NOT COMPLETED|Enrollment||1||
48316498|NCT02553265|101101158|FG000|STARTED|First Intervention (28 Days)||9||
48316499|NCT02553265|101101159|FG001|STARTED|First Intervention (28 Days)||7||
48316500|NCT02553265|101101160|FG002|STARTED|First Intervention (28 Days)||5||
48316501|NCT02553265|101101158|FG000|COMPLETED|First Intervention (28 Days)||8||
48316502|NCT02553265|101101159|FG001|COMPLETED|First Intervention (28 Days)||7||
48316503|NCT02553265|101101160|FG002|COMPLETED|First Intervention (28 Days)||4||
48316504|NCT02553265|101101158|FG000|NOT COMPLETED|First Intervention (28 Days)||1||
48316505|NCT02553265|101101159|FG001|NOT COMPLETED|First Intervention (28 Days)||0||
48316506|NCT02553265|101101160|FG002|NOT COMPLETED|First Intervention (28 Days)||1||
48316507|NCT02553265|101101158|FG000|STARTED|Second Intervention (28 Days)||8||
48316508|NCT02553265|101101159|FG001|STARTED|Second Intervention (28 Days)||7||
48316509|NCT02553265|101101160|FG002|STARTED|Second Intervention (28 Days)||4||
48316510|NCT02553265|101101158|FG000|COMPLETED|Second Intervention (28 Days)||7||
48316511|NCT02553265|101101159|FG001|COMPLETED|Second Intervention (28 Days)||7||
48316512|NCT02553265|101101160|FG002|COMPLETED|Second Intervention (28 Days)||4||
48316513|NCT02553265|101101158|FG000|NOT COMPLETED|Second Intervention (28 Days)||1||
48316514|NCT02553265|101101159|FG001|NOT COMPLETED|Second Intervention (28 Days)||0||
48316515|NCT02553265|101101160|FG002|NOT COMPLETED|Second Intervention (28 Days)||0||
48316516|NCT02553265|101101158|FG000|STARTED|Third Intervention (28 Days)||7||
48316517|NCT02553265|101101159|FG001|STARTED|Third Intervention (28 Days)||7||
48316518|NCT02553265|101101160|FG002|STARTED|Third Intervention (28 Days)||4||
48316519|NCT02553265|101101158|FG000|COMPLETED|Third Intervention (28 Days)||6||
48316520|NCT02553265|101101159|FG001|COMPLETED|Third Intervention (28 Days)||7||
48316521|NCT02553265|101101160|FG002|COMPLETED|Third Intervention (28 Days)||3||
48316522|NCT02553265|101101158|FG000|NOT COMPLETED|Third Intervention (28 Days)||1||
48316523|NCT02553265|101101159|FG001|NOT COMPLETED|Third Intervention (28 Days)||0||
48316524|NCT02553265|101101160|FG002|NOT COMPLETED|Third Intervention (28 Days)||1||
48316525|NCT01590550|101101161|FG000|STARTED|Overall Study||18||
48316526|NCT01590550|101101161|FG000|COMPLETED|Overall Study||18||
48316527|NCT01590550|101101161|FG000|NOT COMPLETED|Overall Study||0||
48316528|NCT00708123|101101162|FG000|STARTED|Period 1||12||
48316529|NCT00708123|101101163|FG001|STARTED|Period 1||12||
48316530|NCT00708123|101101164|FG002|STARTED|Period 1||12||
48316531|NCT00708123|101101165|FG003|STARTED|Period 1||12||
48316532|NCT00708123|101101166|FG004|STARTED|Period 1||12||
48316533|NCT00708123|101101162|FG000|COMPLETED|Period 1||12||
48316534|NCT00708123|101101163|FG001|COMPLETED|Period 1||11||
48316535|NCT00708123|101101164|FG002|COMPLETED|Period 1||11||
48316536|NCT00708123|101101165|FG003|COMPLETED|Period 1||11||
48316537|NCT00708123|101101166|FG004|COMPLETED|Period 1||12||
48316538|NCT00708123|101101162|FG000|NOT COMPLETED|Period 1||0||
48316539|NCT00708123|101101163|FG001|NOT COMPLETED|Period 1||1||
48316540|NCT00708123|101101164|FG002|NOT COMPLETED|Period 1||1||
48407045|NCT02903966|101328509|FG001|NOT COMPLETED|Part B (Day 44 to 112)||2||
48407046|NCT02985684|101328510|FG000|STARTED|6-Month Clinical Success Evaluation||125||
48316541|NCT00708123|101101165|FG003|NOT COMPLETED|Period 1||1||
48316542|NCT00708123|101101166|FG004|NOT COMPLETED|Period 1||0||
48316543|NCT00708123|101101162|FG000|STARTED|Period 2||11||
48316544|NCT00708123|101101163|FG001|STARTED|Period 2||12||
48316545|NCT00708123|101101164|FG002|STARTED|Period 2||12||
48316546|NCT00708123|101101165|FG003|STARTED|Period 2||11||
48316547|NCT00708123|101101166|FG004|STARTED|Period 2||11||
48316548|NCT00708123|101101162|FG000|COMPLETED|Period 2||10||
48407047|NCT02985684|101328510|FG000|COMPLETED|6-Month Clinical Success Evaluation||120||
48316549|NCT00708123|101101163|FG001|COMPLETED|Period 2||12||
48316550|NCT00708123|101101164|FG002|COMPLETED|Period 2||12||
48316551|NCT00708123|101101165|FG003|COMPLETED|Period 2||10||
48316552|NCT00708123|101101166|FG004|COMPLETED|Period 2||11||
48316553|NCT00708123|101101162|FG000|NOT COMPLETED|Period 2||1||
48316554|NCT00708123|101101163|FG001|NOT COMPLETED|Period 2||0||
48316555|NCT00708123|101101164|FG002|NOT COMPLETED|Period 2||0||
48316556|NCT00708123|101101165|FG003|NOT COMPLETED|Period 2||1||
48316557|NCT00708123|101101166|FG004|NOT COMPLETED|Period 2||0||
48316558|NCT00708123|101101162|FG000|STARTED|Period 3||12||
48316559|NCT00708123|101101163|FG001|STARTED|Period 3||10||
48316560|NCT00708123|101101164|FG002|STARTED|Period 3||11||
48316561|NCT00708123|101101165|FG003|STARTED|Period 3||12||
48316562|NCT00708123|101101166|FG004|STARTED|Period 3||10||
48316563|NCT00708123|101101162|FG000|COMPLETED|Period 3||12||
48316564|NCT00708123|101101163|FG001|COMPLETED|Period 3||10||
48316565|NCT00708123|101101164|FG002|COMPLETED|Period 3||10||
48316566|NCT00708123|101101165|FG003|COMPLETED|Period 3||11||
48316567|NCT00708123|101101166|FG004|COMPLETED|Period 3||10||
48316568|NCT00708123|101101162|FG000|NOT COMPLETED|Period 3||0||
48316569|NCT00708123|101101163|FG001|NOT COMPLETED|Period 3||0||
48316570|NCT00708123|101101164|FG002|NOT COMPLETED|Period 3||1||
48316571|NCT00708123|101101165|FG003|NOT COMPLETED|Period 3||1||
48316572|NCT00708123|101101166|FG004|NOT COMPLETED|Period 3||0||
48316573|NCT00708123|101101162|FG000|STARTED|Period 4||10||
48316574|NCT00708123|101101163|FG001|STARTED|Period 4||12||
48316575|NCT00708123|101101164|FG002|STARTED|Period 4||10||
48316576|NCT00708123|101101165|FG003|STARTED|Period 4||10||
48316577|NCT00708123|101101166|FG004|STARTED|Period 4||11||
48316578|NCT00708123|101101162|FG000|COMPLETED|Period 4||10||
48316579|NCT00708123|101101163|FG001|COMPLETED|Period 4||11||
48316580|NCT00708123|101101164|FG002|COMPLETED|Period 4||10||
48316581|NCT00708123|101101165|FG003|COMPLETED|Period 4||10||
48316582|NCT00708123|101101166|FG004|COMPLETED|Period 4||11||
48316583|NCT00708123|101101162|FG000|NOT COMPLETED|Period 4||0||
48316584|NCT00708123|101101163|FG001|NOT COMPLETED|Period 4||1||
48316585|NCT00708123|101101164|FG002|NOT COMPLETED|Period 4||0||
48316586|NCT00708123|101101165|FG003|NOT COMPLETED|Period 4||0||
48316587|NCT00708123|101101166|FG004|NOT COMPLETED|Period 4||0||
48316588|NCT00708123|101101162|FG000|STARTED|Period 5||10||
48316589|NCT00708123|101101163|FG001|STARTED|Period 5||10||
48316590|NCT00708123|101101164|FG002|STARTED|Period 5||11||
48316591|NCT00708123|101101165|FG003|STARTED|Period 5||11||
48316592|NCT00708123|101101166|FG004|STARTED|Period 5||10||
48316593|NCT00708123|101101162|FG000|COMPLETED|Period 5||10||
48316594|NCT00708123|101101163|FG001|COMPLETED|Period 5||10||
48316595|NCT00708123|101101164|FG002|COMPLETED|Period 5||11||
48316596|NCT00708123|101101165|FG003|COMPLETED|Period 5||11||
48316597|NCT00708123|101101166|FG004|COMPLETED|Period 5||10||
48316598|NCT00708123|101101162|FG000|NOT COMPLETED|Period 5||0||
48316599|NCT00708123|101101163|FG001|NOT COMPLETED|Period 5||0||
48316600|NCT00708123|101101164|FG002|NOT COMPLETED|Period 5||0||
48316601|NCT00708123|101101165|FG003|NOT COMPLETED|Period 5||0||
48316602|NCT00708123|101101166|FG004|NOT COMPLETED|Period 5||0||
48615093|NCT02223351|101844825|FG001|Second Intervention (8 Days)|Overall Study||24||
48615094|NCT02223351|101844824|FG000|COMPLETED|Overall Study||24||
48615095|NCT02223351|101844825|FG001|COMPLETED|Overall Study||24||
48615096|NCT02223351|101844824|FG000|NOT COMPLETED|Overall Study||0||
48615097|NCT02223351|101844825|FG001|NOT COMPLETED|Overall Study||0||
48615098|NCT00792909|101844826|FG000|STARTED|Overall Study||51||
48615099|NCT00792909|101844827|FG001|STARTED|Overall Study||59||
48615100|NCT00792909|101844828|FG002|STARTED|Overall Study||62||
48615101|NCT00792909|101844826|FG000|COMPLETED|Overall Study||51||
48615102|NCT00792909|101844827|FG001|COMPLETED|Overall Study||58||
48734236|NCT03775512|102133878|FG000|COMPLETED|Overall Study||162||
48734237|NCT03775512|102133879|FG001|COMPLETED|Overall Study||75||
48316603|NCT01035099|101101167|FG000|STARTED|Overall Study||18||
48316604|NCT01035099|101101168|FG001|STARTED|Overall Study||22||
48316605|NCT01035099|101101167|FG000|COMPLETED|Overall Study||18||
48316606|NCT01035099|101101168|FG001|COMPLETED|Overall Study||22||
48316607|NCT01035099|101101167|FG000|NOT COMPLETED|Overall Study||0||
48316608|NCT01035099|101101168|FG001|NOT COMPLETED|Overall Study||0||
48316609|NCT00434421|101101169|FG000|STARTED|Overall Study||28||
48316610|NCT00434421|101101169|FG000|COMPLETED|Overall Study||26||
48316611|NCT00434421|101101169|FG000|NOT COMPLETED|Overall Study||2||
48316612|NCT02255409|101101170|FG000|STARTED|Overall Study||318||
48316613|NCT02255409|101101171|FG001|STARTED|Overall Study||289||
48316614|NCT02255409|101101170|FG000|COMPLETED|Overall Study||304||
48316615|NCT02255409|101101171|FG001|COMPLETED|Overall Study||258||
48316616|NCT02255409|101101170|FG000|NOT COMPLETED|Overall Study||14||
48316617|NCT02255409|101101171|FG001|NOT COMPLETED|Overall Study||31||
48316618|NCT01438489|101101172|FG000|STARTED|Overall Study||103||
48615103|NCT00792909|101844828|FG002|COMPLETED|Overall Study||62||
48615104|NCT00792909|101844826|FG000|NOT COMPLETED|Overall Study||0||
48316619|NCT01438489|101101173|FG001|STARTED|Overall Study||100||
48316620|NCT01438489|101101174|FG002|STARTED|Overall Study||104||
48615105|NCT00792909|101844827|FG001|NOT COMPLETED|Overall Study||1||
48615106|NCT00792909|101844828|FG002|NOT COMPLETED|Overall Study||0||
48734238|NCT03775512|102133878|FG000|NOT COMPLETED|Overall Study||29||
48316621|NCT01438489|101101172|FG000|COMPLETED|Overall Study||77||
48316622|NCT01438489|101101173|FG001|COMPLETED|Overall Study||84||
48316623|NCT01438489|101101174|FG002|COMPLETED|Overall Study||85||
48316624|NCT01438489|101101172|FG000|NOT COMPLETED|Overall Study||26||
48316625|NCT01438489|101101173|FG001|NOT COMPLETED|Overall Study||16||
48316626|NCT01438489|101101174|FG002|NOT COMPLETED|Overall Study||19||
48316627|NCT01986920|101101175|FG000|STARTED|A- 101 25%||35|It is the same 35 participants in each treatment so total participants is 35.|35
48316628|NCT01986920|101101176|FG001|STARTED|A- 101 25%||0|It is the same 35 participants in each treatment so total participants is 35.|0
48316629|NCT01986920|101101177|FG002|STARTED|A- 101 25%||0|It is the same 35 participants in each treatment so total participants is 35.|0
48615107|NCT01431339|101844829|FG000|STARTED|Overall Study||371||
48615108|NCT01431339|101844830|FG001|STARTED|Overall Study||368||
48615109|NCT01431339|101844829|FG000|Safety Population|Overall Study||368||
48615110|NCT01431339|101844830|FG001|Safety Population|Overall Study||367||
48316630|NCT01986920|101101178|FG003|STARTED|A- 101 25%||0|It is the same 35 participants in each treatment so total participants is 35.|0
48316631|NCT01986920|101101175|FG000|COMPLETED|A- 101 25%||34|Participants receives all treatments, one treatment/lesion simultaneously. 1 Participant=4 lesion|34
48316632|NCT01986920|101101176|FG001|COMPLETED|A- 101 25%||0|Participants receives all treatments, one treatment/lesion simultaneously. 1 Participant=4 lesion|0
48316633|NCT01986920|101101177|FG002|COMPLETED|A- 101 25%||0|Participants receives all treatments, one treatment/lesion simultaneously. 1 Participant=4 lesion|0
48316634|NCT01986920|101101178|FG003|COMPLETED|A- 101 25%||0|Participants receives all treatments, one treatment/lesion simultaneously. 1 Participant=4 lesion|0
48316635|NCT01986920|101101175|FG000|NOT COMPLETED|A- 101 25%||1||1
48316636|NCT01986920|101101176|FG001|NOT COMPLETED|A- 101 25%||0||0
48316637|NCT01986920|101101177|FG002|NOT COMPLETED|A- 101 25%||0||0
48316638|NCT01986920|101101178|FG003|NOT COMPLETED|A- 101 25%||0||0
48316639|NCT01986920|101101175|FG000|STARTED|A-101 32.5%||0||0
48316640|NCT01986920|101101176|FG001|STARTED|A-101 32.5%||35||35
48316641|NCT01986920|101101177|FG002|STARTED|A-101 32.5%||0||0
48316642|NCT01986920|101101178|FG003|STARTED|A-101 32.5%||0||0
48316643|NCT01986920|101101175|FG000|COMPLETED|A-101 32.5%||0||0
48316644|NCT01986920|101101176|FG001|COMPLETED|A-101 32.5%||34||34
48316645|NCT01986920|101101177|FG002|COMPLETED|A-101 32.5%||0||0
48615111|NCT01431339|101844829|FG000|COMPLETED|Overall Study||332||
48615112|NCT01431339|101844830|FG001|COMPLETED|Overall Study||333||
48615113|NCT01431339|101844829|FG000|NOT COMPLETED|Overall Study||39||
48615114|NCT01431339|101844830|FG001|NOT COMPLETED|Overall Study||35||
48615115|NCT02526160|101844831|FG000|STARTED|Double-Blind (Placebo-Controlled) Period||66||
48615116|NCT02526160|101844832|FG001|STARTED|Double-Blind (Placebo-Controlled) Period||68||
48615117|NCT02526160|101844831|FG000|COMPLETED|Double-Blind (Placebo-Controlled) Period||66||
48615118|NCT02526160|101844832|FG001|COMPLETED|Double-Blind (Placebo-Controlled) Period||67||
48615119|NCT02526160|101844831|FG000|NOT COMPLETED|Double-Blind (Placebo-Controlled) Period||0||
48316646|NCT01986920|101101178|FG003|COMPLETED|A-101 32.5%||0||0
48316647|NCT01986920|101101175|FG000|NOT COMPLETED|A-101 32.5%||0||0
48316648|NCT01986920|101101176|FG001|NOT COMPLETED|A-101 32.5%||1||1
48316649|NCT01986920|101101177|FG002|NOT COMPLETED|A-101 32.5%||0||0
48316650|NCT01986920|101101178|FG003|NOT COMPLETED|A-101 32.5%||0||0
48316651|NCT01986920|101101175|FG000|STARTED|A-101 40%||0||0
48316652|NCT01986920|101101176|FG001|STARTED|A-101 40%||0||0
48316653|NCT01986920|101101177|FG002|STARTED|A-101 40%||35||35
48316654|NCT01986920|101101178|FG003|STARTED|A-101 40%||0||0
48316655|NCT01986920|101101175|FG000|COMPLETED|A-101 40%||0||0
48316656|NCT01986920|101101176|FG001|COMPLETED|A-101 40%||0||0
48316657|NCT01986920|101101177|FG002|COMPLETED|A-101 40%||34||34
48316658|NCT01986920|101101178|FG003|COMPLETED|A-101 40%||0||0
48316659|NCT01986920|101101175|FG000|NOT COMPLETED|A-101 40%||0||0
48316660|NCT01986920|101101176|FG001|NOT COMPLETED|A-101 40%||0||0
48316661|NCT01986920|101101177|FG002|NOT COMPLETED|A-101 40%||1||1
48316662|NCT01986920|101101178|FG003|NOT COMPLETED|A-101 40%||0||0
48316663|NCT01986920|101101175|FG000|STARTED|Placebo||0||0
48316664|NCT01986920|101101176|FG001|STARTED|Placebo||0||0
48316665|NCT01986920|101101177|FG002|STARTED|Placebo||0||0
48316666|NCT01986920|101101178|FG003|STARTED|Placebo||35||35
48316667|NCT01986920|101101175|FG000|COMPLETED|Placebo||0||0
48316668|NCT01986920|101101176|FG001|COMPLETED|Placebo||0||0
48316669|NCT01986920|101101177|FG002|COMPLETED|Placebo||0||0
48316670|NCT01986920|101101178|FG003|COMPLETED|Placebo||34||34
48316671|NCT01986920|101101175|FG000|NOT COMPLETED|Placebo||0||0
48316672|NCT01986920|101101176|FG001|NOT COMPLETED|Placebo||0||0
48316673|NCT01986920|101101177|FG002|NOT COMPLETED|Placebo||0||0
48316674|NCT01986920|101101178|FG003|NOT COMPLETED|Placebo||1||1
48316675|NCT04391036|101101179|FG000|STARTED|Overall Study||15||
48615120|NCT02526160|101844832|FG001|NOT COMPLETED|Double-Blind (Placebo-Controlled) Period||1||
48615121|NCT02526160|101844831|FG000|STARTED|Open-label Treatment Continuation Period||66||
48615122|NCT02526160|101844832|FG001|STARTED|Open-label Treatment Continuation Period||67||
48615123|NCT02526160|101844831|FG000|COMPLETED|Open-label Treatment Continuation Period||63||
48656945|NCT03382873|101943730|FG000|COMPLETED|Overall Study||55||
48316676|NCT04391036|101101180|FG001|STARTED|Overall Study||15||
48316677|NCT04391036|101101179|FG000|COMPLETED|Overall Study||15||
48316678|NCT04391036|101101180|FG001|COMPLETED|Overall Study||15||
48316679|NCT04391036|101101179|FG000|NOT COMPLETED|Overall Study||0||
48316680|NCT04391036|101101180|FG001|NOT COMPLETED|Overall Study||0||
48316681|NCT02374099|101101181|FG000|STARTED|Overall Study||48||
48316682|NCT02374099|101101182|FG001|STARTED|Overall Study||49||
48316683|NCT02374099|101101181|FG000|Participants Treated|Overall Study||46||
48316684|NCT02374099|101101182|FG001|Participants Treated|Overall Study||48||
48316685|NCT02374099|101101181|FG000|COMPLETED|Overall Study||0||
48316686|NCT02374099|101101182|FG001|COMPLETED|Overall Study||0||
48316687|NCT02374099|101101181|FG000|NOT COMPLETED|Overall Study||48||
48316688|NCT02374099|101101182|FG001|NOT COMPLETED|Overall Study||49||
48316689|NCT01066585|101101183|FG000|STARTED|Overall Study||211||
48316690|NCT01066585|101101184|FG001|STARTED|Overall Study||199||
48316691|NCT01066585|101101183|FG000|COMPLETED|Overall Study||210||
48316692|NCT01066585|101101184|FG001|COMPLETED|Overall Study||196||
48316693|NCT01066585|101101183|FG000|NOT COMPLETED|Overall Study||1||
48316694|NCT01066585|101101184|FG001|NOT COMPLETED|Overall Study||3||
48316695|NCT00625989|101101185|FG000|STARTED|Overall Study||6||
48316696|NCT00625989|101101186|FG001|STARTED|Overall Study||6||
48316697|NCT00625989|101101185|FG000|COMPLETED|Overall Study||6||
48316698|NCT00625989|101101186|FG001|COMPLETED|Overall Study||6||
48316699|NCT00625989|101101185|FG000|NOT COMPLETED|Overall Study||0||
48316700|NCT00625989|101101186|FG001|NOT COMPLETED|Overall Study||0||
48316701|NCT00258011|101101187|FG000|STARTED|Overall Study||3||
48316702|NCT00258011|101101187|FG000|COMPLETED|Overall Study||3||
48316703|NCT00258011|101101187|FG000|NOT COMPLETED|Overall Study||0||
48316704|NCT03829657|101101188|FG000|STARTED|OL Treatment Period (Week 1 to Week 16)||85||
48316705|NCT03829657|101101189|FG001|STARTED|OL Treatment Period (Week 1 to Week 16)||85||
48316706|NCT03829657|101101190|FG002|STARTED|OL Treatment Period (Week 1 to Week 16)||33||
48159625|NCT00659490|100715675|FG000|NOT COMPLETED|Overall Study||2||
48316707|NCT03829657|101101191|FG003|STARTED|OL Treatment Period (Week 1 to Week 16)||0||
48316708|NCT03829657|101101192|FG004|STARTED|OL Treatment Period (Week 1 to Week 16)||0||
48316709|NCT03829657|101101188|FG000|COMPLETED|OL Treatment Period (Week 1 to Week 16)||52||
48316710|NCT03829657|101101189|FG001|COMPLETED|OL Treatment Period (Week 1 to Week 16)||64||
48316711|NCT03829657|101101190|FG002|COMPLETED|OL Treatment Period (Week 1 to Week 16)||12||
48316712|NCT03829657|101101191|FG003|COMPLETED|OL Treatment Period (Week 1 to Week 16)||0||
48316713|NCT03829657|101101192|FG004|COMPLETED|OL Treatment Period (Week 1 to Week 16)||0||
48316714|NCT03829657|101101188|FG000|NOT COMPLETED|OL Treatment Period (Week 1 to Week 16)||33||
48316715|NCT03829657|101101189|FG001|NOT COMPLETED|OL Treatment Period (Week 1 to Week 16)||21||
48316716|NCT03829657|101101190|FG002|NOT COMPLETED|OL Treatment Period (Week 1 to Week 16)||21||
48316717|NCT03829657|101101191|FG003|NOT COMPLETED|OL Treatment Period (Week 1 to Week 16)||0||
48316718|NCT03829657|101101192|FG004|NOT COMPLETED|OL Treatment Period (Week 1 to Week 16)||0||
48316719|NCT03829657|101101188|FG000|STARTED|RW Treatment Period (Week 16 to Week 24)||0||
48316720|NCT03829657|101101189|FG001|STARTED|RW Treatment Period (Week 16 to Week 24)||0||
48316721|NCT03829657|101101190|FG002|STARTED|RW Treatment Period (Week 16 to Week 24)||0||
48316722|NCT03829657|101101191|FG003|STARTED|RW Treatment Period (Week 16 to Week 24)||64||
48316723|NCT03829657|101101192|FG004|STARTED|RW Treatment Period (Week 16 to Week 24)||64||
48316724|NCT03829657|101101188|FG000|COMPLETED|RW Treatment Period (Week 16 to Week 24)||0||
48316725|NCT03829657|101101189|FG001|COMPLETED|RW Treatment Period (Week 16 to Week 24)||0||
48316726|NCT03829657|101101190|FG002|COMPLETED|RW Treatment Period (Week 16 to Week 24)||0||
48159626|NCT00659490|100715676|FG001|NOT COMPLETED|Overall Study||0||
48159627|NCT00659490|100715677|FG002|NOT COMPLETED|Overall Study||1||
48159628|NCT03909178|100715678|FG000|STARTED|Overall Study||57||
48159629|NCT03909178|100715679|FG001|STARTED|Overall Study||53||
48159630|NCT03909178|100715678|FG000|COMPLETED|Overall Study||54||
48159631|NCT03909178|100715679|FG001|COMPLETED|Overall Study||49||
48159632|NCT03909178|100715678|FG000|NOT COMPLETED|Overall Study||3||
48159633|NCT03909178|100715679|FG001|NOT COMPLETED|Overall Study||4||
48159634|NCT00746096|100715680|FG000|STARTED|Overall Study||58||
48159635|NCT00746096|100715681|FG001|STARTED|Overall Study||57||
48159636|NCT00746096|100715680|FG000|COMPLETED|Overall Study||48||
48159637|NCT00746096|100715681|FG001|COMPLETED|Overall Study||54||
48316727|NCT03829657|101101191|FG003|COMPLETED|RW Treatment Period (Week 16 to Week 24)||61||
48316728|NCT03829657|101101192|FG004|COMPLETED|RW Treatment Period (Week 16 to Week 24)||58||
48316729|NCT03829657|101101188|FG000|NOT COMPLETED|RW Treatment Period (Week 16 to Week 24)||0||
48316730|NCT03829657|101101189|FG001|NOT COMPLETED|RW Treatment Period (Week 16 to Week 24)||0||
48316731|NCT03829657|101101190|FG002|NOT COMPLETED|RW Treatment Period (Week 16 to Week 24)||0||
48316732|NCT03829657|101101191|FG003|NOT COMPLETED|RW Treatment Period (Week 16 to Week 24)||3||
48316733|NCT03829657|101101192|FG004|NOT COMPLETED|RW Treatment Period (Week 16 to Week 24)||6||
48316734|NCT04338009|101101193|FG000|STARTED|Overall Study||77||
48316735|NCT04338009|101101194|FG001|STARTED|Overall Study||75||
48316736|NCT04338009|101101193|FG000|COMPLETED|Overall Study||77||
48316737|NCT04338009|101101194|FG001|COMPLETED|Overall Study||75||
48316738|NCT04338009|101101193|FG000|NOT COMPLETED|Overall Study||0||
48316739|NCT04338009|101101194|FG001|NOT COMPLETED|Overall Study||0||
48316740|NCT02187172|101101195|FG000|STARTED|Overall Study||22||
48316741|NCT02187172|101101196|FG001|STARTED|Overall Study||21||
48316742|NCT02187172|101101195|FG000|RCT Phase Completed|Overall Study||22|Week 12 for both arms|
48316743|NCT02187172|101101196|FG001|RCT Phase Completed|Overall Study||19|Week 12 for both arms|
48316744|NCT02187172|101101195|FG000|COMPLETED|Overall Study||19|Received total of 52 weeks of ustekinumab. Week 52 for Ustekinumab arm, Week 64 for Placebo arm.|
48316745|NCT02187172|101101196|FG001|COMPLETED|Overall Study||15|Received total of 52 weeks of ustekinumab. Week 52 for Ustekinumab arm, Week 64 for Placebo arm.|
48159638|NCT00746096|100715680|FG000|NOT COMPLETED|Overall Study||10||
48159639|NCT00746096|100715681|FG001|NOT COMPLETED|Overall Study||3||
48159640|NCT00847405|100715682|FG000|STARTED|First Intervention||14||
48316746|NCT02187172|101101195|FG000|NOT COMPLETED|Overall Study||3||
48316747|NCT02187172|101101196|FG001|NOT COMPLETED|Overall Study||6||
48316748|NCT01843842|101101197|FG000|STARTED|Overall Study||154||
48316749|NCT01843842|101101198|FG001|STARTED|Overall Study||152||
48316750|NCT01843842|101101197|FG000|COMPLETED|Overall Study||153||
48316751|NCT01843842|101101198|FG001|COMPLETED|Overall Study||151||
48316752|NCT01843842|101101197|FG000|NOT COMPLETED|Overall Study||1||
48316753|NCT01843842|101101198|FG001|NOT COMPLETED|Overall Study||1||
48316754|NCT03357731|101101199|FG000|STARTED|Overall Study||8|started = received Period 1 assigned treatment|
48316755|NCT03357731|101101200|FG001|STARTED|Overall Study||7|started = received Period 1 assigned treatment|
48316756|NCT03357731|101101201|FG002|STARTED|Overall Study||7|started = received Period 1 assigned treatment|
48316757|NCT03357731|101101202|FG003|STARTED|Overall Study||7|started = received Period 1 assigned treatment|
48316758|NCT03357731|101101203|FG004|STARTED|Overall Study||8|started = received Period 1 assigned treatment|
48316759|NCT03357731|101101204|FG005|STARTED|Overall Study||8|started = received Period 1 assigned treatment|
48316760|NCT03357731|101101199|FG000|Completed Period 1 (P1)|Overall Study||8||
48316761|NCT03357731|101101200|FG001|Completed Period 1 (P1)|Overall Study||7||
48316762|NCT03357731|101101201|FG002|Completed Period 1 (P1)|Overall Study||7||
48316763|NCT03357731|101101202|FG003|Completed Period 1 (P1)|Overall Study||6||
48316764|NCT03357731|101101203|FG004|Completed Period 1 (P1)|Overall Study||7||
48316765|NCT03357731|101101204|FG005|Completed Period 1 (P1)|Overall Study||8||
48316766|NCT03357731|101101199|FG000|Completed Period 2 (P2)|Overall Study||8||
48316767|NCT03357731|101101200|FG001|Completed Period 2 (P2)|Overall Study||7||
48316768|NCT03357731|101101201|FG002|Completed Period 2 (P2)|Overall Study||7||
48316769|NCT03357731|101101202|FG003|Completed Period 2 (P2)|Overall Study||4||
48316770|NCT03357731|101101203|FG004|Completed Period 2 (P2)|Overall Study||7||
48316771|NCT03357731|101101204|FG005|Completed Period 2 (P2)|Overall Study||7||
48316772|NCT03357731|101101199|FG000|COMPLETED|Overall Study||8|completed = finished Period 3 (P3) assigned treatment|
48316773|NCT03357731|101101200|FG001|COMPLETED|Overall Study||7|completed = finished Period 3 (P3) assigned treatment|
48316774|NCT03357731|101101201|FG002|COMPLETED|Overall Study||6|completed = finished Period 3 (P3) assigned treatment|
48316775|NCT03357731|101101202|FG003|COMPLETED|Overall Study||4|completed = finished Period 3 (P3) assigned treatment|
48316776|NCT03357731|101101203|FG004|COMPLETED|Overall Study||7|completed = finished Period 3 (P3) assigned treatment|
48316777|NCT03357731|101101204|FG005|COMPLETED|Overall Study||7|completed = finished Period 3 (P3) assigned treatment|
48316778|NCT03357731|101101199|FG000|NOT COMPLETED|Overall Study||0||
48316779|NCT03357731|101101200|FG001|NOT COMPLETED|Overall Study||0||
48316780|NCT03357731|101101201|FG002|NOT COMPLETED|Overall Study||1||
48316781|NCT03357731|101101202|FG003|NOT COMPLETED|Overall Study||3||
48316782|NCT03357731|101101203|FG004|NOT COMPLETED|Overall Study||1||
48316783|NCT03357731|101101204|FG005|NOT COMPLETED|Overall Study||1||
48316784|NCT03221751|101101205|FG000|STARTED|Overall Study||1||
48615124|NCT02526160|101844832|FG001|COMPLETED|Open-label Treatment Continuation Period||63||
48615125|NCT02526160|101844831|FG000|NOT COMPLETED|Open-label Treatment Continuation Period||3||
48615126|NCT02526160|101844832|FG001|NOT COMPLETED|Open-label Treatment Continuation Period||4||
48615127|NCT02526160|101844831|FG000|STARTED|Open-Label Treatment Extension Period I||63||
48615128|NCT02526160|101844832|FG001|STARTED|Open-Label Treatment Extension Period I||63||
48615129|NCT02526160|101844831|FG000|COMPLETED|Open-Label Treatment Extension Period I||60||
48615130|NCT02526160|101844832|FG001|COMPLETED|Open-Label Treatment Extension Period I||59||
48615131|NCT02526160|101844831|FG000|NOT COMPLETED|Open-Label Treatment Extension Period I||3||
48615132|NCT02526160|101844832|FG001|NOT COMPLETED|Open-Label Treatment Extension Period I||4||
48615133|NCT02526160|101844831|FG000|STARTED|Open-Label Treatment Extension Period II||52||
48615134|NCT02526160|101844832|FG001|STARTED|Open-Label Treatment Extension Period II||49||
48615135|NCT02526160|101844831|FG000|COMPLETED|Open-Label Treatment Extension Period II||51||
48615136|NCT02526160|101844832|FG001|COMPLETED|Open-Label Treatment Extension Period II||49||
48615137|NCT02526160|101844831|FG000|NOT COMPLETED|Open-Label Treatment Extension Period II||1||
48615138|NCT02526160|101844832|FG001|NOT COMPLETED|Open-Label Treatment Extension Period II||0||
48615139|NCT02465437|101844833|FG000|STARTED|Overall Study||9||
48615140|NCT02465437|101844834|FG001|STARTED|Overall Study||9||
48615141|NCT02465437|101844835|FG002|STARTED|Overall Study||9||
48615142|NCT02465437|101844836|FG003|STARTED|Overall Study||15||
48734239|NCT03775512|102133879|FG001|NOT COMPLETED|Overall Study||17||
48734240|NCT00721188|102133880|FG000|STARTED|Overall Study||11||
48316785|NCT03221751|101101206|FG001|STARTED|Overall Study||1||
48316786|NCT03221751|101101205|FG000|COMPLETED|Overall Study||0||
48316787|NCT03221751|101101206|FG001|COMPLETED|Overall Study||1||
48316788|NCT03221751|101101205|FG000|NOT COMPLETED|Overall Study||1||
48316789|NCT03221751|101101206|FG001|NOT COMPLETED|Overall Study||0||
48316790|NCT01722604|101101207|FG000|STARTED|Overall Study||129||
48316791|NCT01722604|101101208|FG001|STARTED|Overall Study||129||
48316792|NCT01722604|101101207|FG000|COMPLETED|Overall Study||123||
48316793|NCT01722604|101101208|FG001|COMPLETED|Overall Study||120||
48316794|NCT01722604|101101207|FG000|NOT COMPLETED|Overall Study||6||
48316795|NCT01722604|101101208|FG001|NOT COMPLETED|Overall Study||9||
48615143|NCT02465437|101844833|FG000|COMPLETED|Overall Study||8||
48734241|NCT00721188|102133880|FG000|COMPLETED|Overall Study||11||
48316796|NCT00702364|101101209|FG000|STARTED|Overall Study||26||
48316797|NCT00702364|101101210|FG001|STARTED|Overall Study||29||
48316798|NCT00702364|101101209|FG000|COMPLETED|Overall Study||24||
48316799|NCT00702364|101101210|FG001|COMPLETED|Overall Study||25||
48316800|NCT00702364|101101209|FG000|NOT COMPLETED|Overall Study||2||
48316801|NCT00702364|101101210|FG001|NOT COMPLETED|Overall Study||4||
48316802|NCT00652366|101101211|FG000|STARTED|Overall Study||106||
48316803|NCT00652366|101101212|FG001|STARTED|Overall Study||75||
48316804|NCT00652366|101101213|FG002|STARTED|Overall Study||71||
48316805|NCT00652366|101101214|FG003|STARTED|Overall Study||179||
48316806|NCT00652366|101101215|FG004|STARTED|Overall Study||36||
48316807|NCT00652366|101101211|FG000|COMPLETED|Overall Study||0||
48316808|NCT00652366|101101212|FG001|COMPLETED|Overall Study||0||
48316809|NCT00652366|101101213|FG002|COMPLETED|Overall Study||0||
48316810|NCT00652366|101101214|FG003|COMPLETED|Overall Study||0||
48316811|NCT00652366|101101215|FG004|COMPLETED|Overall Study||0||
48316812|NCT00652366|101101211|FG000|NOT COMPLETED|Overall Study||106||
48316813|NCT00652366|101101212|FG001|NOT COMPLETED|Overall Study||75||
48316814|NCT00652366|101101213|FG002|NOT COMPLETED|Overall Study||71||
48316815|NCT00652366|101101214|FG003|NOT COMPLETED|Overall Study||179||
48316816|NCT00652366|101101215|FG004|NOT COMPLETED|Overall Study||36||
48316817|NCT01756040|101101216|FG000|STARTED|IP in Preterm Infants: Cohort 1||44||
48316818|NCT01756040|101101216|FG000|COMPLETED|IP in Preterm Infants: Cohort 1||43||
48316819|NCT01756040|101101216|FG000|NOT COMPLETED|IP in Preterm Infants: Cohort 1||1||
48316820|NCT01756040|101101216|FG000|STARTED|IP in Preterm Infants: Cohort 2||167||
48316821|NCT01756040|101101216|FG000|COMPLETED|IP in Preterm Infants: Cohort 2||158||
48316822|NCT01756040|101101216|FG000|NOT COMPLETED|IP in Preterm Infants: Cohort 2||9||
48316823|NCT01707043|101101217|FG000|STARTED|Overall Study||10||
48316824|NCT01707043|101101218|FG001|STARTED|Overall Study||10||
48316825|NCT01707043|101101217|FG000|COMPLETED|Overall Study||10||
48316826|NCT01707043|101101218|FG001|COMPLETED|Overall Study||10||
48316827|NCT01707043|101101217|FG000|NOT COMPLETED|Overall Study||0||
48316828|NCT01707043|101101218|FG001|NOT COMPLETED|Overall Study||0||
48316829|NCT01224626|101101219|FG000|STARTED|Overall Study||42||
48316830|NCT01224626|101101219|FG000|COMPLETED|Overall Study||41||
48316831|NCT01224626|101101219|FG000|NOT COMPLETED|Overall Study||1||
48316832|NCT02737852|101101220|FG000|STARTED|Overall Study||32||
48316833|NCT02737852|101101220|FG000|COMPLETED|Overall Study||30||
48316834|NCT02737852|101101220|FG000|NOT COMPLETED|Overall Study||2||
48316835|NCT02087956|101101221|FG000|STARTED|Overall Study||111||
48316836|NCT02087956|101101222|FG001|STARTED|Overall Study||112||
48316837|NCT02087956|101101221|FG000|COMPLETED|Overall Study||105||
48316838|NCT02087956|101101222|FG001|COMPLETED|Overall Study||107||
48316839|NCT02087956|101101221|FG000|NOT COMPLETED|Overall Study||6||
48316840|NCT02087956|101101222|FG001|NOT COMPLETED|Overall Study||5||
48316841|NCT00433914|101101223|FG000|STARTED|Overall Study||30||
48316842|NCT00433914|101101224|FG001|STARTED|Overall Study||30||
48316843|NCT00433914|101101223|FG000|COMPLETED|Overall Study||30||
48316844|NCT00433914|101101224|FG001|COMPLETED|Overall Study||27||
48316845|NCT00433914|101101223|FG000|NOT COMPLETED|Overall Study||0||
48316846|NCT00433914|101101224|FG001|NOT COMPLETED|Overall Study||3||
48316847|NCT00891982|101101225|FG000|STARTED|Overall Study||30||
48316848|NCT00891982|101101226|FG001|STARTED|Overall Study||31||
48316849|NCT00891982|101101225|FG000|COMPLETED|Overall Study||28||
48316850|NCT00891982|101101226|FG001|COMPLETED|Overall Study||30||
48316851|NCT00891982|101101225|FG000|NOT COMPLETED|Overall Study||2||
48316852|NCT00891982|101101226|FG001|NOT COMPLETED|Overall Study||1||
48159641|NCT00847405|100715683|FG001|STARTED|First Intervention||14||
48159642|NCT00847405|100715682|FG000|COMPLETED|First Intervention||14||
48159643|NCT00847405|100715683|FG001|COMPLETED|First Intervention||13||
48159644|NCT00847405|100715682|FG000|NOT COMPLETED|First Intervention||0||
48159645|NCT00847405|100715683|FG001|NOT COMPLETED|First Intervention||1||
48159646|NCT00847405|100715682|FG000|STARTED|Washout of 7 Days||14||
48159647|NCT00847405|100715683|FG001|STARTED|Washout of 7 Days||13||
48316853|NCT04329702|101101227|FG000|STARTED|Overall Study||16||
48316854|NCT04329702|101101228|FG001|STARTED|Overall Study||14||
48316855|NCT04329702|101101229|FG002|STARTED|Overall Study||15||
48316856|NCT04329702|101101227|FG000|COMPLETED|Overall Study||13||
48316857|NCT04329702|101101228|FG001|COMPLETED|Overall Study||8||
48316858|NCT04329702|101101229|FG002|COMPLETED|Overall Study||13||
48316859|NCT04329702|101101227|FG000|NOT COMPLETED|Overall Study||3||
48316860|NCT04329702|101101228|FG001|NOT COMPLETED|Overall Study||6||
48316861|NCT04329702|101101229|FG002|NOT COMPLETED|Overall Study||2||
48316862|NCT04172714|101101230|FG000|STARTED|Overall Study||30||
48316863|NCT04172714|101101230|FG000|COMPLETED|Overall Study||30||
48316864|NCT04172714|101101230|FG000|NOT COMPLETED|Overall Study||0||
48316865|NCT01786603|101101231|FG000|STARTED|Overall Study||60||
48316866|NCT01786603|101101232|FG001|STARTED|Overall Study||20||
48316867|NCT01786603|101101231|FG000|COMPLETED|Overall Study||42||
48316868|NCT01786603|101101232|FG001|COMPLETED|Overall Study||8||
48316869|NCT01786603|101101231|FG000|NOT COMPLETED|Overall Study||18||
48316870|NCT01786603|101101232|FG001|NOT COMPLETED|Overall Study||12||
48316871|NCT04143009|101101233|FG000|STARTED|Pre-pilot||5||
48316872|NCT04143009|101101234|FG001|STARTED|Pre-pilot||3||
48316873|NCT04143009|101101235|FG002|STARTED|Pre-pilot||4||
48316874|NCT04143009|101101233|FG000|COMPLETED|Pre-pilot||5||
48316875|NCT04143009|101101234|FG001|COMPLETED|Pre-pilot||3||
48316876|NCT04143009|101101235|FG002|COMPLETED|Pre-pilot||4||
48316877|NCT04143009|101101233|FG000|NOT COMPLETED|Pre-pilot||0||
48316878|NCT04143009|101101234|FG001|NOT COMPLETED|Pre-pilot||0||
48316879|NCT04143009|101101235|FG002|NOT COMPLETED|Pre-pilot||0||
48316880|NCT04143009|101101233|FG000|STARTED|Pilot Trial||0||
48316881|NCT04143009|101101234|FG001|STARTED|Pilot Trial||40||
48316882|NCT04143009|101101235|FG002|STARTED|Pilot Trial||40||
48316883|NCT04143009|101101233|FG000|COMPLETED|Pilot Trial||0||
48316884|NCT04143009|101101234|FG001|COMPLETED|Pilot Trial||39||
48316885|NCT04143009|101101235|FG002|COMPLETED|Pilot Trial||39||
48316886|NCT04143009|101101233|FG000|NOT COMPLETED|Pilot Trial||0||
48316887|NCT04143009|101101234|FG001|NOT COMPLETED|Pilot Trial||1||
48316888|NCT04143009|101101235|FG002|NOT COMPLETED|Pilot Trial||1||
48316889|NCT01977599|101101236|FG000|STARTED|Overall Study||1118||
48316890|NCT01977599|101101237|FG001|STARTED|Overall Study||1122||
48316891|NCT01977599|101101236|FG000|COMPLETED|Overall Study||1118||
48316892|NCT01977599|101101237|FG001|COMPLETED|Overall Study||1122||
48316893|NCT01977599|101101236|FG000|NOT COMPLETED|Overall Study||0||
48316894|NCT01977599|101101237|FG001|NOT COMPLETED|Overall Study||0||
48316895|NCT02833922|101101238|FG000|STARTED|Overall Study||718||
48615144|NCT02465437|101844834|FG001|COMPLETED|Overall Study||8||
48615145|NCT02465437|101844835|FG002|COMPLETED|Overall Study||8||
48615146|NCT02465437|101844836|FG003|COMPLETED|Overall Study||14||
48615147|NCT02465437|101844833|FG000|NOT COMPLETED|Overall Study||1||
48615148|NCT02465437|101844834|FG001|NOT COMPLETED|Overall Study||1||
48615149|NCT02465437|101844835|FG002|NOT COMPLETED|Overall Study||1||
48615150|NCT02465437|101844836|FG003|NOT COMPLETED|Overall Study||1||
48615151|NCT03113968|101844837|FG000|STARTED|Overall Study||203||
48615152|NCT03113968|101844838|FG001|STARTED|Overall Study||200||
48615153|NCT03113968|101844837|FG000|COMPLETED|Overall Study||172||
48615154|NCT03113968|101844838|FG001|COMPLETED|Overall Study||196||
48615155|NCT03113968|101844837|FG000|NOT COMPLETED|Overall Study||31||
48615156|NCT03113968|101844838|FG001|NOT COMPLETED|Overall Study||4||
48316896|NCT02833922|101101238|FG000|COMPLETED|Overall Study||336||
48316897|NCT02833922|101101238|FG000|NOT COMPLETED|Overall Study||382||
48316898|NCT02904915|101101239|FG000|STARTED|Overall Study||25||
48316899|NCT02904915|101101240|FG001|STARTED|Overall Study||25||
48316900|NCT02904915|101101239|FG000|COMPLETED|Overall Study||25||
48316901|NCT02904915|101101240|FG001|COMPLETED|Overall Study||25||
48316902|NCT02904915|101101239|FG000|NOT COMPLETED|Overall Study||0||
48316903|NCT02904915|101101240|FG001|NOT COMPLETED|Overall Study||0||
48316904|NCT02004262|101101241|FG000|STARTED|Overall Study||73||
48316905|NCT02004262|101101242|FG001|STARTED|Overall Study||68||
48316906|NCT02004262|101101243|FG002|STARTED|Overall Study||72||
48316907|NCT02004262|101101244|FG003|STARTED|Overall Study||29||
48316908|NCT02004262|101101245|FG004|STARTED|Overall Study||31||
48316909|NCT02004262|101101246|FG005|STARTED|Overall Study||30||
48316910|NCT02004262|101101241|FG000|Treated|Overall Study||68||
48316911|NCT02004262|101101242|FG001|Treated|Overall Study||58||
48316912|NCT02004262|101101243|FG002|Treated|Overall Study||43||
48316913|NCT02004262|101101244|FG003|Treated|Overall Study||26||
48316914|NCT02004262|101101245|FG004|Treated|Overall Study||29||
48316915|NCT02004262|101101246|FG005|Treated|Overall Study||11||
48316916|NCT02004262|101101241|FG000|COMPLETED|Overall Study||0|No predetermined study completion date or study completion event specified in protocol.|
48316917|NCT02004262|101101242|FG001|COMPLETED|Overall Study||0|No predetermined study completion date or study completion event specified in protocol.|
48316918|NCT02004262|101101243|FG002|COMPLETED|Overall Study||0|No predetermined study completion date or study completion event specified in protocol.|
48316919|NCT02004262|101101244|FG003|COMPLETED|Overall Study||0|No predetermined study completion date or study completion event specified in protocol.|
48316920|NCT02004262|101101245|FG004|COMPLETED|Overall Study||0|No predetermined study completion date or study completion event specified in protocol.|
48316921|NCT02004262|101101246|FG005|COMPLETED|Overall Study||0|No predetermined study completion date or study completion event specified in protocol.|
48316922|NCT02004262|101101241|FG000|NOT COMPLETED|Overall Study||73||
48316923|NCT02004262|101101242|FG001|NOT COMPLETED|Overall Study||68||
48615157|NCT00943397|101844839|FG000|STARTED|Overall Study||32||
48316924|NCT02004262|101101243|FG002|NOT COMPLETED|Overall Study||72||
48316925|NCT02004262|101101244|FG003|NOT COMPLETED|Overall Study||29||
48316926|NCT02004262|101101245|FG004|NOT COMPLETED|Overall Study||31||
48316927|NCT02004262|101101246|FG005|NOT COMPLETED|Overall Study||30||
48316928|NCT05074251|101101247|FG000|STARTED|Overall Study||86||
48316929|NCT05074251|101101248|FG001|STARTED|Overall Study||94||
48316930|NCT05074251|101101247|FG000|COMPLETED|Overall Study||85||
48316931|NCT05074251|101101248|FG001|COMPLETED|Overall Study||91||
48316932|NCT05074251|101101247|FG000|NOT COMPLETED|Overall Study||1||
48316933|NCT05074251|101101248|FG001|NOT COMPLETED|Overall Study||3||
48316934|NCT00788372|101101249|FG000|STARTED|Period 1 (up to 4 Weeks)||142||
48316935|NCT00788372|101101249|FG000|COMPLETED|Period 1 (up to 4 Weeks)||111||
48316936|NCT00788372|101101249|FG000|NOT COMPLETED|Period 1 (up to 4 Weeks)||31||
48316937|NCT00788372|101101249|FG000|STARTED|Period 2 (Week 4 to Week 52)||111||
48615158|NCT00943397|101844840|FG001|STARTED|Overall Study||158||
48615159|NCT00943397|101844839|FG000|COMPLETED|Overall Study||17||
48615160|NCT00943397|101844840|FG001|COMPLETED|Overall Study||86||
48615161|NCT00943397|101844839|FG000|NOT COMPLETED|Overall Study||15||
48615162|NCT00943397|101844840|FG001|NOT COMPLETED|Overall Study||72||
48615163|NCT00438204|101844841|FG000|STARTED|Overall Study||39||
48615164|NCT00438204|101844841|FG000|COMPLETED|Overall Study||39||
48615165|NCT00438204|101844841|FG000|NOT COMPLETED|Overall Study||0||
48615166|NCT03574974|101844842|FG000|STARTED|Overall Study||15||
48615167|NCT03574974|101844843|FG001|STARTED|Overall Study||12||
48615168|NCT03574974|101844842|FG000|COMPLETED|Overall Study||14||
48615169|NCT03574974|101844843|FG001|COMPLETED|Overall Study||11||
48615170|NCT03574974|101844842|FG000|NOT COMPLETED|Overall Study||1||
48615171|NCT03574974|101844843|FG001|NOT COMPLETED|Overall Study||1||
48615172|NCT03586050|101844844|FG000|STARTED|Overall Study||33||
48615173|NCT03586050|101844844|FG000|Full Analysis Set (FAS)|Overall Study||30||
48615174|NCT03586050|101844844|FG000|COMPLETED|Overall Study||28||
48615175|NCT03586050|101844844|FG000|NOT COMPLETED|Overall Study||5||
48316938|NCT00788372|101101249|FG000|COMPLETED|Period 2 (Week 4 to Week 52)||79||
48316939|NCT00788372|101101249|FG000|NOT COMPLETED|Period 2 (Week 4 to Week 52)||32||
48316940|NCT00432042|101101250|FG000|STARTED|Overall Study||479||
48316941|NCT00432042|101101251|FG001|STARTED|Overall Study||235||
48316942|NCT00432042|101101252|FG002|STARTED|Overall Study||241||
48316943|NCT00432042|101101250|FG000|Vaccinated|Overall Study||477||
48316944|NCT00432042|101101251|FG001|Vaccinated|Overall Study||235||
48316945|NCT00432042|101101252|FG002|Vaccinated|Overall Study||240||
48316946|NCT00432042|101101250|FG000|COMPLETED|Overall Study||472||
48316947|NCT00432042|101101251|FG001|COMPLETED|Overall Study||234||
48316948|NCT00432042|101101252|FG002|COMPLETED|Overall Study||239||
48615176|NCT02600923|101844845|FG000|STARTED|Overall Study||131||
48615177|NCT02600923|101844845|FG000|Treated|Overall Study||130||
48615178|NCT02600923|101844845|FG000|COMPLETED|Overall Study||0||
48615179|NCT02600923|101844845|FG000|NOT COMPLETED|Overall Study||131||
48615180|NCT03335813|101844846|FG000|STARTED|Overall Study||7||
48615181|NCT03335813|101844846|FG000|COMPLETED|Overall Study||6||
48615182|NCT03335813|101844846|FG000|NOT COMPLETED|Overall Study||1||
48615183|NCT00028262|101844847|FG000|STARTED|Overall Study||10||
48615184|NCT00028262|101844847|FG000|COMPLETED|Overall Study||9||
48615185|NCT00028262|101844847|FG000|NOT COMPLETED|Overall Study||1||
48615186|NCT01001520|101844848|FG000|STARTED|Medication Period 1||22||
48615187|NCT01001520|101844849|FG001|STARTED|Medication Period 1||24||
48615188|NCT01001520|101844848|FG000|COMPLETED|Medication Period 1||18||
48615189|NCT01001520|101844849|FG001|COMPLETED|Medication Period 1||17||
48615190|NCT01001520|101844848|FG000|NOT COMPLETED|Medication Period 1||4||
48615191|NCT01001520|101844849|FG001|NOT COMPLETED|Medication Period 1||7||
48615192|NCT01001520|101844848|FG000|STARTED|Washout Period||18||
48615193|NCT01001520|101844849|FG001|STARTED|Washout Period||17||
48615194|NCT01001520|101844848|FG000|COMPLETED|Washout Period||16||
48615195|NCT01001520|101844849|FG001|COMPLETED|Washout Period||16||
48615196|NCT01001520|101844848|FG000|NOT COMPLETED|Washout Period||2||
48615197|NCT01001520|101844849|FG001|NOT COMPLETED|Washout Period||1||
48316949|NCT00432042|101101250|FG000|NOT COMPLETED|Overall Study||7||
48316950|NCT00432042|101101251|FG001|NOT COMPLETED|Overall Study||1||
48316951|NCT00432042|101101252|FG002|NOT COMPLETED|Overall Study||2||
48316952|NCT03127384|101101253|FG000|STARTED|Overall Study||49||
48316953|NCT03127384|101101253|FG000|Completed 3 Month Visit|Overall Study||47||
48316954|NCT03127384|101101253|FG000|COMPLETED|Overall Study||43||
48316955|NCT03127384|101101253|FG000|NOT COMPLETED|Overall Study||6||
48316956|NCT01422915|101101254|FG000|STARTED|Overall Study||4||
48316957|NCT01422915|101101254|FG000|COMPLETED|Overall Study||3||
48316958|NCT01422915|101101254|FG000|NOT COMPLETED|Overall Study||1||
48316959|NCT01355484|101101255|FG000|STARTED|Overall Study||160||
48316960|NCT01355484|101101256|FG001|STARTED|Overall Study||161||
48615198|NCT01001520|101844848|FG000|STARTED|Medication Period 2||16||
48615199|NCT01001520|101844849|FG001|STARTED|Medication Period 2||16||
48615200|NCT01001520|101844848|FG000|COMPLETED|Medication Period 2||16||
48615201|NCT01001520|101844849|FG001|COMPLETED|Medication Period 2||13||
48316961|NCT01355484|101101255|FG000|COMPLETED|Overall Study||109||
48316962|NCT01355484|101101256|FG001|COMPLETED|Overall Study||107||
48316963|NCT01355484|101101255|FG000|NOT COMPLETED|Overall Study||51||
48316964|NCT01355484|101101256|FG001|NOT COMPLETED|Overall Study||54||
48316965|NCT00550680|101101257|FG000|STARTED|Overall Study||208||
48316966|NCT00550680|101101257|FG000|COMPLETED|Overall Study||152||
48316967|NCT00550680|101101257|FG000|NOT COMPLETED|Overall Study||56||
48316968|NCT03861936|101101258|FG000|STARTED|Overall Study||48||
48316969|NCT03861936|101101259|FG001|STARTED|Overall Study||53||
48615202|NCT01001520|101844848|FG000|NOT COMPLETED|Medication Period 2||0||
48615203|NCT01001520|101844849|FG001|NOT COMPLETED|Medication Period 2||3||
48734242|NCT00721188|102133880|FG000|NOT COMPLETED|Overall Study||0||
48615204|NCT01307891|101844850|FG000|STARTED|Overall Study||42||
48615205|NCT01307891|101844851|FG001|STARTED|Overall Study||22||
48734243|NCT00766051|102133881|FG000|STARTED|Overall Study||12||
48316970|NCT03861936|101101260|FG002|STARTED|Overall Study||49||
48316971|NCT03861936|101101258|FG000|COMPLETED|Overall Study||34||
48615206|NCT01307891|101844850|FG000|COMPLETED|Overall Study||39||
48615207|NCT01307891|101844851|FG001|COMPLETED|Overall Study||21||
48615208|NCT01307891|101844850|FG000|NOT COMPLETED|Overall Study||3||
48615209|NCT01307891|101844851|FG001|NOT COMPLETED|Overall Study||1||
48615210|NCT02111174|101844852|FG000|STARTED|Treatment and Primary Outcome||18||
48615211|NCT02111174|101844853|FG001|STARTED|Treatment and Primary Outcome||18||
48615212|NCT02111174|101844852|FG000|COMPLETED|Treatment and Primary Outcome||15||
48615213|NCT02111174|101844853|FG001|COMPLETED|Treatment and Primary Outcome||16||
48615214|NCT02111174|101844852|FG000|NOT COMPLETED|Treatment and Primary Outcome||3||
48615215|NCT02111174|101844853|FG001|NOT COMPLETED|Treatment and Primary Outcome||2||
48615216|NCT02111174|101844852|FG000|STARTED|Secondary Outcomes (2 and 3 Month f/u)||15||
48615217|NCT02111174|101844853|FG001|STARTED|Secondary Outcomes (2 and 3 Month f/u)||16||
48615218|NCT02111174|101844852|FG000|2 Month Follow up Complete|Secondary Outcomes (2 and 3 Month f/u)||8||
48615219|NCT02111174|101844853|FG001|2 Month Follow up Complete|Secondary Outcomes (2 and 3 Month f/u)||11||
48615220|NCT02111174|101844852|FG000|COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||7||
48615221|NCT02111174|101844853|FG001|COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||9||
48615222|NCT02111174|101844852|FG000|NOT COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||8||
48615223|NCT02111174|101844853|FG001|NOT COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||7||
48615224|NCT01869777|101844854|FG000|STARTED|Overall Study||102||
48615225|NCT01869777|101844854|FG000|COMPLETED|Overall Study||101||
48615226|NCT01869777|101844854|FG000|NOT COMPLETED|Overall Study||1||
48615227|NCT01302418|101844855|FG000|STARTED|Overall Study||272||
48615228|NCT01302418|101844855|FG000|COMPLETED|Overall Study||254||
48615229|NCT01302418|101844855|FG000|NOT COMPLETED|Overall Study||18||
48615230|NCT01733121|101844856|FG000|STARTED|Double-Blind Period (Week 0 to 6)||51||
48615231|NCT01733121|101844857|FG001|STARTED|Double-Blind Period (Week 0 to 6)||51||
48615232|NCT01733121|101844856|FG000|COMPLETED|Double-Blind Period (Week 0 to 6)||44||
48615233|NCT01733121|101844857|FG001|COMPLETED|Double-Blind Period (Week 0 to 6)||46||
48615234|NCT01733121|101844856|FG000|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7||
48615235|NCT01733121|101844857|FG001|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||5||
48615236|NCT01733121|101844856|FG000|STARTED|Follow-Up Period (Week 6 to 8)||44||
48615237|NCT01733121|101844857|FG001|STARTED|Follow-Up Period (Week 6 to 8)||46||
48615238|NCT01733121|101844856|FG000|COMPLETED|Follow-Up Period (Week 6 to 8)||44||
48615239|NCT01733121|101844857|FG001|COMPLETED|Follow-Up Period (Week 6 to 8)||46||
48615240|NCT01733121|101844856|FG000|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0||
48615241|NCT01733121|101844857|FG001|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0||
48615242|NCT00333710|101844858|FG000|STARTED|Overall Study||19||
48615243|NCT00333710|101844859|FG001|STARTED|Overall Study||18||
48615244|NCT00333710|101844860|FG002|STARTED|Overall Study||16||
48615245|NCT00333710|101844858|FG000|COMPLETED|Overall Study||8||
48615246|NCT00333710|101844859|FG001|COMPLETED|Overall Study||14||
48615247|NCT00333710|101844860|FG002|COMPLETED|Overall Study||15||
48615248|NCT00333710|101844858|FG000|NOT COMPLETED|Overall Study||11||
48615249|NCT00333710|101844859|FG001|NOT COMPLETED|Overall Study||4||
48615250|NCT00333710|101844860|FG002|NOT COMPLETED|Overall Study||1||
48615251|NCT01247350|101844861|FG000|STARTED|Overall Study||6||
48615252|NCT01247350|101844862|FG001|STARTED|Overall Study||6||
48615253|NCT01247350|101844863|FG002|STARTED|Overall Study||6||
48615254|NCT01247350|101844864|FG003|STARTED|Overall Study||7||
48615255|NCT01247350|101844865|FG004|STARTED|Overall Study||9||
48615256|NCT01247350|101844861|FG000|Received Multiple Doses of Study Drug|Overall Study||0||
48615257|NCT01247350|101844862|FG001|Received Multiple Doses of Study Drug|Overall Study||0||
48615258|NCT01247350|101844863|FG002|Received Multiple Doses of Study Drug|Overall Study||6||
48615259|NCT01247350|101844864|FG003|Received Multiple Doses of Study Drug|Overall Study||6||
48615260|NCT01247350|101844865|FG004|Received Multiple Doses of Study Drug|Overall Study||5||
48615261|NCT01247350|101844861|FG000|COMPLETED|Overall Study||6||
48615262|NCT01247350|101844862|FG001|COMPLETED|Overall Study||6||
48615263|NCT01247350|101844863|FG002|COMPLETED|Overall Study||5||
48615264|NCT01247350|101844864|FG003|COMPLETED|Overall Study||6||
48615265|NCT01247350|101844865|FG004|COMPLETED|Overall Study||8||
48615266|NCT01247350|101844861|FG000|NOT COMPLETED|Overall Study||0||
48615267|NCT01247350|101844862|FG001|NOT COMPLETED|Overall Study||0||
48615268|NCT01247350|101844863|FG002|NOT COMPLETED|Overall Study||1||
48615269|NCT01247350|101844864|FG003|NOT COMPLETED|Overall Study||1||
48615270|NCT01247350|101844865|FG004|NOT COMPLETED|Overall Study||1||
48615271|NCT02014519|101844866|FG000|STARTED|Overall Study||2000||
48615272|NCT02014519|101844866|FG000|COMPLETED|Overall Study||2000||
48615273|NCT02014519|101844866|FG000|NOT COMPLETED|Overall Study||0||
48615274|NCT03045653|101844867|FG000|STARTED|Overall Study||30||
48615275|NCT03045653|101844867|FG000|COMPLETED|Overall Study||30||
48615276|NCT03045653|101844867|FG000|NOT COMPLETED|Overall Study||0||
48615277|NCT00753675|101844868|FG000|STARTED|Overall Study||59||
48615278|NCT00753675|101844869|FG001|STARTED|Overall Study||59||
48615279|NCT00753675|101844870|FG002|STARTED|Overall Study||56||
48615280|NCT00753675|101844868|FG000|COMPLETED|Overall Study||0||
48615281|NCT00753675|101844869|FG001|COMPLETED|Overall Study||0||
48615282|NCT00753675|101844870|FG002|COMPLETED|Overall Study||0||
48615283|NCT00753675|101844868|FG000|NOT COMPLETED|Overall Study||59||
48615284|NCT00753675|101844869|FG001|NOT COMPLETED|Overall Study||59||
48615285|NCT00753675|101844870|FG002|NOT COMPLETED|Overall Study||56||
48615286|NCT01575756|101844871|FG000|STARTED|Treatment Period 1||11||
48615287|NCT01575756|101844872|FG001|STARTED|Treatment Period 1||11||
48615288|NCT01575756|101844871|FG000|COMPLETED|Treatment Period 1||11||
48615289|NCT01575756|101844872|FG001|COMPLETED|Treatment Period 1||11||
48615290|NCT01575756|101844871|FG000|NOT COMPLETED|Treatment Period 1||0||
48615291|NCT01575756|101844872|FG001|NOT COMPLETED|Treatment Period 1||0||
48615292|NCT01575756|101844871|FG000|STARTED|Treatment Period 2||11||
48615293|NCT01575756|101844872|FG001|STARTED|Treatment Period 2||11||
48615294|NCT01575756|101844871|FG000|COMPLETED|Treatment Period 2||11||
48615295|NCT01575756|101844872|FG001|COMPLETED|Treatment Period 2||11||
48615296|NCT01575756|101844871|FG000|NOT COMPLETED|Treatment Period 2||0||
48615297|NCT01575756|101844872|FG001|NOT COMPLETED|Treatment Period 2||0||
48615298|NCT00943592|101844873|FG000|STARTED|Overall Study||82||
48615299|NCT00943592|101844873|FG000|Maximum Tolerated Dose|Overall Study||74||
48615300|NCT00943592|101844873|FG000|COMPLETED|Overall Study||79||
48615301|NCT00943592|101844873|FG000|NOT COMPLETED|Overall Study||3||
48615302|NCT02007720|101844874|FG000|STARTED|Overall Study||436|876 participants were randomized|
48615303|NCT02007720|101844875|FG001|STARTED|Overall Study||440|876 participants were randomized|
48615304|NCT02007720|101844874|FG000|Full Analysis Set|Overall Study||433|6 patients were misrandomized and excluded from the fuoll analysis set|
48615305|NCT02007720|101844875|FG001|Full Analysis Set|Overall Study||437|6 patients were misrandomized and excluded from the fuoll analysis set|
48615306|NCT02007720|101844874|FG000|Safety Set|Overall Study||426|among these 858 had a least one dose of study drug and at least one post baseline assessment|
48615307|NCT02007720|101844875|FG001|Safety Set|Overall Study||432|among these 858 had a least one dose of study drug and at least one post baseline assessment|
48615308|NCT02007720|101844874|FG000|COMPLETED|Overall Study||354|Phase completion is defined as death or actual follow up greater or equal to Day 165|
48615309|NCT02007720|101844875|FG001|COMPLETED|Overall Study||368|Phase completion is defined as death or actual follow up greater or equal to Day 165|
48615310|NCT02007720|101844874|FG000|NOT COMPLETED|Overall Study||82||
48615311|NCT02007720|101844875|FG001|NOT COMPLETED|Overall Study||72||
48615312|NCT04406714|101844876|FG000|STARTED|Overall Study||2001||
48615313|NCT04406714|101844877|FG001|STARTED|Overall Study||2001||
48615314|NCT04406714|101844878|FG002|STARTED|Overall Study||158||
48615315|NCT04406714|101844879|FG003|STARTED|Overall Study||158||
48615316|NCT04406714|101844876|FG000|COMPLETED|Overall Study||2001||
48615317|NCT04406714|101844877|FG001|COMPLETED|Overall Study||2001||
48316972|NCT03861936|101101259|FG001|COMPLETED|Overall Study||43||
48316973|NCT03861936|101101260|FG002|COMPLETED|Overall Study||39||
48316974|NCT03861936|101101258|FG000|NOT COMPLETED|Overall Study||14||
48316975|NCT03861936|101101259|FG001|NOT COMPLETED|Overall Study||10||
48316976|NCT03861936|101101260|FG002|NOT COMPLETED|Overall Study||10||
48615318|NCT04406714|101844878|FG002|COMPLETED|Overall Study||158||
48615319|NCT04406714|101844879|FG003|COMPLETED|Overall Study||158||
48615320|NCT04406714|101844876|FG000|NOT COMPLETED|Overall Study||0||
48615321|NCT04406714|101844877|FG001|NOT COMPLETED|Overall Study||0||
48615322|NCT04406714|101844878|FG002|NOT COMPLETED|Overall Study||0||
48615323|NCT04406714|101844879|FG003|NOT COMPLETED|Overall Study||0||
48615324|NCT00500578|101844880|FG000|STARTED|Overall Study||18||
48615325|NCT00500578|101844881|FG001|STARTED|Overall Study||32||
48615326|NCT00500578|101844880|FG000|COMPLETED|Overall Study||18||
48615327|NCT00500578|101844881|FG001|COMPLETED|Overall Study||32||
48615328|NCT00500578|101844880|FG000|NOT COMPLETED|Overall Study||0||
48615329|NCT00500578|101844881|FG001|NOT COMPLETED|Overall Study||0||
48615330|NCT04530838|101844882|FG000|STARTED|Overall Study||225||
48615331|NCT04530838|101844883|FG001|STARTED|Overall Study||224||
48615332|NCT04530838|101844884|FG002|STARTED|Overall Study||217||
48615333|NCT04530838|101844882|FG000|COMPLETED|Overall Study||217||
48615334|NCT04530838|101844883|FG001|COMPLETED|Overall Study||220||
48615335|NCT04530838|101844884|FG002|COMPLETED|Overall Study||211||
48615336|NCT04530838|101844882|FG000|NOT COMPLETED|Overall Study||8||
48615337|NCT04530838|101844883|FG001|NOT COMPLETED|Overall Study||4||
48615338|NCT04530838|101844884|FG002|NOT COMPLETED|Overall Study||6||
48316977|NCT01449461|101101261|FG000|STARTED|Overall Study||6||
48316978|NCT01449461|101101262|FG001|STARTED|Overall Study||18||
48316979|NCT01449461|101101263|FG002|STARTED|Overall Study||18||
48316980|NCT01449461|101101264|FG003|STARTED|Overall Study||32||
48316981|NCT01449461|101101265|FG004|STARTED|Overall Study||48||
48316982|NCT01449461|101101266|FG005|STARTED|Overall Study||15||
48316983|NCT01449461|101101261|FG000|COMPLETED|Overall Study||0||
48316984|NCT01449461|101101262|FG001|COMPLETED|Overall Study||0||
48316985|NCT01449461|101101263|FG002|COMPLETED|Overall Study||0||
48316986|NCT01449461|101101264|FG003|COMPLETED|Overall Study||0||
48316987|NCT01449461|101101265|FG004|COMPLETED|Overall Study||0||
48316988|NCT01449461|101101266|FG005|COMPLETED|Overall Study||0||
48316989|NCT01449461|101101261|FG000|NOT COMPLETED|Overall Study||6||
48316990|NCT01449461|101101262|FG001|NOT COMPLETED|Overall Study||18||
48316991|NCT01449461|101101263|FG002|NOT COMPLETED|Overall Study||18||
48316992|NCT01449461|101101264|FG003|NOT COMPLETED|Overall Study||32||
48316993|NCT01449461|101101265|FG004|NOT COMPLETED|Overall Study||48||
48316994|NCT01449461|101101266|FG005|NOT COMPLETED|Overall Study||15||
48316995|NCT00139776|101101267|FG000|STARTED|Period I||1772||
48316996|NCT00139776|101101268|FG001|STARTED|Period I||0||
48316997|NCT00139776|101101269|FG002|STARTED|Period I||0||
48316998|NCT00139776|101101270|FG003|STARTED|Period I||0||
48316999|NCT00139776|101101267|FG000|COMPLETED|Period I||1197||
48317000|NCT00139776|101101268|FG001|COMPLETED|Period I||0||
48317001|NCT00139776|101101269|FG002|COMPLETED|Period I||0||
48317002|NCT00139776|101101270|FG003|COMPLETED|Period I||0||
48317003|NCT00139776|101101267|FG000|NOT COMPLETED|Period I||575||
48317004|NCT00139776|101101268|FG001|NOT COMPLETED|Period I||0||
48317005|NCT00139776|101101269|FG002|NOT COMPLETED|Period I||0||
48317006|NCT00139776|101101270|FG003|NOT COMPLETED|Period I||0||
48317007|NCT00139776|101101267|FG000|STARTED|Period II||0||
48317008|NCT00139776|101101268|FG001|STARTED|Period II||1197||
48317009|NCT00139776|101101269|FG002|STARTED|Period II||0||
48317010|NCT00139776|101101270|FG003|STARTED|Period II||0||
48317011|NCT00139776|101101267|FG000|COMPLETED|Period II||0||
48317012|NCT00139776|101101268|FG001|COMPLETED|Period II||875||
48317013|NCT00139776|101101269|FG002|COMPLETED|Period II||0||
48317014|NCT00139776|101101270|FG003|COMPLETED|Period II||0||
48317015|NCT00139776|101101267|FG000|NOT COMPLETED|Period II||0||
48317016|NCT00139776|101101268|FG001|NOT COMPLETED|Period II||322||
48317017|NCT00139776|101101269|FG002|NOT COMPLETED|Period II||0||
48317018|NCT00139776|101101270|FG003|NOT COMPLETED|Period II||0||
48615339|NCT00666211|101844885|FG000|STARTED|Overall Study||42||
48317019|NCT00139776|101101267|FG000|STARTED|Period III||0||
48317020|NCT00139776|101101268|FG001|STARTED|Period III||0||
48317021|NCT00139776|101101269|FG002|STARTED|Period III||431||
48317022|NCT00139776|101101270|FG003|STARTED|Period III||427||
48317023|NCT00139776|101101267|FG000|COMPLETED|Period III||0||
48317024|NCT00139776|101101268|FG001|COMPLETED|Period III||0||
48317025|NCT00139776|101101269|FG002|COMPLETED|Period III||355||
48317026|NCT00139776|101101270|FG003|COMPLETED|Period III||321||
48317027|NCT00139776|101101267|FG000|NOT COMPLETED|Period III||0||
48317028|NCT00139776|101101268|FG001|NOT COMPLETED|Period III||0||
48317029|NCT00139776|101101269|FG002|NOT COMPLETED|Period III||76||
48317030|NCT00139776|101101270|FG003|NOT COMPLETED|Period III||106||
48615340|NCT00666211|101844886|FG001|STARTED|Overall Study||56||
48615341|NCT00666211|101844885|FG000|COMPLETED|Overall Study||22||
48615342|NCT00666211|101844886|FG001|COMPLETED|Overall Study||18||
48615343|NCT00666211|101844885|FG000|NOT COMPLETED|Overall Study||20||
48615344|NCT00666211|101844886|FG001|NOT COMPLETED|Overall Study||38||
48615345|NCT03628378|101844887|FG000|STARTED|Overall Study||67||
48615346|NCT03628378|101844888|FG001|STARTED|Overall Study||63||
48615347|NCT03628378|101844887|FG000|COMPLETED|Overall Study||67||
48615348|NCT03628378|101844888|FG001|COMPLETED|Overall Study||63||
48615349|NCT03628378|101844887|FG000|NOT COMPLETED|Overall Study||0||
48615350|NCT03628378|101844888|FG001|NOT COMPLETED|Overall Study||0||
48615351|NCT02533934|101844889|FG000|STARTED|Overall Study||42||
48615352|NCT02533934|101844890|FG001|STARTED|Overall Study||26||
48615353|NCT02533934|101844889|FG000|COMPLETED|Overall Study||42||
48615354|NCT02533934|101844890|FG001|COMPLETED|Overall Study||26||
48615355|NCT02533934|101844889|FG000|NOT COMPLETED|Overall Study||0||
48615356|NCT02533934|101844890|FG001|NOT COMPLETED|Overall Study||0||
48615357|NCT02536105|101844891|FG000|STARTED|Concerta Open Label||80||
48615358|NCT02536105|101844891|FG000|Completion of Phase|Concerta Open Label||76||
48615359|NCT02536105|101844891|FG000|COMPLETED|Concerta Open Label||72|Number of participants who completed the entire study.|
48734244|NCT00766051|102133882|FG001|STARTED|Overall Study||10||
48734245|NCT00766051|102133881|FG000|COMPLETED|Overall Study||10||
48734246|NCT00766051|102133882|FG001|COMPLETED|Overall Study||10||
48159648|NCT00847405|100715682|FG000|COMPLETED|Washout of 7 Days||13||
48317031|NCT03370536|101101271|FG000|STARTED|Overall Study||1||
48317032|NCT03370536|101101271|FG000|COMPLETED|Overall Study||0||
48317033|NCT03370536|101101271|FG000|NOT COMPLETED|Overall Study||1||
48615360|NCT02536105|101844891|FG000|NOT COMPLETED|Concerta Open Label||8||
48615361|NCT02536105|101844891|FG000|STARTED|Placebo||74||
48615362|NCT02536105|101844891|FG000|Completion of Placebo Day|Placebo||74||
48615363|NCT02536105|101844891|FG000|COMPLETED|Placebo||72|Number of participants who completed the entire study.|
48615364|NCT02536105|101844891|FG000|NOT COMPLETED|Placebo||2||
48615365|NCT02536105|101844891|FG000|STARTED|Methylphenidate HCl ER Tablet 1||72||
48615366|NCT02536105|101844891|FG000|Completion of MPH HCl ER Tab 1 Day|Methylphenidate HCl ER Tablet 1||72||
48615367|NCT02536105|101844891|FG000|COMPLETED|Methylphenidate HCl ER Tablet 1||72|Number of participants who completed the entire study.|
48734247|NCT00766051|102133881|FG000|NOT COMPLETED|Overall Study||2||
48734248|NCT00766051|102133882|FG001|NOT COMPLETED|Overall Study||0||
48734249|NCT01000324|102133883|FG000|STARTED|Year 16||40||
48317034|NCT02614859|101101272|FG000|STARTED|Overall Study||9||
48615368|NCT02536105|101844891|FG000|NOT COMPLETED|Methylphenidate HCl ER Tablet 1||0||
48615369|NCT02536105|101844891|FG000|STARTED|Methylphenidate HCl ER Tablet 2||73||
48734250|NCT01000324|102133883|FG000|COMPLETED|Year 16||40||
48317035|NCT02614859|101101273|FG001|STARTED|Overall Study||20||
48317036|NCT02614859|101101272|FG000|COMPLETED|Overall Study||9||
48615370|NCT02536105|101844891|FG000|Completion of MPH HCl ER Tablet 2 Phase|Methylphenidate HCl ER Tablet 2||73||
48317037|NCT02614859|101101273|FG001|COMPLETED|Overall Study||19||
48656946|NCT03382873|101943731|FG001|COMPLETED|Overall Study||60||
48734251|NCT01000324|102133883|FG000|NOT COMPLETED|Year 16||0||
48734252|NCT01000324|102133883|FG000|STARTED|Year 17||32||
48734253|NCT01000324|102133883|FG000|COMPLETED|Year 17||32||
48317038|NCT02614859|101101272|FG000|NOT COMPLETED|Overall Study||0||
48317039|NCT02614859|101101273|FG001|NOT COMPLETED|Overall Study||1||
48615371|NCT02536105|101844891|FG000|COMPLETED|Methylphenidate HCl ER Tablet 2||72|Number of participants who completed the entire study.|
48615372|NCT02536105|101844891|FG000|NOT COMPLETED|Methylphenidate HCl ER Tablet 2||1||
48615373|NCT02536105|101844891|FG000|STARTED|Methylphenidate HCl ER Suspension||74||
48615374|NCT02536105|101844891|FG000|Completion of MPH HCl ER Susp Phase|Methylphenidate HCl ER Suspension||74||
48615375|NCT02536105|101844891|FG000|COMPLETED|Methylphenidate HCl ER Suspension||72|Number of participants who completed the entire study.|
48615376|NCT02536105|101844891|FG000|NOT COMPLETED|Methylphenidate HCl ER Suspension||2||
48317040|NCT01197521|101101274|FG000|STARTED|Overall Study||310||
48317041|NCT01197521|101101275|FG001|STARTED|Overall Study||304||
48317042|NCT01197521|101101276|FG002|STARTED|Overall Study||304||
48317043|NCT01197521|101101274|FG000|Randomised But Did Not Receive Treatment|Overall Study||1||
48317044|NCT01197521|101101275|FG001|Randomised But Did Not Receive Treatment|Overall Study||2||
48615377|NCT03861091|101844892|FG000|STARTED|Overall Study||41||
48615378|NCT03861091|101844893|FG001|STARTED|Overall Study||43||
48615379|NCT03861091|101844892|FG000|COMPLETED|Overall Study||41||
48615380|NCT03861091|101844893|FG001|COMPLETED|Overall Study||43||
48615381|NCT03861091|101844892|FG000|NOT COMPLETED|Overall Study||0||
48615382|NCT03861091|101844893|FG001|NOT COMPLETED|Overall Study||0||
48615383|NCT04033146|101844894|FG000|STARTED|Overall Study||10||
48159649|NCT00847405|100715683|FG001|COMPLETED|Washout of 7 Days||13||
48159650|NCT00847405|100715682|FG000|NOT COMPLETED|Washout of 7 Days||1||
48159651|NCT00847405|100715683|FG001|NOT COMPLETED|Washout of 7 Days||0||
48159652|NCT00847405|100715682|FG000|STARTED|Second Intervention||13||
48159653|NCT00847405|100715683|FG001|STARTED|Second Intervention||13||
48159654|NCT00847405|100715682|FG000|COMPLETED|Second Intervention||13||
48159655|NCT00847405|100715683|FG001|COMPLETED|Second Intervention||13||
48159656|NCT00847405|100715682|FG000|NOT COMPLETED|Second Intervention||0||
48159657|NCT00847405|100715683|FG001|NOT COMPLETED|Second Intervention||0||
48159658|NCT00335257|100715684|FG000|STARTED|Overall Study||15542||
48159659|NCT00335257|100715685|FG001|STARTED|Overall Study||9377||
48159660|NCT00335257|100715686|FG002|STARTED|Overall Study||60190||
48159661|NCT00335257|100715684|FG000|COMPLETED|Overall Study||15542||
48159662|NCT00335257|100715685|FG001|COMPLETED|Overall Study||9377||
48159663|NCT00335257|100715686|FG002|COMPLETED|Overall Study||60190||
48159664|NCT00335257|100715684|FG000|NOT COMPLETED|Overall Study||0||
48159665|NCT00335257|100715685|FG001|NOT COMPLETED|Overall Study||0||
48159666|NCT00335257|100715686|FG002|NOT COMPLETED|Overall Study||0||
48159667|NCT05292534|100715687|FG000|STARTED|Overall Study||18||
48159668|NCT05292534|100715688|FG001|STARTED|Overall Study||20||
48159669|NCT05292534|100715687|FG000|COMPLETED|Overall Study||15||
48159670|NCT05292534|100715688|FG001|COMPLETED|Overall Study||15||
48159671|NCT05292534|100715687|FG000|NOT COMPLETED|Overall Study||3||
48159672|NCT05292534|100715688|FG001|NOT COMPLETED|Overall Study||5||
48159673|NCT03108157|100715689|FG000|STARTED|Overall Study||176||
48159674|NCT03108157|100715690|FG001|STARTED|Overall Study||176||
48159675|NCT03108157|100715689|FG000|COMPLETED|Overall Study||161||
48159676|NCT03108157|100715690|FG001|COMPLETED|Overall Study||172||
48159677|NCT03108157|100715689|FG000|NOT COMPLETED|Overall Study||15||
48159678|NCT03108157|100715690|FG001|NOT COMPLETED|Overall Study||4||
48159679|NCT01750879|100715691|FG000|STARTED|Overall Study||30||
48159680|NCT01750879|100715692|FG001|STARTED|Overall Study||11||
48159681|NCT01750879|100715691|FG000|DBPCFC2|Overall Study||20||
48159682|NCT01750879|100715692|FG001|DBPCFC2|Overall Study||8||
48159683|NCT01750879|100715691|FG000|DBPCFC3|Overall Study||20||
48159684|NCT01750879|100715692|FG001|DBPCFC3|Overall Study||0||
48159685|NCT01750879|100715691|FG000|COMPLETED|Overall Study||20||
48159686|NCT01750879|100715692|FG001|COMPLETED|Overall Study||8||
48317045|NCT01197521|101101276|FG002|Randomised But Did Not Receive Treatment|Overall Study||2||
48317046|NCT01197521|101101274|FG000|COMPLETED|Overall Study||207||
48317047|NCT01197521|101101275|FG001|COMPLETED|Overall Study||191||
48317048|NCT01197521|101101276|FG002|COMPLETED|Overall Study||161||
48317049|NCT01197521|101101274|FG000|NOT COMPLETED|Overall Study||103||
48317050|NCT01197521|101101275|FG001|NOT COMPLETED|Overall Study||113||
48317051|NCT01197521|101101276|FG002|NOT COMPLETED|Overall Study||143||
48615384|NCT04033146|101844895|FG001|STARTED|Overall Study||6||
48615385|NCT04033146|101844894|FG000|COMPLETED|Overall Study||10||
48615386|NCT04033146|101844895|FG001|COMPLETED|Overall Study||6||
48615387|NCT04033146|101844894|FG000|NOT COMPLETED|Overall Study||0||
48159687|NCT01750879|100715691|FG000|NOT COMPLETED|Overall Study||10||
48159688|NCT01750879|100715692|FG001|NOT COMPLETED|Overall Study||3||
48159689|NCT00724464|100715693|FG000|STARTED|Overall Study||332||
48159690|NCT00724464|100715693|FG000|COMPLETED|Overall Study||309||
48159691|NCT00724464|100715693|FG000|NOT COMPLETED|Overall Study||23||
48159692|NCT03299686|100715694|FG000|STARTED|Treatment Epoch||70||
48159693|NCT03299686|100715695|FG001|STARTED|Treatment Epoch||48||
48159694|NCT03299686|100715694|FG000|PD (Pharmacodynamics) Analysis Set|Treatment Epoch||69|All subjects with available PD data, who received any study drug, and no major protocol deviations|
48159695|NCT03299686|100715695|FG001|PD (Pharmacodynamics) Analysis Set|Treatment Epoch||48|All subjects with available PD data, who received any study drug, and no major protocol deviations|
48615388|NCT04033146|101844895|FG001|NOT COMPLETED|Overall Study||0||
48159696|NCT03299686|100715694|FG000|COMPLETED|Treatment Epoch||59||
48159697|NCT03299686|100715695|FG001|COMPLETED|Treatment Epoch||44||
48159698|NCT03299686|100715694|FG000|NOT COMPLETED|Treatment Epoch||11||
48159699|NCT03299686|100715695|FG001|NOT COMPLETED|Treatment Epoch||4||
48159700|NCT03299686|100715694|FG000|STARTED|Follow-up Epoch||59||
48159701|NCT03299686|100715695|FG001|STARTED|Follow-up Epoch||44||
48159702|NCT03299686|100715694|FG000|COMPLETED|Follow-up Epoch||59||
48159703|NCT03299686|100715695|FG001|COMPLETED|Follow-up Epoch||43||
48159704|NCT03299686|100715694|FG000|NOT COMPLETED|Follow-up Epoch||0||
48159705|NCT03299686|100715695|FG001|NOT COMPLETED|Follow-up Epoch||1||
48159706|NCT01780935|100715696|FG000|STARTED|Overall Study||335||
48159707|NCT01780935|100715697|FG001|STARTED|Overall Study||336||
48159708|NCT01780935|100715696|FG000|Safety Set|Overall Study||334||
48159709|NCT01780935|100715697|FG001|Safety Set|Overall Study||336||
48159710|NCT01780935|100715696|FG000|COMPLETED|Overall Study||0||
48159711|NCT01780935|100715697|FG001|COMPLETED|Overall Study||0||
48159712|NCT01780935|100715696|FG000|NOT COMPLETED|Overall Study||335||
48615389|NCT01619878|101844896|FG000|STARTED|6 Week Follow-up Phase||20||
48615390|NCT01619878|101844896|FG000|COMPLETED|6 Week Follow-up Phase||19||
48615391|NCT01619878|101844896|FG000|NOT COMPLETED|6 Week Follow-up Phase||1||
48615392|NCT01619878|101844896|FG000|STARTED|Follow-up at 12 Months of Age||20||
48615393|NCT01619878|101844896|FG000|COMPLETED|Follow-up at 12 Months of Age||17||
48615394|NCT01619878|101844896|FG000|NOT COMPLETED|Follow-up at 12 Months of Age||3||
48615395|NCT01074177|101844897|FG000|STARTED|Overall Study||24||
48615396|NCT01074177|101844897|FG000|COMPLETED|Overall Study||24||
48159713|NCT01780935|100715697|FG001|NOT COMPLETED|Overall Study||336||
48615397|NCT01074177|101844897|FG000|NOT COMPLETED|Overall Study||0||
48615398|NCT02542397|101844898|FG000|STARTED|Overall Study||75||
48615399|NCT02542397|101844898|FG000|COMPLETED|Overall Study||59||
48615400|NCT02542397|101844898|FG000|NOT COMPLETED|Overall Study||16||
48615401|NCT00762762|101844899|FG000|STARTED|Overall Study||30||
48615402|NCT00762762|101844900|FG001|STARTED|Overall Study||30||
48615403|NCT00762762|101844899|FG000|COMPLETED|Overall Study||24||
48615404|NCT00762762|101844900|FG001|COMPLETED|Overall Study||22||
48615405|NCT00762762|101844899|FG000|NOT COMPLETED|Overall Study||6||
48615406|NCT00762762|101844900|FG001|NOT COMPLETED|Overall Study||8||
48734254|NCT01000324|102133883|FG000|NOT COMPLETED|Year 17||0||
48734255|NCT01000324|102133883|FG000|STARTED|Year 18||29||
48734256|NCT01000324|102133883|FG000|COMPLETED|Year 18||29||
48159714|NCT00595504|100715698|FG000|STARTED|Overall Study||16||
48159715|NCT00595504|100715699|FG001|STARTED|Overall Study||9||
48159716|NCT00595504|100715698|FG000|COMPLETED|Overall Study||14||
48159717|NCT00595504|100715699|FG001|COMPLETED|Overall Study||6||
48159718|NCT00595504|100715698|FG000|NOT COMPLETED|Overall Study||2||
48159719|NCT00595504|100715699|FG001|NOT COMPLETED|Overall Study||3||
48159720|NCT01691521|100715700|FG000|STARTED|Overall Study||191||
48159721|NCT01691521|100715701|FG001|STARTED|Overall Study||191||
48615407|NCT01405898|101844901|FG000|STARTED|Overall Study||34||
48615408|NCT01405898|101844902|FG001|STARTED|Overall Study||34||
48615409|NCT01405898|101844901|FG000|COMPLETED|Overall Study||32||
48615410|NCT01405898|101844902|FG001|COMPLETED|Overall Study||32||
48734257|NCT01000324|102133883|FG000|NOT COMPLETED|Year 18||0||
48734258|NCT01000324|102133883|FG000|STARTED|Year 19||28||
48734259|NCT01000324|102133883|FG000|COMPLETED|Year 19||28||
48159722|NCT01691521|100715702|FG002|STARTED|Overall Study||194||
48317052|NCT02634151|101101277|FG000|STARTED|Overall Study||53||
48317053|NCT02634151|101101278|FG001|STARTED|Overall Study||52||
48317054|NCT02634151|101101277|FG000|Full Analysis Set|Overall Study||53||
48317055|NCT02634151|101101278|FG001|Full Analysis Set|Overall Study||52||
48317056|NCT02634151|101101277|FG000|Safety Set|Overall Study||54||
48317057|NCT02634151|101101278|FG001|Safety Set|Overall Study||51||
48317058|NCT02634151|101101277|FG000|COMPLETED|Overall Study||52||
48317059|NCT02634151|101101278|FG001|COMPLETED|Overall Study||50||
48734260|NCT01000324|102133883|FG000|NOT COMPLETED|Year 19||0||
48734261|NCT01000324|102133883|FG000|STARTED|Year 20||28||
48734262|NCT01000324|102133883|FG000|COMPLETED|Year 20||28||
48159723|NCT01691521|100715700|FG000|COMPLETED|Overall Study||179||
48159724|NCT01691521|100715701|FG001|COMPLETED|Overall Study||175||
48159725|NCT01691521|100715702|FG002|COMPLETED|Overall Study||185||
48317060|NCT02634151|101101277|FG000|NOT COMPLETED|Overall Study||1||
48317061|NCT02634151|101101278|FG001|NOT COMPLETED|Overall Study||2||
48615411|NCT01405898|101844901|FG000|NOT COMPLETED|Overall Study||2||
48615412|NCT01405898|101844902|FG001|NOT COMPLETED|Overall Study||2||
48615413|NCT01951417|101844903|FG000|STARTED|Overall Study||81||
48615414|NCT01951417|101844903|FG000|COMPLETED|Overall Study||72||
48615415|NCT01951417|101844903|FG000|NOT COMPLETED|Overall Study||9||
48615416|NCT00991289|101844904|FG000|STARTED|Overall Study||67||
48159726|NCT01691521|100715700|FG000|NOT COMPLETED|Overall Study||12||
48615417|NCT00991289|101844904|FG000|COMPLETED Week 16|Overall Study||61||
48615418|NCT00991289|101844904|FG000|COMPLETED|Overall Study||55||
48615419|NCT00991289|101844904|FG000|NOT COMPLETED|Overall Study||12||
48615420|NCT02907463|101844905|FG000|STARTED|Overall Study||280||
48615421|NCT02907463|101844905|FG000|Enrolled Cohort|Overall Study||280||
48734263|NCT01000324|102133883|FG000|NOT COMPLETED|Year 20||0||
48734264|NCT01424033|102133884|FG000|STARTED|Overall Study||5||
48734265|NCT01424033|102133884|FG000|COMPLETED|Overall Study||0||
48734266|NCT01424033|102133884|FG000|NOT COMPLETED|Overall Study||5||
48734267|NCT02110095|102133885|FG000|STARTED|Overall Study||15||
48734268|NCT02110095|102133885|FG000|COMPLETED|Overall Study||8||
48734269|NCT02110095|102133885|FG000|NOT COMPLETED|Overall Study||7||
48734270|NCT02424175|102133886|FG000|STARTED|Overall Study||10||
48734271|NCT02424175|102133886|FG000|COMPLETED|Overall Study||10||
48734272|NCT02424175|102133886|FG000|NOT COMPLETED|Overall Study||0||
48734273|NCT02578186|102133887|FG000|STARTED|Period 1 (First of Crossover)||17|2 re-enrolled subjects have a count in each sequence in Started Row and a corresponding disposition.|
48734274|NCT02578186|102133888|FG001|STARTED|Period 1 (First of Crossover)||18|2 re-enrolled subjects have a count in each sequence in Started Row and a corresponding disposition.|
48734275|NCT02578186|102133887|FG000|COMPLETED|Period 1 (First of Crossover)||12||
48734276|NCT02578186|102133888|FG001|COMPLETED|Period 1 (First of Crossover)||13||
48734277|NCT02578186|102133887|FG000|NOT COMPLETED|Period 1 (First of Crossover)||5||
48734278|NCT02578186|102133888|FG001|NOT COMPLETED|Period 1 (First of Crossover)||5||
48734279|NCT02578186|102133887|FG000|STARTED|Period 2 (Second of Crossover)||12||
48734280|NCT02578186|102133888|FG001|STARTED|Period 2 (Second of Crossover)||13||
48734281|NCT02578186|102133887|FG000|COMPLETED|Period 2 (Second of Crossover)||12||
48734282|NCT02578186|102133888|FG001|COMPLETED|Period 2 (Second of Crossover)||13||
48734283|NCT02578186|102133887|FG000|NOT COMPLETED|Period 2 (Second of Crossover)||0||
48734284|NCT02578186|102133888|FG001|NOT COMPLETED|Period 2 (Second of Crossover)||0||
48734285|NCT00940498|102133889|FG000|STARTED|Overall Study||4||
48734286|NCT00940498|102133890|FG001|STARTED|Overall Study||4||
48734287|NCT00940498|102133891|FG002|STARTED|Overall Study||4||
48734288|NCT00940498|102133892|FG003|STARTED|Overall Study||4||
48734289|NCT00940498|102133893|FG004|STARTED|Overall Study||43||
48734290|NCT00940498|102133894|FG005|STARTED|Overall Study||7||
48734291|NCT00940498|102133895|FG006|STARTED|Overall Study||8||
48734292|NCT00940498|102133896|FG007|STARTED|Overall Study||4||
48734293|NCT00940498|102133889|FG000|COMPLETED|Overall Study||1||
48734294|NCT00940498|102133890|FG001|COMPLETED|Overall Study||3||
48734295|NCT00940498|102133891|FG002|COMPLETED|Overall Study||1||
48734296|NCT00940498|102133892|FG003|COMPLETED|Overall Study||2||
48734297|NCT00940498|102133893|FG004|COMPLETED|Overall Study||34||
48159727|NCT01691521|100715701|FG001|NOT COMPLETED|Overall Study||16||
48159728|NCT01691521|100715702|FG002|NOT COMPLETED|Overall Study||9||
48159729|NCT00626366|100715703|FG000|STARTED|Overall Study||9||
48159730|NCT00626366|100715704|FG001|STARTED|Overall Study||9||
48159731|NCT00626366|100715703|FG000|COMPLETED|Overall Study||9||
48159732|NCT00626366|100715704|FG001|COMPLETED|Overall Study||9||
48159733|NCT00626366|100715703|FG000|NOT COMPLETED|Overall Study||0||
48159734|NCT00626366|100715704|FG001|NOT COMPLETED|Overall Study||0||
48159735|NCT00582946|100715705|FG000|STARTED|Overall Study||16||
48159736|NCT00582946|100715705|FG000|COMPLETED|Overall Study||16||
48159737|NCT00582946|100715705|FG000|NOT COMPLETED|Overall Study||0||
48159738|NCT01564368|100715706|FG000|STARTED|Overall Study||406||
48159739|NCT01564368|100715706|FG000|Randomized in Parent Study|Overall Study||272||
48159740|NCT01564368|100715706|FG000|Acceptable Baseline Imaging|Overall Study||263||
48159741|NCT01564368|100715706|FG000|Acceptable Post Baseline Image|Overall Study||242||
48317062|NCT01380730|101101279|FG000|STARTED|Overall Study||78||
48317063|NCT01380730|101101280|FG001|STARTED|Overall Study||79||
48734298|NCT00940498|102133894|FG005|COMPLETED|Overall Study||6||
48734299|NCT00940498|102133895|FG006|COMPLETED|Overall Study||7||
48734300|NCT00940498|102133896|FG007|COMPLETED|Overall Study||3||
48734301|NCT00940498|102133889|FG000|NOT COMPLETED|Overall Study||3||
48734302|NCT00940498|102133890|FG001|NOT COMPLETED|Overall Study||1||
48734303|NCT00940498|102133891|FG002|NOT COMPLETED|Overall Study||3||
48734304|NCT00940498|102133892|FG003|NOT COMPLETED|Overall Study||2||
48734305|NCT00940498|102133893|FG004|NOT COMPLETED|Overall Study||9||
48734306|NCT00940498|102133894|FG005|NOT COMPLETED|Overall Study||1||
48734307|NCT00940498|102133895|FG006|NOT COMPLETED|Overall Study||1||
48734308|NCT00940498|102133896|FG007|NOT COMPLETED|Overall Study||1||
48734309|NCT04266925|102133897|FG000|STARTED|1 Referee Game (~1 Hour)||23||
48734310|NCT04266925|102133898|FG001|STARTED|1 Referee Game (~1 Hour)||26||
48734311|NCT04266925|102133897|FG000|COMPLETED|1 Referee Game (~1 Hour)||23||
48734312|NCT04266925|102133898|FG001|COMPLETED|1 Referee Game (~1 Hour)||26||
48734313|NCT04266925|102133897|FG000|NOT COMPLETED|1 Referee Game (~1 Hour)||0||
48734314|NCT04266925|102133898|FG001|NOT COMPLETED|1 Referee Game (~1 Hour)||0||
48734315|NCT04266925|102133897|FG000|STARTED|3 Referee Game (~1 Hour)||23||
48734316|NCT04266925|102133898|FG001|STARTED|3 Referee Game (~1 Hour)||26||
48734317|NCT04266925|102133897|FG000|COMPLETED|3 Referee Game (~1 Hour)||23||
48159742|NCT01564368|100715706|FG000|Baseline and Early Treatment Usable|Overall Study||227||
48317064|NCT01380730|101101281|FG002|STARTED|Overall Study||79||
48159743|NCT01564368|100715706|FG000|Baseline and Mid-treatment Usable|Overall Study||210||
48188746|NCT01033643|100783325|FG004|NOT COMPLETED|Overall Study||0||
48734318|NCT04266925|102133898|FG001|COMPLETED|3 Referee Game (~1 Hour)||26||
48734319|NCT04266925|102133897|FG000|NOT COMPLETED|3 Referee Game (~1 Hour)||0||
48734320|NCT04266925|102133898|FG001|NOT COMPLETED|3 Referee Game (~1 Hour)||0||
48734321|NCT03364309|102133899|FG000|STARTED|Induction Period||88||
48734322|NCT03364309|102133900|FG001|STARTED|Induction Period||174||
48734323|NCT03364309|102133901|FG002|STARTED|Induction Period||176||
48734324|NCT03364309|102133902|FG003|STARTED|Induction Period||0||
48159744|NCT01564368|100715706|FG000|Baseline and Post-Treatment Usable|Overall Study||186||
48159745|NCT01564368|100715706|FG000|Usable Re-test Scan|Overall Study||71||
48159746|NCT01564368|100715706|FG000|COMPLETED|Overall Study||242||
48159747|NCT01564368|100715706|FG000|NOT COMPLETED|Overall Study||164||
48159748|NCT00525525|100715707|FG000|STARTED|Overall Study||59||
48159749|NCT00525525|100715708|FG001|STARTED|Overall Study||15||
48159750|NCT00525525|100715707|FG000|COMPLETED|Overall Study||59||
48159751|NCT00525525|100715708|FG001|COMPLETED|Overall Study||15||
48159752|NCT00525525|100715707|FG000|NOT COMPLETED|Overall Study||0||
48734325|NCT03364309|102133903|FG004|STARTED|Induction Period||0||
48734326|NCT03364309|102133904|FG005|STARTED|Induction Period||0||
48734327|NCT03364309|102133905|FG006|STARTED|Induction Period||0||
48734328|NCT03364309|102133906|FG007|STARTED|Induction Period||0||
48734329|NCT03364309|102133907|FG008|STARTED|Induction Period||0||
48734330|NCT03364309|102133908|FG009|STARTED|Induction Period||0||
48734331|NCT03364309|102133909|FG010|STARTED|Induction Period||0||
48734332|NCT03364309|102133910|FG011|STARTED|Induction Period||0||
48734333|NCT03364309|102133911|FG012|STARTED|Induction Period||0||
48734334|NCT03364309|102133912|FG013|STARTED|Induction Period||0||
48734335|NCT03364309|102133913|FG014|STARTED|Induction Period||0||
48734336|NCT03364309|102133914|FG015|STARTED|Induction Period||0||
48734337|NCT03364309|102133915|FG016|STARTED|Induction Period||0||
48734338|NCT03364309|102133916|FG017|STARTED|Induction Period||0||
48734339|NCT03364309|102133917|FG018|STARTED|Induction Period||0||
48159753|NCT00525525|100715708|FG001|NOT COMPLETED|Overall Study||0||
48159754|NCT02201056|100715709|FG000|STARTED|Overall Study||12||
48159755|NCT02201056|100715710|FG001|STARTED|Overall Study||6||
48159756|NCT02201056|100715711|FG002|STARTED|Overall Study||6||
48734340|NCT03364309|102133899|FG000|Received at Least One Dose of Study Drug|Induction Period||88||
48734341|NCT03364309|102133900|FG001|Received at Least One Dose of Study Drug|Induction Period||174||
48734342|NCT03364309|102133901|FG002|Received at Least One Dose of Study Drug|Induction Period||176||
48734343|NCT03364309|102133902|FG003|Received at Least One Dose of Study Drug|Induction Period||0||
48734344|NCT03364309|102133903|FG004|Received at Least One Dose of Study Drug|Induction Period||0||
48734345|NCT03364309|102133904|FG005|Received at Least One Dose of Study Drug|Induction Period||0||
48734346|NCT03364309|102133905|FG006|Received at Least One Dose of Study Drug|Induction Period||0||
48734347|NCT03364309|102133906|FG007|Received at Least One Dose of Study Drug|Induction Period||0||
48734348|NCT03364309|102133907|FG008|Received at Least One Dose of Study Drug|Induction Period||0||
48159757|NCT02201056|100715712|FG003|STARTED|Overall Study||6||
48159758|NCT02201056|100715713|FG004|STARTED|Overall Study||6||
48159759|NCT02201056|100715714|FG005|STARTED|Overall Study||6||
48734349|NCT03364309|102133908|FG009|Received at Least One Dose of Study Drug|Induction Period||0||
48734350|NCT03364309|102133909|FG010|Received at Least One Dose of Study Drug|Induction Period||0||
48734351|NCT03364309|102133910|FG011|Received at Least One Dose of Study Drug|Induction Period||0||
48734352|NCT03364309|102133911|FG012|Received at Least One Dose of Study Drug|Induction Period||0||
48734353|NCT03364309|102133912|FG013|Received at Least One Dose of Study Drug|Induction Period||0||
48734354|NCT03364309|102133913|FG014|Received at Least One Dose of Study Drug|Induction Period||0||
48734355|NCT03364309|102133914|FG015|Received at Least One Dose of Study Drug|Induction Period||0||
48734356|NCT03364309|102133915|FG016|Received at Least One Dose of Study Drug|Induction Period||0||
48317065|NCT01380730|101101282|FG003|STARTED|Overall Study||79||
48317066|NCT01380730|101101283|FG004|STARTED|Overall Study||78||
48317067|NCT01380730|101101284|FG005|STARTED|Overall Study||79||
48734357|NCT03364309|102133916|FG017|Received at Least One Dose of Study Drug|Induction Period||0||
48734358|NCT03364309|102133917|FG018|Received at Least One Dose of Study Drug|Induction Period||0||
48734359|NCT03364309|102133899|FG000|COMPLETED|Induction Period||82||
48734360|NCT03364309|102133900|FG001|COMPLETED|Induction Period||170||
48734361|NCT03364309|102133901|FG002|COMPLETED|Induction Period||175||
48734362|NCT03364309|102133902|FG003|COMPLETED|Induction Period||0||
48734363|NCT03364309|102133903|FG004|COMPLETED|Induction Period||0||
48734364|NCT03364309|102133904|FG005|COMPLETED|Induction Period||0||
48734365|NCT03364309|102133905|FG006|COMPLETED|Induction Period||0||
48734366|NCT03364309|102133906|FG007|COMPLETED|Induction Period||0||
48317068|NCT01380730|101101285|FG006|STARTED|Overall Study||79||
48317069|NCT01380730|101101286|FG007|STARTED|Overall Study||80||
48317070|NCT01380730|101101279|FG000|Received Treatment|Overall Study||78||
48734367|NCT03364309|102133907|FG008|COMPLETED|Induction Period||0||
48159760|NCT02201056|100715715|FG006|STARTED|Overall Study||6||
48159761|NCT02201056|100715709|FG000|COMPLETED|Overall Study||12||
48317071|NCT01380730|101101280|FG001|Received Treatment|Overall Study||77||
48317072|NCT01380730|101101281|FG002|Received Treatment|Overall Study||79||
48317073|NCT01380730|101101282|FG003|Received Treatment|Overall Study||79||
48317074|NCT01380730|101101283|FG004|Received Treatment|Overall Study||78||
48734368|NCT03364309|102133908|FG009|COMPLETED|Induction Period||0||
48734369|NCT03364309|102133909|FG010|COMPLETED|Induction Period||0||
48734370|NCT03364309|102133910|FG011|COMPLETED|Induction Period||0||
48734371|NCT03364309|102133911|FG012|COMPLETED|Induction Period||0||
48734372|NCT03364309|102133912|FG013|COMPLETED|Induction Period||0||
48734373|NCT03364309|102133913|FG014|COMPLETED|Induction Period||0||
48734374|NCT03364309|102133914|FG015|COMPLETED|Induction Period||0||
48734375|NCT03364309|102133915|FG016|COMPLETED|Induction Period||0||
48734376|NCT03364309|102133916|FG017|COMPLETED|Induction Period||0||
48734377|NCT03364309|102133917|FG018|COMPLETED|Induction Period||0||
48734378|NCT03364309|102133899|FG000|NOT COMPLETED|Induction Period||6||
48734379|NCT03364309|102133900|FG001|NOT COMPLETED|Induction Period||4||
48734380|NCT03364309|102133901|FG002|NOT COMPLETED|Induction Period||1||
48734381|NCT03364309|102133902|FG003|NOT COMPLETED|Induction Period||0||
48734382|NCT03364309|102133903|FG004|NOT COMPLETED|Induction Period||0||
48734383|NCT03364309|102133904|FG005|NOT COMPLETED|Induction Period||0||
48734384|NCT03364309|102133905|FG006|NOT COMPLETED|Induction Period||0||
48734385|NCT03364309|102133906|FG007|NOT COMPLETED|Induction Period||0||
48734386|NCT03364309|102133907|FG008|NOT COMPLETED|Induction Period||0||
48734387|NCT03364309|102133908|FG009|NOT COMPLETED|Induction Period||0||
48734388|NCT03364309|102133909|FG010|NOT COMPLETED|Induction Period||0||
48734389|NCT03364309|102133910|FG011|NOT COMPLETED|Induction Period||0||
48734390|NCT03364309|102133911|FG012|NOT COMPLETED|Induction Period||0||
48734391|NCT03364309|102133912|FG013|NOT COMPLETED|Induction Period||0||
48734392|NCT03364309|102133913|FG014|NOT COMPLETED|Induction Period||0||
48734393|NCT03364309|102133914|FG015|NOT COMPLETED|Induction Period||0||
48734394|NCT03364309|102133915|FG016|NOT COMPLETED|Induction Period||0||
48734395|NCT03364309|102133916|FG017|NOT COMPLETED|Induction Period||0||
48734396|NCT03364309|102133917|FG018|NOT COMPLETED|Induction Period||0||
48734397|NCT03364309|102133899|FG000|STARTED|Maintenance Period||0||
48734398|NCT03364309|102133900|FG001|STARTED|Maintenance Period||0||
48734399|NCT03364309|102133901|FG002|STARTED|Maintenance Period||0||
48734400|NCT03364309|102133902|FG003|STARTED|Maintenance Period||47||
48734401|NCT03364309|102133903|FG004|STARTED|Maintenance Period||92||
48734402|NCT03364309|102133904|FG005|STARTED|Maintenance Period||50||
48734403|NCT03364309|102133905|FG006|STARTED|Maintenance Period||100||
48734404|NCT03364309|102133906|FG007|STARTED|Maintenance Period||3||
48734405|NCT03364309|102133907|FG008|STARTED|Maintenance Period||79||
48734406|NCT03364309|102133908|FG009|STARTED|Maintenance Period||31||
48734407|NCT03364309|102133909|FG010|STARTED|Maintenance Period||23||
48734408|NCT03364309|102133910|FG011|STARTED|Maintenance Period||0||
48734409|NCT03364309|102133911|FG012|STARTED|Maintenance Period||0||
48734410|NCT03364309|102133912|FG013|STARTED|Maintenance Period||0||
48734411|NCT03364309|102133913|FG014|STARTED|Maintenance Period||0||
48734412|NCT03364309|102133914|FG015|STARTED|Maintenance Period||0||
48734413|NCT03364309|102133915|FG016|STARTED|Maintenance Period||0||
48734414|NCT03364309|102133916|FG017|STARTED|Maintenance Period||0||
48734415|NCT03364309|102133917|FG018|STARTED|Maintenance Period||0||
48734416|NCT03364309|102133899|FG000|Received at Least One Dose of Study Drug|Maintenance Period||0||
48734417|NCT03364309|102133900|FG001|Received at Least One Dose of Study Drug|Maintenance Period||0||
48734418|NCT03364309|102133901|FG002|Received at Least One Dose of Study Drug|Maintenance Period||0||
48734419|NCT03364309|102133902|FG003|Received at Least One Dose of Study Drug|Maintenance Period||47||
48734420|NCT03364309|102133903|FG004|Received at Least One Dose of Study Drug|Maintenance Period||92||
48734421|NCT03364309|102133904|FG005|Received at Least One Dose of Study Drug|Maintenance Period||50||
48734422|NCT03364309|102133905|FG006|Received at Least One Dose of Study Drug|Maintenance Period||100||
48734423|NCT03364309|102133906|FG007|Received at Least One Dose of Study Drug|Maintenance Period||3||
48734424|NCT03364309|102133907|FG008|Received at Least One Dose of Study Drug|Maintenance Period||79||
48734425|NCT03364309|102133908|FG009|Received at Least One Dose of Study Drug|Maintenance Period||31||
48734426|NCT03364309|102133909|FG010|Received at Least One Dose of Study Drug|Maintenance Period||23||
48734427|NCT03364309|102133910|FG011|Received at Least One Dose of Study Drug|Maintenance Period||0||
48734428|NCT03364309|102133911|FG012|Received at Least One Dose of Study Drug|Maintenance Period||0||
48734429|NCT03364309|102133912|FG013|Received at Least One Dose of Study Drug|Maintenance Period||0||
48734430|NCT03364309|102133913|FG014|Received at Least One Dose of Study Drug|Maintenance Period||0||
48734431|NCT03364309|102133914|FG015|Received at Least One Dose of Study Drug|Maintenance Period||0||
48734432|NCT03364309|102133915|FG016|Received at Least One Dose of Study Drug|Maintenance Period||0||
48734433|NCT03364309|102133916|FG017|Received at Least One Dose of Study Drug|Maintenance Period||0||
48734434|NCT03364309|102133917|FG018|Received at Least One Dose of Study Drug|Maintenance Period||0||
48734435|NCT03364309|102133899|FG000|COMPLETED|Maintenance Period||0||
48734436|NCT03364309|102133900|FG001|COMPLETED|Maintenance Period||0||
48734437|NCT03364309|102133901|FG002|COMPLETED|Maintenance Period||0||
48734438|NCT03364309|102133902|FG003|COMPLETED|Maintenance Period||3||
48734439|NCT03364309|102133903|FG004|COMPLETED|Maintenance Period||80||
48734440|NCT03364309|102133904|FG005|COMPLETED|Maintenance Period||4||
48734441|NCT03364309|102133905|FG006|COMPLETED|Maintenance Period||84||
48734442|NCT03364309|102133906|FG007|COMPLETED|Maintenance Period||1||
48734443|NCT03364309|102133907|FG008|COMPLETED|Maintenance Period||73||
48734444|NCT03364309|102133908|FG009|COMPLETED|Maintenance Period||27||
48734445|NCT03364309|102133909|FG010|COMPLETED|Maintenance Period||17||
48734446|NCT03364309|102133910|FG011|COMPLETED|Maintenance Period||0||
48734447|NCT03364309|102133911|FG012|COMPLETED|Maintenance Period||0||
48734448|NCT03364309|102133912|FG013|COMPLETED|Maintenance Period||0||
48734449|NCT03364309|102133913|FG014|COMPLETED|Maintenance Period||0||
48734450|NCT03364309|102133914|FG015|COMPLETED|Maintenance Period||0||
48734451|NCT03364309|102133915|FG016|COMPLETED|Maintenance Period||0||
48734452|NCT03364309|102133916|FG017|COMPLETED|Maintenance Period||0||
48734453|NCT03364309|102133917|FG018|COMPLETED|Maintenance Period||0||
48734454|NCT03364309|102133899|FG000|NOT COMPLETED|Maintenance Period||0||
48734455|NCT03364309|102133900|FG001|NOT COMPLETED|Maintenance Period||0||
48734456|NCT03364309|102133901|FG002|NOT COMPLETED|Maintenance Period||0||
48734457|NCT03364309|102133902|FG003|NOT COMPLETED|Maintenance Period||44||
48734458|NCT03364309|102133903|FG004|NOT COMPLETED|Maintenance Period||12||
48734459|NCT03364309|102133904|FG005|NOT COMPLETED|Maintenance Period||46||
48734460|NCT03364309|102133905|FG006|NOT COMPLETED|Maintenance Period||16||
48734461|NCT03364309|102133906|FG007|NOT COMPLETED|Maintenance Period||2||
48615422|NCT02907463|101844905|FG000|Per Protocol Cohort|Overall Study||276||
48615423|NCT02907463|101844905|FG000|COMPLETED|Overall Study||243||
48615424|NCT02907463|101844905|FG000|NOT COMPLETED|Overall Study||37||
48615425|NCT02051790|101844906|FG000|STARTED|Overall Study||241||
48615426|NCT02051790|101844906|FG000|COMPLETED|Overall Study||241||
48615427|NCT02051790|101844906|FG000|NOT COMPLETED|Overall Study||0||
48734462|NCT03364309|102133907|FG008|NOT COMPLETED|Maintenance Period||6||
48734463|NCT03364309|102133908|FG009|NOT COMPLETED|Maintenance Period||4||
48734464|NCT03364309|102133909|FG010|NOT COMPLETED|Maintenance Period||6||
48734465|NCT03364309|102133910|FG011|NOT COMPLETED|Maintenance Period||0||
48734466|NCT03364309|102133911|FG012|NOT COMPLETED|Maintenance Period||0||
48734467|NCT03364309|102133912|FG013|NOT COMPLETED|Maintenance Period||0||
48734468|NCT03364309|102133913|FG014|NOT COMPLETED|Maintenance Period||0||
48734469|NCT03364309|102133914|FG015|NOT COMPLETED|Maintenance Period||0||
48734470|NCT03364309|102133915|FG016|NOT COMPLETED|Maintenance Period||0||
48734471|NCT03364309|102133916|FG017|NOT COMPLETED|Maintenance Period||0||
48734472|NCT03364309|102133917|FG018|NOT COMPLETED|Maintenance Period||0||
48734473|NCT03364309|102133899|FG000|STARTED|Re-treatment (Maintenance) Period||0||
48734474|NCT03364309|102133900|FG001|STARTED|Re-treatment (Maintenance) Period||0||
48734475|NCT03364309|102133901|FG002|STARTED|Re-treatment (Maintenance) Period||0||
48734476|NCT03364309|102133902|FG003|STARTED|Re-treatment (Maintenance) Period||0||
48734477|NCT03364309|102133903|FG004|STARTED|Re-treatment (Maintenance) Period||0||
48734478|NCT03364309|102133904|FG005|STARTED|Re-treatment (Maintenance) Period||0||
48734479|NCT03364309|102133905|FG006|STARTED|Re-treatment (Maintenance) Period||0||
48734480|NCT03364309|102133906|FG007|STARTED|Re-treatment (Maintenance) Period||0||
48734481|NCT03364309|102133907|FG008|STARTED|Re-treatment (Maintenance) Period||0||
48734482|NCT03364309|102133908|FG009|STARTED|Re-treatment (Maintenance) Period||0||
48734483|NCT03364309|102133909|FG010|STARTED|Re-treatment (Maintenance) Period||0||
48734484|NCT03364309|102133910|FG011|STARTED|Re-treatment (Maintenance) Period||2||
48734485|NCT03364309|102133911|FG012|STARTED|Re-treatment (Maintenance) Period||43||
48734486|NCT03364309|102133912|FG013|STARTED|Re-treatment (Maintenance) Period||7||
48734487|NCT03364309|102133913|FG014|STARTED|Re-treatment (Maintenance) Period||45||
48734488|NCT03364309|102133914|FG015|STARTED|Re-treatment (Maintenance) Period||10||
48734489|NCT03364309|102133915|FG016|STARTED|Re-treatment (Maintenance) Period||0||
48734490|NCT03364309|102133916|FG017|STARTED|Re-treatment (Maintenance) Period||0||
48734491|NCT03364309|102133917|FG018|STARTED|Re-treatment (Maintenance) Period||0||
48734492|NCT03364309|102133899|FG000|COMPLETED|Re-treatment (Maintenance) Period||0||
48734493|NCT03364309|102133900|FG001|COMPLETED|Re-treatment (Maintenance) Period||0||
48734494|NCT03364309|102133901|FG002|COMPLETED|Re-treatment (Maintenance) Period||0||
48734495|NCT03364309|102133902|FG003|COMPLETED|Re-treatment (Maintenance) Period||0||
48734496|NCT03364309|102133903|FG004|COMPLETED|Re-treatment (Maintenance) Period||0||
48615428|NCT01711983|101844907|FG000|STARTED|6-Month Clinical Success Evaluation||400||
48615429|NCT01711983|101844907|FG000|COMPLETED|6-Month Clinical Success Evaluation||368||
48615430|NCT01711983|101844907|FG000|NOT COMPLETED|6-Month Clinical Success Evaluation||32||
48734497|NCT03364309|102133904|FG005|COMPLETED|Re-treatment (Maintenance) Period||0||
48734498|NCT03364309|102133905|FG006|COMPLETED|Re-treatment (Maintenance) Period||0||
48734499|NCT03364309|102133906|FG007|COMPLETED|Re-treatment (Maintenance) Period||0||
48734500|NCT03364309|102133907|FG008|COMPLETED|Re-treatment (Maintenance) Period||0||
48734501|NCT03364309|102133908|FG009|COMPLETED|Re-treatment (Maintenance) Period||0||
48734502|NCT03364309|102133909|FG010|COMPLETED|Re-treatment (Maintenance) Period||0||
48734503|NCT03364309|102133910|FG011|COMPLETED|Re-treatment (Maintenance) Period||2||
48615431|NCT01711983|101844907|FG000|STARTED|6-Month Closure Evaluation||368||
48734504|NCT03364309|102133911|FG012|COMPLETED|Re-treatment (Maintenance) Period||42||
48734505|NCT03364309|102133912|FG013|COMPLETED|Re-treatment (Maintenance) Period||6||
48734506|NCT03364309|102133913|FG014|COMPLETED|Re-treatment (Maintenance) Period||43||
48615432|NCT01711983|101844907|FG000|COMPLETED|6-Month Closure Evaluation||342||
48734507|NCT03364309|102133914|FG015|COMPLETED|Re-treatment (Maintenance) Period||8||
48734508|NCT03364309|102133915|FG016|COMPLETED|Re-treatment (Maintenance) Period||0||
48734509|NCT03364309|102133916|FG017|COMPLETED|Re-treatment (Maintenance) Period||0||
48734510|NCT03364309|102133917|FG018|COMPLETED|Re-treatment (Maintenance) Period||0||
48734511|NCT03364309|102133899|FG000|NOT COMPLETED|Re-treatment (Maintenance) Period||0||
48317075|NCT01380730|101101284|FG005|Received Treatment|Overall Study||79||
48317076|NCT01380730|101101285|FG006|Received Treatment|Overall Study||79||
48317077|NCT01380730|101101286|FG007|Received Treatment|Overall Study||80||
48317078|NCT01380730|101101279|FG000|COMPLETED|Overall Study||78||
48317079|NCT01380730|101101280|FG001|COMPLETED|Overall Study||79||
48407048|NCT02985684|101328510|FG000|NOT COMPLETED|6-Month Clinical Success Evaluation||5||
48615433|NCT01711983|101844907|FG000|NOT COMPLETED|6-Month Closure Evaluation||26||
48615434|NCT01711983|101844907|FG000|STARTED|36-Month Closure Evaluation||342||
48615435|NCT01711983|101844907|FG000|COMPLETED|36-Month Closure Evaluation||278||
48615436|NCT01711983|101844907|FG000|NOT COMPLETED|36-Month Closure Evaluation||64||
48615437|NCT01289548|101844908|FG000|STARTED|Overall Study||40||
48615438|NCT01289548|101844909|FG001|STARTED|Overall Study||40||
48615439|NCT01289548|101844910|FG002|STARTED|Overall Study||40||
48615440|NCT01289548|101844908|FG000|Donors|Overall Study||20||
48615441|NCT01289548|101844909|FG001|Donors|Overall Study||20||
48615442|NCT01289548|101844910|FG002|Donors|Overall Study||20||
48615443|NCT01289548|101844908|FG000|Recipients|Overall Study||20||
48317080|NCT01380730|101101281|FG002|COMPLETED|Overall Study||79||
48317081|NCT01380730|101101282|FG003|COMPLETED|Overall Study||79||
48317082|NCT01380730|101101283|FG004|COMPLETED|Overall Study||77||
48317083|NCT01380730|101101284|FG005|COMPLETED|Overall Study||79||
48317084|NCT01380730|101101285|FG006|COMPLETED|Overall Study||79||
48317085|NCT01380730|101101286|FG007|COMPLETED|Overall Study||80||
48317086|NCT01380730|101101279|FG000|NOT COMPLETED|Overall Study||0||
48317087|NCT01380730|101101280|FG001|NOT COMPLETED|Overall Study||0||
48317088|NCT01380730|101101281|FG002|NOT COMPLETED|Overall Study||0||
48407049|NCT02985684|101328510|FG000|STARTED|6-Month Closure Success Evaluation||120||
48407050|NCT02985684|101328510|FG000|COMPLETED|6-Month Closure Success Evaluation||112||
48407051|NCT02985684|101328510|FG000|NOT COMPLETED|6-Month Closure Success Evaluation||8||
48407052|NCT03073200|101328511|FG000|STARTED|Double Blind Treatment Period||56||
48407053|NCT03073200|101328512|FG001|STARTED|Double Blind Treatment Period||115||
48407054|NCT03073200|101328513|FG002|STARTED|Double Blind Treatment Period||30||
48407055|NCT03073200|101328514|FG003|STARTED|Double Blind Treatment Period||0||
48407056|NCT03073200|101328515|FG004|STARTED|Double Blind Treatment Period||0||
48407057|NCT03073200|101328516|FG005|STARTED|Double Blind Treatment Period||0||
48407058|NCT03073200|101328517|FG006|STARTED|Double Blind Treatment Period||0||
48407059|NCT03073200|101328518|FG007|STARTED|Double Blind Treatment Period||0||
48407060|NCT03073200|101328519|FG008|STARTED|Double Blind Treatment Period||0||
48407061|NCT03073200|101328520|FG009|STARTED|Double Blind Treatment Period||0||
48407062|NCT03073200|101328521|FG010|STARTED|Double Blind Treatment Period||0||
48407063|NCT03073200|101328522|FG011|STARTED|Double Blind Treatment Period||0||
48407064|NCT03073200|101328523|FG012|STARTED|Double Blind Treatment Period||0||
48407065|NCT03073200|101328524|FG013|STARTED|Double Blind Treatment Period||0||
48407066|NCT03073200|101328525|FG014|STARTED|Double Blind Treatment Period||0||
48407067|NCT03073200|101328511|FG000|Participants in Etanercept Approved Countries|Double Blind Treatment Period||19||
48407068|NCT03073200|101328512|FG001|Participants in Etanercept Approved Countries|Double Blind Treatment Period||38||
48407069|NCT03073200|101328513|FG002|Participants in Etanercept Approved Countries|Double Blind Treatment Period||30||
48407070|NCT03073200|101328514|FG003|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0||
48407071|NCT03073200|101328515|FG004|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0||
48407072|NCT03073200|101328516|FG005|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0||
48407073|NCT03073200|101328517|FG006|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0||
48407074|NCT03073200|101328518|FG007|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0||
48407075|NCT03073200|101328519|FG008|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0||
48407076|NCT03073200|101328520|FG009|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0||
48407077|NCT03073200|101328521|FG010|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0||
48407078|NCT03073200|101328522|FG011|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0||
48615444|NCT01289548|101844909|FG001|Recipients|Overall Study||20||
48615445|NCT01289548|101844910|FG002|Recipients|Overall Study||20||
48615446|NCT01289548|101844908|FG000|COMPLETED|Overall Study||40||
48615447|NCT01289548|101844909|FG001|COMPLETED|Overall Study||40||
48615448|NCT01289548|101844910|FG002|COMPLETED|Overall Study||40||
48615449|NCT01289548|101844908|FG000|NOT COMPLETED|Overall Study||0||
48317089|NCT01380730|101101282|FG003|NOT COMPLETED|Overall Study||0||
48317090|NCT01380730|101101283|FG004|NOT COMPLETED|Overall Study||1||
48317091|NCT01380730|101101284|FG005|NOT COMPLETED|Overall Study||0||
48615450|NCT01289548|101844909|FG001|NOT COMPLETED|Overall Study||0||
48615451|NCT01289548|101844910|FG002|NOT COMPLETED|Overall Study||0||
48615452|NCT01867515|101844911|FG000|STARTED|Overall Study||13||
48615453|NCT01867515|101844912|FG001|STARTED|Overall Study||12||
48615454|NCT01867515|101844913|FG002|STARTED|Overall Study||25||
48615455|NCT01867515|101844911|FG000|COMPLETED|Overall Study||13||
48615456|NCT01867515|101844912|FG001|COMPLETED|Overall Study||11||
48615457|NCT01867515|101844913|FG002|COMPLETED|Overall Study||14||
48615458|NCT01867515|101844911|FG000|NOT COMPLETED|Overall Study||0||
48317092|NCT01380730|101101285|FG006|NOT COMPLETED|Overall Study||0||
48317093|NCT01380730|101101286|FG007|NOT COMPLETED|Overall Study||0||
48317094|NCT00595556|101101287|FG000|STARTED|Overall Study||20||
48317095|NCT00595556|101101288|FG001|STARTED|Overall Study||20||
48317096|NCT00595556|101101287|FG000|COMPLETED|Overall Study||17||
48317097|NCT00595556|101101288|FG001|COMPLETED|Overall Study||19||
48317098|NCT00595556|101101287|FG000|NOT COMPLETED|Overall Study||3||
48317099|NCT00595556|101101288|FG001|NOT COMPLETED|Overall Study||1||
48317100|NCT01476475|101101289|FG000|STARTED|Overall Study||161||
48317101|NCT01476475|101101290|FG001|STARTED|Overall Study||162||
48317102|NCT01476475|101101289|FG000|COMPLETED|Overall Study||150||
48317103|NCT01476475|101101290|FG001|COMPLETED|Overall Study||159||
48317104|NCT01476475|101101289|FG000|NOT COMPLETED|Overall Study||11||
48317105|NCT01476475|101101290|FG001|NOT COMPLETED|Overall Study||3||
48317106|NCT03028870|101101291|FG000|STARTED|Overall Study||74||
48317107|NCT03028870|101101292|FG001|STARTED|Overall Study||67||
48317108|NCT03028870|101101293|FG002|STARTED|Overall Study||76||
48317109|NCT03028870|101101294|FG003|STARTED|Overall Study||74||
48317110|NCT03028870|101101291|FG000|COMPLETED|Overall Study||57||
48317111|NCT03028870|101101292|FG001|COMPLETED|Overall Study||57||
48317112|NCT03028870|101101293|FG002|COMPLETED|Overall Study||60||
48317113|NCT03028870|101101294|FG003|COMPLETED|Overall Study||65||
48317114|NCT03028870|101101291|FG000|NOT COMPLETED|Overall Study||17||
48317115|NCT03028870|101101292|FG001|NOT COMPLETED|Overall Study||10||
48317116|NCT03028870|101101293|FG002|NOT COMPLETED|Overall Study||16||
48317117|NCT03028870|101101294|FG003|NOT COMPLETED|Overall Study||9||
48317118|NCT01021956|101101295|FG000|STARTED|Overall Study||3||
48317119|NCT01021956|101101296|FG001|STARTED|Overall Study||3||
48317120|NCT01021956|101101297|FG002|STARTED|Overall Study||3||
48317121|NCT01021956|101101298|FG003|STARTED|Overall Study||1||
48317122|NCT01021956|101101295|FG000|COMPLETED|Overall Study||3||
48317123|NCT01021956|101101296|FG001|COMPLETED|Overall Study||3||
48317124|NCT01021956|101101297|FG002|COMPLETED|Overall Study||3||
48317125|NCT01021956|101101298|FG003|COMPLETED|Overall Study||1||
48317126|NCT01021956|101101295|FG000|NOT COMPLETED|Overall Study||0||
48317127|NCT01021956|101101296|FG001|NOT COMPLETED|Overall Study||0||
48734512|NCT03364309|102133900|FG001|NOT COMPLETED|Re-treatment (Maintenance) Period||0||
48734513|NCT03364309|102133901|FG002|NOT COMPLETED|Re-treatment (Maintenance) Period||0||
48734514|NCT03364309|102133902|FG003|NOT COMPLETED|Re-treatment (Maintenance) Period||0||
48734515|NCT03364309|102133903|FG004|NOT COMPLETED|Re-treatment (Maintenance) Period||0||
48734516|NCT03364309|102133904|FG005|NOT COMPLETED|Re-treatment (Maintenance) Period||0||
48734517|NCT03364309|102133905|FG006|NOT COMPLETED|Re-treatment (Maintenance) Period||0||
48734518|NCT03364309|102133906|FG007|NOT COMPLETED|Re-treatment (Maintenance) Period||0||
48734519|NCT03364309|102133907|FG008|NOT COMPLETED|Re-treatment (Maintenance) Period||0||
48734520|NCT03364309|102133908|FG009|NOT COMPLETED|Re-treatment (Maintenance) Period||0||
48734521|NCT03364309|102133909|FG010|NOT COMPLETED|Re-treatment (Maintenance) Period||0||
48734522|NCT03364309|102133910|FG011|NOT COMPLETED|Re-treatment (Maintenance) Period||0||
48734523|NCT03364309|102133911|FG012|NOT COMPLETED|Re-treatment (Maintenance) Period||1||
48734524|NCT03364309|102133912|FG013|NOT COMPLETED|Re-treatment (Maintenance) Period||1||
48734525|NCT03364309|102133913|FG014|NOT COMPLETED|Re-treatment (Maintenance) Period||2||
48734526|NCT03364309|102133914|FG015|NOT COMPLETED|Re-treatment (Maintenance) Period||2||
48734527|NCT03364309|102133915|FG016|NOT COMPLETED|Re-treatment (Maintenance) Period||0||
48317128|NCT01021956|101101297|FG002|NOT COMPLETED|Overall Study||0||
48317129|NCT01021956|101101298|FG003|NOT COMPLETED|Overall Study||0||
48317130|NCT01423162|101101299|FG000|STARTED|Overall Study||11||
48317131|NCT01423162|101101300|FG001|STARTED|Overall Study||9||
48317132|NCT01423162|101101299|FG000|COMPLETED|Overall Study||11||
48317133|NCT01423162|101101300|FG001|COMPLETED|Overall Study||9||
48317134|NCT01423162|101101299|FG000|NOT COMPLETED|Overall Study||0||
48407079|NCT03073200|101328523|FG012|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0||
48407080|NCT03073200|101328524|FG013|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0||
48317135|NCT01423162|101101300|FG001|NOT COMPLETED|Overall Study||0||
48317136|NCT02322125|101101301|FG000|STARTED|Overall Study||12||
48317137|NCT02322125|101101301|FG000|COMPLETED|Overall Study||10||
48317138|NCT02322125|101101301|FG000|NOT COMPLETED|Overall Study||2||
48317139|NCT04050670|101101302|FG000|STARTED|Period 1||18||
48317140|NCT04050670|101101303|FG001|STARTED|Period 1||18||
48317141|NCT04050670|101101304|FG002|STARTED|Period 1||18||
48734528|NCT03364309|102133916|FG017|NOT COMPLETED|Re-treatment (Maintenance) Period||0||
48159762|NCT02201056|100715710|FG001|COMPLETED|Overall Study||6||
48159763|NCT02201056|100715711|FG002|COMPLETED|Overall Study||6||
48159764|NCT02201056|100715712|FG003|COMPLETED|Overall Study||6||
48317142|NCT04050670|101101302|FG000|Received at Least One Dose of Study Drug|Period 1||18||
48317143|NCT04050670|101101303|FG001|Received at Least One Dose of Study Drug|Period 1||18||
48317144|NCT04050670|101101304|FG002|Received at Least One Dose of Study Drug|Period 1||18||
48317145|NCT04050670|101101302|FG000|COMPLETED|Period 1||18||
48734529|NCT03364309|102133917|FG018|NOT COMPLETED|Re-treatment (Maintenance) Period||0||
48734530|NCT03364309|102133899|FG000|STARTED|Post-Treatment Followup Period||0||
48317146|NCT04050670|101101303|FG001|COMPLETED|Period 1||18||
48317147|NCT04050670|101101304|FG002|COMPLETED|Period 1||18||
48317148|NCT04050670|101101302|FG000|NOT COMPLETED|Period 1||0||
48317149|NCT04050670|101101303|FG001|NOT COMPLETED|Period 1||0||
48317150|NCT04050670|101101304|FG002|NOT COMPLETED|Period 1||0||
48317151|NCT04050670|101101302|FG000|STARTED|Period 2||18||
48317152|NCT04050670|101101303|FG001|STARTED|Period 2||18||
48317153|NCT04050670|101101304|FG002|STARTED|Period 2||18||
48317154|NCT04050670|101101302|FG000|Received at Least One Dose|Period 2||18||
48317155|NCT04050670|101101303|FG001|Received at Least One Dose|Period 2||18||
48317156|NCT04050670|101101304|FG002|Received at Least One Dose|Period 2||18||
48317157|NCT04050670|101101302|FG000|COMPLETED|Period 2||18||
48317158|NCT04050670|101101303|FG001|COMPLETED|Period 2||18||
48317159|NCT04050670|101101304|FG002|COMPLETED|Period 2||18||
48317160|NCT04050670|101101302|FG000|NOT COMPLETED|Period 2||0||
48317161|NCT04050670|101101303|FG001|NOT COMPLETED|Period 2||0||
48317162|NCT04050670|101101304|FG002|NOT COMPLETED|Period 2||0||
48615459|NCT01867515|101844912|FG001|NOT COMPLETED|Overall Study||1||
48615460|NCT01867515|101844913|FG002|NOT COMPLETED|Overall Study||11||
48615461|NCT02541422|101844914|FG000|STARTED|First Intervention||23||
48615462|NCT02541422|101844915|FG001|STARTED|First Intervention||26||
48615463|NCT02541422|101844914|FG000|COMPLETED|First Intervention||23||
48615464|NCT02541422|101844915|FG001|COMPLETED|First Intervention||26||
48615465|NCT02541422|101844914|FG000|NOT COMPLETED|First Intervention||0||
48615466|NCT02541422|101844915|FG001|NOT COMPLETED|First Intervention||0||
48615467|NCT02541422|101844914|FG000|STARTED|Second Intervention||23||
48615468|NCT02541422|101844915|FG001|STARTED|Second Intervention||26||
48615469|NCT02541422|101844914|FG000|COMPLETED|Second Intervention||23||
48615470|NCT02541422|101844915|FG001|COMPLETED|Second Intervention||26||
48615471|NCT02541422|101844914|FG000|NOT COMPLETED|Second Intervention||0||
48615472|NCT02541422|101844915|FG001|NOT COMPLETED|Second Intervention||0||
48615473|NCT00181883|101844916|FG000|STARTED|Overall Study||30||
48615474|NCT00181883|101844916|FG000|COMPLETED|Overall Study||20||
48615475|NCT00181883|101844916|FG000|NOT COMPLETED|Overall Study||10||
48615476|NCT00718094|101844917|FG000|STARTED|Overall Study||15||
48615477|NCT00718094|101844918|FG001|STARTED|Overall Study||5||
48615478|NCT00718094|101844917|FG000|COMPLETED|Overall Study||15||
48615479|NCT00718094|101844918|FG001|COMPLETED|Overall Study||5||
48615480|NCT00718094|101844917|FG000|NOT COMPLETED|Overall Study||0||
48615481|NCT00718094|101844918|FG001|NOT COMPLETED|Overall Study||0||
48615482|NCT01062893|101844919|FG000|STARTED|Overall Study||41||
48615483|NCT01062893|101844920|FG001|STARTED|Overall Study||41||
48615484|NCT01062893|101844919|FG000|COMPLETED|Overall Study||27||
48615485|NCT01062893|101844920|FG001|COMPLETED|Overall Study||28||
48615486|NCT01062893|101844919|FG000|NOT COMPLETED|Overall Study||14||
48615487|NCT01062893|101844920|FG001|NOT COMPLETED|Overall Study||13||
48615488|NCT01697800|101844921|FG000|STARTED|Overall Study||15||
48317163|NCT04050670|101101302|FG000|STARTED|Period 3||18||
48317164|NCT04050670|101101303|FG001|STARTED|Period 3||18||
48615489|NCT01697800|101844922|FG001|STARTED|Overall Study||25||
48615490|NCT01697800|101844921|FG000|COMPLETED|Overall Study||15||
48615491|NCT01697800|101844922|FG001|COMPLETED|Overall Study||24||
48615492|NCT01697800|101844921|FG000|NOT COMPLETED|Overall Study||0||
48615493|NCT01697800|101844922|FG001|NOT COMPLETED|Overall Study||1||
48615494|NCT00112918|101844923|FG000|STARTED|Overall Study||1151||
48615495|NCT00112918|101844924|FG001|STARTED|Overall Study||1155||
48615496|NCT00112918|101844925|FG002|STARTED|Overall Study||1145||
48615497|NCT00112918|101844923|FG000|Received Treatment|Overall Study||1126||
48615498|NCT00112918|101844924|FG001|Received Treatment|Overall Study||1145||
48159765|NCT02201056|100715713|FG004|COMPLETED|Overall Study||6||
48159766|NCT02201056|100715714|FG005|COMPLETED|Overall Study||6||
48159767|NCT02201056|100715715|FG006|COMPLETED|Overall Study||6||
48159768|NCT02201056|100715709|FG000|NOT COMPLETED|Overall Study||0||
48159769|NCT02201056|100715710|FG001|NOT COMPLETED|Overall Study||0||
48159770|NCT02201056|100715711|FG002|NOT COMPLETED|Overall Study||0||
48159771|NCT02201056|100715712|FG003|NOT COMPLETED|Overall Study||0||
48159772|NCT02201056|100715713|FG004|NOT COMPLETED|Overall Study||0||
48317165|NCT04050670|101101304|FG002|STARTED|Period 3||18||
48317166|NCT04050670|101101302|FG000|Received at Least One Dose|Period 3||18||
48317167|NCT04050670|101101303|FG001|Received at Least One Dose|Period 3||17||
48317168|NCT04050670|101101304|FG002|Received at Least One Dose|Period 3||18||
48615499|NCT00112918|101844925|FG002|Received Treatment|Overall Study||1135||
48615500|NCT00112918|101844923|FG000|Stage III Disease Population|Overall Study||955||
48734531|NCT03364309|102133900|FG001|STARTED|Post-Treatment Followup Period||0||
48317169|NCT04050670|101101302|FG000|COMPLETED|Period 3||18||
48317170|NCT04050670|101101303|FG001|COMPLETED|Period 3||17||
48317171|NCT04050670|101101304|FG002|COMPLETED|Period 3||18||
48317172|NCT04050670|101101302|FG000|NOT COMPLETED|Period 3||0||
48317173|NCT04050670|101101303|FG001|NOT COMPLETED|Period 3||1||
48317174|NCT04050670|101101304|FG002|NOT COMPLETED|Period 3||0||
48317175|NCT01617070|101101305|FG000|STARTED|LNAA (4 Weeks)||10||
48317176|NCT01617070|101101305|FG000|COMPLETED|LNAA (4 Weeks)||10||
48317177|NCT01617070|101101305|FG000|NOT COMPLETED|LNAA (4 Weeks)||0||
48317178|NCT01617070|101101305|FG000|STARTED|Washout (4 Weeks)||10||
48317179|NCT01617070|101101305|FG000|COMPLETED|Washout (4 Weeks)||10||
48317180|NCT01617070|101101305|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
48317181|NCT01617070|101101305|FG000|STARTED|BH4 Therapy (4 Weeks)||10||
48317182|NCT01617070|101101305|FG000|COMPLETED|BH4 Therapy (4 Weeks)||10||
48317183|NCT01617070|101101305|FG000|NOT COMPLETED|BH4 Therapy (4 Weeks)||0||
48317184|NCT01617070|101101305|FG000|STARTED|BH4 and LNAA (4 Weeks)||10||
48317185|NCT01617070|101101305|FG000|COMPLETED|BH4 and LNAA (4 Weeks)||9||
48317186|NCT01617070|101101305|FG000|NOT COMPLETED|BH4 and LNAA (4 Weeks)||1||
48317187|NCT00330876|101101306|FG000|STARTED|Overall Study||449||
48317188|NCT00330876|101101307|FG001|STARTED|Overall Study||90||
48317189|NCT00330876|101101306|FG000|COMPLETED|Overall Study||378||
48317190|NCT00330876|101101307|FG001|COMPLETED|Overall Study||77||
48317191|NCT00330876|101101306|FG000|NOT COMPLETED|Overall Study||71||
48317192|NCT00330876|101101307|FG001|NOT COMPLETED|Overall Study||13||
48317193|NCT00880399|101101308|FG000|STARTED|Overall Study||108||
48317194|NCT00880399|101101309|FG001|STARTED|Overall Study||113||
48317195|NCT00880399|101101310|FG002|STARTED|Overall Study||107||
48317196|NCT00880399|101101308|FG000|COMPLETED|Overall Study||77||
48317197|NCT00880399|101101309|FG001|COMPLETED|Overall Study||84||
48317198|NCT00880399|101101310|FG002|COMPLETED|Overall Study||81||
48317199|NCT00880399|101101308|FG000|NOT COMPLETED|Overall Study||31||
48317200|NCT00880399|101101309|FG001|NOT COMPLETED|Overall Study||29||
48317201|NCT00880399|101101310|FG002|NOT COMPLETED|Overall Study||26||
48317202|NCT01924182|101101311|FG000|STARTED|Overall Study||3||
48317203|NCT01924182|101101312|FG001|STARTED|Overall Study||0||
48317204|NCT01924182|101101311|FG000|COMPLETED|Overall Study||2||
48317205|NCT01924182|101101312|FG001|COMPLETED|Overall Study||0||
48317206|NCT01924182|101101311|FG000|NOT COMPLETED|Overall Study||1||
48317207|NCT01924182|101101312|FG001|NOT COMPLETED|Overall Study||0||
48317208|NCT00634634|101101313|FG000|STARTED|Overall Study||1||
48317209|NCT00634634|101101314|FG001|STARTED|Overall Study||3||
48317210|NCT00634634|101101315|FG002|STARTED|Overall Study||9||
48317211|NCT00634634|101101316|FG003|STARTED|Overall Study||39||
48317212|NCT00634634|101101313|FG000|COMPLETED|Overall Study||1||
48317213|NCT00634634|101101314|FG001|COMPLETED|Overall Study||3||
48317214|NCT00634634|101101315|FG002|COMPLETED|Overall Study||9||
48317215|NCT00634634|101101316|FG003|COMPLETED|Overall Study||39||
48317216|NCT00634634|101101313|FG000|NOT COMPLETED|Overall Study||0||
48317217|NCT00634634|101101314|FG001|NOT COMPLETED|Overall Study||0||
48317218|NCT00634634|101101315|FG002|NOT COMPLETED|Overall Study||0||
48317219|NCT00634634|101101316|FG003|NOT COMPLETED|Overall Study||0||
48317220|NCT02701387|101101317|FG000|STARTED|Overall Study||7||
48317221|NCT02701387|101101317|FG000|COMPLETED|Overall Study||7||
48317222|NCT02701387|101101317|FG000|NOT COMPLETED|Overall Study||0||
48317223|NCT03785925|101101318|FG000|STARTED|Overall Study||188||
48317224|NCT03785925|101101318|FG000|COMPLETED|Overall Study||172||
48317225|NCT03785925|101101318|FG000|NOT COMPLETED|Overall Study||16||
48317226|NCT01947816|101101319|FG000|STARTED|Overall Study||1593|Number of participants with CRFs attained|
48317227|NCT01947816|101101319|FG000|COMPLETED|Overall Study||1523|Number of participants not excluded from the safety and/or efficacy analysis sets|
48317228|NCT01947816|101101319|FG000|NOT COMPLETED|Overall Study||70||
48317229|NCT00396201|101101320|FG000|STARTED|Treatment Period||22||
48317230|NCT00396201|101101320|FG000|COMPLETED|Treatment Period||22||
48317231|NCT00396201|101101320|FG000|NOT COMPLETED|Treatment Period||0||
48317232|NCT00396201|101101320|FG000|STARTED|Follow-up Period||21||
48317233|NCT00396201|101101320|FG000|COMPLETED|Follow-up Period||21||
48317234|NCT00396201|101101320|FG000|NOT COMPLETED|Follow-up Period||0||
48317235|NCT01024010|101101321|FG000|STARTED|Overall Study||48||
48317236|NCT01024010|101101322|FG001|STARTED|Overall Study||34||
48317237|NCT01024010|101101321|FG000|COMPLETED|Overall Study||48||
48317238|NCT01024010|101101322|FG001|COMPLETED|Overall Study||34||
48317239|NCT01024010|101101321|FG000|NOT COMPLETED|Overall Study||0||
48317240|NCT01024010|101101322|FG001|NOT COMPLETED|Overall Study||0||
48317241|NCT01516970|101101323|FG000|STARTED|Overall Study||159||
48317242|NCT01516970|101101324|FG001|STARTED|Overall Study||153||
48317243|NCT01516970|101101323|FG000|COMPLETED|Overall Study||141||
48317244|NCT01516970|101101324|FG001|COMPLETED|Overall Study||132||
48317245|NCT01516970|101101323|FG000|NOT COMPLETED|Overall Study||18||
48317246|NCT01516970|101101324|FG001|NOT COMPLETED|Overall Study||21||
48317247|NCT02871778|101101325|FG000|STARTED|Part A: Treatment Period 1||43||
48317248|NCT02871778|101101326|FG001|STARTED|Part A: Treatment Period 1||41||
48317249|NCT02871778|101101327|FG002|STARTED|Part A: Treatment Period 1||21||
48317250|NCT02871778|101101328|FG003|STARTED|Part A: Treatment Period 1||18||
48317251|NCT02871778|101101329|FG004|STARTED|Part A: Treatment Period 1||0||
48317252|NCT02871778|101101330|FG005|STARTED|Part A: Treatment Period 1||0||
48317253|NCT02871778|101101331|FG006|STARTED|Part A: Treatment Period 1||0||
48317254|NCT02871778|101101332|FG007|STARTED|Part A: Treatment Period 1||0||
48317255|NCT02871778|101101325|FG000|Safety Analysis Set|Part A: Treatment Period 1||44||
48317256|NCT02871778|101101326|FG001|Safety Analysis Set|Part A: Treatment Period 1||40||
48317257|NCT02871778|101101327|FG002|Safety Analysis Set|Part A: Treatment Period 1||21||
48317258|NCT02871778|101101328|FG003|Safety Analysis Set|Part A: Treatment Period 1||18||
48317259|NCT02871778|101101329|FG004|Safety Analysis Set|Part A: Treatment Period 1||0||
48317260|NCT02871778|101101330|FG005|Safety Analysis Set|Part A: Treatment Period 1||0||
48317261|NCT02871778|101101331|FG006|Safety Analysis Set|Part A: Treatment Period 1||0||
48317262|NCT02871778|101101332|FG007|Safety Analysis Set|Part A: Treatment Period 1||0||
48317263|NCT02871778|101101325|FG000|COMPLETED|Part A: Treatment Period 1||40||
48317264|NCT02871778|101101326|FG001|COMPLETED|Part A: Treatment Period 1||37||
48317265|NCT02871778|101101327|FG002|COMPLETED|Part A: Treatment Period 1||18||
48317266|NCT02871778|101101328|FG003|COMPLETED|Part A: Treatment Period 1||16||
48317267|NCT02871778|101101329|FG004|COMPLETED|Part A: Treatment Period 1||0||
48317268|NCT02871778|101101330|FG005|COMPLETED|Part A: Treatment Period 1||0||
48317269|NCT02871778|101101331|FG006|COMPLETED|Part A: Treatment Period 1||0||
48317270|NCT02871778|101101332|FG007|COMPLETED|Part A: Treatment Period 1||0||
48317271|NCT02871778|101101325|FG000|NOT COMPLETED|Part A: Treatment Period 1||3||
48317272|NCT02871778|101101326|FG001|NOT COMPLETED|Part A: Treatment Period 1||4||
48317273|NCT02871778|101101327|FG002|NOT COMPLETED|Part A: Treatment Period 1||3||
48317274|NCT02871778|101101328|FG003|NOT COMPLETED|Part A: Treatment Period 1||2||
48317275|NCT02871778|101101329|FG004|NOT COMPLETED|Part A: Treatment Period 1||0||
48317276|NCT02871778|101101330|FG005|NOT COMPLETED|Part A: Treatment Period 1||0||
48317277|NCT02871778|101101331|FG006|NOT COMPLETED|Part A: Treatment Period 1||0||
48317278|NCT02871778|101101332|FG007|NOT COMPLETED|Part A: Treatment Period 1||0||
48317279|NCT02871778|101101325|FG000|STARTED|Part A: Treatment Period 2||40||
48317280|NCT02871778|101101326|FG001|STARTED|Part A: Treatment Period 2||37||
48317281|NCT02871778|101101327|FG002|STARTED|Part A: Treatment Period 2||18||
48317282|NCT02871778|101101328|FG003|STARTED|Part A: Treatment Period 2||16||
48317283|NCT02871778|101101329|FG004|STARTED|Part A: Treatment Period 2||0||
48317284|NCT02871778|101101330|FG005|STARTED|Part A: Treatment Period 2||0||
48317285|NCT02871778|101101331|FG006|STARTED|Part A: Treatment Period 2||0||
48317286|NCT02871778|101101332|FG007|STARTED|Part A: Treatment Period 2||0||
48317287|NCT02871778|101101325|FG000|Safety Analysis Set|Part A: Treatment Period 2||40||
48317288|NCT02871778|101101326|FG001|Safety Analysis Set|Part A: Treatment Period 2||37||
48317289|NCT02871778|101101327|FG002|Safety Analysis Set|Part A: Treatment Period 2||18||
48317290|NCT02871778|101101328|FG003|Safety Analysis Set|Part A: Treatment Period 2||16||
48317291|NCT02871778|101101329|FG004|Safety Analysis Set|Part A: Treatment Period 2||0||
48317292|NCT02871778|101101330|FG005|Safety Analysis Set|Part A: Treatment Period 2||0||
48317293|NCT02871778|101101331|FG006|Safety Analysis Set|Part A: Treatment Period 2||0||
48317294|NCT02871778|101101332|FG007|Safety Analysis Set|Part A: Treatment Period 2||0||
48317295|NCT02871778|101101325|FG000|COMPLETED|Part A: Treatment Period 2||37||
48317296|NCT02871778|101101326|FG001|COMPLETED|Part A: Treatment Period 2||35||
48317297|NCT02871778|101101327|FG002|COMPLETED|Part A: Treatment Period 2||17||
48317298|NCT02871778|101101328|FG003|COMPLETED|Part A: Treatment Period 2||15||
48317299|NCT02871778|101101329|FG004|COMPLETED|Part A: Treatment Period 2||0||
48317300|NCT02871778|101101330|FG005|COMPLETED|Part A: Treatment Period 2||0||
48317301|NCT02871778|101101331|FG006|COMPLETED|Part A: Treatment Period 2||0||
48159773|NCT02201056|100715714|FG005|NOT COMPLETED|Overall Study||0||
48159774|NCT02201056|100715715|FG006|NOT COMPLETED|Overall Study||0||
48159775|NCT01191840|100715716|FG000|STARTED|Overall Study||254||
48159776|NCT01191840|100715717|FG001|STARTED|Overall Study||255||
48159777|NCT01191840|100715716|FG000|COMPLETED|Overall Study||240||
48159778|NCT01191840|100715717|FG001|COMPLETED|Overall Study||240||
48159779|NCT01191840|100715716|FG000|NOT COMPLETED|Overall Study||14||
48159780|NCT01191840|100715717|FG001|NOT COMPLETED|Overall Study||15||
48159781|NCT00758459|100715718|FG000|STARTED|Overall Study||35||
48159782|NCT00758459|100715719|FG001|STARTED|Overall Study||39||
48159783|NCT00758459|100715718|FG000|COMPLETED|Overall Study||32||
48159784|NCT00758459|100715719|FG001|COMPLETED|Overall Study||35||
48317302|NCT02871778|101101332|FG007|COMPLETED|Part A: Treatment Period 2||0||
48317303|NCT02871778|101101325|FG000|NOT COMPLETED|Part A: Treatment Period 2||3||
48317304|NCT02871778|101101326|FG001|NOT COMPLETED|Part A: Treatment Period 2||2||
48317305|NCT02871778|101101327|FG002|NOT COMPLETED|Part A: Treatment Period 2||1||
48317306|NCT02871778|101101328|FG003|NOT COMPLETED|Part A: Treatment Period 2||1||
48317307|NCT02871778|101101329|FG004|NOT COMPLETED|Part A: Treatment Period 2||0||
48159785|NCT00758459|100715718|FG000|NOT COMPLETED|Overall Study||3||
48159786|NCT00758459|100715719|FG001|NOT COMPLETED|Overall Study||4||
48159787|NCT01226511|100715720|FG000|STARTED|Acute Treatment Period||140||
48159788|NCT01226511|100715721|FG001|STARTED|Acute Treatment Period||141||
48159789|NCT01226511|100715720|FG000|COMPLETED|Acute Treatment Period||108||
48159790|NCT01226511|100715721|FG001|COMPLETED|Acute Treatment Period||110||
48159791|NCT01226511|100715720|FG000|NOT COMPLETED|Acute Treatment Period||32||
48159792|NCT01226511|100715721|FG001|NOT COMPLETED|Acute Treatment Period||31||
48317308|NCT02871778|101101330|FG005|NOT COMPLETED|Part A: Treatment Period 2||0||
48317309|NCT02871778|101101331|FG006|NOT COMPLETED|Part A: Treatment Period 2||0||
48317310|NCT02871778|101101332|FG007|NOT COMPLETED|Part A: Treatment Period 2||0||
48317311|NCT02871778|101101325|FG000|STARTED|Part B: Treatment Period 3||0||
48317312|NCT02871778|101101326|FG001|STARTED|Part B: Treatment Period 3||0||
48317313|NCT02871778|101101327|FG002|STARTED|Part B: Treatment Period 3||0||
48317314|NCT02871778|101101328|FG003|STARTED|Part B: Treatment Period 3||0||
48317315|NCT02871778|101101329|FG004|STARTED|Part B: Treatment Period 3||11||
48317316|NCT02871778|101101330|FG005|STARTED|Part B: Treatment Period 3||27||
48317317|NCT02871778|101101331|FG006|STARTED|Part B: Treatment Period 3||7||
48317318|NCT02871778|101101332|FG007|STARTED|Part B: Treatment Period 3||12||
48317319|NCT02871778|101101325|FG000|Safety Analysis Set|Part B: Treatment Period 3||0||
48317320|NCT02871778|101101326|FG001|Safety Analysis Set|Part B: Treatment Period 3||0||
48317321|NCT02871778|101101327|FG002|Safety Analysis Set|Part B: Treatment Period 3||0||
48317322|NCT02871778|101101328|FG003|Safety Analysis Set|Part B: Treatment Period 3||0||
48317323|NCT02871778|101101329|FG004|Safety Analysis Set|Part B: Treatment Period 3||11||
48317324|NCT02871778|101101330|FG005|Safety Analysis Set|Part B: Treatment Period 3||27||
48317325|NCT02871778|101101331|FG006|Safety Analysis Set|Part B: Treatment Period 3||7||
48317326|NCT02871778|101101332|FG007|Safety Analysis Set|Part B: Treatment Period 3||12||
48317327|NCT02871778|101101325|FG000|COMPLETED|Part B: Treatment Period 3||0||
48317328|NCT02871778|101101326|FG001|COMPLETED|Part B: Treatment Period 3||0||
48317329|NCT02871778|101101327|FG002|COMPLETED|Part B: Treatment Period 3||0||
48317330|NCT02871778|101101328|FG003|COMPLETED|Part B: Treatment Period 3||0||
48317331|NCT02871778|101101329|FG004|COMPLETED|Part B: Treatment Period 3||10||
48317332|NCT02871778|101101330|FG005|COMPLETED|Part B: Treatment Period 3||26||
48317333|NCT02871778|101101331|FG006|COMPLETED|Part B: Treatment Period 3||6||
48317334|NCT02871778|101101332|FG007|COMPLETED|Part B: Treatment Period 3||12||
48317335|NCT02871778|101101325|FG000|NOT COMPLETED|Part B: Treatment Period 3||0||
48317336|NCT02871778|101101326|FG001|NOT COMPLETED|Part B: Treatment Period 3||0||
48317337|NCT02871778|101101327|FG002|NOT COMPLETED|Part B: Treatment Period 3||0||
48317338|NCT02871778|101101328|FG003|NOT COMPLETED|Part B: Treatment Period 3||0||
48317339|NCT02871778|101101329|FG004|NOT COMPLETED|Part B: Treatment Period 3||1||
48317340|NCT02871778|101101330|FG005|NOT COMPLETED|Part B: Treatment Period 3||1||
48317341|NCT02871778|101101331|FG006|NOT COMPLETED|Part B: Treatment Period 3||1||
48317342|NCT02871778|101101332|FG007|NOT COMPLETED|Part B: Treatment Period 3||0||
48317343|NCT01517893|101104010|FG000|STARTED|Overall Study||8||
48317344|NCT01517893|101104011|FG001|STARTED|Overall Study||7||
48317345|NCT01517893|101104010|FG000|COMPLETED|Overall Study||5||
48317346|NCT01517893|101104011|FG001|COMPLETED|Overall Study||7||
48317347|NCT01517893|101104010|FG000|NOT COMPLETED|Overall Study||3||
48317348|NCT01517893|101104011|FG001|NOT COMPLETED|Overall Study||0||
48317349|NCT01999465|101104012|FG000|STARTED|Overall Study||10||
48317350|NCT01999465|101104013|FG001|STARTED|Overall Study||10||
48317351|NCT01999465|101104012|FG000|COMPLETED|Overall Study||10||
48317352|NCT01999465|101104013|FG001|COMPLETED|Overall Study||7||
48317353|NCT01999465|101104012|FG000|NOT COMPLETED|Overall Study||0||
48317354|NCT01999465|101104013|FG001|NOT COMPLETED|Overall Study||3||
48317355|NCT01489670|101104014|FG000|STARTED|Overall Study||387||
48317356|NCT01489670|101104014|FG000|COMPLETED|Overall Study||334||
48317357|NCT01489670|101104014|FG000|NOT COMPLETED|Overall Study||53||
48317358|NCT00876187|101104015|FG000|STARTED|Overall Study||233||
48734532|NCT03364309|102133901|FG002|STARTED|Post-Treatment Followup Period||0||
48159793|NCT01226511|100715720|FG000|STARTED|Extension Treatment Period||108||
48159794|NCT01226511|100715721|FG001|STARTED|Extension Treatment Period||110||
48159795|NCT01226511|100715720|FG000|COMPLETED|Extension Treatment Period||81||
48159796|NCT01226511|100715721|FG001|COMPLETED|Extension Treatment Period||83||
48159797|NCT01226511|100715720|FG000|NOT COMPLETED|Extension Treatment Period||27||
48734533|NCT03364309|102133902|FG003|STARTED|Post-Treatment Followup Period||0||
48734534|NCT03364309|102133903|FG004|STARTED|Post-Treatment Followup Period||0||
48734535|NCT03364309|102133904|FG005|STARTED|Post-Treatment Followup Period||0||
48734536|NCT03364309|102133905|FG006|STARTED|Post-Treatment Followup Period||0||
48159798|NCT01226511|100715721|FG001|NOT COMPLETED|Extension Treatment Period||27||
48159799|NCT01226511|100715720|FG000|STARTED|Taper Period||51||
48159800|NCT01226511|100715721|FG001|STARTED|Taper Period||57||
48159801|NCT01226511|100715720|FG000|COMPLETED|Taper Period||46||
48159802|NCT01226511|100715721|FG001|COMPLETED|Taper Period||54||
48159803|NCT01226511|100715720|FG000|NOT COMPLETED|Taper Period||5||
48159804|NCT01226511|100715721|FG001|NOT COMPLETED|Taper Period||3||
48159805|NCT01986881|100715722|FG000|STARTED|Overall Study||2752||
48317359|NCT00876187|101104016|FG001|STARTED|Overall Study||233||
48317360|NCT00876187|101104017|FG002|STARTED|Overall Study||298||
48317361|NCT00876187|101104018|FG003|STARTED|Overall Study||297||
48317362|NCT00876187|101104019|FG004|STARTED|Overall Study||298||
48317363|NCT00876187|101104015|FG000|Treated|Overall Study||230||
48317364|NCT00876187|101104016|FG001|Treated|Overall Study||232||
48734537|NCT03364309|102133906|FG007|STARTED|Post-Treatment Followup Period||0||
48734538|NCT03364309|102133907|FG008|STARTED|Post-Treatment Followup Period||0||
48734539|NCT03364309|102133908|FG009|STARTED|Post-Treatment Followup Period||0||
48159806|NCT01986881|100715723|FG001|STARTED|Overall Study||2747||
48159807|NCT01986881|100715724|FG002|STARTED|Overall Study||2747||
48159808|NCT01986881|100715722|FG000|Treated|Overall Study||2746||
48159809|NCT01986881|100715723|FG001|Treated|Overall Study||2747||
48159810|NCT01986881|100715724|FG002|Treated|Overall Study||2745||
48159811|NCT01986881|100715722|FG000|Participants Enrolled in the Insulin +/- Metformin Glycemic Sub-Study|Overall Study||348||
48159812|NCT01986881|100715723|FG001|Participants Enrolled in the Insulin +/- Metformin Glycemic Sub-Study|Overall Study||370||
48159813|NCT01986881|100715724|FG002|Participants Enrolled in the Insulin +/- Metformin Glycemic Sub-Study|Overall Study||347||
48159814|NCT01986881|100715722|FG000|Participants Enrolled in the Sulfonylurea Monotherapy Glycemic Sub-Study|Overall Study||55||
48159815|NCT01986881|100715723|FG001|Participants Enrolled in the Sulfonylurea Monotherapy Glycemic Sub-Study|Overall Study||54||
48159816|NCT01986881|100715724|FG002|Participants Enrolled in the Sulfonylurea Monotherapy Glycemic Sub-Study|Overall Study||48||
48159817|NCT01986881|100715722|FG000|Participants Enrolled in the Metformin With Sulfonylurea Glycemic Sub-Study|Overall Study||100||
48159818|NCT01986881|100715723|FG001|Participants Enrolled in the Metformin With Sulfonylurea Glycemic Sub-Study|Overall Study||113||
48159819|NCT01986881|100715724|FG002|Participants Enrolled in the Metformin With Sulfonylurea Glycemic Sub-Study|Overall Study||117||
48159820|NCT01986881|100715722|FG000|COMPLETED|Overall Study||2422||
48159821|NCT01986881|100715723|FG001|COMPLETED|Overall Study||2401||
48159822|NCT01986881|100715724|FG002|COMPLETED|Overall Study||2389||
48159823|NCT01986881|100715722|FG000|NOT COMPLETED|Overall Study||330||
48159824|NCT01986881|100715723|FG001|NOT COMPLETED|Overall Study||346||
48159825|NCT01986881|100715724|FG002|NOT COMPLETED|Overall Study||358||
48159826|NCT02416492|100715725|FG000|STARTED|Overall Study||15||
48159827|NCT02416492|100715726|FG001|STARTED|Overall Study||15||
48159828|NCT02416492|100715727|FG002|STARTED|Overall Study||16||
48159829|NCT02416492|100715728|FG003|STARTED|Overall Study||15||
48159830|NCT02416492|100715725|FG000|COMPLETED|Overall Study||15||
48159831|NCT02416492|100715726|FG001|COMPLETED|Overall Study||15||
48159832|NCT02416492|100715727|FG002|COMPLETED|Overall Study||16||
48159833|NCT02416492|100715728|FG003|COMPLETED|Overall Study||15||
48159834|NCT02416492|100715725|FG000|NOT COMPLETED|Overall Study||0||
48159835|NCT02416492|100715726|FG001|NOT COMPLETED|Overall Study||0||
48159836|NCT02416492|100715727|FG002|NOT COMPLETED|Overall Study||0||
48159837|NCT02416492|100715728|FG003|NOT COMPLETED|Overall Study||0||
48159838|NCT03338621|100715729|FG000|STARTED|Overall Study||150||
48159839|NCT03338621|100715730|FG001|STARTED|Overall Study||153||
48159840|NCT03338621|100715731|FG002|STARTED|Overall Study||152||
48159841|NCT03338621|100715729|FG000|COMPLETED|Overall Study||121||
48159842|NCT03338621|100715730|FG001|COMPLETED|Overall Study||134||
48159843|NCT03338621|100715731|FG002|COMPLETED|Overall Study||117||
48159844|NCT03338621|100715729|FG000|NOT COMPLETED|Overall Study||29||
48159845|NCT03338621|100715730|FG001|NOT COMPLETED|Overall Study||19||
48159846|NCT03338621|100715731|FG002|NOT COMPLETED|Overall Study||35||
48159847|NCT04766086|100715732|FG000|STARTED|Overall Study||103||
48159848|NCT04766086|100715733|FG001|STARTED|Overall Study||99||
48159849|NCT04766086|100715734|FG002|STARTED|Overall Study||104||
48159850|NCT04766086|100715732|FG000|Vaccinated|Overall Study||102||
48159851|NCT04766086|100715733|FG001|Vaccinated|Overall Study||99||
48159852|NCT04766086|100715734|FG002|Vaccinated|Overall Study||103||
48159853|NCT04766086|100715732|FG000|COMPLETED|Overall Study||99||
48159854|NCT04766086|100715733|FG001|COMPLETED|Overall Study||93||
48159855|NCT04766086|100715734|FG002|COMPLETED|Overall Study||98||
48159856|NCT04766086|100715732|FG000|NOT COMPLETED|Overall Study||4||
48159857|NCT04766086|100715733|FG001|NOT COMPLETED|Overall Study||6||
48159858|NCT04766086|100715734|FG002|NOT COMPLETED|Overall Study||6||
48159859|NCT04382924|100715735|FG000|STARTED|Overall Study||52||
48159860|NCT04382924|100715736|FG001|STARTED|Overall Study||56||
48159861|NCT04382924|100715737|FG002|STARTED|Overall Study||60||
48159862|NCT04382924|100715735|FG000|COMPLETED|Overall Study||44||
48159863|NCT04382924|100715736|FG001|COMPLETED|Overall Study||46||
48159864|NCT04382924|100715737|FG002|COMPLETED|Overall Study||48||
48159865|NCT04382924|100715735|FG000|NOT COMPLETED|Overall Study||8||
48159866|NCT04382924|100715736|FG001|NOT COMPLETED|Overall Study||10||
48159867|NCT04382924|100715737|FG002|NOT COMPLETED|Overall Study||12||
48159868|NCT00045435|100715738|FG000|STARTED|Overall Study||17||
48159869|NCT00045435|100715738|FG000|COMPLETED|Overall Study||17||
48159870|NCT00045435|100715738|FG000|NOT COMPLETED|Overall Study||0||
48159871|NCT02252432|100715739|FG000|STARTED|Overall Study||5||
48159872|NCT02252432|100715740|FG001|STARTED|Overall Study||6||
48159873|NCT02252432|100715741|FG002|STARTED|Overall Study||2||
48317365|NCT00876187|101104017|FG002|Treated|Overall Study||295||
48159874|NCT02252432|100715739|FG000|COMPLETED|Overall Study||5||
48159875|NCT02252432|100715740|FG001|COMPLETED|Overall Study||6||
48159876|NCT02252432|100715741|FG002|COMPLETED|Overall Study||2||
48159877|NCT02252432|100715739|FG000|NOT COMPLETED|Overall Study||0||
48159878|NCT02252432|100715740|FG001|NOT COMPLETED|Overall Study||0||
48159879|NCT02252432|100715741|FG002|NOT COMPLETED|Overall Study||0||
48159880|NCT04860518|100715742|FG000|STARTED|Overall Study||3||
48159881|NCT04860518|100715743|FG001|STARTED|Overall Study||4||
48159882|NCT04860518|100715742|FG000|COMPLETED|Overall Study||2||
48159883|NCT04860518|100715743|FG001|COMPLETED|Overall Study||3||
48317366|NCT00876187|101104018|FG003|Treated|Overall Study||295||
48159884|NCT04860518|100715742|FG000|NOT COMPLETED|Overall Study||1||
48159885|NCT04860518|100715743|FG001|NOT COMPLETED|Overall Study||1||
48159886|NCT01436201|100715744|FG000|STARTED|Overall Study||24||
48159887|NCT01436201|100715744|FG000|Received at Least 1 Dose of Study Drug|Overall Study||24||
48159888|NCT01436201|100715744|FG000|COMPLETED|Overall Study||20||
48159889|NCT01436201|100715744|FG000|NOT COMPLETED|Overall Study||4||
48159890|NCT02130284|100715745|FG000|STARTED|Overall Study||80||
48159891|NCT02130284|100715745|FG000|COMPLETED|Overall Study||71||
48159892|NCT02130284|100715745|FG000|NOT COMPLETED|Overall Study||9||
48159893|NCT02348684|100715746|FG000|STARTED|Overall Study||20||
48159894|NCT02348684|100715746|FG000|COMPLETED|Overall Study||20||
48159895|NCT02348684|100715746|FG000|NOT COMPLETED|Overall Study||0||
48159896|NCT00384059|100715747|FG000|STARTED|Infant Series||141||
48159897|NCT00384059|100715748|FG001|STARTED|Infant Series||145||
48159898|NCT00384059|100715747|FG000|Vaccinated Dose 1|Infant Series||139||
48159899|NCT00384059|100715748|FG001|Vaccinated Dose 1|Infant Series||139||
48159900|NCT00384059|100715747|FG000|Vaccinated Dose 2|Infant Series||136||
48159901|NCT00384059|100715748|FG001|Vaccinated Dose 2|Infant Series||135||
48159902|NCT00384059|100715747|FG000|COMPLETED|Infant Series||135||
48159903|NCT00384059|100715748|FG001|COMPLETED|Infant Series||132||
48159904|NCT00384059|100715747|FG000|NOT COMPLETED|Infant Series||6||
48317367|NCT00876187|101104019|FG004|Treated|Overall Study||295||
48317368|NCT00876187|101104015|FG000|Completed Treatment|Overall Study||128||
48317369|NCT00876187|101104016|FG001|Completed Treatment|Overall Study||146||
48317370|NCT00876187|101104017|FG002|Completed Treatment|Overall Study||193||
48317371|NCT00876187|101104018|FG003|Completed Treatment|Overall Study||188||
48317372|NCT00876187|101104019|FG004|Completed Treatment|Overall Study||185||
48615501|NCT00112918|101844924|FG001|Stage III Disease Population|Overall Study||960||
48615502|NCT00112918|101844925|FG002|Stage III Disease Population|Overall Study||952||
48615503|NCT00112918|101844923|FG000|COMPLETED|Overall Study||854||
48615504|NCT00112918|101844924|FG001|COMPLETED|Overall Study||810||
48615505|NCT00112918|101844925|FG002|COMPLETED|Overall Study||846||
48615506|NCT00112918|101844923|FG000|NOT COMPLETED|Overall Study||297||
48615507|NCT00112918|101844924|FG001|NOT COMPLETED|Overall Study||345||
48615508|NCT00112918|101844925|FG002|NOT COMPLETED|Overall Study||299||
48159905|NCT00384059|100715748|FG001|NOT COMPLETED|Infant Series||13||
48159906|NCT00384059|100715747|FG000|STARTED|After Infant Series||135||
48159907|NCT00384059|100715748|FG001|STARTED|After Infant Series||132||
48159908|NCT00384059|100715747|FG000|COMPLETED|After Infant Series||131||
48159909|NCT00384059|100715748|FG001|COMPLETED|After Infant Series||122||
48159910|NCT00384059|100715747|FG000|NOT COMPLETED|After Infant Series||4||
48159911|NCT00384059|100715748|FG001|NOT COMPLETED|After Infant Series||10||
48159912|NCT00384059|100715747|FG000|STARTED|Toddler Dose||131||
48159913|NCT00384059|100715748|FG001|STARTED|Toddler Dose||122||
48159914|NCT00384059|100715747|FG000|COMPLETED|Toddler Dose||130||
48159915|NCT00384059|100715748|FG001|COMPLETED|Toddler Dose||120||
48159916|NCT00384059|100715747|FG000|NOT COMPLETED|Toddler Dose||1||
48159917|NCT00384059|100715748|FG001|NOT COMPLETED|Toddler Dose||2||
48159918|NCT00524225|100715749|FG000|STARTED|Overall Study||3||
48159919|NCT00524225|100715749|FG000|COMPLETED|Overall Study||3||
48159920|NCT00524225|100715749|FG000|NOT COMPLETED|Overall Study||0||
48159921|NCT02277743|100715750|FG000|STARTED|Overall Study||224||
48159922|NCT02277743|100715751|FG001|STARTED|Overall Study||224||
48159923|NCT02277743|100715752|FG002|STARTED|Overall Study||223||
48159924|NCT02277743|100715750|FG000|Treated|Overall Study||223||
48159925|NCT02277743|100715751|FG001|Treated|Overall Study||223||
48159926|NCT02277743|100715752|FG002|Treated|Overall Study||223||
48159927|NCT02277743|100715750|FG000|Safety Population|Overall Study||222||
48159928|NCT02277743|100715751|FG001|Safety Population|Overall Study||229||
48159929|NCT02277743|100715752|FG002|Safety Population|Overall Study||218||
48159930|NCT02277743|100715750|FG000|COMPLETED|Overall Study||184||
48159931|NCT02277743|100715751|FG001|COMPLETED|Overall Study||208||
48159932|NCT02277743|100715752|FG002|COMPLETED|Overall Study||197||
48159933|NCT02277743|100715750|FG000|NOT COMPLETED|Overall Study||40||
48317373|NCT00876187|101104015|FG000|COMPLETED|Overall Study||23||
48317374|NCT00876187|101104016|FG001|COMPLETED|Overall Study||18||
48615509|NCT00871624|101844926|FG000|STARTED|Overall Study||18||
48615510|NCT00871624|101844927|FG001|STARTED|Overall Study||18||
48615511|NCT00871624|101844926|FG000|COMPLETED|Overall Study||16||
48615512|NCT00871624|101844927|FG001|COMPLETED|Overall Study||17||
48615513|NCT00871624|101844926|FG000|NOT COMPLETED|Overall Study||2||
48159934|NCT02277743|100715751|FG001|NOT COMPLETED|Overall Study||16||
48159935|NCT02277743|100715752|FG002|NOT COMPLETED|Overall Study||26||
48159936|NCT00871689|100715753|FG000|STARTED|Overall Study||2||
48159937|NCT00871689|100715753|FG000|COMPLETED|Overall Study||2||
48159938|NCT00871689|100715753|FG000|NOT COMPLETED|Overall Study||0||
48159939|NCT03786952|100715754|FG000|STARTED|Overall Study||56||
48159940|NCT03786952|100715755|FG001|STARTED|Overall Study||59||
48159941|NCT03786952|100715756|FG002|STARTED|Overall Study||58||
48159942|NCT03786952|100715757|FG003|STARTED|Overall Study||57||
48159943|NCT03786952|100715758|FG004|STARTED|Overall Study||97||
48159944|NCT03786952|100715759|FG005|STARTED|Overall Study||87||
48159945|NCT03786952|100715760|FG006|STARTED|Overall Study||94||
48317375|NCT00876187|101104017|FG002|COMPLETED|Overall Study||19||
48615514|NCT00871624|101844927|FG001|NOT COMPLETED|Overall Study||1||
48615515|NCT02247739|101844928|FG000|STARTED|Overall Study||5||
48615516|NCT02247739|101844929|FG001|STARTED|Overall Study||6||
48615517|NCT02247739|101844930|FG002|STARTED|Overall Study||5||
48615518|NCT02247739|101844931|FG003|STARTED|Overall Study||5||
48615519|NCT02247739|101844932|FG004|STARTED|Overall Study||6||
48615520|NCT02247739|101844933|FG005|STARTED|Overall Study||5||
48615521|NCT02247739|101844928|FG000|COMPLETED|Overall Study||5||
48615522|NCT02247739|101844929|FG001|COMPLETED|Overall Study||3||
48734540|NCT03364309|102133909|FG010|STARTED|Post-Treatment Followup Period||0||
48407081|NCT03073200|101328525|FG014|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0||
48407082|NCT03073200|101328511|FG000|COMPLETED|Double Blind Treatment Period||54||
48407083|NCT03073200|101328512|FG001|COMPLETED|Double Blind Treatment Period||114||
48407084|NCT03073200|101328513|FG002|COMPLETED|Double Blind Treatment Period||30||
48407085|NCT03073200|101328514|FG003|COMPLETED|Double Blind Treatment Period||0||
48159946|NCT03786952|100715761|FG007|STARTED|Overall Study||98||
48159947|NCT03786952|100715754|FG000|COMPLETED|Overall Study||56||
48159948|NCT03786952|100715755|FG001|COMPLETED|Overall Study||59||
48159949|NCT03786952|100715756|FG002|COMPLETED|Overall Study||58||
48159950|NCT03786952|100715757|FG003|COMPLETED|Overall Study||57||
48159951|NCT03786952|100715758|FG004|COMPLETED|Overall Study||97||
48159952|NCT03786952|100715759|FG005|COMPLETED|Overall Study||87||
48159953|NCT03786952|100715760|FG006|COMPLETED|Overall Study||94||
48159954|NCT03786952|100715761|FG007|COMPLETED|Overall Study||98||
48407086|NCT03073200|101328515|FG004|COMPLETED|Double Blind Treatment Period||0||
48407087|NCT03073200|101328516|FG005|COMPLETED|Double Blind Treatment Period||0||
48407088|NCT03073200|101328517|FG006|COMPLETED|Double Blind Treatment Period||0||
48734541|NCT03364309|102133910|FG011|STARTED|Post-Treatment Followup Period||0||
48734542|NCT03364309|102133911|FG012|STARTED|Post-Treatment Followup Period||0||
48734543|NCT03364309|102133912|FG013|STARTED|Post-Treatment Followup Period||0||
48734544|NCT03364309|102133913|FG014|STARTED|Post-Treatment Followup Period||0||
48734545|NCT03364309|102133914|FG015|STARTED|Post-Treatment Followup Period||0||
48734546|NCT03364309|102133915|FG016|STARTED|Post-Treatment Followup Period||11||
48734547|NCT03364309|102133916|FG017|STARTED|Post-Treatment Followup Period||375||
48734548|NCT03364309|102133917|FG018|STARTED|Post-Treatment Followup Period||2||
48734549|NCT03364309|102133899|FG000|COMPLETED|Post-Treatment Followup Period||0||
48407089|NCT03073200|101328518|FG007|COMPLETED|Double Blind Treatment Period||0||
48407090|NCT03073200|101328519|FG008|COMPLETED|Double Blind Treatment Period||0||
48407091|NCT03073200|101328520|FG009|COMPLETED|Double Blind Treatment Period||0||
48734550|NCT03364309|102133900|FG001|COMPLETED|Post-Treatment Followup Period||0||
48734551|NCT03364309|102133901|FG002|COMPLETED|Post-Treatment Followup Period||0||
48734552|NCT03364309|102133902|FG003|COMPLETED|Post-Treatment Followup Period||0||
48734553|NCT03364309|102133903|FG004|COMPLETED|Post-Treatment Followup Period||0||
48159955|NCT03786952|100715754|FG000|NOT COMPLETED|Overall Study||0||
48407092|NCT03073200|101328521|FG010|COMPLETED|Double Blind Treatment Period||0||
48407093|NCT03073200|101328522|FG011|COMPLETED|Double Blind Treatment Period||0||
48407094|NCT03073200|101328523|FG012|COMPLETED|Double Blind Treatment Period||0||
48615523|NCT02247739|101844930|FG002|COMPLETED|Overall Study||4||
48615524|NCT02247739|101844931|FG003|COMPLETED|Overall Study||5||
48615525|NCT02247739|101844932|FG004|COMPLETED|Overall Study||5||
48615526|NCT02247739|101844933|FG005|COMPLETED|Overall Study||4||
48615527|NCT02247739|101844928|FG000|NOT COMPLETED|Overall Study||0||
48615528|NCT02247739|101844929|FG001|NOT COMPLETED|Overall Study||3||
48615529|NCT02247739|101844930|FG002|NOT COMPLETED|Overall Study||1||
48615530|NCT02247739|101844931|FG003|NOT COMPLETED|Overall Study||0||
48615531|NCT02247739|101844932|FG004|NOT COMPLETED|Overall Study||1||
48615532|NCT02247739|101844933|FG005|NOT COMPLETED|Overall Study||1||
48615533|NCT03565874|101844934|FG000|STARTED|Overall Study||6||
48615534|NCT03565874|101844934|FG000|COMPLETED|Overall Study||4||
48615535|NCT03565874|101844934|FG000|NOT COMPLETED|Overall Study||2||
48615536|NCT02061813|101844935|FG000|STARTED|Overall Study||40||160
48615537|NCT02061813|101844935|FG000|Abametapir Lotion|Overall Study||40||40
48615538|NCT02061813|101844935|FG000|Vehicle Lotion|Overall Study||40||40
48615539|NCT02061813|101844935|FG000|Saline 0.9%|Overall Study||40||40
48159956|NCT03786952|100715755|FG001|NOT COMPLETED|Overall Study||0||
48159957|NCT03786952|100715756|FG002|NOT COMPLETED|Overall Study||0||
48159958|NCT03786952|100715757|FG003|NOT COMPLETED|Overall Study||0||
48615540|NCT02061813|101844935|FG000|SLS 0.2%|Overall Study||40||40
48159959|NCT03786952|100715758|FG004|NOT COMPLETED|Overall Study||0||
48159960|NCT03786952|100715759|FG005|NOT COMPLETED|Overall Study||0||
48159961|NCT03786952|100715760|FG006|NOT COMPLETED|Overall Study||0||
48159962|NCT03786952|100715761|FG007|NOT COMPLETED|Overall Study||0||
48159963|NCT00117156|100715762|FG000|STARTED|Overall Study||26||
48159964|NCT00117156|100715762|FG000|COMPLETED|Overall Study||15||
48159965|NCT00117156|100715762|FG000|NOT COMPLETED|Overall Study||11||
48159966|NCT02755597|100715763|FG000|STARTED|Overall Study||194||
48734554|NCT03364309|102133904|FG005|COMPLETED|Post-Treatment Followup Period||0||
48734555|NCT03364309|102133905|FG006|COMPLETED|Post-Treatment Followup Period||0||
48734556|NCT03364309|102133906|FG007|COMPLETED|Post-Treatment Followup Period||0||
48734557|NCT03364309|102133907|FG008|COMPLETED|Post-Treatment Followup Period||0||
48317376|NCT00876187|101104018|FG003|COMPLETED|Overall Study||22||
48317377|NCT00876187|101104019|FG004|COMPLETED|Overall Study||27||
48317378|NCT00876187|101104015|FG000|NOT COMPLETED|Overall Study||210||
48317379|NCT00876187|101104016|FG001|NOT COMPLETED|Overall Study||215||
48317380|NCT00876187|101104017|FG002|NOT COMPLETED|Overall Study||279||
48317381|NCT00876187|101104018|FG003|NOT COMPLETED|Overall Study||275||
48317382|NCT00876187|101104019|FG004|NOT COMPLETED|Overall Study||271||
48317383|NCT03200366|101104020|FG000|STARTED|Baseline Interview With Randomization||123||
48317384|NCT03200366|101104021|FG001|STARTED|Baseline Interview With Randomization||120||
48317385|NCT03200366|101104022|FG002|STARTED|Baseline Interview With Randomization||128||
48317386|NCT03200366|101104020|FG000|COMPLETED|Baseline Interview With Randomization||123||
48317387|NCT03200366|101104021|FG001|COMPLETED|Baseline Interview With Randomization||120||
48317388|NCT03200366|101104022|FG002|COMPLETED|Baseline Interview With Randomization||128||
48317389|NCT03200366|101104020|FG000|NOT COMPLETED|Baseline Interview With Randomization||0||
48317390|NCT03200366|101104021|FG001|NOT COMPLETED|Baseline Interview With Randomization||0||
48317391|NCT03200366|101104022|FG002|NOT COMPLETED|Baseline Interview With Randomization||0||
48317392|NCT03200366|101104020|FG000|STARTED|Tailored DVD Intervention Given||123||
48317393|NCT03200366|101104021|FG001|STARTED|Tailored DVD Intervention Given||120||
48317394|NCT03200366|101104022|FG002|STARTED|Tailored DVD Intervention Given||0||
48317395|NCT03200366|101104020|FG000|COMPLETED|Tailored DVD Intervention Given||123|Tailored DVD mailed 1-2 days post-randomization to participants in the 2 intervention arms: Tailored DVD and Tailored DVD + Patient Navigation. DVD was NOT mailed to participants in Usual Care arm.|
48317396|NCT03200366|101104021|FG001|COMPLETED|Tailored DVD Intervention Given||120|Tailored DVD mailed 1-2 days post-randomization to participants in the 2 intervention arms: Tailored DVD and Tailored DVD + Patient Navigation. DVD was NOT mailed to participants in Usual Care arm.|
48317397|NCT03200366|101104022|FG002|COMPLETED|Tailored DVD Intervention Given||0|Tailored DVD mailed 1-2 days post-randomization to participants in the 2 intervention arms: Tailored DVD and Tailored DVD + Patient Navigation. DVD was NOT mailed to participants in Usual Care arm.|
48317398|NCT03200366|101104020|FG000|NOT COMPLETED|Tailored DVD Intervention Given||0||
48317399|NCT03200366|101104021|FG001|NOT COMPLETED|Tailored DVD Intervention Given||0||
48317400|NCT03200366|101104022|FG002|NOT COMPLETED|Tailored DVD Intervention Given||0||
48317401|NCT03200366|101104020|FG000|STARTED|Patient Navigation Intervention Given||0|Patient Navigation delivered from 2 weeks post-randomization up to 6 months post-randomization to only participants in Tailored DVD + Patient Navigation arm.|
48317402|NCT03200366|101104021|FG001|STARTED|Patient Navigation Intervention Given||120|Patient Navigation delivered from 2 weeks post-randomization up to 6 months post-randomization to only participants in Tailored DVD + Patient Navigation arm.|
48317403|NCT03200366|101104022|FG002|STARTED|Patient Navigation Intervention Given||0|Patient Navigation delivered from 2 weeks post-randomization up to 6 months post-randomization to only participants in Tailored DVD + Patient Navigation arm.|
48317404|NCT03200366|101104020|FG000|COMPLETED|Patient Navigation Intervention Given||0||
48317405|NCT03200366|101104021|FG001|COMPLETED|Patient Navigation Intervention Given||89||
48317406|NCT03200366|101104022|FG002|COMPLETED|Patient Navigation Intervention Given||0||
48317407|NCT03200366|101104020|FG000|NOT COMPLETED|Patient Navigation Intervention Given||0||
48317408|NCT03200366|101104021|FG001|NOT COMPLETED|Patient Navigation Intervention Given||31||
48317409|NCT03200366|101104022|FG002|NOT COMPLETED|Patient Navigation Intervention Given||0||
48317410|NCT03200366|101104020|FG000|STARTED|6 Month Post-Baseline Interview||123|"Started number excludes 2 participants in Tailored DVD +Patient Navigation arm that were deceased before 6 month post-baseline timepoint."|
48317411|NCT03200366|101104021|FG001|STARTED|6 Month Post-Baseline Interview||118|"Started number excludes 2 participants in Tailored DVD +Patient Navigation arm that were deceased before 6 month post-baseline timepoint."|
48317412|NCT03200366|101104022|FG002|STARTED|6 Month Post-Baseline Interview||128|"Started number excludes 2 participants in Tailored DVD +Patient Navigation arm that were deceased before 6 month post-baseline timepoint."|
48317413|NCT03200366|101104020|FG000|COMPLETED|6 Month Post-Baseline Interview||93||
48317414|NCT03200366|101104021|FG001|COMPLETED|6 Month Post-Baseline Interview||95||
48317415|NCT03200366|101104022|FG002|COMPLETED|6 Month Post-Baseline Interview||109||
48317416|NCT03200366|101104020|FG000|NOT COMPLETED|6 Month Post-Baseline Interview||30||
48317417|NCT03200366|101104021|FG001|NOT COMPLETED|6 Month Post-Baseline Interview||23||
48317418|NCT03200366|101104022|FG002|NOT COMPLETED|6 Month Post-Baseline Interview||19||
48317419|NCT03200366|101104020|FG000|STARTED|9 Month Post-Baseline Interview||121|"Started number excludes participants that were deceased or withdrawn before 9 month post-baseline timepoint: Tailored DVD arm n=2; Tailored DVD + Patient Navigation arm n=4; and Usual Care arm n=1."|
48317420|NCT03200366|101104021|FG001|STARTED|9 Month Post-Baseline Interview||116|"Started number excludes participants that were deceased or withdrawn before 9 month post-baseline timepoint: Tailored DVD arm n=2; Tailored DVD + Patient Navigation arm n=4; and Usual Care arm n=1."|
48317421|NCT03200366|101104022|FG002|STARTED|9 Month Post-Baseline Interview||127|"Started number excludes participants that were deceased or withdrawn before 9 month post-baseline timepoint: Tailored DVD arm n=2; Tailored DVD + Patient Navigation arm n=4; and Usual Care arm n=1."|
48615541|NCT02061813|101844935|FG000|COMPLETED|Overall Study||37||148
48615542|NCT02061813|101844935|FG000|NOT COMPLETED|Overall Study||3||12
48615543|NCT02459197|101844936|FG000|STARTED|Overall Study||58||
48615544|NCT02459197|101844937|FG001|STARTED|Overall Study||56||
48615545|NCT02459197|101844936|FG000|COMPLETED|Overall Study||58||
48615546|NCT02459197|101844937|FG001|COMPLETED|Overall Study||55||
48734558|NCT03364309|102133908|FG009|COMPLETED|Post-Treatment Followup Period||0||
48734559|NCT03364309|102133909|FG010|COMPLETED|Post-Treatment Followup Period||0||
48317422|NCT03200366|101104020|FG000|COMPLETED|9 Month Post-Baseline Interview||97||
48317423|NCT03200366|101104021|FG001|COMPLETED|9 Month Post-Baseline Interview||95||
48615547|NCT02459197|101844936|FG000|NOT COMPLETED|Overall Study||0||
48615548|NCT02459197|101844937|FG001|NOT COMPLETED|Overall Study||1||
48615549|NCT00816777|101844938|FG000|STARTED|Overall Study||2||
48615550|NCT00816777|101844939|FG001|STARTED|Overall Study||2||
48615551|NCT00816777|101844938|FG000|COMPLETED|Overall Study||2||
48615552|NCT00816777|101844939|FG001|COMPLETED|Overall Study||2||
48615553|NCT00816777|101844938|FG000|NOT COMPLETED|Overall Study||0||
48615554|NCT00816777|101844939|FG001|NOT COMPLETED|Overall Study||0||
48615555|NCT01005576|101844940|FG000|STARTED|Overall Study||21||
48615556|NCT01005576|101844940|FG000|COMPLETED|Overall Study||21||
48615557|NCT01005576|101844940|FG000|NOT COMPLETED|Overall Study||0||
48615558|NCT02489448|101844941|FG000|STARTED|Overall Study||68||
48615559|NCT02489448|101844941|FG000|Phase 1 Started|Overall Study||7||
48615560|NCT02489448|101844941|FG000|3 mg Dose|Overall Study||4||
48317424|NCT03200366|101104022|FG002|COMPLETED|9 Month Post-Baseline Interview||116||
48317425|NCT03200366|101104020|FG000|NOT COMPLETED|9 Month Post-Baseline Interview||24||
48317426|NCT03200366|101104021|FG001|NOT COMPLETED|9 Month Post-Baseline Interview||21||
48317427|NCT03200366|101104022|FG002|NOT COMPLETED|9 Month Post-Baseline Interview||11||
48317428|NCT00800436|101104023|FG000|STARTED|Overall Study||6||
48317429|NCT00800436|101104024|FG001|STARTED|Overall Study||6||
48317430|NCT00800436|101104025|FG002|STARTED|Overall Study||6||
48317431|NCT00800436|101104026|FG003|STARTED|Overall Study||6||
48317432|NCT00800436|101104027|FG004|STARTED|Overall Study||6||
48317433|NCT00800436|101104028|FG005|STARTED|Overall Study||20||
48317434|NCT00800436|101104029|FG006|STARTED|Overall Study||20||
48317435|NCT00800436|101104023|FG000|COMPLETED|Overall Study||6||
48317436|NCT00800436|101104024|FG001|COMPLETED|Overall Study||6||
48317437|NCT00800436|101104025|FG002|COMPLETED|Overall Study||5||
48317438|NCT00800436|101104026|FG003|COMPLETED|Overall Study||5||
48317439|NCT00800436|101104027|FG004|COMPLETED|Overall Study||6||
48317440|NCT00800436|101104028|FG005|COMPLETED|Overall Study||20||
48317441|NCT00800436|101104029|FG006|COMPLETED|Overall Study||20||
48317442|NCT00800436|101104023|FG000|NOT COMPLETED|Overall Study||0||
48317443|NCT00800436|101104024|FG001|NOT COMPLETED|Overall Study||0||
48317444|NCT00800436|101104025|FG002|NOT COMPLETED|Overall Study||1||
48317445|NCT00800436|101104026|FG003|NOT COMPLETED|Overall Study||1||
48317446|NCT00800436|101104027|FG004|NOT COMPLETED|Overall Study||0||
48317447|NCT00800436|101104028|FG005|NOT COMPLETED|Overall Study||0||
48317448|NCT00800436|101104029|FG006|NOT COMPLETED|Overall Study||0||
48317449|NCT00841568|101104030|FG000|STARTED|Overall Study||17||
48317450|NCT00841568|101104030|FG000|COMPLETED|Overall Study||12||
48317451|NCT00841568|101104030|FG000|NOT COMPLETED|Overall Study||5||
48317452|NCT04906980|101104031|FG000|STARTED|Overall Study||2||
48317453|NCT04906980|101104032|FG001|STARTED|Overall Study||3||
48317454|NCT04906980|101104031|FG000|COMPLETED|Overall Study||2||
48317455|NCT04906980|101104032|FG001|COMPLETED|Overall Study||3||
48317456|NCT04906980|101104031|FG000|NOT COMPLETED|Overall Study||0||
48317457|NCT04906980|101104032|FG001|NOT COMPLETED|Overall Study||0||
48317458|NCT02086786|101104033|FG000|STARTED|Overall Study||35||
48317459|NCT02086786|101104034|FG001|STARTED|Overall Study||35||
48317460|NCT02086786|101104033|FG000|COMPLETED|Overall Study||17||
48317461|NCT02086786|101104034|FG001|COMPLETED|Overall Study||19||
48317462|NCT02086786|101104033|FG000|NOT COMPLETED|Overall Study||18||
48317463|NCT02086786|101104034|FG001|NOT COMPLETED|Overall Study||16||
48317464|NCT00632099|101104035|FG000|STARTED|Overall Study||10||
48317465|NCT00632099|101104036|FG001|STARTED|Overall Study||11||
48317466|NCT00632099|101104035|FG000|COMPLETED|Overall Study||7||
48317467|NCT00632099|101104036|FG001|COMPLETED|Overall Study||8||
48317468|NCT00632099|101104035|FG000|NOT COMPLETED|Overall Study||3||
48317469|NCT00632099|101104036|FG001|NOT COMPLETED|Overall Study||3||
48317470|NCT02137512|101104037|FG000|STARTED|2-Week Baseline Sensor-Augmented Pump||30||
48317471|NCT02137512|101104037|FG000|COMPLETED|2-Week Baseline Sensor-Augmented Pump||30||
48317472|NCT02137512|101104037|FG000|NOT COMPLETED|2-Week Baseline Sensor-Augmented Pump||0||
48615561|NCT02489448|101844941|FG000|10 mg Dose|Overall Study||3||
48615562|NCT02489448|101844941|FG000|Phase 1 Completed|Overall Study||7||
48615563|NCT02489448|101844941|FG000|Phase 2 Started|Overall Study||61||
48615564|NCT02489448|101844941|FG000|Phase 2 Completed|Overall Study||56||
48317473|NCT02137512|101104037|FG000|STARTED|2-Week Overnight-Only Closed-Loop||30||
48317474|NCT02137512|101104037|FG000|COMPLETED|2-Week Overnight-Only Closed-Loop||30||
48317475|NCT02137512|101104037|FG000|NOT COMPLETED|2-Week Overnight-Only Closed-Loop||0||
48317476|NCT02137512|101104037|FG000|STARTED|2-Week 24/7 Closed-Loop||30||
48317477|NCT02137512|101104037|FG000|COMPLETED|2-Week 24/7 Closed-Loop||30||
48615565|NCT02489448|101844941|FG000|COMPLETED|Overall Study||63||
48317478|NCT02137512|101104037|FG000|NOT COMPLETED|2-Week 24/7 Closed-Loop||0||
48317479|NCT02137512|101104037|FG000|STARTED|5-Month 24/7 Closed-Loop||14||
48317480|NCT02137512|101104037|FG000|COMPLETED|5-Month 24/7 Closed-Loop||14||
48317481|NCT02137512|101104037|FG000|NOT COMPLETED|5-Month 24/7 Closed-Loop||0||
48317482|NCT00473343|101104038|FG000|STARTED|Overall Study||102||
48317483|NCT00473343|101104038|FG000|COMPLETED|Overall Study||52||
48317484|NCT00473343|101104038|FG000|NOT COMPLETED|Overall Study||50||
48317485|NCT04518462|101104039|FG000|STARTED|Overall Study||40||
48317486|NCT04518462|101104040|FG001|STARTED|Overall Study||41||
48317487|NCT04518462|101104041|FG002|STARTED|Overall Study||40||
48407095|NCT03073200|101328524|FG013|COMPLETED|Double Blind Treatment Period||0||
48407096|NCT03073200|101328525|FG014|COMPLETED|Double Blind Treatment Period||0||
48407097|NCT03073200|101328511|FG000|NOT COMPLETED|Double Blind Treatment Period||2||
48407098|NCT03073200|101328512|FG001|NOT COMPLETED|Double Blind Treatment Period||1||
48407099|NCT03073200|101328513|FG002|NOT COMPLETED|Double Blind Treatment Period||0||
48407100|NCT03073200|101328514|FG003|NOT COMPLETED|Double Blind Treatment Period||0||
48407101|NCT03073200|101328515|FG004|NOT COMPLETED|Double Blind Treatment Period||0||
48407102|NCT03073200|101328516|FG005|NOT COMPLETED|Double Blind Treatment Period||0||
48407103|NCT03073200|101328517|FG006|NOT COMPLETED|Double Blind Treatment Period||0||
48407104|NCT03073200|101328518|FG007|NOT COMPLETED|Double Blind Treatment Period||0||
48407105|NCT03073200|101328519|FG008|NOT COMPLETED|Double Blind Treatment Period||0||
48407106|NCT03073200|101328520|FG009|NOT COMPLETED|Double Blind Treatment Period||0||
48407107|NCT03073200|101328521|FG010|NOT COMPLETED|Double Blind Treatment Period||0||
48407108|NCT03073200|101328522|FG011|NOT COMPLETED|Double Blind Treatment Period||0||
48407109|NCT03073200|101328523|FG012|NOT COMPLETED|Double Blind Treatment Period||0||
48407110|NCT03073200|101328524|FG013|NOT COMPLETED|Double Blind Treatment Period||0||
48407111|NCT03073200|101328525|FG014|NOT COMPLETED|Double Blind Treatment Period||0||
48407112|NCT03073200|101328511|FG000|STARTED|Open-Label Maintenance Period||0||
48407113|NCT03073200|101328512|FG001|STARTED|Open-Label Maintenance Period||0||
48407114|NCT03073200|101328513|FG002|STARTED|Open-Label Maintenance Period||0||
48407115|NCT03073200|101328514|FG003|STARTED|Open-Label Maintenance Period||53||
48317488|NCT04518462|101104039|FG000|COMPLETED|Overall Study||39||
48317489|NCT04518462|101104040|FG001|COMPLETED|Overall Study||40||
48317490|NCT04518462|101104041|FG002|COMPLETED|Overall Study||39||
48407116|NCT03073200|101328515|FG004|STARTED|Open-Label Maintenance Period||113||
48407117|NCT03073200|101328516|FG005|STARTED|Open-Label Maintenance Period||28||
48407118|NCT03073200|101328517|FG006|STARTED|Open-Label Maintenance Period||0||
48317491|NCT04518462|101104039|FG000|NOT COMPLETED|Overall Study||1||
48317492|NCT04518462|101104040|FG001|NOT COMPLETED|Overall Study||1||
48317493|NCT04518462|101104041|FG002|NOT COMPLETED|Overall Study||1||
48317494|NCT02841397|101104042|FG000|STARTED|Overall Study||50||
48317495|NCT02841397|101104042|FG000|COMPLETED|Overall Study||48||
48317496|NCT02841397|101104042|FG000|NOT COMPLETED|Overall Study||2||
48317497|NCT00402649|101104043|FG000|STARTED|Overall Study||35||
48317498|NCT00402649|101104043|FG000|COMPLETED|Overall Study||33||
48317499|NCT00402649|101104043|FG000|NOT COMPLETED|Overall Study||2||
48317500|NCT02839265|101104044|FG000|STARTED|Overall Study||33||
48317501|NCT02839265|101104044|FG000|COMPLETED|Overall Study||29||
48317502|NCT02839265|101104044|FG000|NOT COMPLETED|Overall Study||4||
48317503|NCT02076997|101104045|FG000|STARTED|Overall Study||23||
48317504|NCT02076997|101104045|FG000|COMPLETED|Overall Study||22||
48317505|NCT02076997|101104045|FG000|NOT COMPLETED|Overall Study||1||
48317506|NCT00393887|101104046|FG000|STARTED|Overall Study||50||
48317507|NCT00393887|101104047|FG001|STARTED|Overall Study||50||
48317508|NCT00393887|101104046|FG000|1 Year|Overall Study||45||
48317509|NCT00393887|101104047|FG001|1 Year|Overall Study||50||
48317510|NCT00393887|101104046|FG000|COMPLETED|Overall Study||34||
48317511|NCT00393887|101104047|FG001|COMPLETED|Overall Study||41||
48317512|NCT00393887|101104046|FG000|NOT COMPLETED|Overall Study||16||
48317513|NCT00393887|101104047|FG001|NOT COMPLETED|Overall Study||9||
48317514|NCT01991990|101104048|FG000|STARTED|Overall Study||6||
48317515|NCT01991990|101104049|FG001|STARTED|Overall Study||12||
48317516|NCT01991990|101104048|FG000|COMPLETED|Overall Study||6||
48317517|NCT01991990|101104049|FG001|COMPLETED|Overall Study||12||
48317518|NCT01991990|101104048|FG000|NOT COMPLETED|Overall Study||0||
48317519|NCT01991990|101104049|FG001|NOT COMPLETED|Overall Study||0||
48317520|NCT03631784|101104050|FG000|STARTED|Overall Study||112||
48317521|NCT03631784|101104051|FG001|STARTED|Overall Study||102||
48317522|NCT03631784|101104050|FG000|COMPLETED|Overall Study||0||
48317523|NCT03631784|101104051|FG001|COMPLETED|Overall Study||0||
48317524|NCT03631784|101104050|FG000|NOT COMPLETED|Overall Study||112||
48317525|NCT03631784|101104051|FG001|NOT COMPLETED|Overall Study||102||
48317526|NCT00923130|101104052|FG000|STARTED|Overall Study||30||
48407119|NCT03073200|101328518|FG007|STARTED|Open-Label Maintenance Period||0||
48407120|NCT03073200|101328519|FG008|STARTED|Open-Label Maintenance Period||0||
48317527|NCT00923130|101104052|FG000|COMPLETED|Overall Study||5||
48317528|NCT00923130|101104052|FG000|NOT COMPLETED|Overall Study||25||
48317529|NCT00257725|101104053|FG000|STARTED|Overall Study||11||
48317530|NCT00257725|101104053|FG000|COMPLETED|Overall Study||8||
48407121|NCT03073200|101328520|FG009|STARTED|Open-Label Maintenance Period||0||
48407122|NCT03073200|101328521|FG010|STARTED|Open-Label Maintenance Period||0||
48407123|NCT03073200|101328522|FG011|STARTED|Open-Label Maintenance Period||0||
48407124|NCT03073200|101328523|FG012|STARTED|Open-Label Maintenance Period||0||
48317531|NCT00257725|101104053|FG000|NOT COMPLETED|Overall Study||3||
48317532|NCT02716987|101104054|FG000|STARTED|Overall Study||4||
48317533|NCT02716987|101104055|FG001|STARTED|Overall Study||2||
48317534|NCT02716987|101104056|FG002|STARTED|Overall Study||5||
48317535|NCT02716987|101104057|FG003|STARTED|Overall Study||2||
48317536|NCT02716987|101104058|FG004|STARTED|Overall Study||6||
48317537|NCT02716987|101104059|FG005|STARTED|Overall Study||1||
48615566|NCT02489448|101844941|FG000|NOT COMPLETED|Overall Study||5||
48734560|NCT03364309|102133910|FG011|COMPLETED|Post-Treatment Followup Period||0||
48734561|NCT03364309|102133911|FG012|COMPLETED|Post-Treatment Followup Period||0||
48734562|NCT03364309|102133912|FG013|COMPLETED|Post-Treatment Followup Period||0||
48734563|NCT03364309|102133913|FG014|COMPLETED|Post-Treatment Followup Period||0||
48159967|NCT02755597|100715764|FG001|STARTED|Overall Study||97||
48159968|NCT02755597|100715763|FG000|COMPLETED|Overall Study||0||
48159969|NCT02755597|100715764|FG001|COMPLETED|Overall Study||0||
48159970|NCT02755597|100715763|FG000|NOT COMPLETED|Overall Study||194||
48159971|NCT02755597|100715764|FG001|NOT COMPLETED|Overall Study||97||
48159972|NCT01557322|100715765|FG000|STARTED|Overall Study||211||
48159973|NCT01557322|100715766|FG001|STARTED|Overall Study||1543||
48159974|NCT01557322|100715765|FG000|COMPLETED|Overall Study||211||
48159975|NCT01557322|100715766|FG001|COMPLETED|Overall Study||1543||
48159976|NCT01557322|100715765|FG000|NOT COMPLETED|Overall Study||0||
48159977|NCT01557322|100715766|FG001|NOT COMPLETED|Overall Study||0||
48159978|NCT00638235|100715767|FG000|STARTED|Overall Study||141||
48159979|NCT00638235|100715768|FG001|STARTED|Overall Study||26||
48159980|NCT00638235|100715769|FG002|STARTED|Overall Study||81||
48159981|NCT00638235|100715770|FG003|STARTED|Overall Study||56||
48159982|NCT00638235|100715771|FG004|STARTED|Overall Study||55||
48159983|NCT00638235|100715772|FG005|STARTED|Overall Study||139||
48159984|NCT00638235|100715773|FG006|STARTED|Overall Study||23||
48159985|NCT00638235|100715774|FG007|STARTED|Overall Study||35||
48159986|NCT00638235|100715775|FG008|STARTED|Overall Study||142||
48159987|NCT00638235|100715767|FG000|COMPLETED|Overall Study||110||
48159988|NCT00638235|100715768|FG001|COMPLETED|Overall Study||23||
48159989|NCT00638235|100715769|FG002|COMPLETED|Overall Study||63||
48159990|NCT00638235|100715770|FG003|COMPLETED|Overall Study||46||
48159991|NCT00638235|100715771|FG004|COMPLETED|Overall Study||42||
48159992|NCT00638235|100715772|FG005|COMPLETED|Overall Study||113||
48159993|NCT00638235|100715773|FG006|COMPLETED|Overall Study||23||
48159994|NCT00638235|100715774|FG007|COMPLETED|Overall Study||34||
48159995|NCT00638235|100715775|FG008|COMPLETED|Overall Study||124||
48159996|NCT00638235|100715767|FG000|NOT COMPLETED|Overall Study||31||
48159997|NCT00638235|100715768|FG001|NOT COMPLETED|Overall Study||3||
48159998|NCT00638235|100715769|FG002|NOT COMPLETED|Overall Study||18||
48159999|NCT00638235|100715770|FG003|NOT COMPLETED|Overall Study||10||
48160000|NCT00638235|100715771|FG004|NOT COMPLETED|Overall Study||13||
48160001|NCT00638235|100715772|FG005|NOT COMPLETED|Overall Study||26||
48160002|NCT00638235|100715773|FG006|NOT COMPLETED|Overall Study||0||
48160003|NCT00638235|100715774|FG007|NOT COMPLETED|Overall Study||1||
48160004|NCT00638235|100715775|FG008|NOT COMPLETED|Overall Study||18||
48160005|NCT00963911|100715776|FG000|STARTED|Overall Study||1674||
48160006|NCT00963911|100715776|FG000|COMPLETED|Overall Study||1674||
48317538|NCT02716987|101104054|FG000|COMPLETED|Overall Study||4||
48615567|NCT02488018|101844942|FG000|STARTED|Overall Study||10||
48615568|NCT02488018|101844942|FG000|COMPLETED|Overall Study||10||
48615569|NCT02488018|101844942|FG000|NOT COMPLETED|Overall Study||0||
48615570|NCT00614172|101844943|FG000|STARTED|Overall Study||50||
48615571|NCT00614172|101844943|FG000|COMPLETED|Overall Study||50||
48615572|NCT00614172|101844943|FG000|NOT COMPLETED|Overall Study||0||
48615573|NCT02368132|101844944|FG000|STARTED|Overall Study||112||
48615574|NCT02368132|101844945|FG001|STARTED|Overall Study||122||
48615575|NCT02368132|101844946|FG002|STARTED|Overall Study||85||
48734564|NCT03364309|102133914|FG015|COMPLETED|Post-Treatment Followup Period||0||
48317539|NCT02716987|101104055|FG001|COMPLETED|Overall Study||2||
48317540|NCT02716987|101104056|FG002|COMPLETED|Overall Study||4||
48317541|NCT02716987|101104057|FG003|COMPLETED|Overall Study||2||
48734565|NCT03364309|102133915|FG016|COMPLETED|Post-Treatment Followup Period||6||
48734566|NCT03364309|102133916|FG017|COMPLETED|Post-Treatment Followup Period||344||
48734567|NCT03364309|102133917|FG018|COMPLETED|Post-Treatment Followup Period||0||
48734568|NCT03364309|102133899|FG000|NOT COMPLETED|Post-Treatment Followup Period||0||
48734569|NCT03364309|102133900|FG001|NOT COMPLETED|Post-Treatment Followup Period||0||
48160007|NCT00963911|100715776|FG000|NOT COMPLETED|Overall Study||0||
48160008|NCT01520402|100715777|FG000|STARTED|Overall Study||35||
48160009|NCT01520402|100715777|FG000|COMPLETED|Overall Study||30||
48160010|NCT01520402|100715777|FG000|NOT COMPLETED|Overall Study||5||
48160011|NCT00612534|100715778|FG000|STARTED|Overall Study||24||
48160012|NCT00612534|100715779|FG001|STARTED|Overall Study||26||
48160013|NCT00612534|100715780|FG002|STARTED|Overall Study||20||
48160014|NCT00612534|100715781|FG003|STARTED|Overall Study||24||
48160015|NCT00612534|100715778|FG000|COMPLETED|Overall Study||11||
48160016|NCT00612534|100715779|FG001|COMPLETED|Overall Study||9||
48160017|NCT00612534|100715780|FG002|COMPLETED|Overall Study||13||
48317542|NCT02716987|101104058|FG004|COMPLETED|Overall Study||5||
48317543|NCT02716987|101104059|FG005|COMPLETED|Overall Study||0||
48615576|NCT02368132|101844944|FG000|COMPLETED|Overall Study||32|3 Month Follow-Up Completed|
48656947|NCT03382873|101943730|FG000|NOT COMPLETED|Overall Study||31||
48160018|NCT00612534|100715781|FG003|COMPLETED|Overall Study||7||
48317544|NCT02716987|101104054|FG000|NOT COMPLETED|Overall Study||0||
48407125|NCT03073200|101328524|FG013|STARTED|Open-Label Maintenance Period||0||
48407126|NCT03073200|101328525|FG014|STARTED|Open-Label Maintenance Period||0||
48407127|NCT03073200|101328511|FG000|COMPLETED|Open-Label Maintenance Period||0||
48407128|NCT03073200|101328512|FG001|COMPLETED|Open-Label Maintenance Period||0||
48407129|NCT03073200|101328513|FG002|COMPLETED|Open-Label Maintenance Period||0||
48407130|NCT03073200|101328514|FG003|COMPLETED|Open-Label Maintenance Period||49||
48407131|NCT03073200|101328515|FG004|COMPLETED|Open-Label Maintenance Period||109||
48407132|NCT03073200|101328516|FG005|COMPLETED|Open-Label Maintenance Period||28||
48407133|NCT03073200|101328517|FG006|COMPLETED|Open-Label Maintenance Period||0||
48407134|NCT03073200|101328518|FG007|COMPLETED|Open-Label Maintenance Period||0||
48407135|NCT03073200|101328519|FG008|COMPLETED|Open-Label Maintenance Period||0||
48407136|NCT03073200|101328520|FG009|COMPLETED|Open-Label Maintenance Period||0||
48407137|NCT03073200|101328521|FG010|COMPLETED|Open-Label Maintenance Period||0||
48407138|NCT03073200|101328522|FG011|COMPLETED|Open-Label Maintenance Period||0||
48407139|NCT03073200|101328523|FG012|COMPLETED|Open-Label Maintenance Period||0||
48407140|NCT03073200|101328524|FG013|COMPLETED|Open-Label Maintenance Period||0||
48407141|NCT03073200|101328525|FG014|COMPLETED|Open-Label Maintenance Period||0||
48407142|NCT03073200|101328511|FG000|NOT COMPLETED|Open-Label Maintenance Period||0||
48407143|NCT03073200|101328512|FG001|NOT COMPLETED|Open-Label Maintenance Period||0||
48407144|NCT03073200|101328513|FG002|NOT COMPLETED|Open-Label Maintenance Period||0||
48407145|NCT03073200|101328514|FG003|NOT COMPLETED|Open-Label Maintenance Period||4||
48407146|NCT03073200|101328515|FG004|NOT COMPLETED|Open-Label Maintenance Period||4||
48407147|NCT03073200|101328516|FG005|NOT COMPLETED|Open-Label Maintenance Period||0||
48734570|NCT03364309|102133901|FG002|NOT COMPLETED|Post-Treatment Followup Period||0||
48734571|NCT03364309|102133902|FG003|NOT COMPLETED|Post-Treatment Followup Period||0||
48734572|NCT03364309|102133903|FG004|NOT COMPLETED|Post-Treatment Followup Period||0||
48734573|NCT03364309|102133904|FG005|NOT COMPLETED|Post-Treatment Followup Period||0||
48734574|NCT03364309|102133905|FG006|NOT COMPLETED|Post-Treatment Followup Period||0||
48734575|NCT03364309|102133906|FG007|NOT COMPLETED|Post-Treatment Followup Period||0||
48734576|NCT03364309|102133907|FG008|NOT COMPLETED|Post-Treatment Followup Period||0||
48734577|NCT03364309|102133908|FG009|NOT COMPLETED|Post-Treatment Followup Period||0||
48734578|NCT03364309|102133909|FG010|NOT COMPLETED|Post-Treatment Followup Period||0||
48734579|NCT03364309|102133910|FG011|NOT COMPLETED|Post-Treatment Followup Period||0||
48734580|NCT03364309|102133911|FG012|NOT COMPLETED|Post-Treatment Followup Period||0||
48734581|NCT03364309|102133912|FG013|NOT COMPLETED|Post-Treatment Followup Period||0||
48734582|NCT03364309|102133913|FG014|NOT COMPLETED|Post-Treatment Followup Period||0||
48734583|NCT03364309|102133914|FG015|NOT COMPLETED|Post-Treatment Followup Period||0||
48734584|NCT03364309|102133915|FG016|NOT COMPLETED|Post-Treatment Followup Period||5||
48734585|NCT03364309|102133916|FG017|NOT COMPLETED|Post-Treatment Followup Period||31||
48734586|NCT03364309|102133917|FG018|NOT COMPLETED|Post-Treatment Followup Period||2||
48734587|NCT01973413|102133918|FG000|STARTED|Overall Study||12||
48734588|NCT01973413|102133919|FG001|STARTED|Overall Study||20||
48734589|NCT01973413|102133918|FG000|COMPLETED|Overall Study||11||
48734590|NCT01973413|102133919|FG001|COMPLETED|Overall Study||20||
48734591|NCT01973413|102133918|FG000|NOT COMPLETED|Overall Study||1||
48734592|NCT01973413|102133919|FG001|NOT COMPLETED|Overall Study||0||
48734593|NCT03657849|102133920|FG000|STARTED|Overall Study||60||144
48734594|NCT03657849|102133920|FG000|COMPLETED|Overall Study||60||141
48734595|NCT03657849|102133920|FG000|NOT COMPLETED|Overall Study||0||3
48734596|NCT02058563|102133921|FG000|STARTED|Overall Study||454||
48734597|NCT02058563|102133922|FG001|STARTED|Overall Study||457||
48734598|NCT02058563|102133921|FG000|COMPLETED|Overall Study||426||
48734599|NCT02058563|102133922|FG001|COMPLETED|Overall Study||433||
48734600|NCT02058563|102133921|FG000|NOT COMPLETED|Overall Study||28||
48734601|NCT02058563|102133922|FG001|NOT COMPLETED|Overall Study||24||
48734602|NCT03922620|102133923|FG000|STARTED|Overall Study||1||
48734603|NCT03922620|102133924|FG001|STARTED|Overall Study||0||
48734604|NCT03922620|102133923|FG000|COMPLETED|Overall Study||0||
48734605|NCT03922620|102133924|FG001|COMPLETED|Overall Study||0||
48734606|NCT03922620|102133923|FG000|NOT COMPLETED|Overall Study||1||
48734607|NCT03922620|102133924|FG001|NOT COMPLETED|Overall Study||0||
48734608|NCT01279616|102133925|FG000|STARTED|Overall Study||8||
48734609|NCT01279616|102133925|FG000|COMPLETED|Overall Study||1||
48734610|NCT01279616|102133925|FG000|NOT COMPLETED|Overall Study||7||
48734611|NCT02218593|102133926|FG000|STARTED|Overall Study||25||
48734612|NCT02218593|102133926|FG000|COMPLETED|Overall Study||25||
48734613|NCT02218593|102133926|FG000|NOT COMPLETED|Overall Study||0||
48734614|NCT01371552|102133927|FG000|STARTED|Part 1, First 3 Days||19||
48407148|NCT03073200|101328517|FG006|NOT COMPLETED|Open-Label Maintenance Period||0||
48615577|NCT02368132|101844945|FG001|COMPLETED|Overall Study||71|3 Month Follow-Up Completed|
48734615|NCT01371552|102133928|FG001|STARTED|Part 1, First 3 Days||17||
48734616|NCT01371552|102133929|FG002|STARTED|Part 1, First 3 Days||20||
48734617|NCT01371552|102133930|FG003|STARTED|Part 1, First 3 Days||20||
48734618|NCT01371552|102133931|FG004|STARTED|Part 1, First 3 Days||15||
48734619|NCT01371552|102133932|FG005|STARTED|Part 1, First 3 Days||18||
48734620|NCT01371552|102133927|FG000|COMPLETED|Part 1, First 3 Days||19||
48734621|NCT01371552|102133928|FG001|COMPLETED|Part 1, First 3 Days||17||
48734622|NCT01371552|102133929|FG002|COMPLETED|Part 1, First 3 Days||19||
48734623|NCT01371552|102133930|FG003|COMPLETED|Part 1, First 3 Days||20||
48734624|NCT01371552|102133931|FG004|COMPLETED|Part 1, First 3 Days||15||
48734625|NCT01371552|102133932|FG005|COMPLETED|Part 1, First 3 Days||18||
48734626|NCT01371552|102133927|FG000|NOT COMPLETED|Part 1, First 3 Days||0||
48734627|NCT01371552|102133928|FG001|NOT COMPLETED|Part 1, First 3 Days||0||
48734628|NCT01371552|102133929|FG002|NOT COMPLETED|Part 1, First 3 Days||1||
48734629|NCT01371552|102133930|FG003|NOT COMPLETED|Part 1, First 3 Days||0||
48734630|NCT01371552|102133931|FG004|NOT COMPLETED|Part 1, First 3 Days||0||
48734631|NCT01371552|102133932|FG005|NOT COMPLETED|Part 1, First 3 Days||0||
48734632|NCT01371552|102133927|FG000|STARTED|Part 1, Second 3 Days||19||
48734633|NCT01371552|102133928|FG001|STARTED|Part 1, Second 3 Days||17||
48734634|NCT01371552|102133929|FG002|STARTED|Part 1, Second 3 Days||18||
48734635|NCT01371552|102133930|FG003|STARTED|Part 1, Second 3 Days||20||
48734636|NCT01371552|102133931|FG004|STARTED|Part 1, Second 3 Days||15||
48734637|NCT01371552|102133932|FG005|STARTED|Part 1, Second 3 Days||18||
48734638|NCT01371552|102133927|FG000|COMPLETED|Part 1, Second 3 Days||18||
48734639|NCT01371552|102133928|FG001|COMPLETED|Part 1, Second 3 Days||17||
48734640|NCT01371552|102133929|FG002|COMPLETED|Part 1, Second 3 Days||18||
48734641|NCT01371552|102133930|FG003|COMPLETED|Part 1, Second 3 Days||20||
48734642|NCT01371552|102133931|FG004|COMPLETED|Part 1, Second 3 Days||15||
48734643|NCT01371552|102133932|FG005|COMPLETED|Part 1, Second 3 Days||18||
48734644|NCT01371552|102133927|FG000|NOT COMPLETED|Part 1, Second 3 Days||1||
48734645|NCT01371552|102133928|FG001|NOT COMPLETED|Part 1, Second 3 Days||0||
48734646|NCT01371552|102133929|FG002|NOT COMPLETED|Part 1, Second 3 Days||0||
48734647|NCT01371552|102133930|FG003|NOT COMPLETED|Part 1, Second 3 Days||0||
48734648|NCT01371552|102133931|FG004|NOT COMPLETED|Part 1, Second 3 Days||0||
48734649|NCT01371552|102133932|FG005|NOT COMPLETED|Part 1, Second 3 Days||0||
48734650|NCT01371552|102133927|FG000|STARTED|Part 1, Third 3 Days||19||
48734651|NCT01371552|102133928|FG001|STARTED|Part 1, Third 3 Days||17||
48734652|NCT01371552|102133929|FG002|STARTED|Part 1, Third 3 Days||18||
48734653|NCT01371552|102133930|FG003|STARTED|Part 1, Third 3 Days||20||
48734654|NCT01371552|102133931|FG004|STARTED|Part 1, Third 3 Days||15||
48734655|NCT01371552|102133932|FG005|STARTED|Part 1, Third 3 Days||18||
48734656|NCT01371552|102133927|FG000|COMPLETED|Part 1, Third 3 Days||19||
48734657|NCT01371552|102133928|FG001|COMPLETED|Part 1, Third 3 Days||17||
48734658|NCT01371552|102133929|FG002|COMPLETED|Part 1, Third 3 Days||18||
48734659|NCT01371552|102133930|FG003|COMPLETED|Part 1, Third 3 Days||20||
48734660|NCT01371552|102133931|FG004|COMPLETED|Part 1, Third 3 Days||14||
48734661|NCT01371552|102133932|FG005|COMPLETED|Part 1, Third 3 Days||17||
48734662|NCT01371552|102133927|FG000|NOT COMPLETED|Part 1, Third 3 Days||0||
48734663|NCT01371552|102133928|FG001|NOT COMPLETED|Part 1, Third 3 Days||0||
48734664|NCT01371552|102133929|FG002|NOT COMPLETED|Part 1, Third 3 Days||0||
48734665|NCT01371552|102133930|FG003|NOT COMPLETED|Part 1, Third 3 Days||0||
48734666|NCT01371552|102133931|FG004|NOT COMPLETED|Part 1, Third 3 Days||1||
48734667|NCT01371552|102133932|FG005|NOT COMPLETED|Part 1, Third 3 Days||1||
48734668|NCT01371552|102133927|FG000|STARTED|Part 2, One Week||18||
48734669|NCT01371552|102133928|FG001|STARTED|Part 2, One Week||17||
48734670|NCT01371552|102133929|FG002|STARTED|Part 2, One Week||18||
48734671|NCT01371552|102133930|FG003|STARTED|Part 2, One Week||20||
48734672|NCT01371552|102133931|FG004|STARTED|Part 2, One Week||15||
48734673|NCT01371552|102133932|FG005|STARTED|Part 2, One Week||18||
48734674|NCT01371552|102133927|FG000|COMPLETED|Part 2, One Week||18||
48734675|NCT01371552|102133928|FG001|COMPLETED|Part 2, One Week||17||
48734676|NCT01371552|102133929|FG002|COMPLETED|Part 2, One Week||18||
48734677|NCT01371552|102133930|FG003|COMPLETED|Part 2, One Week||20||
48734678|NCT01371552|102133931|FG004|COMPLETED|Part 2, One Week||15||
48734679|NCT01371552|102133932|FG005|COMPLETED|Part 2, One Week||18||
48734680|NCT01371552|102133927|FG000|NOT COMPLETED|Part 2, One Week||0||
48734681|NCT01371552|102133928|FG001|NOT COMPLETED|Part 2, One Week||0||
48734682|NCT01371552|102133929|FG002|NOT COMPLETED|Part 2, One Week||0||
48734683|NCT01371552|102133930|FG003|NOT COMPLETED|Part 2, One Week||0||
48734684|NCT01371552|102133931|FG004|NOT COMPLETED|Part 2, One Week||0||
48734685|NCT01371552|102133932|FG005|NOT COMPLETED|Part 2, One Week||0||
48734686|NCT05492786|102133933|FG000|STARTED|Overall Study||24835||
48734687|NCT05492786|102133934|FG001|STARTED|Overall Study||24854||
48734688|NCT05492786|102133935|FG002|STARTED|Overall Study||24912||
48734689|NCT05492786|102133936|FG003|STARTED|Overall Study||5851||
48734690|NCT05492786|102133933|FG000|COMPLETED|Overall Study||24835||
48734691|NCT05492786|102133934|FG001|COMPLETED|Overall Study||24854||
48734692|NCT05492786|102133935|FG002|COMPLETED|Overall Study||24912||
48734693|NCT05492786|102133936|FG003|COMPLETED|Overall Study||5851||
48734694|NCT05492786|102133933|FG000|NOT COMPLETED|Overall Study||0||
48734695|NCT05492786|102133934|FG001|NOT COMPLETED|Overall Study||0||
48734696|NCT05492786|102133935|FG002|NOT COMPLETED|Overall Study||0||
48734697|NCT05492786|102133936|FG003|NOT COMPLETED|Overall Study||0||
48734698|NCT03416127|102133937|FG000|STARTED|Overall Study||12||
48734699|NCT03416127|102133938|FG001|STARTED|Overall Study||12||
48734700|NCT03416127|102133939|FG002|STARTED|Overall Study||12||
48734701|NCT03416127|102133937|FG000|COMPLETED|Overall Study||12||
48734702|NCT03416127|102133938|FG001|COMPLETED|Overall Study||11||
48734703|NCT03416127|102133939|FG002|COMPLETED|Overall Study||11||
48734704|NCT03416127|102133937|FG000|NOT COMPLETED|Overall Study||0||
48734705|NCT03416127|102133938|FG001|NOT COMPLETED|Overall Study||1||
48734706|NCT03416127|102133939|FG002|NOT COMPLETED|Overall Study||1||
48615578|NCT02368132|101844946|FG002|COMPLETED|Overall Study||50|3 Month Follow-Up Completed|
48615579|NCT02368132|101844944|FG000|NOT COMPLETED|Overall Study||80||
48615580|NCT02368132|101844945|FG001|NOT COMPLETED|Overall Study||51||
48734707|NCT03318016|102133940|FG000|STARTED|Overall Study||0||
48734708|NCT03318016|102133941|FG001|STARTED|Overall Study||3||
48734709|NCT03318016|102133942|FG002|STARTED|Overall Study||2||
48734710|NCT03318016|102133943|FG003|STARTED|Overall Study||0||
48734711|NCT03318016|102133944|FG004|STARTED|Overall Study||0||
48734712|NCT03318016|102133940|FG000|COMPLETED|Overall Study||0||
48734713|NCT03318016|102133941|FG001|COMPLETED|Overall Study||3||
48734714|NCT03318016|102133942|FG002|COMPLETED|Overall Study||2||
48734715|NCT03318016|102133943|FG003|COMPLETED|Overall Study||0||
48734716|NCT03318016|102133944|FG004|COMPLETED|Overall Study||0||
48734717|NCT03318016|102133940|FG000|NOT COMPLETED|Overall Study||0||
48734718|NCT03318016|102133941|FG001|NOT COMPLETED|Overall Study||0||
48734719|NCT03318016|102133942|FG002|NOT COMPLETED|Overall Study||0||
48734720|NCT03318016|102133943|FG003|NOT COMPLETED|Overall Study||0||
48734721|NCT03318016|102133944|FG004|NOT COMPLETED|Overall Study||0||
48734722|NCT00599755|102133945|FG000|STARTED|Overall Study||68||
48734723|NCT00599755|102133945|FG000|COMPLETED|Overall Study||49||
48734724|NCT00599755|102133945|FG000|NOT COMPLETED|Overall Study||19||
48734725|NCT01128946|102133946|FG000|STARTED|Period I||20||
48734726|NCT01128946|102133947|FG001|STARTED|Period I||21||
48734727|NCT01128946|102133948|FG002|STARTED|Period I||21||
48734728|NCT01128946|102133949|FG003|STARTED|Period I||21||
48734729|NCT01128946|102133946|FG000|COMPLETED|Period I||20||
48734730|NCT01128946|102133947|FG001|COMPLETED|Period I||20||
48734731|NCT01128946|102133948|FG002|COMPLETED|Period I||20||
48734732|NCT01128946|102133949|FG003|COMPLETED|Period I||20||
48734733|NCT01128946|102133946|FG000|NOT COMPLETED|Period I||0||
48734734|NCT01128946|102133947|FG001|NOT COMPLETED|Period I||1||
48734735|NCT01128946|102133948|FG002|NOT COMPLETED|Period I||1||
48734736|NCT01128946|102133949|FG003|NOT COMPLETED|Period I||1||
48734737|NCT01128946|102133946|FG000|STARTED|Period II||20||
48734738|NCT01128946|102133947|FG001|STARTED|Period II||20||
48615581|NCT02368132|101844946|FG002|NOT COMPLETED|Overall Study||35||
48615582|NCT00784719|101844947|FG000|STARTED|Overall Study||47||
48615583|NCT00784719|101844948|FG001|STARTED|Overall Study||46||
48615584|NCT00784719|101844949|FG002|STARTED|Overall Study||47||
48615585|NCT00784719|101844950|FG003|STARTED|Overall Study||48||
48615586|NCT00784719|101844951|FG004|STARTED|Overall Study||48||
48615587|NCT00784719|101844952|FG005|STARTED|Overall Study||44||
48615588|NCT00784719|101844953|FG006|STARTED|Overall Study||47||
48615589|NCT00784719|101844947|FG000|COMPLETED|Overall Study||44||
48615590|NCT00784719|101844948|FG001|COMPLETED|Overall Study||43||
48734739|NCT01128946|102133948|FG002|STARTED|Period II||20||
48734740|NCT01128946|102133949|FG003|STARTED|Period II||20||
48734741|NCT01128946|102133946|FG000|COMPLETED|Period II||20||
48734742|NCT01128946|102133947|FG001|COMPLETED|Period II||19||
48734743|NCT01128946|102133948|FG002|COMPLETED|Period II||20||
48734744|NCT01128946|102133949|FG003|COMPLETED|Period II||19||
48734745|NCT01128946|102133946|FG000|NOT COMPLETED|Period II||0||
48734746|NCT01128946|102133947|FG001|NOT COMPLETED|Period II||1||
48734747|NCT01128946|102133948|FG002|NOT COMPLETED|Period II||0||
48734748|NCT01128946|102133949|FG003|NOT COMPLETED|Period II||1||
48734749|NCT01128946|102133946|FG000|STARTED|Period III||20||
48734750|NCT01128946|102133947|FG001|STARTED|Period III||19||
48734751|NCT01128946|102133948|FG002|STARTED|Period III||20||
48734752|NCT01128946|102133949|FG003|STARTED|Period III||19||
48734753|NCT01128946|102133946|FG000|COMPLETED|Period III||19||
48734754|NCT01128946|102133947|FG001|COMPLETED|Period III||19||
48734755|NCT01128946|102133948|FG002|COMPLETED|Period III||20||
48734756|NCT01128946|102133949|FG003|COMPLETED|Period III||19||
48734757|NCT01128946|102133946|FG000|NOT COMPLETED|Period III||1||
48734758|NCT01128946|102133947|FG001|NOT COMPLETED|Period III||0||
48734759|NCT01128946|102133948|FG002|NOT COMPLETED|Period III||0||
48734760|NCT01128946|102133949|FG003|NOT COMPLETED|Period III||0||
48734761|NCT01128946|102133946|FG000|STARTED|Period IV||19||
48734762|NCT01128946|102133947|FG001|STARTED|Period IV||20||
48734763|NCT01128946|102133948|FG002|STARTED|Period IV||19||
48734764|NCT01128946|102133949|FG003|STARTED|Period IV||19||
48734765|NCT01128946|102133946|FG000|COMPLETED|Period IV||19||
48734766|NCT01128946|102133947|FG001|COMPLETED|Period IV||20||
48734767|NCT01128946|102133948|FG002|COMPLETED|Period IV||19||
48734768|NCT01128946|102133949|FG003|COMPLETED|Period IV||19||
48734769|NCT01128946|102133946|FG000|NOT COMPLETED|Period IV||0||
48734770|NCT01128946|102133947|FG001|NOT COMPLETED|Period IV||0||
48734771|NCT01128946|102133948|FG002|NOT COMPLETED|Period IV||0||
48734772|NCT01128946|102133949|FG003|NOT COMPLETED|Period IV||0||
48734773|NCT03679624|102133950|FG000|STARTED|Overall Study||1||
48734774|NCT03679624|102133951|FG001|STARTED|Overall Study||0||
48734775|NCT03679624|102133950|FG000|COMPLETED|Overall Study||0||
48734776|NCT03679624|102133951|FG001|COMPLETED|Overall Study||0||
48734777|NCT03679624|102133950|FG000|NOT COMPLETED|Overall Study||1||
48734778|NCT03679624|102133951|FG001|NOT COMPLETED|Overall Study||0||
48734779|NCT01718444|102133952|FG000|STARTED|Overall Study||0||
48734780|NCT01718444|102133953|FG001|STARTED|Overall Study||0||
48734781|NCT01718444|102133952|FG000|COMPLETED|Overall Study||0||
48734782|NCT01718444|102133953|FG001|COMPLETED|Overall Study||0||
48734783|NCT01718444|102133952|FG000|NOT COMPLETED|Overall Study||0||
48734784|NCT01718444|102133953|FG001|NOT COMPLETED|Overall Study||0||
48734785|NCT03282097|102133954|FG000|STARTED|Randomized and Completed Baseline||214||
48734786|NCT03282097|102133955|FG001|STARTED|Randomized and Completed Baseline||215||
48734787|NCT03282097|102133954|FG000|COMPLETED|Randomized and Completed Baseline||213||
48734788|NCT03282097|102133955|FG001|COMPLETED|Randomized and Completed Baseline||214||
48734789|NCT03282097|102133954|FG000|NOT COMPLETED|Randomized and Completed Baseline||1||
48734790|NCT03282097|102133955|FG001|NOT COMPLETED|Randomized and Completed Baseline||1||
48734791|NCT03282097|102133954|FG000|STARTED|Intervention Visit Complete||213||
48734792|NCT03282097|102133955|FG001|STARTED|Intervention Visit Complete||214||
48734793|NCT03282097|102133954|FG000|COMPLETED|Intervention Visit Complete||171||
48734794|NCT03282097|102133955|FG001|COMPLETED|Intervention Visit Complete||155||
48734795|NCT03282097|102133954|FG000|NOT COMPLETED|Intervention Visit Complete||42||
48734796|NCT03282097|102133955|FG001|NOT COMPLETED|Intervention Visit Complete||59||
48734797|NCT03282097|102133954|FG000|STARTED|Primary Outcome Data Collection Complete||171||
48734798|NCT03282097|102133955|FG001|STARTED|Primary Outcome Data Collection Complete||155||
48160019|NCT00612534|100715778|FG000|NOT COMPLETED|Overall Study||13||
48160020|NCT00612534|100715779|FG001|NOT COMPLETED|Overall Study||17||
48160021|NCT00612534|100715780|FG002|NOT COMPLETED|Overall Study||7||
48734799|NCT03282097|102133954|FG000|COMPLETED|Primary Outcome Data Collection Complete||168||
48734800|NCT03282097|102133955|FG001|COMPLETED|Primary Outcome Data Collection Complete||152||
48734801|NCT03282097|102133954|FG000|NOT COMPLETED|Primary Outcome Data Collection Complete||3||
48734802|NCT03282097|102133955|FG001|NOT COMPLETED|Primary Outcome Data Collection Complete||3||
48734803|NCT03282097|102133954|FG000|STARTED|15 Month Follow-up Complete||170|Dyads that missed the primary outcome data collection visit still had the opportunity to complete 15 month follow up interview.|
48734804|NCT03282097|102133955|FG001|STARTED|15 Month Follow-up Complete||155|Dyads that missed the primary outcome data collection visit still had the opportunity to complete 15 month follow up interview.|
48734805|NCT03282097|102133954|FG000|COMPLETED|15 Month Follow-up Complete||164||
48160022|NCT00612534|100715781|FG003|NOT COMPLETED|Overall Study||17||
48160023|NCT00943306|100715782|FG000|STARTED|Overall Study||19||
48160024|NCT00943306|100715782|FG000|COMPLETED|Overall Study||16||
48160025|NCT00943306|100715782|FG000|NOT COMPLETED|Overall Study||3||
48160026|NCT01521884|100715783|FG000|STARTED|Overall Study||62||
48160027|NCT01521884|100715783|FG000|COMPLETED|Overall Study||35||
48407149|NCT03073200|101328518|FG007|NOT COMPLETED|Open-Label Maintenance Period||0||
48407150|NCT03073200|101328519|FG008|NOT COMPLETED|Open-Label Maintenance Period||0||
48407151|NCT03073200|101328520|FG009|NOT COMPLETED|Open-Label Maintenance Period||0||
48407152|NCT03073200|101328521|FG010|NOT COMPLETED|Open-Label Maintenance Period||0||
48734806|NCT03282097|102133955|FG001|COMPLETED|15 Month Follow-up Complete||146||
48734807|NCT03282097|102133954|FG000|NOT COMPLETED|15 Month Follow-up Complete||6||
48734808|NCT03282097|102133955|FG001|NOT COMPLETED|15 Month Follow-up Complete||9||
48734809|NCT02679287|102133956|FG000|STARTED|Period 1: Randomization-Study Session 1||47|Randomization|
48734810|NCT02679287|102133957|FG001|STARTED|Period 1: Randomization-Study Session 1||46|Randomization|
48734811|NCT02679287|102133956|FG000|COMPLETED|Period 1: Randomization-Study Session 1||43|Completion of Study Session 1 Group A=SAP Group B=Evening/Overnight CLC|
48734812|NCT02679287|102133957|FG001|COMPLETED|Period 1: Randomization-Study Session 1||40|Completion of Study Session 1 Group A=SAP Group B=Evening/Overnight CLC|
48734813|NCT02679287|102133956|FG000|NOT COMPLETED|Period 1: Randomization-Study Session 1||4||
48734814|NCT02679287|102133957|FG001|NOT COMPLETED|Period 1: Randomization-Study Session 1||6||
48734815|NCT02679287|102133956|FG000|STARTED|Period 2||43||
48734816|NCT02679287|102133957|FG001|STARTED|Period 2||40||
48734817|NCT02679287|102133956|FG000|COMPLETED|Period 2||40|"Completed Study Session 2:~Group A: Evening/Overnight CLC Group B: 24/7 CLC"|
48734818|NCT02679287|102133957|FG001|COMPLETED|Period 2||40|"Completed Study Session 2:~Group A: Evening/Overnight CLC Group B: 24/7 CLC"|
48734819|NCT02679287|102133956|FG000|NOT COMPLETED|Period 2||3||
48734820|NCT02679287|102133957|FG001|NOT COMPLETED|Period 2||0||
48734821|NCT02679287|102133956|FG000|STARTED|Period 3||40||
48734822|NCT02679287|102133957|FG001|STARTED|Period 3||40||
48734823|NCT02679287|102133956|FG000|COMPLETED|Period 3||40|"Completed Study Session 3:~Group A: 24/7 CLC Group B: Evening/Overnight CLC"|
48734824|NCT02679287|102133957|FG001|COMPLETED|Period 3||39|"Completed Study Session 3:~Group A: 24/7 CLC Group B: Evening/Overnight CLC"|
48734825|NCT02679287|102133956|FG000|NOT COMPLETED|Period 3||0||
48734826|NCT02679287|102133957|FG001|NOT COMPLETED|Period 3||1||
48734827|NCT02679287|102133956|FG000|STARTED|Phase 4||40|"Completed Study Session 4:~Group A: Evening/Overnight CLC Group B: SAP"|
48734828|NCT02679287|102133957|FG001|STARTED|Phase 4||39|"Completed Study Session 4:~Group A: Evening/Overnight CLC Group B: SAP"|
48734829|NCT02679287|102133956|FG000|COMPLETED|Phase 4||40||
48734830|NCT02679287|102133957|FG001|COMPLETED|Phase 4||39||
48734831|NCT02679287|102133956|FG000|NOT COMPLETED|Phase 4||0||
48734832|NCT02679287|102133957|FG001|NOT COMPLETED|Phase 4||0||
48734833|NCT03654885|102133958|FG000|STARTED|Overall Study||107||107
48734834|NCT03654885|102133959|FG001|STARTED|Overall Study||51||51
48734835|NCT03654885|102133958|FG000|Intent-to-Treat (ITT) Population|Overall Study||95|Intent-to-Treat (ITT) Population included all enrolled eyes/participants that were randomized to and received study glaucoma surgery (XEN-45 or trabeculectomy). Analyses were based on the randomized surgery.|95
48734836|NCT03654885|102133959|FG001|Intent-to-Treat (ITT) Population|Overall Study||44|Intent-to-Treat (ITT) Population included all enrolled eyes/participants that were randomized to and received study glaucoma surgery (XEN-45 or trabeculectomy). Analyses were based on the randomized surgery.|44
48734837|NCT03654885|102133958|FG000|Safety Population|Overall Study||95|Safety Population included all enrolled participants that have undergone study glaucoma surgery.|95
48734838|NCT03654885|102133959|FG001|Safety Population|Overall Study||44|Safety Population included all enrolled participants that have undergone study glaucoma surgery.|44
48734839|NCT03654885|102133958|FG000|COMPLETED|Overall Study||77||77
48734840|NCT03654885|102133959|FG001|COMPLETED|Overall Study||38||38
48734841|NCT03654885|102133958|FG000|NOT COMPLETED|Overall Study||30||30
48734842|NCT03654885|102133959|FG001|NOT COMPLETED|Overall Study||13||13
48734843|NCT02863328|102133960|FG000|STARTED|Overall Study||411|One participant was duplicate, hence removed from 'started' population.|
48734844|NCT02863328|102133961|FG001|STARTED|Overall Study||410|One participant was duplicate, hence removed from 'started' population.|
48734845|NCT02863328|102133960|FG000|Full Analysis Set (FAS)|Overall Study||411||
48734846|NCT02863328|102133961|FG001|Full Analysis Set (FAS)|Overall Study||410||
48734847|NCT02863328|102133960|FG000|Safety Analysis Set (SAS)|Overall Study||410||
48734848|NCT02863328|102133961|FG001|Safety Analysis Set (SAS)|Overall Study||409||
48734849|NCT02863328|102133960|FG000|COMPLETED|Overall Study||400||
48734850|NCT02863328|102133961|FG001|COMPLETED|Overall Study||387||
48734851|NCT02863328|102133960|FG000|NOT COMPLETED|Overall Study||11||
48734852|NCT02863328|102133961|FG001|NOT COMPLETED|Overall Study||23||
48734853|NCT01229722|102133962|FG000|STARTED|Overall Study||36||
48734854|NCT01229722|102133963|FG001|STARTED|Overall Study||34||
48734855|NCT01229722|102133962|FG000|COMPLETED|Overall Study||36||
48734856|NCT01229722|102133963|FG001|COMPLETED|Overall Study||30||
48734857|NCT01229722|102133962|FG000|NOT COMPLETED|Overall Study||0||
48734858|NCT01229722|102133963|FG001|NOT COMPLETED|Overall Study||4||
48734859|NCT02218008|102133964|FG000|STARTED|Stage 1 (S1)||280||
48734860|NCT02218008|102133965|FG001|STARTED|Stage 1 (S1)||63||
48734861|NCT02218008|102133966|FG002|STARTED|Stage 1 (S1)||63||
48615591|NCT00784719|101844949|FG002|COMPLETED|Overall Study||46||
48615592|NCT00784719|101844950|FG003|COMPLETED|Overall Study||48||
48615593|NCT00784719|101844951|FG004|COMPLETED|Overall Study||42||
48615594|NCT00784719|101844952|FG005|COMPLETED|Overall Study||41||
48615595|NCT00784719|101844953|FG006|COMPLETED|Overall Study||42||
48615596|NCT00784719|101844947|FG000|NOT COMPLETED|Overall Study||3||
48615597|NCT00784719|101844948|FG001|NOT COMPLETED|Overall Study||3||
48615598|NCT00784719|101844949|FG002|NOT COMPLETED|Overall Study||1||
48615599|NCT00784719|101844950|FG003|NOT COMPLETED|Overall Study||0||
48615600|NCT00784719|101844951|FG004|NOT COMPLETED|Overall Study||6||
48615601|NCT00784719|101844952|FG005|NOT COMPLETED|Overall Study||3||
48615602|NCT00784719|101844953|FG006|NOT COMPLETED|Overall Study||5||
48615603|NCT00447902|101844954|FG000|STARTED|Overall Study||5||
48615604|NCT00447902|101844955|FG001|STARTED|Overall Study||6||
48615605|NCT00447902|101844954|FG000|COMPLETED|Overall Study||1||
48615606|NCT00447902|101844955|FG001|COMPLETED|Overall Study||0||
48615607|NCT00447902|101844954|FG000|NOT COMPLETED|Overall Study||4||
48615608|NCT00447902|101844955|FG001|NOT COMPLETED|Overall Study||6||
48615609|NCT00707057|101844956|FG000|STARTED|Overall Study||169||
48615610|NCT00707057|101844957|FG001|STARTED|Overall Study||87||
48615611|NCT00707057|101844956|FG000|COMPLETED|Overall Study||161||
48615612|NCT00707057|101844957|FG001|COMPLETED|Overall Study||83||
48615613|NCT00707057|101844956|FG000|NOT COMPLETED|Overall Study||8||
48615614|NCT00707057|101844957|FG001|NOT COMPLETED|Overall Study||4||
48615615|NCT01472445|101844958|FG000|STARTED|Overall Study||25||
48615616|NCT01472445|101844959|FG001|STARTED|Overall Study||16||
48615617|NCT01472445|101844958|FG000|COMPLETED|Overall Study||25||
48615618|NCT01472445|101844959|FG001|COMPLETED|Overall Study||16||
48615619|NCT01472445|101844958|FG000|NOT COMPLETED|Overall Study||0||
48615620|NCT01472445|101844959|FG001|NOT COMPLETED|Overall Study||0||
48615621|NCT03012841|101844960|FG000|STARTED|Overall Study||165||
48615622|NCT03012841|101844961|FG001|STARTED|Overall Study||21||
48615623|NCT03012841|101844960|FG000|COMPLETED|Overall Study||145||
48615624|NCT03012841|101844961|FG001|COMPLETED|Overall Study||0||
48734862|NCT02218008|102133967|FG003|STARTED|Stage 1 (S1)||0||
48734863|NCT02218008|102133968|FG004|STARTED|Stage 1 (S1)||0||
48734864|NCT02218008|102133969|FG005|STARTED|Stage 1 (S1)||0||
48734865|NCT02218008|102133964|FG000|COMPLETED|Stage 1 (S1)||258||
48734866|NCT02218008|102133965|FG001|COMPLETED|Stage 1 (S1)||56||
48734867|NCT02218008|102133966|FG002|COMPLETED|Stage 1 (S1)||48||
48734868|NCT02218008|102133967|FG003|COMPLETED|Stage 1 (S1)||0||
48615625|NCT03012841|101844960|FG000|NOT COMPLETED|Overall Study||20||
48734869|NCT02218008|102133968|FG004|COMPLETED|Stage 1 (S1)||0||
48734870|NCT02218008|102133969|FG005|COMPLETED|Stage 1 (S1)||0||
48734871|NCT02218008|102133964|FG000|NOT COMPLETED|Stage 1 (S1)||22||
48734872|NCT02218008|102133965|FG001|NOT COMPLETED|Stage 1 (S1)||7||
48615626|NCT03012841|101844961|FG001|NOT COMPLETED|Overall Study||21||
48615627|NCT00086450|101844962|FG000|STARTED|Overall Study||953||
48615628|NCT00086450|101844963|FG001|STARTED|Overall Study||947||
48615629|NCT00086450|101844962|FG000|COMPLETED|Overall Study||953||
48615630|NCT00086450|101844963|FG001|COMPLETED|Overall Study||947||
48615631|NCT00086450|101844962|FG000|NOT COMPLETED|Overall Study||0||
48615632|NCT00086450|101844963|FG001|NOT COMPLETED|Overall Study||0||
48615633|NCT03318003|101844964|FG000|STARTED|Overall Study||21||
48615634|NCT03318003|101844965|FG001|STARTED|Overall Study||22||
48615635|NCT03318003|101844964|FG000|COMPLETED|Overall Study||20||
48615636|NCT03318003|101844965|FG001|COMPLETED|Overall Study||20||
48615637|NCT03318003|101844964|FG000|NOT COMPLETED|Overall Study||1||
48615638|NCT03318003|101844965|FG001|NOT COMPLETED|Overall Study||2||
48615639|NCT01214668|101844966|FG000|STARTED|Overall Study||4||
48615640|NCT01214668|101844967|FG001|STARTED|Overall Study||3||
48615641|NCT01214668|101844968|FG002|STARTED|Overall Study||6||
48615642|NCT01214668|101844969|FG003|STARTED|Overall Study||6||
48615643|NCT01214668|101844970|FG004|STARTED|Overall Study||6||
48615644|NCT01214668|101844971|FG005|STARTED|Overall Study||6||
48615645|NCT01214668|101844966|FG000|Received at Least One Dose of Study Drug|Overall Study||4||
48615646|NCT01214668|101844967|FG001|Received at Least One Dose of Study Drug|Overall Study||3||
48615647|NCT01214668|101844968|FG002|Received at Least One Dose of Study Drug|Overall Study||6||
48615648|NCT01214668|101844969|FG003|Received at Least One Dose of Study Drug|Overall Study||6||
48615649|NCT01214668|101844970|FG004|Received at Least One Dose of Study Drug|Overall Study||6||
48615650|NCT01214668|101844971|FG005|Received at Least One Dose of Study Drug|Overall Study||6||
48615651|NCT01214668|101844966|FG000|COMPLETED|Overall Study||0||
48615652|NCT01214668|101844967|FG001|COMPLETED|Overall Study||0||
48615653|NCT01214668|101844968|FG002|COMPLETED|Overall Study||0||
48615654|NCT01214668|101844969|FG003|COMPLETED|Overall Study||0||
48615655|NCT01214668|101844970|FG004|COMPLETED|Overall Study||0||
48615656|NCT01214668|101844971|FG005|COMPLETED|Overall Study||0||
48615657|NCT01214668|101844966|FG000|NOT COMPLETED|Overall Study||4||
48615658|NCT01214668|101844967|FG001|NOT COMPLETED|Overall Study||3||
48615659|NCT01214668|101844968|FG002|NOT COMPLETED|Overall Study||6||
48615660|NCT01214668|101844969|FG003|NOT COMPLETED|Overall Study||6||
48615661|NCT01214668|101844970|FG004|NOT COMPLETED|Overall Study||6||
48615662|NCT01214668|101844971|FG005|NOT COMPLETED|Overall Study||6||
48615663|NCT03441685|101844972|FG000|STARTED|Overall Study||23||
48615664|NCT03441685|101844973|FG001|STARTED|Overall Study||8||
48615665|NCT03441685|101844974|FG002|STARTED|Overall Study||7||
48615666|NCT03441685|101844972|FG000|COMPLETED|Overall Study||23||
48615667|NCT03441685|101844973|FG001|COMPLETED|Overall Study||8||
48615668|NCT03441685|101844974|FG002|COMPLETED|Overall Study||7||
48615669|NCT03441685|101844972|FG000|NOT COMPLETED|Overall Study||0||
48615670|NCT03441685|101844973|FG001|NOT COMPLETED|Overall Study||0||
48615671|NCT03441685|101844974|FG002|NOT COMPLETED|Overall Study||0||
48615672|NCT00074815|101844975|FG000|STARTED|Overall Study||42||
48734873|NCT02218008|102133966|FG002|NOT COMPLETED|Stage 1 (S1)||15||
48734874|NCT02218008|102133967|FG003|NOT COMPLETED|Stage 1 (S1)||0||
48734875|NCT02218008|102133968|FG004|NOT COMPLETED|Stage 1 (S1)||0||
48734876|NCT02218008|102133969|FG005|NOT COMPLETED|Stage 1 (S1)||0||
48734877|NCT02218008|102133964|FG000|STARTED|Stage 2 (S2)||0|Subjects randomized in Stage 2 are a subset of those randomized to placebo in Stage 1.|
48734878|NCT02218008|102133965|FG001|STARTED|Stage 2 (S2)||0|Subjects randomized in Stage 2 are a subset of those randomized to placebo in Stage 1.|
48734879|NCT02218008|102133966|FG002|STARTED|Stage 2 (S2)||0|Subjects randomized in Stage 2 are a subset of those randomized to placebo in Stage 1.|
48734880|NCT02218008|102133967|FG003|STARTED|Stage 2 (S2)||62|Subjects randomized in Stage 2 are a subset of those randomized to placebo in Stage 1.|
48734881|NCT02218008|102133968|FG004|STARTED|Stage 2 (S2)||62|Subjects randomized in Stage 2 are a subset of those randomized to placebo in Stage 1.|
48734882|NCT02218008|102133969|FG005|STARTED|Stage 2 (S2)||63|Subjects randomized in Stage 2 are a subset of those randomized to placebo in Stage 1.|
48734883|NCT02218008|102133964|FG000|COMPLETED|Stage 2 (S2)||0||
48734884|NCT02218008|102133965|FG001|COMPLETED|Stage 2 (S2)||0||
48734885|NCT02218008|102133966|FG002|COMPLETED|Stage 2 (S2)||0||
48734886|NCT02218008|102133967|FG003|COMPLETED|Stage 2 (S2)||58||
48734887|NCT02218008|102133968|FG004|COMPLETED|Stage 2 (S2)||58||
48734888|NCT02218008|102133969|FG005|COMPLETED|Stage 2 (S2)||57||
48734889|NCT02218008|102133964|FG000|NOT COMPLETED|Stage 2 (S2)||0||
48734890|NCT02218008|102133965|FG001|NOT COMPLETED|Stage 2 (S2)||0||
48734891|NCT02218008|102133966|FG002|NOT COMPLETED|Stage 2 (S2)||0||
48734892|NCT02218008|102133967|FG003|NOT COMPLETED|Stage 2 (S2)||4||
48734893|NCT02218008|102133968|FG004|NOT COMPLETED|Stage 2 (S2)||4||
48734894|NCT02218008|102133969|FG005|NOT COMPLETED|Stage 2 (S2)||6||
48615673|NCT00074815|101844976|FG001|STARTED|Overall Study||40||
48615674|NCT00074815|101844977|FG002|STARTED|Overall Study||42||
48615675|NCT00074815|101844975|FG000|COMPLETED|Overall Study||37||
48615676|NCT00074815|101844976|FG001|COMPLETED|Overall Study||34||
48615677|NCT00074815|101844977|FG002|COMPLETED|Overall Study||30||
48615678|NCT00074815|101844975|FG000|NOT COMPLETED|Overall Study||5||
48615679|NCT00074815|101844976|FG001|NOT COMPLETED|Overall Study||6||
48615680|NCT00074815|101844977|FG002|NOT COMPLETED|Overall Study||12||
48734895|NCT02466009|102133970|FG000|STARTED|Overall Study||27||
48734896|NCT02466009|102133970|FG000|COMPLETED|Overall Study||27||
48734897|NCT02466009|102133970|FG000|NOT COMPLETED|Overall Study||0||
48734898|NCT01832155|102133971|FG000|STARTED|Beginning of Study: Baseline at 0 Week||18||
48734899|NCT01832155|102133972|FG001|STARTED|Beginning of Study: Baseline at 0 Week||18||
48734900|NCT01832155|102133971|FG000|COMPLETED|Beginning of Study: Baseline at 0 Week||17||
48734901|NCT01832155|102133972|FG001|COMPLETED|Beginning of Study: Baseline at 0 Week||18||
48734902|NCT01832155|102133971|FG000|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||1||
48734903|NCT01832155|102133972|FG001|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||0||
48734904|NCT01832155|102133971|FG000|STARTED|Mid-point of Study: 0 - 4 Weeks||17||
48734905|NCT01832155|102133972|FG001|STARTED|Mid-point of Study: 0 - 4 Weeks||18||
48734906|NCT01832155|102133971|FG000|COMPLETED|Mid-point of Study: 0 - 4 Weeks||16||
48734907|NCT01832155|102133972|FG001|COMPLETED|Mid-point of Study: 0 - 4 Weeks||18||
48734908|NCT01832155|102133971|FG000|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||1||
48734909|NCT01832155|102133972|FG001|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||0||
48734910|NCT01832155|102133971|FG000|STARTED|End of Study: 4 - 8 Weeks||16||
48734911|NCT01832155|102133972|FG001|STARTED|End of Study: 4 - 8 Weeks||18||
48734912|NCT01832155|102133971|FG000|COMPLETED|End of Study: 4 - 8 Weeks||16||
48734913|NCT01832155|102133972|FG001|COMPLETED|End of Study: 4 - 8 Weeks||18||
48734914|NCT01832155|102133971|FG000|NOT COMPLETED|End of Study: 4 - 8 Weeks||0||
48734915|NCT01832155|102133972|FG001|NOT COMPLETED|End of Study: 4 - 8 Weeks||0||
48734916|NCT01840345|102136942|FG000|STARTED|Overall Study||11||
48734917|NCT01840345|102136942|FG000|COMPLETED|Overall Study||10||
48734918|NCT01840345|102136942|FG000|NOT COMPLETED|Overall Study||1||
48734919|NCT01900652|102136943|FG000|STARTED|Overall Study||83||
48734920|NCT01900652|102136944|FG001|STARTED|Overall Study||28||
48734921|NCT01900652|102136943|FG000|Post-Erlotinib Progression Tumor Sample|Overall Study||66||
48734922|NCT01900652|102136944|FG001|Post-Erlotinib Progression Tumor Sample|Overall Study||23||
48734923|NCT01900652|102136943|FG000|COMPLETED|Overall Study||75||
48734924|NCT01900652|102136944|FG001|COMPLETED|Overall Study||25||
48734925|NCT01900652|102136943|FG000|NOT COMPLETED|Overall Study||8||
48734926|NCT01900652|102136944|FG001|NOT COMPLETED|Overall Study||3||
48734927|NCT00176462|102136945|FG000|STARTED|Induction (4 Weeks)||21||
48734928|NCT00176462|102136946|FG001|STARTED|Induction (4 Weeks)||39||
48734929|NCT00176462|102136945|FG000|COMPLETED|Induction (4 Weeks)||20||
48734930|NCT00176462|102136946|FG001|COMPLETED|Induction (4 Weeks)||34||
48734931|NCT00176462|102136945|FG000|NOT COMPLETED|Induction (4 Weeks)||1||
48734932|NCT00176462|102136946|FG001|NOT COMPLETED|Induction (4 Weeks)||5||
48734933|NCT00176462|102136945|FG000|STARTED|Consolidation (12 Weeks)||20||
48734934|NCT00176462|102136946|FG001|STARTED|Consolidation (12 Weeks)||34||
48734935|NCT00176462|102136945|FG000|COMPLETED|Consolidation (12 Weeks)||20||
48734936|NCT00176462|102136946|FG001|COMPLETED|Consolidation (12 Weeks)||29||
48734937|NCT00176462|102136945|FG000|NOT COMPLETED|Consolidation (12 Weeks)||0||
48734938|NCT00176462|102136946|FG001|NOT COMPLETED|Consolidation (12 Weeks)||5||
48734939|NCT00176462|102136945|FG000|STARTED|Delayed Intensification (8 Weeks)||20||
48734940|NCT00176462|102136946|FG001|STARTED|Delayed Intensification (8 Weeks)||29||
48734941|NCT00176462|102136945|FG000|COMPLETED|Delayed Intensification (8 Weeks)||20||
48734942|NCT00176462|102136946|FG001|COMPLETED|Delayed Intensification (8 Weeks)||29||
48734943|NCT00176462|102136945|FG000|NOT COMPLETED|Delayed Intensification (8 Weeks)||0||
48734944|NCT00176462|102136946|FG001|NOT COMPLETED|Delayed Intensification (8 Weeks)||0||
48734945|NCT00176462|102136945|FG000|STARTED|Intensive Continuation (8X8-week Cycles)||20||
48734946|NCT00176462|102136946|FG001|STARTED|Intensive Continuation (8X8-week Cycles)||29||
48734947|NCT00176462|102136945|FG000|COMPLETED|Intensive Continuation (8X8-week Cycles)||19||
48734948|NCT00176462|102136946|FG001|COMPLETED|Intensive Continuation (8X8-week Cycles)||26||
48734949|NCT00176462|102136945|FG000|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||1||
48734950|NCT00176462|102136946|FG001|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||3||
48734951|NCT00176462|102136945|FG000|STARTED|Continuation -up to 30mos Post Remission||19||
48734952|NCT00176462|102136946|FG001|STARTED|Continuation -up to 30mos Post Remission||26||
48734953|NCT00176462|102136945|FG000|COMPLETED|Continuation -up to 30mos Post Remission||19||
48734954|NCT00176462|102136946|FG001|COMPLETED|Continuation -up to 30mos Post Remission||26||
48734955|NCT00176462|102136945|FG000|NOT COMPLETED|Continuation -up to 30mos Post Remission||0||
48734956|NCT00176462|102136946|FG001|NOT COMPLETED|Continuation -up to 30mos Post Remission||0||
48734957|NCT01450098|102136947|FG000|STARTED|Period 1||8||
48734958|NCT01450098|102136948|FG001|STARTED|Period 1||31||
48734959|NCT01450098|102136947|FG000|Received at Least 1 Dose of Study Drug|Period 1||8||
48734960|NCT01450098|102136948|FG001|Received at Least 1 Dose of Study Drug|Period 1||31||
48734961|NCT01450098|102136947|FG000|COMPLETED|Period 1||8||
48734962|NCT01450098|102136948|FG001|COMPLETED|Period 1||31||
48734963|NCT01450098|102136947|FG000|NOT COMPLETED|Period 1||0||
48734964|NCT01450098|102136948|FG001|NOT COMPLETED|Period 1||0||
48734965|NCT01450098|102136947|FG000|STARTED|Washout Period of at Least 14 Days||8||
48734966|NCT01450098|102136948|FG001|STARTED|Washout Period of at Least 14 Days||31||
48734967|NCT01450098|102136947|FG000|COMPLETED|Washout Period of at Least 14 Days||8||
48734968|NCT01450098|102136948|FG001|COMPLETED|Washout Period of at Least 14 Days||31||
48734969|NCT01450098|102136947|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||0||
48734970|NCT01450098|102136948|FG001|NOT COMPLETED|Washout Period of at Least 14 Days||0||
48734971|NCT01450098|102136947|FG000|STARTED|Period 2||8||
48734972|NCT01450098|102136948|FG001|STARTED|Period 2||31||
48734973|NCT01450098|102136947|FG000|Received at Least 1 Dose of Study Drug|Period 2||8||
48734974|NCT01450098|102136948|FG001|Received at Least 1 Dose of Study Drug|Period 2||31||
48734975|NCT01450098|102136947|FG000|COMPLETED|Period 2||8||
48734976|NCT01450098|102136948|FG001|COMPLETED|Period 2||31||
48734977|NCT01450098|102136947|FG000|NOT COMPLETED|Period 2||0||
48734978|NCT01450098|102136948|FG001|NOT COMPLETED|Period 2||0||
48734979|NCT01450098|102136947|FG000|STARTED|Washout of at Least 14 Days||8||
48734980|NCT01450098|102136948|FG001|STARTED|Washout of at Least 14 Days||31||
48734981|NCT01450098|102136947|FG000|COMPLETED|Washout of at Least 14 Days||8||
48734982|NCT01450098|102136948|FG001|COMPLETED|Washout of at Least 14 Days||31||
48734983|NCT01450098|102136947|FG000|NOT COMPLETED|Washout of at Least 14 Days||0||
48734984|NCT01450098|102136948|FG001|NOT COMPLETED|Washout of at Least 14 Days||0||
48734985|NCT01450098|102136947|FG000|STARTED|Period 3||8||
48734986|NCT01450098|102136948|FG001|STARTED|Period 3||31||
48734987|NCT01450098|102136947|FG000|Received at Least 1 Dose of Study Drug|Period 3||8||
48734988|NCT01450098|102136948|FG001|Received at Least 1 Dose of Study Drug|Period 3||30||
48734989|NCT01450098|102136947|FG000|COMPLETED|Period 3||8||
48734990|NCT01450098|102136948|FG001|COMPLETED|Period 3||28||
48734991|NCT01450098|102136947|FG000|NOT COMPLETED|Period 3||0||
48734992|NCT01450098|102136948|FG001|NOT COMPLETED|Period 3||3||
48734993|NCT00856726|102136949|FG000|STARTED|Overall Study||26||
48734994|NCT00856726|102136949|FG000|COMPLETED|Overall Study||26||
48734995|NCT00856726|102136949|FG000|NOT COMPLETED|Overall Study||0||
48734996|NCT00066963|102136950|FG000|STARTED|Overall Study||126||
48734997|NCT00066963|102136951|FG001|STARTED|Overall Study||124||
48734998|NCT00066963|102136952|FG002|STARTED|Overall Study||126||
48734999|NCT00066963|102136950|FG000|COMPLETED|Overall Study||100||
48735000|NCT00066963|102136951|FG001|COMPLETED|Overall Study||93||
48735001|NCT00066963|102136952|FG002|COMPLETED|Overall Study||87||
48735002|NCT00066963|102136950|FG000|NOT COMPLETED|Overall Study||26||
48735003|NCT00066963|102136951|FG001|NOT COMPLETED|Overall Study||31||
48735004|NCT00066963|102136952|FG002|NOT COMPLETED|Overall Study||39||
48735005|NCT03213834|102136953|FG000|STARTED|Overall Study||3||
48735006|NCT03213834|102136954|FG001|STARTED|Overall Study||2||
48735007|NCT03213834|102136953|FG000|COMPLETED|Overall Study||3||
48735008|NCT03213834|102136954|FG001|COMPLETED|Overall Study||2||
48735009|NCT03213834|102136953|FG000|NOT COMPLETED|Overall Study||0||
48735010|NCT03213834|102136954|FG001|NOT COMPLETED|Overall Study||0||
48735011|NCT01635855|102136955|FG000|STARTED|Overall Study||117||
48735012|NCT01635855|102136955|FG000|COMPLETED|Overall Study||113||
48735013|NCT01635855|102136955|FG000|NOT COMPLETED|Overall Study||4||
48735014|NCT03929640|102136956|FG000|STARTED|Overall Study||24|Randomized subjects|
48735015|NCT03929640|102136957|FG001|STARTED|Overall Study||25|Randomized subjects|
48735016|NCT03929640|102136956|FG000|Received Study Drug|Overall Study||20|Met final eligibility criteria/received study drug|
48735017|NCT03929640|102136957|FG001|Received Study Drug|Overall Study||21|Met final eligibility criteria/received study drug|
48160028|NCT01521884|100715783|FG000|NOT COMPLETED|Overall Study||27||
48160029|NCT02323646|100715784|FG000|STARTED|Treatment Course 1||14||
48160030|NCT02323646|100715785|FG001|STARTED|Treatment Course 1||13||
48160031|NCT02323646|100715786|FG002|STARTED|Treatment Course 1||15||
48160032|NCT02323646|100715784|FG000|COMPLETED|Treatment Course 1||11||
48735018|NCT03929640|102136956|FG000|COMPLETED|Overall Study||18|Completed 2w survey|
48735019|NCT03929640|102136957|FG001|COMPLETED|Overall Study||16|Completed 2w survey|
48735020|NCT03929640|102136956|FG000|NOT COMPLETED|Overall Study||6||
48735021|NCT03929640|102136957|FG001|NOT COMPLETED|Overall Study||9||
48735022|NCT02967510|102136958|FG000|STARTED|Overall Study||70||
48735023|NCT02967510|102136959|FG001|STARTED|Overall Study||70||
48735024|NCT02967510|102136960|FG002|STARTED|Overall Study||72||
48160033|NCT02323646|100715785|FG001|COMPLETED|Treatment Course 1||10||
48160034|NCT02323646|100715786|FG002|COMPLETED|Treatment Course 1||12||
48160035|NCT02323646|100715784|FG000|NOT COMPLETED|Treatment Course 1||3||
48160036|NCT02323646|100715785|FG001|NOT COMPLETED|Treatment Course 1||3||
48160037|NCT02323646|100715786|FG002|NOT COMPLETED|Treatment Course 1||3||
48735025|NCT02967510|102136961|FG003|STARTED|Overall Study||71||
48735026|NCT02967510|102136958|FG000|COMPLETED|Overall Study||66||
48735027|NCT02967510|102136959|FG001|COMPLETED|Overall Study||67||
48735028|NCT02967510|102136960|FG002|COMPLETED|Overall Study||65||
48160038|NCT02323646|100715784|FG000|STARTED|Treatment Course 2||11||
48160039|NCT02323646|100715785|FG001|STARTED|Treatment Course 2||10||
48160040|NCT02323646|100715786|FG002|STARTED|Treatment Course 2||12||
48160041|NCT02323646|100715784|FG000|COMPLETED|Treatment Course 2||10||
48735029|NCT02967510|102136961|FG003|COMPLETED|Overall Study||63||
48735030|NCT02967510|102136958|FG000|NOT COMPLETED|Overall Study||4||
48160042|NCT02323646|100715785|FG001|COMPLETED|Treatment Course 2||9||
48160043|NCT02323646|100715786|FG002|COMPLETED|Treatment Course 2||9||
48160044|NCT02323646|100715784|FG000|NOT COMPLETED|Treatment Course 2||1||
48160045|NCT02323646|100715785|FG001|NOT COMPLETED|Treatment Course 2||1||
48160046|NCT02323646|100715786|FG002|NOT COMPLETED|Treatment Course 2||3||
48160047|NCT03021668|100715787|FG000|STARTED|Overall Study||62||
48160048|NCT03021668|100715788|FG001|STARTED|Overall Study||62||
48317545|NCT02716987|101104055|FG001|NOT COMPLETED|Overall Study||0||
48615681|NCT04878120|101844978|FG000|STARTED|Overall Study||13||
48615682|NCT04878120|101844979|FG001|STARTED|Overall Study||12||
48615683|NCT04878120|101844978|FG000|COMPLETED|Overall Study||12||
48615684|NCT04878120|101844979|FG001|COMPLETED|Overall Study||11||
48615685|NCT04878120|101844978|FG000|NOT COMPLETED|Overall Study||1||
48615686|NCT04878120|101844979|FG001|NOT COMPLETED|Overall Study||1||
48615687|NCT02896569|101844980|FG000|STARTED|Overall Study||25||
48615688|NCT02896569|101844981|FG001|STARTED|Overall Study||24||
48615689|NCT02896569|101844980|FG000|COMPLETED|Overall Study||21||
48615690|NCT02896569|101844981|FG001|COMPLETED|Overall Study||19||
48615691|NCT02896569|101844980|FG000|NOT COMPLETED|Overall Study||4||
48615692|NCT02896569|101844981|FG001|NOT COMPLETED|Overall Study||5||
48615693|NCT01649362|101844982|FG000|STARTED|Overall Study||47||
48615694|NCT01649362|101844983|FG001|STARTED|Overall Study||54||
48615695|NCT01649362|101844982|FG000|COMPLETED|Overall Study||46||
48615696|NCT01649362|101844983|FG001|COMPLETED|Overall Study||40||
48615697|NCT01649362|101844982|FG000|NOT COMPLETED|Overall Study||1||
48615698|NCT01649362|101844983|FG001|NOT COMPLETED|Overall Study||14||
48615699|NCT05259163|101844984|FG000|STARTED|Initial Testing - 1st Intervention||56||
48615700|NCT05259163|101844985|FG001|STARTED|Initial Testing - 1st Intervention||56||
48615701|NCT05259163|101844984|FG000|COMPLETED|Initial Testing - 1st Intervention||55||
48615702|NCT05259163|101844985|FG001|COMPLETED|Initial Testing - 1st Intervention||56||
48615703|NCT05259163|101844984|FG000|NOT COMPLETED|Initial Testing - 1st Intervention||1||
48615704|NCT05259163|101844985|FG001|NOT COMPLETED|Initial Testing - 1st Intervention||0||
48615705|NCT05259163|101844984|FG000|STARTED|1 Hour (+/- 30 Min) - 2nd Intervention||55||
48615706|NCT05259163|101844985|FG001|STARTED|1 Hour (+/- 30 Min) - 2nd Intervention||56||
48615707|NCT05259163|101844984|FG000|COMPLETED|1 Hour (+/- 30 Min) - 2nd Intervention||55||
48615708|NCT05259163|101844985|FG001|COMPLETED|1 Hour (+/- 30 Min) - 2nd Intervention||56||
48615709|NCT05259163|101844984|FG000|NOT COMPLETED|1 Hour (+/- 30 Min) - 2nd Intervention||0||
48615710|NCT05259163|101844985|FG001|NOT COMPLETED|1 Hour (+/- 30 Min) - 2nd Intervention||0||
48615711|NCT00101868|101844986|FG000|STARTED|Overall Study||316||
48615712|NCT00101868|101844987|FG001|STARTED|Overall Study||315||
48615713|NCT00101868|101844986|FG000|COMPLETED|Overall Study||287||
48615714|NCT00101868|101844987|FG001|COMPLETED|Overall Study||283||
48615715|NCT00101868|101844986|FG000|NOT COMPLETED|Overall Study||29||
48615716|NCT00101868|101844987|FG001|NOT COMPLETED|Overall Study||32||
48615717|NCT02521792|101844988|FG000|STARTED|Overall Study||6||
48615718|NCT02521792|101844988|FG000|Received Treatment|Overall Study||4||
48615719|NCT02521792|101844988|FG000|COMPLETED|Overall Study||0||
48615720|NCT02521792|101844988|FG000|NOT COMPLETED|Overall Study||6||
48615721|NCT03410992|101844989|FG000|STARTED|Initial Treatment Period: up to Wk16||86||
48615722|NCT03410992|101844990|FG001|STARTED|Initial Treatment Period: up to Wk16||349||
48615723|NCT03410992|101844991|FG002|STARTED|Initial Treatment Period: up to Wk16||0||
48615724|NCT03410992|101844992|FG003|STARTED|Initial Treatment Period: up to Wk16||0||
48615725|NCT03410992|101844993|FG004|STARTED|Initial Treatment Period: up to Wk16||0||
48615726|NCT03410992|101844994|FG005|STARTED|Initial Treatment Period: up to Wk16||0||
48615727|NCT03410992|101844995|FG006|STARTED|Initial Treatment Period: up to Wk16||0||
48615728|NCT03410992|101844996|FG007|STARTED|Initial Treatment Period: up to Wk16||0||
48615729|NCT03410992|101844997|FG008|STARTED|Initial Treatment Period: up to Wk16||0||
48615730|NCT03410992|101844998|FG009|STARTED|Initial Treatment Period: up to Wk16||0||
48615731|NCT03410992|101844999|FG010|STARTED|Initial Treatment Period: up to Wk16||0||
48615732|NCT03410992|101844989|FG000|COMPLETED|Initial Treatment Period: up to Wk16||82||
48615733|NCT03410992|101844990|FG001|COMPLETED|Initial Treatment Period: up to Wk16||340||
48615734|NCT03410992|101844991|FG002|COMPLETED|Initial Treatment Period: up to Wk16||0||
48615735|NCT03410992|101844992|FG003|COMPLETED|Initial Treatment Period: up to Wk16||0||
48615736|NCT03410992|101844993|FG004|COMPLETED|Initial Treatment Period: up to Wk16||0||
48615737|NCT03410992|101844994|FG005|COMPLETED|Initial Treatment Period: up to Wk16||0||
48615738|NCT03410992|101844995|FG006|COMPLETED|Initial Treatment Period: up to Wk16||0||
48615739|NCT03410992|101844996|FG007|COMPLETED|Initial Treatment Period: up to Wk16||0||
48615740|NCT03410992|101844997|FG008|COMPLETED|Initial Treatment Period: up to Wk16||0||
48160049|NCT03021668|100715787|FG000|COMPLETED|Overall Study||62||
48160050|NCT03021668|100715788|FG001|COMPLETED|Overall Study||61||
48160051|NCT03021668|100715787|FG000|NOT COMPLETED|Overall Study||0||
48160052|NCT03021668|100715788|FG001|NOT COMPLETED|Overall Study||1||
48160053|NCT02736825|100715789|FG000|STARTED|Overall Study||127||
48160054|NCT02736825|100715790|FG001|STARTED|Overall Study||135||
48615741|NCT03410992|101844998|FG009|COMPLETED|Initial Treatment Period: up to Wk16||0||
48615742|NCT03410992|101844999|FG010|COMPLETED|Initial Treatment Period: up to Wk16||0||
48615743|NCT03410992|101844989|FG000|NOT COMPLETED|Initial Treatment Period: up to Wk16||4||
48160055|NCT02736825|100715789|FG000|COMPLETED|Overall Study||117||
48160056|NCT02736825|100715790|FG001|COMPLETED|Overall Study||123||
48160057|NCT02736825|100715789|FG000|NOT COMPLETED|Overall Study||10||
48735031|NCT02967510|102136959|FG001|NOT COMPLETED|Overall Study||3||
48735032|NCT02967510|102136960|FG002|NOT COMPLETED|Overall Study||7||
48735033|NCT02967510|102136961|FG003|NOT COMPLETED|Overall Study||8||
48735034|NCT01206582|102136962|FG000|STARTED|Overall Study||11||
48735035|NCT01206582|102136963|FG001|STARTED|Overall Study||9||
48735036|NCT01206582|102136962|FG000|COMPLETED|Overall Study||9||
48735037|NCT01206582|102136963|FG001|COMPLETED|Overall Study||7||
48735038|NCT01206582|102136962|FG000|NOT COMPLETED|Overall Study||2||
48735039|NCT01206582|102136963|FG001|NOT COMPLETED|Overall Study||2||
48735040|NCT02474407|102136964|FG000|STARTED|First Intervention (14 Days)||39||
48735041|NCT02474407|102136965|FG001|STARTED|First Intervention (14 Days)||39||
48735042|NCT02474407|102136964|FG000|COMPLETED|First Intervention (14 Days)||39||
48735043|NCT02474407|102136965|FG001|COMPLETED|First Intervention (14 Days)||39||
48735044|NCT02474407|102136964|FG000|NOT COMPLETED|First Intervention (14 Days)||0||
48735045|NCT02474407|102136965|FG001|NOT COMPLETED|First Intervention (14 Days)||0||
48735046|NCT02474407|102136964|FG000|STARTED|Washout (14 Days)||39||
48735047|NCT02474407|102136965|FG001|STARTED|Washout (14 Days)||39||
48735048|NCT02474407|102136964|FG000|COMPLETED|Washout (14 Days)||39||
48735049|NCT02474407|102136965|FG001|COMPLETED|Washout (14 Days)||39||
48735050|NCT02474407|102136964|FG000|NOT COMPLETED|Washout (14 Days)||0||
48735051|NCT02474407|102136965|FG001|NOT COMPLETED|Washout (14 Days)||0||
48735052|NCT02474407|102136964|FG000|STARTED|Second Intervention (14 Days)||39||
48735053|NCT02474407|102136965|FG001|STARTED|Second Intervention (14 Days)||39||
48735054|NCT02474407|102136964|FG000|COMPLETED|Second Intervention (14 Days)||39||
48735055|NCT02474407|102136965|FG001|COMPLETED|Second Intervention (14 Days)||39||
48735056|NCT02474407|102136964|FG000|NOT COMPLETED|Second Intervention (14 Days)||0||
48735057|NCT02474407|102136965|FG001|NOT COMPLETED|Second Intervention (14 Days)||0||
48735058|NCT00887926|102136966|FG000|STARTED|Overall Study||3||
48735059|NCT00887926|102136967|FG001|STARTED|Overall Study||14||
48735060|NCT00887926|102136968|FG002|STARTED|Overall Study||3||
48735061|NCT00887926|102136969|FG003|STARTED|Overall Study||5||
48735062|NCT00887926|102136966|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
48735063|NCT00887926|102136967|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13||
48735064|NCT00887926|102136968|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
48735065|NCT00887926|102136969|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5||
48735066|NCT00887926|102136966|FG000|COMPLETED|Overall Study||3||
48735067|NCT00887926|102136967|FG001|COMPLETED|Overall Study||13||
48735068|NCT00887926|102136968|FG002|COMPLETED|Overall Study||3||
48735069|NCT00887926|102136969|FG003|COMPLETED|Overall Study||5||
48735070|NCT00887926|102136966|FG000|NOT COMPLETED|Overall Study||0||
48735071|NCT00887926|102136967|FG001|NOT COMPLETED|Overall Study||1||
48735072|NCT00887926|102136968|FG002|NOT COMPLETED|Overall Study||0||
48735073|NCT00887926|102136969|FG003|NOT COMPLETED|Overall Study||0||
48735074|NCT00206336|102136970|FG000|STARTED|Overall Study||20||
48735075|NCT00206336|102136970|FG000|COMPLETED|Overall Study||20||
48735076|NCT00206336|102136970|FG000|NOT COMPLETED|Overall Study||0||
48735077|NCT00765570|102136971|FG000|STARTED|Overall Study||9||
48735078|NCT00765570|102136972|FG001|STARTED|Overall Study||3||
48735079|NCT00765570|102136971|FG000|COMPLETED|Overall Study||7||
48735080|NCT00765570|102136972|FG001|COMPLETED|Overall Study||3||
48735081|NCT00765570|102136971|FG000|NOT COMPLETED|Overall Study||2||
48735082|NCT00765570|102136972|FG001|NOT COMPLETED|Overall Study||0||
48735083|NCT02638168|102136973|FG000|STARTED|Overall Study||3|This was with-in subject trial|
48735084|NCT02638168|102136974|FG001|STARTED|Overall Study||0|This was with-in subject trial|
48735085|NCT02638168|102136973|FG000|COMPLETED|Overall Study||3||
48735086|NCT02638168|102136974|FG001|COMPLETED|Overall Study||0||
48735087|NCT02638168|102136973|FG000|NOT COMPLETED|Overall Study||0||
48735088|NCT02638168|102136974|FG001|NOT COMPLETED|Overall Study||0||
48735089|NCT00652951|102136975|FG000|STARTED|Primary Phase||260||
48735090|NCT00652951|102136976|FG001|STARTED|Primary Phase||260||
48735091|NCT00652951|102136977|FG002|STARTED|Primary Phase||260||
48735092|NCT00652951|102136975|FG000|COMPLETED|Primary Phase||260||
48735093|NCT00652951|102136976|FG001|COMPLETED|Primary Phase||260||
48735094|NCT00652951|102136977|FG002|COMPLETED|Primary Phase||260||
48735095|NCT00652951|102136975|FG000|NOT COMPLETED|Primary Phase||0||
48735096|NCT00652951|102136976|FG001|NOT COMPLETED|Primary Phase||0||
48735097|NCT00652951|102136977|FG002|NOT COMPLETED|Primary Phase||0||
48735098|NCT00652951|102136975|FG000|STARTED|Booster Phase||257||
48735099|NCT00652951|102136976|FG001|STARTED|Booster Phase||259||
48735100|NCT00652951|102136977|FG002|STARTED|Booster Phase||258||
48735101|NCT00652951|102136975|FG000|COMPLETED|Booster Phase||256||
48735102|NCT00652951|102136976|FG001|COMPLETED|Booster Phase||258||
48735103|NCT00652951|102136977|FG002|COMPLETED|Booster Phase||258||
48735104|NCT00652951|102136975|FG000|NOT COMPLETED|Booster Phase||1||
48735105|NCT00652951|102136976|FG001|NOT COMPLETED|Booster Phase||1||
48735106|NCT00652951|102136977|FG002|NOT COMPLETED|Booster Phase||0||
48735107|NCT01969435|102136978|FG000|STARTED|Overall Study||50||
48735108|NCT01969435|102136978|FG000|COMPLETED|Overall Study||50||
48735109|NCT01969435|102136978|FG000|NOT COMPLETED|Overall Study||0||
48735110|NCT03165916|102136979|FG000|STARTED|Overall Study||58||
48735111|NCT03165916|102136980|FG001|STARTED|Overall Study||57||
48767625|NCT03678493|102222781|FG001|NOT COMPLETED|Overall Study||0||
48735112|NCT03165916|102136979|FG000|Reconstruction Interventions|Overall Study||59||
48735113|NCT03165916|102136980|FG001|Reconstruction Interventions|Overall Study||57||
48317546|NCT02716987|101104056|FG002|NOT COMPLETED|Overall Study||1||
48317547|NCT02716987|101104057|FG003|NOT COMPLETED|Overall Study||0||
48317548|NCT02716987|101104058|FG004|NOT COMPLETED|Overall Study||1||
48735114|NCT03165916|102136979|FG000|COMPLETED|Overall Study||58||
48735115|NCT03165916|102136980|FG001|COMPLETED|Overall Study||57||
48735116|NCT03165916|102136979|FG000|NOT COMPLETED|Overall Study||0||
48735117|NCT03165916|102136980|FG001|NOT COMPLETED|Overall Study||0||
48735118|NCT03304119|102136981|FG000|STARTED|Overall Study||37||
48735119|NCT03304119|102136982|FG001|STARTED|Overall Study||55||
48735120|NCT03304119|102136981|FG000|COMPLETED|Overall Study||37||
48735121|NCT03304119|102136982|FG001|COMPLETED|Overall Study||55||
48735122|NCT03304119|102136981|FG000|NOT COMPLETED|Overall Study||0||
48735123|NCT03304119|102136982|FG001|NOT COMPLETED|Overall Study||0||
48735124|NCT04177212|102136983|FG000|STARTED|Overall Study||55||
48735125|NCT04177212|102136984|FG001|STARTED|Overall Study||62||
48735126|NCT04177212|102136983|FG000|Safety Analysis Set|Overall Study||43|Participants who were randomized to Group A but treated according to the injection scheme of Group B due to coronavirus disease 2019 (COVID-19) pandemic measures were analyzed in Group B. Participants who were treated only once due to any reason were analyzed in Group B.|
48735127|NCT04177212|102136984|FG001|Safety Analysis Set|Overall Study||74|Participants who were randomized to Group A but treated according to the injection scheme of Group B due to coronavirus disease 2019 (COVID-19) pandemic measures were analyzed in Group B. Participants who were treated only once due to any reason were analyzed in Group B.|
48735128|NCT04177212|102136983|FG000|Modified Full Analysis Set|Overall Study||46|Participants randomized to Group A but treated as per Group B injection scheme due to COVID-19 pandemic measures were analyzed in Group B. Participants treated only once with all missing treatments due to reasons not related to pandemic measures such as premature withdrawal/protocol deviations, were analyzed in treatment group they were randomized to and participants treated only once with at least one missing treatment due to reasons related to pandemic measures were analyzed in Group B.|
48735129|NCT04177212|102136984|FG001|Modified Full Analysis Set|Overall Study||71|Participants randomized to Group A but treated as per Group B injection scheme due to COVID-19 pandemic measures were analyzed in Group B. Participants treated only once with all missing treatments due to reasons not related to pandemic measures such as premature withdrawal/protocol deviations, were analyzed in treatment group they were randomized to and participants treated only once with at least one missing treatment due to reasons related to pandemic measures were analyzed in Group B.|
48735130|NCT04177212|102136983|FG000|COMPLETED|Overall Study||43||
48735131|NCT04177212|102136984|FG001|COMPLETED|Overall Study||47||
48735132|NCT04177212|102136983|FG000|NOT COMPLETED|Overall Study||12||
48735133|NCT04177212|102136984|FG001|NOT COMPLETED|Overall Study||15||
48735134|NCT03790917|102136985|FG000|STARTED|Overall Study||201||
48735135|NCT03790917|102136985|FG000|COMPLETED|Overall Study||200||
48735136|NCT03790917|102136985|FG000|NOT COMPLETED|Overall Study||1||
48735137|NCT01574651|102136986|FG000|STARTED|Overall Study||476||
48735138|NCT01574651|102136987|FG001|STARTED|Overall Study||458||
48735139|NCT01574651|102136986|FG000|Full Analysis Set (FAS)|Overall Study||476||
48735140|NCT01574651|102136987|FG001|Full Analysis Set (FAS)|Overall Study||458||
48735141|NCT01574651|102136986|FG000|Per Protocol Set (PPS)|Overall Study||373||
48735142|NCT01574651|102136987|FG001|Per Protocol Set (PPS)|Overall Study||374||
48735143|NCT01574651|102136986|FG000|COMPLETED|Overall Study||415||
48735144|NCT01574651|102136987|FG001|COMPLETED|Overall Study||406||
48735145|NCT01574651|102136986|FG000|NOT COMPLETED|Overall Study||61||
48735146|NCT01574651|102136987|FG001|NOT COMPLETED|Overall Study||52||
48735147|NCT02373774|102136988|FG000|STARTED|Overall Study||40||
48735148|NCT02373774|102136989|FG001|STARTED|Overall Study||41||
48735149|NCT02373774|102136988|FG000|COMPLETED|Overall Study||40||
48735150|NCT02373774|102136989|FG001|COMPLETED|Overall Study||38||
48735151|NCT02373774|102136988|FG000|NOT COMPLETED|Overall Study||0||
48735152|NCT02373774|102136989|FG001|NOT COMPLETED|Overall Study||3||
48735153|NCT02355210|102136990|FG000|STARTED|Overall Study||19||
48735154|NCT02355210|102136991|FG001|STARTED|Overall Study||18||
48735155|NCT02355210|102136992|FG002|STARTED|Overall Study||16||
48735156|NCT02355210|102136993|FG003|STARTED|Overall Study||17||
48735157|NCT02355210|102136994|FG004|STARTED|Overall Study||19||
48735158|NCT02355210|102136995|FG005|STARTED|Overall Study||18||
48317549|NCT02716987|101104059|FG005|NOT COMPLETED|Overall Study||1||
48317550|NCT03329911|101104060|FG000|STARTED|Overall Study||326||
48317551|NCT03329911|101104061|FG001|STARTED|Overall Study||325||
48317552|NCT03329911|101104060|FG000|COMPLETED|Overall Study||209||
48317553|NCT03329911|101104061|FG001|COMPLETED|Overall Study||222||
48317554|NCT03329911|101104060|FG000|NOT COMPLETED|Overall Study||117||
48317555|NCT03329911|101104061|FG001|NOT COMPLETED|Overall Study||103||
48317556|NCT00354770|101104062|FG000|STARTED|Overall Study||25||
48317557|NCT00354770|101104063|FG001|STARTED|Overall Study||25||
48317558|NCT00354770|101104062|FG000|COMPLETED|Overall Study||22||
48317559|NCT00354770|101104063|FG001|COMPLETED|Overall Study||22||
48317560|NCT00354770|101104062|FG000|NOT COMPLETED|Overall Study||3||
48317561|NCT00354770|101104063|FG001|NOT COMPLETED|Overall Study||3||
48317562|NCT01560780|101104064|FG000|STARTED|Overall Study||42||
48317563|NCT01560780|101104065|FG001|STARTED|Overall Study||42||
48317564|NCT01560780|101104064|FG000|Clinical Follow-Up at 12 Months|Overall Study||42||
48317565|NCT01560780|101104065|FG001|Clinical Follow-Up at 12 Months|Overall Study||42||
48735159|NCT02355210|102136990|FG000|COMPLETED|Overall Study||19||
48160058|NCT02736825|100715790|FG001|NOT COMPLETED|Overall Study||12||
48160059|NCT00215540|100715791|FG000|STARTED|Overall Study||45||
48160060|NCT00215540|100715792|FG001|STARTED|Overall Study||47||
48735160|NCT02355210|102136991|FG001|COMPLETED|Overall Study||18||
48735161|NCT02355210|102136992|FG002|COMPLETED|Overall Study||16||
48735162|NCT02355210|102136993|FG003|COMPLETED|Overall Study||17||
48735163|NCT02355210|102136994|FG004|COMPLETED|Overall Study||19||
48735164|NCT02355210|102136995|FG005|COMPLETED|Overall Study||18||
48735165|NCT02355210|102136990|FG000|NOT COMPLETED|Overall Study||0||
48735166|NCT02355210|102136991|FG001|NOT COMPLETED|Overall Study||0||
48735167|NCT02355210|102136992|FG002|NOT COMPLETED|Overall Study||0||
48735168|NCT02355210|102136993|FG003|NOT COMPLETED|Overall Study||0||
48735169|NCT02355210|102136994|FG004|NOT COMPLETED|Overall Study||0||
48735170|NCT02355210|102136995|FG005|NOT COMPLETED|Overall Study||0||
48735171|NCT02652260|102136996|FG000|STARTED|Overall Study||43||
48735172|NCT02652260|102136997|FG001|STARTED|Overall Study||43||
48735173|NCT02652260|102136996|FG000|COMPLETED|Overall Study||43||
48735174|NCT02652260|102136997|FG001|COMPLETED|Overall Study||41||
48735175|NCT02652260|102136996|FG000|NOT COMPLETED|Overall Study||0||
48735176|NCT02652260|102136997|FG001|NOT COMPLETED|Overall Study||2||
48735177|NCT00774800|102136998|FG000|STARTED|Intervention 1||22||
48735178|NCT00774800|102136998|FG000|Received at Least One Dose of Study Drug|Intervention 1||22||
48735179|NCT00774800|102136998|FG000|COMPLETED|Intervention 1||22||
48735180|NCT00774800|102136998|FG000|NOT COMPLETED|Intervention 1||0||
48735181|NCT00774800|102136998|FG000|STARTED|Washout (3 to 10 Days)||22||
48735182|NCT00774800|102136998|FG000|COMPLETED|Washout (3 to 10 Days)||22||
48735183|NCT00774800|102136998|FG000|NOT COMPLETED|Washout (3 to 10 Days)||0||
48735184|NCT00774800|102136998|FG000|STARTED|Intervention 2||22||
48735185|NCT00774800|102136998|FG000|Received at Least One Dose of Study Drug|Intervention 2||22||
48735186|NCT00774800|102136998|FG000|COMPLETED|Intervention 2||22||
48735187|NCT00774800|102136998|FG000|NOT COMPLETED|Intervention 2||0||
48735188|NCT00774800|102136998|FG000|STARTED|Washout (3 to 10 Days)||22||
48735189|NCT00774800|102136998|FG000|COMPLETED|Washout (3 to 10 Days)||22||
48735190|NCT00774800|102136998|FG000|NOT COMPLETED|Washout (3 to 10 Days)||0||
48735191|NCT00774800|102136998|FG000|STARTED|Intervention 3||22||
48735192|NCT00774800|102136998|FG000|Received at Least One Dose of Study Drug|Intervention 3||22||
48735193|NCT00774800|102136998|FG000|COMPLETED|Intervention 3||22||
48735194|NCT00774800|102136998|FG000|NOT COMPLETED|Intervention 3||0||
48735195|NCT00774800|102136998|FG000|STARTED|Washout (3 to 10 Days)||22||
48735196|NCT00774800|102136998|FG000|COMPLETED|Washout (3 to 10 Days)||22||
48735197|NCT00774800|102136998|FG000|NOT COMPLETED|Washout (3 to 10 Days)||0||
48160061|NCT00215540|100715793|FG002|STARTED|Overall Study||44||
48160062|NCT00215540|100715791|FG000|COMPLETED|Overall Study||44||
48160063|NCT00215540|100715792|FG001|COMPLETED|Overall Study||47||
48160064|NCT00215540|100715793|FG002|COMPLETED|Overall Study||44||
48160065|NCT00215540|100715791|FG000|NOT COMPLETED|Overall Study||1||
48160066|NCT00215540|100715792|FG001|NOT COMPLETED|Overall Study||0||
48160067|NCT00215540|100715793|FG002|NOT COMPLETED|Overall Study||0||
48160068|NCT01817374|100715794|FG000|STARTED|Overall Study||6||
48160069|NCT01817374|100715794|FG000|COMPLETED|Overall Study||6||
48317566|NCT01560780|101104064|FG000|Completed Study Drug for 12 Months|Overall Study||27||
48317567|NCT01560780|101104065|FG001|Completed Study Drug for 12 Months|Overall Study||27||
48317568|NCT01560780|101104064|FG000|COMPLETED|Overall Study||29|Underwent Angiography at 12 months|
48735198|NCT00774800|102136998|FG000|STARTED|Intervention 4||22||
48735199|NCT00774800|102136998|FG000|Received at Least One Dose of Study Drug|Intervention 4||21||
48735200|NCT00774800|102136998|FG000|COMPLETED|Intervention 4||21||
48735201|NCT00774800|102136998|FG000|NOT COMPLETED|Intervention 4||1||
48735202|NCT00612560|102136999|FG000|STARTED|Overall Study||7||
48735203|NCT00612560|102137000|FG001|STARTED|Overall Study||7||
48735204|NCT00612560|102137001|FG002|STARTED|Overall Study||8||
48317569|NCT01560780|101104065|FG001|COMPLETED|Overall Study||30|Underwent Angiography at 12 months|
48735205|NCT00612560|102137002|FG003|STARTED|Overall Study||6||
48735206|NCT00612560|102136999|FG000|COMPLETED|Overall Study||7||
48735207|NCT00612560|102137000|FG001|COMPLETED|Overall Study||7||
48735208|NCT00612560|102137001|FG002|COMPLETED|Overall Study||8||
48735209|NCT00612560|102137002|FG003|COMPLETED|Overall Study||6||
48735210|NCT00612560|102136999|FG000|NOT COMPLETED|Overall Study||0||
48735211|NCT00612560|102137000|FG001|NOT COMPLETED|Overall Study||0||
48735212|NCT00612560|102137001|FG002|NOT COMPLETED|Overall Study||0||
48735213|NCT00612560|102137002|FG003|NOT COMPLETED|Overall Study||0||
48735214|NCT00896025|102137003|FG000|STARTED|Overall Study||8||
48160070|NCT01817374|100715794|FG000|NOT COMPLETED|Overall Study||0||
48160071|NCT03745222|100715795|FG000|STARTED|Overall Study||0||
48317570|NCT01560780|101104064|FG000|NOT COMPLETED|Overall Study||13||
48735215|NCT00896025|102137003|FG000|COMPLETED|Overall Study||8||
48735216|NCT00896025|102137003|FG000|NOT COMPLETED|Overall Study||0||
48735217|NCT00475904|102137004|FG000|STARTED|Overall Study||140||
48735218|NCT00475904|102137005|FG001|STARTED|Overall Study||144||
48735219|NCT00475904|102137006|FG002|STARTED|Overall Study||76||
48160072|NCT03745222|100715796|FG001|STARTED|Overall Study||1||
48160073|NCT03745222|100715797|FG002|STARTED|Overall Study||0||
48160074|NCT03745222|100715795|FG000|COMPLETED|Overall Study||0||
48160075|NCT03745222|100715796|FG001|COMPLETED|Overall Study||0||
48160076|NCT03745222|100715797|FG002|COMPLETED|Overall Study||0||
48160077|NCT03745222|100715795|FG000|NOT COMPLETED|Overall Study||0||
48160078|NCT03745222|100715796|FG001|NOT COMPLETED|Overall Study||1||
48160079|NCT03745222|100715797|FG002|NOT COMPLETED|Overall Study||0||
48160080|NCT00312702|100715798|FG000|STARTED|Immunization Phase||5||
48160081|NCT00312702|100715799|FG001|STARTED|Immunization Phase||13||
48160082|NCT00312702|100715800|FG002|STARTED|Immunization Phase||0||
48160083|NCT00312702|100715798|FG000|COMPLETED|Immunization Phase||5||
48160084|NCT00312702|100715799|FG001|COMPLETED|Immunization Phase||12||
48160085|NCT00312702|100715800|FG002|COMPLETED|Immunization Phase||0||
48160086|NCT00312702|100715798|FG000|NOT COMPLETED|Immunization Phase||0||
48160087|NCT00312702|100715799|FG001|NOT COMPLETED|Immunization Phase||1||
48160088|NCT00312702|100715800|FG002|NOT COMPLETED|Immunization Phase||0||
48160089|NCT00312702|100715798|FG000|STARTED|Challenge Phase||0||
48160090|NCT00312702|100715799|FG001|STARTED|Challenge Phase||12||
48160091|NCT00312702|100715800|FG002|STARTED|Challenge Phase||1||
48160092|NCT00312702|100715798|FG000|COMPLETED|Challenge Phase||0||
48160093|NCT00312702|100715799|FG001|COMPLETED|Challenge Phase||12||
48160094|NCT00312702|100715800|FG002|COMPLETED|Challenge Phase||1||
48160095|NCT00312702|100715798|FG000|NOT COMPLETED|Challenge Phase||0||
48160096|NCT00312702|100715799|FG001|NOT COMPLETED|Challenge Phase||0||
48160097|NCT00312702|100715800|FG002|NOT COMPLETED|Challenge Phase||0||
48160098|NCT01518946|100715801|FG000|STARTED|Open-label Phase||24||
48160099|NCT01518946|100715802|FG001|STARTED|Open-label Phase||0||
48160100|NCT01518946|100715803|FG002|STARTED|Open-label Phase||0||
48160101|NCT01518946|100715801|FG000|COMPLETED|Open-label Phase||20||
48160102|NCT01518946|100715802|FG001|COMPLETED|Open-label Phase||0||
48160103|NCT01518946|100715803|FG002|COMPLETED|Open-label Phase||0||
48160104|NCT01518946|100715801|FG000|NOT COMPLETED|Open-label Phase||4||
48160105|NCT01518946|100715802|FG001|NOT COMPLETED|Open-label Phase||0||
48160106|NCT01518946|100715803|FG002|NOT COMPLETED|Open-label Phase||0||
48160107|NCT01518946|100715801|FG000|STARTED|Randomized Phase (First Intervention)||0||
48160108|NCT01518946|100715802|FG001|STARTED|Randomized Phase (First Intervention)||10||
48160109|NCT01518946|100715803|FG002|STARTED|Randomized Phase (First Intervention)||10||
48160110|NCT01518946|100715801|FG000|COMPLETED|Randomized Phase (First Intervention)||0||
48160111|NCT01518946|100715802|FG001|COMPLETED|Randomized Phase (First Intervention)||9||
48160112|NCT01518946|100715803|FG002|COMPLETED|Randomized Phase (First Intervention)||10||
48160113|NCT01518946|100715801|FG000|NOT COMPLETED|Randomized Phase (First Intervention)||0||
48160114|NCT01518946|100715802|FG001|NOT COMPLETED|Randomized Phase (First Intervention)||1||
48160115|NCT01518946|100715803|FG002|NOT COMPLETED|Randomized Phase (First Intervention)||0||
48160116|NCT01518946|100715801|FG000|STARTED|Randomized Phase (Second Intervention)||0||
48160117|NCT01518946|100715802|FG001|STARTED|Randomized Phase (Second Intervention)||9||
48160118|NCT01518946|100715803|FG002|STARTED|Randomized Phase (Second Intervention)||10||
48160119|NCT01518946|100715801|FG000|COMPLETED|Randomized Phase (Second Intervention)||0||
48160120|NCT01518946|100715802|FG001|COMPLETED|Randomized Phase (Second Intervention)||9||
48317571|NCT01560780|101104065|FG001|NOT COMPLETED|Overall Study||12||
48317572|NCT03339206|101104066|FG000|STARTED|Overall Study||262||
48317573|NCT03339206|101104067|FG001|STARTED|Overall Study||263||
48317574|NCT03339206|101104068|FG002|STARTED|Overall Study||264||
48317575|NCT03339206|101104066|FG000|COMPLETED|Overall Study||262||
48160121|NCT01518946|100715803|FG002|COMPLETED|Randomized Phase (Second Intervention)||10||
48160122|NCT01518946|100715801|FG000|NOT COMPLETED|Randomized Phase (Second Intervention)||0||
48160123|NCT01518946|100715802|FG001|NOT COMPLETED|Randomized Phase (Second Intervention)||0||
48160124|NCT01518946|100715803|FG002|NOT COMPLETED|Randomized Phase (Second Intervention)||0||
48160125|NCT02535364|100715804|FG000|STARTED|Part A Screening Through Leukapheresis||82||
48160126|NCT02535364|100715804|FG000|COMPLETED|Part A Screening Through Leukapheresis||57||
48160127|NCT02535364|100715804|FG000|NOT COMPLETED|Part A Screening Through Leukapheresis||25||
48160128|NCT02535364|100715804|FG000|STARTED|Part B Screening||57||
48160129|NCT02535364|100715804|FG000|COMPLETED|Part B Screening||40||
48160130|NCT02535364|100715804|FG000|NOT COMPLETED|Part B Screening||17||
48160131|NCT02535364|100715804|FG000|STARTED|Study Treatment||40||
48160132|NCT02535364|100715804|FG000|COMPLETED|Study Treatment||38||
48160133|NCT02535364|100715804|FG000|NOT COMPLETED|Study Treatment||2||
48317576|NCT03339206|101104067|FG001|COMPLETED|Overall Study||263||
48317577|NCT03339206|101104068|FG002|COMPLETED|Overall Study||264||
48317578|NCT03339206|101104066|FG000|NOT COMPLETED|Overall Study||0||
48160134|NCT02535364|100715804|FG000|STARTED|12-Month Follow-up Period||38||
48160135|NCT02535364|100715804|FG000|COMPLETED|12-Month Follow-up Period||3||
48160136|NCT02535364|100715804|FG000|NOT COMPLETED|12-Month Follow-up Period||35||
48160137|NCT01861457|100715805|FG000|STARTED|Overall Study||20||
48160138|NCT01861457|100715806|FG001|STARTED|Overall Study||19||
48160139|NCT01861457|100715805|FG000|COMPLETED|Overall Study||20||
48160140|NCT01861457|100715806|FG001|COMPLETED|Overall Study||19||
48317579|NCT03339206|101104067|FG001|NOT COMPLETED|Overall Study||0||
48317580|NCT03339206|101104068|FG002|NOT COMPLETED|Overall Study||0||
48317581|NCT00112671|101104069|FG000|STARTED|Overall Study||17||
48317582|NCT00112671|101104069|FG000|COMPLETED|Overall Study||17||
48160141|NCT01861457|100715805|FG000|NOT COMPLETED|Overall Study||0||
48615744|NCT03410992|101844990|FG001|NOT COMPLETED|Initial Treatment Period: up to Wk16||9||
48615745|NCT03410992|101844991|FG002|NOT COMPLETED|Initial Treatment Period: up to Wk16||0||
48615746|NCT03410992|101844992|FG003|NOT COMPLETED|Initial Treatment Period: up to Wk16||0||
48615747|NCT03410992|101844993|FG004|NOT COMPLETED|Initial Treatment Period: up to Wk16||0||
48615748|NCT03410992|101844994|FG005|NOT COMPLETED|Initial Treatment Period: up to Wk16||0||
48615749|NCT03410992|101844995|FG006|NOT COMPLETED|Initial Treatment Period: up to Wk16||0||
48615750|NCT03410992|101844996|FG007|NOT COMPLETED|Initial Treatment Period: up to Wk16||0||
48615751|NCT03410992|101844997|FG008|NOT COMPLETED|Initial Treatment Period: up to Wk16||0||
48615752|NCT03410992|101844998|FG009|NOT COMPLETED|Initial Treatment Period: up to Wk16||0||
48615753|NCT03410992|101844999|FG010|NOT COMPLETED|Initial Treatment Period: up to Wk16||0||
48615754|NCT03410992|101844989|FG000|STARTED|Week 16 Assessment||82||
48615755|NCT03410992|101844990|FG001|STARTED|Week 16 Assessment||340||
48615756|NCT03410992|101844991|FG002|STARTED|Week 16 Assessment||0||
48615757|NCT03410992|101844992|FG003|STARTED|Week 16 Assessment||0||
48615758|NCT03410992|101844993|FG004|STARTED|Week 16 Assessment||0||
48615759|NCT03410992|101844994|FG005|STARTED|Week 16 Assessment||0||
48615760|NCT03410992|101844995|FG006|STARTED|Week 16 Assessment||0||
48615761|NCT03410992|101844996|FG007|STARTED|Week 16 Assessment||0||
48615762|NCT03410992|101844997|FG008|STARTED|Week 16 Assessment||0||
48615763|NCT03410992|101844998|FG009|STARTED|Week 16 Assessment||0||
48615764|NCT03410992|101844999|FG010|STARTED|Week 16 Assessment||0||
48615765|NCT03410992|101844989|FG000|Received Escape Treatment|Week 16 Assessment||81||
48615766|NCT03410992|101844990|FG001|Received Escape Treatment|Week 16 Assessment||23||
48615767|NCT03410992|101844991|FG002|Received Escape Treatment|Week 16 Assessment||0||
48615768|NCT03410992|101844992|FG003|Received Escape Treatment|Week 16 Assessment||0||
48735220|NCT00475904|102137004|FG000|COMPLETED|Overall Study||125||
48735221|NCT00475904|102137005|FG001|COMPLETED|Overall Study||131||
48160142|NCT01861457|100715806|FG001|NOT COMPLETED|Overall Study||0||
48160143|NCT01337986|100715807|FG000|STARTED|Overall Study||23||
48160144|NCT01337986|100715808|FG001|STARTED|Overall Study||23||
48160145|NCT01337986|100715807|FG000|COMPLETED|Overall Study||20||
48160146|NCT01337986|100715808|FG001|COMPLETED|Overall Study||18||
48160147|NCT01337986|100715807|FG000|NOT COMPLETED|Overall Study||3||
48615769|NCT03410992|101844993|FG004|Received Escape Treatment|Week 16 Assessment||0||
48615770|NCT03410992|101844994|FG005|Received Escape Treatment|Week 16 Assessment||0||
48615771|NCT03410992|101844995|FG006|Received Escape Treatment|Week 16 Assessment||0||
48615772|NCT03410992|101844996|FG007|Received Escape Treatment|Week 16 Assessment||0||
48615773|NCT03410992|101844997|FG008|Received Escape Treatment|Week 16 Assessment||0||
48615774|NCT03410992|101844998|FG009|Received Escape Treatment|Week 16 Assessment||0||
48615775|NCT03410992|101844999|FG010|Received Escape Treatment|Week 16 Assessment||0||
48615776|NCT03410992|101844989|FG000|COMPLETED|Week 16 Assessment||1||
48615777|NCT03410992|101844990|FG001|COMPLETED|Week 16 Assessment||311||
48615778|NCT03410992|101844991|FG002|COMPLETED|Week 16 Assessment||0||
48615779|NCT03410992|101844992|FG003|COMPLETED|Week 16 Assessment||0||
48615780|NCT03410992|101844993|FG004|COMPLETED|Week 16 Assessment||0||
48615781|NCT03410992|101844994|FG005|COMPLETED|Week 16 Assessment||0||
48615782|NCT03410992|101844995|FG006|COMPLETED|Week 16 Assessment||0||
48615783|NCT03410992|101844996|FG007|COMPLETED|Week 16 Assessment||0||
48615784|NCT03410992|101844997|FG008|COMPLETED|Week 16 Assessment||0||
48615785|NCT03410992|101844998|FG009|COMPLETED|Week 16 Assessment||0||
48735222|NCT00475904|102137006|FG002|COMPLETED|Overall Study||72||
48735223|NCT00475904|102137004|FG000|NOT COMPLETED|Overall Study||15||
48735224|NCT00475904|102137005|FG001|NOT COMPLETED|Overall Study||13||
48735225|NCT00475904|102137006|FG002|NOT COMPLETED|Overall Study||4||
48615786|NCT03410992|101844999|FG010|COMPLETED|Week 16 Assessment||0||
48615787|NCT03410992|101844989|FG000|NOT COMPLETED|Week 16 Assessment||81||
48735226|NCT01732770|102137007|FG000|STARTED|Overall Study||322||
48735227|NCT01732770|102137008|FG001|STARTED|Overall Study||321||
48735228|NCT01732770|102137007|FG000|Received Study Treatment|Overall Study||320||
48735229|NCT01732770|102137008|FG001|Received Study Treatment|Overall Study||320||
48160148|NCT01337986|100715808|FG001|NOT COMPLETED|Overall Study||5||
48160149|NCT02613221|100715809|FG000|STARTED|Overall Study||56||
48160150|NCT02613221|100715809|FG000|Safety Population: Received Study Drug|Overall Study||55||
48160151|NCT02613221|100715809|FG000|COMPLETED|Overall Study||1||
48160152|NCT02613221|100715809|FG000|NOT COMPLETED|Overall Study||55||
48615788|NCT03410992|101844990|FG001|NOT COMPLETED|Week 16 Assessment||29||
48615789|NCT03410992|101844991|FG002|NOT COMPLETED|Week 16 Assessment||0||
48615790|NCT03410992|101844992|FG003|NOT COMPLETED|Week 16 Assessment||0||
48615791|NCT03410992|101844993|FG004|NOT COMPLETED|Week 16 Assessment||0||
48615792|NCT03410992|101844994|FG005|NOT COMPLETED|Week 16 Assessment||0||
48615793|NCT03410992|101844995|FG006|NOT COMPLETED|Week 16 Assessment||0||
48615794|NCT03410992|101844996|FG007|NOT COMPLETED|Week 16 Assessment||0||
48615795|NCT03410992|101844997|FG008|NOT COMPLETED|Week 16 Assessment||0||
48615796|NCT03410992|101844998|FG009|NOT COMPLETED|Week 16 Assessment||0||
48615797|NCT03410992|101844999|FG010|NOT COMPLETED|Week 16 Assessment||0||
48735230|NCT01732770|102137007|FG000|COMPLETED|Overall Study||312||
48735231|NCT01732770|102137008|FG001|COMPLETED|Overall Study||313||
48735232|NCT01732770|102137007|FG000|NOT COMPLETED|Overall Study||10||
48735233|NCT01732770|102137008|FG001|NOT COMPLETED|Overall Study||8||
48735234|NCT03928717|102137009|FG000|STARTED|Overall Study||30||
48317583|NCT00112671|101104069|FG000|NOT COMPLETED|Overall Study||0||
48317584|NCT01230242|101104070|FG000|STARTED|Overall Study||4||
48317585|NCT01230242|101104070|FG000|COMPLETED|Overall Study||1||
48317586|NCT01230242|101104070|FG000|NOT COMPLETED|Overall Study||3||
48317587|NCT03769246|101104071|FG000|STARTED|Overall Study||15||
48317588|NCT03769246|101104072|FG001|STARTED|Overall Study||15||
48317589|NCT03769246|101104071|FG000|COMPLETED|Overall Study||13||
48317590|NCT03769246|101104072|FG001|COMPLETED|Overall Study||15||
48317591|NCT03769246|101104071|FG000|NOT COMPLETED|Overall Study||2||
48615798|NCT03410992|101844989|FG000|STARTED|Randomized-Withdrawal Period: up to Wk56||0||
48615799|NCT03410992|101844990|FG001|STARTED|Randomized-Withdrawal Period: up to Wk56||0||
48615800|NCT03410992|101844991|FG002|STARTED|Randomized-Withdrawal Period: up to Wk56||1||
48615801|NCT03410992|101844992|FG003|STARTED|Randomized-Withdrawal Period: up to Wk56||105||
48615802|NCT03410992|101844993|FG004|STARTED|Randomized-Withdrawal Period: up to Wk56||100||
48615803|NCT03410992|101844994|FG005|STARTED|Randomized-Withdrawal Period: up to Wk56||106||
48615804|NCT03410992|101844995|FG006|STARTED|Randomized-Withdrawal Period: up to Wk56||0||
48615805|NCT03410992|101844996|FG007|STARTED|Randomized-Withdrawal Period: up to Wk56||0||
48615806|NCT03410992|101844997|FG008|STARTED|Randomized-Withdrawal Period: up to Wk56||0||
48615807|NCT03410992|101844998|FG009|STARTED|Randomized-Withdrawal Period: up to Wk56||0||
48615808|NCT03410992|101844999|FG010|STARTED|Randomized-Withdrawal Period: up to Wk56||0||
48615809|NCT03410992|101844989|FG000|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0||
48615810|NCT03410992|101844990|FG001|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0||
48615811|NCT03410992|101844991|FG002|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0||
48615812|NCT03410992|101844992|FG003|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||67||
48615813|NCT03410992|101844993|FG004|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||4||
48615814|NCT03410992|101844994|FG005|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||7||
48615815|NCT03410992|101844995|FG006|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0||
48615816|NCT03410992|101844996|FG007|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0||
48407153|NCT03073200|101328522|FG011|NOT COMPLETED|Open-Label Maintenance Period||0||
48407154|NCT03073200|101328523|FG012|NOT COMPLETED|Open-Label Maintenance Period||0||
48407155|NCT03073200|101328524|FG013|NOT COMPLETED|Open-Label Maintenance Period||0||
48407156|NCT03073200|101328525|FG014|NOT COMPLETED|Open-Label Maintenance Period||0||
48615817|NCT03410992|101844997|FG008|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0||
48317592|NCT03769246|101104072|FG001|NOT COMPLETED|Overall Study||0||
48317593|NCT02369848|101104073|FG000|STARTED|Overall Study||60||
48317594|NCT02369848|101104073|FG000|30 Day Primary Safety Endpoint|Overall Study||58||
48317595|NCT02369848|101104073|FG000|12 Month Primary Endpoint|Overall Study||30||
48407157|NCT03073200|101328511|FG000|STARTED|Extension Period||0||
48407158|NCT03073200|101328512|FG001|STARTED|Extension Period||0||
48615818|NCT03410992|101844998|FG009|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0||
48615819|NCT03410992|101844999|FG010|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0||
48615820|NCT03410992|101844989|FG000|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0||
48615821|NCT03410992|101844990|FG001|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0||
48615822|NCT03410992|101844991|FG002|COMPLETED|Randomized-Withdrawal Period: up to Wk56||1||
48615823|NCT03410992|101844992|FG003|COMPLETED|Randomized-Withdrawal Period: up to Wk56||33||
48615824|NCT03410992|101844993|FG004|COMPLETED|Randomized-Withdrawal Period: up to Wk56||93||
48615825|NCT03410992|101844994|FG005|COMPLETED|Randomized-Withdrawal Period: up to Wk56||94||
48615826|NCT03410992|101844995|FG006|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0||
48615827|NCT03410992|101844996|FG007|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0||
48615828|NCT03410992|101844997|FG008|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0||
48615829|NCT03410992|101844998|FG009|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0||
48615830|NCT03410992|101844999|FG010|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0||
48317596|NCT02369848|101104073|FG000|COMPLETED|Overall Study||56||
48317597|NCT02369848|101104073|FG000|NOT COMPLETED|Overall Study||4||
48317598|NCT02329964|101104074|FG000|STARTED|Overall Study||40||
48317599|NCT02329964|101104075|FG001|STARTED|Overall Study||40||
48317600|NCT02329964|101104074|FG000|COMPLETED|Overall Study||40||
48317601|NCT02329964|101104075|FG001|COMPLETED|Overall Study||40||
48317602|NCT02329964|101104074|FG000|NOT COMPLETED|Overall Study||0||
48317603|NCT02329964|101104075|FG001|NOT COMPLETED|Overall Study||0||
48317604|NCT02159729|101104076|FG000|STARTED|Overall Study||140||
48317605|NCT02159729|101104077|FG001|STARTED|Overall Study||65||
48317606|NCT02159729|101104076|FG000|COMPLETED|Overall Study||98||
48317607|NCT02159729|101104077|FG001|COMPLETED|Overall Study||44||
48317608|NCT02159729|101104076|FG000|NOT COMPLETED|Overall Study||42||
48317609|NCT02159729|101104077|FG001|NOT COMPLETED|Overall Study||21||
48317610|NCT00825162|101104078|FG000|STARTED|Overall Study||710||
48317611|NCT00825162|101104079|FG001|STARTED|Overall Study||880||
48407159|NCT03073200|101328513|FG002|STARTED|Extension Period||0||
48317612|NCT00825162|101104080|FG002|STARTED|Overall Study||402||
48407160|NCT03073200|101328514|FG003|STARTED|Extension Period||0||
48407161|NCT03073200|101328515|FG004|STARTED|Extension Period||0||
48615831|NCT03410992|101844989|FG000|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0||
48615832|NCT03410992|101844990|FG001|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0||
48615833|NCT03410992|101844991|FG002|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0||
48615834|NCT03410992|101844992|FG003|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||72||
48615835|NCT03410992|101844993|FG004|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||7||
48615836|NCT03410992|101844994|FG005|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||12||
48615837|NCT03410992|101844995|FG006|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0||
48615838|NCT03410992|101844996|FG007|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0||
48615839|NCT03410992|101844997|FG008|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0||
48615840|NCT03410992|101844998|FG009|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0||
48615841|NCT03410992|101844999|FG010|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0||
48160153|NCT03633929|100715810|FG000|STARTED|Overall Study||19||
48160154|NCT03633929|100715810|FG000|COMPLETED|Overall Study||15||
48160155|NCT03633929|100715810|FG000|NOT COMPLETED|Overall Study||4||
48160156|NCT00708435|100715811|FG000|STARTED|Overall Study||107||
48160157|NCT00708435|100715812|FG001|STARTED|Overall Study||109||
48160158|NCT00708435|100715811|FG000|COMPLETED|Overall Study||82||
48160159|NCT00708435|100715812|FG001|COMPLETED|Overall Study||92||
48160160|NCT00708435|100715811|FG000|NOT COMPLETED|Overall Study||25||
48160161|NCT00708435|100715812|FG001|NOT COMPLETED|Overall Study||17||
48160162|NCT01991821|100715813|FG000|STARTED|Overall Study||169||
48160163|NCT01991821|100715814|FG001|STARTED|Overall Study||178||
48160164|NCT01991821|100715813|FG000|COMPLETED|Overall Study||6||
48160165|NCT01991821|100715814|FG001|COMPLETED|Overall Study||11||
48160166|NCT01991821|100715813|FG000|NOT COMPLETED|Overall Study||163||
48160167|NCT01991821|100715814|FG001|NOT COMPLETED|Overall Study||167||
48160168|NCT01755702|100715815|FG000|STARTED|Period I||66||
48160169|NCT01755702|100715815|FG000|Received Paracetamol|Period I||16||
48160170|NCT01755702|100715815|FG000|Received Placebo|Period I||17||
48160171|NCT01755702|100715815|FG000|Received Ibuprofen|Period I||16||
48160172|NCT01755702|100715815|FG000|Received Paracetamol/Caffeine|Period I||17||
48160173|NCT01755702|100715815|FG000|COMPLETED|Period I||66||
48160174|NCT01755702|100715815|FG000|NOT COMPLETED|Period I||0||
48160175|NCT01755702|100715815|FG000|STARTED|Wash Out Period I||66||
48160176|NCT01755702|100715815|FG000|COMPLETED|Wash Out Period I||63||
48160177|NCT01755702|100715815|FG000|NOT COMPLETED|Wash Out Period I||3||
48160178|NCT01755702|100715815|FG000|STARTED|Period II||63||
48160179|NCT01755702|100715815|FG000|Received Ibuprofen|Period II||11||
48160180|NCT01755702|100715815|FG000|Received Placebo|Period II||15||
48160181|NCT01755702|100715815|FG000|Received Paracetamol/Caffeine|Period II||20||
48160182|NCT01755702|100715815|FG000|Received Paracetamol|Period II||17||
48160183|NCT01755702|100715815|FG000|COMPLETED|Period II||63||
48160184|NCT01755702|100715815|FG000|NOT COMPLETED|Period II||0||
48160185|NCT01755702|100715815|FG000|STARTED|Washout Period II||63||
48160186|NCT01755702|100715815|FG000|COMPLETED|Washout Period II||58||
48160187|NCT01755702|100715815|FG000|NOT COMPLETED|Washout Period II||5||
48160188|NCT01755702|100715815|FG000|STARTED|Period III||58||
48160189|NCT01755702|100715815|FG000|Received Paracetamol|Period III||17||
48160190|NCT01755702|100715815|FG000|Received Placebo|Period III||13||
48160191|NCT01755702|100715815|FG000|Received Paracetamol/Caffeine|Period III||10||
48160192|NCT01755702|100715815|FG000|Received Ibuprofen|Period III||18||
48407162|NCT03073200|101328516|FG005|STARTED|Extension Period||0||
48407163|NCT03073200|101328517|FG006|STARTED|Extension Period||34||
48615842|NCT03410992|101844989|FG000|STARTED|Escape Treatment: 12 Weeks||0||
48615843|NCT03410992|101844990|FG001|STARTED|Escape Treatment: 12 Weeks||0||
48615844|NCT03410992|101844991|FG002|STARTED|Escape Treatment: 12 Weeks||0||
48615845|NCT03410992|101844992|FG003|STARTED|Escape Treatment: 12 Weeks||0||
48615846|NCT03410992|101844993|FG004|STARTED|Escape Treatment: 12 Weeks||0||
48615847|NCT03410992|101844994|FG005|STARTED|Escape Treatment: 12 Weeks||0||
48615848|NCT03410992|101844995|FG006|STARTED|Escape Treatment: 12 Weeks||81||
48615849|NCT03410992|101844996|FG007|STARTED|Escape Treatment: 12 Weeks||23||
48615850|NCT03410992|101844997|FG008|STARTED|Escape Treatment: 12 Weeks||67||
48615851|NCT03410992|101844998|FG009|STARTED|Escape Treatment: 12 Weeks||4||
48615852|NCT03410992|101844999|FG010|STARTED|Escape Treatment: 12 Weeks||7||
48615853|NCT03410992|101844989|FG000|COMPLETED|Escape Treatment: 12 Weeks||0||
48615854|NCT03410992|101844990|FG001|COMPLETED|Escape Treatment: 12 Weeks||0||
48160193|NCT01755702|100715815|FG000|COMPLETED|Period III||58||
48160194|NCT01755702|100715815|FG000|NOT COMPLETED|Period III||0||
48160195|NCT01478009|100715816|FG000|STARTED|Overall Study||50||
48160196|NCT01478009|100715817|FG001|STARTED|Overall Study||50||
48160197|NCT01478009|100715816|FG000|COMPLETED|Overall Study||49||
48160198|NCT01478009|100715817|FG001|COMPLETED|Overall Study||49||
48407164|NCT03073200|101328518|FG007|STARTED|Extension Period||68||
48407165|NCT03073200|101328519|FG008|STARTED|Extension Period||9||
48160199|NCT01478009|100715816|FG000|NOT COMPLETED|Overall Study||1||
48160200|NCT01478009|100715817|FG001|NOT COMPLETED|Overall Study||1||
48160201|NCT01105702|100715818|FG000|STARTED|Overall Study||28||
48160202|NCT01105702|100715818|FG000|COMPLETED|Overall Study||10||
48615855|NCT03410992|101844991|FG002|COMPLETED|Escape Treatment: 12 Weeks||0||
48615856|NCT03410992|101844992|FG003|COMPLETED|Escape Treatment: 12 Weeks||0||
48615857|NCT03410992|101844993|FG004|COMPLETED|Escape Treatment: 12 Weeks||0||
48615858|NCT03410992|101844994|FG005|COMPLETED|Escape Treatment: 12 Weeks||0||
48615859|NCT03410992|101844995|FG006|COMPLETED|Escape Treatment: 12 Weeks||81||
48615860|NCT03410992|101844996|FG007|COMPLETED|Escape Treatment: 12 Weeks||22||
48615861|NCT03410992|101844997|FG008|COMPLETED|Escape Treatment: 12 Weeks||66||
48615862|NCT03410992|101844998|FG009|COMPLETED|Escape Treatment: 12 Weeks||4||
48615863|NCT03410992|101844999|FG010|COMPLETED|Escape Treatment: 12 Weeks||7||
48615864|NCT03410992|101844989|FG000|NOT COMPLETED|Escape Treatment: 12 Weeks||0||
48615865|NCT03410992|101844990|FG001|NOT COMPLETED|Escape Treatment: 12 Weeks||0||
48615866|NCT03410992|101844991|FG002|NOT COMPLETED|Escape Treatment: 12 Weeks||0||
48615867|NCT03410992|101844992|FG003|NOT COMPLETED|Escape Treatment: 12 Weeks||0||
48615868|NCT03410992|101844993|FG004|NOT COMPLETED|Escape Treatment: 12 Weeks||0||
48317613|NCT00825162|101104078|FG000|COMPLETED|Overall Study||682||
48317614|NCT00825162|101104079|FG001|COMPLETED|Overall Study||859||
48317615|NCT00825162|101104080|FG002|COMPLETED|Overall Study||396||
48317616|NCT00825162|101104078|FG000|NOT COMPLETED|Overall Study||28||
48317617|NCT00825162|101104079|FG001|NOT COMPLETED|Overall Study||21||
48317618|NCT00825162|101104080|FG002|NOT COMPLETED|Overall Study||6||
48317619|NCT04013529|101104081|FG000|STARTED|Overall Study||20||
48317620|NCT04013529|101104082|FG001|STARTED|Overall Study||20||
48317621|NCT04013529|101104081|FG000|COMPLETED|Overall Study||19||
48317622|NCT04013529|101104082|FG001|COMPLETED|Overall Study||19||
48317623|NCT04013529|101104081|FG000|NOT COMPLETED|Overall Study||1||
48317624|NCT04013529|101104082|FG001|NOT COMPLETED|Overall Study||1||
48317625|NCT03016325|101104083|FG000|STARTED|Treatment Period||48|Started = Entering treatment period|
48317626|NCT03016325|101104084|FG001|STARTED|Treatment Period||49|Started = Entering treatment period|
48317627|NCT03016325|101104085|FG002|STARTED|Treatment Period||71|Started = Entering treatment period|
48317628|NCT03016325|101104086|FG003|STARTED|Treatment Period||71|Started = Entering treatment period|
48317629|NCT03016325|101104087|FG004|STARTED|Treatment Period||72|Started = Entering treatment period|
48317630|NCT03016325|101104088|FG005|STARTED|Treatment Period||6|Started = Entering treatment period|
48317631|NCT03016325|101104089|FG006|STARTED|Treatment Period||6|Started = Entering treatment period|
48317632|NCT03016325|101104090|FG007|STARTED|Treatment Period||6|Started = Entering treatment period|
48317633|NCT03016325|101104083|FG000|COMPLETED|Treatment Period||48|Completed = Finished 120 hour treatment period|
48317634|NCT03016325|101104084|FG001|COMPLETED|Treatment Period||48|Completed = Finished 120 hour treatment period|
48317635|NCT03016325|101104085|FG002|COMPLETED|Treatment Period||70|Completed = Finished 120 hour treatment period|
48317636|NCT03016325|101104086|FG003|COMPLETED|Treatment Period||71|Completed = Finished 120 hour treatment period|
48317637|NCT03016325|101104087|FG004|COMPLETED|Treatment Period||70|Completed = Finished 120 hour treatment period|
48317638|NCT03016325|101104088|FG005|COMPLETED|Treatment Period||6|Completed = Finished 120 hour treatment period|
48317639|NCT03016325|101104089|FG006|COMPLETED|Treatment Period||6|Completed = Finished 120 hour treatment period|
48317640|NCT03016325|101104090|FG007|COMPLETED|Treatment Period||6|Completed = Finished 120 hour treatment period|
48407166|NCT03073200|101328520|FG009|STARTED|Extension Period||0||
48407167|NCT03073200|101328521|FG010|STARTED|Extension Period||0||
48407168|NCT03073200|101328522|FG011|STARTED|Extension Period||0||
48407169|NCT03073200|101328523|FG012|STARTED|Extension Period||0||
48407170|NCT03073200|101328524|FG013|STARTED|Extension Period||0||
48407171|NCT03073200|101328525|FG014|STARTED|Extension Period||0||
48407172|NCT03073200|101328511|FG000|COMPLETED|Extension Period||0||
48407173|NCT03073200|101328512|FG001|COMPLETED|Extension Period||0||
48407174|NCT03073200|101328513|FG002|COMPLETED|Extension Period||0||
48615869|NCT03410992|101844994|FG005|NOT COMPLETED|Escape Treatment: 12 Weeks||0||
48615870|NCT03410992|101844995|FG006|NOT COMPLETED|Escape Treatment: 12 Weeks||0||
48317641|NCT03016325|101104083|FG000|NOT COMPLETED|Treatment Period||0||
48317642|NCT03016325|101104084|FG001|NOT COMPLETED|Treatment Period||1||
48317643|NCT03016325|101104085|FG002|NOT COMPLETED|Treatment Period||1||
48615871|NCT03410992|101844996|FG007|NOT COMPLETED|Escape Treatment: 12 Weeks||1||
48615872|NCT03410992|101844997|FG008|NOT COMPLETED|Escape Treatment: 12 Weeks||1||
48615873|NCT03410992|101844998|FG009|NOT COMPLETED|Escape Treatment: 12 Weeks||0||
48615874|NCT03410992|101844999|FG010|NOT COMPLETED|Escape Treatment: 12 Weeks||0||
48615875|NCT00379899|101845000|FG000|STARTED|Overall Study||180||
48615876|NCT00379899|101845001|FG001|STARTED|Overall Study||180||
48615877|NCT00379899|101845000|FG000|COMPLETED|Overall Study||140||
48615878|NCT00379899|101845001|FG001|COMPLETED|Overall Study||140||
48317644|NCT03016325|101104086|FG003|NOT COMPLETED|Treatment Period||0||
48317645|NCT03016325|101104087|FG004|NOT COMPLETED|Treatment Period||2||
48407175|NCT03073200|101328514|FG003|COMPLETED|Extension Period||0||
48407176|NCT03073200|101328515|FG004|COMPLETED|Extension Period||0||
48407177|NCT03073200|101328516|FG005|COMPLETED|Extension Period||0||
48615879|NCT00379899|101845000|FG000|NOT COMPLETED|Overall Study||40||
48615880|NCT00379899|101845001|FG001|NOT COMPLETED|Overall Study||40||
48615881|NCT02100280|101845002|FG000|STARTED|Overall Study||48||
48615882|NCT02100280|101845003|FG001|STARTED|Overall Study||48||
48615883|NCT02100280|101845002|FG000|COMPLETED|Overall Study||44||
48615884|NCT02100280|101845003|FG001|COMPLETED|Overall Study||44||
48735235|NCT03928717|102137010|FG001|STARTED|Overall Study||30||
48735236|NCT03928717|102137009|FG000|COMPLETED|Overall Study||25||
48735237|NCT03928717|102137010|FG001|COMPLETED|Overall Study||27||
48735238|NCT03928717|102137009|FG000|NOT COMPLETED|Overall Study||5||
48735239|NCT03928717|102137010|FG001|NOT COMPLETED|Overall Study||3||
48735240|NCT00847886|102137011|FG000|STARTED|Overall Study||12||
48317646|NCT03016325|101104088|FG005|NOT COMPLETED|Treatment Period||0||
48317647|NCT03016325|101104089|FG006|NOT COMPLETED|Treatment Period||0||
48317648|NCT03016325|101104090|FG007|NOT COMPLETED|Treatment Period||0||
48615885|NCT02100280|101845002|FG000|NOT COMPLETED|Overall Study||4||
48615886|NCT02100280|101845003|FG001|NOT COMPLETED|Overall Study||4||
48615887|NCT04754646|101845004|FG000|STARTED|Overall Study||50||
48615888|NCT04754646|101845004|FG000|COMPLETED|Overall Study||50||
48615889|NCT04754646|101845004|FG000|NOT COMPLETED|Overall Study||0||
48615890|NCT00613366|101845005|FG000|STARTED|Overall Study||20||
48615891|NCT00613366|101845006|FG001|STARTED|Overall Study||20||
48615892|NCT00613366|101845005|FG000|COMPLETED|Overall Study||17||
48615893|NCT00613366|101845006|FG001|COMPLETED|Overall Study||18||
48615894|NCT00613366|101845005|FG000|NOT COMPLETED|Overall Study||3||
48615895|NCT00613366|101845006|FG001|NOT COMPLETED|Overall Study||2||
48615896|NCT03014206|101845007|FG000|STARTED|Overall Study||696||
48615897|NCT03014206|101845007|FG000|COMPLETED|Overall Study||684||
48615898|NCT03014206|101845007|FG000|NOT COMPLETED|Overall Study||12||
48615899|NCT00270296|101845008|FG000|STARTED|Overall Study||285||
48615900|NCT00270296|101845009|FG001|STARTED|Overall Study||275||
48615901|NCT00270296|101845010|FG002|STARTED|Overall Study||170||
48615902|NCT00270296|101845008|FG000|COMPLETED|Overall Study||186||
48615903|NCT00270296|101845009|FG001|COMPLETED|Overall Study||185||
48615904|NCT00270296|101845010|FG002|COMPLETED|Overall Study||109||
48615905|NCT00270296|101845008|FG000|NOT COMPLETED|Overall Study||99||
48615906|NCT00270296|101845009|FG001|NOT COMPLETED|Overall Study||90||
48615907|NCT00270296|101845010|FG002|NOT COMPLETED|Overall Study||61||
48615908|NCT01971567|101845011|FG000|STARTED|Overall Study||56||
48615909|NCT01971567|101845012|FG001|STARTED|Overall Study||51||
48615910|NCT01971567|101845011|FG000|COMPLETED|Overall Study||52||
48615911|NCT01971567|101845012|FG001|COMPLETED|Overall Study||49||
48615912|NCT01971567|101845011|FG000|NOT COMPLETED|Overall Study||4||
48615913|NCT01971567|101845012|FG001|NOT COMPLETED|Overall Study||2||
48615914|NCT00751140|101845013|FG000|STARTED|Overall Study||20||
48615915|NCT00751140|101845013|FG000|COMPLETED|Overall Study||19||
48615916|NCT00751140|101845013|FG000|NOT COMPLETED|Overall Study||1||
48615917|NCT03675360|101845014|FG000|STARTED|Overall Study||75||
48615918|NCT03675360|101845015|FG001|STARTED|Overall Study||75||
48615919|NCT03675360|101845014|FG000|COMPLETED|Overall Study||73||
48615920|NCT03675360|101845015|FG001|COMPLETED|Overall Study||69||
48615921|NCT03675360|101845014|FG000|NOT COMPLETED|Overall Study||2||
48615922|NCT03675360|101845015|FG001|NOT COMPLETED|Overall Study||6||
48615923|NCT02688933|101845016|FG000|STARTED|Overall Study||320||
48735241|NCT00847886|102137012|FG001|STARTED|Overall Study||4||
48317649|NCT03016325|101104083|FG000|STARTED|32-Day Follow-Up Period||48|Started = Entering treatment period|
48317650|NCT03016325|101104084|FG001|STARTED|32-Day Follow-Up Period||49|Started = Entering treatment period|
48317651|NCT03016325|101104085|FG002|STARTED|32-Day Follow-Up Period||71|Started = Entering treatment period|
48317652|NCT03016325|101104086|FG003|STARTED|32-Day Follow-Up Period||71|Started = Entering treatment period|
48317653|NCT03016325|101104087|FG004|STARTED|32-Day Follow-Up Period||72|Started = Entering treatment period|
48317654|NCT03016325|101104088|FG005|STARTED|32-Day Follow-Up Period||6|Started = Entering treatment period|
48317655|NCT03016325|101104089|FG006|STARTED|32-Day Follow-Up Period||6|Started = Entering treatment period|
48317656|NCT03016325|101104090|FG007|STARTED|32-Day Follow-Up Period||6|Started = Entering treatment period|
48317657|NCT03016325|101104083|FG000|COMPLETED|32-Day Follow-Up Period||44|Completed = Finished 32-day follow-up period|
48317658|NCT03016325|101104084|FG001|COMPLETED|32-Day Follow-Up Period||47|Completed = Finished 32-day follow-up period|
48317659|NCT03016325|101104085|FG002|COMPLETED|32-Day Follow-Up Period||62|Completed = Finished 32-day follow-up period|
48317660|NCT03016325|101104086|FG003|COMPLETED|32-Day Follow-Up Period||63|Completed = Finished 32-day follow-up period|
48317661|NCT03016325|101104087|FG004|COMPLETED|32-Day Follow-Up Period||64|Completed = Finished 32-day follow-up period|
48407178|NCT03073200|101328517|FG006|COMPLETED|Extension Period||31||
48615924|NCT02688933|101845017|FG001|STARTED|Overall Study||318||
48317662|NCT03016325|101104088|FG005|COMPLETED|32-Day Follow-Up Period||6|Completed = Finished 32-day follow-up period|
48368043|NCT03567291|101230092|FG000|COMPLETED|Period III||0||
48615925|NCT02688933|101845016|FG000|COMPLETED|Overall Study||291||
48615926|NCT02688933|101845017|FG001|COMPLETED|Overall Study||281||
48615927|NCT02688933|101845016|FG000|NOT COMPLETED|Overall Study||29||
48615928|NCT02688933|101845017|FG001|NOT COMPLETED|Overall Study||37||
48615929|NCT00327717|101845018|FG000|STARTED|Overall Study||120||
48615930|NCT00327717|101845019|FG001|STARTED|Overall Study||120||
48615931|NCT00327717|101845018|FG000|COMPLETED|Overall Study||111||
48615932|NCT00327717|101845019|FG001|COMPLETED|Overall Study||106||
48615933|NCT00327717|101845018|FG000|NOT COMPLETED|Overall Study||9||
48615934|NCT00327717|101845019|FG001|NOT COMPLETED|Overall Study||14||
48615935|NCT02620787|101845020|FG000|STARTED|Overall Study||12||
48735242|NCT00847886|102137011|FG000|COMPLETED|Overall Study||12||
48317663|NCT03016325|101104089|FG006|COMPLETED|32-Day Follow-Up Period||5|Completed = Finished 32-day follow-up period|
48317664|NCT03016325|101104090|FG007|COMPLETED|32-Day Follow-Up Period||6|Completed = Finished 32-day follow-up period|
48317665|NCT03016325|101104083|FG000|NOT COMPLETED|32-Day Follow-Up Period||4||
48317666|NCT03016325|101104084|FG001|NOT COMPLETED|32-Day Follow-Up Period||2||
48317667|NCT03016325|101104085|FG002|NOT COMPLETED|32-Day Follow-Up Period||9||
48317668|NCT03016325|101104086|FG003|NOT COMPLETED|32-Day Follow-Up Period||8||
48317669|NCT03016325|101104087|FG004|NOT COMPLETED|32-Day Follow-Up Period||8||
48317670|NCT03016325|101104088|FG005|NOT COMPLETED|32-Day Follow-Up Period||0||
48317671|NCT03016325|101104089|FG006|NOT COMPLETED|32-Day Follow-Up Period||1||
48317672|NCT03016325|101104090|FG007|NOT COMPLETED|32-Day Follow-Up Period||0||
48317673|NCT03016325|101104083|FG000|STARTED|182-Day Follow-Up Period||48|Started = Entering treatment period|
48317674|NCT03016325|101104084|FG001|STARTED|182-Day Follow-Up Period||49|Started = Entering treatment period|
48317675|NCT03016325|101104085|FG002|STARTED|182-Day Follow-Up Period||71|Started = Entering treatment period|
48317676|NCT03016325|101104086|FG003|STARTED|182-Day Follow-Up Period||71|Started = Entering treatment period|
48317677|NCT03016325|101104087|FG004|STARTED|182-Day Follow-Up Period||72|Started = Entering treatment period|
48317678|NCT03016325|101104088|FG005|STARTED|182-Day Follow-Up Period||6|Started = Entering treatment period|
48317679|NCT03016325|101104089|FG006|STARTED|182-Day Follow-Up Period||6|Started = Entering treatment period|
48317680|NCT03016325|101104090|FG007|STARTED|182-Day Follow-Up Period||6|Started = Entering treatment period|
48317681|NCT03016325|101104083|FG000|COMPLETED|182-Day Follow-Up Period||44|Completed = Finished 182-day follow-up period|
48735243|NCT00847886|102137012|FG001|COMPLETED|Overall Study||3||
48735244|NCT00847886|102137011|FG000|NOT COMPLETED|Overall Study||0||
48735245|NCT00847886|102137012|FG001|NOT COMPLETED|Overall Study||1||
48735246|NCT03276546|102137013|FG000|STARTED|Overall Study||23||
48735247|NCT03276546|102137013|FG000|COMPLETED|Overall Study||20||
48735248|NCT03276546|102137013|FG000|NOT COMPLETED|Overall Study||3||
48735249|NCT00349778|102137014|FG000|STARTED|Overall Study||102||
48735250|NCT00349778|102137014|FG000|COMPLETED|Overall Study||102||
48735251|NCT00349778|102137014|FG000|NOT COMPLETED|Overall Study||0||
48735252|NCT02413489|102137015|FG000|STARTED|Overall Study||15||
48735253|NCT02413489|102137016|FG001|STARTED|Overall Study||16||
48735254|NCT02413489|102137017|FG002|STARTED|Overall Study||5||
48735255|NCT02413489|102137015|FG000|COMPLETED|Overall Study||0||
48735256|NCT02413489|102137016|FG001|COMPLETED|Overall Study||0||
48735257|NCT02413489|102137017|FG002|COMPLETED|Overall Study||0||
48735258|NCT02413489|102137015|FG000|NOT COMPLETED|Overall Study||15||
48735259|NCT02413489|102137016|FG001|NOT COMPLETED|Overall Study||16||
48160203|NCT01105702|100715818|FG000|NOT COMPLETED|Overall Study||18||
48160204|NCT04128293|100715819|FG000|STARTED|Treatment Period 1 (1 Day)||4||
48160205|NCT04128293|100715820|FG001|STARTED|Treatment Period 1 (1 Day)||4||
48160206|NCT04128293|100715821|FG002|STARTED|Treatment Period 1 (1 Day)||4||
48160207|NCT04128293|100715822|FG003|STARTED|Treatment Period 1 (1 Day)||4||
48160208|NCT04128293|100715819|FG000|COMPLETED|Treatment Period 1 (1 Day)||4||
48317682|NCT03016325|101104084|FG001|COMPLETED|182-Day Follow-Up Period||45|Completed = Finished 182-day follow-up period|
48317683|NCT03016325|101104085|FG002|COMPLETED|182-Day Follow-Up Period||60|Completed = Finished 182-day follow-up period|
48317684|NCT03016325|101104086|FG003|COMPLETED|182-Day Follow-Up Period||58|Completed = Finished 182-day follow-up period|
48317685|NCT03016325|101104087|FG004|COMPLETED|182-Day Follow-Up Period||60|Completed = Finished 182-day follow-up period|
48407179|NCT03073200|101328518|FG007|COMPLETED|Extension Period||62||
48407180|NCT03073200|101328519|FG008|COMPLETED|Extension Period||7||
48407181|NCT03073200|101328520|FG009|COMPLETED|Extension Period||0||
48407182|NCT03073200|101328521|FG010|COMPLETED|Extension Period||0||
48407183|NCT03073200|101328522|FG011|COMPLETED|Extension Period||0||
48407184|NCT03073200|101328523|FG012|COMPLETED|Extension Period||0||
48407185|NCT03073200|101328524|FG013|COMPLETED|Extension Period||0||
48735260|NCT02413489|102137017|FG002|NOT COMPLETED|Overall Study||5||
48735261|NCT02663622|102137018|FG000|STARTED|Overall Study||6||
48735262|NCT02663622|102137019|FG001|STARTED|Overall Study||6||
48735263|NCT02663622|102137020|FG002|STARTED|Overall Study||6||
48735264|NCT02663622|102137021|FG003|STARTED|Overall Study||26||
48735265|NCT02663622|102137018|FG000|COMPLETED|Overall Study||3||
48735266|NCT02663622|102137019|FG001|COMPLETED|Overall Study||5||
48735267|NCT02663622|102137020|FG002|COMPLETED|Overall Study||5||
48160209|NCT04128293|100715820|FG001|COMPLETED|Treatment Period 1 (1 Day)||4||
48160210|NCT04128293|100715821|FG002|COMPLETED|Treatment Period 1 (1 Day)||4||
48160211|NCT04128293|100715822|FG003|COMPLETED|Treatment Period 1 (1 Day)||4||
48160212|NCT04128293|100715819|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
48160213|NCT04128293|100715820|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
48160214|NCT04128293|100715821|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
48160215|NCT04128293|100715822|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
48317686|NCT03016325|101104088|FG005|COMPLETED|182-Day Follow-Up Period||1|Completed = Finished 182-day follow-up period|
48317687|NCT03016325|101104089|FG006|COMPLETED|182-Day Follow-Up Period||2|Completed = Finished 182-day follow-up period|
48317688|NCT03016325|101104090|FG007|COMPLETED|182-Day Follow-Up Period||1|Completed = Finished 182-day follow-up period|
48317689|NCT03016325|101104083|FG000|NOT COMPLETED|182-Day Follow-Up Period||4||
48317690|NCT03016325|101104084|FG001|NOT COMPLETED|182-Day Follow-Up Period||4||
48317691|NCT03016325|101104085|FG002|NOT COMPLETED|182-Day Follow-Up Period||11||
48317692|NCT03016325|101104086|FG003|NOT COMPLETED|182-Day Follow-Up Period||13||
48368044|NCT03567291|101230093|FG001|COMPLETED|Period III||0||
48317693|NCT03016325|101104087|FG004|NOT COMPLETED|182-Day Follow-Up Period||12||
48317694|NCT03016325|101104088|FG005|NOT COMPLETED|182-Day Follow-Up Period||5||
48317695|NCT03016325|101104089|FG006|NOT COMPLETED|182-Day Follow-Up Period||4||
48317696|NCT03016325|101104090|FG007|NOT COMPLETED|182-Day Follow-Up Period||5||
48317697|NCT05051904|101104091|FG000|STARTED|Overall Study||12316||
48317698|NCT05051904|101104092|FG001|STARTED|Overall Study||6712||
48317699|NCT05051904|101104093|FG002|STARTED|Overall Study||20329||
48735268|NCT02663622|102137021|FG003|COMPLETED|Overall Study||17||
48735269|NCT02663622|102137018|FG000|NOT COMPLETED|Overall Study||3||
48735270|NCT02663622|102137019|FG001|NOT COMPLETED|Overall Study||1||
48735271|NCT02663622|102137020|FG002|NOT COMPLETED|Overall Study||1||
48735272|NCT02663622|102137021|FG003|NOT COMPLETED|Overall Study||9||
48735273|NCT01773187|102137022|FG000|STARTED|Overall Study||220||
48317700|NCT05051904|101104091|FG000|Crude|Overall Study||12316||
48317701|NCT05051904|101104092|FG001|Crude|Overall Study||6712||
48407186|NCT03073200|101328525|FG014|COMPLETED|Extension Period||0||
48735274|NCT01773187|102137023|FG001|STARTED|Overall Study||107||
48735275|NCT01773187|102137022|FG000|COMPLETED|Overall Study||167||
48735276|NCT01773187|102137023|FG001|COMPLETED|Overall Study||75||
48735277|NCT01773187|102137022|FG000|NOT COMPLETED|Overall Study||53||
48735278|NCT01773187|102137023|FG001|NOT COMPLETED|Overall Study||32||
48735279|NCT01357551|102137024|FG000|STARTED|Overall Study||110||
48735280|NCT01357551|102137025|FG001|STARTED|Overall Study||112||
48735281|NCT01357551|102137024|FG000|COMPLETED|Overall Study||88||
48317702|NCT05051904|101104093|FG002|Crude|Overall Study||20329||
48368045|NCT03567291|101230094|FG002|COMPLETED|Period III||0||
48368046|NCT03567291|101230095|FG003|COMPLETED|Period III||48||
48735282|NCT01357551|102137025|FG001|COMPLETED|Overall Study||101||
48735283|NCT01357551|102137024|FG000|NOT COMPLETED|Overall Study||22||
48735284|NCT01357551|102137025|FG001|NOT COMPLETED|Overall Study||11||
48735285|NCT00958165|102137026|FG000|STARTED|Overall Study||81||
48735286|NCT00958165|102137026|FG000|Treated|Overall Study||72||
48735287|NCT00958165|102137026|FG000|COMPLETED|Overall Study||67||
48735288|NCT00958165|102137026|FG000|NOT COMPLETED|Overall Study||14||
48735289|NCT04343755|102137027|FG000|STARTED|Overall Study||52||
48735290|NCT04343755|102137027|FG000|COMPLETED|Overall Study||40||
48735291|NCT04343755|102137027|FG000|NOT COMPLETED|Overall Study||12||
48735292|NCT04441255|102137028|FG000|STARTED|Period 1 (1 Day)||7||
48735293|NCT04441255|102137029|FG001|STARTED|Period 1 (1 Day)||7||
48735294|NCT04441255|102137028|FG000|COMPLETED|Period 1 (1 Day)||7||
48735295|NCT04441255|102137029|FG001|COMPLETED|Period 1 (1 Day)||7||
48735296|NCT04441255|102137028|FG000|NOT COMPLETED|Period 1 (1 Day)||0||
48735297|NCT04441255|102137029|FG001|NOT COMPLETED|Period 1 (1 Day)||0||
48735298|NCT04441255|102137028|FG000|STARTED|Washout Period (10 Days)||7||
48735299|NCT04441255|102137029|FG001|STARTED|Washout Period (10 Days)||7||
48735300|NCT04441255|102137028|FG000|COMPLETED|Washout Period (10 Days)||7||
48735301|NCT04441255|102137029|FG001|COMPLETED|Washout Period (10 Days)||7||
48735302|NCT04441255|102137028|FG000|NOT COMPLETED|Washout Period (10 Days)||0||
48735303|NCT04441255|102137029|FG001|NOT COMPLETED|Washout Period (10 Days)||0||
48735304|NCT04441255|102137028|FG000|STARTED|Period 2 (1 Day)||7||
48735305|NCT04441255|102137029|FG001|STARTED|Period 2 (1 Day)||7||
48735306|NCT04441255|102137028|FG000|COMPLETED|Period 2 (1 Day)||7||
48735307|NCT04441255|102137029|FG001|COMPLETED|Period 2 (1 Day)||7||
48735308|NCT04441255|102137028|FG000|NOT COMPLETED|Period 2 (1 Day)||0||
48735309|NCT04441255|102137029|FG001|NOT COMPLETED|Period 2 (1 Day)||0||
48735310|NCT03850535|102137030|FG000|STARTED|Overall Study||4||
48735311|NCT03850535|102137031|FG001|STARTED|Overall Study||9||
48735312|NCT03850535|102137032|FG002|STARTED|Overall Study||6||
48735313|NCT03850535|102137033|FG003|STARTED|Overall Study||4||
48735314|NCT03850535|102137030|FG000|COMPLETED|Overall Study||0||
48735315|NCT03850535|102137031|FG001|COMPLETED|Overall Study||0||
48735316|NCT03850535|102137032|FG002|COMPLETED|Overall Study||0||
48735317|NCT03850535|102137033|FG003|COMPLETED|Overall Study||0||
48735318|NCT03850535|102137030|FG000|NOT COMPLETED|Overall Study||4||
48735319|NCT03850535|102137031|FG001|NOT COMPLETED|Overall Study||9||
48735320|NCT03850535|102137032|FG002|NOT COMPLETED|Overall Study||6||
48735321|NCT03850535|102137033|FG003|NOT COMPLETED|Overall Study||4||
48735322|NCT01180296|102137034|FG000|STARTED|Overall Study||20||
48735323|NCT01180296|102137035|FG001|STARTED|Overall Study||16||
48735324|NCT01180296|102137034|FG000|COMPLETED|Overall Study||19||
48735325|NCT01180296|102137035|FG001|COMPLETED|Overall Study||14||
48735326|NCT01180296|102137034|FG000|NOT COMPLETED|Overall Study||1||
48735327|NCT01180296|102137035|FG001|NOT COMPLETED|Overall Study||2||
48735328|NCT00765063|102137036|FG000|STARTED|Overall Study||62||
48735329|NCT00765063|102137036|FG000|COMPLETED|Overall Study||30||
48735330|NCT00765063|102137036|FG000|NOT COMPLETED|Overall Study||32||
48735331|NCT02775916|102137037|FG000|STARTED|Overall Study||20||
48735332|NCT02775916|102137038|FG001|STARTED|Overall Study||10||
48735333|NCT02775916|102137037|FG000|COMPLETED|Overall Study||17||
48735334|NCT02775916|102137038|FG001|COMPLETED|Overall Study||10||
48735335|NCT02775916|102137037|FG000|NOT COMPLETED|Overall Study||3||
48735336|NCT02775916|102137038|FG001|NOT COMPLETED|Overall Study||0||
48735337|NCT03274063|102137039|FG000|STARTED|Overall Study||40||
48735338|NCT03274063|102137040|FG001|STARTED|Overall Study||20||
48735339|NCT03274063|102137039|FG000|COMPLETED|Overall Study||36||
48735340|NCT03274063|102137040|FG001|COMPLETED|Overall Study||18||
48735341|NCT03274063|102137039|FG000|NOT COMPLETED|Overall Study||4||
48735342|NCT03274063|102137040|FG001|NOT COMPLETED|Overall Study||2||
48735343|NCT00258817|102137041|FG000|STARTED|Overall Study||15||
48735344|NCT00258817|102137042|FG001|STARTED|Overall Study||15||
48735345|NCT00258817|102137041|FG000|COMPLETED|Overall Study||15||
48735346|NCT00258817|102137042|FG001|COMPLETED|Overall Study||15||
48735347|NCT00258817|102137041|FG000|NOT COMPLETED|Overall Study||0||
48735348|NCT00258817|102137042|FG001|NOT COMPLETED|Overall Study||0||
48735349|NCT00787189|102137043|FG000|STARTED|Overall Study||32||
48735350|NCT00787189|102137044|FG001|STARTED|Overall Study||32||
48317703|NCT05051904|101104091|FG000|s-IPTW Adjusted|Overall Study||12231|Balanced to account for potential confounding effects through an inverse probability of treatment weighting (IPTW) method|
48317704|NCT05051904|101104092|FG001|s-IPTW Adjusted|Overall Study||6682|Balanced to account for potential confounding effects through an inverse probability of treatment weighting (IPTW) method|
48317705|NCT05051904|101104093|FG002|s-IPTW Adjusted|Overall Study||20422|Balanced to account for potential confounding effects through an inverse probability of treatment weighting (IPTW) method|
48317706|NCT05051904|101104091|FG000|COMPLETED|Overall Study||12316||
48317707|NCT05051904|101104092|FG001|COMPLETED|Overall Study||6712||
48317708|NCT05051904|101104093|FG002|COMPLETED|Overall Study||20329||
48317709|NCT05051904|101104091|FG000|NOT COMPLETED|Overall Study||0||
48735351|NCT00787189|102137043|FG000|COMPLETED|Overall Study||30||
48735352|NCT00787189|102137044|FG001|COMPLETED|Overall Study||30||
48735353|NCT00787189|102137043|FG000|NOT COMPLETED|Overall Study||2||
48735354|NCT00787189|102137044|FG001|NOT COMPLETED|Overall Study||2||
48735355|NCT02881762|102137045|FG000|STARTED|First Intervention (4 Weeks)||5||
48735356|NCT02881762|102137046|FG001|STARTED|First Intervention (4 Weeks)||5||
48735357|NCT02881762|102137045|FG000|COMPLETED|First Intervention (4 Weeks)||5||
48735358|NCT02881762|102137046|FG001|COMPLETED|First Intervention (4 Weeks)||4||
48735359|NCT02881762|102137045|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0||
48735360|NCT02881762|102137046|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1||
48735361|NCT02881762|102137045|FG000|STARTED|Washout (4 Weeks)||5||
48735362|NCT02881762|102137046|FG001|STARTED|Washout (4 Weeks)||4||
48735363|NCT02881762|102137045|FG000|COMPLETED|Washout (4 Weeks)||5||
48735364|NCT02881762|102137046|FG001|COMPLETED|Washout (4 Weeks)||4||
48735365|NCT02881762|102137045|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
48735366|NCT02881762|102137046|FG001|NOT COMPLETED|Washout (4 Weeks)||0||
48735367|NCT02881762|102137045|FG000|STARTED|Second Intervention (4 Weeks)||5||
48735368|NCT02881762|102137046|FG001|STARTED|Second Intervention (4 Weeks)||4||
48735369|NCT02881762|102137045|FG000|COMPLETED|Second Intervention (4 Weeks)||5||
48735370|NCT02881762|102137046|FG001|COMPLETED|Second Intervention (4 Weeks)||4||
48735371|NCT02881762|102137045|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0||
48735372|NCT02881762|102137046|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0||
48735373|NCT02881762|102137045|FG000|STARTED|Followup No Maraviroc First Only (4 Wks)||5||
48735374|NCT02881762|102137046|FG001|STARTED|Followup No Maraviroc First Only (4 Wks)||4||
48735375|NCT02881762|102137045|FG000|COMPLETED|Followup No Maraviroc First Only (4 Wks)||5||
48735376|NCT02881762|102137046|FG001|COMPLETED|Followup No Maraviroc First Only (4 Wks)||4||
48735377|NCT02881762|102137045|FG000|NOT COMPLETED|Followup No Maraviroc First Only (4 Wks)||0||
48735378|NCT02881762|102137046|FG001|NOT COMPLETED|Followup No Maraviroc First Only (4 Wks)||0||
48735379|NCT00850538|102137047|FG000|STARTED|Overall Study||101||
48735380|NCT00850538|102137047|FG000|COMPLETED|Overall Study||60||
48735381|NCT00850538|102137047|FG000|NOT COMPLETED|Overall Study||41||
48735382|NCT00543387|102137048|FG000|STARTED|Panel 1 + Panel 2||3||
48735383|NCT00543387|102137049|FG001|STARTED|Panel 1 + Panel 2||3||
48735384|NCT00543387|102137050|FG002|STARTED|Panel 1 + Panel 2||3||
48735385|NCT00543387|102137051|FG003|STARTED|Panel 1 + Panel 2||3||
48735386|NCT00543387|102137052|FG004|STARTED|Panel 1 + Panel 2||3||
48735387|NCT00543387|102137053|FG005|STARTED|Panel 1 + Panel 2||3||
48735388|NCT00543387|102137054|FG006|STARTED|Panel 1 + Panel 2||6||
48735389|NCT00543387|102137055|FG007|STARTED|Panel 1 + Panel 2||6||
48735390|NCT00543387|102137056|FG008|STARTED|Panel 1 + Panel 2||5||
48735391|NCT00543387|102137057|FG009|STARTED|Panel 1 + Panel 2||0||
48735392|NCT00543387|102137058|FG010|STARTED|Panel 1 + Panel 2||0||
48735393|NCT00543387|102137048|FG000|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0||
48735394|NCT00543387|102137049|FG001|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||1||
48735395|NCT00543387|102137050|FG002|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0||
48735396|NCT00543387|102137051|FG003|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0||
48735397|NCT00543387|102137052|FG004|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||2||
48735398|NCT00543387|102137053|FG005|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||1||
48735399|NCT00543387|102137054|FG006|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0||
48735400|NCT00543387|102137055|FG007|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0||
48735401|NCT00543387|102137056|FG008|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0||
48735402|NCT00543387|102137057|FG009|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0||
48735403|NCT00543387|102137058|FG010|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0||
48735404|NCT00543387|102137048|FG000|COMPLETED|Panel 1 + Panel 2||0||
48735405|NCT00543387|102137049|FG001|COMPLETED|Panel 1 + Panel 2||0||
48735406|NCT00543387|102137050|FG002|COMPLETED|Panel 1 + Panel 2||0||
48735407|NCT00543387|102137051|FG003|COMPLETED|Panel 1 + Panel 2||0||
48735408|NCT00543387|102137052|FG004|COMPLETED|Panel 1 + Panel 2||0||
48735409|NCT00543387|102137053|FG005|COMPLETED|Panel 1 + Panel 2||0||
48735410|NCT00543387|102137054|FG006|COMPLETED|Panel 1 + Panel 2||0||
48735411|NCT00543387|102137055|FG007|COMPLETED|Panel 1 + Panel 2||0||
48735412|NCT00543387|102137056|FG008|COMPLETED|Panel 1 + Panel 2||0||
48735413|NCT00543387|102137057|FG009|COMPLETED|Panel 1 + Panel 2||0||
48735414|NCT00543387|102137058|FG010|COMPLETED|Panel 1 + Panel 2||0||
48735415|NCT00543387|102137048|FG000|NOT COMPLETED|Panel 1 + Panel 2||3||
48735416|NCT00543387|102137049|FG001|NOT COMPLETED|Panel 1 + Panel 2||3||
48735417|NCT00543387|102137050|FG002|NOT COMPLETED|Panel 1 + Panel 2||3||
48735418|NCT00543387|102137051|FG003|NOT COMPLETED|Panel 1 + Panel 2||3||
48735419|NCT00543387|102137052|FG004|NOT COMPLETED|Panel 1 + Panel 2||3||
48735420|NCT00543387|102137053|FG005|NOT COMPLETED|Panel 1 + Panel 2||3||
48735421|NCT00543387|102137054|FG006|NOT COMPLETED|Panel 1 + Panel 2||6||
48735422|NCT00543387|102137055|FG007|NOT COMPLETED|Panel 1 + Panel 2||6||
48735423|NCT00543387|102137056|FG008|NOT COMPLETED|Panel 1 + Panel 2||5||
48735424|NCT00543387|102137057|FG009|NOT COMPLETED|Panel 1 + Panel 2||0||
48735425|NCT00543387|102137058|FG010|NOT COMPLETED|Panel 1 + Panel 2||0||
48735426|NCT00543387|102137048|FG000|STARTED|Crossover Participants||0||
48735427|NCT00543387|102137049|FG001|STARTED|Crossover Participants||0||
48735428|NCT00543387|102137050|FG002|STARTED|Crossover Participants||0||
48735429|NCT00543387|102137051|FG003|STARTED|Crossover Participants||0||
48735430|NCT00543387|102137052|FG004|STARTED|Crossover Participants||0||
48735431|NCT00543387|102137053|FG005|STARTED|Crossover Participants||0||
48735432|NCT00543387|102137054|FG006|STARTED|Crossover Participants||0||
48735433|NCT00543387|102137055|FG007|STARTED|Crossover Participants||0||
48735434|NCT00543387|102137056|FG008|STARTED|Crossover Participants||0||
48735435|NCT00543387|102137057|FG009|STARTED|Crossover Participants||1||
48735436|NCT00543387|102137058|FG010|STARTED|Crossover Participants||3||
48735437|NCT00543387|102137048|FG000|COMPLETED|Crossover Participants||0||
48735438|NCT00543387|102137049|FG001|COMPLETED|Crossover Participants||0||
48735439|NCT00543387|102137050|FG002|COMPLETED|Crossover Participants||0||
48735440|NCT00543387|102137051|FG003|COMPLETED|Crossover Participants||0||
48735441|NCT00543387|102137052|FG004|COMPLETED|Crossover Participants||0||
48735442|NCT00543387|102137053|FG005|COMPLETED|Crossover Participants||0||
48735443|NCT00543387|102137054|FG006|COMPLETED|Crossover Participants||0||
48735444|NCT00543387|102137055|FG007|COMPLETED|Crossover Participants||0||
48735445|NCT00543387|102137056|FG008|COMPLETED|Crossover Participants||0||
48735446|NCT00543387|102137057|FG009|COMPLETED|Crossover Participants||0||
48735447|NCT00543387|102137058|FG010|COMPLETED|Crossover Participants||0||
48735448|NCT00543387|102137048|FG000|NOT COMPLETED|Crossover Participants||0||
48735449|NCT00543387|102137049|FG001|NOT COMPLETED|Crossover Participants||0||
48735450|NCT00543387|102137050|FG002|NOT COMPLETED|Crossover Participants||0||
48735451|NCT00543387|102137051|FG003|NOT COMPLETED|Crossover Participants||0||
48735452|NCT00543387|102137052|FG004|NOT COMPLETED|Crossover Participants||0||
48735453|NCT00543387|102137053|FG005|NOT COMPLETED|Crossover Participants||0||
48735454|NCT00543387|102137054|FG006|NOT COMPLETED|Crossover Participants||0||
48735455|NCT00543387|102137055|FG007|NOT COMPLETED|Crossover Participants||0||
48735456|NCT00543387|102137056|FG008|NOT COMPLETED|Crossover Participants||0||
48735457|NCT00543387|102137057|FG009|NOT COMPLETED|Crossover Participants||1||
48735458|NCT00543387|102137058|FG010|NOT COMPLETED|Crossover Participants||3||
48735459|NCT02748070|102137059|FG000|STARTED|Overall Study||41||
48735460|NCT02748070|102137060|FG001|STARTED|Overall Study||40||
48735461|NCT02748070|102137059|FG000|Randomized and Treated|Overall Study||40||
48735462|NCT02748070|102137060|FG001|Randomized and Treated|Overall Study||40||
48735463|NCT02748070|102137059|FG000|COMPLETED|Overall Study||33||
48735464|NCT02748070|102137060|FG001|COMPLETED|Overall Study||39||
48735465|NCT02748070|102137059|FG000|NOT COMPLETED|Overall Study||8||
48735466|NCT02748070|102137060|FG001|NOT COMPLETED|Overall Study||1||
48735467|NCT00770601|102137061|FG000|STARTED|Overall Study||7||
48735468|NCT00770601|102137061|FG000|COMPLETED|Overall Study||6||
48735469|NCT00770601|102137061|FG000|NOT COMPLETED|Overall Study||1||
48735470|NCT03543137|102137062|FG000|STARTED|Study Period 1: Up to Day 1||18||
48735471|NCT03543137|102137063|FG001|STARTED|Study Period 1: Up to Day 1||19||
48735472|NCT03543137|102137062|FG000|COMPLETED|Study Period 1: Up to Day 1||18||
48735473|NCT03543137|102137063|FG001|COMPLETED|Study Period 1: Up to Day 1||19||
48735474|NCT03543137|102137062|FG000|NOT COMPLETED|Study Period 1: Up to Day 1||0||
48735475|NCT03543137|102137063|FG001|NOT COMPLETED|Study Period 1: Up to Day 1||0||
48735476|NCT03543137|102137062|FG000|STARTED|Washout Period: 5 to 7 Days||18||
48735477|NCT03543137|102137063|FG001|STARTED|Washout Period: 5 to 7 Days||19||
48735478|NCT03543137|102137062|FG000|COMPLETED|Washout Period: 5 to 7 Days||18||
48735479|NCT03543137|102137063|FG001|COMPLETED|Washout Period: 5 to 7 Days||19||
48735480|NCT03543137|102137062|FG000|NOT COMPLETED|Washout Period: 5 to 7 Days||0||
48735481|NCT03543137|102137063|FG001|NOT COMPLETED|Washout Period: 5 to 7 Days||0||
48735482|NCT03543137|102137062|FG000|STARTED|Study Period 2: Up to Day 8||18||
48735483|NCT03543137|102137063|FG001|STARTED|Study Period 2: Up to Day 8||19||
48735484|NCT03543137|102137062|FG000|Treated|Study Period 2: Up to Day 8||16||
48735485|NCT03543137|102137063|FG001|Treated|Study Period 2: Up to Day 8||18||
48735486|NCT03543137|102137062|FG000|COMPLETED|Study Period 2: Up to Day 8||16||
48735487|NCT03543137|102137063|FG001|COMPLETED|Study Period 2: Up to Day 8||18||
48735488|NCT03543137|102137062|FG000|NOT COMPLETED|Study Period 2: Up to Day 8||2||
48735489|NCT03543137|102137063|FG001|NOT COMPLETED|Study Period 2: Up to Day 8||1||
48735490|NCT00720343|102137064|FG000|STARTED|Overall Study||30||
48735491|NCT00720343|102137065|FG001|STARTED|Overall Study||30||
48735492|NCT00720343|102137064|FG000|COMPLETED|Overall Study||29||
48735493|NCT00720343|102137065|FG001|COMPLETED|Overall Study||28||
48735494|NCT00720343|102137064|FG000|NOT COMPLETED|Overall Study||1||
48735495|NCT00720343|102137065|FG001|NOT COMPLETED|Overall Study||2||
48735496|NCT00539305|102137066|FG000|STARTED|Overall Study||10||
48735497|NCT00539305|102137067|FG001|STARTED|Overall Study||12||
48735498|NCT00539305|102137066|FG000|COMPLETED|Overall Study||9||
48735499|NCT00539305|102137067|FG001|COMPLETED|Overall Study||10||
48735500|NCT00539305|102137066|FG000|NOT COMPLETED|Overall Study||1||
48735501|NCT00539305|102137067|FG001|NOT COMPLETED|Overall Study||2||
48735502|NCT00826618|102137068|FG000|STARTED|Overall Study||6||
48735503|NCT00826618|102137068|FG000|COMPLETED|Overall Study||5||
48735504|NCT00826618|102137068|FG000|NOT COMPLETED|Overall Study||1||
48735505|NCT04182672|102137069|FG000|STARTED|Overall Study||22||24
48735506|NCT04182672|102137069|FG000|COMPLETED|Overall Study||22||24
48735507|NCT04182672|102137069|FG000|NOT COMPLETED|Overall Study||0||0
48735508|NCT02100969|102137070|FG000|STARTED|Overall Study||23||
48735509|NCT02100969|102137070|FG000|COMPLETED|Overall Study||22||
48735510|NCT02100969|102137070|FG000|NOT COMPLETED|Overall Study||1||
48735511|NCT03967054|102137071|FG000|STARTED|Overall Study||2191||7
48407187|NCT03073200|101328511|FG000|NOT COMPLETED|Extension Period||0||
48407188|NCT03073200|101328512|FG001|NOT COMPLETED|Extension Period||0||
48407189|NCT03073200|101328513|FG002|NOT COMPLETED|Extension Period||0||
48735512|NCT03967054|102137072|FG001|STARTED|Overall Study||1933||7
48735513|NCT03967054|102137071|FG000|COMPLETED|Overall Study||2191||7
48735514|NCT03967054|102137072|FG001|COMPLETED|Overall Study||1933||7
48735515|NCT03967054|102137071|FG000|NOT COMPLETED|Overall Study||0||0
48735516|NCT03967054|102137072|FG001|NOT COMPLETED|Overall Study||0||0
48735517|NCT03421106|102137073|FG000|STARTED|Sample A (Followed for 1 Year)||158||
48735518|NCT03421106|102137074|FG001|STARTED|Sample A (Followed for 1 Year)||159||
48407190|NCT03073200|101328514|FG003|NOT COMPLETED|Extension Period||0||
48735519|NCT03421106|102137073|FG000|COMPLETED|Sample A (Followed for 1 Year)||102||
48735520|NCT03421106|102137074|FG001|COMPLETED|Sample A (Followed for 1 Year)||105||
48735521|NCT03421106|102137073|FG000|NOT COMPLETED|Sample A (Followed for 1 Year)||56||
48735522|NCT03421106|102137074|FG001|NOT COMPLETED|Sample A (Followed for 1 Year)||54||
48735523|NCT03421106|102137073|FG000|STARTED|Sample B (Evaluated at Post Only)||85||
48735524|NCT03421106|102137074|FG001|STARTED|Sample B (Evaluated at Post Only)||102||
48735525|NCT03421106|102137073|FG000|COMPLETED|Sample B (Evaluated at Post Only)||85||
48735526|NCT03421106|102137074|FG001|COMPLETED|Sample B (Evaluated at Post Only)||102||
48735527|NCT03421106|102137073|FG000|NOT COMPLETED|Sample B (Evaluated at Post Only)||0||
48735528|NCT03421106|102137074|FG001|NOT COMPLETED|Sample B (Evaluated at Post Only)||0||
48735529|NCT02489942|102137075|FG000|STARTED|Overall Study||8145||
48735530|NCT02489942|102137075|FG000|Case Report Form (CRF) Collected|Overall Study||8059||
48735531|NCT02489942|102137075|FG000|Treated|Overall Study||8057||
48735532|NCT02489942|102137075|FG000|COMPLETED|Overall Study||4729||
48735533|NCT02489942|102137075|FG000|NOT COMPLETED|Overall Study||3416||
48317710|NCT05051904|101104092|FG001|NOT COMPLETED|Overall Study||0||
48317711|NCT05051904|101104093|FG002|NOT COMPLETED|Overall Study||0||
48317712|NCT02159703|101104094|FG000|STARTED|Overall Study||60||
48317713|NCT02159703|101104094|FG000|COMPLETED|Overall Study||60||
48735534|NCT00549445|102137076|FG000|STARTED|Overall Study||23||
48735535|NCT00549445|102137077|FG001|STARTED|Overall Study||30||
48735536|NCT00549445|102137076|FG000|COMPLETED|Overall Study||8||
48735537|NCT00549445|102137077|FG001|COMPLETED|Overall Study||13||
48735538|NCT00549445|102137076|FG000|NOT COMPLETED|Overall Study||15||
48735539|NCT00549445|102137077|FG001|NOT COMPLETED|Overall Study||17||
48735540|NCT01339897|102137078|FG000|STARTED|Overall Study||7||
48735541|NCT01339897|102137079|FG001|STARTED|Overall Study||6||
48735542|NCT01339897|102137080|FG002|STARTED|Overall Study||6||
48735543|NCT01339897|102137081|FG003|STARTED|Overall Study||6||
48735544|NCT01339897|102137078|FG000|COMPLETED|Overall Study||6||
48735545|NCT01339897|102137079|FG001|COMPLETED|Overall Study||6||
48735546|NCT01339897|102137080|FG002|COMPLETED|Overall Study||6||
48735547|NCT01339897|102137081|FG003|COMPLETED|Overall Study||5||
48735548|NCT01339897|102137078|FG000|NOT COMPLETED|Overall Study||1||
48735549|NCT01339897|102137079|FG001|NOT COMPLETED|Overall Study||0||
48735550|NCT01339897|102137080|FG002|NOT COMPLETED|Overall Study||0||
48735551|NCT01339897|102137081|FG003|NOT COMPLETED|Overall Study||1||
48735552|NCT01771250|102137082|FG000|STARTED|Period 1||8||
48735553|NCT01771250|102137083|FG001|STARTED|Period 1||7||
48735554|NCT01771250|102137082|FG000|Received at Least One Dose of Study Drug|Period 1||7||
48735555|NCT01771250|102137083|FG001|Received at Least One Dose of Study Drug|Period 1||7||
48735556|NCT01771250|102137082|FG000|COMPLETED|Period 1||7||
48735557|NCT01771250|102137083|FG001|COMPLETED|Period 1||7||
48735558|NCT01771250|102137082|FG000|NOT COMPLETED|Period 1||1||
48735559|NCT01771250|102137083|FG001|NOT COMPLETED|Period 1||0||
48735560|NCT01771250|102137082|FG000|STARTED|Period 2||7||
48735561|NCT01771250|102137083|FG001|STARTED|Period 2||7||
48735562|NCT01771250|102137082|FG000|COMPLETED|Period 2||7||
48735563|NCT01771250|102137083|FG001|COMPLETED|Period 2||7||
48735564|NCT01771250|102137082|FG000|NOT COMPLETED|Period 2||0||
48735565|NCT01771250|102137083|FG001|NOT COMPLETED|Period 2||0||
48735566|NCT02170870|102137084|FG000|STARTED|Overall Study||13||
48735567|NCT02170870|102137085|FG001|STARTED|Overall Study||11||
48735568|NCT02170870|102137086|FG002|STARTED|Overall Study||20||
48735569|NCT02170870|102137087|FG003|STARTED|Overall Study||20||
48735570|NCT02170870|102137088|FG004|STARTED|Overall Study||20||
48317714|NCT02159703|101104094|FG000|NOT COMPLETED|Overall Study||0||
48317715|NCT03113656|101104095|FG000|STARTED|Overall Study||9||
48317716|NCT03113656|101104096|FG001|STARTED|Overall Study||7||
48317717|NCT03113656|101104095|FG000|COMPLETED|Overall Study||9||
48317718|NCT03113656|101104096|FG001|COMPLETED|Overall Study||7||
48317719|NCT03113656|101104095|FG000|NOT COMPLETED|Overall Study||0||
48317720|NCT03113656|101104096|FG001|NOT COMPLETED|Overall Study||0||
48317721|NCT01598779|101104097|FG000|STARTED|Overall Study||150||
48317722|NCT01598779|101104097|FG000|COMPLETED|Overall Study||150||
48317723|NCT01598779|101104097|FG000|NOT COMPLETED|Overall Study||0||
48317724|NCT00549939|101104098|FG000|STARTED|12-week Double Blind Treatment Period||57||
48317725|NCT00549939|101104099|FG001|STARTED|12-week Double Blind Treatment Period||57||
48735571|NCT02170870|102137089|FG005|STARTED|Overall Study||20||
48735572|NCT02170870|102137084|FG000|COMPLETED|Overall Study||13||
48735573|NCT02170870|102137085|FG001|COMPLETED|Overall Study||11||
48735574|NCT02170870|102137086|FG002|COMPLETED|Overall Study||20||
48735575|NCT02170870|102137087|FG003|COMPLETED|Overall Study||20||
48735576|NCT02170870|102137088|FG004|COMPLETED|Overall Study||20||
48735577|NCT02170870|102137089|FG005|COMPLETED|Overall Study||20||
48735578|NCT02170870|102137084|FG000|NOT COMPLETED|Overall Study||0||
48735579|NCT02170870|102137085|FG001|NOT COMPLETED|Overall Study||0||
48735580|NCT02170870|102137086|FG002|NOT COMPLETED|Overall Study||0||
48735581|NCT02170870|102137087|FG003|NOT COMPLETED|Overall Study||0||
48735582|NCT02170870|102137088|FG004|NOT COMPLETED|Overall Study||0||
48735583|NCT02170870|102137089|FG005|NOT COMPLETED|Overall Study||0||
48735584|NCT00466921|102137090|FG000|STARTED|First 3 Cycles of Treatment||33||
48735585|NCT00466921|102137090|FG000|Completed 1 Cycle|First 3 Cycles of Treatment||32||
48735586|NCT00466921|102137090|FG000|Started Cycle 2|First 3 Cycles of Treatment||31||
48735587|NCT00466921|102137090|FG000|Completed 3 Cycles|First 3 Cycles of Treatment||26||
48735588|NCT00466921|102137090|FG000|COMPLETED|First 3 Cycles of Treatment||26||
48735589|NCT00466921|102137090|FG000|NOT COMPLETED|First 3 Cycles of Treatment||7||
48735590|NCT00466921|102137090|FG000|STARTED|Completed 4 Cycles/Reached 1st Response||26||
48735591|NCT00466921|102137090|FG000|Completed 4 Cycles/1st Response|Completed 4 Cycles/Reached 1st Response||21||
48735592|NCT00466921|102137090|FG000|COMPLETED|Completed 4 Cycles/Reached 1st Response||21||
48735593|NCT00466921|102137090|FG000|NOT COMPLETED|Completed 4 Cycles/Reached 1st Response||5||
48735594|NCT00466921|102137090|FG000|STARTED|Continued Treatment||21|Patients with partial response/stable disease continued for up to 2 years of treatment. Patients with complete response were treated with up to 2 more cycles.|
48735595|NCT00466921|102137090|FG000|COMPLETED|Continued Treatment||21||
48735596|NCT00466921|102137090|FG000|NOT COMPLETED|Continued Treatment||0||
48735597|NCT00466921|102137090|FG000|STARTED|Follow up for a Minimum of 1 Year||33|All patients who have at least one dose of study treatment go into follow up for survival endpoints.|
48735598|NCT00466921|102137090|FG000|COMPLETED|Follow up for a Minimum of 1 Year||27||
48735599|NCT00466921|102137090|FG000|NOT COMPLETED|Follow up for a Minimum of 1 Year||6||
48735600|NCT01593592|102137091|FG000|STARTED|Overall Study||35||
48735601|NCT01593592|102137092|FG001|STARTED|Overall Study||35||
48735602|NCT01593592|102137091|FG000|COMPLETED|Overall Study||35||
48735603|NCT01593592|102137092|FG001|COMPLETED|Overall Study||35||
48735604|NCT01593592|102137091|FG000|NOT COMPLETED|Overall Study||0||
48735605|NCT01593592|102137092|FG001|NOT COMPLETED|Overall Study||0||
48735606|NCT00734968|102137093|FG000|STARTED|Overall Study||77||
48735607|NCT00734968|102137094|FG001|STARTED|Overall Study||76||
48735608|NCT00734968|102137093|FG000|COMPLETED|Overall Study||76||
48735609|NCT00734968|102137094|FG001|COMPLETED|Overall Study||75||
48735610|NCT00734968|102137093|FG000|NOT COMPLETED|Overall Study||1||
48735611|NCT00734968|102137094|FG001|NOT COMPLETED|Overall Study||1||
48735612|NCT00858637|102137095|FG000|STARTED|Active Comparison Phase||127||
48735613|NCT00858637|102137096|FG001|STARTED|Active Comparison Phase||0||
48735614|NCT00858637|102137097|FG002|STARTED|Active Comparison Phase||0||
48735615|NCT00858637|102137098|FG003|STARTED|Active Comparison Phase||133||
48735616|NCT00858637|102137099|FG004|STARTED|Active Comparison Phase||0||
48735617|NCT00858637|102137100|FG005|STARTED|Active Comparison Phase||0||
48735618|NCT00858637|102137095|FG000|COMPLETED|Active Comparison Phase||103||
48735619|NCT00858637|102137096|FG001|COMPLETED|Active Comparison Phase||0||
48735620|NCT00858637|102137097|FG002|COMPLETED|Active Comparison Phase||0||
48735621|NCT00858637|102137098|FG003|COMPLETED|Active Comparison Phase||115||
48735622|NCT00858637|102137099|FG004|COMPLETED|Active Comparison Phase||0||
48735623|NCT00858637|102137100|FG005|COMPLETED|Active Comparison Phase||0||
48735624|NCT00858637|102137095|FG000|NOT COMPLETED|Active Comparison Phase||24||
48735625|NCT00858637|102137096|FG001|NOT COMPLETED|Active Comparison Phase||0||
48735626|NCT00858637|102137097|FG002|NOT COMPLETED|Active Comparison Phase||0||
48735627|NCT00858637|102137098|FG003|NOT COMPLETED|Active Comparison Phase||18||
48735628|NCT00858637|102137099|FG004|NOT COMPLETED|Active Comparison Phase||0||
48735629|NCT00858637|102137100|FG005|NOT COMPLETED|Active Comparison Phase||0||
48735630|NCT00858637|102137095|FG000|STARTED|Placebo-controlled Withdrawal Phase||0||
48735631|NCT00858637|102137096|FG001|STARTED|Placebo-controlled Withdrawal Phase||49||
48735632|NCT00858637|102137097|FG002|STARTED|Placebo-controlled Withdrawal Phase||54||
48735633|NCT00858637|102137098|FG003|STARTED|Placebo-controlled Withdrawal Phase||0||
48735634|NCT00858637|102137099|FG004|STARTED|Placebo-controlled Withdrawal Phase||56||
48735635|NCT00858637|102137100|FG005|STARTED|Placebo-controlled Withdrawal Phase||59||
48735636|NCT00858637|102137095|FG000|COMPLETED|Placebo-controlled Withdrawal Phase||0||
48735637|NCT00858637|102137096|FG001|COMPLETED|Placebo-controlled Withdrawal Phase||49||
48735638|NCT00858637|102137097|FG002|COMPLETED|Placebo-controlled Withdrawal Phase||53||
48735639|NCT00858637|102137098|FG003|COMPLETED|Placebo-controlled Withdrawal Phase||0||
48735640|NCT00858637|102137099|FG004|COMPLETED|Placebo-controlled Withdrawal Phase||55||
48735641|NCT00858637|102137100|FG005|COMPLETED|Placebo-controlled Withdrawal Phase||58||
48735642|NCT00858637|102137095|FG000|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0||
48735643|NCT00858637|102137096|FG001|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0||
48735644|NCT00858637|102137097|FG002|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1||
48735645|NCT00858637|102137098|FG003|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0||
48735646|NCT00858637|102137099|FG004|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1||
48735647|NCT00858637|102137100|FG005|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1||
48735648|NCT01706588|102137101|FG000|STARTED|Overall Study||15||
48735649|NCT01706588|102137102|FG001|STARTED|Overall Study||15||
48735650|NCT01706588|102137103|FG002|STARTED|Overall Study||15||
48735651|NCT01706588|102137104|FG003|STARTED|Overall Study||14||
48735652|NCT01706588|102137105|FG004|STARTED|Overall Study||16||
48735653|NCT01706588|102137101|FG000|COMPLETED|Overall Study||15||
48735654|NCT01706588|102137102|FG001|COMPLETED|Overall Study||15||
48735655|NCT01706588|102137103|FG002|COMPLETED|Overall Study||15||
48735656|NCT01706588|102137104|FG003|COMPLETED|Overall Study||14||
48735657|NCT01706588|102137105|FG004|COMPLETED|Overall Study||16||
48735658|NCT01706588|102137101|FG000|NOT COMPLETED|Overall Study||0||
48735659|NCT01706588|102137102|FG001|NOT COMPLETED|Overall Study||0||
48735660|NCT01706588|102137103|FG002|NOT COMPLETED|Overall Study||0||
48735661|NCT01706588|102137104|FG003|NOT COMPLETED|Overall Study||0||
48735662|NCT01706588|102137105|FG004|NOT COMPLETED|Overall Study||0||
48735663|NCT02937558|102137106|FG000|STARTED|Double-blind Phase||3||
48735664|NCT02937558|102137107|FG001|STARTED|Double-blind Phase||2||
48735665|NCT02937558|102137106|FG000|COMPLETED|Double-blind Phase||3||
48735666|NCT02937558|102137107|FG001|COMPLETED|Double-blind Phase||2||
48735667|NCT02937558|102137106|FG000|NOT COMPLETED|Double-blind Phase||0||
48735668|NCT02937558|102137107|FG001|NOT COMPLETED|Double-blind Phase||0||
48735669|NCT02937558|102137106|FG000|STARTED|Open-label Phase||5||
48735670|NCT02937558|102137107|FG001|STARTED|Open-label Phase||0||
48735671|NCT02937558|102137106|FG000|COMPLETED|Open-label Phase||5||
48735672|NCT02937558|102137107|FG001|COMPLETED|Open-label Phase||0||
48735673|NCT02937558|102137106|FG000|NOT COMPLETED|Open-label Phase||0||
48735674|NCT02937558|102137107|FG001|NOT COMPLETED|Open-label Phase||0||
48735675|NCT02478164|102137108|FG000|STARTED|Overall Study||15||
48735676|NCT02478164|102137108|FG000|COMPLETED|Overall Study||0||
48735677|NCT02478164|102137108|FG000|NOT COMPLETED|Overall Study||15||
48735678|NCT02806960|102137109|FG000|STARTED|Period 1||3||
48735679|NCT02806960|102137110|FG001|STARTED|Period 1||3||
48735680|NCT02806960|102137111|FG002|STARTED|Period 1||3||
48735681|NCT02806960|102137112|FG003|STARTED|Period 1||3||
48735682|NCT02806960|102137109|FG000|COMPLETED|Period 1||0||
48735683|NCT02806960|102137110|FG001|COMPLETED|Period 1||0||
48735684|NCT02806960|102137111|FG002|COMPLETED|Period 1||0||
48735685|NCT02806960|102137112|FG003|COMPLETED|Period 1||0||
48735686|NCT02806960|102137109|FG000|NOT COMPLETED|Period 1||3||
48735687|NCT02806960|102137110|FG001|NOT COMPLETED|Period 1||3||
48735688|NCT02806960|102137111|FG002|NOT COMPLETED|Period 1||3||
48735689|NCT02806960|102137112|FG003|NOT COMPLETED|Period 1||3||
48735690|NCT02806960|102137109|FG000|STARTED|Period 2||0||
48735691|NCT02806960|102137110|FG001|STARTED|Period 2||0||
48735692|NCT02806960|102137111|FG002|STARTED|Period 2||0||
48735693|NCT02806960|102137112|FG003|STARTED|Period 2||0||
48735694|NCT02806960|102137109|FG000|COMPLETED|Period 2||0||
48735695|NCT02806960|102137110|FG001|COMPLETED|Period 2||0||
48735696|NCT02806960|102137111|FG002|COMPLETED|Period 2||0||
48735697|NCT02806960|102137112|FG003|COMPLETED|Period 2||0||
48735698|NCT02806960|102137109|FG000|NOT COMPLETED|Period 2||0||
48735699|NCT02806960|102137110|FG001|NOT COMPLETED|Period 2||0||
48735700|NCT02806960|102137111|FG002|NOT COMPLETED|Period 2||0||
48735701|NCT02806960|102137112|FG003|NOT COMPLETED|Period 2||0||
48735702|NCT02806960|102137109|FG000|STARTED|Period 3||0||
48735703|NCT02806960|102137110|FG001|STARTED|Period 3||0||
48735704|NCT02806960|102137111|FG002|STARTED|Period 3||0||
48735705|NCT02806960|102137112|FG003|STARTED|Period 3||0||
48735706|NCT02806960|102137109|FG000|COMPLETED|Period 3||0||
48735707|NCT02806960|102137110|FG001|COMPLETED|Period 3||0||
48735708|NCT02806960|102137111|FG002|COMPLETED|Period 3||0||
48735709|NCT02806960|102137112|FG003|COMPLETED|Period 3||0||
48735710|NCT02806960|102137109|FG000|NOT COMPLETED|Period 3||0||
48735711|NCT02806960|102137110|FG001|NOT COMPLETED|Period 3||0||
48735712|NCT02806960|102137111|FG002|NOT COMPLETED|Period 3||0||
48735713|NCT02806960|102137112|FG003|NOT COMPLETED|Period 3||0||
48735714|NCT02806960|102137109|FG000|STARTED|Period 4||0||
48735715|NCT02806960|102137110|FG001|STARTED|Period 4||0||
48735716|NCT02806960|102137111|FG002|STARTED|Period 4||0||
48735717|NCT02806960|102137112|FG003|STARTED|Period 4||0||
48735718|NCT02806960|102137109|FG000|COMPLETED|Period 4||0||
48735719|NCT02806960|102137110|FG001|COMPLETED|Period 4||0||
48735720|NCT02806960|102137111|FG002|COMPLETED|Period 4||0||
48735721|NCT02806960|102137112|FG003|COMPLETED|Period 4||0||
48735722|NCT02806960|102137109|FG000|NOT COMPLETED|Period 4||0||
48735723|NCT02806960|102137110|FG001|NOT COMPLETED|Period 4||0||
48735724|NCT02806960|102137111|FG002|NOT COMPLETED|Period 4||0||
48735725|NCT02806960|102137112|FG003|NOT COMPLETED|Period 4||0||
48735726|NCT04016259|102137113|FG000|STARTED|Overall Study||15||
48735727|NCT04016259|102137114|FG001|STARTED|Overall Study||15||
48735728|NCT04016259|102137113|FG000|COMPLETED|Overall Study||15||
48735729|NCT04016259|102137114|FG001|COMPLETED|Overall Study||15||
48735730|NCT04016259|102137113|FG000|NOT COMPLETED|Overall Study||0||
48735731|NCT04016259|102137114|FG001|NOT COMPLETED|Overall Study||0||
48735732|NCT00934128|102137115|FG000|STARTED|First Intervention (2 Hours)||15||
48160216|NCT04128293|100715819|FG000|STARTED|Washout Period 1 (Up to 7 Days)||4||
48407191|NCT03073200|101328515|FG004|NOT COMPLETED|Extension Period||0||
48407192|NCT03073200|101328516|FG005|NOT COMPLETED|Extension Period||0||
48407193|NCT03073200|101328517|FG006|NOT COMPLETED|Extension Period||3||
48407194|NCT03073200|101328518|FG007|NOT COMPLETED|Extension Period||6||
48407195|NCT03073200|101328519|FG008|NOT COMPLETED|Extension Period||2||
48615936|NCT02620787|101845021|FG001|STARTED|Overall Study||6||
48160217|NCT04128293|100715820|FG001|STARTED|Washout Period 1 (Up to 7 Days)||4||
48160218|NCT04128293|100715821|FG002|STARTED|Washout Period 1 (Up to 7 Days)||4||
48160219|NCT04128293|100715822|FG003|STARTED|Washout Period 1 (Up to 7 Days)||4||
48160220|NCT04128293|100715819|FG000|COMPLETED|Washout Period 1 (Up to 7 Days)||4||
48160221|NCT04128293|100715820|FG001|COMPLETED|Washout Period 1 (Up to 7 Days)||4||
48160222|NCT04128293|100715821|FG002|COMPLETED|Washout Period 1 (Up to 7 Days)||4||
48160223|NCT04128293|100715822|FG003|COMPLETED|Washout Period 1 (Up to 7 Days)||4||
48160224|NCT04128293|100715819|FG000|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0||
48160225|NCT04128293|100715820|FG001|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0||
48160226|NCT04128293|100715821|FG002|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0||
48160227|NCT04128293|100715822|FG003|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0||
48160228|NCT04128293|100715819|FG000|STARTED|Treatment Period 2 (1 Day)||4||
48160229|NCT04128293|100715820|FG001|STARTED|Treatment Period 2 (1 Day)||4||
48160230|NCT04128293|100715821|FG002|STARTED|Treatment Period 2 (1 Day)||4||
48160231|NCT04128293|100715822|FG003|STARTED|Treatment Period 2 (1 Day)||4||
48160232|NCT04128293|100715819|FG000|COMPLETED|Treatment Period 2 (1 Day)||4||
48160233|NCT04128293|100715820|FG001|COMPLETED|Treatment Period 2 (1 Day)||4||
48160234|NCT04128293|100715821|FG002|COMPLETED|Treatment Period 2 (1 Day)||4||
48160235|NCT04128293|100715822|FG003|COMPLETED|Treatment Period 2 (1 Day)||4||
48160236|NCT04128293|100715819|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
48160237|NCT04128293|100715820|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
48160238|NCT04128293|100715821|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
48160239|NCT04128293|100715822|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
48407196|NCT03073200|101328520|FG009|NOT COMPLETED|Extension Period||0||
48407197|NCT03073200|101328521|FG010|NOT COMPLETED|Extension Period||0||
48407198|NCT03073200|101328522|FG011|NOT COMPLETED|Extension Period||0||
48615937|NCT02620787|101845020|FG000|COMPLETED|Overall Study||10||
48615938|NCT02620787|101845021|FG001|COMPLETED|Overall Study||6||
48615939|NCT02620787|101845020|FG000|NOT COMPLETED|Overall Study||2||
48615940|NCT02620787|101845021|FG001|NOT COMPLETED|Overall Study||0||
48615941|NCT03870334|101845022|FG000|STARTED|Overall Study||12||
48615942|NCT03870334|101845023|FG001|STARTED|Overall Study||11||
48615943|NCT03870334|101845022|FG000|COMPLETED|Overall Study||12||
48615944|NCT03870334|101845023|FG001|COMPLETED|Overall Study||11||
48615945|NCT03870334|101845022|FG000|NOT COMPLETED|Overall Study||0||
48615946|NCT03870334|101845023|FG001|NOT COMPLETED|Overall Study||0||
48615947|NCT01158261|101845024|FG000|STARTED|Overall Study||300||
48615948|NCT01158261|101845024|FG000|COMPLETED|Overall Study||283||
48615949|NCT01158261|101845024|FG000|NOT COMPLETED|Overall Study||17||
48615950|NCT01144455|101845025|FG000|STARTED|Overall Study||69||
48615951|NCT01144455|101845026|FG001|STARTED|Overall Study||71||
48615952|NCT01144455|101845027|FG002|STARTED|Overall Study||74||
48615953|NCT01144455|101845025|FG000|COMPLETED|Overall Study||19||
48615954|NCT01144455|101845026|FG001|COMPLETED|Overall Study||29||
48615955|NCT01144455|101845027|FG002|COMPLETED|Overall Study||38||
48615956|NCT01144455|101845025|FG000|NOT COMPLETED|Overall Study||50||
48615957|NCT01144455|101845026|FG001|NOT COMPLETED|Overall Study||42||
48615958|NCT01144455|101845027|FG002|NOT COMPLETED|Overall Study||36||
48615959|NCT00803712|101845028|FG000|STARTED|Overall Study||154||
48615960|NCT00803712|101845029|FG001|STARTED|Overall Study||155||
48615961|NCT00803712|101845028|FG000|Full Analysis Set|Overall Study||153||
48615962|NCT00803712|101845029|FG001|Full Analysis Set|Overall Study||151||
48615963|NCT00803712|101845028|FG000|Safety Analysis Set|Overall Study||155||
48615964|NCT00803712|101845029|FG001|Safety Analysis Set|Overall Study||154||
48615965|NCT00803712|101845028|FG000|COMPLETED|Overall Study||118||
48615966|NCT00803712|101845029|FG001|COMPLETED|Overall Study||128||
48615967|NCT00803712|101845028|FG000|NOT COMPLETED|Overall Study||36||
48615968|NCT00803712|101845029|FG001|NOT COMPLETED|Overall Study||27||
48615969|NCT00954122|101845030|FG000|STARTED|Overall Study||35||
48615970|NCT00954122|101845030|FG000|COMPLETED|Overall Study||28||
48615971|NCT00954122|101845030|FG000|NOT COMPLETED|Overall Study||7||
48160240|NCT04128293|100715819|FG000|STARTED|Washout Period 2 (Up to 7 Days)||4||
48160241|NCT04128293|100715820|FG001|STARTED|Washout Period 2 (Up to 7 Days)||4||
48160242|NCT04128293|100715821|FG002|STARTED|Washout Period 2 (Up to 7 Days)||4||
48160243|NCT04128293|100715822|FG003|STARTED|Washout Period 2 (Up to 7 Days)||4||
48160244|NCT04128293|100715819|FG000|COMPLETED|Washout Period 2 (Up to 7 Days)||0||
48160245|NCT04128293|100715820|FG001|COMPLETED|Washout Period 2 (Up to 7 Days)||0||
48160246|NCT04128293|100715821|FG002|COMPLETED|Washout Period 2 (Up to 7 Days)||0||
48160247|NCT04128293|100715822|FG003|COMPLETED|Washout Period 2 (Up to 7 Days)||0||
48160248|NCT04128293|100715819|FG000|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4||
48160249|NCT04128293|100715820|FG001|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4||
48160250|NCT04128293|100715821|FG002|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4||
48160251|NCT04128293|100715822|FG003|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4||
48160252|NCT04128293|100715819|FG000|STARTED|Treatment Period 3 (1 Day)||0||
48160253|NCT04128293|100715820|FG001|STARTED|Treatment Period 3 (1 Day)||0||
48160254|NCT04128293|100715821|FG002|STARTED|Treatment Period 3 (1 Day)||0||
48160255|NCT04128293|100715822|FG003|STARTED|Treatment Period 3 (1 Day)||0||
48160256|NCT04128293|100715819|FG000|COMPLETED|Treatment Period 3 (1 Day)||0||
48160257|NCT04128293|100715820|FG001|COMPLETED|Treatment Period 3 (1 Day)||0||
48160258|NCT04128293|100715821|FG002|COMPLETED|Treatment Period 3 (1 Day)||0||
48160259|NCT04128293|100715822|FG003|COMPLETED|Treatment Period 3 (1 Day)||0||
48160260|NCT04128293|100715819|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
48160261|NCT04128293|100715820|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
48160262|NCT04128293|100715821|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
48615972|NCT01129245|101845031|FG000|STARTED|Control Cycle (no Celecoxib or Placebo)||10||
48615973|NCT01129245|101845032|FG001|STARTED|Control Cycle (no Celecoxib or Placebo)||10||
48615974|NCT01129245|101845031|FG000|COMPLETED|Control Cycle (no Celecoxib or Placebo)||10||
48615975|NCT01129245|101845032|FG001|COMPLETED|Control Cycle (no Celecoxib or Placebo)||10||
48615976|NCT01129245|101845031|FG000|NOT COMPLETED|Control Cycle (no Celecoxib or Placebo)||0||
48615977|NCT01129245|101845032|FG001|NOT COMPLETED|Control Cycle (no Celecoxib or Placebo)||0||
48615978|NCT01129245|101845031|FG000|STARTED|Treatment Cycle 1||10||
48615979|NCT01129245|101845032|FG001|STARTED|Treatment Cycle 1||10||
48615980|NCT01129245|101845031|FG000|COMPLETED|Treatment Cycle 1||10||
48615981|NCT01129245|101845032|FG001|COMPLETED|Treatment Cycle 1||10||
48615982|NCT01129245|101845031|FG000|NOT COMPLETED|Treatment Cycle 1||0||
48615983|NCT01129245|101845032|FG001|NOT COMPLETED|Treatment Cycle 1||0||
48615984|NCT01129245|101845031|FG000|STARTED|Washout Cycle||10||
48615985|NCT01129245|101845032|FG001|STARTED|Washout Cycle||10||
48615986|NCT01129245|101845031|FG000|COMPLETED|Washout Cycle||10||
48615987|NCT01129245|101845032|FG001|COMPLETED|Washout Cycle||10||
48615988|NCT01129245|101845031|FG000|NOT COMPLETED|Washout Cycle||0||
48615989|NCT01129245|101845032|FG001|NOT COMPLETED|Washout Cycle||0||
48160263|NCT04128293|100715822|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
48160264|NCT04128293|100715819|FG000|STARTED|Washout Period 3 (Up to 7 Days)||0||
48160265|NCT04128293|100715820|FG001|STARTED|Washout Period 3 (Up to 7 Days)||0||
48160266|NCT04128293|100715821|FG002|STARTED|Washout Period 3 (Up to 7 Days)||0||
48160267|NCT04128293|100715822|FG003|STARTED|Washout Period 3 (Up to 7 Days)||0||
48160268|NCT04128293|100715819|FG000|COMPLETED|Washout Period 3 (Up to 7 Days)||0||
48160269|NCT04128293|100715820|FG001|COMPLETED|Washout Period 3 (Up to 7 Days)||0||
48160270|NCT04128293|100715821|FG002|COMPLETED|Washout Period 3 (Up to 7 Days)||0||
48160271|NCT04128293|100715822|FG003|COMPLETED|Washout Period 3 (Up to 7 Days)||0||
48160272|NCT04128293|100715819|FG000|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0||
48160273|NCT04128293|100715820|FG001|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0||
48160274|NCT04128293|100715821|FG002|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0||
48160275|NCT04128293|100715822|FG003|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0||
48160276|NCT04128293|100715819|FG000|STARTED|Treatment Period 4 (1 Day)||0||
48160277|NCT04128293|100715820|FG001|STARTED|Treatment Period 4 (1 Day)||0||
48160278|NCT04128293|100715821|FG002|STARTED|Treatment Period 4 (1 Day)||0||
48160279|NCT04128293|100715822|FG003|STARTED|Treatment Period 4 (1 Day)||0||
48160280|NCT04128293|100715819|FG000|COMPLETED|Treatment Period 4 (1 Day)||0||
48160281|NCT04128293|100715820|FG001|COMPLETED|Treatment Period 4 (1 Day)||0||
48160282|NCT04128293|100715821|FG002|COMPLETED|Treatment Period 4 (1 Day)||0||
48160283|NCT04128293|100715822|FG003|COMPLETED|Treatment Period 4 (1 Day)||0||
48160284|NCT04128293|100715819|FG000|NOT COMPLETED|Treatment Period 4 (1 Day)||0||
48160285|NCT04128293|100715820|FG001|NOT COMPLETED|Treatment Period 4 (1 Day)||0||
48160286|NCT04128293|100715821|FG002|NOT COMPLETED|Treatment Period 4 (1 Day)||0||
48160287|NCT04128293|100715822|FG003|NOT COMPLETED|Treatment Period 4 (1 Day)||0||
48160288|NCT00530803|100715823|FG000|STARTED|Overall Study||50||
48160289|NCT00530803|100715824|FG001|STARTED|Overall Study||50||
48160290|NCT00530803|100715823|FG000|COMPLETED|Overall Study||50||
48160291|NCT00530803|100715824|FG001|COMPLETED|Overall Study||50||
48160292|NCT00530803|100715823|FG000|NOT COMPLETED|Overall Study||0||
48160293|NCT00530803|100715824|FG001|NOT COMPLETED|Overall Study||0||
48160294|NCT02124889|100715825|FG000|STARTED|Overall Study||12||
48615990|NCT01129245|101845031|FG000|STARTED|Treatment Cycle 2||10||
48615991|NCT01129245|101845032|FG001|STARTED|Treatment Cycle 2||10||
48615992|NCT01129245|101845031|FG000|COMPLETED|Treatment Cycle 2||10||
48615993|NCT01129245|101845032|FG001|COMPLETED|Treatment Cycle 2||10||
48615994|NCT01129245|101845031|FG000|NOT COMPLETED|Treatment Cycle 2||0||
48615995|NCT01129245|101845032|FG001|NOT COMPLETED|Treatment Cycle 2||0||
48615996|NCT00705757|101845033|FG000|STARTED|Overall Study||32||
48615997|NCT00705757|101845034|FG001|STARTED|Overall Study||29||
48615998|NCT00705757|101845035|FG002|STARTED|Overall Study||28||
48615999|NCT00705757|101845033|FG000|COMPLETED|Overall Study||19||
48616000|NCT00705757|101845034|FG001|COMPLETED|Overall Study||21||
48616001|NCT00705757|101845035|FG002|COMPLETED|Overall Study||17||
48616002|NCT00705757|101845033|FG000|NOT COMPLETED|Overall Study||13||
48616003|NCT00705757|101845034|FG001|NOT COMPLETED|Overall Study||8||
48616004|NCT00705757|101845035|FG002|NOT COMPLETED|Overall Study||11||
48616005|NCT02493517|101845036|FG000|STARTED|Overall Study||64||
48317726|NCT00549939|101104100|FG002|STARTED|12-week Double Blind Treatment Period||58||
48317727|NCT00549939|101104098|FG000|COMPLETED|12-week Double Blind Treatment Period||56||
48317728|NCT00549939|101104099|FG001|COMPLETED|12-week Double Blind Treatment Period||55||
48160295|NCT02124889|100715826|FG001|STARTED|Overall Study||12||
48160296|NCT02124889|100715825|FG000|COMPLETED|Overall Study||12||
48160297|NCT02124889|100715826|FG001|COMPLETED|Overall Study||12||
48160298|NCT02124889|100715825|FG000|NOT COMPLETED|Overall Study||0||
48160299|NCT02124889|100715826|FG001|NOT COMPLETED|Overall Study||0||
48160300|NCT00524030|100715827|FG000|STARTED|Overall Study||32||
48160301|NCT00524030|100715828|FG001|STARTED|Overall Study||129||
48160302|NCT00524030|100715827|FG000|Completed Double-Blind Treatment Phase|Overall Study||15||
48160303|NCT00524030|100715828|FG001|Completed Double-Blind Treatment Phase|Overall Study||70||
48160304|NCT00524030|100715827|FG000|Completed Taper/Titration Phase|Overall Study||15||
48160305|NCT00524030|100715828|FG001|Completed Taper/Titration Phase|Overall Study||70||
48160306|NCT00524030|100715827|FG000|COMPLETED|Overall Study||15||
48160307|NCT00524030|100715828|FG001|COMPLETED|Overall Study||70||
48160308|NCT00524030|100715827|FG000|NOT COMPLETED|Overall Study||17||
48160309|NCT00524030|100715828|FG001|NOT COMPLETED|Overall Study||59||
48317729|NCT00549939|101104100|FG002|COMPLETED|12-week Double Blind Treatment Period||56||
48317730|NCT00549939|101104098|FG000|NOT COMPLETED|12-week Double Blind Treatment Period||1||
48317731|NCT00549939|101104099|FG001|NOT COMPLETED|12-week Double Blind Treatment Period||2||
48317732|NCT00549939|101104100|FG002|NOT COMPLETED|12-week Double Blind Treatment Period||2||
48317733|NCT00549939|101104098|FG000|STARTED|40-week Open Label Treatment Period||0||
48317734|NCT00549939|101104099|FG001|STARTED|40-week Open Label Treatment Period||80||
48317735|NCT00549939|101104100|FG002|STARTED|40-week Open Label Treatment Period||83||
48317736|NCT00549939|101104098|FG000|COMPLETED|40-week Open Label Treatment Period||0||
48317737|NCT00549939|101104099|FG001|COMPLETED|40-week Open Label Treatment Period||75||
48317738|NCT00549939|101104100|FG002|COMPLETED|40-week Open Label Treatment Period||78||
48317739|NCT00549939|101104098|FG000|NOT COMPLETED|40-week Open Label Treatment Period||0||
48317740|NCT00549939|101104099|FG001|NOT COMPLETED|40-week Open Label Treatment Period||5||
48317741|NCT00549939|101104100|FG002|NOT COMPLETED|40-week Open Label Treatment Period||5||
48317742|NCT03901079|101104101|FG000|STARTED|Overall Study||20||
48407199|NCT03073200|101328523|FG012|NOT COMPLETED|Extension Period||0||
48407200|NCT03073200|101328524|FG013|NOT COMPLETED|Extension Period||0||
48407201|NCT03073200|101328525|FG014|NOT COMPLETED|Extension Period||0||
48407202|NCT03073200|101328511|FG000|STARTED|Randomized Withdrawal Period||0||
48407203|NCT03073200|101328512|FG001|STARTED|Randomized Withdrawal Period||0||
48407204|NCT03073200|101328513|FG002|STARTED|Randomized Withdrawal Period||0||
48407205|NCT03073200|101328514|FG003|STARTED|Randomized Withdrawal Period||0||
48407206|NCT03073200|101328515|FG004|STARTED|Randomized Withdrawal Period||0||
48407207|NCT03073200|101328516|FG005|STARTED|Randomized Withdrawal Period||0||
48407208|NCT03073200|101328517|FG006|STARTED|Randomized Withdrawal Period||0||
48407209|NCT03073200|101328518|FG007|STARTED|Randomized Withdrawal Period||0||
48407210|NCT03073200|101328519|FG008|STARTED|Randomized Withdrawal Period||0||
48317743|NCT03901079|101104101|FG000|COMPLETED|Overall Study||12||
48407211|NCT03073200|101328520|FG009|STARTED|Randomized Withdrawal Period||33||
48407212|NCT03073200|101328521|FG010|STARTED|Randomized Withdrawal Period||34||
48616006|NCT02493517|101845037|FG001|STARTED|Overall Study||64||
48616007|NCT02493517|101845036|FG000|COMPLETED|Overall Study||62||
48616008|NCT02493517|101845037|FG001|COMPLETED|Overall Study||57||
48317744|NCT03901079|101104101|FG000|NOT COMPLETED|Overall Study||8||
48317745|NCT00524342|101104102|FG000|STARTED|Overall Study||7||
48317746|NCT00524342|101104102|FG000|COMPLETED|Overall Study||7||
48317747|NCT00524342|101104102|FG000|NOT COMPLETED|Overall Study||0||
48317748|NCT02324920|101104103|FG000|STARTED|Overall Study||64||
48407213|NCT03073200|101328522|FG011|STARTED|Randomized Withdrawal Period||33||
48407214|NCT03073200|101328523|FG012|STARTED|Randomized Withdrawal Period||0||
48160310|NCT03761537|100715829|FG000|STARTED|Overall Study||140||
48160311|NCT03761537|100715830|FG001|STARTED|Overall Study||137||
48160312|NCT03761537|100715829|FG000|COMPLETED|Overall Study||125||
48160313|NCT03761537|100715830|FG001|COMPLETED|Overall Study||120||
48160314|NCT03761537|100715829|FG000|NOT COMPLETED|Overall Study||15||
48160315|NCT03761537|100715830|FG001|NOT COMPLETED|Overall Study||17||
48160316|NCT03171480|100715831|FG000|STARTED|Overall Study||89||
48160317|NCT03171480|100715832|FG001|STARTED|Overall Study||87||
48160318|NCT03171480|100715831|FG000|COMPLETED|Overall Study||89||
48160319|NCT03171480|100715832|FG001|COMPLETED|Overall Study||87||
48160320|NCT03171480|100715831|FG000|NOT COMPLETED|Overall Study||0||
48160321|NCT03171480|100715832|FG001|NOT COMPLETED|Overall Study||0||
48160322|NCT01712009|100715833|FG000|STARTED|Overall Study||198||
48160323|NCT01712009|100715834|FG001|STARTED|Overall Study||200||
48160324|NCT01712009|100715835|FG002|STARTED|Overall Study||202||
48407215|NCT03073200|101328524|FG013|STARTED|Randomized Withdrawal Period||0||
48160325|NCT01712009|100715833|FG000|Received Pegfilgrastim|Overall Study||191||
48160326|NCT01712009|100715834|FG001|Received Pegfilgrastim|Overall Study||196||
48160327|NCT01712009|100715835|FG002|Received Pegfilgrastim|Overall Study||200||
48188747|NCT01033643|100783326|FG005|NOT COMPLETED|Overall Study||1||
48407216|NCT03073200|101328525|FG014|STARTED|Randomized Withdrawal Period||0||
48407217|NCT03073200|101328511|FG000|COMPLETED|Randomized Withdrawal Period||0||
48407218|NCT03073200|101328512|FG001|COMPLETED|Randomized Withdrawal Period||0||
48407219|NCT03073200|101328513|FG002|COMPLETED|Randomized Withdrawal Period||0||
48407220|NCT03073200|101328514|FG003|COMPLETED|Randomized Withdrawal Period||0||
48407221|NCT03073200|101328515|FG004|COMPLETED|Randomized Withdrawal Period||0||
48407222|NCT03073200|101328516|FG005|COMPLETED|Randomized Withdrawal Period||0||
48317749|NCT02324920|101104104|FG001|STARTED|Overall Study||64||
48317750|NCT02324920|101104103|FG000|COMPLETED|Overall Study||63||
48317751|NCT02324920|101104104|FG001|COMPLETED|Overall Study||64||
48317752|NCT02324920|101104103|FG000|NOT COMPLETED|Overall Study||1||
48317753|NCT02324920|101104104|FG001|NOT COMPLETED|Overall Study||0||
48317754|NCT03427047|101104105|FG000|STARTED|Overall Study||46||
48317755|NCT03427047|101104106|FG001|STARTED|Overall Study||36||
48317756|NCT03427047|101104105|FG000|COMPLETED|Overall Study||46||
48317757|NCT03427047|101104106|FG001|COMPLETED|Overall Study||34||
48317758|NCT03427047|101104105|FG000|NOT COMPLETED|Overall Study||0||
48317759|NCT03427047|101104106|FG001|NOT COMPLETED|Overall Study||2||
48317760|NCT01087775|101104107|FG000|STARTED|Overall Study||25||
48317761|NCT01087775|101104107|FG000|COMPLETED|Overall Study||23||
48407223|NCT03073200|101328517|FG006|COMPLETED|Randomized Withdrawal Period||0||
48407224|NCT03073200|101328518|FG007|COMPLETED|Randomized Withdrawal Period||0||
48407225|NCT03073200|101328519|FG008|COMPLETED|Randomized Withdrawal Period||0||
48407226|NCT03073200|101328520|FG009|COMPLETED|Randomized Withdrawal Period||33||
48407227|NCT03073200|101328521|FG010|COMPLETED|Randomized Withdrawal Period||32||
48407228|NCT03073200|101328522|FG011|COMPLETED|Randomized Withdrawal Period||30||
48407229|NCT03073200|101328523|FG012|COMPLETED|Randomized Withdrawal Period||0||
48407230|NCT03073200|101328524|FG013|COMPLETED|Randomized Withdrawal Period||0||
48407231|NCT03073200|101328525|FG014|COMPLETED|Randomized Withdrawal Period||0||
48407232|NCT03073200|101328511|FG000|NOT COMPLETED|Randomized Withdrawal Period||0||
48407233|NCT03073200|101328512|FG001|NOT COMPLETED|Randomized Withdrawal Period||0||
48407234|NCT03073200|101328513|FG002|NOT COMPLETED|Randomized Withdrawal Period||0||
48735733|NCT00934128|102137116|FG001|STARTED|First Intervention (2 Hours)||15||
48735734|NCT00934128|102137115|FG000|COMPLETED|First Intervention (2 Hours)||10||
48735735|NCT00934128|102137116|FG001|COMPLETED|First Intervention (2 Hours)||13||
48735736|NCT00934128|102137115|FG000|NOT COMPLETED|First Intervention (2 Hours)||5||
48735737|NCT00934128|102137116|FG001|NOT COMPLETED|First Intervention (2 Hours)||2||
48735738|NCT00934128|102137115|FG000|STARTED|Washout Period (1 Hour)||10||
48735739|NCT00934128|102137116|FG001|STARTED|Washout Period (1 Hour)||13||
48735740|NCT00934128|102137115|FG000|COMPLETED|Washout Period (1 Hour)||3||
48735741|NCT00934128|102137116|FG001|COMPLETED|Washout Period (1 Hour)||8||
48735742|NCT00934128|102137115|FG000|NOT COMPLETED|Washout Period (1 Hour)||7||
48735743|NCT00934128|102137116|FG001|NOT COMPLETED|Washout Period (1 Hour)||5||
48735744|NCT00934128|102137115|FG000|STARTED|Second Intervention (2 Hours)||3||
48735745|NCT00934128|102137116|FG001|STARTED|Second Intervention (2 Hours)||8||
48735746|NCT00934128|102137115|FG000|COMPLETED|Second Intervention (2 Hours)||3||
48735747|NCT00934128|102137116|FG001|COMPLETED|Second Intervention (2 Hours)||5||
48735748|NCT00934128|102137115|FG000|NOT COMPLETED|Second Intervention (2 Hours)||0||
48317762|NCT01087775|101104107|FG000|NOT COMPLETED|Overall Study||2||
48317763|NCT00094770|101104108|FG000|STARTED|Year 1 ( Week 0 to Week 52)||588||
48407235|NCT03073200|101328514|FG003|NOT COMPLETED|Randomized Withdrawal Period||0||
48407236|NCT03073200|101328515|FG004|NOT COMPLETED|Randomized Withdrawal Period||0||
48407237|NCT03073200|101328516|FG005|NOT COMPLETED|Randomized Withdrawal Period||0||
48407238|NCT03073200|101328517|FG006|NOT COMPLETED|Randomized Withdrawal Period||0||
48407239|NCT03073200|101328518|FG007|NOT COMPLETED|Randomized Withdrawal Period||0||
48407240|NCT03073200|101328519|FG008|NOT COMPLETED|Randomized Withdrawal Period||0||
48317764|NCT00094770|101104109|FG001|STARTED|Year 1 ( Week 0 to Week 52)||584||
48317765|NCT00094770|101104108|FG000|COMPLETED|Year 1 ( Week 0 to Week 52)||386||
48317766|NCT00094770|101104109|FG001|COMPLETED|Year 1 ( Week 0 to Week 52)||412||
48317767|NCT00094770|101104108|FG000|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||202||
48317768|NCT00094770|101104109|FG001|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||172||
48317769|NCT00094770|101104108|FG000|STARTED|Year 2 (Week 0 to Week 104)||588||
48317770|NCT00094770|101104109|FG001|STARTED|Year 2 (Week 0 to Week 104)||584||
48317771|NCT00094770|101104108|FG000|COMPLETED|Year 2 (Week 0 to Week 104)||255||
48317772|NCT00094770|101104109|FG001|COMPLETED|Year 2 (Week 0 to Week 104)||264||
48317773|NCT00094770|101104108|FG000|NOT COMPLETED|Year 2 (Week 0 to Week 104)||333||
48407241|NCT03073200|101328520|FG009|NOT COMPLETED|Randomized Withdrawal Period||0||
48317774|NCT00094770|101104109|FG001|NOT COMPLETED|Year 2 (Week 0 to Week 104)||320||
48317775|NCT03186677|101104110|FG000|STARTED|Period 1||3||
48317776|NCT03186677|101104111|FG001|STARTED|Period 1||3||
48317777|NCT03186677|101104112|FG002|STARTED|Period 1||3||
48317778|NCT03186677|101104113|FG003|STARTED|Period 1||0||
48407242|NCT03073200|101328521|FG010|NOT COMPLETED|Randomized Withdrawal Period||2||
48735749|NCT00934128|102137116|FG001|NOT COMPLETED|Second Intervention (2 Hours)||3||
48317779|NCT03186677|101104114|FG004|STARTED|Period 1||0||
48317780|NCT03186677|101104110|FG000|COMPLETED|Period 1||3||
48317781|NCT03186677|101104111|FG001|COMPLETED|Period 1||3||
48317782|NCT03186677|101104112|FG002|COMPLETED|Period 1||3||
48407243|NCT03073200|101328522|FG011|NOT COMPLETED|Randomized Withdrawal Period||3||
48317783|NCT03186677|101104113|FG003|COMPLETED|Period 1||0||
48317784|NCT03186677|101104114|FG004|COMPLETED|Period 1||0||
48317785|NCT03186677|101104110|FG000|NOT COMPLETED|Period 1||0||
48317786|NCT03186677|101104111|FG001|NOT COMPLETED|Period 1||0||
48317787|NCT03186677|101104112|FG002|NOT COMPLETED|Period 1||0||
48317788|NCT03186677|101104113|FG003|NOT COMPLETED|Period 1||0||
48317789|NCT03186677|101104114|FG004|NOT COMPLETED|Period 1||0||
48317790|NCT03186677|101104110|FG000|STARTED|Period 2||0||
48407244|NCT03073200|101328523|FG012|NOT COMPLETED|Randomized Withdrawal Period||0||
48407245|NCT03073200|101328524|FG013|NOT COMPLETED|Randomized Withdrawal Period||0||
48407246|NCT03073200|101328525|FG014|NOT COMPLETED|Randomized Withdrawal Period||0||
48407247|NCT03073200|101328511|FG000|STARTED|Post-Treatment Follow-Up Period||0||
48407248|NCT03073200|101328512|FG001|STARTED|Post-Treatment Follow-Up Period||0||
48407249|NCT03073200|101328513|FG002|STARTED|Post-Treatment Follow-Up Period||0||
48407250|NCT03073200|101328514|FG003|STARTED|Post-Treatment Follow-Up Period||0||
48407251|NCT03073200|101328515|FG004|STARTED|Post-Treatment Follow-Up Period||0||
48407252|NCT03073200|101328516|FG005|STARTED|Post-Treatment Follow-Up Period||0||
48407253|NCT03073200|101328517|FG006|STARTED|Post-Treatment Follow-Up Period||0||
48407254|NCT03073200|101328518|FG007|STARTED|Post-Treatment Follow-Up Period||0||
48407255|NCT03073200|101328519|FG008|STARTED|Post-Treatment Follow-Up Period||0||
48407256|NCT03073200|101328520|FG009|STARTED|Post-Treatment Follow-Up Period||0||
48407257|NCT03073200|101328521|FG010|STARTED|Post-Treatment Follow-Up Period||0||
48407258|NCT03073200|101328522|FG011|STARTED|Post-Treatment Follow-Up Period||0||
48407259|NCT03073200|101328523|FG012|STARTED|Post-Treatment Follow-Up Period||6||
48407260|NCT03073200|101328524|FG013|STARTED|Post-Treatment Follow-Up Period||166||
48407261|NCT03073200|101328525|FG014|STARTED|Post-Treatment Follow-Up Period||2||
48407262|NCT03073200|101328511|FG000|COMPLETED|Post-Treatment Follow-Up Period||0||
48407263|NCT03073200|101328512|FG001|COMPLETED|Post-Treatment Follow-Up Period||0||
48407264|NCT03073200|101328513|FG002|COMPLETED|Post-Treatment Follow-Up Period||0||
48407265|NCT03073200|101328514|FG003|COMPLETED|Post-Treatment Follow-Up Period||0||
48407266|NCT03073200|101328515|FG004|COMPLETED|Post-Treatment Follow-Up Period||0||
48407267|NCT03073200|101328516|FG005|COMPLETED|Post-Treatment Follow-Up Period||0||
48407268|NCT03073200|101328517|FG006|COMPLETED|Post-Treatment Follow-Up Period||0||
48407269|NCT03073200|101328518|FG007|COMPLETED|Post-Treatment Follow-Up Period||0||
48407270|NCT03073200|101328519|FG008|COMPLETED|Post-Treatment Follow-Up Period||0||
48407271|NCT03073200|101328520|FG009|COMPLETED|Post-Treatment Follow-Up Period||0||
48407272|NCT03073200|101328521|FG010|COMPLETED|Post-Treatment Follow-Up Period||0||
48407273|NCT03073200|101328522|FG011|COMPLETED|Post-Treatment Follow-Up Period||0||
48407274|NCT03073200|101328523|FG012|COMPLETED|Post-Treatment Follow-Up Period||6||
48407275|NCT03073200|101328524|FG013|COMPLETED|Post-Treatment Follow-Up Period||139||
48407276|NCT03073200|101328525|FG014|COMPLETED|Post-Treatment Follow-Up Period||1||
48407277|NCT03073200|101328511|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
48407278|NCT03073200|101328512|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
48407279|NCT03073200|101328513|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
48407280|NCT03073200|101328514|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
48407281|NCT03073200|101328515|FG004|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
48407282|NCT03073200|101328516|FG005|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
48407283|NCT03073200|101328517|FG006|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
48407284|NCT03073200|101328518|FG007|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
48407285|NCT03073200|101328519|FG008|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
48407286|NCT03073200|101328520|FG009|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
48407287|NCT03073200|101328521|FG010|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
48407288|NCT03073200|101328522|FG011|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
48407289|NCT03073200|101328523|FG012|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
48407290|NCT03073200|101328524|FG013|NOT COMPLETED|Post-Treatment Follow-Up Period||27||
48407291|NCT03073200|101328525|FG014|NOT COMPLETED|Post-Treatment Follow-Up Period||1||
48407292|NCT02736929|101328526|FG000|STARTED|Main Study||78||
48407293|NCT02736929|101328527|FG001|STARTED|Main Study||34||
48407294|NCT02736929|101328528|FG002|STARTED|Main Study||0||
48407295|NCT02736929|101328526|FG000|COMPLETED|Main Study||70||
48407296|NCT02736929|101328527|FG001|COMPLETED|Main Study||32||
48407297|NCT02736929|101328528|FG002|COMPLETED|Main Study||0||
48407298|NCT02736929|101328526|FG000|NOT COMPLETED|Main Study||8||
48407299|NCT02736929|101328527|FG001|NOT COMPLETED|Main Study||2||
48407300|NCT02736929|101328528|FG002|NOT COMPLETED|Main Study||0||
48407301|NCT02736929|101328526|FG000|STARTED|Optional Cross-Over||0||
48407302|NCT02736929|101328527|FG001|STARTED|Optional Cross-Over||0||
48407303|NCT02736929|101328528|FG002|STARTED|Optional Cross-Over||27||
48407304|NCT02736929|101328526|FG000|COMPLETED|Optional Cross-Over||0||
48407305|NCT02736929|101328527|FG001|COMPLETED|Optional Cross-Over||0||
48317791|NCT03186677|101104111|FG001|STARTED|Period 2||0||
48317792|NCT03186677|101104112|FG002|STARTED|Period 2||0||
48317793|NCT03186677|101104113|FG003|STARTED|Period 2||5||
48317794|NCT03186677|101104114|FG004|STARTED|Period 2||2||
48317795|NCT03186677|101104110|FG000|COMPLETED|Period 2||0||
48317796|NCT03186677|101104111|FG001|COMPLETED|Period 2||0||
48317797|NCT03186677|101104112|FG002|COMPLETED|Period 2||0||
48407306|NCT02736929|101328528|FG002|COMPLETED|Optional Cross-Over||21||
48407307|NCT02736929|101328526|FG000|NOT COMPLETED|Optional Cross-Over||0||
48407308|NCT02736929|101328527|FG001|NOT COMPLETED|Optional Cross-Over||0||
48407309|NCT02736929|101328528|FG002|NOT COMPLETED|Optional Cross-Over||6||
48407310|NCT01305941|101328529|FG000|STARTED|Overall Study||32||
48407311|NCT01305941|101328529|FG000|COMPLETED|Overall Study||22||
48407312|NCT01305941|101328529|FG000|NOT COMPLETED|Overall Study||10||
48407313|NCT00383266|101328530|FG000|STARTED|Overall Study||9||
48407314|NCT00383266|101328530|FG000|COMPLETED|Overall Study||9||
48407315|NCT00383266|101328530|FG000|NOT COMPLETED|Overall Study||0||
48407316|NCT00537771|101328531|FG000|STARTED|Overall Study||178||
48407317|NCT00537771|101328532|FG001|STARTED|Overall Study||175||
48407318|NCT00537771|101328531|FG000|COMPLETED|Overall Study||149||
48735750|NCT01769196|102137117|FG000|STARTED|Overall Study||272||
48735751|NCT01769196|102137118|FG001|STARTED|Overall Study||272||
48735752|NCT01769196|102137117|FG000|COMPLETED|Overall Study||0||
48735753|NCT01769196|102137118|FG001|COMPLETED|Overall Study||0||
48160328|NCT01712009|100715833|FG000|Received Naproxen / Loratadine|Overall Study||0||
48160329|NCT01712009|100715834|FG001|Received Naproxen / Loratadine|Overall Study||193||
48160330|NCT01712009|100715835|FG002|Received Naproxen / Loratadine|Overall Study||198||
48160331|NCT01712009|100715833|FG000|COMPLETED|Overall Study||160||
48160332|NCT01712009|100715834|FG001|COMPLETED|Overall Study||171||
48160333|NCT01712009|100715835|FG002|COMPLETED|Overall Study||181||
48160334|NCT01712009|100715833|FG000|NOT COMPLETED|Overall Study||38||
48160335|NCT01712009|100715834|FG001|NOT COMPLETED|Overall Study||29||
48160336|NCT01712009|100715835|FG002|NOT COMPLETED|Overall Study||21||
48160337|NCT02991482|100715836|FG000|STARTED|Overall Study||73||
48160338|NCT02991482|100715837|FG001|STARTED|Overall Study||71||
48160339|NCT02991482|100715836|FG000|Crossed-over to Pembrolizumab at Progression|Overall Study||0||
48160340|NCT02991482|100715837|FG001|Crossed-over to Pembrolizumab at Progression|Overall Study||45||
48160341|NCT02991482|100715836|FG000|COMPLETED|Overall Study||8||
48160342|NCT02991482|100715837|FG001|COMPLETED|Overall Study||5||
48160343|NCT02991482|100715836|FG000|NOT COMPLETED|Overall Study||65||
48160344|NCT02991482|100715837|FG001|NOT COMPLETED|Overall Study||66||
48160345|NCT01787097|100715838|FG000|STARTED|Overall Study||8||
48160346|NCT01787097|100715839|FG001|STARTED|Overall Study||7||
48160347|NCT01787097|100715840|FG002|STARTED|Overall Study||7||
48160348|NCT01787097|100715841|FG003|STARTED|Overall Study||9||
48160349|NCT01787097|100715838|FG000|COMPLETED|Overall Study||7||
48160350|NCT01787097|100715839|FG001|COMPLETED|Overall Study||7||
48160351|NCT01787097|100715840|FG002|COMPLETED|Overall Study||7||
48160352|NCT01787097|100715841|FG003|COMPLETED|Overall Study||9||
48160353|NCT01787097|100715838|FG000|NOT COMPLETED|Overall Study||1||
48160354|NCT01787097|100715839|FG001|NOT COMPLETED|Overall Study||0||
48160355|NCT01787097|100715840|FG002|NOT COMPLETED|Overall Study||0||
48160356|NCT01787097|100715841|FG003|NOT COMPLETED|Overall Study||0||
48160357|NCT03122119|100715842|FG000|STARTED|Overall Study||51||
48160358|NCT03122119|100715842|FG000|COMPLETED|Overall Study||50||
48160359|NCT03122119|100715842|FG000|NOT COMPLETED|Overall Study||1||
48160360|NCT00998400|100715843|FG000|STARTED|Overall Study||50||
48160361|NCT00998400|100715844|FG001|STARTED|Overall Study||50||
48160362|NCT00998400|100715843|FG000|COMPLETED|Overall Study||48||
48160363|NCT00998400|100715844|FG001|COMPLETED|Overall Study||48||
48160364|NCT00998400|100715843|FG000|NOT COMPLETED|Overall Study||2||
48160365|NCT00998400|100715844|FG001|NOT COMPLETED|Overall Study||2||
48160366|NCT02907814|100715845|FG000|STARTED|Overall Study||6||
48160367|NCT02907814|100715846|FG001|STARTED|Overall Study||0||
48160368|NCT02907814|100715845|FG000|COMPLETED|Overall Study||0||
48160369|NCT02907814|100715846|FG001|COMPLETED|Overall Study||0||
48160370|NCT02907814|100715845|FG000|NOT COMPLETED|Overall Study||6||
48160371|NCT02907814|100715846|FG001|NOT COMPLETED|Overall Study||0||
48407319|NCT00537771|101328532|FG001|COMPLETED|Overall Study||114||
48407320|NCT00537771|101328531|FG000|NOT COMPLETED|Overall Study||29||
48407321|NCT00537771|101328532|FG001|NOT COMPLETED|Overall Study||61||
48407322|NCT01807611|101328533|FG000|STARTED|Overall Study||82||
48407323|NCT01807611|101328533|FG000|COMPLETED|Overall Study||78||
48407324|NCT01807611|101328533|FG000|NOT COMPLETED|Overall Study||4||
48407325|NCT03296072|101328534|FG000|STARTED|Treatment Period 1||10||
48160372|NCT00695786|100715847|FG000|STARTED|Overall Study||2||
48160373|NCT00695786|100715848|FG001|STARTED|Overall Study||79||
48160374|NCT00695786|100715849|FG002|STARTED|Overall Study||31||
48160375|NCT00695786|100715850|FG003|STARTED|Overall Study||44||
48160376|NCT00695786|100715847|FG000|COMPLETED|Overall Study||1||
48160377|NCT00695786|100715848|FG001|COMPLETED|Overall Study||67||
48407326|NCT03296072|101328535|FG001|STARTED|Treatment Period 1||11||
48407327|NCT03296072|101328536|FG002|STARTED|Treatment Period 1||10||
48407328|NCT03296072|101328537|FG003|STARTED|Treatment Period 1||10||
48407329|NCT03296072|101328538|FG004|STARTED|Treatment Period 1||10||
48735754|NCT01769196|102137117|FG000|NOT COMPLETED|Overall Study||272||
48735755|NCT01769196|102137118|FG001|NOT COMPLETED|Overall Study||272||
48735756|NCT00385138|102137119|FG000|STARTED|Overall Study||2695||
48735757|NCT00385138|102137120|FG001|STARTED|Overall Study||2669||
48735758|NCT00385138|102137119|FG000|Intent-to-treat (ITT)|Overall Study||2693||
48735759|NCT00385138|102137120|FG001|Intent-to-treat (ITT)|Overall Study||2669||
48735760|NCT00385138|102137119|FG000|Modified Intent-to-treat (mITT)|Overall Study||2656||
48735761|NCT00385138|102137120|FG001|Modified Intent-to-treat (mITT)|Overall Study||2645||
48735762|NCT00385138|102137119|FG000|Safety Population|Overall Study||2662||
48735763|NCT00385138|102137120|FG001|Safety Population|Overall Study||2650||
48735764|NCT00385138|102137119|FG000|COMPLETED|Overall Study||2665||
48735765|NCT00385138|102137120|FG001|COMPLETED|Overall Study||2641||
48735766|NCT00385138|102137119|FG000|NOT COMPLETED|Overall Study||30||
48735767|NCT00385138|102137120|FG001|NOT COMPLETED|Overall Study||28||
48735768|NCT00225498|102137121|FG000|STARTED|Overall Study||10||
48735769|NCT00225498|102137121|FG000|COMPLETED|Overall Study||10||
48735770|NCT00225498|102137121|FG000|NOT COMPLETED|Overall Study||0||
48735771|NCT01393639|102137122|FG000|STARTED|Overall Study||45||
48735772|NCT01393639|102137123|FG001|STARTED|Overall Study||47||
48735773|NCT01393639|102137124|FG002|STARTED|Overall Study||45||
48735774|NCT01393639|102137125|FG003|STARTED|Overall Study||48||
48735775|NCT01393639|102137126|FG004|STARTED|Overall Study||45||
48735776|NCT01393639|102137127|FG005|STARTED|Overall Study||46||
48735777|NCT01393639|102137128|FG006|STARTED|Overall Study||47||
48735778|NCT01393639|102137122|FG000|COMPLETED|Overall Study||42||
48735779|NCT01393639|102137123|FG001|COMPLETED|Overall Study||40||
48735780|NCT01393639|102137124|FG002|COMPLETED|Overall Study||44||
48735781|NCT01393639|102137125|FG003|COMPLETED|Overall Study||43||
48735782|NCT01393639|102137126|FG004|COMPLETED|Overall Study||44||
48735783|NCT01393639|102137127|FG005|COMPLETED|Overall Study||44||
48735784|NCT01393639|102137128|FG006|COMPLETED|Overall Study||39||
48735785|NCT01393639|102137122|FG000|NOT COMPLETED|Overall Study||3||
48735786|NCT01393639|102137123|FG001|NOT COMPLETED|Overall Study||7||
48735787|NCT01393639|102137124|FG002|NOT COMPLETED|Overall Study||1||
48735788|NCT01393639|102137125|FG003|NOT COMPLETED|Overall Study||5||
48735789|NCT01393639|102137126|FG004|NOT COMPLETED|Overall Study||1||
48735790|NCT01393639|102137127|FG005|NOT COMPLETED|Overall Study||2||
48735791|NCT01393639|102137128|FG006|NOT COMPLETED|Overall Study||8||
48735792|NCT01366885|102137129|FG000|STARTED|Overall Study||20||
48735793|NCT01366885|102137129|FG000|COMPLETED|Overall Study||19||
48735794|NCT01366885|102137129|FG000|NOT COMPLETED|Overall Study||1||
48317798|NCT03186677|101104113|FG003|COMPLETED|Period 2||5||
48317799|NCT03186677|101104114|FG004|COMPLETED|Period 2||2||
48317800|NCT03186677|101104110|FG000|NOT COMPLETED|Period 2||0||
48317801|NCT03186677|101104111|FG001|NOT COMPLETED|Period 2||0||
48317802|NCT03186677|101104112|FG002|NOT COMPLETED|Period 2||0||
48317803|NCT03186677|101104113|FG003|NOT COMPLETED|Period 2||0||
48317804|NCT03186677|101104114|FG004|NOT COMPLETED|Period 2||0||
48317805|NCT04247061|101104115|FG000|STARTED|Overall Study||13||
48317806|NCT04247061|101104115|FG000|COMPLETED|Overall Study||4||
48317807|NCT04247061|101104115|FG000|NOT COMPLETED|Overall Study||9||
48317808|NCT00889265|101104116|FG000|STARTED|Overall Study||51||
48317809|NCT00889265|101104116|FG000|COMPLETED|Overall Study||44||
48317810|NCT00889265|101104116|FG000|NOT COMPLETED|Overall Study||7||
48317811|NCT01940471|101104117|FG000|STARTED|Period 1: Double-blind Phase||582||
48317812|NCT01940471|101104118|FG001|STARTED|Period 1: Double-blind Phase||293||
48317813|NCT01940471|101104119|FG002|STARTED|Period 1: Double-blind Phase||0||
48735795|NCT05224453|102137130|FG000|STARTED|Overall Study||38||
48735796|NCT05224453|102137131|FG001|STARTED|Overall Study||38||
48735797|NCT05224453|102137130|FG000|COMPLETED|Overall Study||36||
48735798|NCT05224453|102137131|FG001|COMPLETED|Overall Study||35||
48735799|NCT05224453|102137130|FG000|NOT COMPLETED|Overall Study||2||
48735800|NCT05224453|102137131|FG001|NOT COMPLETED|Overall Study||3||
48735801|NCT00881647|102137132|FG000|STARTED|Overall Study||29||
48735802|NCT00881647|102137133|FG001|STARTED|Overall Study||16||
48735803|NCT00881647|102137132|FG000|COMPLETED|Overall Study||27||
48735804|NCT00881647|102137133|FG001|COMPLETED|Overall Study||15||
48735805|NCT00881647|102137132|FG000|NOT COMPLETED|Overall Study||2||
48735806|NCT00881647|102137133|FG001|NOT COMPLETED|Overall Study||1||
48735807|NCT00851786|102137134|FG000|STARTED|Overall Study||296||
48735808|NCT00851786|102137135|FG001|STARTED|Overall Study||99||
48735809|NCT00851786|102137134|FG000|COMPLETED|Overall Study||291||
48735810|NCT00851786|102137135|FG001|COMPLETED|Overall Study||97||
48735811|NCT00851786|102137134|FG000|NOT COMPLETED|Overall Study||5||
48735812|NCT00851786|102137135|FG001|NOT COMPLETED|Overall Study||2||
48735813|NCT01740401|102137136|FG000|STARTED|Overall Study||10||
48735814|NCT01740401|102137136|FG000|COMPLETED|Overall Study||0||
48735815|NCT01740401|102137136|FG000|NOT COMPLETED|Overall Study||10||
48735816|NCT04042324|102137137|FG000|STARTED|UFH and Triferic Admixture (Day 1)||12||
48735817|NCT04042324|102137138|FG001|STARTED|UFH and Triferic Admixture (Day 1)||0||
48317814|NCT01940471|101104120|FG003|STARTED|Period 1: Double-blind Phase||0||
48317815|NCT01940471|101104117|FG000|COMPLETED|Period 1: Double-blind Phase||515||
48317816|NCT01940471|101104118|FG001|COMPLETED|Period 1: Double-blind Phase||253||
48317817|NCT01940471|101104119|FG002|COMPLETED|Period 1: Double-blind Phase||0||
48317818|NCT01940471|101104120|FG003|COMPLETED|Period 1: Double-blind Phase||0||
48317819|NCT01940471|101104117|FG000|NOT COMPLETED|Period 1: Double-blind Phase||67||
48317820|NCT01940471|101104118|FG001|NOT COMPLETED|Period 1: Double-blind Phase||40||
48368047|NCT03567291|101230092|FG000|NOT COMPLETED|Period III||0||
48735818|NCT04042324|102137139|FG002|STARTED|UFH and Triferic Admixture (Day 1)||0||
48735819|NCT04042324|102137137|FG000|COMPLETED|UFH and Triferic Admixture (Day 1)||12||
48735820|NCT04042324|102137138|FG001|COMPLETED|UFH and Triferic Admixture (Day 1)||0||
48735821|NCT04042324|102137139|FG002|COMPLETED|UFH and Triferic Admixture (Day 1)||0||
48735822|NCT04042324|102137137|FG000|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0||
48735823|NCT04042324|102137138|FG001|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0||
48735824|NCT04042324|102137139|FG002|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0||
48735825|NCT04042324|102137137|FG000|STARTED|Triferic Post-dialyzer (Day 3)||0||
48735826|NCT04042324|102137138|FG001|STARTED|Triferic Post-dialyzer (Day 3)||12||
48735827|NCT04042324|102137139|FG002|STARTED|Triferic Post-dialyzer (Day 3)||0||
48735828|NCT04042324|102137137|FG000|COMPLETED|Triferic Post-dialyzer (Day 3)||0||
48735829|NCT04042324|102137138|FG001|COMPLETED|Triferic Post-dialyzer (Day 3)||12||
48735830|NCT04042324|102137139|FG002|COMPLETED|Triferic Post-dialyzer (Day 3)||0||
48735831|NCT04042324|102137137|FG000|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0||
48735832|NCT04042324|102137138|FG001|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0||
48735833|NCT04042324|102137139|FG002|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0||
48735834|NCT04042324|102137137|FG000|STARTED|Triferic Pre-dialyzer (Day 5)||0||
48735835|NCT04042324|102137138|FG001|STARTED|Triferic Pre-dialyzer (Day 5)||0||
48735836|NCT04042324|102137139|FG002|STARTED|Triferic Pre-dialyzer (Day 5)||12||
48735837|NCT04042324|102137137|FG000|COMPLETED|Triferic Pre-dialyzer (Day 5)||0||
48735838|NCT04042324|102137138|FG001|COMPLETED|Triferic Pre-dialyzer (Day 5)||0||
48735839|NCT04042324|102137139|FG002|COMPLETED|Triferic Pre-dialyzer (Day 5)||12||
48735840|NCT04042324|102137137|FG000|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0||
48735841|NCT04042324|102137138|FG001|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0||
48735842|NCT04042324|102137139|FG002|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0||
48735843|NCT00928694|102137140|FG000|STARTED|First Intervention||7||
48735844|NCT00928694|102137141|FG001|STARTED|First Intervention||7||
48735845|NCT00928694|102137140|FG000|COMPLETED|First Intervention||7||
48735846|NCT00928694|102137141|FG001|COMPLETED|First Intervention||7||
48735847|NCT00928694|102137140|FG000|NOT COMPLETED|First Intervention||0||
48735848|NCT00928694|102137141|FG001|NOT COMPLETED|First Intervention||0||
48735849|NCT00928694|102137140|FG000|STARTED|Second Intervention||7||
48735850|NCT00928694|102137141|FG001|STARTED|Second Intervention||7||
48735851|NCT00928694|102137140|FG000|COMPLETED|Second Intervention||7||
48735852|NCT00928694|102137141|FG001|COMPLETED|Second Intervention||7||
48735853|NCT00928694|102137140|FG000|NOT COMPLETED|Second Intervention||0||
48735854|NCT00928694|102137141|FG001|NOT COMPLETED|Second Intervention||0||
48735855|NCT01598922|102137142|FG000|STARTED|Overall Study||37||
48735856|NCT01598922|102137143|FG001|STARTED|Overall Study||40||
48735857|NCT01598922|102137142|FG000|COMPLETED|Overall Study||34||
48735858|NCT01598922|102137143|FG001|COMPLETED|Overall Study||30||
48735859|NCT01598922|102137142|FG000|NOT COMPLETED|Overall Study||3||
48735860|NCT01598922|102137143|FG001|NOT COMPLETED|Overall Study||10||
48735861|NCT02440685|102137144|FG000|STARTED|Overall Study||3||
48735862|NCT02440685|102137145|FG001|STARTED|Overall Study||4||
48735863|NCT02440685|102137146|FG002|STARTED|Overall Study||3||
48735864|NCT02440685|102137147|FG003|STARTED|Overall Study||4||
48735865|NCT02440685|102137148|FG004|STARTED|Overall Study||7||
48735866|NCT02440685|102137149|FG005|STARTED|Overall Study||15||
48735867|NCT02440685|102137150|FG006|STARTED|Overall Study||5||
48735868|NCT02440685|102137151|FG007|STARTED|Overall Study||7||
48735869|NCT02440685|102137152|FG008|STARTED|Overall Study||3||
48735870|NCT02440685|102137144|FG000|COMPLETED|Overall Study||0||
48735871|NCT02440685|102137145|FG001|COMPLETED|Overall Study||0||
48735872|NCT02440685|102137146|FG002|COMPLETED|Overall Study||0||
48735873|NCT02440685|102137147|FG003|COMPLETED|Overall Study||0||
48735874|NCT02440685|102137148|FG004|COMPLETED|Overall Study||0||
48735875|NCT02440685|102137149|FG005|COMPLETED|Overall Study||0||
48735876|NCT02440685|102137150|FG006|COMPLETED|Overall Study||0||
48735877|NCT02440685|102137151|FG007|COMPLETED|Overall Study||0||
48735878|NCT02440685|102137152|FG008|COMPLETED|Overall Study||0||
48317821|NCT01940471|101104119|FG002|NOT COMPLETED|Period 1: Double-blind Phase||0||
48317822|NCT01940471|101104120|FG003|NOT COMPLETED|Period 1: Double-blind Phase||0||
48368048|NCT03567291|101230093|FG001|NOT COMPLETED|Period III||0||
48735879|NCT02440685|102137144|FG000|NOT COMPLETED|Overall Study||3||
48735880|NCT02440685|102137145|FG001|NOT COMPLETED|Overall Study||4||
48735881|NCT02440685|102137146|FG002|NOT COMPLETED|Overall Study||3||
48735882|NCT02440685|102137147|FG003|NOT COMPLETED|Overall Study||4||
48735883|NCT02440685|102137148|FG004|NOT COMPLETED|Overall Study||7||
48735884|NCT02440685|102137149|FG005|NOT COMPLETED|Overall Study||15||
48735885|NCT02440685|102137150|FG006|NOT COMPLETED|Overall Study||5||
48735886|NCT02440685|102137151|FG007|NOT COMPLETED|Overall Study||7||
48735887|NCT02440685|102137152|FG008|NOT COMPLETED|Overall Study||3||
48735888|NCT02703324|102137153|FG000|STARTED|Period One||5||
48317823|NCT01940471|101104117|FG000|STARTED|Period 2: Open-Label TAF Extension Phase||0|At the end of Double-blind Phase, participants were given the option to receive TAF in an OL TAF Extension Phase for up to 240 or 288 weeks.|
48735889|NCT02703324|102137154|FG001|STARTED|Period One||5||
48735890|NCT02703324|102137155|FG002|STARTED|Period One||5||
48735891|NCT02703324|102137156|FG003|STARTED|Period One||5||
48735892|NCT02703324|102137157|FG004|STARTED|Period One||5||
48735893|NCT02703324|102137158|FG005|STARTED|Period One||5||
48735894|NCT02703324|102137153|FG000|Received Study Drug|Period One||5||
48735895|NCT02703324|102137154|FG001|Received Study Drug|Period One||5||
48735896|NCT02703324|102137155|FG002|Received Study Drug|Period One||5||
48735897|NCT02703324|102137156|FG003|Received Study Drug|Period One||5||
48735898|NCT02703324|102137157|FG004|Received Study Drug|Period One||5||
48735899|NCT02703324|102137158|FG005|Received Study Drug|Period One||5||
48735900|NCT02703324|102137153|FG000|COMPLETED|Period One||5||
48735901|NCT02703324|102137154|FG001|COMPLETED|Period One||5||
48735902|NCT02703324|102137155|FG002|COMPLETED|Period One||5||
48735903|NCT02703324|102137156|FG003|COMPLETED|Period One||5||
48735904|NCT02703324|102137157|FG004|COMPLETED|Period One||5||
48735905|NCT02703324|102137158|FG005|COMPLETED|Period One||5||
48735906|NCT02703324|102137153|FG000|NOT COMPLETED|Period One||0||
48735907|NCT02703324|102137154|FG001|NOT COMPLETED|Period One||0||
48735908|NCT02703324|102137155|FG002|NOT COMPLETED|Period One||0||
48735909|NCT02703324|102137156|FG003|NOT COMPLETED|Period One||0||
48735910|NCT02703324|102137157|FG004|NOT COMPLETED|Period One||0||
48735911|NCT02703324|102137158|FG005|NOT COMPLETED|Period One||0||
48735912|NCT02703324|102137153|FG000|STARTED|Period Two||5||
48735913|NCT02703324|102137154|FG001|STARTED|Period Two||5||
48735914|NCT02703324|102137155|FG002|STARTED|Period Two||5||
48735915|NCT02703324|102137156|FG003|STARTED|Period Two||5||
48735916|NCT02703324|102137157|FG004|STARTED|Period Two||5||
48735917|NCT02703324|102137158|FG005|STARTED|Period Two||5||
48735918|NCT02703324|102137153|FG000|Received Study Drug|Period Two||5||
48735919|NCT02703324|102137154|FG001|Received Study Drug|Period Two||5||
48735920|NCT02703324|102137155|FG002|Received Study Drug|Period Two||5||
48735921|NCT02703324|102137156|FG003|Received Study Drug|Period Two||5||
48735922|NCT02703324|102137157|FG004|Received Study Drug|Period Two||5||
48735923|NCT02703324|102137158|FG005|Received Study Drug|Period Two||5||
48735924|NCT02703324|102137153|FG000|COMPLETED|Period Two||5||
48735925|NCT02703324|102137154|FG001|COMPLETED|Period Two||5||
48735926|NCT02703324|102137155|FG002|COMPLETED|Period Two||4||
48735927|NCT02703324|102137156|FG003|COMPLETED|Period Two||5||
48735928|NCT02703324|102137157|FG004|COMPLETED|Period Two||5||
48735929|NCT02703324|102137158|FG005|COMPLETED|Period Two||5||
48735930|NCT02703324|102137153|FG000|NOT COMPLETED|Period Two||0||
48735931|NCT02703324|102137154|FG001|NOT COMPLETED|Period Two||0||
48735932|NCT02703324|102137155|FG002|NOT COMPLETED|Period Two||1||
48735933|NCT02703324|102137156|FG003|NOT COMPLETED|Period Two||0||
48735934|NCT02703324|102137157|FG004|NOT COMPLETED|Period Two||0||
48735935|NCT02703324|102137158|FG005|NOT COMPLETED|Period Two||0||
48735936|NCT02703324|102137153|FG000|STARTED|Period Three||5||
48735937|NCT02703324|102137154|FG001|STARTED|Period Three||5||
48735938|NCT02703324|102137155|FG002|STARTED|Period Three||4||
48160378|NCT00695786|100715849|FG002|COMPLETED|Overall Study||23||
48160379|NCT00695786|100715850|FG003|COMPLETED|Overall Study||36||
48317824|NCT01940471|101104118|FG001|STARTED|Period 2: Open-Label TAF Extension Phase||0|At the end of Double-blind Phase, participants were given the option to receive TAF in an OL TAF Extension Phase for up to 240 or 288 weeks.|
48368049|NCT03567291|101230094|FG002|NOT COMPLETED|Period III||0||
48735939|NCT02703324|102137156|FG003|STARTED|Period Three||5||
48160380|NCT00695786|100715847|FG000|NOT COMPLETED|Overall Study||1||
48160381|NCT00695786|100715848|FG001|NOT COMPLETED|Overall Study||12||
48735940|NCT02703324|102137157|FG004|STARTED|Period Three||5||
48735941|NCT02703324|102137158|FG005|STARTED|Period Three||5||
48735942|NCT02703324|102137153|FG000|Received Study Drug|Period Three||5||
48735943|NCT02703324|102137154|FG001|Received Study Drug|Period Three||5||
48735944|NCT02703324|102137155|FG002|Received Study Drug|Period Three||4||
48735945|NCT02703324|102137156|FG003|Received Study Drug|Period Three||5||
48735946|NCT02703324|102137157|FG004|Received Study Drug|Period Three||5||
48735947|NCT02703324|102137158|FG005|Received Study Drug|Period Three||5||
48735948|NCT02703324|102137153|FG000|COMPLETED|Period Three||5||
48735949|NCT02703324|102137154|FG001|COMPLETED|Period Three||5||
48735950|NCT02703324|102137155|FG002|COMPLETED|Period Three||4||
48735951|NCT02703324|102137156|FG003|COMPLETED|Period Three||5||
48735952|NCT02703324|102137157|FG004|COMPLETED|Period Three||5||
48735953|NCT02703324|102137158|FG005|COMPLETED|Period Three||5||
48735954|NCT02703324|102137153|FG000|NOT COMPLETED|Period Three||0||
48735955|NCT02703324|102137154|FG001|NOT COMPLETED|Period Three||0||
48735956|NCT02703324|102137155|FG002|NOT COMPLETED|Period Three||0||
48735957|NCT02703324|102137156|FG003|NOT COMPLETED|Period Three||0||
48735958|NCT02703324|102137157|FG004|NOT COMPLETED|Period Three||0||
48735959|NCT02703324|102137158|FG005|NOT COMPLETED|Period Three||0||
48735960|NCT02703324|102137153|FG000|STARTED|Period Four||5||
48735961|NCT02703324|102137154|FG001|STARTED|Period Four||4||
48735962|NCT02703324|102137155|FG002|STARTED|Period Four||4||
48735963|NCT02703324|102137156|FG003|STARTED|Period Four||5||
48735964|NCT02703324|102137157|FG004|STARTED|Period Four||5||
48735965|NCT02703324|102137158|FG005|STARTED|Period Four||5||
48735966|NCT02703324|102137153|FG000|Received Study Drug|Period Four||5||
48735967|NCT02703324|102137154|FG001|Received Study Drug|Period Four||4||
48735968|NCT02703324|102137155|FG002|Received Study Drug|Period Four||4||
48735969|NCT02703324|102137156|FG003|Received Study Drug|Period Four||5||
48735970|NCT02703324|102137157|FG004|Received Study Drug|Period Four||5||
48735971|NCT02703324|102137158|FG005|Received Study Drug|Period Four||5||
48735972|NCT02703324|102137153|FG000|COMPLETED|Period Four||5||
48735973|NCT02703324|102137154|FG001|COMPLETED|Period Four||4||
48735974|NCT02703324|102137155|FG002|COMPLETED|Period Four||4||
48735975|NCT02703324|102137156|FG003|COMPLETED|Period Four||5||
48735976|NCT02703324|102137157|FG004|COMPLETED|Period Four||5||
48735977|NCT02703324|102137158|FG005|COMPLETED|Period Four||5||
48735978|NCT02703324|102137153|FG000|NOT COMPLETED|Period Four||0||
48735979|NCT02703324|102137154|FG001|NOT COMPLETED|Period Four||0||
48735980|NCT02703324|102137155|FG002|NOT COMPLETED|Period Four||0||
48735981|NCT02703324|102137156|FG003|NOT COMPLETED|Period Four||0||
48735982|NCT02703324|102137157|FG004|NOT COMPLETED|Period Four||0||
48735983|NCT02703324|102137158|FG005|NOT COMPLETED|Period Four||0||
48735984|NCT01301833|102137159|FG000|STARTED|Overall Study||212||
48735985|NCT01301833|102137160|FG001|STARTED|Overall Study||80||
48735986|NCT01301833|102137161|FG002|STARTED|Overall Study||95||
48160382|NCT00695786|100715849|FG002|NOT COMPLETED|Overall Study||8||
48160383|NCT00695786|100715850|FG003|NOT COMPLETED|Overall Study||8||
48735987|NCT01301833|102137162|FG003|STARTED|Overall Study||75||
48735988|NCT01301833|102137159|FG000|COMPLETED|Overall Study||197||
48735989|NCT01301833|102137160|FG001|COMPLETED|Overall Study||72||
48735990|NCT01301833|102137161|FG002|COMPLETED|Overall Study||88||
48735991|NCT01301833|102137162|FG003|COMPLETED|Overall Study||68||
48735992|NCT01301833|102137159|FG000|NOT COMPLETED|Overall Study||15||
48735993|NCT01301833|102137160|FG001|NOT COMPLETED|Overall Study||8||
48735994|NCT01301833|102137161|FG002|NOT COMPLETED|Overall Study||7||
48735995|NCT01301833|102137162|FG003|NOT COMPLETED|Overall Study||7||
48735996|NCT04047979|102137163|FG000|STARTED|Overall Study||30||
48160384|NCT02178059|100715851|FG000|STARTED|First Intervention||17||
48160385|NCT02178059|100715852|FG001|STARTED|First Intervention||17||
48160386|NCT02178059|100715851|FG000|COMPLETED|First Intervention||17||
48735997|NCT04047979|102137164|FG001|STARTED|Overall Study||8||
48735998|NCT04047979|102137163|FG000|COMPLETED|Overall Study||18||
48735999|NCT04047979|102137164|FG001|COMPLETED|Overall Study||8||
48736000|NCT04047979|102137163|FG000|NOT COMPLETED|Overall Study||12||
48736001|NCT04047979|102137164|FG001|NOT COMPLETED|Overall Study||0||
48736002|NCT03315572|102137165|FG000|STARTED|Overall Study||14||
48736003|NCT03315572|102137166|FG001|STARTED|Overall Study||14||
48736004|NCT03315572|102137165|FG000|COMPLETED|Overall Study||14||
48736005|NCT03315572|102137166|FG001|COMPLETED|Overall Study||14||
48736006|NCT03315572|102137165|FG000|NOT COMPLETED|Overall Study||0||
48736007|NCT03315572|102137166|FG001|NOT COMPLETED|Overall Study||0||
48736008|NCT00791908|102137167|FG000|STARTED|Overall Study||15||
48736009|NCT00791908|102137167|FG000|COMPLETED|Overall Study||15||
48736010|NCT00791908|102137167|FG000|NOT COMPLETED|Overall Study||0||
48736011|NCT01898429|102137168|FG000|STARTED|Phase 1||5||
48736012|NCT01898429|102137169|FG001|STARTED|Phase 1||0||
48736013|NCT01898429|102137170|FG002|STARTED|Phase 1||0||
48736014|NCT01898429|102137168|FG000|COMPLETED|Phase 1||5||
48736015|NCT01898429|102137169|FG001|COMPLETED|Phase 1||0||
48736016|NCT01898429|102137170|FG002|COMPLETED|Phase 1||0||
48736017|NCT01898429|102137168|FG000|NOT COMPLETED|Phase 1||0||
48736018|NCT01898429|102137169|FG001|NOT COMPLETED|Phase 1||0||
48736019|NCT01898429|102137170|FG002|NOT COMPLETED|Phase 1||0||
48736020|NCT01898429|102137168|FG000|STARTED|Phase 2||0||
48736021|NCT01898429|102137169|FG001|STARTED|Phase 2||5||
48160387|NCT02178059|100715852|FG001|COMPLETED|First Intervention||17||
48160388|NCT02178059|100715851|FG000|NOT COMPLETED|First Intervention||0||
48160389|NCT02178059|100715852|FG001|NOT COMPLETED|First Intervention||0||
48160390|NCT02178059|100715851|FG000|STARTED|Washout||17||
48160391|NCT02178059|100715852|FG001|STARTED|Washout||17||
48160392|NCT02178059|100715851|FG000|COMPLETED|Washout||16||
48160393|NCT02178059|100715852|FG001|COMPLETED|Washout||17||
48160394|NCT02178059|100715851|FG000|NOT COMPLETED|Washout||1||
48736022|NCT01898429|102137170|FG002|STARTED|Phase 2||0||
48736023|NCT01898429|102137168|FG000|COMPLETED|Phase 2||0||
48736024|NCT01898429|102137169|FG001|COMPLETED|Phase 2||5||
48736025|NCT01898429|102137170|FG002|COMPLETED|Phase 2||0||
48736026|NCT01898429|102137168|FG000|NOT COMPLETED|Phase 2||0||
48736027|NCT01898429|102137169|FG001|NOT COMPLETED|Phase 2||0||
48736028|NCT01898429|102137170|FG002|NOT COMPLETED|Phase 2||0||
48736029|NCT01898429|102137168|FG000|STARTED|Phase 3||0||
48736030|NCT01898429|102137169|FG001|STARTED|Phase 3||0||
48736031|NCT01898429|102137170|FG002|STARTED|Phase 3||5||
48736032|NCT01898429|102137168|FG000|COMPLETED|Phase 3||0||
48736033|NCT01898429|102137169|FG001|COMPLETED|Phase 3||0||
48160395|NCT02178059|100715852|FG001|NOT COMPLETED|Washout||0||
48160396|NCT02178059|100715851|FG000|STARTED|Second Intervention||16||
48736034|NCT01898429|102137170|FG002|COMPLETED|Phase 3||5||
48736035|NCT01898429|102137168|FG000|NOT COMPLETED|Phase 3||0||
48736036|NCT01898429|102137169|FG001|NOT COMPLETED|Phase 3||0||
48736037|NCT01898429|102137170|FG002|NOT COMPLETED|Phase 3||0||
48736038|NCT01858740|102137171|FG000|STARTED|Overall Study||20||
48736039|NCT01858740|102137171|FG000|Day 28 Post Transplant|Overall Study||20||
48736040|NCT01858740|102137171|FG000|Day 100 Post Transplant|Overall Study||18||
48736041|NCT01858740|102137171|FG000|1 Year Post Transplant|Overall Study||18||
48736042|NCT01858740|102137171|FG000|COMPLETED|Overall Study||16||
48736043|NCT01858740|102137171|FG000|NOT COMPLETED|Overall Study||4||
48736044|NCT02870101|102137172|FG000|STARTED|Overall Study||2767||
48736045|NCT02870101|102137172|FG000|COMPLETED|Overall Study||2598||
48736046|NCT02870101|102137172|FG000|NOT COMPLETED|Overall Study||169||
48736047|NCT01856582|102137173|FG000|STARTED|Overall Study||23||
48736048|NCT01856582|102137173|FG000|COMPLETED|Overall Study||22||
48736049|NCT01856582|102137173|FG000|NOT COMPLETED|Overall Study||1||
48736050|NCT00711971|102137174|FG000|STARTED|Overall Study||42||
48736051|NCT00711971|102137175|FG001|STARTED|Overall Study||42||
48736052|NCT00711971|102137176|FG002|STARTED|Overall Study||42||
48736053|NCT00711971|102137174|FG000|COMPLETED|Overall Study||39||
48736054|NCT00711971|102137175|FG001|COMPLETED|Overall Study||38||
48736055|NCT00711971|102137176|FG002|COMPLETED|Overall Study||41||
48736056|NCT00711971|102137174|FG000|NOT COMPLETED|Overall Study||3||
48736057|NCT00711971|102137175|FG001|NOT COMPLETED|Overall Study||4||
48736058|NCT00711971|102137176|FG002|NOT COMPLETED|Overall Study||1||
48736059|NCT00753454|102137177|FG000|STARTED|Overall Study||168||
48736060|NCT00753454|102137177|FG000|COMPLETED|Overall Study||154||
48736061|NCT00753454|102137177|FG000|NOT COMPLETED|Overall Study||14||
48736062|NCT03932760|102137178|FG000|STARTED|Overall Study||40||
48736063|NCT03932760|102137179|FG001|STARTED|Overall Study||41||
48736064|NCT03932760|102137178|FG000|Baseline|Overall Study||36|Number of participants who completed survey at baseline.|
48317825|NCT01940471|101104119|FG002|STARTED|Period 2: Open-Label TAF Extension Phase||514|At the end of Double-blind Phase, participants were given the option to receive TAF in an OL TAF Extension Phase for up to 240 or 288 weeks.|
48317826|NCT01940471|101104120|FG003|STARTED|Period 2: Open-Label TAF Extension Phase||253|At the end of Double-blind Phase, participants were given the option to receive TAF in an OL TAF Extension Phase for up to 240 or 288 weeks.|
48317827|NCT01940471|101104117|FG000|COMPLETED|Period 2: Open-Label TAF Extension Phase||0||
48317828|NCT01940471|101104118|FG001|COMPLETED|Period 2: Open-Label TAF Extension Phase||0||
48317829|NCT01940471|101104119|FG002|COMPLETED|Period 2: Open-Label TAF Extension Phase||422||
48317830|NCT01940471|101104120|FG003|COMPLETED|Period 2: Open-Label TAF Extension Phase||213||
48317831|NCT01940471|101104117|FG000|NOT COMPLETED|Period 2: Open-Label TAF Extension Phase||0||
48317832|NCT01940471|101104118|FG001|NOT COMPLETED|Period 2: Open-Label TAF Extension Phase||0||
48407330|NCT03296072|101328539|FG005|STARTED|Treatment Period 1||11||
48407331|NCT03296072|101328534|FG000|COMPLETED|Treatment Period 1||10||
48407332|NCT03296072|101328535|FG001|COMPLETED|Treatment Period 1||11||
48616009|NCT02493517|101845036|FG000|NOT COMPLETED|Overall Study||2||
48616010|NCT02493517|101845037|FG001|NOT COMPLETED|Overall Study||7||
48616011|NCT04613739|101845038|FG000|STARTED|Overall Study||19||
48616012|NCT04613739|101845039|FG001|STARTED|Overall Study||37||
48616013|NCT04613739|101845038|FG000|COMPLETED|Overall Study||12|Completed four-month survey|
48616014|NCT04613739|101845039|FG001|COMPLETED|Overall Study||25|Completed four-month survey|
48616015|NCT04613739|101845038|FG000|NOT COMPLETED|Overall Study||7||
48616016|NCT04613739|101845039|FG001|NOT COMPLETED|Overall Study||12||
48616017|NCT02259400|101845040|FG000|STARTED|Overall Study||62||
48616018|NCT02259400|101845041|FG001|STARTED|Overall Study||62||
48616019|NCT02259400|101845040|FG000|COMPLETED|Overall Study||62||
48616020|NCT02259400|101845041|FG001|COMPLETED|Overall Study||60||
48616021|NCT02259400|101845040|FG000|NOT COMPLETED|Overall Study||0||
48616022|NCT02259400|101845041|FG001|NOT COMPLETED|Overall Study||2||
48736065|NCT03932760|102137179|FG001|Baseline|Overall Study||33|Number of participants who completed survey at baseline.|
48736066|NCT03932760|102137178|FG000|Post|Overall Study||29|Number of participants who completed survey post intervention.|
48736067|NCT03932760|102137179|FG001|Post|Overall Study||30|Number of participants who completed survey post intervention.|
48736068|NCT03932760|102137178|FG000|2 Months|Overall Study||31|Number of participants who completed survey at 2 months.|
48616023|NCT00522548|101845042|FG000|STARTED|Overall Study||18||
48736069|NCT03932760|102137179|FG001|2 Months|Overall Study||29|Number of participants who completed survey at 2 months.|
48736070|NCT03932760|102137178|FG000|4 Months|Overall Study||31|Number of participants who completed survey at 4 months.|
48736071|NCT03932760|102137179|FG001|4 Months|Overall Study||29|Number of participants who completed survey at 4 months.|
48736072|NCT03932760|102137178|FG000|6 Months|Overall Study||30|Number of participants who completed survey at 6 months.|
48736073|NCT03932760|102137179|FG001|6 Months|Overall Study||28|Number of participants who completed survey at 6 months.|
48736074|NCT03932760|102137178|FG000|8 Months|Overall Study||30|Number of participants who completed survey at 8 months.|
48736075|NCT03932760|102137179|FG001|8 Months|Overall Study||28|Number of participants who completed survey at 8 months.|
48736076|NCT03932760|102137178|FG000|COMPLETED|Overall Study||32||
48317833|NCT01940471|101104119|FG002|NOT COMPLETED|Period 2: Open-Label TAF Extension Phase||92||
48317834|NCT01940471|101104120|FG003|NOT COMPLETED|Period 2: Open-Label TAF Extension Phase||40||
48317835|NCT02349048|101104121|FG000|STARTED|Overall Study||59||
48616024|NCT00522548|101845043|FG001|STARTED|Overall Study||19||
48736077|NCT03932760|102137179|FG001|COMPLETED|Overall Study||30||
48736078|NCT03932760|102137178|FG000|NOT COMPLETED|Overall Study||8||
48736079|NCT03932760|102137179|FG001|NOT COMPLETED|Overall Study||11||
48736080|NCT01934010|102137180|FG000|STARTED|Overall Study||114||
48736081|NCT01934010|102137181|FG001|STARTED|Overall Study||67||
48736082|NCT01934010|102137182|FG002|STARTED|Overall Study||76||
48736083|NCT01934010|102137180|FG000|COMPLETED|Overall Study||91||
48736084|NCT01934010|102137181|FG001|COMPLETED|Overall Study||56||
48736085|NCT01934010|102137182|FG002|COMPLETED|Overall Study||74||
48736086|NCT01934010|102137180|FG000|NOT COMPLETED|Overall Study||23||
48736087|NCT01934010|102137181|FG001|NOT COMPLETED|Overall Study||11||
48736088|NCT01934010|102137182|FG002|NOT COMPLETED|Overall Study||2||
48736089|NCT02206035|102137183|FG000|STARTED|Overall Study||45||
48736090|NCT02206035|102137184|FG001|STARTED|Overall Study||130||
48736091|NCT02206035|102137185|FG002|STARTED|Overall Study||204||
48736092|NCT02206035|102137183|FG000|COMPLETED|Overall Study||35||
48736093|NCT02206035|102137184|FG001|COMPLETED|Overall Study||130||
48736094|NCT02206035|102137185|FG002|COMPLETED|Overall Study||29||
48736095|NCT02206035|102137183|FG000|NOT COMPLETED|Overall Study||10||
48736096|NCT02206035|102137184|FG001|NOT COMPLETED|Overall Study||0||
48736097|NCT02206035|102137185|FG002|NOT COMPLETED|Overall Study||175||
48736098|NCT02702180|102137186|FG000|STARTED|Double-blind Treatment Period||46||
48736099|NCT02702180|102137187|FG001|STARTED|Double-blind Treatment Period||45||
48736100|NCT02702180|102137188|FG002|STARTED|Double-blind Treatment Period||47||
48736101|NCT02702180|102137186|FG000|COMPLETED|Double-blind Treatment Period||45||
48736102|NCT02702180|102137187|FG001|COMPLETED|Double-blind Treatment Period||44||
48736103|NCT02702180|102137188|FG002|COMPLETED|Double-blind Treatment Period||43||
48736104|NCT02702180|102137186|FG000|NOT COMPLETED|Double-blind Treatment Period||1||
48736105|NCT02702180|102137187|FG001|NOT COMPLETED|Double-blind Treatment Period||1||
48736106|NCT02702180|102137188|FG002|NOT COMPLETED|Double-blind Treatment Period||4||
48736107|NCT02702180|102137186|FG000|STARTED|Open-label Treatment Period||45||
48736108|NCT02702180|102137187|FG001|STARTED|Open-label Treatment Period||43||
48736109|NCT02702180|102137188|FG002|STARTED|Open-label Treatment Period||43||
48736110|NCT02702180|102137186|FG000|COMPLETED|Open-label Treatment Period||45||
48736111|NCT02702180|102137187|FG001|COMPLETED|Open-label Treatment Period||42||
48736112|NCT02702180|102137188|FG002|COMPLETED|Open-label Treatment Period||41||
48736113|NCT02702180|102137186|FG000|NOT COMPLETED|Open-label Treatment Period||0||
48736114|NCT02702180|102137187|FG001|NOT COMPLETED|Open-label Treatment Period||1||
48736115|NCT02702180|102137188|FG002|NOT COMPLETED|Open-label Treatment Period||2||
48736116|NCT04599465|102137189|FG000|STARTED|Overall Study||69||
48736117|NCT04599465|102137189|FG000|COMPLETED|Overall Study||66||
48736118|NCT04599465|102137189|FG000|NOT COMPLETED|Overall Study||3||
48736119|NCT01578577|102137190|FG000|STARTED|Overall Study||305||
48736120|NCT01578577|102137191|FG001|STARTED|Overall Study||302||
48736121|NCT01578577|102137192|FG002|STARTED|Overall Study||313||
48736122|NCT01578577|102137190|FG000|COMPLETED|Overall Study||254||
48736123|NCT01578577|102137191|FG001|COMPLETED|Overall Study||262||
48736124|NCT01578577|102137192|FG002|COMPLETED|Overall Study||278||
48736125|NCT01578577|102137190|FG000|NOT COMPLETED|Overall Study||51||
48736126|NCT01578577|102137191|FG001|NOT COMPLETED|Overall Study||40||
48736127|NCT01578577|102137192|FG002|NOT COMPLETED|Overall Study||35||
48736128|NCT01059318|102137193|FG000|STARTED|Core Study (26 Week)||24||
48736129|NCT01059318|102137193|FG000|Everolimus 2.5 mg for 4 Weeks|Core Study (26 Week)||24||
48736130|NCT01059318|102137193|FG000|Everolimus 5 mg for 4 Weeks|Core Study (26 Week)||24||
48736131|NCT01059318|102137193|FG000|Everolimus 10 mg for 18 Weeks|Core Study (26 Week)||24||
48736132|NCT01059318|102137193|FG000|Pharmacokinetics (PK) Analysis Set|Core Study (26 Week)||16||
48736133|NCT01059318|102137193|FG000|COMPLETED|Core Study (26 Week)||20||
48736134|NCT01059318|102137193|FG000|NOT COMPLETED|Core Study (26 Week)||4||
48736135|NCT01059318|102137193|FG000|STARTED|Extension (36 Week)||20||
48736136|NCT01059318|102137193|FG000|COMPLETED|Extension (36 Week)||17||
48736137|NCT01059318|102137193|FG000|NOT COMPLETED|Extension (36 Week)||3||
48736138|NCT00627367|102137194|FG000|STARTED|Overall Study||112||
48736139|NCT00627367|102137195|FG001|STARTED|Overall Study||112||
48736140|NCT00627367|102137194|FG000|COMPLETED|Overall Study||112||
48736141|NCT00627367|102137195|FG001|COMPLETED|Overall Study||112||
48736142|NCT00627367|102137194|FG000|NOT COMPLETED|Overall Study||0||
48736143|NCT00627367|102137195|FG001|NOT COMPLETED|Overall Study||0||
48736144|NCT01610336|102137196|FG000|STARTED|Overall Study||5||
48736145|NCT01610336|102137197|FG001|STARTED|Overall Study||7||
48736146|NCT01610336|102137198|FG002|STARTED|Overall Study||6||
48736147|NCT01610336|102137199|FG003|STARTED|Overall Study||7||
48736148|NCT01610336|102137200|FG004|STARTED|Overall Study||4||
48736149|NCT01610336|102137201|FG005|STARTED|Overall Study||12||
48736150|NCT01610336|102137202|FG006|STARTED|Overall Study||5||
48736151|NCT01610336|102137203|FG007|STARTED|Overall Study||7||
48736152|NCT01610336|102137204|FG008|STARTED|Overall Study||8||
48736153|NCT01610336|102137205|FG009|STARTED|Overall Study||53||
48736154|NCT01610336|102137206|FG010|STARTED|Overall Study||47||
48736155|NCT01610336|102137196|FG000|COMPLETED|Overall Study||0||
48736156|NCT01610336|102137197|FG001|COMPLETED|Overall Study||0||
48736157|NCT01610336|102137198|FG002|COMPLETED|Overall Study||0||
48736158|NCT01610336|102137199|FG003|COMPLETED|Overall Study||0||
48736159|NCT01610336|102137200|FG004|COMPLETED|Overall Study||0||
48736160|NCT01610336|102137201|FG005|COMPLETED|Overall Study||0||
48736161|NCT01610336|102137202|FG006|COMPLETED|Overall Study||0||
48736162|NCT01610336|102137203|FG007|COMPLETED|Overall Study||0||
48736163|NCT01610336|102137204|FG008|COMPLETED|Overall Study||0||
48736164|NCT01610336|102137205|FG009|COMPLETED|Overall Study||0||
48736165|NCT01610336|102137206|FG010|COMPLETED|Overall Study||0||
48736166|NCT01610336|102137196|FG000|NOT COMPLETED|Overall Study||5||
48736167|NCT01610336|102137197|FG001|NOT COMPLETED|Overall Study||7||
48736168|NCT01610336|102137198|FG002|NOT COMPLETED|Overall Study||6||
48317836|NCT02349048|101104122|FG001|STARTED|Overall Study||9||
48317837|NCT02349048|101104121|FG000|COMPLETED|Overall Study||54||
48736169|NCT01610336|102137199|FG003|NOT COMPLETED|Overall Study||7||
48736170|NCT01610336|102137200|FG004|NOT COMPLETED|Overall Study||4||
48736171|NCT01610336|102137201|FG005|NOT COMPLETED|Overall Study||12||
48736172|NCT01610336|102137202|FG006|NOT COMPLETED|Overall Study||5||
48736173|NCT01610336|102137203|FG007|NOT COMPLETED|Overall Study||7||
48736174|NCT01610336|102137204|FG008|NOT COMPLETED|Overall Study||8||
48736175|NCT01610336|102137205|FG009|NOT COMPLETED|Overall Study||53||
48736176|NCT01610336|102137206|FG010|NOT COMPLETED|Overall Study||47||
48736177|NCT01463306|102137207|FG000|STARTED|Overall Study||384||
48736178|NCT01463306|102137208|FG001|STARTED|Overall Study||210||
48736179|NCT01463306|102137209|FG002|STARTED|Overall Study||11||
48736180|NCT01463306|102137207|FG000|COMPLETED|Overall Study||298||
48736181|NCT01463306|102137208|FG001|COMPLETED|Overall Study||158||
48736182|NCT01463306|102137209|FG002|COMPLETED|Overall Study||6||
48736183|NCT01463306|102137207|FG000|NOT COMPLETED|Overall Study||86||
48736184|NCT01463306|102137208|FG001|NOT COMPLETED|Overall Study||52||
48736185|NCT01463306|102137209|FG002|NOT COMPLETED|Overall Study||5||
48736186|NCT00921843|102137210|FG000|STARTED|Overall Study||10||
48736187|NCT00921843|102137211|FG001|STARTED|Overall Study||10||
48736188|NCT00921843|102137212|FG002|STARTED|Overall Study||11||
48736189|NCT00921843|102137213|FG003|STARTED|Overall Study||30||
48736190|NCT00921843|102137210|FG000|COMPLETED|Overall Study||10||
48736191|NCT00921843|102137211|FG001|COMPLETED|Overall Study||10||
48736192|NCT00921843|102137212|FG002|COMPLETED|Overall Study||11||
48736193|NCT00921843|102137213|FG003|COMPLETED|Overall Study||30||
48736194|NCT00921843|102137210|FG000|NOT COMPLETED|Overall Study||0||
48736195|NCT00921843|102137211|FG001|NOT COMPLETED|Overall Study||0||
48736196|NCT00921843|102137212|FG002|NOT COMPLETED|Overall Study||0||
48736197|NCT00921843|102137213|FG003|NOT COMPLETED|Overall Study||0||
48736198|NCT03137225|102137214|FG000|STARTED|First 4 Hour Measurement Period||1||
48736199|NCT03137225|102137215|FG001|STARTED|First 4 Hour Measurement Period||0||
48736200|NCT03137225|102137214|FG000|COMPLETED|First 4 Hour Measurement Period||1||
48736201|NCT03137225|102137215|FG001|COMPLETED|First 4 Hour Measurement Period||0||
48736202|NCT03137225|102137214|FG000|NOT COMPLETED|First 4 Hour Measurement Period||0||
48736203|NCT03137225|102137215|FG001|NOT COMPLETED|First 4 Hour Measurement Period||0||
48736204|NCT03137225|102137214|FG000|STARTED|Second 4 Hour Measurement Period||1||
48736205|NCT03137225|102137215|FG001|STARTED|Second 4 Hour Measurement Period||0||
48317838|NCT02349048|101104122|FG001|COMPLETED|Overall Study||9||
48317839|NCT02349048|101104121|FG000|NOT COMPLETED|Overall Study||5||
48317840|NCT02349048|101104122|FG001|NOT COMPLETED|Overall Study||0||
48317841|NCT02943564|101104123|FG000|STARTED|Overall Study||217||
48317842|NCT02943564|101104124|FG001|STARTED|Overall Study||211||
48317843|NCT02943564|101104125|FG002|STARTED|Overall Study||210||
48407333|NCT03296072|101328536|FG002|COMPLETED|Treatment Period 1||10||
48407334|NCT03296072|101328537|FG003|COMPLETED|Treatment Period 1||10||
48736206|NCT03137225|102137214|FG000|COMPLETED|Second 4 Hour Measurement Period||1||
48736207|NCT03137225|102137215|FG001|COMPLETED|Second 4 Hour Measurement Period||0||
48736208|NCT03137225|102137214|FG000|NOT COMPLETED|Second 4 Hour Measurement Period||0||
48736209|NCT03137225|102137215|FG001|NOT COMPLETED|Second 4 Hour Measurement Period||0||
48736210|NCT02155920|102137216|FG000|STARTED|Overall Study||11||
48736211|NCT02155920|102137216|FG000|COMPLETED|Overall Study||11||
48736212|NCT02155920|102137216|FG000|NOT COMPLETED|Overall Study||0||
48736213|NCT02315534|102137217|FG000|STARTED|Overall Study||4||
48736214|NCT02315534|102137218|FG001|STARTED|Overall Study||30||
48736215|NCT02315534|102137217|FG000|Assessment of Dose-limiting Toxicity (DLT)|Overall Study||0||
48736216|NCT02315534|102137218|FG001|Assessment of Dose-limiting Toxicity (DLT)|Overall Study||0||
48736217|NCT02315534|102137217|FG000|Off Treatment Due to Radiologic Disease Progression (PD)|Overall Study||2||
48736218|NCT02315534|102137218|FG001|Off Treatment Due to Radiologic Disease Progression (PD)|Overall Study||20||
48736219|NCT02315534|102137217|FG000|Off Treatment Due to Clinically Unacceptable Toxicities|Overall Study||1||
48736220|NCT02315534|102137218|FG001|Off Treatment Due to Clinically Unacceptable Toxicities|Overall Study||7||
48736221|NCT02315534|102137217|FG000|Off Treatment Due to Patient Request|Overall Study||1||
48736222|NCT02315534|102137218|FG001|Off Treatment Due to Patient Request|Overall Study||2||
48736223|NCT02315534|102137217|FG000|Off Treatment Due to Clinical PD|Overall Study||0||
48317844|NCT02943564|101104123|FG000|Responder|Overall Study||83||
48317845|NCT02943564|101104124|FG001|Responder|Overall Study||77||
48317846|NCT02943564|101104125|FG002|Responder|Overall Study||77||
48407335|NCT03296072|101328538|FG004|COMPLETED|Treatment Period 1||10||
48407336|NCT03296072|101328539|FG005|COMPLETED|Treatment Period 1||11||
48407337|NCT03296072|101328534|FG000|NOT COMPLETED|Treatment Period 1||0||
48407338|NCT03296072|101328535|FG001|NOT COMPLETED|Treatment Period 1||0||
48407339|NCT03296072|101328536|FG002|NOT COMPLETED|Treatment Period 1||0||
48407340|NCT03296072|101328537|FG003|NOT COMPLETED|Treatment Period 1||0||
48407341|NCT03296072|101328538|FG004|NOT COMPLETED|Treatment Period 1||0||
48407342|NCT03296072|101328539|FG005|NOT COMPLETED|Treatment Period 1||0||
48407343|NCT03296072|101328534|FG000|STARTED|Treament Period 1: Wash Out Period||10||
48407344|NCT03296072|101328535|FG001|STARTED|Treament Period 1: Wash Out Period||11||
48407345|NCT03296072|101328536|FG002|STARTED|Treament Period 1: Wash Out Period||10||
48407346|NCT03296072|101328537|FG003|STARTED|Treament Period 1: Wash Out Period||10||
48736224|NCT02315534|102137218|FG001|Off Treatment Due to Clinical PD|Overall Study||1||
48736225|NCT02315534|102137217|FG000|COMPLETED|Overall Study||4||
48736226|NCT02315534|102137218|FG001|COMPLETED|Overall Study||30||
48736227|NCT02315534|102137217|FG000|NOT COMPLETED|Overall Study||0||
48736228|NCT02315534|102137218|FG001|NOT COMPLETED|Overall Study||0||
48736229|NCT04120402|102137219|FG000|STARTED|Overall Study||163||
48736230|NCT04120402|102137220|FG001|STARTED|Overall Study||155||
48736231|NCT04120402|102137219|FG000|COMPLETED|Overall Study||156||
48736232|NCT04120402|102137220|FG001|COMPLETED|Overall Study||148||
48736233|NCT04120402|102137219|FG000|NOT COMPLETED|Overall Study||7||
48736234|NCT04120402|102137220|FG001|NOT COMPLETED|Overall Study||7||
48736235|NCT01855360|102137221|FG000|STARTED|Overall Study||40||
48736236|NCT01855360|102137221|FG000|COMPLETED|Overall Study||30||
48736237|NCT01855360|102137221|FG000|NOT COMPLETED|Overall Study||10||
48736238|NCT00779025|102137222|FG000|STARTED|Overall Study||82||
48736239|NCT00779025|102137222|FG000|COMPLETED|Overall Study||81||
48736240|NCT00779025|102137222|FG000|NOT COMPLETED|Overall Study||1||
48736241|NCT00379912|102137223|FG000|STARTED|Overall Study||7||
48736242|NCT00379912|102137224|FG001|STARTED|Overall Study||8||
48736243|NCT00379912|102137223|FG000|COMPLETED|Overall Study||6||
48736244|NCT00379912|102137224|FG001|COMPLETED|Overall Study||8||
48736245|NCT00379912|102137223|FG000|NOT COMPLETED|Overall Study||1||
48736246|NCT00379912|102137224|FG001|NOT COMPLETED|Overall Study||0||
48736247|NCT03477838|102137225|FG000|STARTED|Overall Study||28||
48736248|NCT03477838|102137225|FG000|COMPLETED|Overall Study||14||
48736249|NCT03477838|102137225|FG000|NOT COMPLETED|Overall Study||14||
48736250|NCT03539601|102137226|FG000|STARTED|Overall Study||60||
48736251|NCT03539601|102137227|FG001|STARTED|Overall Study||59||
48736252|NCT03539601|102137228|FG002|STARTED|Overall Study||71||
48736253|NCT03539601|102137229|FG003|STARTED|Overall Study||47||
48736254|NCT03539601|102137226|FG000|Treated|Overall Study||59||
48736255|NCT03539601|102137227|FG001|Treated|Overall Study||58||
48736256|NCT03539601|102137228|FG002|Treated|Overall Study||71||
48317847|NCT02943564|101104123|FG000|Non-Responder|Overall Study||134||
48317848|NCT02943564|101104124|FG001|Non-Responder|Overall Study||134||
48317849|NCT02943564|101104125|FG002|Non-Responder|Overall Study||133||
48317850|NCT02943564|101104123|FG000|COMPLETED|Overall Study||207||
48736257|NCT03539601|102137229|FG003|Treated|Overall Study||47||
48736258|NCT03539601|102137226|FG000|COMPLETED|Overall Study||54||
48736259|NCT03539601|102137227|FG001|COMPLETED|Overall Study||52||
48736260|NCT03539601|102137228|FG002|COMPLETED|Overall Study||65||
48736261|NCT03539601|102137229|FG003|COMPLETED|Overall Study||46||
48736262|NCT03539601|102137226|FG000|NOT COMPLETED|Overall Study||6||
48736263|NCT03539601|102137227|FG001|NOT COMPLETED|Overall Study||7||
48736264|NCT03539601|102137228|FG002|NOT COMPLETED|Overall Study||6||
48736265|NCT03539601|102137229|FG003|NOT COMPLETED|Overall Study||1||
48317851|NCT02943564|101104124|FG001|COMPLETED|Overall Study||198||
48317852|NCT02943564|101104125|FG002|COMPLETED|Overall Study||201||
48317853|NCT02943564|101104123|FG000|NOT COMPLETED|Overall Study||10||
48317854|NCT02943564|101104124|FG001|NOT COMPLETED|Overall Study||13||
48440024|NCT01266642|101410014|FG001|COMPLETED|Overall Study||137||
48656948|NCT03382873|101943731|FG001|NOT COMPLETED|Overall Study||62||
48736266|NCT04178720|102137230|FG000|STARTED|Overall Study||40||80
48736267|NCT04178720|102137231|FG001|STARTED|Overall Study||78||156
48736268|NCT04178720|102137230|FG000|COMPLETED|Overall Study||38||76
48317855|NCT02943564|101104125|FG002|NOT COMPLETED|Overall Study||9||
48317856|NCT01231659|101104126|FG000|STARTED|Overall Study||72||
48368050|NCT03567291|101230095|FG003|NOT COMPLETED|Period III||85||
48656949|NCT04984590|101943732|FG000|STARTED|Overall Study||9||9
48656950|NCT04984590|101943732|FG000|COMPLETED|Overall Study||9||9
48656951|NCT04984590|101943732|FG000|NOT COMPLETED|Overall Study||0||0
48656952|NCT02741193|101943733|FG000|STARTED|Overall Study||2||
48656953|NCT02741193|101943733|FG000|COMPLETED|Overall Study||0||
48656954|NCT02741193|101943733|FG000|NOT COMPLETED|Overall Study||2||
48656955|NCT01340170|101943734|FG000|STARTED|Overall Study||79|ITT population|83
48656956|NCT01340170|101943735|FG001|STARTED|Overall Study||86|ITT population|99
48656957|NCT01340170|101943736|FG002|STARTED|Overall Study||3|ITT population|6
48656958|NCT01340170|101943734|FG000|Permanent Restoration (Start + 3 Months)|Overall Study||79|ITT population|83
48656959|NCT01340170|101943735|FG001|Permanent Restoration (Start + 3 Months)|Overall Study||81|ITT population|94
48657091|NCT03648372|101943768|FG011|NOT COMPLETED|Overall Study||5||
48736269|NCT04178720|102137231|FG001|COMPLETED|Overall Study||77||154
48736270|NCT04178720|102137230|FG000|NOT COMPLETED|Overall Study||2||4
48317857|NCT01231659|101104126|FG000|Per Protocol (PP) Set|Overall Study||72|All patients that were treated per protocol and analyzed as 1 group|
48317858|NCT01231659|101104126|FG000|Safety Set|Overall Study||72|All patients who received at least 1 dose of the study drug|
48317859|NCT01231659|101104126|FG000|COMPLETED|Overall Study||0||
48317860|NCT01231659|101104126|FG000|NOT COMPLETED|Overall Study||72||
48317861|NCT04744207|101104127|FG000|STARTED|Treatment||33||
48317862|NCT04744207|101104128|FG001|STARTED|Treatment||36||
48317863|NCT04744207|101104127|FG000|COMPLETED|Treatment||30||
48317864|NCT04744207|101104128|FG001|COMPLETED|Treatment||34||
48317865|NCT04744207|101104127|FG000|NOT COMPLETED|Treatment||3||
48317866|NCT04744207|101104128|FG001|NOT COMPLETED|Treatment||2||
48317867|NCT04744207|101104127|FG000|STARTED|Follow-up||30||
48407347|NCT03296072|101328538|FG004|STARTED|Treament Period 1: Wash Out Period||10||
48407348|NCT03296072|101328539|FG005|STARTED|Treament Period 1: Wash Out Period||11||
48407349|NCT03296072|101328534|FG000|COMPLETED|Treament Period 1: Wash Out Period||10||
48407350|NCT03296072|101328535|FG001|COMPLETED|Treament Period 1: Wash Out Period||11||
48317868|NCT04744207|101104128|FG001|STARTED|Follow-up||34||
48317869|NCT04744207|101104127|FG000|COMPLETED|Follow-up||30||
48317870|NCT04744207|101104128|FG001|COMPLETED|Follow-up||34||
48317871|NCT04744207|101104127|FG000|NOT COMPLETED|Follow-up||0||
48317872|NCT04744207|101104128|FG001|NOT COMPLETED|Follow-up||0||
48317873|NCT03328702|101104129|FG000|STARTED|Overall Study||4||
48317874|NCT03328702|101104129|FG000|COMPLETED|Overall Study||4||
48317875|NCT03328702|101104129|FG000|NOT COMPLETED|Overall Study||0||
48317876|NCT00616122|101104130|FG000|STARTED|Overall Study||4||
48317877|NCT00616122|101104131|FG001|STARTED|Overall Study||7||
48317878|NCT00616122|101104132|FG002|STARTED|Overall Study||10||
48317879|NCT00616122|101104133|FG003|STARTED|Overall Study||11||
48317880|NCT00616122|101104130|FG000|COMPLETED|Overall Study||4||
48317881|NCT00616122|101104131|FG001|COMPLETED|Overall Study||7||
48407351|NCT03296072|101328536|FG002|COMPLETED|Treament Period 1: Wash Out Period||10||
48407352|NCT03296072|101328537|FG003|COMPLETED|Treament Period 1: Wash Out Period||10||
48407353|NCT03296072|101328538|FG004|COMPLETED|Treament Period 1: Wash Out Period||10||
48407354|NCT03296072|101328539|FG005|COMPLETED|Treament Period 1: Wash Out Period||11||
48407355|NCT03296072|101328534|FG000|NOT COMPLETED|Treament Period 1: Wash Out Period||0||
48407356|NCT03296072|101328535|FG001|NOT COMPLETED|Treament Period 1: Wash Out Period||0||
48317882|NCT00616122|101104132|FG002|COMPLETED|Overall Study||10||
48317883|NCT00616122|101104133|FG003|COMPLETED|Overall Study||0||
48317884|NCT00616122|101104130|FG000|NOT COMPLETED|Overall Study||0||
48317885|NCT00616122|101104131|FG001|NOT COMPLETED|Overall Study||0||
48317886|NCT00616122|101104132|FG002|NOT COMPLETED|Overall Study||0||
48407357|NCT03296072|101328536|FG002|NOT COMPLETED|Treament Period 1: Wash Out Period||0||
48616025|NCT00522548|101845042|FG000|Consented to Pharmacokinetic Study|Overall Study||11||
48317887|NCT00616122|101104133|FG003|NOT COMPLETED|Overall Study||11||
48317888|NCT00939783|101104134|FG000|STARTED|Overall Study||649||
48317889|NCT00939783|101104134|FG000|Treated|Overall Study||648||
48616026|NCT00522548|101845043|FG001|Consented to Pharmacokinetic Study|Overall Study||10||
48317890|NCT00939783|101104134|FG000|COMPLETED|Overall Study||0||
48317891|NCT00939783|101104134|FG000|NOT COMPLETED|Overall Study||649||
48317892|NCT03523728|101104135|FG000|STARTED|Stage 1 (24 Months)||78||
48616027|NCT00522548|101845042|FG000|Completed 0/2 PK Visits|Overall Study||3||
48616028|NCT00522548|101845043|FG001|Completed 0/2 PK Visits|Overall Study||4||
48616029|NCT00522548|101845042|FG000|Completed 1/2 PK Visits|Overall Study||1||
48616030|NCT00522548|101845043|FG001|Completed 1/2 PK Visits|Overall Study||1||
48616031|NCT00522548|101845042|FG000|Completed 2/2 PK Visits|Overall Study||7||
48616032|NCT00522548|101845043|FG001|Completed 2/2 PK Visits|Overall Study||5||
48616033|NCT00522548|101845042|FG000|COMPLETED|Overall Study||16||
48616034|NCT00522548|101845043|FG001|COMPLETED|Overall Study||15||
48616035|NCT00522548|101845042|FG000|NOT COMPLETED|Overall Study||2||
48616036|NCT00522548|101845043|FG001|NOT COMPLETED|Overall Study||4||
48616037|NCT00335517|101845044|FG000|STARTED|Overall Study||100||
48616038|NCT00335517|101845044|FG000|COMPLETED|Overall Study||98||
48616039|NCT00335517|101845044|FG000|NOT COMPLETED|Overall Study||2||
48616040|NCT01242241|101845045|FG000|STARTED|Overall Study||40||
48616041|NCT01242241|101845046|FG001|STARTED|Overall Study||40||
48616042|NCT01242241|101845045|FG000|COMPLETED|Overall Study||40||
48616043|NCT01242241|101845046|FG001|COMPLETED|Overall Study||40||
48616044|NCT01242241|101845045|FG000|NOT COMPLETED|Overall Study||0||
48616045|NCT01242241|101845046|FG001|NOT COMPLETED|Overall Study||0||
48616046|NCT01733745|101845047|FG000|STARTED|Overall Study||13||
48616047|NCT01733745|101845048|FG001|STARTED|Overall Study||13||
48616048|NCT01733745|101845047|FG000|COMPLETED|Overall Study||13||
48616049|NCT01733745|101845048|FG001|COMPLETED|Overall Study||13||
48616050|NCT01733745|101845047|FG000|NOT COMPLETED|Overall Study||0||
48616051|NCT01733745|101845048|FG001|NOT COMPLETED|Overall Study||0||
48616052|NCT01051817|101845049|FG000|STARTED|Overall Study||38||
48616053|NCT01051817|101845050|FG001|STARTED|Overall Study||35||
48616054|NCT01051817|101845049|FG000|COMPLETED|Overall Study||35||
48616055|NCT01051817|101845050|FG001|COMPLETED|Overall Study||26||
48317893|NCT03523728|101104136|FG001|STARTED|Stage 1 (24 Months)||78||
48317894|NCT03523728|101104137|FG002|STARTED|Stage 1 (24 Months)||80||
48317895|NCT03523728|101104138|FG003|STARTED|Stage 1 (24 Months)||0||
48317896|NCT03523728|101104139|FG004|STARTED|Stage 1 (24 Months)||0||
48317897|NCT03523728|101104135|FG000|COMPLETED|Stage 1 (24 Months)||12||
48317898|NCT03523728|101104136|FG001|COMPLETED|Stage 1 (24 Months)||10||
48317899|NCT03523728|101104137|FG002|COMPLETED|Stage 1 (24 Months)||12||
48317900|NCT03523728|101104138|FG003|COMPLETED|Stage 1 (24 Months)||0||
48317901|NCT03523728|101104139|FG004|COMPLETED|Stage 1 (24 Months)||0||
48317902|NCT03523728|101104135|FG000|NOT COMPLETED|Stage 1 (24 Months)||66||
48317903|NCT03523728|101104136|FG001|NOT COMPLETED|Stage 1 (24 Months)||68||
48407358|NCT03296072|101328537|FG003|NOT COMPLETED|Treament Period 1: Wash Out Period||0||
48407359|NCT03296072|101328538|FG004|NOT COMPLETED|Treament Period 1: Wash Out Period||0||
48407360|NCT03296072|101328539|FG005|NOT COMPLETED|Treament Period 1: Wash Out Period||0||
48736271|NCT04178720|102137231|FG001|NOT COMPLETED|Overall Study||1||2
48736272|NCT02781610|102137232|FG000|STARTED|Overall Study||140|Randomized to the ERR-10 or ERR-14 arm if allocated to ERR treatment group, or randomized to the NERR-14 or NERR-21 arm if allocated to NERR treatment group.|
48736273|NCT02781610|102137233|FG001|STARTED|Overall Study||137|Randomized to the ERR-10 or ERR-14 arm if allocated to ERR treatment group, or randomized to the NERR-14 or NERR-21 arm if allocated to NERR treatment group.|
48736274|NCT02781610|102137234|FG002|STARTED|Overall Study||353|Randomized to the ERR-10 or ERR-14 arm if allocated to ERR treatment group, or randomized to the NERR-14 or NERR-21 arm if allocated to NERR treatment group.|
48736275|NCT02781610|102137235|FG003|STARTED|Overall Study||352|Randomized to the ERR-10 or ERR-14 arm if allocated to ERR treatment group, or randomized to the NERR-14 or NERR-21 arm if allocated to NERR treatment group.|
48736276|NCT02781610|102137232|FG000|COMPLETED|Overall Study||134|Completed last study visit (Day 25 for ERR-10 arm, Day 29 for ERR-14 arm or NERR-14 arm, and Day 36 for NERR-21 arm)|
48736277|NCT02781610|102137233|FG001|COMPLETED|Overall Study||130|Completed last study visit (Day 25 for ERR-10 arm, Day 29 for ERR-14 arm or NERR-14 arm, and Day 36 for NERR-21 arm)|
48736278|NCT02781610|102137234|FG002|COMPLETED|Overall Study||336|Completed last study visit (Day 25 for ERR-10 arm, Day 29 for ERR-14 arm or NERR-14 arm, and Day 36 for NERR-21 arm)|
48736279|NCT02781610|102137235|FG003|COMPLETED|Overall Study||323|Completed last study visit (Day 25 for ERR-10 arm, Day 29 for ERR-14 arm or NERR-14 arm, and Day 36 for NERR-21 arm)|
48736280|NCT02781610|102137232|FG000|NOT COMPLETED|Overall Study||6||
48736281|NCT02781610|102137233|FG001|NOT COMPLETED|Overall Study||7||
48736282|NCT02781610|102137234|FG002|NOT COMPLETED|Overall Study||17||
48736283|NCT02781610|102137235|FG003|NOT COMPLETED|Overall Study||29||
48736284|NCT02519595|102137236|FG000|STARTED|Overall Study||58||
48736285|NCT02519595|102137237|FG001|STARTED|Overall Study||57||
48736286|NCT02519595|102137238|FG002|STARTED|Overall Study||56||
48736287|NCT02519595|102137236|FG000|COMPLETED|Overall Study||50||
48736288|NCT02519595|102137237|FG001|COMPLETED|Overall Study||35||
48736289|NCT02519595|102137238|FG002|COMPLETED|Overall Study||40||
48736290|NCT02519595|102137236|FG000|NOT COMPLETED|Overall Study||8||
48317904|NCT03523728|101104137|FG002|NOT COMPLETED|Stage 1 (24 Months)||68||
48317905|NCT03523728|101104138|FG003|NOT COMPLETED|Stage 1 (24 Months)||0||
48317906|NCT03523728|101104139|FG004|NOT COMPLETED|Stage 1 (24 Months)||0||
48317907|NCT03523728|101104135|FG000|STARTED|Stage 2 (24 Months)||0||
48317908|NCT03523728|101104136|FG001|STARTED|Stage 2 (24 Months)||0||
48317909|NCT03523728|101104137|FG002|STARTED|Stage 2 (24 Months)||0||
48317910|NCT03523728|101104138|FG003|STARTED|Stage 2 (24 Months)||123||
48317911|NCT03523728|101104139|FG004|STARTED|Stage 2 (24 Months)||119||
48317912|NCT03523728|101104135|FG000|Treated|Stage 2 (24 Months)||0||
48317913|NCT03523728|101104136|FG001|Treated|Stage 2 (24 Months)||0||
48317914|NCT03523728|101104137|FG002|Treated|Stage 2 (24 Months)||0||
48317915|NCT03523728|101104138|FG003|Treated|Stage 2 (24 Months)||122||
48317916|NCT03523728|101104139|FG004|Treated|Stage 2 (24 Months)||119||
48407361|NCT03296072|101328534|FG000|STARTED|Treament Period 2||10||
48407362|NCT03296072|101328535|FG001|STARTED|Treament Period 2||11||
48736291|NCT02519595|102137237|FG001|NOT COMPLETED|Overall Study||22||
48160397|NCT02178059|100715852|FG001|STARTED|Second Intervention||17||
48160398|NCT02178059|100715851|FG000|COMPLETED|Second Intervention||16||
48160399|NCT02178059|100715852|FG001|COMPLETED|Second Intervention||17||
48160400|NCT02178059|100715851|FG000|NOT COMPLETED|Second Intervention||0||
48160401|NCT02178059|100715852|FG001|NOT COMPLETED|Second Intervention||0||
48160402|NCT03215901|100715853|FG000|STARTED|Overall Study||199||
48160403|NCT03215901|100715854|FG001|STARTED|Overall Study||112||
48160404|NCT03215901|100715855|FG002|STARTED|Overall Study||116||
48317917|NCT03523728|101104135|FG000|Estimated Glomerular Filtration Rate (eGFR) Between 45 and 89.9 mL/Min/1.73 m^2 at Screening|Stage 2 (24 Months)||0||
48317918|NCT03523728|101104136|FG001|Estimated Glomerular Filtration Rate (eGFR) Between 45 and 89.9 mL/Min/1.73 m^2 at Screening|Stage 2 (24 Months)||0||
48317919|NCT03523728|101104137|FG002|Estimated Glomerular Filtration Rate (eGFR) Between 45 and 89.9 mL/Min/1.73 m^2 at Screening|Stage 2 (24 Months)||0||
48368051|NCT03691623|101230096|FG000|STARTED|Overall Study||39||
48407363|NCT03296072|101328536|FG002|STARTED|Treament Period 2||10||
48407364|NCT03296072|101328537|FG003|STARTED|Treament Period 2||10||
48160405|NCT03215901|100715853|FG000|COMPLETED|Overall Study||199||
48160406|NCT03215901|100715854|FG001|COMPLETED|Overall Study||112||
48160407|NCT03215901|100715855|FG002|COMPLETED|Overall Study||116||
48160408|NCT03215901|100715853|FG000|NOT COMPLETED|Overall Study||0||
48160409|NCT03215901|100715854|FG001|NOT COMPLETED|Overall Study||0||
48317920|NCT03523728|101104138|FG003|Estimated Glomerular Filtration Rate (eGFR) Between 45 and 89.9 mL/Min/1.73 m^2 at Screening|Stage 2 (24 Months)||97||
48317921|NCT03523728|101104139|FG004|Estimated Glomerular Filtration Rate (eGFR) Between 45 and 89.9 mL/Min/1.73 m^2 at Screening|Stage 2 (24 Months)||90||
48317922|NCT03523728|101104135|FG000|eGFR Between 30 and 44.9 mL/Min/1.73 m^2 at Screening|Stage 2 (24 Months)||0||
48317923|NCT03523728|101104136|FG001|eGFR Between 30 and 44.9 mL/Min/1.73 m^2 at Screening|Stage 2 (24 Months)||0||
48317924|NCT03523728|101104137|FG002|eGFR Between 30 and 44.9 mL/Min/1.73 m^2 at Screening|Stage 2 (24 Months)||0||
48317925|NCT03523728|101104138|FG003|eGFR Between 30 and 44.9 mL/Min/1.73 m^2 at Screening|Stage 2 (24 Months)||25||
48317926|NCT03523728|101104139|FG004|eGFR Between 30 and 44.9 mL/Min/1.73 m^2 at Screening|Stage 2 (24 Months)||29||
48317927|NCT03523728|101104135|FG000|COMPLETED|Stage 2 (24 Months)||0||
48317928|NCT03523728|101104136|FG001|COMPLETED|Stage 2 (24 Months)||0||
48317929|NCT03523728|101104137|FG002|COMPLETED|Stage 2 (24 Months)||0||
48317930|NCT03523728|101104138|FG003|COMPLETED|Stage 2 (24 Months)||0||
48317931|NCT03523728|101104139|FG004|COMPLETED|Stage 2 (24 Months)||0||
48317932|NCT03523728|101104135|FG000|NOT COMPLETED|Stage 2 (24 Months)||0||
48317933|NCT03523728|101104136|FG001|NOT COMPLETED|Stage 2 (24 Months)||0||
48317934|NCT03523728|101104137|FG002|NOT COMPLETED|Stage 2 (24 Months)||0||
48317935|NCT03523728|101104138|FG003|NOT COMPLETED|Stage 2 (24 Months)||123||
48317936|NCT03523728|101104139|FG004|NOT COMPLETED|Stage 2 (24 Months)||119||
48317937|NCT00441974|101104140|FG000|STARTED|Overall Study||1470||
48317938|NCT00441974|101104140|FG000|COMPLETED|Overall Study||1342||
48317939|NCT00441974|101104140|FG000|NOT COMPLETED|Overall Study||128||
48317940|NCT00645593|101104141|FG000|STARTED|Overall Study||29||
48317941|NCT00645593|101104142|FG001|STARTED|Overall Study||60||
48317942|NCT00645593|101104141|FG000|COMPLETED|Overall Study||28||
48317943|NCT00645593|101104142|FG001|COMPLETED|Overall Study||60||
48317944|NCT00645593|101104141|FG000|NOT COMPLETED|Overall Study||1||
48317945|NCT00645593|101104142|FG001|NOT COMPLETED|Overall Study||0||
48317946|NCT00734799|101104143|FG000|STARTED|Overall Study||9||
48317947|NCT00734799|101104144|FG001|STARTED|Overall Study||13||
48317948|NCT00734799|101104143|FG000|COMPLETED|Overall Study||9||
48317949|NCT00734799|101104144|FG001|COMPLETED|Overall Study||9||
48317950|NCT00734799|101104143|FG000|NOT COMPLETED|Overall Study||0||
48317951|NCT00734799|101104144|FG001|NOT COMPLETED|Overall Study||4||
48317952|NCT02121262|101104145|FG000|STARTED|Overall Study||139||
48317953|NCT02121262|101104146|FG001|STARTED|Overall Study||145||
48317954|NCT02121262|101104145|FG000|Treated|Overall Study||129||
48317955|NCT02121262|101104146|FG001|Treated|Overall Study||145||
48317956|NCT02121262|101104145|FG000|Modified Intent-to-treat Population|Overall Study||127||
48317957|NCT02121262|101104146|FG001|Modified Intent-to-treat Population|Overall Study||145||
48317958|NCT02121262|101104145|FG000|COMPLETED|Overall Study||108||
48317959|NCT02121262|101104146|FG001|COMPLETED|Overall Study||135||
48317960|NCT02121262|101104145|FG000|NOT COMPLETED|Overall Study||31||
48317961|NCT02121262|101104146|FG001|NOT COMPLETED|Overall Study||10||
48317962|NCT00365456|101104147|FG000|STARTED|Trial Period I (12 Months)||407||
48317963|NCT00365456|101104148|FG001|STARTED|Trial Period I (12 Months)||0||
48317964|NCT00365456|101104147|FG000|COMPLETED|Trial Period I (12 Months)||282||
48317965|NCT00365456|101104148|FG001|COMPLETED|Trial Period I (12 Months)||0||
48317966|NCT00365456|101104147|FG000|NOT COMPLETED|Trial Period I (12 Months)||125||
48317967|NCT00365456|101104148|FG001|NOT COMPLETED|Trial Period I (12 Months)||0||
48317968|NCT00365456|101104147|FG000|STARTED|Trial Period II (12 Months)||0||
48317969|NCT00365456|101104148|FG001|STARTED|Trial Period II (12 Months)||282||
48317970|NCT00365456|101104147|FG000|COMPLETED|Trial Period II (12 Months)||0||
48317971|NCT00365456|101104148|FG001|COMPLETED|Trial Period II (12 Months)||268||
48317972|NCT00365456|101104147|FG000|NOT COMPLETED|Trial Period II (12 Months)||0||
48317973|NCT00365456|101104148|FG001|NOT COMPLETED|Trial Period II (12 Months)||14||
48317974|NCT00365456|101104147|FG000|STARTED|Trial Period III (12 Months)||136||
48317975|NCT00365456|101104148|FG001|STARTED|Trial Period III (12 Months)||132||
48317976|NCT00365456|101104147|FG000|COMPLETED|Trial Period III (12 Months)||118||
48317977|NCT00365456|101104148|FG001|COMPLETED|Trial Period III (12 Months)||127||
48317978|NCT00365456|101104147|FG000|NOT COMPLETED|Trial Period III (12 Months)||18||
48317979|NCT00365456|101104148|FG001|NOT COMPLETED|Trial Period III (12 Months)||5||
48317980|NCT03959332|101104149|FG000|STARTED|Overall Study||16||
48317981|NCT03959332|101104150|FG001|STARTED|Overall Study||16||
48317982|NCT03959332|101104149|FG000|COMPLETED|Overall Study||16||
48317983|NCT03959332|101104150|FG001|COMPLETED|Overall Study||16||
48317984|NCT03959332|101104149|FG000|NOT COMPLETED|Overall Study||0||
48317985|NCT03959332|101104150|FG001|NOT COMPLETED|Overall Study||0||
48317986|NCT01733628|101104151|FG000|STARTED|Overall Study||143||
48317987|NCT01733628|101104151|FG000|COMPLETED|Overall Study||143||
48317988|NCT01733628|101104151|FG000|NOT COMPLETED|Overall Study||0||
48317989|NCT05515250|101104152|FG000|STARTED|Overall Study||1||
48317990|NCT05515250|101104152|FG000|COMPLETED|Overall Study||1||
48317991|NCT05515250|101104152|FG000|NOT COMPLETED|Overall Study||0||
48317992|NCT02340585|101104153|FG000|STARTED|Anterior Cohort||182||
48317993|NCT02340585|101104153|FG000|COMPLETED|Anterior Cohort||182||
48317994|NCT02340585|101104153|FG000|NOT COMPLETED|Anterior Cohort||0||
48317995|NCT02340585|101104153|FG000|STARTED|Posterior Cohort||116||
48317996|NCT02340585|101104153|FG000|COMPLETED|Posterior Cohort||116||
48317997|NCT02340585|101104153|FG000|NOT COMPLETED|Posterior Cohort||0||
48317998|NCT02340585|101104153|FG000|STARTED|Post-approval Study (PAS)||298||
48317999|NCT02340585|101104153|FG000|COMPLETED|Post-approval Study (PAS)||298||
48318000|NCT02340585|101104153|FG000|NOT COMPLETED|Post-approval Study (PAS)||0||
48318001|NCT02866279|101104154|FG000|STARTED|Overall Study||51||
48318002|NCT02866279|101104155|FG001|STARTED|Overall Study||52||
48318003|NCT02866279|101104156|FG002|STARTED|Overall Study||52||
48318004|NCT02866279|101104154|FG000|COMPLETED|Overall Study||51||
48318005|NCT02866279|101104155|FG001|COMPLETED|Overall Study||52||
48318006|NCT02866279|101104156|FG002|COMPLETED|Overall Study||52||
48318007|NCT02866279|101104154|FG000|NOT COMPLETED|Overall Study||0||
48318008|NCT02866279|101104155|FG001|NOT COMPLETED|Overall Study||0||
48318009|NCT02866279|101104156|FG002|NOT COMPLETED|Overall Study||0||
48318010|NCT02113436|101104157|FG000|STARTED|Period 1: 8 Weeks||150||
48318011|NCT02113436|101104158|FG001|STARTED|Period 1: 8 Weeks||150||
48318012|NCT02113436|101104159|FG002|STARTED|Period 1: 8 Weeks||0||
48318013|NCT02113436|101104160|FG003|STARTED|Period 1: 8 Weeks||0||
48318014|NCT02113436|101104157|FG000|COMPLETED|Period 1: 8 Weeks||142||
48318015|NCT02113436|101104158|FG001|COMPLETED|Period 1: 8 Weeks||148||
48318016|NCT02113436|101104159|FG002|COMPLETED|Period 1: 8 Weeks||0||
48318017|NCT02113436|101104160|FG003|COMPLETED|Period 1: 8 Weeks||0||
48318018|NCT02113436|101104157|FG000|NOT COMPLETED|Period 1: 8 Weeks||8||
48318019|NCT02113436|101104158|FG001|NOT COMPLETED|Period 1: 8 Weeks||2||
48318020|NCT02113436|101104159|FG002|NOT COMPLETED|Period 1: 8 Weeks||0||
48318021|NCT02113436|101104160|FG003|NOT COMPLETED|Period 1: 8 Weeks||0||
48318022|NCT02113436|101104157|FG000|STARTED|Period 2: 16 Weeks||0||
48318023|NCT02113436|101104158|FG001|STARTED|Period 2: 16 Weeks||0||
48318024|NCT02113436|101104159|FG002|STARTED|Period 2: 16 Weeks||141||
48318025|NCT02113436|101104160|FG003|STARTED|Period 2: 16 Weeks||147||
48318026|NCT02113436|101104157|FG000|COMPLETED|Period 2: 16 Weeks||0||
48318027|NCT02113436|101104158|FG001|COMPLETED|Period 2: 16 Weeks||0||
48318028|NCT02113436|101104159|FG002|COMPLETED|Period 2: 16 Weeks||132||
48318029|NCT02113436|101104160|FG003|COMPLETED|Period 2: 16 Weeks||136||
48318030|NCT02113436|101104157|FG000|NOT COMPLETED|Period 2: 16 Weeks||0||
48318031|NCT02113436|101104158|FG001|NOT COMPLETED|Period 2: 16 Weeks||0||
48318032|NCT02113436|101104159|FG002|NOT COMPLETED|Period 2: 16 Weeks||9||
48318033|NCT02113436|101104160|FG003|NOT COMPLETED|Period 2: 16 Weeks||11||
48318034|NCT02242578|101104161|FG000|STARTED|Overall Study||0||
48318035|NCT02242578|101104162|FG001|STARTED|Overall Study||0||
48318036|NCT02242578|101104161|FG000|COMPLETED|Overall Study||0||
48318037|NCT02242578|101104162|FG001|COMPLETED|Overall Study||0||
48318038|NCT02242578|101104161|FG000|NOT COMPLETED|Overall Study||0||
48318039|NCT02242578|101104162|FG001|NOT COMPLETED|Overall Study||0||
48318040|NCT00282334|101104163|FG000|STARTED|Overall Study||113||
48318041|NCT00282334|101104164|FG001|STARTED|Overall Study||123||
48318042|NCT00282334|101104163|FG000|COMPLETED|Overall Study||105||
48318043|NCT00282334|101104164|FG001|COMPLETED|Overall Study||118||
48318044|NCT00282334|101104163|FG000|NOT COMPLETED|Overall Study||8||
48318045|NCT00282334|101104164|FG001|NOT COMPLETED|Overall Study||5||
48318046|NCT04854434|101104165|FG000|STARTED|Overall Study||4||
48318047|NCT04854434|101104166|FG001|STARTED|Overall Study||5||
48318048|NCT04854434|101104167|FG002|STARTED|Overall Study||4||
48318049|NCT04854434|101104165|FG000|COMPLETED|Overall Study||0||
48318050|NCT04854434|101104166|FG001|COMPLETED|Overall Study||1||
48318051|NCT04854434|101104167|FG002|COMPLETED|Overall Study||0||
48318052|NCT04854434|101104165|FG000|NOT COMPLETED|Overall Study||4||
48318053|NCT04854434|101104166|FG001|NOT COMPLETED|Overall Study||4||
48318054|NCT04854434|101104167|FG002|NOT COMPLETED|Overall Study||4||
48318055|NCT01417195|101104168|FG000|STARTED|Overall Study||60||
48318056|NCT01417195|101104169|FG001|STARTED|Overall Study||62||
48318057|NCT01417195|101104168|FG000|COMPLETED|Overall Study||57||
48318058|NCT01417195|101104169|FG001|COMPLETED|Overall Study||61||
48318059|NCT01417195|101104168|FG000|NOT COMPLETED|Overall Study||3||
48318060|NCT01417195|101104169|FG001|NOT COMPLETED|Overall Study||1||
48318061|NCT03704142|101104170|FG000|STARTED|Overall Study||10||
48318062|NCT03704142|101104171|FG001|STARTED|Overall Study||10||
48318063|NCT03704142|101104172|FG002|STARTED|Overall Study||10||
48318064|NCT03704142|101104173|FG003|STARTED|Overall Study||10||
48318065|NCT03704142|101104170|FG000|COMPLETED|Overall Study||10||
48318066|NCT03704142|101104171|FG001|COMPLETED|Overall Study||10||
48318067|NCT03704142|101104172|FG002|COMPLETED|Overall Study||10||
48318068|NCT03704142|101104173|FG003|COMPLETED|Overall Study||10||
48318069|NCT03704142|101104170|FG000|NOT COMPLETED|Overall Study||0||
48318070|NCT03704142|101104171|FG001|NOT COMPLETED|Overall Study||0||
48318071|NCT03704142|101104172|FG002|NOT COMPLETED|Overall Study||0||
48318072|NCT03704142|101104173|FG003|NOT COMPLETED|Overall Study||0||
48318073|NCT00607386|101104174|FG000|STARTED|Overall Study||28||
48318074|NCT00607386|101104174|FG000|COMPLETED|Overall Study||27||
48318075|NCT00607386|101104174|FG000|NOT COMPLETED|Overall Study||1||
48318076|NCT00917150|101104175|FG000|STARTED|Overall Study||192||
48318077|NCT00917150|101104176|FG001|STARTED|Overall Study||198||
48318078|NCT00917150|101104177|FG002|STARTED|Overall Study||191||
48318079|NCT00917150|101104178|FG003|STARTED|Overall Study||190||
48318080|NCT00917150|101104175|FG000|COMPLETED|Overall Study||155||
48318081|NCT00917150|101104176|FG001|COMPLETED|Overall Study||161||
48318082|NCT00917150|101104177|FG002|COMPLETED|Overall Study||149||
48318083|NCT00917150|101104178|FG003|COMPLETED|Overall Study||156||
48318084|NCT00917150|101104175|FG000|NOT COMPLETED|Overall Study||37||
48318085|NCT00917150|101104176|FG001|NOT COMPLETED|Overall Study||37||
48318086|NCT00917150|101104177|FG002|NOT COMPLETED|Overall Study||42||
48318087|NCT00917150|101104178|FG003|NOT COMPLETED|Overall Study||34||
48318088|NCT05003622|101104179|FG000|STARTED|Overall Study||3||
48318089|NCT05003622|101104179|FG000|COMPLETED|Overall Study||0||
48318090|NCT05003622|101104179|FG000|NOT COMPLETED|Overall Study||3||
48318091|NCT01785160|101104180|FG000|STARTED|Treatment Period 1: Raltegravir||25||
48736292|NCT02519595|102137238|FG002|NOT COMPLETED|Overall Study||16||
48736293|NCT01529034|102137239|FG000|STARTED|Overall Study||175||
48736294|NCT01529034|102137239|FG000|Exposed|Overall Study||161||
48736295|NCT01529034|102137239|FG000|COMPLETED|Overall Study||1||
48736296|NCT01529034|102137239|FG000|NOT COMPLETED|Overall Study||174||
48160410|NCT03215901|100715855|FG002|NOT COMPLETED|Overall Study||0||
48160411|NCT01238640|100715856|FG000|STARTED|Overall Study||84||
48160412|NCT01238640|100715856|FG000|COMPLETED|Overall Study||84||
48160413|NCT01238640|100715856|FG000|NOT COMPLETED|Overall Study||0||
48160414|NCT03391765|100715857|FG000|STARTED|Overall Study||51||
48160415|NCT03391765|100715858|FG001|STARTED|Overall Study||45||
48160416|NCT03391765|100715859|FG002|STARTED|Overall Study||23||
48160417|NCT03391765|100715860|FG003|STARTED|Overall Study||23||
48160418|NCT03391765|100715857|FG000|COMPLETED|Overall Study||0||
48160419|NCT03391765|100715858|FG001|COMPLETED|Overall Study||0||
48160420|NCT03391765|100715859|FG002|COMPLETED|Overall Study||0||
48160421|NCT03391765|100715860|FG003|COMPLETED|Overall Study||0||
48160422|NCT03391765|100715857|FG000|NOT COMPLETED|Overall Study||51||
48160423|NCT03391765|100715858|FG001|NOT COMPLETED|Overall Study||45||
48160424|NCT03391765|100715859|FG002|NOT COMPLETED|Overall Study||23||
48160425|NCT03391765|100715860|FG003|NOT COMPLETED|Overall Study||23||
48160426|NCT02240108|100715861|FG000|STARTED|Overall Study||35||
48160427|NCT02240108|100715862|FG001|STARTED|Overall Study||46||
48160428|NCT02240108|100715861|FG000|Intent-to-treat (ITT) Population|Overall Study||35|Received at least 1 dose of study drug|
48318092|NCT01785160|101104180|FG000|COMPLETED|Treatment Period 1: Raltegravir||24||
48736297|NCT01712204|102137240|FG000|STARTED|Overall Study||41||
48736298|NCT01712204|102137241|FG001|STARTED|Overall Study||41||
48736299|NCT01712204|102137240|FG000|COMPLETED|Overall Study||33||
48736300|NCT01712204|102137241|FG001|COMPLETED|Overall Study||36||
48736301|NCT01712204|102137240|FG000|NOT COMPLETED|Overall Study||8||
48736302|NCT01712204|102137241|FG001|NOT COMPLETED|Overall Study||5||
48736303|NCT00632619|102137242|FG000|STARTED|Overall Study||33||
48736304|NCT00632619|102137243|FG001|STARTED|Overall Study||35||
48736305|NCT00632619|102137242|FG000|COMPLETED|Overall Study||25||
48736306|NCT00632619|102137243|FG001|COMPLETED|Overall Study||31||
48736307|NCT00632619|102137242|FG000|NOT COMPLETED|Overall Study||8||
48736308|NCT00632619|102137243|FG001|NOT COMPLETED|Overall Study||4||
48736309|NCT04207060|102137244|FG000|STARTED|Overall Study||13||
48736310|NCT04207060|102137245|FG001|STARTED|Overall Study||14||
48736311|NCT04207060|102137244|FG000|COMPLETED|Overall Study||11||
48736312|NCT04207060|102137245|FG001|COMPLETED|Overall Study||14||
48736313|NCT04207060|102137244|FG000|NOT COMPLETED|Overall Study||2||
48736314|NCT04207060|102137245|FG001|NOT COMPLETED|Overall Study||0||
48736315|NCT00794950|102137246|FG000|STARTED|BCG Induction||43||
48736316|NCT00794950|102137246|FG000|COMPLETED|BCG Induction||36||
48736317|NCT00794950|102137246|FG000|NOT COMPLETED|BCG Induction||7||
48160429|NCT02240108|100715862|FG001|Intent-to-treat (ITT) Population|Overall Study||45|Received at least 1 dose of study drug|
48160430|NCT02240108|100715861|FG000|COMPLETED|Overall Study||21||
48160431|NCT02240108|100715862|FG001|COMPLETED|Overall Study||21||
48160432|NCT02240108|100715861|FG000|NOT COMPLETED|Overall Study||14||
48160433|NCT02240108|100715862|FG001|NOT COMPLETED|Overall Study||25||
48160434|NCT02668016|100715863|FG000|STARTED|Month 1||60||
48160435|NCT02668016|100715863|FG000|Received Atorvastatin 20mg|Month 1||20||
48160436|NCT02668016|100715863|FG000|Received Placebo|Month 1||20||
48160437|NCT02668016|100715863|FG000|Received No Tablet|Month 1||20||
48160438|NCT02668016|100715863|FG000|Withdrew|Month 1||0||
48160439|NCT02668016|100715863|FG000|COMPLETED|Month 1||55||
48160440|NCT02668016|100715863|FG000|NOT COMPLETED|Month 1||5||
48160441|NCT02668016|100715863|FG000|STARTED|Month 2||60||
48160442|NCT02668016|100715863|FG000|Received Atorvastatin 20mg|Month 2||20||
48160443|NCT02668016|100715863|FG000|Received Placebo|Month 2||20||
48160444|NCT02668016|100715863|FG000|Received No Tablet|Month 2||20||
48160445|NCT02668016|100715863|FG000|Withdrew|Month 2||2||
48160446|NCT02668016|100715863|FG000|COMPLETED|Month 2||54||
48318093|NCT01785160|101104180|FG000|NOT COMPLETED|Treatment Period 1: Raltegravir||1||
48318094|NCT01785160|101104180|FG000|STARTED|Washout Period of at Least 7 Days||24||
48318095|NCT01785160|101104180|FG000|COMPLETED|Washout Period of at Least 7 Days||23||
48318096|NCT01785160|101104180|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||1||
48318097|NCT01785160|101104180|FG000|STARTED|Treatment Period 2: Raltegravir + Faldap||23||
48736318|NCT00794950|102137246|FG000|STARTED|Beginning Sunitinib Treatment||36||
48736319|NCT00794950|102137246|FG000|COMPLETED|Beginning Sunitinib Treatment||24||
48160447|NCT02668016|100715863|FG000|NOT COMPLETED|Month 2||6||
48160448|NCT02668016|100715863|FG000|STARTED|Month 3||58||
48188748|NCT00821236|100783327|FG000|STARTED|Overall Study||40||
48736320|NCT00794950|102137246|FG000|NOT COMPLETED|Beginning Sunitinib Treatment||12||
48736321|NCT03747640|102137247|FG000|STARTED|Overall Study||15||
48736322|NCT03747640|102137248|FG001|STARTED|Overall Study||15||
48736323|NCT03747640|102137247|FG000|COMPLETED|Overall Study||15||
48318098|NCT01785160|101104180|FG000|COMPLETED|Treatment Period 2: Raltegravir + Faldap||23||
48318099|NCT01785160|101104180|FG000|NOT COMPLETED|Treatment Period 2: Raltegravir + Faldap||0||
48318100|NCT00131469|101104181|FG000|STARTED|Overall Study||38||
48318101|NCT00131469|101104182|FG001|STARTED|Overall Study||40||
48318102|NCT00131469|101104181|FG000|COMPLETED|Overall Study||29||
48318103|NCT00131469|101104182|FG001|COMPLETED|Overall Study||27||
48318104|NCT00131469|101104181|FG000|NOT COMPLETED|Overall Study||9||
48318105|NCT00131469|101104182|FG001|NOT COMPLETED|Overall Study||13||
48318106|NCT02290873|101104183|FG000|STARTED|Overall Study||298||
48318107|NCT02290873|101104184|FG001|STARTED|Overall Study||60||
48318108|NCT02290873|101104185|FG002|STARTED|Overall Study||103||
48318109|NCT02290873|101104183|FG000|Modified Intention to Treat (mITT)|Overall Study||296|All ITT population who received at least 1 complete dose of study medication|
48318110|NCT02290873|101104184|FG001|Modified Intention to Treat (mITT)|Overall Study||60|All ITT population who received at least 1 complete dose of study medication|
48318111|NCT02290873|101104185|FG002|Modified Intention to Treat (mITT)|Overall Study||102|All ITT population who received at least 1 complete dose of study medication|
48318112|NCT02290873|101104183|FG000|Safety Population|Overall Study||296|All randomized patients who received any amount of study drug and were analyzed as treated|
48318113|NCT02290873|101104184|FG001|Safety Population|Overall Study||60|All randomized patients who received any amount of study drug and were analyzed as treated|
48318114|NCT02290873|101104185|FG002|Safety Population|Overall Study||102|All randomized patients who received any amount of study drug and were analyzed as treated|
48318115|NCT02290873|101104183|FG000|COMPLETED|Overall Study||296||
48318116|NCT02290873|101104184|FG001|COMPLETED|Overall Study||59||
48318117|NCT02290873|101104185|FG002|COMPLETED|Overall Study||101||
48318118|NCT02290873|101104183|FG000|NOT COMPLETED|Overall Study||2||
48318119|NCT02290873|101104184|FG001|NOT COMPLETED|Overall Study||1||
48318120|NCT02290873|101104185|FG002|NOT COMPLETED|Overall Study||2||
48318121|NCT00573989|101104186|FG000|STARTED|Erlotinib Phase I||4||
48318122|NCT00573989|101104187|FG001|STARTED|Erlotinib Phase I||6||
48318123|NCT00573989|101104188|FG002|STARTED|Erlotinib Phase I||5||
48318124|NCT00573989|101104189|FG003|STARTED|Erlotinib Phase I||0||
48318125|NCT00573989|101104186|FG000|COMPLETED|Erlotinib Phase I||4||
48318126|NCT00573989|101104187|FG001|COMPLETED|Erlotinib Phase I||6||
48318127|NCT00573989|101104188|FG002|COMPLETED|Erlotinib Phase I||5||
48318128|NCT00573989|101104189|FG003|COMPLETED|Erlotinib Phase I||0||
48318129|NCT00573989|101104186|FG000|NOT COMPLETED|Erlotinib Phase I||0||
48318130|NCT00573989|101104187|FG001|NOT COMPLETED|Erlotinib Phase I||0||
48318131|NCT00573989|101104188|FG002|NOT COMPLETED|Erlotinib Phase I||0||
48318132|NCT00573989|101104189|FG003|NOT COMPLETED|Erlotinib Phase I||0||
48318133|NCT00573989|101104186|FG000|STARTED|Erlotinib 125mg- Phase II||0||
48318134|NCT00573989|101104187|FG001|STARTED|Erlotinib 125mg- Phase II||0||
48736324|NCT03747640|102137248|FG001|COMPLETED|Overall Study||15||
48736325|NCT03747640|102137247|FG000|NOT COMPLETED|Overall Study||0||
48736326|NCT03747640|102137248|FG001|NOT COMPLETED|Overall Study||0||
48736327|NCT01717001|102137249|FG000|STARTED|Overall Study||38||
48736328|NCT01717001|102137250|FG001|STARTED|Overall Study||28||
48318135|NCT00573989|101104188|FG002|STARTED|Erlotinib 125mg- Phase II||0||
48318136|NCT00573989|101104189|FG003|STARTED|Erlotinib 125mg- Phase II||12||
48318137|NCT00573989|101104186|FG000|COMPLETED|Erlotinib 125mg- Phase II||0||
48318138|NCT00573989|101104187|FG001|COMPLETED|Erlotinib 125mg- Phase II||0||
48318139|NCT00573989|101104188|FG002|COMPLETED|Erlotinib 125mg- Phase II||0||
48318140|NCT00573989|101104189|FG003|COMPLETED|Erlotinib 125mg- Phase II||12||
48318141|NCT00573989|101104186|FG000|NOT COMPLETED|Erlotinib 125mg- Phase II||0||
48318142|NCT00573989|101104187|FG001|NOT COMPLETED|Erlotinib 125mg- Phase II||0||
48318143|NCT00573989|101104188|FG002|NOT COMPLETED|Erlotinib 125mg- Phase II||0||
48318144|NCT00573989|101104189|FG003|NOT COMPLETED|Erlotinib 125mg- Phase II||0||
48318145|NCT02164929|101104190|FG000|STARTED|Overall Study||4||
48318146|NCT02164929|101104191|FG001|STARTED|Overall Study||3||
48318147|NCT02164929|101104192|FG002|STARTED|Overall Study||5||
48318148|NCT02164929|101104193|FG003|STARTED|Overall Study||4||
48318149|NCT02164929|101104190|FG000|COMPLETED|Overall Study||3||
48318150|NCT02164929|101104191|FG001|COMPLETED|Overall Study||3||
48318151|NCT02164929|101104192|FG002|COMPLETED|Overall Study||4||
48318152|NCT02164929|101104193|FG003|COMPLETED|Overall Study||2||
48318153|NCT02164929|101104190|FG000|NOT COMPLETED|Overall Study||1||
48318154|NCT02164929|101104191|FG001|NOT COMPLETED|Overall Study||0||
48318155|NCT02164929|101104192|FG002|NOT COMPLETED|Overall Study||1||
48318156|NCT02164929|101104193|FG003|NOT COMPLETED|Overall Study||2||
48318157|NCT00254462|101104194|FG000|STARTED|Overall Study||44||
48318158|NCT00254462|101104195|FG001|STARTED|Overall Study||49||
48318159|NCT00254462|101104194|FG000|COMPLETED|Overall Study||36||
48318160|NCT00254462|101104195|FG001|COMPLETED|Overall Study||39||
48318161|NCT00254462|101104194|FG000|NOT COMPLETED|Overall Study||8||
48318162|NCT00254462|101104195|FG001|NOT COMPLETED|Overall Study||10||
48318163|NCT00960843|101104196|FG000|STARTED|Overall Study||25||
48736329|NCT01717001|102137249|FG000|COMPLETED|Overall Study||32||
48736330|NCT01717001|102137250|FG001|COMPLETED|Overall Study||24||
48318164|NCT00960843|101104197|FG001|STARTED|Overall Study||26||
48318165|NCT00960843|101104196|FG000|COMPLETED|Overall Study||23||
48318166|NCT00960843|101104197|FG001|COMPLETED|Overall Study||21||
48318167|NCT00960843|101104196|FG000|NOT COMPLETED|Overall Study||2||
48318168|NCT00960843|101104197|FG001|NOT COMPLETED|Overall Study||5||
48318169|NCT03300674|101104198|FG000|STARTED|Overall Study||77||
48318170|NCT03300674|101104199|FG001|STARTED|Overall Study||77||
48318171|NCT03300674|101104198|FG000|COMPLETED|Overall Study||77||
48318172|NCT03300674|101104199|FG001|COMPLETED|Overall Study||77||
48318173|NCT03300674|101104198|FG000|NOT COMPLETED|Overall Study||0||
48318174|NCT03300674|101104199|FG001|NOT COMPLETED|Overall Study||0||
48318175|NCT04050982|101104200|FG000|STARTED|Overall Study||9||
48318176|NCT04050982|101104201|FG001|STARTED|Overall Study||2||
48318177|NCT04050982|101104202|FG002|STARTED|Overall Study||0||
48318178|NCT04050982|101104200|FG000|Interfaced With AF CARE Digital Platform|Overall Study||7||
48318179|NCT04050982|101104201|FG001|Interfaced With AF CARE Digital Platform|Overall Study||1||
48318180|NCT04050982|101104202|FG002|Interfaced With AF CARE Digital Platform|Overall Study||0||
48318181|NCT04050982|101104200|FG000|COMPLETED|Overall Study||7||
48318182|NCT04050982|101104201|FG001|COMPLETED|Overall Study||1||
48318183|NCT04050982|101104202|FG002|COMPLETED|Overall Study||0||
48318184|NCT04050982|101104200|FG000|NOT COMPLETED|Overall Study||2||
48318185|NCT04050982|101104201|FG001|NOT COMPLETED|Overall Study||1||
48318186|NCT04050982|101104202|FG002|NOT COMPLETED|Overall Study||0||
48318187|NCT03096730|101104203|FG000|STARTED|Overall Study||30||
48318188|NCT03096730|101104204|FG001|STARTED|Overall Study||30||
48318189|NCT03096730|101104205|FG002|STARTED|Overall Study||30||
48318190|NCT03096730|101104206|FG003|STARTED|Overall Study||30||
48318191|NCT03096730|101104207|FG004|STARTED|Overall Study||30||
48318192|NCT03096730|101104203|FG000|COMPLETED|Overall Study||27||
48318193|NCT03096730|101104204|FG001|COMPLETED|Overall Study||27||
48318194|NCT03096730|101104205|FG002|COMPLETED|Overall Study||27||
48318195|NCT03096730|101104206|FG003|COMPLETED|Overall Study||27||
48318196|NCT03096730|101104207|FG004|COMPLETED|Overall Study||27||
48318197|NCT03096730|101104203|FG000|NOT COMPLETED|Overall Study||3||
48318198|NCT03096730|101104204|FG001|NOT COMPLETED|Overall Study||3||
48318199|NCT03096730|101104205|FG002|NOT COMPLETED|Overall Study||3||
48318200|NCT03096730|101104206|FG003|NOT COMPLETED|Overall Study||3||
48318201|NCT03096730|101104207|FG004|NOT COMPLETED|Overall Study||3||
48318202|NCT01349465|101104208|FG000|STARTED|Overall Study||200||
48318203|NCT01349465|101104209|FG001|STARTED|Overall Study||49||
48318204|NCT01349465|101104208|FG000|COMPLETED|Overall Study||182||
48318205|NCT01349465|101104209|FG001|COMPLETED|Overall Study||27||
48318206|NCT01349465|101104208|FG000|NOT COMPLETED|Overall Study||18||
48318207|NCT01349465|101104209|FG001|NOT COMPLETED|Overall Study||22||
48318208|NCT04701138|101104210|FG000|STARTED|Overall Study||24||
48318209|NCT04701138|101104210|FG000|COMPLETED|Overall Study||23||
48318210|NCT04701138|101104210|FG000|NOT COMPLETED|Overall Study||1||
48318211|NCT00967551|101104211|FG000|STARTED|Overall Study||68||
48318212|NCT00967551|101104212|FG001|STARTED|Overall Study||75||
48318213|NCT00967551|101104211|FG000|COMPLETED|Overall Study||68||
48318214|NCT00967551|101104212|FG001|COMPLETED|Overall Study||75||
48318215|NCT00967551|101104211|FG000|NOT COMPLETED|Overall Study||0||
48318216|NCT00967551|101104212|FG001|NOT COMPLETED|Overall Study||0||
48318217|NCT00455689|101104213|FG000|STARTED|Overall Study||14||
48318218|NCT00455689|101104214|FG001|STARTED|Overall Study||6||
48318219|NCT00455689|101104213|FG000|COMPLETED|Overall Study||14||
48318220|NCT00455689|101104214|FG001|COMPLETED|Overall Study||6||
48318221|NCT00455689|101104213|FG000|NOT COMPLETED|Overall Study||0||
48318222|NCT00455689|101104214|FG001|NOT COMPLETED|Overall Study||0||
48318223|NCT02311153|101104215|FG000|STARTED|Overall Study||53||
48318224|NCT02311153|101104216|FG001|STARTED|Overall Study||49||
48318225|NCT02311153|101104215|FG000|COMPLETED|Overall Study||48||
48318226|NCT02311153|101104216|FG001|COMPLETED|Overall Study||42||
48318227|NCT02311153|101104215|FG000|NOT COMPLETED|Overall Study||5||
48318228|NCT02311153|101104216|FG001|NOT COMPLETED|Overall Study||7||
48318229|NCT00844753|101104217|FG000|STARTED|Overall Study||32||
48318230|NCT00844753|101104218|FG001|STARTED|Overall Study||32||
48318231|NCT00844753|101104219|FG002|STARTED|Overall Study||32||
48318232|NCT00844753|101104220|FG003|STARTED|Overall Study||32||
48318233|NCT00844753|101104217|FG000|COMPLETED|Overall Study||24||
48318234|NCT00844753|101104218|FG001|COMPLETED|Overall Study||29||
48318235|NCT00844753|101104219|FG002|COMPLETED|Overall Study||25||
48318236|NCT00844753|101104220|FG003|COMPLETED|Overall Study||21||
48318237|NCT00844753|101104217|FG000|NOT COMPLETED|Overall Study||8||
48318238|NCT00844753|101104218|FG001|NOT COMPLETED|Overall Study||3||
48318239|NCT00844753|101104219|FG002|NOT COMPLETED|Overall Study||7||
48318240|NCT00844753|101104220|FG003|NOT COMPLETED|Overall Study||11||
48318241|NCT02039375|101104221|FG000|STARTED|Overall Study||35||
48318242|NCT02039375|101104221|FG000|COMPLETED|Overall Study||33||
48736331|NCT01717001|102137249|FG000|NOT COMPLETED|Overall Study||6||
48736332|NCT01717001|102137250|FG001|NOT COMPLETED|Overall Study||4||
48736333|NCT02688985|102137251|FG000|STARTED|Overall Study||23||
48736334|NCT02688985|102137252|FG001|STARTED|Overall Study||31||
48736335|NCT02688985|102137253|FG002|STARTED|Overall Study||28||
48736336|NCT02688985|102137254|FG003|STARTED|Overall Study||18||
48736337|NCT02688985|102137255|FG004|STARTED|Overall Study||31||
48736338|NCT02688985|102137251|FG000|COMPLETED|Overall Study||0||
48736339|NCT02688985|102137252|FG001|COMPLETED|Overall Study||0||
48736340|NCT02688985|102137253|FG002|COMPLETED|Overall Study||0||
48736341|NCT02688985|102137254|FG003|COMPLETED|Overall Study||0||
48736342|NCT02688985|102137255|FG004|COMPLETED|Overall Study||1||
48736343|NCT02688985|102137251|FG000|NOT COMPLETED|Overall Study||23||
48736344|NCT02688985|102137252|FG001|NOT COMPLETED|Overall Study||31||
48736345|NCT02688985|102137253|FG002|NOT COMPLETED|Overall Study||28||
48736346|NCT02688985|102137254|FG003|NOT COMPLETED|Overall Study||18||
48736347|NCT02688985|102137255|FG004|NOT COMPLETED|Overall Study||30||
48736348|NCT01806675|102137256|FG000|STARTED|Overall Study||11||
48736349|NCT01806675|102137257|FG001|STARTED|Overall Study||6||
48736350|NCT01806675|102137258|FG002|STARTED|Overall Study||8||
48736351|NCT01806675|102137256|FG000|COMPLETED|Overall Study||11||
48736352|NCT01806675|102137257|FG001|COMPLETED|Overall Study||6||
48736353|NCT01806675|102137258|FG002|COMPLETED|Overall Study||8||
48736354|NCT01806675|102137256|FG000|NOT COMPLETED|Overall Study||0||
48736355|NCT01806675|102137257|FG001|NOT COMPLETED|Overall Study||0||
48736356|NCT01806675|102137258|FG002|NOT COMPLETED|Overall Study||0||
48736357|NCT05126836|102140085|FG000|STARTED|Overall Study||12||
48736358|NCT05126836|102140086|FG001|STARTED|Overall Study||13||
48736359|NCT05126836|102140085|FG000|COMPLETED|Overall Study||11||
48736360|NCT05126836|102140086|FG001|COMPLETED|Overall Study||12||
48736361|NCT05126836|102140085|FG000|NOT COMPLETED|Overall Study||1||
48736362|NCT05126836|102140086|FG001|NOT COMPLETED|Overall Study||1||
48736363|NCT01361178|102140087|FG000|STARTED|Overall Study||122||
48736364|NCT01361178|102140088|FG001|STARTED|Overall Study||11||
48736365|NCT01361178|102140087|FG000|COMPLETED|Overall Study||109||
48736366|NCT01361178|102140088|FG001|COMPLETED|Overall Study||11||
48736367|NCT01361178|102140087|FG000|NOT COMPLETED|Overall Study||13||
48736368|NCT01361178|102140088|FG001|NOT COMPLETED|Overall Study||0||
48736369|NCT03688074|102140089|FG000|STARTED|Overall Study||59||
48736370|NCT03688074|102140090|FG001|STARTED|Overall Study||57||
48736371|NCT03688074|102140089|FG000|COMPLETED|Overall Study||58||
48736372|NCT03688074|102140090|FG001|COMPLETED|Overall Study||56||
48736373|NCT03688074|102140089|FG000|NOT COMPLETED|Overall Study||1||
48736374|NCT03688074|102140090|FG001|NOT COMPLETED|Overall Study||1||
48736375|NCT03521141|102140091|FG000|STARTED|Overall Study||19||
48736376|NCT03521141|102140092|FG001|STARTED|Overall Study||19||
48318243|NCT02039375|101104221|FG000|NOT COMPLETED|Overall Study||2||
48407365|NCT03296072|101328538|FG004|STARTED|Treament Period 2||10||
48407366|NCT03296072|101328539|FG005|STARTED|Treament Period 2||11||
48407367|NCT03296072|101328534|FG000|COMPLETED|Treament Period 2||10||
48736377|NCT03521141|102140093|FG002|STARTED|Overall Study||20||
48736378|NCT03521141|102140091|FG000|COMPLETED|Overall Study||18||
48736379|NCT03521141|102140092|FG001|COMPLETED|Overall Study||19||
48736380|NCT03521141|102140093|FG002|COMPLETED|Overall Study||19||
48736381|NCT03521141|102140091|FG000|NOT COMPLETED|Overall Study||1||
48736382|NCT03521141|102140092|FG001|NOT COMPLETED|Overall Study||0||
48736383|NCT03521141|102140093|FG002|NOT COMPLETED|Overall Study||1||
48736384|NCT00848783|102140094|FG000|STARTED|Overall Study||4||
48736385|NCT00848783|102140095|FG001|STARTED|Overall Study||3||
48736386|NCT00848783|102140096|FG002|STARTED|Overall Study||1||
48736387|NCT00848783|102140094|FG000|COMPLETED|Overall Study||1||
48736388|NCT00848783|102140095|FG001|COMPLETED|Overall Study||1||
48736389|NCT00848783|102140096|FG002|COMPLETED|Overall Study||1||
48736390|NCT00848783|102140094|FG000|NOT COMPLETED|Overall Study||3||
48736391|NCT00848783|102140095|FG001|NOT COMPLETED|Overall Study||2||
48736392|NCT00848783|102140096|FG002|NOT COMPLETED|Overall Study||0||
48736393|NCT00767819|102140097|FG000|STARTED|Overall Study||37||
48736394|NCT00767819|102140098|FG001|STARTED|Overall Study||24||
48318244|NCT00867321|101104222|FG000|STARTED|Overall Study||4||
48318245|NCT00867321|101104223|FG001|STARTED|Overall Study||3||
48736395|NCT00767819|102140099|FG002|STARTED|Overall Study||10||
48736396|NCT00767819|102140097|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||37||
48736397|NCT00767819|102140098|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||24||
48736398|NCT00767819|102140099|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||10||
48736399|NCT00767819|102140097|FG000|Safety Analysis Set (SAF)|Overall Study||37||
48736400|NCT00767819|102140098|FG001|Safety Analysis Set (SAF)|Overall Study||24||
48318246|NCT00867321|101104224|FG002|STARTED|Overall Study||3||
48736401|NCT00767819|102140099|FG002|Safety Analysis Set (SAF)|Overall Study||10||
48318247|NCT00867321|101104225|FG003|STARTED|Overall Study||6||
48318248|NCT00867321|101104226|FG004|STARTED|Overall Study||5||
48318249|NCT00867321|101104227|FG005|STARTED|Overall Study||3||
48318250|NCT00867321|101104222|FG000|COMPLETED|Overall Study||4||
48318251|NCT00867321|101104223|FG001|COMPLETED|Overall Study||2||
48318252|NCT00867321|101104224|FG002|COMPLETED|Overall Study||3||
48318253|NCT00867321|101104225|FG003|COMPLETED|Overall Study||6||
48736402|NCT00767819|102140097|FG000|COMPLETED|Overall Study||12||
48736403|NCT00767819|102140098|FG001|COMPLETED|Overall Study||5||
48318254|NCT00867321|101104226|FG004|COMPLETED|Overall Study||5||
48318255|NCT00867321|101104227|FG005|COMPLETED|Overall Study||3||
48318256|NCT00867321|101104222|FG000|NOT COMPLETED|Overall Study||0||
48318257|NCT00867321|101104223|FG001|NOT COMPLETED|Overall Study||1||
48318258|NCT00867321|101104224|FG002|NOT COMPLETED|Overall Study||0||
48318259|NCT00867321|101104225|FG003|NOT COMPLETED|Overall Study||0||
48318260|NCT00867321|101104226|FG004|NOT COMPLETED|Overall Study||0||
48318261|NCT00867321|101104227|FG005|NOT COMPLETED|Overall Study||0||
48318262|NCT03077685|101104228|FG000|STARTED|Overall Study||3||
48318263|NCT03077685|101104229|FG001|STARTED|Overall Study||3||
48318264|NCT03077685|101104230|FG002|STARTED|Overall Study||4||
48318265|NCT03077685|101104231|FG003|STARTED|Overall Study||25||
48318266|NCT03077685|101104232|FG004|STARTED|Overall Study||19||
48318267|NCT03077685|101104228|FG000|COMPLETED|Overall Study||2||
48318268|NCT03077685|101104229|FG001|COMPLETED|Overall Study||3||
48318269|NCT03077685|101104230|FG002|COMPLETED|Overall Study||2||
48318270|NCT03077685|101104231|FG003|COMPLETED|Overall Study||19||
48318271|NCT03077685|101104232|FG004|COMPLETED|Overall Study||8||
48318272|NCT03077685|101104228|FG000|NOT COMPLETED|Overall Study||1||
48318273|NCT03077685|101104229|FG001|NOT COMPLETED|Overall Study||0||
48318274|NCT03077685|101104230|FG002|NOT COMPLETED|Overall Study||2||
48318275|NCT03077685|101104231|FG003|NOT COMPLETED|Overall Study||6||
48318276|NCT03077685|101104232|FG004|NOT COMPLETED|Overall Study||11||
48318277|NCT03029143|101104233|FG000|STARTED|Lead-in Period (6 Weeks)||278||
48318278|NCT03029143|101104234|FG001|STARTED|Lead-in Period (6 Weeks)||0||
48318279|NCT03029143|101104235|FG002|STARTED|Lead-in Period (6 Weeks)||0||
48318280|NCT03029143|101104233|FG000|COMPLETED|Lead-in Period (6 Weeks)||109|Completed = Participants who were eligible for randomization or randomized in error; Not completed = Participants who were Lead-In Failure. One participant was randomized to Randomized Treatment Period: Standard Treatment Arm, but was not treated and was thus presented in the Lead-in failure vedolizumab arm for the Safety Analysis Set (N=170).|
48318281|NCT03029143|101104234|FG001|COMPLETED|Lead-in Period (6 Weeks)||0|Completed = Participants who were eligible for randomization or randomized in error; Not completed = Participants who were Lead-In Failure. One participant was randomized to Randomized Treatment Period: Standard Treatment Arm, but was not treated and was thus presented in the Lead-in failure vedolizumab arm for the Safety Analysis Set (N=170).|
48318282|NCT03029143|101104235|FG002|COMPLETED|Lead-in Period (6 Weeks)||0|Completed = Participants who were eligible for randomization or randomized in error; Not completed = Participants who were Lead-In Failure. One participant was randomized to Randomized Treatment Period: Standard Treatment Arm, but was not treated and was thus presented in the Lead-in failure vedolizumab arm for the Safety Analysis Set (N=170).|
48318283|NCT03029143|101104233|FG000|NOT COMPLETED|Lead-in Period (6 Weeks)||169||
48318284|NCT03029143|101104234|FG001|NOT COMPLETED|Lead-in Period (6 Weeks)||0||
48318285|NCT03029143|101104235|FG002|NOT COMPLETED|Lead-in Period (6 Weeks)||0||
48318286|NCT03029143|101104233|FG000|STARTED|Randomized Treatment Period (24 Weeks)||0||
48318287|NCT03029143|101104234|FG001|STARTED|Randomized Treatment Period (24 Weeks)||54||
48318288|NCT03029143|101104235|FG002|STARTED|Randomized Treatment Period (24 Weeks)||55||
48318289|NCT03029143|101104233|FG000|Not Treated Post Randomization|Randomized Treatment Period (24 Weeks)||0||
48318290|NCT03029143|101104234|FG001|Not Treated Post Randomization|Randomized Treatment Period (24 Weeks)||1||
48318291|NCT03029143|101104235|FG002|Not Treated Post Randomization|Randomized Treatment Period (24 Weeks)||0||
48318292|NCT03029143|101104233|FG000|Safety Population|Randomized Treatment Period (24 Weeks)||0|Safety Analysis Set included all participants who were enrolled and received at least one dose of study medication.|
48318293|NCT03029143|101104234|FG001|Safety Population|Randomized Treatment Period (24 Weeks)||53|Safety Analysis Set included all participants who were enrolled and received at least one dose of study medication.|
48318294|NCT03029143|101104235|FG002|Safety Population|Randomized Treatment Period (24 Weeks)||55|Safety Analysis Set included all participants who were enrolled and received at least one dose of study medication.|
48318295|NCT03029143|101104233|FG000|COMPLETED|Randomized Treatment Period (24 Weeks)||0||
48318296|NCT03029143|101104234|FG001|COMPLETED|Randomized Treatment Period (24 Weeks)||31||
48318297|NCT03029143|101104235|FG002|COMPLETED|Randomized Treatment Period (24 Weeks)||31||
48318298|NCT03029143|101104233|FG000|NOT COMPLETED|Randomized Treatment Period (24 Weeks)||0||
48318299|NCT03029143|101104234|FG001|NOT COMPLETED|Randomized Treatment Period (24 Weeks)||23||
48318300|NCT03029143|101104235|FG002|NOT COMPLETED|Randomized Treatment Period (24 Weeks)||24||
48318301|NCT02431702|101104236|FG000|STARTED|Part 1: 2-Month Oral Run-in Phase||273||
48318302|NCT02431702|101104237|FG001|STARTED|Part 1: 2-Month Oral Run-in Phase||0||
48318303|NCT02431702|101104238|FG002|STARTED|Part 1: 2-Month Oral Run-in Phase||0||
48318304|NCT02431702|101104239|FG003|STARTED|Part 1: 2-Month Oral Run-in Phase||0||
48318305|NCT02431702|101104240|FG004|STARTED|Part 1: 2-Month Oral Run-in Phase||0||
48318306|NCT02431702|101104241|FG005|STARTED|Part 1: 2-Month Oral Run-in Phase||0||
48318307|NCT02431702|101104242|FG006|STARTED|Part 1: 2-Month Oral Run-in Phase||64||
48318308|NCT02431702|101104236|FG000|COMPLETED|Part 1: 2-Month Oral Run-in Phase||239||
48318309|NCT02431702|101104237|FG001|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0||
48318310|NCT02431702|101104238|FG002|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0||
48318311|NCT02431702|101104239|FG003|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0||
48318312|NCT02431702|101104240|FG004|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0||
48318313|NCT02431702|101104241|FG005|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0||
48318314|NCT02431702|101104242|FG006|COMPLETED|Part 1: 2-Month Oral Run-in Phase||32||
48318315|NCT02431702|101104236|FG000|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||34||
48318316|NCT02431702|101104237|FG001|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0||
48318317|NCT02431702|101104238|FG002|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0||
48318318|NCT02431702|101104239|FG003|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0||
48318319|NCT02431702|101104240|FG004|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0||
48318320|NCT02431702|101104241|FG005|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0||
48318321|NCT02431702|101104242|FG006|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||32||
48318322|NCT02431702|101104236|FG000|STARTED|Part 2: 9Month Disease Progression Phase||0||
48318323|NCT02431702|101104237|FG001|STARTED|Part 2: 9Month Disease Progression Phase||78||
48318324|NCT02431702|101104238|FG002|STARTED|Part 2: 9Month Disease Progression Phase||157||
48318325|NCT02431702|101104239|FG003|STARTED|Part 2: 9Month Disease Progression Phase||0||
48318326|NCT02431702|101104240|FG004|STARTED|Part 2: 9Month Disease Progression Phase||0||
48318327|NCT02431702|101104241|FG005|STARTED|Part 2: 9Month Disease Progression Phase||0||
48318328|NCT02431702|101104242|FG006|STARTED|Part 2: 9Month Disease Progression Phase||0||
48318329|NCT02431702|101104236|FG000|COMPLETED|Part 2: 9Month Disease Progression Phase||0||
48318330|NCT02431702|101104237|FG001|COMPLETED|Part 2: 9Month Disease Progression Phase||52||
48318331|NCT02431702|101104238|FG002|COMPLETED|Part 2: 9Month Disease Progression Phase||128||
48318332|NCT02431702|101104239|FG003|COMPLETED|Part 2: 9Month Disease Progression Phase||0||
48318333|NCT02431702|101104240|FG004|COMPLETED|Part 2: 9Month Disease Progression Phase||0||
48318334|NCT02431702|101104241|FG005|COMPLETED|Part 2: 9Month Disease Progression Phase||0||
48318335|NCT02431702|101104242|FG006|COMPLETED|Part 2: 9Month Disease Progression Phase||0||
48736404|NCT00767819|102140099|FG002|COMPLETED|Overall Study||10||
48736405|NCT00767819|102140097|FG000|NOT COMPLETED|Overall Study||25||
48736406|NCT00767819|102140098|FG001|NOT COMPLETED|Overall Study||19||
48736407|NCT00767819|102140099|FG002|NOT COMPLETED|Overall Study||0||
48736408|NCT01957202|102140100|FG000|STARTED|Treatment Period 1 (8 Days)||3||
48736409|NCT01957202|102140101|FG001|STARTED|Treatment Period 1 (8 Days)||6||
48736410|NCT01957202|102140102|FG002|STARTED|Treatment Period 1 (8 Days)||6||
48736411|NCT01957202|102140103|FG003|STARTED|Treatment Period 1 (8 Days)||3||
48736412|NCT01957202|102140104|FG004|STARTED|Treatment Period 1 (8 Days)||3||
48736413|NCT01957202|102140105|FG005|STARTED|Treatment Period 1 (8 Days)||2||
48736414|NCT01957202|102140106|FG006|STARTED|Treatment Period 1 (8 Days)||3||
48736415|NCT01957202|102140107|FG007|STARTED|Treatment Period 1 (8 Days)||3||
48736416|NCT01957202|102140108|FG008|STARTED|Treatment Period 1 (8 Days)||3||
48736417|NCT01957202|102140109|FG009|STARTED|Treatment Period 1 (8 Days)||6||
48736418|NCT01957202|102140110|FG010|STARTED|Treatment Period 1 (8 Days)||3||
48736419|NCT01957202|102140111|FG011|STARTED|Treatment Period 1 (8 Days)||6||
48736420|NCT01957202|102140112|FG012|STARTED|Treatment Period 1 (8 Days)||3||
48736421|NCT01957202|102140113|FG013|STARTED|Treatment Period 1 (8 Days)||3||
48736422|NCT01957202|102140114|FG014|STARTED|Treatment Period 1 (8 Days)||6||
48736423|NCT01957202|102140115|FG015|STARTED|Treatment Period 1 (8 Days)||3||
48736424|NCT01957202|102140116|FG016|STARTED|Treatment Period 1 (8 Days)||6||
48736425|NCT01957202|102140117|FG017|STARTED|Treatment Period 1 (8 Days)||3||
48736426|NCT01957202|102140100|FG000|COMPLETED|Treatment Period 1 (8 Days)||3||
48736427|NCT01957202|102140101|FG001|COMPLETED|Treatment Period 1 (8 Days)||6||
48736428|NCT01957202|102140102|FG002|COMPLETED|Treatment Period 1 (8 Days)||6||
48736429|NCT01957202|102140103|FG003|COMPLETED|Treatment Period 1 (8 Days)||3||
48736430|NCT01957202|102140104|FG004|COMPLETED|Treatment Period 1 (8 Days)||3||
48736431|NCT01957202|102140105|FG005|COMPLETED|Treatment Period 1 (8 Days)||2||
48736432|NCT01957202|102140106|FG006|COMPLETED|Treatment Period 1 (8 Days)||3||
48736433|NCT01957202|102140107|FG007|COMPLETED|Treatment Period 1 (8 Days)||3||
48736434|NCT01957202|102140108|FG008|COMPLETED|Treatment Period 1 (8 Days)||3||
48736435|NCT01957202|102140109|FG009|COMPLETED|Treatment Period 1 (8 Days)||6||
48736436|NCT01957202|102140110|FG010|COMPLETED|Treatment Period 1 (8 Days)||3||
48736437|NCT01957202|102140111|FG011|COMPLETED|Treatment Period 1 (8 Days)||6||
48736438|NCT01957202|102140112|FG012|COMPLETED|Treatment Period 1 (8 Days)||3||
48736439|NCT01957202|102140113|FG013|COMPLETED|Treatment Period 1 (8 Days)||3||
48736440|NCT01957202|102140114|FG014|COMPLETED|Treatment Period 1 (8 Days)||6||
48736441|NCT01957202|102140115|FG015|COMPLETED|Treatment Period 1 (8 Days)||3||
48318336|NCT02431702|101104236|FG000|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0||
48318337|NCT02431702|101104237|FG001|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||26||
48318338|NCT02431702|101104238|FG002|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||29||
48318339|NCT02431702|101104239|FG003|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0||
48318340|NCT02431702|101104240|FG004|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0||
48318341|NCT02431702|101104241|FG005|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0||
48736442|NCT01957202|102140116|FG016|COMPLETED|Treatment Period 1 (8 Days)||6||
48736443|NCT01957202|102140117|FG017|COMPLETED|Treatment Period 1 (8 Days)||3||
48318342|NCT02431702|101104242|FG006|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0||
48736444|NCT01957202|102140100|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
48736445|NCT01957202|102140101|FG001|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
48736446|NCT01957202|102140102|FG002|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
48736447|NCT01957202|102140103|FG003|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
48736448|NCT01957202|102140104|FG004|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
48736449|NCT01957202|102140105|FG005|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
48736450|NCT01957202|102140106|FG006|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
48736451|NCT01957202|102140107|FG007|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
48736452|NCT01957202|102140108|FG008|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
48736453|NCT01957202|102140109|FG009|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
48736454|NCT01957202|102140110|FG010|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
48736455|NCT01957202|102140111|FG011|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
48736456|NCT01957202|102140112|FG012|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
48736457|NCT01957202|102140113|FG013|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
48736458|NCT01957202|102140114|FG014|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
48736459|NCT01957202|102140115|FG015|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
48736460|NCT01957202|102140116|FG016|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
48736461|NCT01957202|102140117|FG017|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
48736462|NCT01957202|102140100|FG000|STARTED|Washout Period 1 (14 to 28 Days)||3||
48736463|NCT01957202|102140101|FG001|STARTED|Washout Period 1 (14 to 28 Days)||6||
48736464|NCT01957202|102140102|FG002|STARTED|Washout Period 1 (14 to 28 Days)||6||
48736465|NCT01957202|102140103|FG003|STARTED|Washout Period 1 (14 to 28 Days)||3||
48736466|NCT01957202|102140104|FG004|STARTED|Washout Period 1 (14 to 28 Days)||3||
48736467|NCT01957202|102140105|FG005|STARTED|Washout Period 1 (14 to 28 Days)||2||
48736468|NCT01957202|102140106|FG006|STARTED|Washout Period 1 (14 to 28 Days)||3||
48736469|NCT01957202|102140107|FG007|STARTED|Washout Period 1 (14 to 28 Days)||3||
48736470|NCT01957202|102140108|FG008|STARTED|Washout Period 1 (14 to 28 Days)||3||
48736471|NCT01957202|102140109|FG009|STARTED|Washout Period 1 (14 to 28 Days)||6||
48736472|NCT01957202|102140110|FG010|STARTED|Washout Period 1 (14 to 28 Days)||3||
48736473|NCT01957202|102140111|FG011|STARTED|Washout Period 1 (14 to 28 Days)||6||
48736474|NCT01957202|102140112|FG012|STARTED|Washout Period 1 (14 to 28 Days)||3||
48736475|NCT01957202|102140113|FG013|STARTED|Washout Period 1 (14 to 28 Days)||3||
48736476|NCT01957202|102140114|FG014|STARTED|Washout Period 1 (14 to 28 Days)||6||
48736477|NCT01957202|102140115|FG015|STARTED|Washout Period 1 (14 to 28 Days)||3||
48736478|NCT01957202|102140116|FG016|STARTED|Washout Period 1 (14 to 28 Days)||6||
48736479|NCT01957202|102140117|FG017|STARTED|Washout Period 1 (14 to 28 Days)||3||
48736480|NCT01957202|102140100|FG000|COMPLETED|Washout Period 1 (14 to 28 Days)||3||
48736481|NCT01957202|102140101|FG001|COMPLETED|Washout Period 1 (14 to 28 Days)||6||
48736482|NCT01957202|102140102|FG002|COMPLETED|Washout Period 1 (14 to 28 Days)||6||
48736483|NCT01957202|102140103|FG003|COMPLETED|Washout Period 1 (14 to 28 Days)||3||
48736484|NCT01957202|102140104|FG004|COMPLETED|Washout Period 1 (14 to 28 Days)||3||
48736485|NCT01957202|102140105|FG005|COMPLETED|Washout Period 1 (14 to 28 Days)||2||
48736486|NCT01957202|102140106|FG006|COMPLETED|Washout Period 1 (14 to 28 Days)||3||
48736487|NCT01957202|102140107|FG007|COMPLETED|Washout Period 1 (14 to 28 Days)||3||
48736488|NCT01957202|102140108|FG008|COMPLETED|Washout Period 1 (14 to 28 Days)||3||
48160449|NCT02668016|100715863|FG000|Received Atorvastatin 20mg|Month 3||18||
48160450|NCT02668016|100715863|FG000|Received Placebo|Month 3||20||
48160451|NCT02668016|100715863|FG000|Received No Tablet|Month 3||20||
48160452|NCT02668016|100715863|FG000|Withdrew|Month 3||0||
48160453|NCT02668016|100715863|FG000|COMPLETED|Month 3||47||
48160454|NCT02668016|100715863|FG000|NOT COMPLETED|Month 3||11||
48160455|NCT02668016|100715863|FG000|STARTED|Month 4||58||
48160456|NCT02668016|100715863|FG000|Received Atorvastatin 20mg|Month 4||19||
48160457|NCT02668016|100715863|FG000|Received Placebo|Month 4||19||
48160458|NCT02668016|100715863|FG000|Received No Tablet|Month 4||20||
48160459|NCT02668016|100715863|FG000|Withdrew|Month 4||2||
48160460|NCT02668016|100715863|FG000|COMPLETED|Month 4||53||
48160461|NCT02668016|100715863|FG000|NOT COMPLETED|Month 4||5||
48160462|NCT02668016|100715863|FG000|STARTED|Month 5||56||
48160463|NCT02668016|100715863|FG000|Received Atorvastatin 20mg|Month 5||18||
48160464|NCT02668016|100715863|FG000|Received Placebo|Month 5||19||
48160465|NCT02668016|100715863|FG000|Received No Tablet|Month 5||19||
48160466|NCT02668016|100715863|FG000|Withdrew|Month 5||0||
48160467|NCT02668016|100715863|FG000|COMPLETED|Month 5||53||
48160468|NCT02668016|100715863|FG000|NOT COMPLETED|Month 5||3||
48160469|NCT02668016|100715863|FG000|STARTED|Month 6||56||
48160470|NCT02668016|100715863|FG000|Received Atorvastatin 20mg|Month 6||19||
48160471|NCT02668016|100715863|FG000|Received Placebo|Month 6||17||
48160472|NCT02668016|100715863|FG000|Received No Tablet|Month 6||20||
48160473|NCT02668016|100715863|FG000|Withdrew|Month 6||4||
48160474|NCT02668016|100715863|FG000|COMPLETED|Month 6||50||
48160475|NCT02668016|100715863|FG000|NOT COMPLETED|Month 6||6||
48160476|NCT02668016|100715863|FG000|STARTED|Month 7||52||
48318343|NCT02431702|101104236|FG000|STARTED|Part 3: 9 Month of Additional Treatment||0||
48368052|NCT03691623|101230097|FG001|STARTED|Overall Study||38||
48160477|NCT02668016|100715863|FG000|Received Atorvastatin 20mg|Month 7||18||
48160478|NCT02668016|100715863|FG000|Received Placebo|Month 7||18||
48160479|NCT02668016|100715863|FG000|Received No Tablet|Month 7||16||
48160480|NCT02668016|100715863|FG000|Withdrew|Month 7||0||
48160481|NCT02668016|100715863|FG000|COMPLETED|Month 7||43||
48160482|NCT02668016|100715863|FG000|NOT COMPLETED|Month 7||9||
48160483|NCT02668016|100715863|FG000|STARTED|Month 8||52||
48160484|NCT02668016|100715863|FG000|Received Atorvastatin 20mg|Month 8||18||
48160485|NCT02668016|100715863|FG000|Received Placebo|Month 8||19||
48160486|NCT02668016|100715863|FG000|Received No Tablet|Month 8||15||
48160487|NCT02668016|100715863|FG000|Withdrew|Month 8||1||
48160488|NCT02668016|100715863|FG000|COMPLETED|Month 8||45||
48160489|NCT02668016|100715863|FG000|NOT COMPLETED|Month 8||7||
48160490|NCT02668016|100715863|FG000|STARTED|Month 9||51||
48160491|NCT02668016|100715863|FG000|Received Atorvastatin 20mg|Month 9||15||
48160492|NCT02668016|100715863|FG000|Received Placebo|Month 9||19||
48407368|NCT03296072|101328535|FG001|COMPLETED|Treament Period 2||11||
48407369|NCT03296072|101328536|FG002|COMPLETED|Treament Period 2||10||
48407370|NCT03296072|101328537|FG003|COMPLETED|Treament Period 2||10||
48616056|NCT01051817|101845049|FG000|NOT COMPLETED|Overall Study||3||
48616057|NCT01051817|101845050|FG001|NOT COMPLETED|Overall Study||9||
48616058|NCT01720316|101845051|FG000|STARTED|Double-Blind Glycine Placebo Crossover||1||
48616059|NCT01720316|101845052|FG001|STARTED|Double-Blind Glycine Placebo Crossover||1||
48616060|NCT01720316|101845051|FG000|COMPLETED|Double-Blind Glycine Placebo Crossover||1||
48616061|NCT01720316|101845052|FG001|COMPLETED|Double-Blind Glycine Placebo Crossover||1||
48616062|NCT01720316|101845051|FG000|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0||
48616063|NCT01720316|101845052|FG001|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0||
48616064|NCT01720316|101845051|FG000|STARTED|Open-label Glycine||1||
48616065|NCT01720316|101845052|FG001|STARTED|Open-label Glycine||1||
48616066|NCT01720316|101845051|FG000|COMPLETED|Open-label Glycine||1||
48616067|NCT01720316|101845052|FG001|COMPLETED|Open-label Glycine||1||
48616068|NCT01720316|101845051|FG000|NOT COMPLETED|Open-label Glycine||0||
48616069|NCT01720316|101845052|FG001|NOT COMPLETED|Open-label Glycine||0||
48616070|NCT00237692|101845053|FG000|STARTED|Overall Study||147||
48616071|NCT00237692|101845054|FG001|STARTED|Overall Study||148||
48616072|NCT00237692|101845055|FG002|STARTED|Overall Study||149||
48616073|NCT00237692|101845056|FG003|STARTED|Overall Study||147||
48616074|NCT00237692|101845053|FG000|6 Month f/u|Overall Study||132||
48616075|NCT00237692|101845054|FG001|6 Month f/u|Overall Study||134||
48616076|NCT00237692|101845055|FG002|6 Month f/u|Overall Study||135||
48616077|NCT00237692|101845056|FG003|6 Month f/u|Overall Study||134||
48616078|NCT00237692|101845053|FG000|12 Month f/u|Overall Study||137||
48616079|NCT00237692|101845054|FG001|12 Month f/u|Overall Study||127||
48616080|NCT00237692|101845055|FG002|12 Month f/u|Overall Study||132||
48616081|NCT00237692|101845056|FG003|12 Month f/u|Overall Study||127||
48616082|NCT00237692|101845053|FG000|18 Month f/u|Overall Study||124||
48616083|NCT00237692|101845054|FG001|18 Month f/u|Overall Study||131||
48616084|NCT00237692|101845055|FG002|18 Month f/u|Overall Study||126||
48616085|NCT00237692|101845056|FG003|18 Month f/u|Overall Study||122||
48616086|NCT00237692|101845053|FG000|COMPLETED|Overall Study||129||
48616087|NCT00237692|101845054|FG001|COMPLETED|Overall Study||134||
48616088|NCT00237692|101845055|FG002|COMPLETED|Overall Study||127||
48616089|NCT00237692|101845056|FG003|COMPLETED|Overall Study||128||
48616090|NCT00237692|101845053|FG000|NOT COMPLETED|Overall Study||18||
48616091|NCT00237692|101845054|FG001|NOT COMPLETED|Overall Study||14||
48616092|NCT00237692|101845055|FG002|NOT COMPLETED|Overall Study||22||
48616093|NCT00237692|101845056|FG003|NOT COMPLETED|Overall Study||19||
48616094|NCT04249362|101845057|FG000|STARTED|Overall Study||53||
48160493|NCT02668016|100715863|FG000|Received No Tablet|Month 9||17||
48616095|NCT04249362|101845058|FG001|STARTED|Overall Study||49||
48616096|NCT04249362|101845057|FG000|COMPLETED|Overall Study||19||
48616097|NCT04249362|101845058|FG001|COMPLETED|Overall Study||24||
48616098|NCT04249362|101845057|FG000|NOT COMPLETED|Overall Study||34||
48616099|NCT04249362|101845058|FG001|NOT COMPLETED|Overall Study||25||
48616100|NCT01025284|101845059|FG000|STARTED|Overall Study||38||
48616101|NCT01025284|101845060|FG001|STARTED|Overall Study||18||
48616102|NCT01025284|101845061|FG002|STARTED|Overall Study||8||
48616103|NCT01025284|101845059|FG000|Received at Least 1 Dose of Study Drug|Overall Study||38||
48616104|NCT01025284|101845060|FG001|Received at Least 1 Dose of Study Drug|Overall Study||18||
48616105|NCT01025284|101845061|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8||
48616106|NCT01025284|101845059|FG000|COMPLETED|Overall Study||38||
48616107|NCT01025284|101845060|FG001|COMPLETED|Overall Study||16||
48616108|NCT01025284|101845061|FG002|COMPLETED|Overall Study||8||
48616109|NCT01025284|101845059|FG000|NOT COMPLETED|Overall Study||0||
48616110|NCT01025284|101845060|FG001|NOT COMPLETED|Overall Study||2||
48160494|NCT02668016|100715863|FG000|Withdrew|Month 9||0||
48160495|NCT02668016|100715863|FG000|COMPLETED|Month 9||40||
48160496|NCT02668016|100715863|FG000|NOT COMPLETED|Month 9||11||
48616111|NCT01025284|101845061|FG002|NOT COMPLETED|Overall Study||0||
48616112|NCT00870467|101845062|FG000|STARTED|Double-blind||171||
48616113|NCT00870467|101845063|FG001|STARTED|Double-blind||163||
48616114|NCT00870467|101845064|FG002|STARTED|Double-blind||0||
48736489|NCT01957202|102140109|FG009|COMPLETED|Washout Period 1 (14 to 28 Days)||6||
48736490|NCT01957202|102140110|FG010|COMPLETED|Washout Period 1 (14 to 28 Days)||3||
48736491|NCT01957202|102140111|FG011|COMPLETED|Washout Period 1 (14 to 28 Days)||6||
48736492|NCT01957202|102140112|FG012|COMPLETED|Washout Period 1 (14 to 28 Days)||3||
48736493|NCT01957202|102140113|FG013|COMPLETED|Washout Period 1 (14 to 28 Days)||3||
48736494|NCT01957202|102140114|FG014|COMPLETED|Washout Period 1 (14 to 28 Days)||6||
48736495|NCT01957202|102140115|FG015|COMPLETED|Washout Period 1 (14 to 28 Days)||3||
48736496|NCT01957202|102140116|FG016|COMPLETED|Washout Period 1 (14 to 28 Days)||6||
48736497|NCT01957202|102140117|FG017|COMPLETED|Washout Period 1 (14 to 28 Days)||3||
48736498|NCT01957202|102140100|FG000|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
48736499|NCT01957202|102140101|FG001|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
48736500|NCT01957202|102140102|FG002|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
48736501|NCT01957202|102140103|FG003|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
48736502|NCT01957202|102140104|FG004|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
48736503|NCT01957202|102140105|FG005|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
48736504|NCT01957202|102140106|FG006|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
48318344|NCT02431702|101104237|FG001|STARTED|Part 3: 9 Month of Additional Treatment||0||
48318345|NCT02431702|101104238|FG002|STARTED|Part 3: 9 Month of Additional Treatment||0||
48736505|NCT01957202|102140107|FG007|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
48736506|NCT01957202|102140108|FG008|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
48736507|NCT01957202|102140109|FG009|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
48736508|NCT01957202|102140110|FG010|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
48736509|NCT01957202|102140111|FG011|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
48736510|NCT01957202|102140112|FG012|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
48736511|NCT01957202|102140113|FG013|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
48318346|NCT02431702|101104239|FG003|STARTED|Part 3: 9 Month of Additional Treatment||49||
48368053|NCT03691623|101230098|FG002|STARTED|Overall Study||38||
48318347|NCT02431702|101104240|FG004|STARTED|Part 3: 9 Month of Additional Treatment||57||
48318348|NCT02431702|101104241|FG005|STARTED|Part 3: 9 Month of Additional Treatment||63||
48318349|NCT02431702|101104242|FG006|STARTED|Part 3: 9 Month of Additional Treatment||0||
48318350|NCT02431702|101104236|FG000|COMPLETED|Part 3: 9 Month of Additional Treatment||0||
48318351|NCT02431702|101104237|FG001|COMPLETED|Part 3: 9 Month of Additional Treatment||0||
48318352|NCT02431702|101104238|FG002|COMPLETED|Part 3: 9 Month of Additional Treatment||0||
48318353|NCT02431702|101104239|FG003|COMPLETED|Part 3: 9 Month of Additional Treatment||40||
48318354|NCT02431702|101104240|FG004|COMPLETED|Part 3: 9 Month of Additional Treatment||47||
48318355|NCT02431702|101104241|FG005|COMPLETED|Part 3: 9 Month of Additional Treatment||46||
48318356|NCT02431702|101104242|FG006|COMPLETED|Part 3: 9 Month of Additional Treatment||0||
48318357|NCT02431702|101104236|FG000|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0||
48318358|NCT02431702|101104237|FG001|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0||
48318359|NCT02431702|101104238|FG002|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0||
48318360|NCT02431702|101104239|FG003|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||9||
48318361|NCT02431702|101104240|FG004|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||10||
48318362|NCT02431702|101104241|FG005|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||17||
48318363|NCT02431702|101104242|FG006|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0||
48318364|NCT03817775|101104243|FG000|STARTED|Overall Study||22||
48318365|NCT03817775|101104244|FG001|STARTED|Overall Study||54||
48318366|NCT03817775|101104243|FG000|COMPLETED|Overall Study||22||
48318367|NCT03817775|101104244|FG001|COMPLETED|Overall Study||54||
48318368|NCT03817775|101104243|FG000|NOT COMPLETED|Overall Study||0||
48318369|NCT03817775|101104244|FG001|NOT COMPLETED|Overall Study||0||
48318370|NCT01347554|101104245|FG000|STARTED|Overall Study||237||
48318371|NCT01347554|101104246|FG001|STARTED|Overall Study||242||
48407371|NCT03296072|101328538|FG004|COMPLETED|Treament Period 2||10||
48407372|NCT03296072|101328539|FG005|COMPLETED|Treament Period 2||11||
48407373|NCT03296072|101328534|FG000|NOT COMPLETED|Treament Period 2||0||
48407374|NCT03296072|101328535|FG001|NOT COMPLETED|Treament Period 2||0||
48318372|NCT01347554|101104245|FG000|COMPLETED|Overall Study||230||
48318373|NCT01347554|101104246|FG001|COMPLETED|Overall Study||231||
48318374|NCT01347554|101104245|FG000|NOT COMPLETED|Overall Study||7||
48407375|NCT03296072|101328536|FG002|NOT COMPLETED|Treament Period 2||0||
48407376|NCT03296072|101328537|FG003|NOT COMPLETED|Treament Period 2||0||
48407377|NCT03296072|101328538|FG004|NOT COMPLETED|Treament Period 2||0||
48407378|NCT03296072|101328539|FG005|NOT COMPLETED|Treament Period 2||0||
48407379|NCT03296072|101328534|FG000|STARTED|Treament Period 2: Wash Out Period||10||
48407380|NCT03296072|101328535|FG001|STARTED|Treament Period 2: Wash Out Period||11||
48616115|NCT00870467|101845065|FG003|STARTED|Double-blind||0||
48616116|NCT00870467|101845066|FG004|STARTED|Double-blind||0||
48616117|NCT00870467|101845067|FG005|STARTED|Double-blind||0||
48616118|NCT00870467|101845062|FG000|COMPLETED|Double-blind||155||
48616119|NCT00870467|101845063|FG001|COMPLETED|Double-blind||151||
48616120|NCT00870467|101845064|FG002|COMPLETED|Double-blind||0||
48616121|NCT00870467|101845065|FG003|COMPLETED|Double-blind||0||
48616122|NCT00870467|101845066|FG004|COMPLETED|Double-blind||0||
48616123|NCT00870467|101845067|FG005|COMPLETED|Double-blind||0||
48616124|NCT00870467|101845062|FG000|NOT COMPLETED|Double-blind||16||
48616125|NCT00870467|101845063|FG001|NOT COMPLETED|Double-blind||12||
48616126|NCT00870467|101845064|FG002|NOT COMPLETED|Double-blind||0||
48407381|NCT03296072|101328536|FG002|STARTED|Treament Period 2: Wash Out Period||10||
48407382|NCT03296072|101328537|FG003|STARTED|Treament Period 2: Wash Out Period||10||
48407383|NCT03296072|101328538|FG004|STARTED|Treament Period 2: Wash Out Period||10||
48407384|NCT03296072|101328539|FG005|STARTED|Treament Period 2: Wash Out Period||11||
48407385|NCT03296072|101328534|FG000|COMPLETED|Treament Period 2: Wash Out Period||10||
48407386|NCT03296072|101328535|FG001|COMPLETED|Treament Period 2: Wash Out Period||11||
48407387|NCT03296072|101328536|FG002|COMPLETED|Treament Period 2: Wash Out Period||10||
48407388|NCT03296072|101328537|FG003|COMPLETED|Treament Period 2: Wash Out Period||10||
48407389|NCT03296072|101328538|FG004|COMPLETED|Treament Period 2: Wash Out Period||10||
48407390|NCT03296072|101328539|FG005|COMPLETED|Treament Period 2: Wash Out Period||11||
48407391|NCT03296072|101328534|FG000|NOT COMPLETED|Treament Period 2: Wash Out Period||0||
48440025|NCT01266642|101410013|FG000|NOT COMPLETED|Overall Study||0||
48616127|NCT00870467|101845065|FG003|NOT COMPLETED|Double-blind||0||
48616128|NCT00870467|101845066|FG004|NOT COMPLETED|Double-blind||0||
48616129|NCT00870467|101845067|FG005|NOT COMPLETED|Double-blind||0||
48616130|NCT00870467|101845062|FG000|STARTED|Open-label||0||
48616131|NCT00870467|101845063|FG001|STARTED|Open-label||0||
48616132|NCT00870467|101845064|FG002|STARTED|Open-label||145||
48616133|NCT00870467|101845065|FG003|STARTED|Open-label||127||
48616134|NCT00870467|101845066|FG004|STARTED|Open-label||10||
48616135|NCT00870467|101845067|FG005|STARTED|Open-label||24||
48616136|NCT00870467|101845062|FG000|COMPLETED|Open-label||0||
48616137|NCT00870467|101845063|FG001|COMPLETED|Open-label||0||
48616138|NCT00870467|101845064|FG002|COMPLETED|Open-label||132||
48616139|NCT00870467|101845065|FG003|COMPLETED|Open-label||120||
48616140|NCT00870467|101845066|FG004|COMPLETED|Open-label||5||
48616141|NCT00870467|101845067|FG005|COMPLETED|Open-label||21||
48616142|NCT00870467|101845062|FG000|NOT COMPLETED|Open-label||0||
48736512|NCT01957202|102140114|FG014|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
48736513|NCT01957202|102140115|FG015|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
48736514|NCT01957202|102140116|FG016|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
48736515|NCT01957202|102140117|FG017|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
48736516|NCT01957202|102140100|FG000|STARTED|Treatment Period 2 (8 Days)||3||
48736517|NCT01957202|102140101|FG001|STARTED|Treatment Period 2 (8 Days)||6||
48736518|NCT01957202|102140102|FG002|STARTED|Treatment Period 2 (8 Days)||6||
48736519|NCT01957202|102140103|FG003|STARTED|Treatment Period 2 (8 Days)||3||
48736520|NCT01957202|102140104|FG004|STARTED|Treatment Period 2 (8 Days)||3||
48318375|NCT01347554|101104246|FG001|NOT COMPLETED|Overall Study||11||
48318376|NCT04194528|101104247|FG000|STARTED|Overall Study||2||
48318377|NCT04194528|101104247|FG000|COMPLETED|Overall Study||1||
48318378|NCT04194528|101104247|FG000|NOT COMPLETED|Overall Study||1||
48318379|NCT00143312|101104248|FG000|STARTED|Overall Study||45||
48318380|NCT00143312|101104248|FG000|COMPLETED|Overall Study||29||
48318381|NCT00143312|101104248|FG000|NOT COMPLETED|Overall Study||16||
48318382|NCT02461550|101104249|FG000|STARTED|Overall Study||2||
48318383|NCT02461550|101104249|FG000|COMPLETED|Overall Study||2||
48407392|NCT03296072|101328535|FG001|NOT COMPLETED|Treament Period 2: Wash Out Period||0||
48407393|NCT03296072|101328536|FG002|NOT COMPLETED|Treament Period 2: Wash Out Period||0||
48407394|NCT03296072|101328537|FG003|NOT COMPLETED|Treament Period 2: Wash Out Period||0||
48407395|NCT03296072|101328538|FG004|NOT COMPLETED|Treament Period 2: Wash Out Period||0||
48407396|NCT03296072|101328539|FG005|NOT COMPLETED|Treament Period 2: Wash Out Period||0||
48407397|NCT03296072|101328534|FG000|STARTED|Treament Period 3||10||
48407398|NCT03296072|101328535|FG001|STARTED|Treament Period 3||11||
48407399|NCT03296072|101328536|FG002|STARTED|Treament Period 3||10||
48407400|NCT03296072|101328537|FG003|STARTED|Treament Period 3||10||
48407401|NCT03296072|101328538|FG004|STARTED|Treament Period 3||10||
48407402|NCT03296072|101328539|FG005|STARTED|Treament Period 3||11||
48407403|NCT03296072|101328534|FG000|COMPLETED|Treament Period 3||10||
48407404|NCT03296072|101328535|FG001|COMPLETED|Treament Period 3||11||
48407405|NCT03296072|101328536|FG002|COMPLETED|Treament Period 3||10||
48407406|NCT03296072|101328537|FG003|COMPLETED|Treament Period 3||10||
48407407|NCT03296072|101328538|FG004|COMPLETED|Treament Period 3||10||
48407408|NCT03296072|101328539|FG005|COMPLETED|Treament Period 3||11||
48407409|NCT03296072|101328534|FG000|NOT COMPLETED|Treament Period 3||0||
48407410|NCT03296072|101328535|FG001|NOT COMPLETED|Treament Period 3||0||
48407411|NCT03296072|101328536|FG002|NOT COMPLETED|Treament Period 3||0||
48407412|NCT03296072|101328537|FG003|NOT COMPLETED|Treament Period 3||0||
48407413|NCT03296072|101328538|FG004|NOT COMPLETED|Treament Period 3||0||
48407414|NCT03296072|101328539|FG005|NOT COMPLETED|Treament Period 3||0||
48318384|NCT02461550|101104249|FG000|NOT COMPLETED|Overall Study||0||
48318385|NCT01508702|101104250|FG000|STARTED|Overall Study||107||
48318386|NCT01508702|101104251|FG001|STARTED|Overall Study||107||
48407415|NCT01708915|101328540|FG000|STARTED|Overall Study||204||
48407416|NCT01708915|101328541|FG001|STARTED|Overall Study||201||
48407417|NCT01708915|101328542|FG002|STARTED|Overall Study||198||
48407418|NCT01708915|101328543|FG003|STARTED|Overall Study||202||
48407419|NCT01708915|101328540|FG000|COMPLETED|Overall Study||118||
48407420|NCT01708915|101328541|FG001|COMPLETED|Overall Study||139||
48407421|NCT01708915|101328542|FG002|COMPLETED|Overall Study||152||
48407422|NCT01708915|101328543|FG003|COMPLETED|Overall Study||169||
48407423|NCT01708915|101328540|FG000|NOT COMPLETED|Overall Study||86||
48736521|NCT01957202|102140105|FG005|STARTED|Treatment Period 2 (8 Days)||2||
48736522|NCT01957202|102140106|FG006|STARTED|Treatment Period 2 (8 Days)||3||
48736523|NCT01957202|102140107|FG007|STARTED|Treatment Period 2 (8 Days)||3||
48736524|NCT01957202|102140108|FG008|STARTED|Treatment Period 2 (8 Days)||3||
48318387|NCT01508702|101104250|FG000|COMPLETED|Overall Study||84||
48318388|NCT01508702|101104251|FG001|COMPLETED|Overall Study||94||
48318389|NCT01508702|101104250|FG000|NOT COMPLETED|Overall Study||23||
48318390|NCT01508702|101104251|FG001|NOT COMPLETED|Overall Study||13||
48318391|NCT03134599|101104252|FG000|STARTED|Week 1||10||
48318392|NCT03134599|101104253|FG001|STARTED|Week 1||10||
48318393|NCT03134599|101104254|FG002|STARTED|Week 1||10||
48407424|NCT01708915|101328541|FG001|NOT COMPLETED|Overall Study||62||
48407425|NCT01708915|101328542|FG002|NOT COMPLETED|Overall Study||46||
48407426|NCT01708915|101328543|FG003|NOT COMPLETED|Overall Study||33||
48736525|NCT01957202|102140109|FG009|STARTED|Treatment Period 2 (8 Days)||6||
48736526|NCT01957202|102140110|FG010|STARTED|Treatment Period 2 (8 Days)||3||
48318394|NCT03134599|101104255|FG003|STARTED|Week 1||11||
48318395|NCT03134599|101104256|FG004|STARTED|Week 1||10||
48318396|NCT03134599|101104257|FG005|STARTED|Week 1||9||
48318397|NCT03134599|101104252|FG000|COMPLETED|Week 1||10||
48407427|NCT02728206|101328544|FG000|STARTED|Overall Study||9||
48407428|NCT02728206|101328544|FG000|COMPLETED|Overall Study||8||
48407429|NCT02728206|101328544|FG000|NOT COMPLETED|Overall Study||1||
48407430|NCT01586962|101328545|FG000|STARTED|Overall Study||56||
48407431|NCT01586962|101328545|FG000|COMPLETED|Overall Study||56||
48736527|NCT01957202|102140111|FG011|STARTED|Treatment Period 2 (8 Days)||6||
48736528|NCT01957202|102140112|FG012|STARTED|Treatment Period 2 (8 Days)||3||
48318398|NCT03134599|101104253|FG001|COMPLETED|Week 1||10||
48318399|NCT03134599|101104254|FG002|COMPLETED|Week 1||10||
48736529|NCT01957202|102140113|FG013|STARTED|Treatment Period 2 (8 Days)||3||
48736530|NCT01957202|102140114|FG014|STARTED|Treatment Period 2 (8 Days)||6||
48736531|NCT01957202|102140115|FG015|STARTED|Treatment Period 2 (8 Days)||3||
48736532|NCT01957202|102140116|FG016|STARTED|Treatment Period 2 (8 Days)||6||
48736533|NCT01957202|102140117|FG017|STARTED|Treatment Period 2 (8 Days)||3||
48736534|NCT01957202|102140100|FG000|COMPLETED|Treatment Period 2 (8 Days)||3||
48736535|NCT01957202|102140101|FG001|COMPLETED|Treatment Period 2 (8 Days)||5||
48736536|NCT01957202|102140102|FG002|COMPLETED|Treatment Period 2 (8 Days)||6||
48736537|NCT01957202|102140103|FG003|COMPLETED|Treatment Period 2 (8 Days)||3||
48736538|NCT01957202|102140104|FG004|COMPLETED|Treatment Period 2 (8 Days)||3||
48318400|NCT03134599|101104255|FG003|COMPLETED|Week 1||11||
48318401|NCT03134599|101104256|FG004|COMPLETED|Week 1||9||
48318402|NCT03134599|101104257|FG005|COMPLETED|Week 1||9||
48318403|NCT03134599|101104252|FG000|NOT COMPLETED|Week 1||0||
48160497|NCT02668016|100715863|FG000|STARTED|Month 10||51||
48318404|NCT03134599|101104253|FG001|NOT COMPLETED|Week 1||0||
48318405|NCT03134599|101104254|FG002|NOT COMPLETED|Week 1||0||
48318406|NCT03134599|101104255|FG003|NOT COMPLETED|Week 1||0||
48318407|NCT03134599|101104256|FG004|NOT COMPLETED|Week 1||1||
48318408|NCT03134599|101104257|FG005|NOT COMPLETED|Week 1||0||
48736539|NCT01957202|102140105|FG005|COMPLETED|Treatment Period 2 (8 Days)||2||
48736540|NCT01957202|102140106|FG006|COMPLETED|Treatment Period 2 (8 Days)||3||
48736541|NCT01957202|102140107|FG007|COMPLETED|Treatment Period 2 (8 Days)||3||
48736542|NCT01957202|102140108|FG008|COMPLETED|Treatment Period 2 (8 Days)||3||
48736543|NCT01957202|102140109|FG009|COMPLETED|Treatment Period 2 (8 Days)||6||
48736544|NCT01957202|102140110|FG010|COMPLETED|Treatment Period 2 (8 Days)||3||
48736545|NCT01957202|102140111|FG011|COMPLETED|Treatment Period 2 (8 Days)||6||
48736546|NCT01957202|102140112|FG012|COMPLETED|Treatment Period 2 (8 Days)||3||
48736547|NCT01957202|102140113|FG013|COMPLETED|Treatment Period 2 (8 Days)||3||
48736548|NCT01957202|102140114|FG014|COMPLETED|Treatment Period 2 (8 Days)||6||
48736549|NCT01957202|102140115|FG015|COMPLETED|Treatment Period 2 (8 Days)||3||
48160498|NCT02668016|100715863|FG000|Received Atorvastatin 20mg|Month 10||15||
48318409|NCT03134599|101104252|FG000|STARTED|Week 2||10||
48736550|NCT01957202|102140116|FG016|COMPLETED|Treatment Period 2 (8 Days)||5||
48736551|NCT01957202|102140117|FG017|COMPLETED|Treatment Period 2 (8 Days)||3||
48736552|NCT01957202|102140100|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
48318410|NCT03134599|101104253|FG001|STARTED|Week 2||10||
48736553|NCT01957202|102140101|FG001|NOT COMPLETED|Treatment Period 2 (8 Days)||1||
48160499|NCT02668016|100715863|FG000|Received Placebo|Month 10||18||
48318411|NCT03134599|101104254|FG002|STARTED|Week 2||10||
48736554|NCT01957202|102140102|FG002|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
48736555|NCT01957202|102140103|FG003|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
48736556|NCT01957202|102140104|FG004|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
48736557|NCT01957202|102140105|FG005|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
48736558|NCT01957202|102140106|FG006|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
48736559|NCT01957202|102140107|FG007|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
48736560|NCT01957202|102140108|FG008|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
48736561|NCT01957202|102140109|FG009|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
48736562|NCT01957202|102140110|FG010|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
48736563|NCT01957202|102140111|FG011|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
48736564|NCT01957202|102140112|FG012|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
48736565|NCT01957202|102140113|FG013|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
48736566|NCT01957202|102140114|FG014|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
48736567|NCT01957202|102140115|FG015|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
48736568|NCT01957202|102140116|FG016|NOT COMPLETED|Treatment Period 2 (8 Days)||1||
48736569|NCT01957202|102140117|FG017|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
48736570|NCT01957202|102140100|FG000|STARTED|Washout Period 2 (14 to 28 Days)||3||
48736571|NCT01957202|102140101|FG001|STARTED|Washout Period 2 (14 to 28 Days)||5||
48736572|NCT01957202|102140102|FG002|STARTED|Washout Period 2 (14 to 28 Days)||6||
48736573|NCT01957202|102140103|FG003|STARTED|Washout Period 2 (14 to 28 Days)||3||
48736574|NCT01957202|102140104|FG004|STARTED|Washout Period 2 (14 to 28 Days)||3||
48736575|NCT01957202|102140105|FG005|STARTED|Washout Period 2 (14 to 28 Days)||2||
48736576|NCT01957202|102140106|FG006|STARTED|Washout Period 2 (14 to 28 Days)||3||
48736577|NCT01957202|102140107|FG007|STARTED|Washout Period 2 (14 to 28 Days)||3||
48736578|NCT01957202|102140108|FG008|STARTED|Washout Period 2 (14 to 28 Days)||3||
48736579|NCT01957202|102140109|FG009|STARTED|Washout Period 2 (14 to 28 Days)||6||
48736580|NCT01957202|102140110|FG010|STARTED|Washout Period 2 (14 to 28 Days)||3||
48736581|NCT01957202|102140111|FG011|STARTED|Washout Period 2 (14 to 28 Days)||6||
48318412|NCT03134599|101104255|FG003|STARTED|Week 2||11||
48736582|NCT01957202|102140112|FG012|STARTED|Washout Period 2 (14 to 28 Days)||3||
48318413|NCT03134599|101104256|FG004|STARTED|Week 2||9||
48318414|NCT03134599|101104257|FG005|STARTED|Week 2||9||
48318415|NCT03134599|101104252|FG000|COMPLETED|Week 2||9||
48318416|NCT03134599|101104253|FG001|COMPLETED|Week 2||10||
48736583|NCT01957202|102140113|FG013|STARTED|Washout Period 2 (14 to 28 Days)||3||
48736584|NCT01957202|102140114|FG014|STARTED|Washout Period 2 (14 to 28 Days)||6||
48736585|NCT01957202|102140115|FG015|STARTED|Washout Period 2 (14 to 28 Days)||3||
48736586|NCT01957202|102140116|FG016|STARTED|Washout Period 2 (14 to 28 Days)||5||
48736587|NCT01957202|102140117|FG017|STARTED|Washout Period 2 (14 to 28 Days)||3||
48736588|NCT01957202|102140100|FG000|COMPLETED|Washout Period 2 (14 to 28 Days)||3||
48736589|NCT01957202|102140101|FG001|COMPLETED|Washout Period 2 (14 to 28 Days)||5||
48736590|NCT01957202|102140102|FG002|COMPLETED|Washout Period 2 (14 to 28 Days)||6||
48736591|NCT01957202|102140103|FG003|COMPLETED|Washout Period 2 (14 to 28 Days)||3||
48736592|NCT01957202|102140104|FG004|COMPLETED|Washout Period 2 (14 to 28 Days)||3||
48736593|NCT01957202|102140105|FG005|COMPLETED|Washout Period 2 (14 to 28 Days)||2||
48318417|NCT03134599|101104254|FG002|COMPLETED|Week 2||10||
48318418|NCT03134599|101104255|FG003|COMPLETED|Week 2||10||
48318419|NCT03134599|101104256|FG004|COMPLETED|Week 2||8||
48318420|NCT03134599|101104257|FG005|COMPLETED|Week 2||9||
48407432|NCT01586962|101328545|FG000|NOT COMPLETED|Overall Study||0||
48736594|NCT01957202|102140106|FG006|COMPLETED|Washout Period 2 (14 to 28 Days)||3||
48736595|NCT01957202|102140107|FG007|COMPLETED|Washout Period 2 (14 to 28 Days)||3||
48736596|NCT01957202|102140108|FG008|COMPLETED|Washout Period 2 (14 to 28 Days)||3||
48736597|NCT01957202|102140109|FG009|COMPLETED|Washout Period 2 (14 to 28 Days)||6||
48736598|NCT01957202|102140110|FG010|COMPLETED|Washout Period 2 (14 to 28 Days)||3||
48736599|NCT01957202|102140111|FG011|COMPLETED|Washout Period 2 (14 to 28 Days)||6||
48736600|NCT01957202|102140112|FG012|COMPLETED|Washout Period 2 (14 to 28 Days)||3||
48736601|NCT01957202|102140113|FG013|COMPLETED|Washout Period 2 (14 to 28 Days)||3||
48736602|NCT01957202|102140114|FG014|COMPLETED|Washout Period 2 (14 to 28 Days)||6||
48736603|NCT01957202|102140115|FG015|COMPLETED|Washout Period 2 (14 to 28 Days)||3||
48736604|NCT01957202|102140116|FG016|COMPLETED|Washout Period 2 (14 to 28 Days)||5||
48736605|NCT01957202|102140117|FG017|COMPLETED|Washout Period 2 (14 to 28 Days)||3||
48736606|NCT01957202|102140100|FG000|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
48736607|NCT01957202|102140101|FG001|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
48736608|NCT01957202|102140102|FG002|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
48736609|NCT01957202|102140103|FG003|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
48736610|NCT01957202|102140104|FG004|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
48736611|NCT01957202|102140105|FG005|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
48318421|NCT03134599|101104252|FG000|NOT COMPLETED|Week 2||1||
48318422|NCT03134599|101104253|FG001|NOT COMPLETED|Week 2||0||
48318423|NCT03134599|101104254|FG002|NOT COMPLETED|Week 2||0||
48318424|NCT03134599|101104255|FG003|NOT COMPLETED|Week 2||1||
48318425|NCT03134599|101104256|FG004|NOT COMPLETED|Week 2||1||
48318426|NCT03134599|101104257|FG005|NOT COMPLETED|Week 2||0||
48407433|NCT00384449|101328546|FG000|STARTED|Overall Study||1||
48318427|NCT03134599|101104252|FG000|STARTED|Week 3||9||
48318428|NCT03134599|101104253|FG001|STARTED|Week 3||10||
48736612|NCT01957202|102140106|FG006|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
48736613|NCT01957202|102140107|FG007|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
48736614|NCT01957202|102140108|FG008|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
48736615|NCT01957202|102140109|FG009|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
48736616|NCT01957202|102140110|FG010|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
48736617|NCT01957202|102140111|FG011|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
48736618|NCT01957202|102140112|FG012|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
48736619|NCT01957202|102140113|FG013|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
48736620|NCT01957202|102140114|FG014|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
48736621|NCT01957202|102140115|FG015|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
48736622|NCT01957202|102140116|FG016|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
48736623|NCT01957202|102140117|FG017|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
48736624|NCT01957202|102140100|FG000|STARTED|Treatment Period 3 (8 Days)||3||
48736625|NCT01957202|102140101|FG001|STARTED|Treatment Period 3 (8 Days)||5||
48736626|NCT01957202|102140102|FG002|STARTED|Treatment Period 3 (8 Days)||6||
48736627|NCT01957202|102140103|FG003|STARTED|Treatment Period 3 (8 Days)||3||
48736628|NCT01957202|102140104|FG004|STARTED|Treatment Period 3 (8 Days)||3||
48736629|NCT01957202|102140105|FG005|STARTED|Treatment Period 3 (8 Days)||2||
48736630|NCT01957202|102140106|FG006|STARTED|Treatment Period 3 (8 Days)||3||
48736631|NCT01957202|102140107|FG007|STARTED|Treatment Period 3 (8 Days)||3||
48736632|NCT01957202|102140108|FG008|STARTED|Treatment Period 3 (8 Days)||3||
48736633|NCT01957202|102140109|FG009|STARTED|Treatment Period 3 (8 Days)||6||
48736634|NCT01957202|102140110|FG010|STARTED|Treatment Period 3 (8 Days)||3||
48736635|NCT01957202|102140111|FG011|STARTED|Treatment Period 3 (8 Days)||6||
48736636|NCT01957202|102140112|FG012|STARTED|Treatment Period 3 (8 Days)||3||
48736637|NCT01957202|102140113|FG013|STARTED|Treatment Period 3 (8 Days)||3||
48736638|NCT01957202|102140114|FG014|STARTED|Treatment Period 3 (8 Days)||6||
48736639|NCT01957202|102140115|FG015|STARTED|Treatment Period 3 (8 Days)||3||
48736640|NCT01957202|102140116|FG016|STARTED|Treatment Period 3 (8 Days)||5||
48736641|NCT01957202|102140117|FG017|STARTED|Treatment Period 3 (8 Days)||3||
48736642|NCT01957202|102140100|FG000|COMPLETED|Treatment Period 3 (8 Days)||3||
48736643|NCT01957202|102140101|FG001|COMPLETED|Treatment Period 3 (8 Days)||5||
48736644|NCT01957202|102140102|FG002|COMPLETED|Treatment Period 3 (8 Days)||6||
48736645|NCT01957202|102140103|FG003|COMPLETED|Treatment Period 3 (8 Days)||3||
48736646|NCT01957202|102140104|FG004|COMPLETED|Treatment Period 3 (8 Days)||3||
48736647|NCT01957202|102140105|FG005|COMPLETED|Treatment Period 3 (8 Days)||2||
48736648|NCT01957202|102140106|FG006|COMPLETED|Treatment Period 3 (8 Days)||3||
48736649|NCT01957202|102140107|FG007|COMPLETED|Treatment Period 3 (8 Days)||3||
48736650|NCT01957202|102140108|FG008|COMPLETED|Treatment Period 3 (8 Days)||3||
48736651|NCT01957202|102140109|FG009|COMPLETED|Treatment Period 3 (8 Days)||6||
48736652|NCT01957202|102140110|FG010|COMPLETED|Treatment Period 3 (8 Days)||3||
48736653|NCT01957202|102140111|FG011|COMPLETED|Treatment Period 3 (8 Days)||6||
48736654|NCT01957202|102140112|FG012|COMPLETED|Treatment Period 3 (8 Days)||3||
48736655|NCT01957202|102140113|FG013|COMPLETED|Treatment Period 3 (8 Days)||3||
48736656|NCT01957202|102140114|FG014|COMPLETED|Treatment Period 3 (8 Days)||6||
48736657|NCT01957202|102140115|FG015|COMPLETED|Treatment Period 3 (8 Days)||3||
48736658|NCT01957202|102140116|FG016|COMPLETED|Treatment Period 3 (8 Days)||4||
48736659|NCT01957202|102140117|FG017|COMPLETED|Treatment Period 3 (8 Days)||3||
48736660|NCT01957202|102140100|FG000|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
48736661|NCT01957202|102140101|FG001|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
48736662|NCT01957202|102140102|FG002|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
48736663|NCT01957202|102140103|FG003|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
48736664|NCT01957202|102140104|FG004|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
48736665|NCT01957202|102140105|FG005|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
48736666|NCT01957202|102140106|FG006|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
48736667|NCT01957202|102140107|FG007|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
48736668|NCT01957202|102140108|FG008|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
48736669|NCT01957202|102140109|FG009|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
48736670|NCT01957202|102140110|FG010|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
48736671|NCT01957202|102140111|FG011|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
48736672|NCT01957202|102140112|FG012|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
48736673|NCT01957202|102140113|FG013|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
48736674|NCT01957202|102140114|FG014|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
48736675|NCT01957202|102140115|FG015|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
48736676|NCT01957202|102140116|FG016|NOT COMPLETED|Treatment Period 3 (8 Days)||1||
48736677|NCT01957202|102140117|FG017|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
48736678|NCT02586727|102140118|FG000|STARTED|Overall Study||20||
48736679|NCT02586727|102140119|FG001|STARTED|Overall Study||20||
48736680|NCT02586727|102140118|FG000|COMPLETED|Overall Study||19||
48736681|NCT02586727|102140119|FG001|COMPLETED|Overall Study||20||
48736682|NCT02586727|102140118|FG000|NOT COMPLETED|Overall Study||1||
48736683|NCT02586727|102140119|FG001|NOT COMPLETED|Overall Study||0||
48736684|NCT03369249|102140120|FG000|STARTED|Overall Study||152||
48736685|NCT03369249|102140121|FG001|STARTED|Overall Study||155||
48736686|NCT03369249|102140120|FG000|COMPLETED|Overall Study||135||
48736687|NCT03369249|102140121|FG001|COMPLETED|Overall Study||139||
48736688|NCT03369249|102140120|FG000|NOT COMPLETED|Overall Study||17||
48736689|NCT03369249|102140121|FG001|NOT COMPLETED|Overall Study||16||
48736690|NCT02601833|102140122|FG000|STARTED|Overall Study||56||
48736691|NCT02601833|102140123|FG001|STARTED|Overall Study||42||
48736692|NCT02601833|102140122|FG000|COMPLETED|Overall Study||40||
48736693|NCT02601833|102140123|FG001|COMPLETED|Overall Study||29||
48736694|NCT02601833|102140122|FG000|NOT COMPLETED|Overall Study||16||
48736695|NCT02601833|102140123|FG001|NOT COMPLETED|Overall Study||13||
48736696|NCT02546492|102140124|FG000|STARTED|Overall Study||6||
48736697|NCT02546492|102140124|FG000|COMPLETED|Overall Study||1||
48736698|NCT02546492|102140124|FG000|NOT COMPLETED|Overall Study||5||
48736699|NCT02669212|102140125|FG000|STARTED|Overall Study||25||
48736700|NCT02669212|102140126|FG001|STARTED|Overall Study||27||
48736701|NCT02669212|102140125|FG000|COMPLETED|Overall Study||21||
48736702|NCT02669212|102140126|FG001|COMPLETED|Overall Study||17||
48736703|NCT02669212|102140125|FG000|NOT COMPLETED|Overall Study||4||
48736704|NCT02669212|102140126|FG001|NOT COMPLETED|Overall Study||10||
48736705|NCT00994422|102140127|FG000|STARTED|Overall Study||192||
48736706|NCT00994422|102140128|FG001|STARTED|Overall Study||55||
48736707|NCT00994422|102140127|FG000|COMPLETED|Overall Study||185||
48736708|NCT00994422|102140128|FG001|COMPLETED|Overall Study||54||
48736709|NCT00994422|102140127|FG000|NOT COMPLETED|Overall Study||7||
48736710|NCT00994422|102140128|FG001|NOT COMPLETED|Overall Study||1||
48736711|NCT00344500|102140129|FG000|STARTED|Overall Study||48||
48736712|NCT00344500|102140130|FG001|STARTED|Overall Study||60||
48736713|NCT00344500|102140131|FG002|STARTED|Overall Study||14||
48736714|NCT00344500|102140129|FG000|COMPLETED|Overall Study||25||
48736715|NCT00344500|102140130|FG001|COMPLETED|Overall Study||25||
48736716|NCT00344500|102140131|FG002|COMPLETED|Overall Study||12||
48736717|NCT00344500|102140129|FG000|NOT COMPLETED|Overall Study||23||
48736718|NCT00344500|102140130|FG001|NOT COMPLETED|Overall Study||35||
48736719|NCT00344500|102140131|FG002|NOT COMPLETED|Overall Study||2||
48736720|NCT00704288|102140132|FG000|STARTED|Overall Treatment Period||46||
48736721|NCT00704288|102140133|FG001|STARTED|Overall Treatment Period||59||
48736722|NCT00704288|102140134|FG002|STARTED|Overall Treatment Period||117||
48736723|NCT00704288|102140132|FG000|Naïve|Overall Treatment Period||34||
48736724|NCT00704288|102140133|FG001|Naïve|Overall Treatment Period||37||
48736725|NCT00704288|102140134|FG002|Naïve|Overall Treatment Period||81||
48736726|NCT00704288|102140132|FG000|Pre-treated|Overall Treatment Period||12||
48736727|NCT00704288|102140133|FG001|Pre-treated|Overall Treatment Period||22||
48736728|NCT00704288|102140134|FG002|Pre-treated|Overall Treatment Period||36||
48736729|NCT00704288|102140132|FG000|COMPLETED|Overall Treatment Period||0||
48736730|NCT00704288|102140133|FG001|COMPLETED|Overall Treatment Period||0||
48736731|NCT00704288|102140134|FG002|COMPLETED|Overall Treatment Period||0||
48736732|NCT00704288|102140132|FG000|NOT COMPLETED|Overall Treatment Period||46||
48736733|NCT00704288|102140133|FG001|NOT COMPLETED|Overall Treatment Period||59||
48736734|NCT00704288|102140134|FG002|NOT COMPLETED|Overall Treatment Period||117||
48736735|NCT00704288|102140132|FG000|STARTED|Extended Post Treatment Follow Up Period||46|Subjects had a Post-Treatment Visit 30 (+7) days after the final dose of cabozantinib for designated assessments. Thereafter, during extended Post-Treatment Follow-up, information was collected quarterly until death or loss to follow-up. All participants that started the study also started the follow-up period except for subjects who deceased during the study treatment period.|
48736736|NCT00704288|102140133|FG001|STARTED|Extended Post Treatment Follow Up Period||59|Subjects had a Post-Treatment Visit 30 (+7) days after the final dose of cabozantinib for designated assessments. Thereafter, during extended Post-Treatment Follow-up, information was collected quarterly until death or loss to follow-up. All participants that started the study also started the follow-up period except for subjects who deceased during the study treatment period.|
48736737|NCT00704288|102140134|FG002|STARTED|Extended Post Treatment Follow Up Period||117|Subjects had a Post-Treatment Visit 30 (+7) days after the final dose of cabozantinib for designated assessments. Thereafter, during extended Post-Treatment Follow-up, information was collected quarterly until death or loss to follow-up. All participants that started the study also started the follow-up period except for subjects who deceased during the study treatment period.|
48736738|NCT00704288|102140132|FG000|COMPLETED|Extended Post Treatment Follow Up Period||0|Completed subjects were not discontinued from the extended post treatment follow up. Not completed subjects were discontinued from the extended post treatment follow up.|
48736739|NCT00704288|102140133|FG001|COMPLETED|Extended Post Treatment Follow Up Period||0|Completed subjects were not discontinued from the extended post treatment follow up. Not completed subjects were discontinued from the extended post treatment follow up.|
48736740|NCT00704288|102140134|FG002|COMPLETED|Extended Post Treatment Follow Up Period||0|Completed subjects were not discontinued from the extended post treatment follow up. Not completed subjects were discontinued from the extended post treatment follow up.|
48736741|NCT00704288|102140132|FG000|NOT COMPLETED|Extended Post Treatment Follow Up Period||46||
48736742|NCT00704288|102140133|FG001|NOT COMPLETED|Extended Post Treatment Follow Up Period||59||
48736743|NCT00704288|102140134|FG002|NOT COMPLETED|Extended Post Treatment Follow Up Period||117||
48736744|NCT01807299|102140135|FG000|STARTED|Overall Study||14||
48736745|NCT01807299|102140136|FG001|STARTED|Overall Study||14||
48736746|NCT01807299|102140137|FG002|STARTED|Overall Study||12||
48736747|NCT01807299|102140138|FG003|STARTED|Overall Study||13||
48736748|NCT01807299|102140135|FG000|COMPLETED|Overall Study||11||
48736749|NCT01807299|102140136|FG001|COMPLETED|Overall Study||13||
48736750|NCT01807299|102140137|FG002|COMPLETED|Overall Study||12||
48736751|NCT01807299|102140138|FG003|COMPLETED|Overall Study||11||
48736752|NCT01807299|102140135|FG000|NOT COMPLETED|Overall Study||3||
48736753|NCT01807299|102140136|FG001|NOT COMPLETED|Overall Study||1||
48736754|NCT01807299|102140137|FG002|NOT COMPLETED|Overall Study||0||
48736755|NCT01807299|102140138|FG003|NOT COMPLETED|Overall Study||2||
48736756|NCT01761019|102140139|FG000|STARTED|Overall Study||8||
48736757|NCT01761019|102140139|FG000|COMPLETED|Overall Study||8||
48736758|NCT01761019|102140139|FG000|NOT COMPLETED|Overall Study||0||
48736759|NCT01711645|102140140|FG000|STARTED|Overall Study||55||
48318429|NCT03134599|101104254|FG002|STARTED|Week 3||10||
48736760|NCT01711645|102140140|FG000|COMPLETED|Overall Study||36||
48736761|NCT01711645|102140140|FG000|NOT COMPLETED|Overall Study||19||
48736762|NCT01843062|102140141|FG000|STARTED|Overall Study||155||
48160500|NCT02668016|100715863|FG000|Received No Tablet|Month 10||18||
48160501|NCT02668016|100715863|FG000|Withdrew|Month 10||2||
48160502|NCT02668016|100715863|FG000|COMPLETED|Month 10||43||
48736763|NCT01843062|102140142|FG001|STARTED|Overall Study||78||
48736764|NCT01843062|102140141|FG000|Intention to Treat (ITT) Analysis Set|Overall Study||155||
48736765|NCT01843062|102140142|FG001|Intention to Treat (ITT) Analysis Set|Overall Study||78||
48736766|NCT01843062|102140141|FG000|Safety Analysis Set|Overall Study||154||
48736767|NCT01843062|102140142|FG001|Safety Analysis Set|Overall Study||77||
48736768|NCT01843062|102140141|FG000|BRAF/NRAS Mutation Positive Analysis Set|Overall Study||91|BRAF/NRAS positive = mutations in BRAF/NRAS oncogenes had been detected|
48736769|NCT01843062|102140142|FG001|BRAF/NRAS Mutation Positive Analysis Set|Overall Study||51|BRAF/NRAS positive = mutations in BRAF/NRAS oncogenes had been detected|
48736770|NCT01843062|102140141|FG000|Ongoing at Primary Analysis Data Cut-off|Overall Study||134||
48736771|NCT01843062|102140142|FG001|Ongoing at Primary Analysis Data Cut-off|Overall Study||71||
48736772|NCT01843062|102140141|FG000|COMPLETED|Overall Study||133|Completed the end of study visit or end of study phone call|
48736773|NCT01843062|102140142|FG001|COMPLETED|Overall Study||69|Completed the end of study visit or end of study phone call|
48736774|NCT01843062|102140141|FG000|NOT COMPLETED|Overall Study||22||
48736775|NCT01843062|102140142|FG001|NOT COMPLETED|Overall Study||9||
48736776|NCT04522141|102140143|FG000|STARTED|Overall Study||42||
48736777|NCT04522141|102140144|FG001|STARTED|Overall Study||39||
48736778|NCT04522141|102140143|FG000|COMPLETED|Overall Study||41||
48736779|NCT04522141|102140144|FG001|COMPLETED|Overall Study||39||
48736780|NCT04522141|102140143|FG000|NOT COMPLETED|Overall Study||1||
48736781|NCT04522141|102140144|FG001|NOT COMPLETED|Overall Study||0||
48736782|NCT00724984|102140145|FG000|STARTED|Overall Study||5||
48736783|NCT00724984|102140146|FG001|STARTED|Overall Study||8||
48736784|NCT00724984|102140147|FG002|STARTED|Overall Study||3||
48736785|NCT00724984|102140148|FG003|STARTED|Overall Study||9||
48736786|NCT00724984|102140149|FG004|STARTED|Overall Study||16||
48736787|NCT00724984|102140150|FG005|STARTED|Overall Study||14||
48736788|NCT00724984|102140145|FG000|COMPLETED|Overall Study||4||
48736789|NCT00724984|102140146|FG001|COMPLETED|Overall Study||7||
48736790|NCT00724984|102140147|FG002|COMPLETED|Overall Study||3||
48736791|NCT00724984|102140148|FG003|COMPLETED|Overall Study||7||
48736792|NCT00724984|102140149|FG004|COMPLETED|Overall Study||12||
48736793|NCT00724984|102140150|FG005|COMPLETED|Overall Study||9||
48736794|NCT00724984|102140145|FG000|NOT COMPLETED|Overall Study||1||
48736795|NCT00724984|102140146|FG001|NOT COMPLETED|Overall Study||1||
48736796|NCT00724984|102140147|FG002|NOT COMPLETED|Overall Study||0||
48736797|NCT00724984|102140148|FG003|NOT COMPLETED|Overall Study||2||
48160503|NCT02668016|100715863|FG000|NOT COMPLETED|Month 10||8||
48318430|NCT03134599|101104255|FG003|STARTED|Week 3||10||
48736798|NCT00724984|102140149|FG004|NOT COMPLETED|Overall Study||4||
48736799|NCT00724984|102140150|FG005|NOT COMPLETED|Overall Study||5||
48736800|NCT01415401|102140151|FG000|STARTED|Overall Study||54||
48160504|NCT02668016|100715863|FG000|STARTED|Month 11||49||
48160505|NCT02668016|100715863|FG000|Received Atorvastatin 20mg|Month 11||17||
48160506|NCT02668016|100715863|FG000|Received Placebo|Month 11||15||
48160507|NCT02668016|100715863|FG000|Received No Tablet|Month 11||17||
48160508|NCT02668016|100715863|FG000|Withdrew|Month 11||0||
48160509|NCT02668016|100715863|FG000|COMPLETED|Month 11||42||
48318431|NCT03134599|101104256|FG004|STARTED|Week 3||8||
48318432|NCT03134599|101104257|FG005|STARTED|Week 3||9||
48736801|NCT01415401|102140151|FG000|COMPLETED|Overall Study||47||
48736802|NCT01415401|102140151|FG000|NOT COMPLETED|Overall Study||7||
48736803|NCT00423449|102140152|FG000|STARTED|Overall Study||4||
48736804|NCT00423449|102140153|FG001|STARTED|Overall Study||6||
48736805|NCT00423449|102140154|FG002|STARTED|Overall Study||17||
48736806|NCT00423449|102140155|FG003|STARTED|Overall Study||27||
48736807|NCT00423449|102140156|FG004|STARTED|Overall Study||7||
48736808|NCT00423449|102140152|FG000|COMPLETED|Overall Study||1||
48736809|NCT00423449|102140153|FG001|COMPLETED|Overall Study||2||
48736810|NCT00423449|102140154|FG002|COMPLETED|Overall Study||2||
48736811|NCT00423449|102140155|FG003|COMPLETED|Overall Study||5||
48736812|NCT00423449|102140156|FG004|COMPLETED|Overall Study||0||
48736813|NCT00423449|102140152|FG000|NOT COMPLETED|Overall Study||3||
48736814|NCT00423449|102140153|FG001|NOT COMPLETED|Overall Study||4||
48736815|NCT00423449|102140154|FG002|NOT COMPLETED|Overall Study||15||
48736816|NCT00423449|102140155|FG003|NOT COMPLETED|Overall Study||22||
48736817|NCT00423449|102140156|FG004|NOT COMPLETED|Overall Study||7||
48736818|NCT00303485|102140157|FG000|STARTED|Overall Study||49||
48736819|NCT00303485|102140158|FG001|STARTED|Overall Study||17||
48736820|NCT00303485|102140157|FG000|COMPLETED|Overall Study||48||
48736821|NCT00303485|102140158|FG001|COMPLETED|Overall Study||15||
48736822|NCT00303485|102140157|FG000|NOT COMPLETED|Overall Study||1||
48736823|NCT00303485|102140158|FG001|NOT COMPLETED|Overall Study||2||
48736824|NCT01683825|102140159|FG000|STARTED|Overall Study||10||
48736825|NCT01683825|102140160|FG001|STARTED|Overall Study||6||
48736826|NCT01683825|102140161|FG002|STARTED|Overall Study||7||
48736827|NCT01683825|102140159|FG000|COMPLETED|Overall Study||10||
48736828|NCT01683825|102140160|FG001|COMPLETED|Overall Study||6||
48736829|NCT01683825|102140161|FG002|COMPLETED|Overall Study||7||
48736830|NCT01683825|102140159|FG000|NOT COMPLETED|Overall Study||0||
48736831|NCT01683825|102140160|FG001|NOT COMPLETED|Overall Study||0||
48736832|NCT01683825|102140161|FG002|NOT COMPLETED|Overall Study||0||
48736833|NCT00319254|102140162|FG000|STARTED|Overall Study||75||
48736834|NCT00319254|102140162|FG000|Treated|Overall Study||73||
48736835|NCT00319254|102140162|FG000|COMPLETED|Overall Study||21||
48736836|NCT00319254|102140162|FG000|NOT COMPLETED|Overall Study||54||
48736837|NCT00705367|102140163|FG000|STARTED|Short-term Period||6||
48736838|NCT00705367|102140164|FG001|STARTED|Short-term Period||3||
48736839|NCT00705367|102140163|FG000|COMPLETED|Short-term Period||6||
48736840|NCT00705367|102140164|FG001|COMPLETED|Short-term Period||3||
48736841|NCT00705367|102140163|FG000|NOT COMPLETED|Short-term Period||0||
48736842|NCT00705367|102140164|FG001|NOT COMPLETED|Short-term Period||0||
48736843|NCT00705367|102140163|FG000|STARTED|Long-term Extension Period||9||
48736844|NCT00705367|102140164|FG001|STARTED|Long-term Extension Period||0||
48736845|NCT00705367|102140163|FG000|COMPLETED|Long-term Extension Period||0||
48736846|NCT00705367|102140164|FG001|COMPLETED|Long-term Extension Period||0||
48736847|NCT00705367|102140163|FG000|NOT COMPLETED|Long-term Extension Period||9||
48736848|NCT00705367|102140164|FG001|NOT COMPLETED|Long-term Extension Period||0||
48736849|NCT00566462|102140165|FG000|STARTED|Overall Study||1||
48736850|NCT00566462|102140166|FG001|STARTED|Overall Study||0||
48736851|NCT00566462|102140165|FG000|COMPLETED|Overall Study||1||
48736852|NCT00566462|102140166|FG001|COMPLETED|Overall Study||0||
48736853|NCT00566462|102140165|FG000|NOT COMPLETED|Overall Study||0||
48736854|NCT00566462|102140166|FG001|NOT COMPLETED|Overall Study||0||
48736855|NCT02279095|102140167|FG000|STARTED|Overall Study||58||
48736856|NCT02279095|102140167|FG000|Entered Part A|Overall Study||40||
48736857|NCT02279095|102140167|FG000|Completed Part A|Overall Study||13||
48736858|NCT02279095|102140167|FG000|Entered Part B|Overall Study||54|New Adult Cohort into Part B|
48736859|NCT02279095|102140167|FG000|Completed Part B|Overall Study||16||
48736860|NCT02279095|102140167|FG000|Entered Part C|Overall Study||48||
48736861|NCT02279095|102140167|FG000|Completed Part C|Overall Study||29||
48736862|NCT02279095|102140167|FG000|Entered Part D|Overall Study||2||
48736863|NCT02279095|102140167|FG000|COMPLETED|Overall Study||39||
48736864|NCT02279095|102140167|FG000|NOT COMPLETED|Overall Study||19||
48736865|NCT00709618|102140168|FG000|STARTED|Overall Study||44||
48736866|NCT00709618|102140168|FG000|COMPLETED|Overall Study||14||
48736867|NCT00709618|102140168|FG000|NOT COMPLETED|Overall Study||30||
48736868|NCT02978833|102140169|FG000|STARTED|Overall Study||1||
48736869|NCT02978833|102140170|FG001|STARTED|Overall Study||1||
48736870|NCT02978833|102140169|FG000|COMPLETED|Overall Study||0||
48736871|NCT02978833|102140170|FG001|COMPLETED|Overall Study||0||
48736872|NCT02978833|102140169|FG000|NOT COMPLETED|Overall Study||1||
48736873|NCT02978833|102140170|FG001|NOT COMPLETED|Overall Study||1||
48736874|NCT00595478|102140171|FG000|STARTED|Treatment||37||
48736875|NCT00595478|102140172|FG001|STARTED|Treatment||38||
48736876|NCT00595478|102140171|FG000|COMPLETED|Treatment||37||
48736877|NCT00595478|102140172|FG001|COMPLETED|Treatment||38||
48736878|NCT00595478|102140171|FG000|NOT COMPLETED|Treatment||0||
48736879|NCT00595478|102140172|FG001|NOT COMPLETED|Treatment||0||
48736880|NCT00595478|102140171|FG000|STARTED|36-week Follow-up Period||37||
48736881|NCT00595478|102140172|FG001|STARTED|36-week Follow-up Period||38||
48736882|NCT00595478|102140171|FG000|COMPLETED|36-week Follow-up Period||28||
48736883|NCT00595478|102140172|FG001|COMPLETED|36-week Follow-up Period||30||
48736884|NCT00595478|102140171|FG000|NOT COMPLETED|36-week Follow-up Period||9||
48736885|NCT00595478|102140172|FG001|NOT COMPLETED|36-week Follow-up Period||8||
48736886|NCT02451124|102140173|FG000|STARTED|Overall Study||156||
48736887|NCT02451124|102140173|FG000|COMPLETED|Overall Study||155||
48736888|NCT02451124|102140173|FG000|NOT COMPLETED|Overall Study||1||
48736889|NCT01378325|102140174|FG000|STARTED|Overall Study||40||
48736890|NCT01378325|102140175|FG001|STARTED|Overall Study||40||
48736891|NCT01378325|102140174|FG000|COMPLETED|Overall Study||40||
48736892|NCT01378325|102140175|FG001|COMPLETED|Overall Study||39||
48736893|NCT01378325|102140174|FG000|NOT COMPLETED|Overall Study||0||
48736894|NCT01378325|102140175|FG001|NOT COMPLETED|Overall Study||1||
48736895|NCT02608463|102140176|FG000|STARTED|Overall Study||10||
48736896|NCT02608463|102140177|FG001|STARTED|Overall Study||5||
48736897|NCT02608463|102140178|FG002|STARTED|Overall Study||0||
48736898|NCT02608463|102140179|FG003|STARTED|Overall Study||0||
48736899|NCT02608463|102140176|FG000|COMPLETED|Overall Study||10||
48736900|NCT02608463|102140177|FG001|COMPLETED|Overall Study||5||
48736901|NCT02608463|102140178|FG002|COMPLETED|Overall Study||0||
48736902|NCT02608463|102140179|FG003|COMPLETED|Overall Study||0||
48736903|NCT02608463|102140176|FG000|NOT COMPLETED|Overall Study||0||
48736904|NCT02608463|102140177|FG001|NOT COMPLETED|Overall Study||0||
48736905|NCT02608463|102140178|FG002|NOT COMPLETED|Overall Study||0||
48736906|NCT02608463|102140179|FG003|NOT COMPLETED|Overall Study||0||
48736907|NCT00358436|102140180|FG000|STARTED|Overall Study||600||
48736908|NCT00358436|102140181|FG001|STARTED|Overall Study||204||
48736909|NCT00358436|102140180|FG000|COMPLETED|Overall Study||446||
48736910|NCT00358436|102140181|FG001|COMPLETED|Overall Study||118||
48736911|NCT00358436|102140180|FG000|NOT COMPLETED|Overall Study||154||
48736912|NCT00358436|102140181|FG001|NOT COMPLETED|Overall Study||86||
48736913|NCT01193114|102140182|FG000|STARTED|Overall Study||30||
48736914|NCT01193114|102140183|FG001|STARTED|Overall Study||30||
48736915|NCT01193114|102140182|FG000|COMPLETED|Overall Study||30||
48736916|NCT01193114|102140183|FG001|COMPLETED|Overall Study||30||
48736917|NCT01193114|102140182|FG000|NOT COMPLETED|Overall Study||0||
48736918|NCT01193114|102140183|FG001|NOT COMPLETED|Overall Study||0||
48736919|NCT00513435|102140184|FG000|STARTED|Overall Study||9||
48736920|NCT00513435|102140184|FG000|COMPLETED|Overall Study||9||
48736921|NCT00513435|102140184|FG000|NOT COMPLETED|Overall Study||0||
48736922|NCT02069119|102140185|FG000|STARTED|Overall Study||20||
48736923|NCT02069119|102140186|FG001|STARTED|Overall Study||4||
48736924|NCT02069119|102140187|FG002|STARTED|Overall Study||20||
48736925|NCT02069119|102140188|FG003|STARTED|Overall Study||4||
48736926|NCT02069119|102140185|FG000|COMPLETED|Overall Study||20||
48736927|NCT02069119|102140186|FG001|COMPLETED|Overall Study||4||
48736928|NCT02069119|102140187|FG002|COMPLETED|Overall Study||20||
48736929|NCT02069119|102140188|FG003|COMPLETED|Overall Study||4||
48736930|NCT02069119|102140185|FG000|NOT COMPLETED|Overall Study||0||
48736931|NCT02069119|102140186|FG001|NOT COMPLETED|Overall Study||0||
48736932|NCT02069119|102140187|FG002|NOT COMPLETED|Overall Study||0||
48736933|NCT02069119|102140188|FG003|NOT COMPLETED|Overall Study||0||
48736934|NCT00320515|102140189|FG000|STARTED|Overall Study||69||
48736935|NCT00320515|102140189|FG000|COMPLETED|Overall Study||20||
48736936|NCT00320515|102140189|FG000|NOT COMPLETED|Overall Study||49||
48736937|NCT01067144|102140190|FG000|STARTED|Treatment||207||
48736938|NCT01067144|102140191|FG001|STARTED|Treatment||215||
48736939|NCT01067144|102140190|FG000|COMPLETED|Treatment||203||
48736940|NCT01067144|102140191|FG001|COMPLETED|Treatment||208||
48736941|NCT01067144|102140190|FG000|NOT COMPLETED|Treatment||4||
48736942|NCT01067144|102140191|FG001|NOT COMPLETED|Treatment||7||
48736943|NCT01067144|102140190|FG000|STARTED|Follow-up||203||
48736944|NCT01067144|102140191|FG001|STARTED|Follow-up||208||
48736945|NCT01067144|102140190|FG000|Intention-to-Treat Analysis Set|Follow-up||202|Received allocated treatment and had follow-up data.|
48736946|NCT01067144|102140191|FG001|Intention-to-Treat Analysis Set|Follow-up||208|Received allocated treatment and had follow-up data.|
48736947|NCT01067144|102140190|FG000|COMPLETED|Follow-up||144||
48736948|NCT01067144|102140191|FG001|COMPLETED|Follow-up||152||
48736949|NCT01067144|102140190|FG000|NOT COMPLETED|Follow-up||59||
48736950|NCT01067144|102140191|FG001|NOT COMPLETED|Follow-up||56||
48736951|NCT02008227|102140192|FG000|STARTED|Overall Study||612||
48736952|NCT02008227|102140193|FG001|STARTED|Overall Study||613||
48736953|NCT02008227|102140192|FG000|Treated|Overall Study||579||
48736954|NCT02008227|102140193|FG001|Treated|Overall Study||608||
48736955|NCT02008227|102140192|FG000|COMPLETED|Overall Study||0||
48736956|NCT02008227|102140193|FG001|COMPLETED|Overall Study||0||
48736957|NCT02008227|102140192|FG000|NOT COMPLETED|Overall Study||612||
48736958|NCT02008227|102140193|FG001|NOT COMPLETED|Overall Study||613||
48736959|NCT01625000|102140194|FG000|STARTED|Overall Study||126||
48736960|NCT01625000|102140195|FG001|STARTED|Overall Study||133||
48736961|NCT01625000|102140196|FG002|STARTED|Overall Study||67||
48736962|NCT01625000|102140197|FG003|STARTED|Overall Study||56||
48736963|NCT01625000|102140198|FG004|STARTED|Overall Study||126||
48736964|NCT01625000|102140194|FG000|COMPLETED|Overall Study||74||
48736965|NCT01625000|102140195|FG001|COMPLETED|Overall Study||81||
48736966|NCT01625000|102140196|FG002|COMPLETED|Overall Study||34||
48736967|NCT01625000|102140197|FG003|COMPLETED|Overall Study||37||
48736968|NCT01625000|102140198|FG004|COMPLETED|Overall Study||71||
48736969|NCT01625000|102140194|FG000|NOT COMPLETED|Overall Study||52||
48736970|NCT01625000|102140195|FG001|NOT COMPLETED|Overall Study||52||
48736971|NCT01625000|102140196|FG002|NOT COMPLETED|Overall Study||33||
48736972|NCT01625000|102140197|FG003|NOT COMPLETED|Overall Study||19||
48736973|NCT01625000|102140198|FG004|NOT COMPLETED|Overall Study||55||
48736974|NCT03089541|102140199|FG000|STARTED|Overall Study||29||
48736975|NCT03089541|102140199|FG000|COMPLETED|Overall Study||29||
48736976|NCT03089541|102140199|FG000|NOT COMPLETED|Overall Study||0||
48736977|NCT00741013|102140200|FG000|STARTED|Overall Study||7||
48736978|NCT00741013|102140201|FG001|STARTED|Overall Study||8||
48736979|NCT00741013|102140202|FG002|STARTED|Overall Study||7||
48736980|NCT00741013|102140200|FG000|COMPLETED|Overall Study||6||
48736981|NCT00741013|102140201|FG001|COMPLETED|Overall Study||6||
48736982|NCT00741013|102140202|FG002|COMPLETED|Overall Study||6||
48736983|NCT00741013|102140200|FG000|NOT COMPLETED|Overall Study||1||
48736984|NCT00741013|102140201|FG001|NOT COMPLETED|Overall Study||2||
48736985|NCT00741013|102140202|FG002|NOT COMPLETED|Overall Study||1||
48736986|NCT03781505|102140203|FG000|STARTED|Overall Study||30||
48736987|NCT03781505|102140204|FG001|STARTED|Overall Study||29||
48736988|NCT03781505|102140203|FG000|COMPLETED|Overall Study||30||
48736989|NCT03781505|102140204|FG001|COMPLETED|Overall Study||29||
48736990|NCT03781505|102140203|FG000|NOT COMPLETED|Overall Study||0||
48736991|NCT03781505|102140204|FG001|NOT COMPLETED|Overall Study||0||
48736992|NCT03628976|102140205|FG000|STARTED|Overall Study||12||
48736993|NCT03628976|102140206|FG001|STARTED|Overall Study||12||
48736994|NCT03628976|102140205|FG000|COMPLETED|Overall Study||12||
48736995|NCT03628976|102140206|FG001|COMPLETED|Overall Study||12||
48736996|NCT03628976|102140205|FG000|NOT COMPLETED|Overall Study||0||
48736997|NCT03628976|102140206|FG001|NOT COMPLETED|Overall Study||0||
48736998|NCT03302247|102140207|FG000|STARTED|Overall Study||3||
48736999|NCT03302247|102140207|FG000|COMPLETED|Overall Study||0||
48737000|NCT03302247|102140207|FG000|NOT COMPLETED|Overall Study||3||
48737001|NCT01963845|102140208|FG000|STARTED|Overall Study||25||
48737002|NCT01963845|102140209|FG001|STARTED|Overall Study||25||
48737003|NCT01963845|102140208|FG000|COMPLETED|Overall Study||25||
48737004|NCT01963845|102140209|FG001|COMPLETED|Overall Study||25||
48737005|NCT01963845|102140208|FG000|NOT COMPLETED|Overall Study||0||
48737006|NCT01963845|102140209|FG001|NOT COMPLETED|Overall Study||0||
48737007|NCT03593044|102140210|FG000|STARTED|Overall Study||31||
48737008|NCT03593044|102140210|FG000|COMPLETED|Overall Study||31||
48737009|NCT03593044|102140210|FG000|NOT COMPLETED|Overall Study||0||
48737010|NCT01746225|102140211|FG000|STARTED|Overall Study||83||
48737011|NCT01746225|102140212|FG001|STARTED|Overall Study||86||
48737012|NCT01746225|102140213|FG002|STARTED|Overall Study||86||
48737013|NCT01746225|102140211|FG000|COMPLETED|Overall Study||43||
48737014|NCT01746225|102140212|FG001|COMPLETED|Overall Study||40||
48737015|NCT01746225|102140213|FG002|COMPLETED|Overall Study||43||
48737016|NCT01746225|102140211|FG000|NOT COMPLETED|Overall Study||40||
48737017|NCT01746225|102140212|FG001|NOT COMPLETED|Overall Study||46||
48737018|NCT01746225|102140213|FG002|NOT COMPLETED|Overall Study||43||
48737019|NCT03124836|102140214|FG000|STARTED|Overall Study||28||
48737020|NCT03124836|102140214|FG000|COMPLETED|Overall Study||28||
48737021|NCT03124836|102140214|FG000|NOT COMPLETED|Overall Study||0||
48737022|NCT01177189|102140215|FG000|STARTED|Overall Study||42||
48737023|NCT01177189|102140216|FG001|STARTED|Overall Study||45||
48737024|NCT01177189|102140215|FG000|COMPLETED|Overall Study||42||
48160510|NCT02668016|100715863|FG000|NOT COMPLETED|Month 11||7||
48160511|NCT02668016|100715863|FG000|STARTED|Month 12||49||
48737025|NCT01177189|102140216|FG001|COMPLETED|Overall Study||45||
48737026|NCT01177189|102140215|FG000|NOT COMPLETED|Overall Study||0||
48737027|NCT01177189|102140216|FG001|NOT COMPLETED|Overall Study||0||
48737028|NCT00571038|102140217|FG000|STARTED|Overall Study||219||
48160512|NCT02668016|100715863|FG000|Received Atorvastatin 20mg|Month 12||16||
48160513|NCT02668016|100715863|FG000|Received Placebo|Month 12||17||
48160514|NCT02668016|100715863|FG000|Received No Tablet|Month 12||16||
48737029|NCT00571038|102140218|FG001|STARTED|Overall Study||185||
48737030|NCT00571038|102140217|FG000|6 Month Follow up|Overall Study||208||
48737031|NCT00571038|102140218|FG001|6 Month Follow up|Overall Study||176||
48737032|NCT00571038|102140217|FG000|18 Month Survey Only|Overall Study||199||
48737033|NCT00571038|102140218|FG001|18 Month Survey Only|Overall Study||163||
48737034|NCT00571038|102140217|FG000|COMPLETED|Overall Study||208||
48737035|NCT00571038|102140218|FG001|COMPLETED|Overall Study||171||
48737036|NCT00571038|102140217|FG000|NOT COMPLETED|Overall Study||11||
48737037|NCT00571038|102140218|FG001|NOT COMPLETED|Overall Study||14||
48737038|NCT01248949|102140219|FG000|STARTED|Overall Study||42||
48737039|NCT01248949|102140220|FG001|STARTED|Overall Study||16||
48737040|NCT01248949|102140221|FG002|STARTED|Overall Study||38||
48737041|NCT01248949|102140222|FG003|STARTED|Overall Study||13||
48737042|NCT01248949|102140223|FG004|STARTED|Overall Study||7||
48737043|NCT01248949|102140219|FG000|COMPLETED|Overall Study||9||
48737044|NCT01248949|102140220|FG001|COMPLETED|Overall Study||3||
48318433|NCT03134599|101104252|FG000|COMPLETED|Week 3||9||
48318434|NCT03134599|101104253|FG001|COMPLETED|Week 3||10||
48318435|NCT03134599|101104254|FG002|COMPLETED|Week 3||10||
48318436|NCT03134599|101104255|FG003|COMPLETED|Week 3||9||
48318437|NCT03134599|101104256|FG004|COMPLETED|Week 3||8||
48318438|NCT03134599|101104257|FG005|COMPLETED|Week 3||8||
48318439|NCT03134599|101104252|FG000|NOT COMPLETED|Week 3||0||
48318440|NCT03134599|101104253|FG001|NOT COMPLETED|Week 3||0||
48318441|NCT03134599|101104254|FG002|NOT COMPLETED|Week 3||0||
48318442|NCT03134599|101104255|FG003|NOT COMPLETED|Week 3||1||
48318443|NCT03134599|101104256|FG004|NOT COMPLETED|Week 3||0||
48737045|NCT01248949|102140221|FG002|COMPLETED|Overall Study||1||
48737046|NCT01248949|102140222|FG003|COMPLETED|Overall Study||3||
48737047|NCT01248949|102140223|FG004|COMPLETED|Overall Study||3||
48737048|NCT01248949|102140219|FG000|NOT COMPLETED|Overall Study||33||
48737049|NCT01248949|102140220|FG001|NOT COMPLETED|Overall Study||13||
48737050|NCT01248949|102140221|FG002|NOT COMPLETED|Overall Study||37||
48737051|NCT01248949|102140222|FG003|NOT COMPLETED|Overall Study||10||
48407434|NCT00384449|101328546|FG000|COMPLETED|Overall Study||1||
48407435|NCT00384449|101328546|FG000|NOT COMPLETED|Overall Study||0||
48407436|NCT02432690|101328547|FG000|STARTED|Overall Study||13||
48407437|NCT02432690|101328547|FG000|COMPLETED|Overall Study||13||
48407438|NCT02432690|101328547|FG000|NOT COMPLETED|Overall Study||0||
48407439|NCT04897594|101328548|FG000|STARTED|Overall Study||17||
48407440|NCT04897594|101328549|FG001|STARTED|Overall Study||20||
48407441|NCT04897594|101328550|FG002|STARTED|Overall Study||15||
48407442|NCT04897594|101328548|FG000|COMPLETED|Overall Study||16||
48407443|NCT04897594|101328549|FG001|COMPLETED|Overall Study||19||
48737052|NCT01248949|102140223|FG004|NOT COMPLETED|Overall Study||4||
48737053|NCT01777776|102140224|FG000|STARTED|Overall Study||6||
48737054|NCT01777776|102140225|FG001|STARTED|Overall Study||12||
48737055|NCT01777776|102140226|FG002|STARTED|Overall Study||6||
48737056|NCT01777776|102140227|FG003|STARTED|Overall Study||4||
48737057|NCT01777776|102140224|FG000|COMPLETED|Overall Study||0||
48737058|NCT01777776|102140225|FG001|COMPLETED|Overall Study||0||
48737059|NCT01777776|102140226|FG002|COMPLETED|Overall Study||0||
48737060|NCT01777776|102140227|FG003|COMPLETED|Overall Study||0||
48737061|NCT01777776|102140224|FG000|NOT COMPLETED|Overall Study||6||
48737062|NCT01777776|102140225|FG001|NOT COMPLETED|Overall Study||12||
48737063|NCT01777776|102140226|FG002|NOT COMPLETED|Overall Study||6||
48737064|NCT01777776|102140227|FG003|NOT COMPLETED|Overall Study||4||
48737065|NCT02564978|102140228|FG000|STARTED|Overall Study||37||
48737066|NCT02564978|102140228|FG000|Completed Run-in Phase|Overall Study||36|Completed Run-in Phase and Initiated Treatment Phase|
48737067|NCT02564978|102140228|FG000|Completed Month 33 Visit|Overall Study||21|Primary outcome is assessed at Month 33.|
48737068|NCT02564978|102140228|FG000|Completed Month 45 Visit|Overall Study||10|Minimum required follow-up is through Month 45. Common termination date is reached when the last enrolled participant completes the study through Month 45. Prior to Amendment L, follow-up beyond Month 45 may be completed for those participants enrolled at the beginning of the study and continue on study until the common termination date. As of Amendment L, participants could complete the study per-protocol prior to the common termination date and as early as Month 45 at the discretion of the PI.|
48737069|NCT02564978|102140228|FG000|Completed Month 57 Visit|Overall Study||4|Minimum required follow-up is through Month 45. Common termination date is reached when the last enrolled participant completes the study through Month 45. Prior to Amendment L, follow-up beyond Month 45 may be completed for those participants enrolled at the beginning of the study and continue on study until the common termination date. As of Amendment L, participants could complete the study per-protocol prior to the common termination date and as early as Month 45 at the discretion of the PI.|
48737070|NCT02564978|102140228|FG000|COMPLETED|Overall Study||5||
48737071|NCT02564978|102140228|FG000|NOT COMPLETED|Overall Study||32||
48737072|NCT01451385|102140229|FG000|STARTED|Overall Study||376||
48318444|NCT03134599|101104257|FG005|NOT COMPLETED|Week 3||1||
48318445|NCT00766038|101104258|FG000|STARTED|Overall Study||31||
48318446|NCT00766038|101104259|FG001|STARTED|Overall Study||32||
48318447|NCT00766038|101104258|FG000|COMPLETED|Overall Study||16||
48318448|NCT00766038|101104259|FG001|COMPLETED|Overall Study||18||
48737073|NCT01451385|102140229|FG000|COMPLETED|Overall Study||285||
48318449|NCT00766038|101104258|FG000|NOT COMPLETED|Overall Study||15||
48318450|NCT00766038|101104259|FG001|NOT COMPLETED|Overall Study||14||
48318451|NCT01923285|101104260|FG000|STARTED|Overall Study||76||
48318452|NCT01923285|101104261|FG001|STARTED|Overall Study||76||
48318453|NCT01923285|101104260|FG000|Modified Intent-to-treat|Overall Study||73|6 subjects excluded from MITT (withdrew prior to trial phase): Axium N = 3, Control N = 3|
48407444|NCT04897594|101328550|FG002|COMPLETED|Overall Study||12||
48407445|NCT04897594|101328548|FG000|NOT COMPLETED|Overall Study||1||
48407446|NCT04897594|101328549|FG001|NOT COMPLETED|Overall Study||1||
48737074|NCT01451385|102140229|FG000|NOT COMPLETED|Overall Study||91||
48318454|NCT01923285|101104261|FG001|Modified Intent-to-treat|Overall Study||73|6 subjects excluded from MITT (withdrew prior to trial phase): Axium N = 3, Control N = 3|
48318455|NCT01923285|101104260|FG000|COMPLETED|Overall Study||69||
48318456|NCT01923285|101104261|FG001|COMPLETED|Overall Study||70||
48407447|NCT04897594|101328550|FG002|NOT COMPLETED|Overall Study||3||
48407448|NCT01474889|101328551|FG000|STARTED|Overall Study||13||
48318457|NCT01923285|101104260|FG000|NOT COMPLETED|Overall Study||7||
48318458|NCT01923285|101104261|FG001|NOT COMPLETED|Overall Study||6||
48737075|NCT01286077|102140230|FG000|STARTED|Overall Study||51||
48737076|NCT01286077|102140231|FG001|STARTED|Overall Study||53||
48737077|NCT01286077|102140230|FG000|COMPLETED|Overall Study||41||
48737078|NCT01286077|102140231|FG001|COMPLETED|Overall Study||46||
48737079|NCT01286077|102140230|FG000|NOT COMPLETED|Overall Study||10||
48737080|NCT01286077|102140231|FG001|NOT COMPLETED|Overall Study||7||
48737081|NCT01055314|102140232|FG000|STARTED|Overall Study||100||
48737082|NCT01055314|102140233|FG001|STARTED|Overall Study||75||
48737083|NCT01055314|102140232|FG000|COMPLETED|Overall Study||55||
48737084|NCT01055314|102140233|FG001|COMPLETED|Overall Study||37||
48318459|NCT01236573|101104262|FG000|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1||
48318460|NCT01236573|101104263|FG001|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1||
48318461|NCT01236573|101104264|FG002|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||6||
48318462|NCT01236573|101104265|FG003|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1||
48318463|NCT01236573|101104266|FG004|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0||
48318464|NCT01236573|101104267|FG005|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0||
48737085|NCT01055314|102140232|FG000|NOT COMPLETED|Overall Study||45||
48737086|NCT01055314|102140233|FG001|NOT COMPLETED|Overall Study||38||
48737087|NCT00853151|102140234|FG000|STARTED|Overall Study||38||
48737088|NCT00853151|102140235|FG001|STARTED|Overall Study||37||
48737089|NCT00853151|102140236|FG002|STARTED|Overall Study||38||
48737090|NCT00853151|102140237|FG003|STARTED|Overall Study||18||
48737091|NCT00853151|102140234|FG000|COMPLETED|Overall Study||28||
48737092|NCT00853151|102140235|FG001|COMPLETED|Overall Study||24||
48737093|NCT00853151|102140236|FG002|COMPLETED|Overall Study||30||
48318465|NCT01236573|101104268|FG006|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0||
48318466|NCT01236573|101104269|FG007|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0||
48737094|NCT00853151|102140237|FG003|COMPLETED|Overall Study||15||
48737095|NCT00853151|102140234|FG000|NOT COMPLETED|Overall Study||10||
48737096|NCT00853151|102140235|FG001|NOT COMPLETED|Overall Study||13||
48737097|NCT00853151|102140236|FG002|NOT COMPLETED|Overall Study||8||
48737098|NCT00853151|102140237|FG003|NOT COMPLETED|Overall Study||3||
48737099|NCT00248807|102140238|FG000|STARTED|Overall Study||19||
48737100|NCT00248807|102140239|FG001|STARTED|Overall Study||11||
48737101|NCT00248807|102140238|FG000|COMPLETED|Overall Study||19||
48737102|NCT00248807|102140239|FG001|COMPLETED|Overall Study||11||
48318467|NCT01236573|101104270|FG008|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0||
48318468|NCT01236573|101104271|FG009|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0||
48318469|NCT01236573|101104272|FG010|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0||
48318470|NCT01236573|101104262|FG000|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1||
48318471|NCT01236573|101104263|FG001|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1||
48318472|NCT01236573|101104264|FG002|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||6||
48318473|NCT01236573|101104265|FG003|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1||
48318474|NCT01236573|101104266|FG004|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
48318475|NCT01236573|101104267|FG005|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
48318476|NCT01236573|101104268|FG006|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
48318477|NCT01236573|101104269|FG007|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
48318478|NCT01236573|101104270|FG008|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
48318479|NCT01236573|101104271|FG009|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
48318480|NCT01236573|101104272|FG010|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
48318481|NCT01236573|101104262|FG000|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
48737103|NCT00248807|102140238|FG000|NOT COMPLETED|Overall Study||0||
48737104|NCT00248807|102140239|FG001|NOT COMPLETED|Overall Study||0||
48737105|NCT01461707|102140240|FG000|STARTED|Overall Study||15||
48737106|NCT01461707|102140241|FG001|STARTED|Overall Study||15||
48318482|NCT01236573|101104263|FG001|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
48318483|NCT01236573|101104264|FG002|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
48318484|NCT01236573|101104265|FG003|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
48318485|NCT01236573|101104266|FG004|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
48318486|NCT01236573|101104267|FG005|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
48318487|NCT01236573|101104268|FG006|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
48318488|NCT01236573|101104269|FG007|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
48318489|NCT01236573|101104270|FG008|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
48318490|NCT01236573|101104271|FG009|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
48737107|NCT01461707|102140240|FG000|COMPLETED|Overall Study||14||
48737108|NCT01461707|102140241|FG001|COMPLETED|Overall Study||15||
48737109|NCT01461707|102140240|FG000|NOT COMPLETED|Overall Study||1||
48318491|NCT01236573|101104272|FG010|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
48318492|NCT01236573|101104262|FG000|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0||
48318493|NCT01236573|101104263|FG001|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0||
48318494|NCT01236573|101104264|FG002|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0||
48318495|NCT01236573|101104265|FG003|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0||
48737110|NCT01461707|102140241|FG001|NOT COMPLETED|Overall Study||0||
48737111|NCT00163020|102140242|FG000|STARTED|Overall Study||216||
48737112|NCT00163020|102140243|FG001|STARTED|Overall Study||105||
48737113|NCT00163020|102140242|FG000|COMPLETED|Overall Study||216||
48737114|NCT00163020|102140243|FG001|COMPLETED|Overall Study||103||
48737115|NCT00163020|102140242|FG000|NOT COMPLETED|Overall Study||0||
48318496|NCT01236573|101104266|FG004|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||1||
48318497|NCT01236573|101104267|FG005|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4||
48318498|NCT01236573|101104268|FG006|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3||
48318499|NCT01236573|101104269|FG007|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3||
48318500|NCT01236573|101104270|FG008|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4||
48318501|NCT01236573|101104271|FG009|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4||
48318502|NCT01236573|101104272|FG010|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0||
48318503|NCT01236573|101104262|FG000|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0||
48318504|NCT01236573|101104263|FG001|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0||
48318505|NCT01236573|101104264|FG002|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0||
48318506|NCT01236573|101104265|FG003|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0||
48318507|NCT01236573|101104266|FG004|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1||
48318508|NCT01236573|101104267|FG005|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||4||
48318509|NCT01236573|101104268|FG006|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2||
48318510|NCT01236573|101104269|FG007|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3||
48318511|NCT01236573|101104270|FG008|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2||
48318512|NCT01236573|101104271|FG009|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3||
48318513|NCT01236573|101104272|FG010|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0||
48318514|NCT01236573|101104262|FG000|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0||
48318515|NCT01236573|101104263|FG001|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0||
48318516|NCT01236573|101104264|FG002|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0||
48318517|NCT01236573|101104265|FG003|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0||
48318518|NCT01236573|101104266|FG004|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0||
48318519|NCT01236573|101104267|FG005|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0||
48318520|NCT01236573|101104268|FG006|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1||
48318521|NCT01236573|101104269|FG007|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0||
48318522|NCT01236573|101104270|FG008|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2||
48318523|NCT01236573|101104271|FG009|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1||
48318524|NCT01236573|101104272|FG010|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0||
48318525|NCT01236573|101104262|FG000|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
48318526|NCT01236573|101104263|FG001|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
48318527|NCT01236573|101104264|FG002|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
48318528|NCT01236573|101104265|FG003|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
48318529|NCT01236573|101104266|FG004|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
48318530|NCT01236573|101104267|FG005|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
48318531|NCT01236573|101104268|FG006|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
48318532|NCT01236573|101104269|FG007|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
48318533|NCT01236573|101104270|FG008|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
48318534|NCT01236573|101104271|FG009|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
48737116|NCT00163020|102140243|FG001|NOT COMPLETED|Overall Study||2||
48318535|NCT01236573|101104272|FG010|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||6||
48318536|NCT01236573|101104262|FG000|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
48318537|NCT01236573|101104263|FG001|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
48318538|NCT01236573|101104264|FG002|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
48318539|NCT01236573|101104265|FG003|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
48318540|NCT01236573|101104266|FG004|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
48318541|NCT01236573|101104267|FG005|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
48318542|NCT01236573|101104268|FG006|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
48318543|NCT01236573|101104269|FG007|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
48318544|NCT01236573|101104270|FG008|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
48318545|NCT01236573|101104271|FG009|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
48318546|NCT01236573|101104272|FG010|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||5||
48318547|NCT01236573|101104262|FG000|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
48318548|NCT01236573|101104263|FG001|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
48318549|NCT01236573|101104264|FG002|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
48318550|NCT01236573|101104265|FG003|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
48318551|NCT01236573|101104266|FG004|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
48318552|NCT01236573|101104267|FG005|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
48318553|NCT01236573|101104268|FG006|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
48318554|NCT01236573|101104269|FG007|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
48318555|NCT01236573|101104270|FG008|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
48318556|NCT01236573|101104271|FG009|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
48318557|NCT01236573|101104272|FG010|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||1||
48318558|NCT03765138|101104273|FG000|STARTED|Overall Study||1||
48318559|NCT03765138|101104273|FG000|COMPLETED|Overall Study||0||
48318560|NCT03765138|101104273|FG000|NOT COMPLETED|Overall Study||1||
48318561|NCT00957528|101104274|FG000|STARTED|Overall Study||8||
48737117|NCT00166439|102140244|FG000|STARTED|Overall Study||50||
48737118|NCT00166439|102140244|FG000|COMPLETED|Overall Study||45||
48737119|NCT00166439|102140244|FG000|NOT COMPLETED|Overall Study||5||
48318562|NCT00957528|101104275|FG001|STARTED|Overall Study||9||
48318563|NCT00957528|101104276|FG002|STARTED|Overall Study||9||
48737120|NCT00348673|102140245|FG000|STARTED|Stage 1||6||
48737121|NCT00348673|102140246|FG001|STARTED|Stage 1||6||
48737122|NCT00348673|102140247|FG002|STARTED|Stage 1||7||
48737123|NCT00348673|102140248|FG003|STARTED|Stage 1||6||
48737124|NCT00348673|102140249|FG004|STARTED|Stage 1||4||
48737125|NCT00348673|102140250|FG005|STARTED|Stage 1||0||
48737126|NCT00348673|102140251|FG006|STARTED|Stage 1||0||
48737127|NCT00348673|102140252|FG007|STARTED|Stage 1||0||
48737128|NCT00348673|102140253|FG008|STARTED|Stage 1||0||
48737129|NCT00348673|102140245|FG000|Treated|Stage 1||6||
48737130|NCT00348673|102140246|FG001|Treated|Stage 1||6||
48737131|NCT00348673|102140247|FG002|Treated|Stage 1||6||
48737132|NCT00348673|102140248|FG003|Treated|Stage 1||6||
48737133|NCT00348673|102140249|FG004|Treated|Stage 1||4||
48737134|NCT00348673|102140250|FG005|Treated|Stage 1||0||
48737135|NCT00348673|102140251|FG006|Treated|Stage 1||0||
48737136|NCT00348673|102140252|FG007|Treated|Stage 1||0||
48407449|NCT01474889|101328552|FG001|STARTED|Overall Study||12||
48407450|NCT01474889|101328553|FG002|STARTED|Overall Study||12||
48407451|NCT01474889|101328551|FG000|COMPLETED|Overall Study||11||
48407452|NCT01474889|101328552|FG001|COMPLETED|Overall Study||11||
48407453|NCT01474889|101328553|FG002|COMPLETED|Overall Study||12||
48407454|NCT01474889|101328551|FG000|NOT COMPLETED|Overall Study||2||
48407455|NCT01474889|101328552|FG001|NOT COMPLETED|Overall Study||1||
48407456|NCT01474889|101328553|FG002|NOT COMPLETED|Overall Study||0||
48407457|NCT00926263|101328554|FG000|STARTED|Overall Study||16||
48737137|NCT00348673|102140253|FG008|Treated|Stage 1||0||
48737138|NCT00348673|102140245|FG000|COMPLETED|Stage 1||6||
48737139|NCT00348673|102140246|FG001|COMPLETED|Stage 1||6||
48737140|NCT00348673|102140247|FG002|COMPLETED|Stage 1||6||
48737141|NCT00348673|102140248|FG003|COMPLETED|Stage 1||6||
48737142|NCT00348673|102140249|FG004|COMPLETED|Stage 1||4||
48160515|NCT02668016|100715863|FG000|Withdrew|Month 12||0||
48160516|NCT02668016|100715863|FG000|COMPLETED|Month 12||43||
48160517|NCT02668016|100715863|FG000|NOT COMPLETED|Month 12||6||
48160518|NCT02857426|100715864|FG000|STARTED|Overall Study||47|Started = received treatment|
48160519|NCT02857426|100715865|FG001|STARTED|Overall Study||19|Started = received treatment|
48160520|NCT02857426|100715864|FG000|COMPLETED|Overall Study||0|Completed = continuing in the treatment period|
48160521|NCT02857426|100715865|FG001|COMPLETED|Overall Study||0|Completed = continuing in the treatment period|
48160522|NCT02857426|100715864|FG000|NOT COMPLETED|Overall Study||47||
48160523|NCT02857426|100715865|FG001|NOT COMPLETED|Overall Study||19||
48160524|NCT03916744|100715866|FG000|STARTED|Overall Study||17|Intent-to-Treat (ITT) Population|
48160525|NCT03916744|100715867|FG001|STARTED|Overall Study||40|Intent-to-Treat (ITT) Population|
48160526|NCT03916744|100715868|FG002|STARTED|Overall Study||18|Intent-to-Treat (ITT) Population|
48318564|NCT00957528|101104274|FG000|COMPLETED|Overall Study||8||
48318565|NCT00957528|101104275|FG001|COMPLETED|Overall Study||8||
48318566|NCT00957528|101104276|FG002|COMPLETED|Overall Study||8||
48318567|NCT00957528|101104274|FG000|NOT COMPLETED|Overall Study||0||
48318568|NCT00957528|101104275|FG001|NOT COMPLETED|Overall Study||1||
48318569|NCT00957528|101104276|FG002|NOT COMPLETED|Overall Study||1||
48160527|NCT03916744|100715866|FG000|Received at Least One Dose of Study Drug|Overall Study||17|Safety Evaluable Population|
48318570|NCT02250274|101104277|FG000|STARTED|Overall Study||85||
48318571|NCT02250274|101104278|FG001|STARTED|Overall Study||46||
48318572|NCT02250274|101104277|FG000|COMPLETED|Overall Study||78||
48318573|NCT02250274|101104278|FG001|COMPLETED|Overall Study||40||
48407458|NCT00926263|101328555|FG001|STARTED|Overall Study||12||
48737143|NCT00348673|102140250|FG005|COMPLETED|Stage 1||0||
48737144|NCT00348673|102140251|FG006|COMPLETED|Stage 1||0||
48737145|NCT00348673|102140252|FG007|COMPLETED|Stage 1||0||
48737146|NCT00348673|102140253|FG008|COMPLETED|Stage 1||0||
48737147|NCT00348673|102140245|FG000|NOT COMPLETED|Stage 1||0||
48737148|NCT00348673|102140246|FG001|NOT COMPLETED|Stage 1||0||
48737149|NCT00348673|102140247|FG002|NOT COMPLETED|Stage 1||1||
48737150|NCT00348673|102140248|FG003|NOT COMPLETED|Stage 1||0||
48737151|NCT00348673|102140249|FG004|NOT COMPLETED|Stage 1||0||
48737152|NCT00348673|102140250|FG005|NOT COMPLETED|Stage 1||0||
48737153|NCT00348673|102140251|FG006|NOT COMPLETED|Stage 1||0||
48160528|NCT03916744|100715867|FG001|Received at Least One Dose of Study Drug|Overall Study||40|Safety Evaluable Population|
48160529|NCT03916744|100715868|FG002|Received at Least One Dose of Study Drug|Overall Study||17|Safety Evaluable Population|
48160530|NCT03916744|100715866|FG000|COMPLETED|Overall Study||17||
48160531|NCT03916744|100715867|FG001|COMPLETED|Overall Study||39||
48160532|NCT03916744|100715868|FG002|COMPLETED|Overall Study||16||
48160533|NCT03916744|100715866|FG000|NOT COMPLETED|Overall Study||0||
48160534|NCT03916744|100715867|FG001|NOT COMPLETED|Overall Study||1||
48160535|NCT03916744|100715868|FG002|NOT COMPLETED|Overall Study||2||
48160536|NCT00622180|100715869|FG000|STARTED|Overall Study||6||
48160537|NCT00622180|100715870|FG001|STARTED|Overall Study||7||
48160538|NCT00622180|100715869|FG000|COMPLETED|Overall Study||5||
48160539|NCT00622180|100715870|FG001|COMPLETED|Overall Study||5||
48160540|NCT00622180|100715869|FG000|NOT COMPLETED|Overall Study||1||
48160541|NCT00622180|100715870|FG001|NOT COMPLETED|Overall Study||2||
48160542|NCT01919970|100715871|FG000|STARTED|Overall Study||14||
48160543|NCT01919970|100715872|FG001|STARTED|Overall Study||18||
48407459|NCT00926263|101328554|FG000|COMPLETED|Overall Study||16||
48407460|NCT00926263|101328555|FG001|COMPLETED|Overall Study||12||
48407461|NCT00926263|101328554|FG000|NOT COMPLETED|Overall Study||0||
48407462|NCT00926263|101328555|FG001|NOT COMPLETED|Overall Study||0||
48407463|NCT00711412|101328556|FG000|STARTED|Induction Treatment||44||
48407464|NCT00711412|101328556|FG000|Registered to Study|Induction Treatment||44||
48407465|NCT00711412|101328556|FG000|Started Induction Treatment|Induction Treatment||43||
48407466|NCT00711412|101328556|FG000|COMPLETED|Induction Treatment||40||
48616143|NCT00870467|101845063|FG001|NOT COMPLETED|Open-label||0||
48616144|NCT00870467|101845064|FG002|NOT COMPLETED|Open-label||13||
48616145|NCT00870467|101845065|FG003|NOT COMPLETED|Open-label||7||
48616146|NCT00870467|101845066|FG004|NOT COMPLETED|Open-label||5||
48737154|NCT00348673|102140252|FG007|NOT COMPLETED|Stage 1||0||
48737155|NCT00348673|102140253|FG008|NOT COMPLETED|Stage 1||0||
48737156|NCT00348673|102140245|FG000|STARTED|Stage 2||0||
48160544|NCT01919970|100715871|FG000|COMPLETED|Overall Study||11||
48160545|NCT01919970|100715872|FG001|COMPLETED|Overall Study||18||
48160546|NCT01919970|100715871|FG000|NOT COMPLETED|Overall Study||3||
48160547|NCT01919970|100715872|FG001|NOT COMPLETED|Overall Study||0||
48737157|NCT00348673|102140246|FG001|STARTED|Stage 2||0||
48737158|NCT00348673|102140247|FG002|STARTED|Stage 2||0||
48737159|NCT00348673|102140248|FG003|STARTED|Stage 2||0||
48160548|NCT03364348|100715873|FG000|STARTED|Overall Study||3||
48160549|NCT03364348|100715874|FG001|STARTED|Overall Study||2||
48160550|NCT03364348|100715875|FG002|STARTED|Overall Study||3||
48160551|NCT03364348|100715876|FG003|STARTED|Overall Study||10||
48160552|NCT03364348|100715873|FG000|COMPLETED|Overall Study||3||
48160553|NCT03364348|100715874|FG001|COMPLETED|Overall Study||2||
48160554|NCT03364348|100715875|FG002|COMPLETED|Overall Study||3||
48160555|NCT03364348|100715876|FG003|COMPLETED|Overall Study||10||
48160556|NCT03364348|100715873|FG000|NOT COMPLETED|Overall Study||0||
48160557|NCT03364348|100715874|FG001|NOT COMPLETED|Overall Study||0||
48160558|NCT03364348|100715875|FG002|NOT COMPLETED|Overall Study||0||
48160559|NCT03364348|100715876|FG003|NOT COMPLETED|Overall Study||0||
48160560|NCT00642902|100715877|FG000|STARTED|Overall Study||63||
48160561|NCT00642902|100715878|FG001|STARTED|Overall Study||63||
48160562|NCT00642902|100715879|FG002|STARTED|Overall Study||64||
48160563|NCT00642902|100715880|FG003|STARTED|Overall Study||65||
48160564|NCT00642902|100715877|FG000|Treated|Overall Study||63||
48160565|NCT00642902|100715878|FG001|Treated|Overall Study||63||
48160566|NCT00642902|100715879|FG002|Treated|Overall Study||63||
48160567|NCT00642902|100715880|FG003|Treated|Overall Study||65||
48160568|NCT00642902|100715877|FG000|COMPLETED|Overall Study||23||
48160569|NCT00642902|100715878|FG001|COMPLETED|Overall Study||21||
48160570|NCT00642902|100715879|FG002|COMPLETED|Overall Study||21||
48407467|NCT00711412|101328556|FG000|NOT COMPLETED|Induction Treatment||4||
48407468|NCT00711412|101328556|FG000|STARTED|Evaluated for Combination Treatment||40||
48407469|NCT00711412|101328556|FG000|COMPLETED|Evaluated for Combination Treatment||34||
48407470|NCT00711412|101328556|FG000|NOT COMPLETED|Evaluated for Combination Treatment||6||
48407471|NCT00711412|101328556|FG000|STARTED|Combination Treatment||34||
48616147|NCT00870467|101845067|FG005|NOT COMPLETED|Open-label||3||
48616148|NCT02250300|101845068|FG000|STARTED|Dose Escalation 3.0 mg Phase||0||
48616149|NCT02250300|101845069|FG001|STARTED|Dose Escalation 3.0 mg Phase||0||
48616150|NCT02250300|101845070|FG002|STARTED|Dose Escalation 3.0 mg Phase||3||
48616151|NCT02250300|101845071|FG003|STARTED|Dose Escalation 3.0 mg Phase||0||
48616152|NCT02250300|101845068|FG000|COMPLETED|Dose Escalation 3.0 mg Phase||0||
48737160|NCT00348673|102140249|FG004|STARTED|Stage 2||0||
48160571|NCT00642902|100715880|FG003|COMPLETED|Overall Study||25||
48160572|NCT00642902|100715877|FG000|NOT COMPLETED|Overall Study||40||
48407472|NCT00711412|101328556|FG000|COMPLETED|Combination Treatment||33||
48407473|NCT00711412|101328556|FG000|NOT COMPLETED|Combination Treatment||1||
48407474|NCT00711412|101328556|FG000|STARTED|Evaluation for Response and Surgery||34||
48407475|NCT00711412|101328556|FG000|COMPLETED|Evaluation for Response and Surgery||28||
48616153|NCT02250300|101845069|FG001|COMPLETED|Dose Escalation 3.0 mg Phase||0||
48737161|NCT00348673|102140250|FG005|STARTED|Stage 2||6||
48160573|NCT00642902|100715878|FG001|NOT COMPLETED|Overall Study||42||
48160574|NCT00642902|100715879|FG002|NOT COMPLETED|Overall Study||43||
48616154|NCT02250300|101845070|FG002|COMPLETED|Dose Escalation 3.0 mg Phase||3||
48616155|NCT02250300|101845071|FG003|COMPLETED|Dose Escalation 3.0 mg Phase||0||
48616156|NCT02250300|101845068|FG000|NOT COMPLETED|Dose Escalation 3.0 mg Phase||0||
48616157|NCT02250300|101845069|FG001|NOT COMPLETED|Dose Escalation 3.0 mg Phase||0||
48616158|NCT02250300|101845070|FG002|NOT COMPLETED|Dose Escalation 3.0 mg Phase||0||
48616159|NCT02250300|101845071|FG003|NOT COMPLETED|Dose Escalation 3.0 mg Phase||0||
48616160|NCT02250300|101845068|FG000|STARTED|Dose Escalation 4.0 mg Phase||0||
48160575|NCT00642902|100715880|FG003|NOT COMPLETED|Overall Study||40||
48160576|NCT01807650|100715881|FG000|STARTED|Overall Study||112||112
48160577|NCT01807650|100715881|FG000|COMPLETED|Overall Study||92||92
48318574|NCT02250274|101104277|FG000|NOT COMPLETED|Overall Study||7||
48318575|NCT02250274|101104278|FG001|NOT COMPLETED|Overall Study||6||
48318576|NCT00755274|101104279|FG000|STARTED|Overall Study||24||
48318577|NCT00755274|101104280|FG001|STARTED|Overall Study||8||
48616161|NCT02250300|101845069|FG001|STARTED|Dose Escalation 4.0 mg Phase||0||
48318578|NCT00755274|101104279|FG000|COMPLETED|Overall Study||24||
48318579|NCT00755274|101104280|FG001|COMPLETED|Overall Study||8||
48318580|NCT00755274|101104279|FG000|NOT COMPLETED|Overall Study||0||
48318581|NCT00755274|101104280|FG001|NOT COMPLETED|Overall Study||0||
48616162|NCT02250300|101845070|FG002|STARTED|Dose Escalation 4.0 mg Phase||0||
48616163|NCT02250300|101845071|FG003|STARTED|Dose Escalation 4.0 mg Phase||3||
48616164|NCT02250300|101845068|FG000|COMPLETED|Dose Escalation 4.0 mg Phase||0||
48616165|NCT02250300|101845069|FG001|COMPLETED|Dose Escalation 4.0 mg Phase||0||
48616166|NCT02250300|101845070|FG002|COMPLETED|Dose Escalation 4.0 mg Phase||0||
48616167|NCT02250300|101845071|FG003|COMPLETED|Dose Escalation 4.0 mg Phase||3||
48616168|NCT02250300|101845068|FG000|NOT COMPLETED|Dose Escalation 4.0 mg Phase||0||
48616169|NCT02250300|101845069|FG001|NOT COMPLETED|Dose Escalation 4.0 mg Phase||0||
48616170|NCT02250300|101845070|FG002|NOT COMPLETED|Dose Escalation 4.0 mg Phase||0||
48616171|NCT02250300|101845071|FG003|NOT COMPLETED|Dose Escalation 4.0 mg Phase||0||
48616172|NCT02250300|101845068|FG000|STARTED|Expansion Phase||25||
48616173|NCT02250300|101845069|FG001|STARTED|Expansion Phase||26||
48616174|NCT02250300|101845070|FG002|STARTED|Expansion Phase||0||
48616175|NCT02250300|101845071|FG003|STARTED|Expansion Phase||0||
48616176|NCT02250300|101845068|FG000|COMPLETED|Expansion Phase||19||
48616177|NCT02250300|101845069|FG001|COMPLETED|Expansion Phase||19||
48616178|NCT02250300|101845070|FG002|COMPLETED|Expansion Phase||0||
48616179|NCT02250300|101845071|FG003|COMPLETED|Expansion Phase||0||
48616180|NCT02250300|101845068|FG000|NOT COMPLETED|Expansion Phase||6||
48616181|NCT02250300|101845069|FG001|NOT COMPLETED|Expansion Phase||7||
48616182|NCT02250300|101845070|FG002|NOT COMPLETED|Expansion Phase||0||
48616183|NCT02250300|101845071|FG003|NOT COMPLETED|Expansion Phase||0||
48616184|NCT02283658|101845072|FG000|STARTED|Overall Study||20||
48616185|NCT02283658|101845072|FG000|COMPLETED|Overall Study||19||
48616186|NCT02283658|101845072|FG000|NOT COMPLETED|Overall Study||1||
48616187|NCT00873730|101845073|FG000|STARTED|Overall Study||54||
48616188|NCT00873730|101845074|FG001|STARTED|Overall Study||54||
48616189|NCT00873730|101845073|FG000|COMPLETED|Overall Study||48||
48616190|NCT00873730|101845074|FG001|COMPLETED|Overall Study||49||
48616191|NCT00873730|101845073|FG000|NOT COMPLETED|Overall Study||6||
48616192|NCT00873730|101845074|FG001|NOT COMPLETED|Overall Study||5||
48616193|NCT02131064|101845075|FG000|STARTED|Overall Study||221||
48616194|NCT02131064|101845076|FG001|STARTED|Overall Study||223||
48616195|NCT02131064|101845075|FG000|COMPLETED|Overall Study||196||
48160578|NCT01807650|100715881|FG000|NOT COMPLETED|Overall Study||20||20
48616196|NCT02131064|101845076|FG001|COMPLETED|Overall Study||189||
48616197|NCT02131064|101845075|FG000|NOT COMPLETED|Overall Study||25||
48616198|NCT02131064|101845076|FG001|NOT COMPLETED|Overall Study||34||
48616199|NCT01628848|101845077|FG000|STARTED|Overall Study||87||
48616200|NCT01628848|101845078|FG001|STARTED|Overall Study||87||
48616201|NCT01628848|101845077|FG000|COMPLETED|Overall Study||75||
48616202|NCT01628848|101845078|FG001|COMPLETED|Overall Study||73||
48616203|NCT01628848|101845077|FG000|NOT COMPLETED|Overall Study||12||
48616204|NCT01628848|101845078|FG001|NOT COMPLETED|Overall Study||14||
48616205|NCT04663685|101845079|FG000|STARTED|Overall Study||30||
48616206|NCT04663685|101845079|FG000|COMPLETED|Overall Study||28||
48616207|NCT04663685|101845079|FG000|NOT COMPLETED|Overall Study||2||
48616208|NCT02689804|101845080|FG000|STARTED|Overall Study||18||
48616209|NCT02689804|101845081|FG001|STARTED|Overall Study||16||
48616210|NCT02689804|101845080|FG000|COMPLETED|Overall Study||16||
48616211|NCT02689804|101845081|FG001|COMPLETED|Overall Study||16||
48616212|NCT02689804|101845080|FG000|NOT COMPLETED|Overall Study||2||
48616213|NCT02689804|101845081|FG001|NOT COMPLETED|Overall Study||0||
48616214|NCT03331263|101845082|FG000|STARTED|Period 1||4||
48616215|NCT03331263|101845083|FG001|STARTED|Period 1||4||
48616216|NCT03331263|101845084|FG002|STARTED|Period 1||4||
48616217|NCT03331263|101845082|FG000|COMPLETED|Period 1||4||
48616218|NCT03331263|101845083|FG001|COMPLETED|Period 1||4||
48318582|NCT01131676|101104281|FG000|STARTED|Discontinuation From Treatment||2337||
48318583|NCT01131676|101104282|FG001|STARTED|Discontinuation From Treatment||2347||
48616219|NCT03331263|101845084|FG002|COMPLETED|Period 1||4||
48616220|NCT03331263|101845082|FG000|NOT COMPLETED|Period 1||0||
48616221|NCT03331263|101845083|FG001|NOT COMPLETED|Period 1||0||
48616222|NCT03331263|101845084|FG002|NOT COMPLETED|Period 1||0||
48616223|NCT03331263|101845082|FG000|STARTED|Period 2||4||
48616224|NCT03331263|101845083|FG001|STARTED|Period 2||3||
48616225|NCT03331263|101845084|FG002|STARTED|Period 2||4||
48616226|NCT03331263|101845082|FG000|COMPLETED|Period 2||4||
48616227|NCT03331263|101845083|FG001|COMPLETED|Period 2||3||
48616228|NCT03331263|101845084|FG002|COMPLETED|Period 2||4||
48616229|NCT03331263|101845082|FG000|NOT COMPLETED|Period 2||0||
48616230|NCT03331263|101845083|FG001|NOT COMPLETED|Period 2||0||
48616231|NCT03331263|101845084|FG002|NOT COMPLETED|Period 2||0||
48616232|NCT03331263|101845082|FG000|STARTED|Period 3||4||
48616233|NCT03331263|101845083|FG001|STARTED|Period 3||3||
48616234|NCT03331263|101845084|FG002|STARTED|Period 3||3||
48616235|NCT03331263|101845082|FG000|COMPLETED|Period 3||4||
48616236|NCT03331263|101845083|FG001|COMPLETED|Period 3||3||
48160579|NCT01856712|100715882|FG000|STARTED|Overall Study||23||
48160580|NCT01856712|100715883|FG001|STARTED|Overall Study||22||
48160581|NCT01856712|100715882|FG000|Lost to 14 Day Follow up|Overall Study||6||
48160582|NCT01856712|100715883|FG001|Lost to 14 Day Follow up|Overall Study||2||
48160583|NCT01856712|100715882|FG000|Lost to 45 Day Follow up|Overall Study||1||
48160584|NCT01856712|100715883|FG001|Lost to 45 Day Follow up|Overall Study||1||
48616237|NCT03331263|101845084|FG002|COMPLETED|Period 3||3||
48616238|NCT03331263|101845082|FG000|NOT COMPLETED|Period 3||0||
48616239|NCT03331263|101845083|FG001|NOT COMPLETED|Period 3||0||
48616240|NCT03331263|101845084|FG002|NOT COMPLETED|Period 3||0||
48616241|NCT00398216|101845085|FG000|STARTED|Overall Study||192||
48616242|NCT00398216|101845086|FG001|STARTED|Overall Study||170||
48616243|NCT00398216|101845087|FG002|STARTED|Overall Study||185||
48616244|NCT00398216|101845088|FG003|STARTED|Overall Study||177||
48616245|NCT00398216|101845089|FG004|STARTED|Overall Study||172||
48160585|NCT01856712|100715882|FG000|COMPLETED|Overall Study||16||
48160586|NCT01856712|100715883|FG001|COMPLETED|Overall Study||19||
48160587|NCT01856712|100715882|FG000|NOT COMPLETED|Overall Study||7||
48160588|NCT01856712|100715883|FG001|NOT COMPLETED|Overall Study||3||
48160589|NCT02691182|100715884|FG000|STARTED|Overall Study||38|Number of subjects is based on the Safety Population, defined as all subjects who received at least 1 dose of study drug during the study.|
48160590|NCT02691182|100715885|FG001|STARTED|Overall Study||159|Number of subjects is based on the Safety Population, defined as all subjects who received at least 1 dose of study drug during the study.|
48160591|NCT02691182|100715886|FG002|STARTED|Overall Study||131|Number of subjects is based on the Safety Population, defined as all subjects who received at least 1 dose of study drug during the study.|
48160592|NCT02691182|100715887|FG003|STARTED|Overall Study||163|Number of subjects is based on the Safety Population, defined as all subjects who received at least 1 dose of study drug during the study.|
48160593|NCT02691182|100715884|FG000|COMPLETED|Overall Study||0||
48160594|NCT02691182|100715885|FG001|COMPLETED|Overall Study||1||
48160595|NCT02691182|100715886|FG002|COMPLETED|Overall Study||2||
48616246|NCT00398216|101845085|FG000|COMPLETED|Overall Study||181||
48616247|NCT00398216|101845086|FG001|COMPLETED|Overall Study||151||
48616248|NCT00398216|101845087|FG002|COMPLETED|Overall Study||164||
48616249|NCT00398216|101845088|FG003|COMPLETED|Overall Study||155||
48616250|NCT00398216|101845089|FG004|COMPLETED|Overall Study||157||
48616251|NCT00398216|101845085|FG000|NOT COMPLETED|Overall Study||11||
48616252|NCT00398216|101845086|FG001|NOT COMPLETED|Overall Study||19||
48616253|NCT00398216|101845087|FG002|NOT COMPLETED|Overall Study||21||
48616254|NCT00398216|101845088|FG003|NOT COMPLETED|Overall Study||22||
48616255|NCT00398216|101845089|FG004|NOT COMPLETED|Overall Study||15||
48616256|NCT02169505|101845090|FG000|STARTED|Overall Study||2||
48616257|NCT02169505|101845090|FG000|COMPLETED|Overall Study||1||
48616258|NCT02169505|101845090|FG000|NOT COMPLETED|Overall Study||1||
48616259|NCT02326272|101845091|FG000|STARTED|Initial Period (Week 0 to Week 16)||49||
48616260|NCT02326272|101845092|FG001|STARTED|Initial Period (Week 0 to Week 16)||91||
48616261|NCT02326272|101845093|FG002|STARTED|Initial Period (Week 0 to Week 16)||87||
48616262|NCT02326272|101845094|FG003|STARTED|Initial Period (Week 0 to Week 16)||0||
48616263|NCT02326272|101845095|FG004|STARTED|Initial Period (Week 0 to Week 16)||0||
48616264|NCT02326272|101845096|FG005|STARTED|Initial Period (Week 0 to Week 16)||0||
48616265|NCT02326272|101845097|FG006|STARTED|Initial Period (Week 0 to Week 16)||0||
48616266|NCT02326272|101845098|FG007|STARTED|Initial Period (Week 0 to Week 16)||0||
48616267|NCT02326272|101845099|FG008|STARTED|Initial Period (Week 0 to Week 16)||0||
48616268|NCT02326272|101845100|FG009|STARTED|Initial Period (Week 0 to Week 16)||0||
48616269|NCT02326272|101845101|FG010|STARTED|Initial Period (Week 0 to Week 16)||0||
48616270|NCT02326272|101845102|FG011|STARTED|Initial Period (Week 0 to Week 16)||0||
48318584|NCT01131676|101104283|FG002|STARTED|Discontinuation From Treatment||2344||
48318585|NCT01131676|101104281|FG000|COMPLETED|Discontinuation From Treatment||1650||
48318586|NCT01131676|101104282|FG001|COMPLETED|Discontinuation From Treatment||1790||
48318587|NCT01131676|101104283|FG002|COMPLETED|Discontinuation From Treatment||1800||
48318588|NCT01131676|101104281|FG000|NOT COMPLETED|Discontinuation From Treatment||687||
48318589|NCT01131676|101104282|FG001|NOT COMPLETED|Discontinuation From Treatment||557||
48318590|NCT01131676|101104283|FG002|NOT COMPLETED|Discontinuation From Treatment||544||
48318591|NCT01131676|101104281|FG000|STARTED|Discontinuation From Study (Treated Set)||2333||
48318592|NCT01131676|101104282|FG001|STARTED|Discontinuation From Study (Treated Set)||2345||
48318593|NCT01131676|101104283|FG002|STARTED|Discontinuation From Study (Treated Set)||2342||
48318594|NCT01131676|101104281|FG000|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2316||
48318595|NCT01131676|101104282|FG001|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2324||
48318596|NCT01131676|101104283|FG002|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2327||
48318597|NCT01131676|101104281|FG000|COMPLETED|Discontinuation From Study (Treated Set)||2266||
48616271|NCT02326272|101845103|FG012|STARTED|Initial Period (Week 0 to Week 16)||0||
48616272|NCT02326272|101845104|FG013|STARTED|Initial Period (Week 0 to Week 16)||0||
48616273|NCT02326272|101845105|FG014|STARTED|Initial Period (Week 0 to Week 16)||0||
48616274|NCT02326272|101845091|FG000|Completed Week 16|Initial Period (Week 0 to Week 16)||45||
48616275|NCT02326272|101845092|FG001|Completed Week 16|Initial Period (Week 0 to Week 16)||84||
48616276|NCT02326272|101845093|FG002|Completed Week 16|Initial Period (Week 0 to Week 16)||83||
48616277|NCT02326272|101845094|FG003|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
48616278|NCT02326272|101845095|FG004|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
48616279|NCT02326272|101845096|FG005|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
48616280|NCT02326272|101845097|FG006|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
48616281|NCT02326272|101845098|FG007|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
48616282|NCT02326272|101845099|FG008|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
48616283|NCT02326272|101845100|FG009|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
48616284|NCT02326272|101845101|FG010|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
48616285|NCT02326272|101845102|FG011|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
48616286|NCT02326272|101845103|FG012|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
48616287|NCT02326272|101845104|FG013|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
48616288|NCT02326272|101845105|FG014|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
48616289|NCT02326272|101845091|FG000|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||45||
48616290|NCT02326272|101845092|FG001|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||84||
48616291|NCT02326272|101845093|FG002|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||81||
48616292|NCT02326272|101845094|FG003|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0||
48616293|NCT02326272|101845095|FG004|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0||
48616294|NCT02326272|101845096|FG005|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0||
48616295|NCT02326272|101845097|FG006|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0||
48616296|NCT02326272|101845098|FG007|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0||
48616297|NCT02326272|101845099|FG008|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0||
48616298|NCT02326272|101845100|FG009|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0||
48657092|NCT03648372|101943769|FG012|NOT COMPLETED|Overall Study||6||
48318598|NCT01131676|101104282|FG001|COMPLETED|Discontinuation From Study (Treated Set)||2264||
48318599|NCT01131676|101104283|FG002|COMPLETED|Discontinuation From Study (Treated Set)||2279||
48318600|NCT01131676|101104281|FG000|NOT COMPLETED|Discontinuation From Study (Treated Set)||67||
48318601|NCT01131676|101104282|FG001|NOT COMPLETED|Discontinuation From Study (Treated Set)||81||
48318602|NCT01131676|101104283|FG002|NOT COMPLETED|Discontinuation From Study (Treated Set)||63||
48318603|NCT00574288|101104284|FG000|STARTED|Overall Study||20||
48318604|NCT00574288|101104285|FG001|STARTED|Overall Study||3||
48318605|NCT00574288|101104286|FG002|STARTED|Overall Study||3||
48318606|NCT00574288|101104287|FG003|STARTED|Overall Study||3||
48318607|NCT00574288|101104288|FG004|STARTED|Overall Study||3||
48318608|NCT00574288|101104289|FG005|STARTED|Overall Study||30||
48318609|NCT00574288|101104290|FG006|STARTED|Overall Study||42||
48318610|NCT00574288|101104284|FG000|COMPLETED|Overall Study||0||
48318611|NCT00574288|101104285|FG001|COMPLETED|Overall Study||0||
48318612|NCT00574288|101104286|FG002|COMPLETED|Overall Study||0||
48318613|NCT00574288|101104287|FG003|COMPLETED|Overall Study||1||
48318614|NCT00574288|101104288|FG004|COMPLETED|Overall Study||1||
48318615|NCT00574288|101104289|FG005|COMPLETED|Overall Study||4||
48318616|NCT00574288|101104290|FG006|COMPLETED|Overall Study||14||
48318617|NCT00574288|101104284|FG000|NOT COMPLETED|Overall Study||20||
48318618|NCT00574288|101104285|FG001|NOT COMPLETED|Overall Study||3||
48318619|NCT00574288|101104286|FG002|NOT COMPLETED|Overall Study||3||
48318620|NCT00574288|101104287|FG003|NOT COMPLETED|Overall Study||2||
48318621|NCT00574288|101104288|FG004|NOT COMPLETED|Overall Study||2||
48318622|NCT00574288|101104289|FG005|NOT COMPLETED|Overall Study||26||
48318623|NCT00574288|101104290|FG006|NOT COMPLETED|Overall Study||28||
48318624|NCT00840086|101104291|FG000|STARTED|Overall Study||150||
48318625|NCT00840086|101104291|FG000|COMPLETED|Overall Study||146||
48318626|NCT00840086|101104291|FG000|NOT COMPLETED|Overall Study||4||
48318627|NCT00490451|101104292|FG000|STARTED|Overall Study||63||
48318628|NCT00490451|101104293|FG001|STARTED|Overall Study||38||
48318629|NCT00490451|101104292|FG000|COMPLETED|Overall Study||0||
48318630|NCT00490451|101104293|FG001|COMPLETED|Overall Study||0||
48318631|NCT00490451|101104292|FG000|NOT COMPLETED|Overall Study||63||
48318632|NCT00490451|101104293|FG001|NOT COMPLETED|Overall Study||38||
48318633|NCT04053868|101104294|FG000|STARTED|Overall Study||10||
48318634|NCT04053868|101104295|FG001|STARTED|Overall Study||7||
48318635|NCT04053868|101104294|FG000|COMPLETED|Overall Study||9||
48318636|NCT04053868|101104295|FG001|COMPLETED|Overall Study||7||
48318637|NCT04053868|101104294|FG000|NOT COMPLETED|Overall Study||1||
48318638|NCT04053868|101104295|FG001|NOT COMPLETED|Overall Study||0||
48318639|NCT01967628|101104296|FG000|STARTED|Overall Study||48||
48407476|NCT00711412|101328556|FG000|NOT COMPLETED|Evaluation for Response and Surgery||6||
48407477|NCT00711412|101328556|FG000|STARTED|Survival Follow up Until Death||38||
48407478|NCT00711412|101328556|FG000|COMPLETED|Survival Follow up Until Death||26||
48407479|NCT00711412|101328556|FG000|NOT COMPLETED|Survival Follow up Until Death||12||
48407480|NCT03645811|101328557|FG000|STARTED|Overall Study||32||
48407481|NCT03645811|101328558|FG001|STARTED|Overall Study||32||
48318640|NCT01967628|101104297|FG001|STARTED|Overall Study||50||
48318641|NCT01967628|101104296|FG000|COMPLETED|Overall Study||21||
48318642|NCT01967628|101104297|FG001|COMPLETED|Overall Study||19||
48318643|NCT01967628|101104296|FG000|NOT COMPLETED|Overall Study||27||
48318644|NCT01967628|101104297|FG001|NOT COMPLETED|Overall Study||31||
48318645|NCT01439672|101104298|FG000|STARTED|Overall Study||35||
48318646|NCT01439672|101104298|FG000|COMPLETED|Overall Study||11||
48318647|NCT01439672|101104298|FG000|NOT COMPLETED|Overall Study||24||
48318648|NCT03761615|101104299|FG000|STARTED|Overall Study||25||
48318649|NCT03761615|101104299|FG000|COMPLETED|Overall Study||25||
48318650|NCT03761615|101104299|FG000|NOT COMPLETED|Overall Study||0||
48318651|NCT01022242|101104300|FG000|STARTED|Overall Study||70||
48318652|NCT01022242|101104301|FG001|STARTED|Overall Study||65||
48318653|NCT01022242|101104300|FG000|COMPLETED|Overall Study||49||
48318654|NCT01022242|101104301|FG001|COMPLETED|Overall Study||46||
48318655|NCT01022242|101104300|FG000|NOT COMPLETED|Overall Study||21||
48318656|NCT01022242|101104301|FG001|NOT COMPLETED|Overall Study||19||
48318657|NCT03688880|101104302|FG000|STARTED|Overall Study||29||
48318658|NCT03688880|101104303|FG001|STARTED|Overall Study||60||
48318659|NCT03688880|101104302|FG000|COMPLETED|Overall Study||15||
48318660|NCT03688880|101104303|FG001|COMPLETED|Overall Study||29||
48318661|NCT03688880|101104302|FG000|NOT COMPLETED|Overall Study||14||
48318662|NCT03688880|101104303|FG001|NOT COMPLETED|Overall Study||31||
48318663|NCT01430455|101104304|FG000|STARTED|Overall Study||7||
48318664|NCT01430455|101104304|FG000|COMPLETED|Overall Study||5||
48318665|NCT01430455|101104304|FG000|NOT COMPLETED|Overall Study||2||
48318666|NCT02512224|101104305|FG000|STARTED|Overall Study||2912||
48318667|NCT02512224|101104306|FG001|STARTED|Overall Study||2912||
48318668|NCT02512224|101104305|FG000|COMPLETED|Overall Study||2912||
48318669|NCT02512224|101104306|FG001|COMPLETED|Overall Study||2912||
48318670|NCT02512224|101104305|FG000|NOT COMPLETED|Overall Study||0||
48318671|NCT02512224|101104306|FG001|NOT COMPLETED|Overall Study||0||
48407482|NCT03645811|101328559|FG002|STARTED|Overall Study||32||
48407483|NCT03645811|101328557|FG000|COMPLETED|Overall Study||30||
48407484|NCT03645811|101328558|FG001|COMPLETED|Overall Study||30||
48318672|NCT02054897|101104307|FG000|STARTED|Overall Study||129||
48318673|NCT02054897|101104308|FG001|STARTED|Overall Study||130||
48318674|NCT02054897|101104309|FG002|STARTED|Overall Study||129||
48318675|NCT02054897|101104307|FG000|Exposed|Overall Study||128||
48318676|NCT02054897|101104308|FG001|Exposed|Overall Study||130||
48318677|NCT02054897|101104309|FG002|Exposed|Overall Study||129||
48318678|NCT02054897|101104307|FG000|COMPLETED|Overall Study||119||
48318679|NCT02054897|101104308|FG001|COMPLETED|Overall Study||123||
48407485|NCT03645811|101328559|FG002|COMPLETED|Overall Study||30||
48407486|NCT03645811|101328557|FG000|NOT COMPLETED|Overall Study||2||
48407487|NCT03645811|101328558|FG001|NOT COMPLETED|Overall Study||2||
48318680|NCT02054897|101104309|FG002|COMPLETED|Overall Study||117||
48318681|NCT02054897|101104307|FG000|NOT COMPLETED|Overall Study||10||
48318682|NCT02054897|101104308|FG001|NOT COMPLETED|Overall Study||7||
48318683|NCT02054897|101104309|FG002|NOT COMPLETED|Overall Study||12||
48318684|NCT01911442|101104310|FG000|STARTED|Overall Study||49||
48318685|NCT01911442|101104311|FG001|STARTED|Overall Study||51||
48318686|NCT01911442|101104312|FG002|STARTED|Overall Study||50||
48318687|NCT01911442|101104310|FG000|COMPLETED|Overall Study||43||
48318688|NCT01911442|101104311|FG001|COMPLETED|Overall Study||47||
48318689|NCT01911442|101104312|FG002|COMPLETED|Overall Study||38||
48318690|NCT01911442|101104310|FG000|NOT COMPLETED|Overall Study||6||
48318691|NCT01911442|101104311|FG001|NOT COMPLETED|Overall Study||4||
48318692|NCT01911442|101104312|FG002|NOT COMPLETED|Overall Study||12||
48318693|NCT01517529|101104313|FG000|STARTED|Overall Study||10||
48318694|NCT01517529|101104313|FG000|COMPLETED|Overall Study||10||
48318695|NCT01517529|101104313|FG000|NOT COMPLETED|Overall Study||0||
48318696|NCT02234479|101104314|FG000|STARTED|Overall Study||16||
48318697|NCT02234479|101104315|FG001|STARTED|Overall Study||18||
48318698|NCT02234479|101104314|FG000|COMPLETED|Overall Study||15||
48737162|NCT00348673|102140251|FG006|STARTED|Stage 2||6||
48737163|NCT00348673|102140252|FG007|STARTED|Stage 2||6||
48737164|NCT00348673|102140253|FG008|STARTED|Stage 2||2||
48737165|NCT00348673|102140245|FG000|COMPLETED|Stage 2||0||
48318699|NCT02234479|101104315|FG001|COMPLETED|Overall Study||15||
48318700|NCT02234479|101104314|FG000|NOT COMPLETED|Overall Study||1||
48318701|NCT02234479|101104315|FG001|NOT COMPLETED|Overall Study||3||
48318702|NCT02628236|101104316|FG000|STARTED|Overall Study||14||
48318703|NCT02628236|101104316|FG000|COMPLETED|Overall Study||14||
48318704|NCT02628236|101104316|FG000|NOT COMPLETED|Overall Study||0||
48318705|NCT00366275|101107483|FG000|STARTED|Overall Study||64||
48318706|NCT00366275|101107483|FG000|COMPLETED|Overall Study||58||
48318707|NCT00366275|101107483|FG000|NOT COMPLETED|Overall Study||6||
48318708|NCT00405067|101107484|FG000|STARTED|Overall Study||28||
48318709|NCT00405067|101107485|FG001|STARTED|Overall Study||28||
48318710|NCT00405067|101107486|FG002|STARTED|Overall Study||29||
48318711|NCT00405067|101107484|FG000|COMPLETED|Overall Study||24||
48318712|NCT00405067|101107485|FG001|COMPLETED|Overall Study||19||
48318713|NCT00405067|101107486|FG002|COMPLETED|Overall Study||24||
48318714|NCT00405067|101107484|FG000|NOT COMPLETED|Overall Study||4||
48318715|NCT00405067|101107485|FG001|NOT COMPLETED|Overall Study||9||
48318716|NCT00405067|101107486|FG002|NOT COMPLETED|Overall Study||5||
48318717|NCT02316340|101107487|FG000|STARTED|First Progression||20||
48318718|NCT02316340|101107488|FG001|STARTED|First Progression||22||
48318719|NCT02316340|101107487|FG000|COMPLETED|First Progression||17||
48318720|NCT02316340|101107488|FG001|COMPLETED|First Progression||21||
48318721|NCT02316340|101107487|FG000|NOT COMPLETED|First Progression||3||
48318722|NCT02316340|101107488|FG001|NOT COMPLETED|First Progression||1||
48318723|NCT02316340|101107487|FG000|STARTED|Optional Cross-over (MD Discretion)||5||
48318724|NCT02316340|101107488|FG001|STARTED|Optional Cross-over (MD Discretion)||13||
48318725|NCT02316340|101107487|FG000|COMPLETED|Optional Cross-over (MD Discretion)||2||
48318726|NCT02316340|101107488|FG001|COMPLETED|Optional Cross-over (MD Discretion)||4||
48318727|NCT02316340|101107487|FG000|NOT COMPLETED|Optional Cross-over (MD Discretion)||3||
48318728|NCT02316340|101107488|FG001|NOT COMPLETED|Optional Cross-over (MD Discretion)||9||
48318729|NCT03503877|101107489|FG000|STARTED|Overall Study||127||127
48318730|NCT03503877|101107490|FG001|STARTED|Overall Study||127||127
48318731|NCT03503877|101107489|FG000|COMPLETED|Overall Study||127||127
48318732|NCT03503877|101107490|FG001|COMPLETED|Overall Study||127||127
48318733|NCT03503877|101107489|FG000|NOT COMPLETED|Overall Study||0||0
48318734|NCT03503877|101107490|FG001|NOT COMPLETED|Overall Study||0||0
48318735|NCT02603120|101107491|FG000|STARTED|Double-Blind Treatment Phase||284||
48318736|NCT02603120|101107492|FG001|STARTED|Double-Blind Treatment Phase||283||
48318737|NCT02603120|101107491|FG000|COMPLETED|Double-Blind Treatment Phase||265||
48318738|NCT02603120|101107492|FG001|COMPLETED|Double-Blind Treatment Phase||267||
48318739|NCT02603120|101107491|FG000|NOT COMPLETED|Double-Blind Treatment Phase||19||
48318740|NCT02603120|101107492|FG001|NOT COMPLETED|Double-Blind Treatment Phase||16||
48318741|NCT02603120|101107491|FG000|STARTED|OL Extension B/F/TAF Treatment Phase||259||
48318742|NCT02603120|101107492|FG001|STARTED|OL Extension B/F/TAF Treatment Phase||265||
48318743|NCT02603120|101107491|FG000|COMPLETED|OL Extension B/F/TAF Treatment Phase||254||
48318744|NCT02603120|101107492|FG001|COMPLETED|OL Extension B/F/TAF Treatment Phase||254||
48318745|NCT02603120|101107491|FG000|NOT COMPLETED|OL Extension B/F/TAF Treatment Phase||5||
48318746|NCT02603120|101107492|FG001|NOT COMPLETED|OL Extension B/F/TAF Treatment Phase||11||
48318747|NCT03317795|101107493|FG000|STARTED|Overall Study||9||
48318748|NCT03317795|101107494|FG001|STARTED|Overall Study||9||
48318749|NCT03317795|101107493|FG000|COMPLETED|Overall Study||7||
48318750|NCT03317795|101107494|FG001|COMPLETED|Overall Study||2||
48318751|NCT03317795|101107493|FG000|NOT COMPLETED|Overall Study||2||
48318752|NCT03317795|101107494|FG001|NOT COMPLETED|Overall Study||7||
48318753|NCT00970853|101107495|FG000|STARTED|Overall Study||89||
48318754|NCT00970853|101107496|FG001|STARTED|Overall Study||98||
48318755|NCT00970853|101107495|FG000|COMPLETED|Overall Study||89||
48318756|NCT00970853|101107496|FG001|COMPLETED|Overall Study||98||
48318757|NCT00970853|101107495|FG000|NOT COMPLETED|Overall Study||0||
48407488|NCT03645811|101328559|FG002|NOT COMPLETED|Overall Study||2||
48407489|NCT01605890|101328560|FG000|STARTED|Overall Study||30||
48318758|NCT00970853|101107496|FG001|NOT COMPLETED|Overall Study||0||
48318759|NCT00814892|101107497|FG000|STARTED|Overall Study||2||
48318760|NCT00814892|101107497|FG000|COMPLETED|Overall Study||0||
48318761|NCT00814892|101107497|FG000|NOT COMPLETED|Overall Study||2||
48318762|NCT00906087|101107498|FG000|STARTED|Initial Washout||14||
48737166|NCT00348673|102140246|FG001|COMPLETED|Stage 2||0||
48318763|NCT00906087|101107498|FG000|Completed Screening|Initial Washout||14||
48318764|NCT00906087|101107498|FG000|Begin Washout|Initial Washout||13||
48318765|NCT00906087|101107498|FG000|Completed Washout and Continue Protocol|Initial Washout||12||
48318766|NCT00906087|101107498|FG000|COMPLETED|Initial Washout||12||
48318767|NCT00906087|101107498|FG000|NOT COMPLETED|Initial Washout||2||
48318768|NCT00906087|101107498|FG000|STARTED|Cosopt Treatment 6 Weeks||12||
48318769|NCT00906087|101107498|FG000|COMPLETED|Cosopt Treatment 6 Weeks||12||
48318770|NCT00906087|101107498|FG000|NOT COMPLETED|Cosopt Treatment 6 Weeks||0||
48318771|NCT00906087|101107498|FG000|STARTED|Final Washout Period 4 Weeks||12||
48318772|NCT00906087|101107498|FG000|COMPLETED|Final Washout Period 4 Weeks||12||
48318773|NCT00906087|101107498|FG000|NOT COMPLETED|Final Washout Period 4 Weeks||0||
48318774|NCT02025907|101107499|FG000|STARTED|Overall Study||108||
48318775|NCT02025907|101107500|FG001|STARTED|Overall Study||108||
48318776|NCT02025907|101107499|FG000|COMPLETED|Overall Study||81||
48318777|NCT02025907|101107500|FG001|COMPLETED|Overall Study||96||
48318778|NCT02025907|101107499|FG000|NOT COMPLETED|Overall Study||27||
48318779|NCT02025907|101107500|FG001|NOT COMPLETED|Overall Study||12||
48318780|NCT02953340|101107501|FG000|STARTED|Overall Study||118||
48318781|NCT02953340|101107502|FG001|STARTED|Overall Study||119||
48318782|NCT02953340|101107501|FG000|Safety Population|Overall Study||117|Safety Population includes all participants who receive at least one dose of any protocol-specified drug (TC, SPI-2012 or pegfilgrastim).|
48318783|NCT02953340|101107502|FG001|Safety Population|Overall Study||118|Safety Population includes all participants who receive at least one dose of any protocol-specified drug (TC, SPI-2012 or pegfilgrastim).|
48318784|NCT02953340|101107501|FG000|Entered Safety Follow-up Period|Overall Study||117|Safety Follow-up Period included all participants who received at least one dose of any protocol specified drug (TC or SPI-2012 or pegfilgrastim) and continued for 12 months after last study treatment.|
48318785|NCT02953340|101107502|FG001|Entered Safety Follow-up Period|Overall Study||118|Safety Follow-up Period included all participants who received at least one dose of any protocol specified drug (TC or SPI-2012 or pegfilgrastim) and continued for 12 months after last study treatment.|
48318786|NCT02953340|101107501|FG000|COMPLETED|Overall Study||96||
48318787|NCT02953340|101107502|FG001|COMPLETED|Overall Study||85||
48318788|NCT02953340|101107501|FG000|NOT COMPLETED|Overall Study||22||
48318789|NCT02953340|101107502|FG001|NOT COMPLETED|Overall Study||34||
48318790|NCT01916928|101107503|FG000|STARTED|Overall Study||50||
48318791|NCT01916928|101107503|FG000|COMPLETED|Overall Study||50||
48318792|NCT01916928|101107503|FG000|NOT COMPLETED|Overall Study||0||
48318793|NCT00176605|101107504|FG000|STARTED|Overall Study||15||
48318794|NCT00176605|101107504|FG000|COMPLETED|Overall Study||13||
48318795|NCT00176605|101107504|FG000|NOT COMPLETED|Overall Study||2||
48318796|NCT01290874|101107505|FG000|STARTED|Overall Study||532||
48318797|NCT01290874|101107506|FG001|STARTED|Overall Study||538||
48318798|NCT01290874|101107505|FG000|COMPLETED|Overall Study||122||
48318799|NCT01290874|101107506|FG001|COMPLETED|Overall Study||134||
48318800|NCT01290874|101107505|FG000|NOT COMPLETED|Overall Study||410||
48318801|NCT01290874|101107506|FG001|NOT COMPLETED|Overall Study||404||
48318802|NCT00520884|101107507|FG000|STARTED|Overall Study||3||
48318803|NCT00520884|101107508|FG001|STARTED|Overall Study||2||
48318804|NCT00520884|101107509|FG002|STARTED|Overall Study||2||
48318805|NCT00520884|101107510|FG003|STARTED|Overall Study||3||
48318806|NCT00520884|101107507|FG000|COMPLETED|Overall Study||3|Crossover study, randomized in two strata|
48318807|NCT00520884|101107508|FG001|COMPLETED|Overall Study||2|Crossover study, randomized in two strata|
48318808|NCT00520884|101107509|FG002|COMPLETED|Overall Study||2|Crossover study, randomized in two strata|
48318809|NCT00520884|101107510|FG003|COMPLETED|Overall Study||3|Crossover study, randomized in two strata|
48318810|NCT00520884|101107507|FG000|NOT COMPLETED|Overall Study||0||
48318811|NCT00520884|101107508|FG001|NOT COMPLETED|Overall Study||0||
48318812|NCT00520884|101107509|FG002|NOT COMPLETED|Overall Study||0||
48318813|NCT00520884|101107510|FG003|NOT COMPLETED|Overall Study||0||
48318814|NCT02234284|101107511|FG000|STARTED|Overall Study||100||
48318815|NCT02234284|101107512|FG001|STARTED|Overall Study||92||
48318816|NCT02234284|101107511|FG000|COMPLETED|Overall Study||75||
48318817|NCT02234284|101107512|FG001|COMPLETED|Overall Study||83||
48318818|NCT02234284|101107511|FG000|NOT COMPLETED|Overall Study||25||
48318819|NCT02234284|101107512|FG001|NOT COMPLETED|Overall Study||9||
48318820|NCT00912002|101107513|FG000|STARTED|Overall Study||6||
48318821|NCT00912002|101107513|FG000|COMPLETED|Overall Study||6||
48318822|NCT00912002|101107513|FG000|NOT COMPLETED|Overall Study||0||
48318823|NCT00400881|101107514|FG000|STARTED|Overall Study||62||
48318824|NCT00400881|101107515|FG001|STARTED|Overall Study||60||
48318825|NCT00400881|101107514|FG000|COMPLETED|Overall Study||62||
48318826|NCT00400881|101107515|FG001|COMPLETED|Overall Study||60||
48318827|NCT00400881|101107514|FG000|NOT COMPLETED|Overall Study||0||
48318828|NCT00400881|101107515|FG001|NOT COMPLETED|Overall Study||0||
48318829|NCT03462576|101107516|FG000|STARTED|Overall Study||46||
48318830|NCT03462576|101107517|FG001|STARTED|Overall Study||48||
48318831|NCT03462576|101107518|FG002|STARTED|Overall Study||45||
48318832|NCT03462576|101107516|FG000|COMPLETED|Overall Study||41||
48318833|NCT03462576|101107517|FG001|COMPLETED|Overall Study||37||
48318834|NCT03462576|101107518|FG002|COMPLETED|Overall Study||37||
48318835|NCT03462576|101107516|FG000|NOT COMPLETED|Overall Study||5||
48318836|NCT03462576|101107517|FG001|NOT COMPLETED|Overall Study||11||
48318837|NCT03462576|101107518|FG002|NOT COMPLETED|Overall Study||8||
48318838|NCT01439282|101107519|FG000|STARTED|Overall Study||67||
48318839|NCT01439282|101107520|FG001|STARTED|Overall Study||10||
48318840|NCT01439282|101107519|FG000|COMPLETED|Overall Study||59||
48318841|NCT01439282|101107520|FG001|COMPLETED|Overall Study||9||
48318842|NCT01439282|101107519|FG000|NOT COMPLETED|Overall Study||8||
48318843|NCT01439282|101107520|FG001|NOT COMPLETED|Overall Study||1||
48318844|NCT00527475|101107521|FG000|STARTED|Overall Study||30||
48318845|NCT00527475|101107522|FG001|STARTED|Overall Study||30||
48318846|NCT00527475|101107521|FG000|COMPLETED|Overall Study||27||
48318847|NCT00527475|101107522|FG001|COMPLETED|Overall Study||29||
48318848|NCT00527475|101107521|FG000|NOT COMPLETED|Overall Study||3||
48318849|NCT00527475|101107522|FG001|NOT COMPLETED|Overall Study||1||
48318850|NCT02613936|101107523|FG000|STARTED|Overall Study||20||
48318851|NCT02613936|101107524|FG001|STARTED|Overall Study||20||
48318852|NCT02613936|101107523|FG000|COMPLETED|Overall Study||17||
48318853|NCT02613936|101107524|FG001|COMPLETED|Overall Study||17||
48318854|NCT02613936|101107523|FG000|NOT COMPLETED|Overall Study||3||
48318855|NCT02613936|101107524|FG001|NOT COMPLETED|Overall Study||3||
48318856|NCT03362970|101107525|FG000|STARTED|Overall Study||29||
48318857|NCT03362970|101107526|FG001|STARTED|Overall Study||31||
48318858|NCT03362970|101107525|FG000|COMPLETED|Overall Study||29||
48318859|NCT03362970|101107526|FG001|COMPLETED|Overall Study||31||
48318860|NCT03362970|101107525|FG000|NOT COMPLETED|Overall Study||0||
48318861|NCT03362970|101107526|FG001|NOT COMPLETED|Overall Study||0||
48318862|NCT03891264|101107527|FG000|STARTED|Overall Study||7||
48318863|NCT03891264|101107527|FG000|Received Intervention|Overall Study||3||
48318864|NCT03891264|101107527|FG000|COMPLETED|Overall Study||2||
48318865|NCT03891264|101107527|FG000|NOT COMPLETED|Overall Study||5||
48318866|NCT01439204|101107528|FG000|STARTED|Overall Study||36||
48318867|NCT01439204|101107529|FG001|STARTED|Overall Study||36||
48318868|NCT01439204|101107528|FG000|COMPLETED|Overall Study||32||
48318869|NCT01439204|101107529|FG001|COMPLETED|Overall Study||33||
48318870|NCT01439204|101107528|FG000|NOT COMPLETED|Overall Study||4||
48318871|NCT01439204|101107529|FG001|NOT COMPLETED|Overall Study||3||
48318872|NCT04712110|101107530|FG000|STARTED|Overall Study||50||
48318873|NCT04712110|101107531|FG001|STARTED|Overall Study||150||
48318874|NCT04712110|101107530|FG000|COMPLETED|Overall Study||4||
48318875|NCT04712110|101107531|FG001|COMPLETED|Overall Study||131||
48318876|NCT04712110|101107530|FG000|NOT COMPLETED|Overall Study||46||
48318877|NCT04712110|101107531|FG001|NOT COMPLETED|Overall Study||19||
48318878|NCT02703311|101107532|FG000|STARTED|Overall Study||11||
48318879|NCT02703311|101107532|FG000|Implanted|Overall Study||11||
48318880|NCT02703311|101107532|FG000|30 Day Follow-Up Completed|Overall Study||9||
48318881|NCT02703311|101107532|FG000|COMPLETED|Overall Study||3|Completed Study (2 years)|
48318882|NCT02703311|101107532|FG000|NOT COMPLETED|Overall Study||8||
48737167|NCT00348673|102140247|FG002|COMPLETED|Stage 2||0||
48737168|NCT00348673|102140248|FG003|COMPLETED|Stage 2||0||
48737169|NCT00348673|102140249|FG004|COMPLETED|Stage 2||0||
48737170|NCT00348673|102140250|FG005|COMPLETED|Stage 2||6||
48737171|NCT00348673|102140251|FG006|COMPLETED|Stage 2||6||
48737172|NCT00348673|102140252|FG007|COMPLETED|Stage 2||6||
48737173|NCT00348673|102140253|FG008|COMPLETED|Stage 2||2||
48737174|NCT00348673|102140245|FG000|NOT COMPLETED|Stage 2||0||
48737175|NCT00348673|102140246|FG001|NOT COMPLETED|Stage 2||0||
48318883|NCT00691002|101107533|FG000|STARTED|8-week, Double-blind, 4-arm||353||
48318884|NCT00691002|101107534|FG001|STARTED|8-week, Double-blind, 4-arm||342||
48318885|NCT00691002|101107535|FG002|STARTED|8-week, Double-blind, 4-arm||363||
48318886|NCT00691002|101107536|FG003|STARTED|8-week, Double-blind, 4-arm||181||
48318887|NCT00691002|101107537|FG004|STARTED|8-week, Double-blind, 4-arm||0||
48318888|NCT00691002|101107533|FG000|COMPLETED|8-week, Double-blind, 4-arm||325||
48318889|NCT00691002|101107534|FG001|COMPLETED|8-week, Double-blind, 4-arm||308||
48318890|NCT00691002|101107535|FG002|COMPLETED|8-week, Double-blind, 4-arm||340||
48318891|NCT00691002|101107536|FG003|COMPLETED|8-week, Double-blind, 4-arm||169||
48318892|NCT00691002|101107537|FG004|COMPLETED|8-week, Double-blind, 4-arm||0||
48318893|NCT00691002|101107533|FG000|NOT COMPLETED|8-week, Double-blind, 4-arm||28||
48318894|NCT00691002|101107534|FG001|NOT COMPLETED|8-week, Double-blind, 4-arm||34||
48318895|NCT00691002|101107535|FG002|NOT COMPLETED|8-week, Double-blind, 4-arm||23||
48318896|NCT00691002|101107536|FG003|NOT COMPLETED|8-week, Double-blind, 4-arm||12||
48318897|NCT00691002|101107537|FG004|NOT COMPLETED|8-week, Double-blind, 4-arm||0||
48318898|NCT00691002|101107533|FG000|STARTED|52-week, Open-label, Single Arm||454||
48318899|NCT00691002|101107534|FG001|STARTED|52-week, Open-label, Single Arm||0||
48318900|NCT00691002|101107535|FG002|STARTED|52-week, Open-label, Single Arm||0||
48318901|NCT00691002|101107536|FG003|STARTED|52-week, Open-label, Single Arm||0||
48318902|NCT00691002|101107537|FG004|STARTED|52-week, Open-label, Single Arm||0||
48318903|NCT00691002|101107533|FG000|COMPLETED|52-week, Open-label, Single Arm||403||
48318904|NCT00691002|101107534|FG001|COMPLETED|52-week, Open-label, Single Arm||0||
48318905|NCT00691002|101107535|FG002|COMPLETED|52-week, Open-label, Single Arm||0||
48318906|NCT00691002|101107536|FG003|COMPLETED|52-week, Open-label, Single Arm||0||
48318907|NCT00691002|101107537|FG004|COMPLETED|52-week, Open-label, Single Arm||0||
48737176|NCT00348673|102140247|FG002|NOT COMPLETED|Stage 2||0||
48737177|NCT00348673|102140248|FG003|NOT COMPLETED|Stage 2||0||
48737178|NCT00348673|102140249|FG004|NOT COMPLETED|Stage 2||0||
48318908|NCT00691002|101107533|FG000|NOT COMPLETED|52-week, Open-label, Single Arm||51||
48318909|NCT00691002|101107534|FG001|NOT COMPLETED|52-week, Open-label, Single Arm||0||
48318910|NCT00691002|101107535|FG002|NOT COMPLETED|52-week, Open-label, Single Arm||0||
48318911|NCT00691002|101107536|FG003|NOT COMPLETED|52-week, Open-label, Single Arm||0||
48318912|NCT00691002|101107537|FG004|NOT COMPLETED|52-week, Open-label, Single Arm||0||
48318913|NCT03496428|101107538|FG000|STARTED|Overall Study||6||412
48318914|NCT03496428|101107538|FG000|COMPLETED|Overall Study||6||412
48318915|NCT03496428|101107538|FG000|NOT COMPLETED|Overall Study||0||0
48318916|NCT01513538|101107539|FG000|STARTED|Overall Study||578|Screening has been stopped after 578 patients agreed to participate to the study.|
48318917|NCT01513538|101107539|FG000|COMPLETED|Overall Study||573||
48318918|NCT01513538|101107539|FG000|NOT COMPLETED|Overall Study||5||
48318919|NCT03962101|101107540|FG000|STARTED|Overall Study||45||
48318920|NCT03962101|101107540|FG000|COMPLETED|Overall Study||41||
48318921|NCT03962101|101107540|FG000|NOT COMPLETED|Overall Study||4||
48318922|NCT00133991|101107541|FG000|STARTED|Overall Study||21||
48318923|NCT00133991|101107541|FG000|COMPLETED|Overall Study||17||
48318924|NCT00133991|101107541|FG000|NOT COMPLETED|Overall Study||4||
48318925|NCT03921424|101107542|FG000|STARTED|Overall Study||203||
48318926|NCT03921424|101107543|FG001|STARTED|Overall Study||204||
48318927|NCT03921424|101107542|FG000|Vaccination 1 - (Day 1)|Overall Study||203||
48318928|NCT03921424|101107543|FG001|Vaccination 1 - (Day 1)|Overall Study||204||
48318929|NCT03921424|101107542|FG000|Vaccination 2 - (Week 8)|Overall Study||203||
48318930|NCT03921424|101107543|FG001|Vaccination 2 - (Week 8)|Overall Study||202||
48318931|NCT03921424|101107542|FG000|COMPLETED|Overall Study||203||
48318932|NCT03921424|101107543|FG001|COMPLETED|Overall Study||201||
48318933|NCT03921424|101107542|FG000|NOT COMPLETED|Overall Study||0||
48318934|NCT03921424|101107543|FG001|NOT COMPLETED|Overall Study||3||
48318935|NCT03015259|101107544|FG000|STARTED|Overall Study||613|Safety Population includes all participants who received at least one dose of a treatment.|
48318936|NCT03015259|101107545|FG001|STARTED|Overall Study||622|Safety Population includes all participants who received at least one dose of a treatment.|
48318937|NCT03015259|101107546|FG002|STARTED|Overall Study||204|Safety Population includes all participants who received at least one dose of a treatment.|
48318938|NCT03015259|101107544|FG000|COMPLETED|Overall Study||598|Per Protocol Population includes all participants who provided analyzable data for primary endpoints|
48318939|NCT03015259|101107545|FG001|COMPLETED|Overall Study||604|Per Protocol Population includes all participants who provided analyzable data for primary endpoints|
48318940|NCT03015259|101107546|FG002|COMPLETED|Overall Study||199|Per Protocol Population includes all participants who provided analyzable data for primary endpoints|
48318941|NCT03015259|101107544|FG000|NOT COMPLETED|Overall Study||15||
48318942|NCT03015259|101107545|FG001|NOT COMPLETED|Overall Study||18||
48318943|NCT03015259|101107546|FG002|NOT COMPLETED|Overall Study||5||
48318944|NCT00761007|101107547|FG000|STARTED|Overall Study||142||
48318945|NCT00761007|101107548|FG001|STARTED|Overall Study||135||
48318946|NCT00761007|101107549|FG002|STARTED|Overall Study||139||
48318947|NCT00761007|101107550|FG003|STARTED|Overall Study||138||
48318948|NCT00761007|101107547|FG000|Safety (>=1 Dose of Study Medication)|Overall Study||140||
48318949|NCT00761007|101107548|FG001|Safety (>=1 Dose of Study Medication)|Overall Study||135||
48318950|NCT00761007|101107549|FG002|Safety (>=1 Dose of Study Medication)|Overall Study||139||
48318951|NCT00761007|101107550|FG003|Safety (>=1 Dose of Study Medication)|Overall Study||137||
48318952|NCT00761007|101107547|FG000|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||140||
48318953|NCT00761007|101107548|FG001|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||133||
48318954|NCT00761007|101107549|FG002|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||135||
48318955|NCT00761007|101107550|FG003|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||136||
48318956|NCT00761007|101107547|FG000|COMPLETED|Overall Study||129||
48318957|NCT00761007|101107548|FG001|COMPLETED|Overall Study||124||
48318958|NCT00761007|101107549|FG002|COMPLETED|Overall Study||121||
48318959|NCT00761007|101107550|FG003|COMPLETED|Overall Study||131||
48318960|NCT00761007|101107547|FG000|NOT COMPLETED|Overall Study||13||
48318961|NCT00761007|101107548|FG001|NOT COMPLETED|Overall Study||11||
48318962|NCT00761007|101107549|FG002|NOT COMPLETED|Overall Study||18||
48318963|NCT00761007|101107550|FG003|NOT COMPLETED|Overall Study||7||
48318964|NCT00483561|101107551|FG000|STARTED|Overall Study||26||
48318965|NCT00483561|101107551|FG000|COMPLETED|Overall Study||15||
48318966|NCT00483561|101107551|FG000|NOT COMPLETED|Overall Study||11||
48318967|NCT01775735|101107552|FG000|STARTED|Intervention (6 Months)||8||
48318968|NCT01775735|101107553|FG001|STARTED|Intervention (6 Months)||7||
48318969|NCT01775735|101107552|FG000|COMPLETED|Intervention (6 Months)||8||
48318970|NCT01775735|101107553|FG001|COMPLETED|Intervention (6 Months)||7||
48407490|NCT01605890|101328560|FG000|COMPLETED|Overall Study||28||
48407491|NCT01605890|101328560|FG000|NOT COMPLETED|Overall Study||2||
48407492|NCT02918721|101328561|FG000|STARTED|Overall Study||70||
48318971|NCT01775735|101107552|FG000|NOT COMPLETED|Intervention (6 Months)||0||
48318972|NCT01775735|101107553|FG001|NOT COMPLETED|Intervention (6 Months)||0||
48318973|NCT01775735|101107552|FG000|STARTED|Open Label (24 Months)||8||
48318974|NCT01775735|101107553|FG001|STARTED|Open Label (24 Months)||7||
48318975|NCT01775735|101107552|FG000|COMPLETED|Open Label (24 Months)||7||
48318976|NCT01775735|101107553|FG001|COMPLETED|Open Label (24 Months)||3||
48318977|NCT01775735|101107552|FG000|NOT COMPLETED|Open Label (24 Months)||1||
48318978|NCT01775735|101107553|FG001|NOT COMPLETED|Open Label (24 Months)||4||
48407493|NCT02918721|101328561|FG000|COMPLETED|Overall Study||70||
48407494|NCT02918721|101328561|FG000|NOT COMPLETED|Overall Study||0||
48160596|NCT02691182|100715887|FG003|COMPLETED|Overall Study||1||
48318979|NCT01227044|101107554|FG000|STARTED|Overall Study||25||
48318980|NCT01227044|101107555|FG001|STARTED|Overall Study||26||
48318981|NCT01227044|101107554|FG000|COMPLETED|Overall Study||19||
48318982|NCT01227044|101107555|FG001|COMPLETED|Overall Study||17||
48318983|NCT01227044|101107554|FG000|NOT COMPLETED|Overall Study||6||
48318984|NCT01227044|101107555|FG001|NOT COMPLETED|Overall Study||9||
48318985|NCT01502709|101107556|FG000|STARTED|Overall Study||5||
48407495|NCT01634100|101328562|FG000|STARTED|Overall Study||3||
48407496|NCT01634100|101328563|FG001|STARTED|Overall Study||3||
48616299|NCT02326272|101845101|FG010|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0||
48616300|NCT02326272|101845102|FG011|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0||
48616301|NCT02326272|101845103|FG012|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0||
48616302|NCT02326272|101845104|FG013|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0||
48616303|NCT02326272|101845105|FG014|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0||
48616304|NCT02326272|101845091|FG000|COMPLETED|Initial Period (Week 0 to Week 16)||45||
48616305|NCT02326272|101845092|FG001|COMPLETED|Initial Period (Week 0 to Week 16)||84||
48616306|NCT02326272|101845093|FG002|COMPLETED|Initial Period (Week 0 to Week 16)||81||
48616307|NCT02326272|101845094|FG003|COMPLETED|Initial Period (Week 0 to Week 16)||0||
48160597|NCT02691182|100715884|FG000|NOT COMPLETED|Overall Study||38||
48160598|NCT02691182|100715885|FG001|NOT COMPLETED|Overall Study||158||
48160599|NCT02691182|100715886|FG002|NOT COMPLETED|Overall Study||129||
48160600|NCT02691182|100715887|FG003|NOT COMPLETED|Overall Study||162||
48318986|NCT01502709|101107557|FG001|STARTED|Overall Study||0||
48318987|NCT01502709|101107556|FG000|COMPLETED|Overall Study||1||
48318988|NCT01502709|101107557|FG001|COMPLETED|Overall Study||0||
48318989|NCT01502709|101107556|FG000|NOT COMPLETED|Overall Study||4||
48318990|NCT01502709|101107557|FG001|NOT COMPLETED|Overall Study||0||
48318991|NCT02813694|101107558|FG000|STARTED|Overall Study||370||
48318992|NCT02813694|101107559|FG001|STARTED|Overall Study||368||
48318993|NCT02813694|101107558|FG000|COMPLETED|Overall Study||353|Completed Study (Late Follow Up Assessment)|
48318994|NCT02813694|101107559|FG001|COMPLETED|Overall Study||354|Completed Study (Late Follow Up Assessment)|
48318995|NCT02813694|101107558|FG000|NOT COMPLETED|Overall Study||17||
48318996|NCT02813694|101107559|FG001|NOT COMPLETED|Overall Study||14||
48318997|NCT02511730|101107560|FG000|STARTED|First Reading Session||50||
48318998|NCT02511730|101107561|FG001|STARTED|First Reading Session||50||
48318999|NCT02511730|101107560|FG000|COMPLETED|First Reading Session||50||
48319000|NCT02511730|101107561|FG001|COMPLETED|First Reading Session||50||
48319001|NCT02511730|101107560|FG000|NOT COMPLETED|First Reading Session||0||
48319002|NCT02511730|101107561|FG001|NOT COMPLETED|First Reading Session||0||
48319003|NCT02511730|101107560|FG000|STARTED|4 Week Memory Washout Period||50||
48319004|NCT02511730|101107561|FG001|STARTED|4 Week Memory Washout Period||50||
48319005|NCT02511730|101107560|FG000|COMPLETED|4 Week Memory Washout Period||50||
48319006|NCT02511730|101107561|FG001|COMPLETED|4 Week Memory Washout Period||50||
48319007|NCT02511730|101107560|FG000|NOT COMPLETED|4 Week Memory Washout Period||0||
48319008|NCT02511730|101107561|FG001|NOT COMPLETED|4 Week Memory Washout Period||0||
48319009|NCT02511730|101107560|FG000|STARTED|Session Reading Session||50||
48319010|NCT02511730|101107561|FG001|STARTED|Session Reading Session||50||
48319011|NCT02511730|101107560|FG000|COMPLETED|Session Reading Session||50||
48319012|NCT02511730|101107561|FG001|COMPLETED|Session Reading Session||50||
48319013|NCT02511730|101107560|FG000|NOT COMPLETED|Session Reading Session||0||
48319014|NCT02511730|101107561|FG001|NOT COMPLETED|Session Reading Session||0||
48319015|NCT01246583|101107562|FG000|STARTED|Overall Study||23||
48319016|NCT01246583|101107563|FG001|STARTED|Overall Study||13||
48319017|NCT01246583|101107564|FG002|STARTED|Overall Study||25||
48319018|NCT01246583|101107565|FG003|STARTED|Overall Study||10||
48319019|NCT01246583|101107562|FG000|COMPLETED|Overall Study||22||
48319020|NCT01246583|101107563|FG001|COMPLETED|Overall Study||13||
48319021|NCT01246583|101107564|FG002|COMPLETED|Overall Study||24||
48319022|NCT01246583|101107565|FG003|COMPLETED|Overall Study||9||
48319023|NCT01246583|101107562|FG000|NOT COMPLETED|Overall Study||1||
48319024|NCT01246583|101107563|FG001|NOT COMPLETED|Overall Study||0||
48319025|NCT01246583|101107564|FG002|NOT COMPLETED|Overall Study||1||
48319026|NCT01246583|101107565|FG003|NOT COMPLETED|Overall Study||1||
48737179|NCT00348673|102140250|FG005|NOT COMPLETED|Stage 2||0||
48737180|NCT00348673|102140251|FG006|NOT COMPLETED|Stage 2||0||
48737181|NCT00348673|102140252|FG007|NOT COMPLETED|Stage 2||0||
48737182|NCT00348673|102140253|FG008|NOT COMPLETED|Stage 2||0||
48737183|NCT00532298|102140254|FG000|STARTED|Overall Study||269||
48737184|NCT00532298|102140255|FG001|STARTED|Overall Study||266||
48737185|NCT00532298|102140256|FG002|STARTED|Overall Study||264||
48737186|NCT00532298|102140257|FG003|STARTED|Overall Study||264||
48319027|NCT02577146|101107566|FG000|STARTED|Overall Study||74||
48319028|NCT02577146|101107566|FG000|COMPLETED|Overall Study||46||
48319029|NCT02577146|101107566|FG000|NOT COMPLETED|Overall Study||28||
48319030|NCT02255422|101107567|FG000|STARTED|Overall Study||13||
48319031|NCT02255422|101107568|FG001|STARTED|Overall Study||6||
48319032|NCT02255422|101107569|FG002|STARTED|Overall Study||6||
48737187|NCT00532298|102140258|FG004|STARTED|Overall Study||268||
48737188|NCT00532298|102140259|FG005|STARTED|Overall Study||263||
48737189|NCT00532298|102140254|FG000|COMPLETED|Overall Study||267||
48737190|NCT00532298|102140255|FG001|COMPLETED|Overall Study||265||
48737191|NCT00532298|102140256|FG002|COMPLETED|Overall Study||263||
48737192|NCT00532298|102140257|FG003|COMPLETED|Overall Study||264||
48737193|NCT00532298|102140258|FG004|COMPLETED|Overall Study||267||
48737194|NCT00532298|102140259|FG005|COMPLETED|Overall Study||261||
48737195|NCT00532298|102140254|FG000|NOT COMPLETED|Overall Study||2||
48737196|NCT00532298|102140255|FG001|NOT COMPLETED|Overall Study||1||
48737197|NCT00532298|102140256|FG002|NOT COMPLETED|Overall Study||1||
48737198|NCT00532298|102140257|FG003|NOT COMPLETED|Overall Study||0||
48737199|NCT00532298|102140258|FG004|NOT COMPLETED|Overall Study||1||
48737200|NCT00532298|102140259|FG005|NOT COMPLETED|Overall Study||2||
48737201|NCT02828436|102140260|FG000|STARTED|Period 1||0||
48737202|NCT02828436|102140261|FG001|STARTED|Period 1||9||
48737203|NCT02828436|102140260|FG000|COMPLETED|Period 1||0||
48737204|NCT02828436|102140261|FG001|COMPLETED|Period 1||5||
48737205|NCT02828436|102140260|FG000|NOT COMPLETED|Period 1||0||
48737206|NCT02828436|102140261|FG001|NOT COMPLETED|Period 1||4||
48737207|NCT02828436|102140260|FG000|STARTED|Period 2||9||
48737208|NCT02828436|102140261|FG001|STARTED|Period 2||0||
48737209|NCT02828436|102140260|FG000|COMPLETED|Period 2||1||
48737210|NCT02828436|102140261|FG001|COMPLETED|Period 2||0||
48737211|NCT02828436|102140260|FG000|NOT COMPLETED|Period 2||8||
48737212|NCT02828436|102140261|FG001|NOT COMPLETED|Period 2||0||
48737213|NCT01078363|102140262|FG000|STARTED|Overall Study||47||
48737214|NCT01078363|102140263|FG001|STARTED|Overall Study||49||
48737215|NCT01078363|102140262|FG000|COMPLETED|Overall Study||47||
48160601|NCT00070135|100715888|FG000|STARTED|Overall Study||114||
48319033|NCT02255422|101107570|FG003|STARTED|Overall Study||6||
48319034|NCT02255422|101107571|FG004|STARTED|Overall Study||6||
48319035|NCT02255422|101107572|FG005|STARTED|Overall Study||6||
48319036|NCT02255422|101107573|FG006|STARTED|Overall Study||10||
48319037|NCT02255422|101107567|FG000|COMPLETED|Overall Study||13||
48319038|NCT02255422|101107568|FG001|COMPLETED|Overall Study||6||
48319039|NCT02255422|101107569|FG002|COMPLETED|Overall Study||5||
48319040|NCT02255422|101107570|FG003|COMPLETED|Overall Study||6||
48319041|NCT02255422|101107571|FG004|COMPLETED|Overall Study||6||
48319042|NCT02255422|101107572|FG005|COMPLETED|Overall Study||6||
48737216|NCT01078363|102140263|FG001|COMPLETED|Overall Study||49||
48737217|NCT01078363|102140262|FG000|NOT COMPLETED|Overall Study||0||
48737218|NCT01078363|102140263|FG001|NOT COMPLETED|Overall Study||0||
48737219|NCT01618695|102140264|FG000|STARTED|Core Phase||177||
48737220|NCT01618695|102140265|FG001|STARTED|Core Phase||176||
48737221|NCT01618695|102140266|FG002|STARTED|Core Phase||177||
48737222|NCT01618695|102140267|FG003|STARTED|Core Phase||180||
48160602|NCT00070135|100715888|FG000|COMPLETED|Overall Study||114||
48319043|NCT02255422|101107573|FG006|COMPLETED|Overall Study||8||
48737223|NCT01618695|102140264|FG000|Treated (Safety Analysis Set)|Core Phase||176||
48737224|NCT01618695|102140265|FG001|Treated (Safety Analysis Set)|Core Phase||176||
48160603|NCT00070135|100715888|FG000|NOT COMPLETED|Overall Study||0||
48737225|NCT01618695|102140266|FG002|Treated (Safety Analysis Set)|Core Phase||175||
48737226|NCT01618695|102140267|FG003|Treated (Safety Analysis Set)|Core Phase||180||
48737227|NCT01618695|102140264|FG000|COMPLETED|Core Phase||152||
48737228|NCT01618695|102140265|FG001|COMPLETED|Core Phase||156||
48737229|NCT01618695|102140266|FG002|COMPLETED|Core Phase||147||
48737230|NCT01618695|102140267|FG003|COMPLETED|Core Phase||144||
48737231|NCT01618695|102140264|FG000|NOT COMPLETED|Core Phase||25||
48737232|NCT01618695|102140265|FG001|NOT COMPLETED|Core Phase||20||
48737233|NCT01618695|102140266|FG002|NOT COMPLETED|Core Phase||30||
48737234|NCT01618695|102140267|FG003|NOT COMPLETED|Core Phase||36||
48737235|NCT01618695|102140264|FG000|STARTED|Extension Phase||151||
48737236|NCT01618695|102140265|FG001|STARTED|Extension Phase||156||
48737237|NCT01618695|102140266|FG002|STARTED|Extension Phase||146||
48737238|NCT01618695|102140267|FG003|STARTED|Extension Phase||143||
48737239|NCT01618695|102140264|FG000|COMPLETED|Extension Phase||56||
48737240|NCT01618695|102140265|FG001|COMPLETED|Extension Phase||40||
48737241|NCT01618695|102140266|FG002|COMPLETED|Extension Phase||54||
48737242|NCT01618695|102140267|FG003|COMPLETED|Extension Phase||46||
48737243|NCT01618695|102140264|FG000|NOT COMPLETED|Extension Phase||95||
48737244|NCT01618695|102140265|FG001|NOT COMPLETED|Extension Phase||116||
48737245|NCT01618695|102140266|FG002|NOT COMPLETED|Extension Phase||92||
48737246|NCT01618695|102140267|FG003|NOT COMPLETED|Extension Phase||97||
48737247|NCT00103740|102140268|FG000|STARTED|Period 1 - Core||92||
48737248|NCT00103740|102140269|FG001|STARTED|Period 1 - Core||93||
48319044|NCT02255422|101107567|FG000|NOT COMPLETED|Overall Study||0||
48737249|NCT00103740|102140268|FG000|COMPLETED|Period 1 - Core||85||
48737250|NCT00103740|102140269|FG001|COMPLETED|Period 1 - Core||89||
48737251|NCT00103740|102140268|FG000|NOT COMPLETED|Period 1 - Core||7||
48737252|NCT00103740|102140269|FG001|NOT COMPLETED|Period 1 - Core||4||
48737253|NCT00103740|102140268|FG000|STARTED|Period 2 - Extended Observation Period||78||
48737254|NCT00103740|102140269|FG001|STARTED|Period 2 - Extended Observation Period||63||
48737255|NCT00103740|102140268|FG000|COMPLETED|Period 2 - Extended Observation Period||9||
48737256|NCT00103740|102140269|FG001|COMPLETED|Period 2 - Extended Observation Period||27||
48737257|NCT00103740|102140268|FG000|NOT COMPLETED|Period 2 - Extended Observation Period||69||
48737258|NCT00103740|102140269|FG001|NOT COMPLETED|Period 2 - Extended Observation Period||36||
48737259|NCT02445326|102140270|FG000|STARTED|Overall Study||35||
48319045|NCT02255422|101107568|FG001|NOT COMPLETED|Overall Study||0||
48319046|NCT02255422|101107569|FG002|NOT COMPLETED|Overall Study||1||
48319047|NCT02255422|101107570|FG003|NOT COMPLETED|Overall Study||0||
48319048|NCT02255422|101107571|FG004|NOT COMPLETED|Overall Study||0||
48319049|NCT02255422|101107572|FG005|NOT COMPLETED|Overall Study||0||
48319050|NCT02255422|101107573|FG006|NOT COMPLETED|Overall Study||2||
48319051|NCT00440947|101107574|FG000|STARTED|36-Week Induction Phase||515||
48319052|NCT00440947|101107575|FG001|STARTED|36-Week Induction Phase||0||
48319053|NCT00440947|101107576|FG002|STARTED|36-Week Induction Phase||0||
48319054|NCT00440947|101107577|FG003|STARTED|36-Week Induction Phase||0||
48319055|NCT00440947|101107578|FG004|STARTED|36-Week Induction Phase||0||
48319056|NCT00440947|101107574|FG000|COMPLETED|36-Week Induction Phase||442||
48319057|NCT00440947|101107575|FG001|COMPLETED|36-Week Induction Phase||0||
48319058|NCT00440947|101107576|FG002|COMPLETED|36-Week Induction Phase||0||
48737260|NCT02445326|102140271|FG001|STARTED|Overall Study||38||
48737261|NCT02445326|102140270|FG000|COMPLETED|Overall Study||33||
48737262|NCT02445326|102140271|FG001|COMPLETED|Overall Study||37||
48737263|NCT02445326|102140270|FG000|NOT COMPLETED|Overall Study||2||
48737264|NCT02445326|102140271|FG001|NOT COMPLETED|Overall Study||1||
48737265|NCT01272635|102140272|FG000|STARTED|Overall Study||153||
48737266|NCT01272635|102140273|FG001|STARTED|Overall Study||154||
48737267|NCT01272635|102140274|FG002|STARTED|Overall Study||148||
48737268|NCT01272635|102140275|FG003|STARTED|Overall Study||152||
48737269|NCT01272635|102140272|FG000|COMPLETED|Overall Study||122||
48737270|NCT01272635|102140273|FG001|COMPLETED|Overall Study||134||
48737271|NCT01272635|102140274|FG002|COMPLETED|Overall Study||117||
48737272|NCT01272635|102140275|FG003|COMPLETED|Overall Study||129||
48737273|NCT01272635|102140272|FG000|NOT COMPLETED|Overall Study||31||
48737274|NCT01272635|102140273|FG001|NOT COMPLETED|Overall Study||20||
48737275|NCT01272635|102140274|FG002|NOT COMPLETED|Overall Study||31||
48737276|NCT01272635|102140275|FG003|NOT COMPLETED|Overall Study||23||
48737277|NCT01031979|102140276|FG000|STARTED|Overall Study||14||
48737278|NCT01031979|102140277|FG001|STARTED|Overall Study||12||
48737279|NCT01031979|102140276|FG000|Completed Primary Outcome Measure|Overall Study||12||
48737280|NCT01031979|102140277|FG001|Completed Primary Outcome Measure|Overall Study||12||
48160604|NCT05096208|100715889|FG000|STARTED|Overall Study||247||
48160605|NCT05096208|100715890|FG001|STARTED|Overall Study||249||
48319059|NCT00440947|101107577|FG003|COMPLETED|36-Week Induction Phase||0||
48319060|NCT00440947|101107578|FG004|COMPLETED|36-Week Induction Phase||0||
48737281|NCT01031979|102140276|FG000|COMPLETED|Overall Study||9||
48737282|NCT01031979|102140277|FG001|COMPLETED|Overall Study||8||
48737283|NCT01031979|102140276|FG000|NOT COMPLETED|Overall Study||5||
48737284|NCT01031979|102140277|FG001|NOT COMPLETED|Overall Study||4||
48737285|NCT00132808|102140278|FG000|STARTED|Stratum I||77||
48737286|NCT00132808|102140279|FG001|STARTED|Stratum I||70||
48737287|NCT00132808|102140280|FG002|STARTED|Stratum I||77||
48160606|NCT05096208|100715891|FG002|STARTED|Overall Study||247||
48160607|NCT05096208|100715892|FG003|STARTED|Overall Study||250||
48160608|NCT05096208|100715889|FG000|Vaccinated|Overall Study||247||
48160609|NCT05096208|100715890|FG001|Vaccinated|Overall Study||249||
48160610|NCT05096208|100715891|FG002|Vaccinated|Overall Study||247||
48160611|NCT05096208|100715892|FG003|Vaccinated|Overall Study||249||
48319061|NCT00440947|101107574|FG000|NOT COMPLETED|36-Week Induction Phase||73||
48319062|NCT00440947|101107575|FG001|NOT COMPLETED|36-Week Induction Phase||0||
48319063|NCT00440947|101107576|FG002|NOT COMPLETED|36-Week Induction Phase||0||
48319064|NCT00440947|101107577|FG003|NOT COMPLETED|36-Week Induction Phase||0||
48160612|NCT05096208|100715889|FG000|COMPLETED|Overall Study||243||
48160613|NCT05096208|100715890|FG001|COMPLETED|Overall Study||243||
48160614|NCT05096208|100715891|FG002|COMPLETED|Overall Study||239||
48160615|NCT05096208|100715892|FG003|COMPLETED|Overall Study||245||
48160616|NCT05096208|100715889|FG000|NOT COMPLETED|Overall Study||4||
48160617|NCT05096208|100715890|FG001|NOT COMPLETED|Overall Study||6||
48160618|NCT05096208|100715891|FG002|NOT COMPLETED|Overall Study||8||
48160619|NCT05096208|100715892|FG003|NOT COMPLETED|Overall Study||5||
48160620|NCT01253525|100715893|FG000|STARTED|Overall Study||6||
48160621|NCT01253525|100715893|FG000|Received Any Quantity of Study Drug|Overall Study||6||
48160622|NCT01253525|100715893|FG000|COMPLETED|Overall Study||6||
48160623|NCT01253525|100715893|FG000|NOT COMPLETED|Overall Study||0||
48319065|NCT00440947|101107578|FG004|NOT COMPLETED|36-Week Induction Phase||0||
48319066|NCT00440947|101107574|FG000|STARTED|48-Week Randomization Phase||0||
48319067|NCT00440947|101107575|FG001|STARTED|48-Week Randomization Phase||210||
48319068|NCT00440947|101107576|FG002|STARTED|48-Week Randomization Phase||209||
48319069|NCT00440947|101107577|FG003|STARTED|48-Week Randomization Phase||0||
48319070|NCT00440947|101107578|FG004|STARTED|48-Week Randomization Phase||0||
48737288|NCT00132808|102140278|FG000|COMPLETED|Stratum I||68||
48737289|NCT00132808|102140279|FG001|COMPLETED|Stratum I||58||
48737290|NCT00132808|102140280|FG002|COMPLETED|Stratum I||72||
48737291|NCT00132808|102140278|FG000|NOT COMPLETED|Stratum I||9||
48737292|NCT00132808|102140279|FG001|NOT COMPLETED|Stratum I||12||
48737293|NCT00132808|102140280|FG002|NOT COMPLETED|Stratum I||5||
48737294|NCT00132808|102140278|FG000|STARTED|Stratum II||121||
48737295|NCT00132808|102140279|FG001|STARTED|Stratum II||111||
48737296|NCT00132808|102140280|FG002|STARTED|Stratum II||125||
48737297|NCT00132808|102140278|FG000|COMPLETED|Stratum II||113||
48737298|NCT00132808|102140279|FG001|COMPLETED|Stratum II||96||
48737299|NCT00132808|102140280|FG002|COMPLETED|Stratum II||116||
48737300|NCT00132808|102140278|FG000|NOT COMPLETED|Stratum II||8||
48160624|NCT01936896|100715894|FG000|STARTED|Overall Study||10||
48160625|NCT01936896|100715894|FG000|COMPLETED|Overall Study||10||
48160626|NCT01936896|100715894|FG000|NOT COMPLETED|Overall Study||0||
48160627|NCT03954743|100715895|FG000|STARTED|Overall Study||677||
48319071|NCT00440947|101107574|FG000|COMPLETED|48-Week Randomization Phase||0||
48737301|NCT00132808|102140279|FG001|NOT COMPLETED|Stratum II||15||
48160628|NCT03954743|100715896|FG001|STARTED|Overall Study||674||
48160629|NCT03954743|100715895|FG000|COMPLETED|Overall Study||653||
48160630|NCT03954743|100715896|FG001|COMPLETED|Overall Study||657||
48160631|NCT03954743|100715895|FG000|NOT COMPLETED|Overall Study||24||
48160632|NCT03954743|100715896|FG001|NOT COMPLETED|Overall Study||17||
48160633|NCT00691808|100715897|FG000|STARTED|Overall Study||35||
48160634|NCT00691808|100715898|FG001|STARTED|Overall Study||36||
48737302|NCT00132808|102140280|FG002|NOT COMPLETED|Stratum II||9||
48737303|NCT02324816|102140281|FG000|STARTED|Overall Study||19||
48160635|NCT00691808|100715899|FG002|STARTED|Overall Study||32||
48407497|NCT01634100|101328564|FG002|STARTED|Overall Study||3||
48407498|NCT01634100|101328565|FG003|STARTED|Overall Study||3||
48407499|NCT01634100|101328566|FG004|STARTED|Overall Study||3||
48407500|NCT01634100|101328567|FG005|STARTED|Overall Study||3||
48407501|NCT01634100|101328562|FG000|Received Empa Alone|Overall Study||3||
48319072|NCT00440947|101107575|FG001|COMPLETED|48-Week Randomization Phase||194||
48319073|NCT00440947|101107576|FG002|COMPLETED|48-Week Randomization Phase||185||
48319074|NCT00440947|101107577|FG003|COMPLETED|48-Week Randomization Phase||0||
48319075|NCT00440947|101107578|FG004|COMPLETED|48-Week Randomization Phase||0||
48319076|NCT00440947|101107574|FG000|NOT COMPLETED|48-Week Randomization Phase||0||
48319077|NCT00440947|101107575|FG001|NOT COMPLETED|48-Week Randomization Phase||16||
48319078|NCT00440947|101107576|FG002|NOT COMPLETED|48-Week Randomization Phase||24||
48319079|NCT00440947|101107577|FG003|NOT COMPLETED|48-Week Randomization Phase||0||
48319080|NCT00440947|101107578|FG004|NOT COMPLETED|48-Week Randomization Phase||0||
48319081|NCT00440947|101107574|FG000|STARTED|Optional 60-Week Extension Phase||0||
48319082|NCT00440947|101107575|FG001|STARTED|Optional 60-Week Extension Phase||0||
48319083|NCT00440947|101107576|FG002|STARTED|Optional 60-Week Extension Phase||0||
48319084|NCT00440947|101107577|FG003|STARTED|Optional 60-Week Extension Phase||189||
48319085|NCT00440947|101107578|FG004|STARTED|Optional 60-Week Extension Phase||180||
48319086|NCT00440947|101107574|FG000|COMPLETED|Optional 60-Week Extension Phase||0||
48319087|NCT00440947|101107575|FG001|COMPLETED|Optional 60-Week Extension Phase||0||
48319088|NCT00440947|101107576|FG002|COMPLETED|Optional 60-Week Extension Phase||0||
48319089|NCT00440947|101107577|FG003|COMPLETED|Optional 60-Week Extension Phase||160||
48407502|NCT01634100|101328563|FG001|Received Empa Alone|Overall Study||3||
48319090|NCT00440947|101107578|FG004|COMPLETED|Optional 60-Week Extension Phase||154||
48319091|NCT00440947|101107574|FG000|NOT COMPLETED|Optional 60-Week Extension Phase||0||
48319092|NCT00440947|101107575|FG001|NOT COMPLETED|Optional 60-Week Extension Phase||0||
48319093|NCT00440947|101107576|FG002|NOT COMPLETED|Optional 60-Week Extension Phase||0||
48319094|NCT00440947|101107577|FG003|NOT COMPLETED|Optional 60-Week Extension Phase||29||
48319095|NCT00440947|101107578|FG004|NOT COMPLETED|Optional 60-Week Extension Phase||26||
48319096|NCT01549002|101107579|FG000|STARTED|Overall Study||10||
48319097|NCT01549002|101107580|FG001|STARTED|Overall Study||10||
48407503|NCT01634100|101328564|FG002|Received Empa Alone|Overall Study||3||
48407504|NCT01634100|101328565|FG003|Received Empa Alone|Overall Study||3||
48616308|NCT02326272|101845095|FG004|COMPLETED|Initial Period (Week 0 to Week 16)||0||
48616309|NCT02326272|101845096|FG005|COMPLETED|Initial Period (Week 0 to Week 16)||0||
48616310|NCT02326272|101845097|FG006|COMPLETED|Initial Period (Week 0 to Week 16)||0||
48616311|NCT02326272|101845098|FG007|COMPLETED|Initial Period (Week 0 to Week 16)||0||
48616312|NCT02326272|101845099|FG008|COMPLETED|Initial Period (Week 0 to Week 16)||0||
48616313|NCT02326272|101845100|FG009|COMPLETED|Initial Period (Week 0 to Week 16)||0||
48616314|NCT02326272|101845101|FG010|COMPLETED|Initial Period (Week 0 to Week 16)||0||
48616315|NCT02326272|101845102|FG011|COMPLETED|Initial Period (Week 0 to Week 16)||0||
48616316|NCT02326272|101845103|FG012|COMPLETED|Initial Period (Week 0 to Week 16)||0||
48616317|NCT02326272|101845104|FG013|COMPLETED|Initial Period (Week 0 to Week 16)||0||
48616318|NCT02326272|101845105|FG014|COMPLETED|Initial Period (Week 0 to Week 16)||0||
48616319|NCT02326272|101845091|FG000|NOT COMPLETED|Initial Period (Week 0 to Week 16)||4||
48616320|NCT02326272|101845092|FG001|NOT COMPLETED|Initial Period (Week 0 to Week 16)||7||
48616321|NCT02326272|101845093|FG002|NOT COMPLETED|Initial Period (Week 0 to Week 16)||6||
48616322|NCT02326272|101845094|FG003|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
48616323|NCT02326272|101845095|FG004|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
48616324|NCT02326272|101845096|FG005|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
48616325|NCT02326272|101845097|FG006|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
48616326|NCT02326272|101845098|FG007|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
48616327|NCT02326272|101845099|FG008|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
48616328|NCT02326272|101845100|FG009|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
48737304|NCT02324816|102140281|FG000|COMPLETED|Overall Study||19||
48319098|NCT01549002|101107579|FG000|COMPLETED|Overall Study||10||
48319099|NCT01549002|101107580|FG001|COMPLETED|Overall Study||6||
48319100|NCT01549002|101107579|FG000|NOT COMPLETED|Overall Study||0||
48319101|NCT01549002|101107580|FG001|NOT COMPLETED|Overall Study||4||
48319102|NCT00635479|101107581|FG000|STARTED|Overall Study||55||
48319103|NCT00635479|101107582|FG001|STARTED|Overall Study||60||
48319104|NCT00635479|101107581|FG000|COMPLETED|Overall Study||49||
48319105|NCT00635479|101107582|FG001|COMPLETED|Overall Study||42||
48319106|NCT00635479|101107581|FG000|NOT COMPLETED|Overall Study||6||
48319107|NCT00635479|101107582|FG001|NOT COMPLETED|Overall Study||18||
48319108|NCT02263079|101107583|FG000|STARTED|Overall Study||26||
48319109|NCT02263079|101107584|FG001|STARTED|Overall Study||33||
48319110|NCT02263079|101107585|FG002|STARTED|Overall Study||3||
48319111|NCT02263079|101107583|FG000|COMPLETED|Overall Study||23||
48407505|NCT01634100|101328566|FG004|Received Empa Alone|Overall Study||3||
48407506|NCT01634100|101328567|FG005|Received Empa Alone|Overall Study||3||
48407507|NCT01634100|101328562|FG000|Received Empa + Rifampicin|Overall Study||3||
48407508|NCT01634100|101328563|FG001|Received Empa + Rifampicin|Overall Study||3||
48616329|NCT02326272|101845101|FG010|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
48616330|NCT02326272|101845102|FG011|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
48319112|NCT02263079|101107584|FG001|COMPLETED|Overall Study||25||
48319113|NCT02263079|101107585|FG002|COMPLETED|Overall Study||3||
48319114|NCT02263079|101107583|FG000|NOT COMPLETED|Overall Study||3||
48319115|NCT02263079|101107584|FG001|NOT COMPLETED|Overall Study||8||
48319116|NCT02263079|101107585|FG002|NOT COMPLETED|Overall Study||0||
48319117|NCT00714285|101107586|FG000|STARTED|Overall Study||105||
48319118|NCT00714285|101107587|FG001|STARTED|Overall Study||105||
48407509|NCT01634100|101328564|FG002|Received Empa + Rifampicin|Overall Study||3||
48407510|NCT01634100|101328565|FG003|Received Empa + Rifampicin|Overall Study||3||
48407511|NCT01634100|101328566|FG004|Received Empa + Rifampicin|Overall Study||3||
48407512|NCT01634100|101328567|FG005|Received Empa + Rifampicin|Overall Study||3||
48737305|NCT02324816|102140281|FG000|NOT COMPLETED|Overall Study||0||
48737306|NCT00434642|102140282|FG000|STARTED|Blinded Treatment Phase||242||
48737307|NCT00434642|102140283|FG001|STARTED|Blinded Treatment Phase||242||
48737308|NCT00434642|102140282|FG000|COMPLETED|Blinded Treatment Phase||0||
48737309|NCT00434642|102140283|FG001|COMPLETED|Blinded Treatment Phase||13||
48737310|NCT00434642|102140282|FG000|NOT COMPLETED|Blinded Treatment Phase||242||
48737311|NCT00434642|102140283|FG001|NOT COMPLETED|Blinded Treatment Phase||229||
48737312|NCT00434642|102140282|FG000|STARTED|Open-label Treatment Phase||0||
48737313|NCT00434642|102140283|FG001|STARTED|Open-label Treatment Phase||12||
48737314|NCT00434642|102140282|FG000|COMPLETED|Open-label Treatment Phase||0||
48737315|NCT00434642|102140283|FG001|COMPLETED|Open-label Treatment Phase||1||
48737316|NCT00434642|102140282|FG000|NOT COMPLETED|Open-label Treatment Phase||0||
48737317|NCT00434642|102140283|FG001|NOT COMPLETED|Open-label Treatment Phase||11||
48737318|NCT00992459|102140284|FG000|STARTED|Overall Study||22||
48737319|NCT00992459|102140285|FG001|STARTED|Overall Study||24||
48737320|NCT00992459|102140284|FG000|COMPLETED|Overall Study||21||
48737321|NCT00992459|102140285|FG001|COMPLETED|Overall Study||23||
48737322|NCT00992459|102140284|FG000|NOT COMPLETED|Overall Study||1||
48737323|NCT00992459|102140285|FG001|NOT COMPLETED|Overall Study||1||
48737324|NCT01702246|102140286|FG000|STARTED|Overall Study||24||
48737325|NCT01702246|102140286|FG000|COMPLETED|Overall Study||19||
48737326|NCT01702246|102140286|FG000|NOT COMPLETED|Overall Study||5||
48737327|NCT00887510|102140287|FG000|STARTED|Overall Study||12||
48737328|NCT00887510|102140288|FG001|STARTED|Overall Study||12||
48737329|NCT00887510|102140287|FG000|COMPLETED|Overall Study||12||
48737330|NCT00887510|102140288|FG001|COMPLETED|Overall Study||12||
48737331|NCT00887510|102140287|FG000|NOT COMPLETED|Overall Study||0||
48737332|NCT00887510|102140288|FG001|NOT COMPLETED|Overall Study||0||
48737333|NCT03250182|102140289|FG000|STARTED|Overall Study||30||
48737334|NCT03250182|102140289|FG000|COMPLETED|Overall Study||29||
48737335|NCT03250182|102140289|FG000|NOT COMPLETED|Overall Study||1||
48737336|NCT01317901|102140290|FG000|STARTED|Overall Study||6||
48737337|NCT01317901|102140291|FG001|STARTED|Overall Study||6||
48319119|NCT00714285|101107588|FG002|STARTED|Overall Study||105||
48319120|NCT00714285|101107589|FG003|STARTED|Overall Study||105||
48319121|NCT00714285|101107586|FG000|COMPLETED|Overall Study||105||
48319122|NCT00714285|101107587|FG001|COMPLETED|Overall Study||102||
48319123|NCT00714285|101107588|FG002|COMPLETED|Overall Study||105||
48319124|NCT00714285|101107589|FG003|COMPLETED|Overall Study||104||
48319125|NCT00714285|101107586|FG000|NOT COMPLETED|Overall Study||0||
48319126|NCT00714285|101107587|FG001|NOT COMPLETED|Overall Study||3||
48319127|NCT00714285|101107588|FG002|NOT COMPLETED|Overall Study||0||
48737338|NCT01317901|102140290|FG000|COMPLETED|Overall Study||6||
48737339|NCT01317901|102140291|FG001|COMPLETED|Overall Study||6||
48737340|NCT01317901|102140290|FG000|NOT COMPLETED|Overall Study||0||
48737341|NCT01317901|102140291|FG001|NOT COMPLETED|Overall Study||0||
48737342|NCT01178099|102140292|FG000|STARTED|Overall Study||13||
48737343|NCT01178099|102140293|FG001|STARTED|Overall Study||13||
48737344|NCT01178099|102140292|FG000|COMPLETED|Overall Study||13||
48737345|NCT01178099|102140293|FG001|COMPLETED|Overall Study||12||
48737346|NCT01178099|102140292|FG000|NOT COMPLETED|Overall Study||0||
48737347|NCT01178099|102140293|FG001|NOT COMPLETED|Overall Study||1||
48737348|NCT00432341|102140294|FG000|STARTED|Overall Study||24||
48737349|NCT00432341|102140295|FG001|STARTED|Overall Study||30||
48737350|NCT00432341|102140294|FG000|COMPLETED|Overall Study||24||
48737351|NCT00432341|102140295|FG001|COMPLETED|Overall Study||30||
48737352|NCT00432341|102140294|FG000|NOT COMPLETED|Overall Study||0||
48737353|NCT00432341|102140295|FG001|NOT COMPLETED|Overall Study||0||
48737354|NCT01858766|102140296|FG000|STARTED|Overall Study||27||
48737355|NCT01858766|102140297|FG001|STARTED|Overall Study||28||
48737356|NCT01858766|102140298|FG002|STARTED|Overall Study||11||
48737357|NCT01858766|102140299|FG003|STARTED|Overall Study||10||
48737358|NCT01858766|102140300|FG004|STARTED|Overall Study||27||
48319128|NCT00714285|101107589|FG003|NOT COMPLETED|Overall Study||1||
48319129|NCT01140451|101107590|FG000|STARTED|Overall Study||95|The first week of Study 009e was Total Study Week 48 for Studies 009 and 009e combined.|
48737359|NCT01858766|102140301|FG005|STARTED|Overall Study||28||
48737360|NCT01858766|102140302|FG006|STARTED|Overall Study||7||
48737361|NCT01858766|102140303|FG007|STARTED|Overall Study||7||
48737362|NCT01858766|102140304|FG008|STARTED|Overall Study||1||
48737363|NCT01858766|102140305|FG009|STARTED|Overall Study||4||
48319130|NCT01140451|101107591|FG001|STARTED|Overall Study||96|The first week of Study 009e was Total Study Week 48 for Studies 009 and 009e combined.|
48737364|NCT01858766|102140306|FG010|STARTED|Overall Study||5||
48737365|NCT01858766|102140307|FG011|STARTED|Overall Study||30||
48737366|NCT01858766|102140308|FG012|STARTED|Overall Study||30||
48737367|NCT01858766|102140309|FG013|STARTED|Overall Study||29||
48737368|NCT01858766|102140310|FG014|STARTED|Overall Study||31||
48737369|NCT01858766|102140311|FG015|STARTED|Overall Study||26||
48737370|NCT01858766|102140312|FG016|STARTED|Overall Study||25||
48737371|NCT01858766|102140313|FG017|STARTED|Overall Study||27||
48737372|NCT01858766|102140314|FG018|STARTED|Overall Study||26||
48737373|NCT01858766|102140296|FG000|COMPLETED|Overall Study||26||
48737374|NCT01858766|102140297|FG001|COMPLETED|Overall Study||28||
48737375|NCT01858766|102140298|FG002|COMPLETED|Overall Study||10||
48737376|NCT01858766|102140299|FG003|COMPLETED|Overall Study||10||
48737377|NCT01858766|102140300|FG004|COMPLETED|Overall Study||26||
48737378|NCT01858766|102140301|FG005|COMPLETED|Overall Study||24||
48737379|NCT01858766|102140302|FG006|COMPLETED|Overall Study||7||
48737380|NCT01858766|102140303|FG007|COMPLETED|Overall Study||5||
48737381|NCT01858766|102140304|FG008|COMPLETED|Overall Study||1||
48737382|NCT01858766|102140305|FG009|COMPLETED|Overall Study||4||
48737383|NCT01858766|102140306|FG010|COMPLETED|Overall Study||5||
48737384|NCT01858766|102140307|FG011|COMPLETED|Overall Study||25||
48737385|NCT01858766|102140308|FG012|COMPLETED|Overall Study||25||
48737386|NCT01858766|102140309|FG013|COMPLETED|Overall Study||26||
48737387|NCT01858766|102140310|FG014|COMPLETED|Overall Study||23||
48737388|NCT01858766|102140311|FG015|COMPLETED|Overall Study||20||
48737389|NCT01858766|102140312|FG016|COMPLETED|Overall Study||22||
48737390|NCT01858766|102140313|FG017|COMPLETED|Overall Study||23||
48737391|NCT01858766|102140314|FG018|COMPLETED|Overall Study||22||
48737392|NCT01858766|102140296|FG000|NOT COMPLETED|Overall Study||1||
48737393|NCT01858766|102140297|FG001|NOT COMPLETED|Overall Study||0||
48737394|NCT01858766|102140298|FG002|NOT COMPLETED|Overall Study||1||
48737395|NCT01858766|102140299|FG003|NOT COMPLETED|Overall Study||0||
48737396|NCT01858766|102140300|FG004|NOT COMPLETED|Overall Study||1||
48737397|NCT01858766|102140301|FG005|NOT COMPLETED|Overall Study||4||
48737398|NCT01858766|102140302|FG006|NOT COMPLETED|Overall Study||0||
48737399|NCT01858766|102140303|FG007|NOT COMPLETED|Overall Study||2||
48737400|NCT01858766|102140304|FG008|NOT COMPLETED|Overall Study||0||
48737401|NCT01858766|102140305|FG009|NOT COMPLETED|Overall Study||0||
48737402|NCT01858766|102140306|FG010|NOT COMPLETED|Overall Study||0||
48737403|NCT01858766|102140307|FG011|NOT COMPLETED|Overall Study||5||
48737404|NCT01858766|102140308|FG012|NOT COMPLETED|Overall Study||5||
48737405|NCT01858766|102140309|FG013|NOT COMPLETED|Overall Study||3||
48737406|NCT01858766|102140310|FG014|NOT COMPLETED|Overall Study||8||
48737407|NCT01858766|102140311|FG015|NOT COMPLETED|Overall Study||6||
48737408|NCT01858766|102140312|FG016|NOT COMPLETED|Overall Study||3||
48737409|NCT01858766|102140313|FG017|NOT COMPLETED|Overall Study||4||
48737410|NCT01858766|102140314|FG018|NOT COMPLETED|Overall Study||4||
48737411|NCT00607867|102140315|FG000|STARTED|Overall Study||7||
48737412|NCT00607867|102140316|FG001|STARTED|Overall Study||7||
48737413|NCT00607867|102140315|FG000|COMPLETED|Overall Study||7||
48737414|NCT00607867|102140316|FG001|COMPLETED|Overall Study||7||
48737415|NCT00607867|102140315|FG000|NOT COMPLETED|Overall Study||0||
48737416|NCT00607867|102140316|FG001|NOT COMPLETED|Overall Study||0||
48737417|NCT00003199|102140317|FG000|STARTED|Overall Study||50||
48737418|NCT00003199|102140317|FG000|COMPLETED|Overall Study||28||
48737419|NCT00003199|102140317|FG000|NOT COMPLETED|Overall Study||22||
48737420|NCT01336413|102140318|FG000|STARTED|Overall Study||27||
48737421|NCT01336413|102140319|FG001|STARTED|Overall Study||26||
48737422|NCT01336413|102140318|FG000|COMPLETED|Overall Study||26||
48737423|NCT01336413|102140319|FG001|COMPLETED|Overall Study||18||
48737424|NCT01336413|102140318|FG000|NOT COMPLETED|Overall Study||1||
48737425|NCT01336413|102140319|FG001|NOT COMPLETED|Overall Study||8||
48737426|NCT01685697|102140320|FG000|STARTED|Overall Study||31||
48737427|NCT01685697|102140321|FG001|STARTED|Overall Study||31||
48737428|NCT01685697|102140320|FG000|COMPLETED|Overall Study||28||
48737429|NCT01685697|102140321|FG001|COMPLETED|Overall Study||28||
48737430|NCT01685697|102140320|FG000|NOT COMPLETED|Overall Study||3||
48737431|NCT01685697|102140321|FG001|NOT COMPLETED|Overall Study||3||
48737432|NCT00121186|102140322|FG000|STARTED|Overall Study||1||
48737433|NCT00121186|102140322|FG000|COMPLETED|Overall Study||1||
48737434|NCT00121186|102140322|FG000|NOT COMPLETED|Overall Study||0||
48737435|NCT05388617|102140323|FG000|STARTED|Overall Study||16||
48737436|NCT05388617|102140324|FG001|STARTED|Overall Study||0||
48737437|NCT05388617|102140323|FG000|COMPLETED|Overall Study||16||
48737438|NCT05388617|102140324|FG001|COMPLETED|Overall Study||0||
48737439|NCT05388617|102140323|FG000|NOT COMPLETED|Overall Study||0||
48737440|NCT05388617|102140324|FG001|NOT COMPLETED|Overall Study||0||
48737441|NCT01854034|102140325|FG000|STARTED|Overall Study||29||
48737442|NCT01854034|102140325|FG000|COMPLETED|Overall Study||29||
48737443|NCT01854034|102140325|FG000|NOT COMPLETED|Overall Study||0||
48737444|NCT04124705|102140326|FG000|STARTED|Titration Period||141||
48737445|NCT04124705|102140327|FG001|STARTED|Titration Period||143||
48737446|NCT04124705|102140326|FG000|Received Study Treatment|Titration Period||141||
48737447|NCT04124705|102140327|FG001|Received Study Treatment|Titration Period||143||
48737448|NCT04124705|102140326|FG000|COMPLETED|Titration Period||115||
48737449|NCT04124705|102140327|FG001|COMPLETED|Titration Period||124||
48737450|NCT04124705|102140326|FG000|NOT COMPLETED|Titration Period||26||
48737451|NCT04124705|102140327|FG001|NOT COMPLETED|Titration Period||19||
48737452|NCT04124705|102140326|FG000|STARTED|Stabilization Period||115||
48737453|NCT04124705|102140327|FG001|STARTED|Stabilization Period||124||
48737454|NCT04124705|102140326|FG000|COMPLETED|Stabilization Period||104||
48737455|NCT04124705|102140327|FG001|COMPLETED|Stabilization Period||114||
48737456|NCT04124705|102140326|FG000|NOT COMPLETED|Stabilization Period||11||
48737457|NCT04124705|102140327|FG001|NOT COMPLETED|Stabilization Period||10||
48737458|NCT00510744|102140328|FG000|STARTED|Overall Study||5||
48319131|NCT01140451|101107590|FG000|Completed 24 Weeks|Overall Study||89|Week 24 of Study 009e was Total Study Week 72|
48319132|NCT01140451|101107591|FG001|Completed 24 Weeks|Overall Study||86|Week 24 of Study 009e was Total Study Week 72|
48319133|NCT01140451|101107590|FG000|Completed 48 Weeks|Overall Study||78|Week 48 of Study 009e was Total Study Week 96|
48319134|NCT01140451|101107591|FG001|Completed 48 Weeks|Overall Study||70|Week 48 of Study 009e was Total Study Week 96|
48319135|NCT01140451|101107590|FG000|Completed 72 Weeks|Overall Study||63|Week 72 of Study 009e was Total Study Week 120|
48319136|NCT01140451|101107591|FG001|Completed 72 Weeks|Overall Study||62|Week 72 of Study 009e was Total Study Week 120|
48737459|NCT00510744|102140328|FG000|COMPLETED|Overall Study||5||
48737460|NCT00510744|102140328|FG000|NOT COMPLETED|Overall Study||0||
48737461|NCT01286740|102140329|FG000|STARTED|Overall Study||50||
48737462|NCT01286740|102140329|FG000|Enrolled and Treated|Overall Study||49||
48737463|NCT01286740|102140329|FG000|Week 12 (Primary Endpoint)|Overall Study||49||
48737464|NCT01286740|102140329|FG000|COMPLETED|Overall Study||48||
48737465|NCT01286740|102140329|FG000|NOT COMPLETED|Overall Study||2||
48737466|NCT01207752|102140330|FG000|STARTED|Overall Study||35||
48737467|NCT01207752|102140331|FG001|STARTED|Overall Study||34||
48737468|NCT01207752|102140330|FG000|COMPLETED|Overall Study||33||
48737469|NCT01207752|102140331|FG001|COMPLETED|Overall Study||27||
48737470|NCT01207752|102140330|FG000|NOT COMPLETED|Overall Study||2||
48737471|NCT01207752|102140331|FG001|NOT COMPLETED|Overall Study||7||
48319137|NCT01140451|101107590|FG000|Completed 96 Weeks|Overall Study||57|Week 96 of Study 009e was Total Study Week 144|
48319138|NCT01140451|101107591|FG001|Completed 96 Weeks|Overall Study||54|Week 96 of Study 009e was Total Study Week 144|
48319139|NCT01140451|101107590|FG000|As-Treated Population|Overall Study||95|Received at least 1 dose of study drug in Study 009e|
48319140|NCT01140451|101107591|FG001|As-Treated Population|Overall Study||96|Received at least 1 dose of study drug in Study 009e|
48319141|NCT01140451|101107590|FG000|96-Week Completer Population|Overall Study||78|Completed 48 weeks of treatment in both Study 009 and Study 009e|
48319142|NCT01140451|101107591|FG001|96-Week Completer Population|Overall Study||70|Completed 48 weeks of treatment in both Study 009 and Study 009e|
48319143|NCT01140451|101107590|FG000|144-Week Completer Population|Overall Study||57|Completed 48 weeks of treatment in Study 009 and 96 weeks in Study 009e|
48319144|NCT01140451|101107591|FG001|144-Week Completer Population|Overall Study||54|Completed 48 weeks of treatment in Study 009 and 96 weeks in Study 009e|
48407513|NCT01634100|101328562|FG000|Received Empa + Probenecid|Overall Study||2||
48407514|NCT01634100|101328563|FG001|Received Empa + Probenecid|Overall Study||3||
48407515|NCT01634100|101328564|FG002|Received Empa + Probenecid|Overall Study||2||
48616331|NCT02326272|101845103|FG012|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
48616332|NCT02326272|101845104|FG013|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
48616333|NCT02326272|101845105|FG014|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
48616334|NCT02326272|101845091|FG000|STARTED|Maintenance Period (Week 16 to Week 48)||0||
48616335|NCT02326272|101845092|FG001|STARTED|Maintenance Period (Week 16 to Week 48)||0||
48616336|NCT02326272|101845093|FG002|STARTED|Maintenance Period (Week 16 to Week 48)||0||
48616337|NCT02326272|101845094|FG003|STARTED|Maintenance Period (Week 16 to Week 48)||6||
48616338|NCT02326272|101845095|FG004|STARTED|Maintenance Period (Week 16 to Week 48)||5||
48616339|NCT02326272|101845096|FG005|STARTED|Maintenance Period (Week 16 to Week 48)||76||
48616340|NCT02326272|101845097|FG006|STARTED|Maintenance Period (Week 16 to Week 48)||69||
48616341|NCT02326272|101845098|FG007|STARTED|Maintenance Period (Week 16 to Week 48)||34||
48616342|NCT02326272|101845099|FG008|STARTED|Maintenance Period (Week 16 to Week 48)||8||
48616343|NCT02326272|101845100|FG009|STARTED|Maintenance Period (Week 16 to Week 48)||12||
48616344|NCT02326272|101845101|FG010|STARTED|Maintenance Period (Week 16 to Week 48)||0||
48616345|NCT02326272|101845102|FG011|STARTED|Maintenance Period (Week 16 to Week 48)||0||
48616346|NCT02326272|101845103|FG012|STARTED|Maintenance Period (Week 16 to Week 48)||0||
48737472|NCT00719355|102140332|FG000|STARTED|Overall Study||51||
48737473|NCT00719355|102140333|FG001|STARTED|Overall Study||52||
48737474|NCT00719355|102140332|FG000|Completed 6 Weeks|Overall Study||49||
48319145|NCT01140451|101107590|FG000|COMPLETED|Overall Study||57|Study completion for Study 009e was Week 100 (Total Study Week 148)|
48368054|NCT03691623|101230099|FG003|STARTED|Overall Study||21||
48407516|NCT01634100|101328565|FG003|Received Empa + Probenecid|Overall Study||3||
48616347|NCT02326272|101845104|FG013|STARTED|Maintenance Period (Week 16 to Week 48)||0||
48616348|NCT02326272|101845105|FG014|STARTED|Maintenance Period (Week 16 to Week 48)||0||
48737475|NCT00719355|102140333|FG001|Completed 6 Weeks|Overall Study||48||
48737476|NCT00719355|102140332|FG000|Completed 12 Weeks|Overall Study||43||
48737477|NCT00719355|102140333|FG001|Completed 12 Weeks|Overall Study||46||
48737478|NCT00719355|102140332|FG000|Completed 24 Weeks|Overall Study||34||
48737479|NCT00719355|102140333|FG001|Completed 24 Weeks|Overall Study||43||
48737480|NCT00719355|102140332|FG000|Completed 32 Weeks|Overall Study||33||
48737481|NCT00719355|102140333|FG001|Completed 32 Weeks|Overall Study||39||
48737482|NCT00719355|102140332|FG000|COMPLETED|Overall Study||33||
48737483|NCT00719355|102140333|FG001|COMPLETED|Overall Study||39||
48737484|NCT00719355|102140332|FG000|NOT COMPLETED|Overall Study||18||
48737485|NCT00719355|102140333|FG001|NOT COMPLETED|Overall Study||13||
48737486|NCT02720692|102140334|FG000|STARTED|Overall Study||539||
48737487|NCT02720692|102140335|FG001|STARTED|Overall Study||183||
48737488|NCT02720692|102140334|FG000|Treated|Overall Study||538||
48737489|NCT02720692|102140335|FG001|Treated|Overall Study||183||
48737490|NCT02720692|102140334|FG000|Completed Treatment|Overall Study||519||
48737491|NCT02720692|102140335|FG001|Completed Treatment|Overall Study||177||
48737492|NCT02720692|102140334|FG000|COMPLETED|Overall Study||526||
48737493|NCT02720692|102140335|FG001|COMPLETED|Overall Study||180||
48737494|NCT02720692|102140334|FG000|NOT COMPLETED|Overall Study||13||
48737495|NCT02720692|102140335|FG001|NOT COMPLETED|Overall Study||3||
48737496|NCT04071158|102140336|FG000|STARTED|Overall Study||143||
48737497|NCT04071158|102140337|FG001|STARTED|Overall Study||143||
48737498|NCT04071158|102140338|FG002|STARTED|Overall Study||143||
48737499|NCT04071158|102140339|FG003|STARTED|Overall Study||143||
48737500|NCT04071158|102140340|FG004|STARTED|Overall Study||141||
48737501|NCT04071158|102140336|FG000|Treated|Overall Study||141||
48737502|NCT04071158|102140337|FG001|Treated|Overall Study||141||
48407517|NCT01634100|101328566|FG004|Received Empa + Probenecid|Overall Study||3||
48407518|NCT01634100|101328567|FG005|Received Empa + Probenecid|Overall Study||3||
48407519|NCT01634100|101328562|FG000|COMPLETED|Overall Study||2||
48407520|NCT01634100|101328563|FG001|COMPLETED|Overall Study||3||
48407521|NCT01634100|101328564|FG002|COMPLETED|Overall Study||2||
48407522|NCT01634100|101328565|FG003|COMPLETED|Overall Study||3||
48737503|NCT04071158|102140338|FG002|Treated|Overall Study||143||
48737504|NCT04071158|102140339|FG003|Treated|Overall Study||143||
48737505|NCT04071158|102140340|FG004|Treated|Overall Study||141||
48737506|NCT04071158|102140336|FG000|Safety Population|Overall Study||141|Safety analysis set included all randomized participants who received investigational product. Participants were analyzed according to the investigational product they actually received.|
48737507|NCT04071158|102140337|FG001|Safety Population|Overall Study||141|Safety analysis set included all randomized participants who received investigational product. Participants were analyzed according to the investigational product they actually received.|
48737508|NCT04071158|102140338|FG002|Safety Population|Overall Study||142|Safety analysis set included all randomized participants who received investigational product. Participants were analyzed according to the investigational product they actually received.|
48737509|NCT04071158|102140339|FG003|Safety Population|Overall Study||144|Safety analysis set included all randomized participants who received investigational product. Participants were analyzed according to the investigational product they actually received.|
48737510|NCT04071158|102140340|FG004|Safety Population|Overall Study||141|Safety analysis set included all randomized participants who received investigational product. Participants were analyzed according to the investigational product they actually received.|
48737511|NCT04071158|102140336|FG000|COMPLETED|Overall Study||140||
48319146|NCT01140451|101107591|FG001|COMPLETED|Overall Study||54|Study completion for Study 009e was Week 100 (Total Study Week 148)|
48319147|NCT01140451|101107590|FG000|NOT COMPLETED|Overall Study||38||
48319148|NCT01140451|101107591|FG001|NOT COMPLETED|Overall Study||42||
48319149|NCT01142401|101107592|FG000|STARTED|Randomized Phase||59||
48319150|NCT01142401|101107593|FG001|STARTED|Randomized Phase||59||
48319151|NCT01142401|101107594|FG002|STARTED|Randomized Phase||0||
48319152|NCT01142401|101107592|FG000|COMPLETED|Randomized Phase||59||
48319153|NCT01142401|101107593|FG001|COMPLETED|Randomized Phase||57||
48319154|NCT01142401|101107594|FG002|COMPLETED|Randomized Phase||0||
48319155|NCT01142401|101107592|FG000|NOT COMPLETED|Randomized Phase||0||
48737512|NCT04071158|102140337|FG001|COMPLETED|Overall Study||139||
48737513|NCT04071158|102140338|FG002|COMPLETED|Overall Study||140||
48737514|NCT04071158|102140339|FG003|COMPLETED|Overall Study||140||
48737515|NCT04071158|102140340|FG004|COMPLETED|Overall Study||136||
48737516|NCT04071158|102140336|FG000|NOT COMPLETED|Overall Study||3||
48737517|NCT04071158|102140337|FG001|NOT COMPLETED|Overall Study||4||
48737518|NCT04071158|102140338|FG002|NOT COMPLETED|Overall Study||3||
48737519|NCT04071158|102140339|FG003|NOT COMPLETED|Overall Study||3||
48737520|NCT04071158|102140340|FG004|NOT COMPLETED|Overall Study||5||
48737521|NCT00465088|102140341|FG000|STARTED|Overall Study||114||
48737522|NCT00465088|102140342|FG001|STARTED|Overall Study||79||
48737523|NCT00465088|102140341|FG000|COMPLETED|Overall Study||82||
48737524|NCT00465088|102140342|FG001|COMPLETED|Overall Study||70||
48737525|NCT00465088|102140341|FG000|NOT COMPLETED|Overall Study||32||
48737526|NCT00465088|102140342|FG001|NOT COMPLETED|Overall Study||9||
48737527|NCT02462720|102140343|FG000|STARTED|Part 1||18||
48737528|NCT02462720|102140344|FG001|STARTED|Part 1||17||
48737529|NCT02462720|102140343|FG000|COMPLETED|Part 1||18||
48319156|NCT01142401|101107593|FG001|NOT COMPLETED|Randomized Phase||2||
48319157|NCT01142401|101107594|FG002|NOT COMPLETED|Randomized Phase||0||
48319158|NCT01142401|101107592|FG000|STARTED|Crossover Phase||0||
48319159|NCT01142401|101107593|FG001|STARTED|Crossover Phase||0||
48319160|NCT01142401|101107594|FG002|STARTED|Crossover Phase||27||
48319161|NCT01142401|101107592|FG000|COMPLETED|Crossover Phase||0||
48407523|NCT01634100|101328566|FG004|COMPLETED|Overall Study||3||
48737530|NCT02462720|102140344|FG001|COMPLETED|Part 1||17||
48737531|NCT02462720|102140343|FG000|NOT COMPLETED|Part 1||0||
48319162|NCT01142401|101107593|FG001|COMPLETED|Crossover Phase||0||
48319163|NCT01142401|101107594|FG002|COMPLETED|Crossover Phase||27||
48319164|NCT01142401|101107592|FG000|NOT COMPLETED|Crossover Phase||0||
48319165|NCT01142401|101107593|FG001|NOT COMPLETED|Crossover Phase||0||
48319166|NCT01142401|101107594|FG002|NOT COMPLETED|Crossover Phase||0||
48319167|NCT02289742|101107595|FG000|STARTED|First Wear Period||11||
48737532|NCT02462720|102140344|FG001|NOT COMPLETED|Part 1||0||
48319168|NCT02289742|101107596|FG001|STARTED|First Wear Period||12||
48319169|NCT02289742|101107597|FG002|STARTED|First Wear Period||12||
48319170|NCT02289742|101107598|FG003|STARTED|First Wear Period||10||
48319171|NCT02289742|101107595|FG000|Treated|First Wear Period||11||
48319172|NCT02289742|101107596|FG001|Treated|First Wear Period||11||
48319173|NCT02289742|101107597|FG002|Treated|First Wear Period||12||
48319174|NCT02289742|101107598|FG003|Treated|First Wear Period||9||
48737533|NCT02462720|102140343|FG000|STARTED|Part 2||18||
48737534|NCT02462720|102140344|FG001|STARTED|Part 2||17||
48737535|NCT02462720|102140343|FG000|COMPLETED|Part 2||17||
48737536|NCT02462720|102140344|FG001|COMPLETED|Part 2||16||
48737537|NCT02462720|102140343|FG000|NOT COMPLETED|Part 2||1||
48737538|NCT02462720|102140344|FG001|NOT COMPLETED|Part 2||1||
48319175|NCT02289742|101107595|FG000|COMPLETED|First Wear Period||11||
48319176|NCT02289742|101107596|FG001|COMPLETED|First Wear Period||11||
48319177|NCT02289742|101107597|FG002|COMPLETED|First Wear Period||11||
48319178|NCT02289742|101107598|FG003|COMPLETED|First Wear Period||9||
48319179|NCT02289742|101107595|FG000|NOT COMPLETED|First Wear Period||0||
48319180|NCT02289742|101107596|FG001|NOT COMPLETED|First Wear Period||1||
48319181|NCT02289742|101107597|FG002|NOT COMPLETED|First Wear Period||1||
48737539|NCT01331109|102140345|FG000|STARTED|Overall Study||57||
48737540|NCT01331109|102140345|FG000|COMPLETED|Overall Study||0||
48737541|NCT01331109|102140345|FG000|NOT COMPLETED|Overall Study||57||
48737542|NCT00582998|102140346|FG000|STARTED|Overall Study||119||122
48737543|NCT00582998|102140347|FG001|STARTED|Overall Study||130||141
48737544|NCT00582998|102140346|FG000|COMPLETED|Overall Study||119||122
48737545|NCT00582998|102140347|FG001|COMPLETED|Overall Study||130||141
48737546|NCT00582998|102140346|FG000|NOT COMPLETED|Overall Study||0||0
48737547|NCT00582998|102140347|FG001|NOT COMPLETED|Overall Study||0||0
48737548|NCT00939562|102140348|FG000|STARTED|Period 1||12||
48737549|NCT00939562|102140349|FG001|STARTED|Period 1||12||
48737550|NCT00939562|102140348|FG000|COMPLETED|Period 1||12||
48737551|NCT00939562|102140349|FG001|COMPLETED|Period 1||12||
48737552|NCT00939562|102140348|FG000|NOT COMPLETED|Period 1||0||
48737553|NCT00939562|102140349|FG001|NOT COMPLETED|Period 1||0||
48737554|NCT00939562|102140348|FG000|STARTED|Period 2||12||
48737555|NCT00939562|102140349|FG001|STARTED|Period 2||12||
48737556|NCT00939562|102140348|FG000|COMPLETED|Period 2||12||
48737557|NCT00939562|102140349|FG001|COMPLETED|Period 2||12||
48737558|NCT00939562|102140348|FG000|NOT COMPLETED|Period 2||0||
48737559|NCT00939562|102140349|FG001|NOT COMPLETED|Period 2||0||
48737560|NCT01865448|102140350|FG000|STARTED|Overall Study||17||
48737561|NCT01865448|102140351|FG001|STARTED|Overall Study||17||
48737562|NCT01865448|102140350|FG000|COMPLETED|Overall Study||15||
48319182|NCT02289742|101107598|FG003|NOT COMPLETED|First Wear Period||1||
48319183|NCT02289742|101107595|FG000|STARTED|Second Wear Period||11||
48319184|NCT02289742|101107596|FG001|STARTED|Second Wear Period||11||
48319185|NCT02289742|101107597|FG002|STARTED|Second Wear Period||11||
48737563|NCT01865448|102140351|FG001|COMPLETED|Overall Study||14||
48737564|NCT01865448|102140350|FG000|NOT COMPLETED|Overall Study||2||
48737565|NCT01865448|102140351|FG001|NOT COMPLETED|Overall Study||3||
48737566|NCT02363959|102140352|FG000|STARTED|Overall Study||10||
48737567|NCT02363959|102140353|FG001|STARTED|Overall Study||10||
48737568|NCT02363959|102140352|FG000|COMPLETED|Overall Study||9||
48737569|NCT02363959|102140353|FG001|COMPLETED|Overall Study||10||
48737570|NCT02363959|102140352|FG000|NOT COMPLETED|Overall Study||1||
48737571|NCT02363959|102140353|FG001|NOT COMPLETED|Overall Study||0||
48737572|NCT00630344|102140354|FG000|STARTED|Overall Study||36||
48737573|NCT00630344|102140354|FG000|COMPLETED|Overall Study||0||
48737574|NCT00630344|102140354|FG000|NOT COMPLETED|Overall Study||36||
48737575|NCT03221842|102140355|FG000|STARTED|Period 1 (Open-label)||63||
48737576|NCT03221842|102140356|FG001|STARTED|Period 1 (Open-label)||0||
48737577|NCT03221842|102140355|FG000|COMPLETED|Period 1 (Open-label)||53||
48737578|NCT03221842|102140356|FG001|COMPLETED|Period 1 (Open-label)||0||
48737579|NCT03221842|102140355|FG000|NOT COMPLETED|Period 1 (Open-label)||10||
48737580|NCT03221842|102140356|FG001|NOT COMPLETED|Period 1 (Open-label)||0||
48737581|NCT03221842|102140355|FG000|STARTED|Period 2 (Randomized, Blinded)||7||
48737582|NCT03221842|102140356|FG001|STARTED|Period 2 (Randomized, Blinded)||6||
48737583|NCT03221842|102140355|FG000|COMPLETED|Period 2 (Randomized, Blinded)||6||
48319186|NCT02289742|101107598|FG003|STARTED|Second Wear Period||9||
48319187|NCT02289742|101107595|FG000|COMPLETED|Second Wear Period||11||
48319188|NCT02289742|101107596|FG001|COMPLETED|Second Wear Period||11||
48319189|NCT02289742|101107597|FG002|COMPLETED|Second Wear Period||11||
48737584|NCT03221842|102140356|FG001|COMPLETED|Period 2 (Randomized, Blinded)||5||
48737585|NCT03221842|102140355|FG000|NOT COMPLETED|Period 2 (Randomized, Blinded)||1||
48737586|NCT03221842|102140356|FG001|NOT COMPLETED|Period 2 (Randomized, Blinded)||1||
48737587|NCT00548145|102140357|FG000|STARTED|Overall Study||18||
48737588|NCT00548145|102140358|FG001|STARTED|Overall Study||20||
48737589|NCT00548145|102140357|FG000|COMPLETED|Overall Study||17||
48737590|NCT00548145|102140358|FG001|COMPLETED|Overall Study||16||
48737591|NCT00548145|102140357|FG000|NOT COMPLETED|Overall Study||1||
48737592|NCT00548145|102140358|FG001|NOT COMPLETED|Overall Study||4||
48737593|NCT00386243|102140359|FG000|STARTED|Overall Study||121||
48737594|NCT00386243|102140360|FG001|STARTED|Overall Study||121||
48319190|NCT02289742|101107598|FG003|COMPLETED|Second Wear Period||9||
48319191|NCT02289742|101107595|FG000|NOT COMPLETED|Second Wear Period||0||
48319192|NCT02289742|101107596|FG001|NOT COMPLETED|Second Wear Period||0||
48737595|NCT00386243|102140359|FG000|COMPLETED|Overall Study||114||
48737596|NCT00386243|102140360|FG001|COMPLETED|Overall Study||108||
48737597|NCT00386243|102140359|FG000|NOT COMPLETED|Overall Study||7||
48737598|NCT00386243|102140360|FG001|NOT COMPLETED|Overall Study||13||
48160636|NCT00691808|100715897|FG000|COMPLETED|Overall Study||35||
48160637|NCT00691808|100715898|FG001|COMPLETED|Overall Study||35||
48160638|NCT00691808|100715899|FG002|COMPLETED|Overall Study||32||
48160639|NCT00691808|100715897|FG000|NOT COMPLETED|Overall Study||0||
48160640|NCT00691808|100715898|FG001|NOT COMPLETED|Overall Study||1||
48160641|NCT00691808|100715899|FG002|NOT COMPLETED|Overall Study||0||
48319193|NCT02289742|101107597|FG002|NOT COMPLETED|Second Wear Period||0||
48319194|NCT02289742|101107598|FG003|NOT COMPLETED|Second Wear Period||0||
48319195|NCT02289742|101107595|FG000|STARTED|Third Wear Period||11||
48319196|NCT02289742|101107596|FG001|STARTED|Third Wear Period||11||
48319197|NCT02289742|101107597|FG002|STARTED|Third Wear Period||11||
48319198|NCT02289742|101107598|FG003|STARTED|Third Wear Period||9||
48616349|NCT02326272|101845091|FG000|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0||
48616350|NCT02326272|101845092|FG001|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0||
48616351|NCT02326272|101845093|FG002|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0||
48616352|NCT02326272|101845094|FG003|Completed Week 48|Maintenance Period (Week 16 to Week 48)||5||
48616353|NCT02326272|101845095|FG004|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3||
48616354|NCT02326272|101845096|FG005|Completed Week 48|Maintenance Period (Week 16 to Week 48)||64||
48616355|NCT02326272|101845097|FG006|Completed Week 48|Maintenance Period (Week 16 to Week 48)||61||
48616356|NCT02326272|101845098|FG007|Completed Week 48|Maintenance Period (Week 16 to Week 48)||27||
48616357|NCT02326272|101845099|FG008|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3||
48616358|NCT02326272|101845100|FG009|Completed Week 48|Maintenance Period (Week 16 to Week 48)||10||
48616359|NCT02326272|101845101|FG010|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0||
48616360|NCT02326272|101845102|FG011|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0||
48616361|NCT02326272|101845103|FG012|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0||
48616362|NCT02326272|101845104|FG013|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0||
48616363|NCT02326272|101845105|FG014|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0||
48616364|NCT02326272|101845091|FG000|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
48616365|NCT02326272|101845092|FG001|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
48616366|NCT02326272|101845093|FG002|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
48737599|NCT00851279|102140361|FG000|STARTED|Overall Study||53||
48737600|NCT00851279|102140361|FG000|COMPLETED|Overall Study||53||
48737601|NCT00851279|102140361|FG000|NOT COMPLETED|Overall Study||0||
48737602|NCT02774148|102140362|FG000|STARTED|Overall Study||0||
48737603|NCT02774148|102140363|FG001|STARTED|Overall Study||0||
48737604|NCT02774148|102140362|FG000|COMPLETED|Overall Study||0||
48737605|NCT02774148|102140363|FG001|COMPLETED|Overall Study||0||
48737606|NCT02774148|102140362|FG000|NOT COMPLETED|Overall Study||0||
48737607|NCT02774148|102140363|FG001|NOT COMPLETED|Overall Study||0||
48737608|NCT00381693|102140364|FG000|STARTED|Overall Study||10||
48737609|NCT00381693|102140364|FG000|COMPLETED|Overall Study||2||
48737610|NCT00381693|102140364|FG000|NOT COMPLETED|Overall Study||8||
48737611|NCT03071393|102140365|FG000|STARTED|First Intervention (Single Day Session)||7||
48737612|NCT03071393|102140366|FG001|STARTED|First Intervention (Single Day Session)||10||
48737613|NCT03071393|102140365|FG000|COMPLETED|First Intervention (Single Day Session)||7||
48737614|NCT03071393|102140366|FG001|COMPLETED|First Intervention (Single Day Session)||10||
48737615|NCT03071393|102140365|FG000|NOT COMPLETED|First Intervention (Single Day Session)||0||
48737616|NCT03071393|102140366|FG001|NOT COMPLETED|First Intervention (Single Day Session)||0||
48737617|NCT03071393|102140365|FG000|STARTED|Washout (at Least 7 Days)||7||
48737618|NCT03071393|102140366|FG001|STARTED|Washout (at Least 7 Days)||10||
48737619|NCT03071393|102140365|FG000|COMPLETED|Washout (at Least 7 Days)||7||
48160642|NCT04043962|100715900|FG000|STARTED|Baseline||85||
48160643|NCT04043962|100715900|FG000|COMPLETED|Baseline||85||
48160644|NCT04043962|100715900|FG000|NOT COMPLETED|Baseline||0||
48160645|NCT04043962|100715900|FG000|STARTED|Post-Treatment||85||
48160646|NCT04043962|100715900|FG000|COMPLETED|Post-Treatment||77||
48319199|NCT02289742|101107595|FG000|COMPLETED|Third Wear Period||11||
48319200|NCT02289742|101107596|FG001|COMPLETED|Third Wear Period||10||
48319201|NCT02289742|101107597|FG002|COMPLETED|Third Wear Period||11||
48319202|NCT02289742|101107598|FG003|COMPLETED|Third Wear Period||8||
48319203|NCT02289742|101107595|FG000|NOT COMPLETED|Third Wear Period||0||
48319204|NCT02289742|101107596|FG001|NOT COMPLETED|Third Wear Period||1||
48319205|NCT02289742|101107597|FG002|NOT COMPLETED|Third Wear Period||0||
48319206|NCT02289742|101107598|FG003|NOT COMPLETED|Third Wear Period||1||
48319207|NCT03024970|101107599|FG000|STARTED|First Intervention||34||
48319208|NCT03024970|101107600|FG001|STARTED|First Intervention||38||
48319209|NCT03024970|101107599|FG000|COMPLETED|First Intervention||33||
48319210|NCT03024970|101107600|FG001|COMPLETED|First Intervention||38||
48407524|NCT01634100|101328567|FG005|COMPLETED|Overall Study||3||
48407525|NCT01634100|101328562|FG000|NOT COMPLETED|Overall Study||1||
48407526|NCT01634100|101328563|FG001|NOT COMPLETED|Overall Study||0||
48407527|NCT01634100|101328564|FG002|NOT COMPLETED|Overall Study||1||
48407528|NCT01634100|101328565|FG003|NOT COMPLETED|Overall Study||0||
48407529|NCT01634100|101328566|FG004|NOT COMPLETED|Overall Study||0||
48407530|NCT01634100|101328567|FG005|NOT COMPLETED|Overall Study||0||
48407531|NCT03938636|101328568|FG000|STARTED|Overall Study||44||
48407532|NCT03938636|101328569|FG001|STARTED|Overall Study||41||
48407533|NCT03938636|101328570|FG002|STARTED|Overall Study||31||
48407534|NCT03938636|101328568|FG000|COMPLETED|Overall Study||44||
48407535|NCT03938636|101328569|FG001|COMPLETED|Overall Study||38||
48407536|NCT03938636|101328570|FG002|COMPLETED|Overall Study||28||
48407537|NCT03938636|101328568|FG000|NOT COMPLETED|Overall Study||0||
48407538|NCT03938636|101328569|FG001|NOT COMPLETED|Overall Study||3||
48407539|NCT03938636|101328570|FG002|NOT COMPLETED|Overall Study||3||
48407540|NCT00790218|101328571|FG000|STARTED|Overall Study||6||
48407541|NCT00790218|101328572|FG001|STARTED|Overall Study||6||
48407542|NCT00790218|101328573|FG002|STARTED|Overall Study||7||
48407543|NCT00790218|101328571|FG000|COMPLETED|Overall Study||5||
48407544|NCT00790218|101328572|FG001|COMPLETED|Overall Study||6||
48407545|NCT00790218|101328573|FG002|COMPLETED|Overall Study||7||
48737620|NCT03071393|102140366|FG001|COMPLETED|Washout (at Least 7 Days)||10||
48737621|NCT03071393|102140365|FG000|NOT COMPLETED|Washout (at Least 7 Days)||0||
48737622|NCT03071393|102140366|FG001|NOT COMPLETED|Washout (at Least 7 Days)||0||
48737623|NCT03071393|102140365|FG000|STARTED|Intervention 2 (Single Day Session)||7||
48737624|NCT03071393|102140366|FG001|STARTED|Intervention 2 (Single Day Session)||10||
48737625|NCT03071393|102140365|FG000|COMPLETED|Intervention 2 (Single Day Session)||7||
48737626|NCT03071393|102140366|FG001|COMPLETED|Intervention 2 (Single Day Session)||10||
48737627|NCT03071393|102140365|FG000|NOT COMPLETED|Intervention 2 (Single Day Session)||0||
48737628|NCT03071393|102140366|FG001|NOT COMPLETED|Intervention 2 (Single Day Session)||0||
48737629|NCT04829916|102140367|FG000|STARTED|Overall Study||8||
48737630|NCT04829916|102140368|FG001|STARTED|Overall Study||4||
48737631|NCT04829916|102140367|FG000|COMPLETED|Overall Study||7||
48737632|NCT04829916|102140368|FG001|COMPLETED|Overall Study||4||
48737633|NCT04829916|102140367|FG000|NOT COMPLETED|Overall Study||1||
48737634|NCT04829916|102140368|FG001|NOT COMPLETED|Overall Study||0||
48737635|NCT00637416|102140369|FG000|STARTED|Overall Study||4||
48737636|NCT00637416|102140370|FG001|STARTED|Overall Study||5||
48737637|NCT00637416|102140369|FG000|COMPLETED|Overall Study||3||
48737638|NCT00637416|102140370|FG001|COMPLETED|Overall Study||3||
48737639|NCT00637416|102140369|FG000|NOT COMPLETED|Overall Study||1||
48737640|NCT00637416|102140370|FG001|NOT COMPLETED|Overall Study||2||
48737641|NCT03614325|102140371|FG000|STARTED|Overall Study||20||
48319211|NCT03024970|101107599|FG000|NOT COMPLETED|First Intervention||1||
48319212|NCT03024970|101107600|FG001|NOT COMPLETED|First Intervention||0||
48319213|NCT03024970|101107599|FG000|STARTED|Second Intervention||33||
48319214|NCT03024970|101107600|FG001|STARTED|Second Intervention||38||
48319215|NCT03024970|101107599|FG000|COMPLETED|Second Intervention||32||
48319216|NCT03024970|101107600|FG001|COMPLETED|Second Intervention||38||
48319217|NCT03024970|101107599|FG000|NOT COMPLETED|Second Intervention||1||
48319218|NCT03024970|101107600|FG001|NOT COMPLETED|Second Intervention||0||
48407546|NCT00790218|101328571|FG000|NOT COMPLETED|Overall Study||1||
48407547|NCT00790218|101328572|FG001|NOT COMPLETED|Overall Study||0||
48407548|NCT00790218|101328573|FG002|NOT COMPLETED|Overall Study||0||
48407549|NCT03993119|101328574|FG000|STARTED|Overall Study||192||
48737642|NCT03614325|102140372|FG001|STARTED|Overall Study||20||
48737643|NCT03614325|102140371|FG000|Completed Intervention|Overall Study||17||
48737644|NCT03614325|102140372|FG001|Completed Intervention|Overall Study||17||
48737645|NCT03614325|102140371|FG000|COMPLETED|Overall Study||15||
48737646|NCT03614325|102140372|FG001|COMPLETED|Overall Study||16||
48737647|NCT03614325|102140371|FG000|NOT COMPLETED|Overall Study||5||
48737648|NCT03614325|102140372|FG001|NOT COMPLETED|Overall Study||4||
48319219|NCT01206062|101107601|FG000|STARTED|Overall Study||4678||
48319220|NCT01206062|101107602|FG001|STARTED|Overall Study||4683||
48319221|NCT01206062|101107601|FG000|COMPLETED|Overall Study||4678||
48319222|NCT01206062|101107602|FG001|COMPLETED|Overall Study||4683||
48319223|NCT01206062|101107601|FG000|NOT COMPLETED|Overall Study||0||
48319224|NCT01206062|101107602|FG001|NOT COMPLETED|Overall Study||0||
48319225|NCT00562354|101107603|FG000|STARTED|Overall Study||134||
48319226|NCT00562354|101107604|FG001|STARTED|Overall Study||137||
48319227|NCT00562354|101107603|FG000|Received Study Treatment|Overall Study||134||
48319228|NCT00562354|101107604|FG001|Received Study Treatment|Overall Study||136||
48407550|NCT03993119|101328575|FG001|STARTED|Overall Study||76||
48407551|NCT03993119|101328576|FG002|STARTED|Overall Study||166||
48737649|NCT01991522|102140373|FG000|STARTED|Overall Study||16||
48319229|NCT00562354|101107603|FG000|Evaluable Immunogenicity Population|Overall Study||134||
48319230|NCT00562354|101107604|FG001|Evaluable Immunogenicity Population|Overall Study||134||
48319231|NCT00562354|101107603|FG000|COMPLETED|Overall Study||134||
48319232|NCT00562354|101107604|FG001|COMPLETED|Overall Study||135||
48160647|NCT04043962|100715900|FG000|NOT COMPLETED|Post-Treatment||8||
48160648|NCT04043962|100715900|FG000|STARTED|Follow-up||80||
48160649|NCT04043962|100715900|FG000|COMPLETED|Follow-up||73||
48160650|NCT04043962|100715900|FG000|NOT COMPLETED|Follow-up||7||
48160651|NCT03921190|100715901|FG000|STARTED|Overall Study||56||
48160652|NCT03921190|100715902|FG001|STARTED|Overall Study||64||
48160653|NCT03921190|100715901|FG000|COMPLETED|Overall Study||56||
48160654|NCT03921190|100715902|FG001|COMPLETED|Overall Study||64||
48616367|NCT02326272|101845094|FG003|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||5||
48616368|NCT02326272|101845095|FG004|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3||
48616369|NCT02326272|101845096|FG005|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||63||
48319233|NCT00562354|101107603|FG000|NOT COMPLETED|Overall Study||0||
48160655|NCT03921190|100715901|FG000|NOT COMPLETED|Overall Study||0||
48160656|NCT03921190|100715902|FG001|NOT COMPLETED|Overall Study||0||
48160657|NCT00514943|100715903|FG000|STARTED|Stage 1||62||
48160658|NCT00514943|100715904|FG001|STARTED|Stage 1||62||
48160659|NCT00514943|100715903|FG000|COMPLETED|Stage 1||32||
48160660|NCT00514943|100715904|FG001|COMPLETED|Stage 1||36||
48160661|NCT00514943|100715903|FG000|NOT COMPLETED|Stage 1||30||
48160662|NCT00514943|100715904|FG001|NOT COMPLETED|Stage 1||26||
48160663|NCT00514943|100715903|FG000|STARTED|Stage 2||32||
48160664|NCT00514943|100715904|FG001|STARTED|Stage 2||36||
48160665|NCT00514943|100715903|FG000|COMPLETED|Stage 2||0||
48160666|NCT00514943|100715904|FG001|COMPLETED|Stage 2||0||
48160667|NCT00514943|100715903|FG000|NOT COMPLETED|Stage 2||32||
48160668|NCT00514943|100715904|FG001|NOT COMPLETED|Stage 2||36||
48319234|NCT00562354|101107604|FG001|NOT COMPLETED|Overall Study||2||
48319235|NCT02189161|101107605|FG000|STARTED|Overall Study||10||
48319236|NCT02189161|101107605|FG000|COMPLETED|Overall Study||10||
48319237|NCT02189161|101107605|FG000|NOT COMPLETED|Overall Study||0||
48319238|NCT01556425|101107606|FG000|STARTED|Overall Study||25||
48407552|NCT03993119|101328577|FG003|STARTED|Overall Study||66||
48616370|NCT02326272|101845097|FG006|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||60||
48616371|NCT02326272|101845098|FG007|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||27||
48616372|NCT02326272|101845099|FG008|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3||
48616373|NCT02326272|101845100|FG009|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||10||
48616374|NCT02326272|101845101|FG010|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
48616375|NCT02326272|101845102|FG011|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
48616376|NCT02326272|101845103|FG012|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
48616377|NCT02326272|101845104|FG013|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
48737650|NCT01991522|102140374|FG001|STARTED|Overall Study||17||
48737651|NCT01991522|102140373|FG000|COMPLETED|Overall Study||16||
48737652|NCT01991522|102140374|FG001|COMPLETED|Overall Study||17||
48319239|NCT01556425|101107607|FG001|STARTED|Overall Study||23||
48160669|NCT02401464|100715905|FG000|STARTED|Intervention Period 1 (6 Days)||13||
48160670|NCT02401464|100715906|FG001|STARTED|Intervention Period 1 (6 Days)||13||
48160671|NCT02401464|100715907|FG002|STARTED|Intervention Period 1 (6 Days)||13||
48160672|NCT02401464|100715908|FG003|STARTED|Intervention Period 1 (6 Days)||13||
48160673|NCT02401464|100715905|FG000|COMPLETED|Intervention Period 1 (6 Days)||13||
48160674|NCT02401464|100715906|FG001|COMPLETED|Intervention Period 1 (6 Days)||13||
48160675|NCT02401464|100715907|FG002|COMPLETED|Intervention Period 1 (6 Days)||13||
48160676|NCT02401464|100715908|FG003|COMPLETED|Intervention Period 1 (6 Days)||13||
48160677|NCT02401464|100715905|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0||
48160678|NCT02401464|100715906|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0||
48160679|NCT02401464|100715907|FG002|NOT COMPLETED|Intervention Period 1 (6 Days)||0||
48160680|NCT02401464|100715908|FG003|NOT COMPLETED|Intervention Period 1 (6 Days)||0||
48160681|NCT02401464|100715905|FG000|STARTED|Washout Period (At Least 6 Days)||13||
48160682|NCT02401464|100715906|FG001|STARTED|Washout Period (At Least 6 Days)||13||
48319240|NCT01556425|101107608|FG002|STARTED|Overall Study||18||
48319241|NCT01556425|101107609|FG003|STARTED|Overall Study||18||
48319242|NCT01556425|101107606|FG000|COMPLETED|Overall Study||25||
48319243|NCT01556425|101107607|FG001|COMPLETED|Overall Study||23||
48160683|NCT02401464|100715907|FG002|STARTED|Washout Period (At Least 6 Days)||13||
48160684|NCT02401464|100715908|FG003|STARTED|Washout Period (At Least 6 Days)||13||
48160685|NCT02401464|100715905|FG000|COMPLETED|Washout Period (At Least 6 Days)||13||
48160686|NCT02401464|100715906|FG001|COMPLETED|Washout Period (At Least 6 Days)||13||
48160687|NCT02401464|100715907|FG002|COMPLETED|Washout Period (At Least 6 Days)||13||
48160688|NCT02401464|100715908|FG003|COMPLETED|Washout Period (At Least 6 Days)||13||
48160689|NCT02401464|100715905|FG000|NOT COMPLETED|Washout Period (At Least 6 Days)||0||
48160690|NCT02401464|100715906|FG001|NOT COMPLETED|Washout Period (At Least 6 Days)||0||
48319244|NCT01556425|101107608|FG002|COMPLETED|Overall Study||18||
48319245|NCT01556425|101107609|FG003|COMPLETED|Overall Study||18||
48319246|NCT01556425|101107606|FG000|NOT COMPLETED|Overall Study||0||
48319247|NCT01556425|101107607|FG001|NOT COMPLETED|Overall Study||0||
48319248|NCT01556425|101107608|FG002|NOT COMPLETED|Overall Study||0||
48319249|NCT01556425|101107609|FG003|NOT COMPLETED|Overall Study||0||
48407553|NCT03993119|101328574|FG000|COMPLETED|Overall Study||192||
48407554|NCT03993119|101328575|FG001|COMPLETED|Overall Study||76||
48407555|NCT03993119|101328576|FG002|COMPLETED|Overall Study||166||
48160691|NCT02401464|100715907|FG002|NOT COMPLETED|Washout Period (At Least 6 Days)||0||
48160692|NCT02401464|100715908|FG003|NOT COMPLETED|Washout Period (At Least 6 Days)||0||
48160693|NCT02401464|100715905|FG000|STARTED|Intervention Period 2 (6 Days)||13||
48160694|NCT02401464|100715906|FG001|STARTED|Intervention Period 2 (6 Days)||13||
48160695|NCT02401464|100715907|FG002|STARTED|Intervention Period 2 (6 Days)||13||
48319250|NCT01265797|101107610|FG000|STARTED|Run-in Month||34||
48319251|NCT01265797|101107611|FG001|STARTED|Run-in Month||34||
48319252|NCT01265797|101107610|FG000|COMPLETED|Run-in Month||34||
48319253|NCT01265797|101107611|FG001|COMPLETED|Run-in Month||29||
48319254|NCT01265797|101107610|FG000|NOT COMPLETED|Run-in Month||0||
48319255|NCT01265797|101107611|FG001|NOT COMPLETED|Run-in Month||5||
48319256|NCT01265797|101107610|FG000|STARTED|Blinded Month||34||
48319257|NCT01265797|101107611|FG001|STARTED|Blinded Month||29||
48319258|NCT01265797|101107610|FG000|COMPLETED|Blinded Month||24||
48319259|NCT01265797|101107611|FG001|COMPLETED|Blinded Month||27||
48319260|NCT01265797|101107610|FG000|NOT COMPLETED|Blinded Month||10||
48319261|NCT01265797|101107611|FG001|NOT COMPLETED|Blinded Month||2||
48319262|NCT01265797|101107610|FG000|STARTED|Open Label Month||24||
48319263|NCT01265797|101107611|FG001|STARTED|Open Label Month||27||
48319264|NCT01265797|101107610|FG000|COMPLETED|Open Label Month||24||
48319265|NCT01265797|101107611|FG001|COMPLETED|Open Label Month||26||
48319266|NCT01265797|101107610|FG000|NOT COMPLETED|Open Label Month||0||
48319267|NCT01265797|101107611|FG001|NOT COMPLETED|Open Label Month||1||
48319268|NCT03882970|101107612|FG000|STARTED|Overall Study||359||
48319269|NCT03882970|101107613|FG001|STARTED|Overall Study||361||
48407556|NCT03993119|101328577|FG003|COMPLETED|Overall Study||66||
48407557|NCT03993119|101328574|FG000|NOT COMPLETED|Overall Study||0||
48407558|NCT03993119|101328575|FG001|NOT COMPLETED|Overall Study||0||
48407559|NCT03993119|101328576|FG002|NOT COMPLETED|Overall Study||0||
48407560|NCT03993119|101328577|FG003|NOT COMPLETED|Overall Study||0||
48407561|NCT00608244|101328578|FG000|STARTED|Overall Study||59||
48407562|NCT00608244|101328578|FG000|COMPLETED|Overall Study||57||
48319270|NCT03882970|101107614|FG002|STARTED|Overall Study||359||
48319271|NCT03882970|101107615|FG003|STARTED|Overall Study||365||
48319272|NCT03882970|101107612|FG000|Received at Least One Dose of Study Drug|Overall Study||358||
48319273|NCT03882970|101107613|FG001|Received at Least One Dose of Study Drug|Overall Study||360||
48319274|NCT03882970|101107614|FG002|Received at Least One Dose of Study Drug|Overall Study||359||
48319275|NCT03882970|101107615|FG003|Received at Least One Dose of Study Drug|Overall Study||360||
48319276|NCT03882970|101107612|FG000|COMPLETED|Overall Study||333||
48319277|NCT03882970|101107613|FG001|COMPLETED|Overall Study||321||
48319278|NCT03882970|101107614|FG002|COMPLETED|Overall Study||340||
48319279|NCT03882970|101107615|FG003|COMPLETED|Overall Study||331||
48319280|NCT03882970|101107612|FG000|NOT COMPLETED|Overall Study||26||
48319281|NCT03882970|101107613|FG001|NOT COMPLETED|Overall Study||40||
48319282|NCT03882970|101107614|FG002|NOT COMPLETED|Overall Study||19||
48319283|NCT03882970|101107615|FG003|NOT COMPLETED|Overall Study||34||
48319284|NCT00919100|101107616|FG000|STARTED|Overall Study||40||
48319285|NCT00919100|101107617|FG001|STARTED|Overall Study||41||
48319286|NCT00919100|101107616|FG000|COMPLETED|Overall Study||40||
48319287|NCT00919100|101107617|FG001|COMPLETED|Overall Study||41||
48319288|NCT00919100|101107616|FG000|NOT COMPLETED|Overall Study||0||
48319289|NCT00919100|101107617|FG001|NOT COMPLETED|Overall Study||0||
48319290|NCT00760019|101107618|FG000|STARTED|Overall Study||15||
48319291|NCT00760019|101107619|FG001|STARTED|Overall Study||15||
48319292|NCT00760019|101107620|FG002|STARTED|Overall Study||14||
48319293|NCT00760019|101107621|FG003|STARTED|Overall Study||14||
48319294|NCT00760019|101107618|FG000|COMPLETED|Overall Study||15||
48319295|NCT00760019|101107619|FG001|COMPLETED|Overall Study||15||
48319296|NCT00760019|101107620|FG002|COMPLETED|Overall Study||14||
48319297|NCT00760019|101107621|FG003|COMPLETED|Overall Study||14||
48319298|NCT00760019|101107618|FG000|NOT COMPLETED|Overall Study||0||
48407563|NCT00608244|101328578|FG000|NOT COMPLETED|Overall Study||2||
48407564|NCT03144089|101328579|FG000|STARTED|Overall Study||28||
48407565|NCT03144089|101328580|FG001|STARTED|Overall Study||28||
48407566|NCT03144089|101328579|FG000|COMPLETED|Overall Study||28||
48319299|NCT00760019|101107619|FG001|NOT COMPLETED|Overall Study||0||
48319300|NCT00760019|101107620|FG002|NOT COMPLETED|Overall Study||0||
48319301|NCT00760019|101107621|FG003|NOT COMPLETED|Overall Study||0||
48319302|NCT02554019|101107622|FG000|STARTED|Overall Study||12||
48319303|NCT02554019|101107623|FG001|STARTED|Overall Study||12||
48319304|NCT02554019|101107624|FG002|STARTED|Overall Study||12||
48319305|NCT02554019|101107622|FG000|COMPLETED|Overall Study||10||
48319306|NCT02554019|101107623|FG001|COMPLETED|Overall Study||12||
48319307|NCT02554019|101107624|FG002|COMPLETED|Overall Study||10||
48319308|NCT02554019|101107622|FG000|NOT COMPLETED|Overall Study||2||
48319309|NCT02554019|101107623|FG001|NOT COMPLETED|Overall Study||0||
48319310|NCT02554019|101107624|FG002|NOT COMPLETED|Overall Study||2||
48407567|NCT03144089|101328580|FG001|COMPLETED|Overall Study||28||
48407568|NCT03144089|101328579|FG000|NOT COMPLETED|Overall Study||0||
48407569|NCT03144089|101328580|FG001|NOT COMPLETED|Overall Study||0||
48319311|NCT01848288|101107625|FG000|STARTED|Overall Study||100||
48319312|NCT01848288|101107625|FG000|COMPLETED|Overall Study||97||
48319313|NCT01848288|101107625|FG000|NOT COMPLETED|Overall Study||3||
48319314|NCT01925573|101107626|FG000|STARTED|Overall Study||7||
48319315|NCT01925573|101107626|FG000|COMPLETED|Overall Study||0||
48319316|NCT01925573|101107626|FG000|NOT COMPLETED|Overall Study||7||
48319317|NCT00606320|101107627|FG000|STARTED|Overall Study||59||
48319318|NCT00606320|101107627|FG000|COMPLETED|Overall Study||22||
48319319|NCT00606320|101107627|FG000|NOT COMPLETED|Overall Study||37||
48319320|NCT03784079|101107628|FG000|STARTED|Part 1: Up to Day 24||6||
48319321|NCT03784079|101107629|FG001|STARTED|Part 1: Up to Day 24||6||
48319322|NCT03784079|101107630|FG002|STARTED|Part 1: Up to Day 24||2||
48319323|NCT03784079|101107631|FG003|STARTED|Part 1: Up to Day 24||0||
48319324|NCT03784079|101107632|FG004|STARTED|Part 1: Up to Day 24||0||
48319325|NCT03784079|101107633|FG005|STARTED|Part 1: Up to Day 24||0||
48319326|NCT03784079|101107634|FG006|STARTED|Part 1: Up to Day 24||0||
48319327|NCT03784079|101107628|FG000|COMPLETED|Part 1: Up to Day 24||6||
48319328|NCT03784079|101107629|FG001|COMPLETED|Part 1: Up to Day 24||6||
48319329|NCT03784079|101107630|FG002|COMPLETED|Part 1: Up to Day 24||2||
48319330|NCT03784079|101107631|FG003|COMPLETED|Part 1: Up to Day 24||0||
48319331|NCT03784079|101107632|FG004|COMPLETED|Part 1: Up to Day 24||0||
48319332|NCT03784079|101107633|FG005|COMPLETED|Part 1: Up to Day 24||0||
48319333|NCT03784079|101107634|FG006|COMPLETED|Part 1: Up to Day 24||0||
48319334|NCT03784079|101107628|FG000|NOT COMPLETED|Part 1: Up to Day 24||0||
48319335|NCT03784079|101107629|FG001|NOT COMPLETED|Part 1: Up to Day 24||0||
48319336|NCT03784079|101107630|FG002|NOT COMPLETED|Part 1: Up to Day 24||0||
48319337|NCT03784079|101107631|FG003|NOT COMPLETED|Part 1: Up to Day 24||0||
48319338|NCT03784079|101107632|FG004|NOT COMPLETED|Part 1: Up to Day 24||0||
48319339|NCT03784079|101107633|FG005|NOT COMPLETED|Part 1: Up to Day 24||0||
48319340|NCT03784079|101107634|FG006|NOT COMPLETED|Part 1: Up to Day 24||0||
48319341|NCT03784079|101107628|FG000|STARTED|Part 2: Up to Day 12||0||
48319342|NCT03784079|101107629|FG001|STARTED|Part 2: Up to Day 12||0||
48319343|NCT03784079|101107630|FG002|STARTED|Part 2: Up to Day 12||0||
48319344|NCT03784079|101107631|FG003|STARTED|Part 2: Up to Day 12||6||
48319345|NCT03784079|101107632|FG004|STARTED|Part 2: Up to Day 12||6||
48319346|NCT03784079|101107633|FG005|STARTED|Part 2: Up to Day 12||6||
48319347|NCT03784079|101107634|FG006|STARTED|Part 2: Up to Day 12||2||
48319348|NCT03784079|101107628|FG000|COMPLETED|Part 2: Up to Day 12||0||
48319349|NCT03784079|101107629|FG001|COMPLETED|Part 2: Up to Day 12||0||
48319350|NCT03784079|101107630|FG002|COMPLETED|Part 2: Up to Day 12||0||
48319351|NCT03784079|101107631|FG003|COMPLETED|Part 2: Up to Day 12||6||
48319352|NCT03784079|101107632|FG004|COMPLETED|Part 2: Up to Day 12||6||
48319353|NCT03784079|101107633|FG005|COMPLETED|Part 2: Up to Day 12||6||
48407570|NCT01975376|101328581|FG000|STARTED|Overall Study||8390||
48407571|NCT01975376|101328582|FG001|STARTED|Overall Study||8394||
48407572|NCT01975376|101328581|FG000|Treated|Overall Study||8374||
48407573|NCT01975376|101328582|FG001|Treated|Overall Study||8386||
48407574|NCT01975376|101328581|FG000|COMPLETED|Overall Study||8164||
48407575|NCT01975376|101328582|FG001|COMPLETED|Overall Study||8177||
48407576|NCT01975376|101328581|FG000|NOT COMPLETED|Overall Study||226||
48407577|NCT01975376|101328582|FG001|NOT COMPLETED|Overall Study||217||
48407578|NCT02640755|101328583|FG000|STARTED|Single Dose Period (Day 1 - 8)||3||
48407579|NCT02640755|101328584|FG001|STARTED|Single Dose Period (Day 1 - 8)||1||
48319354|NCT03784079|101107634|FG006|COMPLETED|Part 2: Up to Day 12||2||
48319355|NCT03784079|101107628|FG000|NOT COMPLETED|Part 2: Up to Day 12||0||
48319356|NCT03784079|101107629|FG001|NOT COMPLETED|Part 2: Up to Day 12||0||
48319357|NCT03784079|101107630|FG002|NOT COMPLETED|Part 2: Up to Day 12||0||
48319358|NCT03784079|101107631|FG003|NOT COMPLETED|Part 2: Up to Day 12||0||
48319359|NCT03784079|101107632|FG004|NOT COMPLETED|Part 2: Up to Day 12||0||
48319360|NCT03784079|101107633|FG005|NOT COMPLETED|Part 2: Up to Day 12||0||
48319361|NCT03784079|101107634|FG006|NOT COMPLETED|Part 2: Up to Day 12||0||
48407580|NCT02640755|101328583|FG000|COMPLETED|Single Dose Period (Day 1 - 8)||3||
48407581|NCT02640755|101328584|FG001|COMPLETED|Single Dose Period (Day 1 - 8)||1||
48319362|NCT00255970|101107635|FG000|STARTED|Overall Study||21||
48319363|NCT00255970|101107636|FG001|STARTED|Overall Study||19||
48319364|NCT00255970|101107635|FG000|Screening Visit|Overall Study||21||
48319365|NCT00255970|101107636|FG001|Screening Visit|Overall Study||19||
48319366|NCT00255970|101107635|FG000|Final Visit Week 24|Overall Study||21||
48319367|NCT00255970|101107636|FG001|Final Visit Week 24|Overall Study||19||
48319368|NCT00255970|101107635|FG000|COMPLETED|Overall Study||21||
48319369|NCT00255970|101107636|FG001|COMPLETED|Overall Study||19||
48319370|NCT00255970|101107635|FG000|NOT COMPLETED|Overall Study||0||
48319371|NCT00255970|101107636|FG001|NOT COMPLETED|Overall Study||0||
48319372|NCT03743311|101107637|FG000|STARTED|Overall Study||311||
48319373|NCT03743311|101107638|FG001|STARTED|Overall Study||298||
48319374|NCT03743311|101107639|FG002|STARTED|Overall Study||423||
48319375|NCT03743311|101107637|FG000|COMPLETED|Overall Study||311||
48319376|NCT03743311|101107638|FG001|COMPLETED|Overall Study||298||
48319377|NCT03743311|101107639|FG002|COMPLETED|Overall Study||423||
48319378|NCT03743311|101107637|FG000|NOT COMPLETED|Overall Study||0||
48319379|NCT03743311|101107638|FG001|NOT COMPLETED|Overall Study||0||
48319380|NCT03743311|101107639|FG002|NOT COMPLETED|Overall Study||0||
48319381|NCT00761514|101107640|FG000|STARTED|Overall Study||14||
48319382|NCT00761514|101107640|FG000|COMPLETED|Overall Study||7||
48319383|NCT00761514|101107640|FG000|NOT COMPLETED|Overall Study||7||
48319384|NCT00397813|101107641|FG000|STARTED|Overall Study||36||
48319385|NCT00397813|101107642|FG001|STARTED|Overall Study||0||
48319386|NCT00397813|101107643|FG002|STARTED|Overall Study||0||
48319387|NCT00397813|101107644|FG003|STARTED|Overall Study||12||
48319388|NCT00397813|101107645|FG004|STARTED|Overall Study||5||
48319389|NCT00397813|101107646|FG005|STARTED|Overall Study||24||
48319390|NCT00397813|101107641|FG000|COMPLETED|Overall Study||36||
48319391|NCT00397813|101107642|FG001|COMPLETED|Overall Study||0||
48319392|NCT00397813|101107643|FG002|COMPLETED|Overall Study||0||
48319393|NCT00397813|101107644|FG003|COMPLETED|Overall Study||12||
48319394|NCT00397813|101107645|FG004|COMPLETED|Overall Study||5||
48319395|NCT00397813|101107646|FG005|COMPLETED|Overall Study||24||
48319396|NCT00397813|101107641|FG000|NOT COMPLETED|Overall Study||0||
48319397|NCT00397813|101107642|FG001|NOT COMPLETED|Overall Study||0||
48319398|NCT00397813|101107643|FG002|NOT COMPLETED|Overall Study||0||
48319399|NCT00397813|101107644|FG003|NOT COMPLETED|Overall Study||0||
48319400|NCT00397813|101107645|FG004|NOT COMPLETED|Overall Study||0||
48319401|NCT00397813|101107646|FG005|NOT COMPLETED|Overall Study||0||
48319402|NCT05054114|101107647|FG000|STARTED|Overall Study||315||
48319403|NCT05054114|101107648|FG001|STARTED|Overall Study||315||
48319404|NCT05054114|101107647|FG000|COMPLETED|Overall Study||302||
48319405|NCT05054114|101107648|FG001|COMPLETED|Overall Study||313||
48319406|NCT05054114|101107647|FG000|NOT COMPLETED|Overall Study||13||
48319407|NCT05054114|101107648|FG001|NOT COMPLETED|Overall Study||2||
48319408|NCT03045861|101107649|FG000|STARTED|Part A (Up to 10 Days)||0||
48319409|NCT03045861|101107650|FG001|STARTED|Part A (Up to 10 Days)||0||
48319410|NCT03045861|101107651|FG002|STARTED|Part A (Up to 10 Days)||10||
48319411|NCT03045861|101107652|FG003|STARTED|Part A (Up to 10 Days)||0||
48737653|NCT01991522|102140373|FG000|NOT COMPLETED|Overall Study||0||
48737654|NCT01991522|102140374|FG001|NOT COMPLETED|Overall Study||0||
48737655|NCT02277925|102140375|FG000|STARTED|Overall Study||102||
48737656|NCT02277925|102140376|FG001|STARTED|Overall Study||102||
48737657|NCT02277925|102140375|FG000|Surgery|Overall Study||99|Underwent sacral colpopexy|
48737658|NCT02277925|102140376|FG001|Surgery|Overall Study||101|Underwent sacral colpopexy|
48737659|NCT02277925|102140375|FG000|COMPLETED|Overall Study||95|1 year follow-up|
48737660|NCT02277925|102140376|FG001|COMPLETED|Overall Study||87|1 year follow-up|
48319412|NCT03045861|101107649|FG000|COMPLETED|Part A (Up to 10 Days)||0||
48319413|NCT03045861|101107650|FG001|COMPLETED|Part A (Up to 10 Days)||0||
48319414|NCT03045861|101107651|FG002|COMPLETED|Part A (Up to 10 Days)||10||
48737661|NCT02277925|102140375|FG000|NOT COMPLETED|Overall Study||7||
48737662|NCT02277925|102140376|FG001|NOT COMPLETED|Overall Study||15||
48737663|NCT02596230|102140377|FG000|STARTED|Objective 1, One Visit During 14 Days||3714||
48737664|NCT02596230|102140378|FG001|STARTED|Objective 1, One Visit During 14 Days||1006||
48737665|NCT02596230|102140379|FG002|STARTED|Objective 1, One Visit During 14 Days||0||
48737666|NCT02596230|102140380|FG003|STARTED|Objective 1, One Visit During 14 Days||1375||
48737667|NCT02596230|102140381|FG004|STARTED|Objective 1, One Visit During 14 Days||0||
48737668|NCT02596230|102140377|FG000|COMPLETED|Objective 1, One Visit During 14 Days||3714||
48319415|NCT03045861|101107652|FG003|COMPLETED|Part A (Up to 10 Days)||0||
48319416|NCT03045861|101107649|FG000|NOT COMPLETED|Part A (Up to 10 Days)||0||
48319417|NCT03045861|101107650|FG001|NOT COMPLETED|Part A (Up to 10 Days)||0||
48319418|NCT03045861|101107651|FG002|NOT COMPLETED|Part A (Up to 10 Days)||0||
48319419|NCT03045861|101107652|FG003|NOT COMPLETED|Part A (Up to 10 Days)||0||
48319420|NCT03045861|101107649|FG000|STARTED|Part B (Up to 10 Days)||7||
48319421|NCT03045861|101107650|FG001|STARTED|Part B (Up to 10 Days)||8||
48319422|NCT03045861|101107651|FG002|STARTED|Part B (Up to 10 Days)||0||
48319423|NCT03045861|101107652|FG003|STARTED|Part B (Up to 10 Days)||8||
48319424|NCT03045861|101107649|FG000|COMPLETED|Part B (Up to 10 Days)||7||
48319425|NCT03045861|101107650|FG001|COMPLETED|Part B (Up to 10 Days)||8||
48319426|NCT03045861|101107651|FG002|COMPLETED|Part B (Up to 10 Days)||0||
48737669|NCT02596230|102140378|FG001|COMPLETED|Objective 1, One Visit During 14 Days||1006||
48319427|NCT03045861|101107652|FG003|COMPLETED|Part B (Up to 10 Days)||8||
48319428|NCT03045861|101107649|FG000|NOT COMPLETED|Part B (Up to 10 Days)||0||
48319429|NCT03045861|101107650|FG001|NOT COMPLETED|Part B (Up to 10 Days)||0||
48319430|NCT03045861|101107651|FG002|NOT COMPLETED|Part B (Up to 10 Days)||0||
48319431|NCT03045861|101107652|FG003|NOT COMPLETED|Part B (Up to 10 Days)||0||
48319432|NCT04514523|101107653|FG000|STARTED|Overall Study||84||
48319433|NCT04514523|101107654|FG001|STARTED|Overall Study||7||
48319434|NCT04514523|101107653|FG000|Completed Video or Audio|Overall Study||68||
48319435|NCT04514523|101107654|FG001|Completed Video or Audio|Overall Study||7||
48319436|NCT04514523|101107653|FG000|Completed Post Visit Questionnaire|Overall Study||58||
48319437|NCT04514523|101107654|FG001|Completed Post Visit Questionnaire|Overall Study||7||
48319438|NCT04514523|101107653|FG000|COMPLETED|Overall Study||58||
48319439|NCT04514523|101107654|FG001|COMPLETED|Overall Study||7||
48319440|NCT04514523|101107653|FG000|NOT COMPLETED|Overall Study||26||
48319441|NCT04514523|101107654|FG001|NOT COMPLETED|Overall Study||0||
48160696|NCT02401464|100715908|FG003|STARTED|Intervention Period 2 (6 Days)||13||
48160697|NCT02401464|100715905|FG000|COMPLETED|Intervention Period 2 (6 Days)||13||
48407582|NCT02640755|101328583|FG000|NOT COMPLETED|Single Dose Period (Day 1 - 8)||0||
48407583|NCT02640755|101328584|FG001|NOT COMPLETED|Single Dose Period (Day 1 - 8)||0||
48160698|NCT02401464|100715906|FG001|COMPLETED|Intervention Period 2 (6 Days)||13||
48160699|NCT02401464|100715907|FG002|COMPLETED|Intervention Period 2 (6 Days)||13||
48160700|NCT02401464|100715908|FG003|COMPLETED|Intervention Period 2 (6 Days)||13||
48407584|NCT02640755|101328583|FG000|STARTED|Multiple Dose Period (Day 8 - EoS)||3||
48737670|NCT02596230|102140379|FG002|COMPLETED|Objective 1, One Visit During 14 Days||0||
48737671|NCT02596230|102140380|FG003|COMPLETED|Objective 1, One Visit During 14 Days||1375||
48737672|NCT02596230|102140381|FG004|COMPLETED|Objective 1, One Visit During 14 Days||0||
48737673|NCT02596230|102140377|FG000|NOT COMPLETED|Objective 1, One Visit During 14 Days||0||
48737674|NCT02596230|102140378|FG001|NOT COMPLETED|Objective 1, One Visit During 14 Days||0||
48737675|NCT02596230|102140379|FG002|NOT COMPLETED|Objective 1, One Visit During 14 Days||0||
48737676|NCT02596230|102140380|FG003|NOT COMPLETED|Objective 1, One Visit During 14 Days||0||
48737677|NCT02596230|102140381|FG004|NOT COMPLETED|Objective 1, One Visit During 14 Days||0||
48737678|NCT02596230|102140377|FG000|STARTED|Screening Period for Objective 2||3714||
48737679|NCT02596230|102140378|FG001|STARTED|Screening Period for Objective 2||1006||
48737680|NCT02596230|102140379|FG002|STARTED|Screening Period for Objective 2||910||
48737681|NCT02596230|102140380|FG003|STARTED|Screening Period for Objective 2||1375||
48737682|NCT02596230|102140381|FG004|STARTED|Screening Period for Objective 2||792||
48737683|NCT02596230|102140377|FG000|COMPLETED|Screening Period for Objective 2||0||
48737684|NCT02596230|102140378|FG001|COMPLETED|Screening Period for Objective 2||778||
48737685|NCT02596230|102140379|FG002|COMPLETED|Screening Period for Objective 2||910||
48737686|NCT02596230|102140380|FG003|COMPLETED|Screening Period for Objective 2||529||
48737687|NCT02596230|102140381|FG004|COMPLETED|Screening Period for Objective 2||792||
48737688|NCT02596230|102140377|FG000|NOT COMPLETED|Screening Period for Objective 2||3714||
48737689|NCT02596230|102140378|FG001|NOT COMPLETED|Screening Period for Objective 2||228||
48737690|NCT02596230|102140379|FG002|NOT COMPLETED|Screening Period for Objective 2||0||
48737691|NCT02596230|102140380|FG003|NOT COMPLETED|Screening Period for Objective 2||846||
48737692|NCT02596230|102140381|FG004|NOT COMPLETED|Screening Period for Objective 2||0||
48737693|NCT02596230|102140377|FG000|STARTED|Objective 2, One Year||0||
48737694|NCT02596230|102140378|FG001|STARTED|Objective 2, One Year||778||
48737695|NCT02596230|102140379|FG002|STARTED|Objective 2, One Year||910||
48319442|NCT04490863|101107655|FG000|STARTED|Overall Study||26||
48319443|NCT04490863|101107655|FG000|COMPLETED|Overall Study||26||
48319444|NCT04490863|101107655|FG000|NOT COMPLETED|Overall Study||0||
48737696|NCT02596230|102140380|FG003|STARTED|Objective 2, One Year||529||
48737697|NCT02596230|102140381|FG004|STARTED|Objective 2, One Year||792||
48737698|NCT02596230|102140377|FG000|COMPLETED|Objective 2, One Year||0||
48737699|NCT02596230|102140378|FG001|COMPLETED|Objective 2, One Year||710||
48737700|NCT02596230|102140379|FG002|COMPLETED|Objective 2, One Year||812||
48737701|NCT02596230|102140380|FG003|COMPLETED|Objective 2, One Year||471||
48737702|NCT02596230|102140381|FG004|COMPLETED|Objective 2, One Year||714||
48737703|NCT02596230|102140377|FG000|NOT COMPLETED|Objective 2, One Year||0||
48737704|NCT02596230|102140378|FG001|NOT COMPLETED|Objective 2, One Year||68||
48737705|NCT02596230|102140379|FG002|NOT COMPLETED|Objective 2, One Year||98||
48737706|NCT02596230|102140380|FG003|NOT COMPLETED|Objective 2, One Year||58||
48737707|NCT02596230|102140381|FG004|NOT COMPLETED|Objective 2, One Year||78||
48737708|NCT00244101|102140382|FG000|STARTED|Overall Study||209||
48737709|NCT00244101|102140383|FG001|STARTED|Overall Study||223||
48737710|NCT00244101|102140384|FG002|STARTED|Overall Study||216||
48319445|NCT00677014|101107656|FG000|STARTED|Overall Study||325||
48319446|NCT00677014|101107657|FG001|STARTED|Overall Study||323||
48319447|NCT00677014|101107658|FG002|STARTED|Overall Study||332||
48319448|NCT00677014|101107656|FG000|COMPLETED|Overall Study||281||
48319449|NCT00677014|101107657|FG001|COMPLETED|Overall Study||282||
48319450|NCT00677014|101107658|FG002|COMPLETED|Overall Study||283||
48319451|NCT00677014|101107656|FG000|NOT COMPLETED|Overall Study||44||
48319452|NCT00677014|101107657|FG001|NOT COMPLETED|Overall Study||41||
48319453|NCT00677014|101107658|FG002|NOT COMPLETED|Overall Study||49||
48319454|NCT00822757|101107659|FG000|STARTED|Overall Study||41||
48319455|NCT00822757|101107660|FG001|STARTED|Overall Study||10||
48737711|NCT00244101|102140382|FG000|COMPLETED|Overall Study||209||
48737712|NCT00244101|102140383|FG001|COMPLETED|Overall Study||223||
48737713|NCT00244101|102140384|FG002|COMPLETED|Overall Study||216||
48737714|NCT00244101|102140382|FG000|NOT COMPLETED|Overall Study||0||
48737715|NCT00244101|102140383|FG001|NOT COMPLETED|Overall Study||0||
48319456|NCT00822757|101107659|FG000|COMPLETED|Overall Study||41||
48319457|NCT00822757|101107660|FG001|COMPLETED|Overall Study||10||
48319458|NCT00822757|101107659|FG000|NOT COMPLETED|Overall Study||0||
48319459|NCT00822757|101107660|FG001|NOT COMPLETED|Overall Study||0||
48319460|NCT01692275|101107661|FG000|STARTED|Overall Study||375||
48319461|NCT01692275|101107662|FG001|STARTED|Overall Study||375||
48319462|NCT01692275|101107661|FG000|COMPLETED|Overall Study||309||
48319463|NCT01692275|101107662|FG001|COMPLETED|Overall Study||316||
48319464|NCT01692275|101107661|FG000|NOT COMPLETED|Overall Study||66||
48319465|NCT01692275|101107662|FG001|NOT COMPLETED|Overall Study||59||
48319466|NCT01236300|101107663|FG000|STARTED|Overall Study||66||
48319467|NCT01236300|101107663|FG000|COMPLETED|Overall Study||66||
48737716|NCT00244101|102140384|FG002|NOT COMPLETED|Overall Study||0||
48737717|NCT01663012|102140385|FG000|STARTED|Overall Study||20||
48737718|NCT01663012|102140385|FG000|COMPLETED|Overall Study||20||
48737719|NCT01663012|102140385|FG000|NOT COMPLETED|Overall Study||0||
48319468|NCT01236300|101107663|FG000|NOT COMPLETED|Overall Study||0||
48319469|NCT01076049|101107664|FG000|STARTED|Overall Study||52||
48319470|NCT01076049|101107665|FG001|STARTED|Overall Study||55||
48737720|NCT00479856|102140386|FG000|STARTED|Overall Study||9||
48737721|NCT00479856|102140386|FG000|COMPLETED|Overall Study||6||
48737722|NCT00479856|102140386|FG000|NOT COMPLETED|Overall Study||3||
48737723|NCT02524158|102140387|FG000|STARTED|12-weeks Assessment||76||
48737724|NCT02524158|102140388|FG001|STARTED|12-weeks Assessment||76||
48737725|NCT02524158|102140387|FG000|COMPLETED|12-weeks Assessment||57||
48737726|NCT02524158|102140388|FG001|COMPLETED|12-weeks Assessment||63||
48737727|NCT02524158|102140387|FG000|NOT COMPLETED|12-weeks Assessment||19||
48737728|NCT02524158|102140388|FG001|NOT COMPLETED|12-weeks Assessment||13||
48737729|NCT02524158|102140387|FG000|STARTED|6-month Assessment||76||
48737730|NCT02524158|102140388|FG001|STARTED|6-month Assessment||76||
48737731|NCT02524158|102140387|FG000|COMPLETED|6-month Assessment||54||
48737732|NCT02524158|102140388|FG001|COMPLETED|6-month Assessment||55||
48737733|NCT02524158|102140387|FG000|NOT COMPLETED|6-month Assessment||22||
48737734|NCT02524158|102140388|FG001|NOT COMPLETED|6-month Assessment||21||
48737735|NCT01359943|102140389|FG000|STARTED|Double-blind (Weeks 0 - 16)||88||
48737736|NCT01359943|102140390|FG001|STARTED|Double-blind (Weeks 0 - 16)||89||
48737737|NCT01359943|102140391|FG002|STARTED|Double-blind (Weeks 0 - 16)||44||
48737738|NCT01359943|102140389|FG000|COMPLETED|Double-blind (Weeks 0 - 16)||86||
48737739|NCT01359943|102140390|FG001|COMPLETED|Double-blind (Weeks 0 - 16)||85||
48737740|NCT01359943|102140391|FG002|COMPLETED|Double-blind (Weeks 0 - 16)||44||
48737741|NCT01359943|102140389|FG000|NOT COMPLETED|Double-blind (Weeks 0 - 16)||2||
48737742|NCT01359943|102140390|FG001|NOT COMPLETED|Double-blind (Weeks 0 - 16)||4||
48737743|NCT01359943|102140391|FG002|NOT COMPLETED|Double-blind (Weeks 0 - 16)||0||
48737744|NCT01359943|102140389|FG000|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||86||
48737745|NCT01359943|102140390|FG001|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||84||
48737746|NCT01359943|102140391|FG002|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||44||
48737747|NCT01359943|102140389|FG000|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||78||
48737748|NCT01359943|102140390|FG001|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||71||
48737749|NCT01359943|102140391|FG002|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||36||
48737750|NCT01359943|102140389|FG000|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8||
48737751|NCT01359943|102140390|FG001|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||13||
48737752|NCT01359943|102140391|FG002|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8||
48737753|NCT01359943|102140389|FG000|STARTED|Follow-up (Weeks 52 - 60)||86||
48737754|NCT01359943|102140390|FG001|STARTED|Follow-up (Weeks 52 - 60)||84||
48737755|NCT01359943|102140391|FG002|STARTED|Follow-up (Weeks 52 - 60)||44||
48737756|NCT01359943|102140389|FG000|COMPLETED|Follow-up (Weeks 52 - 60)||78||
48737757|NCT01359943|102140390|FG001|COMPLETED|Follow-up (Weeks 52 - 60)||69||
48737758|NCT01359943|102140391|FG002|COMPLETED|Follow-up (Weeks 52 - 60)||36||
48737759|NCT01359943|102140389|FG000|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8||
48737760|NCT01359943|102140390|FG001|NOT COMPLETED|Follow-up (Weeks 52 - 60)||15||
48737761|NCT01359943|102140391|FG002|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8||
48737762|NCT02287467|102140392|FG000|STARTED|Overall Study||168||
48737763|NCT02287467|102140393|FG001|STARTED|Overall Study||161||
48737764|NCT02287467|102140392|FG000|COMPLETED|Overall Study||156||
48737765|NCT02287467|102140393|FG001|COMPLETED|Overall Study||152||
48737766|NCT02287467|102140392|FG000|NOT COMPLETED|Overall Study||12||
48737767|NCT02287467|102140393|FG001|NOT COMPLETED|Overall Study||9||
48737768|NCT02465372|102140394|FG000|STARTED|Overall Study||349||3
48737769|NCT02465372|102140395|FG001|STARTED|Overall Study||250||2
48737770|NCT02465372|102140394|FG000|COMPLETED|Overall Study||227||3
48737771|NCT02465372|102140395|FG001|COMPLETED|Overall Study||153||2
48737772|NCT02465372|102140394|FG000|NOT COMPLETED|Overall Study||122||0
48737773|NCT02465372|102140395|FG001|NOT COMPLETED|Overall Study||97||0
48737774|NCT01949090|102140396|FG000|STARTED|Overall Study||60||
48737775|NCT01949090|102140397|FG001|STARTED|Overall Study||60||
48737776|NCT01949090|102140398|FG002|STARTED|Overall Study||60||
48737777|NCT01949090|102140399|FG003|STARTED|Overall Study||60||
48737778|NCT01949090|102140400|FG004|STARTED|Overall Study||120||
48737779|NCT01949090|102140396|FG000|COMPLETED|Overall Study||56||
48737780|NCT01949090|102140397|FG001|COMPLETED|Overall Study||58||
48737781|NCT01949090|102140398|FG002|COMPLETED|Overall Study||58||
48737782|NCT01949090|102140399|FG003|COMPLETED|Overall Study||59||
48737783|NCT01949090|102140400|FG004|COMPLETED|Overall Study||116||
48737784|NCT01949090|102140396|FG000|NOT COMPLETED|Overall Study||4||
48737785|NCT01949090|102140397|FG001|NOT COMPLETED|Overall Study||2||
48737786|NCT01949090|102140398|FG002|NOT COMPLETED|Overall Study||2||
48737787|NCT01949090|102140399|FG003|NOT COMPLETED|Overall Study||1||
48737788|NCT01949090|102140400|FG004|NOT COMPLETED|Overall Study||4||
48737789|NCT02692755|102140401|FG000|STARTED|Overall Study||35||
48737790|NCT02692755|102140401|FG000|COMPLETED|Overall Study||35||
48737791|NCT02692755|102140401|FG000|NOT COMPLETED|Overall Study||0||
48737792|NCT01824355|102140402|FG000|STARTED|Overall Study||113||
48737793|NCT01824355|102140402|FG000|COMPLETED|Overall Study||110||
48737794|NCT01824355|102140402|FG000|NOT COMPLETED|Overall Study||3||
48737795|NCT01458418|102140403|FG000|STARTED|Overall Study||0||
48737796|NCT01458418|102140404|FG001|STARTED|Overall Study||0||
48737797|NCT01458418|102140405|FG002|STARTED|Overall Study||0||
48737798|NCT01458418|102140406|FG003|STARTED|Overall Study||4||
48737799|NCT01458418|102140403|FG000|COMPLETED|Overall Study||0||
48737800|NCT01458418|102140404|FG001|COMPLETED|Overall Study||0||
48737801|NCT01458418|102140405|FG002|COMPLETED|Overall Study||0||
48737802|NCT01458418|102140406|FG003|COMPLETED|Overall Study||4||
48737803|NCT01458418|102140403|FG000|NOT COMPLETED|Overall Study||0||
48737804|NCT01458418|102140404|FG001|NOT COMPLETED|Overall Study||0||
48737805|NCT01458418|102140405|FG002|NOT COMPLETED|Overall Study||0||
48737806|NCT01458418|102140406|FG003|NOT COMPLETED|Overall Study||0||
48737807|NCT00546000|102140407|FG000|STARTED|Overall Study||56||
48737808|NCT00546000|102140407|FG000|COMPLETED|Overall Study||52||
48737809|NCT00546000|102140407|FG000|NOT COMPLETED|Overall Study||4||
48737810|NCT00048347|102140408|FG000|STARTED|Overall Study||18||
48737811|NCT00048347|102140408|FG000|COMPLETED|Overall Study||16||
48737812|NCT00048347|102140408|FG000|NOT COMPLETED|Overall Study||2||
48737813|NCT00055692|102144164|FG000|STARTED|Overall Study||46||
48737814|NCT00055692|102144164|FG000|COMPLETED|Overall Study||46||
48737815|NCT00055692|102144164|FG000|NOT COMPLETED|Overall Study||0||
48737816|NCT02454478|102144165|FG000|STARTED|Overall Study||7||
48737817|NCT02454478|102144165|FG000|COMPLETED|Overall Study||6||
48737818|NCT02454478|102144165|FG000|NOT COMPLETED|Overall Study||1||
48737819|NCT01670721|102144166|FG000|STARTED|Overall Study||175||
48737820|NCT01670721|102144166|FG000|COMPLETED|Overall Study||122||
48737821|NCT01670721|102144166|FG000|NOT COMPLETED|Overall Study||53||
48737822|NCT02381015|102144167|FG000|STARTED|Visit 1 - Enrollment||175||
48737823|NCT02381015|102144168|FG001|STARTED|Visit 1 - Enrollment||175||
48737824|NCT02381015|102144169|FG002|STARTED|Visit 1 - Enrollment||175||
48737825|NCT02381015|102144170|FG003|STARTED|Visit 1 - Enrollment||175||
48737826|NCT02381015|102144167|FG000|COMPLETED|Visit 1 - Enrollment||175||
48737827|NCT02381015|102144168|FG001|COMPLETED|Visit 1 - Enrollment||173||
48737828|NCT02381015|102144169|FG002|COMPLETED|Visit 1 - Enrollment||175||
48737829|NCT02381015|102144170|FG003|COMPLETED|Visit 1 - Enrollment||172||
48737830|NCT02381015|102144167|FG000|NOT COMPLETED|Visit 1 - Enrollment||0||
48737831|NCT02381015|102144168|FG001|NOT COMPLETED|Visit 1 - Enrollment||2||
48737832|NCT02381015|102144169|FG002|NOT COMPLETED|Visit 1 - Enrollment||0||
48737833|NCT02381015|102144170|FG003|NOT COMPLETED|Visit 1 - Enrollment||3||
48737834|NCT02381015|102144167|FG000|STARTED|Visit 2 - Results DIsclosure||175||
48737835|NCT02381015|102144168|FG001|STARTED|Visit 2 - Results DIsclosure||173||
48737836|NCT02381015|102144169|FG002|STARTED|Visit 2 - Results DIsclosure||175||
48737837|NCT02381015|102144170|FG003|STARTED|Visit 2 - Results DIsclosure||172||
48737838|NCT02381015|102144167|FG000|COMPLETED|Visit 2 - Results DIsclosure||172||
48737839|NCT02381015|102144168|FG001|COMPLETED|Visit 2 - Results DIsclosure||168||
48737840|NCT02381015|102144169|FG002|COMPLETED|Visit 2 - Results DIsclosure||173||
48737841|NCT02381015|102144170|FG003|COMPLETED|Visit 2 - Results DIsclosure||169||
48737842|NCT02381015|102144167|FG000|NOT COMPLETED|Visit 2 - Results DIsclosure||3||
48737843|NCT02381015|102144168|FG001|NOT COMPLETED|Visit 2 - Results DIsclosure||5||
48737844|NCT02381015|102144169|FG002|NOT COMPLETED|Visit 2 - Results DIsclosure||2||
48737845|NCT02381015|102144170|FG003|NOT COMPLETED|Visit 2 - Results DIsclosure||3||
48737846|NCT02381015|102144167|FG000|STARTED|Visit 3 - 3 Months Followup||172||
48737847|NCT02381015|102144168|FG001|STARTED|Visit 3 - 3 Months Followup||168||
48737848|NCT02381015|102144169|FG002|STARTED|Visit 3 - 3 Months Followup||173||
48737849|NCT02381015|102144170|FG003|STARTED|Visit 3 - 3 Months Followup||169||
48737850|NCT02381015|102144167|FG000|COMPLETED|Visit 3 - 3 Months Followup||172||
48737851|NCT02381015|102144168|FG001|COMPLETED|Visit 3 - 3 Months Followup||168||
48737852|NCT02381015|102144169|FG002|COMPLETED|Visit 3 - 3 Months Followup||173||
48737853|NCT02381015|102144170|FG003|COMPLETED|Visit 3 - 3 Months Followup||169||
48737854|NCT02381015|102144167|FG000|NOT COMPLETED|Visit 3 - 3 Months Followup||0||
48737855|NCT02381015|102144168|FG001|NOT COMPLETED|Visit 3 - 3 Months Followup||0||
48737856|NCT02381015|102144169|FG002|NOT COMPLETED|Visit 3 - 3 Months Followup||0||
48737857|NCT02381015|102144170|FG003|NOT COMPLETED|Visit 3 - 3 Months Followup||0||
48737858|NCT02381015|102144167|FG000|STARTED|Year 3 Chart Review||172||
48737859|NCT02381015|102144168|FG001|STARTED|Year 3 Chart Review||168||
48737860|NCT02381015|102144169|FG002|STARTED|Year 3 Chart Review||173||
48737861|NCT02381015|102144170|FG003|STARTED|Year 3 Chart Review||169||
48737862|NCT02381015|102144167|FG000|COMPLETED|Year 3 Chart Review||125||
48737863|NCT02381015|102144168|FG001|COMPLETED|Year 3 Chart Review||134||
48737864|NCT02381015|102144169|FG002|COMPLETED|Year 3 Chart Review||115||
48737865|NCT02381015|102144170|FG003|COMPLETED|Year 3 Chart Review||118||
48737866|NCT02381015|102144167|FG000|NOT COMPLETED|Year 3 Chart Review||47||
48737867|NCT02381015|102144168|FG001|NOT COMPLETED|Year 3 Chart Review||34||
48737868|NCT02381015|102144169|FG002|NOT COMPLETED|Year 3 Chart Review||58||
48737869|NCT02381015|102144170|FG003|NOT COMPLETED|Year 3 Chart Review||51||
48737870|NCT04395690|102144171|FG000|STARTED|Overall Study||48||
48737871|NCT04395690|102144172|FG001|STARTED|Overall Study||48||
48737872|NCT04395690|102144171|FG000|COMPLETED|Overall Study||47||
48737873|NCT04395690|102144172|FG001|COMPLETED|Overall Study||47||
48737874|NCT04395690|102144171|FG000|NOT COMPLETED|Overall Study||1||
48737875|NCT04395690|102144172|FG001|NOT COMPLETED|Overall Study||1||
48737876|NCT01687101|102144173|FG000|STARTED|Overall Study||32||
48737877|NCT01687101|102144173|FG000|COMPLETED|Overall Study||25||
48737878|NCT01687101|102144173|FG000|NOT COMPLETED|Overall Study||7||
48737879|NCT00567359|102144174|FG000|STARTED|Overall Study||100||
48737880|NCT00567359|102144174|FG000|COMPLETED|Overall Study||99||
48737881|NCT00567359|102144174|FG000|NOT COMPLETED|Overall Study||1||
48737882|NCT04079816|102144175|FG000|STARTED|Overall Study||29||
48737883|NCT04079816|102144175|FG000|COMPLETED|Overall Study||26||
48737884|NCT04079816|102144175|FG000|NOT COMPLETED|Overall Study||3||
48737885|NCT02728089|102144176|FG000|STARTED|Overall Study||115||
48737886|NCT02728089|102144176|FG000|Treated|Overall Study||114||
48737887|NCT02728089|102144176|FG000|COMPLETED|Overall Study||112||
48737888|NCT02728089|102144176|FG000|NOT COMPLETED|Overall Study||3||
48737889|NCT03671304|102144177|FG000|STARTED|Overall Study||8||
48737890|NCT03671304|102144177|FG000|COMPLETED|Overall Study||1||
48737891|NCT03671304|102144177|FG000|NOT COMPLETED|Overall Study||7||
48737892|NCT00666406|102144178|FG000|STARTED|First PK Infusion||6||
48737893|NCT00666406|102144179|FG001|STARTED|First PK Infusion||3||
48737894|NCT00666406|102144178|FG000|COMPLETED|First PK Infusion||6||
48737895|NCT00666406|102144179|FG001|COMPLETED|First PK Infusion||3||
48737896|NCT00666406|102144178|FG000|NOT COMPLETED|First PK Infusion||0||
48737897|NCT00666406|102144179|FG001|NOT COMPLETED|First PK Infusion||0||
48737898|NCT00666406|102144178|FG000|STARTED|Second PK Infusion||6||
48737899|NCT00666406|102144179|FG001|STARTED|Second PK Infusion||3||
48737900|NCT00666406|102144178|FG000|COMPLETED|Second PK Infusion||6||
48737901|NCT00666406|102144179|FG001|COMPLETED|Second PK Infusion||3||
48737902|NCT00666406|102144178|FG000|NOT COMPLETED|Second PK Infusion||0||
48737903|NCT00666406|102144179|FG001|NOT COMPLETED|Second PK Infusion||0||
48737904|NCT01740414|102144180|FG000|STARTED|Overall Study||12||
48737905|NCT01740414|102144181|FG001|STARTED|Overall Study||16||
48319471|NCT01076049|101107666|FG002|STARTED|Overall Study||1||
48319472|NCT01076049|101107664|FG000|COMPLETED|Overall Study||45||
48319473|NCT01076049|101107665|FG001|COMPLETED|Overall Study||52||
48319474|NCT01076049|101107666|FG002|COMPLETED|Overall Study||1||
48319475|NCT01076049|101107664|FG000|NOT COMPLETED|Overall Study||7||
48319476|NCT01076049|101107665|FG001|NOT COMPLETED|Overall Study||3||
48737906|NCT01740414|102144180|FG000|COMPLETED|Overall Study||3|This study employed a within-subjects design. Participants completed both MN-166 and Placebo phases.|
48737907|NCT01740414|102144181|FG001|COMPLETED|Overall Study||8|This study employed a within-subjects design. Participants completed both MN-166 and Placebo phases.|
48737908|NCT01740414|102144180|FG000|NOT COMPLETED|Overall Study||9||
48737909|NCT01740414|102144181|FG001|NOT COMPLETED|Overall Study||8||
48737910|NCT01427933|102144182|FG000|STARTED|Overall Study||71||
48737911|NCT01427933|102144183|FG001|STARTED|Overall Study||70||
48737912|NCT01427933|102144182|FG000|Received at Least 1 Dose of Study Drug|Overall Study||69||
48737913|NCT01427933|102144183|FG001|Received at Least 1 Dose of Study Drug|Overall Study||65||
48737914|NCT01427933|102144182|FG000|COMPLETED|Overall Study||63||
48737915|NCT01427933|102144183|FG001|COMPLETED|Overall Study||57||
48737916|NCT01427933|102144182|FG000|NOT COMPLETED|Overall Study||8||
48737917|NCT01427933|102144183|FG001|NOT COMPLETED|Overall Study||13||
48737918|NCT02391363|102144184|FG000|STARTED|Overall Study||70||
48737919|NCT02391363|102144185|FG001|STARTED|Overall Study||64||
48737920|NCT02391363|102144184|FG000|COMPLETED|Overall Study||59||
48737921|NCT02391363|102144185|FG001|COMPLETED|Overall Study||56||
48737922|NCT02391363|102144184|FG000|NOT COMPLETED|Overall Study||11||
48737923|NCT02391363|102144185|FG001|NOT COMPLETED|Overall Study||8||
48737924|NCT00412243|102144186|FG000|STARTED|Overall Study||50||
48737925|NCT00412243|102144186|FG000|COMPLETED|Overall Study||50||
48737926|NCT00412243|102144186|FG000|NOT COMPLETED|Overall Study||0||
48737927|NCT01487265|102144187|FG000|STARTED|Overall Study||37||
48737928|NCT01487265|102144187|FG000|COMPLETED|Overall Study||0||
48737929|NCT01487265|102144187|FG000|NOT COMPLETED|Overall Study||37||
48737930|NCT01504412|102144188|FG000|STARTED|Overall Study||89||
48737931|NCT01504412|102144189|FG001|STARTED|Overall Study||87||
48319477|NCT01076049|101107666|FG002|NOT COMPLETED|Overall Study||0||
48319478|NCT04419610|101107667|FG000|STARTED|Overall Study||15||
48319479|NCT04419610|101107668|FG001|STARTED|Overall Study||13||
48319480|NCT04419610|101107667|FG000|COMPLETED|Overall Study||10||
48737932|NCT01504412|102144190|FG002|STARTED|Overall Study||90||
48737933|NCT01504412|102144191|FG003|STARTED|Overall Study||94||
48737934|NCT01504412|102144192|FG004|STARTED|Overall Study||90||
48319481|NCT04419610|101107668|FG001|COMPLETED|Overall Study||11||
48319482|NCT04419610|101107667|FG000|NOT COMPLETED|Overall Study||5||
48319483|NCT04419610|101107668|FG001|NOT COMPLETED|Overall Study||2||
48319484|NCT01294579|101107669|FG000|STARTED|Overall Study||49||
48319485|NCT01294579|101107669|FG000|COMPLETED|Overall Study||14||
48737935|NCT01504412|102144188|FG000|COMPLETED|Overall Study||84||
48319486|NCT01294579|101107669|FG000|NOT COMPLETED|Overall Study||35||
48368055|NCT03691623|101230100|FG004|STARTED|Overall Study||21||
48737936|NCT01504412|102144189|FG001|COMPLETED|Overall Study||75||
48737937|NCT01504412|102144190|FG002|COMPLETED|Overall Study||86||
48737938|NCT01504412|102144191|FG003|COMPLETED|Overall Study||75||
48737939|NCT01504412|102144192|FG004|COMPLETED|Overall Study||77||
48737940|NCT01504412|102144188|FG000|NOT COMPLETED|Overall Study||5||
48737941|NCT01504412|102144189|FG001|NOT COMPLETED|Overall Study||12||
48737942|NCT01504412|102144190|FG002|NOT COMPLETED|Overall Study||4||
48737943|NCT01504412|102144191|FG003|NOT COMPLETED|Overall Study||19||
48319487|NCT01632995|101107670|FG000|STARTED|Pre-screening to Enrollment Period||1069|All participants who were assessed for study participation|
48319488|NCT01632995|101107670|FG000|COMPLETED|Pre-screening to Enrollment Period||557|All participants who enrolled in study|
48319489|NCT01632995|101107670|FG000|NOT COMPLETED|Pre-screening to Enrollment Period||512||
48319490|NCT01632995|101107670|FG000|STARTED|Main Study Follow-up Period||557|Participants who enrolled and initiated PrEP|
48319491|NCT01632995|101107670|FG000|COMPLETED|Main Study Follow-up Period||437|Participants who completed 48 weeks of follow-up|
48319492|NCT01632995|101107670|FG000|NOT COMPLETED|Main Study Follow-up Period||120||
48319493|NCT05265312|101107671|FG000|STARTED|Overall Study||873||
48319494|NCT05265312|101107672|FG001|STARTED|Overall Study||1037||
48737944|NCT01504412|102144192|FG004|NOT COMPLETED|Overall Study||13||
48737945|NCT03106636|102144193|FG000|STARTED|Overall Study||226||
48737946|NCT03106636|102144194|FG001|STARTED|Overall Study||190||
48737947|NCT03106636|102144193|FG000|COMPLETED|Overall Study||182|Completed post-intervention data collection|
48737948|NCT03106636|102144194|FG001|COMPLETED|Overall Study||164|Completed post-intervention data collection|
48737949|NCT03106636|102144193|FG000|NOT COMPLETED|Overall Study||44||
48737950|NCT03106636|102144194|FG001|NOT COMPLETED|Overall Study||26||
48737951|NCT01063153|102144195|FG000|STARTED|Overall Study||33||
48737952|NCT01063153|102144196|FG001|STARTED|Overall Study||38||
48737953|NCT01063153|102144195|FG000|COMPLETED|Overall Study||31||
48737954|NCT01063153|102144196|FG001|COMPLETED|Overall Study||26||
48737955|NCT01063153|102144195|FG000|NOT COMPLETED|Overall Study||2||
48737956|NCT01063153|102144196|FG001|NOT COMPLETED|Overall Study||12||
48737957|NCT00350844|102144197|FG000|STARTED|Overall Study||6||
48737958|NCT00350844|102144197|FG000|COMPLETED|Overall Study||5||
48737959|NCT00350844|102144197|FG000|NOT COMPLETED|Overall Study||1||
48737960|NCT00791089|102144198|FG000|STARTED|Overall Study||6||
48737961|NCT00791089|102144199|FG001|STARTED|Overall Study||6||
48737962|NCT00791089|102144198|FG000|Began Actually Taking Fish Oil or Placeb|Overall Study||6||
48160701|NCT02401464|100715905|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0||
48160702|NCT02401464|100715906|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0||
48737963|NCT00791089|102144199|FG001|Began Actually Taking Fish Oil or Placeb|Overall Study||5||
48737964|NCT00791089|102144198|FG000|Six-month Data Collected|Overall Study||6||
48737965|NCT00791089|102144199|FG001|Six-month Data Collected|Overall Study||5||
48737966|NCT00791089|102144198|FG000|COMPLETED|Overall Study||0||
48737967|NCT00791089|102144199|FG001|COMPLETED|Overall Study||0||
48737968|NCT00791089|102144198|FG000|NOT COMPLETED|Overall Study||6||
48737969|NCT00791089|102144199|FG001|NOT COMPLETED|Overall Study||6||
48737970|NCT02352753|102144200|FG000|STARTED|6-Month Dosing Period||153||
48737971|NCT02352753|102144200|FG000|Received Investigational Product|6-Month Dosing Period||153||
48737972|NCT02352753|102144200|FG000|COMPLETED|6-Month Dosing Period||55||
48737973|NCT02352753|102144200|FG000|NOT COMPLETED|6-Month Dosing Period||98||
48737974|NCT02352753|102144200|FG000|STARTED|3-Month Dosing Period||60||
48737975|NCT02352753|102144200|FG000|Received Investigational Product|3-Month Dosing Period||60||
48737976|NCT02352753|102144200|FG000|COMPLETED|3-Month Dosing Period||40||
48737977|NCT02352753|102144200|FG000|NOT COMPLETED|3-Month Dosing Period||20||
48737978|NCT01919801|102144201|FG000|STARTED|Overall Study||61||
48737979|NCT01919801|102144202|FG001|STARTED|Overall Study||60||
48737980|NCT01919801|102144201|FG000|COMPLETED|Overall Study||60||
48737981|NCT01919801|102144202|FG001|COMPLETED|Overall Study||57||
48737982|NCT01919801|102144201|FG000|NOT COMPLETED|Overall Study||1||
48737983|NCT01919801|102144202|FG001|NOT COMPLETED|Overall Study||3||
48737984|NCT00942825|102144203|FG000|STARTED|Overall Study||97||
48737985|NCT00942825|102144204|FG001|STARTED|Overall Study||98||
48737986|NCT00942825|102144203|FG000|COMPLETED|Overall Study||97||
48737987|NCT00942825|102144204|FG001|COMPLETED|Overall Study||98||
48737988|NCT00942825|102144203|FG000|NOT COMPLETED|Overall Study||0||
48737989|NCT00942825|102144204|FG001|NOT COMPLETED|Overall Study||0||
48160703|NCT02401464|100715907|FG002|NOT COMPLETED|Intervention Period 2 (6 Days)||0||
48160704|NCT02401464|100715908|FG003|NOT COMPLETED|Intervention Period 2 (6 Days)||0||
48160705|NCT00861601|100715909|FG000|STARTED|Overall Study||12||
48737990|NCT03056339|102144205|FG000|STARTED|Overall Study||3||
48737991|NCT03056339|102144206|FG001|STARTED|Overall Study||6||
48160706|NCT00861601|100715910|FG001|STARTED|Overall Study||14||
48160707|NCT00861601|100715911|FG002|STARTED|Overall Study||12||
48319495|NCT05265312|101107671|FG000|COMPLETED|Overall Study||873||
48319496|NCT05265312|101107672|FG001|COMPLETED|Overall Study||1037||
48319497|NCT05265312|101107671|FG000|NOT COMPLETED|Overall Study||0||
48319498|NCT05265312|101107672|FG001|NOT COMPLETED|Overall Study||0||
48737992|NCT03056339|102144207|FG002|STARTED|Overall Study||23||
48737993|NCT03056339|102144208|FG003|STARTED|Overall Study||17||
48737994|NCT03056339|102144205|FG000|COMPLETED|Overall Study||3||
48737995|NCT03056339|102144206|FG001|COMPLETED|Overall Study||4||
48737996|NCT03056339|102144207|FG002|COMPLETED|Overall Study||16||
48737997|NCT03056339|102144208|FG003|COMPLETED|Overall Study||16||
48737998|NCT03056339|102144205|FG000|NOT COMPLETED|Overall Study||0||
48737999|NCT03056339|102144206|FG001|NOT COMPLETED|Overall Study||2||
48738000|NCT03056339|102144207|FG002|NOT COMPLETED|Overall Study||7||
48738001|NCT03056339|102144208|FG003|NOT COMPLETED|Overall Study||1||
48738002|NCT03566082|102144209|FG000|STARTED|Overall Study||135||
48160708|NCT00861601|100715909|FG000|COMPLETED|Overall Study||12||
48319499|NCT01921751|101107673|FG000|STARTED|Overall Study||4||
48319500|NCT01921751|101107674|FG001|STARTED|Overall Study||4||
48319501|NCT01921751|101107675|FG002|STARTED|Overall Study||5||
48319502|NCT01921751|101107673|FG000|COMPLETED|Overall Study||4||
48319503|NCT01921751|101107674|FG001|COMPLETED|Overall Study||4||
48319504|NCT01921751|101107675|FG002|COMPLETED|Overall Study||5||
48319505|NCT01921751|101107673|FG000|NOT COMPLETED|Overall Study||0||
48319506|NCT01921751|101107674|FG001|NOT COMPLETED|Overall Study||0||
48319507|NCT01921751|101107675|FG002|NOT COMPLETED|Overall Study||0||
48319508|NCT00950664|101107676|FG000|STARTED|First Intervention||49||
48319509|NCT00950664|101107677|FG001|STARTED|First Intervention||53||
48319510|NCT00950664|101107676|FG000|COMPLETED|First Intervention||46||
48319511|NCT00950664|101107677|FG001|COMPLETED|First Intervention||48||
48319512|NCT00950664|101107676|FG000|NOT COMPLETED|First Intervention||3||
48319513|NCT00950664|101107677|FG001|NOT COMPLETED|First Intervention||5||
48319514|NCT00950664|101107676|FG000|STARTED|Washout Period of 4 Weeks||46||
48319515|NCT00950664|101107677|FG001|STARTED|Washout Period of 4 Weeks||48||
48319516|NCT00950664|101107676|FG000|COMPLETED|Washout Period of 4 Weeks||46||
48319517|NCT00950664|101107677|FG001|COMPLETED|Washout Period of 4 Weeks||48||
48319518|NCT00950664|101107676|FG000|NOT COMPLETED|Washout Period of 4 Weeks||0||
48319519|NCT00950664|101107677|FG001|NOT COMPLETED|Washout Period of 4 Weeks||0||
48319520|NCT00950664|101107676|FG000|STARTED|Second Intervention||46||
48738003|NCT03566082|102144209|FG000|COMPLETED|Overall Study||118||
48738004|NCT03566082|102144209|FG000|NOT COMPLETED|Overall Study||17||
48738005|NCT02152761|102144210|FG000|STARTED|Epoch: Treatment Epoch||75||
48738006|NCT02152761|102144211|FG001|STARTED|Epoch: Treatment Epoch||70||
48738007|NCT02152761|102144212|FG002|STARTED|Epoch: Treatment Epoch||34||
48738008|NCT02152761|102144213|FG003|STARTED|Epoch: Treatment Epoch||72||
48738009|NCT02152761|102144210|FG000|COMPLETED|Epoch: Treatment Epoch||64||
48738010|NCT02152761|102144211|FG001|COMPLETED|Epoch: Treatment Epoch||50||
48738011|NCT02152761|102144212|FG002|COMPLETED|Epoch: Treatment Epoch||29||
48738012|NCT02152761|102144213|FG003|COMPLETED|Epoch: Treatment Epoch||64||
48738013|NCT02152761|102144210|FG000|NOT COMPLETED|Epoch: Treatment Epoch||11||
48738014|NCT02152761|102144211|FG001|NOT COMPLETED|Epoch: Treatment Epoch||20||
48738015|NCT02152761|102144212|FG002|NOT COMPLETED|Epoch: Treatment Epoch||5||
48738016|NCT02152761|102144213|FG003|NOT COMPLETED|Epoch: Treatment Epoch||8||
48738017|NCT02152761|102144210|FG000|STARTED|Epoch: Post-treatment Follow-up Epoch||67||
48738018|NCT02152761|102144211|FG001|STARTED|Epoch: Post-treatment Follow-up Epoch||54||
48738019|NCT02152761|102144212|FG002|STARTED|Epoch: Post-treatment Follow-up Epoch||30||
48738020|NCT02152761|102144213|FG003|STARTED|Epoch: Post-treatment Follow-up Epoch||68||
48738021|NCT02152761|102144210|FG000|COMPLETED|Epoch: Post-treatment Follow-up Epoch||63||
48738022|NCT02152761|102144211|FG001|COMPLETED|Epoch: Post-treatment Follow-up Epoch||47||
48738023|NCT02152761|102144212|FG002|COMPLETED|Epoch: Post-treatment Follow-up Epoch||30||
48738024|NCT02152761|102144213|FG003|COMPLETED|Epoch: Post-treatment Follow-up Epoch||66||
48738025|NCT02152761|102144210|FG000|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||4||
48738026|NCT02152761|102144211|FG001|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||7||
48738027|NCT02152761|102144212|FG002|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||0||
48738028|NCT02152761|102144213|FG003|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||2||
48319521|NCT00950664|101107677|FG001|STARTED|Second Intervention||48||
48319522|NCT00950664|101107676|FG000|COMPLETED|Second Intervention||0||
48319523|NCT00950664|101107677|FG001|COMPLETED|Second Intervention||0||
48319524|NCT00950664|101107676|FG000|NOT COMPLETED|Second Intervention||46||
48319525|NCT00950664|101107677|FG001|NOT COMPLETED|Second Intervention||48||
48319526|NCT02184195|101107678|FG000|STARTED|Overall Study||92||
48319527|NCT02184195|101107679|FG001|STARTED|Overall Study||62||
48319528|NCT02184195|101107678|FG000|COMPLETED|Overall Study||19||
48319529|NCT02184195|101107679|FG001|COMPLETED|Overall Study||7||
48319530|NCT02184195|101107678|FG000|NOT COMPLETED|Overall Study||73||
48319531|NCT02184195|101107679|FG001|NOT COMPLETED|Overall Study||55||
48319532|NCT01390272|101107680|FG000|STARTED|Overall Study||192||
48319533|NCT01390272|101107681|FG001|STARTED|Overall Study||193||
48319534|NCT01390272|101107680|FG000|6 Month Follow up|Overall Study||162||
48319535|NCT01390272|101107681|FG001|6 Month Follow up|Overall Study||171||
48319536|NCT01390272|101107680|FG000|12 Month Follow up|Overall Study||139||
48319537|NCT01390272|101107681|FG001|12 Month Follow up|Overall Study||159||
48319538|NCT01390272|101107680|FG000|18 Month Follow up|Overall Study||155||
48319539|NCT01390272|101107681|FG001|18 Month Follow up|Overall Study||160||
48319540|NCT01390272|101107680|FG000|COMPLETED|Overall Study||175||
48319541|NCT01390272|101107681|FG001|COMPLETED|Overall Study||178||
48738029|NCT00660179|102144214|FG000|STARTED|Overall Study||250||
48738030|NCT00660179|102144215|FG001|STARTED|Overall Study||250||
48319542|NCT01390272|101107680|FG000|NOT COMPLETED|Overall Study||17||
48319543|NCT01390272|101107681|FG001|NOT COMPLETED|Overall Study||15||
48319544|NCT03803059|101107682|FG000|STARTED|Overall Study||35||
48319545|NCT03803059|101107682|FG000|COMPLETED|Overall Study||32||
48319546|NCT03803059|101107682|FG000|NOT COMPLETED|Overall Study||3||
48319547|NCT00807742|101107683|FG000|STARTED|Overall Study||172||
48319548|NCT00807742|101107684|FG001|STARTED|Overall Study||168||
48319549|NCT00807742|101107683|FG000|COMPLETED|Overall Study||126||
48319550|NCT00807742|101107684|FG001|COMPLETED|Overall Study||114||
48738031|NCT00660179|102144216|FG002|STARTED|Overall Study||242||
48738032|NCT00660179|102144214|FG000|COMPLETED|Overall Study||194||
48738033|NCT00660179|102144215|FG001|COMPLETED|Overall Study||192||
48738034|NCT00660179|102144216|FG002|COMPLETED|Overall Study||201||
48738035|NCT00660179|102144214|FG000|NOT COMPLETED|Overall Study||56||
48738036|NCT00660179|102144215|FG001|NOT COMPLETED|Overall Study||58||
48738037|NCT00660179|102144216|FG002|NOT COMPLETED|Overall Study||41||
48738038|NCT05274269|102144217|FG000|STARTED|Overall Study||102||
48738039|NCT05274269|102144218|FG001|STARTED|Overall Study||205||
48738040|NCT05274269|102144217|FG000|COMPLETED|Overall Study||102||
48738041|NCT05274269|102144218|FG001|COMPLETED|Overall Study||197||
48738042|NCT05274269|102144217|FG000|NOT COMPLETED|Overall Study||0||
48738043|NCT05274269|102144218|FG001|NOT COMPLETED|Overall Study||8||
48738044|NCT02159976|102144219|FG000|STARTED|Overall Study||195||
48738045|NCT02159976|102144220|FG001|STARTED|Overall Study||195||
48738046|NCT02159976|102144219|FG000|COMPLETED|Overall Study||165||
48738047|NCT02159976|102144220|FG001|COMPLETED|Overall Study||170||
48738048|NCT02159976|102144219|FG000|NOT COMPLETED|Overall Study||30||
48738049|NCT02159976|102144220|FG001|NOT COMPLETED|Overall Study||25||
48738050|NCT03145259|102144221|FG000|STARTED|Overall Study||12||
48738051|NCT03145259|102144221|FG000|COMPLETED|Overall Study||12||
48738052|NCT03145259|102144221|FG000|NOT COMPLETED|Overall Study||0||
48738053|NCT04090242|102144222|FG000|STARTED|Overall Study||28||
48738054|NCT04090242|102144223|FG001|STARTED|Overall Study||30||
48738055|NCT04090242|102144222|FG000|COMPLETED|Overall Study||27||
48738056|NCT04090242|102144223|FG001|COMPLETED|Overall Study||30||
48738057|NCT04090242|102144222|FG000|NOT COMPLETED|Overall Study||1||
48738058|NCT04090242|102144223|FG001|NOT COMPLETED|Overall Study||0||
48738059|NCT00104650|102144224|FG000|STARTED|Treatment Period (25 Weeks)||37||
48738060|NCT00104650|102144225|FG001|STARTED|Treatment Period (25 Weeks)||36||
48738061|NCT00104650|102144226|FG002|STARTED|Treatment Period (25 Weeks)||38||
48738062|NCT00104650|102144224|FG000|Received Investigational Product|Treatment Period (25 Weeks)||35||
48738063|NCT00104650|102144225|FG001|Received Investigational Product|Treatment Period (25 Weeks)||35||
48738064|NCT00104650|102144226|FG002|Received Investigational Product|Treatment Period (25 Weeks)||38||
48738065|NCT00104650|102144224|FG000|COMPLETED|Treatment Period (25 Weeks)||25||
48738066|NCT00104650|102144225|FG001|COMPLETED|Treatment Period (25 Weeks)||25||
48738067|NCT00104650|102144226|FG002|COMPLETED|Treatment Period (25 Weeks)||28||
48738068|NCT00104650|102144224|FG000|NOT COMPLETED|Treatment Period (25 Weeks)||12||
48738069|NCT00104650|102144225|FG001|NOT COMPLETED|Treatment Period (25 Weeks)||11||
48738070|NCT00104650|102144226|FG002|NOT COMPLETED|Treatment Period (25 Weeks)||10||
48738071|NCT00104650|102144224|FG000|STARTED|Follow-up Period||25||
48738072|NCT00104650|102144225|FG001|STARTED|Follow-up Period||25||
48738073|NCT00104650|102144226|FG002|STARTED|Follow-up Period||28||
48738074|NCT00104650|102144224|FG000|COMPLETED|Follow-up Period||14||
48738075|NCT00104650|102144225|FG001|COMPLETED|Follow-up Period||12||
48738076|NCT00104650|102144226|FG002|COMPLETED|Follow-up Period||18||
48738077|NCT00104650|102144224|FG000|NOT COMPLETED|Follow-up Period||11||
48738078|NCT00104650|102144225|FG001|NOT COMPLETED|Follow-up Period||13||
48738079|NCT00104650|102144226|FG002|NOT COMPLETED|Follow-up Period||10||
48738080|NCT02932748|102144227|FG000|STARTED|Overall Study||71||
48738081|NCT02932748|102144228|FG001|STARTED|Overall Study||80||
48738082|NCT02932748|102144229|FG002|STARTED|Overall Study||36||
48738083|NCT02932748|102144227|FG000|COMPLETED|Overall Study||47||
48738084|NCT02932748|102144228|FG001|COMPLETED|Overall Study||60||
48738085|NCT02932748|102144229|FG002|COMPLETED|Overall Study||28||
48738086|NCT02932748|102144227|FG000|NOT COMPLETED|Overall Study||24||
48738087|NCT02932748|102144228|FG001|NOT COMPLETED|Overall Study||20||
48738088|NCT02932748|102144229|FG002|NOT COMPLETED|Overall Study||8||
48738089|NCT00206440|102144230|FG000|STARTED|Overall Study||21||
48738090|NCT00206440|102144231|FG001|STARTED|Overall Study||22||
48738091|NCT00206440|102144230|FG000|COMPLETED|Overall Study||16||
48738092|NCT00206440|102144231|FG001|COMPLETED|Overall Study||18||
48738093|NCT00206440|102144230|FG000|NOT COMPLETED|Overall Study||5||
48738094|NCT00206440|102144231|FG001|NOT COMPLETED|Overall Study||4||
48738095|NCT00126776|102144232|FG000|STARTED|Overall Study||372||
48738096|NCT00126776|102144233|FG001|STARTED|Overall Study||371||
48738097|NCT00126776|102144232|FG000|COMPLETED|Overall Study||372||
48738098|NCT00126776|102144233|FG001|COMPLETED|Overall Study||371||
48738099|NCT00126776|102144232|FG000|NOT COMPLETED|Overall Study||0||
48738100|NCT00126776|102144233|FG001|NOT COMPLETED|Overall Study||0||
48738101|NCT00434109|102144234|FG000|STARTED|Overall Study||39||
48738102|NCT00434109|102144234|FG000|COMPLETED|Overall Study||21||
48738103|NCT00434109|102144234|FG000|NOT COMPLETED|Overall Study||18||
48738104|NCT01843023|102144235|FG000|STARTED|Overall Study||144||
48738105|NCT01843023|102144236|FG001|STARTED|Overall Study||144||
48738106|NCT01843023|102144235|FG000|3 Months|Overall Study||110||
48738107|NCT01843023|102144236|FG001|3 Months|Overall Study||114||
48738108|NCT01843023|102144235|FG000|COMPLETED|Overall Study||111||
48738109|NCT01843023|102144236|FG001|COMPLETED|Overall Study||109||
48738110|NCT01843023|102144235|FG000|NOT COMPLETED|Overall Study||33||
48738111|NCT01843023|102144236|FG001|NOT COMPLETED|Overall Study||35||
48738112|NCT00972530|102144237|FG000|STARTED|Overall Study||44||
48738113|NCT00972530|102144238|FG001|STARTED|Overall Study||46||
48738114|NCT00972530|102144237|FG000|COMPLETED|Overall Study||44||
48738115|NCT00972530|102144238|FG001|COMPLETED|Overall Study||46||
48738116|NCT00972530|102144237|FG000|NOT COMPLETED|Overall Study||0||
48738117|NCT00972530|102144238|FG001|NOT COMPLETED|Overall Study||0||
48738118|NCT02214290|102144239|FG000|STARTED|First Intervention (7 Days)||8||
48738119|NCT02214290|102144240|FG001|STARTED|First Intervention (7 Days)||8||
48738120|NCT02214290|102144239|FG000|COMPLETED|First Intervention (7 Days)||8||
48738121|NCT02214290|102144240|FG001|COMPLETED|First Intervention (7 Days)||8||
48738122|NCT02214290|102144239|FG000|NOT COMPLETED|First Intervention (7 Days)||0||
48738123|NCT02214290|102144240|FG001|NOT COMPLETED|First Intervention (7 Days)||0||
48738124|NCT02214290|102144239|FG000|STARTED|Washout (14 Days)||8||
48738125|NCT02214290|102144240|FG001|STARTED|Washout (14 Days)||8||
48738126|NCT02214290|102144239|FG000|COMPLETED|Washout (14 Days)||8||
48738127|NCT02214290|102144240|FG001|COMPLETED|Washout (14 Days)||8||
48738128|NCT02214290|102144239|FG000|NOT COMPLETED|Washout (14 Days)||0||
48738129|NCT02214290|102144240|FG001|NOT COMPLETED|Washout (14 Days)||0||
48738130|NCT02214290|102144239|FG000|STARTED|Second Intervention (7 Days)||8||
48738131|NCT02214290|102144240|FG001|STARTED|Second Intervention (7 Days)||8||
48738132|NCT02214290|102144239|FG000|COMPLETED|Second Intervention (7 Days)||8||
48738133|NCT02214290|102144240|FG001|COMPLETED|Second Intervention (7 Days)||8||
48738134|NCT02214290|102144239|FG000|NOT COMPLETED|Second Intervention (7 Days)||0||
48738135|NCT02214290|102144240|FG001|NOT COMPLETED|Second Intervention (7 Days)||0||
48738136|NCT01626092|102144241|FG000|STARTED|Overall Study||3||
48319551|NCT00807742|101107683|FG000|NOT COMPLETED|Overall Study||46||
48319552|NCT00807742|101107684|FG001|NOT COMPLETED|Overall Study||54||
48319553|NCT00964743|101107685|FG000|STARTED|Overall Study||2||
48319554|NCT00964743|101107685|FG000|COMPLETED|Overall Study||0||
48319555|NCT00964743|101107685|FG000|NOT COMPLETED|Overall Study||2||
48319556|NCT00676676|101107686|FG000|STARTED|Overall Study||9||
48319557|NCT00676676|101107686|FG000|COMPLETED|Overall Study||9||
48319558|NCT00676676|101107686|FG000|NOT COMPLETED|Overall Study||0||
48319559|NCT02225080|101107687|FG000|STARTED|Overall Study||100||
48319560|NCT02225080|101107687|FG000|COMPLETED|Overall Study||100||
48319561|NCT02225080|101107687|FG000|NOT COMPLETED|Overall Study||0||
48319562|NCT02124564|101107688|FG000|STARTED|Treatment Period||19||
48319563|NCT02124564|101107688|FG000|Started Treatment Period|Treatment Period||19||
48319564|NCT02124564|101107688|FG000|Started Titration Period|Treatment Period||19||
48319565|NCT02124564|101107688|FG000|Started AED Withdrawal Period|Treatment Period||19||
48319566|NCT02124564|101107688|FG000|Started Monotherapy Period|Treatment Period||17||
48319567|NCT02124564|101107688|FG000|Started Evaluation Period|Treatment Period||17||
48319568|NCT02124564|101107688|FG000|Started Follow-Up Period|Treatment Period||13||
48738137|NCT01626092|102144241|FG000|COMPLETED|Overall Study||3||
48738138|NCT01626092|102144241|FG000|NOT COMPLETED|Overall Study||0||
48738139|NCT03464019|102144242|FG000|STARTED|NODE-301 Part 1||60|Participants received a Test Dose|
48738140|NCT03464019|102144243|FG001|STARTED|NODE-301 Part 1||138|Participants received a Test Dose|
48738141|NCT03464019|102144244|FG002|STARTED|NODE-301 Part 1||233|Participants received a Test Dose|
48738142|NCT03464019|102144242|FG000|Participants Randomized|NODE-301 Part 1||60||
48738143|NCT03464019|102144243|FG001|Participants Randomized|NODE-301 Part 1||138||
48738144|NCT03464019|102144244|FG002|Participants Randomized|NODE-301 Part 1||233||
48738145|NCT03464019|102144242|FG000|Participants in Efficacy Population|NODE-301 Part 1||49||
48738146|NCT03464019|102144243|FG001|Participants in Efficacy Population|NODE-301 Part 1||107||
48738147|NCT03464019|102144244|FG002|Participants in Efficacy Population|NODE-301 Part 1||0||
48738148|NCT03464019|102144242|FG000|COMPLETED|NODE-301 Part 1||60|Participants in safety population|
48738149|NCT03464019|102144243|FG001|COMPLETED|NODE-301 Part 1||138|Participants in safety population|
48738150|NCT03464019|102144244|FG002|COMPLETED|NODE-301 Part 1||0|Participants in safety population|
48738151|NCT03464019|102144242|FG000|NOT COMPLETED|NODE-301 Part 1||0||
48738152|NCT03464019|102144243|FG001|NOT COMPLETED|NODE-301 Part 1||0||
48738153|NCT03464019|102144244|FG002|NOT COMPLETED|NODE-301 Part 1||233||
48319569|NCT02124564|101107688|FG000|COMPLETED|Treatment Period||12||
48319570|NCT02124564|101107688|FG000|NOT COMPLETED|Treatment Period||7||
48368056|NCT03691623|101230101|FG005|STARTED|Overall Study||21||
48738154|NCT03464019|102144242|FG000|STARTED|NODE-301 Part 2 and Part 3||143||
48738155|NCT03464019|102144243|FG001|STARTED|NODE-301 Part 2 and Part 3||160||
48738156|NCT03464019|102144244|FG002|STARTED|NODE-301 Part 2 and Part 3||445||
48738157|NCT03464019|102144242|FG000|Participants Randomized|NODE-301 Part 2 and Part 3||143||
48738158|NCT03464019|102144243|FG001|Participants Randomized|NODE-301 Part 2 and Part 3||160||
48738159|NCT03464019|102144244|FG002|Participants Randomized|NODE-301 Part 2 and Part 3||445||
48738160|NCT03464019|102144242|FG000|Participants in Efficacy Population|NODE-301 Part 2 and Part 3||100||
48738161|NCT03464019|102144243|FG001|Participants in Efficacy Population|NODE-301 Part 2 and Part 3||114||
48738162|NCT03464019|102144244|FG002|Participants in Efficacy Population|NODE-301 Part 2 and Part 3||0||
48738163|NCT03464019|102144242|FG000|COMPLETED|NODE-301 Part 2 and Part 3||76|Participants in safety population|
48738164|NCT03464019|102144243|FG001|COMPLETED|NODE-301 Part 2 and Part 3||81|Participants in safety population|
48738165|NCT03464019|102144244|FG002|COMPLETED|NODE-301 Part 2 and Part 3||0|Participants in safety population|
48738166|NCT03464019|102144242|FG000|NOT COMPLETED|NODE-301 Part 2 and Part 3||67||
48738167|NCT03464019|102144243|FG001|NOT COMPLETED|NODE-301 Part 2 and Part 3||79||
48738168|NCT03464019|102144244|FG002|NOT COMPLETED|NODE-301 Part 2 and Part 3||445||
48738169|NCT00535002|102144245|FG000|STARTED|Overall Study||19||
48738170|NCT00535002|102144246|FG001|STARTED|Overall Study||12||
48738171|NCT00535002|102144247|FG002|STARTED|Overall Study||13||
48738172|NCT00535002|102144248|FG003|STARTED|Overall Study||14||
48738173|NCT00535002|102144249|FG004|STARTED|Overall Study||9||
48738174|NCT00535002|102144250|FG005|STARTED|Overall Study||17||
48738175|NCT00535002|102144251|FG006|STARTED|Overall Study||12||
48738176|NCT00535002|102144252|FG007|STARTED|Overall Study||16||
48738177|NCT00535002|102144245|FG000|COMPLETED|Overall Study||19||
48738178|NCT00535002|102144246|FG001|COMPLETED|Overall Study||12||
48738179|NCT00535002|102144247|FG002|COMPLETED|Overall Study||13||
48738180|NCT00535002|102144248|FG003|COMPLETED|Overall Study||14||
48738181|NCT00535002|102144249|FG004|COMPLETED|Overall Study||9||
48738182|NCT00535002|102144250|FG005|COMPLETED|Overall Study||17||
48738183|NCT00535002|102144251|FG006|COMPLETED|Overall Study||12||
48738184|NCT00535002|102144252|FG007|COMPLETED|Overall Study||16||
48738185|NCT00535002|102144245|FG000|NOT COMPLETED|Overall Study||0||
48738186|NCT00535002|102144246|FG001|NOT COMPLETED|Overall Study||0||
48160709|NCT00861601|100715910|FG001|COMPLETED|Overall Study||14||
48160710|NCT00861601|100715911|FG002|COMPLETED|Overall Study||12||
48160711|NCT00861601|100715909|FG000|NOT COMPLETED|Overall Study||0||
48160712|NCT00861601|100715910|FG001|NOT COMPLETED|Overall Study||0||
48160713|NCT00861601|100715911|FG002|NOT COMPLETED|Overall Study||0||
48160714|NCT00768430|100715912|FG000|STARTED|24 Hour Endpoint||48||
48160715|NCT00768430|100715913|FG001|STARTED|24 Hour Endpoint||25||
48160716|NCT00768430|100715912|FG000|COMPLETED|24 Hour Endpoint||47||
48160717|NCT00768430|100715913|FG001|COMPLETED|24 Hour Endpoint||25||
48160718|NCT00768430|100715912|FG000|NOT COMPLETED|24 Hour Endpoint||1||
48160719|NCT00768430|100715913|FG001|NOT COMPLETED|24 Hour Endpoint||0||
48160720|NCT00768430|100715912|FG000|STARTED|7 Day Endpoint||47||
48160721|NCT00768430|100715913|FG001|STARTED|7 Day Endpoint||25||
48160722|NCT00768430|100715912|FG000|COMPLETED|7 Day Endpoint||45||
48160723|NCT00768430|100715913|FG001|COMPLETED|7 Day Endpoint||22||
48160724|NCT00768430|100715912|FG000|NOT COMPLETED|7 Day Endpoint||2||
48160725|NCT00768430|100715913|FG001|NOT COMPLETED|7 Day Endpoint||3||
48160726|NCT01396317|100715914|FG000|STARTED|Overall Study||10||
48160727|NCT01396317|100715915|FG001|STARTED|Overall Study||10||
48160728|NCT01396317|100715914|FG000|COMPLETED|Overall Study||9||
48738187|NCT00535002|102144247|FG002|NOT COMPLETED|Overall Study||0||
48738188|NCT00535002|102144248|FG003|NOT COMPLETED|Overall Study||0||
48738189|NCT00535002|102144249|FG004|NOT COMPLETED|Overall Study||0||
48738190|NCT00535002|102144250|FG005|NOT COMPLETED|Overall Study||0||
48738191|NCT00535002|102144251|FG006|NOT COMPLETED|Overall Study||0||
48738192|NCT00535002|102144252|FG007|NOT COMPLETED|Overall Study||0||
48738193|NCT00414518|102144253|FG000|STARTED|Overall Study||7||
48738194|NCT00414518|102144254|FG001|STARTED|Overall Study||9||
48738195|NCT00414518|102144253|FG000|COMPLETED|Overall Study||7||
48738196|NCT00414518|102144254|FG001|COMPLETED|Overall Study||9||
48738197|NCT00414518|102144253|FG000|NOT COMPLETED|Overall Study||0||
48738198|NCT00414518|102144254|FG001|NOT COMPLETED|Overall Study||0||
48738199|NCT01821859|102144255|FG000|STARTED|Overall Study||5||
48738200|NCT01821859|102144255|FG000|COMPLETED|Overall Study||0||
48738201|NCT01821859|102144255|FG000|NOT COMPLETED|Overall Study||5||
48738202|NCT03606187|102144256|FG000|STARTED|Overall Study||67||
48738203|NCT03606187|102144257|FG001|STARTED|Overall Study||61||
48738204|NCT03606187|102144256|FG000|COMPLETED|Overall Study||67||
48738205|NCT03606187|102144257|FG001|COMPLETED|Overall Study||61||
48738206|NCT03606187|102144256|FG000|NOT COMPLETED|Overall Study||0||
48738207|NCT03606187|102144257|FG001|NOT COMPLETED|Overall Study||0||
48738208|NCT03068754|102144258|FG000|STARTED|Randomized Treatment Period (RTP)||95||
48160729|NCT01396317|100715915|FG001|COMPLETED|Overall Study||10||
48160730|NCT01396317|100715914|FG000|NOT COMPLETED|Overall Study||1||
48160731|NCT01396317|100715915|FG001|NOT COMPLETED|Overall Study||0||
48160732|NCT00782496|100715916|FG000|STARTED|Overall Study||106||
48160733|NCT00782496|100715917|FG001|STARTED|Overall Study||105||
48160734|NCT00782496|100715916|FG000|COMPLETED|Overall Study||92||
48319571|NCT02124564|101107688|FG000|STARTED|Taper Period||2|Subjects receiving LCM \>200mg/day at the End-of-Study/Early Withdrawal Visit should be tapered off.|
48319572|NCT02124564|101107688|FG000|COMPLETED|Taper Period||2||
48319573|NCT02124564|101107688|FG000|NOT COMPLETED|Taper Period||0||
48738209|NCT03068754|102144259|FG001|STARTED|Randomized Treatment Period (RTP)||48||
48738210|NCT03068754|102144260|FG002|STARTED|Randomized Treatment Period (RTP)||0||
48738211|NCT03068754|102144261|FG003|STARTED|Randomized Treatment Period (RTP)||0||
48738212|NCT03068754|102144258|FG000|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||95||
48738213|NCT03068754|102144259|FG001|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||48||
48738214|NCT03068754|102144260|FG002|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||0||
48738215|NCT03068754|102144261|FG003|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||0||
48738216|NCT03068754|102144258|FG000|Safety Population|Randomized Treatment Period (RTP)||95||
48738217|NCT03068754|102144259|FG001|Safety Population|Randomized Treatment Period (RTP)||47||
48738218|NCT03068754|102144260|FG002|Safety Population|Randomized Treatment Period (RTP)||0||
48738219|NCT03068754|102144261|FG003|Safety Population|Randomized Treatment Period (RTP)||0||
48738220|NCT03068754|102144258|FG000|Modified ITT (mITT)|Randomized Treatment Period (RTP)||93||
48319574|NCT03650842|101107689|FG000|STARTED|Overall Study||25||
48319575|NCT03650842|101107689|FG000|COMPLETED|Overall Study||25||
48319576|NCT03650842|101107689|FG000|NOT COMPLETED|Overall Study||0||
48319577|NCT03332498|101107690|FG000|STARTED|Overall Study||4||
48319578|NCT03332498|101107691|FG001|STARTED|Overall Study||4||
48319579|NCT03332498|101107692|FG002|STARTED|Overall Study||32||
48319580|NCT03332498|101107690|FG000|COMPLETED|Overall Study||4||
48319581|NCT03332498|101107691|FG001|COMPLETED|Overall Study||4||
48319582|NCT03332498|101107692|FG002|COMPLETED|Overall Study||30||
48738221|NCT03068754|102144259|FG001|Modified ITT (mITT)|Randomized Treatment Period (RTP)||46||
48738222|NCT03068754|102144260|FG002|Modified ITT (mITT)|Randomized Treatment Period (RTP)||0||
48738223|NCT03068754|102144261|FG003|Modified ITT (mITT)|Randomized Treatment Period (RTP)||0||
48738224|NCT03068754|102144258|FG000|Completed Taper|Randomized Treatment Period (RTP)||58|Defined as completing the End of RTP Taper Visit at about Week 39 or an early termination visit|
48738225|NCT03068754|102144259|FG001|Completed Taper|Randomized Treatment Period (RTP)||28|Defined as completing the End of RTP Taper Visit at about Week 39 or an early termination visit|
48738226|NCT03068754|102144260|FG002|Completed Taper|Randomized Treatment Period (RTP)||0|Defined as completing the End of RTP Taper Visit at about Week 39 or an early termination visit|
48738227|NCT03068754|102144261|FG003|Completed Taper|Randomized Treatment Period (RTP)||0|Defined as completing the End of RTP Taper Visit at about Week 39 or an early termination visit|
48738228|NCT03068754|102144258|FG000|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||28||
48738229|NCT03068754|102144259|FG001|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||9||
48738230|NCT03068754|102144260|FG002|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||0||
48738231|NCT03068754|102144261|FG003|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||0||
48738232|NCT03068754|102144258|FG000|Completed RTP|Randomized Treatment Period (RTP)||27|Defined as completing 36 weeks of treatment, followed by Week 39 visit or entering the OLE period|
48738233|NCT03068754|102144259|FG001|Completed RTP|Randomized Treatment Period (RTP)||9|Defined as completing 36 weeks of treatment, followed by Week 39 visit or entering the OLE period|
48738234|NCT03068754|102144260|FG002|Completed RTP|Randomized Treatment Period (RTP)||0|Defined as completing 36 weeks of treatment, followed by Week 39 visit or entering the OLE period|
48738235|NCT03068754|102144261|FG003|Completed RTP|Randomized Treatment Period (RTP)||0|Defined as completing 36 weeks of treatment, followed by Week 39 visit or entering the OLE period|
48738236|NCT03068754|102144258|FG000|Enrolled in OLE Period|Randomized Treatment Period (RTP)||25||
48738237|NCT03068754|102144259|FG001|Enrolled in OLE Period|Randomized Treatment Period (RTP)||8||
48738238|NCT03068754|102144260|FG002|Enrolled in OLE Period|Randomized Treatment Period (RTP)||0||
48738239|NCT03068754|102144261|FG003|Enrolled in OLE Period|Randomized Treatment Period (RTP)||0||
48738240|NCT03068754|102144258|FG000|COMPLETED|Randomized Treatment Period (RTP)||28||
48738241|NCT03068754|102144259|FG001|COMPLETED|Randomized Treatment Period (RTP)||9||
48738242|NCT03068754|102144260|FG002|COMPLETED|Randomized Treatment Period (RTP)||0||
48738243|NCT03068754|102144261|FG003|COMPLETED|Randomized Treatment Period (RTP)||0||
48738244|NCT03068754|102144258|FG000|NOT COMPLETED|Randomized Treatment Period (RTP)||67||
48738245|NCT03068754|102144259|FG001|NOT COMPLETED|Randomized Treatment Period (RTP)||39||
48738246|NCT03068754|102144260|FG002|NOT COMPLETED|Randomized Treatment Period (RTP)||0||
48738247|NCT03068754|102144261|FG003|NOT COMPLETED|Randomized Treatment Period (RTP)||0||
48738248|NCT03068754|102144258|FG000|STARTED|Open Label Extension Period (OLE)||0|Safety Population in the OLE - 4 participants who completed RTP were not treated in the OLE|
48738249|NCT03068754|102144259|FG001|STARTED|Open Label Extension Period (OLE)||0|Safety Population in the OLE - 4 participants who completed RTP were not treated in the OLE|
48160735|NCT00782496|100715917|FG001|COMPLETED|Overall Study||90||
48319583|NCT03332498|101107690|FG000|NOT COMPLETED|Overall Study||0||
48319584|NCT03332498|101107691|FG001|NOT COMPLETED|Overall Study||0||
48319585|NCT03332498|101107692|FG002|NOT COMPLETED|Overall Study||2||
48319586|NCT04179734|101107693|FG000|STARTED|Group 1 Bremelanotide, Group 2 Placebo||20||
48319587|NCT04179734|101107694|FG001|STARTED|Group 1 Bremelanotide, Group 2 Placebo||20||
48319588|NCT04179734|101107693|FG000|COMPLETED|Group 1 Bremelanotide, Group 2 Placebo||20||
48160736|NCT00782496|100715916|FG000|NOT COMPLETED|Overall Study||14||
48319589|NCT04179734|101107694|FG001|COMPLETED|Group 1 Bremelanotide, Group 2 Placebo||20||
48319590|NCT04179734|101107693|FG000|NOT COMPLETED|Group 1 Bremelanotide, Group 2 Placebo||0||
48319591|NCT04179734|101107694|FG001|NOT COMPLETED|Group 1 Bremelanotide, Group 2 Placebo||0||
48319592|NCT04179734|101107693|FG000|STARTED|Group 1 Placebo, Group 2 Bremelanotide||20||
48319593|NCT04179734|101107694|FG001|STARTED|Group 1 Placebo, Group 2 Bremelanotide||20||
48319594|NCT04179734|101107693|FG000|COMPLETED|Group 1 Placebo, Group 2 Bremelanotide||16||
48319595|NCT04179734|101107694|FG001|COMPLETED|Group 1 Placebo, Group 2 Bremelanotide||15||
48319596|NCT04179734|101107693|FG000|NOT COMPLETED|Group 1 Placebo, Group 2 Bremelanotide||4||
48319597|NCT04179734|101107694|FG001|NOT COMPLETED|Group 1 Placebo, Group 2 Bremelanotide||5||
48319598|NCT02012621|101107695|FG000|STARTED|Overall Study||807||
48319599|NCT02012621|101107695|FG000|Visit 1 Completed|Overall Study||807||
48319600|NCT02012621|101107695|FG000|Visit 2 Completed|Overall Study||688||
48319601|NCT02012621|101107695|FG000|Visit 3 Completed|Overall Study||444||
48319602|NCT02012621|101107695|FG000|COMPLETED|Overall Study||807||
48319603|NCT02012621|101107695|FG000|NOT COMPLETED|Overall Study||0||
48319604|NCT03703102|101107696|FG000|STARTED|Overall Study||54||
48319605|NCT03703102|101107697|FG001|STARTED|Overall Study||53||
48319606|NCT03703102|101107698|FG002|STARTED|Overall Study||55||
48319607|NCT03703102|101107699|FG003|STARTED|Overall Study||54||
48319608|NCT03703102|101107700|FG004|STARTED|Overall Study||57||
48319609|NCT03703102|101107696|FG000|Completed Treatment Period A|Overall Study||42||
48319610|NCT03703102|101107697|FG001|Completed Treatment Period A|Overall Study||41||
48319611|NCT03703102|101107698|FG002|Completed Treatment Period A|Overall Study||42||
48319612|NCT03703102|101107699|FG003|Completed Treatment Period A|Overall Study||46||
48319613|NCT03703102|101107700|FG004|Completed Treatment Period A|Overall Study||34||
48319614|NCT03703102|101107696|FG000|Completed Treatment Period B|Overall Study||33||
48319615|NCT03703102|101107697|FG001|Completed Treatment Period B|Overall Study||39||
48319616|NCT03703102|101107698|FG002|Completed Treatment Period B|Overall Study||37||
48319617|NCT03703102|101107699|FG003|Completed Treatment Period B|Overall Study||38||
48319618|NCT03703102|101107700|FG004|Completed Treatment Period B|Overall Study||26||
48319619|NCT03703102|101107696|FG000|COMPLETED|Overall Study||32||
48616378|NCT02326272|101845105|FG014|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
48616379|NCT02326272|101845091|FG000|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48616380|NCT02326272|101845092|FG001|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48616381|NCT02326272|101845093|FG002|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48616382|NCT02326272|101845094|FG003|COMPLETED|Maintenance Period (Week 16 to Week 48)||5||
48616383|NCT02326272|101845095|FG004|COMPLETED|Maintenance Period (Week 16 to Week 48)||3||
48616384|NCT02326272|101845096|FG005|COMPLETED|Maintenance Period (Week 16 to Week 48)||63||
48616385|NCT02326272|101845097|FG006|COMPLETED|Maintenance Period (Week 16 to Week 48)||60||
48616386|NCT02326272|101845098|FG007|COMPLETED|Maintenance Period (Week 16 to Week 48)||27||
48616387|NCT02326272|101845099|FG008|COMPLETED|Maintenance Period (Week 16 to Week 48)||3||
48616388|NCT02326272|101845100|FG009|COMPLETED|Maintenance Period (Week 16 to Week 48)||10||
48616389|NCT02326272|101845101|FG010|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48616390|NCT02326272|101845102|FG011|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48616391|NCT02326272|101845103|FG012|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48319620|NCT03703102|101107697|FG001|COMPLETED|Overall Study||38||
48319621|NCT03703102|101107698|FG002|COMPLETED|Overall Study||33||
48319622|NCT03703102|101107699|FG003|COMPLETED|Overall Study||37||
48319623|NCT03703102|101107700|FG004|COMPLETED|Overall Study||24||
48616392|NCT02326272|101845104|FG013|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48616393|NCT02326272|101845105|FG014|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48616394|NCT02326272|101845091|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48319624|NCT03703102|101107696|FG000|NOT COMPLETED|Overall Study||22||
48616395|NCT02326272|101845092|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48616396|NCT02326272|101845093|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48616397|NCT02326272|101845094|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1||
48616398|NCT02326272|101845095|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2||
48616399|NCT02326272|101845096|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||13||
48616400|NCT02326272|101845097|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||9||
48616401|NCT02326272|101845098|FG007|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7||
48616402|NCT02326272|101845099|FG008|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5||
48616403|NCT02326272|101845100|FG009|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2||
48616404|NCT02326272|101845101|FG010|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48616405|NCT02326272|101845102|FG011|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48616406|NCT02326272|101845103|FG012|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48616407|NCT02326272|101845104|FG013|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48616408|NCT02326272|101845105|FG014|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
48616409|NCT02326272|101845091|FG000|STARTED|Open-label Period (Week 48 to Week 144)||0||
48616410|NCT02326272|101845092|FG001|STARTED|Open-label Period (Week 48 to Week 144)||0||
48616411|NCT02326272|101845093|FG002|STARTED|Open-label Period (Week 48 to Week 144)||0||
48657093|NCT03648372|101943770|FG013|NOT COMPLETED|Overall Study||7||
48319625|NCT03703102|101107697|FG001|NOT COMPLETED|Overall Study||15||
48160737|NCT00782496|100715917|FG001|NOT COMPLETED|Overall Study||15||
48160738|NCT02643862|100715918|FG000|STARTED|Overall Study||36||
48160739|NCT02643862|100715919|FG001|STARTED|Overall Study||12||
48160740|NCT02643862|100715918|FG000|COMPLETED|Overall Study||36||
48160741|NCT02643862|100715919|FG001|COMPLETED|Overall Study||12||
48160742|NCT02643862|100715918|FG000|NOT COMPLETED|Overall Study||0||
48160743|NCT02643862|100715919|FG001|NOT COMPLETED|Overall Study||0||
48160744|NCT02943941|100715920|FG000|STARTED|Overall Study||16|All participants|
48160745|NCT02943941|100715920|FG000|COMPLETED|Overall Study||16||
48160746|NCT02943941|100715920|FG000|NOT COMPLETED|Overall Study||0||
48160747|NCT02799472|100715921|FG000|STARTED|Overall Study||11||
48160748|NCT02799472|100715922|FG001|STARTED|Overall Study||28||
48160749|NCT02799472|100715921|FG000|COMPLETED|Overall Study||7||
48160750|NCT02799472|100715922|FG001|COMPLETED|Overall Study||23||
48160751|NCT02799472|100715921|FG000|NOT COMPLETED|Overall Study||4||
48160752|NCT02799472|100715922|FG001|NOT COMPLETED|Overall Study||5||
48160753|NCT03092375|100715923|FG000|STARTED|Overall Study||78||
48319626|NCT03703102|101107698|FG002|NOT COMPLETED|Overall Study||22||
48319627|NCT03703102|101107699|FG003|NOT COMPLETED|Overall Study||17||
48319628|NCT03703102|101107700|FG004|NOT COMPLETED|Overall Study||33||
48319629|NCT00514514|101107701|FG000|STARTED|Pre-phase||802||
48319630|NCT00514514|101107702|FG001|STARTED|Pre-phase||0||
48319631|NCT00514514|101107703|FG002|STARTED|Pre-phase||0||
48319632|NCT00514514|101107701|FG000|COMPLETED|Pre-phase||499||
48319633|NCT00514514|101107702|FG001|COMPLETED|Pre-phase||0||
48319634|NCT00514514|101107703|FG002|COMPLETED|Pre-phase||0||
48319635|NCT00514514|101107701|FG000|NOT COMPLETED|Pre-phase||303||
48319636|NCT00514514|101107702|FG001|NOT COMPLETED|Pre-phase||0||
48319637|NCT00514514|101107703|FG002|NOT COMPLETED|Pre-phase||0||
48319638|NCT00514514|101107701|FG000|STARTED|Randomized - 9 Month||166||
48319639|NCT00514514|101107702|FG001|STARTED|Randomized - 9 Month||171||
48319640|NCT00514514|101107703|FG002|STARTED|Randomized - 9 Month||162||
48319641|NCT00514514|101107701|FG000|Randomized - Received Treatment|Randomized - 9 Month||165||
48319642|NCT00514514|101107702|FG001|Randomized - Received Treatment|Randomized - 9 Month||171||
48319643|NCT00514514|101107703|FG002|Randomized - Received Treatment|Randomized - 9 Month||161||
48319644|NCT00514514|101107701|FG000|COMPLETED|Randomized - 9 Month||127||
48319645|NCT00514514|101107702|FG001|COMPLETED|Randomized - 9 Month||110||
48319646|NCT00514514|101107703|FG002|COMPLETED|Randomized - 9 Month||124||
48319647|NCT00514514|101107701|FG000|NOT COMPLETED|Randomized - 9 Month||39||
48319648|NCT00514514|101107702|FG001|NOT COMPLETED|Randomized - 9 Month||61||
48319649|NCT00514514|101107703|FG002|NOT COMPLETED|Randomized - 9 Month||38||
48319650|NCT00514514|101107701|FG000|STARTED|Extension - 4 Years||145||
48319651|NCT00514514|101107702|FG001|STARTED|Extension - 4 Years||139||
48319652|NCT00514514|101107703|FG002|STARTED|Extension - 4 Years||134||
48319653|NCT00514514|101107701|FG000|Non-randomized (Followed)|Extension - 4 Years||95||
48319654|NCT00514514|101107702|FG001|Non-randomized (Followed)|Extension - 4 Years||0||
48319655|NCT00514514|101107703|FG002|Non-randomized (Followed)|Extension - 4 Years||0||
48319656|NCT00514514|101107701|FG000|COMPLETED|Extension - 4 Years||108||
48319657|NCT00514514|101107702|FG001|COMPLETED|Extension - 4 Years||117||
48319658|NCT00514514|101107703|FG002|COMPLETED|Extension - 4 Years||113||
48319659|NCT00514514|101107701|FG000|NOT COMPLETED|Extension - 4 Years||37||
48319660|NCT00514514|101107702|FG001|NOT COMPLETED|Extension - 4 Years||22||
48160754|NCT03092375|100715924|FG001|STARTED|Overall Study||49||
48160755|NCT03092375|100715925|FG002|STARTED|Overall Study||21||
48160756|NCT03092375|100715926|FG003|STARTED|Overall Study||29||
48160757|NCT03092375|100715923|FG000|COMPLETED|Overall Study||78||
48160758|NCT03092375|100715924|FG001|COMPLETED|Overall Study||48||
48160759|NCT03092375|100715925|FG002|COMPLETED|Overall Study||20||
48160760|NCT03092375|100715926|FG003|COMPLETED|Overall Study||29||
48160761|NCT03092375|100715923|FG000|NOT COMPLETED|Overall Study||0||
48160762|NCT03092375|100715924|FG001|NOT COMPLETED|Overall Study||1||
48160763|NCT03092375|100715925|FG002|NOT COMPLETED|Overall Study||1||
48160764|NCT03092375|100715926|FG003|NOT COMPLETED|Overall Study||0||
48160765|NCT01995539|100715927|FG000|STARTED|Overall Study||181||
48160766|NCT01995539|100715927|FG000|COMPLETED|Overall Study||148||
48160767|NCT01995539|100715927|FG000|NOT COMPLETED|Overall Study||33||
48160768|NCT03131960|100715928|FG000|STARTED|Overall Study||53||
48160769|NCT03131960|100715929|FG001|STARTED|Overall Study||55||
48160770|NCT03131960|100715928|FG000|COMPLETED|Overall Study||53||
48319661|NCT00514514|101107703|FG002|NOT COMPLETED|Extension - 4 Years||21||
48319662|NCT01765920|101107704|FG000|STARTED|Overall Study||169||
48319663|NCT01765920|101107705|FG001|STARTED|Overall Study||173||
48319664|NCT01765920|101107704|FG000|COMPLETED|Overall Study||167||
48319665|NCT01765920|101107705|FG001|COMPLETED|Overall Study||167||
48160771|NCT03131960|100715929|FG001|COMPLETED|Overall Study||54||
48160772|NCT03131960|100715928|FG000|NOT COMPLETED|Overall Study||0||
48160773|NCT03131960|100715929|FG001|NOT COMPLETED|Overall Study||1||
48160774|NCT00402194|100715930|FG000|STARTED|Overall Study||9||
48160775|NCT00402194|100715931|FG001|STARTED|Overall Study||8||
48160776|NCT00402194|100715930|FG000|COMPLETED|Overall Study||9||
48160777|NCT00402194|100715931|FG001|COMPLETED|Overall Study||8||
48160778|NCT00402194|100715930|FG000|NOT COMPLETED|Overall Study||0||
48160779|NCT00402194|100715931|FG001|NOT COMPLETED|Overall Study||0||
48319666|NCT01765920|101107704|FG000|NOT COMPLETED|Overall Study||2||
48319667|NCT01765920|101107705|FG001|NOT COMPLETED|Overall Study||6||
48319668|NCT01717209|101107706|FG000|STARTED|Overall Study||14||
48319669|NCT01717209|101107706|FG000|COMPLETED|Overall Study||14||
48319670|NCT01717209|101107706|FG000|NOT COMPLETED|Overall Study||0||
48319671|NCT01408992|101107707|FG000|STARTED|Overall Study||558||
48319672|NCT01408992|101107707|FG000|COMPLETED|Overall Study||558||
48319673|NCT01408992|101107707|FG000|NOT COMPLETED|Overall Study||0||
48319674|NCT00361270|101107708|FG000|STARTED|Overall Study||49||
48319675|NCT00361270|101107709|FG001|STARTED|Overall Study||39||
48319676|NCT00361270|101107710|FG002|STARTED|Overall Study||35||
48319677|NCT00361270|101107711|FG003|STARTED|Overall Study||38||
48319678|NCT00361270|101107708|FG000|COMPLETED|Overall Study||25||
48319679|NCT00361270|101107709|FG001|COMPLETED|Overall Study||25||
48319680|NCT00361270|101107710|FG002|COMPLETED|Overall Study||25||
48319681|NCT00361270|101107711|FG003|COMPLETED|Overall Study||25||
48319682|NCT00361270|101107708|FG000|NOT COMPLETED|Overall Study||24||
48319683|NCT00361270|101107709|FG001|NOT COMPLETED|Overall Study||14||
48319684|NCT00361270|101107710|FG002|NOT COMPLETED|Overall Study||10||
48319685|NCT00361270|101107711|FG003|NOT COMPLETED|Overall Study||13||
48319686|NCT00885703|101107712|FG000|STARTED|Overall Study||22||
48319687|NCT00885703|101107713|FG001|STARTED|Overall Study||26||
48319688|NCT00885703|101107714|FG002|STARTED|Overall Study||24||
48319689|NCT00885703|101107715|FG003|STARTED|Overall Study||24||
48319690|NCT00885703|101107716|FG004|STARTED|Overall Study||24||
48319691|NCT00885703|101107717|FG005|STARTED|Overall Study||24||
48319692|NCT00885703|101107718|FG006|STARTED|Overall Study||24||
48319693|NCT00885703|101107712|FG000|COMPLETED|Overall Study||12||
48319694|NCT00885703|101107713|FG001|COMPLETED|Overall Study||16||
48319695|NCT00885703|101107714|FG002|COMPLETED|Overall Study||13||
48319696|NCT00885703|101107715|FG003|COMPLETED|Overall Study||15||
48319697|NCT00885703|101107716|FG004|COMPLETED|Overall Study||12||
48319698|NCT00885703|101107717|FG005|COMPLETED|Overall Study||11||
48319699|NCT00885703|101107718|FG006|COMPLETED|Overall Study||18||
48319700|NCT00885703|101107712|FG000|NOT COMPLETED|Overall Study||10||
48616412|NCT02326272|101845094|FG003|STARTED|Open-label Period (Week 48 to Week 144)||0||
48616413|NCT02326272|101845095|FG004|STARTED|Open-label Period (Week 48 to Week 144)||0||
48616414|NCT02326272|101845096|FG005|STARTED|Open-label Period (Week 48 to Week 144)||0||
48616415|NCT02326272|101845097|FG006|STARTED|Open-label Period (Week 48 to Week 144)||0||
48616416|NCT02326272|101845098|FG007|STARTED|Open-label Period (Week 48 to Week 144)||0||
48319701|NCT00885703|101107713|FG001|NOT COMPLETED|Overall Study||10||
48319702|NCT00885703|101107714|FG002|NOT COMPLETED|Overall Study||11||
48319703|NCT00885703|101107715|FG003|NOT COMPLETED|Overall Study||9||
48319704|NCT00885703|101107716|FG004|NOT COMPLETED|Overall Study||12||
48319705|NCT00885703|101107717|FG005|NOT COMPLETED|Overall Study||13||
48319706|NCT00885703|101107718|FG006|NOT COMPLETED|Overall Study||6||
48319707|NCT01827670|101107719|FG000|STARTED|Overall Study||60||
48319708|NCT01827670|101107720|FG001|STARTED|Overall Study||59||
48319709|NCT01827670|101107719|FG000|COMPLETED|Overall Study||57||
48319710|NCT01827670|101107720|FG001|COMPLETED|Overall Study||56||
48319711|NCT01827670|101107719|FG000|NOT COMPLETED|Overall Study||3||
48319712|NCT01827670|101107720|FG001|NOT COMPLETED|Overall Study||3||
48319713|NCT00781911|101107721|FG000|STARTED|Overall Study||31||
48319714|NCT00781911|101107722|FG001|STARTED|Overall Study||12||
48319715|NCT00781911|101107721|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31||
48319716|NCT00781911|101107722|FG001|Received at Least 1 Dose of Study Drug|Overall Study||12||
48319717|NCT00781911|101107721|FG000|COMPLETED|Overall Study||25||
48319718|NCT00781911|101107722|FG001|COMPLETED|Overall Study||4||
48319719|NCT00781911|101107721|FG000|NOT COMPLETED|Overall Study||6||
48319720|NCT00781911|101107722|FG001|NOT COMPLETED|Overall Study||8||
48616417|NCT02326272|101845099|FG008|STARTED|Open-label Period (Week 48 to Week 144)||0||
48616418|NCT02326272|101845100|FG009|STARTED|Open-label Period (Week 48 to Week 144)||0||
48616419|NCT02326272|101845101|FG010|STARTED|Open-label Period (Week 48 to Week 144)||5||
48616420|NCT02326272|101845102|FG011|STARTED|Open-label Period (Week 48 to Week 144)||66||
48616421|NCT02326272|101845103|FG012|STARTED|Open-label Period (Week 48 to Week 144)||59||
48616422|NCT02326272|101845104|FG013|STARTED|Open-label Period (Week 48 to Week 144)||1||
48319721|NCT02351505|101107723|FG000|STARTED|Overall Study||1||
48319722|NCT02351505|101107723|FG000|COMPLETED|Overall Study||1||
48319723|NCT02351505|101107723|FG000|NOT COMPLETED|Overall Study||0||
48319724|NCT00350142|101107724|FG000|STARTED|Overall Study||20||
48319725|NCT00350142|101107724|FG000|COMPLETED|Overall Study||20||
48319726|NCT00350142|101107724|FG000|NOT COMPLETED|Overall Study||0||
48319727|NCT01594515|101107725|FG000|STARTED|Overall Study||6||
48319728|NCT01594515|101107726|FG001|STARTED|Overall Study||6||
48319729|NCT01594515|101107727|FG002|STARTED|Overall Study||6||
48319730|NCT01594515|101107728|FG003|STARTED|Overall Study||6||
48319731|NCT01594515|101107729|FG004|STARTED|Overall Study||6||
48319732|NCT01594515|101107730|FG005|STARTED|Overall Study||6||
48319733|NCT01594515|101107731|FG006|STARTED|Overall Study||6||
48319734|NCT01594515|101107732|FG007|STARTED|Overall Study||6||
48319735|NCT01594515|101107733|FG008|STARTED|Overall Study||6||
48319736|NCT01594515|101107734|FG009|STARTED|Overall Study||16||
48319737|NCT01594515|101107725|FG000|COMPLETED|Overall Study||6||
48319738|NCT01594515|101107726|FG001|COMPLETED|Overall Study||6||
48319739|NCT01594515|101107727|FG002|COMPLETED|Overall Study||6||
48319740|NCT01594515|101107728|FG003|COMPLETED|Overall Study||6||
48319741|NCT01594515|101107729|FG004|COMPLETED|Overall Study||6||
48319742|NCT01594515|101107730|FG005|COMPLETED|Overall Study||6||
48319743|NCT01594515|101107731|FG006|COMPLETED|Overall Study||6||
48319744|NCT01594515|101107732|FG007|COMPLETED|Overall Study||6||
48319745|NCT01594515|101107733|FG008|COMPLETED|Overall Study||6||
48319746|NCT01594515|101107734|FG009|COMPLETED|Overall Study||16||
48319747|NCT01594515|101107725|FG000|NOT COMPLETED|Overall Study||0||
48319748|NCT01594515|101107726|FG001|NOT COMPLETED|Overall Study||0||
48319749|NCT01594515|101107727|FG002|NOT COMPLETED|Overall Study||0||
48319750|NCT01594515|101107728|FG003|NOT COMPLETED|Overall Study||0||
48319751|NCT01594515|101107729|FG004|NOT COMPLETED|Overall Study||0||
48319752|NCT01594515|101107730|FG005|NOT COMPLETED|Overall Study||0||
48319753|NCT01594515|101107731|FG006|NOT COMPLETED|Overall Study||0||
48319754|NCT01594515|101107732|FG007|NOT COMPLETED|Overall Study||0||
48319755|NCT01594515|101107733|FG008|NOT COMPLETED|Overall Study||0||
48319756|NCT01594515|101107734|FG009|NOT COMPLETED|Overall Study||0||
48319757|NCT03455491|101107735|FG000|STARTED|Overall Study||40||
48319758|NCT03455491|101107736|FG001|STARTED|Overall Study||40||
48319759|NCT03455491|101107737|FG002|STARTED|Overall Study||40||
48319760|NCT03455491|101107735|FG000|COMPLETED|Overall Study||40||
48319761|NCT03455491|101107736|FG001|COMPLETED|Overall Study||40||
48319762|NCT03455491|101107737|FG002|COMPLETED|Overall Study||40||
48319763|NCT03455491|101107735|FG000|NOT COMPLETED|Overall Study||0||
48319764|NCT03455491|101107736|FG001|NOT COMPLETED|Overall Study||0||
48319765|NCT03455491|101107737|FG002|NOT COMPLETED|Overall Study||0||
48319766|NCT03448068|101107738|FG000|STARTED|Overall Study||17||
48319767|NCT03448068|101107739|FG001|STARTED|Overall Study||17||
48319768|NCT03448068|101107738|FG000|COMPLETED|Overall Study||17||
48319769|NCT03448068|101107739|FG001|COMPLETED|Overall Study||17||
48319770|NCT03448068|101107738|FG000|NOT COMPLETED|Overall Study||0||
48319771|NCT03448068|101107739|FG001|NOT COMPLETED|Overall Study||0||
48319772|NCT04639973|101107740|FG000|STARTED|Overall Study||65||
48319773|NCT04639973|101107741|FG001|STARTED|Overall Study||63||
48319774|NCT04639973|101107740|FG000|COMPLETED|Overall Study||62||
48319775|NCT04639973|101107741|FG001|COMPLETED|Overall Study||62||
48319776|NCT04639973|101107740|FG000|NOT COMPLETED|Overall Study||3||
48319777|NCT04639973|101107741|FG001|NOT COMPLETED|Overall Study||1||
48319778|NCT03723707|101107742|FG000|STARTED|Overall Study||191||
48319779|NCT03723707|101107743|FG001|STARTED|Overall Study||164||
48319780|NCT03723707|101107742|FG000|COMPLETED|Overall Study||68||
48319781|NCT03723707|101107743|FG001|COMPLETED|Overall Study||78||
48319782|NCT03723707|101107742|FG000|NOT COMPLETED|Overall Study||123||
48319783|NCT03723707|101107743|FG001|NOT COMPLETED|Overall Study||86||
48319784|NCT02573870|101107744|FG000|STARTED|Overall Study||20||
48319785|NCT02573870|101107745|FG001|STARTED|Overall Study||42||
48319786|NCT02573870|101107744|FG000|COMPLETED|Overall Study||20||
48319787|NCT02573870|101107745|FG001|COMPLETED|Overall Study||35||
48319788|NCT02573870|101107744|FG000|NOT COMPLETED|Overall Study||0||
48319789|NCT02573870|101107745|FG001|NOT COMPLETED|Overall Study||7||
48319790|NCT00507559|101107746|FG000|STARTED|Overall Study||155||
48319791|NCT00507559|101107746|FG000|COMPLETED|Overall Study||84||
48319792|NCT00507559|101107746|FG000|NOT COMPLETED|Overall Study||71||
48319793|NCT03594227|101107747|FG000|STARTED|Overall Study||23||
48319794|NCT03594227|101107748|FG001|STARTED|Overall Study||23||
48319795|NCT03594227|101107749|FG002|STARTED|Overall Study||22||
48319796|NCT03594227|101107750|FG003|STARTED|Overall Study||19||
48319797|NCT03594227|101107747|FG000|COMPLETED|Overall Study||18|Includes subjects with a SALT score after D155 occurring on or before the end of treatment date +10.|
48319798|NCT03594227|101107748|FG001|COMPLETED|Overall Study||19|Includes subjects with a SALT score after D155 occurring on or before the end of treatment date +10.|
48319799|NCT03594227|101107749|FG002|COMPLETED|Overall Study||19|Includes subjects with a SALT score after D155 occurring on or before the end of treatment date +10.|
48319800|NCT03594227|101107750|FG003|COMPLETED|Overall Study||14|Includes subjects with a SALT score after D155 occurring on or before the end of treatment date +10.|
48319801|NCT03594227|101107747|FG000|NOT COMPLETED|Overall Study||5||
48319802|NCT03594227|101107748|FG001|NOT COMPLETED|Overall Study||4||
48319803|NCT03594227|101107749|FG002|NOT COMPLETED|Overall Study||3||
48319804|NCT03594227|101107750|FG003|NOT COMPLETED|Overall Study||5||
48319805|NCT00736255|101107751|FG000|STARTED|Overall Study||17||
48319806|NCT00736255|101107752|FG001|STARTED|Overall Study||15||
48319807|NCT00736255|101107751|FG000|COMPLETED|Overall Study||14||
48319808|NCT00736255|101107752|FG001|COMPLETED|Overall Study||14||
48319809|NCT00736255|101107751|FG000|NOT COMPLETED|Overall Study||3||
48319810|NCT00736255|101107752|FG001|NOT COMPLETED|Overall Study||1||
48319811|NCT01087905|101107753|FG000|STARTED|Overall Study||119||
48319812|NCT01087905|101107754|FG001|STARTED|Overall Study||126||
48319813|NCT01087905|101107755|FG002|STARTED|Overall Study||123||
48319814|NCT01087905|101107756|FG003|STARTED|Overall Study||122||
48319815|NCT01087905|101107757|FG004|STARTED|Overall Study||122||
48319816|NCT01087905|101107758|FG005|STARTED|Overall Study||127||
48319817|NCT01087905|101107759|FG006|STARTED|Overall Study||121||
48319818|NCT01087905|101107760|FG007|STARTED|Overall Study||127||
48319819|NCT01087905|101107753|FG000|COMPLETED|Overall Study||90||
48319820|NCT01087905|101107754|FG001|COMPLETED|Overall Study||94||
48319821|NCT01087905|101107755|FG002|COMPLETED|Overall Study||101||
48319822|NCT01087905|101107756|FG003|COMPLETED|Overall Study||86||
48319823|NCT01087905|101107757|FG004|COMPLETED|Overall Study||91||
48319824|NCT01087905|101107758|FG005|COMPLETED|Overall Study||99||
48319825|NCT01087905|101107759|FG006|COMPLETED|Overall Study||98||
48319826|NCT01087905|101107760|FG007|COMPLETED|Overall Study||98||
48319827|NCT01087905|101107753|FG000|NOT COMPLETED|Overall Study||29||
48319828|NCT01087905|101107754|FG001|NOT COMPLETED|Overall Study||32||
48319829|NCT01087905|101107755|FG002|NOT COMPLETED|Overall Study||22||
48319830|NCT01087905|101107756|FG003|NOT COMPLETED|Overall Study||36||
48319831|NCT01087905|101107757|FG004|NOT COMPLETED|Overall Study||31||
48319832|NCT01087905|101107758|FG005|NOT COMPLETED|Overall Study||28||
48407585|NCT02640755|101328584|FG001|STARTED|Multiple Dose Period (Day 8 - EoS)||1||
48407586|NCT02640755|101328583|FG000|COMPLETED|Multiple Dose Period (Day 8 - EoS)||1||
48407587|NCT02640755|101328584|FG001|COMPLETED|Multiple Dose Period (Day 8 - EoS)||0||
48407588|NCT02640755|101328583|FG000|NOT COMPLETED|Multiple Dose Period (Day 8 - EoS)||2||
48407589|NCT02640755|101328584|FG001|NOT COMPLETED|Multiple Dose Period (Day 8 - EoS)||1||
48407590|NCT00844415|101328585|FG000|STARTED|Overall Study||9||
48407591|NCT00844415|101328585|FG000|Pat. Received 75mg Followed by 100mg|Overall Study||3||
48407592|NCT00844415|101328585|FG000|Pat. Received 100mg Followed by 125mg|Overall Study||3||
48407593|NCT00844415|101328585|FG000|Pat. Received 125mg Followed by 150mg|Overall Study||2||
48407594|NCT00844415|101328585|FG000|Pat. Received Single Dose 75mg|Overall Study||1||
48407595|NCT00844415|101328585|FG000|COMPLETED|Overall Study||8||
48407596|NCT00844415|101328585|FG000|NOT COMPLETED|Overall Study||1||
48407597|NCT03404219|101328586|FG000|STARTED|Overall Study||31||
48407598|NCT03404219|101328586|FG000|COMPLETED|Overall Study||31||
48407599|NCT03404219|101328586|FG000|NOT COMPLETED|Overall Study||0||
48319833|NCT01087905|101107759|FG006|NOT COMPLETED|Overall Study||23||
48319834|NCT01087905|101107760|FG007|NOT COMPLETED|Overall Study||29||
48319835|NCT02587650|101107761|FG000|STARTED|Overall Study||0||
48319836|NCT02587650|101107762|FG001|STARTED|Overall Study||0||
48319837|NCT02587650|101107763|FG002|STARTED|Overall Study||1||
48319838|NCT02587650|101107764|FG003|STARTED|Overall Study||0||
48319839|NCT02587650|101107761|FG000|COMPLETED|Overall Study||0||
48319840|NCT02587650|101107762|FG001|COMPLETED|Overall Study||0||
48319841|NCT02587650|101107763|FG002|COMPLETED|Overall Study||1||
48319842|NCT02587650|101107764|FG003|COMPLETED|Overall Study||0||
48319843|NCT02587650|101107761|FG000|NOT COMPLETED|Overall Study||0||
48319844|NCT02587650|101107762|FG001|NOT COMPLETED|Overall Study||0||
48319845|NCT02587650|101107763|FG002|NOT COMPLETED|Overall Study||0||
48319846|NCT02587650|101107764|FG003|NOT COMPLETED|Overall Study||0||
48319847|NCT03061175|101107765|FG000|STARTED|Baseline||47||
48319848|NCT03061175|101107766|FG001|STARTED|Baseline||47||
48319849|NCT03061175|101107765|FG000|COMPLETED|Baseline||46||
48319850|NCT03061175|101107766|FG001|COMPLETED|Baseline||47||
48319851|NCT03061175|101107765|FG000|NOT COMPLETED|Baseline||1||
48319852|NCT03061175|101107766|FG001|NOT COMPLETED|Baseline||0||
48319853|NCT03061175|101107765|FG000|STARTED|Followup 1 at 2-4 Weeks Post-surgery||45||
48319854|NCT03061175|101107766|FG001|STARTED|Followup 1 at 2-4 Weeks Post-surgery||47||
48319855|NCT03061175|101107765|FG000|COMPLETED|Followup 1 at 2-4 Weeks Post-surgery||39||
48319856|NCT03061175|101107766|FG001|COMPLETED|Followup 1 at 2-4 Weeks Post-surgery||44||
48319857|NCT03061175|101107765|FG000|NOT COMPLETED|Followup 1 at 2-4 Weeks Post-surgery||6||
48319858|NCT03061175|101107766|FG001|NOT COMPLETED|Followup 1 at 2-4 Weeks Post-surgery||3||
48319859|NCT03061175|101107765|FG000|STARTED|Followup 2 at 6 Months||45||
48319860|NCT03061175|101107766|FG001|STARTED|Followup 2 at 6 Months||46||
48319861|NCT03061175|101107765|FG000|COMPLETED|Followup 2 at 6 Months||41||
48319862|NCT03061175|101107766|FG001|COMPLETED|Followup 2 at 6 Months||39||
48319863|NCT03061175|101107765|FG000|NOT COMPLETED|Followup 2 at 6 Months||4||
48319864|NCT03061175|101107766|FG001|NOT COMPLETED|Followup 2 at 6 Months||7||
48319865|NCT01471782|101107767|FG000|STARTED|Overall Study||5||
48319866|NCT01471782|101107768|FG001|STARTED|Overall Study||7||
48319867|NCT01471782|101107769|FG002|STARTED|Overall Study||5||
48319868|NCT01471782|101107770|FG003|STARTED|Overall Study||6||
48319869|NCT01471782|101107771|FG004|STARTED|Overall Study||26||
48319870|NCT01471782|101107772|FG005|STARTED|Overall Study||44||
48407600|NCT00488059|101328587|FG000|STARTED|Phase I: ENF 90mg SC BID||29||
48319871|NCT01471782|101107767|FG000|COMPLETED|Overall Study||0||
48319872|NCT01471782|101107768|FG001|COMPLETED|Overall Study||1||
48319873|NCT01471782|101107769|FG002|COMPLETED|Overall Study||0||
48319874|NCT01471782|101107770|FG003|COMPLETED|Overall Study||1||
48319875|NCT01471782|101107771|FG004|COMPLETED|Overall Study||0||
48319876|NCT01471782|101107772|FG005|COMPLETED|Overall Study||3||
48319877|NCT01471782|101107767|FG000|NOT COMPLETED|Overall Study||5||
48319878|NCT01471782|101107768|FG001|NOT COMPLETED|Overall Study||6||
48407601|NCT00488059|101328588|FG001|STARTED|Phase I: ENF 90mg SC BID||0||
48407602|NCT00488059|101328589|FG002|STARTED|Phase I: ENF 90mg SC BID||0||
48407603|NCT00488059|101328587|FG000|COMPLETED|Phase I: ENF 90mg SC BID||14||
48407604|NCT00488059|101328588|FG001|COMPLETED|Phase I: ENF 90mg SC BID||0||
48407605|NCT00488059|101328589|FG002|COMPLETED|Phase I: ENF 90mg SC BID||0||
48738250|NCT03068754|102144260|FG002|STARTED|Open Label Extension Period (OLE)||25|Safety Population in the OLE - 4 participants who completed RTP were not treated in the OLE|
48738251|NCT03068754|102144261|FG003|STARTED|Open Label Extension Period (OLE)||8|Safety Population in the OLE - 4 participants who completed RTP were not treated in the OLE|
48738252|NCT03068754|102144258|FG000|Completed Taper|Open Label Extension Period (OLE)||0|Completed End of Taper visits after Week 84 visit or being terminated early from the OLE period|
48738253|NCT03068754|102144259|FG001|Completed Taper|Open Label Extension Period (OLE)||0|Completed End of Taper visits after Week 84 visit or being terminated early from the OLE period|
48738254|NCT03068754|102144260|FG002|Completed Taper|Open Label Extension Period (OLE)||19|Completed End of Taper visits after Week 84 visit or being terminated early from the OLE period|
48738255|NCT03068754|102144261|FG003|Completed Taper|Open Label Extension Period (OLE)||7|Completed End of Taper visits after Week 84 visit or being terminated early from the OLE period|
48738256|NCT03068754|102144258|FG000|Completed OLE Period|Open Label Extension Period (OLE)||0|Completed Week 84 visit, End of Taper visit and follow up visit|
48160780|NCT02802501|100715932|FG000|STARTED|Double-blind (Up to Day 180)||50||
48160781|NCT02802501|100715933|FG001|STARTED|Double-blind (Up to Day 180)||50||
48160782|NCT02802501|100715934|FG002|STARTED|Double-blind (Up to Day 180)||50||
48160783|NCT02802501|100715932|FG000|COMPLETED|Double-blind (Up to Day 180)||50||
48160784|NCT02802501|100715933|FG001|COMPLETED|Double-blind (Up to Day 180)||50||
48160785|NCT02802501|100715934|FG002|COMPLETED|Double-blind (Up to Day 180)||50||
48160786|NCT02802501|100715932|FG000|NOT COMPLETED|Double-blind (Up to Day 180)||0||
48160787|NCT02802501|100715933|FG001|NOT COMPLETED|Double-blind (Up to Day 180)||0||
48160788|NCT02802501|100715934|FG002|NOT COMPLETED|Double-blind (Up to Day 180)||0||
48160789|NCT02802501|100715932|FG000|STARTED|Open-Label (Day 180 to Day 195)||6||
48160790|NCT02802501|100715933|FG001|STARTED|Open-Label (Day 180 to Day 195)||12||
48160791|NCT02802501|100715934|FG002|STARTED|Open-Label (Day 180 to Day 195)||26||
48160792|NCT02802501|100715932|FG000|COMPLETED|Open-Label (Day 180 to Day 195)||6||
48160793|NCT02802501|100715933|FG001|COMPLETED|Open-Label (Day 180 to Day 195)||12||
48160794|NCT02802501|100715934|FG002|COMPLETED|Open-Label (Day 180 to Day 195)||26||
48160795|NCT02802501|100715932|FG000|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0||
48160796|NCT02802501|100715933|FG001|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0||
48160797|NCT02802501|100715934|FG002|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0||
48616423|NCT02326272|101845105|FG014|STARTED|Open-label Period (Week 48 to Week 144)||40||
48616424|NCT02326272|101845091|FG000|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48616425|NCT02326272|101845092|FG001|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48616426|NCT02326272|101845093|FG002|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48616427|NCT02326272|101845094|FG003|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48616428|NCT02326272|101845095|FG004|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48616429|NCT02326272|101845096|FG005|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48616430|NCT02326272|101845097|FG006|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48616431|NCT02326272|101845098|FG007|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48616432|NCT02326272|101845099|FG008|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48738257|NCT03068754|102144259|FG001|Completed OLE Period|Open Label Extension Period (OLE)||0|Completed Week 84 visit, End of Taper visit and follow up visit|
48767626|NCT03678493|102222782|FG002|NOT COMPLETED|Overall Study||0||
48160798|NCT00106184|100715935|FG000|STARTED|Overall Study||96||
48160799|NCT00106184|100715936|FG001|STARTED|Overall Study||104||
48160800|NCT00106184|100715935|FG000|Treated|Overall Study||93||
48160801|NCT00106184|100715936|FG001|Treated|Overall Study||102||
48160802|NCT00106184|100715935|FG000|COMPLETED|Overall Study||93||
48160803|NCT00106184|100715936|FG001|COMPLETED|Overall Study||102||
48160804|NCT00106184|100715935|FG000|NOT COMPLETED|Overall Study||3||
48160805|NCT00106184|100715936|FG001|NOT COMPLETED|Overall Study||2||
48160806|NCT01490125|100715937|FG000|STARTED|Period I||43||
48160807|NCT01490125|100715938|FG001|STARTED|Period I||42||
48160808|NCT01490125|100715939|FG002|STARTED|Period I||41||
48160809|NCT01490125|100715940|FG003|STARTED|Period I||38||
48616433|NCT02326272|101845100|FG009|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48616434|NCT02326272|101845101|FG010|COMPLETED|Open-label Period (Week 48 to Week 144)||2||
48160810|NCT01490125|100715941|FG004|STARTED|Period I||40||
48160811|NCT01490125|100715942|FG005|STARTED|Period I||42||
48160812|NCT01490125|100715937|FG000|COMPLETED|Period I||37||
48160813|NCT01490125|100715938|FG001|COMPLETED|Period I||37||
48160814|NCT01490125|100715939|FG002|COMPLETED|Period I||37||
48160815|NCT01490125|100715940|FG003|COMPLETED|Period I||33||
48160816|NCT01490125|100715941|FG004|COMPLETED|Period I||36||
48160817|NCT01490125|100715942|FG005|COMPLETED|Period I||37||
48160818|NCT01490125|100715937|FG000|NOT COMPLETED|Period I||6||
48160819|NCT01490125|100715938|FG001|NOT COMPLETED|Period I||5||
48160820|NCT01490125|100715939|FG002|NOT COMPLETED|Period I||4||
48160821|NCT01490125|100715940|FG003|NOT COMPLETED|Period I||5||
48160822|NCT01490125|100715941|FG004|NOT COMPLETED|Period I||4||
48160823|NCT01490125|100715942|FG005|NOT COMPLETED|Period I||5||
48160824|NCT01490125|100715937|FG000|STARTED|Period II||37||
48160825|NCT01490125|100715938|FG001|STARTED|Period II||37||
48160826|NCT01490125|100715939|FG002|STARTED|Period II||37||
48160827|NCT01490125|100715940|FG003|STARTED|Period II||33||
48160828|NCT01490125|100715941|FG004|STARTED|Period II||36||
48160829|NCT01490125|100715942|FG005|STARTED|Period II||37||
48160830|NCT01490125|100715937|FG000|COMPLETED|Period II||34||
48319879|NCT01471782|101107769|FG002|NOT COMPLETED|Overall Study||5||
48319880|NCT01471782|101107770|FG003|NOT COMPLETED|Overall Study||5||
48319881|NCT01471782|101107771|FG004|NOT COMPLETED|Overall Study||26||
48319882|NCT01471782|101107772|FG005|NOT COMPLETED|Overall Study||41||
48319883|NCT01664559|101107773|FG000|STARTED|Overall Study||34||
48319884|NCT01664559|101107774|FG001|STARTED|Overall Study||33||
48319885|NCT01664559|101107773|FG000|COMPLETED|Overall Study||34||
48319886|NCT01664559|101107774|FG001|COMPLETED|Overall Study||33||
48319887|NCT01664559|101107773|FG000|NOT COMPLETED|Overall Study||0||
48319888|NCT01664559|101107774|FG001|NOT COMPLETED|Overall Study||0||
48319889|NCT00823823|101107775|FG000|STARTED|Overall Study||109||
48319890|NCT00823823|101107776|FG001|STARTED|Overall Study||107||
48319891|NCT00823823|101107775|FG000|COMPLETED|Overall Study||101||
48319892|NCT00823823|101107776|FG001|COMPLETED|Overall Study||101||
48319893|NCT00823823|101107775|FG000|NOT COMPLETED|Overall Study||8||
48319894|NCT00823823|101107776|FG001|NOT COMPLETED|Overall Study||6||
48319895|NCT04995055|101107777|FG000|STARTED|Period 1||17||
48319896|NCT04995055|101107778|FG001|STARTED|Period 1||18||
48319897|NCT04995055|101107777|FG000|COMPLETED|Period 1||12||
48319898|NCT04995055|101107778|FG001|COMPLETED|Period 1||13||
48319899|NCT04995055|101107777|FG000|NOT COMPLETED|Period 1||5||
48319900|NCT04995055|101107778|FG001|NOT COMPLETED|Period 1||5||
48319901|NCT04995055|101107777|FG000|STARTED|Period 2||12||
48319902|NCT04995055|101107778|FG001|STARTED|Period 2||13||
48319903|NCT04995055|101107777|FG000|COMPLETED|Period 2||12||
48319904|NCT04995055|101107778|FG001|COMPLETED|Period 2||13||
48319905|NCT04995055|101107777|FG000|NOT COMPLETED|Period 2||0||
48319906|NCT04995055|101107778|FG001|NOT COMPLETED|Period 2||0||
48319907|NCT01918007|101107779|FG000|STARTED|Overall Study||93||
48319908|NCT01918007|101107780|FG001|STARTED|Overall Study||93||
48319909|NCT01918007|101107779|FG000|COMPLETED|Overall Study||68||
48319910|NCT01918007|101107780|FG001|COMPLETED|Overall Study||72||
48319911|NCT01918007|101107779|FG000|NOT COMPLETED|Overall Study||25||
48319912|NCT01918007|101107780|FG001|NOT COMPLETED|Overall Study||21||
48319913|NCT01549275|101107781|FG000|STARTED|Overall Study||76||
48319914|NCT01549275|101107782|FG001|STARTED|Overall Study||29||
48319915|NCT01549275|101107781|FG000|COMPLETED|Overall Study||75||
48616435|NCT02326272|101845102|FG011|COMPLETED|Open-label Period (Week 48 to Week 144)||51||
48616436|NCT02326272|101845103|FG012|COMPLETED|Open-label Period (Week 48 to Week 144)||48||
48616437|NCT02326272|101845104|FG013|COMPLETED|Open-label Period (Week 48 to Week 144)||1||
48616438|NCT02326272|101845105|FG014|COMPLETED|Open-label Period (Week 48 to Week 144)||31||
48616439|NCT02326272|101845091|FG000|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48616440|NCT02326272|101845092|FG001|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48616441|NCT02326272|101845093|FG002|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48616442|NCT02326272|101845094|FG003|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48616443|NCT02326272|101845095|FG004|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48616444|NCT02326272|101845096|FG005|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48616445|NCT02326272|101845097|FG006|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48616446|NCT02326272|101845098|FG007|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48616447|NCT02326272|101845099|FG008|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48616448|NCT02326272|101845100|FG009|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48616449|NCT02326272|101845101|FG010|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||3||
48616450|NCT02326272|101845102|FG011|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||15||
48616451|NCT02326272|101845103|FG012|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||11||
48616452|NCT02326272|101845104|FG013|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
48616453|NCT02326272|101845105|FG014|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||9||
48616454|NCT01702909|101845106|FG000|STARTED|Overall Study||7||
48616455|NCT01702909|101845106|FG000|COMPLETED|Overall Study||7||
48616456|NCT01702909|101845106|FG000|NOT COMPLETED|Overall Study||0||
48616457|NCT00369343|101845107|FG000|STARTED|Double-blind Phase||256||
48616458|NCT00369343|101845108|FG001|STARTED|Double-blind Phase||125||
48616459|NCT00369343|101845107|FG000|COMPLETED|Double-blind Phase||212||
48616460|NCT00369343|101845108|FG001|COMPLETED|Double-blind Phase||109||
48616461|NCT00369343|101845107|FG000|NOT COMPLETED|Double-blind Phase||44||
48616462|NCT00369343|101845108|FG001|NOT COMPLETED|Double-blind Phase||16||
48319916|NCT01549275|101107782|FG001|COMPLETED|Overall Study||29||
48319917|NCT01549275|101107781|FG000|NOT COMPLETED|Overall Study||1||
48319918|NCT01549275|101107782|FG001|NOT COMPLETED|Overall Study||0||
48319919|NCT03711578|101111466|FG000|STARTED|Overall Study||20||
48319920|NCT03711578|101111466|FG000|COMPLETED|Overall Study||20||
48319921|NCT03711578|101111466|FG000|NOT COMPLETED|Overall Study||0||
48319922|NCT01372384|101111467|FG000|STARTED|Overall Study||6||
48319923|NCT01372384|101111467|FG000|COMPLETED|Overall Study||3||
48319924|NCT01372384|101111467|FG000|NOT COMPLETED|Overall Study||3||
48319925|NCT00492752|101111468|FG000|STARTED|Double Blind Treatment||134||
48319926|NCT00492752|101111469|FG001|STARTED|Double Blind Treatment||16||
48319927|NCT00492752|101111470|FG002|STARTED|Double Blind Treatment||70||
48319928|NCT00492752|101111471|FG003|STARTED|Double Blind Treatment||6||
48319929|NCT00492752|101111468|FG000|Received Treatment|Double Blind Treatment||133||
48440026|NCT01266642|101410014|FG001|NOT COMPLETED|Overall Study||1||
48319930|NCT00492752|101111469|FG001|Received Treatment|Double Blind Treatment||16||
48319931|NCT00492752|101111470|FG002|Received Treatment|Double Blind Treatment||69||
48319932|NCT00492752|101111471|FG003|Received Treatment|Double Blind Treatment||6||
48319933|NCT00492752|101111468|FG000|COMPLETED|Double Blind Treatment||120||
48319934|NCT00492752|101111469|FG001|COMPLETED|Double Blind Treatment||16||
48319935|NCT00492752|101111470|FG002|COMPLETED|Double Blind Treatment||67||
48319936|NCT00492752|101111471|FG003|COMPLETED|Double Blind Treatment||6||
48319937|NCT00492752|101111468|FG000|NOT COMPLETED|Double Blind Treatment||14||
48319938|NCT00492752|101111469|FG001|NOT COMPLETED|Double Blind Treatment||0||
48319939|NCT00492752|101111470|FG002|NOT COMPLETED|Double Blind Treatment||3||
48319940|NCT00492752|101111471|FG003|NOT COMPLETED|Double Blind Treatment||0||
48319941|NCT00492752|101111468|FG000|STARTED|Follow-up and/or Open Label Sorafenib||120||
48319942|NCT00492752|101111469|FG001|STARTED|Follow-up and/or Open Label Sorafenib||16||
48319943|NCT00492752|101111470|FG002|STARTED|Follow-up and/or Open Label Sorafenib||67||
48319944|NCT00492752|101111471|FG003|STARTED|Follow-up and/or Open Label Sorafenib||6||
48319945|NCT00492752|101111468|FG000|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||120||
48319946|NCT00492752|101111469|FG001|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0||
48319947|NCT00492752|101111470|FG002|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||67||
48319948|NCT00492752|101111471|FG003|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0||
48319949|NCT00492752|101111468|FG000|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0||
48319950|NCT00492752|101111469|FG001|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||16||
48319951|NCT00492752|101111470|FG002|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0||
48319952|NCT00492752|101111471|FG003|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||6||
48319953|NCT00492752|101111468|FG000|COMPLETED|Follow-up and/or Open Label Sorafenib||34||
48319954|NCT00492752|101111469|FG001|COMPLETED|Follow-up and/or Open Label Sorafenib||0||
48319955|NCT00492752|101111470|FG002|COMPLETED|Follow-up and/or Open Label Sorafenib||20||
48319956|NCT00492752|101111471|FG003|COMPLETED|Follow-up and/or Open Label Sorafenib||0||
48319957|NCT00492752|101111468|FG000|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||86||
48319958|NCT00492752|101111469|FG001|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||16||
48319959|NCT00492752|101111470|FG002|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||47||
48319960|NCT00492752|101111471|FG003|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||6||
48319961|NCT00766532|101111472|FG000|STARTED|Overall Study||12||
48319962|NCT00766532|101111472|FG000|COMPLETED|Overall Study||10||
48319963|NCT00766532|101111472|FG000|NOT COMPLETED|Overall Study||2||
48319964|NCT03923426|101111473|FG000|STARTED|Overall Study||572|All enrolled|
48319965|NCT03923426|101111473|FG000|Full Analysis Set|Overall Study||569|All eligible participants among enrolled|
48319966|NCT03923426|101111473|FG000|COMPLETED|Overall Study||417|Followed through medical records up to 60 days after hospital discharge|
48319967|NCT03923426|101111473|FG000|NOT COMPLETED|Overall Study||155||
48319968|NCT00894556|101111474|FG000|STARTED|Baseline Phase||0||
48319969|NCT00894556|101111475|FG001|STARTED|Baseline Phase||0||
48319970|NCT00894556|101111476|FG002|STARTED|Baseline Phase||0||
48407606|NCT00488059|101328587|FG000|NOT COMPLETED|Phase I: ENF 90mg SC BID||15||
48407607|NCT00488059|101328588|FG001|NOT COMPLETED|Phase I: ENF 90mg SC BID||0||
48407608|NCT00488059|101328589|FG002|NOT COMPLETED|Phase I: ENF 90mg SC BID||0||
48407609|NCT00488059|101328587|FG000|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0||
48407610|NCT00488059|101328588|FG001|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||9||
48407611|NCT00488059|101328589|FG002|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0||
48319971|NCT00894556|101111477|FG003|STARTED|Baseline Phase||194||
48319972|NCT00894556|101111474|FG000|COMPLETED|Baseline Phase||0||
48319973|NCT00894556|101111475|FG001|COMPLETED|Baseline Phase||0||
48407612|NCT00488059|101328587|FG000|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0||
48407613|NCT00488059|101328588|FG001|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||7||
48407614|NCT00488059|101328589|FG002|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0||
48407615|NCT00488059|101328587|FG000|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0||
48407616|NCT00488059|101328588|FG001|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||2||
48407617|NCT00488059|101328589|FG002|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0||
48319974|NCT00894556|101111476|FG002|COMPLETED|Baseline Phase||0||
48319975|NCT00894556|101111477|FG003|COMPLETED|Baseline Phase||109||
48319976|NCT00894556|101111474|FG000|NOT COMPLETED|Baseline Phase||0||
48319977|NCT00894556|101111475|FG001|NOT COMPLETED|Baseline Phase||0||
48319978|NCT00894556|101111476|FG002|NOT COMPLETED|Baseline Phase||0||
48407618|NCT00488059|101328587|FG000|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0||
48407619|NCT00488059|101328588|FG001|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0||
48407620|NCT00488059|101328589|FG002|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||5||
48407621|NCT00488059|101328587|FG000|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0||
48319979|NCT00894556|101111477|FG003|NOT COMPLETED|Baseline Phase||85||
48319980|NCT00894556|101111474|FG000|STARTED|Treatment Phase||37||
48319981|NCT00894556|101111475|FG001|STARTED|Treatment Phase||36||
48319982|NCT00894556|101111476|FG002|STARTED|Treatment Phase||36||
48319983|NCT00894556|101111477|FG003|STARTED|Treatment Phase||0||
48319984|NCT00894556|101111474|FG000|COMPLETED|Treatment Phase||33||
48407622|NCT00488059|101328588|FG001|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0||
48319985|NCT00894556|101111475|FG001|COMPLETED|Treatment Phase||32||
48319986|NCT00894556|101111476|FG002|COMPLETED|Treatment Phase||35||
48319987|NCT00894556|101111477|FG003|COMPLETED|Treatment Phase||0||
48319988|NCT00894556|101111474|FG000|NOT COMPLETED|Treatment Phase||4||
48319989|NCT00894556|101111475|FG001|NOT COMPLETED|Treatment Phase||4||
48319990|NCT00894556|101111476|FG002|NOT COMPLETED|Treatment Phase||1||
48319991|NCT00894556|101111477|FG003|NOT COMPLETED|Treatment Phase||0||
48319992|NCT01834274|101111478|FG000|STARTED|Overall Study||50||
48319993|NCT01834274|101111479|FG001|STARTED|Overall Study||46||
48319994|NCT01834274|101111478|FG000|COMPLETED|Overall Study||3||
48319995|NCT01834274|101111479|FG001|COMPLETED|Overall Study||5||
48319996|NCT01834274|101111478|FG000|NOT COMPLETED|Overall Study||47||
48319997|NCT01834274|101111479|FG001|NOT COMPLETED|Overall Study||41||
48319998|NCT00769184|101111480|FG000|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7||
48319999|NCT00769184|101111481|FG001|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||8||
48407623|NCT00488059|101328589|FG002|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||1||
48407624|NCT00488059|101328587|FG000|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0||
48407625|NCT00488059|101328588|FG001|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0||
48407626|NCT00488059|101328589|FG002|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||4||
48407627|NCT03139435|101328590|FG000|STARTED|Overall Study||20||20
48407628|NCT03139435|101328591|FG001|STARTED|Overall Study||60||120
48407629|NCT03139435|101328590|FG000|COMPLETED|Overall Study||20||20
48407630|NCT03139435|101328591|FG001|COMPLETED|Overall Study||60||120
48407631|NCT03139435|101328590|FG000|NOT COMPLETED|Overall Study||0||0
48407632|NCT03139435|101328591|FG001|NOT COMPLETED|Overall Study||0||0
48407633|NCT01365091|101328592|FG000|STARTED|Period 1||28||
48407634|NCT01365091|101328593|FG001|STARTED|Period 1||28||
48407635|NCT01365091|101328594|FG002|STARTED|Period 1||28||
48407636|NCT01365091|101328595|FG003|STARTED|Period 1||28||
48407637|NCT01365091|101328592|FG000|COMPLETED|Period 1||26||
48407638|NCT01365091|101328593|FG001|COMPLETED|Period 1||26||
48407639|NCT01365091|101328594|FG002|COMPLETED|Period 1||25||
48407640|NCT01365091|101328595|FG003|COMPLETED|Period 1||25||
48407641|NCT01365091|101328592|FG000|NOT COMPLETED|Period 1||2||
48407642|NCT01365091|101328593|FG001|NOT COMPLETED|Period 1||2||
48407643|NCT01365091|101328594|FG002|NOT COMPLETED|Period 1||3||
48407644|NCT01365091|101328595|FG003|NOT COMPLETED|Period 1||3||
48407645|NCT01365091|101328592|FG000|STARTED|Period 2||26||
48407646|NCT01365091|101328593|FG001|STARTED|Period 2||26||
48407647|NCT01365091|101328594|FG002|STARTED|Period 2||25||
48407648|NCT01365091|101328595|FG003|STARTED|Period 2||25||
48407649|NCT01365091|101328592|FG000|COMPLETED|Period 2||25||
48407650|NCT01365091|101328593|FG001|COMPLETED|Period 2||26||
48616463|NCT00369343|101845107|FG000|STARTED|Open-label Phase||212||
48616464|NCT00369343|101845108|FG001|STARTED|Open-label Phase||109||
48616465|NCT00369343|101845107|FG000|COMPLETED|Open-label Phase||155||
48616466|NCT00369343|101845108|FG001|COMPLETED|Open-label Phase||79||
48616467|NCT00369343|101845107|FG000|NOT COMPLETED|Open-label Phase||57||
48616468|NCT00369343|101845108|FG001|NOT COMPLETED|Open-label Phase||30||
48616469|NCT00048035|101845109|FG000|STARTED|Core Period||15||
48616470|NCT00048035|101845110|FG001|STARTED|Core Period||15||
48616471|NCT00048035|101845111|FG002|STARTED|Core Period||15||
48616472|NCT00048035|101845112|FG003|STARTED|Core Period||15||
48616473|NCT00048035|101845113|FG004|STARTED|Core Period||16||
48616474|NCT00048035|101845114|FG005|STARTED|Core Period||15||
48616475|NCT00048035|101845115|FG006|STARTED|Core Period||0||
48616476|NCT00048035|101845116|FG007|STARTED|Core Period||0||
48616477|NCT00048035|101845109|FG000|COMPLETED|Core Period||11||
48616478|NCT00048035|101845110|FG001|COMPLETED|Core Period||13||
48616479|NCT00048035|101845111|FG002|COMPLETED|Core Period||14||
48616480|NCT00048035|101845112|FG003|COMPLETED|Core Period||14||
48320000|NCT00769184|101111480|FG000|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||6||
48320001|NCT00769184|101111481|FG001|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7||
48320002|NCT00769184|101111480|FG000|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1||
48407651|NCT01365091|101328594|FG002|COMPLETED|Period 2||24||
48407652|NCT01365091|101328595|FG003|COMPLETED|Period 2||25||
48407653|NCT01365091|101328592|FG000|NOT COMPLETED|Period 2||1||
48407654|NCT01365091|101328593|FG001|NOT COMPLETED|Period 2||0||
48407655|NCT01365091|101328594|FG002|NOT COMPLETED|Period 2||1||
48407656|NCT01365091|101328595|FG003|NOT COMPLETED|Period 2||0||
48407657|NCT02691468|101328596|FG000|STARTED|Overall Study||54||
48407658|NCT02691468|101328597|FG001|STARTED|Overall Study||54||
48407659|NCT02691468|101328596|FG000|COMPLETED|Overall Study||48||
48407660|NCT02691468|101328597|FG001|COMPLETED|Overall Study||52||
48407661|NCT02691468|101328596|FG000|NOT COMPLETED|Overall Study||6||
48407662|NCT02691468|101328597|FG001|NOT COMPLETED|Overall Study||2||
48616481|NCT00048035|101845113|FG004|COMPLETED|Core Period||15||
48616482|NCT00048035|101845114|FG005|COMPLETED|Core Period||14||
48407663|NCT00360672|101328598|FG000|STARTED|Overall Study||27||
48407664|NCT00360672|101328598|FG000|COMPLETED|Overall Study||27||
48407665|NCT00360672|101328598|FG000|NOT COMPLETED|Overall Study||0||
48407666|NCT00744692|101328599|FG000|STARTED|Overall Study||22||
48616483|NCT00048035|101845115|FG006|COMPLETED|Core Period||0||
48616484|NCT00048035|101845116|FG007|COMPLETED|Core Period||0||
48616485|NCT00048035|101845109|FG000|NOT COMPLETED|Core Period||4||
48407667|NCT00744692|101328599|FG000|COMPLETED|Overall Study||22||
48407668|NCT00744692|101328599|FG000|NOT COMPLETED|Overall Study||0||
48407669|NCT01099761|101328600|FG000|STARTED|Overall Study||9||
48407670|NCT01099761|101328601|FG001|STARTED|Overall Study||9||
48407671|NCT01099761|101328602|FG002|STARTED|Overall Study||0||
48407672|NCT01099761|101328603|FG003|STARTED|Overall Study||6||
48407673|NCT01099761|101328600|FG000|COMPLETED|Overall Study||9||
48407674|NCT01099761|101328601|FG001|COMPLETED|Overall Study||9||
48407675|NCT01099761|101328602|FG002|COMPLETED|Overall Study||0||
48320003|NCT00769184|101111481|FG001|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1||
48320004|NCT00769184|101111480|FG000|STARTED|+LCD / +Placebo Only (4 Weeks)||6||
48320005|NCT00769184|101111481|FG001|STARTED|+LCD / +Placebo Only (4 Weeks)||7||
48320006|NCT00769184|101111480|FG000|COMPLETED|+LCD / +Placebo Only (4 Weeks)||6||
48320007|NCT00769184|101111481|FG001|COMPLETED|+LCD / +Placebo Only (4 Weeks)||7||
48320008|NCT00769184|101111480|FG000|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0||
48320009|NCT00769184|101111481|FG001|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0||
48320010|NCT00769184|101111480|FG000|STARTED|No Treatment (6 Weeks)||6||
48320011|NCT00769184|101111481|FG001|STARTED|No Treatment (6 Weeks)||7||
48320012|NCT00769184|101111480|FG000|COMPLETED|No Treatment (6 Weeks)||5||
48320013|NCT00769184|101111481|FG001|COMPLETED|No Treatment (6 Weeks)||6||
48320014|NCT00769184|101111480|FG000|NOT COMPLETED|No Treatment (6 Weeks)||1||
48407676|NCT01099761|101328603|FG003|COMPLETED|Overall Study||6||
48407677|NCT01099761|101328600|FG000|NOT COMPLETED|Overall Study||0||
48407678|NCT01099761|101328601|FG001|NOT COMPLETED|Overall Study||0||
48320015|NCT00769184|101111481|FG001|NOT COMPLETED|No Treatment (6 Weeks)||1||
48320016|NCT02681172|101111482|FG000|STARTED|Overall Study||218||
48320017|NCT02681172|101111482|FG000|Safety Analysis Set|Overall Study||205||
48320018|NCT02681172|101111482|FG000|Full Analysis Set|Overall Study||205||
48320019|NCT02681172|101111482|FG000|Per Protocol Set|Overall Study||205||
48320020|NCT02681172|101111482|FG000|COMPLETED|Overall Study||205||
48320021|NCT02681172|101111482|FG000|NOT COMPLETED|Overall Study||13||
48320022|NCT00982865|101111483|FG000|STARTED|Overall Study||49||
48320023|NCT00982865|101111484|FG001|STARTED|Overall Study||82||
48320024|NCT00982865|101111485|FG002|STARTED|Overall Study||15||
48320025|NCT00982865|101111486|FG003|STARTED|Overall Study||34||
48320026|NCT00982865|101111483|FG000|COMPLETED|Overall Study||49||
48320027|NCT00982865|101111484|FG001|COMPLETED|Overall Study||82||
48320028|NCT00982865|101111485|FG002|COMPLETED|Overall Study||15||
48320029|NCT00982865|101111486|FG003|COMPLETED|Overall Study||34||
48320030|NCT00982865|101111483|FG000|NOT COMPLETED|Overall Study||0||
48320031|NCT00982865|101111484|FG001|NOT COMPLETED|Overall Study||0||
48320032|NCT00982865|101111485|FG002|NOT COMPLETED|Overall Study||0||
48320033|NCT00982865|101111486|FG003|NOT COMPLETED|Overall Study||0||
48320034|NCT01332357|101111487|FG000|STARTED|Overall Study||6139||
48407679|NCT01099761|101328602|FG002|NOT COMPLETED|Overall Study||0||
48407680|NCT01099761|101328603|FG003|NOT COMPLETED|Overall Study||0||
48407681|NCT01866306|101328604|FG000|STARTED|Overall Study||6||
48407682|NCT01866306|101328605|FG001|STARTED|Overall Study||6||
48407683|NCT01866306|101328606|FG002|STARTED|Overall Study||6||
48407684|NCT01866306|101328607|FG003|STARTED|Overall Study||6||
48407685|NCT01866306|101328608|FG004|STARTED|Overall Study||6||
48407686|NCT01866306|101328609|FG005|STARTED|Overall Study||6||
48407687|NCT01866306|101328610|FG006|STARTED|Overall Study||23||
48407688|NCT01866306|101328604|FG000|COMPLETED|Overall Study||6||
48407689|NCT01866306|101328605|FG001|COMPLETED|Overall Study||6||
48407690|NCT01866306|101328606|FG002|COMPLETED|Overall Study||6||
48407691|NCT01866306|101328607|FG003|COMPLETED|Overall Study||6||
48407692|NCT01866306|101328608|FG004|COMPLETED|Overall Study||6||
48407693|NCT01866306|101328609|FG005|COMPLETED|Overall Study||6||
48320035|NCT01332357|101111487|FG000|COMPLETED|Overall Study||6139||
48320036|NCT01332357|101111487|FG000|NOT COMPLETED|Overall Study||0||
48320037|NCT02081534|101111488|FG000|STARTED|Overall Study||23||
48320038|NCT02081534|101111489|FG001|STARTED|Overall Study||21||
48407694|NCT01866306|101328610|FG006|COMPLETED|Overall Study||23||
48407695|NCT01866306|101328604|FG000|NOT COMPLETED|Overall Study||0||
48407696|NCT01866306|101328605|FG001|NOT COMPLETED|Overall Study||0||
48407697|NCT01866306|101328606|FG002|NOT COMPLETED|Overall Study||0||
48616486|NCT00048035|101845110|FG001|NOT COMPLETED|Core Period||2||
48616487|NCT00048035|101845111|FG002|NOT COMPLETED|Core Period||1||
48616488|NCT00048035|101845112|FG003|NOT COMPLETED|Core Period||1||
48320039|NCT02081534|101111490|FG002|STARTED|Overall Study||23||
48320040|NCT02081534|101111491|FG003|STARTED|Overall Study||26||
48320041|NCT02081534|101111492|FG004|STARTED|Overall Study||22||
48407698|NCT01866306|101328607|FG003|NOT COMPLETED|Overall Study||0||
48407699|NCT01866306|101328608|FG004|NOT COMPLETED|Overall Study||0||
48407700|NCT01866306|101328609|FG005|NOT COMPLETED|Overall Study||0||
48407701|NCT01866306|101328610|FG006|NOT COMPLETED|Overall Study||0||
48407702|NCT02058251|101328611|FG000|STARTED|Overall Study||35||
48407703|NCT02058251|101328612|FG001|STARTED|Overall Study||38||
48320042|NCT02081534|101111493|FG005|STARTED|Overall Study||21||
48407704|NCT02058251|101328611|FG000|COMPLETED|Overall Study||35||
48320043|NCT02081534|101111494|FG006|STARTED|Overall Study||26||
48320044|NCT02081534|101111488|FG000|COMPLETED|Overall Study||18||
48407705|NCT02058251|101328612|FG001|COMPLETED|Overall Study||38||
48320045|NCT02081534|101111489|FG001|COMPLETED|Overall Study||13||
48320046|NCT02081534|101111490|FG002|COMPLETED|Overall Study||19||
48320047|NCT02081534|101111491|FG003|COMPLETED|Overall Study||13||
48320048|NCT02081534|101111492|FG004|COMPLETED|Overall Study||18||
48320049|NCT02081534|101111493|FG005|COMPLETED|Overall Study||12||
48320050|NCT02081534|101111494|FG006|COMPLETED|Overall Study||22||
48320051|NCT02081534|101111488|FG000|NOT COMPLETED|Overall Study||5||
48320052|NCT02081534|101111489|FG001|NOT COMPLETED|Overall Study||8||
48320053|NCT02081534|101111490|FG002|NOT COMPLETED|Overall Study||4||
48320054|NCT02081534|101111491|FG003|NOT COMPLETED|Overall Study||13||
48320055|NCT02081534|101111492|FG004|NOT COMPLETED|Overall Study||4||
48320056|NCT02081534|101111493|FG005|NOT COMPLETED|Overall Study||9||
48320057|NCT02081534|101111494|FG006|NOT COMPLETED|Overall Study||4||
48320058|NCT02807480|101111495|FG000|STARTED|Overall Study||46||
48320059|NCT02807480|101111496|FG001|STARTED|Overall Study||48||
48320060|NCT02807480|101111495|FG000|COMPLETED|Overall Study||32||
48320061|NCT02807480|101111496|FG001|COMPLETED|Overall Study||38||
48320062|NCT02807480|101111495|FG000|NOT COMPLETED|Overall Study||14||
48320063|NCT02807480|101111496|FG001|NOT COMPLETED|Overall Study||10||
48320064|NCT02829307|101111497|FG000|STARTED|Overall Study||8||
48320065|NCT02829307|101111497|FG000|COMPLETED|Overall Study||8||
48320066|NCT02829307|101111497|FG000|NOT COMPLETED|Overall Study||0||
48320067|NCT01675635|101111498|FG000|STARTED|Overall Study||117||
48320068|NCT01675635|101111499|FG001|STARTED|Overall Study||117||
48320069|NCT01675635|101111498|FG000|COMPLETED|Overall Study||117||
48320070|NCT01675635|101111499|FG001|COMPLETED|Overall Study||117||
48320071|NCT01675635|101111498|FG000|NOT COMPLETED|Overall Study||0||
48320072|NCT01675635|101111499|FG001|NOT COMPLETED|Overall Study||0||
48320073|NCT02031770|101111500|FG000|STARTED|Overall Study||10||
48320074|NCT02031770|101111501|FG001|STARTED|Overall Study||10||
48320075|NCT02031770|101111500|FG000|COMPLETED|Overall Study||9||
48320076|NCT02031770|101111501|FG001|COMPLETED|Overall Study||9||
48320077|NCT02031770|101111500|FG000|NOT COMPLETED|Overall Study||1||
48320078|NCT02031770|101111501|FG001|NOT COMPLETED|Overall Study||1||
48320079|NCT00777101|101111502|FG000|STARTED|Overall Study||117||
48320080|NCT00777101|101111503|FG001|STARTED|Overall Study||116||
48320081|NCT00777101|101111502|FG000|Treated|Overall Study||116||
48320082|NCT00777101|101111503|FG001|Treated|Overall Study||115||
48320083|NCT00777101|101111502|FG000|COMPLETED|Overall Study||55||
48320084|NCT00777101|101111503|FG001|COMPLETED|Overall Study||65||
48320085|NCT00777101|101111502|FG000|NOT COMPLETED|Overall Study||62||
48320086|NCT00777101|101111503|FG001|NOT COMPLETED|Overall Study||51||
48320087|NCT00961220|101111504|FG000|STARTED|Overall Study||17||
48320088|NCT00961220|101111504|FG000|COMPLETED|Overall Study||10||
48320089|NCT00961220|101111504|FG000|NOT COMPLETED|Overall Study||7||
48320090|NCT02257372|101111505|FG000|STARTED|Overall Study||117||
48320091|NCT02257372|101111506|FG001|STARTED|Overall Study||119||
48320092|NCT02257372|101111505|FG000|COMPLETED|Overall Study||110||
48320093|NCT02257372|101111506|FG001|COMPLETED|Overall Study||109||
48320094|NCT02257372|101111505|FG000|NOT COMPLETED|Overall Study||7||
48320095|NCT02257372|101111506|FG001|NOT COMPLETED|Overall Study||10||
48320096|NCT02701868|101111507|FG000|STARTED|Overall Study||21||
48320097|NCT02701868|101111508|FG001|STARTED|Overall Study||75||
48320098|NCT02701868|101111509|FG002|STARTED|Overall Study||75||
48320099|NCT02701868|101111507|FG000|COMPLETED|Overall Study||21||
48320100|NCT02701868|101111508|FG001|COMPLETED|Overall Study||75||
48320101|NCT02701868|101111509|FG002|COMPLETED|Overall Study||75||
48320102|NCT02701868|101111507|FG000|NOT COMPLETED|Overall Study||0||
48320103|NCT02701868|101111508|FG001|NOT COMPLETED|Overall Study||0||
48320104|NCT02701868|101111509|FG002|NOT COMPLETED|Overall Study||0||
48320105|NCT01901575|101111510|FG000|STARTED|Overall Study||16||
48320106|NCT01901575|101111510|FG000|COMPLETED|Overall Study||16||
48320107|NCT01901575|101111510|FG000|NOT COMPLETED|Overall Study||0||
48320108|NCT01251653|101111511|FG000|STARTED|Overall Study||3||
48320109|NCT01251653|101111512|FG001|STARTED|Overall Study||8||
48320110|NCT01251653|101111513|FG002|STARTED|Overall Study||20||
48320111|NCT01251653|101111514|FG003|STARTED|Overall Study||6||
48320112|NCT01251653|101111515|FG004|STARTED|Overall Study||2||
48320113|NCT01251653|101111516|FG005|STARTED|Overall Study||18||
48320114|NCT01251653|101111517|FG006|STARTED|Overall Study||18||
48320115|NCT01251653|101111518|FG007|STARTED|Overall Study||12||
48320116|NCT01251653|101111519|FG008|STARTED|Overall Study||6||
48320117|NCT01251653|101111511|FG000|COMPLETED|Overall Study||0||
48320118|NCT01251653|101111512|FG001|COMPLETED|Overall Study||0||
48320119|NCT01251653|101111513|FG002|COMPLETED|Overall Study||0||
48320120|NCT01251653|101111514|FG003|COMPLETED|Overall Study||0||
48320121|NCT01251653|101111515|FG004|COMPLETED|Overall Study||0||
48320122|NCT01251653|101111516|FG005|COMPLETED|Overall Study||0||
48320123|NCT01251653|101111517|FG006|COMPLETED|Overall Study||0||
48320124|NCT01251653|101111518|FG007|COMPLETED|Overall Study||0||
48320125|NCT01251653|101111519|FG008|COMPLETED|Overall Study||0||
48320126|NCT01251653|101111511|FG000|NOT COMPLETED|Overall Study||3||
48320127|NCT01251653|101111512|FG001|NOT COMPLETED|Overall Study||8||
48320128|NCT01251653|101111513|FG002|NOT COMPLETED|Overall Study||20||
48320129|NCT01251653|101111514|FG003|NOT COMPLETED|Overall Study||6||
48320130|NCT01251653|101111515|FG004|NOT COMPLETED|Overall Study||2||
48320131|NCT01251653|101111516|FG005|NOT COMPLETED|Overall Study||18||
48320132|NCT01251653|101111517|FG006|NOT COMPLETED|Overall Study||18||
48320133|NCT01251653|101111518|FG007|NOT COMPLETED|Overall Study||12||
48320134|NCT01251653|101111519|FG008|NOT COMPLETED|Overall Study||6||
48320135|NCT01500278|101111520|FG000|STARTED|Week 0 - Week 12||457||
48320136|NCT01500278|101111521|FG001|STARTED|Week 0 - Week 12||458||
48320137|NCT01500278|101111520|FG000|COMPLETED|Week 0 - Week 12||426||
48320138|NCT01500278|101111521|FG001|COMPLETED|Week 0 - Week 12||428||
48320139|NCT01500278|101111520|FG000|NOT COMPLETED|Week 0 - Week 12||31||
48320140|NCT01500278|101111521|FG001|NOT COMPLETED|Week 0 - Week 12||30||
48320141|NCT01500278|101111520|FG000|STARTED|Week 13 - Week 104||426||
48320142|NCT01500278|101111521|FG001|STARTED|Week 13 - Week 104||428||
48320143|NCT01500278|101111520|FG000|COMPLETED|Week 13 - Week 104||287||
48320144|NCT01500278|101111521|FG001|COMPLETED|Week 13 - Week 104||302||
48320145|NCT01500278|101111520|FG000|NOT COMPLETED|Week 13 - Week 104||139||
48320146|NCT01500278|101111521|FG001|NOT COMPLETED|Week 13 - Week 104||126||
48320147|NCT03363321|101111522|FG000|STARTED|Overall Study||5||
48320148|NCT03363321|101111523|FG001|STARTED|Overall Study||4||
48320149|NCT03363321|101111524|FG002|STARTED|Overall Study||4||
48320150|NCT03363321|101111525|FG003|STARTED|Overall Study||5||
48320151|NCT03363321|101111526|FG004|STARTED|Overall Study||2||
48320152|NCT03363321|101111522|FG000|COMPLETED|Overall Study||5||
48320153|NCT03363321|101111523|FG001|COMPLETED|Overall Study||3||
48320154|NCT03363321|101111524|FG002|COMPLETED|Overall Study||4||
48320155|NCT03363321|101111525|FG003|COMPLETED|Overall Study||4||
48320156|NCT03363321|101111526|FG004|COMPLETED|Overall Study||2||
48320157|NCT03363321|101111522|FG000|NOT COMPLETED|Overall Study||0||
48320158|NCT03363321|101111523|FG001|NOT COMPLETED|Overall Study||1||
48320159|NCT03363321|101111524|FG002|NOT COMPLETED|Overall Study||0||
48320160|NCT03363321|101111525|FG003|NOT COMPLETED|Overall Study||1||
48320161|NCT03363321|101111526|FG004|NOT COMPLETED|Overall Study||0||
48320162|NCT01783080|101111527|FG000|STARTED|Overall Study||16||
48320163|NCT01783080|101111527|FG000|COMPLETED|Overall Study||16||
48320164|NCT01783080|101111527|FG000|NOT COMPLETED|Overall Study||0||
48320165|NCT01505634|101111528|FG000|STARTED|Overall Study||101||
48320166|NCT01505634|101111529|FG001|STARTED|Overall Study||101||
48320167|NCT01505634|101111530|FG002|STARTED|Overall Study||100||
48320168|NCT01505634|101111528|FG000|Treated|Overall Study||99||
48320169|NCT01505634|101111529|FG001|Treated|Overall Study||99||
48320170|NCT01505634|101111530|FG002|Treated|Overall Study||100||
48320171|NCT01505634|101111528|FG000|COMPLETED|Overall Study||92||
48320172|NCT01505634|101111529|FG001|COMPLETED|Overall Study||91||
48320173|NCT01505634|101111530|FG002|COMPLETED|Overall Study||94||
48320174|NCT01505634|101111528|FG000|NOT COMPLETED|Overall Study||9||
48320175|NCT01505634|101111529|FG001|NOT COMPLETED|Overall Study||10||
48320176|NCT01505634|101111530|FG002|NOT COMPLETED|Overall Study||6||
48320177|NCT01897285|101111531|FG000|STARTED|Overall Study||20||
48320178|NCT01897285|101111531|FG000|COMPLETED|Overall Study||20||
48320179|NCT01897285|101111531|FG000|NOT COMPLETED|Overall Study||0||
48320180|NCT01199042|101111532|FG000|STARTED|Sleep Laboratory (3 Nights)||29||
48320181|NCT01199042|101111532|FG000|COMPLETED|Sleep Laboratory (3 Nights)||27||
48320182|NCT01199042|101111532|FG000|NOT COMPLETED|Sleep Laboratory (3 Nights)||2||
48320183|NCT01199042|101111532|FG000|STARTED|At Home (3 Months)||27||
48320184|NCT01199042|101111532|FG000|COMPLETED|At Home (3 Months)||26||
48320185|NCT01199042|101111532|FG000|NOT COMPLETED|At Home (3 Months)||1||
48320186|NCT00914927|101111533|FG000|STARTED|Overall Study||18||
48320187|NCT00914927|101111534|FG001|STARTED|Overall Study||16||
48320188|NCT00914927|101111535|FG002|STARTED|Overall Study||17||
48320189|NCT00914927|101111536|FG003|STARTED|Overall Study||16||
48320190|NCT00914927|101111537|FG004|STARTED|Overall Study||21||
48320191|NCT00914927|101111538|FG005|STARTED|Overall Study||21||
48320192|NCT00914927|101111539|FG006|STARTED|Overall Study||21||
48320193|NCT00914927|101111533|FG000|COMPLETED|Overall Study||16||
48320194|NCT00914927|101111534|FG001|COMPLETED|Overall Study||14||
48320195|NCT00914927|101111535|FG002|COMPLETED|Overall Study||17||
48320196|NCT00914927|101111536|FG003|COMPLETED|Overall Study||14||
48320197|NCT00914927|101111537|FG004|COMPLETED|Overall Study||19||
48320198|NCT00914927|101111538|FG005|COMPLETED|Overall Study||21||
48320199|NCT00914927|101111539|FG006|COMPLETED|Overall Study||21||
48320200|NCT00914927|101111533|FG000|NOT COMPLETED|Overall Study||2||
48320201|NCT00914927|101111534|FG001|NOT COMPLETED|Overall Study||2||
48320202|NCT00914927|101111535|FG002|NOT COMPLETED|Overall Study||0||
48320203|NCT00914927|101111536|FG003|NOT COMPLETED|Overall Study||2||
48320204|NCT00914927|101111537|FG004|NOT COMPLETED|Overall Study||2||
48320205|NCT00914927|101111538|FG005|NOT COMPLETED|Overall Study||0||
48320206|NCT00914927|101111539|FG006|NOT COMPLETED|Overall Study||0||
48320207|NCT03341962|101111540|FG000|STARTED|Induction Phase||67||
48320208|NCT03341962|101111541|FG001|STARTED|Induction Phase||67||
48320209|NCT03341962|101111542|FG002|STARTED|Induction Phase||66||
48320210|NCT03341962|101111543|FG003|STARTED|Induction Phase||63||
48320211|NCT03341962|101111544|FG004|STARTED|Induction Phase||0||
48320212|NCT03341962|101111545|FG005|STARTED|Induction Phase||0||
48320213|NCT03341962|101111546|FG006|STARTED|Induction Phase||0||
48320214|NCT03341962|101111547|FG007|STARTED|Induction Phase||0||
48320215|NCT03341962|101111540|FG000|COMPLETED|Induction Phase||53||
48320216|NCT03341962|101111541|FG001|COMPLETED|Induction Phase||48||
48320217|NCT03341962|101111542|FG002|COMPLETED|Induction Phase||50||
48320218|NCT03341962|101111543|FG003|COMPLETED|Induction Phase||52||
48320219|NCT03341962|101111544|FG004|COMPLETED|Induction Phase||0||
48320220|NCT03341962|101111545|FG005|COMPLETED|Induction Phase||0||
48738258|NCT03068754|102144260|FG002|Completed OLE Period|Open Label Extension Period (OLE)||3|Completed Week 84 visit, End of Taper visit and follow up visit|
48738259|NCT03068754|102144261|FG003|Completed OLE Period|Open Label Extension Period (OLE)||2|Completed Week 84 visit, End of Taper visit and follow up visit|
48738260|NCT03068754|102144258|FG000|Completed Treatment in OLE|Open Label Extension Period (OLE)||0|Completed Week 84 visit|
48738261|NCT03068754|102144259|FG001|Completed Treatment in OLE|Open Label Extension Period (OLE)||0|Completed Week 84 visit|
48738262|NCT03068754|102144260|FG002|Completed Treatment in OLE|Open Label Extension Period (OLE)||4|Completed Week 84 visit|
48738263|NCT03068754|102144261|FG003|Completed Treatment in OLE|Open Label Extension Period (OLE)||2|Completed Week 84 visit|
48738264|NCT03068754|102144258|FG000|COMPLETED|Open Label Extension Period (OLE)||0|Completed treatment in OLE period|
48738265|NCT03068754|102144259|FG001|COMPLETED|Open Label Extension Period (OLE)||0|Completed treatment in OLE period|
48738266|NCT03068754|102144260|FG002|COMPLETED|Open Label Extension Period (OLE)||4|Completed treatment in OLE period|
48738267|NCT03068754|102144261|FG003|COMPLETED|Open Label Extension Period (OLE)||2|Completed treatment in OLE period|
48738268|NCT03068754|102144258|FG000|NOT COMPLETED|Open Label Extension Period (OLE)||0||
48738269|NCT03068754|102144259|FG001|NOT COMPLETED|Open Label Extension Period (OLE)||0||
48738270|NCT03068754|102144260|FG002|NOT COMPLETED|Open Label Extension Period (OLE)||21||
48738271|NCT03068754|102144261|FG003|NOT COMPLETED|Open Label Extension Period (OLE)||6||
48738272|NCT00291486|102144262|FG000|STARTED|Overall Study||3||
48738273|NCT00291486|102144263|FG001|STARTED|Overall Study||6||
48738274|NCT00291486|102144264|FG002|STARTED|Overall Study||3||
48320221|NCT03341962|101111546|FG006|COMPLETED|Induction Phase||0||
48320222|NCT03341962|101111547|FG007|COMPLETED|Induction Phase||0||
48738275|NCT00291486|102144265|FG003|STARTED|Overall Study||3||
48738276|NCT00291486|102144266|FG004|STARTED|Overall Study||4||
48738277|NCT00291486|102144262|FG000|COMPLETED|Overall Study||2||
48738278|NCT00291486|102144263|FG001|COMPLETED|Overall Study||3||
48738279|NCT00291486|102144264|FG002|COMPLETED|Overall Study||2||
48738280|NCT00291486|102144265|FG003|COMPLETED|Overall Study||2||
48738281|NCT00291486|102144266|FG004|COMPLETED|Overall Study||3||
48738282|NCT00291486|102144262|FG000|NOT COMPLETED|Overall Study||1||
48738283|NCT00291486|102144263|FG001|NOT COMPLETED|Overall Study||3||
48738284|NCT00291486|102144264|FG002|NOT COMPLETED|Overall Study||1||
48738285|NCT00291486|102144265|FG003|NOT COMPLETED|Overall Study||1||
48738286|NCT00291486|102144266|FG004|NOT COMPLETED|Overall Study||1||
48738287|NCT01363908|102144267|FG000|STARTED|Screening/Enrollment||14||
48738288|NCT01363908|102144268|FG001|STARTED|Screening/Enrollment||16||
48738289|NCT01363908|102144267|FG000|COMPLETED|Screening/Enrollment||13||
48738290|NCT01363908|102144268|FG001|COMPLETED|Screening/Enrollment||16||
48738291|NCT01363908|102144267|FG000|NOT COMPLETED|Screening/Enrollment||1||
48738292|NCT01363908|102144268|FG001|NOT COMPLETED|Screening/Enrollment||0||
48738293|NCT01363908|102144267|FG000|STARTED|Pharmacokinetic (PK) Phase||8||
48738294|NCT01363908|102144268|FG001|STARTED|Pharmacokinetic (PK) Phase||8||
48738295|NCT01363908|102144267|FG000|COMPLETED|Pharmacokinetic (PK) Phase||8||
48738296|NCT01363908|102144268|FG001|COMPLETED|Pharmacokinetic (PK) Phase||8||
48320223|NCT03341962|101111540|FG000|NOT COMPLETED|Induction Phase||14||
48738297|NCT01363908|102144267|FG000|NOT COMPLETED|Pharmacokinetic (PK) Phase||0||
48738298|NCT01363908|102144268|FG001|NOT COMPLETED|Pharmacokinetic (PK) Phase||0||
48738299|NCT01363908|102144267|FG000|STARTED|Chronic Dosing (CD) Phase||13||
48738300|NCT01363908|102144268|FG001|STARTED|Chronic Dosing (CD) Phase||16||
48738301|NCT01363908|102144267|FG000|COMPLETED|Chronic Dosing (CD) Phase||3||
48738302|NCT01363908|102144268|FG001|COMPLETED|Chronic Dosing (CD) Phase||10||
48738303|NCT01363908|102144267|FG000|NOT COMPLETED|Chronic Dosing (CD) Phase||10||
48738304|NCT01363908|102144268|FG001|NOT COMPLETED|Chronic Dosing (CD) Phase||6||
48738305|NCT03223337|102144269|FG000|STARTED|Part 1 (Up to 16 Days)||8||
48738306|NCT03223337|102144270|FG001|STARTED|Part 1 (Up to 16 Days)||8||
48738307|NCT03223337|102144271|FG002|STARTED|Part 1 (Up to 16 Days)||0||
48738308|NCT03223337|102144272|FG003|STARTED|Part 1 (Up to 16 Days)||0||
48320224|NCT03341962|101111541|FG001|NOT COMPLETED|Induction Phase||19||
48320225|NCT03341962|101111542|FG002|NOT COMPLETED|Induction Phase||16||
48320226|NCT03341962|101111543|FG003|NOT COMPLETED|Induction Phase||11||
48320227|NCT03341962|101111544|FG004|NOT COMPLETED|Induction Phase||0||
48320228|NCT03341962|101111545|FG005|NOT COMPLETED|Induction Phase||0||
48320229|NCT03341962|101111546|FG006|NOT COMPLETED|Induction Phase||0||
48320230|NCT03341962|101111547|FG007|NOT COMPLETED|Induction Phase||0||
48320231|NCT03341962|101111540|FG000|STARTED|Maintenance Phase||0|"At end of the IP, 86 IMU-838 treated patients met eligibility criteria for the MP and and were re-randomized to 10 or 30 mg and 27 were re-randomized to the placebo group. One patient was re-randomized in the MP, but switched to the OLE before any treatment."|
48320232|NCT03341962|101111541|FG001|STARTED|Maintenance Phase||0|"At end of the IP, 86 IMU-838 treated patients met eligibility criteria for the MP and and were re-randomized to 10 or 30 mg and 27 were re-randomized to the placebo group. One patient was re-randomized in the MP, but switched to the OLE before any treatment."|
48320233|NCT03341962|101111542|FG002|STARTED|Maintenance Phase||0|"At end of the IP, 86 IMU-838 treated patients met eligibility criteria for the MP and and were re-randomized to 10 or 30 mg and 27 were re-randomized to the placebo group. One patient was re-randomized in the MP, but switched to the OLE before any treatment."|
48320234|NCT03341962|101111543|FG003|STARTED|Maintenance Phase||0|"At end of the IP, 86 IMU-838 treated patients met eligibility criteria for the MP and and were re-randomized to 10 or 30 mg and 27 were re-randomized to the placebo group. One patient was re-randomized in the MP, but switched to the OLE before any treatment."|
48320235|NCT03341962|101111544|FG004|STARTED|Maintenance Phase||45|"At end of the IP, 86 IMU-838 treated patients met eligibility criteria for the MP and and were re-randomized to 10 or 30 mg and 27 were re-randomized to the placebo group. One patient was re-randomized in the MP, but switched to the OLE before any treatment."|
48320236|NCT03341962|101111545|FG005|STARTED|Maintenance Phase||40|"At end of the IP, 86 IMU-838 treated patients met eligibility criteria for the MP and and were re-randomized to 10 or 30 mg and 27 were re-randomized to the placebo group. One patient was re-randomized in the MP, but switched to the OLE before any treatment."|
48320237|NCT03341962|101111546|FG006|STARTED|Maintenance Phase||27|"At end of the IP, 86 IMU-838 treated patients met eligibility criteria for the MP and and were re-randomized to 10 or 30 mg and 27 were re-randomized to the placebo group. One patient was re-randomized in the MP, but switched to the OLE before any treatment."|
48320238|NCT03341962|101111547|FG007|STARTED|Maintenance Phase||0|"At end of the IP, 86 IMU-838 treated patients met eligibility criteria for the MP and and were re-randomized to 10 or 30 mg and 27 were re-randomized to the placebo group. One patient was re-randomized in the MP, but switched to the OLE before any treatment."|
48320239|NCT03341962|101111540|FG000|COMPLETED|Maintenance Phase||0||
48320240|NCT03341962|101111541|FG001|COMPLETED|Maintenance Phase||0||
48320241|NCT03341962|101111542|FG002|COMPLETED|Maintenance Phase||0||
48320242|NCT03341962|101111543|FG003|COMPLETED|Maintenance Phase||0||
48320243|NCT03341962|101111544|FG004|COMPLETED|Maintenance Phase||35||
48320244|NCT03341962|101111545|FG005|COMPLETED|Maintenance Phase||29||
48320245|NCT03341962|101111546|FG006|COMPLETED|Maintenance Phase||21||
48320246|NCT03341962|101111547|FG007|COMPLETED|Maintenance Phase||0||
48320247|NCT03341962|101111540|FG000|NOT COMPLETED|Maintenance Phase||0||
48320248|NCT03341962|101111541|FG001|NOT COMPLETED|Maintenance Phase||0||
48320249|NCT03341962|101111542|FG002|NOT COMPLETED|Maintenance Phase||0||
48320250|NCT03341962|101111543|FG003|NOT COMPLETED|Maintenance Phase||0||
48320251|NCT03341962|101111544|FG004|NOT COMPLETED|Maintenance Phase||10||
48320252|NCT03341962|101111545|FG005|NOT COMPLETED|Maintenance Phase||11||
48320253|NCT03341962|101111546|FG006|NOT COMPLETED|Maintenance Phase||6||
48320254|NCT03341962|101111547|FG007|NOT COMPLETED|Maintenance Phase||0||
48320255|NCT03341962|101111540|FG000|STARTED|Open-label Phase||0|One patient was re-randomized in the MP, but switched to the OLE before any treatment. 114 patients transitioned directly from the induction phase to the OLE and received 30 mg IMU-838 and an additional 75 patients entered the OLE after the MP, resulting in a total of 190 patients in the OLE.|
48320256|NCT03341962|101111541|FG001|STARTED|Open-label Phase||0|One patient was re-randomized in the MP, but switched to the OLE before any treatment. 114 patients transitioned directly from the induction phase to the OLE and received 30 mg IMU-838 and an additional 75 patients entered the OLE after the MP, resulting in a total of 190 patients in the OLE.|
48320257|NCT03341962|101111542|FG002|STARTED|Open-label Phase||0|One patient was re-randomized in the MP, but switched to the OLE before any treatment. 114 patients transitioned directly from the induction phase to the OLE and received 30 mg IMU-838 and an additional 75 patients entered the OLE after the MP, resulting in a total of 190 patients in the OLE.|
48320258|NCT03341962|101111543|FG003|STARTED|Open-label Phase||0|One patient was re-randomized in the MP, but switched to the OLE before any treatment. 114 patients transitioned directly from the induction phase to the OLE and received 30 mg IMU-838 and an additional 75 patients entered the OLE after the MP, resulting in a total of 190 patients in the OLE.|
48320259|NCT03341962|101111544|FG004|STARTED|Open-label Phase||0|One patient was re-randomized in the MP, but switched to the OLE before any treatment. 114 patients transitioned directly from the induction phase to the OLE and received 30 mg IMU-838 and an additional 75 patients entered the OLE after the MP, resulting in a total of 190 patients in the OLE.|
48320260|NCT03341962|101111545|FG005|STARTED|Open-label Phase||0|One patient was re-randomized in the MP, but switched to the OLE before any treatment. 114 patients transitioned directly from the induction phase to the OLE and received 30 mg IMU-838 and an additional 75 patients entered the OLE after the MP, resulting in a total of 190 patients in the OLE.|
48320261|NCT03341962|101111546|FG006|STARTED|Open-label Phase||0|One patient was re-randomized in the MP, but switched to the OLE before any treatment. 114 patients transitioned directly from the induction phase to the OLE and received 30 mg IMU-838 and an additional 75 patients entered the OLE after the MP, resulting in a total of 190 patients in the OLE.|
48368057|NCT03691623|101230096|FG000|Inoculated With Challenge Virus|Overall Study||39||
48368058|NCT03691623|101230097|FG001|Inoculated With Challenge Virus|Overall Study||38||
48368059|NCT03691623|101230098|FG002|Inoculated With Challenge Virus|Overall Study||38||
48320262|NCT03341962|101111547|FG007|STARTED|Open-label Phase||190|One patient was re-randomized in the MP, but switched to the OLE before any treatment. 114 patients transitioned directly from the induction phase to the OLE and received 30 mg IMU-838 and an additional 75 patients entered the OLE after the MP, resulting in a total of 190 patients in the OLE.|
48320263|NCT03341962|101111540|FG000|COMPLETED|Open-label Phase||0|The study was terminated by the sponsor, therefore no patients completed the OLE.|
48320264|NCT03341962|101111541|FG001|COMPLETED|Open-label Phase||0|The study was terminated by the sponsor, therefore no patients completed the OLE.|
48320265|NCT03341962|101111542|FG002|COMPLETED|Open-label Phase||0|The study was terminated by the sponsor, therefore no patients completed the OLE.|
48320266|NCT03341962|101111543|FG003|COMPLETED|Open-label Phase||0|The study was terminated by the sponsor, therefore no patients completed the OLE.|
48320267|NCT03341962|101111544|FG004|COMPLETED|Open-label Phase||0|The study was terminated by the sponsor, therefore no patients completed the OLE.|
48320268|NCT03341962|101111545|FG005|COMPLETED|Open-label Phase||0|The study was terminated by the sponsor, therefore no patients completed the OLE.|
48320269|NCT03341962|101111546|FG006|COMPLETED|Open-label Phase||0|The study was terminated by the sponsor, therefore no patients completed the OLE.|
48320270|NCT03341962|101111547|FG007|COMPLETED|Open-label Phase||0|The study was terminated by the sponsor, therefore no patients completed the OLE.|
48320271|NCT03341962|101111540|FG000|NOT COMPLETED|Open-label Phase||0||
48320272|NCT03341962|101111541|FG001|NOT COMPLETED|Open-label Phase||0||
48320273|NCT03341962|101111542|FG002|NOT COMPLETED|Open-label Phase||0||
48320274|NCT03341962|101111543|FG003|NOT COMPLETED|Open-label Phase||0||
48320275|NCT03341962|101111544|FG004|NOT COMPLETED|Open-label Phase||0||
48320276|NCT03341962|101111545|FG005|NOT COMPLETED|Open-label Phase||0||
48320277|NCT03341962|101111546|FG006|NOT COMPLETED|Open-label Phase||0||
48320278|NCT03341962|101111547|FG007|NOT COMPLETED|Open-label Phase||190||
48320279|NCT00075400|101111548|FG000|STARTED|Overall Study||26||
48320280|NCT00075400|101111548|FG000|COMPLETED|Overall Study||23||
48320281|NCT00075400|101111548|FG000|NOT COMPLETED|Overall Study||3||
48320282|NCT01278745|101111549|FG000|STARTED|Overall Study||89||
48320283|NCT01278745|101111550|FG001|STARTED|Overall Study||74||
48320284|NCT01278745|101111551|FG002|STARTED|Overall Study||121||
48320285|NCT01278745|101111552|FG003|STARTED|Overall Study||78||
48320286|NCT01278745|101111549|FG000|COMPLETED|Overall Study||84||
48320287|NCT01278745|101111550|FG001|COMPLETED|Overall Study||68||
48320288|NCT01278745|101111551|FG002|COMPLETED|Overall Study||0||
48320289|NCT01278745|101111552|FG003|COMPLETED|Overall Study||0||
48320290|NCT01278745|101111549|FG000|NOT COMPLETED|Overall Study||5||
48320291|NCT01278745|101111550|FG001|NOT COMPLETED|Overall Study||6||
48320292|NCT01278745|101111551|FG002|NOT COMPLETED|Overall Study||121||
48320293|NCT01278745|101111552|FG003|NOT COMPLETED|Overall Study||78||
48320294|NCT01811875|101111553|FG000|STARTED|Overall Study||7||
48320295|NCT01811875|101111553|FG000|COMPLETED|Overall Study||5||
48320296|NCT01811875|101111553|FG000|NOT COMPLETED|Overall Study||2||
48320297|NCT00531752|101111554|FG000|STARTED|First Double-blind Intervention Period||17||
48320298|NCT00531752|101111555|FG001|STARTED|First Double-blind Intervention Period||17||
48320299|NCT00531752|101111556|FG002|STARTED|First Double-blind Intervention Period||16||
48320300|NCT00531752|101111557|FG003|STARTED|First Double-blind Intervention Period||16||
48320301|NCT00531752|101111554|FG000|Treated|First Double-blind Intervention Period||16||
48320302|NCT00531752|101111555|FG001|Treated|First Double-blind Intervention Period||17||
48320303|NCT00531752|101111556|FG002|Treated|First Double-blind Intervention Period||16||
48320304|NCT00531752|101111557|FG003|Treated|First Double-blind Intervention Period||16||
48320305|NCT00531752|101111554|FG000|COMPLETED|First Double-blind Intervention Period||11||
48320306|NCT00531752|101111555|FG001|COMPLETED|First Double-blind Intervention Period||13||
48320307|NCT00531752|101111556|FG002|COMPLETED|First Double-blind Intervention Period||9||
48320308|NCT00531752|101111557|FG003|COMPLETED|First Double-blind Intervention Period||13||
48320309|NCT00531752|101111554|FG000|NOT COMPLETED|First Double-blind Intervention Period||6||
48320310|NCT00531752|101111555|FG001|NOT COMPLETED|First Double-blind Intervention Period||4||
48320311|NCT00531752|101111556|FG002|NOT COMPLETED|First Double-blind Intervention Period||7||
48320312|NCT00531752|101111557|FG003|NOT COMPLETED|First Double-blind Intervention Period||3||
48320313|NCT00531752|101111554|FG000|STARTED|Wash-out Period (at Least 7 Days)||11||
48320314|NCT00531752|101111555|FG001|STARTED|Wash-out Period (at Least 7 Days)||13||
48320315|NCT00531752|101111556|FG002|STARTED|Wash-out Period (at Least 7 Days)||9||
48320316|NCT00531752|101111557|FG003|STARTED|Wash-out Period (at Least 7 Days)||13||
48320317|NCT00531752|101111554|FG000|COMPLETED|Wash-out Period (at Least 7 Days)||11||
48320318|NCT00531752|101111555|FG001|COMPLETED|Wash-out Period (at Least 7 Days)||13||
48320319|NCT00531752|101111556|FG002|COMPLETED|Wash-out Period (at Least 7 Days)||9||
48320320|NCT00531752|101111557|FG003|COMPLETED|Wash-out Period (at Least 7 Days)||13||
48320321|NCT00531752|101111554|FG000|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0||
48320322|NCT00531752|101111555|FG001|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0||
48320323|NCT00531752|101111556|FG002|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0||
48320324|NCT00531752|101111557|FG003|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0||
48320325|NCT00531752|101111554|FG000|STARTED|Second Double-blind Intervention Period||11||
48320326|NCT00531752|101111555|FG001|STARTED|Second Double-blind Intervention Period||13||
48320327|NCT00531752|101111556|FG002|STARTED|Second Double-blind Intervention Period||9||
48320328|NCT00531752|101111557|FG003|STARTED|Second Double-blind Intervention Period||13||
48320329|NCT00531752|101111554|FG000|COMPLETED|Second Double-blind Intervention Period||9||
48320330|NCT00531752|101111555|FG001|COMPLETED|Second Double-blind Intervention Period||11||
48320331|NCT00531752|101111556|FG002|COMPLETED|Second Double-blind Intervention Period||9||
48320332|NCT00531752|101111557|FG003|COMPLETED|Second Double-blind Intervention Period||11||
48320333|NCT00531752|101111554|FG000|NOT COMPLETED|Second Double-blind Intervention Period||2||
48738309|NCT03223337|102144269|FG000|COMPLETED|Part 1 (Up to 16 Days)||8||
48738310|NCT03223337|102144270|FG001|COMPLETED|Part 1 (Up to 16 Days)||8||
48738311|NCT03223337|102144271|FG002|COMPLETED|Part 1 (Up to 16 Days)||0||
48738312|NCT03223337|102144272|FG003|COMPLETED|Part 1 (Up to 16 Days)||0||
48738313|NCT03223337|102144269|FG000|NOT COMPLETED|Part 1 (Up to 16 Days)||0||
48738314|NCT03223337|102144270|FG001|NOT COMPLETED|Part 1 (Up to 16 Days)||0||
48738315|NCT03223337|102144271|FG002|NOT COMPLETED|Part 1 (Up to 16 Days)||0||
48738316|NCT03223337|102144272|FG003|NOT COMPLETED|Part 1 (Up to 16 Days)||0||
48738317|NCT03223337|102144269|FG000|STARTED|Part 2 (Up to 16 Days)||0||
48738318|NCT03223337|102144270|FG001|STARTED|Part 2 (Up to 16 Days)||0||
48738319|NCT03223337|102144271|FG002|STARTED|Part 2 (Up to 16 Days)||12||
48738320|NCT03223337|102144272|FG003|STARTED|Part 2 (Up to 16 Days)||9||
48738321|NCT03223337|102144269|FG000|COMPLETED|Part 2 (Up to 16 Days)||0||
48738322|NCT03223337|102144270|FG001|COMPLETED|Part 2 (Up to 16 Days)||0||
48738323|NCT03223337|102144271|FG002|COMPLETED|Part 2 (Up to 16 Days)||12||
48738324|NCT03223337|102144272|FG003|COMPLETED|Part 2 (Up to 16 Days)||9||
48738325|NCT03223337|102144269|FG000|NOT COMPLETED|Part 2 (Up to 16 Days)||0||
48738326|NCT03223337|102144270|FG001|NOT COMPLETED|Part 2 (Up to 16 Days)||0||
48738327|NCT03223337|102144271|FG002|NOT COMPLETED|Part 2 (Up to 16 Days)||0||
48738328|NCT03223337|102144272|FG003|NOT COMPLETED|Part 2 (Up to 16 Days)||0||
48738329|NCT01221350|102144273|FG000|STARTED|Overall Study||28||
48738330|NCT01221350|102144274|FG001|STARTED|Overall Study||27||
48738331|NCT01221350|102144273|FG000|Received Intervention|Overall Study||28||
48738332|NCT01221350|102144274|FG001|Received Intervention|Overall Study||27||
48738333|NCT01221350|102144273|FG000|Analysis Population|Overall Study||23||
48738334|NCT01221350|102144274|FG001|Analysis Population|Overall Study||24||
48738335|NCT01221350|102144273|FG000|COMPLETED|Overall Study||23||
48738336|NCT01221350|102144274|FG001|COMPLETED|Overall Study||24||
48738337|NCT01221350|102144273|FG000|NOT COMPLETED|Overall Study||5||
48738338|NCT01221350|102144274|FG001|NOT COMPLETED|Overall Study||3||
48738339|NCT01807598|102144275|FG000|STARTED|Overall Study||10||
48738340|NCT01807598|102144275|FG000|COMPLETED|Overall Study||4||
48738341|NCT01807598|102144275|FG000|NOT COMPLETED|Overall Study||6||
48738342|NCT00825812|102144276|FG000|STARTED|Overall Study||29||
48738343|NCT00825812|102144277|FG001|STARTED|Overall Study||32||
48738344|NCT00825812|102144278|FG002|STARTED|Overall Study||126||
48738345|NCT00825812|102144279|FG003|STARTED|Overall Study||121||
48738346|NCT00825812|102144276|FG000|TREATED|Overall Study||29||
48738347|NCT00825812|102144277|FG001|TREATED|Overall Study||31||
48738348|NCT00825812|102144278|FG002|TREATED|Overall Study||120||
48738349|NCT00825812|102144279|FG003|TREATED|Overall Study||111||
48738350|NCT00825812|102144276|FG000|COMPLETED|Overall Study||29||
48738351|NCT00825812|102144277|FG001|COMPLETED|Overall Study||31||
48738352|NCT00825812|102144278|FG002|COMPLETED|Overall Study||120||
48738353|NCT00825812|102144279|FG003|COMPLETED|Overall Study||111||
48738354|NCT00825812|102144276|FG000|NOT COMPLETED|Overall Study||0||
48738355|NCT00825812|102144277|FG001|NOT COMPLETED|Overall Study||1||
48738356|NCT00825812|102144278|FG002|NOT COMPLETED|Overall Study||6||
48738357|NCT00825812|102144279|FG003|NOT COMPLETED|Overall Study||10||
48738358|NCT00145574|102144280|FG000|STARTED|Double Blind||65||
48738359|NCT00145574|102144281|FG001|STARTED|Double Blind||65||
48738360|NCT00145574|102144282|FG002|STARTED|Double Blind||64||
48738361|NCT00145574|102144280|FG000|COMPLETED|Double Blind||64||
48738362|NCT00145574|102144281|FG001|COMPLETED|Double Blind||60||
48738363|NCT00145574|102144282|FG002|COMPLETED|Double Blind||62||
48738364|NCT00145574|102144280|FG000|NOT COMPLETED|Double Blind||1||
48738365|NCT00145574|102144281|FG001|NOT COMPLETED|Double Blind||5||
48738366|NCT00145574|102144282|FG002|NOT COMPLETED|Double Blind||2||
48738367|NCT00145574|102144280|FG000|STARTED|Open Label Long-term Extension||0||
48738368|NCT00145574|102144281|FG001|STARTED|Open Label Long-term Extension||0||
48738369|NCT00145574|102144282|FG002|STARTED|Open Label Long-term Extension||184||
48738370|NCT00145574|102144280|FG000|COMPLETED|Open Label Long-term Extension||0||
48738371|NCT00145574|102144281|FG001|COMPLETED|Open Label Long-term Extension||0||
48738372|NCT00145574|102144282|FG002|COMPLETED|Open Label Long-term Extension||173||
48738373|NCT00145574|102144280|FG000|NOT COMPLETED|Open Label Long-term Extension||0||
48738374|NCT00145574|102144281|FG001|NOT COMPLETED|Open Label Long-term Extension||0||
48320334|NCT00531752|101111555|FG001|NOT COMPLETED|Second Double-blind Intervention Period||2||
48320335|NCT00531752|101111556|FG002|NOT COMPLETED|Second Double-blind Intervention Period||0||
48320336|NCT00531752|101111557|FG003|NOT COMPLETED|Second Double-blind Intervention Period||2||
48320337|NCT00530894|101111558|FG000|STARTED|Overall Study||348||
48738375|NCT00145574|102144282|FG002|NOT COMPLETED|Open Label Long-term Extension||11||
48738376|NCT03400475|102144283|FG000|STARTED|Overall Study||24||
48738377|NCT03400475|102144284|FG001|STARTED|Overall Study||22||
48738378|NCT03400475|102144283|FG000|COMPLETED|Overall Study||24||
48738379|NCT03400475|102144284|FG001|COMPLETED|Overall Study||22||
48738380|NCT03400475|102144283|FG000|NOT COMPLETED|Overall Study||0||
48407706|NCT02058251|101328611|FG000|NOT COMPLETED|Overall Study||0||
48407707|NCT02058251|101328612|FG001|NOT COMPLETED|Overall Study||0||
48407708|NCT01819194|101328613|FG000|STARTED|Overall Study||62||
48407709|NCT01819194|101328613|FG000|COMPLETED|Overall Study||60||
48407710|NCT01819194|101328613|FG000|NOT COMPLETED|Overall Study||2||
48407711|NCT00835276|101328614|FG000|STARTED|First Intervention||24||
48407712|NCT00835276|101328615|FG001|STARTED|First Intervention||24||
48407713|NCT00835276|101328614|FG000|COMPLETED|First Intervention||24||
48407714|NCT00835276|101328615|FG001|COMPLETED|First Intervention||24||
48616489|NCT00048035|101845113|FG004|NOT COMPLETED|Core Period||1||
48616490|NCT00048035|101845114|FG005|NOT COMPLETED|Core Period||1||
48616491|NCT00048035|101845115|FG006|NOT COMPLETED|Core Period||0||
48616492|NCT00048035|101845116|FG007|NOT COMPLETED|Core Period||0||
48616493|NCT00048035|101845109|FG000|STARTED|Extension Year 1||0||
48616494|NCT00048035|101845110|FG001|STARTED|Extension Year 1||0||
48616495|NCT00048035|101845111|FG002|STARTED|Extension Year 1||0||
48616496|NCT00048035|101845112|FG003|STARTED|Extension Year 1||0||
48616497|NCT00048035|101845113|FG004|STARTED|Extension Year 1||0||
48616498|NCT00048035|101845114|FG005|STARTED|Extension Year 1||0||
48616499|NCT00048035|101845115|FG006|STARTED|Extension Year 1||27||
48407715|NCT00835276|101328614|FG000|NOT COMPLETED|First Intervention||0||
48407716|NCT00835276|101328615|FG001|NOT COMPLETED|First Intervention||0||
48407717|NCT00835276|101328614|FG000|STARTED|Washout of 7 Days||24||
48407718|NCT00835276|101328615|FG001|STARTED|Washout of 7 Days||24||
48407719|NCT00835276|101328614|FG000|COMPLETED|Washout of 7 Days||24||
48407720|NCT00835276|101328615|FG001|COMPLETED|Washout of 7 Days||24||
48407721|NCT00835276|101328614|FG000|NOT COMPLETED|Washout of 7 Days||0||
48407722|NCT00835276|101328615|FG001|NOT COMPLETED|Washout of 7 Days||0||
48407723|NCT00835276|101328614|FG000|STARTED|Second Intervention||24||
48407724|NCT00835276|101328615|FG001|STARTED|Second Intervention||24||
48407725|NCT00835276|101328614|FG000|COMPLETED|Second Intervention||24||
48407726|NCT00835276|101328615|FG001|COMPLETED|Second Intervention||24||
48407727|NCT00835276|101328614|FG000|NOT COMPLETED|Second Intervention||0||
48407728|NCT00835276|101328615|FG001|NOT COMPLETED|Second Intervention||0||
48616500|NCT00048035|101845116|FG007|STARTED|Extension Year 1||26||
48616501|NCT00048035|101845109|FG000|COMPLETED|Extension Year 1||0||
48407729|NCT02668692|101328616|FG000|STARTED|Overall Study||101||
48407730|NCT02668692|101328617|FG001|STARTED|Overall Study||105||
48616502|NCT00048035|101845110|FG001|COMPLETED|Extension Year 1||0||
48738381|NCT03400475|102144284|FG001|NOT COMPLETED|Overall Study||0||
48738382|NCT03992846|102144285|FG000|STARTED|Overall Study||160||
48738383|NCT03992846|102144286|FG001|STARTED|Overall Study||162||
48738384|NCT03992846|102144287|FG002|STARTED|Overall Study||162||
48738385|NCT03992846|102144285|FG000|Month 3|Overall Study||149||
48738386|NCT03992846|102144286|FG001|Month 3|Overall Study||155||
48738387|NCT03992846|102144287|FG002|Month 3|Overall Study||149||
48738388|NCT03992846|102144285|FG000|Month 6|Overall Study||140||
48738389|NCT03992846|102144286|FG001|Month 6|Overall Study||143||
48738390|NCT03992846|102144287|FG002|Month 6|Overall Study||137||
48738391|NCT03992846|102144285|FG000|COMPLETED|Overall Study||140||
48738392|NCT03992846|102144286|FG001|COMPLETED|Overall Study||143||
48738393|NCT03992846|102144287|FG002|COMPLETED|Overall Study||137||
48738394|NCT03992846|102144285|FG000|NOT COMPLETED|Overall Study||20||
48738395|NCT03992846|102144286|FG001|NOT COMPLETED|Overall Study||19||
48738396|NCT03992846|102144287|FG002|NOT COMPLETED|Overall Study||25||
48738397|NCT02073682|102144288|FG000|STARTED|Overall Study||522||
48738398|NCT02073682|102144289|FG001|STARTED|Overall Study||524||
48738399|NCT02073682|102144288|FG000|COMPLETED|Overall Study||200|In reasons not completed, acronyms are used: Investigator Decision (ID) and Patient Decision (PD)|
48738400|NCT02073682|102144289|FG001|COMPLETED|Overall Study||154|In reasons not completed, acronyms are used: Investigator Decision (ID) and Patient Decision (PD)|
48738401|NCT02073682|102144288|FG000|NOT COMPLETED|Overall Study||322||
48320338|NCT00530894|101111559|FG001|STARTED|Overall Study||351||
48320339|NCT00530894|101111560|FG002|STARTED|Overall Study||179||
48320340|NCT00530894|101111561|FG003|STARTED|Overall Study||179||
48320341|NCT00530894|101111558|FG000|COMPLETED|Overall Study||260||
48320342|NCT00530894|101111559|FG001|COMPLETED|Overall Study||236||
48320343|NCT00530894|101111560|FG002|COMPLETED|Overall Study||124||
48320344|NCT00530894|101111561|FG003|COMPLETED|Overall Study||85||
48320345|NCT00530894|101111558|FG000|NOT COMPLETED|Overall Study||88||
48320346|NCT00530894|101111559|FG001|NOT COMPLETED|Overall Study||115||
48320347|NCT00530894|101111560|FG002|NOT COMPLETED|Overall Study||55||
48320348|NCT00530894|101111561|FG003|NOT COMPLETED|Overall Study||94||
48320349|NCT01445821|101111562|FG000|STARTED|Overall Study||22||
48320350|NCT01445821|101111563|FG001|STARTED|Overall Study||22||
48320351|NCT01445821|101111562|FG000|COMPLETED|Overall Study||22||
48320352|NCT01445821|101111563|FG001|COMPLETED|Overall Study||22||
48320353|NCT01445821|101111562|FG000|NOT COMPLETED|Overall Study||0||
48320354|NCT01445821|101111563|FG001|NOT COMPLETED|Overall Study||0||
48320355|NCT01462435|101111564|FG000|STARTED|Overall Study||106||
48320356|NCT01462435|101111565|FG001|STARTED|Overall Study||109||
48320357|NCT01462435|101111566|FG002|STARTED|Overall Study||107||
48320358|NCT01462435|101111567|FG003|STARTED|Overall Study||106||
48320359|NCT01462435|101111564|FG000|COMPLETED|Overall Study||105||
48320360|NCT01462435|101111565|FG001|COMPLETED|Overall Study||109||
48320361|NCT01462435|101111566|FG002|COMPLETED|Overall Study||106||
48320362|NCT01462435|101111567|FG003|COMPLETED|Overall Study||101||
48320363|NCT01462435|101111564|FG000|NOT COMPLETED|Overall Study||1||
48320364|NCT01462435|101111565|FG001|NOT COMPLETED|Overall Study||0||
48320365|NCT01462435|101111566|FG002|NOT COMPLETED|Overall Study||1||
48320366|NCT01462435|101111567|FG003|NOT COMPLETED|Overall Study||5||
48320367|NCT00003535|101111568|FG000|STARTED|Overall Study||9||
48738402|NCT02073682|102144289|FG001|NOT COMPLETED|Overall Study||370||
48738403|NCT02137096|102144290|FG000|STARTED|Overall Study||1||
48738404|NCT02137096|102144290|FG000|COMPLETED|Overall Study||1||
48738405|NCT02137096|102144290|FG000|NOT COMPLETED|Overall Study||0||
48738406|NCT01237613|102144291|FG000|STARTED|Overall Study||4||
48738407|NCT01237613|102144291|FG000|COMPLETED|Overall Study||4||
48738408|NCT01237613|102144291|FG000|NOT COMPLETED|Overall Study||0||
48738409|NCT00894361|102144292|FG000|STARTED|Overall Study||200||
48738410|NCT00894361|102144293|FG001|STARTED|Overall Study||200||
48738411|NCT00894361|102144292|FG000|COMPLETED|Overall Study||176||
48738412|NCT00894361|102144293|FG001|COMPLETED|Overall Study||136||
48738413|NCT00894361|102144292|FG000|NOT COMPLETED|Overall Study||24||
48738414|NCT00894361|102144293|FG001|NOT COMPLETED|Overall Study||64||
48738415|NCT00302211|102144294|FG000|STARTED|Double Blind Period (New Patients)||26||
48738416|NCT00302211|102144295|FG001|STARTED|Double Blind Period (New Patients)||27||
48738417|NCT00302211|102144296|FG002|STARTED|Double Blind Period (New Patients)||14||
48738418|NCT00302211|102144297|FG003|STARTED|Double Blind Period (New Patients)||0||
48738419|NCT00302211|102144298|FG004|STARTED|Double Blind Period (New Patients)||0||
48738420|NCT00302211|102144294|FG000|COMPLETED|Double Blind Period (New Patients)||23||
48738421|NCT00302211|102144295|FG001|COMPLETED|Double Blind Period (New Patients)||25||
48738422|NCT00302211|102144296|FG002|COMPLETED|Double Blind Period (New Patients)||10||
48738423|NCT00302211|102144297|FG003|COMPLETED|Double Blind Period (New Patients)||0||
48738424|NCT00302211|102144298|FG004|COMPLETED|Double Blind Period (New Patients)||0||
48738425|NCT00302211|102144294|FG000|NOT COMPLETED|Double Blind Period (New Patients)||3||
48320368|NCT00003535|101111568|FG000|COMPLETED|Overall Study||4||
48738426|NCT00302211|102144295|FG001|NOT COMPLETED|Double Blind Period (New Patients)||2||
48738427|NCT00302211|102144296|FG002|NOT COMPLETED|Double Blind Period (New Patients)||4||
48767627|NCT03678493|102222783|FG003|NOT COMPLETED|Overall Study||0||
48320369|NCT00003535|101111568|FG000|NOT COMPLETED|Overall Study||5||
48320370|NCT02289950|101111569|FG000|STARTED|Overall Study||142|214|
48738428|NCT00302211|102144297|FG003|NOT COMPLETED|Double Blind Period (New Patients)||0||
48738429|NCT00302211|102144298|FG004|NOT COMPLETED|Double Blind Period (New Patients)||0||
48738430|NCT00302211|102144294|FG000|STARTED|Open Label-Patients From Double-Blind||0||
48320371|NCT02289950|101111570|FG001|STARTED|Overall Study||72|214|
48320372|NCT02289950|101111569|FG000|Treated|Overall Study||140||
48320373|NCT02289950|101111570|FG001|Treated|Overall Study||71||
48320374|NCT02289950|101111569|FG000|COMPLETED|Overall Study||0||
48320375|NCT02289950|101111570|FG001|COMPLETED|Overall Study||0||
48320376|NCT02289950|101111569|FG000|NOT COMPLETED|Overall Study||142||
48320377|NCT02289950|101111570|FG001|NOT COMPLETED|Overall Study||72||
48320378|NCT02846532|101111571|FG000|STARTED|Overall Study||12||
48320379|NCT02846532|101111572|FG001|STARTED|Overall Study||66||
48320380|NCT02846532|101111573|FG002|STARTED|Overall Study||34||
48320381|NCT02846532|101111571|FG000|COMPLETED|Overall Study||11||
48320382|NCT02846532|101111572|FG001|COMPLETED|Overall Study||63||
48320383|NCT02846532|101111573|FG002|COMPLETED|Overall Study||33||
48320384|NCT02846532|101111571|FG000|NOT COMPLETED|Overall Study||1||
48320385|NCT02846532|101111572|FG001|NOT COMPLETED|Overall Study||3||
48320386|NCT02846532|101111573|FG002|NOT COMPLETED|Overall Study||1||
48320387|NCT05121480|101111574|FG000|STARTED|Overall Study||25||
48320388|NCT05121480|101111575|FG001|STARTED|Overall Study||74||
48320389|NCT05121480|101111576|FG002|STARTED|Overall Study||25||
48320390|NCT05121480|101111577|FG003|STARTED|Overall Study||74||
48320391|NCT05121480|101111578|FG004|STARTED|Overall Study||25||
48320392|NCT05121480|101111579|FG005|STARTED|Overall Study||86||
48320393|NCT05121480|101111580|FG006|STARTED|Overall Study||38||
48320394|NCT05121480|101111581|FG007|STARTED|Overall Study||74||
48320395|NCT05121480|101111574|FG000|COMPLETED|Overall Study||19||
48320396|NCT05121480|101111575|FG001|COMPLETED|Overall Study||56||
48320397|NCT05121480|101111576|FG002|COMPLETED|Overall Study||22||
48320398|NCT05121480|101111577|FG003|COMPLETED|Overall Study||53||
48320399|NCT05121480|101111578|FG004|COMPLETED|Overall Study||20||
48320400|NCT05121480|101111579|FG005|COMPLETED|Overall Study||65||
48320401|NCT05121480|101111580|FG006|COMPLETED|Overall Study||36||
48320402|NCT05121480|101111581|FG007|COMPLETED|Overall Study||57||
48320403|NCT05121480|101111574|FG000|NOT COMPLETED|Overall Study||6||
48320404|NCT05121480|101111575|FG001|NOT COMPLETED|Overall Study||18||
48320405|NCT05121480|101111576|FG002|NOT COMPLETED|Overall Study||3||
48320406|NCT05121480|101111577|FG003|NOT COMPLETED|Overall Study||21||
48320407|NCT05121480|101111578|FG004|NOT COMPLETED|Overall Study||5||
48320408|NCT05121480|101111579|FG005|NOT COMPLETED|Overall Study||21||
48320409|NCT05121480|101111580|FG006|NOT COMPLETED|Overall Study||2||
48320410|NCT05121480|101111581|FG007|NOT COMPLETED|Overall Study||17||
48320411|NCT00675922|101111582|FG000|STARTED|Overall Study||98||
48320412|NCT00675922|101111582|FG000|COMPLETED|Overall Study||98||
48320413|NCT00675922|101111582|FG000|NOT COMPLETED|Overall Study||0||
48320414|NCT04512040|101111583|FG000|STARTED|Overall Study||15||
48320415|NCT04512040|101111584|FG001|STARTED|Overall Study||15||
48320416|NCT04512040|101111583|FG000|COMPLETED|Overall Study||14||
48320417|NCT04512040|101111584|FG001|COMPLETED|Overall Study||14||
48320418|NCT04512040|101111583|FG000|NOT COMPLETED|Overall Study||1||
48320419|NCT04512040|101111584|FG001|NOT COMPLETED|Overall Study||1||
48320420|NCT02411539|101111585|FG000|STARTED|Overall Study||20||
48616503|NCT00048035|101845111|FG002|COMPLETED|Extension Year 1||0||
48616504|NCT00048035|101845112|FG003|COMPLETED|Extension Year 1||0||
48616505|NCT00048035|101845113|FG004|COMPLETED|Extension Year 1||0||
48616506|NCT00048035|101845114|FG005|COMPLETED|Extension Year 1||0||
48616507|NCT00048035|101845115|FG006|COMPLETED|Extension Year 1||16||
48616508|NCT00048035|101845116|FG007|COMPLETED|Extension Year 1||15||
48616509|NCT00048035|101845109|FG000|NOT COMPLETED|Extension Year 1||0||
48616510|NCT00048035|101845110|FG001|NOT COMPLETED|Extension Year 1||0||
48616511|NCT00048035|101845111|FG002|NOT COMPLETED|Extension Year 1||0||
48616512|NCT00048035|101845112|FG003|NOT COMPLETED|Extension Year 1||0||
48616513|NCT00048035|101845113|FG004|NOT COMPLETED|Extension Year 1||0||
48616514|NCT00048035|101845114|FG005|NOT COMPLETED|Extension Year 1||0||
48616515|NCT00048035|101845115|FG006|NOT COMPLETED|Extension Year 1||11||
48616516|NCT00048035|101845116|FG007|NOT COMPLETED|Extension Year 1||11||
48738431|NCT00302211|102144295|FG001|STARTED|Open Label-Patients From Double-Blind||0||
48738432|NCT00302211|102144296|FG002|STARTED|Open Label-Patients From Double-Blind||0||
48738433|NCT00302211|102144297|FG003|STARTED|Open Label-Patients From Double-Blind||26||
48320421|NCT02411539|101111586|FG001|STARTED|Overall Study||20||
48738434|NCT00302211|102144298|FG004|STARTED|Open Label-Patients From Double-Blind||32||
48738435|NCT00302211|102144294|FG000|COMPLETED|Open Label-Patients From Double-Blind||0||
48738436|NCT00302211|102144295|FG001|COMPLETED|Open Label-Patients From Double-Blind||0||
48738437|NCT00302211|102144296|FG002|COMPLETED|Open Label-Patients From Double-Blind||0||
48738438|NCT00302211|102144297|FG003|COMPLETED|Open Label-Patients From Double-Blind||18||
48320422|NCT02411539|101111585|FG000|COMPLETED|Overall Study||18||
48320423|NCT02411539|101111586|FG001|COMPLETED|Overall Study||19||
48616517|NCT00048035|101845109|FG000|STARTED|Extension Year 2||0||
48616518|NCT00048035|101845110|FG001|STARTED|Extension Year 2||0||
48320424|NCT02411539|101111585|FG000|NOT COMPLETED|Overall Study||2||
48320425|NCT02411539|101111586|FG001|NOT COMPLETED|Overall Study||1||
48320426|NCT01576549|101111587|FG000|STARTED|Overall Study||2||
48320427|NCT01576549|101111587|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2||
48320428|NCT01576549|101111587|FG000|Completed Post-Treatment Follow-Up|Overall Study||2||
48320429|NCT01576549|101111587|FG000|COMPLETED|Overall Study||0||
48320430|NCT01576549|101111587|FG000|NOT COMPLETED|Overall Study||2||
48320431|NCT03496220|101111588|FG000|STARTED|First Intervention||15||
48320432|NCT03496220|101111589|FG001|STARTED|First Intervention||4||
48320433|NCT03496220|101111590|FG002|STARTED|First Intervention||10||
48320434|NCT03496220|101111588|FG000|COMPLETED|First Intervention||15||
48320435|NCT03496220|101111589|FG001|COMPLETED|First Intervention||4||
48320436|NCT03496220|101111590|FG002|COMPLETED|First Intervention||10||
48320437|NCT03496220|101111588|FG000|NOT COMPLETED|First Intervention||0||
48320438|NCT03496220|101111589|FG001|NOT COMPLETED|First Intervention||0||
48320439|NCT03496220|101111590|FG002|NOT COMPLETED|First Intervention||0||
48320440|NCT03496220|101111588|FG000|STARTED|Second Intervention||17||
48320441|NCT03496220|101111589|FG001|STARTED|Second Intervention||9||
48320442|NCT03496220|101111590|FG002|STARTED|Second Intervention||11||
48320443|NCT03496220|101111588|FG000|COMPLETED|Second Intervention||17||
48320444|NCT03496220|101111589|FG001|COMPLETED|Second Intervention||9||
48320445|NCT03496220|101111590|FG002|COMPLETED|Second Intervention||11||
48320446|NCT03496220|101111588|FG000|NOT COMPLETED|Second Intervention||0||
48320447|NCT03496220|101111589|FG001|NOT COMPLETED|Second Intervention||0||
48320448|NCT03496220|101111590|FG002|NOT COMPLETED|Second Intervention||0||
48320449|NCT03496220|101111588|FG000|STARTED|Third Intervention||11||
48320450|NCT03496220|101111589|FG001|STARTED|Third Intervention||8||
48320451|NCT03496220|101111590|FG002|STARTED|Third Intervention||5||
48320452|NCT03496220|101111588|FG000|COMPLETED|Third Intervention||11||
48320453|NCT03496220|101111589|FG001|COMPLETED|Third Intervention||8||
48320454|NCT03496220|101111590|FG002|COMPLETED|Third Intervention||5||
48320455|NCT03496220|101111588|FG000|NOT COMPLETED|Third Intervention||0||
48320456|NCT03496220|101111589|FG001|NOT COMPLETED|Third Intervention||0||
48616519|NCT00048035|101845111|FG002|STARTED|Extension Year 2||0||
48616520|NCT00048035|101845112|FG003|STARTED|Extension Year 2||0||
48616521|NCT00048035|101845113|FG004|STARTED|Extension Year 2||0||
48616522|NCT00048035|101845114|FG005|STARTED|Extension Year 2||0||
48616523|NCT00048035|101845115|FG006|STARTED|Extension Year 2||14||
48616524|NCT00048035|101845116|FG007|STARTED|Extension Year 2||13||
48616525|NCT00048035|101845109|FG000|COMPLETED|Extension Year 2||0||
48616526|NCT00048035|101845110|FG001|COMPLETED|Extension Year 2||0||
48616527|NCT00048035|101845111|FG002|COMPLETED|Extension Year 2||0||
48320457|NCT03496220|101111590|FG002|NOT COMPLETED|Third Intervention||0||
48616528|NCT00048035|101845112|FG003|COMPLETED|Extension Year 2||0||
48616529|NCT00048035|101845113|FG004|COMPLETED|Extension Year 2||0||
48616530|NCT00048035|101845114|FG005|COMPLETED|Extension Year 2||0||
48320458|NCT02055820|101111591|FG000|STARTED|Phase I: Dose-Finding||7||
48320459|NCT02055820|101111592|FG001|STARTED|Phase I: Dose-Finding||3||
48320460|NCT02055820|101111593|FG002|STARTED|Phase I: Dose-Finding||8||
48320461|NCT02055820|101111594|FG003|STARTED|Phase I: Dose-Finding||6||
48320462|NCT02055820|101111595|FG004|STARTED|Phase I: Dose-Finding||0||
48320463|NCT02055820|101111596|FG005|STARTED|Phase I: Dose-Finding||7||
48320464|NCT02055820|101111597|FG006|STARTED|Phase I: Dose-Finding||7||
48320465|NCT02055820|101111598|FG007|STARTED|Phase I: Dose-Finding||6||
48320466|NCT02055820|101111599|FG008|STARTED|Phase I: Dose-Finding||6||
48320467|NCT02055820|101111600|FG009|STARTED|Phase I: Dose-Finding||6||
48320468|NCT02055820|101111591|FG000|COMPLETED|Phase I: Dose-Finding||6||
48320469|NCT02055820|101111592|FG001|COMPLETED|Phase I: Dose-Finding||3||
48320470|NCT02055820|101111593|FG002|COMPLETED|Phase I: Dose-Finding||7||
48320471|NCT02055820|101111594|FG003|COMPLETED|Phase I: Dose-Finding||3||
48320472|NCT02055820|101111595|FG004|COMPLETED|Phase I: Dose-Finding||0||
48320473|NCT02055820|101111596|FG005|COMPLETED|Phase I: Dose-Finding||5||
48320474|NCT02055820|101111597|FG006|COMPLETED|Phase I: Dose-Finding||5||
48320475|NCT02055820|101111598|FG007|COMPLETED|Phase I: Dose-Finding||6||
48320476|NCT02055820|101111599|FG008|COMPLETED|Phase I: Dose-Finding||6||
48320477|NCT02055820|101111600|FG009|COMPLETED|Phase I: Dose-Finding||6||
48320478|NCT02055820|101111591|FG000|NOT COMPLETED|Phase I: Dose-Finding||1||
48616531|NCT00048035|101845115|FG006|COMPLETED|Extension Year 2||11||
48616532|NCT00048035|101845116|FG007|COMPLETED|Extension Year 2||10||
48616533|NCT00048035|101845109|FG000|NOT COMPLETED|Extension Year 2||0||
48616534|NCT00048035|101845110|FG001|NOT COMPLETED|Extension Year 2||0||
48616535|NCT00048035|101845111|FG002|NOT COMPLETED|Extension Year 2||0||
48616536|NCT00048035|101845112|FG003|NOT COMPLETED|Extension Year 2||0||
48616537|NCT00048035|101845113|FG004|NOT COMPLETED|Extension Year 2||0||
48616538|NCT00048035|101845114|FG005|NOT COMPLETED|Extension Year 2||0||
48616539|NCT00048035|101845115|FG006|NOT COMPLETED|Extension Year 2||3||
48616540|NCT00048035|101845116|FG007|NOT COMPLETED|Extension Year 2||3||
48616541|NCT00463801|101845117|FG000|STARTED|Overall Study||52||
48616542|NCT00463801|101845117|FG000|COMPLETED|Overall Study||39||
48616543|NCT00463801|101845117|FG000|NOT COMPLETED|Overall Study||13||
48616544|NCT05076604|101845118|FG000|STARTED|Overall Study||157||
48616545|NCT05076604|101845119|FG001|STARTED|Overall Study||157||
48616546|NCT05076604|101845118|FG000|COMPLETED|Overall Study||136||
48616547|NCT05076604|101845119|FG001|COMPLETED|Overall Study||126||
48738439|NCT00302211|102144298|FG004|COMPLETED|Open Label-Patients From Double-Blind||24||
48738440|NCT00302211|102144294|FG000|NOT COMPLETED|Open Label-Patients From Double-Blind||0||
48738441|NCT00302211|102144295|FG001|NOT COMPLETED|Open Label-Patients From Double-Blind||0||
48738442|NCT00302211|102144296|FG002|NOT COMPLETED|Open Label-Patients From Double-Blind||0||
48320479|NCT02055820|101111592|FG001|NOT COMPLETED|Phase I: Dose-Finding||0||
48320480|NCT02055820|101111593|FG002|NOT COMPLETED|Phase I: Dose-Finding||1||
48320481|NCT02055820|101111594|FG003|NOT COMPLETED|Phase I: Dose-Finding||3||
48320482|NCT02055820|101111595|FG004|NOT COMPLETED|Phase I: Dose-Finding||0||
48320483|NCT02055820|101111596|FG005|NOT COMPLETED|Phase I: Dose-Finding||2||
48320484|NCT02055820|101111597|FG006|NOT COMPLETED|Phase I: Dose-Finding||2||
48320485|NCT02055820|101111598|FG007|NOT COMPLETED|Phase I: Dose-Finding||0||
48320486|NCT02055820|101111599|FG008|NOT COMPLETED|Phase I: Dose-Finding||0||
48320487|NCT02055820|101111600|FG009|NOT COMPLETED|Phase I: Dose-Finding||0||
48320488|NCT02055820|101111591|FG000|STARTED|Phase II: Expansion||0||
48320489|NCT02055820|101111592|FG001|STARTED|Phase II: Expansion||0||
48320490|NCT02055820|101111593|FG002|STARTED|Phase II: Expansion||0||
48320491|NCT02055820|101111594|FG003|STARTED|Phase II: Expansion||0||
48320492|NCT02055820|101111595|FG004|STARTED|Phase II: Expansion||208||
48320493|NCT02055820|101111596|FG005|STARTED|Phase II: Expansion||0||
48320494|NCT02055820|101111597|FG006|STARTED|Phase II: Expansion||0||
48320495|NCT02055820|101111598|FG007|STARTED|Phase II: Expansion||0||
48320496|NCT02055820|101111599|FG008|STARTED|Phase II: Expansion||0||
48320497|NCT02055820|101111600|FG009|STARTED|Phase II: Expansion||0||
48320498|NCT02055820|101111591|FG000|COMPLETED|Phase II: Expansion||0||
48320499|NCT02055820|101111592|FG001|COMPLETED|Phase II: Expansion||0||
48320500|NCT02055820|101111593|FG002|COMPLETED|Phase II: Expansion||0||
48320501|NCT02055820|101111594|FG003|COMPLETED|Phase II: Expansion||0||
48320502|NCT02055820|101111595|FG004|COMPLETED|Phase II: Expansion||159||
48320503|NCT02055820|101111596|FG005|COMPLETED|Phase II: Expansion||0||
48320504|NCT02055820|101111597|FG006|COMPLETED|Phase II: Expansion||0||
48320505|NCT02055820|101111598|FG007|COMPLETED|Phase II: Expansion||0||
48320506|NCT02055820|101111599|FG008|COMPLETED|Phase II: Expansion||0||
48320507|NCT02055820|101111600|FG009|COMPLETED|Phase II: Expansion||0||
48320508|NCT02055820|101111591|FG000|NOT COMPLETED|Phase II: Expansion||0||
48320509|NCT02055820|101111592|FG001|NOT COMPLETED|Phase II: Expansion||0||
48320510|NCT02055820|101111593|FG002|NOT COMPLETED|Phase II: Expansion||0||
48320511|NCT02055820|101111594|FG003|NOT COMPLETED|Phase II: Expansion||0||
48320512|NCT02055820|101111595|FG004|NOT COMPLETED|Phase II: Expansion||49||
48320513|NCT02055820|101111596|FG005|NOT COMPLETED|Phase II: Expansion||0||
48320514|NCT02055820|101111597|FG006|NOT COMPLETED|Phase II: Expansion||0||
48320515|NCT02055820|101111598|FG007|NOT COMPLETED|Phase II: Expansion||0||
48320516|NCT02055820|101111599|FG008|NOT COMPLETED|Phase II: Expansion||0||
48320517|NCT02055820|101111600|FG009|NOT COMPLETED|Phase II: Expansion||0||
48320518|NCT02037295|101111601|FG000|STARTED|Phase 1: Crossover UF and OF||9||
48320519|NCT02037295|101111602|FG001|STARTED|Phase 1: Crossover UF and OF||7||
48320520|NCT02037295|101111603|FG002|STARTED|Phase 1: Crossover UF and OF||4||
48320521|NCT02037295|101111604|FG003|STARTED|Phase 1: Crossover UF and OF||7||
48320522|NCT02037295|101111601|FG000|COMPLETED|Phase 1: Crossover UF and OF||9||
48320523|NCT02037295|101111602|FG001|COMPLETED|Phase 1: Crossover UF and OF||7||
48320524|NCT02037295|101111603|FG002|COMPLETED|Phase 1: Crossover UF and OF||4||
48320525|NCT02037295|101111604|FG003|COMPLETED|Phase 1: Crossover UF and OF||7||
48320526|NCT02037295|101111601|FG000|NOT COMPLETED|Phase 1: Crossover UF and OF||0||
48320527|NCT02037295|101111602|FG001|NOT COMPLETED|Phase 1: Crossover UF and OF||0||
48320528|NCT02037295|101111603|FG002|NOT COMPLETED|Phase 1: Crossover UF and OF||0||
48320529|NCT02037295|101111604|FG003|NOT COMPLETED|Phase 1: Crossover UF and OF||0||
48320530|NCT02037295|101111601|FG000|STARTED|Phase 2: Vancomycin and Placebo||9||
48738443|NCT00302211|102144297|FG003|NOT COMPLETED|Open Label-Patients From Double-Blind||8||
48738444|NCT00302211|102144298|FG004|NOT COMPLETED|Open Label-Patients From Double-Blind||8||
48738445|NCT02376179|102144299|FG000|STARTED|Overall Study||84||
48738446|NCT02376179|102144299|FG000|COMPLETED|Overall Study||84||
48738447|NCT02376179|102144299|FG000|NOT COMPLETED|Overall Study||0||
48738448|NCT01196026|102144300|FG000|STARTED|Overall Study||10||
48738449|NCT01196026|102144301|FG001|STARTED|Overall Study||44||
48738450|NCT01196026|102144302|FG002|STARTED|Overall Study||23||
48320531|NCT02037295|101111602|FG001|STARTED|Phase 2: Vancomycin and Placebo||7||
48320532|NCT02037295|101111603|FG002|STARTED|Phase 2: Vancomycin and Placebo||4||
48320533|NCT02037295|101111604|FG003|STARTED|Phase 2: Vancomycin and Placebo||7||
48320534|NCT02037295|101111601|FG000|COMPLETED|Phase 2: Vancomycin and Placebo||8||
48320535|NCT02037295|101111602|FG001|COMPLETED|Phase 2: Vancomycin and Placebo||7||
48320536|NCT02037295|101111603|FG002|COMPLETED|Phase 2: Vancomycin and Placebo||4||
48320537|NCT02037295|101111604|FG003|COMPLETED|Phase 2: Vancomycin and Placebo||6||
48320538|NCT02037295|101111601|FG000|NOT COMPLETED|Phase 2: Vancomycin and Placebo||1||
48320539|NCT02037295|101111602|FG001|NOT COMPLETED|Phase 2: Vancomycin and Placebo||0||
48320540|NCT02037295|101111603|FG002|NOT COMPLETED|Phase 2: Vancomycin and Placebo||0||
48320541|NCT02037295|101111604|FG003|NOT COMPLETED|Phase 2: Vancomycin and Placebo||1||
48320542|NCT00784654|101111605|FG000|STARTED|Open-Label Period (Non-Randomized)||276||
48407731|NCT02668692|101328616|FG000|COMPLETED|Overall Study||100||
48320543|NCT00784654|101111606|FG001|STARTED|Open-Label Period (Non-Randomized)||0||
48320544|NCT00784654|101111607|FG002|STARTED|Open-Label Period (Non-Randomized)||0||
48320545|NCT00784654|101111605|FG000|COMPLETED|Open-Label Period (Non-Randomized)||165||
48320546|NCT00784654|101111606|FG001|COMPLETED|Open-Label Period (Non-Randomized)||0||
48320547|NCT00784654|101111607|FG002|COMPLETED|Open-Label Period (Non-Randomized)||0||
48320548|NCT00784654|101111605|FG000|NOT COMPLETED|Open-Label Period (Non-Randomized)||111||
48320549|NCT00784654|101111606|FG001|NOT COMPLETED|Open-Label Period (Non-Randomized)||0||
48320550|NCT00784654|101111607|FG002|NOT COMPLETED|Open-Label Period (Non-Randomized)||0||
48320551|NCT00784654|101111605|FG000|STARTED|Randomized Withdrawal Period||0||
48320552|NCT00784654|101111606|FG001|STARTED|Randomized Withdrawal Period||78||
48320553|NCT00784654|101111607|FG002|STARTED|Randomized Withdrawal Period||79||
48320554|NCT00784654|101111605|FG000|COMPLETED|Randomized Withdrawal Period||0||
48320555|NCT00784654|101111606|FG001|COMPLETED|Randomized Withdrawal Period||60||
48320556|NCT00784654|101111607|FG002|COMPLETED|Randomized Withdrawal Period||16||
48320557|NCT00784654|101111605|FG000|NOT COMPLETED|Randomized Withdrawal Period||0||
48320558|NCT00784654|101111606|FG001|NOT COMPLETED|Randomized Withdrawal Period||18||
48320559|NCT00784654|101111607|FG002|NOT COMPLETED|Randomized Withdrawal Period||63||
48320560|NCT00884273|101111608|FG000|STARTED|Overall Study||84||
48320561|NCT00884273|101111609|FG001|STARTED|Overall Study||98||
48738451|NCT01196026|102144303|FG003|STARTED|Overall Study||10||
48738452|NCT01196026|102144304|FG004|STARTED|Overall Study||43||
48738453|NCT01196026|102144305|FG005|STARTED|Overall Study||24||
48738454|NCT01196026|102144300|FG000|Completed at Day 28|Overall Study||9||
48738455|NCT01196026|102144301|FG001|Completed at Day 28|Overall Study||41||
48738456|NCT01196026|102144302|FG002|Completed at Day 28|Overall Study||23||
48738457|NCT01196026|102144303|FG003|Completed at Day 28|Overall Study||10||
48738458|NCT01196026|102144304|FG004|Completed at Day 28|Overall Study||42||
48738459|NCT01196026|102144305|FG005|Completed at Day 28|Overall Study||24||
48738460|NCT01196026|102144300|FG000|COMPLETED|Overall Study||9||
48738461|NCT01196026|102144301|FG001|COMPLETED|Overall Study||36||
48738462|NCT01196026|102144302|FG002|COMPLETED|Overall Study||23||
48738463|NCT01196026|102144303|FG003|COMPLETED|Overall Study||10||
48738464|NCT01196026|102144304|FG004|COMPLETED|Overall Study||42||
48738465|NCT01196026|102144305|FG005|COMPLETED|Overall Study||24||
48738466|NCT01196026|102144300|FG000|NOT COMPLETED|Overall Study||1||
48738467|NCT01196026|102144301|FG001|NOT COMPLETED|Overall Study||8||
48738468|NCT01196026|102144302|FG002|NOT COMPLETED|Overall Study||0||
48738469|NCT01196026|102144303|FG003|NOT COMPLETED|Overall Study||0||
48738470|NCT01196026|102144304|FG004|NOT COMPLETED|Overall Study||1||
48738471|NCT01196026|102144305|FG005|NOT COMPLETED|Overall Study||0||
48738472|NCT01440816|102144306|FG000|STARTED|Overall Study||3||
48738473|NCT01440816|102144307|FG001|STARTED|Overall Study||12||
48738474|NCT01440816|102144306|FG000|COMPLETED|Overall Study||2||
48738475|NCT01440816|102144307|FG001|COMPLETED|Overall Study||1||
48320562|NCT00884273|101111608|FG000|Full Analysis Set (FAS)|Overall Study||82||
48320563|NCT00884273|101111609|FG001|Full Analysis Set (FAS)|Overall Study||97||
48320564|NCT00884273|101111608|FG000|Per Protocol (PP) Analysis Set|Overall Study||81||
48320565|NCT00884273|101111609|FG001|Per Protocol (PP) Analysis Set|Overall Study||92||
48320566|NCT00884273|101111608|FG000|Safety Analysis Set|Overall Study||84||
48738476|NCT01440816|102144306|FG000|NOT COMPLETED|Overall Study||1||
48738477|NCT01440816|102144307|FG001|NOT COMPLETED|Overall Study||11||
48738478|NCT03197922|102144308|FG000|STARTED|Overall Study||26||
48738479|NCT03197922|102144309|FG001|STARTED|Overall Study||47||
48738480|NCT03197922|102144310|FG002|STARTED|Overall Study||44||
48738481|NCT03197922|102144308|FG000|COMPLETED|Overall Study||18||
48738482|NCT03197922|102144309|FG001|COMPLETED|Overall Study||32||
48738483|NCT03197922|102144310|FG002|COMPLETED|Overall Study||40||
48738484|NCT03197922|102144308|FG000|NOT COMPLETED|Overall Study||8||
48320567|NCT00884273|101111609|FG001|Safety Analysis Set|Overall Study||98||
48320568|NCT00884273|101111608|FG000|COMPLETED|Overall Study||82||
48320569|NCT00884273|101111609|FG001|COMPLETED|Overall Study||93||
48320570|NCT00884273|101111608|FG000|NOT COMPLETED|Overall Study||2||
48320571|NCT00884273|101111609|FG001|NOT COMPLETED|Overall Study||5||
48320572|NCT01032915|101111610|FG000|STARTED|Overall Study||29||
48320573|NCT01032915|101111611|FG001|STARTED|Overall Study||31||
48320574|NCT01032915|101111612|FG002|STARTED|Overall Study||31||
48738485|NCT03197922|102144309|FG001|NOT COMPLETED|Overall Study||15||
48738486|NCT03197922|102144310|FG002|NOT COMPLETED|Overall Study||4||
48738487|NCT02771197|102144311|FG000|STARTED|Overall Study||20||
48738488|NCT02771197|102144311|FG000|COMPLETED|Overall Study||15||
48738489|NCT02771197|102144311|FG000|NOT COMPLETED|Overall Study||5||
48738490|NCT02687139|102144312|FG000|STARTED|Overall Study||34||
48738491|NCT02687139|102144312|FG000|COMPLETED|Overall Study||34||
48320575|NCT01032915|101111613|FG003|STARTED|Overall Study||34||
48320576|NCT01032915|101111610|FG000|COMPLETED|Overall Study||21||
48320577|NCT01032915|101111611|FG001|COMPLETED|Overall Study||20||
48738492|NCT02687139|102144312|FG000|NOT COMPLETED|Overall Study||0||
48738493|NCT02921490|102144313|FG000|STARTED|Overall Study||10||
48738494|NCT02921490|102144313|FG000|COMPLETED|Overall Study||10||
48738495|NCT02921490|102144313|FG000|NOT COMPLETED|Overall Study||0||
48738496|NCT00889824|102144314|FG000|STARTED|Overall Study||5||
48738497|NCT00889824|102144314|FG000|COMPLETED|Overall Study||5||
48738498|NCT00889824|102144314|FG000|NOT COMPLETED|Overall Study||0||
48738499|NCT00543777|102144315|FG000|STARTED|Overall Study||44||
48738500|NCT00543777|102144315|FG000|COMPLETED|Overall Study||44||
48738501|NCT00543777|102144315|FG000|NOT COMPLETED|Overall Study||0||
48738502|NCT00666224|102144316|FG000|STARTED|Double-Blind||243||
48738503|NCT00666224|102144317|FG001|STARTED|Double-Blind||238||
48738504|NCT00666224|102144316|FG000|COMPLETED|Double-Blind||198||
48738505|NCT00666224|102144317|FG001|COMPLETED|Double-Blind||211||
48738506|NCT00666224|102144316|FG000|NOT COMPLETED|Double-Blind||45||
48738507|NCT00666224|102144317|FG001|NOT COMPLETED|Double-Blind||27||
48738508|NCT00666224|102144316|FG000|STARTED|Open-Label||198||
48738509|NCT00666224|102144317|FG001|STARTED|Open-Label||211||
48738510|NCT00666224|102144316|FG000|COMPLETED|Open-Label||163||
48738511|NCT00666224|102144317|FG001|COMPLETED|Open-Label||126||
48738512|NCT00666224|102144316|FG000|NOT COMPLETED|Open-Label||35||
48738513|NCT00666224|102144317|FG001|NOT COMPLETED|Open-Label||85||
48738514|NCT05236257|102144318|FG000|STARTED|Overall Study||51||
48738515|NCT05236257|102144319|FG001|STARTED|Overall Study||42||
48738516|NCT05236257|102144318|FG000|COMPLETED|Overall Study||0||
48738517|NCT05236257|102144319|FG001|COMPLETED|Overall Study||0||
48738518|NCT05236257|102144318|FG000|NOT COMPLETED|Overall Study||51||
48738519|NCT05236257|102144319|FG001|NOT COMPLETED|Overall Study||42||
48738520|NCT00596830|102144320|FG000|STARTED|Overall Study||342||
48738521|NCT00596830|102144321|FG001|STARTED|Overall Study||339||
48738522|NCT00596830|102144320|FG000|Treated|Overall Study||339||
48738523|NCT00596830|102144321|FG001|Treated|Overall Study||332||
48738524|NCT00596830|102144320|FG000|COMPLETED|Overall Study||0||
48738525|NCT00596830|102144321|FG001|COMPLETED|Overall Study||0||
48738526|NCT00596830|102144320|FG000|NOT COMPLETED|Overall Study||342||
48738527|NCT00596830|102144321|FG001|NOT COMPLETED|Overall Study||339||
48738528|NCT01340053|102144322|FG000|STARTED|Overall Study||47||
48738529|NCT01340053|102144323|FG001|STARTED|Overall Study||46||
48738530|NCT01340053|102144324|FG002|STARTED|Overall Study||47||
48738531|NCT01340053|102144325|FG003|STARTED|Overall Study||46||
48738532|NCT01340053|102144322|FG000|COMPLETED|Overall Study||43||
48738533|NCT01340053|102144323|FG001|COMPLETED|Overall Study||44||
48738534|NCT01340053|102144324|FG002|COMPLETED|Overall Study||43||
48738535|NCT01340053|102144325|FG003|COMPLETED|Overall Study||43||
48738536|NCT01340053|102144322|FG000|NOT COMPLETED|Overall Study||4||
48320578|NCT01032915|101111612|FG002|COMPLETED|Overall Study||24||
48320579|NCT01032915|101111613|FG003|COMPLETED|Overall Study||27||
48320580|NCT01032915|101111610|FG000|NOT COMPLETED|Overall Study||8||
48738537|NCT01340053|102144323|FG001|NOT COMPLETED|Overall Study||2||
48738538|NCT01340053|102144324|FG002|NOT COMPLETED|Overall Study||4||
48738539|NCT01340053|102144325|FG003|NOT COMPLETED|Overall Study||3||
48738540|NCT01363661|102144326|FG000|STARTED|Overall Study||32||
48738541|NCT01363661|102144327|FG001|STARTED|Overall Study||32||
48738542|NCT01363661|102144326|FG000|COMPLETED|Overall Study||18||
48738543|NCT01363661|102144327|FG001|COMPLETED|Overall Study||28||
48738544|NCT01363661|102144326|FG000|NOT COMPLETED|Overall Study||14||
48738545|NCT01363661|102144327|FG001|NOT COMPLETED|Overall Study||4||
48320581|NCT01032915|101111611|FG001|NOT COMPLETED|Overall Study||11||
48738546|NCT02452424|102144328|FG000|STARTED|Overall Study||4||
48738547|NCT02452424|102144329|FG001|STARTED|Overall Study||3||
48738548|NCT02452424|102144330|FG002|STARTED|Overall Study||7||
48738549|NCT02452424|102144331|FG003|STARTED|Overall Study||9||
48738550|NCT02452424|102144332|FG004|STARTED|Overall Study||4||
48738551|NCT02452424|102144333|FG005|STARTED|Overall Study||6||
48738552|NCT02452424|102144334|FG006|STARTED|Overall Study||13||
48738553|NCT02452424|102144335|FG007|STARTED|Overall Study||8||
48738554|NCT02452424|102144336|FG008|STARTED|Overall Study||15||
48738555|NCT02452424|102144337|FG009|STARTED|Overall Study||3||
48738556|NCT02452424|102144338|FG010|STARTED|Overall Study||6||
48738557|NCT02452424|102144328|FG000|COMPLETED|Overall Study||2||
48738558|NCT02452424|102144329|FG001|COMPLETED|Overall Study||0||
48738559|NCT02452424|102144330|FG002|COMPLETED|Overall Study||0||
48738560|NCT02452424|102144331|FG003|COMPLETED|Overall Study||1||
48738561|NCT02452424|102144332|FG004|COMPLETED|Overall Study||2||
48738562|NCT02452424|102144333|FG005|COMPLETED|Overall Study||5||
48738563|NCT02452424|102144334|FG006|COMPLETED|Overall Study||3||
48738564|NCT02452424|102144335|FG007|COMPLETED|Overall Study||4||
48738565|NCT02452424|102144336|FG008|COMPLETED|Overall Study||9||
48738566|NCT02452424|102144337|FG009|COMPLETED|Overall Study||1||
48738567|NCT02452424|102144338|FG010|COMPLETED|Overall Study||4||
48738568|NCT02452424|102144328|FG000|NOT COMPLETED|Overall Study||2||
48738569|NCT02452424|102144329|FG001|NOT COMPLETED|Overall Study||3||
48738570|NCT02452424|102144330|FG002|NOT COMPLETED|Overall Study||7||
48738571|NCT02452424|102144331|FG003|NOT COMPLETED|Overall Study||8||
48738572|NCT02452424|102144332|FG004|NOT COMPLETED|Overall Study||2||
48738573|NCT02452424|102144333|FG005|NOT COMPLETED|Overall Study||1||
48738574|NCT02452424|102144334|FG006|NOT COMPLETED|Overall Study||10||
48738575|NCT02452424|102144335|FG007|NOT COMPLETED|Overall Study||4||
48738576|NCT02452424|102144336|FG008|NOT COMPLETED|Overall Study||6||
48738577|NCT02452424|102144337|FG009|NOT COMPLETED|Overall Study||2||
48738578|NCT02452424|102144338|FG010|NOT COMPLETED|Overall Study||2||
48738579|NCT02919072|102144339|FG000|STARTED|Overall Study||8||
48738580|NCT02919072|102144340|FG001|STARTED|Overall Study||8||
48738581|NCT02919072|102144339|FG000|COMPLETED|Overall Study||8||
48738582|NCT02919072|102144340|FG001|COMPLETED|Overall Study||8||
48738583|NCT02919072|102144339|FG000|NOT COMPLETED|Overall Study||0||
48738584|NCT02919072|102144340|FG001|NOT COMPLETED|Overall Study||0||
48738585|NCT01566500|102144341|FG000|STARTED|Overall Study||140||
48738586|NCT01566500|102144341|FG000|COMPLETED|Overall Study||140||
48738587|NCT01566500|102144341|FG000|NOT COMPLETED|Overall Study||0||
48738588|NCT01514201|102144342|FG000|STARTED|PHASE I: Veliparib + Radiation Therapy||6||
48738589|NCT01514201|102144343|FG001|STARTED|PHASE I: Veliparib + Radiation Therapy||6||
48738590|NCT01514201|102144344|FG002|STARTED|PHASE I: Veliparib + Radiation Therapy||6||
48738591|NCT01514201|102144345|FG003|STARTED|PHASE I: Veliparib + Radiation Therapy||0||
48738592|NCT01514201|102144342|FG000|COMPLETED|PHASE I: Veliparib + Radiation Therapy||5||
48738593|NCT01514201|102144343|FG001|COMPLETED|PHASE I: Veliparib + Radiation Therapy||6||
48738594|NCT01514201|102144344|FG002|COMPLETED|PHASE I: Veliparib + Radiation Therapy||6||
48738595|NCT01514201|102144345|FG003|COMPLETED|PHASE I: Veliparib + Radiation Therapy||0||
48738596|NCT01514201|102144342|FG000|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||1||
48738597|NCT01514201|102144343|FG001|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0||
48738598|NCT01514201|102144344|FG002|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0||
48738599|NCT01514201|102144345|FG003|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0||
48738600|NCT01514201|102144342|FG000|STARTED|PHASE I: Maintenance With Veliparib/TMZ||5||
48738601|NCT01514201|102144343|FG001|STARTED|PHASE I: Maintenance With Veliparib/TMZ||6||
48738602|NCT01514201|102144344|FG002|STARTED|PHASE I: Maintenance With Veliparib/TMZ||6||
48738603|NCT01514201|102144345|FG003|STARTED|PHASE I: Maintenance With Veliparib/TMZ||0||
48738604|NCT01514201|102144342|FG000|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0||
48738605|NCT01514201|102144343|FG001|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0||
48738606|NCT01514201|102144344|FG002|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0||
48738607|NCT01514201|102144345|FG003|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0||
48738608|NCT01514201|102144342|FG000|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||5||
48738609|NCT01514201|102144343|FG001|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||6||
48738610|NCT01514201|102144344|FG002|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||6||
48738611|NCT01514201|102144345|FG003|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0||
48738612|NCT01514201|102144342|FG000|STARTED|PHASE II: Veliparib + Radiation Therapy||0||
48738613|NCT01514201|102144343|FG001|STARTED|PHASE II: Veliparib + Radiation Therapy||0||
48738614|NCT01514201|102144344|FG002|STARTED|PHASE II: Veliparib + Radiation Therapy||0||
48738615|NCT01514201|102144345|FG003|STARTED|PHASE II: Veliparib + Radiation Therapy||47||
48738616|NCT01514201|102144342|FG000|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0||
48738617|NCT01514201|102144343|FG001|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0||
48738618|NCT01514201|102144344|FG002|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0||
48738619|NCT01514201|102144345|FG003|COMPLETED|PHASE II: Veliparib + Radiation Therapy||35||
48738620|NCT01514201|102144342|FG000|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0||
48738621|NCT01514201|102144343|FG001|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0||
48738622|NCT01514201|102144344|FG002|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0||
48738623|NCT01514201|102144345|FG003|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||12||
48738624|NCT01514201|102144342|FG000|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0||
48738625|NCT01514201|102144343|FG001|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0||
48738626|NCT01514201|102144344|FG002|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0||
48320582|NCT01032915|101111612|FG002|NOT COMPLETED|Overall Study||7||
48320583|NCT01032915|101111613|FG003|NOT COMPLETED|Overall Study||7||
48320584|NCT00708500|101111614|FG000|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80||
48320585|NCT00708500|101111615|FG001|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162||
48320586|NCT00708500|101111616|FG002|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162||
48320587|NCT00708500|101111614|FG000|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80||
48320588|NCT00708500|101111615|FG001|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162||
48320589|NCT00708500|101111616|FG002|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||161||
48320590|NCT00708500|101111614|FG000|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||78||
48320591|NCT00708500|101111615|FG001|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||156||
48320592|NCT00708500|101111616|FG002|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||160||
48320593|NCT00708500|101111614|FG000|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2||
48320594|NCT00708500|101111615|FG001|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||6||
48320595|NCT00708500|101111616|FG002|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2||
48320596|NCT00708500|101111614|FG000|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||78||
48320597|NCT00708500|101111615|FG001|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||156||
48320598|NCT00708500|101111616|FG002|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||160||
48738627|NCT01514201|102144345|FG003|STARTED|PHASE II: Maintenance With Veliparib/TMZ||35||
48738628|NCT01514201|102144342|FG000|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0||
48738629|NCT01514201|102144343|FG001|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0||
48738630|NCT01514201|102144344|FG002|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0||
48738631|NCT01514201|102144345|FG003|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||2||
48738632|NCT01514201|102144342|FG000|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0||
48738633|NCT01514201|102144343|FG001|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0||
48738634|NCT01514201|102144344|FG002|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0||
48738635|NCT01514201|102144345|FG003|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||33||
48738636|NCT03495102|102144346|FG000|STARTED|Overall Study||612||
48738637|NCT03495102|102144347|FG001|STARTED|Overall Study||616||
48738638|NCT03495102|102144348|FG002|STARTED|Overall Study||614||
48738639|NCT03495102|102144346|FG000|Received at Least One Dose of Study Drug|Overall Study||612||
48738640|NCT03495102|102144347|FG001|Received at Least One Dose of Study Drug|Overall Study||616||
48738641|NCT03495102|102144348|FG002|Received at Least One Dose of Study Drug|Overall Study||614||
48738642|NCT03495102|102144346|FG000|COMPLETED|Overall Study||556||
48738643|NCT03495102|102144347|FG001|COMPLETED|Overall Study||549||
48738644|NCT03495102|102144348|FG002|COMPLETED|Overall Study||560||
48738645|NCT03495102|102144346|FG000|NOT COMPLETED|Overall Study||56||
48738646|NCT03495102|102144347|FG001|NOT COMPLETED|Overall Study||67||
48738647|NCT03495102|102144348|FG002|NOT COMPLETED|Overall Study||54||
48738648|NCT02781480|102144349|FG000|STARTED|Overall Study||9||
48738649|NCT02781480|102144350|FG001|STARTED|Overall Study||3||
48738650|NCT02781480|102144351|FG002|STARTED|Overall Study||3||
48738651|NCT02781480|102144349|FG000|COMPLETED|Overall Study||9||
48738652|NCT02781480|102144350|FG001|COMPLETED|Overall Study||3||
48738653|NCT02781480|102144351|FG002|COMPLETED|Overall Study||3||
48738654|NCT02781480|102144349|FG000|NOT COMPLETED|Overall Study||0||
48738655|NCT02781480|102144350|FG001|NOT COMPLETED|Overall Study||0||
48738656|NCT02781480|102144351|FG002|NOT COMPLETED|Overall Study||0||
48738657|NCT00566852|102144352|FG000|STARTED|Overall Study||278||
48738658|NCT00566852|102144353|FG001|STARTED|Overall Study||276||
48738659|NCT00566852|102144352|FG000|COMPLETED|Overall Study||71||
48738660|NCT00566852|102144353|FG001|COMPLETED|Overall Study||78||
48738661|NCT00566852|102144352|FG000|NOT COMPLETED|Overall Study||207||
48738662|NCT00566852|102144353|FG001|NOT COMPLETED|Overall Study||198||
48738663|NCT01022138|102144354|FG000|STARTED|Overall Study||43||
48320599|NCT00708500|101111614|FG000|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||23||
48320600|NCT00708500|101111615|FG001|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||104||
48320601|NCT00708500|101111616|FG002|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||105||
48320602|NCT00708500|101111614|FG000|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55||
48320603|NCT00708500|101111615|FG001|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||52||
48738664|NCT01022138|102144354|FG000|COMPLETED|Overall Study||31||
48738665|NCT01022138|102144354|FG000|NOT COMPLETED|Overall Study||12||
48738666|NCT01076036|102144355|FG000|STARTED|Overall Study||10||
48738667|NCT01076036|102144355|FG000|# of Procedures|Overall Study||8||
48738668|NCT01076036|102144355|FG000|Complete CorPath Procedures|Overall Study||8||
48738669|NCT01076036|102144355|FG000|COMPLETED|Overall Study||8||
48738670|NCT01076036|102144355|FG000|NOT COMPLETED|Overall Study||2||
48738671|NCT00858208|102144356|FG000|STARTED|Overall Study||85||
48738672|NCT00858208|102144356|FG000|COMPLETED|Overall Study||6||
48738673|NCT00858208|102144356|FG000|NOT COMPLETED|Overall Study||79||
48738674|NCT01147055|102144357|FG000|STARTED|First Intervention Period||15||
48738675|NCT01147055|102144358|FG001|STARTED|First Intervention Period||0||
48738676|NCT01147055|102144357|FG000|COMPLETED|First Intervention Period||14||
48738677|NCT01147055|102144358|FG001|COMPLETED|First Intervention Period||0||
48738678|NCT01147055|102144357|FG000|NOT COMPLETED|First Intervention Period||1||
48738679|NCT01147055|102144358|FG001|NOT COMPLETED|First Intervention Period||0||
48738680|NCT01147055|102144357|FG000|STARTED|Washout Period (at Least 14 Days)||14||
48738681|NCT01147055|102144358|FG001|STARTED|Washout Period (at Least 14 Days)||0||
48738682|NCT01147055|102144357|FG000|COMPLETED|Washout Period (at Least 14 Days)||14||
48738683|NCT01147055|102144358|FG001|COMPLETED|Washout Period (at Least 14 Days)||0||
48738684|NCT01147055|102144357|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48738685|NCT01147055|102144358|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48738686|NCT01147055|102144357|FG000|STARTED|Second Intervention Period||0||
48738687|NCT01147055|102144358|FG001|STARTED|Second Intervention Period||14||
48738688|NCT01147055|102144357|FG000|COMPLETED|Second Intervention Period||0||
48738689|NCT01147055|102144358|FG001|COMPLETED|Second Intervention Period||14||
48738690|NCT01147055|102144357|FG000|NOT COMPLETED|Second Intervention Period||0||
48738691|NCT01147055|102144358|FG001|NOT COMPLETED|Second Intervention Period||0||
48738692|NCT05249569|102144359|FG000|STARTED|Overall Study||1||
48738693|NCT05249569|102144359|FG000|COMPLETED|Overall Study||0||
48738694|NCT05249569|102144359|FG000|NOT COMPLETED|Overall Study||1||
48738695|NCT00286429|102144360|FG000|STARTED|Overall Study||130||
48738696|NCT00286429|102144361|FG001|STARTED|Overall Study||131||
48738697|NCT00286429|102144362|FG002|STARTED|Overall Study||129||
48738698|NCT00286429|102144360|FG000|COMPLETED|Overall Study||55||
48738699|NCT00286429|102144361|FG001|COMPLETED|Overall Study||83||
48738700|NCT00286429|102144362|FG002|COMPLETED|Overall Study||77||
48738701|NCT00286429|102144360|FG000|NOT COMPLETED|Overall Study||75||
48738702|NCT00286429|102144361|FG001|NOT COMPLETED|Overall Study||48||
48738703|NCT00286429|102144362|FG002|NOT COMPLETED|Overall Study||52||
48738704|NCT04867733|102144363|FG000|STARTED|Overall Study||49||
48738705|NCT04867733|102144363|FG000|COMPLETED|Overall Study||49||
48738706|NCT04867733|102144363|FG000|NOT COMPLETED|Overall Study||0||
48738707|NCT03387020|102144364|FG000|STARTED|Overall Study||13||
48738708|NCT03387020|102144365|FG001|STARTED|Overall Study||3||
48738709|NCT03387020|102144366|FG002|STARTED|Overall Study||5||
48738710|NCT03387020|102144364|FG000|Received Treatment|Overall Study||12||
48738711|NCT03387020|102144365|FG001|Received Treatment|Overall Study||3||
48738712|NCT03387020|102144366|FG002|Received Treatment|Overall Study||5||
48738713|NCT03387020|102144364|FG000|COMPLETED|Overall Study||11||
48738714|NCT03387020|102144365|FG001|COMPLETED|Overall Study||1||
48738715|NCT03387020|102144366|FG002|COMPLETED|Overall Study||5||
48738716|NCT03387020|102144364|FG000|NOT COMPLETED|Overall Study||2||
48320604|NCT00708500|101111616|FG002|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55||
48320605|NCT00708500|101111614|FG000|STARTED|FOLLOWUP||77||
48320606|NCT00708500|101111615|FG001|STARTED|FOLLOWUP||151||
48738717|NCT03387020|102144365|FG001|NOT COMPLETED|Overall Study||2||
48738718|NCT03387020|102144366|FG002|NOT COMPLETED|Overall Study||0||
48738719|NCT00650767|102144367|FG000|STARTED|Overall Study||51||
48738720|NCT00650767|102144368|FG001|STARTED|Overall Study||50||
48738721|NCT00650767|102144369|FG002|STARTED|Overall Study||50||
48738722|NCT00650767|102144370|FG003|STARTED|Overall Study||50||
48738723|NCT00650767|102144367|FG000|COMPLETED|Overall Study||46||
48738724|NCT00650767|102144368|FG001|COMPLETED|Overall Study||41||
48738725|NCT00650767|102144369|FG002|COMPLETED|Overall Study||36||
48738726|NCT00650767|102144370|FG003|COMPLETED|Overall Study||39||
48738727|NCT00650767|102144367|FG000|NOT COMPLETED|Overall Study||5||
48738728|NCT00650767|102144368|FG001|NOT COMPLETED|Overall Study||9||
48738729|NCT00650767|102144369|FG002|NOT COMPLETED|Overall Study||14||
48738730|NCT00650767|102144370|FG003|NOT COMPLETED|Overall Study||11||
48738731|NCT00391027|102144371|FG000|STARTED|Overall Study||135||
48738732|NCT00391027|102144372|FG001|STARTED|Overall Study||122||
48738733|NCT00391027|102144371|FG000|COMPLETED|Overall Study||110||
48738734|NCT00391027|102144372|FG001|COMPLETED|Overall Study||110||
48738735|NCT00391027|102144371|FG000|NOT COMPLETED|Overall Study||25||
48738736|NCT00391027|102144372|FG001|NOT COMPLETED|Overall Study||12||
48738737|NCT01763606|102144373|FG000|STARTED|Overall Study||10||
48738738|NCT01763606|102144374|FG001|STARTED|Overall Study||10||
48738739|NCT01763606|102144373|FG000|COMPLETED|Overall Study||10||
48738740|NCT01763606|102144374|FG001|COMPLETED|Overall Study||10||
48738741|NCT01763606|102144373|FG000|NOT COMPLETED|Overall Study||0||
48738742|NCT01763606|102144374|FG001|NOT COMPLETED|Overall Study||0||
48738743|NCT02352844|102144375|FG000|STARTED|Overall Study||12||
48320607|NCT00708500|101111616|FG002|STARTED|FOLLOWUP||158||
48320608|NCT00708500|101111614|FG000|COMPLETED|FOLLOWUP||37||
48320609|NCT00708500|101111615|FG001|COMPLETED|FOLLOWUP||136||
48320610|NCT00708500|101111616|FG002|COMPLETED|FOLLOWUP||143||
48320611|NCT00708500|101111614|FG000|NOT COMPLETED|FOLLOWUP||40||
48320612|NCT00708500|101111615|FG001|NOT COMPLETED|FOLLOWUP||15||
48320613|NCT00708500|101111616|FG002|NOT COMPLETED|FOLLOWUP||15||
48320614|NCT02684604|101111617|FG000|STARTED|Overall Study||44||
48738744|NCT02352844|102144375|FG000|COMPLETED|Overall Study||12||
48738745|NCT02352844|102144375|FG000|NOT COMPLETED|Overall Study||0||
48738746|NCT02629822|102144376|FG000|STARTED|Base Study||10||
48738747|NCT02629822|102144376|FG000|COMPLETED|Base Study||7||
48738748|NCT02629822|102144376|FG000|NOT COMPLETED|Base Study||3||
48738749|NCT02629822|102144376|FG000|STARTED|Extension Study||6||
48738750|NCT02629822|102144376|FG000|COMPLETED|Extension Study||4||
48738751|NCT02629822|102144376|FG000|NOT COMPLETED|Extension Study||2||
48738752|NCT03210961|102144377|FG000|STARTED|Overall Study||4||
48738753|NCT03210961|102144378|FG001|STARTED|Overall Study||9||
48738754|NCT03210961|102144379|FG002|STARTED|Overall Study||1||
48738755|NCT03210961|102144380|FG003|STARTED|Overall Study||2||
48738756|NCT03210961|102144381|FG004|STARTED|Overall Study||6||
48738757|NCT03210961|102144382|FG005|STARTED|Overall Study||6||
48738758|NCT03210961|102144383|FG006|STARTED|Overall Study||8||
48320615|NCT02684604|101111618|FG001|STARTED|Overall Study||44||
48320616|NCT02684604|101111617|FG000|COMPLETED|Overall Study||44||
48738759|NCT03210961|102144384|FG007|STARTED|Overall Study||7||
48738760|NCT03210961|102144385|FG008|STARTED|Overall Study||8||
48738761|NCT03210961|102144386|FG009|STARTED|Overall Study||6||
48738762|NCT03210961|102144387|FG010|STARTED|Overall Study||7||
48738763|NCT03210961|102144388|FG011|STARTED|Overall Study||5||
48738764|NCT03210961|102144389|FG012|STARTED|Overall Study||14||
48738765|NCT03210961|102144390|FG013|STARTED|Overall Study||15||
48738766|NCT03210961|102144391|FG014|STARTED|Overall Study||11||
48738767|NCT03210961|102144377|FG000|COMPLETED|Overall Study||4||
48738768|NCT03210961|102144378|FG001|COMPLETED|Overall Study||9||
48738769|NCT03210961|102144379|FG002|COMPLETED|Overall Study||1||
48738770|NCT03210961|102144380|FG003|COMPLETED|Overall Study||1||
48738771|NCT03210961|102144381|FG004|COMPLETED|Overall Study||6||
48160831|NCT01490125|100715938|FG001|COMPLETED|Period II||33||
48160832|NCT01490125|100715939|FG002|COMPLETED|Period II||34||
48160833|NCT01490125|100715940|FG003|COMPLETED|Period II||30||
48160834|NCT01490125|100715941|FG004|COMPLETED|Period II||32||
48160835|NCT01490125|100715942|FG005|COMPLETED|Period II||35||
48616548|NCT05076604|101845118|FG000|NOT COMPLETED|Overall Study||21||
48616549|NCT05076604|101845119|FG001|NOT COMPLETED|Overall Study||31||
48616550|NCT01411319|101845120|FG000|STARTED|Overall Study||25||
48616551|NCT01411319|101845120|FG000|COMPLETED|Overall Study||24||
48616552|NCT01411319|101845120|FG000|NOT COMPLETED|Overall Study||1||
48616553|NCT00941304|101845121|FG000|STARTED|Overall Study||31||
48616554|NCT00941304|101845122|FG001|STARTED|Overall Study||30||
48616555|NCT00941304|101845123|FG002|STARTED|Overall Study||31||
48616556|NCT00941304|101845124|FG003|STARTED|Overall Study||30||
48616557|NCT00941304|101845125|FG004|STARTED|Overall Study||31||
48616558|NCT00941304|101845121|FG000|COMPLETED|Overall Study||30||
48616559|NCT00941304|101845122|FG001|COMPLETED|Overall Study||30||
48616560|NCT00941304|101845123|FG002|COMPLETED|Overall Study||31||
48616561|NCT00941304|101845124|FG003|COMPLETED|Overall Study||30||
48616562|NCT00941304|101845125|FG004|COMPLETED|Overall Study||31||
48616563|NCT00941304|101845121|FG000|NOT COMPLETED|Overall Study||1||
48616564|NCT00941304|101845122|FG001|NOT COMPLETED|Overall Study||0||
48616565|NCT00941304|101845123|FG002|NOT COMPLETED|Overall Study||0||
48616566|NCT00941304|101845124|FG003|NOT COMPLETED|Overall Study||0||
48616567|NCT00941304|101845125|FG004|NOT COMPLETED|Overall Study||0||
48616568|NCT01000987|101845126|FG000|STARTED|Overall Study||12||
48616569|NCT01000987|101845127|FG001|STARTED|Overall Study||15||
48616570|NCT01000987|101845128|FG002|STARTED|Overall Study||17||
48616571|NCT01000987|101845126|FG000|COMPLETED|Overall Study||12||
48616572|NCT01000987|101845127|FG001|COMPLETED|Overall Study||15||
48616573|NCT01000987|101845128|FG002|COMPLETED|Overall Study||17||
48616574|NCT01000987|101845126|FG000|NOT COMPLETED|Overall Study||0||
48616575|NCT01000987|101845127|FG001|NOT COMPLETED|Overall Study||0||
48616576|NCT01000987|101845128|FG002|NOT COMPLETED|Overall Study||0||
48616577|NCT01000974|101849410|FG000|STARTED|Primary Vaccination Phase||2963||
48616578|NCT01000974|101849411|FG001|STARTED|Primary Vaccination Phase||520||
48616579|NCT01000974|101849412|FG002|STARTED|Primary Vaccination Phase||520||
48616580|NCT01000974|101849410|FG000|COMPLETED|Primary Vaccination Phase||2625||
48160836|NCT01490125|100715937|FG000|NOT COMPLETED|Period II||3||
48160837|NCT01490125|100715938|FG001|NOT COMPLETED|Period II||4||
48160838|NCT01490125|100715939|FG002|NOT COMPLETED|Period II||3||
48160839|NCT01490125|100715940|FG003|NOT COMPLETED|Period II||3||
48160840|NCT01490125|100715941|FG004|NOT COMPLETED|Period II||4||
48160841|NCT01490125|100715942|FG005|NOT COMPLETED|Period II||2||
48616581|NCT01000974|101849411|FG001|COMPLETED|Primary Vaccination Phase||470||
48616582|NCT01000974|101849412|FG002|COMPLETED|Primary Vaccination Phase||457||
48616583|NCT01000974|101849410|FG000|NOT COMPLETED|Primary Vaccination Phase||338||
48616584|NCT01000974|101849411|FG001|NOT COMPLETED|Primary Vaccination Phase||50||
48616585|NCT01000974|101849412|FG002|NOT COMPLETED|Primary Vaccination Phase||63||
48616586|NCT01000974|101849410|FG000|STARTED|Booster Vaccination Phase||2337||
48616587|NCT01000974|101849411|FG001|STARTED|Booster Vaccination Phase||435||
48616588|NCT01000974|101849412|FG002|STARTED|Booster Vaccination Phase||400||
48616589|NCT01000974|101849410|FG000|COMPLETED|Booster Vaccination Phase||2270||
48616590|NCT01000974|101849411|FG001|COMPLETED|Booster Vaccination Phase||423||
48616591|NCT01000974|101849412|FG002|COMPLETED|Booster Vaccination Phase||386||
48616592|NCT01000974|101849410|FG000|NOT COMPLETED|Booster Vaccination Phase||67||
48616593|NCT01000974|101849411|FG001|NOT COMPLETED|Booster Vaccination Phase||12||
48616594|NCT01000974|101849412|FG002|NOT COMPLETED|Booster Vaccination Phase||14||
48616595|NCT02404610|101849413|FG000|STARTED|Overall Study||54||
48616596|NCT02404610|101849414|FG001|STARTED|Overall Study||53||
48616597|NCT02404610|101849413|FG000|COMPLETED|Overall Study||54||
48616598|NCT02404610|101849414|FG001|COMPLETED|Overall Study||53||
48616599|NCT02404610|101849413|FG000|NOT COMPLETED|Overall Study||0||
48616600|NCT02404610|101849414|FG001|NOT COMPLETED|Overall Study||0||
48616601|NCT02864407|101849415|FG000|STARTED|Overall Study||3223|Enrolled|
48616602|NCT02864407|101849415|FG000|Effectiveness Analysis Set|Overall Study||2105||
48616603|NCT02864407|101849415|FG000|Long-term Safety Analysis Set|Overall Study||813||
48616604|NCT02864407|101849415|FG000|Long-term Effectiveness Analysis Set|Overall Study||767||
48616605|NCT02864407|101849415|FG000|COMPLETED|Overall Study||3100|Safety analysis set|
48616606|NCT02864407|101849415|FG000|NOT COMPLETED|Overall Study||123||
48616607|NCT00667992|101849416|FG000|STARTED|First Intervention 100 Mcg Twice Daily||49||
48616608|NCT00667992|101849417|FG001|STARTED|First Intervention 100 Mcg Twice Daily||50||
48616609|NCT00667992|101849416|FG000|COMPLETED|First Intervention 100 Mcg Twice Daily||44||
48616610|NCT00667992|101849417|FG001|COMPLETED|First Intervention 100 Mcg Twice Daily||45||
48616611|NCT00667992|101849416|FG000|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5||
48616612|NCT00667992|101849417|FG001|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5||
48160842|NCT01490125|100715937|FG000|STARTED|Period III||34||
48160843|NCT01490125|100715938|FG001|STARTED|Period III||33||
48160844|NCT01490125|100715939|FG002|STARTED|Period III||34||
48160845|NCT01490125|100715940|FG003|STARTED|Period III||30||
48160846|NCT01490125|100715941|FG004|STARTED|Period III||32||
48160847|NCT01490125|100715942|FG005|STARTED|Period III||35||
48160848|NCT01490125|100715937|FG000|COMPLETED|Period III||31||
48160849|NCT01490125|100715938|FG001|COMPLETED|Period III||32||
48160850|NCT01490125|100715939|FG002|COMPLETED|Period III||34||
48160851|NCT01490125|100715940|FG003|COMPLETED|Period III||28||
48160852|NCT01490125|100715941|FG004|COMPLETED|Period III||31||
48160853|NCT01490125|100715942|FG005|COMPLETED|Period III||35||
48160854|NCT01490125|100715937|FG000|NOT COMPLETED|Period III||3||
48160855|NCT01490125|100715938|FG001|NOT COMPLETED|Period III||1||
48160856|NCT01490125|100715939|FG002|NOT COMPLETED|Period III||0||
48160857|NCT01490125|100715940|FG003|NOT COMPLETED|Period III||2||
48160858|NCT01490125|100715941|FG004|NOT COMPLETED|Period III||1||
48160859|NCT01490125|100715942|FG005|NOT COMPLETED|Period III||0||
48160860|NCT00459342|100715943|FG000|STARTED|Overall Study||35||
48160861|NCT00459342|100715943|FG000|COMPLETED|Overall Study||34||
48160862|NCT00459342|100715943|FG000|NOT COMPLETED|Overall Study||1||
48160863|NCT02277990|100715944|FG000|STARTED|Overall Study||3495|Randomized: Per the study protocol, only randomized subjects are included in the analysis cohort.|
48160864|NCT02277990|100715945|FG001|STARTED|Overall Study||3488|Randomized: Per the study protocol, only randomized subjects are included in the analysis cohort.|
48160865|NCT02277990|100715944|FG000|COMPLETED|Overall Study||3129|Definition of completed is that subject was followed to 12 months|
48160866|NCT02277990|100715945|FG001|COMPLETED|Overall Study||3112|Definition of completed is that subject was followed to 12 months|
48160867|NCT02277990|100715944|FG000|NOT COMPLETED|Overall Study||366||
48160868|NCT02277990|100715945|FG001|NOT COMPLETED|Overall Study||376||
48160869|NCT01264380|100718684|FG000|STARTED|Period A||8||
48160870|NCT01264380|100718685|FG001|STARTED|Period A||8||
48160871|NCT01264380|100718686|FG002|STARTED|Period A||0||
48160872|NCT01264380|100718684|FG000|COMPLETED|Period A||8||
48160873|NCT01264380|100718685|FG001|COMPLETED|Period A||8||
48160874|NCT01264380|100718686|FG002|COMPLETED|Period A||0||
48160875|NCT01264380|100718684|FG000|NOT COMPLETED|Period A||0||
48160876|NCT01264380|100718685|FG001|NOT COMPLETED|Period A||0||
48160877|NCT01264380|100718686|FG002|NOT COMPLETED|Period A||0||
48160878|NCT01264380|100718684|FG000|STARTED|Period B||8||
48160879|NCT01264380|100718685|FG001|STARTED|Period B||8||
48160880|NCT01264380|100718686|FG002|STARTED|Period B||0||
48160881|NCT01264380|100718684|FG000|COMPLETED|Period B||8||
48160882|NCT01264380|100718685|FG001|COMPLETED|Period B||8||
48160883|NCT01264380|100718686|FG002|COMPLETED|Period B||0||
48160884|NCT01264380|100718684|FG000|NOT COMPLETED|Period B||0||
48160885|NCT01264380|100718685|FG001|NOT COMPLETED|Period B||0||
48160886|NCT01264380|100718686|FG002|NOT COMPLETED|Period B||0||
48160887|NCT01264380|100718684|FG000|STARTED|Period C||0||
48160888|NCT01264380|100718685|FG001|STARTED|Period C||0||
48160889|NCT01264380|100718686|FG002|STARTED|Period C||16||
48160890|NCT01264380|100718684|FG000|COMPLETED|Period C||0||
48160891|NCT01264380|100718685|FG001|COMPLETED|Period C||0||
48160892|NCT01264380|100718686|FG002|COMPLETED|Period C||2||
48160893|NCT01264380|100718684|FG000|NOT COMPLETED|Period C||0||
48160894|NCT01264380|100718685|FG001|NOT COMPLETED|Period C||0||
48160895|NCT01264380|100718686|FG002|NOT COMPLETED|Period C||14||
48160896|NCT00461292|100718687|FG000|STARTED|Treatment Cycle 1||91||
48160897|NCT00461292|100718688|FG001|STARTED|Treatment Cycle 1||92||
48160898|NCT00461292|100718689|FG002|STARTED|Treatment Cycle 1||92||
48160899|NCT00461292|100718687|FG000|COMPLETED|Treatment Cycle 1||76||
48160900|NCT00461292|100718688|FG001|COMPLETED|Treatment Cycle 1||80||
48160901|NCT00461292|100718689|FG002|COMPLETED|Treatment Cycle 1||81||
48160902|NCT00461292|100718687|FG000|NOT COMPLETED|Treatment Cycle 1||15||
48160903|NCT00461292|100718688|FG001|NOT COMPLETED|Treatment Cycle 1||12||
48160904|NCT00461292|100718689|FG002|NOT COMPLETED|Treatment Cycle 1||11||
48160905|NCT00461292|100718687|FG000|STARTED|Treatment Cycle 2||63||
48160906|NCT00461292|100718688|FG001|STARTED|Treatment Cycle 2||74||
48160907|NCT00461292|100718689|FG002|STARTED|Treatment Cycle 2||0||
48160908|NCT00461292|100718687|FG000|COMPLETED|Treatment Cycle 2||58||
48160909|NCT00461292|100718688|FG001|COMPLETED|Treatment Cycle 2||72||
48160910|NCT00461292|100718689|FG002|COMPLETED|Treatment Cycle 2||0||
48160911|NCT00461292|100718687|FG000|NOT COMPLETED|Treatment Cycle 2||5||
48160912|NCT00461292|100718688|FG001|NOT COMPLETED|Treatment Cycle 2||2||
48160913|NCT00461292|100718689|FG002|NOT COMPLETED|Treatment Cycle 2||0||
48160914|NCT02768662|100718690|FG000|STARTED|Overall Study||142||
48160915|NCT02768662|100718690|FG000|COMPLETED|Overall Study||56||
48160916|NCT02768662|100718690|FG000|NOT COMPLETED|Overall Study||86||
48160917|NCT01657266|100718691|FG000|STARTED|Overall Study||73||
48160918|NCT01657266|100718692|FG001|STARTED|Overall Study||75||
48160919|NCT01657266|100718691|FG000|COMPLETED|Overall Study||69||
48160920|NCT01657266|100718692|FG001|COMPLETED|Overall Study||70||
48160921|NCT01657266|100718691|FG000|NOT COMPLETED|Overall Study||4||
48160922|NCT01657266|100718692|FG001|NOT COMPLETED|Overall Study||5||
48160923|NCT01319799|100718693|FG000|STARTED|Overall Study||10||
48160924|NCT01319799|100718693|FG000|COMPLETED|Overall Study||10||
48160925|NCT01319799|100718693|FG000|NOT COMPLETED|Overall Study||0||
48160926|NCT02247336|100718694|FG000|STARTED|Overall Study||252||
48160927|NCT02247336|100718695|FG001|STARTED|Overall Study||253||
48160928|NCT02247336|100718694|FG000|COMPLETED|Overall Study||252||
48320617|NCT02684604|101111618|FG001|COMPLETED|Overall Study||44||
48320618|NCT02684604|101111617|FG000|NOT COMPLETED|Overall Study||0||
48616613|NCT00667992|101849416|FG000|STARTED|Second Intervention 400 Mcg Twice Daily||44||
48160929|NCT02247336|100718695|FG001|COMPLETED|Overall Study||253||
48160930|NCT02247336|100718694|FG000|NOT COMPLETED|Overall Study||0||
48160931|NCT02247336|100718695|FG001|NOT COMPLETED|Overall Study||0||
48160932|NCT01887470|100718696|FG000|STARTED|Overall Study||10||
48160933|NCT01887470|100718697|FG001|STARTED|Overall Study||10||
48160934|NCT01887470|100718698|FG002|STARTED|Overall Study||10||
48160935|NCT01887470|100718699|FG003|STARTED|Overall Study||10||
48160936|NCT01887470|100718696|FG000|COMPLETED|Overall Study||10||
48160937|NCT01887470|100718697|FG001|COMPLETED|Overall Study||10||
48160938|NCT01887470|100718698|FG002|COMPLETED|Overall Study||10||
48160939|NCT01887470|100718699|FG003|COMPLETED|Overall Study||10||
48160940|NCT01887470|100718696|FG000|NOT COMPLETED|Overall Study||0||
48160941|NCT01887470|100718697|FG001|NOT COMPLETED|Overall Study||0||
48160942|NCT01887470|100718698|FG002|NOT COMPLETED|Overall Study||0||
48160943|NCT01887470|100718699|FG003|NOT COMPLETED|Overall Study||0||
48160944|NCT03573908|100718700|FG000|STARTED|Treatment Period||308||
48160945|NCT03573908|100718701|FG001|STARTED|Treatment Period||306||
48160946|NCT03573908|100718702|FG002|STARTED|Treatment Period||0||
48160947|NCT03573908|100718703|FG003|STARTED|Treatment Period||0||
48160948|NCT03573908|100718704|FG004|STARTED|Treatment Period||0||
48160949|NCT03573908|100718700|FG000|COMPLETED|Treatment Period||284|Completed 12-week Treatment Period|
48160950|NCT03573908|100718701|FG001|COMPLETED|Treatment Period||280|Completed 12-week Treatment Period|
48160951|NCT03573908|100718702|FG002|COMPLETED|Treatment Period||0|Completed 12-week Treatment Period|
48160952|NCT03573908|100718703|FG003|COMPLETED|Treatment Period||0|Completed 12-week Treatment Period|
48616614|NCT00667992|101849417|FG001|STARTED|Second Intervention 400 Mcg Twice Daily||45||
48616615|NCT00667992|101849416|FG000|COMPLETED|Second Intervention 400 Mcg Twice Daily||41||
48616616|NCT00667992|101849417|FG001|COMPLETED|Second Intervention 400 Mcg Twice Daily||41||
48616617|NCT00667992|101849416|FG000|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||3||
48616618|NCT00667992|101849417|FG001|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||4||
48616619|NCT00667992|101849416|FG000|STARTED|Wash-out||41||
48616620|NCT00667992|101849417|FG001|STARTED|Wash-out||41||
48616621|NCT00667992|101849416|FG000|COMPLETED|Wash-out||34||
48616622|NCT00667992|101849417|FG001|COMPLETED|Wash-out||36||
48616623|NCT00667992|101849416|FG000|NOT COMPLETED|Wash-out||7||
48616624|NCT00667992|101849417|FG001|NOT COMPLETED|Wash-out||5||
48616625|NCT00667992|101849416|FG000|STARTED|Third Intervention 100 Mcg Twice Daily||34||
48160953|NCT03573908|100718704|FG004|COMPLETED|Treatment Period||0|Completed 12-week Treatment Period|
48160954|NCT03573908|100718700|FG000|NOT COMPLETED|Treatment Period||24||
48320619|NCT02684604|101111618|FG001|NOT COMPLETED|Overall Study||0||
48616626|NCT00667992|101849417|FG001|STARTED|Third Intervention 100 Mcg Twice Daily||36||
48616627|NCT00667992|101849416|FG000|COMPLETED|Third Intervention 100 Mcg Twice Daily||33||
48616628|NCT00667992|101849417|FG001|COMPLETED|Third Intervention 100 Mcg Twice Daily||35||
48616629|NCT00667992|101849416|FG000|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1||
48160955|NCT03573908|100718701|FG001|NOT COMPLETED|Treatment Period||26||
48160956|NCT03573908|100718702|FG002|NOT COMPLETED|Treatment Period||0||
48160957|NCT03573908|100718703|FG003|NOT COMPLETED|Treatment Period||0||
48160958|NCT03573908|100718704|FG004|NOT COMPLETED|Treatment Period||0||
48160959|NCT03573908|100718700|FG000|STARTED|Randomized Withdrawal Period||0||
48160960|NCT03573908|100718701|FG001|STARTED|Randomized Withdrawal Period||0||
48160961|NCT03573908|100718702|FG002|STARTED|Randomized Withdrawal Period||280||
48160962|NCT03573908|100718703|FG003|STARTED|Randomized Withdrawal Period||138||
48160963|NCT03573908|100718704|FG004|STARTED|Randomized Withdrawal Period||139||
48160964|NCT03573908|100718700|FG000|COMPLETED|Randomized Withdrawal Period||0||
48160965|NCT03573908|100718701|FG001|COMPLETED|Randomized Withdrawal Period||0||
48160966|NCT03573908|100718702|FG002|COMPLETED|Randomized Withdrawal Period||272||
48160967|NCT03573908|100718703|FG003|COMPLETED|Randomized Withdrawal Period||136||
48160968|NCT03573908|100718704|FG004|COMPLETED|Randomized Withdrawal Period||137||
48160969|NCT03573908|100718700|FG000|NOT COMPLETED|Randomized Withdrawal Period||0||
48160970|NCT03573908|100718701|FG001|NOT COMPLETED|Randomized Withdrawal Period||0||
48160971|NCT03573908|100718702|FG002|NOT COMPLETED|Randomized Withdrawal Period||8||
48160972|NCT03573908|100718703|FG003|NOT COMPLETED|Randomized Withdrawal Period||2||
48160973|NCT03573908|100718704|FG004|NOT COMPLETED|Randomized Withdrawal Period||2||
48160974|NCT03896009|100718705|FG000|STARTED|Overall Study||456||
48160975|NCT03896009|100718706|FG001|STARTED|Overall Study||455||
48160976|NCT03896009|100718707|FG002|STARTED|Overall Study||456||
48160977|NCT03896009|100718708|FG003|STARTED|Overall Study||227||
48160978|NCT03896009|100718705|FG000|COMPLETED|Overall Study||441||
48160979|NCT03896009|100718706|FG001|COMPLETED|Overall Study||433||
48160980|NCT03896009|100718707|FG002|COMPLETED|Overall Study||434||
48160981|NCT03896009|100718708|FG003|COMPLETED|Overall Study||218||
48160982|NCT03896009|100718705|FG000|NOT COMPLETED|Overall Study||15||
48160983|NCT03896009|100718706|FG001|NOT COMPLETED|Overall Study||22||
48160984|NCT03896009|100718707|FG002|NOT COMPLETED|Overall Study||22||
48160985|NCT03896009|100718708|FG003|NOT COMPLETED|Overall Study||9||
48160986|NCT00586170|100718709|FG000|STARTED|Overall Study||5||
48160987|NCT00586170|100718710|FG001|STARTED|Overall Study||3||
48160988|NCT00586170|100718709|FG000|COMPLETED|Overall Study||5||
48160989|NCT00586170|100718710|FG001|COMPLETED|Overall Study||3||
48160990|NCT00586170|100718709|FG000|NOT COMPLETED|Overall Study||0||
48160991|NCT00586170|100718710|FG001|NOT COMPLETED|Overall Study||0||
48160992|NCT02301156|100718711|FG000|STARTED|Overall Study||64||
48160993|NCT02301156|100718712|FG001|STARTED|Overall Study||62||
48160994|NCT02301156|100718711|FG000|Intent to Treat (ITT) Population|Overall Study||64|Intent-to-treat (ITT) Population included all randomized participants.|
48160995|NCT02301156|100718712|FG001|Intent to Treat (ITT) Population|Overall Study||62|Intent-to-treat (ITT) Population included all randomized participants.|
48160996|NCT02301156|100718711|FG000|Safety Population|Overall Study||59|Safety Population included all participants who received at least one dose of study medication (ublituximab + ibrutinib or ibrutinib alone).|
48160997|NCT02301156|100718712|FG001|Safety Population|Overall Study||58|Safety Population included all participants who received at least one dose of study medication (ublituximab + ibrutinib or ibrutinib alone).|
48160998|NCT02301156|100718711|FG000|COMPLETED|Overall Study||11||
48160999|NCT02301156|100718712|FG001|COMPLETED|Overall Study||10||
48161000|NCT02301156|100718711|FG000|NOT COMPLETED|Overall Study||53||
48161001|NCT02301156|100718712|FG001|NOT COMPLETED|Overall Study||52||
48161002|NCT00903786|100718713|FG000|STARTED|Overall Study||21||
48161003|NCT00903786|100718713|FG000|COMPLETED|Overall Study||6||
48161004|NCT00903786|100718713|FG000|NOT COMPLETED|Overall Study||15||
48161005|NCT04074590|100718714|FG000|STARTED|Overall Study||16||
48161006|NCT04074590|100718715|FG001|STARTED|Overall Study||7||
48161007|NCT04074590|100718714|FG000|COMPLETED|Overall Study||12||
48161008|NCT04074590|100718715|FG001|COMPLETED|Overall Study||7||
48161009|NCT04074590|100718714|FG000|NOT COMPLETED|Overall Study||4||
48161010|NCT04074590|100718715|FG001|NOT COMPLETED|Overall Study||0||
48161011|NCT03124199|100718716|FG000|STARTED|Overall Study||40||
48161012|NCT03124199|100718716|FG000|COMPLETED|Overall Study||36||
48161013|NCT03124199|100718716|FG000|NOT COMPLETED|Overall Study||4||
48161014|NCT02228967|100718717|FG000|STARTED|Overall Study||403||
48161015|NCT02228967|100718718|FG001|STARTED|Overall Study||388||
48161016|NCT02228967|100718717|FG000|COMPLETED|Overall Study||244||
48161017|NCT02228967|100718718|FG001|COMPLETED|Overall Study||228||
48161018|NCT02228967|100718717|FG000|NOT COMPLETED|Overall Study||159||
48161019|NCT02228967|100718718|FG001|NOT COMPLETED|Overall Study||160||
48161020|NCT02417532|100718719|FG000|STARTED|Overall Study||56||
48161021|NCT02417532|100718719|FG000|COMPLETED|Overall Study||56||
48320620|NCT04360551|101111619|FG000|STARTED|Overall Study||12||
48320621|NCT04360551|101111620|FG001|STARTED|Overall Study||12||
48320622|NCT04360551|101111619|FG000|COMPLETED|Overall Study||11||
48320623|NCT04360551|101111620|FG001|COMPLETED|Overall Study||12||
48320624|NCT04360551|101111619|FG000|NOT COMPLETED|Overall Study||1||
48161022|NCT02417532|100718719|FG000|NOT COMPLETED|Overall Study||0||
48161023|NCT01807156|100718720|FG000|STARTED|Overall Study||7||
48161024|NCT01807156|100718720|FG000|COMPLETED|Overall Study||6||
48161025|NCT01807156|100718720|FG000|NOT COMPLETED|Overall Study||1||
48161026|NCT00245102|100718721|FG000|STARTED|Overall Study||44||
48161027|NCT00245102|100718722|FG001|STARTED|Overall Study||16||
48161028|NCT00245102|100718723|FG002|STARTED|Overall Study||46||
48161029|NCT00245102|100718724|FG003|STARTED|Overall Study||13||
48161030|NCT00245102|100718725|FG004|STARTED|Overall Study||5||
48161031|NCT00245102|100718726|FG005|STARTED|Overall Study||23||
48161032|NCT00245102|100718721|FG000|COMPLETED|Overall Study||37||
48320625|NCT04360551|101111620|FG001|NOT COMPLETED|Overall Study||0||
48320626|NCT01888640|101111621|FG000|STARTED|Overall Study||103||
48320627|NCT01888640|101111622|FG001|STARTED|Overall Study||99||
48320628|NCT01888640|101111623|FG002|STARTED|Overall Study||99||
48407732|NCT02668692|101328617|FG001|COMPLETED|Overall Study||105||
48407733|NCT02668692|101328616|FG000|NOT COMPLETED|Overall Study||1||
48161033|NCT00245102|100718722|FG001|COMPLETED|Overall Study||12||
48161034|NCT00245102|100718723|FG002|COMPLETED|Overall Study||39||
48161035|NCT00245102|100718724|FG003|COMPLETED|Overall Study||10||
48161036|NCT00245102|100718725|FG004|COMPLETED|Overall Study||5||
48161037|NCT00245102|100718726|FG005|COMPLETED|Overall Study||19||
48161038|NCT00245102|100718721|FG000|NOT COMPLETED|Overall Study||7||
48161039|NCT00245102|100718722|FG001|NOT COMPLETED|Overall Study||4||
48161040|NCT00245102|100718723|FG002|NOT COMPLETED|Overall Study||7||
48161041|NCT00245102|100718724|FG003|NOT COMPLETED|Overall Study||3||
48161042|NCT00245102|100718725|FG004|NOT COMPLETED|Overall Study||0||
48161043|NCT00245102|100718726|FG005|NOT COMPLETED|Overall Study||4||
48161044|NCT03571737|100718727|FG000|STARTED|Overall Study||13||
48407734|NCT02668692|101328617|FG001|NOT COMPLETED|Overall Study||0||
48407735|NCT00209092|101328618|FG000|STARTED|Overall Study||25||
48161045|NCT03571737|100718728|FG001|STARTED|Overall Study||10||
48161046|NCT03571737|100718727|FG000|COMPLETED|Overall Study||13||
48161047|NCT03571737|100718728|FG001|COMPLETED|Overall Study||10||
48161048|NCT03571737|100718727|FG000|NOT COMPLETED|Overall Study||0||
48161049|NCT03571737|100718728|FG001|NOT COMPLETED|Overall Study||0||
48161050|NCT03333915|100718729|FG000|STARTED|Overall Study||4||
48161051|NCT03333915|100718730|FG001|STARTED|Overall Study||4||
48161052|NCT03333915|100718731|FG002|STARTED|Overall Study||7||
48161053|NCT03333915|100718732|FG003|STARTED|Overall Study||90||
48320629|NCT01888640|101111621|FG000|COMPLETED|Overall Study||76|Per Protocol, completed visit 3|
48161054|NCT03333915|100718733|FG004|STARTED|Overall Study||23||
48161055|NCT03333915|100718729|FG000|COMPLETED|Overall Study||4||
48161056|NCT03333915|100718730|FG001|COMPLETED|Overall Study||3||
48161057|NCT03333915|100718731|FG002|COMPLETED|Overall Study||6||
48161058|NCT03333915|100718732|FG003|COMPLETED|Overall Study||0||
48161059|NCT03333915|100718733|FG004|COMPLETED|Overall Study||0||
48161060|NCT03333915|100718729|FG000|NOT COMPLETED|Overall Study||0||
48161061|NCT03333915|100718730|FG001|NOT COMPLETED|Overall Study||1||
48161062|NCT03333915|100718731|FG002|NOT COMPLETED|Overall Study||1||
48161063|NCT03333915|100718732|FG003|NOT COMPLETED|Overall Study||90||
48161064|NCT03333915|100718733|FG004|NOT COMPLETED|Overall Study||23||
48161065|NCT01859793|100718734|FG000|STARTED|First Intervention (8 Weeks)||20||
48161066|NCT01859793|100718735|FG001|STARTED|First Intervention (8 Weeks)||18||
48161067|NCT01859793|100718734|FG000|COMPLETED|First Intervention (8 Weeks)||15||
48161068|NCT01859793|100718735|FG001|COMPLETED|First Intervention (8 Weeks)||17||
48161069|NCT01859793|100718734|FG000|NOT COMPLETED|First Intervention (8 Weeks)||5||
48161070|NCT01859793|100718735|FG001|NOT COMPLETED|First Intervention (8 Weeks)||1||
48161071|NCT01859793|100718734|FG000|STARTED|Washout Period (4 Weeks)||15||
48161072|NCT01859793|100718735|FG001|STARTED|Washout Period (4 Weeks)||17||
48161073|NCT01859793|100718734|FG000|COMPLETED|Washout Period (4 Weeks)||14||
48161074|NCT01859793|100718735|FG001|COMPLETED|Washout Period (4 Weeks)||16||
48161075|NCT01859793|100718734|FG000|NOT COMPLETED|Washout Period (4 Weeks)||1||
48738772|NCT03210961|102144382|FG005|COMPLETED|Overall Study||6||
48738773|NCT03210961|102144383|FG006|COMPLETED|Overall Study||7||
48738774|NCT03210961|102144384|FG007|COMPLETED|Overall Study||7||
48738775|NCT03210961|102144385|FG008|COMPLETED|Overall Study||8||
48738776|NCT03210961|102144386|FG009|COMPLETED|Overall Study||6||
48738777|NCT03210961|102144387|FG010|COMPLETED|Overall Study||6||
48738778|NCT03210961|102144388|FG011|COMPLETED|Overall Study||5||
48738779|NCT03210961|102144389|FG012|COMPLETED|Overall Study||12||
48738780|NCT03210961|102144390|FG013|COMPLETED|Overall Study||11||
48738781|NCT03210961|102144391|FG014|COMPLETED|Overall Study||9||
48738782|NCT03210961|102144377|FG000|NOT COMPLETED|Overall Study||0||
48738783|NCT03210961|102144378|FG001|NOT COMPLETED|Overall Study||0||
48738784|NCT03210961|102144379|FG002|NOT COMPLETED|Overall Study||0||
48738785|NCT03210961|102144380|FG003|NOT COMPLETED|Overall Study||1||
48738786|NCT03210961|102144381|FG004|NOT COMPLETED|Overall Study||0||
48738787|NCT03210961|102144382|FG005|NOT COMPLETED|Overall Study||0||
48738788|NCT03210961|102144383|FG006|NOT COMPLETED|Overall Study||1||
48738789|NCT03210961|102144384|FG007|NOT COMPLETED|Overall Study||0||
48738790|NCT03210961|102144385|FG008|NOT COMPLETED|Overall Study||0||
48738791|NCT03210961|102144386|FG009|NOT COMPLETED|Overall Study||0||
48738792|NCT03210961|102144387|FG010|NOT COMPLETED|Overall Study||1||
48738793|NCT03210961|102144388|FG011|NOT COMPLETED|Overall Study||0||
48738794|NCT03210961|102144389|FG012|NOT COMPLETED|Overall Study||2||
48738795|NCT03210961|102144390|FG013|NOT COMPLETED|Overall Study||4||
48738796|NCT03210961|102144391|FG014|NOT COMPLETED|Overall Study||2||
48738797|NCT02360228|102144392|FG000|STARTED|Overall Study||9||
48738798|NCT02360228|102144393|FG001|STARTED|Overall Study||8||
48738799|NCT02360228|102144394|FG002|STARTED|Overall Study||8||
48738800|NCT02360228|102144392|FG000|COMPLETED|Overall Study||8||
48738801|NCT02360228|102144393|FG001|COMPLETED|Overall Study||7||
48738802|NCT02360228|102144394|FG002|COMPLETED|Overall Study||7||
48738803|NCT02360228|102144392|FG000|NOT COMPLETED|Overall Study||1||
48738804|NCT02360228|102144393|FG001|NOT COMPLETED|Overall Study||1||
48738805|NCT02360228|102144394|FG002|NOT COMPLETED|Overall Study||1||
48738806|NCT02735343|102144395|FG000|STARTED|Overall Study||1|study was terminated as no longer necessary|
48738807|NCT02735343|102144396|FG001|STARTED|Overall Study||4|study was terminated as no longer necessary|
48738808|NCT02735343|102144395|FG000|COMPLETED|Overall Study||1||
48738809|NCT02735343|102144396|FG001|COMPLETED|Overall Study||2||
48738810|NCT02735343|102144395|FG000|NOT COMPLETED|Overall Study||0||
48738811|NCT02735343|102144396|FG001|NOT COMPLETED|Overall Study||2||
48738812|NCT00577824|102144397|FG000|STARTED|Overall Study||72||
48738813|NCT00577824|102144398|FG001|STARTED|Overall Study||73||
48738814|NCT00577824|102144399|FG002|STARTED|Overall Study||36||
48738815|NCT00577824|102144397|FG000|Full Analysis Set|Overall Study||72||
48738816|NCT00577824|102144398|FG001|Full Analysis Set|Overall Study||72||
48738817|NCT00577824|102144399|FG002|Full Analysis Set|Overall Study||35||
48738818|NCT00577824|102144397|FG000|COMPLETED|Overall Study||65||
48738819|NCT00577824|102144398|FG001|COMPLETED|Overall Study||53||
48738820|NCT00577824|102144399|FG002|COMPLETED|Overall Study||34||
48738821|NCT00577824|102144397|FG000|NOT COMPLETED|Overall Study||7||
48738822|NCT00577824|102144398|FG001|NOT COMPLETED|Overall Study||20||
48738823|NCT00577824|102144399|FG002|NOT COMPLETED|Overall Study||2||
48738824|NCT03852719|102144400|FG000|STARTED|Overall Study||51||
48738825|NCT03852719|102144401|FG001|STARTED|Overall Study||49||
48738826|NCT03852719|102144402|FG002|STARTED|Overall Study||50||
48738827|NCT03852719|102144400|FG000|Did Not Receive BLV|Overall Study||1||
48738828|NCT03852719|102144401|FG001|Did Not Receive BLV|Overall Study||0||
48738829|NCT03852719|102144402|FG002|Did Not Receive BLV|Overall Study||0||
48738830|NCT03852719|102144400|FG000|COMPLETED|Overall Study||0||
48738831|NCT03852719|102144401|FG001|COMPLETED|Overall Study||0||
48738832|NCT03852719|102144402|FG002|COMPLETED|Overall Study||0||
48738833|NCT03852719|102144400|FG000|NOT COMPLETED|Overall Study||51||
48738834|NCT03852719|102144401|FG001|NOT COMPLETED|Overall Study||49||
48738835|NCT03852719|102144402|FG002|NOT COMPLETED|Overall Study||50||
48738836|NCT01735981|102144403|FG000|STARTED|Allocated||13||
48738837|NCT01735981|102144404|FG001|STARTED|Allocated||11||
48738838|NCT01735981|102144403|FG000|COMPLETED|Allocated||11||
48738839|NCT01735981|102144404|FG001|COMPLETED|Allocated||8||
48738840|NCT01735981|102144403|FG000|NOT COMPLETED|Allocated||2||
48738841|NCT01735981|102144404|FG001|NOT COMPLETED|Allocated||3||
48738842|NCT01735981|102144403|FG000|STARTED|Crossed Over||11||
48738843|NCT01735981|102144404|FG001|STARTED|Crossed Over||7||
48738844|NCT01735981|102144403|FG000|COMPLETED|Crossed Over||11||
48738845|NCT01735981|102144404|FG001|COMPLETED|Crossed Over||7||
48738846|NCT01735981|102144403|FG000|NOT COMPLETED|Crossed Over||0||
48738847|NCT01735981|102144404|FG001|NOT COMPLETED|Crossed Over||0||
48738848|NCT01959139|102144405|FG000|STARTED|Phase I: Cohort 1||5||
48738849|NCT01959139|102144406|FG001|STARTED|Phase I: Cohort 1||0||
48738850|NCT01959139|102144407|FG002|STARTED|Phase I: Cohort 1||0||
48738851|NCT01959139|102144408|FG003|STARTED|Phase I: Cohort 1||0||
48738852|NCT01959139|102144405|FG000|COMPLETED|Phase I: Cohort 1||5||
48738853|NCT01959139|102144406|FG001|COMPLETED|Phase I: Cohort 1||0||
48738854|NCT01959139|102144407|FG002|COMPLETED|Phase I: Cohort 1||0||
48738855|NCT01959139|102144408|FG003|COMPLETED|Phase I: Cohort 1||0||
48738856|NCT01959139|102144405|FG000|NOT COMPLETED|Phase I: Cohort 1||0||
48738857|NCT01959139|102144406|FG001|NOT COMPLETED|Phase I: Cohort 1||0||
48738858|NCT01959139|102144407|FG002|NOT COMPLETED|Phase I: Cohort 1||0||
48738859|NCT01959139|102144408|FG003|NOT COMPLETED|Phase I: Cohort 1||0||
48738860|NCT01959139|102144405|FG000|STARTED|Phase I: Cohort 2||0||
48320630|NCT01888640|101111622|FG001|COMPLETED|Overall Study||68|Per Protocol, completed visit 3|
48320631|NCT01888640|101111623|FG002|COMPLETED|Overall Study||94|Per Protocol, completed visit 3|
48320632|NCT01888640|101111621|FG000|NOT COMPLETED|Overall Study||27||
48320633|NCT01888640|101111622|FG001|NOT COMPLETED|Overall Study||31||
48320634|NCT01888640|101111623|FG002|NOT COMPLETED|Overall Study||5||
48320635|NCT03084536|101111624|FG000|STARTED|Overall Study||53||
48320636|NCT03084536|101111625|FG001|STARTED|Overall Study||54||
48320637|NCT03084536|101111626|FG002|STARTED|Overall Study||27||
48320638|NCT03084536|101111624|FG000|COMPLETED|Overall Study||53||
48320639|NCT03084536|101111625|FG001|COMPLETED|Overall Study||54||
48320640|NCT03084536|101111626|FG002|COMPLETED|Overall Study||0||
48320641|NCT03084536|101111624|FG000|NOT COMPLETED|Overall Study||0||
48320642|NCT03084536|101111625|FG001|NOT COMPLETED|Overall Study||0||
48320643|NCT03084536|101111626|FG002|NOT COMPLETED|Overall Study||27||
48320644|NCT03057106|101111627|FG000|STARTED|Overall Study||149|4 patient refused study treatment|
48320645|NCT03057106|101111628|FG001|STARTED|Overall Study||148|4 patient refused study treatment|
48320646|NCT03057106|101111627|FG000|COMPLETED|Overall Study||149||
48320647|NCT03057106|101111628|FG001|COMPLETED|Overall Study||148||
48320648|NCT03057106|101111627|FG000|NOT COMPLETED|Overall Study||0||
48320649|NCT03057106|101111628|FG001|NOT COMPLETED|Overall Study||0||
48320650|NCT00450723|101111629|FG000|STARTED|Overall Study||39||
48320651|NCT00450723|101111629|FG000|COMPLETED|Overall Study||34||
48320652|NCT00450723|101111629|FG000|NOT COMPLETED|Overall Study||5||
48320653|NCT02636582|101111630|FG000|STARTED|Overall Study||4||
48320654|NCT02636582|101111631|FG001|STARTED|Overall Study||9||
48320655|NCT02636582|101111630|FG000|At Surgery|Overall Study||4||
48320656|NCT02636582|101111631|FG001|At Surgery|Overall Study||9||
48320657|NCT02636582|101111630|FG000|1- Month Post-Op|Overall Study||4||
48320658|NCT02636582|101111631|FG001|1- Month Post-Op|Overall Study||9||
48320659|NCT02636582|101111630|FG000|3-6 Months Post-Op|Overall Study||3||
48320660|NCT02636582|101111631|FG001|3-6 Months Post-Op|Overall Study||9||
48320661|NCT02636582|101111630|FG000|COMPLETED|Overall Study||3||
48320662|NCT02636582|101111631|FG001|COMPLETED|Overall Study||9||
48320663|NCT02636582|101111630|FG000|NOT COMPLETED|Overall Study||1||
48320664|NCT02636582|101111631|FG001|NOT COMPLETED|Overall Study||0||
48320665|NCT03917823|101111632|FG000|STARTED|Overall Study||2||
48320666|NCT03917823|101111633|FG001|STARTED|Overall Study||2||
48320667|NCT03917823|101111632|FG000|COMPLETED|Overall Study||1||
48320668|NCT03917823|101111633|FG001|COMPLETED|Overall Study||0||
48320669|NCT03917823|101111632|FG000|NOT COMPLETED|Overall Study||1||
48320670|NCT03917823|101111633|FG001|NOT COMPLETED|Overall Study||2||
48320671|NCT01263483|101111634|FG000|STARTED|Overall Study||75||
48320672|NCT01263483|101111635|FG001|STARTED|Overall Study||76||
48320673|NCT01263483|101111636|FG002|STARTED|Overall Study||79||
48320674|NCT01263483|101111634|FG000|COMPLETED|Overall Study||68||
48320675|NCT01263483|101111635|FG001|COMPLETED|Overall Study||74||
48320676|NCT01263483|101111636|FG002|COMPLETED|Overall Study||74||
48320677|NCT01263483|101111634|FG000|NOT COMPLETED|Overall Study||7||
48738861|NCT01959139|102144406|FG001|STARTED|Phase I: Cohort 2||6||
48738862|NCT01959139|102144407|FG002|STARTED|Phase I: Cohort 2||0||
48738863|NCT01959139|102144408|FG003|STARTED|Phase I: Cohort 2||0||
48320678|NCT01263483|101111635|FG001|NOT COMPLETED|Overall Study||2||
48320679|NCT01263483|101111636|FG002|NOT COMPLETED|Overall Study||5||
48320680|NCT01081912|101111637|FG000|STARTED|Conversion/Titration||510||
48320681|NCT01081912|101111638|FG001|STARTED|Conversion/Titration||0||
48320682|NCT01081912|101111639|FG002|STARTED|Conversion/Titration||0||
48320683|NCT01081912|101111637|FG000|COMPLETED|Conversion/Titration||302||
48320684|NCT01081912|101111638|FG001|COMPLETED|Conversion/Titration||0||
48320685|NCT01081912|101111639|FG002|COMPLETED|Conversion/Titration||0||
48320686|NCT01081912|101111637|FG000|NOT COMPLETED|Conversion/Titration||208||
48320687|NCT01081912|101111638|FG001|NOT COMPLETED|Conversion/Titration||0||
48320688|NCT01081912|101111639|FG002|NOT COMPLETED|Conversion/Titration||0||
48320689|NCT01081912|101111637|FG000|STARTED|Maintenance Treatment||0||
48320690|NCT01081912|101111638|FG001|STARTED|Maintenance Treatment||151||
48320691|NCT01081912|101111639|FG002|STARTED|Maintenance Treatment||151||
48320692|NCT01081912|101111637|FG000|COMPLETED|Maintenance Treatment||0||
48738864|NCT01959139|102144405|FG000|COMPLETED|Phase I: Cohort 2||0||
48738865|NCT01959139|102144406|FG001|COMPLETED|Phase I: Cohort 2||6||
48738866|NCT01959139|102144407|FG002|COMPLETED|Phase I: Cohort 2||0||
48738867|NCT01959139|102144408|FG003|COMPLETED|Phase I: Cohort 2||0||
48320693|NCT01081912|101111638|FG001|COMPLETED|Maintenance Treatment||124||
48320694|NCT01081912|101111639|FG002|COMPLETED|Maintenance Treatment||59||
48320695|NCT01081912|101111637|FG000|NOT COMPLETED|Maintenance Treatment||0||
48320696|NCT01081912|101111638|FG001|NOT COMPLETED|Maintenance Treatment||27||
48320697|NCT01081912|101111639|FG002|NOT COMPLETED|Maintenance Treatment||92||
48320698|NCT04249687|101111640|FG000|STARTED|Overall Study||230||
48320699|NCT04249687|101111641|FG001|STARTED|Overall Study||73||
48320700|NCT04249687|101111640|FG000|COMPLETED|Overall Study||223||
48320701|NCT04249687|101111641|FG001|COMPLETED|Overall Study||67||
48320702|NCT04249687|101111640|FG000|NOT COMPLETED|Overall Study||7||
48320703|NCT04249687|101111641|FG001|NOT COMPLETED|Overall Study||6||
48320704|NCT03152019|101111642|FG000|STARTED|Overall Study||25||
48320705|NCT03152019|101111643|FG001|STARTED|Overall Study||25||
48320706|NCT03152019|101111642|FG000|COMPLETED|Overall Study||25||
48320707|NCT03152019|101111643|FG001|COMPLETED|Overall Study||24||
48320708|NCT03152019|101111642|FG000|NOT COMPLETED|Overall Study||0||
48320709|NCT03152019|101111643|FG001|NOT COMPLETED|Overall Study||1||
48320710|NCT00117598|101111644|FG000|STARTED|Prior to Treatment Cross Over||57||
48320711|NCT00117598|101111645|FG001|STARTED|Prior to Treatment Cross Over||56||
48320712|NCT00117598|101111646|FG002|STARTED|Prior to Treatment Cross Over||56||
48320713|NCT00117598|101111647|FG003|STARTED|Prior to Treatment Cross Over||0||
48320714|NCT00117598|101111648|FG004|STARTED|Prior to Treatment Cross Over||0||
48320715|NCT00117598|101111644|FG000|COMPLETED|Prior to Treatment Cross Over||0||
48320716|NCT00117598|101111645|FG001|COMPLETED|Prior to Treatment Cross Over||3||
48320717|NCT00117598|101111646|FG002|COMPLETED|Prior to Treatment Cross Over||4||
48320718|NCT00117598|101111647|FG003|COMPLETED|Prior to Treatment Cross Over||0||
48320719|NCT00117598|101111648|FG004|COMPLETED|Prior to Treatment Cross Over||0||
48320720|NCT00117598|101111644|FG000|NOT COMPLETED|Prior to Treatment Cross Over||57||
48320721|NCT00117598|101111645|FG001|NOT COMPLETED|Prior to Treatment Cross Over||53||
48320722|NCT00117598|101111646|FG002|NOT COMPLETED|Prior to Treatment Cross Over||52||
48320723|NCT00117598|101111647|FG003|NOT COMPLETED|Prior to Treatment Cross Over||0||
48320724|NCT00117598|101111648|FG004|NOT COMPLETED|Prior to Treatment Cross Over||0||
48320725|NCT00117598|101111644|FG000|STARTED|After Treament Cross Over||0||
48320726|NCT00117598|101111645|FG001|STARTED|After Treament Cross Over||0||
48320727|NCT00117598|101111646|FG002|STARTED|After Treament Cross Over||0||
48320728|NCT00117598|101111647|FG003|STARTED|After Treament Cross Over||3||
48320729|NCT00117598|101111648|FG004|STARTED|After Treament Cross Over||4||
48320730|NCT00117598|101111644|FG000|COMPLETED|After Treament Cross Over||0||
48320731|NCT00117598|101111645|FG001|COMPLETED|After Treament Cross Over||0||
48320732|NCT00117598|101111646|FG002|COMPLETED|After Treament Cross Over||0||
48320733|NCT00117598|101111647|FG003|COMPLETED|After Treament Cross Over||0||
48320734|NCT00117598|101111648|FG004|COMPLETED|After Treament Cross Over||0||
48320735|NCT00117598|101111644|FG000|NOT COMPLETED|After Treament Cross Over||0||
48320736|NCT00117598|101111645|FG001|NOT COMPLETED|After Treament Cross Over||0||
48320737|NCT00117598|101111646|FG002|NOT COMPLETED|After Treament Cross Over||0||
48320738|NCT00117598|101111647|FG003|NOT COMPLETED|After Treament Cross Over||3||
48320739|NCT00117598|101111648|FG004|NOT COMPLETED|After Treament Cross Over||4||
48320740|NCT00265538|101111649|FG000|STARTED|Overall Study||196||
48320741|NCT00265538|101111650|FG001|STARTED|Overall Study||170||
48320742|NCT00265538|101111651|FG002|STARTED|Overall Study||182||
48320743|NCT00265538|101111652|FG003|STARTED|Overall Study||286||
48320744|NCT00265538|101111649|FG000|COMPLETED|Overall Study||186||
48320745|NCT00265538|101111650|FG001|COMPLETED|Overall Study||161||
48320746|NCT00265538|101111651|FG002|COMPLETED|Overall Study||171||
48320747|NCT00265538|101111652|FG003|COMPLETED|Overall Study||267||
48320748|NCT00265538|101111649|FG000|NOT COMPLETED|Overall Study||10||
48320749|NCT00265538|101111650|FG001|NOT COMPLETED|Overall Study||9||
48320750|NCT00265538|101111651|FG002|NOT COMPLETED|Overall Study||11||
48320751|NCT00265538|101111652|FG003|NOT COMPLETED|Overall Study||19||
48320752|NCT03972969|101111653|FG000|STARTED|3-month Follow-up||51||
48320753|NCT03972969|101111654|FG001|STARTED|3-month Follow-up||58||
48320754|NCT03972969|101111655|FG002|STARTED|3-month Follow-up||53||
48320755|NCT03972969|101111653|FG000|COMPLETED|3-month Follow-up||50||
48320756|NCT03972969|101111654|FG001|COMPLETED|3-month Follow-up||57||
48320757|NCT03972969|101111655|FG002|COMPLETED|3-month Follow-up||53||
48320758|NCT03972969|101111653|FG000|NOT COMPLETED|3-month Follow-up||1||
48320759|NCT03972969|101111654|FG001|NOT COMPLETED|3-month Follow-up||1||
48320760|NCT03972969|101111655|FG002|NOT COMPLETED|3-month Follow-up||0||
48320761|NCT03972969|101111653|FG000|STARTED|6-month Follow-up||50||
48320762|NCT03972969|101111654|FG001|STARTED|6-month Follow-up||57||
48320763|NCT03972969|101111655|FG002|STARTED|6-month Follow-up||53||
48320764|NCT03972969|101111653|FG000|COMPLETED|6-month Follow-up||47||
48320765|NCT03972969|101111654|FG001|COMPLETED|6-month Follow-up||54||
48320766|NCT03972969|101111655|FG002|COMPLETED|6-month Follow-up||50||
48320767|NCT03972969|101111653|FG000|NOT COMPLETED|6-month Follow-up||3||
48320768|NCT03972969|101111654|FG001|NOT COMPLETED|6-month Follow-up||3||
48320769|NCT03972969|101111655|FG002|NOT COMPLETED|6-month Follow-up||3||
48320770|NCT02189213|101111656|FG000|STARTED|Overall Study||13||
48320771|NCT02189213|101111657|FG001|STARTED|Overall Study||1||
48320772|NCT02189213|101111656|FG000|COMPLETED|Overall Study||7||
48320773|NCT02189213|101111657|FG001|COMPLETED|Overall Study||1||
48320774|NCT02189213|101111656|FG000|NOT COMPLETED|Overall Study||6||
48320775|NCT02189213|101111657|FG001|NOT COMPLETED|Overall Study||0||
48320776|NCT00346073|101111658|FG000|STARTED|Overall Study||1522||
48320777|NCT00346073|101111659|FG001|STARTED|Overall Study||762||
48320778|NCT00346073|101111658|FG000|COMPLETED|Overall Study||1481||
48320779|NCT00346073|101111659|FG001|COMPLETED|Overall Study||738||
48320780|NCT00346073|101111658|FG000|NOT COMPLETED|Overall Study||41||
48407736|NCT00209092|101328619|FG001|STARTED|Overall Study||26||
48407737|NCT00209092|101328618|FG000|COMPLETED|Overall Study||17||
48407738|NCT00209092|101328619|FG001|COMPLETED|Overall Study||24||
48407739|NCT00209092|101328618|FG000|NOT COMPLETED|Overall Study||8||
48407740|NCT00209092|101328619|FG001|NOT COMPLETED|Overall Study||2||
48407741|NCT00693420|101328620|FG000|STARTED|Overall Study||137||
48320781|NCT00346073|101111659|FG001|NOT COMPLETED|Overall Study||24||
48320782|NCT01097746|101111660|FG000|STARTED|Overall Study||33||
48320783|NCT01097746|101111660|FG000|COMPLETED|Overall Study||28||
48320784|NCT01097746|101111660|FG000|NOT COMPLETED|Overall Study||5||
48320785|NCT05433571|101111661|FG000|STARTED|Period 1||53||
48320786|NCT05433571|101111662|FG001|STARTED|Period 1||49||
48320787|NCT05433571|101111661|FG000|COMPLETED|Period 1||53||
48320788|NCT05433571|101111662|FG001|COMPLETED|Period 1||49||
48320789|NCT05433571|101111661|FG000|NOT COMPLETED|Period 1||0||
48320790|NCT05433571|101111662|FG001|NOT COMPLETED|Period 1||0||
48320791|NCT05433571|101111661|FG000|STARTED|Period 2||53||
48320792|NCT05433571|101111662|FG001|STARTED|Period 2||49||
48320793|NCT05433571|101111661|FG000|COMPLETED|Period 2||53||
48320794|NCT05433571|101111662|FG001|COMPLETED|Period 2||49||
48320795|NCT05433571|101111661|FG000|NOT COMPLETED|Period 2||0||
48320796|NCT05433571|101111662|FG001|NOT COMPLETED|Period 2||0||
48320797|NCT04867473|101111663|FG000|STARTED|Overall Study||5||
48320798|NCT04867473|101111664|FG001|STARTED|Overall Study||10||
48320799|NCT04867473|101111663|FG000|COMPLETED|Overall Study||5||
48320800|NCT04867473|101111664|FG001|COMPLETED|Overall Study||8||
48320801|NCT04867473|101111663|FG000|NOT COMPLETED|Overall Study||0||
48320802|NCT04867473|101111664|FG001|NOT COMPLETED|Overall Study||2||
48320803|NCT03115567|101111665|FG000|STARTED|Overall Study||7||
48320804|NCT03115567|101111666|FG001|STARTED|Overall Study||7||
48320805|NCT03115567|101111665|FG000|COMPLETED|Overall Study||7||
48407742|NCT00693420|101328621|FG001|STARTED|Overall Study||141||
48320806|NCT03115567|101111666|FG001|COMPLETED|Overall Study||7||
48320807|NCT03115567|101111665|FG000|NOT COMPLETED|Overall Study||0||
48320808|NCT03115567|101111666|FG001|NOT COMPLETED|Overall Study||0||
48320809|NCT01114503|101111667|FG000|STARTED|Overall Study||2||
48320810|NCT01114503|101111667|FG000|COMPLETED|Overall Study||2||
48320811|NCT01114503|101111667|FG000|NOT COMPLETED|Overall Study||0||
48320812|NCT00294060|101111668|FG000|STARTED|Overall Study||2013||
48320813|NCT00294060|101111668|FG000|COMPLETED|Overall Study||840||
48320814|NCT00294060|101111668|FG000|NOT COMPLETED|Overall Study||1173||
48320815|NCT02445807|101111669|FG000|STARTED|Overall Study||176||
48320816|NCT02445807|101111670|FG001|STARTED|Overall Study||89||
48320817|NCT02445807|101111669|FG000|COMPLETED|Overall Study||176||
48320818|NCT02445807|101111670|FG001|COMPLETED|Overall Study||89||
48320819|NCT02445807|101111669|FG000|NOT COMPLETED|Overall Study||0||
48320820|NCT02445807|101111670|FG001|NOT COMPLETED|Overall Study||0||
48320821|NCT00271596|101111671|FG000|STARTED|Overall Study||17||
48320822|NCT00271596|101111672|FG001|STARTED|Overall Study||16||
48320823|NCT00271596|101111671|FG000|COMPLETED|Overall Study||16||
48320824|NCT00271596|101111672|FG001|COMPLETED|Overall Study||15||
48320825|NCT00271596|101111671|FG000|NOT COMPLETED|Overall Study||1||
48320826|NCT00271596|101111672|FG001|NOT COMPLETED|Overall Study||1||
48320827|NCT02581202|101111673|FG000|STARTED|Overall Study||216||
48320828|NCT02581202|101111673|FG000|COMPLETED|Overall Study||202||
48320829|NCT02581202|101111673|FG000|NOT COMPLETED|Overall Study||14||
48320830|NCT03581786|101111674|FG000|STARTED|Overall Study||143||
48320831|NCT03581786|101111675|FG001|STARTED|Overall Study||146||
48320832|NCT03581786|101111674|FG000|COMPLETED|Overall Study||0||
48320833|NCT03581786|101111675|FG001|COMPLETED|Overall Study||0||
48320834|NCT03581786|101111674|FG000|NOT COMPLETED|Overall Study||143||
48320835|NCT03581786|101111675|FG001|NOT COMPLETED|Overall Study||146||
48320836|NCT00930761|101111676|FG000|STARTED|Overall Study||50||
48320837|NCT00930761|101111677|FG001|STARTED|Overall Study||51||
48320838|NCT00930761|101111676|FG000|COMPLETED|Overall Study||46||
48320839|NCT00930761|101111677|FG001|COMPLETED|Overall Study||48||
48407743|NCT00693420|101328620|FG000|COMPLETED|Overall Study||131||
48407744|NCT00693420|101328621|FG001|COMPLETED|Overall Study||126||
48407745|NCT00693420|101328620|FG000|NOT COMPLETED|Overall Study||6||
48407746|NCT00693420|101328621|FG001|NOT COMPLETED|Overall Study||15||
48407747|NCT03418376|101328622|FG000|STARTED|Overall Study||12||
48407748|NCT03418376|101328623|FG001|STARTED|Overall Study||11||
48407749|NCT03418376|101328624|FG002|STARTED|Overall Study||11||
48407750|NCT03418376|101328625|FG003|STARTED|Overall Study||11||
48407751|NCT03418376|101328622|FG000|COMPLETED|Overall Study||11||
48320840|NCT00930761|101111676|FG000|NOT COMPLETED|Overall Study||4||
48320841|NCT00930761|101111677|FG001|NOT COMPLETED|Overall Study||3||
48320842|NCT03709654|101111678|FG000|STARTED|Overall Study||23||
48320843|NCT03709654|101111679|FG001|STARTED|Overall Study||13||
48407752|NCT03418376|101328623|FG001|COMPLETED|Overall Study||6||
48407753|NCT03418376|101328624|FG002|COMPLETED|Overall Study||8||
48320844|NCT03709654|101111678|FG000|COMPLETED|Overall Study||20||
48320845|NCT03709654|101111679|FG001|COMPLETED|Overall Study||11||
48320846|NCT03709654|101111678|FG000|NOT COMPLETED|Overall Study||3||
48320847|NCT03709654|101111679|FG001|NOT COMPLETED|Overall Study||2||
48320848|NCT00317109|101111680|FG000|STARTED|Overall Study||84||
48320849|NCT00317109|101111681|FG001|STARTED|Overall Study||84||
48320850|NCT00317109|101111680|FG000|COMPLETED|Overall Study||81||
48320851|NCT00317109|101111681|FG001|COMPLETED|Overall Study||84||
48320852|NCT00317109|101111680|FG000|NOT COMPLETED|Overall Study||3||
48320853|NCT00317109|101111681|FG001|NOT COMPLETED|Overall Study||0||
48320854|NCT00925015|101111682|FG000|STARTED|Overall Study||8||
48320855|NCT00925015|101111683|FG001|STARTED|Overall Study||6||
48320856|NCT00925015|101111684|FG002|STARTED|Overall Study||6||
48320857|NCT00925015|101111682|FG000|COMPLETED|Overall Study||0||
48320858|NCT00925015|101111683|FG001|COMPLETED|Overall Study||0||
48320859|NCT00925015|101111684|FG002|COMPLETED|Overall Study||0||
48320860|NCT00925015|101111682|FG000|NOT COMPLETED|Overall Study||8||
48320861|NCT00925015|101111683|FG001|NOT COMPLETED|Overall Study||6||
48320862|NCT00925015|101111684|FG002|NOT COMPLETED|Overall Study||6||
48320863|NCT02770547|101111685|FG000|STARTED|Overall Study||16||
48320864|NCT02770547|101111686|FG001|STARTED|Overall Study||16||
48320865|NCT02770547|101111685|FG000|COMPLETED|Overall Study||15||
48320866|NCT02770547|101111686|FG001|COMPLETED|Overall Study||15||
48320867|NCT02770547|101111685|FG000|NOT COMPLETED|Overall Study||1||
48320868|NCT02770547|101111686|FG001|NOT COMPLETED|Overall Study||1||
48320869|NCT01485627|101111687|FG000|STARTED|Overall Study||244||19
48320870|NCT01485627|101111688|FG001|STARTED|Overall Study||241||19
48320871|NCT01485627|101111687|FG000|Allocated Caregivers: Total|Overall Study||105||19
48320872|NCT01485627|101111688|FG001|Allocated Caregivers: Total|Overall Study||99||19
48320873|NCT01485627|101111687|FG000|Bereaved Caregivers: Total|Overall Study||63||19
48320874|NCT01485627|101111688|FG001|Bereaved Caregivers: Total|Overall Study||64||19
48320875|NCT01485627|101111687|FG000|Bereaved Caregivers: 1 Month|Overall Study||51||19
48320876|NCT01485627|101111688|FG001|Bereaved Caregivers: 1 Month|Overall Study||51||19
48320877|NCT01485627|101111687|FG000|Bereaved Caregivers: 2 Month Completed|Overall Study||49||19
48320878|NCT01485627|101111688|FG001|Bereaved Caregivers: 2 Month Completed|Overall Study||52||19
48320879|NCT01485627|101111687|FG000|Bereaved Caregivers: 7 Month Completed|Overall Study||48||19
48320880|NCT01485627|101111688|FG001|Bereaved Caregivers: 7 Month Completed|Overall Study||49||19
48320881|NCT01485627|101111687|FG000|COMPLETED|Overall Study||178||19
48320882|NCT01485627|101111688|FG001|COMPLETED|Overall Study||184||19
48738868|NCT01959139|102144405|FG000|NOT COMPLETED|Phase I: Cohort 2||0||
48738869|NCT01959139|102144406|FG001|NOT COMPLETED|Phase I: Cohort 2||0||
48738870|NCT01959139|102144407|FG002|NOT COMPLETED|Phase I: Cohort 2||0||
48738871|NCT01959139|102144408|FG003|NOT COMPLETED|Phase I: Cohort 2||0||
48738872|NCT01959139|102144405|FG000|STARTED|Phase II||0||
48738873|NCT01959139|102144406|FG001|STARTED|Phase II||0||
48738874|NCT01959139|102144407|FG002|STARTED|Phase II||56||
48738875|NCT01959139|102144408|FG003|STARTED|Phase II||55||
48738876|NCT01959139|102144405|FG000|Assessed for AEs|Phase II||0||
48738877|NCT01959139|102144406|FG001|Assessed for AEs|Phase II||0||
48738878|NCT01959139|102144407|FG002|Assessed for AEs|Phase II||54||
48738879|NCT01959139|102144408|FG003|Assessed for AEs|Phase II||51||
48738880|NCT01959139|102144405|FG000|COMPLETED|Phase II||0||
48738881|NCT01959139|102144406|FG001|COMPLETED|Phase II||0||
48738882|NCT01959139|102144407|FG002|COMPLETED|Phase II||0||
48738883|NCT01959139|102144408|FG003|COMPLETED|Phase II||0||
48738884|NCT01959139|102144405|FG000|NOT COMPLETED|Phase II||0||
48738885|NCT01959139|102144406|FG001|NOT COMPLETED|Phase II||0||
48738886|NCT01959139|102144407|FG002|NOT COMPLETED|Phase II||56||
48738887|NCT01959139|102144408|FG003|NOT COMPLETED|Phase II||55||
48738888|NCT00726232|102144409|FG000|STARTED|Initial Phase (Dose-finding)||19||
48738889|NCT00726232|102144410|FG001|STARTED|Initial Phase (Dose-finding)||8||
48738890|NCT00726232|102144411|FG002|STARTED|Initial Phase (Dose-finding)||7||
48738891|NCT00726232|102144412|FG003|STARTED|Initial Phase (Dose-finding)||8||
48738892|NCT00726232|102144413|FG004|STARTED|Initial Phase (Dose-finding)||22||
48738893|NCT00726232|102144414|FG005|STARTED|Initial Phase (Dose-finding)||9||
48738894|NCT00726232|102144415|FG006|STARTED|Initial Phase (Dose-finding)||0||
48320883|NCT01485627|101111687|FG000|NOT COMPLETED|Overall Study||66||0
48320884|NCT01485627|101111688|FG001|NOT COMPLETED|Overall Study||57||0
48320885|NCT00960661|101111689|FG000|STARTED|Basal Insulin Optimization Phase (BIO)||1036||
48320886|NCT00960661|101111690|FG001|STARTED|Basal Insulin Optimization Phase (BIO)||0||
48320887|NCT00960661|101111691|FG002|STARTED|Basal Insulin Optimization Phase (BIO)||0||
48320888|NCT00960661|101111689|FG000|COMPLETED|Basal Insulin Optimization Phase (BIO)||637||
48320889|NCT00960661|101111690|FG001|COMPLETED|Basal Insulin Optimization Phase (BIO)||0||
48320890|NCT00960661|101111691|FG002|COMPLETED|Basal Insulin Optimization Phase (BIO)||0||
48738895|NCT00726232|102144416|FG007|STARTED|Initial Phase (Dose-finding)||0||
48738896|NCT00726232|102144409|FG000|Safety Evaluable Participants|Initial Phase (Dose-finding)||19||
48738897|NCT00726232|102144410|FG001|Safety Evaluable Participants|Initial Phase (Dose-finding)||8||
48738898|NCT00726232|102144411|FG002|Safety Evaluable Participants|Initial Phase (Dose-finding)||7||
48738899|NCT00726232|102144412|FG003|Safety Evaluable Participants|Initial Phase (Dose-finding)||8||
48738900|NCT00726232|102144413|FG004|Safety Evaluable Participants|Initial Phase (Dose-finding)||22||
48320891|NCT00960661|101111689|FG000|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||399||
48320892|NCT00960661|101111690|FG001|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0||
48320893|NCT00960661|101111691|FG002|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0||
48320894|NCT00960661|101111689|FG000|STARTED|Interventional Phase||0||
48407754|NCT03418376|101328625|FG003|COMPLETED|Overall Study||10||
48407755|NCT03418376|101328622|FG000|NOT COMPLETED|Overall Study||1||
48407756|NCT03418376|101328623|FG001|NOT COMPLETED|Overall Study||5||
48407757|NCT03418376|101328624|FG002|NOT COMPLETED|Overall Study||3||
48407758|NCT03418376|101328625|FG003|NOT COMPLETED|Overall Study||1||
48407759|NCT01387074|101328626|FG000|STARTED|Overall Study||108||
48407760|NCT01387074|101328626|FG000|COMPLETED|Overall Study||100||
48407761|NCT01387074|101328626|FG000|NOT COMPLETED|Overall Study||8||
48407762|NCT01976975|101328627|FG000|STARTED|Overall Study||226||
48407763|NCT01976975|101328628|FG001|STARTED|Overall Study||44||
48407764|NCT01976975|101328627|FG000|COMPLETED|Overall Study||79||
48407765|NCT01976975|101328628|FG001|COMPLETED|Overall Study||32||
48407766|NCT01976975|101328627|FG000|NOT COMPLETED|Overall Study||147||
48407767|NCT01976975|101328628|FG001|NOT COMPLETED|Overall Study||12||
48407768|NCT00592176|101328629|FG000|STARTED|Overall Study||5||
48407769|NCT00592176|101328629|FG000|COMPLETED|Overall Study||5||
48407770|NCT00592176|101328629|FG000|NOT COMPLETED|Overall Study||0||
48407771|NCT01154322|101328630|FG000|STARTED|Overall Study||16||
48407772|NCT01154322|101328630|FG000|COMPLETED|Overall Study||14||
48407773|NCT01154322|101328630|FG000|NOT COMPLETED|Overall Study||2||
48407774|NCT02568852|101328631|FG000|STARTED|Overall Study||25||
48407775|NCT02568852|101328632|FG001|STARTED|Overall Study||25||
48407776|NCT02568852|101328631|FG000|COMPLETED|Overall Study||25||
48407777|NCT02568852|101328632|FG001|COMPLETED|Overall Study||25||
48407778|NCT02568852|101328631|FG000|NOT COMPLETED|Overall Study||0||
48616630|NCT00667992|101849417|FG001|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1||
48616631|NCT00667992|101849416|FG000|STARTED|Forth Intervention 400 Mcg Twice Daily||33||
48616632|NCT00667992|101849417|FG001|STARTED|Forth Intervention 400 Mcg Twice Daily||35||
48616633|NCT00667992|101849416|FG000|COMPLETED|Forth Intervention 400 Mcg Twice Daily||33||
48616634|NCT00667992|101849417|FG001|COMPLETED|Forth Intervention 400 Mcg Twice Daily||35||
48616635|NCT00667992|101849416|FG000|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0||
48407779|NCT02568852|101328632|FG001|NOT COMPLETED|Overall Study||0||
48407780|NCT00713284|101328633|FG000|STARTED|Overall Study||29||
48407781|NCT00713284|101328633|FG000|COMPLETED|Overall Study||13||
48407782|NCT00713284|101328633|FG000|NOT COMPLETED|Overall Study||16||
48407783|NCT02864706|101328634|FG000|STARTED|Overall Study||48||
48407784|NCT02864706|101328635|FG001|STARTED|Overall Study||47||
48407785|NCT02864706|101328634|FG000|Safety Set|Overall Study||48||
48407786|NCT02864706|101328635|FG001|Safety Set|Overall Study||47||
48407787|NCT02864706|101328634|FG000|Intent to Treat|Overall Study||46||
48407788|NCT02864706|101328635|FG001|Intent to Treat|Overall Study||47||
48407789|NCT02864706|101328634|FG000|COMPLETED|Overall Study||48||
48407790|NCT02864706|101328635|FG001|COMPLETED|Overall Study||47||
48407791|NCT02864706|101328634|FG000|NOT COMPLETED|Overall Study||0||
48407792|NCT02864706|101328635|FG001|NOT COMPLETED|Overall Study||0||
48407793|NCT03878160|101328636|FG000|STARTED|Overall Study||7||
48407794|NCT03878160|101328637|FG001|STARTED|Overall Study||9||
48407795|NCT03878160|101328638|FG002|STARTED|Overall Study||11||
48407796|NCT03878160|101328636|FG000|COMPLETED|Overall Study||5||
48407797|NCT03878160|101328637|FG001|COMPLETED|Overall Study||8||
48407798|NCT03878160|101328638|FG002|COMPLETED|Overall Study||10||
48407799|NCT03878160|101328636|FG000|NOT COMPLETED|Overall Study||2||
48407800|NCT03878160|101328637|FG001|NOT COMPLETED|Overall Study||1||
48407801|NCT03878160|101328638|FG002|NOT COMPLETED|Overall Study||1||
48407802|NCT02165072|101328639|FG000|STARTED|Overall Study||30||
48407803|NCT02165072|101328639|FG000|COMPLETED|Overall Study||30||
48407804|NCT02165072|101328639|FG000|NOT COMPLETED|Overall Study||0||
48407805|NCT04489940|101328640|FG000|STARTED|Overall Study||11||
48407806|NCT04489940|101328640|FG000|COMPLETED|Overall Study||1||
48407807|NCT04489940|101328640|FG000|NOT COMPLETED|Overall Study||10||
48407808|NCT03152110|101328641|FG000|STARTED|Overall Study||10||
48407809|NCT03152110|101328641|FG000|COMPLETED|Overall Study||7||
48407810|NCT03152110|101328641|FG000|NOT COMPLETED|Overall Study||3||
48407811|NCT02128919|101328642|FG000|STARTED|Overall Study||17||
48407812|NCT02128919|101328643|FG001|STARTED|Overall Study||16||
48407813|NCT02128919|101328642|FG000|COMPLETED|Overall Study||14||
48407814|NCT02128919|101328643|FG001|COMPLETED|Overall Study||15||
48407815|NCT02128919|101328642|FG000|NOT COMPLETED|Overall Study||3||
48407816|NCT02128919|101328643|FG001|NOT COMPLETED|Overall Study||1||
48161076|NCT01859793|100718735|FG001|NOT COMPLETED|Washout Period (4 Weeks)||1||
48407817|NCT01625611|101328644|FG000|STARTED|Overall Study||55||
48320895|NCT00960661|101111690|FG001|STARTED|Interventional Phase||316||
48320896|NCT00960661|101111691|FG002|STARTED|Interventional Phase||321||
48738901|NCT00726232|102144414|FG005|Safety Evaluable Participants|Initial Phase (Dose-finding)||9||
48738902|NCT00726232|102144415|FG006|Safety Evaluable Participants|Initial Phase (Dose-finding)||0||
48738903|NCT00726232|102144416|FG007|Safety Evaluable Participants|Initial Phase (Dose-finding)||0||
48738904|NCT00726232|102144409|FG000|ITT Participants|Initial Phase (Dose-finding)||19||
48738905|NCT00726232|102144410|FG001|ITT Participants|Initial Phase (Dose-finding)||8||
48738906|NCT00726232|102144411|FG002|ITT Participants|Initial Phase (Dose-finding)||7||
48738907|NCT00726232|102144412|FG003|ITT Participants|Initial Phase (Dose-finding)||8||
48738908|NCT00726232|102144413|FG004|ITT Participants|Initial Phase (Dose-finding)||22||
48738909|NCT00726232|102144414|FG005|ITT Participants|Initial Phase (Dose-finding)||9||
48738910|NCT00726232|102144415|FG006|ITT Participants|Initial Phase (Dose-finding)||0||
48738911|NCT00726232|102144416|FG007|ITT Participants|Initial Phase (Dose-finding)||0||
48738912|NCT00726232|102144409|FG000|COMPLETED|Initial Phase (Dose-finding)||6|Represents participants ongoing treatment.|
48738913|NCT00726232|102144410|FG001|COMPLETED|Initial Phase (Dose-finding)||2|Represents participants ongoing treatment.|
48738914|NCT00726232|102144411|FG002|COMPLETED|Initial Phase (Dose-finding)||2|Represents participants ongoing treatment.|
48738915|NCT00726232|102144412|FG003|COMPLETED|Initial Phase (Dose-finding)||0|Represents participants ongoing treatment.|
48738916|NCT00726232|102144413|FG004|COMPLETED|Initial Phase (Dose-finding)||1|Represents participants ongoing treatment.|
48738917|NCT00726232|102144414|FG005|COMPLETED|Initial Phase (Dose-finding)||0|Represents participants ongoing treatment.|
48738918|NCT00726232|102144415|FG006|COMPLETED|Initial Phase (Dose-finding)||0|Represents participants ongoing treatment.|
48738919|NCT00726232|102144416|FG007|COMPLETED|Initial Phase (Dose-finding)||0|Represents participants ongoing treatment.|
48738920|NCT00726232|102144409|FG000|NOT COMPLETED|Initial Phase (Dose-finding)||13||
48738921|NCT00726232|102144410|FG001|NOT COMPLETED|Initial Phase (Dose-finding)||6||
48320897|NCT00960661|101111689|FG000|Intent to Treat Population|Interventional Phase||0||
48320898|NCT00960661|101111690|FG001|Intent to Treat Population|Interventional Phase||315||
48738922|NCT00726232|102144411|FG002|NOT COMPLETED|Initial Phase (Dose-finding)||5||
48738923|NCT00726232|102144412|FG003|NOT COMPLETED|Initial Phase (Dose-finding)||8||
48738924|NCT00726232|102144413|FG004|NOT COMPLETED|Initial Phase (Dose-finding)||21||
48738925|NCT00726232|102144414|FG005|NOT COMPLETED|Initial Phase (Dose-finding)||9||
48738926|NCT00726232|102144415|FG006|NOT COMPLETED|Initial Phase (Dose-finding)||0||
48738927|NCT00726232|102144416|FG007|NOT COMPLETED|Initial Phase (Dose-finding)||0||
48738928|NCT00726232|102144409|FG000|STARTED|Expansion Phase||0||
48738929|NCT00726232|102144410|FG001|STARTED|Expansion Phase||0||
48738930|NCT00726232|102144411|FG002|STARTED|Expansion Phase||0||
48738931|NCT00726232|102144412|FG003|STARTED|Expansion Phase||0||
48738932|NCT00726232|102144413|FG004|STARTED|Expansion Phase||0||
48738933|NCT00726232|102144414|FG005|STARTED|Expansion Phase||0||
48738934|NCT00726232|102144415|FG006|STARTED|Expansion Phase||34||
48738935|NCT00726232|102144416|FG007|STARTED|Expansion Phase||39||
48738936|NCT00726232|102144409|FG000|Safety Evaluable Participants|Expansion Phase||0||
48738937|NCT00726232|102144410|FG001|Safety Evaluable Participants|Expansion Phase||0||
48738938|NCT00726232|102144411|FG002|Safety Evaluable Participants|Expansion Phase||0||
48738939|NCT00726232|102144412|FG003|Safety Evaluable Participants|Expansion Phase||0||
48738940|NCT00726232|102144413|FG004|Safety Evaluable Participants|Expansion Phase||0||
48738941|NCT00726232|102144414|FG005|Safety Evaluable Participants|Expansion Phase||0||
48738942|NCT00726232|102144415|FG006|Safety Evaluable Participants|Expansion Phase||34||
48738943|NCT00726232|102144416|FG007|Safety Evaluable Participants|Expansion Phase||39||
48738944|NCT00726232|102144409|FG000|ITT Participants|Expansion Phase||0||
48738945|NCT00726232|102144410|FG001|ITT Participants|Expansion Phase||0||
48738946|NCT00726232|102144411|FG002|ITT Participants|Expansion Phase||0||
48738947|NCT00726232|102144412|FG003|ITT Participants|Expansion Phase||0||
48738948|NCT00726232|102144413|FG004|ITT Participants|Expansion Phase||0||
48738949|NCT00726232|102144414|FG005|ITT Participants|Expansion Phase||0||
48738950|NCT00726232|102144415|FG006|ITT Participants|Expansion Phase||34||
48738951|NCT00726232|102144416|FG007|ITT Participants|Expansion Phase||39||
48738952|NCT00726232|102144409|FG000|COMPLETED|Expansion Phase||0|Participants ongoing: last patient last visit (LPLV) occurred 20AUG2018 following the data cutoff.|
48738953|NCT00726232|102144410|FG001|COMPLETED|Expansion Phase||0|Participants ongoing: last patient last visit (LPLV) occurred 20AUG2018 following the data cutoff.|
48738954|NCT00726232|102144411|FG002|COMPLETED|Expansion Phase||0|Participants ongoing: last patient last visit (LPLV) occurred 20AUG2018 following the data cutoff.|
48738955|NCT00726232|102144412|FG003|COMPLETED|Expansion Phase||0|Participants ongoing: last patient last visit (LPLV) occurred 20AUG2018 following the data cutoff.|
48738956|NCT00726232|102144413|FG004|COMPLETED|Expansion Phase||0|Participants ongoing: last patient last visit (LPLV) occurred 20AUG2018 following the data cutoff.|
48407818|NCT01625611|101328645|FG001|STARTED|Overall Study||4||
48407819|NCT01625611|101328644|FG000|PET Scan 1|Overall Study||49||
48738957|NCT00726232|102144414|FG005|COMPLETED|Expansion Phase||0|Participants ongoing: last patient last visit (LPLV) occurred 20AUG2018 following the data cutoff.|
48738958|NCT00726232|102144415|FG006|COMPLETED|Expansion Phase||10|Participants ongoing: last patient last visit (LPLV) occurred 20AUG2018 following the data cutoff.|
48738959|NCT00726232|102144416|FG007|COMPLETED|Expansion Phase||1|Participants ongoing: last patient last visit (LPLV) occurred 20AUG2018 following the data cutoff.|
48738960|NCT00726232|102144409|FG000|NOT COMPLETED|Expansion Phase||0||
48407820|NCT01625611|101328645|FG001|PET Scan 1|Overall Study||4||
48407821|NCT01625611|101328644|FG000|Lab 2|Overall Study||48||
48161077|NCT01859793|100718734|FG000|STARTED|2nd Intervention Period||14||
48161078|NCT01859793|100718735|FG001|STARTED|2nd Intervention Period||16||
48161079|NCT01859793|100718734|FG000|COMPLETED|2nd Intervention Period||14||
48161080|NCT01859793|100718735|FG001|COMPLETED|2nd Intervention Period||16||
48161081|NCT01859793|100718734|FG000|NOT COMPLETED|2nd Intervention Period||0||
48161082|NCT01859793|100718735|FG001|NOT COMPLETED|2nd Intervention Period||0||
48161083|NCT00838682|100718736|FG000|STARTED|Overall Study||54||
48161084|NCT00838682|100718737|FG001|STARTED|Overall Study||52||
48161085|NCT00838682|100718736|FG000|COMPLETED|Overall Study||29||
48161086|NCT00838682|100718737|FG001|COMPLETED|Overall Study||33||
48161087|NCT00838682|100718736|FG000|NOT COMPLETED|Overall Study||25||
48161088|NCT00838682|100718737|FG001|NOT COMPLETED|Overall Study||19||
48320899|NCT00960661|101111691|FG002|Intent to Treat Population|Interventional Phase||312||
48320900|NCT00960661|101111689|FG000|Per Protocol Population|Interventional Phase||0||
48320901|NCT00960661|101111690|FG001|Per Protocol Population|Interventional Phase||247||
48320902|NCT00960661|101111691|FG002|Per Protocol Population|Interventional Phase||263||
48320903|NCT00960661|101111689|FG000|COMPLETED|Interventional Phase||0||
48320904|NCT00960661|101111690|FG001|COMPLETED|Interventional Phase||264||
48161089|NCT01498822|100718738|FG000|STARTED|Overall Study||175||
48161090|NCT01498822|100718739|FG001|STARTED|Overall Study||178||
48161091|NCT01498822|100718738|FG000|COMPLETED|Overall Study||121||
48320905|NCT00960661|101111691|FG002|COMPLETED|Interventional Phase||275||
48161092|NCT01498822|100718739|FG001|COMPLETED|Overall Study||122||
48161093|NCT01498822|100718738|FG000|NOT COMPLETED|Overall Study||54||
48161094|NCT01498822|100718739|FG001|NOT COMPLETED|Overall Study||56||
48161095|NCT00509236|100718740|FG000|STARTED|Overall Study||64||
48161096|NCT00509236|100718741|FG001|STARTED|Overall Study||65||
48161097|NCT00509236|100718740|FG000|COMPLETED|Overall Study||47||
48161098|NCT00509236|100718741|FG001|COMPLETED|Overall Study||45||
48161099|NCT00509236|100718740|FG000|NOT COMPLETED|Overall Study||17||
48161100|NCT00509236|100718741|FG001|NOT COMPLETED|Overall Study||20||
48320906|NCT00960661|101111689|FG000|NOT COMPLETED|Interventional Phase||0||
48320907|NCT00960661|101111690|FG001|NOT COMPLETED|Interventional Phase||52||
48320908|NCT00960661|101111691|FG002|NOT COMPLETED|Interventional Phase||46||
48320909|NCT00971178|101111692|FG000|STARTED|Overall Study||35||
48320910|NCT00971178|101111693|FG001|STARTED|Overall Study||35||
48320911|NCT00971178|101111694|FG002|STARTED|Overall Study||35||
48616636|NCT00667992|101849417|FG001|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0||
48616637|NCT00931632|101849418|FG000|STARTED|Overall Study||229||
48616638|NCT00931632|101849419|FG001|STARTED|Overall Study||222||
48616639|NCT00931632|101849418|FG000|COMPLETED|Overall Study||208||
48616640|NCT00931632|101849419|FG001|COMPLETED|Overall Study||204||
48616641|NCT00931632|101849418|FG000|NOT COMPLETED|Overall Study||21||
48616642|NCT00931632|101849419|FG001|NOT COMPLETED|Overall Study||18||
48616643|NCT03066830|101849420|FG000|STARTED|Overall Study||254||
48616644|NCT03066830|101849421|FG001|STARTED|Overall Study||253||
48616645|NCT03066830|101849420|FG000|COMPLETED|Overall Study||221||
48616646|NCT03066830|101849421|FG001|COMPLETED|Overall Study||231||
48616647|NCT03066830|101849420|FG000|NOT COMPLETED|Overall Study||33||
48616648|NCT03066830|101849421|FG001|NOT COMPLETED|Overall Study||22||
48616649|NCT05554640|101849422|FG000|STARTED|Period 1||7||
48161101|NCT04671901|100718742|FG000|STARTED|Overall Study||2||
48616650|NCT05554640|101849423|FG001|STARTED|Period 1||7||
48616651|NCT05554640|101849422|FG000|COMPLETED|Period 1||7||
48161102|NCT04671901|100718742|FG000|COMPLETED|Overall Study||2||
48616652|NCT05554640|101849423|FG001|COMPLETED|Period 1||7||
48616653|NCT05554640|101849422|FG000|NOT COMPLETED|Period 1||0||
48161103|NCT04671901|100718742|FG000|NOT COMPLETED|Overall Study||0||
48161104|NCT01889186|100718743|FG000|STARTED|Overall Study||107||
48161105|NCT01889186|100718744|FG001|STARTED|Overall Study||51||
48738961|NCT00726232|102144410|FG001|NOT COMPLETED|Expansion Phase||0||
48738962|NCT00726232|102144411|FG002|NOT COMPLETED|Expansion Phase||0||
48738963|NCT00726232|102144412|FG003|NOT COMPLETED|Expansion Phase||0||
48738964|NCT00726232|102144413|FG004|NOT COMPLETED|Expansion Phase||0||
48738965|NCT00726232|102144414|FG005|NOT COMPLETED|Expansion Phase||0||
48407822|NCT01625611|101328645|FG001|Lab 2|Overall Study||0||
48407823|NCT01625611|101328644|FG000|PET Scan 2|Overall Study||47||
48407824|NCT01625611|101328645|FG001|PET Scan 2|Overall Study||0||
48738966|NCT00726232|102144415|FG006|NOT COMPLETED|Expansion Phase||24||
48738967|NCT00726232|102144416|FG007|NOT COMPLETED|Expansion Phase||38||
48738968|NCT00475709|102144417|FG000|STARTED|Overall Study||1022||
48738969|NCT00475709|102144417|FG000|Eligible of Analysis|Overall Study||1014||
48738970|NCT00475709|102144417|FG000|COMPLETED|Overall Study||946||
48738971|NCT00475709|102144417|FG000|NOT COMPLETED|Overall Study||76||
48738972|NCT00694018|102144418|FG000|STARTED|Overall Study||118||
48161106|NCT01889186|100718743|FG000|COMPLETED|Overall Study||0||
48407825|NCT01625611|101328644|FG000|COMPLETED|Overall Study||47||
48407826|NCT01625611|101328645|FG001|COMPLETED|Overall Study||4||
48407827|NCT01625611|101328644|FG000|NOT COMPLETED|Overall Study||8||
48407828|NCT01625611|101328645|FG001|NOT COMPLETED|Overall Study||0||
48407829|NCT00441727|101328646|FG000|STARTED|Overall Study||817||
48407830|NCT00441727|101328647|FG001|STARTED|Overall Study||804||
48738973|NCT00694018|102144419|FG001|STARTED|Overall Study||111||
48738974|NCT00694018|102144418|FG000|6 Months|Overall Study||106||
48738975|NCT00694018|102144419|FG001|6 Months|Overall Study||101||
48738976|NCT00694018|102144418|FG000|COMPLETED|Overall Study||105||
48738977|NCT00694018|102144419|FG001|COMPLETED|Overall Study||102||
48738978|NCT00694018|102144418|FG000|NOT COMPLETED|Overall Study||13||
48738979|NCT00694018|102144419|FG001|NOT COMPLETED|Overall Study||9||
48738980|NCT04289311|102144420|FG000|STARTED|Overall Study||30||
48738981|NCT04289311|102144421|FG001|STARTED|Overall Study||30||
48738982|NCT04289311|102144422|FG002|STARTED|Overall Study||15||
48738983|NCT04289311|102144423|FG003|STARTED|Overall Study||5||
48738984|NCT04289311|102144420|FG000|Mid-intervention Assessment (6 Weeks)|Overall Study||25||
48738985|NCT04289311|102144421|FG001|Mid-intervention Assessment (6 Weeks)|Overall Study||25||
48738986|NCT04289311|102144422|FG002|Mid-intervention Assessment (6 Weeks)|Overall Study||15||
48738987|NCT04289311|102144423|FG003|Mid-intervention Assessment (6 Weeks)|Overall Study||5||
48738988|NCT04289311|102144420|FG000|End-of-intervention Assessment (12 Weeks)|Overall Study||26||
48738989|NCT04289311|102144421|FG001|End-of-intervention Assessment (12 Weeks)|Overall Study||26||
48738990|NCT04289311|102144422|FG002|End-of-intervention Assessment (12 Weeks)|Overall Study||15||
48738991|NCT04289311|102144423|FG003|End-of-intervention Assessment (12 Weeks)|Overall Study||5||
48738992|NCT04289311|102144420|FG000|Post-intervention Follow up (24 Weeks)|Overall Study||24||
48738993|NCT04289311|102144421|FG001|Post-intervention Follow up (24 Weeks)|Overall Study||24||
48738994|NCT04289311|102144422|FG002|Post-intervention Follow up (24 Weeks)|Overall Study||15||
48738995|NCT04289311|102144423|FG003|Post-intervention Follow up (24 Weeks)|Overall Study||5||
48738996|NCT04289311|102144420|FG000|COMPLETED|Overall Study||24||
48738997|NCT04289311|102144421|FG001|COMPLETED|Overall Study||24||
48738998|NCT04289311|102144422|FG002|COMPLETED|Overall Study||15||
48738999|NCT04289311|102144423|FG003|COMPLETED|Overall Study||5||
48739000|NCT04289311|102144420|FG000|NOT COMPLETED|Overall Study||6||
48739001|NCT04289311|102144421|FG001|NOT COMPLETED|Overall Study||6||
48739002|NCT04289311|102144422|FG002|NOT COMPLETED|Overall Study||0||
48739003|NCT04289311|102144423|FG003|NOT COMPLETED|Overall Study||0||
48739004|NCT02652156|102144424|FG000|STARTED|Overall Study||4||
48739005|NCT02652156|102144425|FG001|STARTED|Overall Study||6||
48739006|NCT02652156|102144426|FG002|STARTED|Overall Study||4||
48739007|NCT02652156|102144424|FG000|COMPLETED|Overall Study||3||
48739008|NCT02652156|102144425|FG001|COMPLETED|Overall Study||6||
48739009|NCT02652156|102144426|FG002|COMPLETED|Overall Study||4||
48739010|NCT02652156|102144424|FG000|NOT COMPLETED|Overall Study||1||
48739011|NCT02652156|102144425|FG001|NOT COMPLETED|Overall Study||0||
48739012|NCT02652156|102144426|FG002|NOT COMPLETED|Overall Study||0||
48739013|NCT00264537|102144427|FG000|STARTED|Overall Study||160||
48739014|NCT00264537|102144428|FG001|STARTED|Overall Study||159||
48739015|NCT00264537|102144429|FG002|STARTED|Overall Study||159||
48739016|NCT00264537|102144430|FG003|STARTED|Overall Study||159||
48161107|NCT01889186|100718744|FG001|COMPLETED|Overall Study||0||
48161108|NCT01889186|100718743|FG000|NOT COMPLETED|Overall Study||107||
48407831|NCT00441727|101328648|FG002|STARTED|Overall Study||805||
48407832|NCT00441727|101328646|FG000|COMPLETED|Overall Study||711||
48407833|NCT00441727|101328647|FG001|COMPLETED|Overall Study||686||
48407834|NCT00441727|101328648|FG002|COMPLETED|Overall Study||637||
48407835|NCT00441727|101328646|FG000|NOT COMPLETED|Overall Study||106||
48407836|NCT00441727|101328647|FG001|NOT COMPLETED|Overall Study||118||
48407837|NCT00441727|101328648|FG002|NOT COMPLETED|Overall Study||168||
48407838|NCT02853123|101328649|FG000|STARTED|Treatment Period 1||52||
48407839|NCT02853123|101328650|FG001|STARTED|Treatment Period 1||54||
48407840|NCT02853123|101328649|FG000|COMPLETED|Treatment Period 1||52||
48739017|NCT00264537|102144427|FG000|COMPLETED|Overall Study||110||
48739018|NCT00264537|102144428|FG001|COMPLETED|Overall Study||101||
48739019|NCT00264537|102144429|FG002|COMPLETED|Overall Study||109||
48407841|NCT02853123|101328650|FG001|COMPLETED|Treatment Period 1||51||
48739020|NCT00264537|102144430|FG003|COMPLETED|Overall Study||99||
48739021|NCT00264537|102144427|FG000|NOT COMPLETED|Overall Study||50||
48739022|NCT00264537|102144428|FG001|NOT COMPLETED|Overall Study||58||
48739023|NCT00264537|102144429|FG002|NOT COMPLETED|Overall Study||50||
48739024|NCT00264537|102144430|FG003|NOT COMPLETED|Overall Study||60||
48739025|NCT03710642|102144431|FG000|STARTED|Overall Study||27||
48739026|NCT03710642|102144432|FG001|STARTED|Overall Study||8||
48739027|NCT03710642|102144431|FG000|COMPLETED|Overall Study||17||
48739028|NCT03710642|102144432|FG001|COMPLETED|Overall Study||3||
48320912|NCT00971178|101111692|FG000|COMPLETED|Overall Study||33||
48320913|NCT00971178|101111693|FG001|COMPLETED|Overall Study||33||
48320914|NCT00971178|101111694|FG002|COMPLETED|Overall Study||33||
48739029|NCT03710642|102144431|FG000|NOT COMPLETED|Overall Study||10||
48739030|NCT03710642|102144432|FG001|NOT COMPLETED|Overall Study||5||
48739031|NCT01510158|102144433|FG000|STARTED|Overall Study||202||
48739032|NCT01510158|102144434|FG001|STARTED|Overall Study||203||
48739033|NCT01510158|102144435|FG002|STARTED|Overall Study||202||
48739034|NCT01510158|102144433|FG000|COMPLETED|Overall Study||151||
48739035|NCT01510158|102144434|FG001|COMPLETED|Overall Study||150||
48739036|NCT01510158|102144435|FG002|COMPLETED|Overall Study||152||
48739037|NCT01510158|102144433|FG000|NOT COMPLETED|Overall Study||51||
48739038|NCT01510158|102144434|FG001|NOT COMPLETED|Overall Study||53||
48739039|NCT01510158|102144435|FG002|NOT COMPLETED|Overall Study||50||
48161109|NCT01889186|100718744|FG001|NOT COMPLETED|Overall Study||51||
48161110|NCT00738101|100718745|FG000|STARTED|Overall Study||293||
48161111|NCT00738101|100718745|FG000|COMPLETED|Overall Study||286||
48161112|NCT00738101|100718745|FG000|NOT COMPLETED|Overall Study||7||
48161113|NCT01453348|100718746|FG000|STARTED|Overall Study||84||
48161114|NCT01453348|100718747|FG001|STARTED|Overall Study||84||
48161115|NCT01453348|100718748|FG002|STARTED|Overall Study||84||
48161116|NCT01453348|100718746|FG000|COMPLETED|Overall Study||83||
48161117|NCT01453348|100718747|FG001|COMPLETED|Overall Study||83||
48161118|NCT01453348|100718748|FG002|COMPLETED|Overall Study||83||
48161119|NCT01453348|100718746|FG000|NOT COMPLETED|Overall Study||1||
48161120|NCT01453348|100718747|FG001|NOT COMPLETED|Overall Study||1||
48161121|NCT01453348|100718748|FG002|NOT COMPLETED|Overall Study||1||
48320915|NCT00971178|101111692|FG000|NOT COMPLETED|Overall Study||2||
48320916|NCT00971178|101111693|FG001|NOT COMPLETED|Overall Study||2||
48739040|NCT05258149|102144436|FG000|STARTED|Period 1||70||
48739041|NCT05258149|102144437|FG001|STARTED|Period 1||73||
48739042|NCT05258149|102144436|FG000|COMPLETED|Period 1||69||
48739043|NCT05258149|102144437|FG001|COMPLETED|Period 1||72||
48739044|NCT05258149|102144436|FG000|NOT COMPLETED|Period 1||1||
48739045|NCT05258149|102144437|FG001|NOT COMPLETED|Period 1||1||
48739046|NCT05258149|102144436|FG000|STARTED|Period 2||69||
48739047|NCT05258149|102144437|FG001|STARTED|Period 2||72||
48739048|NCT05258149|102144436|FG000|COMPLETED|Period 2||68||
48161122|NCT00676130|100718749|FG000|STARTED|Overall Study||76||
48161123|NCT00676130|100718750|FG001|STARTED|Overall Study||77||
48320917|NCT00971178|101111694|FG002|NOT COMPLETED|Overall Study||2||
48739049|NCT05258149|102144437|FG001|COMPLETED|Period 2||71||
48739050|NCT05258149|102144436|FG000|NOT COMPLETED|Period 2||1||
48739051|NCT05258149|102144437|FG001|NOT COMPLETED|Period 2||1||
48739052|NCT05258149|102144436|FG000|STARTED|Period 3||68||
48739053|NCT05258149|102144437|FG001|STARTED|Period 3||71||
48739054|NCT05258149|102144436|FG000|COMPLETED|Period 3||68||
48739055|NCT05258149|102144437|FG001|COMPLETED|Period 3||70||
48739056|NCT05258149|102144436|FG000|NOT COMPLETED|Period 3||0||
48320918|NCT03548935|101111695|FG000|STARTED|Overall Study||1306||
48320919|NCT03548935|101111696|FG001|STARTED|Overall Study||655||
48320920|NCT03548935|101111695|FG000|Full Analysis Set (FAS)|Overall Study||1306||
48320921|NCT03548935|101111696|FG001|Full Analysis Set (FAS)|Overall Study||655||
48320922|NCT03548935|101111695|FG000|Safety Analysis Set (SAS)|Overall Study||1306||
48320923|NCT03548935|101111696|FG001|Safety Analysis Set (SAS)|Overall Study||655||
48616654|NCT05554640|101849423|FG001|NOT COMPLETED|Period 1||0||
48616655|NCT05554640|101849422|FG000|STARTED|Period 2||7||
48616656|NCT05554640|101849423|FG001|STARTED|Period 2||7||
48616657|NCT05554640|101849422|FG000|COMPLETED|Period 2||7||
48616658|NCT05554640|101849423|FG001|COMPLETED|Period 2||7||
48616659|NCT05554640|101849422|FG000|NOT COMPLETED|Period 2||0||
48320924|NCT03548935|101111695|FG000|COMPLETED|Overall Study||1240||
48616660|NCT05554640|101849423|FG001|NOT COMPLETED|Period 2||0||
48616661|NCT04865588|101849424|FG000|STARTED|Overall Study||29||
48616662|NCT04865588|101849425|FG001|STARTED|Overall Study||31||
48616663|NCT04865588|101849424|FG000|COMPLETED|Overall Study||29||
48616664|NCT04865588|101849425|FG001|COMPLETED|Overall Study||31||
48739057|NCT05258149|102144437|FG001|NOT COMPLETED|Period 3||1||
48739058|NCT00536471|102144438|FG000|STARTED|Overall Study||257||
48739059|NCT00536471|102144439|FG001|STARTED|Overall Study||127||
48616665|NCT04865588|101849424|FG000|NOT COMPLETED|Overall Study||0||
48616666|NCT04865588|101849425|FG001|NOT COMPLETED|Overall Study||0||
48616667|NCT02753816|101849426|FG000|STARTED|Overall Study||7||9
48616668|NCT02753816|101849427|FG001|STARTED|Overall Study||11||11
48616669|NCT02753816|101849428|FG002|STARTED|Overall Study||7||22
48616670|NCT02753816|101849426|FG000|Tranexamic Acid|Overall Study||7||9
48616671|NCT02753816|101849427|FG001|Tranexamic Acid|Overall Study||0||0
48616672|NCT02753816|101849428|FG002|Tranexamic Acid|Overall Study||7||12
48616673|NCT02753816|101849426|FG000|Placebo|Overall Study||0||0
48616674|NCT02753816|101849427|FG001|Placebo|Overall Study||11||11
48616675|NCT02753816|101849428|FG002|Placebo|Overall Study||7||10
48616676|NCT02753816|101849426|FG000|COMPLETED|Overall Study||7||9
48616677|NCT02753816|101849427|FG001|COMPLETED|Overall Study||10||10
48616678|NCT02753816|101849428|FG002|COMPLETED|Overall Study||7||22
48739060|NCT00536471|102144440|FG002|STARTED|Overall Study||261||
48739061|NCT00536471|102144441|FG003|STARTED|Overall Study||131||
48739062|NCT00536471|102144438|FG000|COMPLETED|Overall Study||101||
48739063|NCT00536471|102144439|FG001|COMPLETED|Overall Study||43||
48739064|NCT00536471|102144440|FG002|COMPLETED|Overall Study||122||
48161124|NCT00676130|100718749|FG000|COMPLETED|Overall Study||73||
48161125|NCT00676130|100718750|FG001|COMPLETED|Overall Study||73||
48161126|NCT00676130|100718749|FG000|NOT COMPLETED|Overall Study||3||
48161127|NCT00676130|100718750|FG001|NOT COMPLETED|Overall Study||4||
48161128|NCT00116272|100718751|FG000|STARTED|Overall Study||370||
48161129|NCT00116272|100718752|FG001|STARTED|Overall Study||164||
48161130|NCT00116272|100718751|FG000|COMPLETED|Overall Study||359||
48161131|NCT00116272|100718752|FG001|COMPLETED|Overall Study||158||
48161132|NCT00116272|100718751|FG000|NOT COMPLETED|Overall Study||11||
48161133|NCT00116272|100718752|FG001|NOT COMPLETED|Overall Study||6||
48161134|NCT03135535|100718753|FG000|STARTED|Overall Study||30||
48161135|NCT03135535|100718753|FG000|COMPLETED|Overall Study||30||
48161136|NCT03135535|100718753|FG000|NOT COMPLETED|Overall Study||0||
48161137|NCT01373450|100718754|FG000|STARTED|Crossover Period 1||2||
48161138|NCT01373450|100718755|FG001|STARTED|Crossover Period 1||2||
48320925|NCT03548935|101111696|FG001|COMPLETED|Overall Study||609||
48320926|NCT03548935|101111695|FG000|NOT COMPLETED|Overall Study||66||
48320927|NCT03548935|101111696|FG001|NOT COMPLETED|Overall Study||46||
48320928|NCT02912572|101111697|FG000|STARTED|Overall Study||15||
48320929|NCT02912572|101111698|FG001|STARTED|Overall Study||16||
48320930|NCT02912572|101111699|FG002|STARTED|Overall Study||35||
48320931|NCT02912572|101111700|FG003|STARTED|Overall Study||35||
48320932|NCT02912572|101111697|FG000|COMPLETED|Overall Study||15||
48320933|NCT02912572|101111698|FG001|COMPLETED|Overall Study||16||
48739065|NCT00536471|102144441|FG003|COMPLETED|Overall Study||57||
48161139|NCT01373450|100718756|FG002|STARTED|Crossover Period 1||2||
48320934|NCT02912572|101111699|FG002|COMPLETED|Overall Study||35||
48320935|NCT02912572|101111700|FG003|COMPLETED|Overall Study||35||
48320936|NCT02912572|101111697|FG000|NOT COMPLETED|Overall Study||0||
48320937|NCT02912572|101111698|FG001|NOT COMPLETED|Overall Study||0||
48616679|NCT02753816|101849426|FG000|NOT COMPLETED|Overall Study||0||0
48616680|NCT02753816|101849427|FG001|NOT COMPLETED|Overall Study||1||1
48616681|NCT02753816|101849428|FG002|NOT COMPLETED|Overall Study||0||0
48616682|NCT02106351|101849429|FG000|STARTED|Treatment Cycle 1||71||
48616683|NCT02106351|101849430|FG001|STARTED|Treatment Cycle 1||70||
48739066|NCT00536471|102144438|FG000|NOT COMPLETED|Overall Study||156||
48739067|NCT00536471|102144439|FG001|NOT COMPLETED|Overall Study||84||
48739068|NCT00536471|102144440|FG002|NOT COMPLETED|Overall Study||139||
48739069|NCT00536471|102144441|FG003|NOT COMPLETED|Overall Study||74||
48739070|NCT02223715|102144442|FG000|STARTED|Overall Study||600||
48739071|NCT02223715|102144442|FG000|COMPLETED|Overall Study||496||
48161140|NCT01373450|100718757|FG003|STARTED|Crossover Period 1||2||
48161141|NCT01373450|100718758|FG004|STARTED|Crossover Period 1||2||
48161142|NCT01373450|100718759|FG005|STARTED|Crossover Period 1||2||
48161143|NCT01373450|100718754|FG000|COMPLETED|Crossover Period 1||2||
48161144|NCT01373450|100718755|FG001|COMPLETED|Crossover Period 1||2||
48161145|NCT01373450|100718756|FG002|COMPLETED|Crossover Period 1||2||
48161146|NCT01373450|100718757|FG003|COMPLETED|Crossover Period 1||2||
48161147|NCT01373450|100718758|FG004|COMPLETED|Crossover Period 1||2||
48161148|NCT01373450|100718759|FG005|COMPLETED|Crossover Period 1||2||
48161149|NCT01373450|100718754|FG000|NOT COMPLETED|Crossover Period 1||0||
48161150|NCT01373450|100718755|FG001|NOT COMPLETED|Crossover Period 1||0||
48161151|NCT01373450|100718756|FG002|NOT COMPLETED|Crossover Period 1||0||
48161152|NCT01373450|100718757|FG003|NOT COMPLETED|Crossover Period 1||0||
48161153|NCT01373450|100718758|FG004|NOT COMPLETED|Crossover Period 1||0||
48161154|NCT01373450|100718759|FG005|NOT COMPLETED|Crossover Period 1||0||
48161155|NCT01373450|100718754|FG000|STARTED|7 Day Wash-out||2||
48161156|NCT01373450|100718755|FG001|STARTED|7 Day Wash-out||2||
48161157|NCT01373450|100718756|FG002|STARTED|7 Day Wash-out||2||
48161158|NCT01373450|100718757|FG003|STARTED|7 Day Wash-out||2||
48161159|NCT01373450|100718758|FG004|STARTED|7 Day Wash-out||2||
48161160|NCT01373450|100718759|FG005|STARTED|7 Day Wash-out||2||
48161161|NCT01373450|100718754|FG000|COMPLETED|7 Day Wash-out||2||
48161162|NCT01373450|100718755|FG001|COMPLETED|7 Day Wash-out||2||
48161163|NCT01373450|100718756|FG002|COMPLETED|7 Day Wash-out||2||
48161164|NCT01373450|100718757|FG003|COMPLETED|7 Day Wash-out||2||
48161165|NCT01373450|100718758|FG004|COMPLETED|7 Day Wash-out||2||
48161166|NCT01373450|100718759|FG005|COMPLETED|7 Day Wash-out||2||
48161167|NCT01373450|100718754|FG000|NOT COMPLETED|7 Day Wash-out||0||
48161168|NCT01373450|100718755|FG001|NOT COMPLETED|7 Day Wash-out||0||
48161169|NCT01373450|100718756|FG002|NOT COMPLETED|7 Day Wash-out||0||
48320938|NCT02912572|101111699|FG002|NOT COMPLETED|Overall Study||0||
48320939|NCT02912572|101111700|FG003|NOT COMPLETED|Overall Study||0||
48320940|NCT01611974|101111701|FG000|STARTED|Overall Study||40||
48320941|NCT01611974|101111702|FG001|STARTED|Overall Study||40||
48320942|NCT01611974|101111703|FG002|STARTED|Overall Study||40||
48616684|NCT02106351|101849431|FG002|STARTED|Treatment Cycle 1||71||
48616685|NCT02106351|101849429|FG000|Received Treatment in TC 1|Treatment Cycle 1||70||
48616686|NCT02106351|101849430|FG001|Received Treatment in TC 1|Treatment Cycle 1||70||
48616687|NCT02106351|101849431|FG002|Received Treatment in TC 1|Treatment Cycle 1||70||
48616688|NCT02106351|101849429|FG000|COMPLETED|Treatment Cycle 1||66||
48739072|NCT02223715|102144442|FG000|NOT COMPLETED|Overall Study||104||
48739073|NCT00590863|102144443|FG000|STARTED|Overall Study||221||
48739074|NCT00590863|102144444|FG001|STARTED|Overall Study||220||
48616689|NCT02106351|101849430|FG001|COMPLETED|Treatment Cycle 1||67||
48616690|NCT02106351|101849431|FG002|COMPLETED|Treatment Cycle 1||67||
48616691|NCT02106351|101849429|FG000|NOT COMPLETED|Treatment Cycle 1||5||
48739075|NCT00590863|102144445|FG002|STARTED|Overall Study||224||
48739076|NCT00590863|102144443|FG000|COMPLETED|Overall Study||137||
48739077|NCT00590863|102144444|FG001|COMPLETED|Overall Study||138||
48739078|NCT00590863|102144445|FG002|COMPLETED|Overall Study||146||
48739079|NCT00590863|102144443|FG000|NOT COMPLETED|Overall Study||84||
48616692|NCT02106351|101849430|FG001|NOT COMPLETED|Treatment Cycle 1||3||
48616693|NCT02106351|101849431|FG002|NOT COMPLETED|Treatment Cycle 1||4||
48616694|NCT02106351|101849429|FG000|STARTED|Treatment Cycle 2||0||
48739080|NCT00590863|102144444|FG001|NOT COMPLETED|Overall Study||82||
48739081|NCT00590863|102144445|FG002|NOT COMPLETED|Overall Study||78||
48739082|NCT01048658|102144446|FG000|STARTED|Overall Study||80||
48739083|NCT01048658|102144447|FG001|STARTED|Overall Study||80||
48739084|NCT01048658|102144446|FG000|COMPLETED|Overall Study||80||
48739085|NCT01048658|102144447|FG001|COMPLETED|Overall Study||80||
48739086|NCT01048658|102144446|FG000|NOT COMPLETED|Overall Study||0||
48161170|NCT01373450|100718757|FG003|NOT COMPLETED|7 Day Wash-out||0||
48161171|NCT01373450|100718758|FG004|NOT COMPLETED|7 Day Wash-out||0||
48161172|NCT01373450|100718759|FG005|NOT COMPLETED|7 Day Wash-out||0||
48739087|NCT01048658|102144447|FG001|NOT COMPLETED|Overall Study||0||
48739088|NCT00719680|102144448|FG000|STARTED|Overall Study||21||
48161173|NCT01373450|100718754|FG000|STARTED|Crossover Period 2||2||
48161174|NCT01373450|100718755|FG001|STARTED|Crossover Period 2||2||
48320943|NCT01611974|101111701|FG000|COMPLETED|Overall Study||25||
48320944|NCT01611974|101111702|FG001|COMPLETED|Overall Study||25||
48320945|NCT01611974|101111703|FG002|COMPLETED|Overall Study||24||
48616695|NCT02106351|101849430|FG001|STARTED|Treatment Cycle 2||88||
48616696|NCT02106351|101849431|FG002|STARTED|Treatment Cycle 2||90||
48739089|NCT00719680|102144448|FG000|COMPLETED|Overall Study||16||
48739090|NCT00719680|102144448|FG000|NOT COMPLETED|Overall Study||5||
48739091|NCT00668811|102144449|FG000|STARTED|Overall Study||23||
48739092|NCT00668811|102144449|FG000|COMPLETED|Overall Study||23||
48739093|NCT00668811|102144449|FG000|NOT COMPLETED|Overall Study||0||
48767628|NCT01063751|102222784|FG000|STARTED|Overall Study||234||241
48161175|NCT01373450|100718756|FG002|STARTED|Crossover Period 2||2||
48161176|NCT01373450|100718757|FG003|STARTED|Crossover Period 2||2||
48161177|NCT01373450|100718758|FG004|STARTED|Crossover Period 2||2||
48161178|NCT01373450|100718759|FG005|STARTED|Crossover Period 2||2||
48161179|NCT01373450|100718754|FG000|COMPLETED|Crossover Period 2||2||
48161180|NCT01373450|100718755|FG001|COMPLETED|Crossover Period 2||2||
48161181|NCT01373450|100718756|FG002|COMPLETED|Crossover Period 2||2||
48161182|NCT01373450|100718757|FG003|COMPLETED|Crossover Period 2||2||
48739094|NCT01053988|102144450|FG000|STARTED|2-week, Single-blind Run-In Period||1390||
48739095|NCT01053988|102144451|FG001|STARTED|2-week, Single-blind Run-In Period||0||
48739096|NCT01053988|102144452|FG002|STARTED|2-week, Single-blind Run-In Period||0||
48739097|NCT01053988|102144453|FG003|STARTED|2-week, Single-blind Run-In Period||0||
48739098|NCT01053988|102144454|FG004|STARTED|2-week, Single-blind Run-In Period||0||
48739099|NCT01053988|102144455|FG005|STARTED|2-week, Single-blind Run-In Period||0||
48739100|NCT01053988|102144450|FG000|COMPLETED|2-week, Single-blind Run-In Period||1030||
48739101|NCT01053988|102144451|FG001|COMPLETED|2-week, Single-blind Run-In Period||0||
48739102|NCT01053988|102144452|FG002|COMPLETED|2-week, Single-blind Run-In Period||0||
48739103|NCT01053988|102144453|FG003|COMPLETED|2-week, Single-blind Run-In Period||0||
48739104|NCT01053988|102144454|FG004|COMPLETED|2-week, Single-blind Run-In Period||0||
48739105|NCT01053988|102144455|FG005|COMPLETED|2-week, Single-blind Run-In Period||0||
48739106|NCT01053988|102144450|FG000|NOT COMPLETED|2-week, Single-blind Run-In Period||360||
48739107|NCT01053988|102144451|FG001|NOT COMPLETED|2-week, Single-blind Run-In Period||0||
48739108|NCT01053988|102144452|FG002|NOT COMPLETED|2-week, Single-blind Run-In Period||0||
48739109|NCT01053988|102144453|FG003|NOT COMPLETED|2-week, Single-blind Run-In Period||0||
48739110|NCT01053988|102144454|FG004|NOT COMPLETED|2-week, Single-blind Run-In Period||0||
48739111|NCT01053988|102144455|FG005|NOT COMPLETED|2-week, Single-blind Run-In Period||0||
48739112|NCT01053988|102144450|FG000|STARTED|24-week, Double-blind Treatment Period||0||
48739113|NCT01053988|102144451|FG001|STARTED|24-week, Double-blind Treatment Period||207||
48320946|NCT01611974|101111701|FG000|NOT COMPLETED|Overall Study||15||
48320947|NCT01611974|101111702|FG001|NOT COMPLETED|Overall Study||15||
48320948|NCT01611974|101111703|FG002|NOT COMPLETED|Overall Study||16||
48320949|NCT00535132|101111704|FG000|STARTED|Randomized Population||100||
48320950|NCT00535132|101111705|FG001|STARTED|Randomized Population||101||
48320951|NCT00535132|101111704|FG000|COMPLETED|Randomized Population||100||
48320952|NCT00535132|101111705|FG001|COMPLETED|Randomized Population||101||
48320953|NCT00535132|101111704|FG000|NOT COMPLETED|Randomized Population||0||
48320954|NCT00535132|101111705|FG001|NOT COMPLETED|Randomized Population||0||
48320955|NCT00535132|101111704|FG000|STARTED|Safety Analysis Set||100||
48616697|NCT02106351|101849429|FG000|COMPLETED|Treatment Cycle 2||0||
48616698|NCT02106351|101849430|FG001|COMPLETED|Treatment Cycle 2||83||
48616699|NCT02106351|101849431|FG002|COMPLETED|Treatment Cycle 2||87||
48616700|NCT02106351|101849429|FG000|NOT COMPLETED|Treatment Cycle 2||0||
48616701|NCT02106351|101849430|FG001|NOT COMPLETED|Treatment Cycle 2||5||
48616702|NCT02106351|101849431|FG002|NOT COMPLETED|Treatment Cycle 2||3||
48616703|NCT02106351|101849429|FG000|STARTED|Treatment Cycle 3||0||
48616704|NCT02106351|101849430|FG001|STARTED|Treatment Cycle 3||49||
48616705|NCT02106351|101849431|FG002|STARTED|Treatment Cycle 3||58||
48616706|NCT02106351|101849429|FG000|COMPLETED|Treatment Cycle 3||0||
48616707|NCT02106351|101849430|FG001|COMPLETED|Treatment Cycle 3||45||
48616708|NCT02106351|101849431|FG002|COMPLETED|Treatment Cycle 3||53||
48616709|NCT02106351|101849429|FG000|NOT COMPLETED|Treatment Cycle 3||0||
48616710|NCT02106351|101849430|FG001|NOT COMPLETED|Treatment Cycle 3||4||
48616711|NCT02106351|101849431|FG002|NOT COMPLETED|Treatment Cycle 3||5||
48616712|NCT02106351|101849429|FG000|STARTED|Treatment Cycle 4||0||
48616713|NCT02106351|101849430|FG001|STARTED|Treatment Cycle 4||22||
48616714|NCT02106351|101849431|FG002|STARTED|Treatment Cycle 4||33||
48616715|NCT02106351|101849429|FG000|COMPLETED|Treatment Cycle 4||0||
48616716|NCT02106351|101849430|FG001|COMPLETED|Treatment Cycle 4||21||
48616717|NCT02106351|101849431|FG002|COMPLETED|Treatment Cycle 4||31||
48616718|NCT02106351|101849429|FG000|NOT COMPLETED|Treatment Cycle 4||0||
48616719|NCT02106351|101849430|FG001|NOT COMPLETED|Treatment Cycle 4||1||
48616720|NCT02106351|101849431|FG002|NOT COMPLETED|Treatment Cycle 4||2||
48616721|NCT02249104|101849432|FG000|STARTED|Overall Study||28||
48616722|NCT02249104|101849432|FG000|COMPLETED|Overall Study||25||
48739114|NCT01053988|102144452|FG002|STARTED|24-week, Double-blind Treatment Period||206||
48739115|NCT01053988|102144453|FG003|STARTED|24-week, Double-blind Treatment Period||205||
48739116|NCT01053988|102144454|FG004|STARTED|24-week, Double-blind Treatment Period||206||
48739117|NCT01053988|102144455|FG005|STARTED|24-week, Double-blind Treatment Period||206||
48739118|NCT01053988|102144450|FG000|COMPLETED|24-week, Double-blind Treatment Period||0||
48739119|NCT01053988|102144451|FG001|COMPLETED|24-week, Double-blind Treatment Period||138||
48739120|NCT01053988|102144452|FG002|COMPLETED|24-week, Double-blind Treatment Period||145||
48739121|NCT01053988|102144453|FG003|COMPLETED|24-week, Double-blind Treatment Period||142||
48739122|NCT01053988|102144454|FG004|COMPLETED|24-week, Double-blind Treatment Period||147||
48739123|NCT01053988|102144455|FG005|COMPLETED|24-week, Double-blind Treatment Period||151||
48320956|NCT00535132|101111705|FG001|STARTED|Safety Analysis Set||101||
48320957|NCT00535132|101111704|FG000|COMPLETED|Safety Analysis Set||98||
48320958|NCT00535132|101111705|FG001|COMPLETED|Safety Analysis Set||99||
48320959|NCT00535132|101111704|FG000|NOT COMPLETED|Safety Analysis Set||2||
48320960|NCT00535132|101111705|FG001|NOT COMPLETED|Safety Analysis Set||2||
48320961|NCT00535132|101111704|FG000|STARTED|Intent-to-Treat (ITT) Analysis Set||98||
48616723|NCT02249104|101849432|FG000|NOT COMPLETED|Overall Study||3||
48616724|NCT02686164|101849433|FG000|STARTED|Overall Study||30||
48616725|NCT02686164|101849433|FG000|COMPLETED|Overall Study||27||
48616726|NCT02686164|101849433|FG000|NOT COMPLETED|Overall Study||3||
48616727|NCT03797898|101849434|FG000|STARTED|Overall Study||452||5
48739124|NCT01053988|102144450|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0||
48739125|NCT01053988|102144451|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||69||
48739126|NCT01053988|102144452|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||61||
48739127|NCT01053988|102144453|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||63||
48739128|NCT01053988|102144454|FG004|NOT COMPLETED|24-week, Double-blind Treatment Period||59||
48739129|NCT01053988|102144455|FG005|NOT COMPLETED|24-week, Double-blind Treatment Period||55||
48739130|NCT00952081|102144456|FG000|STARTED|Overall Study||22||
48739131|NCT00952081|102144456|FG000|COMPLETED|Overall Study||22||
48739132|NCT00952081|102144456|FG000|NOT COMPLETED|Overall Study||0||
48739133|NCT01636986|102144457|FG000|STARTED|Overall Study||30||
48739134|NCT01636986|102144458|FG001|STARTED|Overall Study||32||
48739135|NCT01636986|102144457|FG000|COMPLETED|Overall Study||30||
48739136|NCT01636986|102144458|FG001|COMPLETED|Overall Study||30||
48739137|NCT01636986|102144457|FG000|NOT COMPLETED|Overall Study||0||
48739138|NCT01636986|102144458|FG001|NOT COMPLETED|Overall Study||2||
48407842|NCT02853123|101328649|FG000|NOT COMPLETED|Treatment Period 1||0||
48407843|NCT02853123|101328650|FG001|NOT COMPLETED|Treatment Period 1||3||
48739139|NCT02128724|102144459|FG000|STARTED|Overall Study||4||
48739140|NCT02128724|102144460|FG001|STARTED|Overall Study||4||
48739141|NCT02128724|102144461|FG002|STARTED|Overall Study||3||
48739142|NCT02128724|102144462|FG003|STARTED|Overall Study||10||
48739143|NCT02128724|102144459|FG000|COMPLETED|Overall Study||3||
48739144|NCT02128724|102144460|FG001|COMPLETED|Overall Study||3||
48739145|NCT02128724|102144461|FG002|COMPLETED|Overall Study||3||
48739146|NCT02128724|102144462|FG003|COMPLETED|Overall Study||7||
48739147|NCT02128724|102144459|FG000|NOT COMPLETED|Overall Study||1||
48739148|NCT02128724|102144460|FG001|NOT COMPLETED|Overall Study||1||
48739149|NCT02128724|102144461|FG002|NOT COMPLETED|Overall Study||0||
48320962|NCT00535132|101111705|FG001|STARTED|Intent-to-Treat (ITT) Analysis Set||99||
48320963|NCT00535132|101111704|FG000|COMPLETED|Intent-to-Treat (ITT) Analysis Set||95||
48320964|NCT00535132|101111705|FG001|COMPLETED|Intent-to-Treat (ITT) Analysis Set||96||
48320965|NCT00535132|101111704|FG000|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3||
48320966|NCT00535132|101111705|FG001|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3||
48320967|NCT01157364|101111706|FG000|STARTED|Overall Study||15||
48320968|NCT01157364|101111707|FG001|STARTED|Overall Study||21||
48320969|NCT01157364|101111708|FG002|STARTED|Overall Study||21||
48320970|NCT01157364|101111709|FG003|STARTED|Overall Study||18||
48320971|NCT01157364|101111710|FG004|STARTED|Overall Study||11||
48320972|NCT01157364|101111711|FG005|STARTED|Overall Study||23||
48320973|NCT01157364|101111706|FG000|COMPLETED|Overall Study||13||
48320974|NCT01157364|101111707|FG001|COMPLETED|Overall Study||17||
48320975|NCT01157364|101111708|FG002|COMPLETED|Overall Study||17||
48320976|NCT01157364|101111709|FG003|COMPLETED|Overall Study||16||
48320977|NCT01157364|101111710|FG004|COMPLETED|Overall Study||9||
48320978|NCT01157364|101111711|FG005|COMPLETED|Overall Study||22||
48320979|NCT01157364|101111706|FG000|NOT COMPLETED|Overall Study||2||
48320980|NCT01157364|101111707|FG001|NOT COMPLETED|Overall Study||4||
48320981|NCT01157364|101111708|FG002|NOT COMPLETED|Overall Study||4||
48320982|NCT01157364|101111709|FG003|NOT COMPLETED|Overall Study||2||
48320983|NCT01157364|101111710|FG004|NOT COMPLETED|Overall Study||2||
48320984|NCT01157364|101111711|FG005|NOT COMPLETED|Overall Study||1||
48320985|NCT00845650|101111712|FG000|STARTED|Overall Study||31||
48320986|NCT00845650|101111713|FG001|STARTED|Overall Study||5||
48320987|NCT00845650|101111714|FG002|STARTED|Overall Study||31||
48320988|NCT00845650|101111715|FG003|STARTED|Overall Study||14||
48320989|NCT00845650|101111716|FG004|STARTED|Overall Study||31||
48320990|NCT00845650|101111717|FG005|STARTED|Overall Study||17||
48407844|NCT02853123|101328649|FG000|STARTED|Washout Period||52||
48407845|NCT02853123|101328650|FG001|STARTED|Washout Period||51||
48407846|NCT02853123|101328649|FG000|COMPLETED|Washout Period||51||
48739150|NCT02128724|102144462|FG003|NOT COMPLETED|Overall Study||3||
48739151|NCT01999400|102144463|FG000|STARTED|First Intervention (1 Day)||6||
48739152|NCT01999400|102144464|FG001|STARTED|First Intervention (1 Day)||6||
48739153|NCT01999400|102144465|FG002|STARTED|First Intervention (1 Day)||5||
48739154|NCT01999400|102144466|FG003|STARTED|First Intervention (1 Day)||5||
48739155|NCT01999400|102144467|FG004|STARTED|First Intervention (1 Day)||4||
48739156|NCT01999400|102144468|FG005|STARTED|First Intervention (1 Day)||4||
48739157|NCT01999400|102144463|FG000|COMPLETED|First Intervention (1 Day)||4||
48739158|NCT01999400|102144464|FG001|COMPLETED|First Intervention (1 Day)||4||
48320991|NCT00845650|101111712|FG000|COMPLETED|Overall Study||30||
48320992|NCT00845650|101111713|FG001|COMPLETED|Overall Study||5||
48320993|NCT00845650|101111714|FG002|COMPLETED|Overall Study||28||
48320994|NCT00845650|101111715|FG003|COMPLETED|Overall Study||13||
48320995|NCT00845650|101111716|FG004|COMPLETED|Overall Study||28||
48320996|NCT00845650|101111717|FG005|COMPLETED|Overall Study||15||
48320997|NCT00845650|101111712|FG000|NOT COMPLETED|Overall Study||1||
48320998|NCT00845650|101111713|FG001|NOT COMPLETED|Overall Study||0||
48320999|NCT00845650|101111714|FG002|NOT COMPLETED|Overall Study||3||
48321000|NCT00845650|101111715|FG003|NOT COMPLETED|Overall Study||1||
48321001|NCT00845650|101111716|FG004|NOT COMPLETED|Overall Study||3||
48321002|NCT00845650|101111717|FG005|NOT COMPLETED|Overall Study||2||
48739159|NCT01999400|102144465|FG002|COMPLETED|First Intervention (1 Day)||3||
48407847|NCT02853123|101328650|FG001|COMPLETED|Washout Period||48||
48407848|NCT02853123|101328649|FG000|NOT COMPLETED|Washout Period||1||
48407849|NCT02853123|101328650|FG001|NOT COMPLETED|Washout Period||3||
48407850|NCT02853123|101328649|FG000|STARTED|Treatment Period 2||51||
48407851|NCT02853123|101328650|FG001|STARTED|Treatment Period 2||48||
48407852|NCT02853123|101328649|FG000|COMPLETED|Treatment Period 2||51||
48407853|NCT02853123|101328650|FG001|COMPLETED|Treatment Period 2||48||
48407854|NCT02853123|101328649|FG000|NOT COMPLETED|Treatment Period 2||0||
48407855|NCT02853123|101328650|FG001|NOT COMPLETED|Treatment Period 2||0||
48407856|NCT03369704|101328651|FG000|STARTED|Treatment Epoch||162||
48407857|NCT03369704|101328652|FG001|STARTED|Treatment Epoch||175||
48407858|NCT03369704|101328651|FG000|COMPLETED|Treatment Epoch||158||
48407859|NCT03369704|101328652|FG001|COMPLETED|Treatment Epoch||172||
48407860|NCT03369704|101328651|FG000|NOT COMPLETED|Treatment Epoch||4||
48407861|NCT03369704|101328652|FG001|NOT COMPLETED|Treatment Epoch||3||
48407862|NCT03369704|101328651|FG000|STARTED|Follow-up Epoch||161||
48407863|NCT03369704|101328652|FG001|STARTED|Follow-up Epoch||174||
48407864|NCT03369704|101328651|FG000|COMPLETED|Follow-up Epoch||160||
48407865|NCT03369704|101328652|FG001|COMPLETED|Follow-up Epoch||174||
48407866|NCT03369704|101328651|FG000|NOT COMPLETED|Follow-up Epoch||1||
48407867|NCT03369704|101328652|FG001|NOT COMPLETED|Follow-up Epoch||0||
48407868|NCT01681836|101328653|FG000|STARTED|First Intervention||6||
48407869|NCT01681836|101328654|FG001|STARTED|First Intervention||5||
48407870|NCT01681836|101328653|FG000|COMPLETED|First Intervention||6||
48407871|NCT01681836|101328654|FG001|COMPLETED|First Intervention||5||
48407872|NCT01681836|101328653|FG000|NOT COMPLETED|First Intervention||0||
48321003|NCT00067028|101111718|FG000|STARTED|Overall Study||17||
48321004|NCT00067028|101111719|FG001|STARTED|Overall Study||36||
48321005|NCT00067028|101111720|FG002|STARTED|Overall Study||63||
48321006|NCT00067028|101111718|FG000|COMPLETED|Overall Study||17||
48321007|NCT00067028|101111719|FG001|COMPLETED|Overall Study||36||
48321008|NCT00067028|101111720|FG002|COMPLETED|Overall Study||63||
48407873|NCT01681836|101328654|FG001|NOT COMPLETED|First Intervention||0||
48407874|NCT01681836|101328653|FG000|STARTED|Washout Period of 3-7 Days||6||
48407875|NCT01681836|101328654|FG001|STARTED|Washout Period of 3-7 Days||5||
48407876|NCT01681836|101328653|FG000|COMPLETED|Washout Period of 3-7 Days||6||
48407877|NCT01681836|101328654|FG001|COMPLETED|Washout Period of 3-7 Days||5||
48407878|NCT01681836|101328653|FG000|NOT COMPLETED|Washout Period of 3-7 Days||0||
48321009|NCT00067028|101111718|FG000|NOT COMPLETED|Overall Study||0||
48321010|NCT00067028|101111719|FG001|NOT COMPLETED|Overall Study||0||
48321011|NCT00067028|101111720|FG002|NOT COMPLETED|Overall Study||0||
48321012|NCT00338039|101111721|FG000|STARTED|Overall Study||69||
48321013|NCT00338039|101111721|FG000|COMPLETED|Overall Study||69||
48321014|NCT00338039|101111721|FG000|NOT COMPLETED|Overall Study||0||
48321015|NCT01358864|101111722|FG000|STARTED|Overall Study||49||
48407879|NCT01681836|101328654|FG001|NOT COMPLETED|Washout Period of 3-7 Days||0||
48407880|NCT01681836|101328653|FG000|STARTED|Second Intervention||6||
48407881|NCT01681836|101328654|FG001|STARTED|Second Intervention||5||
48407882|NCT01681836|101328653|FG000|COMPLETED|Second Intervention||6||
48407883|NCT01681836|101328654|FG001|COMPLETED|Second Intervention||4||
48321016|NCT01358864|101111723|FG001|STARTED|Overall Study||99||
48407884|NCT01681836|101328653|FG000|NOT COMPLETED|Second Intervention||0||
48407885|NCT01681836|101328654|FG001|NOT COMPLETED|Second Intervention||1||
48407886|NCT00508469|101328655|FG000|STARTED|Overall Study||52||
48407887|NCT00508469|101328656|FG001|STARTED|Overall Study||50||
48407888|NCT00508469|101328655|FG000|COMPLETED|Overall Study||35||
48407889|NCT00508469|101328656|FG001|COMPLETED|Overall Study||40||
48407890|NCT00508469|101328655|FG000|NOT COMPLETED|Overall Study||17||
48321017|NCT01358864|101111724|FG002|STARTED|Overall Study||103||
48321018|NCT01358864|101111725|FG003|STARTED|Overall Study||29||
48321019|NCT01358864|101111726|FG004|STARTED|Overall Study||57||
48321020|NCT01358864|101111727|FG005|STARTED|Overall Study||55||
48321021|NCT01358864|101111728|FG006|STARTED|Overall Study||146||
48407891|NCT00508469|101328656|FG001|NOT COMPLETED|Overall Study||10||
48407892|NCT00864123|101331657|FG000|STARTED|Overall Study||15||
48321022|NCT01358864|101111729|FG007|STARTED|Overall Study||140||
48321023|NCT01358864|101111722|FG000|COMPLETED|Overall Study||18||
48321024|NCT01358864|101111723|FG001|COMPLETED|Overall Study||86||
48321025|NCT01358864|101111724|FG002|COMPLETED|Overall Study||87||
48321026|NCT01358864|101111725|FG003|COMPLETED|Overall Study||10||
48321027|NCT01358864|101111726|FG004|COMPLETED|Overall Study||46||
48321028|NCT01358864|101111727|FG005|COMPLETED|Overall Study||42||
48321029|NCT01358864|101111728|FG006|COMPLETED|Overall Study||81||
48321030|NCT01358864|101111729|FG007|COMPLETED|Overall Study||85||
48321031|NCT01358864|101111722|FG000|NOT COMPLETED|Overall Study||31||
48321032|NCT01358864|101111723|FG001|NOT COMPLETED|Overall Study||13||
48321033|NCT01358864|101111724|FG002|NOT COMPLETED|Overall Study||16||
48321034|NCT01358864|101111725|FG003|NOT COMPLETED|Overall Study||19||
48407893|NCT00864123|101331658|FG001|STARTED|Overall Study||15||
48407894|NCT00864123|101331657|FG000|COMPLETED|Overall Study||15||
48616728|NCT03797898|101849435|FG001|STARTED|Overall Study||485||5
48616729|NCT03797898|101849434|FG000|COMPLETED|Overall Study||378||5
48321035|NCT01358864|101111726|FG004|NOT COMPLETED|Overall Study||11||
48321036|NCT01358864|101111727|FG005|NOT COMPLETED|Overall Study||13||
48321037|NCT01358864|101111728|FG006|NOT COMPLETED|Overall Study||65||
48321038|NCT01358864|101111729|FG007|NOT COMPLETED|Overall Study||55||
48321039|NCT02463409|101111730|FG000|STARTED|Overall Study||6||
48321040|NCT02463409|101111730|FG000|COMPLETED|Overall Study||4||
48321041|NCT02463409|101111730|FG000|NOT COMPLETED|Overall Study||2||
48321042|NCT01709149|101111731|FG000|STARTED|Open-label Lead-in Phase||711||
48321043|NCT01709149|101111732|FG001|STARTED|Open-label Lead-in Phase||0||
48321044|NCT01709149|101111733|FG002|STARTED|Open-label Lead-in Phase||0||
48321045|NCT01709149|101111731|FG000|COMPLETED|Open-label Lead-in Phase||596||
48321046|NCT01709149|101111732|FG001|COMPLETED|Open-label Lead-in Phase||0||
48321047|NCT01709149|101111733|FG002|COMPLETED|Open-label Lead-in Phase||0||
48321048|NCT01709149|101111731|FG000|NOT COMPLETED|Open-label Lead-in Phase||115||
48321049|NCT01709149|101111732|FG001|NOT COMPLETED|Open-label Lead-in Phase||0||
48321050|NCT01709149|101111733|FG002|NOT COMPLETED|Open-label Lead-in Phase||0||
48321051|NCT01709149|101111731|FG000|STARTED|Double-blind, Placebo-controlled Phase||0||
48321052|NCT01709149|101111732|FG001|STARTED|Double-blind, Placebo-controlled Phase||295||
48321053|NCT01709149|101111733|FG002|STARTED|Double-blind, Placebo-controlled Phase||301||
48321054|NCT01709149|101111731|FG000|COMPLETED|Double-blind, Placebo-controlled Phase||0||
48321055|NCT01709149|101111732|FG001|COMPLETED|Double-blind, Placebo-controlled Phase||269||
48321056|NCT01709149|101111733|FG002|COMPLETED|Double-blind, Placebo-controlled Phase||204||
48321057|NCT01709149|101111731|FG000|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0||
48321058|NCT01709149|101111732|FG001|NOT COMPLETED|Double-blind, Placebo-controlled Phase||26||
48321059|NCT01709149|101111733|FG002|NOT COMPLETED|Double-blind, Placebo-controlled Phase||97||
48321060|NCT00081159|101111734|FG000|STARTED|Overall Study||39||
48321061|NCT00081159|101111735|FG001|STARTED|Overall Study||40||
48321062|NCT00081159|101111734|FG000|COMPLETED|Overall Study||37||
48321063|NCT00081159|101111735|FG001|COMPLETED|Overall Study||35||
48321064|NCT00081159|101111734|FG000|NOT COMPLETED|Overall Study||2||
48321065|NCT00081159|101111735|FG001|NOT COMPLETED|Overall Study||5||
48321066|NCT01692964|101111736|FG000|STARTED|Overall Study||237||
48321067|NCT01692964|101111736|FG000|COMPLETED|Overall Study||237||
48321068|NCT01692964|101111736|FG000|NOT COMPLETED|Overall Study||0||
48321069|NCT02898259|101111737|FG000|STARTED|Overall Study||3||
48321070|NCT02898259|101111738|FG001|STARTED|Overall Study||3||
48321071|NCT02898259|101111739|FG002|STARTED|Overall Study||6||
48321072|NCT02898259|101111740|FG003|STARTED|Overall Study||7||
48321073|NCT02898259|101111741|FG004|STARTED|Overall Study||0||
48321074|NCT02898259|101111737|FG000|COMPLETED|Overall Study||2||
48616730|NCT03797898|101849435|FG001|COMPLETED|Overall Study||407||5
48616731|NCT03797898|101849434|FG000|NOT COMPLETED|Overall Study||74||0
48616732|NCT03797898|101849435|FG001|NOT COMPLETED|Overall Study||78||0
48616733|NCT01211756|101849436|FG000|STARTED|Overall Study||1||
48616734|NCT01211756|101849436|FG000|COMPLETED|Overall Study||1||
48616735|NCT01211756|101849436|FG000|NOT COMPLETED|Overall Study||0||
48616736|NCT01050946|101849437|FG000|STARTED|Overall Study||1||
48616737|NCT01050946|101849437|FG000|COMPLETED|Overall Study||1||
48616738|NCT01050946|101849437|FG000|NOT COMPLETED|Overall Study||0||
48616739|NCT00571662|101849438|FG000|STARTED|Overall Study||76||
48616740|NCT00571662|101849438|FG000|COMPLETED|Overall Study||68||
48321075|NCT02898259|101111738|FG001|COMPLETED|Overall Study||2||
48407895|NCT00864123|101331658|FG001|COMPLETED|Overall Study||15||
48407896|NCT00864123|101331657|FG000|NOT COMPLETED|Overall Study||0||
48321076|NCT02898259|101111739|FG002|COMPLETED|Overall Study||1||
48321077|NCT02898259|101111740|FG003|COMPLETED|Overall Study||6||
48321078|NCT02898259|101111741|FG004|COMPLETED|Overall Study||0||
48321079|NCT02898259|101111737|FG000|NOT COMPLETED|Overall Study||1||
48321080|NCT02898259|101111738|FG001|NOT COMPLETED|Overall Study||1||
48321081|NCT02898259|101111739|FG002|NOT COMPLETED|Overall Study||5||
48321082|NCT02898259|101111740|FG003|NOT COMPLETED|Overall Study||1||
48321083|NCT02898259|101111741|FG004|NOT COMPLETED|Overall Study||0||
48616741|NCT00571662|101849438|FG000|NOT COMPLETED|Overall Study||8||
48616742|NCT02630563|101849439|FG000|STARTED|Overall Study||9||
48616743|NCT02630563|101849439|FG000|COMPLETED|Overall Study||8||
48616744|NCT02630563|101849439|FG000|NOT COMPLETED|Overall Study||1||
48616745|NCT02829047|101849440|FG000|STARTED|Overall Study||25||
48616746|NCT02829047|101849440|FG000|COMPLETED|Overall Study||24||
48616747|NCT02829047|101849440|FG000|NOT COMPLETED|Overall Study||1||
48739160|NCT01999400|102144466|FG003|COMPLETED|First Intervention (1 Day)||2||
48739161|NCT01999400|102144467|FG004|COMPLETED|First Intervention (1 Day)||4||
48739162|NCT01999400|102144468|FG005|COMPLETED|First Intervention (1 Day)||3||
48321084|NCT00047060|101111742|FG000|STARTED|Overall Study||5||
48321085|NCT00047060|101111742|FG000|COMPLETED|Overall Study||3||
48321086|NCT00047060|101111742|FG000|NOT COMPLETED|Overall Study||2||
48321087|NCT01437852|101111743|FG000|STARTED|Overall Study||30||
48321088|NCT01437852|101111743|FG000|Received StrataGraft Skin Tissue|Overall Study||30||
48321089|NCT01437852|101111743|FG000|Received Autograft|Overall Study||30||
48321090|NCT01437852|101111743|FG000|COMPLETED|Overall Study||30||
48321091|NCT01437852|101111743|FG000|NOT COMPLETED|Overall Study||0||
48321092|NCT01761084|101111744|FG000|STARTED|Overall Study||71||
48321093|NCT01761084|101111745|FG001|STARTED|Overall Study||70||
48321094|NCT01761084|101111744|FG000|COMPLETED|Overall Study||66||
48321095|NCT01761084|101111745|FG001|COMPLETED|Overall Study||64||
48321096|NCT01761084|101111744|FG000|NOT COMPLETED|Overall Study||5||
48321097|NCT01761084|101111745|FG001|NOT COMPLETED|Overall Study||6||
48321098|NCT05032612|101111746|FG000|STARTED|Overall Study||17||
48321099|NCT05032612|101111747|FG001|STARTED|Overall Study||15||
48321100|NCT05032612|101111746|FG000|COMPLETED|Overall Study||17||
48321101|NCT05032612|101111747|FG001|COMPLETED|Overall Study||15||
48321102|NCT05032612|101111746|FG000|NOT COMPLETED|Overall Study||0||
48321103|NCT05032612|101111747|FG001|NOT COMPLETED|Overall Study||0||
48321104|NCT01379274|101111748|FG000|STARTED|Overall Study||2||
48321105|NCT01379274|101111748|FG000|COMPLETED|Overall Study||1||
48321106|NCT01379274|101111748|FG000|NOT COMPLETED|Overall Study||1||
48321107|NCT01187953|101111749|FG000|STARTED|Overall Study||268||
48321108|NCT01187953|101111750|FG001|STARTED|Overall Study||275||
48321109|NCT01187953|101111749|FG000|Dosed|Overall Study||266||
48321110|NCT01187953|101111750|FG001|Dosed|Overall Study||271||
48321111|NCT01187953|101111749|FG000|COMPLETED|Overall Study||253||
48321112|NCT01187953|101111750|FG001|COMPLETED|Overall Study||254||
48321113|NCT01187953|101111749|FG000|NOT COMPLETED|Overall Study||15||
48321114|NCT01187953|101111750|FG001|NOT COMPLETED|Overall Study||21||
48321115|NCT01761292|101111751|FG000|STARTED|Part 1||20||
48321116|NCT01761292|101111751|FG000|Patients Receiving Drug in Part 1|Part 1||19||
48321117|NCT01761292|101111751|FG000|COMPLETED|Part 1||18||
48321118|NCT01761292|101111751|FG000|NOT COMPLETED|Part 1||2||
48321119|NCT01761292|101111751|FG000|STARTED|Part 2||19||
48321120|NCT01761292|101111751|FG000|COMPLETED|Part 2||19||
48321121|NCT01761292|101111751|FG000|NOT COMPLETED|Part 2||0||
48321122|NCT01761292|101111751|FG000|STARTED|Extension 1||19||
48321123|NCT01761292|101111751|FG000|COMPLETED|Extension 1||18||
48321124|NCT01761292|101111751|FG000|NOT COMPLETED|Extension 1||1||
48321125|NCT01761292|101111751|FG000|STARTED|Extension 2||18||
48321126|NCT01761292|101111751|FG000|COMPLETED|Extension 2||18||
48321127|NCT01761292|101111751|FG000|NOT COMPLETED|Extension 2||0||
48321128|NCT01761292|101111751|FG000|STARTED|Extension 3||18||
48321129|NCT01761292|101111751|FG000|COMPLETED|Extension 3||18||
48321130|NCT01761292|101111751|FG000|NOT COMPLETED|Extension 3||0||
48321131|NCT02396134|101111752|FG000|STARTED|Overall Study||32||
48321132|NCT02396134|101111753|FG001|STARTED|Overall Study||29||
48321133|NCT02396134|101111752|FG000|COMPLETED|Overall Study||32||
48321134|NCT02396134|101111753|FG001|COMPLETED|Overall Study||29||
48321135|NCT02396134|101111752|FG000|NOT COMPLETED|Overall Study||0||
48616748|NCT04613518|101849441|FG000|STARTED|Double-Blind Treatment Period||26|Randomized and Treated|
48616749|NCT04613518|101849442|FG001|STARTED|Double-Blind Treatment Period||4|Randomized and Treated|
48616750|NCT04613518|101849443|FG002|STARTED|Double-Blind Treatment Period||8|Randomized and Treated|
48616751|NCT04613518|101849441|FG000|COMPLETED|Double-Blind Treatment Period||19||
48616752|NCT04613518|101849442|FG001|COMPLETED|Double-Blind Treatment Period||3||
48739163|NCT01999400|102144463|FG000|NOT COMPLETED|First Intervention (1 Day)||2||
48739164|NCT01999400|102144464|FG001|NOT COMPLETED|First Intervention (1 Day)||2||
48321136|NCT02396134|101111753|FG001|NOT COMPLETED|Overall Study||0||
48321137|NCT01227187|101111754|FG000|STARTED|Overall Study||1||
48321138|NCT01227187|101111755|FG001|STARTED|Overall Study||3||
48321139|NCT01227187|101111756|FG002|STARTED|Overall Study||3||
48321140|NCT01227187|101111757|FG003|STARTED|Overall Study||5||
48321141|NCT01227187|101111754|FG000|COMPLETED|Overall Study||1||
48321142|NCT01227187|101111755|FG001|COMPLETED|Overall Study||3||
48321143|NCT01227187|101111756|FG002|COMPLETED|Overall Study||3||
48321144|NCT01227187|101111757|FG003|COMPLETED|Overall Study||4||
48321145|NCT01227187|101111754|FG000|NOT COMPLETED|Overall Study||0||
48321146|NCT01227187|101111755|FG001|NOT COMPLETED|Overall Study||0||
48321147|NCT01227187|101111756|FG002|NOT COMPLETED|Overall Study||0||
48321148|NCT01227187|101111757|FG003|NOT COMPLETED|Overall Study||1||
48321149|NCT01399788|101111758|FG000|STARTED|First Intervention Period||18||
48321150|NCT01399788|101111759|FG001|STARTED|First Intervention Period||18||
48616753|NCT04613518|101849443|FG002|COMPLETED|Double-Blind Treatment Period||7||
48321151|NCT01399788|101111758|FG000|COMPLETED|First Intervention Period||17||
48321152|NCT01399788|101111759|FG001|COMPLETED|First Intervention Period||18||
48321153|NCT01399788|101111758|FG000|NOT COMPLETED|First Intervention Period||1||
48321154|NCT01399788|101111759|FG001|NOT COMPLETED|First Intervention Period||0||
48321155|NCT01399788|101111758|FG000|STARTED|Washout Period (at Least 1 Week)||17||
48321156|NCT01399788|101111759|FG001|STARTED|Washout Period (at Least 1 Week)||18||
48321157|NCT01399788|101111758|FG000|COMPLETED|Washout Period (at Least 1 Week)||17||
48321158|NCT01399788|101111759|FG001|COMPLETED|Washout Period (at Least 1 Week)||18||
48321159|NCT01399788|101111758|FG000|NOT COMPLETED|Washout Period (at Least 1 Week)||0||
48321160|NCT01399788|101111759|FG001|NOT COMPLETED|Washout Period (at Least 1 Week)||0||
48321161|NCT01399788|101111758|FG000|STARTED|Second Intervention Period||17||
48321162|NCT01399788|101111759|FG001|STARTED|Second Intervention Period||18||
48321163|NCT01399788|101111758|FG000|COMPLETED|Second Intervention Period||17||
48321164|NCT01399788|101111759|FG001|COMPLETED|Second Intervention Period||18||
48321165|NCT01399788|101111758|FG000|NOT COMPLETED|Second Intervention Period||0||
48321166|NCT01399788|101111759|FG001|NOT COMPLETED|Second Intervention Period||0||
48321167|NCT01685463|101111760|FG000|STARTED|Overall Study||10||
48321168|NCT01685463|101111761|FG001|STARTED|Overall Study||8||
48321169|NCT01685463|101111760|FG000|COMPLETED|Overall Study||10||
48321170|NCT01685463|101111761|FG001|COMPLETED|Overall Study||8||
48321171|NCT01685463|101111760|FG000|NOT COMPLETED|Overall Study||0||
48321172|NCT01685463|101111761|FG001|NOT COMPLETED|Overall Study||0||
48321173|NCT02324075|101111762|FG000|STARTED|Overall Study||612||612
48321174|NCT02324075|101111763|FG001|STARTED|Overall Study||614||614
48321175|NCT02324075|101111762|FG000|COMPLETED|Overall Study||609||605
48321176|NCT02324075|101111763|FG001|COMPLETED|Overall Study||605||605
48321177|NCT02324075|101111762|FG000|NOT COMPLETED|Overall Study||3||7
48321178|NCT02324075|101111763|FG001|NOT COMPLETED|Overall Study||9||9
48321179|NCT00343889|101111764|FG000|STARTED|Overall Study||190||
48321180|NCT00343889|101111765|FG001|STARTED|Overall Study||189||
48321181|NCT00343889|101111764|FG000|COMPLETED|Overall Study||187||
48321182|NCT00343889|101111765|FG001|COMPLETED|Overall Study||188||
48321183|NCT00343889|101111764|FG000|NOT COMPLETED|Overall Study||3||
48321184|NCT00343889|101111765|FG001|NOT COMPLETED|Overall Study||1||
48321185|NCT03782376|101111766|FG000|STARTED|Overall Study||108||
48321186|NCT03782376|101111767|FG001|STARTED|Overall Study||107||
48321187|NCT03782376|101111766|FG000|COMPLETED|Overall Study||82||
48407897|NCT00864123|101331658|FG001|NOT COMPLETED|Overall Study||0||
48407898|NCT01431521|101331659|FG000|STARTED|Overall Study||10||
48407899|NCT01431521|101331660|FG001|STARTED|Overall Study||5||
48407900|NCT01431521|101331661|FG002|STARTED|Overall Study||11||
48407901|NCT01431521|101331662|FG003|STARTED|Overall Study||5||
48321188|NCT03782376|101111767|FG001|COMPLETED|Overall Study||77||
48321189|NCT03782376|101111766|FG000|NOT COMPLETED|Overall Study||26||
48321190|NCT03782376|101111767|FG001|NOT COMPLETED|Overall Study||30||
48321191|NCT04342871|101111768|FG000|STARTED|Overall Study||53||
48321192|NCT04342871|101111768|FG000|COMPLETED|Overall Study||29||
48321193|NCT04342871|101111768|FG000|NOT COMPLETED|Overall Study||24||
48321194|NCT00750737|101111769|FG000|STARTED|Overall Study||24||
48321195|NCT00750737|101111770|FG001|STARTED|Overall Study||22||
48321196|NCT00750737|101111769|FG000|COMPLETED|Overall Study||21||
48321197|NCT00750737|101111770|FG001|COMPLETED|Overall Study||19||
48321198|NCT00750737|101111769|FG000|NOT COMPLETED|Overall Study||3||
48321199|NCT00750737|101111770|FG001|NOT COMPLETED|Overall Study||3||
48321200|NCT04649476|101111771|FG000|STARTED|Overall Study||34||
48321201|NCT04649476|101111772|FG001|STARTED|Overall Study||34||
48321202|NCT04649476|101111771|FG000|COMPLETED|Overall Study||30||
48321203|NCT04649476|101111772|FG001|COMPLETED|Overall Study||30||
48321204|NCT04649476|101111771|FG000|NOT COMPLETED|Overall Study||4||
48321205|NCT04649476|101111772|FG001|NOT COMPLETED|Overall Study||4||
48321206|NCT02053168|101111773|FG000|STARTED|Overall Study||25||
48321207|NCT02053168|101111773|FG000|COMPLETED|Overall Study||22||
48321208|NCT02053168|101111773|FG000|NOT COMPLETED|Overall Study||3||
48407902|NCT01431521|101331659|FG000|Treated|Overall Study||10||
48321209|NCT04086823|101111774|FG000|STARTED|Overall Study||8||
48321210|NCT04086823|101111775|FG001|STARTED|Overall Study||4||
48321211|NCT04086823|101111776|FG002|STARTED|Overall Study||10||
48321212|NCT04086823|101111777|FG003|STARTED|Overall Study||6||
48321213|NCT04086823|101111774|FG000|COMPLETED|Overall Study||8||
48321214|NCT04086823|101111775|FG001|COMPLETED|Overall Study||4||
48321215|NCT04086823|101111776|FG002|COMPLETED|Overall Study||10||
48321216|NCT04086823|101111777|FG003|COMPLETED|Overall Study||6||
48321217|NCT04086823|101111774|FG000|NOT COMPLETED|Overall Study||0||
48321218|NCT04086823|101111775|FG001|NOT COMPLETED|Overall Study||0||
48321219|NCT04086823|101111776|FG002|NOT COMPLETED|Overall Study||0||
48321220|NCT04086823|101111777|FG003|NOT COMPLETED|Overall Study||0||
48321221|NCT01624662|101111778|FG000|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80||
48407903|NCT01431521|101331660|FG001|Treated|Overall Study||5||
48407904|NCT01431521|101331661|FG002|Treated|Overall Study||10||
48321222|NCT01624662|101111779|FG001|STARTED|Double-Blind Treatment Phase (Wks 1-16)||81||
48321223|NCT01624662|101111780|FG002|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80||
48321224|NCT01624662|101111781|FG003|STARTED|Double-Blind Treatment Phase (Wks 1-16)||82||
48321225|NCT01624662|101111778|FG000|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||70||
48321226|NCT01624662|101111779|FG001|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||78||
48321227|NCT01624662|101111780|FG002|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||76||
48321228|NCT01624662|101111781|FG003|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||82||
48321229|NCT01624662|101111778|FG000|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||10||
48321230|NCT01624662|101111779|FG001|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||3||
48321231|NCT01624662|101111780|FG002|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||4||
48321232|NCT01624662|101111781|FG003|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||0||
48321233|NCT01624662|101111778|FG000|STARTED|Open-Label Extension Phase (Wks 17-24)||70||
48321234|NCT01624662|101111779|FG001|STARTED|Open-Label Extension Phase (Wks 17-24)||78||
48321235|NCT01624662|101111780|FG002|STARTED|Open-Label Extension Phase (Wks 17-24)||72||
48321236|NCT01624662|101111781|FG003|STARTED|Open-Label Extension Phase (Wks 17-24)||79||
48321237|NCT01624662|101111778|FG000|COMPLETED|Open-Label Extension Phase (Wks 17-24)||69||
48321238|NCT01624662|101111779|FG001|COMPLETED|Open-Label Extension Phase (Wks 17-24)||76||
48321239|NCT01624662|101111780|FG002|COMPLETED|Open-Label Extension Phase (Wks 17-24)||71||
48321240|NCT01624662|101111781|FG003|COMPLETED|Open-Label Extension Phase (Wks 17-24)||78||
48321241|NCT01624662|101111778|FG000|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1||
48321242|NCT01624662|101111779|FG001|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2||
48321243|NCT01624662|101111780|FG002|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1||
48321244|NCT01624662|101111781|FG003|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1||
48321245|NCT04639583|101111782|FG000|STARTED|Overall Study||21||
48321246|NCT04639583|101111782|FG000|NIRS Monitoring|Overall Study||20||
48321247|NCT04639583|101111782|FG000|COMPLETED|Overall Study||20||
48321248|NCT04639583|101111782|FG000|NOT COMPLETED|Overall Study||1||
48321249|NCT01784770|101111783|FG000|STARTED|Overall Study||21||
48321250|NCT01784770|101111783|FG000|COMPLETED|Overall Study||21||
48321251|NCT01784770|101111783|FG000|NOT COMPLETED|Overall Study||0||
48321252|NCT01003275|101111784|FG000|STARTED|Overall Study||11||
48321253|NCT01003275|101111785|FG001|STARTED|Overall Study||11||
48321254|NCT01003275|101111784|FG000|COMPLETED|Overall Study||10||
48321255|NCT01003275|101111785|FG001|COMPLETED|Overall Study||11||
48321256|NCT01003275|101111784|FG000|NOT COMPLETED|Overall Study||1||
48321257|NCT01003275|101111785|FG001|NOT COMPLETED|Overall Study||0||
48321258|NCT02366611|101111786|FG000|STARTED|Overall Study||10||
48321259|NCT02366611|101111787|FG001|STARTED|Overall Study||1||
48321260|NCT02366611|101111786|FG000|COMPLETED|Overall Study||8||
48321261|NCT02366611|101111787|FG001|COMPLETED|Overall Study||1||
48321262|NCT02366611|101111786|FG000|NOT COMPLETED|Overall Study||2||
48321263|NCT02366611|101111787|FG001|NOT COMPLETED|Overall Study||0||
48321264|NCT02501265|101111788|FG000|STARTED|Overall Study||63||
48321265|NCT02501265|101111789|FG001|STARTED|Overall Study||30||
48321266|NCT02501265|101111790|FG002|STARTED|Overall Study||64||
48321267|NCT02501265|101111791|FG003|STARTED|Overall Study||31||
48321268|NCT02501265|101111788|FG000|COMPLETED|Overall Study||46||
48321269|NCT02501265|101111789|FG001|COMPLETED|Overall Study||21||
48321270|NCT02501265|101111790|FG002|COMPLETED|Overall Study||46||
48321271|NCT02501265|101111791|FG003|COMPLETED|Overall Study||23||
48321272|NCT02501265|101111788|FG000|NOT COMPLETED|Overall Study||17||
48321273|NCT02501265|101111789|FG001|NOT COMPLETED|Overall Study||9||
48321274|NCT02501265|101111790|FG002|NOT COMPLETED|Overall Study||18||
48321275|NCT02501265|101111791|FG003|NOT COMPLETED|Overall Study||8||
48321276|NCT01628588|101111792|FG000|STARTED|Overall Study||854||
48321277|NCT01628588|101111792|FG000|COMPLETED|Overall Study||838||
48321278|NCT01628588|101111792|FG000|NOT COMPLETED|Overall Study||16||
48321279|NCT00684255|101111793|FG000|STARTED|Overall Study||1||
48321280|NCT00684255|101111793|FG000|COMPLETED|Overall Study||1||
48321281|NCT00684255|101111793|FG000|NOT COMPLETED|Overall Study||0||
48321282|NCT03201458|101111794|FG000|STARTED|Overall Study||43||
48321283|NCT03201458|101111795|FG001|STARTED|Overall Study||43||
48321284|NCT03201458|101111794|FG000|COMPLETED|Overall Study||39||
48321285|NCT03201458|101111795|FG001|COMPLETED|Overall Study||38||
48321286|NCT03201458|101111794|FG000|NOT COMPLETED|Overall Study||4||
48321287|NCT03201458|101111795|FG001|NOT COMPLETED|Overall Study||5||
48321288|NCT02249143|101111796|FG000|STARTED|Overall Study||24|randomized|
48321289|NCT02249143|101111797|FG001|STARTED|Overall Study||26|randomized|
48407905|NCT01431521|101331662|FG003|Treated|Overall Study||5||
48407906|NCT01431521|101331659|FG000|COMPLETED|Overall Study||10||
48321290|NCT02249143|101111796|FG000|COMPLETED|Overall Study||22||
48321291|NCT02249143|101111797|FG001|COMPLETED|Overall Study||22||
48321292|NCT02249143|101111796|FG000|NOT COMPLETED|Overall Study||2||
48321293|NCT02249143|101111797|FG001|NOT COMPLETED|Overall Study||4||
48321294|NCT02864368|101111798|FG000|STARTED|Overall Study||4||
48321295|NCT02864368|101111799|FG001|STARTED|Overall Study||1||
48321296|NCT02864368|101111800|FG002|STARTED|Overall Study||6||
48321297|NCT02864368|101111801|FG003|STARTED|Overall Study||8||
48321298|NCT02864368|101111802|FG004|STARTED|Overall Study||8||
48321299|NCT02864368|101111798|FG000|COMPLETED|Overall Study||4||
48407907|NCT01431521|101331660|FG001|COMPLETED|Overall Study||5||
48407908|NCT01431521|101331661|FG002|COMPLETED|Overall Study||10||
48657094|NCT03648372|101943771|FG014|NOT COMPLETED|Overall Study||6||
48407909|NCT01431521|101331662|FG003|COMPLETED|Overall Study||5||
48407910|NCT01431521|101331659|FG000|NOT COMPLETED|Overall Study||0||
48407911|NCT01431521|101331660|FG001|NOT COMPLETED|Overall Study||0||
48407912|NCT01431521|101331661|FG002|NOT COMPLETED|Overall Study||1||
48407913|NCT01431521|101331662|FG003|NOT COMPLETED|Overall Study||0||
48407914|NCT01782885|101331663|FG000|STARTED|Overall Study||36||
48407915|NCT01782885|101331664|FG001|STARTED|Overall Study||39||
48407916|NCT01782885|101331663|FG000|COMPLETED|Overall Study||32||
48407917|NCT01782885|101331664|FG001|COMPLETED|Overall Study||33||
48321300|NCT02864368|101111799|FG001|COMPLETED|Overall Study||1||
48321301|NCT02864368|101111800|FG002|COMPLETED|Overall Study||6||
48321302|NCT02864368|101111801|FG003|COMPLETED|Overall Study||8||
48321303|NCT02864368|101111802|FG004|COMPLETED|Overall Study||8||
48321304|NCT02864368|101111798|FG000|NOT COMPLETED|Overall Study||0||
48321305|NCT02864368|101111799|FG001|NOT COMPLETED|Overall Study||0||
48407918|NCT01782885|101331663|FG000|NOT COMPLETED|Overall Study||4||
48407919|NCT01782885|101331664|FG001|NOT COMPLETED|Overall Study||6||
48407920|NCT00789724|101331665|FG000|STARTED|Overall Study||5||
48407921|NCT00789724|101331666|FG001|STARTED|Overall Study||5||
48407922|NCT00789724|101331665|FG000|COMPLETED|Overall Study||5||
48407923|NCT00789724|101331666|FG001|COMPLETED|Overall Study||5||
48407924|NCT00789724|101331665|FG000|NOT COMPLETED|Overall Study||0||
48407925|NCT00789724|101331666|FG001|NOT COMPLETED|Overall Study||0||
48407926|NCT00430027|101331667|FG000|STARTED|Overall Study||8||
48321306|NCT02864368|101111800|FG002|NOT COMPLETED|Overall Study||0||
48321307|NCT02864368|101111801|FG003|NOT COMPLETED|Overall Study||0||
48321308|NCT02864368|101111802|FG004|NOT COMPLETED|Overall Study||0||
48321309|NCT03703882|101111803|FG000|STARTED|Overall Study||88||
48321310|NCT03703882|101111804|FG001|STARTED|Overall Study||43||
48321311|NCT03703882|101111803|FG000|COMPLETED|Overall Study||85||
48321312|NCT03703882|101111804|FG001|COMPLETED|Overall Study||37||
48321313|NCT03703882|101111803|FG000|NOT COMPLETED|Overall Study||3||
48321314|NCT03703882|101111804|FG001|NOT COMPLETED|Overall Study||6||
48321315|NCT00271817|101111805|FG000|STARTED|Part 1||272||
48321316|NCT00271817|101111806|FG001|STARTED|Part 1||272||
48321317|NCT00271817|101111807|FG002|STARTED|Part 1||676||
48321318|NCT00271817|101111805|FG000|COMPLETED|Part 1||166||
48321319|NCT00271817|101111806|FG001|COMPLETED|Part 1||213||
48321320|NCT00271817|101111807|FG002|COMPLETED|Part 1||391||
48321321|NCT00271817|101111805|FG000|NOT COMPLETED|Part 1||106||
48321322|NCT00271817|101111806|FG001|NOT COMPLETED|Part 1||59||
48321323|NCT00271817|101111807|FG002|NOT COMPLETED|Part 1||285||
48321324|NCT00271817|101111805|FG000|STARTED|Part 2||0||
48321325|NCT00271817|101111806|FG001|STARTED|Part 2||266||
48321326|NCT00271817|101111807|FG002|STARTED|Part 2||485||
48321327|NCT00271817|101111805|FG000|COMPLETED|Part 2||0||
48321328|NCT00271817|101111806|FG001|COMPLETED|Part 2||234||
48321329|NCT00271817|101111807|FG002|COMPLETED|Part 2||401||
48321330|NCT00271817|101111805|FG000|NOT COMPLETED|Part 2||0||
48321331|NCT00271817|101111806|FG001|NOT COMPLETED|Part 2||32||
48321332|NCT00271817|101111807|FG002|NOT COMPLETED|Part 2||84||
48321333|NCT03440814|101111808|FG000|STARTED|Overall Study||84||
48321334|NCT03440814|101111809|FG001|STARTED|Overall Study||42||
48407927|NCT00430027|101331667|FG000|COMPLETED|Overall Study||0||
48407928|NCT00430027|101331667|FG000|NOT COMPLETED|Overall Study||8||
48407929|NCT01040728|101331668|FG000|STARTED|Overall Study||31||
48407930|NCT01040728|101331669|FG001|STARTED|Overall Study||30||
48407931|NCT01040728|101331670|FG002|STARTED|Overall Study||31||
48407932|NCT01040728|101331671|FG003|STARTED|Overall Study||30||
48407933|NCT01040728|101331668|FG000|COMPLETED|Overall Study||27||
48407934|NCT01040728|101331669|FG001|COMPLETED|Overall Study||19||
48407935|NCT01040728|101331670|FG002|COMPLETED|Overall Study||30||
48407936|NCT01040728|101331671|FG003|COMPLETED|Overall Study||24||
48407937|NCT01040728|101331668|FG000|NOT COMPLETED|Overall Study||4||
48407938|NCT01040728|101331669|FG001|NOT COMPLETED|Overall Study||11||
48407939|NCT01040728|101331670|FG002|NOT COMPLETED|Overall Study||1||
48407940|NCT01040728|101331671|FG003|NOT COMPLETED|Overall Study||6||
48407941|NCT01744041|101331672|FG000|STARTED|Overall Study||21||
48407942|NCT01744041|101331673|FG001|STARTED|Overall Study||21||
48407943|NCT01744041|101331672|FG000|COMPLETED|Overall Study||15||
48407944|NCT01744041|101331673|FG001|COMPLETED|Overall Study||13||
48407945|NCT01744041|101331672|FG000|NOT COMPLETED|Overall Study||6||
48407946|NCT01744041|101331673|FG001|NOT COMPLETED|Overall Study||8||
48407947|NCT01673425|101331674|FG000|STARTED|Overall Study||5||
48407948|NCT01673425|101331674|FG000|COMPLETED|Overall Study||4||
48321335|NCT03440814|101111808|FG000|Randomized (May or May Not Have Taken Study Drug)|Overall Study||85||
48321336|NCT03440814|101111809|FG001|Randomized (May or May Not Have Taken Study Drug)|Overall Study||42||
48321337|NCT03440814|101111808|FG000|Intent-to-Treat (ITT) Population|Overall Study||82|Double-Blind Treatment Period: Randomized subjects who took at least one dose of study drug and had at least one post-Baseline HQ-CT value.|
48321338|NCT03440814|101111809|FG001|Intent-to-Treat (ITT) Population|Overall Study||42|Double-Blind Treatment Period: Randomized subjects who took at least one dose of study drug and had at least one post-Baseline HQ-CT value.|
48321339|NCT03440814|101111808|FG000|COMPLETED|Overall Study||79||
48321340|NCT03440814|101111809|FG001|COMPLETED|Overall Study||41||
48407949|NCT01673425|101331674|FG000|NOT COMPLETED|Overall Study||1||
48407950|NCT00149890|101331675|FG000|STARTED|Overall Study||39||
48407951|NCT00149890|101331676|FG001|STARTED|Overall Study||38||
48321341|NCT03440814|101111808|FG000|NOT COMPLETED|Overall Study||5||
48321342|NCT03440814|101111809|FG001|NOT COMPLETED|Overall Study||1||
48321343|NCT01890642|101111810|FG000|STARTED|Overall Study||56||
48616754|NCT04613518|101849441|FG000|NOT COMPLETED|Double-Blind Treatment Period||7||
48616755|NCT04613518|101849442|FG001|NOT COMPLETED|Double-Blind Treatment Period||1||
48616756|NCT04613518|101849443|FG002|NOT COMPLETED|Double-Blind Treatment Period||1||
48321344|NCT01890642|101111811|FG001|STARTED|Overall Study||53||
48321345|NCT01890642|101111812|FG002|STARTED|Overall Study||96||
48321346|NCT01890642|101111810|FG000|COMPLETED|Overall Study||56||
48321347|NCT01890642|101111811|FG001|COMPLETED|Overall Study||53||
48321348|NCT01890642|101111812|FG002|COMPLETED|Overall Study||96||
48321349|NCT01890642|101111810|FG000|NOT COMPLETED|Overall Study||0||
48321350|NCT01890642|101111811|FG001|NOT COMPLETED|Overall Study||0||
48321351|NCT01890642|101111812|FG002|NOT COMPLETED|Overall Study||0||
48321352|NCT05112536|101111813|FG000|STARTED|Overall Study||24||
48321353|NCT05112536|101111813|FG000|COMPLETED|Overall Study||24||
48321354|NCT05112536|101111813|FG000|NOT COMPLETED|Overall Study||0||
48321355|NCT01026831|101114678|FG000|STARTED|Overall Study||320||
48321356|NCT01026831|101114679|FG001|STARTED|Overall Study||323||
48321357|NCT01026831|101114678|FG000|COMPLETED|Overall Study||306||
48321358|NCT01026831|101114679|FG001|COMPLETED|Overall Study||312||
48321359|NCT01026831|101114678|FG000|NOT COMPLETED|Overall Study||14||
48321360|NCT01026831|101114679|FG001|NOT COMPLETED|Overall Study||11||
48321361|NCT00563186|101114680|FG000|STARTED|Overall Study||1008||
48321362|NCT00563186|101114681|FG001|STARTED|Overall Study||679||
48616757|NCT04613518|101849441|FG000|STARTED|Open-Label Treatment Period||19||
48321363|NCT00563186|101114680|FG000|COMPLETED|Overall Study||910|excluded if length of stay (LOS)\<48 hours or incomplete data|
48321364|NCT00563186|101114681|FG001|COMPLETED|Overall Study||604|excluded if length of stay (LOS)\<48 hours or incomplete data|
48321365|NCT00563186|101114680|FG000|NOT COMPLETED|Overall Study||98||
48616758|NCT04613518|101849442|FG001|STARTED|Open-Label Treatment Period||3||
48616759|NCT04613518|101849443|FG002|STARTED|Open-Label Treatment Period||7||
48616760|NCT04613518|101849441|FG000|COMPLETED|Open-Label Treatment Period||11||
48739165|NCT01999400|102144465|FG002|NOT COMPLETED|First Intervention (1 Day)||2||
48739166|NCT01999400|102144466|FG003|NOT COMPLETED|First Intervention (1 Day)||3||
48739167|NCT01999400|102144467|FG004|NOT COMPLETED|First Intervention (1 Day)||0||
48739168|NCT01999400|102144468|FG005|NOT COMPLETED|First Intervention (1 Day)||1||
48321366|NCT00563186|101114681|FG001|NOT COMPLETED|Overall Study||75||
48321367|NCT03075527|101114682|FG000|STARTED|Overall Study||19||
48321368|NCT03075527|101114682|FG000|COMPLETED|Overall Study||17||
48321369|NCT03075527|101114682|FG000|NOT COMPLETED|Overall Study||2||
48321370|NCT00558870|101114683|FG000|STARTED|Overall Study||2||
48321371|NCT00558870|101114684|FG001|STARTED|Overall Study||2||
48321372|NCT00558870|101114683|FG000|COMPLETED|Overall Study||2||
48321373|NCT00558870|101114684|FG001|COMPLETED|Overall Study||2||
48616761|NCT04613518|101849442|FG001|COMPLETED|Open-Label Treatment Period||0||
48616762|NCT04613518|101849443|FG002|COMPLETED|Open-Label Treatment Period||1||
48616763|NCT04613518|101849441|FG000|NOT COMPLETED|Open-Label Treatment Period||8||
48739169|NCT01999400|102144463|FG000|STARTED|Washout (10 Days)||5||
48739170|NCT01999400|102144464|FG001|STARTED|Washout (10 Days)||4||
48739171|NCT01999400|102144465|FG002|STARTED|Washout (10 Days)||3||
48739172|NCT01999400|102144466|FG003|STARTED|Washout (10 Days)||2||
48739173|NCT01999400|102144467|FG004|STARTED|Washout (10 Days)||3||
48739174|NCT01999400|102144468|FG005|STARTED|Washout (10 Days)||3||
48739175|NCT01999400|102144463|FG000|COMPLETED|Washout (10 Days)||5||
48739176|NCT01999400|102144464|FG001|COMPLETED|Washout (10 Days)||4||
48739177|NCT01999400|102144465|FG002|COMPLETED|Washout (10 Days)||3||
48739178|NCT01999400|102144466|FG003|COMPLETED|Washout (10 Days)||2||
48739179|NCT01999400|102144467|FG004|COMPLETED|Washout (10 Days)||3||
48739180|NCT01999400|102144468|FG005|COMPLETED|Washout (10 Days)||3||
48739181|NCT01999400|102144463|FG000|NOT COMPLETED|Washout (10 Days)||0||
48739182|NCT01999400|102144464|FG001|NOT COMPLETED|Washout (10 Days)||0||
48739183|NCT01999400|102144465|FG002|NOT COMPLETED|Washout (10 Days)||0||
48739184|NCT01999400|102144466|FG003|NOT COMPLETED|Washout (10 Days)||0||
48739185|NCT01999400|102144467|FG004|NOT COMPLETED|Washout (10 Days)||0||
48739186|NCT01999400|102144468|FG005|NOT COMPLETED|Washout (10 Days)||0||
48739187|NCT01999400|102144463|FG000|STARTED|Second Intervention (1 Day)||5||
48739188|NCT01999400|102144464|FG001|STARTED|Second Intervention (1 Day)||4||
48739189|NCT01999400|102144465|FG002|STARTED|Second Intervention (1 Day)||3||
48739190|NCT01999400|102144466|FG003|STARTED|Second Intervention (1 Day)||2||
48739191|NCT01999400|102144467|FG004|STARTED|Second Intervention (1 Day)||3||
48739192|NCT01999400|102144468|FG005|STARTED|Second Intervention (1 Day)||3||
48739193|NCT01999400|102144463|FG000|COMPLETED|Second Intervention (1 Day)||5||
48739194|NCT01999400|102144464|FG001|COMPLETED|Second Intervention (1 Day)||4||
48739195|NCT01999400|102144465|FG002|COMPLETED|Second Intervention (1 Day)||3||
48321374|NCT00558870|101114683|FG000|NOT COMPLETED|Overall Study||0||
48321375|NCT00558870|101114684|FG001|NOT COMPLETED|Overall Study||0||
48321376|NCT02888093|101114685|FG000|STARTED|Overall Study||22||
48321377|NCT02888093|101114686|FG001|STARTED|Overall Study||22||
48616764|NCT04613518|101849442|FG001|NOT COMPLETED|Open-Label Treatment Period||3||
48739196|NCT01999400|102144466|FG003|COMPLETED|Second Intervention (1 Day)||2||
48739197|NCT01999400|102144467|FG004|COMPLETED|Second Intervention (1 Day)||3||
48739198|NCT01999400|102144468|FG005|COMPLETED|Second Intervention (1 Day)||3||
48739199|NCT01999400|102144463|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48739200|NCT01999400|102144464|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48739201|NCT01999400|102144465|FG002|NOT COMPLETED|Second Intervention (1 Day)||0||
48739202|NCT01999400|102144466|FG003|NOT COMPLETED|Second Intervention (1 Day)||0||
48739203|NCT01999400|102144467|FG004|NOT COMPLETED|Second Intervention (1 Day)||0||
48739204|NCT01999400|102144468|FG005|NOT COMPLETED|Second Intervention (1 Day)||0||
48739205|NCT01999400|102144463|FG000|STARTED|Washout (10 Days)||2||
48739206|NCT01999400|102144464|FG001|STARTED|Washout (10 Days)||0||
48739207|NCT01999400|102144465|FG002|STARTED|Washout (10 Days)||1||
48739208|NCT01999400|102144466|FG003|STARTED|Washout (10 Days)||1||
48739209|NCT01999400|102144467|FG004|STARTED|Washout (10 Days)||1||
48739210|NCT01999400|102144468|FG005|STARTED|Washout (10 Days)||1||
48739211|NCT01999400|102144463|FG000|COMPLETED|Washout (10 Days)||2||
48739212|NCT01999400|102144464|FG001|COMPLETED|Washout (10 Days)||0||
48739213|NCT01999400|102144465|FG002|COMPLETED|Washout (10 Days)||1||
48739214|NCT01999400|102144466|FG003|COMPLETED|Washout (10 Days)||1||
48739215|NCT01999400|102144467|FG004|COMPLETED|Washout (10 Days)||1||
48739216|NCT01999400|102144468|FG005|COMPLETED|Washout (10 Days)||1||
48739217|NCT01999400|102144463|FG000|NOT COMPLETED|Washout (10 Days)||0||
48739218|NCT01999400|102144464|FG001|NOT COMPLETED|Washout (10 Days)||0||
48739219|NCT01999400|102144465|FG002|NOT COMPLETED|Washout (10 Days)||0||
48739220|NCT01999400|102144466|FG003|NOT COMPLETED|Washout (10 Days)||0||
48739221|NCT01999400|102144467|FG004|NOT COMPLETED|Washout (10 Days)||0||
48739222|NCT01999400|102144468|FG005|NOT COMPLETED|Washout (10 Days)||0||
48739223|NCT01999400|102144463|FG000|STARTED|Third Intervention (1 Day)||2||
48739224|NCT01999400|102144464|FG001|STARTED|Third Intervention (1 Day)||0||
48739225|NCT01999400|102144465|FG002|STARTED|Third Intervention (1 Day)||1||
48739226|NCT01999400|102144466|FG003|STARTED|Third Intervention (1 Day)||1||
48739227|NCT01999400|102144467|FG004|STARTED|Third Intervention (1 Day)||1||
48739228|NCT01999400|102144468|FG005|STARTED|Third Intervention (1 Day)||1||
48739229|NCT01999400|102144463|FG000|COMPLETED|Third Intervention (1 Day)||2||
48739230|NCT01999400|102144464|FG001|COMPLETED|Third Intervention (1 Day)||0||
48739231|NCT01999400|102144465|FG002|COMPLETED|Third Intervention (1 Day)||1||
48739232|NCT01999400|102144466|FG003|COMPLETED|Third Intervention (1 Day)||1||
48739233|NCT01999400|102144467|FG004|COMPLETED|Third Intervention (1 Day)||1||
48739234|NCT01999400|102144468|FG005|COMPLETED|Third Intervention (1 Day)||0||
48739235|NCT01999400|102144463|FG000|NOT COMPLETED|Third Intervention (1 Day)||0||
48739236|NCT01999400|102144464|FG001|NOT COMPLETED|Third Intervention (1 Day)||0||
48739237|NCT01999400|102144465|FG002|NOT COMPLETED|Third Intervention (1 Day)||0||
48407952|NCT00149890|101331675|FG000|COMPLETED|Overall Study||26||
48407953|NCT00149890|101331676|FG001|COMPLETED|Overall Study||20||
48407954|NCT00149890|101331675|FG000|NOT COMPLETED|Overall Study||13||
48407955|NCT00149890|101331676|FG001|NOT COMPLETED|Overall Study||18||
48407956|NCT00985738|101331677|FG000|STARTED|Overall Study||8||
48407957|NCT00985738|101331678|FG001|STARTED|Overall Study||8||
48407958|NCT00985738|101331677|FG000|COMPLETED|Overall Study||0||
48407959|NCT00985738|101331678|FG001|COMPLETED|Overall Study||0||
48407960|NCT00985738|101331677|FG000|NOT COMPLETED|Overall Study||8||
48407961|NCT00985738|101331678|FG001|NOT COMPLETED|Overall Study||8||
48739238|NCT01999400|102144466|FG003|NOT COMPLETED|Third Intervention (1 Day)||0||
48739239|NCT01999400|102144467|FG004|NOT COMPLETED|Third Intervention (1 Day)||0||
48739240|NCT01999400|102144468|FG005|NOT COMPLETED|Third Intervention (1 Day)||1||
48739241|NCT01999400|102144463|FG000|STARTED|Washout (10 Days)||1||
48739242|NCT01999400|102144464|FG001|STARTED|Washout (10 Days)||0||
48739243|NCT01999400|102144465|FG002|STARTED|Washout (10 Days)||1||
48739244|NCT01999400|102144466|FG003|STARTED|Washout (10 Days)||0||
48407962|NCT01372813|101331679|FG000|STARTED|Overall Study||3||
48407963|NCT01372813|101331679|FG000|COMPLETED|Overall Study||3||
48407964|NCT01372813|101331679|FG000|NOT COMPLETED|Overall Study||0||
48739245|NCT01999400|102144467|FG004|STARTED|Washout (10 Days)||0||
48739246|NCT01999400|102144468|FG005|STARTED|Washout (10 Days)||0||
48739247|NCT01999400|102144463|FG000|COMPLETED|Washout (10 Days)||1||
48739248|NCT01999400|102144464|FG001|COMPLETED|Washout (10 Days)||0||
48739249|NCT01999400|102144465|FG002|COMPLETED|Washout (10 Days)||1||
48739250|NCT01999400|102144466|FG003|COMPLETED|Washout (10 Days)||0||
48739251|NCT01999400|102144467|FG004|COMPLETED|Washout (10 Days)||0||
48739252|NCT01999400|102144468|FG005|COMPLETED|Washout (10 Days)||0||
48739253|NCT01999400|102144463|FG000|NOT COMPLETED|Washout (10 Days)||0||
48739254|NCT01999400|102144464|FG001|NOT COMPLETED|Washout (10 Days)||0||
48739255|NCT01999400|102144465|FG002|NOT COMPLETED|Washout (10 Days)||0||
48407965|NCT02415595|101331680|FG000|STARTED|Overall Study||50||
48407966|NCT02415595|101331681|FG001|STARTED|Overall Study||52||
48407967|NCT02415595|101331682|FG002|STARTED|Overall Study||51||
48407968|NCT02415595|101331683|FG003|STARTED|Overall Study||53||
48407969|NCT02415595|101331680|FG000|COMPLETED|Overall Study||0||
48407970|NCT02415595|101331681|FG001|COMPLETED|Overall Study||0||
48407971|NCT02415595|101331682|FG002|COMPLETED|Overall Study||0||
48407972|NCT02415595|101331683|FG003|COMPLETED|Overall Study||0||
48407973|NCT02415595|101331680|FG000|NOT COMPLETED|Overall Study||50||
48739256|NCT01999400|102144466|FG003|NOT COMPLETED|Washout (10 Days)||0||
48739257|NCT01999400|102144467|FG004|NOT COMPLETED|Washout (10 Days)||0||
48739258|NCT01999400|102144468|FG005|NOT COMPLETED|Washout (10 Days)||0||
48739259|NCT01999400|102144463|FG000|STARTED|Fourth Intervention (1 Day)||1||
48739260|NCT01999400|102144464|FG001|STARTED|Fourth Intervention (1 Day)||0||
48739261|NCT01999400|102144465|FG002|STARTED|Fourth Intervention (1 Day)||1||
48739262|NCT01999400|102144466|FG003|STARTED|Fourth Intervention (1 Day)||0||
48739263|NCT01999400|102144467|FG004|STARTED|Fourth Intervention (1 Day)||0||
48739264|NCT01999400|102144468|FG005|STARTED|Fourth Intervention (1 Day)||0||
48739265|NCT01999400|102144463|FG000|COMPLETED|Fourth Intervention (1 Day)||1||
48739266|NCT01999400|102144464|FG001|COMPLETED|Fourth Intervention (1 Day)||0||
48739267|NCT01999400|102144465|FG002|COMPLETED|Fourth Intervention (1 Day)||1||
48739268|NCT01999400|102144466|FG003|COMPLETED|Fourth Intervention (1 Day)||0||
48321378|NCT02888093|101114685|FG000|COMPLETED|Overall Study||20||
48321379|NCT02888093|101114686|FG001|COMPLETED|Overall Study||20||
48616765|NCT04613518|101849443|FG002|NOT COMPLETED|Open-Label Treatment Period||6||
48616766|NCT00707967|101849444|FG000|STARTED|Overall Study||22||
48616767|NCT00707967|101849445|FG001|STARTED|Overall Study||8||
48616768|NCT00707967|101849446|FG002|STARTED|Overall Study||7||
48616769|NCT00707967|101849444|FG000|COMPLETED|Overall Study||22||
48616770|NCT00707967|101849445|FG001|COMPLETED|Overall Study||8||
48616771|NCT00707967|101849446|FG002|COMPLETED|Overall Study||7||
48321380|NCT02888093|101114685|FG000|NOT COMPLETED|Overall Study||2||
48321381|NCT02888093|101114686|FG001|NOT COMPLETED|Overall Study||2||
48321382|NCT02572752|101114687|FG000|STARTED|Period 1 Including Washout||23||
48616772|NCT00707967|101849444|FG000|NOT COMPLETED|Overall Study||0||
48616773|NCT00707967|101849445|FG001|NOT COMPLETED|Overall Study||0||
48321383|NCT02572752|101114688|FG001|STARTED|Period 1 Including Washout||23||
48321384|NCT02572752|101114689|FG002|STARTED|Period 1 Including Washout||24||
48321385|NCT02572752|101114687|FG000|COMPLETED|Period 1 Including Washout||23||
48407974|NCT02415595|101331681|FG001|NOT COMPLETED|Overall Study||52||
48407975|NCT02415595|101331682|FG002|NOT COMPLETED|Overall Study||51||
48407976|NCT02415595|101331683|FG003|NOT COMPLETED|Overall Study||53||
48407977|NCT03116841|101331684|FG000|STARTED|Overall Study||3||
48407978|NCT03116841|101331684|FG000|COMPLETED|Overall Study||3||
48407979|NCT03116841|101331684|FG000|NOT COMPLETED|Overall Study||0||
48407980|NCT05307523|101331685|FG000|STARTED|First Condition (3 Weeks)||11||
48407981|NCT05307523|101331686|FG001|STARTED|First Condition (3 Weeks)||6||
48407982|NCT05307523|101331685|FG000|COMPLETED|First Condition (3 Weeks)||9||
48407983|NCT05307523|101331686|FG001|COMPLETED|First Condition (3 Weeks)||6||
48407984|NCT05307523|101331685|FG000|NOT COMPLETED|First Condition (3 Weeks)||2||
48407985|NCT05307523|101331686|FG001|NOT COMPLETED|First Condition (3 Weeks)||0||
48407986|NCT05307523|101331685|FG000|STARTED|Washout (1 Week)||9|No interventions were administered during the washout. Re-assessment took place this week|
48407987|NCT05307523|101331686|FG001|STARTED|Washout (1 Week)||6|No interventions were administered during the washout. Re-assessment took place this week|
48407988|NCT05307523|101331685|FG000|COMPLETED|Washout (1 Week)||9||
48407989|NCT05307523|101331686|FG001|COMPLETED|Washout (1 Week)||6||
48407990|NCT05307523|101331685|FG000|NOT COMPLETED|Washout (1 Week)||0||
48407991|NCT05307523|101331686|FG001|NOT COMPLETED|Washout (1 Week)||0||
48407992|NCT05307523|101331685|FG000|STARTED|Second Condition (3 Weeks)||9||
48407993|NCT05307523|101331686|FG001|STARTED|Second Condition (3 Weeks)||6||
48407994|NCT05307523|101331685|FG000|COMPLETED|Second Condition (3 Weeks)||9||
48407995|NCT05307523|101331686|FG001|COMPLETED|Second Condition (3 Weeks)||6||
48616774|NCT00707967|101849446|FG002|NOT COMPLETED|Overall Study||0||
48616775|NCT02020369|101849447|FG000|STARTED|Overall Study||14||
48616776|NCT02020369|101849448|FG001|STARTED|Overall Study||13||
48616777|NCT02020369|101849447|FG000|COMPLETED|Overall Study||11||
48739269|NCT01999400|102144467|FG004|COMPLETED|Fourth Intervention (1 Day)||0||
48321386|NCT02572752|101114688|FG001|COMPLETED|Period 1 Including Washout||23||
48321387|NCT02572752|101114689|FG002|COMPLETED|Period 1 Including Washout||24||
48321388|NCT02572752|101114687|FG000|NOT COMPLETED|Period 1 Including Washout||0||
48321389|NCT02572752|101114688|FG001|NOT COMPLETED|Period 1 Including Washout||0||
48321390|NCT02572752|101114689|FG002|NOT COMPLETED|Period 1 Including Washout||0||
48321391|NCT02572752|101114687|FG000|STARTED|Period 2 Including Washout||23||
48321392|NCT02572752|101114688|FG001|STARTED|Period 2 Including Washout||23||
48321393|NCT02572752|101114689|FG002|STARTED|Period 2 Including Washout||24||
48321394|NCT02572752|101114687|FG000|COMPLETED|Period 2 Including Washout||23||
48739270|NCT01999400|102144468|FG005|COMPLETED|Fourth Intervention (1 Day)||0||
48321395|NCT02572752|101114688|FG001|COMPLETED|Period 2 Including Washout||23||
48407996|NCT05307523|101331685|FG000|NOT COMPLETED|Second Condition (3 Weeks)||0||
48407997|NCT05307523|101331686|FG001|NOT COMPLETED|Second Condition (3 Weeks)||0||
48616778|NCT02020369|101849448|FG001|COMPLETED|Overall Study||11||
48616779|NCT02020369|101849447|FG000|NOT COMPLETED|Overall Study||3||
48739271|NCT01999400|102144463|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0||
48739272|NCT01999400|102144464|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0||
48321396|NCT02572752|101114689|FG002|COMPLETED|Period 2 Including Washout||24||
48616780|NCT02020369|101849448|FG001|NOT COMPLETED|Overall Study||2||
48616781|NCT02363387|101849449|FG000|STARTED|Overall Study||52||
48739273|NCT01999400|102144465|FG002|NOT COMPLETED|Fourth Intervention (1 Day)||0||
48739274|NCT01999400|102144466|FG003|NOT COMPLETED|Fourth Intervention (1 Day)||0||
48739275|NCT01999400|102144467|FG004|NOT COMPLETED|Fourth Intervention (1 Day)||0||
48739276|NCT01999400|102144468|FG005|NOT COMPLETED|Fourth Intervention (1 Day)||0||
48739277|NCT04327024|102144469|FG000|STARTED|Overall Study||53||
48321397|NCT02572752|101114687|FG000|NOT COMPLETED|Period 2 Including Washout||0||
48321398|NCT02572752|101114688|FG001|NOT COMPLETED|Period 2 Including Washout||0||
48321399|NCT02572752|101114689|FG002|NOT COMPLETED|Period 2 Including Washout||0||
48321400|NCT02572752|101114687|FG000|STARTED|Period 3 Including Washout||23||
48321401|NCT02572752|101114688|FG001|STARTED|Period 3 Including Washout||23||
48321402|NCT02572752|101114689|FG002|STARTED|Period 3 Including Washout||24||
48321403|NCT02572752|101114687|FG000|COMPLETED|Period 3 Including Washout||23||
48739278|NCT04327024|102144470|FG001|STARTED|Overall Study||53||
48321404|NCT02572752|101114688|FG001|COMPLETED|Period 3 Including Washout||23||
48321405|NCT02572752|101114689|FG002|COMPLETED|Period 3 Including Washout||24||
48321406|NCT02572752|101114687|FG000|NOT COMPLETED|Period 3 Including Washout||0||
48321407|NCT02572752|101114688|FG001|NOT COMPLETED|Period 3 Including Washout||0||
48321408|NCT02572752|101114689|FG002|NOT COMPLETED|Period 3 Including Washout||0||
48321409|NCT04718974|101114690|FG000|STARTED|Overall Study||103||
48321410|NCT04718974|101114691|FG001|STARTED|Overall Study||103||
48321411|NCT04718974|101114690|FG000|COMPLETED|Overall Study||91||
48321412|NCT04718974|101114691|FG001|COMPLETED|Overall Study||77||
48321413|NCT04718974|101114690|FG000|NOT COMPLETED|Overall Study||12||
48321414|NCT04718974|101114691|FG001|NOT COMPLETED|Overall Study||26||
48321415|NCT01577186|101114692|FG000|STARTED|Overall Study||480||
48321416|NCT01577186|101114692|FG000|COMPLETED|Overall Study||350||
48321417|NCT01577186|101114692|FG000|NOT COMPLETED|Overall Study||130||
48321418|NCT04762537|101114693|FG000|STARTED|Step 1 (Weeks 0-14)||14||1
48321419|NCT04762537|101114694|FG001|STARTED|Step 1 (Weeks 0-14)||14||1
48321420|NCT04762537|101114695|FG002|STARTED|Step 1 (Weeks 0-14)||6||1
48321421|NCT04762537|101114696|FG003|STARTED|Step 1 (Weeks 0-14)||25||1
48321422|NCT04762537|101114697|FG004|STARTED|Step 1 (Weeks 0-14)||15||1
48739279|NCT04327024|102144471|FG002|STARTED|Overall Study||53||
48739280|NCT04327024|102144469|FG000|COMPLETED|Overall Study||51||
48739281|NCT04327024|102144470|FG001|COMPLETED|Overall Study||49||
48739282|NCT04327024|102144471|FG002|COMPLETED|Overall Study||50||
48739283|NCT04327024|102144469|FG000|NOT COMPLETED|Overall Study||2||
48739284|NCT04327024|102144470|FG001|NOT COMPLETED|Overall Study||4||
48739285|NCT04327024|102144471|FG002|NOT COMPLETED|Overall Study||3||
48739286|NCT02134925|102147277|FG000|STARTED|Overall Study||54||
48739287|NCT02134925|102147278|FG001|STARTED|Overall Study||56||
48739288|NCT02134925|102147277|FG000|Received at Least One Dose of Treatment|Overall Study||53|Received at least one dose of treatment and assessed for AEs|
48739289|NCT02134925|102147278|FG001|Received at Least One Dose of Treatment|Overall Study||50|Received at least one dose of treatment and assessed for AEs|
48739290|NCT02134925|102147277|FG000|COMPLETED|Overall Study||52||
48739291|NCT02134925|102147278|FG001|COMPLETED|Overall Study||50||
48739292|NCT02134925|102147277|FG000|NOT COMPLETED|Overall Study||2||
48739293|NCT02134925|102147278|FG001|NOT COMPLETED|Overall Study||6||
48739294|NCT05011513|102147279|FG000|STARTED|Overall Study||658||
48739295|NCT05011513|102147280|FG001|STARTED|Overall Study||638||
48321423|NCT04762537|101114698|FG005|STARTED|Step 1 (Weeks 0-14)||8||1
48321424|NCT04762537|101114693|FG000|COMPLETED|Step 1 (Weeks 0-14)||7||1
48739296|NCT05011513|102147279|FG000|Treated|Overall Study||654||
48739297|NCT05011513|102147280|FG001|Treated|Overall Study||634||
48739298|NCT05011513|102147279|FG000|COMPLETED|Overall Study||632||
48739299|NCT05011513|102147280|FG001|COMPLETED|Overall Study||618||
48321425|NCT04762537|101114694|FG001|COMPLETED|Step 1 (Weeks 0-14)||6||1
48321426|NCT04762537|101114695|FG002|COMPLETED|Step 1 (Weeks 0-14)||1||1
48321427|NCT04762537|101114696|FG003|COMPLETED|Step 1 (Weeks 0-14)||6||1
48739300|NCT05011513|102147279|FG000|NOT COMPLETED|Overall Study||26||
48739301|NCT05011513|102147280|FG001|NOT COMPLETED|Overall Study||20||
48739302|NCT02451514|102147281|FG000|STARTED|Overall Study||33||
48739303|NCT02451514|102147282|FG001|STARTED|Overall Study||46||
48739304|NCT02451514|102147283|FG002|STARTED|Overall Study||50||
48739305|NCT02451514|102147281|FG000|COMPLETED|Overall Study||33||
48739306|NCT02451514|102147282|FG001|COMPLETED|Overall Study||46||
48739307|NCT02451514|102147283|FG002|COMPLETED|Overall Study||50||
48739308|NCT02451514|102147281|FG000|NOT COMPLETED|Overall Study||0||
48739309|NCT02451514|102147282|FG001|NOT COMPLETED|Overall Study||0||
48739310|NCT02451514|102147283|FG002|NOT COMPLETED|Overall Study||0||
48739311|NCT03672292|102147284|FG000|STARTED|Overall Study||10||
48739312|NCT03672292|102147285|FG001|STARTED|Overall Study||12||
48739313|NCT03672292|102147284|FG000|COMPLETED|Overall Study||6||
48739314|NCT03672292|102147285|FG001|COMPLETED|Overall Study||8||
48739315|NCT03672292|102147284|FG000|NOT COMPLETED|Overall Study||4||
48739316|NCT03672292|102147285|FG001|NOT COMPLETED|Overall Study||4||
48739317|NCT02451995|102147286|FG000|STARTED|Overall Study||42||
48739318|NCT02451995|102147287|FG001|STARTED|Overall Study||41||
48739319|NCT02451995|102147286|FG000|COMPLETED|Overall Study||42||
48739320|NCT02451995|102147287|FG001|COMPLETED|Overall Study||41||
48739321|NCT02451995|102147286|FG000|NOT COMPLETED|Overall Study||0||
48739322|NCT02451995|102147287|FG001|NOT COMPLETED|Overall Study||0||
48739323|NCT02814175|102147288|FG000|STARTED|Part 1||122||
48739324|NCT02814175|102147289|FG001|STARTED|Part 1||123||
48739325|NCT02814175|102147290|FG002|STARTED|Part 1||0||
48739326|NCT02814175|102147291|FG003|STARTED|Part 1||0||
48739327|NCT02814175|102147292|FG004|STARTED|Part 1||0||
48321428|NCT04762537|101114697|FG004|COMPLETED|Step 1 (Weeks 0-14)||12||1
48739328|NCT02814175|102147293|FG005|STARTED|Part 1||0||
48739329|NCT02814175|102147288|FG000|COMPLETED|Part 1||110||
48739330|NCT02814175|102147289|FG001|COMPLETED|Part 1||117||
48739331|NCT02814175|102147290|FG002|COMPLETED|Part 1||0||
48739332|NCT02814175|102147291|FG003|COMPLETED|Part 1||0||
48739333|NCT02814175|102147292|FG004|COMPLETED|Part 1||0||
48739334|NCT02814175|102147293|FG005|COMPLETED|Part 1||0||
48739335|NCT02814175|102147288|FG000|NOT COMPLETED|Part 1||12||
48739336|NCT02814175|102147289|FG001|NOT COMPLETED|Part 1||6||
48321429|NCT04762537|101114698|FG005|COMPLETED|Step 1 (Weeks 0-14)||1||1
48321430|NCT04762537|101114693|FG000|NOT COMPLETED|Step 1 (Weeks 0-14)||7||0
48321431|NCT04762537|101114694|FG001|NOT COMPLETED|Step 1 (Weeks 0-14)||8||0
48321432|NCT04762537|101114695|FG002|NOT COMPLETED|Step 1 (Weeks 0-14)||5||0
48321433|NCT04762537|101114696|FG003|NOT COMPLETED|Step 1 (Weeks 0-14)||19||0
48321434|NCT04762537|101114697|FG004|NOT COMPLETED|Step 1 (Weeks 0-14)||3||0
48321435|NCT04762537|101114698|FG005|NOT COMPLETED|Step 1 (Weeks 0-14)||7||0
48321436|NCT04762537|101114693|FG000|STARTED|Step 2 (Weeks 14-28)||7||1
48739337|NCT02814175|102147290|FG002|NOT COMPLETED|Part 1||0||
48739338|NCT02814175|102147291|FG003|NOT COMPLETED|Part 1||0||
48739339|NCT02814175|102147292|FG004|NOT COMPLETED|Part 1||0||
48321437|NCT04762537|101114694|FG001|STARTED|Step 2 (Weeks 14-28)||25||1
48321438|NCT04762537|101114695|FG002|STARTED|Step 2 (Weeks 14-28)||9||1
48321439|NCT04762537|101114696|FG003|STARTED|Step 2 (Weeks 14-28)||24||1
48321440|NCT04762537|101114697|FG004|STARTED|Step 2 (Weeks 14-28)||13||1
48321441|NCT04762537|101114698|FG005|STARTED|Step 2 (Weeks 14-28)||6||1
48321442|NCT04762537|101114693|FG000|COMPLETED|Step 2 (Weeks 14-28)||4||1
48321443|NCT04762537|101114694|FG001|COMPLETED|Step 2 (Weeks 14-28)||19||1
48321444|NCT04762537|101114695|FG002|COMPLETED|Step 2 (Weeks 14-28)||5||1
48321445|NCT04762537|101114696|FG003|COMPLETED|Step 2 (Weeks 14-28)||7||1
48321446|NCT04762537|101114697|FG004|COMPLETED|Step 2 (Weeks 14-28)||7||1
48321447|NCT04762537|101114698|FG005|COMPLETED|Step 2 (Weeks 14-28)||3||1
48321448|NCT04762537|101114693|FG000|NOT COMPLETED|Step 2 (Weeks 14-28)||3||0
48321449|NCT04762537|101114694|FG001|NOT COMPLETED|Step 2 (Weeks 14-28)||6||0
48321450|NCT04762537|101114695|FG002|NOT COMPLETED|Step 2 (Weeks 14-28)||4||0
48739340|NCT02814175|102147293|FG005|NOT COMPLETED|Part 1||0||
48739341|NCT02814175|102147288|FG000|STARTED|Part 2||0||
48739342|NCT02814175|102147289|FG001|STARTED|Part 2||0||
48739343|NCT02814175|102147290|FG002|STARTED|Part 2||15||
48739344|NCT02814175|102147291|FG003|STARTED|Part 2||95||
48739345|NCT02814175|102147292|FG004|STARTED|Part 2||54||
48739346|NCT02814175|102147293|FG005|STARTED|Part 2||63||
48739347|NCT02814175|102147288|FG000|COMPLETED|Part 2||0||
48739348|NCT02814175|102147289|FG001|COMPLETED|Part 2||0||
48739349|NCT02814175|102147290|FG002|COMPLETED|Part 2||15||
48739350|NCT02814175|102147291|FG003|COMPLETED|Part 2||91||
48739351|NCT02814175|102147292|FG004|COMPLETED|Part 2||52||
48739352|NCT02814175|102147293|FG005|COMPLETED|Part 2||57||
48739353|NCT02814175|102147288|FG000|NOT COMPLETED|Part 2||0||
48739354|NCT02814175|102147289|FG001|NOT COMPLETED|Part 2||0||
48739355|NCT02814175|102147290|FG002|NOT COMPLETED|Part 2||0||
48739356|NCT02814175|102147291|FG003|NOT COMPLETED|Part 2||4||
48739357|NCT02814175|102147292|FG004|NOT COMPLETED|Part 2||2||
48739358|NCT02814175|102147293|FG005|NOT COMPLETED|Part 2||6||
48739359|NCT01010971|102147294|FG000|STARTED|Overall Study||225||
48739360|NCT01010971|102147295|FG001|STARTED|Overall Study||226||
48739361|NCT01010971|102147296|FG002|STARTED|Overall Study||220||
48321451|NCT04762537|101114696|FG003|NOT COMPLETED|Step 2 (Weeks 14-28)||17||0
48321452|NCT04762537|101114697|FG004|NOT COMPLETED|Step 2 (Weeks 14-28)||6||0
48321453|NCT04762537|101114698|FG005|NOT COMPLETED|Step 2 (Weeks 14-28)||3||0
48321454|NCT04762537|101114693|FG000|STARTED|Step 3 (Weeks 28-42)||10||1
48321455|NCT04762537|101114694|FG001|STARTED|Step 3 (Weeks 28-42)||23||1
48321456|NCT04762537|101114695|FG002|STARTED|Step 3 (Weeks 28-42)||12||1
48321457|NCT04762537|101114696|FG003|STARTED|Step 3 (Weeks 28-42)||15||1
48321458|NCT04762537|101114697|FG004|STARTED|Step 3 (Weeks 28-42)||13||1
48321459|NCT04762537|101114698|FG005|STARTED|Step 3 (Weeks 28-42)||7||1
48321460|NCT04762537|101114693|FG000|COMPLETED|Step 3 (Weeks 28-42)||2||1
48321461|NCT04762537|101114694|FG001|COMPLETED|Step 3 (Weeks 28-42)||14||1
48321462|NCT04762537|101114695|FG002|COMPLETED|Step 3 (Weeks 28-42)||9||1
48321463|NCT04762537|101114696|FG003|COMPLETED|Step 3 (Weeks 28-42)||5||1
48321464|NCT04762537|101114697|FG004|COMPLETED|Step 3 (Weeks 28-42)||4||1
48321465|NCT04762537|101114698|FG005|COMPLETED|Step 3 (Weeks 28-42)||3||1
48321466|NCT04762537|101114693|FG000|NOT COMPLETED|Step 3 (Weeks 28-42)||8||0
48321467|NCT04762537|101114694|FG001|NOT COMPLETED|Step 3 (Weeks 28-42)||9||0
48321468|NCT04762537|101114695|FG002|NOT COMPLETED|Step 3 (Weeks 28-42)||3||0
48739362|NCT01010971|102147294|FG000|COMPLETED|Overall Study||222||
48739363|NCT01010971|102147295|FG001|COMPLETED|Overall Study||218||
48739364|NCT01010971|102147296|FG002|COMPLETED|Overall Study||207||
48739365|NCT01010971|102147294|FG000|NOT COMPLETED|Overall Study||3||
48739366|NCT01010971|102147295|FG001|NOT COMPLETED|Overall Study||8||
48739367|NCT01010971|102147296|FG002|NOT COMPLETED|Overall Study||13||
48739368|NCT04158583|102147297|FG000|STARTED|Overall Study||5||
48739369|NCT04158583|102147298|FG001|STARTED|Overall Study||5||
48739370|NCT04158583|102147299|FG002|STARTED|Overall Study||6||
48739371|NCT04158583|102147300|FG003|STARTED|Overall Study||14||
48739372|NCT04158583|102147301|FG004|STARTED|Overall Study||8||
48739373|NCT04158583|102147302|FG005|STARTED|Overall Study||5||
48739374|NCT04158583|102147303|FG006|STARTED|Overall Study||15||
48739375|NCT04158583|102147304|FG007|STARTED|Overall Study||6||
48739376|NCT04158583|102147305|FG008|STARTED|Overall Study||6||
48739377|NCT04158583|102147306|FG009|STARTED|Overall Study||6||
48739378|NCT04158583|102147297|FG000|Pharmacokinetic Population|Overall Study||5||
48739379|NCT04158583|102147298|FG001|Pharmacokinetic Population|Overall Study||5||
48739380|NCT04158583|102147299|FG002|Pharmacokinetic Population|Overall Study||6||
48739381|NCT04158583|102147300|FG003|Pharmacokinetic Population|Overall Study||13||
48739382|NCT04158583|102147301|FG004|Pharmacokinetic Population|Overall Study||6||
48739383|NCT04158583|102147302|FG005|Pharmacokinetic Population|Overall Study||5||
48739384|NCT04158583|102147303|FG006|Pharmacokinetic Population|Overall Study||15||
48739385|NCT04158583|102147304|FG007|Pharmacokinetic Population|Overall Study||6||
48739386|NCT04158583|102147305|FG008|Pharmacokinetic Population|Overall Study||6||
48739387|NCT04158583|102147306|FG009|Pharmacokinetic Population|Overall Study||6||
48739388|NCT04158583|102147297|FG000|COMPLETED|Overall Study||0||
48739389|NCT04158583|102147298|FG001|COMPLETED|Overall Study||0||
48739390|NCT04158583|102147299|FG002|COMPLETED|Overall Study||0||
48739391|NCT04158583|102147300|FG003|COMPLETED|Overall Study||3||
48739392|NCT04158583|102147301|FG004|COMPLETED|Overall Study||1||
48739393|NCT04158583|102147302|FG005|COMPLETED|Overall Study||1||
48739394|NCT04158583|102147303|FG006|COMPLETED|Overall Study||2||
48739395|NCT04158583|102147304|FG007|COMPLETED|Overall Study||2||
48739396|NCT04158583|102147305|FG008|COMPLETED|Overall Study||2||
48739397|NCT04158583|102147306|FG009|COMPLETED|Overall Study||2||
48739398|NCT04158583|102147297|FG000|NOT COMPLETED|Overall Study||5||
48739399|NCT04158583|102147298|FG001|NOT COMPLETED|Overall Study||5||
48739400|NCT04158583|102147299|FG002|NOT COMPLETED|Overall Study||6||
48321469|NCT04762537|101114696|FG003|NOT COMPLETED|Step 3 (Weeks 28-42)||10||0
48321470|NCT04762537|101114697|FG004|NOT COMPLETED|Step 3 (Weeks 28-42)||9||0
48321471|NCT04762537|101114698|FG005|NOT COMPLETED|Step 3 (Weeks 28-42)||4||0
48321472|NCT04762537|101114693|FG000|STARTED|Step 4 (Weeks 42-56)||15||1
48739401|NCT04158583|102147300|FG003|NOT COMPLETED|Overall Study||11||
48739402|NCT04158583|102147301|FG004|NOT COMPLETED|Overall Study||7||
48739403|NCT04158583|102147302|FG005|NOT COMPLETED|Overall Study||4||
48739404|NCT04158583|102147303|FG006|NOT COMPLETED|Overall Study||13||
48739405|NCT04158583|102147304|FG007|NOT COMPLETED|Overall Study||4||
48739406|NCT04158583|102147305|FG008|NOT COMPLETED|Overall Study||4||
48739407|NCT04158583|102147306|FG009|NOT COMPLETED|Overall Study||4||
48739408|NCT00952393|102147307|FG000|STARTED|Overall Study||10||
48739409|NCT00952393|102147307|FG000|COMPLETED|Overall Study||10||
48739410|NCT00952393|102147307|FG000|NOT COMPLETED|Overall Study||0||
48739411|NCT02255461|102147308|FG000|STARTED|Overall Study||3||
48321473|NCT04762537|101114694|FG001|STARTED|Step 4 (Weeks 42-56)||32||1
48739412|NCT02255461|102147309|FG001|STARTED|Overall Study||12||
48739413|NCT02255461|102147310|FG002|STARTED|Overall Study||6||
48739414|NCT02255461|102147311|FG003|STARTED|Overall Study||4||
48739415|NCT02255461|102147312|FG004|STARTED|Overall Study||10||
48739416|NCT02255461|102147308|FG000|COMPLETED|Overall Study||3||
48739417|NCT02255461|102147309|FG001|COMPLETED|Overall Study||10||
48739418|NCT02255461|102147310|FG002|COMPLETED|Overall Study||5||
48739419|NCT02255461|102147311|FG003|COMPLETED|Overall Study||4||
48739420|NCT02255461|102147312|FG004|COMPLETED|Overall Study||8||
48739421|NCT02255461|102147308|FG000|NOT COMPLETED|Overall Study||0||
48739422|NCT02255461|102147309|FG001|NOT COMPLETED|Overall Study||2||
48739423|NCT02255461|102147310|FG002|NOT COMPLETED|Overall Study||1||
48739424|NCT02255461|102147311|FG003|NOT COMPLETED|Overall Study||0||
48739425|NCT02255461|102147312|FG004|NOT COMPLETED|Overall Study||2||
48739426|NCT00526591|102147313|FG000|STARTED|Overall Study||8||
48739427|NCT00526591|102147314|FG001|STARTED|Overall Study||9||
48739428|NCT00526591|102147313|FG000|COMPLETED|Overall Study||8||
48739429|NCT00526591|102147314|FG001|COMPLETED|Overall Study||9||
48739430|NCT00526591|102147313|FG000|NOT COMPLETED|Overall Study||0||
48739431|NCT00526591|102147314|FG001|NOT COMPLETED|Overall Study||0||
48739432|NCT02227667|102147315|FG000|STARTED|Overall Study||16||
48739433|NCT02227667|102147315|FG000|COMPLETED|Overall Study||16||
48739434|NCT02227667|102147315|FG000|NOT COMPLETED|Overall Study||0||
48321474|NCT04762537|101114695|FG002|STARTED|Step 4 (Weeks 42-56)||4||1
48321475|NCT04762537|101114696|FG003|STARTED|Step 4 (Weeks 42-56)||23||1
48321476|NCT04762537|101114697|FG004|STARTED|Step 4 (Weeks 42-56)||18||1
48321477|NCT04762537|101114698|FG005|STARTED|Step 4 (Weeks 42-56)||12||1
48321478|NCT04762537|101114693|FG000|COMPLETED|Step 4 (Weeks 42-56)||11||1
48321479|NCT04762537|101114694|FG001|COMPLETED|Step 4 (Weeks 42-56)||19||1
48739435|NCT02625844|102147316|FG000|STARTED|Overall Study||110||
48739436|NCT02625844|102147316|FG000|COMPLETED|Overall Study||110||
48739437|NCT02625844|102147316|FG000|NOT COMPLETED|Overall Study||0||
48739438|NCT01318408|102147317|FG000|STARTED|Overall Study||24||
48739439|NCT01318408|102147317|FG000|COMPLETED|Overall Study||16||
48739440|NCT01318408|102147317|FG000|NOT COMPLETED|Overall Study||8||
48739441|NCT00939536|102147318|FG000|STARTED|First Intervention||12||
48739442|NCT00939536|102147319|FG001|STARTED|First Intervention||12||
48739443|NCT00939536|102147318|FG000|COMPLETED|First Intervention||12||
48739444|NCT00939536|102147319|FG001|COMPLETED|First Intervention||12||
48739445|NCT00939536|102147318|FG000|NOT COMPLETED|First Intervention||0||
48739446|NCT00939536|102147319|FG001|NOT COMPLETED|First Intervention||0||
48739447|NCT00939536|102147318|FG000|STARTED|Second Intervention||12||
48739448|NCT00939536|102147319|FG001|STARTED|Second Intervention||12||
48739449|NCT00939536|102147318|FG000|COMPLETED|Second Intervention||12||
48739450|NCT00939536|102147319|FG001|COMPLETED|Second Intervention||12||
48739451|NCT00939536|102147318|FG000|NOT COMPLETED|Second Intervention||0||
48739452|NCT00939536|102147319|FG001|NOT COMPLETED|Second Intervention||0||
48739453|NCT01550809|102147320|FG000|STARTED|Overall Study||6||
48321480|NCT04762537|101114695|FG002|COMPLETED|Step 4 (Weeks 42-56)||2||1
48321481|NCT04762537|101114696|FG003|COMPLETED|Step 4 (Weeks 42-56)||14||1
48321482|NCT04762537|101114697|FG004|COMPLETED|Step 4 (Weeks 42-56)||8||1
48321483|NCT04762537|101114698|FG005|COMPLETED|Step 4 (Weeks 42-56)||1||1
48321484|NCT04762537|101114693|FG000|NOT COMPLETED|Step 4 (Weeks 42-56)||4||0
48321485|NCT04762537|101114694|FG001|NOT COMPLETED|Step 4 (Weeks 42-56)||13||0
48321486|NCT04762537|101114695|FG002|NOT COMPLETED|Step 4 (Weeks 42-56)||2||0
48321487|NCT04762537|101114696|FG003|NOT COMPLETED|Step 4 (Weeks 42-56)||9||0
48321488|NCT04762537|101114697|FG004|NOT COMPLETED|Step 4 (Weeks 42-56)||10||0
48321489|NCT04762537|101114698|FG005|NOT COMPLETED|Step 4 (Weeks 42-56)||11||0
48321490|NCT04762537|101114693|FG000|STARTED|Step 5 (Weeks 56-70)||6||1
48321491|NCT04762537|101114694|FG001|STARTED|Step 5 (Weeks 56-70)||13||1
48321492|NCT04762537|101114695|FG002|STARTED|Step 5 (Weeks 56-70)||5||1
48739454|NCT01550809|102147321|FG001|STARTED|Overall Study||6||
48739455|NCT01550809|102147320|FG000|COMPLETED|Overall Study||6||
48739456|NCT01550809|102147321|FG001|COMPLETED|Overall Study||6||
48739457|NCT01550809|102147320|FG000|NOT COMPLETED|Overall Study||0||
48739458|NCT01550809|102147321|FG001|NOT COMPLETED|Overall Study||0||
48739459|NCT02717494|102147322|FG000|STARTED|First Intervention (Step 1)||115||
48739460|NCT02717494|102147323|FG001|STARTED|First Intervention (Step 1)||115||
48739461|NCT02717494|102147324|FG002|STARTED|First Intervention (Step 1)||116||
48739462|NCT02717494|102147322|FG000|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||0|Women who received Placebo in Step 1, and were randomized to Step 2A to receive PPV-23.|
48321493|NCT04762537|101114696|FG003|STARTED|Step 5 (Weeks 56-70)||12||1
48321494|NCT04762537|101114697|FG004|STARTED|Step 5 (Weeks 56-70)||24||1
48321495|NCT04762537|101114698|FG005|STARTED|Step 5 (Weeks 56-70)||5||1
48739463|NCT02717494|102147323|FG001|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||0|Women who received Placebo in Step 1, and were randomized to Step 2A to receive PPV-23.|
48739464|NCT02717494|102147324|FG002|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||53|Women who received Placebo in Step 1, and were randomized to Step 2A to receive PPV-23.|
48739465|NCT02717494|102147322|FG000|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||0|Women who received Placebo in Step 1, and were randomized to Step 2B to receive PCV-10.|
48739466|NCT02717494|102147323|FG001|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||0|Women who received Placebo in Step 1, and were randomized to Step 2B to receive PCV-10.|
48321496|NCT04762537|101114693|FG000|COMPLETED|Step 5 (Weeks 56-70)||4||1
48321497|NCT04762537|101114694|FG001|COMPLETED|Step 5 (Weeks 56-70)||10||1
48321498|NCT04762537|101114695|FG002|COMPLETED|Step 5 (Weeks 56-70)||3||1
48321499|NCT04762537|101114696|FG003|COMPLETED|Step 5 (Weeks 56-70)||11||1
48321500|NCT04762537|101114697|FG004|COMPLETED|Step 5 (Weeks 56-70)||12||1
48321501|NCT04762537|101114698|FG005|COMPLETED|Step 5 (Weeks 56-70)||1||1
48321502|NCT04762537|101114693|FG000|NOT COMPLETED|Step 5 (Weeks 56-70)||2||0
48321503|NCT04762537|101114694|FG001|NOT COMPLETED|Step 5 (Weeks 56-70)||3||0
48321504|NCT04762537|101114695|FG002|NOT COMPLETED|Step 5 (Weeks 56-70)||2||0
48321505|NCT04762537|101114696|FG003|NOT COMPLETED|Step 5 (Weeks 56-70)||1||0
48321506|NCT04762537|101114697|FG004|NOT COMPLETED|Step 5 (Weeks 56-70)||12||0
48321507|NCT04762537|101114698|FG005|NOT COMPLETED|Step 5 (Weeks 56-70)||4||0
48321508|NCT01265550|101114699|FG000|STARTED|Pre Randomization||0||
48321509|NCT01265550|101114700|FG001|STARTED|Pre Randomization||0||
48321510|NCT01265550|101114701|FG002|STARTED|Pre Randomization||0||
48321511|NCT01265550|101114702|FG003|STARTED|Pre Randomization||366||
48321512|NCT01265550|101114699|FG000|COMPLETED|Pre Randomization||0||
48321513|NCT01265550|101114700|FG001|COMPLETED|Pre Randomization||0||
48321514|NCT01265550|101114701|FG002|COMPLETED|Pre Randomization||0||
48321515|NCT01265550|101114702|FG003|COMPLETED|Pre Randomization||78||
48321516|NCT01265550|101114699|FG000|NOT COMPLETED|Pre Randomization||0||
48321517|NCT01265550|101114700|FG001|NOT COMPLETED|Pre Randomization||0||
48321518|NCT01265550|101114701|FG002|NOT COMPLETED|Pre Randomization||0||
48321519|NCT01265550|101114702|FG003|NOT COMPLETED|Pre Randomization||288||
48321520|NCT01265550|101114699|FG000|STARTED|Post Randomization||25||
48321521|NCT01265550|101114700|FG001|STARTED|Post Randomization||27||
48321522|NCT01265550|101114701|FG002|STARTED|Post Randomization||26||
48321523|NCT01265550|101114702|FG003|STARTED|Post Randomization||0||
48321524|NCT01265550|101114699|FG000|COMPLETED|Post Randomization||10||
48321525|NCT01265550|101114700|FG001|COMPLETED|Post Randomization||19||
48321526|NCT01265550|101114701|FG002|COMPLETED|Post Randomization||6||
48321527|NCT01265550|101114702|FG003|COMPLETED|Post Randomization||0||
48321528|NCT01265550|101114699|FG000|NOT COMPLETED|Post Randomization||15||
48321529|NCT01265550|101114700|FG001|NOT COMPLETED|Post Randomization||8||
48321530|NCT01265550|101114701|FG002|NOT COMPLETED|Post Randomization||20||
48321531|NCT01265550|101114702|FG003|NOT COMPLETED|Post Randomization||0||
48321532|NCT02424253|101114703|FG000|STARTED|Overall Study||65||
48321533|NCT02424253|101114704|FG001|STARTED|Overall Study||33||
48321534|NCT02424253|101114703|FG000|COMPLETED|Overall Study||54||
48321535|NCT02424253|101114704|FG001|COMPLETED|Overall Study||24||
48321536|NCT02424253|101114703|FG000|NOT COMPLETED|Overall Study||11||
48739467|NCT02717494|102147324|FG002|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||53|Women who received Placebo in Step 1, and were randomized to Step 2B to receive PCV-10.|
48739468|NCT02717494|102147322|FG000|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||0|Women who received Placebo in Step 1 but were pregnant again, enrolled in Step 3.|
48739469|NCT02717494|102147323|FG001|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||0|Women who received Placebo in Step 1 but were pregnant again, enrolled in Step 3.|
48739470|NCT02717494|102147324|FG002|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||4|Women who received Placebo in Step 1 but were pregnant again, enrolled in Step 3.|
48321537|NCT02424253|101114704|FG001|NOT COMPLETED|Overall Study||9||
48321538|NCT01136655|101114705|FG000|STARTED|BUD 160/FM 2.25 (1 Dose)||54||
48321539|NCT01136655|101114705|FG000|COMPLETED|BUD 160/FM 2.25 (1 Dose)||54||
48321540|NCT01136655|101114705|FG000|NOT COMPLETED|BUD 160/FM 2.25 (1 Dose)||0||
48321541|NCT01136655|101114705|FG000|STARTED|Washout After BUD 160/FM 2.25 (7 Days)||54||
48321542|NCT01136655|101114705|FG000|COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||53||
48739471|NCT02717494|102147322|FG000|COMPLETED|First Intervention (Step 1)||109||
48739472|NCT02717494|102147323|FG001|COMPLETED|First Intervention (Step 1)||108||
48739473|NCT02717494|102147324|FG002|COMPLETED|First Intervention (Step 1)||111||
48739474|NCT02717494|102147322|FG000|NOT COMPLETED|First Intervention (Step 1)||6||
48739475|NCT02717494|102147323|FG001|NOT COMPLETED|First Intervention (Step 1)||7||
48321543|NCT01136655|101114705|FG000|NOT COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||1||
48321544|NCT01136655|101114705|FG000|STARTED|BUD 160/FM 4.5 (1 Dose)||53||
48321545|NCT01136655|101114705|FG000|COMPLETED|BUD 160/FM 4.5 (1 Dose)||53||
48321546|NCT01136655|101114705|FG000|NOT COMPLETED|BUD 160/FM 4.5 (1 Dose)||0||
48321547|NCT01136655|101114705|FG000|STARTED|Washout After BUD 160/FM 4.5 (7 Days)||53||
48321548|NCT01136655|101114705|FG000|COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||52||
48321549|NCT01136655|101114705|FG000|NOT COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||1||
48321550|NCT01136655|101114705|FG000|STARTED|BUD 160/FM 9.0 (1 Dose)||53||
48739476|NCT02717494|102147324|FG002|NOT COMPLETED|First Intervention (Step 1)||5||
48739477|NCT02717494|102147322|FG000|STARTED|Second Intervention (Step 2 or Step 3)||0||
48739478|NCT02717494|102147323|FG001|STARTED|Second Intervention (Step 2 or Step 3)||0||
48739479|NCT02717494|102147324|FG002|STARTED|Second Intervention (Step 2 or Step 3)||110||
48739480|NCT02717494|102147322|FG000|Completed Step 2A|Second Intervention (Step 2 or Step 3)||0||
48739481|NCT02717494|102147323|FG001|Completed Step 2A|Second Intervention (Step 2 or Step 3)||0||
48739482|NCT02717494|102147324|FG002|Completed Step 2A|Second Intervention (Step 2 or Step 3)||52||
48739483|NCT02717494|102147322|FG000|Completed Step 2B|Second Intervention (Step 2 or Step 3)||0||
48739484|NCT02717494|102147323|FG001|Completed Step 2B|Second Intervention (Step 2 or Step 3)||0||
48739485|NCT02717494|102147324|FG002|Completed Step 2B|Second Intervention (Step 2 or Step 3)||50||
48739486|NCT02717494|102147322|FG000|Completed Step 3|Second Intervention (Step 2 or Step 3)||0||
48739487|NCT02717494|102147323|FG001|Completed Step 3|Second Intervention (Step 2 or Step 3)||0||
48739488|NCT02717494|102147324|FG002|Completed Step 3|Second Intervention (Step 2 or Step 3)||4||
48739489|NCT02717494|102147322|FG000|COMPLETED|Second Intervention (Step 2 or Step 3)||0||
48739490|NCT02717494|102147323|FG001|COMPLETED|Second Intervention (Step 2 or Step 3)||0||
48739491|NCT02717494|102147324|FG002|COMPLETED|Second Intervention (Step 2 or Step 3)||106||
48739492|NCT02717494|102147322|FG000|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||0||
48739493|NCT02717494|102147323|FG001|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||0||
48739494|NCT02717494|102147324|FG002|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||4||
48739495|NCT00265317|102147325|FG000|STARTED|Lead-In||13||
48739496|NCT00265317|102147326|FG001|STARTED|Lead-In||17||
48739497|NCT00265317|102147327|FG002|STARTED|Lead-In||0||
48739498|NCT00265317|102147328|FG003|STARTED|Lead-In||0||
48739499|NCT00265317|102147325|FG000|COMPLETED|Lead-In||1||
48739500|NCT00265317|102147326|FG001|COMPLETED|Lead-In||0||
48739501|NCT00265317|102147327|FG002|COMPLETED|Lead-In||0||
48739502|NCT00265317|102147328|FG003|COMPLETED|Lead-In||0||
48739503|NCT00265317|102147325|FG000|NOT COMPLETED|Lead-In||12||
48739504|NCT00265317|102147326|FG001|NOT COMPLETED|Lead-In||17||
48739505|NCT00265317|102147327|FG002|NOT COMPLETED|Lead-In||0||
48739506|NCT00265317|102147328|FG003|NOT COMPLETED|Lead-In||0||
48739507|NCT00265317|102147325|FG000|STARTED|Phase 2||0||
48739508|NCT00265317|102147326|FG001|STARTED|Phase 2||0||
48739509|NCT00265317|102147327|FG002|STARTED|Phase 2||65||
48739510|NCT00265317|102147328|FG003|STARTED|Phase 2||67||
48739511|NCT00265317|102147325|FG000|COMPLETED|Phase 2||0||
48739512|NCT00265317|102147326|FG001|COMPLETED|Phase 2||0||
48739513|NCT00265317|102147327|FG002|COMPLETED|Phase 2||1||
48739514|NCT00265317|102147328|FG003|COMPLETED|Phase 2||2||
48739515|NCT00265317|102147325|FG000|NOT COMPLETED|Phase 2||0||
48739516|NCT00265317|102147326|FG001|NOT COMPLETED|Phase 2||0||
48739517|NCT00265317|102147327|FG002|NOT COMPLETED|Phase 2||64||
48739518|NCT00265317|102147328|FG003|NOT COMPLETED|Phase 2||65||
48739519|NCT00279916|102147329|FG000|STARTED|Overall Study||45||
48739520|NCT00279916|102147330|FG001|STARTED|Overall Study||46||
48739521|NCT00279916|102147329|FG000|COMPLETED|Overall Study||38||
48739522|NCT00279916|102147330|FG001|COMPLETED|Overall Study||41||
48739523|NCT00279916|102147329|FG000|NOT COMPLETED|Overall Study||7||
48739524|NCT00279916|102147330|FG001|NOT COMPLETED|Overall Study||5||
48739525|NCT00649428|102147331|FG000|STARTED|Overall Study||100||
48739526|NCT00649428|102147332|FG001|STARTED|Overall Study||103||
48739527|NCT00649428|102147331|FG000|COMPLETED|Overall Study||80||
48739528|NCT00649428|102147332|FG001|COMPLETED|Overall Study||88||
48739529|NCT00649428|102147331|FG000|NOT COMPLETED|Overall Study||20||
48739530|NCT00649428|102147332|FG001|NOT COMPLETED|Overall Study||15||
48739531|NCT01887184|102147333|FG000|STARTED|Overall Study||25||
48739532|NCT01887184|102147334|FG001|STARTED|Overall Study||25||
48739533|NCT01887184|102147333|FG000|COMPLETED|Overall Study||25||
48739534|NCT01887184|102147334|FG001|COMPLETED|Overall Study||25||
48739535|NCT01887184|102147333|FG000|NOT COMPLETED|Overall Study||0||
48739536|NCT01887184|102147334|FG001|NOT COMPLETED|Overall Study||0||
48739537|NCT00972725|102147335|FG000|STARTED|Overall Study||13||
48739538|NCT00972725|102147336|FG001|STARTED|Overall Study||15||
48739539|NCT00972725|102147335|FG000|COMPLETED|Overall Study||13||
48739540|NCT00972725|102147336|FG001|COMPLETED|Overall Study||15||
48739541|NCT00972725|102147335|FG000|NOT COMPLETED|Overall Study||0||
48739542|NCT00972725|102147336|FG001|NOT COMPLETED|Overall Study||0||
48739543|NCT00203424|102147337|FG000|STARTED|Treatment Period||22||
48739544|NCT00203424|102147337|FG000|COMPLETED|Treatment Period||11||
48739545|NCT00203424|102147337|FG000|NOT COMPLETED|Treatment Period||11||
48739546|NCT00203424|102147337|FG000|STARTED|Follow-up Period||16||
48739547|NCT00203424|102147337|FG000|COMPLETED|Follow-up Period||10||
48739548|NCT00203424|102147337|FG000|NOT COMPLETED|Follow-up Period||6||
48739549|NCT01641601|102147338|FG000|STARTED|Overall Study||3||
48739550|NCT01641601|102147339|FG001|STARTED|Overall Study||5||
48739551|NCT01641601|102147338|FG000|COMPLETED|Overall Study||0||
48739552|NCT01641601|102147339|FG001|COMPLETED|Overall Study||0||
48739553|NCT01641601|102147338|FG000|NOT COMPLETED|Overall Study||3||
48739554|NCT01641601|102147339|FG001|NOT COMPLETED|Overall Study||5||
48739555|NCT00932321|102147340|FG000|STARTED|Overall Study||751||
48739556|NCT00932321|102147341|FG001|STARTED|Overall Study||187||
48739557|NCT00932321|102147340|FG000|MITT Population|Overall Study||705||
48739558|NCT00932321|102147341|FG001|MITT Population|Overall Study||181||
48739559|NCT00932321|102147340|FG000|COMPLETED|Overall Study||580||
48739560|NCT00932321|102147341|FG001|COMPLETED|Overall Study||141||
48739561|NCT00932321|102147340|FG000|NOT COMPLETED|Overall Study||171||
48739562|NCT00932321|102147341|FG001|NOT COMPLETED|Overall Study||46||
48739563|NCT03305770|102147342|FG000|STARTED|Overall Study||70|All randomized subjects|140
48739564|NCT03305770|102147343|FG001|STARTED|Overall Study||37|All randomized subjects|74
48321551|NCT01136655|101114705|FG000|COMPLETED|BUD 160/FM 9.0 (1 Dose)||53||
48321552|NCT01136655|101114705|FG000|NOT COMPLETED|BUD 160/FM 9.0 (1 Dose)||0||
48321553|NCT01136655|101114705|FG000|STARTED|Washout After BUD 160/FM 9.0 (7 Days)||53||
48739565|NCT03305770|102147342|FG000|Enrolled Dispensed Analysis Set|Overall Study||70|Enrolled subjects/eyes exposed to study lenses|140
48767629|NCT01063751|102222784|FG000|Censored (Device Not Implanted)|Overall Study||25||0
48161183|NCT01373450|100718758|FG004|COMPLETED|Crossover Period 2||2||
48161184|NCT01373450|100718759|FG005|COMPLETED|Crossover Period 2||2||
48161185|NCT01373450|100718754|FG000|NOT COMPLETED|Crossover Period 2||0||
48161186|NCT01373450|100718755|FG001|NOT COMPLETED|Crossover Period 2||0||
48321554|NCT01136655|101114705|FG000|COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||51||
48321555|NCT01136655|101114705|FG000|NOT COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||2||
48321556|NCT01136655|101114705|FG000|STARTED|BUD 160 (1 Dose)||51||
48321557|NCT01136655|101114705|FG000|COMPLETED|BUD 160 (1 Dose)||51||
48321558|NCT01136655|101114705|FG000|NOT COMPLETED|BUD 160 (1 Dose)||0||
48616782|NCT02363387|101849450|FG001|STARTED|Overall Study||50||
48616783|NCT02363387|101849449|FG000|COMPLETED|Overall Study||52||
48616784|NCT02363387|101849450|FG001|COMPLETED|Overall Study||50||
48616785|NCT02363387|101849449|FG000|NOT COMPLETED|Overall Study||0||
48616786|NCT02363387|101849450|FG001|NOT COMPLETED|Overall Study||0||
48616787|NCT00974363|101849451|FG000|STARTED|Overall Study||521||
48616788|NCT00974363|101849452|FG001|STARTED|Overall Study||168||
48616789|NCT00974363|101849451|FG000|COMPLETED|Overall Study||521||
48616790|NCT00974363|101849452|FG001|COMPLETED|Overall Study||168||
48616791|NCT00974363|101849451|FG000|NOT COMPLETED|Overall Study||0||
48616792|NCT00974363|101849452|FG001|NOT COMPLETED|Overall Study||0||
48616793|NCT03742986|101849453|FG000|STARTED|Overall Study||4||
48616794|NCT03742986|101849454|FG001|STARTED|Overall Study||4||
48616795|NCT03742986|101849453|FG000|COMPLETED|Overall Study||4||
48616796|NCT03742986|101849454|FG001|COMPLETED|Overall Study||4||
48616797|NCT03742986|101849453|FG000|NOT COMPLETED|Overall Study||0||
48616798|NCT03742986|101849454|FG001|NOT COMPLETED|Overall Study||0||
48616799|NCT00149396|101849455|FG000|STARTED|Overall Study||32||
48616800|NCT00149396|101849455|FG000|Completed NV1020 Therapy|Overall Study||29||
48616801|NCT00149396|101849455|FG000|Completed NV1020 and Chemotherapy|Overall Study||9||
48616802|NCT00149396|101849455|FG000|COMPLETED|Overall Study||9||
48616803|NCT00149396|101849455|FG000|NOT COMPLETED|Overall Study||23||
48616804|NCT01212094|101849456|FG000|STARTED|Year 1: Baseline Monitoring||43||
48616805|NCT01212094|101849457|FG001|STARTED|Year 1: Baseline Monitoring||0||
48616806|NCT01212094|101849458|FG002|STARTED|Year 1: Baseline Monitoring||0||
48616807|NCT01212094|101849456|FG000|COMPLETED|Year 1: Baseline Monitoring||27||
48616808|NCT01212094|101849457|FG001|COMPLETED|Year 1: Baseline Monitoring||0||
48616809|NCT01212094|101849458|FG002|COMPLETED|Year 1: Baseline Monitoring||0||
48616810|NCT01212094|101849456|FG000|NOT COMPLETED|Year 1: Baseline Monitoring||16||
48616811|NCT01212094|101849457|FG001|NOT COMPLETED|Year 1: Baseline Monitoring||0||
48616812|NCT01212094|101849458|FG002|NOT COMPLETED|Year 1: Baseline Monitoring||0||
48616813|NCT01212094|101849456|FG000|STARTED|Years 2 & 3: Treatment Randomization||0||
48616814|NCT01212094|101849457|FG001|STARTED|Years 2 & 3: Treatment Randomization||9||
48616815|NCT01212094|101849458|FG002|STARTED|Years 2 & 3: Treatment Randomization||18||
48616816|NCT01212094|101849456|FG000|COMPLETED|Years 2 & 3: Treatment Randomization||0||
48616817|NCT01212094|101849457|FG001|COMPLETED|Years 2 & 3: Treatment Randomization||5||
48616818|NCT01212094|101849458|FG002|COMPLETED|Years 2 & 3: Treatment Randomization||7||
48616819|NCT01212094|101849456|FG000|NOT COMPLETED|Years 2 & 3: Treatment Randomization||0||
48616820|NCT01212094|101849457|FG001|NOT COMPLETED|Years 2 & 3: Treatment Randomization||4||
48616821|NCT01212094|101849458|FG002|NOT COMPLETED|Years 2 & 3: Treatment Randomization||11||
48616822|NCT02958787|101849459|FG000|STARTED|Overall Study||135||
48616823|NCT02958787|101849459|FG000|COMPLETED|Overall Study||135||
48616824|NCT02958787|101849459|FG000|NOT COMPLETED|Overall Study||0||
48616825|NCT02155699|101849460|FG000|STARTED|Overall Study||7||
48616826|NCT02155699|101849461|FG001|STARTED|Overall Study||5||
48616827|NCT02155699|101849462|FG002|STARTED|Overall Study||20||
48161187|NCT01373450|100718756|FG002|NOT COMPLETED|Crossover Period 2||0||
48161188|NCT01373450|100718757|FG003|NOT COMPLETED|Crossover Period 2||0||
48161189|NCT01373450|100718758|FG004|NOT COMPLETED|Crossover Period 2||0||
48161190|NCT01373450|100718759|FG005|NOT COMPLETED|Crossover Period 2||0||
48321559|NCT01136655|101114705|FG000|STARTED|Washout After BUD 160 (7 Days)||51||
48616828|NCT02155699|101849463|FG003|STARTED|Overall Study||18||
48616829|NCT02155699|101849460|FG000|COMPLETED|Overall Study||7||
48616830|NCT02155699|101849461|FG001|COMPLETED|Overall Study||2||
48616831|NCT02155699|101849462|FG002|COMPLETED|Overall Study||12||
48616832|NCT02155699|101849463|FG003|COMPLETED|Overall Study||13||
48616833|NCT02155699|101849460|FG000|NOT COMPLETED|Overall Study||0||
48616834|NCT02155699|101849461|FG001|NOT COMPLETED|Overall Study||3||
48616835|NCT02155699|101849462|FG002|NOT COMPLETED|Overall Study||8||
48161191|NCT01373450|100718754|FG000|STARTED|7 Day Wash-out||2||
48161192|NCT01373450|100718755|FG001|STARTED|7 Day Wash-out||2||
48161193|NCT01373450|100718756|FG002|STARTED|7 Day Wash-out||2||
48161194|NCT01373450|100718757|FG003|STARTED|7 Day Wash-out||2||
48161195|NCT01373450|100718758|FG004|STARTED|7 Day Wash-out||2||
48161196|NCT01373450|100718759|FG005|STARTED|7 Day Wash-out||2||
48161197|NCT01373450|100718754|FG000|COMPLETED|7 Day Wash-out||2||
48161198|NCT01373450|100718755|FG001|COMPLETED|7 Day Wash-out||2||
48161199|NCT01373450|100718756|FG002|COMPLETED|7 Day Wash-out||2||
48161200|NCT01373450|100718757|FG003|COMPLETED|7 Day Wash-out||2||
48616836|NCT02155699|101849463|FG003|NOT COMPLETED|Overall Study||5||
48616837|NCT00649792|101849464|FG000|STARTED|Overall Study||214||
48616838|NCT00649792|101849464|FG000|COMPLETED|Overall Study||146||
48616839|NCT00649792|101849464|FG000|NOT COMPLETED|Overall Study||68||
48616840|NCT05439421|101849465|FG000|STARTED|Zero Percent Tar||742||
48616841|NCT05439421|101849466|FG001|STARTED|Zero Percent Tar||765||
48616842|NCT05439421|101849465|FG000|COMPLETED|Zero Percent Tar||742||
48616843|NCT05439421|101849466|FG001|COMPLETED|Zero Percent Tar||765||
48616844|NCT05439421|101849465|FG000|NOT COMPLETED|Zero Percent Tar||0||
48616845|NCT05439421|101849466|FG001|NOT COMPLETED|Zero Percent Tar||0||
48616846|NCT05439421|101849465|FG000|STARTED|No Chemicals||764||
48616847|NCT05439421|101849466|FG001|STARTED|No Chemicals||743||
48616848|NCT05439421|101849465|FG000|COMPLETED|No Chemicals||764||
48616849|NCT05439421|101849466|FG001|COMPLETED|No Chemicals||743||
48616850|NCT05439421|101849465|FG000|NOT COMPLETED|No Chemicals||0||
48616851|NCT05439421|101849466|FG001|NOT COMPLETED|No Chemicals||0||
48616852|NCT05439421|101849465|FG000|STARTED|Apple Image||743||
48616853|NCT05439421|101849466|FG001|STARTED|Apple Image||764||
48616854|NCT05439421|101849465|FG000|COMPLETED|Apple Image||743||
48616855|NCT05439421|101849466|FG001|COMPLETED|Apple Image||764||
48616856|NCT05439421|101849465|FG000|NOT COMPLETED|Apple Image||0||
48616857|NCT05439421|101849466|FG001|NOT COMPLETED|Apple Image||0||
48616858|NCT05439421|101849465|FG000|STARTED|Hundred Percent Food Grade Glycerin||746||
48616859|NCT05439421|101849466|FG001|STARTED|Hundred Percent Food Grade Glycerin||761||
48616860|NCT05439421|101849465|FG000|COMPLETED|Hundred Percent Food Grade Glycerin||746||
48616861|NCT05439421|101849466|FG001|COMPLETED|Hundred Percent Food Grade Glycerin||761||
48616862|NCT05439421|101849465|FG000|NOT COMPLETED|Hundred Percent Food Grade Glycerin||0||
48616863|NCT05439421|101849466|FG001|NOT COMPLETED|Hundred Percent Food Grade Glycerin||0||
48616864|NCT05439421|101849465|FG000|STARTED|Ultra Light||731||
48616865|NCT05439421|101849466|FG001|STARTED|Ultra Light||776||
48616866|NCT05439421|101849465|FG000|COMPLETED|Ultra Light||731||
48616867|NCT05439421|101849466|FG001|COMPLETED|Ultra Light||776||
48616868|NCT05439421|101849465|FG000|NOT COMPLETED|Ultra Light||0||
48616869|NCT05439421|101849466|FG001|NOT COMPLETED|Ultra Light||0||
48616870|NCT05439421|101849465|FG000|STARTED|Fresh Hookah Tobacco||706||
48616871|NCT05439421|101849466|FG001|STARTED|Fresh Hookah Tobacco||801||
48616872|NCT05439421|101849465|FG000|COMPLETED|Fresh Hookah Tobacco||706||
48616873|NCT05439421|101849466|FG001|COMPLETED|Fresh Hookah Tobacco||801||
48616874|NCT05439421|101849465|FG000|NOT COMPLETED|Fresh Hookah Tobacco||0||
48616875|NCT05439421|101849466|FG001|NOT COMPLETED|Fresh Hookah Tobacco||0||
48616876|NCT05439421|101849465|FG000|STARTED|Lower Nicotine Tobacco||742||
48616877|NCT05439421|101849466|FG001|STARTED|Lower Nicotine Tobacco||765||
48616878|NCT05439421|101849465|FG000|COMPLETED|Lower Nicotine Tobacco||742||
48616879|NCT05439421|101849466|FG001|COMPLETED|Lower Nicotine Tobacco||765||
48616880|NCT05439421|101849465|FG000|NOT COMPLETED|Lower Nicotine Tobacco||0||
48616881|NCT05439421|101849466|FG001|NOT COMPLETED|Lower Nicotine Tobacco||0||
48616882|NCT05439421|101849465|FG000|STARTED|Premium Shisha Tobacco||764||
48616883|NCT05439421|101849466|FG001|STARTED|Premium Shisha Tobacco||743||
48616884|NCT05439421|101849465|FG000|COMPLETED|Premium Shisha Tobacco||764||
48616885|NCT05439421|101849466|FG001|COMPLETED|Premium Shisha Tobacco||743||
48616886|NCT05439421|101849465|FG000|NOT COMPLETED|Premium Shisha Tobacco||0||
48616887|NCT05439421|101849466|FG001|NOT COMPLETED|Premium Shisha Tobacco||0||
48616888|NCT05439421|101849465|FG000|STARTED|High Quality Shisha Tobacco||743||
48616889|NCT05439421|101849466|FG001|STARTED|High Quality Shisha Tobacco||764||
48161201|NCT01373450|100718758|FG004|COMPLETED|7 Day Wash-out||2||
48161202|NCT01373450|100718759|FG005|COMPLETED|7 Day Wash-out||2||
48161203|NCT01373450|100718754|FG000|NOT COMPLETED|7 Day Wash-out||0||
48161204|NCT01373450|100718755|FG001|NOT COMPLETED|7 Day Wash-out||0||
48161205|NCT01373450|100718756|FG002|NOT COMPLETED|7 Day Wash-out||0||
48161206|NCT01373450|100718757|FG003|NOT COMPLETED|7 Day Wash-out||0||
48161207|NCT01373450|100718758|FG004|NOT COMPLETED|7 Day Wash-out||0||
48161208|NCT01373450|100718759|FG005|NOT COMPLETED|7 Day Wash-out||0||
48161209|NCT01373450|100718754|FG000|STARTED|Crossover Period 3||2||
48161210|NCT01373450|100718755|FG001|STARTED|Crossover Period 3||2||
48616890|NCT05439421|101849465|FG000|COMPLETED|High Quality Shisha Tobacco||743||
48616891|NCT05439421|101849466|FG001|COMPLETED|High Quality Shisha Tobacco||764||
48616892|NCT05439421|101849465|FG000|NOT COMPLETED|High Quality Shisha Tobacco||0||
48616893|NCT05439421|101849466|FG001|NOT COMPLETED|High Quality Shisha Tobacco||0||
48616894|NCT05439421|101849465|FG000|STARTED|Don't Blow Smoke - Blow Clouds||746||
48616895|NCT05439421|101849466|FG001|STARTED|Don't Blow Smoke - Blow Clouds||761||
48161211|NCT01373450|100718756|FG002|STARTED|Crossover Period 3||2||
48739566|NCT03305770|102147343|FG001|Enrolled Dispensed Analysis Set|Overall Study||36|Enrolled subjects/eyes exposed to study lenses|72
48739567|NCT03305770|102147342|FG000|Completed Analysis Set|Overall Study||69|Subjects/eyes in the Enrolled Dispensed set that completed the study|138
48739568|NCT03305770|102147343|FG001|Completed Analysis Set|Overall Study||36|Subjects/eyes in the Enrolled Dispensed set that completed the study|72
48739569|NCT03305770|102147342|FG000|COMPLETED|Overall Study||69||138
48739570|NCT03305770|102147343|FG001|COMPLETED|Overall Study||36||72
48739571|NCT03305770|102147342|FG000|NOT COMPLETED|Overall Study||1||2
48739572|NCT03305770|102147343|FG001|NOT COMPLETED|Overall Study||1||2
48739573|NCT02885246|102147344|FG000|STARTED|Overall Study||1839||
48739574|NCT02885246|102147344|FG000|COMPLETED|Overall Study||1839||
48739575|NCT02885246|102147344|FG000|NOT COMPLETED|Overall Study||0||
48739576|NCT03386487|102147345|FG000|STARTED|Overall Study||116||
48739577|NCT03386487|102147346|FG001|STARTED|Overall Study||112||
48739578|NCT03386487|102147345|FG000|COMPLETED|Overall Study||89||
48739579|NCT03386487|102147346|FG001|COMPLETED|Overall Study||91||
48739580|NCT03386487|102147345|FG000|NOT COMPLETED|Overall Study||27||
48739581|NCT03386487|102147346|FG001|NOT COMPLETED|Overall Study||21||
48739582|NCT03319134|102147347|FG000|STARTED|Overall Study||15||
48739583|NCT03319134|102147348|FG001|STARTED|Overall Study||15||
48739584|NCT03319134|102147349|FG002|STARTED|Overall Study||15||
48739585|NCT03319134|102147347|FG000|COMPLETED|Overall Study||15||
48739586|NCT03319134|102147348|FG001|COMPLETED|Overall Study||15||
48739587|NCT03319134|102147349|FG002|COMPLETED|Overall Study||15||
48739588|NCT03319134|102147347|FG000|NOT COMPLETED|Overall Study||0||
48739589|NCT03319134|102147348|FG001|NOT COMPLETED|Overall Study||0||
48321560|NCT01136655|101114705|FG000|COMPLETED|Washout After BUD 160 (7 Days)||51||
48321561|NCT01136655|101114705|FG000|NOT COMPLETED|Washout After BUD 160 (7 Days)||0||
48321562|NCT01136655|101114705|FG000|STARTED|BUD 160/ Foradil 12.0 (1 Dose)||50||
48321563|NCT01136655|101114705|FG000|COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||50||
48739590|NCT03319134|102147349|FG002|NOT COMPLETED|Overall Study||0||
48739591|NCT02926638|102147350|FG000|STARTED|Overall Study||4||
48739592|NCT02926638|102147351|FG001|STARTED|Overall Study||5||
48739593|NCT02926638|102147350|FG000|Eligible|Overall Study||3||
48739594|NCT02926638|102147351|FG001|Eligible|Overall Study||5||
48739595|NCT02926638|102147350|FG000|COMPLETED|Overall Study||0||
48739596|NCT02926638|102147351|FG001|COMPLETED|Overall Study||0||
48739597|NCT02926638|102147350|FG000|NOT COMPLETED|Overall Study||4||
48739598|NCT02926638|102147351|FG001|NOT COMPLETED|Overall Study||5||
48739599|NCT03831100|102147352|FG000|STARTED|Overall Study||26||
48739600|NCT03831100|102147353|FG001|STARTED|Overall Study||28||
48739601|NCT03831100|102147352|FG000|COMPLETED|Overall Study||20||
48739602|NCT03831100|102147353|FG001|COMPLETED|Overall Study||24||
48739603|NCT03831100|102147352|FG000|NOT COMPLETED|Overall Study||6||
48739604|NCT03831100|102147353|FG001|NOT COMPLETED|Overall Study||4||
48739605|NCT04532034|102147354|FG000|STARTED|Overall Study||12||
48739606|NCT04532034|102147354|FG000|COMPLETED|Overall Study||6||
48739607|NCT04532034|102147354|FG000|NOT COMPLETED|Overall Study||6||
48739608|NCT00345865|102147355|FG000|STARTED|Overall Study||171||
48739609|NCT00345865|102147356|FG001|STARTED|Overall Study||149||
48739610|NCT00345865|102147357|FG002|STARTED|Overall Study||2||
48739611|NCT00345865|102147358|FG003|STARTED|Overall Study||5||
48739612|NCT00345865|102147359|FG004|STARTED|Overall Study||146||
48739613|NCT00345865|102147355|FG000|COMPLETED|Overall Study||171||
48739614|NCT00345865|102147356|FG001|COMPLETED|Overall Study||149||
48739615|NCT00345865|102147357|FG002|COMPLETED|Overall Study||2||
48739616|NCT00345865|102147358|FG003|COMPLETED|Overall Study||5||
48739617|NCT00345865|102147359|FG004|COMPLETED|Overall Study||146||
48739618|NCT00345865|102147355|FG000|NOT COMPLETED|Overall Study||0||
48739619|NCT00345865|102147356|FG001|NOT COMPLETED|Overall Study||0||
48739620|NCT00345865|102147357|FG002|NOT COMPLETED|Overall Study||0||
48739621|NCT00345865|102147358|FG003|NOT COMPLETED|Overall Study||0||
48321564|NCT01136655|101114705|FG000|NOT COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||0||
48321565|NCT01136655|101114705|FG000|STARTED|Washout After BUD 160/ Foradil (7 Days)||50||
48321566|NCT01136655|101114705|FG000|COMPLETED|Washout After BUD 160/ Foradil (7 Days)||50||
48739622|NCT00345865|102147359|FG004|NOT COMPLETED|Overall Study||0||
48739623|NCT03301350|102147360|FG000|STARTED|Overall Study||29||
48739624|NCT03301350|102147360|FG000|COMPLETED|Overall Study||21||
48739625|NCT03301350|102147360|FG000|NOT COMPLETED|Overall Study||8||
48739626|NCT02895100|102147361|FG000|STARTED|Overall Study||25||
48739627|NCT02895100|102147362|FG001|STARTED|Overall Study||25||
48739628|NCT02895100|102147363|FG002|STARTED|Overall Study||23||
48739629|NCT02895100|102147364|FG003|STARTED|Overall Study||25||
48739630|NCT02895100|102147361|FG000|COMPLETED|Overall Study||14||
48321567|NCT01136655|101114705|FG000|NOT COMPLETED|Washout After BUD 160/ Foradil (7 Days)||0||
48321568|NCT01321710|101114706|FG000|STARTED|Overall Study||50||
48739631|NCT02895100|102147362|FG001|COMPLETED|Overall Study||14||
48739632|NCT02895100|102147363|FG002|COMPLETED|Overall Study||15||
48739633|NCT02895100|102147364|FG003|COMPLETED|Overall Study||15||
48739634|NCT02895100|102147361|FG000|NOT COMPLETED|Overall Study||11||
48739635|NCT02895100|102147362|FG001|NOT COMPLETED|Overall Study||11||
48739636|NCT02895100|102147363|FG002|NOT COMPLETED|Overall Study||8||
48739637|NCT02895100|102147364|FG003|NOT COMPLETED|Overall Study||10||
48739638|NCT00452868|102147365|FG000|STARTED|Overall Study||13||
48321569|NCT01321710|101114707|FG001|STARTED|Overall Study||58||
48321570|NCT01321710|101114708|FG002|STARTED|Overall Study||44||
48321571|NCT01321710|101114706|FG000|COMPLETED|Overall Study||46||
48321572|NCT01321710|101114707|FG001|COMPLETED|Overall Study||53||
48321573|NCT01321710|101114708|FG002|COMPLETED|Overall Study||44||
48321574|NCT01321710|101114706|FG000|NOT COMPLETED|Overall Study||4||
48407998|NCT02513394|101331687|FG000|STARTED|Overall Study||2896||
48407999|NCT02513394|101331688|FG001|STARTED|Overall Study||2900||
48616896|NCT05439421|101849465|FG000|COMPLETED|Don't Blow Smoke - Blow Clouds||746||
48616897|NCT05439421|101849466|FG001|COMPLETED|Don't Blow Smoke - Blow Clouds||761||
48616898|NCT05439421|101849465|FG000|NOT COMPLETED|Don't Blow Smoke - Blow Clouds||0||
48616899|NCT05439421|101849466|FG001|NOT COMPLETED|Don't Blow Smoke - Blow Clouds||0||
48616900|NCT05439421|101849465|FG000|STARTED|Contains Natural, Unwashed Tobacco Leaf||731||
48616901|NCT05439421|101849466|FG001|STARTED|Contains Natural, Unwashed Tobacco Leaf||776||
48616902|NCT05439421|101849465|FG000|COMPLETED|Contains Natural, Unwashed Tobacco Leaf||731||
48616903|NCT05439421|101849466|FG001|COMPLETED|Contains Natural, Unwashed Tobacco Leaf||776||
48616904|NCT05439421|101849465|FG000|NOT COMPLETED|Contains Natural, Unwashed Tobacco Leaf||0||
48616905|NCT05439421|101849466|FG001|NOT COMPLETED|Contains Natural, Unwashed Tobacco Leaf||0||
48616906|NCT05439421|101849465|FG000|STARTED|We Only Use FDA Approved Ingredients||706||
48616907|NCT05439421|101849466|FG001|STARTED|We Only Use FDA Approved Ingredients||801||
48616908|NCT05439421|101849465|FG000|COMPLETED|We Only Use FDA Approved Ingredients||706||
48616909|NCT05439421|101849466|FG001|COMPLETED|We Only Use FDA Approved Ingredients||801||
48616910|NCT05439421|101849465|FG000|NOT COMPLETED|We Only Use FDA Approved Ingredients||0||
48616911|NCT05439421|101849466|FG001|NOT COMPLETED|We Only Use FDA Approved Ingredients||0||
48616912|NCT05439421|101849465|FG000|STARTED|H2O Cools Puirfies Tobacco Smoke||753||
48616913|NCT05439421|101849466|FG001|STARTED|H2O Cools Puirfies Tobacco Smoke||754||
48616914|NCT05439421|101849465|FG000|COMPLETED|H2O Cools Puirfies Tobacco Smoke||753||
48616915|NCT05439421|101849466|FG001|COMPLETED|H2O Cools Puirfies Tobacco Smoke||754||
48616916|NCT05439421|101849465|FG000|NOT COMPLETED|H2O Cools Puirfies Tobacco Smoke||0||
48616917|NCT05439421|101849466|FG001|NOT COMPLETED|H2O Cools Puirfies Tobacco Smoke||0||
48616918|NCT05439421|101849465|FG000|STARTED|Natural Flavor||783||
48616919|NCT05439421|101849466|FG001|STARTED|Natural Flavor||724||
48616920|NCT05439421|101849465|FG000|COMPLETED|Natural Flavor||783||
48616921|NCT05439421|101849466|FG001|COMPLETED|Natural Flavor||724||
48616922|NCT05439421|101849465|FG000|NOT COMPLETED|Natural Flavor||0||
48616923|NCT05439421|101849466|FG001|NOT COMPLETED|Natural Flavor||0||
48616924|NCT05439421|101849465|FG000|STARTED|Shisha/Hookah Tobacco is Unique||749||
48616925|NCT05439421|101849466|FG001|STARTED|Shisha/Hookah Tobacco is Unique||758||
48616926|NCT05439421|101849465|FG000|COMPLETED|Shisha/Hookah Tobacco is Unique||749||
48616927|NCT05439421|101849466|FG001|COMPLETED|Shisha/Hookah Tobacco is Unique||758||
48616928|NCT05439421|101849465|FG000|NOT COMPLETED|Shisha/Hookah Tobacco is Unique||0||
48616929|NCT05439421|101849466|FG001|NOT COMPLETED|Shisha/Hookah Tobacco is Unique||0||
48616930|NCT05439421|101849465|FG000|STARTED|Shisha H2O Cools and Filters Smoke||722||
48616931|NCT05439421|101849466|FG001|STARTED|Shisha H2O Cools and Filters Smoke||785||
48616932|NCT05439421|101849465|FG000|COMPLETED|Shisha H2O Cools and Filters Smoke||722||
48616933|NCT05439421|101849466|FG001|COMPLETED|Shisha H2O Cools and Filters Smoke||785||
48616934|NCT05439421|101849465|FG000|NOT COMPLETED|Shisha H2O Cools and Filters Smoke||0||
48616935|NCT05439421|101849466|FG001|NOT COMPLETED|Shisha H2O Cools and Filters Smoke||0||
48616936|NCT04633226|101849467|FG000|STARTED|Overall Study||58||
48616937|NCT04633226|101849467|FG000|Vaccination 1 (~2 Months of Age)|Overall Study||57||
48616938|NCT04633226|101849467|FG000|Vaccination 2 (~4 Months of Age)|Overall Study||56||
48616939|NCT04633226|101849467|FG000|Vaccination 3 (~6 Months of Age)|Overall Study||55||
48616940|NCT04633226|101849467|FG000|Vaccination 4 (~12 to 15 Months of Age)|Overall Study||50||
48616941|NCT04633226|101849467|FG000|COMPLETED|Overall Study||53||
48616942|NCT04633226|101849467|FG000|NOT COMPLETED|Overall Study||5||
48616943|NCT02372344|101849468|FG000|STARTED|Period 1 (Visit 2)||14||
48616944|NCT02372344|101849469|FG001|STARTED|Period 1 (Visit 2)||14||
48616945|NCT02372344|101849470|FG002|STARTED|Period 1 (Visit 2)||14||
48616946|NCT02372344|101849468|FG000|COMPLETED|Period 1 (Visit 2)||14||
48616947|NCT02372344|101849469|FG001|COMPLETED|Period 1 (Visit 2)||14||
48616948|NCT02372344|101849470|FG002|COMPLETED|Period 1 (Visit 2)||14||
48616949|NCT02372344|101849468|FG000|NOT COMPLETED|Period 1 (Visit 2)||0||
48616950|NCT02372344|101849469|FG001|NOT COMPLETED|Period 1 (Visit 2)||0||
48616951|NCT02372344|101849470|FG002|NOT COMPLETED|Period 1 (Visit 2)||0||
48616952|NCT02372344|101849468|FG000|STARTED|Period 2 (Visit 3)||14||
48321575|NCT01321710|101114707|FG001|NOT COMPLETED|Overall Study||5||
48321576|NCT01321710|101114708|FG002|NOT COMPLETED|Overall Study||0||
48321577|NCT02728830|101114709|FG000|STARTED|Overall Study||39||
48321578|NCT02728830|101114709|FG000|COMPLETED|Overall Study||15||
48321579|NCT02728830|101114709|FG000|NOT COMPLETED|Overall Study||24||
48321580|NCT01179009|101114710|FG000|STARTED|Overall Study||10||
48616953|NCT02372344|101849469|FG001|STARTED|Period 2 (Visit 3)||14||
48616954|NCT02372344|101849470|FG002|STARTED|Period 2 (Visit 3)||14||
48616955|NCT02372344|101849468|FG000|COMPLETED|Period 2 (Visit 3)||14||
48321581|NCT01179009|101114711|FG001|STARTED|Overall Study||10||
48321582|NCT01179009|101114710|FG000|COMPLETED|Overall Study||10||
48616956|NCT02372344|101849469|FG001|COMPLETED|Period 2 (Visit 3)||14||
48321583|NCT01179009|101114711|FG001|COMPLETED|Overall Study||10||
48321584|NCT01179009|101114710|FG000|NOT COMPLETED|Overall Study||0||
48321585|NCT01179009|101114711|FG001|NOT COMPLETED|Overall Study||0||
48321586|NCT00578305|101114712|FG000|STARTED|Double-blind Treatment Phase||62||
48321587|NCT00578305|101114713|FG001|STARTED|Double-blind Treatment Phase||60||
48321588|NCT00578305|101114714|FG002|STARTED|Double-blind Treatment Phase||63||
48739639|NCT00452868|102147365|FG000|COMPLETED|Overall Study||11||
48739640|NCT00452868|102147365|FG000|NOT COMPLETED|Overall Study||2||
48739641|NCT00394706|102147366|FG000|STARTED|Overall Study||1819||
48739642|NCT00394706|102147367|FG001|STARTED|Overall Study||1862||
48739643|NCT00394706|102147368|FG002|STARTED|Overall Study||1624||
48739644|NCT00394706|102147369|FG003|STARTED|Overall Study||1633||
48739645|NCT00394706|102147370|FG004|STARTED|Overall Study||1636||
48739646|NCT00394706|102147371|FG005|STARTED|Overall Study||1384||
48739647|NCT00394706|102147372|FG006|STARTED|Overall Study||929||
48739648|NCT00394706|102147373|FG007|STARTED|Overall Study||851||
48739649|NCT00394706|102147366|FG000|COMPLETED|Overall Study||1815||
48739650|NCT00394706|102147367|FG001|COMPLETED|Overall Study||1860||
48739651|NCT00394706|102147368|FG002|COMPLETED|Overall Study||1615||
48739652|NCT00394706|102147369|FG003|COMPLETED|Overall Study||1632||
48739653|NCT00394706|102147370|FG004|COMPLETED|Overall Study||1634||
48739654|NCT00394706|102147371|FG005|COMPLETED|Overall Study||1377||
48739655|NCT00394706|102147372|FG006|COMPLETED|Overall Study||926||
48739656|NCT00394706|102147373|FG007|COMPLETED|Overall Study||851||
48739657|NCT00394706|102147366|FG000|NOT COMPLETED|Overall Study||4||
48739658|NCT00394706|102147367|FG001|NOT COMPLETED|Overall Study||2||
48739659|NCT00394706|102147368|FG002|NOT COMPLETED|Overall Study||9||
48739660|NCT00394706|102147369|FG003|NOT COMPLETED|Overall Study||1||
48739661|NCT00394706|102147370|FG004|NOT COMPLETED|Overall Study||2||
48739662|NCT00394706|102147371|FG005|NOT COMPLETED|Overall Study||7||
48739663|NCT00394706|102147372|FG006|NOT COMPLETED|Overall Study||3||
48739664|NCT00394706|102147373|FG007|NOT COMPLETED|Overall Study||0||
48739665|NCT03088917|102147374|FG000|STARTED|Overall Study||106||
48739666|NCT03088917|102147374|FG000|COMPLETED|Overall Study||10||
48739667|NCT03088917|102147374|FG000|NOT COMPLETED|Overall Study||96||
48739668|NCT01502228|102147375|FG000|STARTED|Overall Study||14||
48739669|NCT01502228|102147375|FG000|COMPLETED|Overall Study||13||
48161212|NCT01373450|100718757|FG003|STARTED|Crossover Period 3||2||
48161213|NCT01373450|100718758|FG004|STARTED|Crossover Period 3||2||
48161214|NCT01373450|100718759|FG005|STARTED|Crossover Period 3||2||
48161215|NCT01373450|100718754|FG000|COMPLETED|Crossover Period 3||2||
48161216|NCT01373450|100718755|FG001|COMPLETED|Crossover Period 3||2||
48161217|NCT01373450|100718756|FG002|COMPLETED|Crossover Period 3||2||
48161218|NCT01373450|100718757|FG003|COMPLETED|Crossover Period 3||2||
48161219|NCT01373450|100718758|FG004|COMPLETED|Crossover Period 3||2||
48161220|NCT01373450|100718759|FG005|COMPLETED|Crossover Period 3||2||
48161221|NCT01373450|100718754|FG000|NOT COMPLETED|Crossover Period 3||0||
48161222|NCT01373450|100718755|FG001|NOT COMPLETED|Crossover Period 3||0||
48161223|NCT01373450|100718756|FG002|NOT COMPLETED|Crossover Period 3||0||
48161224|NCT01373450|100718757|FG003|NOT COMPLETED|Crossover Period 3||0||
48161225|NCT01373450|100718758|FG004|NOT COMPLETED|Crossover Period 3||0||
48739670|NCT01502228|102147375|FG000|NOT COMPLETED|Overall Study||1||
48739671|NCT00301418|102147376|FG000|STARTED|Overall Study||11||
48161226|NCT01373450|100718759|FG005|NOT COMPLETED|Crossover Period 3||0||
48161227|NCT01373450|100718754|FG000|STARTED|7 Day Wash-out||2||
48161228|NCT01373450|100718755|FG001|STARTED|7 Day Wash-out||2||
48161229|NCT01373450|100718756|FG002|STARTED|7 Day Wash-out||2||
48161230|NCT01373450|100718757|FG003|STARTED|7 Day Wash-out||2||
48161231|NCT01373450|100718758|FG004|STARTED|7 Day Wash-out||2||
48161232|NCT01373450|100718759|FG005|STARTED|7 Day Wash-out||2||
48161233|NCT01373450|100718754|FG000|COMPLETED|7 Day Wash-out||2||
48161234|NCT01373450|100718755|FG001|COMPLETED|7 Day Wash-out||2||
48161235|NCT01373450|100718756|FG002|COMPLETED|7 Day Wash-out||2||
48161236|NCT01373450|100718757|FG003|COMPLETED|7 Day Wash-out||2||
48161237|NCT01373450|100718758|FG004|COMPLETED|7 Day Wash-out||2||
48161238|NCT01373450|100718759|FG005|COMPLETED|7 Day Wash-out||2||
48161239|NCT01373450|100718754|FG000|NOT COMPLETED|7 Day Wash-out||0||
48161240|NCT01373450|100718755|FG001|NOT COMPLETED|7 Day Wash-out||0||
48161241|NCT01373450|100718756|FG002|NOT COMPLETED|7 Day Wash-out||0||
48161242|NCT01373450|100718757|FG003|NOT COMPLETED|7 Day Wash-out||0||
48161243|NCT01373450|100718758|FG004|NOT COMPLETED|7 Day Wash-out||0||
48321589|NCT00578305|101114712|FG000|Treated|Double-blind Treatment Phase||62||
48321590|NCT00578305|101114713|FG001|Treated|Double-blind Treatment Phase||60||
48739672|NCT00301418|102147376|FG000|COMPLETED|Overall Study||11||
48739673|NCT00301418|102147376|FG000|NOT COMPLETED|Overall Study||0||
48739674|NCT01433172|102147377|FG000|STARTED|Overall Study||3||
48739675|NCT01433172|102147378|FG001|STARTED|Overall Study||37||
48739676|NCT01433172|102147379|FG002|STARTED|Overall Study||33||
48161244|NCT01373450|100718759|FG005|NOT COMPLETED|7 Day Wash-out||0||
48161245|NCT01373450|100718754|FG000|STARTED|Crossover Period 4||2||
48739677|NCT01433172|102147377|FG000|COMPLETED|Overall Study||3||
48739678|NCT01433172|102147378|FG001|COMPLETED|Overall Study||34||
48739679|NCT01433172|102147379|FG002|COMPLETED|Overall Study||32||
48739680|NCT01433172|102147377|FG000|NOT COMPLETED|Overall Study||0||
48739681|NCT01433172|102147378|FG001|NOT COMPLETED|Overall Study||3||
48739682|NCT01433172|102147379|FG002|NOT COMPLETED|Overall Study||1||
48739683|NCT02553395|102147380|FG000|STARTED|First Intervention||12||
48739684|NCT02553395|102147381|FG001|STARTED|First Intervention||18||
48739685|NCT02553395|102147380|FG000|COMPLETED|First Intervention||12||
48739686|NCT02553395|102147381|FG001|COMPLETED|First Intervention||18||
48321591|NCT00578305|101114714|FG002|Treated|Double-blind Treatment Phase||63||
48321592|NCT00578305|101114712|FG000|COMPLETED|Double-blind Treatment Phase||59||
48321593|NCT00578305|101114713|FG001|COMPLETED|Double-blind Treatment Phase||56||
48321594|NCT00578305|101114714|FG002|COMPLETED|Double-blind Treatment Phase||49||
48739687|NCT02553395|102147380|FG000|NOT COMPLETED|First Intervention||0||
48739688|NCT02553395|102147381|FG001|NOT COMPLETED|First Intervention||0||
48739689|NCT02553395|102147380|FG000|STARTED|Second Intervention||12||
48739690|NCT02553395|102147381|FG001|STARTED|Second Intervention||18||
48739691|NCT02553395|102147380|FG000|COMPLETED|Second Intervention||12||
48739692|NCT02553395|102147381|FG001|COMPLETED|Second Intervention||18||
48739693|NCT02553395|102147380|FG000|NOT COMPLETED|Second Intervention||0||
48739694|NCT02553395|102147381|FG001|NOT COMPLETED|Second Intervention||0||
48739695|NCT04089761|102147382|FG000|STARTED|"Run In Phase"||60||
48739696|NCT04089761|102147382|FG000|COMPLETED|"Run In Phase"||45||
48739697|NCT04089761|102147382|FG000|NOT COMPLETED|"Run In Phase"||15||
48739698|NCT04089761|102147382|FG000|STARTED|"Treatment Phase"||45||
48739699|NCT04089761|102147382|FG000|COMPLETED|"Treatment Phase"||39||
48739700|NCT04089761|102147382|FG000|NOT COMPLETED|"Treatment Phase"||6||
48739701|NCT04089761|102147382|FG000|STARTED|"Follow Up Phase (Optional)"||27||
48739702|NCT04089761|102147382|FG000|COMPLETED|"Follow Up Phase (Optional)"||27||
48739703|NCT04089761|102147382|FG000|NOT COMPLETED|"Follow Up Phase (Optional)"||0||
48739704|NCT00256724|102147383|FG000|STARTED|Overall Study||23||
48739705|NCT00256724|102147384|FG001|STARTED|Overall Study||24||
48739706|NCT00256724|102147383|FG000|COMPLETED|Overall Study||18||
48739707|NCT00256724|102147384|FG001|COMPLETED|Overall Study||16||
48739708|NCT00256724|102147383|FG000|NOT COMPLETED|Overall Study||5||
48739709|NCT00256724|102147384|FG001|NOT COMPLETED|Overall Study||8||
48739710|NCT02175979|102147385|FG000|STARTED|Overall Study||140||
48739711|NCT02175979|102147386|FG001|STARTED|Overall Study||140||
48739712|NCT02175979|102147385|FG000|COMPLETED|Overall Study||133||
48739713|NCT02175979|102147386|FG001|COMPLETED|Overall Study||132||
48739714|NCT02175979|102147385|FG000|NOT COMPLETED|Overall Study||7||
48739715|NCT02175979|102147386|FG001|NOT COMPLETED|Overall Study||8||
48739716|NCT02578199|102147387|FG000|STARTED|Overall Study||31||
48739717|NCT02578199|102147387|FG000|COMPLETED|Overall Study||27||
48739718|NCT02578199|102147387|FG000|NOT COMPLETED|Overall Study||4||
48739719|NCT04618744|102147388|FG000|STARTED|Overall Study||11||
48739720|NCT04618744|102147389|FG001|STARTED|Overall Study||21||
48321595|NCT00578305|101114712|FG000|NOT COMPLETED|Double-blind Treatment Phase||3||
48321596|NCT00578305|101114713|FG001|NOT COMPLETED|Double-blind Treatment Phase||4||
48321597|NCT00578305|101114714|FG002|NOT COMPLETED|Double-blind Treatment Phase||14||
48321598|NCT00578305|101114712|FG000|STARTED|Extension Phase||53||
48739721|NCT04618744|102147388|FG000|COMPLETED|Overall Study||11||
48739722|NCT04618744|102147389|FG001|COMPLETED|Overall Study||19||
48739723|NCT04618744|102147388|FG000|NOT COMPLETED|Overall Study||0||
48739724|NCT04618744|102147389|FG001|NOT COMPLETED|Overall Study||2||
48739725|NCT02333799|102147390|FG000|STARTED|Treatment Period||109|All participants were to receive 6 months of treatment, from Day 1 to week 26 (6 months) or Day 1 to week 39 (9 months). Participants that were culture negative moved to the Follow Up Period. If participants were culture positive or reverted to being culture positive between the Month 4 and Month 6 visits, and their clinical condition suggested they may have ongoing TB infection, their Treatment Period could have been extended to 9 months.|
48739726|NCT02333799|102147390|FG000|COMPLETED|Treatment Period||102||
48739727|NCT02333799|102147390|FG000|NOT COMPLETED|Treatment Period||7||
48739728|NCT02333799|102147390|FG000|STARTED|6 Month Follow Up Period||102||
48739729|NCT02333799|102147390|FG000|COMPLETED|6 Month Follow Up Period||100||
48739730|NCT02333799|102147390|FG000|NOT COMPLETED|6 Month Follow Up Period||2||
48739731|NCT02333799|102147390|FG000|STARTED|7 to 24 Month Follow Up Period||100||
48616957|NCT02372344|101849470|FG002|COMPLETED|Period 2 (Visit 3)||14||
48616958|NCT02372344|101849468|FG000|NOT COMPLETED|Period 2 (Visit 3)||0||
48616959|NCT02372344|101849469|FG001|NOT COMPLETED|Period 2 (Visit 3)||0||
48616960|NCT02372344|101849470|FG002|NOT COMPLETED|Period 2 (Visit 3)||0||
48616961|NCT02372344|101849468|FG000|STARTED|Period 3 (Visit 4)||14||
48616962|NCT02372344|101849469|FG001|STARTED|Period 3 (Visit 4)||14||
48161246|NCT01373450|100718755|FG001|STARTED|Crossover Period 4||2||
48161247|NCT01373450|100718756|FG002|STARTED|Crossover Period 4||2||
48161248|NCT01373450|100718757|FG003|STARTED|Crossover Period 4||2||
48161249|NCT01373450|100718758|FG004|STARTED|Crossover Period 4||2||
48161250|NCT01373450|100718759|FG005|STARTED|Crossover Period 4||2||
48408000|NCT02513394|101331687|FG000|COMPLETED|Overall Study||2884||
48408001|NCT02513394|101331688|FG001|COMPLETED|Overall Study||2877||
48408002|NCT02513394|101331687|FG000|NOT COMPLETED|Overall Study||12||
48408003|NCT02513394|101331688|FG001|NOT COMPLETED|Overall Study||23||
48408004|NCT00628134|101331689|FG000|STARTED|Overall Study||4||
48408005|NCT00628134|101331690|FG001|STARTED|Overall Study||4||
48408006|NCT00628134|101331689|FG000|COMPLETED|Overall Study||4||
48408007|NCT00628134|101331690|FG001|COMPLETED|Overall Study||4||
48408008|NCT00628134|101331689|FG000|NOT COMPLETED|Overall Study||0||
48408009|NCT00628134|101331690|FG001|NOT COMPLETED|Overall Study||0||
48408010|NCT00863317|101331691|FG000|STARTED|Overall Study||68||
48408011|NCT00863317|101331692|FG001|STARTED|Overall Study||73||
48408012|NCT00863317|101331691|FG000|COMPLETED|Overall Study||60||
48408013|NCT00863317|101331692|FG001|COMPLETED|Overall Study||64||
48408014|NCT00863317|101331691|FG000|NOT COMPLETED|Overall Study||8||
48616963|NCT02372344|101849470|FG002|STARTED|Period 3 (Visit 4)||14||
48616964|NCT02372344|101849468|FG000|COMPLETED|Period 3 (Visit 4)||14||
48616965|NCT02372344|101849469|FG001|COMPLETED|Period 3 (Visit 4)||14||
48616966|NCT02372344|101849470|FG002|COMPLETED|Period 3 (Visit 4)||14||
48616967|NCT02372344|101849468|FG000|NOT COMPLETED|Period 3 (Visit 4)||0||
48616968|NCT02372344|101849469|FG001|NOT COMPLETED|Period 3 (Visit 4)||0||
48616969|NCT02372344|101849470|FG002|NOT COMPLETED|Period 3 (Visit 4)||0||
48616970|NCT01801111|101849471|FG000|STARTED|Overall Study||138||
48616971|NCT01801111|101849471|FG000|COMPLETED|Overall Study||0||
48616972|NCT01801111|101849471|FG000|NOT COMPLETED|Overall Study||138||
48616973|NCT01936363|101849472|FG000|STARTED|Overall Study||32||
48616974|NCT01936363|101849473|FG001|STARTED|Overall Study||33||
48616975|NCT01936363|101849472|FG000|COMPLETED|Overall Study||32||
48616976|NCT01936363|101849473|FG001|COMPLETED|Overall Study||33||
48616977|NCT01936363|101849472|FG000|NOT COMPLETED|Overall Study||0||
48616978|NCT01936363|101849473|FG001|NOT COMPLETED|Overall Study||0||
48616979|NCT01367249|101849474|FG000|STARTED|Overall Study||222||
48616980|NCT01367249|101849475|FG001|STARTED|Overall Study||218||
48616981|NCT01367249|101849474|FG000|COMPLETED|Overall Study||213||
48616982|NCT01367249|101849475|FG001|COMPLETED|Overall Study||202||
48616983|NCT01367249|101849474|FG000|NOT COMPLETED|Overall Study||9||
48616984|NCT01367249|101849475|FG001|NOT COMPLETED|Overall Study||16||
48616985|NCT03839394|101849476|FG000|STARTED|Overall Study||25||
48616986|NCT03839394|101849477|FG001|STARTED|Overall Study||24||
48616987|NCT03839394|101849476|FG000|COMPLETED|Overall Study||19||
48616988|NCT03839394|101849477|FG001|COMPLETED|Overall Study||14||
48616989|NCT03839394|101849476|FG000|NOT COMPLETED|Overall Study||6||
48616990|NCT03839394|101849477|FG001|NOT COMPLETED|Overall Study||10||
48616991|NCT01218542|101849478|FG000|STARTED|Overall Study||22||
48161251|NCT01373450|100718754|FG000|COMPLETED|Crossover Period 4||2||
48161252|NCT01373450|100718755|FG001|COMPLETED|Crossover Period 4||2||
48161253|NCT01373450|100718756|FG002|COMPLETED|Crossover Period 4||2||
48161254|NCT01373450|100718757|FG003|COMPLETED|Crossover Period 4||2||
48161255|NCT01373450|100718758|FG004|COMPLETED|Crossover Period 4||2||
48161256|NCT01373450|100718759|FG005|COMPLETED|Crossover Period 4||2||
48161257|NCT01373450|100718754|FG000|NOT COMPLETED|Crossover Period 4||0||
48161258|NCT01373450|100718755|FG001|NOT COMPLETED|Crossover Period 4||0||
48161259|NCT01373450|100718756|FG002|NOT COMPLETED|Crossover Period 4||0||
48161260|NCT01373450|100718757|FG003|NOT COMPLETED|Crossover Period 4||0||
48161261|NCT01373450|100718758|FG004|NOT COMPLETED|Crossover Period 4||0||
48161262|NCT01373450|100718759|FG005|NOT COMPLETED|Crossover Period 4||0||
48161263|NCT01741454|100718760|FG000|STARTED|Overall Study||49||
48161264|NCT01741454|100718761|FG001|STARTED|Overall Study||50||
48161265|NCT01741454|100718762|FG002|STARTED|Overall Study||39||
48161266|NCT01741454|100718763|FG003|STARTED|Overall Study||43||
48161267|NCT01741454|100718760|FG000|COMPLETED|Overall Study||36||
48161268|NCT01741454|100718761|FG001|COMPLETED|Overall Study||44||
48161269|NCT01741454|100718762|FG002|COMPLETED|Overall Study||22||
48161270|NCT01741454|100718763|FG003|COMPLETED|Overall Study||21||
48161271|NCT01741454|100718760|FG000|NOT COMPLETED|Overall Study||13||
48161272|NCT01741454|100718761|FG001|NOT COMPLETED|Overall Study||6||
48408015|NCT00863317|101331692|FG001|NOT COMPLETED|Overall Study||9||
48408016|NCT01922986|101331693|FG000|STARTED|Overall Study||2||
48616992|NCT01218542|101849478|FG000|COMPLETED|Overall Study||13||
48616993|NCT01218542|101849478|FG000|NOT COMPLETED|Overall Study||9||
48616994|NCT00003483|101849479|FG000|STARTED|Overall Study||3||
48321599|NCT00578305|101114713|FG001|STARTED|Extension Phase||50||
48321600|NCT00578305|101114714|FG002|STARTED|Extension Phase||43||
48321601|NCT00578305|101114712|FG000|COMPLETED|Extension Phase||49||
48321602|NCT00578305|101114713|FG001|COMPLETED|Extension Phase||49||
48321603|NCT00578305|101114714|FG002|COMPLETED|Extension Phase||40||
48321604|NCT00578305|101114712|FG000|NOT COMPLETED|Extension Phase||4||
48321605|NCT00578305|101114713|FG001|NOT COMPLETED|Extension Phase||1||
48321606|NCT00578305|101114714|FG002|NOT COMPLETED|Extension Phase||3||
48321607|NCT00578305|101114712|FG000|STARTED|Safety Follow-up Phase||57||
48321608|NCT00578305|101114713|FG001|STARTED|Safety Follow-up Phase||54||
48321609|NCT00578305|101114714|FG002|STARTED|Safety Follow-up Phase||54||
48321610|NCT00578305|101114712|FG000|COMPLETED|Safety Follow-up Phase||11||
48321611|NCT00578305|101114713|FG001|COMPLETED|Safety Follow-up Phase||9||
48321612|NCT00578305|101114714|FG002|COMPLETED|Safety Follow-up Phase||8||
48321613|NCT00578305|101114712|FG000|NOT COMPLETED|Safety Follow-up Phase||46||
48321614|NCT00578305|101114713|FG001|NOT COMPLETED|Safety Follow-up Phase||45||
48321615|NCT00578305|101114714|FG002|NOT COMPLETED|Safety Follow-up Phase||46||
48321616|NCT00066703|101114715|FG000|STARTED|Overall Study||1334||
48321617|NCT00066703|101114716|FG001|STARTED|Overall Study||1338||
48321618|NCT00066703|101114715|FG000|COMPLETED|Overall Study||722||
48321619|NCT00066703|101114716|FG001|COMPLETED|Overall Study||756||
48321620|NCT00066703|101114715|FG000|NOT COMPLETED|Overall Study||612||
48321621|NCT00066703|101114716|FG001|NOT COMPLETED|Overall Study||582||
48321622|NCT03138538|101114717|FG000|STARTED|Overall Study||3||
48321623|NCT03138538|101114718|FG001|STARTED|Overall Study||3||
48321624|NCT03138538|101114719|FG002|STARTED|Overall Study||3||
48321625|NCT03138538|101114720|FG003|STARTED|Overall Study||8||
48321626|NCT03138538|101114721|FG004|STARTED|Overall Study||7||
48616995|NCT00003483|101849479|FG000|COMPLETED|Overall Study||2||
48616996|NCT00003483|101849479|FG000|NOT COMPLETED|Overall Study||1||
48616997|NCT00988000|101849480|FG000|STARTED|Overall Study||49||
48616998|NCT00988000|101849481|FG001|STARTED|Overall Study||51||
48616999|NCT00988000|101849482|FG002|STARTED|Overall Study||57||
48617000|NCT00988000|101849480|FG000|COMPLETED|Overall Study||49||
48617001|NCT00988000|101849481|FG001|COMPLETED|Overall Study||51||
48617002|NCT00988000|101849482|FG002|COMPLETED|Overall Study||57||
48617003|NCT00988000|101849480|FG000|NOT COMPLETED|Overall Study||0||
48617004|NCT00988000|101849481|FG001|NOT COMPLETED|Overall Study||0||
48617005|NCT00988000|101849482|FG002|NOT COMPLETED|Overall Study||0||
48617006|NCT00121719|101849483|FG000|STARTED|Dose Escalation (4 Weeks)||4||
48617007|NCT00121719|101849484|FG001|STARTED|Dose Escalation (4 Weeks)||4||
48321627|NCT03138538|101114722|FG005|STARTED|Overall Study||3||
48321628|NCT03138538|101114717|FG000|COMPLETED|Overall Study||3||
48321629|NCT03138538|101114718|FG001|COMPLETED|Overall Study||3||
48321630|NCT03138538|101114719|FG002|COMPLETED|Overall Study||3||
48321631|NCT03138538|101114720|FG003|COMPLETED|Overall Study||8||
48321632|NCT03138538|101114721|FG004|COMPLETED|Overall Study||7||
48321633|NCT03138538|101114722|FG005|COMPLETED|Overall Study||3||
48321634|NCT03138538|101114717|FG000|NOT COMPLETED|Overall Study||0||
48321635|NCT03138538|101114718|FG001|NOT COMPLETED|Overall Study||0||
48321636|NCT03138538|101114719|FG002|NOT COMPLETED|Overall Study||0||
48321637|NCT03138538|101114720|FG003|NOT COMPLETED|Overall Study||0||
48321638|NCT03138538|101114721|FG004|NOT COMPLETED|Overall Study||0||
48321639|NCT03138538|101114722|FG005|NOT COMPLETED|Overall Study||0||
48321640|NCT02006342|101114723|FG000|STARTED|Overall Study||20||
48321641|NCT02006342|101114724|FG001|STARTED|Overall Study||20||
48321642|NCT02006342|101114723|FG000|COMPLETED|Overall Study||19||
48321643|NCT02006342|101114724|FG001|COMPLETED|Overall Study||20||
48321644|NCT02006342|101114723|FG000|NOT COMPLETED|Overall Study||1||
48321645|NCT02006342|101114724|FG001|NOT COMPLETED|Overall Study||0||
48321646|NCT03861559|101114725|FG000|STARTED|Overall Study||101||
48321647|NCT03861559|101114726|FG001|STARTED|Overall Study||100||
48321648|NCT03861559|101114725|FG000|COMPLETED|Overall Study||99||
48321649|NCT03861559|101114726|FG001|COMPLETED|Overall Study||95||
48321650|NCT03861559|101114725|FG000|NOT COMPLETED|Overall Study||2||
48321651|NCT03861559|101114726|FG001|NOT COMPLETED|Overall Study||5||
48321652|NCT00129766|101114727|FG000|STARTED|Overall Study||3306||
48321653|NCT00129766|101114728|FG001|STARTED|Overall Study||3329||
48321654|NCT00129766|101114727|FG000|COMPLETED|Overall Study||3246||
48321655|NCT00129766|101114728|FG001|COMPLETED|Overall Study||3270||
48321656|NCT00129766|101114727|FG000|NOT COMPLETED|Overall Study||60||
48321657|NCT00129766|101114728|FG001|NOT COMPLETED|Overall Study||59||
48321658|NCT02199080|101114729|FG000|STARTED|Overall Study||2506||
48321659|NCT02199080|101114729|FG000|COMPLETED|Overall Study||2494||
48617008|NCT00121719|101849485|FG002|STARTED|Dose Escalation (4 Weeks)||4||
48617009|NCT00121719|101849486|FG003|STARTED|Dose Escalation (4 Weeks)||3||
48617010|NCT00121719|101849487|FG004|STARTED|Dose Escalation (4 Weeks)||3||
48617011|NCT00121719|101849488|FG005|STARTED|Dose Escalation (4 Weeks)||3||
48617012|NCT00121719|101849489|FG006|STARTED|Dose Escalation (4 Weeks)||12||
48617013|NCT00121719|101849490|FG007|STARTED|Dose Escalation (4 Weeks)||9||
48617014|NCT00121719|101849491|FG008|STARTED|Dose Escalation (4 Weeks)||6||
48617015|NCT00121719|101849492|FG009|STARTED|Dose Escalation (4 Weeks)||3||
48321660|NCT02199080|101114729|FG000|NOT COMPLETED|Overall Study||12||
48321661|NCT02915523|101114730|FG000|STARTED|Dose Determination Phase (Phase 1B)||6||
48321662|NCT02915523|101114731|FG001|STARTED|Dose Determination Phase (Phase 1B)||8||
48321663|NCT02915523|101114732|FG002|STARTED|Dose Determination Phase (Phase 1B)||0||
48321664|NCT02915523|101114733|FG003|STARTED|Dose Determination Phase (Phase 1B)||0||
48321665|NCT02915523|101114730|FG000|Received At Least 1 Dose Of Study Drug|Dose Determination Phase (Phase 1B)||6||
48321666|NCT02915523|101114731|FG001|Received At Least 1 Dose Of Study Drug|Dose Determination Phase (Phase 1B)||8||
48321667|NCT02915523|101114732|FG002|Received At Least 1 Dose Of Study Drug|Dose Determination Phase (Phase 1B)||0||
48321668|NCT02915523|101114733|FG003|Received At Least 1 Dose Of Study Drug|Dose Determination Phase (Phase 1B)||0||
48321669|NCT02915523|101114730|FG000|Dose-limiting Toxicity (DLT) Evaluable|Dose Determination Phase (Phase 1B)||6|Participants who received at least one dose of entinostat or avelumab were evaluated for DLTs over 2 cycles (Cycle 1 and Cycle 2).|
48321670|NCT02915523|101114731|FG001|Dose-limiting Toxicity (DLT) Evaluable|Dose Determination Phase (Phase 1B)||8|Participants who received at least one dose of entinostat or avelumab were evaluated for DLTs over 2 cycles (Cycle 1 and Cycle 2).|
48321671|NCT02915523|101114732|FG002|Dose-limiting Toxicity (DLT) Evaluable|Dose Determination Phase (Phase 1B)||0|Participants who received at least one dose of entinostat or avelumab were evaluated for DLTs over 2 cycles (Cycle 1 and Cycle 2).|
48321672|NCT02915523|101114733|FG003|Dose-limiting Toxicity (DLT) Evaluable|Dose Determination Phase (Phase 1B)||0|Participants who received at least one dose of entinostat or avelumab were evaluated for DLTs over 2 cycles (Cycle 1 and Cycle 2).|
48321673|NCT02915523|101114730|FG000|COMPLETED|Dose Determination Phase (Phase 1B)||0||
48321674|NCT02915523|101114731|FG001|COMPLETED|Dose Determination Phase (Phase 1B)||0||
48321675|NCT02915523|101114732|FG002|COMPLETED|Dose Determination Phase (Phase 1B)||0||
48321676|NCT02915523|101114733|FG003|COMPLETED|Dose Determination Phase (Phase 1B)||0||
48321677|NCT02915523|101114730|FG000|NOT COMPLETED|Dose Determination Phase (Phase 1B)||6||
48321678|NCT02915523|101114731|FG001|NOT COMPLETED|Dose Determination Phase (Phase 1B)||8||
48321679|NCT02915523|101114732|FG002|NOT COMPLETED|Dose Determination Phase (Phase 1B)||0||
48321680|NCT02915523|101114733|FG003|NOT COMPLETED|Dose Determination Phase (Phase 1B)||0||
48321681|NCT02915523|101114730|FG000|STARTED|Expansion Phase (Phase 2)||0||
48321682|NCT02915523|101114731|FG001|STARTED|Expansion Phase (Phase 2)||0||
48321683|NCT02915523|101114732|FG002|STARTED|Expansion Phase (Phase 2)||41||
48321684|NCT02915523|101114733|FG003|STARTED|Expansion Phase (Phase 2)||85||
48321685|NCT02915523|101114730|FG000|Received At Least 1 Dose Of Study Drug|Expansion Phase (Phase 2)||0||
48321686|NCT02915523|101114731|FG001|Received At Least 1 Dose Of Study Drug|Expansion Phase (Phase 2)||0||
48321687|NCT02915523|101114732|FG002|Received At Least 1 Dose Of Study Drug|Expansion Phase (Phase 2)||40||
48321688|NCT02915523|101114733|FG003|Received At Least 1 Dose Of Study Drug|Expansion Phase (Phase 2)||85||
48321689|NCT02915523|101114730|FG000|COMPLETED|Expansion Phase (Phase 2)||0||
48321690|NCT02915523|101114731|FG001|COMPLETED|Expansion Phase (Phase 2)||0||
48321691|NCT02915523|101114732|FG002|COMPLETED|Expansion Phase (Phase 2)||5||
48321692|NCT02915523|101114733|FG003|COMPLETED|Expansion Phase (Phase 2)||0||
48321693|NCT02915523|101114730|FG000|NOT COMPLETED|Expansion Phase (Phase 2)||0||
48321694|NCT02915523|101114731|FG001|NOT COMPLETED|Expansion Phase (Phase 2)||0||
48321695|NCT02915523|101114732|FG002|NOT COMPLETED|Expansion Phase (Phase 2)||36||
48321696|NCT02915523|101114733|FG003|NOT COMPLETED|Expansion Phase (Phase 2)||85||
48321697|NCT01118351|101114734|FG000|STARTED|Overall Study||19||
48321698|NCT01118351|101114734|FG000|COMPLETED|Overall Study||15||
48321699|NCT01118351|101114734|FG000|NOT COMPLETED|Overall Study||4||
48321700|NCT00644787|101114735|FG000|STARTED|Period 1: Titration Phase||156||
48321701|NCT00644787|101114736|FG001|STARTED|Period 1: Titration Phase||0||
48321702|NCT00644787|101114737|FG002|STARTED|Period 1: Titration Phase||0||
48321703|NCT00644787|101114735|FG000|COMPLETED|Period 1: Titration Phase||129||
48321704|NCT00644787|101114736|FG001|COMPLETED|Period 1: Titration Phase||0||
48321705|NCT00644787|101114737|FG002|COMPLETED|Period 1: Titration Phase||0||
48321706|NCT00644787|101114735|FG000|NOT COMPLETED|Period 1: Titration Phase||27||
48321707|NCT00644787|101114736|FG001|NOT COMPLETED|Period 1: Titration Phase||0||
48321708|NCT00644787|101114737|FG002|NOT COMPLETED|Period 1: Titration Phase||0||
48321709|NCT00644787|101114735|FG000|STARTED|Period 2: Double Blind Phase||0||
48321710|NCT00644787|101114736|FG001|STARTED|Period 2: Double Blind Phase||58||
48321711|NCT00644787|101114737|FG002|STARTED|Period 2: Double Blind Phase||62||
48321712|NCT00644787|101114735|FG000|COMPLETED|Period 2: Double Blind Phase||0||
48321713|NCT00644787|101114736|FG001|COMPLETED|Period 2: Double Blind Phase||49||
48321714|NCT00644787|101114737|FG002|COMPLETED|Period 2: Double Blind Phase||55||
48321715|NCT00644787|101114735|FG000|NOT COMPLETED|Period 2: Double Blind Phase||0||
48321716|NCT00644787|101114736|FG001|NOT COMPLETED|Period 2: Double Blind Phase||9||
48321717|NCT00644787|101114737|FG002|NOT COMPLETED|Period 2: Double Blind Phase||7||
48321718|NCT02980224|101114738|FG000|STARTED|Overall Study||89||
48321719|NCT02980224|101114739|FG001|STARTED|Overall Study||91||
48321720|NCT02980224|101114738|FG000|COMPLETED|Overall Study||85||
48321721|NCT02980224|101114739|FG001|COMPLETED|Overall Study||88||
48321722|NCT02980224|101114738|FG000|NOT COMPLETED|Overall Study||4||
48321723|NCT02980224|101114739|FG001|NOT COMPLETED|Overall Study||3||
48321724|NCT00258674|101114740|FG000|STARTED|Overall Study||597||
48321725|NCT00258674|101114741|FG001|STARTED|Overall Study||811||
48321726|NCT00258674|101114742|FG002|STARTED|Overall Study||602||
48321727|NCT00258674|101114740|FG000|COMPLETED|Overall Study||565||
48321728|NCT00258674|101114741|FG001|COMPLETED|Overall Study||758||
48321729|NCT00258674|101114742|FG002|COMPLETED|Overall Study||568||
48321730|NCT00258674|101114740|FG000|NOT COMPLETED|Overall Study||32||
48321731|NCT00258674|101114741|FG001|NOT COMPLETED|Overall Study||53||
48321732|NCT00258674|101114742|FG002|NOT COMPLETED|Overall Study||34||
48321733|NCT00137111|101114743|FG000|STARTED|Window Therapy||0||
48321734|NCT00137111|101114744|FG001|STARTED|Window Therapy||176||
48321735|NCT00137111|101114745|FG002|STARTED|Window Therapy||180||
48321736|NCT00137111|101114746|FG003|STARTED|Window Therapy||142||
48321737|NCT00137111|101114743|FG000|COMPLETED|Window Therapy||0||
48321738|NCT00137111|101114744|FG001|COMPLETED|Window Therapy||176||
48321739|NCT00137111|101114745|FG002|COMPLETED|Window Therapy||180||
48321740|NCT00137111|101114746|FG003|COMPLETED|Window Therapy||142||
48321741|NCT00137111|101114743|FG000|NOT COMPLETED|Window Therapy||0||
48321742|NCT00137111|101114744|FG001|NOT COMPLETED|Window Therapy||0||
48321743|NCT00137111|101114745|FG002|NOT COMPLETED|Window Therapy||0||
48321744|NCT00137111|101114746|FG003|NOT COMPLETED|Window Therapy||0||
48321745|NCT00137111|101114743|FG000|STARTED|Total Therapy||498||
48321746|NCT00137111|101114744|FG001|STARTED|Total Therapy||0||
48321747|NCT00137111|101114745|FG002|STARTED|Total Therapy||0||
48321748|NCT00137111|101114746|FG003|STARTED|Total Therapy||0||
48321749|NCT00137111|101114743|FG000|COMPLETED|Total Therapy||458||
48321750|NCT00137111|101114744|FG001|COMPLETED|Total Therapy||0||
48321751|NCT00137111|101114745|FG002|COMPLETED|Total Therapy||0||
48321752|NCT00137111|101114746|FG003|COMPLETED|Total Therapy||0||
48321753|NCT00137111|101114743|FG000|NOT COMPLETED|Total Therapy||40||
48321754|NCT00137111|101114744|FG001|NOT COMPLETED|Total Therapy||0||
48321755|NCT00137111|101114745|FG002|NOT COMPLETED|Total Therapy||0||
48321756|NCT00137111|101114746|FG003|NOT COMPLETED|Total Therapy||0||
48321757|NCT00549172|101114747|FG000|STARTED|Overall Study||70||
48321758|NCT00549172|101114748|FG001|STARTED|Overall Study||76||
48321759|NCT00549172|101114747|FG000|COMPLETED|Overall Study||70||
48321760|NCT00549172|101114748|FG001|COMPLETED|Overall Study||76||
48321761|NCT00549172|101114747|FG000|NOT COMPLETED|Overall Study||0||
48321762|NCT00549172|101114748|FG001|NOT COMPLETED|Overall Study||0||
48321763|NCT00619073|101114749|FG000|STARTED|First Intervention - 60 Days||8||
48321764|NCT00619073|101114750|FG001|STARTED|First Intervention - 60 Days||8||
48321765|NCT00619073|101114749|FG000|COMPLETED|First Intervention - 60 Days||8||
48321766|NCT00619073|101114750|FG001|COMPLETED|First Intervention - 60 Days||8||
48321767|NCT00619073|101114749|FG000|NOT COMPLETED|First Intervention - 60 Days||0||
48321768|NCT00619073|101114750|FG001|NOT COMPLETED|First Intervention - 60 Days||0||
48321769|NCT00619073|101114749|FG000|STARTED|Washout Period (30 Days)||8||
48321770|NCT00619073|101114750|FG001|STARTED|Washout Period (30 Days)||8||
48321771|NCT00619073|101114749|FG000|COMPLETED|Washout Period (30 Days)||8||
48408017|NCT01922986|101331694|FG001|STARTED|Overall Study||2||
48617016|NCT00121719|101849493|FG010|STARTED|Dose Escalation (4 Weeks)||0||
48617017|NCT00121719|101849494|FG011|STARTED|Dose Escalation (4 Weeks)||0||
48617018|NCT00121719|101849495|FG012|STARTED|Dose Escalation (4 Weeks)||24||
48617019|NCT00121719|101849496|FG013|STARTED|Dose Escalation (4 Weeks)||7||
48617020|NCT00121719|101849483|FG000|COMPLETED|Dose Escalation (4 Weeks)||4||
48617021|NCT00121719|101849484|FG001|COMPLETED|Dose Escalation (4 Weeks)||4||
48617022|NCT00121719|101849485|FG002|COMPLETED|Dose Escalation (4 Weeks)||4||
48617023|NCT00121719|101849486|FG003|COMPLETED|Dose Escalation (4 Weeks)||3||
48617024|NCT00121719|101849487|FG004|COMPLETED|Dose Escalation (4 Weeks)||3||
48617025|NCT00121719|101849488|FG005|COMPLETED|Dose Escalation (4 Weeks)||3||
48617026|NCT00121719|101849489|FG006|COMPLETED|Dose Escalation (4 Weeks)||12||
48739732|NCT02333799|102147390|FG000|COMPLETED|7 to 24 Month Follow Up Period||98||
48739733|NCT02333799|102147390|FG000|NOT COMPLETED|7 to 24 Month Follow Up Period||2||
48739734|NCT00714415|102147391|FG000|STARTED|Overall Study||25||
48617027|NCT00121719|101849490|FG007|COMPLETED|Dose Escalation (4 Weeks)||9||
48739735|NCT00714415|102147392|FG001|STARTED|Overall Study||55||
48321772|NCT00619073|101114750|FG001|COMPLETED|Washout Period (30 Days)||8||
48321773|NCT00619073|101114749|FG000|NOT COMPLETED|Washout Period (30 Days)||0||
48321774|NCT00619073|101114750|FG001|NOT COMPLETED|Washout Period (30 Days)||0||
48321775|NCT00619073|101114749|FG000|STARTED|Second Intervention - 60 Days||8||
48321776|NCT00619073|101114750|FG001|STARTED|Second Intervention - 60 Days||8||
48321777|NCT00619073|101114749|FG000|COMPLETED|Second Intervention - 60 Days||8||
48321778|NCT00619073|101114750|FG001|COMPLETED|Second Intervention - 60 Days||8||
48408018|NCT01922986|101331693|FG000|COMPLETED|Overall Study||2||
48617028|NCT00121719|101849491|FG008|COMPLETED|Dose Escalation (4 Weeks)||6||
48617029|NCT00121719|101849492|FG009|COMPLETED|Dose Escalation (4 Weeks)||3||
48617030|NCT00121719|101849493|FG010|COMPLETED|Dose Escalation (4 Weeks)||0||
48739736|NCT00714415|102147391|FG000|COMPLETED|Overall Study||23||
48321779|NCT00619073|101114749|FG000|NOT COMPLETED|Second Intervention - 60 Days||0||
48321780|NCT00619073|101114750|FG001|NOT COMPLETED|Second Intervention - 60 Days||0||
48321781|NCT02284126|101114751|FG000|STARTED|Overall Study||552||
48321782|NCT02284126|101114752|FG001|STARTED|Overall Study||551||
48321783|NCT02284126|101114751|FG000|COMPLETED|Overall Study||484||
48321784|NCT02284126|101114752|FG001|COMPLETED|Overall Study||489||
48321785|NCT02284126|101114751|FG000|NOT COMPLETED|Overall Study||68||
48321786|NCT02284126|101114752|FG001|NOT COMPLETED|Overall Study||62||
48321787|NCT03073980|101114753|FG000|STARTED|Overall Study||53||
48321788|NCT03073980|101114754|FG001|STARTED|Overall Study||54||
48617031|NCT00121719|101849494|FG011|COMPLETED|Dose Escalation (4 Weeks)||0||
48617032|NCT00121719|101849495|FG012|COMPLETED|Dose Escalation (4 Weeks)||24||
48617033|NCT00121719|101849496|FG013|COMPLETED|Dose Escalation (4 Weeks)||7||
48617034|NCT00121719|101849483|FG000|NOT COMPLETED|Dose Escalation (4 Weeks)||0||
48617035|NCT00121719|101849484|FG001|NOT COMPLETED|Dose Escalation (4 Weeks)||0||
48617036|NCT00121719|101849485|FG002|NOT COMPLETED|Dose Escalation (4 Weeks)||0||
48617037|NCT00121719|101849486|FG003|NOT COMPLETED|Dose Escalation (4 Weeks)||0||
48739737|NCT00714415|102147392|FG001|COMPLETED|Overall Study||55||
48739738|NCT00714415|102147391|FG000|NOT COMPLETED|Overall Study||2||
48739739|NCT00714415|102147392|FG001|NOT COMPLETED|Overall Study||0||
48739740|NCT00607087|102147393|FG000|STARTED|Overall Study||99||
48739741|NCT00607087|102147394|FG001|STARTED|Overall Study||95||
48408019|NCT01922986|101331694|FG001|COMPLETED|Overall Study||2||
48408020|NCT01922986|101331693|FG000|NOT COMPLETED|Overall Study||0||
48408021|NCT01922986|101331694|FG001|NOT COMPLETED|Overall Study||0||
48408022|NCT00609167|101331695|FG000|STARTED|Overall Study||33||
48408023|NCT00609167|101331696|FG001|STARTED|Overall Study||30||
48617038|NCT00121719|101849487|FG004|NOT COMPLETED|Dose Escalation (4 Weeks)||0||
48739742|NCT00607087|102147395|FG002|STARTED|Overall Study||94||
48739743|NCT00607087|102147393|FG000|COMPLETED|Overall Study||84||
48739744|NCT00607087|102147394|FG001|COMPLETED|Overall Study||84||
48161273|NCT01741454|100718762|FG002|NOT COMPLETED|Overall Study||17||
48161274|NCT01741454|100718763|FG003|NOT COMPLETED|Overall Study||22||
48161275|NCT01488708|100718764|FG000|STARTED|Overall Study||940||
48161276|NCT01488708|100718765|FG001|STARTED|Overall Study||578||
48161277|NCT01488708|100718764|FG000|Received at Least 1 Dose of Study Drug|Overall Study||937||
48161278|NCT01488708|100718765|FG001|Received at Least 1 Dose of Study Drug|Overall Study||578||
48161279|NCT01488708|100718764|FG000|Participated in Follow Up|Overall Study||810||
48161280|NCT01488708|100718765|FG001|Participated in Follow Up|Overall Study||526||
48161281|NCT01488708|100718764|FG000|COMPLETED|Overall Study||0||
48161282|NCT01488708|100718765|FG001|COMPLETED|Overall Study||0||
48161283|NCT01488708|100718764|FG000|NOT COMPLETED|Overall Study||940||
48617039|NCT00121719|101849488|FG005|NOT COMPLETED|Dose Escalation (4 Weeks)||0||
48617040|NCT00121719|101849489|FG006|NOT COMPLETED|Dose Escalation (4 Weeks)||0||
48617041|NCT00121719|101849490|FG007|NOT COMPLETED|Dose Escalation (4 Weeks)||0||
48617042|NCT00121719|101849491|FG008|NOT COMPLETED|Dose Escalation (4 Weeks)||0||
48617043|NCT00121719|101849492|FG009|NOT COMPLETED|Dose Escalation (4 Weeks)||0||
48617044|NCT00121719|101849493|FG010|NOT COMPLETED|Dose Escalation (4 Weeks)||0||
48739745|NCT00607087|102147395|FG002|COMPLETED|Overall Study||84||
48739746|NCT00607087|102147393|FG000|NOT COMPLETED|Overall Study||15||
48739747|NCT00607087|102147394|FG001|NOT COMPLETED|Overall Study||11||
48739748|NCT00607087|102147395|FG002|NOT COMPLETED|Overall Study||10||
48739749|NCT00607087|102147393|FG000|STARTED|Period 1||99||
48161284|NCT01488708|100718765|FG001|NOT COMPLETED|Overall Study||578||
48161285|NCT02217280|100718766|FG000|STARTED|Overall Study||20||
48161286|NCT02217280|100718766|FG000|COMPLETED|Overall Study||16||
48161287|NCT02217280|100718766|FG000|NOT COMPLETED|Overall Study||4||
48161288|NCT04555096|100718767|FG000|STARTED|Overall Study||9||
48161289|NCT04555096|100718768|FG001|STARTED|Overall Study||7||
48161290|NCT04555096|100718767|FG000|COMPLETED|Overall Study||4||
48161291|NCT04555096|100718768|FG001|COMPLETED|Overall Study||2||
48161292|NCT04555096|100718767|FG000|NOT COMPLETED|Overall Study||5||
48161293|NCT04555096|100718768|FG001|NOT COMPLETED|Overall Study||5||
48161294|NCT00876915|100718769|FG000|STARTED|Overall Study||50||
48161295|NCT00876915|100718770|FG001|STARTED|Overall Study||48||
48161296|NCT00876915|100718771|FG002|STARTED|Overall Study||101||
48161297|NCT00876915|100718769|FG000|Week 4|Overall Study||38||
48161298|NCT00876915|100718770|FG001|Week 4|Overall Study||45||
48161299|NCT00876915|100718771|FG002|Week 4|Overall Study||0||
48161300|NCT00876915|100718769|FG000|Week 8|Overall Study||33||
48161301|NCT00876915|100718770|FG001|Week 8|Overall Study||36||
48161302|NCT00876915|100718771|FG002|Week 8|Overall Study||0||
48161303|NCT00876915|100718769|FG000|COMPLETED|Overall Study||31||
48161304|NCT00876915|100718770|FG001|COMPLETED|Overall Study||34||
48161305|NCT00876915|100718771|FG002|COMPLETED|Overall Study||101||
48161306|NCT00876915|100718769|FG000|NOT COMPLETED|Overall Study||19||
48161307|NCT00876915|100718770|FG001|NOT COMPLETED|Overall Study||14||
48408024|NCT00609167|101331695|FG000|COMPLETED|Overall Study||25||
48408025|NCT00609167|101331696|FG001|COMPLETED|Overall Study||23||
48408026|NCT00609167|101331695|FG000|NOT COMPLETED|Overall Study||8||
48408027|NCT00609167|101331696|FG001|NOT COMPLETED|Overall Study||7||
48408028|NCT01394211|101331697|FG000|STARTED|Overall Study||2||
48739750|NCT00607087|102147394|FG001|STARTED|Period 1||95||
48161308|NCT00876915|100718771|FG002|NOT COMPLETED|Overall Study||0||
48161309|NCT00643123|100718772|FG000|STARTED|Overall Study||15||
48161310|NCT00643123|100718773|FG001|STARTED|Overall Study||12||
48161311|NCT00643123|100718772|FG000|COMPLETED|Overall Study||10||
48161312|NCT00643123|100718773|FG001|COMPLETED|Overall Study||11||
48161313|NCT00643123|100718772|FG000|NOT COMPLETED|Overall Study||5||
48161314|NCT00643123|100718773|FG001|NOT COMPLETED|Overall Study||1||
48408029|NCT01394211|101331697|FG000|COMPLETED|Overall Study||0||
48408030|NCT01394211|101331697|FG000|NOT COMPLETED|Overall Study||2||
48161315|NCT01201811|100718774|FG000|STARTED|Overall Study||44||
48321789|NCT03073980|101114755|FG002|STARTED|Overall Study||54||
48321790|NCT03073980|101114753|FG000|COMPLETED|Overall Study||43||
48321791|NCT03073980|101114754|FG001|COMPLETED|Overall Study||52||
48321792|NCT03073980|101114755|FG002|COMPLETED|Overall Study||43||
48321793|NCT03073980|101114753|FG000|NOT COMPLETED|Overall Study||10||
48321794|NCT03073980|101114754|FG001|NOT COMPLETED|Overall Study||2||
48321795|NCT03073980|101114755|FG002|NOT COMPLETED|Overall Study||11||
48321796|NCT02882633|101114756|FG000|STARTED|Overall Study||25||
48321797|NCT02882633|101114757|FG001|STARTED|Overall Study||25||
48321798|NCT02882633|101114756|FG000|COMPLETED|Overall Study||23||
48321799|NCT02882633|101114757|FG001|COMPLETED|Overall Study||25||
48321800|NCT02882633|101114756|FG000|NOT COMPLETED|Overall Study||2||
48321801|NCT02882633|101114757|FG001|NOT COMPLETED|Overall Study||0||
48321802|NCT01539590|101114758|FG000|STARTED|Overall Study||3||
48739751|NCT00607087|102147395|FG002|STARTED|Period 1||94||
48321803|NCT01539590|101114759|FG001|STARTED|Overall Study||2||
48321804|NCT01539590|101114758|FG000|Complete Study Treatment|Overall Study||1||
48321805|NCT01539590|101114759|FG001|Complete Study Treatment|Overall Study||2||
48321806|NCT01539590|101114758|FG000|COMPLETED|Overall Study||0||
48321807|NCT01539590|101114759|FG001|COMPLETED|Overall Study||2||
48321808|NCT01539590|101114758|FG000|NOT COMPLETED|Overall Study||3||
48739752|NCT00607087|102147393|FG000|COMPLETED|Period 1||87||
48739753|NCT00607087|102147394|FG001|COMPLETED|Period 1||89||
48739754|NCT00607087|102147395|FG002|COMPLETED|Period 1||89||
48739755|NCT00607087|102147393|FG000|NOT COMPLETED|Period 1||12||
48739756|NCT00607087|102147394|FG001|NOT COMPLETED|Period 1||6||
48321809|NCT01539590|101114759|FG001|NOT COMPLETED|Overall Study||0||
48321810|NCT02287623|101114760|FG000|STARTED|Overall Study||30||
48321811|NCT02287623|101114761|FG001|STARTED|Overall Study||30||
48321812|NCT02287623|101114760|FG000|COMPLETED|Overall Study||30||
48321813|NCT02287623|101114761|FG001|COMPLETED|Overall Study||29||
48739757|NCT00607087|102147395|FG002|NOT COMPLETED|Period 1||5||
48739758|NCT00607087|102147393|FG000|STARTED|Period 2||87||
48739759|NCT00607087|102147394|FG001|STARTED|Period 2||89||
48739760|NCT00607087|102147395|FG002|STARTED|Period 2||89||
48739761|NCT00607087|102147393|FG000|COMPLETED|Period 2||86||
48739762|NCT00607087|102147394|FG001|COMPLETED|Period 2||86||
48321814|NCT02287623|101114760|FG000|NOT COMPLETED|Overall Study||0||
48321815|NCT02287623|101114761|FG001|NOT COMPLETED|Overall Study||1||
48739763|NCT00607087|102147395|FG002|COMPLETED|Period 2||84||
48739764|NCT00607087|102147393|FG000|NOT COMPLETED|Period 2||1||
48739765|NCT00607087|102147394|FG001|NOT COMPLETED|Period 2||3||
48739766|NCT00607087|102147395|FG002|NOT COMPLETED|Period 2||5||
48739767|NCT00607087|102147393|FG000|STARTED|Period 3||86||
48739768|NCT00607087|102147394|FG001|STARTED|Period 3||86||
48739769|NCT00607087|102147395|FG002|STARTED|Period 3||84||
48321816|NCT02656485|101114762|FG000|STARTED|Overall Study||9||
48321817|NCT02656485|101114763|FG001|STARTED|Overall Study||9||
48321818|NCT02656485|101114764|FG002|STARTED|Overall Study||9||
48321819|NCT02656485|101114765|FG003|STARTED|Overall Study||9||
48739770|NCT00607087|102147393|FG000|COMPLETED|Period 3||84||
48739771|NCT00607087|102147394|FG001|COMPLETED|Period 3||84||
48739772|NCT00607087|102147395|FG002|COMPLETED|Period 3||84||
48739773|NCT00607087|102147393|FG000|NOT COMPLETED|Period 3||2||
48739774|NCT00607087|102147394|FG001|NOT COMPLETED|Period 3||2||
48739775|NCT00607087|102147395|FG002|NOT COMPLETED|Period 3||0||
48739776|NCT03549104|102147396|FG000|STARTED|Overall Study||25||
48739777|NCT03549104|102147397|FG001|STARTED|Overall Study||25||
48739778|NCT03549104|102147396|FG000|COMPLETED|Overall Study||19||
48739779|NCT03549104|102147397|FG001|COMPLETED|Overall Study||21||
48321820|NCT02656485|101114762|FG000|COMPLETED|Overall Study||7||
48321821|NCT02656485|101114763|FG001|COMPLETED|Overall Study||6||
48321822|NCT02656485|101114764|FG002|COMPLETED|Overall Study||7||
48321823|NCT02656485|101114765|FG003|COMPLETED|Overall Study||7||
48321824|NCT02656485|101114762|FG000|NOT COMPLETED|Overall Study||2||
48321825|NCT02656485|101114763|FG001|NOT COMPLETED|Overall Study||3||
48321826|NCT02656485|101114764|FG002|NOT COMPLETED|Overall Study||2||
48739780|NCT03549104|102147396|FG000|NOT COMPLETED|Overall Study||6||
48321827|NCT02656485|101114765|FG003|NOT COMPLETED|Overall Study||2||
48321828|NCT04096274|101114766|FG000|STARTED|Phase I||117||11
48321829|NCT04096274|101114767|FG001|STARTED|Phase I||117||10
48321830|NCT04096274|101114766|FG000|COMPLETED|Phase I||112||10
48321831|NCT04096274|101114767|FG001|COMPLETED|Phase I||112||8
48739781|NCT03549104|102147397|FG001|NOT COMPLETED|Overall Study||4||
48739782|NCT03600740|102147398|FG000|STARTED|Overall Study||1||
48739783|NCT03600740|102147398|FG000|COMPLETED|Overall Study||0||
48739784|NCT03600740|102147398|FG000|NOT COMPLETED|Overall Study||1||
48739785|NCT01219985|102147399|FG000|STARTED|Overall Study||50||
48739786|NCT01219985|102147399|FG000|COMPLETED|Overall Study||30||
48739787|NCT01219985|102147399|FG000|NOT COMPLETED|Overall Study||20||
48739788|NCT04240574|102147400|FG000|STARTED|Overall Study||2||
48739789|NCT04240574|102147400|FG000|COMPLETED|Overall Study||2||
48739790|NCT04240574|102147400|FG000|NOT COMPLETED|Overall Study||0||
48739791|NCT00935311|102147401|FG000|STARTED|Overall Study||43||
48739792|NCT00935311|102147402|FG001|STARTED|Overall Study||39||
48739793|NCT00935311|102147403|FG002|STARTED|Overall Study||40||
48739794|NCT00935311|102147401|FG000|COMPLETED|Overall Study||43||
48739795|NCT00935311|102147402|FG001|COMPLETED|Overall Study||39||
48739796|NCT00935311|102147403|FG002|COMPLETED|Overall Study||40||
48739797|NCT00935311|102147401|FG000|NOT COMPLETED|Overall Study||0||
48739798|NCT00935311|102147402|FG001|NOT COMPLETED|Overall Study||0||
48739799|NCT00935311|102147403|FG002|NOT COMPLETED|Overall Study||0||
48739800|NCT01077401|102147404|FG000|STARTED|Overall Study||77||
48321832|NCT04096274|101114766|FG000|NOT COMPLETED|Phase I||5||1
48321833|NCT04096274|101114767|FG001|NOT COMPLETED|Phase I||5||2
48321834|NCT04096274|101114766|FG000|STARTED|Phase II||269||11
48321835|NCT04096274|101114767|FG001|STARTED|Phase II||183||8
48321836|NCT04096274|101114766|FG000|COMPLETED|Phase II||258||10
48321837|NCT04096274|101114767|FG001|COMPLETED|Phase II||172||8
48321838|NCT04096274|101114766|FG000|NOT COMPLETED|Phase II||11||1
48321839|NCT04096274|101114767|FG001|NOT COMPLETED|Phase II||11||0
48321840|NCT00457015|101114768|FG000|STARTED|Overall Study||48||
48321841|NCT00457015|101114769|FG001|STARTED|Overall Study||48||
48321842|NCT00457015|101114768|FG000|COMPLETED|Overall Study||48||
48739801|NCT01077401|102147405|FG001|STARTED|Overall Study||75||
48739802|NCT01077401|102147404|FG000|COMPLETED|Overall Study||59||
48739803|NCT01077401|102147405|FG001|COMPLETED|Overall Study||54||
48739804|NCT01077401|102147404|FG000|NOT COMPLETED|Overall Study||18||
48739805|NCT01077401|102147405|FG001|NOT COMPLETED|Overall Study||21||
48321843|NCT00457015|101114769|FG001|COMPLETED|Overall Study||47||
48321844|NCT00457015|101114768|FG000|NOT COMPLETED|Overall Study||0||
48321845|NCT00457015|101114769|FG001|NOT COMPLETED|Overall Study||1||
48321846|NCT03099187|101114770|FG000|STARTED|Double-blind Treatment||127||
48321847|NCT03099187|101114771|FG001|STARTED|Double-blind Treatment||126||
48321848|NCT03099187|101114772|FG002|STARTED|Double-blind Treatment||0||
48739806|NCT05717400|102147406|FG000|STARTED|Overall Study||2||
48739807|NCT05717400|102147406|FG000|COMPLETED|Overall Study||2||
48739808|NCT05717400|102147406|FG000|NOT COMPLETED|Overall Study||0||
48739809|NCT01288989|102147407|FG000|STARTED|Overall Study||6||
48321849|NCT03099187|101114773|FG003|STARTED|Double-blind Treatment||0||
48321850|NCT03099187|101114770|FG000|COMPLETED|Double-blind Treatment||94||
48321851|NCT03099187|101114771|FG001|COMPLETED|Double-blind Treatment||110||
48321852|NCT03099187|101114772|FG002|COMPLETED|Double-blind Treatment||0||
48321853|NCT03099187|101114773|FG003|COMPLETED|Double-blind Treatment||0||
48739810|NCT01288989|102147408|FG001|STARTED|Overall Study||3||
48739811|NCT01288989|102147409|FG002|STARTED|Overall Study||3||
48739812|NCT01288989|102147410|FG003|STARTED|Overall Study||11||
48739813|NCT01288989|102147411|FG004|STARTED|Overall Study||21||
48321854|NCT03099187|101114770|FG000|NOT COMPLETED|Double-blind Treatment||33||
48321855|NCT03099187|101114771|FG001|NOT COMPLETED|Double-blind Treatment||16||
48321856|NCT03099187|101114772|FG002|NOT COMPLETED|Double-blind Treatment||0||
48321857|NCT03099187|101114773|FG003|NOT COMPLETED|Double-blind Treatment||0||
48321858|NCT03099187|101114770|FG000|STARTED|12-month Safety Follow-up||0||
48321859|NCT03099187|101114771|FG001|STARTED|12-month Safety Follow-up||0||
48739814|NCT01288989|102147407|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
48739815|NCT01288989|102147408|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3||
48739816|NCT01288989|102147409|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
48739817|NCT01288989|102147410|FG003|Received at Least 1 Dose of Study Drug|Overall Study||11||
48739818|NCT01288989|102147411|FG004|Received at Least 1 Dose of Study Drug|Overall Study||21||
48739819|NCT01288989|102147407|FG000|COMPLETED|Overall Study||5||
48739820|NCT01288989|102147408|FG001|COMPLETED|Overall Study||3||
48739821|NCT01288989|102147409|FG002|COMPLETED|Overall Study||3||
48739822|NCT01288989|102147410|FG003|COMPLETED|Overall Study||10||
48739823|NCT01288989|102147411|FG004|COMPLETED|Overall Study||15||
48739824|NCT01288989|102147407|FG000|NOT COMPLETED|Overall Study||1||
48739825|NCT01288989|102147408|FG001|NOT COMPLETED|Overall Study||0||
48321860|NCT03099187|101114772|FG002|STARTED|12-month Safety Follow-up||94||
48321861|NCT03099187|101114773|FG003|STARTED|12-month Safety Follow-up||110||
48321862|NCT03099187|101114770|FG000|COMPLETED|12-month Safety Follow-up||0||
48739826|NCT01288989|102147409|FG002|NOT COMPLETED|Overall Study||0||
48321863|NCT03099187|101114771|FG001|COMPLETED|12-month Safety Follow-up||0||
48321864|NCT03099187|101114772|FG002|COMPLETED|12-month Safety Follow-up||75||
48321865|NCT03099187|101114773|FG003|COMPLETED|12-month Safety Follow-up||84||
48321866|NCT03099187|101114770|FG000|NOT COMPLETED|12-month Safety Follow-up||0||
48321867|NCT03099187|101114771|FG001|NOT COMPLETED|12-month Safety Follow-up||0||
48321868|NCT03099187|101114772|FG002|NOT COMPLETED|12-month Safety Follow-up||19||
48321869|NCT03099187|101114773|FG003|NOT COMPLETED|12-month Safety Follow-up||26||
48321870|NCT01468584|101114774|FG000|STARTED|Overall Study||10||
48321871|NCT01468584|101114774|FG000|COMPLETED|Overall Study||10||
48321872|NCT01468584|101114774|FG000|NOT COMPLETED|Overall Study||0||
48321873|NCT00371865|101114775|FG000|STARTED|Overall Study||57||
48321874|NCT00371865|101114776|FG001|STARTED|Overall Study||57||
48321875|NCT00371865|101114775|FG000|COMPLETED|Overall Study||42||
48321876|NCT00371865|101114776|FG001|COMPLETED|Overall Study||43||
48321877|NCT00371865|101114775|FG000|NOT COMPLETED|Overall Study||15||
48321878|NCT00371865|101114776|FG001|NOT COMPLETED|Overall Study||14||
48321879|NCT01006265|101114777|FG000|STARTED|Overall Study||119||
48321880|NCT01006265|101114778|FG001|STARTED|Overall Study||116||
48321881|NCT01006265|101114779|FG002|STARTED|Overall Study||108||
48321882|NCT01006265|101114780|FG003|STARTED|Overall Study||121||
48321883|NCT01006265|101114777|FG000|Treated|Overall Study||119||
48321884|NCT01006265|101114778|FG001|Treated|Overall Study||114||
48321885|NCT01006265|101114779|FG002|Treated|Overall Study||108||
48321886|NCT01006265|101114780|FG003|Treated|Overall Study||121||
48321887|NCT01006265|101114777|FG000|COMPLETED|Overall Study||113||
48321888|NCT01006265|101114778|FG001|COMPLETED|Overall Study||107||
48321889|NCT01006265|101114779|FG002|COMPLETED|Overall Study||99||
48321890|NCT01006265|101114780|FG003|COMPLETED|Overall Study||116||
48321891|NCT01006265|101114777|FG000|NOT COMPLETED|Overall Study||6||
48321892|NCT01006265|101114778|FG001|NOT COMPLETED|Overall Study||9||
48321893|NCT01006265|101114779|FG002|NOT COMPLETED|Overall Study||9||
48321894|NCT01006265|101114780|FG003|NOT COMPLETED|Overall Study||5||
48321895|NCT04288154|101114781|FG000|STARTED|Overall Study||46||
48321896|NCT04288154|101114782|FG001|STARTED|Overall Study||32||
48321897|NCT04288154|101114781|FG000|COMPLETED|Overall Study||37||
48321898|NCT04288154|101114782|FG001|COMPLETED|Overall Study||23||
48321899|NCT04288154|101114781|FG000|NOT COMPLETED|Overall Study||9||
48739827|NCT01288989|102147410|FG003|NOT COMPLETED|Overall Study||1||
48739828|NCT01288989|102147411|FG004|NOT COMPLETED|Overall Study||6||
48739829|NCT00291018|102147412|FG000|STARTED|Overall Study||103||
48321900|NCT04288154|101114782|FG001|NOT COMPLETED|Overall Study||9||
48739830|NCT00291018|102147413|FG001|STARTED|Overall Study||106||
48739831|NCT00291018|102147414|FG002|STARTED|Overall Study||136||
48739832|NCT00291018|102147412|FG000|Evaluated at 24 Months|Overall Study||99||
48321901|NCT01277549|101114783|FG000|STARTED|Overall Study||41||
48321902|NCT01277549|101114784|FG001|STARTED|Overall Study||29||
48321903|NCT01277549|101114783|FG000|COMPLETED|Overall Study||15||
48321904|NCT01277549|101114784|FG001|COMPLETED|Overall Study||15||
48321905|NCT01277549|101114783|FG000|NOT COMPLETED|Overall Study||26||
48321906|NCT01277549|101114784|FG001|NOT COMPLETED|Overall Study||14||
48321907|NCT01627899|101114785|FG000|STARTED|Overall Study||5||
48321908|NCT01627899|101114785|FG000|COMPLETED|Overall Study||0||
48321909|NCT01627899|101114785|FG000|NOT COMPLETED|Overall Study||5||
48321910|NCT01211600|101114786|FG000|STARTED|Overall Study||370||
48321911|NCT01211600|101114787|FG001|STARTED|Overall Study||376||
48321912|NCT01211600|101114786|FG000|COMPLETED|Overall Study||370||
48321913|NCT01211600|101114787|FG001|COMPLETED|Overall Study||376||
48321914|NCT01211600|101114786|FG000|NOT COMPLETED|Overall Study||0||
48321915|NCT01211600|101114787|FG001|NOT COMPLETED|Overall Study||0||
48321916|NCT00283075|101114788|FG000|STARTED|Overall Study||25||
48321917|NCT00283075|101114789|FG001|STARTED|Overall Study||6||
48321918|NCT00283075|101114788|FG000|COMPLETED|Overall Study||25||
48321919|NCT00283075|101114789|FG001|COMPLETED|Overall Study||6||
48321920|NCT00283075|101114788|FG000|NOT COMPLETED|Overall Study||0||
48321921|NCT00283075|101114789|FG001|NOT COMPLETED|Overall Study||0||
48739833|NCT00291018|102147413|FG001|Evaluated at 24 Months|Overall Study||92||
48739834|NCT00291018|102147414|FG002|Evaluated at 24 Months|Overall Study||105||
48739835|NCT00291018|102147412|FG000|COMPLETED|Overall Study||78||
48739836|NCT00291018|102147413|FG001|COMPLETED|Overall Study||64||
48617045|NCT00121719|101849494|FG011|NOT COMPLETED|Dose Escalation (4 Weeks)||0||
48617046|NCT00121719|101849495|FG012|NOT COMPLETED|Dose Escalation (4 Weeks)||0||
48617047|NCT00121719|101849496|FG013|NOT COMPLETED|Dose Escalation (4 Weeks)||0||
48617048|NCT00121719|101849483|FG000|STARTED|Food-Effect Pilot Study (4 Weeks)||0||
48321922|NCT03116698|101114790|FG000|STARTED|Overall Study||62||
48321923|NCT03116698|101114791|FG001|STARTED|Overall Study||57||
48321924|NCT03116698|101114792|FG002|STARTED|Overall Study||62||
48617049|NCT00121719|101849484|FG001|STARTED|Food-Effect Pilot Study (4 Weeks)||0||
48739837|NCT00291018|102147414|FG002|COMPLETED|Overall Study||93||
48739838|NCT00291018|102147412|FG000|NOT COMPLETED|Overall Study||25||
48739839|NCT00291018|102147413|FG001|NOT COMPLETED|Overall Study||42||
48739840|NCT00291018|102147414|FG002|NOT COMPLETED|Overall Study||43||
48739841|NCT02023996|102147415|FG000|STARTED|Overall Study||42||
48739842|NCT02023996|102147415|FG000|COMPLETED|Overall Study||36||
48739843|NCT02023996|102147415|FG000|NOT COMPLETED|Overall Study||6||
48739844|NCT00592904|102147416|FG000|STARTED|Overall Study||57||
48739845|NCT00592904|102147417|FG001|STARTED|Overall Study||148||
48739846|NCT00592904|102147418|FG002|STARTED|Overall Study||27||
48739847|NCT00592904|102147419|FG003|STARTED|Overall Study||30||
48739848|NCT00592904|102147416|FG000|COMPLETED|Overall Study||32||
48321925|NCT03116698|101114793|FG003|STARTED|Overall Study||57||
48321926|NCT03116698|101114790|FG000|COMPLETED|Overall Study||56||
48321927|NCT03116698|101114791|FG001|COMPLETED|Overall Study||51||
48321928|NCT03116698|101114792|FG002|COMPLETED|Overall Study||54||
48321929|NCT03116698|101114793|FG003|COMPLETED|Overall Study||55||
48321930|NCT03116698|101114790|FG000|NOT COMPLETED|Overall Study||6||
48321931|NCT03116698|101114791|FG001|NOT COMPLETED|Overall Study||6||
48321932|NCT03116698|101114792|FG002|NOT COMPLETED|Overall Study||8||
48321933|NCT03116698|101114793|FG003|NOT COMPLETED|Overall Study||2||
48321934|NCT01997411|101114794|FG000|STARTED|Overall Study||6||
48321935|NCT01997411|101114795|FG001|STARTED|Overall Study||6||
48321936|NCT01997411|101114796|FG002|STARTED|Overall Study||6||
48321937|NCT01997411|101114797|FG003|STARTED|Overall Study||6||
48321938|NCT01997411|101114798|FG004|STARTED|Overall Study||6||
48321939|NCT01997411|101114799|FG005|STARTED|Overall Study||6||
48321940|NCT01997411|101114800|FG006|STARTED|Overall Study||6||
48617050|NCT00121719|101849485|FG002|STARTED|Food-Effect Pilot Study (4 Weeks)||0||
48617051|NCT00121719|101849486|FG003|STARTED|Food-Effect Pilot Study (4 Weeks)||0||
48617052|NCT00121719|101849487|FG004|STARTED|Food-Effect Pilot Study (4 Weeks)||0||
48617053|NCT00121719|101849488|FG005|STARTED|Food-Effect Pilot Study (4 Weeks)||0||
48617054|NCT00121719|101849489|FG006|STARTED|Food-Effect Pilot Study (4 Weeks)||0||
48617055|NCT00121719|101849490|FG007|STARTED|Food-Effect Pilot Study (4 Weeks)||0||
48739849|NCT00592904|102147417|FG001|COMPLETED|Overall Study||93||
48739850|NCT00592904|102147418|FG002|COMPLETED|Overall Study||10||
48739851|NCT00592904|102147419|FG003|COMPLETED|Overall Study||19||
48739852|NCT00592904|102147416|FG000|NOT COMPLETED|Overall Study||25||
48321941|NCT01997411|101114801|FG007|STARTED|Overall Study||6||
48321942|NCT01997411|101114794|FG000|COMPLETED|Overall Study||6||
48321943|NCT01997411|101114795|FG001|COMPLETED|Overall Study||6||
48321944|NCT01997411|101114796|FG002|COMPLETED|Overall Study||6||
48321945|NCT01997411|101114797|FG003|COMPLETED|Overall Study||6||
48321946|NCT01997411|101114798|FG004|COMPLETED|Overall Study||6||
48321947|NCT01997411|101114799|FG005|COMPLETED|Overall Study||5||
48321948|NCT01997411|101114800|FG006|COMPLETED|Overall Study||6||
48321949|NCT01997411|101114801|FG007|COMPLETED|Overall Study||6||
48321950|NCT01997411|101114794|FG000|NOT COMPLETED|Overall Study||0||
48321951|NCT01997411|101114795|FG001|NOT COMPLETED|Overall Study||0||
48321952|NCT01997411|101114796|FG002|NOT COMPLETED|Overall Study||0||
48321953|NCT01997411|101114797|FG003|NOT COMPLETED|Overall Study||0||
48739853|NCT00592904|102147417|FG001|NOT COMPLETED|Overall Study||55||
48739854|NCT00592904|102147418|FG002|NOT COMPLETED|Overall Study||17||
48739855|NCT00592904|102147419|FG003|NOT COMPLETED|Overall Study||11||
48739856|NCT00780416|102147420|FG000|STARTED|Overall Study||126||
48321954|NCT01997411|101114798|FG004|NOT COMPLETED|Overall Study||0||
48408031|NCT02159768|101331698|FG000|STARTED|Overall Study||30||
48408032|NCT02159768|101331698|FG000|COMPLETED|Overall Study||30||
48408033|NCT02159768|101331698|FG000|NOT COMPLETED|Overall Study||0||
48408034|NCT03745989|101331699|FG000|STARTED|Overall Study||3||
48408035|NCT03745989|101331700|FG001|STARTED|Overall Study||12||
48408036|NCT03745989|101331701|FG002|STARTED|Overall Study||15||
48408037|NCT03745989|101331699|FG000|COMPLETED|Overall Study||0||
48408038|NCT03745989|101331700|FG001|COMPLETED|Overall Study||0||
48408039|NCT03745989|101331701|FG002|COMPLETED|Overall Study||0||
48408040|NCT03745989|101331699|FG000|NOT COMPLETED|Overall Study||3||
48408041|NCT03745989|101331700|FG001|NOT COMPLETED|Overall Study||12||
48408042|NCT03745989|101331701|FG002|NOT COMPLETED|Overall Study||15||
48408043|NCT02252588|101331702|FG000|STARTED|Overall Study||24||
48408044|NCT02252588|101331703|FG001|STARTED|Overall Study||20||
48408045|NCT02252588|101331702|FG000|COMPLETED|Overall Study||20||
48408046|NCT02252588|101331703|FG001|COMPLETED|Overall Study||20||
48408047|NCT02252588|101331702|FG000|NOT COMPLETED|Overall Study||4||
48408048|NCT02252588|101331703|FG001|NOT COMPLETED|Overall Study||0||
48408049|NCT00471315|101331704|FG000|STARTED|Overall Study||18||
48408050|NCT00471315|101331704|FG000|COMPLETED|Overall Study||10||
48408051|NCT00471315|101331704|FG000|NOT COMPLETED|Overall Study||8||
48408052|NCT00732654|101331705|FG000|STARTED|Overall Study||10||
48408053|NCT00732654|101331706|FG001|STARTED|Overall Study||10||
48408054|NCT00732654|101331707|FG002|STARTED|Overall Study||10||
48408055|NCT00732654|101331705|FG000|COMPLETED|Overall Study||10||
48408056|NCT00732654|101331706|FG001|COMPLETED|Overall Study||9||
48408057|NCT00732654|101331707|FG002|COMPLETED|Overall Study||10||
48408058|NCT00732654|101331705|FG000|NOT COMPLETED|Overall Study||0||
48408059|NCT00732654|101331706|FG001|NOT COMPLETED|Overall Study||1||
48408060|NCT00732654|101331707|FG002|NOT COMPLETED|Overall Study||0||
48408061|NCT02040298|101331708|FG000|STARTED|First Intervention (3 Months)||25||
48408062|NCT02040298|101331709|FG001|STARTED|First Intervention (3 Months)||25||
48408063|NCT02040298|101331708|FG000|COMPLETED|First Intervention (3 Months)||25||
48408064|NCT02040298|101331709|FG001|COMPLETED|First Intervention (3 Months)||25||
48408065|NCT02040298|101331708|FG000|NOT COMPLETED|First Intervention (3 Months)||0||
48408066|NCT02040298|101331709|FG001|NOT COMPLETED|First Intervention (3 Months)||0||
48408067|NCT02040298|101331708|FG000|STARTED|Second Intervention (2 Months)||25||
48408068|NCT02040298|101331709|FG001|STARTED|Second Intervention (2 Months)||25||
48408069|NCT02040298|101331708|FG000|COMPLETED|Second Intervention (2 Months)||25||
48408070|NCT02040298|101331709|FG001|COMPLETED|Second Intervention (2 Months)||25||
48408071|NCT02040298|101331708|FG000|NOT COMPLETED|Second Intervention (2 Months)||0||
48408072|NCT02040298|101331709|FG001|NOT COMPLETED|Second Intervention (2 Months)||0||
48408073|NCT04358991|101331710|FG000|STARTED|Overall Study||20||
48408074|NCT04358991|101331710|FG000|COMPLETED|Overall Study||20||
48408075|NCT04358991|101331710|FG000|NOT COMPLETED|Overall Study||0||
48408076|NCT02038790|101331711|FG000|STARTED|Day 0 - First Treatment||16||
48408077|NCT02038790|101331712|FG001|STARTED|Day 0 - First Treatment||17||
48408078|NCT02038790|101331711|FG000|COMPLETED|Day 0 - First Treatment||15||
48408079|NCT02038790|101331712|FG001|COMPLETED|Day 0 - First Treatment||16||
48408080|NCT02038790|101331711|FG000|NOT COMPLETED|Day 0 - First Treatment||1||
48408081|NCT02038790|101331712|FG001|NOT COMPLETED|Day 0 - First Treatment||1||
48408082|NCT02038790|101331711|FG000|STARTED|Day 1 - Second Treatment||15||
48408083|NCT02038790|101331712|FG001|STARTED|Day 1 - Second Treatment||16||
48408084|NCT02038790|101331711|FG000|COMPLETED|Day 1 - Second Treatment||15||
48408085|NCT02038790|101331712|FG001|COMPLETED|Day 1 - Second Treatment||16||
48408086|NCT02038790|101331711|FG000|NOT COMPLETED|Day 1 - Second Treatment||0||
48408087|NCT02038790|101331712|FG001|NOT COMPLETED|Day 1 - Second Treatment||0||
48408088|NCT00952419|101331713|FG000|STARTED|Overall Study||215||
48408089|NCT00952419|101331714|FG001|STARTED|Overall Study||208||
48408090|NCT00952419|101331715|FG002|STARTED|Overall Study||51||
48408091|NCT00952419|101331713|FG000|COMPLETED|Overall Study||209||
48408092|NCT00952419|101331714|FG001|COMPLETED|Overall Study||198||
48408093|NCT00952419|101331715|FG002|COMPLETED|Overall Study||51||
48408094|NCT00952419|101331713|FG000|NOT COMPLETED|Overall Study||6||
48408095|NCT00952419|101331714|FG001|NOT COMPLETED|Overall Study||10||
48408096|NCT00952419|101331715|FG002|NOT COMPLETED|Overall Study||0||
48408097|NCT01547806|101331716|FG000|STARTED|Overall Study||49||
48408098|NCT01547806|101331716|FG000|COMPLETED|Overall Study||49||
48408099|NCT01547806|101331716|FG000|NOT COMPLETED|Overall Study||0||
48408100|NCT01044056|101331717|FG000|STARTED|Overall Study||8||
48408101|NCT01044056|101331718|FG001|STARTED|Overall Study||8||
48408102|NCT01044056|101331719|FG002|STARTED|Overall Study||8||
48408103|NCT01044056|101331717|FG000|COMPLETED|Overall Study||8||
48408104|NCT01044056|101331718|FG001|COMPLETED|Overall Study||8||
48408105|NCT01044056|101331719|FG002|COMPLETED|Overall Study||8||
48408106|NCT01044056|101331717|FG000|NOT COMPLETED|Overall Study||0||
48408107|NCT01044056|101331718|FG001|NOT COMPLETED|Overall Study||0||
48408108|NCT01044056|101331719|FG002|NOT COMPLETED|Overall Study||0||
48408109|NCT01425307|101331720|FG000|STARTED|Overall Study||61||
48408110|NCT01425307|101331721|FG001|STARTED|Overall Study||60||
48408111|NCT01425307|101331720|FG000|COMPLETED|Overall Study||42||
48408112|NCT01425307|101331721|FG001|COMPLETED|Overall Study||41||
48408113|NCT01425307|101331720|FG000|NOT COMPLETED|Overall Study||19||
48739857|NCT00780416|102147421|FG001|STARTED|Overall Study||63||
48739858|NCT00780416|102147420|FG000|COMPLETED|Overall Study||114||
48739859|NCT00780416|102147421|FG001|COMPLETED|Overall Study||54||
48739860|NCT00780416|102147420|FG000|NOT COMPLETED|Overall Study||12||
48739861|NCT00780416|102147421|FG001|NOT COMPLETED|Overall Study||9||
48739862|NCT04759157|102147422|FG000|STARTED|Overall Study||20||
48739863|NCT04759157|102147423|FG001|STARTED|Overall Study||20||
48739864|NCT04759157|102147424|FG002|STARTED|Overall Study||17||
48739865|NCT04759157|102147425|FG003|STARTED|Overall Study||17||
48739866|NCT04759157|102147422|FG000|COMPLETED|Overall Study||20||
48739867|NCT04759157|102147423|FG001|COMPLETED|Overall Study||20||
48739868|NCT04759157|102147424|FG002|COMPLETED|Overall Study||17||
48739869|NCT04759157|102147425|FG003|COMPLETED|Overall Study||17||
48739870|NCT04759157|102147422|FG000|NOT COMPLETED|Overall Study||0||
48739871|NCT04759157|102147423|FG001|NOT COMPLETED|Overall Study||0||
48739872|NCT04759157|102147424|FG002|NOT COMPLETED|Overall Study||0||
48739873|NCT04759157|102147425|FG003|NOT COMPLETED|Overall Study||0||
48739874|NCT01332253|102147426|FG000|STARTED|Overall Study||82||
48739875|NCT01332253|102147427|FG001|STARTED|Overall Study||79||
48739876|NCT01332253|102147426|FG000|COMPLETED|Overall Study||82||
48161316|NCT01201811|100718774|FG000|COMPLETED|Overall Study||25||
48161317|NCT01201811|100718774|FG000|NOT COMPLETED|Overall Study||19||
48161318|NCT03728608|100718775|FG000|STARTED|Overall Study||76||
48321955|NCT01997411|101114799|FG005|NOT COMPLETED|Overall Study||1||
48321956|NCT01997411|101114800|FG006|NOT COMPLETED|Overall Study||0||
48321957|NCT01997411|101114801|FG007|NOT COMPLETED|Overall Study||0||
48321958|NCT00794677|101114802|FG000|STARTED|First Intervention||13||
48321959|NCT00794677|101114803|FG001|STARTED|First Intervention||13||
48321960|NCT00794677|101114802|FG000|COMPLETED|First Intervention||11||
48321961|NCT00794677|101114803|FG001|COMPLETED|First Intervention||13||
48321962|NCT00794677|101114802|FG000|NOT COMPLETED|First Intervention||2||
48321963|NCT00794677|101114803|FG001|NOT COMPLETED|First Intervention||0||
48321964|NCT00794677|101114802|FG000|STARTED|Second Intervention||11||
48321965|NCT00794677|101114803|FG001|STARTED|Second Intervention||13||
48321966|NCT00794677|101114802|FG000|COMPLETED|Second Intervention||11||
48321967|NCT00794677|101114803|FG001|COMPLETED|Second Intervention||13||
48321968|NCT00794677|101114802|FG000|NOT COMPLETED|Second Intervention||0||
48321969|NCT00794677|101114803|FG001|NOT COMPLETED|Second Intervention||0||
48321970|NCT02210065|101114804|FG000|STARTED|Overall Study||1||
48321971|NCT02210065|101114804|FG000|COMPLETED|Overall Study||1||
48321972|NCT02210065|101114804|FG000|NOT COMPLETED|Overall Study||0||
48321973|NCT01230307|101114805|FG000|STARTED|Overall Study||6||
48321974|NCT01230307|101114806|FG001|STARTED|Overall Study||6||
48321975|NCT01230307|101114805|FG000|COMPLETED|Overall Study||6||
48321976|NCT01230307|101114806|FG001|COMPLETED|Overall Study||4||
48321977|NCT01230307|101114805|FG000|NOT COMPLETED|Overall Study||0||
48321978|NCT01230307|101114806|FG001|NOT COMPLETED|Overall Study||2||
48739877|NCT01332253|102147427|FG001|COMPLETED|Overall Study||79||
48739878|NCT01332253|102147426|FG000|NOT COMPLETED|Overall Study||0||
48739879|NCT01332253|102147427|FG001|NOT COMPLETED|Overall Study||0||
48739880|NCT04325828|102147428|FG000|STARTED|Overall Study||31||
48739881|NCT04325828|102147428|FG000|COMPLETED|Overall Study||5||
48739882|NCT04325828|102147428|FG000|NOT COMPLETED|Overall Study||26||
48739883|NCT02501590|102147429|FG000|STARTED|Overall Study||13||
48739884|NCT02501590|102147430|FG001|STARTED|Overall Study||35||
48739885|NCT02501590|102147429|FG000|COMPLETED|Overall Study||13||
48739886|NCT02501590|102147430|FG001|COMPLETED|Overall Study||35||
48739887|NCT02501590|102147429|FG000|NOT COMPLETED|Overall Study||0||
48739888|NCT02501590|102147430|FG001|NOT COMPLETED|Overall Study||0||
48739889|NCT01870505|102147431|FG000|STARTED|Overall Study||4||
48739890|NCT01870505|102147432|FG001|STARTED|Overall Study||3||
48739891|NCT01870505|102147433|FG002|STARTED|Overall Study||7||
48739892|NCT01870505|102147434|FG003|STARTED|Overall Study||10||
48739893|NCT01870505|102147435|FG004|STARTED|Overall Study||6||
48739894|NCT01870505|102147436|FG005|STARTED|Overall Study||6||
48161319|NCT03728608|100718776|FG001|STARTED|Overall Study||75||
48161320|NCT03728608|100718775|FG000|COMPLETED|Overall Study||58||
48161321|NCT03728608|100718776|FG001|COMPLETED|Overall Study||62||
48161322|NCT03728608|100718775|FG000|NOT COMPLETED|Overall Study||18||
48161323|NCT03728608|100718776|FG001|NOT COMPLETED|Overall Study||13||
48161324|NCT01013792|100718777|FG000|STARTED|Overall Study||14||
48161325|NCT01013792|100718778|FG001|STARTED|Overall Study||16||
48321979|NCT01152021|101114807|FG000|STARTED|Overall Study||8||
48321980|NCT01152021|101114808|FG001|STARTED|Overall Study||7||
48321981|NCT01152021|101114807|FG000|COMPLETED|Overall Study||2||
48321982|NCT01152021|101114808|FG001|COMPLETED|Overall Study||1||
48739895|NCT01870505|102147437|FG006|STARTED|Overall Study||3||
48161326|NCT01013792|100718777|FG000|COMPLETED|Overall Study||12||
48321983|NCT01152021|101114807|FG000|NOT COMPLETED|Overall Study||6||
48739896|NCT01870505|102147438|FG007|STARTED|Overall Study||6||
48739897|NCT01870505|102147439|FG008|STARTED|Overall Study||7||
48739898|NCT01870505|102147431|FG000|COMPLETED|Overall Study||4||
48739899|NCT01870505|102147432|FG001|COMPLETED|Overall Study||3||
48739900|NCT01870505|102147433|FG002|COMPLETED|Overall Study||7||
48739901|NCT01870505|102147434|FG003|COMPLETED|Overall Study||10||
48739902|NCT01870505|102147435|FG004|COMPLETED|Overall Study||6||
48321984|NCT01152021|101114808|FG001|NOT COMPLETED|Overall Study||6||
48321985|NCT02833974|101114809|FG000|STARTED|Overall Study||14||
48321986|NCT02833974|101114810|FG001|STARTED|Overall Study||22||
48321987|NCT02833974|101114809|FG000|COMPLETED|Overall Study||13||
48321988|NCT02833974|101114810|FG001|COMPLETED|Overall Study||19||
48321989|NCT02833974|101114809|FG000|NOT COMPLETED|Overall Study||1||
48739903|NCT01870505|102147436|FG005|COMPLETED|Overall Study||6||
48739904|NCT01870505|102147437|FG006|COMPLETED|Overall Study||3||
48739905|NCT01870505|102147438|FG007|COMPLETED|Overall Study||6||
48739906|NCT01870505|102147439|FG008|COMPLETED|Overall Study||7||
48739907|NCT01870505|102147431|FG000|NOT COMPLETED|Overall Study||0||
48739908|NCT01870505|102147432|FG001|NOT COMPLETED|Overall Study||0||
48739909|NCT01870505|102147433|FG002|NOT COMPLETED|Overall Study||0||
48739910|NCT01870505|102147434|FG003|NOT COMPLETED|Overall Study||0||
48739911|NCT01870505|102147435|FG004|NOT COMPLETED|Overall Study||0||
48739912|NCT01870505|102147436|FG005|NOT COMPLETED|Overall Study||0||
48739913|NCT01870505|102147437|FG006|NOT COMPLETED|Overall Study||0||
48739914|NCT01870505|102147438|FG007|NOT COMPLETED|Overall Study||0||
48739915|NCT01870505|102147439|FG008|NOT COMPLETED|Overall Study||0||
48739916|NCT00610311|102147440|FG000|STARTED|Overall Study||3||
48739917|NCT00610311|102147440|FG000|COMPLETED|Overall Study||3||
48739918|NCT00610311|102147440|FG000|NOT COMPLETED|Overall Study||0||
48739919|NCT01401517|102147441|FG000|STARTED|Overall Study||18||
48739920|NCT01401517|102147442|FG001|STARTED|Overall Study||19||
48739921|NCT01401517|102147443|FG002|STARTED|Overall Study||18||
48739922|NCT01401517|102147441|FG000|COMPLETED|Overall Study||15||
48739923|NCT01401517|102147442|FG001|COMPLETED|Overall Study||17||
48739924|NCT01401517|102147443|FG002|COMPLETED|Overall Study||15||
48739925|NCT01401517|102147441|FG000|NOT COMPLETED|Overall Study||3||
48739926|NCT01401517|102147442|FG001|NOT COMPLETED|Overall Study||2||
48739927|NCT01401517|102147443|FG002|NOT COMPLETED|Overall Study||3||
48739928|NCT03116685|102147444|FG000|STARTED|Overall Study||13||
48739929|NCT03116685|102147445|FG001|STARTED|Overall Study||12||
48739930|NCT03116685|102147444|FG000|COMPLETED|Overall Study||13||
48739931|NCT03116685|102147445|FG001|COMPLETED|Overall Study||11||
48739932|NCT03116685|102147444|FG000|NOT COMPLETED|Overall Study||0||
48739933|NCT03116685|102147445|FG001|NOT COMPLETED|Overall Study||1||
48739934|NCT00731679|102147446|FG000|STARTED|Overall Study||314||
48739935|NCT00731679|102147447|FG001|STARTED|Overall Study||309||
48739936|NCT00731679|102147446|FG000|COMPLETED|Overall Study||292||
48739937|NCT00731679|102147447|FG001|COMPLETED|Overall Study||283||
48739938|NCT00731679|102147446|FG000|NOT COMPLETED|Overall Study||22||
48739939|NCT00731679|102147447|FG001|NOT COMPLETED|Overall Study||26||
48739940|NCT00195039|102147448|FG000|STARTED|Overall Study||47||
48739941|NCT00195039|102147448|FG000|COMPLETED|Overall Study||47||
48739942|NCT00195039|102147448|FG000|NOT COMPLETED|Overall Study||0||
48739943|NCT02123849|102147449|FG000|STARTED|Overall Study||27||
48739944|NCT02123849|102147450|FG001|STARTED|Overall Study||27||
48739945|NCT02123849|102147449|FG000|COMPLETED|Overall Study||23||
48739946|NCT02123849|102147450|FG001|COMPLETED|Overall Study||18||
48739947|NCT02123849|102147449|FG000|NOT COMPLETED|Overall Study||4||
48321990|NCT02833974|101114810|FG001|NOT COMPLETED|Overall Study||3||
48321991|NCT01486927|101114811|FG000|STARTED|Overall Study||174||
48321992|NCT01486927|101114811|FG000|COMPLETED|Overall Study||161||
48321993|NCT01486927|101114811|FG000|NOT COMPLETED|Overall Study||13||
48321994|NCT00772954|101114812|FG000|STARTED|Overall Study||12||
48321995|NCT00772954|101114813|FG001|STARTED|Overall Study||12||
48739948|NCT02123849|102147450|FG001|NOT COMPLETED|Overall Study||9||
48739949|NCT00931606|102147451|FG000|STARTED|Overall Study||8||
48739950|NCT00931606|102147452|FG001|STARTED|Overall Study||10||
48739951|NCT00931606|102147453|FG002|STARTED|Overall Study||7||
48739952|NCT00931606|102147454|FG003|STARTED|Overall Study||5||
48739953|NCT00931606|102147451|FG000|COMPLETED|Overall Study||3||
48739954|NCT00931606|102147452|FG001|COMPLETED|Overall Study||1||
48739955|NCT00931606|102147453|FG002|COMPLETED|Overall Study||1||
48739956|NCT00931606|102147454|FG003|COMPLETED|Overall Study||2||
48739957|NCT00931606|102147451|FG000|NOT COMPLETED|Overall Study||5||
48739958|NCT00931606|102147452|FG001|NOT COMPLETED|Overall Study||9||
48739959|NCT00931606|102147453|FG002|NOT COMPLETED|Overall Study||6||
48739960|NCT00931606|102147454|FG003|NOT COMPLETED|Overall Study||3||
48321996|NCT00772954|101114814|FG002|STARTED|Overall Study||12||
48321997|NCT00772954|101114812|FG000|COMPLETED|Overall Study||12||
48321998|NCT00772954|101114813|FG001|COMPLETED|Overall Study||12||
48321999|NCT00772954|101114814|FG002|COMPLETED|Overall Study||11||
48739961|NCT01128244|102147455|FG000|STARTED|Overall Study||13||
48739962|NCT01128244|102147455|FG000|COMPLETED|Overall Study||10||
48739963|NCT01128244|102147455|FG000|NOT COMPLETED|Overall Study||3||
48739964|NCT00596752|102147456|FG000|STARTED|Overall Study||415||
48739965|NCT00596752|102147457|FG001|STARTED|Overall Study||425||
48739966|NCT00596752|102147456|FG000|Randomized and Treated|Overall Study||415||
48739967|NCT00596752|102147457|FG001|Randomized and Treated|Overall Study||424||
48739968|NCT00596752|102147456|FG000|COMPLETED|Overall Study||289||
48322000|NCT00772954|101114812|FG000|NOT COMPLETED|Overall Study||0||
48322001|NCT00772954|101114813|FG001|NOT COMPLETED|Overall Study||0||
48739969|NCT00596752|102147457|FG001|COMPLETED|Overall Study||282||
48739970|NCT00596752|102147456|FG000|NOT COMPLETED|Overall Study||126||
48739971|NCT00596752|102147457|FG001|NOT COMPLETED|Overall Study||143||
48739972|NCT01973998|102147458|FG000|STARTED|Overall Study||33||
48739973|NCT01973998|102147459|FG001|STARTED|Overall Study||35||
48739974|NCT01973998|102147458|FG000|COMPLETED|Overall Study||31||
48739975|NCT01973998|102147459|FG001|COMPLETED|Overall Study||33||
48739976|NCT01973998|102147458|FG000|NOT COMPLETED|Overall Study||2||
48739977|NCT01973998|102147459|FG001|NOT COMPLETED|Overall Study||2||
48739978|NCT00183625|102147460|FG000|STARTED|Overall Study||27||
48739979|NCT00183625|102147461|FG001|STARTED|Overall Study||28||
48739980|NCT00183625|102147462|FG002|STARTED|Overall Study||28||
48739981|NCT00183625|102147463|FG003|STARTED|Overall Study||24||
48739982|NCT00183625|102147460|FG000|Obtained Employment|Overall Study||21||
48739983|NCT00183625|102147461|FG001|Obtained Employment|Overall Study||18||
48739984|NCT00183625|102147462|FG002|Obtained Employment|Overall Study||14||
48739985|NCT00183625|102147463|FG003|Obtained Employment|Overall Study||14||
48739986|NCT00183625|102147460|FG000|COMPLETED|Overall Study||9||
48739987|NCT00183625|102147461|FG001|COMPLETED|Overall Study||10||
48739988|NCT00183625|102147462|FG002|COMPLETED|Overall Study||9||
48739989|NCT00183625|102147463|FG003|COMPLETED|Overall Study||10||
48739990|NCT00183625|102147460|FG000|NOT COMPLETED|Overall Study||18||
48739991|NCT00183625|102147461|FG001|NOT COMPLETED|Overall Study||18||
48739992|NCT00183625|102147462|FG002|NOT COMPLETED|Overall Study||19||
48739993|NCT00183625|102147463|FG003|NOT COMPLETED|Overall Study||14||
48739994|NCT01336140|102147464|FG000|STARTED|Overall Study||150||
48739995|NCT01336140|102147465|FG001|STARTED|Overall Study||150||
48739996|NCT01336140|102147464|FG000|COMPLETED|Overall Study||150||
48739997|NCT01336140|102147465|FG001|COMPLETED|Overall Study||150||
48739998|NCT01336140|102147464|FG000|NOT COMPLETED|Overall Study||0||
48739999|NCT01336140|102147465|FG001|NOT COMPLETED|Overall Study||0||
48740000|NCT00193206|102147466|FG000|STARTED|Preoperative Therapy||123||
48740001|NCT00193206|102147466|FG000|COMPLETED|Preoperative Therapy||116||
48740002|NCT00193206|102147466|FG000|NOT COMPLETED|Preoperative Therapy||7||
48740003|NCT00193206|102147466|FG000|STARTED|Surgery||116||
48740004|NCT00193206|102147466|FG000|COMPLETED|Surgery||116||
48740005|NCT00193206|102147466|FG000|NOT COMPLETED|Surgery||0||
48740006|NCT00193206|102147466|FG000|STARTED|Postoperative Therapy||116||
48740007|NCT00193206|102147466|FG000|COMPLETED|Postoperative Therapy||102||
48740008|NCT00193206|102147466|FG000|NOT COMPLETED|Postoperative Therapy||14||
48740009|NCT00837213|102147467|FG000|STARTED|Overall Study||16||
48740010|NCT00837213|102147468|FG001|STARTED|Overall Study||17||
48740011|NCT00837213|102147467|FG000|COMPLETED|Overall Study||10||
48740012|NCT00837213|102147468|FG001|COMPLETED|Overall Study||12||
48740013|NCT00837213|102147467|FG000|NOT COMPLETED|Overall Study||6||
48740014|NCT00837213|102147468|FG001|NOT COMPLETED|Overall Study||5||
48740015|NCT00123123|102147469|FG000|STARTED|Overall Study||59||
48740016|NCT00123123|102147470|FG001|STARTED|Overall Study||58||
48740017|NCT00123123|102147471|FG002|STARTED|Overall Study||58||
48740018|NCT00123123|102147469|FG000|COMPLETED|Overall Study||59||
48740019|NCT00123123|102147470|FG001|COMPLETED|Overall Study||58||
48740020|NCT00123123|102147471|FG002|COMPLETED|Overall Study||58||
48740021|NCT00123123|102147469|FG000|NOT COMPLETED|Overall Study||0||
48740022|NCT00123123|102147470|FG001|NOT COMPLETED|Overall Study||0||
48740023|NCT00123123|102147471|FG002|NOT COMPLETED|Overall Study||0||
48740024|NCT03397342|102147472|FG000|STARTED|Overall Study||5||
48740025|NCT03397342|102147473|FG001|STARTED|Overall Study||0||
48740026|NCT03397342|102147472|FG000|COMPLETED|Overall Study||5||
48740027|NCT03397342|102147473|FG001|COMPLETED|Overall Study||0||
48740028|NCT03397342|102147472|FG000|NOT COMPLETED|Overall Study||0||
48740029|NCT03397342|102147473|FG001|NOT COMPLETED|Overall Study||0||
48740030|NCT05148806|102147474|FG000|STARTED|Overall Study||12342||
48740031|NCT05148806|102147475|FG001|STARTED|Overall Study||8117||
48740032|NCT05148806|102147476|FG002|STARTED|Overall Study||7952||
48740033|NCT05148806|102147474|FG000|COMPLETED|Overall Study||9927||
48740034|NCT05148806|102147475|FG001|COMPLETED|Overall Study||6516||
48740035|NCT05148806|102147476|FG002|COMPLETED|Overall Study||6593||
48740036|NCT05148806|102147474|FG000|NOT COMPLETED|Overall Study||2415||
48740037|NCT05148806|102147475|FG001|NOT COMPLETED|Overall Study||1601||
48740038|NCT05148806|102147476|FG002|NOT COMPLETED|Overall Study||1359||
48740039|NCT02186665|102147477|FG000|STARTED|Overall Study||8||
48740040|NCT02186665|102147478|FG001|STARTED|Overall Study||11||
48740041|NCT02186665|102147477|FG000|COMPLETED|Overall Study||8||
48740042|NCT02186665|102147478|FG001|COMPLETED|Overall Study||10||
48740043|NCT02186665|102147477|FG000|NOT COMPLETED|Overall Study||0||
48740044|NCT02186665|102147478|FG001|NOT COMPLETED|Overall Study||1||
48740045|NCT03755882|102147479|FG000|STARTED|Period 1||23||
48740046|NCT03755882|102147480|FG001|STARTED|Period 1||22||
48740047|NCT03755882|102147479|FG000|COMPLETED|Period 1||19||
48740048|NCT03755882|102147480|FG001|COMPLETED|Period 1||22||
48740049|NCT03755882|102147479|FG000|NOT COMPLETED|Period 1||4||
48740050|NCT03755882|102147480|FG001|NOT COMPLETED|Period 1||0||
48740051|NCT03755882|102147479|FG000|STARTED|Period 2||19||
48740052|NCT03755882|102147480|FG001|STARTED|Period 2||22||
48740053|NCT03755882|102147479|FG000|COMPLETED|Period 2||19||
48740054|NCT03755882|102147480|FG001|COMPLETED|Period 2||22||
48740055|NCT03755882|102147479|FG000|NOT COMPLETED|Period 2||0||
48740056|NCT03755882|102147480|FG001|NOT COMPLETED|Period 2||0||
48740057|NCT00271102|102147481|FG000|STARTED|Overall Study||35||
48740058|NCT00271102|102147482|FG001|STARTED|Overall Study||35||
48740059|NCT00271102|102147481|FG000|COMPLETED|Overall Study||30||
48740060|NCT00271102|102147482|FG001|COMPLETED|Overall Study||30||
48740061|NCT00271102|102147481|FG000|NOT COMPLETED|Overall Study||5||
48740062|NCT00271102|102147482|FG001|NOT COMPLETED|Overall Study||5||
48740063|NCT00321464|102147483|FG000|STARTED|Overall Study||1020||
48740064|NCT00321464|102147484|FG001|STARTED|Overall Study||1026||
48740065|NCT00321464|102147483|FG000|Received Investigational Product|Overall Study||1014||
48322002|NCT00772954|101114814|FG002|NOT COMPLETED|Overall Study||1||
48322003|NCT03077347|101114815|FG000|STARTED|Sham Stimulation (1-20 Minutes)||3||
48322004|NCT03077347|101114816|FG001|STARTED|Sham Stimulation (1-20 Minutes)||3||
48322005|NCT03077347|101114815|FG000|COMPLETED|Sham Stimulation (1-20 Minutes)||3||
48322006|NCT03077347|101114816|FG001|COMPLETED|Sham Stimulation (1-20 Minutes)||3||
48322007|NCT03077347|101114815|FG000|NOT COMPLETED|Sham Stimulation (1-20 Minutes)||0||
48740066|NCT00321464|102147484|FG001|Received Investigational Product|Overall Study||1019||
48740067|NCT00321464|102147483|FG000|COMPLETED|Overall Study||461||
48740068|NCT00321464|102147484|FG001|COMPLETED|Overall Study||468||
48740069|NCT00321464|102147483|FG000|NOT COMPLETED|Overall Study||559||
48740070|NCT00321464|102147484|FG001|NOT COMPLETED|Overall Study||558||
48740071|NCT00930930|102147485|FG000|STARTED|Overall Study||96||
48740072|NCT00930930|102147486|FG001|STARTED|Overall Study||49||
48740073|NCT00930930|102147485|FG000|COMPLETED|Overall Study||75||
48161327|NCT01013792|100718778|FG001|COMPLETED|Overall Study||11||
48161328|NCT01013792|100718777|FG000|NOT COMPLETED|Overall Study||2||
48322008|NCT03077347|101114816|FG001|NOT COMPLETED|Sham Stimulation (1-20 Minutes)||0||
48322009|NCT03077347|101114815|FG000|STARTED|Washout (24-48 Hours)||3||
48740074|NCT00930930|102147486|FG001|COMPLETED|Overall Study||40||
48740075|NCT00930930|102147485|FG000|NOT COMPLETED|Overall Study||21||
48740076|NCT00930930|102147486|FG001|NOT COMPLETED|Overall Study||9||
48740077|NCT03472326|102147487|FG000|STARTED|Part 1: GS-9131 Functional Monotherapy||11||
48740078|NCT03472326|102147488|FG001|STARTED|Part 1: GS-9131 Functional Monotherapy||10||
48740079|NCT03472326|102147489|FG002|STARTED|Part 1: GS-9131 Functional Monotherapy||0||
48740080|NCT03472326|102147490|FG003|STARTED|Part 1: GS-9131 Functional Monotherapy||0||
48740081|NCT03472326|102147487|FG000|COMPLETED|Part 1: GS-9131 Functional Monotherapy||11||
48740082|NCT03472326|102147488|FG001|COMPLETED|Part 1: GS-9131 Functional Monotherapy||10||
48740083|NCT03472326|102147489|FG002|COMPLETED|Part 1: GS-9131 Functional Monotherapy||0||
48740084|NCT03472326|102147490|FG003|COMPLETED|Part 1: GS-9131 Functional Monotherapy||0||
48740085|NCT03472326|102147487|FG000|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0||
48740086|NCT03472326|102147488|FG001|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0||
48740087|NCT03472326|102147489|FG002|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0||
48740088|NCT03472326|102147490|FG003|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0||
48740089|NCT03472326|102147487|FG000|STARTED|Part 2: Combination Therapy||0||
48740090|NCT03472326|102147488|FG001|STARTED|Part 2: Combination Therapy||0||
48740091|NCT03472326|102147489|FG002|STARTED|Part 2: Combination Therapy||1||
48740092|NCT03472326|102147490|FG003|STARTED|Part 2: Combination Therapy||3||
48740093|NCT03472326|102147487|FG000|COMPLETED|Part 2: Combination Therapy||0||
48740094|NCT03472326|102147488|FG001|COMPLETED|Part 2: Combination Therapy||0||
48740095|NCT03472326|102147489|FG002|COMPLETED|Part 2: Combination Therapy||0||
48740096|NCT03472326|102147490|FG003|COMPLETED|Part 2: Combination Therapy||0||
48740097|NCT03472326|102147487|FG000|NOT COMPLETED|Part 2: Combination Therapy||0||
48740098|NCT03472326|102147488|FG001|NOT COMPLETED|Part 2: Combination Therapy||0||
48740099|NCT03472326|102147489|FG002|NOT COMPLETED|Part 2: Combination Therapy||1||
48740100|NCT03472326|102147490|FG003|NOT COMPLETED|Part 2: Combination Therapy||3||
48740101|NCT03040674|102147491|FG000|STARTED|Overall Study||489||
48740102|NCT03040674|102147491|FG000|Participants Completing 3 Month Survey|Overall Study||351||
48740103|NCT03040674|102147491|FG000|Participants Completing 6 Month Survey|Overall Study||241||
48740104|NCT03040674|102147491|FG000|COMPLETED|Overall Study||241|Total number of participants completing the study (6 months post-treatment)|
48740105|NCT03040674|102147491|FG000|NOT COMPLETED|Overall Study||248||
48740106|NCT01159015|102147492|FG000|STARTED|Overall Study||357||
48740107|NCT01159015|102147493|FG001|STARTED|Overall Study||177||
48740108|NCT01159015|102147492|FG000|COMPLETED|Overall Study||339||
48740109|NCT01159015|102147493|FG001|COMPLETED|Overall Study||170||
48740110|NCT01159015|102147492|FG000|NOT COMPLETED|Overall Study||18||
48740111|NCT01159015|102147493|FG001|NOT COMPLETED|Overall Study||7||
48740112|NCT02343406|102147494|FG000|STARTED|Overall Study||88||
48740113|NCT02343406|102147495|FG001|STARTED|Overall Study||86||
48322010|NCT03077347|101114816|FG001|STARTED|Washout (24-48 Hours)||3||
48322011|NCT03077347|101114815|FG000|COMPLETED|Washout (24-48 Hours)||3||
48322012|NCT03077347|101114816|FG001|COMPLETED|Washout (24-48 Hours)||3||
48322013|NCT03077347|101114815|FG000|NOT COMPLETED|Washout (24-48 Hours)||0||
48408114|NCT01425307|101331721|FG001|NOT COMPLETED|Overall Study||19||
48408115|NCT00063986|101331722|FG000|STARTED|Overall Study||110||
48617056|NCT00121719|101849491|FG008|STARTED|Food-Effect Pilot Study (4 Weeks)||0||
48617057|NCT00121719|101849492|FG009|STARTED|Food-Effect Pilot Study (4 Weeks)||0||
48617058|NCT00121719|101849493|FG010|STARTED|Food-Effect Pilot Study (4 Weeks)||6||
48617059|NCT00121719|101849494|FG011|STARTED|Food-Effect Pilot Study (4 Weeks)||5||
48617060|NCT00121719|101849495|FG012|STARTED|Food-Effect Pilot Study (4 Weeks)||0||
48617061|NCT00121719|101849496|FG013|STARTED|Food-Effect Pilot Study (4 Weeks)||0||
48617062|NCT00121719|101849483|FG000|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
48617063|NCT00121719|101849484|FG001|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
48617064|NCT00121719|101849485|FG002|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
48617065|NCT00121719|101849486|FG003|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
48617066|NCT00121719|101849487|FG004|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
48617067|NCT00121719|101849488|FG005|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
48617068|NCT00121719|101849489|FG006|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
48617069|NCT00121719|101849490|FG007|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
48617070|NCT00121719|101849491|FG008|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
48617071|NCT00121719|101849492|FG009|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
48617072|NCT00121719|101849493|FG010|COMPLETED|Food-Effect Pilot Study (4 Weeks)||6||
48617073|NCT00121719|101849494|FG011|COMPLETED|Food-Effect Pilot Study (4 Weeks)||5||
48617074|NCT00121719|101849495|FG012|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
48617075|NCT00121719|101849496|FG013|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
48617076|NCT00121719|101849483|FG000|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
48617077|NCT00121719|101849484|FG001|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
48617078|NCT00121719|101849485|FG002|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
48617079|NCT00121719|101849486|FG003|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
48617080|NCT00121719|101849487|FG004|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
48657095|NCT03648372|101943772|FG015|NOT COMPLETED|Overall Study||6||
48740114|NCT02343406|102147496|FG002|STARTED|Overall Study||60||
48740115|NCT02343406|102147497|FG003|STARTED|Overall Study||26||
48740116|NCT02343406|102147498|FG004|STARTED|Overall Study||6||
48740117|NCT02343406|102147494|FG000|COMPLETED|Overall Study||0||
48740118|NCT02343406|102147495|FG001|COMPLETED|Overall Study||0||
48740119|NCT02343406|102147496|FG002|COMPLETED|Overall Study||2||
48322014|NCT03077347|101114816|FG001|NOT COMPLETED|Washout (24-48 Hours)||0||
48322015|NCT03077347|101114815|FG000|STARTED|Experimental Stimulation (1-20 Minutes)||3||
48322016|NCT03077347|101114816|FG001|STARTED|Experimental Stimulation (1-20 Minutes)||3||
48322017|NCT03077347|101114815|FG000|COMPLETED|Experimental Stimulation (1-20 Minutes)||3||
48322018|NCT03077347|101114816|FG001|COMPLETED|Experimental Stimulation (1-20 Minutes)||3||
48408116|NCT00063986|101331722|FG000|Treated|Overall Study||105||
48740120|NCT02343406|102147497|FG003|COMPLETED|Overall Study||0||
48740121|NCT02343406|102147498|FG004|COMPLETED|Overall Study||1||
48740122|NCT02343406|102147494|FG000|NOT COMPLETED|Overall Study||88||
48740123|NCT02343406|102147495|FG001|NOT COMPLETED|Overall Study||86||
48740124|NCT02343406|102147496|FG002|NOT COMPLETED|Overall Study||58||
48740125|NCT02343406|102147497|FG003|NOT COMPLETED|Overall Study||26||
48740126|NCT02343406|102147498|FG004|NOT COMPLETED|Overall Study||5||
48740127|NCT04207749|102147499|FG000|STARTED|Overall Study||78||156
48740128|NCT04207749|102147500|FG001|STARTED|Overall Study||156||312
48740129|NCT04207749|102147499|FG000|COMPLETED|Overall Study||74||148
48740130|NCT04207749|102147500|FG001|COMPLETED|Overall Study||149||298
48740131|NCT04207749|102147499|FG000|NOT COMPLETED|Overall Study||4||8
48740132|NCT04207749|102147500|FG001|NOT COMPLETED|Overall Study||7||14
48740133|NCT03433417|102147501|FG000|STARTED|Overall Study||12||24
48740134|NCT03433417|102147501|FG000|Treatment With TruSculpt Device|Overall Study||12||12
48740135|NCT03433417|102147501|FG000|No Treatment With TruSculpt Device|Overall Study||12||12
48740136|NCT03433417|102147501|FG000|COMPLETED|Overall Study||12||24
48740137|NCT03433417|102147501|FG000|NOT COMPLETED|Overall Study||0||0
48740138|NCT03431350|102147502|FG000|STARTED|Overall Study||6||
48740139|NCT03431350|102147503|FG001|STARTED|Overall Study||6||
48740140|NCT03431350|102147504|FG002|STARTED|Overall Study||21||
48740141|NCT03431350|102147505|FG003|STARTED|Overall Study||11||
48740142|NCT03431350|102147506|FG004|STARTED|Overall Study||8||
48740143|NCT03431350|102147507|FG005|STARTED|Overall Study||9||
48740144|NCT03431350|102147508|FG006|STARTED|Overall Study||6||
48740145|NCT03431350|102147509|FG007|STARTED|Overall Study||1||
48740146|NCT03431350|102147510|FG008|STARTED|Overall Study||17||
48740147|NCT03431350|102147511|FG009|STARTED|Overall Study||17||
48740148|NCT03431350|102147512|FG010|STARTED|Overall Study||17||
48740149|NCT03431350|102147513|FG011|STARTED|Overall Study||17||
48740150|NCT03431350|102147502|FG000|COMPLETED|Overall Study||0||
48740151|NCT03431350|102147503|FG001|COMPLETED|Overall Study||0||
48740152|NCT03431350|102147504|FG002|COMPLETED|Overall Study||0||
48740153|NCT03431350|102147505|FG003|COMPLETED|Overall Study||0||
48740154|NCT03431350|102147506|FG004|COMPLETED|Overall Study||0||
48322019|NCT03077347|101114815|FG000|NOT COMPLETED|Experimental Stimulation (1-20 Minutes)||0||
48322020|NCT03077347|101114816|FG001|NOT COMPLETED|Experimental Stimulation (1-20 Minutes)||0||
48322021|NCT02829138|101114817|FG000|STARTED|Overall Study||29||
48322022|NCT02829138|101114818|FG001|STARTED|Overall Study||28||
48322023|NCT02829138|101114817|FG000|COMPLETED|Overall Study||28||
48322024|NCT02829138|101114818|FG001|COMPLETED|Overall Study||28||
48322025|NCT02829138|101114817|FG000|NOT COMPLETED|Overall Study||1||
48322026|NCT02829138|101114818|FG001|NOT COMPLETED|Overall Study||0||
48322027|NCT00518154|101114819|FG000|STARTED|Overall Study||7||
48322028|NCT00518154|101114819|FG000|COMPLETED|Overall Study||7||
48322029|NCT00518154|101114819|FG000|NOT COMPLETED|Overall Study||0||
48322030|NCT02318667|101114820|FG000|STARTED|Overall Study||38||
48740155|NCT03431350|102147507|FG005|COMPLETED|Overall Study||0||
48740156|NCT03431350|102147508|FG006|COMPLETED|Overall Study||0||
48322031|NCT02318667|101114820|FG000|COMPLETED|Overall Study||29||
48322032|NCT02318667|101114820|FG000|NOT COMPLETED|Overall Study||9||
48322033|NCT01326546|101114821|FG000|STARTED|Overall Study||189||
48322034|NCT01326546|101114822|FG001|STARTED|Overall Study||189||
48322035|NCT01326546|101114821|FG000|COMPLETED|Overall Study||172||
48322036|NCT01326546|101114822|FG001|COMPLETED|Overall Study||176||
48322037|NCT01326546|101114821|FG000|NOT COMPLETED|Overall Study||17||
48322038|NCT01326546|101114822|FG001|NOT COMPLETED|Overall Study||13||
48322039|NCT02185404|101114823|FG000|STARTED|Overall Study||6||
48322040|NCT02185404|101114823|FG000|COMPLETED|Overall Study||6||
48322041|NCT02185404|101114823|FG000|NOT COMPLETED|Overall Study||0||
48322042|NCT03449095|101114824|FG000|STARTED|Overall Study||320||
48740157|NCT03431350|102147509|FG007|COMPLETED|Overall Study||0||
48322043|NCT03449095|101114825|FG001|STARTED|Overall Study||320||
48322044|NCT03449095|101114824|FG000|COMPLETED|Overall Study||320||
48322045|NCT03449095|101114825|FG001|COMPLETED|Overall Study||320||
48740158|NCT03431350|102147510|FG008|COMPLETED|Overall Study||0||
48740159|NCT03431350|102147511|FG009|COMPLETED|Overall Study||0||
48740160|NCT03431350|102147512|FG010|COMPLETED|Overall Study||0||
48740161|NCT03431350|102147513|FG011|COMPLETED|Overall Study||0||
48740162|NCT03431350|102147502|FG000|NOT COMPLETED|Overall Study||6||
48740163|NCT03431350|102147503|FG001|NOT COMPLETED|Overall Study||6||
48740164|NCT03431350|102147504|FG002|NOT COMPLETED|Overall Study||21||
48322046|NCT03449095|101114824|FG000|NOT COMPLETED|Overall Study||0||
48740165|NCT03431350|102147505|FG003|NOT COMPLETED|Overall Study||11||
48740166|NCT03431350|102147506|FG004|NOT COMPLETED|Overall Study||8||
48740167|NCT03431350|102147507|FG005|NOT COMPLETED|Overall Study||9||
48740168|NCT03431350|102147508|FG006|NOT COMPLETED|Overall Study||6||
48740169|NCT03431350|102147509|FG007|NOT COMPLETED|Overall Study||1||
48740170|NCT03431350|102147510|FG008|NOT COMPLETED|Overall Study||17||
48740171|NCT03431350|102147511|FG009|NOT COMPLETED|Overall Study||17||
48740172|NCT03431350|102147512|FG010|NOT COMPLETED|Overall Study||17||
48740173|NCT03431350|102147513|FG011|NOT COMPLETED|Overall Study||17||
48740174|NCT01483183|102147514|FG000|STARTED|Overall Study||4||
48740175|NCT01483183|102147515|FG001|STARTED|Overall Study||1||
48740176|NCT01483183|102147516|FG002|STARTED|Overall Study||5||
48740177|NCT01483183|102147517|FG003|STARTED|Overall Study||3||
48740178|NCT01483183|102147518|FG004|STARTED|Overall Study||4||
48740179|NCT01483183|102147519|FG005|STARTED|Overall Study||4||
48740180|NCT01483183|102147520|FG006|STARTED|Overall Study||6||
48740181|NCT01483183|102147521|FG007|STARTED|Overall Study||4||
48740182|NCT01483183|102147522|FG008|STARTED|Overall Study||4||
48161329|NCT01013792|100718778|FG001|NOT COMPLETED|Overall Study||5||
48161330|NCT03237858|100718779|FG000|STARTED|Overall Study||200||
48161331|NCT03237858|100718779|FG000|COMPLETED|Overall Study||144||
48161332|NCT03237858|100718779|FG000|NOT COMPLETED|Overall Study||56||
48161333|NCT00674466|100718780|FG000|STARTED|Overall Study||30||
48161334|NCT00674466|100718781|FG001|STARTED|Overall Study||30||
48161335|NCT00674466|100718782|FG002|STARTED|Overall Study||30||
48161336|NCT00674466|100718780|FG000|COMPLETED|Overall Study||23||
48161337|NCT00674466|100718781|FG001|COMPLETED|Overall Study||22||
48322047|NCT03449095|101114825|FG001|NOT COMPLETED|Overall Study||0||
48617081|NCT00121719|101849488|FG005|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
48617082|NCT00121719|101849489|FG006|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
48617083|NCT00121719|101849490|FG007|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
48617084|NCT00121719|101849491|FG008|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
48617085|NCT00121719|101849492|FG009|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
48617086|NCT00121719|101849493|FG010|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
48617087|NCT00121719|101849494|FG011|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
48617088|NCT00121719|101849495|FG012|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
48617089|NCT00121719|101849496|FG013|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
48617090|NCT01476267|101849497|FG000|STARTED|Overall Study||6||
48617091|NCT01476267|101849497|FG000|COMPLETED|Overall Study||6||
48617092|NCT01476267|101849497|FG000|NOT COMPLETED|Overall Study||0||
48617093|NCT05270980|101849498|FG000|STARTED|Overall Study||14||
48617094|NCT05270980|101849499|FG001|STARTED|Overall Study||2||
48617095|NCT05270980|101849500|FG002|STARTED|Overall Study||50||
48617096|NCT05270980|101849501|FG003|STARTED|Overall Study||21||
48617097|NCT05270980|101849498|FG000|COMPLETED|Overall Study||14||
48617098|NCT05270980|101849499|FG001|COMPLETED|Overall Study||2||
48617099|NCT05270980|101849500|FG002|COMPLETED|Overall Study||50||
48617100|NCT05270980|101849501|FG003|COMPLETED|Overall Study||21||
48617101|NCT05270980|101849498|FG000|NOT COMPLETED|Overall Study||0||
48617102|NCT05270980|101849499|FG001|NOT COMPLETED|Overall Study||0||
48617103|NCT05270980|101849500|FG002|NOT COMPLETED|Overall Study||0||
48617104|NCT05270980|101849501|FG003|NOT COMPLETED|Overall Study||0||
48740183|NCT01483183|102147523|FG009|STARTED|Overall Study||5||
48740184|NCT01483183|102147514|FG000|COMPLETED|Overall Study||4||
48740185|NCT01483183|102147515|FG001|COMPLETED|Overall Study||1||
48740186|NCT01483183|102147516|FG002|COMPLETED|Overall Study||5||
48740187|NCT01483183|102147517|FG003|COMPLETED|Overall Study||3||
48161338|NCT00674466|100718782|FG002|COMPLETED|Overall Study||21||
48161339|NCT00674466|100718780|FG000|NOT COMPLETED|Overall Study||7||
48161340|NCT00674466|100718781|FG001|NOT COMPLETED|Overall Study||8||
48161341|NCT00674466|100718782|FG002|NOT COMPLETED|Overall Study||9||
48161342|NCT01555164|100718783|FG000|STARTED|Overall Study||222||
48161343|NCT01555164|100718784|FG001|STARTED|Overall Study||220||
48161344|NCT01555164|100718783|FG000|COMPLETED|Overall Study||182||
48161345|NCT01555164|100718784|FG001|COMPLETED|Overall Study||185||
48161346|NCT01555164|100718783|FG000|NOT COMPLETED|Overall Study||40||
48161347|NCT01555164|100718784|FG001|NOT COMPLETED|Overall Study||35||
48161348|NCT01301274|100718785|FG000|STARTED|Overall Study||34||
48161349|NCT01301274|100718786|FG001|STARTED|Overall Study||32||
48161350|NCT01301274|100718785|FG000|COMPLETED|Overall Study||32||
48161351|NCT01301274|100718786|FG001|COMPLETED|Overall Study||31||
48161352|NCT01301274|100718785|FG000|NOT COMPLETED|Overall Study||2||
48161353|NCT01301274|100718786|FG001|NOT COMPLETED|Overall Study||1||
48161354|NCT03300570|100718787|FG000|STARTED|Overall Study||13|Randomized|
48161355|NCT03300570|100718788|FG001|STARTED|Overall Study||14|Randomized|
48161356|NCT03300570|100718787|FG000|COMPLETED|Overall Study||11|Evaluable for the primary endpoint|
48161357|NCT03300570|100718788|FG001|COMPLETED|Overall Study||13|Evaluable for the primary endpoint|
48617105|NCT00791219|101849502|FG000|STARTED|Overall Study||24||
48740188|NCT01483183|102147518|FG004|COMPLETED|Overall Study||4||
48740189|NCT01483183|102147519|FG005|COMPLETED|Overall Study||4||
48161358|NCT03300570|100718787|FG000|NOT COMPLETED|Overall Study||2||
48161359|NCT03300570|100718788|FG001|NOT COMPLETED|Overall Study||1||
48740190|NCT01483183|102147520|FG006|COMPLETED|Overall Study||4||
48161360|NCT03287414|100718789|FG000|STARTED|Treatment Epoch||14||
48161361|NCT03287414|100718790|FG001|STARTED|Treatment Epoch||16||
48617106|NCT00791219|101849503|FG001|STARTED|Overall Study||76||
48617107|NCT00791219|101849504|FG002|STARTED|Overall Study||75||
48617108|NCT00791219|101849502|FG000|COMPLETED|Overall Study||19||
48617109|NCT00791219|101849503|FG001|COMPLETED|Overall Study||60||
48617110|NCT00791219|101849504|FG002|COMPLETED|Overall Study||61||
48617111|NCT00791219|101849502|FG000|NOT COMPLETED|Overall Study||5||
48617112|NCT00791219|101849503|FG001|NOT COMPLETED|Overall Study||16||
48617113|NCT00791219|101849504|FG002|NOT COMPLETED|Overall Study||14||
48617114|NCT02256839|101849505|FG000|STARTED|Overall Study||53||
48617115|NCT02256839|101849506|FG001|STARTED|Overall Study||215||
48617116|NCT02256839|101849505|FG000|COMPLETED|Overall Study||51||
48617117|NCT02256839|101849506|FG001|COMPLETED|Overall Study||212||
48617118|NCT02256839|101849505|FG000|NOT COMPLETED|Overall Study||2||
48617119|NCT02256839|101849506|FG001|NOT COMPLETED|Overall Study||3||
48617120|NCT01845597|101849507|FG000|STARTED|Overall Study||145||
48617121|NCT01845597|101849507|FG000|5 Year Survivorship|Overall Study||134||
48617122|NCT01845597|101849507|FG000|COMPLETED|Overall Study||115||
48617123|NCT01845597|101849507|FG000|NOT COMPLETED|Overall Study||30||
48617124|NCT00078403|101849508|FG000|STARTED|Overall Study||44||
48617125|NCT00078403|101849509|FG001|STARTED|Overall Study||42||
48617126|NCT00078403|101849510|FG002|STARTED|Overall Study||169||
48617127|NCT00078403|101849508|FG000|COMPLETED|Overall Study||26||
48617128|NCT00078403|101849509|FG001|COMPLETED|Overall Study||26||
48617129|NCT00078403|101849510|FG002|COMPLETED|Overall Study||141||
48617130|NCT00078403|101849508|FG000|NOT COMPLETED|Overall Study||18||
48617131|NCT00078403|101849509|FG001|NOT COMPLETED|Overall Study||16||
48617132|NCT00078403|101849510|FG002|NOT COMPLETED|Overall Study||28||
48617133|NCT00809445|101849511|FG000|STARTED|1 Month Follow-up||429||
48617134|NCT00809445|101849512|FG001|STARTED|1 Month Follow-up||433||
48617135|NCT00809445|101849513|FG002|STARTED|1 Month Follow-up||419||
48617136|NCT00809445|101849511|FG000|COMPLETED|1 Month Follow-up||427||
48617137|NCT00809445|101849512|FG001|COMPLETED|1 Month Follow-up||429||
48617138|NCT00809445|101849513|FG002|COMPLETED|1 Month Follow-up||415||
48617139|NCT00809445|101849511|FG000|NOT COMPLETED|1 Month Follow-up||2||
48617140|NCT00809445|101849512|FG001|NOT COMPLETED|1 Month Follow-up||4||
48617141|NCT00809445|101849513|FG002|NOT COMPLETED|1 Month Follow-up||4||
48617142|NCT00809445|101849511|FG000|STARTED|6 Month Follow-up||429||
48617143|NCT00809445|101849512|FG001|STARTED|6 Month Follow-up||433||
48617144|NCT00809445|101849513|FG002|STARTED|6 Month Follow-up||419||
48617145|NCT00809445|101849511|FG000|COMPLETED|6 Month Follow-up||405||
48617146|NCT00809445|101849512|FG001|COMPLETED|6 Month Follow-up||410||
48617147|NCT00809445|101849513|FG002|COMPLETED|6 Month Follow-up||395||
48617148|NCT00809445|101849511|FG000|NOT COMPLETED|6 Month Follow-up||24||
48617149|NCT00809445|101849512|FG001|NOT COMPLETED|6 Month Follow-up||23||
48617150|NCT00809445|101849513|FG002|NOT COMPLETED|6 Month Follow-up||24||
48617151|NCT04794751|101849514|FG000|STARTED|Period 1||38||
48617152|NCT04794751|101849515|FG001|STARTED|Period 1||37||
48617153|NCT04794751|101849514|FG000|COMPLETED|Period 1||36||
48617154|NCT04794751|101849515|FG001|COMPLETED|Period 1||32||
48617155|NCT04794751|101849514|FG000|NOT COMPLETED|Period 1||2||
48617156|NCT04794751|101849515|FG001|NOT COMPLETED|Period 1||5||
48617157|NCT04794751|101849514|FG000|STARTED|Period 2||36||
48617158|NCT04794751|101849515|FG001|STARTED|Period 2||32||
48617159|NCT04794751|101849514|FG000|COMPLETED|Period 2||35||
48617160|NCT04794751|101849515|FG001|COMPLETED|Period 2||29||
48617161|NCT04794751|101849514|FG000|NOT COMPLETED|Period 2||1||
48617162|NCT04794751|101849515|FG001|NOT COMPLETED|Period 2||3||
48617163|NCT04794751|101849514|FG000|STARTED|Period 3||35||
48617164|NCT04794751|101849515|FG001|STARTED|Period 3||29||
48617165|NCT04794751|101849514|FG000|COMPLETED|Period 3||35||
48617166|NCT04794751|101849515|FG001|COMPLETED|Period 3||29||
48617167|NCT04794751|101849514|FG000|NOT COMPLETED|Period 3||0||
48617168|NCT04794751|101849515|FG001|NOT COMPLETED|Period 3||0||
48617169|NCT00715299|101849516|FG000|STARTED|Overall Study||36||
48617170|NCT00715299|101849516|FG000|COMPLETED|Overall Study||30||
48617171|NCT00715299|101849516|FG000|NOT COMPLETED|Overall Study||6||
48617172|NCT01387178|101849517|FG000|STARTED|Overall Study||11582||
48617173|NCT01387178|101849518|FG001|STARTED|Overall Study||10641||
48617174|NCT01387178|101849517|FG000|COMPLETED|Overall Study||11582||
48617175|NCT01387178|101849518|FG001|COMPLETED|Overall Study||10641||
48617176|NCT01387178|101849517|FG000|NOT COMPLETED|Overall Study||0||
48617177|NCT01387178|101849518|FG001|NOT COMPLETED|Overall Study||0||
48617178|NCT01520207|101849519|FG000|STARTED|Overall Study||27||
48617179|NCT01520207|101849520|FG001|STARTED|Overall Study||25||
48617180|NCT01520207|101849519|FG000|COMPLETED|Overall Study||25||
48617181|NCT01520207|101849520|FG001|COMPLETED|Overall Study||25||
48617182|NCT01520207|101849519|FG000|NOT COMPLETED|Overall Study||2||
48617183|NCT01520207|101849520|FG001|NOT COMPLETED|Overall Study||0||
48617184|NCT00472732|101849521|FG000|STARTED|Overall Study||24||
48617185|NCT00472732|101849522|FG001|STARTED|Overall Study||22||
48617186|NCT00472732|101849521|FG000|COMPLETED|Overall Study||24||
48617187|NCT00472732|101849522|FG001|COMPLETED|Overall Study||22||
48617188|NCT00472732|101849521|FG000|NOT COMPLETED|Overall Study||0||
48617189|NCT00472732|101849522|FG001|NOT COMPLETED|Overall Study||0||
48617190|NCT01715948|101849523|FG000|STARTED|Overall Study||9||
48617191|NCT01715948|101849523|FG000|COMPLETED|Overall Study||8||
48740191|NCT01483183|102147521|FG007|COMPLETED|Overall Study||4||
48740192|NCT01483183|102147522|FG008|COMPLETED|Overall Study||4||
48740193|NCT01483183|102147523|FG009|COMPLETED|Overall Study||4||
48740194|NCT01483183|102147514|FG000|NOT COMPLETED|Overall Study||0||
48740195|NCT01483183|102147515|FG001|NOT COMPLETED|Overall Study||0||
48740196|NCT01483183|102147516|FG002|NOT COMPLETED|Overall Study||0||
48740197|NCT01483183|102147517|FG003|NOT COMPLETED|Overall Study||0||
48617192|NCT01715948|101849523|FG000|NOT COMPLETED|Overall Study||1||
48617193|NCT01579513|101849524|FG000|STARTED|Primary Hospitalization||91||
48617194|NCT01579513|101849525|FG001|STARTED|Primary Hospitalization||99||
48617195|NCT01579513|101849524|FG000|COMPLETED|Primary Hospitalization||81||
48617196|NCT01579513|101849525|FG001|COMPLETED|Primary Hospitalization||95||
48617197|NCT01579513|101849524|FG000|NOT COMPLETED|Primary Hospitalization||10||
48617198|NCT01579513|101849525|FG001|NOT COMPLETED|Primary Hospitalization||4||
48617199|NCT01579513|101849524|FG000|STARTED|1 Year Neurodevelopmental Follow up||81||
48617200|NCT01579513|101849525|FG001|STARTED|1 Year Neurodevelopmental Follow up||95||
48617201|NCT01579513|101849524|FG000|COMPLETED|1 Year Neurodevelopmental Follow up||61||
48617202|NCT01579513|101849525|FG001|COMPLETED|1 Year Neurodevelopmental Follow up||68||
48617203|NCT01579513|101849524|FG000|NOT COMPLETED|1 Year Neurodevelopmental Follow up||20||
48617204|NCT01579513|101849525|FG001|NOT COMPLETED|1 Year Neurodevelopmental Follow up||27||
48617205|NCT01817075|101849526|FG000|STARTED|Overall Study||88||
48617206|NCT01817075|101849527|FG001|STARTED|Overall Study||89||
48617207|NCT01817075|101849526|FG000|COMPLETED|Overall Study||41||
48617208|NCT01817075|101849527|FG001|COMPLETED|Overall Study||54||
48617209|NCT01817075|101849526|FG000|NOT COMPLETED|Overall Study||47||
48617210|NCT01817075|101849527|FG001|NOT COMPLETED|Overall Study||35||
48617211|NCT02573259|101849528|FG000|STARTED|Overall Study||2||
48617212|NCT02573259|101849529|FG001|STARTED|Overall Study||8||
48617213|NCT02573259|101849530|FG002|STARTED|Overall Study||8||
48617214|NCT02573259|101849531|FG003|STARTED|Overall Study||7||
48617215|NCT02573259|101849532|FG004|STARTED|Overall Study||15||
48617216|NCT02573259|101849533|FG005|STARTED|Overall Study||68||
48617217|NCT02573259|101849534|FG006|STARTED|Overall Study||39||
48617218|NCT02573259|101849528|FG000|Treated|Overall Study||2||
48617219|NCT02573259|101849529|FG001|Treated|Overall Study||8||
48617220|NCT02573259|101849530|FG002|Treated|Overall Study||8||
48617221|NCT02573259|101849531|FG003|Treated|Overall Study||7||
48617222|NCT02573259|101849532|FG004|Treated|Overall Study||15||
48740198|NCT01483183|102147518|FG004|NOT COMPLETED|Overall Study||0||
48740199|NCT01483183|102147519|FG005|NOT COMPLETED|Overall Study||0||
48740200|NCT01483183|102147520|FG006|NOT COMPLETED|Overall Study||2||
48740201|NCT01483183|102147521|FG007|NOT COMPLETED|Overall Study||0||
48740202|NCT01483183|102147522|FG008|NOT COMPLETED|Overall Study||0||
48740203|NCT01483183|102147523|FG009|NOT COMPLETED|Overall Study||1||
48617223|NCT02573259|101849533|FG005|Treated|Overall Study||68||
48617224|NCT02573259|101849534|FG006|Treated|Overall Study||38||
48617225|NCT02573259|101849528|FG000|COMPLETED|Overall Study||1||
48617226|NCT02573259|101849529|FG001|COMPLETED|Overall Study||0||
48617227|NCT02573259|101849530|FG002|COMPLETED|Overall Study||2||
48617228|NCT02573259|101849531|FG003|COMPLETED|Overall Study||1||
48617229|NCT02573259|101849532|FG004|COMPLETED|Overall Study||2||
48617230|NCT02573259|101849533|FG005|COMPLETED|Overall Study||10||
48617231|NCT02573259|101849534|FG006|COMPLETED|Overall Study||5||
48617232|NCT02573259|101849528|FG000|NOT COMPLETED|Overall Study||1||
48617233|NCT02573259|101849529|FG001|NOT COMPLETED|Overall Study||8||
48617234|NCT02573259|101849530|FG002|NOT COMPLETED|Overall Study||6||
48617235|NCT02573259|101849531|FG003|NOT COMPLETED|Overall Study||6||
48617236|NCT02573259|101849532|FG004|NOT COMPLETED|Overall Study||13||
48617237|NCT02573259|101849533|FG005|NOT COMPLETED|Overall Study||58||
48617238|NCT02573259|101849534|FG006|NOT COMPLETED|Overall Study||34||
48617239|NCT02302846|101849535|FG000|STARTED|Overall Study||5||
48617240|NCT02302846|101849535|FG000|COMPLETED|Overall Study||4||
48617241|NCT02302846|101849535|FG000|NOT COMPLETED|Overall Study||1||
48617242|NCT02003144|101849536|FG000|STARTED|Blind Induction Phase||41||
48617243|NCT02003144|101849537|FG001|STARTED|Blind Induction Phase||78||
48617244|NCT02003144|101849536|FG000|Received at Least 1 Dose of Study Drug|Blind Induction Phase||41||
48617245|NCT02003144|101849537|FG001|Received at Least 1 Dose of Study Drug|Blind Induction Phase||78||
48617246|NCT02003144|101849536|FG000|COMPLETED|Blind Induction Phase||41||
48617247|NCT02003144|101849537|FG001|COMPLETED|Blind Induction Phase||78||
48617248|NCT02003144|101849536|FG000|NOT COMPLETED|Blind Induction Phase||0||
48617249|NCT02003144|101849537|FG001|NOT COMPLETED|Blind Induction Phase||0||
48617250|NCT02003144|101849536|FG000|STARTED|Open Label Maintenance Phase||41||
48617251|NCT02003144|101849537|FG001|STARTED|Open Label Maintenance Phase||78||
48617252|NCT02003144|101849536|FG000|Received at Least 1 Dose of Study Drug|Open Label Maintenance Phase||41||
48617253|NCT02003144|101849537|FG001|Received at Least 1 Dose of Study Drug|Open Label Maintenance Phase||78||
48617254|NCT02003144|101849536|FG000|COMPLETED|Open Label Maintenance Phase||32||
48617255|NCT02003144|101849537|FG001|COMPLETED|Open Label Maintenance Phase||64||
48617256|NCT02003144|101849536|FG000|NOT COMPLETED|Open Label Maintenance Phase||9||
48740204|NCT03828331|102147524|FG000|STARTED|Overall Study||12||
48740205|NCT03828331|102147524|FG000|COMPLETED|Overall Study||12||
48740206|NCT03828331|102147524|FG000|NOT COMPLETED|Overall Study||0||
48740207|NCT03315039|102147525|FG000|STARTED|Overall Study||4||
48740208|NCT03315039|102147526|FG001|STARTED|Overall Study||3||
48740209|NCT03315039|102147525|FG000|COMPLETED|Overall Study||4||
48740210|NCT03315039|102147526|FG001|COMPLETED|Overall Study||3||
48740211|NCT03315039|102147525|FG000|NOT COMPLETED|Overall Study||0||
48740212|NCT03315039|102147526|FG001|NOT COMPLETED|Overall Study||0||
48740213|NCT01511068|102147527|FG000|STARTED|Overall Study||2||
48740214|NCT01511068|102147527|FG000|COMPLETED|Overall Study||2||
48740215|NCT01511068|102147527|FG000|NOT COMPLETED|Overall Study||0||
48740216|NCT01937260|102147528|FG000|STARTED|Overall Study||21||
48740217|NCT01937260|102147529|FG001|STARTED|Overall Study||10||
48740218|NCT01937260|102147528|FG000|COMPLETED|Overall Study||20||
48740219|NCT01937260|102147529|FG001|COMPLETED|Overall Study||10||
48740220|NCT01937260|102147528|FG000|NOT COMPLETED|Overall Study||1||
48740221|NCT01937260|102147529|FG001|NOT COMPLETED|Overall Study||0||
48740222|NCT00767806|102147530|FG000|STARTED|Overall Study||198||
48740223|NCT00767806|102147531|FG001|STARTED|Overall Study||203||
48740224|NCT00767806|102147530|FG000|COMPLETED|Overall Study||147||
48740225|NCT00767806|102147531|FG001|COMPLETED|Overall Study||156||
48740226|NCT00767806|102147530|FG000|NOT COMPLETED|Overall Study||51||
48740227|NCT00767806|102147531|FG001|NOT COMPLETED|Overall Study||47||
48740228|NCT00797277|102147532|FG000|STARTED|Overall Study||37||
48740229|NCT00797277|102147533|FG001|STARTED|Overall Study||30||
48740230|NCT00797277|102147532|FG000|COMPLETED|Overall Study||37||
48740231|NCT00797277|102147533|FG001|COMPLETED|Overall Study||30||
48740232|NCT00797277|102147532|FG000|NOT COMPLETED|Overall Study||0||
48740233|NCT00797277|102147533|FG001|NOT COMPLETED|Overall Study||0||
48740234|NCT04538417|102147534|FG000|STARTED|Overall Study||8||
48740235|NCT04538417|102147534|FG000|Withdrew to Have Phenol Ablation|Overall Study||1||
48740236|NCT04538417|102147534|FG000|Withdrew to Have Targeted Muscle Reinnervation Therapy|Overall Study||1||
48740237|NCT04538417|102147534|FG000|COMPLETED|Overall Study||6||
48740238|NCT04538417|102147534|FG000|NOT COMPLETED|Overall Study||2||
48740239|NCT02292446|102147535|FG000|STARTED|Overall Study||161||
48740240|NCT02292446|102147535|FG000|COMPLETED|Overall Study||141||
48740241|NCT02292446|102147535|FG000|NOT COMPLETED|Overall Study||20||
48740242|NCT00941915|102147536|FG000|STARTED|Overall Study||60||
48740243|NCT00941915|102147536|FG000|COMPLETED|Overall Study||60||
48740244|NCT00941915|102147536|FG000|NOT COMPLETED|Overall Study||0||
48740245|NCT00413036|102147537|FG000|STARTED|Overall Study||217||
48740246|NCT00413036|102147537|FG000|COMPLETED|Overall Study||0||
48322048|NCT01714687|101114826|FG000|STARTED|Overall Study||29||
48322049|NCT01714687|101114827|FG001|STARTED|Overall Study||30||
48322050|NCT01714687|101114826|FG000|COMPLETED|Overall Study||26||
48322051|NCT01714687|101114827|FG001|COMPLETED|Overall Study||26||
48322052|NCT01714687|101114826|FG000|NOT COMPLETED|Overall Study||3||
48322053|NCT01714687|101114827|FG001|NOT COMPLETED|Overall Study||4||
48322054|NCT00794157|101114828|FG000|STARTED|Overall Study||114||
48322055|NCT00794157|101114829|FG001|STARTED|Overall Study||116||
48322056|NCT00794157|101114830|FG002|STARTED|Overall Study||117||
48322057|NCT00794157|101114828|FG000|COMPLETED|Overall Study||104||
48322058|NCT00794157|101114829|FG001|COMPLETED|Overall Study||106||
48322059|NCT00794157|101114830|FG002|COMPLETED|Overall Study||98||
48322060|NCT00794157|101114828|FG000|NOT COMPLETED|Overall Study||10||
48740247|NCT00413036|102147537|FG000|NOT COMPLETED|Overall Study||217||
48740248|NCT03350815|102147538|FG000|STARTED|Period 1||322||
48740249|NCT03350815|102147539|FG001|STARTED|Period 1||0||
48740250|NCT03350815|102147540|FG002|STARTED|Period 1||0||
48740251|NCT03350815|102147541|FG003|STARTED|Period 1||0||
48740252|NCT03350815|102147538|FG000|Non-responders|Period 1||50|"One patient completed Treatment Period 1 and was randomized (secukinumab 150 mg - 300 mg \[IR\]); however, the patient did not receive any treatment in Treatment Period 2 due to Technical problems."|
48322061|NCT00794157|101114829|FG001|NOT COMPLETED|Overall Study||10||
48322062|NCT00794157|101114830|FG002|NOT COMPLETED|Overall Study||19||
48617257|NCT02003144|101849537|FG001|NOT COMPLETED|Open Label Maintenance Phase||14||
48617258|NCT01249417|101849538|FG000|STARTED|Randomised Population||80||
48617259|NCT01249417|101849539|FG001|STARTED|Randomised Population||80||
48617260|NCT01249417|101849540|FG002|STARTED|Randomised Population||81||
48617261|NCT01249417|101849538|FG000|Treated|Randomised Population||80|Constitutes the safety population.|
48617262|NCT01249417|101849539|FG001|Treated|Randomised Population||80|Constitutes the safety population.|
48617263|NCT01249417|101849540|FG002|Treated|Randomised Population||79|Constitutes the safety population.|
48617264|NCT01249417|101849538|FG000|COMPLETED|Randomised Population||79||
48617265|NCT01249417|101849539|FG001|COMPLETED|Randomised Population||79||
48617266|NCT01249417|101849540|FG002|COMPLETED|Randomised Population||77||
48617267|NCT01249417|101849538|FG000|NOT COMPLETED|Randomised Population||1||
48617268|NCT01249417|101849539|FG001|NOT COMPLETED|Randomised Population||1||
48617269|NCT01249417|101849540|FG002|NOT COMPLETED|Randomised Population||4||
48617270|NCT01249417|101849538|FG000|STARTED|Treatment Phase - ITT Population||79||
48617271|NCT01249417|101849539|FG001|STARTED|Treatment Phase - ITT Population||79||
48617272|NCT01249417|101849540|FG002|STARTED|Treatment Phase - ITT Population||77||
48617273|NCT01249417|101849538|FG000|COMPLETED|Treatment Phase - ITT Population||78||
48617274|NCT01249417|101849539|FG001|COMPLETED|Treatment Phase - ITT Population||75||
48617275|NCT01249417|101849540|FG002|COMPLETED|Treatment Phase - ITT Population||73||
48617276|NCT01249417|101849538|FG000|NOT COMPLETED|Treatment Phase - ITT Population||1||
48617277|NCT01249417|101849539|FG001|NOT COMPLETED|Treatment Phase - ITT Population||4||
48617278|NCT01249417|101849540|FG002|NOT COMPLETED|Treatment Phase - ITT Population||4||
48617279|NCT02171429|101849541|FG000|STARTED|Overall Study||72||
48617280|NCT02171429|101849542|FG001|STARTED|Overall Study||143||
48617281|NCT02171429|101849543|FG002|STARTED|Overall Study||143||
48617282|NCT02171429|101849541|FG000|Completed Week 10 Visit|Overall Study||70||
48617283|NCT02171429|101849542|FG001|Completed Week 10 Visit|Overall Study||141||
48617284|NCT02171429|101849543|FG002|Completed Week 10 Visit|Overall Study||141||
48617285|NCT02171429|101849541|FG000|COMPLETED|Overall Study||71|Participants who rolled into open-label extension study or completed 12 weeks safety follow-up following treatment completion or discontinuation.|
48617286|NCT02171429|101849542|FG001|COMPLETED|Overall Study||140|Participants who rolled into open-label extension study or completed 12 weeks safety follow-up following treatment completion or discontinuation.|
48617287|NCT02171429|101849543|FG002|COMPLETED|Overall Study||138|Participants who rolled into open-label extension study or completed 12 weeks safety follow-up following treatment completion or discontinuation.|
48617288|NCT02171429|101849541|FG000|NOT COMPLETED|Overall Study||1||
48617289|NCT02171429|101849542|FG001|NOT COMPLETED|Overall Study||3||
48617290|NCT02171429|101849543|FG002|NOT COMPLETED|Overall Study||5||
48617291|NCT00970489|101849544|FG000|STARTED|Overall Study||758||
48617292|NCT00970489|101849545|FG001|STARTED|Overall Study||758||
48617293|NCT00970489|101849544|FG000|COMPLETED|Overall Study||704||
48617294|NCT00970489|101849545|FG001|COMPLETED|Overall Study||717||
48617295|NCT00970489|101849544|FG000|NOT COMPLETED|Overall Study||54||
48617296|NCT00970489|101849545|FG001|NOT COMPLETED|Overall Study||41||
48617297|NCT01178125|101849546|FG000|STARTED|Overall Study||2858||
48617298|NCT01178125|101849546|FG000|Safety Population|Overall Study||2765||
48617299|NCT01178125|101849546|FG000|Intent to Treat (ITT) Population|Overall Study||2607||
48767630|NCT01063751|102222784|FG000|COMPLETED|Overall Study||23||25
48767631|NCT01063751|102222784|FG000|NOT COMPLETED|Overall Study||211||216
48322063|NCT03269435|101114831|FG000|STARTED|Overall Study||51||
48322064|NCT03269435|101114832|FG001|STARTED|Overall Study||48||
48322065|NCT03269435|101114831|FG000|COMPLETED|Overall Study||51||
48322066|NCT03269435|101114832|FG001|COMPLETED|Overall Study||48||
48161362|NCT03287414|100718789|FG000|Treated|Treatment Epoch||13||
48161363|NCT03287414|100718790|FG001|Treated|Treatment Epoch||16||
48161364|NCT03287414|100718789|FG000|COMPLETED|Treatment Epoch||6||
48161365|NCT03287414|100718790|FG001|COMPLETED|Treatment Epoch||12||
48161366|NCT03287414|100718789|FG000|NOT COMPLETED|Treatment Epoch||8||
48617300|NCT01178125|101849546|FG000|Pregnancy ITT (PITT) Population|Overall Study||2401||
48617301|NCT01178125|101849546|FG000|COMPLETED|Overall Study||1680||
48617302|NCT01178125|101849546|FG000|NOT COMPLETED|Overall Study||1178||
48617303|NCT01566604|101849547|FG000|STARTED|Overall Study||306||
48617304|NCT01566604|101849548|FG001|STARTED|Overall Study||154||
48617305|NCT01566604|101849547|FG000|Safety Set|Overall Study||305||
48617306|NCT01566604|101849548|FG001|Safety Set|Overall Study||154||
48617307|NCT01566604|101849547|FG000|Full Analysis Set (FAS)|Overall Study||305||
48617308|NCT01566604|101849548|FG001|Full Analysis Set (FAS)|Overall Study||154||
48617309|NCT01566604|101849547|FG000|FAS, Serial Spirometry Subgroup|Overall Study||134||
48161367|NCT03287414|100718790|FG001|NOT COMPLETED|Treatment Epoch||4||
48161368|NCT03287414|100718789|FG000|STARTED|PK/Safety Follow-up Epoch||7||
48161369|NCT03287414|100718790|FG001|STARTED|PK/Safety Follow-up Epoch||13||
48161370|NCT03287414|100718789|FG000|COMPLETED|PK/Safety Follow-up Epoch||7||
48161371|NCT03287414|100718790|FG001|COMPLETED|PK/Safety Follow-up Epoch||13||
48161372|NCT03287414|100718789|FG000|NOT COMPLETED|PK/Safety Follow-up Epoch||0||
48161373|NCT03287414|100718790|FG001|NOT COMPLETED|PK/Safety Follow-up Epoch||0||
48161374|NCT03287414|100718789|FG000|STARTED|PD/Safety Follow-up Epoch||7||
48161375|NCT03287414|100718790|FG001|STARTED|PD/Safety Follow-up Epoch||0||
48161376|NCT03287414|100718789|FG000|COMPLETED|PD/Safety Follow-up Epoch||5||
48161377|NCT03287414|100718790|FG001|COMPLETED|PD/Safety Follow-up Epoch||0||
48161378|NCT03287414|100718789|FG000|NOT COMPLETED|PD/Safety Follow-up Epoch||2||
48161379|NCT03287414|100718790|FG001|NOT COMPLETED|PD/Safety Follow-up Epoch||0||
48161380|NCT04394247|100718791|FG000|STARTED|Overall Study||242||
48161381|NCT04394247|100718791|FG000|COMPLETED|Overall Study||242||
48161382|NCT04394247|100718791|FG000|NOT COMPLETED|Overall Study||0||
48161383|NCT01015976|100718792|FG000|STARTED|Overall Study||5||
48161384|NCT01015976|100718793|FG001|STARTED|Overall Study||5||
48161385|NCT01015976|100718792|FG000|COMPLETED|Overall Study||5||
48161386|NCT01015976|100718793|FG001|COMPLETED|Overall Study||5||
48161387|NCT01015976|100718792|FG000|NOT COMPLETED|Overall Study||0||
48161388|NCT01015976|100718793|FG001|NOT COMPLETED|Overall Study||0||
48161389|NCT01802437|100718794|FG000|STARTED|Overall Study||20||
48161390|NCT01802437|100718795|FG001|STARTED|Overall Study||20||
48161391|NCT01802437|100718794|FG000|COMPLETED|Overall Study||16||
48161392|NCT01802437|100718795|FG001|COMPLETED|Overall Study||16||
48161393|NCT01802437|100718794|FG000|NOT COMPLETED|Overall Study||4||
48161394|NCT01802437|100718795|FG001|NOT COMPLETED|Overall Study||4||
48161395|NCT02093663|100718796|FG000|STARTED|Double Blind Acute Phase (8 Weeks)||27||
48161396|NCT02093663|100718797|FG001|STARTED|Double Blind Acute Phase (8 Weeks)||26||
48617310|NCT01566604|101849548|FG001|FAS, Serial Spirometry Subgroup|Overall Study||58||
48617311|NCT01566604|101849547|FG000|COMPLETED|Overall Study||282||
48617312|NCT01566604|101849548|FG001|COMPLETED|Overall Study||143||
48617313|NCT01566604|101849547|FG000|NOT COMPLETED|Overall Study||24||
48617314|NCT01566604|101849548|FG001|NOT COMPLETED|Overall Study||11||
48617315|NCT02824627|101849549|FG000|STARTED|Overall Study||28||
48617316|NCT02824627|101849550|FG001|STARTED|Overall Study||30||
48617317|NCT02824627|101849549|FG000|COMPLETED|Overall Study||25||
48617318|NCT02824627|101849550|FG001|COMPLETED|Overall Study||27||
48617319|NCT02824627|101849549|FG000|NOT COMPLETED|Overall Study||3||
48617320|NCT02824627|101849550|FG001|NOT COMPLETED|Overall Study||3||
48617321|NCT00441285|101849551|FG000|STARTED|Overall Study||16||
48617322|NCT00441285|101849552|FG001|STARTED|Overall Study||16||
48617323|NCT00441285|101849553|FG002|STARTED|Overall Study||41||
48617324|NCT00441285|101849554|FG003|STARTED|Overall Study||40||
48617325|NCT00441285|101849555|FG004|STARTED|Overall Study||43||
48617326|NCT00441285|101849551|FG000|COMPLETED|Overall Study||16||
48617327|NCT00441285|101849552|FG001|COMPLETED|Overall Study||16||
48617328|NCT00441285|101849553|FG002|COMPLETED|Overall Study||41||
48617329|NCT00441285|101849554|FG003|COMPLETED|Overall Study||40||
48617330|NCT00441285|101849555|FG004|COMPLETED|Overall Study||43||
48617331|NCT00441285|101849551|FG000|NOT COMPLETED|Overall Study||0||
48617332|NCT00441285|101849552|FG001|NOT COMPLETED|Overall Study||0||
48617333|NCT00441285|101849553|FG002|NOT COMPLETED|Overall Study||0||
48617334|NCT00441285|101849554|FG003|NOT COMPLETED|Overall Study||0||
48617335|NCT00441285|101849555|FG004|NOT COMPLETED|Overall Study||0||
48617336|NCT03150329|101849556|FG000|STARTED|Overall Study||6||
48617337|NCT03150329|101849557|FG001|STARTED|Overall Study||46||
48617338|NCT03150329|101849556|FG000|COMPLETED|Overall Study||6||
48161397|NCT02093663|100718798|FG002|STARTED|Double Blind Acute Phase (8 Weeks)||0||
48161398|NCT02093663|100718799|FG003|STARTED|Double Blind Acute Phase (8 Weeks)||0||
48161399|NCT02093663|100718800|FG004|STARTED|Double Blind Acute Phase (8 Weeks)||0||
48161400|NCT02093663|100718796|FG000|COMPLETED|Double Blind Acute Phase (8 Weeks)||19||
48161401|NCT02093663|100718797|FG001|COMPLETED|Double Blind Acute Phase (8 Weeks)||22||
48617339|NCT03150329|101849557|FG001|COMPLETED|Overall Study||46||
48617340|NCT03150329|101849556|FG000|NOT COMPLETED|Overall Study||0||
48617341|NCT03150329|101849557|FG001|NOT COMPLETED|Overall Study||0||
48161402|NCT02093663|100718798|FG002|COMPLETED|Double Blind Acute Phase (8 Weeks)||0||
48161403|NCT02093663|100718799|FG003|COMPLETED|Double Blind Acute Phase (8 Weeks)||0||
48161404|NCT02093663|100718800|FG004|COMPLETED|Double Blind Acute Phase (8 Weeks)||0||
48161405|NCT02093663|100718796|FG000|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||8||
48161406|NCT02093663|100718797|FG001|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||4||
48161407|NCT02093663|100718798|FG002|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0||
48161408|NCT02093663|100718799|FG003|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0||
48161409|NCT02093663|100718800|FG004|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0||
48161410|NCT02093663|100718796|FG000|STARTED|Open Label Acute Phase (8 Weeks)||0||
48161411|NCT02093663|100718797|FG001|STARTED|Open Label Acute Phase (8 Weeks)||0||
48161412|NCT02093663|100718798|FG002|STARTED|Open Label Acute Phase (8 Weeks)||18||
48161413|NCT02093663|100718799|FG003|STARTED|Open Label Acute Phase (8 Weeks)||0||
48161414|NCT02093663|100718800|FG004|STARTED|Open Label Acute Phase (8 Weeks)||0||
48161415|NCT02093663|100718796|FG000|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0||
48161416|NCT02093663|100718797|FG001|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0||
48161417|NCT02093663|100718798|FG002|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||18||
48161418|NCT02093663|100718799|FG003|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0||
48161419|NCT02093663|100718800|FG004|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0||
48161420|NCT02093663|100718796|FG000|COMPLETED|Open Label Acute Phase (8 Weeks)||0||
48161421|NCT02093663|100718797|FG001|COMPLETED|Open Label Acute Phase (8 Weeks)||0||
48161422|NCT02093663|100718798|FG002|COMPLETED|Open Label Acute Phase (8 Weeks)||12||
48161423|NCT02093663|100718799|FG003|COMPLETED|Open Label Acute Phase (8 Weeks)||0||
48161424|NCT02093663|100718800|FG004|COMPLETED|Open Label Acute Phase (8 Weeks)||0||
48161425|NCT02093663|100718796|FG000|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0||
48161426|NCT02093663|100718797|FG001|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0||
48161427|NCT02093663|100718798|FG002|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||6||
48161428|NCT02093663|100718799|FG003|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0||
48161429|NCT02093663|100718800|FG004|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0||
48161430|NCT02093663|100718796|FG000|STARTED|Double Blind Maintenance Phase(26 Weeks)||0||
48161431|NCT02093663|100718797|FG001|STARTED|Double Blind Maintenance Phase(26 Weeks)||0||
48161432|NCT02093663|100718798|FG002|STARTED|Double Blind Maintenance Phase(26 Weeks)||0||
48161433|NCT02093663|100718799|FG003|STARTED|Double Blind Maintenance Phase(26 Weeks)||42||
48161434|NCT02093663|100718800|FG004|STARTED|Double Blind Maintenance Phase(26 Weeks)||45||
48161435|NCT02093663|100718796|FG000|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0||
48161436|NCT02093663|100718797|FG001|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0||
48161437|NCT02093663|100718798|FG002|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0||
48161438|NCT02093663|100718799|FG003|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||26||
48161439|NCT02093663|100718800|FG004|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||26||
48161440|NCT02093663|100718796|FG000|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0||
48161441|NCT02093663|100718797|FG001|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0||
48161442|NCT02093663|100718798|FG002|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0||
48161443|NCT02093663|100718799|FG003|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||12||
48161444|NCT02093663|100718800|FG004|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||15||
48161445|NCT02093663|100718796|FG000|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0||
48161446|NCT02093663|100718797|FG001|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0||
48161447|NCT02093663|100718798|FG002|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0||
48161448|NCT02093663|100718799|FG003|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||4||
48161449|NCT02093663|100718800|FG004|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||4||
48161450|NCT02093663|100718796|FG000|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0||
48161451|NCT02093663|100718797|FG001|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0||
48161452|NCT02093663|100718798|FG002|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0||
48161453|NCT02093663|100718799|FG003|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||32||
48161454|NCT02093663|100718800|FG004|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||34||
48161455|NCT02093663|100718796|FG000|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0||
48161456|NCT02093663|100718797|FG001|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0||
48161457|NCT02093663|100718798|FG002|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0||
48161458|NCT02093663|100718799|FG003|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||10||
48161459|NCT02093663|100718800|FG004|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||11||
48161460|NCT01125722|100718801|FG000|STARTED|Overall Study||37||
48161461|NCT01125722|100718802|FG001|STARTED|Overall Study||37||
48161462|NCT01125722|100718801|FG000|COMPLETED|Overall Study||34||
48161463|NCT01125722|100718802|FG001|COMPLETED|Overall Study||36||
48161464|NCT01125722|100718801|FG000|NOT COMPLETED|Overall Study||3||
48161465|NCT01125722|100718802|FG001|NOT COMPLETED|Overall Study||1||
48161466|NCT02313909|100718803|FG000|STARTED|Overall Study||3609||
48161467|NCT02313909|100718804|FG001|STARTED|Overall Study||3604||
48161468|NCT02313909|100718803|FG000|Treated|Overall Study||3562||
48161469|NCT02313909|100718804|FG001|Treated|Overall Study||3559||
48161470|NCT02313909|100718803|FG000|COMPLETED|Overall Study||3552||
48161471|NCT02313909|100718804|FG001|COMPLETED|Overall Study||3554||
48161472|NCT02313909|100718803|FG000|NOT COMPLETED|Overall Study||57||
48161473|NCT02313909|100718804|FG001|NOT COMPLETED|Overall Study||50||
48161474|NCT03482505|100718805|FG000|STARTED|Overall Study||10||
48161475|NCT03482505|100718805|FG000|COMPLETED|Overall Study||10||
48161476|NCT03482505|100718805|FG000|NOT COMPLETED|Overall Study||0||
48161477|NCT03976466|100718806|FG000|STARTED|Overall Study||44||
48161478|NCT03976466|100718807|FG001|STARTED|Overall Study||43||
48161479|NCT03976466|100718806|FG000|COMPLETED|Overall Study||43||
48161480|NCT03976466|100718807|FG001|COMPLETED|Overall Study||40||
48161481|NCT03976466|100718806|FG000|NOT COMPLETED|Overall Study||1||
48408117|NCT00063986|101331722|FG000|Eligible and Treated|Overall Study||104||
48408118|NCT00063986|101331722|FG000|COMPLETED|Overall Study||104||
48408119|NCT00063986|101331722|FG000|NOT COMPLETED|Overall Study||6||
48408120|NCT02462122|101331723|FG000|STARTED|Overall Study||141||
48408121|NCT02462122|101331724|FG001|STARTED|Overall Study||74||
48408122|NCT02462122|101331723|FG000|COMPLETED|Overall Study||120||
48408123|NCT02462122|101331724|FG001|COMPLETED|Overall Study||61||
48408124|NCT02462122|101331723|FG000|NOT COMPLETED|Overall Study||21||
48408125|NCT02462122|101331724|FG001|NOT COMPLETED|Overall Study||13||
48408126|NCT02431793|101331725|FG000|STARTED|Overall Study||202||
48408127|NCT02431793|101331726|FG001|STARTED|Overall Study||243||
48408128|NCT02431793|101331727|FG002|STARTED|Overall Study||207||
48408129|NCT02431793|101331725|FG000|Completed T1 (3-5 Days Post Enrollment)|Overall Study||136||
48408130|NCT02431793|101331726|FG001|Completed T1 (3-5 Days Post Enrollment)|Overall Study||180||
48408131|NCT02431793|101331727|FG002|Completed T1 (3-5 Days Post Enrollment)|Overall Study||143||
48161482|NCT03976466|100718807|FG001|NOT COMPLETED|Overall Study||3||
48161483|NCT00855595|100718808|FG000|STARTED|Overall Study||106||
48161484|NCT00855595|100718809|FG001|STARTED|Overall Study||101||
48161485|NCT00855595|100718808|FG000|COMPLETED|Overall Study||100||
48161486|NCT00855595|100718809|FG001|COMPLETED|Overall Study||94||
48161487|NCT00855595|100718808|FG000|NOT COMPLETED|Overall Study||6||
48161488|NCT00855595|100718809|FG001|NOT COMPLETED|Overall Study||7||
48161489|NCT01852058|100718810|FG000|STARTED|Treatment Cycle 1, Occurred in Study 120||31||
48161490|NCT01852058|100718811|FG001|STARTED|Treatment Cycle 1, Occurred in Study 120||39||
48161491|NCT01852058|100718812|FG002|STARTED|Treatment Cycle 1, Occurred in Study 120||25||
48161492|NCT01852058|100718813|FG003|STARTED|Treatment Cycle 1, Occurred in Study 120||0||
48161493|NCT01852058|100718814|FG004|STARTED|Treatment Cycle 1, Occurred in Study 120||0||
48161494|NCT01852058|100718815|FG005|STARTED|Treatment Cycle 1, Occurred in Study 120||0||
48161495|NCT01852058|100718816|FG006|STARTED|Treatment Cycle 1, Occurred in Study 120||0||
48161496|NCT01852058|100718817|FG007|STARTED|Treatment Cycle 1, Occurred in Study 120||0||
48161497|NCT01852058|100718818|FG008|STARTED|Treatment Cycle 1, Occurred in Study 120||0||
48161498|NCT01852058|100718819|FG009|STARTED|Treatment Cycle 1, Occurred in Study 120||0||
48161499|NCT01852058|100718820|FG010|STARTED|Treatment Cycle 1, Occurred in Study 120||0||
48408132|NCT02431793|101331725|FG000|Completed T2 (7-14 Days Post Enrollment)|Overall Study||95||
48408133|NCT02431793|101331726|FG001|Completed T2 (7-14 Days Post Enrollment)|Overall Study||141||
48408134|NCT02431793|101331727|FG002|Completed T2 (7-14 Days Post Enrollment)|Overall Study||107||
48408135|NCT02431793|101331725|FG000|Completed T3 (30 Days Post Enrollment)|Overall Study||85||
48408136|NCT02431793|101331726|FG001|Completed T3 (30 Days Post Enrollment)|Overall Study||113||
48408137|NCT02431793|101331727|FG002|Completed T3 (30 Days Post Enrollment)|Overall Study||93||
48408138|NCT02431793|101331725|FG000|COMPLETED|Overall Study||83||
48408139|NCT02431793|101331726|FG001|COMPLETED|Overall Study||109||
48408140|NCT02431793|101331727|FG002|COMPLETED|Overall Study||90||
48161500|NCT01852058|100718821|FG011|STARTED|Treatment Cycle 1, Occurred in Study 120||0||
48161501|NCT01852058|100718810|FG000|COMPLETED|Treatment Cycle 1, Occurred in Study 120||30|Completed=Completed the entire study in this Cycle|
48161502|NCT01852058|100718811|FG001|COMPLETED|Treatment Cycle 1, Occurred in Study 120||39|Completed=Completed the entire study in this Cycle|
48188749|NCT00821236|100783327|FG000|COMPLETED|Overall Study||37||
48161503|NCT01852058|100718812|FG002|COMPLETED|Treatment Cycle 1, Occurred in Study 120||25|Completed=Completed the entire study in this Cycle|
48161504|NCT01852058|100718813|FG003|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0|Completed=Completed the entire study in this Cycle|
48161505|NCT01852058|100718814|FG004|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0|Completed=Completed the entire study in this Cycle|
48161506|NCT01852058|100718815|FG005|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0|Completed=Completed the entire study in this Cycle|
48161507|NCT01852058|100718816|FG006|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0|Completed=Completed the entire study in this Cycle|
48161508|NCT01852058|100718817|FG007|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0|Completed=Completed the entire study in this Cycle|
48161509|NCT01852058|100718818|FG008|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0|Completed=Completed the entire study in this Cycle|
48161510|NCT01852058|100718819|FG009|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0|Completed=Completed the entire study in this Cycle|
48161511|NCT01852058|100718820|FG010|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0|Completed=Completed the entire study in this Cycle|
48161512|NCT01852058|100718821|FG011|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0|Completed=Completed the entire study in this Cycle|
48161513|NCT01852058|100718810|FG000|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||1||
48161514|NCT01852058|100718811|FG001|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0||
48161515|NCT01852058|100718812|FG002|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0||
48161516|NCT01852058|100718813|FG003|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0||
48617342|NCT01932697|101849558|FG000|STARTED|Overall Study||38||
48617343|NCT01932697|101849559|FG001|STARTED|Overall Study||43||
48617344|NCT01932697|101849558|FG000|COMPLETED|Overall Study||36||
48617345|NCT01932697|101849559|FG001|COMPLETED|Overall Study||43||
48617346|NCT01932697|101849558|FG000|NOT COMPLETED|Overall Study||2||
48617347|NCT01932697|101849559|FG001|NOT COMPLETED|Overall Study||0||
48740253|NCT03350815|102147539|FG001|Non-responders|Period 1||0|"One patient completed Treatment Period 1 and was randomized (secukinumab 150 mg - 300 mg \[IR\]); however, the patient did not receive any treatment in Treatment Period 2 due to Technical problems."|
48740254|NCT03350815|102147540|FG002|Non-responders|Period 1||0|"One patient completed Treatment Period 1 and was randomized (secukinumab 150 mg - 300 mg \[IR\]); however, the patient did not receive any treatment in Treatment Period 2 due to Technical problems."|
48767632|NCT01929317|102222785|FG000|STARTED|Dose Increase Effect Verification Phase||61||
48161517|NCT01852058|100718814|FG004|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0||
48617348|NCT01116037|101849560|FG000|STARTED|Overall Study||26||
48617349|NCT01116037|101849560|FG000|COMPLETED|Overall Study||1||
48617350|NCT01116037|101849560|FG000|NOT COMPLETED|Overall Study||25||
48617351|NCT00919633|101849561|FG000|STARTED|Overall Study||28||
48617352|NCT00919633|101849562|FG001|STARTED|Overall Study||25||
48617353|NCT00919633|101849563|FG002|STARTED|Overall Study||27||
48617354|NCT00919633|101849564|FG003|STARTED|Overall Study||26||
48617355|NCT00919633|101849561|FG000|COMPLETED|Overall Study||6||
48617356|NCT00919633|101849562|FG001|COMPLETED|Overall Study||10||
48617357|NCT00919633|101849563|FG002|COMPLETED|Overall Study||4||
48617358|NCT00919633|101849564|FG003|COMPLETED|Overall Study||5||
48617359|NCT00919633|101849561|FG000|NOT COMPLETED|Overall Study||22||
48617360|NCT00919633|101849562|FG001|NOT COMPLETED|Overall Study||15||
48617361|NCT00919633|101849563|FG002|NOT COMPLETED|Overall Study||23||
48617362|NCT00919633|101849564|FG003|NOT COMPLETED|Overall Study||21||
48617363|NCT04195061|101849565|FG000|STARTED|Overall Study||19||
48617364|NCT04195061|101849566|FG001|STARTED|Overall Study||9||
48617365|NCT04195061|101849565|FG000|COMPLETED|Overall Study||19||
48617366|NCT04195061|101849566|FG001|COMPLETED|Overall Study||9||
48617367|NCT04195061|101849565|FG000|NOT COMPLETED|Overall Study||0||
48617368|NCT04195061|101849566|FG001|NOT COMPLETED|Overall Study||0||
48617369|NCT02848664|101849567|FG000|STARTED|Overall Study||11||
48617370|NCT02848664|101849567|FG000|COMPLETED|Overall Study||7||
48617371|NCT02848664|101849567|FG000|NOT COMPLETED|Overall Study||4||
48617372|NCT03077893|101849568|FG000|STARTED|Overall Study||18||
48161518|NCT01852058|100718815|FG005|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0||
48161519|NCT01852058|100718816|FG006|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0||
48617373|NCT03077893|101849569|FG001|STARTED|Overall Study||19||
48617374|NCT03077893|101849568|FG000|COMPLETED|Overall Study||14||
48617375|NCT03077893|101849569|FG001|COMPLETED|Overall Study||16||
48617376|NCT03077893|101849568|FG000|NOT COMPLETED|Overall Study||4||
48617377|NCT03077893|101849569|FG001|NOT COMPLETED|Overall Study||3||
48617378|NCT02864732|101849570|FG000|STARTED|Overall Study||15||
48617379|NCT02864732|101849571|FG001|STARTED|Overall Study||15||
48617380|NCT02864732|101849570|FG000|COMPLETED|Overall Study||13||
48617381|NCT02864732|101849571|FG001|COMPLETED|Overall Study||13||
48617382|NCT02864732|101849570|FG000|NOT COMPLETED|Overall Study||2||
48617383|NCT02864732|101849571|FG001|NOT COMPLETED|Overall Study||2||
48617384|NCT01851655|101849572|FG000|STARTED|Overall Study||12||
48161520|NCT01852058|100718817|FG007|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0||
48617385|NCT01851655|101849573|FG001|STARTED|Overall Study||12||
48617386|NCT01851655|101849572|FG000|COMPLETED|Overall Study||12||
48617387|NCT01851655|101849573|FG001|COMPLETED|Overall Study||12||
48617388|NCT01851655|101849572|FG000|NOT COMPLETED|Overall Study||0||
48617389|NCT01851655|101849573|FG001|NOT COMPLETED|Overall Study||0||
48617390|NCT01526408|101849574|FG000|STARTED|Overall Study||0||
48408141|NCT02431793|101331725|FG000|NOT COMPLETED|Overall Study||119||
48408142|NCT02431793|101331726|FG001|NOT COMPLETED|Overall Study||134||
48408143|NCT02431793|101331727|FG002|NOT COMPLETED|Overall Study||117||
48322067|NCT03269435|101114831|FG000|NOT COMPLETED|Overall Study||0||
48322068|NCT03269435|101114832|FG001|NOT COMPLETED|Overall Study||0||
48322069|NCT02228590|101114833|FG000|STARTED|Overall Study||20||
48408144|NCT02182999|101331728|FG000|STARTED|Overall Study||25||
48408145|NCT02182999|101331729|FG001|STARTED|Overall Study||25||
48408146|NCT02182999|101331728|FG000|COMPLETED|Overall Study||20||
48408147|NCT02182999|101331729|FG001|COMPLETED|Overall Study||22||
48408148|NCT02182999|101331728|FG000|NOT COMPLETED|Overall Study||5||
48408149|NCT02182999|101331729|FG001|NOT COMPLETED|Overall Study||3||
48408150|NCT02705755|101331730|FG000|STARTED|Part A (6 Days)||34|Each participant was titrated to their individual maximum tolerated dose.|
48408151|NCT02705755|101331731|FG001|STARTED|Part A (6 Days)||0|Each participant was titrated to their individual maximum tolerated dose.|
48408152|NCT02705755|101331732|FG002|STARTED|Part A (6 Days)||0|Each participant was titrated to their individual maximum tolerated dose.|
48408153|NCT02705755|101331733|FG003|STARTED|Part A (6 Days)||0|Each participant was titrated to their individual maximum tolerated dose.|
48322070|NCT02228590|101114833|FG000|COMPLETED|Overall Study||19||
48322071|NCT02228590|101114833|FG000|NOT COMPLETED|Overall Study||1||
48322072|NCT00610987|101114834|FG000|STARTED|Overall Study||75||
48408154|NCT02705755|101331730|FG000|Participants Who Received Placebo|Part A (6 Days)||34||
48408155|NCT02705755|101331731|FG001|Participants Who Received Placebo|Part A (6 Days)||0||
48408156|NCT02705755|101331732|FG002|Participants Who Received Placebo|Part A (6 Days)||0||
48408157|NCT02705755|101331733|FG003|Participants Who Received Placebo|Part A (6 Days)||0||
48740255|NCT03350815|102147541|FG003|Non-responders|Period 1||0|"One patient completed Treatment Period 1 and was randomized (secukinumab 150 mg - 300 mg \[IR\]); however, the patient did not receive any treatment in Treatment Period 2 due to Technical problems."|
48740256|NCT03350815|102147538|FG000|Inadequate Responders|Period 1||207||
48322073|NCT00610987|101114835|FG001|STARTED|Overall Study||71||
48322074|NCT00610987|101114834|FG000|COMPLETED|Overall Study||75||
48322075|NCT00610987|101114835|FG001|COMPLETED|Overall Study||71||
48322076|NCT00610987|101114834|FG000|NOT COMPLETED|Overall Study||0||
48322077|NCT00610987|101114835|FG001|NOT COMPLETED|Overall Study||0||
48322078|NCT01951820|101114836|FG000|STARTED|Overall Study||34||
48740257|NCT03350815|102147539|FG001|Inadequate Responders|Period 1||0||
48740258|NCT03350815|102147540|FG002|Inadequate Responders|Period 1||0||
48740259|NCT03350815|102147541|FG003|Inadequate Responders|Period 1||0||
48740260|NCT03350815|102147538|FG000|Responders|Period 1||22||
48322079|NCT01951820|101114837|FG001|STARTED|Overall Study||30||
48322080|NCT01951820|101114836|FG000|COMPLETED|Overall Study||34||
48740261|NCT03350815|102147539|FG001|Responders|Period 1||0||
48161521|NCT01852058|100718818|FG008|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0||
48322081|NCT01951820|101114837|FG001|COMPLETED|Overall Study||30||
48322082|NCT01951820|101114836|FG000|NOT COMPLETED|Overall Study||0||
48322083|NCT01951820|101114837|FG001|NOT COMPLETED|Overall Study||0||
48408158|NCT02705755|101331730|FG000|Participants Who Received 1 mg Study Drug|Part A (6 Days)||17|Participants who were enrolled prior to protocol amendment 2 received a starting dose of 1 mg TD-9855 as an oral solution on Day 2 of Part A and escalated to 10 mg. Beginning with protocol amendment 2, the starting dose was changed to 2.5 mg with dose escalation to 20 mg.|
48408159|NCT02705755|101331731|FG001|Participants Who Received 1 mg Study Drug|Part A (6 Days)||0|Participants who were enrolled prior to protocol amendment 2 received a starting dose of 1 mg TD-9855 as an oral solution on Day 2 of Part A and escalated to 10 mg. Beginning with protocol amendment 2, the starting dose was changed to 2.5 mg with dose escalation to 20 mg.|
48408160|NCT02705755|101331732|FG002|Participants Who Received 1 mg Study Drug|Part A (6 Days)||0|Participants who were enrolled prior to protocol amendment 2 received a starting dose of 1 mg TD-9855 as an oral solution on Day 2 of Part A and escalated to 10 mg. Beginning with protocol amendment 2, the starting dose was changed to 2.5 mg with dose escalation to 20 mg.|
48408161|NCT02705755|101331733|FG003|Participants Who Received 1 mg Study Drug|Part A (6 Days)||0|Participants who were enrolled prior to protocol amendment 2 received a starting dose of 1 mg TD-9855 as an oral solution on Day 2 of Part A and escalated to 10 mg. Beginning with protocol amendment 2, the starting dose was changed to 2.5 mg with dose escalation to 20 mg.|
48740262|NCT03350815|102147540|FG002|Responders|Period 1||0||
48740263|NCT03350815|102147541|FG003|Responders|Period 1||0||
48740264|NCT03350815|102147538|FG000|COMPLETED|Period 1||279||
48740265|NCT03350815|102147539|FG001|COMPLETED|Period 1||0||
48740266|NCT03350815|102147540|FG002|COMPLETED|Period 1||0||
48740267|NCT03350815|102147541|FG003|COMPLETED|Period 1||0||
48740268|NCT03350815|102147538|FG000|NOT COMPLETED|Period 1||43||
48322084|NCT04315181|101114838|FG000|STARTED|Overall Study||11||
48322085|NCT04315181|101114838|FG000|Placebo/Placebo|Overall Study||10||
48322086|NCT04315181|101114838|FG000|Placebo / Oxycodone 20mg|Overall Study||10||
48322087|NCT04315181|101114838|FG000|Placebo / Oxycodone 40mg|Overall Study||10||
48322088|NCT04315181|101114838|FG000|Gabapentin 600mg / Placebo|Overall Study||10||
48322089|NCT04315181|101114838|FG000|Gabapentin 1200mg / Placebo|Overall Study||10||
48322090|NCT04315181|101114838|FG000|Gabapentin 600mg / Oxycodone 20mg|Overall Study||10||
48322091|NCT04315181|101114838|FG000|Gabapentin 1200mg / Oxycodone 20mg|Overall Study||10||
48322092|NCT04315181|101114838|FG000|Gabapentin 600mg / Oxycodone 40mg|Overall Study||10||
48322093|NCT04315181|101114838|FG000|Gabapentin 1200mg / Oxycodone 40mg|Overall Study||10||
48322094|NCT04315181|101114838|FG000|COMPLETED|Overall Study||10||
48740269|NCT03350815|102147539|FG001|NOT COMPLETED|Period 1||0||
48740270|NCT03350815|102147540|FG002|NOT COMPLETED|Period 1||0||
48740271|NCT03350815|102147541|FG003|NOT COMPLETED|Period 1||0||
48740272|NCT03350815|102147538|FG000|STARTED|Period 2||0||
48740273|NCT03350815|102147539|FG001|STARTED|Period 2||102||
48740274|NCT03350815|102147540|FG002|STARTED|Period 2||105||
48740275|NCT03350815|102147541|FG003|STARTED|Period 2||22||
48740276|NCT03350815|102147538|FG000|COMPLETED|Period 2||0||
48740277|NCT03350815|102147539|FG001|COMPLETED|Period 2||86||
48161522|NCT01852058|100718819|FG009|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0||
48161523|NCT01852058|100718820|FG010|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0||
48161524|NCT01852058|100718821|FG011|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0||
48161525|NCT01852058|100718810|FG000|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0||
48161526|NCT01852058|100718811|FG001|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0||
48161527|NCT01852058|100718812|FG002|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0||
48161528|NCT01852058|100718813|FG003|STARTED|Treatment Cycle2:Retreatment 1,Study 121||9||
48161529|NCT01852058|100718814|FG004|STARTED|Treatment Cycle2:Retreatment 1,Study 121||45||
48322095|NCT04315181|101114838|FG000|NOT COMPLETED|Overall Study||1||
48322096|NCT00886600|101114839|FG000|STARTED|Double-blind Monotherapy||32||
48161530|NCT01852058|100718815|FG005|STARTED|Treatment Cycle2:Retreatment 1,Study 121||36||
48161531|NCT01852058|100718816|FG006|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0||
48161532|NCT01852058|100718817|FG007|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0||
48161533|NCT01852058|100718818|FG008|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0||
48161534|NCT01852058|100718819|FG009|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0||
48161535|NCT01852058|100718820|FG010|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0||
48322097|NCT00886600|101114840|FG001|STARTED|Double-blind Monotherapy||29||
48322098|NCT00886600|101114841|FG002|STARTED|Double-blind Monotherapy||30||
48322099|NCT00886600|101114842|FG003|STARTED|Double-blind Monotherapy||31||
48322100|NCT00886600|101114839|FG000|COMPLETED|Double-blind Monotherapy||30||
48161536|NCT01852058|100718821|FG011|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0||
48161537|NCT01852058|100718810|FG000|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0|Completed=Completed the entire study in this Cycle|
48161538|NCT01852058|100718811|FG001|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0|Completed=Completed the entire study in this Cycle|
48161539|NCT01852058|100718812|FG002|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0|Completed=Completed the entire study in this Cycle|
48161540|NCT01852058|100718813|FG003|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||8|Completed=Completed the entire study in this Cycle|
48161541|NCT01852058|100718814|FG004|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||38|Completed=Completed the entire study in this Cycle|
48161542|NCT01852058|100718815|FG005|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||27|Completed=Completed the entire study in this Cycle|
48161543|NCT01852058|100718816|FG006|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0|Completed=Completed the entire study in this Cycle|
48161544|NCT01852058|100718817|FG007|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0|Completed=Completed the entire study in this Cycle|
48161545|NCT01852058|100718818|FG008|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0|Completed=Completed the entire study in this Cycle|
48161546|NCT01852058|100718819|FG009|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0|Completed=Completed the entire study in this Cycle|
48161547|NCT01852058|100718820|FG010|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0|Completed=Completed the entire study in this Cycle|
48161548|NCT01852058|100718821|FG011|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0|Completed=Completed the entire study in this Cycle|
48161549|NCT01852058|100718810|FG000|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0||
48161550|NCT01852058|100718811|FG001|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0||
48161551|NCT01852058|100718812|FG002|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0||
48161552|NCT01852058|100718813|FG003|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||1||
48188750|NCT00821236|100783327|FG000|NOT COMPLETED|Overall Study||3||
48322101|NCT00886600|101114840|FG001|COMPLETED|Double-blind Monotherapy||28||
48322102|NCT00886600|101114841|FG002|COMPLETED|Double-blind Monotherapy||29||
48322103|NCT00886600|101114842|FG003|COMPLETED|Double-blind Monotherapy||29||
48322104|NCT00886600|101114839|FG000|NOT COMPLETED|Double-blind Monotherapy||2||
48322105|NCT00886600|101114840|FG001|NOT COMPLETED|Double-blind Monotherapy||1||
48322106|NCT00886600|101114841|FG002|NOT COMPLETED|Double-blind Monotherapy||1||
48322107|NCT00886600|101114842|FG003|NOT COMPLETED|Double-blind Monotherapy||2||
48322108|NCT00886600|101114839|FG000|STARTED|Combination Therapy Period||28||
48322109|NCT00886600|101114840|FG001|STARTED|Combination Therapy Period||21||
48740278|NCT03350815|102147540|FG002|COMPLETED|Period 2||88||
48740279|NCT03350815|102147541|FG003|COMPLETED|Period 2||22||
48740280|NCT03350815|102147538|FG000|NOT COMPLETED|Period 2||0||
48740281|NCT03350815|102147539|FG001|NOT COMPLETED|Period 2||16||
48740282|NCT03350815|102147540|FG002|NOT COMPLETED|Period 2||17||
48740283|NCT03350815|102147541|FG003|NOT COMPLETED|Period 2||0||
48740284|NCT02100475|102147542|FG000|STARTED|Overall Study||16||
48740285|NCT02100475|102147543|FG001|STARTED|Overall Study||15||
48740286|NCT02100475|102147542|FG000|COMPLETED|Overall Study||14||
48740287|NCT02100475|102147543|FG001|COMPLETED|Overall Study||13||
48740288|NCT02100475|102147542|FG000|NOT COMPLETED|Overall Study||2||
48740289|NCT02100475|102147543|FG001|NOT COMPLETED|Overall Study||2||
48740290|NCT04996251|102147544|FG000|STARTED|Overall Study||62||
48740291|NCT04996251|102147545|FG001|STARTED|Overall Study||67||
48408162|NCT02705755|101331730|FG000|Participants Who Received 2.5 mg Study Drug|Part A (6 Days)||31||
48322110|NCT00886600|101114841|FG002|STARTED|Combination Therapy Period||21||
48322111|NCT00886600|101114842|FG003|STARTED|Combination Therapy Period||23||
48322112|NCT00886600|101114839|FG000|COMPLETED|Combination Therapy Period||28||
48322113|NCT00886600|101114840|FG001|COMPLETED|Combination Therapy Period||21||
48322114|NCT00886600|101114841|FG002|COMPLETED|Combination Therapy Period||19||
48322115|NCT00886600|101114842|FG003|COMPLETED|Combination Therapy Period||23||
48322116|NCT00886600|101114839|FG000|NOT COMPLETED|Combination Therapy Period||0||
48322117|NCT00886600|101114840|FG001|NOT COMPLETED|Combination Therapy Period||0||
48322118|NCT00886600|101114841|FG002|NOT COMPLETED|Combination Therapy Period||2||
48322119|NCT00886600|101114842|FG003|NOT COMPLETED|Combination Therapy Period||0||
48322120|NCT03382665|101114843|FG000|STARTED|Overall Study||70|signed the informed consent|
48322121|NCT03382665|101114843|FG000|Actual Enrollment|Overall Study||59|11 patients were excluded from the study for different reasons|
48322122|NCT03382665|101114843|FG000|5 Year Follow up|Overall Study||25||
48322123|NCT03382665|101114843|FG000|COMPLETED|Overall Study||25|= longest FUP (Study completion was never reached since the study was terminated earlier).|
48322124|NCT03382665|101114843|FG000|NOT COMPLETED|Overall Study||45||
48322125|NCT00545064|101114844|FG000|STARTED|Overall Study||178||
48408163|NCT02705755|101331731|FG001|Participants Who Received 2.5 mg Study Drug|Part A (6 Days)||0||
48408164|NCT02705755|101331732|FG002|Participants Who Received 2.5 mg Study Drug|Part A (6 Days)||0||
48408165|NCT02705755|101331733|FG003|Participants Who Received 2.5 mg Study Drug|Part A (6 Days)||0||
48408166|NCT02705755|101331730|FG000|Participants Who Received 5 mg Study Drug|Part A (6 Days)||29||
48408167|NCT02705755|101331731|FG001|Participants Who Received 5 mg Study Drug|Part A (6 Days)||0||
48408168|NCT02705755|101331732|FG002|Participants Who Received 5 mg Study Drug|Part A (6 Days)||0||
48408169|NCT02705755|101331733|FG003|Participants Who Received 5 mg Study Drug|Part A (6 Days)||0||
48408170|NCT02705755|101331730|FG000|Participants Who Received 10 mg Study Drug|Part A (6 Days)||28||
48408171|NCT02705755|101331731|FG001|Participants Who Received 10 mg Study Drug|Part A (6 Days)||0||
48408172|NCT02705755|101331732|FG002|Participants Who Received 10 mg Study Drug|Part A (6 Days)||0||
48408173|NCT02705755|101331733|FG003|Participants Who Received 10 mg Study Drug|Part A (6 Days)||0||
48408174|NCT02705755|101331730|FG000|Participants Who Received 20 mg Study Drug|Part A (6 Days)||13||
48408175|NCT02705755|101331731|FG001|Participants Who Received 20 mg Study Drug|Part A (6 Days)||0||
48408176|NCT02705755|101331732|FG002|Participants Who Received 20 mg Study Drug|Part A (6 Days)||0||
48740292|NCT04996251|102147544|FG000|COMPLETED|Overall Study||62||
48740293|NCT04996251|102147545|FG001|COMPLETED|Overall Study||67||
48740294|NCT04996251|102147544|FG000|NOT COMPLETED|Overall Study||0||
48740295|NCT04996251|102147545|FG001|NOT COMPLETED|Overall Study||0||
48740296|NCT02429830|102147546|FG000|STARTED|Overall Study||30||
48740297|NCT02429830|102147546|FG000|COMPLETED|Overall Study||27||
48740298|NCT02429830|102147546|FG000|NOT COMPLETED|Overall Study||3||
48740299|NCT02644343|102147547|FG000|STARTED|Overall Study||40||
48740300|NCT02644343|102147547|FG000|COMPLETED|Overall Study||39||
48740301|NCT02644343|102147547|FG000|NOT COMPLETED|Overall Study||1||
48740302|NCT04524364|102147548|FG000|STARTED|Overall Study||45||
48740303|NCT04524364|102147549|FG001|STARTED|Overall Study||227||
48740304|NCT04524364|102147548|FG000|Treated|Overall Study||40||
48740305|NCT04524364|102147549|FG001|Treated|Overall Study||216||
48740306|NCT04524364|102147548|FG000|Wave II: Main Phase Full Analysis Set|Overall Study||0||
48322126|NCT00545064|101114844|FG000|Visit 1 (Baseline)|Overall Study||178||
48322127|NCT00545064|101114844|FG000|Visit 2 (Week 4)|Overall Study||169||
48322128|NCT00545064|101114844|FG000|Visit 3 (Week 8)|Overall Study||176||
48322129|NCT00545064|101114844|FG000|COMPLETED|Overall Study||170||
48322130|NCT00545064|101114844|FG000|NOT COMPLETED|Overall Study||8||
48322131|NCT01181011|101114845|FG000|STARTED|Overall Study||28||
48322132|NCT01181011|101114845|FG000|Received Telmisartan 80mg|Overall Study||27||
48322133|NCT01181011|101114845|FG000|Received Telmisartan 80mg,Amlodipine 5mg|Overall Study||27||
48322134|NCT01181011|101114845|FG000|Received Amlodipine 5mg|Overall Study||26||
48322135|NCT01181011|101114845|FG000|COMPLETED|Overall Study||25||
48322136|NCT01181011|101114845|FG000|NOT COMPLETED|Overall Study||3||
48322137|NCT02223260|101114846|FG000|STARTED|Overall Study||8||
48322138|NCT02223260|101114846|FG000|COMPLETED|Overall Study||8||
48322139|NCT02223260|101114846|FG000|NOT COMPLETED|Overall Study||0||
48322140|NCT01934556|101114847|FG000|STARTED|Overall Study||30||30
48322141|NCT01934556|101114848|FG001|STARTED|Overall Study||60||60
48322142|NCT01934556|101114849|FG002|STARTED|Overall Study||60||60
48322143|NCT01934556|101114847|FG000|COMPLETED|Overall Study||25||25
48322144|NCT01934556|101114848|FG001|COMPLETED|Overall Study||44||44
48322145|NCT01934556|101114849|FG002|COMPLETED|Overall Study||50||50
48322146|NCT01934556|101114847|FG000|NOT COMPLETED|Overall Study||5||5
48322147|NCT01934556|101114848|FG001|NOT COMPLETED|Overall Study||16||16
48740307|NCT04524364|102147549|FG001|Wave II: Main Phase Full Analysis Set|Overall Study||186||
48740308|NCT04524364|102147548|FG000|Wave II: Roll-in Analysis Set (RI AS)|Overall Study||0||
48740309|NCT04524364|102147549|FG001|Wave II: Roll-in Analysis Set (RI AS)|Overall Study||30||
48740310|NCT04524364|102147548|FG000|COMPLETED|Overall Study||40||
48740311|NCT04524364|102147549|FG001|COMPLETED|Overall Study||216||
48740312|NCT04524364|102147548|FG000|NOT COMPLETED|Overall Study||5||
48740313|NCT04524364|102147549|FG001|NOT COMPLETED|Overall Study||11||
48740314|NCT02709330|102147550|FG000|STARTED|Overall Study||50||
48740315|NCT02709330|102147551|FG001|STARTED|Overall Study||10||
48740316|NCT02709330|102147550|FG000|COMPLETED|Overall Study||37||
48740317|NCT02709330|102147551|FG001|COMPLETED|Overall Study||10||
48740318|NCT02709330|102147550|FG000|NOT COMPLETED|Overall Study||13||
48740319|NCT02709330|102147551|FG001|NOT COMPLETED|Overall Study||0||
48740320|NCT03738618|102147552|FG000|STARTED|Overall Study||534|Data reported for the fresh cycle.|
48740321|NCT03738618|102147553|FG001|STARTED|Overall Study||54|Data reported for the fresh cycle.|
48740322|NCT03738618|102147552|FG000|Modified Intention-to-treat (mITT)|Overall Study||533||
48740323|NCT03738618|102147553|FG001|Modified Intention-to-treat (mITT)|Overall Study||54||
48740324|NCT03738618|102147552|FG000|COMPLETED|Overall Study||502||
48740325|NCT03738618|102147553|FG001|COMPLETED|Overall Study||54||
48740326|NCT03738618|102147552|FG000|NOT COMPLETED|Overall Study||32||
48740327|NCT03738618|102147553|FG001|NOT COMPLETED|Overall Study||0||
48740328|NCT01835158|102147554|FG000|STARTED|Overall Study||79||
48740329|NCT01835158|102147555|FG001|STARTED|Overall Study||78||
48740330|NCT01835158|102147554|FG000|COMPLETED|Overall Study||78||
48740331|NCT01835158|102147555|FG001|COMPLETED|Overall Study||72||
48740332|NCT01835158|102147554|FG000|NOT COMPLETED|Overall Study||1||
48740333|NCT01835158|102147555|FG001|NOT COMPLETED|Overall Study||6||
48740334|NCT05786508|102147556|FG000|STARTED|Overall Study||26||
48408177|NCT02705755|101331733|FG003|Participants Who Received 20 mg Study Drug|Part A (6 Days)||0||
48408178|NCT02705755|101331730|FG000|Participants Who Rolled to Part B|Part A (6 Days)||10||
48408179|NCT02705755|101331731|FG001|Participants Who Rolled to Part B|Part A (6 Days)||0||
48408180|NCT02705755|101331732|FG002|Participants Who Rolled to Part B|Part A (6 Days)||0||
48408181|NCT02705755|101331733|FG003|Participants Who Rolled to Part B|Part A (6 Days)||0||
48617391|NCT01526408|101849575|FG001|STARTED|Overall Study||0||
48617392|NCT01526408|101849574|FG000|COMPLETED|Overall Study||0||
48617393|NCT01526408|101849575|FG001|COMPLETED|Overall Study||0||
48617394|NCT01526408|101849574|FG000|NOT COMPLETED|Overall Study||0||
48617395|NCT01526408|101849575|FG001|NOT COMPLETED|Overall Study||0||
48617396|NCT03021317|101849576|FG000|STARTED|Overall Study||0||
48617397|NCT03021317|101849576|FG000|COMPLETED|Overall Study||0||
48617398|NCT03021317|101849576|FG000|NOT COMPLETED|Overall Study||0||
48408182|NCT02705755|101331730|FG000|Participants Who Rolled to Part C|Part A (6 Days)||21||
48617399|NCT01676701|101849577|FG000|STARTED|Overall Study||4||
48617400|NCT01676701|101849578|FG001|STARTED|Overall Study||4||
48617401|NCT01676701|101849577|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4||
48617402|NCT01676701|101849578|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4||
48740335|NCT05786508|102147557|FG001|STARTED|Overall Study||25||
48740336|NCT05786508|102147556|FG000|COMPLETED|Overall Study||24||
48740337|NCT05786508|102147557|FG001|COMPLETED|Overall Study||25||
48740338|NCT05786508|102147556|FG000|NOT COMPLETED|Overall Study||2||
48740339|NCT05786508|102147557|FG001|NOT COMPLETED|Overall Study||0||
48740340|NCT00337207|102147558|FG000|STARTED|Overall Study||55||
48740341|NCT00337207|102147558|FG000|COMPLETED|Overall Study||52||
48740342|NCT00337207|102147558|FG000|NOT COMPLETED|Overall Study||3||
48740343|NCT04406649|102147559|FG000|STARTED|Overall Study||482||
48740344|NCT04406649|102147559|FG000|COMPLETED|Overall Study||205||
48740345|NCT04406649|102147559|FG000|NOT COMPLETED|Overall Study||277||
48740346|NCT01107665|102147560|FG000|STARTED|Overall Study||60||
48740347|NCT01107665|102147560|FG000|COMPLETED|Overall Study||11|Subjects who completed protocol-defined follow-up period.|
48740348|NCT01107665|102147560|FG000|NOT COMPLETED|Overall Study||49||
48740349|NCT00945256|102147561|FG000|STARTED|Overall Study||13||
48740350|NCT00945256|102147562|FG001|STARTED|Overall Study||10||
48740351|NCT00945256|102147563|FG002|STARTED|Overall Study||15||
48440027|NCT05378269|101410015|FG000|STARTED|Overall Study||4||
48657096|NCT03648372|101943773|FG016|NOT COMPLETED|Overall Study||2||
48617403|NCT01676701|101849577|FG000|Completed Post-Treatment Follow-Up|Overall Study||4||
48617404|NCT01676701|101849578|FG001|Completed Post-Treatment Follow-Up|Overall Study||4||
48617405|NCT01676701|101849577|FG000|COMPLETED|Overall Study||0||
48617406|NCT01676701|101849578|FG001|COMPLETED|Overall Study||0||
48617407|NCT01676701|101849577|FG000|NOT COMPLETED|Overall Study||4||
48322148|NCT01934556|101114849|FG002|NOT COMPLETED|Overall Study||10||10
48322149|NCT04324359|101114850|FG000|STARTED|Overall Study||40||
48322150|NCT04324359|101114851|FG001|STARTED|Overall Study||43||
48322151|NCT04324359|101114850|FG000|COMPLETED|Overall Study||39||
48322152|NCT04324359|101114851|FG001|COMPLETED|Overall Study||41||
48322153|NCT04324359|101114850|FG000|NOT COMPLETED|Overall Study||1||
48322154|NCT04324359|101114851|FG001|NOT COMPLETED|Overall Study||2||
48322155|NCT00853671|101114852|FG000|STARTED|Overall Study||50||
48617408|NCT01676701|101849578|FG001|NOT COMPLETED|Overall Study||4||
48617409|NCT04157088|101849579|FG000|STARTED|Overall Study||30||
48617410|NCT04157088|101849579|FG000|Received Treatment|Overall Study||30||
48617411|NCT04157088|101849579|FG000|Participants Off-Study|Overall Study||30||
48617412|NCT04157088|101849579|FG000|COMPLETED|Overall Study||0||
48617413|NCT04157088|101849579|FG000|NOT COMPLETED|Overall Study||30||
48322156|NCT00853671|101114852|FG000|COMPLETED|Overall Study||50||
48322157|NCT00853671|101114852|FG000|NOT COMPLETED|Overall Study||0||
48322158|NCT03129321|101114853|FG000|STARTED|Overall Study||351||
48322159|NCT03129321|101114854|FG001|STARTED|Overall Study||350||
48322160|NCT03129321|101114855|FG002|STARTED|Overall Study||175||
48322161|NCT03129321|101114853|FG000|COMPLETED|Overall Study||253||
48617414|NCT02735980|101849580|FG000|STARTED|Overall Study||58||
48617415|NCT02735980|101849581|FG001|STARTED|Overall Study||60||
48617416|NCT02735980|101849582|FG002|STARTED|Overall Study||15||
48617417|NCT02735980|101849580|FG000|Received at Least 1 Dose of Study Drug|Overall Study||56||
48322162|NCT03129321|101114854|FG001|COMPLETED|Overall Study||241||
48322163|NCT03129321|101114855|FG002|COMPLETED|Overall Study||120||
48322164|NCT03129321|101114853|FG000|NOT COMPLETED|Overall Study||98||
48188751|NCT01902901|100783328|FG000|STARTED|Overall Study||180||
48322165|NCT03129321|101114854|FG001|NOT COMPLETED|Overall Study||109||
48322166|NCT03129321|101114855|FG002|NOT COMPLETED|Overall Study||55||
48740352|NCT00945256|102147564|FG003|STARTED|Overall Study||16||
48740353|NCT00945256|102147565|FG004|STARTED|Overall Study||8||
48740354|NCT00945256|102147561|FG000|COMPLETED|Overall Study||9||
48740355|NCT00945256|102147562|FG001|COMPLETED|Overall Study||8||
48740356|NCT00945256|102147563|FG002|COMPLETED|Overall Study||7||
48740357|NCT00945256|102147564|FG003|COMPLETED|Overall Study||7||
48740358|NCT00945256|102147565|FG004|COMPLETED|Overall Study||7||
48740359|NCT00945256|102147561|FG000|NOT COMPLETED|Overall Study||4||
48740360|NCT00945256|102147562|FG001|NOT COMPLETED|Overall Study||2||
48740361|NCT00945256|102147563|FG002|NOT COMPLETED|Overall Study||8||
48740362|NCT00945256|102147564|FG003|NOT COMPLETED|Overall Study||9||
48740363|NCT00945256|102147565|FG004|NOT COMPLETED|Overall Study||1||
48740364|NCT04417361|102147566|FG000|STARTED|Overall Study||18||
48740365|NCT04417361|102147567|FG001|STARTED|Overall Study||22||
48740366|NCT04417361|102147566|FG000|COMPLETED|Overall Study||17||
48740367|NCT04417361|102147567|FG001|COMPLETED|Overall Study||21||
48740368|NCT04417361|102147566|FG000|NOT COMPLETED|Overall Study||1||
48740369|NCT04417361|102147567|FG001|NOT COMPLETED|Overall Study||1||
48740370|NCT01970306|102147568|FG000|STARTED|Overall Study||78||
48740371|NCT01970306|102147568|FG000|COMPLETED|Overall Study||66||
48740372|NCT01970306|102147568|FG000|NOT COMPLETED|Overall Study||12||
48740373|NCT04538664|102147569|FG000|STARTED|Overall Study||155||
48740374|NCT04538664|102147570|FG001|STARTED|Overall Study||153||
48740375|NCT04538664|102147569|FG000|Treated|Overall Study||155||
48740376|NCT04538664|102147570|FG001|Treated|Overall Study||151||
48740377|NCT04538664|102147569|FG000|COMPLETED|Overall Study||42|As per protocol, participants who died were also considered as completed.|
48740378|NCT04538664|102147570|FG001|COMPLETED|Overall Study||28|As per protocol, participants who died were also considered as completed.|
48740379|NCT04538664|102147569|FG000|NOT COMPLETED|Overall Study||113||
48740380|NCT04538664|102147570|FG001|NOT COMPLETED|Overall Study||125||
48740381|NCT02538042|102147571|FG000|STARTED|Overall Study||17||
48740382|NCT02538042|102147572|FG001|STARTED|Overall Study||17||
48740383|NCT02538042|102147571|FG000|Completed All MCE Sessions|Overall Study||15||
48740384|NCT02538042|102147572|FG001|Completed All MCE Sessions|Overall Study||15||
48740385|NCT02538042|102147571|FG000|Attended Post-Quit Visit|Overall Study||15||
48740386|NCT02538042|102147572|FG001|Attended Post-Quit Visit|Overall Study||14||
48740387|NCT02538042|102147571|FG000|Completed All Post-Quit Visits|Overall Study||12||
48740388|NCT02538042|102147572|FG001|Completed All Post-Quit Visits|Overall Study||12||
48740389|NCT02538042|102147571|FG000|COMPLETED|Overall Study||6||
48740390|NCT02538042|102147572|FG001|COMPLETED|Overall Study||6||
48740391|NCT02538042|102147571|FG000|NOT COMPLETED|Overall Study||11||
48740392|NCT02538042|102147572|FG001|NOT COMPLETED|Overall Study||11||
48740393|NCT00080301|102151401|FG000|STARTED|Overall Study||375||
48740394|NCT00080301|102151402|FG001|STARTED|Overall Study||377||
48740395|NCT00080301|102151401|FG000|Never Treated|Overall Study||5||
48740396|NCT00080301|102151402|FG001|Never Treated|Overall Study||10||
48740397|NCT00080301|102151401|FG000|Still on Treatment|Overall Study||0||
48740398|NCT00080301|102151402|FG001|Still on Treatment|Overall Study||1||
48740399|NCT00080301|102151401|FG000|COMPLETED|Overall Study||370||
48740400|NCT00080301|102151402|FG001|COMPLETED|Overall Study||366||
48740401|NCT00080301|102151401|FG000|NOT COMPLETED|Overall Study||5||
48740402|NCT00080301|102151402|FG001|NOT COMPLETED|Overall Study||11||
48740403|NCT02291419|102151403|FG000|STARTED|Overall Study||1||
48740404|NCT02291419|102151404|FG001|STARTED|Overall Study||5||
48740405|NCT02291419|102151403|FG000|COMPLETED|Overall Study||0||
48740406|NCT02291419|102151404|FG001|COMPLETED|Overall Study||0||
48740407|NCT02291419|102151403|FG000|NOT COMPLETED|Overall Study||1||
48740408|NCT02291419|102151404|FG001|NOT COMPLETED|Overall Study||5||
48740409|NCT00512876|102151405|FG000|STARTED|Overall Study||24||
48740410|NCT00512876|102151405|FG000|COMPLETED|Overall Study||20||
48740411|NCT00512876|102151405|FG000|NOT COMPLETED|Overall Study||4||
48740412|NCT01036321|102151406|FG000|STARTED|Overall Study||36||
48740413|NCT01036321|102151407|FG001|STARTED|Overall Study||35||
48740414|NCT01036321|102151406|FG000|COMPLETED|Overall Study||31||
48740415|NCT01036321|102151407|FG001|COMPLETED|Overall Study||31||
48740416|NCT01036321|102151406|FG000|NOT COMPLETED|Overall Study||5||
48740417|NCT01036321|102151407|FG001|NOT COMPLETED|Overall Study||4||
48740418|NCT04648683|102151408|FG000|STARTED|Overall Study||10||
48740419|NCT04648683|102151409|FG001|STARTED|Overall Study||0||
48740420|NCT04648683|102151408|FG000|COMPLETED|Overall Study||3||
48740421|NCT04648683|102151409|FG001|COMPLETED|Overall Study||0||
48740422|NCT04648683|102151408|FG000|NOT COMPLETED|Overall Study||7||
48740423|NCT04648683|102151409|FG001|NOT COMPLETED|Overall Study||0||
48740424|NCT02133781|102151410|FG000|STARTED|Overall Study||6||
48740425|NCT02133781|102151411|FG001|STARTED|Overall Study||24||
48740426|NCT02133781|102151412|FG002|STARTED|Overall Study||21||
48740427|NCT02133781|102151410|FG000|COMPLETED|Overall Study||6||
48740428|NCT02133781|102151411|FG001|COMPLETED|Overall Study||24||
48740429|NCT02133781|102151412|FG002|COMPLETED|Overall Study||21||
48740430|NCT02133781|102151410|FG000|NOT COMPLETED|Overall Study||0||
48740431|NCT02133781|102151411|FG001|NOT COMPLETED|Overall Study||0||
48740432|NCT02133781|102151412|FG002|NOT COMPLETED|Overall Study||0||
48740433|NCT04498143|102151413|FG000|STARTED|Overall Study||286||
48740434|NCT04498143|102151414|FG001|STARTED|Overall Study||279||
48322167|NCT02941627|101114856|FG000|STARTED|Overall Study||53||
48740435|NCT04498143|102151413|FG000|COMPLETED|Overall Study||232||
48740436|NCT04498143|102151414|FG001|COMPLETED|Overall Study||220||
48740437|NCT04498143|102151413|FG000|NOT COMPLETED|Overall Study||54||
48740438|NCT04498143|102151414|FG001|NOT COMPLETED|Overall Study||59||
48322168|NCT02941627|101114856|FG000|Clinical Safety on Overall Participants|Overall Study||51||
48322169|NCT02941627|101114856|FG000|Clinical Efficiency on English Speaking Participants|Overall Study||33||
48322170|NCT02941627|101114856|FG000|COMPLETED|Overall Study||50||
48322171|NCT02941627|101114856|FG000|NOT COMPLETED|Overall Study||3||
48322172|NCT01308008|101114857|FG000|STARTED|4 Weeks||71||
48322173|NCT01308008|101114858|FG001|STARTED|4 Weeks||73||
48322174|NCT01308008|101114857|FG000|COMPLETED|4 Weeks||62||
48322175|NCT01308008|101114858|FG001|COMPLETED|4 Weeks||71||
48408183|NCT02705755|101331731|FG001|Participants Who Rolled to Part C|Part A (6 Days)||0||
48408184|NCT02705755|101331732|FG002|Participants Who Rolled to Part C|Part A (6 Days)||0||
48408185|NCT02705755|101331733|FG003|Participants Who Rolled to Part C|Part A (6 Days)||0||
48408186|NCT02705755|101331730|FG000|COMPLETED|Part A (6 Days)||29||
48408187|NCT02705755|101331731|FG001|COMPLETED|Part A (6 Days)||0||
48408188|NCT02705755|101331732|FG002|COMPLETED|Part A (6 Days)||0||
48408189|NCT02705755|101331733|FG003|COMPLETED|Part A (6 Days)||0||
48408190|NCT02705755|101331730|FG000|NOT COMPLETED|Part A (6 Days)||5||
48408191|NCT02705755|101331731|FG001|NOT COMPLETED|Part A (6 Days)||0||
48408192|NCT02705755|101331732|FG002|NOT COMPLETED|Part A (6 Days)||0||
48408193|NCT02705755|101331733|FG003|NOT COMPLETED|Part A (6 Days)||0||
48408194|NCT02705755|101331730|FG000|STARTED|Part B (1 Day)||0||
48408195|NCT02705755|101331731|FG001|STARTED|Part B (1 Day)||5||
48408196|NCT02705755|101331732|FG002|STARTED|Part B (1 Day)||5||
48408197|NCT02705755|101331733|FG003|STARTED|Part B (1 Day)||0||
48408198|NCT02705755|101331730|FG000|Received Study Drug|Part B (1 Day)||0||
48408199|NCT02705755|101331731|FG001|Received Study Drug|Part B (1 Day)||5||
48408200|NCT02705755|101331732|FG002|Received Study Drug|Part B (1 Day)||5||
48408201|NCT02705755|101331733|FG003|Received Study Drug|Part B (1 Day)||0||
48408202|NCT02705755|101331730|FG000|COMPLETED|Part B (1 Day)||0||
48408203|NCT02705755|101331731|FG001|COMPLETED|Part B (1 Day)||5||
48740439|NCT03801174|102151415|FG000|STARTED|Overall Study||115||
48740440|NCT03801174|102151416|FG001|STARTED|Overall Study||116||
48740441|NCT03801174|102151415|FG000|COMPLETED|Overall Study||63||
48740442|NCT03801174|102151416|FG001|COMPLETED|Overall Study||80||
48740443|NCT03801174|102151415|FG000|NOT COMPLETED|Overall Study||52||
48740444|NCT03801174|102151416|FG001|NOT COMPLETED|Overall Study||36||
48740445|NCT04137731|102151417|FG000|STARTED|Overall Study||20||
48740446|NCT04137731|102151418|FG001|STARTED|Overall Study||20||
48740447|NCT04137731|102151417|FG000|COMPLETED|Overall Study||17||
48740448|NCT04137731|102151418|FG001|COMPLETED|Overall Study||17||
48740449|NCT04137731|102151417|FG000|NOT COMPLETED|Overall Study||3||
48740450|NCT04137731|102151418|FG001|NOT COMPLETED|Overall Study||3||
48740451|NCT01631994|102151419|FG000|STARTED|Overall Study||2||
48740452|NCT01631994|102151420|FG001|STARTED|Overall Study||4||
48740453|NCT01631994|102151419|FG000|COMPLETED|Overall Study||2||
48740454|NCT01631994|102151420|FG001|COMPLETED|Overall Study||4||
48740455|NCT01631994|102151419|FG000|NOT COMPLETED|Overall Study||0||
48740456|NCT01631994|102151420|FG001|NOT COMPLETED|Overall Study||0||
48740457|NCT04057807|102151421|FG000|STARTED|Overall Study||12||
48740458|NCT04057807|102151421|FG000|1 Week Follow up|Overall Study||11||
48740459|NCT04057807|102151421|FG000|6 Month Follow up|Overall Study||12||
48740460|NCT04057807|102151421|FG000|COMPLETED|Overall Study||12||
48740461|NCT04057807|102151421|FG000|NOT COMPLETED|Overall Study||0||
48740462|NCT01292187|102151422|FG000|STARTED|Overall Study||86||
48740463|NCT01292187|102151423|FG001|STARTED|Overall Study||43||
48740464|NCT01292187|102151422|FG000|COMPLETED|Overall Study||69||
48740465|NCT01292187|102151423|FG001|COMPLETED|Overall Study||30||
48740466|NCT01292187|102151422|FG000|NOT COMPLETED|Overall Study||17||
48740467|NCT01292187|102151423|FG001|NOT COMPLETED|Overall Study||13||
48740468|NCT01132313|102151424|FG000|STARTED|Overall Study||17||
48740469|NCT01132313|102151425|FG001|STARTED|Overall Study||17||
48740470|NCT01132313|102151426|FG002|STARTED|Overall Study||81||
48322176|NCT01308008|101114857|FG000|NOT COMPLETED|4 Weeks||9||
48322177|NCT01308008|101114858|FG001|NOT COMPLETED|4 Weeks||2||
48322178|NCT01308008|101114857|FG000|STARTED|6 Months||62||
48740471|NCT01132313|102151427|FG003|STARTED|Overall Study||80||
48740472|NCT01132313|102151428|FG004|STARTED|Overall Study||79||
48740473|NCT01132313|102151429|FG005|STARTED|Overall Study||79||
48740474|NCT01132313|102151430|FG006|STARTED|Overall Study||49||
48740475|NCT01132313|102151431|FG007|STARTED|Overall Study||32||
48740476|NCT01132313|102151432|FG008|STARTED|Overall Study||26||
48740477|NCT01132313|102151433|FG009|STARTED|Overall Study||25||
48740478|NCT01132313|102151434|FG010|STARTED|Overall Study||1||
48740479|NCT01132313|102151435|FG011|STARTED|Overall Study||2||
48740480|NCT01132313|102151424|FG000|COMPLETED|Overall Study||14||
48740481|NCT01132313|102151425|FG001|COMPLETED|Overall Study||17||
48740482|NCT01132313|102151426|FG002|COMPLETED|Overall Study||61||
48740483|NCT01132313|102151427|FG003|COMPLETED|Overall Study||48||
48740484|NCT01132313|102151428|FG004|COMPLETED|Overall Study||34||
48740485|NCT01132313|102151429|FG005|COMPLETED|Overall Study||54||
48740486|NCT01132313|102151430|FG006|COMPLETED|Overall Study||19||
48161553|NCT01852058|100718814|FG004|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||7||
48161554|NCT01852058|100718815|FG005|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||9||
48161555|NCT01852058|100718816|FG006|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0||
48161556|NCT01852058|100718817|FG007|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0||
48161557|NCT01852058|100718818|FG008|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0||
48161558|NCT01852058|100718819|FG009|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0||
48161559|NCT01852058|100718820|FG010|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0||
48161560|NCT01852058|100718821|FG011|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0||
48161561|NCT01852058|100718810|FG000|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0||
48161562|NCT01852058|100718811|FG001|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0||
48161563|NCT01852058|100718812|FG002|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0||
48161564|NCT01852058|100718813|FG003|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0||
48161565|NCT01852058|100718814|FG004|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0||
48161566|NCT01852058|100718815|FG005|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0||
48161567|NCT01852058|100718816|FG006|STARTED|Treatment Cycle3:Retreatment 2,Study 121||5||
48161568|NCT01852058|100718817|FG007|STARTED|Treatment Cycle3:Retreatment 2,Study 121||16||
48161569|NCT01852058|100718818|FG008|STARTED|Treatment Cycle3:Retreatment 2,Study 121||34||
48161570|NCT01852058|100718819|FG009|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0||
48161571|NCT01852058|100718820|FG010|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0||
48161572|NCT01852058|100718821|FG011|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0||
48161573|NCT01852058|100718810|FG000|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0|Completed=Completed the entire study in this Cycle|
48161574|NCT01852058|100718811|FG001|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0|Completed=Completed the entire study in this Cycle|
48188544|NCT02068885|100783270|FG000|Provided Data at End of Test Phase|Overall Study||54|Sample size completers|
48740487|NCT01132313|102151431|FG007|COMPLETED|Overall Study||24||
48740488|NCT01132313|102151432|FG008|COMPLETED|Overall Study||5||
48740489|NCT01132313|102151433|FG009|COMPLETED|Overall Study||5||
48740490|NCT01132313|102151434|FG010|COMPLETED|Overall Study||0||
48740491|NCT01132313|102151435|FG011|COMPLETED|Overall Study||2||
48740492|NCT01132313|102151424|FG000|NOT COMPLETED|Overall Study||3||
48740493|NCT01132313|102151425|FG001|NOT COMPLETED|Overall Study||0||
48161575|NCT01852058|100718812|FG002|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0|Completed=Completed the entire study in this Cycle|
48161576|NCT01852058|100718813|FG003|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0|Completed=Completed the entire study in this Cycle|
48161577|NCT01852058|100718814|FG004|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0|Completed=Completed the entire study in this Cycle|
48161578|NCT01852058|100718815|FG005|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0|Completed=Completed the entire study in this Cycle|
48161579|NCT01852058|100718816|FG006|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||5|Completed=Completed the entire study in this Cycle|
48161580|NCT01852058|100718817|FG007|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||15|Completed=Completed the entire study in this Cycle|
48161581|NCT01852058|100718818|FG008|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||33|Completed=Completed the entire study in this Cycle|
48161582|NCT01852058|100718819|FG009|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0|Completed=Completed the entire study in this Cycle|
48161583|NCT01852058|100718820|FG010|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0|Completed=Completed the entire study in this Cycle|
48161584|NCT01852058|100718821|FG011|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0|Completed=Completed the entire study in this Cycle|
48161585|NCT01852058|100718810|FG000|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0||
48161586|NCT01852058|100718811|FG001|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0||
48161587|NCT01852058|100718812|FG002|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0||
48161588|NCT01852058|100718813|FG003|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0||
48161589|NCT01852058|100718814|FG004|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0||
48161590|NCT01852058|100718815|FG005|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0||
48161591|NCT01852058|100718816|FG006|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0||
48161592|NCT01852058|100718817|FG007|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||1||
48161593|NCT01852058|100718818|FG008|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||1||
48161594|NCT01852058|100718819|FG009|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0||
48322179|NCT01308008|101114858|FG001|STARTED|6 Months||71||
48408204|NCT02705755|101331732|FG002|COMPLETED|Part B (1 Day)||5||
48408205|NCT02705755|101331733|FG003|COMPLETED|Part B (1 Day)||0||
48740494|NCT01132313|102151426|FG002|NOT COMPLETED|Overall Study||20||
48740495|NCT01132313|102151427|FG003|NOT COMPLETED|Overall Study||32||
48161595|NCT01852058|100718820|FG010|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0||
48161596|NCT01852058|100718821|FG011|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0||
48161597|NCT01852058|100718810|FG000|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0||
48161598|NCT01852058|100718811|FG001|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0||
48161599|NCT01852058|100718812|FG002|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0||
48161600|NCT01852058|100718813|FG003|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0||
48161601|NCT01852058|100718814|FG004|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0||
48161602|NCT01852058|100718815|FG005|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0||
48161603|NCT01852058|100718816|FG006|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0||
48161604|NCT01852058|100718817|FG007|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0||
48161605|NCT01852058|100718818|FG008|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0||
48161606|NCT01852058|100718819|FG009|STARTED|Treatment Cycle4:Retreatment 3,Study 121||3||
48161607|NCT01852058|100718820|FG010|STARTED|Treatment Cycle4:Retreatment 3,Study 121||4||
48161608|NCT01852058|100718821|FG011|STARTED|Treatment Cycle4:Retreatment 3,Study 121||4||
48161609|NCT01852058|100718810|FG000|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0|Completed=Completed the entire study in this Cycle|
48161610|NCT01852058|100718811|FG001|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0|Completed=Completed the entire study in this Cycle|
48161611|NCT01852058|100718812|FG002|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0|Completed=Completed the entire study in this Cycle|
48161612|NCT01852058|100718813|FG003|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0|Completed=Completed the entire study in this Cycle|
48161613|NCT01852058|100718814|FG004|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0|Completed=Completed the entire study in this Cycle|
48161614|NCT01852058|100718815|FG005|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0|Completed=Completed the entire study in this Cycle|
48161615|NCT01852058|100718816|FG006|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0|Completed=Completed the entire study in this Cycle|
48188752|NCT01902901|100783329|FG001|STARTED|Overall Study||203||
48740496|NCT01132313|102151428|FG004|NOT COMPLETED|Overall Study||45||
48740497|NCT01132313|102151429|FG005|NOT COMPLETED|Overall Study||25||
48740498|NCT01132313|102151430|FG006|NOT COMPLETED|Overall Study||30||
48740499|NCT01132313|102151431|FG007|NOT COMPLETED|Overall Study||8||
48740500|NCT01132313|102151432|FG008|NOT COMPLETED|Overall Study||21||
48740501|NCT01132313|102151433|FG009|NOT COMPLETED|Overall Study||20||
48740502|NCT01132313|102151434|FG010|NOT COMPLETED|Overall Study||1||
48740503|NCT01132313|102151435|FG011|NOT COMPLETED|Overall Study||0||
48740504|NCT01442714|102151436|FG000|STARTED|Overall Study||33||
48740505|NCT01442714|102151436|FG000|COMPLETED|Overall Study||21||
48740506|NCT01442714|102151436|FG000|NOT COMPLETED|Overall Study||12||
48161616|NCT01852058|100718817|FG007|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0|Completed=Completed the entire study in this Cycle|
48161617|NCT01852058|100718818|FG008|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0|Completed=Completed the entire study in this Cycle|
48161618|NCT01852058|100718819|FG009|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||3|Completed=Completed the entire study in this Cycle|
48161619|NCT01852058|100718820|FG010|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||4|Completed=Completed the entire study in this Cycle|
48161620|NCT01852058|100718821|FG011|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||4|Completed=Completed the entire study in this Cycle|
48161621|NCT01852058|100718810|FG000|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0||
48161622|NCT01852058|100718811|FG001|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0||
48161623|NCT01852058|100718812|FG002|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0||
48322180|NCT01308008|101114857|FG000|COMPLETED|6 Months||54||
48322181|NCT01308008|101114858|FG001|COMPLETED|6 Months||62||
48322182|NCT01308008|101114857|FG000|NOT COMPLETED|6 Months||8||
48322183|NCT01308008|101114858|FG001|NOT COMPLETED|6 Months||9||
48322184|NCT01308008|101114857|FG000|STARTED|12 Months||54||
48322185|NCT01308008|101114858|FG001|STARTED|12 Months||62||
48322186|NCT01308008|101114857|FG000|COMPLETED|12 Months||46||
48322187|NCT01308008|101114858|FG001|COMPLETED|12 Months||58||
48322188|NCT01308008|101114857|FG000|NOT COMPLETED|12 Months||8||
48408206|NCT02705755|101331730|FG000|NOT COMPLETED|Part B (1 Day)||0||
48408207|NCT02705755|101331731|FG001|NOT COMPLETED|Part B (1 Day)||0||
48408208|NCT02705755|101331732|FG002|NOT COMPLETED|Part B (1 Day)||0||
48408209|NCT02705755|101331733|FG003|NOT COMPLETED|Part B (1 Day)||0||
48408210|NCT02705755|101331730|FG000|STARTED|Part C (20 Weeks)||0||
48408211|NCT02705755|101331731|FG001|STARTED|Part C (20 Weeks)||0||
48617418|NCT02735980|101849581|FG001|Received at Least 1 Dose of Study Drug|Overall Study||60||
48617419|NCT02735980|101849582|FG002|Received at Least 1 Dose of Study Drug|Overall Study||15||
48617420|NCT02735980|101849580|FG000|COMPLETED|Overall Study||48||
48617421|NCT02735980|101849581|FG001|COMPLETED|Overall Study||49||
48617422|NCT02735980|101849582|FG002|COMPLETED|Overall Study||14||
48617423|NCT02735980|101849580|FG000|NOT COMPLETED|Overall Study||10||
48617424|NCT02735980|101849581|FG001|NOT COMPLETED|Overall Study||11||
48617425|NCT02735980|101849582|FG002|NOT COMPLETED|Overall Study||1||
48617426|NCT01255904|101849583|FG000|STARTED|Overall Study||45||
48617427|NCT01255904|101849584|FG001|STARTED|Overall Study||45||
48161624|NCT01852058|100718813|FG003|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0||
48161625|NCT01852058|100718814|FG004|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0||
48161626|NCT01852058|100718815|FG005|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0||
48161627|NCT01852058|100718816|FG006|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0||
48161628|NCT01852058|100718817|FG007|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0||
48161629|NCT01852058|100718818|FG008|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0||
48161630|NCT01852058|100718819|FG009|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0||
48161631|NCT01852058|100718820|FG010|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0||
48161632|NCT01852058|100718821|FG011|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0||
48322189|NCT01308008|101114858|FG001|NOT COMPLETED|12 Months||4||
48322190|NCT02270242|101114859|FG000|STARTED|Overall Study||3555||
48322191|NCT02270242|101114860|FG001|STARTED|Overall Study||3564||
48322192|NCT02270242|101114859|FG000|COMPLETED|Overall Study||3496||
48322193|NCT02270242|101114860|FG001|COMPLETED|Overall Study||3511||
48322194|NCT02270242|101114859|FG000|NOT COMPLETED|Overall Study||59||
48322195|NCT02270242|101114860|FG001|NOT COMPLETED|Overall Study||53||
48322196|NCT01356407|101114861|FG000|STARTED|Overall Study||150||
48322197|NCT01356407|101114862|FG001|STARTED|Overall Study||150||
48322198|NCT01356407|101114861|FG000|COMPLETED|Overall Study||144||
48322199|NCT01356407|101114862|FG001|COMPLETED|Overall Study||146||
48322200|NCT01356407|101114861|FG000|NOT COMPLETED|Overall Study||6||
48322201|NCT01356407|101114862|FG001|NOT COMPLETED|Overall Study||4||
48322202|NCT02588976|101114863|FG000|STARTED|Overall Study||30||
48408212|NCT02705755|101331732|FG002|STARTED|Part C (20 Weeks)||0||
48617428|NCT01255904|101849583|FG000|COMPLETED|Overall Study||44||
48617429|NCT01255904|101849584|FG001|COMPLETED|Overall Study||41||
48617430|NCT01255904|101849583|FG000|NOT COMPLETED|Overall Study||1||
48617431|NCT01255904|101849584|FG001|NOT COMPLETED|Overall Study||4||
48617432|NCT04202497|101849585|FG000|STARTED|Baseline Scan (Day-1)||7||
48617433|NCT04202497|101849586|FG001|STARTED|Baseline Scan (Day-1)||0||
48617434|NCT04202497|101849587|FG002|STARTED|Baseline Scan (Day-1)||0||
48322203|NCT02588976|101114863|FG000|COMPLETED|Overall Study||30||
48322204|NCT02588976|101114863|FG000|NOT COMPLETED|Overall Study||0||
48322205|NCT04225923|101114864|FG000|STARTED|Overall Study||38||
48322206|NCT04225923|101114865|FG001|STARTED|Overall Study||11||
48408213|NCT02705755|101331733|FG003|STARTED|Part C (20 Weeks)||21||
48408214|NCT02705755|101331730|FG000|Received Study Drug|Part C (20 Weeks)||0||
48161633|NCT03502616|100718822|FG000|STARTED|Up to Week 16||134||
48161634|NCT03502616|100718823|FG001|STARTED|Up to Week 16||136||
48161635|NCT03502616|100718822|FG000|Treated|Up to Week 16||133||
48161636|NCT03502616|100718823|FG001|Treated|Up to Week 16||136||
48161637|NCT03502616|100718822|FG000|COMPLETED|Up to Week 16||132||
48617435|NCT04202497|101849588|FG003|STARTED|Baseline Scan (Day-1)||0||
48617436|NCT04202497|101849585|FG000|COMPLETED|Baseline Scan (Day-1)||6||
48322207|NCT04225923|101114866|FG002|STARTED|Overall Study||38||
48617437|NCT04202497|101849586|FG001|COMPLETED|Baseline Scan (Day-1)||0||
48617438|NCT04202497|101849587|FG002|COMPLETED|Baseline Scan (Day-1)||0||
48617439|NCT04202497|101849588|FG003|COMPLETED|Baseline Scan (Day-1)||0||
48617440|NCT04202497|101849585|FG000|NOT COMPLETED|Baseline Scan (Day-1)||1||
48617441|NCT04202497|101849586|FG001|NOT COMPLETED|Baseline Scan (Day-1)||0||
48617442|NCT04202497|101849587|FG002|NOT COMPLETED|Baseline Scan (Day-1)||0||
48617443|NCT04202497|101849588|FG003|NOT COMPLETED|Baseline Scan (Day-1)||0||
48617444|NCT04202497|101849585|FG000|STARTED|Treatment Period (Day 1 Through Day 2-3)||0||
48617445|NCT04202497|101849586|FG001|STARTED|Treatment Period (Day 1 Through Day 2-3)||2||
48617446|NCT04202497|101849587|FG002|STARTED|Treatment Period (Day 1 Through Day 2-3)||2||
48617447|NCT04202497|101849588|FG003|STARTED|Treatment Period (Day 1 Through Day 2-3)||2||
48617448|NCT04202497|101849585|FG000|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0||
48617449|NCT04202497|101849586|FG001|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||2||
48617450|NCT04202497|101849587|FG002|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||2||
48617451|NCT04202497|101849588|FG003|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||2||
48617452|NCT04202497|101849585|FG000|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0||
48617453|NCT04202497|101849586|FG001|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0||
48617454|NCT04202497|101849587|FG002|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0||
48617455|NCT04202497|101849588|FG003|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0||
48617456|NCT02949947|101849589|FG000|STARTED|Overall Study||1||
48617457|NCT02949947|101849590|FG001|STARTED|Overall Study||2||
48617458|NCT02949947|101849589|FG000|COMPLETED|Overall Study||0||
48617459|NCT02949947|101849590|FG001|COMPLETED|Overall Study||1||
48617460|NCT02949947|101849589|FG000|NOT COMPLETED|Overall Study||1||
48617461|NCT02949947|101849590|FG001|NOT COMPLETED|Overall Study||1||
48617462|NCT00490971|101849591|FG000|STARTED|Acute/Continuation||614||
48617463|NCT00490971|101849592|FG001|STARTED|Acute/Continuation||148||
48617464|NCT00490971|101849593|FG002|STARTED|Acute/Continuation||0||
48617465|NCT00490971|101849594|FG003|STARTED|Acute/Continuation||0||
48617466|NCT00490971|101849595|FG004|STARTED|Acute/Continuation||0||
48617467|NCT00490971|101849591|FG000|COMPLETED|Acute/Continuation||308||
48617468|NCT00490971|101849592|FG001|COMPLETED|Acute/Continuation||86||
48617469|NCT00490971|101849593|FG002|COMPLETED|Acute/Continuation||0||
48617470|NCT00490971|101849594|FG003|COMPLETED|Acute/Continuation||0||
48617471|NCT00490971|101849595|FG004|COMPLETED|Acute/Continuation||0||
48617472|NCT00490971|101849591|FG000|NOT COMPLETED|Acute/Continuation||306||
48617473|NCT00490971|101849592|FG001|NOT COMPLETED|Acute/Continuation||62||
48617474|NCT00490971|101849593|FG002|NOT COMPLETED|Acute/Continuation||0||
48617475|NCT00490971|101849594|FG003|NOT COMPLETED|Acute/Continuation||0||
48617476|NCT00490971|101849595|FG004|NOT COMPLETED|Acute/Continuation||0||
48740507|NCT00930553|102151437|FG000|STARTED|Overall Study||1314||
48740508|NCT00930553|102151437|FG000|Participants Entered From CAMMS223|Overall Study||141||
48161638|NCT03502616|100718823|FG001|COMPLETED|Up to Week 16||133||
48161639|NCT03502616|100718822|FG000|NOT COMPLETED|Up to Week 16||2||
48161640|NCT03502616|100718823|FG001|NOT COMPLETED|Up to Week 16||3||
48161641|NCT03502616|100718822|FG000|STARTED|Week 16 to Week 48||132||
48161642|NCT03502616|100718823|FG001|STARTED|Week 16 to Week 48||133||
48161643|NCT03502616|100718822|FG000|Treated|Week 16 to Week 48||132||
48161644|NCT03502616|100718823|FG001|Treated|Week 16 to Week 48||133||
48161645|NCT03502616|100718822|FG000|COMPLETED|Week 16 to Week 48||125||
48161646|NCT03502616|100718823|FG001|COMPLETED|Week 16 to Week 48||127||
48161647|NCT03502616|100718822|FG000|NOT COMPLETED|Week 16 to Week 48||7||
48161648|NCT03502616|100718823|FG001|NOT COMPLETED|Week 16 to Week 48||6||
48161649|NCT03810534|100718824|FG000|STARTED|Standard of Care (5-10 Months)||40||
48161650|NCT03810534|100718825|FG001|STARTED|Standard of Care (5-10 Months)||46||
48161651|NCT03810534|100718826|FG002|STARTED|Standard of Care (5-10 Months)||54||
48161652|NCT03810534|100718827|FG003|STARTED|Standard of Care (5-10 Months)||62||
48161653|NCT03810534|100718828|FG004|STARTED|Standard of Care (5-10 Months)||34||
48161654|NCT03810534|100718829|FG005|STARTED|Standard of Care (5-10 Months)||88||
48161655|NCT03810534|100718824|FG000|Patients Started|Standard of Care (5-10 Months)||20||
48161656|NCT03810534|100718825|FG001|Patients Started|Standard of Care (5-10 Months)||23||
48161657|NCT03810534|100718826|FG002|Patients Started|Standard of Care (5-10 Months)||27||
48161658|NCT03810534|100718827|FG003|Patients Started|Standard of Care (5-10 Months)||31||
48161659|NCT03810534|100718828|FG004|Patients Started|Standard of Care (5-10 Months)||17||
48161660|NCT03810534|100718829|FG005|Patients Started|Standard of Care (5-10 Months)||44||
48161661|NCT03810534|100718824|FG000|Caregivers Started|Standard of Care (5-10 Months)||20||
48161662|NCT03810534|100718825|FG001|Caregivers Started|Standard of Care (5-10 Months)||23||
48161663|NCT03810534|100718826|FG002|Caregivers Started|Standard of Care (5-10 Months)||27||
48161664|NCT03810534|100718827|FG003|Caregivers Started|Standard of Care (5-10 Months)||31||
48161665|NCT03810534|100718828|FG004|Caregivers Started|Standard of Care (5-10 Months)||17||
48617477|NCT00490971|101849591|FG000|STARTED|Maintenance||0||
48740509|NCT00930553|102151437|FG000|Participants Entered From CAMMS323|Overall Study||488||
48161666|NCT03810534|100718829|FG005|Caregivers Started|Standard of Care (5-10 Months)||44||
48322208|NCT04225923|101114864|FG000|COMPLETED|Overall Study||33||
48322209|NCT04225923|101114865|FG001|COMPLETED|Overall Study||10||
48617478|NCT00490971|101849592|FG001|STARTED|Maintenance||0||
48617479|NCT00490971|101849593|FG002|STARTED|Maintenance||147||
48617480|NCT00490971|101849594|FG003|STARTED|Maintenance||149||
48617481|NCT00490971|101849595|FG004|STARTED|Maintenance||83||
48617482|NCT00490971|101849591|FG000|COMPLETED|Maintenance||0||
48617483|NCT00490971|101849592|FG001|COMPLETED|Maintenance||0||
48617484|NCT00490971|101849593|FG002|COMPLETED|Maintenance||96||
48617485|NCT00490971|101849594|FG003|COMPLETED|Maintenance||96||
48617486|NCT00490971|101849595|FG004|COMPLETED|Maintenance||44||
48617487|NCT00490971|101849591|FG000|NOT COMPLETED|Maintenance||0||
48617488|NCT00490971|101849592|FG001|NOT COMPLETED|Maintenance||0||
48617489|NCT00490971|101849593|FG002|NOT COMPLETED|Maintenance||51||
48617490|NCT00490971|101849594|FG003|NOT COMPLETED|Maintenance||53||
48617491|NCT00490971|101849595|FG004|NOT COMPLETED|Maintenance||39||
48617492|NCT02504320|101849596|FG000|STARTED|Treatment Period 1||19||
48617493|NCT02504320|101849597|FG001|STARTED|Treatment Period 1||19||
48617494|NCT02504320|101849598|FG002|STARTED|Treatment Period 1||20||
48617495|NCT02504320|101849599|FG003|STARTED|Treatment Period 1||20||
48617496|NCT02504320|101849596|FG000|COMPLETED|Treatment Period 1||19||
48617497|NCT02504320|101849597|FG001|COMPLETED|Treatment Period 1||19||
48617498|NCT02504320|101849598|FG002|COMPLETED|Treatment Period 1||19||
48617499|NCT02504320|101849599|FG003|COMPLETED|Treatment Period 1||20||
48617500|NCT02504320|101849596|FG000|NOT COMPLETED|Treatment Period 1||0||
48617501|NCT02504320|101849597|FG001|NOT COMPLETED|Treatment Period 1||0||
48617502|NCT02504320|101849598|FG002|NOT COMPLETED|Treatment Period 1||1||
48617503|NCT02504320|101849599|FG003|NOT COMPLETED|Treatment Period 1||0||
48617504|NCT02504320|101849596|FG000|STARTED|Treatment Period 2||19||
48617505|NCT02504320|101849597|FG001|STARTED|Treatment Period 2||19||
48617506|NCT02504320|101849598|FG002|STARTED|Treatment Period 2||19||
48617507|NCT02504320|101849599|FG003|STARTED|Treatment Period 2||20||
48740510|NCT00930553|102151437|FG000|Participants Entered From CAMMS324|Overall Study||685||
48740511|NCT00930553|102151437|FG000|COMPLETED|Overall Study||1091||
48740512|NCT00930553|102151437|FG000|NOT COMPLETED|Overall Study||223||
48740513|NCT01505374|102151438|FG000|STARTED|Overall Study||30||
48740514|NCT01505374|102151439|FG001|STARTED|Overall Study||30||
48740515|NCT01505374|102151438|FG000|COMPLETED|Overall Study||29||
48740516|NCT01505374|102151439|FG001|COMPLETED|Overall Study||30||
48322210|NCT04225923|101114866|FG002|COMPLETED|Overall Study||33||
48322211|NCT04225923|101114864|FG000|NOT COMPLETED|Overall Study||5||
48322212|NCT04225923|101114865|FG001|NOT COMPLETED|Overall Study||1||
48322213|NCT04225923|101114866|FG002|NOT COMPLETED|Overall Study||5||
48322214|NCT00790907|101114867|FG000|STARTED|Overall Study||1209||
48322215|NCT00790907|101114868|FG001|STARTED|Overall Study||1024||
48322216|NCT00790907|101114869|FG002|STARTED|Overall Study||1002||
48322217|NCT00790907|101114867|FG000|COMPLETED|Overall Study||754||
48408215|NCT02705755|101331731|FG001|Received Study Drug|Part C (20 Weeks)||0||
48408216|NCT02705755|101331732|FG002|Received Study Drug|Part C (20 Weeks)||0||
48408217|NCT02705755|101331733|FG003|Received Study Drug|Part C (20 Weeks)||21||
48408218|NCT02705755|101331730|FG000|COMPLETED|Part C (20 Weeks)||0||
48408219|NCT02705755|101331731|FG001|COMPLETED|Part C (20 Weeks)||0||
48408220|NCT02705755|101331732|FG002|COMPLETED|Part C (20 Weeks)||0||
48408221|NCT02705755|101331733|FG003|COMPLETED|Part C (20 Weeks)||11||
48408222|NCT02705755|101331730|FG000|NOT COMPLETED|Part C (20 Weeks)||0||
48408223|NCT02705755|101331731|FG001|NOT COMPLETED|Part C (20 Weeks)||0||
48408224|NCT02705755|101331732|FG002|NOT COMPLETED|Part C (20 Weeks)||0||
48408225|NCT02705755|101331733|FG003|NOT COMPLETED|Part C (20 Weeks)||10||
48408226|NCT03099304|101331734|FG000|STARTED|DB Period: Day 1 to Week 24||32||
48408227|NCT03099304|101331735|FG001|STARTED|DB Period: Day 1 to Week 24||31||
48408228|NCT03099304|101331736|FG002|STARTED|DB Period: Day 1 to Week 24||31||
48408229|NCT03099304|101331737|FG003|STARTED|DB Period: Day 1 to Week 24||30||
48408230|NCT03099304|101331738|FG004|STARTED|DB Period: Day 1 to Week 24||33||
48408231|NCT03099304|101331739|FG005|STARTED|DB Period: Day 1 to Week 24||0||
48408232|NCT03099304|101331734|FG000|COMPLETED|DB Period: Day 1 to Week 24||27||
48408233|NCT03099304|101331735|FG001|COMPLETED|DB Period: Day 1 to Week 24||26||
48617508|NCT02504320|101849596|FG000|COMPLETED|Treatment Period 2||19||
48617509|NCT02504320|101849597|FG001|COMPLETED|Treatment Period 2||18||
48617510|NCT02504320|101849598|FG002|COMPLETED|Treatment Period 2||19||
48617511|NCT02504320|101849599|FG003|COMPLETED|Treatment Period 2||20||
48617512|NCT02504320|101849596|FG000|NOT COMPLETED|Treatment Period 2||0||
48617513|NCT02504320|101849597|FG001|NOT COMPLETED|Treatment Period 2||1||
48617514|NCT02504320|101849598|FG002|NOT COMPLETED|Treatment Period 2||0||
48617515|NCT02504320|101849599|FG003|NOT COMPLETED|Treatment Period 2||0||
48617516|NCT02504320|101849596|FG000|STARTED|Treatment Period 3||19||
48617517|NCT02504320|101849597|FG001|STARTED|Treatment Period 3||18||
48617518|NCT02504320|101849598|FG002|STARTED|Treatment Period 3||19||
48617519|NCT02504320|101849599|FG003|STARTED|Treatment Period 3||20||
48617520|NCT02504320|101849596|FG000|COMPLETED|Treatment Period 3||19||
48322218|NCT00790907|101114868|FG001|COMPLETED|Overall Study||684||
48322219|NCT00790907|101114869|FG002|COMPLETED|Overall Study||663||
48617521|NCT02504320|101849597|FG001|COMPLETED|Treatment Period 3||18||
48617522|NCT02504320|101849598|FG002|COMPLETED|Treatment Period 3||18||
48617523|NCT02504320|101849599|FG003|COMPLETED|Treatment Period 3||19||
48322220|NCT00790907|101114867|FG000|NOT COMPLETED|Overall Study||455||
48322221|NCT00790907|101114868|FG001|NOT COMPLETED|Overall Study||340||
48322222|NCT00790907|101114869|FG002|NOT COMPLETED|Overall Study||339||
48322223|NCT01081249|101114870|FG000|STARTED|Overall Study||11||
48322224|NCT01081249|101114871|FG001|STARTED|Overall Study||7||
48322225|NCT01081249|101114870|FG000|First Psychotherapy Appointment (1 Day)|Overall Study||11||
48322226|NCT01081249|101114871|FG001|First Psychotherapy Appointment (1 Day)|Overall Study||6||
48322227|NCT01081249|101114870|FG000|Washout (5-10 Days)|Overall Study||11||
48322228|NCT01081249|101114871|FG001|Washout (5-10 Days)|Overall Study||6||
48322229|NCT01081249|101114870|FG000|Second Psychotherapy Appointment (1 Day)|Overall Study||11||
48322230|NCT01081249|101114871|FG001|Second Psychotherapy Appointment (1 Day)|Overall Study||6||
48322231|NCT01081249|101114870|FG000|COMPLETED|Overall Study||11||
48322232|NCT01081249|101114871|FG001|COMPLETED|Overall Study||6||
48322233|NCT01081249|101114870|FG000|NOT COMPLETED|Overall Study||0||
48322234|NCT01081249|101114871|FG001|NOT COMPLETED|Overall Study||1||
48322235|NCT00879645|101114872|FG000|STARTED|Overall Study||9||
48322236|NCT00879645|101114873|FG001|STARTED|Overall Study||6||
48322237|NCT00879645|101114874|FG002|STARTED|Overall Study||6||
48322238|NCT00879645|101114875|FG003|STARTED|Overall Study||7||
48322239|NCT00879645|101114872|FG000|COMPLETED|Overall Study||8||
48322240|NCT00879645|101114873|FG001|COMPLETED|Overall Study||6||
48322241|NCT00879645|101114874|FG002|COMPLETED|Overall Study||6||
48322242|NCT00879645|101114875|FG003|COMPLETED|Overall Study||7||
48322243|NCT00879645|101114872|FG000|NOT COMPLETED|Overall Study||1||
48322244|NCT00879645|101114873|FG001|NOT COMPLETED|Overall Study||0||
48322245|NCT00879645|101114874|FG002|NOT COMPLETED|Overall Study||0||
48322246|NCT00879645|101114875|FG003|NOT COMPLETED|Overall Study||0||
48322247|NCT04784182|101114876|FG000|STARTED|Overall Study||1||
48322248|NCT04784182|101114877|FG001|STARTED|Overall Study||2||
48322249|NCT04784182|101114876|FG000|COMPLETED|Overall Study||1||
48322250|NCT04784182|101114877|FG001|COMPLETED|Overall Study||2||
48322251|NCT04784182|101114876|FG000|NOT COMPLETED|Overall Study||0||
48322252|NCT04784182|101114877|FG001|NOT COMPLETED|Overall Study||0||
48322253|NCT03374189|101114878|FG000|STARTED|Overall Study||40||
48322254|NCT03374189|101114879|FG001|STARTED|Overall Study||39||
48322255|NCT03374189|101114878|FG000|COMPLETED|Overall Study||39||
48322256|NCT03374189|101114879|FG001|COMPLETED|Overall Study||39||
48322257|NCT03374189|101114878|FG000|NOT COMPLETED|Overall Study||1||
48322258|NCT03374189|101114879|FG001|NOT COMPLETED|Overall Study||0||
48322259|NCT02343159|101114880|FG000|STARTED|Overall Study||27||
48322260|NCT02343159|101114881|FG001|STARTED|Overall Study||27||
48322261|NCT02343159|101114882|FG002|STARTED|Overall Study||30||
48322262|NCT02343159|101114880|FG000|COMPLETED|Overall Study||1||
48322263|NCT02343159|101114881|FG001|COMPLETED|Overall Study||1||
48322264|NCT02343159|101114882|FG002|COMPLETED|Overall Study||0||
48322265|NCT02343159|101114880|FG000|NOT COMPLETED|Overall Study||26||
48322266|NCT02343159|101114881|FG001|NOT COMPLETED|Overall Study||26||
48322267|NCT02343159|101114882|FG002|NOT COMPLETED|Overall Study||30||
48322268|NCT02258451|101114883|FG000|STARTED|Overall Study||142|Randomized|
48322269|NCT02258451|101114884|FG001|STARTED|Overall Study||141|Randomized|
48322270|NCT02258451|101114883|FG000|COMPLETED|Overall Study||0|As exemestane and everolimus given in this study as study treatment was of indefinite duration and ended only at progression, withdrawal, death, or study termination, no participants were considered to have completed their respective treatment regimen. However, all participants discontinued all study treatments.|
48322271|NCT02258451|101114884|FG001|COMPLETED|Overall Study||0|As exemestane and everolimus given in this study as study treatment was of indefinite duration and ended only at progression, withdrawal, death, or study termination, no participants were considered to have completed their respective treatment regimen. However, all participants discontinued all study treatments.|
48322272|NCT02258451|101114883|FG000|NOT COMPLETED|Overall Study||142||
48322273|NCT02258451|101114884|FG001|NOT COMPLETED|Overall Study||141||
48322274|NCT01973777|101114885|FG000|STARTED|Overall Study||51||
48322275|NCT01973777|101114885|FG000|One Year Follow-up|Overall Study||44||
48322276|NCT01973777|101114885|FG000|COMPLETED|Overall Study||44||
48322277|NCT01973777|101114885|FG000|NOT COMPLETED|Overall Study||7||
48322278|NCT01970995|101114886|FG000|STARTED|Confinement Period (Population at Day 5)||78||
48322279|NCT01970995|101114887|FG001|STARTED|Confinement Period (Population at Day 5)||42||
48322280|NCT01970995|101114888|FG002|STARTED|Confinement Period (Population at Day 5)||40||
48322281|NCT01970995|101114886|FG000|COMPLETED|Confinement Period (Population at Day 5)||77||
48322282|NCT01970995|101114887|FG001|COMPLETED|Confinement Period (Population at Day 5)||41||
48322283|NCT01970995|101114888|FG002|COMPLETED|Confinement Period (Population at Day 5)||39||
48322284|NCT01970995|101114886|FG000|NOT COMPLETED|Confinement Period (Population at Day 5)||1||
48322285|NCT01970995|101114887|FG001|NOT COMPLETED|Confinement Period (Population at Day 5)||1||
48322286|NCT01970995|101114888|FG002|NOT COMPLETED|Confinement Period (Population at Day 5)||1||
48322287|NCT01970995|101114886|FG000|STARTED|End of Study (Population at Day 90)||77||
48322288|NCT01970995|101114887|FG001|STARTED|End of Study (Population at Day 90)||41||
48322289|NCT01970995|101114888|FG002|STARTED|End of Study (Population at Day 90)||39||
48322290|NCT01970995|101114886|FG000|COMPLETED|End of Study (Population at Day 90)||76||
48322291|NCT01970995|101114887|FG001|COMPLETED|End of Study (Population at Day 90)||41||
48322292|NCT01970995|101114888|FG002|COMPLETED|End of Study (Population at Day 90)||38||
48322293|NCT01970995|101114886|FG000|NOT COMPLETED|End of Study (Population at Day 90)||1||
48322294|NCT01970995|101114887|FG001|NOT COMPLETED|End of Study (Population at Day 90)||0||
48322295|NCT01970995|101114888|FG002|NOT COMPLETED|End of Study (Population at Day 90)||1||
48322296|NCT04486950|101114889|FG000|STARTED|Overall Study||4||
48322297|NCT04486950|101114890|FG001|STARTED|Overall Study||2||
48322298|NCT04486950|101114891|FG002|STARTED|Overall Study||2||
48322299|NCT04486950|101114892|FG003|STARTED|Overall Study||6||
48322300|NCT04486950|101114893|FG004|STARTED|Overall Study||6||
48322301|NCT04486950|101114894|FG005|STARTED|Overall Study||6||
48322302|NCT04486950|101114895|FG006|STARTED|Overall Study||6||
48322303|NCT04486950|101114889|FG000|COMPLETED|Overall Study||4||
48322304|NCT04486950|101114890|FG001|COMPLETED|Overall Study||2||
48322305|NCT04486950|101114891|FG002|COMPLETED|Overall Study||2||
48322306|NCT04486950|101114892|FG003|COMPLETED|Overall Study||6||
48322307|NCT04486950|101114893|FG004|COMPLETED|Overall Study||6||
48322308|NCT04486950|101114894|FG005|COMPLETED|Overall Study||5||
48322309|NCT04486950|101114895|FG006|COMPLETED|Overall Study||6||
48322310|NCT04486950|101114889|FG000|NOT COMPLETED|Overall Study||0||
48322311|NCT04486950|101114890|FG001|NOT COMPLETED|Overall Study||0||
48322312|NCT04486950|101114891|FG002|NOT COMPLETED|Overall Study||0||
48322313|NCT04486950|101114892|FG003|NOT COMPLETED|Overall Study||0||
48322314|NCT04486950|101114893|FG004|NOT COMPLETED|Overall Study||0||
48322315|NCT04486950|101114894|FG005|NOT COMPLETED|Overall Study||1||
48322316|NCT04486950|101114895|FG006|NOT COMPLETED|Overall Study||0||
48322317|NCT04677959|101114896|FG000|STARTED|Overall Study||185||
48322318|NCT04677959|101114897|FG001|STARTED|Overall Study||242||
48322319|NCT04677959|101114896|FG000|Safety Analysis Set|Overall Study||185|All participants in the DS group who received at least 1 dose of IMP and all participants in the SoC group.|
48322320|NCT04677959|101114897|FG001|Safety Analysis Set|Overall Study||224|All participants in the DS group who received at least 1 dose of IMP and all participants in the SoC group.|
48322321|NCT04677959|101114896|FG000|COMPLETED|Overall Study||173||
48322322|NCT04677959|101114897|FG001|COMPLETED|Overall Study||183||
48322323|NCT04677959|101114896|FG000|NOT COMPLETED|Overall Study||12||
48322324|NCT04677959|101114897|FG001|NOT COMPLETED|Overall Study||59||
48322325|NCT00464334|101114898|FG000|STARTED|Overall Study||5||
48322326|NCT00464334|101114899|FG001|STARTED|Overall Study||13||
48322327|NCT00464334|101114900|FG002|STARTED|Overall Study||8||
48322328|NCT00464334|101114901|FG003|STARTED|Overall Study||8||
48322329|NCT00464334|101114902|FG004|STARTED|Overall Study||7||
48322330|NCT00464334|101114903|FG005|STARTED|Overall Study||7||
48322331|NCT00464334|101114904|FG006|STARTED|Overall Study||9||
48322332|NCT00464334|101114905|FG007|STARTED|Overall Study||8||
48322333|NCT00464334|101114906|FG008|STARTED|Overall Study||8||
48322334|NCT00464334|101114907|FG009|STARTED|Overall Study||5||
48322335|NCT00464334|101114908|FG010|STARTED|Overall Study||8||
48322336|NCT00464334|101114898|FG000|COMPLETED|Overall Study||4||
48322337|NCT00464334|101114899|FG001|COMPLETED|Overall Study||5||
48322338|NCT00464334|101114900|FG002|COMPLETED|Overall Study||3||
48322339|NCT00464334|101114901|FG003|COMPLETED|Overall Study||4||
48322340|NCT00464334|101114902|FG004|COMPLETED|Overall Study||3||
48322341|NCT00464334|101114903|FG005|COMPLETED|Overall Study||3||
48322342|NCT00464334|101114904|FG006|COMPLETED|Overall Study||6||
48322343|NCT00464334|101114905|FG007|COMPLETED|Overall Study||7||
48322344|NCT00464334|101114906|FG008|COMPLETED|Overall Study||2||
48322345|NCT00464334|101114907|FG009|COMPLETED|Overall Study||4||
48322346|NCT00464334|101114908|FG010|COMPLETED|Overall Study||4||
48322347|NCT00464334|101114898|FG000|NOT COMPLETED|Overall Study||1||
48617524|NCT02504320|101849596|FG000|NOT COMPLETED|Treatment Period 3||0||
48617525|NCT02504320|101849597|FG001|NOT COMPLETED|Treatment Period 3||0||
48322348|NCT00464334|101114899|FG001|NOT COMPLETED|Overall Study||8||
48322349|NCT00464334|101114900|FG002|NOT COMPLETED|Overall Study||5||
48322350|NCT00464334|101114901|FG003|NOT COMPLETED|Overall Study||4||
48322351|NCT00464334|101114902|FG004|NOT COMPLETED|Overall Study||4||
48322352|NCT00464334|101114903|FG005|NOT COMPLETED|Overall Study||4||
48322353|NCT00464334|101114904|FG006|NOT COMPLETED|Overall Study||3||
48322354|NCT00464334|101114905|FG007|NOT COMPLETED|Overall Study||1||
48322355|NCT00464334|101114906|FG008|NOT COMPLETED|Overall Study||6||
48322356|NCT00464334|101114907|FG009|NOT COMPLETED|Overall Study||1||
48322357|NCT00464334|101114908|FG010|NOT COMPLETED|Overall Study||4||
48322358|NCT03631732|101114909|FG000|STARTED|Randomized Phase Up to Week 24||331||
48322359|NCT03631732|101114910|FG001|STARTED|Randomized Phase Up to Week 24||165||
48322360|NCT03631732|101114909|FG000|COMPLETED|Randomized Phase Up to Week 24||324||
48617526|NCT02504320|101849598|FG002|NOT COMPLETED|Treatment Period 3||1||
48617527|NCT02504320|101849599|FG003|NOT COMPLETED|Treatment Period 3||1||
48617528|NCT02504320|101849596|FG000|STARTED|Treatment Period 4||19||
48322361|NCT03631732|101114910|FG001|COMPLETED|Randomized Phase Up to Week 24||163||
48322362|NCT03631732|101114909|FG000|NOT COMPLETED|Randomized Phase Up to Week 24||7||
48322363|NCT03631732|101114910|FG001|NOT COMPLETED|Randomized Phase Up to Week 24||2||
48322364|NCT03631732|101114909|FG000|STARTED|B/F/TAF Treatment Phase (After Week 24)||319||
48322365|NCT03631732|101114910|FG001|STARTED|B/F/TAF Treatment Phase (After Week 24)||163||
48617529|NCT02504320|101849597|FG001|STARTED|Treatment Period 4||18||
48322366|NCT03631732|101114909|FG000|COMPLETED|B/F/TAF Treatment Phase (After Week 24)||303||
48617530|NCT02504320|101849598|FG002|STARTED|Treatment Period 4||18||
48322367|NCT03631732|101114910|FG001|COMPLETED|B/F/TAF Treatment Phase (After Week 24)||158||
48322368|NCT03631732|101114909|FG000|NOT COMPLETED|B/F/TAF Treatment Phase (After Week 24)||16||
48322369|NCT03631732|101114910|FG001|NOT COMPLETED|B/F/TAF Treatment Phase (After Week 24)||5||
48322370|NCT00075023|101114911|FG000|STARTED|Pilot Study||5||
48322371|NCT00075023|101114912|FG001|STARTED|Pilot Study||5||
48322372|NCT00075023|101114911|FG000|COMPLETED|Pilot Study||3||
48322373|NCT00075023|101114912|FG001|COMPLETED|Pilot Study||3||
48322374|NCT00075023|101114911|FG000|NOT COMPLETED|Pilot Study||2||
48322375|NCT00075023|101114912|FG001|NOT COMPLETED|Pilot Study||2||
48322376|NCT00075023|101114911|FG000|STARTED|Part Two||0||
48322377|NCT00075023|101114912|FG001|STARTED|Part Two||0||
48322378|NCT00075023|101114911|FG000|COMPLETED|Part Two||0||
48322379|NCT00075023|101114912|FG001|COMPLETED|Part Two||0||
48322380|NCT00075023|101114911|FG000|NOT COMPLETED|Part Two||0||
48322381|NCT00075023|101114912|FG001|NOT COMPLETED|Part Two||0||
48322382|NCT02966509|101114913|FG000|STARTED|Baseline Satisfaction Survey||105||
48322383|NCT02966509|101114914|FG001|STARTED|Baseline Satisfaction Survey||108||
48322384|NCT02966509|101114913|FG000|COMPLETED|Baseline Satisfaction Survey||101||
48322385|NCT02966509|101114914|FG001|COMPLETED|Baseline Satisfaction Survey||101||
48322386|NCT02966509|101114913|FG000|NOT COMPLETED|Baseline Satisfaction Survey||4||
48322387|NCT02966509|101114914|FG001|NOT COMPLETED|Baseline Satisfaction Survey||7||
48322388|NCT02966509|101114913|FG000|STARTED|6 Month Satisfaction Decision Survey||105||
48322389|NCT02966509|101114914|FG001|STARTED|6 Month Satisfaction Decision Survey||108||
48322390|NCT02966509|101114913|FG000|COMPLETED|6 Month Satisfaction Decision Survey||80||
48322391|NCT02966509|101114914|FG001|COMPLETED|6 Month Satisfaction Decision Survey||77||
48322392|NCT02966509|101114913|FG000|NOT COMPLETED|6 Month Satisfaction Decision Survey||25||
48322393|NCT02966509|101114914|FG001|NOT COMPLETED|6 Month Satisfaction Decision Survey||31||
48322394|NCT02966509|101114913|FG000|STARTED|6 Month Satisfaction Survey||105||
48322395|NCT02966509|101114914|FG001|STARTED|6 Month Satisfaction Survey||108||
48408234|NCT03099304|101331736|FG002|COMPLETED|DB Period: Day 1 to Week 24||30||
48408235|NCT03099304|101331737|FG003|COMPLETED|DB Period: Day 1 to Week 24||26||
48408236|NCT03099304|101331738|FG004|COMPLETED|DB Period: Day 1 to Week 24||30||
48408237|NCT03099304|101331739|FG005|COMPLETED|DB Period: Day 1 to Week 24||0||
48408238|NCT03099304|101331734|FG000|NOT COMPLETED|DB Period: Day 1 to Week 24||5||
48408239|NCT03099304|101331735|FG001|NOT COMPLETED|DB Period: Day 1 to Week 24||5||
48408240|NCT03099304|101331736|FG002|NOT COMPLETED|DB Period: Day 1 to Week 24||1||
48408241|NCT03099304|101331737|FG003|NOT COMPLETED|DB Period: Day 1 to Week 24||4||
48408242|NCT03099304|101331738|FG004|NOT COMPLETED|DB Period: Day 1 to Week 24||3||
48408243|NCT03099304|101331739|FG005|NOT COMPLETED|DB Period: Day 1 to Week 24||0||
48408244|NCT03099304|101331734|FG000|STARTED|DB Period: Weeks 24 to 52||0||
48408245|NCT03099304|101331735|FG001|STARTED|DB Period: Weeks 24 to 52||11||
48408246|NCT03099304|101331736|FG002|STARTED|DB Period: Weeks 24 to 52||45||
48740517|NCT01505374|102151438|FG000|NOT COMPLETED|Overall Study||1||
48740518|NCT01505374|102151439|FG001|NOT COMPLETED|Overall Study||0||
48740519|NCT00904488|102151440|FG000|STARTED|Overall Study||5||
48740520|NCT00904488|102151441|FG001|STARTED|Overall Study||6||
48740521|NCT00904488|102151440|FG000|COMPLETED|Overall Study||5||
48740522|NCT00904488|102151441|FG001|COMPLETED|Overall Study||6||
48740523|NCT00904488|102151440|FG000|NOT COMPLETED|Overall Study||0||
48322396|NCT02966509|101114913|FG000|COMPLETED|6 Month Satisfaction Survey||58||
48322397|NCT02966509|101114914|FG001|COMPLETED|6 Month Satisfaction Survey||60||
48322398|NCT02966509|101114913|FG000|NOT COMPLETED|6 Month Satisfaction Survey||47||
48322399|NCT02966509|101114914|FG001|NOT COMPLETED|6 Month Satisfaction Survey||48||
48322400|NCT02966509|101114913|FG000|STARTED|6-Month Utilization and Cost||105||
48322401|NCT02966509|101114914|FG001|STARTED|6-Month Utilization and Cost||108||
48322402|NCT02966509|101114913|FG000|COMPLETED|6-Month Utilization and Cost||105||
48322403|NCT02966509|101114914|FG001|COMPLETED|6-Month Utilization and Cost||108||
48322404|NCT02966509|101114913|FG000|NOT COMPLETED|6-Month Utilization and Cost||0||
48322405|NCT02966509|101114914|FG001|NOT COMPLETED|6-Month Utilization and Cost||0||
48322406|NCT02966509|101114913|FG000|STARTED|15-Month Utilization and Cost||105||
48322407|NCT02966509|101114914|FG001|STARTED|15-Month Utilization and Cost||108||
48322408|NCT02966509|101114913|FG000|COMPLETED|15-Month Utilization and Cost||105||
48322409|NCT02966509|101114914|FG001|COMPLETED|15-Month Utilization and Cost||108||
48322410|NCT02966509|101114913|FG000|NOT COMPLETED|15-Month Utilization and Cost||0||
48322411|NCT02966509|101114914|FG001|NOT COMPLETED|15-Month Utilization and Cost||0||
48408247|NCT03099304|101331737|FG003|STARTED|DB Period: Weeks 24 to 52||44||
48408248|NCT03099304|101331738|FG004|STARTED|DB Period: Weeks 24 to 52||47||
48408249|NCT03099304|101331739|FG005|STARTED|DB Period: Weeks 24 to 52||0||
48322412|NCT02966509|101114913|FG000|STARTED|End of Life Utilization and Cost 6 Month||105||
48322413|NCT02966509|101114914|FG001|STARTED|End of Life Utilization and Cost 6 Month||108||
48322414|NCT02966509|101114913|FG000|COMPLETED|End of Life Utilization and Cost 6 Month||36||
48322415|NCT02966509|101114914|FG001|COMPLETED|End of Life Utilization and Cost 6 Month||33||
48322416|NCT02966509|101114913|FG000|NOT COMPLETED|End of Life Utilization and Cost 6 Month||69||
48408250|NCT03099304|101331734|FG000|COMPLETED|DB Period: Weeks 24 to 52||0||
48408251|NCT03099304|101331735|FG001|COMPLETED|DB Period: Weeks 24 to 52||10||
48740524|NCT00904488|102151441|FG001|NOT COMPLETED|Overall Study||0||
48740525|NCT01327677|102151442|FG000|STARTED|Overall Study||68||
48408252|NCT03099304|101331736|FG002|COMPLETED|DB Period: Weeks 24 to 52||43||
48408253|NCT03099304|101331737|FG003|COMPLETED|DB Period: Weeks 24 to 52||37||
48408254|NCT03099304|101331738|FG004|COMPLETED|DB Period: Weeks 24 to 52||45||
48408255|NCT03099304|101331739|FG005|COMPLETED|DB Period: Weeks 24 to 52||0||
48408256|NCT03099304|101331734|FG000|NOT COMPLETED|DB Period: Weeks 24 to 52||0||
48408257|NCT03099304|101331735|FG001|NOT COMPLETED|DB Period: Weeks 24 to 52||1||
48408258|NCT03099304|101331736|FG002|NOT COMPLETED|DB Period: Weeks 24 to 52||2||
48408259|NCT03099304|101331737|FG003|NOT COMPLETED|DB Period: Weeks 24 to 52||7||
48408260|NCT03099304|101331738|FG004|NOT COMPLETED|DB Period: Weeks 24 to 52||2||
48322417|NCT02966509|101114914|FG001|NOT COMPLETED|End of Life Utilization and Cost 6 Month||75||
48322418|NCT02966509|101114913|FG000|STARTED|End of Life Utilization and Cost 15month||105||
48322419|NCT02966509|101114914|FG001|STARTED|End of Life Utilization and Cost 15month||108||
48322420|NCT02966509|101114913|FG000|COMPLETED|End of Life Utilization and Cost 15month||60||
48322421|NCT02966509|101114914|FG001|COMPLETED|End of Life Utilization and Cost 15month||60||
48322422|NCT02966509|101114913|FG000|NOT COMPLETED|End of Life Utilization and Cost 15month||45||
48322423|NCT02966509|101114914|FG001|NOT COMPLETED|End of Life Utilization and Cost 15month||48||
48322424|NCT04467424|101114915|FG000|STARTED|Overall Study||100||
48322425|NCT04467424|101114916|FG001|STARTED|Overall Study||100||
48322426|NCT04467424|101114915|FG000|COMPLETED|Overall Study||100||
48408261|NCT03099304|101331739|FG005|NOT COMPLETED|DB Period: Weeks 24 to 52||0||
48408262|NCT03099304|101331734|FG000|STARTED|104-week Open-Label Extension Period||0||
48408263|NCT03099304|101331735|FG001|STARTED|104-week Open-Label Extension Period||0||
48408264|NCT03099304|101331736|FG002|STARTED|104-week Open-Label Extension Period||28||
48408265|NCT03099304|101331737|FG003|STARTED|104-week Open-Label Extension Period||21||
48408266|NCT03099304|101331738|FG004|STARTED|104-week Open-Label Extension Period||28||
48408267|NCT03099304|101331739|FG005|STARTED|104-week Open-Label Extension Period||46||
48408268|NCT03099304|101331734|FG000|COMPLETED|104-week Open-Label Extension Period||0||
48408269|NCT03099304|101331735|FG001|COMPLETED|104-week Open-Label Extension Period||0||
48408270|NCT03099304|101331736|FG002|COMPLETED|104-week Open-Label Extension Period||11||
48408271|NCT03099304|101331737|FG003|COMPLETED|104-week Open-Label Extension Period||8||
48408272|NCT03099304|101331738|FG004|COMPLETED|104-week Open-Label Extension Period||12||
48408273|NCT03099304|101331739|FG005|COMPLETED|104-week Open-Label Extension Period||23||
48408274|NCT03099304|101331734|FG000|NOT COMPLETED|104-week Open-Label Extension Period||0||
48408275|NCT03099304|101331735|FG001|NOT COMPLETED|104-week Open-Label Extension Period||0||
48408276|NCT03099304|101331736|FG002|NOT COMPLETED|104-week Open-Label Extension Period||17||
48740526|NCT01327677|102151443|FG001|STARTED|Overall Study||69||
48740527|NCT01327677|102151442|FG000|COMPLETED|Overall Study||48||
48740528|NCT01327677|102151443|FG001|COMPLETED|Overall Study||56||
48740529|NCT01327677|102151442|FG000|NOT COMPLETED|Overall Study||20||
48740530|NCT01327677|102151443|FG001|NOT COMPLETED|Overall Study||13||
48740531|NCT01362894|102151444|FG000|STARTED|Period One, 1 Week||119||
48740532|NCT01362894|102151445|FG001|STARTED|Period One, 1 Week||117||
48740533|NCT01362894|102151444|FG000|COMPLETED|Period One, 1 Week||119||
48740534|NCT01362894|102151445|FG001|COMPLETED|Period One, 1 Week||117||
48740535|NCT01362894|102151444|FG000|NOT COMPLETED|Period One, 1 Week||0||
48740536|NCT01362894|102151445|FG001|NOT COMPLETED|Period One, 1 Week||0||
48408277|NCT03099304|101331737|FG003|NOT COMPLETED|104-week Open-Label Extension Period||13||
48408278|NCT03099304|101331738|FG004|NOT COMPLETED|104-week Open-Label Extension Period||16||
48408279|NCT03099304|101331739|FG005|NOT COMPLETED|104-week Open-Label Extension Period||23||
48408280|NCT01131078|101331740|FG000|STARTED|Overall Study||101||
48408281|NCT01131078|101331741|FG001|STARTED|Overall Study||102||
48408282|NCT01131078|101331742|FG002|STARTED|Overall Study||103||
48408283|NCT01131078|101331740|FG000|COMPLETED|Overall Study||0||
48740537|NCT01362894|102151444|FG000|STARTED|Period Two, 1 Week||118||
48740538|NCT01362894|102151445|FG001|STARTED|Period Two, 1 Week||115||
48740539|NCT01362894|102151444|FG000|COMPLETED|Period Two, 1 Week||118||
48740540|NCT01362894|102151445|FG001|COMPLETED|Period Two, 1 Week||115||
48740541|NCT01362894|102151444|FG000|NOT COMPLETED|Period Two, 1 Week||0||
48740542|NCT01362894|102151445|FG001|NOT COMPLETED|Period Two, 1 Week||0||
48740543|NCT01797263|102151446|FG000|STARTED|Overall Study||129|Baseline|
48740544|NCT01797263|102151447|FG001|STARTED|Overall Study||127|Baseline|
48740545|NCT01797263|102151446|FG000|1 Month|Overall Study||96||
48740546|NCT01797263|102151447|FG001|1 Month|Overall Study||87||
48322427|NCT04467424|101114916|FG001|COMPLETED|Overall Study||100||
48322428|NCT04467424|101114915|FG000|NOT COMPLETED|Overall Study||0||
48322429|NCT04467424|101114916|FG001|NOT COMPLETED|Overall Study||0||
48322430|NCT02662036|101114917|FG000|STARTED|Overall Study||35||
48322431|NCT02662036|101114918|FG001|STARTED|Overall Study||35||
48322432|NCT02662036|101114917|FG000|COMPLETED|Overall Study||22||
48322433|NCT02662036|101114918|FG001|COMPLETED|Overall Study||22||
48322434|NCT02662036|101114917|FG000|NOT COMPLETED|Overall Study||13||
48322435|NCT02662036|101114918|FG001|NOT COMPLETED|Overall Study||13||
48322436|NCT04294719|101114919|FG000|STARTED|Overall Study||19||
48408284|NCT01131078|101331741|FG001|COMPLETED|Overall Study||1||
48408285|NCT01131078|101331742|FG002|COMPLETED|Overall Study||1||
48408286|NCT01131078|101331740|FG000|NOT COMPLETED|Overall Study||101||
48408287|NCT01131078|101331741|FG001|NOT COMPLETED|Overall Study||101||
48322437|NCT04294719|101114919|FG000|COMPLETED|Overall Study||18||
48322438|NCT04294719|101114919|FG000|NOT COMPLETED|Overall Study||1||
48322439|NCT04169373|101114920|FG000|STARTED|Week 1 to Week 14||209|Randomized|
48322440|NCT04169373|101114921|FG001|STARTED|Week 1 to Week 14||211|Randomized|
48322441|NCT04169373|101114922|FG002|STARTED|Week 1 to Week 14||158|Randomized|
48322442|NCT04169373|101114923|FG003|STARTED|Week 1 to Week 14||156|Randomized|
48322443|NCT04169373|101114920|FG000|Received Study Drug|Week 1 to Week 14||209|Study drug refers to either upadacitinib or placebo|
48322444|NCT04169373|101114921|FG001|Received Study Drug|Week 1 to Week 14||211|Study drug refers to either upadacitinib or placebo|
48322445|NCT04169373|101114922|FG002|Received Study Drug|Week 1 to Week 14||157|Study drug refers to either upadacitinib or placebo|
48161667|NCT03810534|100718824|FG000|Completed 7-day (Patients)|Standard of Care (5-10 Months)||16||
48161668|NCT03810534|100718825|FG001|Completed 7-day (Patients)|Standard of Care (5-10 Months)||20||
48161669|NCT03810534|100718826|FG002|Completed 7-day (Patients)|Standard of Care (5-10 Months)||23||
48161670|NCT03810534|100718827|FG003|Completed 7-day (Patients)|Standard of Care (5-10 Months)||29||
48161671|NCT03810534|100718828|FG004|Completed 7-day (Patients)|Standard of Care (5-10 Months)||13||
48322446|NCT04169373|101114923|FG003|Received Study Drug|Week 1 to Week 14||156|Study drug refers to either upadacitinib or placebo|
48322447|NCT04169373|101114920|FG000|COMPLETED|Week 1 to Week 14||204|Completed Week 14|
48322448|NCT04169373|101114921|FG001|COMPLETED|Week 1 to Week 14||206|Completed Week 14|
48322449|NCT04169373|101114922|FG002|COMPLETED|Week 1 to Week 14||149|Completed Week 14|
48322450|NCT04169373|101114923|FG003|COMPLETED|Week 1 to Week 14||142|Completed Week 14|
48322451|NCT04169373|101114920|FG000|NOT COMPLETED|Week 1 to Week 14||5||
48322452|NCT04169373|101114921|FG001|NOT COMPLETED|Week 1 to Week 14||5||
48322453|NCT04169373|101114922|FG002|NOT COMPLETED|Week 1 to Week 14||9||
48322454|NCT04169373|101114923|FG003|NOT COMPLETED|Week 1 to Week 14||14||
48322455|NCT04169373|101114920|FG000|STARTED|Week 14 to Week 52||204||
48322456|NCT04169373|101114921|FG001|STARTED|Week 14 to Week 52||206||
48322457|NCT04169373|101114922|FG002|STARTED|Week 14 to Week 52||149||
48322458|NCT04169373|101114923|FG003|STARTED|Week 14 to Week 52||142||
48322459|NCT04169373|101114920|FG000|COMPLETED|Week 14 to Week 52||192|Completed Week 52|
48322460|NCT04169373|101114921|FG001|COMPLETED|Week 14 to Week 52||194|Completed Week 52|
48322461|NCT04169373|101114922|FG002|COMPLETED|Week 14 to Week 52||138|Completed Week 52|
48617531|NCT02504320|101849599|FG003|STARTED|Treatment Period 4||19||
48617532|NCT02504320|101849596|FG000|COMPLETED|Treatment Period 4||19||
48617533|NCT02504320|101849597|FG001|COMPLETED|Treatment Period 4||18||
48617534|NCT02504320|101849598|FG002|COMPLETED|Treatment Period 4||18||
48617535|NCT02504320|101849599|FG003|COMPLETED|Treatment Period 4||19||
48617536|NCT02504320|101849596|FG000|NOT COMPLETED|Treatment Period 4||0||
48617537|NCT02504320|101849597|FG001|NOT COMPLETED|Treatment Period 4||0||
48617538|NCT02504320|101849598|FG002|NOT COMPLETED|Treatment Period 4||0||
48617539|NCT02504320|101849599|FG003|NOT COMPLETED|Treatment Period 4||0||
48617540|NCT05136417|101849600|FG000|STARTED|Overall Study||100||
48617541|NCT05136417|101849600|FG000|COMPLETED|Overall Study||100||
48617542|NCT05136417|101849600|FG000|NOT COMPLETED|Overall Study||0||
48740547|NCT01797263|102151446|FG000|3 Month|Overall Study||87||
48740548|NCT01797263|102151447|FG001|3 Month|Overall Study||84||
48740549|NCT01797263|102151446|FG000|6 Month|Overall Study||90||
48740550|NCT01797263|102151447|FG001|6 Month|Overall Study||85||
48740551|NCT01797263|102151446|FG000|9 Month|Overall Study||92||
48740552|NCT01797263|102151447|FG001|9 Month|Overall Study||87||
48740553|NCT01797263|102151446|FG000|COMPLETED|Overall Study||92||
48740554|NCT01797263|102151447|FG001|COMPLETED|Overall Study||87||
48740555|NCT01797263|102151446|FG000|NOT COMPLETED|Overall Study||37||
48740556|NCT01797263|102151447|FG001|NOT COMPLETED|Overall Study||40||
48740557|NCT03748641|102151448|FG000|STARTED|Overall Study||212||
48740558|NCT03748641|102151449|FG001|STARTED|Overall Study||211||
48740559|NCT03748641|102151450|FG002|STARTED|Overall Study||123||
48740560|NCT03748641|102151451|FG003|STARTED|Overall Study||124||
48740561|NCT03748641|102151452|FG004|STARTED|Overall Study||95||
48740562|NCT03748641|102151448|FG000|Breast Cancer Gene (BRCA) Subgroup|Overall Study||113||
48740563|NCT03748641|102151449|FG001|Breast Cancer Gene (BRCA) Subgroup|Overall Study||112||
48740564|NCT03748641|102151450|FG002|Breast Cancer Gene (BRCA) Subgroup|Overall Study||0||
48740565|NCT03748641|102151451|FG003|Breast Cancer Gene (BRCA) Subgroup|Overall Study||0||
48740566|NCT03748641|102151452|FG004|Breast Cancer Gene (BRCA) Subgroup|Overall Study||52||
48740567|NCT03748641|102151448|FG000|COMPLETED|Overall Study||0||
48740568|NCT03748641|102151449|FG001|COMPLETED|Overall Study||0||
48740569|NCT03748641|102151450|FG002|COMPLETED|Overall Study||0||
48740570|NCT03748641|102151451|FG003|COMPLETED|Overall Study||0||
48740571|NCT03748641|102151452|FG004|COMPLETED|Overall Study||0||
48740572|NCT03748641|102151448|FG000|NOT COMPLETED|Overall Study||212||
48740573|NCT03748641|102151449|FG001|NOT COMPLETED|Overall Study||211||
48740574|NCT03748641|102151450|FG002|NOT COMPLETED|Overall Study||123||
48740575|NCT03748641|102151451|FG003|NOT COMPLETED|Overall Study||124||
48740576|NCT03748641|102151452|FG004|NOT COMPLETED|Overall Study||95||
48740577|NCT02292719|102151453|FG000|STARTED|Overall Study||9||
48740578|NCT02292719|102151454|FG001|STARTED|Overall Study||11||
48740579|NCT02292719|102151455|FG002|STARTED|Overall Study||10||
48740580|NCT02292719|102151456|FG003|STARTED|Overall Study||9||
48740581|NCT02292719|102151457|FG004|STARTED|Overall Study||21||
48740582|NCT02292719|102151458|FG005|STARTED|Overall Study||10||
48740583|NCT02292719|102151453|FG000|COMPLETED|Overall Study||9||
48740584|NCT02292719|102151454|FG001|COMPLETED|Overall Study||11||
48740585|NCT02292719|102151455|FG002|COMPLETED|Overall Study||9||
48740586|NCT02292719|102151456|FG003|COMPLETED|Overall Study||8||
48740587|NCT02292719|102151457|FG004|COMPLETED|Overall Study||20||
48740588|NCT02292719|102151458|FG005|COMPLETED|Overall Study||10||
48740589|NCT02292719|102151453|FG000|NOT COMPLETED|Overall Study||0||
48740590|NCT02292719|102151454|FG001|NOT COMPLETED|Overall Study||0||
48740591|NCT02292719|102151455|FG002|NOT COMPLETED|Overall Study||1||
48740592|NCT02292719|102151456|FG003|NOT COMPLETED|Overall Study||1||
48740593|NCT02292719|102151457|FG004|NOT COMPLETED|Overall Study||1||
48740594|NCT02292719|102151458|FG005|NOT COMPLETED|Overall Study||0||
48740595|NCT02969356|102151459|FG000|STARTED|Overall Study||157||
48740596|NCT02969356|102151459|FG000|Intent-to-Treat (ITT) Population|Overall Study||153||
48740597|NCT02969356|102151459|FG000|COMPLETED|Overall Study||134||
48740598|NCT02969356|102151459|FG000|NOT COMPLETED|Overall Study||23||
48740599|NCT03160898|102151460|FG000|STARTED|Overall Study||115||
48740600|NCT03160898|102151461|FG001|STARTED|Overall Study||113||
48740601|NCT03160898|102151462|FG002|STARTED|Overall Study||113||
48408288|NCT01131078|101331742|FG002|NOT COMPLETED|Overall Study||102||
48617543|NCT01683604|101849601|FG000|STARTED|Overall Study||37||
48617544|NCT01683604|101849601|FG000|COMPLETED|Overall Study||32||
48740602|NCT03160898|102151463|FG003|STARTED|Overall Study||117||
48740603|NCT03160898|102151460|FG000|COMPLETED|Overall Study||95||
48740604|NCT03160898|102151461|FG001|COMPLETED|Overall Study||100||
48322462|NCT04169373|101114923|FG003|COMPLETED|Week 14 to Week 52||133|Completed Week 52|
48322463|NCT04169373|101114920|FG000|NOT COMPLETED|Week 14 to Week 52||12||
48617545|NCT01683604|101849601|FG000|NOT COMPLETED|Overall Study||5||
48740605|NCT03160898|102151462|FG002|COMPLETED|Overall Study||97||
48740606|NCT03160898|102151463|FG003|COMPLETED|Overall Study||98||
48740607|NCT03160898|102151460|FG000|NOT COMPLETED|Overall Study||20||
48161672|NCT03810534|100718829|FG005|Completed 7-day (Patients)|Standard of Care (5-10 Months)||40||
48161673|NCT03810534|100718824|FG000|Completed 7-Day (Caregivers)|Standard of Care (5-10 Months)||18||
48161674|NCT03810534|100718825|FG001|Completed 7-Day (Caregivers)|Standard of Care (5-10 Months)||21||
48161675|NCT03810534|100718826|FG002|Completed 7-Day (Caregivers)|Standard of Care (5-10 Months)||23||
48161676|NCT03810534|100718827|FG003|Completed 7-Day (Caregivers)|Standard of Care (5-10 Months)||29||
48161677|NCT03810534|100718828|FG004|Completed 7-Day (Caregivers)|Standard of Care (5-10 Months)||13||
48161678|NCT03810534|100718829|FG005|Completed 7-Day (Caregivers)|Standard of Care (5-10 Months)||38||
48161679|NCT03810534|100718824|FG000|Completed 30-day (Patients)|Standard of Care (5-10 Months)||14||
48161680|NCT03810534|100718825|FG001|Completed 30-day (Patients)|Standard of Care (5-10 Months)||16||
48161681|NCT03810534|100718826|FG002|Completed 30-day (Patients)|Standard of Care (5-10 Months)||21||
48161682|NCT03810534|100718827|FG003|Completed 30-day (Patients)|Standard of Care (5-10 Months)||23||
48161683|NCT03810534|100718828|FG004|Completed 30-day (Patients)|Standard of Care (5-10 Months)||12||
48161684|NCT03810534|100718829|FG005|Completed 30-day (Patients)|Standard of Care (5-10 Months)||38||
48161685|NCT03810534|100718824|FG000|Completed 30-Day (Caregivers)|Standard of Care (5-10 Months)||14||
48161686|NCT03810534|100718825|FG001|Completed 30-Day (Caregivers)|Standard of Care (5-10 Months)||16||
48161687|NCT03810534|100718826|FG002|Completed 30-Day (Caregivers)|Standard of Care (5-10 Months)||21||
48161688|NCT03810534|100718827|FG003|Completed 30-Day (Caregivers)|Standard of Care (5-10 Months)||23||
48161689|NCT03810534|100718828|FG004|Completed 30-Day (Caregivers)|Standard of Care (5-10 Months)||10||
48161690|NCT03810534|100718829|FG005|Completed 30-Day (Caregivers)|Standard of Care (5-10 Months)||32||
48161691|NCT03810534|100718824|FG000|Completed 60-Day (Patients)|Standard of Care (5-10 Months)||10||
48161692|NCT03810534|100718825|FG001|Completed 60-Day (Patients)|Standard of Care (5-10 Months)||16||
48161693|NCT03810534|100718826|FG002|Completed 60-Day (Patients)|Standard of Care (5-10 Months)||17||
48161694|NCT03810534|100718827|FG003|Completed 60-Day (Patients)|Standard of Care (5-10 Months)||20||
48161695|NCT03810534|100718828|FG004|Completed 60-Day (Patients)|Standard of Care (5-10 Months)||10||
48161696|NCT03810534|100718829|FG005|Completed 60-Day (Patients)|Standard of Care (5-10 Months)||32||
48161697|NCT03810534|100718824|FG000|Completed 60-Day (Caregivers)|Standard of Care (5-10 Months)||10||
48161698|NCT03810534|100718825|FG001|Completed 60-Day (Caregivers)|Standard of Care (5-10 Months)||16||
48161699|NCT03810534|100718826|FG002|Completed 60-Day (Caregivers)|Standard of Care (5-10 Months)||15||
48161700|NCT03810534|100718827|FG003|Completed 60-Day (Caregivers)|Standard of Care (5-10 Months)||20||
48161701|NCT03810534|100718828|FG004|Completed 60-Day (Caregivers)|Standard of Care (5-10 Months)||9||
48161702|NCT03810534|100718829|FG005|Completed 60-Day (Caregivers)|Standard of Care (5-10 Months)||31||
48161703|NCT03810534|100718824|FG000|COMPLETED|Standard of Care (5-10 Months)||20||
48161704|NCT03810534|100718825|FG001|COMPLETED|Standard of Care (5-10 Months)||32||
48161705|NCT03810534|100718826|FG002|COMPLETED|Standard of Care (5-10 Months)||32||
48161706|NCT03810534|100718827|FG003|COMPLETED|Standard of Care (5-10 Months)||40||
48161707|NCT03810534|100718828|FG004|COMPLETED|Standard of Care (5-10 Months)||19||
48161708|NCT03810534|100718829|FG005|COMPLETED|Standard of Care (5-10 Months)||63||
48161709|NCT03810534|100718824|FG000|NOT COMPLETED|Standard of Care (5-10 Months)||20||
48161710|NCT03810534|100718825|FG001|NOT COMPLETED|Standard of Care (5-10 Months)||14||
48161711|NCT03810534|100718826|FG002|NOT COMPLETED|Standard of Care (5-10 Months)||22||
48161712|NCT03810534|100718827|FG003|NOT COMPLETED|Standard of Care (5-10 Months)||22||
48161713|NCT03810534|100718828|FG004|NOT COMPLETED|Standard of Care (5-10 Months)||15||
48161714|NCT03810534|100718829|FG005|NOT COMPLETED|Standard of Care (5-10 Months)||25||
48161715|NCT03810534|100718824|FG000|STARTED|Pre-Implementation Phase (2 Months)||0||
48161716|NCT03810534|100718825|FG001|STARTED|Pre-Implementation Phase (2 Months)||0||
48161717|NCT03810534|100718826|FG002|STARTED|Pre-Implementation Phase (2 Months)||0||
48161718|NCT03810534|100718827|FG003|STARTED|Pre-Implementation Phase (2 Months)||0||
48161719|NCT03810534|100718828|FG004|STARTED|Pre-Implementation Phase (2 Months)||0||
48408289|NCT00927576|101331743|FG000|STARTED|Overall Study||237||
48408290|NCT00927576|101331744|FG001|STARTED|Overall Study||28||
48161720|NCT03810534|100718829|FG005|STARTED|Pre-Implementation Phase (2 Months)||0||
48161721|NCT03810534|100718824|FG000|Patients Started|Pre-Implementation Phase (2 Months)||0||
48161722|NCT03810534|100718825|FG001|Patients Started|Pre-Implementation Phase (2 Months)||0||
48161723|NCT03810534|100718826|FG002|Patients Started|Pre-Implementation Phase (2 Months)||0||
48161724|NCT03810534|100718827|FG003|Patients Started|Pre-Implementation Phase (2 Months)||0||
48161725|NCT03810534|100718828|FG004|Patients Started|Pre-Implementation Phase (2 Months)||0||
48161726|NCT03810534|100718829|FG005|Patients Started|Pre-Implementation Phase (2 Months)||0||
48161727|NCT03810534|100718824|FG000|Caregivers Started|Pre-Implementation Phase (2 Months)||0||
48161728|NCT03810534|100718825|FG001|Caregivers Started|Pre-Implementation Phase (2 Months)||0||
48408291|NCT00927576|101331743|FG000|Cognitive Testing|Overall Study||237||
48161729|NCT03810534|100718826|FG002|Caregivers Started|Pre-Implementation Phase (2 Months)||0||
48161730|NCT03810534|100718827|FG003|Caregivers Started|Pre-Implementation Phase (2 Months)||0||
48161731|NCT03810534|100718828|FG004|Caregivers Started|Pre-Implementation Phase (2 Months)||0||
48161732|NCT03810534|100718829|FG005|Caregivers Started|Pre-Implementation Phase (2 Months)||0||
48322464|NCT04169373|101114921|FG001|NOT COMPLETED|Week 14 to Week 52||12||
48408292|NCT00927576|101331744|FG001|Cognitive Testing|Overall Study||28||
48161733|NCT03810534|100718824|FG000|Completed 7-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
48161734|NCT03810534|100718825|FG001|Completed 7-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
48161735|NCT03810534|100718826|FG002|Completed 7-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
48161736|NCT03810534|100718827|FG003|Completed 7-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
48161737|NCT03810534|100718828|FG004|Completed 7-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
48161738|NCT03810534|100718829|FG005|Completed 7-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
48161739|NCT03810534|100718824|FG000|Completed 7-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
48161740|NCT03810534|100718825|FG001|Completed 7-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
48161741|NCT03810534|100718826|FG002|Completed 7-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
48161742|NCT03810534|100718827|FG003|Completed 7-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
48161743|NCT03810534|100718828|FG004|Completed 7-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
48161744|NCT03810534|100718829|FG005|Completed 7-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
48161745|NCT03810534|100718824|FG000|Completed 30-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
48161746|NCT03810534|100718825|FG001|Completed 30-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
48161747|NCT03810534|100718826|FG002|Completed 30-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
48161748|NCT03810534|100718827|FG003|Completed 30-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
48161749|NCT03810534|100718828|FG004|Completed 30-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
48161750|NCT03810534|100718829|FG005|Completed 30-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
48161751|NCT03810534|100718824|FG000|Completed 30-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
48161752|NCT03810534|100718825|FG001|Completed 30-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
48161753|NCT03810534|100718826|FG002|Completed 30-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
48161754|NCT03810534|100718827|FG003|Completed 30-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
48161755|NCT03810534|100718828|FG004|Completed 30-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
48161756|NCT03810534|100718829|FG005|Completed 30-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
48161757|NCT03810534|100718824|FG000|Completed 60-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
48161758|NCT03810534|100718825|FG001|Completed 60-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
48161759|NCT03810534|100718826|FG002|Completed 60-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
48161760|NCT03810534|100718827|FG003|Completed 60-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
48161761|NCT03810534|100718828|FG004|Completed 60-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
48161762|NCT03810534|100718829|FG005|Completed 60-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
48161763|NCT03810534|100718824|FG000|Completed 60-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
48161764|NCT03810534|100718825|FG001|Completed 60-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
48161765|NCT03810534|100718826|FG002|Completed 60-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
48161766|NCT03810534|100718827|FG003|Completed 60-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
48161767|NCT03810534|100718828|FG004|Completed 60-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
48161768|NCT03810534|100718829|FG005|Completed 60-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
48161769|NCT03810534|100718824|FG000|COMPLETED|Pre-Implementation Phase (2 Months)||0||
48161770|NCT03810534|100718825|FG001|COMPLETED|Pre-Implementation Phase (2 Months)||0||
48161771|NCT03810534|100718826|FG002|COMPLETED|Pre-Implementation Phase (2 Months)||0||
48161772|NCT03810534|100718827|FG003|COMPLETED|Pre-Implementation Phase (2 Months)||0||
48161773|NCT03810534|100718828|FG004|COMPLETED|Pre-Implementation Phase (2 Months)||0||
48161774|NCT03810534|100718829|FG005|COMPLETED|Pre-Implementation Phase (2 Months)||0||
48161775|NCT03810534|100718824|FG000|NOT COMPLETED|Pre-Implementation Phase (2 Months)||0||
48161776|NCT03810534|100718825|FG001|NOT COMPLETED|Pre-Implementation Phase (2 Months)||0||
48161777|NCT03810534|100718826|FG002|NOT COMPLETED|Pre-Implementation Phase (2 Months)||0||
48161778|NCT03810534|100718827|FG003|NOT COMPLETED|Pre-Implementation Phase (2 Months)||0||
48161779|NCT03810534|100718828|FG004|NOT COMPLETED|Pre-Implementation Phase (2 Months)||0||
48161780|NCT03810534|100718829|FG005|NOT COMPLETED|Pre-Implementation Phase (2 Months)||0||
48161781|NCT03810534|100718824|FG000|STARTED|Connect-Home (5-10 Months)||82||
48161782|NCT03810534|100718825|FG001|STARTED|Connect-Home (5-10 Months)||80||
48161783|NCT03810534|100718826|FG002|STARTED|Connect-Home (5-10 Months)||66||
48161784|NCT03810534|100718827|FG003|STARTED|Connect-Home (5-10 Months)||54||
48161785|NCT03810534|100718828|FG004|STARTED|Connect-Home (5-10 Months)||10||
48161786|NCT03810534|100718829|FG005|STARTED|Connect-Home (5-10 Months)||38||
48161787|NCT03810534|100718824|FG000|Patients Started|Connect-Home (5-10 Months)||41||
48161788|NCT03810534|100718825|FG001|Patients Started|Connect-Home (5-10 Months)||40||
48161789|NCT03810534|100718826|FG002|Patients Started|Connect-Home (5-10 Months)||33||
48161790|NCT03810534|100718827|FG003|Patients Started|Connect-Home (5-10 Months)||27||
48161791|NCT03810534|100718828|FG004|Patients Started|Connect-Home (5-10 Months)||5||
48161792|NCT03810534|100718829|FG005|Patients Started|Connect-Home (5-10 Months)||19||
48161793|NCT03810534|100718824|FG000|Caregivers Started|Connect-Home (5-10 Months)||41||
48161794|NCT03810534|100718825|FG001|Caregivers Started|Connect-Home (5-10 Months)||40||
48161795|NCT03810534|100718826|FG002|Caregivers Started|Connect-Home (5-10 Months)||33||
48161796|NCT03810534|100718827|FG003|Caregivers Started|Connect-Home (5-10 Months)||27||
48161797|NCT03810534|100718828|FG004|Caregivers Started|Connect-Home (5-10 Months)||5||
48161798|NCT03810534|100718829|FG005|Caregivers Started|Connect-Home (5-10 Months)||19||
48161799|NCT03810534|100718824|FG000|Completed 7-Day (Patients)|Connect-Home (5-10 Months)||38||
48161800|NCT03810534|100718825|FG001|Completed 7-Day (Patients)|Connect-Home (5-10 Months)||35||
48161801|NCT03810534|100718826|FG002|Completed 7-Day (Patients)|Connect-Home (5-10 Months)||27||
48161802|NCT03810534|100718827|FG003|Completed 7-Day (Patients)|Connect-Home (5-10 Months)||23||
48161803|NCT03810534|100718828|FG004|Completed 7-Day (Patients)|Connect-Home (5-10 Months)||4||
48161804|NCT03810534|100718829|FG005|Completed 7-Day (Patients)|Connect-Home (5-10 Months)||14||
48161805|NCT03810534|100718824|FG000|Completed 7-Day (Caregivers)|Connect-Home (5-10 Months)||35||
48161806|NCT03810534|100718825|FG001|Completed 7-Day (Caregivers)|Connect-Home (5-10 Months)||34||
48161807|NCT03810534|100718826|FG002|Completed 7-Day (Caregivers)|Connect-Home (5-10 Months)||29||
48161808|NCT03810534|100718827|FG003|Completed 7-Day (Caregivers)|Connect-Home (5-10 Months)||24||
48161809|NCT03810534|100718828|FG004|Completed 7-Day (Caregivers)|Connect-Home (5-10 Months)||4||
48161810|NCT03810534|100718829|FG005|Completed 7-Day (Caregivers)|Connect-Home (5-10 Months)||13||
48161811|NCT03810534|100718824|FG000|Completed 30-Day (Patients)|Connect-Home (5-10 Months)||35||
48161812|NCT03810534|100718825|FG001|Completed 30-Day (Patients)|Connect-Home (5-10 Months)||31||
48161813|NCT03810534|100718826|FG002|Completed 30-Day (Patients)|Connect-Home (5-10 Months)||25||
48161814|NCT03810534|100718827|FG003|Completed 30-Day (Patients)|Connect-Home (5-10 Months)||19||
48161815|NCT03810534|100718828|FG004|Completed 30-Day (Patients)|Connect-Home (5-10 Months)||3||
48161816|NCT03810534|100718829|FG005|Completed 30-Day (Patients)|Connect-Home (5-10 Months)||12||
48161817|NCT03810534|100718824|FG000|Completed 30-Day (Caregivers)|Connect-Home (5-10 Months)||34||
48161818|NCT03810534|100718825|FG001|Completed 30-Day (Caregivers)|Connect-Home (5-10 Months)||30||
48161819|NCT03810534|100718826|FG002|Completed 30-Day (Caregivers)|Connect-Home (5-10 Months)||25||
48161820|NCT03810534|100718827|FG003|Completed 30-Day (Caregivers)|Connect-Home (5-10 Months)||21||
48161821|NCT03810534|100718828|FG004|Completed 30-Day (Caregivers)|Connect-Home (5-10 Months)||2||
48161822|NCT03810534|100718829|FG005|Completed 30-Day (Caregivers)|Connect-Home (5-10 Months)||10||
48161823|NCT03810534|100718824|FG000|Completed 60-Day (Patients)|Connect-Home (5-10 Months)||30||
48161824|NCT03810534|100718825|FG001|Completed 60-Day (Patients)|Connect-Home (5-10 Months)||25||
48161825|NCT03810534|100718826|FG002|Completed 60-Day (Patients)|Connect-Home (5-10 Months)||23||
48161826|NCT03810534|100718827|FG003|Completed 60-Day (Patients)|Connect-Home (5-10 Months)||19||
48161827|NCT03810534|100718828|FG004|Completed 60-Day (Patients)|Connect-Home (5-10 Months)||2||
48161828|NCT03810534|100718829|FG005|Completed 60-Day (Patients)|Connect-Home (5-10 Months)||10||
48161829|NCT03810534|100718824|FG000|Completed 60-Day (Caregivers)|Connect-Home (5-10 Months)||32||
48161830|NCT03810534|100718825|FG001|Completed 60-Day (Caregivers)|Connect-Home (5-10 Months)||27||
48161831|NCT03810534|100718826|FG002|Completed 60-Day (Caregivers)|Connect-Home (5-10 Months)||21||
48161832|NCT03810534|100718827|FG003|Completed 60-Day (Caregivers)|Connect-Home (5-10 Months)||19||
48161833|NCT03810534|100718828|FG004|Completed 60-Day (Caregivers)|Connect-Home (5-10 Months)||2||
48161834|NCT03810534|100718829|FG005|Completed 60-Day (Caregivers)|Connect-Home (5-10 Months)||9||
48161835|NCT03810534|100718824|FG000|COMPLETED|Connect-Home (5-10 Months)||62||
48161836|NCT03810534|100718825|FG001|COMPLETED|Connect-Home (5-10 Months)||52||
48161837|NCT03810534|100718826|FG002|COMPLETED|Connect-Home (5-10 Months)||44||
48161838|NCT03810534|100718827|FG003|COMPLETED|Connect-Home (5-10 Months)||38||
48161839|NCT03810534|100718828|FG004|COMPLETED|Connect-Home (5-10 Months)||4||
48161840|NCT03810534|100718829|FG005|COMPLETED|Connect-Home (5-10 Months)||19||
48161841|NCT03810534|100718824|FG000|NOT COMPLETED|Connect-Home (5-10 Months)||20||
48161842|NCT03810534|100718825|FG001|NOT COMPLETED|Connect-Home (5-10 Months)||28||
48161843|NCT03810534|100718826|FG002|NOT COMPLETED|Connect-Home (5-10 Months)||22||
48161844|NCT03810534|100718827|FG003|NOT COMPLETED|Connect-Home (5-10 Months)||16||
48161845|NCT03810534|100718828|FG004|NOT COMPLETED|Connect-Home (5-10 Months)||6||
48161846|NCT03810534|100718829|FG005|NOT COMPLETED|Connect-Home (5-10 Months)||19||
48161847|NCT01529008|100718830|FG000|STARTED|Screening||35||
48161848|NCT01529008|100718831|FG001|STARTED|Screening||33||
48161849|NCT01529008|100718830|FG000|COMPLETED|Screening||35||
48161850|NCT01529008|100718831|FG001|COMPLETED|Screening||33||
48161851|NCT01529008|100718830|FG000|NOT COMPLETED|Screening||0||
48161852|NCT01529008|100718831|FG001|NOT COMPLETED|Screening||0||
48161853|NCT01529008|100718830|FG000|STARTED|Bone Marrow Harvesting||35||
48161854|NCT01529008|100718831|FG001|STARTED|Bone Marrow Harvesting||33||
48161855|NCT01529008|100718830|FG000|COMPLETED|Bone Marrow Harvesting||34||
48161856|NCT01529008|100718831|FG001|COMPLETED|Bone Marrow Harvesting||30||
48161857|NCT01529008|100718830|FG000|NOT COMPLETED|Bone Marrow Harvesting||1||
48322465|NCT04169373|101114922|FG002|NOT COMPLETED|Week 14 to Week 52||11||
48322466|NCT04169373|101114923|FG003|NOT COMPLETED|Week 14 to Week 52||9||
48322467|NCT02813551|101114924|FG000|STARTED|Overall Study||59||
48322468|NCT02813551|101114925|FG001|STARTED|Overall Study||59||
48322469|NCT02813551|101114924|FG000|COMPLETED|Overall Study||58||
48322470|NCT02813551|101114925|FG001|COMPLETED|Overall Study||57||
48322471|NCT02813551|101114924|FG000|NOT COMPLETED|Overall Study||1||
48322472|NCT02813551|101114925|FG001|NOT COMPLETED|Overall Study||2||
48322473|NCT01441037|101114926|FG000|STARTED|Overall Study||27||
48322474|NCT01441037|101114926|FG000|COMPLETED|Overall Study||27||
48322475|NCT01441037|101114926|FG000|NOT COMPLETED|Overall Study||0||
48322476|NCT02457637|101114927|FG000|STARTED|Recruitment||2600||
48322477|NCT02457637|101114927|FG000|COMPLETED|Recruitment||2600||
48322478|NCT02457637|101114927|FG000|NOT COMPLETED|Recruitment||0||
48322479|NCT02457637|101114927|FG000|STARTED|28-Days Hospitalization and Observation||2600||
48617546|NCT01747499|101849602|FG000|STARTED|Overall Study||3||
48617547|NCT01747499|101849603|FG001|STARTED|Overall Study||3||
48617548|NCT01747499|101849604|FG002|STARTED|Overall Study||3||
48322480|NCT02457637|101114927|FG000|Liver Transplantation|28-Days Hospitalization and Observation||124||
48408293|NCT00927576|101331743|FG000|COMPLETED|Overall Study||237||
48408294|NCT00927576|101331744|FG001|COMPLETED|Overall Study||28||
48408295|NCT00927576|101331743|FG000|NOT COMPLETED|Overall Study||0||
48408296|NCT00927576|101331744|FG001|NOT COMPLETED|Overall Study||0||
48408297|NCT02996110|101331745|FG000|STARTED|Pre-Treatment||65|Initial Randomization|
48408298|NCT02996110|101331746|FG001|STARTED|Pre-Treatment||56|Initial Randomization|
48408299|NCT02996110|101331747|FG002|STARTED|Pre-Treatment||26|Initial Randomization|
48617549|NCT01747499|101849605|FG003|STARTED|Overall Study||6||
48617550|NCT01747499|101849606|FG004|STARTED|Overall Study||39||
48617551|NCT01747499|101849602|FG000|COMPLETED|Overall Study||2||
48617552|NCT01747499|101849603|FG001|COMPLETED|Overall Study||2||
48617553|NCT01747499|101849604|FG002|COMPLETED|Overall Study||3||
48617554|NCT01747499|101849605|FG003|COMPLETED|Overall Study||4||
48617555|NCT01747499|101849606|FG004|COMPLETED|Overall Study||24||
48617556|NCT01747499|101849602|FG000|NOT COMPLETED|Overall Study||1||
48617557|NCT01747499|101849603|FG001|NOT COMPLETED|Overall Study||1||
48617558|NCT01747499|101849604|FG002|NOT COMPLETED|Overall Study||0||
48617559|NCT01747499|101849605|FG003|NOT COMPLETED|Overall Study||2||
48617560|NCT01747499|101849606|FG004|NOT COMPLETED|Overall Study||15||
48617561|NCT03506438|101849607|FG000|STARTED|Overall Study||55||
48322481|NCT02457637|101114927|FG000|Death|28-Days Hospitalization and Observation||74||
48322482|NCT02457637|101114927|FG000|COMPLETED|28-Days Hospitalization and Observation||2600||
48322483|NCT02457637|101114927|FG000|NOT COMPLETED|28-Days Hospitalization and Observation||0||
48322484|NCT02457637|101114927|FG000|STARTED|Clinic or Telephone Follow-up||2600||
48322485|NCT02457637|101114927|FG000|One-year Liver Transplantation|Clinic or Telephone Follow-up||182||
48322486|NCT02457637|101114927|FG000|One-year Death|Clinic or Telephone Follow-up||475||
48617562|NCT03506438|101849608|FG001|STARTED|Overall Study||56||
48617563|NCT03506438|101849609|FG002|STARTED|Overall Study||55||
48740608|NCT03160898|102151461|FG001|NOT COMPLETED|Overall Study||13||
48740609|NCT03160898|102151462|FG002|NOT COMPLETED|Overall Study||16||
48740610|NCT03160898|102151463|FG003|NOT COMPLETED|Overall Study||19||
48322487|NCT02457637|101114927|FG000|COMPLETED|Clinic or Telephone Follow-up||2529||
48322488|NCT02457637|101114927|FG000|NOT COMPLETED|Clinic or Telephone Follow-up||71||
48322489|NCT01111851|101114928|FG000|STARTED|Overall Study||8||
48322490|NCT01111851|101114929|FG001|STARTED|Overall Study||8||
48322491|NCT01111851|101114928|FG000|COMPLETED|Overall Study||6||
48322492|NCT01111851|101114929|FG001|COMPLETED|Overall Study||8||
48740611|NCT01959841|102151464|FG000|STARTED|Overall Study||252||
48322493|NCT01111851|101114928|FG000|NOT COMPLETED|Overall Study||2||
48322494|NCT01111851|101114929|FG001|NOT COMPLETED|Overall Study||0||
48322495|NCT01202656|101114930|FG000|STARTED|Cycle 1||67||
48322496|NCT01202656|101114931|FG001|STARTED|Cycle 1||62||
48322497|NCT01202656|101114930|FG000|COMPLETED|Cycle 1||67||
48322498|NCT01202656|101114931|FG001|COMPLETED|Cycle 1||62||
48322499|NCT01202656|101114930|FG000|NOT COMPLETED|Cycle 1||0||
48322500|NCT01202656|101114931|FG001|NOT COMPLETED|Cycle 1||0||
48322501|NCT01202656|101114930|FG000|STARTED|CrossoverCycle||18||
48322502|NCT01202656|101114931|FG001|STARTED|CrossoverCycle||14||
48322503|NCT01202656|101114930|FG000|COMPLETED|CrossoverCycle||18||
48322504|NCT01202656|101114931|FG001|COMPLETED|CrossoverCycle||14||
48322505|NCT01202656|101114930|FG000|NOT COMPLETED|CrossoverCycle||0||
48322506|NCT01202656|101114931|FG001|NOT COMPLETED|CrossoverCycle||0||
48322507|NCT00574275|101114932|FG000|STARTED|Overall Study||275||
48322508|NCT00574275|101114933|FG001|STARTED|Overall Study||271||
48322509|NCT00574275|101114932|FG000|TREATED|Overall Study||273||
48322510|NCT00574275|101114933|FG001|TREATED|Overall Study||268||
48322511|NCT00574275|101114932|FG000|SAFETY POPULATION|Overall Study||271||
48322512|NCT00574275|101114933|FG001|SAFETY POPULATION|Overall Study||270||
48322513|NCT00574275|101114932|FG000|COMPLETED|Overall Study||0||
48322514|NCT00574275|101114933|FG001|COMPLETED|Overall Study||0||
48322515|NCT00574275|101114932|FG000|NOT COMPLETED|Overall Study||275||
48322516|NCT00574275|101114933|FG001|NOT COMPLETED|Overall Study||271||
48322517|NCT03366298|101114934|FG000|STARTED|Overall Study||3||
48322518|NCT03366298|101114935|FG001|STARTED|Overall Study||3||
48322519|NCT03366298|101114936|FG002|STARTED|Overall Study||3||
48322520|NCT03366298|101114937|FG003|STARTED|Overall Study||3||
48322521|NCT03366298|101114934|FG000|COMPLETED|Overall Study||3||
48322522|NCT03366298|101114935|FG001|COMPLETED|Overall Study||3||
48322523|NCT03366298|101114936|FG002|COMPLETED|Overall Study||3||
48408300|NCT02996110|101331748|FG003|STARTED|Pre-Treatment||17|Initial Randomization|
48408301|NCT02996110|101331749|FG004|STARTED|Pre-Treatment||18|Initial Randomization|
48408302|NCT02996110|101331745|FG000|COMPLETED|Pre-Treatment||65|Continuing Into Treatment Period|
48408303|NCT02996110|101331746|FG001|COMPLETED|Pre-Treatment||55|Continuing Into Treatment Period|
48408304|NCT02996110|101331747|FG002|COMPLETED|Pre-Treatment||25|Continuing Into Treatment Period|
48408305|NCT02996110|101331748|FG003|COMPLETED|Pre-Treatment||17|Continuing Into Treatment Period|
48408306|NCT02996110|101331749|FG004|COMPLETED|Pre-Treatment||16|Continuing Into Treatment Period|
48408307|NCT02996110|101331745|FG000|NOT COMPLETED|Pre-Treatment||0||
48408308|NCT02996110|101331746|FG001|NOT COMPLETED|Pre-Treatment||1||
48322524|NCT03366298|101114937|FG003|COMPLETED|Overall Study||3||
48408309|NCT02996110|101331747|FG002|NOT COMPLETED|Pre-Treatment||1||
48408310|NCT02996110|101331748|FG003|NOT COMPLETED|Pre-Treatment||0||
48408311|NCT02996110|101331749|FG004|NOT COMPLETED|Pre-Treatment||2||
48408312|NCT02996110|101331745|FG000|STARTED|Track 1||30||
48408313|NCT02996110|101331746|FG001|STARTED|Track 1||30||
48740612|NCT01959841|102151465|FG001|STARTED|Overall Study||250||
48740613|NCT01959841|102151466|FG002|STARTED|Overall Study||249||
48740614|NCT01959841|102151464|FG000|Full Analysis Set Included|Overall Study||247||
48740615|NCT01959841|102151465|FG001|Full Analysis Set Included|Overall Study||243||
48740616|NCT01959841|102151466|FG002|Full Analysis Set Included|Overall Study||245||
48322525|NCT03366298|101114934|FG000|NOT COMPLETED|Overall Study||0||
48322526|NCT03366298|101114935|FG001|NOT COMPLETED|Overall Study||0||
48322527|NCT03366298|101114936|FG002|NOT COMPLETED|Overall Study||0||
48322528|NCT03366298|101114937|FG003|NOT COMPLETED|Overall Study||0||
48322529|NCT00326209|101114938|FG000|STARTED|Overall Study||393||
48322530|NCT00326209|101114938|FG000|Safety Population|Overall Study||388|Received at least 1 dose of study drug and had at least 1 post-baseline safety assessment.|
48322531|NCT00326209|101114938|FG000|COMPLETED|Overall Study||111||
48322532|NCT00326209|101114938|FG000|NOT COMPLETED|Overall Study||282||
48322533|NCT01261507|101114939|FG000|STARTED|Overall Study||15||
48322534|NCT01261507|101114939|FG000|COMPLETED|Overall Study||15||
48408314|NCT02996110|101331747|FG002|STARTED|Track 1||0||
48322535|NCT01261507|101114939|FG000|NOT COMPLETED|Overall Study||0||
48322536|NCT00975156|101114940|FG000|STARTED|Overall Study||11||
48322537|NCT00975156|101114941|FG001|STARTED|Overall Study||10||
48322538|NCT00975156|101114940|FG000|COMPLETED|Overall Study||11||
48322539|NCT00975156|101114941|FG001|COMPLETED|Overall Study||9||
48322540|NCT00975156|101114940|FG000|NOT COMPLETED|Overall Study||0||
48322541|NCT00975156|101114941|FG001|NOT COMPLETED|Overall Study||1||
48322542|NCT02365714|101114942|FG000|STARTED|Overall Study||2||
48322543|NCT02365714|101114942|FG000|COMPLETED|Overall Study||2||
48322544|NCT02365714|101114942|FG000|NOT COMPLETED|Overall Study||0||
48322545|NCT01183559|101114943|FG000|STARTED|Overall Study||9||
48322546|NCT01183559|101114943|FG000|COMPLETED|Overall Study||9||
48322547|NCT01183559|101114943|FG000|NOT COMPLETED|Overall Study||0||
48322548|NCT00542269|101114944|FG000|STARTED|Overall Study||61||
48322549|NCT00542269|101114945|FG001|STARTED|Overall Study||60||
48322550|NCT00542269|101114946|FG002|STARTED|Overall Study||57||
48322551|NCT00542269|101114944|FG000|COMPLETED|Overall Study||48||
48322552|NCT00542269|101114945|FG001|COMPLETED|Overall Study||54||
48322553|NCT00542269|101114946|FG002|COMPLETED|Overall Study||51||
48322554|NCT00542269|101114944|FG000|NOT COMPLETED|Overall Study||13||
48322555|NCT00542269|101114945|FG001|NOT COMPLETED|Overall Study||6||
48322556|NCT00542269|101114946|FG002|NOT COMPLETED|Overall Study||6||
48322557|NCT01394627|101114947|FG000|STARTED|First Intervention (1 Day)||8||
48322558|NCT01394627|101114948|FG001|STARTED|First Intervention (1 Day)||13||
48322559|NCT01394627|101114947|FG000|COMPLETED|First Intervention (1 Day)||8||
48322560|NCT01394627|101114948|FG001|COMPLETED|First Intervention (1 Day)||12||
48322561|NCT01394627|101114947|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48322562|NCT01394627|101114948|FG001|NOT COMPLETED|First Intervention (1 Day)||1||
48322563|NCT01394627|101114947|FG000|STARTED|Washout (1-3 Months)||8||
48322564|NCT01394627|101114948|FG001|STARTED|Washout (1-3 Months)||12||
48322565|NCT01394627|101114947|FG000|COMPLETED|Washout (1-3 Months)||7||
48322566|NCT01394627|101114948|FG001|COMPLETED|Washout (1-3 Months)||12||
48322567|NCT01394627|101114947|FG000|NOT COMPLETED|Washout (1-3 Months)||1||
48322568|NCT01394627|101114948|FG001|NOT COMPLETED|Washout (1-3 Months)||0||
48322569|NCT01394627|101114947|FG000|STARTED|Second Intervention (1 Day)||7||
48322570|NCT01394627|101114948|FG001|STARTED|Second Intervention (1 Day)||12||
48322571|NCT01394627|101114947|FG000|COMPLETED|Second Intervention (1 Day)||7||
48322572|NCT01394627|101114948|FG001|COMPLETED|Second Intervention (1 Day)||12||
48322573|NCT01394627|101114947|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48322574|NCT01394627|101114948|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48322575|NCT01360554|101114949|FG000|STARTED|Overall Study||439||
48322576|NCT01360554|101114950|FG001|STARTED|Overall Study||439||
48322577|NCT01360554|101114949|FG000|Treated|Overall Study||436||
48322578|NCT01360554|101114950|FG001|Treated|Overall Study||436||
48322579|NCT01360554|101114949|FG000|COMPLETED|Overall Study||0||
48322580|NCT01360554|101114950|FG001|COMPLETED|Overall Study||0||
48322581|NCT01360554|101114949|FG000|NOT COMPLETED|Overall Study||439||
48322582|NCT01360554|101114950|FG001|NOT COMPLETED|Overall Study||439||
48322583|NCT01820364|101114951|FG000|STARTED|Part I: LGX818||15||
48322584|NCT01820364|101114952|FG001|STARTED|Part I: LGX818||0||
48322585|NCT01820364|101114951|FG000|COMPLETED|Part I: LGX818||1||
48322586|NCT01820364|101114952|FG001|COMPLETED|Part I: LGX818||0||
48322587|NCT01820364|101114951|FG000|NOT COMPLETED|Part I: LGX818||14||
48322588|NCT01820364|101114952|FG001|NOT COMPLETED|Part I: LGX818||0||
48322589|NCT01820364|101114951|FG000|STARTED|Part II: LGX818 + MEK162||0||
48322590|NCT01820364|101114952|FG001|STARTED|Part II: LGX818 + MEK162||1||
48322591|NCT01820364|101114951|FG000|COMPLETED|Part II: LGX818 + MEK162||0||
48322592|NCT01820364|101114952|FG001|COMPLETED|Part II: LGX818 + MEK162||0||
48322593|NCT01820364|101114951|FG000|NOT COMPLETED|Part II: LGX818 + MEK162||0||
48322594|NCT01820364|101114952|FG001|NOT COMPLETED|Part II: LGX818 + MEK162||1||
48322595|NCT01744665|101114953|FG000|STARTED|Monitoring Phase||59||
48322596|NCT01744665|101114953|FG000|COMPLETED|Monitoring Phase||41||
48322597|NCT01744665|101114953|FG000|NOT COMPLETED|Monitoring Phase||18||
48322598|NCT01744665|101114953|FG000|STARTED|Consolidation Phase||41||
48322599|NCT01744665|101114953|FG000|COMPLETED|Consolidation Phase||22||
48322600|NCT01744665|101114953|FG000|NOT COMPLETED|Consolidation Phase||19||
48322601|NCT01744665|101114953|FG000|STARTED|Treatment Free Remission Phase||32||
48322602|NCT01744665|101114953|FG000|COMPLETED|Treatment Free Remission Phase||32||
48322603|NCT01744665|101114953|FG000|NOT COMPLETED|Treatment Free Remission Phase||0||
48322604|NCT01744665|101114953|FG000|STARTED|Re-initiation Phase||17||
48322605|NCT01744665|101114953|FG000|COMPLETED|Re-initiation Phase||4||
48322606|NCT01744665|101114953|FG000|NOT COMPLETED|Re-initiation Phase||13||
48322607|NCT01970501|101114954|FG000|STARTED|Overall Study||134||
48322608|NCT01970501|101114955|FG001|STARTED|Overall Study||133||
48322609|NCT01970501|101114954|FG000|Randomization (Visit 2)|Overall Study||134|Blinding will be accomplished by providing study drug (i.e., bucindolol or metoprolol tablets) in capsules that are visually indistinguishable and provided in numbered kits. Only the numbers of the kits to be administered to a given patient, and not the identity of the study drug, will be provided to sites. Investigators, site personnel, and patients will not be informed of the blinded study drug assignment at the time of study completion.|
48322610|NCT01970501|101114955|FG001|Randomization (Visit 2)|Overall Study||133|Blinding will be accomplished by providing study drug (i.e., bucindolol or metoprolol tablets) in capsules that are visually indistinguishable and provided in numbered kits. Only the numbers of the kits to be administered to a given patient, and not the identity of the study drug, will be provided to sites. Investigators, site personnel, and patients will not be informed of the blinded study drug assignment at the time of study completion.|
48322611|NCT01970501|101114954|FG000|Initial Dose Level 1|Overall Study||35|Either Bucindolol 6.25mg BID or Metoprolol XL 25mg QD|
48322612|NCT01970501|101114955|FG001|Initial Dose Level 1|Overall Study||45|Either Bucindolol 6.25mg BID or Metoprolol XL 25mg QD|
48322613|NCT01970501|101114954|FG000|Initial Dose Level 2|Overall Study||45|Either Bucindolol 12.5 mg BID or Metoprolol XL 50 mg QD|
48368060|NCT03691623|101230099|FG003|Inoculated With Challenge Virus|Overall Study||21||
48322614|NCT01970501|101114955|FG001|Initial Dose Level 2|Overall Study||38|Either Bucindolol 12.5 mg BID or Metoprolol XL 50 mg QD|
48322615|NCT01970501|101114954|FG000|Initial Dose Level 3|Overall Study||51|Either Bucindolol 25 mg BID or Metoprolol XL 100 mg QD|
48322616|NCT01970501|101114955|FG001|Initial Dose Level 3|Overall Study||45|Either Bucindolol 25 mg BID or Metoprolol XL 100 mg QD|
48322617|NCT01970501|101114954|FG000|Initial Dose Level 4|Overall Study||3|Either Bucindolol 50 mg BID or Metoprolol XL 200 mg QD|
48322618|NCT01970501|101114955|FG001|Initial Dose Level 4|Overall Study||5|Either Bucindolol 50 mg BID or Metoprolol XL 200 mg QD|
48322619|NCT01970501|101114954|FG000|Drug Lead-in Period|Overall Study||134|Bucindolol taken twice daily. Starting dose of 6.25 mg, 12.5 mg, 25 mg, or 50 mg bid depending upon pre-study beta-blocker dose. Sites instructed to uptitrate to target dose of 50 mg bid (subjects \< 75 kg) or 100 mg bid (subjects \>= 75 kg). Metoprolol succinate taken once per day and a placebo capsule taken once per day. Metoprolol succinate starting dose is 25 mg daily with dose titrations until 200 mg once daily or the maximum tolerated dose is achieved.|
48322620|NCT01970501|101114955|FG001|Drug Lead-in Period|Overall Study||133|Bucindolol taken twice daily. Starting dose of 6.25 mg, 12.5 mg, 25 mg, or 50 mg bid depending upon pre-study beta-blocker dose. Sites instructed to uptitrate to target dose of 50 mg bid (subjects \< 75 kg) or 100 mg bid (subjects \>= 75 kg). Metoprolol succinate taken once per day and a placebo capsule taken once per day. Metoprolol succinate starting dose is 25 mg daily with dose titrations until 200 mg once daily or the maximum tolerated dose is achieved.|
48322621|NCT01970501|101114954|FG000|Attained Target Dose|Overall Study||112||
48322622|NCT01970501|101114955|FG001|Attained Target Dose|Overall Study||96||
48322623|NCT01970501|101114954|FG000|24-Week Follow Up Period|Overall Study||132|Sponsor requested that the last visit be between Aug-Dec 2017 and therefore a number of participants completed this arm prior to 24 week and are noted as sponsor or investigator initiated.|
48322624|NCT01970501|101114955|FG001|24-Week Follow Up Period|Overall Study||126|Sponsor requested that the last visit be between Aug-Dec 2017 and therefore a number of participants completed this arm prior to 24 week and are noted as sponsor or investigator initiated.|
48322625|NCT01970501|101114954|FG000|Treatment Extension Period|Overall Study||77|Sponsor requested that the last visit be between Aug-Dec 2017 and therefore a majority of participants were not enrolled in this treatment extension period.|
48322626|NCT01970501|101114955|FG001|Treatment Extension Period|Overall Study||64|Sponsor requested that the last visit be between Aug-Dec 2017 and therefore a majority of participants were not enrolled in this treatment extension period.|
48322627|NCT01970501|101114954|FG000|COMPLETED|Overall Study||107||
48408315|NCT02996110|101331748|FG003|STARTED|Track 1||0||
48408316|NCT02996110|101331749|FG004|STARTED|Track 1||0||
48617564|NCT03506438|101849610|FG003|STARTED|Overall Study||56||
48617565|NCT03506438|101849611|FG004|STARTED|Overall Study||19||
48322628|NCT01970501|101114955|FG001|COMPLETED|Overall Study||105||
48322629|NCT01970501|101114954|FG000|NOT COMPLETED|Overall Study||27||
48322630|NCT01970501|101114955|FG001|NOT COMPLETED|Overall Study||28||
48322631|NCT02232802|101114956|FG000|STARTED|Period 1||24||
48322632|NCT02232802|101114957|FG001|STARTED|Period 1||23||
48322633|NCT02232802|101114956|FG000|COMPLETED|Period 1||22||
48322634|NCT02232802|101114957|FG001|COMPLETED|Period 1||22||
48322635|NCT02232802|101114956|FG000|NOT COMPLETED|Period 1||2||
48322636|NCT02232802|101114957|FG001|NOT COMPLETED|Period 1||1||
48322637|NCT02232802|101114956|FG000|STARTED|Washout||22||
48322638|NCT02232802|101114957|FG001|STARTED|Washout||22||
48322639|NCT02232802|101114956|FG000|COMPLETED|Washout||22||
48322640|NCT02232802|101114957|FG001|COMPLETED|Washout||22||
48322641|NCT02232802|101114956|FG000|NOT COMPLETED|Washout||0||
48322642|NCT02232802|101114957|FG001|NOT COMPLETED|Washout||0||
48322643|NCT02232802|101114956|FG000|STARTED|Period 2||22||
48322644|NCT02232802|101114957|FG001|STARTED|Period 2||22||
48322645|NCT02232802|101114956|FG000|COMPLETED|Period 2||22||
48322646|NCT02232802|101114957|FG001|COMPLETED|Period 2||22||
48322647|NCT02232802|101114956|FG000|NOT COMPLETED|Period 2||0||
48322648|NCT02232802|101114957|FG001|NOT COMPLETED|Period 2||0||
48322649|NCT02232802|101114956|FG000|STARTED|Washout||22||
48322650|NCT02232802|101114957|FG001|STARTED|Washout||22||
48322651|NCT02232802|101114956|FG000|COMPLETED|Washout||22||
48322652|NCT02232802|101114957|FG001|COMPLETED|Washout||22||
48322653|NCT02232802|101114956|FG000|NOT COMPLETED|Washout||0||
48322654|NCT02232802|101114957|FG001|NOT COMPLETED|Washout||0||
48322655|NCT00841789|101114958|FG000|STARTED|Overall Study||103||
48322656|NCT00841789|101114959|FG001|STARTED|Overall Study||102||
48322657|NCT00841789|101114958|FG000|COMPLETED|Overall Study||98||
48322658|NCT00841789|101114959|FG001|COMPLETED|Overall Study||99||
48322659|NCT00841789|101114958|FG000|NOT COMPLETED|Overall Study||5||
48322660|NCT00841789|101114959|FG001|NOT COMPLETED|Overall Study||3||
48322661|NCT01183143|101114960|FG000|STARTED|Overall Study||215||
48322662|NCT01183143|101114960|FG000|Intention to Treat (ITT) Population|Overall Study||204||
48408317|NCT02996110|101331745|FG000|Re-Randomized to Track 2|Track 1||5||
48408318|NCT02996110|101331746|FG001|Re-Randomized to Track 2|Track 1||6||
48408319|NCT02996110|101331747|FG002|Re-Randomized to Track 2|Track 1||0||
48322663|NCT01183143|101114960|FG000|COMPLETED|Overall Study||65||
48322664|NCT01183143|101114960|FG000|NOT COMPLETED|Overall Study||150||
48322665|NCT03577730|101114961|FG000|STARTED|Overall Study||34|Started is defined as randomized (n=65). Six participants were withdrawn prior to randomization.|
48322666|NCT03577730|101114962|FG001|STARTED|Overall Study||31|Started is defined as randomized (n=65). Six participants were withdrawn prior to randomization.|
48322667|NCT03577730|101114961|FG000|Received Treatment|Overall Study||33||
48322668|NCT03577730|101114962|FG001|Received Treatment|Overall Study||31||
48322669|NCT03577730|101114961|FG000|COMPLETED|Overall Study||30||
48322670|NCT03577730|101114962|FG001|COMPLETED|Overall Study||30||
48322671|NCT03577730|101114961|FG000|NOT COMPLETED|Overall Study||4||
48322672|NCT03577730|101114962|FG001|NOT COMPLETED|Overall Study||1||
48322673|NCT00053417|101114963|FG000|STARTED|Overall Study||47||
48322674|NCT00053417|101114964|FG001|STARTED|Overall Study||52||
48322675|NCT00053417|101114965|FG002|STARTED|Overall Study||50||
48408320|NCT02996110|101331748|FG003|Re-Randomized to Track 2|Track 1||0||
48322676|NCT00053417|101114966|FG003|STARTED|Overall Study||57||
48322677|NCT00053417|101114963|FG000|COMPLETED|Overall Study||45||
48322678|NCT00053417|101114964|FG001|COMPLETED|Overall Study||50||
48322679|NCT00053417|101114965|FG002|COMPLETED|Overall Study||49||
48322680|NCT00053417|101114966|FG003|COMPLETED|Overall Study||51||
48322681|NCT00053417|101114963|FG000|NOT COMPLETED|Overall Study||2||
48322682|NCT00053417|101114964|FG001|NOT COMPLETED|Overall Study||2||
48322683|NCT00053417|101114965|FG002|NOT COMPLETED|Overall Study||1||
48322684|NCT00053417|101114966|FG003|NOT COMPLETED|Overall Study||6||
48322685|NCT00805480|101114967|FG000|STARTED|Overall Study||30||
48322686|NCT00805480|101114968|FG001|STARTED|Overall Study||29||
48322687|NCT00805480|101114969|FG002|STARTED|Overall Study||31||
48322688|NCT00805480|101114970|FG003|STARTED|Overall Study||10||
48322689|NCT00805480|101114967|FG000|Pharmacodynamic Analysis Set|Overall Study||30||
48322690|NCT00805480|101114968|FG001|Pharmacodynamic Analysis Set|Overall Study||25||
48322691|NCT00805480|101114969|FG002|Pharmacodynamic Analysis Set|Overall Study||29||
48322692|NCT00805480|101114970|FG003|Pharmacodynamic Analysis Set|Overall Study||10||
48322693|NCT00805480|101114967|FG000|COMPLETED|Overall Study||16||
48322694|NCT00805480|101114968|FG001|COMPLETED|Overall Study||22||
48322695|NCT00805480|101114969|FG002|COMPLETED|Overall Study||19||
48322696|NCT00805480|101114970|FG003|COMPLETED|Overall Study||5||
48322697|NCT00805480|101114967|FG000|NOT COMPLETED|Overall Study||14||
48322698|NCT00805480|101114968|FG001|NOT COMPLETED|Overall Study||7||
48322699|NCT00805480|101114969|FG002|NOT COMPLETED|Overall Study||12||
48322700|NCT00805480|101114970|FG003|NOT COMPLETED|Overall Study||5||
48322701|NCT00763815|101114971|FG000|STARTED|Overall Study||161||
48322702|NCT00763815|101114972|FG001|STARTED|Overall Study||323||
48322703|NCT00763815|101114971|FG000|Treated/Safety Population|Overall Study||161||
48322704|NCT00763815|101114972|FG001|Treated/Safety Population|Overall Study||323||
48322705|NCT00763815|101114971|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study||159||
48322706|NCT00763815|101114972|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||320||
48322707|NCT00763815|101114971|FG000|COMPLETED|Overall Study||109||
48322708|NCT00763815|101114972|FG001|COMPLETED|Overall Study||239||
48322709|NCT00763815|101114971|FG000|NOT COMPLETED|Overall Study||52||
48322710|NCT00763815|101114972|FG001|NOT COMPLETED|Overall Study||84||
48322711|NCT03963011|101114973|FG000|STARTED|Overall Study||8||
48322712|NCT03963011|101114974|FG001|STARTED|Overall Study||6||
48322713|NCT03963011|101114973|FG000|COMPLETED|Overall Study||8||
48322714|NCT03963011|101114974|FG001|COMPLETED|Overall Study||6||
48322715|NCT03963011|101114973|FG000|NOT COMPLETED|Overall Study||0||
48322716|NCT03963011|101114974|FG001|NOT COMPLETED|Overall Study||0||
48322717|NCT02256540|101114975|FG000|STARTED|Overall Study||6||
48322718|NCT02256540|101114976|FG001|STARTED|Overall Study||6||
48322719|NCT02256540|101114977|FG002|STARTED|Overall Study||6||
48322720|NCT02256540|101114975|FG000|COMPLETED|Overall Study||6||
48322721|NCT02256540|101114976|FG001|COMPLETED|Overall Study||5||
48322722|NCT02256540|101114977|FG002|COMPLETED|Overall Study||4||
48322723|NCT02256540|101114975|FG000|NOT COMPLETED|Overall Study||0||
48322724|NCT02256540|101114976|FG001|NOT COMPLETED|Overall Study||1||
48322725|NCT02256540|101114977|FG002|NOT COMPLETED|Overall Study||2||
48322726|NCT01239342|101114978|FG000|STARTED|Overall Study||29||
48322727|NCT01239342|101114979|FG001|STARTED|Overall Study||14||
48322728|NCT01239342|101114978|FG000|COMPLETED|Overall Study||26||
48322729|NCT01239342|101114979|FG001|COMPLETED|Overall Study||8||
48322730|NCT01239342|101114978|FG000|NOT COMPLETED|Overall Study||3||
48322731|NCT01239342|101114979|FG001|NOT COMPLETED|Overall Study||6||
48322732|NCT03681119|101114980|FG000|STARTED|Overall Study||72||
48322733|NCT03681119|101114981|FG001|STARTED|Overall Study||11||
48322734|NCT03681119|101114980|FG000|COMPLETED|Overall Study||66||
48322735|NCT03681119|101114981|FG001|COMPLETED|Overall Study||11||
48322736|NCT03681119|101114980|FG000|NOT COMPLETED|Overall Study||6||
48322737|NCT03681119|101114981|FG001|NOT COMPLETED|Overall Study||0||
48322738|NCT00250835|101114982|FG000|STARTED|Overall Study||38||
48322739|NCT00250835|101114982|FG000|COMPLETED|Overall Study||37||
48322740|NCT00250835|101114982|FG000|NOT COMPLETED|Overall Study||1||
48322741|NCT00088374|101114983|FG000|STARTED|Overall Study||9||
48322742|NCT00088374|101114983|FG000|COMPLETED|Overall Study||7||
48322743|NCT00088374|101114983|FG000|NOT COMPLETED|Overall Study||2||
48322744|NCT02443883|101114984|FG000|STARTED|Overall Study||40||
48322745|NCT02443883|101114985|FG001|STARTED|Overall Study||42||
48322746|NCT02443883|101114986|FG002|STARTED|Overall Study||41||
48322747|NCT02443883|101114987|FG003|STARTED|Overall Study||41||
48322748|NCT02443883|101114984|FG000|Received at Least One Dose of Study Drug|Overall Study||38||
48322749|NCT02443883|101114985|FG001|Received at Least One Dose of Study Drug|Overall Study||42||
48322750|NCT02443883|101114986|FG002|Received at Least One Dose of Study Drug|Overall Study||41||
48322751|NCT02443883|101114987|FG003|Received at Least One Dose of Study Drug|Overall Study||40||
48322752|NCT02443883|101114984|FG000|COMPLETED|Overall Study||34||
48322753|NCT02443883|101114985|FG001|COMPLETED|Overall Study||38||
48322754|NCT02443883|101114986|FG002|COMPLETED|Overall Study||40||
48322755|NCT02443883|101114987|FG003|COMPLETED|Overall Study||36||
48322756|NCT02443883|101114984|FG000|NOT COMPLETED|Overall Study||6||
48322757|NCT02443883|101114985|FG001|NOT COMPLETED|Overall Study||4||
48322758|NCT02443883|101114986|FG002|NOT COMPLETED|Overall Study||1||
48322759|NCT02443883|101114987|FG003|NOT COMPLETED|Overall Study||5||
48322760|NCT00556452|101114988|FG000|STARTED|Overall Study||6||
48322761|NCT00556452|101114989|FG001|STARTED|Overall Study||21||
48322762|NCT00556452|101114990|FG002|STARTED|Overall Study||19||
48322763|NCT00556452|101114988|FG000|COMPLETED|Overall Study||6||
48740617|NCT01959841|102151464|FG000|Full Analysis Set Excluded|Overall Study||5||
48740618|NCT01959841|102151465|FG001|Full Analysis Set Excluded|Overall Study||7||
48740619|NCT01959841|102151466|FG002|Full Analysis Set Excluded|Overall Study||4||
48740620|NCT01959841|102151464|FG000|Reason FAS Excluding 1|Overall Study||5|Subjects who are found not to have herpes zoster|
48740621|NCT01959841|102151465|FG001|Reason FAS Excluding 1|Overall Study||5|Subjects who are found not to have herpes zoster|
48740622|NCT01959841|102151466|FG002|Reason FAS Excluding 1|Overall Study||4|Subjects who are found not to have herpes zoster|
48740623|NCT01959841|102151464|FG000|Reason FAS Excluding 2|Overall Study||0|Those who have not received any dose of the study drug after randomization.|
48740624|NCT01959841|102151465|FG001|Reason FAS Excluding 2|Overall Study||1|Those who have not received any dose of the study drug after randomization.|
48740625|NCT01959841|102151466|FG002|Reason FAS Excluding 2|Overall Study||0|Those who have not received any dose of the study drug after randomization.|
48740626|NCT01959841|102151464|FG000|Reason FAS Excluding 3|Overall Study||0|Those who have no efficacy assessment data after study drug administration.|
48740627|NCT01959841|102151465|FG001|Reason FAS Excluding 3|Overall Study||1|Those who have no efficacy assessment data after study drug administration.|
48740628|NCT01959841|102151466|FG002|Reason FAS Excluding 3|Overall Study||0|Those who have no efficacy assessment data after study drug administration.|
48740629|NCT01959841|102151464|FG000|COMPLETED|Overall Study||209||
48740630|NCT01959841|102151465|FG001|COMPLETED|Overall Study||193||
48740631|NCT01959841|102151466|FG002|COMPLETED|Overall Study||206||
48740632|NCT01959841|102151464|FG000|NOT COMPLETED|Overall Study||43||
48740633|NCT01959841|102151465|FG001|NOT COMPLETED|Overall Study||57||
48740634|NCT01959841|102151466|FG002|NOT COMPLETED|Overall Study||43||
48740635|NCT00742417|102151467|FG000|STARTED|Randomized||21||
48740636|NCT00742417|102151468|FG001|STARTED|Randomized||21||
48740637|NCT00742417|102151467|FG000|COMPLETED|Randomized||19||
48740638|NCT00742417|102151468|FG001|COMPLETED|Randomized||20||
48740639|NCT00742417|102151467|FG000|NOT COMPLETED|Randomized||2||
48740640|NCT00742417|102151468|FG001|NOT COMPLETED|Randomized||1||
48740641|NCT00742417|102151467|FG000|STARTED|Intensive Period||19||
48740642|NCT00742417|102151468|FG001|STARTED|Intensive Period||20||
48740643|NCT00742417|102151467|FG000|COMPLETED|Intensive Period||16||
48740644|NCT00742417|102151468|FG001|COMPLETED|Intensive Period||19||
48740645|NCT00742417|102151467|FG000|NOT COMPLETED|Intensive Period||3||
48740646|NCT00742417|102151468|FG001|NOT COMPLETED|Intensive Period||1||
48740647|NCT00742417|102151467|FG000|STARTED|Maintenance I||16||
48740648|NCT00742417|102151468|FG001|STARTED|Maintenance I||19||
48740649|NCT00742417|102151467|FG000|COMPLETED|Maintenance I||16||
48740650|NCT00742417|102151468|FG001|COMPLETED|Maintenance I||19||
48740651|NCT00742417|102151467|FG000|NOT COMPLETED|Maintenance I||0||
48740652|NCT00742417|102151468|FG001|NOT COMPLETED|Maintenance I||0||
48740653|NCT00742417|102151467|FG000|STARTED|Maintenance II||16||
48740654|NCT00742417|102151468|FG001|STARTED|Maintenance II||19||
48740655|NCT00742417|102151467|FG000|COMPLETED|Maintenance II||16||
48740656|NCT00742417|102151468|FG001|COMPLETED|Maintenance II||19||
48740657|NCT00742417|102151467|FG000|NOT COMPLETED|Maintenance II||0||
48740658|NCT00742417|102151468|FG001|NOT COMPLETED|Maintenance II||0||
48740659|NCT00799903|102151469|FG000|STARTED|Overall Study||7904||
48740660|NCT00799903|102151470|FG001|STARTED|Overall Study||7924||
48740661|NCT00799903|102151469|FG000|COMPLETED|Overall Study||7631||
48740662|NCT00799903|102151470|FG001|COMPLETED|Overall Study||7646||
48740663|NCT00799903|102151469|FG000|NOT COMPLETED|Overall Study||273||
48740664|NCT00799903|102151470|FG001|NOT COMPLETED|Overall Study||278||
48740665|NCT03201419|102151471|FG000|STARTED|Overall Study||60||
48740666|NCT03201419|102151472|FG001|STARTED|Overall Study||27||
48740667|NCT03201419|102151473|FG002|STARTED|Overall Study||24||
48740668|NCT03201419|102151474|FG003|STARTED|Overall Study||14||
48740669|NCT03201419|102151475|FG004|STARTED|Overall Study||13||
48740670|NCT03201419|102151476|FG005|STARTED|Overall Study||34||
48740671|NCT03201419|102151477|FG006|STARTED|Overall Study||87||
48740672|NCT03201419|102151478|FG007|STARTED|Overall Study||26||
48740673|NCT03201419|102151479|FG008|STARTED|Overall Study||17||
48322764|NCT00556452|101114989|FG001|COMPLETED|Overall Study||21||
48322765|NCT00556452|101114990|FG002|COMPLETED|Overall Study||19||
48740674|NCT03201419|102151471|FG000|COMPLETED|Overall Study||52||
48740675|NCT03201419|102151472|FG001|COMPLETED|Overall Study||24||
48322766|NCT00556452|101114988|FG000|NOT COMPLETED|Overall Study||0||
48322767|NCT00556452|101114989|FG001|NOT COMPLETED|Overall Study||0||
48322768|NCT00556452|101114990|FG002|NOT COMPLETED|Overall Study||0||
48322769|NCT03998046|101118057|FG000|STARTED|Overall Study||38||
48322770|NCT03998046|101118058|FG001|STARTED|Overall Study||42||
48322771|NCT03998046|101118057|FG000|COMPLETED|Overall Study||38||
48322772|NCT03998046|101118058|FG001|COMPLETED|Overall Study||42||
48322773|NCT03998046|101118057|FG000|NOT COMPLETED|Overall Study||0||
48322774|NCT03998046|101118058|FG001|NOT COMPLETED|Overall Study||0||
48322775|NCT02181829|101118059|FG000|STARTED|Overall Study||10||
48322776|NCT02181829|101118059|FG000|COMPLETED|Overall Study||10||
48322777|NCT02181829|101118059|FG000|NOT COMPLETED|Overall Study||0||
48322778|NCT00330382|101118060|FG000|STARTED|Overall Study||67||
48322779|NCT00330382|101118061|FG001|STARTED|Overall Study||65||
48740676|NCT03201419|102151473|FG002|COMPLETED|Overall Study||22||
48740677|NCT03201419|102151474|FG003|COMPLETED|Overall Study||14||
48740678|NCT03201419|102151475|FG004|COMPLETED|Overall Study||12||
48740679|NCT03201419|102151476|FG005|COMPLETED|Overall Study||33||
48740680|NCT03201419|102151477|FG006|COMPLETED|Overall Study||81||
48740681|NCT03201419|102151478|FG007|COMPLETED|Overall Study||25||
48740682|NCT03201419|102151479|FG008|COMPLETED|Overall Study||15||
48740683|NCT03201419|102151471|FG000|NOT COMPLETED|Overall Study||8||
48740684|NCT03201419|102151472|FG001|NOT COMPLETED|Overall Study||3||
48740685|NCT03201419|102151473|FG002|NOT COMPLETED|Overall Study||2||
48740686|NCT03201419|102151474|FG003|NOT COMPLETED|Overall Study||0||
48740687|NCT03201419|102151475|FG004|NOT COMPLETED|Overall Study||1||
48740688|NCT03201419|102151476|FG005|NOT COMPLETED|Overall Study||1||
48740689|NCT03201419|102151477|FG006|NOT COMPLETED|Overall Study||6||
48740690|NCT03201419|102151478|FG007|NOT COMPLETED|Overall Study||1||
48740691|NCT03201419|102151479|FG008|NOT COMPLETED|Overall Study||2||
48740692|NCT02525588|102151480|FG000|STARTED|Overall Study||48||
48740693|NCT02525588|102151481|FG001|STARTED|Overall Study||48||
48740694|NCT02525588|102151480|FG000|COMPLETED|Overall Study||42||
48740695|NCT02525588|102151481|FG001|COMPLETED|Overall Study||45||
48740696|NCT02525588|102151480|FG000|NOT COMPLETED|Overall Study||6||
48740697|NCT02525588|102151481|FG001|NOT COMPLETED|Overall Study||3||
48740698|NCT01008943|102151482|FG000|STARTED|Overall Study||16||
48740699|NCT01008943|102151482|FG000|COMPLETED|Overall Study||15||
48740700|NCT01008943|102151482|FG000|NOT COMPLETED|Overall Study||1||
48740701|NCT02488005|102151483|FG000|STARTED|Overall Study||15||
48740702|NCT02488005|102151483|FG000|COMPLETED|Overall Study||13||
48740703|NCT02488005|102151483|FG000|NOT COMPLETED|Overall Study||2||
48740704|NCT01822197|102151484|FG000|STARTED|Overall Study||30||
48740705|NCT01822197|102151484|FG000|COMPLETED|Overall Study||30||
48740706|NCT01822197|102151484|FG000|NOT COMPLETED|Overall Study||0||
48740707|NCT02551822|102151485|FG000|STARTED|Overall Study||11||
48740708|NCT02551822|102151486|FG001|STARTED|Overall Study||12||
48740709|NCT02551822|102151485|FG000|COMPLETED|Overall Study||9||
48740710|NCT02551822|102151486|FG001|COMPLETED|Overall Study||10||
48740711|NCT02551822|102151485|FG000|NOT COMPLETED|Overall Study||2||
48740712|NCT02551822|102151486|FG001|NOT COMPLETED|Overall Study||2||
48740713|NCT00965575|102151487|FG000|STARTED|Overall Study||6||
48740714|NCT00965575|102151488|FG001|STARTED|Overall Study||5||
48740715|NCT00965575|102151487|FG000|COMPLETED|Overall Study||5||
48740716|NCT00965575|102151488|FG001|COMPLETED|Overall Study||5||
48740717|NCT00965575|102151487|FG000|NOT COMPLETED|Overall Study||1||
48740718|NCT00965575|102151488|FG001|NOT COMPLETED|Overall Study||0||
48740719|NCT02798978|102151489|FG000|STARTED|Part 1 (30 Days)||10||
48740720|NCT02798978|102151490|FG001|STARTED|Part 1 (30 Days)||6||
48740721|NCT02798978|102151491|FG002|STARTED|Part 1 (30 Days)||6||
48740722|NCT02798978|102151492|FG003|STARTED|Part 1 (30 Days)||6||
48740723|NCT02798978|102151493|FG004|STARTED|Part 1 (30 Days)||6||
48740724|NCT02798978|102151494|FG005|STARTED|Part 1 (30 Days)||6||
48740725|NCT02798978|102151495|FG006|STARTED|Part 1 (30 Days)||0||
48740726|NCT02798978|102151489|FG000|COMPLETED|Part 1 (30 Days)||10||
48740727|NCT02798978|102151490|FG001|COMPLETED|Part 1 (30 Days)||6||
48740728|NCT02798978|102151491|FG002|COMPLETED|Part 1 (30 Days)||6||
48740729|NCT02798978|102151492|FG003|COMPLETED|Part 1 (30 Days)||6||
48740730|NCT02798978|102151493|FG004|COMPLETED|Part 1 (30 Days)||6||
48740731|NCT02798978|102151494|FG005|COMPLETED|Part 1 (30 Days)||6||
48740732|NCT02798978|102151495|FG006|COMPLETED|Part 1 (30 Days)||0||
48740733|NCT02798978|102151489|FG000|NOT COMPLETED|Part 1 (30 Days)||0||
48740734|NCT02798978|102151490|FG001|NOT COMPLETED|Part 1 (30 Days)||0||
48740735|NCT02798978|102151491|FG002|NOT COMPLETED|Part 1 (30 Days)||0||
48740736|NCT02798978|102151492|FG003|NOT COMPLETED|Part 1 (30 Days)||0||
48740737|NCT02798978|102151493|FG004|NOT COMPLETED|Part 1 (30 Days)||0||
48740738|NCT02798978|102151494|FG005|NOT COMPLETED|Part 1 (30 Days)||0||
48740739|NCT02798978|102151495|FG006|NOT COMPLETED|Part 1 (30 Days)||0||
48740740|NCT02798978|102151489|FG000|STARTED|Part 2 (45 Days)||0||
48740741|NCT02798978|102151490|FG001|STARTED|Part 2 (45 Days)||0||
48322780|NCT00330382|101118060|FG000|COMPLETED|Overall Study||43||
48322781|NCT00330382|101118061|FG001|COMPLETED|Overall Study||48||
48740742|NCT02798978|102151491|FG002|STARTED|Part 2 (45 Days)||0||
48322782|NCT00330382|101118060|FG000|NOT COMPLETED|Overall Study||24||
48322783|NCT00330382|101118061|FG001|NOT COMPLETED|Overall Study||17||
48161858|NCT01529008|100718831|FG001|NOT COMPLETED|Bone Marrow Harvesting||3||
48161859|NCT01529008|100718830|FG000|STARTED|Treatment||34||
48161860|NCT01529008|100718831|FG001|STARTED|Treatment||30||
48161861|NCT01529008|100718830|FG000|COMPLETED|Treatment||25||
48161862|NCT01529008|100718831|FG001|COMPLETED|Treatment||29||
48322784|NCT04707157|101118062|FG000|STARTED|Overall Study||45||
48322785|NCT04707157|101118063|FG001|STARTED|Overall Study||23||
48322786|NCT04707157|101118062|FG000|Received at Least One Dose of Study Drug|Overall Study||45||
48322787|NCT04707157|101118063|FG001|Received at Least One Dose of Study Drug|Overall Study||23||
48322788|NCT04707157|101118062|FG000|COMPLETED|Overall Study||20||
48322789|NCT04707157|101118063|FG001|COMPLETED|Overall Study||14||
48322790|NCT04707157|101118062|FG000|NOT COMPLETED|Overall Study||25||
48322791|NCT04707157|101118063|FG001|NOT COMPLETED|Overall Study||9||
48322792|NCT01389752|101118064|FG000|STARTED|Study Period 1||11||
48322793|NCT01389752|101118065|FG001|STARTED|Study Period 1||11||
48322794|NCT01389752|101118064|FG000|COMPLETED|Study Period 1||11||
48322795|NCT01389752|101118065|FG001|COMPLETED|Study Period 1||9||
48322796|NCT01389752|101118064|FG000|NOT COMPLETED|Study Period 1||0||
48322797|NCT01389752|101118065|FG001|NOT COMPLETED|Study Period 1||2||
48740743|NCT02798978|102151492|FG003|STARTED|Part 2 (45 Days)||0||
48740744|NCT02798978|102151493|FG004|STARTED|Part 2 (45 Days)||0||
48740745|NCT02798978|102151494|FG005|STARTED|Part 2 (45 Days)||0||
48740746|NCT02798978|102151495|FG006|STARTED|Part 2 (45 Days)||0||
48740747|NCT02798978|102151489|FG000|COMPLETED|Part 2 (45 Days)||0||
48740748|NCT02798978|102151490|FG001|COMPLETED|Part 2 (45 Days)||0||
48740749|NCT02798978|102151491|FG002|COMPLETED|Part 2 (45 Days)||0||
48740750|NCT02798978|102151492|FG003|COMPLETED|Part 2 (45 Days)||0||
48740751|NCT02798978|102151493|FG004|COMPLETED|Part 2 (45 Days)||0||
48740752|NCT02798978|102151494|FG005|COMPLETED|Part 2 (45 Days)||0||
48740753|NCT02798978|102151495|FG006|COMPLETED|Part 2 (45 Days)||0||
48740754|NCT02798978|102151489|FG000|NOT COMPLETED|Part 2 (45 Days)||0||
48740755|NCT02798978|102151490|FG001|NOT COMPLETED|Part 2 (45 Days)||0||
48740756|NCT02798978|102151491|FG002|NOT COMPLETED|Part 2 (45 Days)||0||
48740757|NCT02798978|102151492|FG003|NOT COMPLETED|Part 2 (45 Days)||0||
48740758|NCT02798978|102151493|FG004|NOT COMPLETED|Part 2 (45 Days)||0||
48740759|NCT02798978|102151494|FG005|NOT COMPLETED|Part 2 (45 Days)||0||
48740760|NCT02798978|102151495|FG006|NOT COMPLETED|Part 2 (45 Days)||0||
48740761|NCT01511016|102151496|FG000|STARTED|Overall Study||8||
48740762|NCT01511016|102151497|FG001|STARTED|Overall Study||9||
48740763|NCT01511016|102151496|FG000|COMPLETED|Overall Study||6||
48740764|NCT01511016|102151497|FG001|COMPLETED|Overall Study||7||
48740765|NCT01511016|102151496|FG000|NOT COMPLETED|Overall Study||2||
48740766|NCT01511016|102151497|FG001|NOT COMPLETED|Overall Study||2||
48740767|NCT03592368|102151498|FG000|STARTED|Overall Study||29||
48740768|NCT03592368|102151499|FG001|STARTED|Overall Study||26||
48740769|NCT03592368|102151500|FG002|STARTED|Overall Study||20||
48740770|NCT03592368|102151501|FG003|STARTED|Overall Study||22||
48740771|NCT03592368|102151498|FG000|COMPLETED|Overall Study||28||
48740772|NCT03592368|102151499|FG001|COMPLETED|Overall Study||24||
48740773|NCT03592368|102151500|FG002|COMPLETED|Overall Study||20||
48740774|NCT03592368|102151501|FG003|COMPLETED|Overall Study||21||
48740775|NCT03592368|102151498|FG000|NOT COMPLETED|Overall Study||1||
48740776|NCT03592368|102151499|FG001|NOT COMPLETED|Overall Study||2||
48740777|NCT03592368|102151500|FG002|NOT COMPLETED|Overall Study||0||
48740778|NCT03592368|102151501|FG003|NOT COMPLETED|Overall Study||1||
48740779|NCT00713544|102151502|FG000|STARTED|Overall Study||52||
48740780|NCT00713544|102151503|FG001|STARTED|Overall Study||52||
48740781|NCT00713544|102151504|FG002|STARTED|Overall Study||52||
48740782|NCT00713544|102151505|FG003|STARTED|Overall Study||76||
48740783|NCT00713544|102151506|FG004|STARTED|Overall Study||65||
48740784|NCT00713544|102151507|FG005|STARTED|Overall Study||76||
48740785|NCT00713544|102151502|FG000|COMPLETED|Overall Study||45||
48740786|NCT00713544|102151503|FG001|COMPLETED|Overall Study||46||
48740787|NCT00713544|102151504|FG002|COMPLETED|Overall Study||41||
48740788|NCT00713544|102151505|FG003|COMPLETED|Overall Study||66||
48740789|NCT00713544|102151506|FG004|COMPLETED|Overall Study||57||
48740790|NCT00713544|102151507|FG005|COMPLETED|Overall Study||67||
48740791|NCT00713544|102151502|FG000|NOT COMPLETED|Overall Study||7||
48740792|NCT00713544|102151503|FG001|NOT COMPLETED|Overall Study||6||
48740793|NCT00713544|102151504|FG002|NOT COMPLETED|Overall Study||11||
48740794|NCT00713544|102151505|FG003|NOT COMPLETED|Overall Study||10||
48740795|NCT00713544|102151506|FG004|NOT COMPLETED|Overall Study||8||
48740796|NCT00713544|102151507|FG005|NOT COMPLETED|Overall Study||9||
48740797|NCT02737475|102151508|FG000|STARTED|Overall Study||4|Treated|
48740798|NCT02737475|102151509|FG001|STARTED|Overall Study||4|Treated|
48740799|NCT02737475|102151510|FG002|STARTED|Overall Study||4|Treated|
48322798|NCT01389752|101118064|FG000|STARTED|Study Period 2||11||
48740800|NCT02737475|102151511|FG003|STARTED|Overall Study||4|Treated|
48740801|NCT02737475|102151512|FG004|STARTED|Overall Study||4|Treated|
48740802|NCT02737475|102151513|FG005|STARTED|Overall Study||7|Treated|
48740803|NCT02737475|102151514|FG006|STARTED|Overall Study||8|Treated|
48740804|NCT02737475|102151515|FG007|STARTED|Overall Study||12|Treated|
48740805|NCT02737475|102151516|FG008|STARTED|Overall Study||8|Treated|
48740806|NCT02737475|102151517|FG009|STARTED|Overall Study||8|Treated|
48322799|NCT01389752|101118065|FG001|STARTED|Study Period 2||9||
48322800|NCT01389752|101118064|FG000|COMPLETED|Study Period 2||10||
48740807|NCT02737475|102151518|FG010|STARTED|Overall Study||4|Treated|
48740808|NCT02737475|102151519|FG011|STARTED|Overall Study||10|Treated|
48740809|NCT02737475|102151520|FG012|STARTED|Overall Study||7|Treated|
48408321|NCT02996110|101331749|FG004|Re-Randomized to Track 2|Track 1||0||
48408322|NCT02996110|101331745|FG000|COMPLETED|Track 1||7||
48408323|NCT02996110|101331746|FG001|COMPLETED|Track 1||8||
48408324|NCT02996110|101331747|FG002|COMPLETED|Track 1||0||
48408325|NCT02996110|101331748|FG003|COMPLETED|Track 1||0||
48408326|NCT02996110|101331749|FG004|COMPLETED|Track 1||0||
48408327|NCT02996110|101331745|FG000|NOT COMPLETED|Track 1||23||
48408328|NCT02996110|101331746|FG001|NOT COMPLETED|Track 1||22||
48408329|NCT02996110|101331747|FG002|NOT COMPLETED|Track 1||0||
48408330|NCT02996110|101331748|FG003|NOT COMPLETED|Track 1||0||
48408331|NCT02996110|101331749|FG004|NOT COMPLETED|Track 1||0||
48408332|NCT02996110|101331745|FG000|STARTED|Track 2||46||
48408333|NCT02996110|101331746|FG001|STARTED|Track 2||32||
48408334|NCT02996110|101331747|FG002|STARTED|Track 2||31||
48408335|NCT02996110|101331748|FG003|STARTED|Track 2||21||
48408336|NCT02996110|101331749|FG004|STARTED|Track 2||22||
48408337|NCT02996110|101331745|FG000|No Pre-Randomization|Track 2||35||
48408338|NCT02996110|101331746|FG001|No Pre-Randomization|Track 2||25||
48408339|NCT02996110|101331747|FG002|No Pre-Randomization|Track 2||25||
48408340|NCT02996110|101331748|FG003|No Pre-Randomization|Track 2||17||
48408341|NCT02996110|101331749|FG004|No Pre-Randomization|Track 2||16||
48617566|NCT03506438|101849612|FG005|STARTED|Overall Study||18||
48740810|NCT02737475|102151521|FG013|STARTED|Overall Study||8|Treated|
48740811|NCT02737475|102151522|FG014|STARTED|Overall Study||6|Treated|
48740812|NCT02737475|102151523|FG015|STARTED|Overall Study||18|Treated|
48740813|NCT02737475|102151524|FG016|STARTED|Overall Study||12|Treated|
48740814|NCT02737475|102151525|FG017|STARTED|Overall Study||6|Treated|
48740815|NCT02737475|102151526|FG018|STARTED|Overall Study||7|Treated|
48740816|NCT02737475|102151527|FG019|STARTED|Overall Study||1|Treated|
48740817|NCT02737475|102151528|FG020|STARTED|Overall Study||6|Treated|
48740818|NCT02737475|102151529|FG021|STARTED|Overall Study||9|Treated|
48740819|NCT02737475|102151530|FG022|STARTED|Overall Study||2|Treated|
48740820|NCT02737475|102151531|FG023|STARTED|Overall Study||2|Treated|
48740821|NCT02737475|102151532|FG024|STARTED|Overall Study||2|Treated|
48408342|NCT02996110|101331745|FG000|Re-Randomized From Track 1 Nivolumab + Relatlimab|Track 2||2||
48408343|NCT02996110|101331746|FG001|Re-Randomized From Track 1 Nivolumab + Relatlimab|Track 2||0||
48408344|NCT02996110|101331747|FG002|Re-Randomized From Track 1 Nivolumab + Relatlimab|Track 2||2||
48408345|NCT02996110|101331748|FG003|Re-Randomized From Track 1 Nivolumab + Relatlimab|Track 2||1||
48408346|NCT02996110|101331749|FG004|Re-Randomized From Track 1 Nivolumab + Relatlimab|Track 2||1||
48617567|NCT03506438|101849607|FG000|COMPLETED|Overall Study||47||
48617568|NCT03506438|101849608|FG001|COMPLETED|Overall Study||49||
48617569|NCT03506438|101849609|FG002|COMPLETED|Overall Study||47||
48617570|NCT03506438|101849610|FG003|COMPLETED|Overall Study||49||
48617571|NCT03506438|101849611|FG004|COMPLETED|Overall Study||19||
48617572|NCT03506438|101849612|FG005|COMPLETED|Overall Study||18||
48617573|NCT03506438|101849607|FG000|NOT COMPLETED|Overall Study||8||
48617574|NCT03506438|101849608|FG001|NOT COMPLETED|Overall Study||7||
48617575|NCT03506438|101849609|FG002|NOT COMPLETED|Overall Study||8||
48617576|NCT03506438|101849610|FG003|NOT COMPLETED|Overall Study||7||
48617577|NCT03506438|101849611|FG004|NOT COMPLETED|Overall Study||0||
48617578|NCT03506438|101849612|FG005|NOT COMPLETED|Overall Study||0||
48617579|NCT00733278|101849613|FG000|STARTED|Overall Study||7||
48617580|NCT00733278|101849613|FG000|COMPLETED|Overall Study||7||
48617581|NCT00733278|101849613|FG000|NOT COMPLETED|Overall Study||0||
48617582|NCT03801642|101849614|FG000|STARTED|Overall Study||30||
48617583|NCT03801642|101849615|FG001|STARTED|Overall Study||16||
48617584|NCT03801642|101849614|FG000|COMPLETED|Overall Study||30||
48617585|NCT03801642|101849615|FG001|COMPLETED|Overall Study||16||
48617586|NCT03801642|101849614|FG000|NOT COMPLETED|Overall Study||0||
48617587|NCT03801642|101849615|FG001|NOT COMPLETED|Overall Study||0||
48617588|NCT03075267|101849616|FG000|STARTED|Overall Study||32||
48617589|NCT03075267|101849617|FG001|STARTED|Overall Study||32||
48617590|NCT03075267|101849618|FG002|STARTED|Overall Study||32||
48617591|NCT03075267|101849616|FG000|COMPLETED|Overall Study||31||
48617592|NCT03075267|101849617|FG001|COMPLETED|Overall Study||32||
48617593|NCT03075267|101849618|FG002|COMPLETED|Overall Study||32||
48617594|NCT03075267|101849616|FG000|NOT COMPLETED|Overall Study||1||
48617595|NCT03075267|101849617|FG001|NOT COMPLETED|Overall Study||0||
48617596|NCT03075267|101849618|FG002|NOT COMPLETED|Overall Study||0||
48617597|NCT03146741|101849619|FG000|STARTED|Overall Study||20||
48617598|NCT03146741|101849619|FG000|COMPLETED|Overall Study||10||
48617599|NCT03146741|101849619|FG000|NOT COMPLETED|Overall Study||10||
48617600|NCT03498313|101849620|FG000|STARTED|Experimental Period 1||9||
48617601|NCT03498313|101849621|FG001|STARTED|Experimental Period 1||8||
48408347|NCT02996110|101331745|FG000|Re-Randomized From Track 1 Nivolumab + Ipilimumab|Track 2||0||
48408348|NCT02996110|101331746|FG001|Re-Randomized From Track 1 Nivolumab + Ipilimumab|Track 2||3||
48408349|NCT02996110|101331747|FG002|Re-Randomized From Track 1 Nivolumab + Ipilimumab|Track 2||1||
48617602|NCT03498313|101849622|FG002|STARTED|Experimental Period 1||9||
48617603|NCT03498313|101849623|FG003|STARTED|Experimental Period 1||5||
48617604|NCT03498313|101849624|FG004|STARTED|Experimental Period 1||9||
48617605|NCT03498313|101849625|FG005|STARTED|Experimental Period 1||6||
48740822|NCT02737475|102151533|FG025|STARTED|Overall Study||2|Treated|
48740823|NCT02737475|102151534|FG026|STARTED|Overall Study||1|Treated|
48740824|NCT02737475|102151508|FG000|COMPLETED|Overall Study||3|Participants continuing in the study|
48740825|NCT02737475|102151509|FG001|COMPLETED|Overall Study||4|Participants continuing in the study|
48740826|NCT02737475|102151510|FG002|COMPLETED|Overall Study||4|Participants continuing in the study|
48740827|NCT02737475|102151511|FG003|COMPLETED|Overall Study||3|Participants continuing in the study|
48740828|NCT02737475|102151512|FG004|COMPLETED|Overall Study||3|Participants continuing in the study|
48740829|NCT02737475|102151513|FG005|COMPLETED|Overall Study||4|Participants continuing in the study|
48740830|NCT02737475|102151514|FG006|COMPLETED|Overall Study||8|Participants continuing in the study|
48740831|NCT02737475|102151515|FG007|COMPLETED|Overall Study||10|Participants continuing in the study|
48740832|NCT02737475|102151516|FG008|COMPLETED|Overall Study||7|Participants continuing in the study|
48740833|NCT02737475|102151517|FG009|COMPLETED|Overall Study||8|Participants continuing in the study|
48740834|NCT02737475|102151518|FG010|COMPLETED|Overall Study||3|Participants continuing in the study|
48740835|NCT02737475|102151519|FG011|COMPLETED|Overall Study||6|Participants continuing in the study|
48740836|NCT02737475|102151520|FG012|COMPLETED|Overall Study||5|Participants continuing in the study|
48740837|NCT02737475|102151521|FG013|COMPLETED|Overall Study||6|Participants continuing in the study|
48740838|NCT02737475|102151522|FG014|COMPLETED|Overall Study||5|Participants continuing in the study|
48740839|NCT02737475|102151523|FG015|COMPLETED|Overall Study||15|Participants continuing in the study|
48740840|NCT02737475|102151524|FG016|COMPLETED|Overall Study||10|Participants continuing in the study|
48740841|NCT02737475|102151525|FG017|COMPLETED|Overall Study||2|Participants continuing in the study|
48740842|NCT02737475|102151526|FG018|COMPLETED|Overall Study||5|Participants continuing in the study|
48740843|NCT02737475|102151527|FG019|COMPLETED|Overall Study||1|Participants continuing in the study|
48161863|NCT01529008|100718830|FG000|NOT COMPLETED|Treatment||9||
48740844|NCT02737475|102151528|FG020|COMPLETED|Overall Study||4|Participants continuing in the study|
48740845|NCT02737475|102151529|FG021|COMPLETED|Overall Study||8|Participants continuing in the study|
48740846|NCT02737475|102151530|FG022|COMPLETED|Overall Study||2|Participants continuing in the study|
48740847|NCT02737475|102151531|FG023|COMPLETED|Overall Study||1|Participants continuing in the study|
48740848|NCT02737475|102151532|FG024|COMPLETED|Overall Study||1|Participants continuing in the study|
48740849|NCT02737475|102151533|FG025|COMPLETED|Overall Study||1|Participants continuing in the study|
48740850|NCT02737475|102151534|FG026|COMPLETED|Overall Study||0|Participants continuing in the study|
48740851|NCT02737475|102151508|FG000|NOT COMPLETED|Overall Study||1||
48740852|NCT02737475|102151509|FG001|NOT COMPLETED|Overall Study||0||
48740853|NCT02737475|102151510|FG002|NOT COMPLETED|Overall Study||0||
48740854|NCT02737475|102151511|FG003|NOT COMPLETED|Overall Study||1||
48740855|NCT02737475|102151512|FG004|NOT COMPLETED|Overall Study||1||
48740856|NCT02737475|102151513|FG005|NOT COMPLETED|Overall Study||3||
48740857|NCT02737475|102151514|FG006|NOT COMPLETED|Overall Study||0||
48740858|NCT02737475|102151515|FG007|NOT COMPLETED|Overall Study||2||
48740859|NCT02737475|102151516|FG008|NOT COMPLETED|Overall Study||1||
48740860|NCT02737475|102151517|FG009|NOT COMPLETED|Overall Study||0||
48740861|NCT02737475|102151518|FG010|NOT COMPLETED|Overall Study||1||
48740862|NCT02737475|102151519|FG011|NOT COMPLETED|Overall Study||4||
48740863|NCT02737475|102151520|FG012|NOT COMPLETED|Overall Study||2||
48740864|NCT02737475|102151521|FG013|NOT COMPLETED|Overall Study||2||
48740865|NCT02737475|102151522|FG014|NOT COMPLETED|Overall Study||1||
48740866|NCT02737475|102151523|FG015|NOT COMPLETED|Overall Study||3||
48740867|NCT02737475|102151524|FG016|NOT COMPLETED|Overall Study||2||
48740868|NCT02737475|102151525|FG017|NOT COMPLETED|Overall Study||4||
48740869|NCT02737475|102151526|FG018|NOT COMPLETED|Overall Study||2||
48740870|NCT02737475|102151527|FG019|NOT COMPLETED|Overall Study||0||
48740871|NCT02737475|102151528|FG020|NOT COMPLETED|Overall Study||2||
48740872|NCT02737475|102151529|FG021|NOT COMPLETED|Overall Study||1||
48740873|NCT02737475|102151530|FG022|NOT COMPLETED|Overall Study||0||
48740874|NCT02737475|102151531|FG023|NOT COMPLETED|Overall Study||1||
48740875|NCT02737475|102151532|FG024|NOT COMPLETED|Overall Study||1||
48740876|NCT02737475|102151533|FG025|NOT COMPLETED|Overall Study||1||
48740877|NCT02737475|102151534|FG026|NOT COMPLETED|Overall Study||1||
48740878|NCT00991939|102151535|FG000|STARTED|Overall Study||5||
48740879|NCT00991939|102151536|FG001|STARTED|Overall Study||3||
48740880|NCT00991939|102151535|FG000|COMPLETED|Overall Study||0||
48740881|NCT00991939|102151536|FG001|COMPLETED|Overall Study||1||
48740882|NCT00991939|102151535|FG000|NOT COMPLETED|Overall Study||5||
48740883|NCT00991939|102151536|FG001|NOT COMPLETED|Overall Study||2||
48740884|NCT00832416|102151537|FG000|STARTED|Overall Study||110||
48740885|NCT00832416|102151538|FG001|STARTED|Overall Study||113||
48740886|NCT00832416|102151539|FG002|STARTED|Overall Study||115||
48740887|NCT00832416|102151540|FG003|STARTED|Overall Study||227||
48740888|NCT00832416|102151537|FG000|COMPLETED|Overall Study||64||
48740889|NCT00832416|102151538|FG001|COMPLETED|Overall Study||60||
48740890|NCT00832416|102151539|FG002|COMPLETED|Overall Study||54||
48740891|NCT00832416|102151540|FG003|COMPLETED|Overall Study||144||
48740892|NCT00832416|102151537|FG000|NOT COMPLETED|Overall Study||46||
48740893|NCT00832416|102151538|FG001|NOT COMPLETED|Overall Study||53||
48740894|NCT00832416|102151539|FG002|NOT COMPLETED|Overall Study||61||
48740895|NCT00832416|102151540|FG003|NOT COMPLETED|Overall Study||83||
48740896|NCT02446717|102151541|FG000|STARTED|Overall Study||6||
48740897|NCT02446717|102151542|FG001|STARTED|Overall Study||22||
48740898|NCT02446717|102151543|FG002|STARTED|Overall Study||22||
48740899|NCT02446717|102151544|FG003|STARTED|Overall Study||44||
48740900|NCT02446717|102151545|FG004|STARTED|Overall Study||47||
48740901|NCT02446717|102151541|FG000|COMPLETED|Overall Study||6||
48740902|NCT02446717|102151542|FG001|COMPLETED|Overall Study||21||
48161864|NCT01529008|100718831|FG001|NOT COMPLETED|Treatment||1||
48161865|NCT01529008|100718830|FG000|STARTED|Efficacy Analysis||25||
48161866|NCT01529008|100718831|FG001|STARTED|Efficacy Analysis||29||
48161867|NCT01529008|100718830|FG000|COMPLETED|Efficacy Analysis||23||
48161868|NCT01529008|100718831|FG001|COMPLETED|Efficacy Analysis||26||
48740903|NCT02446717|102151543|FG002|COMPLETED|Overall Study||20||
48740904|NCT02446717|102151544|FG003|COMPLETED|Overall Study||43||
48161869|NCT01529008|100718830|FG000|NOT COMPLETED|Efficacy Analysis||2||
48161870|NCT01529008|100718831|FG001|NOT COMPLETED|Efficacy Analysis||3||
48161871|NCT01769170|100718832|FG000|STARTED|Overall Study||303||
48161872|NCT01769170|100718833|FG001|STARTED|Overall Study||149||
48740905|NCT02446717|102151545|FG004|COMPLETED|Overall Study||46||
48161873|NCT01769170|100718832|FG000|COMPLETED|Overall Study||232||
48161874|NCT01769170|100718833|FG001|COMPLETED|Overall Study||122||
48161875|NCT01769170|100718832|FG000|NOT COMPLETED|Overall Study||71||
48161876|NCT01769170|100718833|FG001|NOT COMPLETED|Overall Study||27||
48740906|NCT02446717|102151541|FG000|NOT COMPLETED|Overall Study||0||
48740907|NCT02446717|102151542|FG001|NOT COMPLETED|Overall Study||1||
48740908|NCT02446717|102151543|FG002|NOT COMPLETED|Overall Study||2||
48740909|NCT02446717|102151544|FG003|NOT COMPLETED|Overall Study||1||
48740910|NCT02446717|102151545|FG004|NOT COMPLETED|Overall Study||1||
48322801|NCT01389752|101118065|FG001|COMPLETED|Study Period 2||9||
48322802|NCT01389752|101118064|FG000|NOT COMPLETED|Study Period 2||1||
48322803|NCT01389752|101118065|FG001|NOT COMPLETED|Study Period 2||0||
48322804|NCT00583362|101118066|FG000|STARTED|Overall Study||298||
48617606|NCT03498313|101849620|FG000|COMPLETED|Experimental Period 1||8||
48322805|NCT00583362|101118066|FG000|COMPLETED|Overall Study||96||
48322806|NCT00583362|101118066|FG000|NOT COMPLETED|Overall Study||202||
48322807|NCT01682135|101118067|FG000|STARTED|Overall Study||6||
48322808|NCT01682135|101118068|FG001|STARTED|Overall Study||10||
48322809|NCT01682135|101118069|FG002|STARTED|Overall Study||12||
48322810|NCT01682135|101118067|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
48322811|NCT01682135|101118068|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10||
48322812|NCT01682135|101118069|FG002|Received at Least 1 Dose of Study Drug|Overall Study||12||
48322813|NCT01682135|101118067|FG000|COMPLETED|Overall Study||6||
48617607|NCT03498313|101849621|FG001|COMPLETED|Experimental Period 1||7||
48617608|NCT03498313|101849622|FG002|COMPLETED|Experimental Period 1||9||
48617609|NCT03498313|101849623|FG003|COMPLETED|Experimental Period 1||4||
48617610|NCT03498313|101849624|FG004|COMPLETED|Experimental Period 1||9||
48617611|NCT03498313|101849625|FG005|COMPLETED|Experimental Period 1||6||
48740911|NCT01397461|102151546|FG000|STARTED|Overall Study||155||
48740912|NCT01397461|102151547|FG001|STARTED|Overall Study||156||
48740913|NCT01397461|102151548|FG002|STARTED|Overall Study||154||
48740914|NCT01397461|102151546|FG000|COMPLETED|Overall Study||153||
48740915|NCT01397461|102151547|FG001|COMPLETED|Overall Study||150||
48322814|NCT01682135|101118068|FG001|COMPLETED|Overall Study||10||
48322815|NCT01682135|101118069|FG002|COMPLETED|Overall Study||12||
48322816|NCT01682135|101118067|FG000|NOT COMPLETED|Overall Study||0||
48322817|NCT01682135|101118068|FG001|NOT COMPLETED|Overall Study||0||
48322818|NCT01682135|101118069|FG002|NOT COMPLETED|Overall Study||0||
48322819|NCT03775421|101118070|FG000|STARTED|Overall Study||111||
48322820|NCT03775421|101118070|FG000|COMPLETED|Overall Study||1||
48322821|NCT03775421|101118070|FG000|NOT COMPLETED|Overall Study||110||
48322822|NCT00665457|101118071|FG000|STARTED|Overall Study||3||
48322823|NCT00665457|101118071|FG000|COMPLETED|Overall Study||3|All three subjects completed chemotherapy treatment and went on to surgery.|
48322824|NCT00665457|101118071|FG000|NOT COMPLETED|Overall Study||0||
48322825|NCT00562588|101118072|FG000|STARTED|Overall Study||260||
48322826|NCT00562588|101118073|FG001|STARTED|Overall Study||283||
48322827|NCT00562588|101118072|FG000|COMPLETED|Overall Study||168||
48322828|NCT00562588|101118073|FG001|COMPLETED|Overall Study||184||
48617612|NCT03498313|101849620|FG000|NOT COMPLETED|Experimental Period 1||1||
48617613|NCT03498313|101849621|FG001|NOT COMPLETED|Experimental Period 1||1||
48617614|NCT03498313|101849622|FG002|NOT COMPLETED|Experimental Period 1||0||
48617615|NCT03498313|101849623|FG003|NOT COMPLETED|Experimental Period 1||1||
48740916|NCT01397461|102151548|FG002|COMPLETED|Overall Study||152||
48740917|NCT01397461|102151546|FG000|NOT COMPLETED|Overall Study||2||
48740918|NCT01397461|102151547|FG001|NOT COMPLETED|Overall Study||6||
48740919|NCT01397461|102151548|FG002|NOT COMPLETED|Overall Study||2||
48322829|NCT00562588|101118072|FG000|NOT COMPLETED|Overall Study||92||
48322830|NCT00562588|101118073|FG001|NOT COMPLETED|Overall Study||99||
48322831|NCT04036968|101118074|FG000|STARTED|Overall Study||31||
48322832|NCT04036968|101118074|FG000|Placebo + Placebo|Overall Study||31||
48322833|NCT04036968|101118074|FG000|Hydromorphoe 4mg + Placebo|Overall Study||31||
48322834|NCT04036968|101118074|FG000|Hydromorphone 4mg + Cannabidiol 50mg|Overall Study||31||
48322835|NCT04036968|101118074|FG000|Hydromorphone 4mg + Cannabidiol 100mg|Overall Study||31||
48322836|NCT04036968|101118074|FG000|Hydromorphone 4mg + Cannabidiol 200mg|Overall Study||31||
48322837|NCT04036968|101118074|FG000|COMPLETED|Overall Study||31||
48322838|NCT04036968|101118074|FG000|NOT COMPLETED|Overall Study||0||
48322839|NCT00631371|101118075|FG000|STARTED|Overall Study||400||
48322840|NCT00631371|101118076|FG001|STARTED|Overall Study||391||
48322841|NCT00631371|101118075|FG000|Treated|Overall Study||393||
48322842|NCT00631371|101118076|FG001|Treated|Overall Study||391||
48322843|NCT00631371|101118075|FG000|COMPLETED|Overall Study||0||
48322844|NCT00631371|101118076|FG001|COMPLETED|Overall Study||0||
48408350|NCT02996110|101331748|FG003|Re-Randomized From Track 1 Nivolumab + Ipilimumab|Track 2||1||
48440028|NCT05378269|101410016|FG001|STARTED|Overall Study||3||
48740920|NCT03402035|102151549|FG000|STARTED|Overall Study||624||
48740921|NCT03402035|102151550|FG001|STARTED|Overall Study||427||
48740922|NCT03402035|102151549|FG000|COMPLETED|Overall Study||624||
48322845|NCT00631371|101118075|FG000|NOT COMPLETED|Overall Study||400||
48322846|NCT00631371|101118076|FG001|NOT COMPLETED|Overall Study||391||
48322847|NCT00205855|101118077|FG000|STARTED|Overall Study||65||
48322848|NCT00205855|101118077|FG000|COMPLETED|Overall Study||44||
48322849|NCT00205855|101118077|FG000|NOT COMPLETED|Overall Study||21||
48322850|NCT02586675|101118078|FG000|STARTED|Overall Study||7||
48322851|NCT02586675|101118078|FG000|COMPLETED|Overall Study||7||
48617616|NCT03498313|101849624|FG004|NOT COMPLETED|Experimental Period 1||0||
48740923|NCT03402035|102151550|FG001|COMPLETED|Overall Study||427||
48740924|NCT03402035|102151549|FG000|NOT COMPLETED|Overall Study||0||
48322852|NCT02586675|101118078|FG000|NOT COMPLETED|Overall Study||0||
48322853|NCT05030012|101118079|FG000|STARTED|Overall Study||6||
48322854|NCT05030012|101118080|FG001|STARTED|Overall Study||9||
48322855|NCT05030012|101118079|FG000|COMPLETED|Overall Study||6||
48161877|NCT02512679|100718834|FG000|STARTED|Overall Study||20||
48161878|NCT02512679|100718835|FG001|STARTED|Overall Study||0||
48161879|NCT02512679|100718834|FG000|COMPLETED|Overall Study||20||
48161880|NCT02512679|100718835|FG001|COMPLETED|Overall Study||0||
48161881|NCT02512679|100718834|FG000|NOT COMPLETED|Overall Study||0||
48161882|NCT02512679|100718835|FG001|NOT COMPLETED|Overall Study||0||
48322856|NCT05030012|101118080|FG001|COMPLETED|Overall Study||9||
48322857|NCT05030012|101118079|FG000|NOT COMPLETED|Overall Study||0||
48322858|NCT05030012|101118080|FG001|NOT COMPLETED|Overall Study||0||
48322859|NCT00814775|101118081|FG000|STARTED|Overall Study||23||
48322860|NCT00814775|101118082|FG001|STARTED|Overall Study||20||
48322861|NCT00814775|101118081|FG000|COMPLETED|Overall Study||23||
48322862|NCT00814775|101118082|FG001|COMPLETED|Overall Study||20||
48322863|NCT00814775|101118081|FG000|NOT COMPLETED|Overall Study||0||
48322864|NCT00814775|101118082|FG001|NOT COMPLETED|Overall Study||0||
48322865|NCT02193074|101118083|FG000|STARTED|Overall Study||41||
48322866|NCT02193074|101118084|FG001|STARTED|Overall Study||80||
48322867|NCT02193074|101118083|FG000|Completed During Follow-Up Period|Overall Study||11||
48322868|NCT02193074|101118084|FG001|Completed During Follow-Up Period|Overall Study||26||
48322869|NCT02193074|101118083|FG000|Completed Due to Early Study Termination|Overall Study||13||
48322870|NCT02193074|101118084|FG001|Completed Due to Early Study Termination|Overall Study||39||
48322871|NCT02193074|101118083|FG000|COMPLETED|Overall Study||24||
48322872|NCT02193074|101118084|FG001|COMPLETED|Overall Study||65||
48322873|NCT02193074|101118083|FG000|NOT COMPLETED|Overall Study||17||
48322874|NCT02193074|101118084|FG001|NOT COMPLETED|Overall Study||15||
48322875|NCT01014689|101118085|FG000|STARTED|Overall Study||191||
48161883|NCT01163643|100718836|FG000|STARTED|Overall Study||68||
48161884|NCT01163643|100718837|FG001|STARTED|Overall Study||37||
48322876|NCT01014689|101118086|FG001|STARTED|Overall Study||187||
48322877|NCT01014689|101118085|FG000|COMPLETED|Overall Study||178||
48322878|NCT01014689|101118086|FG001|COMPLETED|Overall Study||174||
48322879|NCT01014689|101118085|FG000|NOT COMPLETED|Overall Study||13||
48322880|NCT01014689|101118086|FG001|NOT COMPLETED|Overall Study||13||
48322881|NCT01033734|101118087|FG000|STARTED|Overall Study||8||
48322882|NCT01033734|101118087|FG000|COMPLETED|Overall Study||7||
48322883|NCT01033734|101118087|FG000|NOT COMPLETED|Overall Study||1||
48322884|NCT00903175|101118088|FG000|STARTED|Period 1 - First Line||238||
48322885|NCT00903175|101118089|FG001|STARTED|Period 1 - First Line||231||
48322886|NCT00903175|101118088|FG000|COMPLETED|Period 1 - First Line||161||
48322887|NCT00903175|101118089|FG001|COMPLETED|Period 1 - First Line||142||
48161885|NCT01163643|100718838|FG002|STARTED|Overall Study||35||
48161886|NCT01163643|100718839|FG003|STARTED|Overall Study||74||
48161887|NCT01163643|100718840|FG004|STARTED|Overall Study||69||
48161888|NCT01163643|100718841|FG005|STARTED|Overall Study||73||
48161889|NCT01163643|100718836|FG000|COMPLETED|Overall Study||62||
48161890|NCT01163643|100718837|FG001|COMPLETED|Overall Study||35||
48161891|NCT01163643|100718838|FG002|COMPLETED|Overall Study||33||
48161892|NCT01163643|100718839|FG003|COMPLETED|Overall Study||69||
48161893|NCT01163643|100718840|FG004|COMPLETED|Overall Study||61||
48161894|NCT01163643|100718841|FG005|COMPLETED|Overall Study||66||
48161895|NCT01163643|100718836|FG000|NOT COMPLETED|Overall Study||6||
48161896|NCT01163643|100718837|FG001|NOT COMPLETED|Overall Study||2||
48161897|NCT01163643|100718838|FG002|NOT COMPLETED|Overall Study||2||
48161898|NCT01163643|100718839|FG003|NOT COMPLETED|Overall Study||5||
48161899|NCT01163643|100718840|FG004|NOT COMPLETED|Overall Study||8||
48161900|NCT01163643|100718841|FG005|NOT COMPLETED|Overall Study||7||
48161901|NCT02309112|100718842|FG000|STARTED|Overall Study||5||
48161902|NCT02309112|100718843|FG001|STARTED|Overall Study||5||
48161903|NCT02309112|100718844|FG002|STARTED|Overall Study||5||
48161904|NCT02309112|100718842|FG000|Completed Yoga Intervention|Overall Study||4||
48161905|NCT02309112|100718843|FG001|Completed Yoga Intervention|Overall Study||5||
48161906|NCT02309112|100718844|FG002|Completed Yoga Intervention|Overall Study||4||
48161907|NCT02309112|100718842|FG000|COMPLETED|Overall Study||4||
48322888|NCT00903175|101118088|FG000|NOT COMPLETED|Period 1 - First Line||77||
48322889|NCT00903175|101118089|FG001|NOT COMPLETED|Period 1 - First Line||89||
48322890|NCT00903175|101118088|FG000|STARTED|Period 2 - Second Line||128||
48322891|NCT00903175|101118089|FG001|STARTED|Period 2 - Second Line||116||
48322892|NCT00903175|101118088|FG000|COMPLETED|Period 2 - Second Line||79||
48408351|NCT02996110|101331749|FG004|Re-Randomized From Track 1 Nivolumab + Ipilimumab|Track 2||0||
48408352|NCT02996110|101331745|FG000|Re-Randomized From Track 2 Nivolumab + Relatlimab|Track 2||7||
48161908|NCT02309112|100718843|FG001|COMPLETED|Overall Study||4||
48161909|NCT02309112|100718844|FG002|COMPLETED|Overall Study||4||
48161910|NCT02309112|100718842|FG000|NOT COMPLETED|Overall Study||1||
48161911|NCT02309112|100718843|FG001|NOT COMPLETED|Overall Study||1||
48161912|NCT02309112|100718844|FG002|NOT COMPLETED|Overall Study||1||
48161913|NCT01480596|100718845|FG000|STARTED|Overall Study||22||
48161914|NCT01480596|100718846|FG001|STARTED|Overall Study||18||
48161915|NCT01480596|100718845|FG000|COMPLETED|Overall Study||17||
48161916|NCT01480596|100718846|FG001|COMPLETED|Overall Study||16||
48161917|NCT01480596|100718845|FG000|NOT COMPLETED|Overall Study||5||
48161918|NCT01480596|100718846|FG001|NOT COMPLETED|Overall Study||2||
48161919|NCT03439189|100718847|FG000|STARTED|Overall Study||343||
48161920|NCT03439189|100718847|FG000|COMPLETED|Overall Study||261||
48161921|NCT03439189|100718847|FG000|NOT COMPLETED|Overall Study||82||
48161922|NCT03929562|100718848|FG000|STARTED|From Baseline to 1 Month Follow Up||26||
48161923|NCT03929562|100718849|FG001|STARTED|From Baseline to 1 Month Follow Up||25||
48161924|NCT03929562|100718848|FG000|COMPLETED|From Baseline to 1 Month Follow Up||22||
48161925|NCT03929562|100718849|FG001|COMPLETED|From Baseline to 1 Month Follow Up||24||
48161926|NCT03929562|100718848|FG000|NOT COMPLETED|From Baseline to 1 Month Follow Up||4||
48161927|NCT03929562|100718849|FG001|NOT COMPLETED|From Baseline to 1 Month Follow Up||1||
48161928|NCT03929562|100718848|FG000|STARTED|1 Month Follow Up to 4 Month Follow Up||22||
48161929|NCT03929562|100718849|FG001|STARTED|1 Month Follow Up to 4 Month Follow Up||24||
48161930|NCT03929562|100718848|FG000|COMPLETED|1 Month Follow Up to 4 Month Follow Up||20||
48161931|NCT03929562|100718849|FG001|COMPLETED|1 Month Follow Up to 4 Month Follow Up||24||
48161932|NCT03929562|100718848|FG000|NOT COMPLETED|1 Month Follow Up to 4 Month Follow Up||2||
48161933|NCT03929562|100718849|FG001|NOT COMPLETED|1 Month Follow Up to 4 Month Follow Up||0||
48161934|NCT04571099|100718850|FG000|STARTED|Overall Study||3||
48161935|NCT04571099|100718851|FG001|STARTED|Overall Study||22||
48161936|NCT04571099|100718852|FG002|STARTED|Overall Study||3||
48161937|NCT04571099|100718850|FG000|COMPLETED|Overall Study||3||
48408353|NCT02996110|101331746|FG001|Re-Randomized From Track 2 Nivolumab + Relatlimab|Track 2||0||
48617617|NCT03498313|101849625|FG005|NOT COMPLETED|Experimental Period 1||0||
48161938|NCT04571099|100718851|FG001|COMPLETED|Overall Study||22||
48161939|NCT04571099|100718852|FG002|COMPLETED|Overall Study||3||
48617618|NCT03498313|101849620|FG000|STARTED|Washout Period 1||8||
48617619|NCT03498313|101849621|FG001|STARTED|Washout Period 1||7||
48617620|NCT03498313|101849622|FG002|STARTED|Washout Period 1||9||
48617621|NCT03498313|101849623|FG003|STARTED|Washout Period 1||4||
48617622|NCT03498313|101849624|FG004|STARTED|Washout Period 1||9||
48617623|NCT03498313|101849625|FG005|STARTED|Washout Period 1||6||
48161940|NCT04571099|100718850|FG000|NOT COMPLETED|Overall Study||0||
48161941|NCT04571099|100718851|FG001|NOT COMPLETED|Overall Study||0||
48161942|NCT04571099|100718852|FG002|NOT COMPLETED|Overall Study||0||
48161943|NCT01960725|100718853|FG000|STARTED|Overall Study||33||
48161944|NCT01960725|100718854|FG001|STARTED|Overall Study||33||
48161945|NCT01960725|100718853|FG000|Received First Vaccine|Overall Study||33||
48161946|NCT01960725|100718854|FG001|Received First Vaccine|Overall Study||33||
48161947|NCT01960725|100718853|FG000|Recieved Second Vaccine|Overall Study||33||
48161948|NCT01960725|100718854|FG001|Recieved Second Vaccine|Overall Study||33||
48161949|NCT01960725|100718853|FG000|Received Third Vaccine|Overall Study||32||
48161950|NCT01960725|100718854|FG001|Received Third Vaccine|Overall Study||32||
48161951|NCT01960725|100718853|FG000|COMPLETED|Overall Study||27|Immunogenicity data completed|
48161952|NCT01960725|100718854|FG001|COMPLETED|Overall Study||28|Immunogenicity data completed|
48161953|NCT01960725|100718853|FG000|NOT COMPLETED|Overall Study||6||
48161954|NCT01960725|100718854|FG001|NOT COMPLETED|Overall Study||5||
48161955|NCT01036022|100718855|FG000|STARTED|Overall Study||15||
48161956|NCT01036022|100718856|FG001|STARTED|Overall Study||11||
48161957|NCT01036022|100718857|FG002|STARTED|Overall Study||12||
48161958|NCT01036022|100718858|FG003|STARTED|Overall Study||12||
48161959|NCT01036022|100718859|FG004|STARTED|Overall Study||12||
48161960|NCT01036022|100718860|FG005|STARTED|Overall Study||16||
48161961|NCT01036022|100718855|FG000|COMPLETED|Overall Study||13||
48161962|NCT01036022|100718856|FG001|COMPLETED|Overall Study||7||
48161963|NCT01036022|100718857|FG002|COMPLETED|Overall Study||8||
48161964|NCT01036022|100718858|FG003|COMPLETED|Overall Study||10||
48161965|NCT01036022|100718859|FG004|COMPLETED|Overall Study||9||
48161966|NCT01036022|100718860|FG005|COMPLETED|Overall Study||13||
48161967|NCT01036022|100718855|FG000|NOT COMPLETED|Overall Study||2||
48161968|NCT01036022|100718856|FG001|NOT COMPLETED|Overall Study||4||
48161969|NCT01036022|100718857|FG002|NOT COMPLETED|Overall Study||4||
48161970|NCT01036022|100718858|FG003|NOT COMPLETED|Overall Study||2||
48161971|NCT01036022|100718859|FG004|NOT COMPLETED|Overall Study||3||
48161972|NCT01036022|100718860|FG005|NOT COMPLETED|Overall Study||3||
48161973|NCT02949921|100718861|FG000|STARTED|Overall Study||10||
48161974|NCT02949921|100718862|FG001|STARTED|Overall Study||10||
48161975|NCT02949921|100718861|FG000|COMPLETED|Overall Study||10||
48161976|NCT02949921|100718862|FG001|COMPLETED|Overall Study||10||
48161977|NCT02949921|100718861|FG000|NOT COMPLETED|Overall Study||0||
48161978|NCT02949921|100718862|FG001|NOT COMPLETED|Overall Study||0||
48161979|NCT02162680|100718863|FG000|STARTED|Overall Study||33||
48161980|NCT02162680|100718864|FG001|STARTED|Overall Study||33||
48161981|NCT02162680|100718865|FG002|STARTED|Overall Study||32||
48161982|NCT02162680|100718863|FG000|COMPLETED|Overall Study||33||
48161983|NCT02162680|100718864|FG001|COMPLETED|Overall Study||33||
48617624|NCT03498313|101849620|FG000|COMPLETED|Washout Period 1||7||
48161984|NCT02162680|100718865|FG002|COMPLETED|Overall Study||32||
48161985|NCT02162680|100718863|FG000|NOT COMPLETED|Overall Study||0||
48161986|NCT02162680|100718864|FG001|NOT COMPLETED|Overall Study||0||
48161987|NCT02162680|100718865|FG002|NOT COMPLETED|Overall Study||0||
48161988|NCT00697190|100718866|FG000|STARTED|First Intervention||19||
48161989|NCT00697190|100718867|FG001|STARTED|First Intervention||20||
48161990|NCT00697190|100718866|FG000|COMPLETED|First Intervention||19||
48161991|NCT00697190|100718867|FG001|COMPLETED|First Intervention||20||
48161992|NCT00697190|100718866|FG000|NOT COMPLETED|First Intervention||0||
48161993|NCT00697190|100718867|FG001|NOT COMPLETED|First Intervention||0||
48161994|NCT00697190|100718866|FG000|STARTED|Second Intervention||18||
48161995|NCT00697190|100718867|FG001|STARTED|Second Intervention||20||
48161996|NCT00697190|100718866|FG000|COMPLETED|Second Intervention||18||
48161997|NCT00697190|100718867|FG001|COMPLETED|Second Intervention||20||
48161998|NCT00697190|100718866|FG000|NOT COMPLETED|Second Intervention||0||
48161999|NCT00697190|100718867|FG001|NOT COMPLETED|Second Intervention||0||
48162000|NCT00840801|100718868|FG000|STARTED|Part A: Screening- Day 28 Postdose 2||150||
48162001|NCT00840801|100718869|FG001|STARTED|Part A: Screening- Day 28 Postdose 2||152||
48162002|NCT00840801|100718870|FG002|STARTED|Part A: Screening- Day 28 Postdose 2||0||
48162003|NCT00840801|100718868|FG000|COMPLETED|Part A: Screening- Day 28 Postdose 2||149||
48162004|NCT00840801|100718869|FG001|COMPLETED|Part A: Screening- Day 28 Postdose 2||152||
48162005|NCT00840801|100718870|FG002|COMPLETED|Part A: Screening- Day 28 Postdose 2||0||
48162006|NCT00840801|100718868|FG000|NOT COMPLETED|Part A: Screening- Day 28 Postdose 2||1||
48617625|NCT03498313|101849621|FG001|COMPLETED|Washout Period 1||4||
48162007|NCT00840801|100718869|FG001|NOT COMPLETED|Part A: Screening- Day 28 Postdose 2||0||
48162008|NCT00840801|100718870|FG002|NOT COMPLETED|Part A: Screening- Day 28 Postdose 2||0||
48162009|NCT00840801|100718868|FG000|STARTED|Part B:Day 28 Postdose2-Day 28 Postdose3||0||
48617626|NCT03498313|101849622|FG002|COMPLETED|Washout Period 1||9||
48617627|NCT03498313|101849623|FG003|COMPLETED|Washout Period 1||3||
48617628|NCT03498313|101849624|FG004|COMPLETED|Washout Period 1||9||
48617629|NCT03498313|101849625|FG005|COMPLETED|Washout Period 1||5||
48617630|NCT03498313|101849620|FG000|NOT COMPLETED|Washout Period 1||1||
48740925|NCT03402035|102151550|FG001|NOT COMPLETED|Overall Study||0||
48740926|NCT04034004|102151551|FG000|STARTED|Overall Study||18||
48322893|NCT00903175|101118089|FG001|COMPLETED|Period 2 - Second Line||80||
48740927|NCT04034004|102151552|FG001|STARTED|Overall Study||18||
48740928|NCT04034004|102151553|FG002|STARTED|Overall Study||17||
48740929|NCT04034004|102151554|FG003|STARTED|Overall Study||18||
48740930|NCT04034004|102151551|FG000|COMPLETED|Overall Study||15||
48740931|NCT04034004|102151552|FG001|COMPLETED|Overall Study||15||
48740932|NCT04034004|102151553|FG002|COMPLETED|Overall Study||15||
48740933|NCT04034004|102151554|FG003|COMPLETED|Overall Study||14||
48322894|NCT00903175|101118088|FG000|NOT COMPLETED|Period 2 - Second Line||49||
48322895|NCT00903175|101118089|FG001|NOT COMPLETED|Period 2 - Second Line||36||
48322896|NCT01797575|101118090|FG000|STARTED|Baseline Allocation||5||
48322897|NCT01797575|101118091|FG001|STARTED|Baseline Allocation||9||
48322898|NCT01797575|101118092|FG002|STARTED|Baseline Allocation||9||
48617631|NCT03498313|101849621|FG001|NOT COMPLETED|Washout Period 1||3||
48617632|NCT03498313|101849622|FG002|NOT COMPLETED|Washout Period 1||0||
48617633|NCT03498313|101849623|FG003|NOT COMPLETED|Washout Period 1||1||
48617634|NCT03498313|101849624|FG004|NOT COMPLETED|Washout Period 1||0||
48617635|NCT03498313|101849625|FG005|NOT COMPLETED|Washout Period 1||1||
48617636|NCT03498313|101849620|FG000|STARTED|Experimental Period 2||7||
48617637|NCT03498313|101849621|FG001|STARTED|Experimental Period 2||4||
48617638|NCT03498313|101849622|FG002|STARTED|Experimental Period 2||9||
48617639|NCT03498313|101849623|FG003|STARTED|Experimental Period 2||3||
48617640|NCT03498313|101849624|FG004|STARTED|Experimental Period 2||9||
48617641|NCT03498313|101849625|FG005|STARTED|Experimental Period 2||5||
48617642|NCT03498313|101849620|FG000|COMPLETED|Experimental Period 2||7||
48617643|NCT03498313|101849621|FG001|COMPLETED|Experimental Period 2||4||
48617644|NCT03498313|101849622|FG002|COMPLETED|Experimental Period 2||9||
48617645|NCT03498313|101849623|FG003|COMPLETED|Experimental Period 2||3||
48617646|NCT03498313|101849624|FG004|COMPLETED|Experimental Period 2||8||
48617647|NCT03498313|101849625|FG005|COMPLETED|Experimental Period 2||3||
48617648|NCT03498313|101849620|FG000|NOT COMPLETED|Experimental Period 2||0||
48617649|NCT03498313|101849621|FG001|NOT COMPLETED|Experimental Period 2||0||
48617650|NCT03498313|101849622|FG002|NOT COMPLETED|Experimental Period 2||0||
48617651|NCT03498313|101849623|FG003|NOT COMPLETED|Experimental Period 2||0||
48740934|NCT04034004|102151551|FG000|NOT COMPLETED|Overall Study||3||
48322899|NCT01797575|101118093|FG003|STARTED|Baseline Allocation||15||
48322900|NCT01797575|101118090|FG000|COMPLETED|Baseline Allocation||4||
48322901|NCT01797575|101118091|FG001|COMPLETED|Baseline Allocation||8||
48322902|NCT01797575|101118092|FG002|COMPLETED|Baseline Allocation||4||
48322903|NCT01797575|101118093|FG003|COMPLETED|Baseline Allocation||8||
48322904|NCT01797575|101118090|FG000|NOT COMPLETED|Baseline Allocation||1||
48322905|NCT01797575|101118091|FG001|NOT COMPLETED|Baseline Allocation||1||
48322906|NCT01797575|101118092|FG002|NOT COMPLETED|Baseline Allocation||5||
48322907|NCT01797575|101118093|FG003|NOT COMPLETED|Baseline Allocation||7||
48322908|NCT01797575|101118090|FG000|STARTED|Week 8 Re-Randomization||4|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|
48617652|NCT03498313|101849624|FG004|NOT COMPLETED|Experimental Period 2||1||
48617653|NCT03498313|101849625|FG005|NOT COMPLETED|Experimental Period 2||2||
48617654|NCT03498313|101849620|FG000|STARTED|Washout Period 2||7||
48617655|NCT03498313|101849621|FG001|STARTED|Washout Period 2||4||
48617656|NCT03498313|101849622|FG002|STARTED|Washout Period 2||9||
48617657|NCT03498313|101849623|FG003|STARTED|Washout Period 2||3||
48617658|NCT03498313|101849624|FG004|STARTED|Washout Period 2||8||
48617659|NCT03498313|101849625|FG005|STARTED|Washout Period 2||3||
48617660|NCT03498313|101849620|FG000|COMPLETED|Washout Period 2||3||
48617661|NCT03498313|101849621|FG001|COMPLETED|Washout Period 2||2||
48617662|NCT03498313|101849622|FG002|COMPLETED|Washout Period 2||9||
48322909|NCT01797575|101118091|FG001|STARTED|Week 8 Re-Randomization||5|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|
48322910|NCT01797575|101118092|FG002|STARTED|Week 8 Re-Randomization||5|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|
48322911|NCT01797575|101118093|FG003|STARTED|Week 8 Re-Randomization||10|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|
48408354|NCT02996110|101331747|FG002|Re-Randomized From Track 2 Nivolumab + Relatlimab|Track 2||2||
48617663|NCT03498313|101849623|FG003|COMPLETED|Washout Period 2||2||
48617664|NCT03498313|101849624|FG004|COMPLETED|Washout Period 2||6||
48617665|NCT03498313|101849625|FG005|COMPLETED|Washout Period 2||1||
48617666|NCT03498313|101849620|FG000|NOT COMPLETED|Washout Period 2||4||
48617667|NCT03498313|101849621|FG001|NOT COMPLETED|Washout Period 2||2||
48740935|NCT04034004|102151552|FG001|NOT COMPLETED|Overall Study||3||
48408355|NCT02996110|101331748|FG003|Re-Randomized From Track 2 Nivolumab + Relatlimab|Track 2||0||
48322912|NCT01797575|101118090|FG000|COMPLETED|Week 8 Re-Randomization||4||
48322913|NCT01797575|101118091|FG001|COMPLETED|Week 8 Re-Randomization||5||
48322914|NCT01797575|101118092|FG002|COMPLETED|Week 8 Re-Randomization||4||
48617668|NCT03498313|101849622|FG002|NOT COMPLETED|Washout Period 2||0||
48617669|NCT03498313|101849623|FG003|NOT COMPLETED|Washout Period 2||1||
48617670|NCT03498313|101849624|FG004|NOT COMPLETED|Washout Period 2||2||
48322915|NCT01797575|101118093|FG003|COMPLETED|Week 8 Re-Randomization||7||
48322916|NCT01797575|101118090|FG000|NOT COMPLETED|Week 8 Re-Randomization||0||
48322917|NCT01797575|101118091|FG001|NOT COMPLETED|Week 8 Re-Randomization||0||
48322918|NCT01797575|101118092|FG002|NOT COMPLETED|Week 8 Re-Randomization||1||
48322919|NCT01797575|101118093|FG003|NOT COMPLETED|Week 8 Re-Randomization||3||
48322920|NCT00429403|101118094|FG000|STARTED|Overall Study||1||
48322921|NCT00429403|101118095|FG001|STARTED|Overall Study||0||
48322922|NCT00429403|101118094|FG000|COMPLETED|Overall Study||1||
48322923|NCT00429403|101118095|FG001|COMPLETED|Overall Study||0||
48322924|NCT00429403|101118094|FG000|NOT COMPLETED|Overall Study||0||
48322925|NCT00429403|101118095|FG001|NOT COMPLETED|Overall Study||0||
48322926|NCT00408694|101118096|FG000|STARTED|Overall Study||46||
48322927|NCT00408694|101118096|FG000|COMPLETED|Overall Study||44||
48322928|NCT00408694|101118096|FG000|NOT COMPLETED|Overall Study||2||
48322929|NCT03237377|101118097|FG000|STARTED|Overall Study||9||
48322930|NCT03237377|101118098|FG001|STARTED|Overall Study||0||
48322931|NCT03237377|101118097|FG000|COMPLETED|Overall Study||9||
48322932|NCT03237377|101118098|FG001|COMPLETED|Overall Study||0||
48322933|NCT03237377|101118097|FG000|NOT COMPLETED|Overall Study||0||
48322934|NCT03237377|101118098|FG001|NOT COMPLETED|Overall Study||0||
48322935|NCT00573430|101118099|FG000|STARTED|Overall Study||40||
48322936|NCT00573430|101118100|FG001|STARTED|Overall Study||45||
48322937|NCT00573430|101118101|FG002|STARTED|Overall Study||43||
48322938|NCT00573430|101118099|FG000|COMPLETED|Overall Study||39||
48322939|NCT00573430|101118100|FG001|COMPLETED|Overall Study||40||
48322940|NCT00573430|101118101|FG002|COMPLETED|Overall Study||33||
48322941|NCT00573430|101118099|FG000|NOT COMPLETED|Overall Study||1||
48322942|NCT00573430|101118100|FG001|NOT COMPLETED|Overall Study||5||
48322943|NCT00573430|101118101|FG002|NOT COMPLETED|Overall Study||10||
48322944|NCT02671136|101118102|FG000|STARTED|Overall Study||3||
48322945|NCT02671136|101118103|FG001|STARTED|Overall Study||0||
48322946|NCT02671136|101118102|FG000|COMPLETED|Overall Study||3||
48322947|NCT02671136|101118103|FG001|COMPLETED|Overall Study||0||
48322948|NCT02671136|101118102|FG000|NOT COMPLETED|Overall Study||0||
48322949|NCT02671136|101118103|FG001|NOT COMPLETED|Overall Study||0||
48322950|NCT02017327|101118104|FG000|STARTED|Overall Study||122||
48408356|NCT02996110|101331749|FG004|Re-Randomized From Track 2 Nivolumab + Relatlimab|Track 2||1||
48617671|NCT03498313|101849625|FG005|NOT COMPLETED|Washout Period 2||2||
48617672|NCT03498313|101849620|FG000|STARTED|Experimental Period 3||3||
48617673|NCT03498313|101849621|FG001|STARTED|Experimental Period 3||2||
48617674|NCT03498313|101849622|FG002|STARTED|Experimental Period 3||9||
48617675|NCT03498313|101849623|FG003|STARTED|Experimental Period 3||2||
48617676|NCT03498313|101849624|FG004|STARTED|Experimental Period 3||6||
48617677|NCT03498313|101849625|FG005|STARTED|Experimental Period 3||1||
48617678|NCT03498313|101849620|FG000|COMPLETED|Experimental Period 3||3||
48617679|NCT03498313|101849621|FG001|COMPLETED|Experimental Period 3||2||
48617680|NCT03498313|101849622|FG002|COMPLETED|Experimental Period 3||9||
48617681|NCT03498313|101849623|FG003|COMPLETED|Experimental Period 3||2||
48617682|NCT03498313|101849624|FG004|COMPLETED|Experimental Period 3||6||
48617683|NCT03498313|101849625|FG005|COMPLETED|Experimental Period 3||1||
48322951|NCT02017327|101118105|FG001|STARTED|Overall Study||125||
48322952|NCT02017327|101118106|FG002|STARTED|Overall Study||132||
48322953|NCT02017327|101118104|FG000|COMPLETED|Overall Study||106||
48322954|NCT02017327|101118105|FG001|COMPLETED|Overall Study||113||
48322955|NCT02017327|101118106|FG002|COMPLETED|Overall Study||117||
48322956|NCT02017327|101118104|FG000|NOT COMPLETED|Overall Study||16||
48322957|NCT02017327|101118105|FG001|NOT COMPLETED|Overall Study||12||
48322958|NCT02017327|101118106|FG002|NOT COMPLETED|Overall Study||15||
48408357|NCT02996110|101331745|FG000|Re-Randomized From Track 2 Nivolumab + BMS986205|Track 2||2||
48408358|NCT02996110|101331746|FG001|Re-Randomized From Track 2 Nivolumab + BMS986205|Track 2||2||
48617684|NCT03498313|101849620|FG000|NOT COMPLETED|Experimental Period 3||0||
48617685|NCT03498313|101849621|FG001|NOT COMPLETED|Experimental Period 3||0||
48617686|NCT03498313|101849622|FG002|NOT COMPLETED|Experimental Period 3||0||
48617687|NCT03498313|101849623|FG003|NOT COMPLETED|Experimental Period 3||0||
48617688|NCT03498313|101849624|FG004|NOT COMPLETED|Experimental Period 3||0||
48322959|NCT00446511|101118107|FG000|STARTED|Overall Study||21||
48322960|NCT00446511|101118108|FG001|STARTED|Overall Study||17||
48322961|NCT00446511|101118109|FG002|STARTED|Overall Study||103||
48322962|NCT00446511|101118110|FG003|STARTED|Overall Study||109||
48322963|NCT00446511|101118107|FG000|COMPLETED|Overall Study||11||
48322964|NCT00446511|101118108|FG001|COMPLETED|Overall Study||15||
48322965|NCT00446511|101118109|FG002|COMPLETED|Overall Study||96||
48322966|NCT00446511|101118110|FG003|COMPLETED|Overall Study||103||
48322967|NCT00446511|101118107|FG000|NOT COMPLETED|Overall Study||10||
48322968|NCT00446511|101118108|FG001|NOT COMPLETED|Overall Study||2||
48322969|NCT00446511|101118109|FG002|NOT COMPLETED|Overall Study||7||
48322970|NCT00446511|101118110|FG003|NOT COMPLETED|Overall Study||6||
48322971|NCT05626270|101118111|FG000|STARTED|Overall Study||15||
48322972|NCT05626270|101118111|FG000|COMPLETED|Overall Study||15||
48322973|NCT05626270|101118111|FG000|NOT COMPLETED|Overall Study||0||
48322974|NCT00333359|101118112|FG000|STARTED|Overall Study||199||
48322975|NCT00333359|101118113|FG001|STARTED|Overall Study||382||
48322976|NCT00333359|101118112|FG000|COMPLETED|Overall Study||126||
48617689|NCT03498313|101849625|FG005|NOT COMPLETED|Experimental Period 3||0||
48617690|NCT03110133|101849626|FG000|STARTED|Week 8||106||
48617691|NCT03110133|101849627|FG001|STARTED|Week 8||100||
48617692|NCT03110133|101849626|FG000|COMPLETED|Week 8||101||
48617693|NCT03110133|101849627|FG001|COMPLETED|Week 8||96||
48617694|NCT03110133|101849626|FG000|NOT COMPLETED|Week 8||5||
48617695|NCT03110133|101849627|FG001|NOT COMPLETED|Week 8||4||
48162010|NCT00840801|100718869|FG001|STARTED|Part B:Day 28 Postdose2-Day 28 Postdose3||0||
48162011|NCT00840801|100718870|FG002|STARTED|Part B:Day 28 Postdose2-Day 28 Postdose3||301||
48322977|NCT00333359|101118113|FG001|COMPLETED|Overall Study||260||
48322978|NCT00333359|101118112|FG000|NOT COMPLETED|Overall Study||73||
48322979|NCT00333359|101118113|FG001|NOT COMPLETED|Overall Study||122||
48322980|NCT03505021|101118114|FG000|STARTED|Overall Study||329||
48322981|NCT03505021|101118115|FG001|STARTED|Overall Study||167||
48617696|NCT03110133|101849626|FG000|STARTED|Week 24||101||
48617697|NCT03110133|101849627|FG001|STARTED|Week 24||96||
48617698|NCT03110133|101849626|FG000|COMPLETED|Week 24||99||
48617699|NCT03110133|101849627|FG001|COMPLETED|Week 24||95||
48617700|NCT03110133|101849626|FG000|NOT COMPLETED|Week 24||2||
48617701|NCT03110133|101849627|FG001|NOT COMPLETED|Week 24||1||
48617702|NCT03421379|101849628|FG000|STARTED|Period 1||34||
48617703|NCT03421379|101849629|FG001|STARTED|Period 1||41||
48617704|NCT03421379|101849628|FG000|Received at Least One Dose of Study Drug|Period 1||33||
48617705|NCT03421379|101849629|FG001|Received at Least One Dose of Study Drug|Period 1||39||
48617706|NCT03421379|101849628|FG000|COMPLETED|Period 1||32||
48162012|NCT00840801|100718868|FG000|COMPLETED|Part B:Day 28 Postdose2-Day 28 Postdose3||0||
48322982|NCT03505021|101118114|FG000|COMPLETED|Overall Study||217||
48617707|NCT03421379|101849629|FG001|COMPLETED|Period 1||37||
48617708|NCT03421379|101849628|FG000|NOT COMPLETED|Period 1||2||
48162013|NCT00840801|100718869|FG001|COMPLETED|Part B:Day 28 Postdose2-Day 28 Postdose3||0||
48162014|NCT00840801|100718870|FG002|COMPLETED|Part B:Day 28 Postdose2-Day 28 Postdose3||297||
48162015|NCT00840801|100718868|FG000|NOT COMPLETED|Part B:Day 28 Postdose2-Day 28 Postdose3||0||
48162016|NCT00840801|100718869|FG001|NOT COMPLETED|Part B:Day 28 Postdose2-Day 28 Postdose3||0||
48162017|NCT00840801|100718870|FG002|NOT COMPLETED|Part B:Day 28 Postdose2-Day 28 Postdose3||4||
48162018|NCT03315130|100718871|FG000|STARTED|Main Portion (12 Weeks)||15||
48617709|NCT03421379|101849629|FG001|NOT COMPLETED|Period 1||4||
48617710|NCT03421379|101849628|FG000|STARTED|Washout Period (3 to 14 Days)||32||
48617711|NCT03421379|101849629|FG001|STARTED|Washout Period (3 to 14 Days)||37||
48322983|NCT03505021|101118115|FG001|COMPLETED|Overall Study||112||
48617712|NCT03421379|101849628|FG000|COMPLETED|Washout Period (3 to 14 Days)||32||
48617713|NCT03421379|101849629|FG001|COMPLETED|Washout Period (3 to 14 Days)||37||
48617714|NCT03421379|101849628|FG000|NOT COMPLETED|Washout Period (3 to 14 Days)||0||
48617715|NCT03421379|101849629|FG001|NOT COMPLETED|Washout Period (3 to 14 Days)||0||
48617716|NCT03421379|101849628|FG000|STARTED|Period 2||32||
48617717|NCT03421379|101849629|FG001|STARTED|Period 2||37||
48322984|NCT03505021|101118114|FG000|NOT COMPLETED|Overall Study||112||
48322985|NCT03505021|101118115|FG001|NOT COMPLETED|Overall Study||55||
48322986|NCT03223428|101118116|FG000|STARTED|Overall Study||223||
48322987|NCT03223428|101118116|FG000|COMPLETED|Overall Study||125||
48617718|NCT03421379|101849628|FG000|COMPLETED|Period 2||32||
48617719|NCT03421379|101849629|FG001|COMPLETED|Period 2||37||
48617720|NCT03421379|101849628|FG000|NOT COMPLETED|Period 2||0||
48322988|NCT03223428|101118116|FG000|NOT COMPLETED|Overall Study||98||
48322989|NCT03287219|101118117|FG000|STARTED|Overall Study||24||
48322990|NCT03287219|101118118|FG001|STARTED|Overall Study||90||
48322991|NCT03287219|101118117|FG000|COMPLETED|Overall Study||24||
48322992|NCT03287219|101118118|FG001|COMPLETED|Overall Study||88||
48322993|NCT03287219|101118117|FG000|NOT COMPLETED|Overall Study||0||
48322994|NCT03287219|101118118|FG001|NOT COMPLETED|Overall Study||2||
48322995|NCT00094055|101118119|FG000|STARTED|Overall Study||60||
48322996|NCT00094055|101118119|FG000|COMPLETED|Overall Study||0||
48322997|NCT00094055|101118119|FG000|NOT COMPLETED|Overall Study||60||
48322998|NCT03430921|101118120|FG000|STARTED|Overall Study||4||
48322999|NCT03430921|101118120|FG000|COMPLETED|Overall Study||2||
48323000|NCT03430921|101118120|FG000|NOT COMPLETED|Overall Study||2||
48323001|NCT00931359|101118121|FG000|STARTED|Overall Study||39||
48323002|NCT00931359|101118122|FG001|STARTED|Overall Study||81||
48323003|NCT00931359|101118121|FG000|COMPLETED|Overall Study||33||
48323004|NCT00931359|101118122|FG001|COMPLETED|Overall Study||68||
48323005|NCT00931359|101118121|FG000|NOT COMPLETED|Overall Study||6||
48323006|NCT00931359|101118122|FG001|NOT COMPLETED|Overall Study||13||
48323007|NCT02562924|101118123|FG000|STARTED|Overall Study||13||
48323008|NCT02562924|101118124|FG001|STARTED|Overall Study||12||
48323009|NCT02562924|101118125|FG002|STARTED|Overall Study||12||
48323010|NCT02562924|101118123|FG000|COMPLETED|Overall Study||12||
48323011|NCT02562924|101118124|FG001|COMPLETED|Overall Study||1||
48323012|NCT02562924|101118125|FG002|COMPLETED|Overall Study||8||
48323013|NCT02562924|101118123|FG000|NOT COMPLETED|Overall Study||1||
48323014|NCT02562924|101118124|FG001|NOT COMPLETED|Overall Study||11||
48323015|NCT02562924|101118125|FG002|NOT COMPLETED|Overall Study||4||
48323016|NCT02788747|101118126|FG000|STARTED|Overall Study||23||
48323017|NCT02788747|101118127|FG001|STARTED|Overall Study||24||
48323018|NCT02788747|101118128|FG002|STARTED|Overall Study||24||
48323019|NCT02788747|101118126|FG000|COMPLETED|Overall Study||22||
48323020|NCT02788747|101118127|FG001|COMPLETED|Overall Study||24||
48323021|NCT02788747|101118128|FG002|COMPLETED|Overall Study||24||
48323022|NCT02788747|101118126|FG000|NOT COMPLETED|Overall Study||1||
48323023|NCT02788747|101118127|FG001|NOT COMPLETED|Overall Study||0||
48323024|NCT02788747|101118128|FG002|NOT COMPLETED|Overall Study||0||
48323025|NCT00754832|101118129|FG000|STARTED|First 6 Weeks Intervention||26||
48323026|NCT00754832|101118130|FG001|STARTED|First 6 Weeks Intervention||30||
48323027|NCT00754832|101118129|FG000|COMPLETED|First 6 Weeks Intervention||18||
48323028|NCT00754832|101118130|FG001|COMPLETED|First 6 Weeks Intervention||28||
48323029|NCT00754832|101118129|FG000|NOT COMPLETED|First 6 Weeks Intervention||8||
48323030|NCT00754832|101118130|FG001|NOT COMPLETED|First 6 Weeks Intervention||2||
48323031|NCT00754832|101118129|FG000|STARTED|2 Weeks Washout||18||
48323032|NCT00754832|101118130|FG001|STARTED|2 Weeks Washout||28||
48323033|NCT00754832|101118129|FG000|COMPLETED|2 Weeks Washout||17||
48323034|NCT00754832|101118130|FG001|COMPLETED|2 Weeks Washout||26||
48323035|NCT00754832|101118129|FG000|NOT COMPLETED|2 Weeks Washout||1||
48323036|NCT00754832|101118130|FG001|NOT COMPLETED|2 Weeks Washout||2||
48323037|NCT00754832|101118129|FG000|STARTED|Second 6 Weeks Intervention||17||
48323038|NCT00754832|101118130|FG001|STARTED|Second 6 Weeks Intervention||26||
48323039|NCT00754832|101118129|FG000|COMPLETED|Second 6 Weeks Intervention||17||
48323040|NCT00754832|101118130|FG001|COMPLETED|Second 6 Weeks Intervention||24||
48323041|NCT00754832|101118129|FG000|NOT COMPLETED|Second 6 Weeks Intervention||0||
48323042|NCT00754832|101118130|FG001|NOT COMPLETED|Second 6 Weeks Intervention||2||
48323043|NCT04818593|101118131|FG000|STARTED|Overall Study||54||231
48323044|NCT04818593|101118132|FG001|STARTED|Overall Study||54||225
48368061|NCT03691623|101230100|FG004|Inoculated With Challenge Virus|Overall Study||21||
48368062|NCT03691623|101230101|FG005|Inoculated With Challenge Virus|Overall Study||21||
48368063|NCT03691623|101230096|FG000|Received Treatment|Overall Study||38||
48368064|NCT03691623|101230097|FG001|Received Treatment|Overall Study||38||
48740936|NCT04034004|102151553|FG002|NOT COMPLETED|Overall Study||2||
48740937|NCT04034004|102151554|FG003|NOT COMPLETED|Overall Study||4||
48740938|NCT02586623|102151555|FG000|STARTED|Open-Label (Up to 16 Weeks)||453||
48740939|NCT02586623|102151556|FG001|STARTED|Open-Label (Up to 16 Weeks)||0||
48323045|NCT04818593|101118131|FG000|COMPLETED|Overall Study||34|Oocyte units were assigned to density gradient and/or ZyMot microfluidics insemination techniques depending on how they met study criteria. Sperm samples that were insufficient for ZyMot processing were not processed and the corresponding participant dyad was withdrawn from the study. The number of oocyte units that started the study for each arm is equal to the number completed, as the unit number (oocytes) is not known for the cycles that were withdrawn from the study and cannot be calculated.|231
48323046|NCT04818593|101118132|FG001|COMPLETED|Overall Study||34|Oocyte units were assigned to density gradient and/or ZyMot microfluidics insemination techniques depending on how they met study criteria. Sperm samples that were insufficient for ZyMot processing were not processed and the corresponding participant dyad was withdrawn from the study. The number of oocyte units that started the study for each arm is equal to the number completed, as the unit number (oocytes) is not known for the cycles that were withdrawn from the study and cannot be calculated.|225
48740940|NCT02586623|102151557|FG002|STARTED|Open-Label (Up to 16 Weeks)||0||
48740941|NCT02586623|102151555|FG000|Received at Least 1 Dose of Study Drug|Open-Label (Up to 16 Weeks)||451||
48740942|NCT02586623|102151556|FG001|Received at Least 1 Dose of Study Drug|Open-Label (Up to 16 Weeks)||0||
48740943|NCT02586623|102151557|FG002|Received at Least 1 Dose of Study Drug|Open-Label (Up to 16 Weeks)||0||
48740944|NCT02586623|102151555|FG000|Safety Set|Open-Label (Up to 16 Weeks)||451||
48740945|NCT02586623|102151556|FG001|Safety Set|Open-Label (Up to 16 Weeks)||0||
48740946|NCT02586623|102151557|FG002|Safety Set|Open-Label (Up to 16 Weeks)||0||
48740947|NCT02586623|102151555|FG000|COMPLETED|Open-Label (Up to 16 Weeks)||253||
48740948|NCT02586623|102151556|FG001|COMPLETED|Open-Label (Up to 16 Weeks)||0||
48740949|NCT02586623|102151557|FG002|COMPLETED|Open-Label (Up to 16 Weeks)||0||
48740950|NCT02586623|102151555|FG000|NOT COMPLETED|Open-Label (Up to 16 Weeks)||200||
48740951|NCT02586623|102151556|FG001|NOT COMPLETED|Open-Label (Up to 16 Weeks)||0||
48740952|NCT02586623|102151557|FG002|NOT COMPLETED|Open-Label (Up to 16 Weeks)||0||
48740953|NCT02586623|102151555|FG000|STARTED|Double-Blind (Up to 12 Weeks)||0||
48740954|NCT02586623|102151556|FG001|STARTED|Double-Blind (Up to 12 Weeks)||127||
48162019|NCT03315130|100718872|FG001|STARTED|Main Portion (12 Weeks)||15||
48323047|NCT04818593|101118131|FG000|NOT COMPLETED|Overall Study||20||0
48323048|NCT04818593|101118132|FG001|NOT COMPLETED|Overall Study||20||0
48617721|NCT03421379|101849629|FG001|NOT COMPLETED|Period 2||0||
48617722|NCT02750332|101849630|FG000|STARTED|Treatment Period 1||10||
48617723|NCT02750332|101849631|FG001|STARTED|Treatment Period 1||10||
48617724|NCT02750332|101849630|FG000|COMPLETED|Treatment Period 1||10||
48323049|NCT02788097|101118133|FG000|STARTED|Overall Study||61||
48323050|NCT02788097|101118134|FG001|STARTED|Overall Study||69||
48323051|NCT02788097|101118133|FG000|COMPLETED|Overall Study||61||
48323052|NCT02788097|101118134|FG001|COMPLETED|Overall Study||69||
48323053|NCT02788097|101118133|FG000|NOT COMPLETED|Overall Study||0||
48323054|NCT02788097|101118134|FG001|NOT COMPLETED|Overall Study||0||
48323055|NCT00513500|101118135|FG000|STARTED|Overall Study||1017||
48408359|NCT02996110|101331747|FG002|Re-Randomized From Track 2 Nivolumab + BMS986205|Track 2||0||
48617725|NCT02750332|101849631|FG001|COMPLETED|Treatment Period 1||9||
48617726|NCT02750332|101849630|FG000|NOT COMPLETED|Treatment Period 1||0||
48617727|NCT02750332|101849631|FG001|NOT COMPLETED|Treatment Period 1||1||
48323056|NCT00513500|101118136|FG001|STARTED|Overall Study||2108||
48323057|NCT00513500|101118135|FG000|COMPLETED|Overall Study||976||
48323058|NCT00513500|101118136|FG001|COMPLETED|Overall Study||2054||
48323059|NCT00513500|101118135|FG000|NOT COMPLETED|Overall Study||41||
48323060|NCT00513500|101118136|FG001|NOT COMPLETED|Overall Study||54||
48162020|NCT03315130|100718873|FG002|STARTED|Main Portion (12 Weeks)||15||
48740955|NCT02586623|102151557|FG002|STARTED|Double-Blind (Up to 12 Weeks)||126||
48740956|NCT02586623|102151555|FG000|Received at Least 1 Dose of Study Drug|Double-Blind (Up to 12 Weeks)||0||
48740957|NCT02586623|102151556|FG001|Received at Least 1 Dose of Study Drug|Double-Blind (Up to 12 Weeks)||126||
48740958|NCT02586623|102151557|FG002|Received at Least 1 Dose of Study Drug|Double-Blind (Up to 12 Weeks)||126||
48740959|NCT02586623|102151555|FG000|Full Analysis Set (FAS)|Double-Blind (Up to 12 Weeks)||0||
48740960|NCT02586623|102151556|FG001|Full Analysis Set (FAS)|Double-Blind (Up to 12 Weeks)||126||
48740961|NCT02586623|102151557|FG002|Full Analysis Set (FAS)|Double-Blind (Up to 12 Weeks)||126||
48740962|NCT02586623|102151555|FG000|COMPLETED|Double-Blind (Up to 12 Weeks)||0||
48740963|NCT02586623|102151556|FG001|COMPLETED|Double-Blind (Up to 12 Weeks)||78||
48740964|NCT02586623|102151557|FG002|COMPLETED|Double-Blind (Up to 12 Weeks)||86||
48740965|NCT02586623|102151555|FG000|NOT COMPLETED|Double-Blind (Up to 12 Weeks)||0||
48740966|NCT02586623|102151556|FG001|NOT COMPLETED|Double-Blind (Up to 12 Weeks)||49||
48740967|NCT02586623|102151557|FG002|NOT COMPLETED|Double-Blind (Up to 12 Weeks)||40||
48740968|NCT04531241|102151558|FG000|STARTED|Period 1||68||
48740969|NCT04531241|102151559|FG001|STARTED|Period 1||67||
48740970|NCT04531241|102151558|FG000|COMPLETED|Period 1||64||
48740971|NCT04531241|102151559|FG001|COMPLETED|Period 1||65||
48740972|NCT04531241|102151558|FG000|NOT COMPLETED|Period 1||4||
48740973|NCT04531241|102151559|FG001|NOT COMPLETED|Period 1||2||
48740974|NCT04531241|102151558|FG000|STARTED|Period 2||64||
48740975|NCT04531241|102151559|FG001|STARTED|Period 2||65||
48740976|NCT04531241|102151558|FG000|COMPLETED|Period 2||63||
48740977|NCT04531241|102151559|FG001|COMPLETED|Period 2||64||
48740978|NCT04531241|102151558|FG000|NOT COMPLETED|Period 2||1||
48740979|NCT04531241|102151559|FG001|NOT COMPLETED|Period 2||1||
48740980|NCT01979952|102151560|FG000|STARTED|Overall Study||56||
48740981|NCT01979952|102151561|FG001|STARTED|Overall Study||57||
48740982|NCT01979952|102151560|FG000|COMPLETED|Overall Study||48||
48740983|NCT01979952|102151561|FG001|COMPLETED|Overall Study||51||
48740984|NCT01979952|102151560|FG000|NOT COMPLETED|Overall Study||8||
48740985|NCT01979952|102151561|FG001|NOT COMPLETED|Overall Study||6||
48162021|NCT03315130|100718874|FG003|STARTED|Main Portion (12 Weeks)||0||
48162022|NCT03315130|100718871|FG000|COMPLETED|Main Portion (12 Weeks)||15||
48740986|NCT02134717|102151562|FG000|STARTED|Overall Study||3||
48740987|NCT02134717|102151562|FG000|COMPLETED|Overall Study||3||
48740988|NCT02134717|102151562|FG000|NOT COMPLETED|Overall Study||0||
48740989|NCT00891228|102151563|FG000|STARTED|Overall Study||32||
48740990|NCT00891228|102151564|FG001|STARTED|Overall Study||33||
48740991|NCT00891228|102151565|FG002|STARTED|Overall Study||34||
48740992|NCT00891228|102151563|FG000|COMPLETED|Overall Study||21||
48740993|NCT00891228|102151564|FG001|COMPLETED|Overall Study||20||
48740994|NCT00891228|102151565|FG002|COMPLETED|Overall Study||19||
48740995|NCT00891228|102151563|FG000|NOT COMPLETED|Overall Study||11||
48617728|NCT02750332|101849630|FG000|STARTED|Treatment Period 2||10||
48617729|NCT02750332|101849631|FG001|STARTED|Treatment Period 2||9||
48617730|NCT02750332|101849630|FG000|COMPLETED|Treatment Period 2||10||
48617731|NCT02750332|101849631|FG001|COMPLETED|Treatment Period 2||9||
48617732|NCT02750332|101849630|FG000|NOT COMPLETED|Treatment Period 2||0||
48617733|NCT02750332|101849631|FG001|NOT COMPLETED|Treatment Period 2||0||
48617734|NCT05057221|101849632|FG000|STARTED|Overall Study||6||
48617735|NCT05057221|101849632|FG000|COMPLETED|Overall Study||6||
48617736|NCT05057221|101849632|FG000|NOT COMPLETED|Overall Study||0||
48617737|NCT00828113|101849633|FG000|STARTED|Overall Study||50||
48617738|NCT00828113|101849634|FG001|STARTED|Overall Study||51||
48617739|NCT00828113|101849633|FG000|COMPLETED|Overall Study||20||
48617740|NCT00828113|101849634|FG001|COMPLETED|Overall Study||20||
48617741|NCT00828113|101849633|FG000|NOT COMPLETED|Overall Study||30||
48617742|NCT00828113|101849634|FG001|NOT COMPLETED|Overall Study||31||
48617743|NCT02895347|101849635|FG000|STARTED|Overall Study||20||
48617744|NCT02895347|101849636|FG001|STARTED|Overall Study||20||
48162023|NCT03315130|100718872|FG001|COMPLETED|Main Portion (12 Weeks)||13||
48162024|NCT03315130|100718873|FG002|COMPLETED|Main Portion (12 Weeks)||15||
48162025|NCT03315130|100718874|FG003|COMPLETED|Main Portion (12 Weeks)||0||
48162026|NCT03315130|100718871|FG000|NOT COMPLETED|Main Portion (12 Weeks)||0||
48617745|NCT02895347|101849635|FG000|COMPLETED|Overall Study||17||
48617746|NCT02895347|101849636|FG001|COMPLETED|Overall Study||19||
48617747|NCT02895347|101849635|FG000|NOT COMPLETED|Overall Study||3||
48617748|NCT02895347|101849636|FG001|NOT COMPLETED|Overall Study||1||
48617749|NCT00953290|101849637|FG000|STARTED|Overall Study||4||
48408360|NCT02996110|101331748|FG003|Re-Randomized From Track 2 Nivolumab + BMS986205|Track 2||1||
48323061|NCT00996944|101118137|FG000|STARTED|Double-blind Treatment Period||22||
48323062|NCT00996944|101118138|FG001|STARTED|Double-blind Treatment Period||12||
48323063|NCT00996944|101118137|FG000|COMPLETED|Double-blind Treatment Period||12||
48323064|NCT00996944|101118138|FG001|COMPLETED|Double-blind Treatment Period||5||
48323065|NCT00996944|101118137|FG000|NOT COMPLETED|Double-blind Treatment Period||10||
48323066|NCT00996944|101118138|FG001|NOT COMPLETED|Double-blind Treatment Period||7||
48323067|NCT00996944|101118137|FG000|STARTED|Long-term Treatment Period||12||
48323068|NCT00996944|101118138|FG001|STARTED|Long-term Treatment Period||5||
48323069|NCT00996944|101118137|FG000|COMPLETED|Long-term Treatment Period||0||
48323070|NCT00996944|101118138|FG001|COMPLETED|Long-term Treatment Period||0||
48323071|NCT00996944|101118137|FG000|NOT COMPLETED|Long-term Treatment Period||12||
48323072|NCT00996944|101118138|FG001|NOT COMPLETED|Long-term Treatment Period||5||
48323073|NCT00183274|101118139|FG000|STARTED|Phase 1: Open-Label||268||
48323074|NCT00183274|101118140|FG001|STARTED|Phase 1: Open-Label||0||
48323075|NCT00183274|101118141|FG002|STARTED|Phase 1: Open-Label||0||
48323076|NCT00183274|101118142|FG003|STARTED|Phase 1: Open-Label||0||
48323077|NCT00183274|101118143|FG004|STARTED|Phase 1: Open-Label||0||
48323078|NCT00183274|101118144|FG005|STARTED|Phase 1: Open-Label||0||
48323079|NCT00183274|101118139|FG000|COMPLETED|Phase 1: Open-Label||158||
48323080|NCT00183274|101118140|FG001|COMPLETED|Phase 1: Open-Label||0||
48323081|NCT00183274|101118141|FG002|COMPLETED|Phase 1: Open-Label||0||
48323082|NCT00183274|101118142|FG003|COMPLETED|Phase 1: Open-Label||0||
48323083|NCT00183274|101118143|FG004|COMPLETED|Phase 1: Open-Label||0||
48323084|NCT00183274|101118144|FG005|COMPLETED|Phase 1: Open-Label||0||
48323085|NCT00183274|101118139|FG000|NOT COMPLETED|Phase 1: Open-Label||110||
48323086|NCT00183274|101118140|FG001|NOT COMPLETED|Phase 1: Open-Label||0||
48323087|NCT00183274|101118141|FG002|NOT COMPLETED|Phase 1: Open-Label||0||
48323088|NCT00183274|101118142|FG003|NOT COMPLETED|Phase 1: Open-Label||0||
48323089|NCT00183274|101118143|FG004|NOT COMPLETED|Phase 1: Open-Label||0||
48323090|NCT00183274|101118144|FG005|NOT COMPLETED|Phase 1: Open-Label||0||
48408361|NCT02996110|101331749|FG004|Re-Randomized From Track 2 Nivolumab + BMS986205|Track 2||2||
48408362|NCT02996110|101331745|FG000|Previously Un-Treated But Re-Randomized|Track 2||0||
48408363|NCT02996110|101331746|FG001|Previously Un-Treated But Re-Randomized|Track 2||0||
48408364|NCT02996110|101331747|FG002|Previously Un-Treated But Re-Randomized|Track 2||0||
48408365|NCT02996110|101331748|FG003|Previously Un-Treated But Re-Randomized|Track 2||1||
48408366|NCT02996110|101331749|FG004|Previously Un-Treated But Re-Randomized|Track 2||0||
48408367|NCT02996110|101331745|FG000|Re-Randomized From Track 2 Nivolumab + Ipilimumab|Track 2||0||
48408368|NCT02996110|101331746|FG001|Re-Randomized From Track 2 Nivolumab + Ipilimumab|Track 2||2||
48408369|NCT02996110|101331747|FG002|Re-Randomized From Track 2 Nivolumab + Ipilimumab|Track 2||1||
48408370|NCT02996110|101331748|FG003|Re-Randomized From Track 2 Nivolumab + Ipilimumab|Track 2||0||
48408371|NCT02996110|101331749|FG004|Re-Randomized From Track 2 Nivolumab + Ipilimumab|Track 2||2||
48408372|NCT02996110|101331745|FG000|COMPLETED|Track 2||4||
48408373|NCT02996110|101331746|FG001|COMPLETED|Track 2||3||
48408374|NCT02996110|101331747|FG002|COMPLETED|Track 2||1||
48408375|NCT02996110|101331748|FG003|COMPLETED|Track 2||1||
48408376|NCT02996110|101331749|FG004|COMPLETED|Track 2||1||
48408377|NCT02996110|101331745|FG000|NOT COMPLETED|Track 2||42||
48408378|NCT02996110|101331746|FG001|NOT COMPLETED|Track 2||29||
48408379|NCT02996110|101331747|FG002|NOT COMPLETED|Track 2||30||
48408380|NCT02996110|101331748|FG003|NOT COMPLETED|Track 2||20||
48408381|NCT02996110|101331749|FG004|NOT COMPLETED|Track 2||21||
48408382|NCT00712270|101331750|FG000|STARTED|Overall Study||21|Unknown - study was terminated back in 2009 with limited data available. Randomization is not known|
48408383|NCT00712270|101331750|FG000|COMPLETED|Overall Study||7|Unknown - study was terminated back in 2009 with limited data available. Randomization is not known|
48740996|NCT00891228|102151564|FG001|NOT COMPLETED|Overall Study||13||
48740997|NCT00891228|102151565|FG002|NOT COMPLETED|Overall Study||15||
48740998|NCT01388907|102151566|FG000|STARTED|Overall Study||33||
48740999|NCT01388907|102151567|FG001|STARTED|Overall Study||28||
48741000|NCT01388907|102151566|FG000|COMPLETED|Overall Study||31||
48408384|NCT00712270|101331750|FG000|NOT COMPLETED|Overall Study||14||
48408385|NCT02076243|101331751|FG000|STARTED|Overall Study||2||
48741001|NCT01388907|102151567|FG001|COMPLETED|Overall Study||28||
48741002|NCT01388907|102151566|FG000|NOT COMPLETED|Overall Study||2||
48741003|NCT01388907|102151567|FG001|NOT COMPLETED|Overall Study||0||
48323091|NCT00183274|101118139|FG000|STARTED|Phase 2: Double-Blind||0||
48323092|NCT00183274|101118140|FG001|STARTED|Phase 2: Double-Blind||82||
48323093|NCT00183274|101118141|FG002|STARTED|Phase 2: Double-Blind||54||
48323094|NCT00183274|101118142|FG003|STARTED|Phase 2: Double-Blind||0||
48323095|NCT00183274|101118143|FG004|STARTED|Phase 2: Double-Blind||0||
48323096|NCT00183274|101118144|FG005|STARTED|Phase 2: Double-Blind||0||
48323097|NCT00183274|101118139|FG000|COMPLETED|Phase 2: Double-Blind||0||
48323098|NCT00183274|101118140|FG001|COMPLETED|Phase 2: Double-Blind||56||
48323099|NCT00183274|101118141|FG002|COMPLETED|Phase 2: Double-Blind||11||
48408386|NCT02076243|101331751|FG000|COMPLETED|Overall Study||0||
48408387|NCT02076243|101331751|FG000|NOT COMPLETED|Overall Study||2||
48741004|NCT05431478|102151568|FG000|STARTED|Period 1, Approximately 14 Days||34||68
48408388|NCT00505518|101331752|FG000|STARTED|Overall Study||9||
48162027|NCT03315130|100718872|FG001|NOT COMPLETED|Main Portion (12 Weeks)||2||
48162028|NCT03315130|100718873|FG002|NOT COMPLETED|Main Portion (12 Weeks)||0||
48162029|NCT03315130|100718874|FG003|NOT COMPLETED|Main Portion (12 Weeks)||0||
48162030|NCT03315130|100718871|FG000|STARTED|EP:Before Switch to 0.3 mg/kg(Week13-48)||22||
48162031|NCT03315130|100718872|FG001|STARTED|EP:Before Switch to 0.3 mg/kg(Week13-48)||21||
48162032|NCT03315130|100718873|FG002|STARTED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0||
48162033|NCT03315130|100718874|FG003|STARTED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0||
48162034|NCT03315130|100718871|FG000|COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||21||
48162035|NCT03315130|100718872|FG001|COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||21||
48323100|NCT00183274|101118142|FG003|COMPLETED|Phase 2: Double-Blind||0||
48323101|NCT00183274|101118143|FG004|COMPLETED|Phase 2: Double-Blind||0||
48323102|NCT00183274|101118144|FG005|COMPLETED|Phase 2: Double-Blind||0||
48323103|NCT00183274|101118139|FG000|NOT COMPLETED|Phase 2: Double-Blind||0||
48323104|NCT00183274|101118140|FG001|NOT COMPLETED|Phase 2: Double-Blind||26||
48188753|NCT01902901|100783328|FG000|COMPLETED|Overall Study||180||
48323105|NCT00183274|101118141|FG002|NOT COMPLETED|Phase 2: Double-Blind||43||
48323106|NCT00183274|101118142|FG003|NOT COMPLETED|Phase 2: Double-Blind||0||
48323107|NCT00183274|101118143|FG004|NOT COMPLETED|Phase 2: Double-Blind||0||
48323108|NCT00183274|101118144|FG005|NOT COMPLETED|Phase 2: Double-Blind||0||
48323109|NCT00183274|101118139|FG000|STARTED|Phase 3: Double-Blind||0||
48323110|NCT00183274|101118140|FG001|STARTED|Phase 3: Double-Blind||0||
48323111|NCT00183274|101118141|FG002|STARTED|Phase 3: Double-Blind||0||
48323112|NCT00183274|101118142|FG003|STARTED|Phase 3: Double-Blind||15||
48323113|NCT00183274|101118143|FG004|STARTED|Phase 3: Double-Blind||34||
48323114|NCT00183274|101118144|FG005|STARTED|Phase 3: Double-Blind||10||
48323115|NCT00183274|101118139|FG000|COMPLETED|Phase 3: Double-Blind||0||
48323116|NCT00183274|101118140|FG001|COMPLETED|Phase 3: Double-Blind||0||
48323117|NCT00183274|101118141|FG002|COMPLETED|Phase 3: Double-Blind||0||
48323118|NCT00183274|101118142|FG003|COMPLETED|Phase 3: Double-Blind||13||
48323119|NCT00183274|101118143|FG004|COMPLETED|Phase 3: Double-Blind||14||
48323120|NCT00183274|101118144|FG005|COMPLETED|Phase 3: Double-Blind||6||
48323121|NCT00183274|101118139|FG000|NOT COMPLETED|Phase 3: Double-Blind||0||
48323122|NCT00183274|101118140|FG001|NOT COMPLETED|Phase 3: Double-Blind||0||
48323123|NCT00183274|101118141|FG002|NOT COMPLETED|Phase 3: Double-Blind||0||
48323124|NCT00183274|101118142|FG003|NOT COMPLETED|Phase 3: Double-Blind||2||
48323125|NCT00183274|101118143|FG004|NOT COMPLETED|Phase 3: Double-Blind||20||
48323126|NCT00183274|101118144|FG005|NOT COMPLETED|Phase 3: Double-Blind||4||
48323127|NCT02595723|101118145|FG000|STARTED|First Intervention (4 Days)||8||
48323128|NCT02595723|101118146|FG001|STARTED|First Intervention (4 Days)||6||
48323129|NCT02595723|101118147|FG002|STARTED|First Intervention (4 Days)||7||
48323130|NCT02595723|101118145|FG000|COMPLETED|First Intervention (4 Days)||8||
48323131|NCT02595723|101118146|FG001|COMPLETED|First Intervention (4 Days)||6||
48323132|NCT02595723|101118147|FG002|COMPLETED|First Intervention (4 Days)||7||
48323133|NCT02595723|101118145|FG000|NOT COMPLETED|First Intervention (4 Days)||0||
48323134|NCT02595723|101118146|FG001|NOT COMPLETED|First Intervention (4 Days)||0||
48323135|NCT02595723|101118147|FG002|NOT COMPLETED|First Intervention (4 Days)||0||
48323136|NCT02595723|101118145|FG000|STARTED|First Washout (21 Days)||8||
48323137|NCT02595723|101118146|FG001|STARTED|First Washout (21 Days)||6||
48323138|NCT02595723|101118147|FG002|STARTED|First Washout (21 Days)||7||
48323139|NCT02595723|101118145|FG000|COMPLETED|First Washout (21 Days)||6||
48323140|NCT02595723|101118146|FG001|COMPLETED|First Washout (21 Days)||6||
48323141|NCT02595723|101118147|FG002|COMPLETED|First Washout (21 Days)||7||
48323142|NCT02595723|101118145|FG000|NOT COMPLETED|First Washout (21 Days)||2||
48323143|NCT02595723|101118146|FG001|NOT COMPLETED|First Washout (21 Days)||0||
48741005|NCT05431478|102151569|FG001|STARTED|Period 1, Approximately 14 Days||34||68
48741006|NCT05431478|102151568|FG000|COMPLETED|Period 1, Approximately 14 Days||34||68
48741007|NCT05431478|102151569|FG001|COMPLETED|Period 1, Approximately 14 Days||34||68
48741008|NCT05431478|102151568|FG000|NOT COMPLETED|Period 1, Approximately 14 Days||0||0
48741009|NCT05431478|102151569|FG001|NOT COMPLETED|Period 1, Approximately 14 Days||0||0
48741010|NCT05431478|102151568|FG000|STARTED|Period 2, Approximately 14 Days||34||68
48741011|NCT05431478|102151569|FG001|STARTED|Period 2, Approximately 14 Days||34||68
48741012|NCT05431478|102151568|FG000|COMPLETED|Period 2, Approximately 14 Days||34||68
48741013|NCT05431478|102151569|FG001|COMPLETED|Period 2, Approximately 14 Days||34||68
48408389|NCT00505518|101331752|FG000|COMPLETED|Overall Study||9||
48408390|NCT00505518|101331752|FG000|NOT COMPLETED|Overall Study||0||
48323144|NCT02595723|101118147|FG002|NOT COMPLETED|First Washout (21 Days)||0||
48323145|NCT02595723|101118145|FG000|STARTED|Second Intervention (4 Days)||6||
48323146|NCT02595723|101118146|FG001|STARTED|Second Intervention (4 Days)||6||
48323147|NCT02595723|101118147|FG002|STARTED|Second Intervention (4 Days)||7||
48323148|NCT02595723|101118145|FG000|COMPLETED|Second Intervention (4 Days)||6||
48323149|NCT02595723|101118146|FG001|COMPLETED|Second Intervention (4 Days)||6||
48323150|NCT02595723|101118147|FG002|COMPLETED|Second Intervention (4 Days)||7||
48323151|NCT02595723|101118145|FG000|NOT COMPLETED|Second Intervention (4 Days)||0||
48323152|NCT02595723|101118146|FG001|NOT COMPLETED|Second Intervention (4 Days)||0||
48408391|NCT01501162|101331753|FG000|STARTED|Overall Study||65||
48741014|NCT05431478|102151568|FG000|NOT COMPLETED|Period 2, Approximately 14 Days||0||0
48323153|NCT02595723|101118147|FG002|NOT COMPLETED|Second Intervention (4 Days)||0||
48323154|NCT02595723|101118145|FG000|STARTED|Second Washout (21 Days)||6||
48323155|NCT02595723|101118146|FG001|STARTED|Second Washout (21 Days)||6||
48323156|NCT02595723|101118147|FG002|STARTED|Second Washout (21 Days)||7||
48323157|NCT02595723|101118145|FG000|COMPLETED|Second Washout (21 Days)||6||
48323158|NCT02595723|101118146|FG001|COMPLETED|Second Washout (21 Days)||5||
48408392|NCT01501162|101331754|FG001|STARTED|Overall Study||65||
48408393|NCT01501162|101331753|FG000|COMPLETED|Overall Study||57||
48741015|NCT05431478|102151569|FG001|NOT COMPLETED|Period 2, Approximately 14 Days||0||0
48741016|NCT03054649|102151570|FG000|STARTED|Overall Study||27||27
48741017|NCT03054649|102151571|FG001|STARTED|Overall Study||27||26
48741018|NCT03054649|102151570|FG000|COMPLETED|Overall Study||27||27
48617750|NCT00953290|101849637|FG000|COMPLETED|Overall Study||4||
48617751|NCT00953290|101849637|FG000|NOT COMPLETED|Overall Study||0||
48617752|NCT04010461|101849638|FG000|STARTED|Overall Study||53||
48617753|NCT04010461|101849638|FG000|Participants Who Had Baseline Measurements|Overall Study||47||
48162036|NCT03315130|100718873|FG002|COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0||
48162037|NCT03315130|100718874|FG003|COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0||
48162038|NCT03315130|100718871|FG000|NOT COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||1||
48162039|NCT03315130|100718872|FG001|NOT COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0||
48162040|NCT03315130|100718873|FG002|NOT COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0||
48162041|NCT03315130|100718874|FG003|NOT COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0||
48162042|NCT03315130|100718871|FG000|STARTED|EP:After Switch to 0.3 mg/kg(Week48-122)||0||
48162043|NCT03315130|100718872|FG001|STARTED|EP:After Switch to 0.3 mg/kg(Week48-122)||21||
48162044|NCT03315130|100718873|FG002|STARTED|EP:After Switch to 0.3 mg/kg(Week48-122)||0||
48162045|NCT03315130|100718874|FG003|STARTED|EP:After Switch to 0.3 mg/kg(Week48-122)||21||
48323159|NCT02595723|101118147|FG002|COMPLETED|Second Washout (21 Days)||7||
48323160|NCT02595723|101118145|FG000|NOT COMPLETED|Second Washout (21 Days)||0||
48323161|NCT02595723|101118146|FG001|NOT COMPLETED|Second Washout (21 Days)||1||
48323162|NCT02595723|101118147|FG002|NOT COMPLETED|Second Washout (21 Days)||0||
48323163|NCT02595723|101118145|FG000|STARTED|Third Intervention (4 Days)||6||
48323164|NCT02595723|101118146|FG001|STARTED|Third Intervention (4 Days)||5||
48323165|NCT02595723|101118147|FG002|STARTED|Third Intervention (4 Days)||7||
48323166|NCT02595723|101118145|FG000|COMPLETED|Third Intervention (4 Days)||6||
48323167|NCT02595723|101118146|FG001|COMPLETED|Third Intervention (4 Days)||5||
48408394|NCT01501162|101331754|FG001|COMPLETED|Overall Study||60||
48408395|NCT01501162|101331753|FG000|NOT COMPLETED|Overall Study||8||
48617754|NCT04010461|101849638|FG000|TMS to dlPFC, Without a Concurrent Task (Passive)|Overall Study||41||
48617755|NCT04010461|101849638|FG000|TMS to Vertex, Without Concurrent Task (Control)|Overall Study||43||
48617756|NCT04010461|101849638|FG000|TMS to dlPFC, During Task (Active)|Overall Study||40||
48617757|NCT04010461|101849638|FG000|Completed MRI Sessions|Overall Study||40||
48323168|NCT02595723|101118147|FG002|COMPLETED|Third Intervention (4 Days)||7||
48323169|NCT02595723|101118145|FG000|NOT COMPLETED|Third Intervention (4 Days)||0||
48323170|NCT02595723|101118146|FG001|NOT COMPLETED|Third Intervention (4 Days)||0||
48408396|NCT01501162|101331754|FG001|NOT COMPLETED|Overall Study||5||
48408397|NCT00424840|101331755|FG000|STARTED|Overall Study||3||
48408398|NCT00424840|101331756|FG001|STARTED|Overall Study||4||
48408399|NCT00424840|101331757|FG002|STARTED|Overall Study||5||
48408400|NCT00424840|101331755|FG000|COMPLETED|Overall Study||3||
48408401|NCT00424840|101331756|FG001|COMPLETED|Overall Study||4||
48617758|NCT04010461|101849638|FG000|COMPLETED|Overall Study||40||
48617759|NCT04010461|101849638|FG000|NOT COMPLETED|Overall Study||13||
48617760|NCT00424593|101849639|FG000|STARTED|Acute Double-Blind Period||115||
48617761|NCT00424593|101849640|FG001|STARTED|Acute Double-Blind Period||121||
48617762|NCT00424593|101849639|FG000|COMPLETED|Acute Double-Blind Period||84||
48323171|NCT02595723|101118147|FG002|NOT COMPLETED|Third Intervention (4 Days)||0||
48323172|NCT02821715|101118148|FG000|STARTED|Overall Study||8||
48323173|NCT02821715|101118149|FG001|STARTED|Overall Study||8||
48323174|NCT02821715|101118150|FG002|STARTED|Overall Study||8||
48408402|NCT00424840|101331757|FG002|COMPLETED|Overall Study||5||
48408403|NCT00424840|101331755|FG000|NOT COMPLETED|Overall Study||0||
48408404|NCT00424840|101331756|FG001|NOT COMPLETED|Overall Study||0||
48408405|NCT00424840|101331757|FG002|NOT COMPLETED|Overall Study||0||
48408406|NCT00102804|101331758|FG000|STARTED|Overall Study||441||
48408407|NCT00102804|101331759|FG001|STARTED|Overall Study||222||
48323175|NCT02821715|101118151|FG003|STARTED|Overall Study||9||
48323176|NCT02821715|101118152|FG004|STARTED|Overall Study||6||
48323177|NCT02821715|101118153|FG005|STARTED|Overall Study||9||
48323178|NCT02821715|101118148|FG000|COMPLETED|Overall Study||7||
48323179|NCT02821715|101118149|FG001|COMPLETED|Overall Study||8||
48323180|NCT02821715|101118150|FG002|COMPLETED|Overall Study||8||
48323181|NCT02821715|101118151|FG003|COMPLETED|Overall Study||9||
48323182|NCT02821715|101118152|FG004|COMPLETED|Overall Study||6||
48323183|NCT02821715|101118153|FG005|COMPLETED|Overall Study||9||
48323184|NCT02821715|101118148|FG000|NOT COMPLETED|Overall Study||1||
48323185|NCT02821715|101118149|FG001|NOT COMPLETED|Overall Study||0||
48323186|NCT02821715|101118150|FG002|NOT COMPLETED|Overall Study||0||
48323187|NCT02821715|101118151|FG003|NOT COMPLETED|Overall Study||0||
48323188|NCT02821715|101118152|FG004|NOT COMPLETED|Overall Study||0||
48323189|NCT02821715|101118153|FG005|NOT COMPLETED|Overall Study||0||
48323190|NCT03655756|101118154|FG000|STARTED|Overall Study||7||
48323191|NCT03655756|101118154|FG000|COMPLETED|Overall Study||6||
48323192|NCT03655756|101118154|FG000|NOT COMPLETED|Overall Study||1||
48323193|NCT01732809|101118155|FG000|STARTED|Overall Study||9||18
48323194|NCT01732809|101118156|FG001|STARTED|Overall Study||10||20
48323195|NCT01732809|101118155|FG000|COMPLETED|Overall Study||9||18
48323196|NCT01732809|101118156|FG001|COMPLETED|Overall Study||9||18
48323197|NCT01732809|101118155|FG000|NOT COMPLETED|Overall Study||0||0
48408408|NCT00102804|101331758|FG000|Received at Least 1 Dose of Study Drug|Overall Study||434||
48408409|NCT00102804|101331759|FG001|Received at Least 1 Dose of Study Drug|Overall Study||222||
48408410|NCT00102804|101331758|FG000|COMPLETED|Overall Study||0||
48408411|NCT00102804|101331759|FG001|COMPLETED|Overall Study||0||
48617763|NCT00424593|101849640|FG001|COMPLETED|Acute Double-Blind Period||98||
48617764|NCT00424593|101849639|FG000|NOT COMPLETED|Acute Double-Blind Period||31||
48617765|NCT00424593|101849640|FG001|NOT COMPLETED|Acute Double-Blind Period||23||
48617766|NCT00424593|101849639|FG000|STARTED|Dose-Blind Extension Period||181||
48617767|NCT00424593|101849640|FG001|STARTED|Dose-Blind Extension Period||0||
48617768|NCT00424593|101849639|FG000|COMPLETED|Dose-Blind Extension Period||117||
48617769|NCT00424593|101849640|FG001|COMPLETED|Dose-Blind Extension Period||0||
48617770|NCT00424593|101849639|FG000|NOT COMPLETED|Dose-Blind Extension Period||64||
48617771|NCT00424593|101849640|FG001|NOT COMPLETED|Dose-Blind Extension Period||0||
48617772|NCT01909804|101849641|FG000|STARTED|Overall Study||26||
48617773|NCT01909804|101849642|FG001|STARTED|Overall Study||28||
48617774|NCT01909804|101849643|FG002|STARTED|Overall Study||27||
48617775|NCT01909804|101849644|FG003|STARTED|Overall Study||26||
48617776|NCT01909804|101849645|FG004|STARTED|Overall Study||26||
48617777|NCT01909804|101849646|FG005|STARTED|Overall Study||25||
48323198|NCT01732809|101118156|FG001|NOT COMPLETED|Overall Study||1||2
48323199|NCT04075721|101118157|FG000|STARTED|Overall Study||2||
48323200|NCT04075721|101118158|FG001|STARTED|Overall Study||4||
48323201|NCT04075721|101118159|FG002|STARTED|Overall Study||4||
48323202|NCT04075721|101118157|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||2||
48323203|NCT04075721|101118158|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||5||
48323204|NCT04075721|101118159|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||3||
48323205|NCT04075721|101118157|FG000|Pharmacodynamics (Pd) Analysis Set|Overall Study||2||
48323206|NCT04075721|101118158|FG001|Pharmacodynamics (Pd) Analysis Set|Overall Study||5||
48323207|NCT04075721|101118159|FG002|Pharmacodynamics (Pd) Analysis Set|Overall Study||3||
48323208|NCT04075721|101118157|FG000|COMPLETED|Overall Study||2||
48323209|NCT04075721|101118158|FG001|COMPLETED|Overall Study||4||
48323210|NCT04075721|101118159|FG002|COMPLETED|Overall Study||4||
48408412|NCT00102804|101331758|FG000|NOT COMPLETED|Overall Study||441||
48408413|NCT00102804|101331759|FG001|NOT COMPLETED|Overall Study||222||
48408414|NCT01432938|101331760|FG000|STARTED|First Intervention||14||
48617778|NCT01909804|101849647|FG006|STARTED|Overall Study||27||
48617779|NCT01909804|101849648|FG007|STARTED|Overall Study||26||
48617780|NCT01909804|101849649|FG008|STARTED|Overall Study||27||
48741019|NCT03054649|102151571|FG001|COMPLETED|Overall Study||27||26
48741020|NCT03054649|102151570|FG000|NOT COMPLETED|Overall Study||0||0
48741021|NCT03054649|102151571|FG001|NOT COMPLETED|Overall Study||0||0
48741022|NCT02837029|102151572|FG000|STARTED|Screening||15||
48741023|NCT02837029|102151573|FG001|STARTED|Screening||12||
48323211|NCT04075721|101118157|FG000|NOT COMPLETED|Overall Study||0||
48323212|NCT04075721|101118158|FG001|NOT COMPLETED|Overall Study||0||
48323213|NCT04075721|101118159|FG002|NOT COMPLETED|Overall Study||0||
48323214|NCT01066364|101118160|FG000|STARTED|Overall Study||25||
48323215|NCT01066364|101118161|FG001|STARTED|Overall Study||25||
48323216|NCT01066364|101118160|FG000|COMPLETED|Overall Study||22||
48323217|NCT01066364|101118161|FG001|COMPLETED|Overall Study||23||
48323218|NCT01066364|101118160|FG000|NOT COMPLETED|Overall Study||3||
48323219|NCT01066364|101118161|FG001|NOT COMPLETED|Overall Study||2||
48323220|NCT03001674|101118162|FG000|STARTED|Overall Study||10||
48323221|NCT03001674|101118163|FG001|STARTED|Overall Study||5||
48323222|NCT03001674|101118162|FG000|COMPLETED|Overall Study||10||
48323223|NCT03001674|101118163|FG001|COMPLETED|Overall Study||5||
48323224|NCT03001674|101118162|FG000|NOT COMPLETED|Overall Study||0||
48323225|NCT03001674|101118163|FG001|NOT COMPLETED|Overall Study||0||
48323226|NCT00940589|101118164|FG000|STARTED|Overall Study||39||
48323227|NCT00940589|101118165|FG001|STARTED|Overall Study||34||
48323228|NCT00940589|101118164|FG000|COMPLETED|Overall Study||31||
48323229|NCT00940589|101118165|FG001|COMPLETED|Overall Study||29||
48323230|NCT00940589|101118164|FG000|NOT COMPLETED|Overall Study||8||
48323231|NCT00940589|101118165|FG001|NOT COMPLETED|Overall Study||5||
48323232|NCT02248727|101118166|FG000|STARTED|Overall Study||30||
48323233|NCT02248727|101118166|FG000|COMPLETED|Overall Study||30||
48323234|NCT02248727|101118166|FG000|NOT COMPLETED|Overall Study||0||
48323235|NCT03711500|101118167|FG000|STARTED|Overall Study||12||
48323236|NCT03711500|101118168|FG001|STARTED|Overall Study||12||
48323237|NCT03711500|101118169|FG002|STARTED|Overall Study||12||
48323238|NCT03711500|101118170|FG003|STARTED|Overall Study||9||
48323239|NCT03711500|101118167|FG000|COMPLETED|Overall Study||12||
48323240|NCT03711500|101118168|FG001|COMPLETED|Overall Study||11||
48323241|NCT03711500|101118169|FG002|COMPLETED|Overall Study||12||
48323242|NCT03711500|101118170|FG003|COMPLETED|Overall Study||9||
48323243|NCT03711500|101118167|FG000|NOT COMPLETED|Overall Study||0||
48323244|NCT03711500|101118168|FG001|NOT COMPLETED|Overall Study||1||
48323245|NCT03711500|101118169|FG002|NOT COMPLETED|Overall Study||0||
48323246|NCT03711500|101118170|FG003|NOT COMPLETED|Overall Study||0||
48323247|NCT02530528|101118171|FG000|STARTED|Overall Study||13||13
48323248|NCT02530528|101118172|FG001|STARTED|Overall Study||13||13
48323249|NCT02530528|101118173|FG002|STARTED|Overall Study||14||14
48323250|NCT02530528|101118174|FG003|STARTED|Overall Study||14||14
48323251|NCT02530528|101118175|FG004|STARTED|Overall Study||13||13
48323252|NCT02530528|101118176|FG005|STARTED|Overall Study||13||13
48323253|NCT02530528|101118177|FG006|STARTED|Overall Study||14||14
48323254|NCT02530528|101118178|FG007|STARTED|Overall Study||14||14
48323255|NCT02530528|101118171|FG000|COMPLETED|Overall Study||12|27 were treated with both interventions, though interventions differ with application time. 24 subjects completed with passing treatment baseline values.|12
48323256|NCT02530528|101118172|FG001|COMPLETED|Overall Study||12|27 were treated with both interventions, though interventions differ with application time. 24 subjects completed with passing treatment baseline values.|12
48323257|NCT02530528|101118173|FG002|COMPLETED|Overall Study||12|27 were treated with both interventions, though interventions differ with application time. 24 subjects completed with passing treatment baseline values.|12
48323258|NCT02530528|101118174|FG003|COMPLETED|Overall Study||12|27 were treated with both interventions, though interventions differ with application time. 24 subjects completed with passing treatment baseline values.|12
48323259|NCT02530528|101118175|FG004|COMPLETED|Overall Study||12|27 were treated with both interventions, though interventions differ with application time. 24 subjects completed with passing treatment baseline values.|12
48323260|NCT02530528|101118176|FG005|COMPLETED|Overall Study||12|27 were treated with both interventions, though interventions differ with application time. 24 subjects completed with passing treatment baseline values.|12
48323261|NCT02530528|101118177|FG006|COMPLETED|Overall Study||12|27 were treated with both interventions, though interventions differ with application time. 24 subjects completed with passing treatment baseline values.|12
48323262|NCT02530528|101118178|FG007|COMPLETED|Overall Study||12|27 were treated with both interventions, though interventions differ with application time. 24 subjects completed with passing treatment baseline values.|12
48323263|NCT02530528|101118171|FG000|NOT COMPLETED|Overall Study||1||1
48323264|NCT02530528|101118172|FG001|NOT COMPLETED|Overall Study||1||1
48323265|NCT02530528|101118173|FG002|NOT COMPLETED|Overall Study||2||2
48323266|NCT02530528|101118174|FG003|NOT COMPLETED|Overall Study||2||2
48741024|NCT02837029|102151574|FG002|STARTED|Screening||0||
48741025|NCT02837029|102151572|FG000|COMPLETED|Screening||8||
48741026|NCT02837029|102151573|FG001|COMPLETED|Screening||9||
48741027|NCT02837029|102151574|FG002|COMPLETED|Screening||0||
48741028|NCT02837029|102151572|FG000|NOT COMPLETED|Screening||7||
48741029|NCT02837029|102151573|FG001|NOT COMPLETED|Screening||3||
48741030|NCT02837029|102151574|FG002|NOT COMPLETED|Screening||0||
48741031|NCT02837029|102151572|FG000|STARTED|Induction Treatment With Y90||8||
48741032|NCT02837029|102151573|FG001|STARTED|Induction Treatment With Y90||9||
48741033|NCT02837029|102151574|FG002|STARTED|Induction Treatment With Y90||0||
48741034|NCT02837029|102151572|FG000|COMPLETED|Induction Treatment With Y90||8||
48741035|NCT02837029|102151573|FG001|COMPLETED|Induction Treatment With Y90||9||
48741036|NCT02837029|102151574|FG002|COMPLETED|Induction Treatment With Y90||0||
48741037|NCT02837029|102151572|FG000|NOT COMPLETED|Induction Treatment With Y90||0||
48741038|NCT02837029|102151573|FG001|NOT COMPLETED|Induction Treatment With Y90||0||
48741039|NCT02837029|102151574|FG002|NOT COMPLETED|Induction Treatment With Y90||0||
48323267|NCT02530528|101118175|FG004|NOT COMPLETED|Overall Study||1||1
48323268|NCT02530528|101118176|FG005|NOT COMPLETED|Overall Study||1||1
48323269|NCT02530528|101118177|FG006|NOT COMPLETED|Overall Study||2||2
48741040|NCT02837029|102151572|FG000|STARTED|Cycle 1 (DLT Monitoring Period)||8||
48741041|NCT02837029|102151573|FG001|STARTED|Cycle 1 (DLT Monitoring Period)||9||
48741042|NCT02837029|102151574|FG002|STARTED|Cycle 1 (DLT Monitoring Period)||0||
48741043|NCT02837029|102151572|FG000|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||6||
48741044|NCT02837029|102151573|FG001|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||7||
48741045|NCT02837029|102151574|FG002|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||0||
48323270|NCT02530528|101118178|FG007|NOT COMPLETED|Overall Study||2||2
48323271|NCT03557892|101118179|FG000|STARTED|Overall Study||14||
48323272|NCT03557892|101118180|FG001|STARTED|Overall Study||14||
48323273|NCT03557892|101118179|FG000|COMPLETED|Overall Study||14||
48323274|NCT03557892|101118180|FG001|COMPLETED|Overall Study||14||
48323275|NCT03557892|101118179|FG000|NOT COMPLETED|Overall Study||0||
48323276|NCT03557892|101118180|FG001|NOT COMPLETED|Overall Study||0||
48323277|NCT01798589|101118181|FG000|STARTED|Overall Study||16||
48323278|NCT01798589|101118181|FG000|COMPLETED|Overall Study||16||
48323279|NCT01798589|101118181|FG000|NOT COMPLETED|Overall Study||0||
48323280|NCT01967537|101118182|FG000|STARTED|Overall Study||341||
48323281|NCT01967537|101118182|FG000|COMPLETED|Overall Study||281||
48323282|NCT01967537|101118182|FG000|NOT COMPLETED|Overall Study||60||
48323283|NCT00390546|101118183|FG000|STARTED|Overall Study||33||
48323284|NCT00390546|101118184|FG001|STARTED|Overall Study||39||
48323285|NCT00390546|101118183|FG000|COMPLETED|Overall Study||27||
48323286|NCT00390546|101118184|FG001|COMPLETED|Overall Study||34||
48323287|NCT00390546|101118183|FG000|NOT COMPLETED|Overall Study||6||
48323288|NCT00390546|101118184|FG001|NOT COMPLETED|Overall Study||5||
48323289|NCT03368170|101118185|FG000|STARTED|Overall Study||39||
48323290|NCT03368170|101118186|FG001|STARTED|Overall Study||36||
48323291|NCT03368170|101118185|FG000|COMPLETED|Overall Study||37||
48323292|NCT03368170|101118186|FG001|COMPLETED|Overall Study||35||
48323293|NCT03368170|101118185|FG000|NOT COMPLETED|Overall Study||2||
48741046|NCT02837029|102151572|FG000|COMPLETED|Cycle 1 (DLT Monitoring Period)||6||
48741047|NCT02837029|102151573|FG001|COMPLETED|Cycle 1 (DLT Monitoring Period)||6||
48741048|NCT02837029|102151574|FG002|COMPLETED|Cycle 1 (DLT Monitoring Period)||0||
48741049|NCT02837029|102151572|FG000|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||2||
48741050|NCT02837029|102151573|FG001|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||3||
48741051|NCT02837029|102151574|FG002|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||0||
48741052|NCT02837029|102151572|FG000|STARTED|Cycle 2 and Beyond||6||
48741053|NCT02837029|102151573|FG001|STARTED|Cycle 2 and Beyond||6||
48741054|NCT02837029|102151574|FG002|STARTED|Cycle 2 and Beyond||0||
48741055|NCT02837029|102151572|FG000|COMPLETED|Cycle 2 and Beyond||5||
48741056|NCT02837029|102151573|FG001|COMPLETED|Cycle 2 and Beyond||6||
48741057|NCT02837029|102151574|FG002|COMPLETED|Cycle 2 and Beyond||0||
48741058|NCT02837029|102151572|FG000|NOT COMPLETED|Cycle 2 and Beyond||1||
48741059|NCT02837029|102151573|FG001|NOT COMPLETED|Cycle 2 and Beyond||0||
48741060|NCT02837029|102151574|FG002|NOT COMPLETED|Cycle 2 and Beyond||0||
48741061|NCT02837029|102151572|FG000|STARTED|2 Year Follow-up||6||
48741062|NCT02837029|102151573|FG001|STARTED|2 Year Follow-up||7||
48741063|NCT02837029|102151574|FG002|STARTED|2 Year Follow-up||0||
48741064|NCT02837029|102151572|FG000|COMPLETED|2 Year Follow-up||0||
48741065|NCT02837029|102151573|FG001|COMPLETED|2 Year Follow-up||0||
48741066|NCT02837029|102151574|FG002|COMPLETED|2 Year Follow-up||0||
48741067|NCT02837029|102151572|FG000|NOT COMPLETED|2 Year Follow-up||6||
48741068|NCT02837029|102151573|FG001|NOT COMPLETED|2 Year Follow-up||7||
48741069|NCT02837029|102151574|FG002|NOT COMPLETED|2 Year Follow-up||0||
48741070|NCT01420926|102151575|FG000|STARTED|Overall Study||82||
48741071|NCT01420926|102151576|FG001|STARTED|Overall Study||81||
48741072|NCT01420926|102151575|FG000|COMPLETED|Overall Study||22||
48741073|NCT01420926|102151576|FG001|COMPLETED|Overall Study||18||
48741074|NCT01420926|102151575|FG000|NOT COMPLETED|Overall Study||60||
48741075|NCT01420926|102151576|FG001|NOT COMPLETED|Overall Study||63||
48741076|NCT03948334|102151577|FG000|STARTED|Overall Study||60||
48323294|NCT03368170|101118186|FG001|NOT COMPLETED|Overall Study||1||
48323295|NCT03031301|101118187|FG000|STARTED|Overall Study||89||
48323296|NCT03031301|101118188|FG001|STARTED|Overall Study||93||
48741077|NCT03948334|102151578|FG001|STARTED|Overall Study||63||
48323297|NCT03031301|101118187|FG000|COMPLETED|Overall Study||71||
48741078|NCT03948334|102151577|FG000|COMPLETED|Overall Study||0||
48323298|NCT03031301|101118188|FG001|COMPLETED|Overall Study||65||
48323299|NCT03031301|101118187|FG000|NOT COMPLETED|Overall Study||18||
48741079|NCT03948334|102151578|FG001|COMPLETED|Overall Study||0||
48741080|NCT03948334|102151577|FG000|NOT COMPLETED|Overall Study||60||
48741081|NCT03948334|102151578|FG001|NOT COMPLETED|Overall Study||63||
48741082|NCT01919229|102151579|FG000|STARTED|Overall Study||4||
48741083|NCT01919229|102151580|FG001|STARTED|Overall Study||6||
48741084|NCT01919229|102151581|FG002|STARTED|Overall Study||4||
48741085|NCT01919229|102151579|FG000|COMPLETED|Overall Study||4||
48741086|NCT01919229|102151580|FG001|COMPLETED|Overall Study||6||
48741087|NCT01919229|102151581|FG002|COMPLETED|Overall Study||3||
48741088|NCT01919229|102151579|FG000|NOT COMPLETED|Overall Study||0||
48741089|NCT01919229|102151580|FG001|NOT COMPLETED|Overall Study||0||
48741090|NCT01919229|102151581|FG002|NOT COMPLETED|Overall Study||1||
48741091|NCT02097030|102151582|FG000|STARTED|First Intervention (3 Days)||15||
48741092|NCT02097030|102151583|FG001|STARTED|First Intervention (3 Days)||17||
48741093|NCT02097030|102151582|FG000|COMPLETED|First Intervention (3 Days)||14||
48741094|NCT02097030|102151583|FG001|COMPLETED|First Intervention (3 Days)||16||
48741095|NCT02097030|102151582|FG000|NOT COMPLETED|First Intervention (3 Days)||1||
48741096|NCT02097030|102151583|FG001|NOT COMPLETED|First Intervention (3 Days)||1||
48741097|NCT02097030|102151582|FG000|STARTED|Second Intervention (3 Days)||14||
48741098|NCT02097030|102151583|FG001|STARTED|Second Intervention (3 Days)||16||
48741099|NCT02097030|102151582|FG000|COMPLETED|Second Intervention (3 Days)||14||
48741100|NCT02097030|102151583|FG001|COMPLETED|Second Intervention (3 Days)||16||
48741101|NCT02097030|102151582|FG000|NOT COMPLETED|Second Intervention (3 Days)||0||
48741102|NCT02097030|102151583|FG001|NOT COMPLETED|Second Intervention (3 Days)||0||
48741103|NCT03499314|102151584|FG000|STARTED|Overall Study||33||
48741104|NCT03499314|102151585|FG001|STARTED|Overall Study||32||
48741105|NCT03499314|102151584|FG000|COMPLETED|Overall Study||31||
48741106|NCT03499314|102151585|FG001|COMPLETED|Overall Study||29||
48741107|NCT03499314|102151584|FG000|NOT COMPLETED|Overall Study||2||
48741108|NCT03499314|102151585|FG001|NOT COMPLETED|Overall Study||3||
48741109|NCT01456169|102151586|FG000|STARTED|Overall Study||133||
48741110|NCT01456169|102151587|FG001|STARTED|Overall Study||127||
48741111|NCT01456169|102151588|FG002|STARTED|Overall Study||135||
48741112|NCT01456169|102151586|FG000|COMPLETED|Overall Study||123||
48741113|NCT01456169|102151587|FG001|COMPLETED|Overall Study||122||
48741114|NCT01456169|102151588|FG002|COMPLETED|Overall Study||123||
48741115|NCT01456169|102151586|FG000|NOT COMPLETED|Overall Study||10||
48741116|NCT01456169|102151587|FG001|NOT COMPLETED|Overall Study||5||
48741117|NCT01456169|102151588|FG002|NOT COMPLETED|Overall Study||12||
48741118|NCT01587040|102151589|FG000|STARTED|Overall Study||17||
48741119|NCT01587040|102151590|FG001|STARTED|Overall Study||3||
48741120|NCT01587040|102151591|FG002|STARTED|Overall Study||37||
48741121|NCT01587040|102151592|FG003|STARTED|Overall Study||4||
48741122|NCT01587040|102151589|FG000|COMPLETED|Overall Study||0||
48741123|NCT01587040|102151590|FG001|COMPLETED|Overall Study||0||
48741124|NCT01587040|102151591|FG002|COMPLETED|Overall Study||0||
48741125|NCT01587040|102151592|FG003|COMPLETED|Overall Study||0||
48741126|NCT01587040|102151589|FG000|NOT COMPLETED|Overall Study||17||
48741127|NCT01587040|102151590|FG001|NOT COMPLETED|Overall Study||3||
48741128|NCT01587040|102151591|FG002|NOT COMPLETED|Overall Study||37||
48741129|NCT01587040|102151592|FG003|NOT COMPLETED|Overall Study||4||
48741130|NCT01327599|102151593|FG000|STARTED|Overall Study||60||
48741131|NCT01327599|102151593|FG000|COMPLETED|Overall Study||57||
48741132|NCT01327599|102151593|FG000|NOT COMPLETED|Overall Study||3||
48741133|NCT00824473|102151594|FG000|STARTED|Overall Study||255||
48741134|NCT00824473|102151595|FG001|STARTED|Overall Study||251||
48741135|NCT00824473|102151594|FG000|COMPLETED|Overall Study||240||
48741136|NCT00824473|102151595|FG001|COMPLETED|Overall Study||238||
48741137|NCT00824473|102151594|FG000|NOT COMPLETED|Overall Study||15||
48741138|NCT00824473|102151595|FG001|NOT COMPLETED|Overall Study||13||
48741139|NCT01680666|102151596|FG000|STARTED|Overall Study||84||
48741140|NCT01680666|102151597|FG001|STARTED|Overall Study||66||
48741141|NCT01680666|102151596|FG000|COMPLETED|Overall Study||84||
48741142|NCT01680666|102151597|FG001|COMPLETED|Overall Study||66||
48741143|NCT01680666|102151596|FG000|NOT COMPLETED|Overall Study||0||
48741144|NCT01680666|102151597|FG001|NOT COMPLETED|Overall Study||0||
48741145|NCT02489318|102151598|FG000|STARTED|Randomized||527||
48741146|NCT02489318|102151599|FG001|STARTED|Randomized||525||
48741147|NCT02489318|102151598|FG000|COMPLETED|Randomized||527||
48741148|NCT02489318|102151599|FG001|COMPLETED|Randomized||524||
48741149|NCT02489318|102151598|FG000|NOT COMPLETED|Randomized||0||
48741150|NCT02489318|102151599|FG001|NOT COMPLETED|Randomized||1||
48741151|NCT02489318|102151598|FG000|STARTED|Treated||527||
48741152|NCT02489318|102151599|FG001|STARTED|Treated||524||
48741153|NCT02489318|102151598|FG000|COMPLETED|Treated||208||
48741154|NCT02489318|102151599|FG001|COMPLETED|Treated||0||
48741155|NCT02489318|102151598|FG000|NOT COMPLETED|Treated||319||
48741156|NCT02489318|102151599|FG001|NOT COMPLETED|Treated||524||
48741157|NCT02489539|102151600|FG000|STARTED|Overall Study||80||
48741158|NCT02489539|102151601|FG001|STARTED|Overall Study||95||
48741159|NCT02489539|102151600|FG000|COMPLETED|Overall Study||78||
48741160|NCT02489539|102151601|FG001|COMPLETED|Overall Study||0||
48741161|NCT02489539|102151600|FG000|NOT COMPLETED|Overall Study||2||
48741162|NCT02489539|102151601|FG001|NOT COMPLETED|Overall Study||95||
48741163|NCT01012258|102151602|FG000|STARTED|Overall Study||66||
48741164|NCT01012258|102151602|FG000|COMPLETED|Overall Study||0||
48741165|NCT01012258|102151602|FG000|NOT COMPLETED|Overall Study||66||
48741166|NCT01721226|102151603|FG000|STARTED|Overall Study||55||
48741167|NCT01721226|102151604|FG001|STARTED|Overall Study||57||
48741168|NCT01721226|102151603|FG000|Baseline|Overall Study||53||
48323300|NCT03031301|101118188|FG001|NOT COMPLETED|Overall Study||28||
48323301|NCT04839380|101118189|FG000|STARTED|Overall Study||49||
48323302|NCT04839380|101118189|FG000|Intent-to-Treat Population|Overall Study||46||
48323303|NCT04839380|101118189|FG000|COMPLETED|Overall Study||44||
48323304|NCT04839380|101118189|FG000|NOT COMPLETED|Overall Study||5||
48323305|NCT00811135|101118190|FG000|STARTED|Overall Study||88||
48323306|NCT00811135|101118190|FG000|COMPLETED|Overall Study||0||
48323307|NCT00811135|101118190|FG000|NOT COMPLETED|Overall Study||88||
48323308|NCT03002155|101118191|FG000|STARTED|Overall Study||10||
48323309|NCT03002155|101118192|FG001|STARTED|Overall Study||14||
48323310|NCT03002155|101118191|FG000|COMPLETED|Overall Study||7||
48323311|NCT03002155|101118192|FG001|COMPLETED|Overall Study||11||
48323312|NCT03002155|101118191|FG000|NOT COMPLETED|Overall Study||3||
48323313|NCT03002155|101118192|FG001|NOT COMPLETED|Overall Study||3||
48162046|NCT03315130|100718871|FG000|COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||0||
48323314|NCT01676714|101118193|FG000|STARTED|Overall Study||10||
48323315|NCT01676714|101118193|FG000|COMPLETED|Overall Study||10||
48323316|NCT01676714|101118193|FG000|NOT COMPLETED|Overall Study||0||
48323317|NCT06033079|101118194|FG000|STARTED|Overall Study||269||
48323318|NCT06033079|101118195|FG001|STARTED|Overall Study||267||
48323319|NCT06033079|101118194|FG000|COMPLETED|Overall Study||269||
48323320|NCT06033079|101118195|FG001|COMPLETED|Overall Study||267||
48323321|NCT06033079|101118194|FG000|NOT COMPLETED|Overall Study||0||
48323322|NCT06033079|101118195|FG001|NOT COMPLETED|Overall Study||0||
48323323|NCT04091087|101118196|FG000|STARTED|Overall Study||33||
48323324|NCT04091087|101118197|FG001|STARTED|Overall Study||33||
48323325|NCT04091087|101118196|FG000|Treated|Overall Study||32||
48323326|NCT04091087|101118197|FG001|Treated|Overall Study||33||
48323327|NCT04091087|101118196|FG000|COMPLETED|Overall Study||23||
48323328|NCT04091087|101118197|FG001|COMPLETED|Overall Study||26||
48162047|NCT03315130|100718872|FG001|COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||17||
48162048|NCT03315130|100718873|FG002|COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||0||
48162049|NCT03315130|100718874|FG003|COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||20||
48162050|NCT03315130|100718871|FG000|NOT COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||0||
48408415|NCT01432938|101331761|FG001|STARTED|First Intervention||14||
48408416|NCT01432938|101331760|FG000|Received at Least 1 Dose of Study Drug|First Intervention||14||
48408417|NCT01432938|101331761|FG001|Received at Least 1 Dose of Study Drug|First Intervention||14||
48408418|NCT01432938|101331760|FG000|COMPLETED|First Intervention||12||
48408419|NCT01432938|101331761|FG001|COMPLETED|First Intervention||14||
48408420|NCT01432938|101331760|FG000|NOT COMPLETED|First Intervention||2||
48741169|NCT01721226|102151604|FG001|Baseline|Overall Study||57||
48741170|NCT01721226|102151603|FG000|Week 12|Overall Study||48||
48741171|NCT01721226|102151604|FG001|Week 12|Overall Study||53||
48741172|NCT01721226|102151603|FG000|Week 24|Overall Study||50||
48741173|NCT01721226|102151604|FG001|Week 24|Overall Study||50||
48741174|NCT01721226|102151603|FG000|COMPLETED|Overall Study||50||
48741175|NCT01721226|102151604|FG001|COMPLETED|Overall Study||50||
48741176|NCT01721226|102151603|FG000|NOT COMPLETED|Overall Study||5||
48741177|NCT01721226|102151604|FG001|NOT COMPLETED|Overall Study||7||
48741178|NCT01915173|102151605|FG000|STARTED|Overall Study||6||
48741179|NCT01915173|102151606|FG001|STARTED|Overall Study||6||
48741180|NCT01915173|102151607|FG002|STARTED|Overall Study||6||
48741181|NCT01915173|102151608|FG003|STARTED|Overall Study||6||
48741182|NCT01915173|102151605|FG000|COMPLETED|Overall Study||6||
48741183|NCT01915173|102151606|FG001|COMPLETED|Overall Study||6||
48741184|NCT01915173|102151607|FG002|COMPLETED|Overall Study||6||
48741185|NCT01915173|102151608|FG003|COMPLETED|Overall Study||6||
48741186|NCT01915173|102151605|FG000|NOT COMPLETED|Overall Study||0||
48741187|NCT01915173|102151606|FG001|NOT COMPLETED|Overall Study||0||
48741188|NCT01915173|102151607|FG002|NOT COMPLETED|Overall Study||0||
48741189|NCT01915173|102151608|FG003|NOT COMPLETED|Overall Study||0||
48741190|NCT02630472|102151609|FG000|STARTED|Overall Study||10||
48741191|NCT02630472|102151610|FG001|STARTED|Overall Study||0||
48741192|NCT02630472|102151609|FG000|COMPLETED|Overall Study||0|Trial was discontinued due to physician priorities; no subjects completed the trial.|
48741193|NCT02630472|102151610|FG001|COMPLETED|Overall Study||0|Trial was discontinued due to physician priorities; no subjects completed the trial.|
48741194|NCT02630472|102151609|FG000|NOT COMPLETED|Overall Study||10||
48741195|NCT02630472|102151610|FG001|NOT COMPLETED|Overall Study||0||
48741196|NCT02915263|102151611|FG000|STARTED|Overall Study||6||
48741197|NCT02915263|102151612|FG001|STARTED|Overall Study||7||
48741198|NCT02915263|102151611|FG000|COMPLETED|Overall Study||3||
48741199|NCT02915263|102151612|FG001|COMPLETED|Overall Study||5||
48741200|NCT02915263|102151611|FG000|NOT COMPLETED|Overall Study||3||
48741201|NCT02915263|102151612|FG001|NOT COMPLETED|Overall Study||2||
48741202|NCT00214539|102151613|FG000|STARTED|Randomized||17||
48741203|NCT00214539|102151614|FG001|STARTED|Randomized||17||
48741204|NCT00214539|102151613|FG000|COMPLETED|Randomized||15||
48741205|NCT00214539|102151614|FG001|COMPLETED|Randomized||17||
48741206|NCT00214539|102151613|FG000|NOT COMPLETED|Randomized||2||
48741207|NCT00214539|102151614|FG001|NOT COMPLETED|Randomized||0||
48741208|NCT00214539|102151613|FG000|STARTED|Treatment Period||15||
48741209|NCT00214539|102151614|FG001|STARTED|Treatment Period||17||
48741210|NCT00214539|102151613|FG000|COMPLETED|Treatment Period||15||
48741211|NCT00214539|102151614|FG001|COMPLETED|Treatment Period||17||
48741212|NCT00214539|102151613|FG000|NOT COMPLETED|Treatment Period||0||
48741213|NCT00214539|102151614|FG001|NOT COMPLETED|Treatment Period||0||
48741214|NCT00214539|102151613|FG000|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||15||
48741215|NCT00214539|102151614|FG001|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||17||
48741216|NCT00214539|102151613|FG000|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||15||
48741217|NCT00214539|102151614|FG001|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||17||
48741218|NCT00214539|102151613|FG000|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0||
48741219|NCT00214539|102151614|FG001|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0||
48741220|NCT00214539|102151613|FG000|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||15||
48741221|NCT00214539|102151614|FG001|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||17||
48741222|NCT00214539|102151613|FG000|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||15||
48741223|NCT00214539|102151614|FG001|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||17||
48741224|NCT00214539|102151613|FG000|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0||
48741225|NCT00214539|102151614|FG001|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0||
48741226|NCT00785980|102151615|FG000|STARTED|Quinine Sulfate Alone||24||
48741227|NCT00785980|102151615|FG000|COMPLETED|Quinine Sulfate Alone||24||
48741228|NCT00785980|102151615|FG000|NOT COMPLETED|Quinine Sulfate Alone||0||
48741229|NCT00785980|102151615|FG000|STARTED|7 Day Washout Period||24||
48741230|NCT00785980|102151615|FG000|COMPLETED|7 Day Washout Period||21||
48741231|NCT00785980|102151615|FG000|NOT COMPLETED|7 Day Washout Period||3||
48741232|NCT00785980|102151615|FG000|STARTED|Ciprofloxacin Alone||21||
48741233|NCT00785980|102151615|FG000|COMPLETED|Ciprofloxacin Alone||21||
48741234|NCT00785980|102151615|FG000|NOT COMPLETED|Ciprofloxacin Alone||0||
48741235|NCT00785980|102151615|FG000|STARTED|Quinine Sulfate With Ciprofloxacin||21||
48741236|NCT00785980|102151615|FG000|COMPLETED|Quinine Sulfate With Ciprofloxacin||21||
48741237|NCT00785980|102151615|FG000|NOT COMPLETED|Quinine Sulfate With Ciprofloxacin||0||
48741238|NCT00773513|102151616|FG000|STARTED|Overall Study||1413|Randomized with informed consent|
48741239|NCT00773513|102151617|FG001|STARTED|Overall Study||1412|Randomized with informed consent|
48741240|NCT00773513|102151616|FG000|Received Study Treatment|Overall Study||1409||
48741241|NCT00773513|102151617|FG001|Received Study Treatment|Overall Study||1409||
48741242|NCT00773513|102151616|FG000|COMPLETED|Overall Study||312||
48741243|NCT00773513|102151617|FG001|COMPLETED|Overall Study||303||
48741244|NCT00773513|102151616|FG000|NOT COMPLETED|Overall Study||1101||
48741245|NCT00773513|102151617|FG001|NOT COMPLETED|Overall Study||1109||
48741246|NCT00855816|102151618|FG000|STARTED|Overall Study||47||
48741247|NCT00855816|102151619|FG001|STARTED|Overall Study||33||
48741248|NCT00855816|102151618|FG000|COMPLETED|Overall Study||21||
48741249|NCT00855816|102151619|FG001|COMPLETED|Overall Study||12||
48741250|NCT00855816|102151618|FG000|NOT COMPLETED|Overall Study||26||
48741251|NCT00855816|102151619|FG001|NOT COMPLETED|Overall Study||21||
48741252|NCT04439539|102151620|FG000|STARTED|IP:W0-36(Post-PA5)/W52(Prior-PA5)||27||
48741253|NCT04439539|102151621|FG001|STARTED|IP:W0-36(Post-PA5)/W52(Prior-PA5)||8||
48741254|NCT04439539|102151622|FG002|STARTED|IP:W0-36(Post-PA5)/W52(Prior-PA5)||19||
48741255|NCT04439539|102151620|FG000|COMPLETED|IP:W0-36(Post-PA5)/W52(Prior-PA5)||26||
48741256|NCT04439539|102151621|FG001|COMPLETED|IP:W0-36(Post-PA5)/W52(Prior-PA5)||8||
48741257|NCT04439539|102151622|FG002|COMPLETED|IP:W0-36(Post-PA5)/W52(Prior-PA5)||17||
48741258|NCT04439539|102151620|FG000|NOT COMPLETED|IP:W0-36(Post-PA5)/W52(Prior-PA5)||1||
48741259|NCT04439539|102151621|FG001|NOT COMPLETED|IP:W0-36(Post-PA5)/W52(Prior-PA5)||0||
48741260|NCT04439539|102151622|FG002|NOT COMPLETED|IP:W0-36(Post-PA5)/W52(Prior-PA5)||2||
48741261|NCT04439539|102151620|FG000|STARTED|Consolidation Phase (CP):CP Week 1 to 12||25||
48741262|NCT04439539|102151621|FG001|STARTED|Consolidation Phase (CP):CP Week 1 to 12||7||
48741263|NCT04439539|102151622|FG002|STARTED|Consolidation Phase (CP):CP Week 1 to 12||17||
48741264|NCT04439539|102151620|FG000|COMPLETED|Consolidation Phase (CP):CP Week 1 to 12||25||
48162051|NCT03315130|100718872|FG001|NOT COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||4||
48162052|NCT03315130|100718873|FG002|NOT COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||0||
48162053|NCT03315130|100718874|FG003|NOT COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||1||
48162054|NCT02939300|100718875|FG000|STARTED|Overall Study||18||
48162055|NCT02939300|100718875|FG000|COMPLETED|Overall Study||18||
48162056|NCT02939300|100718875|FG000|NOT COMPLETED|Overall Study||0||
48162057|NCT00382824|100718876|FG000|STARTED|Overall Study||32||
48162058|NCT00382824|100718877|FG001|STARTED|Overall Study||29||
48162059|NCT00382824|100718876|FG000|COMPLETED|Overall Study||20||
48162060|NCT00382824|100718877|FG001|COMPLETED|Overall Study||16||
48162061|NCT00382824|100718876|FG000|NOT COMPLETED|Overall Study||12||
48162062|NCT00382824|100718877|FG001|NOT COMPLETED|Overall Study||13||
48162063|NCT00185640|100718878|FG000|STARTED|Overall Study||303||
48162064|NCT00185640|100718878|FG000|Transplanted|Overall Study||296||
48162065|NCT00185640|100718878|FG000|90 Days Post-transplant|Overall Study||161||
48162066|NCT00185640|100718878|FG000|COMPLETED|Overall Study||158||
48162067|NCT00185640|100718878|FG000|NOT COMPLETED|Overall Study||145||
48162068|NCT00328614|100718879|FG000|STARTED|Overall Study||4||
48162069|NCT00328614|100718880|FG001|STARTED|Overall Study||4||
48162070|NCT00328614|100718881|FG002|STARTED|Overall Study||6||
48162071|NCT00328614|100718882|FG003|STARTED|Overall Study||6||
48162072|NCT00328614|100718883|FG004|STARTED|Overall Study||6||
48162073|NCT00328614|100718884|FG005|STARTED|Overall Study||6||
48162074|NCT00328614|100718879|FG000|COMPLETED|Overall Study||4||
48162075|NCT00328614|100718880|FG001|COMPLETED|Overall Study||4||
48162076|NCT00328614|100718881|FG002|COMPLETED|Overall Study||6||
48162077|NCT00328614|100718882|FG003|COMPLETED|Overall Study||5||
48162078|NCT00328614|100718883|FG004|COMPLETED|Overall Study||5||
48162079|NCT00328614|100718884|FG005|COMPLETED|Overall Study||5||
48162080|NCT00328614|100718879|FG000|NOT COMPLETED|Overall Study||0||
48162081|NCT00328614|100718880|FG001|NOT COMPLETED|Overall Study||0||
48162082|NCT00328614|100718881|FG002|NOT COMPLETED|Overall Study||0||
48162083|NCT00328614|100718882|FG003|NOT COMPLETED|Overall Study||1||
48162084|NCT00328614|100718883|FG004|NOT COMPLETED|Overall Study||1||
48162085|NCT00328614|100718884|FG005|NOT COMPLETED|Overall Study||1||
48162086|NCT01830595|100718885|FG000|STARTED|First Period||26||
48162087|NCT01830595|100718886|FG001|STARTED|First Period||28||
48162088|NCT01830595|100718885|FG000|Received at Least One Dose|First Period||26||
48162089|NCT01830595|100718886|FG001|Received at Least One Dose|First Period||28||
48162090|NCT01830595|100718885|FG000|COMPLETED|First Period||25||
48162091|NCT01830595|100718886|FG001|COMPLETED|First Period||25||
48162092|NCT01830595|100718885|FG000|NOT COMPLETED|First Period||1||
48162093|NCT01830595|100718886|FG001|NOT COMPLETED|First Period||3||
48162094|NCT01830595|100718885|FG000|STARTED|Washout||25||
48162095|NCT01830595|100718886|FG001|STARTED|Washout||25||
48162096|NCT01830595|100718885|FG000|COMPLETED|Washout||23||
48162097|NCT01830595|100718886|FG001|COMPLETED|Washout||23||
48162098|NCT01830595|100718885|FG000|NOT COMPLETED|Washout||2||
48162099|NCT01830595|100718886|FG001|NOT COMPLETED|Washout||2||
48162100|NCT01830595|100718885|FG000|STARTED|Second Period||23||
48162101|NCT01830595|100718886|FG001|STARTED|Second Period||23||
48162102|NCT01830595|100718885|FG000|COMPLETED|Second Period||23||
48162103|NCT01830595|100718886|FG001|COMPLETED|Second Period||23||
48323329|NCT04091087|101118196|FG000|NOT COMPLETED|Overall Study||10||
48323330|NCT04091087|101118197|FG001|NOT COMPLETED|Overall Study||7||
48323331|NCT00345176|101118198|FG000|STARTED|Overall Study||1012||
48323332|NCT00345176|101118199|FG001|STARTED|Overall Study||1044||
48323333|NCT00345176|101118200|FG002|STARTED|Overall Study||1068||
48323334|NCT00345176|101118201|FG003|STARTED|Overall Study||1079||
48323335|NCT00345176|101118198|FG000|COMPLETED|Overall Study||1007||
48323336|NCT00345176|101118199|FG001|COMPLETED|Overall Study||1038||
48323337|NCT00345176|101118200|FG002|COMPLETED|Overall Study||1062||
48323338|NCT00345176|101118201|FG003|COMPLETED|Overall Study||1069||
48323339|NCT00345176|101118198|FG000|NOT COMPLETED|Overall Study||5||
48323340|NCT00345176|101118199|FG001|NOT COMPLETED|Overall Study||6||
48408421|NCT01432938|101331761|FG001|NOT COMPLETED|First Intervention||0||
48408422|NCT01432938|101331760|FG000|STARTED|Washout Period of at Least 24 Days||12||
48408423|NCT01432938|101331761|FG001|STARTED|Washout Period of at Least 24 Days||14||
48408424|NCT01432938|101331760|FG000|COMPLETED|Washout Period of at Least 24 Days||12||
48408425|NCT01432938|101331761|FG001|COMPLETED|Washout Period of at Least 24 Days||14||
48408426|NCT01432938|101331760|FG000|NOT COMPLETED|Washout Period of at Least 24 Days||0||
48408427|NCT01432938|101331761|FG001|NOT COMPLETED|Washout Period of at Least 24 Days||0||
48741265|NCT04439539|102151621|FG001|COMPLETED|Consolidation Phase (CP):CP Week 1 to 12||7||
48741266|NCT04439539|102151622|FG002|COMPLETED|Consolidation Phase (CP):CP Week 1 to 12||17||
48741267|NCT04439539|102151620|FG000|NOT COMPLETED|Consolidation Phase (CP):CP Week 1 to 12||0||
48741268|NCT04439539|102151621|FG001|NOT COMPLETED|Consolidation Phase (CP):CP Week 1 to 12||0||
48741269|NCT04439539|102151622|FG002|NOT COMPLETED|Consolidation Phase (CP):CP Week 1 to 12||0||
48741270|NCT04439539|102151620|FG000|STARTED|Follow-up (FU): FU Week 0 to 48||26||
48741271|NCT04439539|102151621|FG001|STARTED|Follow-up (FU): FU Week 0 to 48||8||
48741272|NCT04439539|102151622|FG002|STARTED|Follow-up (FU): FU Week 0 to 48||17||
48741273|NCT04439539|102151620|FG000|COMPLETED|Follow-up (FU): FU Week 0 to 48||26||
48741274|NCT04439539|102151621|FG001|COMPLETED|Follow-up (FU): FU Week 0 to 48||2||
48741275|NCT04439539|102151622|FG002|COMPLETED|Follow-up (FU): FU Week 0 to 48||0||
48741276|NCT04439539|102151620|FG000|NOT COMPLETED|Follow-up (FU): FU Week 0 to 48||0||
48741277|NCT04439539|102151621|FG001|NOT COMPLETED|Follow-up (FU): FU Week 0 to 48||6||
48741278|NCT04439539|102151622|FG002|NOT COMPLETED|Follow-up (FU): FU Week 0 to 48||17||
48741279|NCT04487080|102151623|FG000|STARTED|Overall Study||429||
48741280|NCT04487080|102151624|FG001|STARTED|Overall Study||429||
48741281|NCT04487080|102151625|FG002|STARTED|Overall Study||216||
48741282|NCT04487080|102151623|FG000|Treated|Overall Study||421||
48741283|NCT04487080|102151624|FG001|Treated|Overall Study||428||
48741284|NCT04487080|102151625|FG002|Treated|Overall Study||213||
48741285|NCT04487080|102151623|FG000|COMPLETED|Overall Study||94||
48741286|NCT04487080|102151624|FG001|COMPLETED|Overall Study||113||
48741287|NCT04487080|102151625|FG002|COMPLETED|Overall Study||54||
48741288|NCT04487080|102151623|FG000|NOT COMPLETED|Overall Study||335||
48741289|NCT04487080|102151624|FG001|NOT COMPLETED|Overall Study||316||
48741290|NCT04487080|102151625|FG002|NOT COMPLETED|Overall Study||162||
48741291|NCT02784171|102151626|FG000|STARTED|Overall Study||21||
48741292|NCT02784171|102151627|FG001|STARTED|Overall Study||19||
48741293|NCT02784171|102151628|FG002|STARTED|Overall Study||40||
48741294|NCT02784171|102151629|FG003|STARTED|Overall Study||218||
48741295|NCT02784171|102151630|FG004|STARTED|Overall Study||222||
48741296|NCT02784171|102151626|FG000|COMPLETED|Overall Study||21||
48741297|NCT02784171|102151627|FG001|COMPLETED|Overall Study||19||
48741298|NCT02784171|102151628|FG002|COMPLETED|Overall Study||40||
48741299|NCT02784171|102151629|FG003|COMPLETED|Overall Study||218||
48741300|NCT02784171|102151630|FG004|COMPLETED|Overall Study||222||
48741301|NCT02784171|102151626|FG000|NOT COMPLETED|Overall Study||0||
48741302|NCT02784171|102151627|FG001|NOT COMPLETED|Overall Study||0||
48741303|NCT02784171|102151628|FG002|NOT COMPLETED|Overall Study||0||
48741304|NCT02784171|102151629|FG003|NOT COMPLETED|Overall Study||0||
48741305|NCT02784171|102151630|FG004|NOT COMPLETED|Overall Study||0||
48741306|NCT05590728|102151631|FG000|STARTED|Overall Study||4||
48741307|NCT05590728|102151632|FG001|STARTED|Overall Study||4||
48741308|NCT05590728|102151633|FG002|STARTED|Overall Study||4||
48741309|NCT05590728|102151634|FG003|STARTED|Overall Study||4||
48741310|NCT05590728|102151635|FG004|STARTED|Overall Study||0||
48741311|NCT05590728|102151631|FG000|Started Infusion|Overall Study||4||
48741312|NCT05590728|102151632|FG001|Started Infusion|Overall Study||4||
48741313|NCT05590728|102151633|FG002|Started Infusion|Overall Study||4||
48741314|NCT05590728|102151634|FG003|Started Infusion|Overall Study||4||
48741315|NCT05590728|102151635|FG004|Started Infusion|Overall Study||0||
48323341|NCT00345176|101118200|FG002|NOT COMPLETED|Overall Study||6||
48323342|NCT00345176|101118201|FG003|NOT COMPLETED|Overall Study||10||
48323343|NCT02970292|101118202|FG000|STARTED|Overall Study||198||
48741316|NCT05590728|102151631|FG000|Completed Infusion|Overall Study||4||
48741317|NCT05590728|102151632|FG001|Completed Infusion|Overall Study||4||
48741318|NCT05590728|102151633|FG002|Completed Infusion|Overall Study||4||
48741319|NCT05590728|102151634|FG003|Completed Infusion|Overall Study||4||
48741320|NCT05590728|102151635|FG004|Completed Infusion|Overall Study||0||
48741321|NCT05590728|102151631|FG000|Completed Bronchoscopy With BAL|Overall Study||4||
48741322|NCT05590728|102151632|FG001|Completed Bronchoscopy With BAL|Overall Study||4||
48741323|NCT05590728|102151633|FG002|Completed Bronchoscopy With BAL|Overall Study||4||
48741324|NCT05590728|102151634|FG003|Completed Bronchoscopy With BAL|Overall Study||4||
48741325|NCT05590728|102151635|FG004|Completed Bronchoscopy With BAL|Overall Study||0||
48741326|NCT05590728|102151631|FG000|Completed All PK Blood Draws|Overall Study||3||
48741327|NCT05590728|102151632|FG001|Completed All PK Blood Draws|Overall Study||4||
48741328|NCT05590728|102151633|FG002|Completed All PK Blood Draws|Overall Study||4||
48741329|NCT05590728|102151634|FG003|Completed All PK Blood Draws|Overall Study||4||
48741330|NCT05590728|102151635|FG004|Completed All PK Blood Draws|Overall Study||0||
48162104|NCT01830595|100718885|FG000|NOT COMPLETED|Second Period||0||
48162105|NCT01830595|100718886|FG001|NOT COMPLETED|Second Period||0||
48162106|NCT03585296|100718887|FG000|STARTED|Overall Study||22||
48162107|NCT03585296|100718887|FG000|COMPLETED|Overall Study||17||
48162108|NCT03585296|100718887|FG000|NOT COMPLETED|Overall Study||5||
48162109|NCT00246337|100718888|FG000|STARTED|Overall Study||147||
48162110|NCT00246337|100718889|FG001|STARTED|Overall Study||16||
48162111|NCT00246337|100718890|FG002|STARTED|Overall Study||18||
48162112|NCT00246337|100718891|FG003|STARTED|Overall Study||17||
48162113|NCT00246337|100718892|FG004|STARTED|Overall Study||16||
48162114|NCT00246337|100718893|FG005|STARTED|Overall Study||54||
48162115|NCT00246337|100718894|FG006|STARTED|Overall Study||54||
48162116|NCT00246337|100718895|FG007|STARTED|Overall Study||53||
48162117|NCT00246337|100718896|FG008|STARTED|Overall Study||45||
48162118|NCT00246337|100718888|FG000|Completed Period (Initial Dose)|Overall Study||46||
48162119|NCT00246337|100718889|FG001|Completed Period (Initial Dose)|Overall Study||4||
48162120|NCT00246337|100718890|FG002|Completed Period (Initial Dose)|Overall Study||9||
48162121|NCT00246337|100718891|FG003|Completed Period (Initial Dose)|Overall Study||5||
48162122|NCT00246337|100718892|FG004|Completed Period (Initial Dose)|Overall Study||8||
48162123|NCT00246337|100718893|FG005|Completed Period (Initial Dose)|Overall Study||29||
48162124|NCT00246337|100718894|FG006|Completed Period (Initial Dose)|Overall Study||29||
48162125|NCT00246337|100718895|FG007|Completed Period (Initial Dose)|Overall Study||27||
48162126|NCT00246337|100718896|FG008|Completed Period (Initial Dose)|Overall Study||19||
48741331|NCT05590728|102151631|FG000|Completed All Plasma Urea Blood Draws|Overall Study||3||
48741332|NCT05590728|102151632|FG001|Completed All Plasma Urea Blood Draws|Overall Study||4||
48162127|NCT00246337|100718888|FG000|Completed Period (Both Doses)|Overall Study||69||
48162128|NCT00246337|100718889|FG001|Completed Period (Both Doses)|Overall Study||10||
48162129|NCT00246337|100718890|FG002|Completed Period (Both Doses)|Overall Study||6||
48162130|NCT00246337|100718891|FG003|Completed Period (Both Doses)|Overall Study||11||
48162131|NCT00246337|100718892|FG004|Completed Period (Both Doses)|Overall Study||4||
48741333|NCT05590728|102151633|FG002|Completed All Plasma Urea Blood Draws|Overall Study||4||
48741334|NCT05590728|102151634|FG003|Completed All Plasma Urea Blood Draws|Overall Study||4||
48162132|NCT00246337|100718893|FG005|Completed Period (Both Doses)|Overall Study||10||
48162133|NCT00246337|100718894|FG006|Completed Period (Both Doses)|Overall Study||16||
48162134|NCT00246337|100718895|FG007|Completed Period (Both Doses)|Overall Study||13||
48162135|NCT00246337|100718896|FG008|Completed Period (Both Doses)|Overall Study||15||
48162136|NCT00246337|100718888|FG000|COMPLETED|Overall Study||115||
48162137|NCT00246337|100718889|FG001|COMPLETED|Overall Study||14||
48162138|NCT00246337|100718890|FG002|COMPLETED|Overall Study||15||
48162139|NCT00246337|100718891|FG003|COMPLETED|Overall Study||16||
48162140|NCT00246337|100718892|FG004|COMPLETED|Overall Study||12||
48162141|NCT00246337|100718893|FG005|COMPLETED|Overall Study||39||
48162142|NCT00246337|100718894|FG006|COMPLETED|Overall Study||45||
48162143|NCT00246337|100718895|FG007|COMPLETED|Overall Study||40||
48162144|NCT00246337|100718896|FG008|COMPLETED|Overall Study||34||
48162145|NCT00246337|100718888|FG000|NOT COMPLETED|Overall Study||32||
48162146|NCT00246337|100718889|FG001|NOT COMPLETED|Overall Study||2||
48162147|NCT00246337|100718890|FG002|NOT COMPLETED|Overall Study||3||
48162148|NCT00246337|100718891|FG003|NOT COMPLETED|Overall Study||1||
48162149|NCT00246337|100718892|FG004|NOT COMPLETED|Overall Study||4||
48162150|NCT00246337|100718893|FG005|NOT COMPLETED|Overall Study||15||
48162151|NCT00246337|100718894|FG006|NOT COMPLETED|Overall Study||9||
48162152|NCT00246337|100718895|FG007|NOT COMPLETED|Overall Study||13||
48162153|NCT00246337|100718896|FG008|NOT COMPLETED|Overall Study||11||
48162154|NCT03324880|100718897|FG000|STARTED|Overall Study||48||
48617781|NCT01909804|101849650|FG009|STARTED|Overall Study||29||
48617782|NCT01909804|101849651|FG010|STARTED|Overall Study||27||
48617783|NCT01909804|101849652|FG011|STARTED|Overall Study||29||
48741335|NCT05590728|102151635|FG004|Completed All Plasma Urea Blood Draws|Overall Study||0||
48741336|NCT05590728|102151631|FG000|COMPLETED|Overall Study||4||
48741337|NCT05590728|102151632|FG001|COMPLETED|Overall Study||4||
48162155|NCT03324880|100718898|FG001|STARTED|Overall Study||45||
48162156|NCT03324880|100718897|FG000|COMPLETED|Overall Study||46||
48162157|NCT03324880|100718898|FG001|COMPLETED|Overall Study||39||
48162158|NCT03324880|100718897|FG000|NOT COMPLETED|Overall Study||2||
48323344|NCT02970292|101118203|FG001|STARTED|Overall Study||198||
48323345|NCT02970292|101118202|FG000|COMPLETED|Overall Study||174||
48323346|NCT02970292|101118203|FG001|COMPLETED|Overall Study||190||
48323347|NCT02970292|101118202|FG000|NOT COMPLETED|Overall Study||24||
48323348|NCT02970292|101118203|FG001|NOT COMPLETED|Overall Study||8||
48323349|NCT02500121|101118204|FG000|STARTED|Overall Study||53||
48323350|NCT02500121|101118205|FG001|STARTED|Overall Study||55||
48323351|NCT02500121|101118204|FG000|Crossover to Pembrolizumab|Overall Study||27||
48323352|NCT02500121|101118205|FG001|Crossover to Pembrolizumab|Overall Study||0||
48323353|NCT02500121|101118204|FG000|COMPLETED|Overall Study||26|All subjects that|
48323354|NCT02500121|101118205|FG001|COMPLETED|Overall Study||29|All subjects that|
48323355|NCT02500121|101118204|FG000|NOT COMPLETED|Overall Study||27||
48323356|NCT02500121|101118205|FG001|NOT COMPLETED|Overall Study||26||
48323357|NCT01452152|101118206|FG000|STARTED|Overall Study||5||
48323358|NCT01452152|101118207|FG001|STARTED|Overall Study||0||
48323359|NCT01452152|101118208|FG002|STARTED|Overall Study||4||
48323360|NCT01452152|101118206|FG000|COMPLETED|Overall Study||0||
48323361|NCT01452152|101118207|FG001|COMPLETED|Overall Study||0||
48617784|NCT01909804|101849641|FG000|COMPLETED|Overall Study||22||
48617785|NCT01909804|101849642|FG001|COMPLETED|Overall Study||27||
48617786|NCT01909804|101849643|FG002|COMPLETED|Overall Study||27||
48617787|NCT01909804|101849644|FG003|COMPLETED|Overall Study||26||
48741338|NCT05590728|102151633|FG002|COMPLETED|Overall Study||4||
48741339|NCT05590728|102151634|FG003|COMPLETED|Overall Study||4||
48741340|NCT05590728|102151635|FG004|COMPLETED|Overall Study||0||
48741341|NCT05590728|102151631|FG000|NOT COMPLETED|Overall Study||0||
48741342|NCT05590728|102151632|FG001|NOT COMPLETED|Overall Study||0||
48741343|NCT05590728|102151633|FG002|NOT COMPLETED|Overall Study||0||
48741344|NCT05590728|102151634|FG003|NOT COMPLETED|Overall Study||0||
48741345|NCT05590728|102151635|FG004|NOT COMPLETED|Overall Study||0||
48741346|NCT03081884|102151636|FG000|STARTED|Overall Study||61||
48162159|NCT03324880|100718898|FG001|NOT COMPLETED|Overall Study||6||
48323362|NCT01452152|101118208|FG002|COMPLETED|Overall Study||0||
48323363|NCT01452152|101118206|FG000|NOT COMPLETED|Overall Study||5||
48617788|NCT01909804|101849645|FG004|COMPLETED|Overall Study||18||
48741347|NCT03081884|102151636|FG000|COMPLETED|Overall Study||57||
48741348|NCT03081884|102151636|FG000|NOT COMPLETED|Overall Study||4||
48741349|NCT02346461|102151637|FG000|STARTED|Overall Study||6||
48162160|NCT03518125|100718899|FG000|STARTED|Overall Study||50||
48162161|NCT03518125|100718900|FG001|STARTED|Overall Study||50||
48162162|NCT03518125|100718901|FG002|STARTED|Overall Study||49||
48162163|NCT03518125|100718902|FG003|STARTED|Overall Study||52||
48162164|NCT03518125|100718903|FG004|STARTED|Overall Study||52||
48162165|NCT03518125|100718904|FG005|STARTED|Overall Study||52||
48323364|NCT01452152|101118207|FG001|NOT COMPLETED|Overall Study||0||
48323365|NCT01452152|101118208|FG002|NOT COMPLETED|Overall Study||4||
48617789|NCT01909804|101849646|FG005|COMPLETED|Overall Study||21||
48617790|NCT01909804|101849647|FG006|COMPLETED|Overall Study||25||
48617791|NCT01909804|101849648|FG007|COMPLETED|Overall Study||25||
48741350|NCT02346461|102151638|FG001|STARTED|Overall Study||6||
48741351|NCT02346461|102151637|FG000|COMPLETED|Overall Study||6||
48617792|NCT01909804|101849649|FG008|COMPLETED|Overall Study||27||
48617793|NCT01909804|101849650|FG009|COMPLETED|Overall Study||28||
48617794|NCT01909804|101849651|FG010|COMPLETED|Overall Study||26||
48617795|NCT01909804|101849652|FG011|COMPLETED|Overall Study||26||
48617796|NCT01909804|101849641|FG000|NOT COMPLETED|Overall Study||4||
48617797|NCT01909804|101849642|FG001|NOT COMPLETED|Overall Study||1||
48617798|NCT01909804|101849643|FG002|NOT COMPLETED|Overall Study||0||
48617799|NCT01909804|101849644|FG003|NOT COMPLETED|Overall Study||0||
48617800|NCT01909804|101849645|FG004|NOT COMPLETED|Overall Study||8||
48617801|NCT01909804|101849646|FG005|NOT COMPLETED|Overall Study||4||
48617802|NCT01909804|101849647|FG006|NOT COMPLETED|Overall Study||2||
48617803|NCT01909804|101849648|FG007|NOT COMPLETED|Overall Study||1||
48617804|NCT01909804|101849649|FG008|NOT COMPLETED|Overall Study||0||
48617805|NCT01909804|101849650|FG009|NOT COMPLETED|Overall Study||1||
48617806|NCT01909804|101849651|FG010|NOT COMPLETED|Overall Study||1||
48617807|NCT01909804|101849652|FG011|NOT COMPLETED|Overall Study||3||
48617808|NCT04611542|101849653|FG000|STARTED|Overall Study||30||
48617809|NCT04611542|101849653|FG000|COMPLETED|Overall Study||28||
48617810|NCT04611542|101849653|FG000|NOT COMPLETED|Overall Study||2||
48617811|NCT03204643|101849654|FG000|STARTED|Overall Study||323|All those randomized to the intervention were included in the analysis|
48617812|NCT03204643|101849655|FG001|STARTED|Overall Study||314|All those randomized to the intervention were included in the analysis|
48617813|NCT03204643|101849654|FG000|COMPLETED|Overall Study||323||
48617814|NCT03204643|101849655|FG001|COMPLETED|Overall Study||314||
48617815|NCT03204643|101849654|FG000|NOT COMPLETED|Overall Study||0||
48617816|NCT03204643|101849655|FG001|NOT COMPLETED|Overall Study||0||
48617817|NCT01105312|101849656|FG000|STARTED|Overall Study||16||
48617818|NCT01105312|101849657|FG001|STARTED|Overall Study||6||
48323366|NCT02722863|101118209|FG000|STARTED|Overall Study||908||
48323367|NCT02722863|101118209|FG000|COMPLETED|Overall Study||908||
48323368|NCT02722863|101118209|FG000|NOT COMPLETED|Overall Study||0||
48323369|NCT00522431|101118210|FG000|STARTED|Overall Study||149||
48323370|NCT00522431|101118210|FG000|COMPLETED|Overall Study||138||
48323371|NCT00522431|101118210|FG000|NOT COMPLETED|Overall Study||11||
48323372|NCT02246062|101118211|FG000|STARTED|Overall Study||21||
48323373|NCT02246062|101118212|FG001|STARTED|Overall Study||21||
48323374|NCT02246062|101118213|FG002|STARTED|Overall Study||21||
48323375|NCT02246062|101118214|FG003|STARTED|Overall Study||21||
48323376|NCT02246062|101118211|FG000|COMPLETED|Overall Study||21||
48323377|NCT02246062|101118212|FG001|COMPLETED|Overall Study||21||
48323378|NCT02246062|101118213|FG002|COMPLETED|Overall Study||21||
48323379|NCT02246062|101118214|FG003|COMPLETED|Overall Study||21||
48323380|NCT02246062|101118211|FG000|NOT COMPLETED|Overall Study||0||
48323381|NCT02246062|101118212|FG001|NOT COMPLETED|Overall Study||0||
48323382|NCT02246062|101118213|FG002|NOT COMPLETED|Overall Study||0||
48323383|NCT02246062|101118214|FG003|NOT COMPLETED|Overall Study||0||
48323384|NCT01437397|101118215|FG000|STARTED|Overall Study||338||
48323385|NCT01437397|101118216|FG001|STARTED|Overall Study||338||
48323386|NCT01437397|101118217|FG002|STARTED|Overall Study||340||
48323387|NCT01437397|101118218|FG003|STARTED|Overall Study||339||
48323388|NCT01437397|101118219|FG004|STARTED|Overall Study||337||
48323389|NCT01437397|101118215|FG000|COMPLETED|Overall Study||272||
48323390|NCT01437397|101118216|FG001|COMPLETED|Overall Study||276||
48323391|NCT01437397|101118217|FG002|COMPLETED|Overall Study||268||
48323392|NCT01437397|101118218|FG003|COMPLETED|Overall Study||270||
48323393|NCT01437397|101118219|FG004|COMPLETED|Overall Study||236||
48323394|NCT01437397|101118215|FG000|NOT COMPLETED|Overall Study||66||
48323395|NCT01437397|101118216|FG001|NOT COMPLETED|Overall Study||62||
48323396|NCT01437397|101118217|FG002|NOT COMPLETED|Overall Study||72||
48323397|NCT01437397|101118218|FG003|NOT COMPLETED|Overall Study||69||
48323398|NCT01437397|101118219|FG004|NOT COMPLETED|Overall Study||101||
48617819|NCT01105312|101849658|FG002|STARTED|Overall Study||6||
48617820|NCT01105312|101849656|FG000|COMPLETED|Overall Study||13||
48617821|NCT01105312|101849657|FG001|COMPLETED|Overall Study||6||
48617822|NCT01105312|101849658|FG002|COMPLETED|Overall Study||6||
48617823|NCT01105312|101849656|FG000|NOT COMPLETED|Overall Study||3||
48323399|NCT00768521|101118220|FG000|STARTED|Period 1||9||
48323400|NCT00768521|101118221|FG001|STARTED|Period 1||11||
48323401|NCT00768521|101118220|FG000|COMPLETED|Period 1||9||
48323402|NCT00768521|101118221|FG001|COMPLETED|Period 1||11||
48323403|NCT00768521|101118220|FG000|NOT COMPLETED|Period 1||0||
48323404|NCT00768521|101118221|FG001|NOT COMPLETED|Period 1||0||
48323405|NCT00768521|101118220|FG000|STARTED|Period 2||9||
48323406|NCT00768521|101118221|FG001|STARTED|Period 2||11||
48408428|NCT01432938|101331760|FG000|STARTED|Second Intervention||12||
48617824|NCT01105312|101849657|FG001|NOT COMPLETED|Overall Study||0||
48617825|NCT01105312|101849658|FG002|NOT COMPLETED|Overall Study||0||
48617826|NCT02826161|101849659|FG000|STARTED|Overall Study||1||
48617827|NCT02826161|101849660|FG001|STARTED|Overall Study||3||
48617828|NCT02826161|101849659|FG000|Discontinued Due to Treatment Related AE|Overall Study||1||
48617829|NCT02826161|101849660|FG001|Discontinued Due to Treatment Related AE|Overall Study||0||
48617830|NCT02826161|101849659|FG000|Discontinued Due to Death|Overall Study||0||
48617831|NCT02826161|101849660|FG001|Discontinued Due to Death|Overall Study||1||
48617832|NCT02826161|101849659|FG000|Discontinued Due to Patient Withdrawal|Overall Study||0||
48323407|NCT00768521|101118220|FG000|COMPLETED|Period 2||9||
48323408|NCT00768521|101118221|FG001|COMPLETED|Period 2||11||
48323409|NCT00768521|101118220|FG000|NOT COMPLETED|Period 2||0||
48323410|NCT00768521|101118221|FG001|NOT COMPLETED|Period 2||0||
48323411|NCT00385255|101118222|FG000|STARTED|Overall Study||860||
48323412|NCT00385255|101118223|FG001|STARTED|Overall Study||858||
48323413|NCT00385255|101118222|FG000|≥ 65 Years of Age (YOA) Cohort|Overall Study||112||
48323414|NCT00385255|101118223|FG001|≥ 65 Years of Age (YOA) Cohort|Overall Study||109||
48323415|NCT00385255|101118222|FG000|19-64 Years of Age (YOA) Cohort|Overall Study||748||
48323416|NCT00385255|101118223|FG001|19-64 Years of Age (YOA) Cohort|Overall Study||749||
48323417|NCT00385255|101118222|FG000|COMPLETED|Overall Study||839||
48323418|NCT00385255|101118223|FG001|COMPLETED|Overall Study||785||
48323419|NCT00385255|101118222|FG000|NOT COMPLETED|Overall Study||21||
48323420|NCT00385255|101118223|FG001|NOT COMPLETED|Overall Study||73||
48323421|NCT01757678|101118224|FG000|STARTED|Overall Study||276||
48323422|NCT01757678|101118224|FG000|COMPLETED|Overall Study||276||
48617833|NCT02826161|101849660|FG001|Discontinued Due to Patient Withdrawal|Overall Study||1||
48617834|NCT02826161|101849659|FG000|Discontinued Due to Withdrawal of ICF From Further FU|Overall Study||1||
48323423|NCT01757678|101118224|FG000|NOT COMPLETED|Overall Study||0||
48323424|NCT03652662|101118225|FG000|STARTED|Overall Study||18||
48323425|NCT03652662|101118226|FG001|STARTED|Overall Study||16||
48323426|NCT03652662|101118225|FG000|COMPLETED|Overall Study||15||
48323427|NCT03652662|101118226|FG001|COMPLETED|Overall Study||15||
48323428|NCT03652662|101118225|FG000|NOT COMPLETED|Overall Study||3||
48323429|NCT03652662|101118226|FG001|NOT COMPLETED|Overall Study||1||
48323430|NCT00993928|101118227|FG000|STARTED|Overall Study||48||
48323431|NCT00993928|101118228|FG001|STARTED|Overall Study||45||
48323432|NCT00993928|101118227|FG000|COMPLETED|Overall Study||43||
48323433|NCT00993928|101118228|FG001|COMPLETED|Overall Study||38||
48323434|NCT00993928|101118227|FG000|NOT COMPLETED|Overall Study||5||
48323435|NCT00993928|101118228|FG001|NOT COMPLETED|Overall Study||7||
48323436|NCT05194540|101118229|FG000|STARTED|Overall Study||136||
48323437|NCT05194540|101118229|FG000|COMPLETED|Overall Study||117||
48323438|NCT05194540|101118229|FG000|NOT COMPLETED|Overall Study||19||
48323439|NCT00004259|101118230|FG000|STARTED|Overall Study||98||
48323440|NCT00004259|101118231|FG001|STARTED|Overall Study||103||
48323441|NCT00004259|101118232|FG002|STARTED|Overall Study||15||
48323442|NCT00004259|101118233|FG003|STARTED|Overall Study||14||
48323443|NCT00004259|101118230|FG000|COMPLETED|Overall Study||97||
48323444|NCT00004259|101118231|FG001|COMPLETED|Overall Study||99||
48323445|NCT00004259|101118232|FG002|COMPLETED|Overall Study||15||
48323446|NCT00004259|101118233|FG003|COMPLETED|Overall Study||14||
48323447|NCT00004259|101118230|FG000|NOT COMPLETED|Overall Study||1||
48323448|NCT00004259|101118231|FG001|NOT COMPLETED|Overall Study||4||
48323449|NCT00004259|101118232|FG002|NOT COMPLETED|Overall Study||0||
48323450|NCT00004259|101118233|FG003|NOT COMPLETED|Overall Study||0||
48323451|NCT01258504|101118234|FG000|STARTED|Bosentan Single Dose||13||
48323452|NCT01258504|101118234|FG000|COMPLETED|Bosentan Single Dose||13||
48323453|NCT01258504|101118234|FG000|NOT COMPLETED|Bosentan Single Dose||0||
48323454|NCT01258504|101118234|FG000|STARTED|Bosentan Steady-state||13||
48323455|NCT01258504|101118234|FG000|COMPLETED|Bosentan Steady-state||13||
48323456|NCT01258504|101118234|FG000|NOT COMPLETED|Bosentan Steady-state||0||
48323457|NCT01258504|101118234|FG000|STARTED|Bosentan and SJW||13||
48323458|NCT01258504|101118234|FG000|COMPLETED|Bosentan and SJW||13||
48323459|NCT01258504|101118234|FG000|NOT COMPLETED|Bosentan and SJW||0||
48323460|NCT00082888|101118235|FG000|STARTED|Overall Study||42||
48323461|NCT00082888|101118236|FG001|STARTED|Overall Study||15||
48323462|NCT00082888|101118237|FG002|STARTED|Overall Study||36||
48323463|NCT00082888|101118235|FG000|COMPLETED|Overall Study||41||
48323464|NCT00082888|101118236|FG001|COMPLETED|Overall Study||15||
48323465|NCT00082888|101118237|FG002|COMPLETED|Overall Study||36||
48323466|NCT00082888|101118235|FG000|NOT COMPLETED|Overall Study||1||
48323467|NCT00082888|101118236|FG001|NOT COMPLETED|Overall Study||0||
48323468|NCT00082888|101118237|FG002|NOT COMPLETED|Overall Study||0||
48323469|NCT01981590|101118238|FG000|STARTED|Overall Study||15||
48323470|NCT01981590|101118238|FG000|COMPLETED|Overall Study||15||
48323471|NCT01981590|101118238|FG000|NOT COMPLETED|Overall Study||0||
48323472|NCT02370615|101118239|FG000|STARTED|Overall Study||16||
48323473|NCT02370615|101118240|FG001|STARTED|Overall Study||18||
48323474|NCT02370615|101118239|FG000|COMPLETED|Overall Study||15||
48323475|NCT02370615|101118240|FG001|COMPLETED|Overall Study||18||
48323476|NCT02370615|101118239|FG000|NOT COMPLETED|Overall Study||1||
48323477|NCT02370615|101118240|FG001|NOT COMPLETED|Overall Study||0||
48323478|NCT01883635|101118241|FG000|STARTED|Overall Study||24||
48323479|NCT01883635|101118242|FG001|STARTED|Overall Study||20||
48323480|NCT01883635|101118241|FG000|COMPLETED|Overall Study||20||
48323481|NCT01883635|101118242|FG001|COMPLETED|Overall Study||20||
48323482|NCT01883635|101118241|FG000|NOT COMPLETED|Overall Study||4||
48657097|NCT03648372|101943774|FG017|NOT COMPLETED|Overall Study||6||
48323483|NCT01883635|101118242|FG001|NOT COMPLETED|Overall Study||0||
48323484|NCT00713427|101118243|FG000|STARTED|Overall Study||70||
48323485|NCT00713427|101118243|FG000|COMPLETED|Overall Study||66||
48323486|NCT00713427|101118243|FG000|NOT COMPLETED|Overall Study||4||
48323487|NCT02937818|101118244|FG000|STARTED|Overall Study||21||
48323488|NCT02937818|101118245|FG001|STARTED|Overall Study||20||
48323489|NCT02937818|101118246|FG002|STARTED|Overall Study||10||
48323490|NCT02937818|101118247|FG003|STARTED|Overall Study||21||
48323491|NCT02937818|101118244|FG000|COMPLETED|Overall Study||0||
48323492|NCT02937818|101118245|FG001|COMPLETED|Overall Study||0||
48323493|NCT02937818|101118246|FG002|COMPLETED|Overall Study||0||
48323494|NCT02937818|101118247|FG003|COMPLETED|Overall Study||0||
48323495|NCT02937818|101118244|FG000|NOT COMPLETED|Overall Study||21||
48323496|NCT02937818|101118245|FG001|NOT COMPLETED|Overall Study||20||
48323497|NCT02937818|101118246|FG002|NOT COMPLETED|Overall Study||10||
48323498|NCT02937818|101118247|FG003|NOT COMPLETED|Overall Study||21||
48323499|NCT02646982|101118248|FG000|STARTED|Overall Study||38||
48323500|NCT02646982|101118249|FG001|STARTED|Overall Study||39||
48323501|NCT02646982|101118248|FG000|COMPLETED|Overall Study||35||
48323502|NCT02646982|101118249|FG001|COMPLETED|Overall Study||37||
48323503|NCT02646982|101118248|FG000|NOT COMPLETED|Overall Study||3||
48323504|NCT02646982|101118249|FG001|NOT COMPLETED|Overall Study||2||
48323505|NCT01058096|101118250|FG000|STARTED|Double-blind Treatment Phase||154||
48323506|NCT01058096|101118251|FG001|STARTED|Double-blind Treatment Phase||158||
48323507|NCT01058096|101118250|FG000|COMPLETED|Double-blind Treatment Phase||106||
48323508|NCT01058096|101118251|FG001|COMPLETED|Double-blind Treatment Phase||108||
48323509|NCT01058096|101118250|FG000|NOT COMPLETED|Double-blind Treatment Phase||48||
48323510|NCT01058096|101118251|FG001|NOT COMPLETED|Double-blind Treatment Phase||50||
48323511|NCT01058096|101118250|FG000|STARTED|Safety Follow-up||133||
48323512|NCT01058096|101118251|FG001|STARTED|Safety Follow-up||134||
48323513|NCT01058096|101118250|FG000|COMPLETED|Safety Follow-up||129||
48323514|NCT01058096|101118251|FG001|COMPLETED|Safety Follow-up||130||
48323515|NCT01058096|101118250|FG000|NOT COMPLETED|Safety Follow-up||4||
48323516|NCT01058096|101118251|FG001|NOT COMPLETED|Safety Follow-up||4||
48323517|NCT02787863|101118252|FG000|STARTED|Overall Study||33||
48323518|NCT02787863|101118253|FG001|STARTED|Overall Study||34||
48323519|NCT02787863|101118254|FG002|STARTED|Overall Study||25||
48323520|NCT02787863|101118255|FG003|STARTED|Overall Study||25||
48323521|NCT02787863|101118256|FG004|STARTED|Overall Study||32||
48323522|NCT02787863|101118257|FG005|STARTED|Overall Study||18||
48323523|NCT02787863|101118258|FG006|STARTED|Overall Study||25||
48323524|NCT02787863|101118259|FG007|STARTED|Overall Study||27||
48323525|NCT02787863|101118252|FG000|1 Year After Vaccination|Overall Study||32||
48323526|NCT02787863|101118253|FG001|1 Year After Vaccination|Overall Study||33||
48323527|NCT02787863|101118254|FG002|1 Year After Vaccination|Overall Study||23||
48323528|NCT02787863|101118255|FG003|1 Year After Vaccination|Overall Study||25||
48323529|NCT02787863|101118256|FG004|1 Year After Vaccination|Overall Study||32||
48323530|NCT02787863|101118257|FG005|1 Year After Vaccination|Overall Study||18||
48323531|NCT02787863|101118258|FG006|1 Year After Vaccination|Overall Study||25||
48323532|NCT02787863|101118259|FG007|1 Year After Vaccination|Overall Study||27||
48323533|NCT02787863|101118252|FG000|4 Years After Vaccination|Overall Study||32||
48323534|NCT02787863|101118253|FG001|4 Years After Vaccination|Overall Study||33||
48323535|NCT02787863|101118254|FG002|4 Years After Vaccination|Overall Study||23||
48323536|NCT02787863|101118255|FG003|4 Years After Vaccination|Overall Study||25||
48323537|NCT02787863|101118256|FG004|4 Years After Vaccination|Overall Study||32||
48323538|NCT02787863|101118257|FG005|4 Years After Vaccination|Overall Study||18||
48323539|NCT02787863|101118258|FG006|4 Years After Vaccination|Overall Study||25||
48323540|NCT02787863|101118259|FG007|4 Years After Vaccination|Overall Study||27||
48323541|NCT02787863|101118252|FG000|COMPLETED|Overall Study||32||
48323542|NCT02787863|101118253|FG001|COMPLETED|Overall Study||33||
48323543|NCT02787863|101118254|FG002|COMPLETED|Overall Study||23||
48323544|NCT02787863|101118255|FG003|COMPLETED|Overall Study||25||
48323545|NCT02787863|101118256|FG004|COMPLETED|Overall Study||32||
48323546|NCT02787863|101118257|FG005|COMPLETED|Overall Study||18||
48323547|NCT02787863|101118258|FG006|COMPLETED|Overall Study||25||
48323548|NCT02787863|101118259|FG007|COMPLETED|Overall Study||27||
48323549|NCT02787863|101118252|FG000|NOT COMPLETED|Overall Study||1||
48323550|NCT02787863|101118253|FG001|NOT COMPLETED|Overall Study||1||
48323551|NCT02787863|101118254|FG002|NOT COMPLETED|Overall Study||2||
48323552|NCT02787863|101118255|FG003|NOT COMPLETED|Overall Study||0||
48323553|NCT02787863|101118256|FG004|NOT COMPLETED|Overall Study||0||
48323554|NCT02787863|101118257|FG005|NOT COMPLETED|Overall Study||0||
48323555|NCT02787863|101118258|FG006|NOT COMPLETED|Overall Study||0||
48323556|NCT02787863|101118259|FG007|NOT COMPLETED|Overall Study||0||
48323557|NCT00586495|101118260|FG000|STARTED|Treatment Period||95||
48323558|NCT00586495|101118260|FG000|COMPLETED|Treatment Period||0||
48323559|NCT00586495|101118260|FG000|NOT COMPLETED|Treatment Period||95||
48323560|NCT00586495|101118260|FG000|STARTED|Follow-up||92||
48323561|NCT00586495|101118260|FG000|COMPLETED|Follow-up||0||
48323562|NCT00586495|101118260|FG000|NOT COMPLETED|Follow-up||92||
48323563|NCT04191382|101118261|FG000|STARTED|Overall Study||34|Randomized|
48323564|NCT04191382|101118262|FG001|STARTED|Overall Study||36|Randomized|
48323565|NCT04191382|101118263|FG002|STARTED|Overall Study||35|Randomized|
48323566|NCT04191382|101118261|FG000|Treated|Overall Study||33||
48323567|NCT04191382|101118262|FG001|Treated|Overall Study||36||
48323568|NCT04191382|101118263|FG002|Treated|Overall Study||35||
48323569|NCT04191382|101118261|FG000|COMPLETED|Overall Study||33||
48323570|NCT04191382|101118262|FG001|COMPLETED|Overall Study||36||
48323571|NCT04191382|101118263|FG002|COMPLETED|Overall Study||35||
48323572|NCT04191382|101118261|FG000|NOT COMPLETED|Overall Study||1||
48323573|NCT04191382|101118262|FG001|NOT COMPLETED|Overall Study||0||
48323574|NCT04191382|101118263|FG002|NOT COMPLETED|Overall Study||0||
48323575|NCT01425008|101118264|FG000|STARTED|Dose Escalation Phase||4||
48323576|NCT01425008|101118265|FG001|STARTED|Dose Escalation Phase||3||
48323577|NCT01425008|101118266|FG002|STARTED|Dose Escalation Phase||3||
48323578|NCT01425008|101118267|FG003|STARTED|Dose Escalation Phase||3||
48741352|NCT02346461|102151638|FG001|COMPLETED|Overall Study||6||
48741353|NCT02346461|102151637|FG000|NOT COMPLETED|Overall Study||0||
48741354|NCT02346461|102151638|FG001|NOT COMPLETED|Overall Study||0||
48741355|NCT02855268|102151639|FG000|STARTED|DB Period (up to 48 Weeks)||14||
48741356|NCT02855268|102151640|FG001|STARTED|DB Period (up to 48 Weeks)||29||
48741357|NCT02855268|102151639|FG000|COMPLETED|DB Period (up to 48 Weeks)||9||
48741358|NCT02855268|102151640|FG001|COMPLETED|DB Period (up to 48 Weeks)||19||
48741359|NCT02855268|102151639|FG000|NOT COMPLETED|DB Period (up to 48 Weeks)||5||
48741360|NCT02855268|102151640|FG001|NOT COMPLETED|DB Period (up to 48 Weeks)||10||
48741361|NCT02855268|102151639|FG000|STARTED|OLE Period (up to 96 Weeks)||9||
48741362|NCT02855268|102151640|FG001|STARTED|OLE Period (up to 96 Weeks)||19||
48741363|NCT02855268|102151639|FG000|COMPLETED|OLE Period (up to 96 Weeks)||1||
48741364|NCT02855268|102151640|FG001|COMPLETED|OLE Period (up to 96 Weeks)||0||
48741365|NCT02855268|102151639|FG000|NOT COMPLETED|OLE Period (up to 96 Weeks)||8||
48741366|NCT02855268|102151640|FG001|NOT COMPLETED|OLE Period (up to 96 Weeks)||19||
48741367|NCT00742183|102151641|FG000|STARTED|Overall Study||49||
48741368|NCT00742183|102151642|FG001|STARTED|Overall Study||51||
48741369|NCT00742183|102151641|FG000|COMPLETED|Overall Study||40||
48162166|NCT03518125|100718899|FG000|COMPLETED|Overall Study||48||
48162167|NCT03518125|100718900|FG001|COMPLETED|Overall Study||46||
48162168|NCT03518125|100718901|FG002|COMPLETED|Overall Study||49||
48162169|NCT03518125|100718902|FG003|COMPLETED|Overall Study||51||
48162170|NCT03518125|100718903|FG004|COMPLETED|Overall Study||48||
48162171|NCT03518125|100718904|FG005|COMPLETED|Overall Study||44||
48162172|NCT03518125|100718899|FG000|NOT COMPLETED|Overall Study||2||
48162173|NCT03518125|100718900|FG001|NOT COMPLETED|Overall Study||4||
48162174|NCT03518125|100718901|FG002|NOT COMPLETED|Overall Study||0||
48162175|NCT03518125|100718902|FG003|NOT COMPLETED|Overall Study||1||
48162176|NCT03518125|100718903|FG004|NOT COMPLETED|Overall Study||4||
48162177|NCT03518125|100718904|FG005|NOT COMPLETED|Overall Study||8||
48162178|NCT03474549|100718905|FG000|STARTED|Overall Study||160||
48162179|NCT03474549|100718905|FG000|COMPLETED|Overall Study||123||
48162180|NCT03474549|100718905|FG000|NOT COMPLETED|Overall Study||37||
48162181|NCT03395808|100718906|FG000|STARTED|Overall Study||251||
48162182|NCT03395808|100718906|FG000|COMPLETED|Overall Study||251||
48323579|NCT01425008|101118268|FG004|STARTED|Dose Escalation Phase||7||
48323580|NCT01425008|101118269|FG005|STARTED|Dose Escalation Phase||7||
48323581|NCT01425008|101118270|FG006|STARTED|Dose Escalation Phase||3||
48323582|NCT01425008|101118271|FG007|STARTED|Dose Escalation Phase||3||
48323583|NCT01425008|101118272|FG008|STARTED|Dose Escalation Phase||13||
48323584|NCT01425008|101118273|FG009|STARTED|Dose Escalation Phase||4||
48323585|NCT01425008|101118274|FG010|STARTED|Dose Escalation Phase||0||
48323586|NCT01425008|101118275|FG011|STARTED|Dose Escalation Phase||0||
48323587|NCT01425008|101118276|FG012|STARTED|Dose Escalation Phase||0||
48323588|NCT01425008|101118277|FG013|STARTED|Dose Escalation Phase||0||
48323589|NCT01425008|101118278|FG014|STARTED|Dose Escalation Phase||0||
48323590|NCT01425008|101118279|FG015|STARTED|Dose Escalation Phase||0||
48323591|NCT01425008|101118280|FG016|STARTED|Dose Escalation Phase||0||
48323592|NCT01425008|101118281|FG017|STARTED|Dose Escalation Phase||0||
48323593|NCT01425008|101118282|FG018|STARTED|Dose Escalation Phase||0||
48323594|NCT01425008|101118264|FG000|COMPLETED|Dose Escalation Phase||0||
48323595|NCT01425008|101118265|FG001|COMPLETED|Dose Escalation Phase||0||
48323596|NCT01425008|101118266|FG002|COMPLETED|Dose Escalation Phase||0||
48323597|NCT01425008|101118267|FG003|COMPLETED|Dose Escalation Phase||0||
48323598|NCT01425008|101118268|FG004|COMPLETED|Dose Escalation Phase||0||
48323599|NCT01425008|101118269|FG005|COMPLETED|Dose Escalation Phase||0||
48323600|NCT01425008|101118270|FG006|COMPLETED|Dose Escalation Phase||0||
48323601|NCT01425008|101118271|FG007|COMPLETED|Dose Escalation Phase||0||
48323602|NCT01425008|101118272|FG008|COMPLETED|Dose Escalation Phase||0||
48323603|NCT01425008|101118273|FG009|COMPLETED|Dose Escalation Phase||0||
48323604|NCT01425008|101118274|FG010|COMPLETED|Dose Escalation Phase||0||
48323605|NCT01425008|101118275|FG011|COMPLETED|Dose Escalation Phase||0||
48741370|NCT00742183|102151642|FG001|COMPLETED|Overall Study||39||
48741371|NCT00742183|102151641|FG000|NOT COMPLETED|Overall Study||9||
48741372|NCT00742183|102151642|FG001|NOT COMPLETED|Overall Study||12||
48741373|NCT00511134|102151643|FG000|STARTED|Overall Study||1||
48162183|NCT03395808|100718906|FG000|NOT COMPLETED|Overall Study||0||
48162184|NCT01395823|100718907|FG000|STARTED|Overall Study||137||
48162185|NCT01395823|100718908|FG001|STARTED|Overall Study||139||
48162186|NCT01395823|100718907|FG000|COMPLETED|Overall Study||122||
48162187|NCT01395823|100718908|FG001|COMPLETED|Overall Study||130||
48323606|NCT01425008|101118276|FG012|COMPLETED|Dose Escalation Phase||0||
48323607|NCT01425008|101118277|FG013|COMPLETED|Dose Escalation Phase||0||
48323608|NCT01425008|101118278|FG014|COMPLETED|Dose Escalation Phase||0||
48323609|NCT01425008|101118279|FG015|COMPLETED|Dose Escalation Phase||0||
48323610|NCT01425008|101118280|FG016|COMPLETED|Dose Escalation Phase||0||
48323611|NCT01425008|101118281|FG017|COMPLETED|Dose Escalation Phase||0||
48323612|NCT01425008|101118282|FG018|COMPLETED|Dose Escalation Phase||0||
48323613|NCT01425008|101118264|FG000|NOT COMPLETED|Dose Escalation Phase||4||
48323614|NCT01425008|101118265|FG001|NOT COMPLETED|Dose Escalation Phase||3||
48741374|NCT00511134|102151644|FG001|STARTED|Overall Study||3||
48741375|NCT00511134|102151643|FG000|COMPLETED|Overall Study||1||
48741376|NCT00511134|102151644|FG001|COMPLETED|Overall Study||1||
48741377|NCT00511134|102151643|FG000|NOT COMPLETED|Overall Study||0||
48741378|NCT00511134|102151644|FG001|NOT COMPLETED|Overall Study||2||
48741379|NCT05919888|102151645|FG000|STARTED|Overall Study||20||
48741380|NCT05919888|102151646|FG001|STARTED|Overall Study||20||
48617835|NCT02826161|101849660|FG001|Discontinued Due to Withdrawal of ICF From Further FU|Overall Study||1||
48617836|NCT02826161|101849659|FG000|COMPLETED|Overall Study||1||
48617837|NCT02826161|101849660|FG001|COMPLETED|Overall Study||3||
48617838|NCT02826161|101849659|FG000|NOT COMPLETED|Overall Study||0||
48323615|NCT01425008|101118266|FG002|NOT COMPLETED|Dose Escalation Phase||3||
48323616|NCT01425008|101118267|FG003|NOT COMPLETED|Dose Escalation Phase||3||
48323617|NCT01425008|101118268|FG004|NOT COMPLETED|Dose Escalation Phase||7||
48323618|NCT01425008|101118269|FG005|NOT COMPLETED|Dose Escalation Phase||7||
48323619|NCT01425008|101118270|FG006|NOT COMPLETED|Dose Escalation Phase||3||
48617839|NCT02826161|101849660|FG001|NOT COMPLETED|Overall Study||0||
48617840|NCT00235573|101849661|FG000|STARTED|Overall Study||21||
48617841|NCT00235573|101849661|FG000|COMPLETED|Overall Study||21||
48617842|NCT00235573|101849661|FG000|NOT COMPLETED|Overall Study||0||
48617843|NCT02595502|101849662|FG000|STARTED|Period 1||143||
48617844|NCT02595502|101849663|FG001|STARTED|Period 1||142||
48617845|NCT02595502|101849662|FG000|COMPLETED|Period 1||142||
48617846|NCT02595502|101849663|FG001|COMPLETED|Period 1||140||
48617847|NCT02595502|101849662|FG000|NOT COMPLETED|Period 1||1||
48617848|NCT02595502|101849663|FG001|NOT COMPLETED|Period 1||2||
48617849|NCT02595502|101849662|FG000|STARTED|Period 2||142||
48617850|NCT02595502|101849663|FG001|STARTED|Period 2||140||
48617851|NCT02595502|101849662|FG000|COMPLETED|Period 2||141||
48617852|NCT02595502|101849663|FG001|COMPLETED|Period 2||138||
48617853|NCT02595502|101849662|FG000|NOT COMPLETED|Period 2||1||
48741381|NCT05919888|102151647|FG002|STARTED|Overall Study||20||
48741382|NCT05919888|102151645|FG000|COMPLETED|Overall Study||20||
48741383|NCT05919888|102151646|FG001|COMPLETED|Overall Study||20||
48741384|NCT05919888|102151647|FG002|COMPLETED|Overall Study||20||
48741385|NCT05919888|102151645|FG000|NOT COMPLETED|Overall Study||0||
48741386|NCT05919888|102151646|FG001|NOT COMPLETED|Overall Study||0||
48741387|NCT05919888|102151647|FG002|NOT COMPLETED|Overall Study||0||
48741388|NCT01908530|102151648|FG000|STARTED|Overall Study||8||
48741389|NCT01908530|102151649|FG001|STARTED|Overall Study||8||
48741390|NCT01908530|102151650|FG002|STARTED|Overall Study||10||
48323620|NCT01425008|101118271|FG007|NOT COMPLETED|Dose Escalation Phase||3||
48323621|NCT01425008|101118272|FG008|NOT COMPLETED|Dose Escalation Phase||13||
48323622|NCT01425008|101118273|FG009|NOT COMPLETED|Dose Escalation Phase||4||
48323623|NCT01425008|101118274|FG010|NOT COMPLETED|Dose Escalation Phase||0||
48323624|NCT01425008|101118275|FG011|NOT COMPLETED|Dose Escalation Phase||0||
48323625|NCT01425008|101118276|FG012|NOT COMPLETED|Dose Escalation Phase||0||
48323626|NCT01425008|101118277|FG013|NOT COMPLETED|Dose Escalation Phase||0||
48617854|NCT02595502|101849663|FG001|NOT COMPLETED|Period 2||2||
48617855|NCT02595502|101849662|FG000|STARTED|Period 3||141||
48617856|NCT02595502|101849663|FG001|STARTED|Period 3||138||
48617857|NCT02595502|101849662|FG000|COMPLETED|Period 3||140||
48617858|NCT02595502|101849663|FG001|COMPLETED|Period 3||136||
48617859|NCT02595502|101849662|FG000|NOT COMPLETED|Period 3||1||
48741391|NCT01908530|102151648|FG000|COMPLETED|Overall Study||8||
48741392|NCT01908530|102151649|FG001|COMPLETED|Overall Study||8||
48741393|NCT01908530|102151650|FG002|COMPLETED|Overall Study||10||
48323627|NCT01425008|101118278|FG014|NOT COMPLETED|Dose Escalation Phase||0||
48323628|NCT01425008|101118279|FG015|NOT COMPLETED|Dose Escalation Phase||0||
48323629|NCT01425008|101118280|FG016|NOT COMPLETED|Dose Escalation Phase||0||
48323630|NCT01425008|101118281|FG017|NOT COMPLETED|Dose Escalation Phase||0||
48741394|NCT01908530|102151648|FG000|NOT COMPLETED|Overall Study||0||
48741395|NCT01908530|102151649|FG001|NOT COMPLETED|Overall Study||0||
48741396|NCT01908530|102151650|FG002|NOT COMPLETED|Overall Study||0||
48323631|NCT01425008|101118282|FG018|NOT COMPLETED|Dose Escalation Phase||0||
48617860|NCT02595502|101849663|FG001|NOT COMPLETED|Period 3||2||
48617861|NCT02381678|101849664|FG000|STARTED|Overall Study||54||
48741397|NCT00988013|102151651|FG000|STARTED|Overall Study||3||
48741398|NCT00988013|102151652|FG001|STARTED|Overall Study||3||
48741399|NCT00988013|102151653|FG002|STARTED|Overall Study||6||
48741400|NCT00988013|102151654|FG003|STARTED|Overall Study||2||
48741401|NCT00988013|102151651|FG000|COMPLETED|Overall Study||3||
48741402|NCT00988013|102151652|FG001|COMPLETED|Overall Study||3||
48617862|NCT02381678|101849665|FG001|STARTED|Overall Study||139||
48617863|NCT02381678|101849666|FG002|STARTED|Overall Study||32||
48741403|NCT00988013|102151653|FG002|COMPLETED|Overall Study||6||
48162188|NCT01395823|100718907|FG000|NOT COMPLETED|Overall Study||15||
48162189|NCT01395823|100718908|FG001|NOT COMPLETED|Overall Study||9||
48323632|NCT01425008|101118264|FG000|STARTED|Dose Expansion Phase||0||
48323633|NCT01425008|101118265|FG001|STARTED|Dose Expansion Phase||0||
48323634|NCT01425008|101118266|FG002|STARTED|Dose Expansion Phase||0||
48323635|NCT01425008|101118267|FG003|STARTED|Dose Expansion Phase||0||
48323636|NCT01425008|101118268|FG004|STARTED|Dose Expansion Phase||0||
48408429|NCT01432938|101331761|FG001|STARTED|Second Intervention||14||
48408430|NCT01432938|101331760|FG000|COMPLETED|Second Intervention||11||
48408431|NCT01432938|101331761|FG001|COMPLETED|Second Intervention||14||
48408432|NCT01432938|101331760|FG000|NOT COMPLETED|Second Intervention||1||
48408433|NCT01432938|101331761|FG001|NOT COMPLETED|Second Intervention||0||
48741404|NCT00988013|102151654|FG003|COMPLETED|Overall Study||2||
48741405|NCT00988013|102151651|FG000|NOT COMPLETED|Overall Study||0||
48741406|NCT00988013|102151652|FG001|NOT COMPLETED|Overall Study||0||
48323637|NCT01425008|101118269|FG005|STARTED|Dose Expansion Phase||0||
48323638|NCT01425008|101118270|FG006|STARTED|Dose Expansion Phase||0||
48323639|NCT01425008|101118271|FG007|STARTED|Dose Expansion Phase||0||
48323640|NCT01425008|101118272|FG008|STARTED|Dose Expansion Phase||0||
48323641|NCT01425008|101118273|FG009|STARTED|Dose Expansion Phase||0||
48323642|NCT01425008|101118274|FG010|STARTED|Dose Expansion Phase||16||
48323643|NCT01425008|101118275|FG011|STARTED|Dose Expansion Phase||8||
48323644|NCT01425008|101118276|FG012|STARTED|Dose Expansion Phase||16||
48323645|NCT01425008|101118277|FG013|STARTED|Dose Expansion Phase||1||
48323646|NCT01425008|101118278|FG014|STARTED|Dose Expansion Phase||6||
48408434|NCT00189436|101331762|FG000|STARTED|Overall Study||31||
48408435|NCT00189436|101331763|FG001|STARTED|Overall Study||30||
48408436|NCT00189436|101331762|FG000|COMPLETED|Overall Study||23||
48408437|NCT00189436|101331763|FG001|COMPLETED|Overall Study||25||
48408438|NCT00189436|101331762|FG000|NOT COMPLETED|Overall Study||8||
48408439|NCT00189436|101331763|FG001|NOT COMPLETED|Overall Study||5||
48408440|NCT00928304|101331764|FG000|STARTED|Overall Study||39||
48408441|NCT00928304|101331765|FG001|STARTED|Overall Study||70||
48408442|NCT00928304|101331764|FG000|COMPLETED|Overall Study||39||
48408443|NCT00928304|101331765|FG001|COMPLETED|Overall Study||70||
48617864|NCT02381678|101849664|FG000|COMPLETED|Overall Study||54||
48617865|NCT02381678|101849665|FG001|COMPLETED|Overall Study||139||
48617866|NCT02381678|101849666|FG002|COMPLETED|Overall Study||32||
48617867|NCT02381678|101849664|FG000|NOT COMPLETED|Overall Study||0||
48617868|NCT02381678|101849665|FG001|NOT COMPLETED|Overall Study||0||
48617869|NCT02381678|101849666|FG002|NOT COMPLETED|Overall Study||0||
48617870|NCT00485069|101849667|FG000|STARTED|Overall Study||65||
48617871|NCT00485069|101849668|FG001|STARTED|Overall Study||58||
48617872|NCT00485069|101849667|FG000|COMPLETED|Overall Study||47||
48617873|NCT00485069|101849668|FG001|COMPLETED|Overall Study||46||
48617874|NCT00485069|101849667|FG000|NOT COMPLETED|Overall Study||18||
48617875|NCT00485069|101849668|FG001|NOT COMPLETED|Overall Study||12||
48617876|NCT04131712|101849669|FG000|STARTED|Overall Study||9||
48617877|NCT04131712|101849670|FG001|STARTED|Overall Study||0||
48617878|NCT04131712|101849671|FG002|STARTED|Overall Study||19||
48617879|NCT04131712|101849672|FG003|STARTED|Overall Study||16||
48617880|NCT04131712|101849669|FG000|COMPLETED|Overall Study||9||
48617881|NCT04131712|101849670|FG001|COMPLETED|Overall Study||0||
48617882|NCT04131712|101849671|FG002|COMPLETED|Overall Study||16||
48617883|NCT04131712|101849672|FG003|COMPLETED|Overall Study||16||
48617884|NCT04131712|101849669|FG000|NOT COMPLETED|Overall Study||0||
48617885|NCT04131712|101849670|FG001|NOT COMPLETED|Overall Study||0||
48617886|NCT04131712|101849671|FG002|NOT COMPLETED|Overall Study||3||
48617887|NCT04131712|101849672|FG003|NOT COMPLETED|Overall Study||0||
48617888|NCT00627497|101849673|FG000|STARTED|Overall Study||14||
48617889|NCT00627497|101849674|FG001|STARTED|Overall Study||12||
48617890|NCT00627497|101849675|FG002|STARTED|Overall Study||4||
48617891|NCT00627497|101849676|FG003|STARTED|Overall Study||2||
48617892|NCT00627497|101849673|FG000|COMPLETED|Overall Study||13||
48617893|NCT00627497|101849674|FG001|COMPLETED|Overall Study||11||
48617894|NCT00627497|101849675|FG002|COMPLETED|Overall Study||4||
48617895|NCT00627497|101849676|FG003|COMPLETED|Overall Study||2||
48617896|NCT00627497|101849673|FG000|NOT COMPLETED|Overall Study||1||
48617897|NCT00627497|101849674|FG001|NOT COMPLETED|Overall Study||1||
48617898|NCT00627497|101849675|FG002|NOT COMPLETED|Overall Study||0||
48617899|NCT00627497|101849676|FG003|NOT COMPLETED|Overall Study||0||
48323647|NCT01425008|101118279|FG015|STARTED|Dose Expansion Phase||11||
48323648|NCT01425008|101118280|FG016|STARTED|Dose Expansion Phase||20||
48323649|NCT01425008|101118281|FG017|STARTED|Dose Expansion Phase||2||
48408444|NCT00928304|101331764|FG000|NOT COMPLETED|Overall Study||0||
48617900|NCT05502302|101849677|FG000|STARTED|Overall Study||23||
48617901|NCT05502302|101849677|FG000|COMPLETED|Overall Study||15||
48617902|NCT05502302|101849677|FG000|NOT COMPLETED|Overall Study||8||
48323650|NCT01425008|101118282|FG018|STARTED|Dose Expansion Phase||19||
48408445|NCT00928304|101331765|FG001|NOT COMPLETED|Overall Study||0||
48408446|NCT00732238|101331766|FG000|STARTED|Overall Study||33||
48408447|NCT00732238|101331767|FG001|STARTED|Overall Study||28||
48617903|NCT00305227|101849678|FG000|STARTED|Overall Study||50||
48741407|NCT00988013|102151653|FG002|NOT COMPLETED|Overall Study||0||
48617904|NCT00305227|101849679|FG001|STARTED|Overall Study||50||
48617905|NCT00305227|101849678|FG000|COMPLETED|Overall Study||43||
48323651|NCT01425008|101118264|FG000|COMPLETED|Dose Expansion Phase||0||
48323652|NCT01425008|101118265|FG001|COMPLETED|Dose Expansion Phase||0||
48323653|NCT01425008|101118266|FG002|COMPLETED|Dose Expansion Phase||0||
48323654|NCT01425008|101118267|FG003|COMPLETED|Dose Expansion Phase||0||
48741408|NCT00988013|102151654|FG003|NOT COMPLETED|Overall Study||0||
48741409|NCT02396212|102151655|FG000|STARTED|Overall Study||19||
48741410|NCT02396212|102151655|FG000|COMPLETED|Overall Study||16||
48741411|NCT02396212|102151655|FG000|NOT COMPLETED|Overall Study||3||
48741412|NCT05006261|102151656|FG000|STARTED|Overall Study||27||
48323655|NCT01425008|101118268|FG004|COMPLETED|Dose Expansion Phase||0||
48323656|NCT01425008|101118269|FG005|COMPLETED|Dose Expansion Phase||0||
48323657|NCT01425008|101118270|FG006|COMPLETED|Dose Expansion Phase||0||
48408448|NCT00732238|101331766|FG000|COMPLETED|Overall Study||28||
48408449|NCT00732238|101331767|FG001|COMPLETED|Overall Study||27||
48408450|NCT00732238|101331766|FG000|NOT COMPLETED|Overall Study||5||
48408451|NCT00732238|101331767|FG001|NOT COMPLETED|Overall Study||1||
48408452|NCT01387594|101331768|FG000|STARTED|Overall Study||10||
48408453|NCT01387594|101331769|FG001|STARTED|Overall Study||39||
48408454|NCT01387594|101331768|FG000|COMPLETED|Overall Study||10||
48408455|NCT01387594|101331769|FG001|COMPLETED|Overall Study||36||
48408456|NCT01387594|101331768|FG000|NOT COMPLETED|Overall Study||0||
48408457|NCT01387594|101331769|FG001|NOT COMPLETED|Overall Study||3||
48408458|NCT01525420|101331770|FG000|STARTED|Overall Study||59||
48408459|NCT01525420|101331771|FG001|STARTED|Overall Study||62||
48408460|NCT01525420|101331770|FG000|COMPLETED|Overall Study||43||
48408461|NCT01525420|101331771|FG001|COMPLETED|Overall Study||38||
48408462|NCT01525420|101331770|FG000|NOT COMPLETED|Overall Study||16||
48408463|NCT01525420|101331771|FG001|NOT COMPLETED|Overall Study||24||
48408464|NCT02365506|101331772|FG000|STARTED|Overall Study||4||
48408465|NCT02365506|101331773|FG001|STARTED|Overall Study||4||
48408466|NCT02365506|101331774|FG002|STARTED|Overall Study||5||
48408467|NCT02365506|101331772|FG000|COMPLETED|Overall Study||4||
48408468|NCT02365506|101331773|FG001|COMPLETED|Overall Study||4||
48408469|NCT02365506|101331774|FG002|COMPLETED|Overall Study||4||
48408470|NCT02365506|101331772|FG000|NOT COMPLETED|Overall Study||0||
48408471|NCT02365506|101331773|FG001|NOT COMPLETED|Overall Study||0||
48408472|NCT02365506|101331774|FG002|NOT COMPLETED|Overall Study||1||
48408473|NCT01268514|101331775|FG000|STARTED|Overall Study||115||
48408474|NCT01268514|101331775|FG000|Participants Who Received the Device|Overall Study||114||
48408475|NCT01268514|101331775|FG000|COMPLETED|Overall Study||74||
48408476|NCT01268514|101331775|FG000|NOT COMPLETED|Overall Study||41||
48408477|NCT03135262|101331776|FG000|STARTED|Overall Study||9||
48408478|NCT03135262|101331777|FG001|STARTED|Overall Study||6||
48408479|NCT03135262|101331778|FG002|STARTED|Overall Study||7||
48408480|NCT03135262|101331779|FG003|STARTED|Overall Study||6||
48408481|NCT03135262|101331780|FG004|STARTED|Overall Study||1||
48408482|NCT03135262|101331776|FG000|COMPLETED|Overall Study||0||
48408483|NCT03135262|101331777|FG001|COMPLETED|Overall Study||0||
48408484|NCT03135262|101331778|FG002|COMPLETED|Overall Study||0||
48408485|NCT03135262|101331779|FG003|COMPLETED|Overall Study||0||
48408486|NCT03135262|101331780|FG004|COMPLETED|Overall Study||0||
48408487|NCT03135262|101331776|FG000|NOT COMPLETED|Overall Study||9||
48408488|NCT03135262|101331777|FG001|NOT COMPLETED|Overall Study||6||
48408489|NCT03135262|101331778|FG002|NOT COMPLETED|Overall Study||7||
48741413|NCT05006261|102151656|FG000|COMPLETED|Overall Study||26||
48323658|NCT01425008|101118271|FG007|COMPLETED|Dose Expansion Phase||0||
48323659|NCT01425008|101118272|FG008|COMPLETED|Dose Expansion Phase||0||
48323660|NCT01425008|101118273|FG009|COMPLETED|Dose Expansion Phase||0||
48323661|NCT01425008|101118274|FG010|COMPLETED|Dose Expansion Phase||1||
48323662|NCT01425008|101118275|FG011|COMPLETED|Dose Expansion Phase||0||
48323663|NCT01425008|101118276|FG012|COMPLETED|Dose Expansion Phase||0||
48323664|NCT01425008|101118277|FG013|COMPLETED|Dose Expansion Phase||0||
48408490|NCT03135262|101331779|FG003|NOT COMPLETED|Overall Study||6||
48408491|NCT03135262|101331780|FG004|NOT COMPLETED|Overall Study||1||
48408492|NCT02256345|101331781|FG000|STARTED|Overall Study||9||
48408493|NCT02256345|101331782|FG001|STARTED|Overall Study||3||
48408494|NCT02256345|101331781|FG000|COMPLETED|Overall Study||9||
48408495|NCT02256345|101331782|FG001|COMPLETED|Overall Study||3||
48408496|NCT02256345|101331781|FG000|NOT COMPLETED|Overall Study||0||
48408497|NCT02256345|101331782|FG001|NOT COMPLETED|Overall Study||0||
48408498|NCT03399786|101331783|FG000|STARTED|Double-blind Treatment Period (DBTP)||22||
48741414|NCT05006261|102151656|FG000|NOT COMPLETED|Overall Study||1||
48741415|NCT03818035|102151657|FG000|STARTED|Part 1 (Up to 28 Weeks)||880||
48741416|NCT03818035|102151658|FG001|STARTED|Part 1 (Up to 28 Weeks)||0||
48741417|NCT03818035|102151659|FG002|STARTED|Part 1 (Up to 28 Weeks)||0||
48323665|NCT01425008|101118278|FG014|COMPLETED|Dose Expansion Phase||0||
48408499|NCT03399786|101331784|FG001|STARTED|Double-blind Treatment Period (DBTP)||43||
48408500|NCT03399786|101331785|FG002|STARTED|Double-blind Treatment Period (DBTP)||0||
48408501|NCT03399786|101331786|FG003|STARTED|Double-blind Treatment Period (DBTP)||0||
48408502|NCT03399786|101331783|FG000|COMPLETED|Double-blind Treatment Period (DBTP)||21||
48408503|NCT03399786|101331784|FG001|COMPLETED|Double-blind Treatment Period (DBTP)||43||
48741418|NCT03818035|102151660|FG003|STARTED|Part 1 (Up to 28 Weeks)||0||
48408504|NCT03399786|101331785|FG002|COMPLETED|Double-blind Treatment Period (DBTP)||0||
48162190|NCT00990340|100718909|FG000|STARTED|First 14-day Treatment||27||
48162191|NCT00990340|100718910|FG001|STARTED|First 14-day Treatment||25||
48162192|NCT00990340|100718909|FG000|COMPLETED|First 14-day Treatment||21||
48323666|NCT01425008|101118279|FG015|COMPLETED|Dose Expansion Phase||0||
48162193|NCT00990340|100718910|FG001|COMPLETED|First 14-day Treatment||21||
48162194|NCT00990340|100718909|FG000|NOT COMPLETED|First 14-day Treatment||6||
48741419|NCT03818035|102151657|FG000|COMPLETED|Part 1 (Up to 28 Weeks)||823||
48741420|NCT03818035|102151658|FG001|COMPLETED|Part 1 (Up to 28 Weeks)||0||
48741421|NCT03818035|102151659|FG002|COMPLETED|Part 1 (Up to 28 Weeks)||0||
48741422|NCT03818035|102151660|FG003|COMPLETED|Part 1 (Up to 28 Weeks)||0||
48741423|NCT03818035|102151657|FG000|NOT COMPLETED|Part 1 (Up to 28 Weeks)||57||
48741424|NCT03818035|102151658|FG001|NOT COMPLETED|Part 1 (Up to 28 Weeks)||0||
48741425|NCT03818035|102151659|FG002|NOT COMPLETED|Part 1 (Up to 28 Weeks)||0||
48741426|NCT03818035|102151660|FG003|NOT COMPLETED|Part 1 (Up to 28 Weeks)||0||
48741427|NCT03818035|102151657|FG000|STARTED|Part 2 (Week 28 to Week 68)||0||
48741428|NCT03818035|102151658|FG001|STARTED|Part 2 (Week 28 to Week 68)||148||
48741429|NCT03818035|102151659|FG002|STARTED|Part 2 (Week 28 to Week 68)||150||
48741430|NCT03818035|102151660|FG003|STARTED|Part 2 (Week 28 to Week 68)||525||
48741431|NCT03818035|102151657|FG000|Treated|Part 2 (Week 28 to Week 68)||0||
48741432|NCT03818035|102151658|FG001|Treated|Part 2 (Week 28 to Week 68)||148||
48741433|NCT03818035|102151659|FG002|Treated|Part 2 (Week 28 to Week 68)||149||
48741434|NCT03818035|102151660|FG003|Treated|Part 2 (Week 28 to Week 68)||525||
48741435|NCT03818035|102151657|FG000|COMPLETED|Part 2 (Week 28 to Week 68)||0||
48741436|NCT03818035|102151658|FG001|COMPLETED|Part 2 (Week 28 to Week 68)||137||
48741437|NCT03818035|102151659|FG002|COMPLETED|Part 2 (Week 28 to Week 68)||142||
48741438|NCT03818035|102151660|FG003|COMPLETED|Part 2 (Week 28 to Week 68)||496||
48741439|NCT03818035|102151657|FG000|NOT COMPLETED|Part 2 (Week 28 to Week 68)||0||
48741440|NCT03818035|102151658|FG001|NOT COMPLETED|Part 2 (Week 28 to Week 68)||11||
48741441|NCT03818035|102151659|FG002|NOT COMPLETED|Part 2 (Week 28 to Week 68)||8||
48741442|NCT03818035|102151660|FG003|NOT COMPLETED|Part 2 (Week 28 to Week 68)||29||
48741443|NCT01708317|102151661|FG000|STARTED|2010 Control Period||3929||
48741444|NCT01708317|102151661|FG000|COMPLETED|2010 Control Period||3929||
48741445|NCT01708317|102151661|FG000|NOT COMPLETED|2010 Control Period||0||
48741446|NCT01708317|102151661|FG000|STARTED|Initial Education Period||982||
48741447|NCT01708317|102151661|FG000|COMPLETED|Initial Education Period||982||
48741448|NCT01708317|102151661|FG000|NOT COMPLETED|Initial Education Period||0||
48741449|NCT01708317|102151661|FG000|STARTED|ACASI + Education Period||2601||
48741450|NCT01708317|102151661|FG000|COMPLETED|ACASI + Education Period||2601||
48741451|NCT01708317|102151661|FG000|NOT COMPLETED|ACASI + Education Period||0||
48741452|NCT01708317|102151661|FG000|STARTED|Final Education Period||909||
48741453|NCT01708317|102151661|FG000|COMPLETED|Final Education Period||909||
48741454|NCT01708317|102151661|FG000|NOT COMPLETED|Final Education Period||0||
48741455|NCT02362464|102151662|FG000|STARTED|Overall Study||14||
48741456|NCT02362464|102151662|FG000|COMPLETED|Overall Study||8||
48741457|NCT02362464|102151662|FG000|NOT COMPLETED|Overall Study||6||
48741458|NCT00125957|102151663|FG000|STARTED|First Intervention (3 Weeks)||15||
48741459|NCT00125957|102151664|FG001|STARTED|First Intervention (3 Weeks)||17||
48741460|NCT00125957|102151663|FG000|COMPLETED|First Intervention (3 Weeks)||15||
48741461|NCT00125957|102151664|FG001|COMPLETED|First Intervention (3 Weeks)||17||
48741462|NCT00125957|102151663|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0||
48741463|NCT00125957|102151664|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0||
48741464|NCT00125957|102151663|FG000|STARTED|Second Intervention (3 Weeks)||15||
48741465|NCT00125957|102151664|FG001|STARTED|Second Intervention (3 Weeks)||17||
48741466|NCT00125957|102151663|FG000|COMPLETED|Second Intervention (3 Weeks)||15||
48741467|NCT00125957|102151664|FG001|COMPLETED|Second Intervention (3 Weeks)||17||
48162195|NCT00990340|100718910|FG001|NOT COMPLETED|First 14-day Treatment||4||
48162196|NCT00990340|100718909|FG000|STARTED|Second 14-day Treatment||21||
48741468|NCT00125957|102151663|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0||
48741469|NCT00125957|102151664|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0||
48741470|NCT04220554|102151665|FG000|STARTED|Overall Study||51||
48741471|NCT04220554|102151666|FG001|STARTED|Overall Study||52||
48741472|NCT04220554|102151665|FG000|COMPLETED|Overall Study||45||
48741473|NCT04220554|102151666|FG001|COMPLETED|Overall Study||47||
48741474|NCT04220554|102151665|FG000|NOT COMPLETED|Overall Study||6||
48741475|NCT04220554|102151666|FG001|NOT COMPLETED|Overall Study||5||
48741476|NCT03792256|102151667|FG000|STARTED|Overall Study||6||
48741477|NCT03792256|102151668|FG001|STARTED|Overall Study||6||
48741478|NCT03792256|102151667|FG000|COMPLETED|Overall Study||6||
48741479|NCT03792256|102151668|FG001|COMPLETED|Overall Study||3||
48741480|NCT03792256|102151667|FG000|NOT COMPLETED|Overall Study||0||
48741481|NCT03792256|102151668|FG001|NOT COMPLETED|Overall Study||3||
48741482|NCT06385483|102151669|FG000|STARTED|Overall Study||19||
48741483|NCT06385483|102151669|FG000|Started Protocol Therapy|Overall Study||17||
48741484|NCT06385483|102151669|FG000|Eligible, Treated and Mutation Status Confirmed|Overall Study||17|Primary efficacy analysis set|
48741485|NCT06385483|102151669|FG000|COMPLETED|Overall Study||0||
48741486|NCT06385483|102151669|FG000|NOT COMPLETED|Overall Study||19||
48741487|NCT03335774|102151670|FG000|STARTED|Overall Study||51||
48741488|NCT03335774|102151671|FG001|STARTED|Overall Study||52||
48741489|NCT03335774|102151670|FG000|COMPLETED|Overall Study||50||
48741490|NCT03335774|102151671|FG001|COMPLETED|Overall Study||51||
48741491|NCT03335774|102151670|FG000|NOT COMPLETED|Overall Study||1||
48741492|NCT03335774|102151671|FG001|NOT COMPLETED|Overall Study||1||
48323667|NCT01425008|101118280|FG016|COMPLETED|Dose Expansion Phase||0||
48323668|NCT01425008|101118281|FG017|COMPLETED|Dose Expansion Phase||0||
48323669|NCT01425008|101118282|FG018|COMPLETED|Dose Expansion Phase||0||
48323670|NCT01425008|101118264|FG000|NOT COMPLETED|Dose Expansion Phase||0||
48741493|NCT03477396|102151672|FG000|STARTED|Overall Study||2||
48741494|NCT03477396|102151672|FG000|COMPLETED|Overall Study||2||
48323671|NCT01425008|101118265|FG001|NOT COMPLETED|Dose Expansion Phase||0||
48323672|NCT01425008|101118266|FG002|NOT COMPLETED|Dose Expansion Phase||0||
48323673|NCT01425008|101118267|FG003|NOT COMPLETED|Dose Expansion Phase||0||
48323674|NCT01425008|101118268|FG004|NOT COMPLETED|Dose Expansion Phase||0||
48323675|NCT01425008|101118269|FG005|NOT COMPLETED|Dose Expansion Phase||0||
48323676|NCT01425008|101118270|FG006|NOT COMPLETED|Dose Expansion Phase||0||
48741495|NCT03477396|102151672|FG000|NOT COMPLETED|Overall Study||0||
48741496|NCT02021643|102151673|FG000|STARTED|Overall Study||156||
48741497|NCT02021643|102151674|FG001|STARTED|Overall Study||290||
48741498|NCT02021643|102151675|FG002|STARTED|Overall Study||11||
48741499|NCT02021643|102151676|FG003|STARTED|Overall Study||230||
48741500|NCT02021643|102151673|FG000|COMPLETED|Overall Study||147||
48741501|NCT02021643|102151674|FG001|COMPLETED|Overall Study||280||
48741502|NCT02021643|102151675|FG002|COMPLETED|Overall Study||11||
48741503|NCT02021643|102151676|FG003|COMPLETED|Overall Study||218||
48741504|NCT02021643|102151673|FG000|NOT COMPLETED|Overall Study||9||
48741505|NCT02021643|102151674|FG001|NOT COMPLETED|Overall Study||10||
48741506|NCT02021643|102151675|FG002|NOT COMPLETED|Overall Study||0||
48741507|NCT02021643|102151676|FG003|NOT COMPLETED|Overall Study||12||
48741508|NCT03818191|102151677|FG000|STARTED|Overall Study||184||
48741509|NCT03818191|102151678|FG001|STARTED|Overall Study||104||
48741510|NCT03818191|102151677|FG000|COMPLETED|Overall Study||81||
48741511|NCT03818191|102151678|FG001|COMPLETED|Overall Study||51||
48741512|NCT03818191|102151677|FG000|NOT COMPLETED|Overall Study||103||
48741513|NCT03818191|102151678|FG001|NOT COMPLETED|Overall Study||53||
48741514|NCT02293798|102151679|FG000|STARTED|Overall Study||13||26
48741515|NCT02293798|102151679|FG000|COMPLETED|Overall Study||13||26
48741516|NCT02293798|102151679|FG000|NOT COMPLETED|Overall Study||0||0
48741517|NCT01887132|102151680|FG000|STARTED|Overall Study||4||
48741518|NCT01887132|102151680|FG000|COMPLETED|Overall Study||4||
48741519|NCT01887132|102151680|FG000|NOT COMPLETED|Overall Study||0||
48741520|NCT04303572|102151681|FG000|STARTED|Overall Study||1||
48741521|NCT04303572|102151681|FG000|COMPLETED|Overall Study||0||
48741522|NCT04303572|102151681|FG000|NOT COMPLETED|Overall Study||1||
48741523|NCT00687804|102151682|FG000|STARTED|Core Study||116||
48741524|NCT00687804|102151683|FG001|STARTED|Core Study||118||
48741525|NCT00687804|102151684|FG002|STARTED|Core Study||111||
48323677|NCT01425008|101118271|FG007|NOT COMPLETED|Dose Expansion Phase||0||
48741526|NCT00687804|102151682|FG000|COMPLETED|Core Study||102||
48741527|NCT00687804|102151683|FG001|COMPLETED|Core Study||103||
48741528|NCT00687804|102151684|FG002|COMPLETED|Core Study||98||
48741529|NCT00687804|102151682|FG000|NOT COMPLETED|Core Study||14||
48741530|NCT00687804|102151683|FG001|NOT COMPLETED|Core Study||15||
48323678|NCT01425008|101118272|FG008|NOT COMPLETED|Dose Expansion Phase||0||
48323679|NCT01425008|101118273|FG009|NOT COMPLETED|Dose Expansion Phase||0||
48323680|NCT01425008|101118274|FG010|NOT COMPLETED|Dose Expansion Phase||15||
48323681|NCT01425008|101118275|FG011|NOT COMPLETED|Dose Expansion Phase||8||
48323682|NCT01425008|101118276|FG012|NOT COMPLETED|Dose Expansion Phase||16||
48323683|NCT01425008|101118277|FG013|NOT COMPLETED|Dose Expansion Phase||1||
48741531|NCT00687804|102151684|FG002|NOT COMPLETED|Core Study||13||
48741532|NCT00687804|102151682|FG000|STARTED|Open-Label Extension Study||83||
48741533|NCT00687804|102151683|FG001|STARTED|Open-Label Extension Study||83||
48741534|NCT00687804|102151684|FG002|STARTED|Open-Label Extension Study||74||
48741535|NCT00687804|102151682|FG000|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||16||
48741536|NCT00687804|102151683|FG001|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||21||
48741537|NCT00687804|102151684|FG002|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||15||
48741538|NCT00687804|102151682|FG000|COMPLETED|Open-Label Extension Study||73||
48323684|NCT01425008|101118278|FG014|NOT COMPLETED|Dose Expansion Phase||6||
48323685|NCT01425008|101118279|FG015|NOT COMPLETED|Dose Expansion Phase||11||
48323686|NCT01425008|101118280|FG016|NOT COMPLETED|Dose Expansion Phase||20||
48323687|NCT01425008|101118281|FG017|NOT COMPLETED|Dose Expansion Phase||2||
48323688|NCT01425008|101118282|FG018|NOT COMPLETED|Dose Expansion Phase||19||
48323689|NCT01982292|101118283|FG000|STARTED|Overall Study||215||
48323690|NCT01982292|101118284|FG001|STARTED|Overall Study||108||
48323691|NCT01982292|101118283|FG000|Full Analaysis Set (FAS)|Overall Study||213||
48741539|NCT00687804|102151683|FG001|COMPLETED|Open-Label Extension Study||72||
48741540|NCT00687804|102151684|FG002|COMPLETED|Open-Label Extension Study||63||
48741541|NCT00687804|102151682|FG000|NOT COMPLETED|Open-Label Extension Study||10||
48741542|NCT00687804|102151683|FG001|NOT COMPLETED|Open-Label Extension Study||11||
48741543|NCT00687804|102151684|FG002|NOT COMPLETED|Open-Label Extension Study||11||
48741544|NCT00795236|102151685|FG000|STARTED|Overall Study||0||
48741545|NCT00795236|102151686|FG001|STARTED|Overall Study||0||
48741546|NCT00795236|102151685|FG000|COMPLETED|Overall Study||0||
48741547|NCT00795236|102151686|FG001|COMPLETED|Overall Study||0||
48741548|NCT00795236|102151685|FG000|NOT COMPLETED|Overall Study||0||
48741549|NCT00795236|102151686|FG001|NOT COMPLETED|Overall Study||0||
48741550|NCT05307692|102151687|FG000|STARTED|Double-blind (DB) Phase (Day 1- Day 43):||44||
48741551|NCT05307692|102151688|FG001|STARTED|Double-blind (DB) Phase (Day 1- Day 43):||44||
48741552|NCT05307692|102151689|FG002|STARTED|Double-blind (DB) Phase (Day 1- Day 43):||0||
48741553|NCT05307692|102151690|FG003|STARTED|Double-blind (DB) Phase (Day 1- Day 43):||0||
48741554|NCT05307692|102151687|FG000|Treated|Double-blind (DB) Phase (Day 1- Day 43):||42||
48741555|NCT05307692|102151688|FG001|Treated|Double-blind (DB) Phase (Day 1- Day 43):||43||
48741556|NCT05307692|102151689|FG002|Treated|Double-blind (DB) Phase (Day 1- Day 43):||0||
48741557|NCT05307692|102151690|FG003|Treated|Double-blind (DB) Phase (Day 1- Day 43):||0||
48741558|NCT05307692|102151687|FG000|COMPLETED|Double-blind (DB) Phase (Day 1- Day 43):||39||
48741559|NCT05307692|102151688|FG001|COMPLETED|Double-blind (DB) Phase (Day 1- Day 43):||35||
48741560|NCT05307692|102151689|FG002|COMPLETED|Double-blind (DB) Phase (Day 1- Day 43):||0||
48741561|NCT05307692|102151690|FG003|COMPLETED|Double-blind (DB) Phase (Day 1- Day 43):||0||
48741562|NCT05307692|102151687|FG000|NOT COMPLETED|Double-blind (DB) Phase (Day 1- Day 43):||5||
48741563|NCT05307692|102151688|FG001|NOT COMPLETED|Double-blind (DB) Phase (Day 1- Day 43):||9||
48741564|NCT05307692|102151689|FG002|NOT COMPLETED|Double-blind (DB) Phase (Day 1- Day 43):||0||
48741565|NCT05307692|102151690|FG003|NOT COMPLETED|Double-blind (DB) Phase (Day 1- Day 43):||0||
48741566|NCT05307692|102151687|FG000|STARTED|FU Phase (Day 43 to Day 57):||0||
48741567|NCT05307692|102151688|FG001|STARTED|FU Phase (Day 43 to Day 57):||0||
48741568|NCT05307692|102151689|FG002|STARTED|FU Phase (Day 43 to Day 57):||39||
48741569|NCT05307692|102151690|FG003|STARTED|FU Phase (Day 43 to Day 57):||38||
48741570|NCT05307692|102151687|FG000|COMPLETED|FU Phase (Day 43 to Day 57):||0||
48741571|NCT05307692|102151688|FG001|COMPLETED|FU Phase (Day 43 to Day 57):||0||
48741572|NCT05307692|102151689|FG002|COMPLETED|FU Phase (Day 43 to Day 57):||39||
48741573|NCT05307692|102151690|FG003|COMPLETED|FU Phase (Day 43 to Day 57):||34||
48741574|NCT05307692|102151687|FG000|NOT COMPLETED|FU Phase (Day 43 to Day 57):||0||
48741575|NCT05307692|102151688|FG001|NOT COMPLETED|FU Phase (Day 43 to Day 57):||0||
48741576|NCT05307692|102151689|FG002|NOT COMPLETED|FU Phase (Day 43 to Day 57):||0||
48741577|NCT05307692|102151690|FG003|NOT COMPLETED|FU Phase (Day 43 to Day 57):||4||
48741578|NCT00676013|102151691|FG000|STARTED|Overall Study||158||
48323692|NCT01982292|101118284|FG001|Full Analaysis Set (FAS)|Overall Study||108||
48323693|NCT01982292|101118283|FG000|Safety Set|Overall Study||212||
48741579|NCT00676013|102151691|FG000|COMPLETED|Overall Study||157||
48741580|NCT00676013|102151691|FG000|NOT COMPLETED|Overall Study||1||
48741581|NCT01496469|102151692|FG000|STARTED|Overall Study||60||
48741582|NCT01496469|102151693|FG001|STARTED|Overall Study||61||
48741583|NCT01496469|102151692|FG000|COMPLETED|Overall Study||50||
48741584|NCT01496469|102151693|FG001|COMPLETED|Overall Study||53||
48741585|NCT01496469|102151692|FG000|NOT COMPLETED|Overall Study||10||
48741586|NCT01496469|102151693|FG001|NOT COMPLETED|Overall Study||8||
48741587|NCT00871338|102151694|FG000|STARTED|Prior to Booster||142||
48741588|NCT00871338|102151695|FG001|STARTED|Prior to Booster||142||
48741589|NCT00871338|102151694|FG000|COMPLETED|Prior to Booster||140||
48741590|NCT00871338|102151695|FG001|COMPLETED|Prior to Booster||139||
48741591|NCT00871338|102151694|FG000|NOT COMPLETED|Prior to Booster||2||
48741592|NCT00871338|102151695|FG001|NOT COMPLETED|Prior to Booster||3||
48741593|NCT00871338|102151694|FG000|STARTED|After Booster||139||
48741594|NCT00871338|102151695|FG001|STARTED|After Booster||135||
48741595|NCT00871338|102151694|FG000|COMPLETED|After Booster||139||
48741596|NCT00871338|102151695|FG001|COMPLETED|After Booster||135||
48741597|NCT00871338|102151694|FG000|NOT COMPLETED|After Booster||0||
48323694|NCT01982292|101118284|FG001|Safety Set|Overall Study||108||
48741598|NCT00871338|102151695|FG001|NOT COMPLETED|After Booster||0||
48741599|NCT00226811|102151696|FG000|STARTED|Overall Study||78||
48741600|NCT00226811|102151696|FG000|COMPLETED|Overall Study||2||
48741601|NCT00226811|102151696|FG000|NOT COMPLETED|Overall Study||76||
48741602|NCT03259087|102151697|FG000|STARTED|Part 1 and Period 1 of Part 2||8||
48323695|NCT01982292|101118283|FG000|COMPLETED|Overall Study||203||
48323696|NCT01982292|101118284|FG001|COMPLETED|Overall Study||107||
48741603|NCT03259087|102151698|FG001|STARTED|Part 1 and Period 1 of Part 2||8||
48741604|NCT03259087|102151699|FG002|STARTED|Part 1 and Period 1 of Part 2||8||
48741605|NCT03259087|102151700|FG003|STARTED|Part 1 and Period 1 of Part 2||10||
48741606|NCT03259087|102151701|FG004|STARTED|Part 1 and Period 1 of Part 2||8||
48741607|NCT03259087|102151697|FG000|COMPLETED|Part 1 and Period 1 of Part 2||8||
48741608|NCT03259087|102151698|FG001|COMPLETED|Part 1 and Period 1 of Part 2||8||
48741609|NCT03259087|102151699|FG002|COMPLETED|Part 1 and Period 1 of Part 2||8||
48741610|NCT03259087|102151700|FG003|COMPLETED|Part 1 and Period 1 of Part 2||10||
48741611|NCT03259087|102151701|FG004|COMPLETED|Part 1 and Period 1 of Part 2||7||
48741612|NCT03259087|102151697|FG000|NOT COMPLETED|Part 1 and Period 1 of Part 2||0||
48741613|NCT03259087|102151698|FG001|NOT COMPLETED|Part 1 and Period 1 of Part 2||0||
48741614|NCT03259087|102151699|FG002|NOT COMPLETED|Part 1 and Period 1 of Part 2||0||
48741615|NCT03259087|102151700|FG003|NOT COMPLETED|Part 1 and Period 1 of Part 2||0||
48741616|NCT03259087|102151701|FG004|NOT COMPLETED|Part 1 and Period 1 of Part 2||1||
48741617|NCT03259087|102151697|FG000|STARTED|Period 2 of Part 2||0||
48741618|NCT03259087|102151698|FG001|STARTED|Period 2 of Part 2||0||
48741619|NCT03259087|102151699|FG002|STARTED|Period 2 of Part 2||0||
48741620|NCT03259087|102151700|FG003|STARTED|Period 2 of Part 2||0||
48741621|NCT03259087|102151701|FG004|STARTED|Period 2 of Part 2||7||
48741622|NCT03259087|102151697|FG000|COMPLETED|Period 2 of Part 2||0||
48741623|NCT03259087|102151698|FG001|COMPLETED|Period 2 of Part 2||0||
48741624|NCT03259087|102151699|FG002|COMPLETED|Period 2 of Part 2||0||
48741625|NCT03259087|102151700|FG003|COMPLETED|Period 2 of Part 2||0||
48741626|NCT03259087|102151701|FG004|COMPLETED|Period 2 of Part 2||6||
48741627|NCT03259087|102151697|FG000|NOT COMPLETED|Period 2 of Part 2||0||
48741628|NCT03259087|102151698|FG001|NOT COMPLETED|Period 2 of Part 2||0||
48741629|NCT03259087|102151699|FG002|NOT COMPLETED|Period 2 of Part 2||0||
48741630|NCT03259087|102151700|FG003|NOT COMPLETED|Period 2 of Part 2||0||
48741631|NCT03259087|102151701|FG004|NOT COMPLETED|Period 2 of Part 2||1||
48741632|NCT01220739|102151702|FG000|STARTED|Overall Study||7||
48741633|NCT01220739|102151703|FG001|STARTED|Overall Study||5||
48741634|NCT01220739|102151702|FG000|COMPLETED|Overall Study||7||
48741635|NCT01220739|102151703|FG001|COMPLETED|Overall Study||5||
48741636|NCT01220739|102151702|FG000|NOT COMPLETED|Overall Study||0||
48741637|NCT01220739|102151703|FG001|NOT COMPLETED|Overall Study||0||
48741638|NCT03370718|102151704|FG000|STARTED|Overall Study||18||
48741639|NCT03370718|102151704|FG000|COMPLETED|Overall Study||17||
48741640|NCT03370718|102151704|FG000|NOT COMPLETED|Overall Study||1||
48741641|NCT01588561|102151705|FG000|STARTED|Overall Study||14||
48741642|NCT01588561|102151706|FG001|STARTED|Overall Study||1||
48741643|NCT01588561|102151705|FG000|First Injection (Visit 1)|Overall Study||14||
48741644|NCT01588561|102151706|FG001|First Injection (Visit 1)|Overall Study||1||
48741645|NCT01588561|102151705|FG000|Rest Period|Overall Study||14|Generally 2-3 week rest period but a minimum of 1 month for women, based on menstrual cycles.|
48741646|NCT01588561|102151706|FG001|Rest Period|Overall Study||1|Generally 2-3 week rest period but a minimum of 1 month for women, based on menstrual cycles.|
48741647|NCT01588561|102151705|FG000|Second Injection (Visit 2)|Overall Study||14||
48741648|NCT01588561|102151706|FG001|Second Injection (Visit 2)|Overall Study||1||
48741649|NCT01588561|102151705|FG000|COMPLETED|Overall Study||14||
48741650|NCT01588561|102151706|FG001|COMPLETED|Overall Study||1||
48741651|NCT01588561|102151705|FG000|NOT COMPLETED|Overall Study||0||
48741652|NCT01588561|102151706|FG001|NOT COMPLETED|Overall Study||0||
48741653|NCT02491983|102151707|FG000|STARTED|Overall Study||243||
48741654|NCT02491983|102151708|FG001|STARTED|Overall Study||243||
48741655|NCT02491983|102151707|FG000|COMPLETED|Overall Study||241||
48741656|NCT02491983|102151708|FG001|COMPLETED|Overall Study||242||
48741657|NCT02491983|102151707|FG000|NOT COMPLETED|Overall Study||2||
48741658|NCT02491983|102151708|FG001|NOT COMPLETED|Overall Study||1||
48741659|NCT03329092|102151709|FG000|STARTED|Overall Study||282||
48741660|NCT03329092|102151710|FG001|STARTED|Overall Study||140||
48741661|NCT03329092|102151709|FG000|Participants With cIAI|Overall Study||208||
48741662|NCT03329092|102151710|FG001|Participants With cIAI|Overall Study||104||
48741663|NCT03329092|102151709|FG000|Participants With HAP/VAP|Overall Study||74||
48741664|NCT03329092|102151710|FG001|Participants With HAP/VAP|Overall Study||36||
48741665|NCT03329092|102151709|FG000|COMPLETED|Overall Study||242||
48741666|NCT03329092|102151710|FG001|COMPLETED|Overall Study||122||
48741667|NCT03329092|102151709|FG000|NOT COMPLETED|Overall Study||40||
48741668|NCT03329092|102151710|FG001|NOT COMPLETED|Overall Study||18||
48741669|NCT01070173|102151711|FG000|STARTED|Overall Study||33||
48741670|NCT01070173|102151712|FG001|STARTED|Overall Study||8||
48741671|NCT01070173|102151713|FG002|STARTED|Overall Study||11||
48741672|NCT01070173|102151711|FG000|COMPLETED|Overall Study||33||
48741673|NCT01070173|102151712|FG001|COMPLETED|Overall Study||8||
48741674|NCT01070173|102151713|FG002|COMPLETED|Overall Study||11||
48741675|NCT01070173|102151711|FG000|NOT COMPLETED|Overall Study||0||
48741676|NCT01070173|102151712|FG001|NOT COMPLETED|Overall Study||0||
48741677|NCT01070173|102151713|FG002|NOT COMPLETED|Overall Study||0||
48741678|NCT00940901|102151714|FG000|STARTED|Weeks 1-8 (Phase 1)||6||
48741679|NCT00940901|102151715|FG001|STARTED|Weeks 1-8 (Phase 1)||7||
48741680|NCT00940901|102151714|FG000|COMPLETED|Weeks 1-8 (Phase 1)||6||
48741681|NCT00940901|102151715|FG001|COMPLETED|Weeks 1-8 (Phase 1)||7||
48741682|NCT00940901|102151714|FG000|NOT COMPLETED|Weeks 1-8 (Phase 1)||0||
48741683|NCT00940901|102151715|FG001|NOT COMPLETED|Weeks 1-8 (Phase 1)||0||
48741684|NCT00940901|102151714|FG000|STARTED|Week 9-16 (Phase 2)||6||
48741685|NCT00940901|102151715|FG001|STARTED|Week 9-16 (Phase 2)||7||
48741686|NCT00940901|102151714|FG000|COMPLETED|Week 9-16 (Phase 2)||4||
48741687|NCT00940901|102151715|FG001|COMPLETED|Week 9-16 (Phase 2)||4||
48741688|NCT00940901|102151714|FG000|NOT COMPLETED|Week 9-16 (Phase 2)||2||
48741689|NCT00940901|102151715|FG001|NOT COMPLETED|Week 9-16 (Phase 2)||3||
48741690|NCT01518374|102151716|FG000|STARTED|Overall Study||1768||
48741691|NCT01518374|102151716|FG000|COMPLETED|Overall Study||1761||
48741692|NCT01518374|102151716|FG000|NOT COMPLETED|Overall Study||7||
48741693|NCT01015781|102151717|FG000|STARTED|Overall Study||150||
48741694|NCT01015781|102151718|FG001|STARTED|Overall Study||150||
48741695|NCT01015781|102151717|FG000|COMPLETED|Overall Study||113||
48741696|NCT01015781|102151718|FG001|COMPLETED|Overall Study||121||
48741697|NCT01015781|102151717|FG000|NOT COMPLETED|Overall Study||37||
48741698|NCT01015781|102151718|FG001|NOT COMPLETED|Overall Study||29||
48741699|NCT04184297|102151719|FG000|STARTED|Overall Study||2864||
48741700|NCT04184297|102151720|FG001|STARTED|Overall Study||24326||
48741701|NCT04184297|102151719|FG000|COMPLETED|Overall Study||2864||
48741702|NCT04184297|102151720|FG001|COMPLETED|Overall Study||24326||
48741703|NCT04184297|102151719|FG000|NOT COMPLETED|Overall Study||0||
48741704|NCT04184297|102151720|FG001|NOT COMPLETED|Overall Study||0||
48741705|NCT03018691|102151721|FG000|STARTED|Overall Study||24||
48741706|NCT03018691|102151722|FG001|STARTED|Overall Study||25||
48741707|NCT03018691|102151723|FG002|STARTED|Overall Study||24||
48741708|NCT03018691|102151721|FG000|COMPLETED|Overall Study||22||
48741709|NCT03018691|102151722|FG001|COMPLETED|Overall Study||24||
48741710|NCT03018691|102151723|FG002|COMPLETED|Overall Study||17||
48741711|NCT03018691|102151721|FG000|NOT COMPLETED|Overall Study||2||
48741712|NCT03018691|102151722|FG001|NOT COMPLETED|Overall Study||1||
48741713|NCT03018691|102151723|FG002|NOT COMPLETED|Overall Study||7||
48741714|NCT03077919|102151724|FG000|STARTED|Overall Study||74||
48741715|NCT03077919|102151725|FG001|STARTED|Overall Study||39||
48741716|NCT03077919|102151724|FG000|Week 2 Visit|Overall Study||74||
48741717|NCT03077919|102151725|FG001|Week 2 Visit|Overall Study||39||
48741718|NCT03077919|102151724|FG000|Week 4 Visit|Overall Study||73||
48741719|NCT03077919|102151725|FG001|Week 4 Visit|Overall Study||38||
48741720|NCT03077919|102151724|FG000|Week 6 Visit|Overall Study||73||
48741721|NCT03077919|102151725|FG001|Week 6 Visit|Overall Study||38||
48741722|NCT03077919|102151724|FG000|Week 8 Visit|Overall Study||71||
48741723|NCT03077919|102151725|FG001|Week 8 Visit|Overall Study||38||
48741724|NCT03077919|102151724|FG000|Final CAPS|Overall Study||70||
48741725|NCT03077919|102151725|FG001|Final CAPS|Overall Study||38||
48741726|NCT03077919|102151724|FG000|COMPLETED|Overall Study||70||
48741727|NCT03077919|102151725|FG001|COMPLETED|Overall Study||38||
48741728|NCT03077919|102151724|FG000|NOT COMPLETED|Overall Study||4||
48741729|NCT03077919|102151725|FG001|NOT COMPLETED|Overall Study||1||
48741730|NCT04523207|102151726|FG000|STARTED|Overall Study||96||
48741731|NCT04523207|102151727|FG001|STARTED|Overall Study||12||
48741732|NCT04523207|102151726|FG000|Sub-study Participants Who Completed and Transitioned to Main Study|Overall Study||0||
48741733|NCT04523207|102151727|FG001|Sub-study Participants Who Completed and Transitioned to Main Study|Overall Study||12||
48741734|NCT04523207|102151726|FG000|COMPLETED|Overall Study||78||
48741735|NCT04523207|102151727|FG001|COMPLETED|Overall Study||9||
48741736|NCT04523207|102151726|FG000|NOT COMPLETED|Overall Study||18||
48741737|NCT04523207|102151727|FG001|NOT COMPLETED|Overall Study||3||
48741738|NCT00550407|102151728|FG000|STARTED|8-16 Week Preliminary (Open-Label) Phase||215||
48741739|NCT00550407|102151729|FG001|STARTED|8-16 Week Preliminary (Open-Label) Phase||0||
48741740|NCT00550407|102151730|FG002|STARTED|8-16 Week Preliminary (Open-Label) Phase||0||
48741741|NCT00550407|102151728|FG000|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||103||
48323697|NCT01982292|101118283|FG000|NOT COMPLETED|Overall Study||12||
48617906|NCT00305227|101849679|FG001|COMPLETED|Overall Study||44||
48323698|NCT01982292|101118284|FG001|NOT COMPLETED|Overall Study||1||
48323699|NCT01445951|101118285|FG000|STARTED|Overall Study||174||
48323700|NCT01445951|101118286|FG001|STARTED|Overall Study||174||
48323701|NCT01445951|101118287|FG002|STARTED|Overall Study||170||
48323702|NCT01445951|101118285|FG000|COMPLETED|Overall Study||130||
48323703|NCT01445951|101118286|FG001|COMPLETED|Overall Study||138||
48323704|NCT01445951|101118287|FG002|COMPLETED|Overall Study||151||
48323705|NCT01445951|101118285|FG000|NOT COMPLETED|Overall Study||44||
48323706|NCT01445951|101118286|FG001|NOT COMPLETED|Overall Study||36||
48323707|NCT01445951|101118287|FG002|NOT COMPLETED|Overall Study||19||
48323708|NCT01526902|101118288|FG000|STARTED|Overall Study||25||
48323709|NCT01526902|101118289|FG001|STARTED|Overall Study||24||
48323710|NCT01526902|101118288|FG000|COMPLETED|Overall Study||25||
48323711|NCT01526902|101118289|FG001|COMPLETED|Overall Study||24||
48323712|NCT01526902|101118288|FG000|NOT COMPLETED|Overall Study||0||
48323713|NCT01526902|101118289|FG001|NOT COMPLETED|Overall Study||0||
48617907|NCT00305227|101849678|FG000|NOT COMPLETED|Overall Study||7||
48617908|NCT00305227|101849679|FG001|NOT COMPLETED|Overall Study||6||
48617909|NCT04435808|101849680|FG000|STARTED|Overall Study||0||
48617910|NCT04435808|101849681|FG001|STARTED|Overall Study||1||
48617911|NCT04435808|101849680|FG000|COMPLETED|Overall Study||0||
48617912|NCT04435808|101849681|FG001|COMPLETED|Overall Study||0||
48617913|NCT04435808|101849680|FG000|NOT COMPLETED|Overall Study||0||
48617914|NCT04435808|101849681|FG001|NOT COMPLETED|Overall Study||1||
48617915|NCT01081626|101849682|FG000|STARTED|Overall Study||155||
48617916|NCT01081626|101849683|FG001|STARTED|Overall Study||155||
48617917|NCT01081626|101849682|FG000|Assessed for Efficacy|Overall Study||122||
48617918|NCT01081626|101849683|FG001|Assessed for Efficacy|Overall Study||125||
48617919|NCT01081626|101849682|FG000|COMPLETED|Overall Study||95||
48617920|NCT01081626|101849683|FG001|COMPLETED|Overall Study||94||
48617921|NCT01081626|101849682|FG000|NOT COMPLETED|Overall Study||60||
48617922|NCT01081626|101849683|FG001|NOT COMPLETED|Overall Study||61||
48617923|NCT01029262|101849684|FG000|STARTED|Overall Study||79||
48617924|NCT01029262|101849685|FG001|STARTED|Overall Study||160||
48617925|NCT01029262|101849684|FG000|COMPLETED|Overall Study||0||
48617926|NCT01029262|101849685|FG001|COMPLETED|Overall Study||0||
48617927|NCT01029262|101849684|FG000|NOT COMPLETED|Overall Study||79||
48617928|NCT01029262|101849685|FG001|NOT COMPLETED|Overall Study||160||
48617929|NCT04378569|101849686|FG000|STARTED|Overall Study||7||
48617930|NCT04378569|101849687|FG001|STARTED|Overall Study||65||
48617931|NCT04378569|101849688|FG002|STARTED|Overall Study||61||
48617932|NCT04378569|101849689|FG003|STARTED|Overall Study||32||
48617933|NCT04378569|101849690|FG004|STARTED|Overall Study||33||
48617934|NCT04378569|101849691|FG005|STARTED|Overall Study||32||
48617935|NCT04378569|101849686|FG000|COMPLETED|Overall Study||7||
48617936|NCT04378569|101849687|FG001|COMPLETED|Overall Study||56||
48617937|NCT04378569|101849688|FG002|COMPLETED|Overall Study||50||
48617938|NCT04378569|101849689|FG003|COMPLETED|Overall Study||28||
48617939|NCT04378569|101849690|FG004|COMPLETED|Overall Study||23||
48617940|NCT04378569|101849691|FG005|COMPLETED|Overall Study||22||
48617941|NCT04378569|101849686|FG000|NOT COMPLETED|Overall Study||0||
48617942|NCT04378569|101849687|FG001|NOT COMPLETED|Overall Study||9||
48617943|NCT04378569|101849688|FG002|NOT COMPLETED|Overall Study||11||
48617944|NCT04378569|101849689|FG003|NOT COMPLETED|Overall Study||4||
48617945|NCT04378569|101849690|FG004|NOT COMPLETED|Overall Study||10||
48617946|NCT04378569|101849691|FG005|NOT COMPLETED|Overall Study||10||
48617947|NCT02537951|101849692|FG000|STARTED|Overall Study||10||
48617948|NCT02537951|101849692|FG000|COMPLETED|Overall Study||10||
48617949|NCT02537951|101849692|FG000|NOT COMPLETED|Overall Study||0||
48617950|NCT01806168|101849693|FG000|STARTED|Overall Study||11||
48617951|NCT01806168|101849694|FG001|STARTED|Overall Study||10||
48617952|NCT01806168|101849695|FG002|STARTED|Overall Study||10||
48741742|NCT00550407|102151729|FG001|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0||
48741743|NCT00550407|102151730|FG002|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0||
48741744|NCT00550407|102151728|FG000|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||112||
48741745|NCT00550407|102151729|FG001|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0||
48741746|NCT00550407|102151730|FG002|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0||
48741747|NCT00550407|102151728|FG000|STARTED|26-Week Randomized Phase||0||
48741748|NCT00550407|102151729|FG001|STARTED|26-Week Randomized Phase||58||
48741749|NCT00550407|102151730|FG002|STARTED|26-Week Randomized Phase||45||
48741750|NCT00550407|102151728|FG000|COMPLETED|26-Week Randomized Phase||0||
48741751|NCT00550407|102151729|FG001|COMPLETED|26-Week Randomized Phase||15||
48741752|NCT00550407|102151730|FG002|COMPLETED|26-Week Randomized Phase||21||
48741753|NCT00550407|102151728|FG000|NOT COMPLETED|26-Week Randomized Phase||0||
48741754|NCT00550407|102151729|FG001|NOT COMPLETED|26-Week Randomized Phase||43||
48741755|NCT00550407|102151730|FG002|NOT COMPLETED|26-Week Randomized Phase||24||
48741756|NCT03354273|102151731|FG000|STARTED|Overall Study||730||
48741757|NCT03354273|102151731|FG000|Safety Population (Treated)|Overall Study||604||
48741758|NCT03354273|102151731|FG000|Modified Intent-to-Treat (MITT) Population|Overall Study||578||
48741759|NCT03354273|102151731|FG000|Secondary Modified Intent-to-Treat (SMITT) Population|Overall Study||578||
48741760|NCT03354273|102151731|FG000|COMPLETED|Overall Study||578||
48741761|NCT03354273|102151731|FG000|NOT COMPLETED|Overall Study||152||
48741762|NCT04970654|102151732|FG000|STARTED|Overall Study||36||
48741763|NCT04970654|102151733|FG001|STARTED|Overall Study||74||
48741764|NCT04970654|102151732|FG000|Full Analysis Set|Overall Study||36||
48741765|NCT04970654|102151733|FG001|Full Analysis Set|Overall Study||74||
48741766|NCT04970654|102151732|FG000|Safety Analysis Set|Overall Study||36||
48741767|NCT04970654|102151733|FG001|Safety Analysis Set|Overall Study||74||
48741768|NCT04970654|102151732|FG000|COMPLETED|Overall Study||32||
48741769|NCT04970654|102151733|FG001|COMPLETED|Overall Study||71||
48741770|NCT04970654|102151732|FG000|NOT COMPLETED|Overall Study||4||
48741771|NCT04970654|102151733|FG001|NOT COMPLETED|Overall Study||3||
48741772|NCT01804881|102151734|FG000|STARTED|Overall Study||16||
48741773|NCT01804881|102151735|FG001|STARTED|Overall Study||14||
48741774|NCT01804881|102151734|FG000|COMPLETED|Overall Study||11||
48741775|NCT01804881|102151735|FG001|COMPLETED|Overall Study||10||
48741776|NCT01804881|102151734|FG000|NOT COMPLETED|Overall Study||5||
48741777|NCT01804881|102151735|FG001|NOT COMPLETED|Overall Study||4||
48617953|NCT01806168|101849693|FG000|Received Allocated Intervention|Overall Study||11||
48617954|NCT01806168|101849694|FG001|Received Allocated Intervention|Overall Study||9||
48617955|NCT01806168|101849695|FG002|Received Allocated Intervention|Overall Study||9||
48617956|NCT01806168|101849693|FG000|COMPLETED|Overall Study||10||
48617957|NCT01806168|101849694|FG001|COMPLETED|Overall Study||9||
48617958|NCT01806168|101849695|FG002|COMPLETED|Overall Study||7||
48617959|NCT01806168|101849693|FG000|NOT COMPLETED|Overall Study||1||
48617960|NCT01806168|101849694|FG001|NOT COMPLETED|Overall Study||1||
48741778|NCT00581581|102151736|FG000|STARTED|Overall Study||32||
48741779|NCT00581581|102151737|FG001|STARTED|Overall Study||30||
48741780|NCT00581581|102151736|FG000|COMPLETED|Overall Study||32||
48741781|NCT00581581|102151737|FG001|COMPLETED|Overall Study||30||
48741782|NCT00581581|102151736|FG000|NOT COMPLETED|Overall Study||0||
48741783|NCT00581581|102151737|FG001|NOT COMPLETED|Overall Study||0||
48741784|NCT01543074|102151738|FG000|STARTED|Overall Study||5||
48741785|NCT01543074|102151739|FG001|STARTED|Overall Study||7||
48741786|NCT01543074|102151740|FG002|STARTED|Overall Study||5||
48741787|NCT01543074|102151741|FG003|STARTED|Overall Study||6||
48741788|NCT01543074|102151738|FG000|COMPLETED|Overall Study||5||
48741789|NCT01543074|102151739|FG001|COMPLETED|Overall Study||7||
48741790|NCT01543074|102151740|FG002|COMPLETED|Overall Study||5||
48741791|NCT01543074|102151741|FG003|COMPLETED|Overall Study||6||
48741792|NCT01543074|102151738|FG000|NOT COMPLETED|Overall Study||0||
48741793|NCT01543074|102151739|FG001|NOT COMPLETED|Overall Study||0||
48741794|NCT01543074|102151740|FG002|NOT COMPLETED|Overall Study||0||
48741795|NCT01543074|102151741|FG003|NOT COMPLETED|Overall Study||0||
48741796|NCT02920749|102151742|FG000|STARTED|Overall Study||30||
48617961|NCT01806168|101849695|FG002|NOT COMPLETED|Overall Study||3||
48617962|NCT03193047|101849696|FG000|STARTED|Overall Study||31||
48617963|NCT03193047|101849697|FG001|STARTED|Overall Study||28||
48617964|NCT03193047|101849696|FG000|COMPLETED|Overall Study||29||
48617965|NCT03193047|101849697|FG001|COMPLETED|Overall Study||28||
48617966|NCT03193047|101849696|FG000|NOT COMPLETED|Overall Study||2||
48617967|NCT03193047|101849697|FG001|NOT COMPLETED|Overall Study||0||
48617968|NCT00929838|101849698|FG000|STARTED|Overall Study||63||
48741797|NCT02920749|102151743|FG001|STARTED|Overall Study||30||
48741798|NCT02920749|102151744|FG002|STARTED|Overall Study||30||
48741799|NCT02920749|102151745|FG003|STARTED|Overall Study||30||
48741800|NCT02920749|102151742|FG000|COMPLETED|Overall Study||30||
48741801|NCT02920749|102151743|FG001|COMPLETED|Overall Study||30||
48741802|NCT02920749|102151744|FG002|COMPLETED|Overall Study||30||
48741803|NCT02920749|102151745|FG003|COMPLETED|Overall Study||30||
48741804|NCT02920749|102151742|FG000|NOT COMPLETED|Overall Study||0||
48741805|NCT02920749|102151743|FG001|NOT COMPLETED|Overall Study||0||
48741806|NCT02920749|102151744|FG002|NOT COMPLETED|Overall Study||0||
48741807|NCT02920749|102151745|FG003|NOT COMPLETED|Overall Study||0||
48741808|NCT02968368|102154923|FG000|STARTED|Double Blind Phase||111||
48741809|NCT02968368|102154924|FG001|STARTED|Double Blind Phase||56||
48741810|NCT02968368|102154923|FG000|COMPLETED|Double Blind Phase||90||
48741811|NCT02968368|102154924|FG001|COMPLETED|Double Blind Phase||39||
48741812|NCT02968368|102154923|FG000|NOT COMPLETED|Double Blind Phase||21||
48741813|NCT02968368|102154924|FG001|NOT COMPLETED|Double Blind Phase||17||
48741814|NCT02968368|102154923|FG000|STARTED|Open Label Phase||86||
48741815|NCT02968368|102154924|FG001|STARTED|Open Label Phase||39||
48741816|NCT02968368|102154923|FG000|COMPLETED|Open Label Phase||67||
48741817|NCT02968368|102154924|FG001|COMPLETED|Open Label Phase||25||
48741818|NCT02968368|102154923|FG000|NOT COMPLETED|Open Label Phase||19||
48741819|NCT02968368|102154924|FG001|NOT COMPLETED|Open Label Phase||14||
48741820|NCT00410956|102154925|FG000|STARTED|Overall Study||22||
48741821|NCT00410956|102154925|FG000|COMPLETED|Overall Study||3||
48741822|NCT00410956|102154925|FG000|NOT COMPLETED|Overall Study||19||
48741823|NCT02175017|102154926|FG000|STARTED|Overall Study||45||
48741824|NCT02175017|102154927|FG001|STARTED|Overall Study||58||
48741825|NCT02175017|102154926|FG000|COMPLETED|Overall Study||12||
48741826|NCT02175017|102154927|FG001|COMPLETED|Overall Study||15||
48741827|NCT02175017|102154926|FG000|NOT COMPLETED|Overall Study||33||
48741828|NCT02175017|102154927|FG001|NOT COMPLETED|Overall Study||43||
48741829|NCT04367831|102154928|FG000|STARTED|Overall Study||46||4
48741830|NCT04367831|102154929|FG001|STARTED|Overall Study||48||4
48741831|NCT04367831|102154928|FG000|COMPLETED|Overall Study||46||4
48741832|NCT04367831|102154929|FG001|COMPLETED|Overall Study||48||4
48741833|NCT04367831|102154928|FG000|NOT COMPLETED|Overall Study||0||0
48741834|NCT04367831|102154929|FG001|NOT COMPLETED|Overall Study||0||0
48741835|NCT02566317|102154930|FG000|STARTED|Overall Study||276||12
48741836|NCT02566317|102154931|FG001|STARTED|Overall Study||354||12
48741837|NCT02566317|102154930|FG000|COMPLETED|Overall Study||247||12
48741838|NCT02566317|102154931|FG001|COMPLETED|Overall Study||292||12
48741839|NCT02566317|102154930|FG000|NOT COMPLETED|Overall Study||29||0
48741840|NCT02566317|102154931|FG001|NOT COMPLETED|Overall Study||62||0
48741841|NCT00981461|102154932|FG000|STARTED|Overall Study||48||
48741842|NCT00981461|102154933|FG001|STARTED|Overall Study||24||
48741843|NCT00981461|102154932|FG000|COMPLETED|Overall Study||43||
48741844|NCT00981461|102154933|FG001|COMPLETED|Overall Study||22||
48741845|NCT00981461|102154932|FG000|NOT COMPLETED|Overall Study||5||
48741846|NCT00981461|102154933|FG001|NOT COMPLETED|Overall Study||2||
48617969|NCT00929838|101849699|FG001|STARTED|Overall Study||65||
48617970|NCT00929838|101849700|FG002|STARTED|Overall Study||63||
48617971|NCT00929838|101849701|FG003|STARTED|Overall Study||64||
48617972|NCT00929838|101849698|FG000|COMPLETED|Overall Study||53||
48617973|NCT00929838|101849699|FG001|COMPLETED|Overall Study||56||
48617974|NCT00929838|101849700|FG002|COMPLETED|Overall Study||53||
48617975|NCT00929838|101849701|FG003|COMPLETED|Overall Study||55||
48617976|NCT00929838|101849698|FG000|NOT COMPLETED|Overall Study||10||
48617977|NCT00929838|101849699|FG001|NOT COMPLETED|Overall Study||9||
48741847|NCT01632020|102154934|FG000|STARTED|Overall Study||4||
48741848|NCT01632020|102154935|FG001|STARTED|Overall Study||3||
48741849|NCT01632020|102154934|FG000|COMPLETED|Overall Study||2||
48741850|NCT01632020|102154935|FG001|COMPLETED|Overall Study||3||
48741851|NCT01632020|102154934|FG000|NOT COMPLETED|Overall Study||2||
48741852|NCT01632020|102154935|FG001|NOT COMPLETED|Overall Study||0||
48741853|NCT00622505|102154936|FG000|STARTED|Overall Study||79||
48741854|NCT00622505|102154937|FG001|STARTED|Overall Study||42||
48741855|NCT00622505|102154936|FG000|COMPLETED|Overall Study||50||
48741856|NCT00622505|102154937|FG001|COMPLETED|Overall Study||19||
48741857|NCT00622505|102154936|FG000|NOT COMPLETED|Overall Study||29||
48741858|NCT00622505|102154937|FG001|NOT COMPLETED|Overall Study||23||
48741859|NCT03275285|102154938|FG000|STARTED|Overall Study||123||
48741860|NCT03275285|102154939|FG001|STARTED|Overall Study||179||
48741861|NCT03275285|102154938|FG000|Treated|Overall Study||122||
48741862|NCT03275285|102154939|FG001|Treated|Overall Study||177||
48741863|NCT03275285|102154938|FG000|COMPLETED|Overall Study||78||
48741864|NCT03275285|102154939|FG001|COMPLETED|Overall Study||110||
48741865|NCT03275285|102154938|FG000|NOT COMPLETED|Overall Study||45||
48741866|NCT03275285|102154939|FG001|NOT COMPLETED|Overall Study||69||
48617978|NCT00929838|101849700|FG002|NOT COMPLETED|Overall Study||10||
48617979|NCT00929838|101849701|FG003|NOT COMPLETED|Overall Study||9||
48617980|NCT00320242|101849702|FG000|STARTED|Overall Study||16||
48617981|NCT00320242|101849703|FG001|STARTED|Overall Study||16||
48617982|NCT00320242|101849702|FG000|COMPLETED|Overall Study||14||
48617983|NCT00320242|101849703|FG001|COMPLETED|Overall Study||12||
48617984|NCT00320242|101849702|FG000|NOT COMPLETED|Overall Study||2||
48617985|NCT00320242|101849703|FG001|NOT COMPLETED|Overall Study||4||
48617986|NCT04658797|101849704|FG000|STARTED|Overall Study||15||
48617987|NCT04658797|101849705|FG001|STARTED|Overall Study||15||
48617988|NCT04658797|101849704|FG000|COMPLETED|Overall Study||15||
48617989|NCT04658797|101849705|FG001|COMPLETED|Overall Study||15||
48617990|NCT04658797|101849704|FG000|NOT COMPLETED|Overall Study||0||
48617991|NCT04658797|101849705|FG001|NOT COMPLETED|Overall Study||0||
48617992|NCT01261390|101849706|FG000|STARTED|Overall Study||44||
48617993|NCT01261390|101849707|FG001|STARTED|Overall Study||42||
48617994|NCT01261390|101849708|FG002|STARTED|Overall Study||42||
48617995|NCT01261390|101849709|FG003|STARTED|Overall Study||41||
48617996|NCT01261390|101849706|FG000|6-Month Visit|Overall Study||37||
48617997|NCT01261390|101849707|FG001|6-Month Visit|Overall Study||34||
48617998|NCT01261390|101849708|FG002|6-Month Visit|Overall Study||34||
48617999|NCT01261390|101849709|FG003|6-Month Visit|Overall Study||32||
48618000|NCT01261390|101849706|FG000|12-Month Visit|Overall Study||23||
48618001|NCT01261390|101849707|FG001|12-Month Visit|Overall Study||21||
48618002|NCT01261390|101849708|FG002|12-Month Visit|Overall Study||19||
48618003|NCT01261390|101849709|FG003|12-Month Visit|Overall Study||19||
48618004|NCT01261390|101849706|FG000|COMPLETED|Overall Study||37||
48618005|NCT01261390|101849707|FG001|COMPLETED|Overall Study||33||
48618006|NCT01261390|101849708|FG002|COMPLETED|Overall Study||35||
48618007|NCT01261390|101849709|FG003|COMPLETED|Overall Study||33||
48618008|NCT01261390|101849706|FG000|NOT COMPLETED|Overall Study||7||
48618009|NCT01261390|101849707|FG001|NOT COMPLETED|Overall Study||9||
48618010|NCT01261390|101849708|FG002|NOT COMPLETED|Overall Study||7||
48618011|NCT01261390|101849709|FG003|NOT COMPLETED|Overall Study||8||
48741867|NCT02021669|102154940|FG000|STARTED|Overall Study||71||
48741868|NCT02021669|102154941|FG001|STARTED|Overall Study||73||
48162197|NCT00990340|100718910|FG001|STARTED|Second 14-day Treatment||21||
48162198|NCT00990340|100718909|FG000|COMPLETED|Second 14-day Treatment||21||
48162199|NCT00990340|100718910|FG001|COMPLETED|Second 14-day Treatment||21||
48162200|NCT00990340|100718909|FG000|NOT COMPLETED|Second 14-day Treatment||0||
48162201|NCT00990340|100718910|FG001|NOT COMPLETED|Second 14-day Treatment||0||
48162202|NCT01247428|100718911|FG000|STARTED|Overall Study||30||
48162203|NCT01247428|100718911|FG000|COMPLETED|Overall Study||30||
48618012|NCT01468454|101849710|FG000|STARTED|Overall Study||128||
48618013|NCT01468454|101849710|FG000|PETs Completed|Overall Study||128||
48618014|NCT01468454|101849710|FG000|Had Both PET and Surgery|Overall Study||119||
48618015|NCT01468454|101849710|FG000|COMPLETED|Overall Study||119||
48618016|NCT01468454|101849710|FG000|NOT COMPLETED|Overall Study||9||
48618017|NCT03654729|101849711|FG000|STARTED|Overall Study||97||
48618018|NCT03654729|101849712|FG001|STARTED|Overall Study||96||
48618019|NCT03654729|101849713|FG002|STARTED|Overall Study||98||
48618020|NCT03654729|101849711|FG000|Treated|Overall Study||96||
48618021|NCT03654729|101849712|FG001|Treated|Overall Study||93||
48618022|NCT03654729|101849713|FG002|Treated|Overall Study||96||
48618023|NCT03654729|101849711|FG000|COMPLETED|Overall Study||66||
48162204|NCT01247428|100718911|FG000|NOT COMPLETED|Overall Study||0||
48618024|NCT03654729|101849712|FG001|COMPLETED|Overall Study||70||
48618025|NCT03654729|101849713|FG002|COMPLETED|Overall Study||69||
48618026|NCT03654729|101849711|FG000|NOT COMPLETED|Overall Study||31||
48618027|NCT03654729|101849712|FG001|NOT COMPLETED|Overall Study||26||
48618028|NCT03654729|101849713|FG002|NOT COMPLETED|Overall Study||29||
48618029|NCT00493012|101849714|FG000|STARTED|Overall Study||100||
48618030|NCT00493012|101849715|FG001|STARTED|Overall Study||100||
48618031|NCT00493012|101849714|FG000|COMPLETED|Overall Study||82||
48618032|NCT00493012|101849715|FG001|COMPLETED|Overall Study||83||
48618033|NCT00493012|101849714|FG000|NOT COMPLETED|Overall Study||18||
48618034|NCT00493012|101849715|FG001|NOT COMPLETED|Overall Study||17||
48618035|NCT00052078|101849716|FG000|STARTED|Overall Study||133||
48618036|NCT00052078|101849717|FG001|STARTED|Overall Study||139||
48618037|NCT00052078|101849718|FG002|STARTED|Overall Study||140||
48618038|NCT00052078|101849719|FG003|STARTED|Overall Study||76||
48162205|NCT00118092|100718912|FG000|STARTED|Overall Study||17||
48618039|NCT00052078|101849716|FG000|COMPLETED|Overall Study||110||
48618040|NCT00052078|101849717|FG001|COMPLETED|Overall Study||133||
48162206|NCT00118092|100718912|FG000|COMPLETED|Overall Study||15||
48618041|NCT00052078|101849718|FG002|COMPLETED|Overall Study||127||
48162207|NCT00118092|100718912|FG000|NOT COMPLETED|Overall Study||2||
48162208|NCT00691132|100718913|FG000|STARTED|Overall Study||53||
48618042|NCT00052078|101849719|FG003|COMPLETED|Overall Study||61||
48618043|NCT00052078|101849716|FG000|NOT COMPLETED|Overall Study||23||
48618044|NCT00052078|101849717|FG001|NOT COMPLETED|Overall Study||6||
48618045|NCT00052078|101849718|FG002|NOT COMPLETED|Overall Study||13||
48618046|NCT00052078|101849719|FG003|NOT COMPLETED|Overall Study||15||
48618047|NCT01166750|101849720|FG000|STARTED|Overall Study||10||
48618048|NCT01166750|101849721|FG001|STARTED|Overall Study||13||
48618049|NCT01166750|101849720|FG000|COMPLETED|Overall Study||9||
48618050|NCT01166750|101849721|FG001|COMPLETED|Overall Study||13||
48162209|NCT00691132|100718914|FG001|STARTED|Overall Study||54||
48162210|NCT00691132|100718913|FG000|COMPLETED|Overall Study||41||
48162211|NCT00691132|100718914|FG001|COMPLETED|Overall Study||41||
48162212|NCT00691132|100718913|FG000|NOT COMPLETED|Overall Study||12||
48162213|NCT00691132|100718914|FG001|NOT COMPLETED|Overall Study||13||
48162214|NCT04067401|100718915|FG000|STARTED|Overall Study||748||
48323714|NCT02177201|101118290|FG000|STARTED|Overall Study||80||
48618051|NCT01166750|101849720|FG000|NOT COMPLETED|Overall Study||1||
48618052|NCT01166750|101849721|FG001|NOT COMPLETED|Overall Study||0||
48618053|NCT00810199|101849722|FG000|STARTED|Overall Study||279||
48741869|NCT02021669|102154940|FG000|COMPLETED|Overall Study||64||
48741870|NCT02021669|102154941|FG001|COMPLETED|Overall Study||70||
48741871|NCT02021669|102154940|FG000|NOT COMPLETED|Overall Study||7||
48741872|NCT02021669|102154941|FG001|NOT COMPLETED|Overall Study||3||
48741873|NCT00369577|102154942|FG000|STARTED|Overall Study||43||
48741874|NCT00369577|102154943|FG001|STARTED|Overall Study||45||
48741875|NCT00369577|102154944|FG002|STARTED|Overall Study||41||
48741876|NCT00369577|102154942|FG000|COMPLETED|Overall Study||43||
48741877|NCT00369577|102154943|FG001|COMPLETED|Overall Study||45||
48741878|NCT00369577|102154944|FG002|COMPLETED|Overall Study||40||
48741879|NCT00369577|102154942|FG000|NOT COMPLETED|Overall Study||0||
48741880|NCT00369577|102154943|FG001|NOT COMPLETED|Overall Study||0||
48741881|NCT00369577|102154944|FG002|NOT COMPLETED|Overall Study||1||
48741882|NCT04587050|102154945|FG000|STARTED|Overall Study||54||
48741883|NCT04587050|102154946|FG001|STARTED|Overall Study||3||
48741884|NCT04587050|102154945|FG000|COMPLETED|Overall Study||54||
48741885|NCT04587050|102154946|FG001|COMPLETED|Overall Study||3||
48741886|NCT04587050|102154945|FG000|NOT COMPLETED|Overall Study||0||
48741887|NCT04587050|102154946|FG001|NOT COMPLETED|Overall Study||0||
48741888|NCT03777059|102154947|FG000|STARTED|DB Treatment Period (Up to Week 12)||223||
48741889|NCT03777059|102154948|FG001|STARTED|DB Treatment Period (Up to Week 12)||222||
48741890|NCT03777059|102154949|FG002|STARTED|DB Treatment Period (Up to Week 12)||230||
48741891|NCT03777059|102154950|FG003|STARTED|DB Treatment Period (Up to Week 12)||235||
48741892|NCT03777059|102154947|FG000|Treated: Safety Population|DB Treatment Period (Up to Week 12)||222|Safety Population included all participants who received at least 1 dose of study intervention.|
48741893|NCT03777059|102154948|FG001|Treated: Safety Population|DB Treatment Period (Up to Week 12)||221|Safety Population included all participants who received at least 1 dose of study intervention.|
48741894|NCT03777059|102154949|FG002|Treated: Safety Population|DB Treatment Period (Up to Week 12)||228|Safety Population included all participants who received at least 1 dose of study intervention.|
48741895|NCT03777059|102154950|FG003|Treated: Safety Population|DB Treatment Period (Up to Week 12)||231|Safety Population included all participants who received at least 1 dose of study intervention.|
48741896|NCT03777059|102154947|FG000|COMPLETED|DB Treatment Period (Up to Week 12)||201|Out of 805 participants who completed DB Treatment Period, 683 participants did not complete follow-up since they rolled into study 3101-309-002 (NCT03939312), 183 entered Follow-Up Period.|
48741897|NCT03777059|102154948|FG001|COMPLETED|DB Treatment Period (Up to Week 12)||193|Out of 805 participants who completed DB Treatment Period, 683 participants did not complete follow-up since they rolled into study 3101-309-002 (NCT03939312), 183 entered Follow-Up Period.|
48741898|NCT03777059|102154949|FG002|COMPLETED|DB Treatment Period (Up to Week 12)||207|Out of 805 participants who completed DB Treatment Period, 683 participants did not complete follow-up since they rolled into study 3101-309-002 (NCT03939312), 183 entered Follow-Up Period.|
48741899|NCT03777059|102154950|FG003|COMPLETED|DB Treatment Period (Up to Week 12)||204|Out of 805 participants who completed DB Treatment Period, 683 participants did not complete follow-up since they rolled into study 3101-309-002 (NCT03939312), 183 entered Follow-Up Period.|
48741900|NCT03777059|102154947|FG000|NOT COMPLETED|DB Treatment Period (Up to Week 12)||22||
48741901|NCT03777059|102154948|FG001|NOT COMPLETED|DB Treatment Period (Up to Week 12)||29||
48741902|NCT03777059|102154949|FG002|NOT COMPLETED|DB Treatment Period (Up to Week 12)||23||
48741903|NCT03777059|102154950|FG003|NOT COMPLETED|DB Treatment Period (Up to Week 12)||31||
48741904|NCT03777059|102154947|FG000|STARTED|Follow-Up Period (Weeks 12 to 16)||46||
48741905|NCT03777059|102154948|FG001|STARTED|Follow-Up Period (Weeks 12 to 16)||54||
48741906|NCT03777059|102154949|FG002|STARTED|Follow-Up Period (Weeks 12 to 16)||38||
48741907|NCT03777059|102154950|FG003|STARTED|Follow-Up Period (Weeks 12 to 16)||45||
48741908|NCT03777059|102154947|FG000|COMPLETED|Follow-Up Period (Weeks 12 to 16)||41||
48741909|NCT03777059|102154948|FG001|COMPLETED|Follow-Up Period (Weeks 12 to 16)||49||
48741910|NCT03777059|102154949|FG002|COMPLETED|Follow-Up Period (Weeks 12 to 16)||32||
48741911|NCT03777059|102154950|FG003|COMPLETED|Follow-Up Period (Weeks 12 to 16)||36||
48741912|NCT03777059|102154947|FG000|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||5||
48618054|NCT00810199|101849723|FG001|STARTED|Overall Study||277||
48618055|NCT00810199|101849722|FG000|Received Study Drug|Overall Study||277||
48162215|NCT04067401|100718916|FG001|STARTED|Overall Study||737||
48323715|NCT02177201|101118291|FG001|STARTED|Overall Study||80||
48618056|NCT00810199|101849723|FG001|Received Study Drug|Overall Study||276||
48323716|NCT02177201|101118290|FG000|COMPLETED|Overall Study||77||
48618057|NCT00810199|101849722|FG000|Completed Week 24|Overall Study||259||
48162216|NCT04067401|100718915|FG000|Baseline Survey Completion|Overall Study||746||
48162217|NCT04067401|100718916|FG001|Baseline Survey Completion|Overall Study||735||
48162218|NCT04067401|100718915|FG000|1 Month Survey Completion|Overall Study||697||
48162219|NCT04067401|100718916|FG001|1 Month Survey Completion|Overall Study||694||
48162220|NCT04067401|100718915|FG000|6 Month Survey Completion|Overall Study||629||
48162221|NCT04067401|100718916|FG001|6 Month Survey Completion|Overall Study||618||
48162222|NCT04067401|100718915|FG000|COMPLETED|Overall Study||740||
48162223|NCT04067401|100718916|FG001|COMPLETED|Overall Study||737||
48162224|NCT04067401|100718915|FG000|NOT COMPLETED|Overall Study||8||
48162225|NCT04067401|100718916|FG001|NOT COMPLETED|Overall Study||0||
48162226|NCT02259517|100718917|FG000|STARTED|Overall Study||5||
48162227|NCT02259517|100718918|FG001|STARTED|Overall Study||4||
48323717|NCT02177201|101118291|FG001|COMPLETED|Overall Study||77||
48323718|NCT02177201|101118290|FG000|NOT COMPLETED|Overall Study||3||
48323719|NCT02177201|101118291|FG001|NOT COMPLETED|Overall Study||3||
48323720|NCT00623428|101118292|FG000|STARTED|Treatment Period||95||
48323721|NCT00623428|101118293|FG001|STARTED|Treatment Period||93||
48323722|NCT00623428|101118292|FG000|COMPLETED|Treatment Period||95||
48323723|NCT00623428|101118293|FG001|COMPLETED|Treatment Period||66||
48323724|NCT00623428|101118292|FG000|NOT COMPLETED|Treatment Period||0||
48323725|NCT00623428|101118293|FG001|NOT COMPLETED|Treatment Period||27||
48323726|NCT00623428|101118292|FG000|STARTED|Follow-up Period||95||
48323727|NCT00623428|101118293|FG001|STARTED|Follow-up Period||93||
48323728|NCT00623428|101118292|FG000|COMPLETED|Follow-up Period||66||
48323729|NCT00623428|101118293|FG001|COMPLETED|Follow-up Period||78||
48323730|NCT00623428|101118292|FG000|NOT COMPLETED|Follow-up Period||29||
48323731|NCT00623428|101118293|FG001|NOT COMPLETED|Follow-up Period||15||
48408505|NCT03399786|101331786|FG003|COMPLETED|Double-blind Treatment Period (DBTP)||0||
48408506|NCT03399786|101331783|FG000|NOT COMPLETED|Double-blind Treatment Period (DBTP)||1||
48408507|NCT03399786|101331784|FG001|NOT COMPLETED|Double-blind Treatment Period (DBTP)||0||
48408508|NCT03399786|101331785|FG002|NOT COMPLETED|Double-blind Treatment Period (DBTP)||0||
48408509|NCT03399786|101331786|FG003|NOT COMPLETED|Double-blind Treatment Period (DBTP)||0||
48408510|NCT03399786|101331783|FG000|STARTED|Open-label Treatment Period (OLTP)||0||
48408511|NCT03399786|101331784|FG001|STARTED|Open-label Treatment Period (OLTP)||0||
48408512|NCT03399786|101331785|FG002|STARTED|Open-label Treatment Period (OLTP)||20||
48408513|NCT03399786|101331786|FG003|STARTED|Open-label Treatment Period (OLTP)||44||
48408514|NCT03399786|101331783|FG000|COMPLETED|Open-label Treatment Period (OLTP)||0||
48408515|NCT03399786|101331784|FG001|COMPLETED|Open-label Treatment Period (OLTP)||0||
48408516|NCT03399786|101331785|FG002|COMPLETED|Open-label Treatment Period (OLTP)||19||
48408517|NCT03399786|101331786|FG003|COMPLETED|Open-label Treatment Period (OLTP)||43||
48162228|NCT02259517|100718919|FG002|STARTED|Overall Study||24||
48162229|NCT02259517|100718917|FG000|COMPLETED|Overall Study||5||
48323732|NCT00456989|101118294|FG000|STARTED|Overall Study||39||
48323733|NCT00456989|101118294|FG000|COMPLETED|Overall Study||39||
48323734|NCT00456989|101118294|FG000|NOT COMPLETED|Overall Study||0||
48323735|NCT00193063|101118295|FG000|STARTED|Overall Study||41||
48323736|NCT00193063|101118295|FG000|COMPLETED|Overall Study||37||
48323737|NCT00193063|101118295|FG000|NOT COMPLETED|Overall Study||4||
48323738|NCT00879697|101118296|FG000|STARTED|Overall Study||17||
48323739|NCT00879697|101118297|FG001|STARTED|Overall Study||17||
48323740|NCT00879697|101118296|FG000|COMPLETED|Overall Study||15||
48323741|NCT00879697|101118297|FG001|COMPLETED|Overall Study||15||
48323742|NCT00879697|101118296|FG000|NOT COMPLETED|Overall Study||2||
48323743|NCT00879697|101118297|FG001|NOT COMPLETED|Overall Study||2||
48323744|NCT03809611|101118298|FG000|STARTED|Overall Study||62||
48323745|NCT03809611|101118299|FG001|STARTED|Overall Study||62||
48323746|NCT03809611|101118298|FG000|COMPLETED|Overall Study||61||
48323747|NCT03809611|101118299|FG001|COMPLETED|Overall Study||61||
48323748|NCT03809611|101118298|FG000|NOT COMPLETED|Overall Study||1||
48323749|NCT03809611|101118299|FG001|NOT COMPLETED|Overall Study||1||
48323750|NCT01223703|101118300|FG000|STARTED|Overall Study||67||
48323751|NCT01223703|101118301|FG001|STARTED|Overall Study||66||
48323752|NCT01223703|101118300|FG000|COMPLETED|Overall Study||67||
48323753|NCT01223703|101118301|FG001|COMPLETED|Overall Study||66||
48323754|NCT01223703|101118300|FG000|NOT COMPLETED|Overall Study||0||
48323755|NCT01223703|101118301|FG001|NOT COMPLETED|Overall Study||0||
48323756|NCT01621633|101118302|FG000|STARTED|Overall Study||8||
48323757|NCT01621633|101118303|FG001|STARTED|Overall Study||8||
48323758|NCT01621633|101118304|FG002|STARTED|Overall Study||8||
48323759|NCT01621633|101118305|FG003|STARTED|Overall Study||8||
48323760|NCT01621633|101118302|FG000|COMPLETED|Overall Study||8||
48323761|NCT01621633|101118303|FG001|COMPLETED|Overall Study||8||
48323762|NCT01621633|101118304|FG002|COMPLETED|Overall Study||8||
48323763|NCT01621633|101118305|FG003|COMPLETED|Overall Study||8||
48323764|NCT01621633|101118302|FG000|NOT COMPLETED|Overall Study||0||
48323765|NCT01621633|101118303|FG001|NOT COMPLETED|Overall Study||0||
48323766|NCT01621633|101118304|FG002|NOT COMPLETED|Overall Study||0||
48323767|NCT01621633|101118305|FG003|NOT COMPLETED|Overall Study||0||
48323768|NCT00533442|101118306|FG000|STARTED|Allocation and Intent to Treat Analysis||86||
48323769|NCT00533442|101118307|FG001|STARTED|Allocation and Intent to Treat Analysis||84||
48323770|NCT00533442|101118306|FG000|COMPLETED|Allocation and Intent to Treat Analysis||86||
48323771|NCT00533442|101118307|FG001|COMPLETED|Allocation and Intent to Treat Analysis||84||
48323772|NCT00533442|101118306|FG000|NOT COMPLETED|Allocation and Intent to Treat Analysis||0||
48323773|NCT00533442|101118307|FG001|NOT COMPLETED|Allocation and Intent to Treat Analysis||0||
48323774|NCT00533442|101118306|FG000|STARTED|Follow-up||86||
48323775|NCT00533442|101118307|FG001|STARTED|Follow-up||84||
48323776|NCT00533442|101118306|FG000|COMPLETED|Follow-up||77||
48323777|NCT00533442|101118307|FG001|COMPLETED|Follow-up||74||
48323778|NCT00533442|101118306|FG000|NOT COMPLETED|Follow-up||9||
48323779|NCT00533442|101118307|FG001|NOT COMPLETED|Follow-up||10||
48323780|NCT01500109|101118308|FG000|STARTED|Overall Study||0||
48323781|NCT01500109|101118309|FG001|STARTED|Overall Study||0||
48323782|NCT01500109|101118310|FG002|STARTED|Overall Study||0||
48323783|NCT01500109|101118308|FG000|COMPLETED|Overall Study||0||
48323784|NCT01500109|101118309|FG001|COMPLETED|Overall Study||0||
48323785|NCT01500109|101118310|FG002|COMPLETED|Overall Study||0||
48323786|NCT01500109|101118308|FG000|NOT COMPLETED|Overall Study||0||
48323787|NCT01500109|101118309|FG001|NOT COMPLETED|Overall Study||0||
48323788|NCT01500109|101118310|FG002|NOT COMPLETED|Overall Study||0||
48323789|NCT01836783|101118311|FG000|STARTED|Overall Study||10||
48323790|NCT01836783|101118312|FG001|STARTED|Overall Study||12||
48323791|NCT01836783|101118311|FG000|COMPLETED|Overall Study||10||
48323792|NCT01836783|101118312|FG001|COMPLETED|Overall Study||10||
48323793|NCT01836783|101118311|FG000|NOT COMPLETED|Overall Study||0||
48323794|NCT01836783|101118312|FG001|NOT COMPLETED|Overall Study||2||
48323795|NCT00751400|101118313|FG000|STARTED|Overall Study||497||
48323796|NCT00751400|101118313|FG000|Subjects Provided Drug|Overall Study||497||
48323797|NCT00751400|101118313|FG000|Subjects Consumed Drug|Overall Study||485||
48323798|NCT00751400|101118313|FG000|Subjects Provided Detailed Use Data|Overall Study||467||
48323799|NCT00751400|101118313|FG000|COMPLETED|Overall Study||487||
48323800|NCT00751400|101118313|FG000|NOT COMPLETED|Overall Study||10||
48323801|NCT04766021|101118314|FG000|STARTED|Informed Consent/Screening Visit||30||
48323802|NCT04766021|101118314|FG000|COMPLETED|Informed Consent/Screening Visit||11||
48323803|NCT04766021|101118314|FG000|NOT COMPLETED|Informed Consent/Screening Visit||19||
48323804|NCT04766021|101118314|FG000|STARTED|Interventions||11||
48323805|NCT04766021|101118314|FG000|COMPLETED|Interventions||11||
48323806|NCT04766021|101118314|FG000|NOT COMPLETED|Interventions||0||
48323807|NCT01318109|101118315|FG000|STARTED|Overall Study||92||
48323808|NCT01318109|101118316|FG001|STARTED|Overall Study||96||
48323809|NCT01318109|101118317|FG002|STARTED|Overall Study||100||
48323810|NCT01318109|101118315|FG000|COMPLETED|Overall Study||91||
48323811|NCT01318109|101118316|FG001|COMPLETED|Overall Study||93||
48323812|NCT01318109|101118317|FG002|COMPLETED|Overall Study||100||
48323813|NCT01318109|101118315|FG000|NOT COMPLETED|Overall Study||1||
48323814|NCT01318109|101118316|FG001|NOT COMPLETED|Overall Study||3||
48323815|NCT01318109|101118317|FG002|NOT COMPLETED|Overall Study||0||
48323816|NCT04418076|101118318|FG000|STARTED|Overall Study||19||
48323817|NCT04418076|101118319|FG001|STARTED|Overall Study||20||
48323818|NCT04418076|101118320|FG002|STARTED|Overall Study||16||
48323819|NCT04418076|101118321|FG003|STARTED|Overall Study||23||
48323820|NCT04418076|101118318|FG000|9 Participants Had Complete Lab Results at 16 Weeks|Overall Study||1||
48323821|NCT04418076|101118319|FG001|9 Participants Had Complete Lab Results at 16 Weeks|Overall Study||3||
48323822|NCT04418076|101118320|FG002|9 Participants Had Complete Lab Results at 16 Weeks|Overall Study||4||
48323823|NCT04418076|101118321|FG003|9 Participants Had Complete Lab Results at 16 Weeks|Overall Study||1||
48323824|NCT04418076|101118318|FG000|57 Participants Completed 12 Weeks|Overall Study||15||
48323825|NCT04418076|101118319|FG001|57 Participants Completed 12 Weeks|Overall Study||15||
48323826|NCT04418076|101118320|FG002|57 Participants Completed 12 Weeks|Overall Study||11||
48323827|NCT04418076|101118321|FG003|57 Participants Completed 12 Weeks|Overall Study||16||
48323828|NCT04418076|101118318|FG000|COMPLETED|Overall Study||13||
48323829|NCT04418076|101118319|FG001|COMPLETED|Overall Study||15||
48323830|NCT04418076|101118320|FG002|COMPLETED|Overall Study||12||
48323831|NCT04418076|101118321|FG003|COMPLETED|Overall Study||17||
48323832|NCT04418076|101118318|FG000|NOT COMPLETED|Overall Study||6||
48323833|NCT04418076|101118319|FG001|NOT COMPLETED|Overall Study||5||
48323834|NCT04418076|101118320|FG002|NOT COMPLETED|Overall Study||4||
48323835|NCT04418076|101118321|FG003|NOT COMPLETED|Overall Study||6||
48323836|NCT00264238|101118322|FG000|STARTED|Overall Study||15||
48323837|NCT00264238|101118322|FG000|COMPLETED|Overall Study||14||
48323838|NCT00264238|101118322|FG000|NOT COMPLETED|Overall Study||1||
48323839|NCT01250379|101118323|FG000|STARTED|Overall Study||247||
48323840|NCT01250379|101118324|FG001|STARTED|Overall Study||247||
48323841|NCT01250379|101118323|FG000|COMPLETED|Overall Study||45||
48323842|NCT01250379|101118324|FG001|COMPLETED|Overall Study||54||
48323843|NCT01250379|101118323|FG000|NOT COMPLETED|Overall Study||202||
48741913|NCT03777059|102154948|FG001|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||5||
48741914|NCT03777059|102154949|FG002|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||6||
48741915|NCT03777059|102154950|FG003|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||9||
48741916|NCT06098937|102154951|FG000|STARTED|Overall Study||30||
48741917|NCT06098937|102154951|FG000|Kalifilcon A Daily Disposable Toric|Overall Study||30||
48323844|NCT01250379|101118324|FG001|NOT COMPLETED|Overall Study||193||
48323845|NCT01604265|101118325|FG000|STARTED|Overall Study||34||
48323846|NCT01604265|101118326|FG001|STARTED|Overall Study||32||
48323847|NCT01604265|101118325|FG000|COMPLETED|Overall Study||32||
48323848|NCT01604265|101118326|FG001|COMPLETED|Overall Study||32||
48323849|NCT01604265|101118325|FG000|NOT COMPLETED|Overall Study||2||
48323850|NCT01604265|101118326|FG001|NOT COMPLETED|Overall Study||0||
48323851|NCT01566773|101118327|FG000|STARTED|Overall Study||140||
48323852|NCT01566773|101118327|FG000|GP MDI 18 µg BID|Overall Study||64||
48323853|NCT01566773|101118327|FG000|GP MDI 9 µg BID|Overall Study||64||
48323854|NCT01566773|101118327|FG000|GP MDI 4.6 µg BID|Overall Study||62||
48323855|NCT01566773|101118327|FG000|GP MDI 2.4 µg BID|Overall Study||64||
48323856|NCT01566773|101118327|FG000|GP MDI 1.2 µg BID|Overall Study||57||
48323857|NCT01566773|101118327|FG000|GP MDI 0.6 µg BID|Overall Study||59||
48323858|NCT01566773|101118327|FG000|Placebo MDI|Overall Study||62||
48323859|NCT01566773|101118327|FG000|Spiriva® Handihaler®|Overall Study||62||
48323860|NCT01566773|101118327|FG000|COMPLETED|Overall Study||110||
48323861|NCT01566773|101118327|FG000|NOT COMPLETED|Overall Study||30||
48741918|NCT06098937|102154951|FG000|Total1 for Astigmatism|Overall Study||30||
48741919|NCT06098937|102154951|FG000|Precision1 for Astigmatism|Overall Study||30||
48323862|NCT00414453|101118328|FG000|STARTED|Overall Study||19||
48323863|NCT00414453|101118328|FG000|COMPLETED|Overall Study||3||
48323864|NCT00414453|101118328|FG000|NOT COMPLETED|Overall Study||16||
48323865|NCT00401375|101118329|FG000|STARTED|Overall Study||174||
48323866|NCT00401375|101118330|FG001|STARTED|Overall Study||176||
48323867|NCT00401375|101118331|FG002|STARTED|Overall Study||174||
48323868|NCT00401375|101118329|FG000|Received at Least 1 Dose of Study Drug|Overall Study||171|Modified intent-to-treat (mITT)/Safety population|
48323869|NCT00401375|101118330|FG001|Received at Least 1 Dose of Study Drug|Overall Study||173|Modified intent-to-treat (mITT)/Safety population|
48323870|NCT00401375|101118331|FG002|Received at Least 1 Dose of Study Drug|Overall Study||171|Modified intent-to-treat (mITT)/Safety population|
48323871|NCT00401375|101118329|FG000|COMPLETED|Overall Study||152||
48323872|NCT00401375|101118330|FG001|COMPLETED|Overall Study||151||
48323873|NCT00401375|101118331|FG002|COMPLETED|Overall Study||149||
48323874|NCT00401375|101118329|FG000|NOT COMPLETED|Overall Study||22||
48323875|NCT00401375|101118330|FG001|NOT COMPLETED|Overall Study||25||
48323876|NCT00401375|101118331|FG002|NOT COMPLETED|Overall Study||25||
48323877|NCT00762892|101118332|FG000|STARTED|Overall Study||14||
48323878|NCT00762892|101118333|FG001|STARTED|Overall Study||14||
48323879|NCT00762892|101118332|FG000|COMPLETED|Overall Study||9||
48323880|NCT00762892|101118333|FG001|COMPLETED|Overall Study||8||
48741920|NCT06098937|102154951|FG000|MyDay Toric Lenses|Overall Study||30||
48741921|NCT06098937|102154951|FG000|COMPLETED|Overall Study||30||
48741922|NCT06098937|102154951|FG000|NOT COMPLETED|Overall Study||0||
48741923|NCT01687296|102154952|FG000|STARTED|Overall Study||123||
48741924|NCT01687296|102154953|FG001|STARTED|Overall Study||128||
48741925|NCT01687296|102154952|FG000|COMPLETED|Overall Study||116||
48741926|NCT01687296|102154953|FG001|COMPLETED|Overall Study||123||
48323881|NCT00762892|101118332|FG000|NOT COMPLETED|Overall Study||5||
48323882|NCT00762892|101118333|FG001|NOT COMPLETED|Overall Study||6||
48323883|NCT01074190|101118334|FG000|STARTED|Overall Study||115||
48323884|NCT01074190|101118335|FG001|STARTED|Overall Study||115||
48323885|NCT01074190|101118336|FG002|STARTED|Overall Study||115||
48323886|NCT01074190|101118334|FG000|COMPLETED|Overall Study||111||
48323887|NCT01074190|101118335|FG001|COMPLETED|Overall Study||109||
48323888|NCT01074190|101118336|FG002|COMPLETED|Overall Study||112||
48323889|NCT01074190|101118334|FG000|NOT COMPLETED|Overall Study||4||
48741927|NCT01687296|102154952|FG000|NOT COMPLETED|Overall Study||7||
48741928|NCT01687296|102154953|FG001|NOT COMPLETED|Overall Study||5||
48741929|NCT01217463|102154954|FG000|STARTED|Overall Study||99||
48741930|NCT01217463|102154955|FG001|STARTED|Overall Study||102||
48741931|NCT01217463|102154954|FG000|COMPLETED|Overall Study||86||
48741932|NCT01217463|102154955|FG001|COMPLETED|Overall Study||94||
48323890|NCT01074190|101118335|FG001|NOT COMPLETED|Overall Study||6||
48323891|NCT01074190|101118336|FG002|NOT COMPLETED|Overall Study||3||
48323892|NCT03716869|101118337|FG000|STARTED|Overall Study||6436||
48741933|NCT01217463|102154954|FG000|NOT COMPLETED|Overall Study||13||
48741934|NCT01217463|102154955|FG001|NOT COMPLETED|Overall Study||8||
48741935|NCT00389493|102154956|FG000|STARTED|Overall Study||40||
48741936|NCT00389493|102154957|FG001|STARTED|Overall Study||40||
48741937|NCT00389493|102154958|FG002|STARTED|Overall Study||20||
48741938|NCT00389493|102154956|FG000|COMPLETED|Overall Study||37||
48741939|NCT00389493|102154957|FG001|COMPLETED|Overall Study||32||
48741940|NCT00389493|102154958|FG002|COMPLETED|Overall Study||17||
48741941|NCT00389493|102154956|FG000|NOT COMPLETED|Overall Study||3||
48741942|NCT00389493|102154957|FG001|NOT COMPLETED|Overall Study||8||
48741943|NCT00389493|102154958|FG002|NOT COMPLETED|Overall Study||3||
48741944|NCT02363621|102154959|FG000|STARTED|Overall Study||51||
48741945|NCT02363621|102154960|FG001|STARTED|Overall Study||50||
48741946|NCT02363621|102154959|FG000|COMPLETED|Overall Study||50||
48323893|NCT03716869|101118338|FG001|STARTED|Overall Study||6473||
48323894|NCT03716869|101118337|FG000|COMPLETED|Overall Study||6436||
48323895|NCT03716869|101118338|FG001|COMPLETED|Overall Study||6473||
48323896|NCT03716869|101118337|FG000|NOT COMPLETED|Overall Study||0||
48323897|NCT03716869|101118338|FG001|NOT COMPLETED|Overall Study||0||
48323898|NCT00586261|101118339|FG000|STARTED|Overall Study||17||
48323899|NCT00586261|101118340|FG001|STARTED|Overall Study||19||
48323900|NCT00586261|101118339|FG000|COMPLETED|Overall Study||17||
48323901|NCT00586261|101118340|FG001|COMPLETED|Overall Study||19||
48323902|NCT00586261|101118339|FG000|NOT COMPLETED|Overall Study||0||
48323903|NCT00586261|101118340|FG001|NOT COMPLETED|Overall Study||0||
48323904|NCT02459795|101118341|FG000|STARTED|Overall Study||187||
48323905|NCT02459795|101118342|FG001|STARTED|Overall Study||189||
48323906|NCT02459795|101118343|FG002|STARTED|Overall Study||93||
48323907|NCT02459795|101118341|FG000|COMPLETED|Overall Study||181||
48323908|NCT02459795|101118342|FG001|COMPLETED|Overall Study||186||
48323909|NCT02459795|101118343|FG002|COMPLETED|Overall Study||92||
48323910|NCT02459795|101118341|FG000|NOT COMPLETED|Overall Study||6||
48323911|NCT02459795|101118342|FG001|NOT COMPLETED|Overall Study||3||
48323912|NCT02459795|101118343|FG002|NOT COMPLETED|Overall Study||1||
48323913|NCT04962022|101118344|FG000|STARTED|Period 1||12||
48323914|NCT04962022|101118345|FG001|STARTED|Period 1||0||
48323915|NCT04962022|101118344|FG000|COMPLETED|Period 1||11||
48323916|NCT04962022|101118345|FG001|COMPLETED|Period 1||0||
48323917|NCT04962022|101118344|FG000|NOT COMPLETED|Period 1||1||
48323918|NCT04962022|101118345|FG001|NOT COMPLETED|Period 1||0||
48323919|NCT04962022|101118344|FG000|STARTED|Period 2||0||
48323920|NCT04962022|101118345|FG001|STARTED|Period 2||11||
48323921|NCT04962022|101118344|FG000|COMPLETED|Period 2||0||
48323922|NCT04962022|101118345|FG001|COMPLETED|Period 2||11||
48323923|NCT04962022|101118344|FG000|NOT COMPLETED|Period 2||0||
48323924|NCT04962022|101118345|FG001|NOT COMPLETED|Period 2||0||
48323925|NCT01251367|101118346|FG000|STARTED|Overall Study||345||
48323926|NCT01251367|101118346|FG000|Cycle 1|Overall Study||345||
48323927|NCT01251367|101118346|FG000|Cycle 2|Overall Study||297||
48323928|NCT01251367|101118346|FG000|Cycle 3|Overall Study||224||
48323929|NCT01251367|101118346|FG000|Cycle 4|Overall Study||139||
48741947|NCT02363621|102154960|FG001|COMPLETED|Overall Study||50||
48741948|NCT02363621|102154959|FG000|NOT COMPLETED|Overall Study||1||
48741949|NCT02363621|102154960|FG001|NOT COMPLETED|Overall Study||0||
48741950|NCT01698502|102154961|FG000|STARTED|Overall Study||11||
48741951|NCT01698502|102154962|FG001|STARTED|Overall Study||10||
48741952|NCT01698502|102154961|FG000|COMPLETED|Overall Study||11||
48741953|NCT01698502|102154962|FG001|COMPLETED|Overall Study||10||
48741954|NCT01698502|102154961|FG000|NOT COMPLETED|Overall Study||0||
48741955|NCT01698502|102154962|FG001|NOT COMPLETED|Overall Study||0||
48741956|NCT00684775|102154963|FG000|STARTED|Overall Study||19||
48741957|NCT00684775|102154964|FG001|STARTED|Overall Study||19||
48741958|NCT00684775|102154963|FG000|COMPLETED|Overall Study||19||
48323930|NCT01251367|101118346|FG000|COMPLETED|Overall Study||269||
48323931|NCT01251367|101118346|FG000|NOT COMPLETED|Overall Study||76||
48323932|NCT00513409|101118347|FG000|STARTED|Overall Study||84||
48323933|NCT00513409|101118348|FG001|STARTED|Overall Study||79||
48323934|NCT00513409|101118347|FG000|COMPLETED|Overall Study||82||
48323935|NCT00513409|101118348|FG001|COMPLETED|Overall Study||73||
48323936|NCT00513409|101118347|FG000|NOT COMPLETED|Overall Study||2||
48323937|NCT00513409|101118348|FG001|NOT COMPLETED|Overall Study||6||
48323938|NCT02321436|101118349|FG000|STARTED|Overall Study||28||
48323939|NCT02321436|101118350|FG001|STARTED|Overall Study||14||
48323940|NCT02321436|101118349|FG000|COMPLETED|Overall Study||27||
48323941|NCT02321436|101118350|FG001|COMPLETED|Overall Study||13||
48323942|NCT02321436|101118349|FG000|NOT COMPLETED|Overall Study||1||
48323943|NCT02321436|101118350|FG001|NOT COMPLETED|Overall Study||1||
48323944|NCT01650636|101118351|FG000|STARTED|Intervention Phase||150||
48323945|NCT01650636|101118352|FG001|STARTED|Intervention Phase||150||
48323946|NCT01650636|101118351|FG000|COMPLETED|Intervention Phase||150||
48323947|NCT01650636|101118352|FG001|COMPLETED|Intervention Phase||150||
48323948|NCT01650636|101118351|FG000|NOT COMPLETED|Intervention Phase||0||
48323949|NCT01650636|101118352|FG001|NOT COMPLETED|Intervention Phase||0||
48408518|NCT03399786|101331783|FG000|NOT COMPLETED|Open-label Treatment Period (OLTP)||0||
48408519|NCT03399786|101331784|FG001|NOT COMPLETED|Open-label Treatment Period (OLTP)||0||
48408520|NCT03399786|101331785|FG002|NOT COMPLETED|Open-label Treatment Period (OLTP)||1||
48408521|NCT03399786|101331786|FG003|NOT COMPLETED|Open-label Treatment Period (OLTP)||1||
48408522|NCT00654368|101331787|FG000|STARTED|Overall Study||53||
48323950|NCT01650636|101118351|FG000|STARTED|Washout up to 5 Months||150||
48323951|NCT01650636|101118352|FG001|STARTED|Washout up to 5 Months||150||
48323952|NCT01650636|101118351|FG000|COMPLETED|Washout up to 5 Months||141||
48323953|NCT01650636|101118352|FG001|COMPLETED|Washout up to 5 Months||132||
48323954|NCT01650636|101118351|FG000|NOT COMPLETED|Washout up to 5 Months||9||
48323955|NCT01650636|101118352|FG001|NOT COMPLETED|Washout up to 5 Months||18||
48323956|NCT01650636|101118351|FG000|STARTED|5 Month Visit||141||
48323957|NCT01650636|101118352|FG001|STARTED|5 Month Visit||132||
48323958|NCT01650636|101118351|FG000|COMPLETED|5 Month Visit||141||
48323959|NCT01650636|101118352|FG001|COMPLETED|5 Month Visit||132||
48323960|NCT01650636|101118351|FG000|NOT COMPLETED|5 Month Visit||0||
48323961|NCT01650636|101118352|FG001|NOT COMPLETED|5 Month Visit||0||
48323962|NCT01650636|101118351|FG000|STARTED|Washout up to 9 Months||141||
48323963|NCT01650636|101118352|FG001|STARTED|Washout up to 9 Months||132||
48323964|NCT01650636|101118351|FG000|COMPLETED|Washout up to 9 Months||135||
48408523|NCT00654368|101331788|FG001|STARTED|Overall Study||98||
48408524|NCT00654368|101331789|FG002|STARTED|Overall Study||107||
48408525|NCT00654368|101331787|FG000|COMPLETED|Overall Study||0||
48408526|NCT00654368|101331788|FG001|COMPLETED|Overall Study||50||
48408527|NCT00654368|101331789|FG002|COMPLETED|Overall Study||75||
48408528|NCT00654368|101331787|FG000|NOT COMPLETED|Overall Study||53||
48408529|NCT00654368|101331788|FG001|NOT COMPLETED|Overall Study||48||
48618058|NCT00810199|101849723|FG001|Completed Week 24|Overall Study||250||
48618059|NCT00810199|101849722|FG000|Completed Week 52|Overall Study||243||
48618060|NCT00810199|101849723|FG001|Completed Week 52|Overall Study||229||
48618061|NCT00810199|101849722|FG000|Completed Week 104|Overall Study||222||
48618062|NCT00810199|101849723|FG001|Completed Week 104|Overall Study||201||
48618063|NCT00810199|101849722|FG000|COMPLETED|Overall Study||220||
48618064|NCT00810199|101849723|FG001|COMPLETED|Overall Study||195||
48618065|NCT00810199|101849722|FG000|NOT COMPLETED|Overall Study||59||
48618066|NCT00810199|101849723|FG001|NOT COMPLETED|Overall Study||82||
48618067|NCT01587105|101849724|FG000|STARTED|Overall Study||150||
48618068|NCT01587105|101849725|FG001|STARTED|Overall Study||181||
48618069|NCT01587105|101849724|FG000|COMPLETED|Overall Study||144||
48618070|NCT01587105|101849725|FG001|COMPLETED|Overall Study||138||
48618071|NCT01587105|101849724|FG000|NOT COMPLETED|Overall Study||6||
48618072|NCT01587105|101849725|FG001|NOT COMPLETED|Overall Study||43||
48618073|NCT00369915|101849726|FG000|STARTED|Overall Study||10||
48618074|NCT00369915|101849727|FG001|STARTED|Overall Study||7||
48618075|NCT00369915|101849726|FG000|COMPLETED|Overall Study||4||
48618076|NCT00369915|101849727|FG001|COMPLETED|Overall Study||4||
48618077|NCT00369915|101849726|FG000|NOT COMPLETED|Overall Study||6||
48618078|NCT00369915|101849727|FG001|NOT COMPLETED|Overall Study||3||
48618079|NCT01266824|101849728|FG000|STARTED|Overall Study||2||
48618080|NCT01266824|101849729|FG001|STARTED|Overall Study||3||
48618081|NCT01266824|101849728|FG000|COMPLETED|Overall Study||0||
48323965|NCT01650636|101118352|FG001|COMPLETED|Washout up to 9 Months||129||
48323966|NCT01650636|101118351|FG000|NOT COMPLETED|Washout up to 9 Months||6||
48323967|NCT01650636|101118352|FG001|NOT COMPLETED|Washout up to 9 Months||3||
48323968|NCT01650636|101118351|FG000|STARTED|9 Month Visit||135||
48323969|NCT01650636|101118352|FG001|STARTED|9 Month Visit||129||
48323970|NCT01650636|101118351|FG000|COMPLETED|9 Month Visit||135||
48323971|NCT01650636|101118352|FG001|COMPLETED|9 Month Visit||129||
48408530|NCT00654368|101331789|FG002|NOT COMPLETED|Overall Study||32||
48618082|NCT01266824|101849729|FG001|COMPLETED|Overall Study||0||
48618083|NCT01266824|101849728|FG000|NOT COMPLETED|Overall Study||2||
48618084|NCT01266824|101849729|FG001|NOT COMPLETED|Overall Study||3||
48618085|NCT01275144|101849730|FG000|STARTED|First Intervention (6 Days)||14||
48618086|NCT01275144|101849731|FG001|STARTED|First Intervention (6 Days)||14||
48618087|NCT01275144|101849730|FG000|Received at Least 1 Dose of Study Drug|First Intervention (6 Days)||14||
48618088|NCT01275144|101849731|FG001|Received at Least 1 Dose of Study Drug|First Intervention (6 Days)||14||
48323972|NCT01650636|101118351|FG000|NOT COMPLETED|9 Month Visit||0||
48323973|NCT01650636|101118352|FG001|NOT COMPLETED|9 Month Visit||0||
48323974|NCT00357500|101121141|FG000|STARTED|Overall Study||101||
48408531|NCT02280096|101331790|FG000|STARTED|Overall Study||13||
48323975|NCT00357500|101121141|FG000|Began Protocol Therapy|Overall Study||97||
48323976|NCT00357500|101121141|FG000|COMPLETED|Overall Study||24||
48323977|NCT00357500|101121141|FG000|NOT COMPLETED|Overall Study||77||
48323978|NCT03033875|101121142|FG000|STARTED|Overall Study||96||
48323979|NCT03033875|101121143|FG001|STARTED|Overall Study||111||
48323980|NCT03033875|101121144|FG002|STARTED|Overall Study||54||
48323981|NCT03033875|101121142|FG000|Completed Month 3 Assessment|Overall Study||71||
48323982|NCT03033875|101121143|FG001|Completed Month 3 Assessment|Overall Study||83||
48741959|NCT00684775|102154964|FG001|COMPLETED|Overall Study||19||
48741960|NCT00684775|102154963|FG000|NOT COMPLETED|Overall Study||0||
48323983|NCT03033875|101121144|FG002|Completed Month 3 Assessment|Overall Study||43||
48323984|NCT03033875|101121142|FG000|Completed Month 6 Assessment|Overall Study||73||
48323985|NCT03033875|101121143|FG001|Completed Month 6 Assessment|Overall Study||81||
48323986|NCT03033875|101121144|FG002|Completed Month 6 Assessment|Overall Study||46||
48323987|NCT03033875|101121142|FG000|COMPLETED|Overall Study||77||
48323988|NCT03033875|101121143|FG001|COMPLETED|Overall Study||87||
48323989|NCT03033875|101121144|FG002|COMPLETED|Overall Study||42||
48323990|NCT03033875|101121142|FG000|NOT COMPLETED|Overall Study||19||
48323991|NCT03033875|101121143|FG001|NOT COMPLETED|Overall Study||24||
48323992|NCT03033875|101121144|FG002|NOT COMPLETED|Overall Study||12||
48323993|NCT02408471|101121145|FG000|STARTED|Overall Study||97||
48323994|NCT02408471|101121145|FG000|COMPLETED|Overall Study||69||
48323995|NCT02408471|101121145|FG000|NOT COMPLETED|Overall Study||28||
48323996|NCT00439946|101121146|FG000|STARTED|Overall Study||8||
48323997|NCT00439946|101121146|FG000|COMPLETED|Overall Study||8||
48323998|NCT00439946|101121146|FG000|NOT COMPLETED|Overall Study||0||
48323999|NCT02484911|101121147|FG000|STARTED|Overall Study||60||
48324000|NCT02484911|101121148|FG001|STARTED|Overall Study||60||
48324001|NCT02484911|101121147|FG000|COMPLETED|Overall Study||56||
48324002|NCT02484911|101121148|FG001|COMPLETED|Overall Study||58||
48324003|NCT02484911|101121147|FG000|NOT COMPLETED|Overall Study||4||
48324004|NCT02484911|101121148|FG001|NOT COMPLETED|Overall Study||2||
48324005|NCT00847912|101121149|FG000|STARTED|Overall Study||477||
48324006|NCT00847912|101121150|FG001|STARTED|Overall Study||477||
48324007|NCT00847912|101121149|FG000|COMPLETED|Overall Study||468||
48324008|NCT00847912|101121150|FG001|COMPLETED|Overall Study||464||
48324009|NCT00847912|101121149|FG000|NOT COMPLETED|Overall Study||9||
48324010|NCT00847912|101121150|FG001|NOT COMPLETED|Overall Study||13||
48324011|NCT03528512|101121151|FG000|STARTED|Overall Study||3||
48324012|NCT03528512|101121152|FG001|STARTED|Overall Study||2||
48324013|NCT03528512|101121151|FG000|COMPLETED|Overall Study||3||
48324014|NCT03528512|101121152|FG001|COMPLETED|Overall Study||2||
48324015|NCT03528512|101121151|FG000|NOT COMPLETED|Overall Study||0||
48324016|NCT03528512|101121152|FG001|NOT COMPLETED|Overall Study||0||
48324017|NCT02595450|101121153|FG000|STARTED|Overall Study||299||
48324018|NCT02595450|101121153|FG000|Treated|Overall Study||291||
48324019|NCT02595450|101121153|FG000|COMPLETED|Overall Study||218||
48324020|NCT02595450|101121153|FG000|NOT COMPLETED|Overall Study||81||
48324021|NCT01695473|101121154|FG000|STARTED|Overall Study||11||
48324022|NCT01695473|101121154|FG000|COMPLETED|Overall Study||11||
48324023|NCT01695473|101121154|FG000|NOT COMPLETED|Overall Study||0||
48324024|NCT02325219|101121155|FG000|STARTED|Controlled Period (Week 0 - 16)||64||
48324025|NCT02325219|101121156|FG001|STARTED|Controlled Period (Week 0 - 16)||65||
48324026|NCT02325219|101121157|FG002|STARTED|Controlled Period (Week 0 - 16)||63||
48324027|NCT02325219|101121158|FG003|STARTED|Controlled Period (Week 0 - 16)||0||
48324028|NCT02325219|101121159|FG004|STARTED|Controlled Period (Week 0 - 16)||0||
48324029|NCT02325219|101121155|FG000|COMPLETED|Controlled Period (Week 0 - 16)||52||
48324030|NCT02325219|101121156|FG001|COMPLETED|Controlled Period (Week 0 - 16)||63||
48324031|NCT02325219|101121157|FG002|COMPLETED|Controlled Period (Week 0 - 16)||62||
48324032|NCT02325219|101121158|FG003|COMPLETED|Controlled Period (Week 0 - 16)||0||
48324033|NCT02325219|101121159|FG004|COMPLETED|Controlled Period (Week 0 - 16)||0||
48741961|NCT00684775|102154964|FG001|NOT COMPLETED|Overall Study||0||
48324034|NCT02325219|101121155|FG000|NOT COMPLETED|Controlled Period (Week 0 - 16)||12||
48324035|NCT02325219|101121156|FG001|NOT COMPLETED|Controlled Period (Week 0 - 16)||2||
48324036|NCT02325219|101121157|FG002|NOT COMPLETED|Controlled Period (Week 0 - 16)||1||
48324037|NCT02325219|101121158|FG003|NOT COMPLETED|Controlled Period (Week 0 - 16)||0||
48324038|NCT02325219|101121159|FG004|NOT COMPLETED|Controlled Period (Week 0 - 16)||0||
48324039|NCT02325219|101121155|FG000|STARTED|After Controlled Period (Week 16 - 52)||0||
48324040|NCT02325219|101121156|FG001|STARTED|After Controlled Period (Week 16 - 52)||63||
48324041|NCT02325219|101121157|FG002|STARTED|After Controlled Period (Week 16 - 52)||62||
48324042|NCT02325219|101121158|FG003|STARTED|After Controlled Period (Week 16 - 52)||26||
48324043|NCT02325219|101121159|FG004|STARTED|After Controlled Period (Week 16 - 52)||26||
48324044|NCT02325219|101121155|FG000|COMPLETED|After Controlled Period (Week 16 - 52)||0||
48324045|NCT02325219|101121156|FG001|COMPLETED|After Controlled Period (Week 16 - 52)||60||
48324046|NCT02325219|101121157|FG002|COMPLETED|After Controlled Period (Week 16 - 52)||62||
48324047|NCT02325219|101121158|FG003|COMPLETED|After Controlled Period (Week 16 - 52)||26||
48368065|NCT03691623|101230098|FG002|Received Treatment|Overall Study||38||
48741962|NCT02475278|102154965|FG000|STARTED|Overall Study||50||
48741963|NCT02475278|102154965|FG000|COMPLETED|Overall Study||48||
48741964|NCT02475278|102154965|FG000|NOT COMPLETED|Overall Study||2||
48324048|NCT02325219|101121159|FG004|COMPLETED|After Controlled Period (Week 16 - 52)||25||
48324049|NCT02325219|101121155|FG000|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0||
48324050|NCT02325219|101121156|FG001|NOT COMPLETED|After Controlled Period (Week 16 - 52)||3||
48324051|NCT02325219|101121157|FG002|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0||
48324052|NCT02325219|101121158|FG003|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0||
48324053|NCT02325219|101121159|FG004|NOT COMPLETED|After Controlled Period (Week 16 - 52)||1||
48324054|NCT00498173|101121160|FG000|STARTED|Phase 1-Blinded Randomization (8 Weeks)||29||
48324055|NCT00498173|101121161|FG001|STARTED|Phase 1-Blinded Randomization (8 Weeks)||31||
48324056|NCT00498173|101121162|FG002|STARTED|Phase 1-Blinded Randomization (8 Weeks)||0||
48324057|NCT00498173|101121160|FG000|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||27||
48324058|NCT00498173|101121161|FG001|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||30||
48324059|NCT00498173|101121162|FG002|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0||
48324060|NCT00498173|101121160|FG000|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||2||
48618089|NCT01275144|101849730|FG000|COMPLETED|First Intervention (6 Days)||14||
48618090|NCT01275144|101849731|FG001|COMPLETED|First Intervention (6 Days)||14||
48618091|NCT01275144|101849730|FG000|NOT COMPLETED|First Intervention (6 Days)||0||
48618092|NCT01275144|101849731|FG001|NOT COMPLETED|First Intervention (6 Days)||0||
48618093|NCT01275144|101849730|FG000|STARTED|Washout (7 Days)||14||
48618094|NCT01275144|101849731|FG001|STARTED|Washout (7 Days)||14||
48618095|NCT01275144|101849730|FG000|COMPLETED|Washout (7 Days)||14||
48618096|NCT01275144|101849731|FG001|COMPLETED|Washout (7 Days)||14||
48741965|NCT02678351|102154966|FG000|STARTED|Overall Study||74||
48741966|NCT02678351|102154966|FG000|COMPLETED|Overall Study||73||
48324061|NCT00498173|101121161|FG001|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||1||
48324062|NCT00498173|101121162|FG002|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0||
48408532|NCT02280096|101331791|FG001|STARTED|Overall Study||11||
48408533|NCT02280096|101331790|FG000|COMPLETED|Overall Study||11||
48618097|NCT01275144|101849730|FG000|NOT COMPLETED|Washout (7 Days)||0||
48618098|NCT01275144|101849731|FG001|NOT COMPLETED|Washout (7 Days)||0||
48408534|NCT02280096|101331791|FG001|COMPLETED|Overall Study||10||
48408535|NCT02280096|101331790|FG000|NOT COMPLETED|Overall Study||2||
48408536|NCT02280096|101331791|FG001|NOT COMPLETED|Overall Study||1||
48408537|NCT03810053|101331792|FG000|STARTED|Overall Study||290||
48408538|NCT03810053|101331792|FG000|COMPLETED|Overall Study||290||
48408539|NCT03810053|101331792|FG000|NOT COMPLETED|Overall Study||0||
48408540|NCT01756833|101331793|FG000|STARTED|Overall Study||133||
48408541|NCT01756833|101331794|FG001|STARTED|Overall Study||128||
48408542|NCT01756833|101331793|FG000|COMPLETED|Overall Study||129||
48408543|NCT01756833|101331794|FG001|COMPLETED|Overall Study||125||
48408544|NCT01756833|101331793|FG000|NOT COMPLETED|Overall Study||4||
48408545|NCT01756833|101331794|FG001|NOT COMPLETED|Overall Study||3||
48408546|NCT04402385|101331795|FG000|STARTED|Overall Study||25||
48408547|NCT04402385|101331796|FG001|STARTED|Overall Study||25||
48408548|NCT04402385|101331795|FG000|COMPLETED|Overall Study||20||
48408549|NCT04402385|101331796|FG001|COMPLETED|Overall Study||19||
48408550|NCT04402385|101331795|FG000|NOT COMPLETED|Overall Study||5||
48618099|NCT01275144|101849730|FG000|STARTED|Second Intervention (6 Days)||14||
48741967|NCT02678351|102154966|FG000|NOT COMPLETED|Overall Study||1||
48741968|NCT00082407|102154967|FG000|STARTED|Overall Study||255||
48324063|NCT00498173|101121160|FG000|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0||
48408551|NCT04402385|101331796|FG001|NOT COMPLETED|Overall Study||6||
48408552|NCT01401101|101331797|FG000|STARTED|Overall Study||206||
48408553|NCT01401101|101331798|FG001|STARTED|Overall Study||198||
48408554|NCT01401101|101331797|FG000|COMPLETED|Overall Study||184||
48408555|NCT01401101|101331798|FG001|COMPLETED|Overall Study||171||
48408556|NCT01401101|101331797|FG000|NOT COMPLETED|Overall Study||22||
48408557|NCT01401101|101331798|FG001|NOT COMPLETED|Overall Study||27||
48618100|NCT01275144|101849731|FG001|STARTED|Second Intervention (6 Days)||14||
48618101|NCT01275144|101849730|FG000|COMPLETED|Second Intervention (6 Days)||13||
48618102|NCT01275144|101849731|FG001|COMPLETED|Second Intervention (6 Days)||14||
48618103|NCT01275144|101849730|FG000|NOT COMPLETED|Second Intervention (6 Days)||1||
48618104|NCT01275144|101849731|FG001|NOT COMPLETED|Second Intervention (6 Days)||0||
48618105|NCT02675764|101849732|FG000|STARTED|Overall Study||6||
48741969|NCT00082407|102154968|FG001|STARTED|Overall Study||250||
48741970|NCT00082407|102154967|FG000|Received Treatment (Intent to Treat)|Overall Study||253||
48324064|NCT00498173|101121161|FG001|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0||
48324065|NCT00498173|101121162|FG002|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||26||
48324066|NCT00498173|101121160|FG000|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0||
48324067|NCT00498173|101121161|FG001|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0||
48324068|NCT00498173|101121162|FG002|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||26||
48408558|NCT00179998|101331799|FG000|STARTED|Initial Period - 6 Months||12||
48408559|NCT00179998|101331800|FG001|STARTED|Initial Period - 6 Months||12||
48408560|NCT00179998|101331799|FG000|COMPLETED|Initial Period - 6 Months||12||
48408561|NCT00179998|101331800|FG001|COMPLETED|Initial Period - 6 Months||12||
48408562|NCT00179998|101331799|FG000|NOT COMPLETED|Initial Period - 6 Months||0||
48408563|NCT00179998|101331800|FG001|NOT COMPLETED|Initial Period - 6 Months||0||
48408564|NCT00179998|101331799|FG000|STARTED|Crossover Period - 6 Months||12||
48324069|NCT00498173|101121160|FG000|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0||
48324070|NCT00498173|101121161|FG001|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0||
48324071|NCT00498173|101121162|FG002|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0||
48324072|NCT03113500|101121163|FG000|STARTED|Overall Study||48||
48324073|NCT03113500|101121163|FG000|COMPLETED|Overall Study||47||
48324074|NCT03113500|101121163|FG000|NOT COMPLETED|Overall Study||1||
48324075|NCT02597946|101121164|FG000|STARTED|Overall Study||18||
48324076|NCT02597946|101121164|FG000|COMPLETED|Overall Study||0||
48324077|NCT02597946|101121164|FG000|NOT COMPLETED|Overall Study||18||
48324078|NCT04317274|101121165|FG000|STARTED|Overall Study||97||
48324079|NCT04317274|101121166|FG001|STARTED|Overall Study||94||
48324080|NCT04317274|101121167|FG002|STARTED|Overall Study||103||
48324081|NCT04317274|101121168|FG003|STARTED|Overall Study||107||
48324082|NCT04317274|101121165|FG000|COMPLETED|Overall Study||95||
48324083|NCT04317274|101121166|FG001|COMPLETED|Overall Study||91||
48324084|NCT04317274|101121167|FG002|COMPLETED|Overall Study||99||
48324085|NCT04317274|101121168|FG003|COMPLETED|Overall Study||103||
48324086|NCT04317274|101121165|FG000|NOT COMPLETED|Overall Study||2||
48408565|NCT00179998|101331800|FG001|STARTED|Crossover Period - 6 Months||12||
48408566|NCT00179998|101331799|FG000|COMPLETED|Crossover Period - 6 Months||12||
48408567|NCT00179998|101331800|FG001|COMPLETED|Crossover Period - 6 Months||10||
48408568|NCT00179998|101331799|FG000|NOT COMPLETED|Crossover Period - 6 Months||0||
48408569|NCT00179998|101331800|FG001|NOT COMPLETED|Crossover Period - 6 Months||2||
48408570|NCT00636155|101331801|FG000|STARTED|Overall Study||20||
48408571|NCT00636155|101331801|FG000|COMPLETED|Overall Study||2||
48408572|NCT00636155|101331801|FG000|NOT COMPLETED|Overall Study||18||
48408573|NCT02283840|101331802|FG000|STARTED|Overall Study||20||
48408574|NCT02283840|101331803|FG001|STARTED|Overall Study||20||
48618106|NCT02675764|101849733|FG001|STARTED|Overall Study||6||
48618107|NCT02675764|101849732|FG000|COMPLETED|Overall Study||6||
48618108|NCT02675764|101849733|FG001|COMPLETED|Overall Study||6||
48618109|NCT02675764|101849732|FG000|NOT COMPLETED|Overall Study||0||
48324087|NCT04317274|101121166|FG001|NOT COMPLETED|Overall Study||3||
48324088|NCT04317274|101121167|FG002|NOT COMPLETED|Overall Study||4||
48324089|NCT04317274|101121168|FG003|NOT COMPLETED|Overall Study||4||
48324090|NCT00939900|101121169|FG000|STARTED|Overall Study||55||
48324091|NCT00939900|101121170|FG001|STARTED|Overall Study||55||
48324092|NCT00939900|101121169|FG000|COMPLETED|Overall Study||53||
48324093|NCT00939900|101121170|FG001|COMPLETED|Overall Study||48||
48324094|NCT00939900|101121169|FG000|NOT COMPLETED|Overall Study||2||
48324095|NCT00939900|101121170|FG001|NOT COMPLETED|Overall Study||7||
48324096|NCT03313076|101121171|FG000|STARTED|Overall Study||7||
48324097|NCT03313076|101121172|FG001|STARTED|Overall Study||6||
48324098|NCT03313076|101121173|FG002|STARTED|Overall Study||6||
48324099|NCT03313076|101121174|FG003|STARTED|Overall Study||5||
48324100|NCT03313076|101121171|FG000|COMPLETED|Overall Study||5||
48324101|NCT03313076|101121172|FG001|COMPLETED|Overall Study||4||
48324102|NCT03313076|101121173|FG002|COMPLETED|Overall Study||4||
48324103|NCT03313076|101121174|FG003|COMPLETED|Overall Study||3||
48324104|NCT03313076|101121171|FG000|NOT COMPLETED|Overall Study||2||
48324105|NCT03313076|101121172|FG001|NOT COMPLETED|Overall Study||2||
48324106|NCT03313076|101121173|FG002|NOT COMPLETED|Overall Study||2||
48324107|NCT03313076|101121174|FG003|NOT COMPLETED|Overall Study||2||
48324108|NCT01081795|101121175|FG000|STARTED|Overall Study||130||
48324109|NCT01081795|101121176|FG001|STARTED|Overall Study||130||
48324110|NCT01081795|101121177|FG002|STARTED|Overall Study||127||
48324111|NCT01081795|101121175|FG000|COMPLETED|Overall Study||97||
48408575|NCT02283840|101331804|FG002|STARTED|Overall Study||20||
48408576|NCT02283840|101331802|FG000|COMPLETED|Overall Study||20||
48324112|NCT01081795|101121176|FG001|COMPLETED|Overall Study||95||
48324113|NCT01081795|101121177|FG002|COMPLETED|Overall Study||97||
48324114|NCT01081795|101121175|FG000|NOT COMPLETED|Overall Study||33||
48324115|NCT01081795|101121176|FG001|NOT COMPLETED|Overall Study||35||
48408577|NCT02283840|101331803|FG001|COMPLETED|Overall Study||19||
48408578|NCT02283840|101331804|FG002|COMPLETED|Overall Study||20||
48408579|NCT02283840|101331802|FG000|NOT COMPLETED|Overall Study||0||
48408580|NCT02283840|101331803|FG001|NOT COMPLETED|Overall Study||1||
48408581|NCT02283840|101331804|FG002|NOT COMPLETED|Overall Study||0||
48324116|NCT01081795|101121177|FG002|NOT COMPLETED|Overall Study||30||
48324117|NCT03405259|101121178|FG000|STARTED|Overall Study||11||
48324118|NCT03405259|101121179|FG001|STARTED|Overall Study||11||
48324119|NCT03405259|101121178|FG000|COMPLETED|Overall Study||11||
48324120|NCT03405259|101121179|FG001|COMPLETED|Overall Study||11||
48324121|NCT03405259|101121178|FG000|NOT COMPLETED|Overall Study||0||
48324122|NCT03405259|101121179|FG001|NOT COMPLETED|Overall Study||0||
48324123|NCT02261727|101121180|FG000|STARTED|Overall Study||568||
48324124|NCT02261727|101121181|FG001|STARTED|Overall Study||554||
48618110|NCT02675764|101849733|FG001|NOT COMPLETED|Overall Study||0||
48618111|NCT04907214|101849734|FG000|STARTED|Overall Study||16||
48618112|NCT04907214|101849734|FG000|COMPLETED|Overall Study||16||
48618113|NCT04907214|101849734|FG000|NOT COMPLETED|Overall Study||0||
48618114|NCT01945944|101849735|FG000|STARTED|Overall Study||9||
48618115|NCT01945944|101849736|FG001|STARTED|Overall Study||9||
48618116|NCT01945944|101849735|FG000|COMPLETED|Overall Study||8||
48618117|NCT01945944|101849736|FG001|COMPLETED|Overall Study||6||
48618118|NCT01945944|101849735|FG000|NOT COMPLETED|Overall Study||1||
48618119|NCT01945944|101849736|FG001|NOT COMPLETED|Overall Study||3||
48618120|NCT00678015|101849737|FG000|STARTED|Overall Study||12||
48618121|NCT00678015|101849737|FG000|COMPLETED|Overall Study||12||
48618122|NCT00678015|101849737|FG000|NOT COMPLETED|Overall Study||0||
48618123|NCT03744637|101849738|FG000|STARTED|Overall Study||2||
48618124|NCT03744637|101849739|FG001|STARTED|Overall Study||2||
48618125|NCT03744637|101849740|FG002|STARTED|Overall Study||2||
48618126|NCT03744637|101849741|FG003|STARTED|Overall Study||1||
48618127|NCT03744637|101849742|FG004|STARTED|Overall Study||1||
48618128|NCT03744637|101849743|FG005|STARTED|Overall Study||1||
48618129|NCT03744637|101849744|FG006|STARTED|Overall Study||8||
48618130|NCT03744637|101849745|FG007|STARTED|Overall Study||4||
48618131|NCT03744637|101849746|FG008|STARTED|Overall Study||3||
48741971|NCT00082407|102154968|FG001|Received Treatment (Intent to Treat)|Overall Study||248||
48741972|NCT00082407|102154967|FG000|COMPLETED|Overall Study||199||
48741973|NCT00082407|102154968|FG001|COMPLETED|Overall Study||223||
48741974|NCT00082407|102154967|FG000|NOT COMPLETED|Overall Study||56||
48741975|NCT00082407|102154968|FG001|NOT COMPLETED|Overall Study||27||
48741976|NCT02370420|102154969|FG000|STARTED|Overall Study||29||
48741977|NCT02370420|102154970|FG001|STARTED|Overall Study||27||
48741978|NCT02370420|102154969|FG000|COMPLETED|Overall Study||15||
48324125|NCT02261727|101121182|FG002|STARTED|Overall Study||548||
48324126|NCT02261727|101121180|FG000|COMPLETED|Overall Study||411||
48324127|NCT02261727|101121181|FG001|COMPLETED|Overall Study||408||
48324128|NCT02261727|101121182|FG002|COMPLETED|Overall Study||423||
48324129|NCT02261727|101121180|FG000|NOT COMPLETED|Overall Study||157||
48324130|NCT02261727|101121181|FG001|NOT COMPLETED|Overall Study||146||
48324131|NCT02261727|101121182|FG002|NOT COMPLETED|Overall Study||125||
48324132|NCT00838331|101121183|FG000|STARTED|Fresh Blood Transfusion||17||
48324133|NCT00838331|101121183|FG000|COMPLETED|Fresh Blood Transfusion||17||
48324134|NCT00838331|101121183|FG000|NOT COMPLETED|Fresh Blood Transfusion||0||
48324135|NCT00838331|101121183|FG000|STARTED|Aged Blood Transfusion||17||
48324136|NCT00838331|101121183|FG000|COMPLETED|Aged Blood Transfusion||8||
48324137|NCT00838331|101121183|FG000|NOT COMPLETED|Aged Blood Transfusion||9||
48324138|NCT00835237|101121184|FG000|STARTED|Overall Study||887||
48324139|NCT00835237|101121185|FG001|STARTED|Overall Study||445||
48324140|NCT00835237|101121184|FG000|COMPLETED|Overall Study||881||
48324141|NCT00835237|101121185|FG001|COMPLETED|Overall Study||445||
48324142|NCT00835237|101121184|FG000|NOT COMPLETED|Overall Study||6||
48324143|NCT00835237|101121185|FG001|NOT COMPLETED|Overall Study||0||
48324144|NCT00927095|101121186|FG000|STARTED|Overall Study||22||
48324145|NCT00927095|101121187|FG001|STARTED|Overall Study||21||
48324146|NCT00927095|101121188|FG002|STARTED|Overall Study||24||
48324147|NCT00927095|101121186|FG000|COMPLETED|Overall Study||16||
48324148|NCT00927095|101121187|FG001|COMPLETED|Overall Study||17||
48324149|NCT00927095|101121188|FG002|COMPLETED|Overall Study||22||
48324150|NCT00927095|101121186|FG000|NOT COMPLETED|Overall Study||6||
48324151|NCT00927095|101121187|FG001|NOT COMPLETED|Overall Study||4||
48324152|NCT00927095|101121188|FG002|NOT COMPLETED|Overall Study||2||
48324153|NCT05526833|101121189|FG000|STARTED|Overall Study||1||
48324154|NCT05526833|101121190|FG001|STARTED|Overall Study||1||
48324155|NCT05526833|101121191|FG002|STARTED|Overall Study||1||
48324156|NCT05526833|101121189|FG000|COMPLETED|Overall Study||1||
48324157|NCT05526833|101121190|FG001|COMPLETED|Overall Study||1||
48324158|NCT05526833|101121191|FG002|COMPLETED|Overall Study||1||
48618132|NCT03744637|101849747|FG009|STARTED|Overall Study||1||
48618133|NCT03744637|101849738|FG000|COMPLETED|Overall Study||2||
48324159|NCT05526833|101121189|FG000|NOT COMPLETED|Overall Study||0||
48324160|NCT05526833|101121190|FG001|NOT COMPLETED|Overall Study||0||
48324161|NCT05526833|101121191|FG002|NOT COMPLETED|Overall Study||0||
48324162|NCT03461757|101121192|FG000|STARTED|Overall Study||732||
48324163|NCT03461757|101121193|FG001|STARTED|Overall Study||734||
48324164|NCT03461757|101121192|FG000|Treated|Overall Study||682||
48324165|NCT03461757|101121193|FG001|Treated|Overall Study||693||
48324166|NCT03461757|101121192|FG000|COMPLETED|Overall Study||679||
48618134|NCT03744637|101849739|FG001|COMPLETED|Overall Study||2||
48618135|NCT03744637|101849740|FG002|COMPLETED|Overall Study||2||
48618136|NCT03744637|101849741|FG003|COMPLETED|Overall Study||1||
48618137|NCT03744637|101849742|FG004|COMPLETED|Overall Study||1||
48618138|NCT03744637|101849743|FG005|COMPLETED|Overall Study||1||
48741979|NCT02370420|102154970|FG001|COMPLETED|Overall Study||15||
48741980|NCT02370420|102154969|FG000|NOT COMPLETED|Overall Study||14||
48741981|NCT02370420|102154970|FG001|NOT COMPLETED|Overall Study||12||
48741982|NCT02114606|102154971|FG000|STARTED|Overall Study||86||
48741983|NCT02114606|102154971|FG000|COMPLETED|Overall Study||80||
48324167|NCT03461757|101121193|FG001|COMPLETED|Overall Study||689||
48618139|NCT03744637|101849744|FG006|COMPLETED|Overall Study||8||
48618140|NCT03744637|101849745|FG007|COMPLETED|Overall Study||4||
48618141|NCT03744637|101849746|FG008|COMPLETED|Overall Study||3||
48618142|NCT03744637|101849747|FG009|COMPLETED|Overall Study||1||
48618143|NCT03744637|101849738|FG000|NOT COMPLETED|Overall Study||0||
48618144|NCT03744637|101849739|FG001|NOT COMPLETED|Overall Study||0||
48618145|NCT03744637|101849740|FG002|NOT COMPLETED|Overall Study||0||
48618146|NCT03744637|101849741|FG003|NOT COMPLETED|Overall Study||0||
48618147|NCT03744637|101849742|FG004|NOT COMPLETED|Overall Study||0||
48618148|NCT03744637|101849743|FG005|NOT COMPLETED|Overall Study||0||
48618149|NCT03744637|101849744|FG006|NOT COMPLETED|Overall Study||0||
48162230|NCT02259517|100718918|FG001|COMPLETED|Overall Study||4||
48162231|NCT02259517|100718919|FG002|COMPLETED|Overall Study||15||
48162232|NCT02259517|100718917|FG000|NOT COMPLETED|Overall Study||0||
48162233|NCT02259517|100718918|FG001|NOT COMPLETED|Overall Study||0||
48162234|NCT02259517|100718919|FG002|NOT COMPLETED|Overall Study||9||
48162235|NCT02293395|100718920|FG000|STARTED|Overall Study||1519||
48162236|NCT02293395|100718921|FG001|STARTED|Overall Study||1518||
48162237|NCT02293395|100718920|FG000|Treated|Overall Study||1510||
48162238|NCT02293395|100718921|FG001|Treated|Overall Study||1506||
48162239|NCT02293395|100718920|FG000|COMPLETED|Overall Study||1510||
48162240|NCT02293395|100718921|FG001|COMPLETED|Overall Study||1511||
48162241|NCT02293395|100718920|FG000|NOT COMPLETED|Overall Study||9||
48162242|NCT02293395|100718921|FG001|NOT COMPLETED|Overall Study||7||
48162243|NCT01782872|100718922|FG000|STARTED|Overall Study||20||
48162244|NCT01782872|100718923|FG001|STARTED|Overall Study||20||
48162245|NCT01782872|100718924|FG002|STARTED|Overall Study||20||
48162246|NCT01782872|100718925|FG003|STARTED|Overall Study||20||
48162247|NCT01782872|100718922|FG000|COMPLETED|Overall Study||20||
48162248|NCT01782872|100718923|FG001|COMPLETED|Overall Study||19||
48618150|NCT03744637|101849745|FG007|NOT COMPLETED|Overall Study||0||
48618151|NCT03744637|101849746|FG008|NOT COMPLETED|Overall Study||0||
48618152|NCT03744637|101849747|FG009|NOT COMPLETED|Overall Study||0||
48162249|NCT01782872|100718924|FG002|COMPLETED|Overall Study||20||
48162250|NCT01782872|100718925|FG003|COMPLETED|Overall Study||19||
48162251|NCT01782872|100718922|FG000|NOT COMPLETED|Overall Study||0||
48162252|NCT01782872|100718923|FG001|NOT COMPLETED|Overall Study||1||
48162253|NCT01782872|100718924|FG002|NOT COMPLETED|Overall Study||0||
48162254|NCT01782872|100718925|FG003|NOT COMPLETED|Overall Study||1||
48162255|NCT01965782|100718926|FG000|STARTED|Overall Study||0||
48162256|NCT01965782|100718926|FG000|COMPLETED|Overall Study||0||
48162257|NCT01965782|100718926|FG000|NOT COMPLETED|Overall Study||0||
48162258|NCT04934722|100718927|FG000|STARTED|Overall Study||92||
48162259|NCT04934722|100718928|FG001|STARTED|Overall Study||94||
48162260|NCT04934722|100718927|FG000|COMPLETED|Overall Study||0||
48162261|NCT04934722|100718928|FG001|COMPLETED|Overall Study||0||
48162262|NCT04934722|100718927|FG000|NOT COMPLETED|Overall Study||92||
48162263|NCT04934722|100718928|FG001|NOT COMPLETED|Overall Study||94||
48162264|NCT03188120|100718929|FG000|STARTED|Overall Study||193|Case Report Form collected (treated)|
48162265|NCT03188120|100718929|FG000|COMPLETED|Overall Study||146||
48162266|NCT03188120|100718929|FG000|NOT COMPLETED|Overall Study||47||
48162267|NCT02923739|100718930|FG000|STARTED|Overall Study||9||
48618153|NCT00593450|101849748|FG000|STARTED|Overall Study||301||
48162268|NCT02923739|100718931|FG001|STARTED|Overall Study||0||
48162269|NCT02923739|100718932|FG002|STARTED|Overall Study||0||
48162270|NCT02923739|100718933|FG003|STARTED|Overall Study||0||
48162271|NCT02923739|100718930|FG000|COMPLETED|Overall Study||4||
48162272|NCT02923739|100718931|FG001|COMPLETED|Overall Study||0||
48162273|NCT02923739|100718932|FG002|COMPLETED|Overall Study||0||
48162274|NCT02923739|100718933|FG003|COMPLETED|Overall Study||0||
48618154|NCT00593450|101849749|FG001|STARTED|Overall Study||286||
48618155|NCT00593450|101849750|FG002|STARTED|Overall Study||298||
48324168|NCT03461757|101121192|FG000|NOT COMPLETED|Overall Study||53||
48324169|NCT03461757|101121193|FG001|NOT COMPLETED|Overall Study||45||
48324170|NCT03345108|101121194|FG000|STARTED|Period-1||8||
48324171|NCT03345108|101121195|FG001|STARTED|Period-1||8||
48324172|NCT03345108|101121196|FG002|STARTED|Period-1||8||
48324173|NCT03345108|101121197|FG003|STARTED|Period-1||8||
48618156|NCT00593450|101849751|FG003|STARTED|Overall Study||300||
48618157|NCT00593450|101849748|FG000|COMPLETED|Overall Study||284||
48618158|NCT00593450|101849749|FG001|COMPLETED|Overall Study||265||
48618159|NCT00593450|101849750|FG002|COMPLETED|Overall Study||285||
48162275|NCT02923739|100718930|FG000|NOT COMPLETED|Overall Study||5||
48162276|NCT02923739|100718931|FG001|NOT COMPLETED|Overall Study||0||
48162277|NCT02923739|100718932|FG002|NOT COMPLETED|Overall Study||0||
48162278|NCT02923739|100718933|FG003|NOT COMPLETED|Overall Study||0||
48162279|NCT02243202|100718934|FG000|STARTED|Overall Study||82||
48162280|NCT02243202|100718935|FG001|STARTED|Overall Study||85||
48162281|NCT02243202|100718936|FG002|STARTED|Overall Study||84||
48162282|NCT02243202|100718937|FG003|STARTED|Overall Study||84||
48162283|NCT02243202|100718934|FG000|Treated|Overall Study||82||
48162284|NCT02243202|100718935|FG001|Treated|Overall Study||85||
48162285|NCT02243202|100718936|FG002|Treated|Overall Study||84||
48162286|NCT02243202|100718937|FG003|Treated|Overall Study||83||
48162287|NCT02243202|100718934|FG000|COMPLETED|Overall Study||57||
48162288|NCT02243202|100718935|FG001|COMPLETED|Overall Study||60||
48162289|NCT02243202|100718936|FG002|COMPLETED|Overall Study||53||
48162290|NCT02243202|100718937|FG003|COMPLETED|Overall Study||61||
48162291|NCT02243202|100718934|FG000|NOT COMPLETED|Overall Study||25||
48162292|NCT02243202|100718935|FG001|NOT COMPLETED|Overall Study||25||
48162293|NCT02243202|100718936|FG002|NOT COMPLETED|Overall Study||31||
48162294|NCT02243202|100718937|FG003|NOT COMPLETED|Overall Study||23||
48162295|NCT02669095|100718938|FG000|STARTED|Overall Study||75||
48162296|NCT02669095|100718939|FG001|STARTED|Overall Study||75||
48162297|NCT02669095|100718938|FG000|COMPLETED|Overall Study||74||
48162298|NCT02669095|100718939|FG001|COMPLETED|Overall Study||72||
48162299|NCT02669095|100718938|FG000|NOT COMPLETED|Overall Study||1||
48162300|NCT02669095|100718939|FG001|NOT COMPLETED|Overall Study||3||
48162301|NCT00224770|100718940|FG000|STARTED|Overall Study||42||
48162302|NCT00224770|100718941|FG001|STARTED|Overall Study||54||
48162303|NCT00224770|100718942|FG002|STARTED|Overall Study||14||
48162304|NCT00224770|100718940|FG000|COMPLETED|Overall Study||38||
48162305|NCT00224770|100718941|FG001|COMPLETED|Overall Study||52||
48162306|NCT00224770|100718942|FG002|COMPLETED|Overall Study||14||
48162307|NCT00224770|100718940|FG000|NOT COMPLETED|Overall Study||4||
48618160|NCT00593450|101849751|FG003|COMPLETED|Overall Study||271||
48618161|NCT00593450|101849748|FG000|NOT COMPLETED|Overall Study||17||
48618162|NCT00593450|101849749|FG001|NOT COMPLETED|Overall Study||21||
48618163|NCT00593450|101849750|FG002|NOT COMPLETED|Overall Study||13||
48618164|NCT00593450|101849751|FG003|NOT COMPLETED|Overall Study||29||
48618165|NCT00509899|101849752|FG000|STARTED|Overall Study||30||
48618166|NCT00509899|101849753|FG001|STARTED|Overall Study||35||
48618167|NCT00509899|101849754|FG002|STARTED|Overall Study||47||
48162308|NCT00224770|100718941|FG001|NOT COMPLETED|Overall Study||2||
48162309|NCT00224770|100718942|FG002|NOT COMPLETED|Overall Study||0||
48162310|NCT00717314|100718943|FG000|STARTED|Overall Study||43||
48162311|NCT00717314|100718944|FG001|STARTED|Overall Study||44||
48162312|NCT00717314|100718943|FG000|COMPLETED|Overall Study||37||
48162313|NCT00717314|100718944|FG001|COMPLETED|Overall Study||34||
48162314|NCT00717314|100718943|FG000|NOT COMPLETED|Overall Study||6||
48162315|NCT00717314|100718944|FG001|NOT COMPLETED|Overall Study||10||
48162316|NCT03010462|100718945|FG000|STARTED|Overall Study||31||
48162317|NCT03010462|100718946|FG001|STARTED|Overall Study||29||
48162318|NCT03010462|100718945|FG000|COMPLETED|Overall Study||28||
48162319|NCT03010462|100718946|FG001|COMPLETED|Overall Study||28||
48162320|NCT03010462|100718945|FG000|NOT COMPLETED|Overall Study||3||
48162321|NCT03010462|100718946|FG001|NOT COMPLETED|Overall Study||1||
48162322|NCT04359771|100718947|FG000|STARTED|Overall Study||15|1 eye from each patient was assigned to one arm and the other eye of the same patient to the 2nd arm|15
48162323|NCT04359771|100718948|FG001|STARTED|Overall Study||15|1 eye from each patient was assigned to one arm and the other eye of the same patient to the 2nd arm|15
48162324|NCT04359771|100718947|FG000|COMPLETED|Overall Study||13|1 eye from each patient was assigned to one arm and the other eye of the same patient to the 2nd arm|13
48162325|NCT04359771|100718948|FG001|COMPLETED|Overall Study||13|1 eye from each patient was assigned to one arm and the other eye of the same patient to the 2nd arm|13
48162326|NCT04359771|100718947|FG000|NOT COMPLETED|Overall Study||2||2
48162327|NCT04359771|100718948|FG001|NOT COMPLETED|Overall Study||2||2
48618168|NCT00509899|101849755|FG003|STARTED|Overall Study||5||
48618169|NCT00509899|101849756|FG004|STARTED|Overall Study||6||
48618170|NCT00509899|101849757|FG005|STARTED|Overall Study||22||
48162328|NCT00949715|100718949|FG000|STARTED|Overall Study||32||
48162329|NCT00949715|100718950|FG001|STARTED|Overall Study||33||
48162330|NCT00949715|100718949|FG000|COMPLETED|Overall Study||28||
48162331|NCT00949715|100718950|FG001|COMPLETED|Overall Study||33||
48162332|NCT00949715|100718949|FG000|NOT COMPLETED|Overall Study||4||
48162333|NCT00949715|100718950|FG001|NOT COMPLETED|Overall Study||0||
48324174|NCT03345108|101121198|FG004|STARTED|Period-1||8||
48324175|NCT03345108|101121199|FG005|STARTED|Period-1||8||
48324176|NCT03345108|101121194|FG000|COMPLETED|Period-1||8||
48324177|NCT03345108|101121195|FG001|COMPLETED|Period-1||8||
48324178|NCT03345108|101121196|FG002|COMPLETED|Period-1||8||
48324179|NCT03345108|101121197|FG003|COMPLETED|Period-1||8||
48324180|NCT03345108|101121198|FG004|COMPLETED|Period-1||8||
48324181|NCT03345108|101121199|FG005|COMPLETED|Period-1||8||
48324182|NCT03345108|101121194|FG000|NOT COMPLETED|Period-1||0||
48324183|NCT03345108|101121195|FG001|NOT COMPLETED|Period-1||0||
48324184|NCT03345108|101121196|FG002|NOT COMPLETED|Period-1||0||
48324185|NCT03345108|101121197|FG003|NOT COMPLETED|Period-1||0||
48324186|NCT03345108|101121198|FG004|NOT COMPLETED|Period-1||0||
48324187|NCT03345108|101121199|FG005|NOT COMPLETED|Period-1||0||
48324188|NCT03345108|101121194|FG000|STARTED|Period-2||8||
48324189|NCT03345108|101121195|FG001|STARTED|Period-2||8||
48324190|NCT03345108|101121196|FG002|STARTED|Period-2||8||
48324191|NCT03345108|101121197|FG003|STARTED|Period-2||8||
48324192|NCT03345108|101121198|FG004|STARTED|Period-2||8||
48324193|NCT03345108|101121199|FG005|STARTED|Period-2||8||
48324194|NCT03345108|101121194|FG000|COMPLETED|Period-2||8||
48324195|NCT03345108|101121195|FG001|COMPLETED|Period-2||8||
48741984|NCT02114606|102154971|FG000|NOT COMPLETED|Overall Study||6||
48741985|NCT00592488|102154972|FG000|STARTED|Overall Study||6||
48741986|NCT00592488|102154973|FG001|STARTED|Overall Study||7||
48741987|NCT00592488|102154972|FG000|COMPLETED|Overall Study||6||
48741988|NCT00592488|102154973|FG001|COMPLETED|Overall Study||7||
48741989|NCT00592488|102154972|FG000|NOT COMPLETED|Overall Study||0||
48741990|NCT00592488|102154973|FG001|NOT COMPLETED|Overall Study||0||
48741991|NCT00801216|102154974|FG000|STARTED|Overall Study||40||
48741992|NCT00801216|102154974|FG000|COMPLETED|Overall Study||38||
48741993|NCT00801216|102154974|FG000|NOT COMPLETED|Overall Study||2||
48741994|NCT00799435|102154975|FG000|STARTED|Overall Study||1||
48741995|NCT00799435|102154976|FG001|STARTED|Overall Study||1||
48741996|NCT00799435|102154975|FG000|COMPLETED|Overall Study||1||
48741997|NCT00799435|102154976|FG001|COMPLETED|Overall Study||1||
48324196|NCT03345108|101121196|FG002|COMPLETED|Period-2||8||
48324197|NCT03345108|101121197|FG003|COMPLETED|Period-2||8||
48324198|NCT03345108|101121198|FG004|COMPLETED|Period-2||8||
48324199|NCT03345108|101121199|FG005|COMPLETED|Period-2||8||
48324200|NCT03345108|101121194|FG000|NOT COMPLETED|Period-2||0||
48324201|NCT03345108|101121195|FG001|NOT COMPLETED|Period-2||0||
48324202|NCT03345108|101121196|FG002|NOT COMPLETED|Period-2||0||
48324203|NCT03345108|101121197|FG003|NOT COMPLETED|Period-2||0||
48324204|NCT03345108|101121198|FG004|NOT COMPLETED|Period-2||0||
48324205|NCT03345108|101121199|FG005|NOT COMPLETED|Period-2||0||
48324206|NCT03345108|101121194|FG000|STARTED|Period-3||7||
48324207|NCT03345108|101121195|FG001|STARTED|Period-3||8||
48324208|NCT03345108|101121196|FG002|STARTED|Period-3||8||
48324209|NCT03345108|101121197|FG003|STARTED|Period-3||8||
48324210|NCT03345108|101121198|FG004|STARTED|Period-3||8||
48324211|NCT03345108|101121199|FG005|STARTED|Period-3||8||
48324212|NCT03345108|101121194|FG000|COMPLETED|Period-3||7||
48324213|NCT03345108|101121195|FG001|COMPLETED|Period-3||8||
48324214|NCT03345108|101121196|FG002|COMPLETED|Period-3||8||
48324215|NCT03345108|101121197|FG003|COMPLETED|Period-3||8||
48324216|NCT03345108|101121198|FG004|COMPLETED|Period-3||8||
48324217|NCT03345108|101121199|FG005|COMPLETED|Period-3||8||
48324218|NCT03345108|101121194|FG000|NOT COMPLETED|Period-3||0||
48324219|NCT03345108|101121195|FG001|NOT COMPLETED|Period-3||0||
48324220|NCT03345108|101121196|FG002|NOT COMPLETED|Period-3||0||
48324221|NCT03345108|101121197|FG003|NOT COMPLETED|Period-3||0||
48324222|NCT03345108|101121198|FG004|NOT COMPLETED|Period-3||0||
48741998|NCT00799435|102154975|FG000|NOT COMPLETED|Overall Study||0||
48741999|NCT00799435|102154976|FG001|NOT COMPLETED|Overall Study||0||
48742000|NCT02598297|102154977|FG000|STARTED|Overall Study||25||
48742001|NCT02598297|102154978|FG001|STARTED|Overall Study||24||
48742002|NCT02598297|102154977|FG000|Not Treted Wit Study Drug|Overall Study||1||
48742003|NCT02598297|102154978|FG001|Not Treted Wit Study Drug|Overall Study||0||
48742004|NCT02598297|102154977|FG000|Subjects Followed for Survival|Overall Study||1||
48742005|NCT02598297|102154978|FG001|Subjects Followed for Survival|Overall Study||0||
48742006|NCT02598297|102154977|FG000|COMPLETED|Overall Study||0||
48742007|NCT02598297|102154978|FG001|COMPLETED|Overall Study||0||
48742008|NCT02598297|102154977|FG000|NOT COMPLETED|Overall Study||25||
48324223|NCT03345108|101121199|FG005|NOT COMPLETED|Period-3||0||
48324224|NCT02236520|101121200|FG000|STARTED|Overall Study||16||
48324225|NCT02236520|101121201|FG001|STARTED|Overall Study||13||
48324226|NCT02236520|101121202|FG002|STARTED|Overall Study||15||
48324227|NCT02236520|101121203|FG003|STARTED|Overall Study||15||
48324228|NCT02236520|101121200|FG000|COMPLETED|Overall Study||14||
48324229|NCT02236520|101121201|FG001|COMPLETED|Overall Study||8||
48324230|NCT02236520|101121202|FG002|COMPLETED|Overall Study||15||
48324231|NCT02236520|101121203|FG003|COMPLETED|Overall Study||14||
48324232|NCT02236520|101121200|FG000|NOT COMPLETED|Overall Study||2||
48324233|NCT02236520|101121201|FG001|NOT COMPLETED|Overall Study||5||
48324234|NCT02236520|101121202|FG002|NOT COMPLETED|Overall Study||0||
48324235|NCT02236520|101121203|FG003|NOT COMPLETED|Overall Study||1||
48324236|NCT00470600|101121204|FG000|STARTED|Overall Study||86||
48742009|NCT02598297|102154978|FG001|NOT COMPLETED|Overall Study||24||
48324237|NCT00470600|101121205|FG001|STARTED|Overall Study||99||
48324238|NCT00470600|101121204|FG000|COMPLETED|Overall Study||86||
48324239|NCT00470600|101121205|FG001|COMPLETED|Overall Study||99||
48324240|NCT00470600|101121204|FG000|NOT COMPLETED|Overall Study||0||
48324241|NCT00470600|101121205|FG001|NOT COMPLETED|Overall Study||0||
48324242|NCT00109707|101121206|FG000|STARTED|Overall Study||321||
48324243|NCT00109707|101121207|FG001|STARTED|Overall Study||137||
48324244|NCT00109707|101121208|FG002|STARTED|Overall Study||49||
48324245|NCT00109707|101121206|FG000|Entered Extension Study|Overall Study||106||
48324246|NCT00109707|101121207|FG001|Entered Extension Study|Overall Study||15||
48324247|NCT00109707|101121208|FG002|Entered Extension Study|Overall Study||15||
48324248|NCT00109707|101121206|FG000|COMPLETED|Overall Study||67||
48324249|NCT00109707|101121207|FG001|COMPLETED|Overall Study||8||
48324250|NCT00109707|101121208|FG002|COMPLETED|Overall Study||8||
48324251|NCT00109707|101121206|FG000|NOT COMPLETED|Overall Study||254||
48324252|NCT00109707|101121207|FG001|NOT COMPLETED|Overall Study||129||
48324253|NCT00109707|101121208|FG002|NOT COMPLETED|Overall Study||41||
48324254|NCT04417894|101121209|FG000|STARTED|Overall Study||66||
48324255|NCT04417894|101121210|FG001|STARTED|Overall Study||67||
48324256|NCT04417894|101121209|FG000|COMPLETED|Overall Study||53||
48324257|NCT04417894|101121210|FG001|COMPLETED|Overall Study||60||
48324258|NCT04417894|101121209|FG000|NOT COMPLETED|Overall Study||13||
48324259|NCT04417894|101121210|FG001|NOT COMPLETED|Overall Study||7||
48324260|NCT01297335|101121211|FG000|STARTED|Overall Study||10||
48324261|NCT01297335|101121211|FG000|COMPLETED|Overall Study||10||
48324262|NCT01297335|101121211|FG000|NOT COMPLETED|Overall Study||0||
48324263|NCT00720109|101121212|FG000|STARTED|Induction Period||63||
48324264|NCT00720109|101121213|FG001|STARTED|Induction Period||0||
48324265|NCT00720109|101121214|FG002|STARTED|Induction Period||0||
48324266|NCT00720109|101121212|FG000|COMPLETED|Induction Period||57||
48324267|NCT00720109|101121213|FG001|COMPLETED|Induction Period||0||
48324268|NCT00720109|101121214|FG002|COMPLETED|Induction Period||0||
48324269|NCT00720109|101121212|FG000|NOT COMPLETED|Induction Period||6||
48324270|NCT00720109|101121213|FG001|NOT COMPLETED|Induction Period||0||
48324271|NCT00720109|101121214|FG002|NOT COMPLETED|Induction Period||0||
48324272|NCT00720109|101121212|FG000|STARTED|Risk Stratification Period||0||
48324273|NCT00720109|101121213|FG001|STARTED|Risk Stratification Period||48||
48324274|NCT00720109|101121214|FG002|STARTED|Risk Stratification Period||9||
48324275|NCT00720109|101121212|FG000|COMPLETED|Risk Stratification Period||0||
48324276|NCT00720109|101121213|FG001|COMPLETED|Risk Stratification Period||33||
48618171|NCT00509899|101849758|FG006|STARTED|Overall Study||6||
48324277|NCT00720109|101121214|FG002|COMPLETED|Risk Stratification Period||1||
48324278|NCT00720109|101121212|FG000|NOT COMPLETED|Risk Stratification Period||0||
48324279|NCT00720109|101121213|FG001|NOT COMPLETED|Risk Stratification Period||15||
48324280|NCT00720109|101121214|FG002|NOT COMPLETED|Risk Stratification Period||8||
48324281|NCT00586209|101121215|FG000|STARTED|Overall Study||5||
48324282|NCT00586209|101121216|FG001|STARTED|Overall Study||10||
48324283|NCT00586209|101121215|FG000|COMPLETED|Overall Study||5||
48324284|NCT00586209|101121216|FG001|COMPLETED|Overall Study||10||
48324285|NCT00586209|101121215|FG000|NOT COMPLETED|Overall Study||0||
48324286|NCT00586209|101121216|FG001|NOT COMPLETED|Overall Study||0||
48324287|NCT01395394|101121217|FG000|STARTED|Baseline Study Visit||4||
48324288|NCT01395394|101121218|FG001|STARTED|Baseline Study Visit||3||
48324289|NCT01395394|101121219|FG002|STARTED|Baseline Study Visit||5||
48324290|NCT01395394|101121217|FG000|COMPLETED|Baseline Study Visit||3||
48324291|NCT01395394|101121218|FG001|COMPLETED|Baseline Study Visit||3||
48324292|NCT01395394|101121219|FG002|COMPLETED|Baseline Study Visit||5||
48618172|NCT00509899|101849759|FG007|STARTED|Overall Study||3||
48618173|NCT00509899|101849752|FG000|COMPLETED|Overall Study||14||
48618174|NCT00509899|101849753|FG001|COMPLETED|Overall Study||26||
48618175|NCT00509899|101849754|FG002|COMPLETED|Overall Study||27||
48618176|NCT00509899|101849755|FG003|COMPLETED|Overall Study||1||
48618177|NCT00509899|101849756|FG004|COMPLETED|Overall Study||1||
48618178|NCT00509899|101849757|FG005|COMPLETED|Overall Study||12||
48618179|NCT00509899|101849758|FG006|COMPLETED|Overall Study||5||
48618180|NCT00509899|101849759|FG007|COMPLETED|Overall Study||2||
48618181|NCT00509899|101849752|FG000|NOT COMPLETED|Overall Study||16||
48618182|NCT00509899|101849753|FG001|NOT COMPLETED|Overall Study||9||
48618183|NCT00509899|101849754|FG002|NOT COMPLETED|Overall Study||20||
48618184|NCT00509899|101849755|FG003|NOT COMPLETED|Overall Study||4||
48618185|NCT00509899|101849756|FG004|NOT COMPLETED|Overall Study||5||
48618186|NCT00509899|101849757|FG005|NOT COMPLETED|Overall Study||10||
48324293|NCT01395394|101121217|FG000|NOT COMPLETED|Baseline Study Visit||1||
48324294|NCT01395394|101121218|FG001|NOT COMPLETED|Baseline Study Visit||0||
48324295|NCT01395394|101121219|FG002|NOT COMPLETED|Baseline Study Visit||0||
48324296|NCT01395394|101121217|FG000|STARTED|Study Visit 2 (Non-responders Only)||3||
48324297|NCT01395394|101121218|FG001|STARTED|Study Visit 2 (Non-responders Only)||0||
48618187|NCT00509899|101849758|FG006|NOT COMPLETED|Overall Study||1||
48618188|NCT00509899|101849759|FG007|NOT COMPLETED|Overall Study||1||
48324298|NCT01395394|101121219|FG002|STARTED|Study Visit 2 (Non-responders Only)||0||
48324299|NCT01395394|101121217|FG000|COMPLETED|Study Visit 2 (Non-responders Only)||3||
48324300|NCT01395394|101121218|FG001|COMPLETED|Study Visit 2 (Non-responders Only)||0||
48324301|NCT01395394|101121219|FG002|COMPLETED|Study Visit 2 (Non-responders Only)||0||
48324302|NCT01395394|101121217|FG000|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0||
48324303|NCT01395394|101121218|FG001|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0||
48324304|NCT01395394|101121219|FG002|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0||
48324305|NCT03339921|101121220|FG000|STARTED|Overall Study||3||
48324306|NCT03339921|101121221|FG001|STARTED|Overall Study||0||
48324307|NCT03339921|101121220|FG000|COMPLETED|Overall Study||3||
48324308|NCT03339921|101121221|FG001|COMPLETED|Overall Study||0||
48324309|NCT03339921|101121220|FG000|NOT COMPLETED|Overall Study||0||
48324310|NCT03339921|101121221|FG001|NOT COMPLETED|Overall Study||0||
48324311|NCT01232829|101121222|FG000|STARTED|Overall Study||18||
48324312|NCT01232829|101121222|FG000|COMPLETED|Overall Study||18||
48324313|NCT01232829|101121222|FG000|NOT COMPLETED|Overall Study||0||
48324314|NCT01135498|101121223|FG000|STARTED|Overall Study||90||
48324315|NCT01135498|101121223|FG000|COMPLETED|Overall Study||0||
48324316|NCT01135498|101121223|FG000|NOT COMPLETED|Overall Study||90||
48324317|NCT01984268|101121224|FG000|STARTED|Overall Study||15||
48324318|NCT01984268|101121224|FG000|COMPLETED|Overall Study||0||
48324319|NCT01984268|101121224|FG000|NOT COMPLETED|Overall Study||15||
48324320|NCT01535729|101121225|FG000|STARTED|Overall Study||465||
48324321|NCT01535729|101121225|FG000|Treated|Overall Study||385||
48324322|NCT01535729|101121225|FG000|COMPLETED|Overall Study||49||
48324323|NCT01535729|101121225|FG000|NOT COMPLETED|Overall Study||416||
48324324|NCT01548339|101121226|FG000|STARTED|Overall Study||44||
48324325|NCT01548339|101121227|FG001|STARTED|Overall Study||42||
48324326|NCT01548339|101121226|FG000|COMPLETED|Overall Study||38||
48324327|NCT01548339|101121227|FG001|COMPLETED|Overall Study||41||
48324328|NCT01548339|101121226|FG000|NOT COMPLETED|Overall Study||6||
48324329|NCT01548339|101121227|FG001|NOT COMPLETED|Overall Study||1||
48324330|NCT02300298|101121228|FG000|STARTED|Disposition for Nintedanib||10||
48324331|NCT02300298|101121229|FG001|STARTED|Disposition for Nintedanib||0||
48324332|NCT02300298|101121228|FG000|COMPLETED|Disposition for Nintedanib||0||
48324333|NCT02300298|101121229|FG001|COMPLETED|Disposition for Nintedanib||0||
48324334|NCT02300298|101121228|FG000|NOT COMPLETED|Disposition for Nintedanib||10||
48324335|NCT02300298|101121229|FG001|NOT COMPLETED|Disposition for Nintedanib||0||
48324336|NCT02300298|101121228|FG000|STARTED|Disposition for Docetaxel||0||
48324337|NCT02300298|101121229|FG001|STARTED|Disposition for Docetaxel||10||
48324338|NCT02300298|101121228|FG000|COMPLETED|Disposition for Docetaxel||0||
48324339|NCT02300298|101121229|FG001|COMPLETED|Disposition for Docetaxel||0||
48324340|NCT02300298|101121228|FG000|NOT COMPLETED|Disposition for Docetaxel||0||
48324341|NCT02300298|101121229|FG001|NOT COMPLETED|Disposition for Docetaxel||10||
48324342|NCT00143455|101121230|FG000|STARTED|Cohort 1||39||
48742010|NCT01136408|102154979|FG000|STARTED|Overall Study||46||
48742011|NCT01136408|102154980|FG001|STARTED|Overall Study||58||
48324343|NCT00143455|101121231|FG001|STARTED|Cohort 1||39||
48324344|NCT00143455|101121232|FG002|STARTED|Cohort 1||0||
48324345|NCT00143455|101121233|FG003|STARTED|Cohort 1||0||
48324346|NCT00143455|101121230|FG000|Received Treatment|Cohort 1||39||
48324347|NCT00143455|101121231|FG001|Received Treatment|Cohort 1||38||
48324348|NCT00143455|101121232|FG002|Received Treatment|Cohort 1||0||
48324349|NCT00143455|101121233|FG003|Received Treatment|Cohort 1||0||
48324350|NCT00143455|101121230|FG000|COMPLETED|Cohort 1||25||
48324351|NCT00143455|101121231|FG001|COMPLETED|Cohort 1||22||
48324352|NCT00143455|101121232|FG002|COMPLETED|Cohort 1||0||
48324353|NCT00143455|101121233|FG003|COMPLETED|Cohort 1||0||
48324354|NCT00143455|101121230|FG000|NOT COMPLETED|Cohort 1||14||
48324355|NCT00143455|101121231|FG001|NOT COMPLETED|Cohort 1||17||
48324356|NCT00143455|101121232|FG002|NOT COMPLETED|Cohort 1||0||
48324357|NCT00143455|101121233|FG003|NOT COMPLETED|Cohort 1||0||
48324358|NCT00143455|101121230|FG000|STARTED|Cohort 2||0||
48324359|NCT00143455|101121231|FG001|STARTED|Cohort 2||0||
48324360|NCT00143455|101121232|FG002|STARTED|Cohort 2||203||
48324361|NCT00143455|101121233|FG003|STARTED|Cohort 2||204||
48742012|NCT01136408|102154981|FG002|STARTED|Overall Study||62||
48742013|NCT01136408|102154979|FG000|COMPLETED|Overall Study||41||
48324362|NCT00143455|101121230|FG000|Received Treatment|Cohort 2||0||
48324363|NCT00143455|101121231|FG001|Received Treatment|Cohort 2||0||
48324364|NCT00143455|101121232|FG002|Received Treatment|Cohort 2||202||
48324365|NCT00143455|101121233|FG003|Received Treatment|Cohort 2||203||
48324366|NCT00143455|101121230|FG000|COMPLETED|Cohort 2||0||
48324367|NCT00143455|101121231|FG001|COMPLETED|Cohort 2||0||
48324368|NCT00143455|101121232|FG002|COMPLETED|Cohort 2||97||
48324369|NCT00143455|101121233|FG003|COMPLETED|Cohort 2||111||
48324370|NCT00143455|101121230|FG000|NOT COMPLETED|Cohort 2||0||
48324371|NCT00143455|101121231|FG001|NOT COMPLETED|Cohort 2||0||
48324372|NCT00143455|101121232|FG002|NOT COMPLETED|Cohort 2||106||
48324373|NCT00143455|101121233|FG003|NOT COMPLETED|Cohort 2||93||
48324374|NCT00075504|101121234|FG000|STARTED|Overall Study||23||
48324375|NCT00075504|101121235|FG001|STARTED|Overall Study||10||
48324376|NCT00075504|101121234|FG000|COMPLETED|Overall Study||14||
48324377|NCT00075504|101121235|FG001|COMPLETED|Overall Study||3||
48324378|NCT00075504|101121234|FG000|NOT COMPLETED|Overall Study||9||
48324379|NCT00075504|101121235|FG001|NOT COMPLETED|Overall Study||7||
48324380|NCT01471457|101121236|FG000|STARTED|Overall Study||92||
48324381|NCT01471457|101121237|FG001|STARTED|Overall Study||92||
48324382|NCT01471457|101121236|FG000|COMPLETED|Overall Study||73||
48324383|NCT01471457|101121237|FG001|COMPLETED|Overall Study||74||
48324384|NCT01471457|101121236|FG000|NOT COMPLETED|Overall Study||19||
48324385|NCT01471457|101121237|FG001|NOT COMPLETED|Overall Study||18||
48324386|NCT01968135|101121238|FG000|STARTED|Overall Study||16||
48324387|NCT01968135|101121239|FG001|STARTED|Overall Study||16||
48324388|NCT01968135|101121238|FG000|COMPLETED|Overall Study||16||
48324389|NCT01968135|101121239|FG001|COMPLETED|Overall Study||16||
48324390|NCT01968135|101121238|FG000|NOT COMPLETED|Overall Study||0||
48324391|NCT01968135|101121239|FG001|NOT COMPLETED|Overall Study||0||
48324392|NCT01634555|101121240|FG000|STARTED|Overall Study||29||
48324393|NCT01634555|101121240|FG000|Received at Least 1 Dose of Study Drug|Overall Study||29||
48324394|NCT01634555|101121240|FG000|Drug-Drug Interaction (DDI) Population|Overall Study||25||
48324395|NCT01634555|101121240|FG000|COMPLETED|Overall Study||25||
48324396|NCT01634555|101121240|FG000|NOT COMPLETED|Overall Study||4||
48324397|NCT03452371|101121241|FG000|STARTED|Overall Study||21||
48324398|NCT03452371|101121242|FG001|STARTED|Overall Study||23||
48324399|NCT03452371|101121241|FG000|COMPLETED|Overall Study||21||
48324400|NCT03452371|101121242|FG001|COMPLETED|Overall Study||23||
48324401|NCT03452371|101121241|FG000|NOT COMPLETED|Overall Study||0||
48324402|NCT03452371|101121242|FG001|NOT COMPLETED|Overall Study||0||
48324403|NCT00732303|101121243|FG000|STARTED|Overall Study||8||
48324404|NCT00732303|101121243|FG000|COMPLETED|Overall Study||6||
48324405|NCT00732303|101121243|FG000|NOT COMPLETED|Overall Study||2||
48324406|NCT02204150|101121244|FG000|STARTED|Overall Study||56||
48324407|NCT02204150|101121244|FG000|COMPLETED|Overall Study||56||
48324408|NCT02204150|101121244|FG000|NOT COMPLETED|Overall Study||0||
48324409|NCT02551159|101121245|FG000|STARTED|Overall Study||413||
48324410|NCT02551159|101121246|FG001|STARTED|Overall Study||204||
48324411|NCT02551159|101121247|FG002|STARTED|Overall Study||206||
48324412|NCT02551159|101121245|FG000|Full Analysis Set|Overall Study||413|All patients randomized|
48324413|NCT02551159|101121246|FG001|Full Analysis Set|Overall Study||204|All patients randomized|
48324414|NCT02551159|101121247|FG002|Full Analysis Set|Overall Study||206|All patients randomized|
48324415|NCT02551159|101121245|FG000|Safety Analysis Set|Overall Study||408|All patients who received at least one dose of study treatment|
48618189|NCT00929994|101849760|FG000|STARTED|Overall Study||20||
48618190|NCT00929994|101849760|FG000|COMPLETED|Overall Study||14||
48618191|NCT00929994|101849760|FG000|NOT COMPLETED|Overall Study||6||
48618192|NCT01724177|101849761|FG000|STARTED|Overall Study||26||
48324416|NCT02551159|101121246|FG001|Safety Analysis Set|Overall Study||202|All patients who received at least one dose of study treatment|
48324417|NCT02551159|101121247|FG002|Safety Analysis Set|Overall Study||196|All patients who received at least one dose of study treatment|
48324418|NCT02551159|101121245|FG000|PD-L1 TC/IC High Subgroup Analysis Set|Overall Study||190|Patients in the full analysis set with PD-L1 high|
48324419|NCT02551159|101121246|FG001|PD-L1 TC/IC High Subgroup Analysis Set|Overall Study||99|Patients in the full analysis set with PD-L1 high|
48324420|NCT02551159|101121247|FG002|PD-L1 TC/IC High Subgroup Analysis Set|Overall Study||94|Patients in the full analysis set with PD-L1 high|
48324421|NCT02551159|101121245|FG000|COMPLETED|Overall Study||0||
48324422|NCT02551159|101121246|FG001|COMPLETED|Overall Study||0||
48324423|NCT02551159|101121247|FG002|COMPLETED|Overall Study||0||
48324424|NCT02551159|101121245|FG000|NOT COMPLETED|Overall Study||413||
48324425|NCT02551159|101121246|FG001|NOT COMPLETED|Overall Study||204||
48324426|NCT02551159|101121247|FG002|NOT COMPLETED|Overall Study||206||
48324427|NCT02069899|101121248|FG000|STARTED|Overall Study||37||
48324428|NCT02069899|101121249|FG001|STARTED|Overall Study||14||
48324429|NCT02069899|101121250|FG002|STARTED|Overall Study||7||
48324430|NCT02069899|101121248|FG000|Treated in Current Study|Overall Study||22||
48324431|NCT02069899|101121249|FG001|Treated in Current Study|Overall Study||0||
48324432|NCT02069899|101121250|FG002|Treated in Current Study|Overall Study||5||
48324433|NCT02069899|101121248|FG000|COMPLETED|Overall Study||24||
48324434|NCT02069899|101121249|FG001|COMPLETED|Overall Study||13||
48618193|NCT01724177|101849761|FG000|Safety Population|Overall Study||26||
48618194|NCT01724177|101849761|FG000|COMPLETED|Overall Study||0||
48618195|NCT01724177|101849761|FG000|NOT COMPLETED|Overall Study||26||
48618196|NCT00613821|101852847|FG000|STARTED|Overall Study||40||
48618197|NCT00613821|101852848|FG001|STARTED|Overall Study||40||
48618198|NCT00613821|101852847|FG000|COMPLETED|Overall Study||38||
48324435|NCT02069899|101121250|FG002|COMPLETED|Overall Study||4||
48618199|NCT00613821|101852848|FG001|COMPLETED|Overall Study||39||
48324436|NCT02069899|101121248|FG000|NOT COMPLETED|Overall Study||13||
48324437|NCT02069899|101121249|FG001|NOT COMPLETED|Overall Study||1||
48324438|NCT02069899|101121250|FG002|NOT COMPLETED|Overall Study||3||
48324439|NCT03286842|101121251|FG000|STARTED|Overall Study||255||
48324440|NCT03286842|101121251|FG000|COMPLETED|Overall Study||175||
48324441|NCT03286842|101121251|FG000|NOT COMPLETED|Overall Study||80||
48324442|NCT00218491|101121252|FG000|STARTED|Overall Study||40||
48324443|NCT00218491|101121253|FG001|STARTED|Overall Study||33||
48324444|NCT00218491|101121254|FG002|STARTED|Overall Study||38||
48324445|NCT00218491|101121252|FG000|COMPLETED|Overall Study||40||
48324446|NCT00218491|101121253|FG001|COMPLETED|Overall Study||33||
48324447|NCT00218491|101121254|FG002|COMPLETED|Overall Study||38||
48618200|NCT00613821|101852847|FG000|NOT COMPLETED|Overall Study||2||
48324448|NCT00218491|101121252|FG000|NOT COMPLETED|Overall Study||0||
48324449|NCT00218491|101121253|FG001|NOT COMPLETED|Overall Study||0||
48324450|NCT00218491|101121254|FG002|NOT COMPLETED|Overall Study||0||
48324451|NCT03378076|101121255|FG000|STARTED|Overall Study||12||
48324452|NCT03378076|101121256|FG001|STARTED|Overall Study||12||
48324453|NCT03378076|101121255|FG000|COMPLETED|Overall Study||12||
48324454|NCT03378076|101121256|FG001|COMPLETED|Overall Study||12||
48324455|NCT03378076|101121255|FG000|NOT COMPLETED|Overall Study||0||
48324456|NCT03378076|101121256|FG001|NOT COMPLETED|Overall Study||0||
48324457|NCT00919035|101121257|FG000|STARTED|Overall Study||21||
48324458|NCT00919035|101121257|FG000|COMPLETED|Overall Study||21||
48324459|NCT00919035|101121257|FG000|NOT COMPLETED|Overall Study||0||
48324460|NCT02227693|101121258|FG000|STARTED|Overall Study||11||
48324461|NCT02227693|101121259|FG001|STARTED|Overall Study||7||
48324462|NCT02227693|101121260|FG002|STARTED|Overall Study||11||
48324463|NCT02227693|101121261|FG003|STARTED|Overall Study||10||
48324464|NCT02227693|101121258|FG000|COMPLETED|Overall Study||11||
48324465|NCT02227693|101121259|FG001|COMPLETED|Overall Study||7||
48324466|NCT02227693|101121260|FG002|COMPLETED|Overall Study||11||
48324467|NCT02227693|101121261|FG003|COMPLETED|Overall Study||10||
48324468|NCT02227693|101121258|FG000|NOT COMPLETED|Overall Study||0||
48324469|NCT02227693|101121259|FG001|NOT COMPLETED|Overall Study||0||
48324470|NCT02227693|101121260|FG002|NOT COMPLETED|Overall Study||0||
48324471|NCT02227693|101121261|FG003|NOT COMPLETED|Overall Study||0||
48324472|NCT03499028|101121262|FG000|STARTED|Overall Study||226||
48324473|NCT03499028|101121263|FG001|STARTED|Overall Study||220||
48324474|NCT03499028|101121262|FG000|COMPLETED|Overall Study||204||
48324475|NCT03499028|101121263|FG001|COMPLETED|Overall Study||195||
48324476|NCT03499028|101121262|FG000|NOT COMPLETED|Overall Study||22||
48324477|NCT03499028|101121263|FG001|NOT COMPLETED|Overall Study||25||
48324478|NCT03174132|101121264|FG000|STARTED|Overall Study||70||
48324479|NCT03174132|101121264|FG000|COMPLETED|Overall Study||70||
48324480|NCT03174132|101121264|FG000|NOT COMPLETED|Overall Study||0||
48324481|NCT00817531|101121265|FG000|STARTED|Overall Study||22||
48324482|NCT00817531|101121265|FG000|COMPLETED|Overall Study||20||
48324483|NCT00817531|101121265|FG000|NOT COMPLETED|Overall Study||2||
48324484|NCT00861744|101121266|FG000|STARTED|Overall Study||304||
48324485|NCT00861744|101121267|FG001|STARTED|Overall Study||304||
48324486|NCT00861744|101121268|FG002|STARTED|Overall Study||304||
48324487|NCT00861744|101121269|FG003|STARTED|Overall Study||308||
48324488|NCT00861744|101121266|FG000|COMPLETED|Overall Study||287||
48324489|NCT00861744|101121267|FG001|COMPLETED|Overall Study||275||
48324490|NCT00861744|101121268|FG002|COMPLETED|Overall Study||280||
48324491|NCT00861744|101121269|FG003|COMPLETED|Overall Study||275||
48324492|NCT00861744|101121266|FG000|NOT COMPLETED|Overall Study||17||
48324493|NCT00861744|101121267|FG001|NOT COMPLETED|Overall Study||29||
48324494|NCT00861744|101121268|FG002|NOT COMPLETED|Overall Study||24||
48324495|NCT00861744|101121269|FG003|NOT COMPLETED|Overall Study||33||
48324496|NCT02699892|101121270|FG000|STARTED|Overall Study||130||
48324497|NCT02699892|101121270|FG000|COMPLETED|Overall Study||94||
48324498|NCT02699892|101121270|FG000|NOT COMPLETED|Overall Study||36||
48324499|NCT02018822|101121271|FG000|STARTED|Overall Study||50||50
48324500|NCT02018822|101121272|FG001|STARTED|Overall Study||50||50
48324501|NCT02018822|101121273|FG002|STARTED|Overall Study||35||50
48324502|NCT02018822|101121271|FG000|COMPLETED|Overall Study||44|Completed 24 months|44
48324503|NCT02018822|101121272|FG001|COMPLETED|Overall Study||42|Completed 24 months|42
48324504|NCT02018822|101121273|FG002|COMPLETED|Overall Study||29|Completed 24 months|41
48324505|NCT02018822|101121271|FG000|NOT COMPLETED|Overall Study||6||6
48324506|NCT02018822|101121272|FG001|NOT COMPLETED|Overall Study||8||8
48324507|NCT02018822|101121273|FG002|NOT COMPLETED|Overall Study||6||9
48324508|NCT02109484|101121274|FG000|STARTED|Overall Study||5||
48324509|NCT02109484|101121275|FG001|STARTED|Overall Study||13||
48324510|NCT02109484|101121276|FG002|STARTED|Overall Study||12||
48408582|NCT02861118|101331805|FG000|STARTED|Overall Study||194||
48324511|NCT02109484|101121277|FG003|STARTED|Overall Study||12||
48324512|NCT02109484|101121278|FG004|STARTED|Overall Study||50||
48408583|NCT02861118|101331806|FG001|STARTED|Overall Study||116||
48324513|NCT02109484|101121279|FG005|STARTED|Overall Study||12||
48324514|NCT02109484|101121280|FG006|STARTED|Overall Study||50||
48324515|NCT02109484|101121281|FG007|STARTED|Overall Study||50||
48324516|NCT02109484|101121274|FG000|COMPLETED|Overall Study||5||
48324517|NCT02109484|101121275|FG001|COMPLETED|Overall Study||13||
48324518|NCT02109484|101121276|FG002|COMPLETED|Overall Study||12||
48324519|NCT02109484|101121277|FG003|COMPLETED|Overall Study||11||
48324520|NCT02109484|101121278|FG004|COMPLETED|Overall Study||46||
48324521|NCT02109484|101121279|FG005|COMPLETED|Overall Study||11||
48324522|NCT02109484|101121280|FG006|COMPLETED|Overall Study||47||
48324523|NCT02109484|101121281|FG007|COMPLETED|Overall Study||47||
48324524|NCT02109484|101121274|FG000|NOT COMPLETED|Overall Study||0||
48324525|NCT02109484|101121275|FG001|NOT COMPLETED|Overall Study||0||
48324526|NCT02109484|101121276|FG002|NOT COMPLETED|Overall Study||0||
48324527|NCT02109484|101121277|FG003|NOT COMPLETED|Overall Study||1||
48324528|NCT02109484|101121278|FG004|NOT COMPLETED|Overall Study||4||
48324529|NCT02109484|101121279|FG005|NOT COMPLETED|Overall Study||1||
48324530|NCT02109484|101121280|FG006|NOT COMPLETED|Overall Study||3||
48324531|NCT02109484|101121281|FG007|NOT COMPLETED|Overall Study||3||
48324532|NCT01273883|101121282|FG000|STARTED|First Intervention||19||
48324533|NCT01273883|101121283|FG001|STARTED|First Intervention||19||
48324534|NCT01273883|101121282|FG000|COMPLETED|First Intervention||17||
48324535|NCT01273883|101121283|FG001|COMPLETED|First Intervention||18||
48324536|NCT01273883|101121282|FG000|NOT COMPLETED|First Intervention||2||
48324537|NCT01273883|101121283|FG001|NOT COMPLETED|First Intervention||1||
48324538|NCT01273883|101121282|FG000|STARTED|Washout Period of 2 Weeks||17||
48324539|NCT01273883|101121283|FG001|STARTED|Washout Period of 2 Weeks||18||
48324540|NCT01273883|101121282|FG000|COMPLETED|Washout Period of 2 Weeks||17||
48324541|NCT01273883|101121283|FG001|COMPLETED|Washout Period of 2 Weeks||18||
48324542|NCT01273883|101121282|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0||
48324543|NCT01273883|101121283|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0||
48324544|NCT01273883|101121282|FG000|STARTED|Second Intervention||17||
48324545|NCT01273883|101121283|FG001|STARTED|Second Intervention||18||
48324546|NCT01273883|101121282|FG000|COMPLETED|Second Intervention||15||
48324547|NCT01273883|101121283|FG001|COMPLETED|Second Intervention||17||
48324548|NCT01273883|101121282|FG000|NOT COMPLETED|Second Intervention||2||
48324549|NCT01273883|101121283|FG001|NOT COMPLETED|Second Intervention||1||
48324550|NCT00631748|101121284|FG000|STARTED|Overall Study||29||
48324551|NCT00631748|101121285|FG001|STARTED|Overall Study||31||
48324552|NCT00631748|101121284|FG000|COMPLETED|Overall Study||11||
48324553|NCT00631748|101121285|FG001|COMPLETED|Overall Study||9||
48324554|NCT00631748|101121284|FG000|NOT COMPLETED|Overall Study||18||
48324555|NCT00631748|101121285|FG001|NOT COMPLETED|Overall Study||22||
48324556|NCT00336973|101121286|FG000|STARTED|Overall Study||66||
48324557|NCT00336973|101121286|FG000|COMPLETED|Overall Study||33||
48324558|NCT00336973|101121286|FG000|NOT COMPLETED|Overall Study||33||
48324559|NCT00290433|101121287|FG000|STARTED|Overall Study||53||
48324560|NCT00290433|101121287|FG000|COMPLETED|Overall Study||17||
48324561|NCT00290433|101121287|FG000|NOT COMPLETED|Overall Study||36||
48324562|NCT01618942|101121288|FG000|STARTED|Overall Study||50||
48324563|NCT01618942|101121289|FG001|STARTED|Overall Study||50||
48324564|NCT01618942|101121288|FG000|COMPLETED|Overall Study||50||
48324565|NCT01618942|101121289|FG001|COMPLETED|Overall Study||50||
48324566|NCT01618942|101121288|FG000|NOT COMPLETED|Overall Study||0||
48324567|NCT01618942|101121289|FG001|NOT COMPLETED|Overall Study||0||
48324568|NCT01212302|101121290|FG000|STARTED|Overall Study||504||
48324569|NCT01212302|101121290|FG000|COMPLETED|Overall Study||504||
48324570|NCT01212302|101121290|FG000|NOT COMPLETED|Overall Study||0||
48324571|NCT00706134|101121291|FG000|STARTED|Overall Study||189||
48324572|NCT00706134|101121292|FG001|STARTED|Overall Study||192||
48324573|NCT00706134|101121293|FG002|STARTED|Overall Study||189||
48324574|NCT00706134|101121294|FG003|STARTED|Overall Study||186||
48324575|NCT00706134|101121291|FG000|Entered Double-blind Period|Overall Study||187||
48324576|NCT00706134|101121292|FG001|Entered Double-blind Period|Overall Study||192||
48324577|NCT00706134|101121293|FG002|Entered Double-blind Period|Overall Study||189||
48324578|NCT00706134|101121294|FG003|Entered Double-blind Period|Overall Study||186||
48324579|NCT00706134|101121291|FG000|COMPLETED|Overall Study||169||
48324580|NCT00706134|101121292|FG001|COMPLETED|Overall Study||173||
48324581|NCT00706134|101121293|FG002|COMPLETED|Overall Study||183||
48324582|NCT00706134|101121294|FG003|COMPLETED|Overall Study||175||
48324583|NCT00706134|101121291|FG000|NOT COMPLETED|Overall Study||20||
48324584|NCT00706134|101121292|FG001|NOT COMPLETED|Overall Study||19||
48324585|NCT00706134|101121293|FG002|NOT COMPLETED|Overall Study||6||
48324586|NCT00706134|101121294|FG003|NOT COMPLETED|Overall Study||11||
48324587|NCT00236977|101121295|FG000|STARTED|Overall Study||91||
48324588|NCT00236977|101121296|FG001|STARTED|Overall Study||91||
48324589|NCT00236977|101121295|FG000|COMPLETED|Overall Study||70||
48324590|NCT00236977|101121296|FG001|COMPLETED|Overall Study||72||
48324591|NCT00236977|101121295|FG000|NOT COMPLETED|Overall Study||21||
48324592|NCT00236977|101121296|FG001|NOT COMPLETED|Overall Study||19||
48324593|NCT02730884|101121297|FG000|STARTED|Overall Study||3||
48324594|NCT02730884|101121297|FG000|COMPLETED|Overall Study||3||
48324595|NCT02730884|101121297|FG000|NOT COMPLETED|Overall Study||0||
48324596|NCT01661140|101121298|FG000|STARTED|Open-Label Period||427||
48324597|NCT01661140|101121299|FG001|STARTED|Open-Label Period||0||
48324598|NCT01661140|101121300|FG002|STARTED|Open-Label Period||0||
48324599|NCT01661140|101121298|FG000|COMPLETED|Open-Label Period||351||
48324600|NCT01661140|101121299|FG001|COMPLETED|Open-Label Period||0||
48324601|NCT01661140|101121300|FG002|COMPLETED|Open-Label Period||0||
48324602|NCT01661140|101121298|FG000|NOT COMPLETED|Open-Label Period||76||
48324603|NCT01661140|101121299|FG001|NOT COMPLETED|Open-Label Period||0||
48324604|NCT01661140|101121300|FG002|NOT COMPLETED|Open-Label Period||0||
48324605|NCT01661140|101121298|FG000|STARTED|Double-Blind Period||0||
48324606|NCT01661140|101121299|FG001|STARTED|Double-Blind Period||136||
48324607|NCT01661140|101121300|FG002|STARTED|Double-Blind Period||136||
48324608|NCT01661140|101121298|FG000|COMPLETED|Double-Blind Period||0||
48324609|NCT01661140|101121299|FG001|COMPLETED|Double-Blind Period||95||
48324610|NCT01661140|101121300|FG002|COMPLETED|Double-Blind Period||86||
48324611|NCT01661140|101121298|FG000|NOT COMPLETED|Double-Blind Period||0||
48324612|NCT01661140|101121299|FG001|NOT COMPLETED|Double-Blind Period||41||
48324613|NCT01661140|101121300|FG002|NOT COMPLETED|Double-Blind Period||50||
48324614|NCT04153188|101121301|FG000|STARTED|Overall Study||17||
48324615|NCT04153188|101121302|FG001|STARTED|Overall Study||13||
48324616|NCT04153188|101121301|FG000|COMPLETED|Overall Study||14||
48324617|NCT04153188|101121302|FG001|COMPLETED|Overall Study||11||
48324618|NCT04153188|101121301|FG000|NOT COMPLETED|Overall Study||3||
48324619|NCT04153188|101121302|FG001|NOT COMPLETED|Overall Study||2||
48408584|NCT02861118|101331805|FG000|COMPLETED|Overall Study||194||
48408585|NCT02861118|101331806|FG001|COMPLETED|Overall Study||116||
48408586|NCT02861118|101331805|FG000|NOT COMPLETED|Overall Study||0||
48408587|NCT02861118|101331806|FG001|NOT COMPLETED|Overall Study||0||
48408588|NCT00446641|101331807|FG000|STARTED|Overall Study||125||
48408589|NCT00446641|101331808|FG001|STARTED|Overall Study||119||
48408590|NCT00446641|101331807|FG000|COMPLETED|Overall Study||108||
48408591|NCT00446641|101331808|FG001|COMPLETED|Overall Study||109||
48408592|NCT00446641|101331807|FG000|NOT COMPLETED|Overall Study||17||
48408593|NCT00446641|101331808|FG001|NOT COMPLETED|Overall Study||10||
48408594|NCT00576147|101331809|FG000|STARTED|Overall Study||431||
48408595|NCT00576147|101331809|FG000|COMPLETED|Overall Study||431||
48408596|NCT00576147|101331809|FG000|NOT COMPLETED|Overall Study||0||
48408597|NCT00090766|101331810|FG000|STARTED|Overall Study||17||
48408598|NCT00090766|101331811|FG001|STARTED|Overall Study||21||
48408599|NCT00090766|101331812|FG002|STARTED|Overall Study||25||
48618201|NCT00613821|101852848|FG001|NOT COMPLETED|Overall Study||1||
48618202|NCT05044429|101852849|FG000|STARTED|Overall Study||19||
48618203|NCT05044429|101852850|FG001|STARTED|Overall Study||7||
48408600|NCT00090766|101331810|FG000|COMPLETED|Overall Study||14||
48408601|NCT00090766|101331811|FG001|COMPLETED|Overall Study||19||
48742014|NCT01136408|102154980|FG001|COMPLETED|Overall Study||49||
48742015|NCT01136408|102154981|FG002|COMPLETED|Overall Study||57||
48742016|NCT01136408|102154979|FG000|NOT COMPLETED|Overall Study||5||
48742017|NCT01136408|102154980|FG001|NOT COMPLETED|Overall Study||9||
48742018|NCT01136408|102154981|FG002|NOT COMPLETED|Overall Study||5||
48742019|NCT04915729|102154982|FG000|STARTED|Overall Study||744||
48742020|NCT04915729|102154983|FG001|STARTED|Overall Study||745||
48408602|NCT00090766|101331812|FG002|COMPLETED|Overall Study||22||
48408603|NCT00090766|101331810|FG000|NOT COMPLETED|Overall Study||3||
48408604|NCT00090766|101331811|FG001|NOT COMPLETED|Overall Study||2||
48408605|NCT00090766|101331812|FG002|NOT COMPLETED|Overall Study||3||
48408606|NCT00854061|101331813|FG000|STARTED|Overall Study||172||
48408607|NCT00854061|101331813|FG000|Completed 1st Surgery (T-PRED in One Eye and Pred Forte in the Other Eye)|Overall Study||162||
48408608|NCT00854061|101331813|FG000|Completed 2nd Surgery (T-PRED and Pred Forte in Opposite Eyes Compared to 1st Surgery)|Overall Study||149||
48408609|NCT00854061|101331813|FG000|COMPLETED|Overall Study||149||
48408610|NCT00854061|101331813|FG000|NOT COMPLETED|Overall Study||23||
48618204|NCT05044429|101852851|FG002|STARTED|Overall Study||5||
48618205|NCT05044429|101852849|FG000|COMPLETED|Overall Study||19||
48618206|NCT05044429|101852850|FG001|COMPLETED|Overall Study||7||
48618207|NCT05044429|101852851|FG002|COMPLETED|Overall Study||5||
48618208|NCT05044429|101852849|FG000|NOT COMPLETED|Overall Study||0||
48618209|NCT05044429|101852850|FG001|NOT COMPLETED|Overall Study||0||
48618210|NCT05044429|101852851|FG002|NOT COMPLETED|Overall Study||0||
48618211|NCT00675987|101852852|FG000|STARTED|Overall Study||26||
48618212|NCT00675987|101852853|FG001|STARTED|Overall Study||27||
48618213|NCT00675987|101852852|FG000|COMPLETED|Overall Study||26||
48618214|NCT00675987|101852853|FG001|COMPLETED|Overall Study||27||
48618215|NCT00675987|101852852|FG000|NOT COMPLETED|Overall Study||0||
48618216|NCT00675987|101852853|FG001|NOT COMPLETED|Overall Study||0||
48742021|NCT04915729|102154982|FG000|Treated|Overall Study||733||
48742022|NCT04915729|102154983|FG001|Treated|Overall Study||735||
48324620|NCT01709435|101121303|FG000|STARTED|Overall Study||6||
48324621|NCT01709435|101121304|FG001|STARTED|Overall Study||9||
48324622|NCT01709435|101121305|FG002|STARTED|Overall Study||6||
48324623|NCT01709435|101121306|FG003|STARTED|Overall Study||4||
48324624|NCT01709435|101121307|FG004|STARTED|Overall Study||10||
48324625|NCT01709435|101121308|FG005|STARTED|Overall Study||6||
48742023|NCT04915729|102154982|FG000|COMPLETED|Overall Study||671||
48742024|NCT04915729|102154983|FG001|COMPLETED|Overall Study||675||
48324626|NCT01709435|101121303|FG000|COMPLETED|Overall Study||0||
48324627|NCT01709435|101121304|FG001|COMPLETED|Overall Study||0||
48324628|NCT01709435|101121305|FG002|COMPLETED|Overall Study||0||
48408611|NCT04944758|101331814|FG000|STARTED|Overall Study||1||
48408612|NCT04944758|101331814|FG000|COMPLETED|Overall Study||1||
48408613|NCT04944758|101331814|FG000|NOT COMPLETED|Overall Study||0||
48408614|NCT02209259|101331815|FG000|STARTED|Overall Study||56||
48408615|NCT02209259|101331816|FG001|STARTED|Overall Study||56||
48618217|NCT00983645|101852854|FG000|STARTED|Overall Study||8||
48618218|NCT00983645|101852855|FG001|STARTED|Overall Study||7||
48324629|NCT01709435|101121306|FG003|COMPLETED|Overall Study||1||
48324630|NCT01709435|101121307|FG004|COMPLETED|Overall Study||0||
48408616|NCT02209259|101331817|FG002|STARTED|Overall Study||56||
48742025|NCT04915729|102154982|FG000|NOT COMPLETED|Overall Study||73||
48742026|NCT04915729|102154983|FG001|NOT COMPLETED|Overall Study||70||
48324631|NCT01709435|101121308|FG005|COMPLETED|Overall Study||0||
48324632|NCT01709435|101121303|FG000|NOT COMPLETED|Overall Study||6||
48324633|NCT01709435|101121304|FG001|NOT COMPLETED|Overall Study||9||
48742027|NCT01922271|102154984|FG000|STARTED|PERIOD 1||76||
48618219|NCT00983645|101852854|FG000|COMPLETED|Overall Study||8||
48618220|NCT00983645|101852855|FG001|COMPLETED|Overall Study||7||
48618221|NCT00983645|101852854|FG000|NOT COMPLETED|Overall Study||0||
48618222|NCT00983645|101852855|FG001|NOT COMPLETED|Overall Study||0||
48618223|NCT02485483|101852856|FG000|STARTED|Overall Study||277||
48618224|NCT02485483|101852857|FG001|STARTED|Overall Study||1015||
48618225|NCT02485483|101852856|FG000|COMPLETED|Overall Study||223||
48162334|NCT03145766|100718951|FG000|STARTED|Active Vaccination Phase (Day 0-Day 56)||80|Randomized.|
48324634|NCT01709435|101121305|FG002|NOT COMPLETED|Overall Study||6||
48324635|NCT01709435|101121306|FG003|NOT COMPLETED|Overall Study||3||
48324636|NCT01709435|101121307|FG004|NOT COMPLETED|Overall Study||10||
48324637|NCT01709435|101121308|FG005|NOT COMPLETED|Overall Study||6||
48324638|NCT02425826|101121309|FG000|STARTED|Placebo-controlled Phase (Week 0 - 16)||148||
48324639|NCT02425826|101121310|FG001|STARTED|Placebo-controlled Phase (Week 0 - 16)||73||
48324640|NCT02425826|101121311|FG002|STARTED|Placebo-controlled Phase (Week 0 - 16)||0||
48324641|NCT02425826|101121309|FG000|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)||147||
48324642|NCT02425826|101121310|FG001|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)||73||
48324643|NCT02425826|101121311|FG002|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)||0||
48324644|NCT02425826|101121309|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 16)||121||
48324645|NCT02425826|101121310|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 16)||64||
48324646|NCT02425826|101121311|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0||
48324647|NCT02425826|101121309|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||27||
48324648|NCT02425826|101121310|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||9||
48324649|NCT02425826|101121311|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0||
48324650|NCT02425826|101121309|FG000|STARTED|Apremilast Extension Phase (Weeks 16-52)||121||
48324651|NCT02425826|101121310|FG001|STARTED|Apremilast Extension Phase (Weeks 16-52)||0||
48324652|NCT02425826|101121311|FG002|STARTED|Apremilast Extension Phase (Weeks 16-52)||64||
48324653|NCT02425826|101121309|FG000|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||121||
48324654|NCT02425826|101121310|FG001|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||0||
48324655|NCT02425826|101121311|FG002|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||64||
48324656|NCT02425826|101121309|FG000|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||86||
48324657|NCT02425826|101121310|FG001|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0||
48324658|NCT02425826|101121311|FG002|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||50||
48324659|NCT02425826|101121309|FG000|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||35||
48324660|NCT02425826|101121310|FG001|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0||
48324661|NCT02425826|101121311|FG002|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||14||
48324662|NCT02425826|101121309|FG000|STARTED|Post-Treatment Observational Follow-Up||81||
48324663|NCT02425826|101121310|FG001|STARTED|Post-Treatment Observational Follow-Up||0||
48324664|NCT02425826|101121311|FG002|STARTED|Post-Treatment Observational Follow-Up||49||
48324665|NCT02425826|101121309|FG000|COMPLETED|Post-Treatment Observational Follow-Up||80||
48324666|NCT02425826|101121310|FG001|COMPLETED|Post-Treatment Observational Follow-Up||0||
48324667|NCT02425826|101121311|FG002|COMPLETED|Post-Treatment Observational Follow-Up||49||
48324668|NCT02425826|101121309|FG000|NOT COMPLETED|Post-Treatment Observational Follow-Up||1||
48324669|NCT02425826|101121310|FG001|NOT COMPLETED|Post-Treatment Observational Follow-Up||0||
48324670|NCT02425826|101121311|FG002|NOT COMPLETED|Post-Treatment Observational Follow-Up||0||
48618226|NCT02485483|101852857|FG001|COMPLETED|Overall Study||1015||
48618227|NCT02485483|101852856|FG000|NOT COMPLETED|Overall Study||54||
48618228|NCT02485483|101852857|FG001|NOT COMPLETED|Overall Study||0||
48618229|NCT02620683|101852858|FG000|STARTED|First Intervention (Visit 1)||12||
48618230|NCT02620683|101852859|FG001|STARTED|First Intervention (Visit 1)||11||
48618231|NCT02620683|101852858|FG000|COMPLETED|First Intervention (Visit 1)||12||
48324671|NCT00879229|101121312|FG000|STARTED|Overall Study||25||
48324672|NCT00879229|101121313|FG001|STARTED|Overall Study||15||
48324673|NCT00879229|101121312|FG000|COMPLETED|Overall Study||3||
48324674|NCT00879229|101121313|FG001|COMPLETED|Overall Study||1||
48324675|NCT00879229|101121312|FG000|NOT COMPLETED|Overall Study||22||
48324676|NCT00879229|101121313|FG001|NOT COMPLETED|Overall Study||14||
48324677|NCT02590588|101121314|FG000|STARTED|Overall Study||1||
48324678|NCT02590588|101121314|FG000|COMPLETED|Overall Study||0||
48324679|NCT02590588|101121314|FG000|NOT COMPLETED|Overall Study||1||
48324680|NCT03066102|101121315|FG000|STARTED|Overall Study||30||
48324681|NCT03066102|101121315|FG000|COMPLETED|Overall Study||30||
48324682|NCT03066102|101121315|FG000|NOT COMPLETED|Overall Study||0||
48324683|NCT01652885|101121316|FG000|STARTED|Overall Study||23||
48324684|NCT01652885|101121316|FG000|COMPLETED|Overall Study||22||
48324685|NCT01652885|101121316|FG000|NOT COMPLETED|Overall Study||1||
48324686|NCT03239574|101121317|FG000|STARTED|Overall Study||34||
48324687|NCT03239574|101121317|FG000|COMPLETED|Overall Study||34||
48324688|NCT03239574|101121317|FG000|NOT COMPLETED|Overall Study||0||
48324689|NCT02363686|101121318|FG000|STARTED|Overall Study||248||
48324690|NCT02363686|101121318|FG000|COMPLETED|Overall Study||213||
48324691|NCT02363686|101121318|FG000|NOT COMPLETED|Overall Study||35||
48618232|NCT02620683|101852859|FG001|COMPLETED|First Intervention (Visit 1)||11||
48618233|NCT02620683|101852858|FG000|NOT COMPLETED|First Intervention (Visit 1)||0||
48324692|NCT01967550|101121319|FG000|STARTED|Overall Study||153||
48408617|NCT02209259|101331815|FG000|COMPLETED|Overall Study||56||
48408618|NCT02209259|101331816|FG001|COMPLETED|Overall Study||56||
48408619|NCT02209259|101331817|FG002|COMPLETED|Overall Study||56||
48408620|NCT02209259|101331815|FG000|NOT COMPLETED|Overall Study||0||
48408621|NCT02209259|101331816|FG001|NOT COMPLETED|Overall Study||0||
48408622|NCT02209259|101331817|FG002|NOT COMPLETED|Overall Study||0||
48408623|NCT01045551|101331818|FG000|STARTED|Overall Study||10||
48408624|NCT01045551|101331818|FG000|COMPLETED|Overall Study||10||
48408625|NCT01045551|101331818|FG000|NOT COMPLETED|Overall Study||0||
48408626|NCT00679380|101331819|FG000|STARTED|Overall Study||109||
48618234|NCT02620683|101852859|FG001|NOT COMPLETED|First Intervention (Visit 1)||0||
48618235|NCT02620683|101852858|FG000|STARTED|Washout (2 Weeks)||12||
48618236|NCT02620683|101852859|FG001|STARTED|Washout (2 Weeks)||11||
48618237|NCT02620683|101852858|FG000|COMPLETED|Washout (2 Weeks)||12||
48618238|NCT02620683|101852859|FG001|COMPLETED|Washout (2 Weeks)||11||
48618239|NCT02620683|101852858|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
48618240|NCT02620683|101852859|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
48618241|NCT02620683|101852858|FG000|STARTED|Second Intervention (Visit 2)||12||
48618242|NCT02620683|101852859|FG001|STARTED|Second Intervention (Visit 2)||11||
48618243|NCT02620683|101852858|FG000|COMPLETED|Second Intervention (Visit 2)||12||
48618244|NCT02620683|101852859|FG001|COMPLETED|Second Intervention (Visit 2)||11||
48618245|NCT02620683|101852858|FG000|NOT COMPLETED|Second Intervention (Visit 2)||0||
48618246|NCT02620683|101852859|FG001|NOT COMPLETED|Second Intervention (Visit 2)||0||
48618247|NCT01607593|101852860|FG000|STARTED|Overall Study||122||
48162335|NCT03145766|100718952|FG001|STARTED|Active Vaccination Phase (Day 0-Day 56)||80|Randomized.|
48162336|NCT03145766|100718953|FG002|STARTED|Active Vaccination Phase (Day 0-Day 56)||80|Randomized.|
48162337|NCT03145766|100718954|FG003|STARTED|Active Vaccination Phase (Day 0-Day 56)||40|Randomized.|
48162338|NCT03145766|100718955|FG004|STARTED|Active Vaccination Phase (Day 0-Day 56)||40|Randomized.|
48162339|NCT03145766|100718951|FG000|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||80||
48162340|NCT03145766|100718952|FG001|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||80||
48162341|NCT03145766|100718953|FG002|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||80||
48162342|NCT03145766|100718954|FG003|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||39||
48162343|NCT03145766|100718955|FG004|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||41||
48162344|NCT03145766|100718951|FG000|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||77||
48188754|NCT01902901|100783329|FG001|COMPLETED|Overall Study||201||
48408627|NCT00679380|101331820|FG001|STARTED|Overall Study||109||
48408628|NCT00679380|101331821|FG002|STARTED|Overall Study||103||
48408629|NCT00679380|101331822|FG003|STARTED|Overall Study||89||
48408630|NCT00679380|101331819|FG000|COMPLETED|Overall Study||67||
48408631|NCT00679380|101331820|FG001|COMPLETED|Overall Study||76||
48408632|NCT00679380|101331821|FG002|COMPLETED|Overall Study||68||
48408633|NCT00679380|101331822|FG003|COMPLETED|Overall Study||61||
48408634|NCT00679380|101331819|FG000|NOT COMPLETED|Overall Study||42||
48408635|NCT00679380|101331820|FG001|NOT COMPLETED|Overall Study||33||
48408636|NCT00679380|101331821|FG002|NOT COMPLETED|Overall Study||35||
48408637|NCT00679380|101331822|FG003|NOT COMPLETED|Overall Study||28||
48408638|NCT01228149|101331823|FG000|STARTED|Overall Study||32||
48408639|NCT01228149|101331824|FG001|STARTED|Overall Study||30||
48408640|NCT01228149|101331823|FG000|COMPLETED|Overall Study||27||
48408641|NCT01228149|101331824|FG001|COMPLETED|Overall Study||26||
48408642|NCT01228149|101331823|FG000|NOT COMPLETED|Overall Study||5||
48408643|NCT01228149|101331824|FG001|NOT COMPLETED|Overall Study||4||
48618248|NCT01607593|101852860|FG000|COMPLETED|Overall Study||29||
48408644|NCT03860844|101331825|FG000|STARTED|Overall Study||27||
48618249|NCT01607593|101852860|FG000|NOT COMPLETED|Overall Study||93||
48618250|NCT02915159|101852861|FG000|STARTED|Overall Study||92||
48618251|NCT02915159|101852862|FG001|STARTED|Overall Study||95||
48618252|NCT02915159|101852861|FG000|COMPLETED|Overall Study||81||
48324693|NCT01967550|101121320|FG001|STARTED|Overall Study||151||
48324694|NCT01967550|101121319|FG000|COMPLETED|Overall Study||148||
48324695|NCT01967550|101121320|FG001|COMPLETED|Overall Study||149||
48324696|NCT01967550|101121319|FG000|NOT COMPLETED|Overall Study||5||
48324697|NCT01967550|101121320|FG001|NOT COMPLETED|Overall Study||2||
48324698|NCT02982954|101121321|FG000|STARTED|Overall Study||106||
48324699|NCT02982954|101121322|FG001|STARTED|Overall Study||52||
48408645|NCT03860844|101331826|FG001|STARTED|Overall Study||13||
48408646|NCT03860844|101331827|FG002|STARTED|Overall Study||27||
48408647|NCT03860844|101331825|FG000|COMPLETED|Overall Study||19||
48408648|NCT03860844|101331826|FG001|COMPLETED|Overall Study||7||
48408649|NCT03860844|101331827|FG002|COMPLETED|Overall Study||20||
48408650|NCT03860844|101331825|FG000|NOT COMPLETED|Overall Study||8||
48618253|NCT02915159|101852862|FG001|COMPLETED|Overall Study||87||
48618254|NCT02915159|101852861|FG000|NOT COMPLETED|Overall Study||11||
48618255|NCT02915159|101852862|FG001|NOT COMPLETED|Overall Study||8||
48742028|NCT01922271|102154985|FG001|STARTED|PERIOD 1||76||
48408651|NCT03860844|101331826|FG001|NOT COMPLETED|Overall Study||6||
48408652|NCT03860844|101331827|FG002|NOT COMPLETED|Overall Study||7||
48408653|NCT03285490|101331828|FG000|STARTED|Treatment and Response Assessment Period||173||
48408654|NCT03285490|101331829|FG001|STARTED|Treatment and Response Assessment Period||178||
48408655|NCT03285490|101331828|FG000|COMPLETED|Treatment and Response Assessment Period||173||
48408656|NCT03285490|101331829|FG001|COMPLETED|Treatment and Response Assessment Period||178||
48618256|NCT04786691|101852863|FG000|STARTED|First Intervention (2 Hours)||2||
48742029|NCT01922271|102154984|FG000|COMPLETED|PERIOD 1||76||
48742030|NCT01922271|102154985|FG001|COMPLETED|PERIOD 1||76||
48742031|NCT01922271|102154984|FG000|NOT COMPLETED|PERIOD 1||0||
48742032|NCT01922271|102154985|FG001|NOT COMPLETED|PERIOD 1||0||
48742033|NCT01922271|102154984|FG000|STARTED|WASHOUT Period||76||
48742034|NCT01922271|102154985|FG001|STARTED|WASHOUT Period||76||
48742035|NCT01922271|102154984|FG000|COMPLETED|WASHOUT Period||75||
48742036|NCT01922271|102154985|FG001|COMPLETED|WASHOUT Period||76||
48742037|NCT01922271|102154984|FG000|NOT COMPLETED|WASHOUT Period||1||
48742038|NCT01922271|102154985|FG001|NOT COMPLETED|WASHOUT Period||0||
48618257|NCT04786691|101852864|FG001|STARTED|First Intervention (2 Hours)||3||
48742039|NCT01922271|102154984|FG000|STARTED|PERIOD 2||75||
48742040|NCT01922271|102154985|FG001|STARTED|PERIOD 2||76||
48742041|NCT01922271|102154984|FG000|COMPLETED|PERIOD 2||75||
48618258|NCT04786691|101852865|FG002|STARTED|First Intervention (2 Hours)||2||
48742042|NCT01922271|102154985|FG001|COMPLETED|PERIOD 2||76||
48742043|NCT01922271|102154984|FG000|NOT COMPLETED|PERIOD 2||0||
48742044|NCT01922271|102154985|FG001|NOT COMPLETED|PERIOD 2||0||
48742045|NCT02326597|102154986|FG000|STARTED|Overall Study||60||
48742046|NCT02326597|102154987|FG001|STARTED|Overall Study||60||
48742047|NCT02326597|102154986|FG000|COMPLETED|Overall Study||18||
48742048|NCT02326597|102154987|FG001|COMPLETED|Overall Study||28||
48742049|NCT02326597|102154986|FG000|NOT COMPLETED|Overall Study||42||
48742050|NCT02326597|102154987|FG001|NOT COMPLETED|Overall Study||32||
48742051|NCT03742973|102154988|FG000|STARTED|Overall Study||0||
48742052|NCT03742973|102154989|FG001|STARTED|Overall Study||0||
48742053|NCT03742973|102154988|FG000|COMPLETED|Overall Study||0||
48742054|NCT03742973|102154989|FG001|COMPLETED|Overall Study||0||
48324700|NCT02982954|101121323|FG002|STARTED|Overall Study||28||
48324701|NCT02982954|101121324|FG003|STARTED|Overall Study||25||
48324702|NCT02982954|101121321|FG000|COMPLETED|Overall Study||0||
48324703|NCT02982954|101121322|FG001|COMPLETED|Overall Study||0||
48324704|NCT02982954|101121323|FG002|COMPLETED|Overall Study||0||
48324705|NCT02982954|101121324|FG003|COMPLETED|Overall Study||0||
48324706|NCT02982954|101121321|FG000|NOT COMPLETED|Overall Study||106||
48324707|NCT02982954|101121322|FG001|NOT COMPLETED|Overall Study||52||
48324708|NCT02982954|101121323|FG002|NOT COMPLETED|Overall Study||28||
48408657|NCT03285490|101331828|FG000|NOT COMPLETED|Treatment and Response Assessment Period||0||
48408658|NCT03285490|101331829|FG001|NOT COMPLETED|Treatment and Response Assessment Period||0||
48408659|NCT03285490|101331828|FG000|STARTED|Recurrence Follow-up Period||22|Number of participants who achieved 100% AK clearance at Day 57 visit had entered the recurrence follow-up period.|
48408660|NCT03285490|101331829|FG001|STARTED|Recurrence Follow-up Period||97|Number of participants who achieved 100% AK clearance at Day 57 visit had entered the recurrence follow-up period.|
48408661|NCT03285490|101331828|FG000|COMPLETED|Recurrence Follow-up Period||4||
48742055|NCT03742973|102154988|FG000|NOT COMPLETED|Overall Study||0||
48742056|NCT03742973|102154989|FG001|NOT COMPLETED|Overall Study||0||
48742057|NCT04662359|102154990|FG000|STARTED|Overall Study||18||
48742058|NCT04662359|102154990|FG000|COMPLETED|Overall Study||18||
48742059|NCT04662359|102154990|FG000|NOT COMPLETED|Overall Study||0||
48324709|NCT02982954|101121324|FG003|NOT COMPLETED|Overall Study||25||
48324710|NCT01391000|101121325|FG000|STARTED|Overall Study||35||
48618259|NCT04786691|101852866|FG003|STARTED|First Intervention (2 Hours)||4||
48618260|NCT04786691|101852867|FG004|STARTED|First Intervention (2 Hours)||3||
48742060|NCT01200368|102154991|FG000|STARTED|Infant Series||183||
48742061|NCT01200368|102154992|FG001|STARTED|Infant Series||184||
48742062|NCT01200368|102154993|FG002|STARTED|Infant Series||184||
48742063|NCT01200368|102154991|FG000|Vaccinated Dose 1|Infant Series||183||
48742064|NCT01200368|102154992|FG001|Vaccinated Dose 1|Infant Series||183||
48742065|NCT01200368|102154993|FG002|Vaccinated Dose 1|Infant Series||183||
48742066|NCT01200368|102154991|FG000|Vaccinated Dose 2|Infant Series||183||
48742067|NCT01200368|102154992|FG001|Vaccinated Dose 2|Infant Series||182||
48742068|NCT01200368|102154993|FG002|Vaccinated Dose 2|Infant Series||183||
48742069|NCT01200368|102154991|FG000|Vaccinated Dose 3|Infant Series||181||
48742070|NCT01200368|102154992|FG001|Vaccinated Dose 3|Infant Series||178||
48742071|NCT01200368|102154993|FG002|Vaccinated Dose 3|Infant Series||182||
48742072|NCT01200368|102154991|FG000|COMPLETED|Infant Series||180||
48742073|NCT01200368|102154992|FG001|COMPLETED|Infant Series||178||
48742074|NCT01200368|102154993|FG002|COMPLETED|Infant Series||178||
48742075|NCT01200368|102154991|FG000|NOT COMPLETED|Infant Series||3||
48742076|NCT01200368|102154992|FG001|NOT COMPLETED|Infant Series||6||
48742077|NCT01200368|102154993|FG002|NOT COMPLETED|Infant Series||6||
48742078|NCT01200368|102154991|FG000|STARTED|After Infant Series||180||
48742079|NCT01200368|102154992|FG001|STARTED|After Infant Series||178||
48742080|NCT01200368|102154993|FG002|STARTED|After Infant Series||178||
48742081|NCT01200368|102154991|FG000|COMPLETED|After Infant Series||162||
48742082|NCT01200368|102154992|FG001|COMPLETED|After Infant Series||162||
48742083|NCT01200368|102154993|FG002|COMPLETED|After Infant Series||169||
48742084|NCT01200368|102154991|FG000|NOT COMPLETED|After Infant Series||18||
48742085|NCT01200368|102154992|FG001|NOT COMPLETED|After Infant Series||16||
48742086|NCT01200368|102154993|FG002|NOT COMPLETED|After Infant Series||9||
48742087|NCT01200368|102154991|FG000|STARTED|Toddler Dose||162||
48742088|NCT01200368|102154992|FG001|STARTED|Toddler Dose||162||
48742089|NCT01200368|102154993|FG002|STARTED|Toddler Dose||169||
48742090|NCT01200368|102154991|FG000|COMPLETED|Toddler Dose||162||
48742091|NCT01200368|102154992|FG001|COMPLETED|Toddler Dose||159||
48742092|NCT01200368|102154993|FG002|COMPLETED|Toddler Dose||168||
48742093|NCT01200368|102154991|FG000|NOT COMPLETED|Toddler Dose||0||
48742094|NCT01200368|102154992|FG001|NOT COMPLETED|Toddler Dose||3||
48408662|NCT03285490|101331829|FG001|COMPLETED|Recurrence Follow-up Period||36||
48408663|NCT03285490|101331828|FG000|NOT COMPLETED|Recurrence Follow-up Period||18||
48408664|NCT03285490|101331829|FG001|NOT COMPLETED|Recurrence Follow-up Period||61||
48408665|NCT03502941|101331830|FG000|STARTED|Overall Study||3||
48408666|NCT03502941|101331831|FG001|STARTED|Overall Study||5||
48408667|NCT03502941|101331832|FG002|STARTED|Overall Study||8||
48408668|NCT03502941|101331830|FG000|COMPLETED|Overall Study||3||
48408669|NCT03502941|101331831|FG001|COMPLETED|Overall Study||5||
48408670|NCT03502941|101331832|FG002|COMPLETED|Overall Study||8||
48408671|NCT03502941|101331830|FG000|NOT COMPLETED|Overall Study||0||
48408672|NCT03502941|101331831|FG001|NOT COMPLETED|Overall Study||0||
48408673|NCT03502941|101331832|FG002|NOT COMPLETED|Overall Study||0||
48408674|NCT01611662|101331833|FG000|STARTED|Overall Study||32||
48408675|NCT01611662|101331833|FG000|COMPLETED|Overall Study||31||
48408676|NCT01611662|101331833|FG000|NOT COMPLETED|Overall Study||1||
48408677|NCT02332798|101331834|FG000|STARTED|Overall Study||13||
48408678|NCT02332798|101331835|FG001|STARTED|Overall Study||14||
48408679|NCT02332798|101331836|FG002|STARTED|Overall Study||12||
48408680|NCT02332798|101331834|FG000|COMPLETED|Overall Study||12||
48408681|NCT02332798|101331835|FG001|COMPLETED|Overall Study||12||
48408682|NCT02332798|101331836|FG002|COMPLETED|Overall Study||11||
48408683|NCT02332798|101331834|FG000|NOT COMPLETED|Overall Study||1||
48408684|NCT02332798|101331835|FG001|NOT COMPLETED|Overall Study||2||
48408685|NCT02332798|101331836|FG002|NOT COMPLETED|Overall Study||1||
48408686|NCT03277794|101331837|FG000|STARTED|Overall Study||31||
48408687|NCT03277794|101331838|FG001|STARTED|Overall Study||34||
48408688|NCT03277794|101331837|FG000|COMPLETED|Overall Study||28||
48408689|NCT03277794|101331838|FG001|COMPLETED|Overall Study||30||
48408690|NCT03277794|101331837|FG000|NOT COMPLETED|Overall Study||3||
48408691|NCT03277794|101331838|FG001|NOT COMPLETED|Overall Study||4||
48408692|NCT02718625|101331839|FG000|STARTED|Overall Study||1||
48408693|NCT02718625|101331840|FG001|STARTED|Overall Study||2||
48408694|NCT02718625|101331839|FG000|COMPLETED|Overall Study||1||
48408695|NCT02718625|101331840|FG001|COMPLETED|Overall Study||0||
48408696|NCT02718625|101331839|FG000|NOT COMPLETED|Overall Study||0||
48408697|NCT02718625|101331840|FG001|NOT COMPLETED|Overall Study||2||
48408698|NCT04432376|101331841|FG000|STARTED|Double-blind Treatment Period||89||
48408699|NCT04432376|101331842|FG001|STARTED|Double-blind Treatment Period||90||
48408700|NCT04432376|101331843|FG002|STARTED|Double-blind Treatment Period||0||
48408701|NCT04432376|101331841|FG000|COMPLETED|Double-blind Treatment Period||84||
48408702|NCT04432376|101331842|FG001|COMPLETED|Double-blind Treatment Period||79||
48408703|NCT04432376|101331843|FG002|COMPLETED|Double-blind Treatment Period||0||
48742095|NCT01200368|102154993|FG002|NOT COMPLETED|Toddler Dose||1||
48742096|NCT03386721|102154994|FG000|STARTED|Overall Study||26||
48742097|NCT03386721|102154995|FG001|STARTED|Overall Study||32||
48742098|NCT03386721|102154996|FG002|STARTED|Overall Study||3||
48742099|NCT03386721|102154997|FG003|STARTED|Overall Study||5||
48742100|NCT03386721|102154998|FG004|STARTED|Overall Study||2||
48742101|NCT03386721|102154999|FG005|STARTED|Overall Study||22||
48742102|NCT03386721|102155000|FG006|STARTED|Overall Study||3||
48742103|NCT03386721|102155001|FG007|STARTED|Overall Study||2||
48618261|NCT04786691|101852868|FG005|STARTED|First Intervention (2 Hours)||4||
48618262|NCT04786691|101852863|FG000|COMPLETED|First Intervention (2 Hours)||2||
48618263|NCT04786691|101852864|FG001|COMPLETED|First Intervention (2 Hours)||3||
48618264|NCT04786691|101852865|FG002|COMPLETED|First Intervention (2 Hours)||2||
48618265|NCT04786691|101852866|FG003|COMPLETED|First Intervention (2 Hours)||4||
48162345|NCT03145766|100718952|FG001|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||81||
48162346|NCT03145766|100718953|FG002|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||80||
48162347|NCT03145766|100718954|FG003|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||39||
48162348|NCT03145766|100718955|FG004|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||39||
48162349|NCT03145766|100718951|FG000|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||78||
48162350|NCT03145766|100718952|FG001|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||79||
48162351|NCT03145766|100718953|FG002|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||80||
48162352|NCT03145766|100718954|FG003|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||39||
48162353|NCT03145766|100718955|FG004|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||38||
48162354|NCT03145766|100718951|FG000|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||78||
48162355|NCT03145766|100718952|FG001|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||79||
48162356|NCT03145766|100718953|FG002|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||80||
48162357|NCT03145766|100718954|FG003|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||38||
48162358|NCT03145766|100718955|FG004|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||38||
48162359|NCT03145766|100718951|FG000|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||75||
48162360|NCT03145766|100718952|FG001|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||78||
48618266|NCT04786691|101852867|FG004|COMPLETED|First Intervention (2 Hours)||3||
48618267|NCT04786691|101852868|FG005|COMPLETED|First Intervention (2 Hours)||4||
48162361|NCT03145766|100718953|FG002|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||79||
48162362|NCT03145766|100718954|FG003|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||34||
48162363|NCT03145766|100718955|FG004|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||37||
48162364|NCT03145766|100718951|FG000|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||74||
48188755|NCT01902901|100783328|FG000|NOT COMPLETED|Overall Study||0||
48618268|NCT04786691|101852863|FG000|NOT COMPLETED|First Intervention (2 Hours)||0||
48618269|NCT04786691|101852864|FG001|NOT COMPLETED|First Intervention (2 Hours)||0||
48618270|NCT04786691|101852865|FG002|NOT COMPLETED|First Intervention (2 Hours)||0||
48618271|NCT04786691|101852866|FG003|NOT COMPLETED|First Intervention (2 Hours)||0||
48618272|NCT04786691|101852867|FG004|NOT COMPLETED|First Intervention (2 Hours)||0||
48618273|NCT04786691|101852868|FG005|NOT COMPLETED|First Intervention (2 Hours)||0||
48618274|NCT04786691|101852863|FG000|STARTED|Washout Period (2 Days)||2||
48618275|NCT04786691|101852864|FG001|STARTED|Washout Period (2 Days)||3||
48618276|NCT04786691|101852865|FG002|STARTED|Washout Period (2 Days)||2||
48618277|NCT04786691|101852866|FG003|STARTED|Washout Period (2 Days)||4||
48618278|NCT04786691|101852867|FG004|STARTED|Washout Period (2 Days)||3||
48618279|NCT04786691|101852868|FG005|STARTED|Washout Period (2 Days)||4||
48618280|NCT04786691|101852863|FG000|COMPLETED|Washout Period (2 Days)||2||
48618281|NCT04786691|101852864|FG001|COMPLETED|Washout Period (2 Days)||3||
48618282|NCT04786691|101852865|FG002|COMPLETED|Washout Period (2 Days)||2||
48618283|NCT04786691|101852866|FG003|COMPLETED|Washout Period (2 Days)||4||
48618284|NCT04786691|101852867|FG004|COMPLETED|Washout Period (2 Days)||3||
48618285|NCT04786691|101852868|FG005|COMPLETED|Washout Period (2 Days)||4||
48618286|NCT04786691|101852863|FG000|NOT COMPLETED|Washout Period (2 Days)||0||
48618287|NCT04786691|101852864|FG001|NOT COMPLETED|Washout Period (2 Days)||0||
48618288|NCT04786691|101852865|FG002|NOT COMPLETED|Washout Period (2 Days)||0||
48618289|NCT04786691|101852866|FG003|NOT COMPLETED|Washout Period (2 Days)||0||
48618290|NCT04786691|101852867|FG004|NOT COMPLETED|Washout Period (2 Days)||0||
48618291|NCT04786691|101852868|FG005|NOT COMPLETED|Washout Period (2 Days)||0||
48618292|NCT04786691|101852863|FG000|STARTED|Second Intervention (2 Hours)||2||
48742104|NCT03386721|102155002|FG008|STARTED|Overall Study||23||
48742105|NCT03386721|102155003|FG009|STARTED|Overall Study||30||
48742106|NCT03386721|102155004|FG010|STARTED|Overall Study||33||
48742107|NCT03386721|102155005|FG011|STARTED|Overall Study||47||
48742108|NCT03386721|102155006|FG012|STARTED|Overall Study||25||
48742109|NCT03386721|102155007|FG013|STARTED|Overall Study||2||
48742110|NCT03386721|102155008|FG014|STARTED|Overall Study||1||
48742111|NCT03386721|102154994|FG000|Response Evaluable Population|Overall Study||26|Response evaluable population included all participants in the safety population who received at least one dose of simlukafusp alfa/atezolizumab and who had at least one baseline and one on-study tumor assessment.|
48742112|NCT03386721|102154995|FG001|Response Evaluable Population|Overall Study||32|Response evaluable population included all participants in the safety population who received at least one dose of simlukafusp alfa/atezolizumab and who had at least one baseline and one on-study tumor assessment.|
48162365|NCT03145766|100718952|FG001|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||77||
48162366|NCT03145766|100718953|FG002|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||78||
48162367|NCT03145766|100718954|FG003|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||33||
48162368|NCT03145766|100718955|FG004|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||37||
48618293|NCT04786691|101852864|FG001|STARTED|Second Intervention (2 Hours)||3||
48618294|NCT04786691|101852865|FG002|STARTED|Second Intervention (2 Hours)||2||
48618295|NCT04786691|101852866|FG003|STARTED|Second Intervention (2 Hours)||4||
48618296|NCT04786691|101852867|FG004|STARTED|Second Intervention (2 Hours)||3||
48618297|NCT04786691|101852868|FG005|STARTED|Second Intervention (2 Hours)||4||
48618298|NCT04786691|101852863|FG000|COMPLETED|Second Intervention (2 Hours)||2||
48618299|NCT04786691|101852864|FG001|COMPLETED|Second Intervention (2 Hours)||3||
48618300|NCT04786691|101852865|FG002|COMPLETED|Second Intervention (2 Hours)||2||
48618301|NCT04786691|101852866|FG003|COMPLETED|Second Intervention (2 Hours)||4||
48618302|NCT04786691|101852867|FG004|COMPLETED|Second Intervention (2 Hours)||3||
48618303|NCT04786691|101852868|FG005|COMPLETED|Second Intervention (2 Hours)||4||
48618304|NCT04786691|101852863|FG000|NOT COMPLETED|Second Intervention (2 Hours)||0||
48618305|NCT04786691|101852864|FG001|NOT COMPLETED|Second Intervention (2 Hours)||0||
48618306|NCT04786691|101852865|FG002|NOT COMPLETED|Second Intervention (2 Hours)||0||
48618307|NCT04786691|101852866|FG003|NOT COMPLETED|Second Intervention (2 Hours)||0||
48618308|NCT04786691|101852867|FG004|NOT COMPLETED|Second Intervention (2 Hours)||0||
48618309|NCT04786691|101852868|FG005|NOT COMPLETED|Second Intervention (2 Hours)||0||
48618310|NCT04786691|101852863|FG000|STARTED|Washout Period (2 Days)||2||
48618311|NCT04786691|101852864|FG001|STARTED|Washout Period (2 Days)||3||
48618312|NCT04786691|101852865|FG002|STARTED|Washout Period (2 Days)||2||
48618313|NCT04786691|101852866|FG003|STARTED|Washout Period (2 Days)||4||
48618314|NCT04786691|101852867|FG004|STARTED|Washout Period (2 Days)||3||
48618315|NCT04786691|101852868|FG005|STARTED|Washout Period (2 Days)||4||
48618316|NCT04786691|101852863|FG000|COMPLETED|Washout Period (2 Days)||2||
48618317|NCT04786691|101852864|FG001|COMPLETED|Washout Period (2 Days)||3||
48618318|NCT04786691|101852865|FG002|COMPLETED|Washout Period (2 Days)||2||
48618319|NCT04786691|101852866|FG003|COMPLETED|Washout Period (2 Days)||4||
48618320|NCT04786691|101852867|FG004|COMPLETED|Washout Period (2 Days)||3||
48618321|NCT04786691|101852868|FG005|COMPLETED|Washout Period (2 Days)||4||
48162369|NCT03145766|100718951|FG000|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||6||
48618322|NCT04786691|101852863|FG000|NOT COMPLETED|Washout Period (2 Days)||0||
48618323|NCT04786691|101852864|FG001|NOT COMPLETED|Washout Period (2 Days)||0||
48618324|NCT04786691|101852865|FG002|NOT COMPLETED|Washout Period (2 Days)||0||
48657098|NCT03648372|101943775|FG018|NOT COMPLETED|Overall Study||0||
48162370|NCT03145766|100718952|FG001|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||3||
48618325|NCT04786691|101852866|FG003|NOT COMPLETED|Washout Period (2 Days)||0||
48618326|NCT04786691|101852867|FG004|NOT COMPLETED|Washout Period (2 Days)||0||
48618327|NCT04786691|101852868|FG005|NOT COMPLETED|Washout Period (2 Days)||0||
48618328|NCT04786691|101852863|FG000|STARTED|Third Intervention (2 Hours)||2||
48618329|NCT04786691|101852864|FG001|STARTED|Third Intervention (2 Hours)||3||
48618330|NCT04786691|101852865|FG002|STARTED|Third Intervention (2 Hours)||2||
48618331|NCT04786691|101852866|FG003|STARTED|Third Intervention (2 Hours)||4||
48618332|NCT04786691|101852867|FG004|STARTED|Third Intervention (2 Hours)||3||
48618333|NCT04786691|101852868|FG005|STARTED|Third Intervention (2 Hours)||4||
48618334|NCT04786691|101852863|FG000|COMPLETED|Third Intervention (2 Hours)||2||
48618335|NCT04786691|101852864|FG001|COMPLETED|Third Intervention (2 Hours)||3||
48618336|NCT04786691|101852865|FG002|COMPLETED|Third Intervention (2 Hours)||2||
48618337|NCT04786691|101852866|FG003|COMPLETED|Third Intervention (2 Hours)||4||
48618338|NCT04786691|101852867|FG004|COMPLETED|Third Intervention (2 Hours)||3||
48618339|NCT04786691|101852868|FG005|COMPLETED|Third Intervention (2 Hours)||4||
48618340|NCT04786691|101852863|FG000|NOT COMPLETED|Third Intervention (2 Hours)||0||
48618341|NCT04786691|101852864|FG001|NOT COMPLETED|Third Intervention (2 Hours)||0||
48618342|NCT04786691|101852865|FG002|NOT COMPLETED|Third Intervention (2 Hours)||0||
48618343|NCT04786691|101852866|FG003|NOT COMPLETED|Third Intervention (2 Hours)||0||
48618344|NCT04786691|101852867|FG004|NOT COMPLETED|Third Intervention (2 Hours)||0||
48618345|NCT04786691|101852868|FG005|NOT COMPLETED|Third Intervention (2 Hours)||0||
48618346|NCT00956839|101852869|FG000|STARTED|Overall Study||14||
48618347|NCT00956839|101852870|FG001|STARTED|Overall Study||13||
48618348|NCT00956839|101852871|FG002|STARTED|Overall Study||13||
48618349|NCT00956839|101852869|FG000|COMPLETED|Overall Study||11||
48618350|NCT00956839|101852870|FG001|COMPLETED|Overall Study||13||
48618351|NCT00956839|101852871|FG002|COMPLETED|Overall Study||10||
48618352|NCT00956839|101852869|FG000|NOT COMPLETED|Overall Study||3||
48618353|NCT00956839|101852870|FG001|NOT COMPLETED|Overall Study||0||
48618354|NCT00956839|101852871|FG002|NOT COMPLETED|Overall Study||3||
48618355|NCT02408198|101852872|FG000|STARTED|Overall Study||13||
48618356|NCT02408198|101852873|FG001|STARTED|Overall Study||5||
48618357|NCT02408198|101852872|FG000|COMPLETED|Overall Study||10||
48618358|NCT02408198|101852873|FG001|COMPLETED|Overall Study||5||
48618359|NCT02408198|101852872|FG000|NOT COMPLETED|Overall Study||3||
48618360|NCT02408198|101852873|FG001|NOT COMPLETED|Overall Study||0||
48618361|NCT03225287|101852874|FG000|STARTED|Overall Study||10||
48618362|NCT03225287|101852875|FG001|STARTED|Overall Study||6||
48618363|NCT03225287|101852876|FG002|STARTED|Overall Study||3||
48618364|NCT03225287|101852874|FG000|COMPLETED|Overall Study||0||
48618365|NCT03225287|101852875|FG001|COMPLETED|Overall Study||0||
48618366|NCT03225287|101852876|FG002|COMPLETED|Overall Study||0||
48618367|NCT03225287|101852874|FG000|NOT COMPLETED|Overall Study||10||
48618368|NCT03225287|101852875|FG001|NOT COMPLETED|Overall Study||6||
48618369|NCT03225287|101852876|FG002|NOT COMPLETED|Overall Study||3||
48162371|NCT03145766|100718953|FG002|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||2||
48162372|NCT03145766|100718954|FG003|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||7||
48618370|NCT01921517|101852877|FG000|STARTED|Overall Study||42||
48618371|NCT01921517|101852878|FG001|STARTED|Overall Study||38||
48618372|NCT01921517|101852877|FG000|COMPLETED|Overall Study||27||
48618373|NCT01921517|101852878|FG001|COMPLETED|Overall Study||29||
48618374|NCT01921517|101852877|FG000|NOT COMPLETED|Overall Study||15||
48618375|NCT01921517|101852878|FG001|NOT COMPLETED|Overall Study||9||
48618376|NCT01419314|101852879|FG000|STARTED|Start of Study||23||
48618377|NCT01419314|101852880|FG001|STARTED|Start of Study||22||
48618378|NCT01419314|101852879|FG000|COMPLETED|Start of Study||23||
48618379|NCT01419314|101852880|FG001|COMPLETED|Start of Study||22||
48618380|NCT01419314|101852879|FG000|NOT COMPLETED|Start of Study||0||
48618381|NCT01419314|101852880|FG001|NOT COMPLETED|Start of Study||0||
48618382|NCT01419314|101852879|FG000|STARTED|Follow-up at Week 3 of the Trial||23||
48618383|NCT01419314|101852880|FG001|STARTED|Follow-up at Week 3 of the Trial||22||
48618384|NCT01419314|101852879|FG000|COMPLETED|Follow-up at Week 3 of the Trial||17||
48618385|NCT01419314|101852880|FG001|COMPLETED|Follow-up at Week 3 of the Trial||21||
48618386|NCT01419314|101852879|FG000|NOT COMPLETED|Follow-up at Week 3 of the Trial||6||
48618387|NCT01419314|101852880|FG001|NOT COMPLETED|Follow-up at Week 3 of the Trial||1||
48618388|NCT01419314|101852879|FG000|STARTED|Follow-up at Week 6 of the Trial||17||
48618389|NCT01419314|101852880|FG001|STARTED|Follow-up at Week 6 of the Trial||21||
48618390|NCT01419314|101852879|FG000|COMPLETED|Follow-up at Week 6 of the Trial||16||
48324711|NCT01391000|101121326|FG001|STARTED|Overall Study||35||
48324712|NCT01391000|101121325|FG000|COMPLETED|Overall Study||33||
48324713|NCT01391000|101121326|FG001|COMPLETED|Overall Study||35||
48324714|NCT01391000|101121325|FG000|NOT COMPLETED|Overall Study||2||
48324715|NCT01391000|101121326|FG001|NOT COMPLETED|Overall Study||0||
48324716|NCT02549209|101121327|FG000|STARTED|Overall Study||46||
48324717|NCT02549209|101121327|FG000|COMPLETED|Overall Study||46||
48324718|NCT02549209|101121327|FG000|NOT COMPLETED|Overall Study||0||
48324719|NCT03670953|101121328|FG000|STARTED|Dose Adjustment (Weeks 1- 3)||630||
48618391|NCT01419314|101852880|FG001|COMPLETED|Follow-up at Week 6 of the Trial||19||
48618392|NCT01419314|101852879|FG000|NOT COMPLETED|Follow-up at Week 6 of the Trial||1||
48618393|NCT01419314|101852880|FG001|NOT COMPLETED|Follow-up at Week 6 of the Trial||2||
48618394|NCT01101750|101852881|FG000|STARTED|Overall Study||25||
48618395|NCT01101750|101852881|FG000|COMPLETED|Overall Study||9||
48618396|NCT01101750|101852881|FG000|NOT COMPLETED|Overall Study||16||
48618397|NCT00411450|101852882|FG000|STARTED|Overall Study||116||
48618398|NCT00411450|101852882|FG000|Received Treatment|Overall Study||115||
48618399|NCT00411450|101852882|FG000|COMPLETED|Overall Study||113||
48618400|NCT00411450|101852882|FG000|NOT COMPLETED|Overall Study||3||
48618401|NCT01059773|101852883|FG000|STARTED|Overall Study||244||
48324720|NCT03670953|101121329|FG001|STARTED|Dose Adjustment (Weeks 1- 3)||0||
48324721|NCT03670953|101121330|FG002|STARTED|Dose Adjustment (Weeks 1- 3)||0||
48324722|NCT03670953|101121331|FG003|STARTED|Dose Adjustment (Weeks 1- 3)||0||
48324723|NCT03670953|101121328|FG000|COMPLETED|Dose Adjustment (Weeks 1- 3)||589||
48324724|NCT03670953|101121329|FG001|COMPLETED|Dose Adjustment (Weeks 1- 3)||0||
48324725|NCT03670953|101121330|FG002|COMPLETED|Dose Adjustment (Weeks 1- 3)||0||
48324726|NCT03670953|101121331|FG003|COMPLETED|Dose Adjustment (Weeks 1- 3)||0||
48324727|NCT03670953|101121328|FG000|NOT COMPLETED|Dose Adjustment (Weeks 1- 3)||41||
48324728|NCT03670953|101121329|FG001|NOT COMPLETED|Dose Adjustment (Weeks 1- 3)||0||
48324729|NCT03670953|101121330|FG002|NOT COMPLETED|Dose Adjustment (Weeks 1- 3)||0||
48324730|NCT03670953|101121331|FG003|NOT COMPLETED|Dose Adjustment (Weeks 1- 3)||0||
48324731|NCT03670953|101121328|FG000|STARTED|Dose Conversion (Weeks 4 - 7)||0||
48324732|NCT03670953|101121329|FG001|STARTED|Dose Conversion (Weeks 4 - 7)||589||
48618402|NCT01059773|101852884|FG001|STARTED|Overall Study||245||
48618403|NCT01059773|101852883|FG000|COMPLETED|Overall Study||224||
48618404|NCT01059773|101852884|FG001|COMPLETED|Overall Study||221||
48618405|NCT01059773|101852883|FG000|NOT COMPLETED|Overall Study||20||
48618406|NCT01059773|101852884|FG001|NOT COMPLETED|Overall Study||24||
48618407|NCT01514383|101852885|FG000|STARTED|Overall Study||34||
48618408|NCT01514383|101852885|FG000|COMPLETED|Overall Study||34||
48618409|NCT01514383|101852885|FG000|NOT COMPLETED|Overall Study||0||
48618410|NCT02021292|101852886|FG000|STARTED|Overall Study||40||
48618411|NCT02021292|101852887|FG001|STARTED|Overall Study||40||
48618412|NCT02021292|101852886|FG000|COMPLETED|Overall Study||40||
48618413|NCT02021292|101852887|FG001|COMPLETED|Overall Study||37||
48618414|NCT02021292|101852886|FG000|NOT COMPLETED|Overall Study||0||
48618415|NCT02021292|101852887|FG001|NOT COMPLETED|Overall Study||3||
48618416|NCT01912950|101852888|FG000|STARTED|Overall Study||11||22
48618417|NCT01912950|101852888|FG000|Treated Areas on the Forearm|Overall Study||11||11
48618418|NCT01912950|101852888|FG000|Untreated Areas on the Forearm|Overall Study||11||11
48618419|NCT01912950|101852888|FG000|COMPLETED|Overall Study||7||14
48618420|NCT01912950|101852888|FG000|NOT COMPLETED|Overall Study||4||8
48618421|NCT00715559|101852889|FG000|STARTED|Overall Study||3||
48618422|NCT00715559|101852889|FG000|COMPLETED|Overall Study||2||
48618423|NCT00715559|101852889|FG000|NOT COMPLETED|Overall Study||1||
48618424|NCT01441973|101852890|FG000|STARTED|Overall Study||15||
48618425|NCT01441973|101852891|FG001|STARTED|Overall Study||16||
48618426|NCT01441973|101852890|FG000|COMPLETED|Overall Study||0||
48618427|NCT01441973|101852891|FG001|COMPLETED|Overall Study||0||
48618428|NCT01441973|101852890|FG000|NOT COMPLETED|Overall Study||15||
48618429|NCT01441973|101852891|FG001|NOT COMPLETED|Overall Study||16||
48618430|NCT00459810|101852892|FG000|STARTED|Overall Study||21||
48618431|NCT00459810|101852892|FG000|COMPLETED|Overall Study||21||
48324733|NCT03670953|101121330|FG002|STARTED|Dose Conversion (Weeks 4 - 7)||0||
48618432|NCT00459810|101852892|FG000|NOT COMPLETED|Overall Study||0||
48618433|NCT00965237|101852893|FG000|STARTED|Period 1, One Week of Wear||8||
48324734|NCT03670953|101121331|FG003|STARTED|Dose Conversion (Weeks 4 - 7)||0||
48324735|NCT03670953|101121328|FG000|COMPLETED|Dose Conversion (Weeks 4 - 7)||0||
48324736|NCT03670953|101121329|FG001|COMPLETED|Dose Conversion (Weeks 4 - 7)||506||
48324737|NCT03670953|101121330|FG002|COMPLETED|Dose Conversion (Weeks 4 - 7)||0||
48618434|NCT00965237|101852894|FG001|STARTED|Period 1, One Week of Wear||8||
48618435|NCT00965237|101852893|FG000|COMPLETED|Period 1, One Week of Wear||8||
48618436|NCT00965237|101852894|FG001|COMPLETED|Period 1, One Week of Wear||8||
48618437|NCT00965237|101852893|FG000|NOT COMPLETED|Period 1, One Week of Wear||0||
48618438|NCT00965237|101852894|FG001|NOT COMPLETED|Period 1, One Week of Wear||0||
48324738|NCT03670953|101121331|FG003|COMPLETED|Dose Conversion (Weeks 4 - 7)||0||
48324739|NCT03670953|101121328|FG000|NOT COMPLETED|Dose Conversion (Weeks 4 - 7)||0||
48324740|NCT03670953|101121329|FG001|NOT COMPLETED|Dose Conversion (Weeks 4 - 7)||83||
48618439|NCT00965237|101852893|FG000|STARTED|Period 2, One Week of Wear||8||
48618440|NCT00965237|101852894|FG001|STARTED|Period 2, One Week of Wear||8||
48618441|NCT00965237|101852893|FG000|COMPLETED|Period 2, One Week of Wear||8||
48618442|NCT00965237|101852894|FG001|COMPLETED|Period 2, One Week of Wear||8||
48618443|NCT00965237|101852893|FG000|NOT COMPLETED|Period 2, One Week of Wear||0||
48618444|NCT00965237|101852894|FG001|NOT COMPLETED|Period 2, One Week of Wear||0||
48618445|NCT02329327|101852895|FG000|STARTED|Overall Study||477||
48618446|NCT02329327|101852896|FG001|STARTED|Overall Study||2||
48618447|NCT02329327|101852895|FG000|Received At Least 1 Dose of Study Drug|Overall Study||477|Safety Population|
48618448|NCT02329327|101852896|FG001|Received At Least 1 Dose of Study Drug|Overall Study||2|Safety Population|
48618449|NCT02329327|101852895|FG000|Efficacy Population|Overall Study||347|All participants who received at least 1 dose of study drug and who met protocol-specified criteria for bleeding and anti-factor Xa (fXa) levels.|
48618450|NCT02329327|101852896|FG001|Efficacy Population|Overall Study||2|All participants who received at least 1 dose of study drug and who met protocol-specified criteria for bleeding and anti-factor Xa (fXa) levels.|
48618451|NCT02329327|101852895|FG000|Death|Overall Study||3|These deaths occurred during the follow-up period.|
48618452|NCT02329327|101852896|FG001|Death|Overall Study||0|These deaths occurred during the follow-up period.|
48618453|NCT02329327|101852895|FG000|COMPLETED|Overall Study||392||
48618454|NCT02329327|101852896|FG001|COMPLETED|Overall Study||2||
48618455|NCT02329327|101852895|FG000|NOT COMPLETED|Overall Study||85||
48618456|NCT02329327|101852896|FG001|NOT COMPLETED|Overall Study||0||
48162373|NCT03145766|100718955|FG004|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||3||
48162374|NCT03145766|100718951|FG000|STARTED|Follow-up Phase (Day 56 Till Month 7)||74||
48618457|NCT04194489|101852897|FG000|STARTED|Overall Study||105||
48618458|NCT04194489|101852897|FG000|Completed Some or All Baseline Surveys|Overall Study||85||
48618459|NCT04194489|101852897|FG000|Installed FMF Connect App|Overall Study||67||
48618460|NCT04194489|101852897|FG000|Completed Some or All Follow-up Surveys|Overall Study||52||
48618461|NCT04194489|101852897|FG000|COMPLETED|Overall Study||52||
48618462|NCT04194489|101852897|FG000|NOT COMPLETED|Overall Study||53||
48618463|NCT02097823|101852898|FG000|STARTED|Overall Study||11||
48618464|NCT02097823|101852899|FG001|STARTED|Overall Study||4||
48618465|NCT02097823|101852898|FG000|COMPLETED|Overall Study||10||
48618466|NCT02097823|101852899|FG001|COMPLETED|Overall Study||3||
48618467|NCT02097823|101852898|FG000|NOT COMPLETED|Overall Study||1||
48618468|NCT02097823|101852899|FG001|NOT COMPLETED|Overall Study||1||
48618469|NCT01246895|101852900|FG000|STARTED|Overall Study||37||
48618470|NCT01246895|101852901|FG001|STARTED|Overall Study||30||
48618471|NCT01246895|101852900|FG000|COMPLETED|Overall Study||34||
48618472|NCT01246895|101852901|FG001|COMPLETED|Overall Study||26||
48618473|NCT01246895|101852900|FG000|NOT COMPLETED|Overall Study||3||
48618474|NCT01246895|101852901|FG001|NOT COMPLETED|Overall Study||4||
48618475|NCT02039778|101852902|FG000|STARTED|Overall Study||4||
48618476|NCT02039778|101852902|FG000|COMPLETED|Overall Study||0||
48618477|NCT02039778|101852902|FG000|NOT COMPLETED|Overall Study||4||
48618478|NCT00078286|101852903|FG000|STARTED|Overall Study||234||
48618479|NCT00078286|101852904|FG001|STARTED|Overall Study||235||
48618480|NCT00078286|101852903|FG000|COMPLETED|Overall Study||138||
48618481|NCT00078286|101852904|FG001|COMPLETED|Overall Study||152||
48618482|NCT00078286|101852903|FG000|NOT COMPLETED|Overall Study||96||
48618483|NCT00078286|101852904|FG001|NOT COMPLETED|Overall Study||83||
48618484|NCT00936455|101852905|FG000|STARTED|Overall Study||37||
48618485|NCT00936455|101852906|FG001|STARTED|Overall Study||38||
48618486|NCT00936455|101852905|FG000|COMPLETED|Overall Study||37||
48618487|NCT00936455|101852906|FG001|COMPLETED|Overall Study||38||
48618488|NCT00936455|101852905|FG000|NOT COMPLETED|Overall Study||0||
48618489|NCT00936455|101852906|FG001|NOT COMPLETED|Overall Study||0||
48618490|NCT00610168|101852907|FG000|STARTED|Overall Study||75||
48618491|NCT00610168|101852908|FG001|STARTED|Overall Study||7||
48618492|NCT00610168|101852907|FG000|COMPLETED|Overall Study||73||
48618493|NCT00610168|101852908|FG001|COMPLETED|Overall Study||7||
48618494|NCT00610168|101852907|FG000|NOT COMPLETED|Overall Study||2||
48618495|NCT00610168|101852908|FG001|NOT COMPLETED|Overall Study||0||
48618496|NCT01839916|101852909|FG000|STARTED|Overall Study||77||
48618497|NCT01839916|101852909|FG000|COMPLETED|Overall Study||36||
48162375|NCT03145766|100718952|FG001|STARTED|Follow-up Phase (Day 56 Till Month 7)||77||
48618498|NCT01839916|101852909|FG000|NOT COMPLETED|Overall Study||41||
48618499|NCT02078193|101852910|FG000|STARTED|Overall Study||3||
48162376|NCT03145766|100718953|FG002|STARTED|Follow-up Phase (Day 56 Till Month 7)||78||
48162377|NCT03145766|100718954|FG003|STARTED|Follow-up Phase (Day 56 Till Month 7)||33||
48162378|NCT03145766|100718955|FG004|STARTED|Follow-up Phase (Day 56 Till Month 7)||37||
48162379|NCT03145766|100718951|FG000|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||67||
48162380|NCT03145766|100718952|FG001|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||75||
48324741|NCT03670953|101121330|FG002|NOT COMPLETED|Dose Conversion (Weeks 4 - 7)||0||
48324742|NCT03670953|101121331|FG003|NOT COMPLETED|Dose Conversion (Weeks 4 - 7)||0||
48324743|NCT03670953|101121328|FG000|STARTED|Double Blind Maintenance (Weeks 8 - 20)||0||
48324744|NCT03670953|101121329|FG001|STARTED|Double Blind Maintenance (Weeks 8 - 20)||0||
48324745|NCT03670953|101121330|FG002|STARTED|Double Blind Maintenance (Weeks 8 - 20)||256||
48324746|NCT03670953|101121331|FG003|STARTED|Double Blind Maintenance (Weeks 8 - 20)||250||
48324747|NCT03670953|101121328|FG000|COMPLETED|Double Blind Maintenance (Weeks 8 - 20)||0||
48324748|NCT03670953|101121329|FG001|COMPLETED|Double Blind Maintenance (Weeks 8 - 20)||0||
48324749|NCT03670953|101121330|FG002|COMPLETED|Double Blind Maintenance (Weeks 8 - 20)||222||
48618500|NCT02078193|101852910|FG000|COMPLETED|Overall Study||3||
48618501|NCT02078193|101852910|FG000|NOT COMPLETED|Overall Study||0||
48618502|NCT04780815|101852911|FG000|STARTED|Overall Study||6||
48618503|NCT04780815|101852912|FG001|STARTED|Overall Study||5||
48618504|NCT04780815|101852913|FG002|STARTED|Overall Study||3||
48618505|NCT04780815|101852914|FG003|STARTED|Overall Study||2||
48618506|NCT04780815|101852911|FG000|COMPLETED|Overall Study||6||
48618507|NCT04780815|101852912|FG001|COMPLETED|Overall Study||5||
48618508|NCT04780815|101852913|FG002|COMPLETED|Overall Study||3||
48618509|NCT04780815|101852914|FG003|COMPLETED|Overall Study||1||
48618510|NCT04780815|101852911|FG000|NOT COMPLETED|Overall Study||0||
48618511|NCT04780815|101852912|FG001|NOT COMPLETED|Overall Study||0||
48618512|NCT04780815|101852913|FG002|NOT COMPLETED|Overall Study||0||
48618513|NCT04780815|101852914|FG003|NOT COMPLETED|Overall Study||1||
48618514|NCT00492726|101852915|FG000|STARTED|Overall Study||410||
48618515|NCT00492726|101852916|FG001|STARTED|Overall Study||394||
48618516|NCT00492726|101852915|FG000|End of Treatment (EOT, Day 5 to 14)|Overall Study||387||
48618517|NCT00492726|101852916|FG001|End of Treatment (EOT, Day 5 to 14)|Overall Study||377||
48618518|NCT00492726|101852915|FG000|End of Study|Overall Study||360||
48618519|NCT00492726|101852916|FG001|End of Study|Overall Study||358||
48618520|NCT00492726|101852915|FG000|COMPLETED|Overall Study||360||
48618521|NCT00492726|101852916|FG001|COMPLETED|Overall Study||358||
48324750|NCT03670953|101121331|FG003|COMPLETED|Double Blind Maintenance (Weeks 8 - 20)||227||
48324751|NCT03670953|101121328|FG000|NOT COMPLETED|Double Blind Maintenance (Weeks 8 - 20)||0||
48324752|NCT03670953|101121329|FG001|NOT COMPLETED|Double Blind Maintenance (Weeks 8 - 20)||0||
48324753|NCT03670953|101121330|FG002|NOT COMPLETED|Double Blind Maintenance (Weeks 8 - 20)||34||
48324754|NCT03670953|101121331|FG003|NOT COMPLETED|Double Blind Maintenance (Weeks 8 - 20)||23||
48324755|NCT00135668|101121332|FG000|STARTED|Overall Study - Randomized to be Dosed||51||
48408704|NCT04432376|101331841|FG000|NOT COMPLETED|Double-blind Treatment Period||5||
48408705|NCT04432376|101331842|FG001|NOT COMPLETED|Double-blind Treatment Period||11||
48408706|NCT04432376|101331843|FG002|NOT COMPLETED|Double-blind Treatment Period||0||
48408707|NCT04432376|101331841|FG000|STARTED|Enrollment B, Open Label Safety Group.||0||
48408708|NCT04432376|101331842|FG001|STARTED|Enrollment B, Open Label Safety Group.||0||
48408709|NCT04432376|101331843|FG002|STARTED|Enrollment B, Open Label Safety Group.||203||
48408710|NCT04432376|101331841|FG000|COMPLETED|Enrollment B, Open Label Safety Group.||0||
48408711|NCT04432376|101331842|FG001|COMPLETED|Enrollment B, Open Label Safety Group.||0||
48408712|NCT04432376|101331843|FG002|COMPLETED|Enrollment B, Open Label Safety Group.||203||
48408713|NCT04432376|101331841|FG000|NOT COMPLETED|Enrollment B, Open Label Safety Group.||0||
48408714|NCT04432376|101331842|FG001|NOT COMPLETED|Enrollment B, Open Label Safety Group.||0||
48408715|NCT04432376|101331843|FG002|NOT COMPLETED|Enrollment B, Open Label Safety Group.||0||
48408716|NCT02797470|101331844|FG000|STARTED|Overall Study||5||
48408717|NCT02797470|101331845|FG001|STARTED|Overall Study||4||
48618522|NCT00492726|101852915|FG000|NOT COMPLETED|Overall Study||50||
48162381|NCT03145766|100718953|FG002|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||73||
48162382|NCT03145766|100718954|FG003|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||30||
48162383|NCT03145766|100718955|FG004|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||34||
48162384|NCT03145766|100718951|FG000|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||7||
48324756|NCT00135668|101121333|FG001|STARTED|Overall Study - Randomized to be Dosed||49||
48324757|NCT00135668|101121334|FG002|STARTED|Overall Study - Randomized to be Dosed||55||
48618523|NCT00492726|101852916|FG001|NOT COMPLETED|Overall Study||36||
48162385|NCT03145766|100718952|FG001|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||2||
48162386|NCT03145766|100718953|FG002|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||5||
48618524|NCT01687218|101852917|FG000|STARTED|Overall Study||33||
48618525|NCT01687218|101852918|FG001|STARTED|Overall Study||32||
48162387|NCT03145766|100718954|FG003|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||3||
48162388|NCT03145766|100718955|FG004|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||3||
48162389|NCT00985985|100718956|FG000|STARTED|Overall Study||241||
48618526|NCT01687218|101852919|FG002|STARTED|Overall Study||31||
48618527|NCT01687218|101852920|FG003|STARTED|Overall Study||34||
48618528|NCT01687218|101852921|FG004|STARTED|Overall Study||33||
48618529|NCT01687218|101852922|FG005|STARTED|Overall Study||32||
48408718|NCT02797470|101331846|FG002|STARTED|Overall Study||2||
48408719|NCT02797470|101331844|FG000|COMPLETED|Overall Study||5||
48618530|NCT01687218|101852917|FG000|COMPLETED|Overall Study||30||
48618531|NCT01687218|101852918|FG001|COMPLETED|Overall Study||29||
48618532|NCT01687218|101852919|FG002|COMPLETED|Overall Study||30||
48324758|NCT00135668|101121335|FG003|STARTED|Overall Study - Randomized to be Dosed||51||
48324759|NCT00135668|101121332|FG000|COMPLETED|Overall Study - Randomized to be Dosed||50||
48324760|NCT00135668|101121333|FG001|COMPLETED|Overall Study - Randomized to be Dosed||49||
48324761|NCT00135668|101121334|FG002|COMPLETED|Overall Study - Randomized to be Dosed||53||
48324762|NCT00135668|101121335|FG003|COMPLETED|Overall Study - Randomized to be Dosed||51||
48324763|NCT00135668|101121332|FG000|NOT COMPLETED|Overall Study - Randomized to be Dosed||1||
48324764|NCT00135668|101121333|FG001|NOT COMPLETED|Overall Study - Randomized to be Dosed||0||
48324765|NCT00135668|101121334|FG002|NOT COMPLETED|Overall Study - Randomized to be Dosed||2||
48324766|NCT00135668|101121335|FG003|NOT COMPLETED|Overall Study - Randomized to be Dosed||0||
48324767|NCT00135668|101121332|FG000|STARTED|Blinded Treatment Phase-Randomized/Dosed||50||
48324768|NCT00135668|101121333|FG001|STARTED|Blinded Treatment Phase-Randomized/Dosed||49||
48324769|NCT00135668|101121334|FG002|STARTED|Blinded Treatment Phase-Randomized/Dosed||53||
48324770|NCT00135668|101121335|FG003|STARTED|Blinded Treatment Phase-Randomized/Dosed||51||
48324771|NCT00135668|101121332|FG000|COMPLETED|Blinded Treatment Phase-Randomized/Dosed||38||
48324772|NCT00135668|101121333|FG001|COMPLETED|Blinded Treatment Phase-Randomized/Dosed||23||
48324773|NCT00135668|101121334|FG002|COMPLETED|Blinded Treatment Phase-Randomized/Dosed||13||
48324774|NCT00135668|101121335|FG003|COMPLETED|Blinded Treatment Phase-Randomized/Dosed||18||
48324775|NCT00135668|101121332|FG000|NOT COMPLETED|Blinded Treatment Phase-Randomized/Dosed||12||
48324776|NCT00135668|101121333|FG001|NOT COMPLETED|Blinded Treatment Phase-Randomized/Dosed||26||
48324777|NCT00135668|101121334|FG002|NOT COMPLETED|Blinded Treatment Phase-Randomized/Dosed||40||
48618533|NCT01687218|101852920|FG003|COMPLETED|Overall Study||32||
48618534|NCT01687218|101852921|FG004|COMPLETED|Overall Study||32||
48618535|NCT01687218|101852922|FG005|COMPLETED|Overall Study||32||
48742113|NCT03386721|102154996|FG002|Response Evaluable Population|Overall Study||3|Response evaluable population included all participants in the safety population who received at least one dose of simlukafusp alfa/atezolizumab and who had at least one baseline and one on-study tumor assessment.|
48742114|NCT03386721|102154997|FG003|Response Evaluable Population|Overall Study||5|Response evaluable population included all participants in the safety population who received at least one dose of simlukafusp alfa/atezolizumab and who had at least one baseline and one on-study tumor assessment.|
48742115|NCT03386721|102154998|FG004|Response Evaluable Population|Overall Study||0|Response evaluable population included all participants in the safety population who received at least one dose of simlukafusp alfa/atezolizumab and who had at least one baseline and one on-study tumor assessment.|
48742116|NCT03386721|102154999|FG005|Response Evaluable Population|Overall Study||21|Response evaluable population included all participants in the safety population who received at least one dose of simlukafusp alfa/atezolizumab and who had at least one baseline and one on-study tumor assessment.|
48767633|NCT01929317|102222786|FG001|STARTED|Dose Increase Effect Verification Phase||20||
48618536|NCT01687218|101852917|FG000|NOT COMPLETED|Overall Study||3||
48618537|NCT01687218|101852918|FG001|NOT COMPLETED|Overall Study||3||
48618538|NCT01687218|101852919|FG002|NOT COMPLETED|Overall Study||1||
48618539|NCT01687218|101852920|FG003|NOT COMPLETED|Overall Study||2||
48618540|NCT01687218|101852921|FG004|NOT COMPLETED|Overall Study||1||
48618541|NCT01687218|101852922|FG005|NOT COMPLETED|Overall Study||0||
48618542|NCT02667301|101852923|FG000|STARTED|Overall Study||16||
48618543|NCT02667301|101852923|FG000|COMPLETED|Overall Study||14||
48618544|NCT02667301|101852923|FG000|NOT COMPLETED|Overall Study||2||
48618545|NCT03459625|101852924|FG000|STARTED|Overall Study||60||
48618546|NCT03459625|101852925|FG001|STARTED|Overall Study||58||
48618547|NCT03459625|101852924|FG000|COMPLETED|Overall Study||59||
48324778|NCT00135668|101121335|FG003|NOT COMPLETED|Blinded Treatment Phase-Randomized/Dosed||33||
48324779|NCT02192827|101121336|FG000|STARTED|Overall Study||154||
48408720|NCT02797470|101331845|FG001|COMPLETED|Overall Study||4||
48618548|NCT03459625|101852925|FG001|COMPLETED|Overall Study||58||
48618549|NCT03459625|101852924|FG000|NOT COMPLETED|Overall Study||1||
48618550|NCT03459625|101852925|FG001|NOT COMPLETED|Overall Study||0||
48618551|NCT01835912|101852926|FG000|STARTED|Overall Study||10||
48618552|NCT01835912|101852926|FG000|Acute|Overall Study||10||
48618553|NCT01835912|101852926|FG000|Acute Placebo|Overall Study||10||
48618554|NCT01835912|101852926|FG000|Chronic|Overall Study||10||
48618555|NCT01835912|101852926|FG000|Chronic Placebo|Overall Study||10||
48618556|NCT01835912|101852926|FG000|COMPLETED|Overall Study||10||
48618557|NCT01835912|101852926|FG000|NOT COMPLETED|Overall Study||0||
48618558|NCT03471832|101852927|FG000|STARTED|Overall Study||40||40
48618559|NCT03471832|101852928|FG001|STARTED|Overall Study||40||40
48408721|NCT02797470|101331846|FG002|COMPLETED|Overall Study||2||
48618560|NCT03471832|101852927|FG000|COMPLETED|Overall Study||40||40
48618561|NCT03471832|101852928|FG001|COMPLETED|Overall Study||40||40
48618562|NCT03471832|101852927|FG000|NOT COMPLETED|Overall Study||0||0
48618563|NCT03471832|101852928|FG001|NOT COMPLETED|Overall Study||0||0
48618564|NCT01525966|101852929|FG000|STARTED|Overall Study||67||
48618565|NCT01525966|101852929|FG000|COMPLETED|Overall Study||67||
48324780|NCT02192827|101121337|FG001|STARTED|Overall Study||154||
48324781|NCT02192827|101121336|FG000|COMPLETED|Overall Study||116||
48324782|NCT02192827|101121337|FG001|COMPLETED|Overall Study||116||
48324783|NCT02192827|101121336|FG000|NOT COMPLETED|Overall Study||38||
48324784|NCT02192827|101121337|FG001|NOT COMPLETED|Overall Study||38||
48324785|NCT03921021|101121338|FG000|STARTED|Overall Study||17||
48618566|NCT01525966|101852929|FG000|NOT COMPLETED|Overall Study||0||
48618567|NCT01190813|101852930|FG000|STARTED|Overall Study||90||
48618568|NCT01190813|101852931|FG001|STARTED|Overall Study||49||
48618569|NCT01190813|101852930|FG000|2-week Phone Call|Overall Study||87||
48324786|NCT03921021|101121338|FG000|COMPLETED|Overall Study||1||
48324787|NCT03921021|101121338|FG000|NOT COMPLETED|Overall Study||16||
48324788|NCT00858858|101121339|FG000|STARTED|Overall Study||60||
48324789|NCT00858858|101121339|FG000|COMPLETED|Overall Study||42||
48324790|NCT00858858|101121339|FG000|NOT COMPLETED|Overall Study||18||
48324791|NCT04042103|101121340|FG000|STARTED|Overall Study||21||
48324792|NCT04042103|101121340|FG000|COMPLETED|Overall Study||19||
48324793|NCT04042103|101121340|FG000|NOT COMPLETED|Overall Study||2||
48324794|NCT02182687|101121341|FG000|STARTED|Overall Study||24||
48324795|NCT02182687|101121342|FG001|STARTED|Overall Study||30||
48324796|NCT02182687|101121341|FG000|COMPLETED|Overall Study||19||
48324797|NCT02182687|101121342|FG001|COMPLETED|Overall Study||29||
48324798|NCT02182687|101121341|FG000|NOT COMPLETED|Overall Study||5||
48324799|NCT02182687|101121342|FG001|NOT COMPLETED|Overall Study||1||
48324800|NCT02429414|101121343|FG000|STARTED|Overall Study||42||
48324801|NCT02429414|101121344|FG001|STARTED|Overall Study||38||
48324802|NCT02429414|101121343|FG000|COMPLETED|Overall Study||42||
48324803|NCT02429414|101121344|FG001|COMPLETED|Overall Study||37||
48324804|NCT02429414|101121343|FG000|NOT COMPLETED|Overall Study||0||
48324805|NCT02429414|101121344|FG001|NOT COMPLETED|Overall Study||1||
48324806|NCT01534533|101121345|FG000|STARTED|Overall Study||48||
48324807|NCT01534533|101121346|FG001|STARTED|Overall Study||48||
48324808|NCT01534533|101121347|FG002|STARTED|Overall Study||48||
48324809|NCT01534533|101121348|FG003|STARTED|Overall Study||48||
48324810|NCT01534533|101121345|FG000|COMPLETED|Overall Study||40||
48324811|NCT01534533|101121346|FG001|COMPLETED|Overall Study||45||
48324812|NCT01534533|101121347|FG002|COMPLETED|Overall Study||40||
48324813|NCT01534533|101121348|FG003|COMPLETED|Overall Study||44||
48324814|NCT01534533|101121345|FG000|NOT COMPLETED|Overall Study||8||
48324815|NCT01534533|101121346|FG001|NOT COMPLETED|Overall Study||3||
48324816|NCT01534533|101121347|FG002|NOT COMPLETED|Overall Study||8||
48324817|NCT01534533|101121348|FG003|NOT COMPLETED|Overall Study||4||
48324818|NCT02128230|101121349|FG000|STARTED|Overall Study||20||
48324819|NCT02128230|101121349|FG000|COMPLETED|Overall Study||1||
48618570|NCT01190813|101852931|FG001|2-week Phone Call|Overall Study||48||
48324820|NCT02128230|101121349|FG000|NOT COMPLETED|Overall Study||19||
48324821|NCT00730639|101121350|FG000|STARTED|Overall Study||17||
48324822|NCT00730639|101121351|FG001|STARTED|Overall Study||18||
48324823|NCT00730639|101121352|FG002|STARTED|Overall Study||86||
48324824|NCT00730639|101121353|FG003|STARTED|Overall Study||54||
48324825|NCT00730639|101121354|FG004|STARTED|Overall Study||131||
48324826|NCT00730639|101121350|FG000|COMPLETED|Overall Study||0||
48324827|NCT00730639|101121351|FG001|COMPLETED|Overall Study||0||
48324828|NCT00730639|101121352|FG002|COMPLETED|Overall Study||0||
48324829|NCT00730639|101121353|FG003|COMPLETED|Overall Study||0||
48324830|NCT00730639|101121354|FG004|COMPLETED|Overall Study||0||
48324831|NCT00730639|101121350|FG000|NOT COMPLETED|Overall Study||17||
48324832|NCT00730639|101121351|FG001|NOT COMPLETED|Overall Study||18||
48324833|NCT00730639|101121352|FG002|NOT COMPLETED|Overall Study||86||
48324834|NCT00730639|101121353|FG003|NOT COMPLETED|Overall Study||54||
48324835|NCT00730639|101121354|FG004|NOT COMPLETED|Overall Study||131||
48324836|NCT02264990|101121355|FG000|STARTED|Overall Study||297||
48324837|NCT02264990|101121356|FG001|STARTED|Overall Study||298||
48324838|NCT02264990|101121355|FG000|Received Treatment|Overall Study||288||
48324839|NCT02264990|101121356|FG001|Received Treatment|Overall Study||293||
48324840|NCT02264990|101121355|FG000|Received Maintenance Therapy|Overall Study||148||
48324841|NCT02264990|101121356|FG001|Received Maintenance Therapy|Overall Study||123||
48618571|NCT01190813|101852930|FG000|4-week Visit|Overall Study||88||
48618572|NCT01190813|101852931|FG001|4-week Visit|Overall Study||47||
48618573|NCT01190813|101852930|FG000|7-week Phone Call|Overall Study||85||
48618574|NCT01190813|101852931|FG001|7-week Phone Call|Overall Study||46||
48618575|NCT01190813|101852930|FG000|10-week Visit|Overall Study||88||
48767634|NCT01929317|102222785|FG000|COMPLETED|Dose Increase Effect Verification Phase||52||
48324842|NCT02264990|101121355|FG000|COMPLETED|Overall Study||37||
48324843|NCT02264990|101121356|FG001|COMPLETED|Overall Study||39||
48324844|NCT02264990|101121355|FG000|NOT COMPLETED|Overall Study||260||
48324845|NCT02264990|101121356|FG001|NOT COMPLETED|Overall Study||259||
48324846|NCT04817111|101121357|FG000|STARTED|Overall Study||7||
48324847|NCT04817111|101121357|FG000|COMPLETED|Overall Study||7||
48324848|NCT04817111|101121357|FG000|NOT COMPLETED|Overall Study||0||
48324849|NCT01290692|101121358|FG000|STARTED|Overall Study||14||
48324850|NCT01290692|101121358|FG000|COMPLETED|Overall Study||7||
48324851|NCT01290692|101121358|FG000|NOT COMPLETED|Overall Study||7||
48324852|NCT02919436|101121359|FG000|STARTED|Overall Study||305||
48324853|NCT02919436|101121360|FG001|STARTED|Overall Study||305||
48324854|NCT02919436|101121359|FG000|COMPLETED|Overall Study||245||
48324855|NCT02919436|101121360|FG001|COMPLETED|Overall Study||252||
48324856|NCT02919436|101121359|FG000|NOT COMPLETED|Overall Study||60||
48324857|NCT02919436|101121360|FG001|NOT COMPLETED|Overall Study||53||
48324858|NCT01391507|101121361|FG000|STARTED|Overall Study||10||
48324859|NCT01391507|101121362|FG001|STARTED|Overall Study||8||
48324860|NCT01391507|101121363|FG002|STARTED|Overall Study||6||
48324861|NCT01391507|101121364|FG003|STARTED|Overall Study||12||
48324862|NCT01391507|101121361|FG000|COMPLETED|Overall Study||6||
48324863|NCT01391507|101121362|FG001|COMPLETED|Overall Study||4||
48324864|NCT01391507|101121363|FG002|COMPLETED|Overall Study||2||
48324865|NCT01391507|101121364|FG003|COMPLETED|Overall Study||5||
48324866|NCT01391507|101121361|FG000|NOT COMPLETED|Overall Study||4||
48324867|NCT01391507|101121362|FG001|NOT COMPLETED|Overall Study||4||
48324868|NCT01391507|101121363|FG002|NOT COMPLETED|Overall Study||4||
48324869|NCT01391507|101121364|FG003|NOT COMPLETED|Overall Study||7||
48324870|NCT03571646|101121365|FG000|STARTED|Overall Study||3||
48324871|NCT03571646|101121366|FG001|STARTED|Overall Study||3||
48324872|NCT03571646|101121365|FG000|COMPLETED|Overall Study||1||
48324873|NCT03571646|101121366|FG001|COMPLETED|Overall Study||2||
48618576|NCT01190813|101852931|FG001|10-week Visit|Overall Study||48||
48618577|NCT01190813|101852930|FG000|13-week Phone Call|Overall Study||82||
48618578|NCT01190813|101852931|FG001|13-week Phone Call|Overall Study||48||
48618579|NCT01190813|101852930|FG000|16-week Visit|Overall Study||87||
48618580|NCT01190813|101852931|FG001|16-week Visit|Overall Study||46||
48618581|NCT01190813|101852930|FG000|18-week Visit (Masked Primary)|Overall Study||87||
48618582|NCT01190813|101852931|FG001|18-week Visit (Masked Primary)|Overall Study||45||
48324874|NCT03571646|101121365|FG000|NOT COMPLETED|Overall Study||2||
48324875|NCT03571646|101121366|FG001|NOT COMPLETED|Overall Study||1||
48324876|NCT00916357|101121367|FG000|STARTED|Period 1||4||
48324877|NCT00916357|101121368|FG001|STARTED|Period 1||4||
48324878|NCT00916357|101121369|FG002|STARTED|Period 1||4||
48324879|NCT00916357|101121370|FG003|STARTED|Period 1||4||
48324880|NCT00916357|101121371|FG004|STARTED|Period 1||3||
48324881|NCT00916357|101121372|FG005|STARTED|Period 1||4||
48324882|NCT00916357|101121367|FG000|Received at Least 1 Dose of Study Drug|Period 1||4||
48324883|NCT00916357|101121368|FG001|Received at Least 1 Dose of Study Drug|Period 1||4||
48324884|NCT00916357|101121369|FG002|Received at Least 1 Dose of Study Drug|Period 1||4||
48324885|NCT00916357|101121370|FG003|Received at Least 1 Dose of Study Drug|Period 1||4||
48324886|NCT00916357|101121371|FG004|Received at Least 1 Dose of Study Drug|Period 1||3||
48324887|NCT00916357|101121372|FG005|Received at Least 1 Dose of Study Drug|Period 1||4||
48324888|NCT00916357|101121367|FG000|COMPLETED|Period 1||3||
48324889|NCT00916357|101121368|FG001|COMPLETED|Period 1||4||
48324890|NCT00916357|101121369|FG002|COMPLETED|Period 1||4||
48324891|NCT00916357|101121370|FG003|COMPLETED|Period 1||4||
48324892|NCT00916357|101121371|FG004|COMPLETED|Period 1||3||
48324893|NCT00916357|101121372|FG005|COMPLETED|Period 1||4||
48324894|NCT00916357|101121367|FG000|NOT COMPLETED|Period 1||1||
48324895|NCT00916357|101121368|FG001|NOT COMPLETED|Period 1||0||
48324896|NCT00916357|101121369|FG002|NOT COMPLETED|Period 1||0||
48324897|NCT00916357|101121370|FG003|NOT COMPLETED|Period 1||0||
48618583|NCT01190813|101852930|FG000|23-week Phone Call|Overall Study||82||
48618584|NCT01190813|101852931|FG001|23-week Phone Call|Overall Study||41||
48618585|NCT01190813|101852930|FG000|26-week Visit|Overall Study||86||
48618586|NCT01190813|101852931|FG001|26-week Visit|Overall Study||45||
48618587|NCT01190813|101852930|FG000|COMPLETED|Overall Study||86||
48618588|NCT01190813|101852931|FG001|COMPLETED|Overall Study||45||
48618589|NCT01190813|101852930|FG000|NOT COMPLETED|Overall Study||4||
48324898|NCT00916357|101121371|FG004|NOT COMPLETED|Period 1||0||
48324899|NCT00916357|101121372|FG005|NOT COMPLETED|Period 1||0||
48324900|NCT00916357|101121367|FG000|STARTED|Washout (3 to 14 Days)||3||
48324901|NCT00916357|101121368|FG001|STARTED|Washout (3 to 14 Days)||4||
48324902|NCT00916357|101121369|FG002|STARTED|Washout (3 to 14 Days)||4||
48324903|NCT00916357|101121370|FG003|STARTED|Washout (3 to 14 Days)||4||
48324904|NCT00916357|101121371|FG004|STARTED|Washout (3 to 14 Days)||3||
48324905|NCT00916357|101121372|FG005|STARTED|Washout (3 to 14 Days)||4||
48324906|NCT00916357|101121367|FG000|COMPLETED|Washout (3 to 14 Days)||3||
48324907|NCT00916357|101121368|FG001|COMPLETED|Washout (3 to 14 Days)||4||
48324908|NCT00916357|101121369|FG002|COMPLETED|Washout (3 to 14 Days)||4||
48324909|NCT00916357|101121370|FG003|COMPLETED|Washout (3 to 14 Days)||4||
48324910|NCT00916357|101121371|FG004|COMPLETED|Washout (3 to 14 Days)||3||
48324911|NCT00916357|101121372|FG005|COMPLETED|Washout (3 to 14 Days)||4||
48324912|NCT00916357|101121367|FG000|NOT COMPLETED|Washout (3 to 14 Days)||0||
48618590|NCT01190813|101852931|FG001|NOT COMPLETED|Overall Study||4||
48618591|NCT03118518|101852932|FG000|STARTED|Overall Study||108||
48324913|NCT00916357|101121368|FG001|NOT COMPLETED|Washout (3 to 14 Days)||0||
48324914|NCT00916357|101121369|FG002|NOT COMPLETED|Washout (3 to 14 Days)||0||
48324915|NCT00916357|101121370|FG003|NOT COMPLETED|Washout (3 to 14 Days)||0||
48324916|NCT00916357|101121371|FG004|NOT COMPLETED|Washout (3 to 14 Days)||0||
48324917|NCT00916357|101121372|FG005|NOT COMPLETED|Washout (3 to 14 Days)||0||
48324918|NCT00916357|101121367|FG000|STARTED|Period 2||3||
48324919|NCT00916357|101121368|FG001|STARTED|Period 2||4||
48408722|NCT02797470|101331844|FG000|NOT COMPLETED|Overall Study||0||
48408723|NCT02797470|101331845|FG001|NOT COMPLETED|Overall Study||0||
48408724|NCT02797470|101331846|FG002|NOT COMPLETED|Overall Study||0||
48408725|NCT00324272|101331847|FG000|STARTED|Overall Study||18||
48618592|NCT03118518|101852933|FG001|STARTED|Overall Study||102||
48618593|NCT03118518|101852932|FG000|Subject Treated According to Randomization Assignment|Overall Study||104||
48408726|NCT00324272|101331848|FG001|STARTED|Overall Study||20||
48408727|NCT00324272|101331849|FG002|STARTED|Overall Study||18||
48408728|NCT00324272|101331850|FG003|STARTED|Overall Study||18||
48408729|NCT00324272|101331847|FG000|COMPLETED|Overall Study||18||
48408730|NCT00324272|101331848|FG001|COMPLETED|Overall Study||20||
48408731|NCT00324272|101331849|FG002|COMPLETED|Overall Study||18||
48408732|NCT00324272|101331850|FG003|COMPLETED|Overall Study||18||
48408733|NCT00324272|101331847|FG000|NOT COMPLETED|Overall Study||0||
48408734|NCT00324272|101331848|FG001|NOT COMPLETED|Overall Study||0||
48408735|NCT00324272|101331849|FG002|NOT COMPLETED|Overall Study||0||
48408736|NCT00324272|101331850|FG003|NOT COMPLETED|Overall Study||0||
48408737|NCT00002981|101331851|FG000|STARTED|Overall Study||173||
48408738|NCT00002981|101331851|FG000|COMPLETED|Overall Study||167||
48408739|NCT00002981|101331851|FG000|NOT COMPLETED|Overall Study||6||
48408740|NCT00729560|101331852|FG000|STARTED|Overall Study||8||
48618594|NCT03118518|101852933|FG001|Subject Treated According to Randomization Assignment|Overall Study||99||
48618595|NCT03118518|101852932|FG000|COMPLETED|Overall Study||102||
48618596|NCT03118518|101852933|FG001|COMPLETED|Overall Study||91||
48408741|NCT00729560|101331852|FG000|COMPLETED|Overall Study||5||
48618597|NCT03118518|101852932|FG000|NOT COMPLETED|Overall Study||6||
48618598|NCT03118518|101852933|FG001|NOT COMPLETED|Overall Study||11||
48618599|NCT03188055|101852934|FG000|STARTED|Overall Study||48||0
48618600|NCT03188055|101852935|FG001|STARTED|Overall Study||48||0
48408742|NCT00729560|101331852|FG000|NOT COMPLETED|Overall Study||3||
48408743|NCT01366534|101331853|FG000|STARTED|Overall Study||28||
48408744|NCT01366534|101331854|FG001|STARTED|Overall Study||27||
48408745|NCT01366534|101331855|FG002|STARTED|Overall Study||12||
48408746|NCT01366534|101331853|FG000|COMPLETED|Overall Study||26||
48408747|NCT01366534|101331854|FG001|COMPLETED|Overall Study||25||
48618601|NCT03188055|101852936|FG002|STARTED|Overall Study||62||0
48618602|NCT03188055|101852937|FG003|STARTED|Overall Study||38||0
48618603|NCT03188055|101852938|FG004|STARTED|Overall Study||59||0
48618604|NCT03188055|101852939|FG005|STARTED|Overall Study||0||233
48618605|NCT03188055|101852934|FG000|Patients Who Provided Self-Consent|Overall Study||0|These participants count toward the total number of participants who 'started' the study.|0
48618606|NCT03188055|101852935|FG001|Patients Who Provided Self-Consent|Overall Study||24|These participants count toward the total number of participants who 'started' the study.|0
48618607|NCT03188055|101852936|FG002|Patients Who Provided Self-Consent|Overall Study||0|These participants count toward the total number of participants who 'started' the study.|0
48408748|NCT01366534|101331855|FG002|COMPLETED|Overall Study||12||
48408749|NCT01366534|101331853|FG000|NOT COMPLETED|Overall Study||2||
48657099|NCT03648372|101943776|FG019|NOT COMPLETED|Overall Study||1||
48408750|NCT01366534|101331854|FG001|NOT COMPLETED|Overall Study||2||
48408751|NCT01366534|101331855|FG002|NOT COMPLETED|Overall Study||0||
48408752|NCT03748420|101331856|FG000|STARTED|Overall Study||2676||
48408753|NCT03748420|101331857|FG001|STARTED|Overall Study||2745||
48408754|NCT03748420|101331856|FG000|COMPLETED|Overall Study||2421||
48742117|NCT03386721|102155000|FG006|Response Evaluable Population|Overall Study||3|Response evaluable population included all participants in the safety population who received at least one dose of simlukafusp alfa/atezolizumab and who had at least one baseline and one on-study tumor assessment.|
48408755|NCT03748420|101331857|FG001|COMPLETED|Overall Study||2486||
48408756|NCT03748420|101331856|FG000|NOT COMPLETED|Overall Study||255||
48408757|NCT03748420|101331857|FG001|NOT COMPLETED|Overall Study||259||
48408758|NCT04007367|101331858|FG000|STARTED|Open-Label Phase (8-Weeks)||53||
48408759|NCT04007367|101331859|FG001|STARTED|Open-Label Phase (8-Weeks)||0||
48408760|NCT04007367|101331860|FG002|STARTED|Open-Label Phase (8-Weeks)||0||
48408761|NCT04007367|101331858|FG000|COMPLETED|Open-Label Phase (8-Weeks)||5||
48618608|NCT03188055|101852937|FG003|Patients Who Provided Self-Consent|Overall Study||19|These participants count toward the total number of participants who 'started' the study.|0
48618609|NCT03188055|101852938|FG004|Patients Who Provided Self-Consent|Overall Study||0|These participants count toward the total number of participants who 'started' the study.|0
48618610|NCT03188055|101852939|FG005|Patients Who Provided Self-Consent|Overall Study||0|These participants count toward the total number of participants who 'started' the study.|0
48618611|NCT03188055|101852934|FG000|MDS Pre-Intervention Survey Responses|Overall Study||0||0
48618612|NCT03188055|101852935|FG001|MDS Pre-Intervention Survey Responses|Overall Study||0||0
48618613|NCT03188055|101852936|FG002|MDS Pre-Intervention Survey Responses|Overall Study||0||0
48618614|NCT03188055|101852937|FG003|MDS Pre-Intervention Survey Responses|Overall Study||0||0
48618615|NCT03188055|101852938|FG004|MDS Pre-Intervention Survey Responses|Overall Study||0||0
48618616|NCT03188055|101852939|FG005|MDS Pre-Intervention Survey Responses|Overall Study||99||99
48618617|NCT03188055|101852934|FG000|MDS Post-Intervention Survey Responses|Overall Study||0||0
48742118|NCT03386721|102155001|FG007|Response Evaluable Population|Overall Study||2|Response evaluable population included all participants in the safety population who received at least one dose of simlukafusp alfa/atezolizumab and who had at least one baseline and one on-study tumor assessment.|
48742119|NCT03386721|102155002|FG008|Response Evaluable Population|Overall Study||22|Response evaluable population included all participants in the safety population who received at least one dose of simlukafusp alfa/atezolizumab and who had at least one baseline and one on-study tumor assessment.|
48742120|NCT03386721|102155003|FG009|Response Evaluable Population|Overall Study||28|Response evaluable population included all participants in the safety population who received at least one dose of simlukafusp alfa/atezolizumab and who had at least one baseline and one on-study tumor assessment.|
48742121|NCT03386721|102155004|FG010|Response Evaluable Population|Overall Study||32|Response evaluable population included all participants in the safety population who received at least one dose of simlukafusp alfa/atezolizumab and who had at least one baseline and one on-study tumor assessment.|
48742122|NCT03386721|102155005|FG011|Response Evaluable Population|Overall Study||44|Response evaluable population included all participants in the safety population who received at least one dose of simlukafusp alfa/atezolizumab and who had at least one baseline and one on-study tumor assessment.|
48742123|NCT03386721|102155006|FG012|Response Evaluable Population|Overall Study||25|Response evaluable population included all participants in the safety population who received at least one dose of simlukafusp alfa/atezolizumab and who had at least one baseline and one on-study tumor assessment.|
48742124|NCT03386721|102155007|FG013|Response Evaluable Population|Overall Study||2|Response evaluable population included all participants in the safety population who received at least one dose of simlukafusp alfa/atezolizumab and who had at least one baseline and one on-study tumor assessment.|
48742125|NCT03386721|102155008|FG014|Response Evaluable Population|Overall Study||1|Response evaluable population included all participants in the safety population who received at least one dose of simlukafusp alfa/atezolizumab and who had at least one baseline and one on-study tumor assessment.|
48742126|NCT03386721|102154994|FG000|COMPLETED|Overall Study||4||
48742127|NCT03386721|102154995|FG001|COMPLETED|Overall Study||1||
48742128|NCT03386721|102154996|FG002|COMPLETED|Overall Study||0||
48742129|NCT03386721|102154997|FG003|COMPLETED|Overall Study||0||
48742130|NCT03386721|102154998|FG004|COMPLETED|Overall Study||0||
48742131|NCT03386721|102154999|FG005|COMPLETED|Overall Study||1||
48742132|NCT03386721|102155000|FG006|COMPLETED|Overall Study||0||
48742133|NCT03386721|102155001|FG007|COMPLETED|Overall Study||0||
48742134|NCT03386721|102155002|FG008|COMPLETED|Overall Study||1||
48742135|NCT03386721|102155003|FG009|COMPLETED|Overall Study||0||
48440029|NCT05378269|101410017|FG002|STARTED|Overall Study||4||
48408762|NCT04007367|101331859|FG001|COMPLETED|Open-Label Phase (8-Weeks)||0||
48408763|NCT04007367|101331860|FG002|COMPLETED|Open-Label Phase (8-Weeks)||0||
48408764|NCT04007367|101331858|FG000|NOT COMPLETED|Open-Label Phase (8-Weeks)||48||
48408765|NCT04007367|101331859|FG001|NOT COMPLETED|Open-Label Phase (8-Weeks)||0||
48408766|NCT04007367|101331860|FG002|NOT COMPLETED|Open-Label Phase (8-Weeks)||0||
48408767|NCT04007367|101331858|FG000|STARTED|Double-Blind Phase (14-Weeks)||0|Of the five participants who completed the OL Phase, only those participants who meet the randomization criteria for the DB Phase entered it.|
48408768|NCT04007367|101331859|FG001|STARTED|Double-Blind Phase (14-Weeks)||0|Of the five participants who completed the OL Phase, only those participants who meet the randomization criteria for the DB Phase entered it.|
48408769|NCT04007367|101331860|FG002|STARTED|Double-Blind Phase (14-Weeks)||2|Of the five participants who completed the OL Phase, only those participants who meet the randomization criteria for the DB Phase entered it.|
48408770|NCT04007367|101331858|FG000|COMPLETED|Double-Blind Phase (14-Weeks)||0||
48408771|NCT04007367|101331859|FG001|COMPLETED|Double-Blind Phase (14-Weeks)||0||
48408772|NCT04007367|101331860|FG002|COMPLETED|Double-Blind Phase (14-Weeks)||0||
48408773|NCT04007367|101331858|FG000|NOT COMPLETED|Double-Blind Phase (14-Weeks)||0||
48408774|NCT04007367|101331859|FG001|NOT COMPLETED|Double-Blind Phase (14-Weeks)||0||
48408775|NCT04007367|101331860|FG002|NOT COMPLETED|Double-Blind Phase (14-Weeks)||2||
48408776|NCT01327573|101331861|FG000|STARTED|Overall Study||11||
48408777|NCT01327573|101331862|FG001|STARTED|Overall Study||5||
48408778|NCT01327573|101331861|FG000|Received Treatment/Control as Allocated|Overall Study||10||
48408779|NCT01327573|101331862|FG001|Received Treatment/Control as Allocated|Overall Study||5||
48408780|NCT01327573|101331861|FG000|COMPLETED|Overall Study||8||
48408781|NCT01327573|101331862|FG001|COMPLETED|Overall Study||4||
48408782|NCT01327573|101331861|FG000|NOT COMPLETED|Overall Study||3||
48408783|NCT01327573|101331862|FG001|NOT COMPLETED|Overall Study||1||
48408784|NCT00118040|101331863|FG000|STARTED|Overall Study||20||
48408785|NCT00118040|101331864|FG001|STARTED|Overall Study||20||
48408786|NCT00118040|101331865|FG002|STARTED|Overall Study||20||
48408787|NCT00118040|101331863|FG000|COMPLETED|Overall Study||19||
48408788|NCT00118040|101331864|FG001|COMPLETED|Overall Study||18||
48408789|NCT00118040|101331865|FG002|COMPLETED|Overall Study||14||
48408790|NCT00118040|101331863|FG000|NOT COMPLETED|Overall Study||1||
48408791|NCT00118040|101331864|FG001|NOT COMPLETED|Overall Study||2||
48408792|NCT00118040|101331865|FG002|NOT COMPLETED|Overall Study||6||
48408793|NCT01251315|101331866|FG000|STARTED|Overall Study||4||
48408794|NCT01251315|101331867|FG001|STARTED|Overall Study||4||
48408795|NCT01251315|101331868|FG002|STARTED|Overall Study||4||
48408796|NCT01251315|101331869|FG003|STARTED|Overall Study||4||
48408797|NCT01251315|101331870|FG004|STARTED|Overall Study||4||
48408798|NCT01251315|101331871|FG005|STARTED|Overall Study||4||
48408799|NCT01251315|101331866|FG000|COMPLETED|Overall Study||4||
48408800|NCT01251315|101331867|FG001|COMPLETED|Overall Study||4||
48408801|NCT01251315|101331868|FG002|COMPLETED|Overall Study||4||
48408802|NCT01251315|101331869|FG003|COMPLETED|Overall Study||4||
48408803|NCT01251315|101331870|FG004|COMPLETED|Overall Study||4||
48408804|NCT01251315|101331871|FG005|COMPLETED|Overall Study||4||
48408805|NCT01251315|101331866|FG000|NOT COMPLETED|Overall Study||0||
48408806|NCT01251315|101331867|FG001|NOT COMPLETED|Overall Study||0||
48408807|NCT01251315|101331868|FG002|NOT COMPLETED|Overall Study||0||
48408808|NCT01251315|101331869|FG003|NOT COMPLETED|Overall Study||0||
48408809|NCT01251315|101331870|FG004|NOT COMPLETED|Overall Study||0||
48408810|NCT01251315|101331871|FG005|NOT COMPLETED|Overall Study||0||
48408811|NCT01466062|101331872|FG000|STARTED|Overall Study||28||
48408812|NCT01466062|101331872|FG000|COMPLETED|Overall Study||26||
48618618|NCT03188055|101852935|FG001|MDS Post-Intervention Survey Responses|Overall Study||0||0
48408813|NCT01466062|101331872|FG000|NOT COMPLETED|Overall Study||2||
48408814|NCT00086385|101331873|FG000|STARTED|Overall Study||100||
48657100|NCT03648372|101943777|FG020|NOT COMPLETED|Overall Study||0||
48408815|NCT00086385|101331874|FG001|STARTED|Overall Study||99||
48408816|NCT00086385|101331875|FG002|STARTED|Overall Study||104||
48408817|NCT00086385|101331876|FG003|STARTED|Overall Study||99||
48408818|NCT00086385|101331873|FG000|COMPLETED|Overall Study||98||
48408819|NCT00086385|101331874|FG001|COMPLETED|Overall Study||97||
48408820|NCT00086385|101331875|FG002|COMPLETED|Overall Study||103||
48408821|NCT00086385|101331876|FG003|COMPLETED|Overall Study||98||
48408822|NCT00086385|101331873|FG000|NOT COMPLETED|Overall Study||2||
48408823|NCT00086385|101331874|FG001|NOT COMPLETED|Overall Study||2||
48408824|NCT00086385|101331875|FG002|NOT COMPLETED|Overall Study||1||
48408825|NCT00086385|101331876|FG003|NOT COMPLETED|Overall Study||1||
48408826|NCT03374891|101331877|FG000|STARTED|Overall Study||346||
48408827|NCT03374891|101331878|FG001|STARTED|Overall Study||444||
48408828|NCT03374891|101331877|FG000|COMPLETED|Overall Study||323||
48408829|NCT03374891|101331878|FG001|COMPLETED|Overall Study||437||
48408830|NCT03374891|101331877|FG000|NOT COMPLETED|Overall Study||23||
48408831|NCT03374891|101331878|FG001|NOT COMPLETED|Overall Study||7||
48408832|NCT01894776|101331879|FG000|STARTED|Overall Study||15||
48408833|NCT01894776|101331879|FG000|COMPLETED|Overall Study||14||
48408834|NCT01894776|101331879|FG000|NOT COMPLETED|Overall Study||1||
48408835|NCT04241120|101331880|FG000|STARTED|Overall Study||10||
48408836|NCT04241120|101331881|FG001|STARTED|Overall Study||5||
48408837|NCT04241120|101331880|FG000|COMPLETED|Overall Study||10||
48408838|NCT04241120|101331881|FG001|COMPLETED|Overall Study||5||
48408839|NCT04241120|101331880|FG000|NOT COMPLETED|Overall Study||0||
48408840|NCT04241120|101331881|FG001|NOT COMPLETED|Overall Study||0||
48408841|NCT01680991|101331882|FG000|STARTED|Overall Study||12||
48408842|NCT01680991|101331883|FG001|STARTED|Overall Study||23||
48408843|NCT01680991|101331884|FG002|STARTED|Overall Study||13||
48408844|NCT01680991|101331882|FG000|COMPLETED|Overall Study||4||
48408845|NCT01680991|101331883|FG001|COMPLETED|Overall Study||4||
48408846|NCT01680991|101331884|FG002|COMPLETED|Overall Study||9||
48408847|NCT01680991|101331882|FG000|NOT COMPLETED|Overall Study||8||
48408848|NCT01680991|101331883|FG001|NOT COMPLETED|Overall Study||19||
48408849|NCT01680991|101331884|FG002|NOT COMPLETED|Overall Study||4||
48408850|NCT00859573|101331885|FG000|STARTED|Overall Study||6||
48408851|NCT00859573|101331886|FG001|STARTED|Overall Study||3||
48408852|NCT00859573|101331885|FG000|COMPLETED|Overall Study||1||
48408853|NCT00859573|101331886|FG001|COMPLETED|Overall Study||1||
48408854|NCT00859573|101331885|FG000|NOT COMPLETED|Overall Study||5||
48408855|NCT00859573|101331886|FG001|NOT COMPLETED|Overall Study||2||
48408856|NCT03634228|101331887|FG000|STARTED|Overall Study||3||
48162390|NCT00985985|100718957|FG001|STARTED|Overall Study||242||
48162391|NCT00985985|100718958|FG002|STARTED|Overall Study||120||
48162392|NCT00985985|100718959|FG003|STARTED|Overall Study||120||
48408857|NCT03634228|101331888|FG001|STARTED|Overall Study||6||
48408858|NCT03634228|101331889|FG002|STARTED|Overall Study||7||
48408859|NCT03634228|101331890|FG003|STARTED|Overall Study||0||
48408860|NCT03634228|101331887|FG000|COMPLETED|Overall Study||3||
48408861|NCT03634228|101331888|FG001|COMPLETED|Overall Study||6||
48408862|NCT03634228|101331889|FG002|COMPLETED|Overall Study||7||
48408863|NCT03634228|101331890|FG003|COMPLETED|Overall Study||0||
48408864|NCT03634228|101331887|FG000|NOT COMPLETED|Overall Study||0||
48408865|NCT03634228|101331888|FG001|NOT COMPLETED|Overall Study||0||
48408866|NCT03634228|101331889|FG002|NOT COMPLETED|Overall Study||0||
48408867|NCT03634228|101331890|FG003|NOT COMPLETED|Overall Study||0||
48408868|NCT03922711|101331891|FG000|STARTED|Overall Study||7||
48408869|NCT03922711|101331892|FG001|STARTED|Overall Study||8||
48408870|NCT03922711|101331893|FG002|STARTED|Overall Study||8||
48408871|NCT03922711|101331891|FG000|Treatment Group Based on Maximal Possible Highest Dose Received (Used for Analysis)|Overall Study||12|A total of 8 patients were randomized to pridopidine 150 mg BID. Of these, 5 patients discontinued study drug during titration, i.e. did not reach the full maintenance dose. Therefore, they were analyzed under the 100 mg BID group. The 100 mg BID group included patients who received any dose between 75 mg QD and 100 mg BID.|
48408872|NCT03922711|101331892|FG001|Treatment Group Based on Maximal Possible Highest Dose Received (Used for Analysis)|Overall Study||3|A total of 8 patients were randomized to pridopidine 150 mg BID. Of these, 5 patients discontinued study drug during titration, i.e. did not reach the full maintenance dose. Therefore, they were analyzed under the 100 mg BID group. The 100 mg BID group included patients who received any dose between 75 mg QD and 100 mg BID.|
48439902|NCT00563706|101409983|FG006|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3||
48439903|NCT00563706|101409984|FG007|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14||
48439904|NCT00563706|101409985|FG008|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11||
48439905|NCT00563706|101409977|FG000|STARTED|Taper Phase (Day 29 up to Day 35)||20||
48439906|NCT00563706|101409978|FG001|STARTED|Taper Phase (Day 29 up to Day 35)||13||
48618619|NCT03188055|101852936|FG002|MDS Post-Intervention Survey Responses|Overall Study||0||0
48618620|NCT03188055|101852937|FG003|MDS Post-Intervention Survey Responses|Overall Study||0||0
48439907|NCT00563706|101409979|FG002|STARTED|Taper Phase (Day 29 up to Day 35)||3||
48618621|NCT03188055|101852938|FG004|MDS Post-Intervention Survey Responses|Overall Study||0||0
48618622|NCT03188055|101852939|FG005|MDS Post-Intervention Survey Responses|Overall Study||134||134
48618623|NCT03188055|101852934|FG000|Patient Survey 1|Overall Study||0||0
48618624|NCT03188055|101852935|FG001|Patient Survey 1|Overall Study||16||0
48618625|NCT03188055|101852936|FG002|Patient Survey 1|Overall Study||0||0
48618626|NCT03188055|101852937|FG003|Patient Survey 1|Overall Study||13||0
48618627|NCT03188055|101852938|FG004|Patient Survey 1|Overall Study||0||0
48618628|NCT03188055|101852939|FG005|Patient Survey 1|Overall Study||0||0
48618629|NCT03188055|101852934|FG000|Nurse Survey 1|Overall Study||0||0
48618630|NCT03188055|101852935|FG001|Nurse Survey 1|Overall Study||32||0
48618631|NCT03188055|101852936|FG002|Nurse Survey 1|Overall Study||0||0
48618632|NCT03188055|101852937|FG003|Nurse Survey 1|Overall Study||27||0
48618633|NCT03188055|101852938|FG004|Nurse Survey 1|Overall Study||0||0
48618634|NCT03188055|101852939|FG005|Nurse Survey 1|Overall Study||0||0
48324920|NCT00916357|101121369|FG002|STARTED|Period 2||4||
48324921|NCT00916357|101121370|FG003|STARTED|Period 2||4||
48324922|NCT00916357|101121371|FG004|STARTED|Period 2||3||
48324923|NCT00916357|101121372|FG005|STARTED|Period 2||4||
48324924|NCT00916357|101121367|FG000|COMPLETED|Period 2||3||
48324925|NCT00916357|101121368|FG001|COMPLETED|Period 2||4||
48324926|NCT00916357|101121369|FG002|COMPLETED|Period 2||4||
48439908|NCT00563706|101409980|FG003|STARTED|Taper Phase (Day 29 up to Day 35)||9||
48618635|NCT03188055|101852934|FG000|Family Survey 1|Overall Study||0||0
48618636|NCT03188055|101852935|FG001|Family Survey 1|Overall Study||37||0
48618637|NCT03188055|101852936|FG002|Family Survey 1|Overall Study||0||0
48618638|NCT03188055|101852937|FG003|Family Survey 1|Overall Study||38||0
48618639|NCT03188055|101852938|FG004|Family Survey 1|Overall Study||0||0
48618640|NCT03188055|101852939|FG005|Family Survey 1|Overall Study||0||0
48618641|NCT03188055|101852934|FG000|Family Survey 2|Overall Study||0||0
48618642|NCT03188055|101852935|FG001|Family Survey 2|Overall Study||34||0
48618643|NCT03188055|101852936|FG002|Family Survey 2|Overall Study||0||0
48618644|NCT03188055|101852937|FG003|Family Survey 2|Overall Study||35||0
48618645|NCT03188055|101852938|FG004|Family Survey 2|Overall Study||0||0
48618646|NCT03188055|101852939|FG005|Family Survey 2|Overall Study||0||0
48618647|NCT03188055|101852934|FG000|Family Survey 3|Overall Study||0||0
48618648|NCT03188055|101852935|FG001|Family Survey 3|Overall Study||29||0
48618649|NCT03188055|101852936|FG002|Family Survey 3|Overall Study||0||0
48618650|NCT03188055|101852937|FG003|Family Survey 3|Overall Study||26||0
48618651|NCT03188055|101852938|FG004|Family Survey 3|Overall Study||0||0
48618652|NCT03188055|101852939|FG005|Family Survey 3|Overall Study||0||0
48618653|NCT03188055|101852934|FG000|COMPLETED|Overall Study||48||0
48618654|NCT03188055|101852935|FG001|COMPLETED|Overall Study||29||0
48618655|NCT03188055|101852936|FG002|COMPLETED|Overall Study||43||0
48618656|NCT03188055|101852937|FG003|COMPLETED|Overall Study||26||0
48618657|NCT03188055|101852938|FG004|COMPLETED|Overall Study||59||0
48618658|NCT03188055|101852939|FG005|COMPLETED|Overall Study||0||233
48618659|NCT03188055|101852934|FG000|NOT COMPLETED|Overall Study||0||0
48618660|NCT03188055|101852935|FG001|NOT COMPLETED|Overall Study||19||0
48618661|NCT03188055|101852936|FG002|NOT COMPLETED|Overall Study||19||0
48618662|NCT03188055|101852937|FG003|NOT COMPLETED|Overall Study||12||0
48618663|NCT03188055|101852938|FG004|NOT COMPLETED|Overall Study||0||0
48618664|NCT03188055|101852939|FG005|NOT COMPLETED|Overall Study||0||0
48618665|NCT01398852|101852940|FG000|STARTED|Overall Study||372||
48618666|NCT01398852|101852940|FG000|COMPLETED|Overall Study||0||
48618667|NCT01398852|101852940|FG000|NOT COMPLETED|Overall Study||372||
48618668|NCT01190085|101852941|FG000|STARTED|Overall Study||13||
48618669|NCT01190085|101852942|FG001|STARTED|Overall Study||14||
48618670|NCT01190085|101852943|FG002|STARTED|Overall Study||18||
48618671|NCT01190085|101852941|FG000|COMPLETED|Overall Study||13||
48618672|NCT01190085|101852942|FG001|COMPLETED|Overall Study||14||
48618673|NCT01190085|101852943|FG002|COMPLETED|Overall Study||18||
48618674|NCT01190085|101852941|FG000|NOT COMPLETED|Overall Study||0||
48618675|NCT01190085|101852942|FG001|NOT COMPLETED|Overall Study||0||
48618676|NCT01190085|101852943|FG002|NOT COMPLETED|Overall Study||0||
48618677|NCT04030598|101852944|FG000|STARTED|Overall Study||6||
48618678|NCT04030598|101852945|FG001|STARTED|Overall Study||14||
48618679|NCT04030598|101852946|FG002|STARTED|Overall Study||3||
48618680|NCT04030598|101852944|FG000|COMPLETED|Overall Study||6|Completed=Participants who completed study treatment|
48618681|NCT04030598|101852945|FG001|COMPLETED|Overall Study||13|Completed=Participants who completed study treatment|
48618682|NCT04030598|101852946|FG002|COMPLETED|Overall Study||3|Completed=Participants who completed study treatment|
48618683|NCT04030598|101852944|FG000|NOT COMPLETED|Overall Study||0||
48618684|NCT04030598|101852945|FG001|NOT COMPLETED|Overall Study||1||
48618685|NCT04030598|101852946|FG002|NOT COMPLETED|Overall Study||0||
48618686|NCT00115778|101852947|FG000|STARTED|Overall Study||6||
48324927|NCT00916357|101121370|FG003|COMPLETED|Period 2||3||
48742136|NCT03386721|102155004|FG010|COMPLETED|Overall Study||2||
48742137|NCT03386721|102155005|FG011|COMPLETED|Overall Study||6||
48742138|NCT03386721|102155006|FG012|COMPLETED|Overall Study||0||
48742139|NCT03386721|102155007|FG013|COMPLETED|Overall Study||0||
48742140|NCT03386721|102155008|FG014|COMPLETED|Overall Study||0||
48742141|NCT03386721|102154994|FG000|NOT COMPLETED|Overall Study||22||
48742142|NCT03386721|102154995|FG001|NOT COMPLETED|Overall Study||31||
48742143|NCT03386721|102154996|FG002|NOT COMPLETED|Overall Study||3||
48742144|NCT03386721|102154997|FG003|NOT COMPLETED|Overall Study||5||
48742145|NCT03386721|102154998|FG004|NOT COMPLETED|Overall Study||2||
48742146|NCT03386721|102154999|FG005|NOT COMPLETED|Overall Study||21||
48742147|NCT03386721|102155000|FG006|NOT COMPLETED|Overall Study||3||
48742148|NCT03386721|102155001|FG007|NOT COMPLETED|Overall Study||2||
48742149|NCT03386721|102155002|FG008|NOT COMPLETED|Overall Study||22||
48742150|NCT03386721|102155003|FG009|NOT COMPLETED|Overall Study||30||
48742151|NCT03386721|102155004|FG010|NOT COMPLETED|Overall Study||31||
48742152|NCT03386721|102155005|FG011|NOT COMPLETED|Overall Study||41||
48742153|NCT03386721|102155006|FG012|NOT COMPLETED|Overall Study||25||
48742154|NCT03386721|102155007|FG013|NOT COMPLETED|Overall Study||2||
48742155|NCT03386721|102155008|FG014|NOT COMPLETED|Overall Study||1||
48742156|NCT00602420|102155009|FG000|STARTED|Overall Study||257||
48742157|NCT00602420|102155010|FG001|STARTED|Overall Study||253||
48742158|NCT00602420|102155009|FG000|COMPLETED|Overall Study||232||
48742159|NCT00602420|102155010|FG001|COMPLETED|Overall Study||229||
48742160|NCT00602420|102155009|FG000|NOT COMPLETED|Overall Study||25||
48742161|NCT00602420|102155010|FG001|NOT COMPLETED|Overall Study||24||
48742162|NCT00398567|102155011|FG000|STARTED|Overall Study||4||
48742163|NCT00398567|102155012|FG001|STARTED|Overall Study||4||
48742164|NCT00398567|102155013|FG002|STARTED|Overall Study||37||
48742165|NCT00398567|102155011|FG000|COMPLETED|Overall Study||0||
48742166|NCT00398567|102155012|FG001|COMPLETED|Overall Study||0||
48742167|NCT00398567|102155013|FG002|COMPLETED|Overall Study||3||
48742168|NCT00398567|102155011|FG000|NOT COMPLETED|Overall Study||4||
48742169|NCT00398567|102155012|FG001|NOT COMPLETED|Overall Study||4||
48742170|NCT00398567|102155013|FG002|NOT COMPLETED|Overall Study||34||
48742171|NCT01871519|102155014|FG000|STARTED|Overall Study||350||
48742172|NCT01871519|102155014|FG000|COMPLETED|Overall Study||260||
48742173|NCT01871519|102155014|FG000|NOT COMPLETED|Overall Study||90||
48742174|NCT02871635|102155015|FG000|STARTED|Overall Study||72||
48742175|NCT02871635|102155016|FG001|STARTED|Overall Study||75||
48742176|NCT02871635|102155015|FG000|COMPLETED|Overall Study||54||
48742177|NCT02871635|102155016|FG001|COMPLETED|Overall Study||56||
48742178|NCT02871635|102155015|FG000|NOT COMPLETED|Overall Study||18||
48742179|NCT02871635|102155016|FG001|NOT COMPLETED|Overall Study||19||
48742180|NCT00476827|102155017|FG000|STARTED|Overall Study||3||
48742181|NCT00476827|102155018|FG001|STARTED|Overall Study||0||
48742182|NCT00476827|102155019|FG002|STARTED|Overall Study||1||
48742183|NCT00476827|102155020|FG003|STARTED|Overall Study||0||
48742184|NCT00476827|102155021|FG004|STARTED|Overall Study||2||
48742185|NCT00476827|102155022|FG005|STARTED|Overall Study||2||
48742186|NCT00476827|102155017|FG000|COMPLETED|Overall Study||3||
48742187|NCT00476827|102155018|FG001|COMPLETED|Overall Study||0||
48742188|NCT00476827|102155019|FG002|COMPLETED|Overall Study||1||
48742189|NCT00476827|102155020|FG003|COMPLETED|Overall Study||0||
48742190|NCT00476827|102155021|FG004|COMPLETED|Overall Study||2||
48742191|NCT00476827|102155022|FG005|COMPLETED|Overall Study||2||
48742192|NCT00476827|102155017|FG000|NOT COMPLETED|Overall Study||0||
48742193|NCT00476827|102155018|FG001|NOT COMPLETED|Overall Study||0||
48742194|NCT00476827|102155019|FG002|NOT COMPLETED|Overall Study||0||
48742195|NCT00476827|102155020|FG003|NOT COMPLETED|Overall Study||0||
48742196|NCT00476827|102155021|FG004|NOT COMPLETED|Overall Study||0||
48742197|NCT00476827|102155022|FG005|NOT COMPLETED|Overall Study||0||
48742198|NCT05274958|102155023|FG000|STARTED|Overall Study||70||
48742199|NCT05274958|102155024|FG001|STARTED|Overall Study||78||
48742200|NCT05274958|102155023|FG000|COMPLETED|Overall Study||48||
48742201|NCT05274958|102155024|FG001|COMPLETED|Overall Study||43||
48742202|NCT05274958|102155023|FG000|NOT COMPLETED|Overall Study||22||
48742203|NCT05274958|102155024|FG001|NOT COMPLETED|Overall Study||35||
48742204|NCT01450761|102155025|FG000|STARTED|Randomization||566||
48742205|NCT01450761|102155026|FG001|STARTED|Randomization||566||
48742206|NCT01450761|102155025|FG000|COMPLETED|Randomization||562||
48742207|NCT01450761|102155026|FG001|COMPLETED|Randomization||561||
48742208|NCT01450761|102155025|FG000|NOT COMPLETED|Randomization||4||
48742209|NCT01450761|102155026|FG001|NOT COMPLETED|Randomization||5||
48742210|NCT01450761|102155025|FG000|STARTED|Lead-in Chemotherapy||562||
48742211|NCT01450761|102155026|FG001|STARTED|Lead-in Chemotherapy||561||
48742212|NCT01450761|102155025|FG000|COMPLETED|Lead-in Chemotherapy||478||
48742213|NCT01450761|102155026|FG001|COMPLETED|Lead-in Chemotherapy||476||
48742214|NCT01450761|102155025|FG000|NOT COMPLETED|Lead-in Chemotherapy||84||
48742215|NCT01450761|102155026|FG001|NOT COMPLETED|Lead-in Chemotherapy||85||
48742216|NCT01450761|102155025|FG000|STARTED|Treatment With Blinded Study Therapy||478||
48742217|NCT01450761|102155026|FG001|STARTED|Treatment With Blinded Study Therapy||476||
48742218|NCT01450761|102155025|FG000|COMPLETED|Treatment With Blinded Study Therapy||0|Completed = remaining on study therapy|
48742219|NCT01450761|102155026|FG001|COMPLETED|Treatment With Blinded Study Therapy||0|Completed = remaining on study therapy|
48408873|NCT03922711|101331893|FG002|Treatment Group Based on Maximal Possible Highest Dose Received (Used for Analysis)|Overall Study||8|A total of 8 patients were randomized to pridopidine 150 mg BID. Of these, 5 patients discontinued study drug during titration, i.e. did not reach the full maintenance dose. Therefore, they were analyzed under the 100 mg BID group. The 100 mg BID group included patients who received any dose between 75 mg QD and 100 mg BID.|
48408874|NCT03922711|101331891|FG000|COMPLETED|Overall Study||3||
48408875|NCT03922711|101331892|FG001|COMPLETED|Overall Study||3||
48408876|NCT03922711|101331893|FG002|COMPLETED|Overall Study||4||
48408877|NCT03922711|101331891|FG000|NOT COMPLETED|Overall Study||4||
48408878|NCT03922711|101331892|FG001|NOT COMPLETED|Overall Study||5||
48408879|NCT03922711|101331893|FG002|NOT COMPLETED|Overall Study||4||
48408880|NCT02505269|101331894|FG000|STARTED|Overall Study||34||
48408881|NCT02505269|101331894|FG000|COMPLETED|Overall Study||34||
48408882|NCT02505269|101331894|FG000|NOT COMPLETED|Overall Study||0||
48408883|NCT02943668|101331895|FG000|STARTED|Overall Study||2||
48408884|NCT02943668|101331895|FG000|COMPLETED|Overall Study||1||
48408885|NCT02943668|101331895|FG000|NOT COMPLETED|Overall Study||1||
48408886|NCT03649815|101331896|FG000|STARTED|Overall Study||38||
48408887|NCT03649815|101331896|FG000|COMPLETED|Overall Study||38||
48408888|NCT03649815|101331896|FG000|NOT COMPLETED|Overall Study||0||
48408889|NCT03442595|101331897|FG000|STARTED|Overall Study||460||
48408890|NCT03442595|101331898|FG001|STARTED|Overall Study||366||
48408891|NCT03442595|101331897|FG000|COMPLETED|Overall Study||366||
48408892|NCT03442595|101331898|FG001|COMPLETED|Overall Study||366||
48408893|NCT03442595|101331897|FG000|NOT COMPLETED|Overall Study||94||
48408894|NCT03442595|101331898|FG001|NOT COMPLETED|Overall Study||0||
48408895|NCT00641745|101331899|FG000|STARTED|Overall Study||427||
48408896|NCT00641745|101331900|FG001|STARTED|Overall Study||202||
48408897|NCT00641745|101331899|FG000|COMPLETED|Overall Study||147||
48408898|NCT00641745|101331900|FG001|COMPLETED|Overall Study||89||
48408899|NCT00641745|101331899|FG000|NOT COMPLETED|Overall Study||280||
48408900|NCT00641745|101331900|FG001|NOT COMPLETED|Overall Study||113||
48408901|NCT00472043|101331901|FG000|STARTED|Overall Study||33||
48408902|NCT00472043|101331902|FG001|STARTED|Overall Study||33||
48408903|NCT00472043|101331901|FG000|COMPLETED|Overall Study||31||
48408904|NCT00472043|101331902|FG001|COMPLETED|Overall Study||33||
48408905|NCT00472043|101331901|FG000|NOT COMPLETED|Overall Study||2||
48408906|NCT00472043|101331902|FG001|NOT COMPLETED|Overall Study||0||
48408907|NCT00994760|101331903|FG000|STARTED|Overall Study||131||
48408908|NCT00994760|101331903|FG000|COMPLETED|Overall Study||107||
48408909|NCT00994760|101331903|FG000|NOT COMPLETED|Overall Study||24||
48408910|NCT02750501|101331904|FG000|STARTED|Overall Study||44||
48408911|NCT02750501|101331904|FG000|Enrolled|Overall Study||44||
48408912|NCT02750501|101331904|FG000|Treated|Overall Study||39||
48408913|NCT02750501|101331904|FG000|COMPLETED|Overall Study||36||
48408914|NCT02750501|101331904|FG000|NOT COMPLETED|Overall Study||8||
48408915|NCT00498368|101331905|FG000|STARTED|Overall Study||17||
48408916|NCT00498368|101331906|FG001|STARTED|Overall Study||17||
48408917|NCT00498368|101331905|FG000|COMPLETED|Overall Study||14||
48408918|NCT00498368|101331906|FG001|COMPLETED|Overall Study||15||
48408919|NCT00498368|101331905|FG000|NOT COMPLETED|Overall Study||3||
48408920|NCT00498368|101331906|FG001|NOT COMPLETED|Overall Study||2||
48408921|NCT02253160|101331907|FG000|STARTED|Overall Study||1||
48408922|NCT02253160|101331908|FG001|STARTED|Overall Study||12||
48408923|NCT02253160|101331909|FG002|STARTED|Overall Study||10||
48408924|NCT02253160|101331907|FG000|COMPLETED|Overall Study||1||
48618687|NCT00115778|101852948|FG001|STARTED|Overall Study||5||
48618688|NCT00115778|101852947|FG000|COMPLETED|Overall Study||6||
48618689|NCT00115778|101852948|FG001|COMPLETED|Overall Study||4||
48618690|NCT00115778|101852947|FG000|NOT COMPLETED|Overall Study||0||
48618691|NCT00115778|101852948|FG001|NOT COMPLETED|Overall Study||1||
48618692|NCT00572260|101852949|FG000|STARTED|Overall Study||11||
48618693|NCT00572260|101852949|FG000|COMPLETED|Overall Study||11||
48618694|NCT00572260|101852949|FG000|NOT COMPLETED|Overall Study||0||
48618695|NCT01096160|101852950|FG000|STARTED|Overall Study||6||
48618696|NCT01096160|101852951|FG001|STARTED|Overall Study||2||
48618697|NCT01096160|101852952|FG002|STARTED|Overall Study||6||
48618698|NCT01096160|101852953|FG003|STARTED|Overall Study||2||
48618699|NCT01096160|101852954|FG004|STARTED|Overall Study||6||
48618700|NCT01096160|101852955|FG005|STARTED|Overall Study||2||
48618701|NCT01096160|101852956|FG006|STARTED|Overall Study||6||
48742220|NCT01450761|102155025|FG000|NOT COMPLETED|Treatment With Blinded Study Therapy||478||
48742221|NCT01450761|102155026|FG001|NOT COMPLETED|Treatment With Blinded Study Therapy||476||
48742222|NCT02277444|102155027|FG000|STARTED|Overall Study||130||
48742223|NCT02277444|102155027|FG000|Treated|Overall Study||127||
48742224|NCT02277444|102155027|FG000|COMPLETED|Overall Study||0||
48742225|NCT02277444|102155027|FG000|NOT COMPLETED|Overall Study||130||
48408925|NCT02253160|101331908|FG001|COMPLETED|Overall Study||12||
48618702|NCT01096160|101852957|FG007|STARTED|Overall Study||2||
48618703|NCT01096160|101852958|FG008|STARTED|Overall Study||6||
48618704|NCT01096160|101852959|FG009|STARTED|Overall Study||2||
48618705|NCT01096160|101852950|FG000|COMPLETED|Overall Study||6||
48742226|NCT01726582|102155028|FG000|STARTED|Overall Study||229||
48408926|NCT02253160|101331909|FG002|COMPLETED|Overall Study||10||
48742227|NCT01726582|102155028|FG000|Treated|Overall Study||130||
48742228|NCT01726582|102155028|FG000|COMPLETED|Overall Study||45||
48742229|NCT01726582|102155028|FG000|NOT COMPLETED|Overall Study||184||
48742230|NCT01818596|102155029|FG000|STARTED|Overall Study||246||
48742231|NCT01818596|102155030|FG001|STARTED|Overall Study||6||
48742232|NCT01818596|102155029|FG000|COMPLETED|Overall Study||215||
48742233|NCT01818596|102155030|FG001|COMPLETED|Overall Study||6||
48742234|NCT01818596|102155029|FG000|NOT COMPLETED|Overall Study||31||
48742235|NCT01818596|102155030|FG001|NOT COMPLETED|Overall Study||0||
48742236|NCT02506634|102155031|FG000|STARTED|Overall Study||374||
48742237|NCT02506634|102155031|FG000|Participants Who Were Diagnosed as GERD|Overall Study||154||
48742238|NCT02506634|102155031|FG000|Participants Who Received PPI Treatment|Overall Study||357||
48742239|NCT02506634|102155031|FG000|Participants Who Finished GERDQ|Overall Study||342||
48742240|NCT02506634|102155031|FG000|COMPLETED|Overall Study||357||
48742241|NCT02506634|102155031|FG000|NOT COMPLETED|Overall Study||17||
48742242|NCT05234957|102155032|FG000|STARTED|Overall Study||20||
48742243|NCT05234957|102155033|FG001|STARTED|Overall Study||20||
48742244|NCT05234957|102155032|FG000|COMPLETED|Overall Study||20||
48742245|NCT05234957|102155033|FG001|COMPLETED|Overall Study||20||
48742246|NCT05234957|102155032|FG000|NOT COMPLETED|Overall Study||0||
48742247|NCT05234957|102155033|FG001|NOT COMPLETED|Overall Study||0||
48408927|NCT02253160|101331907|FG000|NOT COMPLETED|Overall Study||0||
48408928|NCT02253160|101331908|FG001|NOT COMPLETED|Overall Study||0||
48742248|NCT03343626|102155034|FG000|STARTED|Overall Study||31||
48742249|NCT03343626|102155035|FG001|STARTED|Overall Study||31||
48742250|NCT03343626|102155036|FG002|STARTED|Overall Study||31||
48742251|NCT03343626|102155037|FG003|STARTED|Overall Study||32||
48742252|NCT03343626|102155038|FG004|STARTED|Overall Study||36||
48742253|NCT03343626|102155039|FG005|STARTED|Overall Study||37||
48742254|NCT03343626|102155040|FG006|STARTED|Overall Study||37||
48742255|NCT03343626|102155041|FG007|STARTED|Overall Study||36||
48742256|NCT03343626|102155034|FG000|Safety Analysis Set|Overall Study||31|Safety Analysis Set included all participants who received at least one (1) dose of PIZV or placebo.|
48742257|NCT03343626|102155035|FG001|Safety Analysis Set|Overall Study||31|Safety Analysis Set included all participants who received at least one (1) dose of PIZV or placebo.|
48742258|NCT03343626|102155036|FG002|Safety Analysis Set|Overall Study||31|Safety Analysis Set included all participants who received at least one (1) dose of PIZV or placebo.|
48408929|NCT02253160|101331909|FG002|NOT COMPLETED|Overall Study||0||
48408930|NCT00509028|101331910|FG000|STARTED|Overall Study||121||
48408931|NCT00509028|101331911|FG001|STARTED|Overall Study||120||
48408932|NCT00509028|101331910|FG000|COMPLETED|Overall Study||109||
48408933|NCT00509028|101331911|FG001|COMPLETED|Overall Study||113||
48408934|NCT00509028|101331910|FG000|NOT COMPLETED|Overall Study||12||
48408935|NCT00509028|101331911|FG001|NOT COMPLETED|Overall Study||7||
48408936|NCT00882362|101331912|FG000|STARTED|Overall Study||122||
48408937|NCT00882362|101331913|FG001|STARTED|Overall Study||33||
48408938|NCT00882362|101331912|FG000|COMPLETED|Overall Study||73||
48408939|NCT00882362|101331913|FG001|COMPLETED|Overall Study||10||
48408940|NCT00882362|101331912|FG000|NOT COMPLETED|Overall Study||49||
48408941|NCT00882362|101331913|FG001|NOT COMPLETED|Overall Study||23||
48408942|NCT01828567|101331914|FG000|STARTED|Overall Study||208||
48408943|NCT01828567|101331915|FG001|STARTED|Overall Study||209||
48408944|NCT01828567|101331914|FG000|1 Month|Overall Study||172||
48408945|NCT01828567|101331915|FG001|1 Month|Overall Study||192||
48408946|NCT01828567|101331914|FG000|COMPLETED|Overall Study||177||
48408947|NCT01828567|101331915|FG001|COMPLETED|Overall Study||199||
48408948|NCT01828567|101331914|FG000|NOT COMPLETED|Overall Study||31||
48408949|NCT01828567|101331915|FG001|NOT COMPLETED|Overall Study||10||
48408950|NCT01678560|101331916|FG000|STARTED|Overall Study||26||
48408951|NCT01678560|101331917|FG001|STARTED|Overall Study||26||
48408952|NCT01678560|101331916|FG000|COMPLETED|Overall Study||22||
48408953|NCT01678560|101331917|FG001|COMPLETED|Overall Study||20||
48742259|NCT03343626|102155037|FG003|Safety Analysis Set|Overall Study||32|Safety Analysis Set included all participants who received at least one (1) dose of PIZV or placebo.|
48742260|NCT03343626|102155038|FG004|Safety Analysis Set|Overall Study||36|Safety Analysis Set included all participants who received at least one (1) dose of PIZV or placebo.|
48742261|NCT03343626|102155039|FG005|Safety Analysis Set|Overall Study||37|Safety Analysis Set included all participants who received at least one (1) dose of PIZV or placebo.|
48742262|NCT03343626|102155040|FG006|Safety Analysis Set|Overall Study||37|Safety Analysis Set included all participants who received at least one (1) dose of PIZV or placebo.|
48742263|NCT03343626|102155041|FG007|Safety Analysis Set|Overall Study||36|Safety Analysis Set included all participants who received at least one (1) dose of PIZV or placebo.|
48767635|NCT01929317|102222786|FG001|COMPLETED|Dose Increase Effect Verification Phase||19||
48408954|NCT01678560|101331916|FG000|NOT COMPLETED|Overall Study||4||
48408955|NCT01678560|101331917|FG001|NOT COMPLETED|Overall Study||6||
48408956|NCT01395966|101331918|FG000|STARTED|Overall Study||109||
48408957|NCT01395966|101331919|FG001|STARTED|Overall Study||110||
48408958|NCT01395966|101331920|FG002|STARTED|Overall Study||112||
48408959|NCT01395966|101331918|FG000|COMPLETED|Overall Study||99||
48408960|NCT01395966|101331919|FG001|COMPLETED|Overall Study||91||
48408961|NCT01395966|101331920|FG002|COMPLETED|Overall Study||104||
48408962|NCT01395966|101331918|FG000|NOT COMPLETED|Overall Study||10||
48408963|NCT01395966|101331919|FG001|NOT COMPLETED|Overall Study||19||
48408964|NCT01395966|101331920|FG002|NOT COMPLETED|Overall Study||8||
48408965|NCT00122317|101331921|FG000|STARTED|Overall Study||187||
48408966|NCT00122317|101331921|FG000|COMPLETED|Overall Study||176||
48408967|NCT00122317|101331921|FG000|NOT COMPLETED|Overall Study||11||
48408968|NCT01328769|101331922|FG000|STARTED|Overall Study||25||
48408969|NCT01328769|101331923|FG001|STARTED|Overall Study||24||
48408970|NCT01328769|101331922|FG000|COMPLETED|Overall Study||25||
48408971|NCT01328769|101331923|FG001|COMPLETED|Overall Study||23||
48408972|NCT01328769|101331922|FG000|NOT COMPLETED|Overall Study||0||
48408973|NCT01328769|101331923|FG001|NOT COMPLETED|Overall Study||1||
48408974|NCT02614261|101331924|FG000|STARTED|Double-Blind Treatment Phase||559||
48408975|NCT02614261|101331925|FG001|STARTED|Double-Blind Treatment Phase||279||
48408976|NCT02614261|101331926|FG002|STARTED|Double-Blind Treatment Phase||279||
48408977|NCT02614261|101331927|FG003|STARTED|Double-Blind Treatment Phase||0||
48408978|NCT02614261|101331924|FG000|Received at Least One Dose of Study Drug|Double-Blind Treatment Phase||558||
48408979|NCT02614261|101331925|FG001|Received at Least One Dose of Study Drug|Double-Blind Treatment Phase||278||
48408980|NCT02614261|101331926|FG002|Received at Least One Dose of Study Drug|Double-Blind Treatment Phase||277||
48408981|NCT02614261|101331927|FG003|Received at Least One Dose of Study Drug|Double-Blind Treatment Phase||0||
48408982|NCT02614261|101331924|FG000|Safety Population|Double-Blind Treatment Phase||558||
48618706|NCT01096160|101852951|FG001|COMPLETED|Overall Study||2||
48618707|NCT01096160|101852952|FG002|COMPLETED|Overall Study||5||
48618708|NCT01096160|101852953|FG003|COMPLETED|Overall Study||2||
48618709|NCT01096160|101852954|FG004|COMPLETED|Overall Study||5||
48618710|NCT01096160|101852955|FG005|COMPLETED|Overall Study||2||
48618711|NCT01096160|101852956|FG006|COMPLETED|Overall Study||4||
48618712|NCT01096160|101852957|FG007|COMPLETED|Overall Study||2||
48618713|NCT01096160|101852958|FG008|COMPLETED|Overall Study||4||
48618714|NCT01096160|101852959|FG009|COMPLETED|Overall Study||1||
48742264|NCT03343626|102155034|FG000|Full Analysis Set|Overall Study||30|Full Analysis Set (FAS) included all randomized participants who had received at least one dose of the investigational vaccine/placebo and had provided valid Baseline and at least one post-vaccination serology result.|
48742265|NCT03343626|102155035|FG001|Full Analysis Set|Overall Study||28|Full Analysis Set (FAS) included all randomized participants who had received at least one dose of the investigational vaccine/placebo and had provided valid Baseline and at least one post-vaccination serology result.|
48742266|NCT03343626|102155036|FG002|Full Analysis Set|Overall Study||31|Full Analysis Set (FAS) included all randomized participants who had received at least one dose of the investigational vaccine/placebo and had provided valid Baseline and at least one post-vaccination serology result.|
48618715|NCT01096160|101852950|FG000|NOT COMPLETED|Overall Study||0||
48618716|NCT01096160|101852951|FG001|NOT COMPLETED|Overall Study||0||
48618717|NCT01096160|101852952|FG002|NOT COMPLETED|Overall Study||1||
48618718|NCT01096160|101852953|FG003|NOT COMPLETED|Overall Study||0||
48618719|NCT01096160|101852954|FG004|NOT COMPLETED|Overall Study||1||
48618720|NCT01096160|101852955|FG005|NOT COMPLETED|Overall Study||0||
48618721|NCT01096160|101852956|FG006|NOT COMPLETED|Overall Study||2||
48618722|NCT01096160|101852957|FG007|NOT COMPLETED|Overall Study||0||
48618723|NCT01096160|101852958|FG008|NOT COMPLETED|Overall Study||2||
48618724|NCT01096160|101852959|FG009|NOT COMPLETED|Overall Study||1||
48618725|NCT02219685|101852960|FG000|STARTED|Blinded Treatment Phase||26||
48618726|NCT02219685|101852961|FG001|STARTED|Blinded Treatment Phase||14||
48618727|NCT02219685|101852960|FG000|COMPLETED|Blinded Treatment Phase||24||
48618728|NCT02219685|101852961|FG001|COMPLETED|Blinded Treatment Phase||14||
48742267|NCT03343626|102155037|FG003|Full Analysis Set|Overall Study||30|Full Analysis Set (FAS) included all randomized participants who had received at least one dose of the investigational vaccine/placebo and had provided valid Baseline and at least one post-vaccination serology result.|
48742268|NCT03343626|102155038|FG004|Full Analysis Set|Overall Study||34|Full Analysis Set (FAS) included all randomized participants who had received at least one dose of the investigational vaccine/placebo and had provided valid Baseline and at least one post-vaccination serology result.|
48742269|NCT03343626|102155039|FG005|Full Analysis Set|Overall Study||34|Full Analysis Set (FAS) included all randomized participants who had received at least one dose of the investigational vaccine/placebo and had provided valid Baseline and at least one post-vaccination serology result.|
48767636|NCT01929317|102222785|FG000|NOT COMPLETED|Dose Increase Effect Verification Phase||9||
48618729|NCT02219685|101852960|FG000|NOT COMPLETED|Blinded Treatment Phase||2||
48618730|NCT02219685|101852961|FG001|NOT COMPLETED|Blinded Treatment Phase||0||
48618731|NCT02219685|101852960|FG000|STARTED|Open-Label (After Posttreatment Week 4)||0||
48618732|NCT02219685|101852961|FG001|STARTED|Open-Label (After Posttreatment Week 4)||14||
48618733|NCT02219685|101852960|FG000|COMPLETED|Open-Label (After Posttreatment Week 4)||0||
48618734|NCT02219685|101852961|FG001|COMPLETED|Open-Label (After Posttreatment Week 4)||14||
48618735|NCT02219685|101852960|FG000|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0||
48618736|NCT02219685|101852961|FG001|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0||
48618737|NCT01481558|101852962|FG000|STARTED|Overall Study||20||
48618738|NCT01481558|101852963|FG001|STARTED|Overall Study||20||
48618739|NCT01481558|101852962|FG000|COMPLETED|Overall Study||20||
48618740|NCT01481558|101852963|FG001|COMPLETED|Overall Study||20||
48618741|NCT01481558|101852962|FG000|NOT COMPLETED|Overall Study||0||
48618742|NCT01481558|101852963|FG001|NOT COMPLETED|Overall Study||0||
48618743|NCT01841970|101852964|FG000|STARTED|Overall Study||20||
48618744|NCT01841970|101852964|FG000|COMPLETED|Overall Study||9||
48618745|NCT01841970|101852964|FG000|NOT COMPLETED|Overall Study||11||
48618746|NCT00875563|101852965|FG000|STARTED|Overall Study||42||
48618747|NCT00875563|101852965|FG000|COMPLETED|Overall Study||18||
48618748|NCT00875563|101852965|FG000|NOT COMPLETED|Overall Study||24||
48618749|NCT00514618|101852966|FG000|STARTED|Overall Study||5|The PI has left the institution. Efforts were exhausted in attempting to contact the PI/study team members. No study data are available. No UCI protocol.|
48618750|NCT00514618|101852967|FG001|STARTED|Overall Study||0|The PI has left the institution. Efforts were exhausted in attempting to contact the PI/study team members. No study data are available. No UCI protocol.|
48618751|NCT00514618|101852966|FG000|COMPLETED|Overall Study||5|The PI has left the institution. Efforts were exhausted in attempting to contact the PI/study team members. No study data are available. No UCI protocol.|
48618752|NCT00514618|101852967|FG001|COMPLETED|Overall Study||0|The PI has left the institution. Efforts were exhausted in attempting to contact the PI/study team members. No study data are available. No UCI protocol.|
48618753|NCT00514618|101852966|FG000|NOT COMPLETED|Overall Study||0||
48618754|NCT00514618|101852967|FG001|NOT COMPLETED|Overall Study||0||
48618755|NCT03834025|101852968|FG000|STARTED|Sent Recruitment Letter (Phase 1)||4150||
48618756|NCT03834025|101852969|FG001|STARTED|Sent Recruitment Letter (Phase 1)||3871||
48618757|NCT03834025|101852970|FG002|STARTED|Sent Recruitment Letter (Phase 1)||4121||
48618758|NCT03834025|101852971|FG003|STARTED|Sent Recruitment Letter (Phase 1)||3693||
48618759|NCT03834025|101852972|FG004|STARTED|Sent Recruitment Letter (Phase 1)||0||
48618760|NCT03834025|101852973|FG005|STARTED|Sent Recruitment Letter (Phase 1)||0||
48618761|NCT03834025|101852974|FG006|STARTED|Sent Recruitment Letter (Phase 1)||0||
48618762|NCT03834025|101852968|FG000|Sent Letter|Sent Recruitment Letter (Phase 1)||4150||
48618763|NCT03834025|101852969|FG001|Sent Letter|Sent Recruitment Letter (Phase 1)||3871||
48324928|NCT00916357|101121371|FG004|COMPLETED|Period 2||3||
48324929|NCT00916357|101121372|FG005|COMPLETED|Period 2||4||
48618764|NCT03834025|101852970|FG002|Sent Letter|Sent Recruitment Letter (Phase 1)||4121||
48618765|NCT03834025|101852971|FG003|Sent Letter|Sent Recruitment Letter (Phase 1)||3693||
48618766|NCT03834025|101852972|FG004|Sent Letter|Sent Recruitment Letter (Phase 1)||0||
48618767|NCT03834025|101852973|FG005|Sent Letter|Sent Recruitment Letter (Phase 1)||0||
48618768|NCT03834025|101852974|FG006|Sent Letter|Sent Recruitment Letter (Phase 1)||0||
48618769|NCT03834025|101852968|FG000|Responded to Letter|Sent Recruitment Letter (Phase 1)||36||
48618770|NCT03834025|101852969|FG001|Responded to Letter|Sent Recruitment Letter (Phase 1)||36||
48618771|NCT03834025|101852970|FG002|Responded to Letter|Sent Recruitment Letter (Phase 1)||44||
48618772|NCT03834025|101852971|FG003|Responded to Letter|Sent Recruitment Letter (Phase 1)||44||
48618773|NCT03834025|101852972|FG004|Responded to Letter|Sent Recruitment Letter (Phase 1)||0||
48618774|NCT03834025|101852973|FG005|Responded to Letter|Sent Recruitment Letter (Phase 1)||0||
48618775|NCT03834025|101852974|FG006|Responded to Letter|Sent Recruitment Letter (Phase 1)||0||
48618776|NCT03834025|101852968|FG000|COMPLETED|Sent Recruitment Letter (Phase 1)||36||
48618777|NCT03834025|101852969|FG001|COMPLETED|Sent Recruitment Letter (Phase 1)||36||
48742270|NCT03343626|102155040|FG006|Full Analysis Set|Overall Study||34|Full Analysis Set (FAS) included all randomized participants who had received at least one dose of the investigational vaccine/placebo and had provided valid Baseline and at least one post-vaccination serology result.|
48742271|NCT03343626|102155041|FG007|Full Analysis Set|Overall Study||34|Full Analysis Set (FAS) included all randomized participants who had received at least one dose of the investigational vaccine/placebo and had provided valid Baseline and at least one post-vaccination serology result.|
48618778|NCT03834025|101852970|FG002|COMPLETED|Sent Recruitment Letter (Phase 1)||44||
48618779|NCT03834025|101852971|FG003|COMPLETED|Sent Recruitment Letter (Phase 1)||44||
48618780|NCT03834025|101852972|FG004|COMPLETED|Sent Recruitment Letter (Phase 1)||0||
48618781|NCT03834025|101852973|FG005|COMPLETED|Sent Recruitment Letter (Phase 1)||0||
48618782|NCT03834025|101852974|FG006|COMPLETED|Sent Recruitment Letter (Phase 1)||0||
48618783|NCT03834025|101852968|FG000|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||4114||
48618784|NCT03834025|101852969|FG001|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||3835||
48324930|NCT00916357|101121367|FG000|NOT COMPLETED|Period 2||0||
48324931|NCT00916357|101121368|FG001|NOT COMPLETED|Period 2||0||
48618785|NCT03834025|101852970|FG002|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||4077||
48618786|NCT03834025|101852971|FG003|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||3649||
48618787|NCT03834025|101852972|FG004|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||0||
48618788|NCT03834025|101852973|FG005|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||0||
48618789|NCT03834025|101852974|FG006|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||0||
48618790|NCT03834025|101852968|FG000|STARTED|Randomized to Payment Condition(Phase 2)||0||
48618791|NCT03834025|101852969|FG001|STARTED|Randomized to Payment Condition(Phase 2)||0||
48618792|NCT03834025|101852970|FG002|STARTED|Randomized to Payment Condition(Phase 2)||0||
48618793|NCT03834025|101852971|FG003|STARTED|Randomized to Payment Condition(Phase 2)||0||
48618794|NCT03834025|101852972|FG004|STARTED|Randomized to Payment Condition(Phase 2)||24||
48618795|NCT03834025|101852973|FG005|STARTED|Randomized to Payment Condition(Phase 2)||21||
48618796|NCT03834025|101852974|FG006|STARTED|Randomized to Payment Condition(Phase 2)||28||
48742272|NCT03343626|102155034|FG000|Per Protocol Set|Overall Study||28|Per-Protocol Set (PPS) included participants in the FAS who had no major protocol violations (relevant for the analysis, primary immunogenicity assessment or persistence assessment).|
48742273|NCT03343626|102155035|FG001|Per Protocol Set|Overall Study||25|Per-Protocol Set (PPS) included participants in the FAS who had no major protocol violations (relevant for the analysis, primary immunogenicity assessment or persistence assessment).|
48742274|NCT03343626|102155036|FG002|Per Protocol Set|Overall Study||29|Per-Protocol Set (PPS) included participants in the FAS who had no major protocol violations (relevant for the analysis, primary immunogenicity assessment or persistence assessment).|
48618797|NCT03834025|101852968|FG000|COMPLETED|Randomized to Payment Condition(Phase 2)||0||
48618798|NCT03834025|101852969|FG001|COMPLETED|Randomized to Payment Condition(Phase 2)||0||
48618799|NCT03834025|101852970|FG002|COMPLETED|Randomized to Payment Condition(Phase 2)||0||
48618800|NCT03834025|101852971|FG003|COMPLETED|Randomized to Payment Condition(Phase 2)||0||
48162393|NCT00985985|100718956|FG000|Safety Population|Overall Study||241||
48162394|NCT00985985|100718957|FG001|Safety Population|Overall Study||242||
48162395|NCT00985985|100718958|FG002|Safety Population|Overall Study||119||
48162396|NCT00985985|100718959|FG003|Safety Population|Overall Study||118||
48162397|NCT00985985|100718956|FG000|Full Analysis Set (FAS) Population|Overall Study||241||
48162398|NCT00985985|100718957|FG001|Full Analysis Set (FAS) Population|Overall Study||242||
48162399|NCT00985985|100718958|FG002|Full Analysis Set (FAS) Population|Overall Study||120||
48162400|NCT00985985|100718959|FG003|Full Analysis Set (FAS) Population|Overall Study||119||
48162401|NCT00985985|100718956|FG000|COMPLETED|Overall Study||217||
48162402|NCT00985985|100718957|FG001|COMPLETED|Overall Study||218||
48162403|NCT00985985|100718958|FG002|COMPLETED|Overall Study||109||
48162404|NCT00985985|100718959|FG003|COMPLETED|Overall Study||107||
48162405|NCT00985985|100718956|FG000|NOT COMPLETED|Overall Study||24||
48162406|NCT00985985|100718957|FG001|NOT COMPLETED|Overall Study||24||
48162407|NCT00985985|100718958|FG002|NOT COMPLETED|Overall Study||11||
48162408|NCT00985985|100718959|FG003|NOT COMPLETED|Overall Study||13||
48162409|NCT01673893|100718960|FG000|STARTED|Overall Study||59||
48162410|NCT01673893|100718960|FG000|COMPLETED|Overall Study||59||
48162411|NCT01673893|100718960|FG000|NOT COMPLETED|Overall Study||0||
48162412|NCT01959347|100718961|FG000|STARTED|Overall Study||238||
48324932|NCT00916357|101121369|FG002|NOT COMPLETED|Period 2||0||
48618801|NCT03834025|101852972|FG004|COMPLETED|Randomized to Payment Condition(Phase 2)||24||
48618802|NCT03834025|101852973|FG005|COMPLETED|Randomized to Payment Condition(Phase 2)||21||
48618803|NCT03834025|101852974|FG006|COMPLETED|Randomized to Payment Condition(Phase 2)||27||
48618804|NCT03834025|101852968|FG000|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0||
48162413|NCT01959347|100718962|FG001|STARTED|Overall Study||242||
48162414|NCT01959347|100718961|FG000|COMPLETED|Overall Study||229||
48162415|NCT01959347|100718962|FG001|COMPLETED|Overall Study||235||
48162416|NCT01959347|100718961|FG000|NOT COMPLETED|Overall Study||9||
48162417|NCT01959347|100718962|FG001|NOT COMPLETED|Overall Study||7||
48162418|NCT00229957|100718963|FG000|STARTED|Overall Study||152||
48162419|NCT00229957|100718964|FG001|STARTED|Overall Study||151||
48324933|NCT00916357|101121370|FG003|NOT COMPLETED|Period 2||1||
48324934|NCT00916357|101121371|FG004|NOT COMPLETED|Period 2||0||
48162420|NCT00229957|100718963|FG000|COMPLETED|Overall Study||132||
48162421|NCT00229957|100718964|FG001|COMPLETED|Overall Study||139||
48162422|NCT00229957|100718963|FG000|NOT COMPLETED|Overall Study||20||
48162423|NCT00229957|100718964|FG001|NOT COMPLETED|Overall Study||12||
48162424|NCT02552238|100718965|FG000|STARTED|Overall Study||174||
48162425|NCT02552238|100718965|FG000|COMPLETED|Overall Study||170||
48162426|NCT02552238|100718965|FG000|NOT COMPLETED|Overall Study||4||
48162427|NCT03034018|100718966|FG000|STARTED|Overall Study||30||
48162428|NCT03034018|100718967|FG001|STARTED|Overall Study||30||
48162429|NCT03034018|100718966|FG000|Initiated Assigned Treatment|Overall Study||27||
48162430|NCT03034018|100718967|FG001|Initiated Assigned Treatment|Overall Study||29||
48162431|NCT03034018|100718966|FG000|COMPLETED|Overall Study||25||
48162432|NCT03034018|100718967|FG001|COMPLETED|Overall Study||28||
48162433|NCT03034018|100718966|FG000|NOT COMPLETED|Overall Study||5||
48162434|NCT03034018|100718967|FG001|NOT COMPLETED|Overall Study||2||
48162435|NCT00661661|100718968|FG000|STARTED|Overall Study||382||
48162436|NCT00661661|100718969|FG001|STARTED|Overall Study||105||
48162437|NCT00661661|100718968|FG000|COMPLETED|Overall Study||242||
48162438|NCT00661661|100718969|FG001|COMPLETED|Overall Study||66||
48162439|NCT00661661|100718968|FG000|NOT COMPLETED|Overall Study||140||
48324935|NCT00916357|101121372|FG005|NOT COMPLETED|Period 2||0||
48324936|NCT00916357|101121367|FG000|STARTED|Washout (3 to 14 Days)||3||
48324937|NCT00916357|101121368|FG001|STARTED|Washout (3 to 14 Days)||4||
48162440|NCT00661661|100718969|FG001|NOT COMPLETED|Overall Study||39||
48162441|NCT01076283|100718970|FG000|STARTED|Overall Study||7||
48162442|NCT01076283|100718971|FG001|STARTED|Overall Study||7||
48162443|NCT01076283|100718970|FG000|COMPLETED|Overall Study||6||
48162444|NCT01076283|100718971|FG001|COMPLETED|Overall Study||7||
48162445|NCT01076283|100718970|FG000|NOT COMPLETED|Overall Study||1||
48162446|NCT01076283|100718971|FG001|NOT COMPLETED|Overall Study||0||
48162447|NCT01722162|100718972|FG000|STARTED|Overall Study||23||
48324938|NCT00916357|101121369|FG002|STARTED|Washout (3 to 14 Days)||4||
48324939|NCT00916357|101121370|FG003|STARTED|Washout (3 to 14 Days)||3||
48324940|NCT00916357|101121371|FG004|STARTED|Washout (3 to 14 Days)||3||
48324941|NCT00916357|101121372|FG005|STARTED|Washout (3 to 14 Days)||4||
48324942|NCT00916357|101121367|FG000|COMPLETED|Washout (3 to 14 Days)||3||
48162448|NCT01722162|100718973|FG001|STARTED|Overall Study||24||
48162449|NCT01722162|100718972|FG000|COMPLETED|Overall Study||18||
48162450|NCT01722162|100718973|FG001|COMPLETED|Overall Study||18||
48162451|NCT01722162|100718972|FG000|NOT COMPLETED|Overall Study||5||
48324943|NCT00916357|101121368|FG001|COMPLETED|Washout (3 to 14 Days)||4||
48324944|NCT00916357|101121369|FG002|COMPLETED|Washout (3 to 14 Days)||4||
48324945|NCT00916357|101121370|FG003|COMPLETED|Washout (3 to 14 Days)||3||
48162452|NCT01722162|100718973|FG001|NOT COMPLETED|Overall Study||6||
48162453|NCT02227316|100718974|FG000|STARTED|Overall Study||4||
48162454|NCT02227316|100718975|FG001|STARTED|Overall Study||4||
48162455|NCT02227316|100718976|FG002|STARTED|Overall Study||16||
48162456|NCT02227316|100718977|FG003|STARTED|Overall Study||16||
48162457|NCT02227316|100718974|FG000|COMPLETED|Overall Study||4||
48162458|NCT02227316|100718975|FG001|COMPLETED|Overall Study||4||
48162459|NCT02227316|100718976|FG002|COMPLETED|Overall Study||16||
48162460|NCT02227316|100718977|FG003|COMPLETED|Overall Study||16||
48162461|NCT02227316|100718974|FG000|NOT COMPLETED|Overall Study||0||
48162462|NCT02227316|100718975|FG001|NOT COMPLETED|Overall Study||0||
48162463|NCT02227316|100718976|FG002|NOT COMPLETED|Overall Study||0||
48162464|NCT02227316|100718977|FG003|NOT COMPLETED|Overall Study||0||
48162465|NCT00069784|100718978|FG000|STARTED|Overall Study||6264||
48162466|NCT00069784|100718979|FG001|STARTED|Overall Study||6273||
48162467|NCT00069784|100718978|FG000|Safety Population (Treated)|Overall Study||6231||
48162468|NCT00069784|100718979|FG001|Safety Population (Treated)|Overall Study||6273||
48162469|NCT00069784|100718978|FG000|COMPLETED|Overall Study||5052||
48162470|NCT00069784|100718979|FG001|COMPLETED|Overall Study||6273||
48162471|NCT00069784|100718978|FG000|NOT COMPLETED|Overall Study||1212||
48162472|NCT00069784|100718979|FG001|NOT COMPLETED|Overall Study||0||
48162473|NCT04836858|100718980|FG000|STARTED|Overall Study||38|All participants randomized in the trial.|
48162474|NCT04836858|100718981|FG001|STARTED|Overall Study||17|All participants randomized in the trial.|
48162475|NCT04836858|100718982|FG002|STARTED|Overall Study||8|All participants randomized in the trial.|
48162476|NCT04836858|100718983|FG003|STARTED|Overall Study||8|All participants randomized in the trial.|
48162477|NCT04836858|100718980|FG000|Safety Analysis Set|Overall Study||34|All participants who received any study drug.|
48162478|NCT04836858|100718981|FG001|Safety Analysis Set|Overall Study||17|All participants who received any study drug.|
48162479|NCT04836858|100718982|FG002|Safety Analysis Set|Overall Study||8|All participants who received any study drug.|
48162480|NCT04836858|100718983|FG003|Safety Analysis Set|Overall Study||8|All participants who received any study drug.|
48162481|NCT04836858|100718980|FG000|COMPLETED|Overall Study||30||
48162482|NCT04836858|100718981|FG001|COMPLETED|Overall Study||17||
48162483|NCT04836858|100718982|FG002|COMPLETED|Overall Study||8||
48162484|NCT04836858|100718983|FG003|COMPLETED|Overall Study||6||
48162485|NCT04836858|100718980|FG000|NOT COMPLETED|Overall Study||8||
48162486|NCT04836858|100718981|FG001|NOT COMPLETED|Overall Study||0||
48162487|NCT04836858|100718982|FG002|NOT COMPLETED|Overall Study||0||
48162488|NCT04836858|100718983|FG003|NOT COMPLETED|Overall Study||2||
48162489|NCT04858802|100718984|FG000|STARTED|Overall Study||80||80
48162490|NCT04858802|100718985|FG001|STARTED|Overall Study||80||80
48162491|NCT04858802|100718984|FG000|Completed Day 45 Follow-up Visit|Overall Study||80||80
48162492|NCT04858802|100718985|FG001|Completed Day 45 Follow-up Visit|Overall Study||80||80
48408983|NCT02614261|101331925|FG001|Safety Population|Double-Blind Treatment Phase||273||
48408984|NCT02614261|101331926|FG002|Safety Population|Double-Blind Treatment Phase||282||
48408985|NCT02614261|101331927|FG003|Safety Population|Double-Blind Treatment Phase||0||
48408986|NCT02614261|101331924|FG000|COMPLETED|Double-Blind Treatment Phase||509||
48408987|NCT02614261|101331925|FG001|COMPLETED|Double-Blind Treatment Phase||262||
48408988|NCT02614261|101331926|FG002|COMPLETED|Double-Blind Treatment Phase||266||
48408989|NCT02614261|101331927|FG003|COMPLETED|Double-Blind Treatment Phase||0||
48408990|NCT02614261|101331924|FG000|NOT COMPLETED|Double-Blind Treatment Phase||50||
48408991|NCT02614261|101331925|FG001|NOT COMPLETED|Double-Blind Treatment Phase||17||
48742275|NCT03343626|102155037|FG003|Per Protocol Set|Overall Study||30|Per-Protocol Set (PPS) included participants in the FAS who had no major protocol violations (relevant for the analysis, primary immunogenicity assessment or persistence assessment).|
48742276|NCT03343626|102155038|FG004|Per Protocol Set|Overall Study||34|Per-Protocol Set (PPS) included participants in the FAS who had no major protocol violations (relevant for the analysis, primary immunogenicity assessment or persistence assessment).|
48162493|NCT04858802|100718984|FG000|COMPLETED|Overall Study||78||78
48162494|NCT04858802|100718985|FG001|COMPLETED|Overall Study||78||78
48162495|NCT04858802|100718984|FG000|NOT COMPLETED|Overall Study||2||2
48162496|NCT04858802|100718985|FG001|NOT COMPLETED|Overall Study||2||2
48162497|NCT01800201|100721599|FG000|STARTED|Overall Study||506||
48162498|NCT01800201|100721600|FG001|STARTED|Overall Study||1003||
48162499|NCT01800201|100721599|FG000|COMPLETED|Overall Study||503||
48162500|NCT01800201|100721600|FG001|COMPLETED|Overall Study||1000||
48162501|NCT01800201|100721599|FG000|NOT COMPLETED|Overall Study||3||
48162502|NCT01800201|100721600|FG001|NOT COMPLETED|Overall Study||3||
48162503|NCT03138733|100721601|FG000|STARTED|Overall Study||192|Intent-to-Treat (ITT) population|
48162504|NCT03138733|100721602|FG001|STARTED|Overall Study||198|Intent-to-Treat (ITT) population|
48162505|NCT03138733|100721601|FG000|Modified ITT (mITT)|Overall Study||189|Three patients were excluded from the mITT population in the ceftobiprole group: one patient discontinued prior to receiving study treatment, and two patients were determined by central laboratory results not to have a confirmed positive blood culture for Staphylococcus aureus at baseline|
48162506|NCT03138733|100721602|FG001|Modified ITT (mITT)|Overall Study||198|Three patients were excluded from the mITT population in the ceftobiprole group: one patient discontinued prior to receiving study treatment, and two patients were determined by central laboratory results not to have a confirmed positive blood culture for Staphylococcus aureus at baseline|
48162507|NCT03138733|100721601|FG000|COMPLETED|Overall Study||157||
48162508|NCT03138733|100721602|FG001|COMPLETED|Overall Study||169||
48162509|NCT03138733|100721601|FG000|NOT COMPLETED|Overall Study||35||
48162510|NCT03138733|100721602|FG001|NOT COMPLETED|Overall Study||29||
48162511|NCT05375955|100721603|FG000|STARTED|Treatment (12 Weeks)||44||
48162512|NCT05375955|100721604|FG001|STARTED|Treatment (12 Weeks)||42||
48162513|NCT05375955|100721605|FG002|STARTED|Treatment (12 Weeks)||42||
48162514|NCT05375955|100721606|FG003|STARTED|Treatment (12 Weeks)||34||
48162515|NCT05375955|100721607|FG004|STARTED|Treatment (12 Weeks)||33||
48162516|NCT05375955|100721608|FG005|STARTED|Treatment (12 Weeks)||35||
48162517|NCT05375955|100721609|FG006|STARTED|Treatment (12 Weeks)||33||
48162518|NCT05375955|100721603|FG000|Treated|Treatment (12 Weeks)||44||
48162519|NCT05375955|100721604|FG001|Treated|Treatment (12 Weeks)||42||
48162520|NCT05375955|100721605|FG002|Treated|Treatment (12 Weeks)||42||
48162521|NCT05375955|100721606|FG003|Treated|Treatment (12 Weeks)||34||
48162522|NCT05375955|100721607|FG004|Treated|Treatment (12 Weeks)||33||
48162523|NCT05375955|100721608|FG005|Treated|Treatment (12 Weeks)||35||
48162524|NCT05375955|100721609|FG006|Treated|Treatment (12 Weeks)||33||
48162525|NCT05375955|100721603|FG000|COMPLETED|Treatment (12 Weeks)||32||
48162526|NCT05375955|100721604|FG001|COMPLETED|Treatment (12 Weeks)||34||
48162527|NCT05375955|100721605|FG002|COMPLETED|Treatment (12 Weeks)||29||
48162528|NCT05375955|100721606|FG003|COMPLETED|Treatment (12 Weeks)||25||
48162529|NCT05375955|100721607|FG004|COMPLETED|Treatment (12 Weeks)||28||
48162530|NCT05375955|100721608|FG005|COMPLETED|Treatment (12 Weeks)||30||
48162531|NCT05375955|100721609|FG006|COMPLETED|Treatment (12 Weeks)||29||
48162532|NCT05375955|100721603|FG000|NOT COMPLETED|Treatment (12 Weeks)||12||
48162533|NCT05375955|100721604|FG001|NOT COMPLETED|Treatment (12 Weeks)||8||
48162534|NCT05375955|100721605|FG002|NOT COMPLETED|Treatment (12 Weeks)||13||
48162535|NCT05375955|100721606|FG003|NOT COMPLETED|Treatment (12 Weeks)||9||
48162536|NCT05375955|100721607|FG004|NOT COMPLETED|Treatment (12 Weeks)||5||
48162537|NCT05375955|100721608|FG005|NOT COMPLETED|Treatment (12 Weeks)||5||
48162538|NCT05375955|100721609|FG006|NOT COMPLETED|Treatment (12 Weeks)||4||
48162539|NCT05375955|100721603|FG000|STARTED|Follow-up (up to 5 Weeks)||36||
48162540|NCT05375955|100721604|FG001|STARTED|Follow-up (up to 5 Weeks)||36||
48162541|NCT05375955|100721605|FG002|STARTED|Follow-up (up to 5 Weeks)||36||
48162542|NCT05375955|100721606|FG003|STARTED|Follow-up (up to 5 Weeks)||25||
48162543|NCT05375955|100721607|FG004|STARTED|Follow-up (up to 5 Weeks)||28||
48162544|NCT05375955|100721608|FG005|STARTED|Follow-up (up to 5 Weeks)||31||
48162545|NCT05375955|100721609|FG006|STARTED|Follow-up (up to 5 Weeks)||31||
48162546|NCT05375955|100721603|FG000|COMPLETED|Follow-up (up to 5 Weeks)||32||
48162547|NCT05375955|100721604|FG001|COMPLETED|Follow-up (up to 5 Weeks)||35||
48162548|NCT05375955|100721605|FG002|COMPLETED|Follow-up (up to 5 Weeks)||31||
48162549|NCT05375955|100721606|FG003|COMPLETED|Follow-up (up to 5 Weeks)||25||
48162550|NCT05375955|100721607|FG004|COMPLETED|Follow-up (up to 5 Weeks)||27||
48162551|NCT05375955|100721608|FG005|COMPLETED|Follow-up (up to 5 Weeks)||29||
48162552|NCT05375955|100721609|FG006|COMPLETED|Follow-up (up to 5 Weeks)||29||
48162553|NCT05375955|100721603|FG000|NOT COMPLETED|Follow-up (up to 5 Weeks)||4||
48162554|NCT05375955|100721604|FG001|NOT COMPLETED|Follow-up (up to 5 Weeks)||1||
48162555|NCT05375955|100721605|FG002|NOT COMPLETED|Follow-up (up to 5 Weeks)||5||
48162556|NCT05375955|100721606|FG003|NOT COMPLETED|Follow-up (up to 5 Weeks)||0||
48162557|NCT05375955|100721607|FG004|NOT COMPLETED|Follow-up (up to 5 Weeks)||1||
48162558|NCT05375955|100721608|FG005|NOT COMPLETED|Follow-up (up to 5 Weeks)||2||
48162559|NCT05375955|100721609|FG006|NOT COMPLETED|Follow-up (up to 5 Weeks)||2||
48162560|NCT04366726|100721610|FG000|STARTED|Overall Study||22||
48162561|NCT04366726|100721610|FG000|Received at Least 1 Dose of Study Drug|Overall Study||22||
48162562|NCT04366726|100721610|FG000|COMPLETED|Overall Study||22||
48162563|NCT04366726|100721610|FG000|NOT COMPLETED|Overall Study||0||
48162564|NCT01005303|100721611|FG000|STARTED|Overall Study||36||
48162565|NCT01005303|100721612|FG001|STARTED|Overall Study||38||
48162566|NCT01005303|100721611|FG000|COMPLETED|Overall Study||36||
48162567|NCT01005303|100721612|FG001|COMPLETED|Overall Study||35||
48162568|NCT01005303|100721611|FG000|NOT COMPLETED|Overall Study||0||
48162569|NCT01005303|100721612|FG001|NOT COMPLETED|Overall Study||3||
48162570|NCT00993824|100721613|FG000|STARTED|Overall Study||11||
48162571|NCT00993824|100721614|FG001|STARTED|Overall Study||10||
48162572|NCT00993824|100721613|FG000|COMPLETED|Overall Study||11||
48162573|NCT00993824|100721614|FG001|COMPLETED|Overall Study||10||
48162574|NCT00993824|100721613|FG000|NOT COMPLETED|Overall Study||0||
48162575|NCT00993824|100721614|FG001|NOT COMPLETED|Overall Study||0||
48162576|NCT03557086|100721615|FG000|STARTED|Overall Study||26||
48162577|NCT03557086|100721616|FG001|STARTED|Overall Study||24||
48162578|NCT03557086|100721615|FG000|COMPLETED|Overall Study||26||
48162579|NCT03557086|100721616|FG001|COMPLETED|Overall Study||24||
48162580|NCT03557086|100721615|FG000|NOT COMPLETED|Overall Study||0||
48162581|NCT03557086|100721616|FG001|NOT COMPLETED|Overall Study||0||
48162582|NCT02234063|100721617|FG000|STARTED|Overall Study||1795||
48162583|NCT02234063|100721618|FG001|STARTED|Overall Study||255||
48162584|NCT02234063|100721617|FG000|COMPLETED|Overall Study||1540||
48162585|NCT02234063|100721618|FG001|COMPLETED|Overall Study||212||
48162586|NCT02234063|100721617|FG000|NOT COMPLETED|Overall Study||255||
48162587|NCT02234063|100721618|FG001|NOT COMPLETED|Overall Study||43||
48162588|NCT01785563|100721619|FG000|STARTED|Overall Study||40||
48162589|NCT01785563|100721619|FG000|COMPLETED|Overall Study||27||
48162590|NCT01785563|100721619|FG000|NOT COMPLETED|Overall Study||13||
48162591|NCT05061537|100721620|FG000|STARTED|Treatment Phase||3||
48162592|NCT05061537|100721621|FG001|STARTED|Treatment Phase||4||
48162593|NCT05061537|100721622|FG002|STARTED|Treatment Phase||6||
48162594|NCT05061537|100721623|FG003|STARTED|Treatment Phase||0||
48162595|NCT05061537|100721624|FG004|STARTED|Treatment Phase||0||
48162596|NCT05061537|100721620|FG000|COMPLETED|Treatment Phase||3||
48162597|NCT05061537|100721621|FG001|COMPLETED|Treatment Phase||2||
48162598|NCT05061537|100721622|FG002|COMPLETED|Treatment Phase||2||
48162599|NCT05061537|100721623|FG003|COMPLETED|Treatment Phase||0||
48162600|NCT05061537|100721624|FG004|COMPLETED|Treatment Phase||0||
48162601|NCT05061537|100721620|FG000|NOT COMPLETED|Treatment Phase||0||
48162602|NCT05061537|100721621|FG001|NOT COMPLETED|Treatment Phase||2||
48162603|NCT05061537|100721622|FG002|NOT COMPLETED|Treatment Phase||4||
48767637|NCT01929317|102222786|FG001|NOT COMPLETED|Dose Increase Effect Verification Phase||1||
48162604|NCT05061537|100721623|FG003|NOT COMPLETED|Treatment Phase||0||
48162605|NCT05061537|100721624|FG004|NOT COMPLETED|Treatment Phase||0||
48162606|NCT05061537|100721620|FG000|STARTED|Follow up||3||
48162607|NCT05061537|100721621|FG001|STARTED|Follow up||3||
48162608|NCT05061537|100721622|FG002|STARTED|Follow up||4||
48162609|NCT05061537|100721623|FG003|STARTED|Follow up||0||
48162610|NCT05061537|100721624|FG004|STARTED|Follow up||0||
48162611|NCT05061537|100721620|FG000|COMPLETED|Follow up||1||
48162612|NCT05061537|100721621|FG001|COMPLETED|Follow up||3||
48162613|NCT05061537|100721622|FG002|COMPLETED|Follow up||0||
48162614|NCT05061537|100721623|FG003|COMPLETED|Follow up||0||
48162615|NCT05061537|100721624|FG004|COMPLETED|Follow up||0||
48324946|NCT00916357|101121371|FG004|COMPLETED|Washout (3 to 14 Days)||3||
48324947|NCT00916357|101121372|FG005|COMPLETED|Washout (3 to 14 Days)||4||
48324948|NCT00916357|101121367|FG000|NOT COMPLETED|Washout (3 to 14 Days)||0||
48324949|NCT00916357|101121368|FG001|NOT COMPLETED|Washout (3 to 14 Days)||0||
48324950|NCT00916357|101121369|FG002|NOT COMPLETED|Washout (3 to 14 Days)||0||
48324951|NCT00916357|101121370|FG003|NOT COMPLETED|Washout (3 to 14 Days)||0||
48324952|NCT00916357|101121371|FG004|NOT COMPLETED|Washout (3 to 14 Days)||0||
48324953|NCT00916357|101121372|FG005|NOT COMPLETED|Washout (3 to 14 Days)||0||
48324954|NCT00916357|101121367|FG000|STARTED|Period 3||3||
48324955|NCT00916357|101121368|FG001|STARTED|Period 3||4||
48324956|NCT00916357|101121369|FG002|STARTED|Period 3||4||
48618805|NCT03834025|101852969|FG001|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0||
48618806|NCT03834025|101852970|FG002|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0||
48618807|NCT03834025|101852971|FG003|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0||
48618808|NCT03834025|101852972|FG004|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0||
48618809|NCT03834025|101852973|FG005|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0||
48618810|NCT03834025|101852974|FG006|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||1||
48618811|NCT02318849|101852975|FG000|STARTED|Pre-intervention Cross Sectional Data||249||
48162616|NCT05061537|100721620|FG000|NOT COMPLETED|Follow up||2||
48162617|NCT05061537|100721621|FG001|NOT COMPLETED|Follow up||0||
48162618|NCT05061537|100721622|FG002|NOT COMPLETED|Follow up||4||
48162619|NCT05061537|100721623|FG003|NOT COMPLETED|Follow up||0||
48162620|NCT05061537|100721624|FG004|NOT COMPLETED|Follow up||0||
48162621|NCT05061537|100721620|FG000|STARTED|Long-term Follow-up||2||
48162622|NCT05061537|100721621|FG001|STARTED|Long-term Follow-up||3||
48162623|NCT05061537|100721622|FG002|STARTED|Long-term Follow-up||2||
48162624|NCT05061537|100721623|FG003|STARTED|Long-term Follow-up||0||
48162625|NCT05061537|100721624|FG004|STARTED|Long-term Follow-up||0||
48324957|NCT00916357|101121370|FG003|STARTED|Period 3||3||
48324958|NCT00916357|101121371|FG004|STARTED|Period 3||3||
48324959|NCT00916357|101121372|FG005|STARTED|Period 3||4||
48324960|NCT00916357|101121367|FG000|COMPLETED|Period 3||3||
48324961|NCT00916357|101121368|FG001|COMPLETED|Period 3||4||
48324962|NCT00916357|101121369|FG002|COMPLETED|Period 3||4||
48324963|NCT00916357|101121370|FG003|COMPLETED|Period 3||3||
48324964|NCT00916357|101121371|FG004|COMPLETED|Period 3||3||
48324965|NCT00916357|101121372|FG005|COMPLETED|Period 3||4||
48618812|NCT02318849|101852976|FG001|STARTED|Pre-intervention Cross Sectional Data||677||
48618813|NCT02318849|101852977|FG002|STARTED|Pre-intervention Cross Sectional Data||1212||
48618814|NCT02318849|101852975|FG000|COMPLETED|Pre-intervention Cross Sectional Data||249||
48618815|NCT02318849|101852976|FG001|COMPLETED|Pre-intervention Cross Sectional Data||677||
48618816|NCT02318849|101852977|FG002|COMPLETED|Pre-intervention Cross Sectional Data||1212||
48618817|NCT02318849|101852975|FG000|NOT COMPLETED|Pre-intervention Cross Sectional Data||0||
48618818|NCT02318849|101852976|FG001|NOT COMPLETED|Pre-intervention Cross Sectional Data||0||
48324966|NCT00916357|101121367|FG000|NOT COMPLETED|Period 3||0||
48324967|NCT00916357|101121368|FG001|NOT COMPLETED|Period 3||0||
48162626|NCT05061537|100721620|FG000|COMPLETED|Long-term Follow-up||0||
48162627|NCT05061537|100721621|FG001|COMPLETED|Long-term Follow-up||0||
48162628|NCT05061537|100721622|FG002|COMPLETED|Long-term Follow-up||0||
48162629|NCT05061537|100721623|FG003|COMPLETED|Long-term Follow-up||0||
48162630|NCT05061537|100721624|FG004|COMPLETED|Long-term Follow-up||0||
48162631|NCT05061537|100721620|FG000|NOT COMPLETED|Long-term Follow-up||2||
48162632|NCT05061537|100721621|FG001|NOT COMPLETED|Long-term Follow-up||3||
48324968|NCT00916357|101121369|FG002|NOT COMPLETED|Period 3||0||
48324969|NCT00916357|101121370|FG003|NOT COMPLETED|Period 3||0||
48324970|NCT00916357|101121371|FG004|NOT COMPLETED|Period 3||0||
48324971|NCT00916357|101121372|FG005|NOT COMPLETED|Period 3||0||
48324972|NCT01295216|101121373|FG000|STARTED|Overall Study||316||
48324973|NCT01295216|101121374|FG001|STARTED|Overall Study||321||
48324974|NCT01295216|101121373|FG000|COMPLETED|Overall Study||266||
48324975|NCT01295216|101121374|FG001|COMPLETED|Overall Study||287||
48324976|NCT01295216|101121373|FG000|NOT COMPLETED|Overall Study||50||
48324977|NCT01295216|101121374|FG001|NOT COMPLETED|Overall Study||34||
48324978|NCT00252057|101121375|FG000|STARTED|Overall Study||373||
48324979|NCT00252057|101121376|FG001|STARTED|Overall Study||376||
48324980|NCT00252057|101121375|FG000|COMPLETED|Overall Study||370||
48324981|NCT00252057|101121376|FG001|COMPLETED|Overall Study||368||
48324982|NCT00252057|101121375|FG000|NOT COMPLETED|Overall Study||3||
48324983|NCT00252057|101121376|FG001|NOT COMPLETED|Overall Study||8||
48324984|NCT01079182|101121377|FG000|STARTED|Overall Study||4681||
48324985|NCT01079182|101121377|FG000|COMPLETED|Overall Study||1962||
48324986|NCT01079182|101121377|FG000|NOT COMPLETED|Overall Study||2719||
48324987|NCT02189850|101121378|FG000|STARTED|Overall Study||16|Safety population - all subjects that took preparation.|
48408992|NCT02614261|101331926|FG002|NOT COMPLETED|Double-Blind Treatment Phase||13||
48408993|NCT02614261|101331927|FG003|NOT COMPLETED|Double-Blind Treatment Phase||0||
48408994|NCT02614261|101331924|FG000|STARTED|Open-Label Extension Phase||501||
48408995|NCT02614261|101331925|FG001|STARTED|Open-Label Extension Phase||259||
48408996|NCT02614261|101331926|FG002|STARTED|Open-Label Extension Phase||262||
48408997|NCT02614261|101331927|FG003|STARTED|Open-Label Extension Phase||0||
48408998|NCT02614261|101331924|FG000|Safety Population|Open-Label Extension Phase||501||
48408999|NCT02614261|101331925|FG001|Safety Population|Open-Label Extension Phase||259||
48409000|NCT02614261|101331926|FG002|Safety Population|Open-Label Extension Phase||262||
48409001|NCT02614261|101331927|FG003|Safety Population|Open-Label Extension Phase||0||
48409002|NCT02614261|101331924|FG000|COMPLETED|Open-Label Extension Phase||413||
48618819|NCT02318849|101852977|FG002|NOT COMPLETED|Pre-intervention Cross Sectional Data||0||
48324988|NCT02189850|101121379|FG001|STARTED|Overall Study||13|Safety population - all subjects that took preparation.|
48324989|NCT02189850|101121378|FG000|COMPLETED|Overall Study||14||
48324990|NCT02189850|101121379|FG001|COMPLETED|Overall Study||11||
48324991|NCT02189850|101121378|FG000|NOT COMPLETED|Overall Study||2||
48324992|NCT02189850|101121379|FG001|NOT COMPLETED|Overall Study||2||
48324993|NCT01146873|101121380|FG000|STARTED|Overall Study||148||
48324994|NCT01146873|101121381|FG001|STARTED|Overall Study||150||
48324995|NCT01146873|101121380|FG000|COMPLETED|Overall Study||148||
48324996|NCT01146873|101121381|FG001|COMPLETED|Overall Study||144||
48324997|NCT01146873|101121380|FG000|NOT COMPLETED|Overall Study||0||
48324998|NCT01146873|101121381|FG001|NOT COMPLETED|Overall Study||6||
48324999|NCT01550562|101121382|FG000|STARTED|First Intervention, 4 - 5 Days||1||
48325000|NCT01550562|101121382|FG000|COMPLETED|First Intervention, 4 - 5 Days||1||
48325001|NCT01550562|101121382|FG000|NOT COMPLETED|First Intervention, 4 - 5 Days||0||
48325002|NCT01550562|101121382|FG000|STARTED|Second Intervention, 4 - 5 Days||1||
48325003|NCT01550562|101121382|FG000|COMPLETED|Second Intervention, 4 - 5 Days||1||
48325004|NCT01550562|101121382|FG000|NOT COMPLETED|Second Intervention, 4 - 5 Days||0||
48325005|NCT01550562|101121382|FG000|STARTED|Third Intervention, 4 - 5 Days||1||
48325006|NCT01550562|101121382|FG000|COMPLETED|Third Intervention, 4 - 5 Days||1||
48325007|NCT01550562|101121382|FG000|NOT COMPLETED|Third Intervention, 4 - 5 Days||0||
48325008|NCT01014741|101121383|FG000|STARTED|Overall Study||105||
48325009|NCT01014741|101121384|FG001|STARTED|Overall Study||95||
48325010|NCT01014741|101121383|FG000|COMPLETED|Overall Study||94||
48409003|NCT02614261|101331925|FG001|COMPLETED|Open-Label Extension Phase||204||
48409004|NCT02614261|101331926|FG002|COMPLETED|Open-Label Extension Phase||208||
48409005|NCT02614261|101331927|FG003|COMPLETED|Open-Label Extension Phase||0||
48409006|NCT02614261|101331924|FG000|NOT COMPLETED|Open-Label Extension Phase||88||
48409007|NCT02614261|101331925|FG001|NOT COMPLETED|Open-Label Extension Phase||55||
48657101|NCT03761914|101943778|FG000|STARTED|Overall Study||25||
48325011|NCT01014741|101121384|FG001|COMPLETED|Overall Study||90||
48325012|NCT01014741|101121383|FG000|NOT COMPLETED|Overall Study||11||
48325013|NCT01014741|101121384|FG001|NOT COMPLETED|Overall Study||5||
48325014|NCT00822107|101121385|FG000|STARTED|Overall Study||5||
48325015|NCT00822107|101121385|FG000|COMPLETED|Overall Study||5||
48325016|NCT00822107|101121385|FG000|NOT COMPLETED|Overall Study||0||
48325017|NCT04697628|101121386|FG000|STARTED|Overall Study||253||
48325018|NCT04697628|101121387|FG001|STARTED|Overall Study||249||
48325019|NCT04697628|101121386|FG000|Treated|Overall Study||250||
48325020|NCT04697628|101121387|FG001|Treated|Overall Study||239||
48325021|NCT04697628|101121386|FG000|COMPLETED|Overall Study||114||
48325022|NCT04697628|101121387|FG001|COMPLETED|Overall Study||131||
48325023|NCT04697628|101121386|FG000|NOT COMPLETED|Overall Study||139||
48325024|NCT04697628|101121387|FG001|NOT COMPLETED|Overall Study||118||
48325025|NCT01309659|101121388|FG000|STARTED|Overall Study||9||
48325026|NCT01309659|101121389|FG001|STARTED|Overall Study||10||
48325027|NCT01309659|101121388|FG000|COMPLETED|Overall Study||9||
48325028|NCT01309659|101121389|FG001|COMPLETED|Overall Study||9||
48325029|NCT01309659|101121388|FG000|NOT COMPLETED|Overall Study||0||
48325030|NCT01309659|101121389|FG001|NOT COMPLETED|Overall Study||1||
48409008|NCT02614261|101331926|FG002|NOT COMPLETED|Open-Label Extension Phase||54||
48409009|NCT02614261|101331927|FG003|NOT COMPLETED|Open-Label Extension Phase||0||
48409010|NCT02614261|101331924|FG000|STARTED|Follow-up Phase||453||
48409011|NCT02614261|101331925|FG001|STARTED|Follow-up Phase||228||
48409012|NCT02614261|101331926|FG002|STARTED|Follow-up Phase||231||
48409013|NCT02614261|101331927|FG003|STARTED|Follow-up Phase||0||
48409014|NCT02614261|101331924|FG000|Entered From Double-blind Treatment Phase|Follow-up Phase||15||
48409015|NCT02614261|101331925|FG001|Entered From Double-blind Treatment Phase|Follow-up Phase||5||
48409016|NCT02614261|101331926|FG002|Entered From Double-blind Treatment Phase|Follow-up Phase||3||
48409017|NCT02614261|101331927|FG003|Entered From Double-blind Treatment Phase|Follow-up Phase||0||
48409018|NCT02614261|101331924|FG000|Safety Population (Entered From Double-blind Treatment Phase)|Follow-up Phase||15||
48409019|NCT02614261|101331925|FG001|Safety Population (Entered From Double-blind Treatment Phase)|Follow-up Phase||4||
48409020|NCT02614261|101331926|FG002|Safety Population (Entered From Double-blind Treatment Phase)|Follow-up Phase||4||
48409021|NCT02614261|101331927|FG003|Safety Population (Entered From Double-blind Treatment Phase)|Follow-up Phase||0||
48409022|NCT02614261|101331924|FG000|Entered From Open-label Extension Phase|Follow-up Phase||438||
48409023|NCT02614261|101331925|FG001|Entered From Open-label Extension Phase|Follow-up Phase||223||
48409024|NCT02614261|101331926|FG002|Entered From Open-label Extension Phase|Follow-up Phase||228||
48409025|NCT02614261|101331927|FG003|Entered From Open-label Extension Phase|Follow-up Phase||0||
48325031|NCT00605423|101121390|FG000|STARTED|Overall Study||4||
48325032|NCT00605423|101121391|FG001|STARTED|Overall Study||2||
48325033|NCT00605423|101121390|FG000|COMPLETED|Overall Study||4||
48325034|NCT00605423|101121391|FG001|COMPLETED|Overall Study||2||
48325035|NCT00605423|101121390|FG000|NOT COMPLETED|Overall Study||0||
48325036|NCT00605423|101121391|FG001|NOT COMPLETED|Overall Study||0||
48325037|NCT01262365|101121392|FG000|STARTED|Overall Study||266||
48325038|NCT01262365|101121393|FG001|STARTED|Overall Study||262||
48325039|NCT01262365|101121394|FG002|STARTED|Overall Study||265||
48325040|NCT01262365|101121392|FG000|COMPLETED|Overall Study||176||
48325041|NCT01262365|101121393|FG001|COMPLETED|Overall Study||181||
48325042|NCT01262365|101121394|FG002|COMPLETED|Overall Study||171||
48325043|NCT01262365|101121392|FG000|NOT COMPLETED|Overall Study||90||
48325044|NCT01262365|101121393|FG001|NOT COMPLETED|Overall Study||81||
48325045|NCT01262365|101121394|FG002|NOT COMPLETED|Overall Study||94||
48325046|NCT04081363|101121395|FG000|STARTED|Overall Study||7||
48325047|NCT04081363|101121396|FG001|STARTED|Overall Study||6||
48325048|NCT04081363|101121395|FG000|COMPLETED|Overall Study||6||
48325049|NCT04081363|101121396|FG001|COMPLETED|Overall Study||6||
48325050|NCT04081363|101121395|FG000|NOT COMPLETED|Overall Study||1||
48325051|NCT04081363|101121396|FG001|NOT COMPLETED|Overall Study||0||
48325052|NCT00290615|101121397|FG000|STARTED|Overall Study||30||
48325053|NCT00290615|101121397|FG000|COMPLETED|Overall Study||30||
48325054|NCT00290615|101121397|FG000|NOT COMPLETED|Overall Study||0||
48325055|NCT01093027|101121398|FG000|STARTED|Visit 1||10||
48325056|NCT01093027|101121399|FG001|STARTED|Visit 1||10||
48325057|NCT01093027|101121398|FG000|COMPLETED|Visit 1||10||
48325058|NCT01093027|101121399|FG001|COMPLETED|Visit 1||10||
48325059|NCT01093027|101121398|FG000|NOT COMPLETED|Visit 1||0||
48409026|NCT02614261|101331924|FG000|Safety Population (Entered From Open-label Extension Phase)|Follow-up Phase||438||
48409027|NCT02614261|101331925|FG001|Safety Population (Entered From Open-label Extension Phase)|Follow-up Phase||223||
48409028|NCT02614261|101331926|FG002|Safety Population (Entered From Open-label Extension Phase)|Follow-up Phase||228||
48409029|NCT02614261|101331927|FG003|Safety Population (Entered From Open-label Extension Phase)|Follow-up Phase||0||
48409030|NCT02614261|101331924|FG000|COMPLETED|Follow-up Phase||421||
48409031|NCT02614261|101331925|FG001|COMPLETED|Follow-up Phase||217||
48409032|NCT02614261|101331926|FG002|COMPLETED|Follow-up Phase||217||
48409033|NCT02614261|101331927|FG003|COMPLETED|Follow-up Phase||0||
48409034|NCT02614261|101331924|FG000|NOT COMPLETED|Follow-up Phase||32||
48409035|NCT02614261|101331925|FG001|NOT COMPLETED|Follow-up Phase||11||
48409036|NCT02614261|101331926|FG002|NOT COMPLETED|Follow-up Phase||14||
48409037|NCT02614261|101331927|FG003|NOT COMPLETED|Follow-up Phase||0||
48409038|NCT02614261|101331924|FG000|STARTED|Israel Addendum||0||
48409039|NCT02614261|101331925|FG001|STARTED|Israel Addendum||0||
48409040|NCT02614261|101331926|FG002|STARTED|Israel Addendum||0||
48409041|NCT02614261|101331927|FG003|STARTED|Israel Addendum||29||
48409042|NCT02614261|101331924|FG000|Safety Population|Israel Addendum||0||
48409043|NCT02614261|101331925|FG001|Safety Population|Israel Addendum||0||
48409044|NCT02614261|101331926|FG002|Safety Population|Israel Addendum||0||
48656960|NCT01340170|101943736|FG002|Permanent Restoration (Start + 3 Months)|Overall Study||3|ITT population|6
48325060|NCT01093027|101121399|FG001|NOT COMPLETED|Visit 1||0||
48325061|NCT01093027|101121398|FG000|STARTED|Visit 2||10||
48325062|NCT01093027|101121399|FG001|STARTED|Visit 2||10||
48325063|NCT01093027|101121398|FG000|COMPLETED|Visit 2||10||
48325064|NCT01093027|101121399|FG001|COMPLETED|Visit 2||10||
48325065|NCT01093027|101121398|FG000|NOT COMPLETED|Visit 2||0||
48325066|NCT01093027|101121399|FG001|NOT COMPLETED|Visit 2||0||
48325067|NCT01779024|101121400|FG000|STARTED|1st Visit - Alcohol Self-Administration||8||
48325068|NCT01779024|101121401|FG001|STARTED|1st Visit - Alcohol Self-Administration||9||
48325069|NCT01779024|101121400|FG000|COMPLETED|1st Visit - Alcohol Self-Administration||8||
48325070|NCT01779024|101121401|FG001|COMPLETED|1st Visit - Alcohol Self-Administration||9||
48325071|NCT01779024|101121400|FG000|NOT COMPLETED|1st Visit - Alcohol Self-Administration||0||
48325072|NCT01779024|101121401|FG001|NOT COMPLETED|1st Visit - Alcohol Self-Administration||0||
48325073|NCT01779024|101121400|FG000|STARTED|2nd Visit - Alcohol Self-Administration||8||
48325074|NCT01779024|101121401|FG001|STARTED|2nd Visit - Alcohol Self-Administration||9||
48325075|NCT01779024|101121400|FG000|COMPLETED|2nd Visit - Alcohol Self-Administration||6||
48325076|NCT01779024|101121401|FG001|COMPLETED|2nd Visit - Alcohol Self-Administration||9||
48325077|NCT01779024|101121400|FG000|NOT COMPLETED|2nd Visit - Alcohol Self-Administration||2||
48325078|NCT01779024|101121401|FG001|NOT COMPLETED|2nd Visit - Alcohol Self-Administration||0||
48325079|NCT01779024|101121400|FG000|STARTED|1st Visit - Functional MRI||6||
48325080|NCT01779024|101121401|FG001|STARTED|1st Visit - Functional MRI||7||
48325081|NCT01779024|101121400|FG000|COMPLETED|1st Visit - Functional MRI||4||
48325082|NCT01779024|101121401|FG001|COMPLETED|1st Visit - Functional MRI||5||
48325083|NCT01779024|101121400|FG000|NOT COMPLETED|1st Visit - Functional MRI||2||
48325084|NCT01779024|101121401|FG001|NOT COMPLETED|1st Visit - Functional MRI||2||
48325085|NCT01779024|101121400|FG000|STARTED|2nd Visit - Functional MRI||5||
48325086|NCT01779024|101121401|FG001|STARTED|2nd Visit - Functional MRI||6||
48325087|NCT01779024|101121400|FG000|COMPLETED|2nd Visit - Functional MRI||5||
48325088|NCT01779024|101121401|FG001|COMPLETED|2nd Visit - Functional MRI||6||
48325089|NCT01779024|101121400|FG000|NOT COMPLETED|2nd Visit - Functional MRI||0||
48325090|NCT01779024|101121401|FG001|NOT COMPLETED|2nd Visit - Functional MRI||0||
48325091|NCT02154386|101121402|FG000|STARTED|Overall Study||23||
48325092|NCT02154386|101121403|FG001|STARTED|Overall Study||23||
48325093|NCT02154386|101121402|FG000|COMPLETED|Overall Study||22||
48325094|NCT02154386|101121403|FG001|COMPLETED|Overall Study||21||
48325095|NCT02154386|101121402|FG000|NOT COMPLETED|Overall Study||1||
48325096|NCT02154386|101121403|FG001|NOT COMPLETED|Overall Study||2||
48325097|NCT00936208|101121404|FG000|STARTED|Overall Study||1499||
48325098|NCT00936208|101121405|FG001|STARTED|Overall Study||1596||
48325099|NCT00936208|101121404|FG000|COMPLETED|Overall Study||1462||
48325100|NCT00936208|101121405|FG001|COMPLETED|Overall Study||1574||
48325101|NCT00936208|101121404|FG000|NOT COMPLETED|Overall Study||37||
48325102|NCT00936208|101121405|FG001|NOT COMPLETED|Overall Study||22||
48325103|NCT02678390|101121406|FG000|STARTED|Control (5 Days)||10||
48325104|NCT02678390|101121407|FG001|STARTED|Control (5 Days)||10||
48325105|NCT02678390|101121406|FG000|COMPLETED|Control (5 Days)||10||
48325106|NCT02678390|101121407|FG001|COMPLETED|Control (5 Days)||10||
48325107|NCT02678390|101121406|FG000|NOT COMPLETED|Control (5 Days)||0||
48325108|NCT02678390|101121407|FG001|NOT COMPLETED|Control (5 Days)||0||
48325109|NCT02678390|101121406|FG000|STARTED|MCT (5 Days)||10||
48325110|NCT02678390|101121407|FG001|STARTED|MCT (5 Days)||10||
48325111|NCT02678390|101121406|FG000|COMPLETED|MCT (5 Days)||10||
48325112|NCT02678390|101121407|FG001|COMPLETED|MCT (5 Days)||10||
48325113|NCT02678390|101121406|FG000|NOT COMPLETED|MCT (5 Days)||0||
48325114|NCT02678390|101121407|FG001|NOT COMPLETED|MCT (5 Days)||0||
48325115|NCT02678390|101121406|FG000|STARTED|AE (1 Day)||10||
48325116|NCT02678390|101121407|FG001|STARTED|AE (1 Day)||10||
48325117|NCT02678390|101121406|FG000|COMPLETED|AE (1 Day)||10||
48325118|NCT02678390|101121407|FG001|COMPLETED|AE (1 Day)||9||
48325119|NCT02678390|101121406|FG000|NOT COMPLETED|AE (1 Day)||0||
48325120|NCT02678390|101121407|FG001|NOT COMPLETED|AE (1 Day)||1||
48325121|NCT02678390|101121406|FG000|STARTED|MCT + AE (5 Days)||10||
48325122|NCT02678390|101121407|FG001|STARTED|MCT + AE (5 Days)||9||
48325123|NCT02678390|101121406|FG000|COMPLETED|MCT + AE (5 Days)||10||
48325124|NCT02678390|101121407|FG001|COMPLETED|MCT + AE (5 Days)||9||
48325125|NCT02678390|101121406|FG000|NOT COMPLETED|MCT + AE (5 Days)||0||
48325126|NCT02678390|101121407|FG001|NOT COMPLETED|MCT + AE (5 Days)||0||
48325127|NCT01780662|101121408|FG000|STARTED|Overall Study||3||
48325128|NCT01780662|101121409|FG001|STARTED|Overall Study||13||
48325129|NCT01780662|101121410|FG002|STARTED|Overall Study||30||
48325130|NCT01780662|101121408|FG000|COMPLETED|Overall Study||2||
48325131|NCT01780662|101121409|FG001|COMPLETED|Overall Study||7||
48325132|NCT01780662|101121410|FG002|COMPLETED|Overall Study||20||
48325133|NCT01780662|101121408|FG000|NOT COMPLETED|Overall Study||1||
48325134|NCT01780662|101121409|FG001|NOT COMPLETED|Overall Study||6||
48325135|NCT01780662|101121410|FG002|NOT COMPLETED|Overall Study||10||
48325136|NCT01681433|101121411|FG000|STARTED|Overall Study||36||
48325137|NCT01681433|101121412|FG001|STARTED|Overall Study||36||
48325138|NCT01681433|101121411|FG000|COMPLETED|Overall Study||4||
48325139|NCT01681433|101121412|FG001|COMPLETED|Overall Study||3||
48325140|NCT01681433|101121411|FG000|NOT COMPLETED|Overall Study||32||
48325141|NCT01681433|101121412|FG001|NOT COMPLETED|Overall Study||33||
48325142|NCT04623242|101121413|FG000|STARTED|Overall Study||52||
48325143|NCT04623242|101121414|FG001|STARTED|Overall Study||52||
48325144|NCT04623242|101121415|FG002|STARTED|Overall Study||40||
48325145|NCT04623242|101121416|FG003|STARTED|Overall Study||49||
48325146|NCT04623242|101121417|FG004|STARTED|Overall Study||69||
48325147|NCT04623242|101121413|FG000|COMPLETED|Overall Study||39||
48325148|NCT04623242|101121414|FG001|COMPLETED|Overall Study||36||
48325149|NCT04623242|101121415|FG002|COMPLETED|Overall Study||30||
48325150|NCT04623242|101121416|FG003|COMPLETED|Overall Study||26||
48325151|NCT04623242|101121417|FG004|COMPLETED|Overall Study||69||
48325152|NCT04623242|101121413|FG000|NOT COMPLETED|Overall Study||13||
48325153|NCT04623242|101121414|FG001|NOT COMPLETED|Overall Study||16||
48325154|NCT04623242|101121415|FG002|NOT COMPLETED|Overall Study||10||
48325155|NCT04623242|101121416|FG003|NOT COMPLETED|Overall Study||23||
48325156|NCT04623242|101121417|FG004|NOT COMPLETED|Overall Study||0||
48325157|NCT01484626|101121418|FG000|STARTED|Overall Study||3||
48325158|NCT01484626|101121418|FG000|COMPLETED|Overall Study||3||
48325159|NCT01484626|101121418|FG000|NOT COMPLETED|Overall Study||0||
48325160|NCT02933034|101121419|FG000|STARTED|Overall Study||33||
48325161|NCT02933034|101121419|FG000|Received Both MEMRI and DEMRI Scans|Overall Study||24||
48325162|NCT02933034|101121419|FG000|COMPLETED|Overall Study||24||
48325163|NCT02933034|101121419|FG000|NOT COMPLETED|Overall Study||9||
48325164|NCT01192022|101121420|FG000|STARTED|Overall Study||114||
48325165|NCT01192022|101121421|FG001|STARTED|Overall Study||110||
48325166|NCT01192022|101121422|FG002|STARTED|Overall Study||8||
48325167|NCT01192022|101121423|FG003|STARTED|Overall Study||9||
48325168|NCT01192022|101121424|FG004|STARTED|Overall Study||12||
48325169|NCT01192022|101121420|FG000|Safety Population-Received Treatment|Overall Study||114||
48325170|NCT01192022|101121421|FG001|Safety Population-Received Treatment|Overall Study||109||
48325171|NCT01192022|101121422|FG002|Safety Population-Received Treatment|Overall Study||8||
48325172|NCT01192022|101121423|FG003|Safety Population-Received Treatment|Overall Study||9||
48325173|NCT01192022|101121424|FG004|Safety Population-Received Treatment|Overall Study||12||
48325174|NCT01192022|101121420|FG000|COMPLETED|Overall Study||101||
48325175|NCT01192022|101121421|FG001|COMPLETED|Overall Study||99||
48325176|NCT01192022|101121422|FG002|COMPLETED|Overall Study||7||
48325177|NCT01192022|101121423|FG003|COMPLETED|Overall Study||7||
48325178|NCT01192022|101121424|FG004|COMPLETED|Overall Study||11||
48325179|NCT01192022|101121420|FG000|NOT COMPLETED|Overall Study||13||
48325180|NCT01192022|101121421|FG001|NOT COMPLETED|Overall Study||11||
48325181|NCT01192022|101121422|FG002|NOT COMPLETED|Overall Study||1||
48325182|NCT01192022|101121423|FG003|NOT COMPLETED|Overall Study||2||
48325183|NCT01192022|101121424|FG004|NOT COMPLETED|Overall Study||1||
48325184|NCT03124563|101121425|FG000|STARTED|Overall Study||32|Number of participants enrolled in study and randomly assigned to group|
48325185|NCT03124563|101121426|FG001|STARTED|Overall Study||31|Number of participants enrolled in study and randomly assigned to group|
48325186|NCT03124563|101121425|FG000|Pre-test|Overall Study||30|Number of participants that filled out pre-test measures and started the study|
48325187|NCT03124563|101121426|FG001|Pre-test|Overall Study||30|Number of participants that filled out pre-test measures and started the study|
48325188|NCT03124563|101121425|FG000|COMPLETED|Overall Study||30|Number of participants that completed the study|
48325189|NCT03124563|101121426|FG001|COMPLETED|Overall Study||29|Number of participants that completed the study|
48325190|NCT03124563|101121425|FG000|NOT COMPLETED|Overall Study||2||
48325191|NCT03124563|101121426|FG001|NOT COMPLETED|Overall Study||2||
48325192|NCT01327157|101121427|FG000|STARTED|01-90||7||
48325193|NCT01327157|101121428|FG001|STARTED|01-90||7||
48325194|NCT01327157|101121427|FG000|COMPLETED|01-90||7||
48325195|NCT01327157|101121428|FG001|COMPLETED|01-90||7||
48325196|NCT01327157|101121427|FG000|NOT COMPLETED|01-90||0||
48325197|NCT01327157|101121428|FG001|NOT COMPLETED|01-90||0||
48325198|NCT01327157|101121427|FG000|STARTED|91-180||7||
48325199|NCT01327157|101121428|FG001|STARTED|91-180||0||
48325200|NCT01327157|101121427|FG000|COMPLETED|91-180||7||
48325201|NCT01327157|101121428|FG001|COMPLETED|91-180||0||
48325202|NCT01327157|101121427|FG000|NOT COMPLETED|91-180||0||
48325203|NCT01327157|101121428|FG001|NOT COMPLETED|91-180||0||
48325204|NCT00517829|101121429|FG000|STARTED|Overall Study||75||
48325205|NCT00517829|101121430|FG001|STARTED|Overall Study||75||
48325206|NCT00517829|101121429|FG000|COMPLETED|Overall Study||0||
48325207|NCT00517829|101121430|FG001|COMPLETED|Overall Study||0||
48325208|NCT00517829|101121429|FG000|NOT COMPLETED|Overall Study||75||
48325209|NCT00517829|101121430|FG001|NOT COMPLETED|Overall Study||75||
48325210|NCT02214238|101121431|FG000|STARTED|Overall Study||26||
48325211|NCT02214238|101121432|FG001|STARTED|Overall Study||23||
48325212|NCT02214238|101121431|FG000|COMPLETED|Overall Study||20||
48325213|NCT02214238|101121432|FG001|COMPLETED|Overall Study||17||
48325214|NCT02214238|101121431|FG000|NOT COMPLETED|Overall Study||6||
48325215|NCT02214238|101121432|FG001|NOT COMPLETED|Overall Study||6||
48325216|NCT00371293|101121433|FG000|STARTED|Overall Study||58||
48325217|NCT00371293|101121434|FG001|STARTED|Overall Study||61||
48325218|NCT00371293|101121435|FG002|STARTED|Overall Study||62||
48325219|NCT00371293|101121433|FG000|COMPLETED|Overall Study||48||
48325220|NCT00371293|101121434|FG001|COMPLETED|Overall Study||42||
48325221|NCT00371293|101121435|FG002|COMPLETED|Overall Study||46||
48325222|NCT00371293|101121433|FG000|NOT COMPLETED|Overall Study||10||
48325223|NCT00371293|101121434|FG001|NOT COMPLETED|Overall Study||19||
48325224|NCT00371293|101121435|FG002|NOT COMPLETED|Overall Study||16||
48325225|NCT01292642|101121436|FG000|STARTED|Overall Study||12||
48325226|NCT01292642|101121436|FG000|COMPLETED|Overall Study||7||
48325227|NCT01292642|101121436|FG000|NOT COMPLETED|Overall Study||5||
48325228|NCT02222207|101121437|FG000|STARTED|Overall Study||52||
48325229|NCT02222207|101121437|FG000|Treated and Valid for Full Analysis Set|Overall Study||51||
48325230|NCT02222207|101121437|FG000|COMPLETED|Overall Study||48||
48325231|NCT02222207|101121437|FG000|NOT COMPLETED|Overall Study||4||
48325232|NCT01806779|101121438|FG000|STARTED|Overall Study||90||
48325233|NCT01806779|101121439|FG001|STARTED|Overall Study||84||
48618820|NCT02318849|101852975|FG000|STARTED|Post-intervention Cross Sectional Data||1234|These samples are cross-sectional data; thus, the baseline and post-intevention sample sizes are not the same.|
48618821|NCT02318849|101852976|FG001|STARTED|Post-intervention Cross Sectional Data||735|These samples are cross-sectional data; thus, the baseline and post-intevention sample sizes are not the same.|
48325234|NCT01806779|101121440|FG002|STARTED|Overall Study||23||
48325235|NCT01806779|101121438|FG000|Completed SE Quest. After Using Patches|Overall Study||90||
48325236|NCT01806779|101121439|FG001|Completed SE Quest. After Using Patches|Overall Study||84||
48325237|NCT01806779|101121440|FG002|Completed SE Quest. After Using Patches|Overall Study||2||
48325238|NCT01806779|101121438|FG000|Randomized at Visit 2|Overall Study||90||
48325239|NCT01806779|101121439|FG001|Randomized at Visit 2|Overall Study||84||
48325240|NCT01806779|101121440|FG002|Randomized at Visit 2|Overall Study||0||
48325241|NCT01806779|101121438|FG000|Completed SE Quest. After Randomization|Overall Study||87||
48325242|NCT01806779|101121439|FG001|Completed SE Quest. After Randomization|Overall Study||83||
48325243|NCT01806779|101121440|FG002|Completed SE Quest. After Randomization|Overall Study||0||
48325244|NCT01806779|101121438|FG000|COMPLETED|Overall Study||48||
48325245|NCT01806779|101121439|FG001|COMPLETED|Overall Study||40||
48325246|NCT01806779|101121440|FG002|COMPLETED|Overall Study||0||
48325247|NCT01806779|101121438|FG000|NOT COMPLETED|Overall Study||42||
48325248|NCT01806779|101121439|FG001|NOT COMPLETED|Overall Study||44||
48325249|NCT01806779|101121440|FG002|NOT COMPLETED|Overall Study||23||
48325250|NCT02008682|101121441|FG000|STARTED|Overall Study||184||
48325251|NCT02008682|101121442|FG001|STARTED|Overall Study||184||
48325252|NCT02008682|101121441|FG000|Exposed|Overall Study||183||
48325253|NCT02008682|101121442|FG001|Exposed|Overall Study||184||
48325254|NCT02008682|101121441|FG000|COMPLETED|Overall Study||157||
48325255|NCT02008682|101121442|FG001|COMPLETED|Overall Study||170||
48325256|NCT02008682|101121441|FG000|NOT COMPLETED|Overall Study||27||
48325257|NCT02008682|101121442|FG001|NOT COMPLETED|Overall Study||14||
48325258|NCT02751502|101121443|FG000|STARTED|Overall Study||4||
48325259|NCT02751502|101121443|FG000|COMPLETED|Overall Study||0||
48325260|NCT02751502|101121443|FG000|NOT COMPLETED|Overall Study||4||
48325261|NCT03325673|101121444|FG000|STARTED|Overall Study||42||
48325262|NCT03325673|101121445|FG001|STARTED|Overall Study||42||
48325263|NCT03325673|101121444|FG000|COMPLETED|Overall Study||38||
48325264|NCT03325673|101121445|FG001|COMPLETED|Overall Study||42||
48409045|NCT02614261|101331927|FG003|Safety Population|Israel Addendum||29||
48409046|NCT02614261|101331924|FG000|COMPLETED|Israel Addendum||0||
48409047|NCT02614261|101331925|FG001|COMPLETED|Israel Addendum||0||
48409048|NCT02614261|101331926|FG002|COMPLETED|Israel Addendum||0||
48409049|NCT02614261|101331927|FG003|COMPLETED|Israel Addendum||25||
48409050|NCT02614261|101331924|FG000|NOT COMPLETED|Israel Addendum||0||
48409051|NCT02614261|101331925|FG001|NOT COMPLETED|Israel Addendum||0||
48409052|NCT02614261|101331926|FG002|NOT COMPLETED|Israel Addendum||0||
48409053|NCT02614261|101331927|FG003|NOT COMPLETED|Israel Addendum||4||
48409054|NCT01585168|101331928|FG000|STARTED|Overall Study||18||
48409055|NCT01585168|101331929|FG001|STARTED|Overall Study||18||
48409056|NCT01585168|101331930|FG002|STARTED|Overall Study||16||
48409057|NCT01585168|101331931|FG003|STARTED|Overall Study||19||
48409058|NCT01585168|101331928|FG000|COMPLETED|Overall Study||15||
48409059|NCT01585168|101331929|FG001|COMPLETED|Overall Study||17||
48409060|NCT01585168|101331930|FG002|COMPLETED|Overall Study||15||
48409061|NCT01585168|101331931|FG003|COMPLETED|Overall Study||18||
48409062|NCT01585168|101331928|FG000|NOT COMPLETED|Overall Study||3||
48409063|NCT01585168|101331929|FG001|NOT COMPLETED|Overall Study||1||
48409064|NCT01585168|101331930|FG002|NOT COMPLETED|Overall Study||1||
48409065|NCT01585168|101331931|FG003|NOT COMPLETED|Overall Study||1||
48409066|NCT03605836|101331932|FG000|STARTED|OL Placebo Run-in Period [1 Week]||590||
48409067|NCT03605836|101331933|FG001|STARTED|OL Placebo Run-in Period [1 Week]||0||
48409068|NCT03605836|101331934|FG002|STARTED|OL Placebo Run-in Period [1 Week]||0||
48325265|NCT03325673|101121444|FG000|NOT COMPLETED|Overall Study||4||
48325266|NCT03325673|101121445|FG001|NOT COMPLETED|Overall Study||0||
48325267|NCT03311711|101121446|FG000|STARTED|Overall Study||15||
48325268|NCT03311711|101121447|FG001|STARTED|Overall Study||15||
48325269|NCT03311711|101121448|FG002|STARTED|Overall Study||12||
48325270|NCT03311711|101121449|FG003|STARTED|Overall Study||12||
48325271|NCT03311711|101121450|FG004|STARTED|Overall Study||15||
48325272|NCT03311711|101121451|FG005|STARTED|Overall Study||15||
48325273|NCT03311711|101121452|FG006|STARTED|Overall Study||40||
48325274|NCT03311711|101121453|FG007|STARTED|Overall Study||40||
48325275|NCT03311711|101121454|FG008|STARTED|Overall Study||39||
48325276|NCT03311711|101121455|FG009|STARTED|Overall Study||39||
48325277|NCT03311711|101121446|FG000|COMPLETED|Overall Study||11||
48325278|NCT03311711|101121447|FG001|COMPLETED|Overall Study||11||
48409069|NCT03605836|101331935|FG003|STARTED|OL Placebo Run-in Period [1 Week]||0||
48409070|NCT03605836|101331932|FG000|Treated|OL Placebo Run-in Period [1 Week]||579||
48409071|NCT03605836|101331933|FG001|Treated|OL Placebo Run-in Period [1 Week]||0||
48325279|NCT03311711|101121448|FG002|COMPLETED|Overall Study||12||
48325280|NCT03311711|101121449|FG003|COMPLETED|Overall Study||12||
48325281|NCT03311711|101121450|FG004|COMPLETED|Overall Study||15||
48325282|NCT03311711|101121451|FG005|COMPLETED|Overall Study||15||
48742277|NCT03343626|102155039|FG005|Per Protocol Set|Overall Study||33|Per-Protocol Set (PPS) included participants in the FAS who had no major protocol violations (relevant for the analysis, primary immunogenicity assessment or persistence assessment).|
48742278|NCT03343626|102155040|FG006|Per Protocol Set|Overall Study||34|Per-Protocol Set (PPS) included participants in the FAS who had no major protocol violations (relevant for the analysis, primary immunogenicity assessment or persistence assessment).|
48742279|NCT03343626|102155041|FG007|Per Protocol Set|Overall Study||33|Per-Protocol Set (PPS) included participants in the FAS who had no major protocol violations (relevant for the analysis, primary immunogenicity assessment or persistence assessment).|
48742280|NCT03343626|102155034|FG000|COMPLETED|Overall Study||25||
48742281|NCT03343626|102155035|FG001|COMPLETED|Overall Study||26||
48742282|NCT03343626|102155036|FG002|COMPLETED|Overall Study||29||
48742283|NCT03343626|102155037|FG003|COMPLETED|Overall Study||24||
48742284|NCT03343626|102155038|FG004|COMPLETED|Overall Study||29||
48742285|NCT03343626|102155039|FG005|COMPLETED|Overall Study||32||
48742286|NCT03343626|102155040|FG006|COMPLETED|Overall Study||32||
48742287|NCT03343626|102155041|FG007|COMPLETED|Overall Study||25||
48742288|NCT03343626|102155034|FG000|NOT COMPLETED|Overall Study||6||
48742289|NCT03343626|102155035|FG001|NOT COMPLETED|Overall Study||5||
48742290|NCT03343626|102155036|FG002|NOT COMPLETED|Overall Study||2||
48742291|NCT03343626|102155037|FG003|NOT COMPLETED|Overall Study||8||
48742292|NCT03343626|102155038|FG004|NOT COMPLETED|Overall Study||7||
48742293|NCT03343626|102155039|FG005|NOT COMPLETED|Overall Study||5||
48742294|NCT03343626|102155040|FG006|NOT COMPLETED|Overall Study||5||
48742295|NCT03343626|102155041|FG007|NOT COMPLETED|Overall Study||11||
48742296|NCT05373862|102155042|FG000|STARTED|Overall Study||40||
48742297|NCT05373862|102155042|FG000|COMPLETED|Overall Study||40||
48742298|NCT05373862|102155042|FG000|NOT COMPLETED|Overall Study||0||
48742299|NCT04273893|102155043|FG000|STARTED|Overall Study||26||
48742300|NCT04273893|102155044|FG001|STARTED|Overall Study||27||
48409072|NCT03605836|101331934|FG002|Treated|OL Placebo Run-in Period [1 Week]||0||
48409073|NCT03605836|101331935|FG003|Treated|OL Placebo Run-in Period [1 Week]||0||
48409074|NCT03605836|101331932|FG000|COMPLETED|OL Placebo Run-in Period [1 Week]||440||
48409075|NCT03605836|101331933|FG001|COMPLETED|OL Placebo Run-in Period [1 Week]||0||
48409076|NCT03605836|101331934|FG002|COMPLETED|OL Placebo Run-in Period [1 Week]||0||
48409077|NCT03605836|101331935|FG003|COMPLETED|OL Placebo Run-in Period [1 Week]||0||
48409078|NCT03605836|101331932|FG000|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||150||
48162633|NCT05061537|100721622|FG002|NOT COMPLETED|Long-term Follow-up||2||
48162634|NCT05061537|100721623|FG003|NOT COMPLETED|Long-term Follow-up||0||
48162635|NCT05061537|100721624|FG004|NOT COMPLETED|Long-term Follow-up||0||
48162636|NCT02481375|100721625|FG000|STARTED|Overall Study||206||
48162637|NCT02481375|100721626|FG001|STARTED|Overall Study||202||
48162638|NCT02481375|100721627|FG002|STARTED|Overall Study||201||
48162639|NCT02481375|100721628|FG003|STARTED|Overall Study||200||
48162640|NCT02481375|100721625|FG000|COMPLETED|Overall Study||192||
48162641|NCT02481375|100721626|FG001|COMPLETED|Overall Study||191||
48409079|NCT03605836|101331933|FG001|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||0||
48409080|NCT03605836|101331934|FG002|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||0||
48409081|NCT03605836|101331935|FG003|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||0||
48162642|NCT02481375|100721627|FG002|COMPLETED|Overall Study||191||
48162643|NCT02481375|100721628|FG003|COMPLETED|Overall Study||186||
48162644|NCT02481375|100721625|FG000|NOT COMPLETED|Overall Study||14||
48162645|NCT02481375|100721626|FG001|NOT COMPLETED|Overall Study||11||
48162646|NCT02481375|100721627|FG002|NOT COMPLETED|Overall Study||10||
48162647|NCT02481375|100721628|FG003|NOT COMPLETED|Overall Study||14||
48162648|NCT05067439|100721629|FG000|STARTED|Period 1||26||
48618822|NCT02318849|101852977|FG002|STARTED|Post-intervention Cross Sectional Data||720|These samples are cross-sectional data; thus, the baseline and post-intevention sample sizes are not the same.|
48618823|NCT02318849|101852975|FG000|COMPLETED|Post-intervention Cross Sectional Data||1234||
48618824|NCT02318849|101852976|FG001|COMPLETED|Post-intervention Cross Sectional Data||735||
48618825|NCT02318849|101852977|FG002|COMPLETED|Post-intervention Cross Sectional Data||720||
48618826|NCT02318849|101852975|FG000|NOT COMPLETED|Post-intervention Cross Sectional Data||0||
48618827|NCT02318849|101852976|FG001|NOT COMPLETED|Post-intervention Cross Sectional Data||0||
48618828|NCT02318849|101852977|FG002|NOT COMPLETED|Post-intervention Cross Sectional Data||0||
48618829|NCT00922116|101852978|FG000|STARTED|Overall Study||191||
48618830|NCT00922116|101852978|FG000|COMPLETED|Overall Study||176||
48618831|NCT00922116|101852978|FG000|NOT COMPLETED|Overall Study||15||
48618832|NCT00248651|101852979|FG000|STARTED|Overall Study||97||
48618833|NCT00248651|101852980|FG001|STARTED|Overall Study||98||
48618834|NCT00248651|101852981|FG002|STARTED|Overall Study||97||
48618835|NCT00248651|101852979|FG000|Completed 12 Weeks of Treatment|Overall Study||78||
48618836|NCT00248651|101852980|FG001|Completed 12 Weeks of Treatment|Overall Study||66||
48618837|NCT00248651|101852981|FG002|Completed 12 Weeks of Treatment|Overall Study||75||
48618838|NCT00248651|101852979|FG000|COMPLETED|Overall Study||69||
48618839|NCT00248651|101852980|FG001|COMPLETED|Overall Study||58||
48618840|NCT00248651|101852981|FG002|COMPLETED|Overall Study||65||
48618841|NCT00248651|101852979|FG000|NOT COMPLETED|Overall Study||28||
48618842|NCT00248651|101852980|FG001|NOT COMPLETED|Overall Study||40||
48618843|NCT00248651|101852981|FG002|NOT COMPLETED|Overall Study||32||
48618844|NCT01151345|101852982|FG000|STARTED|First Intervention Period||13||
48742301|NCT04273893|102155043|FG000|Completed Treatment|Overall Study||25||
48742302|NCT04273893|102155044|FG001|Completed Treatment|Overall Study||26||
48742303|NCT04273893|102155043|FG000|Completed 4 Week Follow Up|Overall Study||25||
48742304|NCT04273893|102155044|FG001|Completed 4 Week Follow Up|Overall Study||25||
48742305|NCT04273893|102155043|FG000|COMPLETED|Overall Study||24||
48742306|NCT04273893|102155044|FG001|COMPLETED|Overall Study||19||
48742307|NCT04273893|102155043|FG000|NOT COMPLETED|Overall Study||2||
48742308|NCT04273893|102155044|FG001|NOT COMPLETED|Overall Study||8||
48742309|NCT02223338|102155045|FG000|STARTED|Overall Study||60||
48618845|NCT01151345|101852983|FG001|STARTED|First Intervention Period||13||
48618846|NCT01151345|101852982|FG000|Treated|First Intervention Period||13||
48618847|NCT01151345|101852983|FG001|Treated|First Intervention Period||12||
48618848|NCT01151345|101852982|FG000|COMPLETED|First Intervention Period||13||
48618849|NCT01151345|101852983|FG001|COMPLETED|First Intervention Period||12||
48618850|NCT01151345|101852982|FG000|NOT COMPLETED|First Intervention Period||0||
48618851|NCT01151345|101852983|FG001|NOT COMPLETED|First Intervention Period||1||
48618852|NCT01151345|101852982|FG000|STARTED|Wash-out Period (7 Days)||13||
48618853|NCT01151345|101852983|FG001|STARTED|Wash-out Period (7 Days)||12||
48618854|NCT01151345|101852982|FG000|COMPLETED|Wash-out Period (7 Days)||13||
48618855|NCT01151345|101852983|FG001|COMPLETED|Wash-out Period (7 Days)||12||
48618856|NCT01151345|101852982|FG000|NOT COMPLETED|Wash-out Period (7 Days)||0||
48618857|NCT01151345|101852983|FG001|NOT COMPLETED|Wash-out Period (7 Days)||0||
48618858|NCT01151345|101852982|FG000|STARTED|Second Intervention Period||13||
48618859|NCT01151345|101852983|FG001|STARTED|Second Intervention Period||12||
48618860|NCT01151345|101852982|FG000|COMPLETED|Second Intervention Period||13||
48618861|NCT01151345|101852983|FG001|COMPLETED|Second Intervention Period||12||
48618862|NCT01151345|101852982|FG000|NOT COMPLETED|Second Intervention Period||0||
48618863|NCT01151345|101852983|FG001|NOT COMPLETED|Second Intervention Period||0||
48618864|NCT02718911|101852984|FG000|STARTED|Overall Study||4||
48618865|NCT02718911|101852985|FG001|STARTED|Overall Study||3||
48618866|NCT02718911|101852986|FG002|STARTED|Overall Study||3||
48618867|NCT02718911|101852987|FG003|STARTED|Overall Study||5||
48618868|NCT02718911|101852988|FG004|STARTED|Overall Study||3||
48618869|NCT02718911|101852989|FG005|STARTED|Overall Study||5||
48618870|NCT02718911|101852990|FG006|STARTED|Overall Study||5||
48618871|NCT02718911|101852991|FG007|STARTED|Overall Study||5||
48618872|NCT02718911|101852992|FG008|STARTED|Overall Study||19||
48742310|NCT02223338|102155046|FG001|STARTED|Overall Study||60||
48742311|NCT02223338|102155045|FG000|COMPLETED|Overall Study||60||
48742312|NCT02223338|102155046|FG001|COMPLETED|Overall Study||60||
48742313|NCT02223338|102155045|FG000|NOT COMPLETED|Overall Study||0||
48742314|NCT02223338|102155046|FG001|NOT COMPLETED|Overall Study||0||
48742315|NCT01151371|102155047|FG000|STARTED|Overall Study||149||
48742316|NCT01151371|102155048|FG001|STARTED|Overall Study||150||
48742317|NCT01151371|102155049|FG002|STARTED|Overall Study||153||
48742318|NCT01151371|102155047|FG000|COMPLETED|Overall Study||144||
48742319|NCT01151371|102155048|FG001|COMPLETED|Overall Study||149||
48742320|NCT01151371|102155049|FG002|COMPLETED|Overall Study||146||
48742321|NCT01151371|102155047|FG000|NOT COMPLETED|Overall Study||5||
48742322|NCT01151371|102155048|FG001|NOT COMPLETED|Overall Study||1||
48742323|NCT01151371|102155049|FG002|NOT COMPLETED|Overall Study||7||
48742324|NCT00746863|102155050|FG000|STARTED|Overall Study||21||
48742325|NCT00746863|102155051|FG001|STARTED|Overall Study||21||
48742326|NCT00746863|102155050|FG000|COMPLETED|Overall Study||21||
48742327|NCT00746863|102155051|FG001|COMPLETED|Overall Study||21||
48742328|NCT00746863|102155050|FG000|NOT COMPLETED|Overall Study||0||
48742329|NCT00746863|102155051|FG001|NOT COMPLETED|Overall Study||0||
48742330|NCT03828617|102155052|FG000|STARTED|Overall Study||489||
48742331|NCT03828617|102155053|FG001|STARTED|Overall Study||490||
48618873|NCT02718911|101852993|FG009|STARTED|Overall Study||20||
48618874|NCT02718911|101852984|FG000|Received at Least One Dose of Study Drug|Overall Study||4||
48618875|NCT02718911|101852985|FG001|Received at Least One Dose of Study Drug|Overall Study||3||
48618876|NCT02718911|101852986|FG002|Received at Least One Dose of Study Drug|Overall Study||3||
48618877|NCT02718911|101852987|FG003|Received at Least One Dose of Study Drug|Overall Study||5||
48742332|NCT03828617|102155054|FG002|STARTED|Overall Study||486||
48742333|NCT03828617|102155055|FG003|STARTED|Overall Study||245||
48742334|NCT03828617|102155052|FG000|Vaccinated|Overall Study||488||
48742335|NCT03828617|102155053|FG001|Vaccinated|Overall Study||489||
48742336|NCT03828617|102155054|FG002|Vaccinated|Overall Study||486||
48742337|NCT03828617|102155055|FG003|Vaccinated|Overall Study||245||
48742338|NCT03828617|102155052|FG000|Safety Population|Overall Study||488||
48742339|NCT03828617|102155053|FG001|Safety Population|Overall Study||489||
48742340|NCT03828617|102155054|FG002|Safety Population|Overall Study||486||
48742341|NCT03828617|102155055|FG003|Safety Population|Overall Study||245||
48742342|NCT03828617|102155052|FG000|Evaluable Immunogenicity Population(EIP)|Overall Study||463||
48742343|NCT03828617|102155053|FG001|Evaluable Immunogenicity Population(EIP)|Overall Study||473||
48742344|NCT03828617|102155054|FG002|Evaluable Immunogenicity Population(EIP)|Overall Study||456||
48742345|NCT03828617|102155055|FG003|Evaluable Immunogenicity Population(EIP)|Overall Study||232||
48742346|NCT03828617|102155052|FG000|COMPLETED|Overall Study||465||
48742347|NCT03828617|102155053|FG001|COMPLETED|Overall Study||475||
48742348|NCT03828617|102155054|FG002|COMPLETED|Overall Study||460||
48742349|NCT03828617|102155055|FG003|COMPLETED|Overall Study||235||
48618878|NCT02718911|101852988|FG004|Received at Least One Dose of Study Drug|Overall Study||3||
48618879|NCT02718911|101852989|FG005|Received at Least One Dose of Study Drug|Overall Study||5||
48618880|NCT02718911|101852990|FG006|Received at Least One Dose of Study Drug|Overall Study||5||
48618881|NCT02718911|101852991|FG007|Received at Least One Dose of Study Drug|Overall Study||5||
48618882|NCT02718911|101852992|FG008|Received at Least One Dose of Study Drug|Overall Study||19||
48618883|NCT02718911|101852993|FG009|Received at Least One Dose of Study Drug|Overall Study||20||
48618884|NCT02718911|101852984|FG000|COMPLETED|Overall Study||0||
48618885|NCT02718911|101852985|FG001|COMPLETED|Overall Study||0||
48618886|NCT02718911|101852986|FG002|COMPLETED|Overall Study||0||
48618887|NCT02718911|101852987|FG003|COMPLETED|Overall Study||4||
48618888|NCT02718911|101852988|FG004|COMPLETED|Overall Study||1||
48618889|NCT02718911|101852989|FG005|COMPLETED|Overall Study||2||
48618890|NCT02718911|101852990|FG006|COMPLETED|Overall Study||2||
48618891|NCT02718911|101852991|FG007|COMPLETED|Overall Study||2||
48618892|NCT02718911|101852992|FG008|COMPLETED|Overall Study||7||
48618893|NCT02718911|101852993|FG009|COMPLETED|Overall Study||1||
48618894|NCT02718911|101852984|FG000|NOT COMPLETED|Overall Study||4||
48618895|NCT02718911|101852985|FG001|NOT COMPLETED|Overall Study||3||
48618896|NCT02718911|101852986|FG002|NOT COMPLETED|Overall Study||3||
48618897|NCT02718911|101852987|FG003|NOT COMPLETED|Overall Study||1||
48618898|NCT02718911|101852988|FG004|NOT COMPLETED|Overall Study||2||
48618899|NCT02718911|101852989|FG005|NOT COMPLETED|Overall Study||3||
48618900|NCT02718911|101852990|FG006|NOT COMPLETED|Overall Study||3||
48618901|NCT02718911|101852991|FG007|NOT COMPLETED|Overall Study||3||
48618902|NCT02718911|101852992|FG008|NOT COMPLETED|Overall Study||12||
48618903|NCT02718911|101852993|FG009|NOT COMPLETED|Overall Study||19||
48618904|NCT01450813|101852994|FG000|STARTED|Overall Study||20||
48618905|NCT01450813|101852995|FG001|STARTED|Overall Study||20||
48618906|NCT01450813|101852996|FG002|STARTED|Overall Study||20||
48618907|NCT01450813|101852997|FG003|STARTED|Overall Study||20||
48618908|NCT01450813|101852994|FG000|COMPLETED|Overall Study||19||
48618909|NCT01450813|101852995|FG001|COMPLETED|Overall Study||19||
48618910|NCT01450813|101852996|FG002|COMPLETED|Overall Study||20||
48618911|NCT01450813|101852997|FG003|COMPLETED|Overall Study||17||
48618912|NCT01450813|101852994|FG000|NOT COMPLETED|Overall Study||1||
48618913|NCT01450813|101852995|FG001|NOT COMPLETED|Overall Study||1||
48618914|NCT01450813|101852996|FG002|NOT COMPLETED|Overall Study||0||
48618915|NCT01450813|101852997|FG003|NOT COMPLETED|Overall Study||3||
48618916|NCT03639857|101852998|FG000|STARTED|Overall Study||1||1
48618917|NCT03639857|101852999|FG001|STARTED|Overall Study||3||3
48618918|NCT03639857|101853000|FG002|STARTED|Overall Study||3||3
48618919|NCT03639857|101852998|FG000|COMPLETED|Overall Study||1||1
48618920|NCT03639857|101852999|FG001|COMPLETED|Overall Study||3||3
48618921|NCT03639857|101853000|FG002|COMPLETED|Overall Study||3||3
48618922|NCT03639857|101852998|FG000|NOT COMPLETED|Overall Study||0||0
48618923|NCT03639857|101852999|FG001|NOT COMPLETED|Overall Study||0||0
48618924|NCT03639857|101853000|FG002|NOT COMPLETED|Overall Study||0||0
48618925|NCT00095979|101853001|FG000|STARTED|Overall Study||52||
48618926|NCT00095979|101853001|FG000|COMPLETED|Overall Study||50||
48618927|NCT00095979|101853001|FG000|NOT COMPLETED|Overall Study||2||
48618928|NCT04718870|101853002|FG000|STARTED|Overall Study||18||
48618929|NCT04718870|101853003|FG001|STARTED|Overall Study||23||
48618930|NCT04718870|101853002|FG000|COMPLETED|Overall Study||18||
48618931|NCT04718870|101853003|FG001|COMPLETED|Overall Study||23||
48618932|NCT04718870|101853002|FG000|NOT COMPLETED|Overall Study||0||
48618933|NCT04718870|101853003|FG001|NOT COMPLETED|Overall Study||0||
48618934|NCT02899065|101853004|FG000|STARTED|Randomization to 7 Day Follow Up Contact||100||
48618935|NCT02899065|101853005|FG001|STARTED|Randomization to 7 Day Follow Up Contact||100||
48618936|NCT02899065|101853004|FG000|COMPLETED|Randomization to 7 Day Follow Up Contact||99||
48618937|NCT02899065|101853005|FG001|COMPLETED|Randomization to 7 Day Follow Up Contact||95||
48618938|NCT02899065|101853004|FG000|NOT COMPLETED|Randomization to 7 Day Follow Up Contact||1||
48618939|NCT02899065|101853005|FG001|NOT COMPLETED|Randomization to 7 Day Follow Up Contact||5||
48618940|NCT02899065|101853004|FG000|STARTED|Day 7 to 4 Week Follow Up Contact||99||
48618941|NCT02899065|101853005|FG001|STARTED|Day 7 to 4 Week Follow Up Contact||95||
48618942|NCT02899065|101853004|FG000|COMPLETED|Day 7 to 4 Week Follow Up Contact||75||
48618943|NCT02899065|101853005|FG001|COMPLETED|Day 7 to 4 Week Follow Up Contact||79||
48618944|NCT02899065|101853004|FG000|NOT COMPLETED|Day 7 to 4 Week Follow Up Contact||24||
48618945|NCT02899065|101853005|FG001|NOT COMPLETED|Day 7 to 4 Week Follow Up Contact||16||
48742350|NCT03828617|102155052|FG000|NOT COMPLETED|Overall Study||24||
48618946|NCT04552132|101853006|FG000|STARTED|Overall Study||31||
48618947|NCT04552132|101853007|FG001|STARTED|Overall Study||32||
48618948|NCT04552132|101853006|FG000|COMPLETED|Overall Study||26||
48618949|NCT04552132|101853007|FG001|COMPLETED|Overall Study||29||
48618950|NCT04552132|101853006|FG000|NOT COMPLETED|Overall Study||5||
48618951|NCT04552132|101853007|FG001|NOT COMPLETED|Overall Study||3||
48618952|NCT03372798|101853008|FG000|STARTED|Overall Study||8||
48618953|NCT03372798|101853009|FG001|STARTED|Overall Study||6||
48618954|NCT03372798|101853008|FG000|COMPLETED|Overall Study||7||
48618955|NCT03372798|101853009|FG001|COMPLETED|Overall Study||5||
48618956|NCT03372798|101853008|FG000|NOT COMPLETED|Overall Study||1||
48618957|NCT03372798|101853009|FG001|NOT COMPLETED|Overall Study||1||
48618958|NCT01598610|101853010|FG000|STARTED|Overall Study||220||
48618959|NCT01598610|101853010|FG000|COMPLETED|Overall Study||219||
48618960|NCT01598610|101853010|FG000|NOT COMPLETED|Overall Study||1||
48618961|NCT00808067|101853011|FG000|STARTED|Overall Study||2927||
48742351|NCT03828617|102155053|FG001|NOT COMPLETED|Overall Study||15||
48618962|NCT00808067|101853012|FG001|STARTED|Overall Study||2956||
48618963|NCT00808067|101853011|FG000|COMPLETED|Overall Study||2446||
48618964|NCT00808067|101853012|FG001|COMPLETED|Overall Study||2438||
48618965|NCT00808067|101853011|FG000|NOT COMPLETED|Overall Study||481||
48618966|NCT00808067|101853012|FG001|NOT COMPLETED|Overall Study||518||
48618967|NCT02340000|101853013|FG000|STARTED|Time Period 1||90||
48618968|NCT02340000|101853014|FG001|STARTED|Time Period 1||89||
48618969|NCT02340000|101853013|FG000|COMPLETED|Time Period 1||78||
48618970|NCT02340000|101853014|FG001|COMPLETED|Time Period 1||74||
48618971|NCT02340000|101853013|FG000|NOT COMPLETED|Time Period 1||12||
48618972|NCT02340000|101853014|FG001|NOT COMPLETED|Time Period 1||15||
48618973|NCT02340000|101853013|FG000|STARTED|Time Period 2||69||
48618974|NCT02340000|101853014|FG001|STARTED|Time Period 2||67||
48618975|NCT02340000|101853013|FG000|COMPLETED|Time Period 2||50||
48618976|NCT02340000|101853014|FG001|COMPLETED|Time Period 2||52||
48618977|NCT02340000|101853013|FG000|NOT COMPLETED|Time Period 2||19||
48618978|NCT02340000|101853014|FG001|NOT COMPLETED|Time Period 2||15||
48618979|NCT01715233|101853015|FG000|STARTED|Overall Study||21||
48618980|NCT01715233|101853015|FG000|COMPLETED|Overall Study||21||
48618981|NCT01715233|101853015|FG000|NOT COMPLETED|Overall Study||0||
48618982|NCT05137717|101853016|FG000|STARTED|Overall Study||41||
48618983|NCT05137717|101853016|FG000|COMPLETED|Overall Study||33||
48618984|NCT05137717|101853016|FG000|NOT COMPLETED|Overall Study||8||
48618985|NCT02121860|101853017|FG000|STARTED|Overall Study||8||
48618986|NCT02121860|101853018|FG001|STARTED|Overall Study||12||
48618987|NCT02121860|101853019|FG002|STARTED|Overall Study||8||
48618988|NCT02121860|101853020|FG003|STARTED|Overall Study||8||
48618989|NCT02121860|101853017|FG000|COMPLETED|Overall Study||8||
48618990|NCT02121860|101853018|FG001|COMPLETED|Overall Study||12||
48618991|NCT02121860|101853019|FG002|COMPLETED|Overall Study||8||
48618992|NCT02121860|101853020|FG003|COMPLETED|Overall Study||8||
48618993|NCT02121860|101853017|FG000|NOT COMPLETED|Overall Study||0||
48618994|NCT02121860|101853018|FG001|NOT COMPLETED|Overall Study||0||
48618995|NCT02121860|101853019|FG002|NOT COMPLETED|Overall Study||0||
48618996|NCT02121860|101853020|FG003|NOT COMPLETED|Overall Study||0||
48618997|NCT02550743|101853021|FG000|STARTED|Overall Study||3||
48618998|NCT02550743|101853022|FG001|STARTED|Overall Study||3||
48618999|NCT02550743|101853023|FG002|STARTED|Overall Study||1||
48619000|NCT02550743|101853024|FG003|STARTED|Overall Study||0||
48619001|NCT02550743|101853021|FG000|COMPLETED|Overall Study||3||
48619002|NCT02550743|101853022|FG001|COMPLETED|Overall Study||3||
48619003|NCT02550743|101853023|FG002|COMPLETED|Overall Study||1||
48619004|NCT02550743|101853024|FG003|COMPLETED|Overall Study||0||
48619005|NCT02550743|101853021|FG000|NOT COMPLETED|Overall Study||0||
48742352|NCT03828617|102155054|FG002|NOT COMPLETED|Overall Study||26||
48742353|NCT03828617|102155055|FG003|NOT COMPLETED|Overall Study||10||
48742354|NCT01264406|102155056|FG000|STARTED|Overall Study||65||
48742355|NCT01264406|102155057|FG001|STARTED|Overall Study||66||
48742356|NCT01264406|102155058|FG002|STARTED|Overall Study||67||
48742357|NCT01264406|102155056|FG000|COMPLETED|Overall Study||61||
48742358|NCT01264406|102155057|FG001|COMPLETED|Overall Study||59||
48742359|NCT01264406|102155058|FG002|COMPLETED|Overall Study||51||
48742360|NCT01264406|102155056|FG000|NOT COMPLETED|Overall Study||4||
48742361|NCT01264406|102155057|FG001|NOT COMPLETED|Overall Study||7||
48742362|NCT01264406|102155058|FG002|NOT COMPLETED|Overall Study||16||
48742363|NCT02052752|102155059|FG000|STARTED|Overall Study||30||
48742364|NCT02052752|102155060|FG001|STARTED|Overall Study||30||
48742365|NCT02052752|102155061|FG002|STARTED|Overall Study||30||
48619006|NCT02550743|101853022|FG001|NOT COMPLETED|Overall Study||0||
48619007|NCT02550743|101853023|FG002|NOT COMPLETED|Overall Study||0||
48619008|NCT02550743|101853024|FG003|NOT COMPLETED|Overall Study||0||
48619009|NCT00700375|101853025|FG000|STARTED|Overall Study||30||
48619010|NCT00700375|101853026|FG001|STARTED|Overall Study||29||
48619011|NCT00700375|101853025|FG000|2 Days After Creatinine Mesurement|Overall Study||30||
48619012|NCT00700375|101853026|FG001|2 Days After Creatinine Mesurement|Overall Study||29||
48619013|NCT00700375|101853025|FG000|COMPLETED|Overall Study||30||
48742366|NCT02052752|102155059|FG000|COMPLETED|Overall Study||30||
48742367|NCT02052752|102155060|FG001|COMPLETED|Overall Study||30||
48742368|NCT02052752|102155061|FG002|COMPLETED|Overall Study||30||
48742369|NCT02052752|102155059|FG000|NOT COMPLETED|Overall Study||0||
48742370|NCT02052752|102155060|FG001|NOT COMPLETED|Overall Study||0||
48742371|NCT02052752|102155061|FG002|NOT COMPLETED|Overall Study||0||
48742372|NCT01115673|102155062|FG000|STARTED|Overall Study||239||
48619014|NCT00700375|101853026|FG001|COMPLETED|Overall Study||29||
48619015|NCT00700375|101853025|FG000|NOT COMPLETED|Overall Study||0||
48619016|NCT00700375|101853026|FG001|NOT COMPLETED|Overall Study||0||
48619017|NCT00419757|101853027|FG000|STARTED|Overall Study||127||
48619018|NCT00419757|101853028|FG001|STARTED|Overall Study||123||
48619019|NCT00419757|101853027|FG000|COMPLETED|Overall Study||109||
48619020|NCT00419757|101853028|FG001|COMPLETED|Overall Study||102||
48619021|NCT00419757|101853027|FG000|NOT COMPLETED|Overall Study||18||
48619022|NCT00419757|101853028|FG001|NOT COMPLETED|Overall Study||21||
48619023|NCT00227539|101853029|FG000|STARTED|Overall Study||25||
48619024|NCT00227539|101853029|FG000|COMPLETED|Overall Study||24||
48619025|NCT00227539|101853029|FG000|NOT COMPLETED|Overall Study||1||
48742373|NCT01115673|102155063|FG001|STARTED|Overall Study||241||
48742374|NCT01115673|102155064|FG002|STARTED|Overall Study||60||
48619026|NCT01519817|101853030|FG000|STARTED|Overall Study||4||
48619027|NCT01519817|101853031|FG001|STARTED|Overall Study||3||
48619028|NCT01519817|101853032|FG002|STARTED|Overall Study||16||
48162649|NCT05067439|100721629|FG000|COMPLETED|Period 1||26||
48162650|NCT05067439|100721629|FG000|NOT COMPLETED|Period 1||0||
48162651|NCT05067439|100721629|FG000|STARTED|Period 2||26||
48162652|NCT05067439|100721629|FG000|COMPLETED|Period 2||26||
48162653|NCT05067439|100721629|FG000|NOT COMPLETED|Period 2||0||
48162654|NCT01483937|100721630|FG000|STARTED|Overall Study||15||
48162655|NCT01483937|100721631|FG001|STARTED|Overall Study||17||
48162656|NCT01483937|100721630|FG000|COMPLETED|Overall Study||11||
48162657|NCT01483937|100721631|FG001|COMPLETED|Overall Study||14||
48162658|NCT01483937|100721630|FG000|NOT COMPLETED|Overall Study||4||
48162659|NCT01483937|100721631|FG001|NOT COMPLETED|Overall Study||3||
48162660|NCT00909428|100721632|FG000|STARTED|Overall Study||18||
48619029|NCT01519817|101853033|FG003|STARTED|Overall Study||11||
48619030|NCT01519817|101853030|FG000|COMPLETED|Overall Study||3||
48619031|NCT01519817|101853031|FG001|COMPLETED|Overall Study||3||
48619032|NCT01519817|101853032|FG002|COMPLETED|Overall Study||16||
48619033|NCT01519817|101853033|FG003|COMPLETED|Overall Study||10||
48619034|NCT01519817|101853030|FG000|NOT COMPLETED|Overall Study||1||
48619035|NCT01519817|101853031|FG001|NOT COMPLETED|Overall Study||0||
48619036|NCT01519817|101853032|FG002|NOT COMPLETED|Overall Study||0||
48619037|NCT01519817|101853033|FG003|NOT COMPLETED|Overall Study||1||
48619038|NCT01168921|101853034|FG000|STARTED|Overall Study||23||
48619039|NCT01168921|101853034|FG000|COMPLETED|Overall Study||23||
48619040|NCT01168921|101853034|FG000|NOT COMPLETED|Overall Study||0||
48619041|NCT02168491|101853035|FG000|STARTED|Overall Study||9||
48619042|NCT02168491|101853035|FG000|COMPLETED|Overall Study||8||
48619043|NCT02168491|101853035|FG000|NOT COMPLETED|Overall Study||1||
48619044|NCT01657162|101853036|FG000|STARTED|Overall Study||558|Participants who started Study BA058-05-005.|
48619045|NCT01657162|101853037|FG001|STARTED|Overall Study||581|Participants who started Study BA058-05-005.|
48619046|NCT01657162|101853036|FG000|Study 003 ITT Population|Overall Study||824|This Intent-To-Treat (ITT) population included participants who were randomized into Study 003.|
48619047|NCT01657162|101853037|FG001|Study 003 ITT Population|Overall Study||821|This Intent-To-Treat (ITT) population included participants who were randomized into Study 003.|
48619048|NCT01657162|101853036|FG000|Study 003 Modified ITT (mITT) Population|Overall Study||690|Study003 ITT participants with Study 003 pretreatment \& postbaseline evaluable radiologic assessment|
48619049|NCT01657162|101853037|FG001|Study 003 Modified ITT (mITT) Population|Overall Study||711|Study003 ITT participants with Study 003 pretreatment \& postbaseline evaluable radiologic assessment|
48619050|NCT01657162|101853036|FG000|Completed Study 003|Overall Study||606||
48619051|NCT01657162|101853037|FG001|Completed Study 003|Overall Study||637||
48619052|NCT01657162|101853036|FG000|Study 005 ITT Population|Overall Study||558|All Study 003 ITT participants who enrolled in Study 005 .|
48619053|NCT01657162|101853037|FG001|Study 005 ITT Population|Overall Study||581|All Study 003 ITT participants who enrolled in Study 005 .|
48619054|NCT01657162|101853036|FG000|Study 005 Safety Population|Overall Study||553|All Study 005 ITT participants who received 1 or more doses of alendronate.|
48619055|NCT01657162|101853037|FG001|Study 005 Safety Population|Overall Study||580|All Study 005 ITT participants who received 1 or more doses of alendronate.|
48619056|NCT01657162|101853036|FG000|Study 005 mITT Population|Overall Study||544|Study 003 mITT participants with a Study 005 postbaseline evaluable radiologic test (spine X-ray)|
48619057|NCT01657162|101853037|FG001|Study 005 mITT Population|Overall Study||568|Study 003 mITT participants with a Study 005 postbaseline evaluable radiologic test (spine X-ray)|
48619058|NCT01657162|101853036|FG000|COMPLETED|Overall Study||499||
48619059|NCT01657162|101853037|FG001|COMPLETED|Overall Study||506||
48619060|NCT01657162|101853036|FG000|NOT COMPLETED|Overall Study||59||
48619061|NCT01657162|101853037|FG001|NOT COMPLETED|Overall Study||75||
48619062|NCT03030625|101853038|FG000|STARTED|Overall Study||30||
48619063|NCT03030625|101853038|FG000|COMPLETED|Overall Study||30||
48162661|NCT00909428|100721633|FG001|STARTED|Overall Study||15||
48162662|NCT00909428|100721634|FG002|STARTED|Overall Study||9||
48162663|NCT00909428|100721632|FG000|COMPLETED|Overall Study||5||
48162664|NCT00909428|100721633|FG001|COMPLETED|Overall Study||5||
48162665|NCT00909428|100721634|FG002|COMPLETED|Overall Study||0||
48619064|NCT03030625|101853038|FG000|NOT COMPLETED|Overall Study||0||
48619065|NCT00994110|101853039|FG000|STARTED|Overall Study||217||
48619066|NCT00994110|101853040|FG001|STARTED|Overall Study||222||
48619067|NCT00994110|101853039|FG000|COMPLETED|Overall Study||152||
48619068|NCT00994110|101853040|FG001|COMPLETED|Overall Study||148||
48619069|NCT00994110|101853039|FG000|NOT COMPLETED|Overall Study||65||
48619070|NCT00994110|101853040|FG001|NOT COMPLETED|Overall Study||74||
48619071|NCT03225170|101853041|FG000|STARTED|Overall Study||23||
48619072|NCT03225170|101853042|FG001|STARTED|Overall Study||22||
48619073|NCT03225170|101853043|FG002|STARTED|Overall Study||2||
48619074|NCT03225170|101853041|FG000|COMPLETED|Overall Study||19||
48619075|NCT03225170|101853042|FG001|COMPLETED|Overall Study||17||
48619076|NCT03225170|101853043|FG002|COMPLETED|Overall Study||2||
48619077|NCT03225170|101853041|FG000|NOT COMPLETED|Overall Study||4||
48619078|NCT03225170|101853042|FG001|NOT COMPLETED|Overall Study||5||
48619079|NCT03225170|101853043|FG002|NOT COMPLETED|Overall Study||0||
48619080|NCT01076543|101853044|FG000|STARTED|Overall Study||8||
48325283|NCT03311711|101121452|FG006|COMPLETED|Overall Study||35||
48619081|NCT01076543|101853045|FG001|STARTED|Overall Study||3||
48619082|NCT01076543|101853046|FG002|STARTED|Overall Study||6||
48619083|NCT01076543|101853047|FG003|STARTED|Overall Study||39||
48619084|NCT01076543|101853048|FG004|STARTED|Overall Study||15||
48619085|NCT01076543|101853049|FG005|STARTED|Overall Study||39||
48742375|NCT01115673|102155062|FG000|COMPLETED|Overall Study||239||
48742376|NCT01115673|102155063|FG001|COMPLETED|Overall Study||241||
48742377|NCT01115673|102155064|FG002|COMPLETED|Overall Study||60||
48742378|NCT01115673|102155062|FG000|NOT COMPLETED|Overall Study||0||
48742379|NCT01115673|102155063|FG001|NOT COMPLETED|Overall Study||0||
48742380|NCT01115673|102155064|FG002|NOT COMPLETED|Overall Study||0||
48742381|NCT05305560|102155065|FG000|STARTED|Overall Study||200||
48742382|NCT05305560|102155066|FG001|STARTED|Overall Study||199||
48742383|NCT05305560|102155065|FG000|COMPLETED|Overall Study||200||
48742384|NCT05305560|102155066|FG001|COMPLETED|Overall Study||199||
48742385|NCT05305560|102155065|FG000|NOT COMPLETED|Overall Study||0||
48742386|NCT05305560|102155066|FG001|NOT COMPLETED|Overall Study||0||
48742387|NCT02588261|102155067|FG000|STARTED|Overall Study||267||
48742388|NCT02588261|102155068|FG001|STARTED|Overall Study||263||
48742389|NCT02588261|102155067|FG000|Treated|Overall Study||265||
48742390|NCT02588261|102155068|FG001|Treated|Overall Study||262||
48742391|NCT02588261|102155067|FG000|COMPLETED|Overall Study||0||
48742392|NCT02588261|102155068|FG001|COMPLETED|Overall Study||0||
48742393|NCT02588261|102155067|FG000|NOT COMPLETED|Overall Study||267||
48742394|NCT02588261|102155068|FG001|NOT COMPLETED|Overall Study||263||
48742395|NCT00413218|102155069|FG000|STARTED|Overall Study||223|Four hundred and fifty participants were randomized but 10 participants did not receive treatment.|
48742396|NCT00413218|102155070|FG001|STARTED|Overall Study||227|Four hundred and fifty participants were randomized but 10 participants did not receive treatment.|
48742397|NCT00413218|102155069|FG000|Intent to Treat Population (ITT)|Overall Study||221|The ITT consisted of all randomized participants who received at least one dose of study drug.|
48742398|NCT00413218|102155070|FG001|Intent to Treat Population (ITT)|Overall Study||219|The ITT consisted of all randomized participants who received at least one dose of study drug.|
48742399|NCT00413218|102155069|FG000|COMPLETED|Overall Study||120||
48742400|NCT00413218|102155070|FG001|COMPLETED|Overall Study||131||
48742401|NCT00413218|102155069|FG000|NOT COMPLETED|Overall Study||103||
48742402|NCT00413218|102155070|FG001|NOT COMPLETED|Overall Study||96||
48742403|NCT01486966|102155071|FG000|STARTED|Overall Study||29||
48742404|NCT01486966|102155072|FG001|STARTED|Overall Study||29||
48742405|NCT01486966|102155071|FG000|COMPLETED|Overall Study||29||
48742406|NCT01486966|102155072|FG001|COMPLETED|Overall Study||27||
48742407|NCT01486966|102155071|FG000|NOT COMPLETED|Overall Study||0||
48742408|NCT01486966|102155072|FG001|NOT COMPLETED|Overall Study||2||
48742409|NCT02950480|102155073|FG000|STARTED|Overall Study||2||
48619086|NCT01076543|101853044|FG000|COMPLETED|Overall Study||6||
48619087|NCT01076543|101853045|FG001|COMPLETED|Overall Study||3||
48619088|NCT01076543|101853046|FG002|COMPLETED|Overall Study||6||
48619089|NCT01076543|101853047|FG003|COMPLETED|Overall Study||39||
48619090|NCT01076543|101853048|FG004|COMPLETED|Overall Study||15||
48619091|NCT01076543|101853049|FG005|COMPLETED|Overall Study||39||
48619092|NCT01076543|101853044|FG000|NOT COMPLETED|Overall Study||2||
48619093|NCT01076543|101853045|FG001|NOT COMPLETED|Overall Study||0||
48619094|NCT01076543|101853046|FG002|NOT COMPLETED|Overall Study||0||
48619095|NCT01076543|101853047|FG003|NOT COMPLETED|Overall Study||0||
48619096|NCT01076543|101853048|FG004|NOT COMPLETED|Overall Study||0||
48619097|NCT01076543|101853049|FG005|NOT COMPLETED|Overall Study||0||
48619098|NCT02616783|101853050|FG000|STARTED|Overall Study||111||
48619099|NCT02616783|101853051|FG001|STARTED|Overall Study||56||
48619100|NCT02616783|101853050|FG000|COMPLETED|Overall Study||105||
48619101|NCT02616783|101853051|FG001|COMPLETED|Overall Study||54||
48742410|NCT02950480|102155074|FG001|STARTED|Overall Study||2||
48742411|NCT02950480|102155073|FG000|COMPLETED|Overall Study||1||
48742412|NCT02950480|102155074|FG001|COMPLETED|Overall Study||2||
48742413|NCT02950480|102155073|FG000|NOT COMPLETED|Overall Study||1||
48742414|NCT02950480|102155074|FG001|NOT COMPLETED|Overall Study||0||
48742415|NCT04303559|102155075|FG000|STARTED|Overall Study||1||
48742416|NCT04303559|102155075|FG000|COMPLETED|Overall Study||0||
48742417|NCT04303559|102155075|FG000|NOT COMPLETED|Overall Study||1||
48742418|NCT01314001|102155076|FG000|STARTED|Overall Study||215||
48742419|NCT01314001|102155077|FG001|STARTED|Overall Study||193||
48742420|NCT01314001|102155078|FG002|STARTED|Overall Study||227||
48742421|NCT01314001|102155079|FG003|STARTED|Overall Study||191||
48742422|NCT01314001|102155080|FG004|STARTED|Overall Study||220||
48742423|NCT01314001|102155081|FG005|STARTED|Overall Study||200||
48742424|NCT01314001|102155076|FG000|End-of-Treatment Visit|Overall Study||156||
48742425|NCT01314001|102155077|FG001|End-of-Treatment Visit|Overall Study||141||
48742426|NCT01314001|102155078|FG002|End-of-Treatment Visit|Overall Study||179||
48742427|NCT01314001|102155079|FG003|End-of-Treatment Visit|Overall Study||146||
48742428|NCT01314001|102155080|FG004|End-of-Treatment Visit|Overall Study||174||
48742429|NCT01314001|102155081|FG005|End-of-Treatment Visit|Overall Study||160||
48325284|NCT03311711|101121453|FG007|COMPLETED|Overall Study||35||
48619102|NCT02616783|101853050|FG000|NOT COMPLETED|Overall Study||6||
48619103|NCT02616783|101853051|FG001|NOT COMPLETED|Overall Study||2||
48619104|NCT03489343|101853052|FG000|STARTED|Overall Study||1||
48619105|NCT03489343|101853053|FG001|STARTED|Overall Study||1||
48619106|NCT03489343|101853054|FG002|STARTED|Overall Study||3||
48619107|NCT03489343|101853055|FG003|STARTED|Overall Study||3||
48619108|NCT03489343|101853056|FG004|STARTED|Overall Study||3||
48619109|NCT03489343|101853057|FG005|STARTED|Overall Study||7||
48619110|NCT03489343|101853058|FG006|STARTED|Overall Study||6||
48619111|NCT03489343|101853052|FG000|COMPLETED|Overall Study||0||
48162666|NCT00909428|100721632|FG000|NOT COMPLETED|Overall Study||13||
48619112|NCT03489343|101853053|FG001|COMPLETED|Overall Study||0||
48619113|NCT03489343|101853054|FG002|COMPLETED|Overall Study||0||
48619114|NCT03489343|101853055|FG003|COMPLETED|Overall Study||0||
48619115|NCT03489343|101853056|FG004|COMPLETED|Overall Study||0||
48619116|NCT03489343|101853057|FG005|COMPLETED|Overall Study||0||
48619117|NCT03489343|101853058|FG006|COMPLETED|Overall Study||0||
48619118|NCT03489343|101853052|FG000|NOT COMPLETED|Overall Study||1||
48162667|NCT00909428|100721633|FG001|NOT COMPLETED|Overall Study||10||
48619119|NCT03489343|101853053|FG001|NOT COMPLETED|Overall Study||1||
48619120|NCT03489343|101853054|FG002|NOT COMPLETED|Overall Study||3||
48619121|NCT03489343|101853055|FG003|NOT COMPLETED|Overall Study||3||
48619122|NCT03489343|101853056|FG004|NOT COMPLETED|Overall Study||3||
48619123|NCT03489343|101853057|FG005|NOT COMPLETED|Overall Study||7||
48619124|NCT03489343|101853058|FG006|NOT COMPLETED|Overall Study||6||
48619125|NCT02810418|101853059|FG000|STARTED|Arm A Dose Escalation||6||
48619126|NCT02810418|101853060|FG001|STARTED|Arm A Dose Escalation||8||
48619127|NCT02810418|101853061|FG002|STARTED|Arm A Dose Escalation||0||
48619128|NCT02810418|101853062|FG003|STARTED|Arm A Dose Escalation||0||
48619129|NCT02810418|101853063|FG004|STARTED|Arm A Dose Escalation||0||
48619130|NCT02810418|101853064|FG005|STARTED|Arm A Dose Escalation||0||
48619131|NCT02810418|101853065|FG006|STARTED|Arm A Dose Escalation||0||
48742430|NCT01314001|102155076|FG000|6-Month Follow Up Survey|Overall Study||146||
48742431|NCT01314001|102155077|FG001|6-Month Follow Up Survey|Overall Study||137||
48742432|NCT01314001|102155078|FG002|6-Month Follow Up Survey|Overall Study||165||
48742433|NCT01314001|102155079|FG003|6-Month Follow Up Survey|Overall Study||135||
48742434|NCT01314001|102155080|FG004|6-Month Follow Up Survey|Overall Study||157||
48619132|NCT02810418|101853059|FG000|COMPLETED|Arm A Dose Escalation||4||
48619133|NCT02810418|101853060|FG001|COMPLETED|Arm A Dose Escalation||7||
48619134|NCT02810418|101853061|FG002|COMPLETED|Arm A Dose Escalation||0||
48619135|NCT02810418|101853062|FG003|COMPLETED|Arm A Dose Escalation||0||
48619136|NCT02810418|101853063|FG004|COMPLETED|Arm A Dose Escalation||0||
48619137|NCT02810418|101853064|FG005|COMPLETED|Arm A Dose Escalation||0||
48619138|NCT02810418|101853065|FG006|COMPLETED|Arm A Dose Escalation||0||
48619139|NCT02810418|101853059|FG000|NOT COMPLETED|Arm A Dose Escalation||2||
48619140|NCT02810418|101853060|FG001|NOT COMPLETED|Arm A Dose Escalation||1||
48742435|NCT01314001|102155081|FG005|6-Month Follow Up Survey|Overall Study||139||
48742436|NCT01314001|102155076|FG000|COMPLETED|Overall Study||140||
48742437|NCT01314001|102155077|FG001|COMPLETED|Overall Study||124||
48742438|NCT01314001|102155078|FG002|COMPLETED|Overall Study||158||
48742439|NCT01314001|102155079|FG003|COMPLETED|Overall Study||122||
48619141|NCT02810418|101853061|FG002|NOT COMPLETED|Arm A Dose Escalation||0||
48742440|NCT01314001|102155080|FG004|COMPLETED|Overall Study||148||
48742441|NCT01314001|102155081|FG005|COMPLETED|Overall Study||129||
48742442|NCT01314001|102155076|FG000|NOT COMPLETED|Overall Study||75||
48742443|NCT01314001|102155077|FG001|NOT COMPLETED|Overall Study||69||
48742444|NCT01314001|102155078|FG002|NOT COMPLETED|Overall Study||69||
48742445|NCT01314001|102155079|FG003|NOT COMPLETED|Overall Study||69||
48742446|NCT01314001|102155080|FG004|NOT COMPLETED|Overall Study||72||
48742447|NCT01314001|102155081|FG005|NOT COMPLETED|Overall Study||71||
48742448|NCT04276233|102155082|FG000|STARTED|Overall Study||100||
48742449|NCT04276233|102155082|FG000|COMPLETED|Overall Study||90||
48742450|NCT04276233|102155082|FG000|NOT COMPLETED|Overall Study||10||
48742451|NCT02034877|102155083|FG000|STARTED|Overall Study||200||
48742452|NCT02034877|102155084|FG001|STARTED|Overall Study||999||
48742453|NCT02034877|102155083|FG000|COMPLETED|Overall Study||200||
48742454|NCT02034877|102155084|FG001|COMPLETED|Overall Study||993||
48742455|NCT02034877|102155083|FG000|NOT COMPLETED|Overall Study||0||
48742456|NCT02034877|102155084|FG001|NOT COMPLETED|Overall Study||6||
48742457|NCT00782717|102155085|FG000|STARTED|Overall Study||133||
48742458|NCT00782717|102155086|FG001|STARTED|Overall Study||130||
48742459|NCT00782717|102155085|FG000|COMPLETED|Overall Study||118||
48742460|NCT00782717|102155086|FG001|COMPLETED|Overall Study||102||
48742461|NCT00782717|102155085|FG000|NOT COMPLETED|Overall Study||15||
48742462|NCT00782717|102155086|FG001|NOT COMPLETED|Overall Study||28||
48742463|NCT00860171|102155087|FG000|STARTED|Overall Study||16||
48742464|NCT00860171|102155087|FG000|COMPLETED|Overall Study||16||
48742465|NCT00860171|102155087|FG000|NOT COMPLETED|Overall Study||0||
48742466|NCT03174366|102155088|FG000|STARTED|Overall Study||7||
48742467|NCT03174366|102155088|FG000|COMPLETED|Overall Study||7||
48742468|NCT03174366|102155088|FG000|NOT COMPLETED|Overall Study||0||
48742469|NCT03066193|102155089|FG000|STARTED|Overall Study||17||
48742470|NCT03066193|102155089|FG000|COMPLETED|Overall Study||16||
48742471|NCT03066193|102155089|FG000|NOT COMPLETED|Overall Study||1||
48742472|NCT03078556|102155090|FG000|STARTED|Treatment Period 1 (4 Days)||39||
48742473|NCT03078556|102155091|FG001|STARTED|Treatment Period 1 (4 Days)||39||
48742474|NCT03078556|102155092|FG002|STARTED|Treatment Period 1 (4 Days)||38||
48742475|NCT03078556|102155093|FG003|STARTED|Treatment Period 1 (4 Days)||38||
48742476|NCT03078556|102155090|FG000|COMPLETED|Treatment Period 1 (4 Days)||39||
48742477|NCT03078556|102155091|FG001|COMPLETED|Treatment Period 1 (4 Days)||38||
48742478|NCT03078556|102155092|FG002|COMPLETED|Treatment Period 1 (4 Days)||38||
48742479|NCT03078556|102155093|FG003|COMPLETED|Treatment Period 1 (4 Days)||38||
48742480|NCT03078556|102155090|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
48742481|NCT03078556|102155091|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||1||
48742482|NCT03078556|102155092|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
48742483|NCT03078556|102155093|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
48742484|NCT03078556|102155090|FG000|STARTED|Washout Period 1 (7 Days)||39||
48742485|NCT03078556|102155091|FG001|STARTED|Washout Period 1 (7 Days)||38||
48742486|NCT03078556|102155092|FG002|STARTED|Washout Period 1 (7 Days)||38||
48742487|NCT03078556|102155093|FG003|STARTED|Washout Period 1 (7 Days)||38||
48742488|NCT03078556|102155090|FG000|COMPLETED|Washout Period 1 (7 Days)||37||
48742489|NCT03078556|102155091|FG001|COMPLETED|Washout Period 1 (7 Days)||36||
48742490|NCT03078556|102155092|FG002|COMPLETED|Washout Period 1 (7 Days)||37||
48742491|NCT03078556|102155093|FG003|COMPLETED|Washout Period 1 (7 Days)||37||
48742492|NCT03078556|102155090|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||2||
48742493|NCT03078556|102155091|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||2||
48742494|NCT03078556|102155092|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||1||
48742495|NCT03078556|102155093|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1||
48742496|NCT03078556|102155090|FG000|STARTED|Treatment Period 2 (4 Days)||37||
48742497|NCT03078556|102155091|FG001|STARTED|Treatment Period 2 (4 Days)||36||
48742498|NCT03078556|102155092|FG002|STARTED|Treatment Period 2 (4 Days)||37||
48742499|NCT03078556|102155093|FG003|STARTED|Treatment Period 2 (4 Days)||37||
48742500|NCT03078556|102155090|FG000|COMPLETED|Treatment Period 2 (4 Days)||37||
48742501|NCT03078556|102155091|FG001|COMPLETED|Treatment Period 2 (4 Days)||36||
48742502|NCT03078556|102155092|FG002|COMPLETED|Treatment Period 2 (4 Days)||37||
48742503|NCT03078556|102155093|FG003|COMPLETED|Treatment Period 2 (4 Days)||37||
48742504|NCT03078556|102155090|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
48742505|NCT03078556|102155091|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
48742506|NCT03078556|102155092|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
48742507|NCT03078556|102155093|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
48742508|NCT03078556|102155090|FG000|STARTED|Washout Period 2 (7 Days)||9||
48742509|NCT03078556|102155091|FG001|STARTED|Washout Period 2 (7 Days)||7||
48742510|NCT03078556|102155092|FG002|STARTED|Washout Period 2 (7 Days)||7||
48742511|NCT03078556|102155093|FG003|STARTED|Washout Period 2 (7 Days)||9||
48742512|NCT03078556|102155090|FG000|COMPLETED|Washout Period 2 (7 Days)||9||
48742513|NCT03078556|102155091|FG001|COMPLETED|Washout Period 2 (7 Days)||7||
48742514|NCT03078556|102155092|FG002|COMPLETED|Washout Period 2 (7 Days)||7||
48742515|NCT03078556|102155093|FG003|COMPLETED|Washout Period 2 (7 Days)||9||
48742516|NCT03078556|102155090|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48742517|NCT03078556|102155091|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48742518|NCT03078556|102155092|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48767638|NCT01929317|102222785|FG000|STARTED|Long-term Phase||44||
48409082|NCT03605836|101331932|FG000|STARTED|Double-blind Treatment Period [6 Weeks]||0||
48409083|NCT03605836|101331933|FG001|STARTED|Double-blind Treatment Period [6 Weeks]||147||
48409084|NCT03605836|101331934|FG002|STARTED|Double-blind Treatment Period [6 Weeks]||147||
48409085|NCT03605836|101331935|FG003|STARTED|Double-blind Treatment Period [6 Weeks]||146||
48409086|NCT03605836|101331932|FG000|Treated|Double-blind Treatment Period [6 Weeks]||0||
48409087|NCT03605836|101331933|FG001|Treated|Double-blind Treatment Period [6 Weeks]||145||
48409088|NCT03605836|101331934|FG002|Treated|Double-blind Treatment Period [6 Weeks]||143||
48409089|NCT03605836|101331935|FG003|Treated|Double-blind Treatment Period [6 Weeks]||142||
48409090|NCT03605836|101331932|FG000|COMPLETED|Double-blind Treatment Period [6 Weeks]||0||
48409091|NCT03605836|101331933|FG001|COMPLETED|Double-blind Treatment Period [6 Weeks]||111||
48409092|NCT03605836|101331934|FG002|COMPLETED|Double-blind Treatment Period [6 Weeks]||102||
48409093|NCT03605836|101331935|FG003|COMPLETED|Double-blind Treatment Period [6 Weeks]||123||
48409094|NCT03605836|101331932|FG000|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||0||
48409095|NCT03605836|101331933|FG001|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||36||
48409096|NCT03605836|101331934|FG002|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||45||
48409097|NCT03605836|101331935|FG003|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||23||
48619142|NCT02810418|101853062|FG003|NOT COMPLETED|Arm A Dose Escalation||0||
48619143|NCT02810418|101853063|FG004|NOT COMPLETED|Arm A Dose Escalation||0||
48409098|NCT01488188|101331936|FG000|STARTED|Overall Study||20||
48409099|NCT01488188|101331937|FG001|STARTED|Overall Study||20||
48409100|NCT01488188|101331936|FG000|COMPLETED|Overall Study||20||
48409101|NCT01488188|101331937|FG001|COMPLETED|Overall Study||20||
48619144|NCT02810418|101853064|FG005|NOT COMPLETED|Arm A Dose Escalation||0||
48619145|NCT02810418|101853065|FG006|NOT COMPLETED|Arm A Dose Escalation||0||
48619146|NCT02810418|101853059|FG000|STARTED|Dose Expansion||0||
48619147|NCT02810418|101853060|FG001|STARTED|Dose Expansion||8||
48619148|NCT02810418|101853061|FG002|STARTED|Dose Expansion||6||
48619149|NCT02810418|101853062|FG003|STARTED|Dose Expansion||0||
48619150|NCT02810418|101853063|FG004|STARTED|Dose Expansion||0||
48742519|NCT03078556|102155093|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48742520|NCT03078556|102155090|FG000|STARTED|Treatment Period 3 (4 Days)||9||
48742521|NCT03078556|102155091|FG001|STARTED|Treatment Period 3 (4 Days)||7||
48742522|NCT03078556|102155092|FG002|STARTED|Treatment Period 3 (4 Days)||7||
48619151|NCT02810418|101853064|FG005|STARTED|Dose Expansion||0||
48619152|NCT02810418|101853065|FG006|STARTED|Dose Expansion||0||
48619153|NCT02810418|101853059|FG000|COMPLETED|Dose Expansion||0||
48619154|NCT02810418|101853060|FG001|COMPLETED|Dose Expansion||7||
48619155|NCT02810418|101853061|FG002|COMPLETED|Dose Expansion||3||
48619156|NCT02810418|101853062|FG003|COMPLETED|Dose Expansion||0||
48619157|NCT02810418|101853063|FG004|COMPLETED|Dose Expansion||0||
48619158|NCT02810418|101853064|FG005|COMPLETED|Dose Expansion||0||
48619159|NCT02810418|101853065|FG006|COMPLETED|Dose Expansion||0||
48619160|NCT02810418|101853059|FG000|NOT COMPLETED|Dose Expansion||0||
48742523|NCT03078556|102155093|FG003|STARTED|Treatment Period 3 (4 Days)||9||
48742524|NCT03078556|102155090|FG000|COMPLETED|Treatment Period 3 (4 Days)||9||
48742525|NCT03078556|102155091|FG001|COMPLETED|Treatment Period 3 (4 Days)||7||
48742526|NCT03078556|102155092|FG002|COMPLETED|Treatment Period 3 (4 Days)||7||
48742527|NCT03078556|102155093|FG003|COMPLETED|Treatment Period 3 (4 Days)||9||
48325285|NCT03311711|101121454|FG008|COMPLETED|Overall Study||38||
48325286|NCT03311711|101121455|FG009|COMPLETED|Overall Study||38||
48325287|NCT03311711|101121446|FG000|NOT COMPLETED|Overall Study||4||
48325288|NCT03311711|101121447|FG001|NOT COMPLETED|Overall Study||4||
48325289|NCT03311711|101121448|FG002|NOT COMPLETED|Overall Study||0||
48619161|NCT02810418|101853060|FG001|NOT COMPLETED|Dose Expansion||1||
48619162|NCT02810418|101853061|FG002|NOT COMPLETED|Dose Expansion||3||
48619163|NCT02810418|101853062|FG003|NOT COMPLETED|Dose Expansion||0||
48619164|NCT02810418|101853063|FG004|NOT COMPLETED|Dose Expansion||0||
48619165|NCT02810418|101853064|FG005|NOT COMPLETED|Dose Expansion||0||
48619166|NCT02810418|101853065|FG006|NOT COMPLETED|Dose Expansion||0||
48619167|NCT02810418|101853059|FG000|STARTED|Arm B Dose Escalation||0||
48619168|NCT02810418|101853060|FG001|STARTED|Arm B Dose Escalation||0||
48325290|NCT03311711|101121449|FG003|NOT COMPLETED|Overall Study||0||
48325291|NCT03311711|101121450|FG004|NOT COMPLETED|Overall Study||0||
48325292|NCT03311711|101121451|FG005|NOT COMPLETED|Overall Study||0||
48325293|NCT03311711|101121452|FG006|NOT COMPLETED|Overall Study||5||
48325294|NCT03311711|101121453|FG007|NOT COMPLETED|Overall Study||5||
48325295|NCT03311711|101121454|FG008|NOT COMPLETED|Overall Study||1||
48325296|NCT03311711|101121455|FG009|NOT COMPLETED|Overall Study||1||
48325297|NCT02481921|101121456|FG000|STARTED|Overall Study||117||
48325298|NCT02481921|101121457|FG001|STARTED|Overall Study||125||
48325299|NCT02481921|101121456|FG000|COMPLETED|Overall Study||98||
48325300|NCT02481921|101121457|FG001|COMPLETED|Overall Study||106||
48325301|NCT02481921|101121456|FG000|NOT COMPLETED|Overall Study||19||
48325302|NCT02481921|101121457|FG001|NOT COMPLETED|Overall Study||19||
48325303|NCT03074474|101121458|FG000|STARTED|Overall Study||92||
48325304|NCT03074474|101121458|FG000|COMPLETED|Overall Study||65||
48325305|NCT03074474|101121458|FG000|NOT COMPLETED|Overall Study||27||
48325306|NCT00684788|101121459|FG000|STARTED|Overall Study||17||
48325307|NCT00684788|101121460|FG001|STARTED|Overall Study||18||
48325308|NCT00684788|101121459|FG000|COMPLETED|Overall Study||17||
48325309|NCT00684788|101121460|FG001|COMPLETED|Overall Study||18||
48325310|NCT00684788|101121459|FG000|NOT COMPLETED|Overall Study||0||
48325311|NCT00684788|101121460|FG001|NOT COMPLETED|Overall Study||0||
48325312|NCT04320407|101121461|FG000|STARTED|Overall Study||20||
48325313|NCT04320407|101121461|FG000|COMPLETED|Overall Study||20||
48325314|NCT04320407|101121461|FG000|NOT COMPLETED|Overall Study||0||
48325315|NCT05182554|101124436|FG000|STARTED|Overall Study||0|"The number of participants in each group is the number of people who signed up as a vaccine ambassador in each treatment arm. The Facebook ads were not run in control group counties."|417
48325316|NCT05182554|101124437|FG001|STARTED|Overall Study||0|"The number of participants in each group is the number of people who signed up as a vaccine ambassador in each treatment arm. The Facebook ads were not run in control group counties."|275
48325317|NCT05182554|101124438|FG002|STARTED|Overall Study||4|"The number of participants in each group is the number of people who signed up as a vaccine ambassador in each treatment arm. The Facebook ads were not run in control group counties."|274
48325318|NCT05182554|101124439|FG003|STARTED|Overall Study||2|"The number of participants in each group is the number of people who signed up as a vaccine ambassador in each treatment arm. The Facebook ads were not run in control group counties."|276
48325319|NCT05182554|101124436|FG000|COMPLETED|Overall Study||0|"The study intervention was a social media campaign that displayed ads on Facebook which encouraged people to get a Covid-19 vaccine. As there was no way to complete the study, the number of participants who started and the number of participants who completed the study is the same."|417
48325320|NCT05182554|101124437|FG001|COMPLETED|Overall Study||0|"The study intervention was a social media campaign that displayed ads on Facebook which encouraged people to get a Covid-19 vaccine. As there was no way to complete the study, the number of participants who started and the number of participants who completed the study is the same."|275
48325321|NCT05182554|101124438|FG002|COMPLETED|Overall Study||4|"The study intervention was a social media campaign that displayed ads on Facebook which encouraged people to get a Covid-19 vaccine. As there was no way to complete the study, the number of participants who started and the number of participants who completed the study is the same."|274
48325322|NCT05182554|101124439|FG003|COMPLETED|Overall Study||2|"The study intervention was a social media campaign that displayed ads on Facebook which encouraged people to get a Covid-19 vaccine. As there was no way to complete the study, the number of participants who started and the number of participants who completed the study is the same."|276
48325323|NCT05182554|101124436|FG000|NOT COMPLETED|Overall Study||0||0
48325324|NCT05182554|101124437|FG001|NOT COMPLETED|Overall Study||0||0
48325325|NCT05182554|101124438|FG002|NOT COMPLETED|Overall Study||0||0
48619169|NCT02810418|101853061|FG002|STARTED|Arm B Dose Escalation||0||
48619170|NCT02810418|101853062|FG003|STARTED|Arm B Dose Escalation||6||
48619171|NCT02810418|101853063|FG004|STARTED|Arm B Dose Escalation||3||
48619172|NCT02810418|101853064|FG005|STARTED|Arm B Dose Escalation||6||
48619173|NCT02810418|101853065|FG006|STARTED|Arm B Dose Escalation||0||
48619174|NCT02810418|101853059|FG000|COMPLETED|Arm B Dose Escalation||0||
48619175|NCT02810418|101853060|FG001|COMPLETED|Arm B Dose Escalation||0||
48619176|NCT02810418|101853061|FG002|COMPLETED|Arm B Dose Escalation||0||
48619177|NCT02810418|101853062|FG003|COMPLETED|Arm B Dose Escalation||6||
48619178|NCT02810418|101853063|FG004|COMPLETED|Arm B Dose Escalation||2||
48619179|NCT02810418|101853064|FG005|COMPLETED|Arm B Dose Escalation||4||
48619180|NCT02810418|101853065|FG006|COMPLETED|Arm B Dose Escalation||0||
48619181|NCT02810418|101853059|FG000|NOT COMPLETED|Arm B Dose Escalation||0||
48619182|NCT02810418|101853060|FG001|NOT COMPLETED|Arm B Dose Escalation||0||
48325326|NCT05182554|101124439|FG003|NOT COMPLETED|Overall Study||0||0
48619183|NCT02810418|101853061|FG002|NOT COMPLETED|Arm B Dose Escalation||0||
48619184|NCT02810418|101853062|FG003|NOT COMPLETED|Arm B Dose Escalation||0||
48619185|NCT02810418|101853063|FG004|NOT COMPLETED|Arm B Dose Escalation||1||
48619186|NCT02810418|101853064|FG005|NOT COMPLETED|Arm B Dose Escalation||2||
48619187|NCT02810418|101853065|FG006|NOT COMPLETED|Arm B Dose Escalation||0||
48619188|NCT02810418|101853059|FG000|STARTED|Arm B Combination Therapy||0||
48619189|NCT02810418|101853060|FG001|STARTED|Arm B Combination Therapy||0||
48162668|NCT00909428|100721634|FG002|NOT COMPLETED|Overall Study||9||
48162669|NCT04503096|100721635|FG000|STARTED|Overall Study||24||
48619190|NCT02810418|101853061|FG002|STARTED|Arm B Combination Therapy||0||
48619191|NCT02810418|101853062|FG003|STARTED|Arm B Combination Therapy||0||
48619192|NCT02810418|101853063|FG004|STARTED|Arm B Combination Therapy||0||
48619193|NCT02810418|101853064|FG005|STARTED|Arm B Combination Therapy||0||
48619194|NCT02810418|101853065|FG006|STARTED|Arm B Combination Therapy||5||
48619195|NCT02810418|101853059|FG000|COMPLETED|Arm B Combination Therapy||0||
48619196|NCT02810418|101853060|FG001|COMPLETED|Arm B Combination Therapy||0||
48619197|NCT02810418|101853061|FG002|COMPLETED|Arm B Combination Therapy||0||
48619198|NCT02810418|101853062|FG003|COMPLETED|Arm B Combination Therapy||0||
48619199|NCT02810418|101853063|FG004|COMPLETED|Arm B Combination Therapy||0||
48619200|NCT02810418|101853064|FG005|COMPLETED|Arm B Combination Therapy||0||
48619201|NCT02810418|101853065|FG006|COMPLETED|Arm B Combination Therapy||5||
48619202|NCT02810418|101853059|FG000|NOT COMPLETED|Arm B Combination Therapy||0||
48619203|NCT02810418|101853060|FG001|NOT COMPLETED|Arm B Combination Therapy||0||
48619204|NCT02810418|101853061|FG002|NOT COMPLETED|Arm B Combination Therapy||0||
48162670|NCT04503096|100721635|FG000|COMPLETED|Overall Study||21||
48619205|NCT02810418|101853062|FG003|NOT COMPLETED|Arm B Combination Therapy||0||
48619206|NCT02810418|101853063|FG004|NOT COMPLETED|Arm B Combination Therapy||0||
48162671|NCT04503096|100721635|FG000|NOT COMPLETED|Overall Study||3||
48162672|NCT00641719|100721636|FG000|STARTED|Overall Study||129||
48162673|NCT00641719|100721637|FG001|STARTED|Overall Study||129||
48162674|NCT00641719|100721636|FG000|COMPLETED|Overall Study||99||
48162675|NCT00641719|100721637|FG001|COMPLETED|Overall Study||92||
48162676|NCT00641719|100721636|FG000|NOT COMPLETED|Overall Study||30||
48162677|NCT00641719|100721637|FG001|NOT COMPLETED|Overall Study||37||
48162678|NCT00578721|100721638|FG000|STARTED|Overall Study||24||
48162679|NCT00578721|100721638|FG000|COMPLETED|Overall Study||20||
48162680|NCT00578721|100721638|FG000|NOT COMPLETED|Overall Study||4||
48162681|NCT01960075|100721639|FG000|STARTED|Overall Study||149||
48162682|NCT01960075|100721640|FG001|STARTED|Overall Study||149||
48162683|NCT01960075|100721641|FG002|STARTED|Overall Study||180||
48162684|NCT01960075|100721639|FG000|COMPLETED|Overall Study||141||
48162685|NCT01960075|100721640|FG001|COMPLETED|Overall Study||146||
48162686|NCT01960075|100721641|FG002|COMPLETED|Overall Study||173||
48162687|NCT01960075|100721639|FG000|NOT COMPLETED|Overall Study||8||
48162688|NCT01960075|100721640|FG001|NOT COMPLETED|Overall Study||3||
48162689|NCT01960075|100721641|FG002|NOT COMPLETED|Overall Study||7||
48162690|NCT05050578|100721642|FG000|STARTED|Period 1, 30 Days||82||164
48162691|NCT05050578|100721643|FG001|STARTED|Period 1, 30 Days||80||160
48162692|NCT05050578|100721642|FG000|COMPLETED|Period 1, 30 Days||80||160
48162693|NCT05050578|100721643|FG001|COMPLETED|Period 1, 30 Days||79||158
48162694|NCT05050578|100721642|FG000|NOT COMPLETED|Period 1, 30 Days||2||4
48162695|NCT05050578|100721643|FG001|NOT COMPLETED|Period 1, 30 Days||1||2
48162696|NCT05050578|100721642|FG000|STARTED|Period 2, 30 Days||80||160
48162697|NCT05050578|100721643|FG001|STARTED|Period 2, 30 Days||79||158
48162698|NCT05050578|100721642|FG000|COMPLETED|Period 2, 30 Days||80||160
48162699|NCT05050578|100721643|FG001|COMPLETED|Period 2, 30 Days||78||156
48742528|NCT03078556|102155090|FG000|NOT COMPLETED|Treatment Period 3 (4 Days)||0||
48742529|NCT03078556|102155091|FG001|NOT COMPLETED|Treatment Period 3 (4 Days)||0||
48742530|NCT03078556|102155092|FG002|NOT COMPLETED|Treatment Period 3 (4 Days)||0||
48162700|NCT05050578|100721642|FG000|NOT COMPLETED|Period 2, 30 Days||0||0
48162701|NCT05050578|100721643|FG001|NOT COMPLETED|Period 2, 30 Days||1||2
48162702|NCT03519243|100721644|FG000|STARTED|Overall Study||25||
48162703|NCT03519243|100721645|FG001|STARTED|Overall Study||25||
48162704|NCT03519243|100721646|FG002|STARTED|Overall Study||0||
48162705|NCT03519243|100721647|FG003|STARTED|Overall Study||25||
48162706|NCT03519243|100721644|FG000|COMPLETED|Overall Study||20||
48162707|NCT03519243|100721645|FG001|COMPLETED|Overall Study||21||
48162708|NCT03519243|100721646|FG002|COMPLETED|Overall Study||0||
48162709|NCT03519243|100721647|FG003|COMPLETED|Overall Study||24||
48162710|NCT03519243|100721644|FG000|NOT COMPLETED|Overall Study||5||
48162711|NCT03519243|100721645|FG001|NOT COMPLETED|Overall Study||4||
48162712|NCT03519243|100721646|FG002|NOT COMPLETED|Overall Study||0||
48162713|NCT03519243|100721647|FG003|NOT COMPLETED|Overall Study||1||
48162714|NCT00755222|100721648|FG000|STARTED|Overall Study||111||
48162715|NCT00755222|100721649|FG001|STARTED|Overall Study||36||
48162716|NCT00755222|100721648|FG000|COMPLETED|Overall Study||103||
48742531|NCT03078556|102155093|FG003|NOT COMPLETED|Treatment Period 3 (4 Days)||0||
48742532|NCT01698814|102155094|FG000|STARTED|Overall Study||331||
48162717|NCT00755222|100721649|FG001|COMPLETED|Overall Study||34||
48162718|NCT00755222|100721648|FG000|NOT COMPLETED|Overall Study||8||
48162719|NCT00755222|100721649|FG001|NOT COMPLETED|Overall Study||2||
48162720|NCT02563002|100721650|FG000|STARTED|Overall Study||153||
48162721|NCT02563002|100721651|FG001|STARTED|Overall Study||154||
48162722|NCT02563002|100721650|FG000|Treated|Overall Study||153||
48162723|NCT02563002|100721651|FG001|Treated|Overall Study||143||
48162724|NCT02563002|100721650|FG000|Received Second Course of Pembrolizumab|Overall Study||12||
48162725|NCT02563002|100721651|FG001|Received Second Course of Pembrolizumab|Overall Study||5||
48162726|NCT02563002|100721650|FG000|Switched Over to Pembrolizumab|Overall Study||0||
48162727|NCT02563002|100721651|FG001|Switched Over to Pembrolizumab|Overall Study||7||
48162728|NCT02563002|100721650|FG000|COMPLETED|Overall Study||0||
48162729|NCT02563002|100721651|FG001|COMPLETED|Overall Study||0||
48162730|NCT02563002|100721650|FG000|NOT COMPLETED|Overall Study||153||
48162731|NCT02563002|100721651|FG001|NOT COMPLETED|Overall Study||154||
48162732|NCT00548132|100721652|FG000|STARTED|Overall Study||534||
48162733|NCT00548132|100721653|FG001|STARTED|Overall Study||554||
48742533|NCT01698814|102155095|FG001|STARTED|Overall Study||169||
48742534|NCT01698814|102155094|FG000|COMPLETED|Overall Study||329||
48742535|NCT01698814|102155095|FG001|COMPLETED|Overall Study||166||
48162734|NCT00548132|100721652|FG000|Consented to Study|Overall Study||534||
48162735|NCT00548132|100721653|FG001|Consented to Study|Overall Study||554||
48162736|NCT00548132|100721652|FG000|COMPLETED|Overall Study||534||
48162737|NCT00548132|100721653|FG001|COMPLETED|Overall Study||554||
48162738|NCT00548132|100721652|FG000|NOT COMPLETED|Overall Study||0||
48162739|NCT00548132|100721653|FG001|NOT COMPLETED|Overall Study||0||
48162740|NCT00970216|100721654|FG000|STARTED|Overall Study||160||
48162741|NCT00970216|100721654|FG000|COMPLETED|Overall Study||80||
48162742|NCT00970216|100721654|FG000|NOT COMPLETED|Overall Study||80||
48162743|NCT00278538|100721655|FG000|STARTED|Overall Study||32||
48162744|NCT00278538|100721655|FG000|COMPLETED|Overall Study||30||
48162745|NCT00278538|100721655|FG000|NOT COMPLETED|Overall Study||2||
48162746|NCT01042509|100721656|FG000|STARTED|Overall Study||15||
48742536|NCT01698814|102155094|FG000|NOT COMPLETED|Overall Study||2||
48742537|NCT01698814|102155095|FG001|NOT COMPLETED|Overall Study||3||
48742538|NCT02294058|102155096|FG000|STARTED|Overall Study||448||
48742539|NCT02294058|102155097|FG001|STARTED|Overall Study||451||
48742540|NCT02294058|102155098|FG002|STARTED|Overall Study||447||
48742541|NCT02294058|102155096|FG000|Safety Population|Overall Study||445|Three participants randomized to the interferon beta-1a group received ozanimod in error at some visits (2 participants received ozanimod 0.5 mg and 1 participant received ozanimod 1 mg) and are counted in the ozanimod groups in the Safety Population.|
48742542|NCT02294058|102155097|FG001|Safety Population|Overall Study||453|Three participants randomized to the interferon beta-1a group received ozanimod in error at some visits (2 participants received ozanimod 0.5 mg and 1 participant received ozanimod 1 mg) and are counted in the ozanimod groups in the Safety Population.|
48742543|NCT02294058|102155098|FG002|Safety Population|Overall Study||448|Three participants randomized to the interferon beta-1a group received ozanimod in error at some visits (2 participants received ozanimod 0.5 mg and 1 participant received ozanimod 1 mg) and are counted in the ozanimod groups in the Safety Population.|
48742544|NCT02294058|102155096|FG000|COMPLETED|Overall Study||412||
48742545|NCT02294058|102155097|FG001|COMPLETED|Overall Study||425||
48742546|NCT02294058|102155098|FG002|COMPLETED|Overall Study||418||
48742547|NCT02294058|102155096|FG000|NOT COMPLETED|Overall Study||36||
48742548|NCT02294058|102155097|FG001|NOT COMPLETED|Overall Study||26||
48742549|NCT02294058|102155098|FG002|NOT COMPLETED|Overall Study||29||
48742550|NCT00740584|102155099|FG000|STARTED|Overall Study||12||
48162747|NCT01042509|100721656|FG000|COMPLETED|Overall Study||15||
48162748|NCT01042509|100721656|FG000|NOT COMPLETED|Overall Study||0||
48162749|NCT00601003|100721657|FG000|STARTED|Overall Study||112||
48162750|NCT00601003|100721657|FG000|COMPLETED|Overall Study||76||
48162751|NCT00601003|100721657|FG000|NOT COMPLETED|Overall Study||36||
48162752|NCT03966053|100721658|FG000|STARTED|Overall Study||2||
48162753|NCT03966053|100721658|FG000|COMPLETED|Overall Study||1||
48162754|NCT03966053|100721658|FG000|NOT COMPLETED|Overall Study||1||
48162755|NCT00265330|100721659|FG000|STARTED|Overall Study||162||
48162756|NCT00265330|100721659|FG000|COMPLETED|Overall Study||67||
48162757|NCT00265330|100721659|FG000|NOT COMPLETED|Overall Study||95||
48162758|NCT01106430|100721660|FG000|STARTED|Overall Study||133||
48162759|NCT01106430|100721661|FG001|STARTED|Overall Study||134||
48162760|NCT01106430|100721660|FG000|COMPLETED|Overall Study||100||
48162761|NCT01106430|100721661|FG001|COMPLETED|Overall Study||101||
48162762|NCT01106430|100721660|FG000|NOT COMPLETED|Overall Study||33||
48162763|NCT01106430|100721661|FG001|NOT COMPLETED|Overall Study||33||
48162764|NCT04711356|100721662|FG000|STARTED|Overall Study||50||
48162765|NCT04711356|100721662|FG000|COMPLETED|Overall Study||50||
48162766|NCT04711356|100721662|FG000|NOT COMPLETED|Overall Study||0||
48162767|NCT01583101|100721663|FG000|STARTED|Overall Study||1076||
48162768|NCT01583101|100721664|FG001|STARTED|Overall Study||1161||
48162769|NCT01583101|100721663|FG000|COMPLETED|Overall Study||1076||
48162770|NCT01583101|100721664|FG001|COMPLETED|Overall Study||1161||
48162771|NCT01583101|100721663|FG000|NOT COMPLETED|Overall Study||0||
48162772|NCT01583101|100721664|FG001|NOT COMPLETED|Overall Study||0||
48162773|NCT03682705|100721665|FG000|STARTED|Overall Study||19||
48162774|NCT03682705|100721666|FG001|STARTED|Overall Study||62||
48162775|NCT03682705|100721667|FG002|STARTED|Overall Study||41||
48162776|NCT03682705|100721668|FG003|STARTED|Overall Study||39||
48162777|NCT03682705|100721669|FG004|STARTED|Overall Study||41||
48162778|NCT03682705|100721670|FG005|STARTED|Overall Study||40||
48162779|NCT03682705|100721665|FG000|COMPLETED|Overall Study||17||
48162780|NCT03682705|100721666|FG001|COMPLETED|Overall Study||58||
48162781|NCT03682705|100721667|FG002|COMPLETED|Overall Study||38||
48162782|NCT03682705|100721668|FG003|COMPLETED|Overall Study||34||
48162783|NCT03682705|100721669|FG004|COMPLETED|Overall Study||35||
48162784|NCT03682705|100721670|FG005|COMPLETED|Overall Study||38||
48162785|NCT03682705|100721665|FG000|NOT COMPLETED|Overall Study||2||
48162786|NCT03682705|100721666|FG001|NOT COMPLETED|Overall Study||4||
48162787|NCT03682705|100721667|FG002|NOT COMPLETED|Overall Study||3||
48162788|NCT03682705|100721668|FG003|NOT COMPLETED|Overall Study||5||
48162789|NCT03682705|100721669|FG004|NOT COMPLETED|Overall Study||6||
48162790|NCT03682705|100721670|FG005|NOT COMPLETED|Overall Study||2||
48162791|NCT03685396|100721671|FG000|STARTED|Overall Study||21||
48162792|NCT03685396|100721672|FG001|STARTED|Overall Study||21||
48162793|NCT03685396|100721671|FG000|COMPLETED|Overall Study||21||
48162794|NCT03685396|100721672|FG001|COMPLETED|Overall Study||21||
48162795|NCT03685396|100721671|FG000|NOT COMPLETED|Overall Study||0||
48162796|NCT03685396|100721672|FG001|NOT COMPLETED|Overall Study||0||
48162797|NCT01100255|100721673|FG000|STARTED|Overall Study||8||
48162798|NCT01100255|100721674|FG001|STARTED|Overall Study||7||
48162799|NCT01100255|100721673|FG000|COMPLETED|Overall Study||8||
48162800|NCT01100255|100721674|FG001|COMPLETED|Overall Study||7||
48162801|NCT01100255|100721673|FG000|NOT COMPLETED|Overall Study||0||
48162802|NCT01100255|100721674|FG001|NOT COMPLETED|Overall Study||0||
48162803|NCT00723099|100721675|FG000|STARTED|Overall Study||73||
48162804|NCT00723099|100721675|FG000|COMPLETED|Overall Study||72||
48162805|NCT00723099|100721675|FG000|NOT COMPLETED|Overall Study||1||
48162806|NCT00884754|100721676|FG000|STARTED|Overall Study||30||
48162807|NCT00884754|100721677|FG001|STARTED|Overall Study||30||
48162808|NCT00884754|100721676|FG000|COMPLETED|Overall Study||30||
48162809|NCT00884754|100721677|FG001|COMPLETED|Overall Study||30||
48162810|NCT00884754|100721676|FG000|NOT COMPLETED|Overall Study||0||
48162811|NCT00884754|100721677|FG001|NOT COMPLETED|Overall Study||0||
48162812|NCT01960530|100721678|FG000|STARTED|Overall Study||14||
48162813|NCT01960530|100721678|FG000|COMPLETED|Overall Study||14||
48162814|NCT01960530|100721678|FG000|NOT COMPLETED|Overall Study||0||
48162815|NCT01583686|100721679|FG000|STARTED|Overall Study||3||
48325327|NCT00283595|101124440|FG000|STARTED|Overall Study||10||
48325328|NCT00283595|101124441|FG001|STARTED|Overall Study||11||
48325329|NCT00283595|101124440|FG000|COMPLETED|Overall Study||9||
48325330|NCT00283595|101124441|FG001|COMPLETED|Overall Study||9||
48325331|NCT00283595|101124440|FG000|NOT COMPLETED|Overall Study||1||
48325332|NCT00283595|101124441|FG001|NOT COMPLETED|Overall Study||2||
48325333|NCT01891331|101124442|FG000|STARTED|Overall Study||14||
48325334|NCT01891331|101124443|FG001|STARTED|Overall Study||12||
48325335|NCT01891331|101124444|FG002|STARTED|Overall Study||14||
48325336|NCT01891331|101124445|FG003|STARTED|Overall Study||15||
48325337|NCT01891331|101124442|FG000|COMPLETED|Overall Study||12||
48325338|NCT01891331|101124443|FG001|COMPLETED|Overall Study||10||
48325339|NCT01891331|101124444|FG002|COMPLETED|Overall Study||13||
48325340|NCT01891331|101124445|FG003|COMPLETED|Overall Study||13||
48325341|NCT01891331|101124442|FG000|NOT COMPLETED|Overall Study||2||
48325342|NCT01891331|101124443|FG001|NOT COMPLETED|Overall Study||2||
48325343|NCT01891331|101124444|FG002|NOT COMPLETED|Overall Study||1||
48325344|NCT01891331|101124445|FG003|NOT COMPLETED|Overall Study||2||
48325345|NCT01197326|101124446|FG000|STARTED|Overall Study||205||
48325346|NCT01197326|101124447|FG001|STARTED|Overall Study||209||
48325347|NCT01197326|101124446|FG000|COMPLETED|Overall Study||205||
48325348|NCT01197326|101124447|FG001|COMPLETED|Overall Study||209||
48325349|NCT01197326|101124446|FG000|NOT COMPLETED|Overall Study||0||
48325350|NCT01197326|101124447|FG001|NOT COMPLETED|Overall Study||0||
48325351|NCT01121393|101124448|FG000|STARTED|Overall Study||242||
48325352|NCT01121393|101124449|FG001|STARTED|Overall Study||122||
48325353|NCT01121393|101124448|FG000|Treated|Overall Study||239||
48325354|NCT01121393|101124449|FG001|Treated|Overall Study||113||
48325355|NCT01121393|101124448|FG000|COMPLETED|Overall Study||0||
48325356|NCT01121393|101124449|FG001|COMPLETED|Overall Study||38||
48325357|NCT01121393|101124448|FG000|NOT COMPLETED|Overall Study||242||
48325358|NCT01121393|101124449|FG001|NOT COMPLETED|Overall Study||84||
48325359|NCT03824808|101124450|FG000|STARTED|Overall Study||11||
48325360|NCT03824808|101124451|FG001|STARTED|Overall Study||10||
48325361|NCT03824808|101124450|FG000|COMPLETED|Overall Study||11||
48325362|NCT03824808|101124451|FG001|COMPLETED|Overall Study||10||
48325363|NCT03824808|101124450|FG000|NOT COMPLETED|Overall Study||0||
48325364|NCT03824808|101124451|FG001|NOT COMPLETED|Overall Study||0||
48325365|NCT02698735|101124452|FG000|STARTED|Overall Study||5||20
48325366|NCT02698735|101124452|FG000|COMPLETED|Overall Study||5|One patient was enrolled but declined the intradermal injections. Patient completed all followups.|18
48325367|NCT02698735|101124452|FG000|NOT COMPLETED|Overall Study||0||2
48325368|NCT01445028|101124453|FG000|STARTED|Overall Study||58||
48325369|NCT01445028|101124454|FG001|STARTED|Overall Study||54||
48325370|NCT01445028|101124453|FG000|COMPLETED|Overall Study||58||
48325371|NCT01445028|101124454|FG001|COMPLETED|Overall Study||51||
48325372|NCT01445028|101124453|FG000|NOT COMPLETED|Overall Study||0||
48325373|NCT01445028|101124454|FG001|NOT COMPLETED|Overall Study||3||
48325374|NCT00751777|101124455|FG000|STARTED|Overall Study||81||
48325375|NCT00751777|101124456|FG001|STARTED|Overall Study||39||
48325376|NCT00751777|101124455|FG000|COMPLETED|Overall Study||70||
48325377|NCT00751777|101124456|FG001|COMPLETED|Overall Study||36||
48325378|NCT00751777|101124455|FG000|NOT COMPLETED|Overall Study||11||
48325379|NCT00751777|101124456|FG001|NOT COMPLETED|Overall Study||3||
48325380|NCT02431572|101124457|FG000|STARTED|Overall Study||1||
48325381|NCT02431572|101124458|FG001|STARTED|Overall Study||1||
48325382|NCT02431572|101124459|FG002|STARTED|Overall Study||9||
48325383|NCT02431572|101124457|FG000|COMPLETED|Overall Study||0||
48325384|NCT02431572|101124458|FG001|COMPLETED|Overall Study||1||
48325385|NCT02431572|101124459|FG002|COMPLETED|Overall Study||9||
48325386|NCT02431572|101124457|FG000|NOT COMPLETED|Overall Study||1||
48162816|NCT01583686|100721680|FG001|STARTED|Overall Study||3||
48162817|NCT01583686|100721681|FG002|STARTED|Overall Study||3||
48162818|NCT01583686|100721682|FG003|STARTED|Overall Study||3||
48325387|NCT02431572|101124458|FG001|NOT COMPLETED|Overall Study||0||
48162819|NCT01583686|100721683|FG004|STARTED|Overall Study||3||
48325388|NCT02431572|101124459|FG002|NOT COMPLETED|Overall Study||0||
48325389|NCT00746252|101124460|FG000|STARTED|Overall Study||1||
48325390|NCT00746252|101124461|FG001|STARTED|Overall Study||2||
48162820|NCT01583686|100721679|FG000|COMPLETED|Overall Study||3||
48325391|NCT00746252|101124460|FG000|COMPLETED|Overall Study||0||
48325392|NCT00746252|101124461|FG001|COMPLETED|Overall Study||0||
48325393|NCT00746252|101124460|FG000|NOT COMPLETED|Overall Study||1||
48325394|NCT00746252|101124461|FG001|NOT COMPLETED|Overall Study||2||
48325395|NCT02289222|101124462|FG000|STARTED|Overall Study||48||
48325396|NCT02289222|101124462|FG000|COMPLETED|Overall Study||48||
48162821|NCT01583686|100721680|FG001|COMPLETED|Overall Study||3||
48325397|NCT02289222|101124462|FG000|NOT COMPLETED|Overall Study||0||
48325398|NCT01464307|101124463|FG000|STARTED|Main Period||144||
48325399|NCT01464307|101124464|FG001|STARTED|Main Period||145||
48325400|NCT01464307|101124463|FG000|Treated|Main Period||144||
48325401|NCT01464307|101124464|FG001|Treated|Main Period||145||
48325402|NCT01464307|101124463|FG000|COMPLETED|Main Period||129||
48325403|NCT01464307|101124464|FG001|COMPLETED|Main Period||140||
48325404|NCT01464307|101124463|FG000|NOT COMPLETED|Main Period||15||
48325405|NCT01464307|101124464|FG001|NOT COMPLETED|Main Period||5||
48325406|NCT01464307|101124463|FG000|STARTED|Open-Label Extension Period||269||
48325407|NCT01464307|101124464|FG001|STARTED|Open-Label Extension Period||0||
48409102|NCT01488188|101331936|FG000|NOT COMPLETED|Overall Study||0||
48409103|NCT01488188|101331937|FG001|NOT COMPLETED|Overall Study||0||
48409104|NCT01512108|101331938|FG000|STARTED|Overall Study||243||
48409105|NCT01512108|101331939|FG001|STARTED|Overall Study||120||
48409106|NCT01512108|101331938|FG000|Exposed|Overall Study||240||
48409107|NCT01512108|101331939|FG001|Exposed|Overall Study||120||
48409108|NCT01512108|101331938|FG000|COMPLETED|Overall Study||221||
48409109|NCT01512108|101331939|FG001|COMPLETED|Overall Study||111||
48409110|NCT01512108|101331938|FG000|NOT COMPLETED|Overall Study||22||
48409111|NCT01512108|101331939|FG001|NOT COMPLETED|Overall Study||9||
48409112|NCT02967562|101331940|FG000|STARTED|Overall Study||32||
48409113|NCT02967562|101331941|FG001|STARTED|Overall Study||31||
48409114|NCT02967562|101331940|FG000|COMPLETED|Overall Study||30||
48409115|NCT02967562|101331941|FG001|COMPLETED|Overall Study||30||
48409116|NCT02967562|101331940|FG000|NOT COMPLETED|Overall Study||2||
48325408|NCT01464307|101124463|FG000|Treated|Open-Label Extension Period||269||
48325409|NCT01464307|101124464|FG001|Treated|Open-Label Extension Period||0||
48325410|NCT01464307|101124463|FG000|COMPLETED|Open-Label Extension Period||218||
48409117|NCT02967562|101331941|FG001|NOT COMPLETED|Overall Study||1||
48325411|NCT01464307|101124464|FG001|COMPLETED|Open-Label Extension Period||0||
48325412|NCT01464307|101124463|FG000|NOT COMPLETED|Open-Label Extension Period||51||
48325413|NCT01464307|101124464|FG001|NOT COMPLETED|Open-Label Extension Period||0||
48325414|NCT01773109|101124465|FG000|STARTED|Overall Study||40||
48325415|NCT01773109|101124465|FG000|COMPLETED|Overall Study||37||
48325416|NCT01773109|101124465|FG000|NOT COMPLETED|Overall Study||3||
48325417|NCT04116112|101124466|FG000|STARTED|Overall Study||40||
48325418|NCT04116112|101124467|FG001|STARTED|Overall Study||40||
48325419|NCT04116112|101124468|FG002|STARTED|Overall Study||40||
48325420|NCT04116112|101124466|FG000|COMPLETED|Overall Study||39||
48325421|NCT04116112|101124467|FG001|COMPLETED|Overall Study||36||
48325422|NCT04116112|101124468|FG002|COMPLETED|Overall Study||38||
48325423|NCT04116112|101124466|FG000|NOT COMPLETED|Overall Study||1||
48325424|NCT04116112|101124467|FG001|NOT COMPLETED|Overall Study||4||
48325425|NCT04116112|101124468|FG002|NOT COMPLETED|Overall Study||2||
48325426|NCT03730116|101124469|FG000|STARTED|Inclusion||1909||
48325427|NCT03730116|101124469|FG000|FVFP|Inclusion||1909||
48325428|NCT03730116|101124469|FG000|COMPLETED|Inclusion||1909||
48325429|NCT03730116|101124469|FG000|NOT COMPLETED|Inclusion||0||
48325430|NCT03730116|101124469|FG000|STARTED|1 Month After Inclusion||1909||
48325431|NCT03730116|101124469|FG000|1 Month After Inclusion|1 Month After Inclusion||1909||
48325432|NCT03730116|101124469|FG000|COMPLETED|1 Month After Inclusion||1909||
48325433|NCT03730116|101124469|FG000|NOT COMPLETED|1 Month After Inclusion||0||
48325434|NCT03730116|101124469|FG000|STARTED|3 Month After Inclusion||1909||
48325435|NCT03730116|101124469|FG000|3 Month After Inclusion|3 Month After Inclusion||1909||
48325436|NCT03730116|101124469|FG000|COMPLETED|3 Month After Inclusion||1892||
48325437|NCT03730116|101124469|FG000|NOT COMPLETED|3 Month After Inclusion||17||
48325438|NCT02553512|101124470|FG000|STARTED|Overall Study||167||
48325439|NCT02553512|101124470|FG000|COMPLETED|Overall Study||144||
48325440|NCT02553512|101124470|FG000|NOT COMPLETED|Overall Study||23||
48325441|NCT00915681|101124471|FG000|STARTED|Overall Study||148||
48325442|NCT00915681|101124471|FG000|COMPLETED|Overall Study||102||
48325443|NCT00915681|101124471|FG000|NOT COMPLETED|Overall Study||46||
48325444|NCT00546052|101124472|FG000|STARTED|Overall Study||1738||
48325445|NCT00546052|101124472|FG000|Week 4|Overall Study||1714||
48325446|NCT00546052|101124472|FG000|Week 8|Overall Study||1680||
48409118|NCT00832091|101331942|FG000|STARTED|Overall Study||17||
48409119|NCT00832091|101331943|FG001|STARTED|Overall Study||55||
48409120|NCT00832091|101331942|FG000|COMPLETED|Overall Study||12||
48409121|NCT00832091|101331943|FG001|COMPLETED|Overall Study||53||
48409122|NCT00832091|101331942|FG000|NOT COMPLETED|Overall Study||5||
48409123|NCT00832091|101331943|FG001|NOT COMPLETED|Overall Study||2||
48409124|NCT03669146|101331944|FG000|STARTED|Overall Study||15||
48409125|NCT03669146|101331945|FG001|STARTED|Overall Study||15||
48409126|NCT03669146|101331946|FG002|STARTED|Overall Study||5||
48325447|NCT00546052|101124472|FG000|Week 12|Overall Study||1650||
48325448|NCT00546052|101124472|FG000|Week 32|Overall Study||1583||
48409127|NCT03669146|101331944|FG000|COMPLETED|Overall Study||13||
48619207|NCT02810418|101853064|FG005|NOT COMPLETED|Arm B Combination Therapy||0||
48325449|NCT00546052|101124472|FG000|Week 52|Overall Study||1511||
48325450|NCT00546052|101124472|FG000|COMPLETED|Overall Study||1511||
48325451|NCT00546052|101124472|FG000|NOT COMPLETED|Overall Study||227||
48325452|NCT03326843|101124473|FG000|STARTED|Overall Study||4||
48325453|NCT03326843|101124473|FG000|COMPLETED|Overall Study||4||
48162822|NCT01583686|100721681|FG002|COMPLETED|Overall Study||3||
48162823|NCT01583686|100721682|FG003|COMPLETED|Overall Study||3||
48162824|NCT01583686|100721683|FG004|COMPLETED|Overall Study||3||
48162825|NCT01583686|100721679|FG000|NOT COMPLETED|Overall Study||0||
48162826|NCT01583686|100721680|FG001|NOT COMPLETED|Overall Study||0||
48162827|NCT01583686|100721681|FG002|NOT COMPLETED|Overall Study||0||
48162828|NCT01583686|100721682|FG003|NOT COMPLETED|Overall Study||0||
48162829|NCT01583686|100721683|FG004|NOT COMPLETED|Overall Study||0||
48162830|NCT01446796|100721684|FG000|STARTED|Overall Study||3||
48162831|NCT01446796|100721685|FG001|STARTED|Overall Study||0||
48162832|NCT01446796|100721684|FG000|COMPLETED|Overall Study||2||
48162833|NCT01446796|100721685|FG001|COMPLETED|Overall Study||0||
48162834|NCT01446796|100721684|FG000|NOT COMPLETED|Overall Study||1||
48162835|NCT01446796|100721685|FG001|NOT COMPLETED|Overall Study||0||
48162836|NCT01492686|100721686|FG000|STARTED|Double-blind Phase||69||
48162837|NCT01492686|100721687|FG001|STARTED|Double-blind Phase||68||
48162838|NCT01492686|100721686|FG000|COMPLETED|Double-blind Phase||67||
48162839|NCT01492686|100721687|FG001|COMPLETED|Double-blind Phase||60||
48162840|NCT01492686|100721686|FG000|NOT COMPLETED|Double-blind Phase||2||
48162841|NCT01492686|100721687|FG001|NOT COMPLETED|Double-blind Phase||8||
48162842|NCT01492686|100721686|FG000|STARTED|Open-label Phase||65||
48162843|NCT01492686|100721687|FG001|STARTED|Open-label Phase||58||
48162844|NCT01492686|100721686|FG000|COMPLETED|Open-label Phase||53||
48162845|NCT01492686|100721687|FG001|COMPLETED|Open-label Phase||40||
48162846|NCT01492686|100721686|FG000|NOT COMPLETED|Open-label Phase||12||
48162847|NCT01492686|100721687|FG001|NOT COMPLETED|Open-label Phase||18||
48162848|NCT02832622|100721688|FG000|STARTED|Overall Study||2169||
48162849|NCT02832622|100721688|FG000|COMPLETED|Overall Study||433|Sixteen (16) cardiovascular deaths were included in the 433 subjects who completed the trial as they met one of the endpoint of the trial.|
48162850|NCT02832622|100721688|FG000|NOT COMPLETED|Overall Study||1736||
48162851|NCT01437124|100721689|FG000|STARTED|Overall Study||83||
48162852|NCT01437124|100721689|FG000|COMPLETED|Overall Study||83||
48162853|NCT01437124|100721689|FG000|NOT COMPLETED|Overall Study||0||
48162854|NCT01933880|100721690|FG000|STARTED|Overall Study||153||
48162855|NCT01933880|100721691|FG001|STARTED|Overall Study||41||
48162856|NCT01933880|100721690|FG000|COMPLETED|Overall Study||123||
48162857|NCT01933880|100721691|FG001|COMPLETED|Overall Study||40||
48162858|NCT01933880|100721690|FG000|NOT COMPLETED|Overall Study||30||
48162859|NCT01933880|100721691|FG001|NOT COMPLETED|Overall Study||1||
48162860|NCT02565901|100721692|FG000|STARTED|Overall Study||11||
48162861|NCT02565901|100721693|FG001|STARTED|Overall Study||11||
48162862|NCT02565901|100721694|FG002|STARTED|Overall Study||6||
48162863|NCT02565901|100721692|FG000|COMPLETED|Overall Study||11||
48162864|NCT02565901|100721693|FG001|COMPLETED|Overall Study||11||
48162865|NCT02565901|100721694|FG002|COMPLETED|Overall Study||6||
48162866|NCT02565901|100721692|FG000|NOT COMPLETED|Overall Study||0||
48325454|NCT03326843|101124473|FG000|NOT COMPLETED|Overall Study||0||
48162867|NCT02565901|100721693|FG001|NOT COMPLETED|Overall Study||0||
48162868|NCT02565901|100721694|FG002|NOT COMPLETED|Overall Study||0||
48162869|NCT03021486|100721695|FG000|STARTED|Overall Study||23||
48162870|NCT03021486|100721696|FG001|STARTED|Overall Study||22||
48162871|NCT03021486|100721697|FG002|STARTED|Overall Study||23||
48409128|NCT03669146|101331945|FG001|COMPLETED|Overall Study||14||
48409129|NCT03669146|101331946|FG002|COMPLETED|Overall Study||5||
48409130|NCT03669146|101331944|FG000|NOT COMPLETED|Overall Study||2||
48409131|NCT03669146|101331945|FG001|NOT COMPLETED|Overall Study||1||
48409132|NCT03669146|101331946|FG002|NOT COMPLETED|Overall Study||0||
48409133|NCT00389805|101331947|FG000|STARTED|Phase I||15||
48409134|NCT00389805|101331948|FG001|STARTED|Phase I||12||
48409135|NCT00389805|101331947|FG000|COMPLETED|Phase I||15||
48409136|NCT00389805|101331948|FG001|COMPLETED|Phase I||12||
48409137|NCT00389805|101331947|FG000|NOT COMPLETED|Phase I||0||
48409138|NCT00389805|101331948|FG001|NOT COMPLETED|Phase I||0||
48409139|NCT00389805|101331947|FG000|STARTED|Phase II||0||
48409140|NCT00389805|101331948|FG001|STARTED|Phase II||0||
48409141|NCT00389805|101331947|FG000|COMPLETED|Phase II||0||
48409142|NCT00389805|101331948|FG001|COMPLETED|Phase II||0||
48409143|NCT00389805|101331947|FG000|NOT COMPLETED|Phase II||0||
48409144|NCT00389805|101331948|FG001|NOT COMPLETED|Phase II||0||
48409145|NCT01512693|101331949|FG000|STARTED|Overall Study||8||
48409146|NCT01512693|101331950|FG001|STARTED|Overall Study||9||
48409147|NCT01512693|101331949|FG000|COMPLETED|Overall Study||8||
48409148|NCT01512693|101331950|FG001|COMPLETED|Overall Study||8||
48409149|NCT01512693|101331949|FG000|NOT COMPLETED|Overall Study||0||
48409150|NCT01512693|101331950|FG001|NOT COMPLETED|Overall Study||1||
48409151|NCT03288311|101331951|FG000|STARTED|Overall Study||359||
48409152|NCT03288311|101331952|FG001|STARTED|Overall Study||392||
48409153|NCT03288311|101331951|FG000|COMPLETED|Overall Study||359||
48409154|NCT03288311|101331952|FG001|COMPLETED|Overall Study||392||
48409155|NCT03288311|101331951|FG000|NOT COMPLETED|Overall Study||0||
48409156|NCT03288311|101331952|FG001|NOT COMPLETED|Overall Study||0||
48409157|NCT04280081|101331953|FG000|STARTED|Overall Study||77||
48409158|NCT04280081|101331953|FG000|Enrolled: All NSCLC|Overall Study||47||
48409159|NCT04280081|101331953|FG000|Enrolled: All TC|Overall Study||1||
48409160|NCT04280081|101331953|FG000|Enrolled: All MTC|Overall Study||29||
48409161|NCT04280081|101331953|FG000|PAS: RET Fusion Positive NSCLC|Overall Study||26||
48409162|NCT04280081|101331953|FG000|PAS: RET Fusion Positive TC|Overall Study||1||
48409163|NCT04280081|101331953|FG000|PAS: Advance RET-mutant MTC|Overall Study||26||
48409164|NCT04280081|101331953|FG000|COMPLETED|Overall Study||65||
48409165|NCT04280081|101331953|FG000|NOT COMPLETED|Overall Study||12||
48409166|NCT00085644|101331954|FG000|STARTED|Double-Blind Period||208||
48409167|NCT00085644|101331955|FG001|STARTED|Double-Blind Period||107||
48409168|NCT00085644|101331956|FG002|STARTED|Double-Blind Period||0||
48409169|NCT00085644|101331954|FG000|COMPLETED|Double-Blind Period||195||
48409170|NCT00085644|101331955|FG001|COMPLETED|Double-Blind Period||101||
48409171|NCT00085644|101331956|FG002|COMPLETED|Double-Blind Period||0||
48409172|NCT00085644|101331954|FG000|NOT COMPLETED|Double-Blind Period||13||
48409173|NCT00085644|101331955|FG001|NOT COMPLETED|Double-Blind Period||6||
48409174|NCT00085644|101331956|FG002|NOT COMPLETED|Double-Blind Period||0||
48409175|NCT00085644|101331954|FG000|STARTED|Open-Label Period||0||
48409176|NCT00085644|101331955|FG001|STARTED|Open-Label Period||0||
48409177|NCT00085644|101331956|FG002|STARTED|Open-Label Period||311||
48409178|NCT00085644|101331954|FG000|COMPLETED|Open-Label Period||0||
48409179|NCT00085644|101331955|FG001|COMPLETED|Open-Label Period||0||
48409180|NCT00085644|101331956|FG002|COMPLETED|Open-Label Period||202||
48409181|NCT00085644|101331954|FG000|NOT COMPLETED|Open-Label Period||0||
48409182|NCT00085644|101331955|FG001|NOT COMPLETED|Open-Label Period||0||
48409183|NCT00085644|101331956|FG002|NOT COMPLETED|Open-Label Period||109||
48409184|NCT00998985|101331957|FG000|STARTED|Overall Study||5||
48409185|NCT00998985|101331958|FG001|STARTED|Overall Study||5||
48409186|NCT00998985|101331959|FG002|STARTED|Overall Study||15||
48409187|NCT00998985|101331960|FG003|STARTED|Overall Study||5||
48409188|NCT00998985|101331961|FG004|STARTED|Overall Study||5||
48409189|NCT00998985|101331962|FG005|STARTED|Overall Study||5||
48409190|NCT00998985|101331963|FG006|STARTED|Overall Study||5||
48409191|NCT00998985|101331964|FG007|STARTED|Overall Study||5||
48409192|NCT00998985|101331965|FG008|STARTED|Overall Study||6||
48409193|NCT00998985|101331966|FG009|STARTED|Overall Study||5||
48409194|NCT00998985|101331967|FG010|STARTED|Overall Study||5||
48409195|NCT00998985|101331968|FG011|STARTED|Overall Study||5||
48409196|NCT00998985|101331969|FG012|STARTED|Overall Study||5||
48409197|NCT00998985|101331970|FG013|STARTED|Overall Study||15||
48409198|NCT00998985|101331957|FG000|COMPLETED|Overall Study||5||
48409199|NCT00998985|101331958|FG001|COMPLETED|Overall Study||5||
48409200|NCT00998985|101331959|FG002|COMPLETED|Overall Study||15||
48409201|NCT00998985|101331960|FG003|COMPLETED|Overall Study||5||
48409202|NCT00998985|101331961|FG004|COMPLETED|Overall Study||5||
48409203|NCT00998985|101331962|FG005|COMPLETED|Overall Study||4||
48409204|NCT00998985|101331963|FG006|COMPLETED|Overall Study||5||
48409205|NCT00998985|101331964|FG007|COMPLETED|Overall Study||5||
48409206|NCT00998985|101331965|FG008|COMPLETED|Overall Study||5||
48409207|NCT00998985|101331966|FG009|COMPLETED|Overall Study||5||
48409208|NCT00998985|101331967|FG010|COMPLETED|Overall Study||5||
48409209|NCT00998985|101331968|FG011|COMPLETED|Overall Study||5||
48409210|NCT00998985|101331969|FG012|COMPLETED|Overall Study||5||
48409211|NCT00998985|101331970|FG013|COMPLETED|Overall Study||15||
48409212|NCT00998985|101331957|FG000|NOT COMPLETED|Overall Study||0||
48409213|NCT00998985|101331958|FG001|NOT COMPLETED|Overall Study||0||
48409214|NCT00998985|101331959|FG002|NOT COMPLETED|Overall Study||0||
48409215|NCT00998985|101331960|FG003|NOT COMPLETED|Overall Study||0||
48409216|NCT00998985|101331961|FG004|NOT COMPLETED|Overall Study||0||
48409217|NCT00998985|101331962|FG005|NOT COMPLETED|Overall Study||1||
48409218|NCT00998985|101331963|FG006|NOT COMPLETED|Overall Study||0||
48409219|NCT00998985|101331964|FG007|NOT COMPLETED|Overall Study||0||
48409220|NCT00998985|101331965|FG008|NOT COMPLETED|Overall Study||1||
48409221|NCT00998985|101331966|FG009|NOT COMPLETED|Overall Study||0||
48409222|NCT00998985|101331967|FG010|NOT COMPLETED|Overall Study||0||
48409223|NCT00998985|101331968|FG011|NOT COMPLETED|Overall Study||0||
48409224|NCT00998985|101331969|FG012|NOT COMPLETED|Overall Study||0||
48409225|NCT00998985|101331970|FG013|NOT COMPLETED|Overall Study||0||
48409226|NCT02661256|101331971|FG000|STARTED|Overall Study||7||
48409227|NCT02661256|101331971|FG000|COMPLETED|Overall Study||7||
48409228|NCT02661256|101331971|FG000|NOT COMPLETED|Overall Study||0||
48409229|NCT02698566|101331972|FG000|STARTED|Overall Study||35||
48409230|NCT02698566|101331973|FG001|STARTED|Overall Study||3||
48409231|NCT02698566|101331972|FG000|COMPLETED|Overall Study||35||
48409232|NCT02698566|101331973|FG001|COMPLETED|Overall Study||3||
48409233|NCT02698566|101331972|FG000|NOT COMPLETED|Overall Study||0||
48409234|NCT02698566|101331973|FG001|NOT COMPLETED|Overall Study||0||
48409235|NCT02460172|101331974|FG000|STARTED|Overall Study||25|This is a split-person study|50
48409236|NCT02460172|101331974|FG000|COMPLETED|Overall Study||25||50
48409237|NCT02460172|101331974|FG000|NOT COMPLETED|Overall Study||0||0
48409238|NCT04323098|101331975|FG000|STARTED|Overall Study||22||
48409239|NCT04323098|101331975|FG000|Continuing in the Study|Overall Study||22||
48409240|NCT04323098|101331975|FG000|Completed Week 52 Visit|Overall Study||22||
48409241|NCT04323098|101331975|FG000|COMPLETED|Overall Study||0|Study is still ongoing.|
48409242|NCT04323098|101331975|FG000|NOT COMPLETED|Overall Study||22||
48409243|NCT04724291|101331976|FG000|STARTED|Overall Study||43||
48409244|NCT04724291|101331976|FG000|COMPLETED|Overall Study||40||
48409245|NCT04724291|101331976|FG000|NOT COMPLETED|Overall Study||3||
48409246|NCT03864627|101331977|FG000|STARTED|Overall Study||11||
48409247|NCT03864627|101331978|FG001|STARTED|Overall Study||22||
48742551|NCT00740584|102155099|FG000|COMPLETED|Overall Study||11||
48742552|NCT00740584|102155099|FG000|NOT COMPLETED|Overall Study||1||
48742553|NCT01054456|102155100|FG000|STARTED|Overall Study||36||
48409248|NCT03864627|101331977|FG000|COMPLETED|Overall Study||7||
48409249|NCT03864627|101331978|FG001|COMPLETED|Overall Study||10||
48409250|NCT03864627|101331977|FG000|NOT COMPLETED|Overall Study||4||
48409251|NCT03864627|101331978|FG001|NOT COMPLETED|Overall Study||12||
48409252|NCT01080625|101331979|FG000|STARTED|Overall Study||31||
48409253|NCT01080625|101331980|FG001|STARTED|Overall Study||33||
48742554|NCT01054456|102155100|FG000|COMPLETED|Overall Study||35||
48742555|NCT01054456|102155100|FG000|NOT COMPLETED|Overall Study||1||
48742556|NCT00482625|102155101|FG000|STARTED|Overall Study||6||
48742557|NCT00482625|102155101|FG000|COMPLETED|Overall Study||6||
48742558|NCT00482625|102155101|FG000|NOT COMPLETED|Overall Study||0||
48742559|NCT03618420|102155102|FG000|STARTED|Overall Study||50|Study Start and IRB Approval|
48742560|NCT03618420|102155102|FG000|COMPLETED|Overall Study||50||
48742561|NCT03618420|102155102|FG000|NOT COMPLETED|Overall Study||0||
48742562|NCT03191630|102155103|FG000|STARTED|Overall Study||30||
48742563|NCT03191630|102155104|FG001|STARTED|Overall Study||30||
48742564|NCT03191630|102155103|FG000|COMPLETED|Overall Study||23||
48742565|NCT03191630|102155104|FG001|COMPLETED|Overall Study||23||
48742566|NCT03191630|102155103|FG000|NOT COMPLETED|Overall Study||7||
48742567|NCT03191630|102155104|FG001|NOT COMPLETED|Overall Study||7||
48742568|NCT03782701|102155105|FG000|STARTED|Overall Study||43||86
48742569|NCT03782701|102155105|FG000|Lumify|Overall Study||43||43
48742570|NCT03782701|102155105|FG000|Saline Solution|Overall Study||43||43
48742571|NCT03782701|102155105|FG000|COMPLETED|Overall Study||43||86
48409254|NCT01080625|101331981|FG002|STARTED|Overall Study||32||
48409255|NCT01080625|101331979|FG000|COMPLETED|Overall Study||31||
48409256|NCT01080625|101331980|FG001|COMPLETED|Overall Study||31||
48742572|NCT03782701|102155105|FG000|NOT COMPLETED|Overall Study||0||0
48742573|NCT01961271|102155106|FG000|STARTED|Overall Study||114||
48742574|NCT01961271|102155106|FG000|COMPLETED|Overall Study||64||
48742575|NCT01961271|102155106|FG000|NOT COMPLETED|Overall Study||50||
48742576|NCT03170661|102155107|FG000|STARTED|Overall Study||49||
48742577|NCT03170661|102155108|FG001|STARTED|Overall Study||49||
48742578|NCT03170661|102155107|FG000|COMPLETED|Overall Study||49||
48742579|NCT03170661|102155108|FG001|COMPLETED|Overall Study||49||
48742580|NCT03170661|102155107|FG000|NOT COMPLETED|Overall Study||0||
48742581|NCT03170661|102155108|FG001|NOT COMPLETED|Overall Study||0||
48409257|NCT01080625|101331981|FG002|COMPLETED|Overall Study||31||
48409258|NCT01080625|101331979|FG000|NOT COMPLETED|Overall Study||0||
48409259|NCT01080625|101331980|FG001|NOT COMPLETED|Overall Study||2||
48409260|NCT01080625|101331981|FG002|NOT COMPLETED|Overall Study||1||
48409261|NCT02096471|101334678|FG000|STARTED|Overall Study||19||19
48409262|NCT02096471|101334678|FG000|COMPLETED|Overall Study||6|This is a single group study and the units assigned data element is the target lesion.|6
48742582|NCT01702025|102155109|FG000|STARTED|Overall Study||11||
48742583|NCT01702025|102155110|FG001|STARTED|Overall Study||10||
48742584|NCT01702025|102155111|FG002|STARTED|Overall Study||10||
48409263|NCT02096471|101334678|FG000|NOT COMPLETED|Overall Study||13||13
48409264|NCT03236506|101334679|FG000|STARTED|Overall Study||39||
48409265|NCT03236506|101334680|FG001|STARTED|Overall Study||42||
48409266|NCT03236506|101334681|FG002|STARTED|Overall Study||47||
48409267|NCT03236506|101334679|FG000|COMPLETED|Overall Study||33||
48409268|NCT03236506|101334680|FG001|COMPLETED|Overall Study||37||
48325455|NCT02342015|101124474|FG000|STARTED|Overall Study||20||
48325456|NCT02342015|101124474|FG000|COMPLETED|Overall Study||20||
48325457|NCT02342015|101124474|FG000|NOT COMPLETED|Overall Study||0||
48325458|NCT01069562|101124475|FG000|STARTED|Overall Study||20||
48325459|NCT01069562|101124476|FG001|STARTED|Overall Study||20||
48409269|NCT03236506|101334681|FG002|COMPLETED|Overall Study||40||
48409270|NCT03236506|101334679|FG000|NOT COMPLETED|Overall Study||6||
48409271|NCT03236506|101334680|FG001|NOT COMPLETED|Overall Study||5||
48409272|NCT03236506|101334681|FG002|NOT COMPLETED|Overall Study||7||
48409273|NCT00410514|101334682|FG000|STARTED|Overall Study||65||
48409274|NCT00410514|101334683|FG001|STARTED|Overall Study||70||
48409275|NCT00410514|101334684|FG002|STARTED|Overall Study||65||
48409276|NCT00410514|101334682|FG000|Safety Analysis Set (SAF)|Overall Study||65||
48409277|NCT00410514|101334683|FG001|Safety Analysis Set (SAF)|Overall Study||70||
48409278|NCT00410514|101334684|FG002|Safety Analysis Set (SAF)|Overall Study||65||
48409279|NCT00410514|101334682|FG000|Full Analysis Set (FAS)|Overall Study||63||
48409280|NCT00410514|101334683|FG001|Full Analysis Set (FAS)|Overall Study||64||
48409281|NCT00410514|101334684|FG002|Full Analysis Set (FAS)|Overall Study||58||
48409282|NCT00410514|101334682|FG000|COMPLETED|Overall Study||63||
48409283|NCT00410514|101334683|FG001|COMPLETED|Overall Study||67||
48409284|NCT00410514|101334684|FG002|COMPLETED|Overall Study||58||
48409285|NCT00410514|101334682|FG000|NOT COMPLETED|Overall Study||2||
48409286|NCT00410514|101334683|FG001|NOT COMPLETED|Overall Study||3||
48409287|NCT00410514|101334684|FG002|NOT COMPLETED|Overall Study||7||
48619208|NCT02810418|101853065|FG006|NOT COMPLETED|Arm B Combination Therapy||0||
48619209|NCT00001322|101853066|FG000|STARTED|Phase 1 - Lupron Only||92||
48619210|NCT00001322|101853067|FG001|STARTED|Phase 1 - Lupron Only||0||
48619211|NCT00001322|101853068|FG002|STARTED|Phase 1 - Lupron Only||0||
48619212|NCT00001322|101853066|FG000|COMPLETED|Phase 1 - Lupron Only||92||
48619213|NCT00001322|101853067|FG001|COMPLETED|Phase 1 - Lupron Only||0||
48619214|NCT00001322|101853068|FG002|COMPLETED|Phase 1 - Lupron Only||0||
48619215|NCT00001322|101853066|FG000|NOT COMPLETED|Phase 1 - Lupron Only||0||
48619216|NCT00001322|101853067|FG001|NOT COMPLETED|Phase 1 - Lupron Only||0||
48619217|NCT00001322|101853068|FG002|NOT COMPLETED|Phase 1 - Lupron Only||0||
48619218|NCT00001322|101853066|FG000|STARTED|Phase 2, Period 1 - Crossover Phase||0||
48619219|NCT00001322|101853067|FG001|STARTED|Phase 2, Period 1 - Crossover Phase||42||
48619220|NCT00001322|101853068|FG002|STARTED|Phase 2, Period 1 - Crossover Phase||40||
48619221|NCT00001322|101853066|FG000|COMPLETED|Phase 2, Period 1 - Crossover Phase||0||
48325460|NCT01069562|101124475|FG000|COMPLETED|Overall Study||20||
48325461|NCT01069562|101124476|FG001|COMPLETED|Overall Study||20||
48325462|NCT01069562|101124475|FG000|NOT COMPLETED|Overall Study||0||
48325463|NCT01069562|101124476|FG001|NOT COMPLETED|Overall Study||0||
48325464|NCT02870309|101124477|FG000|STARTED|Overall Study||4||
48325465|NCT02870309|101124477|FG000|COMPLETED|Overall Study||4||
48325466|NCT02870309|101124477|FG000|NOT COMPLETED|Overall Study||0||
48325467|NCT00825500|101124478|FG000|STARTED|Overall Study||125||
48409288|NCT00364832|101334685|FG000|STARTED|Core Period||16||
48409289|NCT00364832|101334686|FG001|STARTED|Core Period||15||
48409290|NCT00364832|101334687|FG002|STARTED|Core Period||15||
48409291|NCT00364832|101334688|FG003|STARTED|Core Period||16||
48409292|NCT00364832|101334689|FG004|STARTED|Core Period||16||
48409293|NCT00364832|101334690|FG005|STARTED|Core Period||12||
48409294|NCT00364832|101334691|FG006|STARTED|Core Period||16||
48409295|NCT00364832|101334692|FG007|STARTED|Core Period||15||
48409296|NCT00364832|101334693|FG008|STARTED|Core Period||16||
48409297|NCT00364832|101334694|FG009|STARTED|Core Period||0||
48409298|NCT00364832|101334695|FG010|STARTED|Core Period||0||
48409299|NCT00364832|101334696|FG011|STARTED|Core Period||0||
48409300|NCT00364832|101334685|FG000|COMPLETED|Core Period||14||
48409301|NCT00364832|101334686|FG001|COMPLETED|Core Period||13||
48409302|NCT00364832|101334687|FG002|COMPLETED|Core Period||14||
48409303|NCT00364832|101334688|FG003|COMPLETED|Core Period||15||
48409304|NCT00364832|101334689|FG004|COMPLETED|Core Period||16||
48409305|NCT00364832|101334690|FG005|COMPLETED|Core Period||12||
48409306|NCT00364832|101334691|FG006|COMPLETED|Core Period||12||
48409307|NCT00364832|101334692|FG007|COMPLETED|Core Period||14||
48409308|NCT00364832|101334693|FG008|COMPLETED|Core Period||16||
48409309|NCT00364832|101334694|FG009|COMPLETED|Core Period||0||
48409310|NCT00364832|101334695|FG010|COMPLETED|Core Period||0||
48409311|NCT00364832|101334696|FG011|COMPLETED|Core Period||0||
48409312|NCT00364832|101334685|FG000|NOT COMPLETED|Core Period||2||
48409313|NCT00364832|101334686|FG001|NOT COMPLETED|Core Period||2||
48409314|NCT00364832|101334687|FG002|NOT COMPLETED|Core Period||1||
48409315|NCT00364832|101334688|FG003|NOT COMPLETED|Core Period||1||
48409316|NCT00364832|101334689|FG004|NOT COMPLETED|Core Period||0||
48409317|NCT00364832|101334690|FG005|NOT COMPLETED|Core Period||0||
48409318|NCT00364832|101334691|FG006|NOT COMPLETED|Core Period||4||
48619222|NCT00001322|101853067|FG001|COMPLETED|Phase 2, Period 1 - Crossover Phase||42||
48162872|NCT03021486|100721695|FG000|COMPLETED|Overall Study||15||
48162873|NCT03021486|100721696|FG001|COMPLETED|Overall Study||16||
48162874|NCT03021486|100721697|FG002|COMPLETED|Overall Study||14||
48162875|NCT03021486|100721695|FG000|NOT COMPLETED|Overall Study||8||
48162876|NCT03021486|100721696|FG001|NOT COMPLETED|Overall Study||6||
48162877|NCT03021486|100721697|FG002|NOT COMPLETED|Overall Study||9||
48162878|NCT02421666|100721698|FG000|STARTED|Overall Study Baseline||272||
48162879|NCT02421666|100721699|FG001|STARTED|Overall Study Baseline||260||
48162880|NCT02421666|100721698|FG000|COMPLETED|Overall Study Baseline||272||
48162881|NCT02421666|100721699|FG001|COMPLETED|Overall Study Baseline||260||
48162882|NCT02421666|100721698|FG000|NOT COMPLETED|Overall Study Baseline||0||
48162883|NCT02421666|100721699|FG001|NOT COMPLETED|Overall Study Baseline||0||
48162884|NCT02421666|100721698|FG000|STARTED|6-month Follow-up||272||
48162885|NCT02421666|100721699|FG001|STARTED|6-month Follow-up||260||
48162886|NCT02421666|100721698|FG000|COMPLETED|6-month Follow-up||259||
48162887|NCT02421666|100721699|FG001|COMPLETED|6-month Follow-up||247||
48325468|NCT00825500|101124479|FG001|STARTED|Overall Study||121||
48619223|NCT00001322|101853068|FG002|COMPLETED|Phase 2, Period 1 - Crossover Phase||40||
48619224|NCT00001322|101853066|FG000|NOT COMPLETED|Phase 2, Period 1 - Crossover Phase||0||
48619225|NCT00001322|101853067|FG001|NOT COMPLETED|Phase 2, Period 1 - Crossover Phase||0||
48742585|NCT01702025|102155112|FG003|STARTED|Overall Study||10||
48742586|NCT01702025|102155109|FG000|COMPLETED|Overall Study||9||
48742587|NCT01702025|102155110|FG001|COMPLETED|Overall Study||9||
48742588|NCT01702025|102155111|FG002|COMPLETED|Overall Study||9||
48742589|NCT01702025|102155112|FG003|COMPLETED|Overall Study||10||
48742590|NCT01702025|102155109|FG000|NOT COMPLETED|Overall Study||2||
48162888|NCT02421666|100721698|FG000|NOT COMPLETED|6-month Follow-up||13||
48619226|NCT00001322|101853068|FG002|NOT COMPLETED|Phase 2, Period 1 - Crossover Phase||0||
48619227|NCT00001322|101853066|FG000|STARTED|Phase 2, Period 2 - Crossover Phase||0||
48619228|NCT00001322|101853067|FG001|STARTED|Phase 2, Period 2 - Crossover Phase||42||
48619229|NCT00001322|101853068|FG002|STARTED|Phase 2, Period 2 - Crossover Phase||40||
48619230|NCT00001322|101853066|FG000|COMPLETED|Phase 2, Period 2 - Crossover Phase||0||
48619231|NCT00001322|101853067|FG001|COMPLETED|Phase 2, Period 2 - Crossover Phase||42||
48619232|NCT00001322|101853068|FG002|COMPLETED|Phase 2, Period 2 - Crossover Phase||40||
48619233|NCT00001322|101853066|FG000|NOT COMPLETED|Phase 2, Period 2 - Crossover Phase||0||
48619234|NCT00001322|101853067|FG001|NOT COMPLETED|Phase 2, Period 2 - Crossover Phase||0||
48619235|NCT00001322|101853068|FG002|NOT COMPLETED|Phase 2, Period 2 - Crossover Phase||0||
48619236|NCT00844090|101853069|FG000|STARTED|Overall Study||52||
48619237|NCT00844090|101853070|FG001|STARTED|Overall Study||54||
48619238|NCT00844090|101853069|FG000|COMPLETED|Overall Study||46||
48619239|NCT00844090|101853070|FG001|COMPLETED|Overall Study||46||
48619240|NCT00844090|101853069|FG000|NOT COMPLETED|Overall Study||6||
48619241|NCT00844090|101853070|FG001|NOT COMPLETED|Overall Study||8||
48619242|NCT01316575|101853071|FG000|STARTED|Overall Study||20||
48619243|NCT01316575|101853072|FG001|STARTED|Overall Study||20||
48619244|NCT01316575|101853071|FG000|COMPLETED|Overall Study||18||
48619245|NCT01316575|101853072|FG001|COMPLETED|Overall Study||19||
48619246|NCT01316575|101853071|FG000|NOT COMPLETED|Overall Study||2||
48619247|NCT01316575|101853072|FG001|NOT COMPLETED|Overall Study||1||
48619248|NCT01235065|101853073|FG000|STARTED|Overall Study||320||
48619249|NCT01235065|101853074|FG001|STARTED|Overall Study||303||
48619250|NCT01235065|101853073|FG000|COMPLETED|Overall Study||320||
48619251|NCT01235065|101853074|FG001|COMPLETED|Overall Study||303||
48619252|NCT01235065|101853073|FG000|NOT COMPLETED|Overall Study||0||
48742591|NCT01702025|102155110|FG001|NOT COMPLETED|Overall Study||1||
48742592|NCT01702025|102155111|FG002|NOT COMPLETED|Overall Study||1||
48162889|NCT02421666|100721699|FG001|NOT COMPLETED|6-month Follow-up||13||
48162890|NCT02421666|100721698|FG000|STARTED|12-month Follow-up||259||
48162891|NCT02421666|100721699|FG001|STARTED|12-month Follow-up||247||
48162892|NCT02421666|100721698|FG000|COMPLETED|12-month Follow-up||248||
48162893|NCT02421666|100721699|FG001|COMPLETED|12-month Follow-up||231||
48162894|NCT02421666|100721698|FG000|NOT COMPLETED|12-month Follow-up||11||
48162895|NCT02421666|100721699|FG001|NOT COMPLETED|12-month Follow-up||16||
48162896|NCT03072238|100721700|FG000|STARTED|Overall Study||554||
48162897|NCT03072238|100721701|FG001|STARTED|Overall Study||547||
48162898|NCT03072238|100721700|FG000|COMPLETED|Overall Study||0||
48162899|NCT03072238|100721701|FG001|COMPLETED|Overall Study||0||
48325469|NCT00825500|101124480|FG002|STARTED|Overall Study||120||
48325470|NCT00825500|101124478|FG000|COMPLETED|Overall Study||125||
48619253|NCT01235065|101853074|FG001|NOT COMPLETED|Overall Study||0||
48619254|NCT02922153|101853075|FG000|STARTED|Overall Study||65||
48619255|NCT02922153|101853076|FG001|STARTED|Overall Study||19||
48619256|NCT02922153|101853075|FG000|COMPLETED|Overall Study||55||
48619257|NCT02922153|101853076|FG001|COMPLETED|Overall Study||17||
48619258|NCT02922153|101853075|FG000|NOT COMPLETED|Overall Study||10||
48619259|NCT02922153|101853076|FG001|NOT COMPLETED|Overall Study||2||
48619260|NCT00268983|101853077|FG000|STARTED|Overall Study||6||
48619261|NCT00268983|101853078|FG001|STARTED|Overall Study||8||
48619262|NCT00268983|101853077|FG000|COMPLETED|Overall Study||3||
48619263|NCT00268983|101853078|FG001|COMPLETED|Overall Study||8||
48619264|NCT00268983|101853077|FG000|NOT COMPLETED|Overall Study||3||
48742593|NCT01702025|102155112|FG003|NOT COMPLETED|Overall Study||0||
48409319|NCT00364832|101334692|FG007|NOT COMPLETED|Core Period||1||
48409320|NCT00364832|101334693|FG008|NOT COMPLETED|Core Period||0||
48409321|NCT00364832|101334694|FG009|NOT COMPLETED|Core Period||0||
48409322|NCT00364832|101334695|FG010|NOT COMPLETED|Core Period||0||
48409323|NCT00364832|101334696|FG011|NOT COMPLETED|Core Period||0||
48409324|NCT00364832|101334685|FG000|STARTED|Extension Year 1||0||
48409325|NCT00364832|101334686|FG001|STARTED|Extension Year 1||0||
48409326|NCT00364832|101334687|FG002|STARTED|Extension Year 1||0||
48409327|NCT00364832|101334688|FG003|STARTED|Extension Year 1||0||
48619265|NCT00268983|101853078|FG001|NOT COMPLETED|Overall Study||0||
48619266|NCT00823264|101853079|FG000|STARTED|Overall Study||10||
48619267|NCT00823264|101853080|FG001|STARTED|Overall Study||7||
48619268|NCT00823264|101853079|FG000|COMPLETED|Overall Study||8||
48619269|NCT00823264|101853080|FG001|COMPLETED|Overall Study||7||
48619270|NCT00823264|101853079|FG000|NOT COMPLETED|Overall Study||2||
48619271|NCT00823264|101853080|FG001|NOT COMPLETED|Overall Study||0||
48619272|NCT05619471|101853081|FG000|STARTED|Overall Study||65||65
48619273|NCT05619471|101853081|FG000|COMPLETED|Overall Study||65||65
48619274|NCT05619471|101853081|FG000|NOT COMPLETED|Overall Study||0||0
48619275|NCT03082729|101853082|FG000|STARTED|Overall Study||70||
48619276|NCT03082729|101853082|FG000|Per Protocol Population Week 16|Overall Study||60||
48619277|NCT03082729|101853082|FG000|COMPLETED|Overall Study||39||
48409328|NCT00364832|101334689|FG004|STARTED|Extension Year 1||0||
48409329|NCT00364832|101334690|FG005|STARTED|Extension Year 1||0||
48409330|NCT00364832|101334691|FG006|STARTED|Extension Year 1||0||
48409331|NCT00364832|101334692|FG007|STARTED|Extension Year 1||0||
48409332|NCT00364832|101334693|FG008|STARTED|Extension Year 1||0||
48409333|NCT00364832|101334694|FG009|STARTED|Extension Year 1||18||
48409334|NCT00364832|101334695|FG010|STARTED|Extension Year 1||17||
48409335|NCT00364832|101334696|FG011|STARTED|Extension Year 1||27||
48409336|NCT00364832|101334685|FG000|COMPLETED|Extension Year 1||0||
48409337|NCT00364832|101334686|FG001|COMPLETED|Extension Year 1||0||
48409338|NCT00364832|101334687|FG002|COMPLETED|Extension Year 1||0||
48409339|NCT00364832|101334688|FG003|COMPLETED|Extension Year 1||0||
48409340|NCT00364832|101334689|FG004|COMPLETED|Extension Year 1||0||
48409341|NCT00364832|101334690|FG005|COMPLETED|Extension Year 1||0||
48409342|NCT00364832|101334691|FG006|COMPLETED|Extension Year 1||0||
48409343|NCT00364832|101334692|FG007|COMPLETED|Extension Year 1||0||
48619278|NCT03082729|101853082|FG000|NOT COMPLETED|Overall Study||31||
48619279|NCT03073486|101853083|FG000|STARTED|Overall Study||493||
48619280|NCT03073486|101853084|FG001|STARTED|Overall Study||251||
48619281|NCT03073486|101853083|FG000|COMPLETED|Overall Study||405||
48619282|NCT03073486|101853084|FG001|COMPLETED|Overall Study||207||
48619283|NCT03073486|101853083|FG000|NOT COMPLETED|Overall Study||88||
48619284|NCT03073486|101853084|FG001|NOT COMPLETED|Overall Study||44||
48619285|NCT00752089|101853085|FG000|STARTED|Overall Study||20||
48619286|NCT00752089|101853085|FG000|Received NaF/ KNO3/ 2% Isopentane|Overall Study||19||
48619287|NCT00752089|101853085|FG000|Received NaF/KNO3/ 0% Isopentane|Overall Study||17||
48619288|NCT00752089|101853085|FG000|Received NaF|Overall Study||18||
48619289|NCT00752089|101853085|FG000|Received Placebo|Overall Study||18||
48619290|NCT00752089|101853085|FG000|COMPLETED|Overall Study||14||
48619291|NCT00752089|101853085|FG000|NOT COMPLETED|Overall Study||6||
48619292|NCT03569098|101853086|FG000|STARTED|Double-Blind Treatment Cycle 1||63||
48619293|NCT03569098|101853087|FG001|STARTED|Double-Blind Treatment Cycle 1||63||
48619294|NCT03569098|101853088|FG002|STARTED|Double-Blind Treatment Cycle 1||60||
48619295|NCT03569098|101853086|FG000|Received Study Medication|Double-Blind Treatment Cycle 1||61||
48619296|NCT03569098|101853087|FG001|Received Study Medication|Double-Blind Treatment Cycle 1||63||
48619297|NCT03569098|101853088|FG002|Received Study Medication|Double-Blind Treatment Cycle 1||56||
48619298|NCT03569098|101853086|FG000|COMPLETED|Double-Blind Treatment Cycle 1||55|Completed the double-blind treatment cycle 1.|
48619299|NCT03569098|101853087|FG001|COMPLETED|Double-Blind Treatment Cycle 1||53|Completed the double-blind treatment cycle 1.|
48619300|NCT03569098|101853088|FG002|COMPLETED|Double-Blind Treatment Cycle 1||49|Completed the double-blind treatment cycle 1.|
48619301|NCT03569098|101853086|FG000|NOT COMPLETED|Double-Blind Treatment Cycle 1||8||
48619302|NCT03569098|101853087|FG001|NOT COMPLETED|Double-Blind Treatment Cycle 1||10||
48619303|NCT03569098|101853088|FG002|NOT COMPLETED|Double-Blind Treatment Cycle 1||11||
48619304|NCT03569098|101853086|FG000|STARTED|Open-Label Treatment Cycle 2||0||
48619305|NCT03569098|101853087|FG001|STARTED|Open-Label Treatment Cycle 2||146||
48619306|NCT03569098|101853088|FG002|STARTED|Open-Label Treatment Cycle 2||0||
48619307|NCT03569098|101853086|FG000|COMPLETED|Open-Label Treatment Cycle 2||0|Completed the open-label treatment cycle 2.|
48619308|NCT03569098|101853087|FG001|COMPLETED|Open-Label Treatment Cycle 2||111|Completed the open-label treatment cycle 2.|
48619309|NCT03569098|101853088|FG002|COMPLETED|Open-Label Treatment Cycle 2||0|Completed the open-label treatment cycle 2.|
48619310|NCT03569098|101853086|FG000|NOT COMPLETED|Open-Label Treatment Cycle 2||0||
48619311|NCT03569098|101853087|FG001|NOT COMPLETED|Open-Label Treatment Cycle 2||35||
48619312|NCT03569098|101853088|FG002|NOT COMPLETED|Open-Label Treatment Cycle 2||0||
48619313|NCT03569098|101853086|FG000|STARTED|Open-Label Treatment Cycle 3||0||
48619314|NCT03569098|101853087|FG001|STARTED|Open-Label Treatment Cycle 3||8||
48619315|NCT03569098|101853088|FG002|STARTED|Open-Label Treatment Cycle 3||56||
48742594|NCT03462719|102155113|FG000|STARTED|Overall Study||106||
48742595|NCT03462719|102155114|FG001|STARTED|Overall Study||105||
48742596|NCT03462719|102155113|FG000|COMPLETED|Overall Study||15||
48742597|NCT03462719|102155114|FG001|COMPLETED|Overall Study||30||
48742598|NCT03462719|102155113|FG000|NOT COMPLETED|Overall Study||91||
48742599|NCT03462719|102155114|FG001|NOT COMPLETED|Overall Study||75||
48742600|NCT01684202|102155115|FG000|STARTED|Dose-escalation Period||15||
48742601|NCT01684202|102155116|FG001|STARTED|Dose-escalation Period||8||
48742602|NCT01684202|102155117|FG002|STARTED|Dose-escalation Period||9||
48742603|NCT01684202|102155118|FG003|STARTED|Dose-escalation Period||11||
48742604|NCT01684202|102155115|FG000|COMPLETED|Dose-escalation Period||14||
48742605|NCT01684202|102155116|FG001|COMPLETED|Dose-escalation Period||7||
48742606|NCT01684202|102155117|FG002|COMPLETED|Dose-escalation Period||9||
48742607|NCT01684202|102155118|FG003|COMPLETED|Dose-escalation Period||11||
48742608|NCT01684202|102155115|FG000|NOT COMPLETED|Dose-escalation Period||1||
48742609|NCT01684202|102155116|FG001|NOT COMPLETED|Dose-escalation Period||1||
48742610|NCT01684202|102155117|FG002|NOT COMPLETED|Dose-escalation Period||0||
48742611|NCT01684202|102155118|FG003|NOT COMPLETED|Dose-escalation Period||0||
48742612|NCT01684202|102155115|FG000|STARTED|Maintenance Period||14||
48742613|NCT01684202|102155116|FG001|STARTED|Maintenance Period||7||
48742614|NCT01684202|102155117|FG002|STARTED|Maintenance Period||9||
48742615|NCT01684202|102155118|FG003|STARTED|Maintenance Period||11||
48742616|NCT01684202|102155115|FG000|COMPLETED|Maintenance Period||13||
48742617|NCT01684202|102155116|FG001|COMPLETED|Maintenance Period||4||
48742618|NCT01684202|102155117|FG002|COMPLETED|Maintenance Period||8||
48742619|NCT01684202|102155118|FG003|COMPLETED|Maintenance Period||10||
48742620|NCT01684202|102155115|FG000|NOT COMPLETED|Maintenance Period||1||
48742621|NCT01684202|102155116|FG001|NOT COMPLETED|Maintenance Period||3||
48742622|NCT01684202|102155117|FG002|NOT COMPLETED|Maintenance Period||1||
48742623|NCT01684202|102155118|FG003|NOT COMPLETED|Maintenance Period||1||
48742624|NCT02197702|102155119|FG000|STARTED|Overall Study||24||
48742625|NCT02197702|102155120|FG001|STARTED|Overall Study||23||
48742626|NCT02197702|102155119|FG000|Withdrew at Visit 1|Overall Study||0||
48742627|NCT02197702|102155120|FG001|Withdrew at Visit 1|Overall Study||1||
48742628|NCT02197702|102155119|FG000|Withdrew at Visit 2|Overall Study||1||
48742629|NCT02197702|102155120|FG001|Withdrew at Visit 2|Overall Study||1||
48742630|NCT02197702|102155119|FG000|Withdrew at Visit 3|Overall Study||0||
48742631|NCT02197702|102155120|FG001|Withdrew at Visit 3|Overall Study||2||
48742632|NCT02197702|102155119|FG000|Analysed for Main Outcome|Overall Study||23||
48742633|NCT02197702|102155120|FG001|Analysed for Main Outcome|Overall Study||22||
48619316|NCT03569098|101853086|FG000|COMPLETED|Open-Label Treatment Cycle 3||0|Completed the open-label treatment cycle 3.|
48742634|NCT02197702|102155119|FG000|COMPLETED|Overall Study||23||
48742635|NCT02197702|102155120|FG001|COMPLETED|Overall Study||19||
48742636|NCT02197702|102155119|FG000|NOT COMPLETED|Overall Study||1||
48742637|NCT02197702|102155120|FG001|NOT COMPLETED|Overall Study||4||
48742638|NCT01837277|102155121|FG000|STARTED|Overall Study||92||
48742639|NCT01837277|102155122|FG001|STARTED|Overall Study||92||
48742640|NCT01837277|102155121|FG000|COMPLETED|Overall Study||70||
48742641|NCT01837277|102155122|FG001|COMPLETED|Overall Study||48||
48742642|NCT01837277|102155121|FG000|NOT COMPLETED|Overall Study||22||
48742643|NCT01837277|102155122|FG001|NOT COMPLETED|Overall Study||44||
48742644|NCT03713281|102155123|FG000|STARTED|Overall Study||28||
48742645|NCT03713281|102155123|FG000|COMPLETED|Overall Study||25||
48742646|NCT03713281|102155123|FG000|NOT COMPLETED|Overall Study||3||
48742647|NCT01369784|102155124|FG000|STARTED|Overall Study||158||
48619317|NCT03569098|101853087|FG001|COMPLETED|Open-Label Treatment Cycle 3||7|Completed the open-label treatment cycle 3.|
48619318|NCT03569098|101853088|FG002|COMPLETED|Open-Label Treatment Cycle 3||50|Completed the open-label treatment cycle 3.|
48619319|NCT03569098|101853086|FG000|NOT COMPLETED|Open-Label Treatment Cycle 3||0||
48619320|NCT03569098|101853087|FG001|NOT COMPLETED|Open-Label Treatment Cycle 3||1||
48619321|NCT03569098|101853088|FG002|NOT COMPLETED|Open-Label Treatment Cycle 3||6||
48619322|NCT03871153|101853089|FG000|STARTED|Overall Study||6||
48619323|NCT03871153|101853089|FG000|COMPLETED|Overall Study||6||
48619324|NCT03871153|101853089|FG000|NOT COMPLETED|Overall Study||0||
48619325|NCT03861780|101853090|FG000|STARTED|Overall Study||51||
48619326|NCT03861780|101853091|FG001|STARTED|Overall Study||50||
48409344|NCT00364832|101334693|FG008|COMPLETED|Extension Year 1||0||
48619327|NCT03861780|101853092|FG002|STARTED|Overall Study||51||
48619328|NCT03861780|101853090|FG000|COMPLETED|Overall Study||51||
48619329|NCT03861780|101853091|FG001|COMPLETED|Overall Study||50||
48619330|NCT03861780|101853092|FG002|COMPLETED|Overall Study||51||
48619331|NCT03861780|101853090|FG000|NOT COMPLETED|Overall Study||0||
48619332|NCT03861780|101853091|FG001|NOT COMPLETED|Overall Study||0||
48619333|NCT03861780|101853092|FG002|NOT COMPLETED|Overall Study||0||
48742648|NCT01369784|102155124|FG000|COMPLETED|Overall Study||146||
48742649|NCT01369784|102155124|FG000|NOT COMPLETED|Overall Study||12||
48742650|NCT02878317|102155125|FG000|STARTED|Overall Study||32||
48742651|NCT02878317|102155126|FG001|STARTED|Overall Study||49||
48619334|NCT01819727|101853093|FG000|STARTED|Overall Study||131||
48619335|NCT01819727|101853094|FG001|STARTED|Overall Study||130||
48619336|NCT01819727|101853093|FG000|COMPLETED|Overall Study||111||
48619337|NCT01819727|101853094|FG001|COMPLETED|Overall Study||102||
48619338|NCT01819727|101853093|FG000|NOT COMPLETED|Overall Study||20||
48619339|NCT01819727|101853094|FG001|NOT COMPLETED|Overall Study||28||
48619340|NCT04771013|101853095|FG000|STARTED|Overall Study||22||
48619341|NCT04771013|101853096|FG001|STARTED|Overall Study||22||
48619342|NCT04771013|101853095|FG000|COMPLETED|Overall Study||20||
48619343|NCT04771013|101853096|FG001|COMPLETED|Overall Study||16||
48742652|NCT02878317|102155125|FG000|COMPLETED|Overall Study||28||
48742653|NCT02878317|102155126|FG001|COMPLETED|Overall Study||49||
48742654|NCT02878317|102155125|FG000|NOT COMPLETED|Overall Study||4||
48742655|NCT02878317|102155126|FG001|NOT COMPLETED|Overall Study||0||
48742656|NCT01359904|102155127|FG000|STARTED|Overall Study||15||
48742657|NCT01359904|102155128|FG001|STARTED|Overall Study||19||
48742658|NCT01359904|102155127|FG000|COMPLETED|Overall Study||14||
48742659|NCT01359904|102155128|FG001|COMPLETED|Overall Study||19||
48742660|NCT01359904|102155127|FG000|NOT COMPLETED|Overall Study||1||
48742661|NCT01359904|102155128|FG001|NOT COMPLETED|Overall Study||0||
48742662|NCT01987102|102155129|FG000|STARTED|2 Courses of HDMTX With SOC Rescue||8||
48742663|NCT01987102|102155130|FG001|STARTED|2 Courses of HDMTX With SOC Rescue||10||
48742664|NCT01987102|102155129|FG000|COMPLETED|2 Courses of HDMTX With SOC Rescue||4||
48742665|NCT01987102|102155130|FG001|COMPLETED|2 Courses of HDMTX With SOC Rescue||4||
48742666|NCT01987102|102155129|FG000|NOT COMPLETED|2 Courses of HDMTX With SOC Rescue||4||
48742667|NCT01987102|102155130|FG001|NOT COMPLETED|2 Courses of HDMTX With SOC Rescue||6||
48742668|NCT01987102|102155129|FG000|STARTED|2 Courses of HDMTX With MOD Rescue||4||
48742669|NCT01987102|102155130|FG001|STARTED|2 Courses of HDMTX With MOD Rescue||4||
48742670|NCT01987102|102155129|FG000|COMPLETED|2 Courses of HDMTX With MOD Rescue||4||
48742671|NCT01987102|102155130|FG001|COMPLETED|2 Courses of HDMTX With MOD Rescue||3||
48742672|NCT01987102|102155129|FG000|NOT COMPLETED|2 Courses of HDMTX With MOD Rescue||0||
48742673|NCT01987102|102155130|FG001|NOT COMPLETED|2 Courses of HDMTX With MOD Rescue||1||
48619344|NCT04771013|101853095|FG000|NOT COMPLETED|Overall Study||2||
48619345|NCT04771013|101853096|FG001|NOT COMPLETED|Overall Study||6||
48619346|NCT04899115|101853097|FG000|STARTED|Overall Study||6||
48619347|NCT04899115|101853098|FG001|STARTED|Overall Study||12||
48619348|NCT04899115|101853097|FG000|COMPLETED|Overall Study||6||
48619349|NCT04899115|101853098|FG001|COMPLETED|Overall Study||12||
48619350|NCT04899115|101853097|FG000|NOT COMPLETED|Overall Study||0||
48619351|NCT04899115|101853098|FG001|NOT COMPLETED|Overall Study||0||
48619352|NCT00814138|101853099|FG000|STARTED|Overall Study||25||
48619353|NCT00814138|101853100|FG001|STARTED|Overall Study||25||
48619354|NCT00814138|101853099|FG000|COMPLETED|Overall Study||24||
48619355|NCT00814138|101853100|FG001|COMPLETED|Overall Study||18||
48619356|NCT00814138|101853099|FG000|NOT COMPLETED|Overall Study||1||
48619357|NCT00814138|101853100|FG001|NOT COMPLETED|Overall Study||7||
48619358|NCT03874013|101853101|FG000|STARTED|Overall Study||22||
48619359|NCT03874013|101853102|FG001|STARTED|Overall Study||22||
48619360|NCT03874013|101853101|FG000|COMPLETED|Overall Study||22||
48742674|NCT04683029|102155131|FG000|STARTED|Overall Study||29||
48742675|NCT04683029|102155132|FG001|STARTED|Overall Study||27||
48742676|NCT04683029|102155131|FG000|COMPLETED|Overall Study||28||
48742677|NCT04683029|102155132|FG001|COMPLETED|Overall Study||27||
48619361|NCT03874013|101853102|FG001|COMPLETED|Overall Study||21||
48619362|NCT03874013|101853101|FG000|NOT COMPLETED|Overall Study||0||
48619363|NCT03874013|101853102|FG001|NOT COMPLETED|Overall Study||1||
48619364|NCT01296412|101853103|FG000|STARTED|Overall Study||326||
48619365|NCT01296412|101853104|FG001|STARTED|Overall Study||327||
48619366|NCT01296412|101853103|FG000|COMPLETED|Overall Study||275||
48619367|NCT01296412|101853104|FG001|COMPLETED|Overall Study||257||
48619368|NCT01296412|101853103|FG000|NOT COMPLETED|Overall Study||51||
48619369|NCT01296412|101853104|FG001|NOT COMPLETED|Overall Study||70||
48619370|NCT03771963|101853105|FG000|STARTED|Overall Study||200||
48619371|NCT03771963|101853105|FG000|COMPLETED|Overall Study||168||
48619372|NCT03771963|101853105|FG000|NOT COMPLETED|Overall Study||32||
48619373|NCT00545623|101853106|FG000|STARTED|Overall Study||32||
48619374|NCT00545623|101853107|FG001|STARTED|Overall Study||31||
48619375|NCT00545623|101853108|FG002|STARTED|Overall Study||33||
48619376|NCT00545623|101853109|FG003|STARTED|Overall Study||34||
48619377|NCT00545623|101853106|FG000|COMPLETED|Overall Study||25||
48619378|NCT00545623|101853107|FG001|COMPLETED|Overall Study||21||
48619379|NCT00545623|101853108|FG002|COMPLETED|Overall Study||20||
48619380|NCT00545623|101853109|FG003|COMPLETED|Overall Study||23||
48619381|NCT00545623|101853106|FG000|NOT COMPLETED|Overall Study||7||
48619382|NCT00545623|101853107|FG001|NOT COMPLETED|Overall Study||10||
48619383|NCT00545623|101853108|FG002|NOT COMPLETED|Overall Study||13||
48619384|NCT00545623|101853109|FG003|NOT COMPLETED|Overall Study||11||
48619385|NCT01167569|101853110|FG000|STARTED|Overall Study||28||
48619386|NCT01167569|101853111|FG001|STARTED|Overall Study||29||
48619387|NCT01167569|101853110|FG000|COMPLETED|Overall Study||27||
48619388|NCT01167569|101853111|FG001|COMPLETED|Overall Study||27||
48619389|NCT01167569|101853110|FG000|NOT COMPLETED|Overall Study||1||
48619390|NCT01167569|101853111|FG001|NOT COMPLETED|Overall Study||2||
48619391|NCT00588146|101853112|FG000|STARTED|First Intervention (Baseline to 6 mo)||5||
48619392|NCT00588146|101853113|FG001|STARTED|First Intervention (Baseline to 6 mo)||5||
48619393|NCT00588146|101853112|FG000|COMPLETED|First Intervention (Baseline to 6 mo)||1||
48619394|NCT00588146|101853113|FG001|COMPLETED|First Intervention (Baseline to 6 mo)||2||
48619395|NCT00588146|101853112|FG000|NOT COMPLETED|First Intervention (Baseline to 6 mo)||4||
48619396|NCT00588146|101853113|FG001|NOT COMPLETED|First Intervention (Baseline to 6 mo)||3||
48619397|NCT00588146|101853112|FG000|STARTED|Second Intervention (6 Months to 1 Year)||1||
48619398|NCT00588146|101853113|FG001|STARTED|Second Intervention (6 Months to 1 Year)||2||
48619399|NCT00588146|101853112|FG000|COMPLETED|Second Intervention (6 Months to 1 Year)||1||
48619400|NCT00588146|101853113|FG001|COMPLETED|Second Intervention (6 Months to 1 Year)||2||
48619401|NCT00588146|101853112|FG000|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0||
48619402|NCT00588146|101853113|FG001|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0||
48619403|NCT00249873|101853114|FG000|STARTED|Overall Study||3772||
48619404|NCT00249873|101853115|FG001|STARTED|Overall Study||3782||
48619405|NCT00249873|101853114|FG000|COMPLETED|Overall Study||2442||
48619406|NCT00249873|101853115|FG001|COMPLETED|Overall Study||2528||
48619407|NCT00249873|101853114|FG000|NOT COMPLETED|Overall Study||1330||
48619408|NCT00249873|101853115|FG001|NOT COMPLETED|Overall Study||1254||
48619409|NCT02224612|101853116|FG000|STARTED|Overall Study||48||
48619410|NCT02224612|101853117|FG001|STARTED|Overall Study||48||
48619411|NCT02224612|101853116|FG000|COMPLETED|Overall Study||48||
48619412|NCT02224612|101853117|FG001|COMPLETED|Overall Study||48||
48619413|NCT02224612|101853116|FG000|NOT COMPLETED|Overall Study||0||
48619414|NCT02224612|101853117|FG001|NOT COMPLETED|Overall Study||0||
48619415|NCT01496313|101853118|FG000|STARTED|Overall Study||40||
48619416|NCT01496313|101853119|FG001|STARTED|Overall Study||41||
48742678|NCT04683029|102155131|FG000|NOT COMPLETED|Overall Study||1||
48742679|NCT04683029|102155132|FG001|NOT COMPLETED|Overall Study||0||
48742680|NCT01391663|102155133|FG000|STARTED|Overall Study||12||
48742681|NCT01391663|102155134|FG001|STARTED|Overall Study||12||
48742682|NCT01391663|102155135|FG002|STARTED|Overall Study||12||
48742683|NCT01391663|102155136|FG003|STARTED|Overall Study||12||
48742684|NCT01391663|102155133|FG000|COMPLETED|Overall Study||12||
48742685|NCT01391663|102155134|FG001|COMPLETED|Overall Study||12||
48742686|NCT01391663|102155135|FG002|COMPLETED|Overall Study||11||
48742687|NCT01391663|102155136|FG003|COMPLETED|Overall Study||12||
48742688|NCT01391663|102155133|FG000|NOT COMPLETED|Overall Study||0||
48619417|NCT01496313|101853118|FG000|COMPLETED|Overall Study||35||
48619418|NCT01496313|101853119|FG001|COMPLETED|Overall Study||26||
48619419|NCT01496313|101853118|FG000|NOT COMPLETED|Overall Study||5||
48619420|NCT01496313|101853119|FG001|NOT COMPLETED|Overall Study||15||
48619421|NCT00325819|101853120|FG000|STARTED|Overall Study||185||
48619422|NCT00325819|101853121|FG001|STARTED|Overall Study||189||
48619423|NCT00325819|101853120|FG000|COMPLETED|Overall Study||176||
48619424|NCT00325819|101853121|FG001|COMPLETED|Overall Study||176||
48619425|NCT00325819|101853120|FG000|NOT COMPLETED|Overall Study||9||
48742689|NCT01391663|102155134|FG001|NOT COMPLETED|Overall Study||0||
48742690|NCT01391663|102155135|FG002|NOT COMPLETED|Overall Study||1||
48619426|NCT00325819|101853121|FG001|NOT COMPLETED|Overall Study||13||
48619427|NCT00113295|101853122|FG000|STARTED|Overall Study||11||
48619428|NCT00113295|101853123|FG001|STARTED|Overall Study||11||
48619429|NCT00113295|101853122|FG000|COMPLETED|Overall Study||6||
48619430|NCT00113295|101853123|FG001|COMPLETED|Overall Study||10||
48619431|NCT00113295|101853122|FG000|NOT COMPLETED|Overall Study||5||
48742691|NCT01391663|102155136|FG003|NOT COMPLETED|Overall Study||0||
48742692|NCT03500640|102155137|FG000|STARTED|DPP Core Program (0-6 Months)||314||
48619432|NCT00113295|101853123|FG001|NOT COMPLETED|Overall Study||1||
48619433|NCT00281697|101853124|FG000|STARTED|Overall Study||459||
48619434|NCT00281697|101853125|FG001|STARTED|Overall Study||225||
48619435|NCT00281697|101853124|FG000|COMPLETED|Overall Study||58||
48619436|NCT00281697|101853125|FG001|COMPLETED|Overall Study||28||
48619437|NCT00281697|101853124|FG000|NOT COMPLETED|Overall Study||401||
48619438|NCT00281697|101853125|FG001|NOT COMPLETED|Overall Study||197||
48619439|NCT00698815|101853126|FG000|STARTED|Overall Study||42||
48619440|NCT00698815|101853127|FG001|STARTED|Overall Study||47||
48742693|NCT03500640|102155138|FG001|STARTED|DPP Core Program (0-6 Months)||0||
48742694|NCT03500640|102155139|FG002|STARTED|DPP Core Program (0-6 Months)||0||
48742695|NCT03500640|102155137|FG000|COMPLETED|DPP Core Program (0-6 Months)||258||
48742696|NCT03500640|102155138|FG001|COMPLETED|DPP Core Program (0-6 Months)||0||
48742697|NCT03500640|102155139|FG002|COMPLETED|DPP Core Program (0-6 Months)||0||
48742698|NCT03500640|102155137|FG000|NOT COMPLETED|DPP Core Program (0-6 Months)||56||
48742699|NCT03500640|102155138|FG001|NOT COMPLETED|DPP Core Program (0-6 Months)||0||
48742700|NCT03500640|102155139|FG002|NOT COMPLETED|DPP Core Program (0-6 Months)||0||
48742701|NCT03500640|102155137|FG000|STARTED|Follow-Up Contacts (7-12 Months)||0|The DPP Core Program intervention ended at 6 months, per protocol.|
48742702|NCT03500640|102155138|FG001|STARTED|Follow-Up Contacts (7-12 Months)||129|The DPP Core Program intervention ended at 6 months, per protocol.|
48742703|NCT03500640|102155139|FG002|STARTED|Follow-Up Contacts (7-12 Months)||129|The DPP Core Program intervention ended at 6 months, per protocol.|
48619441|NCT00698815|101853128|FG002|STARTED|Overall Study||41||
48619442|NCT00698815|101853126|FG000|COMPLETED|Overall Study||32||
48619443|NCT00698815|101853127|FG001|COMPLETED|Overall Study||33||
48619444|NCT00698815|101853128|FG002|COMPLETED|Overall Study||31||
48619445|NCT00698815|101853126|FG000|NOT COMPLETED|Overall Study||10||
48619446|NCT00698815|101853127|FG001|NOT COMPLETED|Overall Study||14||
48742704|NCT03500640|102155137|FG000|COMPLETED|Follow-Up Contacts (7-12 Months)||0|The DPP Core Program intervention ended at 6 months, per protocol.|
48742705|NCT03500640|102155138|FG001|COMPLETED|Follow-Up Contacts (7-12 Months)||95|The DPP Core Program intervention ended at 6 months, per protocol.|
48742706|NCT03500640|102155139|FG002|COMPLETED|Follow-Up Contacts (7-12 Months)||84|The DPP Core Program intervention ended at 6 months, per protocol.|
48742707|NCT03500640|102155137|FG000|NOT COMPLETED|Follow-Up Contacts (7-12 Months)||0||
48742708|NCT03500640|102155138|FG001|NOT COMPLETED|Follow-Up Contacts (7-12 Months)||34||
48619447|NCT00698815|101853128|FG002|NOT COMPLETED|Overall Study||10||
48619448|NCT00583908|101853129|FG000|STARTED|Period 1 - First Intervention||1||
48619449|NCT00583908|101853130|FG001|STARTED|Period 1 - First Intervention||2||
48742709|NCT03500640|102155139|FG002|NOT COMPLETED|Follow-Up Contacts (7-12 Months)||45||
48742710|NCT03500640|102155137|FG000|STARTED|Follow-up Contacts (13-18 Months)||0|The DPP Core Program intervention ended at 6 months, per protocol.|
48742711|NCT03500640|102155138|FG001|STARTED|Follow-up Contacts (13-18 Months)||95|The DPP Core Program intervention ended at 6 months, per protocol.|
48619450|NCT00583908|101853131|FG002|STARTED|Period 1 - First Intervention||1||
48742712|NCT03500640|102155139|FG002|STARTED|Follow-up Contacts (13-18 Months)||84|The DPP Core Program intervention ended at 6 months, per protocol.|
48742713|NCT03500640|102155137|FG000|COMPLETED|Follow-up Contacts (13-18 Months)||0||
48619451|NCT00583908|101853132|FG003|STARTED|Period 1 - First Intervention||1||
48619452|NCT00583908|101853133|FG004|STARTED|Period 1 - First Intervention||2||
48619453|NCT00583908|101853134|FG005|STARTED|Period 1 - First Intervention||1||
48619454|NCT00583908|101853135|FG006|STARTED|Period 1 - First Intervention||1||
48619455|NCT00583908|101853136|FG007|STARTED|Period 1 - First Intervention||1||
48619456|NCT00583908|101853137|FG008|STARTED|Period 1 - First Intervention||1||
48619457|NCT00583908|101853138|FG009|STARTED|Period 1 - First Intervention||1||
48619458|NCT00583908|101853139|FG010|STARTED|Period 1 - First Intervention||1||
48619459|NCT00583908|101853140|FG011|STARTED|Period 1 - First Intervention||1||
48409345|NCT00364832|101334694|FG009|COMPLETED|Extension Year 1||14||
48409346|NCT00364832|101334695|FG010|COMPLETED|Extension Year 1||15||
48409347|NCT00364832|101334696|FG011|COMPLETED|Extension Year 1||17||
48742714|NCT03500640|102155138|FG001|COMPLETED|Follow-up Contacts (13-18 Months)||93||
48742715|NCT03500640|102155139|FG002|COMPLETED|Follow-up Contacts (13-18 Months)||74||
48742716|NCT03500640|102155137|FG000|NOT COMPLETED|Follow-up Contacts (13-18 Months)||0||
48162900|NCT03072238|100721700|FG000|NOT COMPLETED|Overall Study||554||
48742717|NCT03500640|102155138|FG001|NOT COMPLETED|Follow-up Contacts (13-18 Months)||2||
48742718|NCT03500640|102155139|FG002|NOT COMPLETED|Follow-up Contacts (13-18 Months)||10||
48742719|NCT03500640|102155137|FG000|STARTED|Follow-Up Contacts (19-24 Months)||0|A final Wave 6 cohort (n = 25 assigned to DPP Plus and n = 13 assigned to DPP Minimal) were enrolled in PIVOT with a priori knowledge that only 18 months of study follow-up was possible.|
48742720|NCT03500640|102155138|FG001|STARTED|Follow-Up Contacts (19-24 Months)||68|A final Wave 6 cohort (n = 25 assigned to DPP Plus and n = 13 assigned to DPP Minimal) were enrolled in PIVOT with a priori knowledge that only 18 months of study follow-up was possible.|
48742721|NCT03500640|102155139|FG002|STARTED|Follow-Up Contacts (19-24 Months)||61|A final Wave 6 cohort (n = 25 assigned to DPP Plus and n = 13 assigned to DPP Minimal) were enrolled in PIVOT with a priori knowledge that only 18 months of study follow-up was possible.|
48742722|NCT03500640|102155137|FG000|COMPLETED|Follow-Up Contacts (19-24 Months)||0||
48162901|NCT03072238|100721701|FG001|NOT COMPLETED|Overall Study||547||
48162902|NCT01598298|100721702|FG000|STARTED|Overall Study||150||
48742723|NCT03500640|102155138|FG001|COMPLETED|Follow-Up Contacts (19-24 Months)||65||
48742724|NCT03500640|102155139|FG002|COMPLETED|Follow-Up Contacts (19-24 Months)||60||
48742725|NCT03500640|102155137|FG000|NOT COMPLETED|Follow-Up Contacts (19-24 Months)||0||
48742726|NCT03500640|102155138|FG001|NOT COMPLETED|Follow-Up Contacts (19-24 Months)||3||
48742727|NCT03500640|102155139|FG002|NOT COMPLETED|Follow-Up Contacts (19-24 Months)||1||
48742728|NCT04585789|102155140|FG000|STARTED|Overall Study||10||
48742729|NCT04585789|102155141|FG001|STARTED|Overall Study||10||
48742730|NCT04585789|102155140|FG000|COMPLETED|Overall Study||0||
48742731|NCT04585789|102155141|FG001|COMPLETED|Overall Study||0||
48742732|NCT04585789|102155140|FG000|NOT COMPLETED|Overall Study||10||
48742733|NCT04585789|102155141|FG001|NOT COMPLETED|Overall Study||10||
48409348|NCT00364832|101334685|FG000|NOT COMPLETED|Extension Year 1||0||
48409349|NCT00364832|101334686|FG001|NOT COMPLETED|Extension Year 1||0||
48409350|NCT00364832|101334687|FG002|NOT COMPLETED|Extension Year 1||0||
48162903|NCT01598298|100721703|FG001|STARTED|Overall Study||149||
48325471|NCT00825500|101124479|FG001|COMPLETED|Overall Study||121||
48325472|NCT00825500|101124480|FG002|COMPLETED|Overall Study||120||
48325473|NCT00825500|101124478|FG000|NOT COMPLETED|Overall Study||0||
48325474|NCT00825500|101124479|FG001|NOT COMPLETED|Overall Study||0||
48325475|NCT00825500|101124480|FG002|NOT COMPLETED|Overall Study||0||
48325476|NCT01584479|101124481|FG000|STARTED|Overall Study||732||
48325477|NCT01584479|101124482|FG001|STARTED|Overall Study||1686||
48325478|NCT01584479|101124483|FG002|STARTED|Overall Study||852||
48325479|NCT01584479|101124484|FG003|STARTED|Overall Study||1847||
48325480|NCT01584479|101124481|FG000|COMPLETED|Overall Study||732||
48325481|NCT01584479|101124482|FG001|COMPLETED|Overall Study||1686||
48325482|NCT01584479|101124483|FG002|COMPLETED|Overall Study||852||
48325483|NCT01584479|101124484|FG003|COMPLETED|Overall Study||1847||
48325484|NCT01584479|101124481|FG000|NOT COMPLETED|Overall Study||0||
48325485|NCT01584479|101124482|FG001|NOT COMPLETED|Overall Study||0||
48325486|NCT01584479|101124483|FG002|NOT COMPLETED|Overall Study||0||
48325487|NCT01584479|101124484|FG003|NOT COMPLETED|Overall Study||0||
48325488|NCT00866307|101124485|FG000|STARTED|Induction||104||
48325489|NCT00866307|101124486|FG001|STARTED|Induction||0||
48325490|NCT00866307|101124487|FG002|STARTED|Induction||0||
48325491|NCT00866307|101124485|FG000|COMPLETED|Induction||84||
48325492|NCT00866307|101124486|FG001|COMPLETED|Induction||0||
48325493|NCT00866307|101124487|FG002|COMPLETED|Induction||0||
48325494|NCT00866307|101124485|FG000|NOT COMPLETED|Induction||20||
48325495|NCT00866307|101124486|FG001|NOT COMPLETED|Induction||0||
48325496|NCT00866307|101124487|FG002|NOT COMPLETED|Induction||0||
48325497|NCT00866307|101124485|FG000|STARTED|Consolidation/Maintenance||0||
48325498|NCT00866307|101124486|FG001|STARTED|Consolidation/Maintenance||54||
48325499|NCT00866307|101124487|FG002|STARTED|Consolidation/Maintenance||30||
48325500|NCT00866307|101124485|FG000|COMPLETED|Consolidation/Maintenance||0||
48325501|NCT00866307|101124486|FG001|COMPLETED|Consolidation/Maintenance||45||
48325502|NCT00866307|101124487|FG002|COMPLETED|Consolidation/Maintenance||14||
48325503|NCT00866307|101124485|FG000|NOT COMPLETED|Consolidation/Maintenance||0||
48325504|NCT00866307|101124486|FG001|NOT COMPLETED|Consolidation/Maintenance||9||
48325505|NCT00866307|101124487|FG002|NOT COMPLETED|Consolidation/Maintenance||16||
48325506|NCT03021642|101124488|FG000|STARTED|Treatment Period 1 (Day 1)||12||
48325507|NCT03021642|101124489|FG001|STARTED|Treatment Period 1 (Day 1)||12||
48325508|NCT03021642|101124488|FG000|COMPLETED|Treatment Period 1 (Day 1)||12||
48325509|NCT03021642|101124489|FG001|COMPLETED|Treatment Period 1 (Day 1)||12||
48325510|NCT03021642|101124488|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48325511|NCT03021642|101124489|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48325512|NCT03021642|101124488|FG000|STARTED|Washout Period (21 Days)||12||
48325513|NCT03021642|101124489|FG001|STARTED|Washout Period (21 Days)||12||
48325514|NCT03021642|101124488|FG000|COMPLETED|Washout Period (21 Days)||11||
48325515|NCT03021642|101124489|FG001|COMPLETED|Washout Period (21 Days)||11||
48325516|NCT03021642|101124488|FG000|NOT COMPLETED|Washout Period (21 Days)||1||
48325517|NCT03021642|101124489|FG001|NOT COMPLETED|Washout Period (21 Days)||1||
48325518|NCT03021642|101124488|FG000|STARTED|Treatment Period 2 (Day 22)||11||
48325519|NCT03021642|101124489|FG001|STARTED|Treatment Period 2 (Day 22)||11||
48325520|NCT03021642|101124488|FG000|COMPLETED|Treatment Period 2 (Day 22)||11||
48325521|NCT03021642|101124489|FG001|COMPLETED|Treatment Period 2 (Day 22)||11||
48325522|NCT03021642|101124488|FG000|NOT COMPLETED|Treatment Period 2 (Day 22)||0||
48325523|NCT03021642|101124489|FG001|NOT COMPLETED|Treatment Period 2 (Day 22)||0||
48325524|NCT03355300|101124490|FG000|STARTED|Overall Study||5||
48325525|NCT03355300|101124491|FG001|STARTED|Overall Study||6||
48325526|NCT03355300|101124490|FG000|COMPLETED|Overall Study||2||
48325527|NCT03355300|101124491|FG001|COMPLETED|Overall Study||4||
48325528|NCT03355300|101124490|FG000|NOT COMPLETED|Overall Study||3||
48325529|NCT03355300|101124491|FG001|NOT COMPLETED|Overall Study||2||
48325530|NCT01895322|101124492|FG000|STARTED|Overall Study||20||
48325531|NCT01895322|101124492|FG000|COMPLETED|Overall Study||7||
48325532|NCT01895322|101124492|FG000|NOT COMPLETED|Overall Study||13||
48325533|NCT02868242|101124493|FG000|STARTED|Overall Study||19||
48325534|NCT02868242|101124493|FG000|COMPLETED|Overall Study||19||
48325535|NCT02868242|101124493|FG000|NOT COMPLETED|Overall Study||0||
48325536|NCT03194373|101124494|FG000|STARTED|Overall Study||20||
48325537|NCT03194373|101124494|FG000|Received Palbociclib and Carboplatin|Overall Study||19|One participant received carboplatin but never received palbociclib|
48325538|NCT03194373|101124494|FG000|COMPLETED|Overall Study||18|Evaluable for response|
48325539|NCT03194373|101124494|FG000|NOT COMPLETED|Overall Study||2||
48325540|NCT00953758|101124495|FG000|STARTED|Overall Study||3||
48325541|NCT00953758|101124496|FG001|STARTED|Overall Study||3||
48325542|NCT00953758|101124497|FG002|STARTED|Overall Study||4||
48325543|NCT00953758|101124498|FG003|STARTED|Overall Study||4||
48325544|NCT00953758|101124499|FG004|STARTED|Overall Study||8||
48325545|NCT00953758|101124500|FG005|STARTED|Overall Study||3||
48325546|NCT00953758|101124501|FG006|STARTED|Overall Study||3||
48325547|NCT00953758|101124502|FG007|STARTED|Overall Study||5||
48325548|NCT00953758|101124503|FG008|STARTED|Overall Study||9||
48325549|NCT00953758|101124504|FG009|STARTED|Overall Study||5||
48325550|NCT00953758|101124495|FG000|COMPLETED|Overall Study||1||
48325551|NCT00953758|101124496|FG001|COMPLETED|Overall Study||3||
48325552|NCT00953758|101124497|FG002|COMPLETED|Overall Study||2||
48409351|NCT00364832|101334688|FG003|NOT COMPLETED|Extension Year 1||0||
48409352|NCT00364832|101334689|FG004|NOT COMPLETED|Extension Year 1||0||
48409353|NCT00364832|101334690|FG005|NOT COMPLETED|Extension Year 1||0||
48409354|NCT00364832|101334691|FG006|NOT COMPLETED|Extension Year 1||0||
48409355|NCT00364832|101334692|FG007|NOT COMPLETED|Extension Year 1||0||
48409356|NCT00364832|101334693|FG008|NOT COMPLETED|Extension Year 1||0||
48409357|NCT00364832|101334694|FG009|NOT COMPLETED|Extension Year 1||4||
48409358|NCT00364832|101334695|FG010|NOT COMPLETED|Extension Year 1||2||
48409359|NCT00364832|101334696|FG011|NOT COMPLETED|Extension Year 1||10||
48409360|NCT00364832|101334685|FG000|STARTED|Extension Year 2||0||
48409361|NCT00364832|101334686|FG001|STARTED|Extension Year 2||0||
48409362|NCT00364832|101334687|FG002|STARTED|Extension Year 2||0||
48409363|NCT00364832|101334688|FG003|STARTED|Extension Year 2||0||
48409364|NCT00364832|101334689|FG004|STARTED|Extension Year 2||0||
48409365|NCT00364832|101334690|FG005|STARTED|Extension Year 2||0||
48409366|NCT00364832|101334691|FG006|STARTED|Extension Year 2||0||
48409367|NCT00364832|101334692|FG007|STARTED|Extension Year 2||0||
48409368|NCT00364832|101334693|FG008|STARTED|Extension Year 2||0||
48409369|NCT00364832|101334694|FG009|STARTED|Extension Year 2||14||
48409370|NCT00364832|101334695|FG010|STARTED|Extension Year 2||14||
48409371|NCT00364832|101334696|FG011|STARTED|Extension Year 2||14||
48409372|NCT00364832|101334685|FG000|COMPLETED|Extension Year 2||0||
48409373|NCT00364832|101334686|FG001|COMPLETED|Extension Year 2||0||
48409374|NCT00364832|101334687|FG002|COMPLETED|Extension Year 2||0||
48325553|NCT00953758|101124498|FG003|COMPLETED|Overall Study||2||
48325554|NCT00953758|101124499|FG004|COMPLETED|Overall Study||2||
48325555|NCT00953758|101124500|FG005|COMPLETED|Overall Study||2||
48325556|NCT00953758|101124501|FG006|COMPLETED|Overall Study||2||
48325557|NCT00953758|101124502|FG007|COMPLETED|Overall Study||1||
48325558|NCT00953758|101124503|FG008|COMPLETED|Overall Study||6||
48325559|NCT00953758|101124504|FG009|COMPLETED|Overall Study||4||
48325560|NCT00953758|101124495|FG000|NOT COMPLETED|Overall Study||2||
48325561|NCT00953758|101124496|FG001|NOT COMPLETED|Overall Study||0||
48325562|NCT00953758|101124497|FG002|NOT COMPLETED|Overall Study||2||
48325563|NCT00953758|101124498|FG003|NOT COMPLETED|Overall Study||2||
48325564|NCT00953758|101124499|FG004|NOT COMPLETED|Overall Study||6||
48325565|NCT00953758|101124500|FG005|NOT COMPLETED|Overall Study||1||
48325566|NCT00953758|101124501|FG006|NOT COMPLETED|Overall Study||1||
48325567|NCT00953758|101124502|FG007|NOT COMPLETED|Overall Study||4||
48325568|NCT00953758|101124503|FG008|NOT COMPLETED|Overall Study||3||
48325569|NCT00953758|101124504|FG009|NOT COMPLETED|Overall Study||1||
48325570|NCT02918864|101124505|FG000|STARTED|Overall Study||20||
48325571|NCT02918864|101124506|FG001|STARTED|Overall Study||20||
48325572|NCT02918864|101124505|FG000|Endpoint (Week 12)|Overall Study||19||
48619460|NCT00583908|101853129|FG000|COMPLETED|Period 1 - First Intervention||1||
48619461|NCT00583908|101853130|FG001|COMPLETED|Period 1 - First Intervention||2||
48619462|NCT00583908|101853131|FG002|COMPLETED|Period 1 - First Intervention||1||
48325573|NCT02918864|101124506|FG001|Endpoint (Week 12)|Overall Study||19||
48325574|NCT02918864|101124505|FG000|1-month Follow-up (Week 16)|Overall Study||17||
48325575|NCT02918864|101124506|FG001|1-month Follow-up (Week 16)|Overall Study||18||
48325576|NCT02918864|101124505|FG000|3-month Follow-up (Week 24)|Overall Study||16||
48325577|NCT02918864|101124506|FG001|3-month Follow-up (Week 24)|Overall Study||17||
48325578|NCT02918864|101124505|FG000|COMPLETED|Overall Study||16||
48325579|NCT02918864|101124506|FG001|COMPLETED|Overall Study||17||
48325580|NCT02918864|101124505|FG000|NOT COMPLETED|Overall Study||4||
48325581|NCT02918864|101124506|FG001|NOT COMPLETED|Overall Study||3||
48325582|NCT03468855|101124507|FG000|STARTED|Overall Study||34||
48325583|NCT03468855|101124507|FG000|COMPLETED|Overall Study||23||
48325584|NCT03468855|101124507|FG000|NOT COMPLETED|Overall Study||11||
48325585|NCT03728309|101124508|FG000|STARTED|Overall Study||73||
48409375|NCT00364832|101334688|FG003|COMPLETED|Extension Year 2||0||
48409376|NCT00364832|101334689|FG004|COMPLETED|Extension Year 2||0||
48409377|NCT00364832|101334690|FG005|COMPLETED|Extension Year 2||0||
48409378|NCT00364832|101334691|FG006|COMPLETED|Extension Year 2||0||
48409379|NCT00364832|101334692|FG007|COMPLETED|Extension Year 2||0||
48409380|NCT00364832|101334693|FG008|COMPLETED|Extension Year 2||0||
48619463|NCT00583908|101853132|FG003|COMPLETED|Period 1 - First Intervention||1||
48325586|NCT03728309|101124509|FG001|STARTED|Overall Study||136||
48409381|NCT00364832|101334694|FG009|COMPLETED|Extension Year 2||9||
48409382|NCT00364832|101334695|FG010|COMPLETED|Extension Year 2||9||
48409383|NCT00364832|101334696|FG011|COMPLETED|Extension Year 2||11||
48409384|NCT00364832|101334685|FG000|NOT COMPLETED|Extension Year 2||0||
48409385|NCT00364832|101334686|FG001|NOT COMPLETED|Extension Year 2||0||
48409386|NCT00364832|101334687|FG002|NOT COMPLETED|Extension Year 2||0||
48409387|NCT00364832|101334688|FG003|NOT COMPLETED|Extension Year 2||0||
48409388|NCT00364832|101334689|FG004|NOT COMPLETED|Extension Year 2||0||
48325587|NCT03728309|101124508|FG000|mITT Population|Overall Study||71|mITT Population included all randomized participants who have baseline assessment on the Allergan Cheek Smoothness Scale (ACSS) for both cheeks, and are not in the Fitzpatrick V/VI safety cohort.|
48325588|NCT03728309|101124509|FG001|mITT Population|Overall Study||131|mITT Population included all randomized participants who have baseline assessment on the Allergan Cheek Smoothness Scale (ACSS) for both cheeks, and are not in the Fitzpatrick V/VI safety cohort.|
48368066|NCT03691623|101230099|FG003|Received Treatment|Overall Study||21||
48325589|NCT03728309|101124508|FG000|Volite Treated (VT) Population|Overall Study||64|VT Population included participants randomized and received VOLITE treatment at the beginning of the Control Period.|
48325590|NCT03728309|101124509|FG001|Volite Treated (VT) Population|Overall Study||135|VT Population included participants randomized and received VOLITE treatment at the beginning of the Control Period.|
48325591|NCT03728309|101124508|FG000|VOLITE Repeat Treatment (VRT) Population|Overall Study||0|VRT Population included participants in the VT who received VOLITE repeat treatment.|
48325592|NCT03728309|101124509|FG001|VOLITE Repeat Treatment (VRT) Population|Overall Study||79|VRT Population included participants in the VT who received VOLITE repeat treatment.|
48325593|NCT03728309|101124508|FG000|COMPLETED|Overall Study||61||
48325594|NCT03728309|101124509|FG001|COMPLETED|Overall Study||112||
48325595|NCT03728309|101124508|FG000|NOT COMPLETED|Overall Study||12||
48325596|NCT03728309|101124509|FG001|NOT COMPLETED|Overall Study||24||
48325597|NCT01180660|101124510|FG000|STARTED|Overall Study||25||
48325598|NCT01180660|101124511|FG001|STARTED|Overall Study||26||
48325599|NCT01180660|101124510|FG000|COMPLETED|Overall Study||24||
48325600|NCT01180660|101124511|FG001|COMPLETED|Overall Study||26||
48325601|NCT01180660|101124510|FG000|NOT COMPLETED|Overall Study||1||
48325602|NCT01180660|101124511|FG001|NOT COMPLETED|Overall Study||0||
48325603|NCT02436876|101124512|FG000|STARTED|Overall Study||6||
48325604|NCT02436876|101124513|FG001|STARTED|Overall Study||9||
48325605|NCT02436876|101124514|FG002|STARTED|Overall Study||7||
48325606|NCT02436876|101124515|FG003|STARTED|Overall Study||7||
48325607|NCT02436876|101124512|FG000|Treated|Overall Study||6||
48325608|NCT02436876|101124513|FG001|Treated|Overall Study||6||
48325609|NCT02436876|101124514|FG002|Treated|Overall Study||6||
48325610|NCT02436876|101124515|FG003|Treated|Overall Study||7||
48325611|NCT02436876|101124512|FG000|COMPLETED|Overall Study||5||
48325612|NCT02436876|101124513|FG001|COMPLETED|Overall Study||5||
48325613|NCT02436876|101124514|FG002|COMPLETED|Overall Study||5||
48325614|NCT02436876|101124515|FG003|COMPLETED|Overall Study||5||
48325615|NCT02436876|101124512|FG000|NOT COMPLETED|Overall Study||1||
48325616|NCT02436876|101124513|FG001|NOT COMPLETED|Overall Study||4||
48325617|NCT02436876|101124514|FG002|NOT COMPLETED|Overall Study||2||
48325618|NCT02436876|101124515|FG003|NOT COMPLETED|Overall Study||2||
48325619|NCT00820898|101124516|FG000|STARTED|Overall Study||24||
48325620|NCT00820898|101124516|FG000|COMPLETED|Overall Study||23|Eligible and treated patients|
48325621|NCT00820898|101124516|FG000|NOT COMPLETED|Overall Study||1||
48325622|NCT00425386|101124517|FG000|STARTED|Overall Study||46||
48325623|NCT00425386|101124517|FG000|COMPLETED|Overall Study||43||
48325624|NCT00425386|101124517|FG000|NOT COMPLETED|Overall Study||3||
48325625|NCT00971945|101124518|FG000|STARTED|Overall Study||6||
48325626|NCT00971945|101124518|FG000|COMPLETED|Overall Study||0||
48325627|NCT00971945|101124518|FG000|NOT COMPLETED|Overall Study||6||
48325628|NCT00661531|101124519|FG000|STARTED|Overall Study||11||
48325629|NCT00661531|101124519|FG000|COMPLETED|Overall Study||8||
48325630|NCT00661531|101124519|FG000|NOT COMPLETED|Overall Study||3||
48325631|NCT02695628|101124520|FG000|STARTED|Overall Study||5||
48325632|NCT02695628|101124520|FG000|COMPLETED|Overall Study||4||
48325633|NCT02695628|101124520|FG000|NOT COMPLETED|Overall Study||1||
48325634|NCT03124823|101124521|FG000|STARTED|Overall Study||11||
48325635|NCT03124823|101124521|FG000|COMPLETED|Overall Study||11||
48325636|NCT03124823|101124521|FG000|NOT COMPLETED|Overall Study||0||
48325637|NCT02187471|101124522|FG000|STARTED|Overall Study||325||
48325638|NCT02187471|101124523|FG001|STARTED|Overall Study||324||
48325639|NCT02187471|101124524|FG002|STARTED|Overall Study||326||
48325640|NCT02187471|101124525|FG003|STARTED|Overall Study||326||
48325641|NCT02187471|101124522|FG000|COMPLETED|Overall Study||249||
48325642|NCT02187471|101124523|FG001|COMPLETED|Overall Study||242||
48325643|NCT02187471|101124524|FG002|COMPLETED|Overall Study||240||
48325644|NCT02187471|101124525|FG003|COMPLETED|Overall Study||246||
48325645|NCT02187471|101124522|FG000|NOT COMPLETED|Overall Study||76||
48325646|NCT02187471|101124523|FG001|NOT COMPLETED|Overall Study||82||
48325647|NCT02187471|101124524|FG002|NOT COMPLETED|Overall Study||86||
48325648|NCT02187471|101124525|FG003|NOT COMPLETED|Overall Study||80||
48325649|NCT01594853|101124526|FG000|STARTED|Overall Study||16||
48325650|NCT01594853|101124527|FG001|STARTED|Overall Study||15||
48325651|NCT01594853|101124526|FG000|COMPLETED|Overall Study||14||
48325652|NCT01594853|101124527|FG001|COMPLETED|Overall Study||12||
48325653|NCT01594853|101124526|FG000|NOT COMPLETED|Overall Study||2||
48325654|NCT01594853|101124527|FG001|NOT COMPLETED|Overall Study||3||
48325655|NCT03699007|101124528|FG000|STARTED|Treatment Phase (Baseline to 3-Month FU)||33||
48325656|NCT03699007|101124529|FG001|STARTED|Treatment Phase (Baseline to 3-Month FU)||35||
48325657|NCT03699007|101124528|FG000|COMPLETED|Treatment Phase (Baseline to 3-Month FU)||26||
48325658|NCT03699007|101124529|FG001|COMPLETED|Treatment Phase (Baseline to 3-Month FU)||33||
48325659|NCT03699007|101124528|FG000|NOT COMPLETED|Treatment Phase (Baseline to 3-Month FU)||7||
48325660|NCT03699007|101124529|FG001|NOT COMPLETED|Treatment Phase (Baseline to 3-Month FU)||2||
48325661|NCT03699007|101124528|FG000|STARTED|6-month Follow Up||26||
48325662|NCT03699007|101124529|FG001|STARTED|6-month Follow Up||33||
48325663|NCT03699007|101124528|FG000|COMPLETED|6-month Follow Up||24||
48325664|NCT03699007|101124529|FG001|COMPLETED|6-month Follow Up||30||
48325665|NCT03699007|101124528|FG000|NOT COMPLETED|6-month Follow Up||2||
48325666|NCT03699007|101124529|FG001|NOT COMPLETED|6-month Follow Up||3||
48325667|NCT04951037|101124530|FG000|STARTED|Overall Study||60||
48325668|NCT04951037|101124530|FG000|Completed Month 2 Assessment|Overall Study||46||
48325669|NCT04951037|101124530|FG000|Completed Month 3 Assessment|Overall Study||39||
48325670|NCT04951037|101124530|FG000|COMPLETED|Overall Study||29|Completed the study intervention and all study assessments.|
48325671|NCT04951037|101124530|FG000|NOT COMPLETED|Overall Study||31||
48325672|NCT01707472|101124531|FG000|STARTED|Overall Study||4||
48325673|NCT01707472|101124532|FG001|STARTED|Overall Study||6||
48325674|NCT01707472|101124533|FG002|STARTED|Overall Study||8||
48325675|NCT01707472|101124531|FG000|COMPLETED|Overall Study||4||
48325676|NCT01707472|101124532|FG001|COMPLETED|Overall Study||6||
48325677|NCT01707472|101124533|FG002|COMPLETED|Overall Study||8||
48325678|NCT01707472|101124531|FG000|NOT COMPLETED|Overall Study||0||
48325679|NCT01707472|101124532|FG001|NOT COMPLETED|Overall Study||0||
48325680|NCT01707472|101124533|FG002|NOT COMPLETED|Overall Study||0||
48325681|NCT04063371|101124534|FG000|STARTED|Overall Study||100||
48325682|NCT04063371|101124535|FG001|STARTED|Overall Study||100||
48325683|NCT04063371|101124536|FG002|STARTED|Overall Study||100||
48325684|NCT04063371|101124534|FG000|COMPLETED|Overall Study||100||
48325685|NCT04063371|101124535|FG001|COMPLETED|Overall Study||100||
48325686|NCT04063371|101124536|FG002|COMPLETED|Overall Study||100||
48325687|NCT04063371|101124534|FG000|NOT COMPLETED|Overall Study||0||
48325688|NCT04063371|101124535|FG001|NOT COMPLETED|Overall Study||0||
48325689|NCT04063371|101124536|FG002|NOT COMPLETED|Overall Study||0||
48325690|NCT00783094|101124537|FG000|STARTED|Randomized Double-Blind Treatment Period||142||
48325691|NCT00783094|101124538|FG001|STARTED|Randomized Double-Blind Treatment Period||140||
48325692|NCT00783094|101124539|FG002|STARTED|Randomized Double-Blind Treatment Period||140||
48325693|NCT00783094|101124537|FG000|COMPLETED|Randomized Double-Blind Treatment Period||135||
48325694|NCT00783094|101124538|FG001|COMPLETED|Randomized Double-Blind Treatment Period||128||
48619464|NCT00583908|101853133|FG004|COMPLETED|Period 1 - First Intervention||2||
48619465|NCT00583908|101853134|FG005|COMPLETED|Period 1 - First Intervention||1||
48619466|NCT00583908|101853135|FG006|COMPLETED|Period 1 - First Intervention||1||
48619467|NCT00583908|101853136|FG007|COMPLETED|Period 1 - First Intervention||1||
48619468|NCT00583908|101853137|FG008|COMPLETED|Period 1 - First Intervention||1||
48619469|NCT00583908|101853138|FG009|COMPLETED|Period 1 - First Intervention||1||
48325695|NCT00783094|101124539|FG002|COMPLETED|Randomized Double-Blind Treatment Period||131||
48619470|NCT00583908|101853139|FG010|COMPLETED|Period 1 - First Intervention||1||
48619471|NCT00583908|101853140|FG011|COMPLETED|Period 1 - First Intervention||1||
48619472|NCT00583908|101853129|FG000|NOT COMPLETED|Period 1 - First Intervention||0||
48619473|NCT00583908|101853130|FG001|NOT COMPLETED|Period 1 - First Intervention||0||
48619474|NCT00583908|101853131|FG002|NOT COMPLETED|Period 1 - First Intervention||0||
48619475|NCT00583908|101853132|FG003|NOT COMPLETED|Period 1 - First Intervention||0||
48619476|NCT00583908|101853133|FG004|NOT COMPLETED|Period 1 - First Intervention||0||
48619477|NCT00583908|101853134|FG005|NOT COMPLETED|Period 1 - First Intervention||0||
48619478|NCT00583908|101853135|FG006|NOT COMPLETED|Period 1 - First Intervention||0||
48619479|NCT00583908|101853136|FG007|NOT COMPLETED|Period 1 - First Intervention||0||
48619480|NCT00583908|101853137|FG008|NOT COMPLETED|Period 1 - First Intervention||0||
48619481|NCT00583908|101853138|FG009|NOT COMPLETED|Period 1 - First Intervention||0||
48619482|NCT00583908|101853139|FG010|NOT COMPLETED|Period 1 - First Intervention||0||
48619483|NCT00583908|101853140|FG011|NOT COMPLETED|Period 1 - First Intervention||0||
48619484|NCT00583908|101853129|FG000|STARTED|Period 2 - Second Intervention||1||
48619485|NCT00583908|101853130|FG001|STARTED|Period 2 - Second Intervention||2||
48619486|NCT00583908|101853131|FG002|STARTED|Period 2 - Second Intervention||1||
48619487|NCT00583908|101853132|FG003|STARTED|Period 2 - Second Intervention||1||
48619488|NCT00583908|101853133|FG004|STARTED|Period 2 - Second Intervention||2||
48619489|NCT00583908|101853134|FG005|STARTED|Period 2 - Second Intervention||1||
48619490|NCT00583908|101853135|FG006|STARTED|Period 2 - Second Intervention||1||
48619491|NCT00583908|101853136|FG007|STARTED|Period 2 - Second Intervention||1||
48619492|NCT00583908|101853137|FG008|STARTED|Period 2 - Second Intervention||1||
48619493|NCT00583908|101853138|FG009|STARTED|Period 2 - Second Intervention||1||
48619494|NCT00583908|101853139|FG010|STARTED|Period 2 - Second Intervention||1||
48619495|NCT00583908|101853140|FG011|STARTED|Period 2 - Second Intervention||1||
48619496|NCT00583908|101853129|FG000|COMPLETED|Period 2 - Second Intervention||1||
48742734|NCT00377858|102155142|FG000|STARTED|Overall Study||242||
48742735|NCT00377858|102155143|FG001|STARTED|Overall Study||242||
48325696|NCT00783094|101124537|FG000|NOT COMPLETED|Randomized Double-Blind Treatment Period||7||
48325697|NCT00783094|101124538|FG001|NOT COMPLETED|Randomized Double-Blind Treatment Period||12||
48325698|NCT00783094|101124539|FG002|NOT COMPLETED|Randomized Double-Blind Treatment Period||9||
48325699|NCT00783094|101124537|FG000|STARTED|Open-Label Extension Period||135||
48325700|NCT00783094|101124538|FG001|STARTED|Open-Label Extension Period||128||
48619497|NCT00583908|101853130|FG001|COMPLETED|Period 2 - Second Intervention||2||
48325701|NCT00783094|101124539|FG002|STARTED|Open-Label Extension Period||131||
48325702|NCT00783094|101124537|FG000|COMPLETED|Open-Label Extension Period||113||
48325703|NCT00783094|101124538|FG001|COMPLETED|Open-Label Extension Period||109||
48325704|NCT00783094|101124539|FG002|COMPLETED|Open-Label Extension Period||101||
48325705|NCT00783094|101124537|FG000|NOT COMPLETED|Open-Label Extension Period||22||
48325706|NCT00783094|101124538|FG001|NOT COMPLETED|Open-Label Extension Period||19||
48325707|NCT00783094|101124539|FG002|NOT COMPLETED|Open-Label Extension Period||30||
48325708|NCT01368835|101124540|FG000|STARTED|Overall Study||103||
48325709|NCT01368835|101124540|FG000|COMPLETED|Overall Study||70||
48325710|NCT01368835|101124540|FG000|NOT COMPLETED|Overall Study||33||
48325711|NCT03713944|101124541|FG000|STARTED|Study Treatment||30||
48325712|NCT03713944|101124541|FG000|COMPLETED|Study Treatment||0||
48325713|NCT03713944|101124541|FG000|NOT COMPLETED|Study Treatment||30||
48325714|NCT03713944|101124541|FG000|STARTED|Follow up||30|Treatment and Follow up both are at different time period. Therefore, the number of subjects to start follow up is not equal to the number of subjects who have completed treatment.|
48325715|NCT03713944|101124541|FG000|COMPLETED|Follow up||14||
48325716|NCT03713944|101124541|FG000|NOT COMPLETED|Follow up||16||
48325717|NCT01680900|101124542|FG000|STARTED|Overall Study||24||
48325718|NCT01680900|101124543|FG001|STARTED|Overall Study||12||
48325719|NCT01680900|101124542|FG000|COMPLETED|Overall Study||20||
48325720|NCT01680900|101124543|FG001|COMPLETED|Overall Study||11||
48325721|NCT01680900|101124542|FG000|NOT COMPLETED|Overall Study||4||
48325722|NCT01680900|101124543|FG001|NOT COMPLETED|Overall Study||1||
48325723|NCT00957008|101124544|FG000|STARTED|Overall Study||49||
48325724|NCT00957008|101124545|FG001|STARTED|Overall Study||49||
48162904|NCT01598298|100721702|FG000|Patients Evaluable for Primary Endpoint|Overall Study||127|Patient has an in-window BPI assessment at week 2, 6, or 12.|
48162905|NCT01598298|100721703|FG001|Patients Evaluable for Primary Endpoint|Overall Study||128|Patient has an in-window BPI assessment at week 2, 6, or 12.|
48162906|NCT01598298|100721702|FG000|Patients Evaluable for Adverse Events|Overall Study||138||
48162907|NCT01598298|100721703|FG001|Patients Evaluable for Adverse Events|Overall Study||141||
48162908|NCT01598298|100721702|FG000|COMPLETED|Overall Study||110||
48162909|NCT01598298|100721703|FG001|COMPLETED|Overall Study||108||
48325725|NCT00957008|101124546|FG002|STARTED|Overall Study||49||
48325726|NCT00957008|101124547|FG003|STARTED|Overall Study||50||
48325727|NCT00957008|101124544|FG000|COMPLETED|Overall Study||28||
48325728|NCT00957008|101124545|FG001|COMPLETED|Overall Study||37||
48325729|NCT00957008|101124546|FG002|COMPLETED|Overall Study||32||
48325730|NCT00957008|101124547|FG003|COMPLETED|Overall Study||26||
48325731|NCT00957008|101124544|FG000|NOT COMPLETED|Overall Study||21||
48325732|NCT00957008|101124545|FG001|NOT COMPLETED|Overall Study||12||
48325733|NCT00957008|101124546|FG002|NOT COMPLETED|Overall Study||17||
48325734|NCT00957008|101124547|FG003|NOT COMPLETED|Overall Study||24||
48325735|NCT03303950|101124548|FG000|STARTED|Overall Study||6||
48325736|NCT03303950|101124548|FG000|COMPLETED|Overall Study||6||
48325737|NCT03303950|101124548|FG000|NOT COMPLETED|Overall Study||0||
48325738|NCT02987621|101124549|FG000|STARTED|Overall Study||7||
48325739|NCT02987621|101124550|FG001|STARTED|Overall Study||7||
48325740|NCT02987621|101124549|FG000|COMPLETED|Overall Study||7||
48325741|NCT02987621|101124550|FG001|COMPLETED|Overall Study||7||
48325742|NCT02987621|101124549|FG000|NOT COMPLETED|Overall Study||0||
48325743|NCT02987621|101124550|FG001|NOT COMPLETED|Overall Study||0||
48325744|NCT01496066|101124551|FG000|STARTED|Overall Study||403||
48325745|NCT01496066|101124552|FG001|STARTED|Overall Study||197||
48325746|NCT01496066|101124551|FG000|COMPLETED|Overall Study||391||
48325747|NCT01496066|101124552|FG001|COMPLETED|Overall Study||188||
48325748|NCT01496066|101124551|FG000|NOT COMPLETED|Overall Study||12||
48742736|NCT00377858|102155142|FG000|Had at Least One Post-Baseline Value|Overall Study||239||
48742737|NCT00377858|102155143|FG001|Had at Least One Post-Baseline Value|Overall Study||240||
48742738|NCT00377858|102155142|FG000|COMPLETED|Overall Study||211||
48742739|NCT00377858|102155143|FG001|COMPLETED|Overall Study||215||
48742740|NCT00377858|102155142|FG000|NOT COMPLETED|Overall Study||31||
48742741|NCT00377858|102155143|FG001|NOT COMPLETED|Overall Study||27||
48742742|NCT01345188|102155144|FG000|STARTED|Randomization Ranolazine/Placebo 6 Weeks||28||
48742743|NCT01345188|102155144|FG000|COMPLETED|Randomization Ranolazine/Placebo 6 Weeks||26||
48742744|NCT01345188|102155144|FG000|NOT COMPLETED|Randomization Ranolazine/Placebo 6 Weeks||2||
48742745|NCT01345188|102155144|FG000|STARTED|Crossover Ranolazine/Placebo 6 Weeks||26||
48742746|NCT01345188|102155144|FG000|COMPLETED|Crossover Ranolazine/Placebo 6 Weeks||25||
48742747|NCT01345188|102155144|FG000|NOT COMPLETED|Crossover Ranolazine/Placebo 6 Weeks||1||
48742748|NCT00287716|102155145|FG000|STARTED|Overall Study||174||
48742749|NCT00287716|102155146|FG001|STARTED|Overall Study||87||
48742750|NCT00287716|102155147|FG002|STARTED|Overall Study||174||
48742751|NCT00287716|102155145|FG000|COMPLETED|Overall Study||136||
48742752|NCT00287716|102155146|FG001|COMPLETED|Overall Study||70||
48742753|NCT00287716|102155147|FG002|COMPLETED|Overall Study||143||
48742754|NCT00287716|102155145|FG000|NOT COMPLETED|Overall Study||38||
48742755|NCT00287716|102155146|FG001|NOT COMPLETED|Overall Study||17||
48742756|NCT00287716|102155147|FG002|NOT COMPLETED|Overall Study||31||
48742757|NCT03819049|102155148|FG000|STARTED|Overall Study||104||
48742758|NCT03819049|102155149|FG001|STARTED|Overall Study||102||
48742759|NCT03819049|102155150|FG002|STARTED|Overall Study||104||
48742760|NCT03819049|102155151|FG003|STARTED|Overall Study||53||
48742761|NCT03819049|102155152|FG004|STARTED|Overall Study||54||
48742762|NCT03819049|102155153|FG005|STARTED|Overall Study||280||
48742763|NCT03819049|102155154|FG006|STARTED|Overall Study||139||
48742764|NCT03819049|102155148|FG000|Vaccinated|Overall Study||104||
48742765|NCT03819049|102155149|FG001|Vaccinated|Overall Study||102||
48742766|NCT03819049|102155150|FG002|Vaccinated|Overall Study||104||
48742767|NCT03819049|102155151|FG003|Vaccinated|Overall Study||52||
48742768|NCT03819049|102155152|FG004|Vaccinated|Overall Study||54||
48742769|NCT03819049|102155153|FG005|Vaccinated|Overall Study||278||
48742770|NCT03819049|102155154|FG006|Vaccinated|Overall Study||138||
48742771|NCT03819049|102155148|FG000|COMPLETED|Overall Study||103||
48742772|NCT03819049|102155149|FG001|COMPLETED|Overall Study||100||
48742773|NCT03819049|102155150|FG002|COMPLETED|Overall Study||0||
48742774|NCT03819049|102155151|FG003|COMPLETED|Overall Study||52||
48742775|NCT03819049|102155152|FG004|COMPLETED|Overall Study||0||
48742776|NCT03819049|102155153|FG005|COMPLETED|Overall Study||268||
48742777|NCT03819049|102155154|FG006|COMPLETED|Overall Study||136||
48742778|NCT03819049|102155148|FG000|NOT COMPLETED|Overall Study||1||
48742779|NCT03819049|102155149|FG001|NOT COMPLETED|Overall Study||2||
48742780|NCT03819049|102155150|FG002|NOT COMPLETED|Overall Study||104||
48742781|NCT03819049|102155151|FG003|NOT COMPLETED|Overall Study||1||
48742782|NCT03819049|102155152|FG004|NOT COMPLETED|Overall Study||54||
48742783|NCT03819049|102155153|FG005|NOT COMPLETED|Overall Study||12||
48742784|NCT03819049|102155154|FG006|NOT COMPLETED|Overall Study||3||
48742785|NCT01550757|102155155|FG000|STARTED|Overall Study||56||
48742786|NCT01550757|102155156|FG001|STARTED|Overall Study||52||
48742787|NCT01550757|102155157|FG002|STARTED|Overall Study||130||
48742788|NCT01550757|102155158|FG003|STARTED|Overall Study||144||
48742789|NCT01550757|102155155|FG000|COMPLETED|Overall Study||33||
48742790|NCT01550757|102155156|FG001|COMPLETED|Overall Study||38||
48742791|NCT01550757|102155157|FG002|COMPLETED|Overall Study||85||
48742792|NCT01550757|102155158|FG003|COMPLETED|Overall Study||90||
48742793|NCT01550757|102155155|FG000|NOT COMPLETED|Overall Study||23||
48742794|NCT01550757|102155156|FG001|NOT COMPLETED|Overall Study||14||
48742795|NCT01550757|102155157|FG002|NOT COMPLETED|Overall Study||45||
48742796|NCT01550757|102155158|FG003|NOT COMPLETED|Overall Study||54||
48742797|NCT02754726|102155159|FG000|STARTED|Overall Study||35||
48742798|NCT02754726|102155159|FG000|COMPLETED|Overall Study||0||
48742799|NCT02754726|102155159|FG000|NOT COMPLETED|Overall Study||35||
48742800|NCT03267004|102155160|FG000|STARTED|Overall Study||15||
48742801|NCT03267004|102155161|FG001|STARTED|Overall Study||15||
48742802|NCT03267004|102155160|FG000|COMPLETED|Overall Study||15||
48742803|NCT03267004|102155161|FG001|COMPLETED|Overall Study||15||
48742804|NCT03267004|102155160|FG000|NOT COMPLETED|Overall Study||0||
48742805|NCT03267004|102155161|FG001|NOT COMPLETED|Overall Study||0||
48742806|NCT01424501|102155162|FG000|STARTED|Overall Study||7||
48742807|NCT01424501|102155163|FG001|STARTED|Overall Study||6||
48742808|NCT01424501|102155164|FG002|STARTED|Overall Study||24||
48742809|NCT01424501|102155165|FG003|STARTED|Overall Study||25||
48742810|NCT01424501|102155166|FG004|STARTED|Overall Study||40||
48742811|NCT01424501|102155167|FG005|STARTED|Overall Study||40||
48742812|NCT01424501|102155162|FG000|COMPLETED|Overall Study||6||
48742813|NCT01424501|102155163|FG001|COMPLETED|Overall Study||5||
48742814|NCT01424501|102155164|FG002|COMPLETED|Overall Study||22||
48742815|NCT01424501|102155165|FG003|COMPLETED|Overall Study||25||
48742816|NCT01424501|102155166|FG004|COMPLETED|Overall Study||40||
48742817|NCT01424501|102155167|FG005|COMPLETED|Overall Study||40||
48742818|NCT01424501|102155162|FG000|NOT COMPLETED|Overall Study||1||
48742819|NCT01424501|102155163|FG001|NOT COMPLETED|Overall Study||1||
48325749|NCT01496066|101124552|FG001|NOT COMPLETED|Overall Study||9||
48325750|NCT04677712|101124553|FG000|STARTED|Overall Study||7||
48325751|NCT04677712|101124554|FG001|STARTED|Overall Study||8||
48325752|NCT04677712|101124555|FG002|STARTED|Overall Study||9||
48325753|NCT04677712|101124556|FG003|STARTED|Overall Study||9||
48325754|NCT04677712|101124557|FG004|STARTED|Overall Study||8||
48325755|NCT04677712|101124558|FG005|STARTED|Overall Study||7||
48325756|NCT04677712|101124553|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7||
48325757|NCT04677712|101124554|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8||
48325758|NCT04677712|101124555|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9||
48325759|NCT04677712|101124556|FG003|Received at Least 1 Dose of Study Drug|Overall Study||9||
48325760|NCT04677712|101124557|FG004|Received at Least 1 Dose of Study Drug|Overall Study||8||
48325761|NCT04677712|101124558|FG005|Received at Least 1 Dose of Study Drug|Overall Study||7||
48325762|NCT04677712|101124553|FG000|COMPLETED|Overall Study||7||
48325763|NCT04677712|101124554|FG001|COMPLETED|Overall Study||7||
48409389|NCT00364832|101334690|FG005|NOT COMPLETED|Extension Year 2||0||
48409390|NCT00364832|101334691|FG006|NOT COMPLETED|Extension Year 2||0||
48409391|NCT00364832|101334692|FG007|NOT COMPLETED|Extension Year 2||0||
48409392|NCT00364832|101334693|FG008|NOT COMPLETED|Extension Year 2||0||
48619498|NCT00583908|101853131|FG002|COMPLETED|Period 2 - Second Intervention||1||
48619499|NCT00583908|101853132|FG003|COMPLETED|Period 2 - Second Intervention||1||
48619500|NCT00583908|101853133|FG004|COMPLETED|Period 2 - Second Intervention||2||
48619501|NCT00583908|101853134|FG005|COMPLETED|Period 2 - Second Intervention||1||
48619502|NCT00583908|101853135|FG006|COMPLETED|Period 2 - Second Intervention||1||
48619503|NCT00583908|101853136|FG007|COMPLETED|Period 2 - Second Intervention||1||
48619504|NCT00583908|101853137|FG008|COMPLETED|Period 2 - Second Intervention||1||
48619505|NCT00583908|101853138|FG009|COMPLETED|Period 2 - Second Intervention||1||
48619506|NCT00583908|101853139|FG010|COMPLETED|Period 2 - Second Intervention||1||
48619507|NCT00583908|101853140|FG011|COMPLETED|Period 2 - Second Intervention||1||
48619508|NCT00583908|101853129|FG000|NOT COMPLETED|Period 2 - Second Intervention||0||
48619509|NCT00583908|101853130|FG001|NOT COMPLETED|Period 2 - Second Intervention||0||
48619510|NCT00583908|101853131|FG002|NOT COMPLETED|Period 2 - Second Intervention||0||
48619511|NCT00583908|101853132|FG003|NOT COMPLETED|Period 2 - Second Intervention||0||
48619512|NCT00583908|101853133|FG004|NOT COMPLETED|Period 2 - Second Intervention||0||
48619513|NCT00583908|101853134|FG005|NOT COMPLETED|Period 2 - Second Intervention||0||
48619514|NCT00583908|101853135|FG006|NOT COMPLETED|Period 2 - Second Intervention||0||
48619515|NCT00583908|101853136|FG007|NOT COMPLETED|Period 2 - Second Intervention||0||
48619516|NCT00583908|101853137|FG008|NOT COMPLETED|Period 2 - Second Intervention||0||
48619517|NCT00583908|101853138|FG009|NOT COMPLETED|Period 2 - Second Intervention||0||
48619518|NCT00583908|101853139|FG010|NOT COMPLETED|Period 2 - Second Intervention||0||
48619519|NCT00583908|101853140|FG011|NOT COMPLETED|Period 2 - Second Intervention||0||
48619520|NCT00583908|101853129|FG000|STARTED|Period 3 - Third Intervention||1||
48619521|NCT00583908|101853130|FG001|STARTED|Period 3 - Third Intervention||2||
48619522|NCT00583908|101853131|FG002|STARTED|Period 3 - Third Intervention||1||
48619523|NCT00583908|101853132|FG003|STARTED|Period 3 - Third Intervention||1||
48325764|NCT04677712|101124555|FG002|COMPLETED|Overall Study||9||
48409393|NCT00364832|101334694|FG009|NOT COMPLETED|Extension Year 2||5||
48409394|NCT00364832|101334695|FG010|NOT COMPLETED|Extension Year 2||5||
48409395|NCT00364832|101334696|FG011|NOT COMPLETED|Extension Year 2||3||
48409396|NCT00584987|101334697|FG000|STARTED|Overall Study||15||
48409397|NCT00584987|101334698|FG001|STARTED|Overall Study||16||
48409398|NCT00584987|101334699|FG002|STARTED|Overall Study||17||
48409399|NCT00584987|101334700|FG003|STARTED|Overall Study||16||
48409400|NCT00584987|101334697|FG000|COMPLETED|Overall Study||14||
48409401|NCT00584987|101334698|FG001|COMPLETED|Overall Study||15||
48619524|NCT00583908|101853133|FG004|STARTED|Period 3 - Third Intervention||2||
48619525|NCT00583908|101853134|FG005|STARTED|Period 3 - Third Intervention||1||
48619526|NCT00583908|101853135|FG006|STARTED|Period 3 - Third Intervention||1||
48619527|NCT00583908|101853136|FG007|STARTED|Period 3 - Third Intervention||1||
48619528|NCT00583908|101853137|FG008|STARTED|Period 3 - Third Intervention||1||
48657102|NCT03761914|101943779|FG001|STARTED|Overall Study||1||
48325765|NCT04677712|101124556|FG003|COMPLETED|Overall Study||9||
48325766|NCT04677712|101124557|FG004|COMPLETED|Overall Study||8||
48325767|NCT04677712|101124558|FG005|COMPLETED|Overall Study||7||
48325768|NCT04677712|101124553|FG000|NOT COMPLETED|Overall Study||0||
48325769|NCT04677712|101124554|FG001|NOT COMPLETED|Overall Study||1||
48325770|NCT04677712|101124555|FG002|NOT COMPLETED|Overall Study||0||
48325771|NCT04677712|101124556|FG003|NOT COMPLETED|Overall Study||0||
48325772|NCT04677712|101124557|FG004|NOT COMPLETED|Overall Study||0||
48325773|NCT04677712|101124558|FG005|NOT COMPLETED|Overall Study||0||
48325774|NCT01928381|101124559|FG000|STARTED|Screening for Pain Training||143||
48325775|NCT01928381|101124560|FG001|STARTED|Screening for Pain Training||0||
48325776|NCT01928381|101124561|FG002|STARTED|Screening for Pain Training||0||
48325777|NCT01928381|101124562|FG003|STARTED|Screening for Pain Training||0||
48742820|NCT01424501|102155164|FG002|NOT COMPLETED|Overall Study||2||
48742821|NCT01424501|102155165|FG003|NOT COMPLETED|Overall Study||0||
48742822|NCT01424501|102155166|FG004|NOT COMPLETED|Overall Study||0||
48742823|NCT01424501|102155167|FG005|NOT COMPLETED|Overall Study||0||
48742824|NCT01128426|102155168|FG000|STARTED|Overall Study||53902||
48742825|NCT01128426|102155168|FG000|COMPLETED|Overall Study||53902||
48742826|NCT01128426|102155168|FG000|NOT COMPLETED|Overall Study||0||
48742827|NCT01964963|102155169|FG000|STARTED|Overall Study||19192||
48742828|NCT01964963|102155169|FG000|COMPLETED|Overall Study||18249||
48742829|NCT01964963|102155169|FG000|NOT COMPLETED|Overall Study||943||
48742830|NCT05443256|102155170|FG000|STARTED|Overall Study||5||
48742831|NCT05443256|102155171|FG001|STARTED|Overall Study||4||
48742832|NCT05443256|102155170|FG000|COMPLETED|Overall Study||4||
48742833|NCT05443256|102155171|FG001|COMPLETED|Overall Study||4||
48742834|NCT05443256|102155170|FG000|NOT COMPLETED|Overall Study||1||
48742835|NCT05443256|102155171|FG001|NOT COMPLETED|Overall Study||0||
48742836|NCT00889512|102155172|FG000|STARTED|Overall Study||5||
48742837|NCT00889512|102155173|FG001|STARTED|Overall Study||9||
48742838|NCT00889512|102155172|FG000|COMPLETED|Overall Study||5||
48742839|NCT00889512|102155173|FG001|COMPLETED|Overall Study||9||
48742840|NCT00889512|102155172|FG000|NOT COMPLETED|Overall Study||0||
48742841|NCT00889512|102155173|FG001|NOT COMPLETED|Overall Study||0||
48742842|NCT03030417|102155174|FG000|STARTED|Dose Escalation||1||
48742843|NCT03030417|102155175|FG001|STARTED|Dose Escalation||1||
48742844|NCT03030417|102155176|FG002|STARTED|Dose Escalation||3||
48742845|NCT03030417|102155177|FG003|STARTED|Dose Escalation||1||
48742846|NCT03030417|102155178|FG004|STARTED|Dose Escalation||1||
48742847|NCT03030417|102155179|FG005|STARTED|Dose Escalation||9||
48742848|NCT03030417|102155180|FG006|STARTED|Dose Escalation||0||
48742849|NCT03030417|102155181|FG007|STARTED|Dose Escalation||0||
48742850|NCT03030417|102155182|FG008|STARTED|Dose Escalation||10||
48742851|NCT03030417|102155183|FG009|STARTED|Dose Escalation||1||
48742852|NCT03030417|102155184|FG010|STARTED|Dose Escalation||0||
48742853|NCT03030417|102155185|FG011|STARTED|Dose Escalation||0||
48742854|NCT03030417|102155186|FG012|STARTED|Dose Escalation||0||
48742855|NCT03030417|102155174|FG000|Restaging|Dose Escalation||1||
48742856|NCT03030417|102155175|FG001|Restaging|Dose Escalation||1||
48742857|NCT03030417|102155176|FG002|Restaging|Dose Escalation||0||
48742858|NCT03030417|102155177|FG003|Restaging|Dose Escalation||1||
48162910|NCT01598298|100721702|FG000|NOT COMPLETED|Overall Study||40||
48162911|NCT01598298|100721703|FG001|NOT COMPLETED|Overall Study||41||
48162912|NCT02532179|100721704|FG000|STARTED|Overall Study||12||
48742859|NCT03030417|102155178|FG004|Restaging|Dose Escalation||1||
48742860|NCT03030417|102155179|FG005|Restaging|Dose Escalation||9||
48742861|NCT03030417|102155180|FG006|Restaging|Dose Escalation||0||
48742862|NCT03030417|102155181|FG007|Restaging|Dose Escalation||0||
48742863|NCT03030417|102155182|FG008|Restaging|Dose Escalation||7||
48742864|NCT03030417|102155183|FG009|Restaging|Dose Escalation||1||
48742865|NCT03030417|102155184|FG010|Restaging|Dose Escalation||0||
48162913|NCT02532179|100721704|FG000|COMPLETED|Overall Study||9||
48162914|NCT02532179|100721704|FG000|NOT COMPLETED|Overall Study||3||
48162915|NCT01112228|100721705|FG000|STARTED|Overall Study||600||
48162916|NCT01112228|100721705|FG000|COMPLETED|Overall Study||600||
48162917|NCT01112228|100721705|FG000|NOT COMPLETED|Overall Study||0||
48162918|NCT00909480|100721706|FG000|STARTED|Overall Study||228||
48742866|NCT03030417|102155185|FG011|Restaging|Dose Escalation||0||
48742867|NCT03030417|102155186|FG012|Restaging|Dose Escalation||0||
48742868|NCT03030417|102155174|FG000|Pharmacokinetic Sampling|Dose Escalation||1||
48742869|NCT03030417|102155175|FG001|Pharmacokinetic Sampling|Dose Escalation||1||
48742870|NCT03030417|102155176|FG002|Pharmacokinetic Sampling|Dose Escalation||3||
48742871|NCT03030417|102155177|FG003|Pharmacokinetic Sampling|Dose Escalation||1||
48742872|NCT03030417|102155178|FG004|Pharmacokinetic Sampling|Dose Escalation||1||
48742873|NCT03030417|102155179|FG005|Pharmacokinetic Sampling|Dose Escalation||9||
48742874|NCT03030417|102155180|FG006|Pharmacokinetic Sampling|Dose Escalation||0||
48742875|NCT03030417|102155181|FG007|Pharmacokinetic Sampling|Dose Escalation||0||
48742876|NCT03030417|102155182|FG008|Pharmacokinetic Sampling|Dose Escalation||4||
48742877|NCT03030417|102155183|FG009|Pharmacokinetic Sampling|Dose Escalation||0||
48742878|NCT03030417|102155184|FG010|Pharmacokinetic Sampling|Dose Escalation||0||
48742879|NCT03030417|102155185|FG011|Pharmacokinetic Sampling|Dose Escalation||0||
48162919|NCT00909480|100721707|FG001|STARTED|Overall Study||229||
48162920|NCT00909480|100721706|FG000|Exposed|Overall Study||226||
48162921|NCT00909480|100721707|FG001|Exposed|Overall Study||227||
48162922|NCT00909480|100721706|FG000|COMPLETED|Overall Study||190||
48742880|NCT03030417|102155186|FG012|Pharmacokinetic Sampling|Dose Escalation||0||
48742881|NCT03030417|102155174|FG000|Tumor Biopsies|Dose Escalation||0||
48742882|NCT03030417|102155175|FG001|Tumor Biopsies|Dose Escalation||0||
48325778|NCT01928381|101124563|FG004|STARTED|Screening for Pain Training||0||
48325779|NCT01928381|101124564|FG005|STARTED|Screening for Pain Training||0||
48742883|NCT03030417|102155176|FG002|Tumor Biopsies|Dose Escalation||0||
48742884|NCT03030417|102155177|FG003|Tumor Biopsies|Dose Escalation||0||
48162923|NCT00909480|100721707|FG001|COMPLETED|Overall Study||188||
48162924|NCT00909480|100721706|FG000|NOT COMPLETED|Overall Study||38||
48162925|NCT00909480|100721707|FG001|NOT COMPLETED|Overall Study||41||
48162926|NCT01087996|100721708|FG000|STARTED|Overall Study||15||
48162927|NCT01087996|100721709|FG001|STARTED|Overall Study||15||
48162928|NCT01087996|100721708|FG000|COMPLETED|Overall Study||15||
48162929|NCT01087996|100721709|FG001|COMPLETED|Overall Study||15||
48162930|NCT01087996|100721708|FG000|NOT COMPLETED|Overall Study||0||
48162931|NCT01087996|100721709|FG001|NOT COMPLETED|Overall Study||0||
48162932|NCT03997513|100721710|FG000|STARTED|Overall Study||2||
48162933|NCT03997513|100721711|FG001|STARTED|Overall Study||3||
48162934|NCT03997513|100721710|FG000|COMPLETED|Overall Study||2||
48162935|NCT03997513|100721711|FG001|COMPLETED|Overall Study||2||
48162936|NCT03997513|100721710|FG000|NOT COMPLETED|Overall Study||0||
48162937|NCT03997513|100721711|FG001|NOT COMPLETED|Overall Study||1||
48162938|NCT03857230|100721712|FG000|STARTED|Period 1 (Primapur-Gonal-F)||12||
48162939|NCT03857230|100721713|FG001|STARTED|Period 1 (Primapur-Gonal-F)||12||
48162940|NCT03857230|100721712|FG000|COMPLETED|Period 1 (Primapur-Gonal-F)||12||
48162941|NCT03857230|100721713|FG001|COMPLETED|Period 1 (Primapur-Gonal-F)||12||
48162942|NCT03857230|100721712|FG000|NOT COMPLETED|Period 1 (Primapur-Gonal-F)||0||
48742885|NCT03030417|102155178|FG004|Tumor Biopsies|Dose Escalation||0||
48162943|NCT03857230|100721713|FG001|NOT COMPLETED|Period 1 (Primapur-Gonal-F)||0||
48162944|NCT03857230|100721712|FG000|STARTED|Period 2 (Gonal-F-Primapur)||12||
48162945|NCT03857230|100721713|FG001|STARTED|Period 2 (Gonal-F-Primapur)||12||
48162946|NCT03857230|100721712|FG000|COMPLETED|Period 2 (Gonal-F-Primapur)||12||
48742886|NCT03030417|102155179|FG005|Tumor Biopsies|Dose Escalation||0||
48742887|NCT03030417|102155180|FG006|Tumor Biopsies|Dose Escalation||0||
48742888|NCT03030417|102155181|FG007|Tumor Biopsies|Dose Escalation||0||
48742889|NCT03030417|102155182|FG008|Tumor Biopsies|Dose Escalation||0||
48742890|NCT03030417|102155183|FG009|Tumor Biopsies|Dose Escalation||0||
48162947|NCT03857230|100721713|FG001|COMPLETED|Period 2 (Gonal-F-Primapur)||12||
48162948|NCT03857230|100721712|FG000|NOT COMPLETED|Period 2 (Gonal-F-Primapur)||0||
48162949|NCT03857230|100721713|FG001|NOT COMPLETED|Period 2 (Gonal-F-Primapur)||0||
48162950|NCT00749125|100721714|FG000|STARTED|Overall Study||47||
48162951|NCT00749125|100721715|FG001|STARTED|Overall Study||52||
48162952|NCT00749125|100721714|FG000|COMPLETED|Overall Study||36||
48162953|NCT00749125|100721715|FG001|COMPLETED|Overall Study||34||
48162954|NCT00749125|100721714|FG000|NOT COMPLETED|Overall Study||11||
48162955|NCT00749125|100721715|FG001|NOT COMPLETED|Overall Study||18||
48162956|NCT00595270|100721716|FG000|STARTED|Overall Study||116||
48162957|NCT00595270|100721717|FG001|STARTED|Overall Study||117||
48162958|NCT00595270|100721718|FG002|STARTED|Overall Study||116||
48162959|NCT00595270|100721716|FG000|COMPLETED|Overall Study||110||
48742891|NCT03030417|102155184|FG010|Tumor Biopsies|Dose Escalation||0||
48162960|NCT00595270|100721717|FG001|COMPLETED|Overall Study||107||
48162961|NCT00595270|100721718|FG002|COMPLETED|Overall Study||108||
48162962|NCT00595270|100721716|FG000|NOT COMPLETED|Overall Study||6||
48162963|NCT00595270|100721717|FG001|NOT COMPLETED|Overall Study||10||
48162964|NCT00595270|100721718|FG002|NOT COMPLETED|Overall Study||8||
48162965|NCT01203930|100721719|FG000|STARTED|Overall Study||64||
48162966|NCT01203930|100721720|FG001|STARTED|Overall Study||41||
48162967|NCT01203930|100721719|FG000|COMPLETED|Overall Study||43||
48162968|NCT01203930|100721720|FG001|COMPLETED|Overall Study||0||
48162969|NCT01203930|100721719|FG000|NOT COMPLETED|Overall Study||21||
48162970|NCT01203930|100721720|FG001|NOT COMPLETED|Overall Study||41||
48162971|NCT01821417|100721721|FG000|STARTED|Overall Study||37||
48162972|NCT01821417|100721722|FG001|STARTED|Overall Study||31||
48162973|NCT01821417|100721721|FG000|COMPLETED|Overall Study||37||
48162974|NCT01821417|100721722|FG001|COMPLETED|Overall Study||31||
48162975|NCT01821417|100721721|FG000|NOT COMPLETED|Overall Study||0||
48162976|NCT01821417|100721722|FG001|NOT COMPLETED|Overall Study||0||
48325780|NCT01928381|101124565|FG006|STARTED|Screening for Pain Training||0||
48325781|NCT01928381|101124559|FG000|COMPLETED|Screening for Pain Training||83||
48325782|NCT01928381|101124560|FG001|COMPLETED|Screening for Pain Training||0||
48325783|NCT01928381|101124561|FG002|COMPLETED|Screening for Pain Training||0||
48742892|NCT03030417|102155185|FG011|Tumor Biopsies|Dose Escalation||0||
48742893|NCT03030417|102155186|FG012|Tumor Biopsies|Dose Escalation||0||
48742894|NCT03030417|102155174|FG000|COMPLETED|Dose Escalation||1||
48162977|NCT01874145|100721723|FG000|STARTED|Core Period||101||
48162978|NCT01874145|100721724|FG001|STARTED|Core Period||108||
48162979|NCT01874145|100721723|FG000|Full Analysis Set|Core Period||100||
48162980|NCT01874145|100721724|FG001|Full Analysis Set|Core Period||108||
48162981|NCT01874145|100721723|FG000|COMPLETED|Core Period||98||
48162982|NCT01874145|100721724|FG001|COMPLETED|Core Period||101||
48742895|NCT03030417|102155175|FG001|COMPLETED|Dose Escalation||1||
48162983|NCT01874145|100721723|FG000|NOT COMPLETED|Core Period||3||
48742896|NCT03030417|102155176|FG002|COMPLETED|Dose Escalation||3||
48742897|NCT03030417|102155177|FG003|COMPLETED|Dose Escalation||1||
48742898|NCT03030417|102155178|FG004|COMPLETED|Dose Escalation||1||
48162984|NCT01874145|100721724|FG001|NOT COMPLETED|Core Period||7||
48162985|NCT01874145|100721723|FG000|STARTED|Extension Period||97||
48162986|NCT01874145|100721724|FG001|STARTED|Extension Period||101||
48162987|NCT01874145|100721723|FG000|Full Analysis Set|Extension Period||95||
48162988|NCT01874145|100721724|FG001|Full Analysis Set|Extension Period||101||
48162989|NCT01874145|100721723|FG000|COMPLETED|Extension Period||91||
48162990|NCT01874145|100721724|FG001|COMPLETED|Extension Period||97||
48162991|NCT01874145|100721723|FG000|NOT COMPLETED|Extension Period||6||
48162992|NCT01874145|100721724|FG001|NOT COMPLETED|Extension Period||4||
48162993|NCT03160287|100721725|FG000|STARTED|Overall Study||24||
48162994|NCT03160287|100721725|FG000|COMPLETED|Overall Study||22||
48162995|NCT03160287|100721725|FG000|NOT COMPLETED|Overall Study||2||
48162996|NCT01728792|100721726|FG000|STARTED|Overall Study||14||
48162997|NCT01728792|100721727|FG001|STARTED|Overall Study||16||
48162998|NCT01728792|100721728|FG002|STARTED|Overall Study||17||
48162999|NCT01728792|100721729|FG003|STARTED|Overall Study||17||
48163000|NCT01728792|100721730|FG004|STARTED|Overall Study||16||
48163001|NCT01728792|100721726|FG000|COMPLETED|Overall Study||11||
48163002|NCT01728792|100721727|FG001|COMPLETED|Overall Study||14||
48163003|NCT01728792|100721728|FG002|COMPLETED|Overall Study||13||
48163004|NCT01728792|100721729|FG003|COMPLETED|Overall Study||14||
48163005|NCT01728792|100721730|FG004|COMPLETED|Overall Study||16||
48163006|NCT01728792|100721726|FG000|NOT COMPLETED|Overall Study||3||
48163007|NCT01728792|100721727|FG001|NOT COMPLETED|Overall Study||2||
48163008|NCT01728792|100721728|FG002|NOT COMPLETED|Overall Study||4||
48163009|NCT01728792|100721729|FG003|NOT COMPLETED|Overall Study||3||
48163010|NCT01728792|100721730|FG004|NOT COMPLETED|Overall Study||0||
48163011|NCT02944656|100721731|FG000|STARTED|Overall Study||57||
48163012|NCT02944656|100721732|FG001|STARTED|Overall Study||57||
48163013|NCT02944656|100721731|FG000|Completed Procedure Day|Overall Study||54||
48163014|NCT02944656|100721732|FG001|Completed Procedure Day|Overall Study||57||
48163015|NCT02944656|100721731|FG000|Completed Day 1 Follow up|Overall Study||47||
48163016|NCT02944656|100721732|FG001|Completed Day 1 Follow up|Overall Study||47||
48163017|NCT02944656|100721731|FG000|COMPLETED|Overall Study||47||
48163018|NCT02944656|100721732|FG001|COMPLETED|Overall Study||47||
48163019|NCT02944656|100721731|FG000|NOT COMPLETED|Overall Study||10||
48163020|NCT02944656|100721732|FG001|NOT COMPLETED|Overall Study||10||
48163021|NCT01364597|100721733|FG000|STARTED|Overall Study||36||
48163022|NCT01364597|100721734|FG001|STARTED|Overall Study||15||
48163023|NCT01364597|100721735|FG002|STARTED|Overall Study||141||
48163024|NCT01364597|100721736|FG003|STARTED|Overall Study||65||
48163025|NCT01364597|100721733|FG000|Directly Enrolled (DE) Participants|Overall Study||0||
48163026|NCT01364597|100721734|FG001|Directly Enrolled (DE) Participants|Overall Study||0||
48163027|NCT01364597|100721735|FG002|Directly Enrolled (DE) Participants|Overall Study||85||
48163028|NCT01364597|100721736|FG003|Directly Enrolled (DE) Participants|Overall Study||35||
48163029|NCT01364597|100721733|FG000|Long-term Follow-up (LTFU) Participants|Overall Study||36||
48163030|NCT01364597|100721734|FG001|Long-term Follow-up (LTFU) Participants|Overall Study||15||
48163031|NCT01364597|100721735|FG002|Long-term Follow-up (LTFU) Participants|Overall Study||56||
48163032|NCT01364597|100721736|FG003|Long-term Follow-up (LTFU) Participants|Overall Study||30||
48163033|NCT01364597|100721733|FG000|COMPLETED|Overall Study||18||
48163034|NCT01364597|100721734|FG001|COMPLETED|Overall Study||4||
48325784|NCT01928381|101124562|FG003|COMPLETED|Screening for Pain Training||0||
48325785|NCT01928381|101124563|FG004|COMPLETED|Screening for Pain Training||0||
48325786|NCT01928381|101124564|FG005|COMPLETED|Screening for Pain Training||0||
48325787|NCT01928381|101124565|FG006|COMPLETED|Screening for Pain Training||0||
48325788|NCT01928381|101124559|FG000|NOT COMPLETED|Screening for Pain Training||60||
48163035|NCT01364597|100721735|FG002|COMPLETED|Overall Study||65||
48163036|NCT01364597|100721736|FG003|COMPLETED|Overall Study||37||
48163037|NCT01364597|100721733|FG000|NOT COMPLETED|Overall Study||18||
48163038|NCT01364597|100721734|FG001|NOT COMPLETED|Overall Study||11||
48163039|NCT01364597|100721735|FG002|NOT COMPLETED|Overall Study||76||
48163040|NCT01364597|100721736|FG003|NOT COMPLETED|Overall Study||28||
48163041|NCT00864708|100721737|FG000|STARTED|Overall Study||1||
48163042|NCT00864708|100721737|FG000|COMPLETED|Overall Study||1||
48163043|NCT00864708|100721737|FG000|NOT COMPLETED|Overall Study||0||
48163044|NCT02466646|100721738|FG000|STARTED|Overall Study||14||
48163045|NCT02466646|100721739|FG001|STARTED|Overall Study||14||
48163046|NCT02466646|100721740|FG002|STARTED|Overall Study||14||
48163047|NCT02466646|100721738|FG000|COMPLETED|Overall Study||14||
48163048|NCT02466646|100721739|FG001|COMPLETED|Overall Study||14||
48163049|NCT02466646|100721740|FG002|COMPLETED|Overall Study||14||
48163050|NCT02466646|100721738|FG000|NOT COMPLETED|Overall Study||0||
48163051|NCT02466646|100721739|FG001|NOT COMPLETED|Overall Study||0||
48163052|NCT02466646|100721740|FG002|NOT COMPLETED|Overall Study||0||
48163053|NCT01576367|100721741|FG000|STARTED|Overall Study||17||
48325789|NCT01928381|101124560|FG001|NOT COMPLETED|Screening for Pain Training||0||
48325790|NCT01928381|101124561|FG002|NOT COMPLETED|Screening for Pain Training||0||
48325791|NCT01928381|101124562|FG003|NOT COMPLETED|Screening for Pain Training||0||
48163054|NCT01576367|100721741|FG000|COMPLETED|Overall Study||14||
48163055|NCT01576367|100721741|FG000|NOT COMPLETED|Overall Study||3||
48163056|NCT05340751|100721742|FG000|STARTED|Overall Study||35||
48742899|NCT03030417|102155179|FG005|COMPLETED|Dose Escalation||9||
48742900|NCT03030417|102155180|FG006|COMPLETED|Dose Escalation||0||
48742901|NCT03030417|102155181|FG007|COMPLETED|Dose Escalation||0||
48742902|NCT03030417|102155182|FG008|COMPLETED|Dose Escalation||10||
48742903|NCT03030417|102155183|FG009|COMPLETED|Dose Escalation||1||
48742904|NCT03030417|102155184|FG010|COMPLETED|Dose Escalation||0||
48742905|NCT03030417|102155185|FG011|COMPLETED|Dose Escalation||0||
48742906|NCT03030417|102155186|FG012|COMPLETED|Dose Escalation||0||
48742907|NCT03030417|102155174|FG000|NOT COMPLETED|Dose Escalation||0||
48742908|NCT03030417|102155175|FG001|NOT COMPLETED|Dose Escalation||0||
48742909|NCT03030417|102155176|FG002|NOT COMPLETED|Dose Escalation||0||
48742910|NCT03030417|102155177|FG003|NOT COMPLETED|Dose Escalation||0||
48742911|NCT03030417|102155178|FG004|NOT COMPLETED|Dose Escalation||0||
48742912|NCT03030417|102155179|FG005|NOT COMPLETED|Dose Escalation||0||
48742913|NCT03030417|102155180|FG006|NOT COMPLETED|Dose Escalation||0||
48742914|NCT03030417|102155181|FG007|NOT COMPLETED|Dose Escalation||0||
48742915|NCT03030417|102155182|FG008|NOT COMPLETED|Dose Escalation||0||
48742916|NCT03030417|102155183|FG009|NOT COMPLETED|Dose Escalation||0||
48742917|NCT03030417|102155184|FG010|NOT COMPLETED|Dose Escalation||0||
48742918|NCT03030417|102155185|FG011|NOT COMPLETED|Dose Escalation||0||
48742919|NCT03030417|102155186|FG012|NOT COMPLETED|Dose Escalation||0||
48742920|NCT03030417|102155174|FG000|STARTED|Dose Expansion||0||
48742921|NCT03030417|102155175|FG001|STARTED|Dose Expansion||0||
48742922|NCT03030417|102155176|FG002|STARTED|Dose Expansion||0||
48742923|NCT03030417|102155177|FG003|STARTED|Dose Expansion||0||
48742924|NCT03030417|102155178|FG004|STARTED|Dose Expansion||0||
48742925|NCT03030417|102155179|FG005|STARTED|Dose Expansion||5||
48742926|NCT03030417|102155180|FG006|STARTED|Dose Expansion||2||
48742927|NCT03030417|102155181|FG007|STARTED|Dose Expansion||1||
48742928|NCT03030417|102155182|FG008|STARTED|Dose Expansion||0||
48742929|NCT03030417|102155183|FG009|STARTED|Dose Expansion||0||
48742930|NCT03030417|102155184|FG010|STARTED|Dose Expansion||0||
48742931|NCT03030417|102155185|FG011|STARTED|Dose Expansion||0||
48742932|NCT03030417|102155186|FG012|STARTED|Dose Expansion||1||
48742933|NCT03030417|102155174|FG000|Restaging|Dose Expansion||0||
48163057|NCT05340751|100721742|FG000|COMPLETED|Overall Study||32||
48163058|NCT05340751|100721742|FG000|NOT COMPLETED|Overall Study||3||
48163059|NCT03391960|100721743|FG000|STARTED|Overall Study||165||0
48163060|NCT03391960|100721744|FG001|STARTED|Overall Study||0||156
48163061|NCT03391960|100721743|FG000|COMPLETED|Overall Study||165||0
48163062|NCT03391960|100721744|FG001|COMPLETED|Overall Study||0||156
48163063|NCT03391960|100721743|FG000|NOT COMPLETED|Overall Study||0||0
48163064|NCT03391960|100721744|FG001|NOT COMPLETED|Overall Study||0||0
48163065|NCT00954733|100721745|FG000|STARTED|Overall Study||40||
48163066|NCT00954733|100721745|FG000|COMPLETED|Overall Study||39||
48163067|NCT00954733|100721745|FG000|NOT COMPLETED|Overall Study||1||
48163068|NCT00255346|100721746|FG000|STARTED|Overall Study||10||
48163069|NCT00255346|100721747|FG001|STARTED|Overall Study||6||
48163070|NCT00255346|100721748|FG002|STARTED|Overall Study||8||
48163071|NCT00255346|100721749|FG003|STARTED|Overall Study||11||
48163072|NCT00255346|100721750|FG004|STARTED|Overall Study||33||
48163073|NCT00255346|100721746|FG000|COMPLETED|Overall Study||9||
48163074|NCT00255346|100721747|FG001|COMPLETED|Overall Study||6||
48163075|NCT00255346|100721748|FG002|COMPLETED|Overall Study||8||
48163076|NCT00255346|100721749|FG003|COMPLETED|Overall Study||11||
48619529|NCT00583908|101853138|FG009|STARTED|Period 3 - Third Intervention||1||
48619530|NCT00583908|101853139|FG010|STARTED|Period 3 - Third Intervention||1||
48619531|NCT00583908|101853140|FG011|STARTED|Period 3 - Third Intervention||1||
48619532|NCT00583908|101853129|FG000|COMPLETED|Period 3 - Third Intervention||1||
48163077|NCT00255346|100721750|FG004|COMPLETED|Overall Study||33||
48163078|NCT00255346|100721746|FG000|NOT COMPLETED|Overall Study||1||
48163079|NCT00255346|100721747|FG001|NOT COMPLETED|Overall Study||0||
48163080|NCT00255346|100721748|FG002|NOT COMPLETED|Overall Study||0||
48163081|NCT00255346|100721749|FG003|NOT COMPLETED|Overall Study||0||
48163082|NCT00255346|100721750|FG004|NOT COMPLETED|Overall Study||0||
48163083|NCT00457639|100721751|FG000|STARTED|Intervention 1 (6 Months)||9||
48163084|NCT00457639|100721752|FG001|STARTED|Intervention 1 (6 Months)||9||
48163085|NCT00457639|100721751|FG000|COMPLETED|Intervention 1 (6 Months)||6||
48163086|NCT00457639|100721752|FG001|COMPLETED|Intervention 1 (6 Months)||7||
48163087|NCT00457639|100721751|FG000|NOT COMPLETED|Intervention 1 (6 Months)||3||
48163088|NCT00457639|100721752|FG001|NOT COMPLETED|Intervention 1 (6 Months)||2||
48163089|NCT00457639|100721751|FG000|STARTED|Intervention 2 (6 Months)||6||
48163090|NCT00457639|100721752|FG001|STARTED|Intervention 2 (6 Months)||7||
48163091|NCT00457639|100721751|FG000|COMPLETED|Intervention 2 (6 Months)||6||
48163092|NCT00457639|100721752|FG001|COMPLETED|Intervention 2 (6 Months)||6||
48163093|NCT00457639|100721751|FG000|NOT COMPLETED|Intervention 2 (6 Months)||0||
48163094|NCT00457639|100721752|FG001|NOT COMPLETED|Intervention 2 (6 Months)||1||
48163095|NCT04146896|100721753|FG000|STARTED|Overall Study||114||
48163096|NCT04146896|100721754|FG001|STARTED|Overall Study||114||
48163097|NCT04146896|100721753|FG000|COMPLETED|Overall Study||97||
48163098|NCT04146896|100721754|FG001|COMPLETED|Overall Study||92||
48163099|NCT04146896|100721753|FG000|NOT COMPLETED|Overall Study||17||
48163100|NCT04146896|100721754|FG001|NOT COMPLETED|Overall Study||22||
48163101|NCT03489057|100721755|FG000|STARTED|Overall Study||141||
48163102|NCT03489057|100721756|FG001|STARTED|Overall Study||141||
48163103|NCT03489057|100721757|FG002|STARTED|Overall Study||139||
48163104|NCT03489057|100721758|FG003|STARTED|Overall Study||139||
48163105|NCT03489057|100721755|FG000|COMPLETED|Overall Study||106||
48163106|NCT03489057|100721756|FG001|COMPLETED|Overall Study||106||
48163107|NCT03489057|100721757|FG002|COMPLETED|Overall Study||115||
48163108|NCT03489057|100721758|FG003|COMPLETED|Overall Study||115||
48163109|NCT03489057|100721755|FG000|NOT COMPLETED|Overall Study||35||
48163110|NCT03489057|100721756|FG001|NOT COMPLETED|Overall Study||35||
48163111|NCT03489057|100721757|FG002|NOT COMPLETED|Overall Study||24||
48163112|NCT03489057|100721758|FG003|NOT COMPLETED|Overall Study||24||
48163113|NCT00927355|100721759|FG000|STARTED|Overall Study||5||
48163114|NCT00927355|100721760|FG001|STARTED|Overall Study||5||
48163115|NCT00927355|100721759|FG000|COMPLETED|Overall Study||4||
48163116|NCT00927355|100721760|FG001|COMPLETED|Overall Study||4||
48163117|NCT00927355|100721759|FG000|NOT COMPLETED|Overall Study||1||
48619533|NCT00583908|101853130|FG001|COMPLETED|Period 3 - Third Intervention||2||
48163118|NCT00927355|100721760|FG001|NOT COMPLETED|Overall Study||1||
48163119|NCT02696564|100721761|FG000|STARTED|Overall Study||108||
48163120|NCT02696564|100721762|FG001|STARTED|Overall Study||112||
48163121|NCT02696564|100721761|FG000|COMPLETED|Overall Study||94||
48163122|NCT02696564|100721762|FG001|COMPLETED|Overall Study||99||
48163123|NCT02696564|100721761|FG000|NOT COMPLETED|Overall Study||14||
48163124|NCT02696564|100721762|FG001|NOT COMPLETED|Overall Study||13||
48163125|NCT04557826|100721763|FG000|STARTED|Overall Study||25||
48163126|NCT04557826|100721763|FG000|COMPLETED|Overall Study||25||
48163127|NCT04557826|100721763|FG000|NOT COMPLETED|Overall Study||0||
48163128|NCT01672853|100721764|FG000|STARTED|Overall Study||79||
48163129|NCT01672853|100721765|FG001|STARTED|Overall Study||77||
48163130|NCT01672853|100721766|FG002|STARTED|Overall Study||79||
48163131|NCT01672853|100721764|FG000|COMPLETED|Overall Study||69||
48163132|NCT01672853|100721765|FG001|COMPLETED|Overall Study||60||
48163133|NCT01672853|100721766|FG002|COMPLETED|Overall Study||65||
48163134|NCT01672853|100721764|FG000|NOT COMPLETED|Overall Study||10||
48163135|NCT01672853|100721765|FG001|NOT COMPLETED|Overall Study||17||
48163136|NCT01672853|100721766|FG002|NOT COMPLETED|Overall Study||14||
48163137|NCT02739347|100721767|FG000|STARTED|Overall Study||5||
48163138|NCT02739347|100721768|FG001|STARTED|Overall Study||7||
48163139|NCT02739347|100721767|FG000|COMPLETED|Overall Study||2||
48163140|NCT02739347|100721768|FG001|COMPLETED|Overall Study||4||
48163141|NCT02739347|100721767|FG000|NOT COMPLETED|Overall Study||3||
48163142|NCT02739347|100721768|FG001|NOT COMPLETED|Overall Study||3||
48163143|NCT04737109|100721769|FG000|STARTED|Study Treatment||6||
48163144|NCT04737109|100721770|FG001|STARTED|Study Treatment||0||
48163145|NCT04737109|100721771|FG002|STARTED|Study Treatment||0||
48163146|NCT04737109|100721772|FG003|STARTED|Study Treatment||0||
48163147|NCT04737109|100721769|FG000|COMPLETED|Study Treatment||0||
48163148|NCT04737109|100721770|FG001|COMPLETED|Study Treatment||0||
48163149|NCT04737109|100721771|FG002|COMPLETED|Study Treatment||0||
48163150|NCT04737109|100721772|FG003|COMPLETED|Study Treatment||0||
48163151|NCT04737109|100721769|FG000|NOT COMPLETED|Study Treatment||6||
48163152|NCT04737109|100721770|FG001|NOT COMPLETED|Study Treatment||0||
48163153|NCT04737109|100721771|FG002|NOT COMPLETED|Study Treatment||0||
48163154|NCT04737109|100721772|FG003|NOT COMPLETED|Study Treatment||0||
48163155|NCT04737109|100721769|FG000|STARTED|Follow up||5|Treatment and Follow up both are at different time period. Therefore, the number of subjects to start follow up is not equal to the number of subjects who have completed treatment.|
48163156|NCT04737109|100721770|FG001|STARTED|Follow up||0|Treatment and Follow up both are at different time period. Therefore, the number of subjects to start follow up is not equal to the number of subjects who have completed treatment.|
48163157|NCT04737109|100721771|FG002|STARTED|Follow up||0|Treatment and Follow up both are at different time period. Therefore, the number of subjects to start follow up is not equal to the number of subjects who have completed treatment.|
48163158|NCT04737109|100721772|FG003|STARTED|Follow up||0|Treatment and Follow up both are at different time period. Therefore, the number of subjects to start follow up is not equal to the number of subjects who have completed treatment.|
48163159|NCT04737109|100721769|FG000|COMPLETED|Follow up||5||
48163160|NCT04737109|100721770|FG001|COMPLETED|Follow up||0||
48163161|NCT04737109|100721771|FG002|COMPLETED|Follow up||0||
48163162|NCT04737109|100721772|FG003|COMPLETED|Follow up||0||
48163163|NCT04737109|100721769|FG000|NOT COMPLETED|Follow up||0||
48163164|NCT04737109|100721770|FG001|NOT COMPLETED|Follow up||0||
48163165|NCT04737109|100721771|FG002|NOT COMPLETED|Follow up||0||
48163166|NCT04737109|100721772|FG003|NOT COMPLETED|Follow up||0||
48163167|NCT03351738|100721773|FG000|STARTED|Overall Study||23||
48163168|NCT03351738|100721774|FG001|STARTED|Overall Study||20||
48163169|NCT03351738|100721775|FG002|STARTED|Overall Study||24||
48163170|NCT03351738|100721776|FG003|STARTED|Overall Study||22||
48163171|NCT03351738|100721777|FG004|STARTED|Overall Study||21||
48163172|NCT03351738|100721778|FG005|STARTED|Overall Study||22||
48163173|NCT03351738|100721773|FG000|COMPLETED|Overall Study||23||
48163174|NCT03351738|100721774|FG001|COMPLETED|Overall Study||19||
48163175|NCT03351738|100721775|FG002|COMPLETED|Overall Study||24||
48163176|NCT03351738|100721776|FG003|COMPLETED|Overall Study||21||
48163177|NCT03351738|100721777|FG004|COMPLETED|Overall Study||21||
48325792|NCT01928381|101124563|FG004|NOT COMPLETED|Screening for Pain Training||0||
48325793|NCT01928381|101124564|FG005|NOT COMPLETED|Screening for Pain Training||0||
48325794|NCT01928381|101124565|FG006|NOT COMPLETED|Screening for Pain Training||0||
48325795|NCT01928381|101124559|FG000|STARTED|Part 1 - Pain Training||83||
48325796|NCT01928381|101124560|FG001|STARTED|Part 1 - Pain Training||0||
48163178|NCT03351738|100721778|FG005|COMPLETED|Overall Study||22||
48163179|NCT03351738|100721773|FG000|NOT COMPLETED|Overall Study||0||
48163180|NCT03351738|100721774|FG001|NOT COMPLETED|Overall Study||1||
48163181|NCT03351738|100721775|FG002|NOT COMPLETED|Overall Study||0||
48163182|NCT03351738|100721776|FG003|NOT COMPLETED|Overall Study||1||
48163183|NCT03351738|100721777|FG004|NOT COMPLETED|Overall Study||0||
48163184|NCT03351738|100721778|FG005|NOT COMPLETED|Overall Study||0||
48163185|NCT01481545|100721779|FG000|STARTED|Overall Study||16||
48163186|NCT01481545|100721780|FG001|STARTED|Overall Study||46||
48163187|NCT01481545|100721779|FG000|COMPLETED|Overall Study||11||
48163188|NCT01481545|100721780|FG001|COMPLETED|Overall Study||40||
48163189|NCT01481545|100721779|FG000|NOT COMPLETED|Overall Study||5||
48163190|NCT01481545|100721780|FG001|NOT COMPLETED|Overall Study||6||
48163191|NCT03386032|100721781|FG000|STARTED|Overall Study||36||
48325797|NCT01928381|101124561|FG002|STARTED|Part 1 - Pain Training||0||
48325798|NCT01928381|101124562|FG003|STARTED|Part 1 - Pain Training||0||
48325799|NCT01928381|101124563|FG004|STARTED|Part 1 - Pain Training||0||
48325800|NCT01928381|101124564|FG005|STARTED|Part 1 - Pain Training||0||
48325801|NCT01928381|101124565|FG006|STARTED|Part 1 - Pain Training||0||
48325802|NCT01928381|101124559|FG000|COMPLETED|Part 1 - Pain Training||48||
48325803|NCT01928381|101124560|FG001|COMPLETED|Part 1 - Pain Training||0||
48163192|NCT03386032|100721782|FG001|STARTED|Overall Study||18||
48163193|NCT03386032|100721783|FG002|STARTED|Overall Study||11||
48163194|NCT03386032|100721781|FG000|COMPLETED|Overall Study||18||
48163195|NCT03386032|100721782|FG001|COMPLETED|Overall Study||11||
48163196|NCT03386032|100721783|FG002|COMPLETED|Overall Study||11||
48163197|NCT03386032|100721781|FG000|NOT COMPLETED|Overall Study||18||
48163198|NCT03386032|100721782|FG001|NOT COMPLETED|Overall Study||7||
48163199|NCT03386032|100721783|FG002|NOT COMPLETED|Overall Study||0||
48325804|NCT01928381|101124561|FG002|COMPLETED|Part 1 - Pain Training||0||
48325805|NCT01928381|101124562|FG003|COMPLETED|Part 1 - Pain Training||0||
48325806|NCT01928381|101124563|FG004|COMPLETED|Part 1 - Pain Training||0||
48325807|NCT01928381|101124564|FG005|COMPLETED|Part 1 - Pain Training||0||
48325808|NCT01928381|101124565|FG006|COMPLETED|Part 1 - Pain Training||0||
48325809|NCT01928381|101124559|FG000|NOT COMPLETED|Part 1 - Pain Training||35||
48325810|NCT01928381|101124560|FG001|NOT COMPLETED|Part 1 - Pain Training||0||
48325811|NCT01928381|101124561|FG002|NOT COMPLETED|Part 1 - Pain Training||0||
48325812|NCT01928381|101124562|FG003|NOT COMPLETED|Part 1 - Pain Training||0||
48325813|NCT01928381|101124563|FG004|NOT COMPLETED|Part 1 - Pain Training||0||
48325814|NCT01928381|101124564|FG005|NOT COMPLETED|Part 1 - Pain Training||0||
48325815|NCT01928381|101124565|FG006|NOT COMPLETED|Part 1 - Pain Training||0||
48325816|NCT01928381|101124559|FG000|STARTED|Placebo run-in & Part 2 Eligibility||48||
48325817|NCT01928381|101124560|FG001|STARTED|Placebo run-in & Part 2 Eligibility||0||
48325818|NCT01928381|101124561|FG002|STARTED|Placebo run-in & Part 2 Eligibility||0||
48325819|NCT01928381|101124562|FG003|STARTED|Placebo run-in & Part 2 Eligibility||0||
48325820|NCT01928381|101124563|FG004|STARTED|Placebo run-in & Part 2 Eligibility||0||
48325821|NCT01928381|101124564|FG005|STARTED|Placebo run-in & Part 2 Eligibility||0||
48325822|NCT01928381|101124565|FG006|STARTED|Placebo run-in & Part 2 Eligibility||0||
48325823|NCT01928381|101124559|FG000|COMPLETED|Placebo run-in & Part 2 Eligibility||34||
48325824|NCT01928381|101124560|FG001|COMPLETED|Placebo run-in & Part 2 Eligibility||0||
48325825|NCT01928381|101124561|FG002|COMPLETED|Placebo run-in & Part 2 Eligibility||0||
48742934|NCT03030417|102155175|FG001|Restaging|Dose Expansion||0||
48742935|NCT03030417|102155176|FG002|Restaging|Dose Expansion||0||
48742936|NCT03030417|102155177|FG003|Restaging|Dose Expansion||0||
48742937|NCT03030417|102155178|FG004|Restaging|Dose Expansion||0||
48163200|NCT01255592|100721784|FG000|STARTED|Overall Study||26||
48163201|NCT01255592|100721785|FG001|STARTED|Overall Study||26||
48163202|NCT01255592|100721784|FG000|COMPLETED|Overall Study||20||
48163203|NCT01255592|100721785|FG001|COMPLETED|Overall Study||25||
48163204|NCT01255592|100721784|FG000|NOT COMPLETED|Overall Study||6||
48163205|NCT01255592|100721785|FG001|NOT COMPLETED|Overall Study||1||
48325826|NCT01928381|101124562|FG003|COMPLETED|Placebo run-in & Part 2 Eligibility||0||
48325827|NCT01928381|101124563|FG004|COMPLETED|Placebo run-in & Part 2 Eligibility||0||
48325828|NCT01928381|101124564|FG005|COMPLETED|Placebo run-in & Part 2 Eligibility||0||
48325829|NCT01928381|101124565|FG006|COMPLETED|Placebo run-in & Part 2 Eligibility||0||
48325830|NCT01928381|101124559|FG000|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||14||
48325831|NCT01928381|101124560|FG001|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0||
48325832|NCT01928381|101124561|FG002|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0||
48325833|NCT01928381|101124562|FG003|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0||
48742938|NCT03030417|102155179|FG005|Restaging|Dose Expansion||2||
48742939|NCT03030417|102155180|FG006|Restaging|Dose Expansion||2||
48163206|NCT00785707|100721786|FG000|STARTED|Overall Study||31||
48163207|NCT00785707|100721786|FG000|COMPLETED|Overall Study||24||
48163208|NCT00785707|100721786|FG000|NOT COMPLETED|Overall Study||7||
48163209|NCT05076149|100721787|FG000|STARTED|Overall Study||289||
48163210|NCT05076149|100721788|FG001|STARTED|Overall Study||284||
48163211|NCT05076149|100721787|FG000|Pooled Analysis Set|Overall Study||491|The Pooled Full Analysis Set (PFAS) included all randomized participants from this study (VX20-121-103) and from Study VX20-121-102 who carry the intended CFTR genotype and received at least 1dose of study drug during the Treatment Period.|
48325834|NCT01928381|101124563|FG004|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0||
48325835|NCT01928381|101124564|FG005|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0||
48325836|NCT01928381|101124565|FG006|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0||
48325837|NCT01928381|101124559|FG000|STARTED|Part 2 - First Intervention||0||
48325838|NCT01928381|101124560|FG001|STARTED|Part 2 - First Intervention||6||
48325839|NCT01928381|101124561|FG002|STARTED|Part 2 - First Intervention||6||
48325840|NCT01928381|101124562|FG003|STARTED|Part 2 - First Intervention||6||
48325841|NCT01928381|101124563|FG004|STARTED|Part 2 - First Intervention||4||
48325842|NCT01928381|101124564|FG005|STARTED|Part 2 - First Intervention||6||
48325843|NCT01928381|101124565|FG006|STARTED|Part 2 - First Intervention||6||
48325844|NCT01928381|101124559|FG000|COMPLETED|Part 2 - First Intervention||0||
48325845|NCT01928381|101124560|FG001|COMPLETED|Part 2 - First Intervention||6||
48325846|NCT01928381|101124561|FG002|COMPLETED|Part 2 - First Intervention||4||
48325847|NCT01928381|101124562|FG003|COMPLETED|Part 2 - First Intervention||5||
48325848|NCT01928381|101124563|FG004|COMPLETED|Part 2 - First Intervention||4||
48325849|NCT01928381|101124564|FG005|COMPLETED|Part 2 - First Intervention||5||
48325850|NCT01928381|101124565|FG006|COMPLETED|Part 2 - First Intervention||5||
48325851|NCT01928381|101124559|FG000|NOT COMPLETED|Part 2 - First Intervention||0||
48325852|NCT01928381|101124560|FG001|NOT COMPLETED|Part 2 - First Intervention||0||
48325853|NCT01928381|101124561|FG002|NOT COMPLETED|Part 2 - First Intervention||2||
48325854|NCT01928381|101124562|FG003|NOT COMPLETED|Part 2 - First Intervention||1||
48742940|NCT03030417|102155181|FG007|Restaging|Dose Expansion||1||
48742941|NCT03030417|102155182|FG008|Restaging|Dose Expansion||0||
48742942|NCT03030417|102155183|FG009|Restaging|Dose Expansion||0||
48742943|NCT03030417|102155184|FG010|Restaging|Dose Expansion||0||
48742944|NCT03030417|102155185|FG011|Restaging|Dose Expansion||0||
48742945|NCT03030417|102155186|FG012|Restaging|Dose Expansion||0||
48742946|NCT03030417|102155174|FG000|Pharmacokinetic Sampling|Dose Expansion||0||
48742947|NCT03030417|102155175|FG001|Pharmacokinetic Sampling|Dose Expansion||0||
48325855|NCT01928381|101124563|FG004|NOT COMPLETED|Part 2 - First Intervention||0||
48325856|NCT01928381|101124564|FG005|NOT COMPLETED|Part 2 - First Intervention||1||
48325857|NCT01928381|101124565|FG006|NOT COMPLETED|Part 2 - First Intervention||1||
48325858|NCT01928381|101124559|FG000|STARTED|Washout First Intervention||0||
48409402|NCT00584987|101334699|FG002|COMPLETED|Overall Study||16||
48409403|NCT00584987|101334700|FG003|COMPLETED|Overall Study||15||
48409404|NCT00584987|101334697|FG000|NOT COMPLETED|Overall Study||1||
48409405|NCT00584987|101334698|FG001|NOT COMPLETED|Overall Study||1||
48409406|NCT00584987|101334699|FG002|NOT COMPLETED|Overall Study||1||
48409407|NCT00584987|101334700|FG003|NOT COMPLETED|Overall Study||1||
48409408|NCT03537937|101334701|FG000|STARTED|Overall Study||808||
48409409|NCT03537937|101334702|FG001|STARTED|Overall Study||859||
48409410|NCT03537937|101334703|FG002|STARTED|Overall Study||874||
48409411|NCT03537937|101334701|FG000|COMPLETED|Overall Study||808||
48409412|NCT03537937|101334702|FG001|COMPLETED|Overall Study||859||
48409413|NCT03537937|101334703|FG002|COMPLETED|Overall Study||874||
48409414|NCT03537937|101334701|FG000|NOT COMPLETED|Overall Study||0||
48409415|NCT03537937|101334702|FG001|NOT COMPLETED|Overall Study||0||
48409416|NCT03537937|101334703|FG002|NOT COMPLETED|Overall Study||0||
48409417|NCT01188811|101334704|FG000|STARTED|Overall Study||28||
48409418|NCT01188811|101334705|FG001|STARTED|Overall Study||26||
48409419|NCT01188811|101334704|FG000|COMPLETED|Overall Study||22||
48409420|NCT01188811|101334705|FG001|COMPLETED|Overall Study||24||
48409421|NCT01188811|101334704|FG000|NOT COMPLETED|Overall Study||6||
48409422|NCT01188811|101334705|FG001|NOT COMPLETED|Overall Study||2||
48409423|NCT04732780|101334706|FG000|STARTED|Overall Study||253||
48409424|NCT04732780|101334706|FG000|COMPLETED|Overall Study||253||
48409425|NCT04732780|101334706|FG000|NOT COMPLETED|Overall Study||0||
48409426|NCT01518309|101334707|FG000|STARTED|Overall Study||39||
48409427|NCT01518309|101334707|FG000|COMPLETED|Overall Study||0||
48742948|NCT03030417|102155176|FG002|Pharmacokinetic Sampling|Dose Expansion||0||
48742949|NCT03030417|102155177|FG003|Pharmacokinetic Sampling|Dose Expansion||0||
48742950|NCT03030417|102155178|FG004|Pharmacokinetic Sampling|Dose Expansion||0||
48742951|NCT03030417|102155179|FG005|Pharmacokinetic Sampling|Dose Expansion||0||
48325859|NCT01928381|101124560|FG001|STARTED|Washout First Intervention||6||
48325860|NCT01928381|101124561|FG002|STARTED|Washout First Intervention||4||
48325861|NCT01928381|101124562|FG003|STARTED|Washout First Intervention||5||
48325862|NCT01928381|101124563|FG004|STARTED|Washout First Intervention||4||
48325863|NCT01928381|101124564|FG005|STARTED|Washout First Intervention||5||
48325864|NCT01928381|101124565|FG006|STARTED|Washout First Intervention||5||
48325865|NCT01928381|101124559|FG000|COMPLETED|Washout First Intervention||0||
48409428|NCT01518309|101334707|FG000|NOT COMPLETED|Overall Study||39||
48409429|NCT03458234|101334708|FG000|STARTED|Overall Study||5||
48742952|NCT03030417|102155180|FG006|Pharmacokinetic Sampling|Dose Expansion||0||
48742953|NCT03030417|102155181|FG007|Pharmacokinetic Sampling|Dose Expansion||0||
48742954|NCT03030417|102155182|FG008|Pharmacokinetic Sampling|Dose Expansion||0||
48742955|NCT03030417|102155183|FG009|Pharmacokinetic Sampling|Dose Expansion||0||
48742956|NCT03030417|102155184|FG010|Pharmacokinetic Sampling|Dose Expansion||0||
48742957|NCT03030417|102155185|FG011|Pharmacokinetic Sampling|Dose Expansion||0||
48742958|NCT03030417|102155186|FG012|Pharmacokinetic Sampling|Dose Expansion||0||
48742959|NCT03030417|102155174|FG000|Tumor Biopsies|Dose Expansion||0||
48742960|NCT03030417|102155175|FG001|Tumor Biopsies|Dose Expansion||0||
48742961|NCT03030417|102155176|FG002|Tumor Biopsies|Dose Expansion||0||
48742962|NCT03030417|102155177|FG003|Tumor Biopsies|Dose Expansion||0||
48742963|NCT03030417|102155178|FG004|Tumor Biopsies|Dose Expansion||0||
48325866|NCT01928381|101124560|FG001|COMPLETED|Washout First Intervention||6||
48325867|NCT01928381|101124561|FG002|COMPLETED|Washout First Intervention||4||
48325868|NCT01928381|101124562|FG003|COMPLETED|Washout First Intervention||5||
48325869|NCT01928381|101124563|FG004|COMPLETED|Washout First Intervention||3||
48325870|NCT01928381|101124564|FG005|COMPLETED|Washout First Intervention||5||
48325871|NCT01928381|101124565|FG006|COMPLETED|Washout First Intervention||5||
48325872|NCT01928381|101124559|FG000|NOT COMPLETED|Washout First Intervention||0||
48325873|NCT01928381|101124560|FG001|NOT COMPLETED|Washout First Intervention||0||
48325874|NCT01928381|101124561|FG002|NOT COMPLETED|Washout First Intervention||0||
48325875|NCT01928381|101124562|FG003|NOT COMPLETED|Washout First Intervention||0||
48325876|NCT01928381|101124563|FG004|NOT COMPLETED|Washout First Intervention||1||
48325877|NCT01928381|101124564|FG005|NOT COMPLETED|Washout First Intervention||0||
48325878|NCT01928381|101124565|FG006|NOT COMPLETED|Washout First Intervention||0||
48325879|NCT01928381|101124559|FG000|STARTED|Part 2 - Second Intervention||0||
48325880|NCT01928381|101124560|FG001|STARTED|Part 2 - Second Intervention||6||
48409430|NCT03458234|101334708|FG000|COMPLETED|Overall Study||4||
48409431|NCT03458234|101334708|FG000|NOT COMPLETED|Overall Study||1||
48409432|NCT00592072|101334709|FG000|STARTED|First Sequence||6||
48409433|NCT00592072|101334710|FG001|STARTED|First Sequence||6||
48409434|NCT00592072|101334709|FG000|COMPLETED|First Sequence||6||
48409435|NCT00592072|101334710|FG001|COMPLETED|First Sequence||6||
48409436|NCT00592072|101334709|FG000|NOT COMPLETED|First Sequence||0||
48188545|NCT02068885|100783271|FG001|Provided Data at End of Test Phase|Overall Study||48|Sample size completers|
48325881|NCT01928381|101124561|FG002|STARTED|Part 2 - Second Intervention||4||
48325882|NCT01928381|101124562|FG003|STARTED|Part 2 - Second Intervention||5||
48325883|NCT01928381|101124563|FG004|STARTED|Part 2 - Second Intervention||3||
48325884|NCT01928381|101124564|FG005|STARTED|Part 2 - Second Intervention||5||
48325885|NCT01928381|101124565|FG006|STARTED|Part 2 - Second Intervention||5||
48325886|NCT01928381|101124559|FG000|COMPLETED|Part 2 - Second Intervention||0||
48325887|NCT01928381|101124560|FG001|COMPLETED|Part 2 - Second Intervention||5||
48325888|NCT01928381|101124561|FG002|COMPLETED|Part 2 - Second Intervention||4||
48325889|NCT01928381|101124562|FG003|COMPLETED|Part 2 - Second Intervention||4||
48325890|NCT01928381|101124563|FG004|COMPLETED|Part 2 - Second Intervention||3||
48325891|NCT01928381|101124564|FG005|COMPLETED|Part 2 - Second Intervention||5||
48188546|NCT02068885|100783272|FG002|Provided Data at End of Test Phase|Overall Study||46|Sample size completers|
48188547|NCT02068885|100783270|FG000|Included in Intention-to-treat Analysis|Overall Study||56|Two randomized participants excluded: unreliable doubly labeled water (DLW) data, hypothyroidism|
48188548|NCT02068885|100783271|FG001|Included in Intention-to-treat Analysis|Overall Study||52|Two randomized participants excluded: unreliable doubly labeled water (DLW) data, hypothyroidism|
48188549|NCT02068885|100783272|FG002|Included in Intention-to-treat Analysis|Overall Study||54|Two randomized participants excluded: unreliable doubly labeled water (DLW) data, hypothyroidism|
48188550|NCT02068885|100783270|FG000|COMPLETED|Overall Study||54||
48188551|NCT02068885|100783271|FG001|COMPLETED|Overall Study||48||
48188552|NCT02068885|100783272|FG002|COMPLETED|Overall Study||46||
48188553|NCT02068885|100783270|FG000|NOT COMPLETED|Overall Study||3||
48188554|NCT02068885|100783271|FG001|NOT COMPLETED|Overall Study||5||
48188555|NCT02068885|100783272|FG002|NOT COMPLETED|Overall Study||8||
48188556|NCT04172987|100783273|FG000|STARTED|Lead In Period||40||
48188557|NCT04172987|100783273|FG000|Received at Least One Dose of OC|Lead In Period||40||
48188558|NCT04172987|100783273|FG000|COMPLETED|Lead In Period||38||
48188559|NCT04172987|100783273|FG000|NOT COMPLETED|Lead In Period||2||
48188560|NCT04172987|100783273|FG000|STARTED|Period 1||38||
48188561|NCT04172987|100783273|FG000|Received at Least One Dose of OC|Period 1||38||
48188562|NCT04172987|100783273|FG000|COMPLETED|Period 1||37||
48188563|NCT04172987|100783273|FG000|NOT COMPLETED|Period 1||1||
48188564|NCT04172987|100783273|FG000|STARTED|Period 2||37||
48188565|NCT04172987|100783273|FG000|Received at Least One Dose of OC|Period 2||37||
48188566|NCT04172987|100783273|FG000|Received at Least 1 Dose of Tirzepatide|Period 2||28||
48188567|NCT04172987|100783273|FG000|COMPLETED|Period 2||28||
48188568|NCT04172987|100783273|FG000|NOT COMPLETED|Period 2||9||
48188569|NCT02100722|100783274|FG000|STARTED|Overall Study||757||
48188570|NCT02100722|100783275|FG001|STARTED|Overall Study||743||
48188571|NCT02100722|100783274|FG000|Underwent Alternate Procedure|Overall Study||11|Due to patient/physician refusal to undergo/perform procedure or an acute event leading to an alternative treatment|
48188572|NCT02100722|100783275|FG001|Underwent Alternate Procedure|Overall Study||37|Due to patient/physician refusal to undergo/perform procedure or an acute event leading to an alternative treatment|
48188573|NCT02100722|100783274|FG000|COMPLETED|Overall Study||0||
48188574|NCT02100722|100783275|FG001|COMPLETED|Overall Study||0||
48188575|NCT02100722|100783274|FG000|NOT COMPLETED|Overall Study||757||
48188576|NCT02100722|100783275|FG001|NOT COMPLETED|Overall Study||743||
48188577|NCT01036087|100783276|FG000|STARTED|Overall Study||40||
48188578|NCT01036087|100783276|FG000|COMPLETED|Overall Study||37||
48188579|NCT01036087|100783276|FG000|NOT COMPLETED|Overall Study||3||
48188580|NCT04155424|100783277|FG000|STARTED|Overall Study||5||
48188581|NCT04155424|100783277|FG000|Received at Least 1 Dose of Study Drug|Overall Study||5||
48188582|NCT04155424|100783277|FG000|Number of Participants Who Received Study Drug During the Induction Period|Overall Study||5||
48188583|NCT04155424|100783277|FG000|Number of Participants Who Received Study Drug During the Maintenance Period|Overall Study||5||
48188584|NCT04155424|100783277|FG000|COMPLETED|Overall Study||0||
48188585|NCT04155424|100783277|FG000|NOT COMPLETED|Overall Study||5||
48188586|NCT00707863|100783278|FG000|STARTED|Overall Study||6||
48188587|NCT00707863|100783279|FG001|STARTED|Overall Study||11||
48188588|NCT00707863|100783278|FG000|COMPLETED|Overall Study||6||
48188589|NCT00707863|100783279|FG001|COMPLETED|Overall Study||8||
48188590|NCT00707863|100783278|FG000|NOT COMPLETED|Overall Study||0||
48188591|NCT00707863|100783279|FG001|NOT COMPLETED|Overall Study||3||
48188592|NCT00593554|100783280|FG000|STARTED|Overall Study||3||
48188593|NCT00593554|100783281|FG001|STARTED|Overall Study||5||
48188594|NCT00593554|100783280|FG000|COMPLETED|Overall Study||0||
48188595|NCT00593554|100783281|FG001|COMPLETED|Overall Study||0||
48188596|NCT00593554|100783280|FG000|NOT COMPLETED|Overall Study||3||
48188597|NCT00593554|100783281|FG001|NOT COMPLETED|Overall Study||5||
48188598|NCT00432159|100783282|FG000|STARTED|Overall Study||185||
48188599|NCT00432159|100783283|FG001|STARTED|Overall Study||167||
48188600|NCT00432159|100783284|FG002|STARTED|Overall Study||39||
48188601|NCT00432159|100783285|FG003|STARTED|Overall Study||20||
48188602|NCT00432159|100783286|FG004|STARTED|Overall Study||89||
48188603|NCT00432159|100783282|FG000|COMPLETED|Overall Study||163||
48188604|NCT00432159|100783283|FG001|COMPLETED|Overall Study||137||
48188605|NCT00432159|100783284|FG002|COMPLETED|Overall Study||35||
48325892|NCT01928381|101124565|FG006|COMPLETED|Part 2 - Second Intervention||5||
48325893|NCT01928381|101124559|FG000|NOT COMPLETED|Part 2 - Second Intervention||0||
48325894|NCT01928381|101124560|FG001|NOT COMPLETED|Part 2 - Second Intervention||1||
48325895|NCT01928381|101124561|FG002|NOT COMPLETED|Part 2 - Second Intervention||0||
48325896|NCT01928381|101124562|FG003|NOT COMPLETED|Part 2 - Second Intervention||1||
48325897|NCT01928381|101124563|FG004|NOT COMPLETED|Part 2 - Second Intervention||0||
48325898|NCT01928381|101124564|FG005|NOT COMPLETED|Part 2 - Second Intervention||0||
48325899|NCT01928381|101124565|FG006|NOT COMPLETED|Part 2 - Second Intervention||0||
48325900|NCT01928381|101124559|FG000|STARTED|Washout Second Intervention||0||
48325901|NCT01928381|101124560|FG001|STARTED|Washout Second Intervention||5||
48325902|NCT01928381|101124561|FG002|STARTED|Washout Second Intervention||4||
48325903|NCT01928381|101124562|FG003|STARTED|Washout Second Intervention||4||
48325904|NCT01928381|101124563|FG004|STARTED|Washout Second Intervention||3||
48325905|NCT01928381|101124564|FG005|STARTED|Washout Second Intervention||5||
48325906|NCT01928381|101124565|FG006|STARTED|Washout Second Intervention||5||
48325907|NCT01928381|101124559|FG000|COMPLETED|Washout Second Intervention||0||
48325908|NCT01928381|101124560|FG001|COMPLETED|Washout Second Intervention||5||
48325909|NCT01928381|101124561|FG002|COMPLETED|Washout Second Intervention||4||
48325910|NCT01928381|101124562|FG003|COMPLETED|Washout Second Intervention||4||
48325911|NCT01928381|101124563|FG004|COMPLETED|Washout Second Intervention||3||
48325912|NCT01928381|101124564|FG005|COMPLETED|Washout Second Intervention||5||
48325913|NCT01928381|101124565|FG006|COMPLETED|Washout Second Intervention||5||
48325914|NCT01928381|101124559|FG000|NOT COMPLETED|Washout Second Intervention||0||
48325915|NCT01928381|101124560|FG001|NOT COMPLETED|Washout Second Intervention||0||
48325916|NCT01928381|101124561|FG002|NOT COMPLETED|Washout Second Intervention||0||
48325917|NCT01928381|101124562|FG003|NOT COMPLETED|Washout Second Intervention||0||
48325918|NCT01928381|101124563|FG004|NOT COMPLETED|Washout Second Intervention||0||
48325919|NCT01928381|101124564|FG005|NOT COMPLETED|Washout Second Intervention||0||
48325920|NCT01928381|101124565|FG006|NOT COMPLETED|Washout Second Intervention||0||
48325921|NCT01928381|101124559|FG000|STARTED|Part 2 - Third Intervention||0||
48325922|NCT01928381|101124560|FG001|STARTED|Part 2 - Third Intervention||5||
48325923|NCT01928381|101124561|FG002|STARTED|Part 2 - Third Intervention||4||
48325924|NCT01928381|101124562|FG003|STARTED|Part 2 - Third Intervention||4||
48325925|NCT01928381|101124563|FG004|STARTED|Part 2 - Third Intervention||3||
48325926|NCT01928381|101124564|FG005|STARTED|Part 2 - Third Intervention||5||
48325927|NCT01928381|101124565|FG006|STARTED|Part 2 - Third Intervention||5||
48325928|NCT01928381|101124559|FG000|COMPLETED|Part 2 - Third Intervention||0||
48325929|NCT01928381|101124560|FG001|COMPLETED|Part 2 - Third Intervention||5||
48325930|NCT01928381|101124561|FG002|COMPLETED|Part 2 - Third Intervention||4||
48325931|NCT01928381|101124562|FG003|COMPLETED|Part 2 - Third Intervention||4||
48325932|NCT01928381|101124563|FG004|COMPLETED|Part 2 - Third Intervention||3||
48325933|NCT01928381|101124564|FG005|COMPLETED|Part 2 - Third Intervention||5||
48325934|NCT01928381|101124565|FG006|COMPLETED|Part 2 - Third Intervention||5||
48325935|NCT01928381|101124559|FG000|NOT COMPLETED|Part 2 - Third Intervention||0||
48325936|NCT01928381|101124560|FG001|NOT COMPLETED|Part 2 - Third Intervention||0||
48325937|NCT01928381|101124561|FG002|NOT COMPLETED|Part 2 - Third Intervention||0||
48325938|NCT01928381|101124562|FG003|NOT COMPLETED|Part 2 - Third Intervention||0||
48325939|NCT01928381|101124563|FG004|NOT COMPLETED|Part 2 - Third Intervention||0||
48325940|NCT01928381|101124564|FG005|NOT COMPLETED|Part 2 - Third Intervention||0||
48325941|NCT01928381|101124565|FG006|NOT COMPLETED|Part 2 - Third Intervention||0||
48325942|NCT01928381|101124559|FG000|STARTED|Part 2 - Post Third Intervention||0||
48325943|NCT01928381|101124560|FG001|STARTED|Part 2 - Post Third Intervention||5||
48325944|NCT01928381|101124561|FG002|STARTED|Part 2 - Post Third Intervention||4||
48742964|NCT03030417|102155179|FG005|Tumor Biopsies|Dose Expansion||5||
48742965|NCT03030417|102155180|FG006|Tumor Biopsies|Dose Expansion||2||
48325945|NCT01928381|101124562|FG003|STARTED|Part 2 - Post Third Intervention||4||
48325946|NCT01928381|101124563|FG004|STARTED|Part 2 - Post Third Intervention||3||
48325947|NCT01928381|101124564|FG005|STARTED|Part 2 - Post Third Intervention||5||
48325948|NCT01928381|101124565|FG006|STARTED|Part 2 - Post Third Intervention||5||
48325949|NCT01928381|101124559|FG000|COMPLETED|Part 2 - Post Third Intervention||0||
48325950|NCT01928381|101124560|FG001|COMPLETED|Part 2 - Post Third Intervention||5||
48325951|NCT01928381|101124561|FG002|COMPLETED|Part 2 - Post Third Intervention||3||
48325952|NCT01928381|101124562|FG003|COMPLETED|Part 2 - Post Third Intervention||4||
48325953|NCT01928381|101124563|FG004|COMPLETED|Part 2 - Post Third Intervention||3||
48325954|NCT01928381|101124564|FG005|COMPLETED|Part 2 - Post Third Intervention||5||
48325955|NCT01928381|101124565|FG006|COMPLETED|Part 2 - Post Third Intervention||5||
48325956|NCT01928381|101124559|FG000|NOT COMPLETED|Part 2 - Post Third Intervention||0||
48325957|NCT01928381|101124560|FG001|NOT COMPLETED|Part 2 - Post Third Intervention||0||
48325958|NCT01928381|101124561|FG002|NOT COMPLETED|Part 2 - Post Third Intervention||1||
48325959|NCT01928381|101124562|FG003|NOT COMPLETED|Part 2 - Post Third Intervention||0||
48325960|NCT01928381|101124563|FG004|NOT COMPLETED|Part 2 - Post Third Intervention||0||
48325961|NCT01928381|101124564|FG005|NOT COMPLETED|Part 2 - Post Third Intervention||0||
48742966|NCT03030417|102155181|FG007|Tumor Biopsies|Dose Expansion||1||
48742967|NCT03030417|102155182|FG008|Tumor Biopsies|Dose Expansion||0||
48409437|NCT00592072|101334710|FG001|NOT COMPLETED|First Sequence||0||
48409438|NCT00592072|101334709|FG000|STARTED|Wash Out Period||6||
48409439|NCT00592072|101334710|FG001|STARTED|Wash Out Period||6||
48409440|NCT00592072|101334709|FG000|COMPLETED|Wash Out Period||5||
48409441|NCT00592072|101334710|FG001|COMPLETED|Wash Out Period||5||
48409442|NCT00592072|101334709|FG000|NOT COMPLETED|Wash Out Period||1||
48409443|NCT00592072|101334710|FG001|NOT COMPLETED|Wash Out Period||1||
48409444|NCT00592072|101334709|FG000|STARTED|Second Sequence||5||
48409445|NCT00592072|101334710|FG001|STARTED|Second Sequence||5||
48409446|NCT00592072|101334709|FG000|COMPLETED|Second Sequence||5||
48409447|NCT00592072|101334710|FG001|COMPLETED|Second Sequence||5||
48409448|NCT00592072|101334709|FG000|NOT COMPLETED|Second Sequence||0||
48409449|NCT00592072|101334710|FG001|NOT COMPLETED|Second Sequence||0||
48409450|NCT00262639|101334711|FG000|STARTED|Overall Study||18||
48619534|NCT00583908|101853131|FG002|COMPLETED|Period 3 - Third Intervention||1||
48163212|NCT05076149|100721788|FG001|Pooled Analysis Set|Overall Study||480|The Pooled Full Analysis Set (PFAS) included all randomized participants from this study (VX20-121-103) and from Study VX20-121-102 who carry the intended CFTR genotype and received at least 1dose of study drug during the Treatment Period.|
48163213|NCT05076149|100721787|FG000|COMPLETED|Overall Study||279||
48163214|NCT05076149|100721788|FG001|COMPLETED|Overall Study||264||
48163215|NCT05076149|100721787|FG000|NOT COMPLETED|Overall Study||10||
48163216|NCT05076149|100721788|FG001|NOT COMPLETED|Overall Study||20||
48163217|NCT00632281|100721789|FG000|STARTED|Overall Study||38||
48163218|NCT00632281|100721789|FG000|COMPLETED|Overall Study||38||
48163219|NCT00632281|100721789|FG000|NOT COMPLETED|Overall Study||0||
48163220|NCT02202434|100721790|FG000|STARTED|Overall Study||607||
48163221|NCT02202434|100721791|FG001|STARTED|Overall Study||305||
48163222|NCT02202434|100721792|FG002|STARTED|Overall Study||102||
48163223|NCT02202434|100721793|FG003|STARTED|Overall Study||295||
48163224|NCT02202434|100721790|FG000|COMPLETED|Overall Study||498||
48163225|NCT02202434|100721791|FG001|COMPLETED|Overall Study||236||
48163226|NCT02202434|100721792|FG002|COMPLETED|Overall Study||87||
48163227|NCT02202434|100721793|FG003|COMPLETED|Overall Study||258||
48163228|NCT02202434|100721790|FG000|NOT COMPLETED|Overall Study||109||
48163229|NCT02202434|100721791|FG001|NOT COMPLETED|Overall Study||69||
48163230|NCT02202434|100721792|FG002|NOT COMPLETED|Overall Study||15||
48163231|NCT02202434|100721793|FG003|NOT COMPLETED|Overall Study||37||
48163232|NCT00525135|100721794|FG000|STARTED|Overall Study||5||
48163233|NCT00525135|100721794|FG000|COMPLETED|Overall Study||5||
48163234|NCT00525135|100721794|FG000|NOT COMPLETED|Overall Study||0||
48163235|NCT01953003|100721795|FG000|STARTED|Overall Study||56||
48409451|NCT00262639|101334712|FG001|STARTED|Overall Study||26||
48409452|NCT00262639|101334713|FG002|STARTED|Overall Study||9||
48163236|NCT01953003|100721796|FG001|STARTED|Overall Study||56||
48163237|NCT01953003|100721795|FG000|COMPLETED|Overall Study||0||
48163238|NCT01953003|100721796|FG001|COMPLETED|Overall Study||1||
48163239|NCT01953003|100721795|FG000|NOT COMPLETED|Overall Study||56||
48163240|NCT01953003|100721796|FG001|NOT COMPLETED|Overall Study||55||
48409453|NCT00262639|101334714|FG003|STARTED|Overall Study||7||
48409454|NCT00262639|101334711|FG000|COMPLETED|Overall Study||18||
48409455|NCT00262639|101334712|FG001|COMPLETED|Overall Study||26||
48619535|NCT00583908|101853132|FG003|COMPLETED|Period 3 - Third Intervention||1||
48409456|NCT00262639|101334713|FG002|COMPLETED|Overall Study||9||
48619536|NCT00583908|101853133|FG004|COMPLETED|Period 3 - Third Intervention||2||
48619537|NCT00583908|101853134|FG005|COMPLETED|Period 3 - Third Intervention||1||
48619538|NCT00583908|101853135|FG006|COMPLETED|Period 3 - Third Intervention||1||
48619539|NCT00583908|101853136|FG007|COMPLETED|Period 3 - Third Intervention||1||
48619540|NCT00583908|101853137|FG008|COMPLETED|Period 3 - Third Intervention||1||
48619541|NCT00583908|101853138|FG009|COMPLETED|Period 3 - Third Intervention||1||
48619542|NCT00583908|101853139|FG010|COMPLETED|Period 3 - Third Intervention||1||
48619543|NCT00583908|101853140|FG011|COMPLETED|Period 3 - Third Intervention||1||
48619544|NCT00583908|101853129|FG000|NOT COMPLETED|Period 3 - Third Intervention||0||
48619545|NCT00583908|101853130|FG001|NOT COMPLETED|Period 3 - Third Intervention||0||
48619546|NCT00583908|101853131|FG002|NOT COMPLETED|Period 3 - Third Intervention||0||
48619547|NCT00583908|101853132|FG003|NOT COMPLETED|Period 3 - Third Intervention||0||
48619548|NCT00583908|101853133|FG004|NOT COMPLETED|Period 3 - Third Intervention||0||
48619549|NCT00583908|101853134|FG005|NOT COMPLETED|Period 3 - Third Intervention||0||
48619550|NCT00583908|101853135|FG006|NOT COMPLETED|Period 3 - Third Intervention||0||
48619551|NCT00583908|101853136|FG007|NOT COMPLETED|Period 3 - Third Intervention||0||
48619552|NCT00583908|101853137|FG008|NOT COMPLETED|Period 3 - Third Intervention||0||
48619553|NCT00583908|101853138|FG009|NOT COMPLETED|Period 3 - Third Intervention||0||
48619554|NCT00583908|101853139|FG010|NOT COMPLETED|Period 3 - Third Intervention||0||
48619555|NCT00583908|101853140|FG011|NOT COMPLETED|Period 3 - Third Intervention||0||
48619556|NCT00583908|101853129|FG000|STARTED|Period 4 - Fourth Intervention||1||
48619557|NCT00583908|101853130|FG001|STARTED|Period 4 - Fourth Intervention||2||
48619558|NCT00583908|101853131|FG002|STARTED|Period 4 - Fourth Intervention||1||
48619559|NCT00583908|101853132|FG003|STARTED|Period 4 - Fourth Intervention||1||
48619560|NCT00583908|101853133|FG004|STARTED|Period 4 - Fourth Intervention||2||
48619561|NCT00583908|101853134|FG005|STARTED|Period 4 - Fourth Intervention||1||
48619562|NCT00583908|101853135|FG006|STARTED|Period 4 - Fourth Intervention||1||
48619563|NCT00583908|101853136|FG007|STARTED|Period 4 - Fourth Intervention||1||
48619564|NCT00583908|101853137|FG008|STARTED|Period 4 - Fourth Intervention||1||
48619565|NCT00583908|101853138|FG009|STARTED|Period 4 - Fourth Intervention||1||
48619566|NCT00583908|101853139|FG010|STARTED|Period 4 - Fourth Intervention||1||
48742968|NCT03030417|102155183|FG009|Tumor Biopsies|Dose Expansion||0||
48742969|NCT03030417|102155184|FG010|Tumor Biopsies|Dose Expansion||0||
48742970|NCT03030417|102155185|FG011|Tumor Biopsies|Dose Expansion||0||
48742971|NCT03030417|102155186|FG012|Tumor Biopsies|Dose Expansion||1||
48163241|NCT01737684|100721797|FG000|STARTED|Overall Study||8||
48163242|NCT01737684|100721798|FG001|STARTED|Overall Study||8||
48163243|NCT01737684|100721799|FG002|STARTED|Overall Study||0||
48163244|NCT01737684|100721797|FG000|COMPLETED|Overall Study||8||
48163245|NCT01737684|100721798|FG001|COMPLETED|Overall Study||8||
48742972|NCT03030417|102155174|FG000|COMPLETED|Dose Expansion||0||
48742973|NCT03030417|102155175|FG001|COMPLETED|Dose Expansion||0||
48742974|NCT03030417|102155176|FG002|COMPLETED|Dose Expansion||0||
48742975|NCT03030417|102155177|FG003|COMPLETED|Dose Expansion||0||
48742976|NCT03030417|102155178|FG004|COMPLETED|Dose Expansion||0||
48742977|NCT03030417|102155179|FG005|COMPLETED|Dose Expansion||5||
48163246|NCT01737684|100721799|FG002|COMPLETED|Overall Study||0||
48163247|NCT01737684|100721797|FG000|NOT COMPLETED|Overall Study||0||
48163248|NCT01737684|100721798|FG001|NOT COMPLETED|Overall Study||0||
48163249|NCT01737684|100721799|FG002|NOT COMPLETED|Overall Study||0||
48163250|NCT01282801|100721800|FG000|STARTED|First Intervention||9||
48163251|NCT01282801|100721801|FG001|STARTED|First Intervention||9||
48163252|NCT01282801|100721800|FG000|COMPLETED|First Intervention||9||
48163253|NCT01282801|100721801|FG001|COMPLETED|First Intervention||9||
48163254|NCT01282801|100721800|FG000|NOT COMPLETED|First Intervention||0||
48163255|NCT01282801|100721801|FG001|NOT COMPLETED|First Intervention||0||
48163256|NCT01282801|100721800|FG000|STARTED|Washout of 7 Days||9||
48163257|NCT01282801|100721801|FG001|STARTED|Washout of 7 Days||9||
48163258|NCT01282801|100721800|FG000|COMPLETED|Washout of 7 Days||9||
48163259|NCT01282801|100721801|FG001|COMPLETED|Washout of 7 Days||9||
48163260|NCT01282801|100721800|FG000|NOT COMPLETED|Washout of 7 Days||0||
48163261|NCT01282801|100721801|FG001|NOT COMPLETED|Washout of 7 Days||0||
48163262|NCT01282801|100721800|FG000|STARTED|Second Intervention||9||
48163263|NCT01282801|100721801|FG001|STARTED|Second Intervention||9||
48163264|NCT01282801|100721800|FG000|COMPLETED|Second Intervention||9||
48163265|NCT01282801|100721801|FG001|COMPLETED|Second Intervention||8||
48163266|NCT01282801|100721800|FG000|NOT COMPLETED|Second Intervention||0||
48163267|NCT01282801|100721801|FG001|NOT COMPLETED|Second Intervention||1||
48163268|NCT03468933|100721802|FG000|STARTED|Overall Study||16||
48163269|NCT03468933|100721803|FG001|STARTED|Overall Study||16||
48163270|NCT03468933|100721802|FG000|COMPLETED|Overall Study||16||
48163271|NCT03468933|100721803|FG001|COMPLETED|Overall Study||16||
48163272|NCT03468933|100721802|FG000|NOT COMPLETED|Overall Study||0||
48163273|NCT03468933|100721803|FG001|NOT COMPLETED|Overall Study||0||
48163274|NCT01986101|100721804|FG000|STARTED|Overall Study||172||
48163275|NCT01986101|100721805|FG001|STARTED|Overall Study||184||
48619567|NCT00583908|101853140|FG011|STARTED|Period 4 - Fourth Intervention||1||
48163276|NCT01986101|100721806|FG002|STARTED|Overall Study||169||
48619568|NCT00583908|101853129|FG000|COMPLETED|Period 4 - Fourth Intervention||1||
48619569|NCT00583908|101853130|FG001|COMPLETED|Period 4 - Fourth Intervention||2||
48742978|NCT03030417|102155180|FG006|COMPLETED|Dose Expansion||2||
48742979|NCT03030417|102155181|FG007|COMPLETED|Dose Expansion||1||
48163277|NCT01986101|100721804|FG000|Intent-to-Treat Population|Overall Study||171||
48163278|NCT01986101|100721805|FG001|Intent-to-Treat Population|Overall Study||182||
48163279|NCT01986101|100721806|FG002|Intent-to-Treat Population|Overall Study||169||
48163280|NCT01986101|100721804|FG000|Safety Population|Overall Study||172||
48163281|NCT01986101|100721805|FG001|Safety Population|Overall Study||184||
48163282|NCT01986101|100721806|FG002|Safety Population|Overall Study||169||
48163283|NCT01986101|100721804|FG000|COMPLETED|Overall Study||139||
48163284|NCT01986101|100721805|FG001|COMPLETED|Overall Study||157||
48163285|NCT01986101|100721806|FG002|COMPLETED|Overall Study||137||
48163286|NCT01986101|100721804|FG000|NOT COMPLETED|Overall Study||33||
48742980|NCT03030417|102155182|FG008|COMPLETED|Dose Expansion||0||
48742981|NCT03030417|102155183|FG009|COMPLETED|Dose Expansion||0||
48742982|NCT03030417|102155184|FG010|COMPLETED|Dose Expansion||0||
48742983|NCT03030417|102155185|FG011|COMPLETED|Dose Expansion||0||
48619570|NCT00583908|101853131|FG002|COMPLETED|Period 4 - Fourth Intervention||1||
48619571|NCT00583908|101853132|FG003|COMPLETED|Period 4 - Fourth Intervention||1||
48163287|NCT01986101|100721805|FG001|NOT COMPLETED|Overall Study||27||
48163288|NCT01986101|100721806|FG002|NOT COMPLETED|Overall Study||32||
48163289|NCT02713711|100721807|FG000|STARTED|Overall Study||9|14 participants and 58 total psoriatic plaques divided in the 4 groups.|14
48163290|NCT02713711|100721808|FG001|STARTED|Overall Study||6|14 participants and 58 total psoriatic plaques divided in the 4 groups.|15
48325962|NCT01928381|101124565|FG006|NOT COMPLETED|Part 2 - Post Third Intervention||0||
48325963|NCT02798536|101124566|FG000|STARTED|Overall Study||3||
48325964|NCT02798536|101124567|FG001|STARTED|Overall Study||7||
48325965|NCT02798536|101124568|FG002|STARTED|Overall Study||11||
48325966|NCT02798536|101124566|FG000|COMPLETED|Overall Study||3||
48325967|NCT02798536|101124567|FG001|COMPLETED|Overall Study||7||
48325968|NCT02798536|101124568|FG002|COMPLETED|Overall Study||11||
48325969|NCT02798536|101124566|FG000|NOT COMPLETED|Overall Study||0||
48325970|NCT02798536|101124567|FG001|NOT COMPLETED|Overall Study||0||
48325971|NCT02798536|101124568|FG002|NOT COMPLETED|Overall Study||0||
48619572|NCT00583908|101853133|FG004|COMPLETED|Period 4 - Fourth Intervention||2||
48619573|NCT00583908|101853134|FG005|COMPLETED|Period 4 - Fourth Intervention||1||
48619574|NCT00583908|101853135|FG006|COMPLETED|Period 4 - Fourth Intervention||1||
48325972|NCT00278993|101124569|FG000|STARTED|Overall Study||108||
48325973|NCT00278993|101124569|FG000|COMPLETED|Overall Study||1||
48325974|NCT00278993|101124569|FG000|NOT COMPLETED|Overall Study||107||
48325975|NCT01632566|101124570|FG000|STARTED|Overall Study||8||
48325976|NCT01632566|101124571|FG001|STARTED|Overall Study||10||
48325977|NCT01632566|101124572|FG002|STARTED|Overall Study||9||
48325978|NCT01632566|101124573|FG003|STARTED|Overall Study||6||
48325979|NCT01632566|101124574|FG004|STARTED|Overall Study||6||
48325980|NCT01632566|101124570|FG000|Received at Least One Dose LY3031207|Overall Study||8||
48325981|NCT01632566|101124571|FG001|Received at Least One Dose LY3031207|Overall Study||10||
48163291|NCT02713711|100721809|FG002|STARTED|Overall Study||6|14 participants and 58 total psoriatic plaques divided in the 4 groups.|14
48163292|NCT02713711|100721810|FG003|STARTED|Overall Study||10|14 participants and 58 total psoriatic plaques divided in the 4 groups.|15
48163293|NCT02713711|100721807|FG000|COMPLETED|Overall Study||9||14
48163294|NCT02713711|100721808|FG001|COMPLETED|Overall Study||6||15
48163295|NCT02713711|100721809|FG002|COMPLETED|Overall Study||6||14
48163296|NCT02713711|100721810|FG003|COMPLETED|Overall Study||10||15
48163297|NCT02713711|100721807|FG000|NOT COMPLETED|Overall Study||0||0
48325982|NCT01632566|101124572|FG002|Received at Least One Dose LY3031207|Overall Study||9||
48368067|NCT03691623|101230100|FG004|Received Treatment|Overall Study||21||
48325983|NCT01632566|101124573|FG003|Received at Least One Dose LY3031207|Overall Study||0||
48325984|NCT01632566|101124574|FG004|Received at Least One Dose LY3031207|Overall Study||0||
48325985|NCT01632566|101124570|FG000|Received at Least One Dose Simvastatin|Overall Study||0||
48325986|NCT01632566|101124571|FG001|Received at Least One Dose Simvastatin|Overall Study||10||
48325987|NCT01632566|101124572|FG002|Received at Least One Dose Simvastatin|Overall Study||9||
48325988|NCT01632566|101124573|FG003|Received at Least One Dose Simvastatin|Overall Study||4||
48325989|NCT01632566|101124574|FG004|Received at Least One Dose Simvastatin|Overall Study||4||
48325990|NCT01632566|101124570|FG000|COMPLETED|Overall Study||8||
48325991|NCT01632566|101124571|FG001|COMPLETED|Overall Study||7||
48325992|NCT01632566|101124572|FG002|COMPLETED|Overall Study||0||
48325993|NCT01632566|101124573|FG003|COMPLETED|Overall Study||4||
48325994|NCT01632566|101124574|FG004|COMPLETED|Overall Study||4||
48325995|NCT01632566|101124570|FG000|NOT COMPLETED|Overall Study||0||
48325996|NCT01632566|101124571|FG001|NOT COMPLETED|Overall Study||3||
48325997|NCT01632566|101124572|FG002|NOT COMPLETED|Overall Study||9||
48325998|NCT01632566|101124573|FG003|NOT COMPLETED|Overall Study||2||
48325999|NCT01632566|101124574|FG004|NOT COMPLETED|Overall Study||2||
48326000|NCT00980200|101124575|FG000|STARTED|7-day Treatment Period 1||15||
48326001|NCT00980200|101124576|FG001|STARTED|7-day Treatment Period 1||14||
48326002|NCT00980200|101124577|FG002|STARTED|7-day Treatment Period 1||15||
48326003|NCT00980200|101124578|FG003|STARTED|7-day Treatment Period 1||16||
48326004|NCT00980200|101124579|FG004|STARTED|7-day Treatment Period 1||15||
48326005|NCT00980200|101124575|FG000|COMPLETED|7-day Treatment Period 1||15||
48326006|NCT00980200|101124576|FG001|COMPLETED|7-day Treatment Period 1||13||
48326007|NCT00980200|101124577|FG002|COMPLETED|7-day Treatment Period 1||15||
48326008|NCT00980200|101124578|FG003|COMPLETED|7-day Treatment Period 1||16||
48326009|NCT00980200|101124579|FG004|COMPLETED|7-day Treatment Period 1||15||
48326010|NCT00980200|101124575|FG000|NOT COMPLETED|7-day Treatment Period 1||0||
48326011|NCT00980200|101124576|FG001|NOT COMPLETED|7-day Treatment Period 1||1||
48326012|NCT00980200|101124577|FG002|NOT COMPLETED|7-day Treatment Period 1||0||
48326013|NCT00980200|101124578|FG003|NOT COMPLETED|7-day Treatment Period 1||0||
48326014|NCT00980200|101124579|FG004|NOT COMPLETED|7-day Treatment Period 1||0||
48326015|NCT00980200|101124575|FG000|STARTED|7-day Washout Period 1||15||
48326016|NCT00980200|101124576|FG001|STARTED|7-day Washout Period 1||13||
48326017|NCT00980200|101124577|FG002|STARTED|7-day Washout Period 1||15||
48326018|NCT00980200|101124578|FG003|STARTED|7-day Washout Period 1||16||
48326019|NCT00980200|101124579|FG004|STARTED|7-day Washout Period 1||15||
48326020|NCT00980200|101124575|FG000|COMPLETED|7-day Washout Period 1||15||
48619575|NCT00583908|101853136|FG007|COMPLETED|Period 4 - Fourth Intervention||1||
48619576|NCT00583908|101853137|FG008|COMPLETED|Period 4 - Fourth Intervention||1||
48326021|NCT00980200|101124576|FG001|COMPLETED|7-day Washout Period 1||13||
48326022|NCT00980200|101124577|FG002|COMPLETED|7-day Washout Period 1||15||
48326023|NCT00980200|101124578|FG003|COMPLETED|7-day Washout Period 1||16||
48326024|NCT00980200|101124579|FG004|COMPLETED|7-day Washout Period 1||15||
48326025|NCT00980200|101124575|FG000|NOT COMPLETED|7-day Washout Period 1||0||
48326026|NCT00980200|101124576|FG001|NOT COMPLETED|7-day Washout Period 1||0||
48326027|NCT00980200|101124577|FG002|NOT COMPLETED|7-day Washout Period 1||0||
48326028|NCT00980200|101124578|FG003|NOT COMPLETED|7-day Washout Period 1||0||
48326029|NCT00980200|101124579|FG004|NOT COMPLETED|7-day Washout Period 1||0||
48326030|NCT00980200|101124575|FG000|STARTED|7-day Treatment Period 2||15||
48326031|NCT00980200|101124576|FG001|STARTED|7-day Treatment Period 2||13||
48326032|NCT00980200|101124577|FG002|STARTED|7-day Treatment Period 2||15||
48326033|NCT00980200|101124578|FG003|STARTED|7-day Treatment Period 2||16||
48326034|NCT00980200|101124579|FG004|STARTED|7-day Treatment Period 2||15||
48326035|NCT00980200|101124575|FG000|COMPLETED|7-day Treatment Period 2||15||
48326036|NCT00980200|101124576|FG001|COMPLETED|7-day Treatment Period 2||13||
48326037|NCT00980200|101124577|FG002|COMPLETED|7-day Treatment Period 2||15||
48326038|NCT00980200|101124578|FG003|COMPLETED|7-day Treatment Period 2||16||
48326039|NCT00980200|101124579|FG004|COMPLETED|7-day Treatment Period 2||15||
48326040|NCT00980200|101124575|FG000|NOT COMPLETED|7-day Treatment Period 2||0||
48326041|NCT00980200|101124576|FG001|NOT COMPLETED|7-day Treatment Period 2||0||
48326042|NCT00980200|101124577|FG002|NOT COMPLETED|7-day Treatment Period 2||0||
48619577|NCT00583908|101853138|FG009|COMPLETED|Period 4 - Fourth Intervention||1||
48326043|NCT00980200|101124578|FG003|NOT COMPLETED|7-day Treatment Period 2||0||
48326044|NCT00980200|101124579|FG004|NOT COMPLETED|7-day Treatment Period 2||0||
48326045|NCT00980200|101124575|FG000|STARTED|7-day Washout Period 2||15||
48326046|NCT00980200|101124576|FG001|STARTED|7-day Washout Period 2||13||
48326047|NCT00980200|101124577|FG002|STARTED|7-day Washout Period 2||15||
48326048|NCT00980200|101124578|FG003|STARTED|7-day Washout Period 2||16||
48326049|NCT00980200|101124579|FG004|STARTED|7-day Washout Period 2||15||
48326050|NCT00980200|101124575|FG000|COMPLETED|7-day Washout Period 2||15||
48326051|NCT00980200|101124576|FG001|COMPLETED|7-day Washout Period 2||13||
48326052|NCT00980200|101124577|FG002|COMPLETED|7-day Washout Period 2||15||
48326053|NCT00980200|101124578|FG003|COMPLETED|7-day Washout Period 2||16||
48326054|NCT00980200|101124579|FG004|COMPLETED|7-day Washout Period 2||15||
48619578|NCT00583908|101853139|FG010|COMPLETED|Period 4 - Fourth Intervention||1||
48619579|NCT00583908|101853140|FG011|COMPLETED|Period 4 - Fourth Intervention||1||
48657103|NCT03761914|101943780|FG002|STARTED|Overall Study||0||
48326055|NCT00980200|101124575|FG000|NOT COMPLETED|7-day Washout Period 2||0||
48326056|NCT00980200|101124576|FG001|NOT COMPLETED|7-day Washout Period 2||0||
48326057|NCT00980200|101124577|FG002|NOT COMPLETED|7-day Washout Period 2||0||
48326058|NCT00980200|101124578|FG003|NOT COMPLETED|7-day Washout Period 2||0||
48326059|NCT00980200|101124579|FG004|NOT COMPLETED|7-day Washout Period 2||0||
48326060|NCT00980200|101124575|FG000|STARTED|7-day Treatment Period 3||15||
48326061|NCT00980200|101124576|FG001|STARTED|7-day Treatment Period 3||13||
48326062|NCT00980200|101124577|FG002|STARTED|7-day Treatment Period 3||15||
48326063|NCT00980200|101124578|FG003|STARTED|7-day Treatment Period 3||16||
48326064|NCT00980200|101124579|FG004|STARTED|7-day Treatment Period 3||15||
48326065|NCT00980200|101124575|FG000|COMPLETED|7-day Treatment Period 3||15||
48326066|NCT00980200|101124576|FG001|COMPLETED|7-day Treatment Period 3||12||
48326067|NCT00980200|101124577|FG002|COMPLETED|7-day Treatment Period 3||15||
48326068|NCT00980200|101124578|FG003|COMPLETED|7-day Treatment Period 3||16||
48326069|NCT00980200|101124579|FG004|COMPLETED|7-day Treatment Period 3||14||
48326070|NCT00980200|101124575|FG000|NOT COMPLETED|7-day Treatment Period 3||0||
48326071|NCT00980200|101124576|FG001|NOT COMPLETED|7-day Treatment Period 3||1||
48326072|NCT00980200|101124577|FG002|NOT COMPLETED|7-day Treatment Period 3||0||
48326073|NCT00980200|101124578|FG003|NOT COMPLETED|7-day Treatment Period 3||0||
48326074|NCT00980200|101124579|FG004|NOT COMPLETED|7-day Treatment Period 3||1||
48326075|NCT00980200|101124575|FG000|STARTED|7-day Washout Period 3||15||
48326076|NCT00980200|101124576|FG001|STARTED|7-day Washout Period 3||12||
48326077|NCT00980200|101124577|FG002|STARTED|7-day Washout Period 3||15||
48326078|NCT00980200|101124578|FG003|STARTED|7-day Washout Period 3||16||
48326079|NCT00980200|101124579|FG004|STARTED|7-day Washout Period 3||14||
48326080|NCT00980200|101124575|FG000|COMPLETED|7-day Washout Period 3||15||
48326081|NCT00980200|101124576|FG001|COMPLETED|7-day Washout Period 3||12||
48326082|NCT00980200|101124577|FG002|COMPLETED|7-day Washout Period 3||15||
48326083|NCT00980200|101124578|FG003|COMPLETED|7-day Washout Period 3||16||
48619580|NCT00583908|101853129|FG000|NOT COMPLETED|Period 4 - Fourth Intervention||0||
48619581|NCT00583908|101853130|FG001|NOT COMPLETED|Period 4 - Fourth Intervention||0||
48619582|NCT00583908|101853131|FG002|NOT COMPLETED|Period 4 - Fourth Intervention||0||
48619583|NCT00583908|101853132|FG003|NOT COMPLETED|Period 4 - Fourth Intervention||0||
48619584|NCT00583908|101853133|FG004|NOT COMPLETED|Period 4 - Fourth Intervention||0||
48619585|NCT00583908|101853134|FG005|NOT COMPLETED|Period 4 - Fourth Intervention||0||
48619586|NCT00583908|101853135|FG006|NOT COMPLETED|Period 4 - Fourth Intervention||0||
48619587|NCT00583908|101853136|FG007|NOT COMPLETED|Period 4 - Fourth Intervention||0||
48619588|NCT00583908|101853137|FG008|NOT COMPLETED|Period 4 - Fourth Intervention||0||
48619589|NCT00583908|101853138|FG009|NOT COMPLETED|Period 4 - Fourth Intervention||0||
48619590|NCT00583908|101853139|FG010|NOT COMPLETED|Period 4 - Fourth Intervention||0||
48619591|NCT00583908|101853140|FG011|NOT COMPLETED|Period 4 - Fourth Intervention||0||
48619592|NCT04158219|101853141|FG000|STARTED|Overall Study||8||
48619593|NCT04158219|101853141|FG000|COMPLETED|Overall Study||7||
48619594|NCT04158219|101853141|FG000|NOT COMPLETED|Overall Study||1||
48619595|NCT01038687|101853142|FG000|STARTED|Overall Study||12||
48619596|NCT01038687|101853143|FG001|STARTED|Overall Study||11||
48619597|NCT01038687|101853144|FG002|STARTED|Overall Study||13||
48619598|NCT01038687|101853142|FG000|COMPLETED|Overall Study||12||
48619599|NCT01038687|101853143|FG001|COMPLETED|Overall Study||9||
48619600|NCT01038687|101853144|FG002|COMPLETED|Overall Study||12||
48619601|NCT01038687|101853142|FG000|NOT COMPLETED|Overall Study||0||
48619602|NCT01038687|101853143|FG001|NOT COMPLETED|Overall Study||2||
48619603|NCT01038687|101853144|FG002|NOT COMPLETED|Overall Study||1||
48619604|NCT00596102|101853145|FG000|STARTED|Up to Month 6||2283||
48619605|NCT00596102|101853146|FG001|STARTED|Up to Month 6||338||
48326084|NCT00980200|101124579|FG004|COMPLETED|7-day Washout Period 3||14||
48326085|NCT00980200|101124575|FG000|NOT COMPLETED|7-day Washout Period 3||0||
48326086|NCT00980200|101124576|FG001|NOT COMPLETED|7-day Washout Period 3||0||
48326087|NCT00980200|101124577|FG002|NOT COMPLETED|7-day Washout Period 3||0||
48326088|NCT00980200|101124578|FG003|NOT COMPLETED|7-day Washout Period 3||0||
48326089|NCT00980200|101124579|FG004|NOT COMPLETED|7-day Washout Period 3||0||
48326090|NCT00980200|101124575|FG000|STARTED|7-day Treatment Period 4||15||
48326091|NCT00980200|101124576|FG001|STARTED|7-day Treatment Period 4||12||
48326092|NCT00980200|101124577|FG002|STARTED|7-day Treatment Period 4||15||
48326093|NCT00980200|101124578|FG003|STARTED|7-day Treatment Period 4||16||
48326094|NCT00980200|101124579|FG004|STARTED|7-day Treatment Period 4||14||
48326095|NCT00980200|101124575|FG000|COMPLETED|7-day Treatment Period 4||15||
48619606|NCT00596102|101853147|FG002|STARTED|Up to Month 6||637||
48619607|NCT00596102|101853145|FG000|COMPLETED|Up to Month 6||2283||
48619608|NCT00596102|101853146|FG001|COMPLETED|Up to Month 6||338||
48619609|NCT00596102|101853147|FG002|COMPLETED|Up to Month 6||637||
48619610|NCT00596102|101853145|FG000|NOT COMPLETED|Up to Month 6||0||
48619611|NCT00596102|101853146|FG001|NOT COMPLETED|Up to Month 6||0||
48619612|NCT00596102|101853147|FG002|NOT COMPLETED|Up to Month 6||0||
48619613|NCT00596102|101853145|FG000|STARTED|Up to Month 60||2283||
48619614|NCT00596102|101853146|FG001|STARTED|Up to Month 60||338||
48619615|NCT00596102|101853147|FG002|STARTED|Up to Month 60||637||
48619616|NCT00596102|101853145|FG000|COMPLETED|Up to Month 60||102||
48619617|NCT00596102|101853146|FG001|COMPLETED|Up to Month 60||0||
48619618|NCT00596102|101853147|FG002|COMPLETED|Up to Month 60||0||
48619619|NCT00596102|101853145|FG000|NOT COMPLETED|Up to Month 60||2181||
48619620|NCT00596102|101853146|FG001|NOT COMPLETED|Up to Month 60||338||
48619621|NCT00596102|101853147|FG002|NOT COMPLETED|Up to Month 60||637||
48619622|NCT01540513|101853148|FG000|STARTED|Overall Study||12||
48619623|NCT01540513|101853148|FG000|COMPLETED|Overall Study||12||
48619624|NCT01540513|101853148|FG000|NOT COMPLETED|Overall Study||0||
48619625|NCT04346199|101853149|FG000|STARTED|Overall Study||89||
48619626|NCT04346199|101853150|FG001|STARTED|Overall Study||88||
48619627|NCT04346199|101853149|FG000|COMPLETED|Overall Study||74||
48619628|NCT04346199|101853150|FG001|COMPLETED|Overall Study||77||
48619629|NCT04346199|101853149|FG000|NOT COMPLETED|Overall Study||15||
48619630|NCT04346199|101853150|FG001|NOT COMPLETED|Overall Study||11||
48619631|NCT01533116|101853151|FG000|STARTED|Overall Study||14||
48619632|NCT01533116|101853152|FG001|STARTED|Overall Study||13||
48619633|NCT01533116|101853153|FG002|STARTED|Overall Study||13||
48619634|NCT01533116|101853154|FG003|STARTED|Overall Study||12||
48619635|NCT01533116|101853151|FG000|COMPLETED|Overall Study||12||
48619636|NCT01533116|101853152|FG001|COMPLETED|Overall Study||12||
48619637|NCT01533116|101853153|FG002|COMPLETED|Overall Study||12||
48619638|NCT01533116|101853154|FG003|COMPLETED|Overall Study||12||
48619639|NCT01533116|101853151|FG000|NOT COMPLETED|Overall Study||2||
48619640|NCT01533116|101853152|FG001|NOT COMPLETED|Overall Study||1||
48619641|NCT01533116|101853153|FG002|NOT COMPLETED|Overall Study||1||
48619642|NCT01533116|101853154|FG003|NOT COMPLETED|Overall Study||0||
48619643|NCT02288819|101853155|FG000|STARTED|Overall Study||50||
48619644|NCT02288819|101853155|FG000|COMPLETED|Overall Study||50||
48619645|NCT02288819|101853155|FG000|NOT COMPLETED|Overall Study||0||
48619646|NCT03718429|101853156|FG000|STARTED|Baseline Treatment||20||
48619647|NCT03718429|101853157|FG001|STARTED|Baseline Treatment||21||
48619648|NCT03718429|101853158|FG002|STARTED|Baseline Treatment||21||
48619649|NCT03718429|101853159|FG003|STARTED|Baseline Treatment||20||
48619650|NCT03718429|101853156|FG000|COMPLETED|Baseline Treatment||20||
48619651|NCT03718429|101853157|FG001|COMPLETED|Baseline Treatment||21||
48619652|NCT03718429|101853158|FG002|COMPLETED|Baseline Treatment||21||
48619653|NCT03718429|101853159|FG003|COMPLETED|Baseline Treatment||20||
48619654|NCT03718429|101853156|FG000|NOT COMPLETED|Baseline Treatment||0||
48619655|NCT03718429|101853157|FG001|NOT COMPLETED|Baseline Treatment||0||
48619656|NCT03718429|101853158|FG002|NOT COMPLETED|Baseline Treatment||0||
48619657|NCT03718429|101853159|FG003|NOT COMPLETED|Baseline Treatment||0||
48619658|NCT03718429|101853156|FG000|STARTED|Adjunctive Rivaroxaban 2.5 mg||20||
48619659|NCT03718429|101853157|FG001|STARTED|Adjunctive Rivaroxaban 2.5 mg||21||
48619660|NCT03718429|101853158|FG002|STARTED|Adjunctive Rivaroxaban 2.5 mg||21||
48619661|NCT03718429|101853159|FG003|STARTED|Adjunctive Rivaroxaban 2.5 mg||0||
48619662|NCT03718429|101853156|FG000|COMPLETED|Adjunctive Rivaroxaban 2.5 mg||20||
48619663|NCT03718429|101853157|FG001|COMPLETED|Adjunctive Rivaroxaban 2.5 mg||20||
48619664|NCT03718429|101853158|FG002|COMPLETED|Adjunctive Rivaroxaban 2.5 mg||20||
48619665|NCT03718429|101853159|FG003|COMPLETED|Adjunctive Rivaroxaban 2.5 mg||0||
48619666|NCT03718429|101853156|FG000|NOT COMPLETED|Adjunctive Rivaroxaban 2.5 mg||0||
48619667|NCT03718429|101853157|FG001|NOT COMPLETED|Adjunctive Rivaroxaban 2.5 mg||1||
48619668|NCT03718429|101853158|FG002|NOT COMPLETED|Adjunctive Rivaroxaban 2.5 mg||1||
48619669|NCT03718429|101853159|FG003|NOT COMPLETED|Adjunctive Rivaroxaban 2.5 mg||0||
48619670|NCT03718429|101853156|FG000|STARTED|Stopping Aspirin||20||
48619671|NCT03718429|101853157|FG001|STARTED|Stopping Aspirin||20||
48619672|NCT03718429|101853158|FG002|STARTED|Stopping Aspirin||20||
48619673|NCT03718429|101853159|FG003|STARTED|Stopping Aspirin||0||
48619674|NCT03718429|101853156|FG000|COMPLETED|Stopping Aspirin||20||
48619675|NCT03718429|101853157|FG001|COMPLETED|Stopping Aspirin||20||
48619676|NCT03718429|101853158|FG002|COMPLETED|Stopping Aspirin||20||
48619677|NCT03718429|101853159|FG003|COMPLETED|Stopping Aspirin||0||
48619678|NCT03718429|101853156|FG000|NOT COMPLETED|Stopping Aspirin||0||
48619679|NCT03718429|101853157|FG001|NOT COMPLETED|Stopping Aspirin||0||
48619680|NCT03718429|101853158|FG002|NOT COMPLETED|Stopping Aspirin||0||
48619681|NCT03718429|101853159|FG003|NOT COMPLETED|Stopping Aspirin||0||
48619682|NCT01063855|101853160|FG000|STARTED|Overall Study||245||
48619683|NCT01063855|101853161|FG001|STARTED|Overall Study||250||
48619684|NCT01063855|101853160|FG000|COMPLETED|Overall Study||208||
48619685|NCT01063855|101853161|FG001|COMPLETED|Overall Study||221||
48619686|NCT01063855|101853160|FG000|NOT COMPLETED|Overall Study||37||
48619687|NCT01063855|101853161|FG001|NOT COMPLETED|Overall Study||29||
48619688|NCT01062308|101853162|FG000|STARTED|Overall Study||80||
48619689|NCT01062308|101853163|FG001|STARTED|Overall Study||82||
48619690|NCT01062308|101853162|FG000|COMPLETED|Overall Study||64||
48619691|NCT01062308|101853163|FG001|COMPLETED|Overall Study||72||
48619692|NCT01062308|101853162|FG000|NOT COMPLETED|Overall Study||16||
48619693|NCT01062308|101853163|FG001|NOT COMPLETED|Overall Study||10||
48619694|NCT00689338|101853164|FG000|STARTED|Overall Study||216||
48619695|NCT00689338|101853164|FG000|COMPLETED|Overall Study||73||
48619696|NCT00689338|101853164|FG000|NOT COMPLETED|Overall Study||143||
48619697|NCT03327324|101853165|FG000|STARTED|Baseline (Month 0-Month 3)||18||
48619698|NCT03327324|101853166|FG001|STARTED|Baseline (Month 0-Month 3)||20||
48619699|NCT03327324|101853167|FG002|STARTED|Baseline (Month 0-Month 3)||9||
48619700|NCT03327324|101853168|FG003|STARTED|Baseline (Month 0-Month 3)||10||
48619701|NCT03327324|101853169|FG004|STARTED|Baseline (Month 0-Month 3)||15||
48619702|NCT03327324|101853170|FG005|STARTED|Baseline (Month 0-Month 3)||20||
48619703|NCT03327324|101853165|FG000|COMPLETED|Baseline (Month 0-Month 3)||18||
48619704|NCT03327324|101853166|FG001|COMPLETED|Baseline (Month 0-Month 3)||17||
48619705|NCT03327324|101853167|FG002|COMPLETED|Baseline (Month 0-Month 3)||9||
48619706|NCT03327324|101853168|FG003|COMPLETED|Baseline (Month 0-Month 3)||9||
48619707|NCT03327324|101853169|FG004|COMPLETED|Baseline (Month 0-Month 3)||13||
48619708|NCT03327324|101853170|FG005|COMPLETED|Baseline (Month 0-Month 3)||14||
48619709|NCT03327324|101853165|FG000|NOT COMPLETED|Baseline (Month 0-Month 3)||0||
48619710|NCT03327324|101853166|FG001|NOT COMPLETED|Baseline (Month 0-Month 3)||3||
48619711|NCT03327324|101853167|FG002|NOT COMPLETED|Baseline (Month 0-Month 3)||0||
48619712|NCT03327324|101853168|FG003|NOT COMPLETED|Baseline (Month 0-Month 3)||1||
48619713|NCT03327324|101853169|FG004|NOT COMPLETED|Baseline (Month 0-Month 3)||2||
48619714|NCT03327324|101853170|FG005|NOT COMPLETED|Baseline (Month 0-Month 3)||6||
48619715|NCT03327324|101853165|FG000|STARTED|Intervention (Month 3-Month 6)||18||
48619716|NCT03327324|101853166|FG001|STARTED|Intervention (Month 3-Month 6)||17||
48619717|NCT03327324|101853167|FG002|STARTED|Intervention (Month 3-Month 6)||9||
48619718|NCT03327324|101853168|FG003|STARTED|Intervention (Month 3-Month 6)||9||
48619719|NCT03327324|101853169|FG004|STARTED|Intervention (Month 3-Month 6)||13||
48619720|NCT03327324|101853170|FG005|STARTED|Intervention (Month 3-Month 6)||14||
48619721|NCT03327324|101853165|FG000|COMPLETED|Intervention (Month 3-Month 6)||13||
48619722|NCT03327324|101853166|FG001|COMPLETED|Intervention (Month 3-Month 6)||16||
48619723|NCT03327324|101853167|FG002|COMPLETED|Intervention (Month 3-Month 6)||6||
48619724|NCT03327324|101853168|FG003|COMPLETED|Intervention (Month 3-Month 6)||8||
48619725|NCT03327324|101853169|FG004|COMPLETED|Intervention (Month 3-Month 6)||11||
48619726|NCT03327324|101853170|FG005|COMPLETED|Intervention (Month 3-Month 6)||0||
48619727|NCT03327324|101853165|FG000|NOT COMPLETED|Intervention (Month 3-Month 6)||5||
48619728|NCT03327324|101853166|FG001|NOT COMPLETED|Intervention (Month 3-Month 6)||1||
48619729|NCT03327324|101853167|FG002|NOT COMPLETED|Intervention (Month 3-Month 6)||3||
48619730|NCT03327324|101853168|FG003|NOT COMPLETED|Intervention (Month 3-Month 6)||1||
48619731|NCT03327324|101853169|FG004|NOT COMPLETED|Intervention (Month 3-Month 6)||2||
48619732|NCT03327324|101853170|FG005|NOT COMPLETED|Intervention (Month 3-Month 6)||14||
48619733|NCT03327324|101853165|FG000|STARTED|Sustainability Follow-Up 1 (Month 6-9)||13||
48619734|NCT03327324|101853166|FG001|STARTED|Sustainability Follow-Up 1 (Month 6-9)||16||
48619735|NCT03327324|101853167|FG002|STARTED|Sustainability Follow-Up 1 (Month 6-9)||6||
48619736|NCT03327324|101853168|FG003|STARTED|Sustainability Follow-Up 1 (Month 6-9)||8||
48619737|NCT03327324|101853169|FG004|STARTED|Sustainability Follow-Up 1 (Month 6-9)||11||
48619738|NCT03327324|101853170|FG005|STARTED|Sustainability Follow-Up 1 (Month 6-9)||0||
48619739|NCT03327324|101853165|FG000|COMPLETED|Sustainability Follow-Up 1 (Month 6-9)||9||
48619740|NCT03327324|101853166|FG001|COMPLETED|Sustainability Follow-Up 1 (Month 6-9)||14||
48619741|NCT03327324|101853167|FG002|COMPLETED|Sustainability Follow-Up 1 (Month 6-9)||5||
48619742|NCT03327324|101853168|FG003|COMPLETED|Sustainability Follow-Up 1 (Month 6-9)||5||
48619743|NCT03327324|101853169|FG004|COMPLETED|Sustainability Follow-Up 1 (Month 6-9)||6||
48619744|NCT03327324|101853170|FG005|COMPLETED|Sustainability Follow-Up 1 (Month 6-9)||0||
48619745|NCT03327324|101853165|FG000|NOT COMPLETED|Sustainability Follow-Up 1 (Month 6-9)||4||
48619746|NCT03327324|101853166|FG001|NOT COMPLETED|Sustainability Follow-Up 1 (Month 6-9)||2||
48619747|NCT03327324|101853167|FG002|NOT COMPLETED|Sustainability Follow-Up 1 (Month 6-9)||1||
48619748|NCT03327324|101853168|FG003|NOT COMPLETED|Sustainability Follow-Up 1 (Month 6-9)||3||
48619749|NCT03327324|101853169|FG004|NOT COMPLETED|Sustainability Follow-Up 1 (Month 6-9)||5||
48619750|NCT03327324|101853170|FG005|NOT COMPLETED|Sustainability Follow-Up 1 (Month 6-9)||0||
48619751|NCT03327324|101853165|FG000|STARTED|Sustainability Follow-Up 2 (Month 9-12)||9||
48619752|NCT03327324|101853166|FG001|STARTED|Sustainability Follow-Up 2 (Month 9-12)||14||
48619753|NCT03327324|101853167|FG002|STARTED|Sustainability Follow-Up 2 (Month 9-12)||2||
48619754|NCT03327324|101853168|FG003|STARTED|Sustainability Follow-Up 2 (Month 9-12)||0||
48619755|NCT03327324|101853169|FG004|STARTED|Sustainability Follow-Up 2 (Month 9-12)||0||
48619756|NCT03327324|101853170|FG005|STARTED|Sustainability Follow-Up 2 (Month 9-12)||0||
48742984|NCT03030417|102155186|FG012|COMPLETED|Dose Expansion||0||
48619757|NCT03327324|101853165|FG000|COMPLETED|Sustainability Follow-Up 2 (Month 9-12)||7||
48619758|NCT03327324|101853166|FG001|COMPLETED|Sustainability Follow-Up 2 (Month 9-12)||14||
48619759|NCT03327324|101853167|FG002|COMPLETED|Sustainability Follow-Up 2 (Month 9-12)||2||
48619760|NCT03327324|101853168|FG003|COMPLETED|Sustainability Follow-Up 2 (Month 9-12)||0||
48619761|NCT03327324|101853169|FG004|COMPLETED|Sustainability Follow-Up 2 (Month 9-12)||0||
48619762|NCT03327324|101853170|FG005|COMPLETED|Sustainability Follow-Up 2 (Month 9-12)||0||
48619763|NCT03327324|101853165|FG000|NOT COMPLETED|Sustainability Follow-Up 2 (Month 9-12)||2||
48619764|NCT03327324|101853166|FG001|NOT COMPLETED|Sustainability Follow-Up 2 (Month 9-12)||0||
48619765|NCT03327324|101853167|FG002|NOT COMPLETED|Sustainability Follow-Up 2 (Month 9-12)||0||
48742985|NCT03030417|102155174|FG000|NOT COMPLETED|Dose Expansion||0||
48742986|NCT03030417|102155175|FG001|NOT COMPLETED|Dose Expansion||0||
48619766|NCT03327324|101853168|FG003|NOT COMPLETED|Sustainability Follow-Up 2 (Month 9-12)||0||
48619767|NCT03327324|101853169|FG004|NOT COMPLETED|Sustainability Follow-Up 2 (Month 9-12)||0||
48657104|NCT03761914|101943781|FG003|STARTED|Overall Study||0||
48619768|NCT03327324|101853170|FG005|NOT COMPLETED|Sustainability Follow-Up 2 (Month 9-12)||0||
48619769|NCT00765856|101853171|FG000|STARTED|Titration Period||27||
48619770|NCT00765856|101853171|FG000|COMPLETED|Titration Period||24||
48619771|NCT00765856|101853171|FG000|NOT COMPLETED|Titration Period||3||
48619772|NCT00765856|101853171|FG000|STARTED|Maintenance Period||24||
48619773|NCT00765856|101853171|FG000|COMPLETED|Maintenance Period||18||
48619774|NCT00765856|101853171|FG000|NOT COMPLETED|Maintenance Period||6||
48619775|NCT01999985|101853172|FG000|STARTED|Overall Study||8||
48619776|NCT01999985|101853173|FG001|STARTED|Overall Study||3||
48619777|NCT01999985|101853174|FG002|STARTED|Overall Study||14||
48619778|NCT01999985|101853172|FG000|COMPLETED|Overall Study||8||
48619779|NCT01999985|101853173|FG001|COMPLETED|Overall Study||3||
48619780|NCT01999985|101853174|FG002|COMPLETED|Overall Study||14||
48619781|NCT01999985|101853172|FG000|NOT COMPLETED|Overall Study||0||
48619782|NCT01999985|101853173|FG001|NOT COMPLETED|Overall Study||0||
48619783|NCT01999985|101853174|FG002|NOT COMPLETED|Overall Study||0||
48619784|NCT03669549|101853175|FG000|STARTED|Overall Study||15||
48619785|NCT03669549|101853175|FG000|COMPLETED|Overall Study||9||
48619786|NCT03669549|101853175|FG000|NOT COMPLETED|Overall Study||6||
48619787|NCT00606307|101853176|FG000|STARTED|Overall Study||29||
48619788|NCT00606307|101853176|FG000|COMPLETED|Overall Study||18||
48619789|NCT00606307|101853176|FG000|NOT COMPLETED|Overall Study||11||
48619790|NCT02221648|101853177|FG000|STARTED|Overall Study||22||
48619791|NCT02221648|101853178|FG001|STARTED|Overall Study||21||
48619792|NCT02221648|101853177|FG000|COMPLETED|Overall Study||19||
48619793|NCT02221648|101853178|FG001|COMPLETED|Overall Study||18||
48619794|NCT02221648|101853177|FG000|NOT COMPLETED|Overall Study||3||
48619795|NCT02221648|101853178|FG001|NOT COMPLETED|Overall Study||3||
48619796|NCT01223404|101853179|FG000|STARTED|First Intervention (1 Day)||4||
48619797|NCT01223404|101853180|FG001|STARTED|First Intervention (1 Day)||3||
48619798|NCT01223404|101853181|FG002|STARTED|First Intervention (1 Day)||4||
48619799|NCT01223404|101853182|FG003|STARTED|First Intervention (1 Day)||5||
48619800|NCT01223404|101853183|FG004|STARTED|First Intervention (1 Day)||2||
48619801|NCT01223404|101853184|FG005|STARTED|First Intervention (1 Day)||3||
48619802|NCT01223404|101853179|FG000|COMPLETED|First Intervention (1 Day)||4||
48619803|NCT01223404|101853180|FG001|COMPLETED|First Intervention (1 Day)||3||
48619804|NCT01223404|101853181|FG002|COMPLETED|First Intervention (1 Day)||4||
48619805|NCT01223404|101853182|FG003|COMPLETED|First Intervention (1 Day)||4||
48619806|NCT01223404|101853183|FG004|COMPLETED|First Intervention (1 Day)||2||
48619807|NCT01223404|101853184|FG005|COMPLETED|First Intervention (1 Day)||3||
48619808|NCT01223404|101853179|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48619809|NCT01223404|101853180|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48619810|NCT01223404|101853181|FG002|NOT COMPLETED|First Intervention (1 Day)||0||
48619811|NCT01223404|101853182|FG003|NOT COMPLETED|First Intervention (1 Day)||1||
48619812|NCT01223404|101853183|FG004|NOT COMPLETED|First Intervention (1 Day)||0||
48619813|NCT01223404|101853184|FG005|NOT COMPLETED|First Intervention (1 Day)||0||
48619814|NCT01223404|101853179|FG000|STARTED|Second Intervention (1 Day)||4||
48619815|NCT01223404|101853180|FG001|STARTED|Second Intervention (1 Day)||3||
48619816|NCT01223404|101853181|FG002|STARTED|Second Intervention (1 Day)||4||
48326096|NCT00980200|101124576|FG001|COMPLETED|7-day Treatment Period 4||12||
48326097|NCT00980200|101124577|FG002|COMPLETED|7-day Treatment Period 4||15||
48326098|NCT00980200|101124578|FG003|COMPLETED|7-day Treatment Period 4||16||
48326099|NCT00980200|101124579|FG004|COMPLETED|7-day Treatment Period 4||14||
48619817|NCT01223404|101853182|FG003|STARTED|Second Intervention (1 Day)||4||
48619818|NCT01223404|101853183|FG004|STARTED|Second Intervention (1 Day)||2||
48619819|NCT01223404|101853184|FG005|STARTED|Second Intervention (1 Day)||3||
48619820|NCT01223404|101853179|FG000|COMPLETED|Second Intervention (1 Day)||3||
48619821|NCT01223404|101853180|FG001|COMPLETED|Second Intervention (1 Day)||3||
48619822|NCT01223404|101853181|FG002|COMPLETED|Second Intervention (1 Day)||4||
48619823|NCT01223404|101853182|FG003|COMPLETED|Second Intervention (1 Day)||4||
48619824|NCT01223404|101853183|FG004|COMPLETED|Second Intervention (1 Day)||2||
48619825|NCT01223404|101853184|FG005|COMPLETED|Second Intervention (1 Day)||3||
48619826|NCT01223404|101853179|FG000|NOT COMPLETED|Second Intervention (1 Day)||1||
48619827|NCT01223404|101853180|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48619828|NCT01223404|101853181|FG002|NOT COMPLETED|Second Intervention (1 Day)||0||
48619829|NCT01223404|101853182|FG003|NOT COMPLETED|Second Intervention (1 Day)||0||
48619830|NCT01223404|101853183|FG004|NOT COMPLETED|Second Intervention (1 Day)||0||
48619831|NCT01223404|101853184|FG005|NOT COMPLETED|Second Intervention (1 Day)||0||
48619832|NCT01223404|101853179|FG000|STARTED|Third Intervention (1 Day)||3||
48619833|NCT01223404|101853180|FG001|STARTED|Third Intervention (1 Day)||3||
48619834|NCT01223404|101853181|FG002|STARTED|Third Intervention (1 Day)||4||
48619835|NCT01223404|101853182|FG003|STARTED|Third Intervention (1 Day)||4||
48619836|NCT01223404|101853183|FG004|STARTED|Third Intervention (1 Day)||2||
48619837|NCT01223404|101853184|FG005|STARTED|Third Intervention (1 Day)||3||
48619838|NCT01223404|101853179|FG000|COMPLETED|Third Intervention (1 Day)||3||
48619839|NCT01223404|101853180|FG001|COMPLETED|Third Intervention (1 Day)||3||
48326100|NCT00980200|101124575|FG000|NOT COMPLETED|7-day Treatment Period 4||0||
48326101|NCT00980200|101124576|FG001|NOT COMPLETED|7-day Treatment Period 4||0||
48619840|NCT01223404|101853181|FG002|COMPLETED|Third Intervention (1 Day)||4||
48619841|NCT01223404|101853182|FG003|COMPLETED|Third Intervention (1 Day)||3||
48619842|NCT01223404|101853183|FG004|COMPLETED|Third Intervention (1 Day)||2||
48619843|NCT01223404|101853184|FG005|COMPLETED|Third Intervention (1 Day)||3||
48619844|NCT01223404|101853179|FG000|NOT COMPLETED|Third Intervention (1 Day)||0||
48619845|NCT01223404|101853180|FG001|NOT COMPLETED|Third Intervention (1 Day)||0||
48619846|NCT01223404|101853181|FG002|NOT COMPLETED|Third Intervention (1 Day)||0||
48619847|NCT01223404|101853182|FG003|NOT COMPLETED|Third Intervention (1 Day)||1||
48619848|NCT01223404|101853183|FG004|NOT COMPLETED|Third Intervention (1 Day)||0||
48619849|NCT01223404|101853184|FG005|NOT COMPLETED|Third Intervention (1 Day)||0||
48619850|NCT00947310|101856279|FG000|STARTED|Overall Study||514||
48619851|NCT00947310|101856280|FG001|STARTED|Overall Study||500||
48619852|NCT00947310|101856281|FG002|STARTED|Overall Study||486||
48619853|NCT00947310|101856279|FG000|COMPLETED|Overall Study||514||
48619854|NCT00947310|101856280|FG001|COMPLETED|Overall Study||500||
48619855|NCT00947310|101856281|FG002|COMPLETED|Overall Study||486||
48619856|NCT00947310|101856279|FG000|NOT COMPLETED|Overall Study||0||
48619857|NCT00947310|101856280|FG001|NOT COMPLETED|Overall Study||0||
48619858|NCT00947310|101856281|FG002|NOT COMPLETED|Overall Study||0||
48619859|NCT02317991|101856282|FG000|STARTED|Overall Study||65||
48326102|NCT00980200|101124577|FG002|NOT COMPLETED|7-day Treatment Period 4||0||
48326103|NCT00980200|101124578|FG003|NOT COMPLETED|7-day Treatment Period 4||0||
48326104|NCT00980200|101124579|FG004|NOT COMPLETED|7-day Treatment Period 4||0||
48326105|NCT00980200|101124575|FG000|STARTED|7-day Washout Period 4||15||
48326106|NCT00980200|101124576|FG001|STARTED|7-day Washout Period 4||12||
48326107|NCT00980200|101124577|FG002|STARTED|7-day Washout Period 4||15||
48326108|NCT00980200|101124578|FG003|STARTED|7-day Washout Period 4||16||
48326109|NCT00980200|101124579|FG004|STARTED|7-day Washout Period 4||14||
48326110|NCT00980200|101124575|FG000|COMPLETED|7-day Washout Period 4||15||
48326111|NCT00980200|101124576|FG001|COMPLETED|7-day Washout Period 4||12||
48326112|NCT00980200|101124577|FG002|COMPLETED|7-day Washout Period 4||15||
48326113|NCT00980200|101124578|FG003|COMPLETED|7-day Washout Period 4||16||
48326114|NCT00980200|101124579|FG004|COMPLETED|7-day Washout Period 4||14||
48326115|NCT00980200|101124575|FG000|NOT COMPLETED|7-day Washout Period 4||0||
48326116|NCT00980200|101124576|FG001|NOT COMPLETED|7-day Washout Period 4||0||
48326117|NCT00980200|101124577|FG002|NOT COMPLETED|7-day Washout Period 4||0||
48326118|NCT00980200|101124578|FG003|NOT COMPLETED|7-day Washout Period 4||0||
48326119|NCT00980200|101124579|FG004|NOT COMPLETED|7-day Washout Period 4||0||
48326120|NCT00980200|101124575|FG000|STARTED|7-day Treatment Period 5||15||
48326121|NCT00980200|101124576|FG001|STARTED|7-day Treatment Period 5||12||
48326122|NCT00980200|101124577|FG002|STARTED|7-day Treatment Period 5||15||
48326123|NCT00980200|101124578|FG003|STARTED|7-day Treatment Period 5||16||
48326124|NCT00980200|101124579|FG004|STARTED|7-day Treatment Period 5||14||
48326125|NCT00980200|101124575|FG000|COMPLETED|7-day Treatment Period 5||15||
48326126|NCT00980200|101124576|FG001|COMPLETED|7-day Treatment Period 5||12||
48326127|NCT00980200|101124577|FG002|COMPLETED|7-day Treatment Period 5||15||
48326128|NCT00980200|101124578|FG003|COMPLETED|7-day Treatment Period 5||16||
48326129|NCT00980200|101124579|FG004|COMPLETED|7-day Treatment Period 5||14||
48326130|NCT00980200|101124575|FG000|NOT COMPLETED|7-day Treatment Period 5||0||
48326131|NCT00980200|101124576|FG001|NOT COMPLETED|7-day Treatment Period 5||0||
48326132|NCT00980200|101124577|FG002|NOT COMPLETED|7-day Treatment Period 5||0||
48326133|NCT00980200|101124578|FG003|NOT COMPLETED|7-day Treatment Period 5||0||
48326134|NCT00980200|101124579|FG004|NOT COMPLETED|7-day Treatment Period 5||0||
48326135|NCT01344876|101124580|FG000|STARTED|Overall Study||4||
48326136|NCT01344876|101124581|FG001|STARTED|Overall Study||3||
48326137|NCT01344876|101124582|FG002|STARTED|Overall Study||4||
48326138|NCT01344876|101124583|FG003|STARTED|Overall Study||6||
48619860|NCT02317991|101856282|FG000|COMPLETED|Overall Study||0||
48619861|NCT02317991|101856282|FG000|NOT COMPLETED|Overall Study||65||
48619862|NCT04776928|101856283|FG000|STARTED|Overall Study||95||
48619863|NCT04776928|101856284|FG001|STARTED|Overall Study||122||
48619864|NCT04776928|101856283|FG000|COMPLETED|Overall Study||95||
48619865|NCT04776928|101856284|FG001|COMPLETED|Overall Study||122||
48619866|NCT04776928|101856283|FG000|NOT COMPLETED|Overall Study||0||
48619867|NCT04776928|101856284|FG001|NOT COMPLETED|Overall Study||0||
48619868|NCT01316224|101856285|FG000|STARTED|Overall Study||52||
48619869|NCT01316224|101856285|FG000|Completed Visit 1 to Dermatologist|Overall Study||52||
48619870|NCT01316224|101856285|FG000|Completed Visit 1 to Rheumatologist|Overall Study||49||
48619871|NCT01316224|101856285|FG000|Completed Visit 2 to Dermatologist|Overall Study||51||
48619872|NCT01316224|101856285|FG000|Completed Visit 3 to Dermatologist|Overall Study||48||
48619873|NCT01316224|101856285|FG000|Completed Visit 3 to Rheumatologist|Overall Study||39||
48742987|NCT03030417|102155176|FG002|NOT COMPLETED|Dose Expansion||0||
48326139|NCT01344876|101124584|FG004|STARTED|Overall Study||3||
48326140|NCT01344876|101124580|FG000|COMPLETED|Overall Study||3||
48619874|NCT01316224|101856285|FG000|Completed Visit 4 to Dermatologist|Overall Study||42||
48619875|NCT01316224|101856285|FG000|Completed Visit 4 to Rheumatologist|Overall Study||28||
48619876|NCT01316224|101856285|FG000|COMPLETED|Overall Study||42||
48619877|NCT01316224|101856285|FG000|NOT COMPLETED|Overall Study||10||
48619878|NCT04812184|101856286|FG000|STARTED|Overall Study||60||
48619879|NCT04812184|101856287|FG001|STARTED|Overall Study||63||
48326141|NCT01344876|101124581|FG001|COMPLETED|Overall Study||3||
48326142|NCT01344876|101124582|FG002|COMPLETED|Overall Study||3||
48326143|NCT01344876|101124583|FG003|COMPLETED|Overall Study||3||
48326144|NCT01344876|101124584|FG004|COMPLETED|Overall Study||2||
48326145|NCT01344876|101124580|FG000|NOT COMPLETED|Overall Study||1||
48326146|NCT01344876|101124581|FG001|NOT COMPLETED|Overall Study||0||
48326147|NCT01344876|101124582|FG002|NOT COMPLETED|Overall Study||1||
48326148|NCT01344876|101124583|FG003|NOT COMPLETED|Overall Study||3||
48326149|NCT01344876|101124584|FG004|NOT COMPLETED|Overall Study||1||
48326150|NCT03189446|101124585|FG000|STARTED|Overall Study||32||
48326151|NCT03189446|101124585|FG000|COMPLETED|Overall Study||27||
48326152|NCT03189446|101124585|FG000|NOT COMPLETED|Overall Study||5||
48326153|NCT01415427|101124586|FG000|STARTED|Overall Study||29||
48742988|NCT03030417|102155177|FG003|NOT COMPLETED|Dose Expansion||0||
48326154|NCT01415427|101124587|FG001|STARTED|Overall Study||29||
48326155|NCT01415427|101124588|FG002|STARTED|Overall Study||59||
48326156|NCT01415427|101124589|FG003|STARTED|Overall Study||56||
48326157|NCT01415427|101124586|FG000|COMPLETED|Overall Study||0||
48326158|NCT01415427|101124587|FG001|COMPLETED|Overall Study||0||
48326159|NCT01415427|101124588|FG002|COMPLETED|Overall Study||1||
48326160|NCT01415427|101124589|FG003|COMPLETED|Overall Study||0||
48326161|NCT01415427|101124586|FG000|NOT COMPLETED|Overall Study||29||
48326162|NCT01415427|101124587|FG001|NOT COMPLETED|Overall Study||29||
48326163|NCT01415427|101124588|FG002|NOT COMPLETED|Overall Study||58||
48326164|NCT01415427|101124589|FG003|NOT COMPLETED|Overall Study||56||
48326165|NCT00419380|101124590|FG000|STARTED|Overall Study||19||
48326166|NCT00419380|101124591|FG001|STARTED|Overall Study||22||
48326167|NCT00419380|101124590|FG000|COMPLETED|Overall Study||18||
48326168|NCT00419380|101124591|FG001|COMPLETED|Overall Study||12||
48326169|NCT00419380|101124590|FG000|NOT COMPLETED|Overall Study||1||
48326170|NCT00419380|101124591|FG001|NOT COMPLETED|Overall Study||10||
48326171|NCT03864653|101124592|FG000|STARTED|Overall Study||39||
48326172|NCT03864653|101124592|FG000|COMPLETED|Overall Study||38||
48326173|NCT03864653|101124592|FG000|NOT COMPLETED|Overall Study||1||
48326174|NCT01733472|101124593|FG000|STARTED|Overall Study||60||
48326175|NCT01733472|101124594|FG001|STARTED|Overall Study||60||
48326176|NCT01733472|101124593|FG000|COMPLETED|Overall Study||60||
48326177|NCT01733472|101124594|FG001|COMPLETED|Overall Study||60||
48326178|NCT01733472|101124593|FG000|NOT COMPLETED|Overall Study||0||
48326179|NCT01733472|101124594|FG001|NOT COMPLETED|Overall Study||0||
48326180|NCT03289650|101124595|FG000|STARTED|Overall Study||14||
48326181|NCT03289650|101124596|FG001|STARTED|Overall Study||15||
48326182|NCT03289650|101124595|FG000|COMPLETED|Overall Study||14||
48326183|NCT03289650|101124596|FG001|COMPLETED|Overall Study||15||
48326184|NCT03289650|101124595|FG000|NOT COMPLETED|Overall Study||0||
48326185|NCT03289650|101124596|FG001|NOT COMPLETED|Overall Study||0||
48326186|NCT05284760|101124597|FG000|STARTED|Overall Study||12||
48326187|NCT05284760|101124598|FG001|STARTED|Overall Study||12||
48326188|NCT05284760|101124599|FG002|STARTED|Overall Study||12||
48326189|NCT05284760|101124600|FG003|STARTED|Overall Study||12||
48326190|NCT05284760|101124601|FG004|STARTED|Overall Study||12||
48326191|NCT05284760|101124602|FG005|STARTED|Overall Study||12||
48326192|NCT05284760|101124603|FG006|STARTED|Overall Study||4||
48742989|NCT03030417|102155178|FG004|NOT COMPLETED|Dose Expansion||0||
48742990|NCT03030417|102155179|FG005|NOT COMPLETED|Dose Expansion||0||
48326193|NCT05284760|101124604|FG007|STARTED|Overall Study||4||
48326194|NCT05284760|101124605|FG008|STARTED|Overall Study||4||
48326195|NCT05284760|101124606|FG009|STARTED|Overall Study||4||
48326196|NCT05284760|101124607|FG010|STARTED|Overall Study||4||
48326197|NCT05284760|101124608|FG011|STARTED|Overall Study||4||
48326198|NCT05284760|101124597|FG000|COMPLETED|Overall Study||12||
48326199|NCT05284760|101124598|FG001|COMPLETED|Overall Study||12||
48326200|NCT05284760|101124599|FG002|COMPLETED|Overall Study||12||
48326201|NCT05284760|101124600|FG003|COMPLETED|Overall Study||12||
48326202|NCT05284760|101124601|FG004|COMPLETED|Overall Study||12||
48326203|NCT05284760|101124602|FG005|COMPLETED|Overall Study||12||
48326204|NCT05284760|101124603|FG006|COMPLETED|Overall Study||4||
48326205|NCT05284760|101124604|FG007|COMPLETED|Overall Study||4||
48326206|NCT05284760|101124605|FG008|COMPLETED|Overall Study||4||
48326207|NCT05284760|101124606|FG009|COMPLETED|Overall Study||4||
48326208|NCT05284760|101124607|FG010|COMPLETED|Overall Study||4||
48326209|NCT05284760|101124608|FG011|COMPLETED|Overall Study||4||
48326210|NCT05284760|101124597|FG000|NOT COMPLETED|Overall Study||0||
48326211|NCT05284760|101124598|FG001|NOT COMPLETED|Overall Study||0||
48326212|NCT05284760|101124599|FG002|NOT COMPLETED|Overall Study||0||
48326213|NCT05284760|101124600|FG003|NOT COMPLETED|Overall Study||0||
48326214|NCT05284760|101124601|FG004|NOT COMPLETED|Overall Study||0||
48326215|NCT05284760|101124602|FG005|NOT COMPLETED|Overall Study||0||
48326216|NCT05284760|101124603|FG006|NOT COMPLETED|Overall Study||0||
48742991|NCT03030417|102155180|FG006|NOT COMPLETED|Dose Expansion||0||
48326217|NCT05284760|101124604|FG007|NOT COMPLETED|Overall Study||0||
48326218|NCT05284760|101124605|FG008|NOT COMPLETED|Overall Study||0||
48326219|NCT05284760|101124606|FG009|NOT COMPLETED|Overall Study||0||
48326220|NCT05284760|101124607|FG010|NOT COMPLETED|Overall Study||0||
48326221|NCT05284760|101124608|FG011|NOT COMPLETED|Overall Study||0||
48326222|NCT03354754|101124609|FG000|STARTED|Overall Study||2||
48742992|NCT03030417|102155181|FG007|NOT COMPLETED|Dose Expansion||0||
48742993|NCT03030417|102155182|FG008|NOT COMPLETED|Dose Expansion||0||
48742994|NCT03030417|102155183|FG009|NOT COMPLETED|Dose Expansion||0||
48742995|NCT03030417|102155184|FG010|NOT COMPLETED|Dose Expansion||0||
48742996|NCT03030417|102155185|FG011|NOT COMPLETED|Dose Expansion||0||
48742997|NCT03030417|102155186|FG012|NOT COMPLETED|Dose Expansion||1||
48163298|NCT02713711|100721808|FG001|NOT COMPLETED|Overall Study||0||0
48163299|NCT02713711|100721809|FG002|NOT COMPLETED|Overall Study||0||0
48163300|NCT02713711|100721810|FG003|NOT COMPLETED|Overall Study||0||0
48163301|NCT05044325|100721811|FG000|STARTED|Part A:Treatment Period 1||3||
48163302|NCT05044325|100721812|FG001|STARTED|Part A:Treatment Period 1||3||
48163303|NCT05044325|100721813|FG002|STARTED|Part A:Treatment Period 1||3||
48163304|NCT05044325|100721814|FG003|STARTED|Part A:Treatment Period 1||3||
48163305|NCT05044325|100721815|FG004|STARTED|Part A:Treatment Period 1||3||
48163306|NCT05044325|100721816|FG005|STARTED|Part A:Treatment Period 1||3||
48163307|NCT05044325|100721817|FG006|STARTED|Part A:Treatment Period 1||1||
48163308|NCT05044325|100721818|FG007|STARTED|Part A:Treatment Period 1||1||
48163309|NCT05044325|100721819|FG008|STARTED|Part A:Treatment Period 1||0||
48163310|NCT05044325|100721820|FG009|STARTED|Part A:Treatment Period 1||0||
48163311|NCT05044325|100721811|FG000|COMPLETED|Part A:Treatment Period 1||3||
48163312|NCT05044325|100721812|FG001|COMPLETED|Part A:Treatment Period 1||3||
48163313|NCT05044325|100721813|FG002|COMPLETED|Part A:Treatment Period 1||2||
48163314|NCT05044325|100721814|FG003|COMPLETED|Part A:Treatment Period 1||1||
48163315|NCT05044325|100721815|FG004|COMPLETED|Part A:Treatment Period 1||1||
48163316|NCT05044325|100721816|FG005|COMPLETED|Part A:Treatment Period 1||0||
48163317|NCT05044325|100721817|FG006|COMPLETED|Part A:Treatment Period 1||0||
48163318|NCT05044325|100721818|FG007|COMPLETED|Part A:Treatment Period 1||0||
48163319|NCT05044325|100721819|FG008|COMPLETED|Part A:Treatment Period 1||0||
48163320|NCT05044325|100721820|FG009|COMPLETED|Part A:Treatment Period 1||0||
48163321|NCT05044325|100721811|FG000|NOT COMPLETED|Part A:Treatment Period 1||0||
48163322|NCT05044325|100721812|FG001|NOT COMPLETED|Part A:Treatment Period 1||0||
48163323|NCT05044325|100721813|FG002|NOT COMPLETED|Part A:Treatment Period 1||1||
48163324|NCT05044325|100721814|FG003|NOT COMPLETED|Part A:Treatment Period 1||2||
48163325|NCT05044325|100721815|FG004|NOT COMPLETED|Part A:Treatment Period 1||2||
48163326|NCT05044325|100721816|FG005|NOT COMPLETED|Part A:Treatment Period 1||3||
48163327|NCT05044325|100721817|FG006|NOT COMPLETED|Part A:Treatment Period 1||1||
48163328|NCT05044325|100721818|FG007|NOT COMPLETED|Part A:Treatment Period 1||1||
48163329|NCT05044325|100721819|FG008|NOT COMPLETED|Part A:Treatment Period 1||0||
48163330|NCT05044325|100721820|FG009|NOT COMPLETED|Part A:Treatment Period 1||0||
48163331|NCT05044325|100721811|FG000|STARTED|Part A:Treatment Period 2||3||
48163332|NCT05044325|100721812|FG001|STARTED|Part A:Treatment Period 2||3||
48163333|NCT05044325|100721813|FG002|STARTED|Part A:Treatment Period 2||3||
48163334|NCT05044325|100721814|FG003|STARTED|Part A:Treatment Period 2||1||
48163335|NCT05044325|100721815|FG004|STARTED|Part A:Treatment Period 2||2||
48163336|NCT05044325|100721816|FG005|STARTED|Part A:Treatment Period 2||2||
48163337|NCT05044325|100721817|FG006|STARTED|Part A:Treatment Period 2||0||
48163338|NCT05044325|100721818|FG007|STARTED|Part A:Treatment Period 2||0||
48163339|NCT05044325|100721819|FG008|STARTED|Part A:Treatment Period 2||0||
48326223|NCT03354754|101124610|FG001|STARTED|Overall Study||1||
48326224|NCT03354754|101124609|FG000|COMPLETED|Overall Study||2||
48326225|NCT03354754|101124610|FG001|COMPLETED|Overall Study||1||
48742998|NCT04458909|102155187|FG000|STARTED|Overall Study||11||
48742999|NCT04458909|102155188|FG001|STARTED|Overall Study||4||
48743000|NCT04458909|102155187|FG000|Started Protocol Treatment|Overall Study||11||
48743001|NCT04458909|102155188|FG001|Started Protocol Treatment|Overall Study||4||
48743002|NCT04458909|102155187|FG000|COMPLETED|Overall Study||11||
48743003|NCT04458909|102155188|FG001|COMPLETED|Overall Study||4||
48163340|NCT05044325|100721820|FG009|STARTED|Part A:Treatment Period 2||0||
48163341|NCT05044325|100721811|FG000|COMPLETED|Part A:Treatment Period 2||3||
48163342|NCT05044325|100721812|FG001|COMPLETED|Part A:Treatment Period 2||2||
48163343|NCT05044325|100721813|FG002|COMPLETED|Part A:Treatment Period 2||3||
48163344|NCT05044325|100721814|FG003|COMPLETED|Part A:Treatment Period 2||0||
48163345|NCT05044325|100721815|FG004|COMPLETED|Part A:Treatment Period 2||0||
48163346|NCT05044325|100721816|FG005|COMPLETED|Part A:Treatment Period 2||0||
48163347|NCT05044325|100721817|FG006|COMPLETED|Part A:Treatment Period 2||0||
48163348|NCT05044325|100721818|FG007|COMPLETED|Part A:Treatment Period 2||0||
48163349|NCT05044325|100721819|FG008|COMPLETED|Part A:Treatment Period 2||0||
48163350|NCT05044325|100721820|FG009|COMPLETED|Part A:Treatment Period 2||0||
48163351|NCT05044325|100721811|FG000|NOT COMPLETED|Part A:Treatment Period 2||0||
48163352|NCT05044325|100721812|FG001|NOT COMPLETED|Part A:Treatment Period 2||1||
48163353|NCT05044325|100721813|FG002|NOT COMPLETED|Part A:Treatment Period 2||0||
48163354|NCT05044325|100721814|FG003|NOT COMPLETED|Part A:Treatment Period 2||1||
48163355|NCT05044325|100721815|FG004|NOT COMPLETED|Part A:Treatment Period 2||2||
48163356|NCT05044325|100721816|FG005|NOT COMPLETED|Part A:Treatment Period 2||2||
48163357|NCT05044325|100721817|FG006|NOT COMPLETED|Part A:Treatment Period 2||0||
48163358|NCT05044325|100721818|FG007|NOT COMPLETED|Part A:Treatment Period 2||0||
48326226|NCT03354754|101124609|FG000|NOT COMPLETED|Overall Study||0||
48743004|NCT04458909|102155187|FG000|NOT COMPLETED|Overall Study||0||
48326227|NCT03354754|101124610|FG001|NOT COMPLETED|Overall Study||0||
48326228|NCT02706730|101124611|FG000|STARTED|Overall Study||189||
48326229|NCT02706730|101124611|FG000|COMPLETED|Overall Study||156||
48326230|NCT02706730|101124611|FG000|NOT COMPLETED|Overall Study||33||
48326231|NCT03615183|101124612|FG000|STARTED|Overall Study||6||
48326232|NCT03615183|101124613|FG001|STARTED|Overall Study||6||
48326233|NCT03615183|101124614|FG002|STARTED|Overall Study||5||
48326234|NCT03615183|101124615|FG003|STARTED|Overall Study||0||
48326235|NCT03615183|101124616|FG004|STARTED|Overall Study||0||
48326236|NCT03615183|101124612|FG000|COMPLETED|Overall Study||6||
48326237|NCT03615183|101124613|FG001|COMPLETED|Overall Study||6||
48326238|NCT03615183|101124614|FG002|COMPLETED|Overall Study||5||
48326239|NCT03615183|101124615|FG003|COMPLETED|Overall Study||0||
48326240|NCT03615183|101124616|FG004|COMPLETED|Overall Study||0||
48326241|NCT03615183|101124612|FG000|NOT COMPLETED|Overall Study||0||
48326242|NCT03615183|101124613|FG001|NOT COMPLETED|Overall Study||0||
48326243|NCT03615183|101124614|FG002|NOT COMPLETED|Overall Study||0||
48326244|NCT03615183|101124615|FG003|NOT COMPLETED|Overall Study||0||
48326245|NCT03615183|101124616|FG004|NOT COMPLETED|Overall Study||0||
48326246|NCT02370875|101124617|FG000|STARTED|Overall Study||6||6
48326247|NCT02370875|101124618|FG001|STARTED|Overall Study||6||6
48326248|NCT02370875|101124617|FG000|COMPLETED|Overall Study||6||6
48326249|NCT02370875|101124618|FG001|COMPLETED|Overall Study||6||6
48326250|NCT02370875|101124617|FG000|NOT COMPLETED|Overall Study||0||0
48326251|NCT02370875|101124618|FG001|NOT COMPLETED|Overall Study||0||0
48743005|NCT04458909|102155188|FG001|NOT COMPLETED|Overall Study||0||
48743006|NCT00700713|102155189|FG000|STARTED|Overall Study||48||
48743007|NCT00700713|102155190|FG001|STARTED|Overall Study||66||
48743008|NCT00700713|102155191|FG002|STARTED|Overall Study||67||
48743009|NCT00700713|102155189|FG000|COMPLETED|Overall Study||47||
48743010|NCT00700713|102155190|FG001|COMPLETED|Overall Study||66||
48743011|NCT00700713|102155191|FG002|COMPLETED|Overall Study||65||
48743012|NCT00700713|102155189|FG000|NOT COMPLETED|Overall Study||1||
48743013|NCT00700713|102155190|FG001|NOT COMPLETED|Overall Study||0||
48743014|NCT00700713|102155191|FG002|NOT COMPLETED|Overall Study||2||
48409457|NCT00262639|101334714|FG003|COMPLETED|Overall Study||7||
48409458|NCT00262639|101334711|FG000|NOT COMPLETED|Overall Study||0||
48409459|NCT00262639|101334712|FG001|NOT COMPLETED|Overall Study||0||
48409460|NCT00262639|101334713|FG002|NOT COMPLETED|Overall Study||0||
48409461|NCT00262639|101334714|FG003|NOT COMPLETED|Overall Study||0||
48409462|NCT04021628|101334715|FG000|STARTED|Overall Study||160||
48409463|NCT04021628|101334715|FG000|COMPLETED|Overall Study||119||
48409464|NCT04021628|101334715|FG000|NOT COMPLETED|Overall Study||41||
48409465|NCT03887052|101334716|FG000|STARTED|Overall Study||130||
48409466|NCT03887052|101334716|FG000|COMPLETED|Overall Study||121||
48326252|NCT04312009|101124619|FG000|STARTED|Overall Study||104||
48326253|NCT04312009|101124620|FG001|STARTED|Overall Study||101||
48326254|NCT04312009|101124619|FG000|COMPLETED|Overall Study||102||
48326255|NCT04312009|101124620|FG001|COMPLETED|Overall Study||100||
48326256|NCT04312009|101124619|FG000|NOT COMPLETED|Overall Study||2||
48326257|NCT04312009|101124620|FG001|NOT COMPLETED|Overall Study||1||
48326258|NCT01751308|101124621|FG000|STARTED|Phase 1||6||
48326259|NCT01751308|101124622|FG001|STARTED|Phase 1||3||
48326260|NCT01751308|101124623|FG002|STARTED|Phase 1||7||
48326261|NCT01751308|101124624|FG003|STARTED|Phase 1||7||
48409467|NCT03887052|101334716|FG000|NOT COMPLETED|Overall Study||9||
48409468|NCT05013385|101334717|FG000|STARTED|Overall Study||5|Patients who entered the Lead-In Period|
48409469|NCT05013385|101334717|FG000|Patients Who Entered the Randomized Blinded Treatment Period|Overall Study||0||
48743015|NCT00570310|102155192|FG000|STARTED|Overall Study||53||
48326262|NCT01751308|101124625|FG004|STARTED|Phase 1||0||
48326263|NCT01751308|101124621|FG000|COMPLETED|Phase 1||6||
48409470|NCT05013385|101334717|FG000|COMPLETED|Overall Study||0||
48409471|NCT05013385|101334717|FG000|NOT COMPLETED|Overall Study||5||
48743016|NCT00570310|102155193|FG001|STARTED|Overall Study||51||
48743017|NCT00570310|102155192|FG000|COMPLETED|Overall Study||51||
48743018|NCT00570310|102155193|FG001|COMPLETED|Overall Study||45||
48743019|NCT00570310|102155192|FG000|NOT COMPLETED|Overall Study||2||
48326264|NCT01751308|101124622|FG001|COMPLETED|Phase 1||3||
48326265|NCT01751308|101124623|FG002|COMPLETED|Phase 1||7||
48326266|NCT01751308|101124624|FG003|COMPLETED|Phase 1||7||
48326267|NCT01751308|101124625|FG004|COMPLETED|Phase 1||0||
48326268|NCT01751308|101124621|FG000|NOT COMPLETED|Phase 1||0||
48326269|NCT01751308|101124622|FG001|NOT COMPLETED|Phase 1||0||
48326270|NCT01751308|101124623|FG002|NOT COMPLETED|Phase 1||0||
48409472|NCT00193128|101334718|FG000|STARTED|Overall Study||10||
48743020|NCT00570310|102155193|FG001|NOT COMPLETED|Overall Study||6||
48743021|NCT00965250|102155194|FG000|STARTED|Overall Study||37||
48326271|NCT01751308|101124624|FG003|NOT COMPLETED|Phase 1||0||
48409473|NCT00193128|101334719|FG001|STARTED|Overall Study||49||
48409474|NCT00193128|101334718|FG000|COMPLETED|Overall Study||10||
48409475|NCT00193128|101334719|FG001|COMPLETED|Overall Study||39||
48409476|NCT00193128|101334718|FG000|NOT COMPLETED|Overall Study||0||
48409477|NCT00193128|101334719|FG001|NOT COMPLETED|Overall Study||10||
48409478|NCT02168660|101334720|FG000|STARTED|Overall Study||38||
48326272|NCT01751308|101124625|FG004|NOT COMPLETED|Phase 1||0||
48326273|NCT01751308|101124621|FG000|STARTED|Phase 2||0||
48326274|NCT01751308|101124622|FG001|STARTED|Phase 2||0||
48619880|NCT04812184|101856286|FG000|COMPLETED|Overall Study||60||
48619881|NCT04812184|101856287|FG001|COMPLETED|Overall Study||63||
48619882|NCT04812184|101856286|FG000|NOT COMPLETED|Overall Study||0||
48619883|NCT04812184|101856287|FG001|NOT COMPLETED|Overall Study||0||
48619884|NCT01935089|101856288|FG000|STARTED|Overall Study||20||
48619885|NCT01935089|101856288|FG000|COMPLETED|Overall Study||17||
48619886|NCT01935089|101856288|FG000|NOT COMPLETED|Overall Study||3||
48619887|NCT00732069|101856289|FG000|STARTED|First Study Drug||3||
48619888|NCT00732069|101856290|FG001|STARTED|First Study Drug||3||
48619889|NCT00732069|101856291|FG002|STARTED|First Study Drug||3||
48619890|NCT00732069|101856292|FG003|STARTED|First Study Drug||2||
48619891|NCT00732069|101856293|FG004|STARTED|First Study Drug||3||
48326275|NCT01751308|101124623|FG002|STARTED|Phase 2||0||
48326276|NCT01751308|101124624|FG003|STARTED|Phase 2||0||
48326277|NCT01751308|101124625|FG004|STARTED|Phase 2||16||
48326278|NCT01751308|101124621|FG000|COMPLETED|Phase 2||0||
48743022|NCT00965250|102155195|FG001|STARTED|Overall Study||12||
48743023|NCT00965250|102155194|FG000|COMPLETED|Overall Study||37||
48619892|NCT00732069|101856294|FG005|STARTED|First Study Drug||2||
48743024|NCT00965250|102155195|FG001|COMPLETED|Overall Study||12||
48743025|NCT00965250|102155194|FG000|NOT COMPLETED|Overall Study||0||
48743026|NCT00965250|102155195|FG001|NOT COMPLETED|Overall Study||0||
48743027|NCT02096549|102155196|FG000|STARTED|Overall Study||20||
48743028|NCT02096549|102155196|FG000|COMPLETED|Overall Study||20||
48743029|NCT02096549|102155196|FG000|NOT COMPLETED|Overall Study||0||
48743030|NCT04106609|102155197|FG000|STARTED|Overall Study||129||
48743031|NCT04106609|102155198|FG001|STARTED|Overall Study||122||
48743032|NCT04106609|102155197|FG000|COMPLETED|Overall Study||123||
48326279|NCT01751308|101124622|FG001|COMPLETED|Phase 2||0||
48326280|NCT01751308|101124623|FG002|COMPLETED|Phase 2||0||
48409479|NCT02168660|101334721|FG001|STARTED|Overall Study||35||
48409480|NCT02168660|101334722|FG002|STARTED|Overall Study||36||
48743033|NCT04106609|102155198|FG001|COMPLETED|Overall Study||120||
48743034|NCT04106609|102155197|FG000|NOT COMPLETED|Overall Study||6||
48743035|NCT04106609|102155198|FG001|NOT COMPLETED|Overall Study||2||
48743036|NCT03468868|102155199|FG000|STARTED|Overall Study||198||
48743037|NCT03468868|102155200|FG001|STARTED|Overall Study||181||
48743038|NCT03468868|102155199|FG000|COMPLETED|Overall Study||151||
48743039|NCT03468868|102155200|FG001|COMPLETED|Overall Study||115||
48743040|NCT03468868|102155199|FG000|NOT COMPLETED|Overall Study||47||
48743041|NCT03468868|102155200|FG001|NOT COMPLETED|Overall Study||66||
48743042|NCT04170543|102155201|FG000|STARTED|Overall Study||147||
48743043|NCT04170543|102155202|FG001|STARTED|Overall Study||96||
48743044|NCT04170543|102155203|FG002|STARTED|Overall Study||101||
48743045|NCT04170543|102155204|FG003|STARTED|Overall Study||95||
48326281|NCT01751308|101124624|FG003|COMPLETED|Phase 2||0||
48326282|NCT01751308|101124625|FG004|COMPLETED|Phase 2||16||
48326283|NCT01751308|101124621|FG000|NOT COMPLETED|Phase 2||0||
48326284|NCT01751308|101124622|FG001|NOT COMPLETED|Phase 2||0||
48743046|NCT04170543|102155205|FG004|STARTED|Overall Study||160||
48743047|NCT04170543|102155201|FG000|COMPLETED|Overall Study||99||
48743048|NCT04170543|102155202|FG001|COMPLETED|Overall Study||70||
48743049|NCT04170543|102155203|FG002|COMPLETED|Overall Study||70||
48743050|NCT04170543|102155204|FG003|COMPLETED|Overall Study||68||
48743051|NCT04170543|102155205|FG004|COMPLETED|Overall Study||120||
48743052|NCT04170543|102155201|FG000|NOT COMPLETED|Overall Study||48||
48326285|NCT01751308|101124623|FG002|NOT COMPLETED|Phase 2||0||
48409481|NCT02168660|101334720|FG000|COMPLETED|Overall Study||22||
48326286|NCT01751308|101124624|FG003|NOT COMPLETED|Phase 2||0||
48409482|NCT02168660|101334721|FG001|COMPLETED|Overall Study||18||
48326287|NCT01751308|101124625|FG004|NOT COMPLETED|Phase 2||0||
48326288|NCT01324232|101124626|FG000|STARTED|Overall Study||49||
48409483|NCT02168660|101334722|FG002|COMPLETED|Overall Study||21||
48409484|NCT02168660|101334720|FG000|NOT COMPLETED|Overall Study||16||
48619893|NCT00732069|101856289|FG000|COMPLETED|First Study Drug||3||
48619894|NCT00732069|101856290|FG001|COMPLETED|First Study Drug||3||
48619895|NCT00732069|101856291|FG002|COMPLETED|First Study Drug||3||
48619896|NCT00732069|101856292|FG003|COMPLETED|First Study Drug||2||
48619897|NCT00732069|101856293|FG004|COMPLETED|First Study Drug||3||
48743053|NCT04170543|102155202|FG001|NOT COMPLETED|Overall Study||26||
48743054|NCT04170543|102155203|FG002|NOT COMPLETED|Overall Study||31||
48743055|NCT04170543|102155204|FG003|NOT COMPLETED|Overall Study||27||
48743056|NCT04170543|102155205|FG004|NOT COMPLETED|Overall Study||40||
48743057|NCT04809285|102155206|FG000|STARTED|Phase 1||208|Excludes 9 subjects who were screen failures|
48743058|NCT04809285|102155206|FG000|COMPLETED|Phase 1||168||
48743059|NCT04809285|102155206|FG000|NOT COMPLETED|Phase 1||40||
48743060|NCT04809285|102155206|FG000|STARTED|Phase 2||67||
48743061|NCT04809285|102155206|FG000|COMPLETED|Phase 2||60||
48743062|NCT04809285|102155206|FG000|NOT COMPLETED|Phase 2||7||
48743063|NCT03472950|102155207|FG000|STARTED|Overall Study||6||
48743064|NCT03472950|102155208|FG001|STARTED|Overall Study||8||
48743065|NCT03472950|102155207|FG000|COMPLETED|Overall Study||6||
48743066|NCT03472950|102155208|FG001|COMPLETED|Overall Study||4||
48743067|NCT03472950|102155207|FG000|NOT COMPLETED|Overall Study||0||
48743068|NCT03472950|102155208|FG001|NOT COMPLETED|Overall Study||4||
48743069|NCT03251937|102155209|FG000|STARTED|Overall Study||40||
48743070|NCT03251937|102155209|FG000|COMPLETED|Overall Study||37||
48743071|NCT03251937|102155209|FG000|NOT COMPLETED|Overall Study||3||
48743072|NCT03374787|102155210|FG000|STARTED|Overall Study||10||
48743073|NCT03374787|102155210|FG000|COMPLETED|Overall Study||10||
48619898|NCT00732069|101856294|FG005|COMPLETED|First Study Drug||2||
48619899|NCT00732069|101856289|FG000|NOT COMPLETED|First Study Drug||0||
48743074|NCT03374787|102155210|FG000|NOT COMPLETED|Overall Study||0||
48743075|NCT02649556|102157943|FG000|STARTED|Overall Study||230||
48743076|NCT02649556|102157944|FG001|STARTED|Overall Study||424||
48743077|NCT02649556|102157945|FG002|STARTED|Overall Study||152||
48743078|NCT02649556|102157946|FG003|STARTED|Overall Study||51||
48743079|NCT02649556|102157943|FG000|COMPLETED|Overall Study||167||
48743080|NCT02649556|102157944|FG001|COMPLETED|Overall Study||312||
48743081|NCT02649556|102157945|FG002|COMPLETED|Overall Study||102||
48743082|NCT02649556|102157946|FG003|COMPLETED|Overall Study||28||
48743083|NCT02649556|102157943|FG000|NOT COMPLETED|Overall Study||63||
48743084|NCT02649556|102157944|FG001|NOT COMPLETED|Overall Study||112||
48743085|NCT02649556|102157945|FG002|NOT COMPLETED|Overall Study||50||
48743086|NCT02649556|102157946|FG003|NOT COMPLETED|Overall Study||23||
48743087|NCT01643382|102157947|FG000|STARTED|Overall Study||30||
48743088|NCT01643382|102157948|FG001|STARTED|Overall Study||30||
48743089|NCT01643382|102157947|FG000|COMPLETED|Overall Study||30||
48743090|NCT01643382|102157948|FG001|COMPLETED|Overall Study||30||
48743091|NCT01643382|102157947|FG000|NOT COMPLETED|Overall Study||0||
48743092|NCT01643382|102157948|FG001|NOT COMPLETED|Overall Study||0||
48743093|NCT05128578|102157949|FG000|STARTED|Overall Study||30||
48743094|NCT05128578|102157949|FG000|Baseline Survey|Overall Study||24||
48326289|NCT01324232|101124627|FG001|STARTED|Overall Study||53||
48326290|NCT01324232|101124628|FG002|STARTED|Overall Study||54||
48326291|NCT01324232|101124629|FG003|STARTED|Overall Study||53||
48326292|NCT01324232|101124626|FG000|COMPLETED|Overall Study||44||
48326293|NCT01324232|101124627|FG001|COMPLETED|Overall Study||42||
48326294|NCT01324232|101124628|FG002|COMPLETED|Overall Study||41||
48326295|NCT01324232|101124629|FG003|COMPLETED|Overall Study||42||
48619900|NCT00732069|101856290|FG001|NOT COMPLETED|First Study Drug||0||
48619901|NCT00732069|101856291|FG002|NOT COMPLETED|First Study Drug||0||
48619902|NCT00732069|101856292|FG003|NOT COMPLETED|First Study Drug||0||
48619903|NCT00732069|101856293|FG004|NOT COMPLETED|First Study Drug||0||
48743095|NCT05128578|102157949|FG000|Received Intervention|Overall Study||21||
48743096|NCT05128578|102157949|FG000|COMPLETED|Overall Study||16||
48743097|NCT05128578|102157949|FG000|NOT COMPLETED|Overall Study||14||
48743098|NCT03551626|102157950|FG000|STARTED|Overall Study||552||
48743099|NCT03551626|102157950|FG000|COMPLETED|Overall Study||425||
48743100|NCT03551626|102157950|FG000|NOT COMPLETED|Overall Study||127||
48743101|NCT03826186|102157951|FG000|STARTED|Overall Study||60||
48743102|NCT03826186|102157952|FG001|STARTED|Overall Study||60||
48743103|NCT03826186|102157951|FG000|COMPLETED|Overall Study||57||
48619904|NCT00732069|101856294|FG005|NOT COMPLETED|First Study Drug||0||
48619905|NCT00732069|101856289|FG000|STARTED|Washout After First Study Drug||3||
48619906|NCT00732069|101856290|FG001|STARTED|Washout After First Study Drug||3||
48619907|NCT00732069|101856291|FG002|STARTED|Washout After First Study Drug||3||
48743104|NCT03826186|102157952|FG001|COMPLETED|Overall Study||60||
48743105|NCT03826186|102157951|FG000|NOT COMPLETED|Overall Study||3||
48743106|NCT03826186|102157952|FG001|NOT COMPLETED|Overall Study||0||
48743107|NCT02506192|102157953|FG000|STARTED|Overall Study||42||
48326296|NCT01324232|101124626|FG000|NOT COMPLETED|Overall Study||5||
48743108|NCT02506192|102157954|FG001|STARTED|Overall Study||41||
48743109|NCT02506192|102157953|FG000|COMPLETED|Overall Study||41||
48743110|NCT02506192|102157954|FG001|COMPLETED|Overall Study||40||
48326297|NCT01324232|101124627|FG001|NOT COMPLETED|Overall Study||11||
48743111|NCT02506192|102157953|FG000|NOT COMPLETED|Overall Study||1||
48743112|NCT02506192|102157954|FG001|NOT COMPLETED|Overall Study||1||
48743113|NCT03740659|102157955|FG000|STARTED|Overall Study||42||
48326298|NCT01324232|101124628|FG002|NOT COMPLETED|Overall Study||13||
48326299|NCT01324232|101124629|FG003|NOT COMPLETED|Overall Study||11||
48619908|NCT00732069|101856292|FG003|STARTED|Washout After First Study Drug||2||
48743114|NCT03740659|102157956|FG001|STARTED|Overall Study||42||
48743115|NCT03740659|102157957|FG002|STARTED|Overall Study||41||
48743116|NCT03740659|102157955|FG000|COMPLETED|Overall Study||42||
48743117|NCT03740659|102157956|FG001|COMPLETED|Overall Study||42||
48743118|NCT03740659|102157957|FG002|COMPLETED|Overall Study||41||
48743119|NCT03740659|102157955|FG000|NOT COMPLETED|Overall Study||0||
48743120|NCT03740659|102157956|FG001|NOT COMPLETED|Overall Study||0||
48743121|NCT03740659|102157957|FG002|NOT COMPLETED|Overall Study||0||
48743122|NCT00801229|102157958|FG000|STARTED|Signed Consent||38||
48743123|NCT00801229|102157959|FG001|STARTED|Signed Consent||37||
48743124|NCT00801229|102157958|FG000|COMPLETED|Signed Consent||35||
48743125|NCT00801229|102157959|FG001|COMPLETED|Signed Consent||34||
48743126|NCT00801229|102157958|FG000|NOT COMPLETED|Signed Consent||3||
48743127|NCT00801229|102157959|FG001|NOT COMPLETED|Signed Consent||3||
48743128|NCT00801229|102157958|FG000|STARTED|Received Study Drug/Placebo||35||
48743129|NCT00801229|102157959|FG001|STARTED|Received Study Drug/Placebo||34||
48743130|NCT00801229|102157958|FG000|COMPLETED|Received Study Drug/Placebo||31||
48743131|NCT00801229|102157959|FG001|COMPLETED|Received Study Drug/Placebo||30||
48743132|NCT00801229|102157958|FG000|NOT COMPLETED|Received Study Drug/Placebo||4||
48743133|NCT00801229|102157959|FG001|NOT COMPLETED|Received Study Drug/Placebo||4||
48743134|NCT01466127|102157960|FG000|STARTED|Overall Study||30||
48743135|NCT01466127|102157961|FG001|STARTED|Overall Study||30||
48743136|NCT01466127|102157960|FG000|COMPLETED|Overall Study||16||
48743137|NCT01466127|102157961|FG001|COMPLETED|Overall Study||14||
48743138|NCT01466127|102157960|FG000|NOT COMPLETED|Overall Study||14||
48743139|NCT01466127|102157961|FG001|NOT COMPLETED|Overall Study||16||
48743140|NCT01013194|102157962|FG000|STARTED|Overall Study||9||
48743141|NCT01013194|102157963|FG001|STARTED|Overall Study||16||
48743142|NCT01013194|102157962|FG000|COMPLETED|Overall Study||9||
48743143|NCT01013194|102157963|FG001|COMPLETED|Overall Study||16||
48743144|NCT01013194|102157962|FG000|NOT COMPLETED|Overall Study||0||
48326300|NCT00401752|101124630|FG000|STARTED|Overall Study||107||
48326301|NCT00401752|101124631|FG001|STARTED|Overall Study||112||
48326302|NCT00401752|101124630|FG000|Number of Patients Received Treatment|Overall Study||107||
48743145|NCT01013194|102157963|FG001|NOT COMPLETED|Overall Study||0||
48743146|NCT05661851|102157964|FG000|STARTED|Overall Study||58||
48743147|NCT05661851|102157965|FG001|STARTED|Overall Study||60||
48743148|NCT05661851|102157964|FG000|COMPLETED|Overall Study||53||
48743149|NCT05661851|102157965|FG001|COMPLETED|Overall Study||54||
48743150|NCT05661851|102157964|FG000|NOT COMPLETED|Overall Study||5||
48743151|NCT05661851|102157965|FG001|NOT COMPLETED|Overall Study||6||
48743152|NCT03461146|102157966|FG000|STARTED|Overall Study||24||
48743153|NCT03461146|102157966|FG000|COMPLETED|Overall Study||21||
48743154|NCT03461146|102157966|FG000|NOT COMPLETED|Overall Study||3||
48743155|NCT00439296|102157967|FG000|STARTED|Overall Study||5||
48743156|NCT00439296|102157968|FG001|STARTED|Overall Study||4||
48743157|NCT00439296|102157967|FG000|Treatment Course 1|Overall Study||5||
48743158|NCT00439296|102157968|FG001|Treatment Course 1|Overall Study||3||
48743159|NCT00439296|102157967|FG000|Treatment Course 2|Overall Study||1||
48743160|NCT00439296|102157968|FG001|Treatment Course 2|Overall Study||1||
48743161|NCT00439296|102157967|FG000|COMPLETED|Overall Study||5||
48743162|NCT00439296|102157968|FG001|COMPLETED|Overall Study||4||
48743163|NCT00439296|102157967|FG000|NOT COMPLETED|Overall Study||0||
48743164|NCT00439296|102157968|FG001|NOT COMPLETED|Overall Study||0||
48743165|NCT01526213|102157969|FG000|STARTED|Period 1 (5 Days)||3||
48743166|NCT01526213|102157970|FG001|STARTED|Period 1 (5 Days)||3||
48743167|NCT01526213|102157971|FG002|STARTED|Period 1 (5 Days)||3||
48743168|NCT01526213|102157972|FG003|STARTED|Period 1 (5 Days)||3||
48743169|NCT01526213|102157973|FG004|STARTED|Period 1 (5 Days)||3||
48743170|NCT01526213|102157974|FG005|STARTED|Period 1 (5 Days)||3||
48743171|NCT01526213|102157969|FG000|COMPLETED|Period 1 (5 Days)||3||
48743172|NCT01526213|102157970|FG001|COMPLETED|Period 1 (5 Days)||3||
48743173|NCT01526213|102157971|FG002|COMPLETED|Period 1 (5 Days)||3||
48743174|NCT01526213|102157972|FG003|COMPLETED|Period 1 (5 Days)||3||
48743175|NCT01526213|102157973|FG004|COMPLETED|Period 1 (5 Days)||3||
48743176|NCT01526213|102157974|FG005|COMPLETED|Period 1 (5 Days)||3||
48743177|NCT01526213|102157969|FG000|NOT COMPLETED|Period 1 (5 Days)||0||
48743178|NCT01526213|102157970|FG001|NOT COMPLETED|Period 1 (5 Days)||0||
48743179|NCT01526213|102157971|FG002|NOT COMPLETED|Period 1 (5 Days)||0||
48743180|NCT01526213|102157972|FG003|NOT COMPLETED|Period 1 (5 Days)||0||
48743181|NCT01526213|102157973|FG004|NOT COMPLETED|Period 1 (5 Days)||0||
48743182|NCT01526213|102157974|FG005|NOT COMPLETED|Period 1 (5 Days)||0||
48743183|NCT01526213|102157969|FG000|STARTED|Washout 1 (10 Days)||3||
48743184|NCT01526213|102157970|FG001|STARTED|Washout 1 (10 Days)||3||
48743185|NCT01526213|102157971|FG002|STARTED|Washout 1 (10 Days)||3||
48326303|NCT00401752|101124631|FG001|Number of Patients Received Treatment|Overall Study||111||
48326304|NCT00401752|101124630|FG000|Patients Included in ITT Population|Overall Study||106||
48326305|NCT00401752|101124631|FG001|Patients Included in ITT Population|Overall Study||111||
48743186|NCT01526213|102157972|FG003|STARTED|Washout 1 (10 Days)||3||
48743187|NCT01526213|102157973|FG004|STARTED|Washout 1 (10 Days)||3||
48326306|NCT00401752|101124630|FG000|Patients Included in Safety Population|Overall Study||107||
48326307|NCT00401752|101124631|FG001|Patients Included in Safety Population|Overall Study||110||
48743188|NCT01526213|102157974|FG005|STARTED|Washout 1 (10 Days)||3||
48743189|NCT01526213|102157969|FG000|COMPLETED|Washout 1 (10 Days)||3||
48743190|NCT01526213|102157970|FG001|COMPLETED|Washout 1 (10 Days)||3||
48743191|NCT01526213|102157971|FG002|COMPLETED|Washout 1 (10 Days)||3||
48326308|NCT00401752|101124630|FG000|Patients Included in Per-Protocol Popula|Overall Study||100||
48326309|NCT00401752|101124631|FG001|Patients Included in Per-Protocol Popula|Overall Study||99||
48326310|NCT00401752|101124630|FG000|COMPLETED|Overall Study||97||
48326311|NCT00401752|101124631|FG001|COMPLETED|Overall Study||94||
48326312|NCT00401752|101124630|FG000|NOT COMPLETED|Overall Study||10||
48326313|NCT00401752|101124631|FG001|NOT COMPLETED|Overall Study||18||
48326314|NCT02420873|101124632|FG000|STARTED|Overall Study||9||
48326315|NCT02420873|101124633|FG001|STARTED|Overall Study||0||
48326316|NCT02420873|101124634|FG002|STARTED|Overall Study||0||
48326317|NCT02420873|101124632|FG000|COMPLETED|Overall Study||9||
48743192|NCT01526213|102157972|FG003|COMPLETED|Washout 1 (10 Days)||3||
48743193|NCT01526213|102157973|FG004|COMPLETED|Washout 1 (10 Days)||3||
48743194|NCT01526213|102157974|FG005|COMPLETED|Washout 1 (10 Days)||3||
48743195|NCT01526213|102157969|FG000|NOT COMPLETED|Washout 1 (10 Days)||0||
48743196|NCT01526213|102157970|FG001|NOT COMPLETED|Washout 1 (10 Days)||0||
48743197|NCT01526213|102157971|FG002|NOT COMPLETED|Washout 1 (10 Days)||0||
48743198|NCT01526213|102157972|FG003|NOT COMPLETED|Washout 1 (10 Days)||0||
48743199|NCT01526213|102157973|FG004|NOT COMPLETED|Washout 1 (10 Days)||0||
48743200|NCT01526213|102157974|FG005|NOT COMPLETED|Washout 1 (10 Days)||0||
48743201|NCT01526213|102157969|FG000|STARTED|Period 2 (5 Days)||3||
48743202|NCT01526213|102157970|FG001|STARTED|Period 2 (5 Days)||3||
48743203|NCT01526213|102157971|FG002|STARTED|Period 2 (5 Days)||3||
48743204|NCT01526213|102157972|FG003|STARTED|Period 2 (5 Days)||3||
48743205|NCT01526213|102157973|FG004|STARTED|Period 2 (5 Days)||3||
48743206|NCT01526213|102157974|FG005|STARTED|Period 2 (5 Days)||3||
48743207|NCT01526213|102157969|FG000|COMPLETED|Period 2 (5 Days)||3||
48743208|NCT01526213|102157970|FG001|COMPLETED|Period 2 (5 Days)||3||
48743209|NCT01526213|102157971|FG002|COMPLETED|Period 2 (5 Days)||3||
48743210|NCT01526213|102157972|FG003|COMPLETED|Period 2 (5 Days)||3||
48743211|NCT01526213|102157973|FG004|COMPLETED|Period 2 (5 Days)||3||
48743212|NCT01526213|102157974|FG005|COMPLETED|Period 2 (5 Days)||3||
48743213|NCT01526213|102157969|FG000|NOT COMPLETED|Period 2 (5 Days)||0||
48743214|NCT01526213|102157970|FG001|NOT COMPLETED|Period 2 (5 Days)||0||
48743215|NCT01526213|102157971|FG002|NOT COMPLETED|Period 2 (5 Days)||0||
48743216|NCT01526213|102157972|FG003|NOT COMPLETED|Period 2 (5 Days)||0||
48743217|NCT01526213|102157973|FG004|NOT COMPLETED|Period 2 (5 Days)||0||
48743218|NCT01526213|102157974|FG005|NOT COMPLETED|Period 2 (5 Days)||0||
48743219|NCT01526213|102157969|FG000|STARTED|Washout 2 (10 Days)||3||
48743220|NCT01526213|102157970|FG001|STARTED|Washout 2 (10 Days)||3||
48743221|NCT01526213|102157971|FG002|STARTED|Washout 2 (10 Days)||3||
48743222|NCT01526213|102157972|FG003|STARTED|Washout 2 (10 Days)||3||
48743223|NCT01526213|102157973|FG004|STARTED|Washout 2 (10 Days)||3||
48743224|NCT01526213|102157974|FG005|STARTED|Washout 2 (10 Days)||3||
48743225|NCT01526213|102157969|FG000|COMPLETED|Washout 2 (10 Days)||3||
48743226|NCT01526213|102157970|FG001|COMPLETED|Washout 2 (10 Days)||3||
48743227|NCT01526213|102157971|FG002|COMPLETED|Washout 2 (10 Days)||3||
48743228|NCT01526213|102157972|FG003|COMPLETED|Washout 2 (10 Days)||3||
48743229|NCT01526213|102157973|FG004|COMPLETED|Washout 2 (10 Days)||3||
48743230|NCT01526213|102157974|FG005|COMPLETED|Washout 2 (10 Days)||3||
48743231|NCT01526213|102157969|FG000|NOT COMPLETED|Washout 2 (10 Days)||0||
48743232|NCT01526213|102157970|FG001|NOT COMPLETED|Washout 2 (10 Days)||0||
48743233|NCT01526213|102157971|FG002|NOT COMPLETED|Washout 2 (10 Days)||0||
48743234|NCT01526213|102157972|FG003|NOT COMPLETED|Washout 2 (10 Days)||0||
48743235|NCT01526213|102157973|FG004|NOT COMPLETED|Washout 2 (10 Days)||0||
48743236|NCT01526213|102157974|FG005|NOT COMPLETED|Washout 2 (10 Days)||0||
48743237|NCT01526213|102157969|FG000|STARTED|Period 3 (5 Days)||3||
48743238|NCT01526213|102157970|FG001|STARTED|Period 3 (5 Days)||3||
48743239|NCT01526213|102157971|FG002|STARTED|Period 3 (5 Days)||3||
48743240|NCT01526213|102157972|FG003|STARTED|Period 3 (5 Days)||3||
48743241|NCT01526213|102157973|FG004|STARTED|Period 3 (5 Days)||3||
48743242|NCT01526213|102157974|FG005|STARTED|Period 3 (5 Days)||3||
48743243|NCT01526213|102157969|FG000|COMPLETED|Period 3 (5 Days)||3||
48743244|NCT01526213|102157970|FG001|COMPLETED|Period 3 (5 Days)||3||
48743245|NCT01526213|102157971|FG002|COMPLETED|Period 3 (5 Days)||3||
48743246|NCT01526213|102157972|FG003|COMPLETED|Period 3 (5 Days)||3||
48743247|NCT01526213|102157973|FG004|COMPLETED|Period 3 (5 Days)||3||
48743248|NCT01526213|102157974|FG005|COMPLETED|Period 3 (5 Days)||3||
48743249|NCT01526213|102157969|FG000|NOT COMPLETED|Period 3 (5 Days)||0||
48743250|NCT01526213|102157970|FG001|NOT COMPLETED|Period 3 (5 Days)||0||
48743251|NCT01526213|102157971|FG002|NOT COMPLETED|Period 3 (5 Days)||0||
48743252|NCT01526213|102157972|FG003|NOT COMPLETED|Period 3 (5 Days)||0||
48743253|NCT01526213|102157973|FG004|NOT COMPLETED|Period 3 (5 Days)||0||
48743254|NCT01526213|102157974|FG005|NOT COMPLETED|Period 3 (5 Days)||0||
48743255|NCT02221674|102157975|FG000|STARTED|Overall Study||8||
48743256|NCT02221674|102157976|FG001|STARTED|Overall Study||6||
48743257|NCT02221674|102157977|FG002|STARTED|Overall Study||5||
48743258|NCT02221674|102157975|FG000|COMPLETED|Overall Study||7||
48743259|NCT02221674|102157976|FG001|COMPLETED|Overall Study||6||
48743260|NCT02221674|102157977|FG002|COMPLETED|Overall Study||5||
48743261|NCT02221674|102157975|FG000|NOT COMPLETED|Overall Study||1||
48743262|NCT02221674|102157976|FG001|NOT COMPLETED|Overall Study||0||
48743263|NCT02221674|102157977|FG002|NOT COMPLETED|Overall Study||0||
48743264|NCT00066677|102157978|FG000|STARTED|Overall Study||16||
48743265|NCT00066677|102157979|FG001|STARTED|Overall Study||16||
48743266|NCT00066677|102157978|FG000|COMPLETED|Overall Study||16||
48743267|NCT00066677|102157979|FG001|COMPLETED|Overall Study||16||
48743268|NCT00066677|102157978|FG000|NOT COMPLETED|Overall Study||0||
48743269|NCT00066677|102157979|FG001|NOT COMPLETED|Overall Study||0||
48743270|NCT01858363|102157980|FG000|STARTED|Overall Study||222||254
48743271|NCT01858363|102157981|FG001|STARTED|Overall Study||72||79
48743272|NCT01858363|102157980|FG000|Pre-discharge Visit|Overall Study||219||251
48743273|NCT01858363|102157981|FG001|Pre-discharge Visit|Overall Study||72||79
48743274|NCT01858363|102157980|FG000|1-month Visit|Overall Study||214||246
48743275|NCT01858363|102157981|FG001|1-month Visit|Overall Study||68||75
48743276|NCT01858363|102157980|FG000|6-month Visit|Overall Study||208||239
48743277|NCT01858363|102157981|FG001|6-month Visit|Overall Study||64||71
48743278|NCT01858363|102157980|FG000|12-month Vist|Overall Study||205||235
48743279|NCT01858363|102157981|FG001|12-month Vist|Overall Study||61||67
48743280|NCT01858363|102157980|FG000|24-month Visit|Overall Study||184||209
48743281|NCT01858363|102157981|FG001|24-month Visit|Overall Study||58||64
48743282|NCT01858363|102157980|FG000|36-month Visit|Overall Study||169||194
48743283|NCT01858363|102157981|FG001|36-month Visit|Overall Study||53||59
48619909|NCT00732069|101856293|FG004|STARTED|Washout After First Study Drug||3||
48619910|NCT00732069|101856294|FG005|STARTED|Washout After First Study Drug||2||
48619911|NCT00732069|101856289|FG000|COMPLETED|Washout After First Study Drug||2||
48619912|NCT00732069|101856290|FG001|COMPLETED|Washout After First Study Drug||3||
48326318|NCT02420873|101124633|FG001|COMPLETED|Overall Study||0||
48619913|NCT00732069|101856291|FG002|COMPLETED|Washout After First Study Drug||3||
48619914|NCT00732069|101856292|FG003|COMPLETED|Washout After First Study Drug||2||
48619915|NCT00732069|101856293|FG004|COMPLETED|Washout After First Study Drug||3||
48619916|NCT00732069|101856294|FG005|COMPLETED|Washout After First Study Drug||2||
48619917|NCT00732069|101856289|FG000|NOT COMPLETED|Washout After First Study Drug||1||
48619918|NCT00732069|101856290|FG001|NOT COMPLETED|Washout After First Study Drug||0||
48619919|NCT00732069|101856291|FG002|NOT COMPLETED|Washout After First Study Drug||0||
48619920|NCT00732069|101856292|FG003|NOT COMPLETED|Washout After First Study Drug||0||
48619921|NCT00732069|101856293|FG004|NOT COMPLETED|Washout After First Study Drug||0||
48743284|NCT01858363|102157980|FG000|48-month Visit|Overall Study||157||179
48743285|NCT01858363|102157981|FG001|48-month Visit|Overall Study||53||59
48743286|NCT01858363|102157980|FG000|COMPLETED|Overall Study||146||167
48743287|NCT01858363|102157981|FG001|COMPLETED|Overall Study||46||51
48326319|NCT02420873|101124634|FG002|COMPLETED|Overall Study||0||
48619922|NCT00732069|101856294|FG005|NOT COMPLETED|Washout After First Study Drug||0||
48619923|NCT00732069|101856289|FG000|STARTED|Second Study Drug||2||
48619924|NCT00732069|101856290|FG001|STARTED|Second Study Drug||3||
48619925|NCT00732069|101856291|FG002|STARTED|Second Study Drug||3||
48743288|NCT01858363|102157980|FG000|NOT COMPLETED|Overall Study||76||87
48619926|NCT00732069|101856292|FG003|STARTED|Second Study Drug||2||
48743289|NCT01858363|102157981|FG001|NOT COMPLETED|Overall Study||26||28
48743290|NCT01946152|102157982|FG000|STARTED|Overall Study||3||
48743291|NCT01946152|102157983|FG001|STARTED|Overall Study||3||
48619927|NCT00732069|101856293|FG004|STARTED|Second Study Drug||3||
48619928|NCT00732069|101856294|FG005|STARTED|Second Study Drug||2||
48619929|NCT00732069|101856289|FG000|COMPLETED|Second Study Drug||2||
48619930|NCT00732069|101856290|FG001|COMPLETED|Second Study Drug||3||
48619931|NCT00732069|101856291|FG002|COMPLETED|Second Study Drug||3||
48619932|NCT00732069|101856292|FG003|COMPLETED|Second Study Drug||2||
48619933|NCT00732069|101856293|FG004|COMPLETED|Second Study Drug||3||
48619934|NCT00732069|101856294|FG005|COMPLETED|Second Study Drug||2||
48619935|NCT00732069|101856289|FG000|NOT COMPLETED|Second Study Drug||0||
48619936|NCT00732069|101856290|FG001|NOT COMPLETED|Second Study Drug||0||
48619937|NCT00732069|101856291|FG002|NOT COMPLETED|Second Study Drug||0||
48619938|NCT00732069|101856292|FG003|NOT COMPLETED|Second Study Drug||0||
48619939|NCT00732069|101856293|FG004|NOT COMPLETED|Second Study Drug||0||
48619940|NCT00732069|101856294|FG005|NOT COMPLETED|Second Study Drug||0||
48619941|NCT00732069|101856289|FG000|STARTED|Washout After Second Study Drug||2||
48619942|NCT00732069|101856290|FG001|STARTED|Washout After Second Study Drug||3||
48619943|NCT00732069|101856291|FG002|STARTED|Washout After Second Study Drug||3||
48743292|NCT01946152|102157984|FG002|STARTED|Overall Study||6||
48743293|NCT01946152|102157985|FG003|STARTED|Overall Study||8||
48743294|NCT01946152|102157982|FG000|COMPLETED|Overall Study||2||
48743295|NCT01946152|102157983|FG001|COMPLETED|Overall Study||0||
48743296|NCT01946152|102157984|FG002|COMPLETED|Overall Study||0||
48743297|NCT01946152|102157985|FG003|COMPLETED|Overall Study||0||
48743298|NCT01946152|102157982|FG000|NOT COMPLETED|Overall Study||1||
48743299|NCT01946152|102157983|FG001|NOT COMPLETED|Overall Study||3||
48743300|NCT01946152|102157984|FG002|NOT COMPLETED|Overall Study||6||
48619944|NCT00732069|101856292|FG003|STARTED|Washout After Second Study Drug||2||
48619945|NCT00732069|101856293|FG004|STARTED|Washout After Second Study Drug||3||
48619946|NCT00732069|101856294|FG005|STARTED|Washout After Second Study Drug||2||
48619947|NCT00732069|101856289|FG000|COMPLETED|Washout After Second Study Drug||2||
48743301|NCT01946152|102157985|FG003|NOT COMPLETED|Overall Study||8||
48743302|NCT01449006|102157986|FG000|STARTED|Overall Study||8||
48743303|NCT01449006|102157987|FG001|STARTED|Overall Study||9||
48619948|NCT00732069|101856290|FG001|COMPLETED|Washout After Second Study Drug||3||
48619949|NCT00732069|101856291|FG002|COMPLETED|Washout After Second Study Drug||3||
48619950|NCT00732069|101856292|FG003|COMPLETED|Washout After Second Study Drug||2||
48619951|NCT00732069|101856293|FG004|COMPLETED|Washout After Second Study Drug||3||
48619952|NCT00732069|101856294|FG005|COMPLETED|Washout After Second Study Drug||2||
48619953|NCT00732069|101856289|FG000|NOT COMPLETED|Washout After Second Study Drug||0||
48657105|NCT03761914|101943782|FG004|STARTED|Overall Study||0||
48743304|NCT01449006|102157986|FG000|COMPLETED|Overall Study||5||
48619954|NCT00732069|101856290|FG001|NOT COMPLETED|Washout After Second Study Drug||0||
48619955|NCT00732069|101856291|FG002|NOT COMPLETED|Washout After Second Study Drug||0||
48619956|NCT00732069|101856292|FG003|NOT COMPLETED|Washout After Second Study Drug||0||
48619957|NCT00732069|101856293|FG004|NOT COMPLETED|Washout After Second Study Drug||0||
48743305|NCT01449006|102157987|FG001|COMPLETED|Overall Study||9||
48743306|NCT01449006|102157986|FG000|NOT COMPLETED|Overall Study||3||
48743307|NCT01449006|102157987|FG001|NOT COMPLETED|Overall Study||0||
48743308|NCT03980730|102157988|FG000|STARTED|Overall Study||21||
48743309|NCT03980730|102157989|FG001|STARTED|Overall Study||22||
48743310|NCT03980730|102157988|FG000|COMPLETED|Overall Study||19||
48743311|NCT03980730|102157989|FG001|COMPLETED|Overall Study||18||
48743312|NCT03980730|102157988|FG000|NOT COMPLETED|Overall Study||2||
48743313|NCT03980730|102157989|FG001|NOT COMPLETED|Overall Study||4||
48743314|NCT00699608|102157990|FG000|STARTED|First Intervention||16||
48743315|NCT00699608|102157991|FG001|STARTED|First Intervention||15||
48743316|NCT00699608|102157992|FG002|STARTED|First Intervention||15||
48743317|NCT00699608|102157993|FG003|STARTED|First Intervention||15||
48743318|NCT00699608|102157994|FG004|STARTED|First Intervention||15||
48743319|NCT00699608|102157995|FG005|STARTED|First Intervention||15||
48743320|NCT00699608|102157990|FG000|COMPLETED|First Intervention||16||
48743321|NCT00699608|102157991|FG001|COMPLETED|First Intervention||15||
48743322|NCT00699608|102157992|FG002|COMPLETED|First Intervention||14||
48743323|NCT00699608|102157993|FG003|COMPLETED|First Intervention||15||
48743324|NCT00699608|102157994|FG004|COMPLETED|First Intervention||14||
48743325|NCT00699608|102157995|FG005|COMPLETED|First Intervention||15||
48743326|NCT00699608|102157990|FG000|NOT COMPLETED|First Intervention||0||
48743327|NCT00699608|102157991|FG001|NOT COMPLETED|First Intervention||0||
48743328|NCT00699608|102157992|FG002|NOT COMPLETED|First Intervention||1||
48743329|NCT00699608|102157993|FG003|NOT COMPLETED|First Intervention||0||
48743330|NCT00699608|102157994|FG004|NOT COMPLETED|First Intervention||1||
48743331|NCT00699608|102157995|FG005|NOT COMPLETED|First Intervention||0||
48743332|NCT00699608|102157990|FG000|STARTED|First 4-14 Day Washout Period||16||
48743333|NCT00699608|102157991|FG001|STARTED|First 4-14 Day Washout Period||15||
48743334|NCT00699608|102157992|FG002|STARTED|First 4-14 Day Washout Period||14||
48743335|NCT00699608|102157993|FG003|STARTED|First 4-14 Day Washout Period||15||
48743336|NCT00699608|102157994|FG004|STARTED|First 4-14 Day Washout Period||14||
48743337|NCT00699608|102157995|FG005|STARTED|First 4-14 Day Washout Period||15||
48743338|NCT00699608|102157990|FG000|COMPLETED|First 4-14 Day Washout Period||16||
48743339|NCT00699608|102157991|FG001|COMPLETED|First 4-14 Day Washout Period||15||
48743340|NCT00699608|102157992|FG002|COMPLETED|First 4-14 Day Washout Period||14||
48743341|NCT00699608|102157993|FG003|COMPLETED|First 4-14 Day Washout Period||15||
48743342|NCT00699608|102157994|FG004|COMPLETED|First 4-14 Day Washout Period||14||
48743343|NCT00699608|102157995|FG005|COMPLETED|First 4-14 Day Washout Period||15||
48743344|NCT00699608|102157990|FG000|NOT COMPLETED|First 4-14 Day Washout Period||0||
48743345|NCT00699608|102157991|FG001|NOT COMPLETED|First 4-14 Day Washout Period||0||
48743346|NCT00699608|102157992|FG002|NOT COMPLETED|First 4-14 Day Washout Period||0||
48743347|NCT00699608|102157993|FG003|NOT COMPLETED|First 4-14 Day Washout Period||0||
48743348|NCT00699608|102157994|FG004|NOT COMPLETED|First 4-14 Day Washout Period||0||
48743349|NCT00699608|102157995|FG005|NOT COMPLETED|First 4-14 Day Washout Period||0||
48743350|NCT00699608|102157990|FG000|STARTED|Second Intervention||16||
48743351|NCT00699608|102157991|FG001|STARTED|Second Intervention||15||
48743352|NCT00699608|102157992|FG002|STARTED|Second Intervention||14||
48743353|NCT00699608|102157993|FG003|STARTED|Second Intervention||15||
48743354|NCT00699608|102157994|FG004|STARTED|Second Intervention||14||
48743355|NCT00699608|102157995|FG005|STARTED|Second Intervention||15||
48743356|NCT00699608|102157990|FG000|COMPLETED|Second Intervention||16||
48743357|NCT00699608|102157991|FG001|COMPLETED|Second Intervention||15||
48743358|NCT00699608|102157992|FG002|COMPLETED|Second Intervention||13||
48743359|NCT00699608|102157993|FG003|COMPLETED|Second Intervention||14||
48743360|NCT00699608|102157994|FG004|COMPLETED|Second Intervention||14||
48743361|NCT00699608|102157995|FG005|COMPLETED|Second Intervention||15||
48743362|NCT00699608|102157990|FG000|NOT COMPLETED|Second Intervention||0||
48743363|NCT00699608|102157991|FG001|NOT COMPLETED|Second Intervention||0||
48619958|NCT00732069|101856294|FG005|NOT COMPLETED|Washout After Second Study Drug||0||
48619959|NCT00732069|101856289|FG000|STARTED|Third Study Drug||2||
48619960|NCT00732069|101856290|FG001|STARTED|Third Study Drug||3||
48619961|NCT00732069|101856291|FG002|STARTED|Third Study Drug||3||
48619962|NCT00732069|101856292|FG003|STARTED|Third Study Drug||2||
48619963|NCT00732069|101856293|FG004|STARTED|Third Study Drug||3||
48619964|NCT00732069|101856294|FG005|STARTED|Third Study Drug||2||
48619965|NCT00732069|101856289|FG000|COMPLETED|Third Study Drug||2||
48619966|NCT00732069|101856290|FG001|COMPLETED|Third Study Drug||3||
48619967|NCT00732069|101856291|FG002|COMPLETED|Third Study Drug||3||
48619968|NCT00732069|101856292|FG003|COMPLETED|Third Study Drug||2||
48619969|NCT00732069|101856293|FG004|COMPLETED|Third Study Drug||3||
48619970|NCT00732069|101856294|FG005|COMPLETED|Third Study Drug||2||
48619971|NCT00732069|101856289|FG000|NOT COMPLETED|Third Study Drug||0||
48743364|NCT00699608|102157992|FG002|NOT COMPLETED|Second Intervention||1||
48743365|NCT00699608|102157993|FG003|NOT COMPLETED|Second Intervention||1||
48619972|NCT00732069|101856290|FG001|NOT COMPLETED|Third Study Drug||0||
48619973|NCT00732069|101856291|FG002|NOT COMPLETED|Third Study Drug||0||
48619974|NCT00732069|101856292|FG003|NOT COMPLETED|Third Study Drug||0||
48619975|NCT00732069|101856293|FG004|NOT COMPLETED|Third Study Drug||0||
48743366|NCT00699608|102157994|FG004|NOT COMPLETED|Second Intervention||0||
48743367|NCT00699608|102157995|FG005|NOT COMPLETED|Second Intervention||0||
48163359|NCT05044325|100721819|FG008|NOT COMPLETED|Part A:Treatment Period 2||0||
48163360|NCT05044325|100721820|FG009|NOT COMPLETED|Part A:Treatment Period 2||0||
48163361|NCT05044325|100721811|FG000|STARTED|Part A:Treatment Period 3||3||
48326320|NCT02420873|101124632|FG000|NOT COMPLETED|Overall Study||0||
48743368|NCT00699608|102157990|FG000|STARTED|Second 4-14 Day Washout Period||16||
48743369|NCT00699608|102157991|FG001|STARTED|Second 4-14 Day Washout Period||15||
48743370|NCT00699608|102157992|FG002|STARTED|Second 4-14 Day Washout Period||13||
48743371|NCT00699608|102157993|FG003|STARTED|Second 4-14 Day Washout Period||14||
48743372|NCT00699608|102157994|FG004|STARTED|Second 4-14 Day Washout Period||14||
48743373|NCT00699608|102157995|FG005|STARTED|Second 4-14 Day Washout Period||15||
48743374|NCT00699608|102157990|FG000|COMPLETED|Second 4-14 Day Washout Period||16||
48743375|NCT00699608|102157991|FG001|COMPLETED|Second 4-14 Day Washout Period||15||
48743376|NCT00699608|102157992|FG002|COMPLETED|Second 4-14 Day Washout Period||13||
48743377|NCT00699608|102157993|FG003|COMPLETED|Second 4-14 Day Washout Period||14||
48743378|NCT00699608|102157994|FG004|COMPLETED|Second 4-14 Day Washout Period||14||
48743379|NCT00699608|102157995|FG005|COMPLETED|Second 4-14 Day Washout Period||15||
48743380|NCT00699608|102157990|FG000|NOT COMPLETED|Second 4-14 Day Washout Period||0||
48743381|NCT00699608|102157991|FG001|NOT COMPLETED|Second 4-14 Day Washout Period||0||
48743382|NCT00699608|102157992|FG002|NOT COMPLETED|Second 4-14 Day Washout Period||0||
48743383|NCT00699608|102157993|FG003|NOT COMPLETED|Second 4-14 Day Washout Period||0||
48743384|NCT00699608|102157994|FG004|NOT COMPLETED|Second 4-14 Day Washout Period||0||
48743385|NCT00699608|102157995|FG005|NOT COMPLETED|Second 4-14 Day Washout Period||0||
48743386|NCT00699608|102157990|FG000|STARTED|Third Intervention||16||
48743387|NCT00699608|102157991|FG001|STARTED|Third Intervention||15||
48743388|NCT00699608|102157992|FG002|STARTED|Third Intervention||13||
48743389|NCT00699608|102157993|FG003|STARTED|Third Intervention||14||
48743390|NCT00699608|102157994|FG004|STARTED|Third Intervention||14||
48743391|NCT00699608|102157995|FG005|STARTED|Third Intervention||15||
48743392|NCT00699608|102157990|FG000|COMPLETED|Third Intervention||16||
48743393|NCT00699608|102157991|FG001|COMPLETED|Third Intervention||15||
48743394|NCT00699608|102157992|FG002|COMPLETED|Third Intervention||13||
48163362|NCT05044325|100721812|FG001|STARTED|Part A:Treatment Period 3||3||
48163363|NCT05044325|100721813|FG002|STARTED|Part A:Treatment Period 3||3||
48619976|NCT00732069|101856294|FG005|NOT COMPLETED|Third Study Drug||0||
48619977|NCT01789047|101856295|FG000|STARTED|Overall Study||21||
48619978|NCT01789047|101856296|FG001|STARTED|Overall Study||21||
48619979|NCT01789047|101856295|FG000|COMPLETED|Overall Study||17||
48619980|NCT01789047|101856296|FG001|COMPLETED|Overall Study||17||
48619981|NCT01789047|101856295|FG000|NOT COMPLETED|Overall Study||4||
48619982|NCT01789047|101856296|FG001|NOT COMPLETED|Overall Study||4||
48619983|NCT00913081|101856297|FG000|STARTED|Quercetin 500 mg + Niacin 500 mg (1day)||17||
48619984|NCT00913081|101856297|FG000|COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||17||
48163364|NCT05044325|100721814|FG003|STARTED|Part A:Treatment Period 3||0||
48619985|NCT00913081|101856297|FG000|NOT COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||0||
48743395|NCT00699608|102157993|FG003|COMPLETED|Third Intervention||14||
48163365|NCT05044325|100721815|FG004|STARTED|Part A:Treatment Period 3||0||
48163366|NCT05044325|100721816|FG005|STARTED|Part A:Treatment Period 3||0||
48163367|NCT05044325|100721817|FG006|STARTED|Part A:Treatment Period 3||0||
48163368|NCT05044325|100721818|FG007|STARTED|Part A:Treatment Period 3||0||
48163369|NCT05044325|100721819|FG008|STARTED|Part A:Treatment Period 3||0||
48163370|NCT05044325|100721820|FG009|STARTED|Part A:Treatment Period 3||0||
48163371|NCT05044325|100721811|FG000|COMPLETED|Part A:Treatment Period 3||3||
48163372|NCT05044325|100721812|FG001|COMPLETED|Part A:Treatment Period 3||3||
48163373|NCT05044325|100721813|FG002|COMPLETED|Part A:Treatment Period 3||3||
48163374|NCT05044325|100721814|FG003|COMPLETED|Part A:Treatment Period 3||0||
48163375|NCT05044325|100721815|FG004|COMPLETED|Part A:Treatment Period 3||0||
48163376|NCT05044325|100721816|FG005|COMPLETED|Part A:Treatment Period 3||0||
48163377|NCT05044325|100721817|FG006|COMPLETED|Part A:Treatment Period 3||0||
48163378|NCT05044325|100721818|FG007|COMPLETED|Part A:Treatment Period 3||0||
48163379|NCT05044325|100721819|FG008|COMPLETED|Part A:Treatment Period 3||0||
48163380|NCT05044325|100721820|FG009|COMPLETED|Part A:Treatment Period 3||0||
48163381|NCT05044325|100721811|FG000|NOT COMPLETED|Part A:Treatment Period 3||0||
48163382|NCT05044325|100721812|FG001|NOT COMPLETED|Part A:Treatment Period 3||0||
48163383|NCT05044325|100721813|FG002|NOT COMPLETED|Part A:Treatment Period 3||0||
48163384|NCT05044325|100721814|FG003|NOT COMPLETED|Part A:Treatment Period 3||0||
48163385|NCT05044325|100721815|FG004|NOT COMPLETED|Part A:Treatment Period 3||0||
48163386|NCT05044325|100721816|FG005|NOT COMPLETED|Part A:Treatment Period 3||0||
48163387|NCT05044325|100721817|FG006|NOT COMPLETED|Part A:Treatment Period 3||0||
48163388|NCT05044325|100721818|FG007|NOT COMPLETED|Part A:Treatment Period 3||0||
48163389|NCT05044325|100721819|FG008|NOT COMPLETED|Part A:Treatment Period 3||0||
48163390|NCT05044325|100721820|FG009|NOT COMPLETED|Part A:Treatment Period 3||0||
48163391|NCT05044325|100721811|FG000|STARTED|Part B||0||
48163392|NCT05044325|100721812|FG001|STARTED|Part B||0||
48163393|NCT05044325|100721813|FG002|STARTED|Part B||0||
48163394|NCT05044325|100721814|FG003|STARTED|Part B||0||
48163395|NCT05044325|100721815|FG004|STARTED|Part B||0||
48163396|NCT05044325|100721816|FG005|STARTED|Part B||0||
48619986|NCT00913081|101856297|FG000|STARTED|Washout #1 (7 Days)||17||
48619987|NCT00913081|101856297|FG000|COMPLETED|Washout #1 (7 Days)||17||
48619988|NCT00913081|101856297|FG000|NOT COMPLETED|Washout #1 (7 Days)||0||
48619989|NCT00913081|101856297|FG000|STARTED|Quercetin 1000 mg + Niacin 500 mg (1day)||17||
48743396|NCT00699608|102157994|FG004|COMPLETED|Third Intervention||14||
48163397|NCT05044325|100721817|FG006|STARTED|Part B||0||
48163398|NCT05044325|100721818|FG007|STARTED|Part B||0||
48163399|NCT05044325|100721819|FG008|STARTED|Part B||1||
48163400|NCT05044325|100721820|FG009|STARTED|Part B||1||
48163401|NCT05044325|100721811|FG000|COMPLETED|Part B||0||
48163402|NCT05044325|100721812|FG001|COMPLETED|Part B||0||
48163403|NCT05044325|100721813|FG002|COMPLETED|Part B||0||
48163404|NCT05044325|100721814|FG003|COMPLETED|Part B||0||
48163405|NCT05044325|100721815|FG004|COMPLETED|Part B||0||
48163406|NCT05044325|100721816|FG005|COMPLETED|Part B||0||
48163407|NCT05044325|100721817|FG006|COMPLETED|Part B||0||
48163408|NCT05044325|100721818|FG007|COMPLETED|Part B||0||
48163409|NCT05044325|100721819|FG008|COMPLETED|Part B||1||
48163410|NCT05044325|100721820|FG009|COMPLETED|Part B||1||
48163411|NCT05044325|100721811|FG000|NOT COMPLETED|Part B||0||
48163412|NCT05044325|100721812|FG001|NOT COMPLETED|Part B||0||
48163413|NCT05044325|100721813|FG002|NOT COMPLETED|Part B||0||
48163414|NCT05044325|100721814|FG003|NOT COMPLETED|Part B||0||
48163415|NCT05044325|100721815|FG004|NOT COMPLETED|Part B||0||
48163416|NCT05044325|100721816|FG005|NOT COMPLETED|Part B||0||
48163417|NCT05044325|100721817|FG006|NOT COMPLETED|Part B||0||
48619990|NCT00913081|101856297|FG000|COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||17||
48619991|NCT00913081|101856297|FG000|NOT COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||0||
48619992|NCT00913081|101856297|FG000|STARTED|Washout #2 (7 Days)||17||
48619993|NCT00913081|101856297|FG000|COMPLETED|Washout #2 (7 Days)||17||
48619994|NCT00913081|101856297|FG000|NOT COMPLETED|Washout #2 (7 Days)||0||
48619995|NCT00913081|101856297|FG000|STARTED|Quercetin 2000 mg + Niacin 500 mg (1day)||17||
48743397|NCT00699608|102157995|FG005|COMPLETED|Third Intervention||15||
48743398|NCT00699608|102157990|FG000|NOT COMPLETED|Third Intervention||0||
48163418|NCT05044325|100721818|FG007|NOT COMPLETED|Part B||0||
48163419|NCT05044325|100721819|FG008|NOT COMPLETED|Part B||0||
48163420|NCT05044325|100721820|FG009|NOT COMPLETED|Part B||0||
48163421|NCT00709059|100721821|FG000|STARTED|Overall Study||538||
48163422|NCT00709059|100721821|FG000|COMPLETED|Overall Study||444||
48163423|NCT00709059|100721821|FG000|NOT COMPLETED|Overall Study||94||
48163424|NCT01986361|100721822|FG000|STARTED|Overall Study||101||
48163425|NCT01986361|100721823|FG001|STARTED|Overall Study||21||
48163426|NCT01986361|100721822|FG000|COMPLETED|Overall Study||101||
48163427|NCT01986361|100721823|FG001|COMPLETED|Overall Study||21||
48163428|NCT01986361|100721822|FG000|NOT COMPLETED|Overall Study||0||
48163429|NCT01986361|100721823|FG001|NOT COMPLETED|Overall Study||0||
48163430|NCT03303469|100721824|FG000|STARTED|Overall Study||3||
48163431|NCT03303469|100721824|FG000|COMPLETED|Overall Study||1||
48163432|NCT03303469|100721824|FG000|NOT COMPLETED|Overall Study||2||
48163433|NCT03704584|100721825|FG000|STARTED|Overall Study||36||43
48163434|NCT03704584|100721826|FG001|STARTED|Overall Study||26||31
48163435|NCT03704584|100721825|FG000|COMPLETED|Overall Study||35||42
48619996|NCT00913081|101856297|FG000|COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||17||
48619997|NCT00913081|101856297|FG000|NOT COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||0||
48619998|NCT00913081|101856297|FG000|STARTED|Washout #3 (7days)||17||
48619999|NCT00913081|101856297|FG000|COMPLETED|Washout #3 (7days)||17||
48620000|NCT00913081|101856297|FG000|NOT COMPLETED|Washout #3 (7days)||0||
48620001|NCT00913081|101856297|FG000|STARTED|Placebo + Niacin 500 mg (1day)||17||
48620002|NCT00913081|101856297|FG000|COMPLETED|Placebo + Niacin 500 mg (1day)||17||
48620003|NCT00913081|101856297|FG000|NOT COMPLETED|Placebo + Niacin 500 mg (1day)||0||
48620004|NCT02762084|101856298|FG000|STARTED|Overall Study||6||
48620005|NCT02762084|101856299|FG001|STARTED|Overall Study||6||
48620006|NCT02762084|101856300|FG002|STARTED|Overall Study||5||
48620007|NCT02762084|101856298|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
48620008|NCT02762084|101856299|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
48620009|NCT02762084|101856300|FG002|Received at Least 1 Dose of Study Drug|Overall Study||5||
48620010|NCT02762084|101856298|FG000|By Tumor Per Protocol Population (PP)|Overall Study||6|All treatment-targeted tumors except those biopsied and those that did not meet protocol criteria.|
48620011|NCT02762084|101856299|FG001|By Tumor Per Protocol Population (PP)|Overall Study||6|All treatment-targeted tumors except those biopsied and those that did not meet protocol criteria.|
48620012|NCT02762084|101856300|FG002|By Tumor Per Protocol Population (PP)|Overall Study||4|All treatment-targeted tumors except those biopsied and those that did not meet protocol criteria.|
48620013|NCT02762084|101856298|FG000|COMPLETED|Overall Study||5||
48620014|NCT02762084|101856299|FG001|COMPLETED|Overall Study||6||
48620015|NCT02762084|101856300|FG002|COMPLETED|Overall Study||4||
48620016|NCT02762084|101856298|FG000|NOT COMPLETED|Overall Study||1||
48620017|NCT02762084|101856299|FG001|NOT COMPLETED|Overall Study||0||
48620018|NCT02762084|101856300|FG002|NOT COMPLETED|Overall Study||1||
48620019|NCT01714544|101856301|FG000|STARTED|Overall Study||60||
48620020|NCT01714544|101856301|FG000|COMPLETED|Overall Study||57||
48620021|NCT01714544|101856301|FG000|NOT COMPLETED|Overall Study||3||
48620022|NCT01348139|101856302|FG000|STARTED|Period 1||5||
48620023|NCT01348139|101856303|FG001|STARTED|Period 1||4||
48620024|NCT01348139|101856304|FG002|STARTED|Period 1||4||
48620025|NCT01348139|101856305|FG003|STARTED|Period 1||4||
48620026|NCT01348139|101856306|FG004|STARTED|Period 1||5||
48620027|NCT01348139|101856307|FG005|STARTED|Period 1||4||
48620028|NCT01348139|101856302|FG000|COMPLETED|Period 1||4||
48620029|NCT01348139|101856303|FG001|COMPLETED|Period 1||4||
48620030|NCT01348139|101856304|FG002|COMPLETED|Period 1||4||
48620031|NCT01348139|101856305|FG003|COMPLETED|Period 1||4||
48620032|NCT01348139|101856306|FG004|COMPLETED|Period 1||5||
48620033|NCT01348139|101856307|FG005|COMPLETED|Period 1||4||
48620034|NCT01348139|101856302|FG000|NOT COMPLETED|Period 1||1||
48620035|NCT01348139|101856303|FG001|NOT COMPLETED|Period 1||0||
48620036|NCT01348139|101856304|FG002|NOT COMPLETED|Period 1||0||
48620037|NCT01348139|101856305|FG003|NOT COMPLETED|Period 1||0||
48620038|NCT01348139|101856306|FG004|NOT COMPLETED|Period 1||0||
48620039|NCT01348139|101856307|FG005|NOT COMPLETED|Period 1||0||
48620040|NCT01348139|101856302|FG000|STARTED|Period 2||4||
48326321|NCT02420873|101124633|FG001|NOT COMPLETED|Overall Study||0||
48620041|NCT01348139|101856303|FG001|STARTED|Period 2||4||
48620042|NCT01348139|101856304|FG002|STARTED|Period 2||4||
48620043|NCT01348139|101856305|FG003|STARTED|Period 2||4||
48620044|NCT01348139|101856306|FG004|STARTED|Period 2||5||
48620045|NCT01348139|101856307|FG005|STARTED|Period 2||4||
48620046|NCT01348139|101856302|FG000|COMPLETED|Period 2||4||
48620047|NCT01348139|101856303|FG001|COMPLETED|Period 2||4||
48620048|NCT01348139|101856304|FG002|COMPLETED|Period 2||4||
48620049|NCT01348139|101856305|FG003|COMPLETED|Period 2||4||
48620050|NCT01348139|101856306|FG004|COMPLETED|Period 2||5||
48620051|NCT01348139|101856307|FG005|COMPLETED|Period 2||4||
48620052|NCT01348139|101856302|FG000|NOT COMPLETED|Period 2||0||
48620053|NCT01348139|101856303|FG001|NOT COMPLETED|Period 2||0||
48620054|NCT01348139|101856304|FG002|NOT COMPLETED|Period 2||0||
48163436|NCT03704584|100721826|FG001|COMPLETED|Overall Study||26||31
48163437|NCT03704584|100721825|FG000|NOT COMPLETED|Overall Study||1||1
48163438|NCT03704584|100721826|FG001|NOT COMPLETED|Overall Study||0||0
48163439|NCT01352585|100721827|FG000|STARTED|Overall Study||23||
48163440|NCT01352585|100721828|FG001|STARTED|Overall Study||24||
48163441|NCT01352585|100721827|FG000|COMPLETED|Overall Study||15||
48163442|NCT01352585|100721828|FG001|COMPLETED|Overall Study||21||
48163443|NCT01352585|100721827|FG000|NOT COMPLETED|Overall Study||8||
48163444|NCT01352585|100721828|FG001|NOT COMPLETED|Overall Study||3||
48163445|NCT04859660|100721829|FG000|STARTED|Overall Study||81||
48163446|NCT04859660|100721830|FG001|STARTED|Overall Study||80||
48163447|NCT04859660|100721829|FG000|COMPLETED|Overall Study||77||
48163448|NCT04859660|100721830|FG001|COMPLETED|Overall Study||73||
48163449|NCT04859660|100721829|FG000|NOT COMPLETED|Overall Study||4||
48163450|NCT04859660|100721830|FG001|NOT COMPLETED|Overall Study||7||
48163451|NCT02002884|100721831|FG000|STARTED|Main Period (MP)||87||
48163452|NCT02002884|100721832|FG001|STARTED|Main Period (MP)||88||
48163453|NCT02002884|100721833|FG002|STARTED|Main Period (MP)||176||
48163454|NCT02002884|100721834|FG003|STARTED|Main Period (MP)||0||
48163455|NCT02002884|100721831|FG000|Treated|Main Period (MP)||87||
48163456|NCT02002884|100721832|FG001|Treated|Main Period (MP)||87||
48163457|NCT02002884|100721833|FG002|Treated|Main Period (MP)||176||
48163458|NCT02002884|100721834|FG003|Treated|Main Period (MP)||0||
48163459|NCT02002884|100721831|FG000|COMPLETED|Main Period (MP)||81||
48163460|NCT02002884|100721832|FG001|COMPLETED|Main Period (MP)||82||
48163461|NCT02002884|100721833|FG002|COMPLETED|Main Period (MP)||168||
48163462|NCT02002884|100721834|FG003|COMPLETED|Main Period (MP)||0||
48163463|NCT02002884|100721831|FG000|NOT COMPLETED|Main Period (MP)||6||
48163464|NCT02002884|100721832|FG001|NOT COMPLETED|Main Period (MP)||6||
48163465|NCT02002884|100721833|FG002|NOT COMPLETED|Main Period (MP)||8||
48163466|NCT02002884|100721834|FG003|NOT COMPLETED|Main Period (MP)||0||
48163467|NCT02002884|100721831|FG000|STARTED|Open-Label Extension Period (OLEX)||0||
48163468|NCT02002884|100721832|FG001|STARTED|Open-Label Extension Period (OLEX)||0||
48163469|NCT02002884|100721833|FG002|STARTED|Open-Label Extension Period (OLEX)||0||
48163470|NCT02002884|100721834|FG003|STARTED|Open-Label Extension Period (OLEX)||331||
48163471|NCT02002884|100721831|FG000|COMPLETED|Open-Label Extension Period (OLEX)||0||
48163472|NCT02002884|100721832|FG001|COMPLETED|Open-Label Extension Period (OLEX)||0||
48163473|NCT02002884|100721833|FG002|COMPLETED|Open-Label Extension Period (OLEX)||0||
48163474|NCT02002884|100721834|FG003|COMPLETED|Open-Label Extension Period (OLEX)||281||
48163475|NCT02002884|100721831|FG000|NOT COMPLETED|Open-Label Extension Period (OLEX)||0||
48743399|NCT00699608|102157991|FG001|NOT COMPLETED|Third Intervention||0||
48743400|NCT00699608|102157992|FG002|NOT COMPLETED|Third Intervention||0||
48743401|NCT00699608|102157993|FG003|NOT COMPLETED|Third Intervention||0||
48743402|NCT00699608|102157994|FG004|NOT COMPLETED|Third Intervention||0||
48743403|NCT00699608|102157995|FG005|NOT COMPLETED|Third Intervention||0||
48743404|NCT01928927|102157996|FG000|STARTED|Overall Study||29||
48743405|NCT01928927|102157997|FG001|STARTED|Overall Study||15||
48743406|NCT01928927|102157996|FG000|COMPLETED|Overall Study||27||
48743407|NCT01928927|102157997|FG001|COMPLETED|Overall Study||14||
48163476|NCT02002884|100721832|FG001|NOT COMPLETED|Open-Label Extension Period (OLEX)||0||
48620055|NCT01348139|101856305|FG003|NOT COMPLETED|Period 2||0||
48620056|NCT01348139|101856306|FG004|NOT COMPLETED|Period 2||0||
48620057|NCT01348139|101856307|FG005|NOT COMPLETED|Period 2||0||
48620058|NCT01348139|101856302|FG000|STARTED|Period 3||4||
48620059|NCT01348139|101856303|FG001|STARTED|Period 3||4||
48620060|NCT01348139|101856304|FG002|STARTED|Period 3||4||
48620061|NCT01348139|101856305|FG003|STARTED|Period 3||4||
48620062|NCT01348139|101856306|FG004|STARTED|Period 3||5||
48620063|NCT01348139|101856307|FG005|STARTED|Period 3||4||
48620064|NCT01348139|101856302|FG000|COMPLETED|Period 3||4||
48620065|NCT01348139|101856303|FG001|COMPLETED|Period 3||4||
48620066|NCT01348139|101856304|FG002|COMPLETED|Period 3||4||
48620067|NCT01348139|101856305|FG003|COMPLETED|Period 3||4||
48620068|NCT01348139|101856306|FG004|COMPLETED|Period 3||5||
48743408|NCT01928927|102157996|FG000|NOT COMPLETED|Overall Study||2||
48620069|NCT01348139|101856307|FG005|COMPLETED|Period 3||4||
48620070|NCT01348139|101856302|FG000|NOT COMPLETED|Period 3||0||
48620071|NCT01348139|101856303|FG001|NOT COMPLETED|Period 3||0||
48620072|NCT01348139|101856304|FG002|NOT COMPLETED|Period 3||0||
48163477|NCT02002884|100721833|FG002|NOT COMPLETED|Open-Label Extension Period (OLEX)||0||
48163478|NCT02002884|100721834|FG003|NOT COMPLETED|Open-Label Extension Period (OLEX)||50||
48163479|NCT01581840|100721835|FG000|STARTED|Overall Study||45||
48163480|NCT01581840|100721835|FG000|COMPLETED|Overall Study||45||
48163481|NCT01581840|100721835|FG000|NOT COMPLETED|Overall Study||0||
48163482|NCT02801669|100721836|FG000|STARTED|Overall Study||492||
48163483|NCT02801669|100721837|FG001|STARTED|Overall Study||492||
48163484|NCT02801669|100721836|FG000|Received at Least 1 Dose of Study Drug|Overall Study||492||
48163485|NCT02801669|100721837|FG001|Received at Least 1 Dose of Study Drug|Overall Study||490||
48163486|NCT02801669|100721836|FG000|COMPLETED|Overall Study||341||
48163487|NCT02801669|100721837|FG001|COMPLETED|Overall Study||340||
48620073|NCT01348139|101856305|FG003|NOT COMPLETED|Period 3||0||
48743409|NCT01928927|102157997|FG001|NOT COMPLETED|Overall Study||1||
48743410|NCT00687739|102157998|FG000|STARTED|Overall Study||25||
48163488|NCT02801669|100721836|FG000|NOT COMPLETED|Overall Study||151||
48163489|NCT02801669|100721837|FG001|NOT COMPLETED|Overall Study||152||
48163490|NCT02269371|100721838|FG000|STARTED|Overall Study||46||
48163491|NCT02269371|100721839|FG001|STARTED|Overall Study||36||
48163492|NCT02269371|100721838|FG000|COMPLETED|Overall Study||29||
48163493|NCT02269371|100721839|FG001|COMPLETED|Overall Study||25||
48163494|NCT02269371|100721838|FG000|NOT COMPLETED|Overall Study||17||
48163495|NCT02269371|100721839|FG001|NOT COMPLETED|Overall Study||11||
48163496|NCT01320943|100721840|FG000|STARTED|Overall Study||21||
48163497|NCT01320943|100721841|FG001|STARTED|Overall Study||22||
48163498|NCT01320943|100721840|FG000|COMPLETED|Overall Study||20||
48163499|NCT01320943|100721841|FG001|COMPLETED|Overall Study||20||
48163500|NCT01320943|100721840|FG000|NOT COMPLETED|Overall Study||1||
48163501|NCT01320943|100721841|FG001|NOT COMPLETED|Overall Study||2||
48163502|NCT01187914|100721842|FG000|STARTED|Overall Study||40||
48163503|NCT01187914|100721842|FG000|COMPLETED|Overall Study||40||
48163504|NCT01187914|100721842|FG000|NOT COMPLETED|Overall Study||0||
48163505|NCT02013388|100721843|FG000|STARTED|Overall Study||9||
48163506|NCT02013388|100721844|FG001|STARTED|Overall Study||6||
48163507|NCT02013388|100721845|FG002|STARTED|Overall Study||6||
48163508|NCT02013388|100721846|FG003|STARTED|Overall Study||6||
48163509|NCT02013388|100721847|FG004|STARTED|Overall Study||6||
48163510|NCT02013388|100721848|FG005|STARTED|Overall Study||6||
48163511|NCT02013388|100721849|FG006|STARTED|Overall Study||6||
48163512|NCT02013388|100721850|FG007|STARTED|Overall Study||4||
48163513|NCT02013388|100721843|FG000|COMPLETED|Overall Study||8||
48163514|NCT02013388|100721844|FG001|COMPLETED|Overall Study||6||
48163515|NCT02013388|100721845|FG002|COMPLETED|Overall Study||6||
48163516|NCT02013388|100721846|FG003|COMPLETED|Overall Study||6||
48163517|NCT02013388|100721847|FG004|COMPLETED|Overall Study||5||
48163518|NCT02013388|100721848|FG005|COMPLETED|Overall Study||6||
48163519|NCT02013388|100721849|FG006|COMPLETED|Overall Study||6||
48163520|NCT02013388|100721850|FG007|COMPLETED|Overall Study||4||
48163521|NCT02013388|100721843|FG000|NOT COMPLETED|Overall Study||1||
48163522|NCT02013388|100721844|FG001|NOT COMPLETED|Overall Study||0||
48163523|NCT02013388|100721845|FG002|NOT COMPLETED|Overall Study||0||
48163524|NCT02013388|100721846|FG003|NOT COMPLETED|Overall Study||0||
48163525|NCT02013388|100721847|FG004|NOT COMPLETED|Overall Study||1||
48163526|NCT02013388|100721848|FG005|NOT COMPLETED|Overall Study||0||
48163527|NCT02013388|100721849|FG006|NOT COMPLETED|Overall Study||0||
48163528|NCT02013388|100721850|FG007|NOT COMPLETED|Overall Study||0||
48163529|NCT02364180|100721851|FG000|STARTED|Overall Study||11||
48163530|NCT02364180|100721851|FG000|COMPLETED|Overall Study||10||
48163531|NCT02364180|100721851|FG000|NOT COMPLETED|Overall Study||1||
48163532|NCT04006925|100721852|FG000|STARTED|Overall Study||12||
48163533|NCT04006925|100721853|FG001|STARTED|Overall Study||12||
48163534|NCT04006925|100721852|FG000|COMPLETED|Overall Study||10||
48163535|NCT04006925|100721853|FG001|COMPLETED|Overall Study||12||
48163536|NCT04006925|100721852|FG000|NOT COMPLETED|Overall Study||2||
48163537|NCT04006925|100721853|FG001|NOT COMPLETED|Overall Study||0||
48163538|NCT02206217|100721854|FG000|STARTED|Overall Study||90||
48163539|NCT02206217|100721855|FG001|STARTED|Overall Study||93||
48163540|NCT02206217|100721854|FG000|COMPLETED|Overall Study||81||
48163541|NCT02206217|100721855|FG001|COMPLETED|Overall Study||79||
48163542|NCT02206217|100721854|FG000|NOT COMPLETED|Overall Study||9||
48163543|NCT02206217|100721855|FG001|NOT COMPLETED|Overall Study||14||
48163544|NCT01923805|100721856|FG000|STARTED|Overall Study||3|early termination|
48163545|NCT01923805|100721857|FG001|STARTED|Overall Study||5|early termination|
48163546|NCT01923805|100721856|FG000|COMPLETED|Overall Study||0||
48163547|NCT01923805|100721857|FG001|COMPLETED|Overall Study||0||
48163548|NCT01923805|100721856|FG000|NOT COMPLETED|Overall Study||3||
48163549|NCT01923805|100721857|FG001|NOT COMPLETED|Overall Study||5||
48163550|NCT02110732|100724829|FG000|STARTED|Overall Study||20||
48743411|NCT00687739|102157999|FG001|STARTED|Overall Study||15||
48743412|NCT00687739|102158000|FG002|STARTED|Overall Study||25||
48743413|NCT00687739|102158001|FG003|STARTED|Overall Study||14||
48743414|NCT00687739|102157998|FG000|COMPLETED|Overall Study||23||
48163551|NCT02110732|100724830|FG001|STARTED|Overall Study||20||
48743415|NCT00687739|102157999|FG001|COMPLETED|Overall Study||12||
48743416|NCT00687739|102158000|FG002|COMPLETED|Overall Study||23||
48743417|NCT00687739|102158001|FG003|COMPLETED|Overall Study||12||
48163552|NCT02110732|100724829|FG000|COMPLETED|Overall Study||14||
48163553|NCT02110732|100724830|FG001|COMPLETED|Overall Study||17||
48743418|NCT00687739|102157998|FG000|NOT COMPLETED|Overall Study||2||
48163554|NCT02110732|100724829|FG000|NOT COMPLETED|Overall Study||6||
48163555|NCT02110732|100724830|FG001|NOT COMPLETED|Overall Study||3||
48163556|NCT03012061|100724831|FG000|STARTED|Overall Study||143||
48163557|NCT03012061|100724832|FG001|STARTED|Overall Study||139||
48163558|NCT03012061|100724833|FG002|STARTED|Overall Study||139||
48163559|NCT03012061|100724831|FG000|COMPLETED|Overall Study||137||
48163560|NCT03012061|100724832|FG001|COMPLETED|Overall Study||130||
48163561|NCT03012061|100724833|FG002|COMPLETED|Overall Study||131||
48163562|NCT03012061|100724831|FG000|NOT COMPLETED|Overall Study||6||
48163563|NCT03012061|100724832|FG001|NOT COMPLETED|Overall Study||9||
48743419|NCT00687739|102157999|FG001|NOT COMPLETED|Overall Study||3||
48743420|NCT00687739|102158000|FG002|NOT COMPLETED|Overall Study||2||
48743421|NCT00687739|102158001|FG003|NOT COMPLETED|Overall Study||2||
48163564|NCT03012061|100724833|FG002|NOT COMPLETED|Overall Study||8||
48163565|NCT01871558|100724834|FG000|STARTED|Overall Study||21||
48163566|NCT01871558|100724835|FG001|STARTED|Overall Study||21||
48163567|NCT01871558|100724834|FG000|COMPLETED|Overall Study||18||
48163568|NCT01871558|100724835|FG001|COMPLETED|Overall Study||19||
48163569|NCT01871558|100724834|FG000|NOT COMPLETED|Overall Study||3||
48163570|NCT01871558|100724835|FG001|NOT COMPLETED|Overall Study||2||
48163571|NCT03496974|100724836|FG000|STARTED|Overall Study||10||
48163572|NCT03496974|100724837|FG001|STARTED|Overall Study||28||
48163573|NCT03496974|100724836|FG000|COMPLETED|Overall Study||9||
48163574|NCT03496974|100724837|FG001|COMPLETED|Overall Study||20||
48163575|NCT03496974|100724836|FG000|NOT COMPLETED|Overall Study||1||
48163576|NCT03496974|100724837|FG001|NOT COMPLETED|Overall Study||8||
48163577|NCT00818363|100724838|FG000|STARTED|Overall Study||40||
48163578|NCT00818363|100724839|FG001|STARTED|Overall Study||20||
48163579|NCT00818363|100724838|FG000|COMPLETED|Overall Study||40||
48163580|NCT00818363|100724839|FG001|COMPLETED|Overall Study||19||
48163581|NCT00818363|100724838|FG000|NOT COMPLETED|Overall Study||0||
48163582|NCT00818363|100724839|FG001|NOT COMPLETED|Overall Study||1||
48163583|NCT01845974|100724840|FG000|STARTED|Overall Study||4||
48163584|NCT01845974|100724841|FG001|STARTED|Overall Study||9||
48163585|NCT01845974|100724840|FG000|COMPLETED|Overall Study||3||
48163586|NCT01845974|100724841|FG001|COMPLETED|Overall Study||9||
48163587|NCT01845974|100724840|FG000|NOT COMPLETED|Overall Study||1||
48163588|NCT01845974|100724841|FG001|NOT COMPLETED|Overall Study||0||
48163589|NCT04639193|100724842|FG000|STARTED|First Intervention||10||
48163590|NCT04639193|100724843|FG001|STARTED|First Intervention||10||
48163591|NCT04639193|100724842|FG000|COMPLETED|First Intervention||10||
48163592|NCT04639193|100724843|FG001|COMPLETED|First Intervention||10||
48163593|NCT04639193|100724842|FG000|NOT COMPLETED|First Intervention||0||
48743422|NCT01337336|102158002|FG000|STARTED|Overall Study||1078||
48743423|NCT01337336|102158003|FG001|STARTED|Overall Study||2923||
48743424|NCT01337336|102158002|FG000|COMPLETED|Overall Study||1078||
48743425|NCT01337336|102158003|FG001|COMPLETED|Overall Study||2923||
48743426|NCT01337336|102158002|FG000|NOT COMPLETED|Overall Study||0||
48163594|NCT04639193|100724843|FG001|NOT COMPLETED|First Intervention||0||
48163595|NCT04639193|100724842|FG000|STARTED|Second Intervention||10||
48163596|NCT04639193|100724843|FG001|STARTED|Second Intervention||10||
48163597|NCT04639193|100724842|FG000|COMPLETED|Second Intervention||10||
48163598|NCT04639193|100724843|FG001|COMPLETED|Second Intervention||10||
48163599|NCT04639193|100724842|FG000|NOT COMPLETED|Second Intervention||0||
48163600|NCT04639193|100724843|FG001|NOT COMPLETED|Second Intervention||0||
48163601|NCT04639193|100724842|FG000|STARTED|Third Intervention||9||
48743427|NCT01337336|102158003|FG001|NOT COMPLETED|Overall Study||0||
48743428|NCT01650194|102158004|FG000|STARTED|Overall Study||60||
48743429|NCT01650194|102158004|FG000|Treated|Overall Study||60||
48743430|NCT01650194|102158004|FG000|COMPLETED|Overall Study||13||
48743431|NCT01650194|102158004|FG000|NOT COMPLETED|Overall Study||47||
48743432|NCT01367834|102158005|FG000|STARTED|Overall Study||11||
48163602|NCT04639193|100724843|FG001|STARTED|Third Intervention||9||
48163603|NCT04639193|100724842|FG000|COMPLETED|Third Intervention||9||
48163604|NCT04639193|100724843|FG001|COMPLETED|Third Intervention||9||
48163605|NCT04639193|100724842|FG000|NOT COMPLETED|Third Intervention||0||
48163606|NCT04639193|100724843|FG001|NOT COMPLETED|Third Intervention||0||
48163607|NCT01407354|100724844|FG000|STARTED|First Intervention||20||
48163608|NCT01407354|100724845|FG001|STARTED|First Intervention||17||
48163609|NCT01407354|100724844|FG000|COMPLETED|First Intervention||18||
48163610|NCT01407354|100724845|FG001|COMPLETED|First Intervention||15||
48163611|NCT01407354|100724844|FG000|NOT COMPLETED|First Intervention||2||
48163612|NCT01407354|100724845|FG001|NOT COMPLETED|First Intervention||2||
48163613|NCT01407354|100724844|FG000|STARTED|Second Intervention||18||
48163614|NCT01407354|100724845|FG001|STARTED|Second Intervention||15||
48163615|NCT01407354|100724844|FG000|COMPLETED|Second Intervention||18||
48163616|NCT01407354|100724845|FG001|COMPLETED|Second Intervention||13||
48163617|NCT01407354|100724844|FG000|NOT COMPLETED|Second Intervention||0||
48163618|NCT01407354|100724845|FG001|NOT COMPLETED|Second Intervention||2||
48163619|NCT04048863|100724846|FG000|STARTED|Overall Study||43||
48163620|NCT04048863|100724847|FG001|STARTED|Overall Study||0||
48163621|NCT04048863|100724848|FG002|STARTED|Overall Study||0||
48163622|NCT04048863|100724849|FG003|STARTED|Overall Study||0||
48163623|NCT04048863|100724846|FG000|COMPLETED|Overall Study||43||
48163624|NCT04048863|100724847|FG001|COMPLETED|Overall Study||0||
48163625|NCT04048863|100724848|FG002|COMPLETED|Overall Study||0||
48163626|NCT04048863|100724849|FG003|COMPLETED|Overall Study||0||
48163627|NCT04048863|100724846|FG000|NOT COMPLETED|Overall Study||0||
48163628|NCT04048863|100724847|FG001|NOT COMPLETED|Overall Study||0||
48163629|NCT04048863|100724848|FG002|NOT COMPLETED|Overall Study||0||
48163630|NCT04048863|100724849|FG003|NOT COMPLETED|Overall Study||0||
48163631|NCT00258180|100724850|FG000|STARTED|Overall Study||2||
48163632|NCT00258180|100724850|FG000|COMPLETED|Overall Study||2||
48743433|NCT01367834|102158006|FG001|STARTED|Overall Study||6||
48743434|NCT01367834|102158005|FG000|COMPLETED|Overall Study||9||
48163633|NCT00258180|100724850|FG000|NOT COMPLETED|Overall Study||0||
48163634|NCT02991144|100724851|FG000|STARTED|Overall Study||3||
48163635|NCT02991144|100724852|FG001|STARTED|Overall Study||3||
48163636|NCT02991144|100724853|FG002|STARTED|Overall Study||3||
48163637|NCT02991144|100724854|FG003|STARTED|Overall Study||2||
48163638|NCT02991144|100724851|FG000|COMPLETED|Overall Study||3||
48163639|NCT02991144|100724852|FG001|COMPLETED|Overall Study||3||
48163640|NCT02991144|100724853|FG002|COMPLETED|Overall Study||3||
48163641|NCT02991144|100724854|FG003|COMPLETED|Overall Study||2||
48163642|NCT02991144|100724851|FG000|NOT COMPLETED|Overall Study||0||
48163643|NCT02991144|100724852|FG001|NOT COMPLETED|Overall Study||0||
48163644|NCT02991144|100724853|FG002|NOT COMPLETED|Overall Study||0||
48743435|NCT01367834|102158006|FG001|COMPLETED|Overall Study||3||
48743436|NCT01367834|102158005|FG000|NOT COMPLETED|Overall Study||2||
48163645|NCT02991144|100724854|FG003|NOT COMPLETED|Overall Study||0||
48163646|NCT01781390|100724855|FG000|STARTED|Overall Study||35||
48163647|NCT01781390|100724856|FG001|STARTED|Overall Study||35||
48163648|NCT01781390|100724857|FG002|STARTED|Overall Study||36||
48163649|NCT01781390|100724855|FG000|COMPLETED|Overall Study||32||
48163650|NCT01781390|100724856|FG001|COMPLETED|Overall Study||28||
48163651|NCT01781390|100724857|FG002|COMPLETED|Overall Study||32||
48163652|NCT01781390|100724855|FG000|NOT COMPLETED|Overall Study||3||
48163653|NCT01781390|100724856|FG001|NOT COMPLETED|Overall Study||7||
48163654|NCT01781390|100724857|FG002|NOT COMPLETED|Overall Study||4||
48163655|NCT01671839|100724858|FG000|STARTED|Overall Study||55||
48163656|NCT01671839|100724858|FG000|3-year Follow-up|Overall Study||45||
48163657|NCT01671839|100724858|FG000|5-year Follow-up|Overall Study||37||
48163658|NCT01671839|100724858|FG000|COMPLETED|Overall Study||37||
48163659|NCT01671839|100724858|FG000|NOT COMPLETED|Overall Study||18||
48163660|NCT03713021|100724859|FG000|STARTED|Overall Study||27||
48163661|NCT03713021|100724859|FG000|COMPLETED|Overall Study||12||
48163662|NCT03713021|100724859|FG000|NOT COMPLETED|Overall Study||15||
48620074|NCT01348139|101856306|FG004|NOT COMPLETED|Period 3||0||
48620075|NCT01348139|101856307|FG005|NOT COMPLETED|Period 3||0||
48620076|NCT01348139|101856302|FG000|STARTED|Period 4||4||
48620077|NCT01348139|101856303|FG001|STARTED|Period 4||4||
48620078|NCT01348139|101856304|FG002|STARTED|Period 4||4||
48620079|NCT01348139|101856305|FG003|STARTED|Period 4||4||
48620080|NCT01348139|101856306|FG004|STARTED|Period 4||5||
48620081|NCT01348139|101856307|FG005|STARTED|Period 4||4||
48620082|NCT01348139|101856302|FG000|COMPLETED|Period 4||4||
48620083|NCT01348139|101856303|FG001|COMPLETED|Period 4||4||
48620084|NCT01348139|101856304|FG002|COMPLETED|Period 4||4||
48620085|NCT01348139|101856305|FG003|COMPLETED|Period 4||4||
48620086|NCT01348139|101856306|FG004|COMPLETED|Period 4||5||
48620087|NCT01348139|101856307|FG005|COMPLETED|Period 4||4||
48620088|NCT01348139|101856302|FG000|NOT COMPLETED|Period 4||0||
48620089|NCT01348139|101856303|FG001|NOT COMPLETED|Period 4||0||
48620090|NCT01348139|101856304|FG002|NOT COMPLETED|Period 4||0||
48620091|NCT01348139|101856305|FG003|NOT COMPLETED|Period 4||0||
48620092|NCT01348139|101856306|FG004|NOT COMPLETED|Period 4||0||
48620093|NCT01348139|101856307|FG005|NOT COMPLETED|Period 4||0||
48620094|NCT01348139|101856302|FG000|STARTED|Period 5||4||
48620095|NCT01348139|101856303|FG001|STARTED|Period 5||4||
48620096|NCT01348139|101856304|FG002|STARTED|Period 5||4||
48620097|NCT01348139|101856305|FG003|STARTED|Period 5||4||
48620098|NCT01348139|101856306|FG004|STARTED|Period 5||5||
48620099|NCT01348139|101856307|FG005|STARTED|Period 5||4||
48620100|NCT01348139|101856302|FG000|COMPLETED|Period 5||4||
48620101|NCT01348139|101856303|FG001|COMPLETED|Period 5||4||
48743437|NCT01367834|102158006|FG001|NOT COMPLETED|Overall Study||3||
48163663|NCT03245255|100724860|FG000|STARTED|Overall Study||80||
48163664|NCT03245255|100724860|FG000|COMPLETED|Overall Study||71||
48163665|NCT03245255|100724860|FG000|NOT COMPLETED|Overall Study||9||
48163666|NCT00576732|100724861|FG000|STARTED|DOUBLE BLIND||35||
48163667|NCT00576732|100724862|FG001|STARTED|DOUBLE BLIND||30||
48743438|NCT01150097|102158007|FG000|STARTED|Months 24 to 36 Post-transplantation||106||
48743439|NCT01150097|102158008|FG001|STARTED|Months 24 to 36 Post-transplantation||51||
48163668|NCT00576732|100724863|FG002|STARTED|DOUBLE BLIND||31||
48163669|NCT00576732|100724864|FG003|STARTED|DOUBLE BLIND||0||
48163670|NCT00576732|100724865|FG004|STARTED|DOUBLE BLIND||0||
48163671|NCT00576732|100724866|FG005|STARTED|DOUBLE BLIND||0||
48163672|NCT00576732|100724861|FG000|COMPLETED|DOUBLE BLIND||27||
48163673|NCT00576732|100724862|FG001|COMPLETED|DOUBLE BLIND||25||
48163674|NCT00576732|100724863|FG002|COMPLETED|DOUBLE BLIND||25||
48163675|NCT00576732|100724864|FG003|COMPLETED|DOUBLE BLIND||0||
48163676|NCT00576732|100724865|FG004|COMPLETED|DOUBLE BLIND||0||
48163677|NCT00576732|100724866|FG005|COMPLETED|DOUBLE BLIND||0||
48163678|NCT00576732|100724861|FG000|NOT COMPLETED|DOUBLE BLIND||8||
48620102|NCT01348139|101856304|FG002|COMPLETED|Period 5||4||
48620103|NCT01348139|101856305|FG003|COMPLETED|Period 5||4||
48620104|NCT01348139|101856306|FG004|COMPLETED|Period 5||5||
48163679|NCT00576732|100724862|FG001|NOT COMPLETED|DOUBLE BLIND||5||
48163680|NCT00576732|100724863|FG002|NOT COMPLETED|DOUBLE BLIND||6||
48620105|NCT01348139|101856307|FG005|COMPLETED|Period 5||4||
48620106|NCT01348139|101856302|FG000|NOT COMPLETED|Period 5||0||
48620107|NCT01348139|101856303|FG001|NOT COMPLETED|Period 5||0||
48620108|NCT01348139|101856304|FG002|NOT COMPLETED|Period 5||0||
48620109|NCT01348139|101856305|FG003|NOT COMPLETED|Period 5||0||
48620110|NCT01348139|101856306|FG004|NOT COMPLETED|Period 5||0||
48620111|NCT01348139|101856307|FG005|NOT COMPLETED|Period 5||0||
48620112|NCT01348139|101856302|FG000|STARTED|Period 6||4||
48620113|NCT01348139|101856303|FG001|STARTED|Period 6||4||
48620114|NCT01348139|101856304|FG002|STARTED|Period 6||4||
48620115|NCT01348139|101856305|FG003|STARTED|Period 6||4||
48620116|NCT01348139|101856306|FG004|STARTED|Period 6||5||
48620117|NCT01348139|101856307|FG005|STARTED|Period 6||4||
48620118|NCT01348139|101856302|FG000|COMPLETED|Period 6||4||
48620119|NCT01348139|101856303|FG001|COMPLETED|Period 6||4||
48620120|NCT01348139|101856304|FG002|COMPLETED|Period 6||4||
48620121|NCT01348139|101856305|FG003|COMPLETED|Period 6||4||
48620122|NCT01348139|101856306|FG004|COMPLETED|Period 6||5||
48620123|NCT01348139|101856307|FG005|COMPLETED|Period 6||4||
48620124|NCT01348139|101856302|FG000|NOT COMPLETED|Period 6||0||
48620125|NCT01348139|101856303|FG001|NOT COMPLETED|Period 6||0||
48620126|NCT01348139|101856304|FG002|NOT COMPLETED|Period 6||0||
48620127|NCT01348139|101856305|FG003|NOT COMPLETED|Period 6||0||
48620128|NCT01348139|101856306|FG004|NOT COMPLETED|Period 6||0||
48620129|NCT01348139|101856307|FG005|NOT COMPLETED|Period 6||0||
48620130|NCT02849743|101856308|FG000|STARTED|First Intervention (8 Weeks)||6||
48620131|NCT02849743|101856309|FG001|STARTED|First Intervention (8 Weeks)||7||
48620132|NCT02849743|101856308|FG000|COMPLETED|First Intervention (8 Weeks)||6||
48620133|NCT02849743|101856309|FG001|COMPLETED|First Intervention (8 Weeks)||6||
48620134|NCT02849743|101856308|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0||
48620135|NCT02849743|101856309|FG001|NOT COMPLETED|First Intervention (8 Weeks)||1||
48620136|NCT02849743|101856308|FG000|STARTED|Washout (4 Weeks)||6||
48620137|NCT02849743|101856309|FG001|STARTED|Washout (4 Weeks)||6||
48620138|NCT02849743|101856308|FG000|COMPLETED|Washout (4 Weeks)||6||
48620139|NCT02849743|101856309|FG001|COMPLETED|Washout (4 Weeks)||6||
48620140|NCT02849743|101856308|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
48620141|NCT02849743|101856309|FG001|NOT COMPLETED|Washout (4 Weeks)||0||
48620142|NCT02849743|101856308|FG000|STARTED|Second Intervention (8 Weeks)||6||
48620143|NCT02849743|101856309|FG001|STARTED|Second Intervention (8 Weeks)||6||
48620144|NCT02849743|101856308|FG000|COMPLETED|Second Intervention (8 Weeks)||5||
48620145|NCT02849743|101856309|FG001|COMPLETED|Second Intervention (8 Weeks)||6||
48620146|NCT02849743|101856308|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||1||
48620147|NCT02849743|101856309|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0||
48620148|NCT02492165|101856310|FG000|STARTED|Overall Study||100||
48620149|NCT02492165|101856311|FG001|STARTED|Overall Study||60||
48620150|NCT02492165|101856312|FG002|STARTED|Overall Study||60||
48620151|NCT02492165|101856313|FG003|STARTED|Overall Study||30||
48620152|NCT02492165|101856310|FG000|COMPLETED|Overall Study||100||
48620153|NCT02492165|101856311|FG001|COMPLETED|Overall Study||59||
48620154|NCT02492165|101856312|FG002|COMPLETED|Overall Study||60||
48620155|NCT02492165|101856313|FG003|COMPLETED|Overall Study||30||
48620156|NCT02492165|101856310|FG000|NOT COMPLETED|Overall Study||0||
48620157|NCT02492165|101856311|FG001|NOT COMPLETED|Overall Study||1||
48620158|NCT02492165|101856312|FG002|NOT COMPLETED|Overall Study||0||
48620159|NCT02492165|101856313|FG003|NOT COMPLETED|Overall Study||0||
48620160|NCT02157519|101856314|FG000|STARTED|Overall Study||91||
48620161|NCT02157519|101856315|FG001|STARTED|Overall Study||90||
48620162|NCT02157519|101856314|FG000|MEMScap Collected|Overall Study||84||
48620163|NCT02157519|101856315|FG001|MEMScap Collected|Overall Study||86||
48620164|NCT02157519|101856314|FG000|COMPLETED|Overall Study||80||
48620165|NCT02157519|101856315|FG001|COMPLETED|Overall Study||89||
48620166|NCT02157519|101856314|FG000|NOT COMPLETED|Overall Study||11||
48620167|NCT02157519|101856315|FG001|NOT COMPLETED|Overall Study||1||
48620168|NCT02699996|101856316|FG000|STARTED|Overall Study||20||
48620169|NCT02699996|101856317|FG001|STARTED|Overall Study||11||
48620170|NCT02699996|101856316|FG000|COMPLETED|Overall Study||15||
48620171|NCT02699996|101856317|FG001|COMPLETED|Overall Study||9||
48620172|NCT02699996|101856316|FG000|NOT COMPLETED|Overall Study||5||
48620173|NCT02699996|101856317|FG001|NOT COMPLETED|Overall Study||2||
48620174|NCT00525837|101856318|FG000|STARTED|Overall Study||18||
48620175|NCT00525837|101856318|FG000|COMPLETED|Overall Study||14||
48620176|NCT00525837|101856318|FG000|NOT COMPLETED|Overall Study||4||
48620177|NCT06331507|101856319|FG000|STARTED|Overall Study||292||
48620178|NCT06331507|101856319|FG000|COMPLETED|Overall Study||292||
48620179|NCT06331507|101856319|FG000|NOT COMPLETED|Overall Study||0||
48620180|NCT02864069|101856320|FG000|STARTED|Overall Study||18||
48620181|NCT02864069|101856321|FG001|STARTED|Overall Study||13||
48620182|NCT02864069|101856322|FG002|STARTED|Overall Study||21||
48620183|NCT02864069|101856320|FG000|COMPLETED|Overall Study||12||
48620184|NCT02864069|101856321|FG001|COMPLETED|Overall Study||5||
48620185|NCT02864069|101856322|FG002|COMPLETED|Overall Study||13||
48620186|NCT02864069|101856320|FG000|NOT COMPLETED|Overall Study||6||
48620187|NCT02864069|101856321|FG001|NOT COMPLETED|Overall Study||8||
48620188|NCT02864069|101856322|FG002|NOT COMPLETED|Overall Study||8||
48620189|NCT00944710|101856323|FG000|STARTED|10-week Primary Outcome||40||
48620190|NCT00944710|101856324|FG001|STARTED|10-week Primary Outcome||33||
48620191|NCT00944710|101856323|FG000|COMPLETED|10-week Primary Outcome||40||
48620192|NCT00944710|101856324|FG001|COMPLETED|10-week Primary Outcome||33||
48620193|NCT00944710|101856323|FG000|NOT COMPLETED|10-week Primary Outcome||0||
48620194|NCT00944710|101856324|FG001|NOT COMPLETED|10-week Primary Outcome||0||
48620195|NCT00944710|101856323|FG000|STARTED|12-week Visit (Off-treatment)||40||
48620196|NCT00944710|101856324|FG001|STARTED|12-week Visit (Off-treatment)||33||
48620197|NCT00944710|101856323|FG000|COMPLETED|12-week Visit (Off-treatment)||40||
48620198|NCT00944710|101856324|FG001|COMPLETED|12-week Visit (Off-treatment)||33||
48620199|NCT00944710|101856323|FG000|NOT COMPLETED|12-week Visit (Off-treatment)||0||
48620200|NCT00944710|101856324|FG001|NOT COMPLETED|12-week Visit (Off-treatment)||0||
48620201|NCT00944710|101856323|FG000|STARTED|Additional Post 10-week Primary Outcome||40||
48620202|NCT00944710|101856324|FG001|STARTED|Additional Post 10-week Primary Outcome||33||
48620203|NCT00944710|101856323|FG000|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||24||
48620204|NCT00944710|101856324|FG001|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||26||
48620205|NCT00944710|101856323|FG000|COMPLETED|Additional Post 10-week Primary Outcome||23||
48620206|NCT00944710|101856324|FG001|COMPLETED|Additional Post 10-week Primary Outcome||22||
48326322|NCT02420873|101124634|FG002|NOT COMPLETED|Overall Study||0||
48326323|NCT00307151|101124635|FG000|STARTED|Overall Study||82||
48326324|NCT00307151|101124636|FG001|STARTED|Overall Study||82||
48326325|NCT00307151|101124637|FG002|STARTED|Overall Study||147||
48326326|NCT00307151|101124638|FG003|STARTED|Overall Study||140||
48326327|NCT00307151|101124635|FG000|COMPLETED|Overall Study||71||
48326328|NCT00307151|101124636|FG001|COMPLETED|Overall Study||75||
48326329|NCT00307151|101124637|FG002|COMPLETED|Overall Study||127||
48326330|NCT00307151|101124638|FG003|COMPLETED|Overall Study||129||
48326331|NCT00307151|101124635|FG000|NOT COMPLETED|Overall Study||11||
48326332|NCT00307151|101124636|FG001|NOT COMPLETED|Overall Study||7||
48326333|NCT00307151|101124637|FG002|NOT COMPLETED|Overall Study||20||
48326334|NCT00307151|101124638|FG003|NOT COMPLETED|Overall Study||11||
48326335|NCT01864538|101124639|FG000|STARTED|Overall Study||11||
48326336|NCT01864538|101124639|FG000|COMPLETED|Overall Study||0||
48326337|NCT01864538|101124639|FG000|NOT COMPLETED|Overall Study||11||
48326338|NCT01653288|101124640|FG000|STARTED|Overall Study||36||
48326339|NCT01653288|101124641|FG001|STARTED|Overall Study||36||
48326340|NCT01653288|101124640|FG000|COMPLETED|Overall Study||26||
48326341|NCT01653288|101124641|FG001|COMPLETED|Overall Study||35||
48326342|NCT01653288|101124640|FG000|NOT COMPLETED|Overall Study||10||
48326343|NCT01653288|101124641|FG001|NOT COMPLETED|Overall Study||1||
48326344|NCT02830880|101124642|FG000|STARTED|Overall Study||7||
48326345|NCT02830880|101124642|FG000|Completed Visit After Cyle 1|Overall Study||7||
48326346|NCT02830880|101124642|FG000|COMPLETED|Overall Study||4|Completed visit after Cycle 6|
48326347|NCT02830880|101124642|FG000|NOT COMPLETED|Overall Study||3||
48326348|NCT03776175|101124643|FG000|STARTED|Treatment Period (42 Days)||14||
48326349|NCT03776175|101124644|FG001|STARTED|Treatment Period (42 Days)||29||
48326350|NCT03776175|101124645|FG002|STARTED|Treatment Period (42 Days)||28||
48326351|NCT03776175|101124646|FG003|STARTED|Treatment Period (42 Days)||28||
48326352|NCT03776175|101124643|FG000|Treated|Treatment Period (42 Days)||14||
48326353|NCT03776175|101124644|FG001|Treated|Treatment Period (42 Days)||29||
48326354|NCT03776175|101124645|FG002|Treated|Treatment Period (42 Days)||28||
48326355|NCT03776175|101124646|FG003|Treated|Treatment Period (42 Days)||28||
48326356|NCT03776175|101124643|FG000|COMPLETED|Treatment Period (42 Days)||13||
48326357|NCT03776175|101124644|FG001|COMPLETED|Treatment Period (42 Days)||22||
48326358|NCT03776175|101124645|FG002|COMPLETED|Treatment Period (42 Days)||24||
48326359|NCT03776175|101124646|FG003|COMPLETED|Treatment Period (42 Days)||26||
48326360|NCT03776175|101124643|FG000|NOT COMPLETED|Treatment Period (42 Days)||1||
48326361|NCT03776175|101124644|FG001|NOT COMPLETED|Treatment Period (42 Days)||7||
48326362|NCT03776175|101124645|FG002|NOT COMPLETED|Treatment Period (42 Days)||4||
48409485|NCT02168660|101334721|FG001|NOT COMPLETED|Overall Study||17||
48620207|NCT00944710|101856323|FG000|NOT COMPLETED|Additional Post 10-week Primary Outcome||17||
48620208|NCT00944710|101856324|FG001|NOT COMPLETED|Additional Post 10-week Primary Outcome||11||
48620209|NCT01749956|101856325|FG000|STARTED|Overall Study||39||
48620210|NCT01749956|101856325|FG000|COMPLETED|Overall Study||24||
48620211|NCT01749956|101856325|FG000|NOT COMPLETED|Overall Study||15||
48620212|NCT05417412|101856326|FG000|STARTED|Overall Study||12||
48620213|NCT05417412|101856326|FG000|COMPLETED|Overall Study||10||
48620214|NCT05417412|101856326|FG000|NOT COMPLETED|Overall Study||2||
48620215|NCT04054544|101856327|FG000|STARTED|Overall Study||18||
48620216|NCT04054544|101856327|FG000|COMPLETED|Overall Study||18||
48326363|NCT03776175|101124646|FG003|NOT COMPLETED|Treatment Period (42 Days)||2||
48326364|NCT03776175|101124643|FG000|STARTED|Follow-Up Period (35 Days)||13||
48326365|NCT03776175|101124644|FG001|STARTED|Follow-Up Period (35 Days)||22||
48326366|NCT03776175|101124645|FG002|STARTED|Follow-Up Period (35 Days)||24||
48326367|NCT03776175|101124646|FG003|STARTED|Follow-Up Period (35 Days)||26||
48326368|NCT03776175|101124643|FG000|COMPLETED|Follow-Up Period (35 Days)||13||
48326369|NCT03776175|101124644|FG001|COMPLETED|Follow-Up Period (35 Days)||22||
48409486|NCT02168660|101334722|FG002|NOT COMPLETED|Overall Study||15||
48326370|NCT03776175|101124645|FG002|COMPLETED|Follow-Up Period (35 Days)||24||
48620217|NCT04054544|101856327|FG000|NOT COMPLETED|Overall Study||0||
48163681|NCT00576732|100724864|FG003|NOT COMPLETED|DOUBLE BLIND||0||
48163682|NCT00576732|100724865|FG004|NOT COMPLETED|DOUBLE BLIND||0||
48163683|NCT00576732|100724866|FG005|NOT COMPLETED|DOUBLE BLIND||0||
48163684|NCT00576732|100724861|FG000|STARTED|OPEN LABEL||0||
48163685|NCT00576732|100724862|FG001|STARTED|OPEN LABEL||0||
48163686|NCT00576732|100724863|FG002|STARTED|OPEN LABEL||0||
48163687|NCT00576732|100724864|FG003|STARTED|OPEN LABEL||30||
48163688|NCT00576732|100724865|FG004|STARTED|OPEN LABEL||24||
48163689|NCT00576732|100724866|FG005|STARTED|OPEN LABEL||25||
48163690|NCT00576732|100724861|FG000|COMPLETED|OPEN LABEL||0||
48163691|NCT00576732|100724862|FG001|COMPLETED|OPEN LABEL||0||
48163692|NCT00576732|100724863|FG002|COMPLETED|OPEN LABEL||0||
48163693|NCT00576732|100724864|FG003|COMPLETED|OPEN LABEL||19||
48163694|NCT00576732|100724865|FG004|COMPLETED|OPEN LABEL||20||
48163695|NCT00576732|100724866|FG005|COMPLETED|OPEN LABEL||17||
48163696|NCT00576732|100724861|FG000|NOT COMPLETED|OPEN LABEL||0||
48163697|NCT00576732|100724862|FG001|NOT COMPLETED|OPEN LABEL||0||
48163698|NCT00576732|100724863|FG002|NOT COMPLETED|OPEN LABEL||0||
48163699|NCT00576732|100724864|FG003|NOT COMPLETED|OPEN LABEL||11||
48163700|NCT00576732|100724865|FG004|NOT COMPLETED|OPEN LABEL||4||
48163701|NCT00576732|100724866|FG005|NOT COMPLETED|OPEN LABEL||8||
48163702|NCT02696902|100724867|FG000|STARTED|Overall Study||85||
48163703|NCT02696902|100724868|FG001|STARTED|Overall Study||16||
48163704|NCT02696902|100724869|FG002|STARTED|Overall Study||87||
48163705|NCT02696902|100724867|FG000|Treated|Overall Study||83||
48163706|NCT02696902|100724868|FG001|Treated|Overall Study||16||
48163707|NCT02696902|100724869|FG002|Treated|Overall Study||85||
48163708|NCT02696902|100724867|FG000|Intent-to-treat (ITT) Population|Overall Study||85||
48163709|NCT02696902|100724868|FG001|Intent-to-treat (ITT) Population|Overall Study||16||
48163710|NCT02696902|100724869|FG002|Intent-to-treat (ITT) Population|Overall Study||87||
48163711|NCT02696902|100724867|FG000|As-treated Population|Overall Study||83||
48163712|NCT02696902|100724868|FG001|As-treated Population|Overall Study||16||
48163713|NCT02696902|100724869|FG002|As-treated Population|Overall Study||85||
48163714|NCT02696902|100724867|FG000|Modified Intent-to-treat (mITT) Population|Overall Study||83||
48163715|NCT02696902|100724868|FG001|Modified Intent-to-treat (mITT) Population|Overall Study||16||
48163716|NCT02696902|100724869|FG002|Modified Intent-to-treat (mITT) Population|Overall Study||85||
48163717|NCT02696902|100724867|FG000|COMPLETED|Overall Study||63||
48163718|NCT02696902|100724868|FG001|COMPLETED|Overall Study||12||
48163719|NCT02696902|100724869|FG002|COMPLETED|Overall Study||59||
48163720|NCT02696902|100724867|FG000|NOT COMPLETED|Overall Study||22||
48163721|NCT02696902|100724868|FG001|NOT COMPLETED|Overall Study||4||
48163722|NCT02696902|100724869|FG002|NOT COMPLETED|Overall Study||28||
48163723|NCT01460160|100724870|FG000|STARTED|Treatment Phase||106||
48163724|NCT01460160|100724870|FG000|COMPLETED|Treatment Phase||78||
48163725|NCT01460160|100724870|FG000|NOT COMPLETED|Treatment Phase||28||
48163726|NCT01460160|100724870|FG000|STARTED|Follow-up Phase||100||
48163727|NCT01460160|100724870|FG000|COMPLETED|Follow-up Phase||0|Completed = continuing in the follow-up phase|
48163728|NCT01460160|100724870|FG000|NOT COMPLETED|Follow-up Phase||100||
48163729|NCT04472377|100724871|FG000|STARTED|Overall Study||1210||
48163730|NCT04472377|100724871|FG000|COMPLETED|Overall Study||1210||
48163731|NCT04472377|100724871|FG000|NOT COMPLETED|Overall Study||0||
48163732|NCT00186498|100724872|FG000|STARTED|Overall Study||6||
48163733|NCT00186498|100724873|FG001|STARTED|Overall Study||5||
48163734|NCT00186498|100724872|FG000|COMPLETED|Overall Study||4||
48163735|NCT00186498|100724873|FG001|COMPLETED|Overall Study||3||
48163736|NCT00186498|100724872|FG000|NOT COMPLETED|Overall Study||2||
48163737|NCT00186498|100724873|FG001|NOT COMPLETED|Overall Study||2||
48163738|NCT01364922|100724874|FG000|STARTED|Open-label (OL) Period||168||
48163739|NCT01364922|100724875|FG001|STARTED|Open-label (OL) Period||0||
48163740|NCT01364922|100724876|FG002|STARTED|Open-label (OL) Period||0||
48163741|NCT01364922|100724874|FG000|COMPLETED|Open-label (OL) Period||146||
48163742|NCT01364922|100724875|FG001|COMPLETED|Open-label (OL) Period||0||
48163743|NCT01364922|100724876|FG002|COMPLETED|Open-label (OL) Period||0||
48163744|NCT01364922|100724874|FG000|NOT COMPLETED|Open-label (OL) Period||22||
48163745|NCT01364922|100724875|FG001|NOT COMPLETED|Open-label (OL) Period||0||
48163746|NCT01364922|100724876|FG002|NOT COMPLETED|Open-label (OL) Period||0||
48163747|NCT01364922|100724874|FG000|STARTED|Double-Blind (DB) Period||0||
48163748|NCT01364922|100724875|FG001|STARTED|Double-Blind (DB) Period||99||
48163749|NCT01364922|100724876|FG002|STARTED|Double-Blind (DB) Period||47||
48163750|NCT01364922|100724874|FG000|COMPLETED|Double-Blind (DB) Period||0||
48163751|NCT01364922|100724875|FG001|COMPLETED|Double-Blind (DB) Period||94||
48163752|NCT01364922|100724876|FG002|COMPLETED|Double-Blind (DB) Period||42||
48163753|NCT01364922|100724874|FG000|NOT COMPLETED|Double-Blind (DB) Period||0||
48163754|NCT01364922|100724875|FG001|NOT COMPLETED|Double-Blind (DB) Period||5||
48163755|NCT01364922|100724876|FG002|NOT COMPLETED|Double-Blind (DB) Period||5||
48163756|NCT01081041|100724877|FG000|STARTED|Overall Study||33||
48163757|NCT01081041|100724878|FG001|STARTED|Overall Study||81||
48163758|NCT01081041|100724879|FG002|STARTED|Overall Study||73||
48163759|NCT01081041|100724877|FG000|Received at Least 1 Dose of Study Drug|Overall Study||33||
48163760|NCT01081041|100724878|FG001|Received at Least 1 Dose of Study Drug|Overall Study||77||
48163761|NCT01081041|100724879|FG002|Received at Least 1 Dose of Study Drug|Overall Study||71||
48620218|NCT01781208|101856328|FG000|STARTED|Overall Study||62||
48326371|NCT03776175|101124646|FG003|COMPLETED|Follow-Up Period (35 Days)||24||
48326372|NCT03776175|101124643|FG000|NOT COMPLETED|Follow-Up Period (35 Days)||0||
48326373|NCT03776175|101124644|FG001|NOT COMPLETED|Follow-Up Period (35 Days)||0||
48326374|NCT03776175|101124645|FG002|NOT COMPLETED|Follow-Up Period (35 Days)||0||
48326375|NCT03776175|101124646|FG003|NOT COMPLETED|Follow-Up Period (35 Days)||2||
48326376|NCT01000662|101124647|FG000|STARTED|Overall Study||206||
48326377|NCT01000662|101124648|FG001|STARTED|Overall Study||206||
48326378|NCT01000662|101124647|FG000|COMPLETED|Overall Study||202||
48409487|NCT01131130|101334723|FG000|STARTED|Period 1 - Baseline||118||
48409488|NCT01131130|101334723|FG000|COMPLETED|Period 1 - Baseline||117||
48409489|NCT01131130|101334723|FG000|NOT COMPLETED|Period 1 - Baseline||1||
48409490|NCT01131130|101334723|FG000|STARTED|Period 2 - Crossover||117||
48409491|NCT01131130|101334723|FG000|COMPLETED|Period 2 - Crossover||117||
48409492|NCT01131130|101334723|FG000|NOT COMPLETED|Period 2 - Crossover||0||
48409493|NCT01131130|101334723|FG000|STARTED|Period 3- Crossover||117||
48409494|NCT01131130|101334723|FG000|COMPLETED|Period 3- Crossover||116||
48620219|NCT01781208|101856328|FG000|Overall Study|Overall Study||62||
48620220|NCT01781208|101856328|FG000|COMPLETED|Overall Study||62||
48620221|NCT01781208|101856328|FG000|NOT COMPLETED|Overall Study||0||
48326379|NCT01000662|101124648|FG001|COMPLETED|Overall Study||198||
48326380|NCT01000662|101124647|FG000|NOT COMPLETED|Overall Study||4||
48326381|NCT01000662|101124648|FG001|NOT COMPLETED|Overall Study||8||
48326382|NCT05779072|101124649|FG000|STARTED|Overall Study||40||80
48326383|NCT05779072|101124650|FG001|STARTED|Overall Study||43||86
48326384|NCT05779072|101124649|FG000|COMPLETED|Overall Study||39||78
48326385|NCT05779072|101124650|FG001|COMPLETED|Overall Study||37||74
48326386|NCT05779072|101124649|FG000|NOT COMPLETED|Overall Study||1||2
48326387|NCT05779072|101124650|FG001|NOT COMPLETED|Overall Study||6||12
48326388|NCT02286947|101124651|FG000|STARTED|Overall Study||24||
48326389|NCT02286947|101124651|FG000|COMPLETED|Overall Study||22||
48326390|NCT02286947|101124651|FG000|NOT COMPLETED|Overall Study||2||
48326391|NCT00744874|101124652|FG000|STARTED|Overall Study||55||
48326392|NCT00744874|101124652|FG000|COMPLETED|Overall Study||51||
48326393|NCT00744874|101124652|FG000|NOT COMPLETED|Overall Study||4||
48326394|NCT01029366|101124653|FG000|STARTED|Overall Study||18||
48326395|NCT01029366|101124654|FG001|STARTED|Overall Study||8||
48326396|NCT01029366|101124653|FG000|COMPLETED|Overall Study||14||
48326397|NCT01029366|101124654|FG001|COMPLETED|Overall Study||6||
48326398|NCT01029366|101124653|FG000|NOT COMPLETED|Overall Study||4||
48326399|NCT01029366|101124654|FG001|NOT COMPLETED|Overall Study||2||
48326400|NCT03603496|101124655|FG000|STARTED|Overall Study||706||
48326401|NCT03603496|101124656|FG001|STARTED|Overall Study||703||
48326402|NCT03603496|101124655|FG000|COMPLETED|Overall Study||520||
48326403|NCT03603496|101124656|FG001|COMPLETED|Overall Study||518||
48326404|NCT03603496|101124655|FG000|NOT COMPLETED|Overall Study||186||
48326405|NCT03603496|101124656|FG001|NOT COMPLETED|Overall Study||185||
48326406|NCT02135692|101124657|FG000|STARTED|Overall Study||339||
48326407|NCT02135692|101124657|FG000|COMPLETED|Overall Study||0||
48326408|NCT02135692|101124657|FG000|NOT COMPLETED|Overall Study||339||
48326409|NCT00428974|101124658|FG000|STARTED|Overall Study||25||
48326410|NCT00428974|101124659|FG001|STARTED|Overall Study||17||
48326411|NCT00428974|101124660|FG002|STARTED|Overall Study||15||
48326412|NCT00428974|101124661|FG003|STARTED|Overall Study||19||
48326413|NCT00428974|101124658|FG000|COMPLETED|Overall Study||17||
48326414|NCT00428974|101124659|FG001|COMPLETED|Overall Study||17||
48326415|NCT00428974|101124660|FG002|COMPLETED|Overall Study||14||
48326416|NCT00428974|101124661|FG003|COMPLETED|Overall Study||16||
48326417|NCT00428974|101124658|FG000|NOT COMPLETED|Overall Study||8||
48326418|NCT00428974|101124659|FG001|NOT COMPLETED|Overall Study||0||
48326419|NCT00428974|101124660|FG002|NOT COMPLETED|Overall Study||1||
48326420|NCT00428974|101124661|FG003|NOT COMPLETED|Overall Study||3||
48409495|NCT01131130|101334723|FG000|NOT COMPLETED|Period 3- Crossover||1||
48409496|NCT02865928|101334724|FG000|STARTED|Overall Study||22||
48409497|NCT02865928|101334725|FG001|STARTED|Overall Study||20||
48409498|NCT02865928|101334724|FG000|COMPLETED|Overall Study||19||
48409499|NCT02865928|101334725|FG001|COMPLETED|Overall Study||19||
48409500|NCT02865928|101334724|FG000|NOT COMPLETED|Overall Study||3||
48409501|NCT02865928|101334725|FG001|NOT COMPLETED|Overall Study||1||
48409502|NCT02579863|101334726|FG000|STARTED|Overall Study||156||
48409503|NCT02579863|101334727|FG001|STARTED|Overall Study||154||
48409504|NCT02579863|101334726|FG000|Treated|Overall Study||154||
48409505|NCT02579863|101334727|FG001|Treated|Overall Study||148||
48620222|NCT01656395|101856329|FG000|STARTED|Overall Study||60||
48326421|NCT01665144|101124662|FG000|STARTED|Core Part||1105|All randomized patients.|
48326422|NCT01665144|101124663|FG001|STARTED|Core Part||546|All randomized patients.|
48326423|NCT01665144|101124664|FG002|STARTED|Core Part||0|All randomized patients.|
48326424|NCT01665144|101124662|FG000|Safety Set|Core Part||1099|All patients who received at least one dose of study medication. Patients were analyzed according to the actual treatment received.|
48326425|NCT01665144|101124663|FG001|Safety Set|Core Part||546|All patients who received at least one dose of study medication. Patients were analyzed according to the actual treatment received.|
48368068|NCT03691623|101230101|FG005|Received Treatment|Overall Study||21||
48620223|NCT01656395|101856330|FG001|STARTED|Overall Study||127||
48326426|NCT01665144|101124664|FG002|Safety Set|Core Part||0|All patients who received at least one dose of study medication. Patients were analyzed according to the actual treatment received.|
48326427|NCT01665144|101124662|FG000|Full Analysis Set|Core Part||1099|All randomized patients with assigned treatments who took at least one dose of study medication. Patients were analyzed according to the randomized treatment assignment.|
48326428|NCT01665144|101124663|FG001|Full Analysis Set|Core Part||546|All randomized patients with assigned treatments who took at least one dose of study medication. Patients were analyzed according to the randomized treatment assignment.|
48620224|NCT01656395|101856331|FG002|STARTED|Overall Study||142||
48620225|NCT01656395|101856332|FG003|STARTED|Overall Study||53||
48620226|NCT01656395|101856333|FG004|STARTED|Overall Study||60||
48620227|NCT01656395|101856334|FG005|STARTED|Overall Study||134||
48620228|NCT01656395|101856335|FG006|STARTED|Overall Study||0||
48620229|NCT01656395|101856336|FG007|STARTED|Overall Study||0||
48326429|NCT01665144|101124664|FG002|Full Analysis Set|Core Part||0|All randomized patients with assigned treatments who took at least one dose of study medication. Patients were analyzed according to the randomized treatment assignment.|
48326430|NCT01665144|101124662|FG000|COMPLETED|Core Part||903||
48326431|NCT01665144|101124663|FG001|COMPLETED|Core Part||424||
48620230|NCT01656395|101856329|FG000|Treated Participants|Overall Study||58||
48620231|NCT01656395|101856330|FG001|Treated Participants|Overall Study||126||
48620232|NCT01656395|101856331|FG002|Treated Participants|Overall Study||135||
48620233|NCT01656395|101856332|FG003|Treated Participants|Overall Study||52||
48620234|NCT01656395|101856333|FG004|Treated Participants|Overall Study||60||
48743440|NCT01150097|102158009|FG002|STARTED|Months 24 to 36 Post-transplantation||125||
48743441|NCT01150097|102158007|FG000|COMPLETED|Months 24 to 36 Post-transplantation||96||
48743442|NCT01150097|102158008|FG001|COMPLETED|Months 24 to 36 Post-transplantation||49||
48163762|NCT01081041|100724877|FG000|COMPLETED|Overall Study||33||
48163763|NCT01081041|100724878|FG001|COMPLETED|Overall Study||77||
48326432|NCT01665144|101124664|FG002|COMPLETED|Core Part||0||
48326433|NCT01665144|101124662|FG000|NOT COMPLETED|Core Part||202||
48326434|NCT01665144|101124663|FG001|NOT COMPLETED|Core Part||122||
48326435|NCT01665144|101124664|FG002|NOT COMPLETED|Core Part||0||
48326436|NCT01665144|101124662|FG000|STARTED|Extension Part||821||
48326437|NCT01665144|101124663|FG001|STARTED|Extension Part||0||
48326438|NCT01665144|101124664|FG002|STARTED|Extension Part||399||
48326439|NCT01665144|101124662|FG000|COMPLETED|Extension Part||326||
48326440|NCT01665144|101124663|FG001|COMPLETED|Extension Part||0||
48163764|NCT01081041|100724879|FG002|COMPLETED|Overall Study||71||
48326441|NCT01665144|101124664|FG002|COMPLETED|Extension Part||159||
48326442|NCT01665144|101124662|FG000|NOT COMPLETED|Extension Part||495||
48326443|NCT01665144|101124663|FG001|NOT COMPLETED|Extension Part||0||
48326444|NCT01665144|101124664|FG002|NOT COMPLETED|Extension Part||240||
48326445|NCT01263639|101124665|FG000|STARTED|Overall Study||107||
48326446|NCT01263639|101124666|FG001|STARTED|Overall Study||121||
48326447|NCT01263639|101124665|FG000|COMPLETED|Overall Study||34||
48326448|NCT01263639|101124666|FG001|COMPLETED|Overall Study||42||
48326449|NCT01263639|101124665|FG000|NOT COMPLETED|Overall Study||73||
48326450|NCT01263639|101124666|FG001|NOT COMPLETED|Overall Study||79||
48326451|NCT00689871|101124667|FG000|STARTED|Overall Study||455||
48620235|NCT01656395|101856334|FG005|Treated Participants|Overall Study||126||
48163765|NCT01081041|100724877|FG000|NOT COMPLETED|Overall Study||0||
48163766|NCT01081041|100724878|FG001|NOT COMPLETED|Overall Study||4||
48163767|NCT01081041|100724879|FG002|NOT COMPLETED|Overall Study||2||
48163768|NCT03863522|100724880|FG000|STARTED|Overall Study||116||
48326452|NCT00689871|101124668|FG001|STARTED|Overall Study||98||
48326453|NCT00689871|101124669|FG002|STARTED|Overall Study||147||
48326454|NCT00689871|101124670|FG003|STARTED|Overall Study||15||
48620236|NCT01656395|101856335|FG006|Treated Participants|Overall Study||0||
48326455|NCT00689871|101124667|FG000|COMPLETED|Overall Study||280||
48326456|NCT00689871|101124668|FG001|COMPLETED|Overall Study||46||
48326457|NCT00689871|101124669|FG002|COMPLETED|Overall Study||74||
48620237|NCT01656395|101856336|FG007|Treated Participants|Overall Study||0||
48620238|NCT01656395|101856329|FG000|COMPLETED|Overall Study||43||
48620239|NCT01656395|101856330|FG001|COMPLETED|Overall Study||93||
48620240|NCT01656395|101856331|FG002|COMPLETED|Overall Study||106||
48620241|NCT01656395|101856332|FG003|COMPLETED|Overall Study||41||
48620242|NCT01656395|101856333|FG004|COMPLETED|Overall Study||46||
48620243|NCT01656395|101856334|FG005|COMPLETED|Overall Study||94||
48620244|NCT01656395|101856335|FG006|COMPLETED|Overall Study||0||
48620245|NCT01656395|101856336|FG007|COMPLETED|Overall Study||0||
48620246|NCT01656395|101856329|FG000|NOT COMPLETED|Overall Study||17||
48620247|NCT01656395|101856330|FG001|NOT COMPLETED|Overall Study||34||
48620248|NCT01656395|101856331|FG002|NOT COMPLETED|Overall Study||36||
48743443|NCT01150097|102158009|FG002|COMPLETED|Months 24 to 36 Post-transplantation||117||
48743444|NCT01150097|102158007|FG000|NOT COMPLETED|Months 24 to 36 Post-transplantation||10||
48743445|NCT01150097|102158008|FG001|NOT COMPLETED|Months 24 to 36 Post-transplantation||2||
48743446|NCT01150097|102158009|FG002|NOT COMPLETED|Months 24 to 36 Post-transplantation||8||
48743447|NCT01150097|102158007|FG000|STARTED|Months 24 to 48 Post-transplantation||106||
48620249|NCT01656395|101856332|FG003|NOT COMPLETED|Overall Study||12||
48620250|NCT01656395|101856333|FG004|NOT COMPLETED|Overall Study||14||
48620251|NCT01656395|101856334|FG005|NOT COMPLETED|Overall Study||40||
48326458|NCT00689871|101124670|FG003|COMPLETED|Overall Study||8||
48326459|NCT00689871|101124667|FG000|NOT COMPLETED|Overall Study||175||
48326460|NCT00689871|101124668|FG001|NOT COMPLETED|Overall Study||52||
48326461|NCT00689871|101124669|FG002|NOT COMPLETED|Overall Study||73||
48620252|NCT01656395|101856335|FG006|NOT COMPLETED|Overall Study||0||
48620253|NCT01656395|101856336|FG007|NOT COMPLETED|Overall Study||0||
48326462|NCT00689871|101124670|FG003|NOT COMPLETED|Overall Study||7||
48326463|NCT03691974|101124671|FG000|STARTED|Overall Study||89||
48326464|NCT03691974|101124672|FG001|STARTED|Overall Study||91||
48326465|NCT03691974|101124671|FG000|COMPLETED|Overall Study||67||
48326466|NCT03691974|101124672|FG001|COMPLETED|Overall Study||75||
48326467|NCT03691974|101124671|FG000|NOT COMPLETED|Overall Study||22||
48326468|NCT03691974|101124672|FG001|NOT COMPLETED|Overall Study||16||
48326469|NCT00812214|101124673|FG000|STARTED|Overall Study||38||
48326470|NCT00812214|101124674|FG001|STARTED|Overall Study||41||
48326471|NCT00812214|101124673|FG000|COMPLETED|Overall Study||35||
48326472|NCT00812214|101124674|FG001|COMPLETED|Overall Study||40||
48326473|NCT00812214|101124673|FG000|NOT COMPLETED|Overall Study||3||
48326474|NCT00812214|101124674|FG001|NOT COMPLETED|Overall Study||1||
48326475|NCT04942925|101124675|FG000|STARTED|First Wear Period (8 -0/+3 Days)||32||64
48326476|NCT04942925|101124676|FG001|STARTED|First Wear Period (8 -0/+3 Days)||28||56
48326477|NCT04942925|101124675|FG000|COMPLETED|First Wear Period (8 -0/+3 Days)||32||64
48326478|NCT04942925|101124676|FG001|COMPLETED|First Wear Period (8 -0/+3 Days)||26||52
48326479|NCT04942925|101124675|FG000|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0||0
48326480|NCT04942925|101124676|FG001|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||2||4
48326481|NCT04942925|101124675|FG000|STARTED|Second Wear Period (8 -0/+3 Days)||32||64
48326482|NCT04942925|101124676|FG001|STARTED|Second Wear Period (8 -0/+3 Days)||26||52
48326483|NCT04942925|101124675|FG000|COMPLETED|Second Wear Period (8 -0/+3 Days)||32||62
48326484|NCT04942925|101124676|FG001|COMPLETED|Second Wear Period (8 -0/+3 Days)||26||52
48326485|NCT04942925|101124675|FG000|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0||2
48326486|NCT04942925|101124676|FG001|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0||0
48326487|NCT03502993|101124677|FG000|STARTED|Overall Study||5957||
48326488|NCT03502993|101124678|FG001|STARTED|Overall Study||1290||
48326489|NCT03502993|101124677|FG000|COMPLETED|Overall Study||5957||
48326490|NCT03502993|101124678|FG001|COMPLETED|Overall Study||1290||
48326491|NCT03502993|101124677|FG000|NOT COMPLETED|Overall Study||0||
48326492|NCT03502993|101124678|FG001|NOT COMPLETED|Overall Study||0||
48326493|NCT02911922|101124679|FG000|STARTED|Overall Study||1||
48620254|NCT01421498|101856337|FG000|STARTED|Overall Study||293||
48620255|NCT01421498|101856338|FG001|STARTED|Overall Study||295||
48620256|NCT01421498|101856337|FG000|COMPLETED|Overall Study||281||
48620257|NCT01421498|101856338|FG001|COMPLETED|Overall Study||284||
48620258|NCT01421498|101856337|FG000|NOT COMPLETED|Overall Study||12||
48620259|NCT01421498|101856338|FG001|NOT COMPLETED|Overall Study||11||
48620260|NCT01298700|101856339|FG000|STARTED|Overall Study||403||
48620261|NCT01298700|101856340|FG001|STARTED|Overall Study||403||
48620262|NCT01298700|101856339|FG000|Safety Population: Received Study Drug|Overall Study||400||
48620263|NCT01298700|101856340|FG001|Safety Population: Received Study Drug|Overall Study||398||
48620264|NCT01298700|101856339|FG000|COMPLETED|Overall Study||302||
48620265|NCT01298700|101856340|FG001|COMPLETED|Overall Study||303||
48620266|NCT01298700|101856339|FG000|NOT COMPLETED|Overall Study||101||
48620267|NCT01298700|101856340|FG001|NOT COMPLETED|Overall Study||100||
48620268|NCT01831219|101856341|FG000|STARTED|Overall Study||73||
48326494|NCT02911922|101124680|FG001|STARTED|Overall Study||0||
48326495|NCT02911922|101124679|FG000|COMPLETED|Overall Study||1||
48326496|NCT02911922|101124680|FG001|COMPLETED|Overall Study||0||
48326497|NCT02911922|101124679|FG000|NOT COMPLETED|Overall Study||0||
48326498|NCT02911922|101124680|FG001|NOT COMPLETED|Overall Study||0||
48326499|NCT01339559|101124681|FG000|STARTED|Overall Study||766||
48326500|NCT01339559|101124681|FG000|COMPLETED|Overall Study||368||
48326501|NCT01339559|101124681|FG000|NOT COMPLETED|Overall Study||398||
48326502|NCT04325542|101124682|FG000|STARTED|Overall Study||743||
48326503|NCT04325542|101124682|FG000|COMPLETED|Overall Study||742||
48326504|NCT04325542|101124682|FG000|NOT COMPLETED|Overall Study||1||
48326505|NCT01902290|101124683|FG000|STARTED|Overall Study||210||
48326506|NCT01902290|101124684|FG001|STARTED|Overall Study||211||
48326507|NCT01902290|101124683|FG000|Received Study Drug|Overall Study||207||
48620269|NCT01831219|101856342|FG001|STARTED|Overall Study||45||
48620270|NCT01831219|101856341|FG000|COMPLETED|Overall Study||40||
48620271|NCT01831219|101856342|FG001|COMPLETED|Overall Study||21||
48620272|NCT01831219|101856341|FG000|NOT COMPLETED|Overall Study||33||
48620273|NCT01831219|101856342|FG001|NOT COMPLETED|Overall Study||24||
48620274|NCT04458675|101856343|FG000|STARTED|Overall Study||31||
48326508|NCT01902290|101124684|FG001|Received Study Drug|Overall Study||208||
48326509|NCT01902290|101124683|FG000|COMPLETED|Overall Study||162|Completed end of study visit at week 28|
48326510|NCT01902290|101124684|FG001|COMPLETED|Overall Study||158|Completed end of study visit at week 28|
48326511|NCT01902290|101124683|FG000|NOT COMPLETED|Overall Study||48||
48326512|NCT01902290|101124684|FG001|NOT COMPLETED|Overall Study||53||
48326513|NCT00978029|101124685|FG000|STARTED|Overall Study||65||
48326514|NCT00978029|101124686|FG001|STARTED|Overall Study||66||
48620275|NCT04458675|101856344|FG001|STARTED|Overall Study||28||
48743448|NCT01150097|102158008|FG001|STARTED|Months 24 to 48 Post-transplantation||51||
48743449|NCT01150097|102158009|FG002|STARTED|Months 24 to 48 Post-transplantation||0||
48743450|NCT01150097|102158007|FG000|COMPLETED|Months 24 to 48 Post-transplantation||95||
48326515|NCT00978029|101124687|FG002|STARTED|Overall Study||65||
48326516|NCT00978029|101124685|FG000|COMPLETED|Overall Study||64||
48326517|NCT00978029|101124686|FG001|COMPLETED|Overall Study||63||
48326518|NCT00978029|101124687|FG002|COMPLETED|Overall Study||59||
48326519|NCT00978029|101124685|FG000|NOT COMPLETED|Overall Study||1||
48326520|NCT00978029|101124686|FG001|NOT COMPLETED|Overall Study||3||
48326521|NCT00978029|101124687|FG002|NOT COMPLETED|Overall Study||6||
48326522|NCT01784861|101124688|FG000|STARTED|Overall Study||3||
48326523|NCT01784861|101124689|FG001|STARTED|Overall Study||3||
48326524|NCT01784861|101124690|FG002|STARTED|Overall Study||4||
48326525|NCT01784861|101124691|FG003|STARTED|Overall Study||8||
48326526|NCT01784861|101124692|FG004|STARTED|Overall Study||3||
48326527|NCT01784861|101124693|FG005|STARTED|Overall Study||2||
48326528|NCT01784861|101124688|FG000|COMPLETED|Overall Study||3||
48326529|NCT01784861|101124689|FG001|COMPLETED|Overall Study||3||
48326530|NCT01784861|101124690|FG002|COMPLETED|Overall Study||3||
48326531|NCT01784861|101124691|FG003|COMPLETED|Overall Study||3||
48326532|NCT01784861|101124692|FG004|COMPLETED|Overall Study||2||
48326533|NCT01784861|101124693|FG005|COMPLETED|Overall Study||1||
48326534|NCT01784861|101124688|FG000|NOT COMPLETED|Overall Study||0||
48326535|NCT01784861|101124689|FG001|NOT COMPLETED|Overall Study||0||
48326536|NCT01784861|101124690|FG002|NOT COMPLETED|Overall Study||1||
48326537|NCT01784861|101124691|FG003|NOT COMPLETED|Overall Study||5||
48326538|NCT01784861|101124692|FG004|NOT COMPLETED|Overall Study||1||
48326539|NCT01784861|101124693|FG005|NOT COMPLETED|Overall Study||1||
48326540|NCT03436862|101124694|FG000|STARTED|Overall Study||37||
48326541|NCT03436862|101124694|FG000|COMPLETED|Overall Study||31||
48326542|NCT03436862|101124694|FG000|NOT COMPLETED|Overall Study||6||
48326543|NCT01849874|101124695|FG000|STARTED|Overall Study||228||
48326544|NCT01849874|101124696|FG001|STARTED|Overall Study||113||
48326545|NCT01849874|101124695|FG000|Treated|Overall Study||227||
48326546|NCT01849874|101124696|FG001|Treated|Overall Study||106||
48326547|NCT01849874|101124695|FG000|Safety Population|Overall Study||227|Safety population consisted of all participants who received at any dose of study intervention (MEK162 or physician's choice chemotherapy).|
48326548|NCT01849874|101124696|FG001|Safety Population|Overall Study||106|Safety population consisted of all participants who received at any dose of study intervention (MEK162 or physician's choice chemotherapy).|
48326549|NCT01849874|101124695|FG000|Crossover Period|Overall Study||0|After failure of physician's choice chemotherapy in the randomized period, participants entered into the crossover period to receive MEK162 treatment 45 mg orally twice daily with water irrespective of food, continuously, starting on Day 1 of the crossover period. Crossover from physician's choice chemotherapy treatment to MEK162 treatment was no longer permitted after enrollment was early discontinued.|
48326550|NCT01849874|101124696|FG001|Crossover Period|Overall Study||18|After failure of physician's choice chemotherapy in the randomized period, participants entered into the crossover period to receive MEK162 treatment 45 mg orally twice daily with water irrespective of food, continuously, starting on Day 1 of the crossover period. Crossover from physician's choice chemotherapy treatment to MEK162 treatment was no longer permitted after enrollment was early discontinued.|
48326551|NCT01849874|101124695|FG000|COMPLETED|Overall Study||0||
48326552|NCT01849874|101124696|FG001|COMPLETED|Overall Study||0||
48326553|NCT01849874|101124695|FG000|NOT COMPLETED|Overall Study||228||
48326554|NCT01849874|101124696|FG001|NOT COMPLETED|Overall Study||113||
48326555|NCT01140360|101124697|FG000|STARTED|Overall Study||21||
48326556|NCT01140360|101124697|FG000|COMPLETED|Overall Study||15||
48326557|NCT01140360|101124697|FG000|NOT COMPLETED|Overall Study||6||
48326558|NCT03389854|101124698|FG000|STARTED|Overall Study||28||
48326559|NCT03389854|101124699|FG001|STARTED|Overall Study||27||
48326560|NCT03389854|101124700|FG002|STARTED|Overall Study||28||
48326561|NCT03389854|101124701|FG003|STARTED|Overall Study||27||
48326562|NCT03389854|101124698|FG000|COMPLETED|Overall Study||27||
48326563|NCT03389854|101124699|FG001|COMPLETED|Overall Study||21||
48326564|NCT03389854|101124700|FG002|COMPLETED|Overall Study||23||
48326565|NCT03389854|101124701|FG003|COMPLETED|Overall Study||19||
48326566|NCT03389854|101124698|FG000|NOT COMPLETED|Overall Study||1||
48326567|NCT03389854|101124699|FG001|NOT COMPLETED|Overall Study||6||
48326568|NCT03389854|101124700|FG002|NOT COMPLETED|Overall Study||5||
48326569|NCT03389854|101124701|FG003|NOT COMPLETED|Overall Study||8||
48326570|NCT03259074|101124702|FG000|STARTED|Overall Study||287||
48326571|NCT03259074|101124703|FG001|STARTED|Overall Study||286||
48743451|NCT01150097|102158008|FG001|COMPLETED|Months 24 to 48 Post-transplantation||47||
48743452|NCT01150097|102158009|FG002|COMPLETED|Months 24 to 48 Post-transplantation||0||
48743453|NCT01150097|102158007|FG000|NOT COMPLETED|Months 24 to 48 Post-transplantation||11||
48326572|NCT03259074|101124704|FG002|STARTED|Overall Study||286||
48326573|NCT03259074|101124702|FG000|COMPLETED|Overall Study||254||
48326574|NCT03259074|101124703|FG001|COMPLETED|Overall Study||237||
48743454|NCT01150097|102158008|FG001|NOT COMPLETED|Months 24 to 48 Post-transplantation||4||
48743455|NCT01150097|102158009|FG002|NOT COMPLETED|Months 24 to 48 Post-transplantation||0||
48743456|NCT02303093|102158010|FG000|STARTED|Overall Study||344||
48743457|NCT02303093|102158010|FG000|COMPLETED|Overall Study||344||
48743458|NCT02303093|102158010|FG000|NOT COMPLETED|Overall Study||0||
48743459|NCT04112303|102158011|FG000|STARTED|Overall Study||37||
48620276|NCT04458675|101856343|FG000|COMPLETED|Overall Study||31||
48620277|NCT04458675|101856344|FG001|COMPLETED|Overall Study||28||
48620278|NCT04458675|101856343|FG000|NOT COMPLETED|Overall Study||0||
48620279|NCT04458675|101856344|FG001|NOT COMPLETED|Overall Study||0||
48620280|NCT00846053|101856345|FG000|STARTED|Overall Study||13||
48620281|NCT00846053|101856346|FG001|STARTED|Overall Study||8||
48620282|NCT00846053|101856345|FG000|COMPLETED|Overall Study||10||
48620283|NCT00846053|101856346|FG001|COMPLETED|Overall Study||8||
48620284|NCT00846053|101856345|FG000|NOT COMPLETED|Overall Study||3||
48620285|NCT00846053|101856346|FG001|NOT COMPLETED|Overall Study||0||
48743460|NCT04112303|102158011|FG000|COMPLETED|Overall Study||36||
48743461|NCT04112303|102158011|FG000|NOT COMPLETED|Overall Study||1||
48743462|NCT03121365|102158012|FG000|STARTED|Baseline||55||
48743463|NCT03121365|102158013|FG001|STARTED|Baseline||49||
48743464|NCT03121365|102158012|FG000|COMPLETED|Baseline||54||
48743465|NCT03121365|102158013|FG001|COMPLETED|Baseline||48||
48743466|NCT03121365|102158012|FG000|NOT COMPLETED|Baseline||1||
48743467|NCT03121365|102158013|FG001|NOT COMPLETED|Baseline||1||
48743468|NCT03121365|102158012|FG000|STARTED|1 Months||54||
48743469|NCT03121365|102158013|FG001|STARTED|1 Months||48||
48743470|NCT03121365|102158012|FG000|COMPLETED|1 Months||52||
48743471|NCT03121365|102158013|FG001|COMPLETED|1 Months||45||
48743472|NCT03121365|102158012|FG000|NOT COMPLETED|1 Months||2||
48743473|NCT03121365|102158013|FG001|NOT COMPLETED|1 Months||3||
48620286|NCT03268343|101856347|FG000|STARTED|Overall Study||12||
48620287|NCT03268343|101856348|FG001|STARTED|Overall Study||12||
48620288|NCT03268343|101856347|FG000|COMPLETED|Overall Study||12||
48620289|NCT03268343|101856348|FG001|COMPLETED|Overall Study||12||
48620290|NCT03268343|101856347|FG000|NOT COMPLETED|Overall Study||0||
48620291|NCT03268343|101856348|FG001|NOT COMPLETED|Overall Study||0||
48620292|NCT03724357|101856349|FG000|STARTED|Overall Study||3||
48743474|NCT03121365|102158012|FG000|STARTED|4 Months||54||
48743475|NCT03121365|102158013|FG001|STARTED|4 Months||45||
48743476|NCT03121365|102158012|FG000|COMPLETED|4 Months||51||
48743477|NCT03121365|102158013|FG001|COMPLETED|4 Months||44||
48326575|NCT03259074|101124704|FG002|COMPLETED|Overall Study||243||
48326576|NCT03259074|101124702|FG000|NOT COMPLETED|Overall Study||33||
48326577|NCT03259074|101124703|FG001|NOT COMPLETED|Overall Study||49||
48326578|NCT03259074|101124704|FG002|NOT COMPLETED|Overall Study||43||
48326579|NCT01314716|101124705|FG000|STARTED|Double-Blind Phase||136||
48326580|NCT01314716|101124706|FG001|STARTED|Double-Blind Phase||138||
48326581|NCT01314716|101124705|FG000|Randomized and Treated|Double-Blind Phase||135||
48326582|NCT01314716|101124706|FG001|Randomized and Treated|Double-Blind Phase||137||
48326583|NCT01314716|101124705|FG000|COMPLETED|Double-Blind Phase||119||
48326584|NCT01314716|101124706|FG001|COMPLETED|Double-Blind Phase||123||
48326585|NCT01314716|101124705|FG000|NOT COMPLETED|Double-Blind Phase||17||
48326586|NCT01314716|101124706|FG001|NOT COMPLETED|Double-Blind Phase||15||
48326587|NCT01314716|101124705|FG000|STARTED|Open-Label Phase||112||
48326588|NCT01314716|101124706|FG001|STARTED|Open-Label Phase||110||
48326589|NCT01314716|101124705|FG000|COMPLETED|Open-Label Phase||102||
48326590|NCT01314716|101124706|FG001|COMPLETED|Open-Label Phase||98||
48326591|NCT01314716|101124705|FG000|NOT COMPLETED|Open-Label Phase||10||
48326592|NCT01314716|101124706|FG001|NOT COMPLETED|Open-Label Phase||12||
48409506|NCT02579863|101334726|FG000|COMPLETED|Overall Study||0||
48409507|NCT02579863|101334727|FG001|COMPLETED|Overall Study||0||
48743478|NCT03121365|102158012|FG000|NOT COMPLETED|4 Months||3||
48326593|NCT00769002|101124707|FG000|STARTED|Overall Study||9||
48409508|NCT02579863|101334726|FG000|NOT COMPLETED|Overall Study||156||
48409509|NCT02579863|101334727|FG001|NOT COMPLETED|Overall Study||154||
48620293|NCT03724357|101856349|FG000|COMPLETED|Overall Study||1||
48620294|NCT03724357|101856349|FG000|NOT COMPLETED|Overall Study||2||
48620295|NCT03569397|101856350|FG000|STARTED|Overall Study||29||
48620296|NCT03569397|101856351|FG001|STARTED|Overall Study||28||
48620297|NCT03569397|101856350|FG000|COMPLETED|Overall Study||29||
48620298|NCT03569397|101856351|FG001|COMPLETED|Overall Study||28||
48620299|NCT03569397|101856350|FG000|NOT COMPLETED|Overall Study||0||
48620300|NCT03569397|101856351|FG001|NOT COMPLETED|Overall Study||0||
48620301|NCT03124160|101856352|FG000|STARTED|Overall Study||887||
48620302|NCT03124160|101856353|FG001|STARTED|Overall Study||218||
48620303|NCT03124160|101856352|FG000|COMPLETED|Overall Study||426||
48326594|NCT00769002|101124708|FG001|STARTED|Overall Study||9||
48326595|NCT00769002|101124707|FG000|COMPLETED|Overall Study||0||
48743479|NCT03121365|102158013|FG001|NOT COMPLETED|4 Months||1||
48743480|NCT03121365|102158012|FG000|STARTED|7 Months||54||
48743481|NCT03121365|102158013|FG001|STARTED|7 Months||45||
48620304|NCT03124160|101856353|FG001|COMPLETED|Overall Study||91||
48620305|NCT03124160|101856352|FG000|NOT COMPLETED|Overall Study||461||
48620306|NCT03124160|101856353|FG001|NOT COMPLETED|Overall Study||127||
48620307|NCT02359110|101856354|FG000|STARTED|Overall Study||55||
48620308|NCT02359110|101856355|FG001|STARTED|Overall Study||54||
48620309|NCT02359110|101856354|FG000|COMPLETED|Overall Study||55||
48620310|NCT02359110|101856355|FG001|COMPLETED|Overall Study||54||
48620311|NCT02359110|101856354|FG000|NOT COMPLETED|Overall Study||0||
48620312|NCT02359110|101856355|FG001|NOT COMPLETED|Overall Study||0||
48620313|NCT00846586|101856356|FG000|STARTED|Overall Study||570||
48620314|NCT00846586|101856357|FG001|STARTED|Overall Study||564||
48620315|NCT00846586|101856356|FG000|Received Study Drug|Overall Study||570||
48620316|NCT00846586|101856357|FG001|Received Study Drug|Overall Study||561||
48620317|NCT00846586|101856356|FG000|COMPLETED|Overall Study||531||
48620318|NCT00846586|101856357|FG001|COMPLETED|Overall Study||529||
48620319|NCT00846586|101856356|FG000|NOT COMPLETED|Overall Study||39||
48620320|NCT00846586|101856357|FG001|NOT COMPLETED|Overall Study||35||
48620321|NCT00500448|101856358|FG000|STARTED|Overall Study||14||
48620322|NCT00500448|101856359|FG001|STARTED|Overall Study||16||
48620323|NCT00500448|101856358|FG000|COMPLETED|Overall Study||14||
48620324|NCT00500448|101856359|FG001|COMPLETED|Overall Study||16||
48620325|NCT00500448|101856358|FG000|NOT COMPLETED|Overall Study||0||
48620326|NCT00500448|101856359|FG001|NOT COMPLETED|Overall Study||0||
48743482|NCT03121365|102158012|FG000|COMPLETED|7 Months||44||
48743483|NCT03121365|102158013|FG001|COMPLETED|7 Months||37||
48743484|NCT03121365|102158012|FG000|NOT COMPLETED|7 Months||10||
48743485|NCT03121365|102158013|FG001|NOT COMPLETED|7 Months||8||
48743486|NCT00783614|102158014|FG000|STARTED|Overall Study||6||
48743487|NCT00783614|102158015|FG001|STARTED|Overall Study||6||
48620327|NCT02050334|101856360|FG000|STARTED|Overall Study||9||
48620328|NCT02050334|101856361|FG001|STARTED|Overall Study||9||
48620329|NCT02050334|101856360|FG000|COMPLETED|Overall Study||9||
48620330|NCT02050334|101856361|FG001|COMPLETED|Overall Study||9||
48620331|NCT02050334|101856360|FG000|NOT COMPLETED|Overall Study||0||
48620332|NCT02050334|101856361|FG001|NOT COMPLETED|Overall Study||0||
48620333|NCT03528551|101856362|FG000|STARTED|Overall Study||25||
48620334|NCT03528551|101856363|FG001|STARTED|Overall Study||133||
48620335|NCT03528551|101856364|FG002|STARTED|Overall Study||2||
48620336|NCT03528551|101856362|FG000|COMPLETED|Overall Study||23||
48620337|NCT03528551|101856363|FG001|COMPLETED|Overall Study||114||
48620338|NCT03528551|101856364|FG002|COMPLETED|Overall Study||2||
48620339|NCT03528551|101856362|FG000|NOT COMPLETED|Overall Study||2||
48620340|NCT03528551|101856363|FG001|NOT COMPLETED|Overall Study||19||
48620341|NCT03528551|101856364|FG002|NOT COMPLETED|Overall Study||0||
48620342|NCT00676403|101856365|FG000|STARTED|Overall Study||23||
48620343|NCT00676403|101856366|FG001|STARTED|Overall Study||22||
48620344|NCT00676403|101856367|FG002|STARTED|Overall Study||23||
48620345|NCT00676403|101856368|FG003|STARTED|Overall Study||22||
48620346|NCT00676403|101856369|FG004|STARTED|Overall Study||24||
48620347|NCT00676403|101856370|FG005|STARTED|Overall Study||23||
48620348|NCT00676403|101856365|FG000|COMPLETED|Overall Study||21||
48620349|NCT00676403|101856366|FG001|COMPLETED|Overall Study||20||
48620350|NCT00676403|101856367|FG002|COMPLETED|Overall Study||22||
48620351|NCT00676403|101856368|FG003|COMPLETED|Overall Study||17||
48620352|NCT00676403|101856369|FG004|COMPLETED|Overall Study||23||
48620353|NCT00676403|101856370|FG005|COMPLETED|Overall Study||18||
48620354|NCT00676403|101856365|FG000|NOT COMPLETED|Overall Study||2||
48620355|NCT00676403|101856366|FG001|NOT COMPLETED|Overall Study||2||
48620356|NCT00676403|101856367|FG002|NOT COMPLETED|Overall Study||1||
48620357|NCT00676403|101856368|FG003|NOT COMPLETED|Overall Study||5||
48620358|NCT00676403|101856369|FG004|NOT COMPLETED|Overall Study||1||
48620359|NCT00676403|101856370|FG005|NOT COMPLETED|Overall Study||5||
48620360|NCT01825200|101856371|FG000|STARTED|Overall Study||1319||
48620361|NCT01825200|101856372|FG001|STARTED|Overall Study||1321||
48620362|NCT01825200|101856371|FG000|COMPLETED|Overall Study||1314||
48620363|NCT01825200|101856372|FG001|COMPLETED|Overall Study||1314||
48620364|NCT01825200|101856371|FG000|NOT COMPLETED|Overall Study||5||
48620365|NCT01825200|101856372|FG001|NOT COMPLETED|Overall Study||7||
48620366|NCT01001910|101856373|FG000|STARTED|Overall Study||28||
48620367|NCT01001910|101856373|FG000|COMPLETED|Overall Study||22||
48743488|NCT00783614|102158016|FG002|STARTED|Overall Study||5||
48743489|NCT00783614|102158017|FG003|STARTED|Overall Study||5||
48743490|NCT00783614|102158014|FG000|COMPLETED|Overall Study||6||
48743491|NCT00783614|102158015|FG001|COMPLETED|Overall Study||6||
48743492|NCT00783614|102158016|FG002|COMPLETED|Overall Study||5||
48743493|NCT00783614|102158017|FG003|COMPLETED|Overall Study||5||
48743494|NCT00783614|102158014|FG000|NOT COMPLETED|Overall Study||0||
48620368|NCT01001910|101856373|FG000|NOT COMPLETED|Overall Study||6||
48743495|NCT00783614|102158015|FG001|NOT COMPLETED|Overall Study||0||
48620369|NCT01877161|101856374|FG000|STARTED|First Session of Stimulation||12||
48743496|NCT00783614|102158016|FG002|NOT COMPLETED|Overall Study||0||
48620370|NCT01877161|101856374|FG000|COMPLETED|First Session of Stimulation||12||
48620371|NCT01877161|101856374|FG000|NOT COMPLETED|First Session of Stimulation||0||
48620372|NCT01877161|101856374|FG000|STARTED|Washout (at Least 3 Days)||12||
48620373|NCT01877161|101856374|FG000|COMPLETED|Washout (at Least 3 Days)||12||
48620374|NCT01877161|101856374|FG000|NOT COMPLETED|Washout (at Least 3 Days)||0||
48620375|NCT01877161|101856374|FG000|STARTED|Second Session of Stimulation||12||
48620376|NCT01877161|101856374|FG000|COMPLETED|Second Session of Stimulation||12||
48620377|NCT01877161|101856374|FG000|NOT COMPLETED|Second Session of Stimulation||0||
48620378|NCT01877161|101856374|FG000|STARTED|Washout (at Least 3 Days)||12||
48620379|NCT01877161|101856374|FG000|COMPLETED|Washout (at Least 3 Days)||12||
48620380|NCT01877161|101856374|FG000|NOT COMPLETED|Washout (at Least 3 Days)||0||
48620381|NCT01877161|101856374|FG000|STARTED|Third Session of Stimulation||12||
48620382|NCT01877161|101856374|FG000|COMPLETED|Third Session of Stimulation||12||
48620383|NCT01877161|101856374|FG000|NOT COMPLETED|Third Session of Stimulation||0||
48743497|NCT00783614|102158017|FG003|NOT COMPLETED|Overall Study||0||
48743498|NCT00718510|102158018|FG000|STARTED|First Intervention (3 Weeks)||7||
48743499|NCT00718510|102158019|FG001|STARTED|First Intervention (3 Weeks)||8||
48743500|NCT00718510|102158018|FG000|Received Intervention|First Intervention (3 Weeks)||7|Received Intervention|
48743501|NCT00718510|102158019|FG001|Received Intervention|First Intervention (3 Weeks)||7|Received Intervention|
48326596|NCT00769002|101124708|FG001|COMPLETED|Overall Study||0||
48326597|NCT00769002|101124707|FG000|NOT COMPLETED|Overall Study||9||
48326598|NCT00769002|101124708|FG001|NOT COMPLETED|Overall Study||9||
48326599|NCT04036708|101124709|FG000|STARTED|Overall Study||79||
48326600|NCT04036708|101124710|FG001|STARTED|Overall Study||40||
48743502|NCT00718510|102158018|FG000|COMPLETED|First Intervention (3 Weeks)||7||
48743503|NCT00718510|102158019|FG001|COMPLETED|First Intervention (3 Weeks)||7||
48743504|NCT00718510|102158018|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0||
48743505|NCT00718510|102158019|FG001|NOT COMPLETED|First Intervention (3 Weeks)||1||
48743506|NCT00718510|102158018|FG000|STARTED|Washout (5 Days)||7||
48743507|NCT00718510|102158019|FG001|STARTED|Washout (5 Days)||7||
48743508|NCT00718510|102158018|FG000|COMPLETED|Washout (5 Days)||7||
48743509|NCT00718510|102158019|FG001|COMPLETED|Washout (5 Days)||7||
48743510|NCT00718510|102158018|FG000|NOT COMPLETED|Washout (5 Days)||0||
48743511|NCT00718510|102158019|FG001|NOT COMPLETED|Washout (5 Days)||0||
48743512|NCT00718510|102158018|FG000|STARTED|Second Intervention (3 Weeks)||7||
48743513|NCT00718510|102158019|FG001|STARTED|Second Intervention (3 Weeks)||7||
48743514|NCT00718510|102158018|FG000|COMPLETED|Second Intervention (3 Weeks)||6||
48743515|NCT00718510|102158019|FG001|COMPLETED|Second Intervention (3 Weeks)||7||
48743516|NCT00718510|102158018|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||1||
48743517|NCT00718510|102158019|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0||
48743518|NCT03232346|102158020|FG000|STARTED|Overall Study||6||
48743519|NCT03232346|102158021|FG001|STARTED|Overall Study||5||
48743520|NCT03232346|102158020|FG000|COMPLETED|Overall Study||2||
48743521|NCT03232346|102158021|FG001|COMPLETED|Overall Study||3||
48743522|NCT03232346|102158020|FG000|NOT COMPLETED|Overall Study||4||
48743523|NCT03232346|102158021|FG001|NOT COMPLETED|Overall Study||2||
48743524|NCT04363879|102158022|FG000|STARTED|Overall Study||78||
48743525|NCT04363879|102158023|FG001|STARTED|Overall Study||92||
48743526|NCT04363879|102158022|FG000|COMPLETED|Overall Study||78||
48743527|NCT04363879|102158023|FG001|COMPLETED|Overall Study||92||
48743528|NCT04363879|102158022|FG000|NOT COMPLETED|Overall Study||0||
48743529|NCT04363879|102158023|FG001|NOT COMPLETED|Overall Study||0||
48743530|NCT00191308|102158024|FG000|STARTED|Overall Study||30||
48743531|NCT00191308|102158024|FG000|COMPLETED|Overall Study||29||
48743532|NCT00191308|102158024|FG000|NOT COMPLETED|Overall Study||1||
48743533|NCT00203229|102158025|FG000|STARTED|Overall Study||10||
48743534|NCT00203229|102158026|FG001|STARTED|Overall Study||10||
48743535|NCT00203229|102158025|FG000|COMPLETED|Overall Study||7||
48620384|NCT02239640|101856375|FG000|STARTED|Overall Study||984||
48620385|NCT02239640|101856375|FG000|COMPLETED|Overall Study||767||
48620386|NCT02239640|101856375|FG000|NOT COMPLETED|Overall Study||217||
48743536|NCT00203229|102158026|FG001|COMPLETED|Overall Study||7||
48743537|NCT00203229|102158025|FG000|NOT COMPLETED|Overall Study||3||
48743538|NCT00203229|102158026|FG001|NOT COMPLETED|Overall Study||3||
48743539|NCT02532465|102158027|FG000|STARTED|Overall Study||25||
48743540|NCT02532465|102158028|FG001|STARTED|Overall Study||25||
48743541|NCT02532465|102158027|FG000|COMPLETED|Overall Study||24||
48743542|NCT02532465|102158028|FG001|COMPLETED|Overall Study||24||
48620387|NCT02185417|101856376|FG000|STARTED|Overall Study||6767||
48620388|NCT02185417|101856377|FG001|STARTED|Overall Study||6756||
48743543|NCT02532465|102158027|FG000|NOT COMPLETED|Overall Study||1||
48743544|NCT02532465|102158028|FG001|NOT COMPLETED|Overall Study||1||
48743545|NCT03676972|102158029|FG000|STARTED|Overall Study||60||
48326601|NCT04036708|101124711|FG002|STARTED|Overall Study||79||
48326602|NCT04036708|101124712|FG003|STARTED|Overall Study||40||
48743546|NCT03676972|102158029|FG000|COMPLETED|Overall Study||58||
48743547|NCT03676972|102158029|FG000|NOT COMPLETED|Overall Study||2||
48326603|NCT04036708|101124709|FG000|COMPLETED|Overall Study||65||
48326604|NCT04036708|101124710|FG001|COMPLETED|Overall Study||36||
48326605|NCT04036708|101124711|FG002|COMPLETED|Overall Study||65||
48620389|NCT02185417|101856378|FG002|STARTED|Overall Study||4128||
48620390|NCT02185417|101856376|FG000|COMPLETED|Overall Study||6312||
48620391|NCT02185417|101856377|FG001|COMPLETED|Overall Study||6298||
48620392|NCT02185417|101856378|FG002|COMPLETED|Overall Study||4128||
48620393|NCT02185417|101856376|FG000|NOT COMPLETED|Overall Study||455||
48620394|NCT02185417|101856377|FG001|NOT COMPLETED|Overall Study||458||
48620395|NCT02185417|101856378|FG002|NOT COMPLETED|Overall Study||0||
48620396|NCT02104895|101856379|FG000|STARTED|Overall Study||260||
48620397|NCT02104895|101856380|FG001|STARTED|Overall Study||260||
48620398|NCT02104895|101856379|FG000|COMPLETED|Overall Study||260||
48620399|NCT02104895|101856380|FG001|COMPLETED|Overall Study||246||
48620400|NCT02104895|101856379|FG000|NOT COMPLETED|Overall Study||0||
48620401|NCT02104895|101856380|FG001|NOT COMPLETED|Overall Study||14||
48620402|NCT00763360|101856381|FG000|STARTED|Overall Study||61||
48620403|NCT00763360|101856382|FG001|STARTED|Overall Study||60||
48620404|NCT00763360|101856383|FG002|STARTED|Overall Study||63||
48620405|NCT00763360|101856381|FG000|COMPLETED|Overall Study||61||
48620406|NCT00763360|101856382|FG001|COMPLETED|Overall Study||58||
48620407|NCT00763360|101856383|FG002|COMPLETED|Overall Study||63||
48163769|NCT03863522|100724880|FG000|COMPLETED|Overall Study||116||
48163770|NCT03863522|100724880|FG000|NOT COMPLETED|Overall Study||0||
48163771|NCT00405639|100724881|FG000|STARTED|Overall Study||25||
48163772|NCT00405639|100724882|FG001|STARTED|Overall Study||12||
48163773|NCT00405639|100724881|FG000|COMPLETED|Overall Study||22||
48163774|NCT00405639|100724882|FG001|COMPLETED|Overall Study||12||
48163775|NCT00405639|100724881|FG000|NOT COMPLETED|Overall Study||3||
48163776|NCT00405639|100724882|FG001|NOT COMPLETED|Overall Study||0||
48163777|NCT00067990|100724883|FG000|STARTED|Overall Study||77||
48163778|NCT00067990|100724884|FG001|STARTED|Overall Study||76||
48163779|NCT00067990|100724883|FG000|COMPLETED|Overall Study||67||
48163780|NCT00067990|100724884|FG001|COMPLETED|Overall Study||54||
48163781|NCT00067990|100724883|FG000|NOT COMPLETED|Overall Study||10||
48163782|NCT00067990|100724884|FG001|NOT COMPLETED|Overall Study||22||
48163783|NCT03443713|100724885|FG000|STARTED|Start up Visit (2 Hours)||8||
48163784|NCT03443713|100724886|FG001|STARTED|Start up Visit (2 Hours)||8||
48620408|NCT00763360|101856381|FG000|NOT COMPLETED|Overall Study||0||
48620409|NCT00763360|101856382|FG001|NOT COMPLETED|Overall Study||2||
48620410|NCT00763360|101856383|FG002|NOT COMPLETED|Overall Study||0||
48620411|NCT01783743|101856384|FG000|STARTED|Screening of Subjects by CTA During MDA||13509||18
48620412|NCT01783743|101856385|FG001|STARTED|Screening of Subjects by CTA During MDA||13964||18
48620413|NCT01783743|101856384|FG000|COMPLETED|Screening of Subjects by CTA During MDA||10082||18
48620414|NCT01783743|101856385|FG001|COMPLETED|Screening of Subjects by CTA During MDA||9525||18
48620415|NCT01783743|101856384|FG000|NOT COMPLETED|Screening of Subjects by CTA During MDA||3427||0
48620416|NCT01783743|101856385|FG001|NOT COMPLETED|Screening of Subjects by CTA During MDA||4439||0
48163785|NCT03443713|100724887|FG002|STARTED|Start up Visit (2 Hours)||9||
48163786|NCT03443713|100724885|FG000|COMPLETED|Start up Visit (2 Hours)||8||
48163787|NCT03443713|100724886|FG001|COMPLETED|Start up Visit (2 Hours)||8||
48163788|NCT03443713|100724887|FG002|COMPLETED|Start up Visit (2 Hours)||9||
48163789|NCT03443713|100724885|FG000|NOT COMPLETED|Start up Visit (2 Hours)||0||
48163790|NCT03443713|100724886|FG001|NOT COMPLETED|Start up Visit (2 Hours)||0||
48163791|NCT03443713|100724887|FG002|NOT COMPLETED|Start up Visit (2 Hours)||0||
48163792|NCT03443713|100724885|FG000|STARTED|First at Home Period (9-14 Days)||8||
48163793|NCT03443713|100724886|FG001|STARTED|First at Home Period (9-14 Days)||8||
48163794|NCT03443713|100724887|FG002|STARTED|First at Home Period (9-14 Days)||9||
48163795|NCT03443713|100724885|FG000|COMPLETED|First at Home Period (9-14 Days)||8||
48163796|NCT03443713|100724886|FG001|COMPLETED|First at Home Period (9-14 Days)||8||
48163797|NCT03443713|100724887|FG002|COMPLETED|First at Home Period (9-14 Days)||8||
48163798|NCT03443713|100724885|FG000|NOT COMPLETED|First at Home Period (9-14 Days)||0||
48163799|NCT03443713|100724886|FG001|NOT COMPLETED|First at Home Period (9-14 Days)||0||
48163800|NCT03443713|100724887|FG002|NOT COMPLETED|First at Home Period (9-14 Days)||1||
48163801|NCT03443713|100724885|FG000|STARTED|First Exercise Visit (1 Hour)||8||
48163802|NCT03443713|100724886|FG001|STARTED|First Exercise Visit (1 Hour)||8||
48163803|NCT03443713|100724887|FG002|STARTED|First Exercise Visit (1 Hour)||8||
48163804|NCT03443713|100724885|FG000|COMPLETED|First Exercise Visit (1 Hour)||8||
48163805|NCT03443713|100724886|FG001|COMPLETED|First Exercise Visit (1 Hour)||8||
48163806|NCT03443713|100724887|FG002|COMPLETED|First Exercise Visit (1 Hour)||8||
48163807|NCT03443713|100724885|FG000|NOT COMPLETED|First Exercise Visit (1 Hour)||0||
48163808|NCT03443713|100724886|FG001|NOT COMPLETED|First Exercise Visit (1 Hour)||0||
48163809|NCT03443713|100724887|FG002|NOT COMPLETED|First Exercise Visit (1 Hour)||0||
48163810|NCT03443713|100724885|FG000|STARTED|Dexcom Insertion Visit (30 Minutes)||8||
48163811|NCT03443713|100724886|FG001|STARTED|Dexcom Insertion Visit (30 Minutes)||8||
48163812|NCT03443713|100724887|FG002|STARTED|Dexcom Insertion Visit (30 Minutes)||8||
48163813|NCT03443713|100724885|FG000|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8||
48163814|NCT03443713|100724886|FG001|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8||
48163815|NCT03443713|100724887|FG002|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8||
48163816|NCT03443713|100724885|FG000|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0||
48163817|NCT03443713|100724886|FG001|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0||
48163818|NCT03443713|100724887|FG002|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0||
48163819|NCT03443713|100724885|FG000|STARTED|Second at Home Period (2-11 Days)||8||
48163820|NCT03443713|100724886|FG001|STARTED|Second at Home Period (2-11 Days)||8||
48163821|NCT03443713|100724887|FG002|STARTED|Second at Home Period (2-11 Days)||8||
48163822|NCT03443713|100724885|FG000|COMPLETED|Second at Home Period (2-11 Days)||8||
48163823|NCT03443713|100724886|FG001|COMPLETED|Second at Home Period (2-11 Days)||8||
48163824|NCT03443713|100724887|FG002|COMPLETED|Second at Home Period (2-11 Days)||8||
48163825|NCT03443713|100724885|FG000|NOT COMPLETED|Second at Home Period (2-11 Days)||0||
48163826|NCT03443713|100724886|FG001|NOT COMPLETED|Second at Home Period (2-11 Days)||0||
48163827|NCT03443713|100724887|FG002|NOT COMPLETED|Second at Home Period (2-11 Days)||0||
48163828|NCT03443713|100724885|FG000|STARTED|Second Exercise Visit (1 Hour)||8||
48163829|NCT03443713|100724886|FG001|STARTED|Second Exercise Visit (1 Hour)||8||
48163830|NCT03443713|100724887|FG002|STARTED|Second Exercise Visit (1 Hour)||8||
48163831|NCT03443713|100724885|FG000|COMPLETED|Second Exercise Visit (1 Hour)||8||
48163832|NCT03443713|100724886|FG001|COMPLETED|Second Exercise Visit (1 Hour)||8||
48163833|NCT03443713|100724887|FG002|COMPLETED|Second Exercise Visit (1 Hour)||8||
48163834|NCT03443713|100724885|FG000|NOT COMPLETED|Second Exercise Visit (1 Hour)||0||
48163835|NCT03443713|100724886|FG001|NOT COMPLETED|Second Exercise Visit (1 Hour)||0||
48163836|NCT03443713|100724887|FG002|NOT COMPLETED|Second Exercise Visit (1 Hour)||0||
48163837|NCT03443713|100724885|FG000|STARTED|Third at Home Period (8-12 Days)||8||
48163838|NCT03443713|100724886|FG001|STARTED|Third at Home Period (8-12 Days)||8||
48163839|NCT03443713|100724887|FG002|STARTED|Third at Home Period (8-12 Days)||8||
48163840|NCT03443713|100724885|FG000|COMPLETED|Third at Home Period (8-12 Days)||8||
48163841|NCT03443713|100724886|FG001|COMPLETED|Third at Home Period (8-12 Days)||8||
48163842|NCT03443713|100724887|FG002|COMPLETED|Third at Home Period (8-12 Days)||8||
48163843|NCT03443713|100724885|FG000|NOT COMPLETED|Third at Home Period (8-12 Days)||0||
48163844|NCT03443713|100724886|FG001|NOT COMPLETED|Third at Home Period (8-12 Days)||0||
48163845|NCT03443713|100724887|FG002|NOT COMPLETED|Third at Home Period (8-12 Days)||0||
48163846|NCT03443713|100724885|FG000|STARTED|Close-out Visit (30 Minutes)||8||
48163847|NCT03443713|100724886|FG001|STARTED|Close-out Visit (30 Minutes)||8||
48163848|NCT03443713|100724887|FG002|STARTED|Close-out Visit (30 Minutes)||8||
48163849|NCT03443713|100724885|FG000|COMPLETED|Close-out Visit (30 Minutes)||8||
48163850|NCT03443713|100724886|FG001|COMPLETED|Close-out Visit (30 Minutes)||8||
48163851|NCT03443713|100724887|FG002|COMPLETED|Close-out Visit (30 Minutes)||8||
48163852|NCT03443713|100724885|FG000|NOT COMPLETED|Close-out Visit (30 Minutes)||0||
48163853|NCT03443713|100724886|FG001|NOT COMPLETED|Close-out Visit (30 Minutes)||0||
48163854|NCT03443713|100724887|FG002|NOT COMPLETED|Close-out Visit (30 Minutes)||0||
48163855|NCT02412501|100724888|FG000|STARTED|Overall Study||101||
48163856|NCT02412501|100724888|FG000|COMPLETED|Overall Study||101||
48163857|NCT02412501|100724888|FG000|NOT COMPLETED|Overall Study||0||
48163858|NCT00550550|100724889|FG000|STARTED|Overall Study||176||
48163859|NCT00550550|100724890|FG001|STARTED|Overall Study||169||
48163860|NCT00550550|100724889|FG000|Number Treated|Overall Study||175||
48163861|NCT00550550|100724890|FG001|Number Treated|Overall Study||169||
48163862|NCT00550550|100724889|FG000|COMPLETED|Overall Study||142||
48163863|NCT00550550|100724890|FG001|COMPLETED|Overall Study||140||
48163864|NCT00550550|100724889|FG000|NOT COMPLETED|Overall Study||34||
48163865|NCT00550550|100724890|FG001|NOT COMPLETED|Overall Study||29||
48163866|NCT04152343|100724891|FG000|STARTED|Overall Study||57||68
48163867|NCT04152343|100724891|FG000|Completed Procedure|Overall Study||57||68
48163868|NCT04152343|100724891|FG000|Completed 2-3 m Imaging for Efficacy|Overall Study||57||68
48163869|NCT04152343|100724891|FG000|COMPLETED|Overall Study||29|completed 2 year enhanced MRI/CT follow-up|37
48163870|NCT04152343|100724891|FG000|NOT COMPLETED|Overall Study||28||31
48163871|NCT01382602|100724892|FG000|STARTED|Overall Study||93||
48163872|NCT01382602|100724893|FG001|STARTED|Overall Study||50||
48163873|NCT01382602|100724892|FG000|COMPLETED|Overall Study||93||
48163874|NCT01382602|100724893|FG001|COMPLETED|Overall Study||46||
48163875|NCT01382602|100724892|FG000|NOT COMPLETED|Overall Study||0||
48163876|NCT01382602|100724893|FG001|NOT COMPLETED|Overall Study||4||
48163877|NCT00980005|100724894|FG000|STARTED|Overall Study||1055||
48163878|NCT00980005|100724895|FG001|STARTED|Overall Study||1061||
48163879|NCT00980005|100724894|FG000|COMPLETED|Overall Study||1008||
48163880|NCT00980005|100724895|FG001|COMPLETED|Overall Study||998||
48163881|NCT00980005|100724894|FG000|NOT COMPLETED|Overall Study||47||
48163882|NCT00980005|100724895|FG001|NOT COMPLETED|Overall Study||63||
48163883|NCT00462670|100724896|FG000|STARTED|Overall Study||57||
48163884|NCT00462670|100724897|FG001|STARTED|Overall Study||53||
48163885|NCT00462670|100724896|FG000|COMPLETED|Overall Study||52||
48163886|NCT00462670|100724897|FG001|COMPLETED|Overall Study||46||
48163887|NCT00462670|100724896|FG000|NOT COMPLETED|Overall Study||5||
48163888|NCT00462670|100724897|FG001|NOT COMPLETED|Overall Study||7||
48163889|NCT03154281|100724898|FG000|STARTED|Overall Study||8||
48163890|NCT03154281|100724899|FG001|STARTED|Overall Study||6||
48163891|NCT03154281|100724900|FG002|STARTED|Overall Study||0||
48163892|NCT03154281|100724901|FG003|STARTED|Overall Study||0||
48163893|NCT03154281|100724898|FG000|COMPLETED|Overall Study||7||
48163894|NCT03154281|100724899|FG001|COMPLETED|Overall Study||4||
48163895|NCT03154281|100724900|FG002|COMPLETED|Overall Study||0||
48163896|NCT03154281|100724901|FG003|COMPLETED|Overall Study||0||
48163897|NCT03154281|100724898|FG000|NOT COMPLETED|Overall Study||1||
48163898|NCT03154281|100724899|FG001|NOT COMPLETED|Overall Study||2||
48163899|NCT03154281|100724900|FG002|NOT COMPLETED|Overall Study||0||
48163900|NCT03154281|100724901|FG003|NOT COMPLETED|Overall Study||0||
48163901|NCT03610737|100724902|FG000|STARTED|Overall Study||77||
48163902|NCT03610737|100724903|FG001|STARTED|Overall Study||78||
48163903|NCT03610737|100724902|FG000|COMPLETED|Overall Study||69||
48163904|NCT03610737|100724903|FG001|COMPLETED|Overall Study||69||
48163905|NCT03610737|100724902|FG000|NOT COMPLETED|Overall Study||8||
48163906|NCT03610737|100724903|FG001|NOT COMPLETED|Overall Study||9||
48163907|NCT02623816|100724904|FG000|STARTED|Overall Study||40||
48163908|NCT02623816|100724905|FG001|STARTED|Overall Study||24||
48163909|NCT02623816|100724904|FG000|COMPLETED|Overall Study||38||
48163910|NCT02623816|100724905|FG001|COMPLETED|Overall Study||22||
48163911|NCT02623816|100724904|FG000|NOT COMPLETED|Overall Study||2||
48163912|NCT02623816|100724905|FG001|NOT COMPLETED|Overall Study||2||
48163913|NCT01377480|100724906|FG000|STARTED|Overall Study||32||
48163914|NCT01377480|100724907|FG001|STARTED|Overall Study||30||
48163915|NCT01377480|100724908|FG002|STARTED|Overall Study||28||
48163916|NCT01377480|100724909|FG003|STARTED|Overall Study||30||
48163917|NCT01377480|100724906|FG000|COMPLETED|Overall Study||32||
48163918|NCT01377480|100724907|FG001|COMPLETED|Overall Study||29||
48163919|NCT01377480|100724908|FG002|COMPLETED|Overall Study||18||
48163920|NCT01377480|100724909|FG003|COMPLETED|Overall Study||19||
48163921|NCT01377480|100724906|FG000|NOT COMPLETED|Overall Study||0||
48163922|NCT01377480|100724907|FG001|NOT COMPLETED|Overall Study||1||
48163923|NCT01377480|100724908|FG002|NOT COMPLETED|Overall Study||10||
48163924|NCT01377480|100724909|FG003|NOT COMPLETED|Overall Study||11||
48163925|NCT00591864|100724910|FG000|STARTED|Overall Study||89||
48163926|NCT00591864|100724910|FG000|COMPLETED|Overall Study||84||
48163927|NCT00591864|100724910|FG000|NOT COMPLETED|Overall Study||5||
48163928|NCT03982043|100724911|FG000|STARTED|Overall Study||43||
48163929|NCT03982043|100724912|FG001|STARTED|Overall Study||4||
48163930|NCT03982043|100724911|FG000|COMPLETED|Overall Study||43||
48163931|NCT03982043|100724912|FG001|COMPLETED|Overall Study||4||
48163932|NCT03982043|100724911|FG000|NOT COMPLETED|Overall Study||0||
48163933|NCT03982043|100724912|FG001|NOT COMPLETED|Overall Study||0||
48163934|NCT00058019|100724913|FG000|STARTED|Overall Study||39||
48163935|NCT00058019|100724914|FG001|STARTED|Overall Study||12||
48163936|NCT00058019|100724913|FG000|COMPLETED|Overall Study||39||
48163937|NCT00058019|100724914|FG001|COMPLETED|Overall Study||12||
48163938|NCT00058019|100724913|FG000|NOT COMPLETED|Overall Study||0||
48163939|NCT00058019|100724914|FG001|NOT COMPLETED|Overall Study||0||
48163940|NCT02061696|100724915|FG000|STARTED|Overall Study||17||
48163941|NCT02061696|100724916|FG001|STARTED|Overall Study||22||
48163942|NCT02061696|100724915|FG000|COMPLETED|Overall Study||17||
48163943|NCT02061696|100724916|FG001|COMPLETED|Overall Study||22||
48163944|NCT02061696|100724915|FG000|NOT COMPLETED|Overall Study||0||
48163945|NCT02061696|100724916|FG001|NOT COMPLETED|Overall Study||0||
48326606|NCT04036708|101124712|FG003|COMPLETED|Overall Study||36||
48163946|NCT05414318|100724917|FG000|STARTED|Overall Study||43||
48743548|NCT02481297|102158030|FG000|STARTED|Overall Study||1||
48163947|NCT05414318|100724918|FG001|STARTED|Overall Study||12||
48163948|NCT05414318|100724917|FG000|COMPLETED|Overall Study||21||
48163949|NCT05414318|100724918|FG001|COMPLETED|Overall Study||5||
48163950|NCT05414318|100724917|FG000|NOT COMPLETED|Overall Study||22||
48163951|NCT05414318|100724918|FG001|NOT COMPLETED|Overall Study||7||
48163952|NCT01175148|100724919|FG000|STARTED|Overall Study||30||
48163953|NCT01175148|100724920|FG001|STARTED|Overall Study||30||
48163954|NCT01175148|100724919|FG000|COMPLETED|Overall Study||30||
48163955|NCT01175148|100724920|FG001|COMPLETED|Overall Study||30||
48163956|NCT01175148|100724919|FG000|NOT COMPLETED|Overall Study||0||
48163957|NCT01175148|100724920|FG001|NOT COMPLETED|Overall Study||0||
48163958|NCT00510458|100724921|FG000|STARTED|Overall Study||74||78
48163959|NCT00510458|100724921|FG000|COMPLETED|Overall Study||27||27
48163960|NCT00510458|100724921|FG000|NOT COMPLETED|Overall Study||47||51
48163961|NCT05737433|100724922|FG000|STARTED|Overall Study||6||
48743549|NCT02481297|102158031|FG001|STARTED|Overall Study||6||
48743550|NCT02481297|102158030|FG000|COMPLETED|Overall Study||1||
48743551|NCT02481297|102158031|FG001|COMPLETED|Overall Study||6||
48743552|NCT02481297|102158030|FG000|NOT COMPLETED|Overall Study||0||
48743553|NCT02481297|102158031|FG001|NOT COMPLETED|Overall Study||0||
48743554|NCT04628780|102158032|FG000|STARTED|Overall Study||4||
48163962|NCT05737433|100724922|FG000|COMPLETED|Overall Study||6||
48163963|NCT05737433|100724922|FG000|NOT COMPLETED|Overall Study||0||
48163964|NCT01641926|100724923|FG000|STARTED|Overall Study||143||
48163965|NCT01641926|100724924|FG001|STARTED|Overall Study||145||
48163966|NCT01641926|100724925|FG002|STARTED|Overall Study||57||
48163967|NCT01641926|100724926|FG003|STARTED|Overall Study||57||
48163968|NCT01641926|100724923|FG000|Treated (All Participants as Treated)|Overall Study||142||
48163969|NCT01641926|100724924|FG001|Treated (All Participants as Treated)|Overall Study||144||
48326607|NCT04036708|101124709|FG000|NOT COMPLETED|Overall Study||14||
48743555|NCT04628780|102158033|FG001|STARTED|Overall Study||4||
48743556|NCT04628780|102158034|FG002|STARTED|Overall Study||4||
48743557|NCT04628780|102158035|FG003|STARTED|Overall Study||3||
48743558|NCT04628780|102158036|FG004|STARTED|Overall Study||16||
48743559|NCT04628780|102158037|FG005|STARTED|Overall Study||6||
48743560|NCT04628780|102158032|FG000|COMPLETED|Overall Study||0||
48743561|NCT04628780|102158033|FG001|COMPLETED|Overall Study||0||
48743562|NCT04628780|102158034|FG002|COMPLETED|Overall Study||0||
48743563|NCT04628780|102158035|FG003|COMPLETED|Overall Study||0||
48743564|NCT04628780|102158036|FG004|COMPLETED|Overall Study||0||
48743565|NCT04628780|102158037|FG005|COMPLETED|Overall Study||0||
48743566|NCT04628780|102158032|FG000|NOT COMPLETED|Overall Study||4||
48743567|NCT04628780|102158033|FG001|NOT COMPLETED|Overall Study||4||
48743568|NCT04628780|102158034|FG002|NOT COMPLETED|Overall Study||4||
48163970|NCT01641926|100724925|FG002|Treated (All Participants as Treated)|Overall Study||56||
48163971|NCT01641926|100724926|FG003|Treated (All Participants as Treated)|Overall Study||57||
48163972|NCT01641926|100724923|FG000|COMPLETED|Overall Study||115||
48163973|NCT01641926|100724924|FG001|COMPLETED|Overall Study||130||
48163974|NCT01641926|100724925|FG002|COMPLETED|Overall Study||46||
48326608|NCT04036708|101124710|FG001|NOT COMPLETED|Overall Study||4||
48743569|NCT04628780|102158035|FG003|NOT COMPLETED|Overall Study||3||
48163975|NCT01641926|100724926|FG003|COMPLETED|Overall Study||53||
48163976|NCT01641926|100724923|FG000|NOT COMPLETED|Overall Study||28||
48163977|NCT01641926|100724924|FG001|NOT COMPLETED|Overall Study||15||
48163978|NCT01641926|100724925|FG002|NOT COMPLETED|Overall Study||11||
48326609|NCT04036708|101124711|FG002|NOT COMPLETED|Overall Study||14||
48743570|NCT04628780|102158036|FG004|NOT COMPLETED|Overall Study||16||
48743571|NCT04628780|102158037|FG005|NOT COMPLETED|Overall Study||6||
48163979|NCT01641926|100724926|FG003|NOT COMPLETED|Overall Study||4||
48163980|NCT00100932|100724927|FG000|STARTED|Overall Study||78||
48163981|NCT00100932|100724928|FG001|STARTED|Overall Study||28||
48163982|NCT00100932|100724927|FG000|COMPLETED|Overall Study||5||
48163983|NCT00100932|100724928|FG001|COMPLETED|Overall Study||1||
48163984|NCT00100932|100724927|FG000|NOT COMPLETED|Overall Study||73||
48163985|NCT00100932|100724928|FG001|NOT COMPLETED|Overall Study||27||
48163986|NCT03541044|100724929|FG000|STARTED|Study Period 1: Up to Day 1||23||
48163987|NCT03541044|100724930|FG001|STARTED|Study Period 1: Up to Day 1||23||
48163988|NCT03541044|100724929|FG000|COMPLETED|Study Period 1: Up to Day 1||23||
48163989|NCT03541044|100724930|FG001|COMPLETED|Study Period 1: Up to Day 1||23||
48163990|NCT03541044|100724929|FG000|NOT COMPLETED|Study Period 1: Up to Day 1||0||
48163991|NCT03541044|100724930|FG001|NOT COMPLETED|Study Period 1: Up to Day 1||0||
48163992|NCT03541044|100724929|FG000|STARTED|Washout Period: 5 to 7 Days||23||
48163993|NCT03541044|100724930|FG001|STARTED|Washout Period: 5 to 7 Days||23||
48163994|NCT03541044|100724929|FG000|COMPLETED|Washout Period: 5 to 7 Days||23||
48163995|NCT03541044|100724930|FG001|COMPLETED|Washout Period: 5 to 7 Days||23||
48163996|NCT03541044|100724929|FG000|NOT COMPLETED|Washout Period: 5 to 7 Days||0||
48163997|NCT03541044|100724930|FG001|NOT COMPLETED|Washout Period: 5 to 7 Days||0||
48163998|NCT03541044|100724929|FG000|STARTED|Study Period 2: Up to Day 8||23||
48163999|NCT03541044|100724930|FG001|STARTED|Study Period 2: Up to Day 8||23||
48164000|NCT03541044|100724929|FG000|COMPLETED|Study Period 2: Up to Day 8||21||
48164001|NCT03541044|100724930|FG001|COMPLETED|Study Period 2: Up to Day 8||23||
48164002|NCT03541044|100724929|FG000|NOT COMPLETED|Study Period 2: Up to Day 8||2||
48164003|NCT03541044|100724930|FG001|NOT COMPLETED|Study Period 2: Up to Day 8||0||
48164004|NCT00297115|100724931|FG000|STARTED|Overall Study||772||
48164005|NCT00297115|100724932|FG001|STARTED|Overall Study||796||
48164006|NCT00297115|100724931|FG000|COMPLETED|Overall Study||527||
48164007|NCT00297115|100724932|FG001|COMPLETED|Overall Study||550||
48164008|NCT00297115|100724931|FG000|NOT COMPLETED|Overall Study||245||
48164009|NCT00297115|100724932|FG001|NOT COMPLETED|Overall Study||246||
48164010|NCT01650519|100724933|FG000|STARTED|Overall Study||20||
48164011|NCT01650519|100724934|FG001|STARTED|Overall Study||31||
48164012|NCT01650519|100724933|FG000|COMPLETED|Overall Study||19||
48164013|NCT01650519|100724934|FG001|COMPLETED|Overall Study||31||
48164014|NCT01650519|100724933|FG000|NOT COMPLETED|Overall Study||1||
48164015|NCT01650519|100724934|FG001|NOT COMPLETED|Overall Study||0||
48164016|NCT03421496|100724935|FG000|STARTED|Overall Study||0||
48164017|NCT03421496|100724936|FG001|STARTED|Overall Study||0||
48164018|NCT03421496|100724935|FG000|COMPLETED|Overall Study||0||
48164019|NCT03421496|100724936|FG001|COMPLETED|Overall Study||0||
48164020|NCT03421496|100724935|FG000|NOT COMPLETED|Overall Study||0||
48164021|NCT03421496|100724936|FG001|NOT COMPLETED|Overall Study||0||
48164022|NCT02053077|100724937|FG000|STARTED|Overall Study||150||
48409510|NCT01440972|101334728|FG000|STARTED|Overall Study||24||
48620417|NCT01783743|101856384|FG000|STARTED|Rescreening of Subjects by Senior Grader||13509||18
48620418|NCT01783743|101856385|FG001|STARTED|Rescreening of Subjects by Senior Grader||13964||18
48620419|NCT01783743|101856384|FG000|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||46||18
48620420|NCT01783743|101856385|FG001|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||409||18
48620421|NCT01783743|101856384|FG000|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1721||18
48620422|NCT01783743|101856385|FG001|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1786||18
48620423|NCT01783743|101856384|FG000|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||846||18
48620424|NCT01783743|101856385|FG001|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||849||18
48620425|NCT01783743|101856384|FG000|COMPLETED|Rescreening of Subjects by Senior Grader||2613||18
48620426|NCT01783743|101856385|FG001|COMPLETED|Rescreening of Subjects by Senior Grader||3044||18
48620427|NCT01783743|101856384|FG000|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10896||0
48620428|NCT01783743|101856385|FG001|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10920||0
48409511|NCT01440972|101334729|FG001|STARTED|Overall Study||21||
48164023|NCT02053077|100724937|FG000|COMPLETED|Overall Study||150||
48164024|NCT02053077|100724937|FG000|NOT COMPLETED|Overall Study||0||
48164025|NCT00787319|100724938|FG000|STARTED|Overall Study||108||
48164026|NCT00787319|100724938|FG000|COMPLETED|Overall Study||45||
48164027|NCT00787319|100724938|FG000|NOT COMPLETED|Overall Study||63||
48164028|NCT01153269|100724939|FG000|STARTED|Overall Study||33||
48164029|NCT01153269|100724939|FG000|Participants Analyzed|Overall Study||33||
48164030|NCT01153269|100724939|FG000|COMPLETED|Overall Study||31||
48164031|NCT01153269|100724939|FG000|NOT COMPLETED|Overall Study||2||
48164032|NCT02821819|100724940|FG000|STARTED|Overall Study||15||
48164033|NCT02821819|100724940|FG000|COMPLETED|Overall Study||14||
48164034|NCT02821819|100724940|FG000|NOT COMPLETED|Overall Study||1||
48409512|NCT01440972|101334728|FG000|COMPLETED|Overall Study||21||
48409513|NCT01440972|101334729|FG001|COMPLETED|Overall Study||19||
48409514|NCT01440972|101334728|FG000|NOT COMPLETED|Overall Study||3||
48164035|NCT01289418|100724941|FG000|STARTED|Day 8 Survey||6525||
48164036|NCT01289418|100724941|FG000|COMPLETED|Day 8 Survey||4307||
48164037|NCT01289418|100724941|FG000|NOT COMPLETED|Day 8 Survey||2218||
48164038|NCT01289418|100724941|FG000|STARTED|Day 29 Survey||6525||
48164039|NCT01289418|100724941|FG000|COMPLETED|Day 29 Survey||4057||
48164040|NCT01289418|100724941|FG000|NOT COMPLETED|Day 29 Survey||2468||
48164041|NCT02167217|100724942|FG000|STARTED|Overall Study||25||
48164042|NCT02167217|100724942|FG000|COMPLETED|Overall Study||23||
48164043|NCT02167217|100724942|FG000|NOT COMPLETED|Overall Study||2||
48164044|NCT00535743|100724943|FG000|STARTED|Overall Study||5||
48164045|NCT00535743|100724944|FG001|STARTED|Overall Study||11||
48164046|NCT00535743|100724945|FG002|STARTED|Overall Study||11||
48164047|NCT00535743|100724946|FG003|STARTED|Overall Study||11||
48164048|NCT00535743|100724947|FG004|STARTED|Overall Study||11||
48164049|NCT00535743|100724948|FG005|STARTED|Overall Study||10||
48164050|NCT00535743|100724949|FG006|STARTED|Overall Study||3||
48164051|NCT00535743|100724950|FG007|STARTED|Overall Study||5||
48164052|NCT00535743|100724951|FG008|STARTED|Overall Study||5||
48164053|NCT00535743|100724952|FG009|STARTED|Overall Study||5||
48164054|NCT00535743|100724953|FG010|STARTED|Overall Study||5||
48164055|NCT00535743|100724954|FG011|STARTED|Overall Study||5||
48164056|NCT00535743|100724955|FG012|STARTED|Overall Study||5||
48164057|NCT00535743|100724956|FG013|STARTED|Overall Study||10||
48164058|NCT00535743|100724957|FG014|STARTED|Overall Study||9||
48164059|NCT00535743|100724958|FG015|STARTED|Overall Study||13||
48164060|NCT00535743|100724959|FG016|STARTED|Overall Study||10||
48164061|NCT00535743|100724960|FG017|STARTED|Overall Study||11||
48164062|NCT00535743|100724961|FG018|STARTED|Overall Study||3||
48164063|NCT00535743|100724962|FG019|STARTED|Overall Study||5||
48164064|NCT00535743|100724963|FG020|STARTED|Overall Study||5||
48164065|NCT00535743|100724964|FG021|STARTED|Overall Study||5||
48164066|NCT00535743|100724965|FG022|STARTED|Overall Study||6||
48164067|NCT00535743|100724966|FG023|STARTED|Overall Study||5||
48164068|NCT00535743|100724943|FG000|Treated|Overall Study||5|All participants as treated|
48164069|NCT00535743|100724944|FG001|Treated|Overall Study||11|All participants as treated|
48164070|NCT00535743|100724945|FG002|Treated|Overall Study||11|All participants as treated|
48164071|NCT00535743|100724946|FG003|Treated|Overall Study||11|All participants as treated|
48164072|NCT00535743|100724947|FG004|Treated|Overall Study||11|All participants as treated|
48326610|NCT04036708|101124712|FG003|NOT COMPLETED|Overall Study||4||
48326611|NCT00506883|101124713|FG000|STARTED|Overall Study||52||
48743572|NCT01776840|102158038|FG000|STARTED|Overall Study||261||
48164073|NCT00535743|100724948|FG005|Treated|Overall Study||10|All participants as treated|
48164074|NCT00535743|100724949|FG006|Treated|Overall Study||3|All participants as treated|
48164075|NCT00535743|100724950|FG007|Treated|Overall Study||5|All participants as treated|
48164076|NCT00535743|100724951|FG008|Treated|Overall Study||4|All participants as treated|
48164077|NCT00535743|100724952|FG009|Treated|Overall Study||5|All participants as treated|
48164078|NCT00535743|100724953|FG010|Treated|Overall Study||5|All participants as treated|
48164079|NCT00535743|100724954|FG011|Treated|Overall Study||5|All participants as treated|
48164080|NCT00535743|100724955|FG012|Treated|Overall Study||5|All participants as treated|
48164081|NCT00535743|100724956|FG013|Treated|Overall Study||10|All participants as treated|
48164082|NCT00535743|100724957|FG014|Treated|Overall Study||9|All participants as treated|
48164083|NCT00535743|100724958|FG015|Treated|Overall Study||13|All participants as treated|
48164084|NCT00535743|100724959|FG016|Treated|Overall Study||10|All participants as treated|
48164085|NCT00535743|100724960|FG017|Treated|Overall Study||11|All participants as treated|
48164086|NCT00535743|100724961|FG018|Treated|Overall Study||3|All participants as treated|
48164087|NCT00535743|100724962|FG019|Treated|Overall Study||5|All participants as treated|
48164088|NCT00535743|100724963|FG020|Treated|Overall Study||5|All participants as treated|
48164089|NCT00535743|100724964|FG021|Treated|Overall Study||5|All participants as treated|
48164090|NCT00535743|100724965|FG022|Treated|Overall Study||6|All participants as treated|
48164091|NCT00535743|100724966|FG023|Treated|Overall Study||5|All participants as treated|
48164092|NCT00535743|100724943|FG000|COMPLETED|Overall Study||5||
48164093|NCT00535743|100724944|FG001|COMPLETED|Overall Study||11||
48164094|NCT00535743|100724945|FG002|COMPLETED|Overall Study||11||
48164095|NCT00535743|100724946|FG003|COMPLETED|Overall Study||11||
48164096|NCT00535743|100724947|FG004|COMPLETED|Overall Study||11||
48164097|NCT00535743|100724948|FG005|COMPLETED|Overall Study||10||
48164098|NCT00535743|100724949|FG006|COMPLETED|Overall Study||3||
48164099|NCT00535743|100724950|FG007|COMPLETED|Overall Study||5||
48326612|NCT00506883|101124714|FG001|STARTED|Overall Study||74||
48326613|NCT00506883|101124715|FG002|STARTED|Overall Study||59||
48326614|NCT00506883|101124713|FG000|COMPLETED|Overall Study||45||
48326615|NCT00506883|101124714|FG001|COMPLETED|Overall Study||71||
48164100|NCT00535743|100724951|FG008|COMPLETED|Overall Study||4||
48164101|NCT00535743|100724952|FG009|COMPLETED|Overall Study||4||
48164102|NCT00535743|100724953|FG010|COMPLETED|Overall Study||5||
48164103|NCT00535743|100724954|FG011|COMPLETED|Overall Study||5||
48164104|NCT00535743|100724955|FG012|COMPLETED|Overall Study||5||
48164105|NCT00535743|100724956|FG013|COMPLETED|Overall Study||10||
48164106|NCT00535743|100724957|FG014|COMPLETED|Overall Study||9||
48164107|NCT00535743|100724958|FG015|COMPLETED|Overall Study||13||
48164108|NCT00535743|100724959|FG016|COMPLETED|Overall Study||10||
48164109|NCT00535743|100724960|FG017|COMPLETED|Overall Study||11||
48164110|NCT00535743|100724961|FG018|COMPLETED|Overall Study||3||
48164111|NCT00535743|100724962|FG019|COMPLETED|Overall Study||5||
48164112|NCT00535743|100724963|FG020|COMPLETED|Overall Study||5||
48164113|NCT00535743|100724964|FG021|COMPLETED|Overall Study||4||
48164114|NCT00535743|100724965|FG022|COMPLETED|Overall Study||6||
48164115|NCT00535743|100724966|FG023|COMPLETED|Overall Study||5||
48164116|NCT00535743|100724943|FG000|NOT COMPLETED|Overall Study||0||
48164117|NCT00535743|100724944|FG001|NOT COMPLETED|Overall Study||0||
48326616|NCT00506883|101124715|FG002|COMPLETED|Overall Study||55||
48326617|NCT00506883|101124713|FG000|NOT COMPLETED|Overall Study||7||
48326618|NCT00506883|101124714|FG001|NOT COMPLETED|Overall Study||3||
48326619|NCT00506883|101124715|FG002|NOT COMPLETED|Overall Study||4||
48326620|NCT00797823|101124716|FG000|STARTED|Pilot Studies||0||
48409515|NCT01440972|101334729|FG001|NOT COMPLETED|Overall Study||2||
48409516|NCT00796549|101334730|FG000|STARTED|Overall Study||218||
48409517|NCT00796549|101334730|FG000|Entered|Overall Study||69||
48409518|NCT00796549|101334730|FG000|COMPLETED|Overall Study||0||
48409519|NCT00796549|101334730|FG000|NOT COMPLETED|Overall Study||218||
48409520|NCT00515099|101334731|FG000|STARTED|Overall Study||38||
48326621|NCT00797823|101124717|FG001|STARTED|Pilot Studies||0||
48326622|NCT00797823|101124718|FG002|STARTED|Pilot Studies||6||
48620429|NCT01048541|101856386|FG000|STARTED|Overall Study||18||
48620430|NCT01048541|101856387|FG001|STARTED|Overall Study||19||
48620431|NCT01048541|101856386|FG000|COMPLETED|Overall Study||17||
48620432|NCT01048541|101856387|FG001|COMPLETED|Overall Study||19||
48620433|NCT01048541|101856386|FG000|NOT COMPLETED|Overall Study||1||
48620434|NCT01048541|101856387|FG001|NOT COMPLETED|Overall Study||0||
48620435|NCT04428385|101856388|FG000|STARTED|Overall Study||1101||24
48620436|NCT04428385|101856389|FG001|STARTED|Overall Study||1104||24
48620437|NCT04428385|101856388|FG000|COMPLETED|Overall Study||1101||24
48620438|NCT04428385|101856389|FG001|COMPLETED|Overall Study||1104||24
48620439|NCT04428385|101856388|FG000|NOT COMPLETED|Overall Study||0||0
48620440|NCT04428385|101856389|FG001|NOT COMPLETED|Overall Study||0||0
48620441|NCT03902613|101856390|FG000|STARTED|Overall Study||1||
48620442|NCT03902613|101856390|FG000|COMPLETED|Overall Study||0||
48620443|NCT03902613|101856390|FG000|NOT COMPLETED|Overall Study||1||
48620444|NCT01982695|101856391|FG000|STARTED|Overall Study||12||
48620445|NCT01982695|101856392|FG001|STARTED|Overall Study||11||
48620446|NCT01982695|101856391|FG000|COMPLETED|Overall Study||12||
48620447|NCT01982695|101856392|FG001|COMPLETED|Overall Study||10||
48743573|NCT01776840|102158039|FG001|STARTED|Overall Study||262||
48743574|NCT01776840|102158038|FG000|COMPLETED|Overall Study||103||
48743575|NCT01776840|102158039|FG001|COMPLETED|Overall Study||107||
48743576|NCT01776840|102158038|FG000|NOT COMPLETED|Overall Study||158||
48743577|NCT01776840|102158039|FG001|NOT COMPLETED|Overall Study||155||
48743578|NCT00655629|102158040|FG000|STARTED|Overall Study||172||
48743579|NCT00655629|102158041|FG001|STARTED|Overall Study||167||
48743580|NCT00655629|102158040|FG000|Participants Received Treatment|Overall Study||171||
48743581|NCT00655629|102158041|FG001|Participants Received Treatment|Overall Study||166||
48743582|NCT00655629|102158040|FG000|COMPLETED|Overall Study||151||
48743583|NCT00655629|102158041|FG001|COMPLETED|Overall Study||144||
48743584|NCT00655629|102158040|FG000|NOT COMPLETED|Overall Study||21||
48743585|NCT00655629|102158041|FG001|NOT COMPLETED|Overall Study||23||
48743586|NCT02219334|102158042|FG000|STARTED|Overall Study||32||
48743587|NCT02219334|102158043|FG001|STARTED|Overall Study||23||
48326623|NCT00797823|101124716|FG000|COMPLETED|Pilot Studies||0||
48326624|NCT00797823|101124717|FG001|COMPLETED|Pilot Studies||0||
48620448|NCT01982695|101856391|FG000|NOT COMPLETED|Overall Study||0||
48620449|NCT01982695|101856392|FG001|NOT COMPLETED|Overall Study||1||
48620450|NCT00902577|101856393|FG000|STARTED|Overall Study||50||
48620451|NCT00902577|101856393|FG000|FMISO/PET|Overall Study||38|"3 images lost/Not Acquired~1 Image uninterpretable"|
48326625|NCT00797823|101124718|FG002|COMPLETED|Pilot Studies||6||
48326626|NCT00797823|101124716|FG000|NOT COMPLETED|Pilot Studies||0||
48326627|NCT00797823|101124717|FG001|NOT COMPLETED|Pilot Studies||0||
48409521|NCT00515099|101334732|FG001|STARTED|Overall Study||20||
48409522|NCT00515099|101334731|FG000|COMPLETED|Overall Study||35||
48620452|NCT00902577|101856393|FG000|DCE MRI|Overall Study||31|2 images lost/Not Acquired 9 Image uninterpretable|
48657106|NCT03761914|101943778|FG000|COMPLETED|Overall Study||25||
48743588|NCT02219334|102158042|FG000|COMPLETED|Overall Study||24||
48620453|NCT00902577|101856393|FG000|DSE MRI|Overall Study||37|2 images lost/Not Acquired 3 Image uninterpretable|
48620454|NCT00902577|101856393|FG000|DWI MRI|Overall Study||39|3 images lost/Not Acquired|
48620455|NCT00902577|101856393|FG000|COMPLETED|Overall Study||42||
48620456|NCT00902577|101856393|FG000|NOT COMPLETED|Overall Study||8||
48620457|NCT01754519|101856394|FG000|STARTED|Overall Study||1||
48620458|NCT01754519|101856394|FG000|COMPLETED|Overall Study||1||
48620459|NCT01754519|101856394|FG000|NOT COMPLETED|Overall Study||0||
48620460|NCT00338741|101856395|FG000|STARTED|Overall Study||34||
48620461|NCT00338741|101856396|FG001|STARTED|Overall Study||2||
48620462|NCT00338741|101856395|FG000|COMPLETED|Overall Study||32||
48620463|NCT00338741|101856396|FG001|COMPLETED|Overall Study||2||
48620464|NCT00338741|101856395|FG000|NOT COMPLETED|Overall Study||2||
48620465|NCT00338741|101856396|FG001|NOT COMPLETED|Overall Study||0||
48620466|NCT03478371|101856397|FG000|STARTED|Overall Study||94||
48620467|NCT03478371|101856397|FG000|Received Tampon D|Overall Study||91||
48620468|NCT03478371|101856397|FG000|Received Tampon M|Overall Study||92||
48620469|NCT03478371|101856397|FG000|Recived Tampon T|Overall Study||90||
48620470|NCT03478371|101856397|FG000|Received Tampon V|Overall Study||91||
48620471|NCT03478371|101856397|FG000|COMPLETED|Overall Study||89||
48620472|NCT03478371|101856397|FG000|NOT COMPLETED|Overall Study||5||
48620473|NCT00103285|101856398|FG000|STARTED|Induction||5377||
48620474|NCT00103285|101856399|FG001|STARTED|Induction||0||
48620475|NCT00103285|101856400|FG002|STARTED|Induction||0||
48620476|NCT00103285|101856401|FG003|STARTED|Induction||0||
48620477|NCT00103285|101856402|FG004|STARTED|Induction||0||
48620478|NCT00103285|101856403|FG005|STARTED|Induction||0||
48620479|NCT00103285|101856404|FG006|STARTED|Induction||0||
48620480|NCT00103285|101856405|FG007|STARTED|Induction||0||
48620481|NCT00103285|101856398|FG000|COMPLETED|Induction||4028||
48620482|NCT00103285|101856399|FG001|COMPLETED|Induction||0||
48620483|NCT00103285|101856400|FG002|COMPLETED|Induction||0||
48620484|NCT00103285|101856401|FG003|COMPLETED|Induction||0||
48620485|NCT00103285|101856402|FG004|COMPLETED|Induction||0||
48620486|NCT00103285|101856403|FG005|COMPLETED|Induction||0||
48620487|NCT00103285|101856404|FG006|COMPLETED|Induction||0||
48620488|NCT00103285|101856405|FG007|COMPLETED|Induction||0||
48620489|NCT00103285|101856398|FG000|NOT COMPLETED|Induction||1349||
48620490|NCT00103285|101856399|FG001|NOT COMPLETED|Induction||0||
48620491|NCT00103285|101856400|FG002|NOT COMPLETED|Induction||0||
48620492|NCT00103285|101856401|FG003|NOT COMPLETED|Induction||0||
48620493|NCT00103285|101856402|FG004|NOT COMPLETED|Induction||0||
48620494|NCT00103285|101856403|FG005|NOT COMPLETED|Induction||0||
48620495|NCT00103285|101856404|FG006|NOT COMPLETED|Induction||0||
48620496|NCT00103285|101856405|FG007|NOT COMPLETED|Induction||0||
48620497|NCT00103285|101856398|FG000|STARTED|Response Assignment||0||
48620498|NCT00103285|101856399|FG001|STARTED|Response Assignment||939||
48620499|NCT00103285|101856400|FG002|STARTED|Response Assignment||937||
48620500|NCT00103285|101856401|FG003|STARTED|Response Assignment||503||
48620501|NCT00103285|101856402|FG004|STARTED|Response Assignment||509||
48620502|NCT00103285|101856403|FG005|STARTED|Response Assignment||249||
48620503|NCT00103285|101856404|FG006|STARTED|Response Assignment||248||
48620504|NCT00103285|101856405|FG007|STARTED|Response Assignment||643||
48620505|NCT00103285|101856398|FG000|COMPLETED|Response Assignment||0||
48620506|NCT00103285|101856399|FG001|COMPLETED|Response Assignment||807||
48620507|NCT00103285|101856400|FG002|COMPLETED|Response Assignment||853||
48620508|NCT00103285|101856401|FG003|COMPLETED|Response Assignment||441||
48620509|NCT00103285|101856402|FG004|COMPLETED|Response Assignment||425||
48743589|NCT02219334|102158043|FG001|COMPLETED|Overall Study||20||
48326628|NCT00797823|101124718|FG002|NOT COMPLETED|Pilot Studies||0||
48326629|NCT00797823|101124716|FG000|STARTED|First Period (Initial Randomization)||4||
48326630|NCT00797823|101124717|FG001|STARTED|First Period (Initial Randomization)||4||
48743590|NCT02219334|102158042|FG000|NOT COMPLETED|Overall Study||8||
48743591|NCT02219334|102158043|FG001|NOT COMPLETED|Overall Study||3||
48743592|NCT03712787|102158044|FG000|STARTED|Overall Study||87|enrolled and treated|
48743593|NCT03712787|102158045|FG001|STARTED|Overall Study||97|enrolled and treated|
48620510|NCT00103285|101856403|FG005|COMPLETED|Response Assignment||201||
48620511|NCT00103285|101856404|FG006|COMPLETED|Response Assignment||199||
48620512|NCT00103285|101856405|FG007|COMPLETED|Response Assignment||523||
48743594|NCT03712787|102158046|FG002|STARTED|Overall Study||88|enrolled and treated|
48620513|NCT00103285|101856398|FG000|NOT COMPLETED|Response Assignment||0||
48743595|NCT03712787|102158047|FG003|STARTED|Overall Study||91|enrolled and treated|
48743596|NCT03712787|102158044|FG000|COMPLETED|Overall Study||0||
48743597|NCT03712787|102158045|FG001|COMPLETED|Overall Study||0||
48620514|NCT00103285|101856399|FG001|NOT COMPLETED|Response Assignment||132||
48620515|NCT00103285|101856400|FG002|NOT COMPLETED|Response Assignment||84||
48620516|NCT00103285|101856401|FG003|NOT COMPLETED|Response Assignment||62||
48620517|NCT00103285|101856402|FG004|NOT COMPLETED|Response Assignment||84||
48620518|NCT00103285|101856403|FG005|NOT COMPLETED|Response Assignment||48||
48620519|NCT00103285|101856404|FG006|NOT COMPLETED|Response Assignment||49||
48620520|NCT00103285|101856405|FG007|NOT COMPLETED|Response Assignment||120||
48620521|NCT00059228|101856406|FG000|STARTED|Overall Study||6||
48620522|NCT00059228|101856407|FG001|STARTED|Overall Study||6||
48743598|NCT03712787|102158046|FG002|COMPLETED|Overall Study||0||
48743599|NCT03712787|102158047|FG003|COMPLETED|Overall Study||0||
48326631|NCT00797823|101124718|FG002|STARTED|First Period (Initial Randomization)||0||
48326632|NCT00797823|101124716|FG000|COMPLETED|First Period (Initial Randomization)||3||
48326633|NCT00797823|101124717|FG001|COMPLETED|First Period (Initial Randomization)||4||
48326634|NCT00797823|101124718|FG002|COMPLETED|First Period (Initial Randomization)||0||
48326635|NCT00797823|101124716|FG000|NOT COMPLETED|First Period (Initial Randomization)||1||
48326636|NCT00797823|101124717|FG001|NOT COMPLETED|First Period (Initial Randomization)||0||
48326637|NCT00797823|101124718|FG002|NOT COMPLETED|First Period (Initial Randomization)||0||
48326638|NCT00797823|101124716|FG000|STARTED|Second Period (Crossover)||3||
48326639|NCT00797823|101124717|FG001|STARTED|Second Period (Crossover)||4||
48326640|NCT00797823|101124718|FG002|STARTED|Second Period (Crossover)||0||
48326641|NCT00797823|101124716|FG000|COMPLETED|Second Period (Crossover)||3||
48326642|NCT00797823|101124717|FG001|COMPLETED|Second Period (Crossover)||4||
48326643|NCT00797823|101124718|FG002|COMPLETED|Second Period (Crossover)||0||
48326644|NCT00797823|101124716|FG000|NOT COMPLETED|Second Period (Crossover)||0||
48620523|NCT00059228|101856406|FG000|COMPLETED|Overall Study||6||
48620524|NCT00059228|101856407|FG001|COMPLETED|Overall Study||5||
48620525|NCT00059228|101856406|FG000|NOT COMPLETED|Overall Study||0||
48620526|NCT00059228|101856407|FG001|NOT COMPLETED|Overall Study||1||
48620527|NCT01716663|101856408|FG000|STARTED|Overall Study||234||
48620528|NCT01716663|101856408|FG000|Safety|Overall Study||230||
48620529|NCT01716663|101856408|FG000|COMPLETED|Overall Study||228||
48620530|NCT01716663|101856408|FG000|NOT COMPLETED|Overall Study||6||
48620531|NCT02881658|101856409|FG000|STARTED|Overall Study||100||
48620532|NCT02881658|101856410|FG001|STARTED|Overall Study||101||
48620533|NCT02881658|101856409|FG000|COMPLETED|Overall Study||98||
48620534|NCT02881658|101856410|FG001|COMPLETED|Overall Study||96||
48620535|NCT02881658|101856409|FG000|NOT COMPLETED|Overall Study||2||
48620536|NCT02881658|101856410|FG001|NOT COMPLETED|Overall Study||5||
48620537|NCT01464190|101856411|FG000|STARTED|Overall Study||391||
48620538|NCT01464190|101856412|FG001|STARTED|Overall Study||268||
48326645|NCT00797823|101124717|FG001|NOT COMPLETED|Second Period (Crossover)||0||
48326646|NCT00797823|101124718|FG002|NOT COMPLETED|Second Period (Crossover)||0||
48326647|NCT01100437|101124719|FG000|STARTED|Screening||4||
48326648|NCT01100437|101124720|FG001|STARTED|Screening||2||
48326649|NCT01100437|101124721|FG002|STARTED|Screening||8||
48326650|NCT01100437|101124719|FG000|COMPLETED|Screening||4||
48326651|NCT01100437|101124720|FG001|COMPLETED|Screening||2||
48326652|NCT01100437|101124721|FG002|COMPLETED|Screening||8||
48326653|NCT01100437|101124719|FG000|NOT COMPLETED|Screening||0||
48326654|NCT01100437|101124720|FG001|NOT COMPLETED|Screening||0||
48326655|NCT01100437|101124721|FG002|NOT COMPLETED|Screening||0||
48620539|NCT01464190|101856411|FG000|COMPLETED|Overall Study||322||
48620540|NCT01464190|101856412|FG001|COMPLETED|Overall Study||227||
48620541|NCT01464190|101856411|FG000|NOT COMPLETED|Overall Study||69||
48620542|NCT01464190|101856412|FG001|NOT COMPLETED|Overall Study||41||
48620543|NCT01307813|101856413|FG000|STARTED|Overall Study||4||
48620544|NCT01307813|101856413|FG000|COMPLETED|Overall Study||4||
48620545|NCT01307813|101856413|FG000|NOT COMPLETED|Overall Study||0||
48620546|NCT03286218|101856414|FG000|STARTED|Qualification Phase Period 1||48||
48620547|NCT03286218|101856415|FG001|STARTED|Qualification Phase Period 1||48||
48326656|NCT01100437|101124719|FG000|STARTED|Titration/Stabilization||4||
48620548|NCT03286218|101856416|FG002|STARTED|Qualification Phase Period 1||0||
48620549|NCT03286218|101856417|FG003|STARTED|Qualification Phase Period 1||0||
48620550|NCT03286218|101856418|FG004|STARTED|Qualification Phase Period 1||0||
48620551|NCT03286218|101856419|FG005|STARTED|Qualification Phase Period 1||0||
48620552|NCT03286218|101856420|FG006|STARTED|Qualification Phase Period 1||0||
48620553|NCT03286218|101856421|FG007|STARTED|Qualification Phase Period 1||0||
48326657|NCT01100437|101124720|FG001|STARTED|Titration/Stabilization||2||
48326658|NCT01100437|101124721|FG002|STARTED|Titration/Stabilization||8||
48326659|NCT01100437|101124719|FG000|COMPLETED|Titration/Stabilization||4||
48326660|NCT01100437|101124720|FG001|COMPLETED|Titration/Stabilization||2||
48326661|NCT01100437|101124721|FG002|COMPLETED|Titration/Stabilization||2||
48326662|NCT01100437|101124719|FG000|NOT COMPLETED|Titration/Stabilization||0||
48326663|NCT01100437|101124720|FG001|NOT COMPLETED|Titration/Stabilization||0||
48326664|NCT01100437|101124721|FG002|NOT COMPLETED|Titration/Stabilization||6||
48326665|NCT01100437|101124719|FG000|STARTED|Maintenance||4||
48326666|NCT01100437|101124720|FG001|STARTED|Maintenance||2||
48326667|NCT01100437|101124721|FG002|STARTED|Maintenance||2||
48326668|NCT01100437|101124719|FG000|COMPLETED|Maintenance||4||
48326669|NCT01100437|101124720|FG001|COMPLETED|Maintenance||2||
48620554|NCT03286218|101856422|FG008|STARTED|Qualification Phase Period 1||0||
48620555|NCT03286218|101856423|FG009|STARTED|Qualification Phase Period 1||0||
48620556|NCT03286218|101856424|FG010|STARTED|Qualification Phase Period 1||0||
48620557|NCT03286218|101856425|FG011|STARTED|Qualification Phase Period 1||0||
48620558|NCT03286218|101856414|FG000|Received at Least One Dose of Study Drug|Qualification Phase Period 1||47||
48620559|NCT03286218|101856415|FG001|Received at Least One Dose of Study Drug|Qualification Phase Period 1||47||
48620560|NCT03286218|101856416|FG002|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0||
48620561|NCT03286218|101856417|FG003|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0||
48620562|NCT03286218|101856418|FG004|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0||
48620563|NCT03286218|101856419|FG005|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0||
48620564|NCT03286218|101856420|FG006|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0||
48620565|NCT03286218|101856421|FG007|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0||
48620566|NCT03286218|101856422|FG008|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0||
48620567|NCT03286218|101856423|FG009|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0||
48620568|NCT03286218|101856424|FG010|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0||
48620569|NCT03286218|101856425|FG011|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0||
48620570|NCT03286218|101856414|FG000|COMPLETED|Qualification Phase Period 1||47||
48620571|NCT03286218|101856415|FG001|COMPLETED|Qualification Phase Period 1||47||
48620572|NCT03286218|101856416|FG002|COMPLETED|Qualification Phase Period 1||0||
48620573|NCT03286218|101856417|FG003|COMPLETED|Qualification Phase Period 1||0||
48620574|NCT03286218|101856418|FG004|COMPLETED|Qualification Phase Period 1||0||
48620575|NCT03286218|101856419|FG005|COMPLETED|Qualification Phase Period 1||0||
48620576|NCT03286218|101856420|FG006|COMPLETED|Qualification Phase Period 1||0||
48620577|NCT03286218|101856421|FG007|COMPLETED|Qualification Phase Period 1||0||
48620578|NCT03286218|101856422|FG008|COMPLETED|Qualification Phase Period 1||0||
48620579|NCT03286218|101856423|FG009|COMPLETED|Qualification Phase Period 1||0||
48620580|NCT03286218|101856424|FG010|COMPLETED|Qualification Phase Period 1||0||
48620581|NCT03286218|101856425|FG011|COMPLETED|Qualification Phase Period 1||0||
48620582|NCT03286218|101856414|FG000|NOT COMPLETED|Qualification Phase Period 1||1||
48620583|NCT03286218|101856415|FG001|NOT COMPLETED|Qualification Phase Period 1||1||
48620584|NCT03286218|101856416|FG002|NOT COMPLETED|Qualification Phase Period 1||0||
48620585|NCT03286218|101856417|FG003|NOT COMPLETED|Qualification Phase Period 1||0||
48620586|NCT03286218|101856418|FG004|NOT COMPLETED|Qualification Phase Period 1||0||
48620587|NCT03286218|101856419|FG005|NOT COMPLETED|Qualification Phase Period 1||0||
48620588|NCT03286218|101856420|FG006|NOT COMPLETED|Qualification Phase Period 1||0||
48620589|NCT03286218|101856421|FG007|NOT COMPLETED|Qualification Phase Period 1||0||
48620590|NCT03286218|101856422|FG008|NOT COMPLETED|Qualification Phase Period 1||0||
48620591|NCT03286218|101856423|FG009|NOT COMPLETED|Qualification Phase Period 1||0||
48620592|NCT03286218|101856424|FG010|NOT COMPLETED|Qualification Phase Period 1||0||
48620593|NCT03286218|101856425|FG011|NOT COMPLETED|Qualification Phase Period 1||0||
48620594|NCT03286218|101856414|FG000|STARTED|Qualification Phase Period 2||47||
48620595|NCT03286218|101856415|FG001|STARTED|Qualification Phase Period 2||47||
48620596|NCT03286218|101856416|FG002|STARTED|Qualification Phase Period 2||0||
48620597|NCT03286218|101856417|FG003|STARTED|Qualification Phase Period 2||0||
48620598|NCT03286218|101856418|FG004|STARTED|Qualification Phase Period 2||0||
48620599|NCT03286218|101856419|FG005|STARTED|Qualification Phase Period 2||0||
48326670|NCT01100437|101124721|FG002|COMPLETED|Maintenance||0||
48326671|NCT01100437|101124719|FG000|NOT COMPLETED|Maintenance||0||
48326672|NCT01100437|101124720|FG001|NOT COMPLETED|Maintenance||0||
48326673|NCT01100437|101124721|FG002|NOT COMPLETED|Maintenance||2||
48620600|NCT03286218|101856420|FG006|STARTED|Qualification Phase Period 2||0||
48620601|NCT03286218|101856421|FG007|STARTED|Qualification Phase Period 2||0||
48620602|NCT03286218|101856422|FG008|STARTED|Qualification Phase Period 2||0||
48620603|NCT03286218|101856423|FG009|STARTED|Qualification Phase Period 2||0||
48620604|NCT03286218|101856424|FG010|STARTED|Qualification Phase Period 2||0||
48326674|NCT01100437|101124719|FG000|STARTED|Treatment 1||4||
48326675|NCT01100437|101124720|FG001|STARTED|Treatment 1||2||
48326676|NCT01100437|101124721|FG002|STARTED|Treatment 1||0||
48326677|NCT01100437|101124719|FG000|COMPLETED|Treatment 1||4||
48620605|NCT03286218|101856425|FG011|STARTED|Qualification Phase Period 2||0||
48620606|NCT03286218|101856414|FG000|COMPLETED|Qualification Phase Period 2||30||
48620607|NCT03286218|101856415|FG001|COMPLETED|Qualification Phase Period 2||28||
48620608|NCT03286218|101856416|FG002|COMPLETED|Qualification Phase Period 2||0||
48620609|NCT03286218|101856417|FG003|COMPLETED|Qualification Phase Period 2||0||
48620610|NCT03286218|101856418|FG004|COMPLETED|Qualification Phase Period 2||0||
48620611|NCT03286218|101856419|FG005|COMPLETED|Qualification Phase Period 2||0||
48620612|NCT03286218|101856420|FG006|COMPLETED|Qualification Phase Period 2||0||
48620613|NCT03286218|101856421|FG007|COMPLETED|Qualification Phase Period 2||0||
48620614|NCT03286218|101856422|FG008|COMPLETED|Qualification Phase Period 2||0||
48620615|NCT03286218|101856423|FG009|COMPLETED|Qualification Phase Period 2||0||
48620616|NCT03286218|101856424|FG010|COMPLETED|Qualification Phase Period 2||0||
48620617|NCT03286218|101856425|FG011|COMPLETED|Qualification Phase Period 2||0||
48620618|NCT03286218|101856414|FG000|NOT COMPLETED|Qualification Phase Period 2||17||
48620619|NCT03286218|101856415|FG001|NOT COMPLETED|Qualification Phase Period 2||19||
48620620|NCT03286218|101856416|FG002|NOT COMPLETED|Qualification Phase Period 2||0||
48620621|NCT03286218|101856417|FG003|NOT COMPLETED|Qualification Phase Period 2||0||
48620622|NCT03286218|101856418|FG004|NOT COMPLETED|Qualification Phase Period 2||0||
48620623|NCT03286218|101856419|FG005|NOT COMPLETED|Qualification Phase Period 2||0||
48620624|NCT03286218|101856420|FG006|NOT COMPLETED|Qualification Phase Period 2||0||
48620625|NCT03286218|101856421|FG007|NOT COMPLETED|Qualification Phase Period 2||0||
48620626|NCT03286218|101856422|FG008|NOT COMPLETED|Qualification Phase Period 2||0||
48620627|NCT03286218|101856423|FG009|NOT COMPLETED|Qualification Phase Period 2||0||
48620628|NCT03286218|101856424|FG010|NOT COMPLETED|Qualification Phase Period 2||0||
48620629|NCT03286218|101856425|FG011|NOT COMPLETED|Qualification Phase Period 2||0||
48620630|NCT03286218|101856414|FG000|STARTED|Treatment Phase Period 1||0||
48620631|NCT03286218|101856415|FG001|STARTED|Treatment Phase Period 1||0||
48620632|NCT03286218|101856416|FG002|STARTED|Treatment Phase Period 1||6||
48620633|NCT03286218|101856417|FG003|STARTED|Treatment Phase Period 1||6||
48620634|NCT03286218|101856418|FG004|STARTED|Treatment Phase Period 1||5||
48620635|NCT03286218|101856419|FG005|STARTED|Treatment Phase Period 1||6||
48620636|NCT03286218|101856420|FG006|STARTED|Treatment Phase Period 1||6||
48620637|NCT03286218|101856421|FG007|STARTED|Treatment Phase Period 1||6||
48620638|NCT03286218|101856422|FG008|STARTED|Treatment Phase Period 1||6||
48620639|NCT03286218|101856423|FG009|STARTED|Treatment Phase Period 1||6||
48620640|NCT03286218|101856424|FG010|STARTED|Treatment Phase Period 1||5||
48620641|NCT03286218|101856425|FG011|STARTED|Treatment Phase Period 1||6||
48620642|NCT03286218|101856414|FG000|Received at Least One Dose of Study Drug|Treatment Phase Period 1||0||
48620643|NCT03286218|101856415|FG001|Received at Least One Dose of Study Drug|Treatment Phase Period 1||0||
48620644|NCT03286218|101856416|FG002|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6||
48620645|NCT03286218|101856417|FG003|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6||
48620646|NCT03286218|101856418|FG004|Received at Least One Dose of Study Drug|Treatment Phase Period 1||5||
48620647|NCT03286218|101856419|FG005|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6||
48620648|NCT03286218|101856420|FG006|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6||
48620649|NCT03286218|101856421|FG007|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6||
48620650|NCT03286218|101856422|FG008|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6||
48620651|NCT03286218|101856423|FG009|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6||
48620652|NCT03286218|101856424|FG010|Received at Least One Dose of Study Drug|Treatment Phase Period 1||5||
48620653|NCT03286218|101856425|FG011|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6||
48620654|NCT03286218|101856414|FG000|COMPLETED|Treatment Phase Period 1||0||
48620655|NCT03286218|101856415|FG001|COMPLETED|Treatment Phase Period 1||0||
48620656|NCT03286218|101856416|FG002|COMPLETED|Treatment Phase Period 1||5||
48620657|NCT03286218|101856417|FG003|COMPLETED|Treatment Phase Period 1||5||
48620658|NCT03286218|101856418|FG004|COMPLETED|Treatment Phase Period 1||5||
48620659|NCT03286218|101856419|FG005|COMPLETED|Treatment Phase Period 1||5||
48620660|NCT03286218|101856420|FG006|COMPLETED|Treatment Phase Period 1||6||
48620661|NCT03286218|101856421|FG007|COMPLETED|Treatment Phase Period 1||6||
48620662|NCT03286218|101856422|FG008|COMPLETED|Treatment Phase Period 1||6||
48620663|NCT03286218|101856423|FG009|COMPLETED|Treatment Phase Period 1||6||
48620664|NCT03286218|101856424|FG010|COMPLETED|Treatment Phase Period 1||5||
48620665|NCT03286218|101856425|FG011|COMPLETED|Treatment Phase Period 1||5||
48620666|NCT03286218|101856414|FG000|NOT COMPLETED|Treatment Phase Period 1||0||
48620667|NCT03286218|101856415|FG001|NOT COMPLETED|Treatment Phase Period 1||0||
48620668|NCT03286218|101856416|FG002|NOT COMPLETED|Treatment Phase Period 1||1||
48620669|NCT03286218|101856417|FG003|NOT COMPLETED|Treatment Phase Period 1||1||
48620670|NCT03286218|101856418|FG004|NOT COMPLETED|Treatment Phase Period 1||0||
48620671|NCT03286218|101856419|FG005|NOT COMPLETED|Treatment Phase Period 1||1||
48620672|NCT03286218|101856420|FG006|NOT COMPLETED|Treatment Phase Period 1||0||
48620673|NCT03286218|101856421|FG007|NOT COMPLETED|Treatment Phase Period 1||0||
48620674|NCT03286218|101856422|FG008|NOT COMPLETED|Treatment Phase Period 1||0||
48620675|NCT03286218|101856423|FG009|NOT COMPLETED|Treatment Phase Period 1||0||
48620676|NCT03286218|101856424|FG010|NOT COMPLETED|Treatment Phase Period 1||0||
48657107|NCT03761914|101943779|FG001|COMPLETED|Overall Study||1||
48620677|NCT03286218|101856425|FG011|NOT COMPLETED|Treatment Phase Period 1||1||
48620678|NCT03286218|101856414|FG000|STARTED|Treatment Phase Period 2||0||
48620679|NCT03286218|101856415|FG001|STARTED|Treatment Phase Period 2||0||
48620680|NCT03286218|101856416|FG002|STARTED|Treatment Phase Period 2||5||
48620681|NCT03286218|101856417|FG003|STARTED|Treatment Phase Period 2||5||
48620682|NCT03286218|101856418|FG004|STARTED|Treatment Phase Period 2||5||
48620683|NCT03286218|101856419|FG005|STARTED|Treatment Phase Period 2||5||
48620684|NCT03286218|101856420|FG006|STARTED|Treatment Phase Period 2||6||
48620685|NCT03286218|101856421|FG007|STARTED|Treatment Phase Period 2||6||
48620686|NCT03286218|101856422|FG008|STARTED|Treatment Phase Period 2||6||
48620687|NCT03286218|101856423|FG009|STARTED|Treatment Phase Period 2||6||
48620688|NCT03286218|101856424|FG010|STARTED|Treatment Phase Period 2||5||
48620689|NCT03286218|101856425|FG011|STARTED|Treatment Phase Period 2||5||
48620690|NCT03286218|101856414|FG000|COMPLETED|Treatment Phase Period 2||0||
48620691|NCT03286218|101856415|FG001|COMPLETED|Treatment Phase Period 2||0||
48620692|NCT03286218|101856416|FG002|COMPLETED|Treatment Phase Period 2||5||
48326678|NCT01100437|101124720|FG001|COMPLETED|Treatment 1||2||
48326679|NCT01100437|101124721|FG002|COMPLETED|Treatment 1||0||
48326680|NCT01100437|101124719|FG000|NOT COMPLETED|Treatment 1||0||
48326681|NCT01100437|101124720|FG001|NOT COMPLETED|Treatment 1||0||
48326682|NCT01100437|101124721|FG002|NOT COMPLETED|Treatment 1||0||
48326683|NCT01100437|101124719|FG000|STARTED|Washout (4 Days)||4||
48326684|NCT01100437|101124720|FG001|STARTED|Washout (4 Days)||2||
48326685|NCT01100437|101124721|FG002|STARTED|Washout (4 Days)||0||
48326686|NCT01100437|101124719|FG000|COMPLETED|Washout (4 Days)||4||
48326687|NCT01100437|101124720|FG001|COMPLETED|Washout (4 Days)||2||
48326688|NCT01100437|101124721|FG002|COMPLETED|Washout (4 Days)||0||
48326689|NCT01100437|101124719|FG000|NOT COMPLETED|Washout (4 Days)||0||
48326690|NCT01100437|101124720|FG001|NOT COMPLETED|Washout (4 Days)||0||
48326691|NCT01100437|101124721|FG002|NOT COMPLETED|Washout (4 Days)||0||
48326692|NCT01100437|101124719|FG000|STARTED|Treatment 2||4||
48326693|NCT01100437|101124720|FG001|STARTED|Treatment 2||2||
48326694|NCT01100437|101124721|FG002|STARTED|Treatment 2||0||
48326695|NCT01100437|101124719|FG000|COMPLETED|Treatment 2||4||
48326696|NCT01100437|101124720|FG001|COMPLETED|Treatment 2||2||
48326697|NCT01100437|101124721|FG002|COMPLETED|Treatment 2||0||
48326698|NCT01100437|101124719|FG000|NOT COMPLETED|Treatment 2||0||
48326699|NCT01100437|101124720|FG001|NOT COMPLETED|Treatment 2||0||
48326700|NCT01100437|101124721|FG002|NOT COMPLETED|Treatment 2||0||
48326701|NCT01294670|101124722|FG000|STARTED|Overall Study||7||
48620693|NCT03286218|101856417|FG003|COMPLETED|Treatment Phase Period 2||5||
48620694|NCT03286218|101856418|FG004|COMPLETED|Treatment Phase Period 2||5||
48620695|NCT03286218|101856419|FG005|COMPLETED|Treatment Phase Period 2||5||
48620696|NCT03286218|101856420|FG006|COMPLETED|Treatment Phase Period 2||6||
48620697|NCT03286218|101856421|FG007|COMPLETED|Treatment Phase Period 2||6||
48620698|NCT03286218|101856422|FG008|COMPLETED|Treatment Phase Period 2||6||
48620699|NCT03286218|101856423|FG009|COMPLETED|Treatment Phase Period 2||6||
48620700|NCT03286218|101856424|FG010|COMPLETED|Treatment Phase Period 2||5||
48620701|NCT03286218|101856425|FG011|COMPLETED|Treatment Phase Period 2||5||
48620702|NCT03286218|101856414|FG000|NOT COMPLETED|Treatment Phase Period 2||0||
48620703|NCT03286218|101856415|FG001|NOT COMPLETED|Treatment Phase Period 2||0||
48620704|NCT03286218|101856416|FG002|NOT COMPLETED|Treatment Phase Period 2||0||
48620705|NCT03286218|101856417|FG003|NOT COMPLETED|Treatment Phase Period 2||0||
48620706|NCT03286218|101856418|FG004|NOT COMPLETED|Treatment Phase Period 2||0||
48620707|NCT03286218|101856419|FG005|NOT COMPLETED|Treatment Phase Period 2||0||
48620708|NCT03286218|101856420|FG006|NOT COMPLETED|Treatment Phase Period 2||0||
48620709|NCT03286218|101856421|FG007|NOT COMPLETED|Treatment Phase Period 2||0||
48743600|NCT03712787|102158044|FG000|NOT COMPLETED|Overall Study||87||
48743601|NCT03712787|102158045|FG001|NOT COMPLETED|Overall Study||97||
48743602|NCT03712787|102158046|FG002|NOT COMPLETED|Overall Study||88||
48743603|NCT03712787|102158047|FG003|NOT COMPLETED|Overall Study||91||
48743604|NCT04794270|102158048|FG000|STARTED|Period 1||35||
48743605|NCT04794270|102158049|FG001|STARTED|Period 1||36||
48743606|NCT04794270|102158048|FG000|COMPLETED|Period 1||33||
48743607|NCT04794270|102158049|FG001|COMPLETED|Period 1||36||
48326702|NCT01294670|101124723|FG001|STARTED|Overall Study||3||
48326703|NCT01294670|101124724|FG002|STARTED|Overall Study||3||
48620710|NCT03286218|101856422|FG008|NOT COMPLETED|Treatment Phase Period 2||0||
48620711|NCT03286218|101856423|FG009|NOT COMPLETED|Treatment Phase Period 2||0||
48620712|NCT03286218|101856424|FG010|NOT COMPLETED|Treatment Phase Period 2||0||
48620713|NCT03286218|101856425|FG011|NOT COMPLETED|Treatment Phase Period 2||0||
48620714|NCT03286218|101856414|FG000|STARTED|Treatment Phase Period 3||0||
48620715|NCT03286218|101856415|FG001|STARTED|Treatment Phase Period 3||0||
48326704|NCT01294670|101124725|FG003|STARTED|Overall Study||9||
48326705|NCT01294670|101124726|FG004|STARTED|Overall Study||5||
48620716|NCT03286218|101856416|FG002|STARTED|Treatment Phase Period 3||5||
48620717|NCT03286218|101856417|FG003|STARTED|Treatment Phase Period 3||5||
48743608|NCT04794270|102158048|FG000|NOT COMPLETED|Period 1||2||
48326706|NCT01294670|101124722|FG000|COMPLETED|Overall Study||6||
48326707|NCT01294670|101124723|FG001|COMPLETED|Overall Study||3||
48326708|NCT01294670|101124724|FG002|COMPLETED|Overall Study||3||
48620718|NCT03286218|101856418|FG004|STARTED|Treatment Phase Period 3||5||
48326709|NCT01294670|101124725|FG003|COMPLETED|Overall Study||9||
48326710|NCT01294670|101124726|FG004|COMPLETED|Overall Study||5||
48326711|NCT01294670|101124722|FG000|NOT COMPLETED|Overall Study||1||
48326712|NCT01294670|101124723|FG001|NOT COMPLETED|Overall Study||0||
48326713|NCT01294670|101124724|FG002|NOT COMPLETED|Overall Study||0||
48326714|NCT01294670|101124725|FG003|NOT COMPLETED|Overall Study||0||
48326715|NCT01294670|101124726|FG004|NOT COMPLETED|Overall Study||0||
48326716|NCT00411554|101124727|FG000|STARTED|Overall Study||163||
48326717|NCT00411554|101124728|FG001|STARTED|Overall Study||156||
48326718|NCT00411554|101124727|FG000|COMPLETED|Overall Study||155||
48326719|NCT00411554|101124728|FG001|COMPLETED|Overall Study||147||
48326720|NCT00411554|101124727|FG000|NOT COMPLETED|Overall Study||8||
48326721|NCT00411554|101124728|FG001|NOT COMPLETED|Overall Study||9||
48326722|NCT00262873|101124729|FG000|STARTED|Overall Study||8||
48743609|NCT04794270|102158049|FG001|NOT COMPLETED|Period 1||0||
48326723|NCT00262873|101124729|FG000|COMPLETED|Overall Study||0||
48326724|NCT00262873|101124729|FG000|NOT COMPLETED|Overall Study||8||
48326725|NCT01617460|101124730|FG000|STARTED|Overall Study||86||
48326726|NCT01617460|101124730|FG000|COMPLETED|Overall Study||46||
48326727|NCT01617460|101124730|FG000|NOT COMPLETED|Overall Study||40||
48326728|NCT03451773|101124731|FG000|STARTED|Overall Study||1||
48326729|NCT03451773|101124732|FG001|STARTED|Overall Study||6||
48326730|NCT03451773|101124731|FG000|COMPLETED|Overall Study||0||
48326731|NCT03451773|101124732|FG001|COMPLETED|Overall Study||0||
48326732|NCT03451773|101124731|FG000|NOT COMPLETED|Overall Study||1||
48326733|NCT03451773|101124732|FG001|NOT COMPLETED|Overall Study||6||
48326734|NCT04442230|101124733|FG000|STARTED|Overall Study||23||
48326735|NCT04442230|101124734|FG001|STARTED|Overall Study||25||
48326736|NCT04442230|101124733|FG000|COMPLETED|Overall Study||23||
48326737|NCT04442230|101124734|FG001|COMPLETED|Overall Study||24||
48326738|NCT04442230|101124733|FG000|NOT COMPLETED|Overall Study||0||
48326739|NCT04442230|101124734|FG001|NOT COMPLETED|Overall Study||1||
48326740|NCT00179309|101124735|FG000|STARTED|Treatment||25||
48326741|NCT00179309|101124736|FG001|STARTED|Treatment||23||
48326742|NCT00179309|101124735|FG000|COMPLETED|Treatment||21||
48326743|NCT00179309|101124736|FG001|COMPLETED|Treatment||18||
48326744|NCT00179309|101124735|FG000|NOT COMPLETED|Treatment||4||
48326745|NCT00179309|101124736|FG001|NOT COMPLETED|Treatment||5||
48326746|NCT00179309|101124735|FG000|STARTED|Crossover||0||
48326747|NCT00179309|101124736|FG001|STARTED|Crossover||3||
48326748|NCT00179309|101124735|FG000|COMPLETED|Crossover||0||
48326749|NCT00179309|101124736|FG001|COMPLETED|Crossover||3||
48326750|NCT00179309|101124735|FG000|NOT COMPLETED|Crossover||0||
48326751|NCT00179309|101124736|FG001|NOT COMPLETED|Crossover||0||
48326752|NCT01137773|101124737|FG000|STARTED|Overall Study||33||
48326753|NCT01137773|101124738|FG001|STARTED|Overall Study||23||
48326754|NCT01137773|101124737|FG000|COMPLETED|Overall Study||24||
48326755|NCT01137773|101124738|FG001|COMPLETED|Overall Study||20||
48326756|NCT01137773|101124737|FG000|NOT COMPLETED|Overall Study||9||
48326757|NCT01137773|101124738|FG001|NOT COMPLETED|Overall Study||3||
48326758|NCT04899232|101124739|FG000|STARTED|Screening Period||20||
48326759|NCT04899232|101124740|FG001|STARTED|Screening Period||20||
48326760|NCT04899232|101124741|FG002|STARTED|Screening Period||12||
48326761|NCT04899232|101124739|FG000|COMPLETED|Screening Period||15||
48326762|NCT04899232|101124740|FG001|COMPLETED|Screening Period||20||
48326763|NCT04899232|101124741|FG002|COMPLETED|Screening Period||12||
48326764|NCT04899232|101124739|FG000|NOT COMPLETED|Screening Period||5||
48326765|NCT04899232|101124740|FG001|NOT COMPLETED|Screening Period||0||
48326766|NCT04899232|101124741|FG002|NOT COMPLETED|Screening Period||0||
48620719|NCT03286218|101856419|FG005|STARTED|Treatment Phase Period 3||5||
48743610|NCT04794270|102158048|FG000|STARTED|Period 2||33||
48743611|NCT04794270|102158049|FG001|STARTED|Period 2||36||
48743612|NCT04794270|102158048|FG000|COMPLETED|Period 2||32||
48326767|NCT04899232|101124739|FG000|STARTED|Treatment Period||15||
48326768|NCT04899232|101124740|FG001|STARTED|Treatment Period||20||
48326769|NCT04899232|101124741|FG002|STARTED|Treatment Period||12||
48326770|NCT04899232|101124739|FG000|COMPLETED|Treatment Period||15||
48326771|NCT04899232|101124740|FG001|COMPLETED|Treatment Period||20||
48620720|NCT03286218|101856420|FG006|STARTED|Treatment Phase Period 3||6||
48620721|NCT03286218|101856421|FG007|STARTED|Treatment Phase Period 3||6||
48620722|NCT03286218|101856422|FG008|STARTED|Treatment Phase Period 3||6||
48620723|NCT03286218|101856423|FG009|STARTED|Treatment Phase Period 3||6||
48620724|NCT03286218|101856424|FG010|STARTED|Treatment Phase Period 3||5||
48620725|NCT03286218|101856425|FG011|STARTED|Treatment Phase Period 3||5||
48620726|NCT03286218|101856414|FG000|COMPLETED|Treatment Phase Period 3||0||
48620727|NCT03286218|101856415|FG001|COMPLETED|Treatment Phase Period 3||0||
48743613|NCT04794270|102158049|FG001|COMPLETED|Period 2||36||
48743614|NCT04794270|102158048|FG000|NOT COMPLETED|Period 2||1||
48326772|NCT04899232|101124741|FG002|COMPLETED|Treatment Period||12||
48326773|NCT04899232|101124739|FG000|NOT COMPLETED|Treatment Period||0||
48326774|NCT04899232|101124740|FG001|NOT COMPLETED|Treatment Period||0||
48409523|NCT00515099|101334732|FG001|COMPLETED|Overall Study||16||
48409524|NCT00515099|101334731|FG000|NOT COMPLETED|Overall Study||3||
48409525|NCT00515099|101334732|FG001|NOT COMPLETED|Overall Study||4||
48409526|NCT01435122|101334733|FG000|STARTED|Overall Study||30||
48409527|NCT01435122|101334733|FG000|COMPLETED|Overall Study||22||
48409528|NCT01435122|101334733|FG000|NOT COMPLETED|Overall Study||8||
48409529|NCT02100410|101334734|FG000|STARTED|Exposure Pair 1, 30 Minutes||8||
48409530|NCT02100410|101334735|FG001|STARTED|Exposure Pair 1, 30 Minutes||8||
48409531|NCT02100410|101334736|FG002|STARTED|Exposure Pair 1, 30 Minutes||8||
48409532|NCT02100410|101334737|FG003|STARTED|Exposure Pair 1, 30 Minutes||8||
48409533|NCT02100410|101334738|FG004|STARTED|Exposure Pair 1, 30 Minutes||8||
48409534|NCT02100410|101334739|FG005|STARTED|Exposure Pair 1, 30 Minutes||9||
48409535|NCT02100410|101334734|FG000|COMPLETED|Exposure Pair 1, 30 Minutes||8||
48409536|NCT02100410|101334735|FG001|COMPLETED|Exposure Pair 1, 30 Minutes||8||
48409537|NCT02100410|101334736|FG002|COMPLETED|Exposure Pair 1, 30 Minutes||8||
48409538|NCT02100410|101334737|FG003|COMPLETED|Exposure Pair 1, 30 Minutes||8||
48409539|NCT02100410|101334738|FG004|COMPLETED|Exposure Pair 1, 30 Minutes||8||
48409540|NCT02100410|101334739|FG005|COMPLETED|Exposure Pair 1, 30 Minutes||9||
48743615|NCT04794270|102158049|FG001|NOT COMPLETED|Period 2||0||
48743616|NCT00412893|102158050|FG000|STARTED|Overall Study||263||
48743617|NCT00412893|102158051|FG001|STARTED|Overall Study||264||
48743618|NCT00412893|102158050|FG000|Received Treatment|Overall Study||258||
48743619|NCT00412893|102158051|FG001|Received Treatment|Overall Study||258||
48743620|NCT00412893|102158050|FG000|COMPLETED|Overall Study||118||
48743621|NCT00412893|102158051|FG001|COMPLETED|Overall Study||120||
48743622|NCT00412893|102158050|FG000|NOT COMPLETED|Overall Study||145||
48743623|NCT00412893|102158051|FG001|NOT COMPLETED|Overall Study||144||
48743624|NCT01862536|102158052|FG000|STARTED|Overall Study||13||
48409541|NCT02100410|101334734|FG000|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0||
48409542|NCT02100410|101334735|FG001|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0||
48409543|NCT02100410|101334736|FG002|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0||
48409544|NCT02100410|101334737|FG003|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0||
48409545|NCT02100410|101334738|FG004|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0||
48409546|NCT02100410|101334739|FG005|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0||
48409547|NCT02100410|101334734|FG000|STARTED|Exposure Pair 2, 30 Minutes||8||
48409548|NCT02100410|101334735|FG001|STARTED|Exposure Pair 2, 30 Minutes||8||
48409549|NCT02100410|101334736|FG002|STARTED|Exposure Pair 2, 30 Minutes||8||
48409550|NCT02100410|101334737|FG003|STARTED|Exposure Pair 2, 30 Minutes||8||
48409551|NCT02100410|101334738|FG004|STARTED|Exposure Pair 2, 30 Minutes||8||
48409552|NCT02100410|101334739|FG005|STARTED|Exposure Pair 2, 30 Minutes||9||
48409553|NCT02100410|101334734|FG000|COMPLETED|Exposure Pair 2, 30 Minutes||8||
48409554|NCT02100410|101334735|FG001|COMPLETED|Exposure Pair 2, 30 Minutes||8||
48409555|NCT02100410|101334736|FG002|COMPLETED|Exposure Pair 2, 30 Minutes||8||
48409556|NCT02100410|101334737|FG003|COMPLETED|Exposure Pair 2, 30 Minutes||8||
48409557|NCT02100410|101334738|FG004|COMPLETED|Exposure Pair 2, 30 Minutes||8||
48743625|NCT01862536|102158053|FG001|STARTED|Overall Study||23||
48743626|NCT01862536|102158052|FG000|COMPLETED|Overall Study||10||
48326775|NCT04899232|101124741|FG002|NOT COMPLETED|Treatment Period||0||
48326776|NCT03300466|101124742|FG000|STARTED|Overall Study||10||
48326777|NCT03300466|101124743|FG001|STARTED|Overall Study||10||
48326778|NCT03300466|101124742|FG000|COMPLETED|Overall Study||9||
48326779|NCT03300466|101124743|FG001|COMPLETED|Overall Study||10||
48326780|NCT03300466|101124742|FG000|NOT COMPLETED|Overall Study||1||
48326781|NCT03300466|101124743|FG001|NOT COMPLETED|Overall Study||0||
48326782|NCT01923129|101124744|FG000|STARTED|Overall Study||71||
48326783|NCT01923129|101124745|FG001|STARTED|Overall Study||71||
48326784|NCT01923129|101124744|FG000|COMPLETED|Overall Study||71||
48326785|NCT01923129|101124745|FG001|COMPLETED|Overall Study||71||
48326786|NCT01923129|101124744|FG000|NOT COMPLETED|Overall Study||0||
48326787|NCT01923129|101124745|FG001|NOT COMPLETED|Overall Study||0||
48326788|NCT00313209|101124746|FG000|STARTED|Overall Study||466||
48326789|NCT00313209|101124747|FG001|STARTED|Overall Study||467||
48326790|NCT00313209|101124746|FG000|COMPLETED|Overall Study||359||
48326791|NCT00313209|101124747|FG001|COMPLETED|Overall Study||385||
48326792|NCT00313209|101124746|FG000|NOT COMPLETED|Overall Study||107||
48326793|NCT00313209|101124747|FG001|NOT COMPLETED|Overall Study||82||
48326794|NCT04041284|101124748|FG000|STARTED|DB Phase (12 Weeks)||178||
48326795|NCT04041284|101124749|FG001|STARTED|DB Phase (12 Weeks)||175||
48326796|NCT04041284|101124748|FG000|DB Safety Analysis Set|DB Phase (12 Weeks)||177|All randomized participants who received at least 1 dose of study drug during the DB treatment period.|
48326797|NCT04041284|101124749|FG001|DB Safety Analysis Set|DB Phase (12 Weeks)||176|All randomized participants who received at least 1 dose of study drug during the DB treatment period.|
48326798|NCT04041284|101124748|FG000|DB Modified Intent-to-treat (mITT) Analysis Set|DB Phase (12 Weeks)||178|All randomized participants who received at least 1 dose of study drug and had at least 10 days of postrandomization efficacy assessment on the primary endpoint.|
48326799|NCT04041284|101124749|FG001|DB Modified Intent-to-treat (mITT) Analysis Set|DB Phase (12 Weeks)||175|All randomized participants who received at least 1 dose of study drug and had at least 10 days of postrandomization efficacy assessment on the primary endpoint.|
48326800|NCT04041284|101124748|FG000|COMPLETED|DB Phase (12 Weeks)||166||
48326801|NCT04041284|101124749|FG001|COMPLETED|DB Phase (12 Weeks)||164||
48326802|NCT04041284|101124748|FG000|NOT COMPLETED|DB Phase (12 Weeks)||12||
48326803|NCT04041284|101124749|FG001|NOT COMPLETED|DB Phase (12 Weeks)||11||
48326804|NCT04041284|101124748|FG000|STARTED|OL Phase (12 Weeks)||166||
48326805|NCT04041284|101124749|FG001|STARTED|OL Phase (12 Weeks)||164||
48326806|NCT04041284|101124748|FG000|OL Safety Analysis Set|OL Phase (12 Weeks)||165|All participants who received at least 1 of dose of study drug during the OL treatment period.|
48326807|NCT04041284|101124749|FG001|OL Safety Analysis Set|OL Phase (12 Weeks)||165|All participants who received at least 1 of dose of study drug during the OL treatment period.|
48326808|NCT04041284|101124748|FG000|OL mITT Analysis Set|OL Phase (12 Weeks)||165|All participants who received at least 1 dose of study drug during the OL treatment period and had at least 10 days of diary entries during the OL period.|
48326809|NCT04041284|101124749|FG001|OL mITT Analysis Set|OL Phase (12 Weeks)||161|All participants who received at least 1 dose of study drug during the OL treatment period and had at least 10 days of diary entries during the OL period.|
48326810|NCT04041284|101124748|FG000|COMPLETED|OL Phase (12 Weeks)||154||
48326811|NCT04041284|101124749|FG001|COMPLETED|OL Phase (12 Weeks)||155||
48326812|NCT04041284|101124748|FG000|NOT COMPLETED|OL Phase (12 Weeks)||12||
48326813|NCT04041284|101124749|FG001|NOT COMPLETED|OL Phase (12 Weeks)||9||
48326814|NCT03344003|101124750|FG000|STARTED|Overall Study||8||
48326815|NCT03344003|101124751|FG001|STARTED|Overall Study||6||
48326816|NCT03344003|101124750|FG000|COMPLETED|Overall Study||6|Study terminated prior to planned completion|
48326817|NCT03344003|101124751|FG001|COMPLETED|Overall Study||6|Study terminated prior to planned completion|
48326818|NCT03344003|101124750|FG000|NOT COMPLETED|Overall Study||2||
48409558|NCT02100410|101334739|FG005|COMPLETED|Exposure Pair 2, 30 Minutes||9||
48326819|NCT03344003|101124751|FG001|NOT COMPLETED|Overall Study||0||
48326820|NCT00606086|101124752|FG000|STARTED|Overall Study||72||
48326821|NCT00606086|101124753|FG001|STARTED|Overall Study||68||
48326822|NCT00606086|101124752|FG000|COMPLETED|Overall Study||60||
48326823|NCT00606086|101124753|FG001|COMPLETED|Overall Study||53||
48326824|NCT00606086|101124752|FG000|NOT COMPLETED|Overall Study||12||
48326825|NCT00606086|101124753|FG001|NOT COMPLETED|Overall Study||15||
48326826|NCT00159861|101124754|FG000|STARTED|Core Study - 16 Weeks||133||
48326827|NCT00159861|101124755|FG001|STARTED|Core Study - 16 Weeks||134||
48326828|NCT00159861|101124754|FG000|Treated|Core Study - 16 Weeks||131||
48326829|NCT00159861|101124755|FG001|Treated|Core Study - 16 Weeks||134||
48326830|NCT00159861|101124754|FG000|COMPLETED|Core Study - 16 Weeks||108||
48326831|NCT00159861|101124755|FG001|COMPLETED|Core Study - 16 Weeks||122||
48326832|NCT00159861|101124754|FG000|NOT COMPLETED|Core Study - 16 Weeks||25||
48326833|NCT00159861|101124755|FG001|NOT COMPLETED|Core Study - 16 Weeks||12||
48326834|NCT00159861|101124754|FG000|STARTED|Extension Study - up to 3 Years||115||
48326835|NCT00159861|101124755|FG001|STARTED|Extension Study - up to 3 Years||127||
48326836|NCT00159861|101124754|FG000|Treated|Extension Study - up to 3 Years||115||
48326837|NCT00159861|101124755|FG001|Treated|Extension Study - up to 3 Years||127||
48326838|NCT00159861|101124754|FG000|COMPLETED|Extension Study - up to 3 Years||53||
48326839|NCT00159861|101124755|FG001|COMPLETED|Extension Study - up to 3 Years||56||
48326840|NCT00159861|101124754|FG000|NOT COMPLETED|Extension Study - up to 3 Years||62||
48326841|NCT00159861|101124755|FG001|NOT COMPLETED|Extension Study - up to 3 Years||71||
48326842|NCT01462266|101124756|FG000|STARTED|Overall Study||330||
48326843|NCT01462266|101124757|FG001|STARTED|Overall Study||330||
48326844|NCT01462266|101124756|FG000|Treated|Overall Study||329||
48326845|NCT01462266|101124757|FG001|Treated|Overall Study||329||
48326846|NCT01462266|101124756|FG000|COMPLETED|Overall Study||295||
48326847|NCT01462266|101124757|FG001|COMPLETED|Overall Study||303||
48326848|NCT01462266|101124756|FG000|NOT COMPLETED|Overall Study||35||
48326849|NCT01462266|101124757|FG001|NOT COMPLETED|Overall Study||27||
48326850|NCT02161211|101124758|FG000|STARTED|Overall Study||92||
48326851|NCT02161211|101124759|FG001|STARTED|Overall Study||94||
48326852|NCT02161211|101124760|FG002|STARTED|Overall Study||93||
48326853|NCT02161211|101124758|FG000|COMPLETED|Overall Study||59||
48326854|NCT02161211|101124759|FG001|COMPLETED|Overall Study||62||
48326855|NCT02161211|101124760|FG002|COMPLETED|Overall Study||63||
48326856|NCT02161211|101124758|FG000|NOT COMPLETED|Overall Study||33||
48326857|NCT02161211|101124759|FG001|NOT COMPLETED|Overall Study||32||
48326858|NCT02161211|101124760|FG002|NOT COMPLETED|Overall Study||30||
48326859|NCT04749459|101124761|FG000|STARTED|Overall Study||14||
48326860|NCT04749459|101124761|FG000|CSM Classic|Overall Study||12||
48326861|NCT04749459|101124761|FG000|CSM Strawberry Flavor|Overall Study||10||
48326862|NCT04749459|101124761|FG000|P2 Control Standard|Overall Study||14||
48326863|NCT04749459|101124761|FG000|COMPLETED|Overall Study||14||
48326864|NCT04749459|101124761|FG000|NOT COMPLETED|Overall Study||0||
48164118|NCT00535743|100724945|FG002|NOT COMPLETED|Overall Study||0||
48326865|NCT03595553|101124762|FG000|STARTED|Overall Study||370||
48326866|NCT03595553|101124763|FG001|STARTED|Overall Study||375||
48326867|NCT03595553|101124762|FG000|COMPLETED|Overall Study||312||
48326868|NCT03595553|101124763|FG001|COMPLETED|Overall Study||327||
48409559|NCT02100410|101334734|FG000|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0||
48409560|NCT02100410|101334735|FG001|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0||
48409561|NCT02100410|101334736|FG002|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0||
48409562|NCT02100410|101334737|FG003|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0||
48409563|NCT02100410|101334738|FG004|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0||
48409564|NCT02100410|101334739|FG005|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0||
48409565|NCT02100410|101334734|FG000|STARTED|Exposure Pair 3, 30 Minutes||8||
48409566|NCT02100410|101334735|FG001|STARTED|Exposure Pair 3, 30 Minutes||8||
48409567|NCT02100410|101334736|FG002|STARTED|Exposure Pair 3, 30 Minutes||8||
48409568|NCT02100410|101334737|FG003|STARTED|Exposure Pair 3, 30 Minutes||8||
48409569|NCT02100410|101334738|FG004|STARTED|Exposure Pair 3, 30 Minutes||8||
48409570|NCT02100410|101334739|FG005|STARTED|Exposure Pair 3, 30 Minutes||9||
48409571|NCT02100410|101334734|FG000|COMPLETED|Exposure Pair 3, 30 Minutes||8||
48409572|NCT02100410|101334735|FG001|COMPLETED|Exposure Pair 3, 30 Minutes||8||
48409573|NCT02100410|101334736|FG002|COMPLETED|Exposure Pair 3, 30 Minutes||8||
48409574|NCT02100410|101334737|FG003|COMPLETED|Exposure Pair 3, 30 Minutes||8||
48409575|NCT02100410|101334738|FG004|COMPLETED|Exposure Pair 3, 30 Minutes||8||
48409576|NCT02100410|101334739|FG005|COMPLETED|Exposure Pair 3, 30 Minutes||9||
48409577|NCT02100410|101334734|FG000|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0||
48409578|NCT02100410|101334735|FG001|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0||
48409579|NCT02100410|101334736|FG002|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0||
48409580|NCT02100410|101334737|FG003|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0||
48409581|NCT02100410|101334738|FG004|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0||
48409582|NCT02100410|101334739|FG005|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0||
48409583|NCT01957215|101334740|FG000|STARTED|Overall Study||135||
48409584|NCT01957215|101334741|FG001|STARTED|Overall Study||135||
48409585|NCT01957215|101334740|FG000|COMPLETED|Overall Study||122||
48409586|NCT01957215|101334741|FG001|COMPLETED|Overall Study||123||
48620728|NCT03286218|101856416|FG002|COMPLETED|Treatment Phase Period 3||5||
48620729|NCT03286218|101856417|FG003|COMPLETED|Treatment Phase Period 3||5||
48620730|NCT03286218|101856418|FG004|COMPLETED|Treatment Phase Period 3||5||
48620731|NCT03286218|101856419|FG005|COMPLETED|Treatment Phase Period 3||5||
48620732|NCT03286218|101856420|FG006|COMPLETED|Treatment Phase Period 3||6||
48326869|NCT03595553|101124762|FG000|NOT COMPLETED|Overall Study||58||
48326870|NCT03595553|101124763|FG001|NOT COMPLETED|Overall Study||48||
48326871|NCT01040052|101124764|FG000|STARTED|Overall Study||30||
48326872|NCT01040052|101124764|FG000|COMPLETED|Overall Study||30||
48326873|NCT01040052|101124764|FG000|NOT COMPLETED|Overall Study||0||
48326874|NCT00091832|101124765|FG000|STARTED|Overall Study||43||
48326875|NCT00091832|101124766|FG001|STARTED|Overall Study||42||
48326876|NCT00091832|101124767|FG002|STARTED|Overall Study||42||
48326877|NCT00091832|101124768|FG003|STARTED|Overall Study||43||
48326878|NCT00091832|101124769|FG004|STARTED|Overall Study||42||
48409587|NCT01957215|101334740|FG000|NOT COMPLETED|Overall Study||13||
48409588|NCT01957215|101334741|FG001|NOT COMPLETED|Overall Study||12||
48620733|NCT03286218|101856421|FG007|COMPLETED|Treatment Phase Period 3||6||
48620734|NCT03286218|101856422|FG008|COMPLETED|Treatment Phase Period 3||6||
48620735|NCT03286218|101856423|FG009|COMPLETED|Treatment Phase Period 3||6||
48620736|NCT03286218|101856424|FG010|COMPLETED|Treatment Phase Period 3||5||
48620737|NCT03286218|101856425|FG011|COMPLETED|Treatment Phase Period 3||5||
48620738|NCT03286218|101856414|FG000|NOT COMPLETED|Treatment Phase Period 3||0||
48326879|NCT00091832|101124770|FG005|STARTED|Overall Study||43||
48409589|NCT00257322|101334742|FG000|STARTED|Overall Study||20||
48409590|NCT00257322|101334742|FG000|COMPLETED|Overall Study||16||
48409591|NCT00257322|101334742|FG000|NOT COMPLETED|Overall Study||4||
48409592|NCT03077711|101334743|FG000|STARTED|Overall Study||47||
48409593|NCT03077711|101334744|FG001|STARTED|Overall Study||45||
48409594|NCT03077711|101334743|FG000|COMPLETED|Overall Study||43||
48409595|NCT03077711|101334744|FG001|COMPLETED|Overall Study||43||
48409596|NCT03077711|101334743|FG000|NOT COMPLETED|Overall Study||4||
48409597|NCT03077711|101334744|FG001|NOT COMPLETED|Overall Study||2||
48620739|NCT03286218|101856415|FG001|NOT COMPLETED|Treatment Phase Period 3||0||
48620740|NCT03286218|101856416|FG002|NOT COMPLETED|Treatment Phase Period 3||0||
48620741|NCT03286218|101856417|FG003|NOT COMPLETED|Treatment Phase Period 3||0||
48620742|NCT03286218|101856418|FG004|NOT COMPLETED|Treatment Phase Period 3||0||
48620743|NCT03286218|101856419|FG005|NOT COMPLETED|Treatment Phase Period 3||0||
48326880|NCT00091832|101124765|FG000|Received Study Medication|Overall Study||43||
48326881|NCT00091832|101124766|FG001|Received Study Medication|Overall Study||42||
48326882|NCT00091832|101124767|FG002|Received Study Medication|Overall Study||41||
48326883|NCT00091832|101124768|FG003|Received Study Medication|Overall Study||43||
48743627|NCT01862536|102158053|FG001|COMPLETED|Overall Study||16||
48743628|NCT01862536|102158052|FG000|NOT COMPLETED|Overall Study||3||
48743629|NCT01862536|102158053|FG001|NOT COMPLETED|Overall Study||7||
48743630|NCT03089580|102158054|FG000|STARTED|Overall Study||14||28
48743631|NCT03089580|102158054|FG000|COMPLETED|Overall Study||12||24
48743632|NCT03089580|102158054|FG000|NOT COMPLETED|Overall Study||2||4
48743633|NCT03329846|102158055|FG000|STARTED|Overall Study||10||
48743634|NCT03329846|102158056|FG001|STARTED|Overall Study||10||
48743635|NCT03329846|102158055|FG000|COMPLETED|Overall Study||2||
48326884|NCT00091832|101124769|FG004|Received Study Medication|Overall Study||42||
48326885|NCT00091832|101124770|FG005|Received Study Medication|Overall Study||43||
48326886|NCT00091832|101124765|FG000|COMPLETED|Overall Study||29||
48326887|NCT00091832|101124766|FG001|COMPLETED|Overall Study||31||
48326888|NCT00091832|101124767|FG002|COMPLETED|Overall Study||30||
48326889|NCT00091832|101124768|FG003|COMPLETED|Overall Study||29||
48326890|NCT00091832|101124769|FG004|COMPLETED|Overall Study||27||
48326891|NCT00091832|101124770|FG005|COMPLETED|Overall Study||32||
48326892|NCT00091832|101124765|FG000|NOT COMPLETED|Overall Study||14||
48326893|NCT00091832|101124766|FG001|NOT COMPLETED|Overall Study||11||
48326894|NCT00091832|101124767|FG002|NOT COMPLETED|Overall Study||12||
48326895|NCT00091832|101124768|FG003|NOT COMPLETED|Overall Study||14||
48326896|NCT00091832|101124769|FG004|NOT COMPLETED|Overall Study||15||
48326897|NCT00091832|101124770|FG005|NOT COMPLETED|Overall Study||11||
48326898|NCT04016311|101124771|FG000|STARTED|Overall Study||18||
48326899|NCT04016311|101124772|FG001|STARTED|Overall Study||20||
48326900|NCT04016311|101124771|FG000|COMPLETED|Overall Study||17||
48326901|NCT04016311|101124772|FG001|COMPLETED|Overall Study||20||
48326902|NCT04016311|101124771|FG000|NOT COMPLETED|Overall Study||1||
48326903|NCT04016311|101124772|FG001|NOT COMPLETED|Overall Study||0||
48326904|NCT03548558|101124773|FG000|STARTED|Phase 1: 16 Total Fortnightly Sessions||173||10
48326905|NCT03548558|101124774|FG001|STARTED|Phase 1: 16 Total Fortnightly Sessions||202||10
48326906|NCT03548558|101124775|FG002|STARTED|Phase 1: 16 Total Fortnightly Sessions||201||10
48326907|NCT03548558|101124776|FG003|STARTED|Phase 1: 16 Total Fortnightly Sessions||199||10
48326908|NCT03548558|101124777|FG004|STARTED|Phase 1: 16 Total Fortnightly Sessions||377||20
48326909|NCT03548558|101124778|FG005|STARTED|Phase 1: 16 Total Fortnightly Sessions||0||0
48326910|NCT03548558|101124779|FG006|STARTED|Phase 1: 16 Total Fortnightly Sessions||0||0
48326911|NCT03548558|101124773|FG000|COMPLETED|Phase 1: 16 Total Fortnightly Sessions||161||10
48326912|NCT03548558|101124774|FG001|COMPLETED|Phase 1: 16 Total Fortnightly Sessions||185||10
48326913|NCT03548558|101124775|FG002|COMPLETED|Phase 1: 16 Total Fortnightly Sessions||191||10
48326914|NCT03548558|101124776|FG003|COMPLETED|Phase 1: 16 Total Fortnightly Sessions||182||10
48326915|NCT03548558|101124777|FG004|COMPLETED|Phase 1: 16 Total Fortnightly Sessions||351||20
48326916|NCT03548558|101124778|FG005|COMPLETED|Phase 1: 16 Total Fortnightly Sessions||0||0
48326917|NCT03548558|101124779|FG006|COMPLETED|Phase 1: 16 Total Fortnightly Sessions||0||0
48326918|NCT03548558|101124773|FG000|NOT COMPLETED|Phase 1: 16 Total Fortnightly Sessions||12||0
48326919|NCT03548558|101124774|FG001|NOT COMPLETED|Phase 1: 16 Total Fortnightly Sessions||17||0
48326920|NCT03548558|101124775|FG002|NOT COMPLETED|Phase 1: 16 Total Fortnightly Sessions||10||0
48326921|NCT03548558|101124776|FG003|NOT COMPLETED|Phase 1: 16 Total Fortnightly Sessions||17||0
48326922|NCT03548558|101124777|FG004|NOT COMPLETED|Phase 1: 16 Total Fortnightly Sessions||26||0
48326923|NCT03548558|101124778|FG005|NOT COMPLETED|Phase 1: 16 Total Fortnightly Sessions||0||0
48326924|NCT03548558|101124779|FG006|NOT COMPLETED|Phase 1: 16 Total Fortnightly Sessions||0||0
48326925|NCT03548558|101124773|FG000|STARTED|Phase 2: Booster Sessions Every 2 Months||0||0
48326926|NCT03548558|101124774|FG001|STARTED|Phase 2: Booster Sessions Every 2 Months||0||0
48326927|NCT03548558|101124775|FG002|STARTED|Phase 2: Booster Sessions Every 2 Months||0||0
48326928|NCT03548558|101124776|FG003|STARTED|Phase 2: Booster Sessions Every 2 Months||0||0
48326929|NCT03548558|101124777|FG004|STARTED|Phase 2: Booster Sessions Every 2 Months||377||20
48326930|NCT03548558|101124778|FG005|STARTED|Phase 2: Booster Sessions Every 2 Months||394||20
48326931|NCT03548558|101124779|FG006|STARTED|Phase 2: Booster Sessions Every 2 Months||378||20
48326932|NCT03548558|101124773|FG000|COMPLETED|Phase 2: Booster Sessions Every 2 Months||0||0
48743636|NCT03329846|102158056|FG001|COMPLETED|Overall Study||1||
48743637|NCT03329846|102158055|FG000|NOT COMPLETED|Overall Study||8||
48326933|NCT03548558|101124774|FG001|COMPLETED|Phase 2: Booster Sessions Every 2 Months||0||0
48326934|NCT03548558|101124775|FG002|COMPLETED|Phase 2: Booster Sessions Every 2 Months||0||0
48326935|NCT03548558|101124776|FG003|COMPLETED|Phase 2: Booster Sessions Every 2 Months||0||0
48326936|NCT03548558|101124777|FG004|COMPLETED|Phase 2: Booster Sessions Every 2 Months||308||20
48368069|NCT03691623|101230096|FG000|COMPLETED|Overall Study||39||
48743638|NCT03329846|102158056|FG001|NOT COMPLETED|Overall Study||9||
48743639|NCT00790192|102158057|FG000|STARTED|Overall Study||125||
48743640|NCT00790192|102158058|FG001|STARTED|Overall Study||121||
48409598|NCT00673816|101334745|FG000|STARTED|Overall Study||2||
48409599|NCT00673816|101334745|FG000|COMPLETED|Overall Study||0||
48409600|NCT00673816|101334745|FG000|NOT COMPLETED|Overall Study||2||
48409601|NCT00053014|101334746|FG000|STARTED|Overall Study||5||
48409602|NCT00053014|101334746|FG000|COMPLETED|Overall Study||5||
48409603|NCT00053014|101334746|FG000|NOT COMPLETED|Overall Study||0||
48409604|NCT02145754|101334747|FG000|STARTED|Overall Study||235||
48620744|NCT03286218|101856420|FG006|NOT COMPLETED|Treatment Phase Period 3||0||
48743641|NCT00790192|102158059|FG002|STARTED|Overall Study||120||
48743642|NCT00790192|102158060|FG003|STARTED|Overall Study||122||
48743643|NCT00790192|102158057|FG000|COMPLETED|Overall Study||89||
48743644|NCT00790192|102158058|FG001|COMPLETED|Overall Study||93||
48743645|NCT00790192|102158059|FG002|COMPLETED|Overall Study||97||
48743646|NCT00790192|102158060|FG003|COMPLETED|Overall Study||74||
48743647|NCT00790192|102158057|FG000|NOT COMPLETED|Overall Study||36||
48743648|NCT00790192|102158058|FG001|NOT COMPLETED|Overall Study||28||
48743649|NCT00790192|102158059|FG002|NOT COMPLETED|Overall Study||23||
48743650|NCT00790192|102158060|FG003|NOT COMPLETED|Overall Study||48||
48743651|NCT05350163|102158061|FG000|STARTED|Overall Study||10||
48743652|NCT05350163|102158062|FG001|STARTED|Overall Study||0||
48743653|NCT05350163|102158063|FG002|STARTED|Overall Study||0||
48743654|NCT05350163|102158064|FG003|STARTED|Overall Study||1||
48743655|NCT05350163|102158065|FG004|STARTED|Overall Study||0||
48743656|NCT05350163|102158066|FG005|STARTED|Overall Study||0||
48743657|NCT05350163|102158061|FG000|COMPLETED|Overall Study||0||
48743658|NCT05350163|102158062|FG001|COMPLETED|Overall Study||0||
48743659|NCT05350163|102158063|FG002|COMPLETED|Overall Study||0||
48743660|NCT05350163|102158064|FG003|COMPLETED|Overall Study||0||
48743661|NCT05350163|102158065|FG004|COMPLETED|Overall Study||0||
48743662|NCT05350163|102158066|FG005|COMPLETED|Overall Study||0||
48743663|NCT05350163|102158061|FG000|NOT COMPLETED|Overall Study||10||
48743664|NCT05350163|102158062|FG001|NOT COMPLETED|Overall Study||0||
48620745|NCT03286218|101856421|FG007|NOT COMPLETED|Treatment Phase Period 3||0||
48620746|NCT03286218|101856422|FG008|NOT COMPLETED|Treatment Phase Period 3||0||
48620747|NCT03286218|101856423|FG009|NOT COMPLETED|Treatment Phase Period 3||0||
48620748|NCT03286218|101856424|FG010|NOT COMPLETED|Treatment Phase Period 3||0||
48620749|NCT03286218|101856425|FG011|NOT COMPLETED|Treatment Phase Period 3||0||
48620750|NCT03286218|101856414|FG000|STARTED|Treatment Phase Period 4||0||
48743665|NCT05350163|102158063|FG002|NOT COMPLETED|Overall Study||0||
48743666|NCT05350163|102158064|FG003|NOT COMPLETED|Overall Study||1||
48743667|NCT05350163|102158065|FG004|NOT COMPLETED|Overall Study||0||
48743668|NCT05350163|102158066|FG005|NOT COMPLETED|Overall Study||0||
48743669|NCT04854551|102158067|FG000|STARTED|Overall Study||7||
48743670|NCT04854551|102158068|FG001|STARTED|Overall Study||6||
48743671|NCT04854551|102158067|FG000|COMPLETED|Overall Study||6||
48743672|NCT04854551|102158068|FG001|COMPLETED|Overall Study||5||
48743673|NCT04854551|102158067|FG000|NOT COMPLETED|Overall Study||1||
48743674|NCT04854551|102158068|FG001|NOT COMPLETED|Overall Study||1||
48743675|NCT01633541|102158069|FG000|STARTED|Overall Study||36||
48743676|NCT01633541|102158070|FG001|STARTED|Overall Study||18||
48743677|NCT01633541|102158069|FG000|COMPLETED|Overall Study||35||
48743678|NCT01633541|102158070|FG001|COMPLETED|Overall Study||18||
48743679|NCT01633541|102158069|FG000|NOT COMPLETED|Overall Study||1||
48743680|NCT01633541|102158070|FG001|NOT COMPLETED|Overall Study||0||
48743681|NCT00575965|102158071|FG000|STARTED|Overall Study||18||
48409605|NCT02145754|101334747|FG000|COMPLETED|Overall Study||235||
48620751|NCT03286218|101856415|FG001|STARTED|Treatment Phase Period 4||0||
48620752|NCT03286218|101856416|FG002|STARTED|Treatment Phase Period 4||5||
48620753|NCT03286218|101856417|FG003|STARTED|Treatment Phase Period 4||5||
48620754|NCT03286218|101856418|FG004|STARTED|Treatment Phase Period 4||5||
48620755|NCT03286218|101856419|FG005|STARTED|Treatment Phase Period 4||5||
48620756|NCT03286218|101856420|FG006|STARTED|Treatment Phase Period 4||6||
48620757|NCT03286218|101856421|FG007|STARTED|Treatment Phase Period 4||6||
48620758|NCT03286218|101856422|FG008|STARTED|Treatment Phase Period 4||6||
48620759|NCT03286218|101856423|FG009|STARTED|Treatment Phase Period 4||6||
48620760|NCT03286218|101856424|FG010|STARTED|Treatment Phase Period 4||5||
48620761|NCT03286218|101856425|FG011|STARTED|Treatment Phase Period 4||5||
48620762|NCT03286218|101856414|FG000|COMPLETED|Treatment Phase Period 4||0||
48743682|NCT00575965|102158071|FG000|COMPLETED|Overall Study||18||
48743683|NCT00575965|102158071|FG000|NOT COMPLETED|Overall Study||0||
48409606|NCT02145754|101334747|FG000|NOT COMPLETED|Overall Study||0||
48409607|NCT00976963|101334748|FG000|STARTED|Overall Study||150||
48743684|NCT01126723|102158072|FG000|STARTED|Overall Study||35||
48743685|NCT01126723|102158073|FG001|STARTED|Overall Study||31||
48743686|NCT01126723|102158072|FG000|COMPLETED|Overall Study||29||
48743687|NCT01126723|102158073|FG001|COMPLETED|Overall Study||28||
48743688|NCT01126723|102158072|FG000|NOT COMPLETED|Overall Study||6||
48743689|NCT01126723|102158073|FG001|NOT COMPLETED|Overall Study||3||
48743690|NCT03571555|102158074|FG000|STARTED|Overall Study||252||
48409608|NCT00976963|101334749|FG001|STARTED|Overall Study||150||
48440030|NCT05378269|101410018|FG003|STARTED|Overall Study||3||
48743691|NCT03571555|102158075|FG001|STARTED|Overall Study||263||
48743692|NCT03571555|102158074|FG000|COMPLETED|Overall Study||177||
48743693|NCT03571555|102158075|FG001|COMPLETED|Overall Study||195||
48743694|NCT03571555|102158074|FG000|NOT COMPLETED|Overall Study||75||
48743695|NCT03571555|102158075|FG001|NOT COMPLETED|Overall Study||68||
48743696|NCT02517541|102158076|FG000|STARTED|Baseline Period (Own Product)||74||
48743697|NCT02517541|102158076|FG000|COMPLETED|Baseline Period (Own Product)||73||
48743698|NCT02517541|102158076|FG000|NOT COMPLETED|Baseline Period (Own Product)||1||
48743699|NCT02517541|102158076|FG000|STARTED|Test Period (SenSura Mio Convex Soft)||73||
48743700|NCT02517541|102158076|FG000|COMPLETED|Test Period (SenSura Mio Convex Soft)||61||
48743701|NCT02517541|102158076|FG000|NOT COMPLETED|Test Period (SenSura Mio Convex Soft)||12||
48743702|NCT05066165|102158077|FG000|STARTED|C1:DoseLevel1 Assignment||1||
48743703|NCT05066165|102158078|FG001|STARTED|C1:DoseLevel1 Assignment||5||
48743704|NCT05066165|102158077|FG000|COMPLETED|C1:DoseLevel1 Assignment||1||
48743705|NCT05066165|102158078|FG001|COMPLETED|C1:DoseLevel1 Assignment||1||
48620763|NCT03286218|101856415|FG001|COMPLETED|Treatment Phase Period 4||0||
48620764|NCT03286218|101856416|FG002|COMPLETED|Treatment Phase Period 4||5||
48743706|NCT05066165|102158077|FG000|NOT COMPLETED|C1:DoseLevel1 Assignment||0||
48743707|NCT05066165|102158078|FG001|NOT COMPLETED|C1:DoseLevel1 Assignment||4||
48743708|NCT05066165|102158077|FG000|STARTED|C1:DoseLevel1 Dosed Participants (W1-16)||1||
48743709|NCT05066165|102158078|FG001|STARTED|C1:DoseLevel1 Dosed Participants (W1-16)||1||
48743710|NCT05066165|102158077|FG000|COMPLETED|C1:DoseLevel1 Dosed Participants (W1-16)||0||
48743711|NCT05066165|102158078|FG001|COMPLETED|C1:DoseLevel1 Dosed Participants (W1-16)||0||
48326937|NCT03548558|101124778|FG005|COMPLETED|Phase 2: Booster Sessions Every 2 Months||323||20
48326938|NCT03548558|101124779|FG006|COMPLETED|Phase 2: Booster Sessions Every 2 Months||313||20
48326939|NCT03548558|101124773|FG000|NOT COMPLETED|Phase 2: Booster Sessions Every 2 Months||0||0
48743712|NCT05066165|102158077|FG000|NOT COMPLETED|C1:DoseLevel1 Dosed Participants (W1-16)||1||
48743713|NCT05066165|102158078|FG001|NOT COMPLETED|C1:DoseLevel1 Dosed Participants (W1-16)||1||
48743714|NCT05066165|102158077|FG000|STARTED|Cohort2:Dose Level 2||0||
48743715|NCT05066165|102158078|FG001|STARTED|Cohort2:Dose Level 2||0||
48743716|NCT05066165|102158077|FG000|COMPLETED|Cohort2:Dose Level 2||0||
48743717|NCT05066165|102158078|FG001|COMPLETED|Cohort2:Dose Level 2||0||
48743718|NCT05066165|102158077|FG000|NOT COMPLETED|Cohort2:Dose Level 2||0||
48743719|NCT05066165|102158078|FG001|NOT COMPLETED|Cohort2:Dose Level 2||0||
48743720|NCT04950465|102158079|FG000|STARTED|Overall Study||66||
48743721|NCT04950465|102158080|FG001|STARTED|Overall Study||67||
48743722|NCT04950465|102158081|FG002|STARTED|Overall Study||64||
48743723|NCT04950465|102158079|FG000|COMPLETED|Overall Study||65||
48743724|NCT04950465|102158080|FG001|COMPLETED|Overall Study||67||
48743725|NCT04950465|102158081|FG002|COMPLETED|Overall Study||64||
48743726|NCT04950465|102158079|FG000|NOT COMPLETED|Overall Study||1||
48743727|NCT04950465|102158080|FG001|NOT COMPLETED|Overall Study||0||
48743728|NCT04950465|102158081|FG002|NOT COMPLETED|Overall Study||0||
48743729|NCT04775953|102158082|FG000|STARTED|Overall Study||100||
48743730|NCT04775953|102158083|FG001|STARTED|Overall Study||100||
48743731|NCT04775953|102158082|FG000|COMPLETED|Overall Study||84||
48743732|NCT04775953|102158083|FG001|COMPLETED|Overall Study||81||
48743733|NCT04775953|102158082|FG000|NOT COMPLETED|Overall Study||16||
48743734|NCT04775953|102158083|FG001|NOT COMPLETED|Overall Study||19||
48743735|NCT00587678|102158084|FG000|STARTED|Overall Study||22||
48743736|NCT00587678|102158085|FG001|STARTED|Overall Study||22||
48743737|NCT00587678|102158086|FG002|STARTED|Overall Study||41||
48743738|NCT00587678|102158084|FG000|COMPLETED|Overall Study||16||
48743739|NCT00587678|102158085|FG001|COMPLETED|Overall Study||18||
48743740|NCT00587678|102158086|FG002|COMPLETED|Overall Study||33||
48743741|NCT00587678|102158084|FG000|NOT COMPLETED|Overall Study||6||
48743742|NCT00587678|102158085|FG001|NOT COMPLETED|Overall Study||4||
48743743|NCT00587678|102158086|FG002|NOT COMPLETED|Overall Study||8||
48743744|NCT00061893|102158087|FG000|STARTED|Overall Study||38||
48620765|NCT03286218|101856417|FG003|COMPLETED|Treatment Phase Period 4||5||
48743745|NCT00061893|102158087|FG000|COMPLETED|Overall Study||20||
48743746|NCT00061893|102158087|FG000|NOT COMPLETED|Overall Study||18||
48743747|NCT03650088|102158088|FG000|STARTED|Overall Study||18||
48620766|NCT03286218|101856418|FG004|COMPLETED|Treatment Phase Period 4||5||
48620767|NCT03286218|101856419|FG005|COMPLETED|Treatment Phase Period 4||5||
48620768|NCT03286218|101856420|FG006|COMPLETED|Treatment Phase Period 4||6||
48620769|NCT03286218|101856421|FG007|COMPLETED|Treatment Phase Period 4||6||
48620770|NCT03286218|101856422|FG008|COMPLETED|Treatment Phase Period 4||6||
48620771|NCT03286218|101856423|FG009|COMPLETED|Treatment Phase Period 4||6||
48620772|NCT03286218|101856424|FG010|COMPLETED|Treatment Phase Period 4||5||
48743748|NCT03650088|102158088|FG000|COMPLETED|Overall Study||17||
48743749|NCT03650088|102158088|FG000|NOT COMPLETED|Overall Study||1||
48743750|NCT00984308|102158089|FG000|STARTED|Overall Study||110||
48743751|NCT00984308|102158090|FG001|STARTED|Overall Study||115||
48743752|NCT00984308|102158089|FG000|COMPLETED|Overall Study||92||
48620773|NCT03286218|101856425|FG011|COMPLETED|Treatment Phase Period 4||4||
48657108|NCT03761914|101943780|FG002|COMPLETED|Overall Study||0||
48743753|NCT00984308|102158090|FG001|COMPLETED|Overall Study||109||
48743754|NCT00984308|102158089|FG000|NOT COMPLETED|Overall Study||18||
48743755|NCT00984308|102158090|FG001|NOT COMPLETED|Overall Study||6||
48743756|NCT00286494|102158091|FG000|STARTED|Overall Study||97||
48743757|NCT00286494|102158092|FG001|STARTED|Overall Study||197||
48164119|NCT00535743|100724946|FG003|NOT COMPLETED|Overall Study||0||
48164120|NCT00535743|100724947|FG004|NOT COMPLETED|Overall Study||0||
48164121|NCT00535743|100724948|FG005|NOT COMPLETED|Overall Study||0||
48164122|NCT00535743|100724949|FG006|NOT COMPLETED|Overall Study||0||
48164123|NCT00535743|100724950|FG007|NOT COMPLETED|Overall Study||0||
48164124|NCT00535743|100724951|FG008|NOT COMPLETED|Overall Study||1||
48164125|NCT00535743|100724952|FG009|NOT COMPLETED|Overall Study||1||
48164126|NCT00535743|100724953|FG010|NOT COMPLETED|Overall Study||0||
48326940|NCT03548558|101124774|FG001|NOT COMPLETED|Phase 2: Booster Sessions Every 2 Months||0||0
48326941|NCT03548558|101124775|FG002|NOT COMPLETED|Phase 2: Booster Sessions Every 2 Months||0||0
48326942|NCT03548558|101124776|FG003|NOT COMPLETED|Phase 2: Booster Sessions Every 2 Months||0||0
48326943|NCT03548558|101124777|FG004|NOT COMPLETED|Phase 2: Booster Sessions Every 2 Months||69||0
48326944|NCT03548558|101124778|FG005|NOT COMPLETED|Phase 2: Booster Sessions Every 2 Months||71||0
48368070|NCT03691623|101230097|FG001|COMPLETED|Overall Study||38||
48620774|NCT03286218|101856414|FG000|NOT COMPLETED|Treatment Phase Period 4||0||
48620775|NCT03286218|101856415|FG001|NOT COMPLETED|Treatment Phase Period 4||0||
48620776|NCT03286218|101856416|FG002|NOT COMPLETED|Treatment Phase Period 4||0||
48620777|NCT03286218|101856417|FG003|NOT COMPLETED|Treatment Phase Period 4||0||
48620778|NCT03286218|101856418|FG004|NOT COMPLETED|Treatment Phase Period 4||0||
48620779|NCT03286218|101856419|FG005|NOT COMPLETED|Treatment Phase Period 4||0||
48620780|NCT03286218|101856420|FG006|NOT COMPLETED|Treatment Phase Period 4||0||
48620781|NCT03286218|101856421|FG007|NOT COMPLETED|Treatment Phase Period 4||0||
48620782|NCT03286218|101856422|FG008|NOT COMPLETED|Treatment Phase Period 4||0||
48620783|NCT03286218|101856423|FG009|NOT COMPLETED|Treatment Phase Period 4||0||
48620784|NCT03286218|101856424|FG010|NOT COMPLETED|Treatment Phase Period 4||0||
48620785|NCT03286218|101856425|FG011|NOT COMPLETED|Treatment Phase Period 4||1||
48620786|NCT03286218|101856414|FG000|STARTED|Treatment Phase Period 5||0||
48620787|NCT03286218|101856415|FG001|STARTED|Treatment Phase Period 5||0||
48620788|NCT03286218|101856416|FG002|STARTED|Treatment Phase Period 5||5||
48620789|NCT03286218|101856417|FG003|STARTED|Treatment Phase Period 5||5||
48620790|NCT03286218|101856418|FG004|STARTED|Treatment Phase Period 5||5||
48620791|NCT03286218|101856419|FG005|STARTED|Treatment Phase Period 5||5||
48620792|NCT03286218|101856420|FG006|STARTED|Treatment Phase Period 5||6||
48620793|NCT03286218|101856421|FG007|STARTED|Treatment Phase Period 5||6||
48620794|NCT03286218|101856422|FG008|STARTED|Treatment Phase Period 5||6||
48620795|NCT03286218|101856423|FG009|STARTED|Treatment Phase Period 5||6||
48620796|NCT03286218|101856424|FG010|STARTED|Treatment Phase Period 5||5||
48620797|NCT03286218|101856425|FG011|STARTED|Treatment Phase Period 5||4||
48620798|NCT03286218|101856414|FG000|COMPLETED|Treatment Phase Period 5||0||
48620799|NCT03286218|101856415|FG001|COMPLETED|Treatment Phase Period 5||0||
48620800|NCT03286218|101856416|FG002|COMPLETED|Treatment Phase Period 5||5||
48620801|NCT03286218|101856417|FG003|COMPLETED|Treatment Phase Period 5||5||
48620802|NCT03286218|101856418|FG004|COMPLETED|Treatment Phase Period 5||5||
48620803|NCT03286218|101856419|FG005|COMPLETED|Treatment Phase Period 5||5||
48620804|NCT03286218|101856420|FG006|COMPLETED|Treatment Phase Period 5||6||
48620805|NCT03286218|101856421|FG007|COMPLETED|Treatment Phase Period 5||6||
48620806|NCT03286218|101856422|FG008|COMPLETED|Treatment Phase Period 5||6||
48620807|NCT03286218|101856423|FG009|COMPLETED|Treatment Phase Period 5||6||
48743758|NCT00286494|102158093|FG002|STARTED|Overall Study||199||
48743759|NCT00286494|102158091|FG000|COMPLETED|Overall Study||71||
48620808|NCT03286218|101856424|FG010|COMPLETED|Treatment Phase Period 5||5||
48620809|NCT03286218|101856425|FG011|COMPLETED|Treatment Phase Period 5||4||
48620810|NCT03286218|101856414|FG000|NOT COMPLETED|Treatment Phase Period 5||0||
48620811|NCT03286218|101856415|FG001|NOT COMPLETED|Treatment Phase Period 5||0||
48620812|NCT03286218|101856416|FG002|NOT COMPLETED|Treatment Phase Period 5||0||
48620813|NCT03286218|101856417|FG003|NOT COMPLETED|Treatment Phase Period 5||0||
48620814|NCT03286218|101856418|FG004|NOT COMPLETED|Treatment Phase Period 5||0||
48620815|NCT03286218|101856419|FG005|NOT COMPLETED|Treatment Phase Period 5||0||
48743760|NCT00286494|102158092|FG001|COMPLETED|Overall Study||153||
48743761|NCT00286494|102158093|FG002|COMPLETED|Overall Study||160||
48743762|NCT00286494|102158091|FG000|NOT COMPLETED|Overall Study||26||
48743763|NCT00286494|102158092|FG001|NOT COMPLETED|Overall Study||44||
48743764|NCT00286494|102158093|FG002|NOT COMPLETED|Overall Study||39||
48743765|NCT02756572|102158094|FG000|STARTED|Overall Study||30||
48743766|NCT02756572|102158094|FG000|COMPLETED|Overall Study||30||
48743767|NCT02756572|102158094|FG000|NOT COMPLETED|Overall Study||0||
48743768|NCT04037865|102158095|FG000|STARTED|Overall Study||8||
48743769|NCT04037865|102158095|FG000|COMPLETED|Overall Study||8||
48743770|NCT04037865|102158095|FG000|NOT COMPLETED|Overall Study||0||
48743771|NCT00592124|102158096|FG000|STARTED|Overall Study||28||
48743772|NCT00592124|102158097|FG001|STARTED|Overall Study||29||
48164127|NCT00535743|100724954|FG011|NOT COMPLETED|Overall Study||0||
48164128|NCT00535743|100724955|FG012|NOT COMPLETED|Overall Study||0||
48743773|NCT00592124|102158098|FG002|STARTED|Overall Study||30||
48743774|NCT00592124|102158099|FG003|STARTED|Overall Study||27||
48743775|NCT00592124|102158100|FG004|STARTED|Overall Study||27||
48743776|NCT00592124|102158101|FG005|STARTED|Overall Study||27||
48743777|NCT00592124|102158096|FG000|COMPLETED|Overall Study||24||
48743778|NCT00592124|102158097|FG001|COMPLETED|Overall Study||24||
48164129|NCT00535743|100724956|FG013|NOT COMPLETED|Overall Study||0||
48164130|NCT00535743|100724957|FG014|NOT COMPLETED|Overall Study||0||
48164131|NCT00535743|100724958|FG015|NOT COMPLETED|Overall Study||0||
48164132|NCT00535743|100724959|FG016|NOT COMPLETED|Overall Study||0||
48164133|NCT00535743|100724960|FG017|NOT COMPLETED|Overall Study||0||
48164134|NCT00535743|100724961|FG018|NOT COMPLETED|Overall Study||0||
48164135|NCT00535743|100724962|FG019|NOT COMPLETED|Overall Study||0||
48164136|NCT00535743|100724963|FG020|NOT COMPLETED|Overall Study||0||
48164137|NCT00535743|100724964|FG021|NOT COMPLETED|Overall Study||1||
48164138|NCT00535743|100724965|FG022|NOT COMPLETED|Overall Study||0||
48164139|NCT00535743|100724966|FG023|NOT COMPLETED|Overall Study||0||
48164140|NCT03701295|100724967|FG000|STARTED|Overall Study||1||
48164141|NCT03701295|100724967|FG000|COMPLETED|Overall Study||1||
48164142|NCT03701295|100724967|FG000|NOT COMPLETED|Overall Study||0||
48164143|NCT01336634|100724968|FG000|STARTED|Overall Study||84|All participants who received at least one dose of study treatment were included in the All Treated Population (ATP)|
48164144|NCT01336634|100724969|FG001|STARTED|Overall Study||57|All participants who received at least one dose of study treatment were included in the All Treated Population (ATP)|
48164145|NCT01336634|100724970|FG002|STARTED|Overall Study||36|All participants who received at least one dose of study treatment were included in the All Treated Population (ATP)|
48164146|NCT01336634|100724968|FG000|2nd Line Plus All Treated|Overall Study||78|All Treated Population who had relapsed or progressed after receiving at least one line of prior anti-cancer therapy for metastatic disease.|
48164147|NCT01336634|100724969|FG001|2nd Line Plus All Treated|Overall Study||57|All Treated Population who had relapsed or progressed after receiving at least one line of prior anti-cancer therapy for metastatic disease.|
48164148|NCT01336634|100724970|FG002|2nd Line Plus All Treated|Overall Study||0|All Treated Population who had relapsed or progressed after receiving at least one line of prior anti-cancer therapy for metastatic disease.|
48164149|NCT01336634|100724968|FG000|1st Line All Treated|Overall Study||6|All Treated Population who had not received any prior anti-cancer therapy for metastatic disease.|
48164150|NCT01336634|100724969|FG001|1st Line All Treated|Overall Study||2|All Treated Population who had not received any prior anti-cancer therapy for metastatic disease.|
48164151|NCT01336634|100724970|FG002|1st Line All Treated|Overall Study||34|All Treated Population who had not received any prior anti-cancer therapy for metastatic disease.|
48164152|NCT01336634|100724968|FG000|Crossover|Overall Study||20|All Treated Population who were assigned to monotherapy cohort and elected to crossover to combination treatment following disease progression on monotherapy.|
48164153|NCT01336634|100724969|FG001|Crossover|Overall Study||0|All Treated Population who were assigned to monotherapy cohort and elected to crossover to combination treatment following disease progression on monotherapy.|
48164154|NCT01336634|100724970|FG002|Crossover|Overall Study||0|All Treated Population who were assigned to monotherapy cohort and elected to crossover to combination treatment following disease progression on monotherapy.|
48164155|NCT01336634|100724968|FG000|COMPLETED|Overall Study||70|Study ended when progression of disease had occurred in all patients in Cohorts B and C, a minimum of 70% of subjects had died in each cohort, or five years had passed since the last subject's first dose, whichever came first.|
48164156|NCT01336634|100724969|FG001|COMPLETED|Overall Study||49|Study ended when progression of disease had occurred in all patients in Cohorts B and C, a minimum of 70% of subjects had died in each cohort, or five years had passed since the last subject's first dose, whichever came first.|
48164157|NCT01336634|100724970|FG002|COMPLETED|Overall Study||27|Study ended when progression of disease had occurred in all patients in Cohorts B and C, a minimum of 70% of subjects had died in each cohort, or five years had passed since the last subject's first dose, whichever came first.|
48164158|NCT01336634|100724968|FG000|NOT COMPLETED|Overall Study||14||
48164159|NCT01336634|100724969|FG001|NOT COMPLETED|Overall Study||8||
48164160|NCT01336634|100724970|FG002|NOT COMPLETED|Overall Study||9||
48164161|NCT02736968|100724971|FG000|STARTED|Overall Study||0||
48164162|NCT02736968|100724972|FG001|STARTED|Overall Study||1||
48164163|NCT02736968|100724973|FG002|STARTED|Overall Study||17||
48164164|NCT02736968|100724974|FG003|STARTED|Overall Study||16||
48164165|NCT02736968|100724975|FG004|STARTED|Overall Study||0||
48164166|NCT02736968|100724976|FG005|STARTED|Overall Study||0||
48164167|NCT02736968|100724977|FG006|STARTED|Overall Study||30||
48164168|NCT02736968|100724978|FG007|STARTED|Overall Study||29||
48164169|NCT02736968|100724971|FG000|COMPLETED|Overall Study||0||
48164170|NCT02736968|100724972|FG001|COMPLETED|Overall Study||1||
48164171|NCT02736968|100724973|FG002|COMPLETED|Overall Study||17||
48164172|NCT02736968|100724974|FG003|COMPLETED|Overall Study||16||
48164173|NCT02736968|100724975|FG004|COMPLETED|Overall Study||0||
48164174|NCT02736968|100724976|FG005|COMPLETED|Overall Study||0||
48164175|NCT02736968|100724977|FG006|COMPLETED|Overall Study||22||
48164176|NCT02736968|100724978|FG007|COMPLETED|Overall Study||27||
48164177|NCT02736968|100724971|FG000|NOT COMPLETED|Overall Study||0||
48164178|NCT02736968|100724972|FG001|NOT COMPLETED|Overall Study||0||
48164179|NCT02736968|100724973|FG002|NOT COMPLETED|Overall Study||0||
48164180|NCT02736968|100724974|FG003|NOT COMPLETED|Overall Study||0||
48164181|NCT02736968|100724975|FG004|NOT COMPLETED|Overall Study||0||
48164182|NCT02736968|100724976|FG005|NOT COMPLETED|Overall Study||0||
48164183|NCT02736968|100724977|FG006|NOT COMPLETED|Overall Study||8||
48164184|NCT02736968|100724978|FG007|NOT COMPLETED|Overall Study||2||
48164185|NCT03148236|100724979|FG000|STARTED|Overall Study||10||
48164186|NCT03148236|100724980|FG001|STARTED|Overall Study||10||
48164187|NCT03148236|100724979|FG000|COMPLETED|Overall Study||10||
48164188|NCT03148236|100724980|FG001|COMPLETED|Overall Study||10||
48164189|NCT03148236|100724979|FG000|NOT COMPLETED|Overall Study||0||
48164190|NCT03148236|100724980|FG001|NOT COMPLETED|Overall Study||0||
48164191|NCT00584402|100724981|FG000|STARTED|Overall Study||8||
48164192|NCT00584402|100724981|FG000|COMPLETED|Overall Study||8||
48164193|NCT00584402|100724981|FG000|NOT COMPLETED|Overall Study||0||
48164194|NCT03559218|100724982|FG000|STARTED|Overall Study||12||
48164195|NCT03559218|100724983|FG001|STARTED|Overall Study||13||
48164196|NCT03559218|100724982|FG000|COMPLETED|Overall Study||11||
48164197|NCT03559218|100724983|FG001|COMPLETED|Overall Study||13||
48164198|NCT03559218|100724982|FG000|NOT COMPLETED|Overall Study||1||
48164199|NCT03559218|100724983|FG001|NOT COMPLETED|Overall Study||0||
48164200|NCT01835262|100724984|FG000|STARTED|Overall Study||45||
48164201|NCT01835262|100724985|FG001|STARTED|Overall Study||45||
48164202|NCT01835262|100724984|FG000|COMPLETED|Overall Study||45||
48164203|NCT01835262|100724985|FG001|COMPLETED|Overall Study||45||
48164204|NCT01835262|100724984|FG000|NOT COMPLETED|Overall Study||0||
48164205|NCT01835262|100724985|FG001|NOT COMPLETED|Overall Study||0||
48164206|NCT02352363|100724986|FG000|STARTED|Overall Study||278||
48164207|NCT02352363|100724987|FG001|STARTED|Overall Study||130||
48164208|NCT02352363|100724986|FG000|COMPLETED|Overall Study||271||
48164209|NCT02352363|100724987|FG001|COMPLETED|Overall Study||127||
48164210|NCT02352363|100724986|FG000|NOT COMPLETED|Overall Study||7||
48164211|NCT02352363|100724987|FG001|NOT COMPLETED|Overall Study||3||
48164212|NCT00939731|100724988|FG000|STARTED|First Intervention Period||12||
48164213|NCT00939731|100724989|FG001|STARTED|First Intervention Period||12||
48164214|NCT00939731|100724988|FG000|COMPLETED|First Intervention Period||12||
48164215|NCT00939731|100724989|FG001|COMPLETED|First Intervention Period||12||
48164216|NCT00939731|100724988|FG000|NOT COMPLETED|First Intervention Period||0||
48164217|NCT00939731|100724989|FG001|NOT COMPLETED|First Intervention Period||0||
48164218|NCT00939731|100724988|FG000|STARTED|Washout Period (at Least 14 Days)||12||
48164219|NCT00939731|100724989|FG001|STARTED|Washout Period (at Least 14 Days)||12||
48164220|NCT00939731|100724988|FG000|COMPLETED|Washout Period (at Least 14 Days)||12||
48164221|NCT00939731|100724989|FG001|COMPLETED|Washout Period (at Least 14 Days)||12||
48164222|NCT00939731|100724988|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48164223|NCT00939731|100724989|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48164224|NCT00939731|100724988|FG000|STARTED|Second Intervention Period||12||
48164225|NCT00939731|100724989|FG001|STARTED|Second Intervention Period||12||
48164226|NCT00939731|100724988|FG000|COMPLETED|Second Intervention Period||12||
48164227|NCT00939731|100724989|FG001|COMPLETED|Second Intervention Period||12||
48164228|NCT00939731|100724988|FG000|NOT COMPLETED|Second Intervention Period||0||
48164229|NCT00939731|100724989|FG001|NOT COMPLETED|Second Intervention Period||0||
48164230|NCT00094328|100724990|FG000|STARTED|Overall Study||14||
48164231|NCT00094328|100724990|FG000|COMPLETED|Overall Study||13||
48164232|NCT00094328|100724990|FG000|NOT COMPLETED|Overall Study||1||
48164233|NCT00861614|100724991|FG000|STARTED|Overall Study||393||
48164234|NCT00861614|100724992|FG001|STARTED|Overall Study||396||
48164235|NCT00861614|100724991|FG000|COMPLETED|Overall Study||22||
48164236|NCT00861614|100724992|FG001|COMPLETED|Overall Study||28||
48164237|NCT00861614|100724991|FG000|NOT COMPLETED|Overall Study||371||
48164238|NCT00861614|100724992|FG001|NOT COMPLETED|Overall Study||368||
48164239|NCT03183388|100724993|FG000|STARTED|Overall Study||30||
48164240|NCT03183388|100724994|FG001|STARTED|Overall Study||30||
48164241|NCT03183388|100724993|FG000|Completed Mid-point|Overall Study||20||
48164242|NCT03183388|100724994|FG001|Completed Mid-point|Overall Study||19||
48164243|NCT03183388|100724993|FG000|Completed Participation in Intervention and Endpoint Assessment|Overall Study||19||
48164244|NCT03183388|100724994|FG001|Completed Participation in Intervention and Endpoint Assessment|Overall Study||16||
48164245|NCT03183388|100724993|FG000|Completed All Procedures Including Endpoint Imaging|Overall Study||17||
48164246|NCT03183388|100724994|FG001|Completed All Procedures Including Endpoint Imaging|Overall Study||14||
48164247|NCT03183388|100724993|FG000|COMPLETED|Overall Study||17||
48164248|NCT03183388|100724994|FG001|COMPLETED|Overall Study||14||
48164249|NCT03183388|100724993|FG000|NOT COMPLETED|Overall Study||13||
48164250|NCT03183388|100724994|FG001|NOT COMPLETED|Overall Study||16||
48164251|NCT01350505|100724995|FG000|STARTED|Overall Study||21||
48164252|NCT01350505|100724995|FG000|COMPLETED|Overall Study||17||
48164253|NCT01350505|100724995|FG000|NOT COMPLETED|Overall Study||4||
48164254|NCT01642602|100724996|FG000|STARTED|Overall Study||104||
48164255|NCT01642602|100724996|FG000|COMPLETED|Overall Study||102||
48164256|NCT01642602|100724996|FG000|NOT COMPLETED|Overall Study||2||
48164257|NCT02914314|100724997|FG000|STARTED|Core Phase (Up to 20 Weeks)||4||
48164258|NCT02914314|100724998|FG001|STARTED|Core Phase (Up to 20 Weeks)||5||
48164259|NCT02914314|100724999|FG002|STARTED|Core Phase (Up to 20 Weeks)||9||
48164260|NCT02914314|100725000|FG003|STARTED|Core Phase (Up to 20 Weeks)||3||
48164261|NCT02914314|100724997|FG000|Participants Who Did Not Take EIAED|Core Phase (Up to 20 Weeks)||4||
48164262|NCT02914314|100724998|FG001|Participants Who Did Not Take EIAED|Core Phase (Up to 20 Weeks)||3||
48164263|NCT02914314|100724999|FG002|Participants Who Did Not Take EIAED|Core Phase (Up to 20 Weeks)||5||
48164264|NCT02914314|100725000|FG003|Participants Who Did Not Take EIAED|Core Phase (Up to 20 Weeks)||1||
48164265|NCT02914314|100724997|FG000|Participants Who Took EIAED|Core Phase (Up to 20 Weeks)||0||
48164266|NCT02914314|100724998|FG001|Participants Who Took EIAED|Core Phase (Up to 20 Weeks)||2||
48164267|NCT02914314|100724999|FG002|Participants Who Took EIAED|Core Phase (Up to 20 Weeks)||4||
48164268|NCT02914314|100725000|FG003|Participants Who Took EIAED|Core Phase (Up to 20 Weeks)||2||
48164269|NCT02914314|100724997|FG000|COMPLETED|Core Phase (Up to 20 Weeks)||4||
48164270|NCT02914314|100724998|FG001|COMPLETED|Core Phase (Up to 20 Weeks)||5||
48164271|NCT02914314|100724999|FG002|COMPLETED|Core Phase (Up to 20 Weeks)||8||
48164272|NCT02914314|100725000|FG003|COMPLETED|Core Phase (Up to 20 Weeks)||1||
48164273|NCT02914314|100724997|FG000|NOT COMPLETED|Core Phase (Up to 20 Weeks)||0||
48164274|NCT02914314|100724998|FG001|NOT COMPLETED|Core Phase (Up to 20 Weeks)||0||
48164275|NCT02914314|100724999|FG002|NOT COMPLETED|Core Phase (Up to 20 Weeks)||1||
48164276|NCT02914314|100725000|FG003|NOT COMPLETED|Core Phase (Up to 20 Weeks)||2||
48164277|NCT02914314|100724997|FG000|STARTED|Extension Phase (Up to 36 Weeks)||4||
48164278|NCT02914314|100724998|FG001|STARTED|Extension Phase (Up to 36 Weeks)||5||
48164279|NCT02914314|100724999|FG002|STARTED|Extension Phase (Up to 36 Weeks)||8||
48164280|NCT02914314|100725000|FG003|STARTED|Extension Phase (Up to 36 Weeks)||1||
48164281|NCT02914314|100724997|FG000|COMPLETED|Extension Phase (Up to 36 Weeks)||4||
48164282|NCT02914314|100724998|FG001|COMPLETED|Extension Phase (Up to 36 Weeks)||5||
48164283|NCT02914314|100724999|FG002|COMPLETED|Extension Phase (Up to 36 Weeks)||6||
48164284|NCT02914314|100725000|FG003|COMPLETED|Extension Phase (Up to 36 Weeks)||1||
48164285|NCT02914314|100724997|FG000|NOT COMPLETED|Extension Phase (Up to 36 Weeks)||0||
48164286|NCT02914314|100724998|FG001|NOT COMPLETED|Extension Phase (Up to 36 Weeks)||0||
48164287|NCT02914314|100724999|FG002|NOT COMPLETED|Extension Phase (Up to 36 Weeks)||2||
48164288|NCT02914314|100725000|FG003|NOT COMPLETED|Extension Phase (Up to 36 Weeks)||0||
48164289|NCT00003511|100725001|FG000|STARTED|Overall Study||5||
48164290|NCT00003511|100725001|FG000|COMPLETED|Overall Study||1||
48164291|NCT00003511|100725001|FG000|NOT COMPLETED|Overall Study||4||
48164292|NCT01119768|100725002|FG000|STARTED|Treatment Period||154||
48164293|NCT01119768|100725003|FG001|STARTED|Treatment Period||151||
48164294|NCT01119768|100725002|FG000|COMPLETED|Treatment Period||136||
48164295|NCT01119768|100725003|FG001|COMPLETED|Treatment Period||126||
48164296|NCT01119768|100725002|FG000|NOT COMPLETED|Treatment Period||18||
48164297|NCT01119768|100725003|FG001|NOT COMPLETED|Treatment Period||25||
48164298|NCT01119768|100725002|FG000|STARTED|Follow-up||136||
48164299|NCT01119768|100725003|FG001|STARTED|Follow-up||124||
48164300|NCT01119768|100725002|FG000|COMPLETED|Follow-up||135||
48164301|NCT01119768|100725003|FG001|COMPLETED|Follow-up||122||
48164302|NCT01119768|100725002|FG000|NOT COMPLETED|Follow-up||1||
48164303|NCT01119768|100725003|FG001|NOT COMPLETED|Follow-up||2||
48164304|NCT00171873|100725004|FG000|STARTED|Overall Study||42||
48164305|NCT00171873|100725005|FG001|STARTED|Overall Study||43||
48164306|NCT00171873|100725004|FG000|COMPLETED|Overall Study||33||
48164307|NCT00171873|100725005|FG001|COMPLETED|Overall Study||40||
48164308|NCT00171873|100725004|FG000|NOT COMPLETED|Overall Study||9||
48164309|NCT00171873|100725005|FG001|NOT COMPLETED|Overall Study||3||
48164310|NCT01316770|100725006|FG000|STARTED|Overall Study||9||9
48164311|NCT01316770|100725007|FG001|STARTED|Overall Study||9||9
48164312|NCT01316770|100725006|FG000|COMPLETED|Overall Study||9||9
48164313|NCT01316770|100725007|FG001|COMPLETED|Overall Study||9||9
48164314|NCT01316770|100725006|FG000|NOT COMPLETED|Overall Study||0||0
48164315|NCT01316770|100725007|FG001|NOT COMPLETED|Overall Study||0||0
48164316|NCT00880425|100725008|FG000|STARTED|Overall Study||18||
48164317|NCT00880425|100725009|FG001|STARTED|Overall Study||27||
48164318|NCT00880425|100725008|FG000|COMPLETED|Overall Study||18||
48164319|NCT00880425|100725009|FG001|COMPLETED|Overall Study||27||
48164320|NCT00880425|100725008|FG000|NOT COMPLETED|Overall Study||0||
48164321|NCT00880425|100725009|FG001|NOT COMPLETED|Overall Study||0||
48164322|NCT02496767|100725010|FG000|STARTED|Open-label Lead-in Phase||744||
48164323|NCT02496767|100725011|FG001|STARTED|Open-label Lead-in Phase||0||
48164324|NCT02496767|100725012|FG002|STARTED|Open-label Lead-in Phase||0||
48164325|NCT02496767|100725013|FG003|STARTED|Open-label Lead-in Phase||0||
48164326|NCT02496767|100725014|FG004|STARTED|Open-label Lead-in Phase||0||
48164327|NCT02496767|100725015|FG005|STARTED|Open-label Lead-in Phase||0||
48164328|NCT02496767|100725016|FG006|STARTED|Open-label Lead-in Phase||0||
48164329|NCT02496767|100725017|FG007|STARTED|Open-label Lead-in Phase||0||
48164330|NCT02496767|100725010|FG000|COMPLETED|Open-label Lead-in Phase||565||
48164331|NCT02496767|100725011|FG001|COMPLETED|Open-label Lead-in Phase||0||
48164332|NCT02496767|100725012|FG002|COMPLETED|Open-label Lead-in Phase||0||
48164333|NCT02496767|100725013|FG003|COMPLETED|Open-label Lead-in Phase||0||
48164334|NCT02496767|100725014|FG004|COMPLETED|Open-label Lead-in Phase||0||
48164335|NCT02496767|100725015|FG005|COMPLETED|Open-label Lead-in Phase||0||
48164336|NCT02496767|100725016|FG006|COMPLETED|Open-label Lead-in Phase||0||
48164337|NCT02496767|100725017|FG007|COMPLETED|Open-label Lead-in Phase||0||
48164338|NCT02496767|100725010|FG000|NOT COMPLETED|Open-label Lead-in Phase||179||
48164339|NCT02496767|100725011|FG001|NOT COMPLETED|Open-label Lead-in Phase||0||
48164340|NCT02496767|100725012|FG002|NOT COMPLETED|Open-label Lead-in Phase||0||
48164341|NCT02496767|100725013|FG003|NOT COMPLETED|Open-label Lead-in Phase||0||
48164342|NCT02496767|100725014|FG004|NOT COMPLETED|Open-label Lead-in Phase||0||
48164343|NCT02496767|100725015|FG005|NOT COMPLETED|Open-label Lead-in Phase||0||
48164344|NCT02496767|100725016|FG006|NOT COMPLETED|Open-label Lead-in Phase||0||
48164345|NCT02496767|100725017|FG007|NOT COMPLETED|Open-label Lead-in Phase||0||
48164346|NCT02496767|100725010|FG000|STARTED|Double-blind, Placebo-controlled Phase||0||
48164347|NCT02496767|100725011|FG001|STARTED|Double-blind, Placebo-controlled Phase||188||
48164348|NCT02496767|100725012|FG002|STARTED|Double-blind, Placebo-controlled Phase||126||
48164349|NCT02496767|100725013|FG003|STARTED|Double-blind, Placebo-controlled Phase||126||
48164350|NCT02496767|100725014|FG004|STARTED|Double-blind, Placebo-controlled Phase||125||
48164351|NCT02496767|100725015|FG005|STARTED|Double-blind, Placebo-controlled Phase||0||
48164352|NCT02496767|100725016|FG006|STARTED|Double-blind, Placebo-controlled Phase||0||
48164353|NCT02496767|100725017|FG007|STARTED|Double-blind, Placebo-controlled Phase||0||
48164354|NCT02496767|100725010|FG000|COMPLETED|Double-blind, Placebo-controlled Phase||0||
48164355|NCT02496767|100725011|FG001|COMPLETED|Double-blind, Placebo-controlled Phase||132||
48164356|NCT02496767|100725012|FG002|COMPLETED|Double-blind, Placebo-controlled Phase||80||
48164357|NCT02496767|100725013|FG003|COMPLETED|Double-blind, Placebo-controlled Phase||65||
48164358|NCT02496767|100725014|FG004|COMPLETED|Double-blind, Placebo-controlled Phase||59||
48164359|NCT02496767|100725015|FG005|COMPLETED|Double-blind, Placebo-controlled Phase||0||
48164360|NCT02496767|100725016|FG006|COMPLETED|Double-blind, Placebo-controlled Phase||0||
48164361|NCT02496767|100725017|FG007|COMPLETED|Double-blind, Placebo-controlled Phase||0||
48164362|NCT02496767|100725010|FG000|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0||
48164363|NCT02496767|100725011|FG001|NOT COMPLETED|Double-blind, Placebo-controlled Phase||56||
48164364|NCT02496767|100725012|FG002|NOT COMPLETED|Double-blind, Placebo-controlled Phase||46||
48164365|NCT02496767|100725013|FG003|NOT COMPLETED|Double-blind, Placebo-controlled Phase||61||
48164366|NCT02496767|100725014|FG004|NOT COMPLETED|Double-blind, Placebo-controlled Phase||66||
48164367|NCT02496767|100725015|FG005|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0||
48164368|NCT02496767|100725016|FG006|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0||
48164369|NCT02496767|100725017|FG007|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0||
48164370|NCT02496767|100725010|FG000|STARTED|Double-blind, Withdrawal Phase||0||
48164371|NCT02496767|100725011|FG001|STARTED|Double-blind, Withdrawal Phase||0||
48164372|NCT02496767|100725012|FG002|STARTED|Double-blind, Withdrawal Phase||0||
48164373|NCT02496767|100725013|FG003|STARTED|Double-blind, Withdrawal Phase||0||
48164374|NCT02496767|100725014|FG004|STARTED|Double-blind, Withdrawal Phase||0||
48164375|NCT02496767|100725015|FG005|STARTED|Double-blind, Withdrawal Phase||132||
48164376|NCT02496767|100725016|FG006|STARTED|Double-blind, Withdrawal Phase||103||
48164377|NCT02496767|100725017|FG007|STARTED|Double-blind, Withdrawal Phase||101||
48164378|NCT02496767|100725010|FG000|COMPLETED|Double-blind, Withdrawal Phase||0||
48164379|NCT02496767|100725011|FG001|COMPLETED|Double-blind, Withdrawal Phase||0||
48164380|NCT02496767|100725012|FG002|COMPLETED|Double-blind, Withdrawal Phase||0||
48164381|NCT02496767|100725013|FG003|COMPLETED|Double-blind, Withdrawal Phase||0||
48164382|NCT02496767|100725014|FG004|COMPLETED|Double-blind, Withdrawal Phase||0||
48164383|NCT02496767|100725015|FG005|COMPLETED|Double-blind, Withdrawal Phase||126||
48164384|NCT02496767|100725016|FG006|COMPLETED|Double-blind, Withdrawal Phase||99||
48164385|NCT02496767|100725017|FG007|COMPLETED|Double-blind, Withdrawal Phase||96||
48164386|NCT02496767|100725010|FG000|NOT COMPLETED|Double-blind, Withdrawal Phase||0||
48164387|NCT02496767|100725011|FG001|NOT COMPLETED|Double-blind, Withdrawal Phase||0||
48164388|NCT02496767|100725012|FG002|NOT COMPLETED|Double-blind, Withdrawal Phase||0||
48164389|NCT02496767|100725013|FG003|NOT COMPLETED|Double-blind, Withdrawal Phase||0||
48164390|NCT02496767|100725014|FG004|NOT COMPLETED|Double-blind, Withdrawal Phase||0||
48164391|NCT02496767|100725015|FG005|NOT COMPLETED|Double-blind, Withdrawal Phase||6||
48164392|NCT02496767|100725016|FG006|NOT COMPLETED|Double-blind, Withdrawal Phase||4||
48164393|NCT02496767|100725017|FG007|NOT COMPLETED|Double-blind, Withdrawal Phase||5||
48164394|NCT03155932|100725018|FG000|STARTED|Overall Study||2||
48326945|NCT03548558|101124779|FG006|NOT COMPLETED|Phase 2: Booster Sessions Every 2 Months||65||0
48326946|NCT03193398|101128228|FG000|STARTED|Overall Study||53||
48326947|NCT03193398|101128229|FG001|STARTED|Overall Study||51||
48326948|NCT03193398|101128228|FG000|COMPLETED|Overall Study||38||
48326949|NCT03193398|101128229|FG001|COMPLETED|Overall Study||35||
48326950|NCT03193398|101128228|FG000|NOT COMPLETED|Overall Study||15||
48326951|NCT03193398|101128229|FG001|NOT COMPLETED|Overall Study||16||
48326952|NCT00630955|101128230|FG000|STARTED|Overall Study||34||
48326953|NCT00630955|101128231|FG001|STARTED|Overall Study||37||
48326954|NCT00630955|101128232|FG002|STARTED|Overall Study||40||
48326955|NCT00630955|101128230|FG000|COMPLETED|Overall Study||31||
48326956|NCT00630955|101128231|FG001|COMPLETED|Overall Study||31||
48620816|NCT03286218|101856420|FG006|NOT COMPLETED|Treatment Phase Period 5||0||
48620817|NCT03286218|101856421|FG007|NOT COMPLETED|Treatment Phase Period 5||0||
48620818|NCT03286218|101856422|FG008|NOT COMPLETED|Treatment Phase Period 5||0||
48620819|NCT03286218|101856423|FG009|NOT COMPLETED|Treatment Phase Period 5||0||
48620820|NCT03286218|101856424|FG010|NOT COMPLETED|Treatment Phase Period 5||0||
48164395|NCT03155932|100725018|FG000|Participants Escalated to 2 mg Dose of APD334 at Week 12 to Week 24|Overall Study||2||
48326957|NCT00630955|101128232|FG002|COMPLETED|Overall Study||28||
48326958|NCT00630955|101128230|FG000|NOT COMPLETED|Overall Study||3||
48326959|NCT00630955|101128231|FG001|NOT COMPLETED|Overall Study||6||
48620821|NCT03286218|101856425|FG011|NOT COMPLETED|Treatment Phase Period 5||0||
48620822|NCT00433550|101856426|FG000|STARTED|Overall Study||17||
48620823|NCT00433550|101856427|FG001|STARTED|Overall Study||10||
48620824|NCT00433550|101856428|FG002|STARTED|Overall Study||6||
48164396|NCT03155932|100725018|FG000|COMPLETED|Overall Study||2||
48164397|NCT03155932|100725018|FG000|NOT COMPLETED|Overall Study||0||
48164398|NCT02357290|100725019|FG000|STARTED|Overall Study||40||
48164399|NCT02357290|100725019|FG000|Exposed|Overall Study||26||
48164400|NCT02357290|100725019|FG000|COMPLETED|Overall Study||14||
48164401|NCT02357290|100725019|FG000|NOT COMPLETED|Overall Study||26||
48164402|NCT02648971|100725020|FG000|STARTED|Overall Study||18||
48164403|NCT02648971|100725021|FG001|STARTED|Overall Study||18||
48743779|NCT00592124|102158098|FG002|COMPLETED|Overall Study||24||
48743780|NCT00592124|102158099|FG003|COMPLETED|Overall Study||24||
48743781|NCT00592124|102158100|FG004|COMPLETED|Overall Study||24||
48743782|NCT00592124|102158101|FG005|COMPLETED|Overall Study||24||
48743783|NCT00592124|102158096|FG000|NOT COMPLETED|Overall Study||4||
48743784|NCT00592124|102158097|FG001|NOT COMPLETED|Overall Study||5||
48743785|NCT00592124|102158098|FG002|NOT COMPLETED|Overall Study||6||
48743786|NCT00592124|102158099|FG003|NOT COMPLETED|Overall Study||3||
48743787|NCT00592124|102158100|FG004|NOT COMPLETED|Overall Study||3||
48743788|NCT00592124|102158101|FG005|NOT COMPLETED|Overall Study||3||
48743789|NCT05315479|102158102|FG000|STARTED|Overall Study||19||
48743790|NCT05315479|102158102|FG000|COMPLETED|Overall Study||19||
48743791|NCT05315479|102158102|FG000|NOT COMPLETED|Overall Study||0||
48743792|NCT02727907|102158103|FG000|STARTED|Overall Study||53||
48743793|NCT02727907|102158104|FG001|STARTED|Overall Study||56||
48743794|NCT02727907|102158105|FG002|STARTED|Overall Study||54||
48164404|NCT02648971|100725020|FG000|COMPLETED|Overall Study||18||
48164405|NCT02648971|100725021|FG001|COMPLETED|Overall Study||18||
48164406|NCT02648971|100725020|FG000|NOT COMPLETED|Overall Study||0||
48164407|NCT02648971|100725021|FG001|NOT COMPLETED|Overall Study||0||
48743795|NCT02727907|102158103|FG000|Recived One Injection of Drug|Overall Study||53||
48743796|NCT02727907|102158104|FG001|Recived One Injection of Drug|Overall Study||55||
48743797|NCT02727907|102158105|FG002|Recived One Injection of Drug|Overall Study||54||
48743798|NCT02727907|102158103|FG000|COMPLETED|Overall Study||40||
48743799|NCT02727907|102158104|FG001|COMPLETED|Overall Study||43||
48743800|NCT02727907|102158105|FG002|COMPLETED|Overall Study||43||
48164408|NCT01774071|100725022|FG000|STARTED|Overall Study||19||
48164409|NCT01774071|100725023|FG001|STARTED|Overall Study||0||
48164410|NCT01774071|100725022|FG000|COMPLETED|Overall Study||19||
48164411|NCT01774071|100725023|FG001|COMPLETED|Overall Study||0||
48164412|NCT01774071|100725022|FG000|NOT COMPLETED|Overall Study||0||
48743801|NCT02727907|102158103|FG000|NOT COMPLETED|Overall Study||13||
48743802|NCT02727907|102158104|FG001|NOT COMPLETED|Overall Study||13||
48743803|NCT02727907|102158105|FG002|NOT COMPLETED|Overall Study||11||
48164413|NCT01774071|100725023|FG001|NOT COMPLETED|Overall Study||0||
48164414|NCT01338012|100725024|FG000|STARTED|Overall Study||8||
48164415|NCT01338012|100725024|FG000|COMPLETED|Overall Study||0||
48164416|NCT01338012|100725024|FG000|NOT COMPLETED|Overall Study||8||
48164417|NCT01862796|100725025|FG000|STARTED|Overall Study||19||
48164418|NCT01862796|100725026|FG001|STARTED|Overall Study||18||
48164419|NCT01862796|100725027|FG002|STARTED|Overall Study||24||
48164420|NCT01862796|100725025|FG000|COMPLETED|Overall Study||19||
48164421|NCT01862796|100725026|FG001|COMPLETED|Overall Study||18||
48164422|NCT01862796|100725027|FG002|COMPLETED|Overall Study||23||
48164423|NCT01862796|100725025|FG000|NOT COMPLETED|Overall Study||0||
48164424|NCT01862796|100725026|FG001|NOT COMPLETED|Overall Study||0||
48164425|NCT01862796|100725027|FG002|NOT COMPLETED|Overall Study||1||
48164426|NCT04599101|100725028|FG000|STARTED|Overall Study||12||
48164427|NCT04599101|100725029|FG001|STARTED|Overall Study||9||
48164428|NCT04599101|100725028|FG000|COMPLETED|Overall Study||7||
48164429|NCT04599101|100725029|FG001|COMPLETED|Overall Study||4||
48164430|NCT04599101|100725028|FG000|NOT COMPLETED|Overall Study||5||
48164431|NCT04599101|100725029|FG001|NOT COMPLETED|Overall Study||5||
48164432|NCT04399356|100725030|FG000|STARTED|Overall Study||36||
48164433|NCT04399356|100725031|FG001|STARTED|Overall Study||37||
48164434|NCT04399356|100725030|FG000|COMPLETED|Overall Study||33||
48164435|NCT04399356|100725031|FG001|COMPLETED|Overall Study||34||
48164436|NCT04399356|100725030|FG000|NOT COMPLETED|Overall Study||3||
48164437|NCT04399356|100725031|FG001|NOT COMPLETED|Overall Study||3||
48164438|NCT01872910|100725032|FG000|STARTED|Overall Study||30||
48164439|NCT01872910|100725033|FG001|STARTED|Overall Study||31||
48164440|NCT01872910|100725034|FG002|STARTED|Overall Study||30||
48164441|NCT01872910|100725035|FG003|STARTED|Overall Study||15||
48164442|NCT01872910|100725036|FG004|STARTED|Overall Study||15||
48164443|NCT01872910|100725037|FG005|STARTED|Overall Study||3||
48164444|NCT01872910|100725032|FG000|Received Any Study Drug|Overall Study||30||
48164445|NCT01872910|100725033|FG001|Received Any Study Drug|Overall Study||31||
48164446|NCT01872910|100725034|FG002|Received Any Study Drug|Overall Study||30||
48164447|NCT01872910|100725035|FG003|Received Any Study Drug|Overall Study||15||
48164448|NCT01872910|100725036|FG004|Received Any Study Drug|Overall Study||15||
48743804|NCT01597635|102158106|FG000|STARTED|Part A||5||
48743805|NCT01597635|102158107|FG001|STARTED|Part A||0||
48743806|NCT01597635|102158108|FG002|STARTED|Part A||0||
48743807|NCT01597635|102158106|FG000|COMPLETED|Part A||2||
48743808|NCT01597635|102158107|FG001|COMPLETED|Part A||0||
48743809|NCT01597635|102158108|FG002|COMPLETED|Part A||0||
48164449|NCT01872910|100725037|FG005|Received Any Study Drug|Overall Study||3||
48164450|NCT01872910|100725032|FG000|COMPLETED|Overall Study||28||
48164451|NCT01872910|100725033|FG001|COMPLETED|Overall Study||31||
48164452|NCT01872910|100725034|FG002|COMPLETED|Overall Study||28||
48164453|NCT01872910|100725035|FG003|COMPLETED|Overall Study||15||
48164454|NCT01872910|100725036|FG004|COMPLETED|Overall Study||15||
48164455|NCT01872910|100725037|FG005|COMPLETED|Overall Study||3||
48164456|NCT01872910|100725032|FG000|NOT COMPLETED|Overall Study||2||
48164457|NCT01872910|100725033|FG001|NOT COMPLETED|Overall Study||0||
48164458|NCT01872910|100725034|FG002|NOT COMPLETED|Overall Study||2||
48164459|NCT01872910|100725035|FG003|NOT COMPLETED|Overall Study||0||
48164460|NCT01872910|100725036|FG004|NOT COMPLETED|Overall Study||0||
48164461|NCT01872910|100725037|FG005|NOT COMPLETED|Overall Study||0||
48164462|NCT00920023|100725038|FG000|STARTED|Overall Study||15||
48164463|NCT00920023|100725038|FG000|COMPLETED|Overall Study||15||
48164464|NCT00920023|100725038|FG000|NOT COMPLETED|Overall Study||0||
48164465|NCT01054573|100725039|FG000|STARTED|Overall Study||9||
48164466|NCT01054573|100725040|FG001|STARTED|Overall Study||32||
48164467|NCT01054573|100725041|FG002|STARTED|Overall Study||22||
48164468|NCT01054573|100725042|FG003|STARTED|Overall Study||27||
48164469|NCT01054573|100725039|FG000|COMPLETED|Overall Study||8||
48164470|NCT01054573|100725040|FG001|COMPLETED|Overall Study||28||
48164471|NCT01054573|100725041|FG002|COMPLETED|Overall Study||19||
48164472|NCT01054573|100725042|FG003|COMPLETED|Overall Study||25||
48164473|NCT01054573|100725039|FG000|NOT COMPLETED|Overall Study||1||
48164474|NCT01054573|100725040|FG001|NOT COMPLETED|Overall Study||4||
48164475|NCT01054573|100725041|FG002|NOT COMPLETED|Overall Study||3||
48164476|NCT01054573|100725042|FG003|NOT COMPLETED|Overall Study||2||
48620825|NCT00433550|101856426|FG000|COMPLETED|Overall Study||17||
48620826|NCT00433550|101856427|FG001|COMPLETED|Overall Study||10||
48164477|NCT02567825|100725043|FG000|STARTED|Overall Study||129||
48164478|NCT02567825|100725044|FG001|STARTED|Overall Study||121||
48620827|NCT00433550|101856428|FG002|COMPLETED|Overall Study||6||
48620828|NCT00433550|101856426|FG000|NOT COMPLETED|Overall Study||0||
48620829|NCT00433550|101856427|FG001|NOT COMPLETED|Overall Study||0||
48164479|NCT02567825|100725043|FG000|COMPLETED|Overall Study||108||
48164480|NCT02567825|100725044|FG001|COMPLETED|Overall Study||100||
48164481|NCT02567825|100725043|FG000|NOT COMPLETED|Overall Study||21||
48164482|NCT02567825|100725044|FG001|NOT COMPLETED|Overall Study||21||
48164483|NCT01536184|100725045|FG000|STARTED|Overall Study||8||
48164484|NCT01536184|100725046|FG001|STARTED|Overall Study||4||
48164485|NCT01536184|100725045|FG000|COMPLETED|Overall Study||8||
48164486|NCT01536184|100725046|FG001|COMPLETED|Overall Study||4||
48164487|NCT01536184|100725045|FG000|NOT COMPLETED|Overall Study||0||
48164488|NCT01536184|100725046|FG001|NOT COMPLETED|Overall Study||0||
48164489|NCT02444663|100725047|FG000|STARTED|Clinician Valgus||9||
48164490|NCT02444663|100725047|FG000|COMPLETED|Clinician Valgus||9||
48164491|NCT02444663|100725047|FG000|NOT COMPLETED|Clinician Valgus||0||
48164492|NCT02444663|100725047|FG000|STARTED|Clinician Varus||9||
48164493|NCT02444663|100725047|FG000|COMPLETED|Clinician Varus||9||
48164494|NCT02444663|100725047|FG000|NOT COMPLETED|Clinician Varus||0||
48164495|NCT02444663|100725047|FG000|STARTED|Device Valgus 0N||9||
48164496|NCT02444663|100725047|FG000|COMPLETED|Device Valgus 0N||9||
48164497|NCT02444663|100725047|FG000|NOT COMPLETED|Device Valgus 0N||0||
48164498|NCT02444663|100725047|FG000|STARTED|Device Valgus 10N||9||
48164499|NCT02444663|100725047|FG000|COMPLETED|Device Valgus 10N||9||
48620830|NCT00433550|101856428|FG002|NOT COMPLETED|Overall Study||0||
48164500|NCT02444663|100725047|FG000|NOT COMPLETED|Device Valgus 10N||0||
48164501|NCT02444663|100725047|FG000|STARTED|Device Valgus 20N||9||
48164502|NCT02444663|100725047|FG000|COMPLETED|Device Valgus 20N||9||
48164503|NCT02444663|100725047|FG000|NOT COMPLETED|Device Valgus 20N||0||
48164504|NCT02444663|100725047|FG000|STARTED|Device Valgus 30N||9||
48164505|NCT02444663|100725047|FG000|COMPLETED|Device Valgus 30N||9||
48164506|NCT02444663|100725047|FG000|NOT COMPLETED|Device Valgus 30N||0||
48620831|NCT04534517|101856429|FG000|STARTED|Overall Study||114||
48164507|NCT02444663|100725047|FG000|STARTED|Device Varus 0N||9||
48164508|NCT02444663|100725047|FG000|COMPLETED|Device Varus 0N||9||
48164509|NCT02444663|100725047|FG000|NOT COMPLETED|Device Varus 0N||0||
48164510|NCT02444663|100725047|FG000|STARTED|Device Varus 10N||9||
48164511|NCT02444663|100725047|FG000|COMPLETED|Device Varus 10N||9||
48164512|NCT02444663|100725047|FG000|NOT COMPLETED|Device Varus 10N||0||
48164513|NCT02444663|100725047|FG000|STARTED|Device Varus 20N||9||
48164514|NCT02444663|100725047|FG000|COMPLETED|Device Varus 20N||9||
48164515|NCT02444663|100725047|FG000|NOT COMPLETED|Device Varus 20N||0||
48164516|NCT02444663|100725047|FG000|STARTED|Device Varus 30N||9||
48164517|NCT02444663|100725047|FG000|COMPLETED|Device Varus 30N||9||
48164518|NCT02444663|100725047|FG000|NOT COMPLETED|Device Varus 30N||0||
48164519|NCT03176238|100725048|FG000|STARTED|Overall Study||199||
48164520|NCT03176238|100725049|FG001|STARTED|Overall Study||36||
48164521|NCT03176238|100725048|FG000|COMPLETED|Overall Study||0||
48164522|NCT03176238|100725049|FG001|COMPLETED|Overall Study||0||
48164523|NCT03176238|100725048|FG000|NOT COMPLETED|Overall Study||199||
48164524|NCT03176238|100725049|FG001|NOT COMPLETED|Overall Study||36||
48164525|NCT04616014|100725050|FG000|STARTED|Overall Study||7||
48164526|NCT04616014|100725050|FG000|COMPLETED|Overall Study||7||
48164527|NCT04616014|100725050|FG000|NOT COMPLETED|Overall Study||0||
48164528|NCT03673462|100725051|FG000|STARTED|Overall Study||2099||
48164529|NCT03673462|100725052|FG001|STARTED|Overall Study||698||
48164530|NCT03673462|100725051|FG000|Safety Analysis Set (SafAS)|Overall Study||2080|Safety Analysis Set (SafAS) included all participants who had received at least one dose of the study vaccines and had any safety data available.|
48164531|NCT03673462|100725052|FG001|Safety Analysis Set (SafAS)|Overall Study||697|Safety Analysis Set (SafAS) included all participants who had received at least one dose of the study vaccines and had any safety data available.|
48164532|NCT03673462|100725051|FG000|Vaccinated at 2 Months|Overall Study||2080||
48164533|NCT03673462|100725052|FG001|Vaccinated at 2 Months|Overall Study||695||
48164534|NCT03673462|100725051|FG000|Vaccinated at 4 Months|Overall Study||2005||
48164535|NCT03673462|100725052|FG001|Vaccinated at 4 Months|Overall Study||663||
48164536|NCT03673462|100725051|FG000|Vaccinated at 6 Months|Overall Study||1951||
48164537|NCT03673462|100725052|FG001|Vaccinated at 6 Months|Overall Study||648||
48164538|NCT03673462|100725051|FG000|Vaccinated at 12 Months|Overall Study||1838||
48164539|NCT03673462|100725052|FG001|Vaccinated at 12 Months|Overall Study||623||
48164540|NCT03673462|100725051|FG000|COMPLETED|Overall Study||1799||
48164541|NCT03673462|100725052|FG001|COMPLETED|Overall Study||611||
48164542|NCT03673462|100725051|FG000|NOT COMPLETED|Overall Study||300||
48164543|NCT03673462|100725052|FG001|NOT COMPLETED|Overall Study||87||
48164544|NCT01600222|100725053|FG000|STARTED|Overall Study||37||
48164545|NCT01600222|100725053|FG000|COMPLETED|Overall Study||35||
48164546|NCT01600222|100725053|FG000|NOT COMPLETED|Overall Study||2||
48164547|NCT02759185|100725054|FG000|STARTED|Stage 1||20||
48164548|NCT02759185|100725055|FG001|STARTED|Stage 1||20||
48164549|NCT02759185|100725056|FG002|STARTED|Stage 1||20||
48164550|NCT02759185|100725057|FG003|STARTED|Stage 1||20||
48164551|NCT02759185|100725058|FG004|STARTED|Stage 1||0||
48164552|NCT02759185|100725059|FG005|STARTED|Stage 1||0||
48164553|NCT02759185|100725060|FG006|STARTED|Stage 1||0||
48164554|NCT02759185|100725054|FG000|COMPLETED|Stage 1||19||
48164555|NCT02759185|100725055|FG001|COMPLETED|Stage 1||19||
48164556|NCT02759185|100725056|FG002|COMPLETED|Stage 1||17||
48164557|NCT02759185|100725057|FG003|COMPLETED|Stage 1||20||
48164558|NCT02759185|100725058|FG004|COMPLETED|Stage 1||0||
48164559|NCT02759185|100725059|FG005|COMPLETED|Stage 1||0||
48164560|NCT02759185|100725060|FG006|COMPLETED|Stage 1||0||
48164561|NCT02759185|100725054|FG000|NOT COMPLETED|Stage 1||1||
48164562|NCT02759185|100725055|FG001|NOT COMPLETED|Stage 1||1||
48164563|NCT02759185|100725056|FG002|NOT COMPLETED|Stage 1||3||
48164564|NCT02759185|100725057|FG003|NOT COMPLETED|Stage 1||0||
48164565|NCT02759185|100725058|FG004|NOT COMPLETED|Stage 1||0||
48164566|NCT02759185|100725059|FG005|NOT COMPLETED|Stage 1||0||
48164567|NCT02759185|100725060|FG006|NOT COMPLETED|Stage 1||0||
48164568|NCT02759185|100725054|FG000|STARTED|Stage 2||0||
48164569|NCT02759185|100725055|FG001|STARTED|Stage 2||0||
48164570|NCT02759185|100725056|FG002|STARTED|Stage 2||0||
48164571|NCT02759185|100725057|FG003|STARTED|Stage 2||0||
48164572|NCT02759185|100725058|FG004|STARTED|Stage 2||29||
48164573|NCT02759185|100725059|FG005|STARTED|Stage 2||27||
48164574|NCT02759185|100725060|FG006|STARTED|Stage 2||18||
48164575|NCT02759185|100725054|FG000|COMPLETED|Stage 2||0||
48164576|NCT02759185|100725055|FG001|COMPLETED|Stage 2||0||
48164577|NCT02759185|100725056|FG002|COMPLETED|Stage 2||0||
48164578|NCT02759185|100725057|FG003|COMPLETED|Stage 2||0||
48164579|NCT02759185|100725058|FG004|COMPLETED|Stage 2||27||
48164580|NCT02759185|100725059|FG005|COMPLETED|Stage 2||24||
48164581|NCT02759185|100725060|FG006|COMPLETED|Stage 2||17||
48164582|NCT02759185|100725054|FG000|NOT COMPLETED|Stage 2||0||
48164583|NCT02759185|100725055|FG001|NOT COMPLETED|Stage 2||0||
48164584|NCT02759185|100725056|FG002|NOT COMPLETED|Stage 2||0||
48164585|NCT02759185|100725057|FG003|NOT COMPLETED|Stage 2||0||
48164586|NCT02759185|100725058|FG004|NOT COMPLETED|Stage 2||2||
48164587|NCT02759185|100725059|FG005|NOT COMPLETED|Stage 2||3||
48164588|NCT02759185|100725060|FG006|NOT COMPLETED|Stage 2||1||
48164589|NCT00949884|100725061|FG000|STARTED|Overall Study||420||
48164590|NCT00949884|100725062|FG001|STARTED|Overall Study||52||
48164591|NCT00949884|100725063|FG002|STARTED|Overall Study||469||
48164592|NCT00949884|100725061|FG000|COMPLETED|Overall Study||370||
48164593|NCT00949884|100725062|FG001|COMPLETED|Overall Study||37||
48164594|NCT00949884|100725063|FG002|COMPLETED|Overall Study||411||
48164595|NCT00949884|100725061|FG000|NOT COMPLETED|Overall Study||50||
48164596|NCT00949884|100725062|FG001|NOT COMPLETED|Overall Study||15||
48164597|NCT00949884|100725063|FG002|NOT COMPLETED|Overall Study||58||
48164598|NCT03821337|100725064|FG000|STARTED|Overall Study||1||
48164599|NCT03821337|100725065|FG001|STARTED|Overall Study||0||
48164600|NCT03821337|100725064|FG000|COMPLETED|Overall Study||1||
48164601|NCT03821337|100725065|FG001|COMPLETED|Overall Study||0||
48164602|NCT03821337|100725064|FG000|NOT COMPLETED|Overall Study||0||
48164603|NCT03821337|100725065|FG001|NOT COMPLETED|Overall Study||0||
48164604|NCT00113360|100725066|FG000|STARTED|Overall Study||67||
48164605|NCT00113360|100725066|FG000|COMPLETED|Overall Study||60||
48164606|NCT00113360|100725066|FG000|NOT COMPLETED|Overall Study||7||
48164607|NCT01857622|100725067|FG000|STARTED|Overall Study||50||
48164608|NCT01857622|100725068|FG001|STARTED|Overall Study||22||
48164609|NCT01857622|100725069|FG002|STARTED|Overall Study||21||
48164610|NCT01857622|100725067|FG000|COMPLETED|Overall Study||39||
48164611|NCT01857622|100725068|FG001|COMPLETED|Overall Study||21||
48164612|NCT01857622|100725069|FG002|COMPLETED|Overall Study||19||
48164613|NCT01857622|100725067|FG000|NOT COMPLETED|Overall Study||11||
48164614|NCT01857622|100725068|FG001|NOT COMPLETED|Overall Study||1||
48164615|NCT01857622|100725069|FG002|NOT COMPLETED|Overall Study||2||
48164616|NCT01272960|100725070|FG000|STARTED|Overall Study||14||
48164617|NCT01272960|100725071|FG001|STARTED|Overall Study||15||
48164618|NCT01272960|100725070|FG000|COMPLETED|Overall Study||14||
48164619|NCT01272960|100725071|FG001|COMPLETED|Overall Study||15||
48164620|NCT01272960|100725070|FG000|NOT COMPLETED|Overall Study||0||
48164621|NCT01272960|100725071|FG001|NOT COMPLETED|Overall Study||0||
48164622|NCT02306122|100725072|FG000|STARTED|Initial Physician Randomization||0|Patent participants are not included in this period.|
48164623|NCT02306122|100725073|FG001|STARTED|Initial Physician Randomization||0|Patent participants are not included in this period.|
48164624|NCT02306122|100725074|FG002|STARTED|Initial Physician Randomization||0|Patent participants are not included in this period.|
48164625|NCT02306122|100725075|FG003|STARTED|Initial Physician Randomization||0|Patent participants are not included in this period.|
48164626|NCT02306122|100725076|FG004|STARTED|Initial Physician Randomization||0|Patent participants are not included in this period.|
48164627|NCT02306122|100725077|FG005|STARTED|Initial Physician Randomization||0|Patent participants are not included in this period.|
48164628|NCT02306122|100725078|FG006|STARTED|Initial Physician Randomization||0|Patent participants are not included in this period.|
48326960|NCT00630955|101128232|FG002|NOT COMPLETED|Overall Study||12||
48326961|NCT02556255|101128233|FG000|STARTED|Overall Study||50||
48326962|NCT02556255|101128233|FG000|COMPLETED|Overall Study||46||
48326963|NCT02556255|101128233|FG000|NOT COMPLETED|Overall Study||4||
48326964|NCT03955133|101128234|FG000|STARTED|Overall Study||19|participants recruited|3
48326965|NCT03955133|101128234|FG000|COMPLETED|Overall Study||19|All care homes that started the intervention completed the study. However, numbers of care homes and participants fell far short of planned.|3
48326966|NCT03955133|101128234|FG000|NOT COMPLETED|Overall Study||0||0
48326967|NCT01340209|101128235|FG000|STARTED|Overall Study||57||
48326968|NCT01340209|101128236|FG001|STARTED|Overall Study||114||
48326969|NCT01340209|101128237|FG002|STARTED|Overall Study||114||
48326970|NCT01340209|101128235|FG000|COMPLETED|Overall Study||52||
48326971|NCT01340209|101128236|FG001|COMPLETED|Overall Study||106||
48326972|NCT01340209|101128237|FG002|COMPLETED|Overall Study||106||
48409609|NCT00976963|101334748|FG000|Treated With Assigned Intervention|Overall Study||146||
48620832|NCT04534517|101856429|FG000|COMPLETED|Overall Study||110||
48620833|NCT04534517|101856429|FG000|NOT COMPLETED|Overall Study||4||
48620834|NCT02948829|101856430|FG000|STARTED|Overall Study||200||
48164629|NCT02306122|100725079|FG007|STARTED|Initial Physician Randomization||0|Patent participants are not included in this period.|
48164630|NCT02306122|100725080|FG008|STARTED|Initial Physician Randomization||29|Patent participants are not included in this period.|
48164631|NCT02306122|100725081|FG009|STARTED|Initial Physician Randomization||31|Patent participants are not included in this period.|
48164632|NCT02306122|100725082|FG010|STARTED|Initial Physician Randomization||31|Patent participants are not included in this period.|
48164633|NCT02306122|100725072|FG000|COMPLETED|Initial Physician Randomization||0|Patient participants are not included in this period.|
48164634|NCT02306122|100725073|FG001|COMPLETED|Initial Physician Randomization||0|Patient participants are not included in this period.|
48164635|NCT02306122|100725074|FG002|COMPLETED|Initial Physician Randomization||0|Patient participants are not included in this period.|
48164636|NCT02306122|100725075|FG003|COMPLETED|Initial Physician Randomization||0|Patient participants are not included in this period.|
48164637|NCT02306122|100725076|FG004|COMPLETED|Initial Physician Randomization||0|Patient participants are not included in this period.|
48164638|NCT02306122|100725077|FG005|COMPLETED|Initial Physician Randomization||0|Patient participants are not included in this period.|
48164639|NCT02306122|100725078|FG006|COMPLETED|Initial Physician Randomization||0|Patient participants are not included in this period.|
48164640|NCT02306122|100725079|FG007|COMPLETED|Initial Physician Randomization||0|Patient participants are not included in this period.|
48164641|NCT02306122|100725080|FG008|COMPLETED|Initial Physician Randomization||28|Patient participants are not included in this period.|
48164642|NCT02306122|100725081|FG009|COMPLETED|Initial Physician Randomization||31|Patient participants are not included in this period.|
48164643|NCT02306122|100725082|FG010|COMPLETED|Initial Physician Randomization||31|Patient participants are not included in this period.|
48164644|NCT02306122|100725072|FG000|NOT COMPLETED|Initial Physician Randomization||0||
48164645|NCT02306122|100725073|FG001|NOT COMPLETED|Initial Physician Randomization||0||
48164646|NCT02306122|100725074|FG002|NOT COMPLETED|Initial Physician Randomization||0||
48164647|NCT02306122|100725075|FG003|NOT COMPLETED|Initial Physician Randomization||0||
48164648|NCT02306122|100725076|FG004|NOT COMPLETED|Initial Physician Randomization||0||
48164649|NCT02306122|100725077|FG005|NOT COMPLETED|Initial Physician Randomization||0||
48164650|NCT02306122|100725078|FG006|NOT COMPLETED|Initial Physician Randomization||0||
48164651|NCT02306122|100725079|FG007|NOT COMPLETED|Initial Physician Randomization||0||
48164652|NCT02306122|100725080|FG008|NOT COMPLETED|Initial Physician Randomization||1||
48164653|NCT02306122|100725081|FG009|NOT COMPLETED|Initial Physician Randomization||0||
48164654|NCT02306122|100725082|FG010|NOT COMPLETED|Initial Physician Randomization||0||
48164655|NCT02306122|100725072|FG000|STARTED|Post Nonadherence Subgroup Randomization||244|Only those patients with a nonadherence event are included in this period.|
48164656|NCT02306122|100725073|FG001|STARTED|Post Nonadherence Subgroup Randomization||123|Only those patients with a nonadherence event are included in this period.|
48326973|NCT01340209|101128235|FG000|NOT COMPLETED|Overall Study||5||
48326974|NCT01340209|101128236|FG001|NOT COMPLETED|Overall Study||8||
48326975|NCT01340209|101128237|FG002|NOT COMPLETED|Overall Study||8||
48326976|NCT00648375|101128238|FG000|STARTED|Overall Study||1||
48326977|NCT00648375|101128239|FG001|STARTED|Overall Study||2||
48326978|NCT00648375|101128238|FG000|COMPLETED|Overall Study||1||
48326979|NCT00648375|101128239|FG001|COMPLETED|Overall Study||2||
48326980|NCT00648375|101128238|FG000|NOT COMPLETED|Overall Study||0||
48326981|NCT00648375|101128239|FG001|NOT COMPLETED|Overall Study||0||
48326982|NCT00429858|101128240|FG000|STARTED|Overall Study||21||
48326983|NCT00429858|101128240|FG000|COMPLETED|Overall Study||19||
48326984|NCT00429858|101128240|FG000|NOT COMPLETED|Overall Study||2||
48326985|NCT02326805|101128241|FG000|STARTED|Overall Study||106||
48326986|NCT02326805|101128242|FG001|STARTED|Overall Study||48||
48326987|NCT02326805|101128241|FG000|COMPLETED|Overall Study||103||
48326988|NCT02326805|101128242|FG001|COMPLETED|Overall Study||47||
48326989|NCT02326805|101128241|FG000|NOT COMPLETED|Overall Study||3||
48326990|NCT02326805|101128242|FG001|NOT COMPLETED|Overall Study||1||
48326991|NCT01656031|101128243|FG000|STARTED|Overall Study||39||
48409610|NCT00976963|101334749|FG001|Treated With Assigned Intervention|Overall Study||150||
48409611|NCT00976963|101334748|FG000|COMPLETED|Overall Study||146||
48409612|NCT00976963|101334749|FG001|COMPLETED|Overall Study||150||
48409613|NCT00976963|101334748|FG000|NOT COMPLETED|Overall Study||4||
48409614|NCT00976963|101334749|FG001|NOT COMPLETED|Overall Study||0||
48409615|NCT00623766|101334750|FG000|STARTED|Induction Phase (Day 1 to Week 24)||51||
48409616|NCT00623766|101334751|FG001|STARTED|Induction Phase (Day 1 to Week 24)||21||
48409617|NCT00623766|101334750|FG000|COMPLETED|Induction Phase (Day 1 to Week 24)||15||
48409618|NCT00623766|101334751|FG001|COMPLETED|Induction Phase (Day 1 to Week 24)||5||
48409619|NCT00623766|101334750|FG000|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||36||
48743810|NCT01597635|102158106|FG000|NOT COMPLETED|Part A||3||
48743811|NCT01597635|102158107|FG001|NOT COMPLETED|Part A||0||
48326992|NCT01656031|101128243|FG000|COMPLETED|Overall Study||39||
48409620|NCT00623766|101334751|FG001|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||16||
48409621|NCT00623766|101334750|FG000|STARTED|Maintenance Phase (Week 24 to Year 2)||11||
48409622|NCT00623766|101334751|FG001|STARTED|Maintenance Phase (Week 24 to Year 2)||2||
48409623|NCT00623766|101334750|FG000|COMPLETED|Maintenance Phase (Week 24 to Year 2)||1||
48409624|NCT00623766|101334751|FG001|COMPLETED|Maintenance Phase (Week 24 to Year 2)||0||
48743812|NCT01597635|102158108|FG002|NOT COMPLETED|Part A||0||
48743813|NCT01597635|102158106|FG000|STARTED|Part B||0||
48743814|NCT01597635|102158107|FG001|STARTED|Part B||20||
48743815|NCT01597635|102158108|FG002|STARTED|Part B||19||
48743816|NCT01597635|102158106|FG000|COMPLETED|Part B||0||
48326993|NCT01656031|101128243|FG000|NOT COMPLETED|Overall Study||0||
48326994|NCT00267748|101128244|FG000|STARTED|Non-randomized Period||25||
48326995|NCT00267748|101128245|FG001|STARTED|Non-randomized Period||0||
48743817|NCT01597635|102158107|FG001|COMPLETED|Part B||14||
48743818|NCT01597635|102158108|FG002|COMPLETED|Part B||15||
48743819|NCT01597635|102158106|FG000|NOT COMPLETED|Part B||0||
48743820|NCT01597635|102158107|FG001|NOT COMPLETED|Part B||6||
48743821|NCT01597635|102158108|FG002|NOT COMPLETED|Part B||4||
48743822|NCT02045095|102158109|FG000|STARTED|Overall Study||3||
48409625|NCT00623766|101334750|FG000|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||10||
48409626|NCT00623766|101334751|FG001|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||2||
48409627|NCT02613338|101334752|FG000|STARTED|Overall Study||30||
48743823|NCT02045095|102158110|FG001|STARTED|Overall Study||4||
48409628|NCT02613338|101334752|FG000|COMPLETED|Overall Study||30||
48409629|NCT02613338|101334752|FG000|NOT COMPLETED|Overall Study||0||
48743824|NCT02045095|102158111|FG002|STARTED|Overall Study||4||
48743825|NCT02045095|102158112|FG003|STARTED|Overall Study||4||
48743826|NCT02045095|102158113|FG004|STARTED|Overall Study||5||
48743827|NCT02045095|102158114|FG005|STARTED|Overall Study||8||
48743828|NCT02045095|102158115|FG006|STARTED|Overall Study||1||
48743829|NCT02045095|102158109|FG000|COMPLETED|Overall Study||0||
48743830|NCT02045095|102158110|FG001|COMPLETED|Overall Study||0||
48743831|NCT02045095|102158111|FG002|COMPLETED|Overall Study||0||
48743832|NCT02045095|102158112|FG003|COMPLETED|Overall Study||0||
48743833|NCT02045095|102158113|FG004|COMPLETED|Overall Study||0||
48743834|NCT02045095|102158114|FG005|COMPLETED|Overall Study||0||
48743835|NCT02045095|102158115|FG006|COMPLETED|Overall Study||0||
48743836|NCT02045095|102158109|FG000|NOT COMPLETED|Overall Study||3||
48743837|NCT02045095|102158110|FG001|NOT COMPLETED|Overall Study||4||
48743838|NCT02045095|102158111|FG002|NOT COMPLETED|Overall Study||4||
48743839|NCT02045095|102158112|FG003|NOT COMPLETED|Overall Study||4||
48743840|NCT02045095|102158113|FG004|NOT COMPLETED|Overall Study||5||
48743841|NCT02045095|102158114|FG005|NOT COMPLETED|Overall Study||8||
48743842|NCT02045095|102158115|FG006|NOT COMPLETED|Overall Study||1||
48326996|NCT00267748|101128246|FG002|STARTED|Non-randomized Period||0||
48326997|NCT00267748|101128244|FG000|COMPLETED|Non-randomized Period||2||
48326998|NCT00267748|101128245|FG001|COMPLETED|Non-randomized Period||0||
48326999|NCT00267748|101128246|FG002|COMPLETED|Non-randomized Period||0||
48327000|NCT00267748|101128244|FG000|NOT COMPLETED|Non-randomized Period||23||
48327001|NCT00267748|101128245|FG001|NOT COMPLETED|Non-randomized Period||0||
48327002|NCT00267748|101128246|FG002|NOT COMPLETED|Non-randomized Period||0||
48327003|NCT00267748|101128244|FG000|STARTED|Randomized Period||0||
48327004|NCT00267748|101128245|FG001|STARTED|Randomized Period||146||
48327005|NCT00267748|101128246|FG002|STARTED|Randomized Period||146||
48327006|NCT00267748|101128244|FG000|Treated|Randomized Period||0||
48327007|NCT00267748|101128245|FG001|Treated|Randomized Period||146||
48327008|NCT00267748|101128246|FG002|Treated|Randomized Period||143||
48327009|NCT00267748|101128244|FG000|COMPLETED|Randomized Period||0||
48327010|NCT00267748|101128245|FG001|COMPLETED|Randomized Period||19||
48327011|NCT00267748|101128246|FG002|COMPLETED|Randomized Period||14||
48327012|NCT00267748|101128244|FG000|NOT COMPLETED|Randomized Period||0||
48327013|NCT00267748|101128245|FG001|NOT COMPLETED|Randomized Period||127||
48327014|NCT00267748|101128246|FG002|NOT COMPLETED|Randomized Period||132||
48327015|NCT02706873|101128247|FG000|STARTED|Period 1 (Weeks 1 to 48)||315||
48327016|NCT02706873|101128248|FG001|STARTED|Period 1 (Weeks 1 to 48)||55||
48327017|NCT02706873|101128249|FG002|STARTED|Period 1 (Weeks 1 to 48)||317||
48327018|NCT02706873|101128250|FG003|STARTED|Period 1 (Weeks 1 to 48)||315||
48327019|NCT02706873|101128247|FG000|Received Study Drug|Period 1 (Weeks 1 to 48)||314||
48327020|NCT02706873|101128248|FG001|Received Study Drug|Period 1 (Weeks 1 to 48)||55||
48327021|NCT02706873|101128249|FG002|Received Study Drug|Period 1 (Weeks 1 to 48)||317||
48327022|NCT02706873|101128250|FG003|Received Study Drug|Period 1 (Weeks 1 to 48)||314||
48327023|NCT02706873|101128247|FG000|Global Analysis Population|Period 1 (Weeks 1 to 48)||314|Participants enrolled in the methotrexate, upadacitinib 15 mg and 30 mg treatment groups|
48327024|NCT02706873|101128248|FG001|Global Analysis Population|Period 1 (Weeks 1 to 48)||0|Participants enrolled in the methotrexate, upadacitinib 15 mg and 30 mg treatment groups|
48327025|NCT02706873|101128249|FG002|Global Analysis Population|Period 1 (Weeks 1 to 48)||317|Participants enrolled in the methotrexate, upadacitinib 15 mg and 30 mg treatment groups|
48327026|NCT02706873|101128250|FG003|Global Analysis Population|Period 1 (Weeks 1 to 48)||314|Participants enrolled in the methotrexate, upadacitinib 15 mg and 30 mg treatment groups|
48327027|NCT02706873|101128247|FG000|Japan Sub-study|Period 1 (Weeks 1 to 48)||28|Participants in the methotrexate, upadacitinib 7.5, 15, and 30 mg treatment groups enrolled in Japan|
48327028|NCT02706873|101128248|FG001|Japan Sub-study|Period 1 (Weeks 1 to 48)||55|Participants in the methotrexate, upadacitinib 7.5, 15, and 30 mg treatment groups enrolled in Japan|
48327029|NCT02706873|101128249|FG002|Japan Sub-study|Period 1 (Weeks 1 to 48)||27|Participants in the methotrexate, upadacitinib 7.5, 15, and 30 mg treatment groups enrolled in Japan|
48620835|NCT02948829|101856430|FG000|COMPLETED|Overall Study||184||
48620836|NCT02948829|101856430|FG000|NOT COMPLETED|Overall Study||16||
48620837|NCT02260817|101856431|FG000|STARTED|Overall Study||14||
48620838|NCT02260817|101856432|FG001|STARTED|Overall Study||95||
48620839|NCT02260817|101856431|FG000|COMPLETED|Overall Study||14||
48620840|NCT02260817|101856432|FG001|COMPLETED|Overall Study||58||
48620841|NCT02260817|101856431|FG000|NOT COMPLETED|Overall Study||0||
48620842|NCT02260817|101856432|FG001|NOT COMPLETED|Overall Study||37||
48620843|NCT01090180|101856433|FG000|STARTED|Overall Study||33||
48620844|NCT01090180|101856434|FG001|STARTED|Overall Study||29||
48620845|NCT01090180|101856433|FG000|COMPLETED|Overall Study||22||
48743843|NCT02041325|102158116|FG000|STARTED|Overall Study||22||
48743844|NCT02041325|102158117|FG001|STARTED|Overall Study||16||
48743845|NCT02041325|102158116|FG000|COMPLETED|Overall Study||19||
48743846|NCT02041325|102158117|FG001|COMPLETED|Overall Study||13||
48743847|NCT02041325|102158116|FG000|NOT COMPLETED|Overall Study||3||
48743848|NCT02041325|102158117|FG001|NOT COMPLETED|Overall Study||3||
48743849|NCT01362348|102158118|FG000|STARTED|Overall Study||19||
48743850|NCT01362348|102158118|FG000|COMPLETED|Overall Study||5||
48327030|NCT02706873|101128250|FG003|Japan Sub-study|Period 1 (Weeks 1 to 48)||28|Participants in the methotrexate, upadacitinib 7.5, 15, and 30 mg treatment groups enrolled in Japan|
48327031|NCT02706873|101128247|FG000|Completed Week 24 Study Drug|Period 1 (Weeks 1 to 48)||268||
48327032|NCT02706873|101128248|FG001|Completed Week 24 Study Drug|Period 1 (Weeks 1 to 48)||51||
48327033|NCT02706873|101128249|FG002|Completed Week 24 Study Drug|Period 1 (Weeks 1 to 48)||290||
48327034|NCT02706873|101128250|FG003|Completed Week 24 Study Drug|Period 1 (Weeks 1 to 48)||282||
48327035|NCT02706873|101128247|FG000|Received Combination Rescue Therapy at Week 26|Period 1 (Weeks 1 to 48)||37||
48327036|NCT02706873|101128248|FG001|Received Combination Rescue Therapy at Week 26|Period 1 (Weeks 1 to 48)||3||
48327037|NCT02706873|101128249|FG002|Received Combination Rescue Therapy at Week 26|Period 1 (Weeks 1 to 48)||19||
48620846|NCT01090180|101856434|FG001|COMPLETED|Overall Study||21||
48620847|NCT01090180|101856433|FG000|NOT COMPLETED|Overall Study||11||
48620848|NCT01090180|101856434|FG001|NOT COMPLETED|Overall Study||8||
48620849|NCT00102596|101856435|FG000|STARTED|Part A||11||
48743851|NCT01362348|102158118|FG000|NOT COMPLETED|Overall Study||14||
48743852|NCT03571204|102158119|FG000|STARTED|Overall Study||8||
48743853|NCT03571204|102158120|FG001|STARTED|Overall Study||8||
48743854|NCT03571204|102158121|FG002|STARTED|Overall Study||5||
48409630|NCT02583360|101334753|FG000|STARTED|Overall Study||60||
48409631|NCT02583360|101334754|FG001|STARTED|Overall Study||49||
48620850|NCT00102596|101856436|FG001|STARTED|Part A||0||
48327038|NCT02706873|101128250|FG003|Received Combination Rescue Therapy at Week 26|Period 1 (Weeks 1 to 48)||9||
48327039|NCT02706873|101128247|FG000|COMPLETED|Period 1 (Weeks 1 to 48)||256|Completed Week 48|
48327040|NCT02706873|101128248|FG001|COMPLETED|Period 1 (Weeks 1 to 48)||51|Completed Week 48|
48327041|NCT02706873|101128249|FG002|COMPLETED|Period 1 (Weeks 1 to 48)||277|Completed Week 48|
48327042|NCT02706873|101128250|FG003|COMPLETED|Period 1 (Weeks 1 to 48)||271|Completed Week 48|
48327043|NCT02706873|101128247|FG000|NOT COMPLETED|Period 1 (Weeks 1 to 48)||59||
48620851|NCT00102596|101856435|FG000|Participants Assigned Treatment|Part A||5||
48620852|NCT00102596|101856436|FG001|Participants Assigned Treatment|Part A||0||
48620853|NCT00102596|101856435|FG000|COMPLETED|Part A||4||
48743855|NCT03571204|102158119|FG000|COMPLETED|Overall Study||7||
48743856|NCT03571204|102158120|FG001|COMPLETED|Overall Study||6||
48327044|NCT02706873|101128248|FG001|NOT COMPLETED|Period 1 (Weeks 1 to 48)||4||
48327045|NCT02706873|101128249|FG002|NOT COMPLETED|Period 1 (Weeks 1 to 48)||40||
48327046|NCT02706873|101128250|FG003|NOT COMPLETED|Period 1 (Weeks 1 to 48)||44||
48327047|NCT02706873|101128247|FG000|STARTED|Period 2 (Weeks 48 to 260)||253|Nine participants who completed Period 1 opted not to enter Period 2.|
48164657|NCT02306122|100725074|FG002|STARTED|Post Nonadherence Subgroup Randomization||121|Only those patients with a nonadherence event are included in this period.|
48164658|NCT02306122|100725075|FG003|STARTED|Post Nonadherence Subgroup Randomization||274|Only those patients with a nonadherence event are included in this period.|
48164659|NCT02306122|100725076|FG004|STARTED|Post Nonadherence Subgroup Randomization||134|Only those patients with a nonadherence event are included in this period.|
48327048|NCT02706873|101128248|FG001|STARTED|Period 2 (Weeks 48 to 260)||50|Nine participants who completed Period 1 opted not to enter Period 2.|
48327049|NCT02706873|101128249|FG002|STARTED|Period 2 (Weeks 48 to 260)||275|Nine participants who completed Period 1 opted not to enter Period 2.|
48327050|NCT02706873|101128250|FG003|STARTED|Period 2 (Weeks 48 to 260)||268|Nine participants who completed Period 1 opted not to enter Period 2.|
48743857|NCT03571204|102158121|FG002|COMPLETED|Overall Study||5||
48743858|NCT03571204|102158119|FG000|NOT COMPLETED|Overall Study||1||
48743859|NCT03571204|102158120|FG001|NOT COMPLETED|Overall Study||2||
48743860|NCT03571204|102158121|FG002|NOT COMPLETED|Overall Study||0||
48743861|NCT02946034|102158122|FG000|STARTED|Overall Study||10||
48743862|NCT02946034|102158122|FG000|COMPLETED|Overall Study||10||
48743863|NCT02946034|102158122|FG000|NOT COMPLETED|Overall Study||0||
48743864|NCT01358825|102158123|FG000|STARTED|Overall Study||12||
48743865|NCT01358825|102158124|FG001|STARTED|Overall Study||46||
48743866|NCT01358825|102158123|FG000|COMPLETED|Overall Study||12||
48743867|NCT01358825|102158124|FG001|COMPLETED|Overall Study||45||
48743868|NCT01358825|102158123|FG000|NOT COMPLETED|Overall Study||0||
48327051|NCT02706873|101128247|FG000|Received Study Drug|Period 2 (Weeks 48 to 260)||242||
48327052|NCT02706873|101128248|FG001|Received Study Drug|Period 2 (Weeks 48 to 260)||48||
48327053|NCT02706873|101128249|FG002|Received Study Drug|Period 2 (Weeks 48 to 260)||273||
48327054|NCT02706873|101128250|FG003|Received Study Drug|Period 2 (Weeks 48 to 260)||260||
48327055|NCT02706873|101128247|FG000|COMPLETED|Period 2 (Weeks 48 to 260)||163||
48327056|NCT02706873|101128248|FG001|COMPLETED|Period 2 (Weeks 48 to 260)||40||
48327057|NCT02706873|101128249|FG002|COMPLETED|Period 2 (Weeks 48 to 260)||217||
48327058|NCT02706873|101128250|FG003|COMPLETED|Period 2 (Weeks 48 to 260)||187||
48327059|NCT02706873|101128247|FG000|NOT COMPLETED|Period 2 (Weeks 48 to 260)||90||
48327060|NCT02706873|101128248|FG001|NOT COMPLETED|Period 2 (Weeks 48 to 260)||10||
48327061|NCT02706873|101128249|FG002|NOT COMPLETED|Period 2 (Weeks 48 to 260)||58||
48327062|NCT02706873|101128250|FG003|NOT COMPLETED|Period 2 (Weeks 48 to 260)||81||
48327063|NCT00584480|101128251|FG000|STARTED|First 8 Weeks (40 Treatments)||10||
48327064|NCT00584480|101128251|FG000|COMPLETED|First 8 Weeks (40 Treatments)||10||
48368071|NCT03691623|101230098|FG002|COMPLETED|Overall Study||38||
48409632|NCT02583360|101334753|FG000|COMPLETED|Overall Study||60||
48409633|NCT02583360|101334754|FG001|COMPLETED|Overall Study||49||
48409634|NCT02583360|101334753|FG000|NOT COMPLETED|Overall Study||0||
48620854|NCT00102596|101856436|FG001|COMPLETED|Part A||0||
48620855|NCT00102596|101856435|FG000|NOT COMPLETED|Part A||7||
48620856|NCT00102596|101856436|FG001|NOT COMPLETED|Part A||0||
48620857|NCT00102596|101856435|FG000|STARTED|Part B||0||
48620858|NCT00102596|101856436|FG001|STARTED|Part B||10||
48620859|NCT00102596|101856435|FG000|COMPLETED|Part B||0||
48620860|NCT00102596|101856436|FG001|COMPLETED|Part B||10||
48620861|NCT00102596|101856435|FG000|NOT COMPLETED|Part B||0||
48620862|NCT00102596|101856436|FG001|NOT COMPLETED|Part B||0||
48743869|NCT01358825|102158124|FG001|NOT COMPLETED|Overall Study||1||
48743870|NCT00725049|102158125|FG000|STARTED|Overall Study||17||
48743871|NCT00725049|102158126|FG001|STARTED|Overall Study||20||
48743872|NCT00725049|102158125|FG000|COMPLETED|Overall Study||17||
48743873|NCT00725049|102158126|FG001|COMPLETED|Overall Study||20||
48743874|NCT00725049|102158125|FG000|NOT COMPLETED|Overall Study||0||
48743875|NCT00725049|102158126|FG001|NOT COMPLETED|Overall Study||0||
48743876|NCT02634333|102158127|FG000|STARTED|Overall Study||200||200
48743877|NCT02634333|102158128|FG001|STARTED|Overall Study||199||199
48743878|NCT02634333|102158127|FG000|COMPLETED|Overall Study||160||160
48743879|NCT02634333|102158128|FG001|COMPLETED|Overall Study||167||167
48327065|NCT00584480|101128251|FG000|NOT COMPLETED|First 8 Weeks (40 Treatments)||0||
48327066|NCT00584480|101128251|FG000|STARTED|4-Week Break From Treatment||10||
48327067|NCT00584480|101128251|FG000|COMPLETED|4-Week Break From Treatment||10||
48327068|NCT00584480|101128251|FG000|NOT COMPLETED|4-Week Break From Treatment||0||
48327069|NCT00584480|101128251|FG000|STARTED|Second 8 Weeks (40 Treatments)||10||
48327070|NCT00584480|101128251|FG000|COMPLETED|Second 8 Weeks (40 Treatments)||10||
48327071|NCT00584480|101128251|FG000|NOT COMPLETED|Second 8 Weeks (40 Treatments)||0||
48743880|NCT02634333|102158127|FG000|NOT COMPLETED|Overall Study||40||40
48327072|NCT02239939|101128252|FG000|STARTED|Overall Study||20||
48743881|NCT02634333|102158128|FG001|NOT COMPLETED|Overall Study||32||32
48743882|NCT02442349|102158129|FG000|STARTED|Overall Study||171||
48743883|NCT02442349|102158129|FG000|COMPLETED|Overall Study||0||
48743884|NCT02442349|102158129|FG000|NOT COMPLETED|Overall Study||171||
48743885|NCT02485561|102158130|FG000|STARTED|Overall Study||161||
48743886|NCT02485561|102158131|FG001|STARTED|Overall Study||157||
48743887|NCT02485561|102158132|FG002|STARTED|Overall Study||159||
48743888|NCT02485561|102158130|FG000|Completed 1 mo Survey|Overall Study||145||
48743889|NCT02485561|102158131|FG001|Completed 1 mo Survey|Overall Study||138||
48327073|NCT02239939|101128253|FG001|STARTED|Overall Study||17||
48327074|NCT02239939|101128252|FG000|COMPLETED|Overall Study||18||
48327075|NCT02239939|101128253|FG001|COMPLETED|Overall Study||15||
48327076|NCT02239939|101128252|FG000|NOT COMPLETED|Overall Study||2||
48327077|NCT02239939|101128253|FG001|NOT COMPLETED|Overall Study||2||
48327078|NCT01568606|101128254|FG000|STARTED|Overall Study||20||
48743890|NCT02485561|102158132|FG002|Completed 1 mo Survey|Overall Study||144||
48743891|NCT02485561|102158130|FG000|COMPLETED|Overall Study||133|Completed 12 month follow up survey (final time point)|
48327079|NCT01568606|101128254|FG000|COMPLETED|Overall Study||20||
48327080|NCT01568606|101128254|FG000|NOT COMPLETED|Overall Study||0||
48327081|NCT00919503|101128255|FG000|STARTED|Overall Study||84||
48327082|NCT00919503|101128256|FG001|STARTED|Overall Study||14||
48743892|NCT02485561|102158131|FG001|COMPLETED|Overall Study||118|Completed 12 month follow up survey (final time point)|
48743893|NCT02485561|102158132|FG002|COMPLETED|Overall Study||136|Completed 12 month follow up survey (final time point)|
48743894|NCT02485561|102158130|FG000|NOT COMPLETED|Overall Study||28||
48743895|NCT02485561|102158131|FG001|NOT COMPLETED|Overall Study||39||
48743896|NCT02485561|102158132|FG002|NOT COMPLETED|Overall Study||23||
48743897|NCT02747186|102158133|FG000|STARTED|First Intervention||12||
48743898|NCT02747186|102158134|FG001|STARTED|First Intervention||12||
48743899|NCT02747186|102158133|FG000|COMPLETED|First Intervention||12||
48327083|NCT00919503|101128255|FG000|COMPLETED|Overall Study||84||
48327084|NCT00919503|101128256|FG001|COMPLETED|Overall Study||14||
48327085|NCT00919503|101128255|FG000|NOT COMPLETED|Overall Study||0||
48327086|NCT00919503|101128256|FG001|NOT COMPLETED|Overall Study||0||
48327087|NCT03920670|101128257|FG000|STARTED|Overall Study||60||
48327088|NCT03920670|101128258|FG001|STARTED|Overall Study||60||
48743900|NCT02747186|102158134|FG001|COMPLETED|First Intervention||12||
48743901|NCT02747186|102158133|FG000|NOT COMPLETED|First Intervention||0||
48743902|NCT02747186|102158134|FG001|NOT COMPLETED|First Intervention||0||
48327089|NCT03920670|101128257|FG000|COMPLETED|Overall Study||57||
48327090|NCT03920670|101128258|FG001|COMPLETED|Overall Study||58||
48327091|NCT03920670|101128257|FG000|NOT COMPLETED|Overall Study||3||
48327092|NCT03920670|101128258|FG001|NOT COMPLETED|Overall Study||2||
48327093|NCT02415712|101128259|FG000|STARTED|Overall Study||147||
48327094|NCT02415712|101128259|FG000|COMPLETED|Overall Study||131||
48327095|NCT02415712|101128259|FG000|NOT COMPLETED|Overall Study||16||
48620863|NCT00102596|101856435|FG000|STARTED|Part C||0||
48327096|NCT01602692|101128260|FG000|STARTED|Overall Study||20||
48327097|NCT01602692|101128261|FG001|STARTED|Overall Study||20||
48620864|NCT00102596|101856436|FG001|STARTED|Part C||2||
48620865|NCT00102596|101856435|FG000|COMPLETED|Part C||0||
48620866|NCT00102596|101856436|FG001|COMPLETED|Part C||2||
48327098|NCT01602692|101128260|FG000|COMPLETED|Overall Study||20||
48327099|NCT01602692|101128261|FG001|COMPLETED|Overall Study||20||
48327100|NCT01602692|101128260|FG000|NOT COMPLETED|Overall Study||0||
48327101|NCT01602692|101128261|FG001|NOT COMPLETED|Overall Study||0||
48327102|NCT00003460|101128262|FG000|STARTED|Overall Study||13||
48327103|NCT00003460|101128262|FG000|COMPLETED|Overall Study||12||
48327104|NCT00003460|101128262|FG000|NOT COMPLETED|Overall Study||1||
48620867|NCT00102596|101856435|FG000|NOT COMPLETED|Part C||0||
48620868|NCT00102596|101856436|FG001|NOT COMPLETED|Part C||0||
48620869|NCT02053493|101856437|FG000|STARTED|Overall Study||51||
48620870|NCT02053493|101856438|FG001|STARTED|Overall Study||59||
48620871|NCT02053493|101856437|FG000|COMPLETED|Overall Study||50||
48620872|NCT02053493|101856438|FG001|COMPLETED|Overall Study||58||
48620873|NCT02053493|101856437|FG000|NOT COMPLETED|Overall Study||1||
48620874|NCT02053493|101856438|FG001|NOT COMPLETED|Overall Study||1||
48620875|NCT03234036|101856439|FG000|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||8||
48620876|NCT03234036|101856440|FG001|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||8||
48620877|NCT03234036|101856441|FG002|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||0||
48620878|NCT03234036|101856442|FG003|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||0||
48620879|NCT03234036|101856439|FG000|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||8||
48620880|NCT03234036|101856440|FG001|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||8||
48620881|NCT03234036|101856441|FG002|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0||
48620882|NCT03234036|101856442|FG003|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0||
48620883|NCT03234036|101856439|FG000|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0||
48620884|NCT03234036|101856440|FG001|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0||
48620885|NCT03234036|101856441|FG002|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0||
48620886|NCT03234036|101856442|FG003|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0||
48620887|NCT03234036|101856439|FG000|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||8||
48620888|NCT03234036|101856440|FG001|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||8||
48620889|NCT03234036|101856441|FG002|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||0||
48620890|NCT03234036|101856442|FG003|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||0||
48620891|NCT03234036|101856439|FG000|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||7||
48620892|NCT03234036|101856440|FG001|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||7||
48620893|NCT03234036|101856441|FG002|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0||
48620894|NCT03234036|101856442|FG003|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0||
48620895|NCT03234036|101856439|FG000|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||1||
48620896|NCT03234036|101856440|FG001|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||1||
48620897|NCT03234036|101856441|FG002|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0||
48620898|NCT03234036|101856442|FG003|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0||
48620899|NCT03234036|101856439|FG000|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||7||
48620900|NCT03234036|101856440|FG001|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||7||
48620901|NCT03234036|101856441|FG002|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||0||
48620902|NCT03234036|101856442|FG003|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||0||
48620903|NCT03234036|101856439|FG000|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||7||
48620904|NCT03234036|101856440|FG001|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||7||
48620905|NCT03234036|101856441|FG002|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0||
48620906|NCT03234036|101856442|FG003|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0||
48620907|NCT03234036|101856439|FG000|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0||
48620908|NCT03234036|101856440|FG001|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0||
48620909|NCT03234036|101856441|FG002|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0||
48327105|NCT01479543|101128263|FG000|STARTED|Overall Study||21||
48327106|NCT01479543|101128264|FG001|STARTED|Overall Study||20||
48620910|NCT03234036|101856442|FG003|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0||
48620911|NCT03234036|101856439|FG000|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||7||
48620912|NCT03234036|101856440|FG001|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||7||
48620913|NCT03234036|101856441|FG002|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||0||
48620914|NCT03234036|101856442|FG003|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||0||
48620915|NCT03234036|101856439|FG000|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||7||
48327107|NCT01479543|101128265|FG002|STARTED|Overall Study||21||
48327108|NCT01479543|101128266|FG003|STARTED|Overall Study||20||
48327109|NCT01479543|101128267|FG004|STARTED|Overall Study||21||
48327110|NCT01479543|101128263|FG000|COMPLETED|Overall Study||20||
48743903|NCT02747186|102158133|FG000|STARTED|Washout (1 Week)||12||
48743904|NCT02747186|102158134|FG001|STARTED|Washout (1 Week)||12||
48743905|NCT02747186|102158133|FG000|COMPLETED|Washout (1 Week)||12||
48743906|NCT02747186|102158134|FG001|COMPLETED|Washout (1 Week)||12||
48743907|NCT02747186|102158133|FG000|NOT COMPLETED|Washout (1 Week)||0||
48743908|NCT02747186|102158134|FG001|NOT COMPLETED|Washout (1 Week)||0||
48743909|NCT02747186|102158133|FG000|STARTED|Second Intervention||12||
48743910|NCT02747186|102158134|FG001|STARTED|Second Intervention||12||
48743911|NCT02747186|102158133|FG000|COMPLETED|Second Intervention||12||
48743912|NCT02747186|102158134|FG001|COMPLETED|Second Intervention||12||
48327111|NCT01479543|101128264|FG001|COMPLETED|Overall Study||20||
48327112|NCT01479543|101128265|FG002|COMPLETED|Overall Study||20||
48327113|NCT01479543|101128266|FG003|COMPLETED|Overall Study||20||
48327114|NCT01479543|101128267|FG004|COMPLETED|Overall Study||20||
48327115|NCT01479543|101128263|FG000|NOT COMPLETED|Overall Study||1||
48327116|NCT01479543|101128264|FG001|NOT COMPLETED|Overall Study||0||
48327117|NCT01479543|101128265|FG002|NOT COMPLETED|Overall Study||1||
48620916|NCT03234036|101856440|FG001|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||7||
48620917|NCT03234036|101856441|FG002|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0||
48620918|NCT03234036|101856442|FG003|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0||
48620919|NCT03234036|101856439|FG000|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0||
48620920|NCT03234036|101856440|FG001|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0||
48620921|NCT03234036|101856441|FG002|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0||
48620922|NCT03234036|101856442|FG003|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0||
48743913|NCT02747186|102158133|FG000|NOT COMPLETED|Second Intervention||0||
48743914|NCT02747186|102158134|FG001|NOT COMPLETED|Second Intervention||0||
48743915|NCT02286921|102158135|FG000|STARTED|Overall Study||94||
48743916|NCT02286921|102158136|FG001|STARTED|Overall Study||101||
48327118|NCT01479543|101128266|FG003|NOT COMPLETED|Overall Study||0||
48327119|NCT01479543|101128267|FG004|NOT COMPLETED|Overall Study||1||
48743917|NCT02286921|102158135|FG000|COMPLETED|Overall Study||94||
48743918|NCT02286921|102158136|FG001|COMPLETED|Overall Study||101||
48743919|NCT02286921|102158135|FG000|NOT COMPLETED|Overall Study||0||
48743920|NCT02286921|102158136|FG001|NOT COMPLETED|Overall Study||0||
48743921|NCT01362608|102158137|FG000|STARTED|Overall Study||67||
48743922|NCT01362608|102158138|FG001|STARTED|Overall Study||69||
48743923|NCT01362608|102158137|FG000|COMPLETED|Overall Study||63||
48743924|NCT01362608|102158138|FG001|COMPLETED|Overall Study||61||
48743925|NCT01362608|102158137|FG000|NOT COMPLETED|Overall Study||4||
48743926|NCT01362608|102158138|FG001|NOT COMPLETED|Overall Study||8||
48743927|NCT01521026|102158139|FG000|STARTED|Overall Study||38||
48743928|NCT01521026|102158140|FG001|STARTED|Overall Study||31||
48743929|NCT01521026|102158139|FG000|COMPLETED|Overall Study||23||
48164660|NCT02306122|100725077|FG005|STARTED|Post Nonadherence Subgroup Randomization||137|Only those patients with a nonadherence event are included in this period.|
48620923|NCT03234036|101856439|FG000|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||7||
48620924|NCT03234036|101856440|FG001|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||7||
48743930|NCT01521026|102158140|FG001|COMPLETED|Overall Study||28||
48743931|NCT01521026|102158139|FG000|NOT COMPLETED|Overall Study||15||
48743932|NCT01521026|102158140|FG001|NOT COMPLETED|Overall Study||3||
48743933|NCT01380769|102158141|FG000|STARTED|Overall Study||100||
48743934|NCT01380769|102158142|FG001|STARTED|Overall Study||57||
48743935|NCT01380769|102158141|FG000|COMPLETED|Overall Study||91||
48743936|NCT01380769|102158142|FG001|COMPLETED|Overall Study||43||
48743937|NCT01380769|102158141|FG000|NOT COMPLETED|Overall Study||9||
48743938|NCT01380769|102158142|FG001|NOT COMPLETED|Overall Study||14||
48620925|NCT03234036|101856441|FG002|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||0||
48620926|NCT03234036|101856442|FG003|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||0||
48620927|NCT03234036|101856439|FG000|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||7||
48620928|NCT03234036|101856440|FG001|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||7||
48620929|NCT03234036|101856441|FG002|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0||
48743939|NCT01525615|102158143|FG000|STARTED|Overall Study||132||
48743940|NCT01525615|102158144|FG001|STARTED|Overall Study||133||
48743941|NCT01525615|102158145|FG002|STARTED|Overall Study||139||
48743942|NCT01525615|102158143|FG000|COMPLETED|Overall Study||118||
48743943|NCT01525615|102158144|FG001|COMPLETED|Overall Study||126||
48620930|NCT03234036|101856442|FG003|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0||
48620931|NCT03234036|101856439|FG000|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0||
48743944|NCT01525615|102158145|FG002|COMPLETED|Overall Study||133||
48743945|NCT01525615|102158143|FG000|NOT COMPLETED|Overall Study||14||
48743946|NCT01525615|102158144|FG001|NOT COMPLETED|Overall Study||7||
48743947|NCT01525615|102158145|FG002|NOT COMPLETED|Overall Study||6||
48743948|NCT02680665|102158146|FG000|STARTED|Overall Study||120||
48743949|NCT02680665|102158146|FG000|COMPLETED|Overall Study||115||
48164661|NCT02306122|100725078|FG006|STARTED|Post Nonadherence Subgroup Randomization||220|Only those patients with a nonadherence event are included in this period.|
48164662|NCT02306122|100725079|FG007|STARTED|Post Nonadherence Subgroup Randomization||221|Only those patients with a nonadherence event are included in this period.|
48164663|NCT02306122|100725080|FG008|STARTED|Post Nonadherence Subgroup Randomization||28|Only those patients with a nonadherence event are included in this period.|
48164664|NCT02306122|100725081|FG009|STARTED|Post Nonadherence Subgroup Randomization||31|Only those patients with a nonadherence event are included in this period.|
48164665|NCT02306122|100725082|FG010|STARTED|Post Nonadherence Subgroup Randomization||31|Only those patients with a nonadherence event are included in this period.|
48164666|NCT02306122|100725072|FG000|COMPLETED|Post Nonadherence Subgroup Randomization||244||
48164667|NCT02306122|100725073|FG001|COMPLETED|Post Nonadherence Subgroup Randomization||123||
48164668|NCT02306122|100725074|FG002|COMPLETED|Post Nonadherence Subgroup Randomization||121||
48164669|NCT02306122|100725075|FG003|COMPLETED|Post Nonadherence Subgroup Randomization||274||
48164670|NCT02306122|100725076|FG004|COMPLETED|Post Nonadherence Subgroup Randomization||134||
48164671|NCT02306122|100725077|FG005|COMPLETED|Post Nonadherence Subgroup Randomization||137||
48164672|NCT02306122|100725078|FG006|COMPLETED|Post Nonadherence Subgroup Randomization||220||
48164673|NCT02306122|100725079|FG007|COMPLETED|Post Nonadherence Subgroup Randomization||221||
48164674|NCT02306122|100725080|FG008|COMPLETED|Post Nonadherence Subgroup Randomization||28||
48620932|NCT03234036|101856440|FG001|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0||
48743950|NCT02680665|102158146|FG000|NOT COMPLETED|Overall Study||5||
48743951|NCT00836186|102158147|FG000|STARTED|Overall Study||82||
48743952|NCT00836186|102158147|FG000|COMPLETED|Overall Study||81||
48743953|NCT00836186|102158147|FG000|NOT COMPLETED|Overall Study||1||
48743954|NCT02724449|102158148|FG000|STARTED|Overall Study||16||
48743955|NCT02724449|102158148|FG000|COMPLETED|Overall Study||16||
48743956|NCT02724449|102158148|FG000|NOT COMPLETED|Overall Study||0||
48743957|NCT03863509|102158149|FG000|STARTED|Overall Study||139||
48743958|NCT03863509|102158150|FG001|STARTED|Overall Study||192||
48743959|NCT03863509|102158151|FG002|STARTED|Overall Study||119||
48743960|NCT03863509|102158149|FG000|COMPLETED|Overall Study||117||
48743961|NCT03863509|102158150|FG001|COMPLETED|Overall Study||164||
48743962|NCT03863509|102158151|FG002|COMPLETED|Overall Study||114||
48743963|NCT03863509|102158149|FG000|NOT COMPLETED|Overall Study||22||
48743964|NCT03863509|102158150|FG001|NOT COMPLETED|Overall Study||28||
48620933|NCT03234036|101856441|FG002|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0||
48620934|NCT03234036|101856442|FG003|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0||
48620935|NCT03234036|101856439|FG000|STARTED|Part 2 (Up to 25 Days)||0||
48620936|NCT03234036|101856440|FG001|STARTED|Part 2 (Up to 25 Days)||0||
48620937|NCT03234036|101856441|FG002|STARTED|Part 2 (Up to 25 Days)||3||
48620938|NCT03234036|101856442|FG003|STARTED|Part 2 (Up to 25 Days)||7||
48620939|NCT03234036|101856439|FG000|COMPLETED|Part 2 (Up to 25 Days)||0||
48620940|NCT03234036|101856440|FG001|COMPLETED|Part 2 (Up to 25 Days)||0||
48620941|NCT03234036|101856441|FG002|COMPLETED|Part 2 (Up to 25 Days)||3||
48620942|NCT03234036|101856442|FG003|COMPLETED|Part 2 (Up to 25 Days)||7||
48620943|NCT03234036|101856439|FG000|NOT COMPLETED|Part 2 (Up to 25 Days)||0||
48620944|NCT03234036|101856440|FG001|NOT COMPLETED|Part 2 (Up to 25 Days)||0||
48620945|NCT03234036|101856441|FG002|NOT COMPLETED|Part 2 (Up to 25 Days)||0||
48620946|NCT03234036|101856442|FG003|NOT COMPLETED|Part 2 (Up to 25 Days)||0||
48620947|NCT03041636|101856443|FG000|STARTED|Overall Study||1||
48620948|NCT03041636|101856443|FG000|COMPLETED|Overall Study||1||
48327120|NCT01347034|101128268|FG000|STARTED|Overall Study||6||
48327121|NCT01347034|101128269|FG001|STARTED|Overall Study||14||
48743965|NCT03863509|102158151|FG002|NOT COMPLETED|Overall Study||5||
48743966|NCT01176058|102158152|FG000|STARTED|Overall Study||9||
48743967|NCT01176058|102158153|FG001|STARTED|Overall Study||8||
48743968|NCT01176058|102158152|FG000|COMPLETED|Overall Study||5||
48743969|NCT01176058|102158153|FG001|COMPLETED|Overall Study||5||
48620949|NCT03041636|101856443|FG000|NOT COMPLETED|Overall Study||0||
48620950|NCT02782741|101856444|FG000|STARTED|Blinded Treatment Period: up to Week 49||51|Randomized and treated participants.|
48620951|NCT02782741|101856445|FG001|STARTED|Blinded Treatment Period: up to Week 49||49|Randomized and treated participants.|
48620952|NCT02782741|101856446|FG002|STARTED|Blinded Treatment Period: up to Week 49||0|Randomized and treated participants.|
48743970|NCT01176058|102158152|FG000|NOT COMPLETED|Overall Study||4||
48743971|NCT01176058|102158153|FG001|NOT COMPLETED|Overall Study||3||
48743972|NCT00358007|102158154|FG000|STARTED|Overall Study||30||
48743973|NCT00358007|102158154|FG000|COMPLETED|Overall Study||28||
48743974|NCT00358007|102158154|FG000|NOT COMPLETED|Overall Study||2||
48743975|NCT00732875|102158155|FG000|STARTED|Overall Study||92||
48743976|NCT00732875|102158155|FG000|COMPLETED|Overall Study||57||
48743977|NCT00732875|102158155|FG000|NOT COMPLETED|Overall Study||35||
48743978|NCT02741596|102158156|FG000|STARTED|Overall Study||109||
48743979|NCT02741596|102158157|FG001|STARTED|Overall Study||103||
48743980|NCT02741596|102158156|FG000|COMPLETED|Overall Study||31||
48743981|NCT02741596|102158157|FG001|COMPLETED|Overall Study||25||
48743982|NCT02741596|102158156|FG000|NOT COMPLETED|Overall Study||78||
48743983|NCT02741596|102158157|FG001|NOT COMPLETED|Overall Study||78||
48743984|NCT04756804|102158158|FG000|STARTED|Overall Study||25||
48743985|NCT04756804|102158159|FG001|STARTED|Overall Study||26||
48620953|NCT02782741|101856444|FG000|Safety Population|Blinded Treatment Period: up to Week 49||51|Included participants who received at least 1 infusion in blinded treatment period (also known as PAP) and were analyzed according to the treatment received.|
48620954|NCT02782741|101856445|FG001|Safety Population|Blinded Treatment Period: up to Week 49||49|Included participants who received at least 1 infusion in blinded treatment period (also known as PAP) and were analyzed according to the treatment received.|
48620955|NCT02782741|101856446|FG002|Safety Population|Blinded Treatment Period: up to Week 49||0|Included participants who received at least 1 infusion in blinded treatment period (also known as PAP) and were analyzed according to the treatment received.|
48620956|NCT02782741|101856444|FG000|COMPLETED|Blinded Treatment Period: up to Week 49||51||
48743986|NCT04756804|102158158|FG000|COMPLETED|Overall Study||25||
48743987|NCT04756804|102158159|FG001|COMPLETED|Overall Study||25||
48743988|NCT04756804|102158158|FG000|NOT COMPLETED|Overall Study||0||
48743989|NCT04756804|102158159|FG001|NOT COMPLETED|Overall Study||1||
48743990|NCT01459588|102158160|FG000|STARTED|Overall Study||105||
48743991|NCT01459588|102158161|FG001|STARTED|Overall Study||51||
48743992|NCT01459588|102158162|FG002|STARTED|Overall Study||103||
48743993|NCT01459588|102158163|FG003|STARTED|Overall Study||56||
48743994|NCT01459588|102158160|FG000|COMPLETED|Overall Study||104||
48743995|NCT01459588|102158161|FG001|COMPLETED|Overall Study||49||
48743996|NCT01459588|102158162|FG002|COMPLETED|Overall Study||102||
48743997|NCT01459588|102158163|FG003|COMPLETED|Overall Study||55||
48743998|NCT01459588|102158160|FG000|NOT COMPLETED|Overall Study||1||
48743999|NCT01459588|102158161|FG001|NOT COMPLETED|Overall Study||2||
48744000|NCT01459588|102158162|FG002|NOT COMPLETED|Overall Study||1||
48744001|NCT01459588|102158163|FG003|NOT COMPLETED|Overall Study||1||
48744002|NCT02342223|102158164|FG000|STARTED|Overall Study||20||
48744003|NCT02342223|102158164|FG000|COMPLETED|Overall Study||19||
48744004|NCT02342223|102158164|FG000|NOT COMPLETED|Overall Study||1||
48744005|NCT00462306|102158165|FG000|STARTED|Overall Study||4074||
48744006|NCT00462306|102158166|FG001|STARTED|Overall Study||503||
48744007|NCT00462306|102158165|FG000|COMPLETED|Overall Study||4074||
48744008|NCT00462306|102158166|FG001|COMPLETED|Overall Study||490||
48744009|NCT00462306|102158165|FG000|NOT COMPLETED|Overall Study||0||
48744010|NCT00462306|102158166|FG001|NOT COMPLETED|Overall Study||13||
48744011|NCT02330055|102158167|FG000|STARTED|Overall Study||50||
48744012|NCT02330055|102158168|FG001|STARTED|Overall Study||49||
48744013|NCT02330055|102158167|FG000|COMPLETED|Overall Study||40||
48744014|NCT02330055|102158168|FG001|COMPLETED|Overall Study||40||
48744015|NCT02330055|102158167|FG000|NOT COMPLETED|Overall Study||10||
48744016|NCT02330055|102158168|FG001|NOT COMPLETED|Overall Study||9||
48744017|NCT01822457|102158169|FG000|STARTED|Overall Study||20||
48744018|NCT01822457|102158170|FG001|STARTED|Overall Study||17||
48744019|NCT01822457|102158169|FG000|COMPLETED|Overall Study||16||
48744020|NCT01822457|102158170|FG001|COMPLETED|Overall Study||12||
48744021|NCT01822457|102158169|FG000|NOT COMPLETED|Overall Study||4||
48744022|NCT01822457|102158170|FG001|NOT COMPLETED|Overall Study||5||
48744023|NCT02707146|102158171|FG000|STARTED|Overall Study||359||
48744024|NCT02707146|102158172|FG001|STARTED|Overall Study||391||
48744025|NCT02707146|102158171|FG000|COMPLETED|Overall Study||359||
48744026|NCT02707146|102158172|FG001|COMPLETED|Overall Study||388||
48744027|NCT02707146|102158171|FG000|NOT COMPLETED|Overall Study||0||
48744028|NCT02707146|102158172|FG001|NOT COMPLETED|Overall Study||3||
48744029|NCT01951651|102158173|FG000|STARTED|Overall Study||12||
48744030|NCT01951651|102158174|FG001|STARTED|Overall Study||12||
48744031|NCT01951651|102158173|FG000|COMPLETED|Overall Study||8||
48744032|NCT01951651|102158174|FG001|COMPLETED|Overall Study||10||
48744033|NCT01951651|102158173|FG000|NOT COMPLETED|Overall Study||4||
48744034|NCT01951651|102158174|FG001|NOT COMPLETED|Overall Study||2||
48744035|NCT00269919|102158175|FG000|STARTED|Overall Study||40||
48744036|NCT00269919|102158175|FG000|Treated|Overall Study||39||
48744037|NCT00269919|102158175|FG000|COMPLETED|Overall Study||13||
48744038|NCT00269919|102158175|FG000|NOT COMPLETED|Overall Study||27||
48744039|NCT00571974|102158176|FG000|STARTED|Phase I||9||
48744040|NCT00571974|102158177|FG001|STARTED|Phase I||0||
48744041|NCT00571974|102158176|FG000|COMPLETED|Phase I||9||
48744042|NCT00571974|102158177|FG001|COMPLETED|Phase I||0||
48744043|NCT00571974|102158176|FG000|NOT COMPLETED|Phase I||0||
48744044|NCT00571974|102158177|FG001|NOT COMPLETED|Phase I||0||
48744045|NCT00571974|102158176|FG000|STARTED|Phase II||0||
48744046|NCT00571974|102158177|FG001|STARTED|Phase II||21||
48744047|NCT00571974|102158176|FG000|COMPLETED|Phase II||0||
48744048|NCT00571974|102158177|FG001|COMPLETED|Phase II||17||
48744049|NCT00571974|102158176|FG000|NOT COMPLETED|Phase II||0||
48744050|NCT00571974|102158177|FG001|NOT COMPLETED|Phase II||4||
48744051|NCT00239928|102158178|FG000|STARTED|Overall Study||61||
48744052|NCT00239928|102158178|FG000|COMPLETED|Overall Study||51||
48744053|NCT00239928|102158178|FG000|NOT COMPLETED|Overall Study||10||
48744054|NCT01402817|102158179|FG000|STARTED|Overall Study||19||
48744055|NCT01402817|102158179|FG000|COMPLETED|Overall Study||8||
48744056|NCT01402817|102158179|FG000|NOT COMPLETED|Overall Study||11||
48744057|NCT03004911|102158180|FG000|STARTED|Overall Study||20||
48744058|NCT03004911|102158181|FG001|STARTED|Overall Study||20||
48744059|NCT03004911|102158180|FG000|COMPLETED|Overall Study||19||
48744060|NCT03004911|102158181|FG001|COMPLETED|Overall Study||17||
48744061|NCT03004911|102158180|FG000|NOT COMPLETED|Overall Study||1||
48744062|NCT03004911|102158181|FG001|NOT COMPLETED|Overall Study||3||
48744063|NCT00411671|102158182|FG000|STARTED|Overall Study||105||
48744064|NCT00411671|102158182|FG000|COMPLETED|Overall Study||85||
48744065|NCT00411671|102158182|FG000|NOT COMPLETED|Overall Study||20||
48744066|NCT00977171|102158183|FG000|STARTED|Overall Study||3||
48744067|NCT00977171|102158183|FG000|COMPLETED|Overall Study||3||
48744068|NCT00977171|102158183|FG000|NOT COMPLETED|Overall Study||0||
48744069|NCT02362724|102158184|FG000|STARTED|Overall Study||59||
48744070|NCT02362724|102158185|FG001|STARTED|Overall Study||30||
48744071|NCT02362724|102158184|FG000|COMPLETED|Overall Study||53||
48744072|NCT02362724|102158185|FG001|COMPLETED|Overall Study||29||
48744073|NCT02362724|102158184|FG000|NOT COMPLETED|Overall Study||6||
48744074|NCT02362724|102158185|FG001|NOT COMPLETED|Overall Study||1||
48744075|NCT01965704|102158186|FG000|STARTED|Overall Study||48||
48744076|NCT01965704|102158187|FG001|STARTED|Overall Study||48||
48744077|NCT01965704|102158188|FG002|STARTED|Overall Study||50||
48744078|NCT01965704|102158189|FG003|STARTED|Overall Study||50||
48744079|NCT01965704|102158186|FG000|Received Intervention|Overall Study||45||
48744080|NCT01965704|102158187|FG001|Received Intervention|Overall Study||45||
48744081|NCT01965704|102158188|FG002|Received Intervention|Overall Study||47||
48744082|NCT01965704|102158189|FG003|Received Intervention|Overall Study||47||
48744083|NCT01965704|102158186|FG000|Analyzable Population|Overall Study||45|Received treatment and met all eligibility criteria|
48744084|NCT01965704|102158187|FG001|Analyzable Population|Overall Study||45|Received treatment and met all eligibility criteria|
48744085|NCT01965704|102158188|FG002|Analyzable Population|Overall Study||41|Received treatment and met all eligibility criteria|
48744086|NCT01965704|102158189|FG003|Analyzable Population|Overall Study||41|Received treatment and met all eligibility criteria|
48744087|NCT01965704|102158186|FG000|COMPLETED|Overall Study||45||
48744088|NCT01965704|102158187|FG001|COMPLETED|Overall Study||45||
48744089|NCT01965704|102158188|FG002|COMPLETED|Overall Study||45||
48744090|NCT01965704|102158189|FG003|COMPLETED|Overall Study||45||
48744091|NCT01965704|102158186|FG000|NOT COMPLETED|Overall Study||3||
48744092|NCT01965704|102158187|FG001|NOT COMPLETED|Overall Study||3||
48744093|NCT01965704|102158188|FG002|NOT COMPLETED|Overall Study||5||
48744094|NCT01965704|102158189|FG003|NOT COMPLETED|Overall Study||5||
48744095|NCT01582139|102158190|FG000|STARTED|Overall Study||6||
48744096|NCT01582139|102158191|FG001|STARTED|Overall Study||6||
48744097|NCT01582139|102158190|FG000|COMPLETED|Overall Study||6||
48744098|NCT01582139|102158191|FG001|COMPLETED|Overall Study||6||
48744099|NCT01582139|102158190|FG000|NOT COMPLETED|Overall Study||0||
48744100|NCT01582139|102158191|FG001|NOT COMPLETED|Overall Study||0||
48744101|NCT03229109|102158192|FG000|STARTED|Overall Study||50||
48744102|NCT03229109|102158193|FG001|STARTED|Overall Study||50||
48744103|NCT03229109|102158194|FG002|STARTED|Overall Study||50||
48744104|NCT03229109|102158195|FG003|STARTED|Overall Study||51||
48744105|NCT03229109|102158192|FG000|COMPLETED|Overall Study||50||
48744106|NCT03229109|102158193|FG001|COMPLETED|Overall Study||50||
48744107|NCT03229109|102158194|FG002|COMPLETED|Overall Study||50||
48744108|NCT03229109|102158195|FG003|COMPLETED|Overall Study||50||
48744109|NCT03229109|102158192|FG000|NOT COMPLETED|Overall Study||0||
48744110|NCT03229109|102158193|FG001|NOT COMPLETED|Overall Study||0||
48744111|NCT03229109|102158194|FG002|NOT COMPLETED|Overall Study||0||
48744112|NCT03229109|102158195|FG003|NOT COMPLETED|Overall Study||1||
48744113|NCT01370265|102158196|FG000|STARTED|Resting Myocardial Blood Flow (MBF)||6||
48744114|NCT01370265|102158197|FG001|STARTED|Resting Myocardial Blood Flow (MBF)||6||
48744115|NCT01370265|102158196|FG000|COMPLETED|Resting Myocardial Blood Flow (MBF)||6||
48744116|NCT01370265|102158197|FG001|COMPLETED|Resting Myocardial Blood Flow (MBF)||6||
48744117|NCT01370265|102158196|FG000|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0||
48744118|NCT01370265|102158197|FG001|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0||
48744119|NCT01370265|102158196|FG000|STARTED|Washout Period (50-minute Period Decay)||6||
48744120|NCT01370265|102158197|FG001|STARTED|Washout Period (50-minute Period Decay)||6||
48744121|NCT01370265|102158196|FG000|COMPLETED|Washout Period (50-minute Period Decay)||6||
48744122|NCT01370265|102158197|FG001|COMPLETED|Washout Period (50-minute Period Decay)||6||
48744123|NCT01370265|102158196|FG000|NOT COMPLETED|Washout Period (50-minute Period Decay)||0||
48744124|NCT01370265|102158197|FG001|NOT COMPLETED|Washout Period (50-minute Period Decay)||0||
48744125|NCT01370265|102158196|FG000|STARTED|First Intervention||6||
48744126|NCT01370265|102158197|FG001|STARTED|First Intervention||6||
48744127|NCT01370265|102158196|FG000|COMPLETED|First Intervention||5||
48744128|NCT01370265|102158197|FG001|COMPLETED|First Intervention||5||
48744129|NCT01370265|102158196|FG000|NOT COMPLETED|First Intervention||1||
48744130|NCT01370265|102158197|FG001|NOT COMPLETED|First Intervention||1||
48744131|NCT01370265|102158196|FG000|STARTED|Washout Period (50-minute Period Decay)||5||
48744132|NCT01370265|102158197|FG001|STARTED|Washout Period (50-minute Period Decay)||5||
48744133|NCT01370265|102158196|FG000|COMPLETED|Washout Period (50-minute Period Decay)||5||
48744134|NCT01370265|102158197|FG001|COMPLETED|Washout Period (50-minute Period Decay)||5||
48744135|NCT01370265|102158196|FG000|NOT COMPLETED|Washout Period (50-minute Period Decay)||0||
48744136|NCT01370265|102158197|FG001|NOT COMPLETED|Washout Period (50-minute Period Decay)||0||
48744137|NCT01370265|102158196|FG000|STARTED|Second Intervention||5||
48744138|NCT01370265|102158197|FG001|STARTED|Second Intervention||5||
48744139|NCT01370265|102158196|FG000|COMPLETED|Second Intervention||5||
48744140|NCT01370265|102158197|FG001|COMPLETED|Second Intervention||5||
48744141|NCT01370265|102158196|FG000|NOT COMPLETED|Second Intervention||0||
48744142|NCT01370265|102158197|FG001|NOT COMPLETED|Second Intervention||0||
48744143|NCT02392806|102158198|FG000|STARTED|Overall Study||22||
48744144|NCT02392806|102158199|FG001|STARTED|Overall Study||21||
48744145|NCT02392806|102158198|FG000|COMPLETED|Overall Study||22||
48744146|NCT02392806|102158199|FG001|COMPLETED|Overall Study||21||
48744147|NCT02392806|102158198|FG000|NOT COMPLETED|Overall Study||0||
48744148|NCT02392806|102158199|FG001|NOT COMPLETED|Overall Study||0||
48744149|NCT01426958|102158200|FG000|STARTED|Overall Study||24||
48744150|NCT01426958|102158200|FG000|COMPLETED|Overall Study||22||
48744151|NCT01426958|102158200|FG000|NOT COMPLETED|Overall Study||2||
48744152|NCT01559675|102158201|FG000|STARTED|Overall Study||58||
48744153|NCT01559675|102158202|FG001|STARTED|Overall Study||63||
48744154|NCT01559675|102158201|FG000|COMPLETED|Overall Study||43||
48744155|NCT01559675|102158202|FG001|COMPLETED|Overall Study||49||
48744156|NCT01559675|102158201|FG000|NOT COMPLETED|Overall Study||15||
48744157|NCT01559675|102158202|FG001|NOT COMPLETED|Overall Study||14||
48744158|NCT01764711|102158203|FG000|STARTED|Overall Study||8||
48744159|NCT01764711|102158204|FG001|STARTED|Overall Study||5||
48744160|NCT01764711|102158203|FG000|COMPLETED|Overall Study||8||
48744161|NCT01764711|102158204|FG001|COMPLETED|Overall Study||5||
48744162|NCT01764711|102158203|FG000|NOT COMPLETED|Overall Study||0||
48744163|NCT01764711|102158204|FG001|NOT COMPLETED|Overall Study||0||
48744164|NCT03294590|102158205|FG000|STARTED|Overall Study||377|Number of parent/caregiver-child dyads randomized|
48744165|NCT03294590|102158206|FG001|STARTED|Overall Study||377|Number of parent/caregiver-child dyads randomized|
48744166|NCT03294590|102158205|FG000|Number of Parent/Caregiver Participants|Overall Study||377||
48744167|NCT03294590|102158206|FG001|Number of Parent/Caregiver Participants|Overall Study||377||
48744168|NCT03294590|102158205|FG000|Number of Children Participants|Overall Study||377||
48744169|NCT03294590|102158206|FG001|Number of Children Participants|Overall Study||377||
48744170|NCT03294590|102158205|FG000|4-month Time Point (Survey)|Overall Study||290||
48744171|NCT03294590|102158206|FG001|4-month Time Point (Survey)|Overall Study||288||
48164675|NCT02306122|100725081|FG009|COMPLETED|Post Nonadherence Subgroup Randomization||31||
48164676|NCT02306122|100725082|FG010|COMPLETED|Post Nonadherence Subgroup Randomization||31||
48620957|NCT02782741|101856445|FG001|COMPLETED|Blinded Treatment Period: up to Week 49||44||
48620958|NCT02782741|101856446|FG002|COMPLETED|Blinded Treatment Period: up to Week 49||0||
48620959|NCT02782741|101856444|FG000|NOT COMPLETED|Blinded Treatment Period: up to Week 49||0||
48620960|NCT02782741|101856445|FG001|NOT COMPLETED|Blinded Treatment Period: up to Week 49||5||
48620961|NCT02782741|101856446|FG002|NOT COMPLETED|Blinded Treatment Period: up to Week 49||0||
48620962|NCT02782741|101856444|FG000|STARTED|Open-label Long-term: Week 50 to 289||51||
48620963|NCT02782741|101856445|FG001|STARTED|Open-label Long-term: Week 50 to 289||44||
48620964|NCT02782741|101856446|FG002|STARTED|Open-label Long-term: Week 50 to 289||1||
48620965|NCT02782741|101856444|FG000|Safety Population|Open-label Long-term: Week 50 to 289||51|Included participants who received at least 1 infusion in open-label long-term phase and were analyzed according to the treatment received.|
48620966|NCT02782741|101856445|FG001|Safety Population|Open-label Long-term: Week 50 to 289||44|Included participants who received at least 1 infusion in open-label long-term phase and were analyzed according to the treatment received.|
48620967|NCT02782741|101856446|FG002|Safety Population|Open-label Long-term: Week 50 to 289||1|Included participants who received at least 1 infusion in open-label long-term phase and were analyzed according to the treatment received.|
48620968|NCT02782741|101856444|FG000|COMPLETED|Open-label Long-term: Week 50 to 289||44||
48620969|NCT02782741|101856445|FG001|COMPLETED|Open-label Long-term: Week 50 to 289||36||
48620970|NCT02782741|101856446|FG002|COMPLETED|Open-label Long-term: Week 50 to 289||1||
48620971|NCT02782741|101856444|FG000|NOT COMPLETED|Open-label Long-term: Week 50 to 289||7||
48620972|NCT02782741|101856445|FG001|NOT COMPLETED|Open-label Long-term: Week 50 to 289||8||
48620973|NCT02782741|101856446|FG002|NOT COMPLETED|Open-label Long-term: Week 50 to 289||0||
48620974|NCT01274351|101856447|FG000|STARTED|Overall Study||112|participants enrolled|
48620975|NCT01274351|101856447|FG000|COMPLETED|Overall Study||92||
48620976|NCT01274351|101856447|FG000|NOT COMPLETED|Overall Study||20||
48620977|NCT00971867|101856448|FG000|STARTED|Overall Study||11||
48620978|NCT00971867|101856448|FG000|COMPLETED|Overall Study||0||
48620979|NCT00971867|101856448|FG000|NOT COMPLETED|Overall Study||11||
48620980|NCT02554760|101856449|FG000|STARTED|Overall Study||9||
48620981|NCT02554760|101856450|FG001|STARTED|Overall Study||10||
48620982|NCT02554760|101856449|FG000|COMPLETED|Overall Study||9||
48620983|NCT02554760|101856450|FG001|COMPLETED|Overall Study||10||
48620984|NCT02554760|101856449|FG000|NOT COMPLETED|Overall Study||0||
48620985|NCT02554760|101856450|FG001|NOT COMPLETED|Overall Study||0||
48620986|NCT02700048|101856451|FG000|STARTED|Overall Study||0||
48620987|NCT02700048|101856452|FG001|STARTED|Overall Study||3||
48744172|NCT03294590|102158205|FG000|12-month Time Point (Survey)|Overall Study||282||
48744173|NCT03294590|102158206|FG001|12-month Time Point (Survey)|Overall Study||290||
48744174|NCT03294590|102158205|FG000|12-month Time Point (Oral Exam)|Overall Study||206||
48620988|NCT02700048|101856451|FG000|COMPLETED|Overall Study||0||
48164677|NCT02306122|100725072|FG000|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0||
48164678|NCT02306122|100725073|FG001|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0||
48620989|NCT02700048|101856452|FG001|COMPLETED|Overall Study||0||
48620990|NCT02700048|101856451|FG000|NOT COMPLETED|Overall Study||0||
48620991|NCT02700048|101856452|FG001|NOT COMPLETED|Overall Study||3||
48620992|NCT03335800|101856453|FG000|STARTED|Overall Study||419927||
48620993|NCT03335800|101856453|FG000|Received Irregular Pulse Notification|Overall Study||2161||
48620994|NCT03335800|101856453|FG000|Attended First Study Visit|Overall Study||945||
48620995|NCT03335800|101856453|FG000|ECG Patch Shipped|Overall Study||658||
48620996|NCT03335800|101856453|FG000|ECG Patch Returned for Analysis|Overall Study||450||
48620997|NCT03335800|101856453|FG000|Attended Second Study Visit|Overall Study||396||
48620998|NCT03335800|101856453|FG000|COMPLETED|Overall Study||396||
48620999|NCT03335800|101856453|FG000|NOT COMPLETED|Overall Study||419531||
48621000|NCT01368263|101856454|FG000|STARTED|Overall Study||6||
48621001|NCT01368263|101856455|FG001|STARTED|Overall Study||1||
48621002|NCT01368263|101856456|FG002|STARTED|Overall Study||1||
48621003|NCT01368263|101856454|FG000|COMPLETED|Overall Study||6||
48621004|NCT01368263|101856455|FG001|COMPLETED|Overall Study||1||
48621005|NCT01368263|101856456|FG002|COMPLETED|Overall Study||1||
48621006|NCT01368263|101856454|FG000|NOT COMPLETED|Overall Study||0||
48621007|NCT01368263|101856455|FG001|NOT COMPLETED|Overall Study||0||
48621008|NCT01368263|101856456|FG002|NOT COMPLETED|Overall Study||0||
48621009|NCT02322749|101856457|FG000|STARTED|Period 1||8||
48621010|NCT02322749|101856458|FG001|STARTED|Period 1||8||
48621011|NCT02322749|101856459|FG002|STARTED|Period 1||8||
48621012|NCT02322749|101856460|FG003|STARTED|Period 1||8||
48621013|NCT02322749|101856461|FG004|STARTED|Period 1||8||
48621014|NCT02322749|101856462|FG005|STARTED|Period 1||8||
48621015|NCT02322749|101856457|FG000|COMPLETED|Period 1||8||
48621016|NCT02322749|101856458|FG001|COMPLETED|Period 1||8||
48621017|NCT02322749|101856459|FG002|COMPLETED|Period 1||8||
48621018|NCT02322749|101856460|FG003|COMPLETED|Period 1||8||
48621019|NCT02322749|101856461|FG004|COMPLETED|Period 1||8||
48621020|NCT02322749|101856462|FG005|COMPLETED|Period 1||8||
48621021|NCT02322749|101856457|FG000|NOT COMPLETED|Period 1||0||
48621022|NCT02322749|101856458|FG001|NOT COMPLETED|Period 1||0||
48744175|NCT03294590|102158206|FG001|12-month Time Point (Oral Exam)|Overall Study||185||
48621023|NCT02322749|101856459|FG002|NOT COMPLETED|Period 1||0||
48621024|NCT02322749|101856460|FG003|NOT COMPLETED|Period 1||0||
48621025|NCT02322749|101856461|FG004|NOT COMPLETED|Period 1||0||
48164679|NCT02306122|100725074|FG002|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0||
48164680|NCT02306122|100725075|FG003|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0||
48164681|NCT02306122|100725076|FG004|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0||
48164682|NCT02306122|100725077|FG005|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0||
48164683|NCT02306122|100725078|FG006|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0||
48164684|NCT02306122|100725079|FG007|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0||
48164685|NCT02306122|100725080|FG008|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0||
48164686|NCT02306122|100725081|FG009|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0||
48164687|NCT02306122|100725082|FG010|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0||
48164688|NCT03565068|100725083|FG000|STARTED|Overall Study||12||
48164689|NCT03565068|100725084|FG001|STARTED|Overall Study||4||
48164690|NCT03565068|100725085|FG002|STARTED|Overall Study||12||
48164691|NCT03565068|100725086|FG003|STARTED|Overall Study||4||
48164692|NCT03565068|100725087|FG004|STARTED|Overall Study||12||
48164693|NCT03565068|100725088|FG005|STARTED|Overall Study||1||
48164694|NCT03565068|100725089|FG006|STARTED|Overall Study||4||
48164695|NCT03565068|100725090|FG007|STARTED|Overall Study||17||
48164696|NCT03565068|100725091|FG008|STARTED|Overall Study||9||
48164697|NCT03565068|100725083|FG000|COMPLETED|Overall Study||12||
48164698|NCT03565068|100725084|FG001|COMPLETED|Overall Study||4||
48164699|NCT03565068|100725085|FG002|COMPLETED|Overall Study||11||
48164700|NCT03565068|100725086|FG003|COMPLETED|Overall Study||4||
48164701|NCT03565068|100725087|FG004|COMPLETED|Overall Study||8||
48164702|NCT03565068|100725088|FG005|COMPLETED|Overall Study||0||
48164703|NCT03565068|100725089|FG006|COMPLETED|Overall Study||3||
48164704|NCT03565068|100725090|FG007|COMPLETED|Overall Study||9||
48164705|NCT03565068|100725091|FG008|COMPLETED|Overall Study||8||
48164706|NCT03565068|100725083|FG000|NOT COMPLETED|Overall Study||0||
48164707|NCT03565068|100725084|FG001|NOT COMPLETED|Overall Study||0||
48164708|NCT03565068|100725085|FG002|NOT COMPLETED|Overall Study||1||
48164709|NCT03565068|100725086|FG003|NOT COMPLETED|Overall Study||0||
48164710|NCT03565068|100725087|FG004|NOT COMPLETED|Overall Study||4||
48164711|NCT03565068|100725088|FG005|NOT COMPLETED|Overall Study||1||
48164712|NCT03565068|100725089|FG006|NOT COMPLETED|Overall Study||1||
48164713|NCT03565068|100725090|FG007|NOT COMPLETED|Overall Study||8||
48164714|NCT03565068|100725091|FG008|NOT COMPLETED|Overall Study||1||
48164715|NCT02956434|100725092|FG000|STARTED|Overall Study||10||
48164716|NCT02956434|100725093|FG001|STARTED|Overall Study||10||
48164717|NCT02956434|100725094|FG002|STARTED|Overall Study||10||
48164718|NCT02956434|100725095|FG003|STARTED|Overall Study||10||
48164719|NCT02956434|100725092|FG000|COMPLETED|Overall Study||10||
48164720|NCT02956434|100725093|FG001|COMPLETED|Overall Study||10||
48164721|NCT02956434|100725094|FG002|COMPLETED|Overall Study||10||
48164722|NCT02956434|100725095|FG003|COMPLETED|Overall Study||10||
48164723|NCT02956434|100725092|FG000|NOT COMPLETED|Overall Study||0||
48164724|NCT02956434|100725093|FG001|NOT COMPLETED|Overall Study||0||
48164725|NCT02956434|100725094|FG002|NOT COMPLETED|Overall Study||0||
48164726|NCT02956434|100725095|FG003|NOT COMPLETED|Overall Study||0||
48164727|NCT04615182|100725096|FG000|STARTED|Overall Study||90||
48164728|NCT04615182|100725096|FG000|Per Protocol Population|Overall Study||83||
48164729|NCT04615182|100725096|FG000|COMPLETED|Overall Study||75||
48164730|NCT04615182|100725096|FG000|NOT COMPLETED|Overall Study||15||
48164731|NCT04704154|100725097|FG000|STARTED|Overall Study||30|Assigned to treatment|
48164732|NCT04704154|100725098|FG001|STARTED|Overall Study||20|Assigned to treatment|
48164733|NCT04704154|100725099|FG002|STARTED|Overall Study||30|Assigned to treatment|
48164734|NCT04704154|100725100|FG003|STARTED|Overall Study||20|Assigned to treatment|
48164735|NCT04704154|100725101|FG004|STARTED|Overall Study||45|Assigned to treatment|
48164736|NCT04704154|100725102|FG005|STARTED|Overall Study||30|Assigned to treatment|
48621026|NCT02322749|101856462|FG005|NOT COMPLETED|Period 1||0||
48621027|NCT02322749|101856457|FG000|STARTED|Period 2||8||
48621028|NCT02322749|101856458|FG001|STARTED|Period 2||8||
48621029|NCT02322749|101856459|FG002|STARTED|Period 2||8||
48164737|NCT04704154|100725097|FG000|COMPLETED|Overall Study||7|Ongoing with treatment till primary completion cut-off|
48164738|NCT04704154|100725098|FG001|COMPLETED|Overall Study||1|Ongoing with treatment till primary completion cut-off|
48621030|NCT02322749|101856460|FG003|STARTED|Period 2||8||
48164739|NCT04704154|100725099|FG002|COMPLETED|Overall Study||7|Ongoing with treatment till primary completion cut-off|
48164740|NCT04704154|100725100|FG003|COMPLETED|Overall Study||0|Ongoing with treatment till primary completion cut-off|
48164741|NCT04704154|100725101|FG004|COMPLETED|Overall Study||1|Ongoing with treatment till primary completion cut-off|
48164742|NCT04704154|100725102|FG005|COMPLETED|Overall Study||0|Ongoing with treatment till primary completion cut-off|
48621031|NCT02322749|101856461|FG004|STARTED|Period 2||8||
48164743|NCT04704154|100725097|FG000|NOT COMPLETED|Overall Study||23||
48164744|NCT04704154|100725098|FG001|NOT COMPLETED|Overall Study||19||
48164745|NCT04704154|100725099|FG002|NOT COMPLETED|Overall Study||23||
48621032|NCT02322749|101856462|FG005|STARTED|Period 2||8||
48621033|NCT02322749|101856457|FG000|COMPLETED|Period 2||8||
48621034|NCT02322749|101856458|FG001|COMPLETED|Period 2||8||
48164746|NCT04704154|100725100|FG003|NOT COMPLETED|Overall Study||20||
48164747|NCT04704154|100725101|FG004|NOT COMPLETED|Overall Study||44||
48164748|NCT04704154|100725102|FG005|NOT COMPLETED|Overall Study||30||
48164749|NCT04207840|100725103|FG000|STARTED|Treatment Period 1||9||
48164750|NCT04207840|100725104|FG001|STARTED|Treatment Period 1||10||
48164751|NCT04207840|100725105|FG002|STARTED|Treatment Period 1||9||
48164752|NCT04207840|100725103|FG000|COMPLETED|Treatment Period 1||9||
48164753|NCT04207840|100725104|FG001|COMPLETED|Treatment Period 1||10||
48164754|NCT04207840|100725105|FG002|COMPLETED|Treatment Period 1||9||
48164755|NCT04207840|100725103|FG000|NOT COMPLETED|Treatment Period 1||0||
48164756|NCT04207840|100725104|FG001|NOT COMPLETED|Treatment Period 1||0||
48164757|NCT04207840|100725105|FG002|NOT COMPLETED|Treatment Period 1||0||
48164758|NCT04207840|100725103|FG000|STARTED|Washout Period 1 (2-7 Days)||9||
48164759|NCT04207840|100725104|FG001|STARTED|Washout Period 1 (2-7 Days)||10||
48164760|NCT04207840|100725105|FG002|STARTED|Washout Period 1 (2-7 Days)||9||
48164761|NCT04207840|100725103|FG000|COMPLETED|Washout Period 1 (2-7 Days)||9||
48164762|NCT04207840|100725104|FG001|COMPLETED|Washout Period 1 (2-7 Days)||10||
48164763|NCT04207840|100725105|FG002|COMPLETED|Washout Period 1 (2-7 Days)||8||
48164764|NCT04207840|100725103|FG000|NOT COMPLETED|Washout Period 1 (2-7 Days)||0||
48164765|NCT04207840|100725104|FG001|NOT COMPLETED|Washout Period 1 (2-7 Days)||0||
48164766|NCT04207840|100725105|FG002|NOT COMPLETED|Washout Period 1 (2-7 Days)||1||
48164767|NCT04207840|100725103|FG000|STARTED|Treatment Period 2||9||
48164768|NCT04207840|100725104|FG001|STARTED|Treatment Period 2||10||
48164769|NCT04207840|100725105|FG002|STARTED|Treatment Period 2||8||
48164770|NCT04207840|100725103|FG000|COMPLETED|Treatment Period 2||9||
48164771|NCT04207840|100725104|FG001|COMPLETED|Treatment Period 2||10||
48164772|NCT04207840|100725105|FG002|COMPLETED|Treatment Period 2||8||
48164773|NCT04207840|100725103|FG000|NOT COMPLETED|Treatment Period 2||0||
48164774|NCT04207840|100725104|FG001|NOT COMPLETED|Treatment Period 2||0||
48164775|NCT04207840|100725105|FG002|NOT COMPLETED|Treatment Period 2||0||
48164776|NCT04207840|100725103|FG000|STARTED|Washout Period 2 (2-7 Days)||9||
48164777|NCT04207840|100725104|FG001|STARTED|Washout Period 2 (2-7 Days)||10||
48164778|NCT04207840|100725105|FG002|STARTED|Washout Period 2 (2-7 Days)||8||
48164779|NCT04207840|100725103|FG000|COMPLETED|Washout Period 2 (2-7 Days)||9||
48164780|NCT04207840|100725104|FG001|COMPLETED|Washout Period 2 (2-7 Days)||10||
48164781|NCT04207840|100725105|FG002|COMPLETED|Washout Period 2 (2-7 Days)||7||
48164782|NCT04207840|100725103|FG000|NOT COMPLETED|Washout Period 2 (2-7 Days)||0||
48164783|NCT04207840|100725104|FG001|NOT COMPLETED|Washout Period 2 (2-7 Days)||0||
48164784|NCT04207840|100725105|FG002|NOT COMPLETED|Washout Period 2 (2-7 Days)||1||
48164785|NCT04207840|100725103|FG000|STARTED|Treatment Period 3||9||
48164786|NCT04207840|100725104|FG001|STARTED|Treatment Period 3||10||
48164787|NCT04207840|100725105|FG002|STARTED|Treatment Period 3||7||
48164788|NCT04207840|100725103|FG000|COMPLETED|Treatment Period 3||9||
48164789|NCT04207840|100725104|FG001|COMPLETED|Treatment Period 3||10||
48164790|NCT04207840|100725105|FG002|COMPLETED|Treatment Period 3||7||
48164791|NCT04207840|100725103|FG000|NOT COMPLETED|Treatment Period 3||0||
48164792|NCT04207840|100725104|FG001|NOT COMPLETED|Treatment Period 3||0||
48164793|NCT04207840|100725105|FG002|NOT COMPLETED|Treatment Period 3||0||
48164794|NCT00699140|100725106|FG000|STARTED|Overall Study||18||
48164795|NCT00699140|100725106|FG000|COMPLETED|Overall Study||18||
48164796|NCT00699140|100725106|FG000|NOT COMPLETED|Overall Study||0||
48164797|NCT02343003|100725107|FG000|STARTED|Overall Study||76||
48164798|NCT02343003|100725108|FG001|STARTED|Overall Study||75||
48164799|NCT02343003|100725107|FG000|COMPLETED|Overall Study||58|Completion is with respect to the 6-month primary outcome.|
48164800|NCT02343003|100725108|FG001|COMPLETED|Overall Study||68|Completion is with respect to the 6-month primary outcome.|
48164801|NCT02343003|100725107|FG000|NOT COMPLETED|Overall Study||18||
48164802|NCT02343003|100725108|FG001|NOT COMPLETED|Overall Study||7||
48164803|NCT03463915|100725109|FG000|STARTED|Overall Study||45||
48164804|NCT03463915|100725110|FG001|STARTED|Overall Study||45||
48164805|NCT03463915|100725109|FG000|COMPLETED|Overall Study||35||
48164806|NCT03463915|100725110|FG001|COMPLETED|Overall Study||36||
48164807|NCT03463915|100725109|FG000|NOT COMPLETED|Overall Study||10||
48164808|NCT03463915|100725110|FG001|NOT COMPLETED|Overall Study||9||
48164809|NCT02294630|100725111|FG000|STARTED|Overall Study||37||
48164810|NCT02294630|100725112|FG001|STARTED|Overall Study||38||
48164811|NCT02294630|100725113|FG002|STARTED|Overall Study||35||
48164812|NCT02294630|100725114|FG003|STARTED|Overall Study||39||
48164813|NCT02294630|100725111|FG000|COMPLETED|Overall Study||37||
48164814|NCT02294630|100725112|FG001|COMPLETED|Overall Study||38||
48164815|NCT02294630|100725113|FG002|COMPLETED|Overall Study||35||
48164816|NCT02294630|100725114|FG003|COMPLETED|Overall Study||39||
48164817|NCT02294630|100725111|FG000|NOT COMPLETED|Overall Study||0||
48164818|NCT02294630|100725112|FG001|NOT COMPLETED|Overall Study||0||
48164819|NCT02294630|100725113|FG002|NOT COMPLETED|Overall Study||0||
48164820|NCT02294630|100725114|FG003|NOT COMPLETED|Overall Study||0||
48164821|NCT00553501|100725115|FG000|STARTED|Overall Study||59||
48164822|NCT00553501|100725115|FG000|COMPLETED|Overall Study||55||
48164823|NCT00553501|100725115|FG000|NOT COMPLETED|Overall Study||4||
48164824|NCT04195880|100725116|FG000|STARTED|Overall Study||3205||
48164825|NCT04195880|100725117|FG001|STARTED|Overall Study||3338||
48744176|NCT03294590|102158205|FG000|24-month Time Point (Survey)|Overall Study||272||
48744177|NCT03294590|102158206|FG001|24-month Time Point (Survey)|Overall Study||270||
48744178|NCT03294590|102158205|FG000|24-month Time Point (Oral Exam)|Overall Study||160||
48744179|NCT03294590|102158206|FG001|24-month Time Point (Oral Exam)|Overall Study||156||
48744180|NCT03294590|102158205|FG000|COMPLETED|Overall Study||272|542 parent/caregiver participants completed at least the questionnaire assessment of the final study visit (24-month time point)|
48767639|NCT01929317|102222786|FG001|STARTED|Long-term Phase||18||
48164826|NCT04195880|100725116|FG000|COMPLETED|Overall Study||3205||
48164827|NCT04195880|100725117|FG001|COMPLETED|Overall Study||3338||
48164828|NCT04195880|100725116|FG000|NOT COMPLETED|Overall Study||0||
48164829|NCT04195880|100725117|FG001|NOT COMPLETED|Overall Study||0||
48164830|NCT02276066|100725118|FG000|STARTED|Overall Study||41||
48164831|NCT02276066|100725119|FG001|STARTED|Overall Study||32||
48164832|NCT02276066|100725118|FG000|COMPLETED|Overall Study||20||
48164833|NCT02276066|100725119|FG001|COMPLETED|Overall Study||21||
48164834|NCT02276066|100725118|FG000|NOT COMPLETED|Overall Study||21||
48164835|NCT02276066|100725119|FG001|NOT COMPLETED|Overall Study||11||
48164836|NCT03941015|100725120|FG000|STARTED|Overall Study||38||
48164837|NCT03941015|100725121|FG001|STARTED|Overall Study||207||
48164838|NCT03941015|100725120|FG000|COMPLETED|Overall Study||38||
48164839|NCT03941015|100725121|FG001|COMPLETED|Overall Study||204||
48164840|NCT03941015|100725120|FG000|NOT COMPLETED|Overall Study||0||
48164841|NCT03941015|100725121|FG001|NOT COMPLETED|Overall Study||3||
48164842|NCT03485911|100725122|FG000|STARTED|Part 1||41||
48164843|NCT03485911|100725123|FG001|STARTED|Part 1||40||
48164844|NCT03485911|100725124|FG002|STARTED|Part 1||20||
48164845|NCT03485911|100725125|FG003|STARTED|Part 1||20||
48164846|NCT03485911|100725122|FG000|COMPLETED|Part 1||37||
48164847|NCT03485911|100725123|FG001|COMPLETED|Part 1||37||
48164848|NCT03485911|100725124|FG002|COMPLETED|Part 1||17||
48164849|NCT03485911|100725125|FG003|COMPLETED|Part 1||17||
48164850|NCT03485911|100725122|FG000|NOT COMPLETED|Part 1||4||
48164851|NCT03485911|100725123|FG001|NOT COMPLETED|Part 1||3||
48164852|NCT03485911|100725124|FG002|NOT COMPLETED|Part 1||3||
48164853|NCT03485911|100725125|FG003|NOT COMPLETED|Part 1||3||
48164854|NCT03485911|100725122|FG000|STARTED|Part 2||37||
48164855|NCT03485911|100725123|FG001|STARTED|Part 2||37||
48164856|NCT03485911|100725124|FG002|STARTED|Part 2||17||
48164857|NCT03485911|100725125|FG003|STARTED|Part 2||17||
48164858|NCT03485911|100725122|FG000|COMPLETED|Part 2||28||
48164859|NCT03485911|100725123|FG001|COMPLETED|Part 2||31||
48164860|NCT03485911|100725124|FG002|COMPLETED|Part 2||15||
48164861|NCT03485911|100725125|FG003|COMPLETED|Part 2||14||
48164862|NCT03485911|100725122|FG000|NOT COMPLETED|Part 2||9||
48164863|NCT03485911|100725123|FG001|NOT COMPLETED|Part 2||6||
48164864|NCT03485911|100725124|FG002|NOT COMPLETED|Part 2||2||
48164865|NCT03485911|100725125|FG003|NOT COMPLETED|Part 2||3||
48164866|NCT03485911|100725122|FG000|STARTED|Part 3||26||
48164867|NCT03485911|100725123|FG001|STARTED|Part 3||26||
48164868|NCT03485911|100725124|FG002|STARTED|Part 3||15||
48164869|NCT03485911|100725125|FG003|STARTED|Part 3||14||
48164870|NCT03485911|100725122|FG000|COMPLETED|Part 3||7||
48164871|NCT03485911|100725123|FG001|COMPLETED|Part 3||4||
48164872|NCT03485911|100725124|FG002|COMPLETED|Part 3||5||
48164873|NCT03485911|100725125|FG003|COMPLETED|Part 3||4||
48164874|NCT03485911|100725122|FG000|NOT COMPLETED|Part 3||19||
48164875|NCT03485911|100725123|FG001|NOT COMPLETED|Part 3||22||
48164876|NCT03485911|100725124|FG002|NOT COMPLETED|Part 3||10||
48164877|NCT03485911|100725125|FG003|NOT COMPLETED|Part 3||10||
48164878|NCT00500240|100725126|FG000|STARTED|Overall Study||25||
48164879|NCT00500240|100725127|FG001|STARTED|Overall Study||26||
48164880|NCT00500240|100725126|FG000|COMPLETED|Overall Study||25||
48164881|NCT00500240|100725127|FG001|COMPLETED|Overall Study||26||
48164882|NCT00500240|100725126|FG000|NOT COMPLETED|Overall Study||0||
48164883|NCT00500240|100725127|FG001|NOT COMPLETED|Overall Study||0||
48164884|NCT02002182|100725128|FG000|STARTED|Overall Study||9||
48164885|NCT02002182|100725129|FG001|STARTED|Overall Study||6||
48164886|NCT02002182|100725128|FG000|COMPLETED|Overall Study||4||
48164887|NCT02002182|100725129|FG001|COMPLETED|Overall Study||5||
48164888|NCT02002182|100725128|FG000|NOT COMPLETED|Overall Study||5||
48164889|NCT02002182|100725129|FG001|NOT COMPLETED|Overall Study||1||
48164890|NCT03749447|100725130|FG000|STARTED|Overall Study||143||
48164891|NCT03749447|100725131|FG001|STARTED|Overall Study||127||
48164892|NCT03749447|100725130|FG000|COMPLETED|Overall Study||0||
48164893|NCT03749447|100725131|FG001|COMPLETED|Overall Study||0||
48164894|NCT03749447|100725130|FG000|NOT COMPLETED|Overall Study||143||
48164895|NCT03749447|100725131|FG001|NOT COMPLETED|Overall Study||127||
48164896|NCT03214081|100725132|FG000|STARTED|Overall Study||1237||
48164897|NCT03214081|100725132|FG000|COMPLETED|Overall Study||1174||
48164898|NCT03214081|100725132|FG000|NOT COMPLETED|Overall Study||63||
48164899|NCT03635489|100725133|FG000|STARTED|Overall Study||49||
48164900|NCT03635489|100725134|FG001|STARTED|Overall Study||51||
48164901|NCT03635489|100725133|FG000|COMPLETED|Overall Study||0||
48164902|NCT03635489|100725134|FG001|COMPLETED|Overall Study||0||
48164903|NCT03635489|100725133|FG000|NOT COMPLETED|Overall Study||49||
48164904|NCT03635489|100725134|FG001|NOT COMPLETED|Overall Study||51||
48164905|NCT00658138|100725135|FG000|STARTED|Overall Study||61||
48164906|NCT00658138|100725135|FG000|COMPLETED|Overall Study||40||
48164907|NCT00658138|100725135|FG000|NOT COMPLETED|Overall Study||21||
48164908|NCT04707196|100725136|FG000|STARTED|Overall Study||137||
48164909|NCT04707196|100725137|FG001|STARTED|Overall Study||63||
48164910|NCT04707196|100725136|FG000|Received at Least 1 Dose of Study Drug|Overall Study||137||
48164911|NCT04707196|100725137|FG001|Received at Least 1 Dose of Study Drug|Overall Study||63||
48164912|NCT04707196|100725136|FG000|COMPLETED|Overall Study||108|Participants who completed 6 cycles of study intervention were considered completers.|
48164913|NCT04707196|100725137|FG001|COMPLETED|Overall Study||43|Participants who completed 6 cycles of study intervention were considered completers.|
48164914|NCT04707196|100725136|FG000|NOT COMPLETED|Overall Study||29||
48164915|NCT04707196|100725137|FG001|NOT COMPLETED|Overall Study||20||
48164916|NCT01336621|100725138|FG000|STARTED|Primary Reporting Phase (Upto 5.8 Years)||98||
48164917|NCT01336621|100725138|FG000|COMPLETED|Primary Reporting Phase (Upto 5.8 Years)||0||
48164918|NCT01336621|100725138|FG000|NOT COMPLETED|Primary Reporting Phase (Upto 5.8 Years)||98||
48164919|NCT01336621|100725138|FG000|STARTED|SFUCP (up to 2.6 Years)||9||
48164920|NCT01336621|100725138|FG000|COMPLETED|SFUCP (up to 2.6 Years)||0||
48164921|NCT01336621|100725138|FG000|NOT COMPLETED|SFUCP (up to 2.6 Years)||9||
48164922|NCT03757234|100725139|FG000|STARTED|Overall Study||75||
48164923|NCT03757234|100725140|FG001|STARTED|Overall Study||18||
48164924|NCT03757234|100725141|FG002|STARTED|Overall Study||17||
48164925|NCT03757234|100725142|FG003|STARTED|Overall Study||17||
48164926|NCT03757234|100725143|FG004|STARTED|Overall Study||74||
48164927|NCT03757234|100725139|FG000|Completed PTE Visit|Overall Study||72||
48164928|NCT03757234|100725140|FG001|Completed PTE Visit|Overall Study||16||
48164929|NCT03757234|100725141|FG002|Completed PTE Visit|Overall Study||17||
48164930|NCT03757234|100725142|FG003|Completed PTE Visit|Overall Study||16||
48164931|NCT03757234|100725143|FG004|Completed PTE Visit|Overall Study||71||
48164932|NCT03757234|100725139|FG000|COMPLETED|Overall Study||72||
48164933|NCT03757234|100725140|FG001|COMPLETED|Overall Study||16||
48164934|NCT03757234|100725141|FG002|COMPLETED|Overall Study||17||
48164935|NCT03757234|100725142|FG003|COMPLETED|Overall Study||16||
48164936|NCT03757234|100725143|FG004|COMPLETED|Overall Study||70||
48164937|NCT03757234|100725139|FG000|NOT COMPLETED|Overall Study||3||
48164938|NCT03757234|100725140|FG001|NOT COMPLETED|Overall Study||2||
48164939|NCT03757234|100725141|FG002|NOT COMPLETED|Overall Study||0||
48164940|NCT03757234|100725142|FG003|NOT COMPLETED|Overall Study||1||
48164941|NCT03757234|100725143|FG004|NOT COMPLETED|Overall Study||4||
48164942|NCT02938169|100725144|FG000|STARTED|Overall Study||15||
48164943|NCT02938169|100725145|FG001|STARTED|Overall Study||15||
48164944|NCT02938169|100725146|FG002|STARTED|Overall Study||15||
48164945|NCT02938169|100725147|FG003|STARTED|Overall Study||15||
48164946|NCT02938169|100725144|FG000|COMPLETED|Overall Study||13||
48327122|NCT01347034|101128268|FG000|COMPLETED|Overall Study||6||
48327123|NCT01347034|101128269|FG001|COMPLETED|Overall Study||14||
48164947|NCT02938169|100725145|FG001|COMPLETED|Overall Study||13||
48164948|NCT02938169|100725146|FG002|COMPLETED|Overall Study||10||
48164949|NCT02938169|100725147|FG003|COMPLETED|Overall Study||12||
48164950|NCT02938169|100725144|FG000|NOT COMPLETED|Overall Study||2||
48164951|NCT02938169|100725145|FG001|NOT COMPLETED|Overall Study||2||
48164952|NCT02938169|100725146|FG002|NOT COMPLETED|Overall Study||5||
48164953|NCT02938169|100725147|FG003|NOT COMPLETED|Overall Study||3||
48164954|NCT02924324|100725148|FG000|STARTED|Overall Study||28||
48621035|NCT02322749|101856459|FG002|COMPLETED|Period 2||8||
48164955|NCT02924324|100725149|FG001|STARTED|Overall Study||28||
48164956|NCT02924324|100725148|FG000|COMPLETED|Overall Study||28||
48164957|NCT02924324|100725149|FG001|COMPLETED|Overall Study||28||
48164958|NCT02924324|100725148|FG000|NOT COMPLETED|Overall Study||0||
48164959|NCT02924324|100725149|FG001|NOT COMPLETED|Overall Study||0||
48164960|NCT01370005|100725150|FG000|STARTED|Overall Study||272||
48164961|NCT01370005|100725151|FG001|STARTED|Overall Study||276||
48164962|NCT01370005|100725152|FG002|STARTED|Overall Study||277||
48164963|NCT01370005|100725150|FG000|COMPLETED|Overall Study||256||
48164964|NCT01370005|100725151|FG001|COMPLETED|Overall Study||265||
48164965|NCT01370005|100725152|FG002|COMPLETED|Overall Study||266||
48164966|NCT01370005|100725150|FG000|NOT COMPLETED|Overall Study||16||
48164967|NCT01370005|100725151|FG001|NOT COMPLETED|Overall Study||11||
48164968|NCT01370005|100725152|FG002|NOT COMPLETED|Overall Study||11||
48164969|NCT01148862|100725153|FG000|STARTED|First Intervention||25||
48164970|NCT01148862|100725154|FG001|STARTED|First Intervention||25||
48164971|NCT01148862|100725153|FG000|COMPLETED|First Intervention||25||
48164972|NCT01148862|100725154|FG001|COMPLETED|First Intervention||25||
48164973|NCT01148862|100725153|FG000|NOT COMPLETED|First Intervention||0||
48164974|NCT01148862|100725154|FG001|NOT COMPLETED|First Intervention||0||
48164975|NCT01148862|100725153|FG000|STARTED|Washout Period of 2 Weeks||25||
48164976|NCT01148862|100725154|FG001|STARTED|Washout Period of 2 Weeks||25||
48164977|NCT01148862|100725153|FG000|COMPLETED|Washout Period of 2 Weeks||25||
48164978|NCT01148862|100725154|FG001|COMPLETED|Washout Period of 2 Weeks||25||
48327124|NCT01347034|101128268|FG000|NOT COMPLETED|Overall Study||0||
48164979|NCT01148862|100725153|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0||
48164980|NCT01148862|100725154|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0||
48164981|NCT01148862|100725153|FG000|STARTED|Second Intervention||25||
48164982|NCT01148862|100725154|FG001|STARTED|Second Intervention||25||
48164983|NCT01148862|100725153|FG000|COMPLETED|Second Intervention||25||
48164984|NCT01148862|100725154|FG001|COMPLETED|Second Intervention||23||
48164985|NCT01148862|100725153|FG000|NOT COMPLETED|Second Intervention||0||
48164986|NCT01148862|100725154|FG001|NOT COMPLETED|Second Intervention||2||
48164987|NCT00633919|100725155|FG000|STARTED|Overall Study||63||
48164988|NCT00633919|100725156|FG001|STARTED|Overall Study||61||
48164989|NCT00633919|100725155|FG000|COMPLETED|Overall Study||36||
48164990|NCT00633919|100725156|FG001|COMPLETED|Overall Study||39||
48164991|NCT00633919|100725155|FG000|NOT COMPLETED|Overall Study||27||
48164992|NCT00633919|100725156|FG001|NOT COMPLETED|Overall Study||22||
48164993|NCT01287520|100728426|FG000|STARTED|Overall Study||3||
48164994|NCT01287520|100728427|FG001|STARTED|Overall Study||7||
48164995|NCT01287520|100728428|FG002|STARTED|Overall Study||5||
48164996|NCT01287520|100728429|FG003|STARTED|Overall Study||7||
48164997|NCT01287520|100728430|FG004|STARTED|Overall Study||3||
48164998|NCT01287520|100728431|FG005|STARTED|Overall Study||4||
48164999|NCT01287520|100728432|FG006|STARTED|Overall Study||2||
48165000|NCT01287520|100728433|FG007|STARTED|Overall Study||5||
48165001|NCT01287520|100728434|FG008|STARTED|Overall Study||5||
48165002|NCT01287520|100728426|FG000|COMPLETED|Overall Study||0||
48165003|NCT01287520|100728427|FG001|COMPLETED|Overall Study||0||
48165004|NCT01287520|100728428|FG002|COMPLETED|Overall Study||0||
48165005|NCT01287520|100728429|FG003|COMPLETED|Overall Study||0||
48165006|NCT01287520|100728430|FG004|COMPLETED|Overall Study||0||
48165007|NCT01287520|100728431|FG005|COMPLETED|Overall Study||0||
48165008|NCT01287520|100728432|FG006|COMPLETED|Overall Study||0||
48165009|NCT01287520|100728433|FG007|COMPLETED|Overall Study||0||
48165010|NCT01287520|100728434|FG008|COMPLETED|Overall Study||0||
48165011|NCT01287520|100728426|FG000|NOT COMPLETED|Overall Study||3||
48165012|NCT01287520|100728427|FG001|NOT COMPLETED|Overall Study||7||
48165013|NCT01287520|100728428|FG002|NOT COMPLETED|Overall Study||5||
48165014|NCT01287520|100728429|FG003|NOT COMPLETED|Overall Study||7||
48165015|NCT01287520|100728430|FG004|NOT COMPLETED|Overall Study||3||
48165016|NCT01287520|100728431|FG005|NOT COMPLETED|Overall Study||4||
48621036|NCT02322749|101856460|FG003|COMPLETED|Period 2||6||
48621037|NCT02322749|101856461|FG004|COMPLETED|Period 2||8||
48621038|NCT02322749|101856462|FG005|COMPLETED|Period 2||8||
48621039|NCT02322749|101856457|FG000|NOT COMPLETED|Period 2||0||
48621040|NCT02322749|101856458|FG001|NOT COMPLETED|Period 2||0||
48621041|NCT02322749|101856459|FG002|NOT COMPLETED|Period 2||0||
48621042|NCT02322749|101856460|FG003|NOT COMPLETED|Period 2||2||
48621043|NCT02322749|101856461|FG004|NOT COMPLETED|Period 2||0||
48621044|NCT02322749|101856462|FG005|NOT COMPLETED|Period 2||0||
48621045|NCT02322749|101856457|FG000|STARTED|Period 3||8||
48621046|NCT02322749|101856458|FG001|STARTED|Period 3||8||
48621047|NCT02322749|101856459|FG002|STARTED|Period 3||8||
48621048|NCT02322749|101856460|FG003|STARTED|Period 3||6||
48621049|NCT02322749|101856461|FG004|STARTED|Period 3||8||
48744181|NCT03294590|102158206|FG001|COMPLETED|Overall Study||270|542 parent/caregiver participants completed at least the questionnaire assessment of the final study visit (24-month time point)|
48744182|NCT03294590|102158205|FG000|NOT COMPLETED|Overall Study||105||
48744183|NCT03294590|102158206|FG001|NOT COMPLETED|Overall Study||107||
48744184|NCT02741635|102158207|FG000|STARTED|Overall Study||15||
48744185|NCT02741635|102158207|FG000|COMPLETED|Overall Study||14||
48744186|NCT02741635|102158207|FG000|NOT COMPLETED|Overall Study||1||
48744187|NCT00494585|102158208|FG000|STARTED|Overall Study||22||
48744188|NCT00494585|102158208|FG000|COMPLETED|Overall Study||22||
48744189|NCT00494585|102158208|FG000|NOT COMPLETED|Overall Study||0||
48744190|NCT01073449|102158209|FG000|STARTED|Overall Study||3362||
48744191|NCT01073449|102158209|FG000|COMPLETED|Overall Study||3362||
48165017|NCT01287520|100728432|FG006|NOT COMPLETED|Overall Study||2||
48621050|NCT02322749|101856462|FG005|STARTED|Period 3||8||
48621051|NCT02322749|101856457|FG000|COMPLETED|Period 3||8||
48621052|NCT02322749|101856458|FG001|COMPLETED|Period 3||8||
48621053|NCT02322749|101856459|FG002|COMPLETED|Period 3||7||
48621054|NCT02322749|101856460|FG003|COMPLETED|Period 3||6||
48621055|NCT02322749|101856461|FG004|COMPLETED|Period 3||8||
48621056|NCT02322749|101856462|FG005|COMPLETED|Period 3||8||
48165018|NCT01287520|100728433|FG007|NOT COMPLETED|Overall Study||5||
48165019|NCT01287520|100728434|FG008|NOT COMPLETED|Overall Study||5||
48165020|NCT02130453|100728435|FG000|STARTED|Overall Study||134||
48165021|NCT02130453|100728435|FG000|COMPLETED|Overall Study||134||
48165022|NCT02130453|100728435|FG000|NOT COMPLETED|Overall Study||0||
48165023|NCT01866163|100728436|FG000|STARTED|Overall Study||323||
48165024|NCT01866163|100728437|FG001|STARTED|Overall Study||103||
48165025|NCT01866163|100728436|FG000|COMPLETED|Overall Study||313||
48165026|NCT01866163|100728437|FG001|COMPLETED|Overall Study||99||
48165027|NCT01866163|100728436|FG000|NOT COMPLETED|Overall Study||10||
48621057|NCT02322749|101856457|FG000|NOT COMPLETED|Period 3||0||
48621058|NCT02322749|101856458|FG001|NOT COMPLETED|Period 3||0||
48621059|NCT02322749|101856459|FG002|NOT COMPLETED|Period 3||1||
48165028|NCT01866163|100728437|FG001|NOT COMPLETED|Overall Study||4||
48165029|NCT03354325|100728438|FG000|STARTED|Overall Study||151||
48165030|NCT03354325|100728439|FG001|STARTED|Overall Study||153||
48165031|NCT03354325|100728438|FG000|COMPLETED|Overall Study||131||
48621060|NCT02322749|101856460|FG003|NOT COMPLETED|Period 3||0||
48621061|NCT02322749|101856461|FG004|NOT COMPLETED|Period 3||0||
48621062|NCT02322749|101856462|FG005|NOT COMPLETED|Period 3||0||
48621063|NCT05133323|101856463|FG000|STARTED|Overall Study||97||
48621064|NCT05133323|101856464|FG001|STARTED|Overall Study||46||
48744192|NCT01073449|102158209|FG000|NOT COMPLETED|Overall Study||0||
48621065|NCT05133323|101856465|FG002|STARTED|Overall Study||94||
48621066|NCT05133323|101856463|FG000|Received at Least 1 Dose of Study Drug|Overall Study||97||
48621067|NCT05133323|101856464|FG001|Received at Least 1 Dose of Study Drug|Overall Study||46||
48621068|NCT05133323|101856465|FG002|Received at Least 1 Dose of Study Drug|Overall Study||94||
48621069|NCT05133323|101856463|FG000|COMPLETED|Overall Study||95||
48621070|NCT05133323|101856464|FG001|COMPLETED|Overall Study||45||
48327125|NCT01347034|101128269|FG001|NOT COMPLETED|Overall Study||0||
48327126|NCT01182428|101128270|FG000|STARTED|Overall Study||304||
48327127|NCT01182428|101128271|FG001|STARTED|Overall Study||151||
48327128|NCT01182428|101128270|FG000|COMPLETED|Overall Study||293||
48327129|NCT01182428|101128271|FG001|COMPLETED|Overall Study||150||
48327130|NCT01182428|101128270|FG000|NOT COMPLETED|Overall Study||11||
48327131|NCT01182428|101128271|FG001|NOT COMPLETED|Overall Study||1||
48327132|NCT02465073|101128272|FG000|STARTED|Overall Study||17||
48327133|NCT02465073|101128273|FG001|STARTED|Overall Study||16||
48327134|NCT02465073|101128274|FG002|STARTED|Overall Study||16||
48327135|NCT02465073|101128272|FG000|COMPLETED|Overall Study||15||
48327136|NCT02465073|101128273|FG001|COMPLETED|Overall Study||15||
48327137|NCT02465073|101128274|FG002|COMPLETED|Overall Study||15||
48327138|NCT02465073|101128272|FG000|NOT COMPLETED|Overall Study||2||
48327139|NCT02465073|101128273|FG001|NOT COMPLETED|Overall Study||1||
48327140|NCT02465073|101128274|FG002|NOT COMPLETED|Overall Study||1||
48327141|NCT02095535|101128275|FG000|STARTED|Recruitment||20||
48327142|NCT02095535|101128275|FG000|COMPLETED|Recruitment||18||
48327143|NCT02095535|101128275|FG000|NOT COMPLETED|Recruitment||2||
48327144|NCT02095535|101128275|FG000|STARTED|Analysis||18||
48327145|NCT02095535|101128275|FG000|COMPLETED|Analysis||18||
48327146|NCT02095535|101128275|FG000|NOT COMPLETED|Analysis||0||
48327147|NCT02573155|101128276|FG000|STARTED|Treatment Period 1||16||
48327148|NCT02573155|101128277|FG001|STARTED|Treatment Period 1||38||
48327149|NCT02573155|101128276|FG000|COMPLETED|Treatment Period 1||16||
48327150|NCT02573155|101128277|FG001|COMPLETED|Treatment Period 1||38||
48327151|NCT02573155|101128276|FG000|NOT COMPLETED|Treatment Period 1||0||
48327152|NCT02573155|101128277|FG001|NOT COMPLETED|Treatment Period 1||0||
48327153|NCT02573155|101128276|FG000|STARTED|Washout Between Treatment Period 1 and 2||16||
48327154|NCT02573155|101128277|FG001|STARTED|Washout Between Treatment Period 1 and 2||38||
48327155|NCT02573155|101128276|FG000|COMPLETED|Washout Between Treatment Period 1 and 2||16||
48327156|NCT02573155|101128277|FG001|COMPLETED|Washout Between Treatment Period 1 and 2||33||
48327157|NCT02573155|101128276|FG000|NOT COMPLETED|Washout Between Treatment Period 1 and 2||0||
48327158|NCT02573155|101128277|FG001|NOT COMPLETED|Washout Between Treatment Period 1 and 2||5||
48327159|NCT02573155|101128276|FG000|STARTED|Period 2||16||
48327160|NCT02573155|101128277|FG001|STARTED|Period 2||33||
48327161|NCT02573155|101128276|FG000|COMPLETED|Period 2||16||
48327162|NCT02573155|101128277|FG001|COMPLETED|Period 2||33||
48327163|NCT02573155|101128276|FG000|NOT COMPLETED|Period 2||0||
48327164|NCT02573155|101128277|FG001|NOT COMPLETED|Period 2||0||
48327165|NCT02573155|101128276|FG000|STARTED|Washout Between Treatment Period 2 and 3||16||
48327166|NCT02573155|101128277|FG001|STARTED|Washout Between Treatment Period 2 and 3||33||
48327167|NCT02573155|101128276|FG000|COMPLETED|Washout Between Treatment Period 2 and 3||15||
48327168|NCT02573155|101128277|FG001|COMPLETED|Washout Between Treatment Period 2 and 3||31||
48327169|NCT02573155|101128276|FG000|NOT COMPLETED|Washout Between Treatment Period 2 and 3||1||
48327170|NCT02573155|101128277|FG001|NOT COMPLETED|Washout Between Treatment Period 2 and 3||2||
48327171|NCT02573155|101128276|FG000|STARTED|Period 3||15||
48327172|NCT02573155|101128277|FG001|STARTED|Period 3||31||
48327173|NCT02573155|101128276|FG000|COMPLETED|Period 3||15||
48327174|NCT02573155|101128277|FG001|COMPLETED|Period 3||31||
48327175|NCT02573155|101128276|FG000|NOT COMPLETED|Period 3||0||
48409635|NCT02583360|101334754|FG001|NOT COMPLETED|Overall Study||0||
48621071|NCT05133323|101856465|FG002|COMPLETED|Overall Study||93||
48327176|NCT02573155|101128277|FG001|NOT COMPLETED|Period 3||0||
48327177|NCT02573155|101128276|FG000|STARTED|Washout Between Treatment Period 3 and 4||0||
48409636|NCT03304912|101334755|FG000|STARTED|Overall Study||95||
48621072|NCT05133323|101856463|FG000|NOT COMPLETED|Overall Study||2||
48621073|NCT05133323|101856464|FG001|NOT COMPLETED|Overall Study||1||
48621074|NCT05133323|101856465|FG002|NOT COMPLETED|Overall Study||1||
48327178|NCT02573155|101128277|FG001|STARTED|Washout Between Treatment Period 3 and 4||31||
48327179|NCT02573155|101128276|FG000|COMPLETED|Washout Between Treatment Period 3 and 4||0||
48327180|NCT02573155|101128277|FG001|COMPLETED|Washout Between Treatment Period 3 and 4||29||
48409637|NCT03304912|101334755|FG000|COMPLETED|Overall Study||42||
48621075|NCT01409239|101856466|FG000|STARTED|Overall Study||16||
48327181|NCT02573155|101128276|FG000|NOT COMPLETED|Washout Between Treatment Period 3 and 4||0||
48327182|NCT02573155|101128277|FG001|NOT COMPLETED|Washout Between Treatment Period 3 and 4||2||
48327183|NCT02573155|101128276|FG000|STARTED|Period 4||0||
48327184|NCT02573155|101128277|FG001|STARTED|Period 4||29||
48327185|NCT02573155|101128276|FG000|COMPLETED|Period 4||0||
48327186|NCT02573155|101128277|FG001|COMPLETED|Period 4||29||
48327187|NCT02573155|101128276|FG000|NOT COMPLETED|Period 4||0||
48327188|NCT02573155|101128277|FG001|NOT COMPLETED|Period 4||0||
48621076|NCT01409239|101856467|FG001|STARTED|Overall Study||17||
48621077|NCT01409239|101856466|FG000|COMPLETED|Overall Study||16||
48621078|NCT01409239|101856467|FG001|COMPLETED|Overall Study||17||
48409638|NCT03304912|101334755|FG000|NOT COMPLETED|Overall Study||53||
48409639|NCT05283499|101334756|FG000|STARTED|Overall Study||26||
48409640|NCT05283499|101334757|FG001|STARTED|Overall Study||27||
48409641|NCT05283499|101334756|FG000|COMPLETED|Overall Study||25||
48409642|NCT05283499|101334757|FG001|COMPLETED|Overall Study||25||
48409643|NCT05283499|101334756|FG000|NOT COMPLETED|Overall Study||1||
48409644|NCT05283499|101334757|FG001|NOT COMPLETED|Overall Study||2||
48409645|NCT04396106|101334758|FG000|STARTED|Overall Study||41||
48409646|NCT04396106|101334759|FG001|STARTED|Overall Study||40||
48409647|NCT04396106|101334760|FG002|STARTED|Overall Study||0||
48409648|NCT04396106|101334761|FG003|STARTED|Overall Study||2||
48409649|NCT04396106|101334758|FG000|COMPLETED|Overall Study||37||
48409650|NCT04396106|101334759|FG001|COMPLETED|Overall Study||37||
48409651|NCT04396106|101334760|FG002|COMPLETED|Overall Study||0||
48327189|NCT02573155|101128276|FG000|STARTED|Washout Between Treatment Period 4 and 5||0||
48327190|NCT02573155|101128277|FG001|STARTED|Washout Between Treatment Period 4 and 5||29||
48327191|NCT02573155|101128276|FG000|COMPLETED|Washout Between Treatment Period 4 and 5||0||
48327192|NCT02573155|101128277|FG001|COMPLETED|Washout Between Treatment Period 4 and 5||28||
48327193|NCT02573155|101128276|FG000|NOT COMPLETED|Washout Between Treatment Period 4 and 5||0||
48327194|NCT02573155|101128277|FG001|NOT COMPLETED|Washout Between Treatment Period 4 and 5||1||
48327195|NCT02573155|101128276|FG000|STARTED|Period 5||0||
48327196|NCT02573155|101128277|FG001|STARTED|Period 5||28||
48327197|NCT02573155|101128276|FG000|COMPLETED|Period 5||0||
48327198|NCT02573155|101128277|FG001|COMPLETED|Period 5||28||
48327199|NCT02573155|101128276|FG000|NOT COMPLETED|Period 5||0||
48327200|NCT02573155|101128277|FG001|NOT COMPLETED|Period 5||0||
48327201|NCT00590590|101128278|FG000|STARTED|Overall Study||39||
48327202|NCT00590590|101128279|FG001|STARTED|Overall Study||39||
48327203|NCT00590590|101128280|FG002|STARTED|Overall Study||27||
48327204|NCT00590590|101128278|FG000|COMPLETED|Overall Study||32||
48327205|NCT00590590|101128279|FG001|COMPLETED|Overall Study||33||
48327206|NCT00590590|101128280|FG002|COMPLETED|Overall Study||21||
48327207|NCT00590590|101128278|FG000|NOT COMPLETED|Overall Study||7||
48327208|NCT00590590|101128279|FG001|NOT COMPLETED|Overall Study||6||
48327209|NCT00590590|101128280|FG002|NOT COMPLETED|Overall Study||6||
48409652|NCT04396106|101334761|FG003|COMPLETED|Overall Study||1||
48409653|NCT04396106|101334758|FG000|NOT COMPLETED|Overall Study||4||
48409654|NCT04396106|101334759|FG001|NOT COMPLETED|Overall Study||3||
48327210|NCT03298022|101128281|FG000|STARTED|Overall Study||24||
48327211|NCT03298022|101128281|FG000|Number of Participants Who Received 8 Doses of ALTB-168|Overall Study||10||
48327212|NCT03298022|101128281|FG000|Number of Participants Who Received 10 Doses of ALTB-168|Overall Study||14||
48327213|NCT03298022|101128281|FG000|COMPLETED|Overall Study||11||
48327214|NCT03298022|101128281|FG000|NOT COMPLETED|Overall Study||13||
48327215|NCT01965262|101128282|FG000|STARTED|First Intervention (7 Days)||15||
48327216|NCT01965262|101128283|FG001|STARTED|First Intervention (7 Days)||15||
48327217|NCT01965262|101128282|FG000|COMPLETED|First Intervention (7 Days)||15||
48327218|NCT01965262|101128283|FG001|COMPLETED|First Intervention (7 Days)||15||
48327219|NCT01965262|101128282|FG000|NOT COMPLETED|First Intervention (7 Days)||0||
48327220|NCT01965262|101128283|FG001|NOT COMPLETED|First Intervention (7 Days)||0||
48327221|NCT01965262|101128282|FG000|STARTED|Second Intervention (7 Days)||15||
48409655|NCT04396106|101334760|FG002|NOT COMPLETED|Overall Study||0||
48409656|NCT04396106|101334761|FG003|NOT COMPLETED|Overall Study||1||
48409657|NCT02352090|101334762|FG000|STARTED|Overall Study||20||
48409658|NCT02352090|101334763|FG001|STARTED|Overall Study||20||
48409659|NCT02352090|101334764|FG002|STARTED|Overall Study||19||
48744193|NCT00867165|102158210|FG000|STARTED|Overall Study||93||
48744194|NCT00867165|102158211|FG001|STARTED|Overall Study||45||
48327222|NCT01965262|101128283|FG001|STARTED|Second Intervention (7 Days)||15||
48327223|NCT01965262|101128282|FG000|COMPLETED|Second Intervention (7 Days)||14||
48327224|NCT01965262|101128283|FG001|COMPLETED|Second Intervention (7 Days)||5||
48327225|NCT01965262|101128282|FG000|NOT COMPLETED|Second Intervention (7 Days)||1||
48409660|NCT02352090|101334762|FG000|COMPLETED|Overall Study||19||
48744195|NCT00867165|102158210|FG000|COMPLETED|Overall Study||89||
48327226|NCT01965262|101128283|FG001|NOT COMPLETED|Second Intervention (7 Days)||10||
48409661|NCT02352090|101334763|FG001|COMPLETED|Overall Study||20||
48327227|NCT03303794|101128284|FG000|STARTED|Overall Study||13||
48327228|NCT03303794|101128285|FG001|STARTED|Overall Study||12||
48327229|NCT03303794|101128284|FG000|COMPLETED|Overall Study||13||
48409662|NCT02352090|101334764|FG002|COMPLETED|Overall Study||17||
48409663|NCT02352090|101334762|FG000|NOT COMPLETED|Overall Study||1||
48327230|NCT03303794|101128285|FG001|COMPLETED|Overall Study||12||
48327231|NCT03303794|101128284|FG000|NOT COMPLETED|Overall Study||0||
48327232|NCT03303794|101128285|FG001|NOT COMPLETED|Overall Study||0||
48327233|NCT03402607|101128286|FG000|STARTED|Overall Study||6||
48327234|NCT03402607|101128287|FG001|STARTED|Overall Study||6||
48327235|NCT03402607|101128286|FG000|COMPLETED|Overall Study||6||
48409664|NCT02352090|101334763|FG001|NOT COMPLETED|Overall Study||0||
48409665|NCT02352090|101334764|FG002|NOT COMPLETED|Overall Study||2||
48744196|NCT00867165|102158211|FG001|COMPLETED|Overall Study||45||
48744197|NCT00867165|102158210|FG000|NOT COMPLETED|Overall Study||4||
48744198|NCT00867165|102158211|FG001|NOT COMPLETED|Overall Study||0||
48744199|NCT00950846|102158212|FG000|STARTED|Overall Study||40||
48327236|NCT03402607|101128287|FG001|COMPLETED|Overall Study||6||
48327237|NCT03402607|101128286|FG000|NOT COMPLETED|Overall Study||0||
48327238|NCT03402607|101128287|FG001|NOT COMPLETED|Overall Study||0||
48327239|NCT00898560|101128288|FG000|STARTED|Overall Study||20||
48327240|NCT00898560|101128288|FG000|COMPLETED|Overall Study||19||
48327241|NCT00898560|101128288|FG000|NOT COMPLETED|Overall Study||1||
48327242|NCT01849172|101128289|FG000|STARTED|Overall Study||180||
48327243|NCT01849172|101128290|FG001|STARTED|Overall Study||180||
48327244|NCT01849172|101128289|FG000|COMPLETED|Overall Study||173||
48327245|NCT01849172|101128290|FG001|COMPLETED|Overall Study||174||
48327246|NCT01849172|101128289|FG000|NOT COMPLETED|Overall Study||7||
48327247|NCT01849172|101128290|FG001|NOT COMPLETED|Overall Study||6||
48327248|NCT02065154|101128291|FG000|STARTED|Overall Study||39||
48327249|NCT02065154|101128291|FG000|COMPLETED|Overall Study||39||
48327250|NCT02065154|101128291|FG000|NOT COMPLETED|Overall Study||0||
48327251|NCT01618214|101128292|FG000|STARTED|Overall Study||172||
48327252|NCT01618214|101128293|FG001|STARTED|Overall Study||172||
48327253|NCT01618214|101128292|FG000|Exposed|Overall Study||172||
48327254|NCT01618214|101128293|FG001|Exposed|Overall Study||172||
48327255|NCT01618214|101128292|FG000|COMPLETED|Overall Study||162||
48327256|NCT01618214|101128293|FG001|COMPLETED|Overall Study||159||
48327257|NCT01618214|101128292|FG000|NOT COMPLETED|Overall Study||10||
48327258|NCT01618214|101128293|FG001|NOT COMPLETED|Overall Study||13||
48327259|NCT00516737|101128294|FG000|STARTED|Overall Study||103||
48327260|NCT00516737|101128295|FG001|STARTED|Overall Study||104||
48327261|NCT00516737|101128294|FG000|COMPLETED|Overall Study||92||
48327262|NCT00516737|101128295|FG001|COMPLETED|Overall Study||96||
48621079|NCT01409239|101856466|FG000|NOT COMPLETED|Overall Study||0||
48621080|NCT01409239|101856467|FG001|NOT COMPLETED|Overall Study||0||
48327263|NCT00516737|101128294|FG000|NOT COMPLETED|Overall Study||11||
48327264|NCT00516737|101128295|FG001|NOT COMPLETED|Overall Study||8||
48327265|NCT00749996|101128296|FG000|STARTED|Overall Study||75||
48327266|NCT00749996|101128297|FG001|STARTED|Overall Study||71||
48327267|NCT00749996|101128296|FG000|6 Weeks Follow-up|Overall Study||72||
48327268|NCT00749996|101128297|FG001|6 Weeks Follow-up|Overall Study||67||
48327269|NCT00749996|101128296|FG000|3 Months Follow-up|Overall Study||72||
48327270|NCT00749996|101128297|FG001|3 Months Follow-up|Overall Study||68||
48327271|NCT00749996|101128296|FG000|6 Months Follow-up|Overall Study||71||
48327272|NCT00749996|101128297|FG001|6 Months Follow-up|Overall Study||63||
48327273|NCT00749996|101128296|FG000|12 Months Follow-up|Overall Study||68||
48327274|NCT00749996|101128297|FG001|12 Months Follow-up|Overall Study||60||
48327275|NCT00749996|101128296|FG000|24 Months Follow up|Overall Study||57||
48327276|NCT00749996|101128297|FG001|24 Months Follow up|Overall Study||58||
48327277|NCT00749996|101128296|FG000|COMPLETED|Overall Study||57||
48327278|NCT00749996|101128297|FG001|COMPLETED|Overall Study||58||
48327279|NCT00749996|101128296|FG000|NOT COMPLETED|Overall Study||18||
48327280|NCT00749996|101128297|FG001|NOT COMPLETED|Overall Study||13||
48327281|NCT01780831|101128298|FG000|STARTED|Overall Study||10||
48327282|NCT01780831|101128299|FG001|STARTED|Overall Study||6||
48327283|NCT01780831|101128300|FG002|STARTED|Overall Study||26||
48327284|NCT01780831|101128301|FG003|STARTED|Overall Study||10||
48327285|NCT01780831|101128298|FG000|COMPLETED|Overall Study||10||
48327286|NCT01780831|101128299|FG001|COMPLETED|Overall Study||6||
48327287|NCT01780831|101128300|FG002|COMPLETED|Overall Study||22||
48327288|NCT01780831|101128301|FG003|COMPLETED|Overall Study||9||
48327289|NCT01780831|101128298|FG000|NOT COMPLETED|Overall Study||0||
48327290|NCT01780831|101128299|FG001|NOT COMPLETED|Overall Study||0||
48327291|NCT01780831|101128300|FG002|NOT COMPLETED|Overall Study||4||
48327292|NCT01780831|101128301|FG003|NOT COMPLETED|Overall Study||1||
48327293|NCT03099486|101128302|FG000|STARTED|Overall Study||2||
48327294|NCT03099486|101128302|FG000|COMPLETED|Overall Study||2||
48327295|NCT03099486|101128302|FG000|NOT COMPLETED|Overall Study||0||
48327296|NCT03237065|101128303|FG000|STARTED|Overall Study||61||
48621081|NCT01239394|101856468|FG000|STARTED|Overall Study||42||
48621082|NCT01239394|101856468|FG000|COMPLETED|Overall Study||41||
48621083|NCT01239394|101856468|FG000|NOT COMPLETED|Overall Study||1||
48621084|NCT03492437|101856469|FG000|STARTED|Treatment Period 1||20||
48621085|NCT03492437|101856470|FG001|STARTED|Treatment Period 1||0||
48621086|NCT03492437|101856469|FG000|COMPLETED|Treatment Period 1||20||
48327297|NCT03237065|101128304|FG001|STARTED|Overall Study||61||
48327298|NCT03237065|101128303|FG000|Safety Analysis Set|Overall Study||62||
48621087|NCT03492437|101856470|FG001|COMPLETED|Treatment Period 1||0||
48621088|NCT03492437|101856469|FG000|NOT COMPLETED|Treatment Period 1||0||
48327299|NCT03237065|101128304|FG001|Safety Analysis Set|Overall Study||57||
48327300|NCT03237065|101128303|FG000|COMPLETED|Overall Study||57||
48327301|NCT03237065|101128304|FG001|COMPLETED|Overall Study||57||
48327302|NCT03237065|101128303|FG000|NOT COMPLETED|Overall Study||4||
48327303|NCT03237065|101128304|FG001|NOT COMPLETED|Overall Study||4||
48327304|NCT02240654|101128305|FG000|STARTED|Overall Study||1706||
48327305|NCT02240654|101128306|FG001|STARTED|Overall Study||2813||
48327306|NCT02240654|101128307|FG002|STARTED|Overall Study||28619||
48621089|NCT03492437|101856470|FG001|NOT COMPLETED|Treatment Period 1||0||
48621090|NCT03492437|101856469|FG000|STARTED|Treatment Period 2||0||
48327307|NCT02240654|101128308|FG003|STARTED|Overall Study||2150||
48327308|NCT02240654|101128309|FG004|STARTED|Overall Study||1285||
48327309|NCT02240654|101128305|FG000|COMPLETED|Overall Study||1706||
48327310|NCT02240654|101128306|FG001|COMPLETED|Overall Study||2813||
48327311|NCT02240654|101128307|FG002|COMPLETED|Overall Study||28619||
48327312|NCT02240654|101128308|FG003|COMPLETED|Overall Study||2150||
48327313|NCT02240654|101128309|FG004|COMPLETED|Overall Study||1285||
48327314|NCT02240654|101128305|FG000|NOT COMPLETED|Overall Study||0||
48327315|NCT02240654|101128306|FG001|NOT COMPLETED|Overall Study||0||
48327316|NCT02240654|101128307|FG002|NOT COMPLETED|Overall Study||0||
48744200|NCT00950846|102158212|FG000|COMPLETED|Overall Study||30||
48744201|NCT00950846|102158212|FG000|NOT COMPLETED|Overall Study||10||
48744202|NCT01016600|102161625|FG000|STARTED|Overall Study||9||
48744203|NCT01016600|102161626|FG001|STARTED|Overall Study||4||
48744204|NCT01016600|102161627|FG002|STARTED|Overall Study||6||
48744205|NCT01016600|102161628|FG003|STARTED|Overall Study||12||
48744206|NCT01016600|102161625|FG000|COMPLETED|Overall Study||8||
48744207|NCT01016600|102161626|FG001|COMPLETED|Overall Study||4||
48744208|NCT01016600|102161627|FG002|COMPLETED|Overall Study||6||
48744209|NCT01016600|102161628|FG003|COMPLETED|Overall Study||12||
48744210|NCT01016600|102161625|FG000|NOT COMPLETED|Overall Study||1||
48327317|NCT02240654|101128308|FG003|NOT COMPLETED|Overall Study||0||
48327318|NCT02240654|101128309|FG004|NOT COMPLETED|Overall Study||0||
48327319|NCT00793650|101128310|FG000|STARTED|Overall Study||19||
48327320|NCT00793650|101128311|FG001|STARTED|Overall Study||20||
48327321|NCT00793650|101128310|FG000|COMPLETED|Overall Study||19||
48327322|NCT00793650|101128311|FG001|COMPLETED|Overall Study||20||
48327323|NCT00793650|101128310|FG000|NOT COMPLETED|Overall Study||0||
48327324|NCT00793650|101128311|FG001|NOT COMPLETED|Overall Study||0||
48327325|NCT00700271|101128312|FG000|STARTED|Overall Study||278||
48327326|NCT00700271|101128313|FG001|STARTED|Overall Study||268||
48327327|NCT00700271|101128312|FG000|COMPLETED|Overall Study||264||
48327328|NCT00700271|101128313|FG001|COMPLETED|Overall Study||256||
48327329|NCT00700271|101128312|FG000|NOT COMPLETED|Overall Study||14||
48327330|NCT00700271|101128313|FG001|NOT COMPLETED|Overall Study||12||
48327331|NCT03076983|101128314|FG000|STARTED|Overall Study||55||
48327332|NCT03076983|101128315|FG001|STARTED|Overall Study||25||
48327333|NCT03076983|101128314|FG000|COMPLETED|Overall Study||55||
48327334|NCT03076983|101128315|FG001|COMPLETED|Overall Study||25||
48327335|NCT03076983|101128314|FG000|NOT COMPLETED|Overall Study||0||
48327336|NCT03076983|101128315|FG001|NOT COMPLETED|Overall Study||0||
48327337|NCT00603915|101128316|FG000|STARTED|Overall Study||20||
48327338|NCT00603915|101128316|FG000|COMPLETED|Overall Study||19||
48327339|NCT00603915|101128316|FG000|NOT COMPLETED|Overall Study||1||
48327340|NCT00845728|101128317|FG000|STARTED|Overall Study||1723||
48327341|NCT00845728|101128318|FG001|STARTED|Overall Study||1721||
48327342|NCT00845728|101128317|FG000|Exposed|Overall Study||1721||
48327343|NCT00845728|101128318|FG001|Exposed|Overall Study||1718||
48327344|NCT00845728|101128317|FG000|COMPLETED|Overall Study||1337||
48327345|NCT00845728|101128318|FG001|COMPLETED|Overall Study||1379||
48327346|NCT00845728|101128317|FG000|NOT COMPLETED|Overall Study||386||
48327347|NCT00845728|101128318|FG001|NOT COMPLETED|Overall Study||342||
48327348|NCT01265524|101128319|FG000|STARTED|Overall Study||59||
48327349|NCT01265524|101128320|FG001|STARTED|Overall Study||52||
48327350|NCT01265524|101128319|FG000|COMPLETED|Overall Study||41||
48327351|NCT01265524|101128320|FG001|COMPLETED|Overall Study||46||
48327352|NCT01265524|101128319|FG000|NOT COMPLETED|Overall Study||18||
48327353|NCT01265524|101128320|FG001|NOT COMPLETED|Overall Study||6||
48327354|NCT00566930|101128321|FG000|STARTED|Overall Study||29||
48327355|NCT00566930|101128322|FG001|STARTED|Overall Study||36||
48327356|NCT00566930|101128323|FG002|STARTED|Overall Study||33||
48327357|NCT00566930|101128321|FG000|COMPLETED|Overall Study||27||
48327358|NCT00566930|101128322|FG001|COMPLETED|Overall Study||32||
48327359|NCT00566930|101128323|FG002|COMPLETED|Overall Study||32||
48327360|NCT00566930|101128321|FG000|NOT COMPLETED|Overall Study||2||
48327361|NCT00566930|101128322|FG001|NOT COMPLETED|Overall Study||4||
48327362|NCT00566930|101128323|FG002|NOT COMPLETED|Overall Study||1||
48744211|NCT01016600|102161626|FG001|NOT COMPLETED|Overall Study||0||
48744212|NCT01016600|102161627|FG002|NOT COMPLETED|Overall Study||0||
48744213|NCT01016600|102161628|FG003|NOT COMPLETED|Overall Study||0||
48327363|NCT00465595|101128324|FG000|STARTED|Overall Study||27||
48327364|NCT00465595|101128325|FG001|STARTED|Overall Study||29||
48327365|NCT00465595|101128324|FG000|COMPLETED|Overall Study||22||
48327366|NCT00465595|101128325|FG001|COMPLETED|Overall Study||24||
48744214|NCT04050618|102161629|FG000|STARTED|First Intervention||58||
48744215|NCT04050618|102161630|FG001|STARTED|First Intervention||56||
48327367|NCT00465595|101128324|FG000|NOT COMPLETED|Overall Study||5||
48327368|NCT00465595|101128325|FG001|NOT COMPLETED|Overall Study||5||
48327369|NCT01857713|101128326|FG000|STARTED|Overall Study||95||
48327370|NCT01857713|101128326|FG000|COMPLETED|Overall Study||89||
48327371|NCT01857713|101128326|FG000|NOT COMPLETED|Overall Study||6||
48327372|NCT02347176|101128327|FG000|STARTED|Overall Study||51||
48327373|NCT02347176|101128328|FG001|STARTED|Overall Study||50||
48327374|NCT02347176|101128329|FG002|STARTED|Overall Study||51||
48327375|NCT02347176|101128330|FG003|STARTED|Overall Study||52||
48744216|NCT04050618|102161629|FG000|COMPLETED|First Intervention||56||
48744217|NCT04050618|102161630|FG001|COMPLETED|First Intervention||56||
48327376|NCT02347176|101128327|FG000|COMPLETED|Overall Study||39||
48327377|NCT02347176|101128328|FG001|COMPLETED|Overall Study||40||
48621091|NCT03492437|101856470|FG001|STARTED|Treatment Period 2||20||
48621092|NCT03492437|101856469|FG000|COMPLETED|Treatment Period 2||0||
48621093|NCT03492437|101856470|FG001|COMPLETED|Treatment Period 2||19||
48621094|NCT03492437|101856469|FG000|NOT COMPLETED|Treatment Period 2||0||
48621095|NCT03492437|101856470|FG001|NOT COMPLETED|Treatment Period 2||1||
48621096|NCT01569126|101856471|FG000|STARTED|Overall Study||8||
48327378|NCT02347176|101128329|FG002|COMPLETED|Overall Study||43||
48327379|NCT02347176|101128330|FG003|COMPLETED|Overall Study||48||
48621097|NCT01569126|101856472|FG001|STARTED|Overall Study||8||
48621098|NCT01569126|101856473|FG002|STARTED|Overall Study||8||
48621099|NCT01569126|101856474|FG003|STARTED|Overall Study||8||
48621100|NCT01569126|101856475|FG004|STARTED|Overall Study||12||
48621101|NCT01569126|101856476|FG005|STARTED|Overall Study||12||
48621102|NCT01569126|101856471|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8||
48621103|NCT01569126|101856472|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8||
48621104|NCT01569126|101856473|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8||
48621105|NCT01569126|101856474|FG003|Received at Least 1 Dose of Study Drug|Overall Study||8||
48621106|NCT01569126|101856475|FG004|Received at Least 1 Dose of Study Drug|Overall Study||12||
48621107|NCT01569126|101856476|FG005|Received at Least 1 Dose of Study Drug|Overall Study||12||
48621108|NCT01569126|101856471|FG000|COMPLETED|Overall Study||8||
48621109|NCT01569126|101856472|FG001|COMPLETED|Overall Study||8||
48621110|NCT01569126|101856473|FG002|COMPLETED|Overall Study||8||
48621111|NCT01569126|101856474|FG003|COMPLETED|Overall Study||8||
48621112|NCT01569126|101856475|FG004|COMPLETED|Overall Study||12||
48621113|NCT01569126|101856476|FG005|COMPLETED|Overall Study||12||
48621114|NCT01569126|101856471|FG000|NOT COMPLETED|Overall Study||0||
48621115|NCT01569126|101856472|FG001|NOT COMPLETED|Overall Study||0||
48621116|NCT01569126|101856473|FG002|NOT COMPLETED|Overall Study||0||
48744218|NCT04050618|102161629|FG000|NOT COMPLETED|First Intervention||2||
48744219|NCT04050618|102161630|FG001|NOT COMPLETED|First Intervention||0||
48744220|NCT04050618|102161629|FG000|STARTED|Second Intervention||56||
48744221|NCT04050618|102161630|FG001|STARTED|Second Intervention||56||
48744222|NCT04050618|102161629|FG000|COMPLETED|Second Intervention||55||
48744223|NCT04050618|102161630|FG001|COMPLETED|Second Intervention||56||
48744224|NCT04050618|102161629|FG000|NOT COMPLETED|Second Intervention||1||
48744225|NCT04050618|102161630|FG001|NOT COMPLETED|Second Intervention||0||
48744226|NCT02660853|102161631|FG000|STARTED|Overall Study||25||
48744227|NCT02660853|102161631|FG000|COMPLETED|Overall Study||25||
48744228|NCT02660853|102161631|FG000|NOT COMPLETED|Overall Study||0||
48744229|NCT04871425|102161632|FG000|STARTED|Overall Study||57||
48744230|NCT04871425|102161633|FG001|STARTED|Overall Study||53||
48744231|NCT04871425|102161632|FG000|COMPLETED|Overall Study||42||
48744232|NCT04871425|102161633|FG001|COMPLETED|Overall Study||45||
48744233|NCT04871425|102161632|FG000|NOT COMPLETED|Overall Study||15||
48744234|NCT04871425|102161633|FG001|NOT COMPLETED|Overall Study||8||
48744235|NCT00844376|102161634|FG000|STARTED|Period 1: First Intervention||6||
48744236|NCT00844376|102161635|FG001|STARTED|Period 1: First Intervention||6||
48744237|NCT00844376|102161634|FG000|COMPLETED|Period 1: First Intervention||5||
48621117|NCT01569126|101856474|FG003|NOT COMPLETED|Overall Study||0||
48621118|NCT01569126|101856475|FG004|NOT COMPLETED|Overall Study||0||
48621119|NCT01569126|101856476|FG005|NOT COMPLETED|Overall Study||0||
48621120|NCT01026948|101856477|FG000|STARTED|Overall Study||70||
48621121|NCT01026948|101856477|FG000|COMPLETED|Overall Study||62||
48621122|NCT01026948|101856477|FG000|NOT COMPLETED|Overall Study||8||
48621123|NCT01573000|101856478|FG000|STARTED|Dosimetric and Therapeutic Treatment||42||
48621124|NCT01573000|101856479|FG001|STARTED|Dosimetric and Therapeutic Treatment||36||
48621125|NCT01573000|101856478|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||7||
48621126|NCT01573000|101856479|FG001|COMPLETED|Dosimetric and Therapeutic Treatment||1||
48621127|NCT01573000|101856478|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35||
48621128|NCT01573000|101856479|FG001|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35||
48621129|NCT01573000|101856478|FG000|STARTED|Crossover Phase||0||
48621130|NCT01573000|101856479|FG001|STARTED|Crossover Phase||19||
48621131|NCT01573000|101856478|FG000|COMPLETED|Crossover Phase||0||
48621132|NCT01573000|101856479|FG001|COMPLETED|Crossover Phase||1||
48621133|NCT01573000|101856478|FG000|NOT COMPLETED|Crossover Phase||0||
48621134|NCT01573000|101856479|FG001|NOT COMPLETED|Crossover Phase||18||
48621135|NCT01573000|101856478|FG000|STARTED|Long-Term Follow-Up||14||
48621136|NCT01573000|101856479|FG001|STARTED|Long-Term Follow-Up||5||
48621137|NCT01573000|101856478|FG000|COMPLETED|Long-Term Follow-Up||11||
48621138|NCT01573000|101856479|FG001|COMPLETED|Long-Term Follow-Up||4||
48621139|NCT01573000|101856478|FG000|NOT COMPLETED|Long-Term Follow-Up||3||
48327380|NCT02347176|101128327|FG000|NOT COMPLETED|Overall Study||12||
48409666|NCT02705352|101334765|FG000|STARTED|Overall Study||1||
48409667|NCT02705352|101334766|FG001|STARTED|Overall Study||0||
48621140|NCT01573000|101856479|FG001|NOT COMPLETED|Long-Term Follow-Up||1||
48744238|NCT00844376|102161635|FG001|COMPLETED|Period 1: First Intervention||6||
48744239|NCT00844376|102161634|FG000|NOT COMPLETED|Period 1: First Intervention||1||
48744240|NCT00844376|102161635|FG001|NOT COMPLETED|Period 1: First Intervention||0||
48744241|NCT00844376|102161634|FG000|STARTED|Period 2: Second Intervention||5||
48744242|NCT00844376|102161635|FG001|STARTED|Period 2: Second Intervention||6||
48744243|NCT00844376|102161634|FG000|COMPLETED|Period 2: Second Intervention||5||
48744244|NCT00844376|102161635|FG001|COMPLETED|Period 2: Second Intervention||6||
48744245|NCT00844376|102161634|FG000|NOT COMPLETED|Period 2: Second Intervention||0||
48744246|NCT00844376|102161635|FG001|NOT COMPLETED|Period 2: Second Intervention||0||
48744247|NCT04485546|102161636|FG000|STARTED|Overall Study||37||
48744248|NCT04485546|102161636|FG000|COMPLETED|Overall Study||29||
48327381|NCT02347176|101128328|FG001|NOT COMPLETED|Overall Study||10||
48327382|NCT02347176|101128329|FG002|NOT COMPLETED|Overall Study||8||
48327383|NCT02347176|101128330|FG003|NOT COMPLETED|Overall Study||4||
48327384|NCT01536860|101128331|FG000|STARTED|First Intervention (1 Day)||4||
48327385|NCT01536860|101128332|FG001|STARTED|First Intervention (1 Day)||4||
48327386|NCT01536860|101128333|FG002|STARTED|First Intervention (1 Day)||4||
48327387|NCT01536860|101128331|FG000|COMPLETED|First Intervention (1 Day)||4||
48327388|NCT01536860|101128332|FG001|COMPLETED|First Intervention (1 Day)||4||
48327389|NCT01536860|101128333|FG002|COMPLETED|First Intervention (1 Day)||4||
48327390|NCT01536860|101128331|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48409668|NCT02705352|101334765|FG000|COMPLETED|Overall Study||1||
48621141|NCT04396626|101856480|FG000|STARTED|Overall Study||975||
48621142|NCT04396626|101856480|FG000|COMPLETED|Overall Study||0||
48327391|NCT01536860|101128332|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48327392|NCT01536860|101128333|FG002|NOT COMPLETED|First Intervention (1 Day)||0||
48621143|NCT04396626|101856480|FG000|NOT COMPLETED|Overall Study||975||
48621144|NCT00917124|101856481|FG000|STARTED|Overall Study||100||
48621145|NCT00917124|101856482|FG001|STARTED|Overall Study||100||
48621146|NCT00917124|101856481|FG000|COMPLETED|Overall Study||96||
48621147|NCT00917124|101856482|FG001|COMPLETED|Overall Study||94||
48621148|NCT00917124|101856481|FG000|NOT COMPLETED|Overall Study||4||
48621149|NCT00917124|101856482|FG001|NOT COMPLETED|Overall Study||6||
48621150|NCT00577772|101856483|FG000|STARTED|Overall Study||10||
48621151|NCT00577772|101856484|FG001|STARTED|Overall Study||7||
48621152|NCT00577772|101856483|FG000|COMPLETED|Overall Study||10||
48621153|NCT00577772|101856484|FG001|COMPLETED|Overall Study||6||
48621154|NCT00577772|101856483|FG000|NOT COMPLETED|Overall Study||0||
48621155|NCT00577772|101856484|FG001|NOT COMPLETED|Overall Study||1||
48409669|NCT02705352|101334766|FG001|COMPLETED|Overall Study||0||
48409670|NCT02705352|101334765|FG000|NOT COMPLETED|Overall Study||0||
48409671|NCT02705352|101334766|FG001|NOT COMPLETED|Overall Study||0||
48409672|NCT04247828|101334767|FG000|STARTED|Overall Study||30||
48409673|NCT04247828|101334767|FG000|Started - Controls|Overall Study||19||
48409674|NCT04247828|101334767|FG000|Started - Participants With SPI|Overall Study||11||
48409675|NCT04247828|101334767|FG000|COMPLETED|Overall Study||21||
48409676|NCT04247828|101334767|FG000|NOT COMPLETED|Overall Study||9||
48409677|NCT01685372|101334768|FG000|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7||
48409678|NCT01685372|101334769|FG001|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9||
48409679|NCT01685372|101334768|FG000|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7||
48409680|NCT01685372|101334769|FG001|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9||
48409681|NCT01685372|101334768|FG000|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0||
48409682|NCT01685372|101334769|FG001|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0||
48409683|NCT01685372|101334768|FG000|STARTED|Timepoint 2 (T2): 2nd Blood Draw||7||
48409684|NCT01685372|101334769|FG001|STARTED|Timepoint 2 (T2): 2nd Blood Draw||9||
48409685|NCT01685372|101334768|FG000|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||7||
48409686|NCT01685372|101334769|FG001|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||9||
48409687|NCT01685372|101334768|FG000|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0||
48409688|NCT01685372|101334769|FG001|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0||
48409689|NCT01685372|101334768|FG000|STARTED|Timepoint 3 (T3): 3rd Blood Draw||7||
48409690|NCT01685372|101334769|FG001|STARTED|Timepoint 3 (T3): 3rd Blood Draw||9||
48409691|NCT01685372|101334768|FG000|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4||
48409692|NCT01685372|101334769|FG001|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||5||
48409693|NCT01685372|101334768|FG000|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||3||
48409694|NCT01685372|101334769|FG001|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4||
48409695|NCT04227119|101334770|FG000|STARTED|Overall Study||11||
48409696|NCT04227119|101334770|FG000|COMPLETED|Overall Study||11||
48327393|NCT01536860|101128331|FG000|STARTED|Washout Period (3 Days)||4||
48327394|NCT01536860|101128332|FG001|STARTED|Washout Period (3 Days)||4||
48327395|NCT01536860|101128333|FG002|STARTED|Washout Period (3 Days)||4||
48327396|NCT01536860|101128331|FG000|COMPLETED|Washout Period (3 Days)||4||
48327397|NCT01536860|101128332|FG001|COMPLETED|Washout Period (3 Days)||4||
48327398|NCT01536860|101128333|FG002|COMPLETED|Washout Period (3 Days)||4||
48327399|NCT01536860|101128331|FG000|NOT COMPLETED|Washout Period (3 Days)||0||
48327400|NCT01536860|101128332|FG001|NOT COMPLETED|Washout Period (3 Days)||0||
48327401|NCT01536860|101128333|FG002|NOT COMPLETED|Washout Period (3 Days)||0||
48327402|NCT01536860|101128331|FG000|STARTED|Second Intervention (1 Day)||4||
48327403|NCT01536860|101128332|FG001|STARTED|Second Intervention (1 Day)||4||
48327404|NCT01536860|101128333|FG002|STARTED|Second Intervention (1 Day)||4||
48327405|NCT01536860|101128331|FG000|COMPLETED|Second Intervention (1 Day)||4||
48327406|NCT01536860|101128332|FG001|COMPLETED|Second Intervention (1 Day)||4||
48409697|NCT04227119|101334770|FG000|NOT COMPLETED|Overall Study||0||
48409698|NCT00191386|101334771|FG000|STARTED|Overall Study||228||
48409699|NCT00191386|101334771|FG000|6 Months|Overall Study||183||
48409700|NCT00191386|101334771|FG000|12 Months|Overall Study||149||
48409701|NCT00191386|101334771|FG000|2 Years|Overall Study||105||
48409702|NCT00191386|101334771|FG000|3 Years|Overall Study||65||
48327407|NCT01536860|101128333|FG002|COMPLETED|Second Intervention (1 Day)||4||
48327408|NCT01536860|101128331|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48327409|NCT01536860|101128332|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48327410|NCT01536860|101128333|FG002|NOT COMPLETED|Second Intervention (1 Day)||0||
48327411|NCT01536860|101128331|FG000|STARTED|Washout Period (3 Days)||4||
48409703|NCT00191386|101334771|FG000|COMPLETED|Overall Study||68||
48409704|NCT00191386|101334771|FG000|NOT COMPLETED|Overall Study||160||
48409705|NCT03898323|101334772|FG000|STARTED|Overall Study||3||
48409706|NCT03898323|101334772|FG000|COMPLETED|Overall Study||2||
48409707|NCT03898323|101334772|FG000|NOT COMPLETED|Overall Study||1||
48409708|NCT00617162|101334773|FG000|STARTED|Overall Study||60||
48409709|NCT00617162|101334774|FG001|STARTED|Overall Study||30||
48409710|NCT00617162|101334773|FG000|COMPLETED|Overall Study||53||
48409711|NCT00617162|101334774|FG001|COMPLETED|Overall Study||27||
48409712|NCT00617162|101334773|FG000|NOT COMPLETED|Overall Study||7||
48327412|NCT01536860|101128332|FG001|STARTED|Washout Period (3 Days)||4||
48327413|NCT01536860|101128333|FG002|STARTED|Washout Period (3 Days)||4||
48327414|NCT01536860|101128331|FG000|COMPLETED|Washout Period (3 Days)||3||
48327415|NCT01536860|101128332|FG001|COMPLETED|Washout Period (3 Days)||4||
48327416|NCT01536860|101128333|FG002|COMPLETED|Washout Period (3 Days)||4||
48409713|NCT00617162|101334774|FG001|NOT COMPLETED|Overall Study||3||
48409714|NCT00108277|101334775|FG000|STARTED|Overall Study||29||
48621156|NCT01645059|101856485|FG000|STARTED|Overall Study||129||
48621157|NCT01645059|101856485|FG000|COMPLETED|Overall Study||129||
48409715|NCT00108277|101334776|FG001|STARTED|Overall Study||28||
48409716|NCT00108277|101334777|FG002|STARTED|Overall Study||35||
48409717|NCT00108277|101334775|FG000|COMPLETED|Overall Study||19||
48409718|NCT00108277|101334776|FG001|COMPLETED|Overall Study||16||
48409719|NCT00108277|101334777|FG002|COMPLETED|Overall Study||19||
48409720|NCT00108277|101334775|FG000|NOT COMPLETED|Overall Study||10||
48409721|NCT00108277|101334776|FG001|NOT COMPLETED|Overall Study||12||
48409722|NCT00108277|101334777|FG002|NOT COMPLETED|Overall Study||16||
48409723|NCT04330989|101334778|FG000|STARTED|Overall Study||51||
48409724|NCT04330989|101334779|FG001|STARTED|Overall Study||49||
48409725|NCT04330989|101334780|FG002|STARTED|Overall Study||100||
48409726|NCT04330989|101334781|FG003|STARTED|Overall Study||100||
48409727|NCT04330989|101334778|FG000|Liveborn Infants During Study|Overall Study||43||
48409728|NCT04330989|101334779|FG001|Liveborn Infants During Study|Overall Study||46||
48409729|NCT04330989|101334780|FG002|Liveborn Infants During Study|Overall Study||87||
48409730|NCT04330989|101334781|FG003|Liveborn Infants During Study|Overall Study||90||
48409731|NCT04330989|101334778|FG000|COMPLETED|Overall Study||41||
48409732|NCT04330989|101334779|FG001|COMPLETED|Overall Study||43||
48409733|NCT04330989|101334780|FG002|COMPLETED|Overall Study||88||
48409734|NCT04330989|101334781|FG003|COMPLETED|Overall Study||83||
48409735|NCT04330989|101334778|FG000|NOT COMPLETED|Overall Study||10||
48409736|NCT04330989|101334779|FG001|NOT COMPLETED|Overall Study||6||
48409737|NCT04330989|101334780|FG002|NOT COMPLETED|Overall Study||12||
48409738|NCT04330989|101334781|FG003|NOT COMPLETED|Overall Study||17||
48165032|NCT03354325|100728439|FG001|COMPLETED|Overall Study||138||
48409739|NCT00464620|101334782|FG000|STARTED|Overall Study||50||
48409740|NCT00464620|101334783|FG001|STARTED|Overall Study||200||
48409741|NCT00464620|101334784|FG002|STARTED|Overall Study||116||
48409742|NCT00464620|101334782|FG000|COMPLETED|Overall Study||48||
48409743|NCT00464620|101334783|FG001|COMPLETED|Overall Study||198||
48409744|NCT00464620|101334784|FG002|COMPLETED|Overall Study||109||
48409745|NCT00464620|101334782|FG000|NOT COMPLETED|Overall Study||2||
48409746|NCT00464620|101334783|FG001|NOT COMPLETED|Overall Study||2||
48409747|NCT00464620|101334784|FG002|NOT COMPLETED|Overall Study||7||
48409748|NCT02279160|101334785|FG000|STARTED|Overall Study||40||
48409749|NCT02279160|101334786|FG001|STARTED|Overall Study||21||
48409750|NCT02279160|101334785|FG000|COMPLETED|Overall Study||34||
48409751|NCT02279160|101334786|FG001|COMPLETED|Overall Study||19||
48409752|NCT02279160|101334785|FG000|NOT COMPLETED|Overall Study||6||
48409753|NCT02279160|101334786|FG001|NOT COMPLETED|Overall Study||2||
48409754|NCT00691054|101334787|FG000|STARTED|Overall Study||20||
48409755|NCT00691054|101334787|FG000|COMPLETED|Overall Study||19||
48409756|NCT00691054|101334787|FG000|NOT COMPLETED|Overall Study||1||
48409757|NCT04157751|101334788|FG000|STARTED|Overall Study||265|Randomised|
48409758|NCT04157751|101334789|FG001|STARTED|Overall Study||265|Randomised|
48409759|NCT04157751|101334788|FG000|Treated|Overall Study||264||
48409760|NCT04157751|101334789|FG001|Treated|Overall Study||260||
48409761|NCT04157751|101334788|FG000|COMPLETED|Overall Study||202||
48409762|NCT04157751|101334789|FG001|COMPLETED|Overall Study||208||
48409763|NCT04157751|101334788|FG000|NOT COMPLETED|Overall Study||63||
48409764|NCT04157751|101334789|FG001|NOT COMPLETED|Overall Study||57||
48409765|NCT05104749|101334790|FG000|STARTED|Overall Study||38||
48165033|NCT03354325|100728438|FG000|NOT COMPLETED|Overall Study||20||
48165034|NCT03354325|100728439|FG001|NOT COMPLETED|Overall Study||15||
48409766|NCT05104749|101334791|FG001|STARTED|Overall Study||39||
48409767|NCT05104749|101334790|FG000|COMPLETED|Overall Study||36||
48409768|NCT05104749|101334791|FG001|COMPLETED|Overall Study||36||
48409769|NCT05104749|101334790|FG000|NOT COMPLETED|Overall Study||2||
48409770|NCT05104749|101334791|FG001|NOT COMPLETED|Overall Study||3||
48409771|NCT01478581|101334792|FG000|STARTED|Overall Study||13||
48409772|NCT01478581|101334793|FG001|STARTED|Overall Study||18||
48409773|NCT01478581|101334794|FG002|STARTED|Overall Study||18||
48409774|NCT01478581|101334795|FG003|STARTED|Overall Study||43||
48409775|NCT01478581|101334792|FG000|COMPLETED|Overall Study||13||
48409776|NCT01478581|101334793|FG001|COMPLETED|Overall Study||18||
48409777|NCT01478581|101334794|FG002|COMPLETED|Overall Study||18||
48409778|NCT01478581|101334795|FG003|COMPLETED|Overall Study||43||
48409779|NCT01478581|101334792|FG000|NOT COMPLETED|Overall Study||0||
48409780|NCT01478581|101334793|FG001|NOT COMPLETED|Overall Study||0||
48409781|NCT01478581|101334794|FG002|NOT COMPLETED|Overall Study||0||
48409782|NCT01478581|101334795|FG003|NOT COMPLETED|Overall Study||0||
48409783|NCT01987752|101334796|FG000|STARTED|Overall Study||732||
48409784|NCT01987752|101334796|FG000|COMPLETED|Overall Study||732||
48409785|NCT01987752|101334796|FG000|NOT COMPLETED|Overall Study||0||
48409786|NCT00242710|101334797|FG000|STARTED|Core Study (up to Year 1)||373||
48409787|NCT00242710|101334798|FG001|STARTED|Core Study (up to Year 1)||353||
48409788|NCT00242710|101334799|FG002|STARTED|Core Study (up to Year 1)||183||
48409789|NCT00242710|101334800|FG003|STARTED|Core Study (up to Year 1)||174||
48409790|NCT00242710|101334797|FG000|Treated|Core Study (up to Year 1)||361||
48409791|NCT00242710|101334798|FG001|Treated|Core Study (up to Year 1)||349||
48165035|NCT04255342|100728440|FG000|STARTED|Overall Study||25||
48165036|NCT04255342|100728440|FG000|COMPLETED|Overall Study||22||
48409792|NCT00242710|101334799|FG002|Treated|Core Study (up to Year 1)||179||
48409793|NCT00242710|101334800|FG003|Treated|Core Study (up to Year 1)||172||
48409794|NCT00242710|101334797|FG000|COMPLETED|Core Study (up to Year 1)||287||
48409795|NCT00242710|101334798|FG001|COMPLETED|Core Study (up to Year 1)||289||
48409796|NCT00242710|101334799|FG002|COMPLETED|Core Study (up to Year 1)||132||
48409797|NCT00242710|101334800|FG003|COMPLETED|Core Study (up to Year 1)||143||
48409798|NCT00242710|101334797|FG000|NOT COMPLETED|Core Study (up to Year 1)||86||
48409799|NCT00242710|101334798|FG001|NOT COMPLETED|Core Study (up to Year 1)||64||
48409800|NCT00242710|101334799|FG002|NOT COMPLETED|Core Study (up to Year 1)||51||
48409801|NCT00242710|101334800|FG003|NOT COMPLETED|Core Study (up to Year 1)||31||
48409802|NCT00242710|101334797|FG000|STARTED|Period Between Core Study and Extension||287||
48409803|NCT00242710|101334798|FG001|STARTED|Period Between Core Study and Extension||289||
48409804|NCT00242710|101334799|FG002|STARTED|Period Between Core Study and Extension||132||
48409805|NCT00242710|101334800|FG003|STARTED|Period Between Core Study and Extension||143||
48409806|NCT00242710|101334797|FG000|COMPLETED|Period Between Core Study and Extension||168||
48409807|NCT00242710|101334798|FG001|COMPLETED|Period Between Core Study and Extension||177||
48409808|NCT00242710|101334799|FG002|COMPLETED|Period Between Core Study and Extension||84||
48409809|NCT00242710|101334800|FG003|COMPLETED|Period Between Core Study and Extension||94||
48409810|NCT00242710|101334797|FG000|NOT COMPLETED|Period Between Core Study and Extension||119||
48409811|NCT00242710|101334798|FG001|NOT COMPLETED|Period Between Core Study and Extension||112||
48409812|NCT00242710|101334799|FG002|NOT COMPLETED|Period Between Core Study and Extension||48||
48409813|NCT00242710|101334800|FG003|NOT COMPLETED|Period Between Core Study and Extension||49||
48744249|NCT04485546|102161636|FG000|NOT COMPLETED|Overall Study||8||
48744250|NCT00491491|102161637|FG000|STARTED|Overall Study||22||
48744251|NCT00491491|102161638|FG001|STARTED|Overall Study||21||
48744252|NCT00491491|102161637|FG000|COMPLETED|Overall Study||22||
48744253|NCT00491491|102161638|FG001|COMPLETED|Overall Study||21||
48744254|NCT00491491|102161637|FG000|NOT COMPLETED|Overall Study||0||
48744255|NCT00491491|102161638|FG001|NOT COMPLETED|Overall Study||0||
48744256|NCT04846322|102161639|FG000|STARTED|Overall Study||100||
48744257|NCT04846322|102161639|FG000|COMPLETED|Overall Study||100||
48744258|NCT04846322|102161639|FG000|NOT COMPLETED|Overall Study||0||
48744259|NCT04566601|102161640|FG000|STARTED|Overall Study||128||
48744260|NCT04566601|102161641|FG001|STARTED|Overall Study||52||
48409814|NCT00242710|101334797|FG000|STARTED|Study Extension (up to Year 2)||168||
48409815|NCT00242710|101334798|FG001|STARTED|Study Extension (up to Year 2)||177||
48409816|NCT00242710|101334799|FG002|STARTED|Study Extension (up to Year 2)||84||
48409817|NCT00242710|101334800|FG003|STARTED|Study Extension (up to Year 2)||94||
48409818|NCT00242710|101334797|FG000|COMPLETED|Study Extension (up to Year 2)||141||
48409819|NCT00242710|101334798|FG001|COMPLETED|Study Extension (up to Year 2)||148||
48409820|NCT00242710|101334799|FG002|COMPLETED|Study Extension (up to Year 2)||69||
48744261|NCT04566601|102161642|FG002|STARTED|Overall Study||53||
48744262|NCT04566601|102161643|FG003|STARTED|Overall Study||53||
48744263|NCT04566601|102161644|FG004|STARTED|Overall Study||104||
48327417|NCT01536860|101128331|FG000|NOT COMPLETED|Washout Period (3 Days)||1||
48327418|NCT01536860|101128332|FG001|NOT COMPLETED|Washout Period (3 Days)||0||
48327419|NCT01536860|101128333|FG002|NOT COMPLETED|Washout Period (3 Days)||0||
48327420|NCT01536860|101128331|FG000|STARTED|Third Intervention (1 Day)||3||
48327421|NCT01536860|101128332|FG001|STARTED|Third Intervention (1 Day)||4||
48327422|NCT01536860|101128333|FG002|STARTED|Third Intervention (1 Day)||4||
48327423|NCT01536860|101128331|FG000|COMPLETED|Third Intervention (1 Day)||3||
48327424|NCT01536860|101128332|FG001|COMPLETED|Third Intervention (1 Day)||4||
48327425|NCT01536860|101128333|FG002|COMPLETED|Third Intervention (1 Day)||4||
48327426|NCT01536860|101128331|FG000|NOT COMPLETED|Third Intervention (1 Day)||0||
48327427|NCT01536860|101128332|FG001|NOT COMPLETED|Third Intervention (1 Day)||0||
48327428|NCT01536860|101128333|FG002|NOT COMPLETED|Third Intervention (1 Day)||0||
48327429|NCT03354663|101128334|FG000|STARTED|Enrollment to Catheter Insertion||156||
48327430|NCT03354663|101128334|FG000|COMPLETED|Enrollment to Catheter Insertion||151||
48327431|NCT03354663|101128334|FG000|NOT COMPLETED|Enrollment to Catheter Insertion||5||
48327432|NCT03354663|101128334|FG000|STARTED|Completed 30-day Visit||151||
48327433|NCT03354663|101128334|FG000|COMPLETED|Completed 30-day Visit||149||
48327434|NCT03354663|101128334|FG000|NOT COMPLETED|Completed 30-day Visit||2||
48327435|NCT00166205|101128335|FG000|STARTED|Overall Study||276||
48327436|NCT00166205|101128335|FG000|Intervention - SAGB Surgery|Overall Study||276||
48327437|NCT00166205|101128335|FG000|COMPLETED|Overall Study||228||
48327438|NCT00166205|101128335|FG000|NOT COMPLETED|Overall Study||48||
48327439|NCT00692211|101128336|FG000|STARTED|Overall Study||202||
48327440|NCT00692211|101128337|FG001|STARTED|Overall Study||202||
48409821|NCT00242710|101334800|FG003|COMPLETED|Study Extension (up to Year 2)||84||
48409822|NCT00242710|101334797|FG000|NOT COMPLETED|Study Extension (up to Year 2)||27||
48409823|NCT00242710|101334798|FG001|NOT COMPLETED|Study Extension (up to Year 2)||29||
48409824|NCT00242710|101334799|FG002|NOT COMPLETED|Study Extension (up to Year 2)||15||
48744264|NCT04566601|102161640|FG000|COMPLETED|Overall Study||95|Completed planned trial treatment of 12 weeks.|
48327441|NCT00692211|101128336|FG000|COMPLETED|Overall Study||202||
48327442|NCT00692211|101128337|FG001|COMPLETED|Overall Study||202||
48327443|NCT00692211|101128336|FG000|NOT COMPLETED|Overall Study||0||
48744265|NCT04566601|102161641|FG001|COMPLETED|Overall Study||40|Completed planned trial treatment of 12 weeks.|
48744266|NCT04566601|102161642|FG002|COMPLETED|Overall Study||35|Completed planned trial treatment of 12 weeks.|
48744267|NCT04566601|102161643|FG003|COMPLETED|Overall Study||40|Completed planned trial treatment of 12 weeks.|
48744268|NCT04566601|102161644|FG004|COMPLETED|Overall Study||77|Completed planned trial treatment of 12 weeks.|
48744269|NCT04566601|102161640|FG000|NOT COMPLETED|Overall Study||33||
48744270|NCT04566601|102161641|FG001|NOT COMPLETED|Overall Study||12||
48744271|NCT04566601|102161642|FG002|NOT COMPLETED|Overall Study||18||
48744272|NCT04566601|102161643|FG003|NOT COMPLETED|Overall Study||13||
48327444|NCT00692211|101128337|FG001|NOT COMPLETED|Overall Study||0||
48327445|NCT02111993|101128338|FG000|STARTED|Overall Study||30||
48327446|NCT02111993|101128339|FG001|STARTED|Overall Study||30||
48327447|NCT02111993|101128338|FG000|COMPLETED|Overall Study||25||
48327448|NCT02111993|101128339|FG001|COMPLETED|Overall Study||26||
48327449|NCT02111993|101128338|FG000|NOT COMPLETED|Overall Study||5||
48327450|NCT02111993|101128339|FG001|NOT COMPLETED|Overall Study||4||
48327451|NCT02889796|101128340|FG000|STARTED|Overall Study||477||
48327452|NCT02889796|101128341|FG001|STARTED|Overall Study||480||
48327453|NCT02889796|101128342|FG002|STARTED|Overall Study||325||
48327454|NCT02889796|101128343|FG003|STARTED|Overall Study||190||
48327455|NCT02889796|101128344|FG004|STARTED|Overall Study||191||
48327456|NCT02889796|101128345|FG005|STARTED|Overall Study||96||
48327457|NCT02889796|101128340|FG000|COMPLETED|Overall Study||424||
48327458|NCT02889796|101128341|FG001|COMPLETED|Overall Study||422||
48327459|NCT02889796|101128342|FG002|COMPLETED|Overall Study||281||
48327460|NCT02889796|101128343|FG003|COMPLETED|Overall Study||181||
48327461|NCT02889796|101128344|FG004|COMPLETED|Overall Study||185||
48327462|NCT02889796|101128345|FG005|COMPLETED|Overall Study||24||
48327463|NCT02889796|101128340|FG000|NOT COMPLETED|Overall Study||53||
48327464|NCT02889796|101128341|FG001|NOT COMPLETED|Overall Study||58||
48327465|NCT02889796|101128342|FG002|NOT COMPLETED|Overall Study||44||
48327466|NCT02889796|101128343|FG003|NOT COMPLETED|Overall Study||9||
48327467|NCT02889796|101128344|FG004|NOT COMPLETED|Overall Study||6||
48327468|NCT02889796|101128345|FG005|NOT COMPLETED|Overall Study||72||
48327469|NCT02013180|101128346|FG000|STARTED|Overall Study||119||
48327470|NCT02013180|101128347|FG001|STARTED|Overall Study||361||
48327471|NCT02013180|101128346|FG000|COMPLETED|Overall Study||119||
48327472|NCT02013180|101128347|FG001|COMPLETED|Overall Study||361||
48327473|NCT02013180|101128346|FG000|NOT COMPLETED|Overall Study||0||
48327474|NCT02013180|101128347|FG001|NOT COMPLETED|Overall Study||0||
48327475|NCT00223496|101128348|FG000|STARTED|Overall Study||32||
48327476|NCT00223496|101128348|FG000|COMPLETED|Overall Study||10||
48327477|NCT00223496|101128348|FG000|NOT COMPLETED|Overall Study||22||
48327478|NCT01568593|101128349|FG000|STARTED|Overall Study||48||
48327479|NCT01568593|101128350|FG001|STARTED|Overall Study||45||
48327480|NCT01568593|101128349|FG000|COMPLETED|Overall Study||41||
48744273|NCT04566601|102161644|FG004|NOT COMPLETED|Overall Study||27||
48744274|NCT01839058|102161645|FG000|STARTED|Overall Study||21||
48744275|NCT01839058|102161646|FG001|STARTED|Overall Study||19||
48744276|NCT01839058|102161645|FG000|COMPLETED|Overall Study||17||
48744277|NCT01839058|102161646|FG001|COMPLETED|Overall Study||16||
48327481|NCT01568593|101128350|FG001|COMPLETED|Overall Study||42||
48327482|NCT01568593|101128349|FG000|NOT COMPLETED|Overall Study||7||
48327483|NCT01568593|101128350|FG001|NOT COMPLETED|Overall Study||3||
48327484|NCT02424526|101128351|FG000|STARTED|Overall Study||9||
48327485|NCT02424526|101128352|FG001|STARTED|Overall Study||10||
48327486|NCT02424526|101128351|FG000|COMPLETED|Overall Study||9||
48327487|NCT02424526|101128352|FG001|COMPLETED|Overall Study||10||
48327488|NCT02424526|101128351|FG000|NOT COMPLETED|Overall Study||0||
48327489|NCT02424526|101128352|FG001|NOT COMPLETED|Overall Study||0||
48327490|NCT02229552|101128353|FG000|STARTED|Baseline||237||
48327491|NCT02229552|101128353|FG000|COMPLETED|Baseline||231||
48327492|NCT02229552|101128353|FG000|NOT COMPLETED|Baseline||6||
48327493|NCT02229552|101128353|FG000|STARTED|1-year Follow up||231||
48327494|NCT02229552|101128353|FG000|COMPLETED|1-year Follow up||206||
48327495|NCT02229552|101128353|FG000|NOT COMPLETED|1-year Follow up||25||
48327496|NCT02229552|101128353|FG000|STARTED|2-Year Follow up||231||
48327497|NCT02229552|101128353|FG000|COMPLETED|2-Year Follow up||205||
48327498|NCT02229552|101128353|FG000|NOT COMPLETED|2-Year Follow up||26||
48744278|NCT01839058|102161645|FG000|NOT COMPLETED|Overall Study||4||
48744279|NCT01839058|102161646|FG001|NOT COMPLETED|Overall Study||3||
48744280|NCT02910466|102161647|FG000|STARTED|Overall Study||39||
48744281|NCT02910466|102161647|FG000|Safety Set|Overall Study||39|The safety population consisted of all enrolled participants who received at least 1 dose of rhPTH(1-84) regardless of study (SHP634-402 or AAAE0544 \[NCT01199614\] core study).|
48744282|NCT02910466|102161647|FG000|Treated|Overall Study||36||
48744283|NCT02910466|102161647|FG000|COMPLETED|Overall Study||0||
48744284|NCT02910466|102161647|FG000|NOT COMPLETED|Overall Study||39||
48744285|NCT02412228|102161648|FG000|STARTED|Overall Study||12||
48744286|NCT02412228|102161648|FG000|COMPLETED|Overall Study||12||
48744287|NCT02412228|102161648|FG000|NOT COMPLETED|Overall Study||0||
48744288|NCT01395901|102161649|FG000|STARTED|Overall Study||336||
48744289|NCT01395901|102161650|FG001|STARTED|Overall Study||334||
48744290|NCT01395901|102161649|FG000|COMPLETED|Overall Study||326||
48744291|NCT01395901|102161650|FG001|COMPLETED|Overall Study||329||
48744292|NCT01395901|102161649|FG000|NOT COMPLETED|Overall Study||10||
48744293|NCT01395901|102161650|FG001|NOT COMPLETED|Overall Study||5||
48744294|NCT03776747|102161651|FG000|STARTED|Overall Study||0||
48744295|NCT03776747|102161652|FG001|STARTED|Overall Study||18||
48744296|NCT03776747|102161651|FG000|COMPLETED|Overall Study||0||
48744297|NCT03776747|102161652|FG001|COMPLETED|Overall Study||18||
48744298|NCT03776747|102161651|FG000|NOT COMPLETED|Overall Study||0||
48744299|NCT03776747|102161652|FG001|NOT COMPLETED|Overall Study||0||
48744300|NCT03087513|102161653|FG000|STARTED|First Intervention||40||
48165037|NCT04255342|100728440|FG000|NOT COMPLETED|Overall Study||3||
48165038|NCT04525547|100728441|FG000|STARTED|Overall Study||70||
48744301|NCT03087513|102161653|FG000|COMPLETED|First Intervention||40||
48744302|NCT03087513|102161653|FG000|NOT COMPLETED|First Intervention||0||
48165039|NCT04525547|100728441|FG000|COMPLETED|Overall Study||65||
48165040|NCT04525547|100728441|FG000|NOT COMPLETED|Overall Study||5||
48165041|NCT02760056|100728442|FG000|STARTED|Overall Study||10||
48165042|NCT02760056|100728443|FG001|STARTED|Overall Study||5||
48165043|NCT02760056|100728442|FG000|COMPLETED|Overall Study||10||
48165044|NCT02760056|100728443|FG001|COMPLETED|Overall Study||5||
48165045|NCT02760056|100728442|FG000|NOT COMPLETED|Overall Study||0||
48165046|NCT02760056|100728443|FG001|NOT COMPLETED|Overall Study||0||
48621158|NCT01645059|101856485|FG000|NOT COMPLETED|Overall Study||0||
48621159|NCT01705977|101856486|FG000|STARTED|Treatment Period (Year 1)||2009||
48621160|NCT01705977|101856487|FG001|STARTED|Treatment Period (Year 1)||2010||
48621161|NCT01705977|101856486|FG000|Intent-to-Treat Population|Treatment Period (Year 1)||2002||
48621162|NCT01705977|101856487|FG001|Intent-to-Treat Population|Treatment Period (Year 1)||2001||
48621163|NCT01705977|101856486|FG000|COMPLETED|Treatment Period (Year 1)||1729||
48621164|NCT01705977|101856487|FG001|COMPLETED|Treatment Period (Year 1)||1741||
48621165|NCT01705977|101856486|FG000|NOT COMPLETED|Treatment Period (Year 1)||280||
48621166|NCT01705977|101856487|FG001|NOT COMPLETED|Treatment Period (Year 1)||269||
48621167|NCT01705977|101856486|FG000|STARTED|Follow-up Period (Years 2 to 5)||1670||
48621168|NCT01705977|101856487|FG001|STARTED|Follow-up Period (Years 2 to 5)||1695||
48621169|NCT01705977|101856486|FG000|COMPLETED|Follow-up Period (Years 2 to 5)||1474||
48621170|NCT01705977|101856487|FG001|COMPLETED|Follow-up Period (Years 2 to 5)||1514||
48621171|NCT01705977|101856486|FG000|NOT COMPLETED|Follow-up Period (Years 2 to 5)||196||
48621172|NCT01705977|101856487|FG001|NOT COMPLETED|Follow-up Period (Years 2 to 5)||181||
48621173|NCT02634073|101856488|FG000|STARTED|Overall Study||4||
48621174|NCT02634073|101856489|FG001|STARTED|Overall Study||4||
48621175|NCT02634073|101856490|FG002|STARTED|Overall Study||4||
48621176|NCT02634073|101856491|FG003|STARTED|Overall Study||4||
48621177|NCT02634073|101856488|FG000|COMPLETED|Overall Study||4||
48744303|NCT03087513|102161653|FG000|STARTED|Second Intervention After 3 hr Washout||40||
48744304|NCT03087513|102161653|FG000|COMPLETED|Second Intervention After 3 hr Washout||38||
48744305|NCT03087513|102161653|FG000|NOT COMPLETED|Second Intervention After 3 hr Washout||2||
48744306|NCT03066063|102161654|FG000|STARTED|Overall Study||24||
48744307|NCT03066063|102161655|FG001|STARTED|Overall Study||25||
48744308|NCT03066063|102161656|FG002|STARTED|Overall Study||19||
48744309|NCT03066063|102161657|FG003|STARTED|Overall Study||24||
48744310|NCT03066063|102161654|FG000|COMPLETED|Overall Study||19||
48621178|NCT02634073|101856489|FG001|COMPLETED|Overall Study||4||
48621179|NCT02634073|101856490|FG002|COMPLETED|Overall Study||4||
48744311|NCT03066063|102161655|FG001|COMPLETED|Overall Study||21||
48744312|NCT03066063|102161656|FG002|COMPLETED|Overall Study||13||
48165047|NCT04534114|100728444|FG000|STARTED|Main Treatment Period||77||
48165048|NCT04534114|100728445|FG001|STARTED|Main Treatment Period||79||
48165049|NCT04534114|100728446|FG002|STARTED|Main Treatment Period||76||
48165050|NCT04534114|100728447|FG003|STARTED|Main Treatment Period||75||
48165051|NCT04534114|100728444|FG000|COMPLETED|Main Treatment Period||67||
48165052|NCT04534114|100728445|FG001|COMPLETED|Main Treatment Period||66||
48165053|NCT04534114|100728446|FG002|COMPLETED|Main Treatment Period||64||
48165054|NCT04534114|100728447|FG003|COMPLETED|Main Treatment Period||61||
48621180|NCT02634073|101856491|FG003|COMPLETED|Overall Study||4||
48621181|NCT02634073|101856488|FG000|NOT COMPLETED|Overall Study||0||
48621182|NCT02634073|101856489|FG001|NOT COMPLETED|Overall Study||0||
48621183|NCT02634073|101856490|FG002|NOT COMPLETED|Overall Study||0||
48621184|NCT02634073|101856491|FG003|NOT COMPLETED|Overall Study||0||
48621185|NCT00991081|101856492|FG000|STARTED|Phase I, Formative Research||20||
48621186|NCT00991081|101856493|FG001|STARTED|Phase I, Formative Research||0||
48621187|NCT00991081|101856494|FG002|STARTED|Phase I, Formative Research||0||
48744313|NCT03066063|102161657|FG003|COMPLETED|Overall Study||18||
48744314|NCT03066063|102161654|FG000|NOT COMPLETED|Overall Study||5||
48744315|NCT03066063|102161655|FG001|NOT COMPLETED|Overall Study||4||
48744316|NCT03066063|102161656|FG002|NOT COMPLETED|Overall Study||6||
48744317|NCT03066063|102161657|FG003|NOT COMPLETED|Overall Study||6||
48744318|NCT01125800|102161658|FG000|STARTED|Phase I||11||
48744319|NCT01125800|102161659|FG001|STARTED|Phase I||16||
48744320|NCT01125800|102161660|FG002|STARTED|Phase I||11||
48744321|NCT01125800|102161661|FG003|STARTED|Phase I||21||
48744322|NCT01125800|102161662|FG004|STARTED|Phase I||0||
48744323|NCT01125800|102161658|FG000|COMPLETED|Phase I||3||
48744324|NCT01125800|102161659|FG001|COMPLETED|Phase I||7||
48744325|NCT01125800|102161660|FG002|COMPLETED|Phase I||7||
48744326|NCT01125800|102161661|FG003|COMPLETED|Phase I||10||
48744327|NCT01125800|102161662|FG004|COMPLETED|Phase I||0||
48744328|NCT01125800|102161658|FG000|NOT COMPLETED|Phase I||8||
48744329|NCT01125800|102161659|FG001|NOT COMPLETED|Phase I||9||
48744330|NCT01125800|102161660|FG002|NOT COMPLETED|Phase I||4||
48744331|NCT01125800|102161661|FG003|NOT COMPLETED|Phase I||11||
48744332|NCT01125800|102161662|FG004|NOT COMPLETED|Phase I||0||
48744333|NCT01125800|102161658|FG000|STARTED|Phase II||0||
48744334|NCT01125800|102161659|FG001|STARTED|Phase II||0||
48744335|NCT01125800|102161660|FG002|STARTED|Phase II||0||
48744336|NCT01125800|102161661|FG003|STARTED|Phase II||1||
48744337|NCT01125800|102161662|FG004|STARTED|Phase II||16||
48744338|NCT01125800|102161658|FG000|COMPLETED|Phase II||0||
48744339|NCT01125800|102161659|FG001|COMPLETED|Phase II||0||
48744340|NCT01125800|102161660|FG002|COMPLETED|Phase II||0||
48744341|NCT01125800|102161661|FG003|COMPLETED|Phase II||0||
48744342|NCT01125800|102161662|FG004|COMPLETED|Phase II||5||
48744343|NCT01125800|102161658|FG000|NOT COMPLETED|Phase II||0||
48744344|NCT01125800|102161659|FG001|NOT COMPLETED|Phase II||0||
48744345|NCT01125800|102161660|FG002|NOT COMPLETED|Phase II||0||
48621188|NCT00991081|101856492|FG000|COMPLETED|Phase I, Formative Research||20||
48621189|NCT00991081|101856493|FG001|COMPLETED|Phase I, Formative Research||0||
48621190|NCT00991081|101856494|FG002|COMPLETED|Phase I, Formative Research||0||
48621191|NCT00991081|101856492|FG000|NOT COMPLETED|Phase I, Formative Research||0||
48621192|NCT00991081|101856493|FG001|NOT COMPLETED|Phase I, Formative Research||0||
48621193|NCT00991081|101856494|FG002|NOT COMPLETED|Phase I, Formative Research||0||
48621194|NCT00991081|101856492|FG000|STARTED|Phase II, Randomized Control Trial||0||
48621195|NCT00991081|101856493|FG001|STARTED|Phase II, Randomized Control Trial||17||
48621196|NCT00991081|101856494|FG002|STARTED|Phase II, Randomized Control Trial||19||
48621197|NCT00991081|101856492|FG000|Received First Clinical Call|Phase II, Randomized Control Trial||0||
48621198|NCT00991081|101856493|FG001|Received First Clinical Call|Phase II, Randomized Control Trial||16||
48744346|NCT01125800|102161661|FG003|NOT COMPLETED|Phase II||1||
48744347|NCT01125800|102161662|FG004|NOT COMPLETED|Phase II||11||
48744348|NCT00786799|102161663|FG000|STARTED|Overall Study||14||
48744349|NCT00786799|102161664|FG001|STARTED|Overall Study||13||
48744350|NCT00786799|102161663|FG000|COMPLETED|Overall Study||13||
48744351|NCT00786799|102161664|FG001|COMPLETED|Overall Study||12||
48744352|NCT00786799|102161663|FG000|NOT COMPLETED|Overall Study||1||
48744353|NCT00786799|102161664|FG001|NOT COMPLETED|Overall Study||1||
48744354|NCT05561582|102161665|FG000|STARTED|Overall Study||20||
48744355|NCT05561582|102161666|FG001|STARTED|Overall Study||20||
48744356|NCT05561582|102161667|FG002|STARTED|Overall Study||20||
48744357|NCT05561582|102161665|FG000|COMPLETED|Overall Study||20||
48621199|NCT00991081|101856494|FG002|Received First Clinical Call|Phase II, Randomized Control Trial||17||
48621200|NCT00991081|101856492|FG000|COMPLETED|Phase II, Randomized Control Trial||0||
48621201|NCT00991081|101856493|FG001|COMPLETED|Phase II, Randomized Control Trial||15||
48621202|NCT00991081|101856494|FG002|COMPLETED|Phase II, Randomized Control Trial||15||
48621203|NCT00991081|101856492|FG000|NOT COMPLETED|Phase II, Randomized Control Trial||0||
48621204|NCT00991081|101856493|FG001|NOT COMPLETED|Phase II, Randomized Control Trial||2||
48621205|NCT00991081|101856494|FG002|NOT COMPLETED|Phase II, Randomized Control Trial||4||
48744358|NCT05561582|102161666|FG001|COMPLETED|Overall Study||20||
48744359|NCT05561582|102161667|FG002|COMPLETED|Overall Study||20||
48744360|NCT05561582|102161665|FG000|NOT COMPLETED|Overall Study||0||
48744361|NCT05561582|102161666|FG001|NOT COMPLETED|Overall Study||0||
48744362|NCT05561582|102161667|FG002|NOT COMPLETED|Overall Study||0||
48744363|NCT01080807|102161668|FG000|STARTED|Overall Study||193||
48744364|NCT01080807|102161669|FG001|STARTED|Overall Study||190||
48744365|NCT01080807|102161668|FG000|COMPLETED|Overall Study||158||
48744366|NCT01080807|102161669|FG001|COMPLETED|Overall Study||167||
48744367|NCT01080807|102161668|FG000|NOT COMPLETED|Overall Study||35||
48744368|NCT01080807|102161669|FG001|NOT COMPLETED|Overall Study||23||
48744369|NCT03400852|102161670|FG000|STARTED|Blinded Treatment Period||29|Period 2 arm not included in Period 1|
48621206|NCT01204203|101856495|FG000|STARTED|Overall Study||8||
48621207|NCT01204203|101856495|FG000|COMPLETED|Overall Study||8||
48621208|NCT01204203|101856495|FG000|NOT COMPLETED|Overall Study||0||
48621209|NCT01973218|101856496|FG000|STARTED|Overall Study||176||
48621210|NCT01973218|101856497|FG001|STARTED|Overall Study||88||
48621211|NCT01973218|101856496|FG000|COMPLETED|Overall Study||174||
48621212|NCT01973218|101856497|FG001|COMPLETED|Overall Study||88||
48621213|NCT01973218|101856496|FG000|NOT COMPLETED|Overall Study||2||
48621214|NCT01973218|101856497|FG001|NOT COMPLETED|Overall Study||0||
48621215|NCT01950299|101856498|FG000|STARTED|Overall Study||33||
48621216|NCT01950299|101856499|FG001|STARTED|Overall Study||31||
48621217|NCT01950299|101856500|FG002|STARTED|Overall Study||35||
48621218|NCT01950299|101856498|FG000|COMPLETED|Overall Study||22||
48621219|NCT01950299|101856499|FG001|COMPLETED|Overall Study||27||
48621220|NCT01950299|101856500|FG002|COMPLETED|Overall Study||28||
48621221|NCT01950299|101856498|FG000|NOT COMPLETED|Overall Study||11||
48621222|NCT01950299|101856499|FG001|NOT COMPLETED|Overall Study||4||
48621223|NCT01950299|101856500|FG002|NOT COMPLETED|Overall Study||7||
48621224|NCT04386902|101856501|FG000|STARTED|Overall Study||60||
48621225|NCT04386902|101856501|FG000|COMPLETED|Overall Study||50||
48621226|NCT04386902|101856501|FG000|NOT COMPLETED|Overall Study||10||
48621227|NCT00269152|101856502|FG000|STARTED|Overall Study||63||
48621228|NCT00269152|101856503|FG001|STARTED|Overall Study||59||
48621229|NCT00269152|101856502|FG000|COMPLETED|Overall Study||45||
48621230|NCT00269152|101856503|FG001|COMPLETED|Overall Study||49||
48621231|NCT00269152|101856502|FG000|NOT COMPLETED|Overall Study||18||
48621232|NCT00269152|101856503|FG001|NOT COMPLETED|Overall Study||10||
48621233|NCT04182958|101856504|FG000|STARTED|Overall Study||8||
48744370|NCT03400852|102161671|FG001|STARTED|Blinded Treatment Period||15|Period 2 arm not included in Period 1|
48744371|NCT03400852|102161672|FG002|STARTED|Blinded Treatment Period||0|Period 2 arm not included in Period 1|
48744372|NCT03400852|102161670|FG000|COMPLETED|Blinded Treatment Period||20||
48744373|NCT03400852|102161671|FG001|COMPLETED|Blinded Treatment Period||9||
48744374|NCT03400852|102161672|FG002|COMPLETED|Blinded Treatment Period||0||
48744375|NCT03400852|102161670|FG000|NOT COMPLETED|Blinded Treatment Period||9||
48744376|NCT03400852|102161671|FG001|NOT COMPLETED|Blinded Treatment Period||6||
48744377|NCT03400852|102161672|FG002|NOT COMPLETED|Blinded Treatment Period||0||
48744378|NCT03400852|102161670|FG000|STARTED|Open Label Period||0|Period 1 arms not included in Period 2|
48744379|NCT03400852|102161671|FG001|STARTED|Open Label Period||0|Period 1 arms not included in Period 2|
48744380|NCT03400852|102161672|FG002|STARTED|Open Label Period||24|Period 1 arms not included in Period 2|
48744381|NCT03400852|102161670|FG000|COMPLETED|Open Label Period||0||
48744382|NCT03400852|102161671|FG001|COMPLETED|Open Label Period||0||
48744383|NCT03400852|102161672|FG002|COMPLETED|Open Label Period||2||
48744384|NCT03400852|102161670|FG000|NOT COMPLETED|Open Label Period||0||
48744385|NCT03400852|102161671|FG001|NOT COMPLETED|Open Label Period||0||
48744386|NCT03400852|102161672|FG002|NOT COMPLETED|Open Label Period||22||
48744387|NCT02487095|102161673|FG000|STARTED|Phase I Dose Escalation||6||
48744388|NCT02487095|102161674|FG001|STARTED|Phase I Dose Escalation||6||
48744389|NCT02487095|102161675|FG002|STARTED|Phase I Dose Escalation||3||
48744390|NCT02487095|102161676|FG003|STARTED|Phase I Dose Escalation||6||
48744391|NCT02487095|102161677|FG004|STARTED|Phase I Dose Escalation||0||
48744392|NCT02487095|102161673|FG000|COMPLETED|Phase I Dose Escalation||6||
48327499|NCT01562548|101128354|FG000|STARTED|Overall Study||25||
48327500|NCT01562548|101128355|FG001|STARTED|Overall Study||15||
48621234|NCT04182958|101856504|FG000|COMPLETED|Overall Study||8||
48621235|NCT04182958|101856504|FG000|NOT COMPLETED|Overall Study||0||
48621236|NCT03933449|101856505|FG000|STARTED|Overall Study||62||
48621237|NCT03933449|101856506|FG001|STARTED|Overall Study||61||
48621238|NCT03933449|101856505|FG000|Treated|Overall Study||62||
48621239|NCT03933449|101856506|FG001|Treated|Overall Study||59||
48621240|NCT03933449|101856505|FG000|Received Second Course|Overall Study||1||
48657109|NCT03761914|101943781|FG003|COMPLETED|Overall Study||0||
48744393|NCT02487095|102161674|FG001|COMPLETED|Phase I Dose Escalation||6||
48327501|NCT01562548|101128356|FG002|STARTED|Overall Study||25||
48327502|NCT01562548|101128357|FG003|STARTED|Overall Study||14||
48327503|NCT01562548|101128354|FG000|COMPLETED|Overall Study||25||
48327504|NCT01562548|101128355|FG001|COMPLETED|Overall Study||15||
48327505|NCT01562548|101128356|FG002|COMPLETED|Overall Study||24||
48327506|NCT01562548|101128357|FG003|COMPLETED|Overall Study||14||
48327507|NCT01562548|101128354|FG000|NOT COMPLETED|Overall Study||0||
48327508|NCT01562548|101128355|FG001|NOT COMPLETED|Overall Study||0||
48327509|NCT01562548|101128356|FG002|NOT COMPLETED|Overall Study||1||
48409825|NCT00242710|101334800|FG003|NOT COMPLETED|Study Extension (up to Year 2)||10||
48327510|NCT01562548|101128357|FG003|NOT COMPLETED|Overall Study||0||
48165055|NCT04534114|100728444|FG000|NOT COMPLETED|Main Treatment Period||10||
48165056|NCT04534114|100728445|FG001|NOT COMPLETED|Main Treatment Period||13||
48165057|NCT04534114|100728446|FG002|NOT COMPLETED|Main Treatment Period||12||
48621241|NCT03933449|101856506|FG001|Received Second Course|Overall Study||0||
48621242|NCT03933449|101856505|FG000|Discontinued|Overall Study||62||
48621243|NCT03933449|101856506|FG001|Discontinued|Overall Study||61||
48621244|NCT03933449|101856505|FG000|COMPLETED|Overall Study||0||
48621245|NCT03933449|101856506|FG001|COMPLETED|Overall Study||0||
48621246|NCT03933449|101856505|FG000|NOT COMPLETED|Overall Study||62||
48621247|NCT03933449|101856506|FG001|NOT COMPLETED|Overall Study||61||
48744394|NCT02487095|102161675|FG002|COMPLETED|Phase I Dose Escalation||3||
48744395|NCT02487095|102161676|FG003|COMPLETED|Phase I Dose Escalation||6||
48744396|NCT02487095|102161677|FG004|COMPLETED|Phase I Dose Escalation||0||
48744397|NCT02487095|102161673|FG000|NOT COMPLETED|Phase I Dose Escalation||0||
48744398|NCT02487095|102161674|FG001|NOT COMPLETED|Phase I Dose Escalation||0||
48744399|NCT02487095|102161675|FG002|NOT COMPLETED|Phase I Dose Escalation||0||
48744400|NCT02487095|102161676|FG003|NOT COMPLETED|Phase I Dose Escalation||0||
48744401|NCT02487095|102161677|FG004|NOT COMPLETED|Phase I Dose Escalation||0||
48744402|NCT02487095|102161673|FG000|STARTED|Dose Expansion||0||
48744403|NCT02487095|102161674|FG001|STARTED|Dose Expansion||0||
48744404|NCT02487095|102161675|FG002|STARTED|Dose Expansion||0||
48744405|NCT02487095|102161676|FG003|STARTED|Dose Expansion||0||
48744406|NCT02487095|102161677|FG004|STARTED|Dose Expansion||41||
48744407|NCT02487095|102161673|FG000|COMPLETED|Dose Expansion||0||
48744408|NCT02487095|102161674|FG001|COMPLETED|Dose Expansion||0||
48744409|NCT02487095|102161675|FG002|COMPLETED|Dose Expansion||0||
48744410|NCT02487095|102161676|FG003|COMPLETED|Dose Expansion||0||
48744411|NCT02487095|102161677|FG004|COMPLETED|Dose Expansion||40||
48744412|NCT02487095|102161673|FG000|NOT COMPLETED|Dose Expansion||0||
48744413|NCT02487095|102161674|FG001|NOT COMPLETED|Dose Expansion||0||
48744414|NCT02487095|102161675|FG002|NOT COMPLETED|Dose Expansion||0||
48744415|NCT02487095|102161676|FG003|NOT COMPLETED|Dose Expansion||0||
48744416|NCT02487095|102161677|FG004|NOT COMPLETED|Dose Expansion||1||
48744417|NCT03148613|102161678|FG000|STARTED|Overall Study||39||
48744418|NCT03148613|102161679|FG001|STARTED|Overall Study||31||
48744419|NCT03148613|102161678|FG000|COMPLETED|Overall Study||39||
48744420|NCT03148613|102161679|FG001|COMPLETED|Overall Study||31||
48744421|NCT03148613|102161678|FG000|NOT COMPLETED|Overall Study||0||
48744422|NCT03148613|102161679|FG001|NOT COMPLETED|Overall Study||0||
48744423|NCT02274792|102161680|FG000|STARTED|Overall Study||132||
48744424|NCT02274792|102161680|FG000|Received Treatment|Overall Study||131||
48744425|NCT02274792|102161680|FG000|COMPLETED|Overall Study||107||
48744426|NCT02274792|102161680|FG000|NOT COMPLETED|Overall Study||25||
48744427|NCT01293825|102161681|FG000|STARTED|Overall Study||30||
48744428|NCT01293825|102161681|FG000|COMPLETED|Overall Study||20||
48744429|NCT01293825|102161681|FG000|NOT COMPLETED|Overall Study||10||
48744430|NCT02795117|102161682|FG000|STARTED|Overall Study||193||
48744431|NCT02795117|102161683|FG001|STARTED|Overall Study||193||
48744432|NCT02795117|102161684|FG002|STARTED|Overall Study||100||
48744433|NCT02795117|102161682|FG000|COMPLETED|Overall Study||175||
48744434|NCT02795117|102161683|FG001|COMPLETED|Overall Study||166||
48744435|NCT02795117|102161684|FG002|COMPLETED|Overall Study||88||
48744436|NCT02795117|102161682|FG000|NOT COMPLETED|Overall Study||18||
48744437|NCT02795117|102161683|FG001|NOT COMPLETED|Overall Study||27||
48744438|NCT02795117|102161684|FG002|NOT COMPLETED|Overall Study||12||
48744439|NCT00181766|102161685|FG000|STARTED|Overall Study||45||
48744440|NCT00181766|102161685|FG000|COMPLETED|Overall Study||33||
48744441|NCT00181766|102161685|FG000|NOT COMPLETED|Overall Study||12||
48744442|NCT00896298|102161686|FG000|STARTED|Overall Study||13||
48744443|NCT00896298|102161687|FG001|STARTED|Overall Study||12||
48165058|NCT04534114|100728447|FG003|NOT COMPLETED|Main Treatment Period||14||
48621248|NCT00315445|101856507|FG000|STARTED|Overall Study||45||
48621249|NCT00315445|101856508|FG001|STARTED|Overall Study||43||
48621250|NCT00315445|101856509|FG002|STARTED|Overall Study||46||
48744444|NCT00896298|102161686|FG000|COMPLETED|Overall Study||10||
48744445|NCT00896298|102161687|FG001|COMPLETED|Overall Study||9||
48744446|NCT00896298|102161686|FG000|NOT COMPLETED|Overall Study||3||
48744447|NCT00896298|102161687|FG001|NOT COMPLETED|Overall Study||3||
48744448|NCT04254666|102161688|FG000|STARTED|Overall Study||6||
48744449|NCT04254666|102161688|FG000|COMPLETED|Overall Study||6||
48744450|NCT04254666|102161688|FG000|NOT COMPLETED|Overall Study||0||
48744451|NCT01340586|102161689|FG000|STARTED|Overall Study||8||
48744452|NCT01340586|102161690|FG001|STARTED|Overall Study||8||
48744453|NCT01340586|102161689|FG000|COMPLETED|Overall Study||8||
48744454|NCT01340586|102161690|FG001|COMPLETED|Overall Study||8||
48744455|NCT01340586|102161689|FG000|NOT COMPLETED|Overall Study||0||
48744456|NCT01340586|102161690|FG001|NOT COMPLETED|Overall Study||0||
48744457|NCT04544358|102161691|FG000|STARTED|Overall Study||12||
48744458|NCT04544358|102161692|FG001|STARTED|Overall Study||10||
48744459|NCT04544358|102161691|FG000|COMPLETED|Overall Study||12||
48744460|NCT04544358|102161692|FG001|COMPLETED|Overall Study||10||
48744461|NCT04544358|102161691|FG000|NOT COMPLETED|Overall Study||0||
48744462|NCT04544358|102161692|FG001|NOT COMPLETED|Overall Study||0||
48621251|NCT00315445|101856507|FG000|COMPLETED|Overall Study||18||
48621252|NCT00315445|101856508|FG001|COMPLETED|Overall Study||27||
48621253|NCT00315445|101856509|FG002|COMPLETED|Overall Study||22||
48327511|NCT02469090|101128358|FG000|STARTED|Period 1: Dose Titration Phase||141||
48327512|NCT02469090|101128359|FG001|STARTED|Period 1: Dose Titration Phase||0||
48327513|NCT02469090|101128360|FG002|STARTED|Period 1: Dose Titration Phase||0||
48409826|NCT00610714|101334801|FG000|STARTED|Overall Study||105||
48621254|NCT00315445|101856507|FG000|NOT COMPLETED|Overall Study||27||
48621255|NCT00315445|101856508|FG001|NOT COMPLETED|Overall Study||16||
48621256|NCT00315445|101856509|FG002|NOT COMPLETED|Overall Study||24||
48621257|NCT02957357|101856510|FG000|STARTED|Overall Study||10479||
48621258|NCT02957357|101856511|FG001|STARTED|Overall Study||835||
48621259|NCT02957357|101856510|FG000|COMPLETED|Overall Study||10479||
48621260|NCT02957357|101856511|FG001|COMPLETED|Overall Study||835||
48621261|NCT02957357|101856510|FG000|NOT COMPLETED|Overall Study||0||
48621262|NCT02957357|101856511|FG001|NOT COMPLETED|Overall Study||0||
48621263|NCT02346708|101856512|FG000|STARTED|Overall Study||24||
48621264|NCT02346708|101856513|FG001|STARTED|Overall Study||25||
48621265|NCT02346708|101856512|FG000|COMPLETED|Overall Study||22||
48744463|NCT01076959|102161693|FG000|STARTED|Overall Study||7740||
48744464|NCT01076959|102161693|FG000|COMPLETED|Overall Study||5490||
48744465|NCT01076959|102161693|FG000|NOT COMPLETED|Overall Study||2250||
48744466|NCT03956550|102161694|FG000|STARTED|Overall Study||88||
48744467|NCT03956550|102161695|FG001|STARTED|Overall Study||86||
48744468|NCT03956550|102161696|FG002|STARTED|Overall Study||85||
48744469|NCT03956550|102161694|FG000|COMPLETED|Overall Study||18||
48744470|NCT03956550|102161695|FG001|COMPLETED|Overall Study||14||
48744471|NCT03956550|102161696|FG002|COMPLETED|Overall Study||15||
48744472|NCT03956550|102161694|FG000|NOT COMPLETED|Overall Study||70||
48744473|NCT03956550|102161695|FG001|NOT COMPLETED|Overall Study||72||
48621266|NCT02346708|101856513|FG001|COMPLETED|Overall Study||24||
48621267|NCT02346708|101856512|FG000|NOT COMPLETED|Overall Study||2||
48621268|NCT02346708|101856513|FG001|NOT COMPLETED|Overall Study||1||
48744474|NCT03956550|102161696|FG002|NOT COMPLETED|Overall Study||70||
48744475|NCT03359174|102161697|FG000|STARTED|Overall Study||2||
48744476|NCT03359174|102161697|FG000|COMPLETED|Overall Study||1||
48744477|NCT03359174|102161697|FG000|NOT COMPLETED|Overall Study||1||
48744478|NCT00604565|102161698|FG000|STARTED|Overall Study||4||
48744479|NCT00604565|102161699|FG001|STARTED|Overall Study||7||
48744480|NCT00604565|102161698|FG000|COMPLETED|Overall Study||4||
48744481|NCT00604565|102161699|FG001|COMPLETED|Overall Study||4||
48744482|NCT00604565|102161698|FG000|NOT COMPLETED|Overall Study||0||
48744483|NCT00604565|102161699|FG001|NOT COMPLETED|Overall Study||3||
48621269|NCT03589807|101856514|FG000|STARTED|Overall Study||27||
48621270|NCT03589807|101856515|FG001|STARTED|Overall Study||30||
48744484|NCT00806988|102161700|FG000|STARTED|Overall Study||150||
48744485|NCT00806988|102161701|FG001|STARTED|Overall Study||151||
48744486|NCT00806988|102161700|FG000|COMPLETED|Overall Study||123||
48744487|NCT00806988|102161701|FG001|COMPLETED|Overall Study||108||
48744488|NCT00806988|102161700|FG000|NOT COMPLETED|Overall Study||27||
48744489|NCT00806988|102161701|FG001|NOT COMPLETED|Overall Study||43||
48744490|NCT02279667|102161702|FG000|STARTED|Overall Study||6||
48327514|NCT02469090|101128358|FG000|COMPLETED|Period 1: Dose Titration Phase||109||
48327515|NCT02469090|101128359|FG001|COMPLETED|Period 1: Dose Titration Phase||0||
48327516|NCT02469090|101128360|FG002|COMPLETED|Period 1: Dose Titration Phase||0||
48621271|NCT03589807|101856516|FG002|STARTED|Overall Study||33||
48621272|NCT03589807|101856517|FG003|STARTED|Overall Study||32||
48621273|NCT03589807|101856518|FG004|STARTED|Overall Study||28||
48621274|NCT03589807|101856519|FG005|STARTED|Overall Study||30||
48621275|NCT03589807|101856514|FG000|COMPLETED|Overall Study||27||
48165059|NCT04534114|100728444|FG000|STARTED|Extension Treatment Period||62||
48165060|NCT04534114|100728445|FG001|STARTED|Extension Treatment Period||61||
48165061|NCT04534114|100728446|FG002|STARTED|Extension Treatment Period||63||
48165062|NCT04534114|100728447|FG003|STARTED|Extension Treatment Period||58||
48165063|NCT04534114|100728444|FG000|COMPLETED|Extension Treatment Period||59||
48165064|NCT04534114|100728445|FG001|COMPLETED|Extension Treatment Period||57||
48165065|NCT04534114|100728446|FG002|COMPLETED|Extension Treatment Period||62||
48165066|NCT04534114|100728447|FG003|COMPLETED|Extension Treatment Period||53||
48165067|NCT04534114|100728444|FG000|NOT COMPLETED|Extension Treatment Period||3||
48165068|NCT04534114|100728445|FG001|NOT COMPLETED|Extension Treatment Period||4||
48165069|NCT04534114|100728446|FG002|NOT COMPLETED|Extension Treatment Period||1||
48165070|NCT04534114|100728447|FG003|NOT COMPLETED|Extension Treatment Period||5||
48165071|NCT01861522|100728448|FG000|STARTED|Overall Study||240||
48165072|NCT01861522|100728449|FG001|STARTED|Overall Study||232||
48165073|NCT01861522|100728448|FG000|COMPLETED|Overall Study||237||
48165074|NCT01861522|100728449|FG001|COMPLETED|Overall Study||232||
48165075|NCT01861522|100728448|FG000|NOT COMPLETED|Overall Study||3||
48165076|NCT01861522|100728449|FG001|NOT COMPLETED|Overall Study||0||
48165077|NCT00770432|100728450|FG000|STARTED|Overall Study||102||
48165078|NCT00770432|100728451|FG001|STARTED|Overall Study||101||
48165079|NCT00770432|100728450|FG000|COMPLETED|Overall Study||98||
48165080|NCT00770432|100728451|FG001|COMPLETED|Overall Study||94||
48165081|NCT00770432|100728450|FG000|NOT COMPLETED|Overall Study||4||
48165082|NCT00770432|100728451|FG001|NOT COMPLETED|Overall Study||7||
48165083|NCT04631705|100728452|FG000|STARTED|Overall Study||3||
48165084|NCT04631705|100728453|FG001|STARTED|Overall Study||3||
48165085|NCT04631705|100728454|FG002|STARTED|Overall Study||3||
48165086|NCT04631705|100728455|FG003|STARTED|Overall Study||3||
48165087|NCT04631705|100728456|FG004|STARTED|Overall Study||3||
48165088|NCT04631705|100728457|FG005|STARTED|Overall Study||3||
48165089|NCT04631705|100728458|FG006|STARTED|Overall Study||10||
48165090|NCT04631705|100728459|FG007|STARTED|Overall Study||8||
48165091|NCT04631705|100728460|FG008|STARTED|Overall Study||9||
48165092|NCT04631705|100728452|FG000|COMPLETED|Overall Study||3||
48165093|NCT04631705|100728453|FG001|COMPLETED|Overall Study||3||
48165094|NCT04631705|100728454|FG002|COMPLETED|Overall Study||3||
48165095|NCT04631705|100728455|FG003|COMPLETED|Overall Study||3||
48165096|NCT04631705|100728456|FG004|COMPLETED|Overall Study||3||
48165097|NCT04631705|100728457|FG005|COMPLETED|Overall Study||3||
48165098|NCT04631705|100728458|FG006|COMPLETED|Overall Study||9||
48165099|NCT04631705|100728459|FG007|COMPLETED|Overall Study||8||
48165100|NCT04631705|100728460|FG008|COMPLETED|Overall Study||9||
48165101|NCT04631705|100728452|FG000|NOT COMPLETED|Overall Study||0||
48165102|NCT04631705|100728453|FG001|NOT COMPLETED|Overall Study||0||
48165103|NCT04631705|100728454|FG002|NOT COMPLETED|Overall Study||0||
48165104|NCT04631705|100728455|FG003|NOT COMPLETED|Overall Study||0||
48165105|NCT04631705|100728456|FG004|NOT COMPLETED|Overall Study||0||
48165106|NCT04631705|100728457|FG005|NOT COMPLETED|Overall Study||0||
48165107|NCT04631705|100728458|FG006|NOT COMPLETED|Overall Study||1||
48165108|NCT04631705|100728459|FG007|NOT COMPLETED|Overall Study||0||
48165109|NCT04631705|100728460|FG008|NOT COMPLETED|Overall Study||0||
48165110|NCT02337517|100728461|FG000|STARTED|Overall Study||6||
48165111|NCT02337517|100728461|FG000|COMPLETED|Overall Study||6||
48165112|NCT02337517|100728461|FG000|NOT COMPLETED|Overall Study||0||
48165113|NCT01164228|100728462|FG000|STARTED|Overall Study||47||
48165114|NCT01164228|100728463|FG001|STARTED|Overall Study||40||
48165115|NCT01164228|100728462|FG000|Receipt of Protocol Therapy|Overall Study||46||
48165116|NCT01164228|100728463|FG001|Receipt of Protocol Therapy|Overall Study||37||
48165117|NCT01164228|100728462|FG000|Treated and Eligible Patients|Overall Study||45||
48165118|NCT01164228|100728463|FG001|Treated and Eligible Patients|Overall Study||37||
48165119|NCT01164228|100728462|FG000|COMPLETED|Overall Study||3||
48165120|NCT01164228|100728463|FG001|COMPLETED|Overall Study||2||
48409827|NCT00610714|101334802|FG001|STARTED|Overall Study||106||
48165121|NCT01164228|100728462|FG000|NOT COMPLETED|Overall Study||44||
48165122|NCT01164228|100728463|FG001|NOT COMPLETED|Overall Study||38||
48165123|NCT02204579|100728464|FG000|STARTED|Overall Study||7||
48165124|NCT02204579|100728464|FG000|Participants Started in Pre-Amendment|Overall Study||2||
48165125|NCT02204579|100728464|FG000|Participants Started in Post-Amendment|Overall Study||5||
48165126|NCT02204579|100728464|FG000|Treated|Overall Study||5||
48165127|NCT02204579|100728464|FG000|COMPLETED|Overall Study||5||
48165128|NCT02204579|100728464|FG000|NOT COMPLETED|Overall Study||2||
48165129|NCT02597907|100728465|FG000|STARTED|Overall Study||44||
48165130|NCT02597907|100728466|FG001|STARTED|Overall Study||44||
48165131|NCT02597907|100728465|FG000|COMPLETED|Overall Study||44||
48165132|NCT02597907|100728466|FG001|COMPLETED|Overall Study||44||
48165133|NCT02597907|100728465|FG000|NOT COMPLETED|Overall Study||0||
48165134|NCT02597907|100728466|FG001|NOT COMPLETED|Overall Study||0||
48165135|NCT01449240|100728467|FG000|STARTED|Overall Study||10||
48165136|NCT01449240|100728467|FG000|COMPLETED|Overall Study||10||
48165137|NCT01449240|100728467|FG000|NOT COMPLETED|Overall Study||0||
48165138|NCT02180438|100728468|FG000|STARTED|Overall Study||30||
48165139|NCT02180438|100728468|FG000|COMPLETED|Overall Study||29||
48165140|NCT02180438|100728468|FG000|NOT COMPLETED|Overall Study||1||
48327517|NCT02469090|101128358|FG000|NOT COMPLETED|Period 1: Dose Titration Phase||32||
48327518|NCT02469090|101128359|FG001|NOT COMPLETED|Period 1: Dose Titration Phase||0||
48327519|NCT02469090|101128360|FG002|NOT COMPLETED|Period 1: Dose Titration Phase||0||
48327520|NCT02469090|101128358|FG000|STARTED|Period 2: Maintenance Treatment Phase||0||
48327521|NCT02469090|101128359|FG001|STARTED|Period 2: Maintenance Treatment Phase||55||
48327522|NCT02469090|101128360|FG002|STARTED|Period 2: Maintenance Treatment Phase||54||
48327523|NCT02469090|101128358|FG000|COMPLETED|Period 2: Maintenance Treatment Phase||0||
48327524|NCT02469090|101128359|FG001|COMPLETED|Period 2: Maintenance Treatment Phase||46||
48327525|NCT02469090|101128360|FG002|COMPLETED|Period 2: Maintenance Treatment Phase||34||
48327526|NCT02469090|101128358|FG000|NOT COMPLETED|Period 2: Maintenance Treatment Phase||0||
48327527|NCT02469090|101128359|FG001|NOT COMPLETED|Period 2: Maintenance Treatment Phase||9||
48327528|NCT02469090|101128360|FG002|NOT COMPLETED|Period 2: Maintenance Treatment Phase||20||
48327529|NCT03534427|101128361|FG000|STARTED|Overall Study||20||
48327530|NCT03534427|101128362|FG001|STARTED|Overall Study||20||
48327531|NCT03534427|101128361|FG000|COMPLETED|Overall Study||20||
48327532|NCT03534427|101128362|FG001|COMPLETED|Overall Study||20||
48327533|NCT03534427|101128361|FG000|NOT COMPLETED|Overall Study||0||
48327534|NCT03534427|101128362|FG001|NOT COMPLETED|Overall Study||0||
48327535|NCT00326898|101128363|FG000|STARTED|Overall Study||647||
48327536|NCT00326898|101128364|FG001|STARTED|Overall Study||649||
48327537|NCT00326898|101128365|FG002|STARTED|Overall Study||647||
48327538|NCT00326898|101128363|FG000|Patients With Toxicity Data|Overall Study||625||
48327539|NCT00326898|101128364|FG001|Patients With Toxicity Data|Overall Study||628||
48327540|NCT00326898|101128365|FG002|Patients With Toxicity Data|Overall Study||626||
48327541|NCT00326898|101128363|FG000|Patients With Clear Cell Histology|Overall Study||542||
48327542|NCT00326898|101128364|FG001|Patients With Clear Cell Histology|Overall Study||540||
48327543|NCT00326898|101128365|FG002|Patients With Clear Cell Histology|Overall Study||540||
48327544|NCT00326898|101128363|FG000|Patients With >=1 Follow-up MUGA Scan|Overall Study||513||
48327545|NCT00326898|101128364|FG001|Patients With >=1 Follow-up MUGA Scan|Overall Study||510||
48327546|NCT00326898|101128365|FG002|Patients With >=1 Follow-up MUGA Scan|Overall Study||580||
48327547|NCT00326898|101128363|FG000|COMPLETED|Overall Study||296||
48327548|NCT00326898|101128364|FG001|COMPLETED|Overall Study||306||
48327549|NCT00326898|101128365|FG002|COMPLETED|Overall Study||444||
48327550|NCT00326898|101128363|FG000|NOT COMPLETED|Overall Study||351||
48327551|NCT00326898|101128364|FG001|NOT COMPLETED|Overall Study||343||
48327552|NCT00326898|101128365|FG002|NOT COMPLETED|Overall Study||203||
48327553|NCT00264875|101128366|FG000|STARTED|Overall Study||220||
48327554|NCT00264875|101128366|FG000|COMPLETED|Overall Study||190||
48327555|NCT00264875|101128366|FG000|NOT COMPLETED|Overall Study||30||
48327556|NCT01297270|101128367|FG000|STARTED|Overall Study||262||
48327557|NCT01297270|101128368|FG001|STARTED|Overall Study||264||
48327558|NCT01297270|101128369|FG002|STARTED|Overall Study||132||
48327559|NCT01297270|101128367|FG000|COMPLETED|Overall Study||217||
48327560|NCT01297270|101128368|FG001|COMPLETED|Overall Study||192||
48327561|NCT01297270|101128369|FG002|COMPLETED|Overall Study||103||
48327562|NCT01297270|101128367|FG000|NOT COMPLETED|Overall Study||45||
48327563|NCT01297270|101128368|FG001|NOT COMPLETED|Overall Study||72||
48327564|NCT01297270|101128369|FG002|NOT COMPLETED|Overall Study||29||
48327565|NCT03524339|101128370|FG000|STARTED|Overall Study||66||
48327566|NCT03524339|101128371|FG001|STARTED|Overall Study||66||
48327567|NCT03524339|101128370|FG000|COMPLETED|Overall Study||57||
48327568|NCT03524339|101128371|FG001|COMPLETED|Overall Study||62||
48327569|NCT03524339|101128370|FG000|NOT COMPLETED|Overall Study||9||
48327570|NCT03524339|101128371|FG001|NOT COMPLETED|Overall Study||4||
48327571|NCT04247425|101128372|FG000|STARTED|Overall Study||10||
48327572|NCT04247425|101128372|FG000|COMPLETED|Overall Study||9||
48327573|NCT04247425|101128372|FG000|NOT COMPLETED|Overall Study||1||
48327574|NCT03958552|101128373|FG000|STARTED|Overall Study||10||
48327575|NCT03958552|101128374|FG001|STARTED|Overall Study||35||
48327576|NCT03958552|101128373|FG000|COMPLETED|Overall Study||10||
48327577|NCT03958552|101128374|FG001|COMPLETED|Overall Study||35||
48327578|NCT03958552|101128373|FG000|NOT COMPLETED|Overall Study||0||
48327579|NCT03958552|101128374|FG001|NOT COMPLETED|Overall Study||0||
48327580|NCT03847987|101128375|FG000|STARTED|Overall Study||16||
48327581|NCT03847987|101128376|FG001|STARTED|Overall Study||8||
48327582|NCT03847987|101128375|FG000|COMPLETED|Overall Study||13||
48327583|NCT03847987|101128376|FG001|COMPLETED|Overall Study||8||
48327584|NCT03847987|101128375|FG000|NOT COMPLETED|Overall Study||3||
48327585|NCT03847987|101128376|FG001|NOT COMPLETED|Overall Study||0||
48327586|NCT02002975|101128377|FG000|STARTED|Overall Study||18223||
48327587|NCT02002975|101128377|FG000|COMPLETED|Overall Study||17651||
48327588|NCT02002975|101128377|FG000|NOT COMPLETED|Overall Study||572||
48327589|NCT01692301|101128378|FG000|STARTED|Overall Study||229||
48327590|NCT01692301|101128379|FG001|STARTED|Overall Study||225||
48327591|NCT01692301|101128378|FG000|COMPLETED|Overall Study||184||
48327592|NCT01692301|101128379|FG001|COMPLETED|Overall Study||183||
48327593|NCT01692301|101128378|FG000|NOT COMPLETED|Overall Study||45||
48327594|NCT01692301|101128379|FG001|NOT COMPLETED|Overall Study||42||
48327595|NCT03557281|101128380|FG000|STARTED|Overall Study||18||
48327596|NCT03557281|101128381|FG001|STARTED|Overall Study||9||
48327597|NCT03557281|101128382|FG002|STARTED|Overall Study||17||
48327598|NCT03557281|101128383|FG003|STARTED|Overall Study||16||
48327599|NCT03557281|101128384|FG004|STARTED|Overall Study||16||
48327600|NCT03557281|101128380|FG000|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Overall Study||18||
48327601|NCT03557281|101128381|FG001|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Overall Study||9||
48327602|NCT03557281|101128382|FG002|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Overall Study||17||
48327603|NCT03557281|101128383|FG003|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Overall Study||16||
48327604|NCT03557281|101128384|FG004|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Overall Study||15||
48327605|NCT03557281|101128380|FG000|COMPLETED|Overall Study||18||
48327606|NCT03557281|101128381|FG001|COMPLETED|Overall Study||8||
48327607|NCT03557281|101128382|FG002|COMPLETED|Overall Study||15||
48327608|NCT03557281|101128383|FG003|COMPLETED|Overall Study||15||
48327609|NCT03557281|101128384|FG004|COMPLETED|Overall Study||13||
48327610|NCT03557281|101128380|FG000|NOT COMPLETED|Overall Study||0||
48327611|NCT03557281|101128381|FG001|NOT COMPLETED|Overall Study||1||
48327612|NCT03557281|101128382|FG002|NOT COMPLETED|Overall Study||2||
48327613|NCT03557281|101128383|FG003|NOT COMPLETED|Overall Study||1||
48327614|NCT03557281|101128384|FG004|NOT COMPLETED|Overall Study||3||
48327615|NCT01272999|101128385|FG000|STARTED|Overall Study||357||
48327616|NCT01272999|101128386|FG001|STARTED|Overall Study||34||
48327617|NCT01272999|101128385|FG000|COMPLETED|Overall Study||357||
48327618|NCT01272999|101128386|FG001|COMPLETED|Overall Study||34||
48327619|NCT01272999|101128385|FG000|NOT COMPLETED|Overall Study||0||
48327620|NCT01272999|101128386|FG001|NOT COMPLETED|Overall Study||0||
48327621|NCT02692495|101128387|FG000|STARTED|Overall Study||12||
48327622|NCT02692495|101128388|FG001|STARTED|Overall Study||4||
48327623|NCT02692495|101128387|FG000|COMPLETED|Overall Study||12||
48327624|NCT02692495|101128388|FG001|COMPLETED|Overall Study||4||
48327625|NCT02692495|101128387|FG000|NOT COMPLETED|Overall Study||0||
48327626|NCT02692495|101128388|FG001|NOT COMPLETED|Overall Study||0||
48327627|NCT02772432|101128389|FG000|STARTED|Overall Study||31||
48327628|NCT02772432|101128390|FG001|STARTED|Overall Study||22||
48327629|NCT02772432|101128389|FG000|COMPLETED|Overall Study||19||
48327630|NCT02772432|101128390|FG001|COMPLETED|Overall Study||21||
48327631|NCT02772432|101128389|FG000|NOT COMPLETED|Overall Study||12||
48327632|NCT02772432|101128390|FG001|NOT COMPLETED|Overall Study||1||
48327633|NCT00852995|101128391|FG000|STARTED|Overall Study||46||
48327634|NCT00852995|101128392|FG001|STARTED|Overall Study||43||
48327635|NCT00852995|101128393|FG002|STARTED|Overall Study||44||
48327636|NCT00852995|101128394|FG003|STARTED|Overall Study||45||
48327637|NCT00852995|101128395|FG004|STARTED|Overall Study||50||
48327638|NCT00852995|101128391|FG000|COMPLETED|Overall Study||38||
48327639|NCT00852995|101128392|FG001|COMPLETED|Overall Study||42||
48327640|NCT00852995|101128393|FG002|COMPLETED|Overall Study||39||
48327641|NCT00852995|101128394|FG003|COMPLETED|Overall Study||40||
48327642|NCT00852995|101128395|FG004|COMPLETED|Overall Study||46||
48327643|NCT00852995|101128391|FG000|NOT COMPLETED|Overall Study||8||
48327644|NCT00852995|101128392|FG001|NOT COMPLETED|Overall Study||1||
48327645|NCT00852995|101128393|FG002|NOT COMPLETED|Overall Study||5||
48327646|NCT00852995|101128394|FG003|NOT COMPLETED|Overall Study||5||
48327647|NCT00852995|101128395|FG004|NOT COMPLETED|Overall Study||4||
48327648|NCT01031914|101128396|FG000|STARTED|Overall Study||36||
48327649|NCT01031914|101128396|FG000|COMPLETED|Overall Study||36||
48327650|NCT01031914|101128396|FG000|NOT COMPLETED|Overall Study||0||
48327651|NCT01564862|101128397|FG000|STARTED|Overall Study||198||
48327652|NCT01564862|101128398|FG001|STARTED|Overall Study||210||
48327653|NCT01564862|101128399|FG002|STARTED|Overall Study||194||
48327654|NCT01564862|101128397|FG000|Received Treatment|Overall Study||196||
48327655|NCT01564862|101128398|FG001|Received Treatment|Overall Study||207||
48327656|NCT01564862|101128399|FG002|Received Treatment|Overall Study||191||
48327657|NCT01564862|101128397|FG000|COMPLETED|Overall Study||168||
48327658|NCT01564862|101128398|FG001|COMPLETED|Overall Study||176||
48327659|NCT01564862|101128399|FG002|COMPLETED|Overall Study||164||
48327660|NCT01564862|101128397|FG000|NOT COMPLETED|Overall Study||30||
48327661|NCT01564862|101128398|FG001|NOT COMPLETED|Overall Study||34||
48327662|NCT01564862|101128399|FG002|NOT COMPLETED|Overall Study||30||
48327663|NCT01580488|101128400|FG000|STARTED|Overall Study||24||
48327664|NCT01580488|101128400|FG000|COMPLETED|Overall Study||23||
48327665|NCT01580488|101128400|FG000|NOT COMPLETED|Overall Study||1||
48327666|NCT04428424|101128401|FG000|STARTED|Overall Study||1493||
48327667|NCT04428424|101128401|FG000|COMPLETED|Overall Study||1246||
48327668|NCT04428424|101128401|FG000|NOT COMPLETED|Overall Study||247||
48327669|NCT00424827|101128402|FG000|STARTED|Overall Study||11||
48327670|NCT00424827|101128402|FG000|COMPLETED|Overall Study||10||
48327671|NCT00424827|101128402|FG000|NOT COMPLETED|Overall Study||1||
48327672|NCT00512798|101128403|FG000|STARTED|Overall Study||19||
48327673|NCT00512798|101128404|FG001|STARTED|Overall Study||28||
48327674|NCT00512798|101128403|FG000|COMPLETED|Overall Study||0||
48327675|NCT00512798|101128404|FG001|COMPLETED|Overall Study||1||
48327676|NCT00512798|101128403|FG000|NOT COMPLETED|Overall Study||19||
48327677|NCT00512798|101128404|FG001|NOT COMPLETED|Overall Study||27||
48368072|NCT03691623|101230099|FG003|COMPLETED|Overall Study||21||
48327678|NCT02064387|101128405|FG000|STARTED|Part 1 Max 23.5 Months Followup Duration||1||
48327679|NCT02064387|101128406|FG001|STARTED|Part 1 Max 23.5 Months Followup Duration||1||
48327680|NCT02064387|101128407|FG002|STARTED|Part 1 Max 23.5 Months Followup Duration||4||
48327681|NCT02064387|101128408|FG003|STARTED|Part 1 Max 23.5 Months Followup Duration||4||
48327682|NCT02064387|101128409|FG004|STARTED|Part 1 Max 23.5 Months Followup Duration||4||
48327683|NCT02064387|101128410|FG005|STARTED|Part 1 Max 23.5 Months Followup Duration||3||
48327684|NCT02064387|101128411|FG006|STARTED|Part 1 Max 23.5 Months Followup Duration||4||
48327685|NCT02064387|101128412|FG007|STARTED|Part 1 Max 23.5 Months Followup Duration||8||
48327686|NCT02064387|101128413|FG008|STARTED|Part 1 Max 23.5 Months Followup Duration||3||
48327687|NCT02064387|101128414|FG009|STARTED|Part 1 Max 23.5 Months Followup Duration||6||
48327688|NCT02064387|101128415|FG010|STARTED|Part 1 Max 23.5 Months Followup Duration||0||
48327689|NCT02064387|101128416|FG011|STARTED|Part 1 Max 23.5 Months Followup Duration||0||
48327690|NCT02064387|101128405|FG000|COMPLETED|Part 1 Max 23.5 Months Followup Duration||1||
48165141|NCT01298921|100728469|FG000|STARTED|Overall Study||0||
48165142|NCT01298921|100728470|FG001|STARTED|Overall Study||0||
48165143|NCT01298921|100728469|FG000|COMPLETED|Overall Study||0||
48165144|NCT01298921|100728470|FG001|COMPLETED|Overall Study||0||
48327691|NCT02064387|101128406|FG001|COMPLETED|Part 1 Max 23.5 Months Followup Duration||1||
48327692|NCT02064387|101128407|FG002|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4||
48327693|NCT02064387|101128408|FG003|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4||
48327694|NCT02064387|101128409|FG004|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4||
48327695|NCT02064387|101128410|FG005|COMPLETED|Part 1 Max 23.5 Months Followup Duration||3||
48327696|NCT02064387|101128411|FG006|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4||
48327697|NCT02064387|101128412|FG007|COMPLETED|Part 1 Max 23.5 Months Followup Duration||6||
48327698|NCT02064387|101128413|FG008|COMPLETED|Part 1 Max 23.5 Months Followup Duration||2||
48327699|NCT02064387|101128414|FG009|COMPLETED|Part 1 Max 23.5 Months Followup Duration||5||
48327700|NCT02064387|101128415|FG010|COMPLETED|Part 1 Max 23.5 Months Followup Duration||0||
48327701|NCT02064387|101128416|FG011|COMPLETED|Part 1 Max 23.5 Months Followup Duration||0||
48327702|NCT02064387|101128405|FG000|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0||
48327703|NCT02064387|101128406|FG001|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0||
48327704|NCT02064387|101128407|FG002|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0||
48327705|NCT02064387|101128408|FG003|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0||
48327706|NCT02064387|101128409|FG004|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0||
48327707|NCT02064387|101128410|FG005|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0||
48327708|NCT02064387|101128411|FG006|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0||
48327709|NCT02064387|101128412|FG007|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||2||
48327710|NCT02064387|101128413|FG008|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||1||
48327711|NCT02064387|101128414|FG009|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||1||
48327712|NCT02064387|101128415|FG010|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0||
48327713|NCT02064387|101128416|FG011|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0||
48327714|NCT02064387|101128405|FG000|STARTED|Part 2 Max 35 Months Followup Duration||0||
48327715|NCT02064387|101128406|FG001|STARTED|Part 2 Max 35 Months Followup Duration||0||
48327716|NCT02064387|101128407|FG002|STARTED|Part 2 Max 35 Months Followup Duration||0||
48327717|NCT02064387|101128408|FG003|STARTED|Part 2 Max 35 Months Followup Duration||0||
48327718|NCT02064387|101128409|FG004|STARTED|Part 2 Max 35 Months Followup Duration||0||
48327719|NCT02064387|101128410|FG005|STARTED|Part 2 Max 35 Months Followup Duration||0||
48327720|NCT02064387|101128411|FG006|STARTED|Part 2 Max 35 Months Followup Duration||0||
48327721|NCT02064387|101128412|FG007|STARTED|Part 2 Max 35 Months Followup Duration||0||
48327722|NCT02064387|101128413|FG008|STARTED|Part 2 Max 35 Months Followup Duration||0||
48327723|NCT02064387|101128414|FG009|STARTED|Part 2 Max 35 Months Followup Duration||0||
48327724|NCT02064387|101128415|FG010|STARTED|Part 2 Max 35 Months Followup Duration||35||
48327725|NCT02064387|101128416|FG011|STARTED|Part 2 Max 35 Months Followup Duration||6||
48327726|NCT02064387|101128405|FG000|COMPLETED|Part 2 Max 35 Months Followup Duration||0||
48327727|NCT02064387|101128406|FG001|COMPLETED|Part 2 Max 35 Months Followup Duration||0||
48327728|NCT02064387|101128407|FG002|COMPLETED|Part 2 Max 35 Months Followup Duration||0||
48327729|NCT02064387|101128408|FG003|COMPLETED|Part 2 Max 35 Months Followup Duration||0||
48327730|NCT02064387|101128409|FG004|COMPLETED|Part 2 Max 35 Months Followup Duration||0||
48327731|NCT02064387|101128410|FG005|COMPLETED|Part 2 Max 35 Months Followup Duration||0||
48327732|NCT02064387|101128411|FG006|COMPLETED|Part 2 Max 35 Months Followup Duration||0||
48327733|NCT02064387|101128412|FG007|COMPLETED|Part 2 Max 35 Months Followup Duration||0||
48327734|NCT02064387|101128413|FG008|COMPLETED|Part 2 Max 35 Months Followup Duration||0||
48368073|NCT03691623|101230100|FG004|COMPLETED|Overall Study||21||
48409828|NCT00610714|101334801|FG000|COMPLETED|Overall Study||79||
48165145|NCT01298921|100728469|FG000|NOT COMPLETED|Overall Study||0||
48165146|NCT01298921|100728470|FG001|NOT COMPLETED|Overall Study||0||
48165147|NCT00792103|100728471|FG000|STARTED|Overall Study||198||
48165148|NCT00792103|100728471|FG000|COMPLETED|Overall Study||65||
48165149|NCT00792103|100728471|FG000|NOT COMPLETED|Overall Study||133||
48165150|NCT00337662|100728472|FG000|STARTED|Study Period II||0||
48165151|NCT00337662|100728473|FG001|STARTED|Study Period II||0||
48165152|NCT00337662|100728474|FG002|STARTED|Study Period II||0||
48327735|NCT02064387|101128414|FG009|COMPLETED|Part 2 Max 35 Months Followup Duration||0||
48327736|NCT02064387|101128415|FG010|COMPLETED|Part 2 Max 35 Months Followup Duration||29||
48327737|NCT02064387|101128416|FG011|COMPLETED|Part 2 Max 35 Months Followup Duration||3||
48327738|NCT02064387|101128405|FG000|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0||
48327739|NCT02064387|101128406|FG001|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0||
48327740|NCT02064387|101128407|FG002|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0||
48327741|NCT02064387|101128408|FG003|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0||
48327742|NCT02064387|101128409|FG004|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0||
48327743|NCT02064387|101128410|FG005|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0||
48327744|NCT02064387|101128411|FG006|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0||
48327745|NCT02064387|101128412|FG007|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0||
48327746|NCT02064387|101128413|FG008|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0||
48327747|NCT02064387|101128414|FG009|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0||
48327748|NCT02064387|101128415|FG010|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||6||
48327749|NCT02064387|101128416|FG011|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||3||
48327750|NCT00281879|101128417|FG000|STARTED|Overall Study||128||
48327751|NCT00281879|101128418|FG001|STARTED|Overall Study||36||
48327752|NCT00281879|101128419|FG002|STARTED|Overall Study||20||
48327753|NCT00281879|101128420|FG003|STARTED|Overall Study||0||
48327754|NCT00281879|101128421|FG004|STARTED|Overall Study||6||
48327755|NCT00281879|101128422|FG005|STARTED|Overall Study||9||
48327756|NCT00281879|101128423|FG006|STARTED|Overall Study||0||
48327757|NCT00281879|101128424|FG007|STARTED|Overall Study||1||
48327758|NCT00281879|101128417|FG000|COMPLETED|Overall Study||0||
48327759|NCT00281879|101128418|FG001|COMPLETED|Overall Study||0||
48327760|NCT00281879|101128419|FG002|COMPLETED|Overall Study||0||
48327761|NCT00281879|101128420|FG003|COMPLETED|Overall Study||0||
48327762|NCT00281879|101128421|FG004|COMPLETED|Overall Study||0||
48327763|NCT00281879|101128422|FG005|COMPLETED|Overall Study||0||
48327764|NCT00281879|101128423|FG006|COMPLETED|Overall Study||0||
48327765|NCT00281879|101128424|FG007|COMPLETED|Overall Study||0||
48327766|NCT00281879|101128417|FG000|NOT COMPLETED|Overall Study||128||
48327767|NCT00281879|101128418|FG001|NOT COMPLETED|Overall Study||36||
48327768|NCT00281879|101128419|FG002|NOT COMPLETED|Overall Study||20||
48327769|NCT00281879|101128420|FG003|NOT COMPLETED|Overall Study||0||
48327770|NCT00281879|101128421|FG004|NOT COMPLETED|Overall Study||6||
48327771|NCT00281879|101128422|FG005|NOT COMPLETED|Overall Study||9||
48327772|NCT00281879|101128423|FG006|NOT COMPLETED|Overall Study||0||
48327773|NCT00281879|101128424|FG007|NOT COMPLETED|Overall Study||1||
48327774|NCT00253630|101128425|FG000|STARTED|Overall Study||37||
48327775|NCT00253630|101128425|FG000|COMPLETED|Overall Study||35||
48327776|NCT00253630|101128425|FG000|NOT COMPLETED|Overall Study||2||
48327777|NCT01411085|101128426|FG000|STARTED|Overall Study||10||
48327778|NCT01411085|101128426|FG000|COMPLETED|Overall Study||7||
48327779|NCT01411085|101128426|FG000|NOT COMPLETED|Overall Study||3||
48327780|NCT02797808|101128427|FG000|STARTED|Overall Study||23||
48327781|NCT02797808|101128428|FG001|STARTED|Overall Study||18||
48327782|NCT02797808|101128427|FG000|COMPLETED|Overall Study||16||
48327783|NCT02797808|101128428|FG001|COMPLETED|Overall Study||15||
48327784|NCT02797808|101128427|FG000|NOT COMPLETED|Overall Study||7||
48409829|NCT00610714|101334802|FG001|COMPLETED|Overall Study||82||
48409830|NCT00610714|101334801|FG000|NOT COMPLETED|Overall Study||26||
48409831|NCT00610714|101334802|FG001|NOT COMPLETED|Overall Study||24||
48409832|NCT02343952|101334803|FG000|STARTED|Study Treatment||93||
48409833|NCT02343952|101334803|FG000|COMPLETED|Study Treatment||40||
48327785|NCT02797808|101128428|FG001|NOT COMPLETED|Overall Study||3||
48327786|NCT02482129|101128429|FG000|STARTED|Overall Study||32||
48327787|NCT02482129|101128430|FG001|STARTED|Overall Study||11||
48327788|NCT02482129|101128429|FG000|Treated, as Randomized|Overall Study||30||
48327789|NCT02482129|101128430|FG001|Treated, as Randomized|Overall Study||9||
48327790|NCT02482129|101128429|FG000|COMPLETED|Overall Study||26||
48409834|NCT02343952|101334803|FG000|NOT COMPLETED|Study Treatment||53||
48327791|NCT02482129|101128430|FG001|COMPLETED|Overall Study||9||
48327792|NCT02482129|101128429|FG000|NOT COMPLETED|Overall Study||6||
48327793|NCT02482129|101128430|FG001|NOT COMPLETED|Overall Study||2||
48327794|NCT04011280|101128431|FG000|STARTED|Overall Study||14||
48327795|NCT04011280|101128432|FG001|STARTED|Overall Study||14||
48327796|NCT04011280|101128431|FG000|COMPLETED|Overall Study||9||
48409835|NCT02343952|101334803|FG000|STARTED|Follow up||83||
48409836|NCT02343952|101334803|FG000|COMPLETED|Follow up||38||
48409837|NCT02343952|101334803|FG000|NOT COMPLETED|Follow up||45||
48327797|NCT04011280|101128432|FG001|COMPLETED|Overall Study||12||
48327798|NCT04011280|101128431|FG000|NOT COMPLETED|Overall Study||5||
48327799|NCT04011280|101128432|FG001|NOT COMPLETED|Overall Study||2||
48409838|NCT02748785|101334804|FG000|STARTED|Visit 1- Visit 2||69||
48327800|NCT01060059|101128433|FG000|STARTED|Overall Study||444||
48327801|NCT01060059|101128434|FG001|STARTED|Overall Study||438||
48327802|NCT01060059|101128433|FG000|COMPLETED|Overall Study||377||
48327803|NCT01060059|101128434|FG001|COMPLETED|Overall Study||371||
48327804|NCT01060059|101128433|FG000|NOT COMPLETED|Overall Study||67||
48327805|NCT01060059|101128434|FG001|NOT COMPLETED|Overall Study||67||
48327806|NCT00705783|101128435|FG000|STARTED|Conversion Phase||633||
48327807|NCT00705783|101128436|FG001|STARTED|Conversion Phase||0||
48327808|NCT00705783|101128437|FG002|STARTED|Conversion Phase||0||
48327809|NCT00705783|101128435|FG000|Received Study Medication|Conversion Phase||632||
48327810|NCT00705783|101128436|FG001|Received Study Medication|Conversion Phase||0||
48327811|NCT00705783|101128437|FG002|Received Study Medication|Conversion Phase||0||
48327812|NCT00705783|101128435|FG000|COMPLETED|Conversion Phase||500||
48327813|NCT00705783|101128436|FG001|COMPLETED|Conversion Phase||0||
48327814|NCT00705783|101128437|FG002|COMPLETED|Conversion Phase||0||
48327815|NCT00705783|101128435|FG000|NOT COMPLETED|Conversion Phase||133||
48327816|NCT00705783|101128436|FG001|NOT COMPLETED|Conversion Phase||0||
48327817|NCT00705783|101128437|FG002|NOT COMPLETED|Conversion Phase||0||
48327818|NCT00705783|101128435|FG000|STARTED|Oral Stabilization Phase||710||
48327819|NCT00705783|101128436|FG001|STARTED|Oral Stabilization Phase||0||
48327820|NCT00705783|101128437|FG002|STARTED|Oral Stabilization Phase||0||
48327821|NCT00705783|101128435|FG000|Received Study Medication|Oral Stabilization Phase||709||
48327822|NCT00705783|101128436|FG001|Received Study Medication|Oral Stabilization Phase||0||
48327823|NCT00705783|101128437|FG002|Received Study Medication|Oral Stabilization Phase||0||
48327824|NCT00705783|101128435|FG000|COMPLETED|Oral Stabilization Phase||576||
48327825|NCT00705783|101128436|FG001|COMPLETED|Oral Stabilization Phase||0||
48327826|NCT00705783|101128437|FG002|COMPLETED|Oral Stabilization Phase||0||
48327827|NCT00705783|101128435|FG000|NOT COMPLETED|Oral Stabilization Phase||134||
48327828|NCT00705783|101128436|FG001|NOT COMPLETED|Oral Stabilization Phase||0||
48327829|NCT00705783|101128437|FG002|NOT COMPLETED|Oral Stabilization Phase||0||
48327830|NCT00705783|101128435|FG000|STARTED|Depot Stabilization Phase||576||
48327831|NCT00705783|101128436|FG001|STARTED|Depot Stabilization Phase||0||
48327832|NCT00705783|101128437|FG002|STARTED|Depot Stabilization Phase||0||
48327833|NCT00705783|101128435|FG000|COMPLETED|Depot Stabilization Phase||403||
48327834|NCT00705783|101128436|FG001|COMPLETED|Depot Stabilization Phase||0||
48327835|NCT00705783|101128437|FG002|COMPLETED|Depot Stabilization Phase||0||
48327836|NCT00705783|101128435|FG000|NOT COMPLETED|Depot Stabilization Phase||173||
48327837|NCT00705783|101128436|FG001|NOT COMPLETED|Depot Stabilization Phase||0||
48327838|NCT00705783|101128437|FG002|NOT COMPLETED|Depot Stabilization Phase||0||
48327839|NCT00705783|101128435|FG000|STARTED|Depot Maintenance Phase||0||
48327840|NCT00705783|101128436|FG001|STARTED|Depot Maintenance Phase||269||
48327841|NCT00705783|101128437|FG002|STARTED|Depot Maintenance Phase||134||
48327842|NCT00705783|101128435|FG000|COMPLETED|Depot Maintenance Phase||0||
48327843|NCT00705783|101128436|FG001|COMPLETED|Depot Maintenance Phase||23||
48327844|NCT00705783|101128437|FG002|COMPLETED|Depot Maintenance Phase||3||
48327845|NCT00705783|101128435|FG000|NOT COMPLETED|Depot Maintenance Phase||0||
48327846|NCT00705783|101128436|FG001|NOT COMPLETED|Depot Maintenance Phase||246||
48327847|NCT00705783|101128437|FG002|NOT COMPLETED|Depot Maintenance Phase||131||
48327848|NCT03124784|101128438|FG000|STARTED|Overall Study||27||
48327849|NCT03124784|101128438|FG000|COMPLETED|Overall Study||25||
48327850|NCT03124784|101128438|FG000|NOT COMPLETED|Overall Study||2||
48327851|NCT00748579|101128439|FG000|STARTED|Overall Study||2||
48327852|NCT00748579|101128440|FG001|STARTED|Overall Study||0||
48327853|NCT00748579|101128439|FG000|COMPLETED|Overall Study||2||
48327854|NCT00748579|101128440|FG001|COMPLETED|Overall Study||0||
48327855|NCT00748579|101128439|FG000|NOT COMPLETED|Overall Study||0||
48327856|NCT00748579|101128440|FG001|NOT COMPLETED|Overall Study||0||
48327857|NCT01738971|101128441|FG000|STARTED|Overall Study||54||
48327858|NCT01738971|101128442|FG001|STARTED|Overall Study||58||
48327859|NCT01738971|101128443|FG002|STARTED|Overall Study||56||
48327860|NCT01738971|101128441|FG000|COMPLETED|Overall Study||35||
48327861|NCT01738971|101128442|FG001|COMPLETED|Overall Study||28||
48327862|NCT01738971|101128443|FG002|COMPLETED|Overall Study||39||
48327863|NCT01738971|101128441|FG000|NOT COMPLETED|Overall Study||19||
48327864|NCT01738971|101128442|FG001|NOT COMPLETED|Overall Study||30||
48327865|NCT01738971|101128443|FG002|NOT COMPLETED|Overall Study||17||
48327866|NCT04849780|101128444|FG000|STARTED|Period 1||45||
48409839|NCT02748785|101334805|FG001|STARTED|Visit 1- Visit 2||68||
48409840|NCT02748785|101334806|FG002|STARTED|Visit 1- Visit 2||71||
48327867|NCT04849780|101128445|FG001|STARTED|Period 1||47||
48327868|NCT04849780|101128444|FG000|COMPLETED|Period 1||41||
48327869|NCT04849780|101128445|FG001|COMPLETED|Period 1||47||
48327870|NCT04849780|101128444|FG000|NOT COMPLETED|Period 1||4||
48327871|NCT04849780|101128445|FG001|NOT COMPLETED|Period 1||0||
48327872|NCT04849780|101128444|FG000|STARTED|Period 2||41||
48327873|NCT04849780|101128445|FG001|STARTED|Period 2||0||
48327874|NCT04849780|101128444|FG000|COMPLETED|Period 2||39||
48327875|NCT04849780|101128445|FG001|COMPLETED|Period 2||0||
48327876|NCT04849780|101128444|FG000|NOT COMPLETED|Period 2||2||
48327877|NCT04849780|101128445|FG001|NOT COMPLETED|Period 2||0||
48327878|NCT01175902|101128446|FG000|STARTED|Overall Study||22||
48327879|NCT01175902|101128447|FG001|STARTED|Overall Study||22||
48744491|NCT02279667|102161703|FG001|STARTED|Overall Study||6||
48744492|NCT02279667|102161704|FG002|STARTED|Overall Study||6||
48744493|NCT02279667|102161702|FG000|COMPLETED|Overall Study||6||
48744494|NCT02279667|102161703|FG001|COMPLETED|Overall Study||6||
48744495|NCT02279667|102161704|FG002|COMPLETED|Overall Study||6||
48744496|NCT02279667|102161702|FG000|NOT COMPLETED|Overall Study||0||
48744497|NCT02279667|102161703|FG001|NOT COMPLETED|Overall Study||0||
48744498|NCT02279667|102161704|FG002|NOT COMPLETED|Overall Study||0||
48744499|NCT01479868|102161705|FG000|STARTED|Overall Study||106||
48744500|NCT01479868|102161705|FG000|COMPLETED|Overall Study||97||
48744501|NCT01479868|102161705|FG000|NOT COMPLETED|Overall Study||9||
48744502|NCT04390243|102161706|FG000|STARTED|Overall Study||6||
48744503|NCT04390243|102161706|FG000|COMPLETED|Overall Study||0||
48744504|NCT04390243|102161706|FG000|NOT COMPLETED|Overall Study||6||
48744505|NCT00972335|102161707|FG000|STARTED|Overall Study||17||
48744506|NCT00972335|102161707|FG000|COMPLETED|Overall Study||0||
48744507|NCT00972335|102161707|FG000|NOT COMPLETED|Overall Study||17||
48744508|NCT00483405|102161708|FG000|STARTED|Overall Study||28||
48744509|NCT00483405|102161708|FG000|COMPLETED|Overall Study||0||
48165153|NCT00337662|100728475|FG003|STARTED|Study Period II||628||
48165154|NCT00337662|100728472|FG000|COMPLETED|Study Period II||0||
48165155|NCT00337662|100728473|FG001|COMPLETED|Study Period II||0||
48165156|NCT00337662|100728474|FG002|COMPLETED|Study Period II||0||
48165157|NCT00337662|100728475|FG003|COMPLETED|Study Period II||522||
48165158|NCT00337662|100728472|FG000|NOT COMPLETED|Study Period II||0||
48165159|NCT00337662|100728473|FG001|NOT COMPLETED|Study Period II||0||
48165160|NCT00337662|100728474|FG002|NOT COMPLETED|Study Period II||0||
48165161|NCT00337662|100728475|FG003|NOT COMPLETED|Study Period II||106||
48165162|NCT00337662|100728472|FG000|STARTED|Study Period III||186||
48165163|NCT00337662|100728473|FG001|STARTED|Study Period III||192||
48165164|NCT00337662|100728474|FG002|STARTED|Study Period III||144||
48165165|NCT00337662|100728475|FG003|STARTED|Study Period III||0||
48165166|NCT00337662|100728472|FG000|COMPLETED|Study Period III||126||
48165167|NCT00337662|100728473|FG001|COMPLETED|Study Period III||134||
48165168|NCT00337662|100728474|FG002|COMPLETED|Study Period III||100||
48165169|NCT00337662|100728475|FG003|COMPLETED|Study Period III||0||
48165170|NCT00337662|100728472|FG000|NOT COMPLETED|Study Period III||60||
48165171|NCT00337662|100728473|FG001|NOT COMPLETED|Study Period III||58||
48165172|NCT00337662|100728474|FG002|NOT COMPLETED|Study Period III||44||
48165173|NCT00337662|100728475|FG003|NOT COMPLETED|Study Period III||0||
48165174|NCT02150837|100728476|FG000|STARTED|Overall Study||62||
48165175|NCT02150837|100728477|FG001|STARTED|Overall Study||310||
48165176|NCT02150837|100728476|FG000|COMPLETED|Overall Study||37||
48165177|NCT02150837|100728477|FG001|COMPLETED|Overall Study||185||
48165178|NCT02150837|100728476|FG000|NOT COMPLETED|Overall Study||25||
48165179|NCT02150837|100728477|FG001|NOT COMPLETED|Overall Study||125||
48165180|NCT02798211|100728478|FG000|STARTED|Period 1||103|Screened patients=349 Screen passed patient=271 Screened failure=78 Randomized=103|
48165181|NCT02798211|100728479|FG001|STARTED|Period 1||103|Screened patients=349 Screen passed patient=271 Screened failure=78 Randomized=103|
48165182|NCT02798211|100728480|FG002|STARTED|Period 1||52|Screened patients=349 Screen passed patient=271 Screened failure=78 Randomized=103|
48165183|NCT02798211|100728481|FG003|STARTED|Period 1||0|Screened patients=349 Screen passed patient=271 Screened failure=78 Randomized=103|
48165184|NCT02798211|100728482|FG004|STARTED|Period 1||0|Screened patients=349 Screen passed patient=271 Screened failure=78 Randomized=103|
48165185|NCT02798211|100728483|FG005|STARTED|Period 1||0|Screened patients=349 Screen passed patient=271 Screened failure=78 Randomized=103|
48165186|NCT02798211|100728478|FG000|COMPLETED|Period 1||97||
48165187|NCT02798211|100728479|FG001|COMPLETED|Period 1||93||
48165188|NCT02798211|100728480|FG002|COMPLETED|Period 1||46||
48165189|NCT02798211|100728481|FG003|COMPLETED|Period 1||0||
48165190|NCT02798211|100728482|FG004|COMPLETED|Period 1||0||
48165191|NCT02798211|100728483|FG005|COMPLETED|Period 1||0||
48744510|NCT00483405|102161708|FG000|NOT COMPLETED|Overall Study||28||
48744511|NCT02222558|102161709|FG000|STARTED|Period 1: Single Dose||25||
48744512|NCT02222558|102161710|FG001|STARTED|Period 1: Single Dose||0||
48744513|NCT02222558|102161711|FG002|STARTED|Period 1: Single Dose||0||
48744514|NCT02222558|102161712|FG003|STARTED|Period 1: Single Dose||0||
48744515|NCT02222558|102161713|FG004|STARTED|Period 1: Single Dose||0||
48165192|NCT02798211|100728478|FG000|NOT COMPLETED|Period 1||6||
48165193|NCT02798211|100728479|FG001|NOT COMPLETED|Period 1||10||
48165194|NCT02798211|100728480|FG002|NOT COMPLETED|Period 1||6||
48165195|NCT02798211|100728481|FG003|NOT COMPLETED|Period 1||0||
48165196|NCT02798211|100728482|FG004|NOT COMPLETED|Period 1||0||
48165197|NCT02798211|100728483|FG005|NOT COMPLETED|Period 1||0||
48165198|NCT02798211|100728478|FG000|STARTED|Period 2||97|Completed treatment period 1 and continued to treatment period 2|
48165199|NCT02798211|100728479|FG001|STARTED|Period 2||0|Completed treatment period 1 and continued to treatment period 2|
48165200|NCT02798211|100728480|FG002|STARTED|Period 2||0|Completed treatment period 1 and continued to treatment period 2|
48165201|NCT02798211|100728481|FG003|STARTED|Period 2||50|Completed treatment period 1 and continued to treatment period 2|
48188606|NCT00432159|100783285|FG003|COMPLETED|Overall Study||15||
48744516|NCT02222558|102161714|FG005|STARTED|Period 1: Single Dose||0||
48744517|NCT02222558|102161709|FG000|COMPLETED|Period 1: Single Dose||21||
48744518|NCT02222558|102161710|FG001|COMPLETED|Period 1: Single Dose||0||
48327880|NCT01175902|101128446|FG000|COMPLETED|Overall Study||22||
48327881|NCT01175902|101128447|FG001|COMPLETED|Overall Study||22||
48327882|NCT01175902|101128446|FG000|NOT COMPLETED|Overall Study||0||
48327883|NCT01175902|101128447|FG001|NOT COMPLETED|Overall Study||0||
48621276|NCT03589807|101856515|FG001|COMPLETED|Overall Study||23||
48165202|NCT02798211|100728482|FG004|STARTED|Period 2||42|Completed treatment period 1 and continued to treatment period 2|
48327884|NCT02490293|101128448|FG000|STARTED|Overall Study||96||
48327885|NCT02490293|101128449|FG001|STARTED|Overall Study||102||
48621277|NCT03589807|101856516|FG002|COMPLETED|Overall Study||31||
48621278|NCT03589807|101856517|FG003|COMPLETED|Overall Study||28||
48621279|NCT03589807|101856518|FG004|COMPLETED|Overall Study||26||
48621280|NCT03589807|101856519|FG005|COMPLETED|Overall Study||29||
48621281|NCT03589807|101856514|FG000|NOT COMPLETED|Overall Study||0||
48621282|NCT03589807|101856515|FG001|NOT COMPLETED|Overall Study||7||
48621283|NCT03589807|101856516|FG002|NOT COMPLETED|Overall Study||2||
48621284|NCT03589807|101856517|FG003|NOT COMPLETED|Overall Study||4||
48621285|NCT03589807|101856518|FG004|NOT COMPLETED|Overall Study||2||
48621286|NCT03589807|101856519|FG005|NOT COMPLETED|Overall Study||1||
48621287|NCT00856791|101856520|FG000|STARTED|Overall Study||1||
48621288|NCT00856791|101856520|FG000|COMPLETED|Overall Study||1||
48621289|NCT00856791|101856520|FG000|NOT COMPLETED|Overall Study||0||
48621290|NCT02557399|101856521|FG000|STARTED|Overall Study||172||
48621291|NCT02557399|101856522|FG001|STARTED|Overall Study||177||
48621292|NCT02557399|101856521|FG000|COMPLETED|Overall Study||165||
48621293|NCT02557399|101856522|FG001|COMPLETED|Overall Study||169||
48621294|NCT02557399|101856521|FG000|NOT COMPLETED|Overall Study||7||
48621295|NCT02557399|101856522|FG001|NOT COMPLETED|Overall Study||8||
48165203|NCT02798211|100728483|FG005|STARTED|Period 2||46|Completed treatment period 1 and continued to treatment period 2|
48165204|NCT02798211|100728478|FG000|COMPLETED|Period 2||83|Completed treatment period 2|
48327886|NCT02490293|101128448|FG000|COMPLETED|Overall Study||94||
48327887|NCT02490293|101128449|FG001|COMPLETED|Overall Study||99||
48327888|NCT02490293|101128448|FG000|NOT COMPLETED|Overall Study||2||
48327889|NCT02490293|101128449|FG001|NOT COMPLETED|Overall Study||3||
48621296|NCT01896193|101856523|FG000|STARTED|Overall Study||62||
48621297|NCT01896193|101856524|FG001|STARTED|Overall Study||65||
48165205|NCT02798211|100728479|FG001|COMPLETED|Period 2||0|Completed treatment period 2|
48621298|NCT01896193|101856523|FG000|COMPLETED|Overall Study||41||
48621299|NCT01896193|101856524|FG001|COMPLETED|Overall Study||53||
48621300|NCT01896193|101856523|FG000|NOT COMPLETED|Overall Study||21||
48621301|NCT01896193|101856524|FG001|NOT COMPLETED|Overall Study||12||
48621302|NCT02417753|101856525|FG000|STARTED|Overall Study||1||
48621303|NCT02417753|101856525|FG000|COMPLETED|Overall Study||0||
48621304|NCT02417753|101856525|FG000|NOT COMPLETED|Overall Study||1||
48621305|NCT03904420|101856526|FG000|STARTED|Overall Study||2||
48409841|NCT02748785|101334807|FG003|STARTED|Visit 1- Visit 2||69||
48409842|NCT02748785|101334804|FG000|COMPLETED|Visit 1- Visit 2||59||
48409843|NCT02748785|101334805|FG001|COMPLETED|Visit 1- Visit 2||49||
48409844|NCT02748785|101334806|FG002|COMPLETED|Visit 1- Visit 2||57||
48409845|NCT02748785|101334807|FG003|COMPLETED|Visit 1- Visit 2||63||
48409846|NCT02748785|101334804|FG000|NOT COMPLETED|Visit 1- Visit 2||10||
48409847|NCT02748785|101334805|FG001|NOT COMPLETED|Visit 1- Visit 2||19||
48409848|NCT02748785|101334806|FG002|NOT COMPLETED|Visit 1- Visit 2||14||
48409849|NCT02748785|101334807|FG003|NOT COMPLETED|Visit 1- Visit 2||6||
48409850|NCT02748785|101334804|FG000|STARTED|Visit 2-Visit 3||59||
48409851|NCT02748785|101334805|FG001|STARTED|Visit 2-Visit 3||49||
48409852|NCT02748785|101334806|FG002|STARTED|Visit 2-Visit 3||57||
48409853|NCT02748785|101334807|FG003|STARTED|Visit 2-Visit 3||63||
48409854|NCT02748785|101334804|FG000|COMPLETED|Visit 2-Visit 3||54||
48409855|NCT02748785|101334805|FG001|COMPLETED|Visit 2-Visit 3||44||
48409856|NCT02748785|101334806|FG002|COMPLETED|Visit 2-Visit 3||49||
48409857|NCT02748785|101334807|FG003|COMPLETED|Visit 2-Visit 3||52||
48409858|NCT02748785|101334804|FG000|NOT COMPLETED|Visit 2-Visit 3||5||
48409859|NCT02748785|101334805|FG001|NOT COMPLETED|Visit 2-Visit 3||5||
48409860|NCT02748785|101334806|FG002|NOT COMPLETED|Visit 2-Visit 3||8||
48409861|NCT02748785|101334807|FG003|NOT COMPLETED|Visit 2-Visit 3||11||
48409862|NCT02748785|101334804|FG000|STARTED|Visit 3- Visit 4||54||
48409863|NCT02748785|101334805|FG001|STARTED|Visit 3- Visit 4||44||
48409864|NCT02748785|101334806|FG002|STARTED|Visit 3- Visit 4||49||
48409865|NCT02748785|101334807|FG003|STARTED|Visit 3- Visit 4||52||
48409866|NCT02748785|101334804|FG000|COMPLETED|Visit 3- Visit 4||53||
48744519|NCT02222558|102161711|FG002|COMPLETED|Period 1: Single Dose||0||
48744520|NCT02222558|102161712|FG003|COMPLETED|Period 1: Single Dose||0||
48744521|NCT02222558|102161713|FG004|COMPLETED|Period 1: Single Dose||0||
48744522|NCT02222558|102161714|FG005|COMPLETED|Period 1: Single Dose||0||
48744523|NCT02222558|102161709|FG000|NOT COMPLETED|Period 1: Single Dose||4||
48744524|NCT02222558|102161710|FG001|NOT COMPLETED|Period 1: Single Dose||0||
48744525|NCT02222558|102161711|FG002|NOT COMPLETED|Period 1: Single Dose||0||
48744526|NCT02222558|102161712|FG003|NOT COMPLETED|Period 1: Single Dose||0||
48744527|NCT02222558|102161713|FG004|NOT COMPLETED|Period 1: Single Dose||0||
48744528|NCT02222558|102161714|FG005|NOT COMPLETED|Period 1: Single Dose||0||
48409867|NCT02748785|101334805|FG001|COMPLETED|Visit 3- Visit 4||43||
48409868|NCT02748785|101334806|FG002|COMPLETED|Visit 3- Visit 4||47||
48409869|NCT02748785|101334807|FG003|COMPLETED|Visit 3- Visit 4||50||
48409870|NCT02748785|101334804|FG000|NOT COMPLETED|Visit 3- Visit 4||1||
48409871|NCT02748785|101334805|FG001|NOT COMPLETED|Visit 3- Visit 4||1||
48409872|NCT02748785|101334806|FG002|NOT COMPLETED|Visit 3- Visit 4||2||
48409873|NCT02748785|101334807|FG003|NOT COMPLETED|Visit 3- Visit 4||2||
48409874|NCT05333289|101334808|FG000|STARTED|Overall Study||72||
48621306|NCT03904420|101856527|FG001|STARTED|Overall Study||2||
48621307|NCT03904420|101856526|FG000|COMPLETED|Overall Study||0||
48621308|NCT03904420|101856527|FG001|COMPLETED|Overall Study||0||
48621309|NCT03904420|101856526|FG000|NOT COMPLETED|Overall Study||2||
48621310|NCT03904420|101856527|FG001|NOT COMPLETED|Overall Study||2||
48621311|NCT02862080|101856528|FG000|STARTED|7 Days Before Any Intervention||1||
48621312|NCT02862080|101856529|FG001|STARTED|7 Days Before Any Intervention||1||
48621313|NCT02862080|101856530|FG002|STARTED|7 Days Before Any Intervention||1||
48621314|NCT02862080|101856531|FG003|STARTED|7 Days Before Any Intervention||1||
48621315|NCT02862080|101856528|FG000|COMPLETED|7 Days Before Any Intervention||1||
48621316|NCT02862080|101856529|FG001|COMPLETED|7 Days Before Any Intervention||1||
48621317|NCT02862080|101856530|FG002|COMPLETED|7 Days Before Any Intervention||1||
48621318|NCT02862080|101856531|FG003|COMPLETED|7 Days Before Any Intervention||1||
48621319|NCT02862080|101856528|FG000|NOT COMPLETED|7 Days Before Any Intervention||0||
48621320|NCT02862080|101856529|FG001|NOT COMPLETED|7 Days Before Any Intervention||0||
48621321|NCT02862080|101856530|FG002|NOT COMPLETED|7 Days Before Any Intervention||0||
48621322|NCT02862080|101856531|FG003|NOT COMPLETED|7 Days Before Any Intervention||0||
48621323|NCT02862080|101856528|FG000|STARTED|3 Days Before Any Intervention||1||
48621324|NCT02862080|101856529|FG001|STARTED|3 Days Before Any Intervention||1||
48409875|NCT05333289|101334809|FG001|STARTED|Overall Study||71||
48409876|NCT05333289|101334810|FG002|STARTED|Overall Study||71||
48409877|NCT05333289|101334811|FG003|STARTED|Overall Study||72||
48409878|NCT05333289|101334812|FG004|STARTED|Overall Study||72||
48409879|NCT05333289|101334813|FG005|STARTED|Overall Study||71||
48744529|NCT02222558|102161709|FG000|STARTED|Period 2: Two Times Daily Dosing 90 mg||0||
48744530|NCT02222558|102161710|FG001|STARTED|Period 2: Two Times Daily Dosing 90 mg||21||
48744531|NCT02222558|102161711|FG002|STARTED|Period 2: Two Times Daily Dosing 90 mg||0||
48744532|NCT02222558|102161712|FG003|STARTED|Period 2: Two Times Daily Dosing 90 mg||0||
48744533|NCT02222558|102161713|FG004|STARTED|Period 2: Two Times Daily Dosing 90 mg||0||
48744534|NCT02222558|102161714|FG005|STARTED|Period 2: Two Times Daily Dosing 90 mg||0||
48744535|NCT02222558|102161709|FG000|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0||
48744536|NCT02222558|102161710|FG001|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||21||
48744537|NCT02222558|102161711|FG002|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0||
48744538|NCT02222558|102161712|FG003|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0||
48744539|NCT02222558|102161713|FG004|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0||
48744540|NCT02222558|102161714|FG005|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0||
48744541|NCT02222558|102161709|FG000|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0||
48744542|NCT02222558|102161710|FG001|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0||
48744543|NCT02222558|102161711|FG002|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0||
48744544|NCT02222558|102161712|FG003|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0||
48744545|NCT02222558|102161713|FG004|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0||
48744546|NCT02222558|102161714|FG005|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0||
48744547|NCT02222558|102161709|FG000|STARTED|Period 3||0||
48744548|NCT02222558|102161710|FG001|STARTED|Period 3||0||
48744549|NCT02222558|102161711|FG002|STARTED|Period 3||4||
48744550|NCT02222558|102161712|FG003|STARTED|Period 3||1||
48744551|NCT02222558|102161713|FG004|STARTED|Period 3||8||
48744552|NCT02222558|102161714|FG005|STARTED|Period 3||8||
48744553|NCT02222558|102161709|FG000|COMPLETED|Period 3||0||
48744554|NCT02222558|102161710|FG001|COMPLETED|Period 3||0||
48744555|NCT02222558|102161711|FG002|COMPLETED|Period 3||4||
48744556|NCT02222558|102161712|FG003|COMPLETED|Period 3||1||
48744557|NCT02222558|102161713|FG004|COMPLETED|Period 3||8||
48744558|NCT02222558|102161714|FG005|COMPLETED|Period 3||7||
48744559|NCT02222558|102161709|FG000|NOT COMPLETED|Period 3||0||
48744560|NCT02222558|102161710|FG001|NOT COMPLETED|Period 3||0||
48744561|NCT02222558|102161711|FG002|NOT COMPLETED|Period 3||0||
48744562|NCT02222558|102161712|FG003|NOT COMPLETED|Period 3||0||
48744563|NCT02222558|102161713|FG004|NOT COMPLETED|Period 3||0||
48744564|NCT02222558|102161714|FG005|NOT COMPLETED|Period 3||1||
48744565|NCT01556451|102161715|FG000|STARTED|Overall Study||180||
48744566|NCT01556451|102161715|FG000|COMPLETED|Overall Study||180||
48744567|NCT01556451|102161715|FG000|NOT COMPLETED|Overall Study||0||
48744568|NCT00936702|102161716|FG000|STARTED|Overall Study||46||
48744569|NCT00936702|102161716|FG000|COMPLETED|Overall Study||0||
48744570|NCT00936702|102161716|FG000|NOT COMPLETED|Overall Study||46||
48744571|NCT02640547|102161717|FG000|STARTED|Overall Study||394||
48744572|NCT02640547|102161717|FG000|COMPLETED|Overall Study||383|HCV ribonucleic acid (RNA) treatment assessment performed at least 10 weeks post-treatment|
48744573|NCT02640547|102161717|FG000|NOT COMPLETED|Overall Study||11||
48744574|NCT00466440|102161718|FG000|STARTED|Overall Study||14||
48744575|NCT00466440|102161719|FG001|STARTED|Overall Study||48||
48744576|NCT00466440|102161720|FG002|STARTED|Overall Study||46||
48744577|NCT00466440|102161718|FG000|Received at Least One Dose of Study Drug|Overall Study||14||
48744578|NCT00466440|102161719|FG001|Received at Least One Dose of Study Drug|Overall Study||47||
48744579|NCT00466440|102161720|FG002|Received at Least One Dose of Study Drug|Overall Study||41||
48744580|NCT00466440|102161718|FG000|COMPLETED|Overall Study||0||
48744581|NCT00466440|102161719|FG001|COMPLETED|Overall Study||36||
48744582|NCT00466440|102161720|FG002|COMPLETED|Overall Study||34||
48744583|NCT00466440|102161718|FG000|NOT COMPLETED|Overall Study||14||
48744584|NCT00466440|102161719|FG001|NOT COMPLETED|Overall Study||12||
48744585|NCT00466440|102161720|FG002|NOT COMPLETED|Overall Study||12||
48744586|NCT00900666|102161721|FG000|STARTED|Overall Study||10||
48744587|NCT00900666|102161722|FG001|STARTED|Overall Study||9||
48744588|NCT00900666|102161721|FG000|COMPLETED|Overall Study||10||
48744589|NCT00900666|102161722|FG001|COMPLETED|Overall Study||9||
48744590|NCT00900666|102161721|FG000|NOT COMPLETED|Overall Study||0||
48744591|NCT00900666|102161722|FG001|NOT COMPLETED|Overall Study||0||
48744592|NCT02947646|102161723|FG000|STARTED|Overall Study||10||
48744593|NCT02947646|102161724|FG001|STARTED|Overall Study||10||
48744594|NCT02947646|102161723|FG000|COMPLETED|Overall Study||10||
48744595|NCT02947646|102161724|FG001|COMPLETED|Overall Study||9||
48744596|NCT02947646|102161723|FG000|NOT COMPLETED|Overall Study||0||
48744597|NCT02947646|102161724|FG001|NOT COMPLETED|Overall Study||1||
48744598|NCT00496080|102161725|FG000|STARTED|Overall Study||87||
48744599|NCT00496080|102161725|FG000|COMPLETED|Overall Study||60||
48744600|NCT00496080|102161725|FG000|NOT COMPLETED|Overall Study||27||
48744601|NCT02927392|102161726|FG000|STARTED|Overall Study||44||
48744602|NCT02927392|102161727|FG001|STARTED|Overall Study||25||
48744603|NCT02927392|102161726|FG000|COMPLETED|Overall Study||28||
48744604|NCT02927392|102161727|FG001|COMPLETED|Overall Study||25||
48744605|NCT02927392|102161726|FG000|NOT COMPLETED|Overall Study||16||
48744606|NCT02927392|102161727|FG001|NOT COMPLETED|Overall Study||0||
48744607|NCT02794766|102161728|FG000|STARTED|Overall Study||15||
48744608|NCT02794766|102161729|FG001|STARTED|Overall Study||15||
48188607|NCT00432159|100783286|FG004|COMPLETED|Overall Study||79||
48621325|NCT02862080|101856530|FG002|STARTED|3 Days Before Any Intervention||1||
48621326|NCT02862080|101856531|FG003|STARTED|3 Days Before Any Intervention||1||
48621327|NCT02862080|101856528|FG000|COMPLETED|3 Days Before Any Intervention||1||
48621328|NCT02862080|101856529|FG001|COMPLETED|3 Days Before Any Intervention||1||
48621329|NCT02862080|101856530|FG002|COMPLETED|3 Days Before Any Intervention||1||
48621330|NCT02862080|101856531|FG003|COMPLETED|3 Days Before Any Intervention||1||
48621331|NCT02862080|101856528|FG000|NOT COMPLETED|3 Days Before Any Intervention||0||
48621332|NCT02862080|101856529|FG001|NOT COMPLETED|3 Days Before Any Intervention||0||
48621333|NCT02862080|101856530|FG002|NOT COMPLETED|3 Days Before Any Intervention||0||
48621334|NCT02862080|101856531|FG003|NOT COMPLETED|3 Days Before Any Intervention||0||
48621335|NCT02862080|101856528|FG000|STARTED|Intervention 1 (1 Week)||1||
48621336|NCT02862080|101856529|FG001|STARTED|Intervention 1 (1 Week)||1||
48621337|NCT02862080|101856530|FG002|STARTED|Intervention 1 (1 Week)||1||
48621338|NCT02862080|101856531|FG003|STARTED|Intervention 1 (1 Week)||1||
48621339|NCT02862080|101856528|FG000|COMPLETED|Intervention 1 (1 Week)||1||
48621340|NCT02862080|101856529|FG001|COMPLETED|Intervention 1 (1 Week)||1||
48621341|NCT02862080|101856530|FG002|COMPLETED|Intervention 1 (1 Week)||1||
48621342|NCT02862080|101856531|FG003|COMPLETED|Intervention 1 (1 Week)||1||
48621343|NCT02862080|101856528|FG000|NOT COMPLETED|Intervention 1 (1 Week)||0||
48621344|NCT02862080|101856529|FG001|NOT COMPLETED|Intervention 1 (1 Week)||0||
48621345|NCT02862080|101856530|FG002|NOT COMPLETED|Intervention 1 (1 Week)||0||
48621346|NCT02862080|101856531|FG003|NOT COMPLETED|Intervention 1 (1 Week)||0||
48621347|NCT02862080|101856528|FG000|STARTED|Washout (1 Week)||1||
48621348|NCT02862080|101856529|FG001|STARTED|Washout (1 Week)||1||
48621349|NCT02862080|101856530|FG002|STARTED|Washout (1 Week)||1||
48621350|NCT02862080|101856531|FG003|STARTED|Washout (1 Week)||1||
48621351|NCT02862080|101856528|FG000|COMPLETED|Washout (1 Week)||1||
48621352|NCT02862080|101856529|FG001|COMPLETED|Washout (1 Week)||1||
48621353|NCT02862080|101856530|FG002|COMPLETED|Washout (1 Week)||1||
48621354|NCT02862080|101856531|FG003|COMPLETED|Washout (1 Week)||1||
48621355|NCT02862080|101856528|FG000|NOT COMPLETED|Washout (1 Week)||0||
48621356|NCT02862080|101856529|FG001|NOT COMPLETED|Washout (1 Week)||0||
48621357|NCT02862080|101856530|FG002|NOT COMPLETED|Washout (1 Week)||0||
48621358|NCT02862080|101856531|FG003|NOT COMPLETED|Washout (1 Week)||0||
48621359|NCT02862080|101856528|FG000|STARTED|Intervention 2 (1 Week)||1||
48621360|NCT02862080|101856529|FG001|STARTED|Intervention 2 (1 Week)||1||
48621361|NCT02862080|101856530|FG002|STARTED|Intervention 2 (1 Week)||1||
48621362|NCT02862080|101856531|FG003|STARTED|Intervention 2 (1 Week)||1||
48621363|NCT02862080|101856528|FG000|COMPLETED|Intervention 2 (1 Week)||1||
48621364|NCT02862080|101856529|FG001|COMPLETED|Intervention 2 (1 Week)||1||
48621365|NCT02862080|101856530|FG002|COMPLETED|Intervention 2 (1 Week)||1||
48621366|NCT02862080|101856531|FG003|COMPLETED|Intervention 2 (1 Week)||1||
48621367|NCT02862080|101856528|FG000|NOT COMPLETED|Intervention 2 (1 Week)||0||
48621368|NCT02862080|101856529|FG001|NOT COMPLETED|Intervention 2 (1 Week)||0||
48621369|NCT02862080|101856530|FG002|NOT COMPLETED|Intervention 2 (1 Week)||0||
48621370|NCT02862080|101856531|FG003|NOT COMPLETED|Intervention 2 (1 Week)||0||
48621371|NCT02862080|101856528|FG000|STARTED|Washout (1 Week)||1||
48621372|NCT02862080|101856529|FG001|STARTED|Washout (1 Week)||1||
48621373|NCT02862080|101856530|FG002|STARTED|Washout (1 Week)||1||
48621374|NCT02862080|101856531|FG003|STARTED|Washout (1 Week)||1||
48621375|NCT02862080|101856528|FG000|COMPLETED|Washout (1 Week)||1||
48621376|NCT02862080|101856529|FG001|COMPLETED|Washout (1 Week)||1||
48621377|NCT02862080|101856530|FG002|COMPLETED|Washout (1 Week)||1||
48621378|NCT02862080|101856531|FG003|COMPLETED|Washout (1 Week)||1||
48621379|NCT02862080|101856528|FG000|NOT COMPLETED|Washout (1 Week)||0||
48621380|NCT02862080|101856529|FG001|NOT COMPLETED|Washout (1 Week)||0||
48621381|NCT02862080|101856530|FG002|NOT COMPLETED|Washout (1 Week)||0||
48621382|NCT02862080|101856531|FG003|NOT COMPLETED|Washout (1 Week)||0||
48327890|NCT01908101|101128450|FG000|STARTED|Overall Study||68||
48621383|NCT02862080|101856528|FG000|STARTED|Intervention 1 Again (1 Week)||1||
48621384|NCT02862080|101856529|FG001|STARTED|Intervention 1 Again (1 Week)||1||
48621385|NCT02862080|101856530|FG002|STARTED|Intervention 1 Again (1 Week)||1||
48621386|NCT02862080|101856531|FG003|STARTED|Intervention 1 Again (1 Week)||1||
48621387|NCT02862080|101856528|FG000|COMPLETED|Intervention 1 Again (1 Week)||1||
48621388|NCT02862080|101856529|FG001|COMPLETED|Intervention 1 Again (1 Week)||1||
48621389|NCT02862080|101856530|FG002|COMPLETED|Intervention 1 Again (1 Week)||1||
48621390|NCT02862080|101856531|FG003|COMPLETED|Intervention 1 Again (1 Week)||1||
48621391|NCT02862080|101856528|FG000|NOT COMPLETED|Intervention 1 Again (1 Week)||0||
48621392|NCT02862080|101856529|FG001|NOT COMPLETED|Intervention 1 Again (1 Week)||0||
48621393|NCT02862080|101856530|FG002|NOT COMPLETED|Intervention 1 Again (1 Week)||0||
48621394|NCT02862080|101856531|FG003|NOT COMPLETED|Intervention 1 Again (1 Week)||0||
48621395|NCT02175225|101856532|FG000|STARTED|Overall Study||145||
48621396|NCT02175225|101856533|FG001|STARTED|Overall Study||149||
48621397|NCT02175225|101856532|FG000|Initiated Study Drug|Overall Study||144||
48621398|NCT02175225|101856533|FG001|Initiated Study Drug|Overall Study||147||
48621399|NCT02175225|101856532|FG000|90 Day Outcome Obtained|Overall Study||140||
48621400|NCT02175225|101856533|FG001|90 Day Outcome Obtained|Overall Study||143||
48621401|NCT02175225|101856532|FG000|180 Day Outcome Obtained|Overall Study||135||
48621402|NCT02175225|101856533|FG001|180 Day Outcome Obtained|Overall Study||135||
48621403|NCT02175225|101856532|FG000|COMPLETED|Overall Study||137||
48621404|NCT02175225|101856533|FG001|COMPLETED|Overall Study||138||
48621405|NCT02175225|101856532|FG000|NOT COMPLETED|Overall Study||8||
48621406|NCT02175225|101856533|FG001|NOT COMPLETED|Overall Study||11||
48621407|NCT02291029|101856534|FG000|STARTED|Overall Study||8||
48621408|NCT02291029|101856535|FG001|STARTED|Overall Study||4||
48621409|NCT02291029|101856536|FG002|STARTED|Overall Study||21||
48621410|NCT02291029|101856537|FG003|STARTED|Overall Study||11||
48621411|NCT02291029|101856538|FG004|STARTED|Overall Study||13||
48621412|NCT02291029|101856539|FG005|STARTED|Overall Study||12||
48621413|NCT02291029|101856534|FG000|COMPLETED|Overall Study||8||
48621414|NCT02291029|101856535|FG001|COMPLETED|Overall Study||3||
48621415|NCT02291029|101856536|FG002|COMPLETED|Overall Study||20||
48621416|NCT02291029|101856537|FG003|COMPLETED|Overall Study||11||
48621417|NCT02291029|101856538|FG004|COMPLETED|Overall Study||13||
48621418|NCT02291029|101856539|FG005|COMPLETED|Overall Study||12||
48621419|NCT02291029|101856534|FG000|NOT COMPLETED|Overall Study||0||
48621420|NCT02291029|101856535|FG001|NOT COMPLETED|Overall Study||1||
48621421|NCT02291029|101856536|FG002|NOT COMPLETED|Overall Study||1||
48621422|NCT02291029|101856537|FG003|NOT COMPLETED|Overall Study||0||
48621423|NCT02291029|101856538|FG004|NOT COMPLETED|Overall Study||0||
48621424|NCT02291029|101856539|FG005|NOT COMPLETED|Overall Study||0||
48621425|NCT02121795|101856540|FG000|STARTED|Double-Blind Phase||334||
48621426|NCT02121795|101856541|FG001|STARTED|Double-Blind Phase||334||
48621427|NCT02121795|101856540|FG000|Safety Analysis Set|Double-Blind Phase||333||
48744609|NCT02794766|102161730|FG002|STARTED|Overall Study||15||
48744610|NCT02794766|102161728|FG000|COMPLETED|Overall Study||15||
48744611|NCT02794766|102161729|FG001|COMPLETED|Overall Study||15||
48744612|NCT02794766|102161730|FG002|COMPLETED|Overall Study||14||
48744613|NCT02794766|102161728|FG000|NOT COMPLETED|Overall Study||0||
48744614|NCT02794766|102161729|FG001|NOT COMPLETED|Overall Study||0||
48744615|NCT02794766|102161730|FG002|NOT COMPLETED|Overall Study||1||
48744616|NCT04115384|102161731|FG000|STARTED|Overall Study||3||
48744617|NCT04115384|102161731|FG000|COMPLETED|Overall Study||3||
48327891|NCT01908101|101128450|FG000|COMPLETED|Overall Study||59||
48621428|NCT02121795|101856541|FG001|Safety Analysis Set|Double-Blind Phase||330||
48621429|NCT02121795|101856540|FG000|COMPLETED|Double-Blind Phase||296||
48621430|NCT02121795|101856541|FG001|COMPLETED|Double-Blind Phase||300||
48621431|NCT02121795|101856540|FG000|NOT COMPLETED|Double-Blind Phase||38||
48621432|NCT02121795|101856541|FG001|NOT COMPLETED|Double-Blind Phase||34||
48621433|NCT02121795|101856540|FG000|STARTED|Open-Label Phase||33||
48621434|NCT02121795|101856541|FG001|STARTED|Open-Label Phase||31||
48621435|NCT02121795|101856540|FG000|COMPLETED|Open-Label Phase||21||
48621436|NCT02121795|101856541|FG001|COMPLETED|Open-Label Phase||21||
48621437|NCT02121795|101856540|FG000|NOT COMPLETED|Open-Label Phase||12||
48621438|NCT02121795|101856541|FG001|NOT COMPLETED|Open-Label Phase||10||
48621439|NCT00165503|101856542|FG000|STARTED|Overall Study||16||
48744618|NCT04115384|102161731|FG000|NOT COMPLETED|Overall Study||0||
48621440|NCT00165503|101856542|FG000|COMPLETED|Overall Study||0||
48621441|NCT00165503|101856542|FG000|NOT COMPLETED|Overall Study||16||
48744619|NCT02544503|102161732|FG000|STARTED|Overall Study||66||
48744620|NCT02544503|102161733|FG001|STARTED|Overall Study||34||
48744621|NCT02544503|102161732|FG000|Completed First Study Assessment|Overall Study||42|For stroke patients, the first study visit occurred one month after their stroke.|
48744622|NCT02544503|102161733|FG001|Completed First Study Assessment|Overall Study||31|For stroke patients, the first study visit occurred one month after their stroke.|
48621442|NCT00129441|101856543|FG000|STARTED|Overall Study||9||
48744623|NCT02544503|102161732|FG000|Stroke Patients Who Completed the 6 Month Post-stroke Assessment|Overall Study||32||
48165206|NCT02798211|100728480|FG002|COMPLETED|Period 2||0|Completed treatment period 2|
48165207|NCT02798211|100728481|FG003|COMPLETED|Period 2||43|Completed treatment period 2|
48165208|NCT02798211|100728482|FG004|COMPLETED|Period 2||34|Completed treatment period 2|
48165209|NCT02798211|100728483|FG005|COMPLETED|Period 2||40|Completed treatment period 2|
48621443|NCT00129441|101856544|FG001|STARTED|Overall Study||6||
48621444|NCT00129441|101856543|FG000|Baseline, Visit 1|Overall Study||9||
48621445|NCT00129441|101856544|FG001|Baseline, Visit 1|Overall Study||6||
48621446|NCT00129441|101856543|FG000|Week 1, Visit 2|Overall Study||9||
48621447|NCT00129441|101856544|FG001|Week 1, Visit 2|Overall Study||6||
48621448|NCT00129441|101856543|FG000|Week 2, Visit 3|Overall Study||9||
48621449|NCT00129441|101856544|FG001|Week 2, Visit 3|Overall Study||6||
48621450|NCT00129441|101856543|FG000|Week 3, Visit 4|Overall Study||9||
48621451|NCT00129441|101856544|FG001|Week 3, Visit 4|Overall Study||6||
48621452|NCT00129441|101856543|FG000|Week 4, Visit 5|Overall Study||9||
48621453|NCT00129441|101856544|FG001|Week 4, Visit 5|Overall Study||6||
48621454|NCT00129441|101856543|FG000|Week 5, Visit 6|Overall Study||9||
48621455|NCT00129441|101856544|FG001|Week 5, Visit 6|Overall Study||6||
48621456|NCT00129441|101856543|FG000|Week 26, Visit 7|Overall Study||9||
48621457|NCT00129441|101856544|FG001|Week 26, Visit 7|Overall Study||6||
48621458|NCT00129441|101856543|FG000|Year 1, Visit 8|Overall Study||9||
48621459|NCT00129441|101856544|FG001|Year 1, Visit 8|Overall Study||6||
48621460|NCT00129441|101856543|FG000|COMPLETED|Overall Study||9||
48621461|NCT00129441|101856544|FG001|COMPLETED|Overall Study||6||
48621462|NCT00129441|101856543|FG000|NOT COMPLETED|Overall Study||0||
48621463|NCT00129441|101856544|FG001|NOT COMPLETED|Overall Study||0||
48621464|NCT00379145|101856545|FG000|STARTED|Overall Study||20||
48621465|NCT00379145|101856545|FG000|COMPLETED|Overall Study||20|Eligible and treated patients|
48621466|NCT00379145|101856545|FG000|NOT COMPLETED|Overall Study||0||
48621467|NCT00964028|101856546|FG000|STARTED|Overall Study||25||
48621468|NCT00964028|101856547|FG001|STARTED|Overall Study||25||
48621469|NCT00964028|101856546|FG000|COMPLETED|Overall Study||25||
48621470|NCT00964028|101856547|FG001|COMPLETED|Overall Study||24||
48621471|NCT00964028|101856546|FG000|NOT COMPLETED|Overall Study||0||
48621472|NCT00964028|101856547|FG001|NOT COMPLETED|Overall Study||1||
48621473|NCT02743364|101856548|FG000|STARTED|Overall Study||6||
48621474|NCT02743364|101856549|FG001|STARTED|Overall Study||2||
48621475|NCT02743364|101856548|FG000|COMPLETED|Overall Study||6||
48621476|NCT02743364|101856549|FG001|COMPLETED|Overall Study||2||
48621477|NCT02743364|101856548|FG000|NOT COMPLETED|Overall Study||0||
48621478|NCT02743364|101856549|FG001|NOT COMPLETED|Overall Study||0||
48621479|NCT02104427|101856550|FG000|STARTED|Overall Study||12||
48621480|NCT02104427|101856550|FG000|COMPLETED|Overall Study||12||
48621481|NCT02104427|101856550|FG000|NOT COMPLETED|Overall Study||0||
48621482|NCT03139552|101856551|FG000|STARTED|Overall Study||150||
48621483|NCT03139552|101856551|FG000|COMPLETED|Overall Study||147|3 subjects did not complete tastings of all three items.|
48621484|NCT03139552|101856551|FG000|NOT COMPLETED|Overall Study||3||
48621485|NCT01099358|101856552|FG000|STARTED|Overall Study||4||
48621486|NCT01099358|101856553|FG001|STARTED|Overall Study||6||
48621487|NCT01099358|101856554|FG002|STARTED|Overall Study||21||
48621488|NCT01099358|101856555|FG003|STARTED|Overall Study||16||
48621489|NCT01099358|101856552|FG000|Received at Least One Dose of Study Drug|Overall Study||3||
48621490|NCT01099358|101856553|FG001|Received at Least One Dose of Study Drug|Overall Study||6||
48165210|NCT02798211|100728478|FG000|NOT COMPLETED|Period 2||14||
48621491|NCT01099358|101856554|FG002|Received at Least One Dose of Study Drug|Overall Study||20||
48621492|NCT01099358|101856555|FG003|Received at Least One Dose of Study Drug|Overall Study||15||
48621493|NCT01099358|101856552|FG000|COMPLETED|Overall Study||1||
48621494|NCT01099358|101856553|FG001|COMPLETED|Overall Study||5||
48621495|NCT01099358|101856554|FG002|COMPLETED|Overall Study||13||
48621496|NCT01099358|101856555|FG003|COMPLETED|Overall Study||12||
48621497|NCT01099358|101856552|FG000|NOT COMPLETED|Overall Study||3||
48621498|NCT01099358|101856553|FG001|NOT COMPLETED|Overall Study||1||
48621499|NCT01099358|101856554|FG002|NOT COMPLETED|Overall Study||8||
48621500|NCT01099358|101856555|FG003|NOT COMPLETED|Overall Study||4||
48621501|NCT01149655|101856556|FG000|STARTED|Period 1 - Conversion Phase||186||
48744624|NCT02544503|102161733|FG001|Stroke Patients Who Completed the 6 Month Post-stroke Assessment|Overall Study||0||
48744625|NCT02544503|102161732|FG000|COMPLETED|Overall Study||32||
48744626|NCT02544503|102161733|FG001|COMPLETED|Overall Study||31||
48744627|NCT02544503|102161732|FG000|NOT COMPLETED|Overall Study||34||
48744628|NCT02544503|102161733|FG001|NOT COMPLETED|Overall Study||3||
48744629|NCT00068341|102161734|FG000|STARTED|Overall Study||15||
48327892|NCT01908101|101128450|FG000|NOT COMPLETED|Overall Study||9||
48621502|NCT01149655|101856557|FG001|STARTED|Period 1 - Conversion Phase||0||
48621503|NCT01149655|101856558|FG002|STARTED|Period 1 - Conversion Phase||0||
48621504|NCT01149655|101856559|FG003|STARTED|Period 1 - Conversion Phase||0||
48165211|NCT02798211|100728479|FG001|NOT COMPLETED|Period 2||0||
48744630|NCT00068341|102161735|FG001|STARTED|Overall Study||15||
48165212|NCT02798211|100728480|FG002|NOT COMPLETED|Period 2||0||
48327893|NCT02104583|101128451|FG000|STARTED|Overall Study||48||
48327894|NCT02104583|101128452|FG001|STARTED|Overall Study||46||
48621505|NCT01149655|101856556|FG000|COMPLETED|Period 1 - Conversion Phase||168||
48621506|NCT01149655|101856557|FG001|COMPLETED|Period 1 - Conversion Phase||0||
48621507|NCT01149655|101856558|FG002|COMPLETED|Period 1 - Conversion Phase||0||
48621508|NCT01149655|101856559|FG003|COMPLETED|Period 1 - Conversion Phase||0||
48621509|NCT01149655|101856556|FG000|NOT COMPLETED|Period 1 - Conversion Phase||18||
48621510|NCT01149655|101856557|FG001|NOT COMPLETED|Period 1 - Conversion Phase||0||
48621511|NCT01149655|101856558|FG002|NOT COMPLETED|Period 1 - Conversion Phase||0||
48621512|NCT01149655|101856559|FG003|NOT COMPLETED|Period 1 - Conversion Phase||0||
48621513|NCT01149655|101856556|FG000|STARTED|Period 2-Stabilization Phase||0||
48744631|NCT00068341|102161736|FG002|STARTED|Overall Study||44||
48744632|NCT00068341|102161734|FG000|COMPLETED|Overall Study||15||
48744633|NCT00068341|102161735|FG001|COMPLETED|Overall Study||15||
48165213|NCT02798211|100728481|FG003|NOT COMPLETED|Period 2||7||
48165214|NCT02798211|100728482|FG004|NOT COMPLETED|Period 2||8||
48327895|NCT02104583|101128453|FG002|STARTED|Overall Study||70||
48327896|NCT02104583|101128454|FG003|STARTED|Overall Study||74||
48327897|NCT02104583|101128455|FG004|STARTED|Overall Study||75||
48621514|NCT01149655|101856557|FG001|STARTED|Period 2-Stabilization Phase||183||
48621515|NCT01149655|101856558|FG002|STARTED|Period 2-Stabilization Phase||0||
48744634|NCT00068341|102161736|FG002|COMPLETED|Overall Study||44||
48744635|NCT00068341|102161734|FG000|NOT COMPLETED|Overall Study||0||
48744636|NCT00068341|102161735|FG001|NOT COMPLETED|Overall Study||0||
48744637|NCT00068341|102161736|FG002|NOT COMPLETED|Overall Study||0||
48744638|NCT02587520|102161737|FG000|STARTED|Overall Study||80||
48744639|NCT02587520|102161738|FG001|STARTED|Overall Study||71||
48744640|NCT02587520|102161739|FG002|STARTED|Overall Study||78||
48621516|NCT01149655|101856559|FG003|STARTED|Period 2-Stabilization Phase||0||
48621517|NCT01149655|101856556|FG000|COMPLETED|Period 2-Stabilization Phase||0||
48744641|NCT02587520|102161740|FG003|STARTED|Overall Study||79||
48744642|NCT02587520|102161741|FG004|STARTED|Overall Study||75||
48327898|NCT02104583|101128451|FG000|COMPLETED|Overall Study||30||
48327899|NCT02104583|101128452|FG001|COMPLETED|Overall Study||35||
48621518|NCT01149655|101856557|FG001|COMPLETED|Period 2-Stabilization Phase||146||
48744643|NCT02587520|102161742|FG005|STARTED|Overall Study||75||
48744644|NCT02587520|102161743|FG006|STARTED|Overall Study||76||
48744645|NCT02587520|102161744|FG007|STARTED|Overall Study||73||
48744646|NCT02587520|102161745|FG008|STARTED|Overall Study||76||
48744647|NCT02587520|102161746|FG009|STARTED|Overall Study||76||
48744648|NCT02587520|102161747|FG010|STARTED|Overall Study||76||
48744649|NCT02587520|102161748|FG011|STARTED|Overall Study||73||
48621519|NCT01149655|101856558|FG002|COMPLETED|Period 2-Stabilization Phase||0||
48621520|NCT01149655|101856559|FG003|COMPLETED|Period 2-Stabilization Phase||0||
48621521|NCT01149655|101856556|FG000|NOT COMPLETED|Period 2-Stabilization Phase||0||
48621522|NCT01149655|101856557|FG001|NOT COMPLETED|Period 2-Stabilization Phase||37||
48621523|NCT01149655|101856558|FG002|NOT COMPLETED|Period 2-Stabilization Phase||0||
48621524|NCT01149655|101856559|FG003|NOT COMPLETED|Period 2-Stabilization Phase||0||
48621525|NCT01149655|101856556|FG000|STARTED|Period 3-DB Maintenance Phase||0||
48621526|NCT01149655|101856557|FG001|STARTED|Period 3-DB Maintenance Phase||0||
48744650|NCT02587520|102161749|FG012|STARTED|Overall Study||77||
48744651|NCT02587520|102161750|FG013|STARTED|Overall Study||74||
48621527|NCT01149655|101856558|FG002|STARTED|Period 3-DB Maintenance Phase||98||
48621528|NCT01149655|101856559|FG003|STARTED|Period 3-DB Maintenance Phase||48||
48744652|NCT02587520|102161751|FG014|STARTED|Overall Study||78||
48744653|NCT02587520|102161752|FG015|STARTED|Overall Study||72||
48744654|NCT02587520|102161753|FG016|STARTED|Overall Study||76||
48744655|NCT02587520|102161754|FG017|STARTED|Overall Study||78||
48744656|NCT02587520|102161737|FG000|Safety Analysis Set (SafAS)|Overall Study||79|All participants who received study vaccine, analyzed according to vaccine actually received.|
48744657|NCT02587520|102161738|FG001|Safety Analysis Set (SafAS)|Overall Study||71|All participants who received study vaccine, analyzed according to vaccine actually received.|
48744658|NCT02587520|102161739|FG002|Safety Analysis Set (SafAS)|Overall Study||77|All participants who received study vaccine, analyzed according to vaccine actually received.|
48744659|NCT02587520|102161740|FG003|Safety Analysis Set (SafAS)|Overall Study||77|All participants who received study vaccine, analyzed according to vaccine actually received.|
48744660|NCT02587520|102161741|FG004|Safety Analysis Set (SafAS)|Overall Study||75|All participants who received study vaccine, analyzed according to vaccine actually received.|
48744661|NCT02587520|102161742|FG005|Safety Analysis Set (SafAS)|Overall Study||75|All participants who received study vaccine, analyzed according to vaccine actually received.|
48744662|NCT02587520|102161743|FG006|Safety Analysis Set (SafAS)|Overall Study||76|All participants who received study vaccine, analyzed according to vaccine actually received.|
48744663|NCT02587520|102161744|FG007|Safety Analysis Set (SafAS)|Overall Study||73|All participants who received study vaccine, analyzed according to vaccine actually received.|
48744664|NCT02587520|102161745|FG008|Safety Analysis Set (SafAS)|Overall Study||76|All participants who received study vaccine, analyzed according to vaccine actually received.|
48744665|NCT02587520|102161746|FG009|Safety Analysis Set (SafAS)|Overall Study||76|All participants who received study vaccine, analyzed according to vaccine actually received.|
48621529|NCT01149655|101856556|FG000|COMPLETED|Period 3-DB Maintenance Phase||0||
48621530|NCT01149655|101856557|FG001|COMPLETED|Period 3-DB Maintenance Phase||0||
48621531|NCT01149655|101856558|FG002|COMPLETED|Period 3-DB Maintenance Phase||15||
48621532|NCT01149655|101856559|FG003|COMPLETED|Period 3-DB Maintenance Phase||6||
48621533|NCT01149655|101856556|FG000|NOT COMPLETED|Period 3-DB Maintenance Phase||0||
48621534|NCT01149655|101856557|FG001|NOT COMPLETED|Period 3-DB Maintenance Phase||0||
48621535|NCT01149655|101856558|FG002|NOT COMPLETED|Period 3-DB Maintenance Phase||83||
48621536|NCT01149655|101856559|FG003|NOT COMPLETED|Period 3-DB Maintenance Phase||42||
48621537|NCT01610037|101856560|FG000|STARTED|All Patients||407||
48621538|NCT01610037|101856561|FG001|STARTED|All Patients||405||
48621539|NCT01610037|101856562|FG002|STARTED|All Patients||404||
48621540|NCT01610037|101856560|FG000|Randomized Set (RAN)|All Patients||407||
48621541|NCT01610037|101856561|FG001|Randomized Set (RAN)|All Patients||405||
48621542|NCT01610037|101856562|FG002|Randomized Set (RAN)|All Patients||404||
48621543|NCT01610037|101856560|FG000|Full Analysis Set (FAS)|All Patients||407||
48621544|NCT01610037|101856561|FG001|Full Analysis Set (FAS)|All Patients||405||
48744666|NCT02587520|102161747|FG010|Safety Analysis Set (SafAS)|Overall Study||76|All participants who received study vaccine, analyzed according to vaccine actually received.|
48767640|NCT01929317|102222785|FG000|COMPLETED|Long-term Phase||25||
48327900|NCT02104583|101128453|FG002|COMPLETED|Overall Study||54||
48327901|NCT02104583|101128454|FG003|COMPLETED|Overall Study||57||
48327902|NCT02104583|101128455|FG004|COMPLETED|Overall Study||63||
48621545|NCT01610037|101856562|FG002|Full Analysis Set (FAS)|All Patients||403||
48621546|NCT01610037|101856560|FG000|COMPLETED|All Patients||348||
48327903|NCT02104583|101128451|FG000|NOT COMPLETED|Overall Study||18||
48327904|NCT02104583|101128452|FG001|NOT COMPLETED|Overall Study||11||
48621547|NCT01610037|101856561|FG001|COMPLETED|All Patients||354||
48621548|NCT01610037|101856562|FG002|COMPLETED|All Patients||320||
48621549|NCT01610037|101856560|FG000|NOT COMPLETED|All Patients||59||
48165215|NCT02798211|100728483|FG005|NOT COMPLETED|Period 2||6||
48165216|NCT02508532|100728484|FG000|STARTED|Part 1 - Dose Determining Period||6||
48165217|NCT02508532|100728485|FG001|STARTED|Part 1 - Dose Determining Period||6||
48165218|NCT02508532|100728486|FG002|STARTED|Part 1 - Dose Determining Period||6||
48165219|NCT02508532|100728487|FG003|STARTED|Part 1 - Dose Determining Period||6||
48165220|NCT02508532|100728488|FG004|STARTED|Part 1 - Dose Determining Period||6||
48165221|NCT02508532|100728489|FG005|STARTED|Part 1 - Dose Determining Period||6||
48165222|NCT02508532|100728490|FG006|STARTED|Part 1 - Dose Determining Period||7||
48165223|NCT02508532|100728491|FG007|STARTED|Part 1 - Dose Determining Period||3||
48165224|NCT02508532|100728492|FG008|STARTED|Part 1 - Dose Determining Period||0||
48165225|NCT02508532|100728484|FG000|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0||
48165226|NCT02508532|100728485|FG001|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0||
48165227|NCT02508532|100728486|FG002|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0||
48165228|NCT02508532|100728487|FG003|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0||
48165229|NCT02508532|100728488|FG004|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0||
48165230|NCT02508532|100728489|FG005|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||6||
48165231|NCT02508532|100728490|FG006|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||7||
48165232|NCT02508532|100728491|FG007|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0||
48165233|NCT02508532|100728492|FG008|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0||
48165234|NCT02508532|100728484|FG000|COMPLETED|Part 1 - Dose Determining Period||6||
48165235|NCT02508532|100728485|FG001|COMPLETED|Part 1 - Dose Determining Period||6||
48165236|NCT02508532|100728486|FG002|COMPLETED|Part 1 - Dose Determining Period||6||
48165237|NCT02508532|100728487|FG003|COMPLETED|Part 1 - Dose Determining Period||6||
48165238|NCT02508532|100728488|FG004|COMPLETED|Part 1 - Dose Determining Period||6||
48165239|NCT02508532|100728489|FG005|COMPLETED|Part 1 - Dose Determining Period||6||
48165240|NCT02508532|100728490|FG006|COMPLETED|Part 1 - Dose Determining Period||6||
48165241|NCT02508532|100728491|FG007|COMPLETED|Part 1 - Dose Determining Period||2||
48165242|NCT02508532|100728492|FG008|COMPLETED|Part 1 - Dose Determining Period||0||
48165243|NCT02508532|100728484|FG000|NOT COMPLETED|Part 1 - Dose Determining Period||0||
48165244|NCT02508532|100728485|FG001|NOT COMPLETED|Part 1 - Dose Determining Period||0||
48165245|NCT02508532|100728486|FG002|NOT COMPLETED|Part 1 - Dose Determining Period||0||
48165246|NCT02508532|100728487|FG003|NOT COMPLETED|Part 1 - Dose Determining Period||0||
48165247|NCT02508532|100728488|FG004|NOT COMPLETED|Part 1 - Dose Determining Period||0||
48165248|NCT02508532|100728489|FG005|NOT COMPLETED|Part 1 - Dose Determining Period||0||
48165249|NCT02508532|100728490|FG006|NOT COMPLETED|Part 1 - Dose Determining Period||1||
48165250|NCT02508532|100728491|FG007|NOT COMPLETED|Part 1 - Dose Determining Period||1||
48165251|NCT02508532|100728492|FG008|NOT COMPLETED|Part 1 - Dose Determining Period||0||
48165252|NCT02508532|100728484|FG000|STARTED|Part 2 - Treatment||0||
48165253|NCT02508532|100728485|FG001|STARTED|Part 2 - Treatment||0||
48165254|NCT02508532|100728486|FG002|STARTED|Part 2 - Treatment||0||
48165255|NCT02508532|100728487|FG003|STARTED|Part 2 - Treatment||0||
48165256|NCT02508532|100728488|FG004|STARTED|Part 2 - Treatment||0||
48165257|NCT02508532|100728489|FG005|STARTED|Part 2 - Treatment||0||
48165258|NCT02508532|100728490|FG006|STARTED|Part 2 - Treatment||0||
48165259|NCT02508532|100728491|FG007|STARTED|Part 2 - Treatment||0||
48165260|NCT02508532|100728492|FG008|STARTED|Part 2 - Treatment||217||
48165261|NCT02508532|100728484|FG000|COMPLETED|Part 2 - Treatment||0||
48165262|NCT02508532|100728485|FG001|COMPLETED|Part 2 - Treatment||0||
48165263|NCT02508532|100728486|FG002|COMPLETED|Part 2 - Treatment||0||
48165264|NCT02508532|100728487|FG003|COMPLETED|Part 2 - Treatment||0||
48165265|NCT02508532|100728488|FG004|COMPLETED|Part 2 - Treatment||0||
48165266|NCT02508532|100728489|FG005|COMPLETED|Part 2 - Treatment||0||
48165267|NCT02508532|100728490|FG006|COMPLETED|Part 2 - Treatment||0||
48165268|NCT02508532|100728491|FG007|COMPLETED|Part 2 - Treatment||0||
48744667|NCT02587520|102161748|FG011|Safety Analysis Set (SafAS)|Overall Study||72|All participants who received study vaccine, analyzed according to vaccine actually received.|
48165269|NCT02508532|100728492|FG008|COMPLETED|Part 2 - Treatment||0||
48165270|NCT02508532|100728484|FG000|NOT COMPLETED|Part 2 - Treatment||0||
48165271|NCT02508532|100728485|FG001|NOT COMPLETED|Part 2 - Treatment||0||
48165272|NCT02508532|100728486|FG002|NOT COMPLETED|Part 2 - Treatment||0||
48165273|NCT02508532|100728487|FG003|NOT COMPLETED|Part 2 - Treatment||0||
48165274|NCT02508532|100728488|FG004|NOT COMPLETED|Part 2 - Treatment||0||
48165275|NCT02508532|100728489|FG005|NOT COMPLETED|Part 2 - Treatment||0||
48165276|NCT02508532|100728490|FG006|NOT COMPLETED|Part 2 - Treatment||0||
48165277|NCT02508532|100728491|FG007|NOT COMPLETED|Part 2 - Treatment||0||
48165278|NCT02508532|100728492|FG008|NOT COMPLETED|Part 2 - Treatment||217||
48165279|NCT02508532|100728484|FG000|STARTED|Part 1 and Part 2 End of Study||6||
48165280|NCT02508532|100728485|FG001|STARTED|Part 1 and Part 2 End of Study||6||
48165281|NCT02508532|100728486|FG002|STARTED|Part 1 and Part 2 End of Study||6||
48165282|NCT02508532|100728487|FG003|STARTED|Part 1 and Part 2 End of Study||6||
48744668|NCT02587520|102161749|FG012|Safety Analysis Set (SafAS)|Overall Study||77|All participants who received study vaccine, analyzed according to vaccine actually received.|
48165283|NCT02508532|100728488|FG004|STARTED|Part 1 and Part 2 End of Study||6||
48165284|NCT02508532|100728489|FG005|STARTED|Part 1 and Part 2 End of Study||0||
48165285|NCT02508532|100728490|FG006|STARTED|Part 1 and Part 2 End of Study||0||
48165286|NCT02508532|100728491|FG007|STARTED|Part 1 and Part 2 End of Study||3||
48165287|NCT02508532|100728492|FG008|STARTED|Part 1 and Part 2 End of Study||217||
48165288|NCT02508532|100728484|FG000|COMPLETED|Part 1 and Part 2 End of Study||0||
48165289|NCT02508532|100728485|FG001|COMPLETED|Part 1 and Part 2 End of Study||0||
48165290|NCT02508532|100728486|FG002|COMPLETED|Part 1 and Part 2 End of Study||0||
48165291|NCT02508532|100728487|FG003|COMPLETED|Part 1 and Part 2 End of Study||0||
48165292|NCT02508532|100728488|FG004|COMPLETED|Part 1 and Part 2 End of Study||0||
48165293|NCT02508532|100728489|FG005|COMPLETED|Part 1 and Part 2 End of Study||0||
48165294|NCT02508532|100728490|FG006|COMPLETED|Part 1 and Part 2 End of Study||0||
48165295|NCT02508532|100728491|FG007|COMPLETED|Part 1 and Part 2 End of Study||0||
48165296|NCT02508532|100728492|FG008|COMPLETED|Part 1 and Part 2 End of Study||0||
48165297|NCT02508532|100728484|FG000|NOT COMPLETED|Part 1 and Part 2 End of Study||6||
48165298|NCT02508532|100728485|FG001|NOT COMPLETED|Part 1 and Part 2 End of Study||6||
48165299|NCT02508532|100728486|FG002|NOT COMPLETED|Part 1 and Part 2 End of Study||6||
48165300|NCT02508532|100728487|FG003|NOT COMPLETED|Part 1 and Part 2 End of Study||6||
48165301|NCT02508532|100728488|FG004|NOT COMPLETED|Part 1 and Part 2 End of Study||6||
48165302|NCT02508532|100728489|FG005|NOT COMPLETED|Part 1 and Part 2 End of Study||0||
48165303|NCT02508532|100728490|FG006|NOT COMPLETED|Part 1 and Part 2 End of Study||0||
48165304|NCT02508532|100728491|FG007|NOT COMPLETED|Part 1 and Part 2 End of Study||3||
48165305|NCT02508532|100728492|FG008|NOT COMPLETED|Part 1 and Part 2 End of Study||217||
48165306|NCT02460263|100728493|FG000|STARTED|In-Center Period||30||
48165307|NCT02460263|100728493|FG000|COMPLETED|In-Center Period||30||
48165308|NCT02460263|100728493|FG000|NOT COMPLETED|In-Center Period||0||
48165309|NCT02460263|100728493|FG000|STARTED|Transition Period||30||
48165310|NCT02460263|100728493|FG000|COMPLETED|Transition Period||28||
48165311|NCT02460263|100728493|FG000|NOT COMPLETED|Transition Period||2||
48165312|NCT02460263|100728493|FG000|STARTED|In-Home Period||28||
48165313|NCT02460263|100728493|FG000|COMPLETED|In-Home Period||28||
48165314|NCT02460263|100728493|FG000|NOT COMPLETED|In-Home Period||0||
48165315|NCT01215357|100728494|FG000|STARTED|Overall Study||34||
48165316|NCT01215357|100728494|FG000|COMPLETED|Overall Study||22||
48165317|NCT01215357|100728494|FG000|NOT COMPLETED|Overall Study||12||
48165318|NCT04887948|100728495|FG000|STARTED|Overall Study||190||
48165319|NCT04887948|100728496|FG001|STARTED|Overall Study||191||
48165320|NCT04887948|100728497|FG002|STARTED|Overall Study||189||
48165321|NCT04887948|100728495|FG000|Vaccinated|Overall Study||187||
48165322|NCT04887948|100728496|FG001|Vaccinated|Overall Study||187||
48165323|NCT04887948|100728497|FG002|Vaccinated|Overall Study||185||
48165324|NCT04887948|100728495|FG000|COMPLETED|Overall Study||184||
48165325|NCT04887948|100728496|FG001|COMPLETED|Overall Study||177||
48165326|NCT04887948|100728497|FG002|COMPLETED|Overall Study||182||
48165327|NCT04887948|100728495|FG000|NOT COMPLETED|Overall Study||6||
48165328|NCT04887948|100728496|FG001|NOT COMPLETED|Overall Study||14||
48165329|NCT04887948|100728497|FG002|NOT COMPLETED|Overall Study||7||
48165330|NCT02254408|100728498|FG000|STARTED|Overall Study||96||
48165331|NCT02254408|100728499|FG001|STARTED|Overall Study||93||
48165332|NCT02254408|100728498|FG000|COMPLETED|Overall Study||88||
48165333|NCT02254408|100728499|FG001|COMPLETED|Overall Study||83||
48165334|NCT02254408|100728498|FG000|NOT COMPLETED|Overall Study||8||
48165335|NCT02254408|100728499|FG001|NOT COMPLETED|Overall Study||10||
48165336|NCT01964521|100728500|FG000|STARTED|Overall Study||24||
48165337|NCT01964521|100728500|FG000|COMPLETED|Overall Study||20||
48165338|NCT01964521|100728500|FG000|NOT COMPLETED|Overall Study||4||
48744669|NCT02587520|102161750|FG013|Safety Analysis Set (SafAS)|Overall Study||73|All participants who received study vaccine, analyzed according to vaccine actually received.|
48744670|NCT02587520|102161751|FG014|Safety Analysis Set (SafAS)|Overall Study||78|All participants who received study vaccine, analyzed according to vaccine actually received.|
48767641|NCT01929317|102222786|FG001|COMPLETED|Long-term Phase||14||
48165339|NCT01316341|100728501|FG000|STARTED|Overall Study||6||
48165340|NCT01316341|100728502|FG001|STARTED|Overall Study||9||
48165341|NCT01316341|100728503|FG002|STARTED|Overall Study||9||
48165342|NCT01316341|100728501|FG000|COMPLETED|Overall Study||6||
48165343|NCT01316341|100728502|FG001|COMPLETED|Overall Study||9||
48165344|NCT01316341|100728503|FG002|COMPLETED|Overall Study||9||
48165345|NCT01316341|100728501|FG000|NOT COMPLETED|Overall Study||0||
48165346|NCT01316341|100728502|FG001|NOT COMPLETED|Overall Study||0||
48165347|NCT01316341|100728503|FG002|NOT COMPLETED|Overall Study||0||
48165348|NCT01975220|100728504|FG000|STARTED|Test Period 1||12||
48165349|NCT01975220|100728505|FG001|STARTED|Test Period 1||12||
48165350|NCT01975220|100728506|FG002|STARTED|Test Period 1||12||
48165351|NCT01975220|100728507|FG003|STARTED|Test Period 1||12||
48165352|NCT01975220|100728508|FG004|STARTED|Test Period 1||12||
48165353|NCT01975220|100728509|FG005|STARTED|Test Period 1||12||
48165354|NCT01975220|100728504|FG000|COMPLETED|Test Period 1||12||
48165355|NCT01975220|100728505|FG001|COMPLETED|Test Period 1||11||
48165356|NCT01975220|100728506|FG002|COMPLETED|Test Period 1||12||
48165357|NCT01975220|100728507|FG003|COMPLETED|Test Period 1||12||
48165358|NCT01975220|100728508|FG004|COMPLETED|Test Period 1||12||
48165359|NCT01975220|100728509|FG005|COMPLETED|Test Period 1||12||
48165360|NCT01975220|100728504|FG000|NOT COMPLETED|Test Period 1||0||
48165361|NCT01975220|100728505|FG001|NOT COMPLETED|Test Period 1||1||
48744671|NCT02587520|102161752|FG015|Safety Analysis Set (SafAS)|Overall Study||72|All participants who received study vaccine, analyzed according to vaccine actually received.|
48744672|NCT02587520|102161753|FG016|Safety Analysis Set (SafAS)|Overall Study||76|All participants who received study vaccine, analyzed according to vaccine actually received.|
48744673|NCT02587520|102161754|FG017|Safety Analysis Set (SafAS)|Overall Study||78|All participants who received study vaccine, analyzed according to vaccine actually received.|
48744674|NCT02587520|102161737|FG000|COMPLETED|Overall Study||78||
48744675|NCT02587520|102161738|FG001|COMPLETED|Overall Study||69||
48744676|NCT02587520|102161739|FG002|COMPLETED|Overall Study||77||
48165362|NCT01975220|100728506|FG002|NOT COMPLETED|Test Period 1||0||
48165363|NCT01975220|100728507|FG003|NOT COMPLETED|Test Period 1||0||
48165364|NCT01975220|100728508|FG004|NOT COMPLETED|Test Period 1||0||
48165365|NCT01975220|100728509|FG005|NOT COMPLETED|Test Period 1||0||
48165366|NCT01975220|100728504|FG000|STARTED|Test Period 2||12||
48165367|NCT01975220|100728505|FG001|STARTED|Test Period 2||11||
48165368|NCT01975220|100728506|FG002|STARTED|Test Period 2||12||
48165369|NCT01975220|100728507|FG003|STARTED|Test Period 2||12||
48165370|NCT01975220|100728508|FG004|STARTED|Test Period 2||12||
48165371|NCT01975220|100728509|FG005|STARTED|Test Period 2||12||
48165372|NCT01975220|100728504|FG000|COMPLETED|Test Period 2||12||
48165373|NCT01975220|100728505|FG001|COMPLETED|Test Period 2||11||
48165374|NCT01975220|100728506|FG002|COMPLETED|Test Period 2||12||
48165375|NCT01975220|100728507|FG003|COMPLETED|Test Period 2||12||
48165376|NCT01975220|100728508|FG004|COMPLETED|Test Period 2||12||
48165377|NCT01975220|100728509|FG005|COMPLETED|Test Period 2||12||
48165378|NCT01975220|100728504|FG000|NOT COMPLETED|Test Period 2||0||
48165379|NCT01975220|100728505|FG001|NOT COMPLETED|Test Period 2||0||
48165380|NCT01975220|100728506|FG002|NOT COMPLETED|Test Period 2||0||
48165381|NCT01975220|100728507|FG003|NOT COMPLETED|Test Period 2||0||
48165382|NCT01975220|100728508|FG004|NOT COMPLETED|Test Period 2||0||
48165383|NCT01975220|100728509|FG005|NOT COMPLETED|Test Period 2||0||
48327905|NCT02104583|101128453|FG002|NOT COMPLETED|Overall Study||16||
48327906|NCT02104583|101128454|FG003|NOT COMPLETED|Overall Study||17||
48327907|NCT02104583|101128455|FG004|NOT COMPLETED|Overall Study||12||
48327908|NCT03042715|101128456|FG000|STARTED|Overall Study||6||
48327909|NCT03042715|101128456|FG000|COMPLETED|Overall Study||5||
48327910|NCT03042715|101128456|FG000|NOT COMPLETED|Overall Study||1||
48327911|NCT01784965|101128457|FG000|STARTED|Overall Study||33||
48327912|NCT01784965|101128458|FG001|STARTED|Overall Study||35||
48327913|NCT01784965|101128457|FG000|COMPLETED|Overall Study||27||
48165384|NCT02213328|100728510|FG000|STARTED|Overall Study||148||
48165385|NCT02213328|100728510|FG000|COMPLETED|Overall Study||120||
48165386|NCT02213328|100728510|FG000|NOT COMPLETED|Overall Study||28||
48165387|NCT03104647|100728511|FG000|STARTED|Overall Study||20||
48165388|NCT03104647|100728511|FG000|COMPLETED|Overall Study||20||
48165389|NCT03104647|100728511|FG000|NOT COMPLETED|Overall Study||0||
48165390|NCT02918500|100728512|FG000|STARTED|Overall Study||2||
48165391|NCT02918500|100728513|FG001|STARTED|Overall Study||2||
48165392|NCT02918500|100728512|FG000|COMPLETED|Overall Study||2||
48165393|NCT02918500|100728513|FG001|COMPLETED|Overall Study||2||
48165394|NCT02918500|100728512|FG000|NOT COMPLETED|Overall Study||0||
48165395|NCT02918500|100728513|FG001|NOT COMPLETED|Overall Study||0||
48165396|NCT00876460|100728514|FG000|STARTED|Combination Therapy Phase||3||
48165397|NCT00876460|100728515|FG001|STARTED|Combination Therapy Phase||7||
48165398|NCT00876460|100728516|FG002|STARTED|Combination Therapy Phase||3||
48165399|NCT00876460|100728517|FG003|STARTED|Combination Therapy Phase||6||
48165400|NCT00876460|100728518|FG004|STARTED|Combination Therapy Phase||7||
48165401|NCT00876460|100728519|FG005|STARTED|Combination Therapy Phase||3||
48165402|NCT00876460|100728520|FG006|STARTED|Combination Therapy Phase||8||
48165403|NCT00876460|100728521|FG007|STARTED|Combination Therapy Phase||6||
48165404|NCT00876460|100728514|FG000|COMPLETED|Combination Therapy Phase||0||
48165405|NCT00876460|100728515|FG001|COMPLETED|Combination Therapy Phase||0||
48327914|NCT01784965|101128458|FG001|COMPLETED|Overall Study||24||
48327915|NCT01784965|101128457|FG000|NOT COMPLETED|Overall Study||6||
48327916|NCT01784965|101128458|FG001|NOT COMPLETED|Overall Study||11||
48327917|NCT00857727|101128459|FG000|STARTED|Overall Study||14||
48744677|NCT02587520|102161740|FG003|COMPLETED|Overall Study||74||
48744678|NCT02587520|102161741|FG004|COMPLETED|Overall Study||75||
48165406|NCT00876460|100728516|FG002|COMPLETED|Combination Therapy Phase||0||
48165407|NCT00876460|100728517|FG003|COMPLETED|Combination Therapy Phase||0||
48165408|NCT00876460|100728518|FG004|COMPLETED|Combination Therapy Phase||0||
48327918|NCT00857727|101128460|FG001|STARTED|Overall Study||14||
48327919|NCT00857727|101128459|FG000|COMPLETED|Overall Study||14||
48327920|NCT00857727|101128460|FG001|COMPLETED|Overall Study||14||
48327921|NCT00857727|101128459|FG000|NOT COMPLETED|Overall Study||0||
48327922|NCT00857727|101128460|FG001|NOT COMPLETED|Overall Study||0||
48327923|NCT00412750|101128461|FG000|STARTED|Overall Study||50||
48327924|NCT00412750|101128462|FG001|STARTED|Overall Study||55||
48327925|NCT00412750|101128463|FG002|STARTED|Overall Study||54||
48327926|NCT00412750|101128461|FG000|COMPLETED|Overall Study||19||
48327927|NCT00412750|101128462|FG001|COMPLETED|Overall Study||34||
48327928|NCT00412750|101128463|FG002|COMPLETED|Overall Study||31||
48327929|NCT00412750|101128461|FG000|NOT COMPLETED|Overall Study||31||
48327930|NCT00412750|101128462|FG001|NOT COMPLETED|Overall Study||21||
48327931|NCT00412750|101128463|FG002|NOT COMPLETED|Overall Study||23||
48327932|NCT01659320|101128464|FG000|STARTED|Overall Study||16||
48327933|NCT01659320|101128464|FG000|COMPLETED|Overall Study||13||
48327934|NCT01659320|101128464|FG000|NOT COMPLETED|Overall Study||3||
48327935|NCT01148537|101128465|FG000|STARTED|Overall Study||44||
48327936|NCT01148537|101128466|FG001|STARTED|Overall Study||44||
48327937|NCT01148537|101128467|FG002|STARTED|Overall Study||44||
48327938|NCT01148537|101128465|FG000|COMPLETED|Overall Study||41||
48327939|NCT01148537|101128466|FG001|COMPLETED|Overall Study||44||
48327940|NCT01148537|101128467|FG002|COMPLETED|Overall Study||41||
48327941|NCT01148537|101128465|FG000|NOT COMPLETED|Overall Study||3||
48327942|NCT01148537|101128466|FG001|NOT COMPLETED|Overall Study||0||
48327943|NCT01148537|101128467|FG002|NOT COMPLETED|Overall Study||3||
48327944|NCT00452699|101128468|FG000|STARTED|Overall Study||306||
48327945|NCT00452699|101128469|FG001|STARTED|Overall Study||315||
48327946|NCT00452699|101128468|FG000|COMPLETED|Overall Study||225||
48327947|NCT00452699|101128469|FG001|COMPLETED|Overall Study||242||
48327948|NCT00452699|101128468|FG000|NOT COMPLETED|Overall Study||81||
48327949|NCT00452699|101128469|FG001|NOT COMPLETED|Overall Study||73||
48327950|NCT00106171|101128470|FG000|STARTED|Overall Study||57||
48327951|NCT00106171|101128471|FG001|STARTED|Overall Study||56||
48327952|NCT00106171|101128470|FG000|COMPLETED|Overall Study||37||
48327953|NCT00106171|101128471|FG001|COMPLETED|Overall Study||46||
48327954|NCT00106171|101128470|FG000|NOT COMPLETED|Overall Study||20||
48327955|NCT00106171|101128471|FG001|NOT COMPLETED|Overall Study||10||
48327956|NCT01870401|101128472|FG000|STARTED|Overall Study||287||
48327957|NCT01870401|101128473|FG001|STARTED|Overall Study||155||
48327958|NCT01870401|101128472|FG000|COMPLETED|Overall Study||137||
48327959|NCT01870401|101128473|FG001|COMPLETED|Overall Study||59||
48327960|NCT01870401|101128472|FG000|NOT COMPLETED|Overall Study||150||
48327961|NCT01870401|101128473|FG001|NOT COMPLETED|Overall Study||96||
48327962|NCT02500628|101128474|FG000|STARTED|Overall Study||38||
48327963|NCT02500628|101128475|FG001|STARTED|Overall Study||23||
48327964|NCT02500628|101128474|FG000|COMPLETED|Overall Study||38||
48327965|NCT02500628|101128475|FG001|COMPLETED|Overall Study||23||
48327966|NCT02500628|101128474|FG000|NOT COMPLETED|Overall Study||0||
48327967|NCT02500628|101128475|FG001|NOT COMPLETED|Overall Study||0||
48327968|NCT05396742|101128476|FG000|STARTED|Overall Study||7||
48327969|NCT05396742|101128477|FG001|STARTED|Overall Study||12||
48327970|NCT05396742|101128478|FG002|STARTED|Overall Study||12||
48327971|NCT05396742|101128479|FG003|STARTED|Overall Study||12||
48327972|NCT05396742|101128480|FG004|STARTED|Overall Study||6||
48327973|NCT05396742|101128476|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7||
48327974|NCT05396742|101128477|FG001|Received at Least 1 Dose of Study Drug|Overall Study||12||
48327975|NCT05396742|101128478|FG002|Received at Least 1 Dose of Study Drug|Overall Study||12||
48327976|NCT05396742|101128479|FG003|Received at Least 1 Dose of Study Drug|Overall Study||12||
48327977|NCT05396742|101128480|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6||
48327978|NCT05396742|101128476|FG000|COMPLETED|Overall Study||7||
48327979|NCT05396742|101128477|FG001|COMPLETED|Overall Study||12||
48327980|NCT05396742|101128478|FG002|COMPLETED|Overall Study||12||
48327981|NCT05396742|101128479|FG003|COMPLETED|Overall Study||12||
48327982|NCT05396742|101128480|FG004|COMPLETED|Overall Study||6||
48327983|NCT05396742|101128476|FG000|NOT COMPLETED|Overall Study||0||
48327984|NCT05396742|101128477|FG001|NOT COMPLETED|Overall Study||0||
48327985|NCT05396742|101128478|FG002|NOT COMPLETED|Overall Study||0||
48327986|NCT05396742|101128479|FG003|NOT COMPLETED|Overall Study||0||
48327987|NCT05396742|101128480|FG004|NOT COMPLETED|Overall Study||0||
48327988|NCT02952222|101128481|FG000|STARTED|Overall Study||19||
48327989|NCT02952222|101128482|FG001|STARTED|Overall Study||20||
48327990|NCT02952222|101128481|FG000|COMPLETED|Overall Study||16||
48327991|NCT02952222|101128482|FG001|COMPLETED|Overall Study||19||
48327992|NCT02952222|101128481|FG000|NOT COMPLETED|Overall Study||3||
48327993|NCT02952222|101128482|FG001|NOT COMPLETED|Overall Study||1||
48327994|NCT00517595|101128483|FG000|STARTED|Overall Study||48||
48327995|NCT00517595|101128483|FG000|COMPLETED|Overall Study||48||
48327996|NCT00517595|101128483|FG000|NOT COMPLETED|Overall Study||0||
48327997|NCT01453855|101128484|FG000|STARTED|Overall Study||442||
48327998|NCT01453855|101128485|FG001|STARTED|Overall Study||422||
48327999|NCT01453855|101128484|FG000|COMPLETED|Overall Study||432||
48328000|NCT01453855|101128485|FG001|COMPLETED|Overall Study||408||
48409880|NCT05333289|101334814|FG006|STARTED|Overall Study||72||
48409881|NCT05333289|101334815|FG007|STARTED|Overall Study||71||
48409882|NCT05333289|101334808|FG000|Received at Least 1 Dose of Investigational Product|Overall Study||71||
48409883|NCT05333289|101334809|FG001|Received at Least 1 Dose of Investigational Product|Overall Study||71||
48409884|NCT05333289|101334810|FG002|Received at Least 1 Dose of Investigational Product|Overall Study||71||
48409885|NCT05333289|101334811|FG003|Received at Least 1 Dose of Investigational Product|Overall Study||71||
48409886|NCT05333289|101334812|FG004|Received at Least 1 Dose of Investigational Product|Overall Study||72||
48409887|NCT05333289|101334813|FG005|Received at Least 1 Dose of Investigational Product|Overall Study||67||
48409888|NCT05333289|101334814|FG006|Received at Least 1 Dose of Investigational Product|Overall Study||72||
48409889|NCT05333289|101334815|FG007|Received at Least 1 Dose of Investigational Product|Overall Study||70||
48409890|NCT05333289|101334808|FG000|Safety Set|Overall Study||71|The Safety Set consisted of all randomly assigned participants who received the investigational product.|
48328001|NCT01453855|101128484|FG000|NOT COMPLETED|Overall Study||10||
48328002|NCT01453855|101128485|FG001|NOT COMPLETED|Overall Study||14||
48328003|NCT03110900|101128486|FG000|STARTED|Overall Study||1||
48328004|NCT03110900|101128487|FG001|STARTED|Overall Study||1||
48328005|NCT03110900|101128486|FG000|COMPLETED|Overall Study||0||
48328006|NCT03110900|101128487|FG001|COMPLETED|Overall Study||0||
48328007|NCT03110900|101128486|FG000|NOT COMPLETED|Overall Study||1||
48328008|NCT03110900|101128487|FG001|NOT COMPLETED|Overall Study||1||
48328009|NCT01054742|101128488|FG000|STARTED|Overall Study||2||
48328010|NCT01054742|101128488|FG000|COMPLETED|Overall Study||2||
48409891|NCT05333289|101334809|FG001|Safety Set|Overall Study||71|The Safety Set consisted of all randomly assigned participants who received the investigational product.|
48328011|NCT01054742|101128488|FG000|NOT COMPLETED|Overall Study||0||
48328012|NCT00623480|101128489|FG000|STARTED|Overall Study||42||
48328013|NCT00623480|101128490|FG001|STARTED|Overall Study||42||
48328014|NCT00623480|101128489|FG000|COMPLETED|Overall Study||35||
48328015|NCT00623480|101128490|FG001|COMPLETED|Overall Study||35||
48328016|NCT00623480|101128489|FG000|NOT COMPLETED|Overall Study||7||
48328017|NCT00623480|101128490|FG001|NOT COMPLETED|Overall Study||7||
48328018|NCT03048422|101128491|FG000|STARTED|Overall Study||217||
48328019|NCT03048422|101128492|FG001|STARTED|Overall Study||215||
48328020|NCT03048422|101128493|FG002|STARTED|Overall Study||211||
48328021|NCT03048422|101128491|FG000|COMPLETED|Overall Study||200||
48328022|NCT03048422|101128492|FG001|COMPLETED|Overall Study||205||
48328023|NCT03048422|101128493|FG002|COMPLETED|Overall Study||202||
48328024|NCT03048422|101128491|FG000|NOT COMPLETED|Overall Study||17||
48328025|NCT03048422|101128492|FG001|NOT COMPLETED|Overall Study||10||
48328026|NCT03048422|101128493|FG002|NOT COMPLETED|Overall Study||9||
48328027|NCT02164981|101128494|FG000|STARTED|Started||23||
48328028|NCT02164981|101128495|FG001|STARTED|Started||19||
48328029|NCT02164981|101128496|FG002|STARTED|Started||18||
48328030|NCT02164981|101128494|FG000|COMPLETED|Started||18|These subjects moved onto the Phase 1|
48328031|NCT02164981|101128495|FG001|COMPLETED|Started||16|These subjects moved onto the Phase 1|
48328032|NCT02164981|101128496|FG002|COMPLETED|Started||18|These subjects moved onto the Phase 1|
48328033|NCT02164981|101128494|FG000|NOT COMPLETED|Started||5||
48328034|NCT02164981|101128495|FG001|NOT COMPLETED|Started||3||
48328035|NCT02164981|101128496|FG002|NOT COMPLETED|Started||0||
48328036|NCT02164981|101128494|FG000|STARTED|Phase 1 (Day 0 - Day 14)||18||
48328037|NCT02164981|101128495|FG001|STARTED|Phase 1 (Day 0 - Day 14)||16||
48328038|NCT02164981|101128496|FG002|STARTED|Phase 1 (Day 0 - Day 14)||18||
48328039|NCT02164981|101128494|FG000|COMPLETED|Phase 1 (Day 0 - Day 14)||18||
48328040|NCT02164981|101128495|FG001|COMPLETED|Phase 1 (Day 0 - Day 14)||14||
48328041|NCT02164981|101128496|FG002|COMPLETED|Phase 1 (Day 0 - Day 14)||18||
48328042|NCT02164981|101128494|FG000|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||0||
48328043|NCT02164981|101128495|FG001|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||2||
48744679|NCT02587520|102161742|FG005|COMPLETED|Overall Study||72||
48744680|NCT02587520|102161743|FG006|COMPLETED|Overall Study||73||
48744681|NCT02587520|102161744|FG007|COMPLETED|Overall Study||71||
48744682|NCT02587520|102161745|FG008|COMPLETED|Overall Study||73||
48744683|NCT02587520|102161746|FG009|COMPLETED|Overall Study||71||
48744684|NCT02587520|102161747|FG010|COMPLETED|Overall Study||73||
48744685|NCT02587520|102161748|FG011|COMPLETED|Overall Study||69||
48744686|NCT02587520|102161749|FG012|COMPLETED|Overall Study||77||
48744687|NCT02587520|102161750|FG013|COMPLETED|Overall Study||73||
48744688|NCT02587520|102161751|FG014|COMPLETED|Overall Study||78||
48744689|NCT02587520|102161752|FG015|COMPLETED|Overall Study||72||
48744690|NCT02587520|102161753|FG016|COMPLETED|Overall Study||76||
48744691|NCT02587520|102161754|FG017|COMPLETED|Overall Study||78||
48328044|NCT02164981|101128496|FG002|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||0||
48328045|NCT02164981|101128494|FG000|STARTED|Phase 2 (Day 14 - Day 28)||18||
48328046|NCT02164981|101128495|FG001|STARTED|Phase 2 (Day 14 - Day 28)||14||
48328047|NCT02164981|101128496|FG002|STARTED|Phase 2 (Day 14 - Day 28)||18||
48744692|NCT02587520|102161737|FG000|NOT COMPLETED|Overall Study||2||
48744693|NCT02587520|102161738|FG001|NOT COMPLETED|Overall Study||2||
48328048|NCT02164981|101128494|FG000|COMPLETED|Phase 2 (Day 14 - Day 28)||16||
48328049|NCT02164981|101128495|FG001|COMPLETED|Phase 2 (Day 14 - Day 28)||12||
48328050|NCT02164981|101128496|FG002|COMPLETED|Phase 2 (Day 14 - Day 28)||18||
48328051|NCT02164981|101128494|FG000|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||2||
48328052|NCT02164981|101128495|FG001|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||2||
48328053|NCT02164981|101128496|FG002|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||0||
48328054|NCT04029519|101128497|FG000|STARTED|Overall Study||84||
48744694|NCT02587520|102161739|FG002|NOT COMPLETED|Overall Study||1||
48744695|NCT02587520|102161740|FG003|NOT COMPLETED|Overall Study||5||
48744696|NCT02587520|102161741|FG004|NOT COMPLETED|Overall Study||0||
48328055|NCT04029519|101128497|FG000|COMPLETED|Overall Study||79||
48328056|NCT04029519|101128497|FG000|NOT COMPLETED|Overall Study||5||
48328057|NCT02542761|101128498|FG000|STARTED|Acclimation Period 1||5||
48328058|NCT02542761|101128499|FG001|STARTED|Acclimation Period 1||5||
48328059|NCT02542761|101128498|FG000|COMPLETED|Acclimation Period 1||5||
48328060|NCT02542761|101128499|FG001|COMPLETED|Acclimation Period 1||5||
48328061|NCT02542761|101128498|FG000|NOT COMPLETED|Acclimation Period 1||0||
48328062|NCT02542761|101128499|FG001|NOT COMPLETED|Acclimation Period 1||0||
48328063|NCT02542761|101128498|FG000|STARTED|First Intervention||5||
48328064|NCT02542761|101128499|FG001|STARTED|First Intervention||5||
48328065|NCT02542761|101128498|FG000|COMPLETED|First Intervention||5||
48328066|NCT02542761|101128499|FG001|COMPLETED|First Intervention||5||
48328067|NCT02542761|101128498|FG000|NOT COMPLETED|First Intervention||0||
48328068|NCT02542761|101128499|FG001|NOT COMPLETED|First Intervention||0||
48328069|NCT02542761|101128498|FG000|STARTED|Acclimation Period 2||5||
48328070|NCT02542761|101128499|FG001|STARTED|Acclimation Period 2||5||
48328071|NCT02542761|101128498|FG000|COMPLETED|Acclimation Period 2||5||
48328072|NCT02542761|101128499|FG001|COMPLETED|Acclimation Period 2||5||
48328073|NCT02542761|101128498|FG000|NOT COMPLETED|Acclimation Period 2||0||
48328074|NCT02542761|101128499|FG001|NOT COMPLETED|Acclimation Period 2||0||
48328075|NCT02542761|101128498|FG000|STARTED|Second Intervention||5||
48328076|NCT02542761|101128499|FG001|STARTED|Second Intervention||5||
48328077|NCT02542761|101128498|FG000|COMPLETED|Second Intervention||5||
48328078|NCT02542761|101128499|FG001|COMPLETED|Second Intervention||5||
48328079|NCT02542761|101128498|FG000|NOT COMPLETED|Second Intervention||0||
48328080|NCT02542761|101128499|FG001|NOT COMPLETED|Second Intervention||0||
48328081|NCT00687362|101128500|FG000|STARTED|Overall Study||22||
48328082|NCT00687362|101128500|FG000|COMPLETED|Overall Study||19||
48328083|NCT00687362|101128500|FG000|NOT COMPLETED|Overall Study||3||
48328084|NCT00488982|101128501|FG000|STARTED|Induction Chemotherapy||125||
48328085|NCT00488982|101128502|FG001|STARTED|Induction Chemotherapy||0||
48328086|NCT00488982|101128503|FG002|STARTED|Induction Chemotherapy||0||
48328087|NCT00488982|101128501|FG000|6 Cycles Completed|Induction Chemotherapy||94||
48328088|NCT00488982|101128502|FG001|6 Cycles Completed|Induction Chemotherapy||0||
48328089|NCT00488982|101128503|FG002|6 Cycles Completed|Induction Chemotherapy||0||
48328090|NCT00488982|101128501|FG000|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||52||
48328091|NCT00488982|101128502|FG001|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||0||
48328092|NCT00488982|101128503|FG002|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||0||
48328093|NCT00488982|101128501|FG000|COMPLETED|Induction Chemotherapy||52||
48328094|NCT00488982|101128502|FG001|COMPLETED|Induction Chemotherapy||0||
48328095|NCT00488982|101128503|FG002|COMPLETED|Induction Chemotherapy||0||
48328096|NCT00488982|101128501|FG000|NOT COMPLETED|Induction Chemotherapy||73||
48328097|NCT00488982|101128502|FG001|NOT COMPLETED|Induction Chemotherapy||0||
48328098|NCT00488982|101128503|FG002|NOT COMPLETED|Induction Chemotherapy||0||
48328099|NCT00488982|101128501|FG000|STARTED|Course 1||0||
48328100|NCT00488982|101128502|FG001|STARTED|Course 1||25||
48328101|NCT00488982|101128503|FG002|STARTED|Course 1||27||
48328102|NCT00488982|101128501|FG000|COMPLETED|Course 1||0||
48328103|NCT00488982|101128502|FG001|COMPLETED|Course 1||13||
48328104|NCT00488982|101128503|FG002|COMPLETED|Course 1||13||
48328105|NCT00488982|101128501|FG000|NOT COMPLETED|Course 1||0||
48328106|NCT00488982|101128502|FG001|NOT COMPLETED|Course 1||12||
48328107|NCT00488982|101128503|FG002|NOT COMPLETED|Course 1||14||
48409892|NCT05333289|101334810|FG002|Safety Set|Overall Study||71|The Safety Set consisted of all randomly assigned participants who received the investigational product.|
48439909|NCT00563706|101409981|FG004|STARTED|Taper Phase (Day 29 up to Day 35)||11||
48328108|NCT00488982|101128501|FG000|STARTED|Course 2||0||
48328109|NCT00488982|101128502|FG001|STARTED|Course 2||13||
48328110|NCT00488982|101128503|FG002|STARTED|Course 2||13||
48328111|NCT00488982|101128501|FG000|COMPLETED|Course 2||0||
48328112|NCT00488982|101128502|FG001|COMPLETED|Course 2||4||
48328113|NCT00488982|101128503|FG002|COMPLETED|Course 2||8||
48328114|NCT00488982|101128501|FG000|NOT COMPLETED|Course 2||0||
48328115|NCT00488982|101128502|FG001|NOT COMPLETED|Course 2||9||
48328116|NCT00488982|101128503|FG002|NOT COMPLETED|Course 2||5||
48328117|NCT00488982|101128501|FG000|STARTED|Course 3||0||
48328118|NCT00488982|101128502|FG001|STARTED|Course 3||4||
48328119|NCT00488982|101128503|FG002|STARTED|Course 3||8||
48328120|NCT00488982|101128501|FG000|COMPLETED|Course 3||0||
48328121|NCT00488982|101128502|FG001|COMPLETED|Course 3||2||
48328122|NCT00488982|101128503|FG002|COMPLETED|Course 3||3||
48328123|NCT00488982|101128501|FG000|NOT COMPLETED|Course 3||0||
48328124|NCT00488982|101128502|FG001|NOT COMPLETED|Course 3||2||
48409893|NCT05333289|101334811|FG003|Safety Set|Overall Study||71|The Safety Set consisted of all randomly assigned participants who received the investigational product.|
48409894|NCT05333289|101334812|FG004|Safety Set|Overall Study||72|The Safety Set consisted of all randomly assigned participants who received the investigational product.|
48409895|NCT05333289|101334813|FG005|Safety Set|Overall Study||67|The Safety Set consisted of all randomly assigned participants who received the investigational product.|
48621550|NCT01610037|101856561|FG001|NOT COMPLETED|All Patients||51||
48744697|NCT02587520|102161742|FG005|NOT COMPLETED|Overall Study||3||
48744698|NCT02587520|102161743|FG006|NOT COMPLETED|Overall Study||3||
48744699|NCT02587520|102161744|FG007|NOT COMPLETED|Overall Study||2||
48744700|NCT02587520|102161745|FG008|NOT COMPLETED|Overall Study||3||
48744701|NCT02587520|102161746|FG009|NOT COMPLETED|Overall Study||5||
48744702|NCT02587520|102161747|FG010|NOT COMPLETED|Overall Study||3||
48744703|NCT02587520|102161748|FG011|NOT COMPLETED|Overall Study||4||
48744704|NCT02587520|102161749|FG012|NOT COMPLETED|Overall Study||0||
48744705|NCT02587520|102161750|FG013|NOT COMPLETED|Overall Study||1||
48744706|NCT02587520|102161751|FG014|NOT COMPLETED|Overall Study||0||
48744707|NCT02587520|102161752|FG015|NOT COMPLETED|Overall Study||0||
48744708|NCT02587520|102161753|FG016|NOT COMPLETED|Overall Study||0||
48744709|NCT02587520|102161754|FG017|NOT COMPLETED|Overall Study||0||
48744710|NCT03038126|102161755|FG000|STARTED|Overall Study||63||
48328125|NCT00488982|101128503|FG002|NOT COMPLETED|Course 3||5||
48328126|NCT00488982|101128501|FG000|STARTED|Response to Course 3||0||
48328127|NCT00488982|101128502|FG001|STARTED|Response to Course 3||2||
48328128|NCT00488982|101128503|FG002|STARTED|Response to Course 3||3||
48328129|NCT00488982|101128501|FG000|COMPLETED|Response to Course 3||0||
48328130|NCT00488982|101128502|FG001|COMPLETED|Response to Course 3||1||
48328131|NCT00488982|101128503|FG002|COMPLETED|Response to Course 3||0||
48328132|NCT00488982|101128501|FG000|NOT COMPLETED|Response to Course 3||0||
48328133|NCT00488982|101128502|FG001|NOT COMPLETED|Response to Course 3||1||
48328134|NCT00488982|101128503|FG002|NOT COMPLETED|Response to Course 3||3||
48328135|NCT01127165|101128504|FG000|STARTED|Overall Study||65||
48328136|NCT01127165|101128505|FG001|STARTED|Overall Study||60||
48744711|NCT03038126|102161756|FG001|STARTED|Overall Study||55||
48744712|NCT03038126|102161755|FG000|COMPLETED|Overall Study||54||
48744713|NCT03038126|102161756|FG001|COMPLETED|Overall Study||51||
48328137|NCT01127165|101128504|FG000|COMPLETED|Overall Study||49||
48328138|NCT01127165|101128505|FG001|COMPLETED|Overall Study||41||
48328139|NCT01127165|101128504|FG000|NOT COMPLETED|Overall Study||16||
48328140|NCT01127165|101128505|FG001|NOT COMPLETED|Overall Study||19||
48328141|NCT02199197|101128506|FG000|STARTED|Overall Study||35||
48328142|NCT02199197|101128507|FG001|STARTED|Overall Study||14||
48328143|NCT02199197|101128506|FG000|COMPLETED|Overall Study||35||
48328144|NCT02199197|101128507|FG001|COMPLETED|Overall Study||12||
48328145|NCT02199197|101128506|FG000|NOT COMPLETED|Overall Study||0||
48328146|NCT02199197|101128507|FG001|NOT COMPLETED|Overall Study||2||
48328147|NCT02918773|101128508|FG000|STARTED|Overall Study||11||776
48328148|NCT02918773|101128509|FG001|STARTED|Overall Study||11||614
48328149|NCT02918773|101128508|FG000|COMPLETED|Overall Study||11||776
48744714|NCT03038126|102161755|FG000|NOT COMPLETED|Overall Study||9||
48328150|NCT02918773|101128509|FG001|COMPLETED|Overall Study||11||614
48328151|NCT02918773|101128508|FG000|NOT COMPLETED|Overall Study||0||0
48328152|NCT02918773|101128509|FG001|NOT COMPLETED|Overall Study||0||0
48744715|NCT03038126|102161756|FG001|NOT COMPLETED|Overall Study||4||
48409896|NCT05333289|101334814|FG006|Safety Set|Overall Study||72|The Safety Set consisted of all randomly assigned participants who received the investigational product.|
48409897|NCT05333289|101334815|FG007|Safety Set|Overall Study||70|The Safety Set consisted of all randomly assigned participants who received the investigational product.|
48409898|NCT05333289|101334808|FG000|Solicited Safety Set|Overall Study||71|The Solicited Safety Set consisted of all participants in the Safety Set who contributed any solicited adverse reaction data.|
48409899|NCT05333289|101334809|FG001|Solicited Safety Set|Overall Study||71|The Solicited Safety Set consisted of all participants in the Safety Set who contributed any solicited adverse reaction data.|
48409900|NCT05333289|101334810|FG002|Solicited Safety Set|Overall Study||71|The Solicited Safety Set consisted of all participants in the Safety Set who contributed any solicited adverse reaction data.|
48409901|NCT05333289|101334811|FG003|Solicited Safety Set|Overall Study||71|The Solicited Safety Set consisted of all participants in the Safety Set who contributed any solicited adverse reaction data.|
48409902|NCT05333289|101334812|FG004|Solicited Safety Set|Overall Study||72|The Solicited Safety Set consisted of all participants in the Safety Set who contributed any solicited adverse reaction data.|
48409903|NCT05333289|101334813|FG005|Solicited Safety Set|Overall Study||67|The Solicited Safety Set consisted of all participants in the Safety Set who contributed any solicited adverse reaction data.|
48409904|NCT05333289|101334814|FG006|Solicited Safety Set|Overall Study||72|The Solicited Safety Set consisted of all participants in the Safety Set who contributed any solicited adverse reaction data.|
48409905|NCT05333289|101334815|FG007|Solicited Safety Set|Overall Study||70|The Solicited Safety Set consisted of all participants in the Safety Set who contributed any solicited adverse reaction data.|
48409906|NCT05333289|101334808|FG000|COMPLETED|Overall Study||62||
48409907|NCT05333289|101334809|FG001|COMPLETED|Overall Study||69||
48409908|NCT05333289|101334810|FG002|COMPLETED|Overall Study||67||
48409909|NCT05333289|101334811|FG003|COMPLETED|Overall Study||64||
48409910|NCT05333289|101334812|FG004|COMPLETED|Overall Study||67||
48409911|NCT05333289|101334813|FG005|COMPLETED|Overall Study||62||
48409912|NCT05333289|101334814|FG006|COMPLETED|Overall Study||67||
48409913|NCT05333289|101334815|FG007|COMPLETED|Overall Study||67||
48409914|NCT05333289|101334808|FG000|NOT COMPLETED|Overall Study||10||
48409915|NCT05333289|101334809|FG001|NOT COMPLETED|Overall Study||2||
48409916|NCT05333289|101334810|FG002|NOT COMPLETED|Overall Study||4||
48621551|NCT01610037|101856562|FG002|NOT COMPLETED|All Patients||84||
48621552|NCT01610037|101856560|FG000|STARTED|Treatment and Follow up Period||407||
48621553|NCT01610037|101856561|FG001|STARTED|Treatment and Follow up Period||405||
48621554|NCT01610037|101856562|FG002|STARTED|Treatment and Follow up Period||404||
48621555|NCT01610037|101856560|FG000|COMPLETED|Treatment and Follow up Period||382||
48621556|NCT01610037|101856561|FG001|COMPLETED|Treatment and Follow up Period||377||
48621557|NCT01610037|101856562|FG002|COMPLETED|Treatment and Follow up Period||378||
48621558|NCT01610037|101856560|FG000|NOT COMPLETED|Treatment and Follow up Period||25||
48621559|NCT01610037|101856561|FG001|NOT COMPLETED|Treatment and Follow up Period||28||
48621560|NCT01610037|101856562|FG002|NOT COMPLETED|Treatment and Follow up Period||26||
48621561|NCT00737100|101856563|FG000|STARTED|Overall Study||168||
48621562|NCT00737100|101856564|FG001|STARTED|Overall Study||166||
48621563|NCT00737100|101856565|FG002|STARTED|Overall Study||176||
48621564|NCT00737100|101856563|FG000|COMPLETED|Overall Study||161||
48621565|NCT00737100|101856564|FG001|COMPLETED|Overall Study||159||
48621566|NCT00737100|101856565|FG002|COMPLETED|Overall Study||169||
48621567|NCT00737100|101856563|FG000|NOT COMPLETED|Overall Study||7||
48621568|NCT00737100|101856564|FG001|NOT COMPLETED|Overall Study||7||
48621569|NCT00737100|101856565|FG002|NOT COMPLETED|Overall Study||7||
48621570|NCT02245815|101856566|FG000|STARTED|Overall Study||45||
48621571|NCT02245815|101856567|FG001|STARTED|Overall Study||45||
48621572|NCT02245815|101856566|FG000|COMPLETED|Overall Study||45||
48621573|NCT02245815|101856567|FG001|COMPLETED|Overall Study||45||
48621574|NCT02245815|101856566|FG000|NOT COMPLETED|Overall Study||0||
48621575|NCT02245815|101856567|FG001|NOT COMPLETED|Overall Study||0||
48621576|NCT04980014|101856568|FG000|STARTED|Overall Study||730||
48621577|NCT04980014|101856568|FG000|Safety Analysis Set|Overall Study||655||
48621578|NCT04980014|101856568|FG000|Effectiveness Analysis Set|Overall Study||482||
48621579|NCT04980014|101856568|FG000|COMPLETED|Overall Study||655||
48621580|NCT04980014|101856568|FG000|NOT COMPLETED|Overall Study||75||
48621581|NCT02498678|101859659|FG000|STARTED|Overall Study||25||
48621582|NCT02498678|101859660|FG001|STARTED|Overall Study||25||
48621583|NCT02498678|101859659|FG000|COMPLETED|Overall Study||25||
48621584|NCT02498678|101859660|FG001|COMPLETED|Overall Study||23||
48621585|NCT02498678|101859659|FG000|NOT COMPLETED|Overall Study||0||
48621586|NCT02498678|101859660|FG001|NOT COMPLETED|Overall Study||2||
48621587|NCT03804268|101859661|FG000|STARTED|Overall Study||160||
48621588|NCT03804268|101859662|FG001|STARTED|Overall Study||163||
48621589|NCT03804268|101859661|FG000|COMPLETED|Overall Study||153||
48621590|NCT03804268|101859662|FG001|COMPLETED|Overall Study||161||
48621591|NCT03804268|101859661|FG000|NOT COMPLETED|Overall Study||7||
48621592|NCT03804268|101859662|FG001|NOT COMPLETED|Overall Study||2||
48621593|NCT02886923|101859663|FG000|STARTED|Period 1||12||
48621594|NCT02886923|101859664|FG001|STARTED|Period 1||11||
48621595|NCT02886923|101859663|FG000|COMPLETED|Period 1||12||
48621596|NCT02886923|101859664|FG001|COMPLETED|Period 1||11||
48621597|NCT02886923|101859663|FG000|NOT COMPLETED|Period 1||0||
48621598|NCT02886923|101859664|FG001|NOT COMPLETED|Period 1||0||
48621599|NCT02886923|101859663|FG000|STARTED|Period 2||12||
48328153|NCT02123485|101131906|FG000|STARTED|Overall Study||18||
48328154|NCT02123485|101131907|FG001|STARTED|Overall Study||17||
48328155|NCT02123485|101131906|FG000|COMPLETED|Overall Study||17||
48328156|NCT02123485|101131907|FG001|COMPLETED|Overall Study||17||
48409917|NCT05333289|101334811|FG003|NOT COMPLETED|Overall Study||8||
48328157|NCT02123485|101131906|FG000|NOT COMPLETED|Overall Study||1||
48328158|NCT02123485|101131907|FG001|NOT COMPLETED|Overall Study||0||
48328159|NCT02926209|101131908|FG000|STARTED|Study Cohort||42||
48328160|NCT02926209|101131909|FG001|STARTED|Study Cohort||37||
48328161|NCT02926209|101131908|FG000|COMPLETED|Study Cohort||41||
48328162|NCT02926209|101131909|FG001|COMPLETED|Study Cohort||37||
48328163|NCT02926209|101131908|FG000|NOT COMPLETED|Study Cohort||1||
48328164|NCT02926209|101131909|FG001|NOT COMPLETED|Study Cohort||0||
48328165|NCT02926209|101131908|FG000|STARTED|Training Cohort - First Patients||20||
48328166|NCT02926209|101131909|FG001|STARTED|Training Cohort - First Patients||0||
48328167|NCT02926209|101131908|FG000|COMPLETED|Training Cohort - First Patients||20||
48328168|NCT02926209|101131909|FG001|COMPLETED|Training Cohort - First Patients||0||
48409918|NCT05333289|101334812|FG004|NOT COMPLETED|Overall Study||5||
48409919|NCT05333289|101334813|FG005|NOT COMPLETED|Overall Study||9||
48409920|NCT05333289|101334814|FG006|NOT COMPLETED|Overall Study||5||
48409921|NCT05333289|101334815|FG007|NOT COMPLETED|Overall Study||4||
48409922|NCT02855086|101334816|FG000|STARTED|Overall Study||2||
48621600|NCT02886923|101859664|FG001|STARTED|Period 2||11||
48621601|NCT02886923|101859663|FG000|COMPLETED|Period 2||12||
48621602|NCT02886923|101859664|FG001|COMPLETED|Period 2||11||
48621603|NCT02886923|101859663|FG000|NOT COMPLETED|Period 2||0||
48621604|NCT02886923|101859664|FG001|NOT COMPLETED|Period 2||0||
48621605|NCT02532374|101859665|FG000|STARTED|Overall Study||16||
48621606|NCT02532374|101859665|FG000|Nicorette Inhalator (Visit 3)|Overall Study||15||
48621607|NCT02532374|101859665|FG000|P3L 50 μg/Puff (Visit 4)|Overall Study||15||
48621608|NCT02532374|101859665|FG000|P3L 80 μg/Puff (Visit 5)|Overall Study||14||
48621609|NCT02532374|101859665|FG000|P3L150 μg/Puff (Visit 6)|Overall Study||14||
48621610|NCT02532374|101859665|FG000|COMPLETED|Overall Study||14||
48621611|NCT02532374|101859665|FG000|NOT COMPLETED|Overall Study||2||
48621612|NCT02982863|101859666|FG000|STARTED|Overall Study||5745||
48621613|NCT02982863|101859667|FG001|STARTED|Overall Study||16745||
48621614|NCT02982863|101859668|FG002|STARTED|Overall Study||13238||
48621615|NCT02982863|101859669|FG003|STARTED|Overall Study||10158||
48621616|NCT02982863|101859670|FG004|STARTED|Overall Study||2760||
48621617|NCT02982863|101859666|FG000|COMPLETED|Overall Study||4936||
48621618|NCT02982863|101859667|FG001|COMPLETED|Overall Study||12484||
48621619|NCT02982863|101859668|FG002|COMPLETED|Overall Study||11386||
48744716|NCT03384940|102161757|FG000|STARTED|Overall Study||53||
48744717|NCT03384940|102161758|FG001|STARTED|Overall Study||15||
48744718|NCT03384940|102161759|FG002|STARTED|Overall Study||18||
48744719|NCT03384940|102161757|FG000|COMPLETED|Overall Study||0|As of database lock for final analysis on 28 Dec 2020|
48744720|NCT03384940|102161758|FG001|COMPLETED|Overall Study||0|As of database lock for final analysis on 28 Dec 2020|
48744721|NCT03384940|102161759|FG002|COMPLETED|Overall Study||0|As of database lock for final analysis on 28 Dec 2020|
48744722|NCT03384940|102161757|FG000|NOT COMPLETED|Overall Study||53||
48744723|NCT03384940|102161758|FG001|NOT COMPLETED|Overall Study||15||
48744724|NCT03384940|102161759|FG002|NOT COMPLETED|Overall Study||18||
48744725|NCT01982123|102161760|FG000|STARTED|Overall Study||12||
48744726|NCT01982123|102161760|FG000|COMPLETED|Overall Study||12||
48744727|NCT01982123|102161760|FG000|NOT COMPLETED|Overall Study||0||
48744728|NCT00671034|102161761|FG000|STARTED|Overall Study||69||
48744729|NCT00671034|102161762|FG001|STARTED|Overall Study||42||
48744730|NCT00671034|102161763|FG002|STARTED|Overall Study||55||
48744731|NCT00671034|102161761|FG000|COMPLETED|Overall Study||30||
48744732|NCT00671034|102161762|FG001|COMPLETED|Overall Study||22||
48744733|NCT00671034|102161763|FG002|COMPLETED|Overall Study||31||
48744734|NCT00671034|102161761|FG000|NOT COMPLETED|Overall Study||39||
48744735|NCT00671034|102161762|FG001|NOT COMPLETED|Overall Study||20||
48744736|NCT00671034|102161763|FG002|NOT COMPLETED|Overall Study||24||
48744737|NCT00655538|102161764|FG000|STARTED|Overall Study||238||
48744738|NCT00655538|102161765|FG001|STARTED|Overall Study||238||
48744739|NCT00655538|102161764|FG000|COMPLETED|Overall Study||214||
48744740|NCT00655538|102161765|FG001|COMPLETED|Overall Study||211||
48744741|NCT00655538|102161764|FG000|NOT COMPLETED|Overall Study||24||
48328169|NCT02926209|101131908|FG000|NOT COMPLETED|Training Cohort - First Patients||0||
48409923|NCT02855086|101334817|FG001|STARTED|Overall Study||1||
48744742|NCT00655538|102161765|FG001|NOT COMPLETED|Overall Study||27||
48744743|NCT00300755|102161766|FG000|STARTED|Overall Study||18||
48409924|NCT02855086|101334816|FG000|COMPLETED|Overall Study||2||
48409925|NCT02855086|101334817|FG001|COMPLETED|Overall Study||1||
48409926|NCT02855086|101334816|FG000|NOT COMPLETED|Overall Study||0||
48409927|NCT02855086|101334817|FG001|NOT COMPLETED|Overall Study||0||
48409928|NCT00378534|101334818|FG000|STARTED|Overall Study||58||
48621620|NCT02982863|101859669|FG003|COMPLETED|Overall Study||8758||
48621621|NCT02982863|101859670|FG004|COMPLETED|Overall Study||2268||
48621622|NCT02982863|101859666|FG000|NOT COMPLETED|Overall Study||809||
48621623|NCT02982863|101859667|FG001|NOT COMPLETED|Overall Study||4261||
48621624|NCT02982863|101859668|FG002|NOT COMPLETED|Overall Study||1852||
48621625|NCT02982863|101859669|FG003|NOT COMPLETED|Overall Study||1400||
48621626|NCT02982863|101859670|FG004|NOT COMPLETED|Overall Study||492||
48621627|NCT00866905|101859671|FG000|STARTED|Overall Study||168||
48621628|NCT00866905|101859671|FG000|COMPLETED|Overall Study||135||
48621629|NCT00866905|101859671|FG000|NOT COMPLETED|Overall Study||33||
48621630|NCT00791999|101859672|FG000|STARTED|Overall Study||72||
48621631|NCT00791999|101859673|FG001|STARTED|Overall Study||82||
48621632|NCT00791999|101859674|FG002|STARTED|Overall Study||85||
48409929|NCT00378534|101334819|FG001|STARTED|Overall Study||58||
48409930|NCT00378534|101334818|FG000|COMPLETED|Overall Study||55||
48409931|NCT00378534|101334819|FG001|COMPLETED|Overall Study||58||
48409932|NCT00378534|101334818|FG000|NOT COMPLETED|Overall Study||3||
48409933|NCT00378534|101334819|FG001|NOT COMPLETED|Overall Study||0||
48409934|NCT00987727|101334820|FG000|STARTED|Overall Study||41||
48409935|NCT00987727|101334821|FG001|STARTED|Overall Study||41||
48409936|NCT00987727|101334820|FG000|COMPLETED|Overall Study||36||
48409937|NCT00987727|101334821|FG001|COMPLETED|Overall Study||34||
48409938|NCT00987727|101334820|FG000|NOT COMPLETED|Overall Study||5||
48409939|NCT00987727|101334821|FG001|NOT COMPLETED|Overall Study||7||
48409940|NCT03744598|101334822|FG000|STARTED|Overall Study||20||
48409941|NCT03744598|101334822|FG000|COMPLETED|Overall Study||19||
48409942|NCT03744598|101334822|FG000|NOT COMPLETED|Overall Study||1||
48409943|NCT02559115|101334823|FG000|STARTED|Overall Study||19||
48621633|NCT00791999|101859675|FG003|STARTED|Overall Study||77||
48621634|NCT00791999|101859672|FG000|COMPLETED|Overall Study||51||
48621635|NCT00791999|101859673|FG001|COMPLETED|Overall Study||66||
48621636|NCT00791999|101859674|FG002|COMPLETED|Overall Study||65||
48621637|NCT00791999|101859675|FG003|COMPLETED|Overall Study||25||
48621638|NCT00791999|101859672|FG000|NOT COMPLETED|Overall Study||21||
48621639|NCT00791999|101859673|FG001|NOT COMPLETED|Overall Study||16||
48621640|NCT00791999|101859674|FG002|NOT COMPLETED|Overall Study||20||
48621641|NCT00791999|101859675|FG003|NOT COMPLETED|Overall Study||52||
48621642|NCT01587885|101859676|FG000|STARTED|Treatment Period 1||26||
48621643|NCT01587885|101859677|FG001|STARTED|Treatment Period 1||22||
48621644|NCT01587885|101859676|FG000|COMPLETED|Treatment Period 1||26||
48621645|NCT01587885|101859677|FG001|COMPLETED|Treatment Period 1||19||
48409944|NCT02559115|101334823|FG000|COMPLETED|Overall Study||16||
48409945|NCT02559115|101334823|FG000|NOT COMPLETED|Overall Study||3||
48409946|NCT03687827|101334824|FG000|STARTED|Treatment Period 1||249||
48621646|NCT01587885|101859676|FG000|NOT COMPLETED|Treatment Period 1||0||
48409947|NCT03687827|101334825|FG001|STARTED|Treatment Period 1||249||
48409948|NCT03687827|101334824|FG000|Full Analysis Set (FAS)|Treatment Period 1||249||
48621647|NCT01587885|101859677|FG001|NOT COMPLETED|Treatment Period 1||3||
48621648|NCT01587885|101859676|FG000|STARTED|Treatment Period 2||26||
48621649|NCT01587885|101859677|FG001|STARTED|Treatment Period 2||19||
48621650|NCT01587885|101859676|FG000|COMPLETED|Treatment Period 2||26||
48621651|NCT01587885|101859677|FG001|COMPLETED|Treatment Period 2||19||
48621652|NCT01587885|101859676|FG000|NOT COMPLETED|Treatment Period 2||0||
48621653|NCT01587885|101859677|FG001|NOT COMPLETED|Treatment Period 2||0||
48621654|NCT00956085|101859678|FG000|STARTED|Overall Study||12||
48621655|NCT00956085|101859678|FG000|COMPLETED|Overall Study||12||
48621656|NCT00956085|101859678|FG000|NOT COMPLETED|Overall Study||0||
48621657|NCT00535652|101859679|FG000|STARTED|Overall Study||23||
48621658|NCT00535652|101859679|FG000|COMPLETED|Overall Study||20||
48621659|NCT00535652|101859679|FG000|NOT COMPLETED|Overall Study||3||
48621660|NCT02492802|101859680|FG000|STARTED|Overall Study||64||
48409949|NCT03687827|101334825|FG001|Full Analysis Set (FAS)|Treatment Period 1||249||
48409950|NCT03687827|101334824|FG000|Safety Analysis Set (SAS)|Treatment Period 1||249||
48409951|NCT03687827|101334825|FG001|Safety Analysis Set (SAS)|Treatment Period 1||249||
48409952|NCT03687827|101334824|FG000|Per Protocol Set|Treatment Period 1||219||
48409953|NCT03687827|101334825|FG001|Per Protocol Set|Treatment Period 1||229||
48409954|NCT03687827|101334824|FG000|COMPLETED|Treatment Period 1||235||
48409955|NCT03687827|101334825|FG001|COMPLETED|Treatment Period 1||241||
48621661|NCT02492802|101859680|FG000|COMPLETED|Overall Study||64||
48621662|NCT02492802|101859680|FG000|NOT COMPLETED|Overall Study||0||
48621663|NCT00715403|101859681|FG000|STARTED|Overall Study||1||
48621664|NCT00715403|101859682|FG001|STARTED|Overall Study||1||
48621665|NCT00715403|101859683|FG002|STARTED|Overall Study||4||
48621666|NCT00715403|101859684|FG003|STARTED|Overall Study||9||
48621667|NCT00715403|101859685|FG004|STARTED|Overall Study||6||
48621668|NCT00715403|101859686|FG005|STARTED|Overall Study||19||
48621669|NCT00715403|101859687|FG006|STARTED|Overall Study||1||
48621670|NCT00715403|101859681|FG000|COMPLETED|Overall Study||0||
48621671|NCT00715403|101859682|FG001|COMPLETED|Overall Study||0||
48621672|NCT00715403|101859683|FG002|COMPLETED|Overall Study||0||
48621673|NCT00715403|101859684|FG003|COMPLETED|Overall Study||0||
48621674|NCT00715403|101859685|FG004|COMPLETED|Overall Study||0||
48621675|NCT00715403|101859686|FG005|COMPLETED|Overall Study||0||
48621676|NCT00715403|101859687|FG006|COMPLETED|Overall Study||0||
48621677|NCT00715403|101859681|FG000|NOT COMPLETED|Overall Study||1||
48621678|NCT00715403|101859682|FG001|NOT COMPLETED|Overall Study||1||
48621679|NCT00715403|101859683|FG002|NOT COMPLETED|Overall Study||4||
48621680|NCT00715403|101859684|FG003|NOT COMPLETED|Overall Study||9||
48621681|NCT00715403|101859685|FG004|NOT COMPLETED|Overall Study||6||
48621682|NCT00715403|101859686|FG005|NOT COMPLETED|Overall Study||19||
48621683|NCT00715403|101859687|FG006|NOT COMPLETED|Overall Study||1||
48621684|NCT02713178|101859688|FG000|STARTED|Overall Study||76||
48409956|NCT03687827|101334824|FG000|NOT COMPLETED|Treatment Period 1||14||
48409957|NCT03687827|101334825|FG001|NOT COMPLETED|Treatment Period 1||8||
48409958|NCT03687827|101334824|FG000|STARTED|Treatment Period 2||235||
48409959|NCT03687827|101334825|FG001|STARTED|Treatment Period 2||241||
48409960|NCT03687827|101334824|FG000|COMPLETED|Treatment Period 2||230||
48409961|NCT03687827|101334825|FG001|COMPLETED|Treatment Period 2||238||
48409962|NCT03687827|101334824|FG000|NOT COMPLETED|Treatment Period 2||5||
48621685|NCT02713178|101859689|FG001|STARTED|Overall Study||77||
48621686|NCT02713178|101859690|FG002|STARTED|Overall Study||79||
48621687|NCT02713178|101859688|FG000|COMPLETED|Overall Study||75||
48621688|NCT02713178|101859689|FG001|COMPLETED|Overall Study||73||
48621689|NCT02713178|101859690|FG002|COMPLETED|Overall Study||74||
48621690|NCT02713178|101859688|FG000|NOT COMPLETED|Overall Study||1||
48621691|NCT02713178|101859689|FG001|NOT COMPLETED|Overall Study||4||
48621692|NCT02713178|101859690|FG002|NOT COMPLETED|Overall Study||5||
48621693|NCT00327340|101859691|FG000|STARTED|Overall Study||23||
48621694|NCT00327340|101859692|FG001|STARTED|Overall Study||46||
48621695|NCT00327340|101859691|FG000|COMPLETED|Overall Study||8||
48621696|NCT00327340|101859692|FG001|COMPLETED|Overall Study||16||
48621697|NCT00327340|101859691|FG000|NOT COMPLETED|Overall Study||15||
48621698|NCT00327340|101859692|FG001|NOT COMPLETED|Overall Study||30||
48621699|NCT01089127|101859693|FG000|STARTED|Overall Study||92||
48621700|NCT01089127|101859694|FG001|STARTED|Overall Study||91||
48621701|NCT01089127|101859695|FG002|STARTED|Overall Study||94||
48621702|NCT01089127|101859696|FG003|STARTED|Overall Study||92||
48621703|NCT01089127|101859697|FG004|STARTED|Overall Study||92||
48621704|NCT01089127|101859698|FG005|STARTED|Overall Study||91||
48621705|NCT01089127|101859693|FG000|Exposed to Study Drug|Overall Study||89||
48621706|NCT01089127|101859694|FG001|Exposed to Study Drug|Overall Study||90||
48621707|NCT01089127|101859695|FG002|Exposed to Study Drug|Overall Study||94||
48621708|NCT01089127|101859696|FG003|Exposed to Study Drug|Overall Study||92||
48621709|NCT01089127|101859697|FG004|Exposed to Study Drug|Overall Study||91||
48621710|NCT01089127|101859698|FG005|Exposed to Study Drug|Overall Study||91||
48621711|NCT01089127|101859693|FG000|COMPLETED|Overall Study||84||
48621712|NCT01089127|101859694|FG001|COMPLETED|Overall Study||86||
48621713|NCT01089127|101859695|FG002|COMPLETED|Overall Study||92||
48621714|NCT01089127|101859696|FG003|COMPLETED|Overall Study||91||
48621715|NCT01089127|101859697|FG004|COMPLETED|Overall Study||90||
48621716|NCT01089127|101859698|FG005|COMPLETED|Overall Study||88||
48621717|NCT01089127|101859693|FG000|NOT COMPLETED|Overall Study||8||
48621718|NCT01089127|101859694|FG001|NOT COMPLETED|Overall Study||5||
48621719|NCT01089127|101859695|FG002|NOT COMPLETED|Overall Study||2||
48621720|NCT01089127|101859696|FG003|NOT COMPLETED|Overall Study||1||
48621721|NCT01089127|101859697|FG004|NOT COMPLETED|Overall Study||2||
48621722|NCT01089127|101859698|FG005|NOT COMPLETED|Overall Study||3||
48621723|NCT02619617|101859699|FG000|STARTED|Period 1 Placebo - 1st AttacK||28||
48621724|NCT02619617|101859700|FG001|STARTED|Period 1 Placebo - 1st AttacK||0||
48621725|NCT02619617|101859699|FG000|Participants Included in PD Analysis|Period 1 Placebo - 1st AttacK||20||
48621726|NCT02619617|101859700|FG001|Participants Included in PD Analysis|Period 1 Placebo - 1st AttacK||0||
48621727|NCT02619617|101859699|FG000|Participants in Safety Set for Period 1|Period 1 Placebo - 1st AttacK||28|participants in Cohort 1 in Period 1 received placebo s.c.|
48621728|NCT02619617|101859700|FG001|Participants in Safety Set for Period 1|Period 1 Placebo - 1st AttacK||0|participants in Cohort 1 in Period 1 received placebo s.c.|
48621729|NCT02619617|101859699|FG000|COMPLETED|Period 1 Placebo - 1st AttacK||28||
48621730|NCT02619617|101859700|FG001|COMPLETED|Period 1 Placebo - 1st AttacK||0||
48621731|NCT02619617|101859699|FG000|NOT COMPLETED|Period 1 Placebo - 1st AttacK||0||
48621732|NCT02619617|101859700|FG001|NOT COMPLETED|Period 1 Placebo - 1st AttacK||0||
48621733|NCT02619617|101859699|FG000|STARTED|Period 2 SOM230 - 2nd Attack||0||
48621734|NCT02619617|101859700|FG001|STARTED|Period 2 SOM230 - 2nd Attack||28||
48621735|NCT02619617|101859699|FG000|Participants in Safety Set for Period 2|Period 2 SOM230 - 2nd Attack||0||
48621736|NCT02619617|101859700|FG001|Participants in Safety Set for Period 2|Period 2 SOM230 - 2nd Attack||28||
48621737|NCT02619617|101859699|FG000|COMPLETED|Period 2 SOM230 - 2nd Attack||0||
48621738|NCT02619617|101859700|FG001|COMPLETED|Period 2 SOM230 - 2nd Attack||24||
48621739|NCT02619617|101859699|FG000|NOT COMPLETED|Period 2 SOM230 - 2nd Attack||0||
48621740|NCT02619617|101859700|FG001|NOT COMPLETED|Period 2 SOM230 - 2nd Attack||4||
48621741|NCT01324947|101859701|FG000|STARTED|Overall Study||74||
48621742|NCT01324947|101859701|FG000|Safety Population|Overall Study||73||
48621743|NCT01324947|101859701|FG000|Efficacy Evaluable Population (EEP)|Overall Study||64||
48621744|NCT01324947|101859701|FG000|COMPLETED|Overall Study||0||
48621745|NCT01324947|101859701|FG000|NOT COMPLETED|Overall Study||74||
48328170|NCT02926209|101131909|FG001|NOT COMPLETED|Training Cohort - First Patients||0||
48328171|NCT01687712|101131910|FG000|STARTED|Cycle 1||549||
48328172|NCT01687712|101131911|FG001|STARTED|Cycle 1||551||
48328173|NCT01687712|101131910|FG000|Received hCG|Cycle 1||516||
48328174|NCT01687712|101131911|FG001|Received hCG|Cycle 1||520||
48328175|NCT01687712|101131910|FG000|Oocyte/Ovum Pick Up|Cycle 1||513||
48621746|NCT02276963|101859702|FG000|STARTED|Overall Study||6||
48621747|NCT02276963|101859702|FG000|COMPLETED|Overall Study||3||
48621748|NCT02276963|101859702|FG000|NOT COMPLETED|Overall Study||3||
48621749|NCT01753713|101859703|FG000|STARTED|Overall Study||14||
48621750|NCT01753713|101859704|FG001|STARTED|Overall Study||19||
48621751|NCT01753713|101859703|FG000|COMPLETED|Overall Study||14||
48621752|NCT01753713|101859704|FG001|COMPLETED|Overall Study||19||
48621753|NCT01753713|101859703|FG000|NOT COMPLETED|Overall Study||0||
48621754|NCT01753713|101859704|FG001|NOT COMPLETED|Overall Study||0||
48657110|NCT03761914|101943782|FG004|COMPLETED|Overall Study||0||
48328176|NCT01687712|101131911|FG001|Oocyte/Ovum Pick Up|Cycle 1||517||
48328177|NCT01687712|101131910|FG000|Fertilization Performed|Cycle 1||508||
48621755|NCT01677741|101859705|FG000|STARTED|Overall Study||3|All subjects who received at least one dose of study treatment were included in All treated population and Safety population|
48621756|NCT01677741|101859706|FG001|STARTED|Overall Study||10|All subjects who received at least one dose of study treatment were included in All treated population and Safety population|
48621757|NCT01677741|101859707|FG002|STARTED|Overall Study||8|All subjects who received at least one dose of study treatment were included in All treated population and Safety population|
48621758|NCT01677741|101859708|FG003|STARTED|Overall Study||6|All subjects who received at least one dose of study treatment were included in All treated population and Safety population|
48744744|NCT00300755|102161767|FG001|STARTED|Overall Study||21||
48744745|NCT00300755|102161768|FG002|STARTED|Overall Study||21||
48744746|NCT00300755|102161766|FG000|COMPLETED|Overall Study||17||
48744747|NCT00300755|102161767|FG001|COMPLETED|Overall Study||17||
48744748|NCT00300755|102161768|FG002|COMPLETED|Overall Study||19||
48744749|NCT00300755|102161766|FG000|NOT COMPLETED|Overall Study||1||
48621759|NCT01677741|101859709|FG004|STARTED|Overall Study||17|All subjects who received at least one dose of study treatment were included in All treated population and Safety population|
48744750|NCT00300755|102161767|FG001|NOT COMPLETED|Overall Study||4||
48744751|NCT00300755|102161768|FG002|NOT COMPLETED|Overall Study||2||
48744752|NCT02562716|102161769|FG000|STARTED|Overall Study||55||
48744753|NCT02562716|102161770|FG001|STARTED|Overall Study||47||
48744754|NCT02562716|102161769|FG000|Participants Assessed for AEs|Overall Study||53||
48744755|NCT02562716|102161770|FG001|Participants Assessed for AEs|Overall Study||45||
48744756|NCT02562716|102161769|FG000|COMPLETED|Overall Study||27||
48744757|NCT02562716|102161770|FG001|COMPLETED|Overall Study||19||
48744758|NCT02562716|102161769|FG000|NOT COMPLETED|Overall Study||28||
48744759|NCT02562716|102161770|FG001|NOT COMPLETED|Overall Study||28||
48744760|NCT03246789|102161771|FG000|STARTED|Overall Study||24||
48744761|NCT03246789|102161772|FG001|STARTED|Overall Study||15||
48744762|NCT03246789|102161771|FG000|COMPLETED|Overall Study||24||
48744763|NCT03246789|102161772|FG001|COMPLETED|Overall Study||15||
48744764|NCT03246789|102161771|FG000|NOT COMPLETED|Overall Study||0||
48744765|NCT03246789|102161772|FG001|NOT COMPLETED|Overall Study||0||
48744766|NCT01588444|102161773|FG000|STARTED|Overall Study||20||
48744767|NCT01588444|102161774|FG001|STARTED|Overall Study||20||
48744768|NCT01588444|102161773|FG000|COMPLETED|Overall Study||20||
48744769|NCT01588444|102161774|FG001|COMPLETED|Overall Study||20||
48744770|NCT01588444|102161773|FG000|NOT COMPLETED|Overall Study||0||
48744771|NCT01588444|102161774|FG001|NOT COMPLETED|Overall Study||0||
48744772|NCT02420379|102161775|FG000|STARTED|Overall Study||26||
48744773|NCT02420379|102161776|FG001|STARTED|Overall Study||7||
48744774|NCT02420379|102161775|FG000|COMPLETED|Overall Study||25||
48744775|NCT02420379|102161776|FG001|COMPLETED|Overall Study||3||
48328178|NCT01687712|101131911|FG001|Fertilization Performed|Cycle 1||512||
48328179|NCT01687712|101131910|FG000|Embryo Transfer|Cycle 1||466||
48328180|NCT01687712|101131911|FG001|Embryo Transfer|Cycle 1||483||
48328181|NCT01687712|101131910|FG000|Biochemical Pregnancy|Cycle 1||163||
48328182|NCT01687712|101131911|FG001|Biochemical Pregnancy|Cycle 1||203||
48328183|NCT01687712|101131910|FG000|Clinical Pregnancy|Cycle 1||114|Ascertained via an ultrasound scan.|
48328184|NCT01687712|101131911|FG001|Clinical Pregnancy|Cycle 1||138|Ascertained via an ultrasound scan.|
48328185|NCT01687712|101131910|FG000|COMPLETED|Cycle 1||101|A subject is listed as Completed if they delivered at least one live neonate.|
48328186|NCT01687712|101131911|FG001|COMPLETED|Cycle 1||122|A subject is listed as Completed if they delivered at least one live neonate.|
48328187|NCT01687712|101131910|FG000|NOT COMPLETED|Cycle 1||448||
48328188|NCT01687712|101131911|FG001|NOT COMPLETED|Cycle 1||429||
48328189|NCT01687712|101131910|FG000|STARTED|Cycle 2||109||
48328190|NCT01687712|101131911|FG001|STARTED|Cycle 2||120||
48328191|NCT01687712|101131910|FG000|Received hCG|Cycle 2||107||
48328192|NCT01687712|101131911|FG001|Received hCG|Cycle 2||119||
48328193|NCT01687712|101131910|FG000|Oocyte/Ovum Pick Up|Cycle 2||107||
48328194|NCT01687712|101131911|FG001|Oocyte/Ovum Pick Up|Cycle 2||119||
48328195|NCT01687712|101131910|FG000|Fertilization Performed|Cycle 2||106||
48328196|NCT01687712|101131911|FG001|Fertilization Performed|Cycle 2||119||
48328197|NCT01687712|101131910|FG000|Embryo Transfer|Cycle 2||101||
48328198|NCT01687712|101131911|FG001|Embryo Transfer|Cycle 2||117||
48328199|NCT01687712|101131910|FG000|Biochemical Pregnancy|Cycle 2||35||
48328200|NCT01687712|101131911|FG001|Biochemical Pregnancy|Cycle 2||43||
48368074|NCT03691623|101230101|FG005|COMPLETED|Overall Study||21||
48744776|NCT02420379|102161775|FG000|NOT COMPLETED|Overall Study||1||
48744777|NCT02420379|102161776|FG001|NOT COMPLETED|Overall Study||4||
48744778|NCT03109184|102161777|FG000|STARTED|Overall Study||60||
48744779|NCT03109184|102161778|FG001|STARTED|Overall Study||59||
48744780|NCT03109184|102161777|FG000|COMPLETED|Overall Study||53||
48744781|NCT03109184|102161778|FG001|COMPLETED|Overall Study||52||
48744782|NCT03109184|102161777|FG000|NOT COMPLETED|Overall Study||7||
48744783|NCT03109184|102161778|FG001|NOT COMPLETED|Overall Study||7||
48744784|NCT01664182|102161779|FG000|STARTED|Overall Study||19||
48744785|NCT01664182|102161780|FG001|STARTED|Overall Study||22||
48744786|NCT01664182|102161779|FG000|COMPLETED|Overall Study||17||
48744787|NCT01664182|102161780|FG001|COMPLETED|Overall Study||18||
48409963|NCT03687827|101334825|FG001|NOT COMPLETED|Treatment Period 2||3||
48165409|NCT00876460|100728519|FG005|COMPLETED|Combination Therapy Phase||0||
48165410|NCT00876460|100728520|FG006|COMPLETED|Combination Therapy Phase||0||
48165411|NCT00876460|100728521|FG007|COMPLETED|Combination Therapy Phase||0||
48165412|NCT00876460|100728514|FG000|NOT COMPLETED|Combination Therapy Phase||3||
48165413|NCT00876460|100728515|FG001|NOT COMPLETED|Combination Therapy Phase||7||
48165414|NCT00876460|100728516|FG002|NOT COMPLETED|Combination Therapy Phase||3||
48165415|NCT00876460|100728517|FG003|NOT COMPLETED|Combination Therapy Phase||6||
48165416|NCT00876460|100728518|FG004|NOT COMPLETED|Combination Therapy Phase||7||
48165417|NCT00876460|100728519|FG005|NOT COMPLETED|Combination Therapy Phase||3||
48621760|NCT01677741|101859710|FG005|STARTED|Overall Study||28|All subjects who received at least one dose of study treatment were included in All treated population and Safety population|
48621761|NCT01677741|101859711|FG006|STARTED|Overall Study||11|All subjects who received at least one dose of study treatment were included in All treated population and Safety population|
48621762|NCT01677741|101859712|FG007|STARTED|Overall Study||2|All subjects who received at least one dose of study treatment were included in All treated population and Safety population|
48621763|NCT01677741|101859705|FG000|DLT Evaluable Population|Overall Study||3|Part 1 subjects fulfilling the All Treated population criteria, and having received an adequate treatment for the first 28 days to enable an appropriate evaluation of study drug related DLTs|
48621764|NCT01677741|101859706|FG001|DLT Evaluable Population|Overall Study||10|Part 1 subjects fulfilling the All Treated population criteria, and having received an adequate treatment for the first 28 days to enable an appropriate evaluation of study drug related DLTs|
48621765|NCT01677741|101859707|FG002|DLT Evaluable Population|Overall Study||8|Part 1 subjects fulfilling the All Treated population criteria, and having received an adequate treatment for the first 28 days to enable an appropriate evaluation of study drug related DLTs|
48621766|NCT01677741|101859708|FG003|DLT Evaluable Population|Overall Study||6|Part 1 subjects fulfilling the All Treated population criteria, and having received an adequate treatment for the first 28 days to enable an appropriate evaluation of study drug related DLTs|
48621767|NCT01677741|101859709|FG004|DLT Evaluable Population|Overall Study||0|Part 1 subjects fulfilling the All Treated population criteria, and having received an adequate treatment for the first 28 days to enable an appropriate evaluation of study drug related DLTs|
48621768|NCT01677741|101859710|FG005|DLT Evaluable Population|Overall Study||0|Part 1 subjects fulfilling the All Treated population criteria, and having received an adequate treatment for the first 28 days to enable an appropriate evaluation of study drug related DLTs|
48621769|NCT01677741|101859711|FG006|DLT Evaluable Population|Overall Study||0|Part 1 subjects fulfilling the All Treated population criteria, and having received an adequate treatment for the first 28 days to enable an appropriate evaluation of study drug related DLTs|
48621770|NCT01677741|101859712|FG007|DLT Evaluable Population|Overall Study||0|Part 1 subjects fulfilling the All Treated population criteria, and having received an adequate treatment for the first 28 days to enable an appropriate evaluation of study drug related DLTs|
48621771|NCT01677741|101859705|FG000|PK Population|Overall Study||3|Subjects fulfilling the All Treated population criteria and for whom pharmacokinetic sample(s) were obtained and analyzed|
48621772|NCT01677741|101859706|FG001|PK Population|Overall Study||10|Subjects fulfilling the All Treated population criteria and for whom pharmacokinetic sample(s) were obtained and analyzed|
48621773|NCT01677741|101859707|FG002|PK Population|Overall Study||8|Subjects fulfilling the All Treated population criteria and for whom pharmacokinetic sample(s) were obtained and analyzed|
48621774|NCT01677741|101859708|FG003|PK Population|Overall Study||6|Subjects fulfilling the All Treated population criteria and for whom pharmacokinetic sample(s) were obtained and analyzed|
48744788|NCT01664182|102161779|FG000|NOT COMPLETED|Overall Study||2||
48744789|NCT01664182|102161780|FG001|NOT COMPLETED|Overall Study||4||
48744790|NCT02486016|102161781|FG000|STARTED|Overall Study||10||
48744791|NCT02486016|102161781|FG000|COMPLETED|Overall Study||10||
48744792|NCT02486016|102161781|FG000|NOT COMPLETED|Overall Study||0||
48744793|NCT01910402|102161782|FG000|STARTED|Randomized Phase (Up to 48 Weeks)||250|Randomized|
48744794|NCT01910402|102161783|FG001|STARTED|Randomized Phase (Up to 48 Weeks)||249|Randomized|
48744795|NCT01910402|102161784|FG002|STARTED|Randomized Phase (Up to 48 Weeks)||0|Randomized|
48744796|NCT01910402|102161782|FG000|ITT-E Population|Randomized Phase (Up to 48 Weeks)||248||
48744797|NCT01910402|102161783|FG001|ITT-E Population|Randomized Phase (Up to 48 Weeks)||247||
48744798|NCT01910402|102161784|FG002|ITT-E Population|Randomized Phase (Up to 48 Weeks)||0||
48744799|NCT01910402|102161782|FG000|COMPLETED|Randomized Phase (Up to 48 Weeks)||206||
48744800|NCT01910402|102161783|FG001|COMPLETED|Randomized Phase (Up to 48 Weeks)||192||
48744801|NCT01910402|102161784|FG002|COMPLETED|Randomized Phase (Up to 48 Weeks)||0||
48744802|NCT01910402|102161782|FG000|NOT COMPLETED|Randomized Phase (Up to 48 Weeks)||44||
48744803|NCT01910402|102161783|FG001|NOT COMPLETED|Randomized Phase (Up to 48 Weeks)||57||
48744804|NCT01910402|102161784|FG002|NOT COMPLETED|Randomized Phase (Up to 48 Weeks)||0||
48744805|NCT01910402|102161782|FG000|STARTED|Continuation Phase(From Weeks 48 to 432)||0||
48165418|NCT00876460|100728520|FG006|NOT COMPLETED|Combination Therapy Phase||8||
48165419|NCT00876460|100728521|FG007|NOT COMPLETED|Combination Therapy Phase||6||
48165420|NCT00876460|100728514|FG000|STARTED|Mono Therapy Phase||0||
48744806|NCT01910402|102161783|FG001|STARTED|Continuation Phase(From Weeks 48 to 432)||0||
48165421|NCT00876460|100728515|FG001|STARTED|Mono Therapy Phase||1||
48621775|NCT01677741|101859709|FG004|PK Population|Overall Study||17|Subjects fulfilling the All Treated population criteria and for whom pharmacokinetic sample(s) were obtained and analyzed|
48621776|NCT01677741|101859710|FG005|PK Population|Overall Study||28|Subjects fulfilling the All Treated population criteria and for whom pharmacokinetic sample(s) were obtained and analyzed|
48621777|NCT01677741|101859711|FG006|PK Population|Overall Study||11|Subjects fulfilling the All Treated population criteria and for whom pharmacokinetic sample(s) were obtained and analyzed|
48165422|NCT00876460|100728516|FG002|STARTED|Mono Therapy Phase||0||
48165423|NCT00876460|100728517|FG003|STARTED|Mono Therapy Phase||1||
48165424|NCT00876460|100728518|FG004|STARTED|Mono Therapy Phase||2||
48165425|NCT00876460|100728519|FG005|STARTED|Mono Therapy Phase||0||
48165426|NCT00876460|100728520|FG006|STARTED|Mono Therapy Phase||1||
48165427|NCT00876460|100728521|FG007|STARTED|Mono Therapy Phase||3||
48165428|NCT00876460|100728514|FG000|COMPLETED|Mono Therapy Phase||0||
48165429|NCT00876460|100728515|FG001|COMPLETED|Mono Therapy Phase||0||
48165430|NCT00876460|100728516|FG002|COMPLETED|Mono Therapy Phase||0||
48165431|NCT00876460|100728517|FG003|COMPLETED|Mono Therapy Phase||0||
48165432|NCT00876460|100728518|FG004|COMPLETED|Mono Therapy Phase||0||
48165433|NCT00876460|100728519|FG005|COMPLETED|Mono Therapy Phase||0||
48621778|NCT01677741|101859712|FG007|PK Population|Overall Study||2|Subjects fulfilling the All Treated population criteria and for whom pharmacokinetic sample(s) were obtained and analyzed|
48621779|NCT01677741|101859705|FG000|COMPLETED|Overall Study||0||
48621780|NCT01677741|101859706|FG001|COMPLETED|Overall Study||0||
48621781|NCT01677741|101859707|FG002|COMPLETED|Overall Study||0||
48621782|NCT01677741|101859708|FG003|COMPLETED|Overall Study||0||
48621783|NCT01677741|101859709|FG004|COMPLETED|Overall Study||0||
48621784|NCT01677741|101859710|FG005|COMPLETED|Overall Study||0||
48744807|NCT01910402|102161784|FG002|STARTED|Continuation Phase(From Weeks 48 to 432)||149||
48744808|NCT01910402|102161782|FG000|COMPLETED|Continuation Phase(From Weeks 48 to 432)||0||
48744809|NCT01910402|102161783|FG001|COMPLETED|Continuation Phase(From Weeks 48 to 432)||0||
48744810|NCT01910402|102161784|FG002|COMPLETED|Continuation Phase(From Weeks 48 to 432)||113||
48744811|NCT01910402|102161782|FG000|NOT COMPLETED|Continuation Phase(From Weeks 48 to 432)||0||
48744812|NCT01910402|102161783|FG001|NOT COMPLETED|Continuation Phase(From Weeks 48 to 432)||0||
48744813|NCT01910402|102161784|FG002|NOT COMPLETED|Continuation Phase(From Weeks 48 to 432)||36||
48744814|NCT02025179|102161785|FG000|STARTED|Overall Study||8||
48744815|NCT02025179|102161786|FG001|STARTED|Overall Study||9||
48744816|NCT02025179|102161787|FG002|STARTED|Overall Study||8||
48744817|NCT02025179|102161785|FG000|COMPLETED|Overall Study||8||
48744818|NCT02025179|102161786|FG001|COMPLETED|Overall Study||9||
48744819|NCT02025179|102161787|FG002|COMPLETED|Overall Study||7||
48744820|NCT02025179|102161785|FG000|NOT COMPLETED|Overall Study||0||
48744821|NCT02025179|102161786|FG001|NOT COMPLETED|Overall Study||0||
48744822|NCT02025179|102161787|FG002|NOT COMPLETED|Overall Study||1||
48744823|NCT02348593|102161788|FG000|STARTED|Overall Study||59||
48744824|NCT02348593|102161789|FG001|STARTED|Overall Study||59||
48744825|NCT02348593|102161790|FG002|STARTED|Overall Study||59||
48744826|NCT02348593|102161791|FG003|STARTED|Overall Study||59||
48744827|NCT02348593|102161788|FG000|COMPLETED|Overall Study||49||
48744828|NCT02348593|102161789|FG001|COMPLETED|Overall Study||51||
48744829|NCT02348593|102161790|FG002|COMPLETED|Overall Study||43||
48744830|NCT02348593|102161791|FG003|COMPLETED|Overall Study||52||
48744831|NCT02348593|102161788|FG000|NOT COMPLETED|Overall Study||10||
48744832|NCT02348593|102161789|FG001|NOT COMPLETED|Overall Study||8||
48744833|NCT02348593|102161790|FG002|NOT COMPLETED|Overall Study||16||
48744834|NCT02348593|102161791|FG003|NOT COMPLETED|Overall Study||7||
48744835|NCT04317040|102161792|FG000|STARTED|Overall Study||116||
48744836|NCT04317040|102161793|FG001|STARTED|Overall Study||118||
48744837|NCT04317040|102161792|FG000|Treated|Overall Study||114||
48744838|NCT04317040|102161793|FG001|Treated|Overall Study||115||
48744839|NCT04317040|102161792|FG000|COMPLETED|Overall Study||98||
48744840|NCT04317040|102161793|FG001|COMPLETED|Overall Study||98||
48744841|NCT04317040|102161792|FG000|NOT COMPLETED|Overall Study||18||
48328201|NCT01687712|101131910|FG000|Clinical Pregnancy|Cycle 2||17|Ascertained via an ultrasound scan.|
48328202|NCT01687712|101131911|FG001|Clinical Pregnancy|Cycle 2||26|Ascertained via an ultrasound scan.|
48744842|NCT04317040|102161793|FG001|NOT COMPLETED|Overall Study||20||
48744843|NCT02336230|102161794|FG000|STARTED|Overall Study||55||
48744844|NCT02336230|102161794|FG000|Full Analysis Set (FAS)|Overall Study||55|The FAS included all participants who provided informed consent, were screened, and were found eligible to enter the study.|
48744845|NCT02336230|102161794|FG000|Safety Analysis Population|Overall Study||54|The Safety Analysis Population included all participants who signed the informed consent form and received at least 1 dose of remestemcel-L.|
48744846|NCT02336230|102161794|FG000|COMPLETED|Overall Study||42||
48744847|NCT02336230|102161794|FG000|NOT COMPLETED|Overall Study||13||
48328203|NCT01687712|101131910|FG000|COMPLETED|Cycle 2||16|A subject is listed as Completed if they delivered at least one live neonate.|
48368075|NCT03691623|101230096|FG000|NOT COMPLETED|Overall Study||0||
48409964|NCT01529827|101334826|FG000|STARTED|Overall Study||94||
48621785|NCT01677741|101859711|FG006|COMPLETED|Overall Study||0||
48621786|NCT01677741|101859712|FG007|COMPLETED|Overall Study||0||
48621787|NCT01677741|101859705|FG000|NOT COMPLETED|Overall Study||3||
48621788|NCT01677741|101859706|FG001|NOT COMPLETED|Overall Study||10||
48621789|NCT01677741|101859707|FG002|NOT COMPLETED|Overall Study||8||
48621790|NCT01677741|101859708|FG003|NOT COMPLETED|Overall Study||6||
48621791|NCT01677741|101859709|FG004|NOT COMPLETED|Overall Study||17||
48621792|NCT01677741|101859710|FG005|NOT COMPLETED|Overall Study||28||
48621793|NCT01677741|101859711|FG006|NOT COMPLETED|Overall Study||11||
48621794|NCT01677741|101859712|FG007|NOT COMPLETED|Overall Study||2||
48621795|NCT01691378|101859713|FG000|STARTED|Overall Study||22||
48621796|NCT01691378|101859714|FG001|STARTED|Overall Study||22||
48621797|NCT01691378|101859713|FG000|COMPLETED|Overall Study||15||
48621798|NCT01691378|101859714|FG001|COMPLETED|Overall Study||20||
48621799|NCT01691378|101859713|FG000|NOT COMPLETED|Overall Study||7||
48621800|NCT01691378|101859714|FG001|NOT COMPLETED|Overall Study||2||
48621801|NCT00577317|101859715|FG000|STARTED|Overall Study||0||
48621802|NCT00577317|101859716|FG001|STARTED|Overall Study||2||
48621803|NCT00577317|101859715|FG000|COMPLETED|Overall Study||0||
48744848|NCT01574274|102161795|FG000|STARTED|Overall Study||119|Randomized|
48744849|NCT01574274|102161796|FG001|STARTED|Overall Study||121|Randomized|
48744850|NCT01574274|102161795|FG000|Evaluable for Induction Events|Overall Study||115||
48744851|NCT01574274|102161796|FG001|Evaluable for Induction Events|Overall Study||115||
48744852|NCT01574274|102161795|FG000|Achieved Complete Remission|Overall Study||109||
48621804|NCT00577317|101859716|FG001|COMPLETED|Overall Study||0||
48621805|NCT00577317|101859715|FG000|NOT COMPLETED|Overall Study||0||
48621806|NCT00577317|101859716|FG001|NOT COMPLETED|Overall Study||2||
48621807|NCT01640548|101859717|FG000|STARTED|Overall Study||309||
48621808|NCT01640548|101859717|FG000|COMPLETED|Overall Study||309||
48621809|NCT01640548|101859717|FG000|NOT COMPLETED|Overall Study||0||
48621810|NCT02364388|101859718|FG000|STARTED|Overall Study||217||
48621811|NCT02364388|101859718|FG000|Biopsied|Overall Study||209||
48621812|NCT02364388|101859718|FG000|Excluded|Overall Study||8||
48621813|NCT02364388|101859718|FG000|COMPLETED|Overall Study||209||
48621814|NCT02364388|101859718|FG000|NOT COMPLETED|Overall Study||8||
48621815|NCT03191552|101859719|FG000|STARTED|Overall Study||9||
48621816|NCT03191552|101859720|FG001|STARTED|Overall Study||9||
48621817|NCT03191552|101859721|FG002|STARTED|Overall Study||8||
48621818|NCT03191552|101859719|FG000|COMPLETED|Overall Study||8||
48621819|NCT03191552|101859720|FG001|COMPLETED|Overall Study||8||
48621820|NCT03191552|101859721|FG002|COMPLETED|Overall Study||8||
48621821|NCT03191552|101859719|FG000|NOT COMPLETED|Overall Study||1||
48621822|NCT03191552|101859720|FG001|NOT COMPLETED|Overall Study||1||
48621823|NCT03191552|101859721|FG002|NOT COMPLETED|Overall Study||0||
48621824|NCT03442725|101859722|FG000|STARTED|Overall Study||8||
48621825|NCT03442725|101859723|FG001|STARTED|Overall Study||8||
48621826|NCT03442725|101859722|FG000|COMPLETED|Overall Study||8||
48621827|NCT03442725|101859723|FG001|COMPLETED|Overall Study||8||
48621828|NCT03442725|101859722|FG000|NOT COMPLETED|Overall Study||0||
48621829|NCT03442725|101859723|FG001|NOT COMPLETED|Overall Study||0||
48621830|NCT03760224|101859724|FG000|STARTED|Overall Study||469||
48621831|NCT03760224|101859725|FG001|STARTED|Overall Study||459||
48621832|NCT03760224|101859724|FG000|COMPLETED|Overall Study||469||
48621833|NCT03760224|101859725|FG001|COMPLETED|Overall Study||459||
48621834|NCT03760224|101859724|FG000|NOT COMPLETED|Overall Study||0||
48621835|NCT03760224|101859725|FG001|NOT COMPLETED|Overall Study||0||
48621836|NCT01484951|101859726|FG000|STARTED|Overall Study||74||
48621837|NCT01484951|101859726|FG000|COMPLETED|Overall Study||69||
48621838|NCT01484951|101859726|FG000|NOT COMPLETED|Overall Study||5||
48621839|NCT00887484|101859727|FG000|STARTED|Split Face Treatment (Weeks 1 and 2)||48||
48621840|NCT00887484|101859727|FG000|COMPLETED|Split Face Treatment (Weeks 1 and 2)||48||
48621841|NCT00887484|101859727|FG000|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0||
48621842|NCT00887484|101859727|FG000|STARTED|Full Face Treatment (Weeks 5 and 8)||48||
48621843|NCT00887484|101859727|FG000|COMPLETED|Full Face Treatment (Weeks 5 and 8)||45||
48744853|NCT01574274|102161796|FG001|Achieved Complete Remission|Overall Study||114||
48744854|NCT01574274|102161795|FG000|Received Post-induction Asparaginase|Overall Study||109||
48744855|NCT01574274|102161796|FG001|Received Post-induction Asparaginase|Overall Study||114||
48621844|NCT00887484|101859727|FG000|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||3||
48621845|NCT00465517|101859728|FG000|STARTED|Overall Study||98||
48621846|NCT00465517|101859729|FG001|STARTED|Overall Study||49||
48621847|NCT00465517|101859728|FG000|COMPLETED|Overall Study||86||
48621848|NCT00465517|101859729|FG001|COMPLETED|Overall Study||45||
48621849|NCT00465517|101859728|FG000|NOT COMPLETED|Overall Study||12||
48621850|NCT00465517|101859729|FG001|NOT COMPLETED|Overall Study||4||
48621851|NCT04789382|101859730|FG000|STARTED|First Wear Period (2 Hours)||9||
48621852|NCT04789382|101859731|FG001|STARTED|First Wear Period (2 Hours)||9||
48621853|NCT04789382|101859732|FG002|STARTED|First Wear Period (2 Hours)||9||
48621854|NCT04789382|101859733|FG003|STARTED|First Wear Period (2 Hours)||9||
48621855|NCT04789382|101859730|FG000|COMPLETED|First Wear Period (2 Hours)||9||
48621856|NCT04789382|101859731|FG001|COMPLETED|First Wear Period (2 Hours)||9||
48621857|NCT04789382|101859732|FG002|COMPLETED|First Wear Period (2 Hours)||9||
48621858|NCT04789382|101859733|FG003|COMPLETED|First Wear Period (2 Hours)||9||
48621859|NCT04789382|101859730|FG000|NOT COMPLETED|First Wear Period (2 Hours)||0||
48621860|NCT04789382|101859731|FG001|NOT COMPLETED|First Wear Period (2 Hours)||0||
48621861|NCT04789382|101859732|FG002|NOT COMPLETED|First Wear Period (2 Hours)||0||
48621862|NCT04789382|101859733|FG003|NOT COMPLETED|First Wear Period (2 Hours)||0||
48621863|NCT04789382|101859730|FG000|STARTED|Washout (Day of & Day Prior to Visit 3)||9||
48621864|NCT04789382|101859731|FG001|STARTED|Washout (Day of & Day Prior to Visit 3)||9||
48621865|NCT04789382|101859732|FG002|STARTED|Washout (Day of & Day Prior to Visit 3)||9||
48621866|NCT04789382|101859733|FG003|STARTED|Washout (Day of & Day Prior to Visit 3)||9||
48621867|NCT04789382|101859730|FG000|COMPLETED|Washout (Day of & Day Prior to Visit 3)||9||
48621868|NCT04789382|101859731|FG001|COMPLETED|Washout (Day of & Day Prior to Visit 3)||9||
48621869|NCT04789382|101859732|FG002|COMPLETED|Washout (Day of & Day Prior to Visit 3)||9||
48621870|NCT04789382|101859733|FG003|COMPLETED|Washout (Day of & Day Prior to Visit 3)||9||
48621871|NCT04789382|101859730|FG000|NOT COMPLETED|Washout (Day of & Day Prior to Visit 3)||0||
48621872|NCT04789382|101859731|FG001|NOT COMPLETED|Washout (Day of & Day Prior to Visit 3)||0||
48621873|NCT04789382|101859732|FG002|NOT COMPLETED|Washout (Day of & Day Prior to Visit 3)||0||
48621874|NCT04789382|101859733|FG003|NOT COMPLETED|Washout (Day of & Day Prior to Visit 3)||0||
48621875|NCT04789382|101859730|FG000|STARTED|Second Wear Period (2 Hours)||9||
48621876|NCT04789382|101859731|FG001|STARTED|Second Wear Period (2 Hours)||9||
48621877|NCT04789382|101859732|FG002|STARTED|Second Wear Period (2 Hours)||9||
48621878|NCT04789382|101859733|FG003|STARTED|Second Wear Period (2 Hours)||9||
48621879|NCT04789382|101859730|FG000|COMPLETED|Second Wear Period (2 Hours)||9||
48621880|NCT04789382|101859731|FG001|COMPLETED|Second Wear Period (2 Hours)||9||
48621881|NCT04789382|101859732|FG002|COMPLETED|Second Wear Period (2 Hours)||9||
48621882|NCT04789382|101859733|FG003|COMPLETED|Second Wear Period (2 Hours)||9||
48621883|NCT04789382|101859730|FG000|NOT COMPLETED|Second Wear Period (2 Hours)||0||
48621884|NCT04789382|101859731|FG001|NOT COMPLETED|Second Wear Period (2 Hours)||0||
48621885|NCT04789382|101859732|FG002|NOT COMPLETED|Second Wear Period (2 Hours)||0||
48165434|NCT00876460|100728520|FG006|COMPLETED|Mono Therapy Phase||0||
48165435|NCT00876460|100728521|FG007|COMPLETED|Mono Therapy Phase||0||
48165436|NCT00876460|100728514|FG000|NOT COMPLETED|Mono Therapy Phase||0||
48165437|NCT00876460|100728515|FG001|NOT COMPLETED|Mono Therapy Phase||1||
48165438|NCT00876460|100728516|FG002|NOT COMPLETED|Mono Therapy Phase||0||
48165439|NCT00876460|100728517|FG003|NOT COMPLETED|Mono Therapy Phase||1||
48165440|NCT00876460|100728518|FG004|NOT COMPLETED|Mono Therapy Phase||2||
48165441|NCT00876460|100728519|FG005|NOT COMPLETED|Mono Therapy Phase||0||
48165442|NCT00876460|100728520|FG006|NOT COMPLETED|Mono Therapy Phase||1||
48165443|NCT00876460|100728521|FG007|NOT COMPLETED|Mono Therapy Phase||3||
48165444|NCT04591977|100728522|FG000|STARTED|Overall Study||46||
48165445|NCT04591977|100728522|FG000|COMPLETED|Overall Study||35||
48165446|NCT04591977|100728522|FG000|NOT COMPLETED|Overall Study||11||
48165447|NCT04244396|100728523|FG000|STARTED|Overall Study||82||
48165448|NCT04244396|100728523|FG000|Procedure Completed|Overall Study||81||
48165449|NCT04244396|100728523|FG000|7-Day Follow-up|Overall Study||81||
48165450|NCT04244396|100728523|FG000|14-Day Follow-up|Overall Study||81||
48165451|NCT04244396|100728523|FG000|3-Month Follow-up|Overall Study||79||
48165452|NCT04244396|100728523|FG000|6-Month Follow-up|Overall Study||76|Withdraw prior to 6M visit N = 4|
48165453|NCT04244396|100728523|FG000|12-Month Follow-up|Overall Study||54|Withdraw prior to 12M visit N = 22|
48165454|NCT04244396|100728523|FG000|15-Month Follow-up|Overall Study||37|Withdraw prior to 15M visit N = 13|
48165455|NCT04244396|100728523|FG000|COMPLETED|Overall Study||42||
48165456|NCT04244396|100728523|FG000|NOT COMPLETED|Overall Study||40||
48165457|NCT03311230|100728524|FG000|STARTED|Overall Study||151||
48165458|NCT03311230|100728525|FG001|STARTED|Overall Study||151||
48165459|NCT03311230|100728526|FG002|STARTED|Overall Study||150||
48165460|NCT03311230|100728527|FG003|STARTED|Overall Study||150||
48165461|NCT03311230|100728524|FG000|COMPLETED|Overall Study||150||
48165462|NCT03311230|100728525|FG001|COMPLETED|Overall Study||146||
48165463|NCT03311230|100728526|FG002|COMPLETED|Overall Study||148||
48165464|NCT03311230|100728527|FG003|COMPLETED|Overall Study||143||
48165465|NCT03311230|100728524|FG000|NOT COMPLETED|Overall Study||1||
48165466|NCT03311230|100728525|FG001|NOT COMPLETED|Overall Study||5||
48165467|NCT03311230|100728526|FG002|NOT COMPLETED|Overall Study||2||
48165468|NCT03311230|100728527|FG003|NOT COMPLETED|Overall Study||7||
48165469|NCT00856661|100728528|FG000|STARTED|Overall Study||135||
48165470|NCT00856661|100728529|FG001|STARTED|Overall Study||135||
48165471|NCT00856661|100728528|FG000|Treated|Overall Study||126||
48165472|NCT00856661|100728529|FG001|Treated|Overall Study||131||
48165473|NCT00856661|100728528|FG000|Randomized Not Treated|Overall Study||9||
48165474|NCT00856661|100728529|FG001|Randomized Not Treated|Overall Study||4||
48165475|NCT00856661|100728528|FG000|COMPLETED|Overall Study||108||
48165476|NCT00856661|100728529|FG001|COMPLETED|Overall Study||106||
48165477|NCT00856661|100728528|FG000|NOT COMPLETED|Overall Study||27||
48165478|NCT00856661|100728529|FG001|NOT COMPLETED|Overall Study||29||
48165479|NCT02716038|100728530|FG000|STARTED|Overall Study||31||
48165480|NCT02716038|100728530|FG000|COMPLETED|Overall Study||26||
48165481|NCT02716038|100728530|FG000|NOT COMPLETED|Overall Study||5||
48165482|NCT00728962|100728531|FG000|STARTED|Implant Placement Surgery||75||
48165483|NCT00728962|100728531|FG000|COMPLETED|Implant Placement Surgery||65||
48621886|NCT04789382|101859733|FG003|NOT COMPLETED|Second Wear Period (2 Hours)||0||
48621887|NCT01534273|101859734|FG000|STARTED|Period 1||3||
48621888|NCT01534273|101859735|FG001|STARTED|Period 1||6||
48621889|NCT01534273|101859736|FG002|STARTED|Period 1||2||
48621890|NCT01534273|101859737|FG003|STARTED|Period 1||7||
48621891|NCT01534273|101859738|FG004|STARTED|Period 1||3||
48621892|NCT01534273|101859739|FG005|STARTED|Period 1||3||
48621893|NCT01534273|101859740|FG006|STARTED|Period 1||6||
48621894|NCT01534273|101859734|FG000|Received at Least 1 Dose of Study Drug|Period 1||3||
48621895|NCT01534273|101859735|FG001|Received at Least 1 Dose of Study Drug|Period 1||6||
48621896|NCT01534273|101859736|FG002|Received at Least 1 Dose of Study Drug|Period 1||2||
48621897|NCT01534273|101859737|FG003|Received at Least 1 Dose of Study Drug|Period 1||7||
48621898|NCT01534273|101859738|FG004|Received at Least 1 Dose of Study Drug|Period 1||3||
48621899|NCT01534273|101859739|FG005|Received at Least 1 Dose of Study Drug|Period 1||3||
48621900|NCT01534273|101859740|FG006|Received at Least 1 Dose of Study Drug|Period 1||6||
48165484|NCT00728962|100728531|FG000|NOT COMPLETED|Implant Placement Surgery||10||
48621901|NCT01534273|101859734|FG000|COMPLETED|Period 1||3||
48621902|NCT01534273|101859735|FG001|COMPLETED|Period 1||6||
48165485|NCT00728962|100728531|FG000|STARTED|Permanent Prosthesis Placement||65||
48165486|NCT00728962|100728531|FG000|COMPLETED|Permanent Prosthesis Placement||62||
48165487|NCT00728962|100728531|FG000|NOT COMPLETED|Permanent Prosthesis Placement||3||
48165488|NCT00728962|100728531|FG000|STARTED|One Year Post Placement Follow-up||62||
48165489|NCT00728962|100728531|FG000|COMPLETED|One Year Post Placement Follow-up||62||
48165490|NCT00728962|100728531|FG000|NOT COMPLETED|One Year Post Placement Follow-up||0||
48165491|NCT00728962|100728531|FG000|STARTED|Two Year Post Placement Follow-up||62||
48165492|NCT00728962|100728531|FG000|COMPLETED|Two Year Post Placement Follow-up||59||
48165493|NCT00728962|100728531|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||3||
48165494|NCT01576718|100728532|FG000|STARTED|Pre-Assignment Period (Run-In Placebo)||889||
48165495|NCT01576718|100728533|FG001|STARTED|Pre-Assignment Period (Run-In Placebo)||0||
48165496|NCT01576718|100728534|FG002|STARTED|Pre-Assignment Period (Run-In Placebo)||0||
48165497|NCT01576718|100728535|FG003|STARTED|Pre-Assignment Period (Run-In Placebo)||0||
48165498|NCT01576718|100728536|FG004|STARTED|Pre-Assignment Period (Run-In Placebo)||0||
48165499|NCT01576718|100728537|FG005|STARTED|Pre-Assignment Period (Run-In Placebo)||0||
48165500|NCT01576718|100728538|FG006|STARTED|Pre-Assignment Period (Run-In Placebo)||0||
48165501|NCT01576718|100728532|FG000|COMPLETED|Pre-Assignment Period (Run-In Placebo)||640||
48165502|NCT01576718|100728533|FG001|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
48165503|NCT01576718|100728534|FG002|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
48165504|NCT01576718|100728535|FG003|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
48165505|NCT01576718|100728536|FG004|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
48621903|NCT01534273|101859736|FG002|COMPLETED|Period 1||2||
48621904|NCT01534273|101859737|FG003|COMPLETED|Period 1||6||
48621905|NCT01534273|101859738|FG004|COMPLETED|Period 1||3||
48621906|NCT01534273|101859739|FG005|COMPLETED|Period 1||3||
48621907|NCT01534273|101859740|FG006|COMPLETED|Period 1||6||
48621908|NCT01534273|101859734|FG000|NOT COMPLETED|Period 1||0||
48621909|NCT01534273|101859735|FG001|NOT COMPLETED|Period 1||0||
48621910|NCT01534273|101859736|FG002|NOT COMPLETED|Period 1||0||
48621911|NCT01534273|101859737|FG003|NOT COMPLETED|Period 1||1||
48621912|NCT01534273|101859738|FG004|NOT COMPLETED|Period 1||0||
48621913|NCT01534273|101859739|FG005|NOT COMPLETED|Period 1||0||
48621914|NCT01534273|101859740|FG006|NOT COMPLETED|Period 1||0||
48621915|NCT01534273|101859734|FG000|STARTED|Period 2||0||
48621916|NCT01534273|101859735|FG001|STARTED|Period 2||0||
48621917|NCT01534273|101859736|FG002|STARTED|Period 2||2||
48165506|NCT01576718|100728537|FG005|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
48165507|NCT01576718|100728538|FG006|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
48165508|NCT01576718|100728532|FG000|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||249||
48165509|NCT01576718|100728533|FG001|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
48165510|NCT01576718|100728534|FG002|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
48165511|NCT01576718|100728535|FG003|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
48165512|NCT01576718|100728536|FG004|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
48165513|NCT01576718|100728537|FG005|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
48165514|NCT01576718|100728538|FG006|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
48165515|NCT01576718|100728532|FG000|STARTED|Treatment Period||0||
48165516|NCT01576718|100728533|FG001|STARTED|Treatment Period||107||
48744856|NCT01574274|102161795|FG000|Eligible|Overall Study||119||
48744857|NCT01574274|102161796|FG001|Eligible|Overall Study||120||
48744858|NCT01574274|102161795|FG000|COMPLETED|Overall Study||87||
48744859|NCT01574274|102161796|FG001|COMPLETED|Overall Study||99||
48165517|NCT01576718|100728534|FG002|STARTED|Treatment Period||107||
48165518|NCT01576718|100728535|FG003|STARTED|Treatment Period||106||
48165519|NCT01576718|100728536|FG004|STARTED|Treatment Period||107||
48165520|NCT01576718|100728537|FG005|STARTED|Treatment Period||106||
48165521|NCT01576718|100728538|FG006|STARTED|Treatment Period||107||
48165522|NCT01576718|100728532|FG000|Safety Population|Treatment Period||0||
48165523|NCT01576718|100728533|FG001|Safety Population|Treatment Period||107||
48165524|NCT01576718|100728534|FG002|Safety Population|Treatment Period||107||
48165525|NCT01576718|100728535|FG003|Safety Population|Treatment Period||106||
48165526|NCT01576718|100728536|FG004|Safety Population|Treatment Period||107||
48165527|NCT01576718|100728537|FG005|Safety Population|Treatment Period||106||
48165528|NCT01576718|100728538|FG006|Safety Population|Treatment Period||106||
48165529|NCT01576718|100728532|FG000|Efficacy Population (Full Analysis Set)|Treatment Period||0||
48165530|NCT01576718|100728533|FG001|Efficacy Population (Full Analysis Set)|Treatment Period||107||
48328204|NCT01687712|101131911|FG001|COMPLETED|Cycle 2||25|A subject is listed as Completed if they delivered at least one live neonate.|
48328205|NCT01687712|101131910|FG000|NOT COMPLETED|Cycle 2||93||
48621918|NCT01534273|101859737|FG003|STARTED|Period 2||6||
48621919|NCT01534273|101859738|FG004|STARTED|Period 2||0||
48621920|NCT01534273|101859739|FG005|STARTED|Period 2||0||
48744860|NCT01574274|102161795|FG000|NOT COMPLETED|Overall Study||32||
48744861|NCT01574274|102161796|FG001|NOT COMPLETED|Overall Study||22||
48744862|NCT00490269|102161797|FG000|STARTED|Dronabinol Then Placebo||6||
48744863|NCT00490269|102161798|FG001|STARTED|Dronabinol Then Placebo||6||
48621921|NCT01534273|101859740|FG006|STARTED|Period 2||0||
48621922|NCT01534273|101859734|FG000|COMPLETED|Period 2||0||
48621923|NCT01534273|101859735|FG001|COMPLETED|Period 2||0||
48621924|NCT01534273|101859736|FG002|COMPLETED|Period 2||2||
48621925|NCT01534273|101859737|FG003|COMPLETED|Period 2||6||
48621926|NCT01534273|101859738|FG004|COMPLETED|Period 2||0||
48621927|NCT01534273|101859739|FG005|COMPLETED|Period 2||0||
48621928|NCT01534273|101859740|FG006|COMPLETED|Period 2||0||
48621929|NCT01534273|101859734|FG000|NOT COMPLETED|Period 2||0||
48744864|NCT00490269|102161797|FG000|COMPLETED|Dronabinol Then Placebo||6||
48165531|NCT01576718|100728534|FG002|Efficacy Population (Full Analysis Set)|Treatment Period||106||
48165532|NCT01576718|100728535|FG003|Efficacy Population (Full Analysis Set)|Treatment Period||102||
48165533|NCT01576718|100728536|FG004|Efficacy Population (Full Analysis Set)|Treatment Period||107||
48165534|NCT01576718|100728537|FG005|Efficacy Population (Full Analysis Set)|Treatment Period||105||
48621930|NCT01534273|101859735|FG001|NOT COMPLETED|Period 2||0||
48621931|NCT01534273|101859736|FG002|NOT COMPLETED|Period 2||0||
48621932|NCT01534273|101859737|FG003|NOT COMPLETED|Period 2||0||
48621933|NCT01534273|101859738|FG004|NOT COMPLETED|Period 2||0||
48621934|NCT01534273|101859739|FG005|NOT COMPLETED|Period 2||0||
48621935|NCT01534273|101859740|FG006|NOT COMPLETED|Period 2||0||
48165535|NCT01576718|100728538|FG006|Efficacy Population (Full Analysis Set)|Treatment Period||103||
48165536|NCT01576718|100728532|FG000|COMPLETED|Treatment Period||0||
48165537|NCT01576718|100728533|FG001|COMPLETED|Treatment Period||82||
48165538|NCT01576718|100728534|FG002|COMPLETED|Treatment Period||87||
48165539|NCT01576718|100728535|FG003|COMPLETED|Treatment Period||75||
48165540|NCT01576718|100728536|FG004|COMPLETED|Treatment Period||80||
48165541|NCT01576718|100728537|FG005|COMPLETED|Treatment Period||58||
48165542|NCT01576718|100728538|FG006|COMPLETED|Treatment Period||77||
48165543|NCT01576718|100728532|FG000|NOT COMPLETED|Treatment Period||0||
48165544|NCT01576718|100728533|FG001|NOT COMPLETED|Treatment Period||25||
48165545|NCT01576718|100728534|FG002|NOT COMPLETED|Treatment Period||20||
48165546|NCT01576718|100728535|FG003|NOT COMPLETED|Treatment Period||31||
48165547|NCT01576718|100728536|FG004|NOT COMPLETED|Treatment Period||27||
48165548|NCT01576718|100728537|FG005|NOT COMPLETED|Treatment Period||48||
48165549|NCT01576718|100728538|FG006|NOT COMPLETED|Treatment Period||30||
48165550|NCT02066402|100728539|FG000|STARTED|Overall Study||300||
48328206|NCT01687712|101131911|FG001|NOT COMPLETED|Cycle 2||95||
48328207|NCT01687712|101131910|FG000|STARTED|Cycle 3||28||
48328208|NCT01687712|101131911|FG001|STARTED|Cycle 3||24||
48328209|NCT01687712|101131910|FG000|Received hCG|Cycle 3||27||
48328210|NCT01687712|101131911|FG001|Received hCG|Cycle 3||24||
48328211|NCT01687712|101131910|FG000|Ooctye/Ovum Pick-Up|Cycle 3||27||
48328212|NCT01687712|101131911|FG001|Ooctye/Ovum Pick-Up|Cycle 3||24||
48328213|NCT01687712|101131910|FG000|Fertilization Performed|Cycle 3||27||
48328214|NCT01687712|101131911|FG001|Fertilization Performed|Cycle 3||24||
48328215|NCT01687712|101131910|FG000|Embryo Transfer|Cycle 3||26||
48328216|NCT01687712|101131911|FG001|Embryo Transfer|Cycle 3||24||
48328217|NCT01687712|101131910|FG000|Biochemically Pregnant|Cycle 3||7||
48328218|NCT01687712|101131911|FG001|Biochemically Pregnant|Cycle 3||2||
48328219|NCT01687712|101131910|FG000|Clinical Pregnancy|Cycle 3||5|Ascertained via an ultrasound scan.|
48328220|NCT01687712|101131911|FG001|Clinical Pregnancy|Cycle 3||0|Ascertained via an ultrasound scan.|
48328221|NCT01687712|101131910|FG000|COMPLETED|Cycle 3||4|A subject is listed as Completed if they delivered at least one live neonate.|
48165551|NCT02066402|100728540|FG001|STARTED|Overall Study||298||
48165552|NCT02066402|100728539|FG000|Participants Received Treatment|Overall Study||292||
48165553|NCT02066402|100728540|FG001|Participants Received Treatment|Overall Study||297||
48165554|NCT02066402|100728539|FG000|Completed Study Treatment Period|Overall Study||261||
48165555|NCT02066402|100728540|FG001|Completed Study Treatment Period|Overall Study||256||
48165556|NCT02066402|100728539|FG000|COMPLETED|Overall Study||274||
48165557|NCT02066402|100728540|FG001|COMPLETED|Overall Study||275||
48165558|NCT02066402|100728539|FG000|NOT COMPLETED|Overall Study||26||
48165559|NCT02066402|100728540|FG001|NOT COMPLETED|Overall Study||23||
48165560|NCT00299000|100728541|FG000|STARTED|Overall Study||2||
48165561|NCT00299000|100728542|FG001|STARTED|Overall Study||2||
48165562|NCT00299000|100728541|FG000|COMPLETED|Overall Study||2||
48165563|NCT00299000|100728542|FG001|COMPLETED|Overall Study||2||
48165564|NCT00299000|100728541|FG000|NOT COMPLETED|Overall Study||0||
48165565|NCT00299000|100728542|FG001|NOT COMPLETED|Overall Study||0||
48165566|NCT01919996|100728543|FG000|STARTED|Overall Study||8||
48165567|NCT01919996|100728543|FG000|COMPLETED|Overall Study||8||
48165568|NCT01919996|100728543|FG000|NOT COMPLETED|Overall Study||0||
48328222|NCT01687712|101131911|FG001|COMPLETED|Cycle 3||0|A subject is listed as Completed if they delivered at least one live neonate.|
48328223|NCT01687712|101131910|FG000|NOT COMPLETED|Cycle 3||24||
48621936|NCT00767572|101859741|FG000|STARTED|First Intervention (12 Weeks)||12||
48621937|NCT00767572|101859741|FG000|COMPLETED|First Intervention (12 Weeks)||12||
48621938|NCT00767572|101859741|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0||
48165569|NCT03528174|100728544|FG000|STARTED|Overall Study||10||
48165570|NCT03528174|100728544|FG000|COMPLETED|Overall Study||8||
48165571|NCT03528174|100728544|FG000|NOT COMPLETED|Overall Study||2||
48165572|NCT01023568|100728545|FG000|STARTED|Overall Study||45||
48165573|NCT01023568|100728546|FG001|STARTED|Overall Study||44||
48165574|NCT01023568|100728547|FG002|STARTED|Overall Study||45||
48165575|NCT01023568|100728545|FG000|COMPLETED|Overall Study||45||
48165576|NCT01023568|100728546|FG001|COMPLETED|Overall Study||44||
48165577|NCT01023568|100728547|FG002|COMPLETED|Overall Study||45||
48165578|NCT01023568|100728545|FG000|NOT COMPLETED|Overall Study||0||
48165579|NCT01023568|100728546|FG001|NOT COMPLETED|Overall Study||0||
48165580|NCT01023568|100728547|FG002|NOT COMPLETED|Overall Study||0||
48165581|NCT04502056|100728548|FG000|STARTED|Overall Study||2046||
48165582|NCT04502056|100728549|FG001|STARTED|Overall Study||2044||
48165583|NCT04502056|100728550|FG002|STARTED|Overall Study||2045||
48165584|NCT04502056|100728551|FG003|STARTED|Overall Study||2046||
48165585|NCT04502056|100728552|FG004|STARTED|Overall Study||2044||
48165586|NCT04502056|100728553|FG005|STARTED|Overall Study||2052||
48165587|NCT04502056|100728554|FG006|STARTED|Overall Study||2046||
48165588|NCT04502056|100728555|FG007|STARTED|Overall Study||2043||
48165589|NCT04502056|100728556|FG008|STARTED|Overall Study||1026||
48165590|NCT04502056|100728557|FG009|STARTED|Overall Study||1025||
48165591|NCT04502056|100728558|FG010|STARTED|Overall Study||1023||
48165592|NCT04502056|100728559|FG011|STARTED|Overall Study||1020||
48165593|NCT04502056|100728548|FG000|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1859||
48165594|NCT04502056|100728549|FG001|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1881||
48165595|NCT04502056|100728550|FG002|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1879||
48165596|NCT04502056|100728551|FG003|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1886||
48165597|NCT04502056|100728552|FG004|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1846||
48165598|NCT04502056|100728553|FG005|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1877||
48165599|NCT04502056|100728554|FG006|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1888||
48165600|NCT04502056|100728555|FG007|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1883||
48621939|NCT00767572|101859741|FG000|STARTED|Washout (4 Weeks)||12||
48621940|NCT00767572|101859741|FG000|COMPLETED|Washout (4 Weeks)||12||
48621941|NCT00767572|101859741|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
48621942|NCT00767572|101859741|FG000|STARTED|Second Intervention (12 Weeks)||12||
48621943|NCT00767572|101859741|FG000|COMPLETED|Second Intervention (12 Weeks)||12||
48621944|NCT00767572|101859741|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0||
48621945|NCT02672176|101859742|FG000|STARTED|Overall Study||161||
48621946|NCT02672176|101859743|FG001|STARTED|Overall Study||158||
48165601|NCT04502056|100728556|FG008|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||947||
48165602|NCT04502056|100728557|FG009|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||942||
48165603|NCT04502056|100728558|FG010|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||946||
48165604|NCT04502056|100728559|FG011|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||928||
48165605|NCT04502056|100728548|FG000|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1799||
48165606|NCT04502056|100728549|FG001|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1828||
48165607|NCT04502056|100728550|FG002|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1830||
48165608|NCT04502056|100728551|FG003|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1835||
48165609|NCT04502056|100728552|FG004|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1792||
48165610|NCT04502056|100728553|FG005|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1820||
48165611|NCT04502056|100728554|FG006|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1821||
48165612|NCT04502056|100728555|FG007|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1844||
48165613|NCT04502056|100728556|FG008|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||914||
48165614|NCT04502056|100728557|FG009|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||912||
48165615|NCT04502056|100728558|FG010|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||928||
48165616|NCT04502056|100728559|FG011|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||900||
48165617|NCT04502056|100728548|FG000|Completed the Follow-up Survey|Overall Study||608||
48165618|NCT04502056|100728549|FG001|Completed the Follow-up Survey|Overall Study||607||
48165619|NCT04502056|100728550|FG002|Completed the Follow-up Survey|Overall Study||591||
48165620|NCT04502056|100728551|FG003|Completed the Follow-up Survey|Overall Study||601||
48165621|NCT04502056|100728552|FG004|Completed the Follow-up Survey|Overall Study||631||
48165622|NCT04502056|100728553|FG005|Completed the Follow-up Survey|Overall Study||598||
48621947|NCT02672176|101859742|FG000|COMPLETED|Overall Study||155||
48621948|NCT02672176|101859743|FG001|COMPLETED|Overall Study||132||
48621949|NCT02672176|101859742|FG000|NOT COMPLETED|Overall Study||6||
48621950|NCT02672176|101859743|FG001|NOT COMPLETED|Overall Study||26||
48165623|NCT04502056|100728554|FG006|Completed the Follow-up Survey|Overall Study||607||
48165624|NCT04502056|100728555|FG007|Completed the Follow-up Survey|Overall Study||607||
48165625|NCT04502056|100728556|FG008|Completed the Follow-up Survey|Overall Study||301||
48165626|NCT04502056|100728557|FG009|Completed the Follow-up Survey|Overall Study||313||
48165627|NCT04502056|100728558|FG010|Completed the Follow-up Survey|Overall Study||291||
48165628|NCT04502056|100728559|FG011|Completed the Follow-up Survey|Overall Study||316||
48165629|NCT04502056|100728548|FG000|COMPLETED|Overall Study||604|Participants who completed follow-up and have no missing on baseline observables, included for follow-up analysis|
48165630|NCT04502056|100728549|FG001|COMPLETED|Overall Study||602|Participants who completed follow-up and have no missing on baseline observables, included for follow-up analysis|
48165631|NCT04502056|100728550|FG002|COMPLETED|Overall Study||586|Participants who completed follow-up and have no missing on baseline observables, included for follow-up analysis|
48165632|NCT04502056|100728551|FG003|COMPLETED|Overall Study||597|Participants who completed follow-up and have no missing on baseline observables, included for follow-up analysis|
48165633|NCT04502056|100728552|FG004|COMPLETED|Overall Study||626|Participants who completed follow-up and have no missing on baseline observables, included for follow-up analysis|
48165634|NCT04502056|100728553|FG005|COMPLETED|Overall Study||596|Participants who completed follow-up and have no missing on baseline observables, included for follow-up analysis|
48165635|NCT04502056|100728554|FG006|COMPLETED|Overall Study||605|Participants who completed follow-up and have no missing on baseline observables, included for follow-up analysis|
48165636|NCT04502056|100728555|FG007|COMPLETED|Overall Study||603|Participants who completed follow-up and have no missing on baseline observables, included for follow-up analysis|
48165637|NCT04502056|100728556|FG008|COMPLETED|Overall Study||298|Participants who completed follow-up and have no missing on baseline observables, included for follow-up analysis|
48165638|NCT04502056|100728557|FG009|COMPLETED|Overall Study||311|Participants who completed follow-up and have no missing on baseline observables, included for follow-up analysis|
48165639|NCT04502056|100728558|FG010|COMPLETED|Overall Study||288|Participants who completed follow-up and have no missing on baseline observables, included for follow-up analysis|
48165640|NCT04502056|100728559|FG011|COMPLETED|Overall Study||614|Participants who completed follow-up and have no missing on baseline observables, included for follow-up analysis|
48165641|NCT04502056|100728548|FG000|NOT COMPLETED|Overall Study||1442||
48165642|NCT04502056|100728549|FG001|NOT COMPLETED|Overall Study||1442||
48165643|NCT04502056|100728550|FG002|NOT COMPLETED|Overall Study||1459||
48165644|NCT04502056|100728551|FG003|NOT COMPLETED|Overall Study||1449||
48165645|NCT04502056|100728552|FG004|NOT COMPLETED|Overall Study||1418||
48165646|NCT04502056|100728553|FG005|NOT COMPLETED|Overall Study||1456||
48165647|NCT04502056|100728554|FG006|NOT COMPLETED|Overall Study||1441||
48165648|NCT04502056|100728555|FG007|NOT COMPLETED|Overall Study||1440||
48165649|NCT04502056|100728556|FG008|NOT COMPLETED|Overall Study||728||
48621951|NCT02937623|101859744|FG000|STARTED|Overall Study||60||
48621952|NCT02937623|101859745|FG001|STARTED|Overall Study||60||
48621953|NCT02937623|101859744|FG000|COMPLETED|Overall Study||60||
48165650|NCT04502056|100728557|FG009|NOT COMPLETED|Overall Study||714||
48621954|NCT02937623|101859745|FG001|COMPLETED|Overall Study||60||
48621955|NCT02937623|101859744|FG000|NOT COMPLETED|Overall Study||0||
48621956|NCT02937623|101859745|FG001|NOT COMPLETED|Overall Study||0||
48621957|NCT01217827|101859746|FG000|STARTED|Overall Study||46||
48621958|NCT01217827|101859747|FG001|STARTED|Overall Study||43||
48621959|NCT01217827|101859746|FG000|COMPLETED|Overall Study||46||
48621960|NCT01217827|101859747|FG001|COMPLETED|Overall Study||43||
48621961|NCT01217827|101859746|FG000|NOT COMPLETED|Overall Study||0||
48621962|NCT01217827|101859747|FG001|NOT COMPLETED|Overall Study||0||
48744865|NCT00490269|102161798|FG001|COMPLETED|Dronabinol Then Placebo||6||
48744866|NCT00490269|102161797|FG000|NOT COMPLETED|Dronabinol Then Placebo||0||
48744867|NCT00490269|102161798|FG001|NOT COMPLETED|Dronabinol Then Placebo||0||
48744868|NCT00490269|102161797|FG000|STARTED|Placebo Then Dronabinol||6||
48744869|NCT00490269|102161798|FG001|STARTED|Placebo Then Dronabinol||6||
48744870|NCT00490269|102161797|FG000|COMPLETED|Placebo Then Dronabinol||6||
48744871|NCT00490269|102161798|FG001|COMPLETED|Placebo Then Dronabinol||6||
48744872|NCT00490269|102161797|FG000|NOT COMPLETED|Placebo Then Dronabinol||0||
48744873|NCT00490269|102161798|FG001|NOT COMPLETED|Placebo Then Dronabinol||0||
48744874|NCT00502671|102161799|FG000|STARTED|Overall Study||228||
48744875|NCT00502671|102161799|FG000|COMPLETED|Overall Study||151||
48744876|NCT00502671|102161799|FG000|NOT COMPLETED|Overall Study||77||
48409965|NCT01529827|101334826|FG000|COMPLETED|Overall Study||94||
48409966|NCT01529827|101334826|FG000|NOT COMPLETED|Overall Study||0||
48409967|NCT03858686|101334827|FG000|STARTED|Period 1||13||
48409968|NCT03858686|101334828|FG001|STARTED|Period 1||14||
48409969|NCT03858686|101334827|FG000|COMPLETED|Period 1||12||
48409970|NCT03858686|101334828|FG001|COMPLETED|Period 1||11||
48409971|NCT03858686|101334827|FG000|NOT COMPLETED|Period 1||1||
48409972|NCT03858686|101334828|FG001|NOT COMPLETED|Period 1||3||
48409973|NCT03858686|101334827|FG000|STARTED|Washout||12||
48409974|NCT03858686|101334828|FG001|STARTED|Washout||11||
48409975|NCT03858686|101334827|FG000|COMPLETED|Washout||12||
48409976|NCT03858686|101334828|FG001|COMPLETED|Washout||11||
48409977|NCT03858686|101334827|FG000|NOT COMPLETED|Washout||0||
48409978|NCT03858686|101334828|FG001|NOT COMPLETED|Washout||0||
48409979|NCT03858686|101334827|FG000|STARTED|Period 2||12||
48409980|NCT03858686|101334828|FG001|STARTED|Period 2||11||
48409981|NCT03858686|101334827|FG000|COMPLETED|Period 2||12||
48409982|NCT03858686|101334828|FG001|COMPLETED|Period 2||10||
48409983|NCT03858686|101334827|FG000|NOT COMPLETED|Period 2||0||
48409984|NCT03858686|101334828|FG001|NOT COMPLETED|Period 2||1||
48409985|NCT04246489|101334829|FG000|STARTED|Overall Study||146||
48409986|NCT04246489|101334829|FG000|COMPLETED|Overall Study||146||
48409987|NCT04246489|101334829|FG000|NOT COMPLETED|Overall Study||0||
48409988|NCT00528840|101334830|FG000|STARTED|Overall Study||201||
48409989|NCT00528840|101334830|FG000|COMPLETED|Overall Study||168||
48409990|NCT00528840|101334830|FG000|NOT COMPLETED|Overall Study||33||
48409991|NCT03935594|101334831|FG000|STARTED|Overall Study||3||
48409992|NCT03935594|101334831|FG000|PRP Treated|Overall Study||3||
48165651|NCT04502056|100728558|FG010|NOT COMPLETED|Overall Study||735||
48165652|NCT04502056|100728559|FG011|NOT COMPLETED|Overall Study||406||
48165653|NCT03717402|100728560|FG000|STARTED|Overall Study||20||
48165654|NCT03717402|100728560|FG000|COMPLETED|Overall Study||20||
48165655|NCT03717402|100728560|FG000|NOT COMPLETED|Overall Study||0||
48165656|NCT02424591|100728561|FG000|STARTED|Overall Study||22||
48165657|NCT02424591|100728562|FG001|STARTED|Overall Study||23||
48165658|NCT02424591|100728561|FG000|COMPLETED|Overall Study||20||
48165659|NCT02424591|100728562|FG001|COMPLETED|Overall Study||20||
48165660|NCT02424591|100728561|FG000|NOT COMPLETED|Overall Study||2||
48165661|NCT02424591|100728562|FG001|NOT COMPLETED|Overall Study||3||
48165662|NCT00041756|100728563|FG000|STARTED|Overall Study||77||
48165663|NCT00041756|100728564|FG001|STARTED|Overall Study||80||
48165664|NCT00041756|100728565|FG002|STARTED|Overall Study||79||
48165665|NCT00041756|100728566|FG003|STARTED|Overall Study||80||
48165666|NCT00041756|100728567|FG004|STARTED|Overall Study||79||
48165667|NCT00041756|100728563|FG000|COMPLETED|Overall Study||69||
48165668|NCT00041756|100728564|FG001|COMPLETED|Overall Study||65||
48165669|NCT00041756|100728565|FG002|COMPLETED|Overall Study||66||
48165670|NCT00041756|100728566|FG003|COMPLETED|Overall Study||64||
48165671|NCT00041756|100728567|FG004|COMPLETED|Overall Study||19||
48165672|NCT00041756|100728563|FG000|NOT COMPLETED|Overall Study||8||
48165673|NCT00041756|100728564|FG001|NOT COMPLETED|Overall Study||15||
48165674|NCT00041756|100728565|FG002|NOT COMPLETED|Overall Study||13||
48165675|NCT00041756|100728566|FG003|NOT COMPLETED|Overall Study||16||
48165676|NCT00041756|100728567|FG004|NOT COMPLETED|Overall Study||60||
48165677|NCT03203694|100728568|FG000|STARTED|Overall Study||13||
48165678|NCT03203694|100728569|FG001|STARTED|Overall Study||13||
48165679|NCT03203694|100728570|FG002|STARTED|Overall Study||15||
48165680|NCT03203694|100728571|FG003|STARTED|Overall Study||18||
48165681|NCT03203694|100728572|FG004|STARTED|Overall Study||20||
48165682|NCT03203694|100728573|FG005|STARTED|Overall Study||20||
48165683|NCT03203694|100728568|FG000|COMPLETED|Overall Study||11||
48165684|NCT03203694|100728569|FG001|COMPLETED|Overall Study||13||
48165685|NCT03203694|100728570|FG002|COMPLETED|Overall Study||15||
48409993|NCT03935594|101334831|FG000|Control|Overall Study||3||
48409994|NCT03935594|101334831|FG000|COMPLETED|Overall Study||0||
48409995|NCT03935594|101334831|FG000|NOT COMPLETED|Overall Study||3||
48409996|NCT02723019|101334832|FG000|STARTED|Overall Study||271||
48409997|NCT02723019|101334833|FG001|STARTED|Overall Study||265||
48409998|NCT02723019|101334832|FG000|COMPLETED|Overall Study||186||
48409999|NCT02723019|101334833|FG001|COMPLETED|Overall Study||175||
48410000|NCT02723019|101334832|FG000|NOT COMPLETED|Overall Study||85||
48621963|NCT00467519|101859748|FG000|STARTED|Overall Study||531||
48410001|NCT02723019|101334833|FG001|NOT COMPLETED|Overall Study||90||
48410002|NCT03676465|101334834|FG000|STARTED|Overall Study||42||21
48410003|NCT03676465|101334835|FG001|STARTED|Overall Study||52||26
48410004|NCT03676465|101334834|FG000|COMPLETED|Overall Study||42||21
48165686|NCT03203694|100728571|FG003|COMPLETED|Overall Study||18||
48165687|NCT03203694|100728572|FG004|COMPLETED|Overall Study||20||
48165688|NCT03203694|100728573|FG005|COMPLETED|Overall Study||20||
48165689|NCT03203694|100728568|FG000|NOT COMPLETED|Overall Study||2||
48165690|NCT03203694|100728569|FG001|NOT COMPLETED|Overall Study||0||
48165691|NCT03203694|100728570|FG002|NOT COMPLETED|Overall Study||0||
48165692|NCT03203694|100728571|FG003|NOT COMPLETED|Overall Study||0||
48165693|NCT03203694|100728572|FG004|NOT COMPLETED|Overall Study||0||
48165694|NCT03203694|100728573|FG005|NOT COMPLETED|Overall Study||0||
48165695|NCT01372605|100728574|FG000|STARTED|Overall Study||149||
48410005|NCT03676465|101334835|FG001|COMPLETED|Overall Study||44||22
48744877|NCT03071887|102161800|FG000|STARTED|Overall Study||13||
48744878|NCT03071887|102161800|FG000|COMPLETED|Overall Study||7||
48744879|NCT03071887|102161800|FG000|NOT COMPLETED|Overall Study||6||
48744880|NCT00354679|102161801|FG000|STARTED|Overall Study||34||
48744881|NCT00354679|102161801|FG000|COMPLETED|Overall Study||33||
48744882|NCT00354679|102161801|FG000|NOT COMPLETED|Overall Study||1||
48744883|NCT02093793|102161802|FG000|STARTED|Overall Study||98||
48744884|NCT02093793|102161803|FG001|STARTED|Overall Study||90||
48744885|NCT02093793|102161804|FG002|STARTED|Overall Study||68||
48744886|NCT02093793|102161802|FG000|COMPLETED|Overall Study||91||
48744887|NCT02093793|102161803|FG001|COMPLETED|Overall Study||80||
48744888|NCT02093793|102161804|FG002|COMPLETED|Overall Study||65||
48744889|NCT02093793|102161802|FG000|NOT COMPLETED|Overall Study||7||
48744890|NCT02093793|102161803|FG001|NOT COMPLETED|Overall Study||10||
48744891|NCT02093793|102161804|FG002|NOT COMPLETED|Overall Study||3||
48744892|NCT01619839|102161805|FG000|STARTED|Overall Study||48||
48744893|NCT01619839|102161806|FG001|STARTED|Overall Study||31||
48744894|NCT01619839|102161807|FG002|STARTED|Overall Study||18||
48744895|NCT01619839|102161808|FG003|STARTED|Overall Study||10||
48621964|NCT00467519|101859749|FG001|STARTED|Overall Study||511||
48621965|NCT00467519|101859748|FG000|COMPLETED|Overall Study||517||
48621966|NCT00467519|101859749|FG001|COMPLETED|Overall Study||488||
48621967|NCT00467519|101859748|FG000|NOT COMPLETED|Overall Study||14||
48621968|NCT00467519|101859749|FG001|NOT COMPLETED|Overall Study||23||
48621969|NCT05401565|101859750|FG000|STARTED|Overall Study||16||
48621970|NCT05401565|101859751|FG001|STARTED|Overall Study||13||
48621971|NCT05401565|101859750|FG000|COMPLETED|Overall Study||13||
48621972|NCT05401565|101859751|FG001|COMPLETED|Overall Study||13||
48621973|NCT05401565|101859750|FG000|NOT COMPLETED|Overall Study||3||
48621974|NCT05401565|101859751|FG001|NOT COMPLETED|Overall Study||0||
48621975|NCT02731300|101859752|FG000|STARTED|Overall Study||15||
48621976|NCT02731300|101859753|FG001|STARTED|Overall Study||7||
48621977|NCT02731300|101859752|FG000|COMPLETED|Overall Study||15||
48621978|NCT02731300|101859753|FG001|COMPLETED|Overall Study||7||
48621979|NCT02731300|101859752|FG000|NOT COMPLETED|Overall Study||0||
48621980|NCT02731300|101859753|FG001|NOT COMPLETED|Overall Study||0||
48621981|NCT03117634|101859754|FG000|STARTED|Overall Study||41||41
48621982|NCT03117634|101859755|FG001|STARTED|Overall Study||13||13
48621983|NCT03117634|101859754|FG000|COMPLETED|Overall Study||39||39
48621984|NCT03117634|101859755|FG001|COMPLETED|Overall Study||13||13
48621985|NCT03117634|101859754|FG000|NOT COMPLETED|Overall Study||2||2
48621986|NCT03117634|101859755|FG001|NOT COMPLETED|Overall Study||0||0
48621987|NCT04685993|101859756|FG000|STARTED|Overall Study||25||
48328224|NCT01687712|101131911|FG001|NOT COMPLETED|Cycle 3||24||
48328225|NCT02937350|101131912|FG000|STARTED|Overall Study||43||
48328226|NCT02937350|101131913|FG001|STARTED|Overall Study||25||
48328227|NCT02937350|101131914|FG002|STARTED|Overall Study||20||
48621988|NCT04685993|101859756|FG000|COMPLETED|Overall Study||23||
48621989|NCT04685993|101859756|FG000|NOT COMPLETED|Overall Study||2||
48621990|NCT03177148|101859757|FG000|STARTED|Overall Study||340||9
48621991|NCT03177148|101859758|FG001|STARTED|Overall Study||12||9
48621992|NCT03177148|101859757|FG000|COMPLETED|Overall Study||289||8
48744896|NCT01619839|102161809|FG004|STARTED|Overall Study||106||
48744897|NCT01619839|102161805|FG000|COMPLETED|Overall Study||43||
48744898|NCT01619839|102161806|FG001|COMPLETED|Overall Study||27||
48744899|NCT01619839|102161807|FG002|COMPLETED|Overall Study||17||
48744900|NCT01619839|102161808|FG003|COMPLETED|Overall Study||9||
48744901|NCT01619839|102161809|FG004|COMPLETED|Overall Study||97||
48744902|NCT01619839|102161805|FG000|NOT COMPLETED|Overall Study||5||
48744903|NCT01619839|102161806|FG001|NOT COMPLETED|Overall Study||4||
48744904|NCT01619839|102161807|FG002|NOT COMPLETED|Overall Study||1||
48744905|NCT01619839|102161808|FG003|NOT COMPLETED|Overall Study||1||
48744906|NCT01619839|102161809|FG004|NOT COMPLETED|Overall Study||9||
48744907|NCT01168726|102161810|FG000|STARTED|Overall Study||111||
48744908|NCT01168726|102161811|FG001|STARTED|Overall Study||121||
48744909|NCT01168726|102161812|FG002|STARTED|Overall Study||133||
48744910|NCT01168726|102161810|FG000|COMPLETED|Overall Study||103||
48744911|NCT01168726|102161811|FG001|COMPLETED|Overall Study||112||
48744912|NCT01168726|102161812|FG002|COMPLETED|Overall Study||128||
48744913|NCT01168726|102161810|FG000|NOT COMPLETED|Overall Study||8||
48744914|NCT01168726|102161811|FG001|NOT COMPLETED|Overall Study||9||
48744915|NCT01168726|102161812|FG002|NOT COMPLETED|Overall Study||5||
48744916|NCT01521507|102161813|FG000|STARTED|Stage 1: Randomized Design||101||
48744917|NCT01521507|102161814|FG001|STARTED|Stage 1: Randomized Design||99||
48744918|NCT01521507|102161813|FG000|Received Initial Treatment (Tx)|Stage 1: Randomized Design||99||
48744919|NCT01521507|102161814|FG001|Received Initial Treatment (Tx)|Stage 1: Randomized Design||98||
48744920|NCT01521507|102161813|FG000|COMPLETED|Stage 1: Randomized Design||98||
48744921|NCT01521507|102161814|FG001|COMPLETED|Stage 1: Randomized Design||94||
48744922|NCT01521507|102161813|FG000|NOT COMPLETED|Stage 1: Randomized Design||3||
48744923|NCT01521507|102161814|FG001|NOT COMPLETED|Stage 1: Randomized Design||5||
48744924|NCT01521507|102161813|FG000|STARTED|Stage 2: Observational Design||98||
48744925|NCT01521507|102161814|FG001|STARTED|Stage 2: Observational Design||94||
48744926|NCT01521507|102161813|FG000|Received Crossover LipiFlow Tx|Stage 2: Observational Design||0||
48744927|NCT01521507|102161814|FG001|Received Crossover LipiFlow Tx|Stage 2: Observational Design||93||
48744928|NCT01521507|102161813|FG000|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||81||
48744929|NCT01521507|102161814|FG001|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||82||
48744930|NCT01521507|102161813|FG000|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||11||
48744931|NCT01521507|102161814|FG001|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||9||
48744932|NCT01521507|102161813|FG000|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||2||
48744933|NCT01521507|102161814|FG001|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||1||
48744934|NCT01521507|102161813|FG000|COMPLETED|Stage 2: Observational Design||94||
48744935|NCT01521507|102161814|FG001|COMPLETED|Stage 2: Observational Design||92||
48744936|NCT01521507|102161813|FG000|NOT COMPLETED|Stage 2: Observational Design||4||
48744937|NCT01521507|102161814|FG001|NOT COMPLETED|Stage 2: Observational Design||2||
48744938|NCT00626275|102161815|FG000|STARTED|Part A - Treatment Period 1||7||
48744939|NCT00626275|102161816|FG001|STARTED|Part A - Treatment Period 1||7||
48744940|NCT00626275|102161817|FG002|STARTED|Part A - Treatment Period 1||7||
48744941|NCT00626275|102161818|FG003|STARTED|Part A - Treatment Period 1||8||
48744942|NCT00626275|102161819|FG004|STARTED|Part A - Treatment Period 1||9||
48744943|NCT00626275|102161820|FG005|STARTED|Part A - Treatment Period 1||8||
48744944|NCT00626275|102161821|FG006|STARTED|Part A - Treatment Period 1||0||
48744945|NCT00626275|102161822|FG007|STARTED|Part A - Treatment Period 1||0||
48621993|NCT03177148|101859758|FG001|COMPLETED|Overall Study||11||8
48621994|NCT03177148|101859757|FG000|NOT COMPLETED|Overall Study||51||1
48621995|NCT03177148|101859758|FG001|NOT COMPLETED|Overall Study||1||1
48621996|NCT02277028|101859759|FG000|STARTED|Overall Study||8||
48621997|NCT02277028|101859760|FG001|STARTED|Overall Study||8||
48621998|NCT02277028|101859759|FG000|COMPLETED|Overall Study||7||
48621999|NCT02277028|101859760|FG001|COMPLETED|Overall Study||7||
48622000|NCT02277028|101859759|FG000|NOT COMPLETED|Overall Study||1||
48622001|NCT02277028|101859760|FG001|NOT COMPLETED|Overall Study||1||
48622002|NCT02374320|101859761|FG000|STARTED|Overall Study||13||
48622003|NCT02374320|101859761|FG000|COMPLETED|Overall Study||13||
48328228|NCT02937350|101131912|FG000|COMPLETED|Overall Study||43||
48622004|NCT02374320|101859761|FG000|NOT COMPLETED|Overall Study||0||
48165696|NCT01372605|100728575|FG001|STARTED|Overall Study||155||
48165697|NCT01372605|100728574|FG000|COMPLETED|Overall Study||137||
48165698|NCT01372605|100728575|FG001|COMPLETED|Overall Study||145||
48165699|NCT01372605|100728574|FG000|NOT COMPLETED|Overall Study||12||
48410006|NCT03676465|101334834|FG000|NOT COMPLETED|Overall Study||0||0
48410007|NCT03676465|101334835|FG001|NOT COMPLETED|Overall Study||8||4
48410008|NCT02485860|101334836|FG000|STARTED|Overall Study||50||
48410009|NCT02485860|101334837|FG001|STARTED|Overall Study||50||
48410010|NCT02485860|101334836|FG000|COMPLETED|Overall Study||44||
48410011|NCT02485860|101334837|FG001|COMPLETED|Overall Study||47||
48410012|NCT02485860|101334836|FG000|NOT COMPLETED|Overall Study||6||
48410013|NCT02485860|101334837|FG001|NOT COMPLETED|Overall Study||3||
48410014|NCT01003067|101334838|FG000|STARTED|Overall Study||136||
48744946|NCT00626275|102161815|FG000|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7||
48744947|NCT00626275|102161816|FG001|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7||
48744948|NCT00626275|102161817|FG002|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7||
48744949|NCT00626275|102161818|FG003|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8||
48744950|NCT00626275|102161819|FG004|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||9||
48410015|NCT01003067|101334839|FG001|STARTED|Overall Study||131||
48622005|NCT00452439|101859762|FG000|STARTED|Overall Study||36||
48622006|NCT00452439|101859763|FG001|STARTED|Overall Study||36||
48622007|NCT00452439|101859762|FG000|COMPLETED|Overall Study||22||
48744951|NCT00626275|102161820|FG005|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8||
48622008|NCT00452439|101859763|FG001|COMPLETED|Overall Study||29||
48622009|NCT00452439|101859762|FG000|NOT COMPLETED|Overall Study||14||
48622010|NCT00452439|101859763|FG001|NOT COMPLETED|Overall Study||7||
48744952|NCT00626275|102161821|FG006|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0||
48744953|NCT00626275|102161822|FG007|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0||
48744954|NCT00626275|102161815|FG000|COMPLETED|Part A - Treatment Period 1||6||
48744955|NCT00626275|102161816|FG001|COMPLETED|Part A - Treatment Period 1||7||
48744956|NCT00626275|102161817|FG002|COMPLETED|Part A - Treatment Period 1||6||
48744957|NCT00626275|102161818|FG003|COMPLETED|Part A - Treatment Period 1||8||
48744958|NCT00626275|102161819|FG004|COMPLETED|Part A - Treatment Period 1||9||
48744959|NCT00626275|102161820|FG005|COMPLETED|Part A - Treatment Period 1||8||
48744960|NCT00626275|102161821|FG006|COMPLETED|Part A - Treatment Period 1||0||
48410016|NCT01003067|101334838|FG000|COMPLETED|Overall Study||103||
48410017|NCT01003067|101334839|FG001|COMPLETED|Overall Study||107||
48410018|NCT01003067|101334838|FG000|NOT COMPLETED|Overall Study||33||
48410019|NCT01003067|101334839|FG001|NOT COMPLETED|Overall Study||24||
48410020|NCT02044367|101334840|FG000|STARTED|Overall Study||9||
48410021|NCT02044367|101334841|FG001|STARTED|Overall Study||9||
48410022|NCT02044367|101334842|FG002|STARTED|Overall Study||9||
48410023|NCT02044367|101334843|FG003|STARTED|Overall Study||9||
48410024|NCT02044367|101334844|FG004|STARTED|Overall Study||9||
48410025|NCT02044367|101334845|FG005|STARTED|Overall Study||9||
48410026|NCT02044367|101334840|FG000|COMPLETED|Overall Study||9||
48410027|NCT02044367|101334841|FG001|COMPLETED|Overall Study||9||
48410028|NCT02044367|101334842|FG002|COMPLETED|Overall Study||9||
48410029|NCT02044367|101334843|FG003|COMPLETED|Overall Study||9||
48410030|NCT02044367|101334844|FG004|COMPLETED|Overall Study||9||
48410031|NCT02044367|101334845|FG005|COMPLETED|Overall Study||9||
48410032|NCT02044367|101334840|FG000|NOT COMPLETED|Overall Study||0||
48410033|NCT02044367|101334841|FG001|NOT COMPLETED|Overall Study||0||
48410034|NCT02044367|101334842|FG002|NOT COMPLETED|Overall Study||0||
48410035|NCT02044367|101334843|FG003|NOT COMPLETED|Overall Study||0||
48410036|NCT02044367|101334844|FG004|NOT COMPLETED|Overall Study||0||
48622011|NCT04846270|101859764|FG000|STARTED|Overall Study||35||
48622012|NCT04846270|101859764|FG000|COMPLETED|Overall Study||35||
48622013|NCT04846270|101859764|FG000|NOT COMPLETED|Overall Study||0||
48622014|NCT00289276|101859765|FG000|STARTED|First Part of FAST Study (Pivotal)||47||
48622015|NCT00289276|101859766|FG001|STARTED|First Part of FAST Study (Pivotal)||0||
48622016|NCT00289276|101859765|FG000|COMPLETED|First Part of FAST Study (Pivotal)||47||
48622017|NCT00289276|101859766|FG001|COMPLETED|First Part of FAST Study (Pivotal)||0||
48622018|NCT00289276|101859765|FG000|NOT COMPLETED|First Part of FAST Study (Pivotal)||0||
48622019|NCT00289276|101859766|FG001|NOT COMPLETED|First Part of FAST Study (Pivotal)||0||
48622020|NCT00289276|101859765|FG000|STARTED|Second Part of FAST Study (Expansion)||0||
48622021|NCT00289276|101859766|FG001|STARTED|Second Part of FAST Study (Expansion)||109||
48622022|NCT00289276|101859765|FG000|COMPLETED|Second Part of FAST Study (Expansion)||0||
48744961|NCT00626275|102161822|FG007|COMPLETED|Part A - Treatment Period 1||0||
48744962|NCT00626275|102161815|FG000|NOT COMPLETED|Part A - Treatment Period 1||1||
48744963|NCT00626275|102161816|FG001|NOT COMPLETED|Part A - Treatment Period 1||0||
48744964|NCT00626275|102161817|FG002|NOT COMPLETED|Part A - Treatment Period 1||1||
48744965|NCT00626275|102161818|FG003|NOT COMPLETED|Part A - Treatment Period 1||0||
48744966|NCT00626275|102161819|FG004|NOT COMPLETED|Part A - Treatment Period 1||0||
48744967|NCT00626275|102161820|FG005|NOT COMPLETED|Part A - Treatment Period 1||0||
48744968|NCT00626275|102161821|FG006|NOT COMPLETED|Part A - Treatment Period 1||0||
48744969|NCT00626275|102161822|FG007|NOT COMPLETED|Part A - Treatment Period 1||0||
48744970|NCT00626275|102161815|FG000|STARTED|Part A - Washout Period 1||6||
48744971|NCT00626275|102161816|FG001|STARTED|Part A - Washout Period 1||7||
48744972|NCT00626275|102161817|FG002|STARTED|Part A - Washout Period 1||6||
48410037|NCT02044367|101334845|FG005|NOT COMPLETED|Overall Study||0||
48410038|NCT02092324|101334846|FG000|STARTED|Overall Study||51||
48410039|NCT02092324|101334846|FG000|End of Cycle 6|Overall Study||25|We expanded accrual to enroll additional evaluable subjects for analysis of the secondary endpoints.|
48410040|NCT02092324|101334846|FG000|Wildtype CSF3R|Overall Study||23|Participants were stratified by CSF3R mutation status|
48410041|NCT02092324|101334846|FG000|Mutant CSF3R|Overall Study||26|Participants were stratified by CSF3R mutation status|
48410042|NCT02092324|101334846|FG000|COMPLETED|Overall Study||32||
48410043|NCT02092324|101334846|FG000|NOT COMPLETED|Overall Study||19||
48410044|NCT00777257|101334847|FG000|STARTED|Overall Study||444||
48410045|NCT00777257|101334848|FG001|STARTED|Overall Study||450||
48410046|NCT00777257|101334849|FG002|STARTED|Overall Study||451||
48410047|NCT00777257|101334847|FG000|COMPLETED|Overall Study||433||
48410048|NCT00777257|101334848|FG001|COMPLETED|Overall Study||438||
48410049|NCT00777257|101334849|FG002|COMPLETED|Overall Study||442||
48410050|NCT00777257|101334847|FG000|NOT COMPLETED|Overall Study||11||
48410051|NCT00777257|101334848|FG001|NOT COMPLETED|Overall Study||12||
48410052|NCT00777257|101334849|FG002|NOT COMPLETED|Overall Study||9||
48410053|NCT01818765|101334850|FG000|STARTED|Overall Study||20||
48622023|NCT00289276|101859766|FG001|COMPLETED|Second Part of FAST Study (Expansion)||106||
48622024|NCT00289276|101859765|FG000|NOT COMPLETED|Second Part of FAST Study (Expansion)||0||
48622025|NCT00289276|101859766|FG001|NOT COMPLETED|Second Part of FAST Study (Expansion)||3||
48622026|NCT02418234|101859767|FG000|STARTED|Overall Study||314||
48622027|NCT02418234|101859767|FG000|COMPLETED|Overall Study||314||
48622028|NCT02418234|101859767|FG000|NOT COMPLETED|Overall Study||0||
48622029|NCT01919164|101859768|FG000|STARTED|Overall Study||108||
48744973|NCT00626275|102161818|FG003|STARTED|Part A - Washout Period 1||8||
48744974|NCT00626275|102161819|FG004|STARTED|Part A - Washout Period 1||9||
48744975|NCT00626275|102161820|FG005|STARTED|Part A - Washout Period 1||8||
48744976|NCT00626275|102161821|FG006|STARTED|Part A - Washout Period 1||0||
48744977|NCT00626275|102161822|FG007|STARTED|Part A - Washout Period 1||0||
48744978|NCT00626275|102161815|FG000|COMPLETED|Part A - Washout Period 1||6||
48744979|NCT00626275|102161816|FG001|COMPLETED|Part A - Washout Period 1||7||
48744980|NCT00626275|102161817|FG002|COMPLETED|Part A - Washout Period 1||6||
48744981|NCT00626275|102161818|FG003|COMPLETED|Part A - Washout Period 1||8||
48744982|NCT00626275|102161819|FG004|COMPLETED|Part A - Washout Period 1||9||
48744983|NCT00626275|102161820|FG005|COMPLETED|Part A - Washout Period 1||8||
48410054|NCT01818765|101334850|FG000|COMPLETED|Overall Study||18|Assessed at 6 months|
48410055|NCT01818765|101334850|FG000|NOT COMPLETED|Overall Study||2||
48410056|NCT02845440|101334851|FG000|STARTED|Overall Study||333||
48410057|NCT02845440|101334852|FG001|STARTED|Overall Study||336||
48410058|NCT02845440|101334853|FG002|STARTED|Overall Study||341||
48410059|NCT02845440|101334854|FG003|STARTED|Overall Study||78||
48622030|NCT01919164|101859769|FG001|STARTED|Overall Study||110||
48622031|NCT01919164|101859770|FG002|STARTED|Overall Study||111||
48622032|NCT01919164|101859771|FG003|STARTED|Overall Study||110||
48744984|NCT00626275|102161821|FG006|COMPLETED|Part A - Washout Period 1||0||
48744985|NCT00626275|102161822|FG007|COMPLETED|Part A - Washout Period 1||0||
48410060|NCT02845440|101334855|FG004|STARTED|Overall Study||77||
48410061|NCT02845440|101334851|FG000|COMPLETED|Overall Study||201||
48410062|NCT02845440|101334852|FG001|COMPLETED|Overall Study||203||
48410063|NCT02845440|101334853|FG002|COMPLETED|Overall Study||204||
48410064|NCT02845440|101334854|FG003|COMPLETED|Overall Study||49||
48410065|NCT02845440|101334855|FG004|COMPLETED|Overall Study||39||
48410066|NCT02845440|101334851|FG000|NOT COMPLETED|Overall Study||132||
48410067|NCT02845440|101334852|FG001|NOT COMPLETED|Overall Study||133||
48410068|NCT02845440|101334853|FG002|NOT COMPLETED|Overall Study||137||
48410069|NCT02845440|101334854|FG003|NOT COMPLETED|Overall Study||29||
48410070|NCT02845440|101334855|FG004|NOT COMPLETED|Overall Study||38||
48410071|NCT01183481|101334856|FG000|STARTED|Overall Study||19||
48410072|NCT01183481|101334856|FG000|COMPLETED|Overall Study||19||
48410073|NCT01183481|101334856|FG000|NOT COMPLETED|Overall Study||0||
48410074|NCT00608491|101334857|FG000|STARTED|Overall Study||94||
48410075|NCT00608491|101334858|FG001|STARTED|Overall Study||94||
48410076|NCT00608491|101334857|FG000|COMPLETED|Overall Study||73||
48410077|NCT00608491|101334858|FG001|COMPLETED|Overall Study||72||
48410078|NCT00608491|101334857|FG000|NOT COMPLETED|Overall Study||21||
48410079|NCT00608491|101334858|FG001|NOT COMPLETED|Overall Study||22||
48410080|NCT00878644|101334859|FG000|STARTED|Overall Study||155||
48410081|NCT00878644|101334860|FG001|STARTED|Overall Study||140||
48410082|NCT00878644|101334859|FG000|COMPLETED|Overall Study||151||
48165700|NCT01372605|100728575|FG001|NOT COMPLETED|Overall Study||10||
48165701|NCT02087501|100728576|FG000|STARTED|Overall Study||30||
48622033|NCT01919164|101859772|FG004|STARTED|Overall Study||110||
48622034|NCT01919164|101859768|FG000|Safety Analysis Set|Overall Study||107|Arm assignments for participants in Safety Set were based on actual treatment received.|
48622035|NCT01919164|101859769|FG001|Safety Analysis Set|Overall Study||109|Arm assignments for participants in Safety Set were based on actual treatment received.|
48622036|NCT01919164|101859770|FG002|Safety Analysis Set|Overall Study||111|Arm assignments for participants in Safety Set were based on actual treatment received.|
48657111|NCT03761914|101943778|FG000|NOT COMPLETED|Overall Study||0||
48622037|NCT01919164|101859771|FG003|Safety Analysis Set|Overall Study||111|Arm assignments for participants in Safety Set were based on actual treatment received.|
48622038|NCT01919164|101859772|FG004|Safety Analysis Set|Overall Study||109|Arm assignments for participants in Safety Set were based on actual treatment received.|
48622039|NCT01919164|101859768|FG000|COMPLETED|Overall Study||65||
48622040|NCT01919164|101859769|FG001|COMPLETED|Overall Study||80||
48622041|NCT01919164|101859770|FG002|COMPLETED|Overall Study||74||
48622042|NCT01919164|101859771|FG003|COMPLETED|Overall Study||82||
48622043|NCT01919164|101859772|FG004|COMPLETED|Overall Study||77||
48622044|NCT01919164|101859768|FG000|NOT COMPLETED|Overall Study||43||
48622045|NCT01919164|101859769|FG001|NOT COMPLETED|Overall Study||30||
48622046|NCT01919164|101859770|FG002|NOT COMPLETED|Overall Study||37||
48622047|NCT01919164|101859771|FG003|NOT COMPLETED|Overall Study||28||
48622048|NCT01919164|101859772|FG004|NOT COMPLETED|Overall Study||33||
48622049|NCT02457195|101859773|FG000|STARTED|Overall Study||50||
48744986|NCT00626275|102161815|FG000|NOT COMPLETED|Part A - Washout Period 1||0||
48744987|NCT00626275|102161816|FG001|NOT COMPLETED|Part A - Washout Period 1||0||
48744988|NCT00626275|102161817|FG002|NOT COMPLETED|Part A - Washout Period 1||0||
48744989|NCT00626275|102161818|FG003|NOT COMPLETED|Part A - Washout Period 1||0||
48744990|NCT00626275|102161819|FG004|NOT COMPLETED|Part A - Washout Period 1||0||
48744991|NCT00626275|102161820|FG005|NOT COMPLETED|Part A - Washout Period 1||0||
48744992|NCT00626275|102161821|FG006|NOT COMPLETED|Part A - Washout Period 1||0||
48744993|NCT00626275|102161822|FG007|NOT COMPLETED|Part A - Washout Period 1||0||
48744994|NCT00626275|102161815|FG000|STARTED|Part A - Treatment Period 2||6||
48744995|NCT00626275|102161816|FG001|STARTED|Part A - Treatment Period 2||7||
48622050|NCT02457195|101859773|FG000|COMPLETED|Overall Study||41||
48622051|NCT02457195|101859773|FG000|NOT COMPLETED|Overall Study||9||
48744996|NCT00626275|102161817|FG002|STARTED|Part A - Treatment Period 2||6||
48622052|NCT00969228|101859774|FG000|STARTED|Overall Study||508||
48744997|NCT00626275|102161818|FG003|STARTED|Part A - Treatment Period 2||8||
48622053|NCT00969228|101859775|FG001|STARTED|Overall Study||176||
48622054|NCT00969228|101859774|FG000|COMPLETED|Overall Study||465||
48622055|NCT00969228|101859775|FG001|COMPLETED|Overall Study||162||
48622056|NCT00969228|101859774|FG000|NOT COMPLETED|Overall Study||43||
48622057|NCT00969228|101859775|FG001|NOT COMPLETED|Overall Study||14||
48622058|NCT00780975|101859776|FG000|STARTED|Overall Study||8||
48622059|NCT00780975|101859776|FG000|COMPLETED|Overall Study||0||
48622060|NCT00780975|101859776|FG000|NOT COMPLETED|Overall Study||8||
48622061|NCT01328964|101859777|FG000|STARTED|Overall Study||2212||
48622062|NCT01328964|101859778|FG001|STARTED|Overall Study||3270||
48622063|NCT01328964|101859779|FG002|STARTED|Overall Study||4424||
48622064|NCT01328964|101859777|FG000|COMPLETED|Overall Study||2212||
48622065|NCT01328964|101859778|FG001|COMPLETED|Overall Study||3270||
48622066|NCT01328964|101859779|FG002|COMPLETED|Overall Study||4424||
48622067|NCT01328964|101859777|FG000|NOT COMPLETED|Overall Study||0||
48744998|NCT00626275|102161819|FG004|STARTED|Part A - Treatment Period 2||9||
48744999|NCT00626275|102161820|FG005|STARTED|Part A - Treatment Period 2||8||
48745000|NCT00626275|102161821|FG006|STARTED|Part A - Treatment Period 2||0||
48745001|NCT00626275|102161822|FG007|STARTED|Part A - Treatment Period 2||0||
48745002|NCT00626275|102161815|FG000|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6||
48745003|NCT00626275|102161816|FG001|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||7||
48745004|NCT00626275|102161817|FG002|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6||
48745005|NCT00626275|102161818|FG003|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8||
48745006|NCT00626275|102161819|FG004|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||9||
48745007|NCT00626275|102161820|FG005|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8||
48745008|NCT00626275|102161821|FG006|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0||
48745009|NCT00626275|102161822|FG007|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0||
48745010|NCT00626275|102161815|FG000|COMPLETED|Part A - Treatment Period 2||6||
48745011|NCT00626275|102161816|FG001|COMPLETED|Part A - Treatment Period 2||7||
48745012|NCT00626275|102161817|FG002|COMPLETED|Part A - Treatment Period 2||6||
48745013|NCT00626275|102161818|FG003|COMPLETED|Part A - Treatment Period 2||8||
48745014|NCT00626275|102161819|FG004|COMPLETED|Part A - Treatment Period 2||9||
48745015|NCT00626275|102161820|FG005|COMPLETED|Part A - Treatment Period 2||8||
48745016|NCT00626275|102161821|FG006|COMPLETED|Part A - Treatment Period 2||0||
48745017|NCT00626275|102161822|FG007|COMPLETED|Part A - Treatment Period 2||0||
48745018|NCT00626275|102161815|FG000|NOT COMPLETED|Part A - Treatment Period 2||0||
48745019|NCT00626275|102161816|FG001|NOT COMPLETED|Part A - Treatment Period 2||0||
48745020|NCT00626275|102161817|FG002|NOT COMPLETED|Part A - Treatment Period 2||0||
48745021|NCT00626275|102161818|FG003|NOT COMPLETED|Part A - Treatment Period 2||0||
48745022|NCT00626275|102161819|FG004|NOT COMPLETED|Part A - Treatment Period 2||0||
48745023|NCT00626275|102161820|FG005|NOT COMPLETED|Part A - Treatment Period 2||0||
48745024|NCT00626275|102161821|FG006|NOT COMPLETED|Part A - Treatment Period 2||0||
48745025|NCT00626275|102161822|FG007|NOT COMPLETED|Part A - Treatment Period 2||0||
48745026|NCT00626275|102161815|FG000|STARTED|Part A - Washout Period 2||6||
48745027|NCT00626275|102161816|FG001|STARTED|Part A - Washout Period 2||7||
48745028|NCT00626275|102161817|FG002|STARTED|Part A - Washout Period 2||6||
48745029|NCT00626275|102161818|FG003|STARTED|Part A - Washout Period 2||8||
48745030|NCT00626275|102161819|FG004|STARTED|Part A - Washout Period 2||9||
48745031|NCT00626275|102161820|FG005|STARTED|Part A - Washout Period 2||8||
48745032|NCT00626275|102161821|FG006|STARTED|Part A - Washout Period 2||0||
48745033|NCT00626275|102161822|FG007|STARTED|Part A - Washout Period 2||0||
48622068|NCT01328964|101859778|FG001|NOT COMPLETED|Overall Study||0||
48622069|NCT01328964|101859779|FG002|NOT COMPLETED|Overall Study||0||
48622070|NCT01077323|101859780|FG000|STARTED|Overall Study||37097||
48622071|NCT01077323|101859781|FG001|STARTED|Overall Study||620799||
48622072|NCT01077323|101859782|FG002|STARTED|Overall Study||12015600||
48622073|NCT01077323|101859780|FG000|COMPLETED|Overall Study||25719||
48622074|NCT01077323|101859781|FG001|COMPLETED|Overall Study||234536||
48622075|NCT01077323|101859782|FG002|COMPLETED|Overall Study||103511||
48622076|NCT01077323|101859780|FG000|NOT COMPLETED|Overall Study||11378||
48622077|NCT01077323|101859781|FG001|NOT COMPLETED|Overall Study||386263||
48622078|NCT01077323|101859782|FG002|NOT COMPLETED|Overall Study||11912089||
48622079|NCT00377637|101859783|FG000|STARTED|Induction Phase||185||
48622080|NCT00377637|101859784|FG001|STARTED|Induction Phase||185||
48622081|NCT00377637|101859785|FG002|STARTED|Induction Phase||0||
48622082|NCT00377637|101859786|FG003|STARTED|Induction Phase||0||
48622083|NCT00377637|101859783|FG000|Safety Population|Induction Phase||180||
48622084|NCT00377637|101859784|FG001|Safety Population|Induction Phase||184||
48622085|NCT00377637|101859785|FG002|Safety Population|Induction Phase||0||
48622086|NCT00377637|101859786|FG003|Safety Population|Induction Phase||0||
48622087|NCT00377637|101859783|FG000|COMPLETED|Induction Phase||156||
48622088|NCT00377637|101859784|FG001|COMPLETED|Induction Phase||150||
48622089|NCT00377637|101859785|FG002|COMPLETED|Induction Phase||0||
48622090|NCT00377637|101859786|FG003|COMPLETED|Induction Phase||0||
48622091|NCT00377637|101859783|FG000|NOT COMPLETED|Induction Phase||29||
48622092|NCT00377637|101859784|FG001|NOT COMPLETED|Induction Phase||35||
48622093|NCT00377637|101859785|FG002|NOT COMPLETED|Induction Phase||0||
48622094|NCT00377637|101859786|FG003|NOT COMPLETED|Induction Phase||0||
48745034|NCT00626275|102161815|FG000|COMPLETED|Part A - Washout Period 2||6||
48745035|NCT00626275|102161816|FG001|COMPLETED|Part A - Washout Period 2||7||
48745036|NCT00626275|102161817|FG002|COMPLETED|Part A - Washout Period 2||6||
48745037|NCT00626275|102161818|FG003|COMPLETED|Part A - Washout Period 2||8||
48622095|NCT00377637|101859783|FG000|STARTED|Maintenance Phase||0||
48622096|NCT00377637|101859784|FG001|STARTED|Maintenance Phase||0||
48622097|NCT00377637|101859785|FG002|STARTED|Maintenance Phase||116||
48622098|NCT00377637|101859786|FG003|STARTED|Maintenance Phase||111||
48328229|NCT02937350|101131913|FG001|COMPLETED|Overall Study||24||
48328230|NCT02937350|101131914|FG002|COMPLETED|Overall Study||20||
48328231|NCT02937350|101131912|FG000|NOT COMPLETED|Overall Study||0||
48328232|NCT02937350|101131913|FG001|NOT COMPLETED|Overall Study||1||
48328233|NCT02937350|101131914|FG002|NOT COMPLETED|Overall Study||0||
48328234|NCT01489527|101131915|FG000|STARTED|Overall Study||205||
48328235|NCT01489527|101131916|FG001|STARTED|Overall Study||201||
48328236|NCT01489527|101131915|FG000|COMPLETED|Overall Study||183||
48328237|NCT01489527|101131916|FG001|COMPLETED|Overall Study||175||
48328238|NCT01489527|101131915|FG000|NOT COMPLETED|Overall Study||22||
48328239|NCT01489527|101131916|FG001|NOT COMPLETED|Overall Study||26||
48328240|NCT03178487|101131917|FG000|STARTED|Period 1||94||
48328241|NCT03178487|101131918|FG001|STARTED|Period 1||93||
48328242|NCT03178487|101131917|FG000|Received Treatment|Period 1||94||
48328243|NCT03178487|101131918|FG001|Received Treatment|Period 1||93||
48622099|NCT00377637|101859783|FG000|COMPLETED|Maintenance Phase||0||
48622100|NCT00377637|101859784|FG001|COMPLETED|Maintenance Phase||0||
48622101|NCT00377637|101859785|FG002|COMPLETED|Maintenance Phase||73||
48622102|NCT00377637|101859786|FG003|COMPLETED|Maintenance Phase||54||
48622103|NCT00377637|101859783|FG000|NOT COMPLETED|Maintenance Phase||0||
48622104|NCT00377637|101859784|FG001|NOT COMPLETED|Maintenance Phase||0||
48622105|NCT00377637|101859785|FG002|NOT COMPLETED|Maintenance Phase||43||
48622106|NCT00377637|101859786|FG003|NOT COMPLETED|Maintenance Phase||57||
48622107|NCT04773223|101859787|FG000|STARTED|Overall Study||668||
48622108|NCT04773223|101859788|FG001|STARTED|Overall Study||257||
48622109|NCT04773223|101859787|FG000|COMPLETED|Overall Study||600||
48622110|NCT04773223|101859788|FG001|COMPLETED|Overall Study||234||
48622111|NCT04773223|101859787|FG000|NOT COMPLETED|Overall Study||68||
48622112|NCT04773223|101859788|FG001|NOT COMPLETED|Overall Study||23||
48622113|NCT05556148|101859789|FG000|STARTED|Overall Study||136||
48745038|NCT00626275|102161819|FG004|COMPLETED|Part A - Washout Period 2||9||
48745039|NCT00626275|102161820|FG005|COMPLETED|Part A - Washout Period 2||8||
48745040|NCT00626275|102161821|FG006|COMPLETED|Part A - Washout Period 2||0||
48328244|NCT03178487|101131917|FG000|COMPLETED|Period 1||90|Completed Period 1|
48328245|NCT03178487|101131918|FG001|COMPLETED|Period 1||89|Completed Period 1|
48328246|NCT03178487|101131917|FG000|NOT COMPLETED|Period 1||4||
48328247|NCT03178487|101131918|FG001|NOT COMPLETED|Period 1||4||
48328248|NCT03178487|101131917|FG000|STARTED|Period 2||90||
48622114|NCT05556148|101859789|FG000|Modified Intent-To-Treat (mITT) Population|Overall Study||102|The mITT population included all participants who used study product at least once and had data from at least one post-baseline quality of life (QoL) questionnaire to support at least one of the primary endpoint assessments.|
48745041|NCT00626275|102161822|FG007|COMPLETED|Part A - Washout Period 2||0||
48745042|NCT00626275|102161815|FG000|NOT COMPLETED|Part A - Washout Period 2||0||
48745043|NCT00626275|102161816|FG001|NOT COMPLETED|Part A - Washout Period 2||0||
48745044|NCT00626275|102161817|FG002|NOT COMPLETED|Part A - Washout Period 2||0||
48745045|NCT00626275|102161818|FG003|NOT COMPLETED|Part A - Washout Period 2||0||
48745046|NCT00626275|102161819|FG004|NOT COMPLETED|Part A - Washout Period 2||0||
48745047|NCT00626275|102161820|FG005|NOT COMPLETED|Part A - Washout Period 2||0||
48745048|NCT00626275|102161821|FG006|NOT COMPLETED|Part A - Washout Period 2||0||
48745049|NCT00626275|102161822|FG007|NOT COMPLETED|Part A - Washout Period 2||0||
48745050|NCT00626275|102161815|FG000|STARTED|Part A - Treatment Period 3||6||
48745051|NCT00626275|102161816|FG001|STARTED|Part A - Treatment Period 3||7||
48745052|NCT00626275|102161817|FG002|STARTED|Part A - Treatment Period 3||6||
48745053|NCT00626275|102161818|FG003|STARTED|Part A - Treatment Period 3||8||
48745054|NCT00626275|102161819|FG004|STARTED|Part A - Treatment Period 3||9||
48745055|NCT00626275|102161820|FG005|STARTED|Part A - Treatment Period 3||8||
48745056|NCT00626275|102161821|FG006|STARTED|Part A - Treatment Period 3||0||
48745057|NCT00626275|102161822|FG007|STARTED|Part A - Treatment Period 3||0||
48745058|NCT00626275|102161815|FG000|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6||
48745059|NCT00626275|102161816|FG001|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||7||
48745060|NCT00626275|102161817|FG002|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6||
48745061|NCT00626275|102161818|FG003|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8||
48745062|NCT00626275|102161819|FG004|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||9||
48745063|NCT00626275|102161820|FG005|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8||
48745064|NCT00626275|102161821|FG006|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0||
48745065|NCT00626275|102161822|FG007|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0||
48745066|NCT00626275|102161815|FG000|COMPLETED|Part A - Treatment Period 3||6||
48745067|NCT00626275|102161816|FG001|COMPLETED|Part A - Treatment Period 3||7||
48745068|NCT00626275|102161817|FG002|COMPLETED|Part A - Treatment Period 3||6||
48745069|NCT00626275|102161818|FG003|COMPLETED|Part A - Treatment Period 3||8||
48745070|NCT00626275|102161819|FG004|COMPLETED|Part A - Treatment Period 3||9||
48622115|NCT05556148|101859789|FG000|COMPLETED|Overall Study||100||
48622116|NCT05556148|101859789|FG000|NOT COMPLETED|Overall Study||36||
48328249|NCT03178487|101131918|FG001|STARTED|Period 2||89||
48328250|NCT03178487|101131917|FG000|Received Treatment|Period 2||89||
48328251|NCT03178487|101131918|FG001|Received Treatment|Period 2||89||
48165702|NCT02087501|100728576|FG000|COMPLETED|Overall Study||20||
48622117|NCT01061606|101859790|FG000|STARTED|Overall Study||8||
48622118|NCT01061606|101859790|FG000|COMPLETED|Overall Study||0||
48622119|NCT01061606|101859790|FG000|NOT COMPLETED|Overall Study||8||
48622120|NCT01460732|101859791|FG000|STARTED|Overall Study||81||
48622121|NCT01460732|101859791|FG000|COMPLETED|Overall Study||81||
48622122|NCT01460732|101859791|FG000|NOT COMPLETED|Overall Study||0||
48622123|NCT01159574|101859792|FG000|STARTED|Treatment Phase||121||
48165703|NCT02087501|100728576|FG000|NOT COMPLETED|Overall Study||10||
48165704|NCT00094211|100728577|FG000|STARTED|Overall Study||221||
48165705|NCT00094211|100728578|FG001|STARTED|Overall Study||259||
48165706|NCT00094211|100728579|FG002|STARTED|Overall Study||230||
48165707|NCT00094211|100728580|FG003|STARTED|Overall Study||186||
48165708|NCT00094211|100728577|FG000|COMPLETED|Overall Study||212||
48165709|NCT00094211|100728578|FG001|COMPLETED|Overall Study||251||
48165710|NCT00094211|100728579|FG002|COMPLETED|Overall Study||220||
48165711|NCT00094211|100728580|FG003|COMPLETED|Overall Study||179||
48165712|NCT00094211|100728577|FG000|NOT COMPLETED|Overall Study||9||
48165713|NCT00094211|100728578|FG001|NOT COMPLETED|Overall Study||8||
48165714|NCT00094211|100728579|FG002|NOT COMPLETED|Overall Study||10||
48165715|NCT00094211|100728580|FG003|NOT COMPLETED|Overall Study||7||
48165716|NCT04461795|100728581|FG000|STARTED|Overall Study||40||
48165717|NCT04461795|100728581|FG000|COMPLETED|Overall Study||35||
48165718|NCT04461795|100728581|FG000|NOT COMPLETED|Overall Study||5||
48165719|NCT01686581|100728582|FG000|STARTED|Overall Study||641||
48165720|NCT01686581|100728582|FG000|Safety Analysis Set; Received Study Drug|Overall Study||633||
48165721|NCT01686581|100728582|FG000|Completed 24 Months|Overall Study||128||
48165722|NCT01686581|100728582|FG000|COMPLETED|Overall Study||464|Completed=Completed Treatment|
48165723|NCT01686581|100728582|FG000|NOT COMPLETED|Overall Study||177||
48165724|NCT02018445|100728583|FG000|STARTED|Overall Study||36||
48165725|NCT02018445|100728583|FG000|COMPLETED|Overall Study||29||
48165726|NCT02018445|100728583|FG000|NOT COMPLETED|Overall Study||7||
48165727|NCT03202472|100728584|FG000|STARTED|Overall Study||50||
48165728|NCT03202472|100728584|FG000|COMPLETED|Overall Study||50||
48165729|NCT03202472|100728584|FG000|NOT COMPLETED|Overall Study||0||
48165730|NCT01351025|100728585|FG000|STARTED|Week 0 - 20||46||
48165731|NCT01351025|100728586|FG001|STARTED|Week 0 - 20||48||
48165732|NCT01351025|100728585|FG000|COMPLETED|Week 0 - 20||43||
48165733|NCT01351025|100728586|FG001|COMPLETED|Week 0 - 20||47||
48165734|NCT01351025|100728585|FG000|NOT COMPLETED|Week 0 - 20||3||
48622124|NCT01159574|101859792|FG000|COMPLETED|Treatment Phase||100|Completion defined as those that were removed from treatment due to disease progression.|
48622125|NCT01159574|101859792|FG000|NOT COMPLETED|Treatment Phase||21||
48622126|NCT01159574|101859792|FG000|STARTED|Follow Up Phase||112|Follow-up includes all patients except those that passed away on treatment or were non-evaluable.|
48622127|NCT01159574|101859792|FG000|COMPLETED|Follow Up Phase||92||
48622128|NCT01159574|101859792|FG000|NOT COMPLETED|Follow Up Phase||20||
48622129|NCT03200548|101859793|FG000|STARTED|Overall Study||11||
48622130|NCT03200548|101859794|FG001|STARTED|Overall Study||14||
48622131|NCT03200548|101859795|FG002|STARTED|Overall Study||14||
48622132|NCT03200548|101859796|FG003|STARTED|Overall Study||13||
48622133|NCT03200548|101859793|FG000|COMPLETED|Overall Study||6||
48622134|NCT03200548|101859794|FG001|COMPLETED|Overall Study||3||
48622135|NCT03200548|101859795|FG002|COMPLETED|Overall Study||7||
48622136|NCT03200548|101859796|FG003|COMPLETED|Overall Study||7||
48622137|NCT03200548|101859793|FG000|NOT COMPLETED|Overall Study||5||
48165735|NCT01351025|100728586|FG001|NOT COMPLETED|Week 0 - 20||1||
48165736|NCT01351025|100728585|FG000|STARTED|Week 20 - 24||43||
48165737|NCT01351025|100728586|FG001|STARTED|Week 20 - 24||47||
48165738|NCT01351025|100728585|FG000|COMPLETED|Week 20 - 24||43||
48165739|NCT01351025|100728586|FG001|COMPLETED|Week 20 - 24||47||
48165740|NCT01351025|100728585|FG000|NOT COMPLETED|Week 20 - 24||0||
48165741|NCT01351025|100728586|FG001|NOT COMPLETED|Week 20 - 24||0||
48165742|NCT01351025|100728585|FG000|STARTED|Week 24 - 44||43||
48165743|NCT01351025|100728586|FG001|STARTED|Week 24 - 44||47||
48165744|NCT01351025|100728585|FG000|COMPLETED|Week 24 - 44||42||
48165745|NCT01351025|100728586|FG001|COMPLETED|Week 24 - 44||43||
48165746|NCT01351025|100728585|FG000|NOT COMPLETED|Week 24 - 44||1||
48622138|NCT03200548|101859794|FG001|NOT COMPLETED|Overall Study||11||
48165747|NCT01351025|100728586|FG001|NOT COMPLETED|Week 24 - 44||4||
48165748|NCT01351025|100728585|FG000|STARTED|Week 44 - 48||42||
48165749|NCT01351025|100728586|FG001|STARTED|Week 44 - 48||43||
48165750|NCT01351025|100728585|FG000|COMPLETED|Week 44 - 48||42||
48165751|NCT01351025|100728586|FG001|COMPLETED|Week 44 - 48||43||
48165752|NCT01351025|100728585|FG000|NOT COMPLETED|Week 44 - 48||0||
48165753|NCT01351025|100728586|FG001|NOT COMPLETED|Week 44 - 48||0||
48165754|NCT04318093|100728587|FG000|STARTED|Overall Study||13||
48165755|NCT04318093|100728588|FG001|STARTED|Overall Study||12||
48165756|NCT04318093|100728587|FG000|COMPLETED|Overall Study||10||
48165757|NCT04318093|100728588|FG001|COMPLETED|Overall Study||9||
48165758|NCT04318093|100728587|FG000|NOT COMPLETED|Overall Study||3||
48165759|NCT04318093|100728588|FG001|NOT COMPLETED|Overall Study||3||
48165760|NCT02707523|100728589|FG000|STARTED|Overall Study||16||
48165761|NCT02707523|100728590|FG001|STARTED|Overall Study||16||
48165762|NCT02707523|100728591|FG002|STARTED|Overall Study||16||
48165763|NCT02707523|100728589|FG000|COMPLETED|Overall Study||16||
48165764|NCT02707523|100728590|FG001|COMPLETED|Overall Study||16||
48165765|NCT02707523|100728591|FG002|COMPLETED|Overall Study||16||
48165766|NCT02707523|100728589|FG000|NOT COMPLETED|Overall Study||0||
48165767|NCT02707523|100728590|FG001|NOT COMPLETED|Overall Study||0||
48165768|NCT02707523|100728591|FG002|NOT COMPLETED|Overall Study||0||
48165769|NCT02884414|100728592|FG000|STARTED|Overall Study||56||
48165770|NCT02884414|100728592|FG000|COMPLETED|Overall Study||56||
48165771|NCT02884414|100728592|FG000|NOT COMPLETED|Overall Study||0||
48165772|NCT00365378|100728593|FG000|STARTED|Vaccination (Day 1 to Month 7)||1204||
48328252|NCT03178487|101131917|FG000|COMPLETED|Period 2||69||
48328253|NCT03178487|101131918|FG001|COMPLETED|Period 2||70||
48328254|NCT03178487|101131917|FG000|NOT COMPLETED|Period 2||21||
48165773|NCT00365378|100728594|FG001|STARTED|Vaccination (Day 1 to Month 7)||1205||
48165774|NCT00365378|100728595|FG002|STARTED|Vaccination (Day 1 to Month 7)||0||
48165775|NCT00365378|100728593|FG000|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1193||
48165776|NCT00365378|100728594|FG001|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1198||
48165777|NCT00365378|100728595|FG002|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||0||
48165778|NCT00365378|100728593|FG000|COMPLETED|Vaccination (Day 1 to Month 7)||993||
48165779|NCT00365378|100728594|FG001|COMPLETED|Vaccination (Day 1 to Month 7)||1038||
48165780|NCT00365378|100728595|FG002|COMPLETED|Vaccination (Day 1 to Month 7)||0||
48165781|NCT00365378|100728593|FG000|NOT COMPLETED|Vaccination (Day 1 to Month 7)||211||
48165782|NCT00365378|100728594|FG001|NOT COMPLETED|Vaccination (Day 1 to Month 7)||167||
48165783|NCT00365378|100728595|FG002|NOT COMPLETED|Vaccination (Day 1 to Month 7)||0||
48165784|NCT00365378|100728593|FG000|STARTED|Follow-up (Month 7 Though Month 48)||993||
48165785|NCT00365378|100728594|FG001|STARTED|Follow-up (Month 7 Though Month 48)||1038||
48165786|NCT00365378|100728595|FG002|STARTED|Follow-up (Month 7 Though Month 48)||0||
48165787|NCT00365378|100728593|FG000|COMPLETED|Follow-up (Month 7 Though Month 48)||835||
48165788|NCT00365378|100728594|FG001|COMPLETED|Follow-up (Month 7 Though Month 48)||836||
48165789|NCT00365378|100728595|FG002|COMPLETED|Follow-up (Month 7 Though Month 48)||0||
48165790|NCT00365378|100728593|FG000|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||158||
48165791|NCT00365378|100728594|FG001|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||202||
48165792|NCT00365378|100728595|FG002|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||0||
48328255|NCT03178487|101131918|FG001|NOT COMPLETED|Period 2||19||
48328256|NCT02669017|101131919|FG000|STARTED|Overall Study||4||
48328257|NCT02669017|101131920|FG001|STARTED|Overall Study||4||
48745071|NCT00626275|102161820|FG005|COMPLETED|Part A - Treatment Period 3||8||
48745072|NCT00626275|102161821|FG006|COMPLETED|Part A - Treatment Period 3||0||
48745073|NCT00626275|102161822|FG007|COMPLETED|Part A - Treatment Period 3||0||
48745074|NCT00626275|102161815|FG000|NOT COMPLETED|Part A - Treatment Period 3||0||
48745075|NCT00626275|102161816|FG001|NOT COMPLETED|Part A - Treatment Period 3||0||
48745076|NCT00626275|102161817|FG002|NOT COMPLETED|Part A - Treatment Period 3||0||
48745077|NCT00626275|102161818|FG003|NOT COMPLETED|Part A - Treatment Period 3||0||
48165793|NCT00365378|100728593|FG000|STARTED|Extension||0||
48165794|NCT00365378|100728594|FG001|STARTED|Extension||0||
48165795|NCT00365378|100728595|FG002|STARTED|Extension||400||
48165796|NCT00365378|100728593|FG000|COMPLETED|Extension||0||
48165797|NCT00365378|100728594|FG001|COMPLETED|Extension||0||
48165798|NCT00365378|100728595|FG002|COMPLETED|Extension||203||
48165799|NCT00365378|100728593|FG000|NOT COMPLETED|Extension||0||
48165800|NCT00365378|100728594|FG001|NOT COMPLETED|Extension||0||
48165801|NCT00365378|100728595|FG002|NOT COMPLETED|Extension||197||
48165802|NCT02344537|100728596|FG000|STARTED|Overall Study||16||
48165803|NCT02344537|100728597|FG001|STARTED|Overall Study||10||
48165804|NCT02344537|100728596|FG000|COMPLETED|Overall Study||12||
48165805|NCT02344537|100728597|FG001|COMPLETED|Overall Study||8||
48165806|NCT02344537|100728596|FG000|NOT COMPLETED|Overall Study||4||
48165807|NCT02344537|100728597|FG001|NOT COMPLETED|Overall Study||2||
48165808|NCT04035200|100728598|FG000|STARTED|Overall Study||38||
48165809|NCT04035200|100728599|FG001|STARTED|Overall Study||38||
48165810|NCT04035200|100728600|FG002|STARTED|Overall Study||38||
48328258|NCT02669017|101131921|FG002|STARTED|Overall Study||4||
48328259|NCT02669017|101131922|FG003|STARTED|Overall Study||5||
48745078|NCT00626275|102161819|FG004|NOT COMPLETED|Part A - Treatment Period 3||0||
48165811|NCT04035200|100728598|FG000|COMPLETED|Overall Study||36||
48328260|NCT02669017|101131923|FG004|STARTED|Overall Study||16||
48745079|NCT00626275|102161820|FG005|NOT COMPLETED|Part A - Treatment Period 3||0||
48165812|NCT04035200|100728599|FG001|COMPLETED|Overall Study||31||
48165813|NCT04035200|100728600|FG002|COMPLETED|Overall Study||34||
48165814|NCT04035200|100728598|FG000|NOT COMPLETED|Overall Study||2||
48165815|NCT04035200|100728599|FG001|NOT COMPLETED|Overall Study||7||
48165816|NCT04035200|100728600|FG002|NOT COMPLETED|Overall Study||4||
48165817|NCT00284141|100728601|FG000|STARTED|Overall Study||98||
48165818|NCT00284141|100728601|FG000|TREATED|Overall Study||96||
48165819|NCT00284141|100728601|FG000|ONGOING TREATMENT|Overall Study||2||
48165820|NCT00284141|100728601|FG000|COMPLETED|Overall Study||0||
48165821|NCT00284141|100728601|FG000|NOT COMPLETED|Overall Study||98||
48165822|NCT03276637|100728602|FG000|STARTED|Overall Study||93|Completed baseline survey|
48165823|NCT03276637|100728603|FG001|STARTED|Overall Study||12|Completed baseline survey|
48165824|NCT03276637|100728602|FG000|Airmen Pre Survey|Overall Study||93||
48165825|NCT03276637|100728603|FG001|Airmen Pre Survey|Overall Study||0||
48165826|NCT03276637|100728602|FG000|Underwent Sequencing|Overall Study||75||
48165827|NCT03276637|100728603|FG001|Underwent Sequencing|Overall Study||0||
48165828|NCT03276637|100728602|FG000|Airmen Post Survey|Overall Study||69||
48165829|NCT03276637|100728603|FG001|Airmen Post Survey|Overall Study||0||
48165830|NCT03276637|100728602|FG000|HCP Pre Survey|Overall Study||0||
48165831|NCT03276637|100728603|FG001|HCP Pre Survey|Overall Study||12||
48165832|NCT03276637|100728602|FG000|HCP Post Survey|Overall Study||0||
48165833|NCT03276637|100728603|FG001|HCP Post Survey|Overall Study||12||
48165834|NCT03276637|100728602|FG000|COMPLETED|Overall Study||69|Completed follow-up survey|
48165835|NCT03276637|100728603|FG001|COMPLETED|Overall Study||12|Completed follow-up survey|
48165836|NCT03276637|100728602|FG000|NOT COMPLETED|Overall Study||24||
48165837|NCT03276637|100728603|FG001|NOT COMPLETED|Overall Study||0||
48165838|NCT05674890|100728604|FG000|STARTED|Overall Study||40|The present study enrolled patients between December 2022 and June 2023. Subjects' participation was limited to the duration of a single clinic appointment. Subjects were not asked to return for study-related testing or follow-up.|40
48165839|NCT05674890|100728605|FG001|STARTED|Overall Study||58|The present study enrolled patients between December 2022 and June 2023. Subjects' participation was limited to the duration of a single clinic appointment. Subjects were not asked to return for study-related testing or follow-up.|58
48165840|NCT05674890|100728604|FG000|COMPLETED|Overall Study||33|The target sample size was reached in June 2023.|33
48165841|NCT05674890|100728605|FG001|COMPLETED|Overall Study||48|The target sample size was reached in June 2023.|48
48165842|NCT05674890|100728604|FG000|NOT COMPLETED|Overall Study||7||7
48165843|NCT05674890|100728605|FG001|NOT COMPLETED|Overall Study||10||10
48165844|NCT04170686|100728606|FG000|STARTED|Screening||74||
48165845|NCT04170686|100728607|FG001|STARTED|Screening||72||
48165846|NCT04170686|100728606|FG000|COMPLETED|Screening||62||
48165847|NCT04170686|100728607|FG001|COMPLETED|Screening||59||
48165848|NCT04170686|100728606|FG000|NOT COMPLETED|Screening||12||
48165849|NCT04170686|100728607|FG001|NOT COMPLETED|Screening||13||
48165850|NCT04170686|100728606|FG000|STARTED|Randomization and Treatment||62||
48165851|NCT04170686|100728607|FG001|STARTED|Randomization and Treatment||59||
48165852|NCT04170686|100728606|FG000|COMPLETED|Randomization and Treatment||36||
48165853|NCT04170686|100728607|FG001|COMPLETED|Randomization and Treatment||44||
48165854|NCT04170686|100728606|FG000|NOT COMPLETED|Randomization and Treatment||26||
48165855|NCT04170686|100728607|FG001|NOT COMPLETED|Randomization and Treatment||15||
48165856|NCT04954586|100728608|FG000|STARTED|Overall Study||19||
48165857|NCT04954586|100728608|FG000|COMPLETED|Overall Study||14||
48165858|NCT04954586|100728608|FG000|NOT COMPLETED|Overall Study||5||
48165859|NCT00815035|100728609|FG000|STARTED|Blinded Phase||10||
48165860|NCT00815035|100728610|FG001|STARTED|Blinded Phase||6||
48165861|NCT00815035|100728611|FG002|STARTED|Blinded Phase||0||
48165862|NCT00815035|100728609|FG000|COMPLETED|Blinded Phase||9||
48165863|NCT00815035|100728610|FG001|COMPLETED|Blinded Phase||6||
48328261|NCT02669017|101131924|FG005|STARTED|Overall Study||26||
48328262|NCT02669017|101131925|FG006|STARTED|Overall Study||19||
48328263|NCT02669017|101131926|FG007|STARTED|Overall Study||69||
48328264|NCT02669017|101131927|FG008|STARTED|Overall Study||36||
48328265|NCT02669017|101131919|FG000|COMPLETED|Overall Study||3||
48328266|NCT02669017|101131920|FG001|COMPLETED|Overall Study||2||
48328267|NCT02669017|101131921|FG002|COMPLETED|Overall Study||2||
48165864|NCT00815035|100728611|FG002|COMPLETED|Blinded Phase||0||
48165865|NCT00815035|100728609|FG000|NOT COMPLETED|Blinded Phase||1||
48165866|NCT00815035|100728610|FG001|NOT COMPLETED|Blinded Phase||0||
48165867|NCT00815035|100728611|FG002|NOT COMPLETED|Blinded Phase||0||
48165868|NCT00815035|100728609|FG000|STARTED|Open Label Extension Phase||0||
48165869|NCT00815035|100728610|FG001|STARTED|Open Label Extension Phase||0||
48165870|NCT00815035|100728611|FG002|STARTED|Open Label Extension Phase||15||
48328268|NCT02669017|101131922|FG003|COMPLETED|Overall Study||1||
48328269|NCT02669017|101131923|FG004|COMPLETED|Overall Study||4||
48328270|NCT02669017|101131924|FG005|COMPLETED|Overall Study||7||
48328271|NCT02669017|101131925|FG006|COMPLETED|Overall Study||8||
48328272|NCT02669017|101131926|FG007|COMPLETED|Overall Study||7||
48328273|NCT02669017|101131927|FG008|COMPLETED|Overall Study||11||
48328274|NCT02669017|101131919|FG000|NOT COMPLETED|Overall Study||1||
48410083|NCT00878644|101334860|FG001|COMPLETED|Overall Study||136||
48328275|NCT02669017|101131920|FG001|NOT COMPLETED|Overall Study||2||
48328276|NCT02669017|101131921|FG002|NOT COMPLETED|Overall Study||2||
48410084|NCT00878644|101334859|FG000|NOT COMPLETED|Overall Study||4||
48165871|NCT00815035|100728609|FG000|COMPLETED|Open Label Extension Phase||0||
48165872|NCT00815035|100728610|FG001|COMPLETED|Open Label Extension Phase||0||
48165873|NCT00815035|100728611|FG002|COMPLETED|Open Label Extension Phase||9||
48165874|NCT00815035|100728609|FG000|NOT COMPLETED|Open Label Extension Phase||0||
48165875|NCT00815035|100728610|FG001|NOT COMPLETED|Open Label Extension Phase||0||
48165876|NCT00815035|100728611|FG002|NOT COMPLETED|Open Label Extension Phase||6||
48165877|NCT04235582|100728612|FG000|STARTED|Overall Study||12||
48165878|NCT04235582|100728613|FG001|STARTED|Overall Study||13||
48165879|NCT04235582|100728614|FG002|STARTED|Overall Study||11||
48165880|NCT04235582|100728612|FG000|COMPLETED|Overall Study||12||
48165881|NCT04235582|100728613|FG001|COMPLETED|Overall Study||12||
48165882|NCT04235582|100728614|FG002|COMPLETED|Overall Study||8||
48165883|NCT04235582|100728612|FG000|NOT COMPLETED|Overall Study||0||
48165884|NCT04235582|100728613|FG001|NOT COMPLETED|Overall Study||1||
48165885|NCT04235582|100728614|FG002|NOT COMPLETED|Overall Study||3||
48165886|NCT03027414|100728615|FG000|STARTED|Overall Study||28||
48165887|NCT03027414|100728616|FG001|STARTED|Overall Study||0||
48165888|NCT03027414|100728617|FG002|STARTED|Overall Study||26||
48165889|NCT03027414|100728615|FG000|COMPLETED|Overall Study||19||
48622139|NCT03200548|101859795|FG002|NOT COMPLETED|Overall Study||7||
48745080|NCT00626275|102161821|FG006|NOT COMPLETED|Part A - Treatment Period 3||0||
48745081|NCT00626275|102161822|FG007|NOT COMPLETED|Part A - Treatment Period 3||0||
48745082|NCT00626275|102161815|FG000|STARTED|Re-randomization Period for Part B||0||
48622140|NCT03200548|101859796|FG003|NOT COMPLETED|Overall Study||6||
48745083|NCT00626275|102161816|FG001|STARTED|Re-randomization Period for Part B||0||
48745084|NCT00626275|102161817|FG002|STARTED|Re-randomization Period for Part B||0||
48745085|NCT00626275|102161818|FG003|STARTED|Re-randomization Period for Part B||0||
48745086|NCT00626275|102161819|FG004|STARTED|Re-randomization Period for Part B||0||
48745087|NCT00626275|102161820|FG005|STARTED|Re-randomization Period for Part B||0||
48745088|NCT00626275|102161821|FG006|STARTED|Re-randomization Period for Part B||20||
48165890|NCT03027414|100728616|FG001|COMPLETED|Overall Study||0||
48165891|NCT03027414|100728617|FG002|COMPLETED|Overall Study||20||
48165892|NCT03027414|100728615|FG000|NOT COMPLETED|Overall Study||9||
48328277|NCT02669017|101131922|FG003|NOT COMPLETED|Overall Study||4||
48328278|NCT02669017|101131923|FG004|NOT COMPLETED|Overall Study||12||
48622141|NCT02717195|101859797|FG000|STARTED|Prospective Confirmation (PC) Period||711||
48622142|NCT02717195|101859798|FG001|STARTED|Prospective Confirmation (PC) Period||387||
48165893|NCT03027414|100728616|FG001|NOT COMPLETED|Overall Study||0||
48165894|NCT03027414|100728617|FG002|NOT COMPLETED|Overall Study||6||
48165895|NCT02786264|100728618|FG000|STARTED|Overall Study||39||
48165896|NCT02786264|100728619|FG001|STARTED|Overall Study||34||
48745089|NCT00626275|102161822|FG007|STARTED|Re-randomization Period for Part B||24||
48745090|NCT00626275|102161815|FG000|COMPLETED|Re-randomization Period for Part B||0||
48745091|NCT00626275|102161816|FG001|COMPLETED|Re-randomization Period for Part B||0||
48745092|NCT00626275|102161817|FG002|COMPLETED|Re-randomization Period for Part B||0||
48767642|NCT01929317|102222785|FG000|NOT COMPLETED|Long-term Phase||19||
48165897|NCT02786264|100728618|FG000|COMPLETED|Overall Study||39||
48165898|NCT02786264|100728619|FG001|COMPLETED|Overall Study||34||
48165899|NCT02786264|100728618|FG000|NOT COMPLETED|Overall Study||0||
48165900|NCT02786264|100728619|FG001|NOT COMPLETED|Overall Study||0||
48165901|NCT02041923|100728620|FG000|STARTED|Overall Study||102||
48165902|NCT02041923|100728621|FG001|STARTED|Overall Study||96||
48165903|NCT02041923|100728620|FG000|COMPLETED|Overall Study||76||
48165904|NCT02041923|100728621|FG001|COMPLETED|Overall Study||66||
48165905|NCT02041923|100728620|FG000|NOT COMPLETED|Overall Study||26||
48165906|NCT02041923|100728621|FG001|NOT COMPLETED|Overall Study||30||
48165907|NCT03328143|100728622|FG000|STARTED|Overall Study||40||
48165908|NCT03328143|100728622|FG000|COMPLETED|Overall Study||31||
48622143|NCT02717195|101859799|FG002|STARTED|Prospective Confirmation (PC) Period||0||
48165909|NCT03328143|100728622|FG000|NOT COMPLETED|Overall Study||9||
48165910|NCT00744263|100728623|FG000|STARTED|Overall Study||42240||
48622144|NCT02717195|101859800|FG003|STARTED|Prospective Confirmation (PC) Period||0||
48622145|NCT02717195|101859801|FG004|STARTED|Prospective Confirmation (PC) Period||0||
48622146|NCT02717195|101859797|FG000|COMPLETED|Prospective Confirmation (PC) Period||421||
48622147|NCT02717195|101859798|FG001|COMPLETED|Prospective Confirmation (PC) Period||276||
48622148|NCT02717195|101859799|FG002|COMPLETED|Prospective Confirmation (PC) Period||0||
48622149|NCT02717195|101859800|FG003|COMPLETED|Prospective Confirmation (PC) Period||0||
48165911|NCT00744263|100728624|FG001|STARTED|Overall Study||42256||
48165912|NCT00744263|100728623|FG000|COMPLETED|Overall Study||37004||
48165913|NCT00744263|100728624|FG001|COMPLETED|Overall Study||36936||
48165914|NCT00744263|100728623|FG000|NOT COMPLETED|Overall Study||5236||
48165915|NCT00744263|100728624|FG001|NOT COMPLETED|Overall Study||5320||
48165916|NCT03729024|100728625|FG000|STARTED|Overall Study||21||42
48165917|NCT03729024|100728625|FG000|COMPLETED|Overall Study||21||42
48165918|NCT03729024|100728625|FG000|NOT COMPLETED|Overall Study||0||0
48165919|NCT00267696|100728626|FG000|STARTED|Overall Study||45||
48165920|NCT00267696|100728626|FG000|COMPLETED|Overall Study||45||
48165921|NCT00267696|100728626|FG000|NOT COMPLETED|Overall Study||0||
48165922|NCT02961374|100728627|FG000|STARTED|Overall Study||46||
48165923|NCT02961374|100728627|FG000|COMPLETED|Overall Study||42||
48165924|NCT02961374|100728627|FG000|NOT COMPLETED|Overall Study||4||
48165925|NCT04466215|100728628|FG000|STARTED|Overall Study||25||
48165926|NCT04466215|100728629|FG001|STARTED|Overall Study||25||
48165927|NCT04466215|100728628|FG000|COMPLETED|Overall Study||25||
48165928|NCT04466215|100728629|FG001|COMPLETED|Overall Study||25||
48165929|NCT04466215|100728628|FG000|NOT COMPLETED|Overall Study||0||
48165930|NCT04466215|100728629|FG001|NOT COMPLETED|Overall Study||0||
48165931|NCT01734434|100728630|FG000|STARTED|Overall Study||500||
48165932|NCT01734434|100728631|FG001|STARTED|Overall Study||500||
48165933|NCT01734434|100728632|FG002|STARTED|Overall Study||1992||
48165934|NCT01734434|100728633|FG003|STARTED|Overall Study||251||
48165935|NCT01734434|100728630|FG000|COMPLETED|Overall Study||490||
48165936|NCT01734434|100728631|FG001|COMPLETED|Overall Study||488||
48165937|NCT01734434|100728632|FG002|COMPLETED|Overall Study||1863||
48165938|NCT01734434|100728633|FG003|COMPLETED|Overall Study||228||
48165939|NCT01734434|100728630|FG000|NOT COMPLETED|Overall Study||10||
48165940|NCT01734434|100728631|FG001|NOT COMPLETED|Overall Study||12||
48165941|NCT01734434|100728632|FG002|NOT COMPLETED|Overall Study||129||
48745093|NCT00626275|102161818|FG003|COMPLETED|Re-randomization Period for Part B||0||
48745094|NCT00626275|102161819|FG004|COMPLETED|Re-randomization Period for Part B||0||
48745095|NCT00626275|102161820|FG005|COMPLETED|Re-randomization Period for Part B||0||
48745096|NCT00626275|102161821|FG006|COMPLETED|Re-randomization Period for Part B||20||
48745097|NCT00626275|102161822|FG007|COMPLETED|Re-randomization Period for Part B||24||
48165942|NCT01734434|100728633|FG003|NOT COMPLETED|Overall Study||23||
48165943|NCT01083641|100728634|FG000|STARTED|Overall Study||17||
48165944|NCT01083641|100728634|FG000|COMPLETED|Overall Study||15||
48165945|NCT01083641|100728634|FG000|NOT COMPLETED|Overall Study||2||
48165946|NCT02966002|100728635|FG000|STARTED|Overall Study||9||
48328279|NCT02669017|101131924|FG005|NOT COMPLETED|Overall Study||19||
48745098|NCT00626275|102161815|FG000|NOT COMPLETED|Re-randomization Period for Part B||0||
48745099|NCT00626275|102161816|FG001|NOT COMPLETED|Re-randomization Period for Part B||0||
48745100|NCT00626275|102161817|FG002|NOT COMPLETED|Re-randomization Period for Part B||0||
48745101|NCT00626275|102161818|FG003|NOT COMPLETED|Re-randomization Period for Part B||0||
48745102|NCT00626275|102161819|FG004|NOT COMPLETED|Re-randomization Period for Part B||0||
48745103|NCT00626275|102161820|FG005|NOT COMPLETED|Re-randomization Period for Part B||0||
48745104|NCT00626275|102161821|FG006|NOT COMPLETED|Re-randomization Period for Part B||0||
48745105|NCT00626275|102161822|FG007|NOT COMPLETED|Re-randomization Period for Part B||0||
48745106|NCT00626275|102161815|FG000|STARTED|Part B||0||
48745107|NCT00626275|102161816|FG001|STARTED|Part B||0||
48745108|NCT00626275|102161817|FG002|STARTED|Part B||0||
48745109|NCT00626275|102161818|FG003|STARTED|Part B||0||
48745110|NCT00626275|102161819|FG004|STARTED|Part B||0||
48745111|NCT00626275|102161820|FG005|STARTED|Part B||0||
48745112|NCT00626275|102161821|FG006|STARTED|Part B||20||
48745113|NCT00626275|102161822|FG007|STARTED|Part B||24||
48745114|NCT00626275|102161815|FG000|COMPLETED|Part B||0||
48745115|NCT00626275|102161816|FG001|COMPLETED|Part B||0||
48745116|NCT00626275|102161817|FG002|COMPLETED|Part B||0||
48745117|NCT00626275|102161818|FG003|COMPLETED|Part B||0||
48745118|NCT00626275|102161819|FG004|COMPLETED|Part B||0||
48745119|NCT00626275|102161820|FG005|COMPLETED|Part B||0||
48745120|NCT00626275|102161821|FG006|COMPLETED|Part B||19||
48745121|NCT00626275|102161822|FG007|COMPLETED|Part B||23||
48745122|NCT00626275|102161815|FG000|NOT COMPLETED|Part B||0||
48745123|NCT00626275|102161816|FG001|NOT COMPLETED|Part B||0||
48745124|NCT00626275|102161817|FG002|NOT COMPLETED|Part B||0||
48745125|NCT00626275|102161818|FG003|NOT COMPLETED|Part B||0||
48745126|NCT00626275|102161819|FG004|NOT COMPLETED|Part B||0||
48745127|NCT00626275|102161820|FG005|NOT COMPLETED|Part B||0||
48745128|NCT00626275|102161821|FG006|NOT COMPLETED|Part B||1||
48745129|NCT00626275|102161822|FG007|NOT COMPLETED|Part B||1||
48745130|NCT02079038|102161823|FG000|STARTED|Modified Intent to Treat Population||112||
48745131|NCT02079038|102161824|FG001|STARTED|Modified Intent to Treat Population||56||
48745132|NCT02079038|102161823|FG000|COMPLETED|Modified Intent to Treat Population||105||
48745133|NCT02079038|102161824|FG001|COMPLETED|Modified Intent to Treat Population||51||
48745134|NCT02079038|102161823|FG000|NOT COMPLETED|Modified Intent to Treat Population||7||
48745135|NCT02079038|102161824|FG001|NOT COMPLETED|Modified Intent to Treat Population||5||
48165947|NCT02966002|100728635|FG000|COMPLETED|Overall Study||5||
48165948|NCT02966002|100728635|FG000|NOT COMPLETED|Overall Study||4||
48165949|NCT01226914|100728636|FG000|STARTED|Overall Study||28||
48165950|NCT01226914|100728637|FG001|STARTED|Overall Study||27||
48165951|NCT01226914|100728636|FG000|COMPLETED|Overall Study||28||
48165952|NCT01226914|100728637|FG001|COMPLETED|Overall Study||27||
48165953|NCT01226914|100728636|FG000|NOT COMPLETED|Overall Study||0||
48745136|NCT02079038|102161823|FG000|STARTED|Completed 6 Months||105||
48745137|NCT02079038|102161824|FG001|STARTED|Completed 6 Months||51||
48745138|NCT02079038|102161823|FG000|COMPLETED|Completed 6 Months||103||
48745139|NCT02079038|102161824|FG001|COMPLETED|Completed 6 Months||50||
48745140|NCT02079038|102161823|FG000|NOT COMPLETED|Completed 6 Months||2||
48165954|NCT01226914|100728637|FG001|NOT COMPLETED|Overall Study||0||
48165955|NCT00622713|100728638|FG000|STARTED|Overall Study||228||
48165956|NCT00622713|100728638|FG000|Exposed to Study Drug|Overall Study||226||
48165957|NCT00622713|100728638|FG000|Intent to Treat (ITT) Population|Overall Study||218||
48328280|NCT02669017|101131925|FG006|NOT COMPLETED|Overall Study||11||
48328281|NCT02669017|101131926|FG007|NOT COMPLETED|Overall Study||62||
48328282|NCT02669017|101131927|FG008|NOT COMPLETED|Overall Study||25||
48328283|NCT03927105|101131928|FG000|STARTED|Overall Study||4||
48328284|NCT03927105|101131928|FG000|Began Treatment|Overall Study||3||
48328285|NCT03927105|101131928|FG000|Follow-up|Overall Study||3||
48328286|NCT03927105|101131928|FG000|COMPLETED|Overall Study||0|completed through primary outcome measure collection; two participants are still in observation for secondary outcome measure assessments (not yet completed).|
48328287|NCT03927105|101131928|FG000|NOT COMPLETED|Overall Study||4||
48328288|NCT01425203|101131929|FG000|STARTED|Treatment Phase||159||
48328289|NCT01425203|101131930|FG001|STARTED|Treatment Phase||79||
48328290|NCT01425203|101131931|FG002|STARTED|Treatment Phase||0||
48328291|NCT01425203|101131929|FG000|Treated (FAS)|Treatment Phase||159||
48328292|NCT01425203|101131930|FG001|Treated (FAS)|Treatment Phase||78||
48328293|NCT01425203|101131931|FG002|Treated (FAS)|Treatment Phase||0||
48328294|NCT01425203|101131929|FG000|COMPLETED|Treatment Phase||132||
48328295|NCT01425203|101131930|FG001|COMPLETED|Treatment Phase||42||
48328296|NCT01425203|101131931|FG002|COMPLETED|Treatment Phase||0||
48328297|NCT01425203|101131929|FG000|NOT COMPLETED|Treatment Phase||27||
48328298|NCT01425203|101131930|FG001|NOT COMPLETED|Treatment Phase||37||
48328299|NCT01425203|101131931|FG002|NOT COMPLETED|Treatment Phase||0||
48328300|NCT01425203|101131929|FG000|STARTED|Crossover Phase||0||
48328301|NCT01425203|101131930|FG001|STARTED|Crossover Phase||0||
48328302|NCT01425203|101131931|FG002|STARTED|Crossover Phase||27||
48328303|NCT01425203|101131929|FG000|COMPLETED|Crossover Phase||0||
48328304|NCT01425203|101131930|FG001|COMPLETED|Crossover Phase||0||
48328305|NCT01425203|101131931|FG002|COMPLETED|Crossover Phase||21||
48328306|NCT01425203|101131929|FG000|NOT COMPLETED|Crossover Phase||0||
48328307|NCT01425203|101131930|FG001|NOT COMPLETED|Crossover Phase||0||
48328308|NCT01425203|101131931|FG002|NOT COMPLETED|Crossover Phase||6||
48328309|NCT01425203|101131929|FG000|STARTED|Follow-up Phase||153||
48328310|NCT01425203|101131930|FG001|STARTED|Follow-up Phase||49||
48328311|NCT01425203|101131931|FG002|STARTED|Follow-up Phase||27||
48328312|NCT01425203|101131929|FG000|COMPLETED|Follow-up Phase||153||
48328313|NCT01425203|101131930|FG001|COMPLETED|Follow-up Phase||49||
48328314|NCT01425203|101131931|FG002|COMPLETED|Follow-up Phase||27||
48328315|NCT01425203|101131929|FG000|NOT COMPLETED|Follow-up Phase||0||
48328316|NCT01425203|101131930|FG001|NOT COMPLETED|Follow-up Phase||0||
48328317|NCT01425203|101131931|FG002|NOT COMPLETED|Follow-up Phase||0||
48328318|NCT01736579|101131932|FG000|STARTED|Overall Study||2||
48328319|NCT01736579|101131933|FG001|STARTED|Overall Study||2||
48328320|NCT01736579|101131932|FG000|COMPLETED|Overall Study||0||
48328321|NCT01736579|101131933|FG001|COMPLETED|Overall Study||0||
48328322|NCT01736579|101131932|FG000|NOT COMPLETED|Overall Study||2||
48328323|NCT01736579|101131933|FG001|NOT COMPLETED|Overall Study||2||
48328324|NCT01834729|101131934|FG000|STARTED|Overall Study||18||
48328325|NCT01834729|101131935|FG001|STARTED|Overall Study||20||
48328326|NCT01834729|101131936|FG002|STARTED|Overall Study||18||
48328327|NCT01834729|101131937|FG003|STARTED|Overall Study||18||
48328328|NCT01834729|101131934|FG000|COMPLETED|Overall Study||17||
48328329|NCT01834729|101131935|FG001|COMPLETED|Overall Study||19||
48328330|NCT01834729|101131936|FG002|COMPLETED|Overall Study||15||
48328331|NCT01834729|101131937|FG003|COMPLETED|Overall Study||16||
48328332|NCT01834729|101131934|FG000|NOT COMPLETED|Overall Study||1||
48328333|NCT01834729|101131935|FG001|NOT COMPLETED|Overall Study||1||
48328334|NCT01834729|101131936|FG002|NOT COMPLETED|Overall Study||3||
48328335|NCT01834729|101131937|FG003|NOT COMPLETED|Overall Study||2||
48328336|NCT01356589|101131938|FG000|STARTED|Overall Study||1288||
48328337|NCT01356589|101131938|FG000|Treated|Overall Study||1285||
48328338|NCT01356589|101131938|FG000|COMPLETED|Overall Study||1283||
48328339|NCT01356589|101131938|FG000|NOT COMPLETED|Overall Study||5||
48328340|NCT00938314|101131939|FG000|STARTED|Cohort 1||24||
48328341|NCT00938314|101131940|FG001|STARTED|Cohort 1||0||
48328342|NCT00938314|101131941|FG002|STARTED|Cohort 1||0||
48328343|NCT00938314|101131942|FG003|STARTED|Cohort 1||8||
48328344|NCT00938314|101131939|FG000|COMPLETED|Cohort 1||22||
48328345|NCT00938314|101131940|FG001|COMPLETED|Cohort 1||0||
48328346|NCT00938314|101131941|FG002|COMPLETED|Cohort 1||0||
48328347|NCT00938314|101131942|FG003|COMPLETED|Cohort 1||6||
48328348|NCT00938314|101131939|FG000|NOT COMPLETED|Cohort 1||2||
48328349|NCT00938314|101131940|FG001|NOT COMPLETED|Cohort 1||0||
48328350|NCT00938314|101131941|FG002|NOT COMPLETED|Cohort 1||0||
48328351|NCT00938314|101131942|FG003|NOT COMPLETED|Cohort 1||2||
48328352|NCT00938314|101131939|FG000|STARTED|Cohort 2||0||
48328353|NCT00938314|101131940|FG001|STARTED|Cohort 2||24||
48328354|NCT00938314|101131941|FG002|STARTED|Cohort 2||0||
48328355|NCT00938314|101131942|FG003|STARTED|Cohort 2||8||
48328356|NCT00938314|101131939|FG000|COMPLETED|Cohort 2||0||
48328357|NCT00938314|101131940|FG001|COMPLETED|Cohort 2||18||
48328358|NCT00938314|101131941|FG002|COMPLETED|Cohort 2||0||
48328359|NCT00938314|101131942|FG003|COMPLETED|Cohort 2||6||
48328360|NCT00938314|101131939|FG000|NOT COMPLETED|Cohort 2||0||
48328361|NCT00938314|101131940|FG001|NOT COMPLETED|Cohort 2||6||
48328362|NCT00938314|101131941|FG002|NOT COMPLETED|Cohort 2||0||
48328363|NCT00938314|101131942|FG003|NOT COMPLETED|Cohort 2||2||
48328364|NCT00938314|101131939|FG000|STARTED|Cohort 3||0||
48328365|NCT00938314|101131940|FG001|STARTED|Cohort 3||0||
48410085|NCT00878644|101334860|FG001|NOT COMPLETED|Overall Study||4||
48410086|NCT01100658|101334861|FG000|STARTED|Overall Study||1||
48410087|NCT01100658|101334861|FG000|COMPLETED|Overall Study||0||
48410088|NCT01100658|101334861|FG000|NOT COMPLETED|Overall Study||1||
48410089|NCT02020304|101334862|FG000|STARTED|Overall Study||30||
48410090|NCT02020304|101334863|FG001|STARTED|Overall Study||28||
48410091|NCT02020304|101334862|FG000|COMPLETED|Overall Study||27||
48410092|NCT02020304|101334863|FG001|COMPLETED|Overall Study||26||
48410093|NCT02020304|101334862|FG000|NOT COMPLETED|Overall Study||3||
48410094|NCT02020304|101334863|FG001|NOT COMPLETED|Overall Study||2||
48410095|NCT00926185|101334864|FG000|STARTED|Overall Study||57||
48410096|NCT00926185|101334865|FG001|STARTED|Overall Study||57||
48410097|NCT00926185|101334866|FG002|STARTED|Overall Study||58||
48410098|NCT00926185|101334867|FG003|STARTED|Overall Study||58||
48410099|NCT00926185|101334864|FG000|COMPLETED|Overall Study||54||
48410100|NCT00926185|101334865|FG001|COMPLETED|Overall Study||51||
48410101|NCT00926185|101334866|FG002|COMPLETED|Overall Study||48||
48410102|NCT00926185|101334867|FG003|COMPLETED|Overall Study||48||
48410103|NCT00926185|101334864|FG000|NOT COMPLETED|Overall Study||3||
48745141|NCT02079038|102161824|FG001|NOT COMPLETED|Completed 6 Months||1||
48328366|NCT00938314|101131941|FG002|STARTED|Cohort 3||24||
48328367|NCT00938314|101131942|FG003|STARTED|Cohort 3||8||
48328368|NCT00938314|101131939|FG000|COMPLETED|Cohort 3||0||
48328369|NCT00938314|101131940|FG001|COMPLETED|Cohort 3||0||
48328370|NCT00938314|101131941|FG002|COMPLETED|Cohort 3||20||
48328371|NCT00938314|101131942|FG003|COMPLETED|Cohort 3||7||
48328372|NCT00938314|101131939|FG000|NOT COMPLETED|Cohort 3||0||
48328373|NCT00938314|101131940|FG001|NOT COMPLETED|Cohort 3||0||
48328374|NCT00938314|101131941|FG002|NOT COMPLETED|Cohort 3||4||
48328375|NCT00938314|101131942|FG003|NOT COMPLETED|Cohort 3||1||
48328376|NCT01285908|101131943|FG000|STARTED|Baseline Measurement||6||
48328377|NCT01285908|101131944|FG001|STARTED|Baseline Measurement||0||
48328378|NCT01285908|101131945|FG002|STARTED|Baseline Measurement||0||
48328379|NCT01285908|101131943|FG000|COMPLETED|Baseline Measurement||3||
48328380|NCT01285908|101131944|FG001|COMPLETED|Baseline Measurement||0||
48328381|NCT01285908|101131945|FG002|COMPLETED|Baseline Measurement||0||
48410104|NCT00926185|101334865|FG001|NOT COMPLETED|Overall Study||6||
48410105|NCT00926185|101334866|FG002|NOT COMPLETED|Overall Study||10||
48410106|NCT00926185|101334867|FG003|NOT COMPLETED|Overall Study||10||
48410107|NCT01602744|101334868|FG000|STARTED|Overall Study||176||
48410108|NCT01602744|101334869|FG001|STARTED|Overall Study||183||
48410109|NCT01602744|101334868|FG000|COMPLETED|Overall Study||146||
48410110|NCT01602744|101334869|FG001|COMPLETED|Overall Study||160||
48410111|NCT01602744|101334868|FG000|NOT COMPLETED|Overall Study||30||
48745142|NCT02300259|102161825|FG000|STARTED|Period 1||16||
48328382|NCT01285908|101131943|FG000|NOT COMPLETED|Baseline Measurement||3||
48328383|NCT01285908|101131944|FG001|NOT COMPLETED|Baseline Measurement||0||
48328384|NCT01285908|101131945|FG002|NOT COMPLETED|Baseline Measurement||0||
48328385|NCT01285908|101131943|FG000|STARTED|Treatment Crossover||0||
48410112|NCT01602744|101334869|FG001|NOT COMPLETED|Overall Study||23||
48410113|NCT02436915|101334870|FG000|STARTED|Overall Study||9||
48328386|NCT01285908|101131944|FG001|STARTED|Treatment Crossover||2||
48328387|NCT01285908|101131945|FG002|STARTED|Treatment Crossover||2||
48328388|NCT01285908|101131943|FG000|COMPLETED|Treatment Crossover||0||
48328389|NCT01285908|101131944|FG001|COMPLETED|Treatment Crossover||2||
48328390|NCT01285908|101131945|FG002|COMPLETED|Treatment Crossover||2||
48410114|NCT02436915|101334871|FG001|STARTED|Overall Study||10||
48410115|NCT02436915|101334870|FG000|COMPLETED|Overall Study||9||
48328391|NCT01285908|101131943|FG000|NOT COMPLETED|Treatment Crossover||0||
48328392|NCT01285908|101131944|FG001|NOT COMPLETED|Treatment Crossover||0||
48328393|NCT01285908|101131945|FG002|NOT COMPLETED|Treatment Crossover||0||
48328394|NCT04673786|101131946|FG000|STARTED|Treatment Period I (Weeks 0 to 16)||256||
48328395|NCT04673786|101131947|FG001|STARTED|Treatment Period I (Weeks 0 to 16)||253||
48328396|NCT04673786|101131948|FG002|STARTED|Treatment Period I (Weeks 0 to 16)||0||
48328397|NCT04673786|101131946|FG000|COMPLETED|Treatment Period I (Weeks 0 to 16)||253||
48328398|NCT04673786|101131947|FG001|COMPLETED|Treatment Period I (Weeks 0 to 16)||249||
48328399|NCT04673786|101131948|FG002|COMPLETED|Treatment Period I (Weeks 0 to 16)||0||
48328400|NCT04673786|101131946|FG000|NOT COMPLETED|Treatment Period I (Weeks 0 to 16)||3||
48328401|NCT04673786|101131947|FG001|NOT COMPLETED|Treatment Period I (Weeks 0 to 16)||4||
48328402|NCT04673786|101131948|FG002|NOT COMPLETED|Treatment Period I (Weeks 0 to 16)||0||
48328403|NCT04673786|101131946|FG000|STARTED|Treatment Period II (Weeks 16 to 52)||253||
48328404|NCT04673786|101131947|FG001|STARTED|Treatment Period II (Weeks 16 to 52)||125||
48328405|NCT04673786|101131948|FG002|STARTED|Treatment Period II (Weeks 16 to 52)||124||
48328406|NCT04673786|101131946|FG000|COMPLETED|Treatment Period II (Weeks 16 to 52)||239||
48328407|NCT04673786|101131947|FG001|COMPLETED|Treatment Period II (Weeks 16 to 52)||122||
48328408|NCT04673786|101131948|FG002|COMPLETED|Treatment Period II (Weeks 16 to 52)||122||
48328409|NCT04673786|101131946|FG000|NOT COMPLETED|Treatment Period II (Weeks 16 to 52)||14||
48328410|NCT04673786|101131947|FG001|NOT COMPLETED|Treatment Period II (Weeks 16 to 52)||3||
48328411|NCT04673786|101131948|FG002|NOT COMPLETED|Treatment Period II (Weeks 16 to 52)||2||
48328412|NCT00713700|101131949|FG000|STARTED|Overall Study||192||
48328413|NCT00713700|101131949|FG000|COMPLETED|Overall Study||188||
48328414|NCT00713700|101131949|FG000|NOT COMPLETED|Overall Study||4||
48328415|NCT03979274|101131950|FG000|STARTED|Treatment Period 1||22||
48328416|NCT03979274|101131951|FG001|STARTED|Treatment Period 1||22||
48328417|NCT03979274|101131950|FG000|COMPLETED|Treatment Period 1||22||
48328418|NCT03979274|101131951|FG001|COMPLETED|Treatment Period 1||22||
48328419|NCT03979274|101131950|FG000|NOT COMPLETED|Treatment Period 1||0||
48328420|NCT03979274|101131951|FG001|NOT COMPLETED|Treatment Period 1||0||
48328421|NCT03979274|101131950|FG000|STARTED|Treatment Period 2||22||
48328422|NCT03979274|101131951|FG001|STARTED|Treatment Period 2||22||
48328423|NCT03979274|101131950|FG000|COMPLETED|Treatment Period 2||22||
48328424|NCT03979274|101131951|FG001|COMPLETED|Treatment Period 2||21||
48328425|NCT03979274|101131950|FG000|NOT COMPLETED|Treatment Period 2||0||
48745143|NCT02300259|102161826|FG001|STARTED|Period 1||16||
48745144|NCT02300259|102161827|FG002|STARTED|Period 1||16||
48745145|NCT02300259|102161825|FG000|Received at Least One Dose of Study Drug|Period 1||16||
48745146|NCT02300259|102161826|FG001|Received at Least One Dose of Study Drug|Period 1||16||
48745147|NCT02300259|102161827|FG002|Received at Least One Dose of Study Drug|Period 1||16||
48328426|NCT03979274|101131951|FG001|NOT COMPLETED|Treatment Period 2||1||
48328427|NCT02867761|101131952|FG000|STARTED|Overall Study||261||
48328428|NCT02867761|101131953|FG001|STARTED|Overall Study||274||
48328429|NCT02867761|101131952|FG000|COMPLETED|Overall Study||233||
48328430|NCT02867761|101131953|FG001|COMPLETED|Overall Study||248||
48328431|NCT02867761|101131952|FG000|NOT COMPLETED|Overall Study||28||
48328432|NCT02867761|101131953|FG001|NOT COMPLETED|Overall Study||26||
48328433|NCT01844895|101131954|FG000|STARTED|Day 1 to Day 28 - Pre-filled Syringe||120||
48328434|NCT01844895|101131954|FG000|COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||117||
48328435|NCT01844895|101131954|FG000|NOT COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||3||
48328436|NCT01844895|101131954|FG000|STARTED|Day 29 - Day113 - Autoinjector||117||
48328437|NCT01844895|101131954|FG000|COMPLETED|Day 29 - Day113 - Autoinjector||111||
48328438|NCT01844895|101131954|FG000|NOT COMPLETED|Day 29 - Day113 - Autoinjector||6||
48328439|NCT01890421|101131955|FG000|STARTED|Overall Study||426||
48328440|NCT01890421|101131955|FG000|COMPLETED|Overall Study||415||
48328441|NCT01890421|101131955|FG000|NOT COMPLETED|Overall Study||11||
48328442|NCT02692209|101131956|FG000|STARTED|Overall Study||298||
48328443|NCT02692209|101131956|FG000|COMPLETED|Overall Study||298||
48328444|NCT02692209|101131956|FG000|NOT COMPLETED|Overall Study||0||
48328445|NCT03678402|101131957|FG000|STARTED|Overall Study||521||
48328446|NCT03678402|101131957|FG000|COMPLETED|Overall Study||521||
48328447|NCT03678402|101131957|FG000|NOT COMPLETED|Overall Study||0||
48328448|NCT01325428|101131958|FG000|STARTED|Part A||26||
48328449|NCT01325428|101131958|FG000|COMPLETED|Part A||10||
48328450|NCT01325428|101131958|FG000|NOT COMPLETED|Part A||16||
48410116|NCT02436915|101334871|FG001|COMPLETED|Overall Study||9||
48745148|NCT02300259|102161825|FG000|COMPLETED|Period 1||16||
48745149|NCT02300259|102161826|FG001|COMPLETED|Period 1||16||
48745150|NCT02300259|102161827|FG002|COMPLETED|Period 1||14||
48745151|NCT02300259|102161825|FG000|NOT COMPLETED|Period 1||0||
48328451|NCT01325428|101131958|FG000|STARTED|Part B||10||
48328452|NCT01325428|101131958|FG000|COMPLETED|Part B||7||
48328453|NCT01325428|101131958|FG000|NOT COMPLETED|Part B||3||
48328454|NCT02268058|101131959|FG000|STARTED|Overall Study||20||
48328455|NCT02268058|101131960|FG001|STARTED|Overall Study||20||
48328456|NCT02268058|101131961|FG002|STARTED|Overall Study||20||
48328457|NCT02268058|101131962|FG003|STARTED|Overall Study||20||
48328458|NCT02268058|101131959|FG000|COMPLETED|Overall Study||19||
48328459|NCT02268058|101131960|FG001|COMPLETED|Overall Study||20||
48328460|NCT02268058|101131961|FG002|COMPLETED|Overall Study||20||
48745152|NCT02300259|102161826|FG001|NOT COMPLETED|Period 1||0||
48745153|NCT02300259|102161827|FG002|NOT COMPLETED|Period 1||2||
48745154|NCT02300259|102161825|FG000|STARTED|Period 2||16||
48745155|NCT02300259|102161826|FG001|STARTED|Period 2||0||
48328461|NCT02268058|101131962|FG003|COMPLETED|Overall Study||20||
48328462|NCT02268058|101131959|FG000|NOT COMPLETED|Overall Study||1||
48328463|NCT02268058|101131960|FG001|NOT COMPLETED|Overall Study||0||
48328464|NCT02268058|101131961|FG002|NOT COMPLETED|Overall Study||0||
48328465|NCT02268058|101131962|FG003|NOT COMPLETED|Overall Study||0||
48328466|NCT02971670|101131963|FG000|STARTED|Overall Study||13||
48328467|NCT02971670|101131964|FG001|STARTED|Overall Study||2||
48328468|NCT02971670|101131965|FG002|STARTED|Overall Study||5||
48328469|NCT02971670|101131966|FG003|STARTED|Overall Study||3||
48328470|NCT02971670|101131963|FG000|COMPLETED|Overall Study||9||
48328471|NCT02971670|101131964|FG001|COMPLETED|Overall Study||1||
48745156|NCT02300259|102161827|FG002|STARTED|Period 2||14||
48745157|NCT02300259|102161825|FG000|COMPLETED|Period 2||15||
48328472|NCT02971670|101131965|FG002|COMPLETED|Overall Study||4||
48328473|NCT02971670|101131966|FG003|COMPLETED|Overall Study||1||
48328474|NCT02971670|101131963|FG000|NOT COMPLETED|Overall Study||4||
48328475|NCT02971670|101131964|FG001|NOT COMPLETED|Overall Study||1||
48328476|NCT02971670|101131965|FG002|NOT COMPLETED|Overall Study||1||
48328477|NCT02971670|101131966|FG003|NOT COMPLETED|Overall Study||2||
48328478|NCT02474082|101131967|FG000|STARTED|Overall Study||105||
48328479|NCT02474082|101131968|FG001|STARTED|Overall Study||97||
48328480|NCT02474082|101131967|FG000|Full Analysis Set (FAS)|Overall Study||105||
48328481|NCT02474082|101131968|FG001|Full Analysis Set (FAS)|Overall Study||95||
48328482|NCT02474082|101131967|FG000|COMPLETED|Overall Study||99||
48328483|NCT02474082|101131968|FG001|COMPLETED|Overall Study||43||
48745158|NCT02300259|102161826|FG001|COMPLETED|Period 2||0||
48745159|NCT02300259|102161827|FG002|COMPLETED|Period 2||13||
48328484|NCT02474082|101131967|FG000|NOT COMPLETED|Overall Study||6||
48328485|NCT02474082|101131968|FG001|NOT COMPLETED|Overall Study||54||
48328486|NCT01119248|101131969|FG000|STARTED|Overall Study||120||
48328487|NCT01119248|101131969|FG000|COMPLETED|Overall Study||115||
48328488|NCT01119248|101131969|FG000|NOT COMPLETED|Overall Study||5||
48328489|NCT02387580|101131970|FG000|STARTED|Overall Study||8||
48328490|NCT02387580|101131971|FG001|STARTED|Overall Study||8||
48328491|NCT02387580|101131972|FG002|STARTED|Overall Study||8||
48328492|NCT02387580|101131973|FG003|STARTED|Overall Study||8||
48328493|NCT02387580|101131974|FG004|STARTED|Overall Study||8||
48328494|NCT02387580|101131975|FG005|STARTED|Overall Study||8||
48328495|NCT02387580|101131970|FG000|COMPLETED|Overall Study||8||
48328496|NCT02387580|101131971|FG001|COMPLETED|Overall Study||8||
48328497|NCT02387580|101131972|FG002|COMPLETED|Overall Study||8||
48328498|NCT02387580|101131973|FG003|COMPLETED|Overall Study||7||
48328499|NCT02387580|101131974|FG004|COMPLETED|Overall Study||8||
48328500|NCT02387580|101131975|FG005|COMPLETED|Overall Study||8||
48328501|NCT02387580|101131970|FG000|NOT COMPLETED|Overall Study||0||
48328502|NCT02387580|101131971|FG001|NOT COMPLETED|Overall Study||0||
48328503|NCT02387580|101131972|FG002|NOT COMPLETED|Overall Study||0||
48328504|NCT02387580|101131973|FG003|NOT COMPLETED|Overall Study||1||
48328505|NCT02387580|101131974|FG004|NOT COMPLETED|Overall Study||0||
48328506|NCT02387580|101131975|FG005|NOT COMPLETED|Overall Study||0||
48328507|NCT01394939|101131976|FG000|STARTED|Overall Study||4||
48328508|NCT01394939|101131977|FG001|STARTED|Overall Study||25||
48328509|NCT01394939|101131978|FG002|STARTED|Overall Study||4||
48328510|NCT01394939|101131979|FG003|STARTED|Overall Study||17||
48328511|NCT01394939|101131976|FG000|COMPLETED|Overall Study||3||
48328512|NCT01394939|101131977|FG001|COMPLETED|Overall Study||15||
48328513|NCT01394939|101131978|FG002|COMPLETED|Overall Study||4||
48328514|NCT01394939|101131979|FG003|COMPLETED|Overall Study||10||
48328515|NCT01394939|101131976|FG000|NOT COMPLETED|Overall Study||1||
48328516|NCT01394939|101131977|FG001|NOT COMPLETED|Overall Study||10||
48328517|NCT01394939|101131978|FG002|NOT COMPLETED|Overall Study||0||
48328518|NCT01394939|101131979|FG003|NOT COMPLETED|Overall Study||7||
48328519|NCT01446419|101131980|FG000|STARTED|Overall Study||147||
48328520|NCT01446419|101131981|FG001|STARTED|Overall Study||78||
48328521|NCT01446419|101131980|FG000|3 Month Follow-up|Overall Study||146||
48328522|NCT01446419|101131981|FG001|3 Month Follow-up|Overall Study||77||
48328523|NCT01446419|101131980|FG000|6 Month Follow-up|Overall Study||144||
48745160|NCT02300259|102161825|FG000|NOT COMPLETED|Period 2||1||
48745161|NCT02300259|102161826|FG001|NOT COMPLETED|Period 2||0||
48745162|NCT02300259|102161827|FG002|NOT COMPLETED|Period 2||1||
48745163|NCT00920855|102161828|FG000|STARTED|Overall Study||5||
48745164|NCT00920855|102161829|FG001|STARTED|Overall Study||4||
48745165|NCT00920855|102161830|FG002|STARTED|Overall Study||31||
48745166|NCT00920855|102161828|FG000|Safety and Efficacy Populations|Overall Study||5||
48328524|NCT01446419|101131981|FG001|6 Month Follow-up|Overall Study||77||
48328525|NCT01446419|101131980|FG000|12 Month Follow-up|Overall Study||142||
48328526|NCT01446419|101131981|FG001|12 Month Follow-up|Overall Study||77||
48328527|NCT01446419|101131980|FG000|COMPLETED|Overall Study||142||
48328528|NCT01446419|101131981|FG001|COMPLETED|Overall Study||77||
48328529|NCT01446419|101131980|FG000|NOT COMPLETED|Overall Study||5||
48328530|NCT01446419|101131981|FG001|NOT COMPLETED|Overall Study||1||
48410117|NCT02436915|101334870|FG000|NOT COMPLETED|Overall Study||0||
48410118|NCT02436915|101334871|FG001|NOT COMPLETED|Overall Study||1||
48410119|NCT03667573|101334872|FG000|STARTED|Overall Study||6||
48410120|NCT03667573|101334873|FG001|STARTED|Overall Study||5||
48410121|NCT03667573|101334874|FG002|STARTED|Overall Study||5||
48410122|NCT03667573|101334875|FG003|STARTED|Overall Study||7||
48410123|NCT03667573|101334872|FG000|COMPLETED|Overall Study||6||
48328531|NCT01849770|101131982|FG000|STARTED|Overall Study||20||
48328532|NCT01849770|101131983|FG001|STARTED|Overall Study||19||
48328533|NCT01849770|101131984|FG002|STARTED|Overall Study||20||
48328534|NCT01849770|101131982|FG000|COMPLETED|Overall Study||20||
48328535|NCT01849770|101131983|FG001|COMPLETED|Overall Study||15||
48328536|NCT01849770|101131984|FG002|COMPLETED|Overall Study||19||
48328537|NCT01849770|101131982|FG000|NOT COMPLETED|Overall Study||0||
48328538|NCT01849770|101131983|FG001|NOT COMPLETED|Overall Study||4||
48328539|NCT01849770|101131984|FG002|NOT COMPLETED|Overall Study||1||
48328540|NCT04560088|101131985|FG000|STARTED|Overall Study||24||
48328541|NCT04560088|101131986|FG001|STARTED|Overall Study||31||
48328542|NCT04560088|101131985|FG000|COMPLETED|Overall Study||19||
48328543|NCT04560088|101131986|FG001|COMPLETED|Overall Study||30||
48328544|NCT04560088|101131985|FG000|NOT COMPLETED|Overall Study||5||
48328545|NCT04560088|101131986|FG001|NOT COMPLETED|Overall Study||1||
48328546|NCT00511355|101131987|FG000|STARTED|Overall Study||60||
48410124|NCT03667573|101334873|FG001|COMPLETED|Overall Study||5||
48410125|NCT03667573|101334874|FG002|COMPLETED|Overall Study||5||
48410126|NCT03667573|101334875|FG003|COMPLETED|Overall Study||7||
48410127|NCT03667573|101334872|FG000|NOT COMPLETED|Overall Study||0||
48410128|NCT03667573|101334873|FG001|NOT COMPLETED|Overall Study||0||
48410129|NCT03667573|101334874|FG002|NOT COMPLETED|Overall Study||0||
48410130|NCT03667573|101334875|FG003|NOT COMPLETED|Overall Study||0||
48410131|NCT01665040|101334876|FG000|STARTED|Overall Study||40||
48410132|NCT01665040|101334876|FG000|COMPLETED|Overall Study||36||
48328547|NCT00511355|101131988|FG001|STARTED|Overall Study||61||
48328548|NCT00511355|101131987|FG000|COMPLETED|Overall Study||53||
48328549|NCT00511355|101131988|FG001|COMPLETED|Overall Study||52||
48410133|NCT01665040|101334876|FG000|NOT COMPLETED|Overall Study||4||
48410134|NCT00939055|101334877|FG000|STARTED|Overall Study||73||
48410135|NCT00939055|101334878|FG001|STARTED|Overall Study||39||
48410136|NCT00939055|101334877|FG000|COMPLETED|Overall Study||69||
48410137|NCT00939055|101334878|FG001|COMPLETED|Overall Study||39||
48410138|NCT00939055|101334877|FG000|NOT COMPLETED|Overall Study||4||
48410139|NCT00939055|101334878|FG001|NOT COMPLETED|Overall Study||0||
48410140|NCT01601873|101334879|FG000|STARTED|Overall Study||50||
48410141|NCT01601873|101334880|FG001|STARTED|Overall Study||47||
48410142|NCT01601873|101334879|FG000|COMPLETED|Overall Study||48||
48410143|NCT01601873|101334880|FG001|COMPLETED|Overall Study||44||
48622150|NCT02717195|101859801|FG004|COMPLETED|Prospective Confirmation (PC) Period||0||
48622151|NCT02717195|101859797|FG000|NOT COMPLETED|Prospective Confirmation (PC) Period||290||
48622152|NCT02717195|101859798|FG001|NOT COMPLETED|Prospective Confirmation (PC) Period||111||
48622153|NCT02717195|101859799|FG002|NOT COMPLETED|Prospective Confirmation (PC) Period||0||
48745167|NCT00920855|102161829|FG001|Safety and Efficacy Populations|Overall Study||4||
48745168|NCT00920855|102161830|FG002|Safety and Efficacy Populations|Overall Study||31||
48745169|NCT00920855|102161828|FG000|COMPLETED|Overall Study||0||
48745170|NCT00920855|102161829|FG001|COMPLETED|Overall Study||1||
48745171|NCT00920855|102161830|FG002|COMPLETED|Overall Study||9||
48745172|NCT00920855|102161828|FG000|NOT COMPLETED|Overall Study||5||
48745173|NCT00920855|102161829|FG001|NOT COMPLETED|Overall Study||3||
48745174|NCT00920855|102161830|FG002|NOT COMPLETED|Overall Study||22||
48745175|NCT03483896|102161831|FG000|STARTED|Overall Study||33||
48745176|NCT03483896|102161832|FG001|STARTED|Overall Study||50||
48622154|NCT02717195|101859800|FG003|NOT COMPLETED|Prospective Confirmation (PC) Period||0||
48622155|NCT02717195|101859801|FG004|NOT COMPLETED|Prospective Confirmation (PC) Period||0||
48622156|NCT02717195|101859797|FG000|STARTED|Double-blind Treatment (DBT) Period||0||
48622157|NCT02717195|101859798|FG001|STARTED|Double-blind Treatment (DBT) Period||0||
48622158|NCT02717195|101859799|FG002|STARTED|Double-blind Treatment (DBT) Period||235||
48622159|NCT02717195|101859800|FG003|STARTED|Double-blind Treatment (DBT) Period||232||
48622160|NCT02717195|101859801|FG004|STARTED|Double-blind Treatment (DBT) Period||230||
48745177|NCT03483896|102161831|FG000|COMPLETED|Overall Study||31||
48745178|NCT03483896|102161832|FG001|COMPLETED|Overall Study||46||
48745179|NCT03483896|102161831|FG000|NOT COMPLETED|Overall Study||2||
48745180|NCT03483896|102161832|FG001|NOT COMPLETED|Overall Study||4||
48745181|NCT02679755|102161833|FG000|STARTED|Overall Study||100||
48745182|NCT02679755|102161834|FG001|STARTED|Overall Study||152||
48745183|NCT02679755|102161833|FG000|COMPLETED|Overall Study||66||
48745184|NCT02679755|102161834|FG001|COMPLETED|Overall Study||47||
48745185|NCT02679755|102161833|FG000|NOT COMPLETED|Overall Study||34||
48745186|NCT02679755|102161834|FG001|NOT COMPLETED|Overall Study||105||
48745187|NCT00947271|102161835|FG000|STARTED|3 Months Post Intervention||254||
48745188|NCT00947271|102161836|FG001|STARTED|3 Months Post Intervention||252||
48745189|NCT00947271|102161837|FG002|STARTED|3 Months Post Intervention||254||
48745190|NCT00947271|102161838|FG003|STARTED|3 Months Post Intervention||250||
48745191|NCT00947271|102161835|FG000|COMPLETED|3 Months Post Intervention||202||
48745192|NCT00947271|102161836|FG001|COMPLETED|3 Months Post Intervention||204||
48745193|NCT00947271|102161837|FG002|COMPLETED|3 Months Post Intervention||218||
48745194|NCT00947271|102161838|FG003|COMPLETED|3 Months Post Intervention||206||
48745195|NCT00947271|102161835|FG000|NOT COMPLETED|3 Months Post Intervention||52||
48745196|NCT00947271|102161836|FG001|NOT COMPLETED|3 Months Post Intervention||48||
48745197|NCT00947271|102161837|FG002|NOT COMPLETED|3 Months Post Intervention||36||
48745198|NCT00947271|102161838|FG003|NOT COMPLETED|3 Months Post Intervention||44||
48745199|NCT00947271|102161835|FG000|STARTED|6 Months Post Intervention||254||
48745200|NCT00947271|102161836|FG001|STARTED|6 Months Post Intervention||252||
48745201|NCT00947271|102161837|FG002|STARTED|6 Months Post Intervention||254||
48745202|NCT00947271|102161838|FG003|STARTED|6 Months Post Intervention||250||
48745203|NCT00947271|102161835|FG000|COMPLETED|6 Months Post Intervention||199||
48745204|NCT00947271|102161836|FG001|COMPLETED|6 Months Post Intervention||199||
48745205|NCT00947271|102161837|FG002|COMPLETED|6 Months Post Intervention||196||
48745206|NCT00947271|102161838|FG003|COMPLETED|6 Months Post Intervention||196||
48745207|NCT00947271|102161835|FG000|NOT COMPLETED|6 Months Post Intervention||55||
48745208|NCT00947271|102161836|FG001|NOT COMPLETED|6 Months Post Intervention||53||
48745209|NCT00947271|102161837|FG002|NOT COMPLETED|6 Months Post Intervention||58||
48745210|NCT00947271|102161838|FG003|NOT COMPLETED|6 Months Post Intervention||54||
48745211|NCT00947271|102161835|FG000|STARTED|9 Months Post Intervention||254||
48745212|NCT00947271|102161836|FG001|STARTED|9 Months Post Intervention||252||
48745213|NCT00947271|102161837|FG002|STARTED|9 Months Post Intervention||254||
48745214|NCT00947271|102161838|FG003|STARTED|9 Months Post Intervention||250||
48745215|NCT00947271|102161835|FG000|COMPLETED|9 Months Post Intervention||184||
48745216|NCT00947271|102161836|FG001|COMPLETED|9 Months Post Intervention||192||
48745217|NCT00947271|102161837|FG002|COMPLETED|9 Months Post Intervention||193||
48745218|NCT00947271|102161838|FG003|COMPLETED|9 Months Post Intervention||191||
48745219|NCT00947271|102161835|FG000|NOT COMPLETED|9 Months Post Intervention||70||
48745220|NCT00947271|102161836|FG001|NOT COMPLETED|9 Months Post Intervention||60||
48745221|NCT00947271|102161837|FG002|NOT COMPLETED|9 Months Post Intervention||61||
48745222|NCT00947271|102161838|FG003|NOT COMPLETED|9 Months Post Intervention||59||
48745223|NCT00947271|102161835|FG000|STARTED|12 Months Post Intervention||254||
48745224|NCT00947271|102161836|FG001|STARTED|12 Months Post Intervention||252||
48745225|NCT00947271|102161837|FG002|STARTED|12 Months Post Intervention||254||
48622161|NCT02717195|101859797|FG000|COMPLETED|Double-blind Treatment (DBT) Period||0||
48622162|NCT02717195|101859798|FG001|COMPLETED|Double-blind Treatment (DBT) Period||0||
48622163|NCT02717195|101859799|FG002|COMPLETED|Double-blind Treatment (DBT) Period||198||
48622164|NCT02717195|101859800|FG003|COMPLETED|Double-blind Treatment (DBT) Period||188||
48745226|NCT00947271|102161838|FG003|STARTED|12 Months Post Intervention||250||
48745227|NCT00947271|102161835|FG000|COMPLETED|12 Months Post Intervention||183||
48165958|NCT00622713|100728638|FG000|COMPLETED|Overall Study||169||
48622165|NCT02717195|101859801|FG004|COMPLETED|Double-blind Treatment (DBT) Period||200||
48622166|NCT02717195|101859797|FG000|NOT COMPLETED|Double-blind Treatment (DBT) Period||0||
48622167|NCT02717195|101859798|FG001|NOT COMPLETED|Double-blind Treatment (DBT) Period||0||
48622168|NCT02717195|101859799|FG002|NOT COMPLETED|Double-blind Treatment (DBT) Period||37||
48622169|NCT02717195|101859800|FG003|NOT COMPLETED|Double-blind Treatment (DBT) Period||44||
48622170|NCT02717195|101859801|FG004|NOT COMPLETED|Double-blind Treatment (DBT) Period||30||
48622171|NCT03110354|101859802|FG000|STARTED|Overall Study||4||
48622172|NCT03110354|101859803|FG001|STARTED|Overall Study||4||
48622173|NCT03110354|101859804|FG002|STARTED|Overall Study||3||
48622174|NCT03110354|101859805|FG003|STARTED|Overall Study||10||
48622175|NCT03110354|101859806|FG004|STARTED|Overall Study||7||
48622176|NCT03110354|101859802|FG000|COMPLETED|Overall Study||0||
48622177|NCT03110354|101859803|FG001|COMPLETED|Overall Study||0||
48622178|NCT03110354|101859804|FG002|COMPLETED|Overall Study||0||
48622179|NCT03110354|101859805|FG003|COMPLETED|Overall Study||0||
48622180|NCT03110354|101859806|FG004|COMPLETED|Overall Study||0||
48622181|NCT03110354|101859802|FG000|NOT COMPLETED|Overall Study||4||
48622182|NCT03110354|101859803|FG001|NOT COMPLETED|Overall Study||4||
48622183|NCT03110354|101859804|FG002|NOT COMPLETED|Overall Study||3||
48745228|NCT00947271|102161836|FG001|COMPLETED|12 Months Post Intervention||192||
48745229|NCT00947271|102161837|FG002|COMPLETED|12 Months Post Intervention||195||
48745230|NCT00947271|102161838|FG003|COMPLETED|12 Months Post Intervention||188||
48745231|NCT00947271|102161835|FG000|NOT COMPLETED|12 Months Post Intervention||71||
48745232|NCT00947271|102161836|FG001|NOT COMPLETED|12 Months Post Intervention||60||
48745233|NCT00947271|102161837|FG002|NOT COMPLETED|12 Months Post Intervention||59||
48745234|NCT00947271|102161838|FG003|NOT COMPLETED|12 Months Post Intervention||62||
48745235|NCT00556894|102161839|FG000|STARTED|Overall Study||82||
48745236|NCT00556894|102161840|FG001|STARTED|Overall Study||87||
48745237|NCT00556894|102161841|FG002|STARTED|Overall Study||84||
48745238|NCT00556894|102161839|FG000|COMPLETED|Overall Study||66||
48745239|NCT00556894|102161840|FG001|COMPLETED|Overall Study||68||
48745240|NCT00556894|102161841|FG002|COMPLETED|Overall Study||65||
48745241|NCT00556894|102161839|FG000|NOT COMPLETED|Overall Study||16||
48745242|NCT00556894|102161840|FG001|NOT COMPLETED|Overall Study||19||
48745243|NCT00556894|102161841|FG002|NOT COMPLETED|Overall Study||19||
48745244|NCT02380287|102161842|FG000|STARTED|Overall Study||1||
48745245|NCT02380287|102161843|FG001|STARTED|Overall Study||3||
48745246|NCT02380287|102161844|FG002|STARTED|Overall Study||3||
48745247|NCT02380287|102161845|FG003|STARTED|Overall Study||3||
48745248|NCT02380287|102161846|FG004|STARTED|Overall Study||3||
48745249|NCT02380287|102161847|FG005|STARTED|Overall Study||3||
48745250|NCT02380287|102161848|FG006|STARTED|Overall Study||3||
48745251|NCT02380287|102161849|FG007|STARTED|Overall Study||3||
48745252|NCT02380287|102161842|FG000|COMPLETED|Overall Study||1||
48745253|NCT02380287|102161843|FG001|COMPLETED|Overall Study||3||
48745254|NCT02380287|102161844|FG002|COMPLETED|Overall Study||2||
48745255|NCT02380287|102161845|FG003|COMPLETED|Overall Study||3||
48745256|NCT02380287|102161846|FG004|COMPLETED|Overall Study||3||
48745257|NCT02380287|102161847|FG005|COMPLETED|Overall Study||3||
48745258|NCT02380287|102161848|FG006|COMPLETED|Overall Study||3||
48745259|NCT02380287|102161849|FG007|COMPLETED|Overall Study||3||
48745260|NCT02380287|102161842|FG000|NOT COMPLETED|Overall Study||0||
48745261|NCT02380287|102161843|FG001|NOT COMPLETED|Overall Study||0||
48745262|NCT02380287|102161844|FG002|NOT COMPLETED|Overall Study||1||
48745263|NCT02380287|102161845|FG003|NOT COMPLETED|Overall Study||0||
48622184|NCT03110354|101859805|FG003|NOT COMPLETED|Overall Study||10||
48622185|NCT03110354|101859806|FG004|NOT COMPLETED|Overall Study||7||
48745264|NCT02380287|102161846|FG004|NOT COMPLETED|Overall Study||0||
48745265|NCT02380287|102161847|FG005|NOT COMPLETED|Overall Study||0||
48745266|NCT02380287|102161848|FG006|NOT COMPLETED|Overall Study||0||
48745267|NCT02380287|102161849|FG007|NOT COMPLETED|Overall Study||0||
48745268|NCT00675909|102161850|FG000|STARTED|Overall Study||60||
48165959|NCT00622713|100728638|FG000|NOT COMPLETED|Overall Study||59||
48622186|NCT02329847|101859807|FG000|STARTED|Overall Study||7||
48622187|NCT02329847|101859808|FG001|STARTED|Overall Study||7||
48622188|NCT02329847|101859809|FG002|STARTED|Overall Study||36||
48622189|NCT02329847|101859810|FG003|STARTED|Overall Study||35||
48622190|NCT02329847|101859811|FG004|STARTED|Overall Study||39||
48622191|NCT02329847|101859812|FG005|STARTED|Overall Study||20||
48745269|NCT00675909|102161851|FG001|STARTED|Overall Study||60||
48745270|NCT00675909|102161852|FG002|STARTED|Overall Study||60||
48745271|NCT00675909|102161850|FG000|COMPLETED|Overall Study||60||
48745272|NCT00675909|102161851|FG001|COMPLETED|Overall Study||60||
48622192|NCT02329847|101859807|FG000|Treated (Safety Analysis Set)|Overall Study||7||
48622193|NCT02329847|101859808|FG001|Treated (Safety Analysis Set)|Overall Study||7||
48745273|NCT00675909|102161852|FG002|COMPLETED|Overall Study||60||
48745274|NCT00675909|102161850|FG000|NOT COMPLETED|Overall Study||0||
48745275|NCT00675909|102161851|FG001|NOT COMPLETED|Overall Study||0||
48745276|NCT00675909|102161852|FG002|NOT COMPLETED|Overall Study||0||
48745277|NCT02607618|102161853|FG000|STARTED|Overall Study||306||
48745278|NCT02607618|102161854|FG001|STARTED|Overall Study||307||
48745279|NCT02607618|102161853|FG000|COMPLETED|Overall Study||295||
48622194|NCT02329847|101859809|FG002|Treated (Safety Analysis Set)|Overall Study||35||
48622195|NCT02329847|101859810|FG003|Treated (Safety Analysis Set)|Overall Study||35||
48622196|NCT02329847|101859811|FG004|Treated (Safety Analysis Set)|Overall Study||37||
48622197|NCT02329847|101859812|FG005|Treated (Safety Analysis Set)|Overall Study||20||
48622198|NCT02329847|101859807|FG000|COMPLETED|Overall Study||0||
48622199|NCT02329847|101859808|FG001|COMPLETED|Overall Study||0||
48622200|NCT02329847|101859809|FG002|COMPLETED|Overall Study||1||
48622201|NCT02329847|101859810|FG003|COMPLETED|Overall Study||0||
48622202|NCT02329847|101859811|FG004|COMPLETED|Overall Study||0||
48622203|NCT02329847|101859812|FG005|COMPLETED|Overall Study||0||
48622204|NCT02329847|101859807|FG000|NOT COMPLETED|Overall Study||7||
48622205|NCT02329847|101859808|FG001|NOT COMPLETED|Overall Study||7||
48622206|NCT02329847|101859809|FG002|NOT COMPLETED|Overall Study||35||
48622207|NCT02329847|101859810|FG003|NOT COMPLETED|Overall Study||35||
48622208|NCT02329847|101859811|FG004|NOT COMPLETED|Overall Study||39||
48622209|NCT02329847|101859812|FG005|NOT COMPLETED|Overall Study||20||
48622210|NCT00614874|101859813|FG000|STARTED|Overall Study||16||
48622211|NCT00614874|101859813|FG000|COMPLETED|Overall Study||14||
48622212|NCT00614874|101859813|FG000|NOT COMPLETED|Overall Study||2||
48622213|NCT02147613|101859814|FG000|STARTED|Overall Study||10||
48622214|NCT02147613|101859815|FG001|STARTED|Overall Study||9||
48622215|NCT02147613|101859814|FG000|COMPLETED|Overall Study||9||
48622216|NCT02147613|101859815|FG001|COMPLETED|Overall Study||6||
48622217|NCT02147613|101859814|FG000|NOT COMPLETED|Overall Study||1||
48622218|NCT02147613|101859815|FG001|NOT COMPLETED|Overall Study||3||
48328550|NCT00511355|101131987|FG000|NOT COMPLETED|Overall Study||7||
48328551|NCT00511355|101131988|FG001|NOT COMPLETED|Overall Study||9||
48328552|NCT01745146|101131989|FG000|STARTED|Overall Study||30||
48328553|NCT01745146|101131990|FG001|STARTED|Overall Study||60||
48328554|NCT01745146|101131989|FG000|Allocation to Intervention|Overall Study||30||
48328555|NCT01745146|101131990|FG001|Allocation to Intervention|Overall Study||60||
48328556|NCT01745146|101131989|FG000|Primary Outcome Assessment|Overall Study||27||
48328557|NCT01745146|101131990|FG001|Primary Outcome Assessment|Overall Study||57||
48328558|NCT01745146|101131989|FG000|Analysis|Overall Study||27||
48328559|NCT01745146|101131990|FG001|Analysis|Overall Study||57||
48328560|NCT01745146|101131989|FG000|COMPLETED|Overall Study||27||
48622219|NCT02723188|101859816|FG000|STARTED|Overall Study||15||
48328561|NCT01745146|101131990|FG001|COMPLETED|Overall Study||57||
48328562|NCT01745146|101131989|FG000|NOT COMPLETED|Overall Study||3||
48328563|NCT01745146|101131990|FG001|NOT COMPLETED|Overall Study||3||
48328564|NCT02876887|101131991|FG000|STARTED|Overall Study||23||
48328565|NCT02876887|101131992|FG001|STARTED|Overall Study||21||
48328566|NCT02876887|101131991|FG000|COMPLETED|Overall Study||19||
48328567|NCT02876887|101131992|FG001|COMPLETED|Overall Study||21||
48622220|NCT02723188|101859817|FG001|STARTED|Overall Study||15||
48622221|NCT02723188|101859818|FG002|STARTED|Overall Study||15||
48622222|NCT02723188|101859816|FG000|COMPLETED|Overall Study||14||
48328568|NCT02876887|101131991|FG000|NOT COMPLETED|Overall Study||4||
48328569|NCT02876887|101131992|FG001|NOT COMPLETED|Overall Study||0||
48328570|NCT00691483|101131993|FG000|STARTED|Overall Study||493||
48622223|NCT02723188|101859817|FG001|COMPLETED|Overall Study||15||
48622224|NCT02723188|101859818|FG002|COMPLETED|Overall Study||15||
48622225|NCT02723188|101859816|FG000|NOT COMPLETED|Overall Study||1||
48622226|NCT02723188|101859817|FG001|NOT COMPLETED|Overall Study||0||
48410144|NCT01601873|101334879|FG000|NOT COMPLETED|Overall Study||2||
48410145|NCT01601873|101334880|FG001|NOT COMPLETED|Overall Study||3||
48622227|NCT02723188|101859818|FG002|NOT COMPLETED|Overall Study||0||
48328571|NCT00691483|101131994|FG001|STARTED|Overall Study||166||
48165960|NCT01782742|100728639|FG000|STARTED|Double-blind Treatment Phase||16||
48165961|NCT01782742|100728640|FG001|STARTED|Double-blind Treatment Phase||4||
48165962|NCT01782742|100728639|FG000|COMPLETED|Double-blind Treatment Phase||15||
48165963|NCT01782742|100728640|FG001|COMPLETED|Double-blind Treatment Phase||4||
48165964|NCT01782742|100728639|FG000|NOT COMPLETED|Double-blind Treatment Phase||1||
48165965|NCT01782742|100728640|FG001|NOT COMPLETED|Double-blind Treatment Phase||0||
48165966|NCT01782742|100728639|FG000|STARTED|Open Label Phase||19||
48165967|NCT01782742|100728640|FG001|STARTED|Open Label Phase||0||
48165968|NCT01782742|100728639|FG000|COMPLETED|Open Label Phase||19||
48165969|NCT01782742|100728640|FG001|COMPLETED|Open Label Phase||0||
48328572|NCT00691483|101131993|FG000|Received Treatment|Overall Study||486||
48328573|NCT00691483|101131994|FG001|Received Treatment|Overall Study||165||
48328574|NCT00691483|101131993|FG000|COMPLETED|Overall Study||425||
48328575|NCT00691483|101131994|FG001|COMPLETED|Overall Study||141||
48328576|NCT00691483|101131993|FG000|NOT COMPLETED|Overall Study||68||
48328577|NCT00691483|101131994|FG001|NOT COMPLETED|Overall Study||25||
48328578|NCT02112370|101131995|FG000|STARTED|Overall Study||74||
48328579|NCT02112370|101131996|FG001|STARTED|Overall Study||74||
48622228|NCT01630135|101859819|FG000|STARTED|Overall Study||131||
48622229|NCT01630135|101859820|FG001|STARTED|Overall Study||130||
48622230|NCT01630135|101859819|FG000|COMPLETED|Overall Study||131||
48622231|NCT01630135|101859820|FG001|COMPLETED|Overall Study||128||
48622232|NCT01630135|101859819|FG000|NOT COMPLETED|Overall Study||0||
48328580|NCT02112370|101131995|FG000|COMPLETED|Overall Study||74||
48328581|NCT02112370|101131996|FG001|COMPLETED|Overall Study||74||
48328582|NCT02112370|101131995|FG000|NOT COMPLETED|Overall Study||0||
48328583|NCT02112370|101131996|FG001|NOT COMPLETED|Overall Study||0||
48328584|NCT00328770|101131997|FG000|STARTED|Overall Study||70||
48328585|NCT00328770|101131997|FG000|COMPLETED|Overall Study||70||
48328586|NCT00328770|101131997|FG000|NOT COMPLETED|Overall Study||0||
48328587|NCT00711100|101131998|FG000|STARTED|Overall Study||104||
48328588|NCT00711100|101131998|FG000|COMPLETED|Overall Study||91||
48622233|NCT01630135|101859820|FG001|NOT COMPLETED|Overall Study||2||
48622234|NCT03505372|101859821|FG000|STARTED|Overall Study||5||
48328589|NCT00711100|101131998|FG000|NOT COMPLETED|Overall Study||13||
48328590|NCT02447848|101131999|FG000|STARTED|Overall Study||76||
48622235|NCT03505372|101859821|FG000|COMPLETED|Overall Study||5||
48622236|NCT03505372|101859821|FG000|NOT COMPLETED|Overall Study||0||
48328591|NCT02447848|101131999|FG000|COMPLETED|Overall Study||65||
48622237|NCT02254772|101859822|FG000|STARTED|Overall Study||9||
48622238|NCT02254772|101859822|FG000|COMPLETED|Overall Study||7||
48622239|NCT02254772|101859822|FG000|NOT COMPLETED|Overall Study||2||
48622240|NCT00596271|101859823|FG000|STARTED|Overall Study||65||
48622241|NCT00596271|101859824|FG001|STARTED|Overall Study||65||
48622242|NCT00596271|101859825|FG002|STARTED|Overall Study||62||
48622243|NCT00596271|101859823|FG000|COMPLETED|Overall Study||60||
48165970|NCT01782742|100728639|FG000|NOT COMPLETED|Open Label Phase||0||
48165971|NCT01782742|100728640|FG001|NOT COMPLETED|Open Label Phase||0||
48165972|NCT03724396|100728641|FG000|STARTED|Overall Study||34||
48165973|NCT03724396|100728642|FG001|STARTED|Overall Study||33||
48165974|NCT03724396|100728641|FG000|Mid Treatment|Overall Study||33||
48165975|NCT03724396|100728642|FG001|Mid Treatment|Overall Study||32||
48165976|NCT03724396|100728641|FG000|Post-Treatment|Overall Study||32||
48165977|NCT03724396|100728642|FG001|Post-Treatment|Overall Study||31||
48165978|NCT03724396|100728641|FG000|6-month Follow-up|Overall Study||32||
48328592|NCT02447848|101131999|FG000|NOT COMPLETED|Overall Study||11||
48165979|NCT03724396|100728642|FG001|6-month Follow-up|Overall Study||32||
48165980|NCT03724396|100728641|FG000|COMPLETED|Overall Study||32||
48165981|NCT03724396|100728642|FG001|COMPLETED|Overall Study||32||
48165982|NCT03724396|100728641|FG000|NOT COMPLETED|Overall Study||2||
48165983|NCT03724396|100728642|FG001|NOT COMPLETED|Overall Study||1||
48328593|NCT03470493|101132000|FG000|STARTED|Overall Study||130||
48622244|NCT00596271|101859824|FG001|COMPLETED|Overall Study||59||
48165984|NCT01396395|100728643|FG000|STARTED|Overall Study||200||
48165985|NCT01396395|100728644|FG001|STARTED|Overall Study||202||
48165986|NCT01396395|100728643|FG000|Safety Analysis Set|Overall Study||197||
48165987|NCT01396395|100728644|FG001|Safety Analysis Set|Overall Study||205||
48622245|NCT00596271|101859825|FG002|COMPLETED|Overall Study||61||
48328594|NCT03470493|101132000|FG000|Met Primary Endpoint|Overall Study||80||
48328595|NCT03470493|101132000|FG000|COMPLETED|Overall Study||130||
48328596|NCT03470493|101132000|FG000|NOT COMPLETED|Overall Study||0||
48328597|NCT02018627|101132001|FG000|STARTED|Overall Study||7||
48328598|NCT02018627|101132002|FG001|STARTED|Overall Study||6||
48328599|NCT02018627|101132001|FG000|COMPLETED|Overall Study||7||
48328600|NCT02018627|101132002|FG001|COMPLETED|Overall Study||6||
48328601|NCT02018627|101132001|FG000|NOT COMPLETED|Overall Study||0||
48328602|NCT02018627|101132002|FG001|NOT COMPLETED|Overall Study||0||
48328603|NCT01558661|101132003|FG000|STARTED|Overall Study||33||
48328604|NCT01558661|101132003|FG000|First Stage|Overall Study||18||
48328605|NCT01558661|101132003|FG000|Second Stage|Overall Study||15||
48328606|NCT01558661|101132003|FG000|COMPLETED|Overall Study||33||
48328607|NCT01558661|101132003|FG000|NOT COMPLETED|Overall Study||0||
48328608|NCT01816243|101132004|FG000|STARTED|Overall Study||39||
48328609|NCT01816243|101132004|FG000|COMPLETED|Overall Study||27||
48328610|NCT01816243|101132004|FG000|NOT COMPLETED|Overall Study||12||
48328611|NCT01097863|101132005|FG000|STARTED|Overall Study||90||
48328612|NCT01097863|101132006|FG001|STARTED|Overall Study||98||
48328613|NCT01097863|101132007|FG002|STARTED|Overall Study||91||
48328614|NCT01097863|101132005|FG000|COMPLETED|Overall Study||89||
48328615|NCT01097863|101132006|FG001|COMPLETED|Overall Study||98||
48622246|NCT00596271|101859823|FG000|NOT COMPLETED|Overall Study||5||
48622247|NCT00596271|101859824|FG001|NOT COMPLETED|Overall Study||6||
48622248|NCT00596271|101859825|FG002|NOT COMPLETED|Overall Study||1||
48622249|NCT00230048|101859826|FG000|STARTED|Overall Study||52||
48622250|NCT00230048|101859827|FG001|STARTED|Overall Study||55||
48622251|NCT00230048|101859826|FG000|Completed Intervention/Control Session|Overall Study||52||
48622252|NCT00230048|101859827|FG001|Completed Intervention/Control Session|Overall Study||55||
48622253|NCT00230048|101859826|FG000|COMPLETED|Overall Study||39||
48622254|NCT00230048|101859827|FG001|COMPLETED|Overall Study||37||
48622255|NCT00230048|101859826|FG000|NOT COMPLETED|Overall Study||13||
48622256|NCT00230048|101859827|FG001|NOT COMPLETED|Overall Study||18||
48622257|NCT01228591|101859828|FG000|STARTED|Baseline||18||
48328616|NCT01097863|101132007|FG002|COMPLETED|Overall Study||89||
48328617|NCT01097863|101132005|FG000|NOT COMPLETED|Overall Study||1||
48328618|NCT01097863|101132006|FG001|NOT COMPLETED|Overall Study||0||
48328619|NCT01097863|101132007|FG002|NOT COMPLETED|Overall Study||2||
48328620|NCT01269710|101132008|FG000|STARTED|Overall Study||4||
48328621|NCT01269710|101132008|FG000|Week 12|Overall Study||3||
48328622|NCT01269710|101132008|FG000|Week 36|Overall Study||2||
48328623|NCT01269710|101132008|FG000|COMPLETED|Overall Study||1||
48328624|NCT01269710|101132008|FG000|NOT COMPLETED|Overall Study||3||
48328625|NCT00272038|101132009|FG000|STARTED|Overall Study||29||
48328626|NCT00272038|101132009|FG000|COMPLETED|Overall Study||22||
48328627|NCT00272038|101132009|FG000|NOT COMPLETED|Overall Study||7||
48328628|NCT00848354|101132010|FG000|STARTED|Phase 1||281||
48328629|NCT00848354|101132011|FG001|STARTED|Phase 1||143||
48328630|NCT00848354|101132010|FG000|COMPLETED|Phase 1||269||
48328631|NCT00848354|101132011|FG001|COMPLETED|Phase 1||129||
48328632|NCT00848354|101132010|FG000|NOT COMPLETED|Phase 1||12||
48328633|NCT00848354|101132011|FG001|NOT COMPLETED|Phase 1||14||
48328634|NCT00848354|101132010|FG000|STARTED|Phase 2 Year 1||260||
48328635|NCT00848354|101132011|FG001|STARTED|Phase 2 Year 1||126||
48328636|NCT00848354|101132010|FG000|COMPLETED|Phase 2 Year 1||242||
48328637|NCT00848354|101132011|FG001|COMPLETED|Phase 2 Year 1||120||
48328638|NCT00848354|101132010|FG000|NOT COMPLETED|Phase 2 Year 1||18||
48328639|NCT00848354|101132011|FG001|NOT COMPLETED|Phase 2 Year 1||6||
48328640|NCT00848354|101132010|FG000|STARTED|Phase 2 Year 2||241||
48328641|NCT00848354|101132011|FG001|STARTED|Phase 2 Year 2||120||
48328642|NCT00848354|101132010|FG000|COMPLETED|Phase 2 Year 2||218||
48328643|NCT00848354|101132011|FG001|COMPLETED|Phase 2 Year 2||113||
48328644|NCT00848354|101132010|FG000|NOT COMPLETED|Phase 2 Year 2||23||
48328645|NCT00848354|101132011|FG001|NOT COMPLETED|Phase 2 Year 2||7||
48622258|NCT01228591|101859829|FG001|STARTED|Baseline||18||
48328646|NCT00781456|101132012|FG000|STARTED|Overall Study||58||
48328647|NCT00781456|101132013|FG001|STARTED|Overall Study||51||
48328648|NCT00781456|101132012|FG000|Received Study Drug|Overall Study||57||
48328649|NCT00781456|101132013|FG001|Received Study Drug|Overall Study||49||
48622259|NCT01228591|101859828|FG000|COMPLETED|Baseline||17||
48622260|NCT01228591|101859829|FG001|COMPLETED|Baseline||16||
48328650|NCT00781456|101132012|FG000|COMPLETED|Overall Study||37||
48328651|NCT00781456|101132013|FG001|COMPLETED|Overall Study||35||
48328652|NCT00781456|101132012|FG000|NOT COMPLETED|Overall Study||21||
48328653|NCT00781456|101132013|FG001|NOT COMPLETED|Overall Study||16||
48622261|NCT01228591|101859828|FG000|NOT COMPLETED|Baseline||1||
48622262|NCT01228591|101859829|FG001|NOT COMPLETED|Baseline||2||
48622263|NCT01228591|101859828|FG000|STARTED|1-Week Follow-Up||17||
48328654|NCT04074928|101132014|FG000|STARTED|Overall Study||1605||
48328655|NCT04074928|101132015|FG001|STARTED|Overall Study||809||
48328656|NCT04074928|101132014|FG000|Received Study Vaccine|Overall Study||1597||
48328657|NCT04074928|101132015|FG001|Received Study Vaccine|Overall Study||805||
48328658|NCT04074928|101132014|FG000|COMPLETED|Overall Study||1370||
48328659|NCT04074928|101132015|FG001|COMPLETED|Overall Study||710||
48328660|NCT04074928|101132014|FG000|NOT COMPLETED|Overall Study||235||
48165988|NCT01396395|100728643|FG000|COMPLETED|Overall Study||160||
48165989|NCT01396395|100728644|FG001|COMPLETED|Overall Study||175||
48165990|NCT01396395|100728643|FG000|NOT COMPLETED|Overall Study||40||
48165991|NCT01396395|100728644|FG001|NOT COMPLETED|Overall Study||27||
48622264|NCT01228591|101859829|FG001|STARTED|1-Week Follow-Up||16||
48622265|NCT01228591|101859828|FG000|COMPLETED|1-Week Follow-Up||17||
48622266|NCT01228591|101859829|FG001|COMPLETED|1-Week Follow-Up||16||
48622267|NCT01228591|101859828|FG000|NOT COMPLETED|1-Week Follow-Up||0||
48622268|NCT01228591|101859829|FG001|NOT COMPLETED|1-Week Follow-Up||0||
48622269|NCT01228591|101859828|FG000|STARTED|Final Visit||17||
48328661|NCT04074928|101132015|FG001|NOT COMPLETED|Overall Study||99||
48328662|NCT02461992|101132016|FG000|STARTED|Overall Study||13||
48328663|NCT02461992|101132016|FG000|COMPLETED|Overall Study||13||
48328664|NCT02461992|101132016|FG000|NOT COMPLETED|Overall Study||0||
48328665|NCT02682901|101132017|FG000|STARTED|Overall Study||43||
48328666|NCT02682901|101132018|FG001|STARTED|Overall Study||41||
48328667|NCT02682901|101132017|FG000|Completed 4 Weeks|Overall Study||38||
48328668|NCT02682901|101132018|FG001|Completed 4 Weeks|Overall Study||39||
48328669|NCT02682901|101132017|FG000|Completed 12 Weeks|Overall Study||36||
48622270|NCT01228591|101859829|FG001|STARTED|Final Visit||16||
48622271|NCT01228591|101859828|FG000|COMPLETED|Final Visit||17||
48622272|NCT01228591|101859829|FG001|COMPLETED|Final Visit||16||
48622273|NCT01228591|101859828|FG000|NOT COMPLETED|Final Visit||0||
48622274|NCT01228591|101859829|FG001|NOT COMPLETED|Final Visit||0||
48622275|NCT02456194|101859830|FG000|STARTED|Overall Study||30||
48622276|NCT02456194|101859830|FG000|COMPLETED|Overall Study||29||
48622277|NCT02456194|101859830|FG000|NOT COMPLETED|Overall Study||1||
48622278|NCT03065647|101859831|FG000|STARTED|Overall Study||3||
48622279|NCT03065647|101859832|FG001|STARTED|Overall Study||12||
48622280|NCT03065647|101859831|FG000|COMPLETED|Overall Study||3||
48622281|NCT03065647|101859832|FG001|COMPLETED|Overall Study||12||
48622282|NCT03065647|101859831|FG000|NOT COMPLETED|Overall Study||0||
48622283|NCT03065647|101859832|FG001|NOT COMPLETED|Overall Study||0||
48622284|NCT04155463|101859833|FG000|STARTED|First Intervention (1 Week)||20||
48622285|NCT04155463|101859834|FG001|STARTED|First Intervention (1 Week)||20||
48622286|NCT04155463|101859833|FG000|COMPLETED|First Intervention (1 Week)||20||
48622287|NCT04155463|101859834|FG001|COMPLETED|First Intervention (1 Week)||19||
48622288|NCT04155463|101859833|FG000|NOT COMPLETED|First Intervention (1 Week)||0||
48622289|NCT04155463|101859834|FG001|NOT COMPLETED|First Intervention (1 Week)||1||
48622290|NCT04155463|101859833|FG000|STARTED|Washout (1 Day)||20||
48622291|NCT04155463|101859834|FG001|STARTED|Washout (1 Day)||19||
48622292|NCT04155463|101859833|FG000|COMPLETED|Washout (1 Day)||20||
48622293|NCT04155463|101859834|FG001|COMPLETED|Washout (1 Day)||19||
48622294|NCT04155463|101859833|FG000|NOT COMPLETED|Washout (1 Day)||0||
48328670|NCT02682901|101132018|FG001|Completed 12 Weeks|Overall Study||37||
48328671|NCT02682901|101132017|FG000|COMPLETED|Overall Study||33||
48328672|NCT02682901|101132018|FG001|COMPLETED|Overall Study||37||
48328673|NCT02682901|101132017|FG000|NOT COMPLETED|Overall Study||10||
48328674|NCT02682901|101132018|FG001|NOT COMPLETED|Overall Study||4||
48328675|NCT04173429|101132019|FG000|STARTED|Overall Study||32||
48328676|NCT04173429|101132020|FG001|STARTED|Overall Study||32||
48328677|NCT04173429|101132019|FG000|Completed the Nadroparin Calcium Therapy and Received Warfarin|Overall Study||32||
48622295|NCT04155463|101859834|FG001|NOT COMPLETED|Washout (1 Day)||0||
48622296|NCT04155463|101859833|FG000|STARTED|Second Intervention (1 Week)||20||
48328678|NCT04173429|101132020|FG001|Completed the Nadroparin Calcium Therapy and Received Warfarin|Overall Study||0||
48622297|NCT04155463|101859834|FG001|STARTED|Second Intervention (1 Week)||19||
48622298|NCT04155463|101859833|FG000|COMPLETED|Second Intervention (1 Week)||20||
48622299|NCT04155463|101859834|FG001|COMPLETED|Second Intervention (1 Week)||19||
48622300|NCT04155463|101859833|FG000|NOT COMPLETED|Second Intervention (1 Week)||0||
48622301|NCT04155463|101859834|FG001|NOT COMPLETED|Second Intervention (1 Week)||0||
48622302|NCT00274742|101859835|FG000|STARTED|Overall Study||12||
48622303|NCT00274742|101859836|FG001|STARTED|Overall Study||13||
48622304|NCT00274742|101859837|FG002|STARTED|Overall Study||6||
48622305|NCT00274742|101859838|FG003|STARTED|Overall Study||9||
48622306|NCT00274742|101859839|FG004|STARTED|Overall Study||32||
48622307|NCT00274742|101859840|FG005|STARTED|Overall Study||4||
48622308|NCT00274742|101859835|FG000|COMPLETED|Overall Study||12||
48622309|NCT00274742|101859836|FG001|COMPLETED|Overall Study||5||
48622310|NCT00274742|101859837|FG002|COMPLETED|Overall Study||4||
48622311|NCT00274742|101859838|FG003|COMPLETED|Overall Study||4||
48622312|NCT00274742|101859839|FG004|COMPLETED|Overall Study||16||
48622313|NCT00274742|101859840|FG005|COMPLETED|Overall Study||1||
48622314|NCT00274742|101859835|FG000|NOT COMPLETED|Overall Study||0||
48622315|NCT00274742|101859836|FG001|NOT COMPLETED|Overall Study||8||
48622316|NCT00274742|101859837|FG002|NOT COMPLETED|Overall Study||2||
48622317|NCT00274742|101859838|FG003|NOT COMPLETED|Overall Study||5||
48622318|NCT00274742|101859839|FG004|NOT COMPLETED|Overall Study||16||
48622319|NCT00274742|101859840|FG005|NOT COMPLETED|Overall Study||3||
48622320|NCT03118934|101859841|FG000|STARTED|Overall Study||34|Randomized and trial fit, as randomized|
48622321|NCT03118934|101859842|FG001|STARTED|Overall Study||31|Randomized and trial fit, as randomized|
48622322|NCT03118934|101859843|FG002|STARTED|Overall Study||34|Randomized and trial fit, as randomized|
48622323|NCT03118934|101859844|FG003|STARTED|Overall Study||29|Randomized and trial fit, as randomized|
48622324|NCT03118934|101859845|FG004|STARTED|Overall Study||29|Randomized and trial fit, as randomized|
48622325|NCT03118934|101859846|FG005|STARTED|Overall Study||25|Randomized and trial fit, as randomized|
48622326|NCT03118934|101859841|FG000|Safety Analysis Set|Overall Study||34|All subjects/eyes exposed to study lenses, except those used for trial fit at Visit 1, as exposed|
48622327|NCT03118934|101859842|FG001|Safety Analysis Set|Overall Study||29|All subjects/eyes exposed to study lenses, except those used for trial fit at Visit 1, as exposed|
48622328|NCT03118934|101859843|FG002|Safety Analysis Set|Overall Study||34|All subjects/eyes exposed to study lenses, except those used for trial fit at Visit 1, as exposed|
48622329|NCT03118934|101859844|FG003|Safety Analysis Set|Overall Study||29|All subjects/eyes exposed to study lenses, except those used for trial fit at Visit 1, as exposed|
48622330|NCT03118934|101859845|FG004|Safety Analysis Set|Overall Study||26|All subjects/eyes exposed to study lenses, except those used for trial fit at Visit 1, as exposed|
48622331|NCT03118934|101859846|FG005|Safety Analysis Set|Overall Study||25|All subjects/eyes exposed to study lenses, except those used for trial fit at Visit 1, as exposed|
48622332|NCT03118934|101859841|FG000|COMPLETED|Overall Study||34|Completed, as randomized|
48622333|NCT03118934|101859842|FG001|COMPLETED|Overall Study||30|Completed, as randomized|
48622334|NCT03118934|101859843|FG002|COMPLETED|Overall Study||33|Completed, as randomized|
48165992|NCT02387996|100728645|FG000|STARTED|Overall Study||270||
48165993|NCT02387996|100728645|FG000|COMPLETED|Overall Study||0|Completed=continuing in the study treatment|
48165994|NCT02387996|100728645|FG000|NOT COMPLETED|Overall Study||270||
48165995|NCT03921346|100728646|FG000|STARTED|Overall Study||74||
48165996|NCT03921346|100728647|FG001|STARTED|Overall Study||76||
48165997|NCT03921346|100728646|FG000|COMPLETED|Overall Study||74||
48165998|NCT03921346|100728647|FG001|COMPLETED|Overall Study||76||
48165999|NCT03921346|100728646|FG000|NOT COMPLETED|Overall Study||0||
48745280|NCT02607618|102161854|FG001|COMPLETED|Overall Study||305||
48745281|NCT02607618|102161853|FG000|NOT COMPLETED|Overall Study||11||
48745282|NCT02607618|102161854|FG001|NOT COMPLETED|Overall Study||2||
48745283|NCT02851303|102161855|FG000|STARTED|Overall Study||15||
48745284|NCT02851303|102161856|FG001|STARTED|Overall Study||13||
48745285|NCT02851303|102161855|FG000|COMPLETED|Overall Study||15||
48745286|NCT02851303|102161856|FG001|COMPLETED|Overall Study||13||
48166000|NCT03921346|100728647|FG001|NOT COMPLETED|Overall Study||0||
48166001|NCT03185832|100728648|FG000|STARTED|Overall Study||69||
48166002|NCT03185832|100728649|FG001|STARTED|Overall Study||102||
48166003|NCT03185832|100728650|FG002|STARTED|Overall Study||68||
48166004|NCT03185832|100728651|FG003|STARTED|Overall Study||115||
48166005|NCT03185832|100728648|FG000|COMPLETED|Overall Study||60||
48166006|NCT03185832|100728649|FG001|COMPLETED|Overall Study||87||
48166007|NCT03185832|100728650|FG002|COMPLETED|Overall Study||58||
48745287|NCT02851303|102161855|FG000|NOT COMPLETED|Overall Study||0||
48745288|NCT02851303|102161856|FG001|NOT COMPLETED|Overall Study||0||
48745289|NCT04816214|102161857|FG000|STARTED|Overall Study||6||
48745290|NCT04816214|102161858|FG001|STARTED|Overall Study||0||
48166008|NCT03185832|100728651|FG003|COMPLETED|Overall Study||104||
48166009|NCT03185832|100728648|FG000|NOT COMPLETED|Overall Study||9||
48166010|NCT03185832|100728649|FG001|NOT COMPLETED|Overall Study||15||
48745291|NCT04816214|102161859|FG002|STARTED|Overall Study||0||
48767643|NCT01929317|102222786|FG001|NOT COMPLETED|Long-term Phase||4||
48166011|NCT03185832|100728650|FG002|NOT COMPLETED|Overall Study||10||
48166012|NCT03185832|100728651|FG003|NOT COMPLETED|Overall Study||11||
48166013|NCT03315936|100728652|FG000|STARTED|Period 1||14|Started are treated|
48166014|NCT03315936|100728653|FG001|STARTED|Period 1||6|Started are treated|
48166015|NCT03315936|100728654|FG002|STARTED|Period 1||6|Started are treated|
48166016|NCT03315936|100728655|FG003|STARTED|Period 1||6|Started are treated|
48166017|NCT03315936|100728656|FG004|STARTED|Period 1||6|Started are treated|
48166018|NCT03315936|100728657|FG005|STARTED|Period 1||6|Started are treated|
48166019|NCT03315936|100728658|FG006|STARTED|Period 1||6|Started are treated|
48166020|NCT03315936|100728659|FG007|STARTED|Period 1||6|Started are treated|
48166021|NCT03315936|100728660|FG008|STARTED|Period 1||6|Started are treated|
48166022|NCT03315936|100728661|FG009|STARTED|Period 1||6|Started are treated|
48166023|NCT03315936|100728652|FG000|COMPLETED|Period 1||14||
48166024|NCT03315936|100728653|FG001|COMPLETED|Period 1||6||
48166025|NCT03315936|100728654|FG002|COMPLETED|Period 1||6||
48166026|NCT03315936|100728655|FG003|COMPLETED|Period 1||6||
48166027|NCT03315936|100728656|FG004|COMPLETED|Period 1||6||
48166028|NCT03315936|100728657|FG005|COMPLETED|Period 1||6||
48166029|NCT03315936|100728658|FG006|COMPLETED|Period 1||6||
48166030|NCT03315936|100728659|FG007|COMPLETED|Period 1||6||
48166031|NCT03315936|100728660|FG008|COMPLETED|Period 1||6||
48166032|NCT03315936|100728661|FG009|COMPLETED|Period 1||6||
48166033|NCT03315936|100728652|FG000|NOT COMPLETED|Period 1||0||
48166034|NCT03315936|100728653|FG001|NOT COMPLETED|Period 1||0||
48166035|NCT03315936|100728654|FG002|NOT COMPLETED|Period 1||0||
48166036|NCT03315936|100728655|FG003|NOT COMPLETED|Period 1||0||
48166037|NCT03315936|100728656|FG004|NOT COMPLETED|Period 1||0||
48166038|NCT03315936|100728657|FG005|NOT COMPLETED|Period 1||0||
48166039|NCT03315936|100728658|FG006|NOT COMPLETED|Period 1||0||
48166040|NCT03315936|100728659|FG007|NOT COMPLETED|Period 1||0||
48166041|NCT03315936|100728660|FG008|NOT COMPLETED|Period 1||0||
48166042|NCT03315936|100728661|FG009|NOT COMPLETED|Period 1||0||
48166043|NCT03315936|100728652|FG000|STARTED|Period 2||0||
48166044|NCT03315936|100728653|FG001|STARTED|Period 2||0||
48166045|NCT03315936|100728654|FG002|STARTED|Period 2||0||
48166046|NCT03315936|100728655|FG003|STARTED|Period 2||0||
48166047|NCT03315936|100728656|FG004|STARTED|Period 2||0||
48166048|NCT03315936|100728657|FG005|STARTED|Period 2||0||
48166049|NCT03315936|100728658|FG006|STARTED|Period 2||0||
48166050|NCT03315936|100728659|FG007|STARTED|Period 2||0||
48166051|NCT03315936|100728660|FG008|STARTED|Period 2||6||
48166052|NCT03315936|100728661|FG009|STARTED|Period 2||6||
48166053|NCT03315936|100728652|FG000|COMPLETED|Period 2||0||
48166054|NCT03315936|100728653|FG001|COMPLETED|Period 2||0||
48166055|NCT03315936|100728654|FG002|COMPLETED|Period 2||0||
48166056|NCT03315936|100728655|FG003|COMPLETED|Period 2||0||
48166057|NCT03315936|100728656|FG004|COMPLETED|Period 2||0||
48166058|NCT03315936|100728657|FG005|COMPLETED|Period 2||0||
48166059|NCT03315936|100728658|FG006|COMPLETED|Period 2||0||
48166060|NCT03315936|100728659|FG007|COMPLETED|Period 2||0||
48166061|NCT03315936|100728660|FG008|COMPLETED|Period 2||6||
48166062|NCT03315936|100728661|FG009|COMPLETED|Period 2||6||
48166063|NCT03315936|100728652|FG000|NOT COMPLETED|Period 2||0||
48166064|NCT03315936|100728653|FG001|NOT COMPLETED|Period 2||0||
48166065|NCT03315936|100728654|FG002|NOT COMPLETED|Period 2||0||
48166066|NCT03315936|100728655|FG003|NOT COMPLETED|Period 2||0||
48166067|NCT03315936|100728656|FG004|NOT COMPLETED|Period 2||0||
48166068|NCT03315936|100728657|FG005|NOT COMPLETED|Period 2||0||
48166069|NCT03315936|100728658|FG006|NOT COMPLETED|Period 2||0||
48166070|NCT03315936|100728659|FG007|NOT COMPLETED|Period 2||0||
48166071|NCT03315936|100728660|FG008|NOT COMPLETED|Period 2||0||
48166072|NCT03315936|100728661|FG009|NOT COMPLETED|Period 2||0||
48166073|NCT03315936|100728652|FG000|STARTED|Period 3||0||
48166074|NCT03315936|100728653|FG001|STARTED|Period 3||0||
48166075|NCT03315936|100728654|FG002|STARTED|Period 3||0||
48166076|NCT03315936|100728655|FG003|STARTED|Period 3||0||
48166077|NCT03315936|100728656|FG004|STARTED|Period 3||0||
48166078|NCT03315936|100728657|FG005|STARTED|Period 3||0||
48166079|NCT03315936|100728658|FG006|STARTED|Period 3||0||
48166080|NCT03315936|100728659|FG007|STARTED|Period 3||0||
48166081|NCT03315936|100728660|FG008|STARTED|Period 3||6||
48166082|NCT03315936|100728661|FG009|STARTED|Period 3||6||
48166083|NCT03315936|100728652|FG000|COMPLETED|Period 3||0||
48166084|NCT03315936|100728653|FG001|COMPLETED|Period 3||0||
48166085|NCT03315936|100728654|FG002|COMPLETED|Period 3||0||
48166086|NCT03315936|100728655|FG003|COMPLETED|Period 3||0||
48166087|NCT03315936|100728656|FG004|COMPLETED|Period 3||0||
48166088|NCT03315936|100728657|FG005|COMPLETED|Period 3||0||
48622335|NCT03118934|101859844|FG003|COMPLETED|Overall Study||28|Completed, as randomized|
48622336|NCT03118934|101859845|FG004|COMPLETED|Overall Study||27|Completed, as randomized|
48622337|NCT03118934|101859846|FG005|COMPLETED|Overall Study||23|Completed, as randomized|
48622338|NCT03118934|101859841|FG000|NOT COMPLETED|Overall Study||0||
48622339|NCT03118934|101859842|FG001|NOT COMPLETED|Overall Study||1||
48622340|NCT03118934|101859843|FG002|NOT COMPLETED|Overall Study||1||
48622341|NCT03118934|101859844|FG003|NOT COMPLETED|Overall Study||1||
48622342|NCT03118934|101859845|FG004|NOT COMPLETED|Overall Study||2||
48622343|NCT03118934|101859846|FG005|NOT COMPLETED|Overall Study||2||
48166089|NCT03315936|100728658|FG006|COMPLETED|Period 3||0||
48166090|NCT03315936|100728659|FG007|COMPLETED|Period 3||0||
48166091|NCT03315936|100728660|FG008|COMPLETED|Period 3||6||
48166092|NCT03315936|100728661|FG009|COMPLETED|Period 3||6||
48166093|NCT03315936|100728652|FG000|NOT COMPLETED|Period 3||0||
48166094|NCT03315936|100728653|FG001|NOT COMPLETED|Period 3||0||
48166095|NCT03315936|100728654|FG002|NOT COMPLETED|Period 3||0||
48166096|NCT03315936|100728655|FG003|NOT COMPLETED|Period 3||0||
48166097|NCT03315936|100728656|FG004|NOT COMPLETED|Period 3||0||
48166098|NCT03315936|100728657|FG005|NOT COMPLETED|Period 3||0||
48166099|NCT03315936|100728658|FG006|NOT COMPLETED|Period 3||0||
48166100|NCT03315936|100728659|FG007|NOT COMPLETED|Period 3||0||
48166101|NCT03315936|100728660|FG008|NOT COMPLETED|Period 3||0||
48166102|NCT03315936|100728661|FG009|NOT COMPLETED|Period 3||0||
48166103|NCT01231841|100728662|FG000|STARTED|Overall Study||20||
48166104|NCT01231841|100728662|FG000|COMPLETED|Overall Study||20||
48166105|NCT01231841|100728662|FG000|NOT COMPLETED|Overall Study||0||
48166106|NCT00659984|100728663|FG000|STARTED|Overall Study||15||
48166107|NCT00659984|100728663|FG000|COMPLETED|Overall Study||14||
48166108|NCT00659984|100728663|FG000|NOT COMPLETED|Overall Study||1||
48166109|NCT02708433|100728664|FG000|STARTED|First Intervention (Visit 1)||12||
48166110|NCT02708433|100728665|FG001|STARTED|First Intervention (Visit 1)||11||
48166111|NCT02708433|100728664|FG000|COMPLETED|First Intervention (Visit 1)||12||
48166112|NCT02708433|100728665|FG001|COMPLETED|First Intervention (Visit 1)||11||
48166113|NCT02708433|100728664|FG000|NOT COMPLETED|First Intervention (Visit 1)||0||
48622344|NCT03131167|101859847|FG000|STARTED|Overall Study||6||
48622345|NCT03131167|101859848|FG001|STARTED|Overall Study||5||
48622346|NCT03131167|101859849|FG002|STARTED|Overall Study||5||
48622347|NCT03131167|101859850|FG003|STARTED|Overall Study||5||
48622348|NCT03131167|101859851|FG004|STARTED|Overall Study||6||
48622349|NCT03131167|101859852|FG005|STARTED|Overall Study||5||
48622350|NCT03131167|101859853|FG006|STARTED|Overall Study||5||
48622351|NCT03131167|101859854|FG007|STARTED|Overall Study||5||
48622352|NCT03131167|101859855|FG008|STARTED|Overall Study||2||
48622353|NCT03131167|101859856|FG009|STARTED|Overall Study||5||
48622354|NCT03131167|101859857|FG010|STARTED|Overall Study||4||
48622355|NCT03131167|101859858|FG011|STARTED|Overall Study||5||
48622356|NCT03131167|101859859|FG012|STARTED|Overall Study||5||
48622357|NCT03131167|101859847|FG000|COMPLETED|Overall Study||6||
48622358|NCT03131167|101859848|FG001|COMPLETED|Overall Study||5||
48622359|NCT03131167|101859849|FG002|COMPLETED|Overall Study||5||
48166114|NCT02708433|100728665|FG001|NOT COMPLETED|First Intervention (Visit 1)||0||
48166115|NCT02708433|100728664|FG000|STARTED|Washout (at Least 1 Week)||12||
48166116|NCT02708433|100728665|FG001|STARTED|Washout (at Least 1 Week)||11||
48166117|NCT02708433|100728664|FG000|COMPLETED|Washout (at Least 1 Week)||12||
48166118|NCT02708433|100728665|FG001|COMPLETED|Washout (at Least 1 Week)||11||
48166119|NCT02708433|100728664|FG000|NOT COMPLETED|Washout (at Least 1 Week)||0||
48166120|NCT02708433|100728665|FG001|NOT COMPLETED|Washout (at Least 1 Week)||0||
48166121|NCT02708433|100728664|FG000|STARTED|Second Intervention (Visit 2)||12||
48166122|NCT02708433|100728665|FG001|STARTED|Second Intervention (Visit 2)||11||
48166123|NCT02708433|100728664|FG000|COMPLETED|Second Intervention (Visit 2)||12||
48166124|NCT02708433|100728665|FG001|COMPLETED|Second Intervention (Visit 2)||11||
48166125|NCT02708433|100728664|FG000|NOT COMPLETED|Second Intervention (Visit 2)||0||
48166126|NCT02708433|100728665|FG001|NOT COMPLETED|Second Intervention (Visit 2)||0||
48166127|NCT01616576|100728666|FG000|STARTED|Overall Study||18||
48166128|NCT01616576|100728667|FG001|STARTED|Overall Study||18||
48166129|NCT01616576|100728666|FG000|COMPLETED|Overall Study||18||
48166130|NCT01616576|100728667|FG001|COMPLETED|Overall Study||18||
48166131|NCT01616576|100728666|FG000|NOT COMPLETED|Overall Study||0||
48166132|NCT01616576|100728667|FG001|NOT COMPLETED|Overall Study||0||
48166133|NCT03342053|100728668|FG000|STARTED|Overall Study||23||
48166134|NCT03342053|100728669|FG001|STARTED|Overall Study||23||
48166135|NCT03342053|100728668|FG000|COMPLETED|Overall Study||21||
48166136|NCT03342053|100728669|FG001|COMPLETED|Overall Study||22||
48166137|NCT03342053|100728668|FG000|NOT COMPLETED|Overall Study||2||
48166138|NCT03342053|100728669|FG001|NOT COMPLETED|Overall Study||1||
48166139|NCT00874432|100728670|FG000|STARTED|Overall Study||8||
48166140|NCT00874432|100728671|FG001|STARTED|Overall Study||4||
48166141|NCT00874432|100728672|FG002|STARTED|Overall Study||17||
48166142|NCT00874432|100728673|FG003|STARTED|Overall Study||14||
48166143|NCT00874432|100728670|FG000|COMPLETED|Overall Study||5||
48622360|NCT03131167|101859850|FG003|COMPLETED|Overall Study||5||
48622361|NCT03131167|101859851|FG004|COMPLETED|Overall Study||6||
48622362|NCT03131167|101859852|FG005|COMPLETED|Overall Study||4||
48622363|NCT03131167|101859853|FG006|COMPLETED|Overall Study||5||
48622364|NCT03131167|101859854|FG007|COMPLETED|Overall Study||5||
48622365|NCT03131167|101859855|FG008|COMPLETED|Overall Study||2||
48622366|NCT03131167|101859856|FG009|COMPLETED|Overall Study||5||
48622367|NCT03131167|101859857|FG010|COMPLETED|Overall Study||4||
48622368|NCT03131167|101859858|FG011|COMPLETED|Overall Study||5||
48622369|NCT03131167|101859859|FG012|COMPLETED|Overall Study||5||
48622370|NCT03131167|101859847|FG000|NOT COMPLETED|Overall Study||0||
48622371|NCT03131167|101859848|FG001|NOT COMPLETED|Overall Study||0||
48622372|NCT03131167|101859849|FG002|NOT COMPLETED|Overall Study||0||
48622373|NCT03131167|101859850|FG003|NOT COMPLETED|Overall Study||0||
48622374|NCT03131167|101859851|FG004|NOT COMPLETED|Overall Study||0||
48622375|NCT03131167|101859852|FG005|NOT COMPLETED|Overall Study||1||
48622376|NCT03131167|101859853|FG006|NOT COMPLETED|Overall Study||0||
48622377|NCT03131167|101859854|FG007|NOT COMPLETED|Overall Study||0||
48622378|NCT03131167|101859855|FG008|NOT COMPLETED|Overall Study||0||
48622379|NCT03131167|101859856|FG009|NOT COMPLETED|Overall Study||0||
48622380|NCT03131167|101859857|FG010|NOT COMPLETED|Overall Study||0||
48622381|NCT03131167|101859858|FG011|NOT COMPLETED|Overall Study||0||
48622382|NCT03131167|101859859|FG012|NOT COMPLETED|Overall Study||0||
48622383|NCT02438280|101859860|FG000|STARTED|Overall Study||14||
48622384|NCT02438280|101859861|FG001|STARTED|Overall Study||13||
48328679|NCT04173429|101132019|FG000|COMPLETED|Overall Study||30||
48328680|NCT04173429|101132020|FG001|COMPLETED|Overall Study||30||
48328681|NCT04173429|101132019|FG000|NOT COMPLETED|Overall Study||2||
48328682|NCT04173429|101132020|FG001|NOT COMPLETED|Overall Study||2||
48328683|NCT01098071|101132021|FG000|STARTED|Overall Study||34||
48328684|NCT01098071|101132021|FG000|COMPLETED|Overall Study||19||
48328685|NCT01098071|101132021|FG000|NOT COMPLETED|Overall Study||15||
48328686|NCT01789814|101132022|FG000|STARTED|Overall Study||12||
48622385|NCT02438280|101859860|FG000|COMPLETED|Overall Study||13||
48622386|NCT02438280|101859861|FG001|COMPLETED|Overall Study||13||
48622387|NCT02438280|101859860|FG000|NOT COMPLETED|Overall Study||1||
48622388|NCT02438280|101859861|FG001|NOT COMPLETED|Overall Study||0||
48622389|NCT01093846|101859862|FG000|STARTED|Overall Study||19||
48622390|NCT01093846|101859863|FG001|STARTED|Overall Study||18||
48622391|NCT01093846|101859864|FG002|STARTED|Overall Study||22||
48622392|NCT01093846|101859862|FG000|COMPLETED|Overall Study||0||
48328687|NCT01789814|101132023|FG001|STARTED|Overall Study||12||
48328688|NCT01789814|101132022|FG000|COMPLETED|Overall Study||12||
48328689|NCT01789814|101132023|FG001|COMPLETED|Overall Study||12||
48328690|NCT01789814|101132022|FG000|NOT COMPLETED|Overall Study||0||
48622393|NCT01093846|101859863|FG001|COMPLETED|Overall Study||0||
48622394|NCT01093846|101859864|FG002|COMPLETED|Overall Study||1||
48622395|NCT01093846|101859862|FG000|NOT COMPLETED|Overall Study||19||
48622396|NCT01093846|101859863|FG001|NOT COMPLETED|Overall Study||18||
48622397|NCT01093846|101859864|FG002|NOT COMPLETED|Overall Study||21||
48622398|NCT03769649|101859865|FG000|STARTED|Overall Study||15||
48622399|NCT03769649|101859865|FG000|COMPLETED|Overall Study||11||
48622400|NCT03769649|101859865|FG000|NOT COMPLETED|Overall Study||4||
48622401|NCT01704755|101859866|FG000|STARTED|Overall Study||208||
48622402|NCT01704755|101859867|FG001|STARTED|Overall Study||172||
48622403|NCT01704755|101859866|FG000|Completed Study Drug|Overall Study||204||
48622404|NCT01704755|101859867|FG001|Completed Study Drug|Overall Study||163||
48622405|NCT01704755|101859866|FG000|COMPLETED|Overall Study||196||
48622406|NCT01704755|101859867|FG001|COMPLETED|Overall Study||165||
48622407|NCT01704755|101859866|FG000|NOT COMPLETED|Overall Study||12||
48622408|NCT01704755|101859867|FG001|NOT COMPLETED|Overall Study||7||
48622409|NCT01768325|101859868|FG000|STARTED|Overall Study||37||
48622410|NCT01768325|101859869|FG001|STARTED|Overall Study||41||
48622411|NCT01768325|101859868|FG000|COMPLETED|Overall Study||37||
48622412|NCT01768325|101859869|FG001|COMPLETED|Overall Study||41||
48622413|NCT01768325|101859868|FG000|NOT COMPLETED|Overall Study||0||
48622414|NCT01768325|101859869|FG001|NOT COMPLETED|Overall Study||0||
48328691|NCT01789814|101132023|FG001|NOT COMPLETED|Overall Study||0||
48328692|NCT01227902|101132024|FG000|STARTED|Overall Study||56||
48328693|NCT01227902|101132025|FG001|STARTED|Overall Study||51||
48328694|NCT01227902|101132026|FG002|STARTED|Overall Study||44||
48328695|NCT01227902|101132027|FG003|STARTED|Overall Study||52||
48328696|NCT01227902|101132024|FG000|COMPLETED|Overall Study||38||
48328697|NCT01227902|101132025|FG001|COMPLETED|Overall Study||38||
48622415|NCT00972959|101859870|FG000|STARTED|Overall Study||17||
48622416|NCT00972959|101859870|FG000|COMPLETED|Overall Study||17||
48622417|NCT00972959|101859870|FG000|NOT COMPLETED|Overall Study||0||
48622418|NCT03934216|101859871|FG000|STARTED|Overall Study||88||
48622419|NCT03934216|101859872|FG001|STARTED|Overall Study||43||
48622420|NCT03934216|101859871|FG000|COMPLETED|Overall Study||30||
48622421|NCT03934216|101859872|FG001|COMPLETED|Overall Study||12||
48622422|NCT03934216|101859871|FG000|NOT COMPLETED|Overall Study||58||
48622423|NCT03934216|101859872|FG001|NOT COMPLETED|Overall Study||31||
48328698|NCT01227902|101132026|FG002|COMPLETED|Overall Study||25||
48328699|NCT01227902|101132027|FG003|COMPLETED|Overall Study||42||
48328700|NCT01227902|101132024|FG000|NOT COMPLETED|Overall Study||18||
48328701|NCT01227902|101132025|FG001|NOT COMPLETED|Overall Study||13||
48328702|NCT01227902|101132026|FG002|NOT COMPLETED|Overall Study||19||
48622424|NCT00628407|101859873|FG000|STARTED|Overall Study||13||
48622425|NCT00628407|101859873|FG000|COMPLETED|Overall Study||13||
48622426|NCT00628407|101859873|FG000|NOT COMPLETED|Overall Study||0||
48622427|NCT02567188|101859874|FG000|STARTED|Overall Study||144||
48622428|NCT02567188|101859874|FG000|COMPLETED|Overall Study||109||
48622429|NCT02567188|101859874|FG000|NOT COMPLETED|Overall Study||35||
48622430|NCT03064113|101859875|FG000|STARTED|Intervention 1 (2 Days)||8||
48622431|NCT03064113|101859876|FG001|STARTED|Intervention 1 (2 Days)||8||
48622432|NCT03064113|101859877|FG002|STARTED|Intervention 1 (2 Days)||8||
48622433|NCT03064113|101859878|FG003|STARTED|Intervention 1 (2 Days)||8||
48622434|NCT03064113|101859875|FG000|COMPLETED|Intervention 1 (2 Days)||8||
48622435|NCT03064113|101859876|FG001|COMPLETED|Intervention 1 (2 Days)||8||
48622436|NCT03064113|101859877|FG002|COMPLETED|Intervention 1 (2 Days)||8||
48622437|NCT03064113|101859878|FG003|COMPLETED|Intervention 1 (2 Days)||8||
48328703|NCT01227902|101132027|FG003|NOT COMPLETED|Overall Study||10||
48328704|NCT04336995|101132028|FG000|STARTED|Overall Study||14||
48328705|NCT04336995|101132028|FG000|COMPLETED|Overall Study||14||
48328706|NCT04336995|101132028|FG000|NOT COMPLETED|Overall Study||0||
48328707|NCT02986230|101132029|FG000|STARTED|Overall Study||11402||11
48328708|NCT02986230|101132030|FG001|STARTED|Overall Study||10138||11
48328709|NCT02986230|101132031|FG002|STARTED|Overall Study||14413||12
48328710|NCT02986230|101132029|FG000|COMPLETED|Overall Study||10122||11
48328711|NCT02986230|101132030|FG001|COMPLETED|Overall Study||9034||11
48328712|NCT02986230|101132031|FG002|COMPLETED|Overall Study||12960||12
48328713|NCT02986230|101132029|FG000|NOT COMPLETED|Overall Study||1280||0
48328714|NCT02986230|101132030|FG001|NOT COMPLETED|Overall Study||1104||0
48328715|NCT02986230|101132031|FG002|NOT COMPLETED|Overall Study||1453||0
48328716|NCT04365465|101132032|FG000|STARTED|Overall Study||20||
48328717|NCT04365465|101132033|FG001|STARTED|Overall Study||20||
48328718|NCT04365465|101132034|FG002|STARTED|Overall Study||20||
48328719|NCT04365465|101132032|FG000|COMPLETED|Overall Study||20||
48410146|NCT00886691|101334881|FG000|STARTED|Overall Study||75||
48410147|NCT00886691|101334882|FG001|STARTED|Overall Study||75||
48410148|NCT00886691|101334881|FG000|COMPLETED|Overall Study||75||
48328720|NCT04365465|101132033|FG001|COMPLETED|Overall Study||20||
48328721|NCT04365465|101132034|FG002|COMPLETED|Overall Study||20||
48328722|NCT04365465|101132032|FG000|NOT COMPLETED|Overall Study||0||
48328723|NCT04365465|101132033|FG001|NOT COMPLETED|Overall Study||0||
48328724|NCT04365465|101132034|FG002|NOT COMPLETED|Overall Study||0||
48328725|NCT01031446|101132035|FG000|STARTED|Overall Study||55||
48328726|NCT01031446|101132035|FG000|COMPLETED|Overall Study||0||
48328727|NCT01031446|101132035|FG000|NOT COMPLETED|Overall Study||55||
48328728|NCT03548051|101132036|FG000|STARTED|Overall Study||6||
48328729|NCT03548051|101132037|FG001|STARTED|Overall Study||4||
48328730|NCT03548051|101132036|FG000|COMPLETED|Overall Study||4||
48410149|NCT00886691|101334882|FG001|COMPLETED|Overall Study||75||
48410150|NCT00886691|101334881|FG000|NOT COMPLETED|Overall Study||0||
48410151|NCT00886691|101334882|FG001|NOT COMPLETED|Overall Study||0||
48410152|NCT03991468|101334883|FG000|STARTED|Overall Study||2000||
48410153|NCT03991468|101334883|FG000|Glass Slide Light Microscopy|Overall Study||2000||
48622438|NCT03064113|101859875|FG000|NOT COMPLETED|Intervention 1 (2 Days)||0||
48622439|NCT03064113|101859876|FG001|NOT COMPLETED|Intervention 1 (2 Days)||0||
48622440|NCT03064113|101859877|FG002|NOT COMPLETED|Intervention 1 (2 Days)||0||
48328731|NCT03548051|101132037|FG001|COMPLETED|Overall Study||3||
48328732|NCT03548051|101132036|FG000|NOT COMPLETED|Overall Study||2||
48328733|NCT03548051|101132037|FG001|NOT COMPLETED|Overall Study||1||
48328734|NCT01675960|101132038|FG000|STARTED|Overall Study||2||
48328735|NCT01675960|101132039|FG001|STARTED|Overall Study||0||
48328736|NCT01675960|101132038|FG000|COMPLETED|Overall Study||2||
48328737|NCT01675960|101132039|FG001|COMPLETED|Overall Study||0||
48328738|NCT01675960|101132038|FG000|NOT COMPLETED|Overall Study||0||
48328739|NCT01675960|101132039|FG001|NOT COMPLETED|Overall Study||0||
48328740|NCT02247193|101132040|FG000|STARTED|Overall Study||15||
48328741|NCT02247193|101132041|FG001|STARTED|Overall Study||15||
48328742|NCT02247193|101132040|FG000|Number Who Underwent Cleft Lip Repair Surgery|Overall Study||15||
48410154|NCT03991468|101334883|FG000|NanoZoomer Whole Slide Imaging|Overall Study||2000||
48622441|NCT03064113|101859878|FG003|NOT COMPLETED|Intervention 1 (2 Days)||0||
48622442|NCT03064113|101859875|FG000|STARTED|Washout (7 Days)||8||
48622443|NCT03064113|101859876|FG001|STARTED|Washout (7 Days)||8||
48622444|NCT03064113|101859877|FG002|STARTED|Washout (7 Days)||8||
48622445|NCT03064113|101859878|FG003|STARTED|Washout (7 Days)||8||
48622446|NCT03064113|101859875|FG000|COMPLETED|Washout (7 Days)||8||
48622447|NCT03064113|101859876|FG001|COMPLETED|Washout (7 Days)||8||
48622448|NCT03064113|101859877|FG002|COMPLETED|Washout (7 Days)||8||
48622449|NCT03064113|101859878|FG003|COMPLETED|Washout (7 Days)||8||
48622450|NCT03064113|101859875|FG000|NOT COMPLETED|Washout (7 Days)||0||
48745292|NCT04816214|102161857|FG000|Full Analysis Set (FAS)|Overall Study||6|FAS included all participants who received any component of the study treatment.|
48745293|NCT04816214|102161858|FG001|Full Analysis Set (FAS)|Overall Study||0|FAS included all participants who received any component of the study treatment.|
48410155|NCT03991468|101334883|FG000|COMPLETED|Overall Study||2000||
48410156|NCT03991468|101334883|FG000|NOT COMPLETED|Overall Study||0||
48410157|NCT02886338|101334884|FG000|STARTED|Overall Study||10||
48410158|NCT02886338|101334884|FG000|COMPLETED|Overall Study||9||
48745294|NCT04816214|102161859|FG002|Full Analysis Set (FAS)|Overall Study||0|FAS included all participants who received any component of the study treatment.|
48745295|NCT04816214|102161857|FG000|Safety Set|Overall Study||6|Safety set included all participants who received at least one dose of study treatment.|
48745296|NCT04816214|102161858|FG001|Safety Set|Overall Study||0|Safety set included all participants who received at least one dose of study treatment.|
48745297|NCT04816214|102161859|FG002|Safety Set|Overall Study||0|Safety set included all participants who received at least one dose of study treatment.|
48745298|NCT04816214|102161857|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||6|PK analysis set included all participants who provided at least one evaluable PK concentration.|
48745299|NCT04816214|102161858|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||0|PK analysis set included all participants who provided at least one evaluable PK concentration.|
48745300|NCT04816214|102161859|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||0|PK analysis set included all participants who provided at least one evaluable PK concentration.|
48745301|NCT04816214|102161857|FG000|COMPLETED|Overall Study||0||
48745302|NCT04816214|102161858|FG001|COMPLETED|Overall Study||0||
48745303|NCT04816214|102161859|FG002|COMPLETED|Overall Study||0||
48745304|NCT04816214|102161857|FG000|NOT COMPLETED|Overall Study||6||
48745305|NCT04816214|102161858|FG001|NOT COMPLETED|Overall Study||0||
48745306|NCT04816214|102161859|FG002|NOT COMPLETED|Overall Study||0||
48745307|NCT03594773|102161860|FG000|STARTED|Overall Study||42|enrolled, randomized, and completed baseline assessment|
48410159|NCT02886338|101334884|FG000|NOT COMPLETED|Overall Study||1||
48410160|NCT00444951|101334885|FG000|STARTED|Overall Study||145||
48410161|NCT00444951|101334886|FG001|STARTED|Overall Study||142||
48410162|NCT00444951|101334887|FG002|STARTED|Overall Study||163||
48410163|NCT00444951|101334885|FG000|COMPLETED|Overall Study||140||
48410164|NCT00444951|101334886|FG001|COMPLETED|Overall Study||136||
48622451|NCT03064113|101859876|FG001|NOT COMPLETED|Washout (7 Days)||0||
48622452|NCT03064113|101859877|FG002|NOT COMPLETED|Washout (7 Days)||0||
48622453|NCT03064113|101859878|FG003|NOT COMPLETED|Washout (7 Days)||0||
48745308|NCT03594773|102161861|FG001|STARTED|Overall Study||35|enrolled, randomized, and completed baseline assessment|
48745309|NCT03594773|102161860|FG000|COMPLETED|Overall Study||36|completed at least 1 session of intervention|
48410165|NCT00444951|101334887|FG002|COMPLETED|Overall Study||160||
48410166|NCT00444951|101334885|FG000|NOT COMPLETED|Overall Study||5||
48622454|NCT03064113|101859875|FG000|STARTED|Intervention 2 (2 Days)||8||
48745310|NCT03594773|102161861|FG001|COMPLETED|Overall Study||29|completed at least 1 session of intervention|
48410167|NCT00444951|101334886|FG001|NOT COMPLETED|Overall Study||6||
48410168|NCT00444951|101334887|FG002|NOT COMPLETED|Overall Study||3||
48410169|NCT04009824|101334888|FG000|STARTED|Overall Study||10||
48410170|NCT04009824|101334889|FG001|STARTED|Overall Study||10||
48410171|NCT04009824|101334890|FG002|STARTED|Overall Study||11||
48410172|NCT04009824|101334891|FG003|STARTED|Overall Study||10||
48622455|NCT03064113|101859876|FG001|STARTED|Intervention 2 (2 Days)||8||
48745311|NCT03594773|102161860|FG000|NOT COMPLETED|Overall Study||6||
48745312|NCT03594773|102161861|FG001|NOT COMPLETED|Overall Study||6||
48745313|NCT02698826|102161862|FG000|STARTED|Overall Study||16||
48745314|NCT02698826|102161862|FG000|COMPLETED|Overall Study||2||
48745315|NCT02698826|102161862|FG000|NOT COMPLETED|Overall Study||14||
48745316|NCT03678311|102161863|FG000|STARTED|Overall Study||9||
48745317|NCT03678311|102161863|FG000|COMPLETED|Overall Study||9||
48745318|NCT03678311|102161863|FG000|NOT COMPLETED|Overall Study||0||
48745319|NCT02021942|102161864|FG000|STARTED|Overall Study||16||
48745320|NCT02021942|102161864|FG000|COMPLETED|Overall Study||16||
48745321|NCT02021942|102161864|FG000|NOT COMPLETED|Overall Study||0||
48745322|NCT00330759|102161865|FG000|STARTED|Overall Study||890||
48745323|NCT00330759|102161866|FG001|STARTED|Overall Study||886||
48745324|NCT00330759|102161865|FG000|Received Investigational Product|Overall Study||878||
48745325|NCT00330759|102161866|FG001|Received Investigational Product|Overall Study||878||
48328743|NCT02247193|101132041|FG001|Number Who Underwent Cleft Lip Repair Surgery|Overall Study||15||
48328744|NCT02247193|101132040|FG000|Number Who Received Botox or Placebo|Overall Study||15||
48328745|NCT02247193|101132041|FG001|Number Who Received Botox or Placebo|Overall Study||15||
48328746|NCT02247193|101132040|FG000|Number Who Completed the 6-month Follow up|Overall Study||15||
48328747|NCT02247193|101132041|FG001|Number Who Completed the 6-month Follow up|Overall Study||15||
48328748|NCT02247193|101132040|FG000|Number Who Completed the 12-month Follow up|Overall Study||15||
48328749|NCT02247193|101132041|FG001|Number Who Completed the 12-month Follow up|Overall Study||15||
48328750|NCT02247193|101132040|FG000|COMPLETED|Overall Study||15||
48745326|NCT00330759|102161865|FG000|COMPLETED|Overall Study||178||
48745327|NCT00330759|102161866|FG001|COMPLETED|Overall Study||180||
48745328|NCT00330759|102161865|FG000|NOT COMPLETED|Overall Study||712||
48745329|NCT00330759|102161866|FG001|NOT COMPLETED|Overall Study||706||
48328751|NCT02247193|101132041|FG001|COMPLETED|Overall Study||15||
48328752|NCT02247193|101132040|FG000|NOT COMPLETED|Overall Study||0||
48328753|NCT02247193|101132041|FG001|NOT COMPLETED|Overall Study||0||
48328754|NCT03175549|101132042|FG000|STARTED|Overall Study||26||
48328755|NCT03175549|101132043|FG001|STARTED|Overall Study||25||
48410173|NCT04009824|101334892|FG004|STARTED|Overall Study||10||
48745330|NCT00410761|102161867|FG000|STARTED|Overall Study||231||
48745331|NCT00410761|102161868|FG001|STARTED|Overall Study||100||
48745332|NCT00410761|102161867|FG000|COMPLETED|Overall Study||111||
48745333|NCT00410761|102161868|FG001|COMPLETED|Overall Study||28||
48745334|NCT00410761|102161867|FG000|NOT COMPLETED|Overall Study||120||
48745335|NCT00410761|102161868|FG001|NOT COMPLETED|Overall Study||72||
48328756|NCT03175549|101132042|FG000|COMPLETED|Overall Study||22||
48328757|NCT03175549|101132043|FG001|COMPLETED|Overall Study||21||
48328758|NCT03175549|101132042|FG000|NOT COMPLETED|Overall Study||4||
48328759|NCT03175549|101132043|FG001|NOT COMPLETED|Overall Study||4||
48328760|NCT02307370|101132044|FG000|STARTED|Overall Study||44||
48328761|NCT02307370|101132044|FG000|30 Day Follow-up|Overall Study||40||
48328762|NCT02307370|101132044|FG000|180 Day Patient Telephone Contact|Overall Study||25||
48328763|NCT02307370|101132044|FG000|COMPLETED|Overall Study||25||
48328764|NCT02307370|101132044|FG000|NOT COMPLETED|Overall Study||19||
48328765|NCT01785134|101132045|FG000|STARTED|Overall Study||41||
48328766|NCT01785134|101132046|FG001|STARTED|Overall Study||40||
48328767|NCT01785134|101132045|FG000|COMPLETED|Overall Study||29||
48328768|NCT01785134|101132046|FG001|COMPLETED|Overall Study||33||
48328769|NCT01785134|101132045|FG000|NOT COMPLETED|Overall Study||12||
48328770|NCT01785134|101132046|FG001|NOT COMPLETED|Overall Study||7||
48328771|NCT04093531|101132047|FG000|STARTED|Overall Study||12||
48328772|NCT04093531|101132047|FG000|COMPLETED|Overall Study||8||
48328773|NCT04093531|101132047|FG000|NOT COMPLETED|Overall Study||4||
48745336|NCT02412098|102161869|FG000|STARTED|Overall Study||14||
48745337|NCT02412098|102161870|FG001|STARTED|Overall Study||14||
48745338|NCT02412098|102161871|FG002|STARTED|Overall Study||21||
48745339|NCT02412098|102161869|FG000|COMPLETED|Overall Study||14||
48745340|NCT02412098|102161870|FG001|COMPLETED|Overall Study||14||
48410174|NCT04009824|101334888|FG000|COMPLETED|Overall Study||8||
48410175|NCT04009824|101334889|FG001|COMPLETED|Overall Study||7||
48410176|NCT04009824|101334890|FG002|COMPLETED|Overall Study||6||
48410177|NCT04009824|101334891|FG003|COMPLETED|Overall Study||8||
48410178|NCT04009824|101334892|FG004|COMPLETED|Overall Study||7||
48410179|NCT04009824|101334888|FG000|NOT COMPLETED|Overall Study||2||
48410180|NCT04009824|101334889|FG001|NOT COMPLETED|Overall Study||3||
48410181|NCT04009824|101334890|FG002|NOT COMPLETED|Overall Study||5||
48410182|NCT04009824|101334891|FG003|NOT COMPLETED|Overall Study||2||
48410183|NCT04009824|101334892|FG004|NOT COMPLETED|Overall Study||3||
48410184|NCT01846208|101334893|FG000|STARTED|Overall Study||28||
48410185|NCT01846208|101334894|FG001|STARTED|Overall Study||24||
48410186|NCT01846208|101334895|FG002|STARTED|Overall Study||40||
48410187|NCT01846208|101334893|FG000|Initiatiated Treatment|Overall Study||27||
48410188|NCT01846208|101334894|FG001|Initiatiated Treatment|Overall Study||23||
48410189|NCT01846208|101334895|FG002|Initiatiated Treatment|Overall Study||39||
48410190|NCT01846208|101334893|FG000|Year 1 Desensitization OFC|Overall Study||23|OFC = oral food challenge|
48410191|NCT01846208|101334894|FG001|Year 1 Desensitization OFC|Overall Study||20|OFC = oral food challenge|
48410192|NCT01846208|101334895|FG002|Year 1 Desensitization OFC|Overall Study||34|OFC = oral food challenge|
48410193|NCT01846208|101334893|FG000|Year 2 Desensitization OFC|Overall Study||19|Completed Year 2 desensitization oral food challenge|
48410194|NCT01846208|101334894|FG001|Year 2 Desensitization OFC|Overall Study||20|Completed Year 2 desensitization oral food challenge|
48410195|NCT01846208|101334895|FG002|Year 2 Desensitization OFC|Overall Study||33|Completed Year 2 desensitization oral food challenge|
48410196|NCT01846208|101334893|FG000|Year 2 Sustained Unresponsiveness OFC|Overall Study||4|Completed Year 2 sustained unresponsiveness oral food challenge (SU OFC)|
48410197|NCT01846208|101334894|FG001|Year 2 Sustained Unresponsiveness OFC|Overall Study||18|Completed Year 2 sustained unresponsiveness oral food challenge (SU OFC)|
48410198|NCT01846208|101334895|FG002|Year 2 Sustained Unresponsiveness OFC|Overall Study||21|Completed Year 2 sustained unresponsiveness oral food challenge (SU OFC)|
48410199|NCT01846208|101334893|FG000|COMPLETED|Overall Study||19||
48410200|NCT01846208|101334894|FG001|COMPLETED|Overall Study||20||
48410201|NCT01846208|101334895|FG002|COMPLETED|Overall Study||32||
48410202|NCT01846208|101334893|FG000|NOT COMPLETED|Overall Study||9||
48410203|NCT01846208|101334894|FG001|NOT COMPLETED|Overall Study||4||
48410204|NCT01846208|101334895|FG002|NOT COMPLETED|Overall Study||8||
48410205|NCT01878175|101334896|FG000|STARTED|Overall Study||15||
48410206|NCT01878175|101334896|FG000|COMPLETED|Overall Study||13||
48410207|NCT01878175|101334896|FG000|NOT COMPLETED|Overall Study||2||
48622456|NCT03064113|101859877|FG002|STARTED|Intervention 2 (2 Days)||8||
48622457|NCT03064113|101859878|FG003|STARTED|Intervention 2 (2 Days)||8||
48622458|NCT03064113|101859875|FG000|COMPLETED|Intervention 2 (2 Days)||8||
48622459|NCT03064113|101859876|FG001|COMPLETED|Intervention 2 (2 Days)||8||
48622460|NCT03064113|101859877|FG002|COMPLETED|Intervention 2 (2 Days)||8||
48622461|NCT03064113|101859878|FG003|COMPLETED|Intervention 2 (2 Days)||8||
48622462|NCT03064113|101859875|FG000|NOT COMPLETED|Intervention 2 (2 Days)||0||
48622463|NCT03064113|101859876|FG001|NOT COMPLETED|Intervention 2 (2 Days)||0||
48622464|NCT03064113|101859877|FG002|NOT COMPLETED|Intervention 2 (2 Days)||0||
48622465|NCT03064113|101859878|FG003|NOT COMPLETED|Intervention 2 (2 Days)||0||
48622466|NCT03064113|101859875|FG000|STARTED|Washout (7 Days)||8||
48622467|NCT03064113|101859876|FG001|STARTED|Washout (7 Days)||8||
48622468|NCT03064113|101859877|FG002|STARTED|Washout (7 Days)||8||
48622469|NCT03064113|101859878|FG003|STARTED|Washout (7 Days)||8||
48622470|NCT03064113|101859875|FG000|COMPLETED|Washout (7 Days)||8||
48622471|NCT03064113|101859876|FG001|COMPLETED|Washout (7 Days)||8||
48622472|NCT03064113|101859877|FG002|COMPLETED|Washout (7 Days)||8||
48622473|NCT03064113|101859878|FG003|COMPLETED|Washout (7 Days)||8||
48622474|NCT03064113|101859875|FG000|NOT COMPLETED|Washout (7 Days)||0||
48622475|NCT03064113|101859876|FG001|NOT COMPLETED|Washout (7 Days)||0||
48622476|NCT03064113|101859877|FG002|NOT COMPLETED|Washout (7 Days)||0||
48622477|NCT03064113|101859878|FG003|NOT COMPLETED|Washout (7 Days)||0||
48410208|NCT01536938|101334897|FG000|STARTED|Overall Study||100||
48410209|NCT01536938|101334898|FG001|STARTED|Overall Study||101||
48410210|NCT01536938|101334899|FG002|STARTED|Overall Study||101||
48410211|NCT01536938|101334897|FG000|COMPLETED|Overall Study||94||
48410212|NCT01536938|101334898|FG001|COMPLETED|Overall Study||94||
48410213|NCT01536938|101334899|FG002|COMPLETED|Overall Study||93||
48622478|NCT03064113|101859875|FG000|STARTED|Intervention 3 (2 Days)||8||
48622479|NCT03064113|101859876|FG001|STARTED|Intervention 3 (2 Days)||8||
48622480|NCT03064113|101859877|FG002|STARTED|Intervention 3 (2 Days)||8||
48622481|NCT03064113|101859878|FG003|STARTED|Intervention 3 (2 Days)||8||
48622482|NCT03064113|101859875|FG000|COMPLETED|Intervention 3 (2 Days)||8||
48622483|NCT03064113|101859876|FG001|COMPLETED|Intervention 3 (2 Days)||8||
48622484|NCT03064113|101859877|FG002|COMPLETED|Intervention 3 (2 Days)||8||
48622485|NCT03064113|101859878|FG003|COMPLETED|Intervention 3 (2 Days)||8||
48622486|NCT03064113|101859875|FG000|NOT COMPLETED|Intervention 3 (2 Days)||0||
48328774|NCT00584194|101132048|FG000|STARTED|Overall Study||278||
48328775|NCT00584194|101132048|FG000|COMPLETED|Overall Study||143||
48328776|NCT00584194|101132048|FG000|NOT COMPLETED|Overall Study||135||
48328777|NCT00640328|101132049|FG000|STARTED|First Treatment Period (Weeks 0-24)||8||
48328778|NCT00640328|101132050|FG001|STARTED|First Treatment Period (Weeks 0-24)||11||
48622487|NCT03064113|101859876|FG001|NOT COMPLETED|Intervention 3 (2 Days)||0||
48622488|NCT03064113|101859877|FG002|NOT COMPLETED|Intervention 3 (2 Days)||0||
48622489|NCT03064113|101859878|FG003|NOT COMPLETED|Intervention 3 (2 Days)||0||
48328779|NCT00640328|101132051|FG002|STARTED|First Treatment Period (Weeks 0-24)||7||
48328780|NCT00640328|101132052|FG003|STARTED|First Treatment Period (Weeks 0-24)||4||
48328781|NCT00640328|101132053|FG004|STARTED|First Treatment Period (Weeks 0-24)||4||
48328782|NCT00640328|101132054|FG005|STARTED|First Treatment Period (Weeks 0-24)||4||
48328783|NCT00640328|101132049|FG000|COMPLETED|First Treatment Period (Weeks 0-24)||8||
48328784|NCT00640328|101132050|FG001|COMPLETED|First Treatment Period (Weeks 0-24)||10||
48328785|NCT00640328|101132051|FG002|COMPLETED|First Treatment Period (Weeks 0-24)||7||
48622490|NCT03064113|101859875|FG000|STARTED|Washout (7 Days)||8||
48622491|NCT03064113|101859876|FG001|STARTED|Washout (7 Days)||8||
48622492|NCT03064113|101859877|FG002|STARTED|Washout (7 Days)||8||
48622493|NCT03064113|101859878|FG003|STARTED|Washout (7 Days)||8||
48622494|NCT03064113|101859875|FG000|COMPLETED|Washout (7 Days)||8||
48622495|NCT03064113|101859876|FG001|COMPLETED|Washout (7 Days)||8||
48622496|NCT03064113|101859877|FG002|COMPLETED|Washout (7 Days)||8||
48622497|NCT03064113|101859878|FG003|COMPLETED|Washout (7 Days)||8||
48622498|NCT03064113|101859875|FG000|NOT COMPLETED|Washout (7 Days)||0||
48622499|NCT03064113|101859876|FG001|NOT COMPLETED|Washout (7 Days)||0||
48622500|NCT03064113|101859877|FG002|NOT COMPLETED|Washout (7 Days)||0||
48622501|NCT03064113|101859878|FG003|NOT COMPLETED|Washout (7 Days)||0||
48622502|NCT03064113|101859875|FG000|STARTED|Intervention 4 (2 Days)||8||
48622503|NCT03064113|101859876|FG001|STARTED|Intervention 4 (2 Days)||8||
48622504|NCT03064113|101859877|FG002|STARTED|Intervention 4 (2 Days)||8||
48622505|NCT03064113|101859878|FG003|STARTED|Intervention 4 (2 Days)||8||
48622506|NCT03064113|101859875|FG000|COMPLETED|Intervention 4 (2 Days)||8||
48622507|NCT03064113|101859876|FG001|COMPLETED|Intervention 4 (2 Days)||8||
48622508|NCT03064113|101859877|FG002|COMPLETED|Intervention 4 (2 Days)||8||
48622509|NCT03064113|101859878|FG003|COMPLETED|Intervention 4 (2 Days)||8||
48622510|NCT03064113|101859875|FG000|NOT COMPLETED|Intervention 4 (2 Days)||0||
48622511|NCT03064113|101859876|FG001|NOT COMPLETED|Intervention 4 (2 Days)||0||
48622512|NCT03064113|101859877|FG002|NOT COMPLETED|Intervention 4 (2 Days)||0||
48622513|NCT03064113|101859878|FG003|NOT COMPLETED|Intervention 4 (2 Days)||0||
48622514|NCT03064113|101859875|FG000|STARTED|Washout (7 Days)||8||
48328786|NCT00640328|101132052|FG003|COMPLETED|First Treatment Period (Weeks 0-24)||4||
48328787|NCT00640328|101132053|FG004|COMPLETED|First Treatment Period (Weeks 0-24)||4||
48328788|NCT00640328|101132054|FG005|COMPLETED|First Treatment Period (Weeks 0-24)||4||
48328789|NCT00640328|101132049|FG000|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0||
48328790|NCT00640328|101132050|FG001|NOT COMPLETED|First Treatment Period (Weeks 0-24)||1||
48328791|NCT00640328|101132051|FG002|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0||
48328792|NCT00640328|101132052|FG003|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0||
48622515|NCT03064113|101859876|FG001|STARTED|Washout (7 Days)||8||
48622516|NCT03064113|101859877|FG002|STARTED|Washout (7 Days)||8||
48622517|NCT03064113|101859878|FG003|STARTED|Washout (7 Days)||8||
48622518|NCT03064113|101859875|FG000|COMPLETED|Washout (7 Days)||8||
48622519|NCT03064113|101859876|FG001|COMPLETED|Washout (7 Days)||8||
48622520|NCT03064113|101859877|FG002|COMPLETED|Washout (7 Days)||8||
48622521|NCT03064113|101859878|FG003|COMPLETED|Washout (7 Days)||8||
48622522|NCT03064113|101859875|FG000|NOT COMPLETED|Washout (7 Days)||0||
48622523|NCT03064113|101859876|FG001|NOT COMPLETED|Washout (7 Days)||0||
48622524|NCT03064113|101859877|FG002|NOT COMPLETED|Washout (7 Days)||0||
48622525|NCT03064113|101859878|FG003|NOT COMPLETED|Washout (7 Days)||0||
48622526|NCT01305564|101859879|FG000|STARTED|Overall Study||200||
48622527|NCT01305564|101859879|FG000|COMPLETED|Overall Study||163||
48622528|NCT01305564|101859879|FG000|NOT COMPLETED|Overall Study||37||
48622529|NCT01491022|101859880|FG000|STARTED|Intervention 1||10||
48622530|NCT01491022|101859881|FG001|STARTED|Intervention 1||12||
48622531|NCT01491022|101859880|FG000|COMPLETED|Intervention 1||9||
48622532|NCT01491022|101859881|FG001|COMPLETED|Intervention 1||11||
48622533|NCT01491022|101859880|FG000|NOT COMPLETED|Intervention 1||1||
48622534|NCT01491022|101859881|FG001|NOT COMPLETED|Intervention 1||1||
48622535|NCT01491022|101859880|FG000|STARTED|2 Week Washout||9||
48622536|NCT01491022|101859881|FG001|STARTED|2 Week Washout||11||
48622537|NCT01491022|101859880|FG000|COMPLETED|2 Week Washout||9||
48622538|NCT01491022|101859881|FG001|COMPLETED|2 Week Washout||11||
48622539|NCT01491022|101859880|FG000|NOT COMPLETED|2 Week Washout||0||
48622540|NCT01491022|101859881|FG001|NOT COMPLETED|2 Week Washout||0||
48328793|NCT00640328|101132053|FG004|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0||
48328794|NCT00640328|101132054|FG005|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0||
48328795|NCT00640328|101132049|FG000|STARTED|Second Treatment Period (Weeks 24-48)||8||
48328796|NCT00640328|101132050|FG001|STARTED|Second Treatment Period (Weeks 24-48)||10||
48622541|NCT01491022|101859880|FG000|STARTED|Intervention 2||9||
48622542|NCT01491022|101859881|FG001|STARTED|Intervention 2||11||
48410214|NCT01536938|101334897|FG000|NOT COMPLETED|Overall Study||6||
48410215|NCT01536938|101334898|FG001|NOT COMPLETED|Overall Study||7||
48410216|NCT01536938|101334899|FG002|NOT COMPLETED|Overall Study||8||
48622543|NCT01491022|101859880|FG000|COMPLETED|Intervention 2||8||
48410217|NCT03461705|101334900|FG000|STARTED|Overall Study||5||
48410218|NCT03461705|101334900|FG000|COMPLETED|Overall Study||5||
48410219|NCT03461705|101334900|FG000|NOT COMPLETED|Overall Study||0||
48410220|NCT02736474|101334901|FG000|STARTED|Overall Study||11||
48622544|NCT01491022|101859881|FG001|COMPLETED|Intervention 2||11||
48622545|NCT01491022|101859880|FG000|NOT COMPLETED|Intervention 2||1||
48622546|NCT01491022|101859881|FG001|NOT COMPLETED|Intervention 2||0||
48622547|NCT00232557|101859882|FG000|STARTED|Overall Study||71||
48622548|NCT00232557|101859883|FG001|STARTED|Overall Study||65||
48622549|NCT00232557|101859882|FG000|COMPLETED|Overall Study||68||
48622550|NCT00232557|101859883|FG001|COMPLETED|Overall Study||60||
48622551|NCT00232557|101859882|FG000|NOT COMPLETED|Overall Study||3||
48622552|NCT00232557|101859883|FG001|NOT COMPLETED|Overall Study||5||
48622553|NCT00661089|101859884|FG000|STARTED|Overall Study||10||
48622554|NCT00661089|101859885|FG001|STARTED|Overall Study||11||
48745341|NCT02412098|102161871|FG002|COMPLETED|Overall Study||21||
48622555|NCT00661089|101859884|FG000|COMPLETED|Overall Study||10||
48622556|NCT00661089|101859885|FG001|COMPLETED|Overall Study||9||
48622557|NCT00661089|101859884|FG000|NOT COMPLETED|Overall Study||0||
48622558|NCT00661089|101859885|FG001|NOT COMPLETED|Overall Study||2||
48622559|NCT02033759|101859886|FG000|STARTED|Overall Study||22||
48622560|NCT02033759|101859887|FG001|STARTED|Overall Study||21||
48622561|NCT02033759|101859886|FG000|COMPLETED|Overall Study||19||
48622562|NCT02033759|101859887|FG001|COMPLETED|Overall Study||19||
48622563|NCT02033759|101859886|FG000|NOT COMPLETED|Overall Study||3||
48622564|NCT02033759|101859887|FG001|NOT COMPLETED|Overall Study||2||
48622565|NCT01619865|101859888|FG000|STARTED|Overall Study||223||
48622566|NCT01619865|101859888|FG000|COMPLETED|Overall Study||219||
48622567|NCT01619865|101859888|FG000|NOT COMPLETED|Overall Study||4||
48622568|NCT00789321|101859889|FG000|STARTED|Overall Study||24||
48622569|NCT00789321|101859890|FG001|STARTED|Overall Study||23||
48622570|NCT00789321|101859889|FG000|COMPLETED|Overall Study||24||
48622571|NCT00789321|101859890|FG001|COMPLETED|Overall Study||22||
48622572|NCT00789321|101859889|FG000|NOT COMPLETED|Overall Study||0||
48622573|NCT00789321|101859890|FG001|NOT COMPLETED|Overall Study||1||
48622574|NCT01204736|101859891|FG000|STARTED|Overall Study||4||
48622575|NCT01204736|101859892|FG001|STARTED|Overall Study||5||
48622576|NCT01204736|101859893|FG002|STARTED|Overall Study||3||
48622577|NCT01204736|101859894|FG003|STARTED|Overall Study||2||
48622578|NCT01204736|101859891|FG000|COMPLETED|Overall Study||4||
48622579|NCT01204736|101859892|FG001|COMPLETED|Overall Study||5||
48622580|NCT01204736|101859893|FG002|COMPLETED|Overall Study||3||
48622581|NCT01204736|101859894|FG003|COMPLETED|Overall Study||2||
48622582|NCT01204736|101859891|FG000|NOT COMPLETED|Overall Study||0||
48622583|NCT01204736|101859892|FG001|NOT COMPLETED|Overall Study||0||
48622584|NCT01204736|101859893|FG002|NOT COMPLETED|Overall Study||0||
48622585|NCT01204736|101859894|FG003|NOT COMPLETED|Overall Study||0||
48622586|NCT00141518|101859895|FG000|STARTED|Overall Study||37||
48622587|NCT00141518|101859896|FG001|STARTED|Overall Study||22||
48622588|NCT00141518|101859897|FG002|STARTED|Overall Study||18||
48622589|NCT00141518|101859895|FG000|Safety Sample|Overall Study||36||
48745342|NCT02412098|102161869|FG000|NOT COMPLETED|Overall Study||0||
48745343|NCT02412098|102161870|FG001|NOT COMPLETED|Overall Study||0||
48745344|NCT02412098|102161871|FG002|NOT COMPLETED|Overall Study||0||
48745345|NCT02366312|102161872|FG000|STARTED|Overall Study||1||
48745346|NCT02366312|102161873|FG001|STARTED|Overall Study||1||
48745347|NCT02366312|102161872|FG000|COMPLETED|Overall Study||1||
48745348|NCT02366312|102161873|FG001|COMPLETED|Overall Study||0||
48745349|NCT02366312|102161872|FG000|NOT COMPLETED|Overall Study||0||
48745350|NCT02366312|102161873|FG001|NOT COMPLETED|Overall Study||1||
48745351|NCT03827655|102161874|FG000|STARTED|Overall Study||52||
48745352|NCT03827655|102161875|FG001|STARTED|Overall Study||27||
48745353|NCT03827655|102161876|FG002|STARTED|Overall Study||51||
48745354|NCT03827655|102161877|FG003|STARTED|Overall Study||27||
48745355|NCT03827655|102161878|FG004|STARTED|Overall Study||52||
48745356|NCT03827655|102161874|FG000|Safety Set|Overall Study||49|Safety Set included all participants who were randomized and received at least 1 dose of double-blind study medication.|
48410221|NCT02736474|101334902|FG001|STARTED|Overall Study||11||
48410222|NCT02736474|101334901|FG000|COMPLETED|Overall Study||11||
48622590|NCT00141518|101859896|FG001|Safety Sample|Overall Study||22||
48622591|NCT00141518|101859897|FG002|Safety Sample|Overall Study||18||
48622592|NCT00141518|101859895|FG000|Full Analysis Sample|Overall Study||27||
48622593|NCT00141518|101859896|FG001|Full Analysis Sample|Overall Study||22||
48622594|NCT00141518|101859897|FG002|Full Analysis Sample|Overall Study||18||
48622595|NCT00141518|101859895|FG000|COMPLETED|Overall Study||21||
48745357|NCT03827655|102161875|FG001|Safety Set|Overall Study||26|Safety Set included all participants who were randomized and received at least 1 dose of double-blind study medication.|
48767644|NCT01812252|102222787|FG000|STARTED|Overall Study||25||
48767645|NCT01812252|102222788|FG001|STARTED|Overall Study||25||
48767646|NCT01812252|102222787|FG000|COMPLETED|Overall Study||6||
48622596|NCT00141518|101859896|FG001|COMPLETED|Overall Study||16||
48622597|NCT00141518|101859897|FG002|COMPLETED|Overall Study||12||
48622598|NCT00141518|101859895|FG000|NOT COMPLETED|Overall Study||16||
48622599|NCT00141518|101859896|FG001|NOT COMPLETED|Overall Study||6||
48622600|NCT00141518|101859897|FG002|NOT COMPLETED|Overall Study||6||
48622601|NCT04350827|101859898|FG000|STARTED|Overall Study||6||
48622602|NCT04350827|101859899|FG001|STARTED|Overall Study||8||
48622603|NCT04350827|101859898|FG000|6 Months|Overall Study||5||
48622604|NCT04350827|101859899|FG001|6 Months|Overall Study||6||
48622605|NCT04350827|101859898|FG000|COMPLETED|Overall Study||5||
48622606|NCT04350827|101859899|FG001|COMPLETED|Overall Study||6||
48622607|NCT04350827|101859898|FG000|NOT COMPLETED|Overall Study||1||
48622608|NCT04350827|101859899|FG001|NOT COMPLETED|Overall Study||2||
48622609|NCT03301636|101859900|FG000|STARTED|Overall Study||7||
48622610|NCT03301636|101859901|FG001|STARTED|Overall Study||6||
48622611|NCT03301636|101859902|FG002|STARTED|Overall Study||8||
48622612|NCT03301636|101859900|FG000|COMPLETED|Overall Study||7||
48622613|NCT03301636|101859901|FG001|COMPLETED|Overall Study||6||
48622614|NCT03301636|101859902|FG002|COMPLETED|Overall Study||8||
48622615|NCT03301636|101859900|FG000|NOT COMPLETED|Overall Study||0||
48622616|NCT03301636|101859901|FG001|NOT COMPLETED|Overall Study||0||
48622617|NCT03301636|101859902|FG002|NOT COMPLETED|Overall Study||0||
48622618|NCT00194129|101859903|FG000|STARTED|Overall Study||15||
48622619|NCT00194129|101859904|FG001|STARTED|Overall Study||16||
48622620|NCT00194129|101859903|FG000|COMPLETED|Overall Study||5||
48622621|NCT00194129|101859904|FG001|COMPLETED|Overall Study||3||
48622622|NCT00194129|101859903|FG000|NOT COMPLETED|Overall Study||10||
48622623|NCT00194129|101859904|FG001|NOT COMPLETED|Overall Study||13||
48622624|NCT01914393|101859905|FG000|STARTED|Overall Study||271||
48622625|NCT01914393|101859906|FG001|STARTED|Overall Study||125||
48622626|NCT01914393|101859907|FG002|STARTED|Overall Study||306||
48622627|NCT01914393|101859905|FG000|COMPLETED|Overall Study||156||
48622628|NCT01914393|101859906|FG001|COMPLETED|Overall Study||54||
48622629|NCT01914393|101859907|FG002|COMPLETED|Overall Study||168||
48622630|NCT01914393|101859905|FG000|NOT COMPLETED|Overall Study||115||
48622631|NCT01914393|101859906|FG001|NOT COMPLETED|Overall Study||71||
48622632|NCT01914393|101859907|FG002|NOT COMPLETED|Overall Study||138||
48622633|NCT04735705|101859908|FG000|STARTED|Overall Study||50||
48622634|NCT04735705|101859908|FG000|COMPLETED|Overall Study||47||
48622635|NCT04735705|101859908|FG000|NOT COMPLETED|Overall Study||3||
48622636|NCT03308669|101859909|FG000|STARTED|Overall Study||10||
48622637|NCT03308669|101859910|FG001|STARTED|Overall Study||20||
48622638|NCT03308669|101859909|FG000|Received at Least One Dose of Study Drug|Overall Study||10||
48622639|NCT03308669|101859910|FG001|Received at Least One Dose of Study Drug|Overall Study||20||
48622640|NCT03308669|101859909|FG000|COMPLETED|Overall Study||10||
48622641|NCT03308669|101859910|FG001|COMPLETED|Overall Study||20||
48622642|NCT03308669|101859909|FG000|NOT COMPLETED|Overall Study||0||
48622643|NCT03308669|101859910|FG001|NOT COMPLETED|Overall Study||0||
48622644|NCT00838097|101859911|FG000|STARTED|Overall Study||321||
48622645|NCT00838097|101859911|FG000|Received Darbepoetin Alfa|Overall Study||319||
48622646|NCT00838097|101859911|FG000|COMPLETED|Overall Study||145||
48622647|NCT00838097|101859911|FG000|NOT COMPLETED|Overall Study||176||
48622648|NCT01705080|101859912|FG000|STARTED|Overall Study||147||
48622649|NCT01705080|101859913|FG001|STARTED|Overall Study||101||
48622650|NCT01705080|101859914|FG002|STARTED|Overall Study||28||
48622651|NCT01705080|101859912|FG000|Renal Artery Ablation Procedure|Overall Study||147||
48622652|NCT01705080|101859913|FG001|Renal Artery Ablation Procedure|Overall Study||101||
48622653|NCT01705080|101859914|FG002|Renal Artery Ablation Procedure|Overall Study||28||
48622654|NCT01705080|101859912|FG000|Discharge Following Renal Artery Ablation Procedure|Overall Study||147||
48622655|NCT01705080|101859913|FG001|Discharge Following Renal Artery Ablation Procedure|Overall Study||100||
48622656|NCT01705080|101859914|FG002|Discharge Following Renal Artery Ablation Procedure|Overall Study||28||
48622657|NCT01705080|101859912|FG000|COMPLETED|Overall Study||72||
48622658|NCT01705080|101859913|FG001|COMPLETED|Overall Study||49||
48622659|NCT01705080|101859914|FG002|COMPLETED|Overall Study||12||
48622660|NCT01705080|101859912|FG000|NOT COMPLETED|Overall Study||75||
48622661|NCT01705080|101859913|FG001|NOT COMPLETED|Overall Study||52||
48622662|NCT01705080|101859914|FG002|NOT COMPLETED|Overall Study||16||
48622663|NCT00372424|101859915|FG000|STARTED|Overall Study||26||
48622664|NCT00372424|101859915|FG000|Treated|Overall Study||25||
48622665|NCT00372424|101859915|FG000|COMPLETED|Overall Study||0||
48622666|NCT00372424|101859915|FG000|NOT COMPLETED|Overall Study||26||
48622667|NCT00928434|101859916|FG000|STARTED|Overall Study||175||
48622668|NCT00928434|101859917|FG001|STARTED|Overall Study||50||
48622669|NCT00928434|101859918|FG002|STARTED|Overall Study||178||
48622670|NCT00928434|101859916|FG000|Full Phase B Analysis Set|Overall Study||137||
48622671|NCT00928434|101859917|FG001|Full Phase B Analysis Set|Overall Study||41||
48622672|NCT00928434|101859918|FG002|Full Phase B Analysis Set|Overall Study||150||
48622673|NCT00928434|101859916|FG000|COMPLETED|Overall Study||131||
48622674|NCT00928434|101859917|FG001|COMPLETED|Overall Study||36||
48622675|NCT00928434|101859918|FG002|COMPLETED|Overall Study||134||
48622676|NCT00928434|101859916|FG000|NOT COMPLETED|Overall Study||44||
48622677|NCT00928434|101859917|FG001|NOT COMPLETED|Overall Study||14||
48622678|NCT00928434|101859918|FG002|NOT COMPLETED|Overall Study||44||
48622679|NCT04460326|101859919|FG000|STARTED|Completed at Least 4 Meals||68||
48622680|NCT04460326|101859920|FG001|STARTED|Completed at Least 4 Meals||69||
48622681|NCT04460326|101859919|FG000|COMPLETED|Completed at Least 4 Meals||61||
48622682|NCT04460326|101859920|FG001|COMPLETED|Completed at Least 4 Meals||61||
48622683|NCT04460326|101859919|FG000|NOT COMPLETED|Completed at Least 4 Meals||7||
48622684|NCT04460326|101859920|FG001|NOT COMPLETED|Completed at Least 4 Meals||8||
48622685|NCT04460326|101859919|FG000|STARTED|Insulin Boluses & Postprandial CGM Data||61||
48622686|NCT04460326|101859920|FG001|STARTED|Insulin Boluses & Postprandial CGM Data||61||
48622687|NCT04460326|101859919|FG000|COMPLETED|Insulin Boluses & Postprandial CGM Data||56||
48410223|NCT02736474|101334902|FG001|COMPLETED|Overall Study||10||
48410224|NCT02736474|101334901|FG000|NOT COMPLETED|Overall Study||0||
48410225|NCT02736474|101334902|FG001|NOT COMPLETED|Overall Study||1||
48410226|NCT00939094|101334903|FG000|STARTED|Overall Study||42||
48410227|NCT00939094|101334904|FG001|STARTED|Overall Study||45||
48622688|NCT04460326|101859920|FG001|COMPLETED|Insulin Boluses & Postprandial CGM Data||49||
48622689|NCT04460326|101859919|FG000|NOT COMPLETED|Insulin Boluses & Postprandial CGM Data||5||
48622690|NCT04460326|101859920|FG001|NOT COMPLETED|Insulin Boluses & Postprandial CGM Data||12||
48622691|NCT04817332|101859921|FG000|STARTED|Overall Study||192||
48622692|NCT04817332|101859922|FG001|STARTED|Overall Study||214||
48622693|NCT04817332|101859921|FG000|COMPLETED|Overall Study||187||
48622694|NCT04817332|101859922|FG001|COMPLETED|Overall Study||211||
48622695|NCT04817332|101859921|FG000|NOT COMPLETED|Overall Study||5||
48622696|NCT04817332|101859922|FG001|NOT COMPLETED|Overall Study||3||
48622697|NCT02048722|101859923|FG000|STARTED|2 Cycles of Treatment||31||
48622698|NCT02048722|101859923|FG000|Attempted 1st Cycle|2 Cycles of Treatment||31||
48622699|NCT02048722|101859923|FG000|Attempted 2nd Cycle|2 Cycles of Treatment||23||
48622700|NCT02048722|101859923|FG000|COMPLETED|2 Cycles of Treatment||23||
48622701|NCT02048722|101859923|FG000|NOT COMPLETED|2 Cycles of Treatment||8||
48745358|NCT03827655|102161876|FG002|Safety Set|Overall Study||48|Safety Set included all participants who were randomized and received at least 1 dose of double-blind study medication.|
48745359|NCT03827655|102161877|FG003|Safety Set|Overall Study||25|Safety Set included all participants who were randomized and received at least 1 dose of double-blind study medication.|
48745360|NCT03827655|102161878|FG004|Safety Set|Overall Study||50|Safety Set included all participants who were randomized and received at least 1 dose of double-blind study medication.|
48745361|NCT03827655|102161874|FG000|Full Analysis Set (FAS)|Overall Study||45|FAS included all participants who were randomized, received at least 1 dose of study drug, and had at least 1 valid postbaseline on-treatment primary efficacy evaluation (bowel movement or tolerating solid food).|
48745362|NCT03827655|102161875|FG001|Full Analysis Set (FAS)|Overall Study||23|FAS included all participants who were randomized, received at least 1 dose of study drug, and had at least 1 valid postbaseline on-treatment primary efficacy evaluation (bowel movement or tolerating solid food).|
48745363|NCT03827655|102161876|FG002|Full Analysis Set (FAS)|Overall Study||42|FAS included all participants who were randomized, received at least 1 dose of study drug, and had at least 1 valid postbaseline on-treatment primary efficacy evaluation (bowel movement or tolerating solid food).|
48622702|NCT02048722|101859923|FG000|STARTED|Reached 1st Response/Continued Treatment||23||
48622703|NCT02048722|101859923|FG000|Assessed for First Response|Reached 1st Response/Continued Treatment||23||
48622704|NCT02048722|101859923|FG000|Went on to Cycle 3 and Beyond|Reached 1st Response/Continued Treatment||13||
48622705|NCT02048722|101859923|FG000|COMPLETED|Reached 1st Response/Continued Treatment||13||
48622706|NCT02048722|101859923|FG000|NOT COMPLETED|Reached 1st Response/Continued Treatment||10||
48622707|NCT02048722|101859923|FG000|STARTED|Follow up 5 Years or Cut of Timepoint||31|All patients that have one does of study drug go into follow up after discontinuing treatment. Patients followed for 5 years or until October 12, 2021, whichever comes first.|
48622708|NCT02048722|101859923|FG000|COMPLETED|Follow up 5 Years or Cut of Timepoint||4||
48622709|NCT02048722|101859923|FG000|NOT COMPLETED|Follow up 5 Years or Cut of Timepoint||27||
48622710|NCT03250689|101859924|FG000|STARTED|Overall Study||5||
48622711|NCT03250689|101859925|FG001|STARTED|Overall Study||14||
48622712|NCT03250689|101859924|FG000|COMPLETED|Overall Study||5||
48767647|NCT01812252|102222788|FG001|COMPLETED|Overall Study||10||
48767648|NCT01812252|102222787|FG000|NOT COMPLETED|Overall Study||19||
48767649|NCT01812252|102222788|FG001|NOT COMPLETED|Overall Study||15||
48767650|NCT00658385|102222789|FG000|STARTED|Overall Study||5||
48767651|NCT00658385|102222789|FG000|COMPLETED|Overall Study||5||
48767652|NCT00658385|102222789|FG000|NOT COMPLETED|Overall Study||0||
48410228|NCT00939094|101334903|FG000|COMPLETED|Overall Study||28||
48410229|NCT00939094|101334904|FG001|COMPLETED|Overall Study||35||
48767653|NCT00684021|102222790|FG000|STARTED|Overall Study||43||
48767654|NCT00684021|102222791|FG001|STARTED|Overall Study||24||
48767655|NCT00684021|102222792|FG002|STARTED|Overall Study||36||
48767656|NCT00684021|102222793|FG003|STARTED|Overall Study||17||
48767657|NCT00684021|102222790|FG000|COMPLETED|Overall Study||41||
48767658|NCT00684021|102222791|FG001|COMPLETED|Overall Study||22||
48767659|NCT00684021|102222792|FG002|COMPLETED|Overall Study||34||
48767660|NCT00684021|102222793|FG003|COMPLETED|Overall Study||15||
48767661|NCT00684021|102222790|FG000|NOT COMPLETED|Overall Study||2||
48767662|NCT00684021|102222791|FG001|NOT COMPLETED|Overall Study||2||
48767663|NCT00684021|102222792|FG002|NOT COMPLETED|Overall Study||2||
48767664|NCT00684021|102222793|FG003|NOT COMPLETED|Overall Study||2||
48767665|NCT01656408|102222794|FG000|STARTED|Overall Study||8||
48622713|NCT03250689|101859925|FG001|COMPLETED|Overall Study||14||
48622714|NCT03250689|101859924|FG000|NOT COMPLETED|Overall Study||0||
48622715|NCT03250689|101859925|FG001|NOT COMPLETED|Overall Study||0||
48622716|NCT00904007|101859926|FG000|STARTED|Overall Study||55||
48622717|NCT00904007|101859927|FG001|STARTED|Overall Study||56||
48622718|NCT00904007|101859926|FG000|COMPLETED|Overall Study||55||
48622719|NCT00904007|101859927|FG001|COMPLETED|Overall Study||56||
48622720|NCT00904007|101859926|FG000|NOT COMPLETED|Overall Study||0||
48622721|NCT00904007|101859927|FG001|NOT COMPLETED|Overall Study||0||
48622722|NCT00678418|101859928|FG000|STARTED|Part A (Double Blind)||126||
48622723|NCT00678418|101859929|FG001|STARTED|Part A (Double Blind)||124||
48622724|NCT00678418|101859928|FG000|COMPLETED|Part A (Double Blind)||67||
48622725|NCT00678418|101859929|FG001|COMPLETED|Part A (Double Blind)||47||
48622726|NCT00678418|101859928|FG000|NOT COMPLETED|Part A (Double Blind)||59||
48622727|NCT00678418|101859929|FG001|NOT COMPLETED|Part A (Double Blind)||77||
48622728|NCT00678418|101859928|FG000|STARTED|Part B (Open Label)||114||
48622729|NCT00678418|101859929|FG001|STARTED|Part B (Open Label)||0||
48622730|NCT00678418|101859928|FG000|COMPLETED|Part B (Open Label)||71||
48745364|NCT03827655|102161877|FG003|Full Analysis Set (FAS)|Overall Study||21|FAS included all participants who were randomized, received at least 1 dose of study drug, and had at least 1 valid postbaseline on-treatment primary efficacy evaluation (bowel movement or tolerating solid food).|
48745365|NCT03827655|102161878|FG004|Full Analysis Set (FAS)|Overall Study||44|FAS included all participants who were randomized, received at least 1 dose of study drug, and had at least 1 valid postbaseline on-treatment primary efficacy evaluation (bowel movement or tolerating solid food).|
48745366|NCT03827655|102161874|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||0|PK Analysis Set included all participants who were randomized, received at least 1 dose and had at least 1 measurable post-dose plasma for TAK-954.|
48622731|NCT00678418|101859929|FG001|COMPLETED|Part B (Open Label)||0||
48622732|NCT00678418|101859928|FG000|NOT COMPLETED|Part B (Open Label)||43||
48622733|NCT00678418|101859929|FG001|NOT COMPLETED|Part B (Open Label)||0||
48622734|NCT00580957|101859930|FG000|STARTED|Overall Study||28||
48622735|NCT00580957|101859931|FG001|STARTED|Overall Study||28||
48622736|NCT00580957|101859930|FG000|COMPLETED|Overall Study||21||
48622737|NCT00580957|101859931|FG001|COMPLETED|Overall Study||21||
48622738|NCT00580957|101859930|FG000|NOT COMPLETED|Overall Study||7||
48622739|NCT00580957|101859931|FG001|NOT COMPLETED|Overall Study||7||
48622740|NCT04369833|101859932|FG000|STARTED|Overall Study||130||
48622741|NCT04369833|101859932|FG000|COMPLETED|Overall Study||129||
48622742|NCT04369833|101859932|FG000|NOT COMPLETED|Overall Study||1||
48745367|NCT03827655|102161875|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||26|PK Analysis Set included all participants who were randomized, received at least 1 dose and had at least 1 measurable post-dose plasma for TAK-954.|
48745368|NCT03827655|102161876|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||47|PK Analysis Set included all participants who were randomized, received at least 1 dose and had at least 1 measurable post-dose plasma for TAK-954.|
48745369|NCT03827655|102161877|FG003|Pharmacokinetic (PK) Analysis Set|Overall Study||24|PK Analysis Set included all participants who were randomized, received at least 1 dose and had at least 1 measurable post-dose plasma for TAK-954.|
48622743|NCT01781962|101859933|FG000|STARTED|Overall Study||206||
48622744|NCT01781962|101859933|FG000|COMPLETED|Overall Study||201||
48622745|NCT01781962|101859933|FG000|NOT COMPLETED|Overall Study||5||
48622746|NCT03148262|101859934|FG000|STARTED|Overall Study||31||
48622747|NCT03148262|101859935|FG001|STARTED|Overall Study||32||
48622748|NCT03148262|101859934|FG000|COMPLETED|Overall Study||28||
48622749|NCT03148262|101859935|FG001|COMPLETED|Overall Study||31||
48622750|NCT03148262|101859934|FG000|NOT COMPLETED|Overall Study||3||
48622751|NCT03148262|101859935|FG001|NOT COMPLETED|Overall Study||1||
48622752|NCT01232790|101859936|FG000|STARTED|Randomization||14||
48622753|NCT01232790|101859937|FG001|STARTED|Randomization||14||
48622754|NCT01232790|101859936|FG000|COMPLETED|Randomization||12||
48622755|NCT01232790|101859937|FG001|COMPLETED|Randomization||12||
48622756|NCT01232790|101859936|FG000|NOT COMPLETED|Randomization||2||
48622757|NCT01232790|101859937|FG001|NOT COMPLETED|Randomization||2||
48622758|NCT01232790|101859936|FG000|STARTED|Initial Assessment||12||
48622759|NCT01232790|101859937|FG001|STARTED|Initial Assessment||12||
48622760|NCT01232790|101859936|FG000|COMPLETED|Initial Assessment||12||
48622761|NCT01232790|101859937|FG001|COMPLETED|Initial Assessment||11||
48622762|NCT01232790|101859936|FG000|NOT COMPLETED|Initial Assessment||0||
48622763|NCT01232790|101859937|FG001|NOT COMPLETED|Initial Assessment||1||
48622764|NCT01232790|101859936|FG000|STARTED|First Crossover||12||
48622765|NCT01232790|101859937|FG001|STARTED|First Crossover||11||
48622766|NCT01232790|101859936|FG000|COMPLETED|First Crossover||11||
48622767|NCT01232790|101859937|FG001|COMPLETED|First Crossover||11||
48622768|NCT01232790|101859936|FG000|NOT COMPLETED|First Crossover||1||
48622769|NCT01232790|101859937|FG001|NOT COMPLETED|First Crossover||0||
48622770|NCT01232790|101859936|FG000|STARTED|Second Crossover||11||
48622771|NCT01232790|101859937|FG001|STARTED|Second Crossover||11||
48622772|NCT01232790|101859936|FG000|COMPLETED|Second Crossover||10||
48622773|NCT01232790|101859937|FG001|COMPLETED|Second Crossover||9||
48622774|NCT01232790|101859936|FG000|NOT COMPLETED|Second Crossover||1||
48622775|NCT01232790|101859937|FG001|NOT COMPLETED|Second Crossover||2||
48622776|NCT00667563|101859938|FG000|STARTED|Overall Study||150||
48622777|NCT00667563|101859938|FG000|COMPLETED|Overall Study||126||
48622778|NCT00667563|101859938|FG000|NOT COMPLETED|Overall Study||24||
48622779|NCT00072410|101859939|FG000|STARTED|Overall Study||3||
48622780|NCT00072410|101859940|FG001|STARTED|Overall Study||4||
48622781|NCT00072410|101859939|FG000|COMPLETED|Overall Study||3||
48622782|NCT00072410|101859940|FG001|COMPLETED|Overall Study||1||
48622783|NCT00072410|101859939|FG000|NOT COMPLETED|Overall Study||0||
48622784|NCT00072410|101859940|FG001|NOT COMPLETED|Overall Study||3||
48622785|NCT01791595|101859941|FG000|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||3||
48622786|NCT01791595|101859942|FG001|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
48622787|NCT01791595|101859943|FG002|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
48622788|NCT01791595|101859944|FG003|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
48622789|NCT01791595|101859945|FG004|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
48622790|NCT01791595|101859946|FG005|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
48622791|NCT01791595|101859947|FG006|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
48622792|NCT01791595|101859941|FG000|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
48622793|NCT01791595|101859942|FG001|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
48622794|NCT01791595|101859943|FG002|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
48622795|NCT01791595|101859944|FG003|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
48622796|NCT01791595|101859945|FG004|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
48622797|NCT01791595|101859946|FG005|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
48622798|NCT01791595|101859947|FG006|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
48622799|NCT01791595|101859941|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||3||
48622800|NCT01791595|101859942|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
48622801|NCT01791595|101859943|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
48328797|NCT00640328|101132051|FG002|STARTED|Second Treatment Period (Weeks 24-48)||7||
48328798|NCT00640328|101132052|FG003|STARTED|Second Treatment Period (Weeks 24-48)||4||
48328799|NCT00640328|101132053|FG004|STARTED|Second Treatment Period (Weeks 24-48)||4||
48328800|NCT00640328|101132054|FG005|STARTED|Second Treatment Period (Weeks 24-48)||4||
48328801|NCT00640328|101132049|FG000|COMPLETED|Second Treatment Period (Weeks 24-48)||8||
48328802|NCT00640328|101132050|FG001|COMPLETED|Second Treatment Period (Weeks 24-48)||10||
48328803|NCT00640328|101132051|FG002|COMPLETED|Second Treatment Period (Weeks 24-48)||7||
48328804|NCT00640328|101132052|FG003|COMPLETED|Second Treatment Period (Weeks 24-48)||4||
48328805|NCT00640328|101132053|FG004|COMPLETED|Second Treatment Period (Weeks 24-48)||3||
48328806|NCT00640328|101132054|FG005|COMPLETED|Second Treatment Period (Weeks 24-48)||4||
48328807|NCT00640328|101132049|FG000|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0||
48328808|NCT00640328|101132050|FG001|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0||
48328809|NCT00640328|101132051|FG002|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0||
48328810|NCT00640328|101132052|FG003|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0||
48328811|NCT00640328|101132053|FG004|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||1||
48328812|NCT00640328|101132054|FG005|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0||
48328813|NCT00640328|101132049|FG000|STARTED|IFUP (Week 48 to Individual Termination)||8||
48328814|NCT00640328|101132050|FG001|STARTED|IFUP (Week 48 to Individual Termination)||11||
48328815|NCT00640328|101132051|FG002|STARTED|IFUP (Week 48 to Individual Termination)||7||
48328816|NCT00640328|101132052|FG003|STARTED|IFUP (Week 48 to Individual Termination)||4||
48328817|NCT00640328|101132053|FG004|STARTED|IFUP (Week 48 to Individual Termination)||4||
48328818|NCT00640328|101132054|FG005|STARTED|IFUP (Week 48 to Individual Termination)||4||
48328819|NCT00640328|101132049|FG000|COMPLETED|IFUP (Week 48 to Individual Termination)||8||
48328820|NCT00640328|101132050|FG001|COMPLETED|IFUP (Week 48 to Individual Termination)||10||
48328821|NCT00640328|101132051|FG002|COMPLETED|IFUP (Week 48 to Individual Termination)||6||
48622802|NCT01791595|101859944|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
48622803|NCT01791595|101859945|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
48622804|NCT01791595|101859946|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
48622805|NCT01791595|101859947|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
48622806|NCT01791595|101859941|FG000|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
48622807|NCT01791595|101859942|FG001|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||5||
48622808|NCT01791595|101859943|FG002|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
48622809|NCT01791595|101859944|FG003|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
48622810|NCT01791595|101859945|FG004|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
48622811|NCT01791595|101859946|FG005|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
48622812|NCT01791595|101859947|FG006|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
48622813|NCT01791595|101859941|FG000|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
48622814|NCT01791595|101859942|FG001|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
48622815|NCT01791595|101859943|FG002|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
48622816|NCT01791595|101859944|FG003|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
48622817|NCT01791595|101859945|FG004|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
48622818|NCT01791595|101859946|FG005|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
48622819|NCT01791595|101859947|FG006|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
48622820|NCT01791595|101859941|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
48622821|NCT01791595|101859942|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||5||
48622822|NCT01791595|101859943|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
48622823|NCT01791595|101859944|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
48622824|NCT01791595|101859945|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
48622825|NCT01791595|101859946|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
48622826|NCT01791595|101859947|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
48622827|NCT01791595|101859941|FG000|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
48622828|NCT01791595|101859942|FG001|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
48622829|NCT01791595|101859943|FG002|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||8||
48622830|NCT01791595|101859944|FG003|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
48622831|NCT01791595|101859945|FG004|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
48622832|NCT01791595|101859946|FG005|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
48622833|NCT01791595|101859947|FG006|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
48622834|NCT01791595|101859941|FG000|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
48622835|NCT01791595|101859942|FG001|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
48622836|NCT01791595|101859943|FG002|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
48622837|NCT01791595|101859944|FG003|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
48622838|NCT01791595|101859945|FG004|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
48622839|NCT01791595|101859946|FG005|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
48622840|NCT01791595|101859947|FG006|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
48622841|NCT01791595|101859941|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
48622842|NCT01791595|101859942|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
48622843|NCT01791595|101859943|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||8||
48622844|NCT01791595|101859944|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
48622845|NCT01791595|101859945|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
48622846|NCT01791595|101859946|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
48622847|NCT01791595|101859947|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
48622848|NCT01791595|101859941|FG000|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
48622849|NCT01791595|101859942|FG001|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
48622850|NCT01791595|101859943|FG002|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
48622851|NCT01791595|101859944|FG003|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||5||
48622852|NCT01791595|101859945|FG004|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
48622853|NCT01791595|101859946|FG005|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
48622854|NCT01791595|101859947|FG006|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
48622855|NCT01791595|101859941|FG000|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
48622856|NCT01791595|101859942|FG001|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
48622857|NCT01791595|101859943|FG002|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
48622858|NCT01791595|101859944|FG003|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||1||
48622859|NCT01791595|101859945|FG004|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
48622860|NCT01791595|101859946|FG005|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
48622861|NCT01791595|101859947|FG006|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
48622862|NCT01791595|101859941|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
48622863|NCT01791595|101859942|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
48622864|NCT01791595|101859943|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
48622865|NCT01791595|101859944|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||4||
48622866|NCT01791595|101859945|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
48622867|NCT01791595|101859946|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
48622868|NCT01791595|101859947|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
48622869|NCT01791595|101859941|FG000|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
48622870|NCT01791595|101859942|FG001|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
48622871|NCT01791595|101859943|FG002|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
48622872|NCT01791595|101859944|FG003|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
48622873|NCT01791595|101859945|FG004|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||11||
48622874|NCT01791595|101859946|FG005|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
48622875|NCT01791595|101859947|FG006|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
48622876|NCT01791595|101859941|FG000|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
48622877|NCT01791595|101859942|FG001|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
48622878|NCT01791595|101859943|FG002|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
48622879|NCT01791595|101859944|FG003|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
48622880|NCT01791595|101859945|FG004|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
48410230|NCT00939094|101334903|FG000|NOT COMPLETED|Overall Study||14||
48622881|NCT01791595|101859946|FG005|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
48622882|NCT01791595|101859947|FG006|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
48622883|NCT01791595|101859941|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
48410231|NCT00939094|101334904|FG001|NOT COMPLETED|Overall Study||10||
48622884|NCT01791595|101859942|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
48622885|NCT01791595|101859943|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
48745370|NCT03827655|102161878|FG004|Pharmacokinetic (PK) Analysis Set|Overall Study||50|PK Analysis Set included all participants who were randomized, received at least 1 dose and had at least 1 measurable post-dose plasma for TAK-954.|
48745371|NCT03827655|102161874|FG000|COMPLETED|Overall Study||45||
48745372|NCT03827655|102161875|FG001|COMPLETED|Overall Study||24||
48745373|NCT03827655|102161876|FG002|COMPLETED|Overall Study||47||
48745374|NCT03827655|102161877|FG003|COMPLETED|Overall Study||25||
48745375|NCT03827655|102161878|FG004|COMPLETED|Overall Study||49||
48622886|NCT01791595|101859944|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
48622887|NCT01791595|101859945|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||11||
48622888|NCT01791595|101859946|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
48622889|NCT01791595|101859947|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
48622890|NCT01791595|101859941|FG000|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
48622891|NCT01791595|101859942|FG001|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
48622892|NCT01791595|101859943|FG002|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
48622893|NCT01791595|101859944|FG003|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
48622894|NCT01791595|101859945|FG004|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
48622895|NCT01791595|101859946|FG005|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||8||
48622896|NCT01791595|101859947|FG006|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
48622897|NCT01791595|101859941|FG000|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
48622898|NCT01791595|101859942|FG001|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
48622899|NCT01791595|101859943|FG002|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
48622900|NCT01791595|101859944|FG003|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
48622901|NCT01791595|101859945|FG004|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
48622902|NCT01791595|101859946|FG005|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
48622903|NCT01791595|101859947|FG006|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
48622904|NCT01791595|101859941|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
48622905|NCT01791595|101859942|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
48622906|NCT01791595|101859943|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
48622907|NCT01791595|101859944|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
48622908|NCT01791595|101859945|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
48622909|NCT01791595|101859946|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||8||
48622910|NCT01791595|101859947|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
48622911|NCT01791595|101859941|FG000|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0||
48622912|NCT01791595|101859942|FG001|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0||
48622913|NCT01791595|101859943|FG002|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0||
48745376|NCT03827655|102161874|FG000|NOT COMPLETED|Overall Study||7||
48745377|NCT03827655|102161875|FG001|NOT COMPLETED|Overall Study||3||
48745378|NCT03827655|102161876|FG002|NOT COMPLETED|Overall Study||4||
48745379|NCT03827655|102161877|FG003|NOT COMPLETED|Overall Study||2||
48745380|NCT03827655|102161878|FG004|NOT COMPLETED|Overall Study||3||
48745381|NCT03573323|102161879|FG000|STARTED|Blinded Treatment Period (Weeks 0-24)||520||
48745382|NCT03573323|102161880|FG001|STARTED|Blinded Treatment Period (Weeks 0-24)||507||
48745383|NCT03573323|102161879|FG000|Received at Least One Dose of Study Drug|Blinded Treatment Period (Weeks 0-24)||519||
48745384|NCT03573323|102161880|FG001|Received at Least One Dose of Study Drug|Blinded Treatment Period (Weeks 0-24)||506||
48745385|NCT03573323|102161879|FG000|COMPLETED|Blinded Treatment Period (Weeks 0-24)||465||
48745386|NCT03573323|102161880|FG001|COMPLETED|Blinded Treatment Period (Weeks 0-24)||459||
48745387|NCT03573323|102161879|FG000|NOT COMPLETED|Blinded Treatment Period (Weeks 0-24)||55||
48745388|NCT03573323|102161880|FG001|NOT COMPLETED|Blinded Treatment Period (Weeks 0-24)||48||
48745389|NCT03573323|102161879|FG000|STARTED|Post-Treatment Follow Up (Weeks 25-36)||465||
48745390|NCT03573323|102161880|FG001|STARTED|Post-Treatment Follow Up (Weeks 25-36)||456||
48745391|NCT03573323|102161879|FG000|COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||406||
48745392|NCT03573323|102161880|FG001|COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||399||
48745393|NCT03573323|102161879|FG000|NOT COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||59||
48745394|NCT03573323|102161880|FG001|NOT COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||57||
48410232|NCT02369211|101334905|FG000|STARTED|Overall Study||43||
48745395|NCT00584415|102161881|FG000|STARTED|Overall Study||119||
48745396|NCT00584415|102161881|FG000|COMPLETED|Overall Study||112||
48745397|NCT00584415|102161881|FG000|NOT COMPLETED|Overall Study||7||
48745398|NCT03393494|102161882|FG000|STARTED|Overall Study||329||
48745399|NCT03393494|102161883|FG001|STARTED|Overall Study||331||
48745400|NCT03393494|102161884|FG002|STARTED|Overall Study||165||
48745401|NCT03393494|102161882|FG000|COMPLETED|Overall Study||261||
48622914|NCT01791595|101859944|FG003|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0||
48622915|NCT01791595|101859945|FG004|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0||
48622916|NCT01791595|101859946|FG005|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0||
48622917|NCT01791595|101859947|FG006|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||11||
48622918|NCT01791595|101859941|FG000|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0||
48622919|NCT01791595|101859942|FG001|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0||
48745402|NCT03393494|102161883|FG001|COMPLETED|Overall Study||256||
48745403|NCT03393494|102161884|FG002|COMPLETED|Overall Study||140||
48745404|NCT03393494|102161882|FG000|NOT COMPLETED|Overall Study||68||
48745405|NCT03393494|102161883|FG001|NOT COMPLETED|Overall Study||75||
48622920|NCT01791595|101859943|FG002|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0||
48622921|NCT01791595|101859944|FG003|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0||
48622922|NCT01791595|101859945|FG004|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0||
48745406|NCT03393494|102161884|FG002|NOT COMPLETED|Overall Study||25||
48745407|NCT04014062|102161885|FG000|STARTED|Period I: Dosing||71||
48745408|NCT04014062|102161886|FG001|STARTED|Period I: Dosing||71||
48745409|NCT04014062|102161885|FG000|COMPLETED|Period I: Dosing||64||
48745410|NCT04014062|102161886|FG001|COMPLETED|Period I: Dosing||65||
48745411|NCT04014062|102161885|FG000|NOT COMPLETED|Period I: Dosing||7||
48745412|NCT04014062|102161886|FG001|NOT COMPLETED|Period I: Dosing||6||
48745413|NCT04014062|102161885|FG000|STARTED|Period II: Crossover Dosing||64||
48745414|NCT04014062|102161886|FG001|STARTED|Period II: Crossover Dosing||65||
48410233|NCT02369211|101334906|FG001|STARTED|Overall Study||43||
48745415|NCT04014062|102161885|FG000|COMPLETED|Period II: Crossover Dosing||64||
48328822|NCT00640328|101132052|FG003|COMPLETED|IFUP (Week 48 to Individual Termination)||3||
48328823|NCT00640328|101132053|FG004|COMPLETED|IFUP (Week 48 to Individual Termination)||4||
48328824|NCT00640328|101132054|FG005|COMPLETED|IFUP (Week 48 to Individual Termination)||4||
48328825|NCT00640328|101132049|FG000|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0||
48328826|NCT00640328|101132050|FG001|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1||
48328827|NCT00640328|101132051|FG002|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1||
48328828|NCT00640328|101132052|FG003|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1||
48328829|NCT00640328|101132053|FG004|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0||
48328830|NCT00640328|101132054|FG005|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0||
48328831|NCT04161131|101132055|FG000|STARTED|Overall Study||28||
48328832|NCT04161131|101132055|FG000|Completed Baseline Surveys|Overall Study||27||
48328833|NCT04161131|101132055|FG000|Received Intervention|Overall Study||22||
48328834|NCT04161131|101132055|FG000|COMPLETED|Overall Study||22||
48328835|NCT04161131|101132055|FG000|NOT COMPLETED|Overall Study||6||
48328836|NCT02799069|101132056|FG000|STARTED|Overall Study||76|randomized|
48328837|NCT02799069|101132057|FG001|STARTED|Overall Study||248|randomized|
48328838|NCT02799069|101132058|FG002|STARTED|Overall Study||247|randomized|
48328839|NCT02799069|101132056|FG000|ITT/Safety|Overall Study||76||
48328840|NCT02799069|101132057|FG001|ITT/Safety|Overall Study||248||
48328841|NCT02799069|101132058|FG002|ITT/Safety|Overall Study||246||
48745416|NCT04014062|102161886|FG001|COMPLETED|Period II: Crossover Dosing||65||
48745417|NCT04014062|102161885|FG000|NOT COMPLETED|Period II: Crossover Dosing||0||
48745418|NCT04014062|102161886|FG001|NOT COMPLETED|Period II: Crossover Dosing||0||
48328842|NCT02799069|101132056|FG000|COMPLETED|Overall Study||68||
48328843|NCT02799069|101132057|FG001|COMPLETED|Overall Study||241||
48410234|NCT02369211|101334905|FG000|COMPLETED|Overall Study||43||
48410235|NCT02369211|101334906|FG001|COMPLETED|Overall Study||41||
48410236|NCT02369211|101334905|FG000|NOT COMPLETED|Overall Study||0||
48622923|NCT01791595|101859946|FG005|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0||
48622924|NCT01791595|101859947|FG006|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||1||
48622925|NCT01791595|101859941|FG000|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0||
48745419|NCT02611817|102161887|FG000|STARTED|Open-label Induction Phase||644||
48745420|NCT02611817|102161888|FG001|STARTED|Open-label Induction Phase||0||
48745421|NCT02611817|102161889|FG002|STARTED|Open-label Induction Phase||0||
48745422|NCT02611817|102161887|FG000|COMPLETED|Open-label Induction Phase||594|Completers included participants who received OL vedolizumab IV and had Week 14 visit.|
48745423|NCT02611817|102161888|FG001|COMPLETED|Open-label Induction Phase||0|Completers included participants who received OL vedolizumab IV and had Week 14 visit.|
48745424|NCT02611817|102161889|FG002|COMPLETED|Open-label Induction Phase||0|Completers included participants who received OL vedolizumab IV and had Week 14 visit.|
48745425|NCT02611817|102161887|FG000|NOT COMPLETED|Open-label Induction Phase||50||
48328844|NCT02799069|101132058|FG002|COMPLETED|Overall Study||240||
48328845|NCT02799069|101132056|FG000|NOT COMPLETED|Overall Study||8||
48745426|NCT02611817|102161888|FG001|NOT COMPLETED|Open-label Induction Phase||0||
48410237|NCT02369211|101334906|FG001|NOT COMPLETED|Overall Study||2||
48410238|NCT00376675|101334907|FG000|STARTED|Overall Study||69||
48745427|NCT02611817|102161889|FG002|NOT COMPLETED|Open-label Induction Phase||0||
48767666|NCT01656408|102222795|FG001|STARTED|Overall Study||8||
48328846|NCT02799069|101132057|FG001|NOT COMPLETED|Overall Study||7||
48328847|NCT02799069|101132058|FG002|NOT COMPLETED|Overall Study||7||
48328848|NCT03686397|101132059|FG000|STARTED|Overall Study||75|MITT Population|
48328849|NCT03686397|101132060|FG001|STARTED|Overall Study||35|MITT Population|
48328850|NCT03686397|101132059|FG000|COMPLETED|Overall Study||70||
48328851|NCT03686397|101132060|FG001|COMPLETED|Overall Study||27||
48328852|NCT03686397|101132059|FG000|NOT COMPLETED|Overall Study||5||
48328853|NCT03686397|101132060|FG001|NOT COMPLETED|Overall Study||8||
48328854|NCT01929408|101132061|FG000|STARTED|Overall Study||703|Number Ss enrolled|
48328855|NCT01929408|101132061|FG000|COMPLETED|Overall Study||695|Total Ss with analyzable data. Incomplete follow-up data could still be included in analyses.|
48328856|NCT01929408|101132061|FG000|NOT COMPLETED|Overall Study||8||
48328857|NCT01212185|101132062|FG000|STARTED|Overall Study||6||
48328858|NCT01212185|101132063|FG001|STARTED|Overall Study||8||
48328859|NCT01212185|101132062|FG000|COMPLETED|Overall Study||4||
48328860|NCT01212185|101132063|FG001|COMPLETED|Overall Study||7||
48328861|NCT01212185|101132062|FG000|NOT COMPLETED|Overall Study||2||
48328862|NCT01212185|101132063|FG001|NOT COMPLETED|Overall Study||1||
48328863|NCT01573273|101132064|FG000|STARTED|TSST : Trier Social Stress Task||24||
48328864|NCT01573273|101132065|FG001|STARTED|TSST : Trier Social Stress Task||25||
48328865|NCT01573273|101132066|FG002|STARTED|TSST : Trier Social Stress Task||0||
48328866|NCT01573273|101132067|FG003|STARTED|TSST : Trier Social Stress Task||0||
48328867|NCT01573273|101132068|FG004|STARTED|TSST : Trier Social Stress Task||0||
48328868|NCT01573273|101132069|FG005|STARTED|TSST : Trier Social Stress Task||0||
48328869|NCT01573273|101132070|FG006|STARTED|TSST : Trier Social Stress Task||32||
48328870|NCT01573273|101132071|FG007|STARTED|TSST : Trier Social Stress Task||31||
48328871|NCT01573273|101132072|FG008|STARTED|TSST : Trier Social Stress Task||0||
48328872|NCT01573273|101132073|FG009|STARTED|TSST : Trier Social Stress Task||0||
48328873|NCT01573273|101132074|FG010|STARTED|TSST : Trier Social Stress Task||0||
48328874|NCT01573273|101132075|FG011|STARTED|TSST : Trier Social Stress Task||0||
48328875|NCT01573273|101132064|FG000|COMPLETED|TSST : Trier Social Stress Task||24||
48328876|NCT01573273|101132065|FG001|COMPLETED|TSST : Trier Social Stress Task||25||
48328877|NCT01573273|101132066|FG002|COMPLETED|TSST : Trier Social Stress Task||0||
48328878|NCT01573273|101132067|FG003|COMPLETED|TSST : Trier Social Stress Task||0||
48328879|NCT01573273|101132068|FG004|COMPLETED|TSST : Trier Social Stress Task||0||
48328880|NCT01573273|101132069|FG005|COMPLETED|TSST : Trier Social Stress Task||0||
48328881|NCT01573273|101132070|FG006|COMPLETED|TSST : Trier Social Stress Task||32||
48328882|NCT01573273|101132071|FG007|COMPLETED|TSST : Trier Social Stress Task||31||
48328883|NCT01573273|101132072|FG008|COMPLETED|TSST : Trier Social Stress Task||0||
48328884|NCT01573273|101132073|FG009|COMPLETED|TSST : Trier Social Stress Task||0||
48328885|NCT01573273|101132074|FG010|COMPLETED|TSST : Trier Social Stress Task||0||
48328886|NCT01573273|101132075|FG011|COMPLETED|TSST : Trier Social Stress Task||0||
48328887|NCT01573273|101132064|FG000|NOT COMPLETED|TSST : Trier Social Stress Task||0||
48328888|NCT01573273|101132065|FG001|NOT COMPLETED|TSST : Trier Social Stress Task||0||
48328889|NCT01573273|101132066|FG002|NOT COMPLETED|TSST : Trier Social Stress Task||0||
48328890|NCT01573273|101132067|FG003|NOT COMPLETED|TSST : Trier Social Stress Task||0||
48745428|NCT02611817|102161887|FG000|STARTED|Double-blind Maintenance Phase||0|Participants who achieved clinical response at Week 6 entered the Maintenance Phase.|
48745429|NCT02611817|102161888|FG001|STARTED|Double-blind Maintenance Phase||135|Participants who achieved clinical response at Week 6 entered the Maintenance Phase.|
48328891|NCT01573273|101132068|FG004|NOT COMPLETED|TSST : Trier Social Stress Task||0||
48328892|NCT01573273|101132069|FG005|NOT COMPLETED|TSST : Trier Social Stress Task||0||
48328893|NCT01573273|101132070|FG006|NOT COMPLETED|TSST : Trier Social Stress Task||0||
48328894|NCT01573273|101132071|FG007|NOT COMPLETED|TSST : Trier Social Stress Task||0||
48328895|NCT01573273|101132072|FG008|NOT COMPLETED|TSST : Trier Social Stress Task||0||
48328896|NCT01573273|101132073|FG009|NOT COMPLETED|TSST : Trier Social Stress Task||0||
48328897|NCT01573273|101132074|FG010|NOT COMPLETED|TSST : Trier Social Stress Task||0||
48328898|NCT01573273|101132075|FG011|NOT COMPLETED|TSST : Trier Social Stress Task||0||
48328899|NCT01573273|101132064|FG000|STARTED|MRI 1||0||
48328900|NCT01573273|101132065|FG001|STARTED|MRI 1||0||
48328901|NCT01573273|101132066|FG002|STARTED|MRI 1||19||
48328902|NCT01573273|101132067|FG003|STARTED|MRI 1||23||
48328903|NCT01573273|101132068|FG004|STARTED|MRI 1||0||
48328904|NCT01573273|101132069|FG005|STARTED|MRI 1||0||
48328905|NCT01573273|101132070|FG006|STARTED|MRI 1||0||
48328906|NCT01573273|101132071|FG007|STARTED|MRI 1||0||
48328907|NCT01573273|101132072|FG008|STARTED|MRI 1||28||
48328908|NCT01573273|101132073|FG009|STARTED|MRI 1||29||
48328909|NCT01573273|101132074|FG010|STARTED|MRI 1||0||
48328910|NCT01573273|101132075|FG011|STARTED|MRI 1||0||
48328911|NCT01573273|101132064|FG000|COMPLETED|MRI 1||0||
48328912|NCT01573273|101132065|FG001|COMPLETED|MRI 1||0||
48328913|NCT01573273|101132066|FG002|COMPLETED|MRI 1||19||
48328914|NCT01573273|101132067|FG003|COMPLETED|MRI 1||23||
48328915|NCT01573273|101132068|FG004|COMPLETED|MRI 1||0||
48328916|NCT01573273|101132069|FG005|COMPLETED|MRI 1||0||
48328917|NCT01573273|101132070|FG006|COMPLETED|MRI 1||0||
48328918|NCT01573273|101132071|FG007|COMPLETED|MRI 1||0||
48328919|NCT01573273|101132072|FG008|COMPLETED|MRI 1||28||
48328920|NCT01573273|101132073|FG009|COMPLETED|MRI 1||29||
48328921|NCT01573273|101132074|FG010|COMPLETED|MRI 1||0||
48328922|NCT01573273|101132075|FG011|COMPLETED|MRI 1||0||
48328923|NCT01573273|101132064|FG000|NOT COMPLETED|MRI 1||0||
48328924|NCT01573273|101132065|FG001|NOT COMPLETED|MRI 1||0||
48328925|NCT01573273|101132066|FG002|NOT COMPLETED|MRI 1||0||
48328926|NCT01573273|101132067|FG003|NOT COMPLETED|MRI 1||0||
48328927|NCT01573273|101132068|FG004|NOT COMPLETED|MRI 1||0||
48328928|NCT01573273|101132069|FG005|NOT COMPLETED|MRI 1||0||
48410239|NCT00376675|101334908|FG001|STARTED|Overall Study||70||
48410240|NCT00376675|101334907|FG000|COMPLETED|Overall Study||49||
48410241|NCT00376675|101334908|FG001|COMPLETED|Overall Study||56||
48410242|NCT00376675|101334907|FG000|NOT COMPLETED|Overall Study||20||
48410243|NCT00376675|101334908|FG001|NOT COMPLETED|Overall Study||14||
48410244|NCT02329860|101334909|FG000|STARTED|Overall Study||267||
48410245|NCT02329860|101334910|FG001|STARTED|Overall Study||133||
48410246|NCT02329860|101334909|FG000|Treated|Overall Study||261||
48410247|NCT02329860|101334910|FG001|Treated|Overall Study||132||
48410248|NCT02329860|101334909|FG000|COMPLETED|Overall Study||161||
48410249|NCT02329860|101334910|FG001|COMPLETED|Overall Study||107||
48745430|NCT02611817|102161889|FG002|STARTED|Double-blind Maintenance Phase||275|Participants who achieved clinical response at Week 6 entered the Maintenance Phase.|
48745431|NCT02611817|102161887|FG000|COMPLETED|Double-blind Maintenance Phase||0||
48745432|NCT02611817|102161888|FG001|COMPLETED|Double-blind Maintenance Phase||73||
48745433|NCT02611817|102161889|FG002|COMPLETED|Double-blind Maintenance Phase||168||
48745434|NCT02611817|102161887|FG000|NOT COMPLETED|Double-blind Maintenance Phase||0||
48745435|NCT02611817|102161888|FG001|NOT COMPLETED|Double-blind Maintenance Phase||62||
48745436|NCT02611817|102161889|FG002|NOT COMPLETED|Double-blind Maintenance Phase||107||
48745437|NCT00754377|102161890|FG000|STARTED|Overall Study||50||
48745438|NCT00754377|102161891|FG001|STARTED|Overall Study||42||
48745439|NCT00754377|102161890|FG000|COMPLETED|Overall Study||50||
48745440|NCT00754377|102161891|FG001|COMPLETED|Overall Study||42||
48745441|NCT00754377|102161890|FG000|NOT COMPLETED|Overall Study||0||
48745442|NCT00754377|102161891|FG001|NOT COMPLETED|Overall Study||0||
48745443|NCT01220167|102161892|FG000|STARTED|Period 1||6||
48745444|NCT01220167|102161893|FG001|STARTED|Period 1||6||
48745445|NCT01220167|102161894|FG002|STARTED|Period 1||6||
48745446|NCT01220167|102161892|FG000|COMPLETED|Period 1||6||
48745447|NCT01220167|102161893|FG001|COMPLETED|Period 1||6||
48745448|NCT01220167|102161894|FG002|COMPLETED|Period 1||6||
48745449|NCT01220167|102161892|FG000|NOT COMPLETED|Period 1||0||
48745450|NCT01220167|102161893|FG001|NOT COMPLETED|Period 1||0||
48745451|NCT01220167|102161894|FG002|NOT COMPLETED|Period 1||0||
48745452|NCT01220167|102161892|FG000|STARTED|Period 2||6||
48745453|NCT01220167|102161893|FG001|STARTED|Period 2||6||
48745454|NCT01220167|102161894|FG002|STARTED|Period 2||6||
48745455|NCT01220167|102161892|FG000|COMPLETED|Period 2||6||
48745456|NCT01220167|102161893|FG001|COMPLETED|Period 2||6||
48745457|NCT01220167|102161894|FG002|COMPLETED|Period 2||6||
48745458|NCT01220167|102161892|FG000|NOT COMPLETED|Period 2||0||
48745459|NCT01220167|102161893|FG001|NOT COMPLETED|Period 2||0||
48745460|NCT01220167|102161894|FG002|NOT COMPLETED|Period 2||0||
48745461|NCT01220167|102161892|FG000|STARTED|Period 3||6||
48745462|NCT01220167|102161893|FG001|STARTED|Period 3||6||
48745463|NCT01220167|102161894|FG002|STARTED|Period 3||6||
48745464|NCT01220167|102161892|FG000|COMPLETED|Period 3||6||
48745465|NCT01220167|102161893|FG001|COMPLETED|Period 3||5||
48745466|NCT01220167|102161894|FG002|COMPLETED|Period 3||6||
48745467|NCT01220167|102161892|FG000|NOT COMPLETED|Period 3||0||
48745468|NCT01220167|102161893|FG001|NOT COMPLETED|Period 3||1||
48745469|NCT01220167|102161894|FG002|NOT COMPLETED|Period 3||0||
48745470|NCT03515824|102161895|FG000|STARTED|Overall Study||3||
48745471|NCT03515824|102161896|FG001|STARTED|Overall Study||4||
48745472|NCT03515824|102161897|FG002|STARTED|Overall Study||15||
48745473|NCT03515824|102161898|FG003|STARTED|Overall Study||0||
48745474|NCT03515824|102161895|FG000|COMPLETED|Overall Study||0||
48745475|NCT03515824|102161896|FG001|COMPLETED|Overall Study||0||
48745476|NCT03515824|102161897|FG002|COMPLETED|Overall Study||0||
48745477|NCT03515824|102161898|FG003|COMPLETED|Overall Study||0||
48745478|NCT03515824|102161895|FG000|NOT COMPLETED|Overall Study||3||
48328929|NCT01573273|101132070|FG006|NOT COMPLETED|MRI 1||0||
48328930|NCT01573273|101132071|FG007|NOT COMPLETED|MRI 1||0||
48328931|NCT01573273|101132072|FG008|NOT COMPLETED|MRI 1||0||
48328932|NCT01573273|101132073|FG009|NOT COMPLETED|MRI 1||0||
48328933|NCT01573273|101132074|FG010|NOT COMPLETED|MRI 1||0||
48328934|NCT01573273|101132075|FG011|NOT COMPLETED|MRI 1||0||
48328935|NCT01573273|101132064|FG000|STARTED|MRI 2||0||
48328936|NCT01573273|101132065|FG001|STARTED|MRI 2||0||
48328937|NCT01573273|101132066|FG002|STARTED|MRI 2||0||
48328938|NCT01573273|101132067|FG003|STARTED|MRI 2||0||
48328939|NCT01573273|101132068|FG004|STARTED|MRI 2||23||
48410250|NCT02329860|101334909|FG000|NOT COMPLETED|Overall Study||106||
48745479|NCT03515824|102161896|FG001|NOT COMPLETED|Overall Study||4||
48745480|NCT03515824|102161897|FG002|NOT COMPLETED|Overall Study||15||
48745481|NCT03515824|102161898|FG003|NOT COMPLETED|Overall Study||0||
48745482|NCT04098809|102161899|FG000|STARTED|Overall Study||27||
48745483|NCT04098809|102161900|FG001|STARTED|Overall Study||25||
48745484|NCT04098809|102161899|FG000|COMPLETED|Overall Study||24||
48745485|NCT04098809|102161900|FG001|COMPLETED|Overall Study||21||
48745486|NCT04098809|102161899|FG000|NOT COMPLETED|Overall Study||3||
48328940|NCT01573273|101132069|FG005|STARTED|MRI 2||18||
48328941|NCT01573273|101132070|FG006|STARTED|MRI 2||0||
48328942|NCT01573273|101132071|FG007|STARTED|MRI 2||0||
48328943|NCT01573273|101132072|FG008|STARTED|MRI 2||0||
48328944|NCT01573273|101132073|FG009|STARTED|MRI 2||0||
48328945|NCT01573273|101132074|FG010|STARTED|MRI 2||27||
48328946|NCT01573273|101132075|FG011|STARTED|MRI 2||28||
48328947|NCT01573273|101132064|FG000|COMPLETED|MRI 2||0||
48328948|NCT01573273|101132065|FG001|COMPLETED|MRI 2||0||
48328949|NCT01573273|101132066|FG002|COMPLETED|MRI 2||0||
48328950|NCT01573273|101132067|FG003|COMPLETED|MRI 2||0||
48328951|NCT01573273|101132068|FG004|COMPLETED|MRI 2||23||
48328952|NCT01573273|101132069|FG005|COMPLETED|MRI 2||18||
48328953|NCT01573273|101132070|FG006|COMPLETED|MRI 2||0||
48328954|NCT01573273|101132071|FG007|COMPLETED|MRI 2||0||
48328955|NCT01573273|101132072|FG008|COMPLETED|MRI 2||0||
48328956|NCT01573273|101132073|FG009|COMPLETED|MRI 2||0||
48328957|NCT01573273|101132074|FG010|COMPLETED|MRI 2||27||
48328958|NCT01573273|101132075|FG011|COMPLETED|MRI 2||28||
48745487|NCT04098809|102161900|FG001|NOT COMPLETED|Overall Study||4||
48745488|NCT00452790|102161901|FG000|STARTED|Infant Series||354||
48745489|NCT00452790|102161902|FG001|STARTED|Infant Series||355||
48745490|NCT00452790|102161901|FG000|Vaccinated Dose 1|Infant Series||353||
48328959|NCT01573273|101132064|FG000|NOT COMPLETED|MRI 2||0||
48328960|NCT01573273|101132065|FG001|NOT COMPLETED|MRI 2||0||
48328961|NCT01573273|101132066|FG002|NOT COMPLETED|MRI 2||0||
48328962|NCT01573273|101132067|FG003|NOT COMPLETED|MRI 2||0||
48328963|NCT01573273|101132068|FG004|NOT COMPLETED|MRI 2||0||
48328964|NCT01573273|101132069|FG005|NOT COMPLETED|MRI 2||0||
48328965|NCT01573273|101132070|FG006|NOT COMPLETED|MRI 2||0||
48745491|NCT00452790|102161902|FG001|Vaccinated Dose 1|Infant Series||353||
48745492|NCT00452790|102161901|FG000|Vaccinated Dose 2|Infant Series||300||
48745493|NCT00452790|102161902|FG001|Vaccinated Dose 2|Infant Series||300||
48745494|NCT00452790|102161901|FG000|Vaccinated Dose 3|Infant Series||221||
48745495|NCT00452790|102161902|FG001|Vaccinated Dose 3|Infant Series||218||
48745496|NCT00452790|102161901|FG000|COMPLETED|Infant Series||219||
48328966|NCT01573273|101132071|FG007|NOT COMPLETED|MRI 2||0||
48328967|NCT01573273|101132072|FG008|NOT COMPLETED|MRI 2||0||
48328968|NCT01573273|101132073|FG009|NOT COMPLETED|MRI 2||0||
48328969|NCT01573273|101132074|FG010|NOT COMPLETED|MRI 2||0||
48328970|NCT01573273|101132075|FG011|NOT COMPLETED|MRI 2||0||
48328971|NCT03047980|101132076|FG000|STARTED|Overall Study||10||
48328972|NCT03047980|101132076|FG000|COMPLETED|Overall Study||9||
48328973|NCT03047980|101132076|FG000|NOT COMPLETED|Overall Study||1||
48328974|NCT03874377|101132077|FG000|STARTED|Overall Study||11||
48328975|NCT03874377|101132077|FG000|COMPLETED|Overall Study||8||
48328976|NCT03874377|101132077|FG000|NOT COMPLETED|Overall Study||3||
48328977|NCT03605680|101132078|FG000|STARTED|SB Placebo Run-in Period (1 Week)||604||
48328978|NCT03605680|101132079|FG001|STARTED|SB Placebo Run-in Period (1 Week)||0||
48745497|NCT00452790|102161902|FG001|COMPLETED|Infant Series||214||
48328979|NCT03605680|101132080|FG002|STARTED|SB Placebo Run-in Period (1 Week)||0||
48328980|NCT03605680|101132081|FG003|STARTED|SB Placebo Run-in Period (1 Week)||0||
48328981|NCT03605680|101132078|FG000|Treated|SB Placebo Run-in Period (1 Week)||584||
48328982|NCT03605680|101132079|FG001|Treated|SB Placebo Run-in Period (1 Week)||0||
48328983|NCT03605680|101132080|FG002|Treated|SB Placebo Run-in Period (1 Week)||0||
48328984|NCT03605680|101132081|FG003|Treated|SB Placebo Run-in Period (1 Week)||0||
48745498|NCT00452790|102161901|FG000|NOT COMPLETED|Infant Series||135||
48745499|NCT00452790|102161902|FG001|NOT COMPLETED|Infant Series||141||
48745500|NCT00452790|102161901|FG000|STARTED|After Infant Series||219||
48745501|NCT00452790|102161902|FG001|STARTED|After Infant Series||214||
48166144|NCT00874432|100728671|FG001|COMPLETED|Overall Study||2||
48166145|NCT00874432|100728672|FG002|COMPLETED|Overall Study||9||
48166146|NCT00874432|100728673|FG003|COMPLETED|Overall Study||11||
48328985|NCT03605680|101132078|FG000|COMPLETED|SB Placebo Run-in Period (1 Week)||466||
48622926|NCT01791595|101859942|FG001|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0||
48622927|NCT01791595|101859943|FG002|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0||
48622928|NCT01791595|101859944|FG003|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0||
48328986|NCT03605680|101132079|FG001|COMPLETED|SB Placebo Run-in Period (1 Week)||0||
48622929|NCT01791595|101859945|FG004|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0||
48622930|NCT01791595|101859946|FG005|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0||
48622931|NCT01791595|101859947|FG006|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||10||
48745502|NCT00452790|102161901|FG000|COMPLETED|After Infant Series||198||
48745503|NCT00452790|102161902|FG001|COMPLETED|After Infant Series||200||
48745504|NCT00452790|102161901|FG000|NOT COMPLETED|After Infant Series||21||
48328987|NCT03605680|101132080|FG002|COMPLETED|SB Placebo Run-in Period (1 Week)||0||
48328988|NCT03605680|101132081|FG003|COMPLETED|SB Placebo Run-in Period (1 Week)||0||
48622932|NCT01716806|101859948|FG000|STARTED|Overall Study||28||
48745505|NCT00452790|102161902|FG001|NOT COMPLETED|After Infant Series||14||
48745506|NCT00452790|102161901|FG000|STARTED|Toddler Dose||198||
48745507|NCT00452790|102161902|FG001|STARTED|Toddler Dose||200||
48745508|NCT00452790|102161901|FG000|COMPLETED|Toddler Dose||198||
48745509|NCT00452790|102161902|FG001|COMPLETED|Toddler Dose||198||
48328989|NCT03605680|101132078|FG000|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||138||
48622933|NCT01716806|101859949|FG001|STARTED|Overall Study||22||
48622934|NCT01716806|101859950|FG002|STARTED|Overall Study||22||
48622935|NCT01716806|101859951|FG003|STARTED|Overall Study||21||
48622936|NCT01716806|101859952|FG004|STARTED|Overall Study||31||
48622937|NCT01716806|101859953|FG005|STARTED|Overall Study||7||
48622938|NCT01716806|101859948|FG000|Received at Least One Dose of Study Drug|Overall Study||27||
48622939|NCT01716806|101859949|FG001|Received at Least One Dose of Study Drug|Overall Study||22||
48328990|NCT03605680|101132079|FG001|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||0||
48328991|NCT03605680|101132080|FG002|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||0||
48328992|NCT03605680|101132081|FG003|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||0||
48328993|NCT03605680|101132078|FG000|STARTED|Double-blind Treatment Period (6 Weeks)||0||
48328994|NCT03605680|101132079|FG001|STARTED|Double-blind Treatment Period (6 Weeks)||154||
48328995|NCT03605680|101132080|FG002|STARTED|Double-blind Treatment Period (6 Weeks)||156||
48328996|NCT03605680|101132081|FG003|STARTED|Double-blind Treatment Period (6 Weeks)||156||
48328997|NCT03605680|101132078|FG000|COMPLETED|Double-blind Treatment Period (6 Weeks)||0||
48328998|NCT03605680|101132079|FG001|COMPLETED|Double-blind Treatment Period (6 Weeks)||110||
48328999|NCT03605680|101132080|FG002|COMPLETED|Double-blind Treatment Period (6 Weeks)||117||
48329000|NCT03605680|101132081|FG003|COMPLETED|Double-blind Treatment Period (6 Weeks)||121||
48329001|NCT03605680|101132078|FG000|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||0||
48329002|NCT03605680|101132079|FG001|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||44||
48329003|NCT03605680|101132080|FG002|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||39||
48329004|NCT03605680|101132081|FG003|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||35||
48329005|NCT00903929|101132082|FG000|STARTED|Overall Study||3||
48329006|NCT00903929|101132083|FG001|STARTED|Overall Study||3||
48329007|NCT00903929|101132084|FG002|STARTED|Overall Study||4||
48329008|NCT00903929|101132085|FG003|STARTED|Overall Study||9||
48329009|NCT00903929|101132082|FG000|COMPLETED|Overall Study||3||
48166147|NCT00874432|100728670|FG000|NOT COMPLETED|Overall Study||3||
48329010|NCT00903929|101132083|FG001|COMPLETED|Overall Study||3||
48329011|NCT00903929|101132084|FG002|COMPLETED|Overall Study||3||
48329012|NCT00903929|101132085|FG003|COMPLETED|Overall Study||6||
48329013|NCT00903929|101132082|FG000|NOT COMPLETED|Overall Study||0||
48329014|NCT00903929|101132083|FG001|NOT COMPLETED|Overall Study||0||
48329015|NCT00903929|101132084|FG002|NOT COMPLETED|Overall Study||1||
48329016|NCT00903929|101132085|FG003|NOT COMPLETED|Overall Study||3||
48329017|NCT02558374|101132086|FG000|STARTED|Overall Study||351||
48329018|NCT02558374|101132087|FG001|STARTED|Overall Study||357||
48329019|NCT02558374|101132086|FG000|COMPLETED|Overall Study||243||
48329020|NCT02558374|101132087|FG001|COMPLETED|Overall Study||314||
48329021|NCT02558374|101132086|FG000|NOT COMPLETED|Overall Study||108||
48622940|NCT01716806|101859950|FG002|Received at Least One Dose of Study Drug|Overall Study||20||
48622941|NCT01716806|101859951|FG003|Received at Least One Dose of Study Drug|Overall Study||21||
48622942|NCT01716806|101859952|FG004|Received at Least One Dose of Study Drug|Overall Study||30||
48745510|NCT00452790|102161901|FG000|NOT COMPLETED|Toddler Dose||0||
48745511|NCT00452790|102161902|FG001|NOT COMPLETED|Toddler Dose||2||
48745512|NCT02741245|102161903|FG000|STARTED|Overall Study||35||
48166148|NCT00874432|100728671|FG001|NOT COMPLETED|Overall Study||2||
48166149|NCT00874432|100728672|FG002|NOT COMPLETED|Overall Study||8||
48166150|NCT00874432|100728673|FG003|NOT COMPLETED|Overall Study||3||
48166151|NCT01547299|100728674|FG000|STARTED|Overall Study||25||
48166152|NCT01547299|100728675|FG001|STARTED|Overall Study||27||
48166153|NCT01547299|100728674|FG000|COMPLETED|Overall Study||23||
48166154|NCT01547299|100728675|FG001|COMPLETED|Overall Study||25||
48166155|NCT01547299|100728674|FG000|NOT COMPLETED|Overall Study||2||
48166156|NCT01547299|100728675|FG001|NOT COMPLETED|Overall Study||2||
48166157|NCT02413463|100728676|FG000|STARTED|Overall Study||30||
48166158|NCT02413463|100728677|FG001|STARTED|Overall Study||30||
48166159|NCT02413463|100728676|FG000|COMPLETED|Overall Study||25||
48166160|NCT02413463|100728677|FG001|COMPLETED|Overall Study||28||
48166161|NCT02413463|100728676|FG000|NOT COMPLETED|Overall Study||5||
48166162|NCT02413463|100728677|FG001|NOT COMPLETED|Overall Study||2||
48166163|NCT04399551|100728678|FG000|STARTED|Overall Study||430|Participants who received study treatment.|
48166164|NCT04399551|100728678|FG000|COMPLETED|Overall Study||402||
48166165|NCT04399551|100728678|FG000|NOT COMPLETED|Overall Study||28||
48745513|NCT02741245|102161904|FG001|STARTED|Overall Study||72||
48745514|NCT02741245|102161905|FG002|STARTED|Overall Study||71||
48745515|NCT02741245|102161906|FG003|STARTED|Overall Study||71||
48745516|NCT02741245|102161907|FG004|STARTED|Overall Study||72||
48745517|NCT02741245|102161903|FG000|COMPLETED|Overall Study||35||
48745518|NCT02741245|102161904|FG001|COMPLETED|Overall Study||71||
48745519|NCT02741245|102161905|FG002|COMPLETED|Overall Study||71||
48745520|NCT02741245|102161906|FG003|COMPLETED|Overall Study||67||
48745521|NCT02741245|102161907|FG004|COMPLETED|Overall Study||70||
48745522|NCT02741245|102161903|FG000|NOT COMPLETED|Overall Study||0||
48745523|NCT02741245|102161904|FG001|NOT COMPLETED|Overall Study||1||
48745524|NCT02741245|102161905|FG002|NOT COMPLETED|Overall Study||0||
48745525|NCT02741245|102161906|FG003|NOT COMPLETED|Overall Study||4||
48745526|NCT02741245|102161907|FG004|NOT COMPLETED|Overall Study||2||
48745527|NCT03637660|102161908|FG000|STARTED|Overall Study||124||
48745528|NCT03637660|102161909|FG001|STARTED|Overall Study||125||
48745529|NCT03637660|102161908|FG000|COMPLETED|Overall Study||82||
48745530|NCT03637660|102161909|FG001|COMPLETED|Overall Study||82||
48745531|NCT03637660|102161908|FG000|NOT COMPLETED|Overall Study||42||
48745532|NCT03637660|102161909|FG001|NOT COMPLETED|Overall Study||43||
48745533|NCT00428948|102161910|FG000|STARTED|Overall Study||961||
48745534|NCT00428948|102161911|FG001|STARTED|Overall Study||484||
48745535|NCT00428948|102161910|FG000|Received Treatment|Overall Study||961||
48166166|NCT01078662|100728679|FG000|STARTED|Overall Study||62||
48166167|NCT01078662|100728680|FG001|STARTED|Overall Study||193||
48166168|NCT01078662|100728681|FG002|STARTED|Overall Study||23||
48166169|NCT01078662|100728682|FG003|STARTED|Overall Study||8||
48166170|NCT01078662|100728683|FG004|STARTED|Overall Study||12||
48166171|NCT01078662|100728679|FG000|COMPLETED|Overall Study||4||
48166172|NCT01078662|100728680|FG001|COMPLETED|Overall Study||25||
48745536|NCT00428948|102161911|FG001|Received Treatment|Overall Study||483||
48745537|NCT00428948|102161910|FG000|COMPLETED|Overall Study||740||
48745538|NCT00428948|102161911|FG001|COMPLETED|Overall Study||417||
48745539|NCT00428948|102161910|FG000|NOT COMPLETED|Overall Study||221||
48745540|NCT00428948|102161911|FG001|NOT COMPLETED|Overall Study||67||
48745541|NCT00479336|102161912|FG000|STARTED|Overall Study||27||
48745542|NCT00479336|102161913|FG001|STARTED|Overall Study||26||
48745543|NCT00479336|102161914|FG002|STARTED|Overall Study||25||
48166173|NCT01078662|100728681|FG002|COMPLETED|Overall Study||2||
48166174|NCT01078662|100728682|FG003|COMPLETED|Overall Study||1||
48166175|NCT01078662|100728683|FG004|COMPLETED|Overall Study||1||
48166176|NCT01078662|100728679|FG000|NOT COMPLETED|Overall Study||58||
48166177|NCT01078662|100728680|FG001|NOT COMPLETED|Overall Study||168||
48745544|NCT00479336|102161915|FG003|STARTED|Overall Study||26||
48166178|NCT01078662|100728681|FG002|NOT COMPLETED|Overall Study||21||
48166179|NCT01078662|100728682|FG003|NOT COMPLETED|Overall Study||7||
48166180|NCT01078662|100728683|FG004|NOT COMPLETED|Overall Study||11||
48166181|NCT02578914|100728684|FG000|STARTED|Overall Study||50||
48166182|NCT02578914|100728685|FG001|STARTED|Overall Study||50||
48166183|NCT02578914|100728684|FG000|COMPLETED|Overall Study||48||
48745545|NCT00479336|102161912|FG000|COMPLETED|Overall Study||23||
48166184|NCT02578914|100728685|FG001|COMPLETED|Overall Study||50||
48166185|NCT02578914|100728684|FG000|NOT COMPLETED|Overall Study||2||
48166186|NCT02578914|100728685|FG001|NOT COMPLETED|Overall Study||0||
48166187|NCT02006121|100728686|FG000|STARTED|Double Blind Phase||54||
48166188|NCT02006121|100728687|FG001|STARTED|Double Blind Phase||53||
48166189|NCT02006121|100728686|FG000|COMPLETED|Double Blind Phase||42||
48166190|NCT02006121|100728687|FG001|COMPLETED|Double Blind Phase||29||
48166191|NCT02006121|100728686|FG000|NOT COMPLETED|Double Blind Phase||12||
48166192|NCT02006121|100728687|FG001|NOT COMPLETED|Double Blind Phase||24||
48166193|NCT02006121|100728686|FG000|STARTED|Open Label Phase||84||
48166194|NCT02006121|100728687|FG001|STARTED|Open Label Phase||0||
48329022|NCT02558374|101132087|FG001|NOT COMPLETED|Overall Study||43||
48329023|NCT01106846|101132088|FG000|STARTED|Overall Study||12||
48329024|NCT01106846|101132089|FG001|STARTED|Overall Study||10||
48329025|NCT01106846|101132088|FG000|COMPLETED|Overall Study||12||
48329026|NCT01106846|101132089|FG001|COMPLETED|Overall Study||9||
48622943|NCT01716806|101859953|FG005|Received at Least One Dose of Study Drug|Overall Study||7||
48622944|NCT01716806|101859948|FG000|COMPLETED|Overall Study||0||
48622945|NCT01716806|101859949|FG001|COMPLETED|Overall Study||0||
48622946|NCT01716806|101859950|FG002|COMPLETED|Overall Study||0||
48745546|NCT00479336|102161913|FG001|COMPLETED|Overall Study||20||
48745547|NCT00479336|102161914|FG002|COMPLETED|Overall Study||24||
48745548|NCT00479336|102161915|FG003|COMPLETED|Overall Study||21||
48745549|NCT00479336|102161912|FG000|NOT COMPLETED|Overall Study||4||
48745550|NCT00479336|102161913|FG001|NOT COMPLETED|Overall Study||6||
48745551|NCT00479336|102161914|FG002|NOT COMPLETED|Overall Study||1||
48745552|NCT00479336|102161915|FG003|NOT COMPLETED|Overall Study||5||
48622947|NCT01716806|101859951|FG003|COMPLETED|Overall Study||0||
48622948|NCT01716806|101859952|FG004|COMPLETED|Overall Study||0||
48622949|NCT01716806|101859953|FG005|COMPLETED|Overall Study||0||
48622950|NCT01716806|101859948|FG000|NOT COMPLETED|Overall Study||28||
48622951|NCT01716806|101859949|FG001|NOT COMPLETED|Overall Study||22||
48622952|NCT01716806|101859950|FG002|NOT COMPLETED|Overall Study||22||
48622953|NCT01716806|101859951|FG003|NOT COMPLETED|Overall Study||21||
48622954|NCT01716806|101859952|FG004|NOT COMPLETED|Overall Study||31||
48622955|NCT01716806|101859953|FG005|NOT COMPLETED|Overall Study||7||
48622956|NCT01462630|101859954|FG000|STARTED|Overall Study||29||
48622957|NCT01462630|101859954|FG000|COMPLETED|Overall Study||22||
48622958|NCT01462630|101859954|FG000|NOT COMPLETED|Overall Study||7||
48745553|NCT01284517|102161916|FG000|STARTED|Overall Study||180||
48745554|NCT01284517|102161917|FG001|STARTED|Overall Study||176||
48745555|NCT01284517|102161916|FG000|COMPLETED|Overall Study||148||
48745556|NCT01284517|102161917|FG001|COMPLETED|Overall Study||140||
48329027|NCT01106846|101132088|FG000|NOT COMPLETED|Overall Study||0||
48329028|NCT01106846|101132089|FG001|NOT COMPLETED|Overall Study||1||
48745557|NCT01284517|102161916|FG000|NOT COMPLETED|Overall Study||32||
48745558|NCT01284517|102161917|FG001|NOT COMPLETED|Overall Study||36||
48745559|NCT02510001|102161918|FG000|STARTED|Overall Study||6||
48745560|NCT02510001|102161919|FG001|STARTED|Overall Study||5||
48745561|NCT02510001|102161920|FG002|STARTED|Overall Study||6||
48745562|NCT02510001|102161921|FG003|STARTED|Overall Study||8||
48745563|NCT02510001|102161922|FG004|STARTED|Overall Study||8||
48329029|NCT02079987|101132090|FG000|STARTED|Overall Study||557||
48329030|NCT02079987|101132091|FG001|STARTED|Overall Study||544||
48329031|NCT02079987|101132090|FG000|COMPLETED|Overall Study||557||
48329032|NCT02079987|101132091|FG001|COMPLETED|Overall Study||544||
48329033|NCT02079987|101132090|FG000|NOT COMPLETED|Overall Study||0||
48329034|NCT02079987|101132091|FG001|NOT COMPLETED|Overall Study||0||
48622959|NCT01439035|101859955|FG000|STARTED|Overall Study||6||
48622960|NCT01439035|101859955|FG000|COMPLETED|Overall Study||6||
48622961|NCT01439035|101859955|FG000|NOT COMPLETED|Overall Study||0||
48622962|NCT00457730|101859956|FG000|STARTED|Overall Study||18||
48166195|NCT02006121|100728686|FG000|COMPLETED|Open Label Phase||59||
48166196|NCT02006121|100728687|FG001|COMPLETED|Open Label Phase||0||
48166197|NCT02006121|100728686|FG000|NOT COMPLETED|Open Label Phase||25||
48166198|NCT02006121|100728687|FG001|NOT COMPLETED|Open Label Phase||0||
48166199|NCT01160484|100728688|FG000|STARTED|Overall Study||40||
48166200|NCT01160484|100728688|FG000|COMPLETED|Overall Study||22||
48166201|NCT01160484|100728688|FG000|NOT COMPLETED|Overall Study||18||
48166202|NCT01336959|100728689|FG000|STARTED|Overall Study||8||
48166203|NCT01336959|100728690|FG001|STARTED|Overall Study||42||
48166204|NCT01336959|100728691|FG002|STARTED|Overall Study||41||
48166205|NCT01336959|100728689|FG000|COMPLETED|Overall Study||8||
48166206|NCT01336959|100728690|FG001|COMPLETED|Overall Study||37||
48329035|NCT03787472|101132092|FG000|STARTED|Period 1||23||
48745564|NCT02510001|102161923|FG005|STARTED|Overall Study||7||
48745565|NCT02510001|102161924|FG006|STARTED|Overall Study||5||
48745566|NCT02510001|102161925|FG007|STARTED|Overall Study||37||
48329036|NCT03787472|101132093|FG001|STARTED|Period 1||22||
48329037|NCT03787472|101132092|FG000|COMPLETED|Period 1||23||
48622963|NCT00457730|101859957|FG001|STARTED|Overall Study||20||
48622964|NCT00457730|101859956|FG000|COMPLETED|Overall Study||14||
48622965|NCT00457730|101859957|FG001|COMPLETED|Overall Study||19||
48622966|NCT00457730|101859956|FG000|NOT COMPLETED|Overall Study||4||
48622967|NCT00457730|101859957|FG001|NOT COMPLETED|Overall Study||1||
48622968|NCT03440619|101859958|FG000|STARTED|Overall Study||28||
48622969|NCT03440619|101859958|FG000|COMPLETED|Overall Study||28||
48745567|NCT02510001|102161918|FG000|COMPLETED|Overall Study||6||
48745568|NCT02510001|102161919|FG001|COMPLETED|Overall Study||5||
48329038|NCT03787472|101132093|FG001|COMPLETED|Period 1||22||
48329039|NCT03787472|101132092|FG000|NOT COMPLETED|Period 1||0||
48329040|NCT03787472|101132093|FG001|NOT COMPLETED|Period 1||0||
48329041|NCT03787472|101132092|FG000|STARTED|Period 2||23||
48329042|NCT03787472|101132093|FG001|STARTED|Period 2||22||
48329043|NCT03787472|101132092|FG000|COMPLETED|Period 2||23||
48329044|NCT03787472|101132093|FG001|COMPLETED|Period 2||22||
48329045|NCT03787472|101132092|FG000|NOT COMPLETED|Period 2||0||
48329046|NCT03787472|101132093|FG001|NOT COMPLETED|Period 2||0||
48329047|NCT01035905|101132094|FG000|STARTED|Overall Study||32||
48622970|NCT03440619|101859958|FG000|NOT COMPLETED|Overall Study||0||
48622971|NCT03498521|101859959|FG000|STARTED|Overall Study||326||
48622972|NCT03498521|101859960|FG001|STARTED|Overall Study||110||
48622973|NCT03498521|101859961|FG002|STARTED|Overall Study||92||
48622974|NCT03498521|101859959|FG000|COMPLETED|Overall Study||0||
48622975|NCT03498521|101859960|FG001|COMPLETED|Overall Study||0||
48622976|NCT03498521|101859961|FG002|COMPLETED|Overall Study||0||
48622977|NCT03498521|101859959|FG000|NOT COMPLETED|Overall Study||326||
48622978|NCT03498521|101859960|FG001|NOT COMPLETED|Overall Study||110||
48622979|NCT03498521|101859961|FG002|NOT COMPLETED|Overall Study||92||
48622980|NCT04940156|101859962|FG000|STARTED|Overall Study||5||
48329048|NCT01035905|101132095|FG001|STARTED|Overall Study||31||
48410251|NCT02329860|101334910|FG001|NOT COMPLETED|Overall Study||26||
48410252|NCT01222416|101334911|FG000|STARTED|Overall Study||50||
48410253|NCT01222416|101334912|FG001|STARTED|Overall Study||0||
48410254|NCT01222416|101334911|FG000|COMPLETED|Overall Study||30||
48410255|NCT01222416|101334912|FG001|COMPLETED|Overall Study||0||
48410256|NCT01222416|101334911|FG000|NOT COMPLETED|Overall Study||20||
48410257|NCT01222416|101334912|FG001|NOT COMPLETED|Overall Study||0||
48410258|NCT03140722|101334913|FG000|STARTED|Overall Study||0||
48410259|NCT03140722|101334914|FG001|STARTED|Overall Study||2||
48410260|NCT03140722|101334913|FG000|COMPLETED|Overall Study||0||
48410261|NCT03140722|101334914|FG001|COMPLETED|Overall Study||2||
48410262|NCT03140722|101334913|FG000|NOT COMPLETED|Overall Study||0||
48410263|NCT03140722|101334914|FG001|NOT COMPLETED|Overall Study||0||
48410264|NCT03189563|101334915|FG000|STARTED|Overall Study||20||
48410265|NCT03189563|101334916|FG001|STARTED|Overall Study||21||
48622981|NCT04940156|101859963|FG001|STARTED|Overall Study||1||
48622982|NCT04940156|101859962|FG000|COMPLETED|Overall Study||5||
48622983|NCT04940156|101859963|FG001|COMPLETED|Overall Study||1||
48622984|NCT04940156|101859962|FG000|NOT COMPLETED|Overall Study||0||
48622985|NCT04940156|101859963|FG001|NOT COMPLETED|Overall Study||0||
48622986|NCT03946059|101859964|FG000|STARTED|Overall Study||13||
48622987|NCT03946059|101859965|FG001|STARTED|Overall Study||12||
48622988|NCT03946059|101859964|FG000|COMPLETED|Overall Study||13||
48622989|NCT03946059|101859965|FG001|COMPLETED|Overall Study||11||
48745569|NCT02510001|102161920|FG002|COMPLETED|Overall Study||6||
48745570|NCT02510001|102161921|FG003|COMPLETED|Overall Study||6||
48745571|NCT02510001|102161922|FG004|COMPLETED|Overall Study||4||
48329049|NCT01035905|101132094|FG000|COMPLETED|Overall Study||31||
48329050|NCT01035905|101132095|FG001|COMPLETED|Overall Study||30||
48329051|NCT01035905|101132094|FG000|NOT COMPLETED|Overall Study||1||
48329052|NCT01035905|101132095|FG001|NOT COMPLETED|Overall Study||1||
48329053|NCT01902966|101132096|FG000|STARTED|Overall Study||5||
48329054|NCT01902966|101132096|FG000|COMPLETED|Overall Study||2||
48329055|NCT01902966|101132096|FG000|NOT COMPLETED|Overall Study||3||
48329056|NCT00825565|101132097|FG000|STARTED|Overall Study||8||
48329057|NCT00825565|101132097|FG000|COMPLETED|Overall Study||8||
48329058|NCT00825565|101132097|FG000|NOT COMPLETED|Overall Study||0||
48410266|NCT03189563|101334917|FG002|STARTED|Overall Study||20||
48410267|NCT03189563|101334915|FG000|ITT Population|Overall Study||20||
48410268|NCT03189563|101334916|FG001|ITT Population|Overall Study||21||
48410269|NCT03189563|101334917|FG002|ITT Population|Overall Study||19||
48410270|NCT03189563|101334915|FG000|Safety Population|Overall Study||20||
48622990|NCT03946059|101859964|FG000|NOT COMPLETED|Overall Study||0||
48622991|NCT03946059|101859965|FG001|NOT COMPLETED|Overall Study||1||
48622992|NCT04421040|101859966|FG000|STARTED|Overall Study||24||
48329059|NCT01515787|101132098|FG000|STARTED|Overall Study||597||
48329060|NCT01515787|101132099|FG001|STARTED|Overall Study||597||
48410271|NCT03189563|101334916|FG001|Safety Population|Overall Study||21||
48410272|NCT03189563|101334917|FG002|Safety Population|Overall Study||19||
48410273|NCT03189563|101334915|FG000|COMPLETED|Overall Study||19||
48410274|NCT03189563|101334916|FG001|COMPLETED|Overall Study||20||
48622993|NCT04421040|101859966|FG000|COMPLETED|Overall Study||24||
48622994|NCT04421040|101859966|FG000|NOT COMPLETED|Overall Study||0||
48410275|NCT03189563|101334917|FG002|COMPLETED|Overall Study||18||
48410276|NCT03189563|101334915|FG000|NOT COMPLETED|Overall Study||1||
48410277|NCT03189563|101334916|FG001|NOT COMPLETED|Overall Study||1||
48410278|NCT03189563|101334917|FG002|NOT COMPLETED|Overall Study||2||
48410279|NCT00606229|101334918|FG000|STARTED|Overall Study||41||
48410280|NCT00606229|101334918|FG000|COMPLETED|Overall Study||19||
48410281|NCT00606229|101334918|FG000|NOT COMPLETED|Overall Study||22||
48410282|NCT00398086|101334919|FG000|STARTED|Overall Study||20||
48410283|NCT00398086|101334920|FG001|STARTED|Overall Study||44||
48410284|NCT00398086|101334921|FG002|STARTED|Overall Study||3||
48410285|NCT00398086|101334919|FG000|Phase 1, Dose Escalation Population|Overall Study||20||
48410286|NCT00398086|101334920|FG001|Phase 1, Dose Escalation Population|Overall Study||7||
48410287|NCT00398086|101334921|FG002|Phase 1, Dose Escalation Population|Overall Study||3||
48410288|NCT00398086|101334919|FG000|COMPLETED|Overall Study||11||
48410289|NCT00398086|101334920|FG001|COMPLETED|Overall Study||21||
48410290|NCT00398086|101334921|FG002|COMPLETED|Overall Study||1||
48410291|NCT00398086|101334919|FG000|NOT COMPLETED|Overall Study||9||
48410292|NCT00398086|101334920|FG001|NOT COMPLETED|Overall Study||23||
48410293|NCT00398086|101334921|FG002|NOT COMPLETED|Overall Study||2||
48410294|NCT02870348|101334922|FG000|STARTED|Overall Study||4||
48410295|NCT02870348|101334922|FG000|COMPLETED|Overall Study||0||
48410296|NCT02870348|101334922|FG000|NOT COMPLETED|Overall Study||4||
48410297|NCT04111185|101334923|FG000|STARTED|Overall Study||17||
48410298|NCT04111185|101334924|FG001|STARTED|Overall Study||14||
48410299|NCT04111185|101334923|FG000|COMPLETED|Overall Study||17||
48410300|NCT04111185|101334924|FG001|COMPLETED|Overall Study||14||
48410301|NCT04111185|101334923|FG000|NOT COMPLETED|Overall Study||0||
48410302|NCT04111185|101334924|FG001|NOT COMPLETED|Overall Study||0||
48410303|NCT01307046|101334925|FG000|STARTED|Overall Study||166||
48410304|NCT01307046|101334926|FG001|STARTED|Overall Study||170||
48745572|NCT02510001|102161923|FG005|COMPLETED|Overall Study||5||
48745573|NCT02510001|102161924|FG006|COMPLETED|Overall Study||3||
48745574|NCT02510001|102161925|FG007|COMPLETED|Overall Study||30||
48745575|NCT02510001|102161918|FG000|NOT COMPLETED|Overall Study||0||
48745576|NCT02510001|102161919|FG001|NOT COMPLETED|Overall Study||0||
48745577|NCT02510001|102161920|FG002|NOT COMPLETED|Overall Study||0||
48745578|NCT02510001|102161921|FG003|NOT COMPLETED|Overall Study||2||
48745579|NCT02510001|102161922|FG004|NOT COMPLETED|Overall Study||4||
48745580|NCT02510001|102161923|FG005|NOT COMPLETED|Overall Study||2||
48745581|NCT02510001|102161924|FG006|NOT COMPLETED|Overall Study||2||
48745582|NCT02510001|102161925|FG007|NOT COMPLETED|Overall Study||7||
48745583|NCT02148523|102161926|FG000|STARTED|Overall Study||67||
48745584|NCT02148523|102161927|FG001|STARTED|Overall Study||67||
48745585|NCT02148523|102161928|FG002|STARTED|Overall Study||67||
48745586|NCT02148523|102161926|FG000|COMPLETED|Overall Study||67||
48745587|NCT02148523|102161927|FG001|COMPLETED|Overall Study||67||
48745588|NCT02148523|102161928|FG002|COMPLETED|Overall Study||67||
48745589|NCT02148523|102161926|FG000|NOT COMPLETED|Overall Study||0||
48410305|NCT01307046|101334925|FG000|COMPLETED|Overall Study||154||
48410306|NCT01307046|101334926|FG001|COMPLETED|Overall Study||159||
48410307|NCT01307046|101334925|FG000|NOT COMPLETED|Overall Study||12||
48410308|NCT01307046|101334926|FG001|NOT COMPLETED|Overall Study||11||
48410309|NCT00721357|101334927|FG000|STARTED|Overall Study||15||
48410310|NCT00721357|101334928|FG001|STARTED|Overall Study||15||
48410311|NCT00721357|101334927|FG000|COMPLETED|Overall Study||15||
48410312|NCT00721357|101334928|FG001|COMPLETED|Overall Study||15||
48410313|NCT00721357|101334927|FG000|NOT COMPLETED|Overall Study||0||
48410314|NCT00721357|101334928|FG001|NOT COMPLETED|Overall Study||0||
48410315|NCT01800162|101334929|FG000|STARTED|Overall Study||1|Study ended early only 1 subject randomized to uterine evacuation.|
48410316|NCT01800162|101334930|FG001|STARTED|Overall Study||0|Study ended early only 1 subject randomized to uterine evacuation.|
48410317|NCT01800162|101334931|FG002|STARTED|Overall Study||1|Study ended early only 1 subject randomized to uterine evacuation.|
48745590|NCT02148523|102161927|FG001|NOT COMPLETED|Overall Study||0||
48745591|NCT02148523|102161928|FG002|NOT COMPLETED|Overall Study||0||
48745592|NCT00539994|102161929|FG000|STARTED|Overall Study||23||
48745593|NCT00539994|102161930|FG001|STARTED|Overall Study||19||
48745594|NCT00539994|102161931|FG002|STARTED|Overall Study||15||
48745595|NCT00539994|102161929|FG000|COMPLETED|Overall Study||20||
48745596|NCT00539994|102161930|FG001|COMPLETED|Overall Study||18||
48745597|NCT00539994|102161931|FG002|COMPLETED|Overall Study||13||
48745598|NCT00539994|102161929|FG000|NOT COMPLETED|Overall Study||3||
48745599|NCT00539994|102161930|FG001|NOT COMPLETED|Overall Study||1||
48745600|NCT00539994|102161931|FG002|NOT COMPLETED|Overall Study||2||
48410318|NCT01800162|101334929|FG000|COMPLETED|Overall Study||1||
48410319|NCT01800162|101334930|FG001|COMPLETED|Overall Study||0||
48410320|NCT01800162|101334931|FG002|COMPLETED|Overall Study||1||
48410321|NCT01800162|101334929|FG000|NOT COMPLETED|Overall Study||0||
48410322|NCT01800162|101334930|FG001|NOT COMPLETED|Overall Study||0||
48410323|NCT01800162|101334931|FG002|NOT COMPLETED|Overall Study||0||
48410324|NCT05302804|101334932|FG000|STARTED|Overall Study||6||
48410325|NCT05302804|101334933|FG001|STARTED|Overall Study||6||
48410326|NCT05302804|101334932|FG000|COMPLETED|Overall Study||6||
48410327|NCT05302804|101334933|FG001|COMPLETED|Overall Study||6||
48410328|NCT05302804|101334932|FG000|NOT COMPLETED|Overall Study||0||
48745601|NCT01227980|102161932|FG000|STARTED|Overall Study||40||
48745602|NCT01227980|102161933|FG001|STARTED|Overall Study||30||
48745603|NCT01227980|102161932|FG000|Scripts Challenge Sessions|Overall Study||26||
48745604|NCT01227980|102161933|FG001|Scripts Challenge Sessions|Overall Study||25||
48745605|NCT01227980|102161932|FG000|Measure Drug Level Concentration|Overall Study||10||
48745606|NCT01227980|102161933|FG001|Measure Drug Level Concentration|Overall Study||0||
48745607|NCT01227980|102161932|FG000|COMPLETED|Overall Study||38||
48745608|NCT01227980|102161933|FG001|COMPLETED|Overall Study||25||
48745609|NCT01227980|102161932|FG000|NOT COMPLETED|Overall Study||2||
48745610|NCT01227980|102161933|FG001|NOT COMPLETED|Overall Study||5||
48745611|NCT02537717|102161934|FG000|STARTED|Overall Study||17||
48745612|NCT02537717|102161934|FG000|COMPLETED|Overall Study||17||
48745613|NCT02537717|102161934|FG000|NOT COMPLETED|Overall Study||0||
48745614|NCT00669214|102161935|FG000|STARTED|Double-Blind Treatment Period (Week 12)||27||
48745615|NCT00669214|102161936|FG001|STARTED|Double-Blind Treatment Period (Week 12)||62||
48745616|NCT00669214|102161935|FG000|COMPLETED|Double-Blind Treatment Period (Week 12)||22||
48745617|NCT00669214|102161936|FG001|COMPLETED|Double-Blind Treatment Period (Week 12)||55||
48745618|NCT00669214|102161935|FG000|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||5||
48745619|NCT00669214|102161936|FG001|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||7||
48745620|NCT00669214|102161935|FG000|STARTED|Open-Label Treatment Period (Week 24)||22||
48745621|NCT00669214|102161936|FG001|STARTED|Open-Label Treatment Period (Week 24)||55||
48745622|NCT00669214|102161935|FG000|COMPLETED|Open-Label Treatment Period (Week 24)||18||
48745623|NCT00669214|102161936|FG001|COMPLETED|Open-Label Treatment Period (Week 24)||46||
48745624|NCT00669214|102161935|FG000|NOT COMPLETED|Open-Label Treatment Period (Week 24)||4||
48745625|NCT00669214|102161936|FG001|NOT COMPLETED|Open-Label Treatment Period (Week 24)||9||
48745626|NCT01100320|102161937|FG000|STARTED|Period 1||43||
48745627|NCT01100320|102161938|FG001|STARTED|Period 1||45||
48745628|NCT01100320|102161937|FG000|COMPLETED|Period 1||38||
48745629|NCT01100320|102161938|FG001|COMPLETED|Period 1||38||
48745630|NCT01100320|102161937|FG000|NOT COMPLETED|Period 1||5||
48745631|NCT01100320|102161938|FG001|NOT COMPLETED|Period 1||7||
48745632|NCT01100320|102161937|FG000|STARTED|Period 2||38||
48410329|NCT05302804|101334933|FG001|NOT COMPLETED|Overall Study||0||
48410330|NCT04037462|101334934|FG000|STARTED|Overall Study||2||
48622995|NCT01765296|101859967|FG000|STARTED|Overall Study||71||
48622996|NCT01765296|101859968|FG001|STARTED|Overall Study||146||
48622997|NCT01765296|101859969|FG002|STARTED|Overall Study||145||
48622998|NCT01765296|101859967|FG000|COMPLETED|Overall Study||66||
48622999|NCT01765296|101859968|FG001|COMPLETED|Overall Study||126||
48623000|NCT01765296|101859969|FG002|COMPLETED|Overall Study||132||
48623001|NCT01765296|101859967|FG000|NOT COMPLETED|Overall Study||5||
48623002|NCT01765296|101859968|FG001|NOT COMPLETED|Overall Study||20||
48623003|NCT01765296|101859969|FG002|NOT COMPLETED|Overall Study||13||
48623004|NCT04210986|101859970|FG000|STARTED|Overall Study||34||
48623005|NCT04210986|101859971|FG001|STARTED|Overall Study||40||
48623006|NCT04210986|101859970|FG000|COMPLETED|Overall Study||25|Protocol completion defined as completion of the final in-person and/or remote assessment, or knowledge of conversion to an alternative treatment modality as defined in the protocol.|
48623007|NCT04210986|101859971|FG001|COMPLETED|Overall Study||35|Protocol completion defined as completion of the final in-person and/or remote assessment, or knowledge of conversion to an alternative treatment modality as defined in the protocol.|
48623008|NCT04210986|101859970|FG000|NOT COMPLETED|Overall Study||9||
48623009|NCT04210986|101859971|FG001|NOT COMPLETED|Overall Study||5||
48745633|NCT01100320|102161938|FG001|STARTED|Period 2||38||
48623010|NCT03028142|101859972|FG000|STARTED|Overall Study||5||
48623011|NCT03028142|101859973|FG001|STARTED|Overall Study||5||
48623012|NCT03028142|101859974|FG002|STARTED|Overall Study||6||
48623013|NCT03028142|101859975|FG003|STARTED|Overall Study||4||
48745634|NCT01100320|102161937|FG000|COMPLETED|Period 2||37||
48745635|NCT01100320|102161938|FG001|COMPLETED|Period 2||37||
48745636|NCT01100320|102161937|FG000|NOT COMPLETED|Period 2||1||
48745637|NCT01100320|102161938|FG001|NOT COMPLETED|Period 2||1||
48745638|NCT01216683|102161939|FG000|STARTED|Induction||65||
48410331|NCT04037462|101334934|FG000|COMPLETED|Overall Study||2||
48410332|NCT04037462|101334934|FG000|NOT COMPLETED|Overall Study||0||
48623014|NCT03028142|101859976|FG004|STARTED|Overall Study||6||
48623015|NCT03028142|101859977|FG005|STARTED|Overall Study||4||
48623016|NCT03028142|101859972|FG000|COMPLETED|Overall Study||4||
48623017|NCT03028142|101859973|FG001|COMPLETED|Overall Study||4||
48623018|NCT03028142|101859974|FG002|COMPLETED|Overall Study||6||
48623019|NCT03028142|101859975|FG003|COMPLETED|Overall Study||4||
48623020|NCT03028142|101859976|FG004|COMPLETED|Overall Study||5||
48623021|NCT03028142|101859977|FG005|COMPLETED|Overall Study||3||
48623022|NCT03028142|101859972|FG000|NOT COMPLETED|Overall Study||1||
48623023|NCT03028142|101859973|FG001|NOT COMPLETED|Overall Study||1||
48623024|NCT03028142|101859974|FG002|NOT COMPLETED|Overall Study||0||
48623025|NCT03028142|101859975|FG003|NOT COMPLETED|Overall Study||0||
48623026|NCT03028142|101859976|FG004|NOT COMPLETED|Overall Study||1||
48623027|NCT03028142|101859977|FG005|NOT COMPLETED|Overall Study||1||
48745639|NCT01216683|102161940|FG001|STARTED|Induction||99||
48745640|NCT01216683|102161941|FG002|STARTED|Induction||125||
48410333|NCT00686699|101334935|FG000|STARTED|Treatment Period 1||4||
48745641|NCT01216683|102161939|FG000|Received Treatment and Assessed for Toxicities|Induction||65||
48745642|NCT01216683|102161940|FG001|Received Treatment and Assessed for Toxicities|Induction||93||
48745643|NCT01216683|102161941|FG002|Received Treatment and Assessed for Toxicities|Induction||122||
48745644|NCT01216683|102161939|FG000|Eligible and Treated|Induction||59||
48745645|NCT01216683|102161940|FG001|Eligible and Treated|Induction||85||
48745646|NCT01216683|102161941|FG002|Eligible and Treated|Induction||114||
48745647|NCT01216683|102161939|FG000|Included in the Primary Analysis of Complete Remission Rate During Induction Treatment|Induction||48||
48745648|NCT01216683|102161940|FG001|Included in the Primary Analysis of Complete Remission Rate During Induction Treatment|Induction||85||
48745649|NCT01216683|102161941|FG002|Included in the Primary Analysis of Complete Remission Rate During Induction Treatment|Induction||89||
48623028|NCT03160716|101859978|FG000|STARTED|Overall Study||60||
48623029|NCT03160716|101859978|FG000|COMPLETED|Overall Study||59||
48623030|NCT03160716|101859978|FG000|NOT COMPLETED|Overall Study||1||
48745650|NCT01216683|102161939|FG000|COMPLETED|Induction||61||
48745651|NCT01216683|102161940|FG001|COMPLETED|Induction||80||
48623031|NCT00773357|101859979|FG000|STARTED|Overall Study||50||
48623032|NCT00773357|101859980|FG001|STARTED|Overall Study||50||
48623033|NCT00773357|101859979|FG000|COMPLETED|Overall Study||50||
48623034|NCT00773357|101859980|FG001|COMPLETED|Overall Study||50||
48623035|NCT00773357|101859979|FG000|NOT COMPLETED|Overall Study||0||
48623036|NCT00773357|101859980|FG001|NOT COMPLETED|Overall Study||0||
48623037|NCT02779491|101859981|FG000|STARTED|Overall Study||32||
48623038|NCT02779491|101859982|FG001|STARTED|Overall Study||27||
48745652|NCT01216683|102161941|FG002|COMPLETED|Induction||104||
48623039|NCT02779491|101859983|FG002|STARTED|Overall Study||18||
48623040|NCT02779491|101859984|FG003|STARTED|Overall Study||17||
48623041|NCT02779491|101859981|FG000|COMPLETED|Overall Study||32||
48623042|NCT02779491|101859982|FG001|COMPLETED|Overall Study||26||
48623043|NCT02779491|101859983|FG002|COMPLETED|Overall Study||17||
48623044|NCT02779491|101859984|FG003|COMPLETED|Overall Study||15||
48623045|NCT02779491|101859981|FG000|NOT COMPLETED|Overall Study||0||
48623046|NCT02779491|101859982|FG001|NOT COMPLETED|Overall Study||1||
48623047|NCT02779491|101859983|FG002|NOT COMPLETED|Overall Study||1||
48623048|NCT02779491|101859984|FG003|NOT COMPLETED|Overall Study||2||
48623049|NCT00948090|101859985|FG000|STARTED|Overall Study||65||
48623050|NCT00948090|101859986|FG001|STARTED|Overall Study||1||
48745653|NCT01216683|102161939|FG000|NOT COMPLETED|Induction||4||
48745654|NCT01216683|102161940|FG001|NOT COMPLETED|Induction||19||
48745655|NCT01216683|102161941|FG002|NOT COMPLETED|Induction||21||
48745656|NCT01216683|102161939|FG000|STARTED|Continuation||59||
48745657|NCT01216683|102161940|FG001|STARTED|Continuation||71||
48745658|NCT01216683|102161941|FG002|STARTED|Continuation||94||
48745659|NCT01216683|102161939|FG000|Received Continuation Treatment|Continuation||59||
48745660|NCT01216683|102161940|FG001|Received Continuation Treatment|Continuation||70||
48745661|NCT01216683|102161941|FG002|Received Continuation Treatment|Continuation||89||
48745662|NCT01216683|102161939|FG000|COMPLETED|Continuation||44||
48745663|NCT01216683|102161940|FG001|COMPLETED|Continuation||56||
48745664|NCT01216683|102161941|FG002|COMPLETED|Continuation||51||
48745665|NCT01216683|102161939|FG000|NOT COMPLETED|Continuation||15||
48745666|NCT01216683|102161940|FG001|NOT COMPLETED|Continuation||15||
48745667|NCT01216683|102161941|FG002|NOT COMPLETED|Continuation||43||
48745668|NCT02493036|102161942|FG000|STARTED|Overall Study||17||
48745669|NCT02493036|102161943|FG001|STARTED|Overall Study||20||
48745670|NCT02493036|102161944|FG002|STARTED|Overall Study||17||
48745671|NCT02493036|102161942|FG000|COMPLETED|Overall Study||16||
48745672|NCT02493036|102161943|FG001|COMPLETED|Overall Study||18||
48745673|NCT02493036|102161944|FG002|COMPLETED|Overall Study||15||
48745674|NCT02493036|102161942|FG000|NOT COMPLETED|Overall Study||1||
48745675|NCT02493036|102161943|FG001|NOT COMPLETED|Overall Study||2||
48745676|NCT02493036|102161944|FG002|NOT COMPLETED|Overall Study||2||
48745677|NCT01560286|102161945|FG000|STARTED|Overall Study||24||
48745678|NCT01560286|102161945|FG000|COMPLETED|Overall Study||24||
48745679|NCT01560286|102161945|FG000|NOT COMPLETED|Overall Study||0||
48745680|NCT03032263|102161946|FG000|STARTED|Overall Study||6||
48745681|NCT03032263|102161947|FG001|STARTED|Overall Study||6||
48745682|NCT03032263|102161946|FG000|COMPLETED|Overall Study||6||
48745683|NCT03032263|102161947|FG001|COMPLETED|Overall Study||6||
48745684|NCT03032263|102161946|FG000|NOT COMPLETED|Overall Study||0||
48745685|NCT03032263|102161947|FG001|NOT COMPLETED|Overall Study||0||
48745686|NCT03149172|102161948|FG000|STARTED|Overall Study||8||
48745687|NCT03149172|102161949|FG001|STARTED|Overall Study||6||
48745688|NCT03149172|102161950|FG002|STARTED|Overall Study||7||
48745689|NCT03149172|102161948|FG000|COMPLETED|Overall Study||6||
48745690|NCT03149172|102161949|FG001|COMPLETED|Overall Study||5||
48745691|NCT03149172|102161950|FG002|COMPLETED|Overall Study||5||
48745692|NCT03149172|102161948|FG000|NOT COMPLETED|Overall Study||2||
48745693|NCT03149172|102161949|FG001|NOT COMPLETED|Overall Study||1||
48745694|NCT03149172|102161950|FG002|NOT COMPLETED|Overall Study||2||
48745695|NCT01799226|102161951|FG000|STARTED|Overall Study||16||
48745696|NCT01799226|102161952|FG001|STARTED|Overall Study||16||
48745697|NCT01799226|102161951|FG000|Right Stent Side|Overall Study||8||
48623051|NCT00948090|101859987|FG002|STARTED|Overall Study||123||
48623052|NCT00948090|101859988|FG003|STARTED|Overall Study||18||
48623053|NCT00948090|101859985|FG000|COMPLETED|Overall Study||22||
48623054|NCT00948090|101859986|FG001|COMPLETED|Overall Study||0||
48623055|NCT00948090|101859987|FG002|COMPLETED|Overall Study||67||
48623056|NCT00948090|101859988|FG003|COMPLETED|Overall Study||7||
48623057|NCT00948090|101859985|FG000|NOT COMPLETED|Overall Study||43||
48623058|NCT00948090|101859986|FG001|NOT COMPLETED|Overall Study||1||
48623059|NCT00948090|101859987|FG002|NOT COMPLETED|Overall Study||56||
48623060|NCT00948090|101859988|FG003|NOT COMPLETED|Overall Study||11||
48623061|NCT01157845|101859989|FG000|STARTED|Overall Study||165||
48623062|NCT01157845|101859989|FG000|COMPLETED|Overall Study||130||
48623063|NCT01157845|101859989|FG000|NOT COMPLETED|Overall Study||35||
48623064|NCT00901342|101859990|FG000|STARTED|Overall Study||104||
48623065|NCT00901342|101859990|FG000|Received at Least 1 Infusion|Overall Study||98||
48623066|NCT00901342|101859990|FG000|COMPLETED|Overall Study||89||
48623067|NCT00901342|101859990|FG000|NOT COMPLETED|Overall Study||15||
48623068|NCT03976752|101859991|FG000|STARTED|Overall Study||4||
48623069|NCT03976752|101859992|FG001|STARTED|Overall Study||37||
48623070|NCT03976752|101859991|FG000|Started Study Arm A|Overall Study||0||
48623071|NCT03976752|101859992|FG001|Started Study Arm A|Overall Study||14||
48623072|NCT03976752|101859991|FG000|Completed Study Arm A|Overall Study||0||
48623073|NCT03976752|101859992|FG001|Completed Study Arm A|Overall Study||8||
48623074|NCT03976752|101859991|FG000|Started Study Arm B|Overall Study||0||
48623075|NCT03976752|101859992|FG001|Started Study Arm B|Overall Study||8||
48623076|NCT03976752|101859991|FG000|Completed Study Arm B|Overall Study||0||
48623077|NCT03976752|101859992|FG001|Completed Study Arm B|Overall Study||8||
48623078|NCT03976752|101859991|FG000|Started Study Arm C|Overall Study||0||
48623079|NCT03976752|101859992|FG001|Started Study Arm C|Overall Study||11||
48623080|NCT03976752|101859991|FG000|Completed Study Arm C|Overall Study||0||
48623081|NCT03976752|101859992|FG001|Completed Study Arm C|Overall Study||8||
48623082|NCT03976752|101859991|FG000|Started Study Arm D|Overall Study||0||
48623083|NCT03976752|101859992|FG001|Started Study Arm D|Overall Study||6||
48623084|NCT03976752|101859991|FG000|Completed Study Arm D|Overall Study||0||
48623085|NCT03976752|101859992|FG001|Completed Study Arm D|Overall Study||4||
48623086|NCT03976752|101859991|FG000|COMPLETED|Overall Study||3||
48623087|NCT03976752|101859992|FG001|COMPLETED|Overall Study||28||
48623088|NCT03976752|101859991|FG000|NOT COMPLETED|Overall Study||1||
48623089|NCT03976752|101859992|FG001|NOT COMPLETED|Overall Study||9||
48623090|NCT01477762|101859993|FG000|STARTED|Overall Study||25||
48623091|NCT01477762|101859994|FG001|STARTED|Overall Study||33||
48623092|NCT01477762|101859995|FG002|STARTED|Overall Study||20||
48623093|NCT01477762|101859996|FG003|STARTED|Overall Study||13||
48623094|NCT01477762|101859993|FG000|COMPLETED|Overall Study||16||
48623095|NCT01477762|101859994|FG001|COMPLETED|Overall Study||20||
48623096|NCT01477762|101859995|FG002|COMPLETED|Overall Study||16||
48623097|NCT01477762|101859996|FG003|COMPLETED|Overall Study||11||
48623098|NCT01477762|101859993|FG000|NOT COMPLETED|Overall Study||9||
48623099|NCT01477762|101859994|FG001|NOT COMPLETED|Overall Study||13||
48623100|NCT01477762|101859995|FG002|NOT COMPLETED|Overall Study||4||
48623101|NCT01477762|101859996|FG003|NOT COMPLETED|Overall Study||2||
48623102|NCT02849587|101859997|FG000|STARTED|Overall Study||65||
48623103|NCT02849587|101859998|FG001|STARTED|Overall Study||70||
48623104|NCT02849587|101859999|FG002|STARTED|Overall Study||64||
48623105|NCT02849587|101859997|FG000|COMPLETED|Overall Study||63||
48623106|NCT02849587|101859998|FG001|COMPLETED|Overall Study||66||
48623107|NCT02849587|101859999|FG002|COMPLETED|Overall Study||62||
48623108|NCT02849587|101859997|FG000|NOT COMPLETED|Overall Study||2||
48623109|NCT02849587|101859998|FG001|NOT COMPLETED|Overall Study||4||
48623110|NCT02849587|101859999|FG002|NOT COMPLETED|Overall Study||2||
48623111|NCT01222104|101860000|FG000|STARTED|Overall Study||634||
48623112|NCT01222104|101860000|FG000|Angio-Seal Deployment Attempted|Overall Study||534||
48623113|NCT01222104|101860000|FG000|Successful Deployment|Overall Study||529||
48623114|NCT01222104|101860000|FG000|Successful Deployment and Hemostasis|Overall Study||524||
48623115|NCT01222104|101860000|FG000|Completed 30-day Visit-Angio-Seal|Overall Study||497||
48623116|NCT01222104|101860000|FG000|Completed 30-day Visit-No Angio-Seal|Overall Study||90||
48623117|NCT01222104|101860000|FG000|COMPLETED|Overall Study||587||
48623118|NCT01222104|101860000|FG000|NOT COMPLETED|Overall Study||47||
48623119|NCT03506048|101860001|FG000|STARTED|Overall Study||4||
48623120|NCT03506048|101860001|FG000|COMPLETED|Overall Study||3||
48623121|NCT03506048|101860001|FG000|NOT COMPLETED|Overall Study||1||
48623122|NCT01507181|101860002|FG000|STARTED|Overall Study||12||
48623123|NCT01507181|101860003|FG001|STARTED|Overall Study||12||
48623124|NCT01507181|101860002|FG000|COMPLETED|Overall Study||12||
48623125|NCT01507181|101860003|FG001|COMPLETED|Overall Study||12||
48623126|NCT01507181|101860002|FG000|NOT COMPLETED|Overall Study||0||
48623127|NCT01507181|101860003|FG001|NOT COMPLETED|Overall Study||0||
48623128|NCT02569892|101863697|FG000|STARTED|Overall Study||10||10
48623129|NCT02569892|101863698|FG001|STARTED|Overall Study||9||9
48623130|NCT02569892|101863697|FG000|COMPLETED|Overall Study||10||10
48623131|NCT02569892|101863698|FG001|COMPLETED|Overall Study||8||8
48623132|NCT02569892|101863697|FG000|NOT COMPLETED|Overall Study||0||0
48623133|NCT02569892|101863698|FG001|NOT COMPLETED|Overall Study||1||1
48623134|NCT00412841|101863699|FG000|STARTED|Overall Study||22||
48623135|NCT00412841|101863700|FG001|STARTED|Overall Study||21||
48623136|NCT00412841|101863699|FG000|COMPLETED|Overall Study||12||
48623137|NCT00412841|101863700|FG001|COMPLETED|Overall Study||16||
48623138|NCT00412841|101863699|FG000|NOT COMPLETED|Overall Study||10||
48623139|NCT00412841|101863700|FG001|NOT COMPLETED|Overall Study||5||
48623140|NCT03016169|101863701|FG000|STARTED|Overall Study||358||
48623141|NCT03016169|101863701|FG000|COMPLETED|Overall Study||269||
48623142|NCT03016169|101863701|FG000|NOT COMPLETED|Overall Study||89||
48623143|NCT00458003|101863702|FG000|STARTED|Overall Study||55||
48623144|NCT00458003|101863703|FG001|STARTED|Overall Study||55||
48623145|NCT00458003|101863702|FG000|COMPLETED|Overall Study||54||
48623146|NCT00458003|101863703|FG001|COMPLETED|Overall Study||54||
48623147|NCT00458003|101863702|FG000|NOT COMPLETED|Overall Study||1||
48623148|NCT00458003|101863703|FG001|NOT COMPLETED|Overall Study||1||
48623149|NCT03924323|101863704|FG000|STARTED|Overall Study||136||
48623150|NCT03924323|101863705|FG001|STARTED|Overall Study||137||
48623151|NCT03924323|101863704|FG000|COMPLETED|Overall Study||117||
48745698|NCT01799226|102161952|FG001|Right Stent Side|Overall Study||8||
48745699|NCT01799226|102161951|FG000|Left Stent Side|Overall Study||8||
48745700|NCT01799226|102161952|FG001|Left Stent Side|Overall Study||8||
48745701|NCT01799226|102161951|FG000|COMPLETED|Overall Study||14||
48745702|NCT01799226|102161952|FG001|COMPLETED|Overall Study||16||
48745703|NCT01799226|102161951|FG000|NOT COMPLETED|Overall Study||2||
48745704|NCT01799226|102161952|FG001|NOT COMPLETED|Overall Study||0||
48745705|NCT00703924|102161953|FG000|STARTED|Overall Study||50||
48745706|NCT00703924|102161954|FG001|STARTED|Overall Study||42||
48745707|NCT00703924|102161953|FG000|COMPLETED|Overall Study||49||
48745708|NCT00703924|102161954|FG001|COMPLETED|Overall Study||41||
48623152|NCT03924323|101863705|FG001|COMPLETED|Overall Study||123||
48623153|NCT03924323|101863704|FG000|NOT COMPLETED|Overall Study||19||
48623154|NCT03924323|101863705|FG001|NOT COMPLETED|Overall Study||14||
48623155|NCT00739648|101863706|FG000|STARTED|Overall Study||108||
48623156|NCT00739648|101863707|FG001|STARTED|Overall Study||214||
48623157|NCT00739648|101863706|FG000|COMPLETED|Overall Study||82||
48623158|NCT00739648|101863707|FG001|COMPLETED|Overall Study||161||
48623159|NCT00739648|101863706|FG000|NOT COMPLETED|Overall Study||26||
48623160|NCT00739648|101863707|FG001|NOT COMPLETED|Overall Study||53||
48623161|NCT03533751|101863708|FG000|STARTED|Overall Study||60||
48623162|NCT03533751|101863709|FG001|STARTED|Overall Study||61||
48623163|NCT03533751|101863710|FG002|STARTED|Overall Study||61||
48623164|NCT03533751|101863711|FG003|STARTED|Overall Study||60||
48623165|NCT03533751|101863712|FG004|STARTED|Overall Study||60||
48623166|NCT03533751|101863708|FG000|Treated|Overall Study||60||
48623167|NCT03533751|101863709|FG001|Treated|Overall Study||61||
48623168|NCT03533751|101863710|FG002|Treated|Overall Study||59||
48623169|NCT03533751|101863711|FG003|Treated|Overall Study||60||
48623170|NCT03533751|101863712|FG004|Treated|Overall Study||60||
48623171|NCT03533751|101863708|FG000|COMPLETED|Overall Study||41||
48623172|NCT03533751|101863709|FG001|COMPLETED|Overall Study||36||
48623173|NCT03533751|101863710|FG002|COMPLETED|Overall Study||39||
48623174|NCT03533751|101863711|FG003|COMPLETED|Overall Study||40||
48623175|NCT03533751|101863712|FG004|COMPLETED|Overall Study||37||
48623176|NCT03533751|101863708|FG000|NOT COMPLETED|Overall Study||19||
48623177|NCT03533751|101863709|FG001|NOT COMPLETED|Overall Study||25||
48623178|NCT03533751|101863710|FG002|NOT COMPLETED|Overall Study||22||
48623179|NCT03533751|101863711|FG003|NOT COMPLETED|Overall Study||20||
48623180|NCT03533751|101863712|FG004|NOT COMPLETED|Overall Study||23||
48623181|NCT01526785|101863713|FG000|STARTED|Overall Study||113||
48623182|NCT01526785|101863713|FG000|COMPLETED|Overall Study||100||
48623183|NCT01526785|101863713|FG000|NOT COMPLETED|Overall Study||13||
48623184|NCT01831895|101863714|FG000|STARTED|Overall Study||17||
48623185|NCT01831895|101863714|FG000|COMPLETED|Overall Study||15||
48623186|NCT01831895|101863714|FG000|NOT COMPLETED|Overall Study||2||
48623187|NCT04805671|101863715|FG000|STARTED|Overall Study||198||
48623188|NCT04805671|101863716|FG001|STARTED|Overall Study||201||
48623189|NCT04805671|101863715|FG000|COMPLETED|Overall Study||8||
48745709|NCT00703924|102161953|FG000|NOT COMPLETED|Overall Study||1||
48745710|NCT00703924|102161954|FG001|NOT COMPLETED|Overall Study||1||
48745711|NCT00681889|102161955|FG000|STARTED|Overall Study||9||
48623190|NCT04805671|101863716|FG001|COMPLETED|Overall Study||10||
48623191|NCT04805671|101863715|FG000|NOT COMPLETED|Overall Study||190||
48623192|NCT04805671|101863716|FG001|NOT COMPLETED|Overall Study||191||
48623193|NCT02144701|101863717|FG000|STARTED|Overall Study||22||
48623194|NCT02144701|101863718|FG001|STARTED|Overall Study||11||
48623195|NCT02144701|101863717|FG000|COMPLETED|Overall Study||13||
48623196|NCT02144701|101863718|FG001|COMPLETED|Overall Study||8||
48623197|NCT02144701|101863717|FG000|NOT COMPLETED|Overall Study||9||
48623198|NCT02144701|101863718|FG001|NOT COMPLETED|Overall Study||3||
48623199|NCT02314728|101863719|FG000|STARTED|Overall Study||117||
48745712|NCT00681889|102161955|FG000|COMPLETED|Overall Study||9||
48745713|NCT00681889|102161955|FG000|NOT COMPLETED|Overall Study||0||
48745714|NCT01236521|102161956|FG000|STARTED|Overall Study||131||
48745715|NCT01236521|102161957|FG001|STARTED|Overall Study||130||
48745716|NCT01236521|102161956|FG000|3-month Completed|Overall Study||122||
48745717|NCT01236521|102161957|FG001|3-month Completed|Overall Study||118||
48745718|NCT01236521|102161956|FG000|6-month Completed|Overall Study||121||
48623200|NCT02314728|101863720|FG001|STARTED|Overall Study||113||
48623201|NCT02314728|101863719|FG000|COMPLETED|Overall Study||116||
48623202|NCT02314728|101863720|FG001|COMPLETED|Overall Study||112||
48623203|NCT02314728|101863719|FG000|NOT COMPLETED|Overall Study||1||
48623204|NCT02314728|101863720|FG001|NOT COMPLETED|Overall Study||1||
48623205|NCT00297648|101863721|FG000|STARTED|Overall Study||89||
48623206|NCT00297648|101863721|FG000|COMPLETED|Overall Study||53||
48623207|NCT00297648|101863721|FG000|NOT COMPLETED|Overall Study||36||
48623208|NCT00313729|101863722|FG000|STARTED|Overall Study||120||
48623209|NCT00313729|101863722|FG000|COMPLETED|Overall Study||120||
48623210|NCT00313729|101863722|FG000|NOT COMPLETED|Overall Study||0||
48623211|NCT02823470|101863723|FG000|STARTED|Overall Study||9||
48623212|NCT02823470|101863724|FG001|STARTED|Overall Study||15||
48623213|NCT02823470|101863723|FG000|COMPLETED|Overall Study||0||
48623214|NCT02823470|101863724|FG001|COMPLETED|Overall Study||0||
48623215|NCT02823470|101863723|FG000|NOT COMPLETED|Overall Study||9||
48623216|NCT02823470|101863724|FG001|NOT COMPLETED|Overall Study||15||
48623217|NCT02992119|101863725|FG000|STARTED|Overall Study||21||
48623218|NCT02992119|101863726|FG001|STARTED|Overall Study||21||
48623219|NCT02992119|101863727|FG002|STARTED|Overall Study||30||
48623220|NCT02992119|101863728|FG003|STARTED|Overall Study||30||
48623221|NCT02992119|101863729|FG004|STARTED|Overall Study||30||
48623222|NCT02992119|101863730|FG005|STARTED|Overall Study||30||
48623223|NCT02992119|101863731|FG006|STARTED|Overall Study||31||
48623224|NCT02992119|101863725|FG000|COMPLETED|Overall Study||19||
48623225|NCT02992119|101863726|FG001|COMPLETED|Overall Study||20||
48623226|NCT02992119|101863727|FG002|COMPLETED|Overall Study||29||
48623227|NCT02992119|101863728|FG003|COMPLETED|Overall Study||30||
48623228|NCT02992119|101863729|FG004|COMPLETED|Overall Study||30||
48623229|NCT02992119|101863730|FG005|COMPLETED|Overall Study||30||
48623230|NCT02992119|101863731|FG006|COMPLETED|Overall Study||28||
48623231|NCT02992119|101863725|FG000|NOT COMPLETED|Overall Study||2||
48623232|NCT02992119|101863726|FG001|NOT COMPLETED|Overall Study||1||
48623233|NCT02992119|101863727|FG002|NOT COMPLETED|Overall Study||1||
48623234|NCT02992119|101863728|FG003|NOT COMPLETED|Overall Study||0||
48623235|NCT02992119|101863729|FG004|NOT COMPLETED|Overall Study||0||
48623236|NCT02992119|101863730|FG005|NOT COMPLETED|Overall Study||0||
48623237|NCT02992119|101863731|FG006|NOT COMPLETED|Overall Study||3||
48623238|NCT02421354|101863732|FG000|STARTED|Overall Study||8||
48623239|NCT02421354|101863732|FG000|COMPLETED|Overall Study||8||
48623240|NCT02421354|101863732|FG000|NOT COMPLETED|Overall Study||0||
48623241|NCT02486692|101863733|FG000|STARTED|Overall Study||30||
48623242|NCT02486692|101863734|FG001|STARTED|Overall Study||30||
48623243|NCT02486692|101863733|FG000|COMPLETED|Overall Study||26||
48623244|NCT02486692|101863734|FG001|COMPLETED|Overall Study||23||
48623245|NCT02486692|101863733|FG000|NOT COMPLETED|Overall Study||4||
48745719|NCT01236521|102161957|FG001|6-month Completed|Overall Study||114||
48745720|NCT01236521|102161956|FG000|9-month Completed|Overall Study||105||
48623246|NCT02486692|101863734|FG001|NOT COMPLETED|Overall Study||7||
48623247|NCT03154086|101863735|FG000|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2||
48623248|NCT03154086|101863736|FG001|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2||
48623249|NCT03154086|101863737|FG002|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2||
48623250|NCT03154086|101863738|FG003|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2||
48623251|NCT03154086|101863739|FG004|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623252|NCT03154086|101863740|FG005|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623253|NCT03154086|101863741|FG006|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623254|NCT03154086|101863742|FG007|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623255|NCT03154086|101863743|FG008|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623256|NCT03154086|101863744|FG009|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623257|NCT03154086|101863745|FG010|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623258|NCT03154086|101863746|FG011|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623259|NCT03154086|101863747|FG012|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48745721|NCT01236521|102161957|FG001|9-month Completed|Overall Study||98||
48745722|NCT01236521|102161956|FG000|12-moth Completed|Overall Study||108||
48745723|NCT01236521|102161957|FG001|12-moth Completed|Overall Study||105||
48623260|NCT03154086|101863748|FG013|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623261|NCT03154086|101863749|FG014|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623262|NCT03154086|101863735|FG000|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2||
48623263|NCT03154086|101863736|FG001|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2||
48623264|NCT03154086|101863737|FG002|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2||
48623265|NCT03154086|101863738|FG003|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2||
48623266|NCT03154086|101863739|FG004|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623267|NCT03154086|101863740|FG005|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623268|NCT03154086|101863741|FG006|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623269|NCT03154086|101863742|FG007|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623270|NCT03154086|101863743|FG008|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623271|NCT03154086|101863744|FG009|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623272|NCT03154086|101863745|FG010|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623273|NCT03154086|101863746|FG011|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623274|NCT03154086|101863747|FG012|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623275|NCT03154086|101863748|FG013|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623276|NCT03154086|101863749|FG014|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623277|NCT03154086|101863735|FG000|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623278|NCT03154086|101863736|FG001|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623279|NCT03154086|101863737|FG002|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623280|NCT03154086|101863738|FG003|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623281|NCT03154086|101863739|FG004|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623282|NCT03154086|101863740|FG005|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623283|NCT03154086|101863741|FG006|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623284|NCT03154086|101863742|FG007|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623285|NCT03154086|101863743|FG008|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623286|NCT03154086|101863744|FG009|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623287|NCT03154086|101863745|FG010|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623288|NCT03154086|101863746|FG011|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623289|NCT03154086|101863747|FG012|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623290|NCT03154086|101863748|FG013|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623291|NCT03154086|101863749|FG014|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
48623292|NCT03154086|101863735|FG000|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2||
48623293|NCT03154086|101863736|FG001|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2||
48623294|NCT03154086|101863737|FG002|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2||
48623295|NCT03154086|101863738|FG003|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2||
48623296|NCT03154086|101863739|FG004|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623297|NCT03154086|101863740|FG005|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623298|NCT03154086|101863741|FG006|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623299|NCT03154086|101863742|FG007|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623300|NCT03154086|101863743|FG008|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623301|NCT03154086|101863744|FG009|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623302|NCT03154086|101863745|FG010|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623303|NCT03154086|101863746|FG011|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623304|NCT03154086|101863747|FG012|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623305|NCT03154086|101863748|FG013|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623306|NCT03154086|101863749|FG014|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623307|NCT03154086|101863735|FG000|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2||
48623308|NCT03154086|101863736|FG001|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2||
48623309|NCT03154086|101863737|FG002|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2||
48623310|NCT03154086|101863738|FG003|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||1||
48623311|NCT03154086|101863739|FG004|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623312|NCT03154086|101863740|FG005|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623313|NCT03154086|101863741|FG006|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623314|NCT03154086|101863742|FG007|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623315|NCT03154086|101863743|FG008|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623316|NCT03154086|101863744|FG009|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623317|NCT03154086|101863745|FG010|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623318|NCT03154086|101863746|FG011|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623319|NCT03154086|101863747|FG012|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623320|NCT03154086|101863748|FG013|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623321|NCT03154086|101863749|FG014|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623322|NCT03154086|101863735|FG000|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623323|NCT03154086|101863736|FG001|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623324|NCT03154086|101863737|FG002|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623325|NCT03154086|101863738|FG003|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||1||
48623326|NCT03154086|101863739|FG004|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623327|NCT03154086|101863740|FG005|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623328|NCT03154086|101863741|FG006|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623329|NCT03154086|101863742|FG007|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623330|NCT03154086|101863743|FG008|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623331|NCT03154086|101863744|FG009|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623332|NCT03154086|101863745|FG010|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623333|NCT03154086|101863746|FG011|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623334|NCT03154086|101863747|FG012|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623335|NCT03154086|101863748|FG013|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623336|NCT03154086|101863749|FG014|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
48623337|NCT03154086|101863735|FG000|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2||
48623338|NCT03154086|101863736|FG001|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2||
48623339|NCT03154086|101863737|FG002|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2||
48623340|NCT03154086|101863738|FG003|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2||
48623341|NCT03154086|101863739|FG004|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48623342|NCT03154086|101863740|FG005|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48623343|NCT03154086|101863741|FG006|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48623344|NCT03154086|101863742|FG007|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48623345|NCT03154086|101863743|FG008|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48623346|NCT03154086|101863744|FG009|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48623347|NCT03154086|101863745|FG010|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48623348|NCT03154086|101863746|FG011|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48623349|NCT03154086|101863747|FG012|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48623350|NCT03154086|101863748|FG013|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48623351|NCT03154086|101863749|FG014|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48623352|NCT03154086|101863735|FG000|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2||
48623353|NCT03154086|101863736|FG001|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2||
48623354|NCT03154086|101863737|FG002|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2||
48623355|NCT03154086|101863738|FG003|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2||
48623356|NCT03154086|101863739|FG004|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48745724|NCT01236521|102161956|FG000|COMPLETED|Overall Study||108||
48745725|NCT01236521|102161957|FG001|COMPLETED|Overall Study||105||
48745726|NCT01236521|102161956|FG000|NOT COMPLETED|Overall Study||23||
48745727|NCT01236521|102161957|FG001|NOT COMPLETED|Overall Study||25||
48745728|NCT02471014|102161958|FG000|STARTED|Overall Study||25||
48745729|NCT02471014|102161959|FG001|STARTED|Overall Study||25||
48745730|NCT02471014|102161958|FG000|COMPLETED|Overall Study||23||
48745731|NCT02471014|102161959|FG001|COMPLETED|Overall Study||23||
48745732|NCT02471014|102161958|FG000|NOT COMPLETED|Overall Study||2||
48745733|NCT02471014|102161959|FG001|NOT COMPLETED|Overall Study||2||
48745734|NCT00837200|102161960|FG000|STARTED|Overall Study||13||
48745735|NCT00837200|102161960|FG000|COMPLETED|Overall Study||13||
48745736|NCT00837200|102161960|FG000|NOT COMPLETED|Overall Study||0||
48623357|NCT03154086|101863740|FG005|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48623358|NCT03154086|101863741|FG006|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48623359|NCT03154086|101863742|FG007|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48623360|NCT03154086|101863743|FG008|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48623361|NCT03154086|101863744|FG009|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48623362|NCT03154086|101863745|FG010|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48623363|NCT03154086|101863746|FG011|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48623364|NCT03154086|101863747|FG012|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48623365|NCT03154086|101863748|FG013|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48623366|NCT03154086|101863749|FG014|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48166207|NCT01336959|100728691|FG002|COMPLETED|Overall Study||40||
48166208|NCT01336959|100728689|FG000|NOT COMPLETED|Overall Study||0||
48623367|NCT03154086|101863735|FG000|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48623368|NCT03154086|101863736|FG001|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48745737|NCT01178268|102161961|FG000|STARTED|Overall Study||367||
48745738|NCT01178268|102161962|FG001|STARTED|Overall Study||121||
48623369|NCT03154086|101863737|FG002|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48745739|NCT01178268|102161961|FG000|COMPLETED|Overall Study||360||
48745740|NCT01178268|102161962|FG001|COMPLETED|Overall Study||120||
48745741|NCT01178268|102161961|FG000|NOT COMPLETED|Overall Study||7||
48623370|NCT03154086|101863738|FG003|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48623371|NCT03154086|101863739|FG004|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48623372|NCT03154086|101863740|FG005|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48623373|NCT03154086|101863741|FG006|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48623374|NCT03154086|101863742|FG007|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48623375|NCT03154086|101863743|FG008|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48623376|NCT03154086|101863744|FG009|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48623377|NCT03154086|101863745|FG010|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48623378|NCT03154086|101863746|FG011|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48623379|NCT03154086|101863747|FG012|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48623380|NCT03154086|101863748|FG013|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48623381|NCT03154086|101863749|FG014|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
48623382|NCT03154086|101863735|FG000|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2||
48623383|NCT03154086|101863736|FG001|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2||
48623384|NCT03154086|101863737|FG002|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2||
48623385|NCT03154086|101863738|FG003|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2||
48745742|NCT01178268|102161962|FG001|NOT COMPLETED|Overall Study||1||
48745743|NCT02478463|102161963|FG000|STARTED|Treatment Period 1 (Up to Day 29)||19||
48745744|NCT02478463|102161963|FG000|COMPLETED|Treatment Period 1 (Up to Day 29)||18||
48745745|NCT02478463|102161963|FG000|NOT COMPLETED|Treatment Period 1 (Up to Day 29)||1||
48745746|NCT02478463|102161963|FG000|STARTED|Washout Period (Up to 42 Days)||18||
48623386|NCT03154086|101863739|FG004|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48623387|NCT03154086|101863740|FG005|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48623388|NCT03154086|101863741|FG006|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48623389|NCT03154086|101863742|FG007|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48623390|NCT03154086|101863743|FG008|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48623391|NCT03154086|101863744|FG009|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48623392|NCT03154086|101863745|FG010|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48623393|NCT03154086|101863746|FG011|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48623394|NCT03154086|101863747|FG012|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48623395|NCT03154086|101863748|FG013|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48745747|NCT02478463|102161963|FG000|COMPLETED|Washout Period (Up to 42 Days)||17||
48745748|NCT02478463|102161963|FG000|NOT COMPLETED|Washout Period (Up to 42 Days)||1||
48745749|NCT02478463|102161963|FG000|STARTED|Treatment Period 2 (Up to 52 Weeks)||17||
48745750|NCT02478463|102161963|FG000|COMPLETED|Treatment Period 2 (Up to 52 Weeks)||16||
48623396|NCT03154086|101863749|FG014|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48623397|NCT03154086|101863735|FG000|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2||
48623398|NCT03154086|101863736|FG001|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||1||
48623399|NCT03154086|101863737|FG002|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2||
48623400|NCT03154086|101863738|FG003|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2||
48623401|NCT03154086|101863739|FG004|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48623402|NCT03154086|101863740|FG005|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48623403|NCT03154086|101863741|FG006|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48623404|NCT03154086|101863742|FG007|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48623405|NCT03154086|101863743|FG008|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48623406|NCT03154086|101863744|FG009|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48745751|NCT02478463|102161963|FG000|NOT COMPLETED|Treatment Period 2 (Up to 52 Weeks)||1||
48745752|NCT01412164|102165733|FG000|STARTED|Overall Study||730||
48745753|NCT01412164|102165733|FG000|COMPLETED|Overall Study||683||
48745754|NCT01412164|102165733|FG000|NOT COMPLETED|Overall Study||47||
48745755|NCT03004365|102165734|FG000|STARTED|Overall Study||8||
48745756|NCT03004365|102165735|FG001|STARTED|Overall Study||8||
48745757|NCT03004365|102165736|FG002|STARTED|Overall Study||8||
48745758|NCT03004365|102165737|FG003|STARTED|Overall Study||9||
48745759|NCT03004365|102165734|FG000|COMPLETED|Overall Study||8||
48745760|NCT03004365|102165735|FG001|COMPLETED|Overall Study||8||
48623407|NCT03154086|101863745|FG010|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48623408|NCT03154086|101863746|FG011|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48623409|NCT03154086|101863747|FG012|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48623410|NCT03154086|101863748|FG013|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48623411|NCT03154086|101863749|FG014|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48623412|NCT03154086|101863735|FG000|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48623413|NCT03154086|101863736|FG001|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||1||
48166209|NCT01336959|100728690|FG001|NOT COMPLETED|Overall Study||5||
48329061|NCT01515787|101132098|FG000|COMPLETED|Overall Study||585||
48623414|NCT03154086|101863737|FG002|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48623415|NCT03154086|101863738|FG003|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48623416|NCT03154086|101863739|FG004|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48623417|NCT03154086|101863740|FG005|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48623418|NCT03154086|101863741|FG006|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48623419|NCT03154086|101863742|FG007|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48657112|NCT03761914|101943779|FG001|NOT COMPLETED|Overall Study||0||
48166210|NCT01336959|100728691|FG002|NOT COMPLETED|Overall Study||1||
48166211|NCT02322814|100728692|FG000|STARTED|Overall Study||16||
48166212|NCT02322814|100728693|FG001|STARTED|Overall Study||43||
48166213|NCT02322814|100728694|FG002|STARTED|Overall Study||47||
48166214|NCT02322814|100728695|FG003|STARTED|Overall Study||32||
48166215|NCT02322814|100728696|FG004|STARTED|Overall Study||31||
48166216|NCT02322814|100728692|FG000|COMPLETED|Overall Study||0||
48166217|NCT02322814|100728693|FG001|COMPLETED|Overall Study||0||
48166218|NCT02322814|100728694|FG002|COMPLETED|Overall Study||0||
48166219|NCT02322814|100728695|FG003|COMPLETED|Overall Study||0||
48745761|NCT03004365|102165736|FG002|COMPLETED|Overall Study||8||
48745762|NCT03004365|102165737|FG003|COMPLETED|Overall Study||9||
48745763|NCT03004365|102165734|FG000|NOT COMPLETED|Overall Study||0||
48745764|NCT03004365|102165735|FG001|NOT COMPLETED|Overall Study||0||
48745765|NCT03004365|102165736|FG002|NOT COMPLETED|Overall Study||0||
48745766|NCT03004365|102165737|FG003|NOT COMPLETED|Overall Study||0||
48745767|NCT04308941|102165738|FG000|STARTED|Overall Study||10||
48745768|NCT04308941|102165739|FG001|STARTED|Overall Study||10||
48745769|NCT04308941|102165740|FG002|STARTED|Overall Study||10||
48745770|NCT04308941|102165738|FG000|COMPLETED|Overall Study||10||
48745771|NCT04308941|102165739|FG001|COMPLETED|Overall Study||10||
48745772|NCT04308941|102165740|FG002|COMPLETED|Overall Study||10||
48745773|NCT04308941|102165738|FG000|NOT COMPLETED|Overall Study||0||
48745774|NCT04308941|102165739|FG001|NOT COMPLETED|Overall Study||0||
48745775|NCT04308941|102165740|FG002|NOT COMPLETED|Overall Study||0||
48745776|NCT03187119|102165741|FG000|STARTED|Overall Study||22||
48745777|NCT03187119|102165742|FG001|STARTED|Overall Study||23||
48745778|NCT03187119|102165741|FG000|COMPLETED|Overall Study||20||
48745779|NCT03187119|102165742|FG001|COMPLETED|Overall Study||18||
48745780|NCT03187119|102165741|FG000|NOT COMPLETED|Overall Study||2||
48745781|NCT03187119|102165742|FG001|NOT COMPLETED|Overall Study||5||
48745782|NCT03361293|102165743|FG000|STARTED|Overall Study||20||
48745783|NCT03361293|102165744|FG001|STARTED|Overall Study||24||
48745784|NCT03361293|102165743|FG000|COMPLETED|Overall Study||19||
48745785|NCT03361293|102165744|FG001|COMPLETED|Overall Study||19||
48745786|NCT03361293|102165743|FG000|NOT COMPLETED|Overall Study||1||
48745787|NCT03361293|102165744|FG001|NOT COMPLETED|Overall Study||5||
48745788|NCT03652181|102165745|FG000|STARTED|Overall Study||123||
48745789|NCT03652181|102165745|FG000|Completed Year 1|Overall Study||102||
48745790|NCT03652181|102165745|FG000|Completed Year 2|Overall Study||69||
48745791|NCT03652181|102165745|FG000|COMPLETED|Overall Study||123||
48745792|NCT03652181|102165745|FG000|NOT COMPLETED|Overall Study||0||
48745793|NCT00706446|102165746|FG000|STARTED|Overall Study||29||
48745794|NCT00706446|102165747|FG001|STARTED|Overall Study||57||
48745795|NCT00706446|102165748|FG002|STARTED|Overall Study||44||
48745796|NCT00706446|102165749|FG003|STARTED|Overall Study||26||
48745797|NCT00706446|102165750|FG004|STARTED|Overall Study||54||
48745798|NCT00706446|102165751|FG005|STARTED|Overall Study||45||
48745799|NCT00706446|102165746|FG000|COMPLETED|Overall Study||3||
48745800|NCT00706446|102165747|FG001|COMPLETED|Overall Study||8||
48745801|NCT00706446|102165748|FG002|COMPLETED|Overall Study||7||
48745802|NCT00706446|102165749|FG003|COMPLETED|Overall Study||4||
48745803|NCT00706446|102165750|FG004|COMPLETED|Overall Study||10||
48166220|NCT02322814|100728696|FG004|COMPLETED|Overall Study||0||
48166221|NCT02322814|100728692|FG000|NOT COMPLETED|Overall Study||16||
48166222|NCT02322814|100728693|FG001|NOT COMPLETED|Overall Study||43||
48166223|NCT02322814|100728694|FG002|NOT COMPLETED|Overall Study||47||
48166224|NCT02322814|100728695|FG003|NOT COMPLETED|Overall Study||32||
48166225|NCT02322814|100728696|FG004|NOT COMPLETED|Overall Study||31||
48166226|NCT03579290|100728697|FG000|STARTED|Overall Study||40||
48166227|NCT03579290|100728697|FG000|COMPLETED|Overall Study||31||
48745804|NCT00706446|102165751|FG005|COMPLETED|Overall Study||7||
48745805|NCT00706446|102165746|FG000|NOT COMPLETED|Overall Study||26||
48745806|NCT00706446|102165747|FG001|NOT COMPLETED|Overall Study||49||
48745807|NCT00706446|102165748|FG002|NOT COMPLETED|Overall Study||37||
48166228|NCT03579290|100728697|FG000|NOT COMPLETED|Overall Study||9||
48166229|NCT01622543|100728698|FG000|STARTED|Overall Study||51||
48166230|NCT01622543|100728699|FG001|STARTED|Overall Study||52||
48166231|NCT01622543|100728698|FG000|COMPLETED|Overall Study||51||
48166232|NCT01622543|100728699|FG001|COMPLETED|Overall Study||52||
48166233|NCT01622543|100728698|FG000|NOT COMPLETED|Overall Study||0||
48166234|NCT01622543|100728699|FG001|NOT COMPLETED|Overall Study||0||
48166235|NCT02601937|100728700|FG000|STARTED|Period 1: Dose Escalation Phase||8||
48745808|NCT00706446|102165749|FG003|NOT COMPLETED|Overall Study||22||
48745809|NCT00706446|102165750|FG004|NOT COMPLETED|Overall Study||44||
48745810|NCT00706446|102165751|FG005|NOT COMPLETED|Overall Study||38||
48745811|NCT00191334|102165752|FG000|STARTED|Overall Study||50||
48745812|NCT00191334|102165752|FG000|COMPLETED|Overall Study||33||
48745813|NCT00191334|102165752|FG000|NOT COMPLETED|Overall Study||17||
48166236|NCT02601937|100728701|FG001|STARTED|Period 1: Dose Escalation Phase||6||
48166237|NCT02601937|100728702|FG002|STARTED|Period 1: Dose Escalation Phase||6||
48166238|NCT02601937|100728703|FG003|STARTED|Period 1: Dose Escalation Phase||7||
48166239|NCT02601937|100728704|FG004|STARTED|Period 1: Dose Escalation Phase||6||
48166240|NCT02601937|100728705|FG005|STARTED|Period 1: Dose Escalation Phase||6||
48166241|NCT02601937|100728706|FG006|STARTED|Period 1: Dose Escalation Phase||7||
48166242|NCT02601937|100728707|FG007|STARTED|Period 1: Dose Escalation Phase||0||
48166243|NCT02601937|100728708|FG008|STARTED|Period 1: Dose Escalation Phase||0||
48166244|NCT02601937|100728709|FG009|STARTED|Period 1: Dose Escalation Phase||0||
48166245|NCT02601937|100728710|FG010|STARTED|Period 1: Dose Escalation Phase||0||
48166246|NCT02601937|100728700|FG000|COMPLETED|Period 1: Dose Escalation Phase||0||
48166247|NCT02601937|100728701|FG001|COMPLETED|Period 1: Dose Escalation Phase||0||
48166248|NCT02601937|100728702|FG002|COMPLETED|Period 1: Dose Escalation Phase||0||
48745814|NCT04549545|102165753|FG000|STARTED|Initial Period||78||
48745815|NCT04549545|102165754|FG001|STARTED|Initial Period||41||
48745816|NCT04549545|102165753|FG000|COMPLETED|Initial Period||68||
48745817|NCT04549545|102165754|FG001|COMPLETED|Initial Period||31||
48745818|NCT04549545|102165753|FG000|NOT COMPLETED|Initial Period||10||
48745819|NCT04549545|102165754|FG001|NOT COMPLETED|Initial Period||10||
48745820|NCT04549545|102165753|FG000|STARTED|Crossover Period||0||
48745821|NCT04549545|102165754|FG001|STARTED|Crossover Period||31||
48745822|NCT04549545|102165753|FG000|COMPLETED|Crossover Period||0||
48745823|NCT04549545|102165754|FG001|COMPLETED|Crossover Period||20||
48745824|NCT04549545|102165753|FG000|NOT COMPLETED|Crossover Period||0||
48745825|NCT04549545|102165754|FG001|NOT COMPLETED|Crossover Period||11||
48745826|NCT00685165|102165755|FG000|STARTED|First Intervention||11||
48745827|NCT00685165|102165756|FG001|STARTED|First Intervention||11||
48745828|NCT00685165|102165755|FG000|COMPLETED|First Intervention||11||
48745829|NCT00685165|102165756|FG001|COMPLETED|First Intervention||11||
48745830|NCT00685165|102165755|FG000|NOT COMPLETED|First Intervention||0||
48745831|NCT00685165|102165756|FG001|NOT COMPLETED|First Intervention||0||
48745832|NCT00685165|102165755|FG000|STARTED|Washout Period of 14 Days||11||
48745833|NCT00685165|102165756|FG001|STARTED|Washout Period of 14 Days||11||
48745834|NCT00685165|102165755|FG000|COMPLETED|Washout Period of 14 Days||10||
48745835|NCT00685165|102165756|FG001|COMPLETED|Washout Period of 14 Days||11||
48745836|NCT00685165|102165755|FG000|NOT COMPLETED|Washout Period of 14 Days||1||
48745837|NCT00685165|102165756|FG001|NOT COMPLETED|Washout Period of 14 Days||0||
48745838|NCT00685165|102165755|FG000|STARTED|Second Intervention||10||
48745839|NCT00685165|102165756|FG001|STARTED|Second Intervention||11||
48745840|NCT00685165|102165755|FG000|COMPLETED|Second Intervention||10||
48745841|NCT00685165|102165756|FG001|COMPLETED|Second Intervention||11||
48745842|NCT00685165|102165755|FG000|NOT COMPLETED|Second Intervention||0||
48745843|NCT00685165|102165756|FG001|NOT COMPLETED|Second Intervention||0||
48166249|NCT02601937|100728703|FG003|COMPLETED|Period 1: Dose Escalation Phase||1||
48166250|NCT02601937|100728704|FG004|COMPLETED|Period 1: Dose Escalation Phase||0||
48166251|NCT02601937|100728705|FG005|COMPLETED|Period 1: Dose Escalation Phase||1||
48166252|NCT02601937|100728706|FG006|COMPLETED|Period 1: Dose Escalation Phase||0||
48166253|NCT02601937|100728707|FG007|COMPLETED|Period 1: Dose Escalation Phase||0||
48166254|NCT02601937|100728708|FG008|COMPLETED|Period 1: Dose Escalation Phase||0||
48745844|NCT02869633|102165757|FG000|STARTED|Overall Study||16||
48745845|NCT02869633|102165758|FG001|STARTED|Overall Study||7||
48745846|NCT02869633|102165757|FG000|COMPLETED|Overall Study||3||
48745847|NCT02869633|102165758|FG001|COMPLETED|Overall Study||2||
48745848|NCT02869633|102165757|FG000|NOT COMPLETED|Overall Study||13||
48745849|NCT02869633|102165758|FG001|NOT COMPLETED|Overall Study||5||
48745850|NCT03360903|102165759|FG000|STARTED|First Intervention||4||
48745851|NCT03360903|102165760|FG001|STARTED|First Intervention||4||
48745852|NCT03360903|102165759|FG000|COMPLETED|First Intervention||4||
48745853|NCT03360903|102165760|FG001|COMPLETED|First Intervention||4||
48745854|NCT03360903|102165759|FG000|NOT COMPLETED|First Intervention||0||
48745855|NCT03360903|102165760|FG001|NOT COMPLETED|First Intervention||0||
48745856|NCT03360903|102165759|FG000|STARTED|Washout (2 Weeks)||4||
48745857|NCT03360903|102165760|FG001|STARTED|Washout (2 Weeks)||4||
48745858|NCT03360903|102165759|FG000|COMPLETED|Washout (2 Weeks)||4||
48745859|NCT03360903|102165760|FG001|COMPLETED|Washout (2 Weeks)||4||
48745860|NCT03360903|102165759|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
48166255|NCT02601937|100728709|FG009|COMPLETED|Period 1: Dose Escalation Phase||0||
48745861|NCT03360903|102165760|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
48745862|NCT03360903|102165759|FG000|STARTED|Second Intervention||4||
48745863|NCT03360903|102165760|FG001|STARTED|Second Intervention||4||
48745864|NCT03360903|102165759|FG000|COMPLETED|Second Intervention||4||
48745865|NCT03360903|102165760|FG001|COMPLETED|Second Intervention||4||
48745866|NCT03360903|102165759|FG000|NOT COMPLETED|Second Intervention||0||
48745867|NCT03360903|102165760|FG001|NOT COMPLETED|Second Intervention||0||
48745868|NCT05065905|102165761|FG000|STARTED|Overall Study||30||
48745869|NCT05065905|102165762|FG001|STARTED|Overall Study||28||
48329062|NCT01515787|101132099|FG001|COMPLETED|Overall Study||543||
48623420|NCT03154086|101863743|FG008|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48623421|NCT03154086|101863744|FG009|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48623422|NCT03154086|101863745|FG010|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48623423|NCT03154086|101863746|FG011|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48623424|NCT03154086|101863747|FG012|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48745870|NCT05065905|102165763|FG002|STARTED|Overall Study||20||
48745871|NCT05065905|102165761|FG000|COMPLETED|Overall Study||30||
48745872|NCT05065905|102165762|FG001|COMPLETED|Overall Study||28||
48745873|NCT05065905|102165763|FG002|COMPLETED|Overall Study||20||
48745874|NCT05065905|102165761|FG000|NOT COMPLETED|Overall Study||0||
48745875|NCT05065905|102165762|FG001|NOT COMPLETED|Overall Study||0||
48745876|NCT05065905|102165763|FG002|NOT COMPLETED|Overall Study||0||
48745877|NCT00662207|102165764|FG000|STARTED|Overall Study||3||
48745878|NCT00662207|102165764|FG000|COMPLETED|Overall Study||3||
48745879|NCT00662207|102165764|FG000|NOT COMPLETED|Overall Study||0||
48745880|NCT00871871|102165765|FG000|STARTED|Part I||18||
48745881|NCT00871871|102165766|FG001|STARTED|Part I||18||
48745882|NCT00871871|102165767|FG002|STARTED|Part I||0||
48745883|NCT00871871|102165768|FG003|STARTED|Part I||0||
48745884|NCT00871871|102165765|FG000|COMPLETED|Part I||15||
48745885|NCT00871871|102165766|FG001|COMPLETED|Part I||15||
48745886|NCT00871871|102165767|FG002|COMPLETED|Part I||0||
48329063|NCT01515787|101132098|FG000|NOT COMPLETED|Overall Study||12||
48329064|NCT01515787|101132099|FG001|NOT COMPLETED|Overall Study||54||
48329065|NCT02531646|101132100|FG000|STARTED|Overall Study||37||
48329066|NCT02531646|101132101|FG001|STARTED|Overall Study||18||
48623425|NCT03154086|101863748|FG013|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48623426|NCT03154086|101863749|FG014|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
48745887|NCT00871871|102165768|FG003|COMPLETED|Part I||0||
48329067|NCT02531646|101132102|FG002|STARTED|Overall Study||11||
48329068|NCT02531646|101132100|FG000|COMPLETED|Overall Study||32||
48623427|NCT03154086|101863735|FG000|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2||
48623428|NCT03154086|101863736|FG001|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2||
48623429|NCT03154086|101863737|FG002|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2||
48623430|NCT03154086|101863738|FG003|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2||
48623431|NCT03154086|101863739|FG004|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48623432|NCT03154086|101863740|FG005|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48623433|NCT03154086|101863741|FG006|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48623434|NCT03154086|101863742|FG007|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48623435|NCT03154086|101863743|FG008|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48623436|NCT03154086|101863744|FG009|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48623437|NCT03154086|101863745|FG010|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48745888|NCT00871871|102165765|FG000|NOT COMPLETED|Part I||3||
48745889|NCT00871871|102165766|FG001|NOT COMPLETED|Part I||3||
48745890|NCT00871871|102165767|FG002|NOT COMPLETED|Part I||0||
48745891|NCT00871871|102165768|FG003|NOT COMPLETED|Part I||0||
48745892|NCT00871871|102165765|FG000|STARTED|Part II||0||
48745893|NCT00871871|102165766|FG001|STARTED|Part II||0||
48745894|NCT00871871|102165767|FG002|STARTED|Part II||13||
48745895|NCT00871871|102165768|FG003|STARTED|Part II||15||
48745896|NCT00871871|102165765|FG000|COMPLETED|Part II||0||
48623438|NCT03154086|101863746|FG011|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48623439|NCT03154086|101863747|FG012|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48623440|NCT03154086|101863748|FG013|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48623441|NCT03154086|101863749|FG014|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48623442|NCT03154086|101863735|FG000|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2||
48623443|NCT03154086|101863736|FG001|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2||
48745897|NCT00871871|102165766|FG001|COMPLETED|Part II||0||
48745898|NCT00871871|102165767|FG002|COMPLETED|Part II||9||
48166256|NCT02601937|100728710|FG010|COMPLETED|Period 1: Dose Escalation Phase||0||
48166257|NCT02601937|100728700|FG000|NOT COMPLETED|Period 1: Dose Escalation Phase||8||
48166258|NCT02601937|100728701|FG001|NOT COMPLETED|Period 1: Dose Escalation Phase||6||
48166259|NCT02601937|100728702|FG002|NOT COMPLETED|Period 1: Dose Escalation Phase||6||
48166260|NCT02601937|100728703|FG003|NOT COMPLETED|Period 1: Dose Escalation Phase||6||
48166261|NCT02601937|100728704|FG004|NOT COMPLETED|Period 1: Dose Escalation Phase||6||
48166262|NCT02601937|100728705|FG005|NOT COMPLETED|Period 1: Dose Escalation Phase||5||
48166263|NCT02601937|100728706|FG006|NOT COMPLETED|Period 1: Dose Escalation Phase||7||
48166264|NCT02601937|100728707|FG007|NOT COMPLETED|Period 1: Dose Escalation Phase||0||
48166265|NCT02601937|100728708|FG008|NOT COMPLETED|Period 1: Dose Escalation Phase||0||
48166266|NCT02601937|100728709|FG009|NOT COMPLETED|Period 1: Dose Escalation Phase||0||
48166267|NCT02601937|100728710|FG010|NOT COMPLETED|Period 1: Dose Escalation Phase||0||
48166268|NCT02601937|100728700|FG000|STARTED|Period 2: Dose Expansion Cohort||0||
48166269|NCT02601937|100728701|FG001|STARTED|Period 2: Dose Expansion Cohort||0||
48166270|NCT02601937|100728702|FG002|STARTED|Period 2: Dose Expansion Cohort||0||
48623444|NCT03154086|101863737|FG002|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2||
48623445|NCT03154086|101863738|FG003|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2||
48623446|NCT03154086|101863739|FG004|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48623447|NCT03154086|101863740|FG005|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48745899|NCT00871871|102165768|FG003|COMPLETED|Part II||11||
48745900|NCT00871871|102165765|FG000|NOT COMPLETED|Part II||0||
48745901|NCT00871871|102165766|FG001|NOT COMPLETED|Part II||0||
48745902|NCT00871871|102165767|FG002|NOT COMPLETED|Part II||4||
48745903|NCT00871871|102165768|FG003|NOT COMPLETED|Part II||4||
48745904|NCT02657889|102165769|FG000|STARTED|Phase 1: (Up to a Maximum of 22 Months)||7||
48745905|NCT02657889|102165770|FG001|STARTED|Phase 1: (Up to a Maximum of 22 Months)||7||
48745906|NCT02657889|102165771|FG002|STARTED|Phase 1: (Up to a Maximum of 22 Months)||0||
48623448|NCT03154086|101863741|FG006|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48623449|NCT03154086|101863742|FG007|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48623450|NCT03154086|101863743|FG008|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48623451|NCT03154086|101863744|FG009|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48623452|NCT03154086|101863745|FG010|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48623453|NCT03154086|101863746|FG011|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48623454|NCT03154086|101863747|FG012|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48623455|NCT03154086|101863748|FG013|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48623456|NCT03154086|101863749|FG014|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48745907|NCT02657889|102165772|FG003|STARTED|Phase 1: (Up to a Maximum of 22 Months)||0||
48745908|NCT02657889|102165769|FG000|COMPLETED|Phase 1: (Up to a Maximum of 22 Months)||0||
48745909|NCT02657889|102165770|FG001|COMPLETED|Phase 1: (Up to a Maximum of 22 Months)||0||
48745910|NCT02657889|102165771|FG002|COMPLETED|Phase 1: (Up to a Maximum of 22 Months)||0||
48745911|NCT02657889|102165772|FG003|COMPLETED|Phase 1: (Up to a Maximum of 22 Months)||0||
48745912|NCT02657889|102165769|FG000|NOT COMPLETED|Phase 1: (Up to a Maximum of 22 Months)||7||
48166271|NCT02601937|100728703|FG003|STARTED|Period 2: Dose Expansion Cohort||0||
48166272|NCT02601937|100728704|FG004|STARTED|Period 2: Dose Expansion Cohort||0||
48166273|NCT02601937|100728705|FG005|STARTED|Period 2: Dose Expansion Cohort||0||
48166274|NCT02601937|100728706|FG006|STARTED|Period 2: Dose Expansion Cohort||0||
48166275|NCT02601937|100728707|FG007|STARTED|Period 2: Dose Expansion Cohort||19||
48166276|NCT02601937|100728708|FG008|STARTED|Period 2: Dose Expansion Cohort||20||
48166277|NCT02601937|100728709|FG009|STARTED|Period 2: Dose Expansion Cohort||18||
48166278|NCT02601937|100728710|FG010|STARTED|Period 2: Dose Expansion Cohort||6||
48166279|NCT02601937|100728700|FG000|COMPLETED|Period 2: Dose Expansion Cohort||0||
48166280|NCT02601937|100728701|FG001|COMPLETED|Period 2: Dose Expansion Cohort||0||
48166281|NCT02601937|100728702|FG002|COMPLETED|Period 2: Dose Expansion Cohort||0||
48166282|NCT02601937|100728703|FG003|COMPLETED|Period 2: Dose Expansion Cohort||0||
48166283|NCT02601937|100728704|FG004|COMPLETED|Period 2: Dose Expansion Cohort||0||
48166284|NCT02601937|100728705|FG005|COMPLETED|Period 2: Dose Expansion Cohort||0||
48166285|NCT02601937|100728706|FG006|COMPLETED|Period 2: Dose Expansion Cohort||0||
48166286|NCT02601937|100728707|FG007|COMPLETED|Period 2: Dose Expansion Cohort||1||
48166287|NCT02601937|100728708|FG008|COMPLETED|Period 2: Dose Expansion Cohort||0||
48166288|NCT02601937|100728709|FG009|COMPLETED|Period 2: Dose Expansion Cohort||0||
48166289|NCT02601937|100728710|FG010|COMPLETED|Period 2: Dose Expansion Cohort||1||
48166290|NCT02601937|100728700|FG000|NOT COMPLETED|Period 2: Dose Expansion Cohort||0||
48166291|NCT02601937|100728701|FG001|NOT COMPLETED|Period 2: Dose Expansion Cohort||0||
48166292|NCT02601937|100728702|FG002|NOT COMPLETED|Period 2: Dose Expansion Cohort||0||
48166293|NCT02601937|100728703|FG003|NOT COMPLETED|Period 2: Dose Expansion Cohort||0||
48166294|NCT02601937|100728704|FG004|NOT COMPLETED|Period 2: Dose Expansion Cohort||0||
48166295|NCT02601937|100728705|FG005|NOT COMPLETED|Period 2: Dose Expansion Cohort||0||
48166296|NCT02601937|100728706|FG006|NOT COMPLETED|Period 2: Dose Expansion Cohort||0||
48166297|NCT02601937|100728707|FG007|NOT COMPLETED|Period 2: Dose Expansion Cohort||18||
48166298|NCT02601937|100728708|FG008|NOT COMPLETED|Period 2: Dose Expansion Cohort||20||
48166299|NCT02601937|100728709|FG009|NOT COMPLETED|Period 2: Dose Expansion Cohort||18||
48166300|NCT02601937|100728710|FG010|NOT COMPLETED|Period 2: Dose Expansion Cohort||5||
48166301|NCT03597035|100728711|FG000|STARTED|Overall Study||8||
48166302|NCT03597035|100728711|FG000|COMPLETED|Overall Study||4||
48166303|NCT03597035|100728711|FG000|NOT COMPLETED|Overall Study||4||
48166304|NCT02912468|100728712|FG000|STARTED|Overall Study||133||
48166305|NCT02912468|100728713|FG001|STARTED|Overall Study||143||
48166306|NCT02912468|100728712|FG000|Treated|Overall Study||133||
48166307|NCT02912468|100728713|FG001|Treated|Overall Study||142||
48166308|NCT02912468|100728712|FG000|Safety Population|Overall Study||132|1 participant of placebo arm received 1 dose of dupilumab: counted in dupilumab for safety analysis.|
48166309|NCT02912468|100728713|FG001|Safety Population|Overall Study||143|1 participant of placebo arm received 1 dose of dupilumab: counted in dupilumab for safety analysis.|
48166310|NCT02912468|100728712|FG000|COMPLETED|Overall Study||124||
48166311|NCT02912468|100728713|FG001|COMPLETED|Overall Study||138||
48166312|NCT02912468|100728712|FG000|NOT COMPLETED|Overall Study||9||
48166313|NCT02912468|100728713|FG001|NOT COMPLETED|Overall Study||5||
48166314|NCT01985828|100728714|FG000|STARTED|Overall Study||53||
48166315|NCT01985828|100728715|FG001|STARTED|Overall Study||30||
48166316|NCT01985828|100728714|FG000|COMPLETED|Overall Study||47||
48623457|NCT03154086|101863735|FG000|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48623458|NCT03154086|101863736|FG001|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48623459|NCT03154086|101863737|FG002|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48623460|NCT03154086|101863738|FG003|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48623461|NCT03154086|101863739|FG004|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48623462|NCT03154086|101863740|FG005|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48623463|NCT03154086|101863741|FG006|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48623464|NCT03154086|101863742|FG007|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48623465|NCT03154086|101863743|FG008|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48623466|NCT03154086|101863744|FG009|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48623467|NCT03154086|101863745|FG010|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48623468|NCT03154086|101863746|FG011|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48745913|NCT02657889|102165770|FG001|NOT COMPLETED|Phase 1: (Up to a Maximum of 22 Months)||7||
48745914|NCT02657889|102165771|FG002|NOT COMPLETED|Phase 1: (Up to a Maximum of 22 Months)||0||
48745915|NCT02657889|102165772|FG003|NOT COMPLETED|Phase 1: (Up to a Maximum of 22 Months)||0||
48767667|NCT01656408|102222796|FG002|STARTED|Overall Study||8||
48166317|NCT01985828|100728715|FG001|COMPLETED|Overall Study||29||
48166318|NCT01985828|100728714|FG000|NOT COMPLETED|Overall Study||6||
48166319|NCT01985828|100728715|FG001|NOT COMPLETED|Overall Study||1||
48166320|NCT00603265|100728716|FG000|STARTED|Overall Study||76||
48166321|NCT00603265|100728717|FG001|STARTED|Overall Study||78||
48166322|NCT00603265|100728718|FG002|STARTED|Overall Study||72||
48166323|NCT00603265|100728716|FG000|Received at Least 1 Dose of Study Drug|Overall Study||75||
48166324|NCT00603265|100728717|FG001|Received at Least 1 Dose of Study Drug|Overall Study||78||
48166325|NCT00603265|100728718|FG002|Received at Least 1 Dose of Study Drug|Overall Study||72||
48166326|NCT00603265|100728716|FG000|COMPLETED|Overall Study||69||
48166327|NCT00603265|100728717|FG001|COMPLETED|Overall Study||62||
48623469|NCT03154086|101863747|FG012|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48623470|NCT03154086|101863748|FG013|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48623471|NCT03154086|101863749|FG014|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
48623472|NCT03154086|101863735|FG000|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2||
48623473|NCT03154086|101863736|FG001|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2||
48623474|NCT03154086|101863737|FG002|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2||
48623475|NCT03154086|101863738|FG003|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2||
48623476|NCT03154086|101863739|FG004|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48623477|NCT03154086|101863740|FG005|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48623478|NCT03154086|101863741|FG006|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48623479|NCT03154086|101863742|FG007|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48623480|NCT03154086|101863743|FG008|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48623481|NCT03154086|101863744|FG009|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48623482|NCT03154086|101863745|FG010|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48745916|NCT02657889|102165769|FG000|STARTED|Phase 2: (Up to a Maximum of 54 Months)||0||
48745917|NCT02657889|102165770|FG001|STARTED|Phase 2: (Up to a Maximum of 54 Months)||0||
48745918|NCT02657889|102165771|FG002|STARTED|Phase 2: (Up to a Maximum of 54 Months)||53||
48745919|NCT02657889|102165772|FG003|STARTED|Phase 2: (Up to a Maximum of 54 Months)||55||
48745920|NCT02657889|102165769|FG000|COMPLETED|Phase 2: (Up to a Maximum of 54 Months)||0||
48745921|NCT02657889|102165770|FG001|COMPLETED|Phase 2: (Up to a Maximum of 54 Months)||0||
48745922|NCT02657889|102165771|FG002|COMPLETED|Phase 2: (Up to a Maximum of 54 Months)||0||
48745923|NCT02657889|102165772|FG003|COMPLETED|Phase 2: (Up to a Maximum of 54 Months)||0||
48745924|NCT02657889|102165769|FG000|NOT COMPLETED|Phase 2: (Up to a Maximum of 54 Months)||0||
48745925|NCT02657889|102165770|FG001|NOT COMPLETED|Phase 2: (Up to a Maximum of 54 Months)||0||
48745926|NCT02657889|102165771|FG002|NOT COMPLETED|Phase 2: (Up to a Maximum of 54 Months)||53||
48745927|NCT02657889|102165772|FG003|NOT COMPLETED|Phase 2: (Up to a Maximum of 54 Months)||55||
48745928|NCT01695135|102165773|FG000|STARTED|Double-blind Treatment Phase||71||
48410334|NCT00686699|101334936|FG001|STARTED|Treatment Period 1||7||
48410335|NCT00686699|101334935|FG000|COMPLETED|Treatment Period 1||4||
48410336|NCT00686699|101334936|FG001|COMPLETED|Treatment Period 1||5||
48410337|NCT00686699|101334935|FG000|NOT COMPLETED|Treatment Period 1||0||
48410338|NCT00686699|101334936|FG001|NOT COMPLETED|Treatment Period 1||2||
48410339|NCT00686699|101334935|FG000|STARTED|Treatment Period 2||4||
48623483|NCT03154086|101863746|FG011|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48623484|NCT03154086|101863747|FG012|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48623485|NCT03154086|101863748|FG013|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48623486|NCT03154086|101863749|FG014|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48623487|NCT03154086|101863735|FG000|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2||
48745929|NCT01695135|102165774|FG001|STARTED|Double-blind Treatment Phase||143||
48745930|NCT01695135|102165775|FG002|STARTED|Double-blind Treatment Phase||0||
48410340|NCT00686699|101334936|FG001|STARTED|Treatment Period 2||5||
48410341|NCT00686699|101334935|FG000|COMPLETED|Treatment Period 2||4||
48410342|NCT00686699|101334936|FG001|COMPLETED|Treatment Period 2||5||
48410343|NCT00686699|101334935|FG000|NOT COMPLETED|Treatment Period 2||0||
48410344|NCT00686699|101334936|FG001|NOT COMPLETED|Treatment Period 2||0||
48410345|NCT03462030|101334937|FG000|STARTED|Overall Study||15||
48623488|NCT03154086|101863736|FG001|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2||
48657113|NCT03761914|101943780|FG002|NOT COMPLETED|Overall Study||0||
48410346|NCT03462030|101334938|FG001|STARTED|Overall Study||15||
48410347|NCT03462030|101334937|FG000|End of Build-up|Overall Study||14||
48410348|NCT03462030|101334938|FG001|End of Build-up|Overall Study||14||
48410349|NCT03462030|101334937|FG000|Month 12 Food Challenge|Overall Study||14||
48745931|NCT01695135|102165776|FG003|STARTED|Double-blind Treatment Phase||0||
48745932|NCT01695135|102165773|FG000|COMPLETED|Double-blind Treatment Phase||0||
48623489|NCT03154086|101863737|FG002|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||1||
48623490|NCT03154086|101863738|FG003|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2||
48623491|NCT03154086|101863739|FG004|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48623492|NCT03154086|101863740|FG005|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48745933|NCT01695135|102165774|FG001|COMPLETED|Double-blind Treatment Phase||4||
48745934|NCT01695135|102165775|FG002|COMPLETED|Double-blind Treatment Phase||0||
48745935|NCT01695135|102165776|FG003|COMPLETED|Double-blind Treatment Phase||0||
48745936|NCT01695135|102165773|FG000|NOT COMPLETED|Double-blind Treatment Phase||71||
48745937|NCT01695135|102165774|FG001|NOT COMPLETED|Double-blind Treatment Phase||139||
48745938|NCT01695135|102165775|FG002|NOT COMPLETED|Double-blind Treatment Phase||0||
48745939|NCT01695135|102165776|FG003|NOT COMPLETED|Double-blind Treatment Phase||0||
48745940|NCT01695135|102165773|FG000|STARTED|Open Label Extension Treatment Phase||0||
48745941|NCT01695135|102165774|FG001|STARTED|Open Label Extension Treatment Phase||0||
48745942|NCT01695135|102165775|FG002|STARTED|Open Label Extension Treatment Phase||49||
48745943|NCT01695135|102165776|FG003|STARTED|Open Label Extension Treatment Phase||80||
48745944|NCT01695135|102165773|FG000|COMPLETED|Open Label Extension Treatment Phase||0||
48745945|NCT01695135|102165774|FG001|COMPLETED|Open Label Extension Treatment Phase||0||
48745946|NCT01695135|102165775|FG002|COMPLETED|Open Label Extension Treatment Phase||9||
48745947|NCT01695135|102165776|FG003|COMPLETED|Open Label Extension Treatment Phase||10||
48745948|NCT01695135|102165773|FG000|NOT COMPLETED|Open Label Extension Treatment Phase||0||
48745949|NCT01695135|102165774|FG001|NOT COMPLETED|Open Label Extension Treatment Phase||0||
48745950|NCT01695135|102165775|FG002|NOT COMPLETED|Open Label Extension Treatment Phase||40||
48745951|NCT01695135|102165776|FG003|NOT COMPLETED|Open Label Extension Treatment Phase||70||
48745952|NCT01473732|102165777|FG000|STARTED|Overall Study||2||
48745953|NCT01473732|102165778|FG001|STARTED|Overall Study||0||
48745954|NCT01473732|102165777|FG000|COMPLETED|Overall Study||0||
48745955|NCT01473732|102165778|FG001|COMPLETED|Overall Study||0||
48745956|NCT01473732|102165777|FG000|NOT COMPLETED|Overall Study||2||
48745957|NCT01473732|102165778|FG001|NOT COMPLETED|Overall Study||0||
48745958|NCT03155724|102165779|FG000|STARTED|Overall Study||53||
48745959|NCT03155724|102165779|FG000|COMPLETED|Overall Study||42||
48745960|NCT03155724|102165779|FG000|NOT COMPLETED|Overall Study||11||
48745961|NCT02003534|102165780|FG000|STARTED|Overall Study||376||
48745962|NCT02003534|102165780|FG000|COMPLETED|Overall Study||329||
48745963|NCT02003534|102165780|FG000|NOT COMPLETED|Overall Study||47||
48745964|NCT04378270|102165781|FG000|STARTED|Overall Study||20||
48745965|NCT04378270|102165781|FG000|COMPLETED|Overall Study||15||
48745966|NCT04378270|102165781|FG000|NOT COMPLETED|Overall Study||5||
48623493|NCT03154086|101863741|FG006|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48745967|NCT04864249|102165782|FG000|STARTED|Overall Study||54||
48745968|NCT04864249|102165783|FG001|STARTED|Overall Study||56||
48745969|NCT04864249|102165782|FG000|COMPLETED|Overall Study||45||
48745970|NCT04864249|102165783|FG001|COMPLETED|Overall Study||31||
48745971|NCT04864249|102165782|FG000|NOT COMPLETED|Overall Study||9||
48745972|NCT04864249|102165783|FG001|NOT COMPLETED|Overall Study||25||
48745973|NCT02532517|102165784|FG000|STARTED|Overall Study||45||
48745974|NCT02532517|102165784|FG000|mITT Analysis Set|Overall Study||44||
48745975|NCT02532517|102165784|FG000|COMPLETED|Overall Study||28||
48745976|NCT02532517|102165784|FG000|NOT COMPLETED|Overall Study||17||
48745977|NCT01980095|102165785|FG000|STARTED|Overall Study||78||
48623494|NCT03154086|101863742|FG007|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48623495|NCT03154086|101863743|FG008|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48623496|NCT03154086|101863744|FG009|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48623497|NCT03154086|101863745|FG010|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48657114|NCT03761914|101943781|FG003|NOT COMPLETED|Overall Study||0||
48745978|NCT01980095|102165786|FG001|STARTED|Overall Study||41||
48745979|NCT01980095|102165785|FG000|Treated|Overall Study||77||
48745980|NCT01980095|102165786|FG001|Treated|Overall Study||41||
48745981|NCT01980095|102165785|FG000|COMPLETED|Overall Study||63||
48745982|NCT01980095|102165786|FG001|COMPLETED|Overall Study||30||
48745983|NCT01980095|102165785|FG000|NOT COMPLETED|Overall Study||15||
48745984|NCT01980095|102165786|FG001|NOT COMPLETED|Overall Study||11||
48745985|NCT00431626|102165787|FG000|STARTED|Overall Study||4||
48745986|NCT00431626|102165788|FG001|STARTED|Overall Study||0||
48745987|NCT00431626|102165787|FG000|COMPLETED|Overall Study||4||
48745988|NCT00431626|102165788|FG001|COMPLETED|Overall Study||0||
48745989|NCT00431626|102165787|FG000|NOT COMPLETED|Overall Study||0||
48329069|NCT02531646|101132101|FG001|COMPLETED|Overall Study||17||
48329070|NCT02531646|101132102|FG002|COMPLETED|Overall Study||11||
48329071|NCT02531646|101132100|FG000|NOT COMPLETED|Overall Study||5||
48329072|NCT02531646|101132101|FG001|NOT COMPLETED|Overall Study||1||
48329073|NCT02531646|101132102|FG002|NOT COMPLETED|Overall Study||0||
48329074|NCT00705939|101132103|FG000|STARTED|Overall Study||12||
48623498|NCT03154086|101863746|FG011|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48623499|NCT03154086|101863747|FG012|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48623500|NCT03154086|101863748|FG013|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48329075|NCT00705939|101132104|FG001|STARTED|Overall Study||14||
48329076|NCT00705939|101132105|FG002|STARTED|Overall Study||18||
48329077|NCT00705939|101132103|FG000|COMPLETED|Overall Study||12||
48623501|NCT03154086|101863749|FG014|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48623502|NCT03154086|101863735|FG000|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48623503|NCT03154086|101863736|FG001|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48623504|NCT03154086|101863737|FG002|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||1||
48623505|NCT03154086|101863738|FG003|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48623506|NCT03154086|101863739|FG004|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48623507|NCT03154086|101863740|FG005|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48623508|NCT03154086|101863741|FG006|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48623509|NCT03154086|101863742|FG007|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48329078|NCT00705939|101132104|FG001|COMPLETED|Overall Study||12||
48329079|NCT00705939|101132105|FG002|COMPLETED|Overall Study||14||
48329080|NCT00705939|101132103|FG000|NOT COMPLETED|Overall Study||0||
48329081|NCT00705939|101132104|FG001|NOT COMPLETED|Overall Study||2||
48329082|NCT00705939|101132105|FG002|NOT COMPLETED|Overall Study||4||
48329083|NCT02543528|101132106|FG000|STARTED|Adaptation Period||0|168|
48329084|NCT02543528|101132107|FG001|STARTED|Adaptation Period||0|168|
48329085|NCT02543528|101132108|FG002|STARTED|Adaptation Period||0|168|
48329086|NCT02543528|101132109|FG003|STARTED|Adaptation Period||0|168|
48329087|NCT02543528|101132110|FG004|STARTED|Adaptation Period||168|168|
48329088|NCT02543528|101132106|FG000|COMPLETED|Adaptation Period||0|142|
48329089|NCT02543528|101132107|FG001|COMPLETED|Adaptation Period||0|142|
48329090|NCT02543528|101132108|FG002|COMPLETED|Adaptation Period||0|142|
48329091|NCT02543528|101132109|FG003|COMPLETED|Adaptation Period||0|142|
48623510|NCT03154086|101863743|FG008|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48623511|NCT03154086|101863744|FG009|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48623512|NCT03154086|101863745|FG010|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48623513|NCT03154086|101863746|FG011|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48623514|NCT03154086|101863747|FG012|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48623515|NCT03154086|101863748|FG013|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48623516|NCT03154086|101863749|FG014|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
48623517|NCT03154086|101863735|FG000|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||3||
48623518|NCT03154086|101863736|FG001|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||2||
48623519|NCT03154086|101863737|FG002|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||1||
48623520|NCT03154086|101863738|FG003|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||2||
48623521|NCT03154086|101863739|FG004|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48623522|NCT03154086|101863740|FG005|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48623523|NCT03154086|101863741|FG006|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48623524|NCT03154086|101863742|FG007|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48623525|NCT03154086|101863743|FG008|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48623526|NCT03154086|101863744|FG009|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48623527|NCT03154086|101863745|FG010|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48623528|NCT03154086|101863746|FG011|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48623529|NCT03154086|101863747|FG012|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48623530|NCT03154086|101863748|FG013|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48623531|NCT03154086|101863749|FG014|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48329092|NCT02543528|101132110|FG004|COMPLETED|Adaptation Period||142|142|
48329093|NCT02543528|101132106|FG000|NOT COMPLETED|Adaptation Period||0||
48329094|NCT02543528|101132107|FG001|NOT COMPLETED|Adaptation Period||0||
48329095|NCT02543528|101132108|FG002|NOT COMPLETED|Adaptation Period||0||
48329096|NCT02543528|101132109|FG003|NOT COMPLETED|Adaptation Period||0||
48329097|NCT02543528|101132110|FG004|NOT COMPLETED|Adaptation Period||26||
48623532|NCT03154086|101863735|FG000|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2||
48623533|NCT03154086|101863736|FG001|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2||
48623534|NCT03154086|101863737|FG002|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||1||
48329098|NCT02543528|101132106|FG000|STARTED|Extended Wear Period||36||
48329099|NCT02543528|101132107|FG001|STARTED|Extended Wear Period||35||
48329100|NCT02543528|101132108|FG002|STARTED|Extended Wear Period||36||
48329101|NCT02543528|101132109|FG003|STARTED|Extended Wear Period||35||
48329102|NCT02543528|101132110|FG004|STARTED|Extended Wear Period||0||
48329103|NCT02543528|101132106|FG000|COMPLETED|Extended Wear Period||8||
48329104|NCT02543528|101132107|FG001|COMPLETED|Extended Wear Period||14||
48623535|NCT03154086|101863738|FG003|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2||
48329105|NCT02543528|101132108|FG002|COMPLETED|Extended Wear Period||13||
48329106|NCT02543528|101132109|FG003|COMPLETED|Extended Wear Period||23||
48329107|NCT02543528|101132110|FG004|COMPLETED|Extended Wear Period||0||
48329108|NCT02543528|101132106|FG000|NOT COMPLETED|Extended Wear Period||28||
48329109|NCT02543528|101132107|FG001|NOT COMPLETED|Extended Wear Period||21||
48329110|NCT02543528|101132108|FG002|NOT COMPLETED|Extended Wear Period||23||
48329111|NCT02543528|101132109|FG003|NOT COMPLETED|Extended Wear Period||12||
48329112|NCT02543528|101132110|FG004|NOT COMPLETED|Extended Wear Period||0||
48329113|NCT03718143|101132111|FG000|STARTED|Overall Study||3||
48329114|NCT03718143|101132112|FG001|STARTED|Overall Study||2||
48329115|NCT03718143|101132113|FG002|STARTED|Overall Study||1||
48329116|NCT03718143|101132111|FG000|COMPLETED|Overall Study||0||
48329117|NCT03718143|101132112|FG001|COMPLETED|Overall Study||0||
48329118|NCT03718143|101132113|FG002|COMPLETED|Overall Study||0||
48329119|NCT03718143|101132111|FG000|NOT COMPLETED|Overall Study||3||
48329120|NCT03718143|101132112|FG001|NOT COMPLETED|Overall Study||2||
48329121|NCT03718143|101132113|FG002|NOT COMPLETED|Overall Study||1||
48329122|NCT00502216|101132114|FG000|STARTED|Overall Study||21||
48329123|NCT00502216|101132115|FG001|STARTED|Overall Study||19||
48329124|NCT00502216|101132114|FG000|COMPLETED|Overall Study||21||
48329125|NCT00502216|101132115|FG001|COMPLETED|Overall Study||19||
48329126|NCT00502216|101132114|FG000|NOT COMPLETED|Overall Study||0||
48329127|NCT00502216|101132115|FG001|NOT COMPLETED|Overall Study||0||
48329128|NCT03988335|101132116|FG000|STARTED|Overall Study||16||
48329129|NCT03988335|101132117|FG001|STARTED|Overall Study||19||
48329130|NCT03988335|101132116|FG000|COMPLETED|Overall Study||14||
48623536|NCT03154086|101863739|FG004|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48623537|NCT03154086|101863740|FG005|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48623538|NCT03154086|101863741|FG006|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48623539|NCT03154086|101863742|FG007|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48623540|NCT03154086|101863743|FG008|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48623541|NCT03154086|101863744|FG009|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48623542|NCT03154086|101863745|FG010|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48623543|NCT03154086|101863746|FG011|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48623544|NCT03154086|101863747|FG012|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48623545|NCT03154086|101863748|FG013|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48623546|NCT03154086|101863749|FG014|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48623547|NCT03154086|101863735|FG000|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||1||
48623548|NCT03154086|101863736|FG001|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48623549|NCT03154086|101863737|FG002|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48623550|NCT03154086|101863738|FG003|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48623551|NCT03154086|101863739|FG004|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48623552|NCT03154086|101863740|FG005|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48623553|NCT03154086|101863741|FG006|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48329131|NCT03988335|101132117|FG001|COMPLETED|Overall Study||18||
48329132|NCT03988335|101132116|FG000|NOT COMPLETED|Overall Study||2||
48329133|NCT03988335|101132117|FG001|NOT COMPLETED|Overall Study||1||
48329134|NCT02435849|101132118|FG000|STARTED|Overall Study||79|Started = Enrolled in All cohorts|
48329135|NCT02435849|101132119|FG001|STARTED|Overall Study||1|Started = Enrolled in All cohorts|
48329136|NCT02435849|101132118|FG000|Enrolled and Infused|Overall Study||79||
48623554|NCT03154086|101863742|FG007|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48329137|NCT02435849|101132119|FG001|Enrolled and Infused|Overall Study||1||
48329138|NCT02435849|101132118|FG000|Discontinued Study Follow-up|Overall Study||48||
48329139|NCT02435849|101132119|FG001|Discontinued Study Follow-up|Overall Study||1||
48329140|NCT02435849|101132118|FG000|COMPLETED|Overall Study||31|Completed = study follow-up completed|
48329141|NCT02435849|101132119|FG001|COMPLETED|Overall Study||0|Completed = study follow-up completed|
48329142|NCT02435849|101132118|FG000|NOT COMPLETED|Overall Study||48||
48329143|NCT02435849|101132119|FG001|NOT COMPLETED|Overall Study||1||
48329144|NCT03551743|101132120|FG000|STARTED|Overall Study||10||
48329145|NCT03551743|101132121|FG001|STARTED|Overall Study||6||
48329146|NCT03551743|101132122|FG002|STARTED|Overall Study||6||
48329147|NCT03551743|101132123|FG003|STARTED|Overall Study||6||
48329148|NCT03551743|101132120|FG000|COMPLETED|Overall Study||8||
48329149|NCT03551743|101132121|FG001|COMPLETED|Overall Study||6||
48623555|NCT03154086|101863743|FG008|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48623556|NCT03154086|101863744|FG009|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48623557|NCT03154086|101863745|FG010|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48623558|NCT03154086|101863746|FG011|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48623559|NCT03154086|101863747|FG012|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48623560|NCT03154086|101863748|FG013|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48329150|NCT03551743|101132122|FG002|COMPLETED|Overall Study||6||
48329151|NCT03551743|101132123|FG003|COMPLETED|Overall Study||6||
48329152|NCT03551743|101132120|FG000|NOT COMPLETED|Overall Study||2||
48329153|NCT03551743|101132121|FG001|NOT COMPLETED|Overall Study||0||
48329154|NCT03551743|101132122|FG002|NOT COMPLETED|Overall Study||0||
48329155|NCT03551743|101132123|FG003|NOT COMPLETED|Overall Study||0||
48329156|NCT00130832|101132124|FG000|STARTED|Overall Study||372||
48329157|NCT00130832|101132125|FG001|STARTED|Overall Study||363||
48329158|NCT00130832|101132124|FG000|COMPLETED|Overall Study||356||
48329159|NCT00130832|101132125|FG001|COMPLETED|Overall Study||346||
48329160|NCT00130832|101132124|FG000|NOT COMPLETED|Overall Study||16||
48329161|NCT00130832|101132125|FG001|NOT COMPLETED|Overall Study||17||
48329162|NCT02851173|101132126|FG000|STARTED|Overall Study||44||
48329163|NCT02851173|101132127|FG001|STARTED|Overall Study||47||
48329164|NCT02851173|101132126|FG000|COMPLETED|Overall Study||42||
48329165|NCT02851173|101132127|FG001|COMPLETED|Overall Study||43||
48329166|NCT02851173|101132126|FG000|NOT COMPLETED|Overall Study||2||
48329167|NCT02851173|101132127|FG001|NOT COMPLETED|Overall Study||4||
48329168|NCT01877083|101132128|FG000|STARTED|Treatment Phase||25||
48329169|NCT01877083|101132128|FG000|COMPLETED|Treatment Phase||5||
48329170|NCT01877083|101132128|FG000|NOT COMPLETED|Treatment Phase||20||
48329171|NCT01877083|101132128|FG000|STARTED|Extension Phase||5||
48329172|NCT01877083|101132128|FG000|COMPLETED|Extension Phase||0||
48329173|NCT01877083|101132128|FG000|NOT COMPLETED|Extension Phase||5||
48329174|NCT03382847|101132129|FG000|STARTED|Overall Study||25||
48410350|NCT03462030|101334938|FG001|Month 12 Food Challenge|Overall Study||14||
48329175|NCT03382847|101132129|FG000|COMPLETED|Overall Study||25||
48329176|NCT03382847|101132129|FG000|NOT COMPLETED|Overall Study||0||
48329177|NCT01110200|101132130|FG000|STARTED|Overall Study||314||
48329178|NCT01110200|101132131|FG001|STARTED|Overall Study||325||
48329179|NCT01110200|101132130|FG000|COMPLETED|Overall Study||208||
48329180|NCT01110200|101132131|FG001|COMPLETED|Overall Study||204||
48329181|NCT01110200|101132130|FG000|NOT COMPLETED|Overall Study||106||
48329182|NCT01110200|101132131|FG001|NOT COMPLETED|Overall Study||121||
48329183|NCT03529773|101132132|FG000|STARTED|Overall Study||12||
48329184|NCT03529773|101132133|FG001|STARTED|Overall Study||12||
48329185|NCT03529773|101132134|FG002|STARTED|Overall Study||12||
48329186|NCT03529773|101132135|FG003|STARTED|Overall Study||12||
48329187|NCT03529773|101132136|FG004|STARTED|Overall Study||12||
48329188|NCT03529773|101132137|FG005|STARTED|Overall Study||12||
48329189|NCT03529773|101132138|FG006|STARTED|Overall Study||12||
48410351|NCT03462030|101334937|FG000|COMPLETED|Overall Study||14||
48623561|NCT03154086|101863749|FG014|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
48623562|NCT03154086|101863735|FG000|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623563|NCT03154086|101863736|FG001|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623564|NCT03154086|101863737|FG002|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623565|NCT03154086|101863738|FG003|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623566|NCT03154086|101863739|FG004|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||6||
48623567|NCT03154086|101863740|FG005|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||2||
48623568|NCT03154086|101863741|FG006|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623569|NCT03154086|101863742|FG007|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623570|NCT03154086|101863743|FG008|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623571|NCT03154086|101863744|FG009|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623572|NCT03154086|101863745|FG010|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623573|NCT03154086|101863746|FG011|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623574|NCT03154086|101863747|FG012|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623575|NCT03154086|101863748|FG013|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623576|NCT03154086|101863749|FG014|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623577|NCT03154086|101863735|FG000|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623578|NCT03154086|101863736|FG001|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623579|NCT03154086|101863737|FG002|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623580|NCT03154086|101863738|FG003|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623581|NCT03154086|101863739|FG004|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||6||
48623582|NCT03154086|101863740|FG005|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||2||
48623583|NCT03154086|101863741|FG006|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623584|NCT03154086|101863742|FG007|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623585|NCT03154086|101863743|FG008|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623586|NCT03154086|101863744|FG009|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623587|NCT03154086|101863745|FG010|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623588|NCT03154086|101863746|FG011|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623589|NCT03154086|101863747|FG012|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623590|NCT03154086|101863748|FG013|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623591|NCT03154086|101863749|FG014|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623592|NCT03154086|101863735|FG000|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48329190|NCT03529773|101132139|FG007|STARTED|Overall Study||12||
48329191|NCT03529773|101132140|FG008|STARTED|Overall Study||12||
48410352|NCT03462030|101334938|FG001|COMPLETED|Overall Study||14||
48329192|NCT03529773|101132141|FG009|STARTED|Overall Study||12||
48329193|NCT03529773|101132142|FG010|STARTED|Overall Study||12||
48329194|NCT03529773|101132143|FG011|STARTED|Overall Study||12||
48329195|NCT03529773|101132144|FG012|STARTED|Overall Study||12||
48329196|NCT03529773|101132145|FG013|STARTED|Overall Study||12||
48329197|NCT03529773|101132146|FG014|STARTED|Overall Study||41||
48329198|NCT03529773|101132147|FG015|STARTED|Overall Study||42||
48329199|NCT03529773|101132148|FG016|STARTED|Overall Study||41||
48329200|NCT03529773|101132149|FG017|STARTED|Overall Study||41||
48329201|NCT03529773|101132150|FG018|STARTED|Overall Study||41||
48329202|NCT03529773|101132151|FG019|STARTED|Overall Study||41||
48329203|NCT03529773|101132152|FG020|STARTED|Overall Study||41||
48329204|NCT03529773|101132153|FG021|STARTED|Overall Study||41||
48329205|NCT03529773|101132154|FG022|STARTED|Overall Study||41||
48329206|NCT03529773|101132155|FG023|STARTED|Overall Study||41||
48329207|NCT03529773|101132156|FG024|STARTED|Overall Study||41||
48329208|NCT03529773|101132157|FG025|STARTED|Overall Study||41||
48329209|NCT03529773|101132158|FG026|STARTED|Overall Study||41||
48329210|NCT03529773|101132159|FG027|STARTED|Overall Study||41||
48329211|NCT03529773|101132160|FG028|STARTED|Overall Study||41||
48329212|NCT03529773|101132161|FG029|STARTED|Overall Study||40||
48329213|NCT03529773|101132162|FG030|STARTED|Overall Study||42||
48329214|NCT03529773|101132163|FG031|STARTED|Overall Study||40||
48329215|NCT03529773|101132164|FG032|STARTED|Overall Study||40||
48329216|NCT03529773|101132165|FG033|STARTED|Overall Study||41||
48329217|NCT03529773|101132166|FG034|STARTED|Overall Study||41||
48329218|NCT03529773|101132167|FG035|STARTED|Overall Study||40||
48329219|NCT03529773|101132168|FG036|STARTED|Overall Study||41||
48329220|NCT03529773|101132169|FG037|STARTED|Overall Study||42||
48329221|NCT03529773|101132170|FG038|STARTED|Overall Study||43||
48329222|NCT03529773|101132171|FG039|STARTED|Overall Study||41||
48329223|NCT03529773|101132132|FG000|COMPLETED|Overall Study||12||
48329224|NCT03529773|101132133|FG001|COMPLETED|Overall Study||12||
48329225|NCT03529773|101132134|FG002|COMPLETED|Overall Study||11||
48329226|NCT03529773|101132135|FG003|COMPLETED|Overall Study||12||
48329227|NCT03529773|101132136|FG004|COMPLETED|Overall Study||11||
48329228|NCT03529773|101132137|FG005|COMPLETED|Overall Study||11||
48329229|NCT03529773|101132138|FG006|COMPLETED|Overall Study||12||
48329230|NCT03529773|101132139|FG007|COMPLETED|Overall Study||11||
48329231|NCT03529773|101132140|FG008|COMPLETED|Overall Study||12||
48329232|NCT03529773|101132141|FG009|COMPLETED|Overall Study||11||
48329233|NCT03529773|101132142|FG010|COMPLETED|Overall Study||11||
48329234|NCT03529773|101132143|FG011|COMPLETED|Overall Study||12||
48329235|NCT03529773|101132144|FG012|COMPLETED|Overall Study||10||
48329236|NCT03529773|101132145|FG013|COMPLETED|Overall Study||11||
48329237|NCT03529773|101132146|FG014|COMPLETED|Overall Study||35||
48329238|NCT03529773|101132147|FG015|COMPLETED|Overall Study||38||
48329239|NCT03529773|101132148|FG016|COMPLETED|Overall Study||40||
48329240|NCT03529773|101132149|FG017|COMPLETED|Overall Study||35||
48329241|NCT03529773|101132150|FG018|COMPLETED|Overall Study||37||
48329242|NCT03529773|101132151|FG019|COMPLETED|Overall Study||37||
48329243|NCT03529773|101132152|FG020|COMPLETED|Overall Study||34||
48329244|NCT03529773|101132153|FG021|COMPLETED|Overall Study||36||
48329245|NCT03529773|101132154|FG022|COMPLETED|Overall Study||34||
48329246|NCT03529773|101132155|FG023|COMPLETED|Overall Study||35||
48329247|NCT03529773|101132156|FG024|COMPLETED|Overall Study||33||
48329248|NCT03529773|101132157|FG025|COMPLETED|Overall Study||30||
48329249|NCT03529773|101132158|FG026|COMPLETED|Overall Study||32||
48329250|NCT03529773|101132159|FG027|COMPLETED|Overall Study||39||
48329251|NCT03529773|101132160|FG028|COMPLETED|Overall Study||40||
48329252|NCT03529773|101132161|FG029|COMPLETED|Overall Study||40||
48329253|NCT03529773|101132162|FG030|COMPLETED|Overall Study||39||
48329254|NCT03529773|101132163|FG031|COMPLETED|Overall Study||40||
48329255|NCT03529773|101132164|FG032|COMPLETED|Overall Study||40||
48329256|NCT03529773|101132165|FG033|COMPLETED|Overall Study||39||
48329257|NCT03529773|101132166|FG034|COMPLETED|Overall Study||37||
48329258|NCT03529773|101132167|FG035|COMPLETED|Overall Study||36||
48329259|NCT03529773|101132168|FG036|COMPLETED|Overall Study||39||
48329260|NCT03529773|101132169|FG037|COMPLETED|Overall Study||36||
48329261|NCT03529773|101132170|FG038|COMPLETED|Overall Study||39||
48329262|NCT03529773|101132171|FG039|COMPLETED|Overall Study||37||
48329263|NCT03529773|101132132|FG000|NOT COMPLETED|Overall Study||0||
48329264|NCT03529773|101132133|FG001|NOT COMPLETED|Overall Study||0||
48329265|NCT03529773|101132134|FG002|NOT COMPLETED|Overall Study||1||
48329266|NCT03529773|101132135|FG003|NOT COMPLETED|Overall Study||0||
48329267|NCT03529773|101132136|FG004|NOT COMPLETED|Overall Study||1||
48329268|NCT03529773|101132137|FG005|NOT COMPLETED|Overall Study||1||
48329269|NCT03529773|101132138|FG006|NOT COMPLETED|Overall Study||0||
48329270|NCT03529773|101132139|FG007|NOT COMPLETED|Overall Study||1||
48329271|NCT03529773|101132140|FG008|NOT COMPLETED|Overall Study||0||
48329272|NCT03529773|101132141|FG009|NOT COMPLETED|Overall Study||1||
48329273|NCT03529773|101132142|FG010|NOT COMPLETED|Overall Study||1||
48329274|NCT03529773|101132143|FG011|NOT COMPLETED|Overall Study||0||
48329275|NCT03529773|101132144|FG012|NOT COMPLETED|Overall Study||2||
48329276|NCT03529773|101132145|FG013|NOT COMPLETED|Overall Study||1||
48329277|NCT03529773|101132146|FG014|NOT COMPLETED|Overall Study||6||
48329278|NCT03529773|101132147|FG015|NOT COMPLETED|Overall Study||4||
48329279|NCT03529773|101132148|FG016|NOT COMPLETED|Overall Study||1||
48329280|NCT03529773|101132149|FG017|NOT COMPLETED|Overall Study||6||
48329281|NCT03529773|101132150|FG018|NOT COMPLETED|Overall Study||4||
48329282|NCT03529773|101132151|FG019|NOT COMPLETED|Overall Study||4||
48329283|NCT03529773|101132152|FG020|NOT COMPLETED|Overall Study||7||
48329284|NCT03529773|101132153|FG021|NOT COMPLETED|Overall Study||5||
48329285|NCT03529773|101132154|FG022|NOT COMPLETED|Overall Study||7||
48329286|NCT03529773|101132155|FG023|NOT COMPLETED|Overall Study||6||
48329287|NCT03529773|101132156|FG024|NOT COMPLETED|Overall Study||8||
48329288|NCT03529773|101132157|FG025|NOT COMPLETED|Overall Study||11||
48329289|NCT03529773|101132158|FG026|NOT COMPLETED|Overall Study||9||
48329290|NCT03529773|101132159|FG027|NOT COMPLETED|Overall Study||2||
48329291|NCT03529773|101132160|FG028|NOT COMPLETED|Overall Study||1||
48329292|NCT03529773|101132161|FG029|NOT COMPLETED|Overall Study||0||
48329293|NCT03529773|101132162|FG030|NOT COMPLETED|Overall Study||3||
48329294|NCT03529773|101132163|FG031|NOT COMPLETED|Overall Study||0||
48329295|NCT03529773|101132164|FG032|NOT COMPLETED|Overall Study||0||
48329296|NCT03529773|101132165|FG033|NOT COMPLETED|Overall Study||2||
48329297|NCT03529773|101132166|FG034|NOT COMPLETED|Overall Study||4||
48329298|NCT03529773|101132167|FG035|NOT COMPLETED|Overall Study||4||
48329299|NCT03529773|101132168|FG036|NOT COMPLETED|Overall Study||2||
48329300|NCT03529773|101132169|FG037|NOT COMPLETED|Overall Study||6||
48329301|NCT03529773|101132170|FG038|NOT COMPLETED|Overall Study||4||
48329302|NCT03529773|101132171|FG039|NOT COMPLETED|Overall Study||4||
48329303|NCT01727895|101132172|FG000|STARTED|Overall Study||10||
48329304|NCT01727895|101132173|FG001|STARTED|Overall Study||5||
48329305|NCT01727895|101132172|FG000|COMPLETED|Overall Study||10||
48329306|NCT01727895|101132173|FG001|COMPLETED|Overall Study||5||
48329307|NCT01727895|101132172|FG000|NOT COMPLETED|Overall Study||0||
48329308|NCT01727895|101132173|FG001|NOT COMPLETED|Overall Study||0||
48329309|NCT03506295|101132174|FG000|STARTED|Overall Study||10||40
48329310|NCT03506295|101132174|FG000|COMPLETED|Overall Study||10||40
48329311|NCT03506295|101132174|FG000|NOT COMPLETED|Overall Study||0||0
48329312|NCT02611154|101132175|FG000|STARTED|Overall Study||5||
48329313|NCT02611154|101132175|FG000|COMPLETED|Overall Study||5||
48329314|NCT02611154|101132175|FG000|NOT COMPLETED|Overall Study||0||
48329315|NCT04356183|101132176|FG000|STARTED|Overall Study||12||
48329316|NCT04356183|101132177|FG001|STARTED|Overall Study||12||
48329317|NCT04356183|101132176|FG000|COMPLETED|Overall Study||10||
48329318|NCT04356183|101132177|FG001|COMPLETED|Overall Study||11||
48329319|NCT04356183|101132176|FG000|NOT COMPLETED|Overall Study||2||
48329320|NCT04356183|101132177|FG001|NOT COMPLETED|Overall Study||1||
48329321|NCT01073566|101132178|FG000|STARTED|Period 1 (6 Weeks)||19||
48329322|NCT01073566|101132179|FG001|STARTED|Period 1 (6 Weeks)||19||
48329323|NCT01073566|101132178|FG000|COMPLETED|Period 1 (6 Weeks)||19||
48329324|NCT01073566|101132179|FG001|COMPLETED|Period 1 (6 Weeks)||19||
48329325|NCT01073566|101132178|FG000|NOT COMPLETED|Period 1 (6 Weeks)||0||
48329326|NCT01073566|101132179|FG001|NOT COMPLETED|Period 1 (6 Weeks)||0||
48329327|NCT01073566|101132178|FG000|STARTED|Period 2 (6 Weeks)||19||
48329328|NCT01073566|101132179|FG001|STARTED|Period 2 (6 Weeks)||19||
48329329|NCT01073566|101132178|FG000|COMPLETED|Period 2 (6 Weeks)||18||
48329330|NCT01073566|101132179|FG001|COMPLETED|Period 2 (6 Weeks)||19||
48329331|NCT01073566|101132178|FG000|NOT COMPLETED|Period 2 (6 Weeks)||1||
48329332|NCT01073566|101132179|FG001|NOT COMPLETED|Period 2 (6 Weeks)||0||
48329333|NCT00763139|101132180|FG000|STARTED|Overall Study||17||
48329334|NCT00763139|101132181|FG001|STARTED|Overall Study||17||
48329335|NCT00763139|101132180|FG000|COMPLETED|Overall Study||12||
48329336|NCT00763139|101132181|FG001|COMPLETED|Overall Study||14||
48329337|NCT00763139|101132180|FG000|NOT COMPLETED|Overall Study||5||
48329338|NCT00763139|101132181|FG001|NOT COMPLETED|Overall Study||3||
48329339|NCT02956382|101132182|FG000|STARTED|Overall Study||3||
48329340|NCT02956382|101132183|FG001|STARTED|Overall Study||6||
48329341|NCT02956382|101132184|FG002|STARTED|Overall Study||6||
48329342|NCT02956382|101132185|FG003|STARTED|Overall Study||1||
48329343|NCT02956382|101132186|FG004|STARTED|Overall Study||8||
48329344|NCT02956382|101132182|FG000|COMPLETED|Overall Study||3||
48329345|NCT02956382|101132183|FG001|COMPLETED|Overall Study||6||
48329346|NCT02956382|101132184|FG002|COMPLETED|Overall Study||6||
48329347|NCT02956382|101132185|FG003|COMPLETED|Overall Study||1||
48329348|NCT02956382|101132186|FG004|COMPLETED|Overall Study||8||
48329349|NCT02956382|101132182|FG000|NOT COMPLETED|Overall Study||0||
48329350|NCT02956382|101132183|FG001|NOT COMPLETED|Overall Study||0||
48329351|NCT02956382|101132184|FG002|NOT COMPLETED|Overall Study||0||
48329352|NCT02956382|101132185|FG003|NOT COMPLETED|Overall Study||0||
48329353|NCT02956382|101132186|FG004|NOT COMPLETED|Overall Study||0||
48329354|NCT04852120|101132187|FG000|STARTED|Overall Study||3000||
48329355|NCT04852120|101132187|FG000|COMPLETED|Overall Study||3000||
48329356|NCT04852120|101132187|FG000|NOT COMPLETED|Overall Study||0||
48329357|NCT01302808|101132188|FG000|STARTED|Overall Study||3||
48329358|NCT01302808|101132189|FG001|STARTED|Overall Study||7||
48329359|NCT01302808|101132190|FG002|STARTED|Overall Study||4||
48329360|NCT01302808|101132191|FG003|STARTED|Overall Study||3||
48329361|NCT01302808|101132188|FG000|COMPLETED|Overall Study||3||
48329362|NCT01302808|101132189|FG001|COMPLETED|Overall Study||7||
48329363|NCT01302808|101132190|FG002|COMPLETED|Overall Study||4||
48329364|NCT01302808|101132191|FG003|COMPLETED|Overall Study||3||
48329365|NCT01302808|101132188|FG000|NOT COMPLETED|Overall Study||0||
48329366|NCT01302808|101132189|FG001|NOT COMPLETED|Overall Study||0||
48329367|NCT01302808|101132190|FG002|NOT COMPLETED|Overall Study||0||
48329368|NCT01302808|101132191|FG003|NOT COMPLETED|Overall Study||0||
48329369|NCT02349178|101132192|FG000|STARTED|Overall Study||6||
48329370|NCT02349178|101132192|FG000|COMPLETED|Overall Study||6||
48329371|NCT02349178|101132192|FG000|NOT COMPLETED|Overall Study||0||
48329372|NCT01515657|101132193|FG000|STARTED|First Intervention||14||
48329373|NCT01515657|101132194|FG001|STARTED|First Intervention||13||
48329374|NCT01515657|101132195|FG002|STARTED|First Intervention||13||
48329375|NCT01515657|101132193|FG000|COMPLETED|First Intervention||14||
48329376|NCT01515657|101132194|FG001|COMPLETED|First Intervention||12||
48329377|NCT01515657|101132195|FG002|COMPLETED|First Intervention||13||
48329378|NCT01515657|101132193|FG000|NOT COMPLETED|First Intervention||0||
48329379|NCT01515657|101132194|FG001|NOT COMPLETED|First Intervention||1||
48329380|NCT01515657|101132195|FG002|NOT COMPLETED|First Intervention||0||
48329381|NCT01515657|101132193|FG000|STARTED|Second Intervention||14||
48329382|NCT01515657|101132194|FG001|STARTED|Second Intervention||12||
48329383|NCT01515657|101132195|FG002|STARTED|Second Intervention||13||
48329384|NCT01515657|101132193|FG000|COMPLETED|Second Intervention||14||
48329385|NCT01515657|101132194|FG001|COMPLETED|Second Intervention||11||
48329386|NCT01515657|101132195|FG002|COMPLETED|Second Intervention||13||
48329387|NCT01515657|101132193|FG000|NOT COMPLETED|Second Intervention||0||
48329388|NCT01515657|101132194|FG001|NOT COMPLETED|Second Intervention||1||
48329389|NCT01515657|101132195|FG002|NOT COMPLETED|Second Intervention||0||
48329390|NCT01515657|101132193|FG000|STARTED|Third Intervention||14||
48329391|NCT01515657|101132194|FG001|STARTED|Third Intervention||11||
48329392|NCT01515657|101132195|FG002|STARTED|Third Intervention||13||
48329393|NCT01515657|101132193|FG000|COMPLETED|Third Intervention||13||
48329394|NCT01515657|101132194|FG001|COMPLETED|Third Intervention||11||
48329395|NCT01515657|101132195|FG002|COMPLETED|Third Intervention||13||
48329396|NCT01515657|101132193|FG000|NOT COMPLETED|Third Intervention||1||
48329397|NCT01515657|101132194|FG001|NOT COMPLETED|Third Intervention||0||
48329398|NCT01515657|101132195|FG002|NOT COMPLETED|Third Intervention||0||
48329399|NCT03340610|101132196|FG000|STARTED|Overall Study||30||
48329400|NCT03340610|101132196|FG000|COMPLETED|Overall Study||27||
48329401|NCT03340610|101132196|FG000|NOT COMPLETED|Overall Study||3||
48329402|NCT02105454|101132197|FG000|STARTED|Overall Study||79||
48329403|NCT02105454|101132197|FG000|COMPLETED|Overall Study||78||
48329404|NCT02105454|101132197|FG000|NOT COMPLETED|Overall Study||1||
48329405|NCT01978093|101132198|FG000|STARTED|Overall Study||297||
48329406|NCT01978093|101132199|FG001|STARTED|Overall Study||303||
48329407|NCT01978093|101132198|FG000|COMPLETED|Overall Study||232||
48329408|NCT01978093|101132199|FG001|COMPLETED|Overall Study||230||
48329409|NCT01978093|101132198|FG000|NOT COMPLETED|Overall Study||65||
48329410|NCT01978093|101132199|FG001|NOT COMPLETED|Overall Study||73||
48329411|NCT03847610|101132200|FG000|STARTED|Overall Study||11||
48329412|NCT03847610|101132200|FG000|COMPLETED|Overall Study||10||
48329413|NCT03847610|101132200|FG000|NOT COMPLETED|Overall Study||1||
48329414|NCT03987854|101132201|FG000|STARTED|Overall Study||29||
48329415|NCT03987854|101132201|FG000|COMPLETED|Overall Study||21||
48329416|NCT03987854|101132201|FG000|NOT COMPLETED|Overall Study||8||
48329417|NCT03650192|101132202|FG000|STARTED|Overall Study||40||
48329418|NCT03650192|101132202|FG000|COMPLETED|Overall Study||40||
48329419|NCT03650192|101132202|FG000|NOT COMPLETED|Overall Study||0||
48329420|NCT01514682|101132203|FG000|STARTED|Overall Study||19||
48329421|NCT01514682|101132204|FG001|STARTED|Overall Study||20||
48329422|NCT01514682|101132203|FG000|COMPLETED|Overall Study||13||
48329423|NCT01514682|101132204|FG001|COMPLETED|Overall Study||14||
48329424|NCT01514682|101132203|FG000|NOT COMPLETED|Overall Study||6||
48329425|NCT01514682|101132204|FG001|NOT COMPLETED|Overall Study||6||
48329426|NCT01977781|101132205|FG000|STARTED|Overall Study||24||
48329427|NCT01977781|101132206|FG001|STARTED|Overall Study||16||
48329428|NCT01977781|101132205|FG000|COMPLETED|Overall Study||18||
48329429|NCT01977781|101132206|FG001|COMPLETED|Overall Study||15||
48329430|NCT01977781|101132205|FG000|NOT COMPLETED|Overall Study||6||
48329431|NCT01977781|101132206|FG001|NOT COMPLETED|Overall Study||1||
48329432|NCT01609842|101132207|FG000|STARTED|Pre-Intervention Control||0||
48329433|NCT01609842|101132208|FG001|STARTED|Pre-Intervention Control||6081||
48329434|NCT01609842|101132207|FG000|COMPLETED|Pre-Intervention Control||0||
48329435|NCT01609842|101132208|FG001|COMPLETED|Pre-Intervention Control||6081||
48329436|NCT01609842|101132207|FG000|NOT COMPLETED|Pre-Intervention Control||0||
48329437|NCT01609842|101132208|FG001|NOT COMPLETED|Pre-Intervention Control||0||
48329438|NCT01609842|101132207|FG000|STARTED|Post-Intervention Control||0||
48329439|NCT01609842|101132208|FG001|STARTED|Post-Intervention Control||2917||
48329440|NCT01609842|101132207|FG000|COMPLETED|Post-Intervention Control||0||
48329441|NCT01609842|101132208|FG001|COMPLETED|Post-Intervention Control||2917||
48329442|NCT01609842|101132207|FG000|NOT COMPLETED|Post-Intervention Control||0||
48329443|NCT01609842|101132208|FG001|NOT COMPLETED|Post-Intervention Control||0||
48329444|NCT01609842|101132207|FG000|STARTED|Concurrent Intervention Control||708||
48329445|NCT01609842|101132208|FG001|STARTED|Concurrent Intervention Control||4869||
48329446|NCT01609842|101132207|FG000|COMPLETED|Concurrent Intervention Control||706||
48329447|NCT01609842|101132208|FG001|COMPLETED|Concurrent Intervention Control||4869||
48329448|NCT01609842|101132207|FG000|NOT COMPLETED|Concurrent Intervention Control||2||
48329449|NCT01609842|101132208|FG001|NOT COMPLETED|Concurrent Intervention Control||0||
48329450|NCT00490568|101132209|FG000|STARTED|Overall Study||1461||
48329451|NCT00490568|101132209|FG000|COMPLETED|Overall Study||97||
48329452|NCT00490568|101132209|FG000|NOT COMPLETED|Overall Study||1364||
48329453|NCT03733392|101132210|FG000|STARTED|Overall Study||339||
48329454|NCT03733392|101132211|FG001|STARTED|Overall Study||40||
48329455|NCT03733392|101132210|FG000|Ablation Procedure|Overall Study||334||
48329456|NCT03733392|101132211|FG001|Ablation Procedure|Overall Study||38||
48329457|NCT03733392|101132210|FG000|Pre-Discharge|Overall Study||334||
48410353|NCT03462030|101334937|FG000|NOT COMPLETED|Overall Study||1||
48410354|NCT03462030|101334938|FG001|NOT COMPLETED|Overall Study||1||
48410355|NCT01564485|101334939|FG000|STARTED|Overall Study||92||
48410356|NCT01564485|101334940|FG001|STARTED|Overall Study||101||
48745990|NCT00431626|102165788|FG001|NOT COMPLETED|Overall Study||0||
48745991|NCT01128049|102165789|FG000|STARTED|Overall Study||5||
48745992|NCT01128049|102165790|FG001|STARTED|Overall Study||5||
48745993|NCT01128049|102165791|FG002|STARTED|Overall Study||5||
48745994|NCT01128049|102165789|FG000|COMPLETED|Overall Study||5||
48745995|NCT01128049|102165790|FG001|COMPLETED|Overall Study||5||
48410357|NCT01564485|101334939|FG000|COMPLETED|Overall Study||84||
48410358|NCT01564485|101334940|FG001|COMPLETED|Overall Study||78||
48410359|NCT01564485|101334939|FG000|NOT COMPLETED|Overall Study||8||
48410360|NCT01564485|101334940|FG001|NOT COMPLETED|Overall Study||23||
48410361|NCT03017040|101334941|FG000|STARTED|Overall Study||1||1
48410362|NCT03017040|101334942|FG001|STARTED|Overall Study||1||1
48410363|NCT03017040|101334941|FG000|COMPLETED|Overall Study||0||0
48410364|NCT03017040|101334942|FG001|COMPLETED|Overall Study||0||0
48166328|NCT00603265|100728718|FG002|COMPLETED|Overall Study||67||
48166329|NCT00603265|100728716|FG000|NOT COMPLETED|Overall Study||7||
48166330|NCT00603265|100728717|FG001|NOT COMPLETED|Overall Study||16||
48166331|NCT00603265|100728718|FG002|NOT COMPLETED|Overall Study||5||
48329458|NCT03733392|101132211|FG001|Pre-Discharge|Overall Study||37||
48410365|NCT03017040|101334941|FG000|NOT COMPLETED|Overall Study||1||1
48410366|NCT03017040|101334942|FG001|NOT COMPLETED|Overall Study||1||1
48410367|NCT02482389|101334943|FG000|STARTED|Overall Study||3||
48410368|NCT02482389|101334943|FG000|COMPLETED|Overall Study||3||
48166332|NCT00944658|100728719|FG000|STARTED|Treatment 12 Weeks||19||
48166333|NCT00944658|100728720|FG001|STARTED|Treatment 12 Weeks||19||
48329459|NCT03733392|101132210|FG000|6-month Follow-Up|Overall Study||312||
48410369|NCT02482389|101334943|FG000|NOT COMPLETED|Overall Study||0||
48410370|NCT03531762|101334944|FG000|STARTED|Treatment Period 1 (8-12 Days)||2||
48410371|NCT03531762|101334945|FG001|STARTED|Treatment Period 1 (8-12 Days)||2||
48410372|NCT03531762|101334946|FG002|STARTED|Treatment Period 1 (8-12 Days)||2||
48410373|NCT03531762|101334947|FG003|STARTED|Treatment Period 1 (8-12 Days)||2||
48745996|NCT01128049|102165791|FG002|COMPLETED|Overall Study||5||
48745997|NCT01128049|102165789|FG000|NOT COMPLETED|Overall Study||0||
48745998|NCT01128049|102165790|FG001|NOT COMPLETED|Overall Study||0||
48745999|NCT01128049|102165791|FG002|NOT COMPLETED|Overall Study||0||
48166334|NCT00944658|100728719|FG000|COMPLETED|Treatment 12 Weeks||19||
48166335|NCT00944658|100728720|FG001|COMPLETED|Treatment 12 Weeks||17||
48329460|NCT03733392|101132211|FG001|6-month Follow-Up|Overall Study||28||
48329461|NCT03733392|101132210|FG000|12-Month Follow-Up|Overall Study||299||
48410374|NCT03531762|101334948|FG004|STARTED|Treatment Period 1 (8-12 Days)||2||
48410375|NCT03531762|101334949|FG005|STARTED|Treatment Period 1 (8-12 Days)||2||
48746000|NCT02734693|102165792|FG000|STARTED|Overall Study||56||
48746001|NCT02734693|102165793|FG001|STARTED|Overall Study||56||
48746002|NCT02734693|102165794|FG002|STARTED|Overall Study||20||
48410376|NCT03531762|101334944|FG000|COMPLETED|Treatment Period 1 (8-12 Days)||2||
48410377|NCT03531762|101334945|FG001|COMPLETED|Treatment Period 1 (8-12 Days)||2||
48329462|NCT03733392|101132211|FG001|12-Month Follow-Up|Overall Study||26||
48329463|NCT03733392|101132210|FG000|COMPLETED|Overall Study||299||
48329464|NCT03733392|101132211|FG001|COMPLETED|Overall Study||26||
48329465|NCT03733392|101132210|FG000|NOT COMPLETED|Overall Study||40||
48329466|NCT03733392|101132211|FG001|NOT COMPLETED|Overall Study||14||
48329467|NCT00915343|101132212|FG000|STARTED|Part A - First Intervention Period||32||
48329468|NCT00915343|101132213|FG001|STARTED|Part A - First Intervention Period||32||
48329469|NCT00915343|101132214|FG002|STARTED|Part A - First Intervention Period||0||
48329470|NCT00915343|101132212|FG000|COMPLETED|Part A - First Intervention Period||32||
48329471|NCT00915343|101132213|FG001|COMPLETED|Part A - First Intervention Period||32||
48623593|NCT03154086|101863736|FG001|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623594|NCT03154086|101863737|FG002|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48329472|NCT00915343|101132214|FG002|COMPLETED|Part A - First Intervention Period||0||
48166336|NCT00944658|100728719|FG000|NOT COMPLETED|Treatment 12 Weeks||0||
48746003|NCT02734693|102165792|FG000|COMPLETED|Overall Study||50||
48746004|NCT02734693|102165793|FG001|COMPLETED|Overall Study||53||
48746005|NCT02734693|102165794|FG002|COMPLETED|Overall Study||17||
48746006|NCT02734693|102165792|FG000|NOT COMPLETED|Overall Study||6||
48746007|NCT02734693|102165793|FG001|NOT COMPLETED|Overall Study||3||
48746008|NCT02734693|102165794|FG002|NOT COMPLETED|Overall Study||3||
48746009|NCT01507688|102165795|FG000|STARTED|Baseline to 6 Month Assessment||129||
48746010|NCT01507688|102165796|FG001|STARTED|Baseline to 6 Month Assessment||129||
48746011|NCT01507688|102165795|FG000|COMPLETED|Baseline to 6 Month Assessment||113||
48746012|NCT01507688|102165796|FG001|COMPLETED|Baseline to 6 Month Assessment||119||
48746013|NCT01507688|102165795|FG000|NOT COMPLETED|Baseline to 6 Month Assessment||16||
48746014|NCT01507688|102165796|FG001|NOT COMPLETED|Baseline to 6 Month Assessment||10||
48746015|NCT01507688|102165795|FG000|STARTED|6 Month to 12 Month Assessment||113||
48746016|NCT01507688|102165796|FG001|STARTED|6 Month to 12 Month Assessment||119||
48746017|NCT01507688|102165795|FG000|COMPLETED|6 Month to 12 Month Assessment||108||
48746018|NCT01507688|102165796|FG001|COMPLETED|6 Month to 12 Month Assessment||116||
48746019|NCT01507688|102165795|FG000|NOT COMPLETED|6 Month to 12 Month Assessment||5||
48746020|NCT01507688|102165796|FG001|NOT COMPLETED|6 Month to 12 Month Assessment||3||
48746021|NCT01855412|102165797|FG000|STARTED|Overall Study||501||
48746022|NCT01855412|102165798|FG001|STARTED|Overall Study||603||
48746023|NCT01855412|102165799|FG002|STARTED|Overall Study||100||
48746024|NCT01855412|102165797|FG000|COMPLETED|Overall Study||289||
48746025|NCT01855412|102165798|FG001|COMPLETED|Overall Study||260||
48746026|NCT01855412|102165799|FG002|COMPLETED|Overall Study||24||
48746027|NCT01855412|102165797|FG000|NOT COMPLETED|Overall Study||212||
48746028|NCT01855412|102165798|FG001|NOT COMPLETED|Overall Study||343||
48746029|NCT01855412|102165799|FG002|NOT COMPLETED|Overall Study||76||
48746030|NCT01253291|102165800|FG000|STARTED|Overall Study||6||
48746031|NCT01253291|102165801|FG001|STARTED|Overall Study||6||
48746032|NCT01253291|102165802|FG002|STARTED|Overall Study||4||
48746033|NCT01253291|102165803|FG003|STARTED|Overall Study||5||
48746034|NCT01253291|102165804|FG004|STARTED|Overall Study||5||
48746035|NCT01253291|102165800|FG000|Received Study Drug During BCDL|Overall Study||6||
48746036|NCT01253291|102165801|FG001|Received Study Drug During BCDL|Overall Study||6||
48746037|NCT01253291|102165802|FG002|Received Study Drug During BCDL|Overall Study||4||
48746038|NCT01253291|102165803|FG003|Received Study Drug During BCDL|Overall Study||5||
48746039|NCT01253291|102165804|FG004|Received Study Drug During BCDL|Overall Study||5||
48746040|NCT01253291|102165800|FG000|COMPLETED|Overall Study||2||
48746041|NCT01253291|102165801|FG001|COMPLETED|Overall Study||4||
48746042|NCT01253291|102165802|FG002|COMPLETED|Overall Study||4||
48746043|NCT01253291|102165803|FG003|COMPLETED|Overall Study||5||
48746044|NCT01253291|102165804|FG004|COMPLETED|Overall Study||3||
48746045|NCT01253291|102165800|FG000|NOT COMPLETED|Overall Study||4||
48746046|NCT01253291|102165801|FG001|NOT COMPLETED|Overall Study||2||
48746047|NCT01253291|102165802|FG002|NOT COMPLETED|Overall Study||0||
48746048|NCT01253291|102165803|FG003|NOT COMPLETED|Overall Study||0||
48746049|NCT01253291|102165804|FG004|NOT COMPLETED|Overall Study||2||
48746050|NCT03553758|102165805|FG000|STARTED|Overall Study||16||
48746051|NCT03553758|102165805|FG000|Completed Screening Visit|Overall Study||16||
48746052|NCT03553758|102165805|FG000|COMPLETED|Overall Study||15||
48746053|NCT03553758|102165805|FG000|NOT COMPLETED|Overall Study||1||
48746054|NCT00759161|102165806|FG000|STARTED|Overall Study||35||
48746055|NCT00759161|102165806|FG000|COMPLETED|Overall Study||35||
48746056|NCT00759161|102165806|FG000|NOT COMPLETED|Overall Study||0||
48746057|NCT04437485|102165807|FG000|STARTED|Overall Study||24||
48746058|NCT04437485|102165808|FG001|STARTED|Overall Study||22||
48746059|NCT04437485|102165807|FG000|COMPLETED|Overall Study||21||
48746060|NCT04437485|102165808|FG001|COMPLETED|Overall Study||18||
48746061|NCT04437485|102165807|FG000|NOT COMPLETED|Overall Study||3||
48746062|NCT04437485|102165808|FG001|NOT COMPLETED|Overall Study||4||
48746063|NCT03218384|102165809|FG000|STARTED|Overall Study||3||
48657115|NCT03761914|101943782|FG004|NOT COMPLETED|Overall Study||0||
48166337|NCT00944658|100728720|FG001|NOT COMPLETED|Treatment 12 Weeks||2||
48166338|NCT00944658|100728719|FG000|STARTED|Follow up 4 Weeks||19||
48166339|NCT00944658|100728720|FG001|STARTED|Follow up 4 Weeks||17||
48166340|NCT00944658|100728719|FG000|COMPLETED|Follow up 4 Weeks||19||
48166341|NCT00944658|100728720|FG001|COMPLETED|Follow up 4 Weeks||17||
48166342|NCT00944658|100728719|FG000|NOT COMPLETED|Follow up 4 Weeks||0||
48166343|NCT00944658|100728720|FG001|NOT COMPLETED|Follow up 4 Weeks||0||
48166344|NCT01674621|100728721|FG000|STARTED|Overall Study||50||
48166345|NCT01674621|100728722|FG001|STARTED|Overall Study||51||
48166346|NCT01674621|100728723|FG002|STARTED|Overall Study||48||
48166347|NCT01674621|100728724|FG003|STARTED|Overall Study||51||
48166348|NCT01674621|100728725|FG004|STARTED|Overall Study||50||
48188608|NCT00432159|100783282|FG000|NOT COMPLETED|Overall Study||22||
48623595|NCT03154086|101863738|FG003|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623596|NCT03154086|101863739|FG004|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623597|NCT03154086|101863740|FG005|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623598|NCT03154086|101863741|FG006|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623599|NCT03154086|101863742|FG007|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623600|NCT03154086|101863743|FG008|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623601|NCT03154086|101863744|FG009|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623602|NCT03154086|101863745|FG010|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623603|NCT03154086|101863746|FG011|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623604|NCT03154086|101863747|FG012|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623605|NCT03154086|101863748|FG013|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623606|NCT03154086|101863749|FG014|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
48623607|NCT03154086|101863735|FG000|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623608|NCT03154086|101863736|FG001|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623609|NCT03154086|101863737|FG002|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623610|NCT03154086|101863738|FG003|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623611|NCT03154086|101863739|FG004|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||6||
48623612|NCT03154086|101863740|FG005|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||2||
48623613|NCT03154086|101863741|FG006|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623614|NCT03154086|101863742|FG007|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623615|NCT03154086|101863743|FG008|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623616|NCT03154086|101863744|FG009|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48746064|NCT03218384|102165810|FG001|STARTED|Overall Study||3||
48746065|NCT03218384|102165809|FG000|COMPLETED|Overall Study||3||
48746066|NCT03218384|102165810|FG001|COMPLETED|Overall Study||3||
48746067|NCT03218384|102165809|FG000|NOT COMPLETED|Overall Study||0||
48746068|NCT03218384|102165810|FG001|NOT COMPLETED|Overall Study||0||
48746069|NCT05757648|102165811|FG000|STARTED|Overall Study||20||40
48746070|NCT05757648|102165811|FG000|COMPLETED|Overall Study||20||40
48746071|NCT05757648|102165811|FG000|NOT COMPLETED|Overall Study||0||0
48746072|NCT01453140|102165812|FG000|STARTED|Overall Study||3||
48746073|NCT01453140|102165812|FG000|COMPLETED|Overall Study||0||
48746074|NCT01453140|102165812|FG000|NOT COMPLETED|Overall Study||3||
48746075|NCT00684996|102165813|FG000|STARTED|Overall Study||5||
48746076|NCT00684996|102165813|FG000|Eligible|Overall Study||5||
48746077|NCT00684996|102165813|FG000|COMPLETED|Overall Study||0||
48746078|NCT00684996|102165813|FG000|NOT COMPLETED|Overall Study||5||
48746079|NCT00590187|102165814|FG000|STARTED|Overall Study||40||
48746080|NCT00590187|102165815|FG001|STARTED|Overall Study||20||
48746081|NCT00590187|102165816|FG002|STARTED|Overall Study||45||
48746082|NCT00590187|102165814|FG000|COMPLETED|Overall Study||40||
48746083|NCT00590187|102165815|FG001|COMPLETED|Overall Study||20||
48746084|NCT00590187|102165816|FG002|COMPLETED|Overall Study||45||
48746085|NCT00590187|102165814|FG000|NOT COMPLETED|Overall Study||0||
48746086|NCT00590187|102165815|FG001|NOT COMPLETED|Overall Study||0||
48746087|NCT00590187|102165816|FG002|NOT COMPLETED|Overall Study||0||
48746088|NCT03101566|102165817|FG000|STARTED|Overall Study||37||
48746089|NCT03101566|102165818|FG001|STARTED|Overall Study||38||
48746090|NCT03101566|102165817|FG000|Received at Least One Dose of Protocol Therapy|Overall Study||35||
48746091|NCT03101566|102165818|FG001|Received at Least One Dose of Protocol Therapy|Overall Study||33||
48746092|NCT03101566|102165817|FG000|Assessed for Primary and Secondary Progression-free Survival|Overall Study||32||
48746093|NCT03101566|102165818|FG001|Assessed for Primary and Secondary Progression-free Survival|Overall Study||33||
48746094|NCT03101566|102165817|FG000|COMPLETED|Overall Study||31||
48746095|NCT03101566|102165818|FG001|COMPLETED|Overall Study||31||
48746096|NCT03101566|102165817|FG000|NOT COMPLETED|Overall Study||6||
48746097|NCT03101566|102165818|FG001|NOT COMPLETED|Overall Study||7||
48746098|NCT04528641|102165819|FG000|STARTED|Overall Study||15||
48746099|NCT04528641|102165820|FG001|STARTED|Overall Study||15||
48746100|NCT04528641|102165821|FG002|STARTED|Overall Study||15||
48746101|NCT04528641|102165822|FG003|STARTED|Overall Study||16||
48746102|NCT04528641|102165823|FG004|STARTED|Overall Study||15||
48746103|NCT04528641|102165824|FG005|STARTED|Overall Study||15||
48746104|NCT04528641|102165819|FG000|COMPLETED|Overall Study||15||
48746105|NCT04528641|102165820|FG001|COMPLETED|Overall Study||15||
48746106|NCT04528641|102165821|FG002|COMPLETED|Overall Study||15||
48746107|NCT04528641|102165822|FG003|COMPLETED|Overall Study||15||
48746108|NCT04528641|102165823|FG004|COMPLETED|Overall Study||15||
48746109|NCT04528641|102165824|FG005|COMPLETED|Overall Study||14||
48623617|NCT03154086|101863745|FG010|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623618|NCT03154086|101863746|FG011|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48746110|NCT04528641|102165819|FG000|NOT COMPLETED|Overall Study||0||
48746111|NCT04528641|102165820|FG001|NOT COMPLETED|Overall Study||0||
48746112|NCT04528641|102165821|FG002|NOT COMPLETED|Overall Study||0||
48746113|NCT04528641|102165822|FG003|NOT COMPLETED|Overall Study||1||
48746114|NCT04528641|102165823|FG004|NOT COMPLETED|Overall Study||0||
48746115|NCT04528641|102165824|FG005|NOT COMPLETED|Overall Study||1||
48746116|NCT00580723|102165825|FG000|STARTED|Overall Study||24||
48623619|NCT03154086|101863747|FG012|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623620|NCT03154086|101863748|FG013|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623621|NCT03154086|101863749|FG014|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623622|NCT03154086|101863735|FG000|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623623|NCT03154086|101863736|FG001|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623624|NCT03154086|101863737|FG002|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623625|NCT03154086|101863738|FG003|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623626|NCT03154086|101863739|FG004|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||6||
48623627|NCT03154086|101863740|FG005|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||2||
48623628|NCT03154086|101863741|FG006|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623629|NCT03154086|101863742|FG007|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623630|NCT03154086|101863743|FG008|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623631|NCT03154086|101863744|FG009|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623632|NCT03154086|101863745|FG010|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623633|NCT03154086|101863746|FG011|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623634|NCT03154086|101863747|FG012|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623635|NCT03154086|101863748|FG013|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623636|NCT03154086|101863749|FG014|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623637|NCT03154086|101863735|FG000|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623638|NCT03154086|101863736|FG001|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623639|NCT03154086|101863737|FG002|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623640|NCT03154086|101863738|FG003|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623641|NCT03154086|101863739|FG004|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623642|NCT03154086|101863740|FG005|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623643|NCT03154086|101863741|FG006|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623644|NCT03154086|101863742|FG007|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623645|NCT03154086|101863743|FG008|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623646|NCT03154086|101863744|FG009|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623647|NCT03154086|101863745|FG010|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48746117|NCT00580723|102165825|FG000|COMPLETED|Overall Study||16||
48746118|NCT00580723|102165825|FG000|NOT COMPLETED|Overall Study||8||
48746119|NCT01156714|102165826|FG000|STARTED|Overall Study||20||
48746120|NCT01156714|102165827|FG001|STARTED|Overall Study||19||
48746121|NCT01156714|102165828|FG002|STARTED|Overall Study||20||
48746122|NCT01156714|102165826|FG000|COMPLETED|Overall Study||11||
48746123|NCT01156714|102165827|FG001|COMPLETED|Overall Study||15||
48746124|NCT01156714|102165828|FG002|COMPLETED|Overall Study||17||
48746125|NCT01156714|102165826|FG000|NOT COMPLETED|Overall Study||9||
48746126|NCT01156714|102165827|FG001|NOT COMPLETED|Overall Study||4||
48746127|NCT01156714|102165828|FG002|NOT COMPLETED|Overall Study||3||
48746128|NCT01787461|102165829|FG000|STARTED|Overall Study||96||
48746129|NCT01787461|102165830|FG001|STARTED|Overall Study||98||
48746130|NCT01787461|102165829|FG000|COMPLETED|Overall Study||82||
48746131|NCT01787461|102165830|FG001|COMPLETED|Overall Study||89||
48746132|NCT01787461|102165829|FG000|NOT COMPLETED|Overall Study||14||
48746133|NCT01787461|102165830|FG001|NOT COMPLETED|Overall Study||9||
48746134|NCT02354235|102165831|FG000|STARTED|Overall Study||70||
48746135|NCT02354235|102165832|FG001|STARTED|Overall Study||68||
48746136|NCT02354235|102165831|FG000|COMPLETED|Overall Study||67||
48746137|NCT02354235|102165832|FG001|COMPLETED|Overall Study||61||
48746138|NCT02354235|102165831|FG000|NOT COMPLETED|Overall Study||3||
48746139|NCT02354235|102165832|FG001|NOT COMPLETED|Overall Study||7||
48746140|NCT01011673|102165833|FG000|STARTED|Randomized||62||
48623648|NCT03154086|101863746|FG011|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623649|NCT03154086|101863747|FG012|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623650|NCT03154086|101863748|FG013|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48746141|NCT01011673|102165834|FG001|STARTED|Randomized||61||
48746142|NCT01011673|102165833|FG000|COMPLETED|Randomized||60||
48746143|NCT01011673|102165834|FG001|COMPLETED|Randomized||60||
48623651|NCT03154086|101863749|FG014|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
48623652|NCT03154086|101863735|FG000|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623653|NCT03154086|101863736|FG001|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48746144|NCT01011673|102165833|FG000|NOT COMPLETED|Randomized||2||
48746145|NCT01011673|102165834|FG001|NOT COMPLETED|Randomized||1||
48746146|NCT01011673|102165833|FG000|STARTED|Emergency Department Portion||60||
48746147|NCT01011673|102165834|FG001|STARTED|Emergency Department Portion||60||
48746148|NCT01011673|102165833|FG000|COMPLETED|Emergency Department Portion||60||
48746149|NCT01011673|102165834|FG001|COMPLETED|Emergency Department Portion||60||
48746150|NCT01011673|102165833|FG000|NOT COMPLETED|Emergency Department Portion||0||
48746151|NCT01011673|102165834|FG001|NOT COMPLETED|Emergency Department Portion||0||
48746152|NCT01011673|102165833|FG000|STARTED|24 Hour Follow-up||60||
48746153|NCT01011673|102165834|FG001|STARTED|24 Hour Follow-up||60||
48746154|NCT01011673|102165833|FG000|COMPLETED|24 Hour Follow-up||57||
48746155|NCT01011673|102165834|FG001|COMPLETED|24 Hour Follow-up||57||
48623654|NCT03154086|101863737|FG002|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623655|NCT03154086|101863738|FG003|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623656|NCT03154086|101863739|FG004|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||6||
48623657|NCT03154086|101863740|FG005|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||2||
48623658|NCT03154086|101863741|FG006|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623659|NCT03154086|101863742|FG007|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623660|NCT03154086|101863743|FG008|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623661|NCT03154086|101863744|FG009|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623662|NCT03154086|101863745|FG010|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623663|NCT03154086|101863746|FG011|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623664|NCT03154086|101863747|FG012|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623665|NCT03154086|101863748|FG013|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623666|NCT03154086|101863749|FG014|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623667|NCT03154086|101863735|FG000|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623668|NCT03154086|101863736|FG001|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623669|NCT03154086|101863737|FG002|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623670|NCT03154086|101863738|FG003|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623671|NCT03154086|101863739|FG004|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||6||
48623672|NCT03154086|101863740|FG005|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||2||
48623673|NCT03154086|101863741|FG006|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623674|NCT03154086|101863742|FG007|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623675|NCT03154086|101863743|FG008|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623676|NCT03154086|101863744|FG009|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623677|NCT03154086|101863745|FG010|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623678|NCT03154086|101863746|FG011|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623679|NCT03154086|101863747|FG012|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623680|NCT03154086|101863748|FG013|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623681|NCT03154086|101863749|FG014|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623682|NCT03154086|101863735|FG000|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623683|NCT03154086|101863736|FG001|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623684|NCT03154086|101863737|FG002|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623685|NCT03154086|101863738|FG003|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623686|NCT03154086|101863739|FG004|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623687|NCT03154086|101863740|FG005|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623688|NCT03154086|101863741|FG006|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623689|NCT03154086|101863742|FG007|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623690|NCT03154086|101863743|FG008|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623691|NCT03154086|101863744|FG009|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623692|NCT03154086|101863745|FG010|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623693|NCT03154086|101863746|FG011|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623694|NCT03154086|101863747|FG012|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623695|NCT03154086|101863748|FG013|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623696|NCT03154086|101863749|FG014|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
48623697|NCT03154086|101863735|FG000|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48623698|NCT03154086|101863736|FG001|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48623699|NCT03154086|101863737|FG002|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48623700|NCT03154086|101863738|FG003|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48746156|NCT01011673|102165833|FG000|NOT COMPLETED|24 Hour Follow-up||3||
48746157|NCT01011673|102165834|FG001|NOT COMPLETED|24 Hour Follow-up||3||
48746158|NCT04140396|102165835|FG000|STARTED|Overall Study||0||
48746159|NCT04140396|102165836|FG001|STARTED|Overall Study||1||
48746160|NCT04140396|102165835|FG000|COMPLETED|Overall Study||0||
48746161|NCT04140396|102165836|FG001|COMPLETED|Overall Study||1||
48746162|NCT04140396|102165835|FG000|NOT COMPLETED|Overall Study||0||
48746163|NCT04140396|102165836|FG001|NOT COMPLETED|Overall Study||0||
48746164|NCT04073186|102165837|FG000|STARTED|First Wearing Cycle||86||
48746165|NCT04073186|102165837|FG000|COMPLETED|First Wearing Cycle||80||
48746166|NCT04073186|102165837|FG000|NOT COMPLETED|First Wearing Cycle||6||
48746167|NCT04073186|102165837|FG000|STARTED|Second Wearing Cycle||80||
48746168|NCT04073186|102165837|FG000|COMPLETED|Second Wearing Cycle||79||
48746169|NCT04073186|102165837|FG000|NOT COMPLETED|Second Wearing Cycle||1||
48746170|NCT02611479|102165838|FG000|STARTED|Baseline Enrollment||184||
48623701|NCT03154086|101863739|FG004|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48746171|NCT02611479|102165838|FG000|COMPLETED|Baseline Enrollment||171||
48746172|NCT02611479|102165838|FG000|NOT COMPLETED|Baseline Enrollment||13||
48746173|NCT02611479|102165838|FG000|STARTED|Post-Surgery Follow-up at 30-90 Days||171||
48166349|NCT01674621|100728721|FG000|Modified Intent-to-Treat Population|Overall Study||47|Randomized participants with pretreatment and end-of-treatment evaluable radiologic assessments.|
48166350|NCT01674621|100728722|FG001|Modified Intent-to-Treat Population|Overall Study||46|Randomized participants with pretreatment and end-of-treatment evaluable radiologic assessments.|
48166351|NCT01674621|100728723|FG002|Modified Intent-to-Treat Population|Overall Study||43|Randomized participants with pretreatment and end-of-treatment evaluable radiologic assessments.|
48329473|NCT00915343|101132212|FG000|NOT COMPLETED|Part A - First Intervention Period||0||
48329474|NCT00915343|101132213|FG001|NOT COMPLETED|Part A - First Intervention Period||0||
48623702|NCT03154086|101863740|FG005|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48623703|NCT03154086|101863741|FG006|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||2||
48623704|NCT03154086|101863742|FG007|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||2||
48623705|NCT03154086|101863743|FG008|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||4||
48623706|NCT03154086|101863744|FG009|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48623707|NCT03154086|101863745|FG010|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48623708|NCT03154086|101863746|FG011|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48623709|NCT03154086|101863747|FG012|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48166352|NCT01674621|100728724|FG003|Modified Intent-to-Treat Population|Overall Study||49|Randomized participants with pretreatment and end-of-treatment evaluable radiologic assessments.|
48166353|NCT01674621|100728725|FG004|Modified Intent-to-Treat Population|Overall Study||46|Randomized participants with pretreatment and end-of-treatment evaluable radiologic assessments.|
48166354|NCT01674621|100728721|FG000|Safety Population|Overall Study||50|All participants who received 1 or more doses of study medication.|
48166355|NCT01674621|100728722|FG001|Safety Population|Overall Study||51|All participants who received 1 or more doses of study medication.|
48166356|NCT01674621|100728723|FG002|Safety Population|Overall Study||47|All participants who received 1 or more doses of study medication.|
48166357|NCT01674621|100728724|FG003|Safety Population|Overall Study||51|All participants who received 1 or more doses of study medication.|
48166358|NCT01674621|100728725|FG004|Safety Population|Overall Study||50|All participants who received 1 or more doses of study medication.|
48166359|NCT01674621|100728721|FG000|COMPLETED|Overall Study||45||
48166360|NCT01674621|100728722|FG001|COMPLETED|Overall Study||43||
48166361|NCT01674621|100728723|FG002|COMPLETED|Overall Study||41||
48166362|NCT01674621|100728724|FG003|COMPLETED|Overall Study||45||
48166363|NCT01674621|100728725|FG004|COMPLETED|Overall Study||44||
48166364|NCT01674621|100728721|FG000|NOT COMPLETED|Overall Study||5||
48329475|NCT00915343|101132214|FG002|NOT COMPLETED|Part A - First Intervention Period||0||
48329476|NCT00915343|101132212|FG000|STARTED|Part A - Second Intervention Period||32||
48329477|NCT00915343|101132213|FG001|STARTED|Part A - Second Intervention Period||32||
48329478|NCT00915343|101132214|FG002|STARTED|Part A - Second Intervention Period||0||
48329479|NCT00915343|101132212|FG000|COMPLETED|Part A - Second Intervention Period||32||
48329480|NCT00915343|101132213|FG001|COMPLETED|Part A - Second Intervention Period||32||
48623710|NCT03154086|101863748|FG013|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48623711|NCT03154086|101863749|FG014|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48623712|NCT03154086|101863735|FG000|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48623713|NCT03154086|101863736|FG001|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48623714|NCT03154086|101863737|FG002|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48623715|NCT03154086|101863738|FG003|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48329481|NCT00915343|101132214|FG002|COMPLETED|Part A - Second Intervention Period||0||
48329482|NCT00915343|101132212|FG000|NOT COMPLETED|Part A - Second Intervention Period||0||
48329483|NCT00915343|101132213|FG001|NOT COMPLETED|Part A - Second Intervention Period||0||
48329484|NCT00915343|101132214|FG002|NOT COMPLETED|Part A - Second Intervention Period||0||
48623716|NCT03154086|101863739|FG004|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48623717|NCT03154086|101863740|FG005|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48623718|NCT03154086|101863741|FG006|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||2||
48623719|NCT03154086|101863742|FG007|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||2||
48623720|NCT03154086|101863743|FG008|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||4||
48623721|NCT03154086|101863744|FG009|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48623722|NCT03154086|101863745|FG010|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48623723|NCT03154086|101863746|FG011|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48623724|NCT03154086|101863747|FG012|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48623725|NCT03154086|101863748|FG013|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48623726|NCT03154086|101863749|FG014|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48623727|NCT03154086|101863735|FG000|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48623728|NCT03154086|101863736|FG001|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48623729|NCT03154086|101863737|FG002|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48623730|NCT03154086|101863738|FG003|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48746174|NCT02611479|102165838|FG000|COMPLETED|Post-Surgery Follow-up at 30-90 Days||169||
48746175|NCT02611479|102165838|FG000|NOT COMPLETED|Post-Surgery Follow-up at 30-90 Days||2||
48623731|NCT03154086|101863739|FG004|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48623732|NCT03154086|101863740|FG005|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48623733|NCT03154086|101863741|FG006|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48623734|NCT03154086|101863742|FG007|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48623735|NCT03154086|101863743|FG008|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48623736|NCT03154086|101863744|FG009|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48623737|NCT03154086|101863745|FG010|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48623738|NCT03154086|101863746|FG011|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48623739|NCT03154086|101863747|FG012|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48623740|NCT03154086|101863748|FG013|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48623741|NCT03154086|101863749|FG014|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
48623742|NCT03154086|101863735|FG000|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623743|NCT03154086|101863736|FG001|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623744|NCT03154086|101863737|FG002|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623745|NCT03154086|101863738|FG003|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48166365|NCT01674621|100728722|FG001|NOT COMPLETED|Overall Study||8||
48166366|NCT01674621|100728723|FG002|NOT COMPLETED|Overall Study||7||
48166367|NCT01674621|100728724|FG003|NOT COMPLETED|Overall Study||6||
48166368|NCT01674621|100728725|FG004|NOT COMPLETED|Overall Study||6||
48166369|NCT02410967|100728726|FG000|STARTED|Treatment Phase (4 Weeks)||27||
48166370|NCT02410967|100728727|FG001|STARTED|Treatment Phase (4 Weeks)||26||
48166371|NCT02410967|100728726|FG000|COMPLETED|Treatment Phase (4 Weeks)||26||
48166372|NCT02410967|100728727|FG001|COMPLETED|Treatment Phase (4 Weeks)||22||
48166373|NCT02410967|100728726|FG000|NOT COMPLETED|Treatment Phase (4 Weeks)||1||
48166374|NCT02410967|100728727|FG001|NOT COMPLETED|Treatment Phase (4 Weeks)||4||
48166375|NCT02410967|100728726|FG000|STARTED|Follow-up Phase (8 Weeks)||26||
48166376|NCT02410967|100728727|FG001|STARTED|Follow-up Phase (8 Weeks)||22||
48329485|NCT00915343|101132212|FG000|STARTED|Part B - Open Label Period||0||
48623746|NCT03154086|101863739|FG004|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623747|NCT03154086|101863740|FG005|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48166377|NCT02410967|100728726|FG000|COMPLETED|Follow-up Phase (8 Weeks)||22||
48166378|NCT02410967|100728727|FG001|COMPLETED|Follow-up Phase (8 Weeks)||16||
48166379|NCT02410967|100728726|FG000|NOT COMPLETED|Follow-up Phase (8 Weeks)||4||
48166380|NCT02410967|100728727|FG001|NOT COMPLETED|Follow-up Phase (8 Weeks)||6||
48166381|NCT01161472|100728728|FG000|STARTED|First Intervention Period||5||
48166382|NCT01161472|100728729|FG001|STARTED|First Intervention Period||5||
48166383|NCT01161472|100728730|FG002|STARTED|First Intervention Period||5||
48166384|NCT01161472|100728731|FG003|STARTED|First Intervention Period||5||
48166385|NCT01161472|100728728|FG000|Treated|First Intervention Period||5||
48166386|NCT01161472|100728729|FG001|Treated|First Intervention Period||5||
48166387|NCT01161472|100728730|FG002|Treated|First Intervention Period||5||
48166388|NCT01161472|100728731|FG003|Treated|First Intervention Period||5||
48166389|NCT01161472|100728728|FG000|COMPLETED|First Intervention Period||5||
48166390|NCT01161472|100728729|FG001|COMPLETED|First Intervention Period||5||
48166391|NCT01161472|100728730|FG002|COMPLETED|First Intervention Period||5||
48166392|NCT01161472|100728731|FG003|COMPLETED|First Intervention Period||5||
48166393|NCT01161472|100728728|FG000|NOT COMPLETED|First Intervention Period||0||
48166394|NCT01161472|100728729|FG001|NOT COMPLETED|First Intervention Period||0||
48166395|NCT01161472|100728730|FG002|NOT COMPLETED|First Intervention Period||0||
48166396|NCT01161472|100728731|FG003|NOT COMPLETED|First Intervention Period||0||
48166397|NCT01161472|100728728|FG000|STARTED|Washout Period (At Least 3 to 6 Days)||5||
48166398|NCT01161472|100728729|FG001|STARTED|Washout Period (At Least 3 to 6 Days)||5||
48329486|NCT00915343|101132213|FG001|STARTED|Part B - Open Label Period||0||
48329487|NCT00915343|101132214|FG002|STARTED|Part B - Open Label Period||59||
48746176|NCT02611479|102165838|FG000|STARTED|Post-Surgery Follow-up at 1-Year||169||
48746177|NCT02611479|102165838|FG000|COMPLETED|Post-Surgery Follow-up at 1-Year||151||
48746178|NCT02611479|102165838|FG000|NOT COMPLETED|Post-Surgery Follow-up at 1-Year||18||
48746179|NCT02611479|102165838|FG000|STARTED|Data Cleaning||151||
48746180|NCT02611479|102165838|FG000|COMPLETED|Data Cleaning||149||
48329488|NCT00915343|101132212|FG000|COMPLETED|Part B - Open Label Period||0||
48746181|NCT02611479|102165838|FG000|NOT COMPLETED|Data Cleaning||2||
48746182|NCT02545608|102165839|FG000|STARTED|Overall Study||9||
48746183|NCT02545608|102165840|FG001|STARTED|Overall Study||100||
48746184|NCT02545608|102165839|FG000|COMPLETED|Overall Study||9||
48166399|NCT01161472|100728730|FG002|STARTED|Washout Period (At Least 3 to 6 Days)||5||
48166400|NCT01161472|100728731|FG003|STARTED|Washout Period (At Least 3 to 6 Days)||5||
48166401|NCT01161472|100728728|FG000|COMPLETED|Washout Period (At Least 3 to 6 Days)||5||
48166402|NCT01161472|100728729|FG001|COMPLETED|Washout Period (At Least 3 to 6 Days)||5||
48166403|NCT01161472|100728730|FG002|COMPLETED|Washout Period (At Least 3 to 6 Days)||5||
48166404|NCT01161472|100728731|FG003|COMPLETED|Washout Period (At Least 3 to 6 Days)||5||
48166405|NCT01161472|100728728|FG000|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0||
48329489|NCT00915343|101132213|FG001|COMPLETED|Part B - Open Label Period||0||
48623748|NCT03154086|101863741|FG006|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||2||
48623749|NCT03154086|101863742|FG007|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||2||
48623750|NCT03154086|101863743|FG008|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||4||
48623751|NCT03154086|101863744|FG009|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623752|NCT03154086|101863745|FG010|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623753|NCT03154086|101863746|FG011|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623754|NCT03154086|101863747|FG012|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623755|NCT03154086|101863748|FG013|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623756|NCT03154086|101863749|FG014|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623757|NCT03154086|101863735|FG000|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623758|NCT03154086|101863736|FG001|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623759|NCT03154086|101863737|FG002|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48329490|NCT00915343|101132214|FG002|COMPLETED|Part B - Open Label Period||57||
48329491|NCT00915343|101132212|FG000|NOT COMPLETED|Part B - Open Label Period||0||
48329492|NCT00915343|101132213|FG001|NOT COMPLETED|Part B - Open Label Period||0||
48329493|NCT00915343|101132214|FG002|NOT COMPLETED|Part B - Open Label Period||2||
48329494|NCT00487539|101132215|FG000|STARTED|Overall Study||331||
48329495|NCT00487539|101132216|FG001|STARTED|Overall Study||72||
48329496|NCT00487539|101132217|FG002|STARTED|Overall Study||331||
48329497|NCT00487539|101132218|FG003|STARTED|Overall Study||331||
48329498|NCT00487539|101132215|FG000|COMPLETED|Overall Study||324||
48329499|NCT00487539|101132216|FG001|COMPLETED|Overall Study||69||
48329500|NCT00487539|101132217|FG002|COMPLETED|Overall Study||328||
48329501|NCT00487539|101132218|FG003|COMPLETED|Overall Study||327||
48329502|NCT00487539|101132215|FG000|NOT COMPLETED|Overall Study||7||
48329503|NCT00487539|101132216|FG001|NOT COMPLETED|Overall Study||3||
48329504|NCT00487539|101132217|FG002|NOT COMPLETED|Overall Study||3||
48329505|NCT00487539|101132218|FG003|NOT COMPLETED|Overall Study||4||
48329506|NCT01394081|101132219|FG000|STARTED|Overall Study||101||
48329507|NCT01394081|101132220|FG001|STARTED|Overall Study||102||
48329508|NCT01394081|101132219|FG000|COMPLETED|Overall Study||101||
48329509|NCT01394081|101132220|FG001|COMPLETED|Overall Study||102||
48329510|NCT01394081|101132219|FG000|NOT COMPLETED|Overall Study||0||
48329511|NCT01394081|101132220|FG001|NOT COMPLETED|Overall Study||0||
48329512|NCT03441178|101132221|FG000|STARTED|Overall Study||36||
48329513|NCT03441178|101132222|FG001|STARTED|Overall Study||44||
48329514|NCT03441178|101132223|FG002|STARTED|Overall Study||21||
48329515|NCT03441178|101132221|FG000|COMPLETED|Overall Study||36||
48329516|NCT03441178|101132222|FG001|COMPLETED|Overall Study||43||
48329517|NCT03441178|101132223|FG002|COMPLETED|Overall Study||20||
48623760|NCT03154086|101863738|FG003|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623761|NCT03154086|101863739|FG004|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623762|NCT03154086|101863740|FG005|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48329518|NCT03441178|101132221|FG000|NOT COMPLETED|Overall Study||0||
48329519|NCT03441178|101132222|FG001|NOT COMPLETED|Overall Study||1||
48329520|NCT03441178|101132223|FG002|NOT COMPLETED|Overall Study||1||
48329521|NCT01926782|101132224|FG000|STARTED|Overall Study||157||
48329522|NCT01926782|101132225|FG001|STARTED|Overall Study||78||
48329523|NCT01926782|101132226|FG002|STARTED|Overall Study||312||
48329524|NCT01926782|101132227|FG003|STARTED|Overall Study||73||
48329525|NCT01926782|101132228|FG004|STARTED|Overall Study||37||
48329526|NCT01926782|101132229|FG005|STARTED|Overall Study||146||
48329527|NCT01926782|101132224|FG000|Treated|Overall Study||157||
48329528|NCT01926782|101132225|FG001|Treated|Overall Study||78||
48329529|NCT01926782|101132226|FG002|Treated|Overall Study||312||
48329530|NCT01926782|101132227|FG003|Treated|Overall Study||72||
48329531|NCT01926782|101132228|FG004|Treated|Overall Study||37||
48329532|NCT01926782|101132229|FG005|Treated|Overall Study||146||
48329533|NCT01926782|101132224|FG000|Completed 24 Weeks Treatment Period|Overall Study||137||
48329534|NCT01926782|101132225|FG001|Completed 24 Weeks Treatment Period|Overall Study||68||
48329535|NCT01926782|101132226|FG002|Completed 24 Weeks Treatment Period|Overall Study||285||
48329536|NCT01926782|101132227|FG003|Completed 24 Weeks Treatment Period|Overall Study||58||
48329537|NCT01926782|101132228|FG004|Completed 24 Weeks Treatment Period|Overall Study||31||
48329538|NCT01926782|101132229|FG005|Completed 24 Weeks Treatment Period|Overall Study||120||
48329539|NCT01926782|101132224|FG000|COMPLETED|Overall Study||129||
48329540|NCT01926782|101132225|FG001|COMPLETED|Overall Study||65||
48329541|NCT01926782|101132226|FG002|COMPLETED|Overall Study||272||
48329542|NCT01926782|101132227|FG003|COMPLETED|Overall Study||53||
48329543|NCT01926782|101132228|FG004|COMPLETED|Overall Study||29||
48329544|NCT01926782|101132229|FG005|COMPLETED|Overall Study||105||
48410378|NCT03531762|101334946|FG002|COMPLETED|Treatment Period 1 (8-12 Days)||2||
48410379|NCT03531762|101334947|FG003|COMPLETED|Treatment Period 1 (8-12 Days)||2||
48657116|NCT03745313|101943783|FG000|STARTED|At 30 Days Follow-up||65||
48329545|NCT01926782|101132224|FG000|NOT COMPLETED|Overall Study||28||
48329546|NCT01926782|101132225|FG001|NOT COMPLETED|Overall Study||13||
48329547|NCT01926782|101132226|FG002|NOT COMPLETED|Overall Study||40||
48329548|NCT01926782|101132227|FG003|NOT COMPLETED|Overall Study||20||
48329549|NCT01926782|101132228|FG004|NOT COMPLETED|Overall Study||8||
48329550|NCT01926782|101132229|FG005|NOT COMPLETED|Overall Study||41||
48410380|NCT03531762|101334948|FG004|COMPLETED|Treatment Period 1 (8-12 Days)||2||
48329551|NCT00907101|101132230|FG000|STARTED|Overall Study||30||
48329552|NCT00907101|101132230|FG000|COMPLETED|Overall Study||30||
48329553|NCT00907101|101132230|FG000|NOT COMPLETED|Overall Study||0||
48329554|NCT00288080|101132231|FG000|STARTED|Overall Study||307||
48329555|NCT00288080|101132232|FG001|STARTED|Overall Study||305||
48329556|NCT00288080|101132231|FG000|COMPLETED|Overall Study||281||
48329557|NCT00288080|101132232|FG001|COMPLETED|Overall Study||282||
48329558|NCT00288080|101132231|FG000|NOT COMPLETED|Overall Study||26||
48329559|NCT00288080|101132232|FG001|NOT COMPLETED|Overall Study||23||
48329560|NCT01175798|101132233|FG000|STARTED|Overall Study||34||
48329561|NCT01175798|101132234|FG001|STARTED|Overall Study||62||
48623763|NCT03154086|101863741|FG006|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||2||
48746185|NCT02545608|102165840|FG001|COMPLETED|Overall Study||93||
48746186|NCT02545608|102165839|FG000|NOT COMPLETED|Overall Study||0||
48746187|NCT02545608|102165840|FG001|NOT COMPLETED|Overall Study||7||
48746188|NCT02870283|102165841|FG000|STARTED|Overall Study||38||
48329562|NCT01175798|101132233|FG000|COMPLETED|Overall Study||27||
48329563|NCT01175798|101132234|FG001|COMPLETED|Overall Study||41||
48329564|NCT01175798|101132233|FG000|NOT COMPLETED|Overall Study||7||
48329565|NCT01175798|101132234|FG001|NOT COMPLETED|Overall Study||21||
48329566|NCT01246791|101132235|FG000|STARTED|Overall Study||12||
48329567|NCT01246791|101132235|FG000|COMPLETED|Overall Study||12||
48329568|NCT01246791|101132235|FG000|NOT COMPLETED|Overall Study||0||
48329569|NCT03665285|101132236|FG000|STARTED|Overall Study||4||
48623764|NCT03154086|101863742|FG007|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||2||
48623765|NCT03154086|101863743|FG008|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||4||
48623766|NCT03154086|101863744|FG009|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623767|NCT03154086|101863745|FG010|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623768|NCT03154086|101863746|FG011|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623769|NCT03154086|101863747|FG012|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623770|NCT03154086|101863748|FG013|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623771|NCT03154086|101863749|FG014|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623772|NCT03154086|101863735|FG000|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623773|NCT03154086|101863736|FG001|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623774|NCT03154086|101863737|FG002|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623775|NCT03154086|101863738|FG003|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623776|NCT03154086|101863739|FG004|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623777|NCT03154086|101863740|FG005|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623778|NCT03154086|101863741|FG006|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623779|NCT03154086|101863742|FG007|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623780|NCT03154086|101863743|FG008|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623781|NCT03154086|101863744|FG009|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623782|NCT03154086|101863745|FG010|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623783|NCT03154086|101863746|FG011|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623784|NCT03154086|101863747|FG012|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623785|NCT03154086|101863748|FG013|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623786|NCT03154086|101863749|FG014|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
48623787|NCT03154086|101863735|FG000|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48623788|NCT03154086|101863736|FG001|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48623789|NCT03154086|101863737|FG002|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48623790|NCT03154086|101863738|FG003|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48623791|NCT03154086|101863739|FG004|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48623792|NCT03154086|101863740|FG005|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48623793|NCT03154086|101863741|FG006|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||2||
48623794|NCT03154086|101863742|FG007|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||2||
48623795|NCT03154086|101863743|FG008|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||5||
48623796|NCT03154086|101863744|FG009|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48623797|NCT03154086|101863745|FG010|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48623798|NCT03154086|101863746|FG011|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48623799|NCT03154086|101863747|FG012|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48623800|NCT03154086|101863748|FG013|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48623801|NCT03154086|101863749|FG014|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48623802|NCT03154086|101863735|FG000|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48623803|NCT03154086|101863736|FG001|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48623804|NCT03154086|101863737|FG002|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48623805|NCT03154086|101863738|FG003|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48623806|NCT03154086|101863739|FG004|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48623807|NCT03154086|101863740|FG005|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48746189|NCT02870283|102165842|FG001|STARTED|Overall Study||35||
48746190|NCT02870283|102165843|FG002|STARTED|Overall Study||34||
48746191|NCT02870283|102165841|FG000|COMPLETED|Overall Study||35||
48746192|NCT02870283|102165842|FG001|COMPLETED|Overall Study||26||
48746193|NCT02870283|102165843|FG002|COMPLETED|Overall Study||15||
48746194|NCT02870283|102165841|FG000|NOT COMPLETED|Overall Study||3||
48329570|NCT03665285|101132237|FG001|STARTED|Overall Study||4||
48329571|NCT03665285|101132238|FG002|STARTED|Overall Study||10||
48329572|NCT03665285|101132239|FG003|STARTED|Overall Study||12||
48329573|NCT03665285|101132240|FG004|STARTED|Overall Study||11||
48329574|NCT03665285|101132241|FG005|STARTED|Overall Study||4||
48623808|NCT03154086|101863741|FG006|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||2||
48623809|NCT03154086|101863742|FG007|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1||
48623810|NCT03154086|101863743|FG008|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||4||
48623811|NCT03154086|101863744|FG009|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48623812|NCT03154086|101863745|FG010|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48623813|NCT03154086|101863746|FG011|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48623814|NCT03154086|101863747|FG012|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48623815|NCT03154086|101863748|FG013|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48623816|NCT03154086|101863749|FG014|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48623817|NCT03154086|101863735|FG000|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48623818|NCT03154086|101863736|FG001|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48623819|NCT03154086|101863737|FG002|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48623820|NCT03154086|101863738|FG003|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48623821|NCT03154086|101863739|FG004|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48623822|NCT03154086|101863740|FG005|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48623823|NCT03154086|101863741|FG006|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48623824|NCT03154086|101863742|FG007|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1||
48623825|NCT03154086|101863743|FG008|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1||
48623826|NCT03154086|101863744|FG009|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48623827|NCT03154086|101863745|FG010|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48657117|NCT03745313|101943783|FG000|COMPLETED|At 30 Days Follow-up||63||
48746195|NCT02870283|102165842|FG001|NOT COMPLETED|Overall Study||9||
48746196|NCT02870283|102165843|FG002|NOT COMPLETED|Overall Study||19||
48746197|NCT01101035|102165844|FG000|STARTED|Overall Study||3101||
48746198|NCT01101035|102165845|FG001|STARTED|Overall Study||3097||
48746199|NCT01101035|102165844|FG000|COMPLETED|Overall Study||1704||
48746200|NCT01101035|102165845|FG001|COMPLETED|Overall Study||1706||
48746201|NCT01101035|102165844|FG000|NOT COMPLETED|Overall Study||1397||
48746202|NCT01101035|102165845|FG001|NOT COMPLETED|Overall Study||1391||
48746203|NCT00988884|102165846|FG000|STARTED|Overall Study||621||
48746204|NCT00988884|102165847|FG001|STARTED|Overall Study||620||
48746205|NCT00988884|102165846|FG000|COMPLETED|Overall Study||586||
48746206|NCT00988884|102165847|FG001|COMPLETED|Overall Study||584||
48746207|NCT00988884|102165846|FG000|NOT COMPLETED|Overall Study||35||
48746208|NCT00988884|102165847|FG001|NOT COMPLETED|Overall Study||36||
48746209|NCT04400058|102165848|FG000|STARTED|Overall Study||105||
48746210|NCT04400058|102165849|FG001|STARTED|Overall Study||102||
48746211|NCT04400058|102165848|FG000|COMPLETED|Overall Study||84||
48746212|NCT04400058|102165849|FG001|COMPLETED|Overall Study||86||
48746213|NCT04400058|102165848|FG000|NOT COMPLETED|Overall Study||21||
48746214|NCT04400058|102165849|FG001|NOT COMPLETED|Overall Study||16||
48746215|NCT04862065|102165850|FG000|STARTED|Screening||15581||
48746216|NCT04862065|102165851|FG001|STARTED|Screening||403||
48746217|NCT04862065|102165852|FG002|STARTED|Screening||404||
48746218|NCT04862065|102165850|FG000|COMPLETED|Screening||15526||
48746219|NCT04862065|102165851|FG001|COMPLETED|Screening||403||
48746220|NCT04862065|102165852|FG002|COMPLETED|Screening||404||
48746221|NCT04862065|102165850|FG000|NOT COMPLETED|Screening||55||
48746222|NCT04862065|102165851|FG001|NOT COMPLETED|Screening||0||
48746223|NCT04862065|102165852|FG002|NOT COMPLETED|Screening||0||
48746224|NCT04862065|102165850|FG000|STARTED|Follow-Up||6||
48746225|NCT04862065|102165851|FG001|STARTED|Follow-Up||0||
48746226|NCT04862065|102165852|FG002|STARTED|Follow-Up||0||
48746227|NCT04862065|102165850|FG000|COMPLETED|Follow-Up||3||
48746228|NCT04862065|102165851|FG001|COMPLETED|Follow-Up||0||
48746229|NCT04862065|102165852|FG002|COMPLETED|Follow-Up||0||
48746230|NCT04862065|102165850|FG000|NOT COMPLETED|Follow-Up||3||
48746231|NCT04862065|102165851|FG001|NOT COMPLETED|Follow-Up||0||
48746232|NCT04862065|102165852|FG002|NOT COMPLETED|Follow-Up||0||
48746233|NCT02518971|102165853|FG000|STARTED|Overall Study||87||
48746234|NCT02518971|102165854|FG001|STARTED|Overall Study||87||
48746235|NCT02518971|102165853|FG000|COMPLETED|Overall Study||64||
48746236|NCT02518971|102165854|FG001|COMPLETED|Overall Study||67||
48746237|NCT02518971|102165853|FG000|NOT COMPLETED|Overall Study||23||
48746238|NCT02518971|102165854|FG001|NOT COMPLETED|Overall Study||20||
48746239|NCT01740713|102165855|FG000|STARTED|Overall Study||6||
48746240|NCT01740713|102165856|FG001|STARTED|Overall Study||8||
48746241|NCT01740713|102165857|FG002|STARTED|Overall Study||7||
48746242|NCT01740713|102165855|FG000|COMPLETED|Overall Study||6||
48746243|NCT01740713|102165856|FG001|COMPLETED|Overall Study||6||
48746244|NCT01740713|102165857|FG002|COMPLETED|Overall Study||6||
48746245|NCT01740713|102165855|FG000|NOT COMPLETED|Overall Study||0||
48746246|NCT01740713|102165856|FG001|NOT COMPLETED|Overall Study||2||
48746247|NCT01740713|102165857|FG002|NOT COMPLETED|Overall Study||1||
48746248|NCT02756338|102165858|FG000|STARTED|Overall Study||77||
48746249|NCT02756338|102165858|FG000|COMPLETED|Overall Study||72||
48746250|NCT02756338|102165858|FG000|NOT COMPLETED|Overall Study||5||
48746251|NCT00086047|102165859|FG000|STARTED|Overall Study||57||
48746252|NCT00086047|102165860|FG001|STARTED|Overall Study||57||
48746253|NCT00086047|102165859|FG000|COMPLETED|Overall Study||50||
48746254|NCT00086047|102165860|FG001|COMPLETED|Overall Study||50||
48746255|NCT00086047|102165859|FG000|NOT COMPLETED|Overall Study||7||
48746256|NCT00086047|102165860|FG001|NOT COMPLETED|Overall Study||7||
48746257|NCT00836589|102165861|FG000|STARTED|Overall Study||1997||
48746258|NCT00836589|102165861|FG000|COMPLETED|Overall Study||731||
48746259|NCT00836589|102165861|FG000|NOT COMPLETED|Overall Study||1266||
48746260|NCT00700440|102165862|FG000|STARTED|Overall Study||100||
48746261|NCT00700440|102165862|FG000|COMPLETED|Overall Study||100||
48746262|NCT00700440|102165862|FG000|NOT COMPLETED|Overall Study||0||
48746263|NCT03920254|102165863|FG000|STARTED|Overall Study||13||
48746264|NCT03920254|102165864|FG001|STARTED|Overall Study||18||
48746265|NCT03920254|102165865|FG002|STARTED|Overall Study||15||
48746266|NCT03920254|102165863|FG000|COMPLETED|Overall Study||0||
48746267|NCT03920254|102165864|FG001|COMPLETED|Overall Study||0||
48746268|NCT03920254|102165865|FG002|COMPLETED|Overall Study||0||
48746269|NCT03920254|102165863|FG000|NOT COMPLETED|Overall Study||13||
48746270|NCT03920254|102165864|FG001|NOT COMPLETED|Overall Study||18||
48746271|NCT03920254|102165865|FG002|NOT COMPLETED|Overall Study||15||
48746272|NCT02420093|102165866|FG000|STARTED|Overall Study||9||
48746273|NCT02420093|102165867|FG001|STARTED|Overall Study||8||
48746274|NCT02420093|102165866|FG000|COMPLETED|Overall Study||8||
48746275|NCT02420093|102165867|FG001|COMPLETED|Overall Study||7||
48746276|NCT02420093|102165866|FG000|NOT COMPLETED|Overall Study||1||
48746277|NCT02420093|102165867|FG001|NOT COMPLETED|Overall Study||1||
48746278|NCT01721161|102165868|FG000|STARTED|Overall Study||41||
48746279|NCT01721161|102165869|FG001|STARTED|Overall Study||41||
48746280|NCT01721161|102165868|FG000|COMPLETED|Overall Study||37||
48746281|NCT01721161|102165869|FG001|COMPLETED|Overall Study||34||
48746282|NCT01721161|102165868|FG000|NOT COMPLETED|Overall Study||4||
48746283|NCT01721161|102165869|FG001|NOT COMPLETED|Overall Study||7||
48746284|NCT02848222|102165870|FG000|STARTED|Overall Study||25||
48746285|NCT02848222|102165871|FG001|STARTED|Overall Study||18||
48746286|NCT02848222|102165872|FG002|STARTED|Overall Study||17||
48746287|NCT02848222|102165870|FG000|COMPLETED|Overall Study||18||
48746288|NCT02848222|102165871|FG001|COMPLETED|Overall Study||17||
48746289|NCT02848222|102165872|FG002|COMPLETED|Overall Study||17||
48746290|NCT02848222|102165870|FG000|NOT COMPLETED|Overall Study||7||
48746291|NCT02848222|102165871|FG001|NOT COMPLETED|Overall Study||1||
48746292|NCT02848222|102165872|FG002|NOT COMPLETED|Overall Study||0||
48746293|NCT00880698|102165873|FG000|STARTED|Overall Study||62||
48746294|NCT00880698|102165874|FG001|STARTED|Overall Study||64||
48746295|NCT00880698|102165875|FG002|STARTED|Overall Study||37||
48746296|NCT00880698|102165876|FG003|STARTED|Overall Study||39||
48746297|NCT00880698|102165873|FG000|COMPLETED|Overall Study||61||
48746298|NCT00880698|102165874|FG001|COMPLETED|Overall Study||61||
48746299|NCT00880698|102165875|FG002|COMPLETED|Overall Study||36||
48746300|NCT00880698|102165876|FG003|COMPLETED|Overall Study||36||
48746301|NCT00880698|102165873|FG000|NOT COMPLETED|Overall Study||1||
48746302|NCT00880698|102165874|FG001|NOT COMPLETED|Overall Study||3||
48746303|NCT00880698|102165875|FG002|NOT COMPLETED|Overall Study||1||
48746304|NCT00880698|102165876|FG003|NOT COMPLETED|Overall Study||3||
48746305|NCT01290757|102165877|FG000|STARTED|Overall Study||90||
48746306|NCT01290757|102165878|FG001|STARTED|Overall Study||90||
48746307|NCT01290757|102165877|FG000|COMPLETED|Overall Study||88||
48746308|NCT01290757|102165878|FG001|COMPLETED|Overall Study||88||
48746309|NCT01290757|102165877|FG000|NOT COMPLETED|Overall Study||2||
48746310|NCT01290757|102165878|FG001|NOT COMPLETED|Overall Study||2||
48746311|NCT01078441|102165879|FG000|STARTED|Overall Study||2||
48746312|NCT01078441|102165879|FG000|COMPLETED|Overall Study||1||
48746313|NCT01078441|102165879|FG000|NOT COMPLETED|Overall Study||1||
48746314|NCT01775774|102165880|FG000|STARTED|Overall Study||3||
48746315|NCT01775774|102165881|FG001|STARTED|Overall Study||3||
48746316|NCT01775774|102165882|FG002|STARTED|Overall Study||3||
48746317|NCT01775774|102165880|FG000|COMPLETED|Overall Study||3||
48746318|NCT01775774|102165881|FG001|COMPLETED|Overall Study||3||
48746319|NCT01775774|102165882|FG002|COMPLETED|Overall Study||3||
48746320|NCT01775774|102165880|FG000|NOT COMPLETED|Overall Study||0||
48746321|NCT01775774|102165881|FG001|NOT COMPLETED|Overall Study||0||
48746322|NCT01775774|102165882|FG002|NOT COMPLETED|Overall Study||0||
48746323|NCT01569841|102165883|FG000|STARTED|Period A (6 Weeks)||12||
48746324|NCT01569841|102165884|FG001|STARTED|Period A (6 Weeks)||12||
48746325|NCT01569841|102165883|FG000|Exposed|Period A (6 Weeks)||12||
48746326|NCT01569841|102165884|FG001|Exposed|Period A (6 Weeks)||12||
48746327|NCT01569841|102165883|FG000|COMPLETED|Period A (6 Weeks)||12||
48746328|NCT01569841|102165884|FG001|COMPLETED|Period A (6 Weeks)||11||
48746329|NCT01569841|102165883|FG000|NOT COMPLETED|Period A (6 Weeks)||0||
48746330|NCT01569841|102165884|FG001|NOT COMPLETED|Period A (6 Weeks)||1||
48746331|NCT01569841|102165883|FG000|STARTED|Period B (6 Weeks)||12||
48746332|NCT01569841|102165884|FG001|STARTED|Period B (6 Weeks)||11||
48746333|NCT01569841|102165883|FG000|Exposed|Period B (6 Weeks)||12||
48746334|NCT01569841|102165884|FG001|Exposed|Period B (6 Weeks)||11||
48746335|NCT01569841|102165883|FG000|COMPLETED|Period B (6 Weeks)||12||
48746336|NCT01569841|102165884|FG001|COMPLETED|Period B (6 Weeks)||11||
48746337|NCT01569841|102165883|FG000|NOT COMPLETED|Period B (6 Weeks)||0||
48746338|NCT01569841|102165884|FG001|NOT COMPLETED|Period B (6 Weeks)||0||
48746339|NCT00556998|102165885|FG000|STARTED|Voriconazole Intravenous (IV)||26||
48746340|NCT00556998|102165885|FG000|Treated|Voriconazole Intravenous (IV)||26||
48746341|NCT00556998|102165885|FG000|COMPLETED|Voriconazole Intravenous (IV)||21||
48746342|NCT00556998|102165885|FG000|NOT COMPLETED|Voriconazole Intravenous (IV)||5||
48746343|NCT00556998|102165885|FG000|STARTED|Voriconazole Oral||22||
48746344|NCT00556998|102165885|FG000|COMPLETED|Voriconazole Oral||20||
48746345|NCT00556998|102165885|FG000|NOT COMPLETED|Voriconazole Oral||2||
48746346|NCT00108862|102165886|FG000|STARTED|Overall Study||405||
48746347|NCT00108862|102165887|FG001|STARTED|Overall Study||401||
48746348|NCT00108862|102165886|FG000|COMPLETED|Overall Study||337||
48746349|NCT00108862|102165887|FG001|COMPLETED|Overall Study||339||
48746350|NCT00108862|102165886|FG000|NOT COMPLETED|Overall Study||68||
48746351|NCT00108862|102165887|FG001|NOT COMPLETED|Overall Study||62||
48746352|NCT01717872|102165888|FG000|STARTED|Overall Study||25||
48746353|NCT01717872|102165889|FG001|STARTED|Overall Study||25||
48746354|NCT01717872|102165888|FG000|COMPLETED|Overall Study||25||
48746355|NCT01717872|102165889|FG001|COMPLETED|Overall Study||25||
48746356|NCT01717872|102165888|FG000|NOT COMPLETED|Overall Study||0||
48746357|NCT01717872|102165889|FG001|NOT COMPLETED|Overall Study||0||
48746358|NCT02792231|102165890|FG000|STARTED|Overall Study||481||
48746359|NCT02792231|102165891|FG001|STARTED|Overall Study||474||
48746360|NCT02792231|102165890|FG000|COMPLETED|Overall Study||399||
48746361|NCT02792231|102165891|FG001|COMPLETED|Overall Study||390||
48746362|NCT02792231|102165890|FG000|NOT COMPLETED|Overall Study||82||
48746363|NCT02792231|102165891|FG001|NOT COMPLETED|Overall Study||84||
48746364|NCT03883581|102165892|FG000|STARTED|Overall Study||28||
48746365|NCT03883581|102165892|FG000|COMPLETED|Overall Study||24||
48410381|NCT03531762|101334949|FG005|COMPLETED|Treatment Period 1 (8-12 Days)||2||
48410382|NCT03531762|101334944|FG000|NOT COMPLETED|Treatment Period 1 (8-12 Days)||0||
48410383|NCT03531762|101334945|FG001|NOT COMPLETED|Treatment Period 1 (8-12 Days)||0||
48410384|NCT03531762|101334946|FG002|NOT COMPLETED|Treatment Period 1 (8-12 Days)||0||
48623828|NCT03154086|101863746|FG011|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48623829|NCT03154086|101863747|FG012|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48410385|NCT03531762|101334947|FG003|NOT COMPLETED|Treatment Period 1 (8-12 Days)||0||
48410386|NCT03531762|101334948|FG004|NOT COMPLETED|Treatment Period 1 (8-12 Days)||0||
48410387|NCT03531762|101334949|FG005|NOT COMPLETED|Treatment Period 1 (8-12 Days)||0||
48410388|NCT03531762|101334944|FG000|STARTED|Treatment Period 2 (8-12 Days)||2||
48410389|NCT03531762|101334945|FG001|STARTED|Treatment Period 2 (8-12 Days)||2||
48623830|NCT03154086|101863748|FG013|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48623831|NCT03154086|101863749|FG014|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
48746366|NCT03883581|102165892|FG000|NOT COMPLETED|Overall Study||4||
48746367|NCT00704938|102165893|FG000|STARTED|Overall Study||2||
48746368|NCT00704938|102165894|FG001|STARTED|Overall Study||1||
48746369|NCT00704938|102165893|FG000|COMPLETED|Overall Study||2||
48746370|NCT00704938|102165894|FG001|COMPLETED|Overall Study||1||
48746371|NCT00704938|102165893|FG000|NOT COMPLETED|Overall Study||0||
48746372|NCT00704938|102165894|FG001|NOT COMPLETED|Overall Study||0||
48746373|NCT01061359|102165895|FG000|STARTED|Overall Study||1972||
48746374|NCT01061359|102165895|FG000|COMPLETED|Overall Study||670||
48746375|NCT01061359|102165895|FG000|NOT COMPLETED|Overall Study||1302||
48746376|NCT01592071|102165896|FG000|STARTED|Overall Study||120||
48746377|NCT01592071|102165896|FG000|COMPLETED|Overall Study||120||
48746378|NCT01592071|102165896|FG000|NOT COMPLETED|Overall Study||0||
48746379|NCT01618669|102165897|FG000|STARTED|Overall Study||578||
48746380|NCT01618669|102165898|FG001|STARTED|Overall Study||569||
48746381|NCT01618669|102165897|FG000|Received Treatment|Overall Study||575||
48746382|NCT01618669|102165898|FG001|Received Treatment|Overall Study||567||
48746383|NCT01618669|102165897|FG000|COMPLETED|Overall Study||544||
48746384|NCT01618669|102165898|FG001|COMPLETED|Overall Study||546||
48746385|NCT01618669|102165897|FG000|NOT COMPLETED|Overall Study||34||
48746386|NCT01618669|102165898|FG001|NOT COMPLETED|Overall Study||23||
48746387|NCT02029911|102165899|FG000|STARTED|Overall Study||60||
48746388|NCT02029911|102165899|FG000|Treated|Overall Study||60||
48746389|NCT02029911|102165899|FG000|COMPLETED|Overall Study||60||
48746390|NCT02029911|102165899|FG000|NOT COMPLETED|Overall Study||0||
48746391|NCT03715803|102165900|FG000|STARTED|Overall Study||91||
48746392|NCT03715803|102165901|FG001|STARTED|Overall Study||126||
48746393|NCT03715803|102165900|FG000|COMPLETED|Overall Study||91||
48746394|NCT03715803|102165901|FG001|COMPLETED|Overall Study||126||
48746395|NCT03715803|102165900|FG000|NOT COMPLETED|Overall Study||0||
48746396|NCT03715803|102165901|FG001|NOT COMPLETED|Overall Study||0||
48746397|NCT01775371|102165902|FG000|STARTED|Overall Study||306||
48746398|NCT01775371|102165903|FG001|STARTED|Overall Study||330||
48746399|NCT01775371|102165902|FG000|COMPLETED|Overall Study||306||
48746400|NCT01775371|102165903|FG001|COMPLETED|Overall Study||330||
48746401|NCT01775371|102165902|FG000|NOT COMPLETED|Overall Study||0||
48746402|NCT01775371|102165903|FG001|NOT COMPLETED|Overall Study||0||
48746403|NCT01425801|102165904|FG000|STARTED|Period 1||9||
48746404|NCT01425801|102165905|FG001|STARTED|Period 1||9||
48746405|NCT01425801|102165906|FG002|STARTED|Period 1||9||
48746406|NCT01425801|102165907|FG003|STARTED|Period 1||12||
48746407|NCT01425801|102165908|FG004|STARTED|Period 1||13||
48746408|NCT01425801|102165909|FG005|STARTED|Period 1||10||
48746409|NCT01425801|102165904|FG000|COMPLETED|Period 1||9||
48746410|NCT01425801|102165905|FG001|COMPLETED|Period 1||9||
48746411|NCT01425801|102165906|FG002|COMPLETED|Period 1||9||
48746412|NCT01425801|102165907|FG003|COMPLETED|Period 1||12||
48746413|NCT01425801|102165908|FG004|COMPLETED|Period 1||12||
48746414|NCT01425801|102165909|FG005|COMPLETED|Period 1||10||
48746415|NCT01425801|102165904|FG000|NOT COMPLETED|Period 1||0||
48746416|NCT01425801|102165905|FG001|NOT COMPLETED|Period 1||0||
48746417|NCT01425801|102165906|FG002|NOT COMPLETED|Period 1||0||
48746418|NCT01425801|102165907|FG003|NOT COMPLETED|Period 1||0||
48746419|NCT01425801|102165908|FG004|NOT COMPLETED|Period 1||1||
48746420|NCT01425801|102165909|FG005|NOT COMPLETED|Period 1||0||
48746421|NCT01425801|102165904|FG000|STARTED|Period 2||9||
48746422|NCT01425801|102165905|FG001|STARTED|Period 2||9||
48746423|NCT01425801|102165906|FG002|STARTED|Period 2||9||
48746424|NCT01425801|102165907|FG003|STARTED|Period 2||12||
48746425|NCT01425801|102165908|FG004|STARTED|Period 2||12||
48746426|NCT01425801|102165909|FG005|STARTED|Period 2||10||
48746427|NCT01425801|102165904|FG000|COMPLETED|Period 2||9||
48746428|NCT01425801|102165905|FG001|COMPLETED|Period 2||9||
48746429|NCT01425801|102165906|FG002|COMPLETED|Period 2||9||
48746430|NCT01425801|102165907|FG003|COMPLETED|Period 2||12||
48746431|NCT01425801|102165908|FG004|COMPLETED|Period 2||11||
48746432|NCT01425801|102165909|FG005|COMPLETED|Period 2||10||
48746433|NCT01425801|102165904|FG000|NOT COMPLETED|Period 2||0||
48746434|NCT01425801|102165905|FG001|NOT COMPLETED|Period 2||0||
48746435|NCT01425801|102165906|FG002|NOT COMPLETED|Period 2||0||
48746436|NCT01425801|102165907|FG003|NOT COMPLETED|Period 2||0||
48746437|NCT01425801|102165908|FG004|NOT COMPLETED|Period 2||1||
48746438|NCT01425801|102165909|FG005|NOT COMPLETED|Period 2||0||
48746439|NCT01425801|102165904|FG000|STARTED|Period 3||9||
48746440|NCT01425801|102165905|FG001|STARTED|Period 3||9||
48410390|NCT03531762|101334946|FG002|STARTED|Treatment Period 2 (8-12 Days)||2||
48410391|NCT03531762|101334947|FG003|STARTED|Treatment Period 2 (8-12 Days)||2||
48410392|NCT03531762|101334948|FG004|STARTED|Treatment Period 2 (8-12 Days)||2||
48746441|NCT01425801|102165906|FG002|STARTED|Period 3||9||
48746442|NCT01425801|102165907|FG003|STARTED|Period 3||12||
48746443|NCT01425801|102165908|FG004|STARTED|Period 3||11||
48746444|NCT01425801|102165909|FG005|STARTED|Period 3||10||
48746445|NCT01425801|102165904|FG000|COMPLETED|Period 3||9||
48746446|NCT01425801|102165905|FG001|COMPLETED|Period 3||9||
48746447|NCT01425801|102165906|FG002|COMPLETED|Period 3||8||
48746448|NCT01425801|102165907|FG003|COMPLETED|Period 3||12||
48746449|NCT01425801|102165908|FG004|COMPLETED|Period 3||11||
48746450|NCT01425801|102165909|FG005|COMPLETED|Period 3||10||
48746451|NCT01425801|102165904|FG000|NOT COMPLETED|Period 3||0||
48746452|NCT01425801|102165905|FG001|NOT COMPLETED|Period 3||0||
48746453|NCT01425801|102165906|FG002|NOT COMPLETED|Period 3||1||
48746454|NCT01425801|102165907|FG003|NOT COMPLETED|Period 3||0||
48746455|NCT01425801|102165908|FG004|NOT COMPLETED|Period 3||0||
48746456|NCT01425801|102165909|FG005|NOT COMPLETED|Period 3||0||
48746457|NCT01425801|102165904|FG000|STARTED|Period 4||9||
48746458|NCT01425801|102165905|FG001|STARTED|Period 4||9||
48746459|NCT01425801|102165906|FG002|STARTED|Period 4||8||
48746460|NCT01425801|102165907|FG003|STARTED|Period 4||12||
48746461|NCT01425801|102165908|FG004|STARTED|Period 4||11||
48746462|NCT01425801|102165909|FG005|STARTED|Period 4||10||
48746463|NCT01425801|102165904|FG000|COMPLETED|Period 4||9||
48746464|NCT01425801|102165905|FG001|COMPLETED|Period 4||9||
48746465|NCT01425801|102165906|FG002|COMPLETED|Period 4||7||
48746466|NCT01425801|102165907|FG003|COMPLETED|Period 4||12||
48746467|NCT01425801|102165908|FG004|COMPLETED|Period 4||11||
48746468|NCT01425801|102165909|FG005|COMPLETED|Period 4||10||
48746469|NCT01425801|102165904|FG000|NOT COMPLETED|Period 4||0||
48746470|NCT01425801|102165905|FG001|NOT COMPLETED|Period 4||0||
48746471|NCT01425801|102165906|FG002|NOT COMPLETED|Period 4||1||
48746472|NCT01425801|102165907|FG003|NOT COMPLETED|Period 4||0||
48746473|NCT01425801|102165908|FG004|NOT COMPLETED|Period 4||0||
48746474|NCT01425801|102165909|FG005|NOT COMPLETED|Period 4||0||
48746475|NCT01425801|102165904|FG000|STARTED|Period 5||9||
48746476|NCT01425801|102165905|FG001|STARTED|Period 5||9||
48746477|NCT01425801|102165906|FG002|STARTED|Period 5||7||
48746478|NCT01425801|102165907|FG003|STARTED|Period 5||12||
48746479|NCT01425801|102165908|FG004|STARTED|Period 5||11||
48746480|NCT01425801|102165909|FG005|STARTED|Period 5||10||
48746481|NCT01425801|102165904|FG000|COMPLETED|Period 5||9||
48746482|NCT01425801|102165905|FG001|COMPLETED|Period 5||9||
48746483|NCT01425801|102165906|FG002|COMPLETED|Period 5||7||
48746484|NCT01425801|102165907|FG003|COMPLETED|Period 5||12||
48746485|NCT01425801|102165908|FG004|COMPLETED|Period 5||11||
48746486|NCT01425801|102165909|FG005|COMPLETED|Period 5||10||
48746487|NCT01425801|102165904|FG000|NOT COMPLETED|Period 5||0||
48746488|NCT01425801|102165905|FG001|NOT COMPLETED|Period 5||0||
48746489|NCT01425801|102165906|FG002|NOT COMPLETED|Period 5||0||
48746490|NCT01425801|102165907|FG003|NOT COMPLETED|Period 5||0||
48746491|NCT01425801|102165908|FG004|NOT COMPLETED|Period 5||0||
48746492|NCT01425801|102165909|FG005|NOT COMPLETED|Period 5||0||
48746493|NCT01425801|102165904|FG000|STARTED|Period 6||9||
48746494|NCT01425801|102165905|FG001|STARTED|Period 6||9||
48746495|NCT01425801|102165906|FG002|STARTED|Period 6||7||
48746496|NCT01425801|102165907|FG003|STARTED|Period 6||12||
48746497|NCT01425801|102165908|FG004|STARTED|Period 6||11||
48746498|NCT01425801|102165909|FG005|STARTED|Period 6||10||
48746499|NCT01425801|102165904|FG000|COMPLETED|Period 6||9||
48746500|NCT01425801|102165905|FG001|COMPLETED|Period 6||9||
48746501|NCT01425801|102165906|FG002|COMPLETED|Period 6||7||
48746502|NCT01425801|102165907|FG003|COMPLETED|Period 6||12||
48746503|NCT01425801|102165908|FG004|COMPLETED|Period 6||11||
48746504|NCT01425801|102165909|FG005|COMPLETED|Period 6||10||
48746505|NCT01425801|102165904|FG000|NOT COMPLETED|Period 6||0||
48746506|NCT01425801|102165905|FG001|NOT COMPLETED|Period 6||0||
48746507|NCT01425801|102165906|FG002|NOT COMPLETED|Period 6||0||
48746508|NCT01425801|102165907|FG003|NOT COMPLETED|Period 6||0||
48746509|NCT01425801|102165908|FG004|NOT COMPLETED|Period 6||0||
48746510|NCT01425801|102165909|FG005|NOT COMPLETED|Period 6||0||
48746511|NCT01272232|102165910|FG000|STARTED|Weeks 0-56||423||
48746512|NCT01272232|102165911|FG001|STARTED|Weeks 0-56||211||
48746513|NCT01272232|102165912|FG002|STARTED|Weeks 0-56||212||
48746514|NCT01272232|102165910|FG000|Exposed|Weeks 0-56||422||
48746515|NCT01272232|102165911|FG001|Exposed|Weeks 0-56||210||
48746516|NCT01272232|102165912|FG002|Exposed|Weeks 0-56||212||
48746517|NCT01272232|102165910|FG000|COMPLETED|Weeks 0-56||324||
48746518|NCT01272232|102165911|FG001|COMPLETED|Weeks 0-56||164||
48746519|NCT01272232|102165912|FG002|COMPLETED|Weeks 0-56||140||
48746520|NCT01272232|102165910|FG000|NOT COMPLETED|Weeks 0-56||99||
48746521|NCT01272232|102165911|FG001|NOT COMPLETED|Weeks 0-56||47||
48746522|NCT01272232|102165912|FG002|NOT COMPLETED|Weeks 0-56||72||
48746523|NCT01272232|102165910|FG000|STARTED|Off Drug Follow-up Period (Weeks 56-68)||324||
48746524|NCT01272232|102165911|FG001|STARTED|Off Drug Follow-up Period (Weeks 56-68)||164||
48746525|NCT01272232|102165912|FG002|STARTED|Off Drug Follow-up Period (Weeks 56-68)||140||
48746526|NCT01272232|102165910|FG000|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||310||
48746527|NCT01272232|102165911|FG001|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||154||
48746528|NCT01272232|102165912|FG002|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||135||
48746529|NCT01272232|102165910|FG000|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||14||
48746530|NCT01272232|102165911|FG001|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||10||
48746531|NCT01272232|102165912|FG002|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||5||
48746532|NCT00615017|102165913|FG000|STARTED|Overall Study||8||
48746533|NCT00615017|102165914|FG001|STARTED|Overall Study||9||
48746534|NCT00615017|102165915|FG002|STARTED|Overall Study||12||
48746535|NCT00615017|102165916|FG003|STARTED|Overall Study||10||
48746536|NCT00615017|102165917|FG004|STARTED|Overall Study||8||
48746537|NCT00615017|102165918|FG005|STARTED|Overall Study||23||
48746538|NCT00615017|102165913|FG000|COMPLETED|Overall Study||8||
48746539|NCT00615017|102165914|FG001|COMPLETED|Overall Study||8||
48746540|NCT00615017|102165915|FG002|COMPLETED|Overall Study||7||
48746541|NCT00615017|102165916|FG003|COMPLETED|Overall Study||9||
48746542|NCT00615017|102165917|FG004|COMPLETED|Overall Study||7||
48746543|NCT00615017|102165918|FG005|COMPLETED|Overall Study||20||
48746544|NCT00615017|102165913|FG000|NOT COMPLETED|Overall Study||0||
48746545|NCT00615017|102165914|FG001|NOT COMPLETED|Overall Study||1||
48746546|NCT00615017|102165915|FG002|NOT COMPLETED|Overall Study||5||
48746547|NCT00615017|102165916|FG003|NOT COMPLETED|Overall Study||1||
48746548|NCT00615017|102165917|FG004|NOT COMPLETED|Overall Study||1||
48746549|NCT00615017|102165918|FG005|NOT COMPLETED|Overall Study||3||
48746550|NCT02995980|102165919|FG000|STARTED|Overall Study||128||
48746551|NCT02995980|102165919|FG000|COMPLETED|Overall Study||114||
48746552|NCT02995980|102165919|FG000|NOT COMPLETED|Overall Study||14||
48746553|NCT00506350|102165920|FG000|STARTED|Overall Study||36||
48746554|NCT00506350|102165921|FG001|STARTED|Overall Study||40||
48746555|NCT00506350|102165922|FG002|STARTED|Overall Study||37||
48746556|NCT00506350|102165923|FG003|STARTED|Overall Study||36||
48746557|NCT00506350|102165924|FG004|STARTED|Overall Study||50||
48746558|NCT00506350|102165925|FG005|STARTED|Overall Study||40||
48746559|NCT00506350|102165926|FG006|STARTED|Overall Study||35||
48746560|NCT00506350|102165927|FG007|STARTED|Overall Study||41||
48746561|NCT00506350|102165928|FG008|STARTED|Overall Study||35||
48746562|NCT00506350|102165920|FG000|COMPLETED|Overall Study||33||
48746563|NCT00506350|102165921|FG001|COMPLETED|Overall Study||37||
48746564|NCT00506350|102165922|FG002|COMPLETED|Overall Study||31||
48746565|NCT00506350|102165923|FG003|COMPLETED|Overall Study||34||
48746566|NCT00506350|102165924|FG004|COMPLETED|Overall Study||40||
48746567|NCT00506350|102165925|FG005|COMPLETED|Overall Study||38||
48746568|NCT00506350|102165926|FG006|COMPLETED|Overall Study||33||
48746569|NCT00506350|102165927|FG007|COMPLETED|Overall Study||36||
48746570|NCT00506350|102165928|FG008|COMPLETED|Overall Study||30||
48746571|NCT00506350|102165920|FG000|NOT COMPLETED|Overall Study||3||
48746572|NCT00506350|102165921|FG001|NOT COMPLETED|Overall Study||3||
48746573|NCT00506350|102165922|FG002|NOT COMPLETED|Overall Study||6||
48746574|NCT00506350|102165923|FG003|NOT COMPLETED|Overall Study||2||
48746575|NCT00506350|102165924|FG004|NOT COMPLETED|Overall Study||10||
48746576|NCT00506350|102165925|FG005|NOT COMPLETED|Overall Study||2||
48746577|NCT00506350|102165926|FG006|NOT COMPLETED|Overall Study||2||
48746578|NCT00506350|102165927|FG007|NOT COMPLETED|Overall Study||5||
48746579|NCT00506350|102165928|FG008|NOT COMPLETED|Overall Study||5||
48746580|NCT02043938|102165929|FG000|STARTED|Overall Study||46||
48746581|NCT02043938|102165929|FG000|COMPLETED|Overall Study||36||
48746582|NCT02043938|102165929|FG000|NOT COMPLETED|Overall Study||10||
48746583|NCT01685567|102165930|FG000|STARTED|Overall Study||219||
48746584|NCT01685567|102165930|FG000|COMPLETED|Overall Study||219||
48746585|NCT01685567|102165930|FG000|NOT COMPLETED|Overall Study||0||
48746586|NCT05579977|102165931|FG000|STARTED|Treatment Phase||75||
48746587|NCT05579977|102165932|FG001|STARTED|Treatment Phase||73||
48746588|NCT05579977|102165933|FG002|STARTED|Treatment Phase||72||
48746589|NCT05579977|102165934|FG003|STARTED|Treatment Phase||73||
48746590|NCT05579977|102165935|FG004|STARTED|Treatment Phase||73||
48746591|NCT05579977|102165936|FG005|STARTED|Treatment Phase||74||
48746592|NCT05579977|102165937|FG006|STARTED|Treatment Phase||73||
48746593|NCT05579977|102165938|FG007|STARTED|Treatment Phase||64||
48746594|NCT05579977|102165939|FG008|STARTED|Treatment Phase||66||
48746595|NCT05579977|102165940|FG009|STARTED|Treatment Phase||64||
48746596|NCT05579977|102165941|FG010|STARTED|Treatment Phase||65||
48746597|NCT05579977|102165942|FG011|STARTED|Treatment Phase||66||
48746598|NCT05579977|102165943|FG012|STARTED|Treatment Phase||64||
48746599|NCT05579977|102165931|FG000|Received Treatment|Treatment Phase||75||
48746600|NCT05579977|102165932|FG001|Received Treatment|Treatment Phase||73||
48746601|NCT05579977|102165933|FG002|Received Treatment|Treatment Phase||72||
48746602|NCT05579977|102165934|FG003|Received Treatment|Treatment Phase||73||
48746603|NCT05579977|102165935|FG004|Received Treatment|Treatment Phase||72||
48746604|NCT05579977|102165936|FG005|Received Treatment|Treatment Phase||74||
48746605|NCT05579977|102165937|FG006|Received Treatment|Treatment Phase||73||
48746606|NCT05579977|102165938|FG007|Received Treatment|Treatment Phase||64||
48746607|NCT05579977|102165939|FG008|Received Treatment|Treatment Phase||66||
48746608|NCT05579977|102165940|FG009|Received Treatment|Treatment Phase||64||
48746609|NCT05579977|102165941|FG010|Received Treatment|Treatment Phase||65||
48746610|NCT05579977|102165942|FG011|Received Treatment|Treatment Phase||66||
48746611|NCT05579977|102165943|FG012|Received Treatment|Treatment Phase||64||
48746612|NCT05579977|102165931|FG000|COMPLETED|Treatment Phase||0||
48746613|NCT05579977|102165932|FG001|COMPLETED|Treatment Phase||0||
48746614|NCT05579977|102165933|FG002|COMPLETED|Treatment Phase||0||
48746615|NCT05579977|102165934|FG003|COMPLETED|Treatment Phase||0||
48746616|NCT05579977|102165935|FG004|COMPLETED|Treatment Phase||0||
48746617|NCT05579977|102165936|FG005|COMPLETED|Treatment Phase||0||
48746618|NCT05579977|102165937|FG006|COMPLETED|Treatment Phase||0||
48746619|NCT05579977|102165938|FG007|COMPLETED|Treatment Phase||0||
48746620|NCT05579977|102165939|FG008|COMPLETED|Treatment Phase||0||
48746621|NCT05579977|102165940|FG009|COMPLETED|Treatment Phase||0||
48746622|NCT05579977|102165941|FG010|COMPLETED|Treatment Phase||0||
48746623|NCT05579977|102165942|FG011|COMPLETED|Treatment Phase||0||
48746624|NCT05579977|102165943|FG012|COMPLETED|Treatment Phase||0||
48746625|NCT05579977|102165931|FG000|NOT COMPLETED|Treatment Phase||75||
48746626|NCT05579977|102165932|FG001|NOT COMPLETED|Treatment Phase||73||
48746627|NCT05579977|102165933|FG002|NOT COMPLETED|Treatment Phase||72||
48746628|NCT05579977|102165934|FG003|NOT COMPLETED|Treatment Phase||73||
48746629|NCT05579977|102165935|FG004|NOT COMPLETED|Treatment Phase||73||
48746630|NCT05579977|102165936|FG005|NOT COMPLETED|Treatment Phase||74||
48746631|NCT05579977|102165937|FG006|NOT COMPLETED|Treatment Phase||73||
48746632|NCT05579977|102165938|FG007|NOT COMPLETED|Treatment Phase||64||
48746633|NCT05579977|102165939|FG008|NOT COMPLETED|Treatment Phase||66||
48746634|NCT05579977|102165940|FG009|NOT COMPLETED|Treatment Phase||64||
48746635|NCT05579977|102165941|FG010|NOT COMPLETED|Treatment Phase||65||
48746636|NCT05579977|102165942|FG011|NOT COMPLETED|Treatment Phase||66||
48746637|NCT05579977|102165943|FG012|NOT COMPLETED|Treatment Phase||64||
48746638|NCT05579977|102165931|FG000|STARTED|Follow up||75||
48746639|NCT05579977|102165932|FG001|STARTED|Follow up||73||
48623832|NCT03154086|101863735|FG000|STARTED|Part B (Up to 25 Days)||0||
48623833|NCT03154086|101863736|FG001|STARTED|Part B (Up to 25 Days)||0||
48623834|NCT03154086|101863737|FG002|STARTED|Part B (Up to 25 Days)||0||
48623835|NCT03154086|101863738|FG003|STARTED|Part B (Up to 25 Days)||0||
48623836|NCT03154086|101863739|FG004|STARTED|Part B (Up to 25 Days)||0||
48623837|NCT03154086|101863740|FG005|STARTED|Part B (Up to 25 Days)||0||
48623838|NCT03154086|101863741|FG006|STARTED|Part B (Up to 25 Days)||0||
48623839|NCT03154086|101863742|FG007|STARTED|Part B (Up to 25 Days)||0||
48623840|NCT03154086|101863743|FG008|STARTED|Part B (Up to 25 Days)||0||
48623841|NCT03154086|101863744|FG009|STARTED|Part B (Up to 25 Days)||10||
48623842|NCT03154086|101863745|FG010|STARTED|Part B (Up to 25 Days)||6||
48623843|NCT03154086|101863746|FG011|STARTED|Part B (Up to 25 Days)||6||
48623844|NCT03154086|101863747|FG012|STARTED|Part B (Up to 25 Days)||6||
48623845|NCT03154086|101863748|FG013|STARTED|Part B (Up to 25 Days)||6||
48623846|NCT03154086|101863749|FG014|STARTED|Part B (Up to 25 Days)||6||
48623847|NCT03154086|101863735|FG000|COMPLETED|Part B (Up to 25 Days)||0||
48623848|NCT03154086|101863736|FG001|COMPLETED|Part B (Up to 25 Days)||0||
48623849|NCT03154086|101863737|FG002|COMPLETED|Part B (Up to 25 Days)||0||
48623850|NCT03154086|101863738|FG003|COMPLETED|Part B (Up to 25 Days)||0||
48623851|NCT03154086|101863739|FG004|COMPLETED|Part B (Up to 25 Days)||0||
48746640|NCT05579977|102165933|FG002|STARTED|Follow up||72||
48746641|NCT05579977|102165934|FG003|STARTED|Follow up||73||
48746642|NCT05579977|102165935|FG004|STARTED|Follow up||72||
48746643|NCT05579977|102165936|FG005|STARTED|Follow up||74||
48623852|NCT03154086|101863740|FG005|COMPLETED|Part B (Up to 25 Days)||0||
48623853|NCT03154086|101863741|FG006|COMPLETED|Part B (Up to 25 Days)||0||
48746644|NCT05579977|102165937|FG006|STARTED|Follow up||73||
48746645|NCT05579977|102165938|FG007|STARTED|Follow up||64||
48746646|NCT05579977|102165939|FG008|STARTED|Follow up||66||
48746647|NCT05579977|102165940|FG009|STARTED|Follow up||64||
48746648|NCT05579977|102165941|FG010|STARTED|Follow up||65||
48746649|NCT05579977|102165942|FG011|STARTED|Follow up||66||
48746650|NCT05579977|102165943|FG012|STARTED|Follow up||64||
48746651|NCT05579977|102165931|FG000|COMPLETED|Follow up||72||
48746652|NCT05579977|102165932|FG001|COMPLETED|Follow up||73||
48746653|NCT05579977|102165933|FG002|COMPLETED|Follow up||72||
48623854|NCT03154086|101863742|FG007|COMPLETED|Part B (Up to 25 Days)||0||
48623855|NCT03154086|101863743|FG008|COMPLETED|Part B (Up to 25 Days)||0||
48623856|NCT03154086|101863744|FG009|COMPLETED|Part B (Up to 25 Days)||10||
48623857|NCT03154086|101863745|FG010|COMPLETED|Part B (Up to 25 Days)||5||
48623858|NCT03154086|101863746|FG011|COMPLETED|Part B (Up to 25 Days)||6||
48623859|NCT03154086|101863747|FG012|COMPLETED|Part B (Up to 25 Days)||6||
48623860|NCT03154086|101863748|FG013|COMPLETED|Part B (Up to 25 Days)||6||
48623861|NCT03154086|101863749|FG014|COMPLETED|Part B (Up to 25 Days)||6||
48623862|NCT03154086|101863735|FG000|NOT COMPLETED|Part B (Up to 25 Days)||0||
48623863|NCT03154086|101863736|FG001|NOT COMPLETED|Part B (Up to 25 Days)||0||
48623864|NCT03154086|101863737|FG002|NOT COMPLETED|Part B (Up to 25 Days)||0||
48623865|NCT03154086|101863738|FG003|NOT COMPLETED|Part B (Up to 25 Days)||0||
48623866|NCT03154086|101863739|FG004|NOT COMPLETED|Part B (Up to 25 Days)||0||
48623867|NCT03154086|101863740|FG005|NOT COMPLETED|Part B (Up to 25 Days)||0||
48623868|NCT03154086|101863741|FG006|NOT COMPLETED|Part B (Up to 25 Days)||0||
48623869|NCT03154086|101863742|FG007|NOT COMPLETED|Part B (Up to 25 Days)||0||
48623870|NCT03154086|101863743|FG008|NOT COMPLETED|Part B (Up to 25 Days)||0||
48623871|NCT03154086|101863744|FG009|NOT COMPLETED|Part B (Up to 25 Days)||0||
48623872|NCT03154086|101863745|FG010|NOT COMPLETED|Part B (Up to 25 Days)||1||
48746654|NCT05579977|102165934|FG003|COMPLETED|Follow up||72||
48746655|NCT05579977|102165935|FG004|COMPLETED|Follow up||70||
48746656|NCT05579977|102165936|FG005|COMPLETED|Follow up||72||
48746657|NCT05579977|102165937|FG006|COMPLETED|Follow up||71||
48746658|NCT05579977|102165938|FG007|COMPLETED|Follow up||59||
48746659|NCT05579977|102165939|FG008|COMPLETED|Follow up||61||
48746660|NCT05579977|102165940|FG009|COMPLETED|Follow up||59||
48746661|NCT05579977|102165941|FG010|COMPLETED|Follow up||60||
48746662|NCT05579977|102165942|FG011|COMPLETED|Follow up||61||
48746663|NCT05579977|102165943|FG012|COMPLETED|Follow up||57||
48746664|NCT05579977|102165931|FG000|NOT COMPLETED|Follow up||3||
48746665|NCT05579977|102165932|FG001|NOT COMPLETED|Follow up||0||
48746666|NCT05579977|102165933|FG002|NOT COMPLETED|Follow up||0||
48746667|NCT05579977|102165934|FG003|NOT COMPLETED|Follow up||1||
48746668|NCT05579977|102165935|FG004|NOT COMPLETED|Follow up||2||
48746669|NCT05579977|102165936|FG005|NOT COMPLETED|Follow up||2||
48746670|NCT05579977|102165937|FG006|NOT COMPLETED|Follow up||2||
48746671|NCT05579977|102165938|FG007|NOT COMPLETED|Follow up||5||
48746672|NCT05579977|102165939|FG008|NOT COMPLETED|Follow up||5||
48746673|NCT05579977|102165940|FG009|NOT COMPLETED|Follow up||5||
48746674|NCT05579977|102165941|FG010|NOT COMPLETED|Follow up||5||
48746675|NCT05579977|102165942|FG011|NOT COMPLETED|Follow up||5||
48746676|NCT05579977|102165943|FG012|NOT COMPLETED|Follow up||7||
48746677|NCT01336933|102165944|FG000|STARTED|Overall Study||34||
48746678|NCT01336933|102165944|FG000|COMPLETED|Overall Study||33||
48746679|NCT01336933|102165944|FG000|NOT COMPLETED|Overall Study||1||
48746680|NCT00999544|102165945|FG000|STARTED|Overall Study||9||
48746681|NCT00999544|102165945|FG000|COMPLETED|Overall Study||8||
48746682|NCT00999544|102165945|FG000|NOT COMPLETED|Overall Study||1||
48746683|NCT01759420|102165946|FG000|STARTED|Overall Study||28||
48746684|NCT01759420|102165946|FG000|COMPLETED|Overall Study||22||
48746685|NCT01759420|102165946|FG000|NOT COMPLETED|Overall Study||6||
48746686|NCT02098746|102165947|FG000|STARTED|Overall Study||294||
48746687|NCT02098746|102165947|FG000|COMPLETED|Overall Study||289||
48746688|NCT02098746|102165947|FG000|NOT COMPLETED|Overall Study||5||
48746689|NCT01155336|102165948|FG000|STARTED|Overall Study||0||
48746690|NCT01155336|102165949|FG001|STARTED|Overall Study||4||
48746691|NCT01155336|102165948|FG000|COMPLETED|Overall Study||0||
48746692|NCT01155336|102165949|FG001|COMPLETED|Overall Study||4||
48746693|NCT01155336|102165948|FG000|NOT COMPLETED|Overall Study||0||
48746694|NCT01155336|102165949|FG001|NOT COMPLETED|Overall Study||0||
48746695|NCT00100789|102165950|FG000|STARTED|Overall Study||67||
48746696|NCT00100789|102165950|FG000|Eligible|Overall Study||64||
48746697|NCT00100789|102165950|FG000|Eligible and Began Protocol Therapy|Overall Study||63||
48746698|NCT00100789|102165950|FG000|COMPLETED|Overall Study||3||
48746699|NCT00100789|102165950|FG000|NOT COMPLETED|Overall Study||64||
48746700|NCT01774799|102165951|FG000|STARTED|Overall Study||212||
48746701|NCT01774799|102165952|FG001|STARTED|Overall Study||190||
48746702|NCT01774799|102165953|FG002|STARTED|Overall Study||212||
48746703|NCT01774799|102165954|FG003|STARTED|Overall Study||190||
48746704|NCT01774799|102165951|FG000|COMPLETED|Overall Study||211||
48746705|NCT01774799|102165952|FG001|COMPLETED|Overall Study||189||
48746706|NCT01774799|102165953|FG002|COMPLETED|Overall Study||212||
48746707|NCT01774799|102165954|FG003|COMPLETED|Overall Study||190||
48746708|NCT01774799|102165951|FG000|NOT COMPLETED|Overall Study||1||
48746709|NCT01774799|102165952|FG001|NOT COMPLETED|Overall Study||1||
48746710|NCT01774799|102165953|FG002|NOT COMPLETED|Overall Study||0||
48746711|NCT01774799|102165954|FG003|NOT COMPLETED|Overall Study||0||
48746712|NCT01535807|102165955|FG000|STARTED|Overall Study||22||
48746713|NCT01535807|102165956|FG001|STARTED|Overall Study||22||
48623873|NCT03154086|101863746|FG011|NOT COMPLETED|Part B (Up to 25 Days)||0||
48657123|NCT03745313|101943783|FG000|COMPLETED|At 1 Year Follow-up||47||
48746714|NCT01535807|102165955|FG000|COMPLETED|Overall Study||20||
48746715|NCT01535807|102165956|FG001|COMPLETED|Overall Study||20||
48746716|NCT01535807|102165955|FG000|NOT COMPLETED|Overall Study||2||
48746717|NCT01535807|102165956|FG001|NOT COMPLETED|Overall Study||2||
48746718|NCT03890588|102165957|FG000|STARTED|Overall Study||2923||16
48746719|NCT03890588|102165958|FG001|STARTED|Overall Study||3372||16
48746720|NCT03890588|102165957|FG000|COMPLETED|Overall Study||2923||16
48746721|NCT03890588|102165958|FG001|COMPLETED|Overall Study||3372||16
48746722|NCT03890588|102165957|FG000|NOT COMPLETED|Overall Study||0||0
48746723|NCT03890588|102165958|FG001|NOT COMPLETED|Overall Study||0||0
48746724|NCT00488488|102165959|FG000|STARTED|Overall Study||1028||
48746725|NCT00488488|102165959|FG000|Analyzed|Overall Study||1025||
48746726|NCT00488488|102165959|FG000|COMPLETED|Overall Study||760||
48746727|NCT00488488|102165959|FG000|NOT COMPLETED|Overall Study||268||
48746728|NCT03010527|102165960|FG000|STARTED|Overall Study||15||
48746729|NCT03010527|102165961|FG001|STARTED|Overall Study||111||
48746730|NCT03010527|102165962|FG002|STARTED|Overall Study||91||
48746731|NCT03010527|102165960|FG000|COMPLETED|Overall Study||15||
48329575|NCT03665285|101132242|FG006|STARTED|Overall Study||4||
48329576|NCT03665285|101132243|FG007|STARTED|Overall Study||47||
48329577|NCT03665285|101132244|FG008|STARTED|Overall Study||13||
48329578|NCT03665285|101132236|FG000|COMPLETED|Overall Study||3||
48329579|NCT03665285|101132237|FG001|COMPLETED|Overall Study||3||
48329580|NCT03665285|101132238|FG002|COMPLETED|Overall Study||5||
48623874|NCT03154086|101863747|FG012|NOT COMPLETED|Part B (Up to 25 Days)||0||
48623875|NCT03154086|101863748|FG013|NOT COMPLETED|Part B (Up to 25 Days)||0||
48623876|NCT03154086|101863749|FG014|NOT COMPLETED|Part B (Up to 25 Days)||0||
48623877|NCT02589145|101863750|FG000|STARTED|Overall Study||4||
48623878|NCT02589145|101863751|FG001|STARTED|Overall Study||2||
48623879|NCT02589145|101863752|FG002|STARTED|Overall Study||2||
48623880|NCT02589145|101863750|FG000|COMPLETED|Overall Study||4||
48623881|NCT02589145|101863751|FG001|COMPLETED|Overall Study||2||
48623882|NCT02589145|101863752|FG002|COMPLETED|Overall Study||2||
48623883|NCT02589145|101863750|FG000|NOT COMPLETED|Overall Study||0||
48623884|NCT02589145|101863751|FG001|NOT COMPLETED|Overall Study||0||
48623885|NCT02589145|101863752|FG002|NOT COMPLETED|Overall Study||0||
48623886|NCT01535924|101863753|FG000|STARTED|Overall Study||3||
48623887|NCT01535924|101863754|FG001|STARTED|Overall Study||3||
48623888|NCT01535924|101863755|FG002|STARTED|Overall Study||3||
48623889|NCT01535924|101863756|FG003|STARTED|Overall Study||4||
48623890|NCT01535924|101863757|FG004|STARTED|Overall Study||6||
48623891|NCT01535924|101863758|FG005|STARTED|Overall Study||7||
48623892|NCT01535924|101863753|FG000|COMPLETED|Overall Study||3||
48623893|NCT01535924|101863754|FG001|COMPLETED|Overall Study||3||
48623894|NCT01535924|101863755|FG002|COMPLETED|Overall Study||3||
48623895|NCT01535924|101863756|FG003|COMPLETED|Overall Study||4||
48623896|NCT01535924|101863757|FG004|COMPLETED|Overall Study||6||
48746732|NCT03010527|102165961|FG001|COMPLETED|Overall Study||92||
48746733|NCT03010527|102165962|FG002|COMPLETED|Overall Study||75||
48329581|NCT03665285|101132239|FG003|COMPLETED|Overall Study||7||
48329582|NCT03665285|101132240|FG004|COMPLETED|Overall Study||9||
48329583|NCT03665285|101132241|FG005|COMPLETED|Overall Study||3||
48329584|NCT03665285|101132242|FG006|COMPLETED|Overall Study||2||
48329585|NCT03665285|101132243|FG007|COMPLETED|Overall Study||19||
48329586|NCT03665285|101132244|FG008|COMPLETED|Overall Study||11||
48329587|NCT03665285|101132236|FG000|NOT COMPLETED|Overall Study||1||
48623897|NCT01535924|101863758|FG005|COMPLETED|Overall Study||7||
48623898|NCT01535924|101863753|FG000|NOT COMPLETED|Overall Study||0||
48623899|NCT01535924|101863754|FG001|NOT COMPLETED|Overall Study||0||
48623900|NCT01535924|101863755|FG002|NOT COMPLETED|Overall Study||0||
48623901|NCT01535924|101863756|FG003|NOT COMPLETED|Overall Study||0||
48623902|NCT01535924|101863757|FG004|NOT COMPLETED|Overall Study||0||
48623903|NCT01535924|101863758|FG005|NOT COMPLETED|Overall Study||0||
48623904|NCT01401595|101863759|FG000|STARTED|Recruitment and Screening||75||
48623905|NCT01401595|101863760|FG001|STARTED|Recruitment and Screening||12||
48623906|NCT01401595|101863759|FG000|COMPLETED|Recruitment and Screening||32||
48746734|NCT03010527|102165960|FG000|NOT COMPLETED|Overall Study||0||
48746735|NCT03010527|102165961|FG001|NOT COMPLETED|Overall Study||19||
48746736|NCT03010527|102165962|FG002|NOT COMPLETED|Overall Study||16||
48329588|NCT03665285|101132237|FG001|NOT COMPLETED|Overall Study||1||
48623907|NCT01401595|101863760|FG001|COMPLETED|Recruitment and Screening||10||
48623908|NCT01401595|101863759|FG000|NOT COMPLETED|Recruitment and Screening||43||
48746737|NCT01165983|102165963|FG000|STARTED|Overall Study||51||
48623909|NCT01401595|101863760|FG001|NOT COMPLETED|Recruitment and Screening||2||
48623910|NCT01401595|101863759|FG000|STARTED|Imaging and Treatment (for NE Arm)||32||
48329589|NCT03665285|101132238|FG002|NOT COMPLETED|Overall Study||5||
48329590|NCT03665285|101132239|FG003|NOT COMPLETED|Overall Study||5||
48623911|NCT01401595|101863760|FG001|STARTED|Imaging and Treatment (for NE Arm)||10||
48623912|NCT01401595|101863759|FG000|COMPLETED|Imaging and Treatment (for NE Arm)||18||
48623913|NCT01401595|101863760|FG001|COMPLETED|Imaging and Treatment (for NE Arm)||10||
48623914|NCT01401595|101863759|FG000|NOT COMPLETED|Imaging and Treatment (for NE Arm)||14||
48623915|NCT01401595|101863760|FG001|NOT COMPLETED|Imaging and Treatment (for NE Arm)||0||
48623916|NCT00954681|101863761|FG000|STARTED|Overall Study||15||
48623917|NCT00954681|101863761|FG000|COMPLETED|Overall Study||10||
48623918|NCT00954681|101863761|FG000|NOT COMPLETED|Overall Study||5||
48623919|NCT05117060|101863762|FG000|STARTED|Overall Study||61||
48623920|NCT05117060|101863763|FG001|STARTED|Overall Study||45||
48623921|NCT05117060|101863764|FG002|STARTED|Overall Study||49||
48623922|NCT05117060|101863765|FG003|STARTED|Overall Study||61||
48623923|NCT05117060|101863762|FG000|COMPLETED|Overall Study||44||
48623924|NCT05117060|101863763|FG001|COMPLETED|Overall Study||29||
48623925|NCT05117060|101863764|FG002|COMPLETED|Overall Study||33||
48623926|NCT05117060|101863765|FG003|COMPLETED|Overall Study||46||
48623927|NCT05117060|101863762|FG000|NOT COMPLETED|Overall Study||17||
48623928|NCT05117060|101863763|FG001|NOT COMPLETED|Overall Study||16||
48623929|NCT05117060|101863764|FG002|NOT COMPLETED|Overall Study||16||
48623930|NCT05117060|101863765|FG003|NOT COMPLETED|Overall Study||15||
48623931|NCT04085601|101863766|FG000|STARTED|Overall Study||35||
48623932|NCT04085601|101863767|FG001|STARTED|Overall Study||18||
48623933|NCT04085601|101863766|FG000|SoC to Pegcetacoplan (Escape Therapy)|Overall Study||0||
48746738|NCT01165983|102165964|FG001|STARTED|Overall Study||49||
48746739|NCT01165983|102165963|FG000|COMPLETED|Overall Study||46||
48746740|NCT01165983|102165964|FG001|COMPLETED|Overall Study||42||
48746741|NCT01165983|102165963|FG000|NOT COMPLETED|Overall Study||5||
48746742|NCT01165983|102165964|FG001|NOT COMPLETED|Overall Study||7||
48746743|NCT03077542|102165965|FG000|STARTED|Overall Study||28||
48746744|NCT03077542|102165966|FG001|STARTED|Overall Study||29||
48746745|NCT03077542|102165965|FG000|COMPLETED|Overall Study||18||
48746746|NCT03077542|102165966|FG001|COMPLETED|Overall Study||27||
48746747|NCT03077542|102165965|FG000|NOT COMPLETED|Overall Study||10||
48746748|NCT03077542|102165966|FG001|NOT COMPLETED|Overall Study||2||
48746749|NCT01271725|102165967|FG000|STARTED|Part A||74||
48746750|NCT01271725|102165968|FG001|STARTED|Part A||0||
48746751|NCT01271725|102165967|FG000|COMPLETED|Part A||39||
48746752|NCT01271725|102165968|FG001|COMPLETED|Part A||0||
48746753|NCT01271725|102165967|FG000|NOT COMPLETED|Part A||35||
48746754|NCT01271725|102165968|FG001|NOT COMPLETED|Part A||0||
48746755|NCT01271725|102165967|FG000|STARTED|Part B||0||
48746756|NCT01271725|102165968|FG001|STARTED|Part B||39||
48746757|NCT01271725|102165967|FG000|COMPLETED|Part B||0||
48746758|NCT01271725|102165968|FG001|COMPLETED|Part B||27||
48623934|NCT04085601|101863767|FG001|SoC to Pegcetacoplan (Escape Therapy)|Overall Study||11||
48623935|NCT04085601|101863766|FG000|COMPLETED|Overall Study||33||
48623936|NCT04085601|101863767|FG001|COMPLETED|Overall Study||17||
48623937|NCT04085601|101863766|FG000|NOT COMPLETED|Overall Study||2||
48623938|NCT04085601|101863767|FG001|NOT COMPLETED|Overall Study||1||
48623939|NCT05438277|101863768|FG000|STARTED|Overall Study||205||209
48623940|NCT05438277|101863769|FG001|STARTED|Overall Study||216||227
48623941|NCT05438277|101863768|FG000|COMPLETED|Overall Study||205||209
48623942|NCT05438277|101863769|FG001|COMPLETED|Overall Study||216||227
48623943|NCT05438277|101863768|FG000|NOT COMPLETED|Overall Study||0||0
48623944|NCT05438277|101863769|FG001|NOT COMPLETED|Overall Study||0||0
48623945|NCT01128296|101863770|FG000|STARTED|Overall Study||1||
48623946|NCT01128296|101863771|FG001|STARTED|Overall Study||1||
48746759|NCT01271725|102165967|FG000|NOT COMPLETED|Part B||0||
48746760|NCT01271725|102165968|FG001|NOT COMPLETED|Part B||12||
48746761|NCT03518294|102165969|FG000|STARTED|Overall Study||10||
48746762|NCT03518294|102165970|FG001|STARTED|Overall Study||18||
48746763|NCT03518294|102165969|FG000|COMPLETED|Overall Study||8||
48746764|NCT03518294|102165970|FG001|COMPLETED|Overall Study||16||
48746765|NCT03518294|102165969|FG000|NOT COMPLETED|Overall Study||2||
48746766|NCT03518294|102165970|FG001|NOT COMPLETED|Overall Study||2||
48746767|NCT01929226|102165971|FG000|STARTED|Overall Study||210||
48746768|NCT01929226|102165972|FG001|STARTED|Overall Study||70||
48746769|NCT01929226|102165971|FG000|COMPLETED|Overall Study||205||
48746770|NCT01929226|102165972|FG001|COMPLETED|Overall Study||69||
48746771|NCT01929226|102165971|FG000|NOT COMPLETED|Overall Study||5||
48746772|NCT01929226|102165972|FG001|NOT COMPLETED|Overall Study||1||
48746773|NCT01798966|102165973|FG000|STARTED|Overall Study||10||
48746774|NCT01798966|102165973|FG000|COMPLETED|Overall Study||10||
48746775|NCT01798966|102165973|FG000|NOT COMPLETED|Overall Study||0||
48746776|NCT04175730|102165974|FG000|STARTED|Overall Study||27||
48746777|NCT04175730|102165975|FG001|STARTED|Overall Study||21||
48746778|NCT04175730|102165974|FG000|COMPLETED|Overall Study||27||
48746779|NCT04175730|102165975|FG001|COMPLETED|Overall Study||21||
48746780|NCT04175730|102165974|FG000|NOT COMPLETED|Overall Study||0||
48746781|NCT04175730|102165975|FG001|NOT COMPLETED|Overall Study||0||
48746782|NCT01745367|102165976|FG000|STARTED|Overall Study||8||
48746783|NCT01745367|102165977|FG001|STARTED|Overall Study||22||
48746784|NCT01745367|102165976|FG000|Treated|Overall Study||8||
48623947|NCT01128296|101863772|FG002|STARTED|Overall Study||1||
48623948|NCT01128296|101863773|FG003|STARTED|Overall Study||1||
48623949|NCT01128296|101863774|FG004|STARTED|Overall Study||1||
48623950|NCT01128296|101863775|FG005|STARTED|Overall Study||26||
48623951|NCT01128296|101863770|FG000|COMPLETED|Overall Study||1||
48623952|NCT01128296|101863771|FG001|COMPLETED|Overall Study||1||
48623953|NCT01128296|101863772|FG002|COMPLETED|Overall Study||1||
48623954|NCT01128296|101863773|FG003|COMPLETED|Overall Study||1||
48623955|NCT01128296|101863774|FG004|COMPLETED|Overall Study||1||
48623956|NCT01128296|101863775|FG005|COMPLETED|Overall Study||21||
48623957|NCT01128296|101863770|FG000|NOT COMPLETED|Overall Study||0||
48623958|NCT01128296|101863771|FG001|NOT COMPLETED|Overall Study||0||
48623959|NCT01128296|101863772|FG002|NOT COMPLETED|Overall Study||0||
48623960|NCT01128296|101863773|FG003|NOT COMPLETED|Overall Study||0||
48623961|NCT01128296|101863774|FG004|NOT COMPLETED|Overall Study||0||
48623962|NCT01128296|101863775|FG005|NOT COMPLETED|Overall Study||5||
48746785|NCT01745367|102165977|FG001|Treated|Overall Study||21||
48746786|NCT01745367|102165976|FG000|COMPLETED|Overall Study||0||
48746787|NCT01745367|102165977|FG001|COMPLETED|Overall Study||0||
48746788|NCT01745367|102165976|FG000|NOT COMPLETED|Overall Study||8||
48746789|NCT01745367|102165977|FG001|NOT COMPLETED|Overall Study||22||
48746790|NCT00239733|102165978|FG000|STARTED|Overall Study||6||
48746791|NCT00239733|102165978|FG000|COMPLETED|Overall Study||6||
48746792|NCT00239733|102165978|FG000|NOT COMPLETED|Overall Study||0||
48746793|NCT02714569|102165979|FG000|STARTED|Part A First Intervention||3||
48746794|NCT02714569|102165980|FG001|STARTED|Part A First Intervention||3||
48746795|NCT02714569|102165981|FG002|STARTED|Part A First Intervention||3||
48746796|NCT02714569|102165982|FG003|STARTED|Part A First Intervention||3||
48623963|NCT01663402|101863776|FG000|STARTED|Overall Study||9462||
48623964|NCT01663402|101863777|FG001|STARTED|Overall Study||9462||
48623965|NCT01663402|101863776|FG000|Treated|Overall Study||9443||
48623966|NCT01663402|101863777|FG001|Treated|Overall Study||9451||
48623967|NCT01663402|101863776|FG000|COMPLETED|Overall Study||7947||
48623968|NCT01663402|101863777|FG001|COMPLETED|Overall Study||7378||
48623969|NCT01663402|101863776|FG000|NOT COMPLETED|Overall Study||1515||
48623970|NCT01663402|101863777|FG001|NOT COMPLETED|Overall Study||2084||
48623971|NCT01450319|101863778|FG000|STARTED|Overall Study||70||
48623972|NCT01450319|101863778|FG000|COMPLETED|Overall Study||70||
48623973|NCT01450319|101863778|FG000|NOT COMPLETED|Overall Study||0||
48623974|NCT02692586|101863779|FG000|STARTED|Overall Study||106||
48623975|NCT02692586|101863779|FG000|COMPLETED|Overall Study||103||
48623976|NCT02692586|101863779|FG000|NOT COMPLETED|Overall Study||3||
48623977|NCT02644278|101863780|FG000|STARTED|Overall Study||3||
48623978|NCT02644278|101863781|FG001|STARTED|Overall Study||3||
48623979|NCT02644278|101863782|FG002|STARTED|Overall Study||6||
48746797|NCT02714569|102165983|FG004|STARTED|Part A First Intervention||3||
48746798|NCT02714569|102165984|FG005|STARTED|Part A First Intervention||3||
48746799|NCT02714569|102165985|FG006|STARTED|Part A First Intervention||0||
48746800|NCT02714569|102165986|FG007|STARTED|Part A First Intervention||0||
48623980|NCT02644278|101863783|FG003|STARTED|Overall Study||3||
48623981|NCT02644278|101863780|FG000|COMPLETED|Overall Study||3||
48623982|NCT02644278|101863781|FG001|COMPLETED|Overall Study||3||
48623983|NCT02644278|101863782|FG002|COMPLETED|Overall Study||6||
48623984|NCT02644278|101863783|FG003|COMPLETED|Overall Study||3||
48623985|NCT02644278|101863780|FG000|NOT COMPLETED|Overall Study||0||
48623986|NCT02644278|101863781|FG001|NOT COMPLETED|Overall Study||0||
48623987|NCT02644278|101863782|FG002|NOT COMPLETED|Overall Study||0||
48623988|NCT02644278|101863783|FG003|NOT COMPLETED|Overall Study||0||
48623989|NCT03429348|101863784|FG000|STARTED|Overall Study||12||
48623990|NCT03429348|101863785|FG001|STARTED|Overall Study||12||
48623991|NCT03429348|101863784|FG000|COMPLETED|Overall Study||12||
48623992|NCT03429348|101863785|FG001|COMPLETED|Overall Study||12||
48623993|NCT03429348|101863784|FG000|NOT COMPLETED|Overall Study||0||
48623994|NCT03429348|101863785|FG001|NOT COMPLETED|Overall Study||0||
48623995|NCT00974311|101863786|FG000|STARTED|DB Phase (up to 24 Months)||800||
48623996|NCT00974311|101863787|FG001|STARTED|DB Phase (up to 24 Months)||399||
48623997|NCT00974311|101863786|FG000|COMPLETED|DB Phase (up to 24 Months)||109||
48623998|NCT00974311|101863787|FG001|COMPLETED|DB Phase (up to 24 Months)||50||
48623999|NCT00974311|101863786|FG000|NOT COMPLETED|DB Phase (up to 24 Months)||691||
48624000|NCT00974311|101863787|FG001|NOT COMPLETED|DB Phase (up to 24 Months)||349||
48624001|NCT00974311|101863786|FG000|STARTED|OLE Phase (up to 77 Months)||109||
48624002|NCT00974311|101863787|FG001|STARTED|OLE Phase (up to 77 Months)||50||
48624003|NCT00974311|101863786|FG000|COMPLETED|OLE Phase (up to 77 Months)||0||
48624004|NCT00974311|101863787|FG001|COMPLETED|OLE Phase (up to 77 Months)||0||
48624005|NCT00974311|101863786|FG000|NOT COMPLETED|OLE Phase (up to 77 Months)||109||
48624006|NCT00974311|101863787|FG001|NOT COMPLETED|OLE Phase (up to 77 Months)||50||
48624007|NCT01775670|101863788|FG000|STARTED|Overall Study||1||
48624008|NCT01775670|101863789|FG001|STARTED|Overall Study||3||
48624009|NCT01775670|101863788|FG000|COMPLETED|Overall Study||0||
48624010|NCT01775670|101863789|FG001|COMPLETED|Overall Study||2||
48624011|NCT01775670|101863788|FG000|NOT COMPLETED|Overall Study||1||
48624012|NCT01775670|101863789|FG001|NOT COMPLETED|Overall Study||1||
48624013|NCT02224625|101863790|FG000|STARTED|Irritation||39||
48624014|NCT02224625|101863790|FG000|COMPLETED|Irritation||33||
48624015|NCT02224625|101863790|FG000|NOT COMPLETED|Irritation||6||
48624016|NCT02224625|101863790|FG000|STARTED|Sensitization||249||
48624017|NCT02224625|101863790|FG000|COMPLETED|Sensitization||194||
48624018|NCT02224625|101863790|FG000|NOT COMPLETED|Sensitization||55||
48624019|NCT02230891|101863791|FG000|STARTED|Baseline||21||
48624020|NCT02230891|101863792|FG001|STARTED|Baseline||18||
48624021|NCT02230891|101863793|FG002|STARTED|Baseline||19||
48624022|NCT02230891|101863791|FG000|COMPLETED|Baseline||21||
48624023|NCT02230891|101863792|FG001|COMPLETED|Baseline||17||
48624024|NCT02230891|101863793|FG002|COMPLETED|Baseline||18||
48624025|NCT02230891|101863791|FG000|NOT COMPLETED|Baseline||0||
48624026|NCT02230891|101863792|FG001|NOT COMPLETED|Baseline||1||
48624027|NCT02230891|101863793|FG002|NOT COMPLETED|Baseline||1||
48624028|NCT02230891|101863791|FG000|STARTED|2 Week||21||
48624029|NCT02230891|101863792|FG001|STARTED|2 Week||17||
48624030|NCT02230891|101863793|FG002|STARTED|2 Week||0||
48624031|NCT02230891|101863791|FG000|COMPLETED|2 Week||18||
48624032|NCT02230891|101863792|FG001|COMPLETED|2 Week||15||
48624033|NCT02230891|101863793|FG002|COMPLETED|2 Week||0||
48624034|NCT02230891|101863791|FG000|NOT COMPLETED|2 Week||3||
48624035|NCT02230891|101863792|FG001|NOT COMPLETED|2 Week||2||
48624036|NCT02230891|101863793|FG002|NOT COMPLETED|2 Week||0||
48624037|NCT02230891|101863791|FG000|STARTED|6 Month||18||
48624038|NCT02230891|101863792|FG001|STARTED|6 Month||15||
48624039|NCT02230891|101863793|FG002|STARTED|6 Month||18||
48624040|NCT02230891|101863791|FG000|COMPLETED|6 Month||17||
48624041|NCT02230891|101863792|FG001|COMPLETED|6 Month||12||
48624042|NCT02230891|101863793|FG002|COMPLETED|6 Month||17||
48624043|NCT02230891|101863791|FG000|NOT COMPLETED|6 Month||1||
48624044|NCT02230891|101863792|FG001|NOT COMPLETED|6 Month||3||
48624045|NCT02230891|101863793|FG002|NOT COMPLETED|6 Month||1||
48624046|NCT02230891|101863791|FG000|STARTED|12 Month||17||
48624047|NCT02230891|101863792|FG001|STARTED|12 Month||12||
48624048|NCT02230891|101863793|FG002|STARTED|12 Month||17||
48624049|NCT02230891|101863791|FG000|COMPLETED|12 Month||16||
48624050|NCT02230891|101863792|FG001|COMPLETED|12 Month||9||
48624051|NCT02230891|101863793|FG002|COMPLETED|12 Month||17||
48624052|NCT02230891|101863791|FG000|NOT COMPLETED|12 Month||1||
48624053|NCT02230891|101863792|FG001|NOT COMPLETED|12 Month||3||
48624054|NCT02230891|101863793|FG002|NOT COMPLETED|12 Month||0||
48624055|NCT02230891|101863791|FG000|STARTED|18 Month End of Study||16||
48624056|NCT02230891|101863792|FG001|STARTED|18 Month End of Study||9||
48624057|NCT02230891|101863793|FG002|STARTED|18 Month End of Study||17||
48624058|NCT02230891|101863791|FG000|COMPLETED|18 Month End of Study||15||
48624059|NCT02230891|101863792|FG001|COMPLETED|18 Month End of Study||9||
48624060|NCT02230891|101863793|FG002|COMPLETED|18 Month End of Study||16||
48624061|NCT02230891|101863791|FG000|NOT COMPLETED|18 Month End of Study||1||
48624062|NCT02230891|101863792|FG001|NOT COMPLETED|18 Month End of Study||0||
48624063|NCT02230891|101863793|FG002|NOT COMPLETED|18 Month End of Study||1||
48624064|NCT00128661|101863794|FG000|STARTED|Overall Study||3727||
48624065|NCT00128661|101863795|FG001|STARTED|Overall Study||3739||
48624066|NCT00128661|101863794|FG000|COMPLETED|Overall Study||3453||
48624067|NCT00128661|101863795|FG001|COMPLETED|Overall Study||3481||
48624068|NCT00128661|101863794|FG000|NOT COMPLETED|Overall Study||274||
48624069|NCT00128661|101863795|FG001|NOT COMPLETED|Overall Study||258||
48624070|NCT04249427|101863796|FG000|STARTED|Overall Study||13||
48624071|NCT04249427|101863797|FG001|STARTED|Overall Study||12||
48624072|NCT04249427|101863796|FG000|COMPLETED|Overall Study||9||
48624073|NCT04249427|101863797|FG001|COMPLETED|Overall Study||8||
48624074|NCT04249427|101863796|FG000|NOT COMPLETED|Overall Study||4||
48624075|NCT04249427|101863797|FG001|NOT COMPLETED|Overall Study||4||
48624076|NCT02895035|101863798|FG000|STARTED|Overall Study||23||
48624077|NCT02895035|101863799|FG001|STARTED|Overall Study||36||
48746801|NCT02714569|102165987|FG008|STARTED|Part A First Intervention||0||
48746802|NCT02714569|102165988|FG009|STARTED|Part A First Intervention||0||
48746803|NCT02714569|102165989|FG010|STARTED|Part A First Intervention||0||
48746804|NCT02714569|102165979|FG000|Received at Least One Dose of Study Drug|Part A First Intervention||3||
48746805|NCT02714569|102165980|FG001|Received at Least One Dose of Study Drug|Part A First Intervention||3||
48746806|NCT02714569|102165981|FG002|Received at Least One Dose of Study Drug|Part A First Intervention||3||
48746807|NCT02714569|102165982|FG003|Received at Least One Dose of Study Drug|Part A First Intervention||3||
48746808|NCT02714569|102165983|FG004|Received at Least One Dose of Study Drug|Part A First Intervention||3||
48746809|NCT02714569|102165984|FG005|Received at Least One Dose of Study Drug|Part A First Intervention||3||
48746810|NCT02714569|102165985|FG006|Received at Least One Dose of Study Drug|Part A First Intervention||0||
48746811|NCT02714569|102165986|FG007|Received at Least One Dose of Study Drug|Part A First Intervention||0||
48746812|NCT02714569|102165987|FG008|Received at Least One Dose of Study Drug|Part A First Intervention||0||
48746813|NCT02714569|102165988|FG009|Received at Least One Dose of Study Drug|Part A First Intervention||0||
48746814|NCT02714569|102165989|FG010|Received at Least One Dose of Study Drug|Part A First Intervention||0||
48746815|NCT02714569|102165979|FG000|COMPLETED|Part A First Intervention||3||
48624078|NCT02895035|101863798|FG000|COMPLETED|Overall Study||18||
48624079|NCT02895035|101863799|FG001|COMPLETED|Overall Study||24||
48624080|NCT02895035|101863798|FG000|NOT COMPLETED|Overall Study||5||
48624081|NCT02895035|101863799|FG001|NOT COMPLETED|Overall Study||12||
48746816|NCT02714569|102165980|FG001|COMPLETED|Part A First Intervention||3||
48746817|NCT02714569|102165981|FG002|COMPLETED|Part A First Intervention||3||
48624082|NCT02974868|101863800|FG000|STARTED|Initial 24-Week Treatment Period (TP)||24||
48624083|NCT02974868|101863801|FG001|STARTED|Initial 24-Week Treatment Period (TP)||23||
48624084|NCT02974868|101863802|FG002|STARTED|Initial 24-Week Treatment Period (TP)||48||
48624085|NCT02974868|101863803|FG003|STARTED|Initial 24-Week Treatment Period (TP)||47||
48624086|NCT02974868|101863800|FG000|COMPLETED|Initial 24-Week Treatment Period (TP)||20||
48624087|NCT02974868|101863801|FG001|COMPLETED|Initial 24-Week Treatment Period (TP)||14||
48624088|NCT02974868|101863802|FG002|COMPLETED|Initial 24-Week Treatment Period (TP)||45||
48624089|NCT02974868|101863803|FG003|COMPLETED|Initial 24-Week Treatment Period (TP)||35||
48624090|NCT02974868|101863800|FG000|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||4||
48624091|NCT02974868|101863801|FG001|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||9||
48746818|NCT02714569|102165982|FG003|COMPLETED|Part A First Intervention||3||
48746819|NCT02714569|102165983|FG004|COMPLETED|Part A First Intervention||3||
48624092|NCT02974868|101863802|FG002|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||3||
48624093|NCT02974868|101863803|FG003|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||12||
48624094|NCT02974868|101863800|FG000|STARTED|Single-Blind Extension (SBE) Period||17|Among 114 participants completed initial treatment period, 96 participants entered SBE period|
48624095|NCT02974868|101863801|FG001|STARTED|Single-Blind Extension (SBE) Period||12|Among 114 participants completed initial treatment period, 96 participants entered SBE period|
48624096|NCT02974868|101863802|FG002|STARTED|Single-Blind Extension (SBE) Period||38|Among 114 participants completed initial treatment period, 96 participants entered SBE period|
48624097|NCT02974868|101863803|FG003|STARTED|Single-Blind Extension (SBE) Period||29|Among 114 participants completed initial treatment period, 96 participants entered SBE period|
48746820|NCT02714569|102165984|FG005|COMPLETED|Part A First Intervention||3||
48746821|NCT02714569|102165985|FG006|COMPLETED|Part A First Intervention||0||
48746822|NCT02714569|102165986|FG007|COMPLETED|Part A First Intervention||0||
48746823|NCT02714569|102165987|FG008|COMPLETED|Part A First Intervention||0||
48746824|NCT02714569|102165988|FG009|COMPLETED|Part A First Intervention||0||
48746825|NCT02714569|102165989|FG010|COMPLETED|Part A First Intervention||0||
48166406|NCT01161472|100728729|FG001|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0||
48166407|NCT01161472|100728730|FG002|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0||
48166408|NCT01161472|100728731|FG003|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0||
48166409|NCT01161472|100728728|FG000|STARTED|Second Intervention Period||5||
48166410|NCT01161472|100728729|FG001|STARTED|Second Intervention Period||5||
48624098|NCT02974868|101863800|FG000|COMPLETED|Single-Blind Extension (SBE) Period||15|Week 28-52 and additional 24 weeks(AT Day 1 -AT Week 24) for those retreated with active treatment|
48624099|NCT02974868|101863801|FG001|COMPLETED|Single-Blind Extension (SBE) Period||11|Week 28-52 and additional 24 weeks(AT Day 1 -AT Week 24) for those retreated with active treatment|
48624100|NCT02974868|101863802|FG002|COMPLETED|Single-Blind Extension (SBE) Period||27|Week 28-52 and additional 24 weeks(AT Day 1 -AT Week 24) for those retreated with active treatment|
48166411|NCT01161472|100728730|FG002|STARTED|Second Intervention Period||5||
48166412|NCT01161472|100728731|FG003|STARTED|Second Intervention Period||5||
48166413|NCT01161472|100728728|FG000|COMPLETED|Second Intervention Period||5||
48166414|NCT01161472|100728729|FG001|COMPLETED|Second Intervention Period||5||
48166415|NCT01161472|100728730|FG002|COMPLETED|Second Intervention Period||5||
48166416|NCT01161472|100728731|FG003|COMPLETED|Second Intervention Period||5||
48166417|NCT01161472|100728728|FG000|NOT COMPLETED|Second Intervention Period||0||
48746826|NCT02714569|102165979|FG000|NOT COMPLETED|Part A First Intervention||0||
48746827|NCT02714569|102165980|FG001|NOT COMPLETED|Part A First Intervention||0||
48746828|NCT02714569|102165981|FG002|NOT COMPLETED|Part A First Intervention||0||
48746829|NCT02714569|102165982|FG003|NOT COMPLETED|Part A First Intervention||0||
48166418|NCT01161472|100728729|FG001|NOT COMPLETED|Second Intervention Period||0||
48166419|NCT01161472|100728730|FG002|NOT COMPLETED|Second Intervention Period||0||
48329591|NCT03665285|101132240|FG004|NOT COMPLETED|Overall Study||2||
48329592|NCT03665285|101132241|FG005|NOT COMPLETED|Overall Study||1||
48166420|NCT01161472|100728731|FG003|NOT COMPLETED|Second Intervention Period||0||
48166421|NCT01161472|100728728|FG000|STARTED|Washout Period (At Least 3 to 6 Days)||5||
48166422|NCT01161472|100728729|FG001|STARTED|Washout Period (At Least 3 to 6 Days)||5||
48166423|NCT01161472|100728730|FG002|STARTED|Washout Period (At Least 3 to 6 Days)||5||
48166424|NCT01161472|100728731|FG003|STARTED|Washout Period (At Least 3 to 6 Days)||5||
48166425|NCT01161472|100728728|FG000|COMPLETED|Washout Period (At Least 3 to 6 Days)||4||
48166426|NCT01161472|100728729|FG001|COMPLETED|Washout Period (At Least 3 to 6 Days)||5||
48166427|NCT01161472|100728730|FG002|COMPLETED|Washout Period (At Least 3 to 6 Days)||5||
48166428|NCT01161472|100728731|FG003|COMPLETED|Washout Period (At Least 3 to 6 Days)||5||
48166429|NCT01161472|100728728|FG000|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||1||
48166430|NCT01161472|100728729|FG001|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0||
48166431|NCT01161472|100728730|FG002|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0||
48166432|NCT01161472|100728731|FG003|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0||
48166433|NCT01161472|100728728|FG000|STARTED|Third Intervention Period||4||
48166434|NCT01161472|100728729|FG001|STARTED|Third Intervention Period||5||
48166435|NCT01161472|100728730|FG002|STARTED|Third Intervention Period||5||
48166436|NCT01161472|100728731|FG003|STARTED|Third Intervention Period||5||
48166437|NCT01161472|100728728|FG000|COMPLETED|Third Intervention Period||4||
48166438|NCT01161472|100728729|FG001|COMPLETED|Third Intervention Period||5||
48329593|NCT03665285|101132242|FG006|NOT COMPLETED|Overall Study||2||
48329594|NCT03665285|101132243|FG007|NOT COMPLETED|Overall Study||28||
48329595|NCT03665285|101132244|FG008|NOT COMPLETED|Overall Study||2||
48329596|NCT01787916|101132245|FG000|STARTED|First Intervention (24 Weeks)||8||
48329597|NCT01787916|101132246|FG001|STARTED|First Intervention (24 Weeks)||7||
48166439|NCT01161472|100728730|FG002|COMPLETED|Third Intervention Period||5||
48166440|NCT01161472|100728731|FG003|COMPLETED|Third Intervention Period||5||
48329598|NCT01787916|101132245|FG000|COMPLETED|First Intervention (24 Weeks)||8||
48746830|NCT02714569|102165983|FG004|NOT COMPLETED|Part A First Intervention||0||
48166441|NCT01161472|100728728|FG000|NOT COMPLETED|Third Intervention Period||0||
48368076|NCT03691623|101230097|FG001|NOT COMPLETED|Overall Study||0||
48329599|NCT01787916|101132246|FG001|COMPLETED|First Intervention (24 Weeks)||7||
48329600|NCT01787916|101132245|FG000|NOT COMPLETED|First Intervention (24 Weeks)||0||
48329601|NCT01787916|101132246|FG001|NOT COMPLETED|First Intervention (24 Weeks)||0||
48624101|NCT02974868|101863803|FG003|COMPLETED|Single-Blind Extension (SBE) Period||23|Week 28-52 and additional 24 weeks(AT Day 1 -AT Week 24) for those retreated with active treatment|
48624102|NCT02974868|101863800|FG000|NOT COMPLETED|Single-Blind Extension (SBE) Period||2||
48624103|NCT02974868|101863801|FG001|NOT COMPLETED|Single-Blind Extension (SBE) Period||1||
48624104|NCT02974868|101863802|FG002|NOT COMPLETED|Single-Blind Extension (SBE) Period||11||
48624105|NCT02974868|101863803|FG003|NOT COMPLETED|Single-Blind Extension (SBE) Period||6||
48624106|NCT02974868|101863800|FG000|STARTED|Cross-Over Extension (COE) Period||7|Among 76 participants completed SBE period, 23 participants entered COE period.|
48624107|NCT02974868|101863801|FG001|STARTED|Cross-Over Extension (COE) Period||2|Among 76 participants completed SBE period, 23 participants entered COE period.|
48624108|NCT02974868|101863802|FG002|STARTED|Cross-Over Extension (COE) Period||11|Among 76 participants completed SBE period, 23 participants entered COE period.|
48624109|NCT02974868|101863803|FG003|STARTED|Cross-Over Extension (COE) Period||3|Among 76 participants completed SBE period, 23 participants entered COE period.|
48624110|NCT02974868|101863800|FG000|COMPLETED|Cross-Over Extension (COE) Period||5|Participants who were PF-06651600 non-responders at Week 52 received PF-06700841, vice versa.|
48624111|NCT02974868|101863801|FG001|COMPLETED|Cross-Over Extension (COE) Period||1|Participants who were PF-06651600 non-responders at Week 52 received PF-06700841, vice versa.|
48624112|NCT02974868|101863802|FG002|COMPLETED|Cross-Over Extension (COE) Period||8|Participants who were PF-06651600 non-responders at Week 52 received PF-06700841, vice versa.|
48624113|NCT02974868|101863803|FG003|COMPLETED|Cross-Over Extension (COE) Period||3|Participants who were PF-06651600 non-responders at Week 52 received PF-06700841, vice versa.|
48624114|NCT02974868|101863800|FG000|NOT COMPLETED|Cross-Over Extension (COE) Period||2||
48624115|NCT02974868|101863801|FG001|NOT COMPLETED|Cross-Over Extension (COE) Period||1||
48624116|NCT02974868|101863802|FG002|NOT COMPLETED|Cross-Over Extension (COE) Period||3||
48624117|NCT02974868|101863803|FG003|NOT COMPLETED|Cross-Over Extension (COE) Period||0||
48624118|NCT02344316|101863804|FG000|STARTED|Overall Study||13||
48166442|NCT01161472|100728729|FG001|NOT COMPLETED|Third Intervention Period||0||
48166443|NCT01161472|100728730|FG002|NOT COMPLETED|Third Intervention Period||0||
48166444|NCT01161472|100728731|FG003|NOT COMPLETED|Third Intervention Period||0||
48166445|NCT01161472|100728728|FG000|STARTED|Washout Period (At Least 3 to 6 Days)||4||
48166446|NCT01161472|100728729|FG001|STARTED|Washout Period (At Least 3 to 6 Days)||5||
48166447|NCT01161472|100728730|FG002|STARTED|Washout Period (At Least 3 to 6 Days)||5||
48624119|NCT02344316|101863805|FG001|STARTED|Overall Study||13||
48624120|NCT02344316|101863804|FG000|COMPLETED|Overall Study||12||
48329602|NCT01787916|101132245|FG000|STARTED|Washout (4 Weeks)||8||
48624121|NCT02344316|101863805|FG001|COMPLETED|Overall Study||11||
48329603|NCT01787916|101132246|FG001|STARTED|Washout (4 Weeks)||7||
48624122|NCT02344316|101863804|FG000|NOT COMPLETED|Overall Study||1||
48624123|NCT02344316|101863805|FG001|NOT COMPLETED|Overall Study||2||
48624124|NCT01396083|101863806|FG000|STARTED|Overall Study||124||
48624125|NCT01396083|101863807|FG001|STARTED|Overall Study||119||
48624126|NCT01396083|101863806|FG000|COMPLETED|Overall Study||113||
48624127|NCT01396083|101863807|FG001|COMPLETED|Overall Study||72||
48624128|NCT01396083|101863806|FG000|NOT COMPLETED|Overall Study||11||
48624129|NCT01396083|101863807|FG001|NOT COMPLETED|Overall Study||47||
48624130|NCT00960193|101863808|FG000|STARTED|Colchicine Alone||24||
48624131|NCT00960193|101863808|FG000|COMPLETED|Colchicine Alone||24||
48624132|NCT00960193|101863808|FG000|NOT COMPLETED|Colchicine Alone||0||
48624133|NCT00960193|101863808|FG000|STARTED|14 Day Washout Period||24||
48624134|NCT00960193|101863808|FG000|COMPLETED|14 Day Washout Period||23||
48624135|NCT00960193|101863808|FG000|NOT COMPLETED|14 Day Washout Period||1||
48624136|NCT00960193|101863808|FG000|STARTED|Seville Orange Juice Alone||23||
48767668|NCT01656408|102222797|FG003|STARTED|Overall Study||7||
48166448|NCT01161472|100728731|FG003|STARTED|Washout Period (At Least 3 to 6 Days)||5||
48166449|NCT01161472|100728728|FG000|COMPLETED|Washout Period (At Least 3 to 6 Days)||4||
48166450|NCT01161472|100728729|FG001|COMPLETED|Washout Period (At Least 3 to 6 Days)||5||
48166451|NCT01161472|100728730|FG002|COMPLETED|Washout Period (At Least 3 to 6 Days)||5||
48166452|NCT01161472|100728731|FG003|COMPLETED|Washout Period (At Least 3 to 6 Days)||5||
48166453|NCT01161472|100728728|FG000|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0||
48166454|NCT01161472|100728729|FG001|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0||
48329604|NCT01787916|101132245|FG000|COMPLETED|Washout (4 Weeks)||8||
48329605|NCT01787916|101132246|FG001|COMPLETED|Washout (4 Weeks)||7||
48166455|NCT01161472|100728730|FG002|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0||
48166456|NCT01161472|100728731|FG003|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0||
48166457|NCT01161472|100728728|FG000|STARTED|Fourth Intervention Period||4||
48166458|NCT01161472|100728729|FG001|STARTED|Fourth Intervention Period||5||
48166459|NCT01161472|100728730|FG002|STARTED|Fourth Intervention Period||5||
48166460|NCT01161472|100728731|FG003|STARTED|Fourth Intervention Period||5||
48166461|NCT01161472|100728728|FG000|COMPLETED|Fourth Intervention Period||4||
48166462|NCT01161472|100728729|FG001|COMPLETED|Fourth Intervention Period||5||
48166463|NCT01161472|100728730|FG002|COMPLETED|Fourth Intervention Period||5||
48166464|NCT01161472|100728731|FG003|COMPLETED|Fourth Intervention Period||5||
48166465|NCT01161472|100728728|FG000|NOT COMPLETED|Fourth Intervention Period||0||
48166466|NCT01161472|100728729|FG001|NOT COMPLETED|Fourth Intervention Period||0||
48166467|NCT01161472|100728730|FG002|NOT COMPLETED|Fourth Intervention Period||0||
48166468|NCT01161472|100728731|FG003|NOT COMPLETED|Fourth Intervention Period||0||
48166469|NCT01216163|100728732|FG000|STARTED|Overall Study||45||
48166470|NCT01216163|100728733|FG001|STARTED|Overall Study||88||
48166471|NCT01216163|100728734|FG002|STARTED|Overall Study||85||
48166472|NCT01216163|100728732|FG000|COMPLETED|Overall Study||44||
48166473|NCT01216163|100728733|FG001|COMPLETED|Overall Study||87||
48166474|NCT01216163|100728734|FG002|COMPLETED|Overall Study||85||
48166475|NCT01216163|100728732|FG000|NOT COMPLETED|Overall Study||1||
48166476|NCT01216163|100728733|FG001|NOT COMPLETED|Overall Study||1||
48166477|NCT01216163|100728734|FG002|NOT COMPLETED|Overall Study||0||
48166478|NCT02118337|100728735|FG000|STARTED|Overall Study||4||
48329606|NCT01787916|101132245|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
48329607|NCT01787916|101132246|FG001|NOT COMPLETED|Washout (4 Weeks)||0||
48329608|NCT01787916|101132245|FG000|STARTED|Second Intervention (24 Weeks)||8||
48329609|NCT01787916|101132246|FG001|STARTED|Second Intervention (24 Weeks)||7||
48329610|NCT01787916|101132245|FG000|COMPLETED|Second Intervention (24 Weeks)||8||
48624137|NCT00960193|101863808|FG000|COMPLETED|Seville Orange Juice Alone||23||
48624138|NCT00960193|101863808|FG000|NOT COMPLETED|Seville Orange Juice Alone||0||
48624139|NCT00960193|101863808|FG000|STARTED|Colchicine With Seville Orange Juice||23||
48624140|NCT00960193|101863808|FG000|COMPLETED|Colchicine With Seville Orange Juice||23||
48624141|NCT00960193|101863808|FG000|NOT COMPLETED|Colchicine With Seville Orange Juice||0||
48624142|NCT00669318|101863809|FG000|STARTED|Overall Study||41||
48624143|NCT00669318|101863809|FG000|COMPLETED|Overall Study||39||
48624144|NCT00669318|101863809|FG000|NOT COMPLETED|Overall Study||2||
48624145|NCT02419807|101863810|FG000|STARTED|Overall Study||102||
48624146|NCT02419807|101863810|FG000|COMPLETED|Overall Study||92||
48624147|NCT02419807|101863810|FG000|NOT COMPLETED|Overall Study||10||
48624148|NCT01996371|101863811|FG000|STARTED|Overall Study||5||
48624149|NCT01996371|101863812|FG001|STARTED|Overall Study||4||
48624150|NCT01996371|101863813|FG002|STARTED|Overall Study||6||
48624151|NCT01996371|101863811|FG000|COMPLETED|Overall Study||5||
48624152|NCT01996371|101863812|FG001|COMPLETED|Overall Study||4||
48624153|NCT01996371|101863813|FG002|COMPLETED|Overall Study||6||
48624154|NCT01996371|101863811|FG000|NOT COMPLETED|Overall Study||0||
48624155|NCT01996371|101863812|FG001|NOT COMPLETED|Overall Study||0||
48624156|NCT01996371|101863813|FG002|NOT COMPLETED|Overall Study||0||
48624157|NCT02189668|101863814|FG000|STARTED|Overall Study||5||
48329611|NCT01787916|101132246|FG001|COMPLETED|Second Intervention (24 Weeks)||7||
48329612|NCT01787916|101132245|FG000|NOT COMPLETED|Second Intervention (24 Weeks)||0||
48166479|NCT02118337|100728736|FG001|STARTED|Overall Study||5||
48329613|NCT01787916|101132246|FG001|NOT COMPLETED|Second Intervention (24 Weeks)||0||
48329614|NCT00191451|101132247|FG000|STARTED|Overall Study||50||
48329615|NCT00191451|101132248|FG001|STARTED|Overall Study||51||
48329616|NCT00191451|101132249|FG002|STARTED|Overall Study||49||
48329617|NCT00191451|101132247|FG000|Received at Least One Dose of Study Drug|Overall Study||50||
48624158|NCT02189668|101863815|FG001|STARTED|Overall Study||9||
48166480|NCT02118337|100728737|FG002|STARTED|Overall Study||3||
48166481|NCT02118337|100728738|FG003|STARTED|Overall Study||3||
48166482|NCT02118337|100728739|FG004|STARTED|Overall Study||9||
48166483|NCT02118337|100728740|FG005|STARTED|Overall Study||6||
48166484|NCT02118337|100728741|FG006|STARTED|Overall Study||4||
48166485|NCT02118337|100728742|FG007|STARTED|Overall Study||42||
48166486|NCT02118337|100728743|FG008|STARTED|Overall Study||21||
48166487|NCT02118337|100728735|FG000|COMPLETED|Overall Study||0||
48166488|NCT02118337|100728736|FG001|COMPLETED|Overall Study||0||
48166489|NCT02118337|100728737|FG002|COMPLETED|Overall Study||0||
48166490|NCT02118337|100728738|FG003|COMPLETED|Overall Study||0||
48624159|NCT02189668|101863814|FG000|COMPLETED|Overall Study||5||
48624160|NCT02189668|101863815|FG001|COMPLETED|Overall Study||9||
48166491|NCT02118337|100728739|FG004|COMPLETED|Overall Study||0||
48329618|NCT00191451|101132248|FG001|Received at Least One Dose of Study Drug|Overall Study||48||
48329619|NCT00191451|101132249|FG002|Received at Least One Dose of Study Drug|Overall Study||47||
48624161|NCT02189668|101863814|FG000|NOT COMPLETED|Overall Study||0||
48166492|NCT02118337|100728740|FG005|COMPLETED|Overall Study||0||
48166493|NCT02118337|100728741|FG006|COMPLETED|Overall Study||0||
48624162|NCT02189668|101863815|FG001|NOT COMPLETED|Overall Study||0||
48624163|NCT03101150|101863816|FG000|STARTED|Overall Study||86||
48624164|NCT03101150|101863817|FG001|STARTED|Overall Study||93||
48410393|NCT03531762|101334949|FG005|STARTED|Treatment Period 2 (8-12 Days)||2||
48410394|NCT03531762|101334944|FG000|COMPLETED|Treatment Period 2 (8-12 Days)||2||
48410395|NCT03531762|101334945|FG001|COMPLETED|Treatment Period 2 (8-12 Days)||2||
48410396|NCT03531762|101334946|FG002|COMPLETED|Treatment Period 2 (8-12 Days)||2||
48166494|NCT02118337|100728742|FG007|COMPLETED|Overall Study||0||
48166495|NCT02118337|100728743|FG008|COMPLETED|Overall Study||0||
48166496|NCT02118337|100728735|FG000|NOT COMPLETED|Overall Study||4||
48166497|NCT02118337|100728736|FG001|NOT COMPLETED|Overall Study||5||
48166498|NCT02118337|100728737|FG002|NOT COMPLETED|Overall Study||3||
48166499|NCT02118337|100728738|FG003|NOT COMPLETED|Overall Study||3||
48410397|NCT03531762|101334947|FG003|COMPLETED|Treatment Period 2 (8-12 Days)||2||
48410398|NCT03531762|101334948|FG004|COMPLETED|Treatment Period 2 (8-12 Days)||2||
48166500|NCT02118337|100728739|FG004|NOT COMPLETED|Overall Study||9||
48166501|NCT02118337|100728740|FG005|NOT COMPLETED|Overall Study||6||
48166502|NCT02118337|100728741|FG006|NOT COMPLETED|Overall Study||4||
48166503|NCT02118337|100728742|FG007|NOT COMPLETED|Overall Study||42||
48166504|NCT02118337|100728743|FG008|NOT COMPLETED|Overall Study||21||
48166505|NCT02026232|100728744|FG000|STARTED|Overall Study||10||
48166506|NCT02026232|100728745|FG001|STARTED|Overall Study||11||
48166507|NCT02026232|100728744|FG000|COMPLETED|Overall Study||7||
48166508|NCT02026232|100728745|FG001|COMPLETED|Overall Study||9||
48166509|NCT02026232|100728744|FG000|NOT COMPLETED|Overall Study||3||
48166510|NCT02026232|100728745|FG001|NOT COMPLETED|Overall Study||2||
48166511|NCT01610154|100728746|FG000|STARTED|Overall Study||85||
48166512|NCT01610154|100728746|FG000|COMPLETED|Overall Study||84||
48166513|NCT01610154|100728746|FG000|NOT COMPLETED|Overall Study||1||
48166514|NCT03522077|100728747|FG000|STARTED|Overall Study||49||
48166515|NCT03522077|100728748|FG001|STARTED|Overall Study||51||
48166516|NCT03522077|100728749|FG002|STARTED|Overall Study||100||
48166517|NCT03522077|100728750|FG003|STARTED|Overall Study||100||
48166518|NCT03522077|100728747|FG000|COMPLETED|Overall Study||49||
48166519|NCT03522077|100728748|FG001|COMPLETED|Overall Study||51||
48166520|NCT03522077|100728749|FG002|COMPLETED|Overall Study||100||
48166521|NCT03522077|100728750|FG003|COMPLETED|Overall Study||100||
48166522|NCT03522077|100728747|FG000|NOT COMPLETED|Overall Study||0||
48166523|NCT03522077|100728748|FG001|NOT COMPLETED|Overall Study||0||
48166524|NCT03522077|100728749|FG002|NOT COMPLETED|Overall Study||0||
48166525|NCT03522077|100728750|FG003|NOT COMPLETED|Overall Study||0||
48166526|NCT04395183|100728751|FG000|STARTED|Overall Study||11||
48166527|NCT04395183|100728752|FG001|STARTED|Overall Study||10||
48166528|NCT04395183|100728753|FG002|STARTED|Overall Study||11||
48166529|NCT04395183|100728754|FG003|STARTED|Overall Study||11||
48166530|NCT04395183|100728751|FG000|COMPLETED|Overall Study||10||
48166531|NCT04395183|100728752|FG001|COMPLETED|Overall Study||10||
48166532|NCT04395183|100728753|FG002|COMPLETED|Overall Study||9||
48166533|NCT04395183|100728754|FG003|COMPLETED|Overall Study||9||
48166534|NCT04395183|100728751|FG000|NOT COMPLETED|Overall Study||1||
48166535|NCT04395183|100728752|FG001|NOT COMPLETED|Overall Study||0||
48166536|NCT04395183|100728753|FG002|NOT COMPLETED|Overall Study||2||
48166537|NCT04395183|100728754|FG003|NOT COMPLETED|Overall Study||2||
48166538|NCT01134601|100728755|FG000|STARTED|Overall Study||1||
48166539|NCT01134601|100728755|FG000|COMPLETED|Overall Study||1||
48166540|NCT01134601|100728755|FG000|NOT COMPLETED|Overall Study||0||
48166541|NCT05822921|100728756|FG000|STARTED|Overall Study||11||
48166542|NCT05822921|100728757|FG001|STARTED|Overall Study||9||
48166543|NCT05822921|100728756|FG000|COMPLETED|Overall Study||10||
48166544|NCT05822921|100728757|FG001|COMPLETED|Overall Study||8||
48166545|NCT05822921|100728756|FG000|NOT COMPLETED|Overall Study||1||
48166546|NCT05822921|100728757|FG001|NOT COMPLETED|Overall Study||1||
48410399|NCT03531762|101334949|FG005|COMPLETED|Treatment Period 2 (8-12 Days)||2||
48410400|NCT03531762|101334944|FG000|NOT COMPLETED|Treatment Period 2 (8-12 Days)||0||
48410401|NCT03531762|101334945|FG001|NOT COMPLETED|Treatment Period 2 (8-12 Days)||0||
48410402|NCT03531762|101334946|FG002|NOT COMPLETED|Treatment Period 2 (8-12 Days)||0||
48410403|NCT03531762|101334947|FG003|NOT COMPLETED|Treatment Period 2 (8-12 Days)||0||
48410404|NCT03531762|101334948|FG004|NOT COMPLETED|Treatment Period 2 (8-12 Days)||0||
48624165|NCT03101150|101863816|FG000|COMPLETED|Overall Study||81||
48166547|NCT00515437|100728758|FG000|STARTED|Overall Study||14||
48166548|NCT00515437|100728759|FG001|STARTED|Overall Study||12||
48166549|NCT00515437|100728760|FG002|STARTED|Overall Study||13||
48166550|NCT00515437|100728761|FG003|STARTED|Overall Study||15||
48166551|NCT00515437|100728758|FG000|COMPLETED|Overall Study||14||
48166552|NCT00515437|100728759|FG001|COMPLETED|Overall Study||12||
48166553|NCT00515437|100728760|FG002|COMPLETED|Overall Study||13||
48166554|NCT00515437|100728761|FG003|COMPLETED|Overall Study||14||
48166555|NCT00515437|100728758|FG000|NOT COMPLETED|Overall Study||0||
48166556|NCT00515437|100728759|FG001|NOT COMPLETED|Overall Study||0||
48410405|NCT03531762|101334949|FG005|NOT COMPLETED|Treatment Period 2 (8-12 Days)||0||
48166557|NCT00515437|100728760|FG002|NOT COMPLETED|Overall Study||0||
48166558|NCT00515437|100728761|FG003|NOT COMPLETED|Overall Study||1||
48166559|NCT01121484|100728762|FG000|STARTED|Overall Study||218||
48166560|NCT01121484|100728763|FG001|STARTED|Overall Study||221||
48166561|NCT01121484|100728762|FG000|Treated|Overall Study||217||
48166562|NCT01121484|100728763|FG001|Treated|Overall Study||217||
48166563|NCT01121484|100728762|FG000|COMPLETED|Overall Study||185||
48166564|NCT01121484|100728763|FG001|COMPLETED|Overall Study||178||
48166565|NCT01121484|100728762|FG000|NOT COMPLETED|Overall Study||33||
48166566|NCT01121484|100728763|FG001|NOT COMPLETED|Overall Study||43||
48166567|NCT02086552|100728764|FG000|STARTED|Overall Study||28||
48166568|NCT02086552|100728764|FG000|COMPLETED|Overall Study||27||
48166569|NCT02086552|100728764|FG000|NOT COMPLETED|Overall Study||1||
48166570|NCT03260127|100728765|FG000|STARTED|Overall Study||42||
48166571|NCT03260127|100728766|FG001|STARTED|Overall Study||40||
48166572|NCT03260127|100728765|FG000|Post-training Assessment|Overall Study||31||
48166573|NCT03260127|100728766|FG001|Post-training Assessment|Overall Study||32||
48166574|NCT03260127|100728765|FG000|COMPLETED|Overall Study||22||
48166575|NCT03260127|100728766|FG001|COMPLETED|Overall Study||23||
48166576|NCT03260127|100728765|FG000|NOT COMPLETED|Overall Study||20||
48166577|NCT03260127|100728766|FG001|NOT COMPLETED|Overall Study||17||
48166578|NCT01341977|100728767|FG000|STARTED|Overall Study||288||
48166579|NCT01341977|100728768|FG001|STARTED|Overall Study||285||
48166580|NCT01341977|100728767|FG000|COMPLETED|Overall Study||274||
48166581|NCT01341977|100728768|FG001|COMPLETED|Overall Study||270||
48166582|NCT01341977|100728767|FG000|NOT COMPLETED|Overall Study||14||
48166583|NCT01341977|100728768|FG001|NOT COMPLETED|Overall Study||15||
48166584|NCT00669903|100728769|FG000|STARTED|Overall Study||23||
48166585|NCT00669903|100728770|FG001|STARTED|Overall Study||37||
48166586|NCT00669903|100728771|FG002|STARTED|Overall Study||18||
48166587|NCT00669903|100728772|FG003|STARTED|Overall Study||22||
48329620|NCT00191451|101132247|FG000|COMPLETED|Overall Study||43||
48329621|NCT00191451|101132248|FG001|COMPLETED|Overall Study||37||
48329622|NCT00191451|101132249|FG002|COMPLETED|Overall Study||35||
48329623|NCT00191451|101132247|FG000|NOT COMPLETED|Overall Study||7||
48329624|NCT00191451|101132248|FG001|NOT COMPLETED|Overall Study||14||
48329625|NCT00191451|101132249|FG002|NOT COMPLETED|Overall Study||14||
48329626|NCT02105415|101132250|FG000|STARTED|Overall Study||76||
48329627|NCT02105415|101132251|FG001|STARTED|Overall Study||84||
48329628|NCT02105415|101132250|FG000|COMPLETED|Overall Study||73||
48329629|NCT02105415|101132251|FG001|COMPLETED|Overall Study||79||
48329630|NCT02105415|101132250|FG000|NOT COMPLETED|Overall Study||3||
48329631|NCT02105415|101132251|FG001|NOT COMPLETED|Overall Study||5||
48329632|NCT00049673|101135789|FG000|STARTED|Overall Study||166||
48329633|NCT00049673|101135790|FG001|STARTED|Overall Study||166||
48329634|NCT00049673|101135789|FG000|COMPLETED|Overall Study||165||
48329635|NCT00049673|101135790|FG001|COMPLETED|Overall Study||163||
48329636|NCT00049673|101135789|FG000|NOT COMPLETED|Overall Study||1||
48329637|NCT00049673|101135790|FG001|NOT COMPLETED|Overall Study||3||
48329638|NCT01535573|101135791|FG000|STARTED|Overall Study||21||
48329639|NCT01535573|101135792|FG001|STARTED|Overall Study||44||
48410406|NCT03531762|101334944|FG000|STARTED|Treatment Period 3 (8-12 Days)||2||
48410407|NCT03531762|101334945|FG001|STARTED|Treatment Period 3 (8-12 Days)||2||
48410408|NCT03531762|101334946|FG002|STARTED|Treatment Period 3 (8-12 Days)||2||
48166588|NCT00669903|100728769|FG000|Completed Treatment Period|Overall Study||23||
48166589|NCT00669903|100728770|FG001|Completed Treatment Period|Overall Study||33||
48166590|NCT00669903|100728771|FG002|Completed Treatment Period|Overall Study||13||
48166591|NCT00669903|100728772|FG003|Completed Treatment Period|Overall Study||19||
48166592|NCT00669903|100728769|FG000|COMPLETED|Overall Study||22||
48166593|NCT00669903|100728770|FG001|COMPLETED|Overall Study||32||
48166594|NCT00669903|100728771|FG002|COMPLETED|Overall Study||13||
48166595|NCT00669903|100728772|FG003|COMPLETED|Overall Study||18||
48166596|NCT00669903|100728769|FG000|NOT COMPLETED|Overall Study||1||
48329640|NCT01535573|101135793|FG002|STARTED|Overall Study||43||
48329641|NCT01535573|101135791|FG000|COMPLETED|Overall Study||13||
48329642|NCT01535573|101135792|FG001|COMPLETED|Overall Study||23||
48329643|NCT01535573|101135793|FG002|COMPLETED|Overall Study||24||
48329644|NCT01535573|101135791|FG000|NOT COMPLETED|Overall Study||8||
48410409|NCT03531762|101334947|FG003|STARTED|Treatment Period 3 (8-12 Days)||2||
48410410|NCT03531762|101334948|FG004|STARTED|Treatment Period 3 (8-12 Days)||2||
48410411|NCT03531762|101334949|FG005|STARTED|Treatment Period 3 (8-12 Days)||2||
48166597|NCT00669903|100728770|FG001|NOT COMPLETED|Overall Study||5||
48166598|NCT00669903|100728771|FG002|NOT COMPLETED|Overall Study||5||
48329645|NCT01535573|101135792|FG001|NOT COMPLETED|Overall Study||21||
48410412|NCT03531762|101334944|FG000|COMPLETED|Treatment Period 3 (8-12 Days)||2||
48410413|NCT03531762|101334945|FG001|COMPLETED|Treatment Period 3 (8-12 Days)||2||
48410414|NCT03531762|101334946|FG002|COMPLETED|Treatment Period 3 (8-12 Days)||2||
48166599|NCT00669903|100728772|FG003|NOT COMPLETED|Overall Study||4||
48166600|NCT02354963|100728773|FG000|STARTED|Overall Study||18||
48166601|NCT02354963|100728774|FG001|STARTED|Overall Study||16||
48166602|NCT02354963|100728773|FG000|COMPLETED|Overall Study||16||
48166603|NCT02354963|100728774|FG001|COMPLETED|Overall Study||15||
48329646|NCT01535573|101135793|FG002|NOT COMPLETED|Overall Study||19||
48329647|NCT01789970|101135794|FG000|STARTED|Open-label Titration Period||625||
48329648|NCT01789970|101135795|FG001|STARTED|Open-label Titration Period||0||
48329649|NCT01789970|101135796|FG002|STARTED|Open-label Titration Period||0||
48166604|NCT02354963|100728773|FG000|NOT COMPLETED|Overall Study||2||
48329650|NCT01789970|101135794|FG000|Safety Analysis Set|Open-label Titration Period||623||
48329651|NCT01789970|101135795|FG001|Safety Analysis Set|Open-label Titration Period||0||
48329652|NCT01789970|101135796|FG002|Safety Analysis Set|Open-label Titration Period||0||
48329653|NCT01789970|101135794|FG000|COMPLETED|Open-label Titration Period||371||
48329654|NCT01789970|101135795|FG001|COMPLETED|Open-label Titration Period||0||
48329655|NCT01789970|101135796|FG002|COMPLETED|Open-label Titration Period||0||
48329656|NCT01789970|101135794|FG000|NOT COMPLETED|Open-label Titration Period||254||
48329657|NCT01789970|101135795|FG001|NOT COMPLETED|Open-label Titration Period||0||
48329658|NCT01789970|101135796|FG002|NOT COMPLETED|Open-label Titration Period||0||
48329659|NCT01789970|101135794|FG000|STARTED|Double-blind Treatment Period (12 Weeks)||0||
48329660|NCT01789970|101135795|FG001|STARTED|Double-blind Treatment Period (12 Weeks)||180||
48329661|NCT01789970|101135796|FG002|STARTED|Double-blind Treatment Period (12 Weeks)||191||
48329662|NCT01789970|101135794|FG000|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||0||
48329663|NCT01789970|101135795|FG001|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||179||
48329664|NCT01789970|101135796|FG002|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||191||
48329665|NCT01789970|101135794|FG000|COMPLETED|Double-blind Treatment Period (12 Weeks)||0||
48329666|NCT01789970|101135795|FG001|COMPLETED|Double-blind Treatment Period (12 Weeks)||130||
48329667|NCT01789970|101135796|FG002|COMPLETED|Double-blind Treatment Period (12 Weeks)||147||
48329668|NCT01789970|101135794|FG000|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0||
48329669|NCT01789970|101135795|FG001|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||50||
48329670|NCT01789970|101135796|FG002|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||44||
48329671|NCT00150592|101135797|FG000|STARTED|Overall Study||121||
48329672|NCT00150592|101135798|FG001|STARTED|Overall Study||57||
48329673|NCT00150592|101135797|FG000|COMPLETED|Overall Study||114||
48329674|NCT00150592|101135798|FG001|COMPLETED|Overall Study||54||
48329675|NCT00150592|101135797|FG000|NOT COMPLETED|Overall Study||7||
48329676|NCT00150592|101135798|FG001|NOT COMPLETED|Overall Study||3||
48329677|NCT00293579|101135799|FG000|STARTED|Overall Study||5||
48329678|NCT00293579|101135799|FG000|COMPLETED|Overall Study||4||
48329679|NCT00293579|101135799|FG000|NOT COMPLETED|Overall Study||1||
48329680|NCT00699907|101135800|FG000|STARTED|Overall Study||14||
48329681|NCT00699907|101135801|FG001|STARTED|Overall Study||57||
48329682|NCT00699907|101135802|FG002|STARTED|Overall Study||56||
48329683|NCT00699907|101135800|FG000|COMPLETED|Overall Study||12||
48329684|NCT00699907|101135801|FG001|COMPLETED|Overall Study||47||
48329685|NCT00699907|101135802|FG002|COMPLETED|Overall Study||48||
48329686|NCT00699907|101135800|FG000|NOT COMPLETED|Overall Study||2||
48329687|NCT00699907|101135801|FG001|NOT COMPLETED|Overall Study||10||
48329688|NCT00699907|101135802|FG002|NOT COMPLETED|Overall Study||8||
48329689|NCT01353703|101135803|FG000|STARTED|Overall Study||112||
48329690|NCT01353703|101135804|FG001|STARTED|Overall Study||112||
48329691|NCT01353703|101135803|FG000|COMPLETED|Overall Study||111||
48329692|NCT01353703|101135804|FG001|COMPLETED|Overall Study||112||
48329693|NCT01353703|101135803|FG000|NOT COMPLETED|Overall Study||1||
48329694|NCT01353703|101135804|FG001|NOT COMPLETED|Overall Study||0||
48329695|NCT01262846|101135805|FG000|STARTED|Overall Study||95||
48329696|NCT01262846|101135806|FG001|STARTED|Overall Study||100||
48329697|NCT01262846|101135805|FG000|COMPLETED|Overall Study||93||
48329698|NCT01262846|101135806|FG001|COMPLETED|Overall Study||97||
48329699|NCT01262846|101135805|FG000|NOT COMPLETED|Overall Study||2||
48329700|NCT01262846|101135806|FG001|NOT COMPLETED|Overall Study||3||
48329701|NCT00353418|101135807|FG000|STARTED|Overall Study||138||
48329702|NCT00353418|101135808|FG001|STARTED|Overall Study||277||
48329703|NCT00353418|101135807|FG000|COMPLETED|Overall Study||55||
48329704|NCT00353418|101135808|FG001|COMPLETED|Overall Study||119||
48410415|NCT03531762|101334947|FG003|COMPLETED|Treatment Period 3 (8-12 Days)||2||
48410416|NCT03531762|101334948|FG004|COMPLETED|Treatment Period 3 (8-12 Days)||2||
48410417|NCT03531762|101334949|FG005|COMPLETED|Treatment Period 3 (8-12 Days)||2||
48329705|NCT00353418|101135807|FG000|NOT COMPLETED|Overall Study||83||
48329706|NCT00353418|101135808|FG001|NOT COMPLETED|Overall Study||158||
48329707|NCT02979431|101135809|FG000|STARTED|Overall Study||44|Intent-to-treat (ITT) Population: The ITT population consisted of all randomized subjects.|
48329708|NCT02979431|101135810|FG001|STARTED|Overall Study||46|Intent-to-treat (ITT) Population: The ITT population consisted of all randomized subjects.|
48329709|NCT02979431|101135811|FG002|STARTED|Overall Study||45|Intent-to-treat (ITT) Population: The ITT population consisted of all randomized subjects.|
48329710|NCT02979431|101135812|FG003|STARTED|Overall Study||45|Intent-to-treat (ITT) Population: The ITT population consisted of all randomized subjects.|
48410418|NCT03531762|101334944|FG000|NOT COMPLETED|Treatment Period 3 (8-12 Days)||0||
48410419|NCT03531762|101334945|FG001|NOT COMPLETED|Treatment Period 3 (8-12 Days)||0||
48410420|NCT03531762|101334946|FG002|NOT COMPLETED|Treatment Period 3 (8-12 Days)||0||
48410421|NCT03531762|101334947|FG003|NOT COMPLETED|Treatment Period 3 (8-12 Days)||0||
48329711|NCT02979431|101135809|FG000|Included in the mITT Population|Overall Study||42|modified ITT (mITT): All randomized subjects who received at least 1 study drug administration.|
48410422|NCT03531762|101334948|FG004|NOT COMPLETED|Treatment Period 3 (8-12 Days)||0||
48329712|NCT02979431|101135810|FG001|Included in the mITT Population|Overall Study||45|modified ITT (mITT): All randomized subjects who received at least 1 study drug administration.|
48329713|NCT02979431|101135811|FG002|Included in the mITT Population|Overall Study||43|modified ITT (mITT): All randomized subjects who received at least 1 study drug administration.|
48329714|NCT02979431|101135812|FG003|Included in the mITT Population|Overall Study||45|modified ITT (mITT): All randomized subjects who received at least 1 study drug administration.|
48410423|NCT03531762|101334949|FG005|NOT COMPLETED|Treatment Period 3 (8-12 Days)||0||
48410424|NCT00853112|101334950|FG000|STARTED|Overall Study||6||
48624166|NCT03101150|101863817|FG001|COMPLETED|Overall Study||83||
48624167|NCT03101150|101863816|FG000|NOT COMPLETED|Overall Study||5||
48624168|NCT03101150|101863817|FG001|NOT COMPLETED|Overall Study||10||
48624169|NCT01265498|101863818|FG000|STARTED|Overall Study||141||
48624170|NCT01265498|101863819|FG001|STARTED|Overall Study||142||
48624171|NCT01265498|101863818|FG000|Both Baseline and Week 72 Biopsy|Overall Study||102||
48624172|NCT01265498|101863819|FG001|Both Baseline and Week 72 Biopsy|Overall Study||98||
48624173|NCT01265498|101863818|FG000|COMPLETED|Overall Study||110||
48624174|NCT01265498|101863819|FG001|COMPLETED|Overall Study||109||
48624175|NCT01265498|101863818|FG000|NOT COMPLETED|Overall Study||31||
48746831|NCT02714569|102165984|FG005|NOT COMPLETED|Part A First Intervention||0||
48746832|NCT02714569|102165985|FG006|NOT COMPLETED|Part A First Intervention||0||
48410425|NCT00853112|101334951|FG001|STARTED|Overall Study||7||
48410426|NCT00853112|101334952|FG002|STARTED|Overall Study||7||
48410427|NCT00853112|101334953|FG003|STARTED|Overall Study||8||
48410428|NCT00853112|101334954|FG004|STARTED|Overall Study||6||
48410429|NCT00853112|101334955|FG005|STARTED|Overall Study||7||
48410430|NCT00853112|101334956|FG006|STARTED|Overall Study||7||
48624176|NCT01265498|101863819|FG001|NOT COMPLETED|Overall Study||33||
48624177|NCT03059914|101863820|FG000|STARTED|Overall Study||4||6
48624178|NCT03059914|101863821|FG001|STARTED|Overall Study||5||9
48624179|NCT03059914|101863820|FG000|COMPLETED|Overall Study||4||6
48746833|NCT02714569|102165986|FG007|NOT COMPLETED|Part A First Intervention||0||
48746834|NCT02714569|102165987|FG008|NOT COMPLETED|Part A First Intervention||0||
48746835|NCT02714569|102165988|FG009|NOT COMPLETED|Part A First Intervention||0||
48746836|NCT02714569|102165989|FG010|NOT COMPLETED|Part A First Intervention||0||
48746837|NCT02714569|102165979|FG000|STARTED|Part A Second Intervention||3||
48746838|NCT02714569|102165980|FG001|STARTED|Part A Second Intervention||3||
48746839|NCT02714569|102165981|FG002|STARTED|Part A Second Intervention||3||
48746840|NCT02714569|102165982|FG003|STARTED|Part A Second Intervention||3||
48746841|NCT02714569|102165983|FG004|STARTED|Part A Second Intervention||3||
48746842|NCT02714569|102165984|FG005|STARTED|Part A Second Intervention||3||
48746843|NCT02714569|102165985|FG006|STARTED|Part A Second Intervention||0||
48746844|NCT02714569|102165986|FG007|STARTED|Part A Second Intervention||0||
48746845|NCT02714569|102165987|FG008|STARTED|Part A Second Intervention||0||
48746846|NCT02714569|102165988|FG009|STARTED|Part A Second Intervention||0||
48746847|NCT02714569|102165989|FG010|STARTED|Part A Second Intervention||0||
48746848|NCT02714569|102165979|FG000|Received at Least One Dose of Study Drug|Part A Second Intervention||3||
48410431|NCT00853112|101334950|FG000|Treated|Overall Study||6||
48410432|NCT00853112|101334951|FG001|Treated|Overall Study||6||
48410433|NCT00853112|101334952|FG002|Treated|Overall Study||7||
48410434|NCT00853112|101334953|FG003|Treated|Overall Study||6||
48410435|NCT00853112|101334954|FG004|Treated|Overall Study||6||
48410436|NCT00853112|101334955|FG005|Treated|Overall Study||7||
48410437|NCT00853112|101334956|FG006|Treated|Overall Study||6||
48410438|NCT00853112|101334950|FG000|COMPLETED|Overall Study||6||
48624180|NCT03059914|101863821|FG001|COMPLETED|Overall Study||5||9
48624181|NCT03059914|101863820|FG000|NOT COMPLETED|Overall Study||0||0
48624182|NCT03059914|101863821|FG001|NOT COMPLETED|Overall Study||0||0
48624183|NCT02900352|101863822|FG000|STARTED|Overall Study||77||
48746849|NCT02714569|102165980|FG001|Received at Least One Dose of Study Drug|Part A Second Intervention||2||
48746850|NCT02714569|102165981|FG002|Received at Least One Dose of Study Drug|Part A Second Intervention||3||
48746851|NCT02714569|102165982|FG003|Received at Least One Dose of Study Drug|Part A Second Intervention||3||
48746852|NCT02714569|102165983|FG004|Received at Least One Dose of Study Drug|Part A Second Intervention||3||
48746853|NCT02714569|102165984|FG005|Received at Least One Dose of Study Drug|Part A Second Intervention||3||
48746854|NCT02714569|102165985|FG006|Received at Least One Dose of Study Drug|Part A Second Intervention||0||
48746855|NCT02714569|102165986|FG007|Received at Least One Dose of Study Drug|Part A Second Intervention||0||
48410439|NCT00853112|101334951|FG001|COMPLETED|Overall Study||6||
48410440|NCT00853112|101334952|FG002|COMPLETED|Overall Study||7||
48624184|NCT02900352|101863823|FG001|STARTED|Overall Study||79||
48746856|NCT02714569|102165987|FG008|Received at Least One Dose of Study Drug|Part A Second Intervention||0||
48767669|NCT01656408|102222798|FG004|STARTED|Overall Study||9||
48329715|NCT02979431|101135809|FG000|Included in the Safety Population|Overall Study||40|Safety: All subjects who received at least 1 study drug administration, as treated.|
48329716|NCT02979431|101135810|FG001|Included in the Safety Population|Overall Study||45|Safety: All subjects who received at least 1 study drug administration, as treated.|
48329717|NCT02979431|101135811|FG002|Included in the Safety Population|Overall Study||44|Safety: All subjects who received at least 1 study drug administration, as treated.|
48329718|NCT02979431|101135812|FG003|Included in the Safety Population|Overall Study||46|Safety: All subjects who received at least 1 study drug administration, as treated.|
48329719|NCT02979431|101135809|FG000|COMPLETED|Overall Study||40||
48329720|NCT02979431|101135810|FG001|COMPLETED|Overall Study||44||
48329721|NCT02979431|101135811|FG002|COMPLETED|Overall Study||43||
48329722|NCT02979431|101135812|FG003|COMPLETED|Overall Study||44||
48329723|NCT02979431|101135809|FG000|NOT COMPLETED|Overall Study||4||
48329724|NCT02979431|101135810|FG001|NOT COMPLETED|Overall Study||2||
48329725|NCT02979431|101135811|FG002|NOT COMPLETED|Overall Study||2||
48329726|NCT02979431|101135812|FG003|NOT COMPLETED|Overall Study||1||
48329727|NCT03187769|101135813|FG000|STARTED|Overall Study||211||
48329728|NCT03187769|101135814|FG001|STARTED|Overall Study||215||
48329729|NCT03187769|101135813|FG000|COMPLETED|Overall Study||165||
48329730|NCT03187769|101135814|FG001|COMPLETED|Overall Study||161||
48329731|NCT03187769|101135813|FG000|NOT COMPLETED|Overall Study||46||
48329732|NCT03187769|101135814|FG001|NOT COMPLETED|Overall Study||54||
48329733|NCT00911989|101135815|FG000|STARTED|Overall Study||4||
48329734|NCT00911989|101135815|FG000|COMPLETED|Overall Study||3||
48329735|NCT00911989|101135815|FG000|NOT COMPLETED|Overall Study||1||
48329736|NCT03839459|101135816|FG000|STARTED|Overall Study||20||
48329737|NCT03839459|101135816|FG000|COMPLETED|Overall Study||15||
48329738|NCT03839459|101135816|FG000|NOT COMPLETED|Overall Study||5||
48329739|NCT01119456|101135817|FG000|STARTED|Overall Study||7||
48329740|NCT01119456|101135818|FG001|STARTED|Overall Study||3||
48329741|NCT01119456|101135819|FG002|STARTED|Overall Study||3||
48329742|NCT01119456|101135820|FG003|STARTED|Overall Study||13||
48329743|NCT01119456|101135821|FG004|STARTED|Overall Study||4||
48329744|NCT01119456|101135822|FG005|STARTED|Overall Study||3||
48329745|NCT01119456|101135823|FG006|STARTED|Overall Study||3||
48329746|NCT01119456|101135824|FG007|STARTED|Overall Study||3||
48329747|NCT01119456|101135817|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7||
48329748|NCT01119456|101135818|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3||
48329749|NCT01119456|101135819|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
48329750|NCT01119456|101135820|FG003|Received at Least 1 Dose of Study Drug|Overall Study||13||
48329751|NCT01119456|101135821|FG004|Received at Least 1 Dose of Study Drug|Overall Study||4||
48329752|NCT01119456|101135822|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3||
48329753|NCT01119456|101135823|FG006|Received at Least 1 Dose of Study Drug|Overall Study||3||
48329754|NCT01119456|101135824|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3||
48746857|NCT02714569|102165988|FG009|Received at Least One Dose of Study Drug|Part A Second Intervention||0||
48746858|NCT02714569|102165989|FG010|Received at Least One Dose of Study Drug|Part A Second Intervention||0||
48746859|NCT02714569|102165979|FG000|COMPLETED|Part A Second Intervention||3||
48746860|NCT02714569|102165980|FG001|COMPLETED|Part A Second Intervention||2||
48746861|NCT02714569|102165981|FG002|COMPLETED|Part A Second Intervention||3||
48746862|NCT02714569|102165982|FG003|COMPLETED|Part A Second Intervention||3||
48746863|NCT02714569|102165983|FG004|COMPLETED|Part A Second Intervention||3||
48746864|NCT02714569|102165984|FG005|COMPLETED|Part A Second Intervention||3||
48746865|NCT02714569|102165985|FG006|COMPLETED|Part A Second Intervention||0||
48746866|NCT02714569|102165986|FG007|COMPLETED|Part A Second Intervention||0||
48166605|NCT02354963|100728774|FG001|NOT COMPLETED|Overall Study||1||
48746867|NCT02714569|102165987|FG008|COMPLETED|Part A Second Intervention||0||
48746868|NCT02714569|102165988|FG009|COMPLETED|Part A Second Intervention||0||
48746869|NCT02714569|102165989|FG010|COMPLETED|Part A Second Intervention||0||
48746870|NCT02714569|102165979|FG000|NOT COMPLETED|Part A Second Intervention||0||
48746871|NCT02714569|102165980|FG001|NOT COMPLETED|Part A Second Intervention||1||
48746872|NCT02714569|102165981|FG002|NOT COMPLETED|Part A Second Intervention||0||
48746873|NCT02714569|102165982|FG003|NOT COMPLETED|Part A Second Intervention||0||
48746874|NCT02714569|102165983|FG004|NOT COMPLETED|Part A Second Intervention||0||
48746875|NCT02714569|102165984|FG005|NOT COMPLETED|Part A Second Intervention||0||
48166606|NCT01187329|100732123|FG000|STARTED|Overall Study||50||
48746876|NCT02714569|102165985|FG006|NOT COMPLETED|Part A Second Intervention||0||
48746877|NCT02714569|102165986|FG007|NOT COMPLETED|Part A Second Intervention||0||
48746878|NCT02714569|102165987|FG008|NOT COMPLETED|Part A Second Intervention||0||
48746879|NCT02714569|102165988|FG009|NOT COMPLETED|Part A Second Intervention||0||
48746880|NCT02714569|102165989|FG010|NOT COMPLETED|Part A Second Intervention||0||
48746881|NCT02714569|102165979|FG000|STARTED|Part A Third Intervention||3||
48746882|NCT02714569|102165980|FG001|STARTED|Part A Third Intervention||2||
48746883|NCT02714569|102165981|FG002|STARTED|Part A Third Intervention||3||
48166607|NCT01187329|100732124|FG001|STARTED|Overall Study||50||
48166608|NCT01187329|100732123|FG000|COMPLETED|Overall Study||49||
48746884|NCT02714569|102165982|FG003|STARTED|Part A Third Intervention||3||
48746885|NCT02714569|102165983|FG004|STARTED|Part A Third Intervention||3||
48746886|NCT02714569|102165984|FG005|STARTED|Part A Third Intervention||3||
48746887|NCT02714569|102165985|FG006|STARTED|Part A Third Intervention||0||
48746888|NCT02714569|102165986|FG007|STARTED|Part A Third Intervention||0||
48746889|NCT02714569|102165987|FG008|STARTED|Part A Third Intervention||0||
48746890|NCT02714569|102165988|FG009|STARTED|Part A Third Intervention||0||
48746891|NCT02714569|102165989|FG010|STARTED|Part A Third Intervention||0||
48746892|NCT02714569|102165979|FG000|Received at Least One Dose of Study Drug|Part A Third Intervention||3||
48329755|NCT01119456|101135817|FG000|COMPLETED|Overall Study||7||
48329756|NCT01119456|101135818|FG001|COMPLETED|Overall Study||3||
48329757|NCT01119456|101135819|FG002|COMPLETED|Overall Study||3||
48329758|NCT01119456|101135820|FG003|COMPLETED|Overall Study||13||
48329759|NCT01119456|101135821|FG004|COMPLETED|Overall Study||4||
48329760|NCT01119456|101135822|FG005|COMPLETED|Overall Study||3||
48746893|NCT02714569|102165980|FG001|Received at Least One Dose of Study Drug|Part A Third Intervention||2||
48746894|NCT02714569|102165981|FG002|Received at Least One Dose of Study Drug|Part A Third Intervention||2||
48746895|NCT02714569|102165982|FG003|Received at Least One Dose of Study Drug|Part A Third Intervention||2||
48746896|NCT02714569|102165983|FG004|Received at Least One Dose of Study Drug|Part A Third Intervention||3||
48746897|NCT02714569|102165984|FG005|Received at Least One Dose of Study Drug|Part A Third Intervention||3||
48746898|NCT02714569|102165985|FG006|Received at Least One Dose of Study Drug|Part A Third Intervention||0||
48746899|NCT02714569|102165986|FG007|Received at Least One Dose of Study Drug|Part A Third Intervention||0||
48746900|NCT02714569|102165987|FG008|Received at Least One Dose of Study Drug|Part A Third Intervention||0||
48746901|NCT02714569|102165988|FG009|Received at Least One Dose of Study Drug|Part A Third Intervention||0||
48746902|NCT02714569|102165989|FG010|Received at Least One Dose of Study Drug|Part A Third Intervention||0||
48746903|NCT02714569|102165979|FG000|COMPLETED|Part A Third Intervention||3||
48746904|NCT02714569|102165980|FG001|COMPLETED|Part A Third Intervention||2||
48746905|NCT02714569|102165981|FG002|COMPLETED|Part A Third Intervention||2||
48746906|NCT02714569|102165982|FG003|COMPLETED|Part A Third Intervention||2||
48746907|NCT02714569|102165983|FG004|COMPLETED|Part A Third Intervention||3||
48746908|NCT02714569|102165984|FG005|COMPLETED|Part A Third Intervention||3||
48746909|NCT02714569|102165985|FG006|COMPLETED|Part A Third Intervention||0||
48746910|NCT02714569|102165986|FG007|COMPLETED|Part A Third Intervention||0||
48746911|NCT02714569|102165987|FG008|COMPLETED|Part A Third Intervention||0||
48746912|NCT02714569|102165988|FG009|COMPLETED|Part A Third Intervention||0||
48746913|NCT02714569|102165989|FG010|COMPLETED|Part A Third Intervention||0||
48746914|NCT02714569|102165979|FG000|NOT COMPLETED|Part A Third Intervention||0||
48746915|NCT02714569|102165980|FG001|NOT COMPLETED|Part A Third Intervention||0||
48746916|NCT02714569|102165981|FG002|NOT COMPLETED|Part A Third Intervention||1||
48329761|NCT01119456|101135823|FG006|COMPLETED|Overall Study||3||
48329762|NCT01119456|101135824|FG007|COMPLETED|Overall Study||3||
48329763|NCT01119456|101135817|FG000|NOT COMPLETED|Overall Study||0||
48329764|NCT01119456|101135818|FG001|NOT COMPLETED|Overall Study||0||
48329765|NCT01119456|101135819|FG002|NOT COMPLETED|Overall Study||0||
48410441|NCT00853112|101334953|FG003|COMPLETED|Overall Study||6||
48746917|NCT02714569|102165982|FG003|NOT COMPLETED|Part A Third Intervention||1||
48410442|NCT00853112|101334954|FG004|COMPLETED|Overall Study||6||
48410443|NCT00853112|101334955|FG005|COMPLETED|Overall Study||7||
48410444|NCT00853112|101334956|FG006|COMPLETED|Overall Study||6||
48410445|NCT00853112|101334950|FG000|NOT COMPLETED|Overall Study||0||
48410446|NCT00853112|101334951|FG001|NOT COMPLETED|Overall Study||1||
48410447|NCT00853112|101334952|FG002|NOT COMPLETED|Overall Study||0||
48410448|NCT00853112|101334953|FG003|NOT COMPLETED|Overall Study||2||
48410449|NCT00853112|101334954|FG004|NOT COMPLETED|Overall Study||0||
48410450|NCT00853112|101334955|FG005|NOT COMPLETED|Overall Study||0||
48410451|NCT00853112|101334956|FG006|NOT COMPLETED|Overall Study||1||
48410452|NCT03298048|101334957|FG000|STARTED|Overall Study||4||
48746918|NCT02714569|102165983|FG004|NOT COMPLETED|Part A Third Intervention||0||
48746919|NCT02714569|102165984|FG005|NOT COMPLETED|Part A Third Intervention||0||
48329766|NCT01119456|101135820|FG003|NOT COMPLETED|Overall Study||0||
48746920|NCT02714569|102165985|FG006|NOT COMPLETED|Part A Third Intervention||0||
48746921|NCT02714569|102165986|FG007|NOT COMPLETED|Part A Third Intervention||0||
48746922|NCT02714569|102165987|FG008|NOT COMPLETED|Part A Third Intervention||0||
48746923|NCT02714569|102165988|FG009|NOT COMPLETED|Part A Third Intervention||0||
48746924|NCT02714569|102165989|FG010|NOT COMPLETED|Part A Third Intervention||0||
48746925|NCT02714569|102165979|FG000|STARTED|Part A Fourth Intervention||4||
48746926|NCT02714569|102165980|FG001|STARTED|Part A Fourth Intervention||2||
48746927|NCT02714569|102165981|FG002|STARTED|Part A Fourth Intervention||3||
48746928|NCT02714569|102165982|FG003|STARTED|Part A Fourth Intervention||2||
48329767|NCT01119456|101135821|FG004|NOT COMPLETED|Overall Study||0||
48329768|NCT01119456|101135822|FG005|NOT COMPLETED|Overall Study||0||
48329769|NCT01119456|101135823|FG006|NOT COMPLETED|Overall Study||0||
48329770|NCT01119456|101135824|FG007|NOT COMPLETED|Overall Study||0||
48410453|NCT03298048|101334958|FG001|STARTED|Overall Study||3||
48410454|NCT03298048|101334959|FG002|STARTED|Overall Study||8||
48410455|NCT03298048|101334957|FG000|COMPLETED|Overall Study||4||
48746929|NCT02714569|102165983|FG004|STARTED|Part A Fourth Intervention||3||
48329771|NCT01665118|101135825|FG000|STARTED|Overall Study||44||88
48329772|NCT01665118|101135825|FG000|Thigh Treated With RF|Overall Study||44||44
48329773|NCT01665118|101135825|FG000|Untreated Thigh|Overall Study||44||44
48329774|NCT01665118|101135825|FG000|COMPLETED|Overall Study||26||52
48329775|NCT01665118|101135825|FG000|NOT COMPLETED|Overall Study||18||36
48329776|NCT00667615|101135826|FG000|STARTED|Overall Study||30||
48329777|NCT00667615|101135826|FG000|COMPLETED|Overall Study||30||
48329778|NCT00667615|101135826|FG000|NOT COMPLETED|Overall Study||0||
48329779|NCT03550066|101135827|FG000|STARTED|Overall Study||49||
48329780|NCT03550066|101135828|FG001|STARTED|Overall Study||41||
48329781|NCT03550066|101135827|FG000|COMPLETED|Overall Study||49||
48329782|NCT03550066|101135828|FG001|COMPLETED|Overall Study||41||
48329783|NCT03550066|101135827|FG000|NOT COMPLETED|Overall Study||0||
48329784|NCT03550066|101135828|FG001|NOT COMPLETED|Overall Study||0||
48329785|NCT01662895|101135829|FG000|STARTED|Overall Study||21||
48329786|NCT01662895|101135830|FG001|STARTED|Overall Study||21||
48329787|NCT01662895|101135829|FG000|Initiated Study Drug|Overall Study||21||
48329788|NCT01662895|101135830|FG001|Initiated Study Drug|Overall Study||21||
48329789|NCT01662895|101135829|FG000|COMPLETED|Overall Study||21||
48329790|NCT01662895|101135830|FG001|COMPLETED|Overall Study||20||
48329791|NCT01662895|101135829|FG000|NOT COMPLETED|Overall Study||0||
48329792|NCT01662895|101135830|FG001|NOT COMPLETED|Overall Study||1||
48329793|NCT00772668|101135831|FG000|STARTED|Overall Study||3||
48329794|NCT00772668|101135831|FG000|COMPLETED|Overall Study||0||
48329795|NCT00772668|101135831|FG000|NOT COMPLETED|Overall Study||3||
48329796|NCT02301403|101135832|FG000|STARTED|Overall Study||315||
48329797|NCT02301403|101135833|FG001|STARTED|Overall Study||308||
48329798|NCT02301403|101135832|FG000|COMPLETED|Overall Study||287||
48329799|NCT02301403|101135833|FG001|COMPLETED|Overall Study||267||
48329800|NCT02301403|101135832|FG000|NOT COMPLETED|Overall Study||28||
48329801|NCT02301403|101135833|FG001|NOT COMPLETED|Overall Study||41||
48329802|NCT01662583|101135834|FG000|STARTED|Overall Study||216||
48329803|NCT01662583|101135835|FG001|STARTED|Overall Study||225||
48329804|NCT01662583|101135836|FG002|STARTED|Overall Study||219||
48329805|NCT01662583|101135834|FG000|COMPLETED|Overall Study||216||
48329806|NCT01662583|101135835|FG001|COMPLETED|Overall Study||225||
48329807|NCT01662583|101135836|FG002|COMPLETED|Overall Study||219||
48329808|NCT01662583|101135834|FG000|NOT COMPLETED|Overall Study||0||
48329809|NCT01662583|101135835|FG001|NOT COMPLETED|Overall Study||0||
48329810|NCT01662583|101135836|FG002|NOT COMPLETED|Overall Study||0||
48329811|NCT00993031|101135837|FG000|STARTED|Overall Study||195||
48329812|NCT00993031|101135838|FG001|STARTED|Overall Study||194||
48329813|NCT00993031|101135837|FG000|Delivered|Overall Study||187||
48329814|NCT00993031|101135838|FG001|Delivered|Overall Study||190||
48329815|NCT00993031|101135837|FG000|COMPLETED|Overall Study||173||
48329816|NCT00993031|101135838|FG001|COMPLETED|Overall Study||175||
48329817|NCT00993031|101135837|FG000|NOT COMPLETED|Overall Study||22||
48329818|NCT00993031|101135838|FG001|NOT COMPLETED|Overall Study||19||
48329819|NCT00209339|101135839|FG000|STARTED|At 12 Months Follow-up||55||
48329820|NCT00209339|101135839|FG000|COMPLETED|At 12 Months Follow-up||40||
48329821|NCT00209339|101135839|FG000|NOT COMPLETED|At 12 Months Follow-up||15||
48329822|NCT00209339|101135839|FG000|STARTED|At 24 Months Follow-up||40||
48329823|NCT00209339|101135839|FG000|COMPLETED|At 24 Months Follow-up||29||
48329824|NCT00209339|101135839|FG000|NOT COMPLETED|At 24 Months Follow-up||11||
48329825|NCT00209339|101135839|FG000|STARTED|At 3 Years Follow-up||29||
48329826|NCT00209339|101135839|FG000|COMPLETED|At 3 Years Follow-up||28||
48329827|NCT00209339|101135839|FG000|NOT COMPLETED|At 3 Years Follow-up||1||
48329828|NCT00209339|101135839|FG000|STARTED|At 4 Years Follow-up||28||
48329829|NCT00209339|101135839|FG000|COMPLETED|At 4 Years Follow-up||23||
48410456|NCT03298048|101334958|FG001|COMPLETED|Overall Study||3||
48410457|NCT03298048|101334959|FG002|COMPLETED|Overall Study||8||
48410458|NCT03298048|101334957|FG000|NOT COMPLETED|Overall Study||0||
48410459|NCT03298048|101334958|FG001|NOT COMPLETED|Overall Study||0||
48410460|NCT03298048|101334959|FG002|NOT COMPLETED|Overall Study||0||
48439910|NCT00563706|101409982|FG005|STARTED|Taper Phase (Day 29 up to Day 35)||14||
48746930|NCT02714569|102165984|FG005|STARTED|Part A Fourth Intervention||3||
48746931|NCT02714569|102165985|FG006|STARTED|Part A Fourth Intervention||0||
48746932|NCT02714569|102165986|FG007|STARTED|Part A Fourth Intervention||0||
48439911|NCT00563706|101409983|FG006|STARTED|Taper Phase (Day 29 up to Day 35)||9||
48439912|NCT00563706|101409984|FG007|STARTED|Taper Phase (Day 29 up to Day 35)||16||
48439913|NCT00563706|101409985|FG008|STARTED|Taper Phase (Day 29 up to Day 35)||32||
48329830|NCT00209339|101135839|FG000|NOT COMPLETED|At 4 Years Follow-up||5||
48329831|NCT00209339|101135839|FG000|STARTED|At 5 Years Follow-up||23||
48329832|NCT00209339|101135839|FG000|COMPLETED|At 5 Years Follow-up||15||
48439914|NCT00563706|101409977|FG000|COMPLETED|Taper Phase (Day 29 up to Day 35)||20||
48439915|NCT00563706|101409978|FG001|COMPLETED|Taper Phase (Day 29 up to Day 35)||13||
48439916|NCT00563706|101409979|FG002|COMPLETED|Taper Phase (Day 29 up to Day 35)||3||
48439917|NCT00563706|101409980|FG003|COMPLETED|Taper Phase (Day 29 up to Day 35)||9||
48439918|NCT00563706|101409981|FG004|COMPLETED|Taper Phase (Day 29 up to Day 35)||11||
48329833|NCT00209339|101135839|FG000|NOT COMPLETED|At 5 Years Follow-up||8||
48329834|NCT00586573|101135840|FG000|STARTED|Overall Study||34||
48329835|NCT00586573|101135840|FG000|COMPLETED|Overall Study||28||
48329836|NCT00586573|101135840|FG000|NOT COMPLETED|Overall Study||6||
48329837|NCT02462473|101135841|FG000|STARTED|Overall Study||9||
48329838|NCT02462473|101135841|FG000|COMPLETED|Overall Study||5||
48329839|NCT02462473|101135841|FG000|NOT COMPLETED|Overall Study||4||
48329840|NCT04397094|101135842|FG000|STARTED|Overall Study||30||
48329841|NCT04397094|101135843|FG001|STARTED|Overall Study||30||
48329842|NCT04397094|101135842|FG000|COMPLETED|Overall Study||30||
48329843|NCT04397094|101135843|FG001|COMPLETED|Overall Study||30||
48329844|NCT04397094|101135842|FG000|NOT COMPLETED|Overall Study||0||
48329845|NCT04397094|101135843|FG001|NOT COMPLETED|Overall Study||0||
48329846|NCT01338415|101135844|FG000|STARTED|Core + Extension||33||
48329847|NCT01338415|101135845|FG001|STARTED|Core + Extension||31||
48439919|NCT00563706|101409982|FG005|COMPLETED|Taper Phase (Day 29 up to Day 35)||14||
48439920|NCT00563706|101409983|FG006|COMPLETED|Taper Phase (Day 29 up to Day 35)||9||
48439921|NCT00563706|101409984|FG007|COMPLETED|Taper Phase (Day 29 up to Day 35)||16||
48439922|NCT00563706|101409985|FG008|COMPLETED|Taper Phase (Day 29 up to Day 35)||32||
48439923|NCT00563706|101409977|FG000|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0||
48439924|NCT00563706|101409978|FG001|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0||
48439925|NCT00563706|101409979|FG002|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0||
48439926|NCT00563706|101409980|FG003|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0||
48439927|NCT00563706|101409981|FG004|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0||
48746933|NCT02714569|102165987|FG008|STARTED|Part A Fourth Intervention||0||
48746934|NCT02714569|102165988|FG009|STARTED|Part A Fourth Intervention||0||
48746935|NCT02714569|102165989|FG010|STARTED|Part A Fourth Intervention||0||
48746936|NCT02714569|102165979|FG000|Received at Least One Dose of Study Drug|Part A Fourth Intervention||3||
48746937|NCT02714569|102165980|FG001|Received at Least One Dose of Study Drug|Part A Fourth Intervention||2||
48746938|NCT02714569|102165981|FG002|Received at Least One Dose of Study Drug|Part A Fourth Intervention||3||
48746939|NCT02714569|102165982|FG003|Received at Least One Dose of Study Drug|Part A Fourth Intervention||2||
48746940|NCT02714569|102165983|FG004|Received at Least One Dose of Study Drug|Part A Fourth Intervention||3||
48746941|NCT02714569|102165984|FG005|Received at Least One Dose of Study Drug|Part A Fourth Intervention||2||
48746942|NCT02714569|102165985|FG006|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0||
48329848|NCT01338415|101135846|FG002|STARTED|Core + Extension||0||
48439928|NCT00563706|101409982|FG005|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0||
48439929|NCT00563706|101409983|FG006|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0||
48329849|NCT01338415|101135844|FG000|Enrolled in FUTURE 3 Extension|Core + Extension||31||
48329850|NCT01338415|101135845|FG001|Enrolled in FUTURE 3 Extension|Core + Extension||27||
48329851|NCT01338415|101135846|FG002|Enrolled in FUTURE 3 Extension|Core + Extension||0||
48329852|NCT01338415|101135844|FG000|COMPLETED|Core + Extension||23||
48410461|NCT00372489|101337635|FG000|STARTED|Overall Study||81||
48410462|NCT00372489|101337635|FG000|COMPLETED|Overall Study||2||
48410463|NCT00372489|101337635|FG000|NOT COMPLETED|Overall Study||79||
48410464|NCT02213081|101337636|FG000|STARTED|Overall Study||1||
48410465|NCT02213081|101337636|FG000|COMPLETED|Overall Study||1||
48410466|NCT02213081|101337636|FG000|NOT COMPLETED|Overall Study||0||
48624185|NCT02900352|101863822|FG000|COMPLETED|Overall Study||49||
48624186|NCT02900352|101863823|FG001|COMPLETED|Overall Study||62||
48624187|NCT02900352|101863822|FG000|NOT COMPLETED|Overall Study||28||
48624188|NCT02900352|101863823|FG001|NOT COMPLETED|Overall Study||17||
48624189|NCT03799614|101863824|FG000|STARTED|Overall Study||15||
48624190|NCT03799614|101863825|FG001|STARTED|Overall Study||15||
48624191|NCT03799614|101863824|FG000|COMPLETED|Overall Study||15||
48410467|NCT01089751|101337637|FG000|STARTED|Overall Study||163||
48410468|NCT01089751|101337638|FG001|STARTED|Overall Study||159||
48410469|NCT01089751|101337637|FG000|COMPLETED|Overall Study||129||
48410470|NCT01089751|101337638|FG001|COMPLETED|Overall Study||132||
48624192|NCT03799614|101863825|FG001|COMPLETED|Overall Study||15||
48746943|NCT02714569|102165986|FG007|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0||
48746944|NCT02714569|102165987|FG008|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0||
48746945|NCT02714569|102165988|FG009|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0||
48746946|NCT02714569|102165989|FG010|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0||
48746947|NCT02714569|102165979|FG000|COMPLETED|Part A Fourth Intervention||3||
48746948|NCT02714569|102165980|FG001|COMPLETED|Part A Fourth Intervention||2||
48746949|NCT02714569|102165981|FG002|COMPLETED|Part A Fourth Intervention||3||
48746950|NCT02714569|102165982|FG003|COMPLETED|Part A Fourth Intervention||2||
48746951|NCT02714569|102165983|FG004|COMPLETED|Part A Fourth Intervention||3||
48746952|NCT02714569|102165984|FG005|COMPLETED|Part A Fourth Intervention||2||
48746953|NCT02714569|102165985|FG006|COMPLETED|Part A Fourth Intervention||0||
48746954|NCT02714569|102165986|FG007|COMPLETED|Part A Fourth Intervention||0||
48624193|NCT03799614|101863824|FG000|NOT COMPLETED|Overall Study||0||
48746955|NCT02714569|102165987|FG008|COMPLETED|Part A Fourth Intervention||0||
48746956|NCT02714569|102165988|FG009|COMPLETED|Part A Fourth Intervention||0||
48746957|NCT02714569|102165989|FG010|COMPLETED|Part A Fourth Intervention||0||
48746958|NCT02714569|102165979|FG000|NOT COMPLETED|Part A Fourth Intervention||1||
48746959|NCT02714569|102165980|FG001|NOT COMPLETED|Part A Fourth Intervention||0||
48746960|NCT02714569|102165981|FG002|NOT COMPLETED|Part A Fourth Intervention||0||
48746961|NCT02714569|102165982|FG003|NOT COMPLETED|Part A Fourth Intervention||0||
48624194|NCT03799614|101863825|FG001|NOT COMPLETED|Overall Study||0||
48624195|NCT01401322|101863826|FG000|STARTED|Overall Study||5||
48624196|NCT01401322|101863826|FG000|COMPLETED|Overall Study||3||
48624197|NCT01401322|101863826|FG000|NOT COMPLETED|Overall Study||2||
48624198|NCT01100853|101863827|FG000|STARTED|Overall Study||51||
48624199|NCT01100853|101863828|FG001|STARTED|Overall Study||49||
48624200|NCT01100853|101863827|FG000|COMPLETED|Overall Study||24||
48624201|NCT01100853|101863828|FG001|COMPLETED|Overall Study||26||
48746962|NCT02714569|102165983|FG004|NOT COMPLETED|Part A Fourth Intervention||0||
48746963|NCT02714569|102165984|FG005|NOT COMPLETED|Part A Fourth Intervention||1||
48746964|NCT02714569|102165985|FG006|NOT COMPLETED|Part A Fourth Intervention||0||
48746965|NCT02714569|102165986|FG007|NOT COMPLETED|Part A Fourth Intervention||0||
48746966|NCT02714569|102165987|FG008|NOT COMPLETED|Part A Fourth Intervention||0||
48746967|NCT02714569|102165988|FG009|NOT COMPLETED|Part A Fourth Intervention||0||
48746968|NCT02714569|102165989|FG010|NOT COMPLETED|Part A Fourth Intervention||0||
48746969|NCT02714569|102165979|FG000|STARTED|Part B (Overall)||0||
48746970|NCT02714569|102165980|FG001|STARTED|Part B (Overall)||0||
48746971|NCT02714569|102165981|FG002|STARTED|Part B (Overall)||0||
48746972|NCT02714569|102165982|FG003|STARTED|Part B (Overall)||0||
48746973|NCT02714569|102165983|FG004|STARTED|Part B (Overall)||0||
48746974|NCT02714569|102165984|FG005|STARTED|Part B (Overall)||0||
48746975|NCT02714569|102165985|FG006|STARTED|Part B (Overall)||8||
48746976|NCT02714569|102165986|FG007|STARTED|Part B (Overall)||8||
48746977|NCT02714569|102165987|FG008|STARTED|Part B (Overall)||8||
48746978|NCT02714569|102165988|FG009|STARTED|Part B (Overall)||8||
48624202|NCT01100853|101863827|FG000|NOT COMPLETED|Overall Study||27||
48746979|NCT02714569|102165989|FG010|STARTED|Part B (Overall)||8||
48746980|NCT02714569|102165979|FG000|COMPLETED|Part B (Overall)||0||
48746981|NCT02714569|102165980|FG001|COMPLETED|Part B (Overall)||0||
48410471|NCT01089751|101337637|FG000|NOT COMPLETED|Overall Study||34||
48624203|NCT01100853|101863828|FG001|NOT COMPLETED|Overall Study||23||
48624204|NCT01543568|101863829|FG000|STARTED|Overall Study||46||
48624205|NCT01543568|101863829|FG000|COMPLETED|Overall Study||45||
48624206|NCT01543568|101863829|FG000|NOT COMPLETED|Overall Study||1||
48624207|NCT03713684|101863830|FG000|STARTED|Overall Study||92||
48624208|NCT03713684|101863831|FG001|STARTED|Overall Study||92||
48746982|NCT02714569|102165981|FG002|COMPLETED|Part B (Overall)||0||
48746983|NCT02714569|102165982|FG003|COMPLETED|Part B (Overall)||0||
48746984|NCT02714569|102165983|FG004|COMPLETED|Part B (Overall)||0||
48624209|NCT03713684|101863832|FG002|STARTED|Overall Study||93||
48624210|NCT03713684|101863833|FG003|STARTED|Overall Study||93||
48624211|NCT03713684|101863830|FG000|Safety Population|Overall Study||92|Participants who received at least 1 dose or part of a dose of the Investigational Medicinal Product (IMP), analyzed according to the treatment actually received.|
48624212|NCT03713684|101863831|FG001|Safety Population|Overall Study||92|Participants who received at least 1 dose or part of a dose of the Investigational Medicinal Product (IMP), analyzed according to the treatment actually received.|
48624213|NCT03713684|101863832|FG002|Safety Population|Overall Study||96|Participants who received at least 1 dose or part of a dose of the Investigational Medicinal Product (IMP), analyzed according to the treatment actually received.|
48624214|NCT03713684|101863833|FG003|Safety Population|Overall Study||90|Participants who received at least 1 dose or part of a dose of the Investigational Medicinal Product (IMP), analyzed according to the treatment actually received.|
48624215|NCT03713684|101863830|FG000|Completed 30-Week Core Treatment Period|Overall Study||50||
48624216|NCT03713684|101863831|FG001|Completed 30-Week Core Treatment Period|Overall Study||52||
48624217|NCT03713684|101863832|FG002|Completed 30-Week Core Treatment Period|Overall Study||51||
48624218|NCT03713684|101863833|FG003|Completed 30-Week Core Treatment Period|Overall Study||49||
48624219|NCT03713684|101863830|FG000|COMPLETED|Overall Study||6|Completed 56-Week treatment period.|
48624220|NCT03713684|101863831|FG001|COMPLETED|Overall Study||5|Completed 56-Week treatment period.|
48624221|NCT03713684|101863832|FG002|COMPLETED|Overall Study||5|Completed 56-Week treatment period.|
48624222|NCT03713684|101863833|FG003|COMPLETED|Overall Study||6|Completed 56-Week treatment period.|
48624223|NCT03713684|101863830|FG000|NOT COMPLETED|Overall Study||86||
48624224|NCT03713684|101863831|FG001|NOT COMPLETED|Overall Study||87||
48624225|NCT03713684|101863832|FG002|NOT COMPLETED|Overall Study||88||
48624226|NCT03713684|101863833|FG003|NOT COMPLETED|Overall Study||87||
48624227|NCT03150082|101863834|FG000|STARTED|Treatment Period 1 (Up to 4 Weeks)||13||
48624228|NCT03150082|101863835|FG001|STARTED|Treatment Period 1 (Up to 4 Weeks)||13||
48624229|NCT03150082|101863834|FG000|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||12||
48624230|NCT03150082|101863835|FG001|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||13||
48624231|NCT03150082|101863834|FG000|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||1||
48746985|NCT02714569|102165984|FG005|COMPLETED|Part B (Overall)||0||
48746986|NCT02714569|102165985|FG006|COMPLETED|Part B (Overall)||7||
48746987|NCT02714569|102165986|FG007|COMPLETED|Part B (Overall)||7||
48746988|NCT02714569|102165987|FG008|COMPLETED|Part B (Overall)||8||
48746989|NCT02714569|102165988|FG009|COMPLETED|Part B (Overall)||6||
48746990|NCT02714569|102165989|FG010|COMPLETED|Part B (Overall)||8||
48746991|NCT02714569|102165979|FG000|NOT COMPLETED|Part B (Overall)||0||
48746992|NCT02714569|102165980|FG001|NOT COMPLETED|Part B (Overall)||0||
48746993|NCT02714569|102165981|FG002|NOT COMPLETED|Part B (Overall)||0||
48746994|NCT02714569|102165982|FG003|NOT COMPLETED|Part B (Overall)||0||
48746995|NCT02714569|102165983|FG004|NOT COMPLETED|Part B (Overall)||0||
48746996|NCT02714569|102165984|FG005|NOT COMPLETED|Part B (Overall)||0||
48746997|NCT02714569|102165985|FG006|NOT COMPLETED|Part B (Overall)||1||
48746998|NCT02714569|102165986|FG007|NOT COMPLETED|Part B (Overall)||1||
48746999|NCT02714569|102165987|FG008|NOT COMPLETED|Part B (Overall)||0||
48747000|NCT02714569|102165988|FG009|NOT COMPLETED|Part B (Overall)||2||
48747001|NCT02714569|102165989|FG010|NOT COMPLETED|Part B (Overall)||0||
48747002|NCT00587158|102165990|FG000|STARTED|Overall Study||49||
48747003|NCT00587158|102165991|FG001|STARTED|Overall Study||51||
48747004|NCT00587158|102165990|FG000|Continued in Study|Overall Study||45||
48166609|NCT01187329|100732124|FG001|COMPLETED|Overall Study||48||
48166610|NCT01187329|100732123|FG000|NOT COMPLETED|Overall Study||1||
48747005|NCT00587158|102165991|FG001|Continued in Study|Overall Study||46||
48747006|NCT00587158|102165990|FG000|COMPLETED|Overall Study||44||
48747007|NCT00587158|102165991|FG001|COMPLETED|Overall Study||43||
48747008|NCT00587158|102165990|FG000|NOT COMPLETED|Overall Study||5||
48747009|NCT00587158|102165991|FG001|NOT COMPLETED|Overall Study||8||
48747010|NCT02610777|102165992|FG000|STARTED|Overall Study||62||
48747011|NCT02610777|102165993|FG001|STARTED|Overall Study||58||
48747012|NCT02610777|102165992|FG000|Response Evaluable Population (REP)|Overall Study||53|Response Evaluable Population (REP) included all participants who received at least 1 dose of study drug, have a disease assessment at baseline, and at least 1 post baseline disease assessment.|
48747013|NCT02610777|102165993|FG001|Response Evaluable Population (REP)|Overall Study||55|Response Evaluable Population (REP) included all participants who received at least 1 dose of study drug, have a disease assessment at baseline, and at least 1 post baseline disease assessment.|
48747014|NCT02610777|102165992|FG000|COMPLETED|Overall Study||0||
48747015|NCT02610777|102165993|FG001|COMPLETED|Overall Study||0||
48747016|NCT02610777|102165992|FG000|NOT COMPLETED|Overall Study||62||
48747017|NCT02610777|102165993|FG001|NOT COMPLETED|Overall Study||58||
48747018|NCT04701333|102165994|FG000|STARTED|Overall Study||36||
48747019|NCT04701333|102165995|FG001|STARTED|Overall Study||37||
48747020|NCT04701333|102165994|FG000|COMPLETED|Overall Study||33||
48747021|NCT04701333|102165995|FG001|COMPLETED|Overall Study||29||
48747022|NCT04701333|102165994|FG000|NOT COMPLETED|Overall Study||3||
48747023|NCT04701333|102165995|FG001|NOT COMPLETED|Overall Study||8||
48747024|NCT00555880|102165996|FG000|STARTED|Treatment Period 1 (1 Day)||13||
48747025|NCT00555880|102165997|FG001|STARTED|Treatment Period 1 (1 Day)||11||
48747026|NCT00555880|102165996|FG000|COMPLETED|Treatment Period 1 (1 Day)||13||
48166611|NCT01187329|100732124|FG001|NOT COMPLETED|Overall Study||2||
48166612|NCT04404478|100732125|FG000|STARTED|Overall Study||26||
48166613|NCT04404478|100732126|FG001|STARTED|Overall Study||26||
48166614|NCT04404478|100732125|FG000|COMPLETED|Overall Study||25||
48166615|NCT04404478|100732126|FG001|COMPLETED|Overall Study||23||
48166616|NCT04404478|100732125|FG000|NOT COMPLETED|Overall Study||1||
48166617|NCT04404478|100732126|FG001|NOT COMPLETED|Overall Study||3||
48166618|NCT04394845|100732127|FG000|STARTED|Overall Study||6||
48166619|NCT04394845|100732127|FG000|COMPLETED|Overall Study||6||
48624232|NCT03150082|101863835|FG001|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||0||
48624233|NCT03150082|101863834|FG000|STARTED|Washout Period (Up to 4 Weeks)||12||
48624234|NCT03150082|101863835|FG001|STARTED|Washout Period (Up to 4 Weeks)||13||
48624235|NCT03150082|101863834|FG000|COMPLETED|Washout Period (Up to 4 Weeks)||12||
48624236|NCT03150082|101863835|FG001|COMPLETED|Washout Period (Up to 4 Weeks)||13||
48624237|NCT03150082|101863834|FG000|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0||
48624238|NCT03150082|101863835|FG001|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0||
48624239|NCT03150082|101863834|FG000|STARTED|Treatment Period 2 (Up to 4 Weeks)||12||
48624240|NCT03150082|101863835|FG001|STARTED|Treatment Period 2 (Up to 4 Weeks)||13||
48624241|NCT03150082|101863834|FG000|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||12||
48624242|NCT03150082|101863835|FG001|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||13||
48624243|NCT03150082|101863834|FG000|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0||
48624244|NCT03150082|101863835|FG001|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0||
48624245|NCT03031340|101863836|FG000|STARTED|Overall Study||2||
48747027|NCT00555880|102165997|FG001|COMPLETED|Treatment Period 1 (1 Day)||11||
48747028|NCT00555880|102165996|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
48747029|NCT00555880|102165997|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
48747030|NCT00555880|102165996|FG000|STARTED|Washout (1 Day)||13||
48624246|NCT03031340|101863837|FG001|STARTED|Overall Study||1||
48624247|NCT03031340|101863836|FG000|COMPLETED|Overall Study||0||
48624248|NCT03031340|101863837|FG001|COMPLETED|Overall Study||0||
48624249|NCT03031340|101863836|FG000|NOT COMPLETED|Overall Study||2||
48624250|NCT03031340|101863837|FG001|NOT COMPLETED|Overall Study||1||
48624251|NCT02337491|101863838|FG000|STARTED|Overall Study||50||
48624252|NCT02337491|101863839|FG001|STARTED|Overall Study||30||
48624253|NCT02337491|101863838|FG000|COMPLETED|Overall Study||0||
48624254|NCT02337491|101863839|FG001|COMPLETED|Overall Study||0||
48624255|NCT02337491|101863838|FG000|NOT COMPLETED|Overall Study||50||
48624256|NCT02337491|101863839|FG001|NOT COMPLETED|Overall Study||30||
48624257|NCT02256696|101863840|FG000|STARTED|Overall Study||56||
48747031|NCT00555880|102165997|FG001|STARTED|Washout (1 Day)||11||
48747032|NCT00555880|102165996|FG000|COMPLETED|Washout (1 Day)||13||
48747033|NCT00555880|102165997|FG001|COMPLETED|Washout (1 Day)||11||
48747034|NCT00555880|102165996|FG000|NOT COMPLETED|Washout (1 Day)||0||
48166620|NCT04394845|100732127|FG000|NOT COMPLETED|Overall Study||0||
48166621|NCT00462722|100732128|FG000|STARTED|Overall Study||50||
48166622|NCT00462722|100732129|FG001|STARTED|Overall Study||55||
48166623|NCT00462722|100732130|FG002|STARTED|Overall Study||54||
48329853|NCT01338415|101135845|FG001|COMPLETED|Core + Extension||22||
48329854|NCT01338415|101135846|FG002|COMPLETED|Core + Extension||0||
48329855|NCT01338415|101135844|FG000|NOT COMPLETED|Core + Extension||10||
48329856|NCT01338415|101135845|FG001|NOT COMPLETED|Core + Extension||9||
48747035|NCT00555880|102165997|FG001|NOT COMPLETED|Washout (1 Day)||0||
48747036|NCT00555880|102165996|FG000|STARTED|Treatment Period 2 (1 Day)||13||
48747037|NCT00555880|102165997|FG001|STARTED|Treatment Period 2 (1 Day)||11||
48747038|NCT00555880|102165996|FG000|COMPLETED|Treatment Period 2 (1 Day)||13||
48747039|NCT00555880|102165997|FG001|COMPLETED|Treatment Period 2 (1 Day)||11||
48747040|NCT00555880|102165996|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
48747041|NCT00555880|102165997|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
48747042|NCT00985465|102165998|FG000|STARTED|Overall Study||141||
48747043|NCT00985465|102165999|FG001|STARTED|Overall Study||69||
48747044|NCT00985465|102165998|FG000|COMPLETED|Overall Study||140||
48747045|NCT00985465|102165999|FG001|COMPLETED|Overall Study||66||
48747046|NCT00985465|102165998|FG000|NOT COMPLETED|Overall Study||1||
48747047|NCT00985465|102165999|FG001|NOT COMPLETED|Overall Study||3||
48747048|NCT00872599|102166000|FG000|STARTED|First Washout Period After Low Salt||16||
48747049|NCT00872599|102166001|FG001|STARTED|First Washout Period After Low Salt||17||
48747050|NCT00872599|102166000|FG000|COMPLETED|First Washout Period After Low Salt||16||
48747051|NCT00872599|102166001|FG001|COMPLETED|First Washout Period After Low Salt||17||
48747052|NCT00872599|102166000|FG000|NOT COMPLETED|First Washout Period After Low Salt||0||
48747053|NCT00872599|102166001|FG001|NOT COMPLETED|First Washout Period After Low Salt||0||
48747054|NCT00872599|102166000|FG000|STARTED|First Drug During High Salt Intake||16||
48747055|NCT00872599|102166001|FG001|STARTED|First Drug During High Salt Intake||17||
48747056|NCT00872599|102166000|FG000|COMPLETED|First Drug During High Salt Intake||16||
48747057|NCT00872599|102166001|FG001|COMPLETED|First Drug During High Salt Intake||17||
48747058|NCT00872599|102166000|FG000|NOT COMPLETED|First Drug During High Salt Intake||0||
48747059|NCT00872599|102166001|FG001|NOT COMPLETED|First Drug During High Salt Intake||0||
48747060|NCT00872599|102166000|FG000|STARTED|Second Washout Period||16||
48747061|NCT00872599|102166001|FG001|STARTED|Second Washout Period||17||
48329857|NCT01338415|101135846|FG002|NOT COMPLETED|Core + Extension||0||
48329858|NCT01338415|101135844|FG000|STARTED|Exceptional Use Treatment Period||0||
48747062|NCT00872599|102166000|FG000|COMPLETED|Second Washout Period||15||
48747063|NCT00872599|102166001|FG001|COMPLETED|Second Washout Period||16||
48329859|NCT01338415|101135845|FG001|STARTED|Exceptional Use Treatment Period||0||
48329860|NCT01338415|101135846|FG002|STARTED|Exceptional Use Treatment Period||10||
48329861|NCT01338415|101135844|FG000|COMPLETED|Exceptional Use Treatment Period||0||
48329862|NCT01338415|101135845|FG001|COMPLETED|Exceptional Use Treatment Period||0||
48747064|NCT00872599|102166000|FG000|NOT COMPLETED|Second Washout Period||1||
48747065|NCT00872599|102166001|FG001|NOT COMPLETED|Second Washout Period||1||
48747066|NCT00872599|102166000|FG000|STARTED|Second Drug During High Salt Intake||15||
48747067|NCT00872599|102166001|FG001|STARTED|Second Drug During High Salt Intake||16||
48747068|NCT00872599|102166000|FG000|COMPLETED|Second Drug During High Salt Intake||15||
48747069|NCT00872599|102166001|FG001|COMPLETED|Second Drug During High Salt Intake||16||
48747070|NCT00872599|102166000|FG000|NOT COMPLETED|Second Drug During High Salt Intake||0||
48747071|NCT00872599|102166001|FG001|NOT COMPLETED|Second Drug During High Salt Intake||0||
48747072|NCT01303939|102166002|FG000|STARTED|Overall Study||22||
48747073|NCT01303939|102166003|FG001|STARTED|Overall Study||15||
48747074|NCT01303939|102166002|FG000|COMPLETED|Overall Study||15||
48747075|NCT01303939|102166003|FG001|COMPLETED|Overall Study||15||
48747076|NCT01303939|102166002|FG000|NOT COMPLETED|Overall Study||7||
48747077|NCT01303939|102166003|FG001|NOT COMPLETED|Overall Study||0||
48747078|NCT02507388|102166004|FG000|STARTED|Overall Study||25||
48747079|NCT02507388|102166005|FG001|STARTED|Overall Study||25||
48747080|NCT02507388|102166004|FG000|COMPLETED|Overall Study||25||
48747081|NCT02507388|102166005|FG001|COMPLETED|Overall Study||25||
48747082|NCT02507388|102166004|FG000|NOT COMPLETED|Overall Study||0||
48747083|NCT02507388|102166005|FG001|NOT COMPLETED|Overall Study||0||
48747084|NCT02673918|102166006|FG000|STARTED|Overall Study||35||
48747085|NCT02673918|102166007|FG001|STARTED|Overall Study||24||
48410472|NCT01089751|101337638|FG001|NOT COMPLETED|Overall Study||27||
48410473|NCT00865202|101337639|FG000|STARTED|Overall Study||152||
48410474|NCT00865202|101337640|FG001|STARTED|Overall Study||149||
48410475|NCT00865202|101337639|FG000|COMPLETED|Overall Study||152||
48166624|NCT00462722|100732128|FG000|COMPLETED|Overall Study||37||
48166625|NCT00462722|100732129|FG001|COMPLETED|Overall Study||51||
48166626|NCT00462722|100732130|FG002|COMPLETED|Overall Study||42||
48166627|NCT00462722|100732128|FG000|NOT COMPLETED|Overall Study||13||
48166628|NCT00462722|100732129|FG001|NOT COMPLETED|Overall Study||4||
48166629|NCT00462722|100732130|FG002|NOT COMPLETED|Overall Study||12||
48166630|NCT01686165|100732131|FG000|STARTED|Overall Study||5||
48166631|NCT01686165|100732131|FG000|COMPLETED|Overall Study||5||
48329863|NCT01338415|101135846|FG002|COMPLETED|Exceptional Use Treatment Period||4||
48329864|NCT01338415|101135844|FG000|NOT COMPLETED|Exceptional Use Treatment Period||0||
48329865|NCT01338415|101135845|FG001|NOT COMPLETED|Exceptional Use Treatment Period||0||
48329866|NCT01338415|101135846|FG002|NOT COMPLETED|Exceptional Use Treatment Period||6||
48329867|NCT03403205|101135847|FG000|STARTED|Primary Evaluation Period (48 Weeks)||105||
48329868|NCT03403205|101135848|FG001|STARTED|Primary Evaluation Period (48 Weeks)||56||
48410476|NCT00865202|101337640|FG001|COMPLETED|Overall Study||149||
48329869|NCT03403205|101135849|FG002|STARTED|Primary Evaluation Period (48 Weeks)||37||
48329870|NCT03403205|101135850|FG003|STARTED|Primary Evaluation Period (48 Weeks)||16||
48329871|NCT03403205|101135851|FG004|STARTED|Primary Evaluation Period (48 Weeks)||0||
48329872|NCT03403205|101135852|FG005|STARTED|Primary Evaluation Period (48 Weeks)||0||
48329873|NCT03403205|101135847|FG000|Received at Least 1 Dose of Study Drug|Primary Evaluation Period (48 Weeks)||104||
48329874|NCT03403205|101135848|FG001|Received at Least 1 Dose of Study Drug|Primary Evaluation Period (48 Weeks)||56||
48410477|NCT00865202|101337639|FG000|NOT COMPLETED|Overall Study||0||
48410478|NCT00865202|101337640|FG001|NOT COMPLETED|Overall Study||0||
48410479|NCT02142712|101337641|FG000|STARTED|Overall Study||1||
48410480|NCT02142712|101337642|FG001|STARTED|Overall Study||1||
48624258|NCT02256696|101863841|FG001|STARTED|Overall Study||53||
48624259|NCT02256696|101863842|FG002|STARTED|Overall Study||48||
48410481|NCT02142712|101337643|FG002|STARTED|Overall Study||1||
48410482|NCT02142712|101337644|FG003|STARTED|Overall Study||0||
48166632|NCT01686165|100732131|FG000|NOT COMPLETED|Overall Study||0||
48329875|NCT03403205|101135849|FG002|Received at Least 1 Dose of Study Drug|Primary Evaluation Period (48 Weeks)||33||
48329876|NCT03403205|101135850|FG003|Received at Least 1 Dose of Study Drug|Primary Evaluation Period (48 Weeks)||14||
48329877|NCT03403205|101135851|FG004|Received at Least 1 Dose of Study Drug|Primary Evaluation Period (48 Weeks)||0||
48329878|NCT03403205|101135852|FG005|Received at Least 1 Dose of Study Drug|Primary Evaluation Period (48 Weeks)||0||
48329879|NCT03403205|101135847|FG000|Completed PEP, Enter Extension|Primary Evaluation Period (48 Weeks)||89||
48329880|NCT03403205|101135848|FG001|Completed PEP, Enter Extension|Primary Evaluation Period (48 Weeks)||49||
48410483|NCT02142712|101337641|FG000|COMPLETED|Overall Study||0||
48410484|NCT02142712|101337642|FG001|COMPLETED|Overall Study||0||
48410485|NCT02142712|101337643|FG002|COMPLETED|Overall Study||0||
48410486|NCT02142712|101337644|FG003|COMPLETED|Overall Study||0||
48624260|NCT02256696|101863840|FG000|COMPLETED|Overall Study||53||
48624261|NCT02256696|101863841|FG001|COMPLETED|Overall Study||50||
48624262|NCT02256696|101863842|FG002|COMPLETED|Overall Study||47||
48624263|NCT02256696|101863840|FG000|NOT COMPLETED|Overall Study||3||
48624264|NCT02256696|101863841|FG001|NOT COMPLETED|Overall Study||3||
48624265|NCT02256696|101863842|FG002|NOT COMPLETED|Overall Study||1||
48624266|NCT01139996|101863843|FG000|STARTED|Overall Study||11||
48624267|NCT01139996|101863844|FG001|STARTED|Overall Study||11||
48624268|NCT01139996|101863843|FG000|COMPLETED|Overall Study||11||
48624269|NCT01139996|101863844|FG001|COMPLETED|Overall Study||11||
48624270|NCT01139996|101863843|FG000|NOT COMPLETED|Overall Study||0||
48624271|NCT01139996|101863844|FG001|NOT COMPLETED|Overall Study||0||
48624272|NCT00313846|101863845|FG000|STARTED|Overall Study||162||
48166633|NCT01928680|100732132|FG000|STARTED|Overall Study||33||
48166634|NCT01928680|100732132|FG000|COMPLETED|Overall Study||33||
48166635|NCT01928680|100732132|FG000|NOT COMPLETED|Overall Study||0||
48166636|NCT03675451|100732133|FG000|STARTED|Overall Study||20||
48410487|NCT02142712|101337641|FG000|NOT COMPLETED|Overall Study||1||
48410488|NCT02142712|101337642|FG001|NOT COMPLETED|Overall Study||1||
48624273|NCT00313846|101863846|FG001|STARTED|Overall Study||164||
48624274|NCT00313846|101863845|FG000|COMPLETED|Overall Study||157||
48624275|NCT00313846|101863846|FG001|COMPLETED|Overall Study||153||
48624276|NCT00313846|101863845|FG000|NOT COMPLETED|Overall Study||5||
48624277|NCT00313846|101863846|FG001|NOT COMPLETED|Overall Study||11||
48166637|NCT03675451|100732133|FG000|COMPLETED|Overall Study||20||
48624278|NCT02062437|101863847|FG000|STARTED|Overall Study||132||
48624279|NCT02062437|101863847|FG000|COMPLETED|Overall Study||80||
48624280|NCT02062437|101863847|FG000|NOT COMPLETED|Overall Study||52||
48166638|NCT03675451|100732133|FG000|NOT COMPLETED|Overall Study||0||
48166639|NCT00803101|100732134|FG000|STARTED|Overall Study||88||
48166640|NCT00803101|100732135|FG001|STARTED|Overall Study||88||
48166641|NCT00803101|100732134|FG000|COMPLETED|Overall Study||70||
48166642|NCT00803101|100732135|FG001|COMPLETED|Overall Study||66||
48166643|NCT00803101|100732134|FG000|NOT COMPLETED|Overall Study||18||
48166644|NCT00803101|100732135|FG001|NOT COMPLETED|Overall Study||22||
48166645|NCT00744328|100732136|FG000|STARTED|Overall Study||26||
48166646|NCT00744328|100732137|FG001|STARTED|Overall Study||30||
48166647|NCT00744328|100732138|FG002|STARTED|Overall Study||29||
48166648|NCT00744328|100732136|FG000|COMPLETED|Overall Study||19||
48166649|NCT00744328|100732137|FG001|COMPLETED|Overall Study||22||
48166650|NCT00744328|100732138|FG002|COMPLETED|Overall Study||21||
48166651|NCT00744328|100732136|FG000|NOT COMPLETED|Overall Study||7||
48166652|NCT00744328|100732137|FG001|NOT COMPLETED|Overall Study||8||
48166653|NCT00744328|100732138|FG002|NOT COMPLETED|Overall Study||8||
48166654|NCT00280826|100732139|FG000|STARTED|Overall Study||6||
48166655|NCT00280826|100732139|FG000|COMPLETED|Overall Study||6||
48166656|NCT00280826|100732139|FG000|NOT COMPLETED|Overall Study||0||
48166657|NCT02392611|100732140|FG000|STARTED|Overall Study||2||
48166658|NCT02392611|100732141|FG001|STARTED|Overall Study||1||
48166659|NCT02392611|100732142|FG002|STARTED|Overall Study||1||
48166660|NCT02392611|100732143|FG003|STARTED|Overall Study||9||
48166661|NCT02392611|100732144|FG004|STARTED|Overall Study||6||
48166662|NCT02392611|100732145|FG005|STARTED|Overall Study||4||
48166663|NCT02392611|100732146|FG006|STARTED|Overall Study||4||
48166664|NCT02392611|100732147|FG007|STARTED|Overall Study||3||
48166665|NCT02392611|100732148|FG008|STARTED|Overall Study||3||
48166666|NCT02392611|100732140|FG000|COMPLETED|Overall Study||1||
48166667|NCT02392611|100732141|FG001|COMPLETED|Overall Study||1||
48166668|NCT02392611|100732142|FG002|COMPLETED|Overall Study||1||
48166669|NCT02392611|100732143|FG003|COMPLETED|Overall Study||3||
48166670|NCT02392611|100732144|FG004|COMPLETED|Overall Study||5||
48166671|NCT02392611|100732145|FG005|COMPLETED|Overall Study||3||
48166672|NCT02392611|100732146|FG006|COMPLETED|Overall Study||3||
48166673|NCT02392611|100732147|FG007|COMPLETED|Overall Study||3||
48166674|NCT02392611|100732148|FG008|COMPLETED|Overall Study||3||
48166675|NCT02392611|100732140|FG000|NOT COMPLETED|Overall Study||1||
48166676|NCT02392611|100732141|FG001|NOT COMPLETED|Overall Study||0||
48166677|NCT02392611|100732142|FG002|NOT COMPLETED|Overall Study||0||
48166678|NCT02392611|100732143|FG003|NOT COMPLETED|Overall Study||6||
48166679|NCT02392611|100732144|FG004|NOT COMPLETED|Overall Study||1||
48166680|NCT02392611|100732145|FG005|NOT COMPLETED|Overall Study||1||
48166681|NCT02392611|100732146|FG006|NOT COMPLETED|Overall Study||1||
48166682|NCT02392611|100732147|FG007|NOT COMPLETED|Overall Study||0||
48166683|NCT02392611|100732148|FG008|NOT COMPLETED|Overall Study||0||
48166684|NCT02542839|100732149|FG000|STARTED|Overall Study||5||
48166685|NCT02542839|100732150|FG001|STARTED|Overall Study||4||
48166686|NCT02542839|100732149|FG000|COMPLETED|Overall Study||5||
48166687|NCT02542839|100732150|FG001|COMPLETED|Overall Study||4||
48166688|NCT02542839|100732149|FG000|NOT COMPLETED|Overall Study||0||
48166689|NCT02542839|100732150|FG001|NOT COMPLETED|Overall Study||0||
48166690|NCT02597790|100732151|FG000|STARTED|Overall Study||45||
48166691|NCT02597790|100732152|FG001|STARTED|Overall Study||41||
48166692|NCT02597790|100732151|FG000|COMPLETED|Overall Study||36||
48166693|NCT02597790|100732152|FG001|COMPLETED|Overall Study||29||
48166694|NCT02597790|100732151|FG000|NOT COMPLETED|Overall Study||9||
48166695|NCT02597790|100732152|FG001|NOT COMPLETED|Overall Study||12||
48166696|NCT00988221|100732153|FG000|STARTED|Part I||35||
48166697|NCT00988221|100732154|FG001|STARTED|Part I||34||
48166698|NCT00988221|100732155|FG002|STARTED|Part I||119||
48166699|NCT00988221|100732156|FG003|STARTED|Part I||0||
48166700|NCT00988221|100732153|FG000|COMPLETED|Part I||31||
48166701|NCT00988221|100732154|FG001|COMPLETED|Part I||24||
48166702|NCT00988221|100732155|FG002|COMPLETED|Part I||111||
48166703|NCT00988221|100732156|FG003|COMPLETED|Part I||0||
48166704|NCT00988221|100732153|FG000|NOT COMPLETED|Part I||4||
48166705|NCT00988221|100732154|FG001|NOT COMPLETED|Part I||10||
48166706|NCT00988221|100732155|FG002|NOT COMPLETED|Part I||8||
48166707|NCT00988221|100732156|FG003|NOT COMPLETED|Part I||0||
48166708|NCT00988221|100732153|FG000|STARTED|Part II||16||
48166709|NCT00988221|100732154|FG001|STARTED|Part II||11||
48166710|NCT00988221|100732155|FG002|STARTED|Part II||55||
48166711|NCT00988221|100732156|FG003|STARTED|Part II||84||
48166712|NCT00988221|100732153|FG000|COMPLETED|Part II||15||
48166713|NCT00988221|100732154|FG001|COMPLETED|Part II||11||
48166714|NCT00988221|100732155|FG002|COMPLETED|Part II||52||
48166715|NCT00988221|100732156|FG003|COMPLETED|Part II||81||
48624281|NCT03781726|101863848|FG000|STARTED|Overall Study||30||
48329881|NCT03403205|101135849|FG002|Completed PEP, Enter Extension|Primary Evaluation Period (48 Weeks)||28||
48329882|NCT03403205|101135850|FG003|Completed PEP, Enter Extension|Primary Evaluation Period (48 Weeks)||12||
48329883|NCT03403205|101135851|FG004|Completed PEP, Enter Extension|Primary Evaluation Period (48 Weeks)||0||
48329884|NCT03403205|101135852|FG005|Completed PEP, Enter Extension|Primary Evaluation Period (48 Weeks)||0||
48329885|NCT03403205|101135847|FG000|Completed PEP, Not Into Extension|Primary Evaluation Period (48 Weeks)||4||
48329886|NCT03403205|101135848|FG001|Completed PEP, Not Into Extension|Primary Evaluation Period (48 Weeks)||3||
48329887|NCT03403205|101135849|FG002|Completed PEP, Not Into Extension|Primary Evaluation Period (48 Weeks)||1||
48329888|NCT03403205|101135850|FG003|Completed PEP, Not Into Extension|Primary Evaluation Period (48 Weeks)||1||
48329889|NCT03403205|101135851|FG004|Completed PEP, Not Into Extension|Primary Evaluation Period (48 Weeks)||0||
48329890|NCT03403205|101135852|FG005|Completed PEP, Not Into Extension|Primary Evaluation Period (48 Weeks)||0||
48329891|NCT03403205|101135847|FG000|COMPLETED|Primary Evaluation Period (48 Weeks)||93||
48329892|NCT03403205|101135848|FG001|COMPLETED|Primary Evaluation Period (48 Weeks)||52||
48329893|NCT03403205|101135849|FG002|COMPLETED|Primary Evaluation Period (48 Weeks)||29||
48329894|NCT03403205|101135850|FG003|COMPLETED|Primary Evaluation Period (48 Weeks)||13||
48329895|NCT03403205|101135851|FG004|COMPLETED|Primary Evaluation Period (48 Weeks)||0||
48329896|NCT03403205|101135852|FG005|COMPLETED|Primary Evaluation Period (48 Weeks)||0||
48329897|NCT03403205|101135847|FG000|NOT COMPLETED|Primary Evaluation Period (48 Weeks)||12||
48329898|NCT03403205|101135848|FG001|NOT COMPLETED|Primary Evaluation Period (48 Weeks)||4||
48329899|NCT03403205|101135849|FG002|NOT COMPLETED|Primary Evaluation Period (48 Weeks)||8||
48329900|NCT03403205|101135850|FG003|NOT COMPLETED|Primary Evaluation Period (48 Weeks)||3||
48329901|NCT03403205|101135851|FG004|NOT COMPLETED|Primary Evaluation Period (48 Weeks)||0||
48329902|NCT03403205|101135852|FG005|NOT COMPLETED|Primary Evaluation Period (48 Weeks)||0||
48329903|NCT03403205|101135847|FG000|STARTED|Extension Period (Up to 60 Months)||89||
48329904|NCT03403205|101135848|FG001|STARTED|Extension Period (Up to 60 Months)||49||
48329905|NCT03403205|101135849|FG002|STARTED|Extension Period (Up to 60 Months)||28||
48329906|NCT03403205|101135850|FG003|STARTED|Extension Period (Up to 60 Months)||12||
48329907|NCT03403205|101135851|FG004|STARTED|Extension Period (Up to 60 Months)||8||
48329908|NCT03403205|101135852|FG005|STARTED|Extension Period (Up to 60 Months)||11||
48329909|NCT03403205|101135847|FG000|COMPLETED|Extension Period (Up to 60 Months)||0||
48329910|NCT03403205|101135848|FG001|COMPLETED|Extension Period (Up to 60 Months)||0||
48329911|NCT03403205|101135849|FG002|COMPLETED|Extension Period (Up to 60 Months)||0||
48329912|NCT03403205|101135850|FG003|COMPLETED|Extension Period (Up to 60 Months)||0||
48329913|NCT03403205|101135851|FG004|COMPLETED|Extension Period (Up to 60 Months)||0||
48329914|NCT03403205|101135852|FG005|COMPLETED|Extension Period (Up to 60 Months)||1||
48329915|NCT03403205|101135847|FG000|NOT COMPLETED|Extension Period (Up to 60 Months)||89||
48329916|NCT03403205|101135848|FG001|NOT COMPLETED|Extension Period (Up to 60 Months)||49||
48329917|NCT03403205|101135849|FG002|NOT COMPLETED|Extension Period (Up to 60 Months)||28||
48329918|NCT03403205|101135850|FG003|NOT COMPLETED|Extension Period (Up to 60 Months)||12||
48329919|NCT03403205|101135851|FG004|NOT COMPLETED|Extension Period (Up to 60 Months)||8||
48329920|NCT03403205|101135852|FG005|NOT COMPLETED|Extension Period (Up to 60 Months)||10||
48329921|NCT03756038|101135853|FG000|STARTED|Overall Study||1||
48329922|NCT03756038|101135854|FG001|STARTED|Overall Study||0||
48329923|NCT03756038|101135853|FG000|COMPLETED|Overall Study||1||
48329924|NCT03756038|101135854|FG001|COMPLETED|Overall Study||0||
48329925|NCT03756038|101135853|FG000|NOT COMPLETED|Overall Study||0||
48329926|NCT03756038|101135854|FG001|NOT COMPLETED|Overall Study||0||
48329927|NCT03598166|101135855|FG000|STARTED|Overall Study||178||
48329928|NCT03598166|101135856|FG001|STARTED|Overall Study||181||
48329929|NCT03598166|101135855|FG000|COMPLETED|Overall Study||178||
48329930|NCT03598166|101135856|FG001|COMPLETED|Overall Study||181||
48329931|NCT03598166|101135855|FG000|NOT COMPLETED|Overall Study||0||
48329932|NCT03598166|101135856|FG001|NOT COMPLETED|Overall Study||0||
48329933|NCT00713583|101135857|FG000|STARTED|Overall Study||45||
48329934|NCT00713583|101135858|FG001|STARTED|Overall Study||40||
48329935|NCT00713583|101135857|FG000|COMPLETED|Overall Study||45||
48329936|NCT00713583|101135858|FG001|COMPLETED|Overall Study||40||
48329937|NCT00713583|101135857|FG000|NOT COMPLETED|Overall Study||0||
48329938|NCT00713583|101135858|FG001|NOT COMPLETED|Overall Study||0||
48329939|NCT03726164|101135859|FG000|STARTED|Overall Study||310||
48329940|NCT03726164|101135860|FG001|STARTED|Overall Study||316||
48329941|NCT03726164|101135859|FG000|COMPLETED|Overall Study||99||
48329942|NCT03726164|101135860|FG001|COMPLETED|Overall Study||119||
48329943|NCT03726164|101135859|FG000|NOT COMPLETED|Overall Study||211||
48329944|NCT03726164|101135860|FG001|NOT COMPLETED|Overall Study||197||
48329945|NCT04327388|101135861|FG000|STARTED|Overall Study||161||
48329946|NCT04327388|101135862|FG001|STARTED|Overall Study||173||
48329947|NCT04327388|101135863|FG002|STARTED|Overall Study||86||
48329948|NCT04327388|101135861|FG000|Treated|Overall Study||159||
48329949|NCT04327388|101135862|FG001|Treated|Overall Study||173||
48329950|NCT04327388|101135863|FG002|Treated|Overall Study||84||
48368077|NCT03691623|101230098|FG002|NOT COMPLETED|Overall Study||0||
48368078|NCT03691623|101230099|FG003|NOT COMPLETED|Overall Study||0||
48624282|NCT03781726|101863848|FG000|COMPLETED|Overall Study||28||
48368079|NCT03691623|101230100|FG004|NOT COMPLETED|Overall Study||0||
48329951|NCT04327388|101135861|FG000|Participants Who Received Second Dose|Overall Study||13|Participants who met prespecified criteria as per protocol amendment 2, received a second dose of the study drug (based on the original treatment group assigned) 24 to 48 hours after the first dose.|
48329952|NCT04327388|101135862|FG001|Participants Who Received Second Dose|Overall Study||11|Participants who met prespecified criteria as per protocol amendment 2, received a second dose of the study drug (based on the original treatment group assigned) 24 to 48 hours after the first dose.|
48329953|NCT04327388|101135863|FG002|Participants Who Received Second Dose|Overall Study||5|Participants who met prespecified criteria as per protocol amendment 2, received a second dose of the study drug (based on the original treatment group assigned) 24 to 48 hours after the first dose.|
48329954|NCT04327388|101135861|FG000|COMPLETED|Overall Study||141||
48329955|NCT04327388|101135862|FG001|COMPLETED|Overall Study||153||
48329956|NCT04327388|101135863|FG002|COMPLETED|Overall Study||75||
48329957|NCT04327388|101135861|FG000|NOT COMPLETED|Overall Study||20||
48410489|NCT02142712|101337643|FG002|NOT COMPLETED|Overall Study||1||
48410490|NCT02142712|101337644|FG003|NOT COMPLETED|Overall Study||0||
48410491|NCT00038142|101337645|FG000|STARTED|Overall Study||32||
48410492|NCT00038142|101337646|FG001|STARTED|Overall Study||14||
48410493|NCT00038142|101337645|FG000|COMPLETED|Overall Study||10||
48410494|NCT00038142|101337646|FG001|COMPLETED|Overall Study||7||
48410495|NCT00038142|101337645|FG000|NOT COMPLETED|Overall Study||22||
48410496|NCT00038142|101337646|FG001|NOT COMPLETED|Overall Study||7||
48410497|NCT00420212|101337647|FG000|STARTED|Overall Study||408||
48410498|NCT00420212|101337648|FG001|STARTED|Overall Study||410||
48410499|NCT00420212|101337649|FG002|STARTED|Overall Study||416||
48329958|NCT04327388|101135862|FG001|NOT COMPLETED|Overall Study||20||
48329959|NCT04327388|101135863|FG002|NOT COMPLETED|Overall Study||11||
48329960|NCT01841333|101135864|FG000|STARTED|Overall Study||31||
48329961|NCT01841333|101135864|FG000|COMPLETED|Overall Study||31||
48329962|NCT01841333|101135864|FG000|NOT COMPLETED|Overall Study||0||
48329963|NCT00132132|101135865|FG000|STARTED|Overall Study||15||
48329964|NCT00132132|101135866|FG001|STARTED|Overall Study||15||
48329965|NCT00132132|101135865|FG000|COMPLETED|Overall Study||8||
48329966|NCT00132132|101135866|FG001|COMPLETED|Overall Study||13||
48329967|NCT00132132|101135865|FG000|NOT COMPLETED|Overall Study||7||
48329968|NCT00132132|101135866|FG001|NOT COMPLETED|Overall Study||2||
48329969|NCT00243659|101135867|FG000|STARTED|Overall Study||22||
48329970|NCT00243659|101135868|FG001|STARTED|Overall Study||8||
48329971|NCT00243659|101135867|FG000|COMPLETED|Overall Study||20||
48329972|NCT00243659|101135868|FG001|COMPLETED|Overall Study||5||
48329973|NCT00243659|101135867|FG000|NOT COMPLETED|Overall Study||2||
48329974|NCT00243659|101135868|FG001|NOT COMPLETED|Overall Study||3||
48329975|NCT02921971|101135869|FG000|STARTED|Overall Study||49||
48329976|NCT02921971|101135870|FG001|STARTED|Overall Study||48||
48329977|NCT02921971|101135869|FG000|COMPLETED|Overall Study||43||
48329978|NCT02921971|101135870|FG001|COMPLETED|Overall Study||44||
48329979|NCT02921971|101135869|FG000|NOT COMPLETED|Overall Study||6||
48329980|NCT02921971|101135870|FG001|NOT COMPLETED|Overall Study||4||
48329981|NCT02896595|101135871|FG000|STARTED|Overall Study||50||
48329982|NCT02896595|101135872|FG001|STARTED|Overall Study||50||
48329983|NCT02896595|101135871|FG000|COMPLETED|Overall Study||50||
48329984|NCT02896595|101135872|FG001|COMPLETED|Overall Study||50||
48329985|NCT02896595|101135871|FG000|NOT COMPLETED|Overall Study||0||
48329986|NCT02896595|101135872|FG001|NOT COMPLETED|Overall Study||0||
48329987|NCT01375764|101135873|FG000|STARTED|Overall Study||33||
48329988|NCT01375764|101135874|FG001|STARTED|Overall Study||31||
48329989|NCT01375764|101135875|FG002|STARTED|Overall Study||32||
48329990|NCT01375764|101135876|FG003|STARTED|Overall Study||32||
48329991|NCT01375764|101135877|FG004|STARTED|Overall Study||32||
48329992|NCT01375764|101135873|FG000|Received Treatment|Overall Study||32||
48329993|NCT01375764|101135874|FG001|Received Treatment|Overall Study||30||
48329994|NCT01375764|101135875|FG002|Received Treatment|Overall Study||32||
48329995|NCT01375764|101135876|FG003|Received Treatment|Overall Study||31||
48329996|NCT01375764|101135877|FG004|Received Treatment|Overall Study||32||
48329997|NCT01375764|101135873|FG000|COMPLETED|Overall Study||31||
48329998|NCT01375764|101135874|FG001|COMPLETED|Overall Study||30||
48329999|NCT01375764|101135875|FG002|COMPLETED|Overall Study||32||
48330000|NCT01375764|101135876|FG003|COMPLETED|Overall Study||31||
48330001|NCT01375764|101135877|FG004|COMPLETED|Overall Study||31||
48410500|NCT00420212|101337647|FG000|COMPLETED|Overall Study||317||
48410501|NCT00420212|101337648|FG001|COMPLETED|Overall Study||315||
48410502|NCT00420212|101337649|FG002|COMPLETED|Overall Study||320||
48410503|NCT00420212|101337647|FG000|NOT COMPLETED|Overall Study||91||
48410504|NCT00420212|101337648|FG001|NOT COMPLETED|Overall Study||95||
48410505|NCT00420212|101337649|FG002|NOT COMPLETED|Overall Study||96||
48410506|NCT00233324|101337650|FG000|STARTED|Main Study||318||
48410507|NCT00233324|101337651|FG001|STARTED|Main Study||335||
48410508|NCT00233324|101337652|FG002|STARTED|Main Study||336||
48330002|NCT01375764|101135873|FG000|NOT COMPLETED|Overall Study||2||
48330003|NCT01375764|101135874|FG001|NOT COMPLETED|Overall Study||1||
48330004|NCT01375764|101135875|FG002|NOT COMPLETED|Overall Study||0||
48330005|NCT01375764|101135876|FG003|NOT COMPLETED|Overall Study||1||
48410509|NCT00233324|101337653|FG003|STARTED|Main Study||327||
48410510|NCT00233324|101337650|FG000|COMPLETED|Main Study||250||
48410511|NCT00233324|101337651|FG001|COMPLETED|Main Study||275||
48330006|NCT01375764|101135877|FG004|NOT COMPLETED|Overall Study||1||
48330007|NCT02474329|101135878|FG000|STARTED|Overall Study||304||
48330008|NCT02474329|101135878|FG000|COMPLETED|Overall Study||291||
48330009|NCT02474329|101135878|FG000|NOT COMPLETED|Overall Study||13||
48330010|NCT01698528|101135879|FG000|STARTED|Overall Study||20||
48330011|NCT01698528|101135880|FG001|STARTED|Overall Study||20||
48330012|NCT01698528|101135879|FG000|COMPLETED|Overall Study||19||
48330013|NCT01698528|101135880|FG001|COMPLETED|Overall Study||16||
48330014|NCT01698528|101135879|FG000|NOT COMPLETED|Overall Study||1||
48330015|NCT01698528|101135880|FG001|NOT COMPLETED|Overall Study||4||
48330016|NCT03790683|101135881|FG000|STARTED|Overall Study||14||
48330017|NCT03790683|101135882|FG001|STARTED|Overall Study||14||
48330018|NCT03790683|101135881|FG000|COMPLETED|Overall Study||14||
48330019|NCT03790683|101135882|FG001|COMPLETED|Overall Study||14||
48330020|NCT03790683|101135881|FG000|NOT COMPLETED|Overall Study||0||
48330021|NCT03790683|101135882|FG001|NOT COMPLETED|Overall Study||0||
48330022|NCT03011333|101135883|FG000|STARTED|Overall Study||12||
48330023|NCT03011333|101135884|FG001|STARTED|Overall Study||27||
48330024|NCT03011333|101135885|FG002|STARTED|Overall Study||25||
48330025|NCT03011333|101135886|FG003|STARTED|Overall Study||47||
48330026|NCT03011333|101135887|FG004|STARTED|Overall Study||50||
48330027|NCT03011333|101135888|FG005|STARTED|Overall Study||41||
48330028|NCT03011333|101135889|FG006|STARTED|Overall Study||41||
48330029|NCT03011333|101135883|FG000|COMPLETED|Overall Study||12||
48330030|NCT03011333|101135884|FG001|COMPLETED|Overall Study||26||
48330031|NCT03011333|101135885|FG002|COMPLETED|Overall Study||25||
48330032|NCT03011333|101135886|FG003|COMPLETED|Overall Study||46||
48330033|NCT03011333|101135887|FG004|COMPLETED|Overall Study||46||
48330034|NCT03011333|101135888|FG005|COMPLETED|Overall Study||37||
48330035|NCT03011333|101135889|FG006|COMPLETED|Overall Study||36||
48330036|NCT03011333|101135883|FG000|NOT COMPLETED|Overall Study||0||
48330037|NCT03011333|101135884|FG001|NOT COMPLETED|Overall Study||1||
48330038|NCT03011333|101135885|FG002|NOT COMPLETED|Overall Study||0||
48330039|NCT03011333|101135886|FG003|NOT COMPLETED|Overall Study||1||
48330040|NCT03011333|101135887|FG004|NOT COMPLETED|Overall Study||4||
48330041|NCT03011333|101135888|FG005|NOT COMPLETED|Overall Study||4||
48330042|NCT03011333|101135889|FG006|NOT COMPLETED|Overall Study||5||
48330043|NCT00725075|101135890|FG000|STARTED|Overall Study||72||
48330044|NCT00725075|101135891|FG001|STARTED|Overall Study||73||
48330045|NCT00725075|101135892|FG002|STARTED|Overall Study||70||
48330046|NCT00725075|101135890|FG000|Treated|Overall Study||71||
48330047|NCT00725075|101135891|FG001|Treated|Overall Study||73||
48330048|NCT00725075|101135892|FG002|Treated|Overall Study||70||
48330049|NCT00725075|101135890|FG000|COMPLETED|Overall Study||61||
48330050|NCT00725075|101135891|FG001|COMPLETED|Overall Study||65||
48330051|NCT00725075|101135892|FG002|COMPLETED|Overall Study||61||
48330052|NCT00725075|101135890|FG000|NOT COMPLETED|Overall Study||11||
48330053|NCT00725075|101135891|FG001|NOT COMPLETED|Overall Study||8||
48330054|NCT00725075|101135892|FG002|NOT COMPLETED|Overall Study||9||
48330055|NCT03115151|101135893|FG000|STARTED|Overall Study||23||
48330056|NCT03115151|101135894|FG001|STARTED|Overall Study||23||
48330057|NCT03115151|101135893|FG000|COMPLETED|Overall Study||17||
48330058|NCT03115151|101135894|FG001|COMPLETED|Overall Study||18||
48330059|NCT03115151|101135893|FG000|NOT COMPLETED|Overall Study||6||
48330060|NCT03115151|101135894|FG001|NOT COMPLETED|Overall Study||5||
48330061|NCT01903837|101135895|FG000|STARTED|Part A||75||
48330062|NCT01903837|101135896|FG001|STARTED|Part A||80||
48330063|NCT01903837|101135897|FG002|STARTED|Part A||86||
48330064|NCT01903837|101135898|FG003|STARTED|Part A||68||
48330065|NCT01903837|101135895|FG000|COMPLETED|Part A||56||
48330066|NCT01903837|101135896|FG001|COMPLETED|Part A||52||
48330067|NCT01903837|101135897|FG002|COMPLETED|Part A||58||
48330068|NCT01903837|101135898|FG003|COMPLETED|Part A||55||
48330069|NCT01903837|101135895|FG000|NOT COMPLETED|Part A||19||
48330070|NCT01903837|101135896|FG001|NOT COMPLETED|Part A||28||
48330071|NCT01903837|101135897|FG002|NOT COMPLETED|Part A||28||
48330072|NCT01903837|101135898|FG003|NOT COMPLETED|Part A||13||
48330073|NCT01903837|101135895|FG000|STARTED|Part B||54|The number of subjects starting the period is not consistent with the number completing the preceding period. It is expected the number of subjects starting the subsequent period will be the same as the number completing the preceding period. This is because 3 subjects discontinued the study after completing Part A, and did not participate in Part B.|
48330074|NCT01903837|101135896|FG001|STARTED|Part B||52|The number of subjects starting the period is not consistent with the number completing the preceding period. It is expected the number of subjects starting the subsequent period will be the same as the number completing the preceding period. This is because 3 subjects discontinued the study after completing Part A, and did not participate in Part B.|
48330075|NCT01903837|101135897|FG002|STARTED|Part B||57|The number of subjects starting the period is not consistent with the number completing the preceding period. It is expected the number of subjects starting the subsequent period will be the same as the number completing the preceding period. This is because 3 subjects discontinued the study after completing Part A, and did not participate in Part B.|
48330076|NCT01903837|101135898|FG003|STARTED|Part B||55|The number of subjects starting the period is not consistent with the number completing the preceding period. It is expected the number of subjects starting the subsequent period will be the same as the number completing the preceding period. This is because 3 subjects discontinued the study after completing Part A, and did not participate in Part B.|
48330077|NCT01903837|101135895|FG000|COMPLETED|Part B||45||
48330078|NCT01903837|101135896|FG001|COMPLETED|Part B||46||
48330079|NCT01903837|101135897|FG002|COMPLETED|Part B||52||
48747086|NCT02673918|102166006|FG000|COMPLETED|Overall Study||29||
48747087|NCT02673918|102166007|FG001|COMPLETED|Overall Study||20||
48747088|NCT02673918|102166006|FG000|NOT COMPLETED|Overall Study||6||
48747089|NCT02673918|102166007|FG001|NOT COMPLETED|Overall Study||4||
48747090|NCT02726620|102166008|FG000|STARTED|Historic Cohort - Three Years||17463||
48330080|NCT01903837|101135898|FG003|COMPLETED|Part B||44||
48330081|NCT01903837|101135895|FG000|NOT COMPLETED|Part B||9||
48330082|NCT01903837|101135896|FG001|NOT COMPLETED|Part B||6||
48330083|NCT01903837|101135897|FG002|NOT COMPLETED|Part B||5||
48330084|NCT01903837|101135898|FG003|NOT COMPLETED|Part B||11||
48747091|NCT02726620|102166009|FG001|STARTED|Historic Cohort - Three Years||0||
48747092|NCT02726620|102166008|FG000|MAP < 65 mmHg: Primary Analysis|Historic Cohort - Three Years||15624|Per study protocol only patients with any MAP \< 65 mmHg will be included in the primary analysis.|
48747093|NCT02726620|102166009|FG001|MAP < 65 mmHg: Primary Analysis|Historic Cohort - Three Years||0|Per study protocol only patients with any MAP \< 65 mmHg will be included in the primary analysis.|
48330085|NCT03891901|101135899|FG000|STARTED|Overall Study||16||
48330086|NCT03891901|101135900|FG001|STARTED|Overall Study||6||
48330087|NCT03891901|101135901|FG002|STARTED|Overall Study||0||
48330088|NCT03891901|101135902|FG003|STARTED|Overall Study||0||
48330089|NCT03891901|101135903|FG004|STARTED|Overall Study||0||
48330090|NCT03891901|101135904|FG005|STARTED|Overall Study||0||
48330091|NCT03891901|101135905|FG006|STARTED|Overall Study||2||
48330092|NCT03891901|101135906|FG007|STARTED|Overall Study||0||
48330093|NCT03891901|101135907|FG008|STARTED|Overall Study||0||
48330094|NCT03891901|101135899|FG000|Began Imatinib Plus Rifabutin and Isoniazid Portion of the Intervention (if Applicable)|Overall Study||14||
48330095|NCT03891901|101135900|FG001|Began Imatinib Plus Rifabutin and Isoniazid Portion of the Intervention (if Applicable)|Overall Study||3||
48330096|NCT03891901|101135901|FG002|Began Imatinib Plus Rifabutin and Isoniazid Portion of the Intervention (if Applicable)|Overall Study||0||
48330097|NCT03891901|101135902|FG003|Began Imatinib Plus Rifabutin and Isoniazid Portion of the Intervention (if Applicable)|Overall Study||0||
48330098|NCT03891901|101135903|FG004|Began Imatinib Plus Rifabutin and Isoniazid Portion of the Intervention (if Applicable)|Overall Study||0||
48330099|NCT03891901|101135904|FG005|Began Imatinib Plus Rifabutin and Isoniazid Portion of the Intervention (if Applicable)|Overall Study||0||
48747094|NCT02726620|102166008|FG000|COMPLETED|Historic Cohort - Three Years||17463||
48747095|NCT02726620|102166009|FG001|COMPLETED|Historic Cohort - Three Years||0||
48330100|NCT03891901|101135905|FG006|Began Imatinib Plus Rifabutin and Isoniazid Portion of the Intervention (if Applicable)|Overall Study||0||
48330101|NCT03891901|101135906|FG007|Began Imatinib Plus Rifabutin and Isoniazid Portion of the Intervention (if Applicable)|Overall Study||0||
48330102|NCT03891901|101135907|FG008|Began Imatinib Plus Rifabutin and Isoniazid Portion of the Intervention (if Applicable)|Overall Study||0||
48330103|NCT03891901|101135899|FG000|COMPLETED|Overall Study||12||
48330104|NCT03891901|101135900|FG001|COMPLETED|Overall Study||2||
48330105|NCT03891901|101135901|FG002|COMPLETED|Overall Study||0||
48330106|NCT03891901|101135902|FG003|COMPLETED|Overall Study||0||
48330107|NCT03891901|101135903|FG004|COMPLETED|Overall Study||0||
48330108|NCT03891901|101135904|FG005|COMPLETED|Overall Study||0||
48330109|NCT03891901|101135905|FG006|COMPLETED|Overall Study||2||
48330110|NCT03891901|101135906|FG007|COMPLETED|Overall Study||0||
48330111|NCT03891901|101135907|FG008|COMPLETED|Overall Study||0||
48330112|NCT03891901|101135899|FG000|NOT COMPLETED|Overall Study||4||
48330113|NCT03891901|101135900|FG001|NOT COMPLETED|Overall Study||4||
48330114|NCT03891901|101135901|FG002|NOT COMPLETED|Overall Study||0||
48330115|NCT03891901|101135902|FG003|NOT COMPLETED|Overall Study||0||
48330116|NCT03891901|101135903|FG004|NOT COMPLETED|Overall Study||0||
48330117|NCT03891901|101135904|FG005|NOT COMPLETED|Overall Study||0||
48330118|NCT03891901|101135905|FG006|NOT COMPLETED|Overall Study||0||
48330119|NCT03891901|101135906|FG007|NOT COMPLETED|Overall Study||0||
48330120|NCT03891901|101135907|FG008|NOT COMPLETED|Overall Study||0||
48330121|NCT00695565|101135908|FG000|STARTED|Overall Study||90||
48330122|NCT00695565|101135909|FG001|STARTED|Overall Study||90||
48330123|NCT00695565|101135908|FG000|COMPLETED|Overall Study||77||
48330124|NCT00695565|101135909|FG001|COMPLETED|Overall Study||81||
48330125|NCT00695565|101135908|FG000|NOT COMPLETED|Overall Study||13||
48330126|NCT00695565|101135909|FG001|NOT COMPLETED|Overall Study||9||
48330127|NCT01678144|101135910|FG000|STARTED|Stage 1: MAR Classic||7||7
48330128|NCT01678144|101135910|FG000|COMPLETED|Stage 1: MAR Classic||6||6
48747096|NCT02726620|102166008|FG000|NOT COMPLETED|Historic Cohort - Three Years||0||
48747097|NCT02726620|102166009|FG001|NOT COMPLETED|Historic Cohort - Three Years||0||
48747098|NCT02726620|102166008|FG000|STARTED|Month 1: Attending Randomization||0||
48747099|NCT02726620|102166009|FG001|STARTED|Month 1: Attending Randomization||485||
48747100|NCT02726620|102166008|FG000|MAP < 65 mmHg: Primary Analysis|Month 1: Attending Randomization||0|Per study protocol only patients with any MAP \< 65 mmHg will be included in the primary analysis.|
48330129|NCT01678144|101135910|FG000|NOT COMPLETED|Stage 1: MAR Classic||1||1
48330130|NCT01678144|101135910|FG000|STARTED|Stage 2: MAR Regular and MAR Expanded||5||5
48330131|NCT01678144|101135910|FG000|COMPLETED|Stage 2: MAR Regular and MAR Expanded||5||5
48747101|NCT02726620|102166009|FG001|MAP < 65 mmHg: Primary Analysis|Month 1: Attending Randomization||432|Per study protocol only patients with any MAP \< 65 mmHg will be included in the primary analysis.|
48767670|NCT01656408|102222799|FG005|STARTED|Overall Study||9||
48747102|NCT02726620|102166008|FG000|Correct IOH Notifications|Month 1: Attending Randomization||0|The decision support notifications log matches the actual occurrens of intraoperative hypotension.|
48747103|NCT02726620|102166009|FG001|Correct IOH Notifications|Month 1: Attending Randomization||313|The decision support notifications log matches the actual occurrens of intraoperative hypotension.|
48747104|NCT02726620|102166008|FG000|COMPLETED|Month 1: Attending Randomization||0||
48747105|NCT02726620|102166009|FG001|COMPLETED|Month 1: Attending Randomization||485||
48747106|NCT02726620|102166008|FG000|NOT COMPLETED|Month 1: Attending Randomization||0||
48747107|NCT02726620|102166009|FG001|NOT COMPLETED|Month 1: Attending Randomization||0||
48330132|NCT01678144|101135910|FG000|NOT COMPLETED|Stage 2: MAR Regular and MAR Expanded||0||0
48330133|NCT03984305|101135911|FG000|STARTED|Overall Study||23||
48330134|NCT03984305|101135912|FG001|STARTED|Overall Study||18||
48330135|NCT03984305|101135911|FG000|COMPLETED|Overall Study||0||
48330136|NCT03984305|101135912|FG001|COMPLETED|Overall Study||0||
48330137|NCT03984305|101135911|FG000|NOT COMPLETED|Overall Study||23||
48747108|NCT02726620|102166008|FG000|STARTED|Months 2-3: In-room Providers Randomized||0||
48747109|NCT02726620|102166009|FG001|STARTED|Months 2-3: In-room Providers Randomized||1253||
48747110|NCT02726620|102166008|FG000|MAP < 65 mmHg: Primary Analysis|Months 2-3: In-room Providers Randomized||0|Per study protocol only patients with any MAP \< 65 mmHg will be included in the primary analysis.|
48747111|NCT02726620|102166009|FG001|MAP < 65 mmHg: Primary Analysis|Months 2-3: In-room Providers Randomized||1103|Per study protocol only patients with any MAP \< 65 mmHg will be included in the primary analysis.|
48747112|NCT02726620|102166008|FG000|Correct IOH Notifications|Months 2-3: In-room Providers Randomized||0|The decision support notifications log matches the actual occurrens of intraoperative hypotension.|
48747113|NCT02726620|102166009|FG001|Correct IOH Notifications|Months 2-3: In-room Providers Randomized||825|The decision support notifications log matches the actual occurrens of intraoperative hypotension.|
48747114|NCT02726620|102166008|FG000|COMPLETED|Months 2-3: In-room Providers Randomized||0||
48747115|NCT02726620|102166009|FG001|COMPLETED|Months 2-3: In-room Providers Randomized||1253||
48747116|NCT02726620|102166008|FG000|NOT COMPLETED|Months 2-3: In-room Providers Randomized||0||
48747117|NCT02726620|102166009|FG001|NOT COMPLETED|Months 2-3: In-room Providers Randomized||0||
48747118|NCT02726620|102166008|FG000|STARTED|Through End of Study: All Interventions||0||
48747119|NCT02726620|102166009|FG001|STARTED|Through End of Study: All Interventions||3234||
48747120|NCT02726620|102166008|FG000|MAP < 65 mmHg: Primary Analysis|Through End of Study: All Interventions||0|Per study protocol only patients with any MAP \< 65 mmHg will be included in the primary analysis.|
48330138|NCT03984305|101135912|FG001|NOT COMPLETED|Overall Study||18||
48330139|NCT01166230|101135913|FG000|STARTED|Overall Study||280||
48330140|NCT01166230|101135914|FG001|STARTED|Overall Study||271||
48330141|NCT01166230|101135913|FG000|COMPLETED|Overall Study||261||
48330142|NCT01166230|101135914|FG001|COMPLETED|Overall Study||255||
48330143|NCT01166230|101135913|FG000|NOT COMPLETED|Overall Study||19||
48330144|NCT01166230|101135914|FG001|NOT COMPLETED|Overall Study||16||
48330145|NCT01496885|101135915|FG000|STARTED|Overall Study||120||
48330146|NCT01496885|101135915|FG000|COMPLETED|Overall Study||97||
48330147|NCT01496885|101135915|FG000|NOT COMPLETED|Overall Study||23||
48330148|NCT03434977|101135916|FG000|STARTED|Intervention Period 1 (6 Days)||6||
48330149|NCT03434977|101135917|FG001|STARTED|Intervention Period 1 (6 Days)||6||
48330150|NCT03434977|101135916|FG000|COMPLETED|Intervention Period 1 (6 Days)||6||
48330151|NCT03434977|101135917|FG001|COMPLETED|Intervention Period 1 (6 Days)||6||
48330152|NCT03434977|101135916|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0||
48330153|NCT03434977|101135917|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0||
48330154|NCT03434977|101135916|FG000|STARTED|Washout Period (at Least 6 Days)||6||
48410512|NCT00233324|101337652|FG002|COMPLETED|Main Study||274||
48410513|NCT00233324|101337653|FG003|COMPLETED|Main Study||280||
48410514|NCT00233324|101337650|FG000|NOT COMPLETED|Main Study||68||
48747121|NCT02726620|102166009|FG001|MAP < 65 mmHg: Primary Analysis|Through End of Study: All Interventions||2793|Per study protocol only patients with any MAP \< 65 mmHg will be included in the primary analysis.|
48747122|NCT02726620|102166008|FG000|Correct IOH Notifications|Through End of Study: All Interventions||0|The decision support notifications log matches the actual occurrens of intraoperative hypotension.|
48747123|NCT02726620|102166009|FG001|Correct IOH Notifications|Through End of Study: All Interventions||2072|The decision support notifications log matches the actual occurrens of intraoperative hypotension.|
48747124|NCT02726620|102166008|FG000|COMPLETED|Through End of Study: All Interventions||0||
48747125|NCT02726620|102166009|FG001|COMPLETED|Through End of Study: All Interventions||3234||
48747126|NCT02726620|102166008|FG000|NOT COMPLETED|Through End of Study: All Interventions||0||
48330155|NCT03434977|101135917|FG001|STARTED|Washout Period (at Least 6 Days)||6||
48330156|NCT03434977|101135916|FG000|COMPLETED|Washout Period (at Least 6 Days)||6||
48330157|NCT03434977|101135917|FG001|COMPLETED|Washout Period (at Least 6 Days)||5||
48330158|NCT03434977|101135916|FG000|NOT COMPLETED|Washout Period (at Least 6 Days)||0||
48330159|NCT03434977|101135917|FG001|NOT COMPLETED|Washout Period (at Least 6 Days)||1||
48330160|NCT03434977|101135916|FG000|STARTED|Intervention Period 2 (6 Days)||6||
48330161|NCT03434977|101135917|FG001|STARTED|Intervention Period 2 (6 Days)||5||
48330162|NCT03434977|101135916|FG000|COMPLETED|Intervention Period 2 (6 Days)||6||
48330163|NCT03434977|101135917|FG001|COMPLETED|Intervention Period 2 (6 Days)||5||
48330164|NCT03434977|101135916|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0||
48330165|NCT03434977|101135917|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0||
48330166|NCT05594173|101135918|FG000|STARTED|Overall Study||20||
48330167|NCT05594173|101135918|FG000|COMPLETED|Overall Study||17||
48330168|NCT05594173|101135918|FG000|NOT COMPLETED|Overall Study||3||
48330169|NCT00874120|101135919|FG000|STARTED|First Intervention||58||
48330170|NCT00874120|101135920|FG001|STARTED|First Intervention||58||
48330171|NCT00874120|101135919|FG000|COMPLETED|First Intervention||52||
48330172|NCT00874120|101135920|FG001|COMPLETED|First Intervention||56||
48330173|NCT00874120|101135919|FG000|NOT COMPLETED|First Intervention||6||
48330174|NCT00874120|101135920|FG001|NOT COMPLETED|First Intervention||2||
48330175|NCT00874120|101135919|FG000|STARTED|Wash-out Period||52||
48747127|NCT02726620|102166009|FG001|NOT COMPLETED|Through End of Study: All Interventions||0||
48747128|NCT01116401|102166010|FG000|STARTED|Overall Study||29||
48747129|NCT01116401|102166010|FG000|COMPLETED|Overall Study||29||
48747130|NCT01116401|102166010|FG000|NOT COMPLETED|Overall Study||0||
48747131|NCT04936061|102166011|FG000|STARTED|Overall Study||6||
48747132|NCT04936061|102166012|FG001|STARTED|Overall Study||9||
48330176|NCT00874120|101135920|FG001|STARTED|Wash-out Period||56||
48330177|NCT00874120|101135919|FG000|COMPLETED|Wash-out Period||52||
48330178|NCT00874120|101135920|FG001|COMPLETED|Wash-out Period||56||
48330179|NCT00874120|101135919|FG000|NOT COMPLETED|Wash-out Period||0||
48330180|NCT00874120|101135920|FG001|NOT COMPLETED|Wash-out Period||0||
48330181|NCT00874120|101135919|FG000|STARTED|Second Intervention||52||
48330182|NCT00874120|101135920|FG001|STARTED|Second Intervention||56||
48330183|NCT00874120|101135919|FG000|COMPLETED|Second Intervention||50||
48747133|NCT04936061|102166013|FG002|STARTED|Overall Study||9||
48747134|NCT04936061|102166011|FG000|COMPLETED|Overall Study||6||
48747135|NCT04936061|102166012|FG001|COMPLETED|Overall Study||9||
48747136|NCT04936061|102166013|FG002|COMPLETED|Overall Study||9||
48747137|NCT04936061|102166011|FG000|NOT COMPLETED|Overall Study||0||
48747138|NCT04936061|102166012|FG001|NOT COMPLETED|Overall Study||0||
48747139|NCT04936061|102166013|FG002|NOT COMPLETED|Overall Study||0||
48747140|NCT01290614|102166014|FG000|STARTED|Overall Study||1070||
48747141|NCT01290614|102166015|FG001|STARTED|Overall Study||1129||
48330184|NCT00874120|101135920|FG001|COMPLETED|Second Intervention||56||
48330185|NCT00874120|101135919|FG000|NOT COMPLETED|Second Intervention||2||
48330186|NCT00874120|101135920|FG001|NOT COMPLETED|Second Intervention||0||
48330187|NCT01972074|101135921|FG000|STARTED|Overall Study||22||
48330188|NCT01972074|101135922|FG001|STARTED|Overall Study||21||
48330189|NCT01972074|101135923|FG002|STARTED|Overall Study||18||
48410515|NCT00233324|101337651|FG001|NOT COMPLETED|Main Study||60||
48747142|NCT01290614|102166014|FG000|COMPLETED|Overall Study||518||
48747143|NCT01290614|102166015|FG001|COMPLETED|Overall Study||1129||
48747144|NCT01290614|102166014|FG000|NOT COMPLETED|Overall Study||552||
48747145|NCT01290614|102166015|FG001|NOT COMPLETED|Overall Study||0||
48747146|NCT01168349|102166016|FG000|STARTED|Overall Study||1055||
48747147|NCT01168349|102166016|FG000|COMPLETED|Overall Study||754||
48747148|NCT01168349|102166016|FG000|NOT COMPLETED|Overall Study||301||
48747149|NCT02403999|102166017|FG000|STARTED|Overall Study||10||
48747150|NCT02403999|102166018|FG001|STARTED|Overall Study||10||
48747151|NCT02403999|102166019|FG002|STARTED|Overall Study||11||
48747152|NCT02403999|102166017|FG000|COMPLETED|Overall Study||10||
48747153|NCT02403999|102166018|FG001|COMPLETED|Overall Study||10||
48747154|NCT02403999|102166019|FG002|COMPLETED|Overall Study||11||
48747155|NCT02403999|102166017|FG000|NOT COMPLETED|Overall Study||0||
48747156|NCT02403999|102166018|FG001|NOT COMPLETED|Overall Study||0||
48747157|NCT02403999|102166019|FG002|NOT COMPLETED|Overall Study||0||
48747158|NCT03579940|102166020|FG000|STARTED|Period 1||3||
48747159|NCT03579940|102166021|FG001|STARTED|Period 1||2||
48747160|NCT03579940|102166022|FG002|STARTED|Period 1||2||
48747161|NCT03579940|102166023|FG003|STARTED|Period 1||2||
48747162|NCT03579940|102166024|FG004|STARTED|Period 1||2||
48747163|NCT03579940|102166025|FG005|STARTED|Period 1||2||
48747164|NCT03579940|102166026|FG006|STARTED|Period 1||3||
48747165|NCT03579940|102166027|FG007|STARTED|Period 1||3||
48747166|NCT03579940|102166028|FG008|STARTED|Period 1||3||
48747167|NCT03579940|102166029|FG009|STARTED|Period 1||2||
48747168|NCT03579940|102166030|FG010|STARTED|Period 1||3||
48747169|NCT03579940|102166020|FG000|Received at Least 1 Dose of Study Drug|Period 1||3||
48747170|NCT03579940|102166021|FG001|Received at Least 1 Dose of Study Drug|Period 1||2||
48747171|NCT03579940|102166022|FG002|Received at Least 1 Dose of Study Drug|Period 1||2||
48747172|NCT03579940|102166023|FG003|Received at Least 1 Dose of Study Drug|Period 1||2||
48747173|NCT03579940|102166024|FG004|Received at Least 1 Dose of Study Drug|Period 1||2||
48747174|NCT03579940|102166025|FG005|Received at Least 1 Dose of Study Drug|Period 1||2||
48330190|NCT01972074|101135921|FG000|COMPLETED|Overall Study||16||
48330191|NCT01972074|101135922|FG001|COMPLETED|Overall Study||17||
48330192|NCT01972074|101135923|FG002|COMPLETED|Overall Study||15||
48747175|NCT03579940|102166026|FG006|Received at Least 1 Dose of Study Drug|Period 1||3||
48747176|NCT03579940|102166027|FG007|Received at Least 1 Dose of Study Drug|Period 1||3||
48747177|NCT03579940|102166028|FG008|Received at Least 1 Dose of Study Drug|Period 1||3||
48747178|NCT03579940|102166029|FG009|Received at Least 1 Dose of Study Drug|Period 1||2||
48747179|NCT03579940|102166030|FG010|Received at Least 1 Dose of Study Drug|Period 1||3||
48410516|NCT00233324|101337652|FG002|NOT COMPLETED|Main Study||62||
48747180|NCT03579940|102166020|FG000|COMPLETED|Period 1||3||
48747181|NCT03579940|102166021|FG001|COMPLETED|Period 1||2||
48747182|NCT03579940|102166022|FG002|COMPLETED|Period 1||2||
48747183|NCT03579940|102166023|FG003|COMPLETED|Period 1||2||
48747184|NCT03579940|102166024|FG004|COMPLETED|Period 1||2||
48747185|NCT03579940|102166025|FG005|COMPLETED|Period 1||2||
48747186|NCT03579940|102166026|FG006|COMPLETED|Period 1||3||
48747187|NCT03579940|102166027|FG007|COMPLETED|Period 1||3||
48747188|NCT03579940|102166028|FG008|COMPLETED|Period 1||3||
48747189|NCT03579940|102166029|FG009|COMPLETED|Period 1||2||
48747190|NCT03579940|102166030|FG010|COMPLETED|Period 1||3||
48747191|NCT03579940|102166020|FG000|NOT COMPLETED|Period 1||0||
48747192|NCT03579940|102166021|FG001|NOT COMPLETED|Period 1||0||
48747193|NCT03579940|102166022|FG002|NOT COMPLETED|Period 1||0||
48747194|NCT03579940|102166023|FG003|NOT COMPLETED|Period 1||0||
48747195|NCT03579940|102166024|FG004|NOT COMPLETED|Period 1||0||
48747196|NCT03579940|102166025|FG005|NOT COMPLETED|Period 1||0||
48747197|NCT03579940|102166026|FG006|NOT COMPLETED|Period 1||0||
48747198|NCT03579940|102166027|FG007|NOT COMPLETED|Period 1||0||
48747199|NCT03579940|102166028|FG008|NOT COMPLETED|Period 1||0||
48747200|NCT03579940|102166029|FG009|NOT COMPLETED|Period 1||0||
48747201|NCT03579940|102166030|FG010|NOT COMPLETED|Period 1||0||
48330193|NCT01972074|101135921|FG000|NOT COMPLETED|Overall Study||6||
48330194|NCT01972074|101135922|FG001|NOT COMPLETED|Overall Study||4||
48330195|NCT01972074|101135923|FG002|NOT COMPLETED|Overall Study||3||
48330196|NCT03379662|101135924|FG000|STARTED|Overall Study||21||
48330197|NCT03379662|101135925|FG001|STARTED|Overall Study||19||
48330198|NCT03379662|101135924|FG000|COMPLETED|Overall Study||21||
48330199|NCT03379662|101135925|FG001|COMPLETED|Overall Study||19||
48330200|NCT03379662|101135924|FG000|NOT COMPLETED|Overall Study||0||
48330201|NCT03379662|101135925|FG001|NOT COMPLETED|Overall Study||0||
48747202|NCT03579940|102166020|FG000|STARTED|Period 2||3||
48747203|NCT03579940|102166021|FG001|STARTED|Period 2||2||
48747204|NCT03579940|102166022|FG002|STARTED|Period 2||2||
48747205|NCT03579940|102166023|FG003|STARTED|Period 2||2||
48747206|NCT03579940|102166024|FG004|STARTED|Period 2||2||
48747207|NCT03579940|102166025|FG005|STARTED|Period 2||2||
48747208|NCT03579940|102166026|FG006|STARTED|Period 2||3||
48747209|NCT03579940|102166027|FG007|STARTED|Period 2||3||
48747210|NCT03579940|102166028|FG008|STARTED|Period 2||3||
48747211|NCT03579940|102166029|FG009|STARTED|Period 2||2||
48747212|NCT03579940|102166030|FG010|STARTED|Period 2||3||
48747213|NCT03579940|102166020|FG000|COMPLETED|Period 2||3||
48747214|NCT03579940|102166021|FG001|COMPLETED|Period 2||2||
48747215|NCT03579940|102166022|FG002|COMPLETED|Period 2||1||
48747216|NCT03579940|102166023|FG003|COMPLETED|Period 2||2||
48747217|NCT03579940|102166024|FG004|COMPLETED|Period 2||2||
48747218|NCT03579940|102166025|FG005|COMPLETED|Period 2||2||
48747219|NCT03579940|102166026|FG006|COMPLETED|Period 2||3||
48747220|NCT03579940|102166027|FG007|COMPLETED|Period 2||3||
48747221|NCT03579940|102166028|FG008|COMPLETED|Period 2||3||
48747222|NCT03579940|102166029|FG009|COMPLETED|Period 2||2||
48747223|NCT03579940|102166030|FG010|COMPLETED|Period 2||3||
48747224|NCT03579940|102166020|FG000|NOT COMPLETED|Period 2||0||
48747225|NCT03579940|102166021|FG001|NOT COMPLETED|Period 2||0||
48747226|NCT03579940|102166022|FG002|NOT COMPLETED|Period 2||1||
48747227|NCT03579940|102166023|FG003|NOT COMPLETED|Period 2||0||
48747228|NCT03579940|102166024|FG004|NOT COMPLETED|Period 2||0||
48747229|NCT03579940|102166025|FG005|NOT COMPLETED|Period 2||0||
48747230|NCT03579940|102166026|FG006|NOT COMPLETED|Period 2||0||
48747231|NCT03579940|102166027|FG007|NOT COMPLETED|Period 2||0||
48747232|NCT03579940|102166028|FG008|NOT COMPLETED|Period 2||0||
48747233|NCT03579940|102166029|FG009|NOT COMPLETED|Period 2||0||
48747234|NCT03579940|102166030|FG010|NOT COMPLETED|Period 2||0||
48747235|NCT03579940|102166020|FG000|STARTED|Period 3||3||
48747236|NCT03579940|102166021|FG001|STARTED|Period 3||2||
48747237|NCT03579940|102166022|FG002|STARTED|Period 3||1||
48747238|NCT03579940|102166023|FG003|STARTED|Period 3||2||
48747239|NCT03579940|102166024|FG004|STARTED|Period 3||2||
48330202|NCT01294800|101135926|FG000|STARTED|Overall Study||111||
48330203|NCT01294800|101135927|FG001|STARTED|Overall Study||113||
48330204|NCT01294800|101135928|FG002|STARTED|Overall Study||113||
48747240|NCT03579940|102166025|FG005|STARTED|Period 3||2||
48330205|NCT01294800|101135929|FG003|STARTED|Overall Study||113||
48330206|NCT01294800|101135926|FG000|COMPLETED|Overall Study||100||
48330207|NCT01294800|101135927|FG001|COMPLETED|Overall Study||103||
48330208|NCT01294800|101135928|FG002|COMPLETED|Overall Study||96||
48747241|NCT03579940|102166026|FG006|STARTED|Period 3||3||
48747242|NCT03579940|102166027|FG007|STARTED|Period 3||3||
48747243|NCT03579940|102166028|FG008|STARTED|Period 3||3||
48747244|NCT03579940|102166029|FG009|STARTED|Period 3||2||
48747245|NCT03579940|102166030|FG010|STARTED|Period 3||3||
48747246|NCT03579940|102166020|FG000|COMPLETED|Period 3||3||
48747247|NCT03579940|102166021|FG001|COMPLETED|Period 3||2||
48747248|NCT03579940|102166022|FG002|COMPLETED|Period 3||1||
48747249|NCT03579940|102166023|FG003|COMPLETED|Period 3||2||
48747250|NCT03579940|102166024|FG004|COMPLETED|Period 3||2||
48330209|NCT01294800|101135929|FG003|COMPLETED|Overall Study||97||
48747251|NCT03579940|102166025|FG005|COMPLETED|Period 3||2||
48747252|NCT03579940|102166026|FG006|COMPLETED|Period 3||3||
48747253|NCT03579940|102166027|FG007|COMPLETED|Period 3||3||
48747254|NCT03579940|102166028|FG008|COMPLETED|Period 3||3||
48747255|NCT03579940|102166029|FG009|COMPLETED|Period 3||2||
48330210|NCT01294800|101135926|FG000|NOT COMPLETED|Overall Study||11||
48330211|NCT01294800|101135927|FG001|NOT COMPLETED|Overall Study||10||
48330212|NCT01294800|101135928|FG002|NOT COMPLETED|Overall Study||17||
48330213|NCT01294800|101135929|FG003|NOT COMPLETED|Overall Study||16||
48330214|NCT02432235|101135930|FG000|STARTED|Overall Study||2||
48330215|NCT02432235|101135931|FG001|STARTED|Overall Study||2||
48330216|NCT02432235|101135932|FG002|STARTED|Overall Study||2||
48330217|NCT02432235|101135933|FG003|STARTED|Overall Study||3||
48330218|NCT02432235|101135934|FG004|STARTED|Overall Study||2||
48330219|NCT02432235|101135935|FG005|STARTED|Overall Study||20||
48410517|NCT00233324|101337653|FG003|NOT COMPLETED|Main Study||47||
48410518|NCT00233324|101337650|FG000|STARTED|Follow up at 18-22 Months Corrected Age||250||
48410519|NCT00233324|101337651|FG001|STARTED|Follow up at 18-22 Months Corrected Age||275||
48410520|NCT00233324|101337652|FG002|STARTED|Follow up at 18-22 Months Corrected Age||274||
48410521|NCT00233324|101337653|FG003|STARTED|Follow up at 18-22 Months Corrected Age||280||
48410522|NCT00233324|101337650|FG000|COMPLETED|Follow up at 18-22 Months Corrected Age||237||
48410523|NCT00233324|101337651|FG001|COMPLETED|Follow up at 18-22 Months Corrected Age||261||
48410524|NCT00233324|101337652|FG002|COMPLETED|Follow up at 18-22 Months Corrected Age||256||
48410525|NCT00233324|101337653|FG003|COMPLETED|Follow up at 18-22 Months Corrected Age||269||
48410526|NCT00233324|101337650|FG000|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||13||
48410527|NCT00233324|101337651|FG001|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||14||
48410528|NCT00233324|101337652|FG002|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||18||
48410529|NCT00233324|101337653|FG003|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||11||
48410530|NCT02272244|101337654|FG000|STARTED|Overall Study||203||
48410531|NCT02272244|101337655|FG001|STARTED|Overall Study||197||
48410532|NCT02272244|101337654|FG000|COMPLETED|Overall Study||203||
48410533|NCT02272244|101337655|FG001|COMPLETED|Overall Study||197||
48410534|NCT02272244|101337654|FG000|NOT COMPLETED|Overall Study||0||
48410535|NCT02272244|101337655|FG001|NOT COMPLETED|Overall Study||0||
48410536|NCT00068822|101337656|FG000|STARTED|First Randomized Intervention||68||
48410537|NCT00068822|101337657|FG001|STARTED|First Randomized Intervention||63||
48410538|NCT00068822|101337656|FG000|COMPLETED|First Randomized Intervention||67||
48410539|NCT00068822|101337657|FG001|COMPLETED|First Randomized Intervention||61||
48410540|NCT00068822|101337656|FG000|NOT COMPLETED|First Randomized Intervention||1||
48410541|NCT00068822|101337657|FG001|NOT COMPLETED|First Randomized Intervention||2||
48410542|NCT00068822|101337656|FG000|STARTED|Optional Crossover Intervention||9||
48410543|NCT00068822|101337657|FG001|STARTED|Optional Crossover Intervention||29||
48410544|NCT00068822|101337656|FG000|Crossover at Month 1|Optional Crossover Intervention||1||
48330220|NCT02432235|101135936|FG006|STARTED|Overall Study||41||
48330221|NCT02432235|101135937|FG007|STARTED|Overall Study||29||
48330222|NCT02432235|101135938|FG008|STARTED|Overall Study||26||
48410545|NCT00068822|101337657|FG001|Crossover at Month 1|Optional Crossover Intervention||2||
48410546|NCT00068822|101337656|FG000|Crossover at Month 3|Optional Crossover Intervention||8||
48410547|NCT00068822|101337657|FG001|Crossover at Month 3|Optional Crossover Intervention||27||
48410548|NCT00068822|101337656|FG000|COMPLETED|Optional Crossover Intervention||9||
48330223|NCT02432235|101135939|FG009|STARTED|Overall Study||3||
48330224|NCT02432235|101135940|FG010|STARTED|Overall Study||2||
48330225|NCT02432235|101135941|FG011|STARTED|Overall Study||1||
48330226|NCT02432235|101135930|FG000|COMPLETED|Overall Study||1||
48624283|NCT03781726|101863848|FG000|NOT COMPLETED|Overall Study||2||
48624284|NCT03322293|101863849|FG000|STARTED|Overall Study||8||
48330227|NCT02432235|101135931|FG001|COMPLETED|Overall Study||0||
48624285|NCT03322293|101863850|FG001|STARTED|Overall Study||8||
48330228|NCT02432235|101135932|FG002|COMPLETED|Overall Study||0||
48624286|NCT03322293|101863851|FG002|STARTED|Overall Study||8||
48624287|NCT03322293|101863849|FG000|COMPLETED|Overall Study||8||
48624288|NCT03322293|101863850|FG001|COMPLETED|Overall Study||8||
48624289|NCT03322293|101863851|FG002|COMPLETED|Overall Study||7||
48624290|NCT03322293|101863849|FG000|NOT COMPLETED|Overall Study||0||
48624291|NCT03322293|101863850|FG001|NOT COMPLETED|Overall Study||0||
48624292|NCT03322293|101863851|FG002|NOT COMPLETED|Overall Study||1||
48624293|NCT00243919|101863852|FG000|STARTED|Overall Study||139||
48624294|NCT00243919|101863853|FG001|STARTED|Overall Study||143||
48747256|NCT03579940|102166030|FG010|COMPLETED|Period 3||3||
48747257|NCT03579940|102166020|FG000|NOT COMPLETED|Period 3||0||
48747258|NCT03579940|102166021|FG001|NOT COMPLETED|Period 3||0||
48747259|NCT03579940|102166022|FG002|NOT COMPLETED|Period 3||0||
48747260|NCT03579940|102166023|FG003|NOT COMPLETED|Period 3||0||
48747261|NCT03579940|102166024|FG004|NOT COMPLETED|Period 3||0||
48747262|NCT03579940|102166025|FG005|NOT COMPLETED|Period 3||0||
48747263|NCT03579940|102166026|FG006|NOT COMPLETED|Period 3||0||
48747264|NCT03579940|102166027|FG007|NOT COMPLETED|Period 3||0||
48747265|NCT03579940|102166028|FG008|NOT COMPLETED|Period 3||0||
48747266|NCT03579940|102166029|FG009|NOT COMPLETED|Period 3||0||
48747267|NCT03579940|102166030|FG010|NOT COMPLETED|Period 3||0||
48747268|NCT01378988|102166031|FG000|STARTED|Overall Study||2||
48747269|NCT01378988|102166032|FG001|STARTED|Overall Study||3||
48747270|NCT01378988|102166031|FG000|COMPLETED|Overall Study||2||
48747271|NCT01378988|102166032|FG001|COMPLETED|Overall Study||3||
48747272|NCT01378988|102166031|FG000|NOT COMPLETED|Overall Study||0||
48747273|NCT01378988|102166032|FG001|NOT COMPLETED|Overall Study||0||
48747274|NCT00479713|102166033|FG000|STARTED|Overall Study||314||
48747275|NCT00479713|102166034|FG001|STARTED|Overall Study||304||
48747276|NCT00479713|102166033|FG000|COMPLETED|Overall Study||301||
48747277|NCT00479713|102166034|FG001|COMPLETED|Overall Study||295||
48747278|NCT00479713|102166033|FG000|NOT COMPLETED|Overall Study||13||
48747279|NCT00479713|102166034|FG001|NOT COMPLETED|Overall Study||9||
48747280|NCT00795535|102166035|FG000|STARTED|Overall Study||95||
48747281|NCT00795535|102166035|FG000|COMPLETED|Overall Study||75||
48330229|NCT02432235|101135933|FG003|COMPLETED|Overall Study||1||
48330230|NCT02432235|101135934|FG004|COMPLETED|Overall Study||0||
48624295|NCT00243919|101863854|FG002|STARTED|Overall Study||126||
48624296|NCT00243919|101863852|FG000|COMPLETED|Overall Study||122||
48624297|NCT00243919|101863853|FG001|COMPLETED|Overall Study||125||
48624298|NCT00243919|101863854|FG002|COMPLETED|Overall Study||115||
48747282|NCT00795535|102166035|FG000|NOT COMPLETED|Overall Study||20||
48747283|NCT00402168|102166036|FG000|STARTED|Randomized||84||
48747284|NCT00402168|102166037|FG001|STARTED|Randomized||89||
48747285|NCT00402168|102166036|FG000|COMPLETED|Randomized||83||
48747286|NCT00402168|102166037|FG001|COMPLETED|Randomized||88||
48747287|NCT00402168|102166036|FG000|NOT COMPLETED|Randomized||1||
48747288|NCT00402168|102166037|FG001|NOT COMPLETED|Randomized||1||
48747289|NCT00402168|102166036|FG000|STARTED|Treatment (up to 12 Months)||83||
48624299|NCT00243919|101863852|FG000|NOT COMPLETED|Overall Study||17||
48624300|NCT00243919|101863853|FG001|NOT COMPLETED|Overall Study||18||
48624301|NCT00243919|101863854|FG002|NOT COMPLETED|Overall Study||11||
48624302|NCT00452374|101863855|FG000|STARTED|Overall Study||48||
48624303|NCT00452374|101863855|FG000|COMPLETED|Overall Study||48||
48624304|NCT00452374|101863855|FG000|NOT COMPLETED|Overall Study||0||
48624305|NCT00249834|101863856|FG000|STARTED|Overall Study||1||
48624306|NCT00249834|101863857|FG001|STARTED|Overall Study||48||
48624307|NCT00249834|101863858|FG002|STARTED|Overall Study||45||
48747290|NCT00402168|102166037|FG001|STARTED|Treatment (up to 12 Months)||88||
48747291|NCT00402168|102166036|FG000|COMPLETED|Treatment (up to 12 Months)||81||
48747292|NCT00402168|102166037|FG001|COMPLETED|Treatment (up to 12 Months)||86||
48747293|NCT00402168|102166036|FG000|NOT COMPLETED|Treatment (up to 12 Months)||2||
48747294|NCT00402168|102166037|FG001|NOT COMPLETED|Treatment (up to 12 Months)||2||
48624308|NCT00249834|101863859|FG003|STARTED|Overall Study||34||
48747295|NCT00402168|102166036|FG000|STARTED|Long Term (LT)||81||
48747296|NCT00402168|102166037|FG001|STARTED|Long Term (LT)||81||
48747297|NCT00402168|102166036|FG000|COMPLETED|Long Term (LT)||70||
48747298|NCT00402168|102166037|FG001|COMPLETED|Long Term (LT)||64||
48747299|NCT00402168|102166036|FG000|NOT COMPLETED|Long Term (LT)||11||
48747300|NCT00402168|102166037|FG001|NOT COMPLETED|Long Term (LT)||17||
48624309|NCT00249834|101863860|FG004|STARTED|Overall Study||24||
48624310|NCT00249834|101863861|FG005|STARTED|Overall Study||10||
48624311|NCT00249834|101863862|FG006|STARTED|Overall Study||2||
48624312|NCT00249834|101863863|FG007|STARTED|Overall Study||2||
48624313|NCT00249834|101863856|FG000|COMPLETED|Overall Study||0||
48624314|NCT00249834|101863857|FG001|COMPLETED|Overall Study||29||
48624315|NCT00249834|101863858|FG002|COMPLETED|Overall Study||31||
48624316|NCT00249834|101863859|FG003|COMPLETED|Overall Study||26||
48624317|NCT00249834|101863860|FG004|COMPLETED|Overall Study||19||
48624318|NCT00249834|101863861|FG005|COMPLETED|Overall Study||8||
48624319|NCT00249834|101863862|FG006|COMPLETED|Overall Study||1||
48624320|NCT00249834|101863863|FG007|COMPLETED|Overall Study||2||
48624321|NCT00249834|101863856|FG000|NOT COMPLETED|Overall Study||1||
48624322|NCT00249834|101863857|FG001|NOT COMPLETED|Overall Study||19||
48624323|NCT00249834|101863858|FG002|NOT COMPLETED|Overall Study||14||
48624324|NCT00249834|101863859|FG003|NOT COMPLETED|Overall Study||8||
48747301|NCT00402168|102166036|FG000|STARTED|Switched From CNI to Belatacept in LT||38||
48767671|NCT01656408|102222800|FG006|STARTED|Overall Study||10||
48624325|NCT00249834|101863860|FG004|NOT COMPLETED|Overall Study||5||
48624326|NCT00249834|101863861|FG005|NOT COMPLETED|Overall Study||2||
48410549|NCT00068822|101337657|FG001|COMPLETED|Optional Crossover Intervention||29||
48410550|NCT00068822|101337656|FG000|NOT COMPLETED|Optional Crossover Intervention||0||
48410551|NCT00068822|101337657|FG001|NOT COMPLETED|Optional Crossover Intervention||0||
48410552|NCT00678249|101337658|FG000|STARTED|Overall Study||97||
48410553|NCT00678249|101337659|FG001|STARTED|Overall Study||93||
48410554|NCT00678249|101337660|FG002|STARTED|Overall Study||37||
48410555|NCT00678249|101337658|FG000|COMPLETED|Overall Study||97||
48410556|NCT00678249|101337659|FG001|COMPLETED|Overall Study||93||
48410557|NCT00678249|101337660|FG002|COMPLETED|Overall Study||37||
48410558|NCT00678249|101337658|FG000|NOT COMPLETED|Overall Study||0||
48410559|NCT00678249|101337659|FG001|NOT COMPLETED|Overall Study||0||
48166716|NCT00988221|100732153|FG000|NOT COMPLETED|Part II||1||
48166717|NCT00988221|100732154|FG001|NOT COMPLETED|Part II||0||
48166718|NCT00988221|100732155|FG002|NOT COMPLETED|Part II||3||
48624327|NCT00249834|101863862|FG006|NOT COMPLETED|Overall Study||1||
48624328|NCT00249834|101863863|FG007|NOT COMPLETED|Overall Study||0||
48624329|NCT00909064|101863864|FG000|STARTED|Overall Study||114||
48624330|NCT00909064|101863864|FG000|COMPLETED|Overall Study||114||
48624331|NCT00909064|101863864|FG000|NOT COMPLETED|Overall Study||0||
48624332|NCT02914834|101863865|FG000|STARTED|Overall Study||12||
48624333|NCT02914834|101863866|FG001|STARTED|Overall Study||15||
48624334|NCT02914834|101863865|FG000|COMPLETED|Overall Study||11||
48624335|NCT02914834|101863866|FG001|COMPLETED|Overall Study||13||
48166719|NCT00988221|100732156|FG003|NOT COMPLETED|Part II||3||
48166720|NCT00988221|100732153|FG000|STARTED|Part III||30||
48166721|NCT00988221|100732154|FG001|STARTED|Part III||24||
48624336|NCT02914834|101863865|FG000|NOT COMPLETED|Overall Study||1||
48624337|NCT02914834|101863866|FG001|NOT COMPLETED|Overall Study||2||
48624338|NCT03428100|101863867|FG000|STARTED|Double-Blind Treatment Week 0 to Week 52||93||
48624339|NCT03428100|101863868|FG001|STARTED|Double-Blind Treatment Week 0 to Week 52||93||
48624340|NCT03428100|101863869|FG002|STARTED|Double-Blind Treatment Week 0 to Week 52||185||
48624341|NCT03428100|101863870|FG003|STARTED|Double-Blind Treatment Week 0 to Week 52||92||
48624342|NCT03428100|101863871|FG004|STARTED|Double-Blind Treatment Week 0 to Week 52||0||
48624343|NCT03428100|101863872|FG005|STARTED|Double-Blind Treatment Week 0 to Week 52||0||
48624344|NCT03428100|101863873|FG006|STARTED|Double-Blind Treatment Week 0 to Week 52||0||
48624345|NCT03428100|101863874|FG007|STARTED|Double-Blind Treatment Week 0 to Week 52||0||
48624346|NCT03428100|101863875|FG008|STARTED|Double-Blind Treatment Week 0 to Week 52||0||
48624347|NCT03428100|101863876|FG009|STARTED|Double-Blind Treatment Week 0 to Week 52||0||
48747302|NCT00402168|102166037|FG001|STARTED|Switched From CNI to Belatacept in LT||0||
48747303|NCT00402168|102166036|FG000|COMPLETED|Switched From CNI to Belatacept in LT||32||
48747304|NCT00402168|102166037|FG001|COMPLETED|Switched From CNI to Belatacept in LT||0||
48747305|NCT00402168|102166036|FG000|NOT COMPLETED|Switched From CNI to Belatacept in LT||6||
48747306|NCT00402168|102166037|FG001|NOT COMPLETED|Switched From CNI to Belatacept in LT||0||
48747307|NCT00795704|102166038|FG000|STARTED|Overall Study||12||
48747308|NCT00795704|102166039|FG001|STARTED|Overall Study||12||
48747309|NCT00795704|102166038|FG000|COMPLETED|Overall Study||8||
48747310|NCT00795704|102166039|FG001|COMPLETED|Overall Study||9||
48747311|NCT00795704|102166038|FG000|NOT COMPLETED|Overall Study||4||
48166722|NCT00988221|100732155|FG002|STARTED|Part III||106||
48166723|NCT00988221|100732156|FG003|STARTED|Part III||0||
48166724|NCT00988221|100732153|FG000|COMPLETED|Part III||29||
48624348|NCT03428100|101863877|FG010|STARTED|Double-Blind Treatment Week 0 to Week 52||0||
48624349|NCT03428100|101863878|FG011|STARTED|Double-Blind Treatment Week 0 to Week 52||0||
48624350|NCT03428100|101863879|FG012|STARTED|Double-Blind Treatment Week 0 to Week 52||0||
48624351|NCT03428100|101863880|FG013|STARTED|Double-Blind Treatment Week 0 to Week 52||0||
48624352|NCT03428100|101863881|FG014|STARTED|Double-Blind Treatment Week 0 to Week 52||0||
48624353|NCT03428100|101863882|FG015|STARTED|Double-Blind Treatment Week 0 to Week 52||0||
48624354|NCT03428100|101863883|FG016|STARTED|Double-Blind Treatment Week 0 to Week 52||0||
48624355|NCT03428100|101863884|FG017|STARTED|Double-Blind Treatment Week 0 to Week 52||0||
48624356|NCT03428100|101863885|FG018|STARTED|Double-Blind Treatment Week 0 to Week 52||0||
48624357|NCT03428100|101863867|FG000|Received at Least One Dose of Study Drug|Double-Blind Treatment Week 0 to Week 52||93||
48624358|NCT03428100|101863868|FG001|Received at Least One Dose of Study Drug|Double-Blind Treatment Week 0 to Week 52||93||
48624359|NCT03428100|101863869|FG002|Received at Least One Dose of Study Drug|Double-Blind Treatment Week 0 to Week 52||184||
48624360|NCT03428100|101863870|FG003|Received at Least One Dose of Study Drug|Double-Blind Treatment Week 0 to Week 52||92||
48624361|NCT03428100|101863871|FG004|Received at Least One Dose of Study Drug|Double-Blind Treatment Week 0 to Week 52||0||
48624362|NCT03428100|101863872|FG005|Received at Least One Dose of Study Drug|Double-Blind Treatment Week 0 to Week 52||0||
48624363|NCT03428100|101863873|FG006|Received at Least One Dose of Study Drug|Double-Blind Treatment Week 0 to Week 52||0||
48624364|NCT03428100|101863874|FG007|Received at Least One Dose of Study Drug|Double-Blind Treatment Week 0 to Week 52||0||
48747312|NCT00795704|102166039|FG001|NOT COMPLETED|Overall Study||3||
48747313|NCT01276639|102166040|FG000|STARTED|Week 0 to 16||363||
48747314|NCT01276639|102166041|FG001|STARTED|Week 0 to 16||361||
48747315|NCT01276639|102166042|FG002|STARTED|Week 0 to 16||177||
48747316|NCT01276639|102166043|FG003|STARTED|Week 0 to 16||0||
48747317|NCT01276639|102166044|FG004|STARTED|Week 0 to 16||0||
48166725|NCT00988221|100732154|FG001|COMPLETED|Part III||23||
48166726|NCT00988221|100732155|FG002|COMPLETED|Part III||103||
48747318|NCT01276639|102166040|FG000|Treated|Week 0 to 16||363||
48747319|NCT01276639|102166041|FG001|Treated|Week 0 to 16||360||
48747320|NCT01276639|102166042|FG002|Treated|Week 0 to 16||177||
48747321|NCT01276639|102166043|FG003|Treated|Week 0 to 16||0||
48747322|NCT01276639|102166044|FG004|Treated|Week 0 to 16||0||
48747323|NCT01276639|102166040|FG000|COMPLETED|Week 0 to 16||313||
48747324|NCT01276639|102166041|FG001|COMPLETED|Week 0 to 16||320||
48166727|NCT00988221|100732156|FG003|COMPLETED|Part III||0||
48166728|NCT00988221|100732153|FG000|NOT COMPLETED|Part III||1||
48166729|NCT00988221|100732154|FG001|NOT COMPLETED|Part III||1||
48166730|NCT00988221|100732155|FG002|NOT COMPLETED|Part III||3||
48166731|NCT00988221|100732156|FG003|NOT COMPLETED|Part III||0||
48330231|NCT02432235|101135935|FG005|COMPLETED|Overall Study||8||
48330232|NCT02432235|101135936|FG006|COMPLETED|Overall Study||23||
48330233|NCT02432235|101135937|FG007|COMPLETED|Overall Study||9||
48166732|NCT03349268|100732157|FG000|STARTED|Overall Study||9117||
48166733|NCT03349268|100732158|FG001|STARTED|Overall Study||10296||
48166734|NCT03349268|100732159|FG002|STARTED|Overall Study||6319||
48166735|NCT03349268|100732157|FG000|COMPLETED|Overall Study||9117||
48166736|NCT03349268|100732158|FG001|COMPLETED|Overall Study||10296||
48166737|NCT03349268|100732159|FG002|COMPLETED|Overall Study||6319||
48166738|NCT03349268|100732157|FG000|NOT COMPLETED|Overall Study||0||
48166739|NCT03349268|100732158|FG001|NOT COMPLETED|Overall Study||0||
48166740|NCT03349268|100732159|FG002|NOT COMPLETED|Overall Study||0||
48166741|NCT01462162|100732160|FG000|STARTED|Overall Study||120||
48166742|NCT01462162|100732160|FG000|COMPLETED|Overall Study||108||
48166743|NCT01462162|100732160|FG000|NOT COMPLETED|Overall Study||12||
48166744|NCT02205801|100732161|FG000|STARTED|Overall Study||11||
48166745|NCT02205801|100732162|FG001|STARTED|Overall Study||8||
48166746|NCT02205801|100732163|FG002|STARTED|Overall Study||9||
48166747|NCT02205801|100732164|FG003|STARTED|Overall Study||8||
48166748|NCT02205801|100732161|FG000|COMPLETED|Overall Study||11||
48166749|NCT02205801|100732162|FG001|COMPLETED|Overall Study||8||
48166750|NCT02205801|100732163|FG002|COMPLETED|Overall Study||9||
48166751|NCT02205801|100732164|FG003|COMPLETED|Overall Study||8||
48166752|NCT02205801|100732161|FG000|NOT COMPLETED|Overall Study||0||
48166753|NCT02205801|100732162|FG001|NOT COMPLETED|Overall Study||0||
48166754|NCT02205801|100732163|FG002|NOT COMPLETED|Overall Study||0||
48330234|NCT02432235|101135938|FG008|COMPLETED|Overall Study||5||
48747325|NCT01276639|102166042|FG002|COMPLETED|Week 0 to 16||132||
48747326|NCT01276639|102166043|FG003|COMPLETED|Week 0 to 16||0||
48747327|NCT01276639|102166044|FG004|COMPLETED|Week 0 to 16||0||
48330235|NCT02432235|101135939|FG009|COMPLETED|Overall Study||0||
48330236|NCT02432235|101135940|FG010|COMPLETED|Overall Study||1||
48330237|NCT02432235|101135941|FG011|COMPLETED|Overall Study||0||
48330238|NCT02432235|101135930|FG000|NOT COMPLETED|Overall Study||1||
48330239|NCT02432235|101135931|FG001|NOT COMPLETED|Overall Study||2||
48747328|NCT01276639|102166040|FG000|NOT COMPLETED|Week 0 to 16||50||
48166755|NCT02205801|100732164|FG003|NOT COMPLETED|Overall Study||0||
48166756|NCT00105586|100732165|FG000|STARTED|Overall Study||92||
48166757|NCT00105586|100732166|FG001|STARTED|Overall Study||85||
48166758|NCT00105586|100732165|FG000|COMPLETED|Overall Study||75||
48166759|NCT00105586|100732166|FG001|COMPLETED|Overall Study||69||
48166760|NCT00105586|100732165|FG000|NOT COMPLETED|Overall Study||17||
48166761|NCT00105586|100732166|FG001|NOT COMPLETED|Overall Study||16||
48166762|NCT00930943|100732167|FG000|STARTED|Overall Study||30||
48166763|NCT00930943|100732167|FG000|COMPLETED|Overall Study||30||
48166764|NCT00930943|100732167|FG000|NOT COMPLETED|Overall Study||0||
48166765|NCT01472562|100732168|FG000|STARTED|Induction Phase (Week 1- 48)||38||
48166766|NCT01472562|100732168|FG000|COMPLETED|Induction Phase (Week 1- 48)||27||
48166767|NCT01472562|100732168|FG000|NOT COMPLETED|Induction Phase (Week 1- 48)||11||
48166768|NCT01472562|100732168|FG000|STARTED|Maintenance Phase (Week 49 to PD)||27||
48166769|NCT01472562|100732168|FG000|COMPLETED|Maintenance Phase (Week 49 to PD)||4||
48166770|NCT01472562|100732168|FG000|NOT COMPLETED|Maintenance Phase (Week 49 to PD)||23||
48166771|NCT01391325|100732169|FG000|STARTED|Overall Study||1732||
48166772|NCT01391325|100732169|FG000|COMPLETED|Overall Study||1238||
48166773|NCT01391325|100732169|FG000|NOT COMPLETED|Overall Study||494||
48166774|NCT01334944|100732170|FG000|STARTED|Overall Study||11||
48166775|NCT01334944|100732171|FG001|STARTED|Overall Study||139||
48166776|NCT01334944|100732170|FG000|Received Singel Dose|Overall Study||1||
48166777|NCT01334944|100732171|FG001|Received Singel Dose|Overall Study||96||
48166778|NCT01334944|100732170|FG000|Received Multiple Doses|Overall Study||10||
48166779|NCT01334944|100732171|FG001|Received Multiple Doses|Overall Study||43||
48166780|NCT01334944|100732170|FG000|COMPLETED|Overall Study||11||
48166781|NCT01334944|100732171|FG001|COMPLETED|Overall Study||139||
48166782|NCT01334944|100732170|FG000|NOT COMPLETED|Overall Study||0||
48166783|NCT01334944|100732171|FG001|NOT COMPLETED|Overall Study||0||
48166784|NCT01139190|100732172|FG000|STARTED|Overall Study||38||
48166785|NCT01139190|100732173|FG001|STARTED|Overall Study||39||
48166786|NCT01139190|100732172|FG000|COMPLETED|Overall Study||38||
48166787|NCT01139190|100732173|FG001|COMPLETED|Overall Study||38||
48166788|NCT01139190|100732172|FG000|NOT COMPLETED|Overall Study||0||
48330240|NCT02432235|101135932|FG002|NOT COMPLETED|Overall Study||2||
48330241|NCT02432235|101135933|FG003|NOT COMPLETED|Overall Study||2||
48330242|NCT02432235|101135934|FG004|NOT COMPLETED|Overall Study||2||
48330243|NCT02432235|101135935|FG005|NOT COMPLETED|Overall Study||12||
48330244|NCT02432235|101135936|FG006|NOT COMPLETED|Overall Study||18||
48330245|NCT02432235|101135937|FG007|NOT COMPLETED|Overall Study||20||
48330246|NCT02432235|101135938|FG008|NOT COMPLETED|Overall Study||21||
48330247|NCT02432235|101135939|FG009|NOT COMPLETED|Overall Study||3||
48330248|NCT02432235|101135940|FG010|NOT COMPLETED|Overall Study||1||
48330249|NCT02432235|101135941|FG011|NOT COMPLETED|Overall Study||1||
48166789|NCT01139190|100732173|FG001|NOT COMPLETED|Overall Study||1||
48747329|NCT01276639|102166041|FG001|NOT COMPLETED|Week 0 to 16||41||
48624365|NCT03428100|101863875|FG008|Received at Least One Dose of Study Drug|Double-Blind Treatment Week 0 to Week 52||0||
48624366|NCT03428100|101863876|FG009|Received at Least One Dose of Study Drug|Double-Blind Treatment Week 0 to Week 52||0||
48166790|NCT03097861|100732174|FG000|STARTED|Overall Study||145||
48166791|NCT03097861|100732175|FG001|STARTED|Overall Study||276||
48166792|NCT03097861|100732176|FG002|STARTED|Overall Study||131||
48166793|NCT03097861|100732174|FG000|Safety Population|Overall Study||143|Randomized and took at least one dose of study drug, by treatment actually received|
48166794|NCT03097861|100732175|FG001|Safety Population|Overall Study||275|Randomized and took at least one dose of study drug, by treatment actually received|
48166795|NCT03097861|100732176|FG002|Safety Population|Overall Study||130|Randomized and took at least one dose of study drug, by treatment actually received|
48624367|NCT03428100|101863877|FG010|Received at Least One Dose of Study Drug|Double-Blind Treatment Week 0 to Week 52||0||
48624368|NCT03428100|101863878|FG011|Received at Least One Dose of Study Drug|Double-Blind Treatment Week 0 to Week 52||0||
48624369|NCT03428100|101863879|FG012|Received at Least One Dose of Study Drug|Double-Blind Treatment Week 0 to Week 52||0||
48166796|NCT03097861|100732174|FG000|Modified Intent to Treat|Overall Study||143|As randomized, received at least one dose of study drug and had at least one diary entry|
48166797|NCT03097861|100732175|FG001|Modified Intent to Treat|Overall Study||275|As randomized, received at least one dose of study drug and had at least one diary entry|
48166798|NCT03097861|100732176|FG002|Modified Intent to Treat|Overall Study||130|As randomized, received at least one dose of study drug and had at least one diary entry|
48166799|NCT03097861|100732174|FG000|Completers|Overall Study||129|Completed the entire treatment period with a recorded primary endpoint|
48166800|NCT03097861|100732175|FG001|Completers|Overall Study||255|Completed the entire treatment period with a recorded primary endpoint|
48166801|NCT03097861|100732176|FG002|Completers|Overall Study||121|Completed the entire treatment period with a recorded primary endpoint|
48624370|NCT03428100|101863880|FG013|Received at Least One Dose of Study Drug|Double-Blind Treatment Week 0 to Week 52||0||
48624371|NCT03428100|101863881|FG014|Received at Least One Dose of Study Drug|Double-Blind Treatment Week 0 to Week 52||0||
48624372|NCT03428100|101863882|FG015|Received at Least One Dose of Study Drug|Double-Blind Treatment Week 0 to Week 52||0||
48624373|NCT03428100|101863883|FG016|Received at Least One Dose of Study Drug|Double-Blind Treatment Week 0 to Week 52||0||
48624374|NCT03428100|101863884|FG017|Received at Least One Dose of Study Drug|Double-Blind Treatment Week 0 to Week 52||0||
48624375|NCT03428100|101863885|FG018|Received at Least One Dose of Study Drug|Double-Blind Treatment Week 0 to Week 52||0||
48624376|NCT03428100|101863867|FG000|COMPLETED|Double-Blind Treatment Week 0 to Week 52||72||
48624377|NCT03428100|101863868|FG001|COMPLETED|Double-Blind Treatment Week 0 to Week 52||80||
48624378|NCT03428100|101863869|FG002|COMPLETED|Double-Blind Treatment Week 0 to Week 52||173||
48166802|NCT03097861|100732174|FG000|Per-protocol Population (PP)|Overall Study||126|Main population for efficacy analysis|
48166803|NCT03097861|100732175|FG001|Per-protocol Population (PP)|Overall Study||234|Main population for efficacy analysis|
48166804|NCT03097861|100732176|FG002|Per-protocol Population (PP)|Overall Study||113|Main population for efficacy analysis|
48166805|NCT03097861|100732174|FG000|COMPLETED|Overall Study||138||
48166806|NCT03097861|100732175|FG001|COMPLETED|Overall Study||254||
48166807|NCT03097861|100732176|FG002|COMPLETED|Overall Study||122||
48166808|NCT03097861|100732174|FG000|NOT COMPLETED|Overall Study||7||
48166809|NCT03097861|100732175|FG001|NOT COMPLETED|Overall Study||22||
48166810|NCT03097861|100732176|FG002|NOT COMPLETED|Overall Study||9||
48166811|NCT01860586|100732177|FG000|STARTED|Overall Study||20||
48166812|NCT01860586|100732177|FG000|COMPLETED|Overall Study||20||
48166813|NCT01860586|100732177|FG000|NOT COMPLETED|Overall Study||0||
48166814|NCT02088632|100732178|FG000|STARTED|Overall Study||3||
48166815|NCT02088632|100732179|FG001|STARTED|Overall Study||3||
48166816|NCT02088632|100732178|FG000|COMPLETED|Overall Study||3||
48166817|NCT02088632|100732179|FG001|COMPLETED|Overall Study||3||
48166818|NCT02088632|100732178|FG000|NOT COMPLETED|Overall Study||0||
48166819|NCT02088632|100732179|FG001|NOT COMPLETED|Overall Study||0||
48166820|NCT02122341|100732180|FG000|STARTED|Overall Study||17||
48166821|NCT02122341|100732181|FG001|STARTED|Overall Study||18||
48166822|NCT02122341|100732180|FG000|COMPLETED|Overall Study||17||
48166823|NCT02122341|100732181|FG001|COMPLETED|Overall Study||18||
48166824|NCT02122341|100732180|FG000|NOT COMPLETED|Overall Study||0||
48166825|NCT02122341|100732181|FG001|NOT COMPLETED|Overall Study||0||
48624379|NCT03428100|101863870|FG003|COMPLETED|Double-Blind Treatment Week 0 to Week 52||85||
48624380|NCT03428100|101863871|FG004|COMPLETED|Double-Blind Treatment Week 0 to Week 52||0||
48166826|NCT02176421|100732182|FG000|STARTED|Overall Study||80||
48624381|NCT03428100|101863872|FG005|COMPLETED|Double-Blind Treatment Week 0 to Week 52||0||
48624382|NCT03428100|101863873|FG006|COMPLETED|Double-Blind Treatment Week 0 to Week 52||0||
48624383|NCT03428100|101863874|FG007|COMPLETED|Double-Blind Treatment Week 0 to Week 52||0||
48624384|NCT03428100|101863875|FG008|COMPLETED|Double-Blind Treatment Week 0 to Week 52||0||
48624385|NCT03428100|101863876|FG009|COMPLETED|Double-Blind Treatment Week 0 to Week 52||0||
48624386|NCT03428100|101863877|FG010|COMPLETED|Double-Blind Treatment Week 0 to Week 52||0||
48624387|NCT03428100|101863878|FG011|COMPLETED|Double-Blind Treatment Week 0 to Week 52||0||
48624388|NCT03428100|101863879|FG012|COMPLETED|Double-Blind Treatment Week 0 to Week 52||0||
48166827|NCT02176421|100732182|FG000|COMPLETED|Overall Study||75||
48166828|NCT02176421|100732182|FG000|NOT COMPLETED|Overall Study||5||
48166829|NCT00633932|100732183|FG000|STARTED|Overall Study||191||
48166830|NCT00633932|100732184|FG001|STARTED|Overall Study||190||
48166831|NCT00633932|100732185|FG002|STARTED|Overall Study||191||
48166832|NCT00633932|100732183|FG000|COMPLETED|Overall Study||179||
48166833|NCT00633932|100732184|FG001|COMPLETED|Overall Study||176||
48166834|NCT00633932|100732185|FG002|COMPLETED|Overall Study||180||
48166835|NCT00633932|100732183|FG000|NOT COMPLETED|Overall Study||12||
48166836|NCT00633932|100732184|FG001|NOT COMPLETED|Overall Study||14||
48166837|NCT00633932|100732185|FG002|NOT COMPLETED|Overall Study||11||
48166838|NCT03501043|100732186|FG000|STARTED|Overall Study||11||
48166839|NCT03501043|100732186|FG000|COMPLETED|Overall Study||10||
48166840|NCT03501043|100732186|FG000|NOT COMPLETED|Overall Study||1||
48166841|NCT01108458|100732187|FG000|STARTED|Overall Study||1||
48166842|NCT01108458|100732187|FG000|COMPLETED|Overall Study||0||
48166843|NCT01108458|100732187|FG000|NOT COMPLETED|Overall Study||1||
48166844|NCT00345384|100732188|FG000|STARTED|Overall Study||19||
48166845|NCT00345384|100732189|FG001|STARTED|Overall Study||19||
48166846|NCT00345384|100732188|FG000|COMPLETED|Overall Study||19||
48166847|NCT00345384|100732189|FG001|COMPLETED|Overall Study||19||
48166848|NCT00345384|100732188|FG000|NOT COMPLETED|Overall Study||0||
48166849|NCT00345384|100732189|FG001|NOT COMPLETED|Overall Study||0||
48166850|NCT02287350|100732190|FG000|STARTED|Overall Study||51||
48166851|NCT02287350|100732190|FG000|COMPLETED|Overall Study||48||
48166852|NCT02287350|100732190|FG000|NOT COMPLETED|Overall Study||3||
48166853|NCT02998021|100732191|FG000|STARTED|Overall Study||8||
48166854|NCT02998021|100732192|FG001|STARTED|Overall Study||2||
48166855|NCT02998021|100732191|FG000|COMPLETED|Overall Study||5||
48166856|NCT02998021|100732192|FG001|COMPLETED|Overall Study||0||
48166857|NCT02998021|100732191|FG000|NOT COMPLETED|Overall Study||3||
48166858|NCT02998021|100732192|FG001|NOT COMPLETED|Overall Study||2||
48166859|NCT01586312|100732193|FG000|STARTED|Overall Study||15||
48166860|NCT01586312|100732194|FG001|STARTED|Overall Study||15||
48166861|NCT01586312|100732193|FG000|COMPLETED|Overall Study||15||
48166862|NCT01586312|100732194|FG001|COMPLETED|Overall Study||15||
48166863|NCT01586312|100732193|FG000|NOT COMPLETED|Overall Study||0||
48166864|NCT01586312|100732194|FG001|NOT COMPLETED|Overall Study||0||
48166865|NCT00114634|100732195|FG000|STARTED|Overall Study||13||
48166866|NCT00114634|100732195|FG000|COMPLETED|Overall Study||10||
48166867|NCT00114634|100732195|FG000|NOT COMPLETED|Overall Study||3||
48166868|NCT00101660|100732196|FG000|STARTED|Overall Study||99||
48166869|NCT00101660|100732197|FG001|STARTED|Overall Study||288||
48166870|NCT00101660|100732196|FG000|COMPLETED|Overall Study||99||
48166871|NCT00101660|100732197|FG001|COMPLETED|Overall Study||288||
48166872|NCT00101660|100732196|FG000|NOT COMPLETED|Overall Study||0||
48166873|NCT00101660|100732197|FG001|NOT COMPLETED|Overall Study||0||
48166874|NCT01374802|100732198|FG000|STARTED|Overall Study||14||
48166875|NCT01374802|100732198|FG000|COMPLETED|Overall Study||14||
48166876|NCT01374802|100732198|FG000|NOT COMPLETED|Overall Study||0||
48166877|NCT04844918|100732199|FG000|STARTED|Overall Study||88||
48166878|NCT04844918|100732200|FG001|STARTED|Overall Study||90||
48166879|NCT04844918|100732201|FG002|STARTED|Overall Study||89||
48166880|NCT04844918|100732199|FG000|Received At Least 1 Dose of Study Drug (Excluding the GCP Compliance Investigative Site)|Overall Study||73||
48166881|NCT04844918|100732200|FG001|Received At Least 1 Dose of Study Drug (Excluding the GCP Compliance Investigative Site)|Overall Study||77||
48166882|NCT04844918|100732201|FG002|Received At Least 1 Dose of Study Drug (Excluding the GCP Compliance Investigative Site)|Overall Study||75||
48166883|NCT04844918|100732199|FG000|COMPLETED|Overall Study||60||
48166884|NCT04844918|100732200|FG001|COMPLETED|Overall Study||65||
48166885|NCT04844918|100732201|FG002|COMPLETED|Overall Study||67||
48166886|NCT04844918|100732199|FG000|NOT COMPLETED|Overall Study||28||
48166887|NCT04844918|100732200|FG001|NOT COMPLETED|Overall Study||25||
48166888|NCT04844918|100732201|FG002|NOT COMPLETED|Overall Study||22||
48166889|NCT04200313|100732202|FG000|STARTED|RCT||219||
48166890|NCT04200313|100732203|FG001|STARTED|RCT||114||
48166891|NCT04200313|100732204|FG002|STARTED|RCT||107||
48166892|NCT04200313|100732205|FG003|STARTED|RCT||0||
48166893|NCT04200313|100732206|FG004|STARTED|RCT||0||
48166894|NCT04200313|100732207|FG005|STARTED|RCT||0||
48166895|NCT04200313|100732208|FG006|STARTED|RCT||0||
48166896|NCT04200313|100732202|FG000|COMPLETED|RCT||216||
48166897|NCT04200313|100732203|FG001|COMPLETED|RCT||113||
48166898|NCT04200313|100732204|FG002|COMPLETED|RCT||107||
48166899|NCT04200313|100732205|FG003|COMPLETED|RCT||0||
48166900|NCT04200313|100732206|FG004|COMPLETED|RCT||0||
48166901|NCT04200313|100732207|FG005|COMPLETED|RCT||0||
48166902|NCT04200313|100732208|FG006|COMPLETED|RCT||0||
48166903|NCT04200313|100732202|FG000|NOT COMPLETED|RCT||3||
48166904|NCT04200313|100732203|FG001|NOT COMPLETED|RCT||1||
48166905|NCT04200313|100732204|FG002|NOT COMPLETED|RCT||0||
48166906|NCT04200313|100732205|FG003|NOT COMPLETED|RCT||0||
48166907|NCT04200313|100732206|FG004|NOT COMPLETED|RCT||0||
48166908|NCT04200313|100732207|FG005|NOT COMPLETED|RCT||0||
48166909|NCT04200313|100732208|FG006|NOT COMPLETED|RCT||0||
48166910|NCT04200313|100732202|FG000|STARTED|BG Run Ancillary Study||0||
48166911|NCT04200313|100732203|FG001|STARTED|BG Run Ancillary Study||0||
48166912|NCT04200313|100732204|FG002|STARTED|BG Run Ancillary Study||0||
48166913|NCT04200313|100732205|FG003|STARTED|BG Run Ancillary Study||58||
48166914|NCT04200313|100732206|FG004|STARTED|BG Run Ancillary Study||0||
48166915|NCT04200313|100732207|FG005|STARTED|BG Run Ancillary Study||0||
48166916|NCT04200313|100732208|FG006|STARTED|BG Run Ancillary Study||0||
48166917|NCT04200313|100732202|FG000|COMPLETED|BG Run Ancillary Study||0||
48166918|NCT04200313|100732203|FG001|COMPLETED|BG Run Ancillary Study||0||
48166919|NCT04200313|100732204|FG002|COMPLETED|BG Run Ancillary Study||0||
48166920|NCT04200313|100732205|FG003|COMPLETED|BG Run Ancillary Study||54||
48166921|NCT04200313|100732206|FG004|COMPLETED|BG Run Ancillary Study||0||
48166922|NCT04200313|100732207|FG005|COMPLETED|BG Run Ancillary Study||0||
48166923|NCT04200313|100732208|FG006|COMPLETED|BG Run Ancillary Study||0||
48166924|NCT04200313|100732202|FG000|NOT COMPLETED|BG Run Ancillary Study||0||
48166925|NCT04200313|100732203|FG001|NOT COMPLETED|BG Run Ancillary Study||0||
48166926|NCT04200313|100732204|FG002|NOT COMPLETED|BG Run Ancillary Study||0||
48166927|NCT04200313|100732205|FG003|NOT COMPLETED|BG Run Ancillary Study||4||
48166928|NCT04200313|100732206|FG004|NOT COMPLETED|BG Run Ancillary Study||0||
48166929|NCT04200313|100732207|FG005|NOT COMPLETED|BG Run Ancillary Study||0||
48166930|NCT04200313|100732208|FG006|NOT COMPLETED|BG Run Ancillary Study||0||
48166931|NCT04200313|100732202|FG000|STARTED|Transition Phase||0||
48166932|NCT04200313|100732203|FG001|STARTED|Transition Phase||0||
48166933|NCT04200313|100732204|FG002|STARTED|Transition Phase||0||
48166934|NCT04200313|100732205|FG003|STARTED|Transition Phase||0||
48166935|NCT04200313|100732206|FG004|STARTED|Transition Phase||148||
48166936|NCT04200313|100732207|FG005|STARTED|Transition Phase||149||
48166937|NCT04200313|100732208|FG006|STARTED|Transition Phase||0||
48166938|NCT04200313|100732202|FG000|COMPLETED|Transition Phase||0||
48166939|NCT04200313|100732203|FG001|COMPLETED|Transition Phase||0||
48166940|NCT04200313|100732204|FG002|COMPLETED|Transition Phase||0||
48166941|NCT04200313|100732205|FG003|COMPLETED|Transition Phase||0||
48166942|NCT04200313|100732206|FG004|COMPLETED|Transition Phase||148||
48166943|NCT04200313|100732207|FG005|COMPLETED|Transition Phase||147||
48166944|NCT04200313|100732208|FG006|COMPLETED|Transition Phase||0||
48166945|NCT04200313|100732202|FG000|NOT COMPLETED|Transition Phase||0||
48166946|NCT04200313|100732203|FG001|NOT COMPLETED|Transition Phase||0||
48166947|NCT04200313|100732204|FG002|NOT COMPLETED|Transition Phase||0||
48166948|NCT04200313|100732205|FG003|NOT COMPLETED|Transition Phase||0||
48166949|NCT04200313|100732206|FG004|NOT COMPLETED|Transition Phase||0||
48166950|NCT04200313|100732207|FG005|NOT COMPLETED|Transition Phase||2||
48166951|NCT04200313|100732208|FG006|NOT COMPLETED|Transition Phase||0||
48166952|NCT04200313|100732202|FG000|STARTED|Extension Phase||0||
48166953|NCT04200313|100732203|FG001|STARTED|Extension Phase||0||
48166954|NCT04200313|100732204|FG002|STARTED|Extension Phase||0||
48166955|NCT04200313|100732205|FG003|STARTED|Extension Phase||0||
48166956|NCT04200313|100732206|FG004|STARTED|Extension Phase||0||
48166957|NCT04200313|100732207|FG005|STARTED|Extension Phase||0||
48166958|NCT04200313|100732208|FG006|STARTED|Extension Phase||90||
48166959|NCT04200313|100732202|FG000|COMPLETED|Extension Phase||0||
48166960|NCT04200313|100732203|FG001|COMPLETED|Extension Phase||0||
48166961|NCT04200313|100732204|FG002|COMPLETED|Extension Phase||0||
48166962|NCT04200313|100732205|FG003|COMPLETED|Extension Phase||0||
48166963|NCT04200313|100732206|FG004|COMPLETED|Extension Phase||0||
48166964|NCT04200313|100732207|FG005|COMPLETED|Extension Phase||0||
48166965|NCT04200313|100732208|FG006|COMPLETED|Extension Phase||84||
48166966|NCT04200313|100732202|FG000|NOT COMPLETED|Extension Phase||0||
48166967|NCT04200313|100732203|FG001|NOT COMPLETED|Extension Phase||0||
48166968|NCT04200313|100732204|FG002|NOT COMPLETED|Extension Phase||0||
48166969|NCT04200313|100732205|FG003|NOT COMPLETED|Extension Phase||0||
48166970|NCT04200313|100732206|FG004|NOT COMPLETED|Extension Phase||0||
48166971|NCT04200313|100732207|FG005|NOT COMPLETED|Extension Phase||0||
48166972|NCT04200313|100732208|FG006|NOT COMPLETED|Extension Phase||6||
48166973|NCT04488003|100732209|FG000|STARTED|Assessed for Eligibility||104||
48166974|NCT04488003|100732210|FG001|STARTED|Assessed for Eligibility||0||
48166975|NCT04488003|100732211|FG002|STARTED|Assessed for Eligibility||0||
48166976|NCT04488003|100732209|FG000|COMPLETED|Assessed for Eligibility||77||
48166977|NCT04488003|100732210|FG001|COMPLETED|Assessed for Eligibility||0||
48166978|NCT04488003|100732211|FG002|COMPLETED|Assessed for Eligibility||0||
48166979|NCT04488003|100732209|FG000|NOT COMPLETED|Assessed for Eligibility||27||
48166980|NCT04488003|100732210|FG001|NOT COMPLETED|Assessed for Eligibility||0||
48166981|NCT04488003|100732211|FG002|NOT COMPLETED|Assessed for Eligibility||0||
48166982|NCT04488003|100732209|FG000|STARTED|Allocated to Treatment||77||
48166983|NCT04488003|100732210|FG001|STARTED|Allocated to Treatment||0||
48166984|NCT04488003|100732211|FG002|STARTED|Allocated to Treatment||0||
48166985|NCT04488003|100732209|FG000|COMPLETED|Allocated to Treatment||0||
48166986|NCT04488003|100732210|FG001|COMPLETED|Allocated to Treatment||0||
48166987|NCT04488003|100732211|FG002|COMPLETED|Allocated to Treatment||0||
48166988|NCT04488003|100732209|FG000|NOT COMPLETED|Allocated to Treatment||77||
48166989|NCT04488003|100732210|FG001|NOT COMPLETED|Allocated to Treatment||0||
48166990|NCT04488003|100732211|FG002|NOT COMPLETED|Allocated to Treatment||0||
48166991|NCT02914184|100732212|FG000|STARTED|Overall Study||400||
48166992|NCT02914184|100732213|FG001|STARTED|Overall Study||396||
48166993|NCT02914184|100732214|FG002|STARTED|Overall Study||402||
48166994|NCT02914184|100732215|FG003|STARTED|Overall Study||402||
48166995|NCT02914184|100732212|FG000|COMPLETED|Overall Study||386||
48166996|NCT02914184|100732213|FG001|COMPLETED|Overall Study||383||
48166997|NCT02914184|100732214|FG002|COMPLETED|Overall Study||385||
48166998|NCT02914184|100732215|FG003|COMPLETED|Overall Study||391||
48166999|NCT02914184|100732212|FG000|NOT COMPLETED|Overall Study||14||
48167000|NCT02914184|100732213|FG001|NOT COMPLETED|Overall Study||13||
48167001|NCT02914184|100732214|FG002|NOT COMPLETED|Overall Study||17||
48167002|NCT02914184|100732215|FG003|NOT COMPLETED|Overall Study||11||
48167003|NCT03002038|100732216|FG000|STARTED|Overall Study||46||
48167004|NCT03002038|100732217|FG001|STARTED|Overall Study||40||
48167005|NCT03002038|100732216|FG000|COMPLETED|Overall Study||35||
48167006|NCT03002038|100732217|FG001|COMPLETED|Overall Study||33||
48167007|NCT03002038|100732216|FG000|NOT COMPLETED|Overall Study||11||
48368080|NCT03691623|101230101|FG005|NOT COMPLETED|Overall Study||0||
48167008|NCT03002038|100732217|FG001|NOT COMPLETED|Overall Study||7||
48167009|NCT03101241|100732218|FG000|STARTED|Overall Study||48||
48167010|NCT03101241|100732219|FG001|STARTED|Overall Study||47||
48167011|NCT03101241|100732218|FG000|COMPLETED|Overall Study||37||
48167012|NCT03101241|100732219|FG001|COMPLETED|Overall Study||42||
48167013|NCT03101241|100732218|FG000|NOT COMPLETED|Overall Study||11||
48167014|NCT03101241|100732219|FG001|NOT COMPLETED|Overall Study||5||
48167015|NCT01090310|100732220|FG000|STARTED|Core Study||29||
48167016|NCT01090310|100732221|FG001|STARTED|Core Study||31||
48167017|NCT01090310|100732222|FG002|STARTED|Core Study||31||
48167018|NCT01090310|100732223|FG003|STARTED|Core Study||34||
48167019|NCT01090310|100732220|FG000|COMPLETED|Core Study||21||
48167020|NCT01090310|100732221|FG001|COMPLETED|Core Study||20||
48167021|NCT01090310|100732222|FG002|COMPLETED|Core Study||24||
48167022|NCT01090310|100732223|FG003|COMPLETED|Core Study||27||
48167023|NCT01090310|100732220|FG000|NOT COMPLETED|Core Study||8||
48167024|NCT01090310|100732221|FG001|NOT COMPLETED|Core Study||11||
48167025|NCT01090310|100732222|FG002|NOT COMPLETED|Core Study||7||
48167026|NCT01090310|100732223|FG003|NOT COMPLETED|Core Study||7||
48167027|NCT01090310|100732220|FG000|STARTED|Extension Study||17||
48167028|NCT01090310|100732221|FG001|STARTED|Extension Study||16||
48167029|NCT01090310|100732222|FG002|STARTED|Extension Study||16||
48167030|NCT01090310|100732223|FG003|STARTED|Extension Study||21||
48167031|NCT01090310|100732220|FG000|COMPLETED|Extension Study||3||
48167032|NCT01090310|100732221|FG001|COMPLETED|Extension Study||0||
48167033|NCT01090310|100732222|FG002|COMPLETED|Extension Study||1||
48167034|NCT01090310|100732223|FG003|COMPLETED|Extension Study||1||
48167035|NCT01090310|100732220|FG000|NOT COMPLETED|Extension Study||14||
48167036|NCT01090310|100732221|FG001|NOT COMPLETED|Extension Study||16||
48167037|NCT01090310|100732222|FG002|NOT COMPLETED|Extension Study||15||
48167038|NCT01090310|100732223|FG003|NOT COMPLETED|Extension Study||20||
48167039|NCT02714868|100732224|FG000|STARTED|Overall Study||47||
48167040|NCT02714868|100732225|FG001|STARTED|Overall Study||35||
48167041|NCT02714868|100732224|FG000|COMPLETED|Overall Study||42||
48167042|NCT02714868|100732225|FG001|COMPLETED|Overall Study||35||
48167043|NCT02714868|100732224|FG000|NOT COMPLETED|Overall Study||5||
48167044|NCT02714868|100732225|FG001|NOT COMPLETED|Overall Study||0||
48167045|NCT01735396|100732226|FG000|STARTED|Overall Study||11||
48167046|NCT01735396|100732226|FG000|COMPLETED|Overall Study||10||
48167047|NCT01735396|100732226|FG000|NOT COMPLETED|Overall Study||1||
48167048|NCT01422369|100732227|FG000|STARTED|NK-104 4mg QD||28||
48167049|NCT01422369|100732227|FG000|COMPLETED|NK-104 4mg QD||28||
48167050|NCT01422369|100732227|FG000|NOT COMPLETED|NK-104 4mg QD||0||
48167051|NCT01422369|100732227|FG000|STARTED|Prezista 800mg/100mg QD||28||
48167052|NCT01422369|100732227|FG000|COMPLETED|Prezista 800mg/100mg QD||28||
48167053|NCT01422369|100732227|FG000|NOT COMPLETED|Prezista 800mg/100mg QD||0||
48167054|NCT01422369|100732227|FG000|STARTED|NK-104 4mg QD & Prezista 800mg/100mg QD||28||
48167055|NCT01422369|100732227|FG000|COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||27||
48167056|NCT01422369|100732227|FG000|NOT COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||1||
48167057|NCT04672096|100732228|FG000|STARTED|Overall Study||10||
48167058|NCT04672096|100732228|FG000|COMPLETED|Overall Study||10||
48167059|NCT04672096|100732228|FG000|NOT COMPLETED|Overall Study||0||
48167060|NCT00402337|100732229|FG000|STARTED|Overall Study||59||
48167061|NCT00402337|100732230|FG001|STARTED|Overall Study||57||
48167062|NCT00402337|100732231|FG002|STARTED|Overall Study||62||
48167063|NCT00402337|100732232|FG003|STARTED|Overall Study||63||
48167064|NCT00402337|100732233|FG004|STARTED|Overall Study||69||
48167065|NCT00402337|100732229|FG000|COMPLETED|Overall Study||54||
48167066|NCT00402337|100732230|FG001|COMPLETED|Overall Study||51||
48167067|NCT00402337|100732231|FG002|COMPLETED|Overall Study||58||
48167068|NCT00402337|100732232|FG003|COMPLETED|Overall Study||51||
48167069|NCT00402337|100732233|FG004|COMPLETED|Overall Study||61||
48167070|NCT00402337|100732229|FG000|NOT COMPLETED|Overall Study||5||
48167071|NCT00402337|100732230|FG001|NOT COMPLETED|Overall Study||6||
48167072|NCT00402337|100732231|FG002|NOT COMPLETED|Overall Study||4||
48167073|NCT00402337|100732232|FG003|NOT COMPLETED|Overall Study||12||
48167074|NCT00402337|100732233|FG004|NOT COMPLETED|Overall Study||8||
48167075|NCT01283321|100732234|FG000|STARTED|Overall Study||10||
48167076|NCT01283321|100732235|FG001|STARTED|Overall Study||10||
48167077|NCT01283321|100732234|FG000|COMPLETED|Overall Study||10||
48167078|NCT01283321|100732235|FG001|COMPLETED|Overall Study||10||
48167079|NCT01283321|100732234|FG000|NOT COMPLETED|Overall Study||0||
48167080|NCT01283321|100732235|FG001|NOT COMPLETED|Overall Study||0||
48167081|NCT02876172|100732236|FG000|STARTED|Overall Study||6||
48167082|NCT02876172|100732237|FG001|STARTED|Overall Study||6||
48167083|NCT02876172|100732236|FG000|COMPLETED|Overall Study||6||
48167084|NCT02876172|100732237|FG001|COMPLETED|Overall Study||6||
48167085|NCT02876172|100732236|FG000|NOT COMPLETED|Overall Study||0||
48167086|NCT02876172|100732237|FG001|NOT COMPLETED|Overall Study||0||
48167087|NCT00720902|100732238|FG000|STARTED|Overall Study||4||
48167088|NCT00720902|100732239|FG001|STARTED|Overall Study||3||
48167089|NCT00720902|100732238|FG000|COMPLETED|Overall Study||0||
48167090|NCT00720902|100732239|FG001|COMPLETED|Overall Study||3||
48167091|NCT00720902|100732238|FG000|NOT COMPLETED|Overall Study||4||
48167092|NCT00720902|100732239|FG001|NOT COMPLETED|Overall Study||0||
48167093|NCT03885011|100732240|FG000|STARTED|Overall Study||53||
48167094|NCT03885011|100732241|FG001|STARTED|Overall Study||55||
48167095|NCT03885011|100732242|FG002|STARTED|Overall Study||58||
48167096|NCT03885011|100732240|FG000|COMPLETED|Overall Study||52||
48167097|NCT03885011|100732241|FG001|COMPLETED|Overall Study||52||
48167098|NCT03885011|100732242|FG002|COMPLETED|Overall Study||57||
48167099|NCT03885011|100732240|FG000|NOT COMPLETED|Overall Study||1||
48167100|NCT03885011|100732241|FG001|NOT COMPLETED|Overall Study||3||
48167101|NCT03885011|100732242|FG002|NOT COMPLETED|Overall Study||1||
48167102|NCT01659658|100732243|FG000|STARTED|Overall Study||90||
48167103|NCT01659658|100732244|FG001|STARTED|Overall Study||26||
48167104|NCT01659658|100732245|FG002|STARTED|Overall Study||10||
48167105|NCT01659658|100732246|FG003|STARTED|Overall Study||2||
48167106|NCT01659658|100732247|FG004|STARTED|Overall Study||49||
48167107|NCT01659658|100732243|FG000|COMPLETED|Overall Study||0||
48167108|NCT01659658|100732244|FG001|COMPLETED|Overall Study||0||
48167109|NCT01659658|100732245|FG002|COMPLETED|Overall Study||0||
48167110|NCT01659658|100732246|FG003|COMPLETED|Overall Study||0||
48167111|NCT01659658|100732247|FG004|COMPLETED|Overall Study||0||
48167112|NCT01659658|100732243|FG000|NOT COMPLETED|Overall Study||90||
48167113|NCT01659658|100732244|FG001|NOT COMPLETED|Overall Study||26||
48167114|NCT01659658|100732245|FG002|NOT COMPLETED|Overall Study||10||
48167115|NCT01659658|100732246|FG003|NOT COMPLETED|Overall Study||2||
48167116|NCT01659658|100732247|FG004|NOT COMPLETED|Overall Study||49||
48167117|NCT01567865|100732248|FG000|STARTED|Enrolled and Vaccinated (Day 0)||163||
48167118|NCT01567865|100732249|FG001|STARTED|Enrolled and Vaccinated (Day 0)||220||
48167119|NCT01567865|100732250|FG002|STARTED|Enrolled and Vaccinated (Day 0)||211||
48167120|NCT01567865|100732251|FG003|STARTED|Enrolled and Vaccinated (Day 0)||224||
48167121|NCT01567865|100732248|FG000|COMPLETED|Enrolled and Vaccinated (Day 0)||163||
48167122|NCT01567865|100732249|FG001|COMPLETED|Enrolled and Vaccinated (Day 0)||220||
48167123|NCT01567865|100732250|FG002|COMPLETED|Enrolled and Vaccinated (Day 0)||211||
48167124|NCT01567865|100732251|FG003|COMPLETED|Enrolled and Vaccinated (Day 0)||224||
48167125|NCT01567865|100732248|FG000|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0||
48167126|NCT01567865|100732249|FG001|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0||
48167127|NCT01567865|100732250|FG002|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0||
48167128|NCT01567865|100732251|FG003|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0||
48167129|NCT01567865|100732248|FG000|STARTED|Evaluated for Immunogenicity||163||
48167130|NCT01567865|100732249|FG001|STARTED|Evaluated for Immunogenicity||220||
48167131|NCT01567865|100732250|FG002|STARTED|Evaluated for Immunogenicity||211||
48167132|NCT01567865|100732251|FG003|STARTED|Evaluated for Immunogenicity||224||
48167133|NCT01567865|100732248|FG000|COMPLETED|Evaluated for Immunogenicity||146||
48167134|NCT01567865|100732249|FG001|COMPLETED|Evaluated for Immunogenicity||195||
48167135|NCT01567865|100732250|FG002|COMPLETED|Evaluated for Immunogenicity||192||
48167136|NCT01567865|100732251|FG003|COMPLETED|Evaluated for Immunogenicity||194||
48167137|NCT01567865|100732248|FG000|NOT COMPLETED|Evaluated for Immunogenicity||17||
48167138|NCT01567865|100732249|FG001|NOT COMPLETED|Evaluated for Immunogenicity||25||
48167139|NCT01567865|100732250|FG002|NOT COMPLETED|Evaluated for Immunogenicity||19||
48167140|NCT01567865|100732251|FG003|NOT COMPLETED|Evaluated for Immunogenicity||30||
48167141|NCT01152294|100732252|FG000|STARTED|Overall Study||213||
48167142|NCT01152294|100732253|FG001|STARTED|Overall Study||188||
48167143|NCT01152294|100732252|FG000|COMPLETED|Overall Study||213||
48167144|NCT01152294|100732253|FG001|COMPLETED|Overall Study||188||
48167145|NCT01152294|100732252|FG000|NOT COMPLETED|Overall Study||0||
48167146|NCT01152294|100732253|FG001|NOT COMPLETED|Overall Study||0||
48167147|NCT00926003|100732254|FG000|STARTED|Baseline||53||
48167148|NCT00926003|100732255|FG001|STARTED|Baseline||54||
48167149|NCT00926003|100732256|FG002|STARTED|Baseline||52||
48167150|NCT00926003|100732254|FG000|COMPLETED|Baseline||53||
48167151|NCT00926003|100732255|FG001|COMPLETED|Baseline||54||
48167152|NCT00926003|100732256|FG002|COMPLETED|Baseline||52||
48167153|NCT00926003|100732254|FG000|NOT COMPLETED|Baseline||0||
48167154|NCT00926003|100732255|FG001|NOT COMPLETED|Baseline||0||
48167155|NCT00926003|100732256|FG002|NOT COMPLETED|Baseline||0||
48167156|NCT00926003|100732254|FG000|STARTED|Post-Training Evaluation||53||
48167157|NCT00926003|100732255|FG001|STARTED|Post-Training Evaluation||54||
48167158|NCT00926003|100732256|FG002|STARTED|Post-Training Evaluation||52||
48167159|NCT00926003|100732254|FG000|COMPLETED|Post-Training Evaluation||52||
48167160|NCT00926003|100732255|FG001|COMPLETED|Post-Training Evaluation||54||
48167161|NCT00926003|100732256|FG002|COMPLETED|Post-Training Evaluation||52||
48167162|NCT00926003|100732254|FG000|NOT COMPLETED|Post-Training Evaluation||1||
48167163|NCT00926003|100732255|FG001|NOT COMPLETED|Post-Training Evaluation||0||
48167164|NCT00926003|100732256|FG002|NOT COMPLETED|Post-Training Evaluation||0||
48167165|NCT00926003|100732254|FG000|STARTED|Post-Training 3-month Follow-up||52||
48167166|NCT00926003|100732255|FG001|STARTED|Post-Training 3-month Follow-up||54||
48167167|NCT00926003|100732256|FG002|STARTED|Post-Training 3-month Follow-up||52||
48167168|NCT00926003|100732254|FG000|COMPLETED|Post-Training 3-month Follow-up||51||
48167169|NCT00926003|100732255|FG001|COMPLETED|Post-Training 3-month Follow-up||54||
48167170|NCT00926003|100732256|FG002|COMPLETED|Post-Training 3-month Follow-up||52||
48167171|NCT00926003|100732254|FG000|NOT COMPLETED|Post-Training 3-month Follow-up||1||
48167172|NCT00926003|100732255|FG001|NOT COMPLETED|Post-Training 3-month Follow-up||0||
48167173|NCT00926003|100732256|FG002|NOT COMPLETED|Post-Training 3-month Follow-up||0||
48167174|NCT00612222|100732257|FG000|STARTED|Overall Study||4||
48330250|NCT01913483|101135942|FG000|STARTED|Overall Study||367|All participants who were randomized to the study were included in the Intent-to-Treat Population.|
48330251|NCT01913483|101135943|FG001|STARTED|Overall Study||365|All participants who were randomized to the study were included in the Intent-to-Treat Population.|
48330252|NCT01913483|101135942|FG000|Received at Least 1 Dose of Study Drug|Overall Study||335|The 656 participants were the same participants for both the Safety Population and mITT Population.|
48330253|NCT01913483|101135943|FG001|Received at Least 1 Dose of Study Drug|Overall Study||321|The 656 participants were the same participants for both the Safety Population and mITT Population.|
48330254|NCT01913483|101135942|FG000|COMPLETED|Overall Study||346|One participant in the Bivalirudin and UFH Arms each died before receiving study drug.|
48330255|NCT01913483|101135943|FG001|COMPLETED|Overall Study||343|One participant in the Bivalirudin and UFH Arms each died before receiving study drug.|
48330256|NCT01913483|101135942|FG000|NOT COMPLETED|Overall Study||21||
48330257|NCT01913483|101135943|FG001|NOT COMPLETED|Overall Study||22||
48330258|NCT04668352|101135944|FG000|STARTED|Overall Study||511||
48330259|NCT04668352|101135945|FG001|STARTED|Overall Study||513||
48330260|NCT04668352|101135944|FG000|COMPLETED|Overall Study||510||
48330261|NCT04668352|101135945|FG001|COMPLETED|Overall Study||511||
48330262|NCT04668352|101135944|FG000|NOT COMPLETED|Overall Study||1||
48330263|NCT04668352|101135945|FG001|NOT COMPLETED|Overall Study||2||
48330264|NCT02926950|101135946|FG000|STARTED|Overall Study||259||
48330265|NCT02926950|101135947|FG001|STARTED|Overall Study||259||
48330266|NCT02926950|101135946|FG000|COMPLETED|Overall Study||210||
48330267|NCT02926950|101135947|FG001|COMPLETED|Overall Study||211||
48330268|NCT02926950|101135946|FG000|NOT COMPLETED|Overall Study||49||
48330269|NCT02926950|101135947|FG001|NOT COMPLETED|Overall Study||48||
48330270|NCT00608985|101135948|FG000|STARTED|Overall Study||177||
48330271|NCT00608985|101135949|FG001|STARTED|Overall Study||186||
48330272|NCT00608985|101135950|FG002|STARTED|Overall Study||176||
48330273|NCT00608985|101135951|FG003|STARTED|Overall Study||168||
48330274|NCT00608985|101135948|FG000|Completed Double-blind Treatment|Overall Study||163||
48330275|NCT00608985|101135949|FG001|Completed Double-blind Treatment|Overall Study||174||
48330276|NCT00608985|101135950|FG002|Completed Double-blind Treatment|Overall Study||171||
48330277|NCT00608985|101135951|FG003|Completed Double-blind Treatment|Overall Study||161||
48330278|NCT00608985|101135948|FG000|COMPLETED|Overall Study||161||
48330279|NCT00608985|101135949|FG001|COMPLETED|Overall Study||173||
48330280|NCT00608985|101135950|FG002|COMPLETED|Overall Study||170||
48330281|NCT00608985|101135951|FG003|COMPLETED|Overall Study||159||
48330282|NCT00608985|101135948|FG000|NOT COMPLETED|Overall Study||16||
48330283|NCT00608985|101135949|FG001|NOT COMPLETED|Overall Study||13||
48330284|NCT00608985|101135950|FG002|NOT COMPLETED|Overall Study||6||
48330285|NCT00608985|101135951|FG003|NOT COMPLETED|Overall Study||9||
48330286|NCT01008280|101135952|FG000|STARTED|Overall Study||88||
48330287|NCT01008280|101135953|FG001|STARTED|Overall Study||92||
48330288|NCT01008280|101135952|FG000|COMPLETED|Overall Study||67||
48330289|NCT01008280|101135953|FG001|COMPLETED|Overall Study||73||
48330290|NCT01008280|101135952|FG000|NOT COMPLETED|Overall Study||21||
48330291|NCT01008280|101135953|FG001|NOT COMPLETED|Overall Study||19||
48330292|NCT01430442|101135954|FG000|STARTED|Overall Study||85||
48330293|NCT01430442|101135955|FG001|STARTED|Overall Study||68||
48330294|NCT01430442|101135956|FG002|STARTED|Overall Study||91||
48330295|NCT01430442|101135957|FG003|STARTED|Overall Study||90||
48330296|NCT01430442|101135958|FG004|STARTED|Overall Study||121||
48330297|NCT01430442|101135959|FG005|STARTED|Overall Study||92||
48330298|NCT01430442|101135960|FG006|STARTED|Overall Study||229||
48330299|NCT01430442|101135961|FG007|STARTED|Overall Study||109||
48330300|NCT01430442|101135954|FG000|COMPLETED|Overall Study||72||
48410560|NCT00678249|101337660|FG002|NOT COMPLETED|Overall Study||0||
48330301|NCT01430442|101135955|FG001|COMPLETED|Overall Study||62||
48330302|NCT01430442|101135956|FG002|COMPLETED|Overall Study||86||
48330303|NCT01430442|101135957|FG003|COMPLETED|Overall Study||86||
48330304|NCT01430442|101135958|FG004|COMPLETED|Overall Study||112||
48330305|NCT01430442|101135959|FG005|COMPLETED|Overall Study||84||
48330306|NCT01430442|101135960|FG006|COMPLETED|Overall Study||210||
48330307|NCT01430442|101135961|FG007|COMPLETED|Overall Study||100||
48330308|NCT01430442|101135954|FG000|NOT COMPLETED|Overall Study||13||
48330309|NCT01430442|101135955|FG001|NOT COMPLETED|Overall Study||6||
48330310|NCT01430442|101135956|FG002|NOT COMPLETED|Overall Study||5||
48410561|NCT00290355|101337661|FG000|STARTED|Overall Study||122||
48410562|NCT00290355|101337662|FG001|STARTED|Overall Study||60||
48410563|NCT00290355|101337661|FG000|COMPLETED|Overall Study||105||
48410564|NCT00290355|101337662|FG001|COMPLETED|Overall Study||55||
48330311|NCT01430442|101135957|FG003|NOT COMPLETED|Overall Study||4||
48330312|NCT01430442|101135958|FG004|NOT COMPLETED|Overall Study||9||
48330313|NCT01430442|101135959|FG005|NOT COMPLETED|Overall Study||8||
48330314|NCT01430442|101135960|FG006|NOT COMPLETED|Overall Study||19||
48330315|NCT01430442|101135961|FG007|NOT COMPLETED|Overall Study||9||
48330316|NCT02918019|101135962|FG000|STARTED|Overall Study||127||
48330317|NCT02918019|101135963|FG001|STARTED|Overall Study||127||
48330318|NCT02918019|101135964|FG002|STARTED|Overall Study||126||
48330319|NCT02918019|101135965|FG003|STARTED|Overall Study||122||
48330320|NCT02918019|101135962|FG000|COMPLETED|Overall Study||121||
48330321|NCT02918019|101135963|FG001|COMPLETED|Overall Study||117||
48330322|NCT02918019|101135964|FG002|COMPLETED|Overall Study||117||
48330323|NCT02918019|101135965|FG003|COMPLETED|Overall Study||113||
48330324|NCT02918019|101135962|FG000|NOT COMPLETED|Overall Study||6||
48330325|NCT02918019|101135963|FG001|NOT COMPLETED|Overall Study||10||
48330326|NCT02918019|101135964|FG002|NOT COMPLETED|Overall Study||9||
48330327|NCT02918019|101135965|FG003|NOT COMPLETED|Overall Study||9||
48410565|NCT00290355|101337661|FG000|NOT COMPLETED|Overall Study||17||
48410566|NCT00290355|101337662|FG001|NOT COMPLETED|Overall Study||5||
48410567|NCT03870893|101337663|FG000|STARTED|Overall Study||23||
48410568|NCT03870893|101337664|FG001|STARTED|Overall Study||24||
48410569|NCT03870893|101337663|FG000|COMPLETED|Overall Study||23||
48410570|NCT03870893|101337664|FG001|COMPLETED|Overall Study||23||
48410571|NCT03870893|101337663|FG000|NOT COMPLETED|Overall Study||0||
48410572|NCT03870893|101337664|FG001|NOT COMPLETED|Overall Study||1||
48410573|NCT01983683|101337665|FG000|STARTED|Overall Study||298||
48330328|NCT03521505|101135966|FG000|STARTED|Overall Study||25||
48330329|NCT03521505|101135967|FG001|STARTED|Overall Study||25||
48330330|NCT03521505|101135966|FG000|COMPLETED|Overall Study||25||
48330331|NCT03521505|101135967|FG001|COMPLETED|Overall Study||25||
48330332|NCT03521505|101135966|FG000|NOT COMPLETED|Overall Study||0||
48330333|NCT03521505|101135967|FG001|NOT COMPLETED|Overall Study||0||
48330334|NCT00758745|101135968|FG000|STARTED|Overall Study||81||
48330335|NCT00758745|101135969|FG001|STARTED|Overall Study||81||
48330336|NCT00758745|101135968|FG000|COMPLETED|Overall Study||60||
48330337|NCT00758745|101135969|FG001|COMPLETED|Overall Study||60||
48330338|NCT00758745|101135968|FG000|NOT COMPLETED|Overall Study||21||
48410574|NCT01983683|101337666|FG001|STARTED|Overall Study||311||
48410575|NCT01983683|101337665|FG000|COMPLETED|Overall Study||260|Include subjects who completed the main study + subjects who completed the re-treatment extension|
48410576|NCT01983683|101337666|FG001|COMPLETED|Overall Study||260|Include subjects who completed the main study + subjects who completed the re-treatment extension|
48410577|NCT01983683|101337665|FG000|NOT COMPLETED|Overall Study||38||
48410578|NCT01983683|101337666|FG001|NOT COMPLETED|Overall Study||51||
48410579|NCT01199198|101337667|FG000|STARTED|Overall Study||24||
48410580|NCT01199198|101337668|FG001|STARTED|Overall Study||24||
48410581|NCT01199198|101337667|FG000|COMPLETED|Overall Study||17||
48167175|NCT00612222|100732257|FG000|COMPLETED|Overall Study||4||
48167176|NCT00612222|100732257|FG000|NOT COMPLETED|Overall Study||0||
48167177|NCT01422135|100732258|FG000|STARTED|Overall Study||4||
48167178|NCT01422135|100732259|FG001|STARTED|Overall Study||4||
48330339|NCT00758745|101135969|FG001|NOT COMPLETED|Overall Study||21||
48330340|NCT04316585|101135970|FG000|STARTED|Overall Study||19||
48330341|NCT04316585|101135971|FG001|STARTED|Overall Study||10||
48167179|NCT01422135|100732260|FG002|STARTED|Overall Study||4||
48167180|NCT01422135|100732261|FG003|STARTED|Overall Study||4||
48330342|NCT04316585|101135970|FG000|COMPLETED|Overall Study||13||
48167181|NCT01422135|100732262|FG004|STARTED|Overall Study||4||
48330343|NCT04316585|101135971|FG001|COMPLETED|Overall Study||5||
48330344|NCT04316585|101135970|FG000|NOT COMPLETED|Overall Study||6||
48330345|NCT04316585|101135971|FG001|NOT COMPLETED|Overall Study||5||
48330346|NCT01445678|101135972|FG000|STARTED|Overall Study||482||
48330347|NCT01445678|101135973|FG001|STARTED|Overall Study||497||
48330348|NCT01445678|101135972|FG000|COMPLETED|Overall Study||452||
48330349|NCT01445678|101135973|FG001|COMPLETED|Overall Study||476||
48330350|NCT01445678|101135972|FG000|NOT COMPLETED|Overall Study||30||
48330351|NCT01445678|101135973|FG001|NOT COMPLETED|Overall Study||21||
48330352|NCT01463098|101135974|FG000|STARTED|Part A (11 Days)||16||
48330353|NCT01463098|101135975|FG001|STARTED|Part A (11 Days)||6||
48330354|NCT01463098|101135976|FG002|STARTED|Part A (11 Days)||6||
48330355|NCT01463098|101135977|FG003|STARTED|Part A (11 Days)||6||
48330356|NCT01463098|101135978|FG004|STARTED|Part A (11 Days)||6||
48330357|NCT01463098|101135979|FG005|STARTED|Part A (11 Days)||6||
48330358|NCT01463098|101135980|FG006|STARTED|Part A (11 Days)||6||
48330359|NCT01463098|101135981|FG007|STARTED|Part A (11 Days)||6||
48330360|NCT01463098|101135982|FG008|STARTED|Part A (11 Days)||6||
48330361|NCT01463098|101135983|FG009|STARTED|Part A (11 Days)||0||
48330362|NCT01463098|101135984|FG010|STARTED|Part A (11 Days)||0||
48330363|NCT01463098|101135985|FG011|STARTED|Part A (11 Days)||0||
48330364|NCT01463098|101135986|FG012|STARTED|Part A (11 Days)||0||
48330365|NCT01463098|101135987|FG013|STARTED|Part A (11 Days)||0||
48330366|NCT01463098|101135974|FG000|COMPLETED|Part A (11 Days)||14||
48330367|NCT01463098|101135975|FG001|COMPLETED|Part A (11 Days)||6||
48330368|NCT01463098|101135976|FG002|COMPLETED|Part A (11 Days)||6||
48330369|NCT01463098|101135977|FG003|COMPLETED|Part A (11 Days)||6||
48330370|NCT01463098|101135978|FG004|COMPLETED|Part A (11 Days)||5||
48747330|NCT01276639|102166042|FG002|NOT COMPLETED|Week 0 to 16||45||
48747331|NCT01276639|102166043|FG003|NOT COMPLETED|Week 0 to 16||0||
48747332|NCT01276639|102166044|FG004|NOT COMPLETED|Week 0 to 16||0||
48747333|NCT01276639|102166040|FG000|STARTED|Week 16 to 52||313||
48747334|NCT01276639|102166041|FG001|STARTED|Week 16 to 52||320||
48747335|NCT01276639|102166042|FG002|STARTED|Week 16 to 52||0||
48747336|NCT01276639|102166043|FG003|STARTED|Week 16 to 52||66||
48747337|NCT01276639|102166044|FG004|STARTED|Week 16 to 52||66||
48747338|NCT01276639|102166040|FG000|COMPLETED|Week 16 to 52||186||
48747339|NCT01276639|102166041|FG001|COMPLETED|Week 16 to 52||219||
48747340|NCT01276639|102166042|FG002|COMPLETED|Week 16 to 52||0||
48747341|NCT01276639|102166043|FG003|COMPLETED|Week 16 to 52||50||
48747342|NCT01276639|102166044|FG004|COMPLETED|Week 16 to 52||45||
48747343|NCT01276639|102166040|FG000|NOT COMPLETED|Week 16 to 52||127||
48747344|NCT01276639|102166041|FG001|NOT COMPLETED|Week 16 to 52||101||
48747345|NCT01276639|102166042|FG002|NOT COMPLETED|Week 16 to 52||0||
48747346|NCT01276639|102166043|FG003|NOT COMPLETED|Week 16 to 52||16||
48747347|NCT01276639|102166044|FG004|NOT COMPLETED|Week 16 to 52||21||
48747348|NCT01508169|102166045|FG000|STARTED|Overall Study||47||
48747349|NCT01508169|102166046|FG001|STARTED|Overall Study||47||
48747350|NCT01508169|102166045|FG000|COMPLETED|Overall Study||44||
48747351|NCT01508169|102166046|FG001|COMPLETED|Overall Study||45||
48747352|NCT01508169|102166045|FG000|NOT COMPLETED|Overall Study||3||
48330371|NCT01463098|101135979|FG005|COMPLETED|Part A (11 Days)||6||
48330372|NCT01463098|101135980|FG006|COMPLETED|Part A (11 Days)||6||
48330373|NCT01463098|101135981|FG007|COMPLETED|Part A (11 Days)||6||
48330374|NCT01463098|101135982|FG008|COMPLETED|Part A (11 Days)||5||
48330375|NCT01463098|101135983|FG009|COMPLETED|Part A (11 Days)||0||
48330376|NCT01463098|101135984|FG010|COMPLETED|Part A (11 Days)||0||
48330377|NCT01463098|101135985|FG011|COMPLETED|Part A (11 Days)||0||
48747353|NCT01508169|102166046|FG001|NOT COMPLETED|Overall Study||2||
48747354|NCT01620086|102166047|FG000|STARTED|Overall Study||13||
48747355|NCT01620086|102166048|FG001|STARTED|Overall Study||11||
48747356|NCT01620086|102166049|FG002|STARTED|Overall Study||2||
48747357|NCT01620086|102166047|FG000|COMPLETED|Overall Study||8||
48747358|NCT01620086|102166048|FG001|COMPLETED|Overall Study||4||
48747359|NCT01620086|102166049|FG002|COMPLETED|Overall Study||2||
48747360|NCT01620086|102166047|FG000|NOT COMPLETED|Overall Study||5||
48747361|NCT01620086|102166048|FG001|NOT COMPLETED|Overall Study||7||
48747362|NCT01620086|102166049|FG002|NOT COMPLETED|Overall Study||0||
48747363|NCT01633788|102166050|FG000|STARTED|Overall Study||57||
48747364|NCT01633788|102166051|FG001|STARTED|Overall Study||58||
48747365|NCT01633788|102166052|FG002|STARTED|Overall Study||59||
48747366|NCT01633788|102166053|FG003|STARTED|Overall Study||58||
48747367|NCT01633788|102166050|FG000|COMPLETED|Overall Study||50||
48330378|NCT01463098|101135986|FG012|COMPLETED|Part A (11 Days)||0||
48330379|NCT01463098|101135987|FG013|COMPLETED|Part A (11 Days)||0||
48747368|NCT01633788|102166051|FG001|COMPLETED|Overall Study||50||
48747369|NCT01633788|102166052|FG002|COMPLETED|Overall Study||49||
48747370|NCT01633788|102166053|FG003|COMPLETED|Overall Study||45||
48747371|NCT01633788|102166050|FG000|NOT COMPLETED|Overall Study||7||
48747372|NCT01633788|102166051|FG001|NOT COMPLETED|Overall Study||8||
48747373|NCT01633788|102166052|FG002|NOT COMPLETED|Overall Study||10||
48747374|NCT01633788|102166053|FG003|NOT COMPLETED|Overall Study||13||
48747375|NCT01673828|102166054|FG000|STARTED|Overall Study||7||
48747376|NCT01673828|102166055|FG001|STARTED|Overall Study||6||
48330380|NCT01463098|101135974|FG000|NOT COMPLETED|Part A (11 Days)||2||
48747377|NCT01673828|102166054|FG000|COMPLETED|Overall Study||7||
48330381|NCT01463098|101135975|FG001|NOT COMPLETED|Part A (11 Days)||0||
48330382|NCT01463098|101135976|FG002|NOT COMPLETED|Part A (11 Days)||0||
48330383|NCT01463098|101135977|FG003|NOT COMPLETED|Part A (11 Days)||0||
48330384|NCT01463098|101135978|FG004|NOT COMPLETED|Part A (11 Days)||1||
48330385|NCT01463098|101135979|FG005|NOT COMPLETED|Part A (11 Days)||0||
48330386|NCT01463098|101135980|FG006|NOT COMPLETED|Part A (11 Days)||0||
48330387|NCT01463098|101135981|FG007|NOT COMPLETED|Part A (11 Days)||0||
48330388|NCT01463098|101135982|FG008|NOT COMPLETED|Part A (11 Days)||1||
48330389|NCT01463098|101135983|FG009|NOT COMPLETED|Part A (11 Days)||0||
48330390|NCT01463098|101135984|FG010|NOT COMPLETED|Part A (11 Days)||0||
48330391|NCT01463098|101135985|FG011|NOT COMPLETED|Part A (11 Days)||0||
48330392|NCT01463098|101135986|FG012|NOT COMPLETED|Part A (11 Days)||0||
48330393|NCT01463098|101135987|FG013|NOT COMPLETED|Part A (11 Days)||0||
48330394|NCT01463098|101135974|FG000|STARTED|Part B (11 Days)||0||
48330395|NCT01463098|101135975|FG001|STARTED|Part B (11 Days)||0||
48330396|NCT01463098|101135976|FG002|STARTED|Part B (11 Days)||0||
48330397|NCT01463098|101135977|FG003|STARTED|Part B (11 Days)||0||
48330398|NCT01463098|101135978|FG004|STARTED|Part B (11 Days)||0||
48330399|NCT01463098|101135979|FG005|STARTED|Part B (11 Days)||0||
48330400|NCT01463098|101135980|FG006|STARTED|Part B (11 Days)||0||
48330401|NCT01463098|101135981|FG007|STARTED|Part B (11 Days)||0||
48330402|NCT01463098|101135982|FG008|STARTED|Part B (11 Days)||0||
48330403|NCT01463098|101135983|FG009|STARTED|Part B (11 Days)||12||
48330404|NCT01463098|101135984|FG010|STARTED|Part B (11 Days)||11||
48330405|NCT01463098|101135985|FG011|STARTED|Part B (11 Days)||13||
48330406|NCT01463098|101135986|FG012|STARTED|Part B (11 Days)||10||
48330407|NCT01463098|101135987|FG013|STARTED|Part B (11 Days)||12||
48330408|NCT01463098|101135974|FG000|COMPLETED|Part B (11 Days)||0||
48330409|NCT01463098|101135975|FG001|COMPLETED|Part B (11 Days)||0||
48330410|NCT01463098|101135976|FG002|COMPLETED|Part B (11 Days)||0||
48330411|NCT01463098|101135977|FG003|COMPLETED|Part B (11 Days)||0||
48330412|NCT01463098|101135978|FG004|COMPLETED|Part B (11 Days)||0||
48330413|NCT01463098|101135979|FG005|COMPLETED|Part B (11 Days)||0||
48330414|NCT01463098|101135980|FG006|COMPLETED|Part B (11 Days)||0||
48330415|NCT01463098|101135981|FG007|COMPLETED|Part B (11 Days)||0||
48330416|NCT01463098|101135982|FG008|COMPLETED|Part B (11 Days)||0||
48330417|NCT01463098|101135983|FG009|COMPLETED|Part B (11 Days)||12||
48330418|NCT01463098|101135984|FG010|COMPLETED|Part B (11 Days)||11||
48330419|NCT01463098|101135985|FG011|COMPLETED|Part B (11 Days)||12||
48330420|NCT01463098|101135986|FG012|COMPLETED|Part B (11 Days)||10||
48330421|NCT01463098|101135987|FG013|COMPLETED|Part B (11 Days)||12||
48330422|NCT01463098|101135974|FG000|NOT COMPLETED|Part B (11 Days)||0||
48330423|NCT01463098|101135975|FG001|NOT COMPLETED|Part B (11 Days)||0||
48330424|NCT01463098|101135976|FG002|NOT COMPLETED|Part B (11 Days)||0||
48330425|NCT01463098|101135977|FG003|NOT COMPLETED|Part B (11 Days)||0||
48330426|NCT01463098|101135978|FG004|NOT COMPLETED|Part B (11 Days)||0||
48330427|NCT01463098|101135979|FG005|NOT COMPLETED|Part B (11 Days)||0||
48330428|NCT01463098|101135980|FG006|NOT COMPLETED|Part B (11 Days)||0||
48330429|NCT01463098|101135981|FG007|NOT COMPLETED|Part B (11 Days)||0||
48330430|NCT01463098|101135982|FG008|NOT COMPLETED|Part B (11 Days)||0||
48330431|NCT01463098|101135983|FG009|NOT COMPLETED|Part B (11 Days)||0||
48330432|NCT01463098|101135984|FG010|NOT COMPLETED|Part B (11 Days)||0||
48330433|NCT01463098|101135985|FG011|NOT COMPLETED|Part B (11 Days)||1||
48330434|NCT01463098|101135986|FG012|NOT COMPLETED|Part B (11 Days)||0||
48330435|NCT01463098|101135987|FG013|NOT COMPLETED|Part B (11 Days)||0||
48330436|NCT01100944|101135988|FG000|STARTED|Dose Escalation Phase 1 Dose Level 1||6||
48330437|NCT01100944|101135989|FG001|STARTED|Dose Escalation Phase 1 Dose Level 1||0||
48330438|NCT01100944|101135990|FG002|STARTED|Dose Escalation Phase 1 Dose Level 1||0||
48330439|NCT01100944|101135988|FG000|COMPLETED|Dose Escalation Phase 1 Dose Level 1||2||
48330440|NCT01100944|101135989|FG001|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0||
48330441|NCT01100944|101135990|FG002|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0||
48330442|NCT01100944|101135988|FG000|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||4||
48330443|NCT01100944|101135989|FG001|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0||
48624389|NCT03428100|101863880|FG013|COMPLETED|Double-Blind Treatment Week 0 to Week 52||0||
48330444|NCT01100944|101135990|FG002|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0||
48330445|NCT01100944|101135988|FG000|STARTED|Dose Escalation Phase 1 Dose Level 2||0||
48330446|NCT01100944|101135989|FG001|STARTED|Dose Escalation Phase 1 Dose Level 2||2||
48624390|NCT03428100|101863881|FG014|COMPLETED|Double-Blind Treatment Week 0 to Week 52||0||
48330447|NCT01100944|101135990|FG002|STARTED|Dose Escalation Phase 1 Dose Level 2||0||
48330448|NCT01100944|101135988|FG000|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0||
48330449|NCT01100944|101135989|FG001|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0||
48330450|NCT01100944|101135990|FG002|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0||
48330451|NCT01100944|101135988|FG000|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0||
48330452|NCT01100944|101135989|FG001|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||2||
48330453|NCT01100944|101135990|FG002|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0||
48330454|NCT01100944|101135988|FG000|STARTED|Expansion Phase - Phase 2||0||
48330455|NCT01100944|101135989|FG001|STARTED|Expansion Phase - Phase 2||0||
48330456|NCT01100944|101135990|FG002|STARTED|Expansion Phase - Phase 2||18||
48410582|NCT01199198|101337668|FG001|COMPLETED|Overall Study||13||
48410583|NCT01199198|101337667|FG000|NOT COMPLETED|Overall Study||7||
48410584|NCT01199198|101337668|FG001|NOT COMPLETED|Overall Study||11||
48410585|NCT02158728|101337669|FG000|STARTED|Overall Study||80||
48410586|NCT02158728|101337669|FG000|COMPLETED|Overall Study||53||
48410587|NCT02158728|101337669|FG000|NOT COMPLETED|Overall Study||27||
48410588|NCT01347073|101337670|FG000|STARTED|Overall Study||23||
48410589|NCT01347073|101337670|FG000|COMPLETED|Overall Study||21||
48410590|NCT01347073|101337670|FG000|NOT COMPLETED|Overall Study||2||
48410591|NCT01092364|101337671|FG000|STARTED|Overall Study||122||
48410592|NCT01092364|101337672|FG001|STARTED|Overall Study||120||
48410593|NCT01092364|101337673|FG002|STARTED|Overall Study||123||
48410594|NCT01092364|101337671|FG000|COMPLETED|Overall Study||104||
48410595|NCT01092364|101337672|FG001|COMPLETED|Overall Study||104||
48410596|NCT01092364|101337673|FG002|COMPLETED|Overall Study||105||
48410597|NCT01092364|101337671|FG000|NOT COMPLETED|Overall Study||18||
48410598|NCT01092364|101337672|FG001|NOT COMPLETED|Overall Study||16||
48410599|NCT01092364|101337673|FG002|NOT COMPLETED|Overall Study||18||
48410600|NCT01023516|101337674|FG000|STARTED|Overall Study||313||
48410601|NCT01023516|101337675|FG001|STARTED|Overall Study||302||
48410602|NCT01023516|101337674|FG000|COMPLETED|Overall Study||289||
48410603|NCT01023516|101337675|FG001|COMPLETED|Overall Study||284||
48410604|NCT01023516|101337674|FG000|NOT COMPLETED|Overall Study||24||
48410605|NCT01023516|101337675|FG001|NOT COMPLETED|Overall Study||18||
48747378|NCT01673828|102166055|FG001|COMPLETED|Overall Study||6||
48747379|NCT01673828|102166054|FG000|NOT COMPLETED|Overall Study||0||
48747380|NCT01673828|102166055|FG001|NOT COMPLETED|Overall Study||0||
48747381|NCT00743249|102166056|FG000|STARTED|Overall Study||30||
48747382|NCT00743249|102166057|FG001|STARTED|Overall Study||30||
48747383|NCT00743249|102166056|FG000|COMPLETED|Overall Study||28||
48747384|NCT00743249|102166057|FG001|COMPLETED|Overall Study||24||
48330457|NCT01100944|101135988|FG000|COMPLETED|Expansion Phase - Phase 2||0||
48330458|NCT01100944|101135989|FG001|COMPLETED|Expansion Phase - Phase 2||0||
48410606|NCT01424306|101337676|FG000|STARTED|Overall Study||4||
48410607|NCT01424306|101337677|FG001|STARTED|Overall Study||4||
48410608|NCT01424306|101337678|FG002|STARTED|Overall Study||3||
48410609|NCT01424306|101337679|FG003|STARTED|Overall Study||3||
48410610|NCT01424306|101337680|FG004|STARTED|Overall Study||5||
48410611|NCT01424306|101337681|FG005|STARTED|Overall Study||6||
48410612|NCT01424306|101337676|FG000|COMPLETED|Overall Study||4||
48410613|NCT01424306|101337677|FG001|COMPLETED|Overall Study||4||
48410614|NCT01424306|101337678|FG002|COMPLETED|Overall Study||3||
48410615|NCT01424306|101337679|FG003|COMPLETED|Overall Study||3||
48410616|NCT01424306|101337680|FG004|COMPLETED|Overall Study||4||
48624391|NCT03428100|101863882|FG015|COMPLETED|Double-Blind Treatment Week 0 to Week 52||0||
48624392|NCT03428100|101863883|FG016|COMPLETED|Double-Blind Treatment Week 0 to Week 52||0||
48624393|NCT03428100|101863884|FG017|COMPLETED|Double-Blind Treatment Week 0 to Week 52||0||
48410617|NCT01424306|101337681|FG005|COMPLETED|Overall Study||6||
48410618|NCT01424306|101337676|FG000|NOT COMPLETED|Overall Study||0||
48624394|NCT03428100|101863885|FG018|COMPLETED|Double-Blind Treatment Week 0 to Week 52||0||
48624395|NCT03428100|101863867|FG000|NOT COMPLETED|Double-Blind Treatment Week 0 to Week 52||21||
48624396|NCT03428100|101863868|FG001|NOT COMPLETED|Double-Blind Treatment Week 0 to Week 52||13||
48624397|NCT03428100|101863869|FG002|NOT COMPLETED|Double-Blind Treatment Week 0 to Week 52||12||
48624398|NCT03428100|101863870|FG003|NOT COMPLETED|Double-Blind Treatment Week 0 to Week 52||7||
48624399|NCT03428100|101863871|FG004|NOT COMPLETED|Double-Blind Treatment Week 0 to Week 52||0||
48624400|NCT03428100|101863872|FG005|NOT COMPLETED|Double-Blind Treatment Week 0 to Week 52||0||
48624401|NCT03428100|101863873|FG006|NOT COMPLETED|Double-Blind Treatment Week 0 to Week 52||0||
48624402|NCT03428100|101863874|FG007|NOT COMPLETED|Double-Blind Treatment Week 0 to Week 52||0||
48624403|NCT03428100|101863875|FG008|NOT COMPLETED|Double-Blind Treatment Week 0 to Week 52||0||
48624404|NCT03428100|101863876|FG009|NOT COMPLETED|Double-Blind Treatment Week 0 to Week 52||0||
48624405|NCT03428100|101863877|FG010|NOT COMPLETED|Double-Blind Treatment Week 0 to Week 52||0||
48624406|NCT03428100|101863878|FG011|NOT COMPLETED|Double-Blind Treatment Week 0 to Week 52||0||
48747385|NCT00743249|102166056|FG000|NOT COMPLETED|Overall Study||2||
48410619|NCT01424306|101337677|FG001|NOT COMPLETED|Overall Study||0||
48410620|NCT01424306|101337678|FG002|NOT COMPLETED|Overall Study||0||
48410621|NCT01424306|101337679|FG003|NOT COMPLETED|Overall Study||0||
48410622|NCT01424306|101337680|FG004|NOT COMPLETED|Overall Study||1||
48410623|NCT01424306|101337681|FG005|NOT COMPLETED|Overall Study||0||
48410624|NCT02252068|101337682|FG000|STARTED|Overall Study||5||
48410625|NCT02252068|101337683|FG001|STARTED|Overall Study||13||
48410626|NCT02252068|101337684|FG002|STARTED|Overall Study||13||
48410627|NCT02252068|101337682|FG000|COMPLETED|Overall Study||3||
48410628|NCT02252068|101337683|FG001|COMPLETED|Overall Study||13||
48410629|NCT02252068|101337684|FG002|COMPLETED|Overall Study||13||
48410630|NCT02252068|101337682|FG000|NOT COMPLETED|Overall Study||2||
48410631|NCT02252068|101337683|FG001|NOT COMPLETED|Overall Study||0||
48410632|NCT02252068|101337684|FG002|NOT COMPLETED|Overall Study||0||
48410633|NCT01998906|101337685|FG000|STARTED|Overall Study||115||
48410634|NCT01998906|101337686|FG001|STARTED|Overall Study||116||
48410635|NCT01998906|101337687|FG002|STARTED|Overall Study||99||
48410636|NCT01998906|101337685|FG000|COMPLETED|Overall Study||1||
48410637|NCT01998906|101337686|FG001|COMPLETED|Overall Study||2||
48410638|NCT01998906|101337687|FG002|COMPLETED|Overall Study||1||
48410639|NCT01998906|101337685|FG000|NOT COMPLETED|Overall Study||114||
48410640|NCT01998906|101337686|FG001|NOT COMPLETED|Overall Study||114||
48330459|NCT01100944|101135990|FG002|COMPLETED|Expansion Phase - Phase 2||18||
48330460|NCT01100944|101135988|FG000|NOT COMPLETED|Expansion Phase - Phase 2||0||
48330461|NCT01100944|101135989|FG001|NOT COMPLETED|Expansion Phase - Phase 2||0||
48330462|NCT01100944|101135990|FG002|NOT COMPLETED|Expansion Phase - Phase 2||0||
48330463|NCT02361216|101135991|FG000|STARTED|3 Day Treatment and 8 Week Follow/up||552||
48330464|NCT02361216|101135992|FG001|STARTED|3 Day Treatment and 8 Week Follow/up||177||
48330465|NCT02361216|101135991|FG000|COMPLETED|3 Day Treatment and 8 Week Follow/up||541||
48330466|NCT02361216|101135992|FG001|COMPLETED|3 Day Treatment and 8 Week Follow/up||158||
48330467|NCT02361216|101135991|FG000|NOT COMPLETED|3 Day Treatment and 8 Week Follow/up||11||
48330468|NCT02361216|101135992|FG001|NOT COMPLETED|3 Day Treatment and 8 Week Follow/up||19||
48330469|NCT02361216|101135991|FG000|STARTED|12-month Follow-up||541||
48330470|NCT02361216|101135992|FG001|STARTED|12-month Follow-up||157||
48330471|NCT02361216|101135991|FG000|COMPLETED|12-month Follow-up||489||
48330472|NCT02361216|101135992|FG001|COMPLETED|12-month Follow-up||130||
48330473|NCT02361216|101135991|FG000|NOT COMPLETED|12-month Follow-up||52||
48330474|NCT02361216|101135992|FG001|NOT COMPLETED|12-month Follow-up||27||
48330475|NCT01394705|101135993|FG000|STARTED|Overall Study||21||
48330476|NCT01394705|101135994|FG001|STARTED|Overall Study||21||
48330477|NCT01394705|101135993|FG000|COMPLETED|Overall Study||19||
48330478|NCT01394705|101135994|FG001|COMPLETED|Overall Study||19||
48330479|NCT01394705|101135993|FG000|NOT COMPLETED|Overall Study||2||
48330480|NCT01394705|101135994|FG001|NOT COMPLETED|Overall Study||2||
48330481|NCT03138876|101135995|FG000|STARTED|Overall Study||20||
48330482|NCT03138876|101135995|FG000|COMPLETED|Overall Study||20||
48330483|NCT03138876|101135995|FG000|NOT COMPLETED|Overall Study||0||
48330484|NCT00428597|101135996|FG000|STARTED|Overall Study||86||
48330485|NCT00428597|101135997|FG001|STARTED|Overall Study||85||
48330486|NCT00428597|101135996|FG000|Received Treatment|Overall Study||83||
48330487|NCT00428597|101135997|FG001|Received Treatment|Overall Study||82||
48330488|NCT00428597|101135996|FG000|COMPLETED|Overall Study||0||
48330489|NCT00428597|101135997|FG001|COMPLETED|Overall Study||0||
48330490|NCT00428597|101135996|FG000|NOT COMPLETED|Overall Study||86||
48330491|NCT00428597|101135997|FG001|NOT COMPLETED|Overall Study||85||
48330492|NCT04823949|101135998|FG000|STARTED|Overall Study||101||
48330493|NCT04823949|101135999|FG001|STARTED|Overall Study||101||
48330494|NCT04823949|101135998|FG000|COMPLETED|Overall Study||101||
48330495|NCT04823949|101135999|FG001|COMPLETED|Overall Study||96||
48330496|NCT04823949|101135998|FG000|NOT COMPLETED|Overall Study||0||
48330497|NCT04823949|101135999|FG001|NOT COMPLETED|Overall Study||5||
48330498|NCT00666458|101136000|FG000|STARTED|Overall Study||403||
48330499|NCT00666458|101136001|FG001|STARTED|Overall Study||398||
48330500|NCT00666458|101136000|FG000|COMPLETED|Overall Study||365||
48330501|NCT00666458|101136001|FG001|COMPLETED|Overall Study||374||
48330502|NCT00666458|101136000|FG000|NOT COMPLETED|Overall Study||38||
48330503|NCT00666458|101136001|FG001|NOT COMPLETED|Overall Study||24||
48330504|NCT00361595|101136002|FG000|STARTED|Overall Study||35||
48330505|NCT00361595|101136002|FG000|COMPLETED|Overall Study||35||
48330506|NCT00361595|101136002|FG000|NOT COMPLETED|Overall Study||0||
48330507|NCT00923117|101136003|FG000|STARTED|Overall Study||44||
48410641|NCT01998906|101337687|FG002|NOT COMPLETED|Overall Study||98||
48410642|NCT02574520|101337688|FG000|STARTED|Overall Study||48|Subjects randomized|
48410643|NCT02574520|101337689|FG001|STARTED|Overall Study||46|Subjects randomized|
48410644|NCT02574520|101337690|FG002|STARTED|Overall Study||153|Subjects randomized|
48410645|NCT02574520|101337691|FG003|STARTED|Overall Study||152|Subjects randomized|
48410646|NCT02574520|101337688|FG000|Dosed|Overall Study||46|ITT subjects who are randomized and dosed. One subject in Part 1 was randomized to receive SABER-Bupivacaine but was treated with Saline Placebo (the safety population includes subjects as randomized).|
48439930|NCT00563706|101409984|FG007|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0||
48330508|NCT00923117|101136004|FG001|STARTED|Overall Study||43||
48330509|NCT00923117|101136003|FG000|COMPLETED|Overall Study||44||
48330510|NCT00923117|101136004|FG001|COMPLETED|Overall Study||43||
48330511|NCT00923117|101136003|FG000|NOT COMPLETED|Overall Study||0||
48330512|NCT00923117|101136004|FG001|NOT COMPLETED|Overall Study||0||
48330513|NCT00356278|101136005|FG000|STARTED|Overall Study||53||
48330514|NCT00356278|101136006|FG001|STARTED|Overall Study||50||
48330515|NCT00356278|101136007|FG002|STARTED|Overall Study||53||
48330516|NCT00356278|101136005|FG000|COMPLETED|Overall Study||28||
48330517|NCT00356278|101136006|FG001|COMPLETED|Overall Study||35||
48330518|NCT00356278|101136007|FG002|COMPLETED|Overall Study||34||
48330519|NCT00356278|101136005|FG000|NOT COMPLETED|Overall Study||25||
48330520|NCT00356278|101136006|FG001|NOT COMPLETED|Overall Study||15||
48330521|NCT00356278|101136007|FG002|NOT COMPLETED|Overall Study||19||
48330522|NCT04600895|101136008|FG000|STARTED|Overall Study||599||
48330523|NCT04600895|101136009|FG001|STARTED|Overall Study||588||
48330524|NCT04600895|101136008|FG000|ITT|Overall Study||599||
48330525|NCT04600895|101136009|FG001|ITT|Overall Study||588||
48330526|NCT04600895|101136008|FG000|MITT|Overall Study||599||
48330527|NCT04600895|101136009|FG001|MITT|Overall Study||588||
48330528|NCT04600895|101136008|FG000|MITT2|Overall Study||539||
48330529|NCT04600895|101136009|FG001|MITT2|Overall Study||505||
48330530|NCT04600895|101136008|FG000|COMPLETED|Overall Study||480||
48330531|NCT04600895|101136009|FG001|COMPLETED|Overall Study||462||
48330532|NCT04600895|101136008|FG000|NOT COMPLETED|Overall Study||119||
48330533|NCT04600895|101136009|FG001|NOT COMPLETED|Overall Study||126||
48330534|NCT01831960|101136010|FG000|STARTED|Overall Study||20||
48330535|NCT01831960|101136011|FG001|STARTED|Overall Study||22||
48330536|NCT01831960|101136010|FG000|COMPLETED|Overall Study||20||
48330537|NCT01831960|101136011|FG001|COMPLETED|Overall Study||22||
48330538|NCT01831960|101136010|FG000|NOT COMPLETED|Overall Study||0||
48330539|NCT01831960|101136011|FG001|NOT COMPLETED|Overall Study||0||
48330540|NCT00464178|101136012|FG000|STARTED|Overall Study||6||
48330541|NCT00464178|101136012|FG000|COMPLETED|Overall Study||4||
48330542|NCT00464178|101136012|FG000|NOT COMPLETED|Overall Study||2||
48330543|NCT01964352|101136013|FG000|STARTED|Overall Study||204||
48330544|NCT01964352|101136014|FG001|STARTED|Overall Study||203||
48330545|NCT01964352|101136015|FG002|STARTED|Overall Study||202||
48330546|NCT01964352|101136016|FG003|STARTED|Overall Study||203||
48330547|NCT01964352|101136013|FG000|COMPLETED|Overall Study||178||
48330548|NCT01964352|101136014|FG001|COMPLETED|Overall Study||192||
48330549|NCT01964352|101136015|FG002|COMPLETED|Overall Study||196||
48330550|NCT01964352|101136016|FG003|COMPLETED|Overall Study||195||
48330551|NCT01964352|101136013|FG000|NOT COMPLETED|Overall Study||26||
48330552|NCT01964352|101136014|FG001|NOT COMPLETED|Overall Study||11||
48330553|NCT01964352|101136015|FG002|NOT COMPLETED|Overall Study||6||
48330554|NCT01964352|101136016|FG003|NOT COMPLETED|Overall Study||8||
48330555|NCT01545700|101136017|FG000|STARTED|Overall Study||34||
48330556|NCT01545700|101136018|FG001|STARTED|Overall Study||33||
48330557|NCT01545700|101136019|FG002|STARTED|Overall Study||33||
48330558|NCT01545700|101136020|FG003|STARTED|Overall Study||34||
48330559|NCT01545700|101136021|FG004|STARTED|Overall Study||33||
48330560|NCT01545700|101136022|FG005|STARTED|Overall Study||33||
48330561|NCT01545700|101136017|FG000|COMPLETED|Overall Study||33||
48330562|NCT01545700|101136018|FG001|COMPLETED|Overall Study||32||
48330563|NCT01545700|101136019|FG002|COMPLETED|Overall Study||31||
48330564|NCT01545700|101136020|FG003|COMPLETED|Overall Study||34||
48330565|NCT01545700|101136021|FG004|COMPLETED|Overall Study||32||
48410647|NCT02574520|101337689|FG001|Dosed|Overall Study||46|ITT subjects who are randomized and dosed. One subject in Part 1 was randomized to receive SABER-Bupivacaine but was treated with Saline Placebo (the safety population includes subjects as randomized).|
48439931|NCT00563706|101409985|FG008|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0||
48439932|NCT01279265|101409986|FG000|STARTED|Overall Study||13||
48747386|NCT00743249|102166057|FG001|NOT COMPLETED|Overall Study||6||
48747387|NCT01432405|102166058|FG000|STARTED|Overall Study||12||
48747388|NCT01432405|102166059|FG001|STARTED|Overall Study||12||
48330566|NCT01545700|101136022|FG005|COMPLETED|Overall Study||33||
48330567|NCT01545700|101136017|FG000|NOT COMPLETED|Overall Study||1||
48330568|NCT01545700|101136018|FG001|NOT COMPLETED|Overall Study||1||
48330569|NCT01545700|101136019|FG002|NOT COMPLETED|Overall Study||2||
48330570|NCT01545700|101136020|FG003|NOT COMPLETED|Overall Study||0||
48330571|NCT01545700|101136021|FG004|NOT COMPLETED|Overall Study||1||
48330572|NCT01545700|101136022|FG005|NOT COMPLETED|Overall Study||0||
48330573|NCT03363633|101136023|FG000|STARTED|Overall Study||12||
48330574|NCT03363633|101136023|FG000|COMPLETED|Overall Study||0||
48330575|NCT03363633|101136023|FG000|NOT COMPLETED|Overall Study||12||
48330576|NCT01282229|101136024|FG000|STARTED|Overall Study||59||
48330577|NCT01282229|101136024|FG000|COMPLETED|Overall Study||57||
48747389|NCT01432405|102166058|FG000|COMPLETED|Overall Study||11||
48330578|NCT01282229|101136024|FG000|NOT COMPLETED|Overall Study||2||
48330579|NCT01337076|101136025|FG000|STARTED|Overall Study||21||
48330580|NCT01337076|101136025|FG000|COMPLETED|Overall Study||19||
48330581|NCT01337076|101136025|FG000|NOT COMPLETED|Overall Study||2||
48330582|NCT03804684|101136026|FG000|STARTED|Overall Study||28||
48330583|NCT03804684|101136027|FG001|STARTED|Overall Study||44||
48330584|NCT03804684|101136026|FG000|COMPLETED|Overall Study||25||
48330585|NCT03804684|101136027|FG001|COMPLETED|Overall Study||26||
48330586|NCT03804684|101136026|FG000|NOT COMPLETED|Overall Study||3||
48330587|NCT03804684|101136027|FG001|NOT COMPLETED|Overall Study||18||
48330588|NCT02062658|101136028|FG000|STARTED|Overall Study||10||
48330589|NCT02062658|101136028|FG000|COMPLETED|Overall Study||8||
48330590|NCT02062658|101136028|FG000|NOT COMPLETED|Overall Study||2||
48330591|NCT04352439|101136029|FG000|STARTED|Overall Study||19||
48330592|NCT04352439|101136029|FG000|COMPLETED|Overall Study||19||
48330593|NCT04352439|101136029|FG000|NOT COMPLETED|Overall Study||0||
48330594|NCT01777152|101136030|FG000|STARTED|Overall Study||226||
48330595|NCT01777152|101136031|FG001|STARTED|Overall Study||226||
48330596|NCT01777152|101136030|FG000|COMPLETED|Overall Study||131|Completed due to study closure by sponsor|
48330597|NCT01777152|101136031|FG001|COMPLETED|Overall Study||116|Completed due to study closure by sponsor|
48330598|NCT01777152|101136030|FG000|NOT COMPLETED|Overall Study||95||
48330599|NCT01777152|101136031|FG001|NOT COMPLETED|Overall Study||110||
48330600|NCT03509350|101136032|FG000|STARTED|Overall Study||252||
48330601|NCT03509350|101136033|FG001|STARTED|Overall Study||249||
48330602|NCT03509350|101136032|FG000|COMPLETED|Overall Study||252||
48330603|NCT03509350|101136033|FG001|COMPLETED|Overall Study||247||
48330604|NCT03509350|101136032|FG000|NOT COMPLETED|Overall Study||0||
48330605|NCT03509350|101136033|FG001|NOT COMPLETED|Overall Study||2||
48330606|NCT02302963|101136034|FG000|STARTED|Overall Study||25||
48330607|NCT02302963|101136035|FG001|STARTED|Overall Study||24||
48330608|NCT02302963|101136034|FG000|COMPLETED|Overall Study||22||
48330609|NCT02302963|101136035|FG001|COMPLETED|Overall Study||22||
48330610|NCT02302963|101136034|FG000|NOT COMPLETED|Overall Study||3||
48330611|NCT02302963|101136035|FG001|NOT COMPLETED|Overall Study||2||
48330612|NCT01731678|101136036|FG000|STARTED|Overall Study||39||
48330613|NCT01731678|101136036|FG000|COMPLETED|Overall Study||32||
48330614|NCT01731678|101136036|FG000|NOT COMPLETED|Overall Study||7||
48330615|NCT00803179|101136037|FG000|STARTED|Overall Study||5||
48330616|NCT00803179|101136037|FG000|COMPLETED|Overall Study||2||
48330617|NCT00803179|101136037|FG000|NOT COMPLETED|Overall Study||3||
48330618|NCT01355705|101136038|FG000|STARTED|Overall Study||14||
48410648|NCT02574520|101337690|FG002|Dosed|Overall Study||148|ITT subjects who are randomized and dosed. One subject in Part 1 was randomized to receive SABER-Bupivacaine but was treated with Saline Placebo (the safety population includes subjects as randomized).|
48410649|NCT02574520|101337691|FG003|Dosed|Overall Study||148|ITT subjects who are randomized and dosed. One subject in Part 1 was randomized to receive SABER-Bupivacaine but was treated with Saline Placebo (the safety population includes subjects as randomized).|
48410650|NCT02574520|101337688|FG000|COMPLETED|Overall Study||46||
48410651|NCT02574520|101337689|FG001|COMPLETED|Overall Study||46||
48410652|NCT02574520|101337690|FG002|COMPLETED|Overall Study||148||
48747390|NCT01432405|102166059|FG001|COMPLETED|Overall Study||10||
48747391|NCT01432405|102166058|FG000|NOT COMPLETED|Overall Study||1||
48747392|NCT01432405|102166059|FG001|NOT COMPLETED|Overall Study||2||
48747393|NCT02524171|102166060|FG000|STARTED|6-month Follow-up||172||
48747394|NCT02524171|102166061|FG001|STARTED|6-month Follow-up||169||
48747395|NCT02524171|102166060|FG000|COMPLETED|6-month Follow-up||119||
48747396|NCT02524171|102166061|FG001|COMPLETED|6-month Follow-up||124||
48747397|NCT02524171|102166060|FG000|NOT COMPLETED|6-month Follow-up||53||
48747398|NCT02524171|102166061|FG001|NOT COMPLETED|6-month Follow-up||45||
48747399|NCT02524171|102166060|FG000|STARTED|12-month Follow-up Interview||172||
48747400|NCT02524171|102166061|FG001|STARTED|12-month Follow-up Interview||169||
48747401|NCT02524171|102166060|FG000|COMPLETED|12-month Follow-up Interview||127||
48747402|NCT02524171|102166061|FG001|COMPLETED|12-month Follow-up Interview||128||
48747403|NCT02524171|102166060|FG000|NOT COMPLETED|12-month Follow-up Interview||45||
48747404|NCT02524171|102166061|FG001|NOT COMPLETED|12-month Follow-up Interview||41||
48747405|NCT01165541|102166062|FG000|STARTED|Quetiapine XR Monotherapy||20||
48747406|NCT01165541|102166062|FG000|COMPLETED|Quetiapine XR Monotherapy||16||
48747407|NCT01165541|102166062|FG000|NOT COMPLETED|Quetiapine XR Monotherapy||4||
48747408|NCT01165541|102166062|FG000|STARTED|Quetiapine XR and Mirtazepine||16||
48747409|NCT01165541|102166062|FG000|COMPLETED|Quetiapine XR and Mirtazepine||11||
48747410|NCT01165541|102166062|FG000|NOT COMPLETED|Quetiapine XR and Mirtazepine||5||
48747411|NCT00165672|102166063|FG000|STARTED|Overall Study||13||
48747412|NCT00165672|102166064|FG001|STARTED|Overall Study||13||
48747413|NCT00165672|102166063|FG000|COMPLETED|Overall Study||13||
48747414|NCT00165672|102166064|FG001|COMPLETED|Overall Study||12||
48330619|NCT01355705|101136038|FG000|COMPLETED|Overall Study||14|1 subject completed but was not evaluable.|
48330620|NCT01355705|101136038|FG000|NOT COMPLETED|Overall Study||0||
48330621|NCT00268242|101136039|FG000|STARTED|Overall Study||24||
48330622|NCT00268242|101136039|FG000|COMPLETED|Overall Study||23||
48330623|NCT00268242|101136039|FG000|NOT COMPLETED|Overall Study||1||
48330624|NCT03310970|101136040|FG000|STARTED|Overall Study||11||
48330625|NCT03310970|101136041|FG001|STARTED|Overall Study||12||
48330626|NCT03310970|101136040|FG000|COMPLETED|Overall Study||11||
48330627|NCT03310970|101136041|FG001|COMPLETED|Overall Study||11||
48330628|NCT03310970|101136040|FG000|NOT COMPLETED|Overall Study||0||
48330629|NCT03310970|101136041|FG001|NOT COMPLETED|Overall Study||1||
48330630|NCT03400800|101136042|FG000|STARTED|Overall Study||810||
48330631|NCT03400800|101136043|FG001|STARTED|Overall Study||807||
48330632|NCT03400800|101136042|FG000|COMPLETED|Overall Study||772||
48330633|NCT03400800|101136043|FG001|COMPLETED|Overall Study||770||
48330634|NCT03400800|101136042|FG000|NOT COMPLETED|Overall Study||38||
48330635|NCT03400800|101136043|FG001|NOT COMPLETED|Overall Study||37||
48330636|NCT02175680|101136044|FG000|STARTED|Overall Study||43||
48330637|NCT02175680|101136044|FG000|COMPLETED|Overall Study||41||
48330638|NCT02175680|101136044|FG000|NOT COMPLETED|Overall Study||2||
48330639|NCT03350217|101136045|FG000|STARTED|Overall Study||79||
48624407|NCT03428100|101863879|FG012|NOT COMPLETED|Double-Blind Treatment Week 0 to Week 52||0||
48624408|NCT03428100|101863880|FG013|NOT COMPLETED|Double-Blind Treatment Week 0 to Week 52||0||
48624409|NCT03428100|101863881|FG014|NOT COMPLETED|Double-Blind Treatment Week 0 to Week 52||0||
48624410|NCT03428100|101863882|FG015|NOT COMPLETED|Double-Blind Treatment Week 0 to Week 52||0||
48624411|NCT03428100|101863883|FG016|NOT COMPLETED|Double-Blind Treatment Week 0 to Week 52||0||
48624412|NCT03428100|101863884|FG017|NOT COMPLETED|Double-Blind Treatment Week 0 to Week 52||0||
48624413|NCT03428100|101863885|FG018|NOT COMPLETED|Double-Blind Treatment Week 0 to Week 52||0||
48624414|NCT03428100|101863867|FG000|STARTED|Long-Term Extension Week 52 to Week 200||0||
48624415|NCT03428100|101863868|FG001|STARTED|Long-Term Extension Week 52 to Week 200||0||
48624416|NCT03428100|101863869|FG002|STARTED|Long-Term Extension Week 52 to Week 200||0||
48624417|NCT03428100|101863870|FG003|STARTED|Long-Term Extension Week 52 to Week 200||0||
48624418|NCT03428100|101863871|FG004|STARTED|Long-Term Extension Week 52 to Week 200||16||
48624419|NCT03428100|101863872|FG005|STARTED|Long-Term Extension Week 52 to Week 200||16||
48624420|NCT03428100|101863873|FG006|STARTED|Long-Term Extension Week 52 to Week 200||25||
48624421|NCT03428100|101863874|FG007|STARTED|Long-Term Extension Week 52 to Week 200||24||
48624422|NCT03428100|101863875|FG008|STARTED|Long-Term Extension Week 52 to Week 200||7||
48624423|NCT03428100|101863876|FG009|STARTED|Long-Term Extension Week 52 to Week 200||22||
48624424|NCT03428100|101863877|FG010|STARTED|Long-Term Extension Week 52 to Week 200||34||
48624425|NCT03428100|101863878|FG011|STARTED|Long-Term Extension Week 52 to Week 200||29||
48624426|NCT03428100|101863879|FG012|STARTED|Long-Term Extension Week 52 to Week 200||24||
48624427|NCT03428100|101863880|FG013|STARTED|Long-Term Extension Week 52 to Week 200||27||
48624428|NCT03428100|101863881|FG014|STARTED|Long-Term Extension Week 52 to Week 200||26||
48624429|NCT03428100|101863882|FG015|STARTED|Long-Term Extension Week 52 to Week 200||13||
48624430|NCT03428100|101863883|FG016|STARTED|Long-Term Extension Week 52 to Week 200||14||
48624431|NCT03428100|101863884|FG017|STARTED|Long-Term Extension Week 52 to Week 200||11||
48624432|NCT03428100|101863885|FG018|STARTED|Long-Term Extension Week 52 to Week 200||12||
48624433|NCT03428100|101863867|FG000|COMPLETED|Long-Term Extension Week 52 to Week 200||0||
48624434|NCT03428100|101863868|FG001|COMPLETED|Long-Term Extension Week 52 to Week 200||0||
48624435|NCT03428100|101863869|FG002|COMPLETED|Long-Term Extension Week 52 to Week 200||0||
48624436|NCT03428100|101863870|FG003|COMPLETED|Long-Term Extension Week 52 to Week 200||0||
48624437|NCT03428100|101863871|FG004|COMPLETED|Long-Term Extension Week 52 to Week 200||2||
48624438|NCT03428100|101863872|FG005|COMPLETED|Long-Term Extension Week 52 to Week 200||6||
48624439|NCT03428100|101863873|FG006|COMPLETED|Long-Term Extension Week 52 to Week 200||5||
48624440|NCT03428100|101863874|FG007|COMPLETED|Long-Term Extension Week 52 to Week 200||6||
48624441|NCT03428100|101863875|FG008|COMPLETED|Long-Term Extension Week 52 to Week 200||3||
48624442|NCT03428100|101863876|FG009|COMPLETED|Long-Term Extension Week 52 to Week 200||5||
48624443|NCT03428100|101863877|FG010|COMPLETED|Long-Term Extension Week 52 to Week 200||5||
48624444|NCT03428100|101863878|FG011|COMPLETED|Long-Term Extension Week 52 to Week 200||10||
48624445|NCT03428100|101863879|FG012|COMPLETED|Long-Term Extension Week 52 to Week 200||1||
48624446|NCT03428100|101863880|FG013|COMPLETED|Long-Term Extension Week 52 to Week 200||6||
48624447|NCT03428100|101863881|FG014|COMPLETED|Long-Term Extension Week 52 to Week 200||4||
48624448|NCT03428100|101863882|FG015|COMPLETED|Long-Term Extension Week 52 to Week 200||4||
48624449|NCT03428100|101863883|FG016|COMPLETED|Long-Term Extension Week 52 to Week 200||1||
48624450|NCT03428100|101863884|FG017|COMPLETED|Long-Term Extension Week 52 to Week 200||1||
48624451|NCT03428100|101863885|FG018|COMPLETED|Long-Term Extension Week 52 to Week 200||2||
48624452|NCT03428100|101863867|FG000|NOT COMPLETED|Long-Term Extension Week 52 to Week 200||0||
48624453|NCT03428100|101863868|FG001|NOT COMPLETED|Long-Term Extension Week 52 to Week 200||0||
48624454|NCT03428100|101863869|FG002|NOT COMPLETED|Long-Term Extension Week 52 to Week 200||0||
48624455|NCT03428100|101863870|FG003|NOT COMPLETED|Long-Term Extension Week 52 to Week 200||0||
48624456|NCT03428100|101863871|FG004|NOT COMPLETED|Long-Term Extension Week 52 to Week 200||14||
48624457|NCT03428100|101863872|FG005|NOT COMPLETED|Long-Term Extension Week 52 to Week 200||10||
48624458|NCT03428100|101863873|FG006|NOT COMPLETED|Long-Term Extension Week 52 to Week 200||20||
48624459|NCT03428100|101863874|FG007|NOT COMPLETED|Long-Term Extension Week 52 to Week 200||18||
48624460|NCT03428100|101863875|FG008|NOT COMPLETED|Long-Term Extension Week 52 to Week 200||4||
48624461|NCT03428100|101863876|FG009|NOT COMPLETED|Long-Term Extension Week 52 to Week 200||17||
48624462|NCT03428100|101863877|FG010|NOT COMPLETED|Long-Term Extension Week 52 to Week 200||29||
48410653|NCT02574520|101337691|FG003|COMPLETED|Overall Study||144||
48410654|NCT02574520|101337688|FG000|NOT COMPLETED|Overall Study||2||
48410655|NCT02574520|101337689|FG001|NOT COMPLETED|Overall Study||0||
48410656|NCT02574520|101337690|FG002|NOT COMPLETED|Overall Study||5||
48410657|NCT02574520|101337691|FG003|NOT COMPLETED|Overall Study||8||
48410658|NCT02430389|101337692|FG000|STARTED|Overall Study||10||
48410659|NCT02430389|101337693|FG001|STARTED|Overall Study||10||
48410660|NCT02430389|101337692|FG000|COMPLETED|Overall Study||10||
48410661|NCT02430389|101337693|FG001|COMPLETED|Overall Study||10||
48410662|NCT02430389|101337692|FG000|NOT COMPLETED|Overall Study||0||
48624463|NCT03428100|101863878|FG011|NOT COMPLETED|Long-Term Extension Week 52 to Week 200||19||
48624464|NCT03428100|101863879|FG012|NOT COMPLETED|Long-Term Extension Week 52 to Week 200||23||
48624465|NCT03428100|101863880|FG013|NOT COMPLETED|Long-Term Extension Week 52 to Week 200||21||
48624466|NCT03428100|101863881|FG014|NOT COMPLETED|Long-Term Extension Week 52 to Week 200||22||
48624467|NCT03428100|101863882|FG015|NOT COMPLETED|Long-Term Extension Week 52 to Week 200||9||
48624468|NCT03428100|101863883|FG016|NOT COMPLETED|Long-Term Extension Week 52 to Week 200||13||
48624469|NCT03428100|101863884|FG017|NOT COMPLETED|Long-Term Extension Week 52 to Week 200||10||
48624470|NCT03428100|101863885|FG018|NOT COMPLETED|Long-Term Extension Week 52 to Week 200||10||
48624471|NCT00511810|101863886|FG000|STARTED|Overall Study||8||
48624472|NCT00511810|101863887|FG001|STARTED|Overall Study||12||
48624473|NCT00511810|101863886|FG000|COMPLETED|Overall Study||7||
48624474|NCT00511810|101863887|FG001|COMPLETED|Overall Study||7||
48624475|NCT00511810|101863886|FG000|NOT COMPLETED|Overall Study||1||
48624476|NCT00511810|101863887|FG001|NOT COMPLETED|Overall Study||5||
48624477|NCT00710931|101863888|FG000|STARTED|Overall Study||34||
48624478|NCT00710931|101863888|FG000|COMPLETED|Overall Study||29||
48624479|NCT00710931|101863888|FG000|NOT COMPLETED|Overall Study||5||
48624480|NCT03167242|101863889|FG000|STARTED|Overall Study||12|All participants who were enrolled in the PK Run-in part or randomized in Parts A or B.|
48624481|NCT03167242|101863890|FG001|STARTED|Overall Study||51|All participants who were enrolled in the PK Run-in part or randomized in Parts A or B.|
48624482|NCT03167242|101863891|FG002|STARTED|Overall Study||51|All participants who were enrolled in the PK Run-in part or randomized in Parts A or B.|
48624483|NCT03167242|101863892|FG003|STARTED|Overall Study||51|All participants who were enrolled in the PK Run-in part or randomized in Parts A or B.|
48624484|NCT03167242|101863893|FG004|STARTED|Overall Study||54|All participants who were enrolled in the PK Run-in part or randomized in Parts A or B.|
48624485|NCT03167242|101863894|FG005|STARTED|Overall Study||51|All participants who were enrolled in the PK Run-in part or randomized in Parts A or B.|
48624486|NCT03167242|101863895|FG006|STARTED|Overall Study||52|All participants who were enrolled in the PK Run-in part or randomized in Parts A or B.|
48624487|NCT03167242|101863896|FG007|STARTED|Overall Study||27|All participants who were enrolled in the PK Run-in part or randomized in Parts A or B.|
48624488|NCT03167242|101863897|FG008|STARTED|Overall Study||53|All participants who were enrolled in the PK Run-in part or randomized in Parts A or B.|
48624489|NCT03167242|101863898|FG009|STARTED|Overall Study||53|All participants who were enrolled in the PK Run-in part or randomized in Parts A or B.|
48624490|NCT03167242|101863899|FG010|STARTED|Overall Study||45|All participants who were enrolled in the PK Run-in part or randomized in Parts A or B.|
48624491|NCT03167242|101863900|FG011|STARTED|Overall Study||24|All participants who were enrolled in the PK Run-in part or randomized in Parts A or B.|
48624492|NCT03167242|101863889|FG000|Full Analysis Set (FAS)|Overall Study||12|All enrolled participants, who received at least one dose of the study treatment|
48624493|NCT03167242|101863890|FG001|Full Analysis Set (FAS)|Overall Study||51|All enrolled participants, who received at least one dose of the study treatment|
48624494|NCT03167242|101863891|FG002|Full Analysis Set (FAS)|Overall Study||51|All enrolled participants, who received at least one dose of the study treatment|
48624495|NCT03167242|101863892|FG003|Full Analysis Set (FAS)|Overall Study||51|All enrolled participants, who received at least one dose of the study treatment|
48624496|NCT03167242|101863893|FG004|Full Analysis Set (FAS)|Overall Study||54|All enrolled participants, who received at least one dose of the study treatment|
48624497|NCT03167242|101863894|FG005|Full Analysis Set (FAS)|Overall Study||51|All enrolled participants, who received at least one dose of the study treatment|
48624498|NCT03167242|101863895|FG006|Full Analysis Set (FAS)|Overall Study||52|All enrolled participants, who received at least one dose of the study treatment|
48624499|NCT03167242|101863896|FG007|Full Analysis Set (FAS)|Overall Study||27|All enrolled participants, who received at least one dose of the study treatment|
48624500|NCT03167242|101863897|FG008|Full Analysis Set (FAS)|Overall Study||52|All enrolled participants, who received at least one dose of the study treatment|
48624501|NCT03167242|101863898|FG009|Full Analysis Set (FAS)|Overall Study||53|All enrolled participants, who received at least one dose of the study treatment|
48624502|NCT03167242|101863899|FG010|Full Analysis Set (FAS)|Overall Study||45|All enrolled participants, who received at least one dose of the study treatment|
48624503|NCT03167242|101863900|FG011|Full Analysis Set (FAS)|Overall Study||24|All enrolled participants, who received at least one dose of the study treatment|
48624504|NCT03167242|101863889|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||12|All enrolled participants with at least 80% compliance to study treatment who had evaluable PK parameter data and did not receive the prohibited medications which could impact PK parameters.|
48624505|NCT03167242|101863890|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||47|All enrolled participants with at least 80% compliance to study treatment who had evaluable PK parameter data and did not receive the prohibited medications which could impact PK parameters.|
48624506|NCT03167242|101863891|FG002|Pharmacokinetics (PK) Analysis Set|Overall Study||51|All enrolled participants with at least 80% compliance to study treatment who had evaluable PK parameter data and did not receive the prohibited medications which could impact PK parameters.|
48624507|NCT03167242|101863892|FG003|Pharmacokinetics (PK) Analysis Set|Overall Study||46|All enrolled participants with at least 80% compliance to study treatment who had evaluable PK parameter data and did not receive the prohibited medications which could impact PK parameters.|
48624508|NCT03167242|101863893|FG004|Pharmacokinetics (PK) Analysis Set|Overall Study||48|All enrolled participants with at least 80% compliance to study treatment who had evaluable PK parameter data and did not receive the prohibited medications which could impact PK parameters.|
48624509|NCT03167242|101863894|FG005|Pharmacokinetics (PK) Analysis Set|Overall Study||46|All enrolled participants with at least 80% compliance to study treatment who had evaluable PK parameter data and did not receive the prohibited medications which could impact PK parameters.|
48624510|NCT03167242|101863895|FG006|Pharmacokinetics (PK) Analysis Set|Overall Study||45|All enrolled participants with at least 80% compliance to study treatment who had evaluable PK parameter data and did not receive the prohibited medications which could impact PK parameters.|
48657124|NCT03745313|101943783|FG000|NOT COMPLETED|At 1 Year Follow-up||4||
48330640|NCT03350217|101136046|FG001|STARTED|Overall Study||81||
48330641|NCT03350217|101136045|FG000|COMPLETED|Overall Study||77||
48624511|NCT03167242|101863896|FG007|Pharmacokinetics (PK) Analysis Set|Overall Study||24|All enrolled participants with at least 80% compliance to study treatment who had evaluable PK parameter data and did not receive the prohibited medications which could impact PK parameters.|
48624512|NCT03167242|101863897|FG008|Pharmacokinetics (PK) Analysis Set|Overall Study||48|All enrolled participants with at least 80% compliance to study treatment who had evaluable PK parameter data and did not receive the prohibited medications which could impact PK parameters.|
48624513|NCT03167242|101863898|FG009|Pharmacokinetics (PK) Analysis Set|Overall Study||46|All enrolled participants with at least 80% compliance to study treatment who had evaluable PK parameter data and did not receive the prohibited medications which could impact PK parameters.|
48624514|NCT03167242|101863899|FG010|Pharmacokinetics (PK) Analysis Set|Overall Study||41|All enrolled participants with at least 80% compliance to study treatment who had evaluable PK parameter data and did not receive the prohibited medications which could impact PK parameters.|
48624515|NCT03167242|101863900|FG011|Pharmacokinetics (PK) Analysis Set|Overall Study||24|All enrolled participants with at least 80% compliance to study treatment who had evaluable PK parameter data and did not receive the prohibited medications which could impact PK parameters.|
48624516|NCT03167242|101863889|FG000|Per-Protocol Set (PPS)|Overall Study||12|All participants comprised in FAS who met predefined criteria related to protocol and treatment compliance.|
48624517|NCT03167242|101863890|FG001|Per-Protocol Set (PPS)|Overall Study||50|All participants comprised in FAS who met predefined criteria related to protocol and treatment compliance.|
48624518|NCT03167242|101863891|FG002|Per-Protocol Set (PPS)|Overall Study||48|All participants comprised in FAS who met predefined criteria related to protocol and treatment compliance.|
48624519|NCT03167242|101863892|FG003|Per-Protocol Set (PPS)|Overall Study||48|All participants comprised in FAS who met predefined criteria related to protocol and treatment compliance.|
48624520|NCT03167242|101863893|FG004|Per-Protocol Set (PPS)|Overall Study||47|All participants comprised in FAS who met predefined criteria related to protocol and treatment compliance.|
48624521|NCT03167242|101863894|FG005|Per-Protocol Set (PPS)|Overall Study||44|All participants comprised in FAS who met predefined criteria related to protocol and treatment compliance.|
48624522|NCT03167242|101863895|FG006|Per-Protocol Set (PPS)|Overall Study||43|All participants comprised in FAS who met predefined criteria related to protocol and treatment compliance.|
48624523|NCT03167242|101863896|FG007|Per-Protocol Set (PPS)|Overall Study||25|All participants comprised in FAS who met predefined criteria related to protocol and treatment compliance.|
48624524|NCT03167242|101863897|FG008|Per-Protocol Set (PPS)|Overall Study||48|All participants comprised in FAS who met predefined criteria related to protocol and treatment compliance.|
48656961|NCT01340170|101943734|FG000|COMPLETED|Overall Study||76|ITT population|79
48747415|NCT00165672|102166063|FG000|NOT COMPLETED|Overall Study||0||
48747416|NCT00165672|102166064|FG001|NOT COMPLETED|Overall Study||1||
48747417|NCT00004092|102166065|FG000|STARTED|Overall Study||21||
48747418|NCT00004092|102166066|FG001|STARTED|Overall Study||51||
48747419|NCT00004092|102166065|FG000|COMPLETED|Overall Study||21||
48747420|NCT00004092|102166066|FG001|COMPLETED|Overall Study||51||
48747421|NCT00004092|102166065|FG000|NOT COMPLETED|Overall Study||0||
48747422|NCT00004092|102166066|FG001|NOT COMPLETED|Overall Study||0||
48747423|NCT00880620|102166067|FG000|STARTED|Overall Study||92|Baseline|
48747424|NCT00880620|102166068|FG001|STARTED|Overall Study||87|Baseline|
48747425|NCT00880620|102166069|FG002|STARTED|Overall Study||104|Baseline|
48747426|NCT00880620|102166070|FG003|STARTED|Overall Study||98|Baseline|
48747427|NCT00880620|102166067|FG000|Week 4|Overall Study||88||
48747428|NCT00880620|102166068|FG001|Week 4|Overall Study||79||
48747429|NCT00880620|102166069|FG002|Week 4|Overall Study||94||
48747430|NCT00880620|102166070|FG003|Week 4|Overall Study||86||
48747431|NCT00880620|102166067|FG000|Week 9|Overall Study||80||
48747432|NCT00880620|102166068|FG001|Week 9|Overall Study||73||
48747433|NCT00880620|102166069|FG002|Week 9|Overall Study||88||
48747434|NCT00880620|102166070|FG003|Week 9|Overall Study||78||
48747435|NCT00880620|102166067|FG000|Week 16|Overall Study||74||
48747436|NCT00880620|102166068|FG001|Week 16|Overall Study||73||
48747437|NCT00880620|102166069|FG002|Week 16|Overall Study||87||
48747438|NCT00880620|102166070|FG003|Week 16|Overall Study||74||
48747439|NCT00880620|102166067|FG000|Week 23|Overall Study||71||
48747440|NCT00880620|102166068|FG001|Week 23|Overall Study||72||
48747441|NCT00880620|102166069|FG002|Week 23|Overall Study||85||
48747442|NCT00880620|102166070|FG003|Week 23|Overall Study||74||
48747443|NCT00880620|102166067|FG000|COMPLETED|Overall Study||71|Week 30|
48747444|NCT00880620|102166068|FG001|COMPLETED|Overall Study||72|Week 30|
48747445|NCT00880620|102166069|FG002|COMPLETED|Overall Study||83|Week 30|
48747446|NCT00880620|102166070|FG003|COMPLETED|Overall Study||74|Week 30|
48747447|NCT00880620|102166067|FG000|NOT COMPLETED|Overall Study||21||
48747448|NCT00880620|102166068|FG001|NOT COMPLETED|Overall Study||15||
48330642|NCT03350217|101136046|FG001|COMPLETED|Overall Study||81||
48330643|NCT03350217|101136045|FG000|NOT COMPLETED|Overall Study||2||
48747449|NCT00880620|102166069|FG002|NOT COMPLETED|Overall Study||21||
48747450|NCT00880620|102166070|FG003|NOT COMPLETED|Overall Study||24||
48747451|NCT02401347|102169316|FG000|STARTED|Overall Study||1||
48747452|NCT02401347|102169317|FG001|STARTED|Overall Study||20||
48747453|NCT02401347|102169316|FG000|COMPLETED|Overall Study||1||
48747454|NCT02401347|102169317|FG001|COMPLETED|Overall Study||20||
48747455|NCT02401347|102169316|FG000|NOT COMPLETED|Overall Study||0||
48747456|NCT02401347|102169317|FG001|NOT COMPLETED|Overall Study||0||
48747457|NCT00584012|102169318|FG000|STARTED|Overall Study||9||
48747458|NCT00584012|102169318|FG000|COMPLETED|Overall Study||8||
48747459|NCT00584012|102169318|FG000|NOT COMPLETED|Overall Study||1||
48747460|NCT01854359|102169319|FG000|STARTED|Overall Study||31||
48747461|NCT01854359|102169320|FG001|STARTED|Overall Study||30||
48747462|NCT01854359|102169319|FG000|COMPLETED|Overall Study||26||
48747463|NCT01854359|102169320|FG001|COMPLETED|Overall Study||22||
48747464|NCT01854359|102169319|FG000|NOT COMPLETED|Overall Study||5||
48747465|NCT01854359|102169320|FG001|NOT COMPLETED|Overall Study||8||
48747466|NCT04332107|102169321|FG000|STARTED|Day 3||171||
48747467|NCT04332107|102169322|FG001|STARTED|Day 3||92||
48747468|NCT04332107|102169321|FG000|COMPLETED|Day 3||145||
48747469|NCT04332107|102169322|FG001|COMPLETED|Day 3||72||
48747470|NCT04332107|102169321|FG000|NOT COMPLETED|Day 3||26||
48747471|NCT04332107|102169322|FG001|NOT COMPLETED|Day 3||20||
48747472|NCT04332107|102169321|FG000|STARTED|Day 14||148||
48167182|NCT01422135|100732263|FG005|STARTED|Overall Study||4||
48167183|NCT01422135|100732258|FG000|COMPLETED|Overall Study||4||
48167184|NCT01422135|100732259|FG001|COMPLETED|Overall Study||4||
48167185|NCT01422135|100732260|FG002|COMPLETED|Overall Study||3||
48167186|NCT01422135|100732261|FG003|COMPLETED|Overall Study||4||
48167187|NCT01422135|100732262|FG004|COMPLETED|Overall Study||4||
48167188|NCT01422135|100732263|FG005|COMPLETED|Overall Study||3||
48167189|NCT01422135|100732258|FG000|NOT COMPLETED|Overall Study||0||
48167190|NCT01422135|100732259|FG001|NOT COMPLETED|Overall Study||0||
48167191|NCT01422135|100732260|FG002|NOT COMPLETED|Overall Study||1||
48167192|NCT01422135|100732261|FG003|NOT COMPLETED|Overall Study||0||
48167193|NCT01422135|100732262|FG004|NOT COMPLETED|Overall Study||0||
48167194|NCT01422135|100732263|FG005|NOT COMPLETED|Overall Study||1||
48167195|NCT00920621|100732264|FG000|STARTED|Overall Study||440||
48167196|NCT00920621|100732265|FG001|STARTED|Overall Study||436||
48167197|NCT00920621|100732266|FG002|STARTED|Overall Study||440||
48624525|NCT03167242|101863898|FG009|Per-Protocol Set (PPS)|Overall Study||46|All participants comprised in FAS who met predefined criteria related to protocol and treatment compliance.|
48624526|NCT03167242|101863899|FG010|Per-Protocol Set (PPS)|Overall Study||40|All participants comprised in FAS who met predefined criteria related to protocol and treatment compliance.|
48624527|NCT03167242|101863900|FG011|Per-Protocol Set (PPS)|Overall Study||22|All participants comprised in FAS who met predefined criteria related to protocol and treatment compliance.|
48624528|NCT03167242|101863889|FG000|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||12|Subset of participants within PK Run-in and Part A and comprised in PK Analysis set from whom rich PK data was collected.|
48624529|NCT03167242|101863890|FG001|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||5|Subset of participants within PK Run-in and Part A and comprised in PK Analysis set from whom rich PK data was collected.|
48624530|NCT03167242|101863891|FG002|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||6|Subset of participants within PK Run-in and Part A and comprised in PK Analysis set from whom rich PK data was collected.|
48624531|NCT03167242|101863892|FG003|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||6|Subset of participants within PK Run-in and Part A and comprised in PK Analysis set from whom rich PK data was collected.|
48624532|NCT03167242|101863893|FG004|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||6|Subset of participants within PK Run-in and Part A and comprised in PK Analysis set from whom rich PK data was collected.|
48624533|NCT03167242|101863894|FG005|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||12|Subset of participants within PK Run-in and Part A and comprised in PK Analysis set from whom rich PK data was collected.|
48167198|NCT00920621|100732267|FG003|STARTED|Overall Study||436||
48167199|NCT00920621|100732264|FG000|COMPLETED|Overall Study||386||
48167200|NCT00920621|100732265|FG001|COMPLETED|Overall Study||391||
48167201|NCT00920621|100732266|FG002|COMPLETED|Overall Study||405||
48167202|NCT00920621|100732267|FG003|COMPLETED|Overall Study||401||
48167203|NCT00920621|100732264|FG000|NOT COMPLETED|Overall Study||54||
48167204|NCT00920621|100732265|FG001|NOT COMPLETED|Overall Study||45||
48167205|NCT00920621|100732266|FG002|NOT COMPLETED|Overall Study||35||
48167206|NCT00920621|100732267|FG003|NOT COMPLETED|Overall Study||35||
48167207|NCT03820323|100732268|FG000|STARTED|Overall Study||355||
48167208|NCT03820323|100732269|FG001|STARTED|Overall Study||349||
48167209|NCT03820323|100732268|FG000|COMPLETED|Overall Study||315||
48167210|NCT03820323|100732269|FG001|COMPLETED|Overall Study||313||
48167211|NCT03820323|100732268|FG000|NOT COMPLETED|Overall Study||40||
48167212|NCT03820323|100732269|FG001|NOT COMPLETED|Overall Study||36||
48167213|NCT02459093|100732270|FG000|STARTED|Overall Study||275||
48167214|NCT02459093|100732271|FG001|STARTED|Overall Study||275||
48624534|NCT03167242|101863895|FG006|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||5|Subset of participants within PK Run-in and Part A and comprised in PK Analysis set from whom rich PK data was collected.|
48624535|NCT03167242|101863896|FG007|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0|Subset of participants within PK Run-in and Part A and comprised in PK Analysis set from whom rich PK data was collected.|
48167215|NCT02459093|100732270|FG000|COMPLETED|Overall Study||263|Received treatment and completed 30 day follow-up|
48167216|NCT02459093|100732271|FG001|COMPLETED|Overall Study||257|Received treatment and completed 30 day follow-up|
48167217|NCT02459093|100732270|FG000|NOT COMPLETED|Overall Study||12||
48167218|NCT02459093|100732271|FG001|NOT COMPLETED|Overall Study||18||
48167219|NCT02044458|100732272|FG000|STARTED|Overall Study||65||
48167220|NCT02044458|100732273|FG001|STARTED|Overall Study||69||
48167221|NCT02044458|100732272|FG000|COMPLETED|Overall Study||62||
48167222|NCT02044458|100732273|FG001|COMPLETED|Overall Study||61||
48167223|NCT02044458|100732272|FG000|NOT COMPLETED|Overall Study||3||
48167224|NCT02044458|100732273|FG001|NOT COMPLETED|Overall Study||8||
48167225|NCT00829686|100732274|FG000|STARTED|Overall Study||13||
48167226|NCT00829686|100732275|FG001|STARTED|Overall Study||18||
48167227|NCT00829686|100732274|FG000|COMPLETED|Overall Study||13||
48167228|NCT00829686|100732275|FG001|COMPLETED|Overall Study||18||
48167229|NCT00829686|100732274|FG000|NOT COMPLETED|Overall Study||0||
48167230|NCT00829686|100732275|FG001|NOT COMPLETED|Overall Study||0||
48167231|NCT04277455|100732276|FG000|STARTED|Overall Study||10||
48167232|NCT04277455|100732276|FG000|COMPLETED|Overall Study||9||
48167233|NCT04277455|100732276|FG000|NOT COMPLETED|Overall Study||1||
48167234|NCT00860067|100732277|FG000|STARTED|Overall Study||1200||
48167235|NCT00860067|100732278|FG001|STARTED|Overall Study||299||
48167236|NCT00860067|100732279|FG002|STARTED|Overall Study||301||
48167237|NCT00860067|100732277|FG000|COMPLETED|Overall Study||1149||
48167238|NCT00860067|100732278|FG001|COMPLETED|Overall Study||290||
48167239|NCT00860067|100732279|FG002|COMPLETED|Overall Study||292||
48167240|NCT00860067|100732277|FG000|NOT COMPLETED|Overall Study||51||
48167241|NCT00860067|100732278|FG001|NOT COMPLETED|Overall Study||9||
48167242|NCT00860067|100732279|FG002|NOT COMPLETED|Overall Study||9||
48167243|NCT03066622|100732280|FG000|STARTED|Overall Study||61||
48167244|NCT03066622|100732281|FG001|STARTED|Overall Study||61||
48167245|NCT03066622|100732280|FG000|COMPLETED|Overall Study||35||
48167246|NCT03066622|100732281|FG001|COMPLETED|Overall Study||35||
48167247|NCT03066622|100732280|FG000|NOT COMPLETED|Overall Study||26||
48167248|NCT03066622|100732281|FG001|NOT COMPLETED|Overall Study||26||
48167249|NCT01540565|100732282|FG000|STARTED|Overall Study||52||
48167250|NCT01540565|100732282|FG000|COMPLETED|Overall Study||50||
48167251|NCT01540565|100732282|FG000|NOT COMPLETED|Overall Study||2||
48167252|NCT04522180|100732283|FG000|STARTED|Overall Study||18||
48167253|NCT04522180|100732284|FG001|STARTED|Overall Study||16||
48167254|NCT04522180|100732283|FG000|Per Protocol Set (Initial Dose)|Overall Study||18|Per protocol set included all participants that started the study and who completed at least 6 of the 8 doses of GHR-LRX with the first 27 Weeks administered and had no significant protocol deviations that impacted efficacy. Initial dose was the dose received up to Week 17 and maximum dose was the dose received following dose escalation up to Week 73.|
48167255|NCT04522180|100732284|FG001|Per Protocol Set (Initial Dose)|Overall Study||14|Per protocol set included all participants that started the study and who completed at least 6 of the 8 doses of GHR-LRX with the first 27 Weeks administered and had no significant protocol deviations that impacted efficacy. Initial dose was the dose received up to Week 17 and maximum dose was the dose received following dose escalation up to Week 73.|
48167256|NCT04522180|100732283|FG000|Increased Dose From Initial 120mg to Maximum Dose 160mg (Week 17 to Week 45)|Overall Study||15||
48167257|NCT04522180|100732284|FG001|Increased Dose From Initial 120mg to Maximum Dose 160mg (Week 17 to Week 45)|Overall Study||0||
48167258|NCT04522180|100732283|FG000|COMPLETED|Overall Study||5|Completed included participants who completed the study treatment.|
48167259|NCT04522180|100732284|FG001|COMPLETED|Overall Study||3|Completed included participants who completed the study treatment.|
48167260|NCT04522180|100732283|FG000|NOT COMPLETED|Overall Study||13||
48167261|NCT04522180|100732284|FG001|NOT COMPLETED|Overall Study||13||
48167262|NCT00977769|100732285|FG000|STARTED|Overall Study||25||
48167263|NCT00977769|100732286|FG001|STARTED|Overall Study||26||
48167264|NCT00977769|100732287|FG002|STARTED|Overall Study||25||
48167265|NCT00977769|100732285|FG000|COMPLETED|Overall Study||25||
48167266|NCT00977769|100732286|FG001|COMPLETED|Overall Study||26||
48167267|NCT00977769|100732287|FG002|COMPLETED|Overall Study||25||
48167268|NCT00977769|100732285|FG000|NOT COMPLETED|Overall Study||0||
48167269|NCT00977769|100732286|FG001|NOT COMPLETED|Overall Study||0||
48167270|NCT00977769|100732287|FG002|NOT COMPLETED|Overall Study||0||
48167271|NCT02748694|100732288|FG000|STARTED|Overall Study||10||
48167272|NCT02748694|100732289|FG001|STARTED|Overall Study||6||
48167273|NCT02748694|100732290|FG002|STARTED|Overall Study||6||
48167274|NCT02748694|100732291|FG003|STARTED|Overall Study||6||
48167275|NCT02748694|100732292|FG004|STARTED|Overall Study||6||
48167276|NCT02748694|100732293|FG005|STARTED|Overall Study||6||
48167277|NCT02748694|100732294|FG006|STARTED|Overall Study||8||
48167278|NCT02748694|100732295|FG007|STARTED|Overall Study||6||
48167279|NCT02748694|100732296|FG008|STARTED|Overall Study||6||
48167280|NCT02748694|100732297|FG009|STARTED|Overall Study||6||
48167281|NCT02748694|100732298|FG010|STARTED|Overall Study||6||
48167282|NCT02748694|100732299|FG011|STARTED|Overall Study||9||
48167283|NCT02748694|100732300|FG012|STARTED|Overall Study||9||
48167284|NCT02748694|100732301|FG013|STARTED|Overall Study||8||
48167285|NCT02748694|100732302|FG014|STARTED|Overall Study||16||
48167286|NCT02748694|100732288|FG000|COMPLETED|Overall Study||10||
48167287|NCT02748694|100732289|FG001|COMPLETED|Overall Study||6||
48167288|NCT02748694|100732290|FG002|COMPLETED|Overall Study||6||
48167289|NCT02748694|100732291|FG003|COMPLETED|Overall Study||6||
48167290|NCT02748694|100732292|FG004|COMPLETED|Overall Study||6||
48167291|NCT02748694|100732293|FG005|COMPLETED|Overall Study||6||
48167292|NCT02748694|100732294|FG006|COMPLETED|Overall Study||8||
48167293|NCT02748694|100732295|FG007|COMPLETED|Overall Study||6||
48167294|NCT02748694|100732296|FG008|COMPLETED|Overall Study||6||
48167295|NCT02748694|100732297|FG009|COMPLETED|Overall Study||6||
48167296|NCT02748694|100732298|FG010|COMPLETED|Overall Study||6||
48167297|NCT02748694|100732299|FG011|COMPLETED|Overall Study||9||
48167298|NCT02748694|100732300|FG012|COMPLETED|Overall Study||9||
48167299|NCT02748694|100732301|FG013|COMPLETED|Overall Study||8||
48167300|NCT02748694|100732302|FG014|COMPLETED|Overall Study||14||
48167301|NCT02748694|100732288|FG000|NOT COMPLETED|Overall Study||0||
48167302|NCT02748694|100732289|FG001|NOT COMPLETED|Overall Study||0||
48167303|NCT02748694|100732290|FG002|NOT COMPLETED|Overall Study||0||
48167304|NCT02748694|100732291|FG003|NOT COMPLETED|Overall Study||0||
48167305|NCT02748694|100732292|FG004|NOT COMPLETED|Overall Study||0||
48167306|NCT02748694|100732293|FG005|NOT COMPLETED|Overall Study||0||
48167307|NCT02748694|100732294|FG006|NOT COMPLETED|Overall Study||0||
48167308|NCT02748694|100732295|FG007|NOT COMPLETED|Overall Study||0||
48167309|NCT02748694|100732296|FG008|NOT COMPLETED|Overall Study||0||
48167310|NCT02748694|100732297|FG009|NOT COMPLETED|Overall Study||0||
48167311|NCT02748694|100732298|FG010|NOT COMPLETED|Overall Study||0||
48167312|NCT02748694|100732299|FG011|NOT COMPLETED|Overall Study||0||
48167313|NCT02748694|100732300|FG012|NOT COMPLETED|Overall Study||0||
48167314|NCT02748694|100732301|FG013|NOT COMPLETED|Overall Study||0||
48167315|NCT02748694|100732302|FG014|NOT COMPLETED|Overall Study||2||
48167316|NCT01238549|100732303|FG000|STARTED|Overall Study||284||
48167317|NCT01238549|100732303|FG000|COMPLETED|Overall Study||248||
48167318|NCT01238549|100732303|FG000|NOT COMPLETED|Overall Study||36||
48167319|NCT03592277|100732304|FG000|STARTED|Overall Study||60||
48624536|NCT03167242|101863897|FG008|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0|Subset of participants within PK Run-in and Part A and comprised in PK Analysis set from whom rich PK data was collected.|
48624537|NCT03167242|101863898|FG009|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0|Subset of participants within PK Run-in and Part A and comprised in PK Analysis set from whom rich PK data was collected.|
48167320|NCT03592277|100732305|FG001|STARTED|Overall Study||60||
48167321|NCT03592277|100732304|FG000|Powered For|Overall Study||60||
48167322|NCT03592277|100732305|FG001|Powered For|Overall Study||60||
48167323|NCT03592277|100732304|FG000|COMPLETED|Overall Study||54||
48167324|NCT03592277|100732305|FG001|COMPLETED|Overall Study||52||
48624538|NCT03167242|101863899|FG010|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0|Subset of participants within PK Run-in and Part A and comprised in PK Analysis set from whom rich PK data was collected.|
48167325|NCT03592277|100732304|FG000|NOT COMPLETED|Overall Study||6||
48167326|NCT03592277|100732305|FG001|NOT COMPLETED|Overall Study||8||
48167327|NCT02917941|100732306|FG000|STARTED|Treatment Period||34||
48167328|NCT02917941|100732306|FG000|COMPLETED|Treatment Period||10||
48167329|NCT02917941|100732306|FG000|NOT COMPLETED|Treatment Period||24||
48167330|NCT02917941|100732306|FG000|STARTED|Survival Follow-up Period||31|Out of 34 Participants, 31 entered the Follow-up Period.|
48167331|NCT02917941|100732306|FG000|COMPLETED|Survival Follow-up Period||26||
48167332|NCT02917941|100732306|FG000|NOT COMPLETED|Survival Follow-up Period||5||
48167333|NCT02306265|100732307|FG000|STARTED|Overall Study||250||
48167334|NCT02306265|100732307|FG000|COMPLETED|Overall Study||249||
48167335|NCT02306265|100732307|FG000|NOT COMPLETED|Overall Study||1||
48167336|NCT03107377|100732308|FG000|STARTED|Overall Study||426||
48167337|NCT03107377|100732309|FG001|STARTED|Overall Study||434||
48167338|NCT03107377|100732308|FG000|COMPLETED|Overall Study||335||
48167339|NCT03107377|100732309|FG001|COMPLETED|Overall Study||335||
48167340|NCT03107377|100732308|FG000|NOT COMPLETED|Overall Study||91||
48167341|NCT03107377|100732309|FG001|NOT COMPLETED|Overall Study||99||
48167342|NCT03872388|100732310|FG000|STARTED|Overall Study||0||
48167343|NCT03872388|100732311|FG001|STARTED|Overall Study||0||
48167344|NCT03872388|100732312|FG002|STARTED|Overall Study||0||
48167345|NCT03872388|100732313|FG003|STARTED|Overall Study||0||
48167346|NCT03872388|100732314|FG004|STARTED|Overall Study||0||
48167347|NCT03872388|100732315|FG005|STARTED|Overall Study||0||
48167348|NCT03872388|100732316|FG006|STARTED|Overall Study||2||
48167349|NCT03872388|100732317|FG007|STARTED|Overall Study||2||
48167350|NCT03872388|100732310|FG000|COMPLETED|Overall Study||0||
48167351|NCT03872388|100732311|FG001|COMPLETED|Overall Study||0||
48167352|NCT03872388|100732312|FG002|COMPLETED|Overall Study||0||
48167353|NCT03872388|100732313|FG003|COMPLETED|Overall Study||0||
48167354|NCT03872388|100732314|FG004|COMPLETED|Overall Study||0||
48167355|NCT03872388|100732315|FG005|COMPLETED|Overall Study||0||
48167356|NCT03872388|100732316|FG006|COMPLETED|Overall Study||1||
48167357|NCT03872388|100732317|FG007|COMPLETED|Overall Study||1||
48167358|NCT03872388|100732310|FG000|NOT COMPLETED|Overall Study||0||
48624539|NCT03167242|101863900|FG011|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0|Subset of participants within PK Run-in and Part A and comprised in PK Analysis set from whom rich PK data was collected.|
48624540|NCT03167242|101863889|FG000|COMPLETED|Overall Study||12||
48624541|NCT03167242|101863890|FG001|COMPLETED|Overall Study||50||
48747473|NCT04332107|102169322|FG001|STARTED|Day 14||78||
48167359|NCT03872388|100732311|FG001|NOT COMPLETED|Overall Study||0||
48167360|NCT03872388|100732312|FG002|NOT COMPLETED|Overall Study||0||
48167361|NCT03872388|100732313|FG003|NOT COMPLETED|Overall Study||0||
48167362|NCT03872388|100732314|FG004|NOT COMPLETED|Overall Study||0||
48167363|NCT03872388|100732315|FG005|NOT COMPLETED|Overall Study||0||
48167364|NCT03872388|100732316|FG006|NOT COMPLETED|Overall Study||1||
48167365|NCT03872388|100732317|FG007|NOT COMPLETED|Overall Study||1||
48167366|NCT01725386|100732318|FG000|STARTED|Overall Study||188||
48167367|NCT01725386|100732319|FG001|STARTED|Overall Study||63||
48167368|NCT01725386|100732318|FG000|COMPLETED|Overall Study||13||
48167369|NCT01725386|100732319|FG001|COMPLETED|Overall Study||17||
48167370|NCT01725386|100732318|FG000|NOT COMPLETED|Overall Study||175||
48167371|NCT01725386|100732319|FG001|NOT COMPLETED|Overall Study||46||
48167372|NCT04145037|100732320|FG000|STARTED|Overall Study||8||
48167373|NCT04145037|100732321|FG001|STARTED|Overall Study||0||
48167374|NCT04145037|100732320|FG000|Mobilized and Apheresed|Overall Study||6||
48167375|NCT04145037|100732321|FG001|Mobilized and Apheresed|Overall Study||0||
48167376|NCT04145037|100732320|FG000|Received AVR-RD-02|Overall Study||5||
48167377|NCT04145037|100732321|FG001|Received AVR-RD-02|Overall Study||0||
48167378|NCT04145037|100732320|FG000|COMPLETED|Overall Study||4||
48167379|NCT04145037|100732321|FG001|COMPLETED|Overall Study||0||
48167380|NCT04145037|100732320|FG000|NOT COMPLETED|Overall Study||4||
48167381|NCT04145037|100732321|FG001|NOT COMPLETED|Overall Study||0||
48167382|NCT02402296|100732322|FG000|STARTED|Overall Study||15||
48167383|NCT02402296|100732323|FG001|STARTED|Overall Study||15||
48167384|NCT02402296|100732322|FG000|COMPLETED|Overall Study||15||
48167385|NCT02402296|100732323|FG001|COMPLETED|Overall Study||15||
48167386|NCT02402296|100732322|FG000|NOT COMPLETED|Overall Study||0||
48167387|NCT02402296|100732323|FG001|NOT COMPLETED|Overall Study||0||
48167388|NCT00301080|100732324|FG000|STARTED|Original Version (2 Arms & 4 Weeks)||4||
48167389|NCT00301080|100732325|FG001|STARTED|Original Version (2 Arms & 4 Weeks)||3||
48167390|NCT00301080|100732326|FG002|STARTED|Original Version (2 Arms & 4 Weeks)||0||
48167391|NCT00301080|100732327|FG003|STARTED|Original Version (2 Arms & 4 Weeks)||0||
48167392|NCT00301080|100732328|FG004|STARTED|Original Version (2 Arms & 4 Weeks)||0||
48167393|NCT00301080|100732324|FG000|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3||
48167394|NCT00301080|100732325|FG001|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3||
48167395|NCT00301080|100732326|FG002|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0||
48167396|NCT00301080|100732327|FG003|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0||
48167397|NCT00301080|100732328|FG004|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0||
48167398|NCT00301080|100732324|FG000|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3||
48167399|NCT00301080|100732325|FG001|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3||
48167400|NCT00301080|100732326|FG002|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0||
48167401|NCT00301080|100732327|FG003|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0||
48167402|NCT00301080|100732328|FG004|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0||
48167403|NCT00301080|100732324|FG000|COMPLETED|Original Version (2 Arms & 4 Weeks)||3||
48167404|NCT00301080|100732325|FG001|COMPLETED|Original Version (2 Arms & 4 Weeks)||3||
48167405|NCT00301080|100732326|FG002|COMPLETED|Original Version (2 Arms & 4 Weeks)||0||
48167406|NCT00301080|100732327|FG003|COMPLETED|Original Version (2 Arms & 4 Weeks)||0||
48167407|NCT00301080|100732328|FG004|COMPLETED|Original Version (2 Arms & 4 Weeks)||0||
48167408|NCT00301080|100732324|FG000|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||1||
48167409|NCT00301080|100732325|FG001|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0||
48167410|NCT00301080|100732326|FG002|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0||
48167411|NCT00301080|100732327|FG003|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0||
48167412|NCT00301080|100732328|FG004|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0||
48167413|NCT00301080|100732324|FG000|STARTED|Revised Version (3 Arms & 12 Weeks)||0||
48167414|NCT00301080|100732325|FG001|STARTED|Revised Version (3 Arms & 12 Weeks)||0||
48167415|NCT00301080|100732326|FG002|STARTED|Revised Version (3 Arms & 12 Weeks)||0||
48167416|NCT00301080|100732327|FG003|STARTED|Revised Version (3 Arms & 12 Weeks)||0||
48167417|NCT00301080|100732328|FG004|STARTED|Revised Version (3 Arms & 12 Weeks)||0||
48167418|NCT00301080|100732324|FG000|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0||
48167419|NCT00301080|100732325|FG001|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0||
48167420|NCT00301080|100732326|FG002|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0||
48167421|NCT00301080|100732327|FG003|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0||
48167422|NCT00301080|100732328|FG004|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0||
48167423|NCT00301080|100732324|FG000|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0||
48167424|NCT00301080|100732325|FG001|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0||
48167425|NCT00301080|100732326|FG002|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0||
48167426|NCT00301080|100732327|FG003|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0||
48167427|NCT00301080|100732328|FG004|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0||
48167428|NCT03980184|100732329|FG000|STARTED|Overall Study||38|Participants randomized|
48188609|NCT00432159|100783283|FG001|NOT COMPLETED|Overall Study||30||
48167429|NCT03980184|100732330|FG001|STARTED|Overall Study||36|Participants randomized|
48167430|NCT03980184|100732329|FG000|Began Treatment|Overall Study||36||
48167431|NCT03980184|100732330|FG001|Began Treatment|Overall Study||34||
48167432|NCT03980184|100732329|FG000|COMPLETED|Overall Study||25||
48167433|NCT03980184|100732330|FG001|COMPLETED|Overall Study||21||
48167434|NCT03980184|100732329|FG000|NOT COMPLETED|Overall Study||13||
48167435|NCT03980184|100732330|FG001|NOT COMPLETED|Overall Study||15||
48167436|NCT02924389|100732331|FG000|STARTED|Overall Study||16||
48167437|NCT02924389|100732332|FG001|STARTED|Overall Study||6||
48167438|NCT02924389|100732331|FG000|COMPLETED|Overall Study||8||
48167439|NCT02924389|100732332|FG001|COMPLETED|Overall Study||6||
48167440|NCT02924389|100732331|FG000|NOT COMPLETED|Overall Study||8||
48167441|NCT02924389|100732332|FG001|NOT COMPLETED|Overall Study||0||
48167442|NCT01350141|100732333|FG000|STARTED|Overall Study||15||
48167443|NCT01350141|100732334|FG001|STARTED|Overall Study||15||
48167444|NCT01350141|100732335|FG002|STARTED|Overall Study||16||
48167445|NCT01350141|100732333|FG000|Treated|Overall Study||14||
48167446|NCT01350141|100732334|FG001|Treated|Overall Study||15||
48167447|NCT01350141|100732335|FG002|Treated|Overall Study||16||
48167448|NCT01350141|100732333|FG000|COMPLETED|Overall Study||12||
48167449|NCT01350141|100732334|FG001|COMPLETED|Overall Study||15||
48167450|NCT01350141|100732335|FG002|COMPLETED|Overall Study||15||
48167451|NCT01350141|100732333|FG000|NOT COMPLETED|Overall Study||3||
48167452|NCT01350141|100732334|FG001|NOT COMPLETED|Overall Study||0||
48167453|NCT01350141|100732335|FG002|NOT COMPLETED|Overall Study||1||
48167454|NCT00525265|100732336|FG000|STARTED|Overall Study||10||
48167455|NCT00525265|100732337|FG001|STARTED|Overall Study||10||
48167456|NCT00525265|100732336|FG000|COMPLETED|Overall Study||9||
48167457|NCT00525265|100732337|FG001|COMPLETED|Overall Study||10||
48167458|NCT00525265|100732336|FG000|NOT COMPLETED|Overall Study||1||
48167459|NCT00525265|100732337|FG001|NOT COMPLETED|Overall Study||0||
48167460|NCT01108757|100732338|FG000|STARTED|Overall Study||26||
48167461|NCT01108757|100732339|FG001|STARTED|Overall Study||26||
48167462|NCT01108757|100732338|FG000|COMPLETED|Overall Study||26||
48167463|NCT01108757|100732339|FG001|COMPLETED|Overall Study||26||
48167464|NCT01108757|100732338|FG000|NOT COMPLETED|Overall Study||0||
48167465|NCT01108757|100732339|FG001|NOT COMPLETED|Overall Study||0||
48167466|NCT03564782|100732340|FG000|STARTED|Overall Study||5||
48167467|NCT03564782|100732340|FG000|COMPLETED|Overall Study||5||
48167468|NCT03564782|100732340|FG000|NOT COMPLETED|Overall Study||0||
48167469|NCT02823964|100732341|FG000|STARTED|Overall Study||25||
48167470|NCT02823964|100732341|FG000|COMPLETED|Overall Study||20||
48167471|NCT02823964|100732341|FG000|NOT COMPLETED|Overall Study||5||
48167472|NCT01737996|100732342|FG000|STARTED|Overall Study||8||
48167473|NCT01737996|100732343|FG001|STARTED|Overall Study||8||
48167474|NCT01737996|100732344|FG002|STARTED|Overall Study||16||
48167475|NCT01737996|100732342|FG000|COMPLETED|Overall Study||8||
48167476|NCT01737996|100732343|FG001|COMPLETED|Overall Study||7||
48167477|NCT01737996|100732344|FG002|COMPLETED|Overall Study||14||
48167478|NCT01737996|100732342|FG000|NOT COMPLETED|Overall Study||0||
48167479|NCT01737996|100732343|FG001|NOT COMPLETED|Overall Study||1||
48167480|NCT01737996|100732344|FG002|NOT COMPLETED|Overall Study||2||
48167481|NCT00192023|100732345|FG000|STARTED|Period III - Double-Blind||107||
48167482|NCT00192023|100732346|FG001|STARTED|Period III - Double-Blind||32||
48167483|NCT00192023|100732345|FG000|COMPLETED|Period III - Double-Blind||100||
48167484|NCT00192023|100732346|FG001|COMPLETED|Period III - Double-Blind||32||
48167485|NCT00192023|100732345|FG000|NOT COMPLETED|Period III - Double-Blind||7||
48167486|NCT00192023|100732346|FG001|NOT COMPLETED|Period III - Double-Blind||0||
48167487|NCT00192023|100732345|FG000|STARTED|Period IV - Optional Open-Label||124||
48167488|NCT00192023|100732346|FG001|STARTED|Period IV - Optional Open-Label||0||
48167489|NCT00192023|100732345|FG000|COMPLETED|Period IV - Optional Open-Label||49||
48167490|NCT00192023|100732346|FG001|COMPLETED|Period IV - Optional Open-Label||0||
48167491|NCT00192023|100732345|FG000|NOT COMPLETED|Period IV - Optional Open-Label||75||
48167492|NCT00192023|100732346|FG001|NOT COMPLETED|Period IV - Optional Open-Label||0||
48167493|NCT01909570|100732347|FG000|STARTED|Overall Study||84||
48167494|NCT01909570|100732348|FG001|STARTED|Overall Study||91||
48167495|NCT01909570|100732347|FG000|COMPLETED|Overall Study||57||
48167496|NCT01909570|100732348|FG001|COMPLETED|Overall Study||64||
48167497|NCT01909570|100732347|FG000|NOT COMPLETED|Overall Study||27||
48167498|NCT01909570|100732348|FG001|NOT COMPLETED|Overall Study||27||
48167499|NCT00369681|100732349|FG000|STARTED|Overall Study||50||
48167500|NCT00369681|100732349|FG000|COMPLETED|Overall Study||49||
48167501|NCT00369681|100732349|FG000|NOT COMPLETED|Overall Study||1||
48167502|NCT02948959|100732350|FG000|STARTED|52 Weeks Treatment Period||135|Randomized.|
48167503|NCT02948959|100732351|FG001|STARTED|52 Weeks Treatment Period||273|Randomized.|
48167504|NCT02948959|100732350|FG000|Treated|52 Weeks Treatment Period||135||
48167505|NCT02948959|100732351|FG001|Treated|52 Weeks Treatment Period||270||
48167506|NCT02948959|100732350|FG000|Safety Population|52 Weeks Treatment Period||134|Participants who actually received at least 1 dose or part of a dose of investigational medicinal product (IMP), analyzed according to the treatment actually received.|
48167507|NCT02948959|100732351|FG001|Safety Population|52 Weeks Treatment Period||271|Participants who actually received at least 1 dose or part of a dose of investigational medicinal product (IMP), analyzed according to the treatment actually received.|
48167508|NCT02948959|100732350|FG000|Type 2 Inflammatory Asthma Phenotype Population|52 Weeks Treatment Period||114|Randomized participants with baseline blood eosinophils \>=150 cells per microliter or baseline fractional exhaled nitric oxide (FeNO) \>=20 parts per billion (ppb).|
48167509|NCT02948959|100732351|FG001|Type 2 Inflammatory Asthma Phenotype Population|52 Weeks Treatment Period||236|Randomized participants with baseline blood eosinophils \>=150 cells per microliter or baseline fractional exhaled nitric oxide (FeNO) \>=20 parts per billion (ppb).|
48167510|NCT02948959|100732350|FG000|Baseline Blood Eosinophils Count >=300 Cells Per Microlitre Population|52 Weeks Treatment Period||84|Randomized participants with baseline blood eosinophil count \>=300 cells per microliter.|
48167511|NCT02948959|100732351|FG001|Baseline Blood Eosinophils Count >=300 Cells Per Microlitre Population|52 Weeks Treatment Period||175|Randomized participants with baseline blood eosinophil count \>=300 cells per microliter.|
48167512|NCT02948959|100732350|FG000|COMPLETED|52 Weeks Treatment Period||130||
48167513|NCT02948959|100732351|FG001|COMPLETED|52 Weeks Treatment Period||248||
48167514|NCT02948959|100732350|FG000|NOT COMPLETED|52 Weeks Treatment Period||5||
48167515|NCT02948959|100732351|FG001|NOT COMPLETED|52 Weeks Treatment Period||25||
48167516|NCT02948959|100732350|FG000|STARTED|12 Weeks Follow-up Period||9|Only participants who completed treatment, did not continue to 1-year long-term open-label extension study (LTS14424; NCT03560466) entered Period 2 (12-week posttreatment follow-up period).|
48167517|NCT02948959|100732351|FG001|STARTED|12 Weeks Follow-up Period||31|Only participants who completed treatment, did not continue to 1-year long-term open-label extension study (LTS14424; NCT03560466) entered Period 2 (12-week posttreatment follow-up period).|
48167518|NCT02948959|100732350|FG000|COMPLETED|12 Weeks Follow-up Period||4||
48167519|NCT02948959|100732351|FG001|COMPLETED|12 Weeks Follow-up Period||19||
48167520|NCT02948959|100732350|FG000|NOT COMPLETED|12 Weeks Follow-up Period||5||
48167521|NCT02948959|100732351|FG001|NOT COMPLETED|12 Weeks Follow-up Period||12||
48167522|NCT02066896|100732352|FG000|STARTED|Overall Study||33||
48167523|NCT02066896|100732353|FG001|STARTED|Overall Study||33||
48624542|NCT03167242|101863891|FG002|COMPLETED|Overall Study||48||
48624543|NCT03167242|101863892|FG003|COMPLETED|Overall Study||50||
48624544|NCT03167242|101863893|FG004|COMPLETED|Overall Study||53||
48624545|NCT03167242|101863894|FG005|COMPLETED|Overall Study||49||
48624546|NCT03167242|101863895|FG006|COMPLETED|Overall Study||50||
48167524|NCT02066896|100732352|FG000|COMPLETED|Overall Study||33||
48167525|NCT02066896|100732353|FG001|COMPLETED|Overall Study||33||
48167526|NCT02066896|100732352|FG000|NOT COMPLETED|Overall Study||0||
48167527|NCT02066896|100732353|FG001|NOT COMPLETED|Overall Study||0||
48167528|NCT01993017|100732354|FG000|STARTED|Overall Study||499||
48167529|NCT01993017|100732355|FG001|STARTED|Overall Study||501||
48747474|NCT04332107|102169321|FG000|COMPLETED|Day 14||131||
48747475|NCT04332107|102169322|FG001|COMPLETED|Day 14||70||
48747476|NCT04332107|102169321|FG000|NOT COMPLETED|Day 14||17||
48747477|NCT04332107|102169322|FG001|NOT COMPLETED|Day 14||8||
48167530|NCT01993017|100732356|FG002|STARTED|Overall Study||500||
48167531|NCT01993017|100732354|FG000|COMPLETED|Overall Study||393||
48167532|NCT01993017|100732355|FG001|COMPLETED|Overall Study||411||
48167533|NCT01993017|100732356|FG002|COMPLETED|Overall Study||421||
48167534|NCT01993017|100732354|FG000|NOT COMPLETED|Overall Study||106||
48167535|NCT01993017|100732355|FG001|NOT COMPLETED|Overall Study||90||
48167536|NCT01993017|100732356|FG002|NOT COMPLETED|Overall Study||79||
48167537|NCT03277378|100732357|FG000|STARTED|Overall Study||135||
48624547|NCT03167242|101863896|FG007|COMPLETED|Overall Study||26||
48624548|NCT03167242|101863897|FG008|COMPLETED|Overall Study||52||
48624549|NCT03167242|101863898|FG009|COMPLETED|Overall Study||53||
48624550|NCT03167242|101863899|FG010|COMPLETED|Overall Study||43||
48624551|NCT03167242|101863900|FG011|COMPLETED|Overall Study||23||
48624552|NCT03167242|101863889|FG000|NOT COMPLETED|Overall Study||0||
48624553|NCT03167242|101863890|FG001|NOT COMPLETED|Overall Study||1||
48624554|NCT03167242|101863891|FG002|NOT COMPLETED|Overall Study||3||
48624555|NCT03167242|101863892|FG003|NOT COMPLETED|Overall Study||1||
48167538|NCT03277378|100732358|FG001|STARTED|Overall Study||135||
48167539|NCT03277378|100732357|FG000|Received Lead Implant|Overall Study||129||
48167540|NCT03277378|100732358|FG001|Received Lead Implant|Overall Study||123||
48167541|NCT03277378|100732357|FG000|Completed Initial Trial|Overall Study||126||
48167542|NCT03277378|100732358|FG001|Completed Initial Trial|Overall Study||122||
48167543|NCT03277378|100732357|FG000|Qualified for Permanent Implant|Overall Study||103||
48167544|NCT03277378|100732358|FG001|Qualified for Permanent Implant|Overall Study||93||
48167545|NCT03277378|100732357|FG000|Not Qualified for Permanent Implant|Overall Study||19||
48167546|NCT03277378|100732358|FG001|Not Qualified for Permanent Implant|Overall Study||20||
48624556|NCT03167242|101863893|FG004|NOT COMPLETED|Overall Study||1||
48624557|NCT03167242|101863894|FG005|NOT COMPLETED|Overall Study||2||
48624558|NCT03167242|101863895|FG006|NOT COMPLETED|Overall Study||2||
48624559|NCT03167242|101863896|FG007|NOT COMPLETED|Overall Study||1||
48624560|NCT03167242|101863897|FG008|NOT COMPLETED|Overall Study||1||
48624561|NCT03167242|101863898|FG009|NOT COMPLETED|Overall Study||0||
48624562|NCT03167242|101863899|FG010|NOT COMPLETED|Overall Study||2||
48624563|NCT03167242|101863900|FG011|NOT COMPLETED|Overall Study||1||
48624564|NCT02592447|101863901|FG000|STARTED|Overall Study||29||
48624565|NCT02592447|101863902|FG001|STARTED|Overall Study||15||
48624566|NCT02592447|101863901|FG000|COMPLETED|Overall Study||27||
48747478|NCT04332107|102169321|FG000|STARTED|Day 21||135||
48747479|NCT04332107|102169322|FG001|STARTED|Day 21||74||
48747480|NCT04332107|102169321|FG000|COMPLETED|Day 21||125||
48167547|NCT03277378|100732357|FG000|Completed Extended Trial With Tonic Stim|Overall Study||8||
48167548|NCT03277378|100732358|FG001|Completed Extended Trial With Tonic Stim|Overall Study||12||
48167549|NCT03277378|100732357|FG000|Exit Study|Overall Study||11||
48167550|NCT03277378|100732358|FG001|Exit Study|Overall Study||8||
48167551|NCT03277378|100732357|FG000|COMPLETED|Overall Study||111||
48167552|NCT03277378|100732358|FG001|COMPLETED|Overall Study||101||
48167553|NCT03277378|100732357|FG000|NOT COMPLETED|Overall Study||24||
48167554|NCT03277378|100732358|FG001|NOT COMPLETED|Overall Study||34||
48167555|NCT01737281|100732359|FG000|STARTED|Overall Study||969||
48167556|NCT01737281|100732360|FG001|STARTED|Overall Study||969||
48167557|NCT01737281|100732359|FG000|COMPLETED|Overall Study||603||
48167558|NCT01737281|100732360|FG001|COMPLETED|Overall Study||689||
48167559|NCT01737281|100732359|FG000|NOT COMPLETED|Overall Study||366||
48167560|NCT01737281|100732360|FG001|NOT COMPLETED|Overall Study||280||
48167561|NCT01861574|100732361|FG000|STARTED|Overall Study||28||
48167562|NCT01861574|100732362|FG001|STARTED|Overall Study||25||
48167563|NCT01861574|100732363|FG002|STARTED|Overall Study||27||
48167564|NCT01861574|100732364|FG003|STARTED|Overall Study||28||
48167565|NCT01861574|100732361|FG000|COMPLETED|Overall Study||28||
48167566|NCT01861574|100732362|FG001|COMPLETED|Overall Study||25||
48167567|NCT01861574|100732363|FG002|COMPLETED|Overall Study||27||
48167568|NCT01861574|100732364|FG003|COMPLETED|Overall Study||28||
48167569|NCT01861574|100732361|FG000|NOT COMPLETED|Overall Study||0||
48167570|NCT01861574|100732362|FG001|NOT COMPLETED|Overall Study||0||
48167571|NCT01861574|100732363|FG002|NOT COMPLETED|Overall Study||0||
48167572|NCT01861574|100732364|FG003|NOT COMPLETED|Overall Study||0||
48167573|NCT00553098|100732365|FG000|STARTED|Overall Study||29||
48167574|NCT00553098|100732365|FG000|COMPLETED|Overall Study||28||
48167575|NCT00553098|100732365|FG000|NOT COMPLETED|Overall Study||1||
48167576|NCT00708526|100732366|FG000|STARTED|Wake up After Anesthesia||11||
48167577|NCT00708526|100732367|FG001|STARTED|Wake up After Anesthesia||11||
48167578|NCT00708526|100732366|FG000|COMPLETED|Wake up After Anesthesia||11||
48167579|NCT00708526|100732367|FG001|COMPLETED|Wake up After Anesthesia||11||
48167580|NCT00708526|100732366|FG000|NOT COMPLETED|Wake up After Anesthesia||0||
48167581|NCT00708526|100732367|FG001|NOT COMPLETED|Wake up After Anesthesia||0||
48167582|NCT00708526|100732366|FG000|STARTED|Return of Cognitive Function||11||
48167583|NCT00708526|100732367|FG001|STARTED|Return of Cognitive Function||11||
48167584|NCT00708526|100732366|FG000|COMPLETED|Return of Cognitive Function||11||
48167585|NCT00708526|100732367|FG001|COMPLETED|Return of Cognitive Function||11||
48167586|NCT00708526|100732366|FG000|NOT COMPLETED|Return of Cognitive Function||0||
48167587|NCT00708526|100732367|FG001|NOT COMPLETED|Return of Cognitive Function||0||
48167588|NCT00509002|100732368|FG000|STARTED|Overall Study||37||
48167589|NCT00509002|100732368|FG000|COMPLETED|Overall Study||37||
48167590|NCT00509002|100732368|FG000|NOT COMPLETED|Overall Study||0||
48167591|NCT03216902|100732369|FG000|STARTED|Overall Study||22||
48167592|NCT03216902|100732370|FG001|STARTED|Overall Study||44||
48167593|NCT03216902|100732371|FG002|STARTED|Overall Study||43||
48167594|NCT03216902|100732372|FG003|STARTED|Overall Study||43||
48167595|NCT03216902|100732373|FG004|STARTED|Overall Study||44||
48167596|NCT03216902|100732374|FG005|STARTED|Overall Study||45||
48167597|NCT03216902|100732369|FG000|COMPLETED|Overall Study||20||
48167598|NCT03216902|100732370|FG001|COMPLETED|Overall Study||43||
48167599|NCT03216902|100732371|FG002|COMPLETED|Overall Study||42||
48167600|NCT03216902|100732372|FG003|COMPLETED|Overall Study||43||
48167601|NCT03216902|100732373|FG004|COMPLETED|Overall Study||43||
48167602|NCT03216902|100732374|FG005|COMPLETED|Overall Study||42||
48167603|NCT03216902|100732369|FG000|NOT COMPLETED|Overall Study||2||
48330644|NCT03350217|101136046|FG001|NOT COMPLETED|Overall Study||0||
48330645|NCT00430508|101136047|FG000|STARTED|Overall Study||140||
48167604|NCT03216902|100732370|FG001|NOT COMPLETED|Overall Study||1||
48167605|NCT03216902|100732371|FG002|NOT COMPLETED|Overall Study||1||
48167606|NCT03216902|100732372|FG003|NOT COMPLETED|Overall Study||0||
48167607|NCT03216902|100732373|FG004|NOT COMPLETED|Overall Study||1||
48330646|NCT00430508|101136048|FG001|STARTED|Overall Study||278||
48330647|NCT00430508|101136049|FG002|STARTED|Overall Study||279||
48330648|NCT00430508|101136050|FG003|STARTED|Overall Study||274||
48330649|NCT00430508|101136047|FG000|COMPLETED|Overall Study||137||
48410663|NCT02430389|101337693|FG001|NOT COMPLETED|Overall Study||0||
48167608|NCT03216902|100732374|FG005|NOT COMPLETED|Overall Study||3||
48167609|NCT02291432|100732375|FG000|STARTED|Overall Study||25||
48167610|NCT02291432|100732375|FG000|Muscle Biopsy|Overall Study||25||
48167611|NCT02291432|100732375|FG000|AMDC Injection|Overall Study||23||
48167612|NCT02291432|100732375|FG000|1-Month Follow Up|Overall Study||23||
48167613|NCT02291432|100732375|FG000|3-Month Follow Up|Overall Study||23||
48167614|NCT02291432|100732375|FG000|6-Month Follow Up|Overall Study||23||
48167615|NCT02291432|100732375|FG000|12-Month Follow Up|Overall Study||23||
48167616|NCT02291432|100732375|FG000|COMPLETED|Overall Study||23||
48167617|NCT02291432|100732375|FG000|NOT COMPLETED|Overall Study||2||
48167618|NCT00868699|100732376|FG000|STARTED|Overall Study||170||
48167619|NCT00868699|100732377|FG001|STARTED|Overall Study||169||
48167620|NCT00868699|100732378|FG002|STARTED|Overall Study||166||
48167621|NCT00868699|100732376|FG000|Intent-to-Treat Population|Overall Study||162||
48330650|NCT00430508|101136048|FG001|COMPLETED|Overall Study||272||
48747481|NCT04332107|102169322|FG001|COMPLETED|Day 21||72||
48747482|NCT04332107|102169321|FG000|NOT COMPLETED|Day 21||10||
48747483|NCT04332107|102169322|FG001|NOT COMPLETED|Day 21||2||
48747484|NCT00757237|102169323|FG000|STARTED|Overall Study||137||
48747485|NCT00757237|102169324|FG001|STARTED|Overall Study||136||
48747486|NCT00757237|102169323|FG000|Treated|Overall Study||136||
48747487|NCT00757237|102169324|FG001|Treated|Overall Study||132||
48747488|NCT00757237|102169323|FG000|COMPLETED|Overall Study||124||
48747489|NCT00757237|102169324|FG001|COMPLETED|Overall Study||111||
48747490|NCT00757237|102169323|FG000|NOT COMPLETED|Overall Study||13||
48167622|NCT00868699|100732377|FG001|Intent-to-Treat Population|Overall Study||162||
48167623|NCT00868699|100732378|FG002|Intent-to-Treat Population|Overall Study||161||
48167624|NCT00868699|100732376|FG000|Safety Population|Overall Study||168||
48167625|NCT00868699|100732377|FG001|Safety Population|Overall Study||167||
48167626|NCT00868699|100732378|FG002|Safety Population|Overall Study||164||
48167627|NCT00868699|100732376|FG000|COMPLETED|Overall Study||127||
48167628|NCT00868699|100732377|FG001|COMPLETED|Overall Study||124||
48167629|NCT00868699|100732378|FG002|COMPLETED|Overall Study||123||
48167630|NCT00868699|100732376|FG000|NOT COMPLETED|Overall Study||43||
48167631|NCT00868699|100732377|FG001|NOT COMPLETED|Overall Study||45||
48167632|NCT00868699|100732378|FG002|NOT COMPLETED|Overall Study||43||
48167633|NCT01062763|100732379|FG000|STARTED|Overall Study||58||
48167634|NCT01062763|100732380|FG001|STARTED|Overall Study||61||
48167635|NCT01062763|100732379|FG000|COMPLETED|Overall Study||55||
48167636|NCT01062763|100732380|FG001|COMPLETED|Overall Study||57||
48167637|NCT01062763|100732379|FG000|NOT COMPLETED|Overall Study||3||
48167638|NCT01062763|100732380|FG001|NOT COMPLETED|Overall Study||4||
48167639|NCT01834222|100732381|FG000|STARTED|Overall Study||659||
48167640|NCT01834222|100732381|FG000|Treated|Overall Study||658||
48167641|NCT01834222|100732381|FG000|COMPLETED|Overall Study||658||
48167642|NCT01834222|100732381|FG000|NOT COMPLETED|Overall Study||1||
48167643|NCT00879996|100732382|FG000|STARTED|Overall Study||28||
48167644|NCT00879996|100732383|FG001|STARTED|Overall Study||26||
48167645|NCT00879996|100732382|FG000|COMPLETED|Overall Study||13||
48167646|NCT00879996|100732383|FG001|COMPLETED|Overall Study||13||
48167647|NCT00879996|100732382|FG000|NOT COMPLETED|Overall Study||15||
48167648|NCT00879996|100732383|FG001|NOT COMPLETED|Overall Study||13||
48167649|NCT01616771|100732384|FG000|STARTED|Macintosh Laryngoscopy for 5 Sec||23||
48167650|NCT01616771|100732384|FG000|COMPLETED|Macintosh Laryngoscopy for 5 Sec||23||
48167651|NCT01616771|100732384|FG000|NOT COMPLETED|Macintosh Laryngoscopy for 5 Sec||0||
48167652|NCT01616771|100732384|FG000|STARTED|GVL Selected by Weight for 5 Sec||23||
48167653|NCT01616771|100732384|FG000|COMPLETED|GVL Selected by Weight for 5 Sec||23||
48167654|NCT01616771|100732384|FG000|NOT COMPLETED|GVL Selected by Weight for 5 Sec||0||
48167655|NCT01616771|100732384|FG000|STARTED|Smaller Sized GVL for 5 Sec||23||
48167656|NCT01616771|100732384|FG000|COMPLETED|Smaller Sized GVL for 5 Sec||19||
48624567|NCT02592447|101863902|FG001|COMPLETED|Overall Study||14||
48624568|NCT02592447|101863901|FG000|NOT COMPLETED|Overall Study||2||
48624569|NCT02592447|101863902|FG001|NOT COMPLETED|Overall Study||1||
48167657|NCT01616771|100732384|FG000|NOT COMPLETED|Smaller Sized GVL for 5 Sec||4||
48167658|NCT01103960|100732385|FG000|STARTED|Overall Study||164||
48167659|NCT01103960|100732386|FG001|STARTED|Overall Study||160||
48410664|NCT04733664|101337694|FG000|STARTED|Overall Study||10||
48410665|NCT04733664|101337694|FG000|COMPLETED|Overall Study||10||
48410666|NCT04733664|101337694|FG000|NOT COMPLETED|Overall Study||0||
48410667|NCT00302055|101337695|FG000|STARTED|Overall Study||23||
48410668|NCT00302055|101337696|FG001|STARTED|Overall Study||49||
48410669|NCT00302055|101337695|FG000|COMPLETED|Overall Study||14||
48624570|NCT01015326|101863903|FG000|STARTED|Overall Study||12||
48624571|NCT01015326|101863904|FG001|STARTED|Overall Study||20||
48747491|NCT00757237|102169324|FG001|NOT COMPLETED|Overall Study||25||
48747492|NCT01825187|102169325|FG000|STARTED|Overall Study||25||
48167660|NCT01103960|100732385|FG000|COMPLETED|Overall Study||159||
48167661|NCT01103960|100732386|FG001|COMPLETED|Overall Study||158||
48410670|NCT00302055|101337696|FG001|COMPLETED|Overall Study||36||
48410671|NCT00302055|101337695|FG000|NOT COMPLETED|Overall Study||9||
48624572|NCT01015326|101863903|FG000|COMPLETED|Overall Study||11||
48624573|NCT01015326|101863904|FG001|COMPLETED|Overall Study||18||
48624574|NCT01015326|101863903|FG000|NOT COMPLETED|Overall Study||1||
48747493|NCT01825187|102169326|FG001|STARTED|Overall Study||25||
48747494|NCT01825187|102169327|FG002|STARTED|Overall Study||25||
48747495|NCT01825187|102169325|FG000|COMPLETED|Overall Study||24||
48167662|NCT01103960|100732385|FG000|NOT COMPLETED|Overall Study||5||
48410672|NCT00302055|101337696|FG001|NOT COMPLETED|Overall Study||13||
48410673|NCT03231228|101337697|FG000|STARTED|Overall Study||33||
48167663|NCT01103960|100732386|FG001|NOT COMPLETED|Overall Study||2||
48167664|NCT02904902|100732387|FG000|STARTED|Overall Study||15||
48167665|NCT02904902|100732387|FG000|COMPLETED|Overall Study||14||
48167666|NCT02904902|100732387|FG000|NOT COMPLETED|Overall Study||1||
48410674|NCT03231228|101337698|FG001|STARTED|Overall Study||28||
48624575|NCT01015326|101863904|FG001|NOT COMPLETED|Overall Study||2||
48747496|NCT01825187|102169326|FG001|COMPLETED|Overall Study||24||
48747497|NCT01825187|102169327|FG002|COMPLETED|Overall Study||24||
48747498|NCT01825187|102169325|FG000|NOT COMPLETED|Overall Study||1||
48330651|NCT00430508|101136049|FG002|COMPLETED|Overall Study||266||
48330652|NCT00430508|101136050|FG003|COMPLETED|Overall Study||269||
48330653|NCT00430508|101136047|FG000|NOT COMPLETED|Overall Study||3||
48624576|NCT01251042|101863905|FG000|STARTED|Overall Study||26||
48624577|NCT01251042|101863906|FG001|STARTED|Overall Study||23||
48624578|NCT01251042|101863905|FG000|COMPLETED|Overall Study||26||
48624579|NCT01251042|101863906|FG001|COMPLETED|Overall Study||23||
48624580|NCT01251042|101863905|FG000|NOT COMPLETED|Overall Study||0||
48624581|NCT01251042|101863906|FG001|NOT COMPLETED|Overall Study||0||
48624582|NCT01447407|101863907|FG000|STARTED|Overall Study||41||
48624583|NCT01447407|101863908|FG001|STARTED|Overall Study||40||
48624584|NCT01447407|101863909|FG002|STARTED|Overall Study||41||
48330654|NCT00430508|101136048|FG001|NOT COMPLETED|Overall Study||6||
48330655|NCT00430508|101136049|FG002|NOT COMPLETED|Overall Study||13||
48330656|NCT00430508|101136050|FG003|NOT COMPLETED|Overall Study||5||
48330657|NCT02025426|101136051|FG000|STARTED|Overall Study||9||
48330658|NCT02025426|101136052|FG001|STARTED|Overall Study||4||
48330659|NCT02025426|101136051|FG000|COMPLETED|Overall Study||9||
48330660|NCT02025426|101136052|FG001|COMPLETED|Overall Study||4||
48330661|NCT02025426|101136051|FG000|NOT COMPLETED|Overall Study||0||
48330662|NCT02025426|101136052|FG001|NOT COMPLETED|Overall Study||0||
48330663|NCT03273166|101136053|FG000|STARTED|Overall Study||82||
48330664|NCT03273166|101136053|FG000|COMPLETED|Overall Study||51||
48330665|NCT03273166|101136053|FG000|NOT COMPLETED|Overall Study||31||
48330666|NCT02041377|101136054|FG000|STARTED|Overall Study||134||
48330667|NCT02041377|101136054|FG000|COMPLETED|Overall Study||134||
48330668|NCT02041377|101136054|FG000|NOT COMPLETED|Overall Study||0||
48330669|NCT01478854|101136055|FG000|STARTED|Overall Study||30||
48330670|NCT01478854|101136055|FG000|COMPLETED|Overall Study||30||
48330671|NCT01478854|101136055|FG000|NOT COMPLETED|Overall Study||0||
48330672|NCT01420146|101136056|FG000|STARTED|Overall Study||20||
48330673|NCT01420146|101136056|FG000|COMPLETED|Overall Study||20||
48330674|NCT01420146|101136056|FG000|NOT COMPLETED|Overall Study||0||
48330675|NCT01141595|101136057|FG000|STARTED|Overall Study||10||
48330676|NCT01141595|101136057|FG000|COMPLETED|Overall Study||8||
48330677|NCT01141595|101136057|FG000|NOT COMPLETED|Overall Study||2||
48330678|NCT00939198|101136058|FG000|STARTED|Overall Study||87||
48330679|NCT00939198|101136058|FG000|COMPLETED|Overall Study||87||
48330680|NCT00939198|101136058|FG000|NOT COMPLETED|Overall Study||0||
48330681|NCT01407094|101136059|FG000|STARTED|Stage 1||146||
48330682|NCT01407094|101136060|FG001|STARTED|Stage 1||150||
48330683|NCT01407094|101136061|FG002|STARTED|Stage 1||0||
48330684|NCT01407094|101136059|FG000|COMPLETED|Stage 1||112||
48330685|NCT01407094|101136060|FG001|COMPLETED|Stage 1||123||
48330686|NCT01407094|101136061|FG002|COMPLETED|Stage 1||0||
48330687|NCT01407094|101136059|FG000|NOT COMPLETED|Stage 1||34||
48330688|NCT01407094|101136060|FG001|NOT COMPLETED|Stage 1||27||
48624585|NCT01447407|101863910|FG003|STARTED|Overall Study||42||
48624586|NCT01447407|101863907|FG000|COMPLETED|Overall Study||39||
48624587|NCT01447407|101863908|FG001|COMPLETED|Overall Study||40||
48330689|NCT01407094|101136061|FG002|NOT COMPLETED|Stage 1||0||
48330690|NCT01407094|101136059|FG000|STARTED|Stage 2||134||
48330691|NCT01407094|101136060|FG001|STARTED|Stage 2||46||
48330692|NCT01407094|101136061|FG002|STARTED|Stage 2||53||
48330693|NCT01407094|101136059|FG000|COMPLETED|Stage 2||113||
48330694|NCT01407094|101136060|FG001|COMPLETED|Stage 2||35||
48330695|NCT01407094|101136061|FG002|COMPLETED|Stage 2||38||
48330696|NCT01407094|101136059|FG000|NOT COMPLETED|Stage 2||21||
48330697|NCT01407094|101136060|FG001|NOT COMPLETED|Stage 2||11||
48624588|NCT01447407|101863909|FG002|COMPLETED|Overall Study||40||
48624589|NCT01447407|101863910|FG003|COMPLETED|Overall Study||40||
48624590|NCT01447407|101863907|FG000|NOT COMPLETED|Overall Study||2||
48624591|NCT01447407|101863908|FG001|NOT COMPLETED|Overall Study||0||
48624592|NCT01447407|101863909|FG002|NOT COMPLETED|Overall Study||1||
48624593|NCT01447407|101863910|FG003|NOT COMPLETED|Overall Study||2||
48624594|NCT03321721|101863911|FG000|STARTED|Overall Study||4||
48624595|NCT03321721|101863912|FG001|STARTED|Overall Study||10||
48624596|NCT03321721|101863913|FG002|STARTED|Overall Study||12||
48624597|NCT03321721|101863911|FG000|COMPLETED|Overall Study||0||
48624598|NCT03321721|101863912|FG001|COMPLETED|Overall Study||2||
48624599|NCT03321721|101863913|FG002|COMPLETED|Overall Study||1||
48624600|NCT03321721|101863911|FG000|NOT COMPLETED|Overall Study||4||
48624601|NCT03321721|101863912|FG001|NOT COMPLETED|Overall Study||8||
48624602|NCT03321721|101863913|FG002|NOT COMPLETED|Overall Study||11||
48624603|NCT01687114|101863914|FG000|STARTED|Overall Study||5||
48624604|NCT01687114|101863914|FG000|COMPLETED|Overall Study||5||
48624605|NCT01687114|101863914|FG000|NOT COMPLETED|Overall Study||0||
48624606|NCT00004547|101863915|FG000|STARTED|Overall Study||83||
48624607|NCT00004547|101863916|FG001|STARTED|Overall Study||48||
48624608|NCT00004547|101863917|FG002|STARTED|Overall Study||57||
48330698|NCT01407094|101136061|FG002|NOT COMPLETED|Stage 2||15||
48330699|NCT00796315|101136062|FG000|STARTED|Overall Study||9||
48330700|NCT00796315|101136063|FG001|STARTED|Overall Study||17||
48624609|NCT00004547|101863915|FG000|Not Evaluable|Overall Study||21||
48624610|NCT00004547|101863916|FG001|Not Evaluable|Overall Study||9||
48330701|NCT00796315|101136064|FG002|STARTED|Overall Study||15||
48330702|NCT00796315|101136062|FG000|COMPLETED|Overall Study||9||
48330703|NCT00796315|101136063|FG001|COMPLETED|Overall Study||16||
48330704|NCT00796315|101136064|FG002|COMPLETED|Overall Study||15||
48330705|NCT00796315|101136062|FG000|NOT COMPLETED|Overall Study||0||
48330706|NCT00796315|101136063|FG001|NOT COMPLETED|Overall Study||1||
48330707|NCT00796315|101136064|FG002|NOT COMPLETED|Overall Study||0||
48330708|NCT05019131|101136065|FG000|STARTED|Overall Study||40||
48330709|NCT05019131|101136066|FG001|STARTED|Overall Study||43||
48330710|NCT05019131|101136065|FG000|COMPLETED|Overall Study||40||
48330711|NCT05019131|101136066|FG001|COMPLETED|Overall Study||40||
48330712|NCT05019131|101136065|FG000|NOT COMPLETED|Overall Study||0||
48330713|NCT05019131|101136066|FG001|NOT COMPLETED|Overall Study||3||
48330714|NCT01408147|101136067|FG000|STARTED|Overall Study||174||5
48624611|NCT00004547|101863917|FG002|Not Evaluable|Overall Study||23||
48624612|NCT00004547|101863915|FG000|COMPLETED|Overall Study||61||
48624613|NCT00004547|101863916|FG001|COMPLETED|Overall Study||39||
48624614|NCT00004547|101863917|FG002|COMPLETED|Overall Study||35||
48624615|NCT00004547|101863915|FG000|NOT COMPLETED|Overall Study||22||
48624616|NCT00004547|101863916|FG001|NOT COMPLETED|Overall Study||9||
48624617|NCT00004547|101863917|FG002|NOT COMPLETED|Overall Study||22||
48624618|NCT01039467|101863918|FG000|STARTED|Overall Study||196||
48624619|NCT01039467|101863919|FG001|STARTED|Overall Study||189||
48330715|NCT01408147|101136068|FG001|STARTED|Overall Study||197||6
48330716|NCT01408147|101136067|FG000|COMPLETED|Overall Study||174||5
48330717|NCT01408147|101136068|FG001|COMPLETED|Overall Study||196||6
48330718|NCT01408147|101136067|FG000|NOT COMPLETED|Overall Study||0||0
48330719|NCT01408147|101136068|FG001|NOT COMPLETED|Overall Study||1||0
48330720|NCT00704964|101136069|FG000|STARTED|Overall Study||746||
48330721|NCT00704964|101136069|FG000|COMPLETED|Overall Study||418||
48410675|NCT03231228|101337697|FG000|COMPLETED|Overall Study||30||
48410676|NCT03231228|101337698|FG001|COMPLETED|Overall Study||28||
48624620|NCT01039467|101863918|FG000|COMPLETED|Overall Study||156||
48624621|NCT01039467|101863919|FG001|COMPLETED|Overall Study||140||
48624622|NCT01039467|101863918|FG000|NOT COMPLETED|Overall Study||40||
48624623|NCT01039467|101863919|FG001|NOT COMPLETED|Overall Study||49||
48624624|NCT01619852|101863920|FG000|STARTED|24 Hour Assessment||75||
48624625|NCT01619852|101863921|FG001|STARTED|24 Hour Assessment||75||
48624626|NCT01619852|101863920|FG000|COMPLETED|24 Hour Assessment||74||
48624627|NCT01619852|101863921|FG001|COMPLETED|24 Hour Assessment||74||
48624628|NCT01619852|101863920|FG000|NOT COMPLETED|24 Hour Assessment||1||
48624629|NCT01619852|101863921|FG001|NOT COMPLETED|24 Hour Assessment||1||
48624630|NCT01619852|101863920|FG000|STARTED|3 Month Follow up||74||
48624631|NCT01619852|101863921|FG001|STARTED|3 Month Follow up||74||
48624632|NCT01619852|101863920|FG000|COMPLETED|3 Month Follow up||43||
48624633|NCT01619852|101863921|FG001|COMPLETED|3 Month Follow up||40||
48624634|NCT01619852|101863920|FG000|NOT COMPLETED|3 Month Follow up||31||
48624635|NCT01619852|101863921|FG001|NOT COMPLETED|3 Month Follow up||34||
48624636|NCT02427841|101863922|FG000|STARTED|Overall Study||19|20 participants enrolled who agreed to participate in the study following completion of the informed consent process. 19 started is the number of participants who were assigned to each Arm/Group. One subject withdrew prior to treatment resulting in a total of 19 subjects enrolled and started treatment.|
48624637|NCT02427841|101863922|FG000|COMPLETED|Overall Study||11||
48624638|NCT02427841|101863922|FG000|NOT COMPLETED|Overall Study||8||
48624639|NCT00447772|101863923|FG000|STARTED|Overall Study||516||
48624640|NCT00447772|101863923|FG000|COMPLETED|Overall Study||489||
48624641|NCT00447772|101863923|FG000|NOT COMPLETED|Overall Study||27||
48624642|NCT05541939|101863924|FG000|STARTED|Overall Study||5||
48410677|NCT03231228|101337697|FG000|NOT COMPLETED|Overall Study||3||
48410678|NCT03231228|101337698|FG001|NOT COMPLETED|Overall Study||0||
48624643|NCT05541939|101863925|FG001|STARTED|Overall Study||4||
48624644|NCT05541939|101863924|FG000|COMPLETED|Overall Study||5||
48624645|NCT05541939|101863925|FG001|COMPLETED|Overall Study||4||
48167667|NCT02117934|100732388|FG000|STARTED|Overall Study||5592||
48167668|NCT02117934|100732389|FG001|STARTED|Overall Study||2782||
48624646|NCT05541939|101863924|FG000|NOT COMPLETED|Overall Study||0||
48624647|NCT05541939|101863925|FG001|NOT COMPLETED|Overall Study||0||
48167669|NCT02117934|100732388|FG000|COMPLETED|Overall Study||5092||
48167670|NCT02117934|100732389|FG001|COMPLETED|Overall Study||2567||
48167671|NCT02117934|100732388|FG000|NOT COMPLETED|Overall Study||500||
48167672|NCT02117934|100732389|FG001|NOT COMPLETED|Overall Study||215||
48167673|NCT01014975|100732390|FG000|STARTED|Overall Study||8||
48167674|NCT01014975|100732391|FG001|STARTED|Overall Study||16||
48167675|NCT01014975|100732392|FG002|STARTED|Overall Study||16||
48330722|NCT00704964|101136069|FG000|NOT COMPLETED|Overall Study||328||
48624648|NCT02925858|101863926|FG000|STARTED|Overall Study||42||
48624649|NCT02925858|101863927|FG001|STARTED|Overall Study||38||
48624650|NCT02925858|101863926|FG000|COMPLETED|Overall Study||42||
48624651|NCT02925858|101863927|FG001|COMPLETED|Overall Study||38||
48624652|NCT02925858|101863926|FG000|NOT COMPLETED|Overall Study||0||
48167676|NCT01014975|100732390|FG000|COMPLETED|Overall Study||4||
48167677|NCT01014975|100732391|FG001|COMPLETED|Overall Study||13||
48330723|NCT03742037|101136070|FG000|STARTED|Treatment Period 1 (1st Dose - Month 6)||85||
48330724|NCT03742037|101136071|FG001|STARTED|Treatment Period 1 (1st Dose - Month 6)||85||
48410679|NCT02515851|101337699|FG000|STARTED|Overall Study||15||
48167678|NCT01014975|100732392|FG002|COMPLETED|Overall Study||10||
48624653|NCT02925858|101863927|FG001|NOT COMPLETED|Overall Study||0||
48624654|NCT03257436|101863928|FG000|STARTED|Overall Study||584||
48624655|NCT03257436|101863928|FG000|COMPLETED|Overall Study||489||
48624656|NCT03257436|101863928|FG000|NOT COMPLETED|Overall Study||95||
48330725|NCT03742037|101136072|FG002|STARTED|Treatment Period 1 (1st Dose - Month 6)||86||
48330726|NCT03742037|101136073|FG003|STARTED|Treatment Period 1 (1st Dose - Month 6)||0||
48330727|NCT03742037|101136074|FG004|STARTED|Treatment Period 1 (1st Dose - Month 6)||0||
48330728|NCT03742037|101136075|FG005|STARTED|Treatment Period 1 (1st Dose - Month 6)||85||
48330729|NCT03742037|101136076|FG006|STARTED|Treatment Period 1 (1st Dose - Month 6)||86||
48330730|NCT03742037|101136070|FG000|COMPLETED|Treatment Period 1 (1st Dose - Month 6)||78||
48330731|NCT03742037|101136071|FG001|COMPLETED|Treatment Period 1 (1st Dose - Month 6)||78||
48330732|NCT03742037|101136072|FG002|COMPLETED|Treatment Period 1 (1st Dose - Month 6)||71||
48330733|NCT03742037|101136073|FG003|COMPLETED|Treatment Period 1 (1st Dose - Month 6)||0||
48330734|NCT03742037|101136074|FG004|COMPLETED|Treatment Period 1 (1st Dose - Month 6)||0||
48330735|NCT03742037|101136075|FG005|COMPLETED|Treatment Period 1 (1st Dose - Month 6)||70||
48330736|NCT03742037|101136076|FG006|COMPLETED|Treatment Period 1 (1st Dose - Month 6)||77||
48330737|NCT03742037|101136070|FG000|NOT COMPLETED|Treatment Period 1 (1st Dose - Month 6)||7||
48330738|NCT03742037|101136071|FG001|NOT COMPLETED|Treatment Period 1 (1st Dose - Month 6)||7||
48330739|NCT03742037|101136072|FG002|NOT COMPLETED|Treatment Period 1 (1st Dose - Month 6)||15||
48330740|NCT03742037|101136073|FG003|NOT COMPLETED|Treatment Period 1 (1st Dose - Month 6)||0||
48330741|NCT03742037|101136074|FG004|NOT COMPLETED|Treatment Period 1 (1st Dose - Month 6)||0||
48330742|NCT03742037|101136075|FG005|NOT COMPLETED|Treatment Period 1 (1st Dose - Month 6)||15||
48330743|NCT03742037|101136076|FG006|NOT COMPLETED|Treatment Period 1 (1st Dose - Month 6)||9||
48330744|NCT03742037|101136070|FG000|STARTED|Treatment Period 2 (Month 6 - Month 12)||78||
48330745|NCT03742037|101136071|FG001|STARTED|Treatment Period 2 (Month 6 - Month 12)||78||
48330746|NCT03742037|101136072|FG002|STARTED|Treatment Period 2 (Month 6 - Month 12)||72||
48330747|NCT03742037|101136073|FG003|STARTED|Treatment Period 2 (Month 6 - Month 12)||35||
48330748|NCT03742037|101136074|FG004|STARTED|Treatment Period 2 (Month 6 - Month 12)||35||
48330749|NCT03742037|101136075|FG005|STARTED|Treatment Period 2 (Month 6 - Month 12)||0||
48330750|NCT03742037|101136076|FG006|STARTED|Treatment Period 2 (Month 6 - Month 12)||77||
48330751|NCT03742037|101136070|FG000|COMPLETED|Treatment Period 2 (Month 6 - Month 12)||74||
48330752|NCT03742037|101136071|FG001|COMPLETED|Treatment Period 2 (Month 6 - Month 12)||74||
48330753|NCT03742037|101136072|FG002|COMPLETED|Treatment Period 2 (Month 6 - Month 12)||59||
48330754|NCT03742037|101136073|FG003|COMPLETED|Treatment Period 2 (Month 6 - Month 12)||30||
48330755|NCT03742037|101136074|FG004|COMPLETED|Treatment Period 2 (Month 6 - Month 12)||35||
48330756|NCT03742037|101136075|FG005|COMPLETED|Treatment Period 2 (Month 6 - Month 12)||0||
48330757|NCT03742037|101136076|FG006|COMPLETED|Treatment Period 2 (Month 6 - Month 12)||68||
48330758|NCT03742037|101136070|FG000|NOT COMPLETED|Treatment Period 2 (Month 6 - Month 12)||4||
48330759|NCT03742037|101136071|FG001|NOT COMPLETED|Treatment Period 2 (Month 6 - Month 12)||4||
48330760|NCT03742037|101136072|FG002|NOT COMPLETED|Treatment Period 2 (Month 6 - Month 12)||13||
48330761|NCT03742037|101136073|FG003|NOT COMPLETED|Treatment Period 2 (Month 6 - Month 12)||5||
48330762|NCT03742037|101136074|FG004|NOT COMPLETED|Treatment Period 2 (Month 6 - Month 12)||0||
48330763|NCT03742037|101136075|FG005|NOT COMPLETED|Treatment Period 2 (Month 6 - Month 12)||0||
48330764|NCT03742037|101136076|FG006|NOT COMPLETED|Treatment Period 2 (Month 6 - Month 12)||9||
48330765|NCT01042600|101136077|FG000|STARTED|Overall Study||31||
48330766|NCT01042600|101136078|FG001|STARTED|Overall Study||30||
48330767|NCT01042600|101136077|FG000|COMPLETED|Overall Study||30||
48330768|NCT01042600|101136078|FG001|COMPLETED|Overall Study||30||
48330769|NCT01042600|101136077|FG000|NOT COMPLETED|Overall Study||1||
48330770|NCT01042600|101136078|FG001|NOT COMPLETED|Overall Study||0||
48330771|NCT01332071|101136079|FG000|STARTED|Period 1||13||
48330772|NCT01332071|101136080|FG001|STARTED|Period 1||13||
48330773|NCT01332071|101136079|FG000|COMPLETED|Period 1||13||
48624657|NCT01365130|101863929|FG000|STARTED|Overall Study||15||
48624658|NCT01365130|101863929|FG000|COMPLETED|Overall Study||13||
48624659|NCT01365130|101863929|FG000|NOT COMPLETED|Overall Study||2||
48330774|NCT01332071|101136080|FG001|COMPLETED|Period 1||13||
48330775|NCT01332071|101136079|FG000|NOT COMPLETED|Period 1||0||
48330776|NCT01332071|101136080|FG001|NOT COMPLETED|Period 1||0||
48330777|NCT01332071|101136079|FG000|STARTED|7-Day Washout Period||13||
48330778|NCT01332071|101136080|FG001|STARTED|7-Day Washout Period||13||
48624660|NCT00570401|101863930|FG000|STARTED|Overall Study||21||
48624661|NCT00570401|101863930|FG000|COMPLETED|Overall Study||19||
48624662|NCT00570401|101863930|FG000|NOT COMPLETED|Overall Study||2||
48624663|NCT00643760|101863931|FG000|STARTED|Overall Study||120||
48624664|NCT00643760|101863932|FG001|STARTED|Overall Study||62||
48624665|NCT00643760|101863933|FG002|STARTED|Overall Study||56||
48330779|NCT01332071|101136079|FG000|COMPLETED|7-Day Washout Period||13||
48330780|NCT01332071|101136080|FG001|COMPLETED|7-Day Washout Period||13||
48330781|NCT01332071|101136079|FG000|NOT COMPLETED|7-Day Washout Period||0||
48330782|NCT01332071|101136080|FG001|NOT COMPLETED|7-Day Washout Period||0||
48624666|NCT00643760|101863934|FG003|STARTED|Overall Study||117||
48330783|NCT01332071|101136079|FG000|STARTED|Period 2||13||
48624667|NCT00643760|101863935|FG004|STARTED|Overall Study||66||
48624668|NCT00643760|101863931|FG000|Safety Population/Treated With Drug|Overall Study||120||
48330784|NCT01332071|101136080|FG001|STARTED|Period 2||13||
48330785|NCT01332071|101136079|FG000|COMPLETED|Period 2||13||
48330786|NCT01332071|101136080|FG001|COMPLETED|Period 2||13||
48330787|NCT01332071|101136079|FG000|NOT COMPLETED|Period 2||0||
48330788|NCT01332071|101136080|FG001|NOT COMPLETED|Period 2||0||
48330789|NCT01400451|101136081|FG000|STARTED|28 Day Lead In With Vemurafenib Alone||6||
48330790|NCT01400451|101136082|FG001|STARTED|28 Day Lead In With Vemurafenib Alone||4||
48330791|NCT01400451|101136083|FG002|STARTED|28 Day Lead In With Vemurafenib Alone||2||
48330792|NCT01400451|101136081|FG000|COMPLETED|28 Day Lead In With Vemurafenib Alone||6||
48330793|NCT01400451|101136082|FG001|COMPLETED|28 Day Lead In With Vemurafenib Alone||4||
48330794|NCT01400451|101136083|FG002|COMPLETED|28 Day Lead In With Vemurafenib Alone||2||
48330795|NCT01400451|101136081|FG000|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0||
48330796|NCT01400451|101136082|FG001|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0||
48330797|NCT01400451|101136083|FG002|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0||
48330798|NCT01400451|101136081|FG000|STARTED|Combination Treatment (or Intended)||6||
48330799|NCT01400451|101136082|FG001|STARTED|Combination Treatment (or Intended)||4||
48330800|NCT01400451|101136083|FG002|STARTED|Combination Treatment (or Intended)||2||
48330801|NCT01400451|101136081|FG000|COMPLETED|Combination Treatment (or Intended)||0||
48330802|NCT01400451|101136082|FG001|COMPLETED|Combination Treatment (or Intended)||0||
48330803|NCT01400451|101136083|FG002|COMPLETED|Combination Treatment (or Intended)||0||
48330804|NCT01400451|101136081|FG000|NOT COMPLETED|Combination Treatment (or Intended)||6||
48330805|NCT01400451|101136082|FG001|NOT COMPLETED|Combination Treatment (or Intended)||4||
48330806|NCT01400451|101136083|FG002|NOT COMPLETED|Combination Treatment (or Intended)||2||
48330807|NCT01512264|101136084|FG000|STARTED|Overall Study||7||
48330808|NCT01512264|101136085|FG001|STARTED|Overall Study||7||
48330809|NCT01512264|101136086|FG002|STARTED|Overall Study||7||
48330810|NCT01512264|101136087|FG003|STARTED|Overall Study||7||
48330811|NCT01512264|101136084|FG000|COMPLETED|Overall Study||7||
48330812|NCT01512264|101136085|FG001|COMPLETED|Overall Study||7||
48330813|NCT01512264|101136086|FG002|COMPLETED|Overall Study||7||
48330814|NCT01512264|101136087|FG003|COMPLETED|Overall Study||6||
48330815|NCT01512264|101136084|FG000|NOT COMPLETED|Overall Study||0||
48330816|NCT01512264|101136085|FG001|NOT COMPLETED|Overall Study||0||
48330817|NCT01512264|101136086|FG002|NOT COMPLETED|Overall Study||0||
48330818|NCT01512264|101136087|FG003|NOT COMPLETED|Overall Study||1||
48330819|NCT04409873|101136088|FG000|STARTED|Overall Study||12||
48330820|NCT04409873|101136089|FG001|STARTED|Overall Study||11||
48330821|NCT04409873|101136090|FG002|STARTED|Overall Study||12||
48330822|NCT04409873|101136091|FG003|STARTED|Overall Study||12||
48330823|NCT04409873|101136092|FG004|STARTED|Overall Study||7||
48330824|NCT04409873|101136088|FG000|COMPLETED|Overall Study||12||
48330825|NCT04409873|101136089|FG001|COMPLETED|Overall Study||8||
48330826|NCT04409873|101136090|FG002|COMPLETED|Overall Study||11||
48330827|NCT04409873|101136091|FG003|COMPLETED|Overall Study||12||
48330828|NCT04409873|101136092|FG004|COMPLETED|Overall Study||6||
48330829|NCT04409873|101136088|FG000|NOT COMPLETED|Overall Study||0||
48330830|NCT04409873|101136089|FG001|NOT COMPLETED|Overall Study||3||
48330831|NCT04409873|101136090|FG002|NOT COMPLETED|Overall Study||1||
48330832|NCT04409873|101136091|FG003|NOT COMPLETED|Overall Study||0||
48330833|NCT04409873|101136092|FG004|NOT COMPLETED|Overall Study||1||
48330834|NCT04372927|101136093|FG000|STARTED|Overall Study||1||
48330835|NCT04372927|101136093|FG000|COMPLETED|Overall Study||0||
48330836|NCT04372927|101136093|FG000|NOT COMPLETED|Overall Study||1||
48330837|NCT01418001|101136094|FG000|STARTED|Overall Study||5||
48330838|NCT01418001|101136094|FG000|COMPLETED|Overall Study||5||
48330839|NCT01418001|101136094|FG000|NOT COMPLETED|Overall Study||0||
48330840|NCT00393874|101136095|FG000|STARTED|Overall Study||18||
48330841|NCT00393874|101136096|FG001|STARTED|Overall Study||17||
48330842|NCT00393874|101136097|FG002|STARTED|Overall Study||15||
48330843|NCT00393874|101136095|FG000|COMPLETED|Overall Study||15||
48330844|NCT00393874|101136096|FG001|COMPLETED|Overall Study||13||
48330845|NCT00393874|101136097|FG002|COMPLETED|Overall Study||13||
48330846|NCT00393874|101136095|FG000|NOT COMPLETED|Overall Study||3||
48330847|NCT00393874|101136096|FG001|NOT COMPLETED|Overall Study||4||
48330848|NCT00393874|101136097|FG002|NOT COMPLETED|Overall Study||2||
48330849|NCT03870555|101136098|FG000|STARTED|Period 1 (2 Days)||2||
48330850|NCT03870555|101136099|FG001|STARTED|Period 1 (2 Days)||2||
48330851|NCT03870555|101136100|FG002|STARTED|Period 1 (2 Days)||2||
48330852|NCT03870555|101136098|FG000|COMPLETED|Period 1 (2 Days)||2||
48330853|NCT03870555|101136099|FG001|COMPLETED|Period 1 (2 Days)||2||
48330854|NCT03870555|101136100|FG002|COMPLETED|Period 1 (2 Days)||2||
48330855|NCT03870555|101136098|FG000|NOT COMPLETED|Period 1 (2 Days)||0||
48330856|NCT03870555|101136099|FG001|NOT COMPLETED|Period 1 (2 Days)||0||
48330857|NCT03870555|101136100|FG002|NOT COMPLETED|Period 1 (2 Days)||0||
48330858|NCT03870555|101136098|FG000|STARTED|Washout Period (at Least 16 Days)||2||
48330859|NCT03870555|101136099|FG001|STARTED|Washout Period (at Least 16 Days)||2||
48330860|NCT03870555|101136100|FG002|STARTED|Washout Period (at Least 16 Days)||2||
48330861|NCT03870555|101136098|FG000|COMPLETED|Washout Period (at Least 16 Days)||2||
48330862|NCT03870555|101136099|FG001|COMPLETED|Washout Period (at Least 16 Days)||2||
48330863|NCT03870555|101136100|FG002|COMPLETED|Washout Period (at Least 16 Days)||2||
48330864|NCT03870555|101136098|FG000|NOT COMPLETED|Washout Period (at Least 16 Days)||0||
48330865|NCT03870555|101136099|FG001|NOT COMPLETED|Washout Period (at Least 16 Days)||0||
48330866|NCT03870555|101136100|FG002|NOT COMPLETED|Washout Period (at Least 16 Days)||0||
48330867|NCT03870555|101136098|FG000|STARTED|Period 2 (2 Days)||2||
48330868|NCT03870555|101136099|FG001|STARTED|Period 2 (2 Days)||2||
48330869|NCT03870555|101136100|FG002|STARTED|Period 2 (2 Days)||2||
48330870|NCT03870555|101136098|FG000|COMPLETED|Period 2 (2 Days)||2||
48330871|NCT03870555|101136099|FG001|COMPLETED|Period 2 (2 Days)||2||
48330872|NCT03870555|101136100|FG002|COMPLETED|Period 2 (2 Days)||2||
48330873|NCT03870555|101136098|FG000|NOT COMPLETED|Period 2 (2 Days)||0||
48330874|NCT03870555|101136099|FG001|NOT COMPLETED|Period 2 (2 Days)||0||
48330875|NCT03870555|101136100|FG002|NOT COMPLETED|Period 2 (2 Days)||0||
48330876|NCT03870555|101136098|FG000|STARTED|Washout Period (at Least 16 Days)||2||
48330877|NCT03870555|101136099|FG001|STARTED|Washout Period (at Least 16 Days)||2||
48330878|NCT03870555|101136100|FG002|STARTED|Washout Period (at Least 16 Days)||2||
48330879|NCT03870555|101136098|FG000|COMPLETED|Washout Period (at Least 16 Days)||2||
48330880|NCT03870555|101136099|FG001|COMPLETED|Washout Period (at Least 16 Days)||2||
48330881|NCT03870555|101136100|FG002|COMPLETED|Washout Period (at Least 16 Days)||2||
48330882|NCT03870555|101136098|FG000|NOT COMPLETED|Washout Period (at Least 16 Days)||0||
48330883|NCT03870555|101136099|FG001|NOT COMPLETED|Washout Period (at Least 16 Days)||0||
48330884|NCT03870555|101136100|FG002|NOT COMPLETED|Washout Period (at Least 16 Days)||0||
48330885|NCT03870555|101136098|FG000|STARTED|Period 3 (2 Days)||2||
48330886|NCT03870555|101136099|FG001|STARTED|Period 3 (2 Days)||2||
48330887|NCT03870555|101136100|FG002|STARTED|Period 3 (2 Days)||2||
48330888|NCT03870555|101136098|FG000|COMPLETED|Period 3 (2 Days)||1||
48330889|NCT03870555|101136099|FG001|COMPLETED|Period 3 (2 Days)||2||
48330890|NCT03870555|101136100|FG002|COMPLETED|Period 3 (2 Days)||2||
48330891|NCT03870555|101136098|FG000|NOT COMPLETED|Period 3 (2 Days)||1||
48330892|NCT03870555|101136099|FG001|NOT COMPLETED|Period 3 (2 Days)||0||
48330893|NCT03870555|101136100|FG002|NOT COMPLETED|Period 3 (2 Days)||0||
48330894|NCT00060346|101136101|FG000|STARTED|Overall Study||16||
48330895|NCT00060346|101136101|FG000|Eligible and Treated|Overall Study||16||
48330896|NCT00060346|101136101|FG000|COMPLETED|Overall Study||16||
48330897|NCT00060346|101136101|FG000|NOT COMPLETED|Overall Study||0||
48330898|NCT01857869|101136102|FG000|STARTED|Primary/Challenge Phase||34||
48330899|NCT01857869|101136103|FG001|STARTED|Primary/Challenge Phase||17||
48330900|NCT01857869|101136104|FG002|STARTED|Primary/Challenge Phase||12||
48330901|NCT01857869|101136105|FG003|STARTED|Primary/Challenge Phase||0||
48330902|NCT01857869|101136106|FG004|STARTED|Primary/Challenge Phase||0||
48330903|NCT01857869|101136107|FG005|STARTED|Primary/Challenge Phase||0||
48330904|NCT01857869|101136108|FG006|STARTED|Primary/Challenge Phase||0||
48330905|NCT01857869|101136109|FG007|STARTED|Primary/Challenge Phase||0||
48330906|NCT01857869|101136110|FG008|STARTED|Primary/Challenge Phase||0||
48330907|NCT01857869|101136111|FG009|STARTED|Primary/Challenge Phase||0||
48330908|NCT01857869|101136102|FG000|COMPLETED|Primary/Challenge Phase||29||
48330909|NCT01857869|101136103|FG001|COMPLETED|Primary/Challenge Phase||16||
48330910|NCT01857869|101136104|FG002|COMPLETED|Primary/Challenge Phase||12||
48330911|NCT01857869|101136105|FG003|COMPLETED|Primary/Challenge Phase||0||
48330912|NCT01857869|101136106|FG004|COMPLETED|Primary/Challenge Phase||0||
48330913|NCT01857869|101136107|FG005|COMPLETED|Primary/Challenge Phase||0||
48330914|NCT01857869|101136108|FG006|COMPLETED|Primary/Challenge Phase||0||
48330915|NCT01857869|101136109|FG007|COMPLETED|Primary/Challenge Phase||0||
48330916|NCT01857869|101136110|FG008|COMPLETED|Primary/Challenge Phase||0||
48330917|NCT01857869|101136111|FG009|COMPLETED|Primary/Challenge Phase||0||
48330918|NCT01857869|101136102|FG000|NOT COMPLETED|Primary/Challenge Phase||5||
48330919|NCT01857869|101136103|FG001|NOT COMPLETED|Primary/Challenge Phase||1||
48330920|NCT01857869|101136104|FG002|NOT COMPLETED|Primary/Challenge Phase||0||
48330921|NCT01857869|101136105|FG003|NOT COMPLETED|Primary/Challenge Phase||0||
48330922|NCT01857869|101136106|FG004|NOT COMPLETED|Primary/Challenge Phase||0||
48330923|NCT01857869|101136107|FG005|NOT COMPLETED|Primary/Challenge Phase||0||
48330924|NCT01857869|101136108|FG006|NOT COMPLETED|Primary/Challenge Phase||0||
48330925|NCT01857869|101136109|FG007|NOT COMPLETED|Primary/Challenge Phase||0||
48330926|NCT01857869|101136110|FG008|NOT COMPLETED|Primary/Challenge Phase||0||
48330927|NCT01857869|101136111|FG009|NOT COMPLETED|Primary/Challenge Phase||0||
48330928|NCT01857869|101136102|FG000|STARTED|Booster/Rechallenge Phase||0||
48330929|NCT01857869|101136103|FG001|STARTED|Booster/Rechallenge Phase||0||
48330930|NCT01857869|101136104|FG002|STARTED|Booster/Rechallenge Phase||0||
48330931|NCT01857869|101136105|FG003|STARTED|Booster/Rechallenge Phase||9||
48330932|NCT01857869|101136106|FG004|STARTED|Booster/Rechallenge Phase||10||
48330933|NCT01857869|101136107|FG005|STARTED|Booster/Rechallenge Phase||2||
48330934|NCT01857869|101136108|FG006|STARTED|Booster/Rechallenge Phase||5||
48330935|NCT01857869|101136109|FG007|STARTED|Booster/Rechallenge Phase||4||
48330936|NCT01857869|101136110|FG008|STARTED|Booster/Rechallenge Phase||3||
48330937|NCT01857869|101136111|FG009|STARTED|Booster/Rechallenge Phase||6||
48330938|NCT01857869|101136102|FG000|COMPLETED|Booster/Rechallenge Phase||0||
48330939|NCT01857869|101136103|FG001|COMPLETED|Booster/Rechallenge Phase||0||
48330940|NCT01857869|101136104|FG002|COMPLETED|Booster/Rechallenge Phase||0||
48330941|NCT01857869|101136105|FG003|COMPLETED|Booster/Rechallenge Phase||7||
48330942|NCT01857869|101136106|FG004|COMPLETED|Booster/Rechallenge Phase||10||
48330943|NCT01857869|101136107|FG005|COMPLETED|Booster/Rechallenge Phase||2||
48330944|NCT01857869|101136108|FG006|COMPLETED|Booster/Rechallenge Phase||5||
48330945|NCT01857869|101136109|FG007|COMPLETED|Booster/Rechallenge Phase||4||
48330946|NCT01857869|101136110|FG008|COMPLETED|Booster/Rechallenge Phase||3||
48330947|NCT01857869|101136111|FG009|COMPLETED|Booster/Rechallenge Phase||6||
48330948|NCT01857869|101136102|FG000|NOT COMPLETED|Booster/Rechallenge Phase||0||
48330949|NCT01857869|101136103|FG001|NOT COMPLETED|Booster/Rechallenge Phase||0||
48330950|NCT01857869|101136104|FG002|NOT COMPLETED|Booster/Rechallenge Phase||0||
48330951|NCT01857869|101136105|FG003|NOT COMPLETED|Booster/Rechallenge Phase||2||
48330952|NCT01857869|101136106|FG004|NOT COMPLETED|Booster/Rechallenge Phase||0||
48330953|NCT01857869|101136107|FG005|NOT COMPLETED|Booster/Rechallenge Phase||0||
48330954|NCT01857869|101136108|FG006|NOT COMPLETED|Booster/Rechallenge Phase||0||
48330955|NCT01857869|101136109|FG007|NOT COMPLETED|Booster/Rechallenge Phase||0||
48330956|NCT01857869|101136110|FG008|NOT COMPLETED|Booster/Rechallenge Phase||0||
48330957|NCT01857869|101136111|FG009|NOT COMPLETED|Booster/Rechallenge Phase||0||
48330958|NCT02740478|101136112|FG000|STARTED|Overall Study||21||
48330959|NCT02740478|101136112|FG000|COMPLETED|Overall Study||20||
48330960|NCT02740478|101136112|FG000|NOT COMPLETED|Overall Study||1||
48330961|NCT03423342|101136113|FG000|STARTED|Overall Study||20||
48330962|NCT03423342|101136114|FG001|STARTED|Overall Study||10||
48330963|NCT03423342|101136113|FG000|COMPLETED|Overall Study||20||
48330964|NCT03423342|101136114|FG001|COMPLETED|Overall Study||10||
48330965|NCT03423342|101136113|FG000|NOT COMPLETED|Overall Study||0||
48330966|NCT03423342|101136114|FG001|NOT COMPLETED|Overall Study||0||
48330967|NCT03321097|101136115|FG000|STARTED|Overall Study||18||
48330968|NCT03321097|101136116|FG001|STARTED|Overall Study||18||
48330969|NCT03321097|101136115|FG000|COMPLETED|Overall Study||18||
48330970|NCT03321097|101136116|FG001|COMPLETED|Overall Study||18||
48330971|NCT03321097|101136115|FG000|NOT COMPLETED|Overall Study||0||
48330972|NCT03321097|101136116|FG001|NOT COMPLETED|Overall Study||0||
48330973|NCT02068547|101136117|FG000|STARTED|Overall Study||4||
48330974|NCT02068547|101136118|FG001|STARTED|Overall Study||4||
48330975|NCT02068547|101136117|FG000|COMPLETED|Overall Study||0||
48330976|NCT02068547|101136118|FG001|COMPLETED|Overall Study||1||
48330977|NCT02068547|101136117|FG000|NOT COMPLETED|Overall Study||4||
48330978|NCT02068547|101136118|FG001|NOT COMPLETED|Overall Study||3||
48330979|NCT01578980|101136119|FG000|STARTED|Overall Study||20||
48330980|NCT01578980|101136119|FG000|COMPLETED|Overall Study||20||
48330981|NCT01578980|101136119|FG000|NOT COMPLETED|Overall Study||0||
48330982|NCT02792842|101136120|FG000|STARTED|Overall Study||24||
48330983|NCT02792842|101136121|FG001|STARTED|Overall Study||27||
48330984|NCT02792842|101136122|FG002|STARTED|Overall Study||28||
48330985|NCT02792842|101136120|FG000|COMPLETED|Overall Study||20||
48330986|NCT02792842|101136121|FG001|COMPLETED|Overall Study||23||
48330987|NCT02792842|101136122|FG002|COMPLETED|Overall Study||21||
48330988|NCT02792842|101136120|FG000|NOT COMPLETED|Overall Study||4||
48330989|NCT02792842|101136121|FG001|NOT COMPLETED|Overall Study||4||
48330990|NCT02792842|101136122|FG002|NOT COMPLETED|Overall Study||7||
48330991|NCT04438174|101136123|FG000|STARTED|Overall Study||1||
48330992|NCT04438174|101136124|FG001|STARTED|Overall Study||0||
48330993|NCT04438174|101136123|FG000|COMPLETED|Overall Study||1||
48330994|NCT04438174|101136124|FG001|COMPLETED|Overall Study||0||
48330995|NCT04438174|101136123|FG000|NOT COMPLETED|Overall Study||0||
48330996|NCT04438174|101136124|FG001|NOT COMPLETED|Overall Study||0||
48330997|NCT03064841|101136125|FG000|STARTED|Overall Study||1537||
48330998|NCT03064841|101136125|FG000|COMPLETED|Overall Study||1520||
48330999|NCT03064841|101136125|FG000|NOT COMPLETED|Overall Study||17||
48331000|NCT03861143|101136126|FG000|STARTED|Overall Study||66||
48331001|NCT03861143|101136127|FG001|STARTED|Overall Study||66||
48331002|NCT03861143|101136128|FG002|STARTED|Overall Study||66||
48331003|NCT03861143|101136126|FG000|COMPLETED|Overall Study||62||
48331004|NCT03861143|101136127|FG001|COMPLETED|Overall Study||59||
48331005|NCT03861143|101136128|FG002|COMPLETED|Overall Study||58||
48331006|NCT03861143|101136126|FG000|NOT COMPLETED|Overall Study||4||
48331007|NCT03861143|101136127|FG001|NOT COMPLETED|Overall Study||7||
48331008|NCT03861143|101136128|FG002|NOT COMPLETED|Overall Study||8||
48331009|NCT01414257|101136129|FG000|STARTED|Overall Study||2860||
48331010|NCT01414257|101136129|FG000|COMPLETED|Overall Study||2838||
48331011|NCT01414257|101136129|FG000|NOT COMPLETED|Overall Study||22||
48331012|NCT00789529|101136130|FG000|STARTED|Overall Study||16||
48331013|NCT00789529|101136131|FG001|STARTED|Overall Study||16||
48331014|NCT00789529|101136130|FG000|COMPLETED|Overall Study||15||
48331015|NCT00789529|101136131|FG001|COMPLETED|Overall Study||15||
48410680|NCT02515851|101337700|FG001|STARTED|Overall Study||15||
48331016|NCT00789529|101136130|FG000|NOT COMPLETED|Overall Study||1||
48331017|NCT00789529|101136131|FG001|NOT COMPLETED|Overall Study||1||
48331018|NCT00883337|101136132|FG000|STARTED|Core Treatment Period||109||
48331019|NCT00883337|101136133|FG001|STARTED|Core Treatment Period||111||
48331020|NCT00883337|101136134|FG002|STARTED|Core Treatment Period||104||
48331021|NCT00883337|101136132|FG000|Treated|Core Treatment Period||109||
48331022|NCT00883337|101136133|FG001|Treated|Core Treatment Period||111||
48331023|NCT00883337|101136134|FG002|Treated|Core Treatment Period||101||
48331024|NCT00883337|101136132|FG000|COMPLETED|Core Treatment Period||89||
48331025|NCT00883337|101136133|FG001|COMPLETED|Core Treatment Period||89||
48331026|NCT00883337|101136134|FG002|COMPLETED|Core Treatment Period||71||
48331027|NCT00883337|101136132|FG000|NOT COMPLETED|Core Treatment Period||20||
48331028|NCT00883337|101136133|FG001|NOT COMPLETED|Core Treatment Period||22||
48331029|NCT00883337|101136134|FG002|NOT COMPLETED|Core Treatment Period||33||
48331030|NCT00883337|101136132|FG000|STARTED|Extension Treatment Period||89||
48331031|NCT00883337|101136133|FG001|STARTED|Extension Treatment Period||89||
48331032|NCT00883337|101136134|FG002|STARTED|Extension Treatment Period||59||
48331033|NCT00883337|101136132|FG000|COMPLETED|Extension Treatment Period||61||
48331034|NCT00883337|101136133|FG001|COMPLETED|Extension Treatment Period||66||
48331035|NCT00883337|101136134|FG002|COMPLETED|Extension Treatment Period||40||
48331036|NCT00883337|101136132|FG000|NOT COMPLETED|Extension Treatment Period||28||
48331037|NCT00883337|101136133|FG001|NOT COMPLETED|Extension Treatment Period||23||
48331038|NCT00883337|101136134|FG002|NOT COMPLETED|Extension Treatment Period||19||
48331039|NCT00291447|101136135|FG000|STARTED|Overall Study||2||
48331040|NCT00291447|101136136|FG001|STARTED|Overall Study||2||
48331041|NCT00291447|101136137|FG002|STARTED|Overall Study||2||
48331042|NCT00291447|101136138|FG003|STARTED|Overall Study||2||
48331043|NCT00291447|101136135|FG000|COMPLETED|Overall Study||2||
48331044|NCT00291447|101136136|FG001|COMPLETED|Overall Study||2||
48331045|NCT00291447|101136137|FG002|COMPLETED|Overall Study||2||
48331046|NCT00291447|101136138|FG003|COMPLETED|Overall Study||2||
48331047|NCT00291447|101136135|FG000|NOT COMPLETED|Overall Study||0||
48331048|NCT00291447|101136136|FG001|NOT COMPLETED|Overall Study||0||
48331049|NCT00291447|101136137|FG002|NOT COMPLETED|Overall Study||0||
48331050|NCT00291447|101136138|FG003|NOT COMPLETED|Overall Study||0||
48331051|NCT01823679|101136139|FG000|STARTED|Overall Study||2||
48331052|NCT01823679|101136139|FG000|COMPLETED|Overall Study||1||
48331053|NCT01823679|101136139|FG000|NOT COMPLETED|Overall Study||1||
48331054|NCT01665807|101136140|FG000|STARTED|Overall Study||411||
48624669|NCT00643760|101863932|FG001|Safety Population/Treated With Drug|Overall Study||62||
48624670|NCT00643760|101863933|FG002|Safety Population/Treated With Drug|Overall Study||56||
48624671|NCT00643760|101863934|FG003|Safety Population/Treated With Drug|Overall Study||116||
48624672|NCT00643760|101863935|FG004|Safety Population/Treated With Drug|Overall Study||66||
48624673|NCT00643760|101863931|FG000|ITT Population|Overall Study||120||
48624674|NCT00643760|101863932|FG001|ITT Population|Overall Study||62||
48624675|NCT00643760|101863933|FG002|ITT Population|Overall Study||56||
48624676|NCT00643760|101863934|FG003|ITT Population|Overall Study||116||
48624677|NCT00643760|101863935|FG004|ITT Population|Overall Study||66||
48624678|NCT00643760|101863931|FG000|COMPLETED|Overall Study||90||
48624679|NCT00643760|101863932|FG001|COMPLETED|Overall Study||47||
48624680|NCT00643760|101863933|FG002|COMPLETED|Overall Study||37||
48624681|NCT00643760|101863934|FG003|COMPLETED|Overall Study||79||
48624682|NCT00643760|101863935|FG004|COMPLETED|Overall Study||47||
48624683|NCT00643760|101863931|FG000|NOT COMPLETED|Overall Study||30||
48624684|NCT00643760|101863932|FG001|NOT COMPLETED|Overall Study||15||
48624685|NCT00643760|101863933|FG002|NOT COMPLETED|Overall Study||19||
48624686|NCT00643760|101863934|FG003|NOT COMPLETED|Overall Study||38||
48624687|NCT00643760|101863935|FG004|NOT COMPLETED|Overall Study||19||
48624688|NCT01065818|101863936|FG000|STARTED|Overall Study||6||
48624689|NCT01065818|101863936|FG000|COMPLETED|Overall Study||4||
48624690|NCT01065818|101863936|FG000|NOT COMPLETED|Overall Study||2||
48331055|NCT01665807|101136141|FG001|STARTED|Overall Study||58||
48331056|NCT01665807|101136142|FG002|STARTED|Overall Study||402||
48331057|NCT01665807|101136140|FG000|COMPLETED|Overall Study||409||
48331058|NCT01665807|101136141|FG001|COMPLETED|Overall Study||58||
48331059|NCT01665807|101136142|FG002|COMPLETED|Overall Study||401||
48331060|NCT01665807|101136140|FG000|NOT COMPLETED|Overall Study||2||
48331061|NCT01665807|101136141|FG001|NOT COMPLETED|Overall Study||0||
48331062|NCT01665807|101136142|FG002|NOT COMPLETED|Overall Study||1||
48624691|NCT01164202|101863937|FG000|STARTED|Overall Study||39||
48624692|NCT01164202|101863938|FG001|STARTED|Overall Study||39||
48624693|NCT01164202|101863937|FG000|COMPLETED|Overall Study||38||
48624694|NCT01164202|101863938|FG001|COMPLETED|Overall Study||39||
48624695|NCT01164202|101863937|FG000|NOT COMPLETED|Overall Study||1||
48624696|NCT01164202|101863938|FG001|NOT COMPLETED|Overall Study||0||
48624697|NCT02515630|101863939|FG000|STARTED|Overall Study||41||
48624698|NCT02515630|101863939|FG000|COMPLETED|Overall Study||25||
48624699|NCT02515630|101863939|FG000|NOT COMPLETED|Overall Study||16||
48624700|NCT00032591|101863940|FG000|STARTED|Screening||1873||
48624701|NCT00032591|101863941|FG001|STARTED|Screening||1872||
48624702|NCT00032591|101863940|FG000|COMPLETED|Screening||1465||
48624703|NCT00032591|101863941|FG001|COMPLETED|Screening||1457||
48331063|NCT02568046|101136143|FG000|STARTED|Overall Study||5||
48331064|NCT02568046|101136144|FG001|STARTED|Overall Study||5||
48331065|NCT02568046|101136143|FG000|COMPLETED|Overall Study||0|Two (2) patients were ongoing at the time of data cut-off for Primary Completion.|
48368081|NCT00449748|101230102|FG000|STARTED|Overall Study||10||
48747499|NCT01825187|102169326|FG001|NOT COMPLETED|Overall Study||1||
48747500|NCT01825187|102169327|FG002|NOT COMPLETED|Overall Study||1||
48747501|NCT00799266|102169328|FG000|STARTED|Overall Study||18|All randomized patients (ITT)|
48747502|NCT00799266|102169329|FG001|STARTED|Overall Study||16|All randomized patients (ITT)|
48747503|NCT00799266|102169328|FG000|Modified Intention-to-treat (MITT)|Overall Study||17|All patients with baseline and at least one post-baseline lumbar spine BMD Z-score|
48747504|NCT00799266|102169329|FG001|Modified Intention-to-treat (MITT)|Overall Study||16|All patients with baseline and at least one post-baseline lumbar spine BMD Z-score|
48747505|NCT00799266|102169328|FG000|Safety Set|Overall Study||18|All patients with at least one infusion of study drug|
48747506|NCT00799266|102169329|FG001|Safety Set|Overall Study||16|All patients with at least one infusion of study drug|
48747507|NCT00799266|102169328|FG000|COMPLETED|Overall Study||15||
48747508|NCT00799266|102169329|FG001|COMPLETED|Overall Study||15||
48747509|NCT00799266|102169328|FG000|NOT COMPLETED|Overall Study||3||
48747510|NCT00799266|102169329|FG001|NOT COMPLETED|Overall Study||1||
48747511|NCT00392392|102169330|FG000|STARTED|Overall Study||29||
48747512|NCT00392392|102169330|FG000|COMPLETED|Overall Study||9||
48747513|NCT00392392|102169330|FG000|NOT COMPLETED|Overall Study||20||
48747514|NCT00148759|102169331|FG000|STARTED|Overall Study||11||
48747515|NCT00148759|102169332|FG001|STARTED|Overall Study||12||
48747516|NCT00148759|102169331|FG000|24-hr PK Sampling|Overall Study||9||
48747517|NCT00148759|102169332|FG001|24-hr PK Sampling|Overall Study||11||
48747518|NCT00148759|102169331|FG000|COMPLETED|Overall Study||9||
48747519|NCT00148759|102169332|FG001|COMPLETED|Overall Study||11||
48747520|NCT00148759|102169331|FG000|NOT COMPLETED|Overall Study||2||
48331066|NCT02568046|101136144|FG001|COMPLETED|Overall Study||2|Two (2) patients were ongoing at the time of data cut-off for Primary Completion.|
48331067|NCT02568046|101136143|FG000|NOT COMPLETED|Overall Study||5||
48331068|NCT02568046|101136144|FG001|NOT COMPLETED|Overall Study||3||
48331069|NCT01765673|101136145|FG000|STARTED|Overall Study||12||
48331070|NCT01765673|101136145|FG000|COMPLETED|Overall Study||11||
48410681|NCT02515851|101337699|FG000|COMPLETED|Overall Study||15||
48410682|NCT02515851|101337700|FG001|COMPLETED|Overall Study||15||
48410683|NCT02515851|101337699|FG000|NOT COMPLETED|Overall Study||0||
48410684|NCT02515851|101337700|FG001|NOT COMPLETED|Overall Study||0||
48410685|NCT00762528|101337701|FG000|STARTED|Overall Study||24||
48410686|NCT00762528|101337702|FG001|STARTED|Overall Study||25||
48410687|NCT00762528|101337701|FG000|COMPLETED|Overall Study||24||
48410688|NCT00762528|101337702|FG001|COMPLETED|Overall Study||25||
48410689|NCT00762528|101337701|FG000|NOT COMPLETED|Overall Study||0||
48410690|NCT00762528|101337702|FG001|NOT COMPLETED|Overall Study||0||
48410691|NCT00634751|101337703|FG000|STARTED|Phase I: 200mg Sorafenib+2DOC||9||
48410692|NCT00634751|101337704|FG001|STARTED|Phase I: 200mg Sorafenib+2DOC||0||
48410693|NCT00634751|101337705|FG002|STARTED|Phase I: 200mg Sorafenib+2DOC||0||
48410694|NCT00634751|101337706|FG003|STARTED|Phase I: 200mg Sorafenib+2DOC||0||
48410695|NCT00634751|101337703|FG000|COMPLETED|Phase I: 200mg Sorafenib+2DOC||8||
48410696|NCT00634751|101337704|FG001|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0||
48410697|NCT00634751|101337705|FG002|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0||
48410698|NCT00634751|101337706|FG003|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0||
48410699|NCT00634751|101337703|FG000|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||1||
48410700|NCT00634751|101337704|FG001|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0||
48410701|NCT00634751|101337705|FG002|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0||
48410702|NCT00634751|101337706|FG003|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0||
48747521|NCT00148759|102169332|FG001|NOT COMPLETED|Overall Study||1||
48747522|NCT03563209|102169333|FG000|STARTED|Overall Study||60||
48331071|NCT01765673|101136145|FG000|NOT COMPLETED|Overall Study||1||
48331072|NCT03694925|101136146|FG000|STARTED|Overall Study||30||
48331073|NCT03694925|101136147|FG001|STARTED|Overall Study||73||
48331074|NCT03694925|101136148|FG002|STARTED|Overall Study||53||
48331075|NCT03694925|101136146|FG000|COMPLETED|Overall Study||30||
48331076|NCT03694925|101136147|FG001|COMPLETED|Overall Study||70||
48331077|NCT03694925|101136148|FG002|COMPLETED|Overall Study||53||
48331078|NCT03694925|101136146|FG000|NOT COMPLETED|Overall Study||0||
48331079|NCT03694925|101136147|FG001|NOT COMPLETED|Overall Study||3||
48331080|NCT03694925|101136148|FG002|NOT COMPLETED|Overall Study||0||
48331081|NCT03107793|101136149|FG000|STARTED|Induction Period (16 Weeks)||498||
48331082|NCT03107793|101136150|FG001|STARTED|Induction Period (16 Weeks)||0||
48331083|NCT03107793|101136151|FG002|STARTED|Induction Period (16 Weeks)||0||
48410703|NCT00634751|101337703|FG000|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0||
48410704|NCT00634751|101337704|FG001|STARTED|Phase I: 400mg Sorafenib BID+2DOC||7||
48410705|NCT00634751|101337705|FG002|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0||
48747523|NCT03563209|102169333|FG000|COMPLETED|Overall Study||60||
48747524|NCT03563209|102169333|FG000|NOT COMPLETED|Overall Study||0||
48747525|NCT01338818|102169334|FG000|STARTED|Overall Study||298||
48747526|NCT01338818|102169334|FG000|COMPLETED|Overall Study||262||
48747527|NCT01338818|102169334|FG000|NOT COMPLETED|Overall Study||36||
48747528|NCT00732212|102169335|FG000|STARTED|Overall Study||112||
48747529|NCT00732212|102169336|FG001|STARTED|Overall Study||123||
48747530|NCT00732212|102169335|FG000|Temporarily Suspended|Overall Study||50||
48331084|NCT03107793|101136152|FG003|STARTED|Induction Period (16 Weeks)||0||
48331085|NCT03107793|101136153|FG004|STARTED|Induction Period (16 Weeks)||0||
48410706|NCT00634751|101337706|FG003|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0||
48410707|NCT00634751|101337703|FG000|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0||
48410708|NCT00634751|101337704|FG001|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||6||
48410709|NCT00634751|101337705|FG002|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0||
48410710|NCT00634751|101337706|FG003|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0||
48624704|NCT00032591|101863940|FG000|NOT COMPLETED|Screening||408||
48624705|NCT00032591|101863941|FG001|NOT COMPLETED|Screening||415||
48624706|NCT00032591|101863940|FG000|STARTED|Randomization||1465||
48624707|NCT00032591|101863941|FG001|STARTED|Randomization||1457||
48410711|NCT00634751|101337703|FG000|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0||
48410712|NCT00634751|101337704|FG001|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||1||
48410713|NCT00634751|101337705|FG002|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0||
48410714|NCT00634751|101337706|FG003|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0||
48410715|NCT00634751|101337703|FG000|STARTED|Pancreatic and Bilial Tract Cancer||0||
48410716|NCT00634751|101337704|FG001|STARTED|Pancreatic and Bilial Tract Cancer||0||
48410717|NCT00634751|101337705|FG002|STARTED|Pancreatic and Bilial Tract Cancer||24||
48410718|NCT00634751|101337706|FG003|STARTED|Pancreatic and Bilial Tract Cancer||8||
48410719|NCT00634751|101337703|FG000|COMPLETED|Pancreatic and Bilial Tract Cancer||0||
48410720|NCT00634751|101337704|FG001|COMPLETED|Pancreatic and Bilial Tract Cancer||0||
48410721|NCT00634751|101337705|FG002|COMPLETED|Pancreatic and Bilial Tract Cancer||23||
48410722|NCT00634751|101337706|FG003|COMPLETED|Pancreatic and Bilial Tract Cancer||7||
48624708|NCT00032591|101863940|FG000|COMPLETED|Randomization||1465||
48624709|NCT00032591|101863941|FG001|COMPLETED|Randomization||1457||
48331086|NCT03107793|101136149|FG000|Participants Who Entered the Maintenance Period|Induction Period (16 Weeks)||0||
48331087|NCT03107793|101136150|FG001|Participants Who Entered the Maintenance Period|Induction Period (16 Weeks)||219||
48331088|NCT03107793|101136151|FG002|Participants Who Entered the Maintenance Period|Induction Period (16 Weeks)||221||
48331089|NCT03107793|101136152|FG003|Participants Who Entered the Maintenance Period|Induction Period (16 Weeks)||0||
48331090|NCT03107793|101136153|FG004|Participants Who Entered the Maintenance Period|Induction Period (16 Weeks)||0||
48331091|NCT03107793|101136149|FG000|Participants Who Entered the Extension Period|Induction Period (16 Weeks)||0||
48331092|NCT03107793|101136150|FG001|Participants Who Entered the Extension Period|Induction Period (16 Weeks)||0||
48331093|NCT03107793|101136151|FG002|Participants Who Entered the Extension Period|Induction Period (16 Weeks)||0||
48624710|NCT00032591|101863940|FG000|NOT COMPLETED|Randomization||0||
48624711|NCT00032591|101863941|FG001|NOT COMPLETED|Randomization||0||
48624712|NCT00032591|101863940|FG000|STARTED|Follow-up||1465||
48624713|NCT00032591|101863941|FG001|STARTED|Follow-up||1457||
48624714|NCT00032591|101863940|FG000|COMPLETED|Follow-up||1463||
48624715|NCT00032591|101863941|FG001|COMPLETED|Follow-up||1452||
48624716|NCT00032591|101863940|FG000|NOT COMPLETED|Follow-up||2||
48624717|NCT00032591|101863941|FG001|NOT COMPLETED|Follow-up||5||
48624718|NCT03205150|101863942|FG000|STARTED|Overall Study||43|Participants randomized|
48624719|NCT03205150|101863943|FG001|STARTED|Overall Study||43|Participants randomized|
48624720|NCT03205150|101863944|FG002|STARTED|Overall Study||21|Participants randomized|
48624721|NCT03205150|101863942|FG000|Safety Analysis Set|Overall Study||43||
48624722|NCT03205150|101863943|FG001|Safety Analysis Set|Overall Study||43||
48624723|NCT03205150|101863944|FG002|Safety Analysis Set|Overall Study||21||
48624724|NCT03205150|101863942|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||42||
48624725|NCT03205150|101863943|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||36||
48331094|NCT03107793|101136152|FG003|Participants Who Entered the Extension Period|Induction Period (16 Weeks)||147||
48331095|NCT03107793|101136153|FG004|Participants Who Entered the Extension Period|Induction Period (16 Weeks)||176||
48331096|NCT03107793|101136149|FG000|COMPLETED|Induction Period (16 Weeks)||488||
48331097|NCT03107793|101136150|FG001|COMPLETED|Induction Period (16 Weeks)||0||
48331098|NCT03107793|101136151|FG002|COMPLETED|Induction Period (16 Weeks)||0||
48331099|NCT03107793|101136152|FG003|COMPLETED|Induction Period (16 Weeks)||0||
48331100|NCT03107793|101136153|FG004|COMPLETED|Induction Period (16 Weeks)||0||
48331101|NCT03107793|101136149|FG000|NOT COMPLETED|Induction Period (16 Weeks)||10||
48331102|NCT03107793|101136150|FG001|NOT COMPLETED|Induction Period (16 Weeks)||0||
48331103|NCT03107793|101136151|FG002|NOT COMPLETED|Induction Period (16 Weeks)||0||
48331104|NCT03107793|101136152|FG003|NOT COMPLETED|Induction Period (16 Weeks)||0||
48331105|NCT03107793|101136153|FG004|NOT COMPLETED|Induction Period (16 Weeks)||0||
48331106|NCT03107793|101136149|FG000|STARTED|Maintenance Period (Week 16-Week 48)||0||
48331107|NCT03107793|101136150|FG001|STARTED|Maintenance Period (Week 16-Week 48)||219||
48331108|NCT03107793|101136151|FG002|STARTED|Maintenance Period (Week 16-Week 48)||221||
48331109|NCT03107793|101136152|FG003|STARTED|Maintenance Period (Week 16-Week 48)||0||
48410723|NCT00634751|101337703|FG000|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0||
48410724|NCT00634751|101337704|FG001|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0||
48410725|NCT00634751|101337705|FG002|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1||
48410726|NCT00634751|101337706|FG003|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1||
48410727|NCT00784459|101337707|FG000|STARTED|Overall Study||11||
48410728|NCT00784459|101337708|FG001|STARTED|Overall Study||13||
48410729|NCT00784459|101337707|FG000|COMPLETED|Overall Study||11||
48410730|NCT00784459|101337708|FG001|COMPLETED|Overall Study||11||
48410731|NCT00784459|101337707|FG000|NOT COMPLETED|Overall Study||0||
48410732|NCT00784459|101337708|FG001|NOT COMPLETED|Overall Study||2||
48624726|NCT03205150|101863944|FG002|Pharmacokinetics (PK) Analysis Set|Overall Study||0||
48624727|NCT03205150|101863942|FG000|Pharmacodynamics (PD) Analysis Set|Overall Study||43||
48624728|NCT03205150|101863943|FG001|Pharmacodynamics (PD) Analysis Set|Overall Study||41||
48624729|NCT03205150|101863944|FG002|Pharmacodynamics (PD) Analysis Set|Overall Study||21||
48624730|NCT03205150|101863942|FG000|COMPLETED|Overall Study||41||
48331110|NCT03107793|101136153|FG004|STARTED|Maintenance Period (Week 16-Week 48)||0||
48331111|NCT03107793|101136149|FG000|COMPLETED|Maintenance Period (Week 16-Week 48)||0||
48331112|NCT03107793|101136150|FG001|COMPLETED|Maintenance Period (Week 16-Week 48)||173||
48331113|NCT03107793|101136151|FG002|COMPLETED|Maintenance Period (Week 16-Week 48)||193||
48331114|NCT03107793|101136152|FG003|COMPLETED|Maintenance Period (Week 16-Week 48)||0||
48331115|NCT03107793|101136153|FG004|COMPLETED|Maintenance Period (Week 16-Week 48)||0||
48331116|NCT03107793|101136149|FG000|NOT COMPLETED|Maintenance Period (Week 16-Week 48)||0||
48331117|NCT03107793|101136150|FG001|NOT COMPLETED|Maintenance Period (Week 16-Week 48)||46||
48331118|NCT03107793|101136151|FG002|NOT COMPLETED|Maintenance Period (Week 16-Week 48)||28||
48331119|NCT03107793|101136152|FG003|NOT COMPLETED|Maintenance Period (Week 16-Week 48)||0||
48331120|NCT03107793|101136153|FG004|NOT COMPLETED|Maintenance Period (Week 16-Week 48)||0||
48331121|NCT03107793|101136149|FG000|STARTED|Extension Period (Week 48- Week 104)||0||
48624731|NCT03205150|101863943|FG001|COMPLETED|Overall Study||36||
48624732|NCT03205150|101863944|FG002|COMPLETED|Overall Study||19||
48624733|NCT03205150|101863942|FG000|NOT COMPLETED|Overall Study||2||
48624734|NCT03205150|101863943|FG001|NOT COMPLETED|Overall Study||7||
48747531|NCT00732212|102169336|FG001|Temporarily Suspended|Overall Study||50||
48747532|NCT00732212|102169335|FG000|COMPLETED|Overall Study||112||
48747533|NCT00732212|102169336|FG001|COMPLETED|Overall Study||123||
48747534|NCT00732212|102169335|FG000|NOT COMPLETED|Overall Study||0||
48747535|NCT00732212|102169336|FG001|NOT COMPLETED|Overall Study||0||
48747536|NCT01253642|102169337|FG000|STARTED|Overall Study||11||
48747537|NCT01253642|102169337|FG000|COMPLETED|Overall Study||6||
48747538|NCT01253642|102169337|FG000|NOT COMPLETED|Overall Study||5||
48747539|NCT03244917|102169338|FG000|STARTED|Overall Study||201||
48747540|NCT03244917|102169339|FG001|STARTED|Overall Study||229||
48747541|NCT03244917|102169338|FG000|COMPLETED|Overall Study||199||
48331122|NCT03107793|101136150|FG001|STARTED|Extension Period (Week 48- Week 104)||0||
48331123|NCT03107793|101136151|FG002|STARTED|Extension Period (Week 48- Week 104)||0||
48331124|NCT03107793|101136152|FG003|STARTED|Extension Period (Week 48- Week 104)||147||
48331125|NCT03107793|101136153|FG004|STARTED|Extension Period (Week 48- Week 104)||176||
48331126|NCT03107793|101136149|FG000|COMPLETED|Extension Period (Week 48- Week 104)||0||
48331127|NCT03107793|101136150|FG001|COMPLETED|Extension Period (Week 48- Week 104)||0||
48331128|NCT03107793|101136151|FG002|COMPLETED|Extension Period (Week 48- Week 104)||0||
48331129|NCT03107793|101136152|FG003|COMPLETED|Extension Period (Week 48- Week 104)||119||
48331130|NCT03107793|101136153|FG004|COMPLETED|Extension Period (Week 48- Week 104)||139||
48747542|NCT03244917|102169339|FG001|COMPLETED|Overall Study||227||
48747543|NCT03244917|102169338|FG000|NOT COMPLETED|Overall Study||2||
48747544|NCT03244917|102169339|FG001|NOT COMPLETED|Overall Study||2||
48747545|NCT02354534|102169340|FG000|STARTED|Overall Study||3||
48747546|NCT02354534|102169341|FG001|STARTED|Overall Study||9||
48747547|NCT02354534|102169342|FG002|STARTED|Overall Study||10||
48747548|NCT02354534|102169343|FG003|STARTED|Overall Study||8||
48747549|NCT02354534|102169340|FG000|COMPLETED|Overall Study||3||
48747550|NCT02354534|102169341|FG001|COMPLETED|Overall Study||9||
48747551|NCT02354534|102169342|FG002|COMPLETED|Overall Study||9||
48747552|NCT02354534|102169343|FG003|COMPLETED|Overall Study||8||
48747553|NCT02354534|102169340|FG000|NOT COMPLETED|Overall Study||0||
48624735|NCT03205150|101863944|FG002|NOT COMPLETED|Overall Study||2||
48624736|NCT01939314|101863945|FG000|STARTED|Overall Study||45||
48624737|NCT01939314|101863946|FG001|STARTED|Overall Study||48||
48624738|NCT01939314|101863945|FG000|15 Minute Endpoint|Overall Study||41||
48624739|NCT01939314|101863946|FG001|15 Minute Endpoint|Overall Study||46||
48624740|NCT01939314|101863945|FG000|24 Hour Endpoint|Overall Study||36||
48624741|NCT01939314|101863946|FG001|24 Hour Endpoint|Overall Study||40||
48624742|NCT01939314|101863945|FG000|COMPLETED|Overall Study||36||
48624743|NCT01939314|101863946|FG001|COMPLETED|Overall Study||40||
48624744|NCT01939314|101863945|FG000|NOT COMPLETED|Overall Study||9||
48624745|NCT01939314|101863946|FG001|NOT COMPLETED|Overall Study||8||
48624746|NCT01502085|101863947|FG000|STARTED|Overall Study||25||
48624747|NCT01502085|101863947|FG000|COMPLETED|Overall Study||25||
48624748|NCT01502085|101863947|FG000|NOT COMPLETED|Overall Study||0||
48624749|NCT01926028|101863948|FG000|STARTED|Overall Study||85||
48624750|NCT01926028|101863949|FG001|STARTED|Overall Study||89||
48747554|NCT02354534|102169341|FG001|NOT COMPLETED|Overall Study||0||
48368082|NCT00449748|101230102|FG000|COMPLETED|Overall Study||10||
48624751|NCT01926028|101863950|FG002|STARTED|Overall Study||14||
48747555|NCT02354534|102169342|FG002|NOT COMPLETED|Overall Study||1||
48747556|NCT02354534|102169343|FG003|NOT COMPLETED|Overall Study||0||
48747557|NCT01623479|102169344|FG000|STARTED|Overall Study||585||
48747558|NCT01623479|102169344|FG000|COMPLETED|Overall Study||585||
48747559|NCT01623479|102169344|FG000|NOT COMPLETED|Overall Study||0||
48747560|NCT00430716|102169345|FG000|STARTED|Double Blind Phase||42||
48747561|NCT00430716|102169346|FG001|STARTED|Double Blind Phase||43||
48331131|NCT03107793|101136149|FG000|NOT COMPLETED|Extension Period (Week 48- Week 104)||0||
48331132|NCT03107793|101136150|FG001|NOT COMPLETED|Extension Period (Week 48- Week 104)||0||
48331133|NCT03107793|101136151|FG002|NOT COMPLETED|Extension Period (Week 48- Week 104)||0||
48331134|NCT03107793|101136152|FG003|NOT COMPLETED|Extension Period (Week 48- Week 104)||28||
48331135|NCT03107793|101136153|FG004|NOT COMPLETED|Extension Period (Week 48- Week 104)||37||
48331136|NCT00797732|101136154|FG000|STARTED|Overall Study||21||
48331137|NCT00797732|101136155|FG001|STARTED|Overall Study||21||
48331138|NCT00797732|101136156|FG002|STARTED|Overall Study||154||
48331139|NCT00797732|101136154|FG000|Evaluable at Baseline|Overall Study||18|Evaluable for quality of life assessment.|
48331140|NCT00797732|101136155|FG001|Evaluable at Baseline|Overall Study||18|Evaluable for quality of life assessment.|
48331141|NCT00797732|101136156|FG002|Evaluable at Baseline|Overall Study||0|Evaluable for quality of life assessment.|
48331142|NCT00797732|101136154|FG000|Evaluable at 20 Weeks|Overall Study||17|Evaluable for quality of life assessment.|
48331143|NCT00797732|101136155|FG001|Evaluable at 20 Weeks|Overall Study||18|Evaluable for quality of life assessment.|
48331144|NCT00797732|101136156|FG002|Evaluable at 20 Weeks|Overall Study||0|Evaluable for quality of life assessment.|
48331145|NCT00797732|101136154|FG000|Evaluable at 12 Months|Overall Study||17|Evaluable for quality of life assessment.|
48331146|NCT00797732|101136155|FG001|Evaluable at 12 Months|Overall Study||18|Evaluable for quality of life assessment.|
48331147|NCT00797732|101136156|FG002|Evaluable at 12 Months|Overall Study||0|Evaluable for quality of life assessment.|
48331148|NCT00797732|101136154|FG000|COMPLETED|Overall Study||16||
48331149|NCT00797732|101136155|FG001|COMPLETED|Overall Study||18||
48331150|NCT00797732|101136156|FG002|COMPLETED|Overall Study||0||
48331151|NCT00797732|101136154|FG000|NOT COMPLETED|Overall Study||5||
48331152|NCT00797732|101136155|FG001|NOT COMPLETED|Overall Study||3||
48331153|NCT00797732|101136156|FG002|NOT COMPLETED|Overall Study||154||
48331154|NCT01895127|101136157|FG000|STARTED|Screening||4||
48331155|NCT01895127|101136158|FG001|STARTED|Screening||7||
48747562|NCT00430716|102169347|FG002|STARTED|Double Blind Phase||45||
48747563|NCT00430716|102169345|FG000|Treated|Double Blind Phase||41||
48747564|NCT00430716|102169346|FG001|Treated|Double Blind Phase||43||
48747565|NCT00430716|102169347|FG002|Treated|Double Blind Phase||45||
48167679|NCT01014975|100732390|FG000|NOT COMPLETED|Overall Study||4||
48167680|NCT01014975|100732391|FG001|NOT COMPLETED|Overall Study||3||
48167681|NCT01014975|100732392|FG002|NOT COMPLETED|Overall Study||6||
48331156|NCT01895127|101136157|FG000|COMPLETED|Screening||4||
48331157|NCT01895127|101136158|FG001|COMPLETED|Screening||7||
48331158|NCT01895127|101136157|FG000|NOT COMPLETED|Screening||0||
48331159|NCT01895127|101136158|FG001|NOT COMPLETED|Screening||0||
48331160|NCT01895127|101136157|FG000|STARTED|Treatment Period (Week 0-Month 3)||3||
48331161|NCT01895127|101136158|FG001|STARTED|Treatment Period (Week 0-Month 3)||7||
48331162|NCT01895127|101136157|FG000|COMPLETED|Treatment Period (Week 0-Month 3)||3||
48331163|NCT01895127|101136158|FG001|COMPLETED|Treatment Period (Week 0-Month 3)||7||
48331164|NCT01895127|101136157|FG000|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0||
48331165|NCT01895127|101136158|FG001|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0||
48331166|NCT01895127|101136157|FG000|STARTED|Month 3 Follow-up & Biopsy||3||
48331167|NCT01895127|101136158|FG001|STARTED|Month 3 Follow-up & Biopsy||7||
48331168|NCT01895127|101136157|FG000|COMPLETED|Month 3 Follow-up & Biopsy||3||
48331169|NCT01895127|101136158|FG001|COMPLETED|Month 3 Follow-up & Biopsy||7||
48331170|NCT01895127|101136157|FG000|NOT COMPLETED|Month 3 Follow-up & Biopsy||0||
48331171|NCT01895127|101136158|FG001|NOT COMPLETED|Month 3 Follow-up & Biopsy||0||
48331172|NCT01895127|101136157|FG000|STARTED|Long Term Follow-up (Month 3-12)||3||
48331173|NCT01895127|101136158|FG001|STARTED|Long Term Follow-up (Month 3-12)||7||
48331174|NCT01895127|101136157|FG000|COMPLETED|Long Term Follow-up (Month 3-12)||1||
48167682|NCT01118455|100732393|FG000|STARTED|Baseline [Visits 1 & 2]||66||
48167683|NCT01118455|100732394|FG001|STARTED|Baseline [Visits 1 & 2]||69||
48167684|NCT01118455|100732393|FG000|Actual Patients Treated|Baseline [Visits 1 & 2]||65||
48167685|NCT01118455|100732394|FG001|Actual Patients Treated|Baseline [Visits 1 & 2]||69||
48167686|NCT01118455|100732393|FG000|COMPLETED|Baseline [Visits 1 & 2]||65||
48167687|NCT01118455|100732394|FG001|COMPLETED|Baseline [Visits 1 & 2]||69||
48167688|NCT01118455|100732393|FG000|NOT COMPLETED|Baseline [Visits 1 & 2]||1||
48410733|NCT02458352|101337709|FG000|STARTED|Overall Study||105||
48747566|NCT00430716|102169345|FG000|COMPLETED|Double Blind Phase||36||
48747567|NCT00430716|102169346|FG001|COMPLETED|Double Blind Phase||38||
48747568|NCT00430716|102169347|FG002|COMPLETED|Double Blind Phase||39||
48747569|NCT00430716|102169345|FG000|NOT COMPLETED|Double Blind Phase||6||
48747570|NCT00430716|102169346|FG001|NOT COMPLETED|Double Blind Phase||5||
48747571|NCT00430716|102169347|FG002|NOT COMPLETED|Double Blind Phase||6||
48747572|NCT00430716|102169345|FG000|STARTED|Open Label Phase||36||
48747573|NCT00430716|102169346|FG001|STARTED|Open Label Phase||38||
48747574|NCT00430716|102169347|FG002|STARTED|Open Label Phase||39||
48747575|NCT00430716|102169345|FG000|COMPLETED|Open Label Phase||27||
48167689|NCT01118455|100732394|FG001|NOT COMPLETED|Baseline [Visits 1 & 2]||0||
48167690|NCT01118455|100732393|FG000|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||65||
48167691|NCT01118455|100732394|FG001|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||69||
48167692|NCT01118455|100732393|FG000|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||65||
48167693|NCT01118455|100732394|FG001|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||69||
48747576|NCT00430716|102169346|FG001|COMPLETED|Open Label Phase||31||
48747577|NCT00430716|102169347|FG002|COMPLETED|Open Label Phase||32||
48747578|NCT00430716|102169345|FG000|NOT COMPLETED|Open Label Phase||9||
48747579|NCT00430716|102169346|FG001|NOT COMPLETED|Open Label Phase||7||
48747580|NCT00430716|102169347|FG002|NOT COMPLETED|Open Label Phase||7||
48747581|NCT03187132|102169348|FG000|STARTED|Inpatient Trauma Only||12||
48747582|NCT03187132|102169349|FG001|STARTED|Inpatient Trauma Only||12||
48747583|NCT03187132|102169348|FG000|COMPLETED|Inpatient Trauma Only||8||
48747584|NCT03187132|102169349|FG001|COMPLETED|Inpatient Trauma Only||0||
48747585|NCT03187132|102169348|FG000|NOT COMPLETED|Inpatient Trauma Only||4||
48747586|NCT03187132|102169349|FG001|NOT COMPLETED|Inpatient Trauma Only||12||
48747587|NCT03187132|102169348|FG000|STARTED|Inpatient Trauma+Pain Clinic, no Opioid||4||
48747588|NCT03187132|102169349|FG001|STARTED|Inpatient Trauma+Pain Clinic, no Opioid||5||
48747589|NCT03187132|102169348|FG000|COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||3||
48747590|NCT03187132|102169349|FG001|COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||0||
48747591|NCT03187132|102169348|FG000|NOT COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||1||
48747592|NCT03187132|102169349|FG001|NOT COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||5||
48747593|NCT03187132|102169348|FG000|STARTED|Inpatient Trauma+Pain Clinic||11||
48747594|NCT03187132|102169349|FG001|STARTED|Inpatient Trauma+Pain Clinic||7||
48747595|NCT03187132|102169348|FG000|COMPLETED|Inpatient Trauma+Pain Clinic||8||
48747596|NCT03187132|102169349|FG001|COMPLETED|Inpatient Trauma+Pain Clinic||0||
48747597|NCT03187132|102169348|FG000|NOT COMPLETED|Inpatient Trauma+Pain Clinic||3||
48747598|NCT03187132|102169349|FG001|NOT COMPLETED|Inpatient Trauma+Pain Clinic||7||
48747599|NCT03187132|102169348|FG000|STARTED|Pain Clinic Only, Fully Remote||76||
48747600|NCT03187132|102169349|FG001|STARTED|Pain Clinic Only, Fully Remote||118||
48747601|NCT03187132|102169348|FG000|COMPLETED|Pain Clinic Only, Fully Remote||43||
48747602|NCT03187132|102169349|FG001|COMPLETED|Pain Clinic Only, Fully Remote||64||
48747603|NCT03187132|102169348|FG000|NOT COMPLETED|Pain Clinic Only, Fully Remote||33||
48747604|NCT03187132|102169349|FG001|NOT COMPLETED|Pain Clinic Only, Fully Remote||54||
48747605|NCT03058692|102169350|FG000|STARTED|Overall Study||61||
48747606|NCT03058692|102169351|FG001|STARTED|Overall Study||59||
48747607|NCT03058692|102169350|FG000|COMPLETED|Overall Study||58||
48747608|NCT03058692|102169351|FG001|COMPLETED|Overall Study||57||
48747609|NCT03058692|102169350|FG000|NOT COMPLETED|Overall Study||3||
48747610|NCT03058692|102169351|FG001|NOT COMPLETED|Overall Study||2||
48747611|NCT03649074|102169352|FG000|STARTED|Overall Study||130||
48747612|NCT03649074|102169353|FG001|STARTED|Overall Study||76||
48747613|NCT03649074|102169352|FG000|COMPLETED|Overall Study||124|Completed study through Day 28|
48747614|NCT03649074|102169353|FG001|COMPLETED|Overall Study||71|Completed study through Day 28|
48747615|NCT03649074|102169352|FG000|NOT COMPLETED|Overall Study||6||
48747616|NCT03649074|102169353|FG001|NOT COMPLETED|Overall Study||5||
48747617|NCT01495286|102169354|FG000|STARTED|Overall Study||30||
48747618|NCT01495286|102169354|FG000|COMPLETED|Overall Study||30||
48747619|NCT01495286|102169354|FG000|NOT COMPLETED|Overall Study||0||
48747620|NCT00352001|102169355|FG000|STARTED|Overall Study||37||
48747621|NCT00352001|102169355|FG000|Azacitidine 75mg/Lenalidomide 5mg-14 Day|Overall Study||3||
48747622|NCT00352001|102169355|FG000|Azacitidine 75mg/Lenalidomide 5mg-21 Day|Overall Study||3||
48747623|NCT00352001|102169355|FG000|Azacitidine 75mg/Lenalidomide 10mg-14day|Overall Study||3||
48747624|NCT00352001|102169355|FG000|COMPLETED|Overall Study||37||
48747625|NCT00352001|102169355|FG000|NOT COMPLETED|Overall Study||0||
48747626|NCT02936635|102169356|FG000|STARTED|Overall Study||115||
48747627|NCT02936635|102169357|FG001|STARTED|Overall Study||165||
48747628|NCT02936635|102169356|FG000|COMPLETED|Overall Study||0||
48747629|NCT02936635|102169357|FG001|COMPLETED|Overall Study||0||
48747630|NCT02936635|102169356|FG000|NOT COMPLETED|Overall Study||115||
48747631|NCT02936635|102169357|FG001|NOT COMPLETED|Overall Study||165||
48747632|NCT02643459|102169358|FG000|STARTED|Overall Study||7901||
48747633|NCT02643459|102169359|FG001|STARTED|Overall Study||8900||
48747634|NCT02643459|102169358|FG000|COMPLETED|Overall Study||7901||
48747635|NCT02643459|102169359|FG001|COMPLETED|Overall Study||8900||
48747636|NCT02643459|102169358|FG000|NOT COMPLETED|Overall Study||0||
48747637|NCT02643459|102169359|FG001|NOT COMPLETED|Overall Study||0||
48747638|NCT01946139|102169360|FG000|STARTED|Overall Study||276||
48747639|NCT01946139|102169360|FG000|COMPLETED|Overall Study||256||
48747640|NCT01946139|102169360|FG000|NOT COMPLETED|Overall Study||20||
48747641|NCT00549640|102169361|FG000|STARTED|Overall Study||40||
48747642|NCT00549640|102169362|FG001|STARTED|Overall Study||40||
48747643|NCT00549640|102169361|FG000|COMPLETED|Overall Study||22||
48747644|NCT00549640|102169362|FG001|COMPLETED|Overall Study||24||
48747645|NCT00549640|102169361|FG000|NOT COMPLETED|Overall Study||18||
48747646|NCT00549640|102169362|FG001|NOT COMPLETED|Overall Study||16||
48747647|NCT03370042|102169363|FG000|STARTED|Overall Study||10||10
48747648|NCT03370042|102169364|FG001|STARTED|Overall Study||10||10
48747649|NCT03370042|102169363|FG000|COMPLETED|Overall Study||10||10
48747650|NCT03370042|102169364|FG001|COMPLETED|Overall Study||10||10
48747651|NCT03370042|102169363|FG000|NOT COMPLETED|Overall Study||0||0
48747652|NCT03370042|102169364|FG001|NOT COMPLETED|Overall Study||0||0
48747653|NCT01544920|102169365|FG000|STARTED|Overall Study||368||
48747654|NCT01544920|102169366|FG001|STARTED|Overall Study||369||
48747655|NCT01544920|102169365|FG000|COMPLETED|Overall Study||349||
48331175|NCT01895127|101136158|FG001|COMPLETED|Long Term Follow-up (Month 3-12)||4||
48331176|NCT01895127|101136157|FG000|NOT COMPLETED|Long Term Follow-up (Month 3-12)||2||
48331177|NCT01895127|101136158|FG001|NOT COMPLETED|Long Term Follow-up (Month 3-12)||3||
48331178|NCT02450578|101136159|FG000|STARTED|Overall Study||6||
48331179|NCT02450578|101136160|FG001|STARTED|Overall Study||6||
48331180|NCT02450578|101136161|FG002|STARTED|Overall Study||6||
48331181|NCT02450578|101136162|FG003|STARTED|Overall Study||4||
48331182|NCT02450578|101136159|FG000|COMPLETED|Overall Study||5||
48331183|NCT02450578|101136160|FG001|COMPLETED|Overall Study||6||
48331184|NCT02450578|101136161|FG002|COMPLETED|Overall Study||6||
48747656|NCT01544920|102169366|FG001|COMPLETED|Overall Study||346||
48747657|NCT01544920|102169365|FG000|NOT COMPLETED|Overall Study||19||
48747658|NCT01544920|102169366|FG001|NOT COMPLETED|Overall Study||23||
48331185|NCT02450578|101136162|FG003|COMPLETED|Overall Study||4||
48331186|NCT02450578|101136159|FG000|NOT COMPLETED|Overall Study||1||
48331187|NCT02450578|101136160|FG001|NOT COMPLETED|Overall Study||0||
48410734|NCT02458352|101337709|FG000|COMPLETED|Overall Study||105||
48747659|NCT05051579|102169367|FG000|STARTED|Overall Study||50||
48747660|NCT05051579|102169368|FG001|STARTED|Overall Study||53||
48747661|NCT05051579|102169369|FG002|STARTED|Overall Study||29||
48747662|NCT05051579|102169370|FG003|STARTED|Overall Study||29||
48747663|NCT05051579|102169371|FG004|STARTED|Overall Study||31||
48747664|NCT05051579|102169372|FG005|STARTED|Overall Study||30||
48747665|NCT05051579|102169373|FG006|STARTED|Overall Study||50||
48747666|NCT05051579|102169367|FG000|COMPLETED|Overall Study||44||
48331188|NCT02450578|101136161|FG002|NOT COMPLETED|Overall Study||0||
48331189|NCT02450578|101136162|FG003|NOT COMPLETED|Overall Study||0||
48331190|NCT00493870|101136163|FG000|STARTED|Overall Study||981||
48331191|NCT00493870|101136164|FG001|STARTED|Overall Study||980||
48331192|NCT00493870|101136163|FG000|COMPLETED|Overall Study||969||
48331193|NCT00493870|101136164|FG001|COMPLETED|Overall Study||965||
48331194|NCT00493870|101136163|FG000|NOT COMPLETED|Overall Study||12||
48331195|NCT00493870|101136164|FG001|NOT COMPLETED|Overall Study||15||
48331196|NCT02838407|101141603|FG000|STARTED|Overall Study||197||
48331197|NCT02838407|101141603|FG000|COMPLETED|Overall Study||197||
48747667|NCT05051579|102169368|FG001|COMPLETED|Overall Study||46||
48747668|NCT05051579|102169369|FG002|COMPLETED|Overall Study||27||
48747669|NCT05051579|102169370|FG003|COMPLETED|Overall Study||24||
48167694|NCT01118455|100732393|FG000|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0||
48624752|NCT01926028|101863948|FG000|COMPLETED|Overall Study||64||
48624753|NCT01926028|101863949|FG001|COMPLETED|Overall Study||67||
48624754|NCT01926028|101863950|FG002|COMPLETED|Overall Study||12||
48624755|NCT01926028|101863948|FG000|NOT COMPLETED|Overall Study||21||
48624756|NCT01926028|101863949|FG001|NOT COMPLETED|Overall Study||22||
48624757|NCT01926028|101863950|FG002|NOT COMPLETED|Overall Study||2||
48624758|NCT02539992|101863951|FG000|STARTED|Overall Study||15||
48624759|NCT02539992|101863952|FG001|STARTED|Overall Study||11||
48624760|NCT02539992|101863953|FG002|STARTED|Overall Study||18||
48624761|NCT02539992|101863951|FG000|COMPLETED|Overall Study||15||
48747670|NCT05051579|102169371|FG004|COMPLETED|Overall Study||23||
48747671|NCT05051579|102169372|FG005|COMPLETED|Overall Study||28||
48747672|NCT05051579|102169373|FG006|COMPLETED|Overall Study||43||
48747673|NCT05051579|102169367|FG000|NOT COMPLETED|Overall Study||6||
48747674|NCT05051579|102169368|FG001|NOT COMPLETED|Overall Study||7||
48747675|NCT05051579|102169369|FG002|NOT COMPLETED|Overall Study||2||
48747676|NCT05051579|102169370|FG003|NOT COMPLETED|Overall Study||5||
48747677|NCT05051579|102169371|FG004|NOT COMPLETED|Overall Study||8||
48747678|NCT05051579|102169372|FG005|NOT COMPLETED|Overall Study||2||
48747679|NCT05051579|102169373|FG006|NOT COMPLETED|Overall Study||7||
48747680|NCT03946748|102169374|FG000|STARTED|Overall Study||24||
48747681|NCT03946748|102169374|FG000|COMPLETED|Overall Study||24||
48747682|NCT03946748|102169374|FG000|NOT COMPLETED|Overall Study||0||
48747683|NCT02836652|102169375|FG000|STARTED|Overall Study||35||
48747684|NCT02836652|102169376|FG001|STARTED|Overall Study||37||
48747685|NCT02836652|102169375|FG000|As-treated Population|Overall Study||31|Cohort of subjects on treatment medication.|
48747686|NCT02836652|102169376|FG001|As-treated Population|Overall Study||34|Cohort of subjects on treatment medication.|
48747687|NCT02836652|102169375|FG000|COMPLETED|Overall Study||17||
48747688|NCT02836652|102169376|FG001|COMPLETED|Overall Study||18||
48747689|NCT02836652|102169375|FG000|NOT COMPLETED|Overall Study||18||
48747690|NCT02836652|102169376|FG001|NOT COMPLETED|Overall Study||19||
48747691|NCT02459119|102169377|FG000|STARTED|Overall Study||17||
48747692|NCT02459119|102169377|FG000|COMPLETED|Overall Study||17||
48747693|NCT02459119|102169377|FG000|NOT COMPLETED|Overall Study||0||
48747694|NCT04388683|102169378|FG000|STARTED|Overall Study||6||
48747695|NCT04388683|102169379|FG001|STARTED|Overall Study||3||
48747696|NCT04388683|102169378|FG000|COMPLETED|Overall Study||5||
48747697|NCT04388683|102169379|FG001|COMPLETED|Overall Study||3||
48747698|NCT04388683|102169378|FG000|NOT COMPLETED|Overall Study||1||
48747699|NCT04388683|102169379|FG001|NOT COMPLETED|Overall Study||0||
48747700|NCT01454596|102169380|FG000|STARTED|Overall Study||1||
48747701|NCT01454596|102169381|FG001|STARTED|Overall Study||1||
48747702|NCT01454596|102169382|FG002|STARTED|Overall Study||1||
48747703|NCT01454596|102169383|FG003|STARTED|Overall Study||1||
48747704|NCT01454596|102169384|FG004|STARTED|Overall Study||1||
48747705|NCT01454596|102169385|FG005|STARTED|Overall Study||1||
48410735|NCT02458352|101337709|FG000|NOT COMPLETED|Overall Study||0||
48747706|NCT01454596|102169386|FG006|STARTED|Overall Study||1||
48747707|NCT01454596|102169387|FG007|STARTED|Overall Study||3||
48747708|NCT01454596|102169388|FG008|STARTED|Overall Study||3||
48747709|NCT01454596|102169389|FG009|STARTED|Overall Study||3||
48624762|NCT02539992|101863952|FG001|COMPLETED|Overall Study||7||
48747710|NCT01454596|102169390|FG010|STARTED|Overall Study||1||
48624763|NCT02539992|101863953|FG002|COMPLETED|Overall Study||14||
48624764|NCT02539992|101863951|FG000|NOT COMPLETED|Overall Study||0||
48410736|NCT01197495|101337710|FG000|STARTED|Overall Study||157||
48747711|NCT01454596|102169391|FG011|STARTED|Overall Study||1||
48747712|NCT01454596|102169380|FG000|COMPLETED|Overall Study||1||
48747713|NCT01454596|102169381|FG001|COMPLETED|Overall Study||1||
48624765|NCT02539992|101863952|FG001|NOT COMPLETED|Overall Study||4||
48624766|NCT02539992|101863953|FG002|NOT COMPLETED|Overall Study||4||
48624767|NCT00072384|101863954|FG000|STARTED|Overall Study||30||
48624768|NCT00072384|101863954|FG000|COMPLETED|Overall Study||21||
48624769|NCT00072384|101863954|FG000|NOT COMPLETED|Overall Study||9||
48624770|NCT00471497|101863955|FG000|STARTED|Core Treatment Phase||283||
48624771|NCT00471497|101863956|FG001|STARTED|Core Treatment Phase||282||
48624772|NCT00471497|101863957|FG002|STARTED|Core Treatment Phase||281||
48624773|NCT00471497|101863955|FG000|Safety Analysis Set|Core Treatment Phase||280||
48624774|NCT00471497|101863956|FG001|Safety Analysis Set|Core Treatment Phase||279||
48624775|NCT00471497|101863957|FG002|Safety Analysis Set|Core Treatment Phase||277||
48624776|NCT00471497|101863955|FG000|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||235||
48167695|NCT01118455|100732394|FG001|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0||
48167696|NCT03434457|100732395|FG000|STARTED|Overall Study||630||
48167697|NCT03434457|100732395|FG000|COMPLETED|Overall Study||630||
48167698|NCT03434457|100732395|FG000|NOT COMPLETED|Overall Study||0||
48624777|NCT00471497|101863956|FG001|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||256||
48624778|NCT00471497|101863957|FG002|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||278||
48167699|NCT02035332|100732396|FG000|STARTED|Overall Study||21||
48657125|NCT03745313|101943783|FG000|STARTED|At 2 Year Follow-up||43||
48167700|NCT02035332|100732396|FG000|Treated|Overall Study||20||
48167701|NCT02035332|100732396|FG000|COMPLETED|Overall Study||20||
48167702|NCT02035332|100732396|FG000|NOT COMPLETED|Overall Study||1||
48167703|NCT01965158|100732397|FG000|STARTED|Overall Study||274||
48624779|NCT00471497|101863955|FG000|Discontinued Core/Entered Ext.|Core Treatment Phase||48||
48624780|NCT00471497|101863956|FG001|Discontinued Core/Entered Ext.|Core Treatment Phase||26||
48624781|NCT00471497|101863957|FG002|Discontinued Core/Entered Ext.|Core Treatment Phase||3||
48624782|NCT00471497|101863955|FG000|COMPLETED|Core Treatment Phase||99|Completed = Completed Core phase as per protocol|
48624783|NCT00471497|101863956|FG001|COMPLETED|Core Treatment Phase||107|Completed = Completed Core phase as per protocol|
48624784|NCT00471497|101863957|FG002|COMPLETED|Core Treatment Phase||99|Completed = Completed Core phase as per protocol|
48624785|NCT00471497|101863955|FG000|NOT COMPLETED|Core Treatment Phase||184||
48624786|NCT00471497|101863956|FG001|NOT COMPLETED|Core Treatment Phase||175||
48747714|NCT01454596|102169382|FG002|COMPLETED|Overall Study||1||
48747715|NCT01454596|102169383|FG003|COMPLETED|Overall Study||1||
48747716|NCT01454596|102169384|FG004|COMPLETED|Overall Study||1||
48747717|NCT01454596|102169385|FG005|COMPLETED|Overall Study||1||
48747718|NCT01454596|102169386|FG006|COMPLETED|Overall Study||1||
48747719|NCT01454596|102169387|FG007|COMPLETED|Overall Study||3||
48747720|NCT01454596|102169388|FG008|COMPLETED|Overall Study||3||
48747721|NCT01454596|102169389|FG009|COMPLETED|Overall Study||2||
48747722|NCT01454596|102169390|FG010|COMPLETED|Overall Study||0||
48747723|NCT01454596|102169391|FG011|COMPLETED|Overall Study||1||
48747724|NCT01454596|102169380|FG000|NOT COMPLETED|Overall Study||0||
48747725|NCT01454596|102169381|FG001|NOT COMPLETED|Overall Study||0||
48747726|NCT01454596|102169382|FG002|NOT COMPLETED|Overall Study||0||
48747727|NCT01454596|102169383|FG003|NOT COMPLETED|Overall Study||0||
48747728|NCT01454596|102169384|FG004|NOT COMPLETED|Overall Study||0||
48747729|NCT01454596|102169385|FG005|NOT COMPLETED|Overall Study||0||
48747730|NCT01454596|102169386|FG006|NOT COMPLETED|Overall Study||0||
48747731|NCT01454596|102169387|FG007|NOT COMPLETED|Overall Study||0||
48747732|NCT01454596|102169388|FG008|NOT COMPLETED|Overall Study||0||
48747733|NCT01454596|102169389|FG009|NOT COMPLETED|Overall Study||1||
48747734|NCT01454596|102169390|FG010|NOT COMPLETED|Overall Study||1||
48747735|NCT01454596|102169391|FG011|NOT COMPLETED|Overall Study||0||
48747736|NCT01594931|102169392|FG000|STARTED|Overall Study||160||
48747737|NCT01594931|102169393|FG001|STARTED|Overall Study||157||
48747738|NCT01594931|102169394|FG002|STARTED|Overall Study||160||
48747739|NCT01594931|102169392|FG000|COMPLETED|Overall Study||131||
48747740|NCT01594931|102169393|FG001|COMPLETED|Overall Study||145||
48747741|NCT01594931|102169394|FG002|COMPLETED|Overall Study||146||
48747742|NCT01594931|102169392|FG000|NOT COMPLETED|Overall Study||29||
48747743|NCT01594931|102169393|FG001|NOT COMPLETED|Overall Study||12||
48747744|NCT01594931|102169394|FG002|NOT COMPLETED|Overall Study||14||
48747745|NCT01384734|102169395|FG000|STARTED|Overall Study||50||
48747746|NCT01384734|102169396|FG001|STARTED|Overall Study||49||
48747747|NCT01384734|102169397|FG002|STARTED|Overall Study||51||
48747748|NCT01384734|102169398|FG003|STARTED|Overall Study||50||
48747749|NCT01384734|102169399|FG004|STARTED|Overall Study||51||
48747750|NCT01384734|102169395|FG000|COMPLETED|Overall Study||33||
48167704|NCT01965158|100732398|FG001|STARTED|Overall Study||273||
48624787|NCT00471497|101863957|FG002|NOT COMPLETED|Core Treatment Phase||182||
48624788|NCT00471497|101863955|FG000|STARTED|Extension Phase||48||
48747751|NCT01384734|102169396|FG001|COMPLETED|Overall Study||25||
48747752|NCT01384734|102169397|FG002|COMPLETED|Overall Study||28||
48747753|NCT01384734|102169398|FG003|COMPLETED|Overall Study||22||
48747754|NCT01384734|102169399|FG004|COMPLETED|Overall Study||22||
48747755|NCT01384734|102169395|FG000|NOT COMPLETED|Overall Study||17||
48747756|NCT01384734|102169396|FG001|NOT COMPLETED|Overall Study||24||
48747757|NCT01384734|102169397|FG002|NOT COMPLETED|Overall Study||23||
48747758|NCT01384734|102169398|FG003|NOT COMPLETED|Overall Study||28||
48747759|NCT01384734|102169399|FG004|NOT COMPLETED|Overall Study||29||
48747760|NCT00716963|102169400|FG000|STARTED|Overall Study||2||
48747761|NCT00716963|102169401|FG001|STARTED|Overall Study||1||
48747762|NCT00716963|102169402|FG002|STARTED|Overall Study||1||
48747763|NCT00716963|102169403|FG003|STARTED|Overall Study||1||
48747764|NCT00716963|102169404|FG004|STARTED|Overall Study||1||
48747765|NCT00716963|102169405|FG005|STARTED|Overall Study||1||
48747766|NCT00716963|102169400|FG000|COMPLETED|Overall Study||1||
48747767|NCT00716963|102169401|FG001|COMPLETED|Overall Study||1||
48747768|NCT00716963|102169402|FG002|COMPLETED|Overall Study||1||
48747769|NCT00716963|102169403|FG003|COMPLETED|Overall Study||1||
48747770|NCT00716963|102169404|FG004|COMPLETED|Overall Study||1||
48747771|NCT00716963|102169405|FG005|COMPLETED|Overall Study||1||
48747772|NCT00716963|102169400|FG000|NOT COMPLETED|Overall Study||1||
48747773|NCT00716963|102169401|FG001|NOT COMPLETED|Overall Study||0||
48747774|NCT00716963|102169402|FG002|NOT COMPLETED|Overall Study||0||
48624789|NCT00471497|101863956|FG001|STARTED|Extension Phase||26||
48624790|NCT00471497|101863957|FG002|STARTED|Extension Phase||3||
48747775|NCT00716963|102169403|FG003|NOT COMPLETED|Overall Study||0||
48747776|NCT00716963|102169404|FG004|NOT COMPLETED|Overall Study||0||
48747777|NCT00716963|102169405|FG005|NOT COMPLETED|Overall Study||0||
48747778|NCT01363700|102169406|FG000|STARTED|Epinastine vs Placebo Period1||43||
48624791|NCT00471497|101863955|FG000|COMPLETED|Extension Phase||21|Completed = Completed Ext. phase as per protocol|
48624792|NCT00471497|101863956|FG001|COMPLETED|Extension Phase||12|Completed = Completed Ext. phase as per protocol|
48624793|NCT00471497|101863957|FG002|COMPLETED|Extension Phase||2|Completed = Completed Ext. phase as per protocol|
48624794|NCT00471497|101863955|FG000|NOT COMPLETED|Extension Phase||27||
48624795|NCT00471497|101863956|FG001|NOT COMPLETED|Extension Phase||14||
48624796|NCT00471497|101863957|FG002|NOT COMPLETED|Extension Phase||1||
48624797|NCT01116921|101863958|FG000|STARTED|Overall Study||53||
48624798|NCT01116921|101863959|FG001|STARTED|Overall Study||50||
48624799|NCT01116921|101863958|FG000|COMPLETED|Overall Study||53||
48624800|NCT01116921|101863959|FG001|COMPLETED|Overall Study||50||
48624801|NCT01116921|101863958|FG000|NOT COMPLETED|Overall Study||0||
48624802|NCT01116921|101863959|FG001|NOT COMPLETED|Overall Study||0||
48624803|NCT00729521|101863960|FG000|STARTED|Overall Study||12494||
48624804|NCT00729521|101863961|FG001|STARTED|Overall Study||14842||
48624805|NCT00729521|101863962|FG002|STARTED|Overall Study||7701||
48747779|NCT01363700|102169407|FG001|STARTED|Epinastine vs Placebo Period1||22||
48747780|NCT01363700|102169408|FG002|STARTED|Epinastine vs Placebo Period1||22||
48747781|NCT01363700|102169409|FG003|STARTED|Epinastine vs Placebo Period1||0||
48747782|NCT01363700|102169410|FG004|STARTED|Epinastine vs Placebo Period1||0||
48747783|NCT01363700|102169406|FG000|COMPLETED|Epinastine vs Placebo Period1||43||
48747784|NCT01363700|102169407|FG001|COMPLETED|Epinastine vs Placebo Period1||21||
48624806|NCT00729521|101863960|FG000|COMPLETED|Overall Study||12494||
48624807|NCT00729521|101863961|FG001|COMPLETED|Overall Study||14842||
48624808|NCT00729521|101863962|FG002|COMPLETED|Overall Study||7701||
48624809|NCT00729521|101863960|FG000|NOT COMPLETED|Overall Study||0||
48624810|NCT00729521|101863961|FG001|NOT COMPLETED|Overall Study||0||
48624811|NCT00729521|101863962|FG002|NOT COMPLETED|Overall Study||0||
48624812|NCT01241279|101863963|FG000|STARTED|Overall Study||4||
48624813|NCT01241279|101863964|FG001|STARTED|Overall Study||2||
48624814|NCT01241279|101863963|FG000|COMPLETED|Overall Study||4||
48624815|NCT01241279|101863964|FG001|COMPLETED|Overall Study||1||
48747785|NCT01363700|102169408|FG002|COMPLETED|Epinastine vs Placebo Period1||22||
48747786|NCT01363700|102169409|FG003|COMPLETED|Epinastine vs Placebo Period1||0||
48747787|NCT01363700|102169410|FG004|COMPLETED|Epinastine vs Placebo Period1||0||
48747788|NCT01363700|102169406|FG000|NOT COMPLETED|Epinastine vs Placebo Period1||0||
48747789|NCT01363700|102169407|FG001|NOT COMPLETED|Epinastine vs Placebo Period1||1||
48747790|NCT01363700|102169408|FG002|NOT COMPLETED|Epinastine vs Placebo Period1||0||
48747791|NCT01363700|102169409|FG003|NOT COMPLETED|Epinastine vs Placebo Period1||0||
48767672|NCT01656408|102222801|FG007|STARTED|Overall Study||8||
48624816|NCT01241279|101863963|FG000|NOT COMPLETED|Overall Study||0||
48624817|NCT01241279|101863964|FG001|NOT COMPLETED|Overall Study||1||
48624818|NCT01883895|101863965|FG000|STARTED|Overall Study||34||
48624819|NCT01883895|101863965|FG000|COMPLETED|Overall Study||32||
48624820|NCT01883895|101863965|FG000|NOT COMPLETED|Overall Study||2||
48624821|NCT01095835|101863966|FG000|STARTED|Overall Study||51||
48624822|NCT01095835|101863967|FG001|STARTED|Overall Study||52||
48624823|NCT01095835|101863968|FG002|STARTED|Overall Study||25||
48624824|NCT01095835|101863966|FG000|COMPLETED|Overall Study||41||
48624825|NCT01095835|101863967|FG001|COMPLETED|Overall Study||40||
48624826|NCT01095835|101863968|FG002|COMPLETED|Overall Study||17||
48747792|NCT01363700|102169410|FG004|NOT COMPLETED|Epinastine vs Placebo Period1||0||
48747793|NCT01363700|102169406|FG000|STARTED|Epinastine vs Olopatadine Period2||0||
48747794|NCT01363700|102169407|FG001|STARTED|Epinastine vs Olopatadine Period2||0||
48747795|NCT01363700|102169408|FG002|STARTED|Epinastine vs Olopatadine Period2||0||
48747796|NCT01363700|102169409|FG003|STARTED|Epinastine vs Olopatadine Period2||43||
48167705|NCT01965158|100732397|FG000|Received Treatment|Overall Study||272||
48167706|NCT01965158|100732398|FG001|Received Treatment|Overall Study||273||
48167707|NCT01965158|100732397|FG000|COMPLETED|Overall Study||233||
48167708|NCT01965158|100732398|FG001|COMPLETED|Overall Study||238||
48167709|NCT01965158|100732397|FG000|NOT COMPLETED|Overall Study||41||
48167710|NCT01965158|100732398|FG001|NOT COMPLETED|Overall Study||35||
48747797|NCT01363700|102169410|FG004|STARTED|Epinastine vs Olopatadine Period2||43||
48747798|NCT01363700|102169406|FG000|COMPLETED|Epinastine vs Olopatadine Period2||0||
48747799|NCT01363700|102169407|FG001|COMPLETED|Epinastine vs Olopatadine Period2||0||
48167711|NCT04203537|100732399|FG000|STARTED|Overall Study||6||
48167712|NCT04203537|100732400|FG001|STARTED|Overall Study||6||
48167713|NCT04203537|100732401|FG002|STARTED|Overall Study||6||
48167714|NCT04203537|100732402|FG003|STARTED|Overall Study||6||
48167715|NCT04203537|100732403|FG004|STARTED|Overall Study||54||
48167716|NCT04203537|100732404|FG005|STARTED|Overall Study||55||
48167717|NCT04203537|100732405|FG006|STARTED|Overall Study||60||
48167718|NCT04203537|100732399|FG000|COMPLETED|Overall Study||6||
48167719|NCT04203537|100732400|FG001|COMPLETED|Overall Study||6||
48624827|NCT01095835|101863966|FG000|NOT COMPLETED|Overall Study||10||
48624828|NCT01095835|101863967|FG001|NOT COMPLETED|Overall Study||12||
48624829|NCT01095835|101863968|FG002|NOT COMPLETED|Overall Study||8||
48624830|NCT01051921|101863969|FG000|STARTED|Overall Study||67||
48624831|NCT01051921|101863969|FG000|COMPLETED|Overall Study||37||
48624832|NCT01051921|101863969|FG000|NOT COMPLETED|Overall Study||30||
48167720|NCT04203537|100732401|FG002|COMPLETED|Overall Study||6||
48410737|NCT01197495|101337711|FG001|STARTED|Overall Study||56||
48624833|NCT00735007|101863970|FG000|STARTED|Overall Study||106||
48624834|NCT00735007|101863970|FG000|COMPLETED|Overall Study||101||
48624835|NCT00735007|101863970|FG000|NOT COMPLETED|Overall Study||5||
48624836|NCT03786380|101863971|FG000|STARTED|Overall Study||35||
48624837|NCT03786380|101863972|FG001|STARTED|Overall Study||22||
48624838|NCT03786380|101863973|FG002|STARTED|Overall Study||54||
48624839|NCT03786380|101863974|FG003|STARTED|Overall Study||63||
48624840|NCT03786380|101863975|FG004|STARTED|Overall Study||28||
48624841|NCT03786380|101863971|FG000|Safety Population|Overall Study||35|Safety Population included all participants who received ≥1 administration of study treatment.|
48624842|NCT03786380|101863972|FG001|Safety Population|Overall Study||22|Safety Population included all participants who received ≥1 administration of study treatment.|
48747800|NCT01363700|102169408|FG002|COMPLETED|Epinastine vs Olopatadine Period2||0||
48747801|NCT01363700|102169409|FG003|COMPLETED|Epinastine vs Olopatadine Period2||43||
48747802|NCT01363700|102169410|FG004|COMPLETED|Epinastine vs Olopatadine Period2||43||
48747803|NCT01363700|102169406|FG000|NOT COMPLETED|Epinastine vs Olopatadine Period2||0||
48747804|NCT01363700|102169407|FG001|NOT COMPLETED|Epinastine vs Olopatadine Period2||0||
48747805|NCT01363700|102169408|FG002|NOT COMPLETED|Epinastine vs Olopatadine Period2||0||
48747806|NCT01363700|102169409|FG003|NOT COMPLETED|Epinastine vs Olopatadine Period2||0||
48747807|NCT01363700|102169410|FG004|NOT COMPLETED|Epinastine vs Olopatadine Period2||0||
48747808|NCT00717249|102169411|FG000|STARTED|Overall Study||326||
48747809|NCT00717249|102169412|FG001|STARTED|Overall Study||165||
48747810|NCT00717249|102169411|FG000|COMPLETED|Overall Study||304||
48747811|NCT00717249|102169412|FG001|COMPLETED|Overall Study||150||
48747812|NCT00717249|102169411|FG000|NOT COMPLETED|Overall Study||22||
48167721|NCT04203537|100732402|FG003|COMPLETED|Overall Study||6||
48167722|NCT04203537|100732403|FG004|COMPLETED|Overall Study||54||
48167723|NCT04203537|100732404|FG005|COMPLETED|Overall Study||55||
48167724|NCT04203537|100732405|FG006|COMPLETED|Overall Study||60||
48167725|NCT04203537|100732399|FG000|NOT COMPLETED|Overall Study||0||
48167726|NCT04203537|100732400|FG001|NOT COMPLETED|Overall Study||0||
48167727|NCT04203537|100732401|FG002|NOT COMPLETED|Overall Study||0||
48167728|NCT04203537|100732402|FG003|NOT COMPLETED|Overall Study||0||
48167729|NCT04203537|100732403|FG004|NOT COMPLETED|Overall Study||0||
48167730|NCT04203537|100732404|FG005|NOT COMPLETED|Overall Study||0||
48167731|NCT04203537|100732405|FG006|NOT COMPLETED|Overall Study||0||
48167732|NCT01108835|100732406|FG000|STARTED|Overall Study||90||
48167733|NCT01108835|100732407|FG001|STARTED|Overall Study||90||
48167734|NCT01108835|100732406|FG000|COMPLETED|Overall Study||73||
48167735|NCT01108835|100732407|FG001|COMPLETED|Overall Study||69||
48410738|NCT01197495|101337710|FG000|COMPLETED|Overall Study||144||
48657126|NCT03745313|101943783|FG000|COMPLETED|At 2 Year Follow-up||42||
48624843|NCT03786380|101863973|FG002|Safety Population|Overall Study||54|Safety Population included all participants who received ≥1 administration of study treatment.|
48624844|NCT03786380|101863974|FG003|Safety Population|Overall Study||62|Safety Population included all participants who received ≥1 administration of study treatment.|
48624845|NCT03786380|101863975|FG004|Safety Population|Overall Study||28|Safety Population included all participants who received ≥1 administration of study treatment.|
48624846|NCT03786380|101863971|FG000|COMPLETED|Overall Study||0||
48624847|NCT03786380|101863972|FG001|COMPLETED|Overall Study||0||
48624848|NCT03786380|101863973|FG002|COMPLETED|Overall Study||0||
48624849|NCT03786380|101863974|FG003|COMPLETED|Overall Study||0||
48624850|NCT03786380|101863975|FG004|COMPLETED|Overall Study||0||
48624851|NCT03786380|101863971|FG000|NOT COMPLETED|Overall Study||35||
48624852|NCT03786380|101863972|FG001|NOT COMPLETED|Overall Study||22||
48624853|NCT03786380|101863973|FG002|NOT COMPLETED|Overall Study||54||
48624854|NCT03786380|101863974|FG003|NOT COMPLETED|Overall Study||63||
48624855|NCT03786380|101863975|FG004|NOT COMPLETED|Overall Study||28||
48624856|NCT00449163|101863976|FG000|STARTED|Overall Study||25||
48331198|NCT02838407|101141603|FG000|NOT COMPLETED|Overall Study||0||
48331199|NCT01265459|101141604|FG000|STARTED|Overall Study||23||
48331200|NCT01265459|101141605|FG001|STARTED|Overall Study||23||
48331201|NCT01265459|101141606|FG002|STARTED|Overall Study||22||
48331202|NCT01265459|101141604|FG000|COMPLETED|Overall Study||23||
48331203|NCT01265459|101141605|FG001|COMPLETED|Overall Study||23||
48331204|NCT01265459|101141606|FG002|COMPLETED|Overall Study||20||
48331205|NCT01265459|101141604|FG000|NOT COMPLETED|Overall Study||0||
48331206|NCT01265459|101141605|FG001|NOT COMPLETED|Overall Study||0||
48331207|NCT01265459|101141606|FG002|NOT COMPLETED|Overall Study||2||
48331208|NCT02067039|101141607|FG000|STARTED|Overall Study||1325||
48331209|NCT02067039|101141608|FG001|STARTED|Overall Study||1340||
48331210|NCT02067039|101141607|FG000|3 Month Survey|Overall Study||824||
48331211|NCT02067039|101141608|FG001|3 Month Survey|Overall Study||766||
48331212|NCT02067039|101141607|FG000|6 Month Survey|Overall Study||735||
48331213|NCT02067039|101141608|FG001|6 Month Survey|Overall Study||756||
48331214|NCT02067039|101141607|FG000|9 Month Survey|Overall Study||748||
48331215|NCT02067039|101141608|FG001|9 Month Survey|Overall Study||838||
48331216|NCT02067039|101141607|FG000|COMPLETED|Overall Study||752|12 month survey|
48331217|NCT02067039|101141608|FG001|COMPLETED|Overall Study||832|12 month survey|
48331218|NCT02067039|101141607|FG000|NOT COMPLETED|Overall Study||573||
48331219|NCT02067039|101141608|FG001|NOT COMPLETED|Overall Study||508||
48331220|NCT01157078|101141609|FG000|STARTED|Overall Study||159||
48331221|NCT01157078|101141610|FG001|STARTED|Overall Study||160||
48331222|NCT01157078|101141609|FG000|Received Treatment|Overall Study||157||
48331223|NCT01157078|101141610|FG001|Received Treatment|Overall Study||159||
48331224|NCT01157078|101141609|FG000|COMPLETED|Overall Study||124||
48331225|NCT01157078|101141610|FG001|COMPLETED|Overall Study||124||
48331226|NCT01157078|101141609|FG000|NOT COMPLETED|Overall Study||35||
48331227|NCT01157078|101141610|FG001|NOT COMPLETED|Overall Study||36||
48331228|NCT04852848|101141611|FG000|STARTED|Overall Study||105||
48331229|NCT04852848|101141612|FG001|STARTED|Overall Study||100||
48331230|NCT04852848|101141611|FG000|COMPLETED|Overall Study||105||
48331231|NCT04852848|101141612|FG001|COMPLETED|Overall Study||100||
48331232|NCT04852848|101141611|FG000|NOT COMPLETED|Overall Study||0||
48331233|NCT04852848|101141612|FG001|NOT COMPLETED|Overall Study||0||
48331234|NCT01084265|101141613|FG000|STARTED|Overall Study||31||
48331235|NCT01084265|101141613|FG000|COMPLETED|Overall Study||31||
48331236|NCT01084265|101141613|FG000|NOT COMPLETED|Overall Study||0||
48331237|NCT01587079|101141614|FG000|STARTED|Overall Study||159||
48331238|NCT01587079|101141614|FG000|COMPLETED|Overall Study||120||
48331239|NCT01587079|101141614|FG000|NOT COMPLETED|Overall Study||39||
48331240|NCT01049035|101141615|FG000|STARTED|Overall Study||107||
48331241|NCT01049035|101141616|FG001|STARTED|Overall Study||108||
48331242|NCT01049035|101141617|FG002|STARTED|Overall Study||107||
48331243|NCT01049035|101141618|FG003|STARTED|Overall Study||75||
48331244|NCT01049035|101141619|FG004|STARTED|Overall Study||75||
48331245|NCT01049035|101141620|FG005|STARTED|Overall Study||54||
48331246|NCT01049035|101141621|FG006|STARTED|Overall Study||54||
48331247|NCT01049035|101141615|FG000|Safety Population|Overall Study||104|Participants who received at least 1 dose of study/control vaccine and had safety data available.|
48331248|NCT01049035|101141616|FG001|Safety Population|Overall Study||102|Participants who received at least 1 dose of study/control vaccine and had safety data available.|
48331249|NCT01049035|101141617|FG002|Safety Population|Overall Study||100|Participants who received at least 1 dose of study/control vaccine and had safety data available.|
48331250|NCT01049035|101141618|FG003|Safety Population|Overall Study||74|Participants who received at least 1 dose of study/control vaccine and had safety data available.|
48331251|NCT01049035|101141619|FG004|Safety Population|Overall Study||70|Participants who received at least 1 dose of study/control vaccine and had safety data available.|
48331252|NCT01049035|101141620|FG005|Safety Population|Overall Study||52|Participants who received at least 1 dose of study/control vaccine and had safety data available.|
48410739|NCT01197495|101337711|FG001|COMPLETED|Overall Study||49||
48624857|NCT00449163|101863976|FG000|COMPLETED|Overall Study||22||
48624858|NCT00449163|101863976|FG000|NOT COMPLETED|Overall Study||3||
48331253|NCT01049035|101141621|FG006|Safety Population|Overall Study||49|Participants who received at least 1 dose of study/control vaccine and had safety data available.|
48331254|NCT01049035|101141615|FG000|COMPLETED|Overall Study||74||
48331255|NCT01049035|101141616|FG001|COMPLETED|Overall Study||87||
48331256|NCT01049035|101141617|FG002|COMPLETED|Overall Study||80||
48331257|NCT01049035|101141618|FG003|COMPLETED|Overall Study||64||
48331258|NCT01049035|101141619|FG004|COMPLETED|Overall Study||71||
48331259|NCT01049035|101141620|FG005|COMPLETED|Overall Study||42||
48331260|NCT01049035|101141621|FG006|COMPLETED|Overall Study||39||
48331261|NCT01049035|101141615|FG000|NOT COMPLETED|Overall Study||33||
48331262|NCT01049035|101141616|FG001|NOT COMPLETED|Overall Study||21||
48331263|NCT01049035|101141617|FG002|NOT COMPLETED|Overall Study||27||
48331264|NCT01049035|101141618|FG003|NOT COMPLETED|Overall Study||11||
48331265|NCT01049035|101141619|FG004|NOT COMPLETED|Overall Study||4||
48331266|NCT01049035|101141620|FG005|NOT COMPLETED|Overall Study||12||
48331267|NCT01049035|101141621|FG006|NOT COMPLETED|Overall Study||15||
48747813|NCT00717249|102169412|FG001|NOT COMPLETED|Overall Study||15||
48747814|NCT03022396|102169413|FG000|STARTED|Overall Study||16||
48747815|NCT03022396|102169414|FG001|STARTED|Overall Study||14||
48747816|NCT03022396|102169415|FG002|STARTED|Overall Study||10||
48747817|NCT03022396|102169416|FG003|STARTED|Overall Study||20||
48331268|NCT02239263|101141622|FG000|STARTED|Overall Study||40||
48331269|NCT02239263|101141622|FG000|COMPLETED|Overall Study||34|6 subjects were programmed with the incorrect settings for testing and therefore were excluded from the final data set.|
48331270|NCT02239263|101141622|FG000|NOT COMPLETED|Overall Study||6||
48331271|NCT04506294|101141623|FG000|STARTED|Overall Study||214||
48331272|NCT04506294|101141624|FG001|STARTED|Overall Study||106||
48331273|NCT04506294|101141623|FG000|COMPLETED|Overall Study||128||
48331274|NCT04506294|101141624|FG001|COMPLETED|Overall Study||84||
48331275|NCT04506294|101141623|FG000|NOT COMPLETED|Overall Study||86||
48331276|NCT04506294|101141624|FG001|NOT COMPLETED|Overall Study||22||
48747818|NCT03022396|102169417|FG004|STARTED|Overall Study||14||
48747819|NCT03022396|102169418|FG005|STARTED|Overall Study||8||
48747820|NCT03022396|102169413|FG000|COMPLETED|Overall Study||16||
48747821|NCT03022396|102169414|FG001|COMPLETED|Overall Study||14||
48331277|NCT01128829|101141625|FG000|STARTED|Overall Study||6||
48331278|NCT01128829|101141626|FG001|STARTED|Overall Study||11||
48331279|NCT01128829|101141625|FG000|COMPLETED|Overall Study||6||
48331280|NCT01128829|101141626|FG001|COMPLETED|Overall Study||11||
48331281|NCT01128829|101141625|FG000|NOT COMPLETED|Overall Study||0||
48331282|NCT01128829|101141626|FG001|NOT COMPLETED|Overall Study||0||
48331283|NCT03244033|101141627|FG000|STARTED|Overall Study||177||
48331284|NCT03244033|101141628|FG001|STARTED|Overall Study||275||
48331285|NCT03244033|101141627|FG000|COMPLETED|Overall Study||177||
48331286|NCT03244033|101141628|FG001|COMPLETED|Overall Study||275||
48331287|NCT03244033|101141627|FG000|NOT COMPLETED|Overall Study||0||
48331288|NCT03244033|101141628|FG001|NOT COMPLETED|Overall Study||0||
48331289|NCT00676715|101141629|FG000|STARTED|Overall Study||54||
48331290|NCT00676715|101141630|FG001|STARTED|Overall Study||55||
48331291|NCT00676715|101141631|FG002|STARTED|Overall Study||55||
48331292|NCT00676715|101141632|FG003|STARTED|Overall Study||54||
48331293|NCT00676715|101141629|FG000|COMPLETED|Overall Study||14||
48331294|NCT00676715|101141630|FG001|COMPLETED|Overall Study||8||
48331295|NCT00676715|101141631|FG002|COMPLETED|Overall Study||14||
48331296|NCT00676715|101141632|FG003|COMPLETED|Overall Study||14||
48331297|NCT00676715|101141629|FG000|NOT COMPLETED|Overall Study||40||
48331298|NCT00676715|101141630|FG001|NOT COMPLETED|Overall Study||47||
48331299|NCT00676715|101141631|FG002|NOT COMPLETED|Overall Study||41||
48331300|NCT00676715|101141632|FG003|NOT COMPLETED|Overall Study||40||
48331301|NCT00527605|101141633|FG000|STARTED|Overall Study||126||
48331302|NCT00527605|101141634|FG001|STARTED|Overall Study||127||
48331303|NCT00527605|101141633|FG000|COMPLETED|Overall Study||113||
48331304|NCT00527605|101141634|FG001|COMPLETED|Overall Study||116||
48747822|NCT03022396|102169415|FG002|COMPLETED|Overall Study||10||
48747823|NCT03022396|102169416|FG003|COMPLETED|Overall Study||20||
48747824|NCT03022396|102169417|FG004|COMPLETED|Overall Study||14||
48747825|NCT03022396|102169418|FG005|COMPLETED|Overall Study||8||
48747826|NCT03022396|102169413|FG000|NOT COMPLETED|Overall Study||0||
48747827|NCT03022396|102169414|FG001|NOT COMPLETED|Overall Study||0||
48747828|NCT03022396|102169415|FG002|NOT COMPLETED|Overall Study||0||
48747829|NCT03022396|102169416|FG003|NOT COMPLETED|Overall Study||0||
48747830|NCT03022396|102169417|FG004|NOT COMPLETED|Overall Study||0||
48747831|NCT03022396|102169418|FG005|NOT COMPLETED|Overall Study||0||
48747832|NCT02763644|102169419|FG000|STARTED|Overall Study||3||
48747833|NCT02763644|102169420|FG001|STARTED|Overall Study||4||
48747834|NCT02763644|102169419|FG000|COMPLETED|Overall Study||0||
48747835|NCT02763644|102169420|FG001|COMPLETED|Overall Study||2||
48747836|NCT02763644|102169419|FG000|NOT COMPLETED|Overall Study||3||
48747837|NCT02763644|102169420|FG001|NOT COMPLETED|Overall Study||2||
48331305|NCT00527605|101141633|FG000|NOT COMPLETED|Overall Study||13||
48331306|NCT00527605|101141634|FG001|NOT COMPLETED|Overall Study||11||
48331307|NCT00774345|101141635|FG000|STARTED|Pre-treatment||160|Started = Randomized|
48747838|NCT02614729|102169421|FG000|STARTED|Overall Study||18||
48747839|NCT02614729|102169422|FG001|STARTED|Overall Study||17||
48747840|NCT02614729|102169421|FG000|COMPLETED|Overall Study||17||
48747841|NCT02614729|102169422|FG001|COMPLETED|Overall Study||17||
48331308|NCT00774345|101141636|FG001|STARTED|Pre-treatment||157|Started = Randomized|
48331309|NCT00774345|101141635|FG000|COMPLETED|Pre-treatment||158|Completed = Treated|
48331310|NCT00774345|101141636|FG001|COMPLETED|Pre-treatment||157|Completed = Treated|
48331311|NCT00774345|101141635|FG000|NOT COMPLETED|Pre-treatment||2||
48331312|NCT00774345|101141636|FG001|NOT COMPLETED|Pre-treatment||0||
48331313|NCT00774345|101141635|FG000|STARTED|Treatment||158||
48331314|NCT00774345|101141636|FG001|STARTED|Treatment||157||
48331315|NCT00774345|101141635|FG000|Participants Escalated to 5mg|Treatment||129||
48331316|NCT00774345|101141636|FG001|Participants Escalated to 5mg|Treatment||149||
48331317|NCT00774345|101141635|FG000|Participants Escalated to 10mg|Treatment||68||
48410740|NCT01197495|101337710|FG000|NOT COMPLETED|Overall Study||13||
48410741|NCT01197495|101337711|FG001|NOT COMPLETED|Overall Study||7||
48410742|NCT04555811|101337712|FG000|STARTED|Overall Study||3||
48410743|NCT04555811|101337713|FG001|STARTED|Overall Study||3||
48410744|NCT04555811|101337714|FG002|STARTED|Overall Study||1||
48410745|NCT04555811|101337712|FG000|COMPLETED|Overall Study||3||
48410746|NCT04555811|101337713|FG001|COMPLETED|Overall Study||3||
48747842|NCT02614729|102169421|FG000|NOT COMPLETED|Overall Study||1||
48747843|NCT02614729|102169422|FG001|NOT COMPLETED|Overall Study||0||
48747844|NCT00887549|102169423|FG000|STARTED|Induction Therapy||70||
48747845|NCT00887549|102169423|FG000|COMPLETED|Induction Therapy||43||
48747846|NCT00887549|102169423|FG000|NOT COMPLETED|Induction Therapy||27||
48747847|NCT00887549|102169423|FG000|STARTED|Maintenance Therapy||43||
48747848|NCT00887549|102169423|FG000|COMPLETED|Maintenance Therapy||0||
48747849|NCT00887549|102169423|FG000|NOT COMPLETED|Maintenance Therapy||43||
48747850|NCT03275740|102169424|FG000|STARTED|Overall Study||3||
48747851|NCT03275740|102169425|FG001|STARTED|Overall Study||3||
48747852|NCT03275740|102169426|FG002|STARTED|Overall Study||3||
48747853|NCT03275740|102169427|FG003|STARTED|Overall Study||3||
48747854|NCT03275740|102169428|FG004|STARTED|Overall Study||3||
48331318|NCT00774345|101141636|FG001|Participants Escalated to 10mg|Treatment||88||
48331319|NCT00774345|101141635|FG000|COMPLETED|Treatment||0||
48331320|NCT00774345|101141636|FG001|COMPLETED|Treatment||0||
48331321|NCT00774345|101141635|FG000|NOT COMPLETED|Treatment||158||
48331322|NCT00774345|101141636|FG001|NOT COMPLETED|Treatment||157||
48410747|NCT04555811|101337714|FG002|COMPLETED|Overall Study||1||
48410748|NCT04555811|101337712|FG000|NOT COMPLETED|Overall Study||0||
48410749|NCT04555811|101337713|FG001|NOT COMPLETED|Overall Study||0||
48410750|NCT04555811|101337714|FG002|NOT COMPLETED|Overall Study||0||
48410751|NCT04412668|101337715|FG000|STARTED|Overall Study||14||
48410752|NCT04412668|101337716|FG001|STARTED|Overall Study||12||
48410753|NCT04412668|101337717|FG002|STARTED|Overall Study||10||
48410754|NCT04412668|101337715|FG000|Received at Least 1 Dose of Study Drug|Overall Study||10||
48410755|NCT04412668|101337716|FG001|Received at Least 1 Dose of Study Drug|Overall Study||12||
48410756|NCT04412668|101337717|FG002|Received at Least 1 Dose of Study Drug|Overall Study||10||
48410757|NCT04412668|101337715|FG000|COMPLETED|Overall Study||7||
48410758|NCT04412668|101337716|FG001|COMPLETED|Overall Study||12||
48410759|NCT04412668|101337717|FG002|COMPLETED|Overall Study||10||
48410760|NCT04412668|101337715|FG000|NOT COMPLETED|Overall Study||7||
48410761|NCT04412668|101337716|FG001|NOT COMPLETED|Overall Study||0||
48747855|NCT03275740|102169429|FG005|STARTED|Overall Study||3||
48747856|NCT03275740|102169430|FG006|STARTED|Overall Study||3||
48747857|NCT03275740|102169431|FG007|STARTED|Overall Study||6||
48747858|NCT03275740|102169432|FG008|STARTED|Overall Study||6||
48747859|NCT03275740|102169433|FG009|STARTED|Overall Study||6||
48747860|NCT03275740|102169434|FG010|STARTED|Overall Study||3||
48747861|NCT03275740|102169435|FG011|STARTED|Overall Study||16||
48747862|NCT03275740|102169424|FG000|COMPLETED|Overall Study||3||
48747863|NCT03275740|102169425|FG001|COMPLETED|Overall Study||3||
48747864|NCT03275740|102169426|FG002|COMPLETED|Overall Study||3||
48747865|NCT03275740|102169427|FG003|COMPLETED|Overall Study||3||
48747866|NCT03275740|102169428|FG004|COMPLETED|Overall Study||2||
48747867|NCT03275740|102169429|FG005|COMPLETED|Overall Study||2||
48747868|NCT03275740|102169430|FG006|COMPLETED|Overall Study||3||
48747869|NCT03275740|102169431|FG007|COMPLETED|Overall Study||6||
48747870|NCT03275740|102169432|FG008|COMPLETED|Overall Study||5||
48331323|NCT05099640|101141637|FG000|STARTED|Part 1: Open-label (14 Days)||157||
48410762|NCT04412668|101337717|FG002|NOT COMPLETED|Overall Study||0||
48410763|NCT02332876|101337718|FG000|STARTED|Overall Study||43||
48410764|NCT02332876|101337719|FG001|STARTED|Overall Study||44||
48747871|NCT03275740|102169433|FG009|COMPLETED|Overall Study||5||
48747872|NCT03275740|102169434|FG010|COMPLETED|Overall Study||3||
48747873|NCT03275740|102169435|FG011|COMPLETED|Overall Study||16||
48747874|NCT03275740|102169424|FG000|NOT COMPLETED|Overall Study||0||
48747875|NCT03275740|102169425|FG001|NOT COMPLETED|Overall Study||0||
48747876|NCT03275740|102169426|FG002|NOT COMPLETED|Overall Study||0||
48747877|NCT03275740|102169427|FG003|NOT COMPLETED|Overall Study||0||
48747878|NCT03275740|102169428|FG004|NOT COMPLETED|Overall Study||1||
48747879|NCT03275740|102169429|FG005|NOT COMPLETED|Overall Study||1||
48747880|NCT03275740|102169430|FG006|NOT COMPLETED|Overall Study||0||
48747881|NCT03275740|102169431|FG007|NOT COMPLETED|Overall Study||0||
48410765|NCT02332876|101337718|FG000|COMPLETED|Overall Study||42||
48410766|NCT02332876|101337719|FG001|COMPLETED|Overall Study||43||
48410767|NCT02332876|101337718|FG000|NOT COMPLETED|Overall Study||1||
48410768|NCT02332876|101337719|FG001|NOT COMPLETED|Overall Study||1||
48410769|NCT00638274|101337720|FG000|STARTED|Overall Study||179||
48410770|NCT00638274|101337721|FG001|STARTED|Overall Study||177||
48410771|NCT00638274|101337720|FG000|COMPLETED|Overall Study||173||
48410772|NCT00638274|101337721|FG001|COMPLETED|Overall Study||172||
48410773|NCT00638274|101337720|FG000|NOT COMPLETED|Overall Study||6||
48410774|NCT00638274|101337721|FG001|NOT COMPLETED|Overall Study||5||
48410775|NCT02015104|101337722|FG000|STARTED|Overall Study||16||
48410776|NCT02015104|101337723|FG001|STARTED|Overall Study||16||
48410777|NCT02015104|101337722|FG000|COMPLETED|Overall Study||15||
48410778|NCT02015104|101337723|FG001|COMPLETED|Overall Study||15||
48410779|NCT02015104|101337722|FG000|NOT COMPLETED|Overall Study||1||
48410780|NCT02015104|101337723|FG001|NOT COMPLETED|Overall Study||1||
48410781|NCT01833026|101337724|FG000|STARTED|Overall Study||22||
48410782|NCT01833026|101337725|FG001|STARTED|Overall Study||34||
48410783|NCT01833026|101337724|FG000|COMPLETED|Overall Study||22||
48410784|NCT01833026|101337725|FG001|COMPLETED|Overall Study||34||
48410785|NCT01833026|101337724|FG000|NOT COMPLETED|Overall Study||0||
48410786|NCT01833026|101337725|FG001|NOT COMPLETED|Overall Study||0||
48410787|NCT00374127|101337726|FG000|STARTED|Overall Study||35||
48410788|NCT00374127|101337726|FG000|COMPLETED|Overall Study||24||
48410789|NCT00374127|101337726|FG000|NOT COMPLETED|Overall Study||11||
48410790|NCT03714256|101337727|FG000|STARTED|Overall Study||14||
48410791|NCT03714256|101337728|FG001|STARTED|Overall Study||19||
48410792|NCT03714256|101337727|FG000|COMPLETED|Overall Study||14||
48410793|NCT03714256|101337728|FG001|COMPLETED|Overall Study||19||
48410794|NCT03714256|101337727|FG000|NOT COMPLETED|Overall Study||0||
48410795|NCT03714256|101337728|FG001|NOT COMPLETED|Overall Study||0||
48410796|NCT00948194|101337729|FG000|STARTED|Overall Study||6||
48410797|NCT00948194|101337730|FG001|STARTED|Overall Study||7||
48410798|NCT00948194|101337729|FG000|COMPLETED|Overall Study||5||
48410799|NCT00948194|101337730|FG001|COMPLETED|Overall Study||7||
48410800|NCT00948194|101337729|FG000|NOT COMPLETED|Overall Study||1||
48410801|NCT00948194|101337730|FG001|NOT COMPLETED|Overall Study||0||
48410802|NCT01885104|101337731|FG000|STARTED|Overall Study||31||
48410803|NCT01885104|101337732|FG001|STARTED|Overall Study||34||
48410804|NCT01885104|101337731|FG000|COMPLETED|Overall Study||29||
48410805|NCT01885104|101337732|FG001|COMPLETED|Overall Study||33||
48410806|NCT01885104|101337731|FG000|NOT COMPLETED|Overall Study||2||
48624859|NCT04609514|101863977|FG000|STARTED|Overall Study||22||
48747882|NCT03275740|102169432|FG008|NOT COMPLETED|Overall Study||1||
48747883|NCT03275740|102169433|FG009|NOT COMPLETED|Overall Study||1||
48747884|NCT03275740|102169434|FG010|NOT COMPLETED|Overall Study||0||
48747885|NCT03275740|102169435|FG011|NOT COMPLETED|Overall Study||0||
48747886|NCT00619515|102169436|FG000|STARTED|Overall Study||73||
48747887|NCT00619515|102169436|FG000|COMPLETED|Overall Study||0||
48747888|NCT00619515|102169436|FG000|NOT COMPLETED|Overall Study||73||
48747889|NCT03914417|102169437|FG000|STARTED|Overall Study||21||
48747890|NCT03914417|102169437|FG000|COMPLETED|Overall Study||19||
48747891|NCT03914417|102169437|FG000|NOT COMPLETED|Overall Study||2||
48410807|NCT01885104|101337732|FG001|NOT COMPLETED|Overall Study||1||
48410808|NCT03285061|101337733|FG000|STARTED|Overall Study||37||
48410809|NCT03285061|101337734|FG001|STARTED|Overall Study||38||
48410810|NCT03285061|101337733|FG000|COMPLETED|Overall Study||36||
48410811|NCT03285061|101337734|FG001|COMPLETED|Overall Study||36||
48410812|NCT03285061|101337733|FG000|NOT COMPLETED|Overall Study||1||
48410813|NCT03285061|101337734|FG001|NOT COMPLETED|Overall Study||2||
48410814|NCT01511640|101337735|FG000|STARTED|First Intervention (11-15 Days)||7||
48410815|NCT01511640|101337736|FG001|STARTED|First Intervention (11-15 Days)||8||
48410816|NCT01511640|101337737|FG002|STARTED|First Intervention (11-15 Days)||7||
48410817|NCT01511640|101337738|FG003|STARTED|First Intervention (11-15 Days)||8||
48410818|NCT01511640|101337735|FG000|COMPLETED|First Intervention (11-15 Days)||5||
48410819|NCT01511640|101337736|FG001|COMPLETED|First Intervention (11-15 Days)||8||
48410820|NCT01511640|101337737|FG002|COMPLETED|First Intervention (11-15 Days)||7||
48410821|NCT01511640|101337738|FG003|COMPLETED|First Intervention (11-15 Days)||7||
48410822|NCT01511640|101337735|FG000|NOT COMPLETED|First Intervention (11-15 Days)||2||
48410823|NCT01511640|101337736|FG001|NOT COMPLETED|First Intervention (11-15 Days)||0||
48410824|NCT01511640|101337737|FG002|NOT COMPLETED|First Intervention (11-15 Days)||0||
48410825|NCT01511640|101337738|FG003|NOT COMPLETED|First Intervention (11-15 Days)||1||
48410826|NCT01511640|101337735|FG000|STARTED|Washout (6-10 Days)||5||
48624860|NCT04609514|101863978|FG001|STARTED|Overall Study||21||
48624861|NCT04609514|101863977|FG000|Per Protocol Week 4|Overall Study||20||
48624862|NCT04609514|101863978|FG001|Per Protocol Week 4|Overall Study||14||
48624863|NCT04609514|101863977|FG000|Per Protocol Week 8|Overall Study||18||
48624864|NCT04609514|101863978|FG001|Per Protocol Week 8|Overall Study||12||
48624865|NCT04609514|101863977|FG000|Per Protocol Week 12|Overall Study||15||
48624866|NCT04609514|101863978|FG001|Per Protocol Week 12|Overall Study||12||
48624867|NCT04609514|101863977|FG000|Survey or Text Per Protocol Week 12|Overall Study||2||
48624868|NCT04609514|101863978|FG001|Survey or Text Per Protocol Week 12|Overall Study||3||
48624869|NCT04609514|101863977|FG000|COMPLETED|Overall Study||17||
48624870|NCT04609514|101863978|FG001|COMPLETED|Overall Study||15||
48624871|NCT04609514|101863977|FG000|NOT COMPLETED|Overall Study||5||
48624872|NCT04609514|101863978|FG001|NOT COMPLETED|Overall Study||6||
48624873|NCT01245101|101863979|FG000|STARTED|Period 1 (Treatment)||15||
48624874|NCT01245101|101863980|FG001|STARTED|Period 1 (Treatment)||0||
48624875|NCT01245101|101863979|FG000|COMPLETED|Period 1 (Treatment)||13||
48624876|NCT01245101|101863980|FG001|COMPLETED|Period 1 (Treatment)||0||
48747892|NCT00954993|102169438|FG000|STARTED|Period 1||3||
48747893|NCT00954993|102169438|FG000|COMPLETED|Period 1||3||
48747894|NCT00954993|102169438|FG000|NOT COMPLETED|Period 1||0||
48747895|NCT00954993|102169438|FG000|STARTED|Washout||3||
48747896|NCT00954993|102169438|FG000|COMPLETED|Washout||3||
48747897|NCT00954993|102169438|FG000|NOT COMPLETED|Washout||0||
48747898|NCT00954993|102169438|FG000|STARTED|Period 2||3||
48747899|NCT00954993|102169438|FG000|COMPLETED|Period 2||3||
48747900|NCT00954993|102169438|FG000|NOT COMPLETED|Period 2||0||
48747901|NCT00154297|102169439|FG000|STARTED|Overall Study||65||
48747902|NCT00154297|102169440|FG001|STARTED|Overall Study||74||
48331324|NCT05099640|101141638|FG001|STARTED|Part 1: Open-label (14 Days)||0||
48331325|NCT05099640|101141639|FG002|STARTED|Part 1: Open-label (14 Days)||0||
48331326|NCT05099640|101141637|FG000|Received at Least 1 Dose of Study Drug|Part 1: Open-label (14 Days)||157||
48624877|NCT01245101|101863979|FG000|NOT COMPLETED|Period 1 (Treatment)||2||
48624878|NCT01245101|101863980|FG001|NOT COMPLETED|Period 1 (Treatment)||0||
48624879|NCT01245101|101863979|FG000|STARTED|Period 2 (Washout)||13||
48624880|NCT01245101|101863980|FG001|STARTED|Period 2 (Washout)||0||
48624881|NCT01245101|101863979|FG000|COMPLETED|Period 2 (Washout)||12||
48624882|NCT01245101|101863980|FG001|COMPLETED|Period 2 (Washout)||0||
48624883|NCT01245101|101863979|FG000|NOT COMPLETED|Period 2 (Washout)||1||
48624884|NCT01245101|101863980|FG001|NOT COMPLETED|Period 2 (Washout)||0||
48624885|NCT01245101|101863979|FG000|STARTED|Period 3 (Treatment)||12||
48624886|NCT01245101|101863980|FG001|STARTED|Period 3 (Treatment)||0||
48624887|NCT01245101|101863979|FG000|COMPLETED|Period 3 (Treatment)||11||
48331327|NCT05099640|101141638|FG001|Received at Least 1 Dose of Study Drug|Part 1: Open-label (14 Days)||0||
48331328|NCT05099640|101141639|FG002|Received at Least 1 Dose of Study Drug|Part 1: Open-label (14 Days)||0||
48331329|NCT05099640|101141637|FG000|COMPLETED|Part 1: Open-label (14 Days)||111||
48331330|NCT05099640|101141638|FG001|COMPLETED|Part 1: Open-label (14 Days)||0||
48331331|NCT05099640|101141639|FG002|COMPLETED|Part 1: Open-label (14 Days)||0||
48331332|NCT05099640|101141637|FG000|NOT COMPLETED|Part 1: Open-label (14 Days)||46||
48331333|NCT05099640|101141638|FG001|NOT COMPLETED|Part 1: Open-label (14 Days)||0||
48331334|NCT05099640|101141639|FG002|NOT COMPLETED|Part 1: Open-label (14 Days)||0||
48624888|NCT01245101|101863980|FG001|COMPLETED|Period 3 (Treatment)||0||
48624889|NCT01245101|101863979|FG000|NOT COMPLETED|Period 3 (Treatment)||1||
48624890|NCT01245101|101863980|FG001|NOT COMPLETED|Period 3 (Treatment)||0||
48747903|NCT00154297|102169439|FG000|COMPLETED|Overall Study||57||
48747904|NCT00154297|102169440|FG001|COMPLETED|Overall Study||67||
48747905|NCT00154297|102169439|FG000|NOT COMPLETED|Overall Study||8||
48747906|NCT00154297|102169440|FG001|NOT COMPLETED|Overall Study||7||
48747907|NCT00255190|102169441|FG000|STARTED|Overall Study||153||
48747908|NCT00255190|102169442|FG001|STARTED|Overall Study||438||
48747909|NCT00255190|102169441|FG000|COMPLETED|Overall Study||103||
48747910|NCT00255190|102169442|FG001|COMPLETED|Overall Study||281||
48747911|NCT00255190|102169441|FG000|NOT COMPLETED|Overall Study||50||
48747912|NCT00255190|102169442|FG001|NOT COMPLETED|Overall Study||157||
48747913|NCT04524858|102169443|FG000|STARTED|Overall Study||1||
48747914|NCT04524858|102169443|FG000|COMPLETED|Overall Study||0||
48747915|NCT04524858|102169443|FG000|NOT COMPLETED|Overall Study||1||
48747916|NCT00381004|102169444|FG000|STARTED|Overall Study||60||
48624891|NCT03843372|101863981|FG000|STARTED|Overall Study||14||
48624892|NCT03843372|101863982|FG001|STARTED|Overall Study||18||
48624893|NCT03843372|101863981|FG000|COMPLETED|Overall Study||12||
48624894|NCT03843372|101863982|FG001|COMPLETED|Overall Study||16||
48624895|NCT03843372|101863981|FG000|NOT COMPLETED|Overall Study||2||
48747917|NCT00381004|102169444|FG000|COMPLETED|Overall Study||60||
48747918|NCT00381004|102169444|FG000|NOT COMPLETED|Overall Study||0||
48747919|NCT02430090|102169445|FG000|STARTED|Overall Study||15||
48747920|NCT02430090|102169446|FG001|STARTED|Overall Study||15||
48747921|NCT02430090|102169447|FG002|STARTED|Overall Study||15||
48747922|NCT02430090|102169445|FG000|COMPLETED|Overall Study||15||
48747923|NCT02430090|102169446|FG001|COMPLETED|Overall Study||15||
48747924|NCT02430090|102169447|FG002|COMPLETED|Overall Study||15||
48747925|NCT02430090|102169445|FG000|NOT COMPLETED|Overall Study||0||
48747926|NCT02430090|102169446|FG001|NOT COMPLETED|Overall Study||0||
48747927|NCT02430090|102169447|FG002|NOT COMPLETED|Overall Study||0||
48747928|NCT00631358|102169448|FG000|STARTED|Overall Study||50||
48747929|NCT00631358|102169449|FG001|STARTED|Overall Study||47||
48747930|NCT00631358|102169448|FG000|COMPLETED|Overall Study||44||
48624896|NCT03843372|101863982|FG001|NOT COMPLETED|Overall Study||2||
48624897|NCT04356937|101863983|FG000|STARTED|Randomization (Safety Population)||161||
48624898|NCT04356937|101863984|FG001|STARTED|Randomization (Safety Population)||82||
48624899|NCT04356937|101863983|FG000|COMPLETED|Randomization (Safety Population)||161||
48747931|NCT00631358|102169449|FG001|COMPLETED|Overall Study||45||
48747932|NCT00631358|102169448|FG000|NOT COMPLETED|Overall Study||6||
48747933|NCT00631358|102169449|FG001|NOT COMPLETED|Overall Study||2||
48747934|NCT02576639|102169450|FG000|STARTED|Overall Study||24||
48747935|NCT02576639|102169451|FG001|STARTED|Overall Study||25||
48747936|NCT02576639|102169452|FG002|STARTED|Overall Study||25||
48747937|NCT02576639|102169453|FG003|STARTED|Overall Study||26||
48747938|NCT02576639|102169454|FG004|STARTED|Overall Study||24||
48747939|NCT02576639|102169450|FG000|Pharmacodynamic Analysis Set|Overall Study||24||
48747940|NCT02576639|102169451|FG001|Pharmacodynamic Analysis Set|Overall Study||24||
48747941|NCT02576639|102169452|FG002|Pharmacodynamic Analysis Set|Overall Study||25||
48747942|NCT02576639|102169453|FG003|Pharmacodynamic Analysis Set|Overall Study||25||
48747943|NCT02576639|102169454|FG004|Pharmacodynamic Analysis Set|Overall Study||25||
48747944|NCT02576639|102169450|FG000|Pharmacokinetic Analysis Set|Overall Study||0||
48747945|NCT02576639|102169451|FG001|Pharmacokinetic Analysis Set|Overall Study||25||
48747946|NCT02576639|102169452|FG002|Pharmacokinetic Analysis Set|Overall Study||25||
48624900|NCT04356937|101863984|FG001|COMPLETED|Randomization (Safety Population)||82||
48624901|NCT04356937|101863983|FG000|NOT COMPLETED|Randomization (Safety Population)||0||
48624902|NCT04356937|101863984|FG001|NOT COMPLETED|Randomization (Safety Population)||0||
48624903|NCT04356937|101863983|FG000|STARTED|Treatment (mITT Population)||161||
48624904|NCT04356937|101863984|FG001|STARTED|Treatment (mITT Population)||82||
48624905|NCT04356937|101863983|FG000|COMPLETED|Treatment (mITT Population)||161||
48624906|NCT04356937|101863984|FG001|COMPLETED|Treatment (mITT Population)||81||
48747947|NCT02576639|102169453|FG003|Pharmacokinetic Analysis Set|Overall Study||26||
48747948|NCT02576639|102169454|FG004|Pharmacokinetic Analysis Set|Overall Study||24||
48747949|NCT02576639|102169450|FG000|Safety Analysis Set|Overall Study||24||
48747950|NCT02576639|102169451|FG001|Safety Analysis Set|Overall Study||25||
48747951|NCT02576639|102169452|FG002|Safety Analysis Set|Overall Study||25||
48747952|NCT02576639|102169453|FG003|Safety Analysis Set|Overall Study||26||
48747953|NCT02576639|102169454|FG004|Safety Analysis Set|Overall Study||24||
48747954|NCT02576639|102169450|FG000|COMPLETED|Overall Study||22||
48747955|NCT02576639|102169451|FG001|COMPLETED|Overall Study||23||
48747956|NCT02576639|102169452|FG002|COMPLETED|Overall Study||23||
48747957|NCT02576639|102169453|FG003|COMPLETED|Overall Study||25||
48747958|NCT02576639|102169454|FG004|COMPLETED|Overall Study||20||
48747959|NCT02576639|102169450|FG000|NOT COMPLETED|Overall Study||2||
48747960|NCT02576639|102169451|FG001|NOT COMPLETED|Overall Study||2||
48747961|NCT02576639|102169452|FG002|NOT COMPLETED|Overall Study||2||
48747962|NCT02576639|102169453|FG003|NOT COMPLETED|Overall Study||1||
48747963|NCT02576639|102169454|FG004|NOT COMPLETED|Overall Study||4||
48747964|NCT02905266|102169455|FG000|STARTED|Treatment Phase Part 1||53|Randomized and treated|
48747965|NCT02905266|102169456|FG001|STARTED|Treatment Phase Part 1||53|Randomized and treated|
48747966|NCT02905266|102169455|FG000|COMPLETED|Treatment Phase Part 1||24|Completed = Continuing in study|
48747967|NCT02905266|102169456|FG001|COMPLETED|Treatment Phase Part 1||30|Completed = Continuing in study|
48747968|NCT02905266|102169455|FG000|NOT COMPLETED|Treatment Phase Part 1||29||
48747969|NCT02905266|102169456|FG001|NOT COMPLETED|Treatment Phase Part 1||23||
48747970|NCT02905266|102169455|FG000|STARTED|Transition From Part 1 to Part 2||24||
48747971|NCT02905266|102169456|FG001|STARTED|Transition From Part 1 to Part 2||30||
48747972|NCT02905266|102169455|FG000|COMPLETED|Transition From Part 1 to Part 2||20||
48624907|NCT04356937|101863983|FG000|NOT COMPLETED|Treatment (mITT Population)||0||
48624908|NCT04356937|101863984|FG001|NOT COMPLETED|Treatment (mITT Population)||1||
48624909|NCT03669588|101863985|FG000|STARTED|Overall Study||84||
48624910|NCT03669588|101863986|FG001|STARTED|Overall Study||83||
48624911|NCT03669588|101863985|FG000|COMPLETED|Overall Study||80||
48624912|NCT03669588|101863986|FG001|COMPLETED|Overall Study||76||
48747973|NCT02905266|102169456|FG001|COMPLETED|Transition From Part 1 to Part 2||22||
48747974|NCT02905266|102169455|FG000|NOT COMPLETED|Transition From Part 1 to Part 2||4||
48747975|NCT02905266|102169456|FG001|NOT COMPLETED|Transition From Part 1 to Part 2||8||
48747976|NCT02905266|102169455|FG000|STARTED|Maintenance Phase Part 2||20||
48747977|NCT02905266|102169456|FG001|STARTED|Maintenance Phase Part 2||22||
48747978|NCT02905266|102169455|FG000|COMPLETED|Maintenance Phase Part 2||8||
48747979|NCT02905266|102169456|FG001|COMPLETED|Maintenance Phase Part 2||14||
48747980|NCT02905266|102169455|FG000|NOT COMPLETED|Maintenance Phase Part 2||12||
48747981|NCT02905266|102169456|FG001|NOT COMPLETED|Maintenance Phase Part 2||8||
48747982|NCT03369418|102169457|FG000|STARTED|Overall Study||16||
48747983|NCT03369418|102169458|FG001|STARTED|Overall Study||14||
48747984|NCT03369418|102169457|FG000|COMPLETED|Overall Study||13||
48747985|NCT03369418|102169458|FG001|COMPLETED|Overall Study||11||
48624913|NCT03669588|101863985|FG000|NOT COMPLETED|Overall Study||4||
48624914|NCT03669588|101863986|FG001|NOT COMPLETED|Overall Study||7||
48747986|NCT03369418|102169457|FG000|NOT COMPLETED|Overall Study||3||
48747987|NCT03369418|102169458|FG001|NOT COMPLETED|Overall Study||3||
48747988|NCT03782233|102169459|FG000|STARTED|Overall Study||50||
48747989|NCT03782233|102169460|FG001|STARTED|Overall Study||33||
48747990|NCT03782233|102169459|FG000|COMPLETED|Overall Study||46||
48747991|NCT03782233|102169460|FG001|COMPLETED|Overall Study||31||
48747992|NCT03782233|102169459|FG000|NOT COMPLETED|Overall Study||4||
48747993|NCT03782233|102169460|FG001|NOT COMPLETED|Overall Study||2||
48747994|NCT01601535|102169461|FG000|STARTED|Phase 1||6||
48747995|NCT01601535|102169462|FG001|STARTED|Phase 1||6||
48747996|NCT01601535|102169463|FG002|STARTED|Phase 1||6||
48747997|NCT01601535|102169464|FG003|STARTED|Phase 1||4||
48747998|NCT01601535|102169465|FG004|STARTED|Phase 1||0||
48747999|NCT01601535|102169466|FG005|STARTED|Phase 1||0||
48748000|NCT01601535|102169461|FG000|COMPLETED|Phase 1||0||
48748001|NCT01601535|102169462|FG001|COMPLETED|Phase 1||0||
48748002|NCT01601535|102169463|FG002|COMPLETED|Phase 1||1||
48748003|NCT01601535|102169464|FG003|COMPLETED|Phase 1||0||
48748004|NCT01601535|102169465|FG004|COMPLETED|Phase 1||0||
48748005|NCT01601535|102169466|FG005|COMPLETED|Phase 1||0||
48748006|NCT01601535|102169461|FG000|NOT COMPLETED|Phase 1||6||
48748007|NCT01601535|102169462|FG001|NOT COMPLETED|Phase 1||6||
48331335|NCT05099640|101141637|FG000|STARTED|Part 2: Randomized Treatment (6 Weeks)||0||
48331336|NCT05099640|101141638|FG001|STARTED|Part 2: Randomized Treatment (6 Weeks)||56||
48331337|NCT05099640|101141639|FG002|STARTED|Part 2: Randomized Treatment (6 Weeks)||54||
48624915|NCT01325350|101863987|FG000|STARTED|Overall Study||61||
48624916|NCT01325350|101863988|FG001|STARTED|Overall Study||61||
48624917|NCT01325350|101863989|FG002|STARTED|Overall Study||61||
48624918|NCT01325350|101863990|FG003|STARTED|Overall Study||61||
48624919|NCT01325350|101863991|FG004|STARTED|Overall Study||62||
48624920|NCT01325350|101863987|FG000|COMPLETED|Overall Study||55||
48624921|NCT01325350|101863988|FG001|COMPLETED|Overall Study||56||
48624922|NCT01325350|101863989|FG002|COMPLETED|Overall Study||44||
48624923|NCT01325350|101863990|FG003|COMPLETED|Overall Study||52||
48624924|NCT01325350|101863991|FG004|COMPLETED|Overall Study||50||
48624925|NCT01325350|101863987|FG000|NOT COMPLETED|Overall Study||6||
48624926|NCT01325350|101863988|FG001|NOT COMPLETED|Overall Study||5||
48624927|NCT01325350|101863989|FG002|NOT COMPLETED|Overall Study||17||
48624928|NCT01325350|101863990|FG003|NOT COMPLETED|Overall Study||9||
48624929|NCT01325350|101863991|FG004|NOT COMPLETED|Overall Study||12||
48624930|NCT03918811|101863992|FG000|STARTED|Overall Study||367||
48624931|NCT03918811|101863993|FG001|STARTED|Overall Study||358||
48624932|NCT03918811|101863992|FG000|COMPLETED|Overall Study||363||
48624933|NCT03918811|101863993|FG001|COMPLETED|Overall Study||345||
48624934|NCT03918811|101863992|FG000|NOT COMPLETED|Overall Study||4||
48624935|NCT03918811|101863993|FG001|NOT COMPLETED|Overall Study||13||
48624936|NCT00545025|101863994|FG000|STARTED|Overall Study||160||
48624937|NCT00545025|101863995|FG001|STARTED|Overall Study||83||
48624938|NCT00545025|101863994|FG000|COMPLETED|Overall Study||160||
48624939|NCT00545025|101863995|FG001|COMPLETED|Overall Study||83||
48624940|NCT00545025|101863994|FG000|NOT COMPLETED|Overall Study||0||
48748008|NCT01601535|102169463|FG002|NOT COMPLETED|Phase 1||5||
48748009|NCT01601535|102169464|FG003|NOT COMPLETED|Phase 1||4||
48748010|NCT01601535|102169465|FG004|NOT COMPLETED|Phase 1||0||
48748011|NCT01601535|102169466|FG005|NOT COMPLETED|Phase 1||0||
48748012|NCT01601535|102169461|FG000|STARTED|Phase 2||0||
48748013|NCT01601535|102169462|FG001|STARTED|Phase 2||0||
48748014|NCT01601535|102169463|FG002|STARTED|Phase 2||0||
48748015|NCT01601535|102169464|FG003|STARTED|Phase 2||0||
48748016|NCT01601535|102169465|FG004|STARTED|Phase 2||20||
48748017|NCT01601535|102169466|FG005|STARTED|Phase 2||12||
48748018|NCT01601535|102169461|FG000|COMPLETED|Phase 2||0||
48748019|NCT01601535|102169462|FG001|COMPLETED|Phase 2||0||
48624941|NCT00545025|101863995|FG001|NOT COMPLETED|Overall Study||0||
48624942|NCT05222880|101863996|FG000|STARTED|Overall Study||139||
48624943|NCT05222880|101863996|FG000|COMPLETED|Overall Study||136||
48748020|NCT01601535|102169463|FG002|COMPLETED|Phase 2||0||
48748021|NCT01601535|102169464|FG003|COMPLETED|Phase 2||0||
48748022|NCT01601535|102169465|FG004|COMPLETED|Phase 2||1||
48748023|NCT01601535|102169466|FG005|COMPLETED|Phase 2||0||
48748024|NCT01601535|102169461|FG000|NOT COMPLETED|Phase 2||0||
48748025|NCT01601535|102169462|FG001|NOT COMPLETED|Phase 2||0||
48748026|NCT01601535|102169463|FG002|NOT COMPLETED|Phase 2||0||
48748027|NCT01601535|102169464|FG003|NOT COMPLETED|Phase 2||0||
48748028|NCT01601535|102169465|FG004|NOT COMPLETED|Phase 2||19||
48748029|NCT01601535|102169466|FG005|NOT COMPLETED|Phase 2||12||
48748030|NCT02913482|102169467|FG000|STARTED|Overall Study||4||
48748031|NCT02913482|102169468|FG001|STARTED|Overall Study||17||
48748032|NCT02913482|102169469|FG002|STARTED|Overall Study||41||
48748033|NCT02913482|102169467|FG000|COMPLETED|Overall Study||3||
48748034|NCT02913482|102169468|FG001|COMPLETED|Overall Study||13||
48748035|NCT02913482|102169469|FG002|COMPLETED|Overall Study||36||
48748036|NCT02913482|102169467|FG000|NOT COMPLETED|Overall Study||1||
48748037|NCT02913482|102169468|FG001|NOT COMPLETED|Overall Study||4||
48748038|NCT02913482|102169469|FG002|NOT COMPLETED|Overall Study||5||
48748039|NCT00411749|102169470|FG000|STARTED|Overall Study||82||
48748040|NCT00411749|102169471|FG001|STARTED|Overall Study||25||
48748041|NCT00411749|102169470|FG000|Vaccinated|Overall Study||82||
48748042|NCT00411749|102169471|FG001|Vaccinated|Overall Study||25||
48748043|NCT00411749|102169470|FG000|COMPLETED|Overall Study||82||
48748044|NCT00411749|102169471|FG001|COMPLETED|Overall Study||25||
48748045|NCT00411749|102169470|FG000|NOT COMPLETED|Overall Study||0||
48748046|NCT00411749|102169471|FG001|NOT COMPLETED|Overall Study||0||
48748047|NCT03259555|102169472|FG000|STARTED|Overall Study||158||
48748048|NCT03259555|102169473|FG001|STARTED|Overall Study||164||
48748049|NCT03259555|102169472|FG000|Received At Least 1 Dose of Study Drug|Overall Study||158|Randomized participants who received at least 1 dose of study drug were analyzed for safety.|
48748050|NCT03259555|102169473|FG001|Received At Least 1 Dose of Study Drug|Overall Study||163|Randomized participants who received at least 1 dose of study drug were analyzed for safety.|
48748051|NCT03259555|102169472|FG000|COMPLETED|Overall Study||124||
48748052|NCT03259555|102169473|FG001|COMPLETED|Overall Study||134||
48748053|NCT03259555|102169472|FG000|NOT COMPLETED|Overall Study||34||
48748054|NCT03259555|102169473|FG001|NOT COMPLETED|Overall Study||30||
48748055|NCT02341235|102169474|FG000|STARTED|Baseline to 6 Months||45||
48748056|NCT02341235|102169475|FG001|STARTED|Baseline to 6 Months||45||
48748057|NCT02341235|102169474|FG000|COMPLETED|Baseline to 6 Months||28||
48748058|NCT02341235|102169475|FG001|COMPLETED|Baseline to 6 Months||31||
48624944|NCT05222880|101863996|FG000|NOT COMPLETED|Overall Study||3||
48748059|NCT02341235|102169474|FG000|NOT COMPLETED|Baseline to 6 Months||17||
48748060|NCT02341235|102169475|FG001|NOT COMPLETED|Baseline to 6 Months||14||
48748061|NCT02341235|102169474|FG000|STARTED|6 Months to 12 Months||28||
48748062|NCT02341235|102169475|FG001|STARTED|6 Months to 12 Months||31||
48624945|NCT01274533|101863997|FG000|STARTED|Overall Study||4||
48624946|NCT01274533|101863997|FG000|COMPLETED|Overall Study||0||
48624947|NCT01274533|101863997|FG000|NOT COMPLETED|Overall Study||4||
48624948|NCT02472730|101863998|FG000|STARTED|Overall Study||110||
48624949|NCT02472730|101863999|FG001|STARTED|Overall Study||109||
48624950|NCT02472730|101863998|FG000|COMPLETED|Overall Study||101||
48624951|NCT02472730|101863999|FG001|COMPLETED|Overall Study||102||
48624952|NCT02472730|101863998|FG000|NOT COMPLETED|Overall Study||9||
48624953|NCT02472730|101863999|FG001|NOT COMPLETED|Overall Study||7||
48624954|NCT00617357|101864000|FG000|STARTED|Overall Study||83||
48624955|NCT00617357|101864000|FG000|COMPLETED|Overall Study||67||
48624956|NCT00617357|101864000|FG000|NOT COMPLETED|Overall Study||16||
48624957|NCT01545388|101864001|FG000|STARTED|Overall Study||138||
48624958|NCT01545388|101864002|FG001|STARTED|Overall Study||133||
48624959|NCT01545388|101864003|FG002|STARTED|Overall Study||66||
48624960|NCT01545388|101864001|FG000|COMPLETED|Overall Study||130||
48624961|NCT01545388|101864002|FG001|COMPLETED|Overall Study||122||
48624962|NCT01545388|101864003|FG002|COMPLETED|Overall Study||58||
48624963|NCT01545388|101864001|FG000|NOT COMPLETED|Overall Study||8||
48624964|NCT01545388|101864002|FG001|NOT COMPLETED|Overall Study||11||
48624965|NCT01545388|101864003|FG002|NOT COMPLETED|Overall Study||8||
48624966|NCT01278342|101864004|FG000|STARTED|Overall Study||7||
48624967|NCT01278342|101864005|FG001|STARTED|Overall Study||31||
48624968|NCT01278342|101864006|FG002|STARTED|Overall Study||32||
48624969|NCT01278342|101864004|FG000|COMPLETED|Overall Study||3||
48624970|NCT01278342|101864005|FG001|COMPLETED|Overall Study||30||
48624971|NCT01278342|101864006|FG002|COMPLETED|Overall Study||32||
48624972|NCT01278342|101864004|FG000|NOT COMPLETED|Overall Study||4||
48624973|NCT01278342|101864005|FG001|NOT COMPLETED|Overall Study||1||
48624974|NCT01278342|101864006|FG002|NOT COMPLETED|Overall Study||0||
48624975|NCT03044314|101864007|FG000|STARTED|Overall Study||27||
48624976|NCT03044314|101864007|FG000|COMPLETED|Overall Study||23||
48624977|NCT03044314|101864007|FG000|NOT COMPLETED|Overall Study||4||
48624978|NCT01251952|101864008|FG000|STARTED|Overall Study||2||
48624979|NCT01251952|101864008|FG000|COMPLETED|Overall Study||1||
48624980|NCT01251952|101864008|FG000|NOT COMPLETED|Overall Study||1||
48624981|NCT02563899|101864009|FG000|STARTED|Overall Study||18||
48748063|NCT02341235|102169474|FG000|COMPLETED|6 Months to 12 Months||22||
48748064|NCT02341235|102169475|FG001|COMPLETED|6 Months to 12 Months||21||
48748065|NCT02341235|102169474|FG000|NOT COMPLETED|6 Months to 12 Months||6||
48748066|NCT02341235|102169475|FG001|NOT COMPLETED|6 Months to 12 Months||10||
48748067|NCT02260934|102169476|FG000|STARTED|Overall Study||22||
48748068|NCT02260934|102169477|FG001|STARTED|Overall Study||21||
48748069|NCT02260934|102169476|FG000|COMPLETED|Overall Study||19||
48748070|NCT02260934|102169477|FG001|COMPLETED|Overall Study||17||
48748071|NCT02260934|102169476|FG000|NOT COMPLETED|Overall Study||3||
48624982|NCT02563899|101864010|FG001|STARTED|Overall Study||5||
48624983|NCT02563899|101864011|FG002|STARTED|Overall Study||10||
48624984|NCT02563899|101864012|FG003|STARTED|Overall Study||6||
48624985|NCT02563899|101864009|FG000|COMPLETED|Overall Study||17||
48624986|NCT02563899|101864010|FG001|COMPLETED|Overall Study||5||
48624987|NCT02563899|101864011|FG002|COMPLETED|Overall Study||9||
48624988|NCT02563899|101864012|FG003|COMPLETED|Overall Study||6||
48624989|NCT02563899|101864009|FG000|NOT COMPLETED|Overall Study||1||
48748072|NCT02260934|102169477|FG001|NOT COMPLETED|Overall Study||4||
48748073|NCT02919761|102169478|FG000|STARTED|Part 1: Open Label||259||
48748074|NCT02919761|102169479|FG001|STARTED|Part 1: Open Label||0||
48748075|NCT02919761|102169480|FG002|STARTED|Part 1: Open Label||0||
48748076|NCT02919761|102169478|FG000|mITT Population|Part 1: Open Label||259|All participants who received study drug and contributed efficacy data.|
48748077|NCT02919761|102169479|FG001|mITT Population|Part 1: Open Label||0|All participants who received study drug and contributed efficacy data.|
48748078|NCT02919761|102169480|FG002|mITT Population|Part 1: Open Label||0|All participants who received study drug and contributed efficacy data.|
48748079|NCT02919761|102169478|FG000|Safety Population|Part 1: Open Label||259|All participants who received study drug.|
48748080|NCT02919761|102169479|FG001|Safety Population|Part 1: Open Label||0|All participants who received study drug.|
48748081|NCT02919761|102169480|FG002|Safety Population|Part 1: Open Label||0|All participants who received study drug.|
48748082|NCT02919761|102169478|FG000|Per Protocol Population|Part 1: Open Label||236|All participants who completed the Part 1 of the study without major protocol deviation.|
48748083|NCT02919761|102169479|FG001|Per Protocol Population|Part 1: Open Label||0|All participants who completed the Part 1 of the study without major protocol deviation.|
48748084|NCT02919761|102169480|FG002|Per Protocol Population|Part 1: Open Label||0|All participants who completed the Part 1 of the study without major protocol deviation.|
48748085|NCT02919761|102169478|FG000|COMPLETED|Part 1: Open Label||235||
48748086|NCT02919761|102169479|FG001|COMPLETED|Part 1: Open Label||0||
48748087|NCT02919761|102169480|FG002|COMPLETED|Part 1: Open Label||0||
48748088|NCT02919761|102169478|FG000|NOT COMPLETED|Part 1: Open Label||24||
48748089|NCT02919761|102169479|FG001|NOT COMPLETED|Part 1: Open Label||0||
48748090|NCT02919761|102169480|FG002|NOT COMPLETED|Part 1: Open Label||0||
48748091|NCT02919761|102169478|FG000|STARTED|Part 2: Double-blind||0||
48748092|NCT02919761|102169479|FG001|STARTED|Part 2: Double-blind||77||
48748093|NCT02919761|102169480|FG002|STARTED|Part 2: Double-blind||77||
48624990|NCT02563899|101864010|FG001|NOT COMPLETED|Overall Study||0||
48624991|NCT02563899|101864011|FG002|NOT COMPLETED|Overall Study||1||
48624992|NCT02563899|101864012|FG003|NOT COMPLETED|Overall Study||0||
48624993|NCT04069715|101864013|FG000|STARTED|Overall Study||47||
48624994|NCT04069715|101864014|FG001|STARTED|Overall Study||48||
48624995|NCT04069715|101864013|FG000|COMPLETED|Overall Study||42||
48624996|NCT04069715|101864014|FG001|COMPLETED|Overall Study||43||
48624997|NCT04069715|101864013|FG000|NOT COMPLETED|Overall Study||5||
48624998|NCT04069715|101864014|FG001|NOT COMPLETED|Overall Study||5||
48624999|NCT03299101|101864015|FG000|STARTED|Overall Study||35||
48625000|NCT03299101|101864015|FG000|COMPLETED|Overall Study||25||
48625001|NCT03299101|101864015|FG000|NOT COMPLETED|Overall Study||10||
48625002|NCT02236000|101864016|FG000|STARTED|Overall Study||6||
48625003|NCT02236000|101864017|FG001|STARTED|Overall Study||10||
48625004|NCT02236000|101864018|FG002|STARTED|Overall Study||8||
48625005|NCT02236000|101864019|FG003|STARTED|Overall Study||3||
48625006|NCT02236000|101864020|FG004|STARTED|Overall Study||22||
48625007|NCT02236000|101864016|FG000|COMPLETED|Overall Study||6||
48625008|NCT02236000|101864017|FG001|COMPLETED|Overall Study||10||
48625009|NCT02236000|101864018|FG002|COMPLETED|Overall Study||8||
48625010|NCT02236000|101864019|FG003|COMPLETED|Overall Study||3||
48625011|NCT02236000|101864020|FG004|COMPLETED|Overall Study||22||
48625012|NCT02236000|101864016|FG000|NOT COMPLETED|Overall Study||0||
48625013|NCT02236000|101864017|FG001|NOT COMPLETED|Overall Study||0||
48625014|NCT02236000|101864018|FG002|NOT COMPLETED|Overall Study||0||
48625015|NCT02236000|101864019|FG003|NOT COMPLETED|Overall Study||0||
48625016|NCT02236000|101864020|FG004|NOT COMPLETED|Overall Study||0||
48625017|NCT01239797|101864021|FG000|STARTED|Randomized Participants||321||
48625018|NCT01239797|101864022|FG001|STARTED|Randomized Participants||325||
48625019|NCT01239797|101864021|FG000|COMPLETED|Randomized Participants||319||
48625020|NCT01239797|101864022|FG001|COMPLETED|Randomized Participants||316||
48625021|NCT01239797|101864021|FG000|NOT COMPLETED|Randomized Participants||2||
48625022|NCT01239797|101864022|FG001|NOT COMPLETED|Randomized Participants||9||
48625023|NCT01239797|101864021|FG000|STARTED|Treated Participants||318|Participants treated|
48625024|NCT01239797|101864022|FG001|STARTED|Treated Participants||317|Participants treated|
48625025|NCT01239797|101864021|FG000|COMPLETED|Treated Participants||0|Participants still on treatment|
48625026|NCT01239797|101864022|FG001|COMPLETED|Treated Participants||0|Participants still on treatment|
48625027|NCT01239797|101864021|FG000|NOT COMPLETED|Treated Participants||318||
48625028|NCT01239797|101864022|FG001|NOT COMPLETED|Treated Participants||317||
48748094|NCT02919761|102169478|FG000|Safety Population|Part 2: Double-blind||0||
48748095|NCT02919761|102169479|FG001|Safety Population|Part 2: Double-blind||77||
48748096|NCT02919761|102169480|FG002|Safety Population|Part 2: Double-blind||77||
48748097|NCT02919761|102169478|FG000|mITT Population|Part 2: Double-blind||0||
48748098|NCT02919761|102169479|FG001|mITT Population|Part 2: Double-blind||77||
48167736|NCT01108835|100732406|FG000|NOT COMPLETED|Overall Study||17||
48625029|NCT02404545|101864023|FG000|STARTED|Overall Study||6||
48625030|NCT02404545|101864024|FG001|STARTED|Overall Study||6||
48625031|NCT02404545|101864023|FG000|COMPLETED|Overall Study||0||
48625032|NCT02404545|101864024|FG001|COMPLETED|Overall Study||0||
48625033|NCT02404545|101864023|FG000|NOT COMPLETED|Overall Study||6||
48625034|NCT02404545|101864024|FG001|NOT COMPLETED|Overall Study||6||
48748099|NCT02919761|102169480|FG002|mITT Population|Part 2: Double-blind||76||
48748100|NCT02919761|102169478|FG000|Per Protocol Population|Part 2: Double-blind||0||
48748101|NCT02919761|102169479|FG001|Per Protocol Population|Part 2: Double-blind||76||
48748102|NCT02919761|102169480|FG002|Per Protocol Population|Part 2: Double-blind||73||
48748103|NCT02919761|102169478|FG000|COMPLETED|Part 2: Double-blind||0||
48748104|NCT02919761|102169479|FG001|COMPLETED|Part 2: Double-blind||71||
48748105|NCT02919761|102169480|FG002|COMPLETED|Part 2: Double-blind||56||
48748106|NCT02919761|102169478|FG000|NOT COMPLETED|Part 2: Double-blind||0||
48748107|NCT02919761|102169479|FG001|NOT COMPLETED|Part 2: Double-blind||6||
48748108|NCT02919761|102169480|FG002|NOT COMPLETED|Part 2: Double-blind||21||
48748109|NCT04393493|102169481|FG000|STARTED|Follow up||40||
48748110|NCT04393493|102169482|FG001|STARTED|Follow up||40||
48748111|NCT04393493|102169481|FG000|COMPLETED|Follow up||40||
48748112|NCT04393493|102169482|FG001|COMPLETED|Follow up||40||
48748113|NCT04393493|102169481|FG000|NOT COMPLETED|Follow up||0||
48748114|NCT04393493|102169482|FG001|NOT COMPLETED|Follow up||0||
48748115|NCT04393493|102169481|FG000|STARTED|First 4 Days of Intervention||40||
48748116|NCT04393493|102169482|FG001|STARTED|First 4 Days of Intervention||40||
48748117|NCT04393493|102169481|FG000|COMPLETED|First 4 Days of Intervention||35||
48748118|NCT04393493|102169482|FG001|COMPLETED|First 4 Days of Intervention||33||
48748119|NCT04393493|102169481|FG000|NOT COMPLETED|First 4 Days of Intervention||5||
48748120|NCT04393493|102169482|FG001|NOT COMPLETED|First 4 Days of Intervention||7||
48748121|NCT01433016|102169483|FG000|STARTED|Overall Study||20||
48748122|NCT01433016|102169483|FG000|COMPLETED|Overall Study||20||
48748123|NCT01433016|102169483|FG000|NOT COMPLETED|Overall Study||0||
48748124|NCT02210000|102169484|FG000|STARTED|Overall Study||57||
48748125|NCT02210000|102169485|FG001|STARTED|Overall Study||57||
48748126|NCT02210000|102169484|FG000|COMPLETED|Overall Study||38||
48748127|NCT02210000|102169485|FG001|COMPLETED|Overall Study||36||
48748128|NCT02210000|102169484|FG000|NOT COMPLETED|Overall Study||19||
48748129|NCT02210000|102169485|FG001|NOT COMPLETED|Overall Study||21||
48748130|NCT02960516|102169486|FG000|STARTED|Overall Study||3||
48748131|NCT02960516|102169487|FG001|STARTED|Overall Study||8||
48748132|NCT02960516|102169488|FG002|STARTED|Overall Study||8||
48748133|NCT02960516|102169486|FG000|COMPLETED|Overall Study||3||
48748134|NCT02960516|102169487|FG001|COMPLETED|Overall Study||8||
48748135|NCT02960516|102169488|FG002|COMPLETED|Overall Study||8||
48748136|NCT02960516|102169486|FG000|NOT COMPLETED|Overall Study||0||
48748137|NCT02960516|102169487|FG001|NOT COMPLETED|Overall Study||0||
48748138|NCT02960516|102169488|FG002|NOT COMPLETED|Overall Study||0||
48748139|NCT00360412|102169489|FG000|STARTED|Overall Study||333||
48748140|NCT00360412|102169490|FG001|STARTED|Overall Study||664||
48748141|NCT00360412|102169489|FG000|COMPLETED|Overall Study||0||
48748142|NCT00360412|102169490|FG001|COMPLETED|Overall Study||2||
48748143|NCT00360412|102169489|FG000|NOT COMPLETED|Overall Study||333||
48748144|NCT00360412|102169490|FG001|NOT COMPLETED|Overall Study||662||
48748145|NCT01135134|102169491|FG000|STARTED|Overall Study||220||
48748146|NCT01135134|102169492|FG001|STARTED|Overall Study||113||
48748147|NCT01135134|102169491|FG000|COMPLETED|Overall Study||218||
48748148|NCT01135134|102169492|FG001|COMPLETED|Overall Study||112||
48748149|NCT01135134|102169491|FG000|NOT COMPLETED|Overall Study||2||
48748150|NCT01135134|102169492|FG001|NOT COMPLETED|Overall Study||1||
48748151|NCT02541812|102169493|FG000|STARTED|Overall Study||10||
48748152|NCT02541812|102169494|FG001|STARTED|Overall Study||10||
48748153|NCT02541812|102169493|FG000|COMPLETED|Overall Study||10||
48748154|NCT02541812|102169494|FG001|COMPLETED|Overall Study||10||
48748155|NCT02541812|102169493|FG000|NOT COMPLETED|Overall Study||0||
48748156|NCT02541812|102169494|FG001|NOT COMPLETED|Overall Study||0||
48748157|NCT03071263|102169495|FG000|STARTED|Overall Study||147||
48748158|NCT03071263|102169496|FG001|STARTED|Overall Study||148||
48748159|NCT03071263|102169495|FG000|COMPLETED|Overall Study||144||
48748160|NCT03071263|102169496|FG001|COMPLETED|Overall Study||141||
48748161|NCT03071263|102169495|FG000|NOT COMPLETED|Overall Study||3||
48748162|NCT03071263|102169496|FG001|NOT COMPLETED|Overall Study||7||
48748163|NCT02336607|102169497|FG000|STARTED|Overall Study||85||
48748164|NCT02336607|102169498|FG001|STARTED|Overall Study||85||
48748165|NCT02336607|102169499|FG002|STARTED|Overall Study||92||
48748166|NCT02336607|102169500|FG003|STARTED|Overall Study||267||
48748167|NCT02336607|102169497|FG000|Patients Included in ITT Population|Overall Study||84||
48625035|NCT00395993|101864025|FG000|STARTED|Overall Study||246||
48625036|NCT00395993|101864026|FG001|STARTED|Overall Study||231||
48625037|NCT00395993|101864025|FG000|COMPLETED|Overall Study||211||
48625038|NCT00395993|101864026|FG001|COMPLETED|Overall Study||212||
48625039|NCT00395993|101864025|FG000|NOT COMPLETED|Overall Study||35||
48625040|NCT00395993|101864026|FG001|NOT COMPLETED|Overall Study||19||
48748168|NCT02336607|102169498|FG001|Patients Included in ITT Population|Overall Study||84||
48748169|NCT02336607|102169499|FG002|Patients Included in ITT Population|Overall Study||91||
48748170|NCT02336607|102169500|FG003|Patients Included in ITT Population|Overall Study||222||
48748171|NCT02336607|102169497|FG000|Patients Included in PP Population|Overall Study||78||
48748172|NCT02336607|102169498|FG001|Patients Included in PP Population|Overall Study||75||
48748173|NCT02336607|102169499|FG002|Patients Included in PP Population|Overall Study||75||
48167737|NCT01108835|100732407|FG001|NOT COMPLETED|Overall Study||21||
48167738|NCT04741802|100732408|FG000|STARTED|Overall Study||26||
48167739|NCT04741802|100732408|FG000|COMPLETED|Overall Study||14||
48167740|NCT04741802|100732408|FG000|NOT COMPLETED|Overall Study||12||
48167741|NCT03697980|100732409|FG000|STARTED|Overall Study||124||
48748174|NCT02336607|102169500|FG003|Patients Included in PP Population|Overall Study||162||
48748175|NCT02336607|102169497|FG000|Patients Included in Safety Population|Overall Study||85||
48748176|NCT02336607|102169498|FG001|Patients Included in Safety Population|Overall Study||85||
48748177|NCT02336607|102169499|FG002|Patients Included in Safety Population|Overall Study||92||
48748178|NCT02336607|102169500|FG003|Patients Included in Safety Population|Overall Study||260||
48748179|NCT02336607|102169497|FG000|COMPLETED|Overall Study||81||
48748180|NCT02336607|102169498|FG001|COMPLETED|Overall Study||75||
48748181|NCT02336607|102169499|FG002|COMPLETED|Overall Study||86||
48748182|NCT02336607|102169500|FG003|COMPLETED|Overall Study||180||
48748183|NCT02336607|102169497|FG000|NOT COMPLETED|Overall Study||4||
48748184|NCT02336607|102169498|FG001|NOT COMPLETED|Overall Study||10||
48748185|NCT02336607|102169499|FG002|NOT COMPLETED|Overall Study||6||
48748186|NCT02336607|102169500|FG003|NOT COMPLETED|Overall Study||87||
48748187|NCT00362648|102169501|FG000|STARTED|Overall Study||2733||
48167742|NCT03697980|100732409|FG000|COMPLETED|Overall Study||119||
48167743|NCT03697980|100732409|FG000|NOT COMPLETED|Overall Study||5||
48167744|NCT03469349|100732410|FG000|STARTED|Overall Study||182||
48167745|NCT03469349|100732411|FG001|STARTED|Overall Study||184||
48167746|NCT03469349|100732410|FG000|COMPLETED|Overall Study||177||
48167747|NCT03469349|100732411|FG001|COMPLETED|Overall Study||174||
48167748|NCT03469349|100732410|FG000|NOT COMPLETED|Overall Study||5||
48167749|NCT03469349|100732411|FG001|NOT COMPLETED|Overall Study||10||
48167750|NCT01777321|100732412|FG000|STARTED|Overall Study||30||
48167751|NCT01777321|100732413|FG001|STARTED|Overall Study||30||
48167752|NCT01777321|100732412|FG000|COMPLETED|Overall Study||30||
48167753|NCT01777321|100732413|FG001|COMPLETED|Overall Study||29||
48167754|NCT01777321|100732412|FG000|NOT COMPLETED|Overall Study||0||
48167755|NCT01777321|100732413|FG001|NOT COMPLETED|Overall Study||1||
48167756|NCT01008475|100732414|FG000|STARTED|Overall Study||3||
48167757|NCT01008475|100732415|FG001|STARTED|Overall Study||3||
48748188|NCT00362648|102169502|FG001|STARTED|Overall Study||2735||
48625041|NCT01614470|101864027|FG000|STARTED|Part 1: Treatment Period 1 (8 Weeks)||20||
48625042|NCT01614470|101864028|FG001|STARTED|Part 1: Treatment Period 1 (8 Weeks)||19||
48748189|NCT00362648|102169503|FG002|STARTED|Overall Study||1018||
48748190|NCT00362648|102169504|FG003|STARTED|Overall Study||1018||
48748191|NCT00362648|102169501|FG000|Vaccinated at Visit 1|Overall Study||2733||
48748192|NCT00362648|102169502|FG001|Vaccinated at Visit 1|Overall Study||2735||
48167758|NCT01008475|100732416|FG002|STARTED|Overall Study||7||
48167759|NCT01008475|100732417|FG003|STARTED|Overall Study||3||
48167760|NCT01008475|100732418|FG004|STARTED|Overall Study||72||
48625043|NCT01614470|101864029|FG002|STARTED|Part 1: Treatment Period 1 (8 Weeks)||0||
48625044|NCT01614470|101864027|FG000|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18||
48625045|NCT01614470|101864028|FG001|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18||
48625046|NCT01614470|101864029|FG002|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0||
48625047|NCT01614470|101864027|FG000|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||2||
48625048|NCT01614470|101864028|FG001|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||1||
48625049|NCT01614470|101864029|FG002|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0||
48625050|NCT01614470|101864027|FG000|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18||
48625051|NCT01614470|101864028|FG001|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18||
48625052|NCT01614470|101864029|FG002|STARTED|Part 1: Washout Period (4 to 8 Weeks)||0||
48625053|NCT01614470|101864027|FG000|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18||
48625054|NCT01614470|101864028|FG001|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18||
48625055|NCT01614470|101864029|FG002|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0||
48625056|NCT01614470|101864027|FG000|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0||
48625057|NCT01614470|101864028|FG001|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0||
48625058|NCT01614470|101864029|FG002|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0||
48625059|NCT01614470|101864027|FG000|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18||
48625060|NCT01614470|101864028|FG001|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18||
48625061|NCT01614470|101864029|FG002|STARTED|Part 1: Treatment Period 2 (8 Weeks)||0||
48625062|NCT01614470|101864027|FG000|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18||
48625063|NCT01614470|101864028|FG001|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18||
48625064|NCT01614470|101864029|FG002|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0||
48625065|NCT01614470|101864027|FG000|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0||
48625066|NCT01614470|101864028|FG001|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0||
48625067|NCT01614470|101864029|FG002|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0||
48625068|NCT01614470|101864027|FG000|STARTED|Part 2: Open-label Period (16 Weeks)||0||
48625069|NCT01614470|101864028|FG001|STARTED|Part 2: Open-label Period (16 Weeks)||0||
48625070|NCT01614470|101864029|FG002|STARTED|Part 2: Open-label Period (16 Weeks)||36||
48625071|NCT01614470|101864027|FG000|COMPLETED|Part 2: Open-label Period (16 Weeks)||0||
48625072|NCT01614470|101864028|FG001|COMPLETED|Part 2: Open-label Period (16 Weeks)||0||
48625073|NCT01614470|101864029|FG002|COMPLETED|Part 2: Open-label Period (16 Weeks)||36||
48625074|NCT01614470|101864027|FG000|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0||
48625075|NCT01614470|101864028|FG001|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0||
48625076|NCT01614470|101864029|FG002|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0||
48625077|NCT01022203|101864030|FG000|STARTED|PreTreatment Assessment||58||
48625078|NCT01022203|101864031|FG001|STARTED|PreTreatment Assessment||56||
48625079|NCT01022203|101864030|FG000|COMPLETED|PreTreatment Assessment||58||
48625080|NCT01022203|101864031|FG001|COMPLETED|PreTreatment Assessment||56||
48625081|NCT01022203|101864030|FG000|NOT COMPLETED|PreTreatment Assessment||0||
48625082|NCT01022203|101864031|FG001|NOT COMPLETED|PreTreatment Assessment||0||
48625083|NCT01022203|101864030|FG000|STARTED|Post Treatment Assessment||58||
48625084|NCT01022203|101864031|FG001|STARTED|Post Treatment Assessment||56||
48625085|NCT01022203|101864030|FG000|COMPLETED|Post Treatment Assessment||44||
48625086|NCT01022203|101864031|FG001|COMPLETED|Post Treatment Assessment||42||
48625087|NCT01022203|101864030|FG000|NOT COMPLETED|Post Treatment Assessment||14||
48625088|NCT01022203|101864031|FG001|NOT COMPLETED|Post Treatment Assessment||14||
48625089|NCT01022203|101864030|FG000|STARTED|Follow-Up Assessment||44||
48625090|NCT01022203|101864031|FG001|STARTED|Follow-Up Assessment||42||
48625091|NCT01022203|101864030|FG000|COMPLETED|Follow-Up Assessment||42||
48625092|NCT01022203|101864031|FG001|COMPLETED|Follow-Up Assessment||40||
48625093|NCT01022203|101864030|FG000|NOT COMPLETED|Follow-Up Assessment||2||
48625094|NCT01022203|101864031|FG001|NOT COMPLETED|Follow-Up Assessment||2||
48625095|NCT00749398|101864032|FG000|STARTED|Overall Study||124||
48625096|NCT00749398|101864032|FG000|COMPLETED|Overall Study||71||
48625097|NCT00749398|101864032|FG000|NOT COMPLETED|Overall Study||53||
48625098|NCT00264147|101864033|FG000|STARTED|Treatment I Period||161||
48625099|NCT00264147|101864034|FG001|STARTED|Treatment I Period||154||
48167761|NCT01008475|100732419|FG005|STARTED|Overall Study||73||
48167762|NCT01008475|100732420|FG006|STARTED|Overall Study||71||
48167763|NCT01008475|100732414|FG000|Safety Analysis Set|Overall Study||3||
48167764|NCT01008475|100732415|FG001|Safety Analysis Set|Overall Study||3||
48167765|NCT01008475|100732416|FG002|Safety Analysis Set|Overall Study||7||
48167766|NCT01008475|100732417|FG003|Safety Analysis Set|Overall Study||3||
48167767|NCT01008475|100732418|FG004|Safety Analysis Set|Overall Study||73||
48167768|NCT01008475|100732419|FG005|Safety Analysis Set|Overall Study||72||
48167769|NCT01008475|100732420|FG006|Safety Analysis Set|Overall Study||69||
48167770|NCT01008475|100732414|FG000|COMPLETED|Overall Study||3||
48167771|NCT01008475|100732415|FG001|COMPLETED|Overall Study||3||
48167772|NCT01008475|100732416|FG002|COMPLETED|Overall Study||7||
48167773|NCT01008475|100732417|FG003|COMPLETED|Overall Study||3||
48167774|NCT01008475|100732418|FG004|COMPLETED|Overall Study||67||
48167775|NCT01008475|100732419|FG005|COMPLETED|Overall Study||67||
48167776|NCT01008475|100732420|FG006|COMPLETED|Overall Study||67||
48167777|NCT01008475|100732414|FG000|NOT COMPLETED|Overall Study||0||
48167778|NCT01008475|100732415|FG001|NOT COMPLETED|Overall Study||0||
48167779|NCT01008475|100732416|FG002|NOT COMPLETED|Overall Study||0||
48167780|NCT01008475|100732417|FG003|NOT COMPLETED|Overall Study||0||
48167781|NCT01008475|100732418|FG004|NOT COMPLETED|Overall Study||5||
48167782|NCT01008475|100732419|FG005|NOT COMPLETED|Overall Study||6||
48167783|NCT01008475|100732420|FG006|NOT COMPLETED|Overall Study||4||
48167784|NCT00399763|100732421|FG000|STARTED|Overall Study||35||
48167785|NCT00399763|100732422|FG001|STARTED|Overall Study||35||
48167786|NCT00399763|100732421|FG000|COMPLETED|Overall Study||33||
48167787|NCT00399763|100732422|FG001|COMPLETED|Overall Study||32||
48625100|NCT00264147|101864035|FG002|STARTED|Treatment I Period||151||
48625101|NCT00264147|101864036|FG003|STARTED|Treatment I Period||140||
48625102|NCT00264147|101864037|FG004|STARTED|Treatment I Period||155||
48625103|NCT00264147|101864038|FG005|STARTED|Treatment I Period||0||
48625104|NCT00264147|101864033|FG000|COMPLETED|Treatment I Period||63||
48625105|NCT00264147|101864034|FG001|COMPLETED|Treatment I Period||71||
48625106|NCT00264147|101864035|FG002|COMPLETED|Treatment I Period||74||
48625107|NCT00264147|101864036|FG003|COMPLETED|Treatment I Period||68||
48625108|NCT00264147|101864037|FG004|COMPLETED|Treatment I Period||99||
48748193|NCT00362648|102169503|FG002|Vaccinated at Visit 1|Overall Study||1018||
48748194|NCT00362648|102169504|FG003|Vaccinated at Visit 1|Overall Study||1018||
48748195|NCT00362648|102169501|FG000|Vaccinated at Visit 2|Overall Study||2657||
48625109|NCT00264147|101864038|FG005|COMPLETED|Treatment I Period||0||
48625110|NCT00264147|101864033|FG000|NOT COMPLETED|Treatment I Period||98||
48625111|NCT00264147|101864034|FG001|NOT COMPLETED|Treatment I Period||83||
48625112|NCT00264147|101864035|FG002|NOT COMPLETED|Treatment I Period||77||
48625113|NCT00264147|101864036|FG003|NOT COMPLETED|Treatment I Period||72||
48625114|NCT00264147|101864037|FG004|NOT COMPLETED|Treatment I Period||56||
48625115|NCT00264147|101864038|FG005|NOT COMPLETED|Treatment I Period||0||
48625116|NCT00264147|101864033|FG000|STARTED|Treatment II Period||0||
48625117|NCT00264147|101864034|FG001|STARTED|Treatment II Period||0||
48625118|NCT00264147|101864035|FG002|STARTED|Treatment II Period||0||
48625119|NCT00264147|101864036|FG003|STARTED|Treatment II Period||0||
48625120|NCT00264147|101864037|FG004|STARTED|Treatment II Period||180||
48625121|NCT00264147|101864038|FG005|STARTED|Treatment II Period||149||
48625122|NCT00264147|101864033|FG000|COMPLETED|Treatment II Period||0||
48625123|NCT00264147|101864034|FG001|COMPLETED|Treatment II Period||0||
48748196|NCT00362648|102169502|FG001|Vaccinated at Visit 2|Overall Study||2666||
48748197|NCT00362648|102169503|FG002|Vaccinated at Visit 2|Overall Study||1013||
48748198|NCT00362648|102169504|FG003|Vaccinated at Visit 2|Overall Study||1009||
48748199|NCT00362648|102169501|FG000|Vaccinated at Visit 3|Overall Study||2613||
48748200|NCT00362648|102169502|FG001|Vaccinated at Visit 3|Overall Study||2612||
48748201|NCT00362648|102169503|FG002|Vaccinated at Visit 3|Overall Study||1009||
48748202|NCT00362648|102169504|FG003|Vaccinated at Visit 3|Overall Study||1007||
48167788|NCT00399763|100732421|FG000|NOT COMPLETED|Overall Study||2||
48625124|NCT00264147|101864035|FG002|COMPLETED|Treatment II Period||0||
48625125|NCT00264147|101864036|FG003|COMPLETED|Treatment II Period||0||
48625126|NCT00264147|101864037|FG004|COMPLETED|Treatment II Period||147||
48748203|NCT00362648|102169501|FG000|COMPLETED|Overall Study||2607||
48748204|NCT00362648|102169502|FG001|COMPLETED|Overall Study||2601||
48748205|NCT00362648|102169503|FG002|COMPLETED|Overall Study||1009||
48748206|NCT00362648|102169504|FG003|COMPLETED|Overall Study||1007||
48167789|NCT00399763|100732422|FG001|NOT COMPLETED|Overall Study||3||
48625127|NCT00264147|101864038|FG005|COMPLETED|Treatment II Period||116||
48167790|NCT01973036|100732423|FG000|STARTED|Overall Study||108|The group to which the subject was randomized|
48167791|NCT01973036|100732424|FG001|STARTED|Overall Study||93|The group to which the subject was randomized|
48167792|NCT01973036|100732423|FG000|Received Assigned Intervention|Overall Study||113|The intervention completed. (Some subjects rejected arm assignment or required opposite treatment.)|
48167793|NCT01973036|100732424|FG001|Received Assigned Intervention|Overall Study||88|The intervention completed. (Some subjects rejected arm assignment or required opposite treatment.)|
48167794|NCT01973036|100732423|FG000|COMPLETED|Overall Study||108|Data analyzed according to original arm assignment, not treatment completed.|
48625128|NCT00264147|101864033|FG000|NOT COMPLETED|Treatment II Period||0||
48625129|NCT00264147|101864034|FG001|NOT COMPLETED|Treatment II Period||0||
48625130|NCT00264147|101864035|FG002|NOT COMPLETED|Treatment II Period||0||
48625131|NCT00264147|101864036|FG003|NOT COMPLETED|Treatment II Period||0||
48625132|NCT00264147|101864037|FG004|NOT COMPLETED|Treatment II Period||33||
48625133|NCT00264147|101864038|FG005|NOT COMPLETED|Treatment II Period||33||
48625134|NCT02697214|101864039|FG000|STARTED|Overall Study||26|Each subject wore standard EKG, Polar H7 and 2 wrist monitoring devices|26
48625135|NCT02697214|101864040|FG001|STARTED|Overall Study||25|Each subject wore standard EKG, Polar H7 and 2 wrist monitoring devices|25
48625136|NCT02697214|101864041|FG002|STARTED|Overall Study||25|Each subject wore standard EKG, Polar H7 and 2 wrist monitoring devices|25
48625137|NCT02697214|101864042|FG003|STARTED|Overall Study||24|Each subject wore standard EKG, Polar H7 and 2 wrist monitoring devices|24
48625138|NCT02697214|101864043|FG004|STARTED|Overall Study||50|Each subject wore standard EKG, Polar H7 and 2 wrist monitoring devices|50
48625139|NCT02697214|101864044|FG005|STARTED|Overall Study||50|Each subject wore standard EKG, Polar H7 and 2 wrist monitoring devices|50
48625140|NCT02697214|101864039|FG000|Heart Rate at 2mph|Overall Study||26||26
48625141|NCT02697214|101864040|FG001|Heart Rate at 2mph|Overall Study||25||25
48625142|NCT02697214|101864041|FG002|Heart Rate at 2mph|Overall Study||25||25
48625143|NCT02697214|101864042|FG003|Heart Rate at 2mph|Overall Study||24||24
48625144|NCT02697214|101864043|FG004|Heart Rate at 2mph|Overall Study||50||50
48625145|NCT02697214|101864044|FG005|Heart Rate at 2mph|Overall Study||50||50
48625146|NCT02697214|101864039|FG000|Heart Rate at 3mph|Overall Study||26||26
48625147|NCT02697214|101864040|FG001|Heart Rate at 3mph|Overall Study||25||25
48625148|NCT02697214|101864041|FG002|Heart Rate at 3mph|Overall Study||25||25
48625149|NCT02697214|101864042|FG003|Heart Rate at 3mph|Overall Study||24||24
48625150|NCT02697214|101864043|FG004|Heart Rate at 3mph|Overall Study||50||50
48625151|NCT02697214|101864044|FG005|Heart Rate at 3mph|Overall Study||50||50
48625152|NCT02697214|101864039|FG000|Heart Rate at 4mph|Overall Study||26||26
48167795|NCT01973036|100732424|FG001|COMPLETED|Overall Study||93|Data analyzed according to original arm assignment, not treatment completed.|
48167796|NCT01973036|100732423|FG000|NOT COMPLETED|Overall Study||0||
48167797|NCT01973036|100732424|FG001|NOT COMPLETED|Overall Study||0||
48748207|NCT00362648|102169501|FG000|NOT COMPLETED|Overall Study||126||
48748208|NCT00362648|102169502|FG001|NOT COMPLETED|Overall Study||134||
48167798|NCT00152009|100732425|FG000|STARTED|Overall Study||87||
48167799|NCT00152009|100732426|FG001|STARTED|Overall Study||86||
48167800|NCT00152009|100732427|FG002|STARTED|Overall Study||86||
48167801|NCT00152009|100732428|FG003|STARTED|Overall Study||86||
48167802|NCT00152009|100732425|FG000|COMPLETED|Overall Study||58||
48167803|NCT00152009|100732426|FG001|COMPLETED|Overall Study||55||
48167804|NCT00152009|100732427|FG002|COMPLETED|Overall Study||49||
48167805|NCT00152009|100732428|FG003|COMPLETED|Overall Study||53||
48167806|NCT00152009|100732425|FG000|NOT COMPLETED|Overall Study||29||
48331338|NCT05099640|101141637|FG000|Received at Least 1 Dose of Study Drug|Part 2: Randomized Treatment (6 Weeks)||0||
48625153|NCT02697214|101864040|FG001|Heart Rate at 4mph|Overall Study||25||25
48625154|NCT02697214|101864041|FG002|Heart Rate at 4mph|Overall Study||25||25
48625155|NCT02697214|101864042|FG003|Heart Rate at 4mph|Overall Study||24||24
48625156|NCT02697214|101864043|FG004|Heart Rate at 4mph|Overall Study||50||50
48625157|NCT02697214|101864044|FG005|Heart Rate at 4mph|Overall Study||50||50
48625158|NCT02697214|101864039|FG000|Heart Rate at 6mph|Overall Study||26||26
48625159|NCT02697214|101864040|FG001|Heart Rate at 6mph|Overall Study||25||25
48625160|NCT02697214|101864041|FG002|Heart Rate at 6mph|Overall Study||25||25
48625161|NCT02697214|101864042|FG003|Heart Rate at 6mph|Overall Study||24||24
48625162|NCT02697214|101864043|FG004|Heart Rate at 6mph|Overall Study||50||50
48625163|NCT02697214|101864044|FG005|Heart Rate at 6mph|Overall Study||50||50
48625164|NCT02697214|101864039|FG000|COMPLETED|Overall Study||26||26
48748209|NCT00362648|102169503|FG002|NOT COMPLETED|Overall Study||9||
48167807|NCT00152009|100732426|FG001|NOT COMPLETED|Overall Study||31||
48167808|NCT00152009|100732427|FG002|NOT COMPLETED|Overall Study||37||
48167809|NCT00152009|100732428|FG003|NOT COMPLETED|Overall Study||33||
48167810|NCT04000594|100732429|FG000|STARTED|Overall Study||4||
48167811|NCT04000594|100732430|FG001|STARTED|Overall Study||4||
48167812|NCT04000594|100732431|FG002|STARTED|Overall Study||4||
48167813|NCT04000594|100732429|FG000|COMPLETED|Overall Study||3||
48167814|NCT04000594|100732430|FG001|COMPLETED|Overall Study||4||
48167815|NCT04000594|100732431|FG002|COMPLETED|Overall Study||4||
48167816|NCT04000594|100732429|FG000|NOT COMPLETED|Overall Study||1||
48331339|NCT05099640|101141638|FG001|Received at Least 1 Dose of Study Drug|Part 2: Randomized Treatment (6 Weeks)||56||
48331340|NCT05099640|101141639|FG002|Received at Least 1 Dose of Study Drug|Part 2: Randomized Treatment (6 Weeks)||54||
48625165|NCT02697214|101864040|FG001|COMPLETED|Overall Study||25||25
48625166|NCT02697214|101864041|FG002|COMPLETED|Overall Study||25||25
48625167|NCT02697214|101864042|FG003|COMPLETED|Overall Study||24||24
48625168|NCT02697214|101864043|FG004|COMPLETED|Overall Study||50||50
48625169|NCT02697214|101864044|FG005|COMPLETED|Overall Study||50||50
48625170|NCT02697214|101864039|FG000|NOT COMPLETED|Overall Study||0||0
48167817|NCT04000594|100732430|FG001|NOT COMPLETED|Overall Study||0||
48167818|NCT04000594|100732431|FG002|NOT COMPLETED|Overall Study||0||
48167819|NCT00621296|100732432|FG000|STARTED|Overall Study||15||
48167820|NCT00621296|100732432|FG000|COMPLETED|Overall Study||1||
48167821|NCT00621296|100732432|FG000|NOT COMPLETED|Overall Study||14||
48625171|NCT02697214|101864040|FG001|NOT COMPLETED|Overall Study||0||0
48625172|NCT02697214|101864041|FG002|NOT COMPLETED|Overall Study||0||0
48625173|NCT02697214|101864042|FG003|NOT COMPLETED|Overall Study||0||0
48625174|NCT02697214|101864043|FG004|NOT COMPLETED|Overall Study||0||0
48625175|NCT02697214|101864044|FG005|NOT COMPLETED|Overall Study||0||0
48625176|NCT02460289|101864045|FG000|STARTED|Overall Study||63||
48625177|NCT02460289|101864045|FG000|Intent to Treat (ITT) Population|Overall Study||56||
48625178|NCT02460289|101864045|FG000|Safety Population (SP)|Overall Study||61||
48625179|NCT02460289|101864045|FG000|COMPLETED|Overall Study||53||
48625180|NCT02460289|101864045|FG000|NOT COMPLETED|Overall Study||10||
48625181|NCT01855958|101864046|FG000|STARTED|Overall Study||13||
48625182|NCT01855958|101864047|FG001|STARTED|Overall Study||13||
48167822|NCT02192775|100732433|FG000|STARTED|Overall Study||2||
48167823|NCT02192775|100732433|FG000|COMPLETED|Overall Study||0||
48167824|NCT02192775|100732433|FG000|NOT COMPLETED|Overall Study||2||
48167825|NCT03560245|100732434|FG000|STARTED|Overall Study||53||
48167826|NCT03560245|100732435|FG001|STARTED|Overall Study||55||
48167827|NCT03560245|100732434|FG000|COMPLETED|Overall Study||48||
48167828|NCT03560245|100732435|FG001|COMPLETED|Overall Study||48||
48167829|NCT03560245|100732434|FG000|NOT COMPLETED|Overall Study||5||
48167830|NCT03560245|100732435|FG001|NOT COMPLETED|Overall Study||7||
48167831|NCT00960752|100732436|FG000|STARTED|Overall Study||13||
48167832|NCT00960752|100732437|FG001|STARTED|Overall Study||13||
48167833|NCT00960752|100732438|FG002|STARTED|Overall Study||19||
48625183|NCT01855958|101864046|FG000|COMPLETED|Overall Study||12||
48625184|NCT01855958|101864047|FG001|COMPLETED|Overall Study||13||
48625185|NCT01855958|101864046|FG000|NOT COMPLETED|Overall Study||1||
48625186|NCT01855958|101864047|FG001|NOT COMPLETED|Overall Study||0||
48625187|NCT00871234|101864048|FG000|STARTED|Overall Study||28||
48625188|NCT00871234|101864048|FG000|COMPLETED|Overall Study||23||
48625189|NCT00871234|101864048|FG000|NOT COMPLETED|Overall Study||5||
48625190|NCT01405560|101864049|FG000|STARTED|Overall Study||42||
48625191|NCT01405560|101864049|FG000|COMPLETED|Overall Study||41||
48625192|NCT01405560|101864049|FG000|NOT COMPLETED|Overall Study||1||
48748210|NCT00362648|102169504|FG003|NOT COMPLETED|Overall Study||11||
48167834|NCT00960752|100732436|FG000|COMPLETED|Overall Study||13||
48167835|NCT00960752|100732437|FG001|COMPLETED|Overall Study||13||
48167836|NCT00960752|100732438|FG002|COMPLETED|Overall Study||17||
48167837|NCT00960752|100732436|FG000|NOT COMPLETED|Overall Study||0||
48167838|NCT00960752|100732437|FG001|NOT COMPLETED|Overall Study||0||
48167839|NCT00960752|100732438|FG002|NOT COMPLETED|Overall Study||2||
48167840|NCT03355755|100732439|FG000|STARTED|Overall Study||15||
48167841|NCT03355755|100732439|FG000|COMPLETED|Overall Study||13||
48167842|NCT03355755|100732439|FG000|NOT COMPLETED|Overall Study||2||
48167843|NCT02076074|100732440|FG000|STARTED|Overall Study||50||
48167844|NCT02076074|100732440|FG000|COMPLETED|Overall Study||50||
48167845|NCT02076074|100732440|FG000|NOT COMPLETED|Overall Study||0||
48167846|NCT01032044|100732441|FG000|STARTED|Overall Study||82||
48167847|NCT01032044|100732442|FG001|STARTED|Overall Study||82||
48331341|NCT05099640|101141637|FG000|COMPLETED|Part 2: Randomized Treatment (6 Weeks)||0||
48331342|NCT05099640|101141638|FG001|COMPLETED|Part 2: Randomized Treatment (6 Weeks)||55||
48331343|NCT05099640|101141639|FG002|COMPLETED|Part 2: Randomized Treatment (6 Weeks)||54||
48331344|NCT05099640|101141637|FG000|NOT COMPLETED|Part 2: Randomized Treatment (6 Weeks)||0||
48331345|NCT05099640|101141638|FG001|NOT COMPLETED|Part 2: Randomized Treatment (6 Weeks)||1||
48331346|NCT05099640|101141639|FG002|NOT COMPLETED|Part 2: Randomized Treatment (6 Weeks)||0||
48410827|NCT01511640|101337736|FG001|STARTED|Washout (6-10 Days)||8||
48410828|NCT01511640|101337737|FG002|STARTED|Washout (6-10 Days)||7||
48410829|NCT01511640|101337738|FG003|STARTED|Washout (6-10 Days)||7||
48410830|NCT01511640|101337735|FG000|COMPLETED|Washout (6-10 Days)||5||
48625193|NCT03242941|101864050|FG000|STARTED|Overall Study||16||
48625194|NCT03242941|101864050|FG000|COMPLETED|Overall Study||14||
48625195|NCT03242941|101864050|FG000|NOT COMPLETED|Overall Study||2||
48625196|NCT01064479|101864051|FG000|STARTED|Overall Study||60||
48625197|NCT01064479|101864052|FG001|STARTED|Overall Study||59||
48625198|NCT01064479|101864051|FG000|COMPLETED|Overall Study||45||
48625199|NCT01064479|101864052|FG001|COMPLETED|Overall Study||42||
48625200|NCT01064479|101864051|FG000|NOT COMPLETED|Overall Study||15||
48625201|NCT01064479|101864052|FG001|NOT COMPLETED|Overall Study||17||
48167848|NCT01032044|100732441|FG000|Procedure|Overall Study||74||
48167849|NCT01032044|100732442|FG001|Procedure|Overall Study||75||
48167850|NCT01032044|100732441|FG000|COMPLETED|Overall Study||57||
48410831|NCT01511640|101337736|FG001|COMPLETED|Washout (6-10 Days)||8||
48748211|NCT00726414|102169505|FG000|STARTED|First Intervention||11||
48167851|NCT01032044|100732442|FG001|COMPLETED|Overall Study||62||
48167852|NCT01032044|100732441|FG000|NOT COMPLETED|Overall Study||25||
48625202|NCT01095497|101864053|FG000|STARTED|Intravenous CINRYZE||14||
48625203|NCT01095497|101864054|FG001|STARTED|Intravenous CINRYZE||12||
48625204|NCT01095497|101864053|FG000|COMPLETED|Intravenous CINRYZE||13||
48625205|NCT01095497|101864054|FG001|COMPLETED|Intravenous CINRYZE||12||
48167853|NCT01032044|100732442|FG001|NOT COMPLETED|Overall Study||20||
48167854|NCT02091739|100732443|FG000|STARTED|MP: 16 Weeks||36||
48167855|NCT02091739|100732444|FG001|STARTED|MP: 16 Weeks||74||
48331347|NCT01537211|101141640|FG000|STARTED|Overall Study||4||
48331348|NCT01537211|101141641|FG001|STARTED|Overall Study||6||
48331349|NCT01537211|101141640|FG000|COMPLETED|Overall Study||4||
48331350|NCT01537211|101141641|FG001|COMPLETED|Overall Study||5||
48331351|NCT01537211|101141640|FG000|NOT COMPLETED|Overall Study||0||
48331352|NCT01537211|101141641|FG001|NOT COMPLETED|Overall Study||1||
48331353|NCT02275338|101141642|FG000|STARTED|Overall Study||52||
48331354|NCT02275338|101141642|FG000|Completed Phase 1|Overall Study||25||
48331355|NCT02275338|101141642|FG000|Started Phase 2|Overall Study||21||
48331356|NCT02275338|101141642|FG000|COMPLETED|Overall Study||19||
48331357|NCT02275338|101141642|FG000|NOT COMPLETED|Overall Study||33||
48331358|NCT00323557|101141643|FG000|STARTED|Overall Study||25||
48331359|NCT00323557|101141644|FG001|STARTED|Overall Study||7||
48331360|NCT00323557|101141643|FG000|COMPLETED|Overall Study||24||
48331361|NCT00323557|101141644|FG001|COMPLETED|Overall Study||7||
48331362|NCT00323557|101141643|FG000|NOT COMPLETED|Overall Study||1||
48331363|NCT00323557|101141644|FG001|NOT COMPLETED|Overall Study||0||
48331364|NCT02170662|101141645|FG000|STARTED|Overall Study||3||
48331365|NCT02170662|101141646|FG001|STARTED|Overall Study||6||
48331366|NCT02170662|101141645|FG000|COMPLETED|Overall Study||3||
48331367|NCT02170662|101141646|FG001|COMPLETED|Overall Study||6||
48331368|NCT02170662|101141645|FG000|NOT COMPLETED|Overall Study||0||
48331369|NCT02170662|101141646|FG001|NOT COMPLETED|Overall Study||0||
48331370|NCT02684981|101141647|FG000|STARTED|Overall Study||4100|Number of patients started are treated with known treatment.|
48331371|NCT02684981|101141648|FG001|STARTED|Overall Study||3179|Number of patients started are treated with known treatment.|
48331372|NCT02684981|101141649|FG002|STARTED|Overall Study||2186|Number of patients started are treated with known treatment.|
48331373|NCT02684981|101141647|FG000|COMPLETED|Overall Study||3860||
48331374|NCT02684981|101141648|FG001|COMPLETED|Overall Study||2969||
48331375|NCT02684981|101141649|FG002|COMPLETED|Overall Study||2059||
48331376|NCT02684981|101141647|FG000|NOT COMPLETED|Overall Study||240||
48331377|NCT02684981|101141648|FG001|NOT COMPLETED|Overall Study||210||
48331378|NCT02684981|101141649|FG002|NOT COMPLETED|Overall Study||127||
48331379|NCT02665286|101141650|FG000|STARTED|Overall Study||79||
48331380|NCT02665286|101141651|FG001|STARTED|Overall Study||80||
48331381|NCT02665286|101141652|FG002|STARTED|Overall Study||81||
48331382|NCT02665286|101141650|FG000|COMPLETED|Overall Study||76||
48331383|NCT02665286|101141651|FG001|COMPLETED|Overall Study||78||
48331384|NCT02665286|101141652|FG002|COMPLETED|Overall Study||80||
48331385|NCT02665286|101141650|FG000|NOT COMPLETED|Overall Study||3||
48331386|NCT02665286|101141651|FG001|NOT COMPLETED|Overall Study||2||
48331387|NCT02665286|101141652|FG002|NOT COMPLETED|Overall Study||1||
48331388|NCT00714792|101141653|FG000|STARTED|Overall Study||10||
48331389|NCT00714792|101141654|FG001|STARTED|Overall Study||8||
48331390|NCT00714792|101141653|FG000|COMPLETED|Overall Study||10||
48331391|NCT00714792|101141654|FG001|COMPLETED|Overall Study||8||
48331392|NCT00714792|101141653|FG000|NOT COMPLETED|Overall Study||0||
48331393|NCT00714792|101141654|FG001|NOT COMPLETED|Overall Study||0||
48331394|NCT01707693|101141655|FG000|STARTED|Overall Study Allocation||59|Allocated to Intervention and Control Arms Time 1 measures|
48331395|NCT01707693|101141656|FG001|STARTED|Overall Study Allocation||62|Allocated to Intervention and Control Arms Time 1 measures|
48331396|NCT01707693|101141655|FG000|COMPLETED|Overall Study Allocation||46|Participants that completed both Time 1 (baseline) and Time 2 Measures (3 month)|
48625206|NCT01095497|101864053|FG000|NOT COMPLETED|Intravenous CINRYZE||1||
48625207|NCT01095497|101864054|FG001|NOT COMPLETED|Intravenous CINRYZE||0||
48625208|NCT01095497|101864053|FG000|STARTED|Subcutaneous CINRYZE||13||
48625209|NCT01095497|101864054|FG001|STARTED|Subcutaneous CINRYZE||12||
48625210|NCT01095497|101864053|FG000|COMPLETED|Subcutaneous CINRYZE||12||
48625211|NCT01095497|101864054|FG001|COMPLETED|Subcutaneous CINRYZE||12||
48625212|NCT01095497|101864053|FG000|NOT COMPLETED|Subcutaneous CINRYZE||1||
48625213|NCT01095497|101864054|FG001|NOT COMPLETED|Subcutaneous CINRYZE||0||
48625214|NCT00496340|101864055|FG000|STARTED|Overall Study||42||
48625215|NCT00496340|101864055|FG000|COMPLETED|Overall Study||42||
48625216|NCT00496340|101864055|FG000|NOT COMPLETED|Overall Study||0||
48625217|NCT04494646|101864056|FG000|STARTED|Overall Study||21||
48625218|NCT04494646|101864057|FG001|STARTED|Overall Study||19||
48625219|NCT04494646|101864056|FG000|COMPLETED|Overall Study||21||
48625220|NCT04494646|101864057|FG001|COMPLETED|Overall Study||17||
48625221|NCT04494646|101864056|FG000|NOT COMPLETED|Overall Study||0||
48331397|NCT01707693|101141656|FG001|COMPLETED|Overall Study Allocation||54|Participants that completed both Time 1 (baseline) and Time 2 Measures (3 month)|
48331398|NCT01707693|101141655|FG000|NOT COMPLETED|Overall Study Allocation||13||
48331399|NCT01707693|101141656|FG001|NOT COMPLETED|Overall Study Allocation||8||
48331400|NCT01707693|101141655|FG000|STARTED|Time 3 Measures @ 6 Mth||46||
48331401|NCT01707693|101141656|FG001|STARTED|Time 3 Measures @ 6 Mth||54||
48331402|NCT01707693|101141655|FG000|COMPLETED|Time 3 Measures @ 6 Mth||46||
48331403|NCT01707693|101141656|FG001|COMPLETED|Time 3 Measures @ 6 Mth||49||
48331404|NCT01707693|101141655|FG000|NOT COMPLETED|Time 3 Measures @ 6 Mth||0||
48331405|NCT01707693|101141656|FG001|NOT COMPLETED|Time 3 Measures @ 6 Mth||5||
48331406|NCT03285243|101141657|FG000|STARTED|Overall Study||52||
48625222|NCT04494646|101864057|FG001|NOT COMPLETED|Overall Study||2||
48625223|NCT01719380|101867409|FG000|STARTED|Overall Study||2||
48625224|NCT01719380|101867410|FG001|STARTED|Overall Study||7||
48167856|NCT02091739|100732445|FG002|STARTED|MP: 16 Weeks||74||
48748212|NCT00726414|102169506|FG001|STARTED|First Intervention||11||
48748213|NCT00726414|102169505|FG000|COMPLETED|First Intervention||11||
48748214|NCT00726414|102169506|FG001|COMPLETED|First Intervention||11||
48748215|NCT00726414|102169505|FG000|NOT COMPLETED|First Intervention||0||
48748216|NCT00726414|102169506|FG001|NOT COMPLETED|First Intervention||0||
48748217|NCT00726414|102169505|FG000|STARTED|Washout Period of 7 Days||11||
48748218|NCT00726414|102169506|FG001|STARTED|Washout Period of 7 Days||11||
48748219|NCT00726414|102169505|FG000|COMPLETED|Washout Period of 7 Days||11||
48748220|NCT00726414|102169506|FG001|COMPLETED|Washout Period of 7 Days||11||
48748221|NCT00726414|102169505|FG000|NOT COMPLETED|Washout Period of 7 Days||0||
48748222|NCT00726414|102169506|FG001|NOT COMPLETED|Washout Period of 7 Days||0||
48748223|NCT00726414|102169505|FG000|STARTED|Second Intervention||11||
48748224|NCT00726414|102169506|FG001|STARTED|Second Intervention||11||
48748225|NCT00726414|102169505|FG000|COMPLETED|Second Intervention||11||
48748226|NCT00726414|102169506|FG001|COMPLETED|Second Intervention||11||
48748227|NCT00726414|102169505|FG000|NOT COMPLETED|Second Intervention||0||
48748228|NCT00726414|102169506|FG001|NOT COMPLETED|Second Intervention||0||
48748229|NCT00988598|102169507|FG000|STARTED|Overall Study||10||
48748230|NCT00988598|102169508|FG001|STARTED|Overall Study||5||
48748231|NCT00988598|102169507|FG000|COMPLETED|Overall Study||8||
48748232|NCT00988598|102169508|FG001|COMPLETED|Overall Study||5||
48748233|NCT00988598|102169507|FG000|NOT COMPLETED|Overall Study||2||
48748234|NCT00988598|102169508|FG001|NOT COMPLETED|Overall Study||0||
48748235|NCT00890825|102169509|FG000|STARTED|Overall Study||44||
48748236|NCT00890825|102169510|FG001|STARTED|Overall Study||43||
48748237|NCT00890825|102169509|FG000|COMPLETED|Overall Study||30||
48748238|NCT00890825|102169510|FG001|COMPLETED|Overall Study||29||
48748239|NCT00890825|102169509|FG000|NOT COMPLETED|Overall Study||14||
48748240|NCT00890825|102169510|FG001|NOT COMPLETED|Overall Study||14||
48748241|NCT02252146|102169511|FG000|STARTED|Overall Study||6||
48748242|NCT02252146|102169511|FG000|COMPLETED|Overall Study||0||
48748243|NCT02252146|102169511|FG000|NOT COMPLETED|Overall Study||6||
48748244|NCT04033367|102169512|FG000|STARTED|DB Period (Up to Week 12)||127||
48748245|NCT04033367|102169513|FG001|STARTED|DB Period (Up to Week 12)||61||
48748246|NCT04033367|102169512|FG000|COMPLETED|DB Period (Up to Week 12)||122||
48748247|NCT04033367|102169513|FG001|COMPLETED|DB Period (Up to Week 12)||60||
48748248|NCT04033367|102169512|FG000|NOT COMPLETED|DB Period (Up to Week 12)||5||
48748249|NCT04033367|102169513|FG001|NOT COMPLETED|DB Period (Up to Week 12)||1||
48748250|NCT04033367|102169512|FG000|STARTED|OLE Period (Week 12 to Week 24)||122||
48748251|NCT04033367|102169513|FG001|STARTED|OLE Period (Week 12 to Week 24)||60||
48748252|NCT04033367|102169512|FG000|COMPLETED|OLE Period (Week 12 to Week 24)||117||
48748253|NCT04033367|102169513|FG001|COMPLETED|OLE Period (Week 12 to Week 24)||59||
48748254|NCT04033367|102169512|FG000|NOT COMPLETED|OLE Period (Week 12 to Week 24)||5||
48748255|NCT04033367|102169513|FG001|NOT COMPLETED|OLE Period (Week 12 to Week 24)||1||
48748256|NCT01458639|102169514|FG000|STARTED|Overall Study||18||
48748257|NCT01458639|102169514|FG000|COMPLETED|Overall Study||12||
48748258|NCT01458639|102169514|FG000|NOT COMPLETED|Overall Study||6||
48748259|NCT03868254|102169515|FG000|STARTED|Overall Study||98||116
48748260|NCT03868254|102169516|FG001|STARTED|Overall Study||76||96
48748261|NCT03868254|102169515|FG000|COMPLETED|Overall Study||98||116
48167857|NCT02091739|100732446|FG003|STARTED|MP: 16 Weeks||0||
48167858|NCT02091739|100732447|FG004|STARTED|MP: 16 Weeks||0||
48167859|NCT02091739|100732443|FG000|COMPLETED|MP: 16 Weeks||32||
48167860|NCT02091739|100732444|FG001|COMPLETED|MP: 16 Weeks||69||
48167861|NCT02091739|100732445|FG002|COMPLETED|MP: 16 Weeks||72||
48167862|NCT02091739|100732446|FG003|COMPLETED|MP: 16 Weeks||0||
48167863|NCT02091739|100732447|FG004|COMPLETED|MP: 16 Weeks||0||
48167864|NCT02091739|100732443|FG000|NOT COMPLETED|MP: 16 Weeks||4||
48167865|NCT02091739|100732444|FG001|NOT COMPLETED|MP: 16 Weeks||5||
48167866|NCT02091739|100732445|FG002|NOT COMPLETED|MP: 16 Weeks||2||
48331407|NCT03285243|101141658|FG001|STARTED|Overall Study||52||
48748262|NCT03868254|102169516|FG001|COMPLETED|Overall Study||76||96
48748263|NCT03868254|102169515|FG000|NOT COMPLETED|Overall Study||0||0
48748264|NCT03868254|102169516|FG001|NOT COMPLETED|Overall Study||0||0
48748265|NCT03435185|102169517|FG000|STARTED|Overall Study||44||
48748266|NCT03435185|102169518|FG001|STARTED|Overall Study||43||
48167867|NCT02091739|100732446|FG003|NOT COMPLETED|MP: 16 Weeks||0||
48167868|NCT02091739|100732447|FG004|NOT COMPLETED|MP: 16 Weeks||0||
48748267|NCT03435185|102169517|FG000|COMPLETED|Overall Study||43||
48748268|NCT03435185|102169518|FG001|COMPLETED|Overall Study||28||
48748269|NCT03435185|102169517|FG000|NOT COMPLETED|Overall Study||1||
48748270|NCT03435185|102169518|FG001|NOT COMPLETED|Overall Study||15||
48748271|NCT00934635|102169519|FG000|STARTED|Overall Study||0||
48748272|NCT00934635|102169520|FG001|STARTED|Overall Study||1||
48748273|NCT00934635|102169521|FG002|STARTED|Overall Study||0||
48748274|NCT00934635|102169522|FG003|STARTED|Overall Study||0||
48748275|NCT00934635|102169523|FG004|STARTED|Overall Study||0||
48167869|NCT02091739|100732443|FG000|STARTED|EP: 48 Weeks||0||
48167870|NCT02091739|100732444|FG001|STARTED|EP: 48 Weeks||0||
48625225|NCT01719380|101867411|FG002|STARTED|Overall Study||9||
48331408|NCT03285243|101141657|FG000|COMPLETED|Overall Study||52|found to have met exclusion criteria after enrollment|
48331409|NCT03285243|101141658|FG001|COMPLETED|Overall Study||51|found to have met exclusion criteria after enrollment|
48331410|NCT03285243|101141657|FG000|NOT COMPLETED|Overall Study||0||
48331411|NCT03285243|101141658|FG001|NOT COMPLETED|Overall Study||1||
48331412|NCT02263833|101141659|FG000|STARTED|Overall Study||742||
48331413|NCT02263833|101141659|FG000|COMPLETED|Overall Study||742||
48331414|NCT02263833|101141659|FG000|NOT COMPLETED|Overall Study||0||
48331415|NCT03657043|101141660|FG000|STARTED|Overall Study||8||
48331416|NCT03657043|101141661|FG001|STARTED|Overall Study||8||
48331417|NCT03657043|101141662|FG002|STARTED|Overall Study||0||
48331418|NCT03657043|101141663|FG003|STARTED|Overall Study||0||
48331419|NCT03657043|101141664|FG004|STARTED|Overall Study||82||
48331420|NCT03657043|101141660|FG000|COMPLETED|Overall Study||0||
48331421|NCT03657043|101141661|FG001|COMPLETED|Overall Study||0||
48331422|NCT03657043|101141662|FG002|COMPLETED|Overall Study||0||
48331423|NCT03657043|101141663|FG003|COMPLETED|Overall Study||0||
48331424|NCT03657043|101141664|FG004|COMPLETED|Overall Study||0||
48331425|NCT03657043|101141660|FG000|NOT COMPLETED|Overall Study||8||
48331426|NCT03657043|101141661|FG001|NOT COMPLETED|Overall Study||8||
48331427|NCT03657043|101141662|FG002|NOT COMPLETED|Overall Study||0||
48331428|NCT03657043|101141663|FG003|NOT COMPLETED|Overall Study||0||
48331429|NCT03657043|101141664|FG004|NOT COMPLETED|Overall Study||82||
48331430|NCT03591380|101141665|FG000|STARTED|Overall Study||3||
48331431|NCT03591380|101141665|FG000|COMPLETED|Overall Study||3||
48331432|NCT03591380|101141665|FG000|NOT COMPLETED|Overall Study||0||
48331433|NCT02507011|101141666|FG000|STARTED|First Intervention||1||
48331434|NCT02507011|101141667|FG001|STARTED|First Intervention||1||
48331435|NCT02507011|101141666|FG000|COMPLETED|First Intervention||1||
48331436|NCT02507011|101141667|FG001|COMPLETED|First Intervention||1||
48331437|NCT02507011|101141666|FG000|NOT COMPLETED|First Intervention||0||
48331438|NCT02507011|101141667|FG001|NOT COMPLETED|First Intervention||0||
48331439|NCT02507011|101141666|FG000|STARTED|Second Intervention||1||
48331440|NCT02507011|101141667|FG001|STARTED|Second Intervention||1||
48625226|NCT01719380|101867412|FG003|STARTED|Overall Study||8||
48625227|NCT01719380|101867413|FG004|STARTED|Overall Study||3||
48625228|NCT01719380|101867414|FG005|STARTED|Overall Study||8||
48625229|NCT01719380|101867415|FG006|STARTED|Overall Study||10||
48625230|NCT01719380|101867416|FG007|STARTED|Overall Study||7||
48625231|NCT01719380|101867417|FG008|STARTED|Overall Study||50||
48625232|NCT01719380|101867418|FG009|STARTED|Overall Study||52||
48625233|NCT01719380|101867409|FG000|COMPLETED|Overall Study||0||
48625234|NCT01719380|101867410|FG001|COMPLETED|Overall Study||0||
48625235|NCT01719380|101867411|FG002|COMPLETED|Overall Study||0||
48748276|NCT00934635|102169524|FG005|STARTED|Overall Study||0||
48625236|NCT01719380|101867412|FG003|COMPLETED|Overall Study||0||
48625237|NCT01719380|101867413|FG004|COMPLETED|Overall Study||0||
48625238|NCT01719380|101867414|FG005|COMPLETED|Overall Study||0||
48625239|NCT01719380|101867415|FG006|COMPLETED|Overall Study||0||
48625240|NCT01719380|101867416|FG007|COMPLETED|Overall Study||0||
48625241|NCT01719380|101867417|FG008|COMPLETED|Overall Study||0||
48625242|NCT01719380|101867418|FG009|COMPLETED|Overall Study||1||
48625243|NCT01719380|101867409|FG000|NOT COMPLETED|Overall Study||2||
48625244|NCT01719380|101867410|FG001|NOT COMPLETED|Overall Study||7||
48625245|NCT01719380|101867411|FG002|NOT COMPLETED|Overall Study||9||
48625246|NCT01719380|101867412|FG003|NOT COMPLETED|Overall Study||8||
48625247|NCT01719380|101867413|FG004|NOT COMPLETED|Overall Study||3||
48625248|NCT01719380|101867414|FG005|NOT COMPLETED|Overall Study||8||
48625249|NCT01719380|101867415|FG006|NOT COMPLETED|Overall Study||10||
48625250|NCT01719380|101867416|FG007|NOT COMPLETED|Overall Study||7||
48625251|NCT01719380|101867417|FG008|NOT COMPLETED|Overall Study||50||
48625252|NCT01719380|101867418|FG009|NOT COMPLETED|Overall Study||51||
48625253|NCT00723229|101867419|FG000|STARTED|First Intervention||25||
48625254|NCT00723229|101867420|FG001|STARTED|First Intervention||23||
48625255|NCT00723229|101867419|FG000|COMPLETED|First Intervention||18||
48625256|NCT00723229|101867420|FG001|COMPLETED|First Intervention||20||
48625257|NCT00723229|101867419|FG000|NOT COMPLETED|First Intervention||7||
48625258|NCT00723229|101867420|FG001|NOT COMPLETED|First Intervention||3||
48625259|NCT00723229|101867419|FG000|STARTED|Second Intervention||18||
48625260|NCT00723229|101867420|FG001|STARTED|Second Intervention||20||
48625261|NCT00723229|101867419|FG000|COMPLETED|Second Intervention||18||
48625262|NCT00723229|101867420|FG001|COMPLETED|Second Intervention||20||
48748277|NCT00934635|102169525|FG006|STARTED|Overall Study||0||
48748278|NCT00934635|102169526|FG007|STARTED|Overall Study||0||
48748279|NCT00934635|102169527|FG008|STARTED|Overall Study||1||
48748280|NCT00934635|102169519|FG000|COMPLETED|Overall Study||0||
48748281|NCT00934635|102169520|FG001|COMPLETED|Overall Study||1||
48748282|NCT00934635|102169521|FG002|COMPLETED|Overall Study||0||
48331441|NCT02507011|101141666|FG000|COMPLETED|Second Intervention||1||
48625263|NCT00723229|101867419|FG000|NOT COMPLETED|Second Intervention||0||
48625264|NCT00723229|101867420|FG001|NOT COMPLETED|Second Intervention||0||
48748283|NCT00934635|102169522|FG003|COMPLETED|Overall Study||0||
48748284|NCT00934635|102169523|FG004|COMPLETED|Overall Study||0||
48410832|NCT01511640|101337737|FG002|COMPLETED|Washout (6-10 Days)||7||
48410833|NCT01511640|101337738|FG003|COMPLETED|Washout (6-10 Days)||6||
48410834|NCT01511640|101337735|FG000|NOT COMPLETED|Washout (6-10 Days)||0||
48410835|NCT01511640|101337736|FG001|NOT COMPLETED|Washout (6-10 Days)||0||
48410836|NCT01511640|101337737|FG002|NOT COMPLETED|Washout (6-10 Days)||0||
48410837|NCT01511640|101337738|FG003|NOT COMPLETED|Washout (6-10 Days)||1||
48410838|NCT01511640|101337735|FG000|STARTED|Third Intervention (11-15 Days)||5||
48748285|NCT00934635|102169524|FG005|COMPLETED|Overall Study||0||
48748286|NCT00934635|102169525|FG006|COMPLETED|Overall Study||0||
48748287|NCT00934635|102169526|FG007|COMPLETED|Overall Study||0||
48748288|NCT00934635|102169527|FG008|COMPLETED|Overall Study||1||
48748289|NCT00934635|102169519|FG000|NOT COMPLETED|Overall Study||0||
48748290|NCT00934635|102169520|FG001|NOT COMPLETED|Overall Study||0||
48748291|NCT00934635|102169521|FG002|NOT COMPLETED|Overall Study||0||
48748292|NCT00934635|102169522|FG003|NOT COMPLETED|Overall Study||0||
48748293|NCT00934635|102169523|FG004|NOT COMPLETED|Overall Study||0||
48748294|NCT00934635|102169524|FG005|NOT COMPLETED|Overall Study||0||
48748295|NCT00934635|102169525|FG006|NOT COMPLETED|Overall Study||0||
48748296|NCT00934635|102169526|FG007|NOT COMPLETED|Overall Study||0||
48748297|NCT00934635|102169527|FG008|NOT COMPLETED|Overall Study||0||
48748298|NCT02232022|102169528|FG000|STARTED|Overall Study||53||
48748299|NCT02232022|102169528|FG000|COMPLETED|Overall Study||51||
48748300|NCT02232022|102169528|FG000|NOT COMPLETED|Overall Study||2||
48748301|NCT02052544|102169529|FG000|STARTED|Overall Study||123||
48748302|NCT02052544|102169529|FG000|COMPLETED|Overall Study||123||
48748303|NCT02052544|102169529|FG000|NOT COMPLETED|Overall Study||0||
48748304|NCT02477124|102169530|FG000|STARTED|Overall Study||514||
48748305|NCT02477124|102169530|FG000|COMPLETED|Overall Study||514||
48167871|NCT02091739|100732445|FG002|STARTED|EP: 48 Weeks||0||
48167872|NCT02091739|100732446|FG003|STARTED|EP: 48 Weeks||84||
48167873|NCT02091739|100732447|FG004|STARTED|EP: 48 Weeks||89||
48167874|NCT02091739|100732443|FG000|COMPLETED|EP: 48 Weeks||0|Participants who completed the MP (n=173), entered the 2 treatment arms of the EP of the study.|
48167875|NCT02091739|100732444|FG001|COMPLETED|EP: 48 Weeks||0|Participants who completed the MP (n=173), entered the 2 treatment arms of the EP of the study.|
48167876|NCT02091739|100732445|FG002|COMPLETED|EP: 48 Weeks||0|Participants who completed the MP (n=173), entered the 2 treatment arms of the EP of the study.|
48167877|NCT02091739|100732446|FG003|COMPLETED|EP: 48 Weeks||76|Participants who completed the MP (n=173), entered the 2 treatment arms of the EP of the study.|
48167878|NCT02091739|100732447|FG004|COMPLETED|EP: 48 Weeks||75|Participants who completed the MP (n=173), entered the 2 treatment arms of the EP of the study.|
48167879|NCT02091739|100732443|FG000|NOT COMPLETED|EP: 48 Weeks||0||
48167880|NCT02091739|100732444|FG001|NOT COMPLETED|EP: 48 Weeks||0||
48167881|NCT02091739|100732445|FG002|NOT COMPLETED|EP: 48 Weeks||0||
48167882|NCT02091739|100732446|FG003|NOT COMPLETED|EP: 48 Weeks||8||
48167883|NCT02091739|100732447|FG004|NOT COMPLETED|EP: 48 Weeks||14||
48167884|NCT04772053|100732448|FG000|STARTED|Overall Study||6||
48167885|NCT04772053|100732448|FG000|COMPLETED|Overall Study||0||
48167886|NCT04772053|100732448|FG000|NOT COMPLETED|Overall Study||6||
48167887|NCT01905254|100732449|FG000|STARTED|Overall Study||34||
48167888|NCT01905254|100732449|FG000|COMPLETED|Overall Study||34||
48167889|NCT01905254|100732449|FG000|NOT COMPLETED|Overall Study||0||
48167890|NCT02875834|100732450|FG000|STARTED|Open-label Phase||267||
48167891|NCT02875834|100732451|FG001|STARTED|Open-label Phase||0||
48167892|NCT02875834|100732452|FG002|STARTED|Open-label Phase||0||
48167893|NCT02875834|100732453|FG003|STARTED|Open-label Phase||0||
48167894|NCT02875834|100732450|FG000|COMPLETED|Open-label Phase||260||
48167895|NCT02875834|100732451|FG001|COMPLETED|Open-label Phase||0||
48167896|NCT02875834|100732452|FG002|COMPLETED|Open-label Phase||0||
48410839|NCT01511640|101337736|FG001|STARTED|Third Intervention (11-15 Days)||8||
48410840|NCT01511640|101337737|FG002|STARTED|Third Intervention (11-15 Days)||7||
48410841|NCT01511640|101337738|FG003|STARTED|Third Intervention (11-15 Days)||6||
48748306|NCT02477124|102169530|FG000|NOT COMPLETED|Overall Study||0||
48410842|NCT01511640|101337735|FG000|COMPLETED|Third Intervention (11-15 Days)||4||
48748307|NCT03010319|102169531|FG000|STARTED|Overall Study||110||
48748308|NCT03010319|102169532|FG001|STARTED|Overall Study||116||
48748309|NCT03010319|102169531|FG000|COMPLETED|Overall Study||84||
48748310|NCT03010319|102169532|FG001|COMPLETED|Overall Study||87||
48748311|NCT03010319|102169531|FG000|NOT COMPLETED|Overall Study||26||
48331442|NCT02507011|101141667|FG001|COMPLETED|Second Intervention||1||
48331443|NCT02507011|101141666|FG000|NOT COMPLETED|Second Intervention||0||
48331444|NCT02507011|101141667|FG001|NOT COMPLETED|Second Intervention||0||
48331445|NCT01276171|101141668|FG000|STARTED|Overall Study||249||
48331446|NCT01276171|101141669|FG001|STARTED|Overall Study||244||
48331447|NCT01276171|101141670|FG002|STARTED|Overall Study||256||
48331448|NCT01276171|101141668|FG000|COMPLETED|Overall Study||249||
48331449|NCT01276171|101141669|FG001|COMPLETED|Overall Study||244||
48331450|NCT01276171|101141670|FG002|COMPLETED|Overall Study||256||
48331451|NCT01276171|101141668|FG000|NOT COMPLETED|Overall Study||0||
48331452|NCT01276171|101141669|FG001|NOT COMPLETED|Overall Study||0||
48331453|NCT01276171|101141670|FG002|NOT COMPLETED|Overall Study||0||
48331454|NCT02323698|101141671|FG000|STARTED|Overall Study||2||
48331455|NCT02323698|101141672|FG001|STARTED|Overall Study||2||
48331456|NCT02323698|101141673|FG002|STARTED|Overall Study||2||
48331457|NCT02323698|101141674|FG003|STARTED|Overall Study||2||
48331458|NCT02323698|101141675|FG004|STARTED|Overall Study||2||
48331459|NCT02323698|101141676|FG005|STARTED|Overall Study||2||
48331460|NCT02323698|101141671|FG000|Completed First Intervention (5 Days)|Overall Study||2||
48331461|NCT02323698|101141672|FG001|Completed First Intervention (5 Days)|Overall Study||2||
48331462|NCT02323698|101141673|FG002|Completed First Intervention (5 Days)|Overall Study||2||
48331463|NCT02323698|101141674|FG003|Completed First Intervention (5 Days)|Overall Study||2||
48331464|NCT02323698|101141675|FG004|Completed First Intervention (5 Days)|Overall Study||2||
48331465|NCT02323698|101141676|FG005|Completed First Intervention (5 Days)|Overall Study||2||
48331466|NCT02323698|101141671|FG000|Completed Second Intervention (5 Days)|Overall Study||2||
48331467|NCT02323698|101141672|FG001|Completed Second Intervention (5 Days)|Overall Study||2||
48331468|NCT02323698|101141673|FG002|Completed Second Intervention (5 Days)|Overall Study||1||
48331469|NCT02323698|101141674|FG003|Completed Second Intervention (5 Days)|Overall Study||2||
48331470|NCT02323698|101141675|FG004|Completed Second Intervention (5 Days)|Overall Study||2||
48331471|NCT02323698|101141676|FG005|Completed Second Intervention (5 Days)|Overall Study||2||
48331472|NCT02323698|101141671|FG000|Completed Third Intervention (5 Days)|Overall Study||2||
48331473|NCT02323698|101141672|FG001|Completed Third Intervention (5 Days)|Overall Study||2||
48331474|NCT02323698|101141673|FG002|Completed Third Intervention (5 Days)|Overall Study||0||
48331475|NCT02323698|101141674|FG003|Completed Third Intervention (5 Days)|Overall Study||2||
48331476|NCT02323698|101141675|FG004|Completed Third Intervention (5 Days)|Overall Study||1||
48331477|NCT02323698|101141676|FG005|Completed Third Intervention (5 Days)|Overall Study||2||
48331478|NCT02323698|101141671|FG000|COMPLETED|Overall Study||2||
48331479|NCT02323698|101141672|FG001|COMPLETED|Overall Study||2||
48331480|NCT02323698|101141673|FG002|COMPLETED|Overall Study||0||
48331481|NCT02323698|101141674|FG003|COMPLETED|Overall Study||2||
48331482|NCT02323698|101141675|FG004|COMPLETED|Overall Study||1||
48331483|NCT02323698|101141676|FG005|COMPLETED|Overall Study||2||
48331484|NCT02323698|101141671|FG000|NOT COMPLETED|Overall Study||0||
48331485|NCT02323698|101141672|FG001|NOT COMPLETED|Overall Study||0||
48331486|NCT02323698|101141673|FG002|NOT COMPLETED|Overall Study||2||
48331487|NCT02323698|101141674|FG003|NOT COMPLETED|Overall Study||0||
48331488|NCT02323698|101141675|FG004|NOT COMPLETED|Overall Study||1||
48331489|NCT02323698|101141676|FG005|NOT COMPLETED|Overall Study||0||
48331490|NCT03778112|101141677|FG000|STARTED|Overall Study||4||
48331491|NCT03778112|101141678|FG001|STARTED|Overall Study||50||
48331492|NCT03778112|101141677|FG000|COMPLETED|Overall Study||4||
48331493|NCT03778112|101141678|FG001|COMPLETED|Overall Study||50||
48331494|NCT03778112|101141677|FG000|NOT COMPLETED|Overall Study||0||
48331495|NCT03778112|101141678|FG001|NOT COMPLETED|Overall Study||0||
48331496|NCT02437162|101141679|FG000|STARTED|Overall Study||116||
48331497|NCT02437162|101141680|FG001|STARTED|Overall Study||116||
48331498|NCT02437162|101141681|FG002|STARTED|Overall Study||115||
48331499|NCT02437162|101141679|FG000|Treated|Overall Study||116||
48331500|NCT02437162|101141680|FG001|Treated|Overall Study||116||
48331501|NCT02437162|101141681|FG002|Treated|Overall Study||114||
48331502|NCT02437162|101141679|FG000|Early Escape at Week 16|Overall Study||26||
48331503|NCT02437162|101141680|FG001|Early Escape at Week 16|Overall Study||21||
48331504|NCT02437162|101141681|FG002|Early Escape at Week 16|Overall Study||14||
48331505|NCT02437162|101141679|FG000|Cross Over at Week 24|Overall Study||87||
48331506|NCT02437162|101141680|FG001|Cross Over at Week 24|Overall Study||0||
48331507|NCT02437162|101141681|FG002|Cross Over at Week 24|Overall Study||0||
48331508|NCT02437162|101141679|FG000|COMPLETED|Overall Study||9||
48331509|NCT02437162|101141680|FG001|COMPLETED|Overall Study||8||
48331510|NCT02437162|101141681|FG002|COMPLETED|Overall Study||6||
48331511|NCT02437162|101141679|FG000|NOT COMPLETED|Overall Study||107||
48331512|NCT02437162|101141680|FG001|NOT COMPLETED|Overall Study||108||
48331513|NCT02437162|101141681|FG002|NOT COMPLETED|Overall Study||109||
48748312|NCT03010319|102169532|FG001|NOT COMPLETED|Overall Study||29||
48748313|NCT03049917|102169533|FG000|STARTED|Overall Study||90||
48748314|NCT03049917|102169534|FG001|STARTED|Overall Study||89||
48748315|NCT03049917|102169535|FG002|STARTED|Overall Study||93||
48748316|NCT03049917|102169536|FG003|STARTED|Overall Study||92||
48748317|NCT03049917|102169537|FG004|STARTED|Overall Study||88||
48748318|NCT03049917|102169533|FG000|COMPLETED|Overall Study||31||
48748319|NCT03049917|102169534|FG001|COMPLETED|Overall Study||31||
48748320|NCT03049917|102169535|FG002|COMPLETED|Overall Study||44||
48748321|NCT03049917|102169536|FG003|COMPLETED|Overall Study||51||
48748322|NCT03049917|102169537|FG004|COMPLETED|Overall Study||54||
48748323|NCT03049917|102169533|FG000|NOT COMPLETED|Overall Study||59||
48748324|NCT03049917|102169534|FG001|NOT COMPLETED|Overall Study||58||
48748325|NCT03049917|102169535|FG002|NOT COMPLETED|Overall Study||49||
48748326|NCT03049917|102169536|FG003|NOT COMPLETED|Overall Study||41||
48748327|NCT03049917|102169537|FG004|NOT COMPLETED|Overall Study||34||
48748328|NCT03830359|102169538|FG000|STARTED|Overall Study||62||
48748329|NCT03830359|102169538|FG000|COMPLETED|Overall Study||62||
48748330|NCT03830359|102169538|FG000|NOT COMPLETED|Overall Study||0||
48167897|NCT02875834|100732453|FG003|COMPLETED|Open-label Phase||0||
48331514|NCT00956254|101141682|FG000|STARTED|Overall Study||18||
48331515|NCT00956254|101141682|FG000|COMPLETED|Overall Study||18||
48748331|NCT02800863|102169539|FG000|STARTED|Overall Study||426||
48331516|NCT00956254|101141682|FG000|NOT COMPLETED|Overall Study||0||
48331517|NCT00662792|101141683|FG000|STARTED|Period 1||34||
48331518|NCT00662792|101141684|FG001|STARTED|Period 1||38||
48331519|NCT00662792|101141685|FG002|STARTED|Period 1||36||
48331520|NCT00662792|101141686|FG003|STARTED|Period 1||39||
48331521|NCT00662792|101141683|FG000|Treated|Period 1||34||
48331522|NCT00662792|101141684|FG001|Treated|Period 1||37||
48331523|NCT00662792|101141685|FG002|Treated|Period 1||36||
48331524|NCT00662792|101141686|FG003|Treated|Period 1||39||
48331525|NCT00662792|101141683|FG000|COMPLETED|Period 1||32|Not prematurely discontinued study medication|
48331526|NCT00662792|101141684|FG001|COMPLETED|Period 1||31|Not prematurely discontinued study medication|
48331527|NCT00662792|101141685|FG002|COMPLETED|Period 1||32|Not prematurely discontinued study medication|
48331528|NCT00662792|101141686|FG003|COMPLETED|Period 1||39|Not prematurely discontinued study medication|
48331529|NCT00662792|101141683|FG000|NOT COMPLETED|Period 1||2||
48331530|NCT00662792|101141684|FG001|NOT COMPLETED|Period 1||7||
48331531|NCT00662792|101141685|FG002|NOT COMPLETED|Period 1||4||
48331532|NCT00662792|101141686|FG003|NOT COMPLETED|Period 1||0||
48331533|NCT00662792|101141683|FG000|STARTED|Period 2||32||
48410843|NCT01511640|101337736|FG001|COMPLETED|Third Intervention (11-15 Days)||7||
48410844|NCT01511640|101337737|FG002|COMPLETED|Third Intervention (11-15 Days)||7||
48748332|NCT02800863|102169539|FG000|COMPLETED|Overall Study||198||
48748333|NCT02800863|102169539|FG000|NOT COMPLETED|Overall Study||228||
48748334|NCT02758717|102169540|FG000|STARTED|Overall Study||46||
48748335|NCT02758717|102169540|FG000|COMPLETED|Overall Study||46||
48748336|NCT02758717|102169540|FG000|NOT COMPLETED|Overall Study||0||
48748337|NCT02366195|102169541|FG000|STARTED|Overall Study||112||
48748338|NCT02366195|102169541|FG000|Received Study Drug|Overall Study||111||
48748339|NCT02366195|102169541|FG000|COMPLETED|Overall Study||58||
48748340|NCT02366195|102169541|FG000|NOT COMPLETED|Overall Study||54||
48748341|NCT00617175|102169542|FG000|STARTED|Overall Study||954||
48748342|NCT00617175|102169543|FG001|STARTED|Overall Study||948||
48748343|NCT00617175|102169542|FG000|COMPLETED|Overall Study||954||
48748344|NCT00617175|102169543|FG001|COMPLETED|Overall Study||948||
48748345|NCT00617175|102169542|FG000|NOT COMPLETED|Overall Study||0||
48748346|NCT00617175|102169543|FG001|NOT COMPLETED|Overall Study||0||
48748347|NCT00409539|102169544|FG000|STARTED|Overall Study||111||
48748348|NCT00409539|102169545|FG001|STARTED|Overall Study||111||
48748349|NCT00409539|102169546|FG002|STARTED|Overall Study||109||
48748350|NCT00409539|102169547|FG003|STARTED|Overall Study||109||
48748351|NCT00409539|102169548|FG004|STARTED|Overall Study||110||
48331534|NCT00662792|101141684|FG001|STARTED|Period 2||31||
48331535|NCT00662792|101141685|FG002|STARTED|Period 2||32||
48331536|NCT00662792|101141686|FG003|STARTED|Period 2||39||
48331537|NCT00662792|101141683|FG000|Treated|Period 2||32||
48331538|NCT00662792|101141684|FG001|Treated|Period 2||31||
48331539|NCT00662792|101141685|FG002|Treated|Period 2||32||
48331540|NCT00662792|101141686|FG003|Treated|Period 2||39||
48331541|NCT00662792|101141683|FG000|COMPLETED|Period 2||31|Not prematurely discontinued from study medication|
48331542|NCT00662792|101141684|FG001|COMPLETED|Period 2||31|Not prematurely discontinued from study medication|
48368083|NCT00449748|101230102|FG000|NOT COMPLETED|Overall Study||0||
48748352|NCT00409539|102169544|FG000|COMPLETED|Overall Study||100||
48748353|NCT00409539|102169545|FG001|COMPLETED|Overall Study||100||
48748354|NCT00409539|102169546|FG002|COMPLETED|Overall Study||95||
48748355|NCT00409539|102169547|FG003|COMPLETED|Overall Study||97||
48748356|NCT00409539|102169548|FG004|COMPLETED|Overall Study||85||
48748357|NCT00409539|102169544|FG000|NOT COMPLETED|Overall Study||11||
48748358|NCT00409539|102169545|FG001|NOT COMPLETED|Overall Study||11||
48748359|NCT00409539|102169546|FG002|NOT COMPLETED|Overall Study||14||
48748360|NCT00409539|102169547|FG003|NOT COMPLETED|Overall Study||12||
48748361|NCT00409539|102169548|FG004|NOT COMPLETED|Overall Study||25||
48748362|NCT03324802|102169549|FG000|STARTED|Overall Study||54||
48331543|NCT00662792|101141685|FG002|COMPLETED|Period 2||32|Not prematurely discontinued from study medication|
48331544|NCT00662792|101141686|FG003|COMPLETED|Period 2||36|Not prematurely discontinued from study medication|
48331545|NCT00662792|101141683|FG000|NOT COMPLETED|Period 2||1||
48625265|NCT01710020|101867421|FG000|STARTED|Period 1||12||
48625266|NCT01710020|101867421|FG000|COMPLETED|Period 1||11||
48625267|NCT01710020|101867421|FG000|NOT COMPLETED|Period 1||1||
48625268|NCT01710020|101867421|FG000|STARTED|Washout Period (at Least 14 Days)||11||
48625269|NCT01710020|101867421|FG000|COMPLETED|Washout Period (at Least 14 Days)||11||
48625270|NCT01710020|101867421|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48625271|NCT01710020|101867421|FG000|STARTED|Period 2||11||
48625272|NCT01710020|101867421|FG000|COMPLETED|Period 2||11||
48625273|NCT01710020|101867421|FG000|NOT COMPLETED|Period 2||0||
48625274|NCT02287038|101867422|FG000|STARTED|Overall Study||23||
48625275|NCT02287038|101867423|FG001|STARTED|Overall Study||21||
48625276|NCT02287038|101867422|FG000|COMPLETED|Overall Study||18||
48625277|NCT02287038|101867423|FG001|COMPLETED|Overall Study||18||
48625278|NCT02287038|101867422|FG000|NOT COMPLETED|Overall Study||5||
48625279|NCT02287038|101867423|FG001|NOT COMPLETED|Overall Study||3||
48625280|NCT01668836|101867424|FG000|STARTED|Overall Study||12||
48625281|NCT01668836|101867425|FG001|STARTED|Overall Study||12||
48748363|NCT03324802|102169550|FG001|STARTED|Overall Study||53||
48748364|NCT03324802|102169549|FG000|COMPLETED|Overall Study||54||
48748365|NCT03324802|102169550|FG001|COMPLETED|Overall Study||53||
48748366|NCT03324802|102169549|FG000|NOT COMPLETED|Overall Study||0||
48748367|NCT03324802|102169550|FG001|NOT COMPLETED|Overall Study||0||
48748368|NCT00961181|102169551|FG000|STARTED|Overall Study||81||
48748369|NCT00961181|102169551|FG000|COMPLETED|Overall Study||76||
48748370|NCT00961181|102169551|FG000|NOT COMPLETED|Overall Study||5||
48748371|NCT02254473|102169552|FG000|STARTED|Overall Study||9||
48748372|NCT02254473|102169553|FG001|STARTED|Overall Study||3||
48748373|NCT02254473|102169552|FG000|COMPLETED|Overall Study||7||
48748374|NCT02254473|102169553|FG001|COMPLETED|Overall Study||2||
48748375|NCT02254473|102169552|FG000|NOT COMPLETED|Overall Study||2||
48748376|NCT02254473|102169553|FG001|NOT COMPLETED|Overall Study||1||
48748377|NCT02513121|102169554|FG000|STARTED|Overall Study||20||
48748378|NCT02513121|102169555|FG001|STARTED|Overall Study||20||
48748379|NCT02513121|102169554|FG000|COMPLETED|Overall Study||20||
48748380|NCT02513121|102169555|FG001|COMPLETED|Overall Study||20||
48748381|NCT02513121|102169554|FG000|NOT COMPLETED|Overall Study||0||
48748382|NCT02513121|102169555|FG001|NOT COMPLETED|Overall Study||0||
48748383|NCT03796637|102169556|FG000|STARTED|Overall Study||6||
48748384|NCT03796637|102169556|FG000|COMPLETED|Overall Study||6||
48748385|NCT03796637|102169556|FG000|NOT COMPLETED|Overall Study||0||
48748386|NCT01606709|102169557|FG000|STARTED|Overall Study||4||
48748387|NCT01606709|102169558|FG001|STARTED|Overall Study||3||
48748388|NCT01606709|102169557|FG000|COMPLETED|Overall Study||4||
48748389|NCT01606709|102169558|FG001|COMPLETED|Overall Study||3||
48748390|NCT01606709|102169557|FG000|NOT COMPLETED|Overall Study||0||
48748391|NCT01606709|102169558|FG001|NOT COMPLETED|Overall Study||0||
48748392|NCT00040443|102169559|FG000|STARTED|Overall Study||84||
48748393|NCT00040443|102169560|FG001|STARTED|Overall Study||91||
48748394|NCT00040443|102169559|FG000|COMPLETED|Overall Study||84||
48748395|NCT00040443|102169560|FG001|COMPLETED|Overall Study||91||
48748396|NCT00040443|102169559|FG000|NOT COMPLETED|Overall Study||0||
48748397|NCT00040443|102169560|FG001|NOT COMPLETED|Overall Study||0||
48625282|NCT01668836|101867426|FG002|STARTED|Overall Study||12||
48625283|NCT01668836|101867427|FG003|STARTED|Overall Study||12||
48625284|NCT01668836|101867424|FG000|COMPLETED|Overall Study||12||
48748398|NCT03476135|102169561|FG000|STARTED|Overall Study||42||
48748399|NCT03476135|102169562|FG001|STARTED|Overall Study||49||
48748400|NCT03476135|102169561|FG000|COMPLETED|Overall Study||42||
48748401|NCT03476135|102169562|FG001|COMPLETED|Overall Study||49||
48748402|NCT03476135|102169561|FG000|NOT COMPLETED|Overall Study||0||
48748403|NCT03476135|102169562|FG001|NOT COMPLETED|Overall Study||0||
48748404|NCT01702558|102169563|FG000|STARTED|Overall Study||7||
48748405|NCT01702558|102169564|FG001|STARTED|Overall Study||5||
48748406|NCT01702558|102169565|FG002|STARTED|Overall Study||6||
48748407|NCT01702558|102169566|FG003|STARTED|Overall Study||81||
48748408|NCT01702558|102169567|FG004|STARTED|Overall Study||80||
48748409|NCT01702558|102169563|FG000|COMPLETED|Overall Study||3||
48748410|NCT01702558|102169564|FG001|COMPLETED|Overall Study||1||
48748411|NCT01702558|102169565|FG002|COMPLETED|Overall Study||1||
48748412|NCT01702558|102169566|FG003|COMPLETED|Overall Study||34||
48748413|NCT01702558|102169567|FG004|COMPLETED|Overall Study||38||
48748414|NCT01702558|102169563|FG000|NOT COMPLETED|Overall Study||4||
48748415|NCT01702558|102169564|FG001|NOT COMPLETED|Overall Study||4||
48625285|NCT01668836|101867425|FG001|COMPLETED|Overall Study||12||
48748416|NCT01702558|102169565|FG002|NOT COMPLETED|Overall Study||5||
48625286|NCT01668836|101867426|FG002|COMPLETED|Overall Study||12||
48625287|NCT01668836|101867427|FG003|COMPLETED|Overall Study||12||
48748417|NCT01702558|102169566|FG003|NOT COMPLETED|Overall Study||47||
48748418|NCT01702558|102169567|FG004|NOT COMPLETED|Overall Study||42||
48748419|NCT03101254|102169568|FG000|STARTED|Overall Study||5||
48748420|NCT03101254|102169569|FG001|STARTED|Overall Study||0||
48748421|NCT03101254|102169570|FG002|STARTED|Overall Study||0||
48625288|NCT01668836|101867424|FG000|NOT COMPLETED|Overall Study||0||
48167898|NCT02875834|100732450|FG000|NOT COMPLETED|Open-label Phase||7||
48167899|NCT02875834|100732451|FG001|NOT COMPLETED|Open-label Phase||0||
48167900|NCT02875834|100732452|FG002|NOT COMPLETED|Open-label Phase||0||
48167901|NCT02875834|100732453|FG003|NOT COMPLETED|Open-label Phase||0||
48167902|NCT02875834|100732450|FG000|STARTED|Randomized Treatment Phase||0||
48167903|NCT02875834|100732451|FG001|STARTED|Randomized Treatment Phase||99||
48625289|NCT01668836|101867425|FG001|NOT COMPLETED|Overall Study||0||
48625290|NCT01668836|101867426|FG002|NOT COMPLETED|Overall Study||0||
48625291|NCT01668836|101867427|FG003|NOT COMPLETED|Overall Study||0||
48625292|NCT04541355|101867428|FG000|STARTED|Overall Study||16||
48625293|NCT04541355|101867428|FG000|COMPLETED|Overall Study||16||
48625294|NCT04541355|101867428|FG000|NOT COMPLETED|Overall Study||0||
48625295|NCT01100502|101867429|FG000|STARTED|Overall Study||165||
48625296|NCT01100502|101867430|FG001|STARTED|Overall Study||164||
48625297|NCT01100502|101867429|FG000|COMPLETED|Overall Study||89||
48625298|NCT01100502|101867430|FG001|COMPLETED|Overall Study||70||
48625299|NCT01100502|101867429|FG000|NOT COMPLETED|Overall Study||76||
48625300|NCT01100502|101867430|FG001|NOT COMPLETED|Overall Study||94||
48625301|NCT01418339|101867431|FG000|STARTED|Overall Study||90||
48625302|NCT01418339|101867432|FG001|STARTED|Overall Study||45||
48625303|NCT01418339|101867431|FG000|COMPLETED|Overall Study||78||
48625304|NCT01418339|101867432|FG001|COMPLETED|Overall Study||35||
48625305|NCT01418339|101867431|FG000|NOT COMPLETED|Overall Study||12||
48625306|NCT01418339|101867432|FG001|NOT COMPLETED|Overall Study||10||
48625307|NCT01195779|101867433|FG000|STARTED|Overall Study||0||
48625308|NCT01195779|101867434|FG001|STARTED|Overall Study||0||
48625309|NCT01195779|101867435|FG002|STARTED|Overall Study||0||
48625310|NCT01195779|101867436|FG003|STARTED|Overall Study||0||
48625311|NCT01195779|101867437|FG004|STARTED|Overall Study||1||
48625312|NCT01195779|101867438|FG005|STARTED|Overall Study||0||
48625313|NCT01195779|101867439|FG006|STARTED|Overall Study||0||
48625314|NCT01195779|101867440|FG007|STARTED|Overall Study||1||
48625315|NCT01195779|101867441|FG008|STARTED|Overall Study||0||
48625316|NCT01195779|101867442|FG009|STARTED|Overall Study||0||
48625317|NCT01195779|101867443|FG010|STARTED|Overall Study||0||
48625318|NCT01195779|101867444|FG011|STARTED|Overall Study||1||
48625319|NCT01195779|101867445|FG012|STARTED|Overall Study||0||
48625320|NCT01195779|101867446|FG013|STARTED|Overall Study||1||
48625321|NCT01195779|101867433|FG000|COMPLETED|Overall Study||0||
48625322|NCT01195779|101867434|FG001|COMPLETED|Overall Study||0||
48625323|NCT01195779|101867435|FG002|COMPLETED|Overall Study||0||
48625324|NCT01195779|101867436|FG003|COMPLETED|Overall Study||0||
48625325|NCT01195779|101867437|FG004|COMPLETED|Overall Study||1||
48625326|NCT01195779|101867438|FG005|COMPLETED|Overall Study||0||
48625327|NCT01195779|101867439|FG006|COMPLETED|Overall Study||0||
48625328|NCT01195779|101867440|FG007|COMPLETED|Overall Study||1||
48625329|NCT01195779|101867441|FG008|COMPLETED|Overall Study||0||
48625330|NCT01195779|101867442|FG009|COMPLETED|Overall Study||0||
48625331|NCT01195779|101867443|FG010|COMPLETED|Overall Study||0||
48748422|NCT03101254|102169571|FG003|STARTED|Overall Study||0||
48748423|NCT03101254|102169568|FG000|COMPLETED|Overall Study||5||
48748424|NCT03101254|102169569|FG001|COMPLETED|Overall Study||0||
48748425|NCT03101254|102169570|FG002|COMPLETED|Overall Study||0||
48748426|NCT03101254|102169571|FG003|COMPLETED|Overall Study||0||
48748427|NCT03101254|102169568|FG000|NOT COMPLETED|Overall Study||0||
48748428|NCT03101254|102169569|FG001|NOT COMPLETED|Overall Study||0||
48748429|NCT03101254|102169570|FG002|NOT COMPLETED|Overall Study||0||
48748430|NCT03101254|102169571|FG003|NOT COMPLETED|Overall Study||0||
48748431|NCT00764361|102169572|FG000|STARTED|Overall Study||8||
48748432|NCT00764361|102169573|FG001|STARTED|Overall Study||7||
48748433|NCT00764361|102169572|FG000|COMPLETED|Overall Study||6||
48748434|NCT00764361|102169573|FG001|COMPLETED|Overall Study||3||
48748435|NCT00764361|102169572|FG000|NOT COMPLETED|Overall Study||2||
48748436|NCT00764361|102169573|FG001|NOT COMPLETED|Overall Study||4||
48748437|NCT04537793|102169574|FG000|STARTED|Part A (15 Days)||18||
48167904|NCT02875834|100732452|FG002|STARTED|Randomized Treatment Phase||99||
48167905|NCT02875834|100732453|FG003|STARTED|Randomized Treatment Phase||50||
48625332|NCT01195779|101867444|FG011|COMPLETED|Overall Study||1||
48167906|NCT02875834|100732450|FG000|COMPLETED|Randomized Treatment Phase||0||
48625333|NCT01195779|101867445|FG012|COMPLETED|Overall Study||0||
48625334|NCT01195779|101867446|FG013|COMPLETED|Overall Study||1||
48625335|NCT01195779|101867433|FG000|NOT COMPLETED|Overall Study||0||
48625336|NCT01195779|101867434|FG001|NOT COMPLETED|Overall Study||0||
48625337|NCT01195779|101867435|FG002|NOT COMPLETED|Overall Study||0||
48625338|NCT01195779|101867436|FG003|NOT COMPLETED|Overall Study||0||
48625339|NCT01195779|101867437|FG004|NOT COMPLETED|Overall Study||0||
48748438|NCT04537793|102169575|FG001|STARTED|Part A (15 Days)||0||
48748439|NCT04537793|102169574|FG000|COMPLETED|Part A (15 Days)||18||
48748440|NCT04537793|102169575|FG001|COMPLETED|Part A (15 Days)||0||
48748441|NCT04537793|102169574|FG000|NOT COMPLETED|Part A (15 Days)||0||
48748442|NCT04537793|102169575|FG001|NOT COMPLETED|Part A (15 Days)||0||
48625340|NCT01195779|101867438|FG005|NOT COMPLETED|Overall Study||0||
48625341|NCT01195779|101867439|FG006|NOT COMPLETED|Overall Study||0||
48625342|NCT01195779|101867440|FG007|NOT COMPLETED|Overall Study||0||
48625343|NCT01195779|101867441|FG008|NOT COMPLETED|Overall Study||0||
48625344|NCT01195779|101867442|FG009|NOT COMPLETED|Overall Study||0||
48625345|NCT01195779|101867443|FG010|NOT COMPLETED|Overall Study||0||
48625346|NCT01195779|101867444|FG011|NOT COMPLETED|Overall Study||0||
48625347|NCT01195779|101867445|FG012|NOT COMPLETED|Overall Study||0||
48625348|NCT01195779|101867446|FG013|NOT COMPLETED|Overall Study||0||
48625349|NCT01285843|101867447|FG000|STARTED|Overall Study||20||
48625350|NCT01285843|101867448|FG001|STARTED|Overall Study||20||
48625351|NCT01285843|101867447|FG000|COMPLETED|Overall Study||18||
48625352|NCT01285843|101867448|FG001|COMPLETED|Overall Study||18||
48625353|NCT01285843|101867447|FG000|NOT COMPLETED|Overall Study||2||
48625354|NCT01285843|101867448|FG001|NOT COMPLETED|Overall Study||2||
48625355|NCT05324306|101867449|FG000|STARTED|Overall Study||27||
48625356|NCT05324306|101867449|FG000|COMPLETED|Overall Study||27||
48625357|NCT05324306|101867449|FG000|NOT COMPLETED|Overall Study||0||
48625358|NCT03092752|101867450|FG000|STARTED|Overall Study||523585|Data for these patients was available in database.|
48625359|NCT03092752|101867450|FG000|COMPLETED|Overall Study||162116|These many patients satisfies the inclusion criteria and hence included in the study.|
48625360|NCT03092752|101867450|FG000|NOT COMPLETED|Overall Study||361469||
48625361|NCT02976519|101867451|FG000|STARTED|Treatment Period 1 (Part 1 and Part 2)||8|Started are treated|
48625362|NCT02976519|101867452|FG001|STARTED|Treatment Period 1 (Part 1 and Part 2)||8|Started are treated|
48625363|NCT02976519|101867453|FG002|STARTED|Treatment Period 1 (Part 1 and Part 2)||8|Started are treated|
48625364|NCT02976519|101867454|FG003|STARTED|Treatment Period 1 (Part 1 and Part 2)||8|Started are treated|
48167907|NCT02875834|100732451|FG001|COMPLETED|Randomized Treatment Phase||85||
48167908|NCT02875834|100732452|FG002|COMPLETED|Randomized Treatment Phase||88||
48625365|NCT02976519|101867455|FG004|STARTED|Treatment Period 1 (Part 1 and Part 2)||8|Started are treated|
48625366|NCT02976519|101867456|FG005|STARTED|Treatment Period 1 (Part 1 and Part 2)||12|Started are treated|
48625367|NCT02976519|101867457|FG006|STARTED|Treatment Period 1 (Part 1 and Part 2)||12|Started are treated|
48625368|NCT02976519|101867451|FG000|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8||
48625369|NCT02976519|101867452|FG001|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||7||
48625370|NCT02976519|101867453|FG002|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8||
48625371|NCT02976519|101867454|FG003|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||7||
48625372|NCT02976519|101867455|FG004|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8||
48625373|NCT02976519|101867456|FG005|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||12||
48625374|NCT02976519|101867457|FG006|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||12||
48625375|NCT02976519|101867451|FG000|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0||
48625376|NCT02976519|101867452|FG001|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||1||
48625377|NCT02976519|101867453|FG002|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0||
48625378|NCT02976519|101867454|FG003|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||1||
48625379|NCT02976519|101867455|FG004|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0||
48625380|NCT02976519|101867456|FG005|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0||
48625381|NCT02976519|101867457|FG006|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0||
48625382|NCT02976519|101867451|FG000|STARTED|Wash-out Period (Part 2 Only)||0||
48625383|NCT02976519|101867452|FG001|STARTED|Wash-out Period (Part 2 Only)||0||
48625384|NCT02976519|101867453|FG002|STARTED|Wash-out Period (Part 2 Only)||0||
48625385|NCT02976519|101867454|FG003|STARTED|Wash-out Period (Part 2 Only)||0||
48625386|NCT02976519|101867455|FG004|STARTED|Wash-out Period (Part 2 Only)||0||
48625387|NCT02976519|101867456|FG005|STARTED|Wash-out Period (Part 2 Only)||12||
48625388|NCT02976519|101867457|FG006|STARTED|Wash-out Period (Part 2 Only)||12||
48625389|NCT02976519|101867451|FG000|COMPLETED|Wash-out Period (Part 2 Only)||0||
48625390|NCT02976519|101867452|FG001|COMPLETED|Wash-out Period (Part 2 Only)||0||
48625391|NCT02976519|101867453|FG002|COMPLETED|Wash-out Period (Part 2 Only)||0||
48625392|NCT02976519|101867454|FG003|COMPLETED|Wash-out Period (Part 2 Only)||0||
48625393|NCT02976519|101867455|FG004|COMPLETED|Wash-out Period (Part 2 Only)||0||
48625394|NCT02976519|101867456|FG005|COMPLETED|Wash-out Period (Part 2 Only)||12||
48625395|NCT02976519|101867457|FG006|COMPLETED|Wash-out Period (Part 2 Only)||10||
48625396|NCT02976519|101867451|FG000|NOT COMPLETED|Wash-out Period (Part 2 Only)||0||
48625397|NCT02976519|101867452|FG001|NOT COMPLETED|Wash-out Period (Part 2 Only)||0||
48625398|NCT02976519|101867453|FG002|NOT COMPLETED|Wash-out Period (Part 2 Only)||0||
48625399|NCT02976519|101867454|FG003|NOT COMPLETED|Wash-out Period (Part 2 Only)||0||
48625400|NCT02976519|101867455|FG004|NOT COMPLETED|Wash-out Period (Part 2 Only)||0||
48625401|NCT02976519|101867456|FG005|NOT COMPLETED|Wash-out Period (Part 2 Only)||0||
48625402|NCT02976519|101867457|FG006|NOT COMPLETED|Wash-out Period (Part 2 Only)||2||
48625403|NCT02976519|101867451|FG000|STARTED|Treatment Period 2 (Part 2 Only)||0||
48625404|NCT02976519|101867452|FG001|STARTED|Treatment Period 2 (Part 2 Only)||0||
48625405|NCT02976519|101867453|FG002|STARTED|Treatment Period 2 (Part 2 Only)||0||
48625406|NCT02976519|101867454|FG003|STARTED|Treatment Period 2 (Part 2 Only)||0||
48625407|NCT02976519|101867455|FG004|STARTED|Treatment Period 2 (Part 2 Only)||0||
48625408|NCT02976519|101867456|FG005|STARTED|Treatment Period 2 (Part 2 Only)||12||
48625409|NCT02976519|101867457|FG006|STARTED|Treatment Period 2 (Part 2 Only)||10||
48625410|NCT02976519|101867451|FG000|COMPLETED|Treatment Period 2 (Part 2 Only)||0||
48625411|NCT02976519|101867452|FG001|COMPLETED|Treatment Period 2 (Part 2 Only)||0||
48625412|NCT02976519|101867453|FG002|COMPLETED|Treatment Period 2 (Part 2 Only)||0||
48625413|NCT02976519|101867454|FG003|COMPLETED|Treatment Period 2 (Part 2 Only)||0||
48625414|NCT02976519|101867455|FG004|COMPLETED|Treatment Period 2 (Part 2 Only)||0||
48748443|NCT04537793|102169574|FG000|STARTED|Part B (24 Weeks)||0||
48748444|NCT04537793|102169575|FG001|STARTED|Part B (24 Weeks)||75||
48748445|NCT04537793|102169574|FG000|COMPLETED|Part B (24 Weeks)||0||
48748446|NCT04537793|102169575|FG001|COMPLETED|Part B (24 Weeks)||74||
48748447|NCT04537793|102169574|FG000|NOT COMPLETED|Part B (24 Weeks)||0||
48748448|NCT04537793|102169575|FG001|NOT COMPLETED|Part B (24 Weeks)||1||
48748449|NCT01794000|102169576|FG000|STARTED|Double-Blind Phase (DBP)||171||
48748450|NCT01794000|102169577|FG001|STARTED|Double-Blind Phase (DBP)||170||
48748451|NCT01794000|102169576|FG000|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170||
48748452|NCT01794000|102169577|FG001|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170||
48748453|NCT01794000|102169576|FG000|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||169||
48748454|NCT01794000|102169577|FG001|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||166||
48748455|NCT01794000|102169576|FG000|COMPLETED|Double-Blind Phase (DBP)||2||
48748456|NCT01794000|102169577|FG001|COMPLETED|Double-Blind Phase (DBP)||4||
48748457|NCT01794000|102169576|FG000|NOT COMPLETED|Double-Blind Phase (DBP)||169||
48748458|NCT01794000|102169577|FG001|NOT COMPLETED|Double-Blind Phase (DBP)||166||
48748459|NCT01794000|102169576|FG000|STARTED|Open-Label Extension Phase (OLE)||3||
48748460|NCT01794000|102169577|FG001|STARTED|Open-Label Extension Phase (OLE)||0||
48748461|NCT01794000|102169576|FG000|COMPLETED|Open-Label Extension Phase (OLE)||0||
48748462|NCT01794000|102169577|FG001|COMPLETED|Open-Label Extension Phase (OLE)||0||
48625415|NCT02976519|101867456|FG005|COMPLETED|Treatment Period 2 (Part 2 Only)||12||
48625416|NCT02976519|101867457|FG006|COMPLETED|Treatment Period 2 (Part 2 Only)||9||
48625417|NCT02976519|101867451|FG000|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0||
48625418|NCT02976519|101867452|FG001|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0||
48625419|NCT02976519|101867453|FG002|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0||
48625420|NCT02976519|101867454|FG003|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0||
48625421|NCT02976519|101867455|FG004|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0||
48625422|NCT02976519|101867456|FG005|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0||
48625423|NCT02976519|101867457|FG006|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||1||
48625424|NCT01618968|101867458|FG000|STARTED|Overall Study||13||
48625425|NCT01618968|101867459|FG001|STARTED|Overall Study||12||
48625426|NCT01618968|101867460|FG002|STARTED|Overall Study||12||
48625427|NCT01618968|101867461|FG003|STARTED|Overall Study||12||
48625428|NCT01618968|101867458|FG000|Received Treatment A|Overall Study||12||
48625429|NCT01618968|101867459|FG001|Received Treatment A|Overall Study||12||
48625430|NCT01618968|101867460|FG002|Received Treatment A|Overall Study||12||
48625431|NCT01618968|101867461|FG003|Received Treatment A|Overall Study||11||
48625432|NCT01618968|101867458|FG000|Received Treatment B|Overall Study||13||
48625433|NCT01618968|101867459|FG001|Received Treatment B|Overall Study||12||
48625434|NCT01618968|101867460|FG002|Received Treatment B|Overall Study||12||
48625435|NCT01618968|101867461|FG003|Received Treatment B|Overall Study||12||
48625436|NCT01618968|101867458|FG000|Received Treatment C|Overall Study||12||
48625437|NCT01618968|101867459|FG001|Received Treatment C|Overall Study||12||
48625438|NCT01618968|101867460|FG002|Received Treatment C|Overall Study||12||
48625439|NCT01618968|101867461|FG003|Received Treatment C|Overall Study||11||
48625440|NCT01618968|101867458|FG000|COMPLETED|Overall Study||12||
48625441|NCT01618968|101867459|FG001|COMPLETED|Overall Study||12||
48625442|NCT01618968|101867460|FG002|COMPLETED|Overall Study||12||
48625443|NCT01618968|101867461|FG003|COMPLETED|Overall Study||11||
48625444|NCT01618968|101867458|FG000|NOT COMPLETED|Overall Study||1||
48625445|NCT01618968|101867459|FG001|NOT COMPLETED|Overall Study||0||
48625446|NCT01618968|101867460|FG002|NOT COMPLETED|Overall Study||0||
48625447|NCT01618968|101867461|FG003|NOT COMPLETED|Overall Study||1||
48331546|NCT00662792|101141684|FG001|NOT COMPLETED|Period 2||0||
48331547|NCT00662792|101141685|FG002|NOT COMPLETED|Period 2||0||
48331548|NCT00662792|101141686|FG003|NOT COMPLETED|Period 2||3||
48331549|NCT00662792|101141683|FG000|STARTED|Period 3||31||
48331550|NCT00662792|101141684|FG001|STARTED|Period 3||31||
48331551|NCT00662792|101141685|FG002|STARTED|Period 3||32||
48331552|NCT00662792|101141686|FG003|STARTED|Period 3||36||
48331553|NCT00662792|101141683|FG000|Treated|Period 3||31||
48331554|NCT00662792|101141684|FG001|Treated|Period 3||31||
48331555|NCT00662792|101141685|FG002|Treated|Period 3||32||
48331556|NCT00662792|101141686|FG003|Treated|Period 3||36||
48331557|NCT00662792|101141683|FG000|COMPLETED|Period 3||30|Not prematurely discontinued from study medication|
48331558|NCT00662792|101141684|FG001|COMPLETED|Period 3||31|Not prematurely discontinued from study medication|
48410845|NCT01511640|101337738|FG003|COMPLETED|Third Intervention (11-15 Days)||6||
48410846|NCT01511640|101337735|FG000|NOT COMPLETED|Third Intervention (11-15 Days)||1||
48410847|NCT01511640|101337736|FG001|NOT COMPLETED|Third Intervention (11-15 Days)||1||
48410848|NCT01511640|101337737|FG002|NOT COMPLETED|Third Intervention (11-15 Days)||0||
48410849|NCT01511640|101337738|FG003|NOT COMPLETED|Third Intervention (11-15 Days)||0||
48410850|NCT01563406|101337739|FG000|STARTED|Overall Study||60||
48410851|NCT01563406|101337740|FG001|STARTED|Overall Study||30||
48410852|NCT01563406|101337741|FG002|STARTED|Overall Study||30||
48410853|NCT01563406|101337742|FG003|STARTED|Overall Study||29||
48625448|NCT00828711|101867462|FG000|STARTED|Overall Study||118||
48625449|NCT00828711|101867463|FG001|STARTED|Overall Study||125||
48625450|NCT00828711|101867464|FG002|STARTED|Overall Study||131||
48625451|NCT00828711|101867462|FG000|COMPLETED|Overall Study||117||
48625452|NCT00828711|101867463|FG001|COMPLETED|Overall Study||125||
48625453|NCT00828711|101867464|FG002|COMPLETED|Overall Study||131||
48625454|NCT00828711|101867462|FG000|NOT COMPLETED|Overall Study||1||
48625455|NCT00828711|101867463|FG001|NOT COMPLETED|Overall Study||0||
48625456|NCT00828711|101867464|FG002|NOT COMPLETED|Overall Study||0||
48625457|NCT03817606|101867465|FG000|STARTED|Overall Study||2||
48625458|NCT03817606|101867466|FG001|STARTED|Overall Study||2||
48625459|NCT03817606|101867465|FG000|COMPLETED|Overall Study||0||
48625460|NCT03817606|101867466|FG001|COMPLETED|Overall Study||0||
48625461|NCT03817606|101867465|FG000|NOT COMPLETED|Overall Study||2||
48625462|NCT03817606|101867466|FG001|NOT COMPLETED|Overall Study||2||
48625463|NCT03638128|101867467|FG000|STARTED|Overall Study||21||
48625464|NCT03638128|101867468|FG001|STARTED|Overall Study||27||
48625465|NCT03638128|101867469|FG002|STARTED|Overall Study||27||
48625466|NCT03638128|101867467|FG000|COMPLETED|Overall Study||5||
48625467|NCT03638128|101867468|FG001|COMPLETED|Overall Study||8||
48625468|NCT03638128|101867469|FG002|COMPLETED|Overall Study||1||
48625469|NCT03638128|101867467|FG000|NOT COMPLETED|Overall Study||16||
48625470|NCT03638128|101867468|FG001|NOT COMPLETED|Overall Study||19||
48625471|NCT03638128|101867469|FG002|NOT COMPLETED|Overall Study||26||
48625472|NCT01959113|101867470|FG000|STARTED|Overall Study||5||10
48625473|NCT01959113|101867470|FG000|COMPLETED|Overall Study||5||10
48625474|NCT01959113|101867470|FG000|NOT COMPLETED|Overall Study||0||0
48625475|NCT01307787|101867471|FG000|STARTED|Overall Study||19||
48625476|NCT01307787|101867472|FG001|STARTED|Overall Study||15||
48625477|NCT01307787|101867471|FG000|T1= After 9 Weeks Post Intervention|Overall Study||18||
48625478|NCT01307787|101867472|FG001|T1= After 9 Weeks Post Intervention|Overall Study||15||
48625479|NCT01307787|101867471|FG000|T2= After 22 Weeks at Follow-up|Overall Study||17||
48625480|NCT01307787|101867472|FG001|T2= After 22 Weeks at Follow-up|Overall Study||15||
48625481|NCT01307787|101867471|FG000|COMPLETED|Overall Study||17||
48625482|NCT01307787|101867472|FG001|COMPLETED|Overall Study||15||
48625483|NCT01307787|101867471|FG000|NOT COMPLETED|Overall Study||2||
48625484|NCT01307787|101867472|FG001|NOT COMPLETED|Overall Study||0||
48625485|NCT00126594|101867473|FG000|STARTED|Overall Study||40||
48625486|NCT00126594|101867474|FG001|STARTED|Overall Study||40||
48625487|NCT00126594|101867473|FG000|COMPLETED|Overall Study||1||
48625488|NCT00126594|101867474|FG001|COMPLETED|Overall Study||3||
48625489|NCT00126594|101867473|FG000|NOT COMPLETED|Overall Study||39||
48625490|NCT00126594|101867474|FG001|NOT COMPLETED|Overall Study||37||
48625491|NCT01805895|101867475|FG000|STARTED|Overall Study||8||
48625492|NCT01805895|101867476|FG001|STARTED|Overall Study||8||
48331559|NCT00662792|101141685|FG002|COMPLETED|Period 3||30|Not prematurely discontinued from study medication|
48331560|NCT00662792|101141686|FG003|COMPLETED|Period 3||35|Not prematurely discontinued from study medication|
48410854|NCT01563406|101337739|FG000|COMPLETED|Overall Study||60||
48625493|NCT01805895|101867475|FG000|COMPLETED|Overall Study||8||
48625494|NCT01805895|101867476|FG001|COMPLETED|Overall Study||8||
48625495|NCT01805895|101867475|FG000|NOT COMPLETED|Overall Study||0||
48625496|NCT01805895|101867476|FG001|NOT COMPLETED|Overall Study||0||
48625497|NCT01774591|101867477|FG000|STARTED|Overall Study||10||
48625498|NCT01774591|101867478|FG001|STARTED|Overall Study||11||
48625499|NCT01774591|101867477|FG000|COMPLETED|Overall Study||9||
48625500|NCT01774591|101867478|FG001|COMPLETED|Overall Study||7||
48331561|NCT00662792|101141683|FG000|NOT COMPLETED|Period 3||1||
48331562|NCT00662792|101141684|FG001|NOT COMPLETED|Period 3||0||
48331563|NCT00662792|101141685|FG002|NOT COMPLETED|Period 3||2||
48331564|NCT00662792|101141686|FG003|NOT COMPLETED|Period 3||1||
48410855|NCT01563406|101337740|FG001|COMPLETED|Overall Study||30||
48625501|NCT01774591|101867477|FG000|NOT COMPLETED|Overall Study||1||
48625502|NCT01774591|101867478|FG001|NOT COMPLETED|Overall Study||4||
48625503|NCT01639352|101867479|FG000|STARTED|Overall Study||20||
48625504|NCT01639352|101867479|FG000|COMPLETED|Overall Study||20||
48625505|NCT01639352|101867479|FG000|NOT COMPLETED|Overall Study||0||
48625506|NCT02187783|101867480|FG000|STARTED|Overall Study||106||
48625507|NCT02187783|101867480|FG000|Patients With Solid Tumors|Overall Study||105||
48625508|NCT02187783|101867480|FG000|COMPLETED|Overall Study||0||
48625509|NCT02187783|101867480|FG000|NOT COMPLETED|Overall Study||106||
48625510|NCT02783170|101867481|FG000|STARTED|Overall Study||43||
48625511|NCT02783170|101867482|FG001|STARTED|Overall Study||38||
48748463|NCT01794000|102169576|FG000|NOT COMPLETED|Open-Label Extension Phase (OLE)||3||
48748464|NCT01794000|102169577|FG001|NOT COMPLETED|Open-Label Extension Phase (OLE)||0||
48748465|NCT02109640|102169578|FG000|STARTED|Overall Study||27||
48748466|NCT02109640|102169579|FG001|STARTED|Overall Study||23||
48748467|NCT02109640|102169578|FG000|COMPLETED|Overall Study||27||
48748468|NCT02109640|102169579|FG001|COMPLETED|Overall Study||23||
48748469|NCT02109640|102169578|FG000|NOT COMPLETED|Overall Study||0||
48748470|NCT02109640|102169579|FG001|NOT COMPLETED|Overall Study||0||
48748471|NCT02428192|102169580|FG000|STARTED|Overall Study||12||
48748472|NCT02428192|102169581|FG001|STARTED|Overall Study||8||
48748473|NCT02428192|102169580|FG000|COMPLETED|Overall Study||0||
48748474|NCT02428192|102169581|FG001|COMPLETED|Overall Study||7||
48748475|NCT02428192|102169580|FG000|NOT COMPLETED|Overall Study||12||
48748476|NCT02428192|102169581|FG001|NOT COMPLETED|Overall Study||1||
48748477|NCT01191723|102169582|FG000|STARTED|Overall Study||9||
48748478|NCT01191723|102169583|FG001|STARTED|Overall Study||9||
48748479|NCT01191723|102169584|FG002|STARTED|Overall Study||9||
48748480|NCT01191723|102169585|FG003|STARTED|Overall Study||9||
48748481|NCT01191723|102169586|FG004|STARTED|Overall Study||9||
48748482|NCT01191723|102169587|FG005|STARTED|Overall Study||9||
48748483|NCT01191723|102169582|FG000|COMPLETED|Overall Study||9||
48748484|NCT01191723|102169583|FG001|COMPLETED|Overall Study||9||
48748485|NCT01191723|102169584|FG002|COMPLETED|Overall Study||9||
48748486|NCT01191723|102169585|FG003|COMPLETED|Overall Study||9||
48748487|NCT01191723|102169586|FG004|COMPLETED|Overall Study||9||
48748488|NCT01191723|102169587|FG005|COMPLETED|Overall Study||9||
48748489|NCT01191723|102169582|FG000|NOT COMPLETED|Overall Study||0||
48748490|NCT01191723|102169583|FG001|NOT COMPLETED|Overall Study||0||
48748491|NCT01191723|102169584|FG002|NOT COMPLETED|Overall Study||0||
48748492|NCT01191723|102169585|FG003|NOT COMPLETED|Overall Study||0||
48748493|NCT01191723|102169586|FG004|NOT COMPLETED|Overall Study||0||
48748494|NCT01191723|102169587|FG005|NOT COMPLETED|Overall Study||0||
48748495|NCT01860287|102169588|FG000|STARTED|Overall Study||18||
48748496|NCT01860287|102169589|FG001|STARTED|Overall Study||15||
48748497|NCT01860287|102169590|FG002|STARTED|Overall Study||15||
48748498|NCT01860287|102169588|FG000|COMPLETED|Overall Study||18||
48748499|NCT01860287|102169589|FG001|COMPLETED|Overall Study||15||
48748500|NCT01860287|102169590|FG002|COMPLETED|Overall Study||15||
48748501|NCT01860287|102169588|FG000|NOT COMPLETED|Overall Study||0||
48748502|NCT01860287|102169589|FG001|NOT COMPLETED|Overall Study||0||
48748503|NCT01860287|102169590|FG002|NOT COMPLETED|Overall Study||0||
48748504|NCT00550953|102169591|FG000|STARTED|Overall Study||156||
48748505|NCT00550953|102169592|FG001|STARTED|Overall Study||158||
48748506|NCT00550953|102169591|FG000|COMPLETED|Overall Study||150||
48748507|NCT00550953|102169592|FG001|COMPLETED|Overall Study||152||
48167909|NCT02875834|100732453|FG003|COMPLETED|Randomized Treatment Phase||41||
48625512|NCT02783170|101867481|FG000|Safety Population|Overall Study||42||
48625513|NCT02783170|101867482|FG001|Safety Population|Overall Study||38||
48625514|NCT02783170|101867481|FG000|COMPLETED|Overall Study||42||
48625515|NCT02783170|101867482|FG001|COMPLETED|Overall Study||38||
48625516|NCT02783170|101867481|FG000|NOT COMPLETED|Overall Study||1||
48625517|NCT02783170|101867482|FG001|NOT COMPLETED|Overall Study||0||
48625518|NCT00528424|101867483|FG000|STARTED|Overall Study||286||
48625519|NCT00528424|101867483|FG000|COMPLETED|Overall Study||257||
48625520|NCT00528424|101867483|FG000|NOT COMPLETED|Overall Study||29||
48625521|NCT02456727|101867484|FG000|STARTED|Overall Study||389|Participants who were baselined and completed an oral consent.|
48625522|NCT02456727|101867485|FG001|STARTED|Overall Study||390|Participants who were baselined and completed an oral consent.|
48625523|NCT02456727|101867484|FG000|Initiated Treatment|Overall Study||346|Participants who signed the treatment consent form and attended at least one session of acupuncture.|
48625524|NCT02456727|101867485|FG001|Initiated Treatment|Overall Study||360|Participants who signed the treatment consent form and attended at least one session of acupuncture.|
48625525|NCT02456727|101867484|FG000|6 Week|Overall Study||298|Patients who completed the week 6 follow up questionnaires.|
48625526|NCT02456727|101867485|FG001|6 Week|Overall Study||320|Patients who completed the week 6 follow up questionnaires.|
48625527|NCT02456727|101867484|FG000|12 Week|Overall Study||295|Patients who completed the week 12 follow up questionnaires.|
48656962|NCT01340170|101943735|FG001|COMPLETED|Overall Study||79|ITT population|91
48748508|NCT00550953|102169591|FG000|NOT COMPLETED|Overall Study||6||
48748509|NCT00550953|102169592|FG001|NOT COMPLETED|Overall Study||6||
48748510|NCT02163824|102169593|FG000|STARTED|Overall Study||129||
48748511|NCT02163824|102169594|FG001|STARTED|Overall Study||125||
48748512|NCT02163824|102169595|FG002|STARTED|Overall Study||126||
48748513|NCT02163824|102169593|FG000|COMPLETED|Overall Study||127||
48748514|NCT02163824|102169594|FG001|COMPLETED|Overall Study||124||
48748515|NCT02163824|102169595|FG002|COMPLETED|Overall Study||124||
48748516|NCT02163824|102169593|FG000|NOT COMPLETED|Overall Study||2||
48748517|NCT02163824|102169594|FG001|NOT COMPLETED|Overall Study||1||
48748518|NCT02163824|102169595|FG002|NOT COMPLETED|Overall Study||2||
48748519|NCT02730728|102169596|FG000|STARTED|Overall Study||53||
48748520|NCT02730728|102169597|FG001|STARTED|Overall Study||53||
48748521|NCT02730728|102169598|FG002|STARTED|Overall Study||53||
48748522|NCT02730728|102169596|FG000|COMPLETED|Overall Study||53||
48748523|NCT02730728|102169597|FG001|COMPLETED|Overall Study||51||
48748524|NCT02730728|102169598|FG002|COMPLETED|Overall Study||52||
48748525|NCT02730728|102169596|FG000|NOT COMPLETED|Overall Study||0||
48748526|NCT02730728|102169597|FG001|NOT COMPLETED|Overall Study||2||
48748527|NCT02730728|102169598|FG002|NOT COMPLETED|Overall Study||1||
48748528|NCT01879683|102169599|FG000|STARTED|Overall Study||10||
48748529|NCT01879683|102169599|FG000|COMPLETED|Overall Study||9||
48748530|NCT01879683|102169599|FG000|NOT COMPLETED|Overall Study||1||
48748531|NCT01023711|102169600|FG000|STARTED|Overall Study||107||
48748532|NCT01023711|102169600|FG000|COMPLETED|Overall Study||107||
48748533|NCT01023711|102169600|FG000|NOT COMPLETED|Overall Study||0||
48748534|NCT01751984|102169601|FG000|STARTED|Overall Study||37||
48748535|NCT01751984|102169602|FG001|STARTED|Overall Study||19||
48748536|NCT01751984|102169601|FG000|COMPLETED|Overall Study||31||
48748537|NCT01751984|102169602|FG001|COMPLETED|Overall Study||15||
48748538|NCT01751984|102169601|FG000|NOT COMPLETED|Overall Study||6||
48748539|NCT01751984|102169602|FG001|NOT COMPLETED|Overall Study||4||
48748540|NCT01546857|102169603|FG000|STARTED|Overall Study||14||
48748541|NCT01546857|102169604|FG001|STARTED|Overall Study||20||
48748542|NCT01546857|102169603|FG000|COMPLETED|Overall Study||12||
48748543|NCT01546857|102169604|FG001|COMPLETED|Overall Study||17||
48748544|NCT01546857|102169603|FG000|NOT COMPLETED|Overall Study||2||
48748545|NCT01546857|102169604|FG001|NOT COMPLETED|Overall Study||3||
48748546|NCT02631551|102169605|FG000|STARTED|Overall Study||302||
48748547|NCT02631551|102169606|FG001|STARTED|Overall Study||297||
48167910|NCT02875834|100732450|FG000|NOT COMPLETED|Randomized Treatment Phase||0||
48167911|NCT02875834|100732451|FG001|NOT COMPLETED|Randomized Treatment Phase||14||
48748548|NCT02631551|102169607|FG002|STARTED|Overall Study||294||
48748549|NCT02631551|102169608|FG003|STARTED|Overall Study||287||
48748550|NCT02631551|102169605|FG000|COMPLETED|Overall Study||289||
48748551|NCT02631551|102169606|FG001|COMPLETED|Overall Study||278||
48748552|NCT02631551|102169607|FG002|COMPLETED|Overall Study||283||
48748553|NCT02631551|102169608|FG003|COMPLETED|Overall Study||276||
48748554|NCT02631551|102169605|FG000|NOT COMPLETED|Overall Study||13||
48748555|NCT02631551|102169606|FG001|NOT COMPLETED|Overall Study||19||
48748556|NCT02631551|102169607|FG002|NOT COMPLETED|Overall Study||11||
48748557|NCT02631551|102169608|FG003|NOT COMPLETED|Overall Study||11||
48625528|NCT02456727|101867485|FG001|12 Week|Overall Study||310|Patients who completed the week 12 follow up questionnaires.|
48625529|NCT02456727|101867484|FG000|24 Week|Overall Study||280|Patients who completed the week 24 follow up questionnaires.|
48625530|NCT02456727|101867485|FG001|24 Week|Overall Study||284|Patients who completed the week 24 follow up questionnaires.|
48625531|NCT02456727|101867484|FG000|COMPLETED|Overall Study||280||
48625532|NCT02456727|101867485|FG001|COMPLETED|Overall Study||284||
48625533|NCT02456727|101867484|FG000|NOT COMPLETED|Overall Study||109||
48625534|NCT02456727|101867485|FG001|NOT COMPLETED|Overall Study||106||
48625535|NCT03080935|101867486|FG000|STARTED|Overall Study||745||
48625536|NCT03080935|101867487|FG001|STARTED|Overall Study||855||
48625537|NCT03080935|101867486|FG000|COMPLETED|Overall Study||695||
48167912|NCT02875834|100732452|FG002|NOT COMPLETED|Randomized Treatment Phase||11||
48167913|NCT02875834|100732453|FG003|NOT COMPLETED|Randomized Treatment Phase||9||
48167914|NCT03086018|100732454|FG000|STARTED|Field Testing||30||
48167915|NCT03086018|100732454|FG000|COMPLETED|Field Testing||30||
48167916|NCT03086018|100732454|FG000|NOT COMPLETED|Field Testing||0||
48167917|NCT03086018|100732454|FG000|STARTED|Final Testing for End of Trial||30||
48167918|NCT03086018|100732454|FG000|COMPLETED|Final Testing for End of Trial||28||
48167919|NCT03086018|100732454|FG000|NOT COMPLETED|Final Testing for End of Trial||2||
48167920|NCT03607825|100732455|FG000|STARTED|Overall Study||33||
48167921|NCT03607825|100732455|FG000|COMPLETED|Overall Study||33||
48625538|NCT03080935|101867487|FG001|COMPLETED|Overall Study||786||
48625539|NCT03080935|101867486|FG000|NOT COMPLETED|Overall Study||50||
48625540|NCT03080935|101867487|FG001|NOT COMPLETED|Overall Study||69||
48625541|NCT00671788|101867488|FG000|STARTED|Overall Study||35||
48625542|NCT00671788|101867488|FG000|COMPLETED|Overall Study||21||
48625543|NCT00671788|101867488|FG000|NOT COMPLETED|Overall Study||14||
48625544|NCT01085643|101867489|FG000|STARTED|Overall Study||4||
48625545|NCT01085643|101867489|FG000|COMPLETED|Overall Study||4||
48625546|NCT01085643|101867489|FG000|NOT COMPLETED|Overall Study||0||
48625547|NCT01053741|101867490|FG000|STARTED|1st Intervention||5||
48625548|NCT01053741|101867491|FG001|STARTED|1st Intervention||6||
48625549|NCT01053741|101867490|FG000|COMPLETED|1st Intervention||5||
48625550|NCT01053741|101867491|FG001|COMPLETED|1st Intervention||6||
48625551|NCT01053741|101867490|FG000|NOT COMPLETED|1st Intervention||0||
48625552|NCT01053741|101867491|FG001|NOT COMPLETED|1st Intervention||0||
48625553|NCT01053741|101867490|FG000|STARTED|14 Day Washout||5||
48625554|NCT01053741|101867491|FG001|STARTED|14 Day Washout||6||
48625555|NCT01053741|101867490|FG000|COMPLETED|14 Day Washout||5||
48625556|NCT01053741|101867491|FG001|COMPLETED|14 Day Washout||6||
48625557|NCT01053741|101867490|FG000|NOT COMPLETED|14 Day Washout||0||
48625558|NCT01053741|101867491|FG001|NOT COMPLETED|14 Day Washout||0||
48167922|NCT03607825|100732455|FG000|NOT COMPLETED|Overall Study||0||
48167923|NCT01751230|100732456|FG000|STARTED|Overall Study||20||
48167924|NCT01751230|100732457|FG001|STARTED|Overall Study||20||
48167925|NCT01751230|100732456|FG000|COMPLETED|Overall Study||19||
48167926|NCT01751230|100732457|FG001|COMPLETED|Overall Study||16||
48167927|NCT01751230|100732456|FG000|NOT COMPLETED|Overall Study||1||
48167928|NCT01751230|100732457|FG001|NOT COMPLETED|Overall Study||4||
48167929|NCT03556358|100732458|FG000|STARTED|Overall Study||404||
48167930|NCT03556358|100732459|FG001|STARTED|Overall Study||405||
48167931|NCT03556358|100732458|FG000|Subjects Treated|Overall Study||401|Treated: Subjects treated with epirubicin and /or cyclophosphamide in cycle 1.|
48167932|NCT03556358|100732459|FG001|Subjects Treated|Overall Study||405|Treated: Subjects treated with epirubicin and /or cyclophosphamide in cycle 1.|
48167933|NCT03556358|100732458|FG000|Subjects Receiving TX05 or Herceptin|Overall Study||394|TX05 or Herceptin was received at Cycle 5|
48167934|NCT03556358|100732459|FG001|Subjects Receiving TX05 or Herceptin|Overall Study||400|TX05 or Herceptin was received at Cycle 5|
48167935|NCT03556358|100732458|FG000|COMPLETED|Overall Study||393||
48167936|NCT03556358|100732459|FG001|COMPLETED|Overall Study||393||
48167937|NCT03556358|100732458|FG000|NOT COMPLETED|Overall Study||11||
48167938|NCT03556358|100732459|FG001|NOT COMPLETED|Overall Study||12||
48625559|NCT01053741|101867490|FG000|STARTED|2nd Study Intervention||5||
48625560|NCT01053741|101867491|FG001|STARTED|2nd Study Intervention||6||
48625561|NCT01053741|101867490|FG000|COMPLETED|2nd Study Intervention||5||
48625562|NCT01053741|101867491|FG001|COMPLETED|2nd Study Intervention||5||
48625563|NCT01053741|101867490|FG000|NOT COMPLETED|2nd Study Intervention||0||
48625564|NCT01053741|101867491|FG001|NOT COMPLETED|2nd Study Intervention||1||
48625565|NCT02643875|101867492|FG000|STARTED|Overall Study||36||72
48625566|NCT02643875|101867492|FG000|Received 0.75|Overall Study||36||36
48625567|NCT02643875|101867492|FG000|Received 1.75 D|Overall Study||36||36
48625568|NCT02643875|101867492|FG000|COMPLETED|Overall Study||28||56
48167939|NCT02961881|100732460|FG000|STARTED|Overall Study||7||
48625569|NCT02643875|101867492|FG000|NOT COMPLETED|Overall Study||8||16
48625570|NCT01499810|101867493|FG000|STARTED|Overall Study||53||
48625571|NCT01499810|101867493|FG000|COMPLETED|Overall Study||41||
48625572|NCT01499810|101867493|FG000|NOT COMPLETED|Overall Study||12||
48625573|NCT02175121|101867494|FG000|STARTED|Overall Study||34||
48167940|NCT02961881|100732461|FG001|STARTED|Overall Study||8||
48167941|NCT02961881|100732462|FG002|STARTED|Overall Study||8||
48167942|NCT02961881|100732463|FG003|STARTED|Overall Study||6||
48167943|NCT02961881|100732464|FG004|STARTED|Overall Study||6||
48625574|NCT02175121|101867495|FG001|STARTED|Overall Study||35||
48625575|NCT02175121|101867496|FG002|STARTED|Overall Study||34||
48625576|NCT02175121|101867497|FG003|STARTED|Overall Study||35||
48625577|NCT02175121|101867498|FG004|STARTED|Overall Study||34||
48625578|NCT02175121|101867494|FG000|COMPLETED|Overall Study||33||
48625579|NCT02175121|101867495|FG001|COMPLETED|Overall Study||34||
48625580|NCT02175121|101867496|FG002|COMPLETED|Overall Study||32||
48625581|NCT02175121|101867497|FG003|COMPLETED|Overall Study||34||
48625582|NCT02175121|101867498|FG004|COMPLETED|Overall Study||33||
48625583|NCT02175121|101867494|FG000|NOT COMPLETED|Overall Study||1||
48625584|NCT02175121|101867495|FG001|NOT COMPLETED|Overall Study||1||
48625585|NCT02175121|101867496|FG002|NOT COMPLETED|Overall Study||2||
48625586|NCT02175121|101867497|FG003|NOT COMPLETED|Overall Study||1||
48625587|NCT02175121|101867498|FG004|NOT COMPLETED|Overall Study||1||
48625588|NCT00823134|101867499|FG000|STARTED|Overall Study||23||
48625589|NCT00823134|101867499|FG000|COMPLETED|Overall Study||22||
48625590|NCT00823134|101867499|FG000|NOT COMPLETED|Overall Study||1||
48625591|NCT02373865|101867500|FG000|STARTED|Overall Study||2||
48625592|NCT02373865|101867501|FG001|STARTED|Overall Study||2||
48625593|NCT02373865|101867500|FG000|COMPLETED|Overall Study||2||
48625594|NCT02373865|101867501|FG001|COMPLETED|Overall Study||2||
48625595|NCT02373865|101867500|FG000|NOT COMPLETED|Overall Study||0||
48625596|NCT02373865|101867501|FG001|NOT COMPLETED|Overall Study||0||
48625597|NCT03217591|101867502|FG000|STARTED|Overall Study||54||
48625598|NCT03217591|101867503|FG001|STARTED|Overall Study||50||
48625599|NCT03217591|101867504|FG002|STARTED|Overall Study||52||
48625600|NCT03217591|101867502|FG000|COMPLETED|Overall Study||51||
48625601|NCT03217591|101867503|FG001|COMPLETED|Overall Study||47||
48748558|NCT03043885|102169609|FG000|STARTED|Overall Study||10||
48748559|NCT03043885|102169610|FG001|STARTED|Overall Study||10||
48748560|NCT03043885|102169611|FG002|STARTED|Overall Study||10||
48748561|NCT03043885|102169612|FG003|STARTED|Overall Study||10||
48748562|NCT03043885|102169609|FG000|COMPLETED|Overall Study||10||
48748563|NCT03043885|102169610|FG001|COMPLETED|Overall Study||10||
48748564|NCT03043885|102169611|FG002|COMPLETED|Overall Study||10||
48748565|NCT03043885|102169612|FG003|COMPLETED|Overall Study||10||
48748566|NCT03043885|102169609|FG000|NOT COMPLETED|Overall Study||0||
48625602|NCT03217591|101867504|FG002|COMPLETED|Overall Study||42||
48625603|NCT03217591|101867502|FG000|NOT COMPLETED|Overall Study||3||
48625604|NCT03217591|101867503|FG001|NOT COMPLETED|Overall Study||3||
48625605|NCT03217591|101867504|FG002|NOT COMPLETED|Overall Study||10||
48625606|NCT02163395|101867505|FG000|STARTED|Overall Study||44||
48625607|NCT02163395|101867505|FG000|COMPLETED|Overall Study||39||
48625608|NCT02163395|101867505|FG000|NOT COMPLETED|Overall Study||5||
48625609|NCT01507350|101867506|FG000|STARTED|Overall Study||9||
48625610|NCT01507350|101867506|FG000|COMPLETED|Overall Study||9||
48625611|NCT01507350|101867506|FG000|NOT COMPLETED|Overall Study||0||
48625612|NCT01494818|101867507|FG000|STARTED|Overall Study||39||
48625613|NCT01494818|101867508|FG001|STARTED|Overall Study||39||
48625614|NCT01494818|101867507|FG000|COMPLETED|Overall Study||37||
48625615|NCT01494818|101867508|FG001|COMPLETED|Overall Study||37||
48625616|NCT01494818|101867507|FG000|NOT COMPLETED|Overall Study||2||
48625617|NCT01494818|101867508|FG001|NOT COMPLETED|Overall Study||2||
48625618|NCT01460303|101867509|FG000|STARTED|Overall Study||25||
48625619|NCT01460303|101867510|FG001|STARTED|Overall Study||24||
48625620|NCT01460303|101867509|FG000|COMPLETED|Overall Study||25||
48625621|NCT01460303|101867510|FG001|COMPLETED|Overall Study||24||
48625622|NCT01460303|101867509|FG000|NOT COMPLETED|Overall Study||0||
48625623|NCT01460303|101867510|FG001|NOT COMPLETED|Overall Study||0||
48625624|NCT01198002|101867511|FG000|STARTED|Treatment Period 1 (Weeks 0-52)||345||
48625625|NCT01198002|101867512|FG001|STARTED|Treatment Period 1 (Weeks 0-52)||347||
48625626|NCT01198002|101867513|FG002|STARTED|Treatment Period 1 (Weeks 0-52)||349||
48625627|NCT01198002|101867511|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345||
48625628|NCT01198002|101867512|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345||
48625629|NCT01198002|101867513|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||348||
48625630|NCT01198002|101867511|FG000|Week 16 NR|Treatment Period 1 (Weeks 0-52)||58||
48625631|NCT01198002|101867512|FG001|Week 16 NR|Treatment Period 1 (Weeks 0-52)||62||
48748567|NCT03043885|102169610|FG001|NOT COMPLETED|Overall Study||0||
48748568|NCT03043885|102169611|FG002|NOT COMPLETED|Overall Study||0||
48748569|NCT03043885|102169612|FG003|NOT COMPLETED|Overall Study||0||
48625632|NCT01198002|101867513|FG002|Week 16 NR|Treatment Period 1 (Weeks 0-52)||90||
48625633|NCT01198002|101867511|FG000|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||293||
48625634|NCT01198002|101867512|FG001|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||303||
48625635|NCT01198002|101867513|FG002|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||307||
48625636|NCT01198002|101867511|FG000|COMPLETED|Treatment Period 1 (Weeks 0-52)||70||
48625637|NCT01198002|101867512|FG001|COMPLETED|Treatment Period 1 (Weeks 0-52)||73||
48625638|NCT01198002|101867513|FG002|COMPLETED|Treatment Period 1 (Weeks 0-52)||80||
48625639|NCT01198002|101867511|FG000|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||275||
48625640|NCT01198002|101867512|FG001|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||274||
48625641|NCT01198002|101867513|FG002|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||269||
48625642|NCT01198002|101867511|FG000|STARTED|Treatment Period 2 (Weeks 52-100)||70||
48625643|NCT01198002|101867512|FG001|STARTED|Treatment Period 2 (Weeks 52-100)||73||
48625644|NCT01198002|101867513|FG002|STARTED|Treatment Period 2 (Weeks 52-100)||80||
48625645|NCT01198002|101867511|FG000|COMPLETED|Treatment Period 2 (Weeks 52-100)||1||
48625646|NCT01198002|101867512|FG001|COMPLETED|Treatment Period 2 (Weeks 52-100)||0||
48625647|NCT01198002|101867513|FG002|COMPLETED|Treatment Period 2 (Weeks 52-100)||2||
48167944|NCT02961881|100732460|FG000|Started Week 4 SC Dosing|Overall Study||6||
48167945|NCT02961881|100732461|FG001|Started Week 4 SC Dosing|Overall Study||7||
48167946|NCT02961881|100732462|FG002|Started Week 4 SC Dosing|Overall Study||7||
48167947|NCT02961881|100732463|FG003|Started Week 4 SC Dosing|Overall Study||6||
48167948|NCT02961881|100732464|FG004|Started Week 4 SC Dosing|Overall Study||5||
48167949|NCT02961881|100732460|FG000|Started Week 5-6 cIV Dosing|Overall Study||6||
48167950|NCT02961881|100732461|FG001|Started Week 5-6 cIV Dosing|Overall Study||5||
48167951|NCT02961881|100732462|FG002|Started Week 5-6 cIV Dosing|Overall Study||6||
48167952|NCT02961881|100732463|FG003|Started Week 5-6 cIV Dosing|Overall Study||6||
48167953|NCT02961881|100732464|FG004|Started Week 5-6 cIV Dosing|Overall Study||5||
48167954|NCT02961881|100732460|FG000|COMPLETED|Overall Study||5|Participants who completed investigational product|
48167955|NCT02961881|100732461|FG001|COMPLETED|Overall Study||4|Participants who completed investigational product|
48167956|NCT02961881|100732462|FG002|COMPLETED|Overall Study||5|Participants who completed investigational product|
48167957|NCT02961881|100732463|FG003|COMPLETED|Overall Study||6|Participants who completed investigational product|
48167958|NCT02961881|100732464|FG004|COMPLETED|Overall Study||5|Participants who completed investigational product|
48167959|NCT02961881|100732460|FG000|NOT COMPLETED|Overall Study||2||
48167960|NCT02961881|100732461|FG001|NOT COMPLETED|Overall Study||4||
48167961|NCT02961881|100732462|FG002|NOT COMPLETED|Overall Study||3||
48167962|NCT02961881|100732463|FG003|NOT COMPLETED|Overall Study||0||
48167963|NCT02961881|100732464|FG004|NOT COMPLETED|Overall Study||1||
48167964|NCT01126060|100735632|FG000|STARTED|Overall Study||40||
48167965|NCT01126060|100735633|FG001|STARTED|Overall Study||40||
48167966|NCT01126060|100735632|FG000|COMPLETED|Overall Study||40||
48167967|NCT01126060|100735633|FG001|COMPLETED|Overall Study||38||
48625648|NCT01198002|101867511|FG000|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||69||
48625649|NCT01198002|101867512|FG001|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||73||
48625650|NCT01198002|101867513|FG002|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||78||
48625651|NCT03657069|101867514|FG000|STARTED|Overall Study||11||22
48625652|NCT03657069|101867514|FG000|COMPLETED|Overall Study||11||22
48625653|NCT03657069|101867514|FG000|NOT COMPLETED|Overall Study||0||0
48625654|NCT04553666|101867515|FG000|STARTED|Overall Study||7||
48625655|NCT04553666|101867516|FG001|STARTED|Overall Study||7||
48625656|NCT04553666|101867515|FG000|COMPLETED|Overall Study||7||
48625657|NCT04553666|101867516|FG001|COMPLETED|Overall Study||7||
48625658|NCT04553666|101867515|FG000|NOT COMPLETED|Overall Study||0||
48625659|NCT04553666|101867516|FG001|NOT COMPLETED|Overall Study||0||
48625660|NCT01064414|101867517|FG000|STARTED|Core Period: Baseline to Week 26||90||
48625661|NCT01064414|101867518|FG001|STARTED|Core Period: Baseline to Week 26||90||
48625662|NCT01064414|101867519|FG002|STARTED|Core Period: Baseline to Week 26||89||
48167968|NCT01126060|100735632|FG000|NOT COMPLETED|Overall Study||0||
48167969|NCT01126060|100735633|FG001|NOT COMPLETED|Overall Study||2||
48167970|NCT00750282|100735634|FG000|STARTED|Overall Study||69||
48167971|NCT00750282|100735635|FG001|STARTED|Overall Study||82||
48167972|NCT00750282|100735636|FG002|STARTED|Overall Study||126||
48167973|NCT00750282|100735637|FG003|STARTED|Overall Study||148||
48167974|NCT00750282|100735634|FG000|COMPLETED|Overall Study||69||
48167975|NCT00750282|100735635|FG001|COMPLETED|Overall Study||81||
48167976|NCT00750282|100735636|FG002|COMPLETED|Overall Study||125||
48167977|NCT00750282|100735637|FG003|COMPLETED|Overall Study||147||
48167978|NCT00750282|100735634|FG000|NOT COMPLETED|Overall Study||0||
48167979|NCT00750282|100735635|FG001|NOT COMPLETED|Overall Study||1||
48167980|NCT00750282|100735636|FG002|NOT COMPLETED|Overall Study||1||
48167981|NCT00750282|100735637|FG003|NOT COMPLETED|Overall Study||1||
48167982|NCT01233609|100735638|FG000|STARTED|Overall Study||46||
48167983|NCT01233609|100735639|FG001|STARTED|Overall Study||44||
48167984|NCT01233609|100735638|FG000|COMPLETED|Overall Study||37||
48625663|NCT01064414|101867517|FG000|COMPLETED|Core Period: Baseline to Week 26||77||
48625664|NCT01064414|101867518|FG001|COMPLETED|Core Period: Baseline to Week 26||75||
48167985|NCT01233609|100735639|FG001|COMPLETED|Overall Study||42||
48167986|NCT01233609|100735638|FG000|NOT COMPLETED|Overall Study||9||
48167987|NCT01233609|100735639|FG001|NOT COMPLETED|Overall Study||2||
48167988|NCT02768558|100735640|FG000|STARTED|Overall Study||3||
48167989|NCT02768558|100735641|FG001|STARTED|Overall Study||5||
48748570|NCT03621657|102169613|FG000|STARTED|Overall Study||0||
48748571|NCT03621657|102169614|FG001|STARTED|Overall Study||0||
48748572|NCT03621657|102169615|FG002|STARTED|Overall Study||1||
48748573|NCT03621657|102169613|FG000|COMPLETED|Overall Study||0||
48748574|NCT03621657|102169614|FG001|COMPLETED|Overall Study||0||
48748575|NCT03621657|102169615|FG002|COMPLETED|Overall Study||1||
48748576|NCT03621657|102169613|FG000|NOT COMPLETED|Overall Study||0||
48748577|NCT03621657|102169614|FG001|NOT COMPLETED|Overall Study||0||
48748578|NCT03621657|102169615|FG002|NOT COMPLETED|Overall Study||0||
48748579|NCT00740207|102169616|FG000|STARTED|Overall Study||17||
48748580|NCT00740207|102169617|FG001|STARTED|Overall Study||16||
48748581|NCT00740207|102169616|FG000|COMPLETED|Overall Study||17||
48748582|NCT00740207|102169617|FG001|COMPLETED|Overall Study||16||
48748583|NCT00740207|102169616|FG000|NOT COMPLETED|Overall Study||0||
48748584|NCT00740207|102169617|FG001|NOT COMPLETED|Overall Study||0||
48167990|NCT02768558|100735640|FG000|Eligible|Overall Study||3|Participants contributing data to results are considered to have completed the study|
48167991|NCT02768558|100735641|FG001|Eligible|Overall Study||5|Participants contributing data to results are considered to have completed the study|
48167992|NCT02768558|100735640|FG000|COMPLETED|Overall Study||3||
48167993|NCT02768558|100735641|FG001|COMPLETED|Overall Study||5||
48167994|NCT02768558|100735640|FG000|NOT COMPLETED|Overall Study||0||
48167995|NCT02768558|100735641|FG001|NOT COMPLETED|Overall Study||0||
48167996|NCT02667886|100735642|FG000|STARTED|Dose Escalation (Part A)||3||
48167997|NCT02667886|100735643|FG001|STARTED|Dose Escalation (Part A)||7||
48167998|NCT02667886|100735644|FG002|STARTED|Dose Escalation (Part A)||6||
48167999|NCT02667886|100735645|FG003|STARTED|Dose Escalation (Part A)||0||
48168000|NCT02667886|100735646|FG004|STARTED|Dose Escalation (Part A)||0||
48168001|NCT02667886|100735642|FG000|Received at Least 1 Dose of Study Drug|Dose Escalation (Part A)||3||
48168002|NCT02667886|100735643|FG001|Received at Least 1 Dose of Study Drug|Dose Escalation (Part A)||7||
48168003|NCT02667886|100735644|FG002|Received at Least 1 Dose of Study Drug|Dose Escalation (Part A)||6||
48168004|NCT02667886|100735645|FG003|Received at Least 1 Dose of Study Drug|Dose Escalation (Part A)||0||
48168005|NCT02667886|100735646|FG004|Received at Least 1 Dose of Study Drug|Dose Escalation (Part A)||0||
48168006|NCT02667886|100735642|FG000|COMPLETED|Dose Escalation (Part A)||1||
48625665|NCT01064414|101867519|FG002|COMPLETED|Core Period: Baseline to Week 26||82||
48625666|NCT01064414|101867517|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||13||
48625667|NCT01064414|101867518|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||15||
48625668|NCT01064414|101867519|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||7||
48625669|NCT01064414|101867517|FG000|STARTED|Extension Period: Week 26 to Week 52||76||
48625670|NCT01064414|101867518|FG001|STARTED|Extension Period: Week 26 to Week 52||72||
48625671|NCT01064414|101867519|FG002|STARTED|Extension Period: Week 26 to Week 52||81||
48625672|NCT01064414|101867517|FG000|COMPLETED|Extension Period: Week 26 to Week 52||64||
48625673|NCT01064414|101867518|FG001|COMPLETED|Extension Period: Week 26 to Week 52||67||
48625674|NCT01064414|101867519|FG002|COMPLETED|Extension Period: Week 26 to Week 52||76||
48625675|NCT01064414|101867517|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||12||
48625676|NCT01064414|101867518|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||5||
48625677|NCT01064414|101867519|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||5||
48625678|NCT05081388|101867520|FG000|STARTED|Overall Study||4||
48625679|NCT05081388|101867521|FG001|STARTED|Overall Study||5||
48625680|NCT05081388|101867522|FG002|STARTED|Overall Study||6||
48625681|NCT05081388|101867523|FG003|STARTED|Overall Study||6||
48625682|NCT05081388|101867524|FG004|STARTED|Overall Study||4||
48625683|NCT05081388|101867520|FG000|COMPLETED|Overall Study||3||
48625684|NCT05081388|101867521|FG001|COMPLETED|Overall Study||4||
48625685|NCT05081388|101867522|FG002|COMPLETED|Overall Study||6||
48748585|NCT00721396|102169618|FG000|STARTED|Overall Study||627||
48748586|NCT00721396|102169619|FG001|STARTED|Overall Study||628||
48748587|NCT00721396|102169620|FG002|STARTED|Overall Study||318||
48748588|NCT00721396|102169621|FG003|STARTED|Overall Study||312||
48168007|NCT02667886|100735643|FG001|COMPLETED|Dose Escalation (Part A)||0||
48168008|NCT02667886|100735644|FG002|COMPLETED|Dose Escalation (Part A)||0||
48168009|NCT02667886|100735645|FG003|COMPLETED|Dose Escalation (Part A)||0||
48168010|NCT02667886|100735646|FG004|COMPLETED|Dose Escalation (Part A)||0||
48168011|NCT02667886|100735642|FG000|NOT COMPLETED|Dose Escalation (Part A)||2||
48168012|NCT02667886|100735643|FG001|NOT COMPLETED|Dose Escalation (Part A)||7||
48625686|NCT05081388|101867523|FG003|COMPLETED|Overall Study||5||
48168013|NCT02667886|100735644|FG002|NOT COMPLETED|Dose Escalation (Part A)||6||
48625687|NCT05081388|101867524|FG004|COMPLETED|Overall Study||4||
48625688|NCT05081388|101867520|FG000|NOT COMPLETED|Overall Study||1||
48748589|NCT00721396|102169618|FG000|COMPLETED|Overall Study||597||
48748590|NCT00721396|102169619|FG001|COMPLETED|Overall Study||592||
48748591|NCT00721396|102169620|FG002|COMPLETED|Overall Study||308||
48748592|NCT00721396|102169621|FG003|COMPLETED|Overall Study||302||
48748593|NCT00721396|102169618|FG000|NOT COMPLETED|Overall Study||30||
48748594|NCT00721396|102169619|FG001|NOT COMPLETED|Overall Study||36||
48625689|NCT05081388|101867521|FG001|NOT COMPLETED|Overall Study||1||
48625690|NCT05081388|101867522|FG002|NOT COMPLETED|Overall Study||0||
48625691|NCT05081388|101867523|FG003|NOT COMPLETED|Overall Study||1||
48625692|NCT05081388|101867524|FG004|NOT COMPLETED|Overall Study||0||
48625693|NCT00726609|101867525|FG000|STARTED|Overall Study||214||
48625694|NCT00726609|101867525|FG000|COMPLETED|Overall Study||116||
48625695|NCT00726609|101867525|FG000|NOT COMPLETED|Overall Study||98||
48625696|NCT01791985|101867526|FG000|STARTED|Overall Study||52||
48168014|NCT02667886|100735645|FG003|NOT COMPLETED|Dose Escalation (Part A)||0||
48625697|NCT01791985|101867526|FG000|COMPLETED|Overall Study||44||
48625698|NCT01791985|101867526|FG000|NOT COMPLETED|Overall Study||8||
48625699|NCT02389959|101867527|FG000|STARTED|Overall Study||20||
48625700|NCT02389959|101867528|FG001|STARTED|Overall Study||20||
48625701|NCT02389959|101867527|FG000|COMPLETED|Overall Study||18||
48625702|NCT02389959|101867528|FG001|COMPLETED|Overall Study||19||
48168015|NCT02667886|100735646|FG004|NOT COMPLETED|Dose Escalation (Part A)||0||
48168016|NCT02667886|100735642|FG000|STARTED|Dose Expansion (Part B)||0||
48168017|NCT02667886|100735643|FG001|STARTED|Dose Expansion (Part B)||0||
48748595|NCT00721396|102169620|FG002|NOT COMPLETED|Overall Study||10||
48748596|NCT00721396|102169621|FG003|NOT COMPLETED|Overall Study||10||
48748597|NCT02807623|102169622|FG000|STARTED|Overall Study||98||
48748598|NCT02807623|102169623|FG001|STARTED|Overall Study||100||
48748599|NCT02807623|102169624|FG002|STARTED|Overall Study||102||
48748600|NCT02807623|102169622|FG000|COMPLETED|Overall Study||75||
48625703|NCT02389959|101867527|FG000|NOT COMPLETED|Overall Study||2||
48625704|NCT02389959|101867528|FG001|NOT COMPLETED|Overall Study||1||
48625705|NCT03102762|101867529|FG000|STARTED|Overall Study||35||
48625706|NCT03102762|101867530|FG001|STARTED|Overall Study||35||
48625707|NCT03102762|101867529|FG000|COMPLETED|Overall Study||34||
48625708|NCT03102762|101867530|FG001|COMPLETED|Overall Study||35||
48625709|NCT03102762|101867529|FG000|NOT COMPLETED|Overall Study||1||
48625710|NCT03102762|101867530|FG001|NOT COMPLETED|Overall Study||0||
48625711|NCT00863707|101867531|FG000|STARTED|Overall Study||174||
48748601|NCT02807623|102169623|FG001|COMPLETED|Overall Study||79||
48748602|NCT02807623|102169624|FG002|COMPLETED|Overall Study||79||
48748603|NCT02807623|102169622|FG000|NOT COMPLETED|Overall Study||23||
48748604|NCT02807623|102169623|FG001|NOT COMPLETED|Overall Study||21||
48748605|NCT02807623|102169624|FG002|NOT COMPLETED|Overall Study||23||
48168018|NCT02667886|100735644|FG002|STARTED|Dose Expansion (Part B)||0||
48168019|NCT02667886|100735645|FG003|STARTED|Dose Expansion (Part B)||55||
48168020|NCT02667886|100735646|FG004|STARTED|Dose Expansion (Part B)||0||
48168021|NCT02667886|100735642|FG000|Received at Least 1 Dose of Study Drug|Dose Expansion (Part B)||0||
48168022|NCT02667886|100735643|FG001|Received at Least 1 Dose of Study Drug|Dose Expansion (Part B)||0||
48168023|NCT02667886|100735644|FG002|Received at Least 1 Dose of Study Drug|Dose Expansion (Part B)||0||
48168024|NCT02667886|100735645|FG003|Received at Least 1 Dose of Study Drug|Dose Expansion (Part B)||55||
48168025|NCT02667886|100735646|FG004|Received at Least 1 Dose of Study Drug|Dose Expansion (Part B)||0||
48168026|NCT02667886|100735642|FG000|COMPLETED|Dose Expansion (Part B)||0||
48168027|NCT02667886|100735643|FG001|COMPLETED|Dose Expansion (Part B)||0||
48168028|NCT02667886|100735644|FG002|COMPLETED|Dose Expansion (Part B)||0||
48168029|NCT02667886|100735645|FG003|COMPLETED|Dose Expansion (Part B)||1||
48168030|NCT02667886|100735646|FG004|COMPLETED|Dose Expansion (Part B)||0||
48168031|NCT02667886|100735642|FG000|NOT COMPLETED|Dose Expansion (Part B)||0||
48168032|NCT02667886|100735643|FG001|NOT COMPLETED|Dose Expansion (Part B)||0||
48168033|NCT02667886|100735644|FG002|NOT COMPLETED|Dose Expansion (Part B)||0||
48168034|NCT02667886|100735645|FG003|NOT COMPLETED|Dose Expansion (Part B)||54||
48168035|NCT02667886|100735646|FG004|NOT COMPLETED|Dose Expansion (Part B)||0||
48168036|NCT02667886|100735642|FG000|STARTED|Dose Escalation and Expansion (Part C)||0||
48168037|NCT02667886|100735643|FG001|STARTED|Dose Escalation and Expansion (Part C)||0||
48168038|NCT02667886|100735644|FG002|STARTED|Dose Escalation and Expansion (Part C)||0||
48168039|NCT02667886|100735645|FG003|STARTED|Dose Escalation and Expansion (Part C)||0||
48168040|NCT02667886|100735646|FG004|STARTED|Dose Escalation and Expansion (Part C)||3||
48625712|NCT00863707|101867532|FG001|STARTED|Overall Study||337||
48625713|NCT00863707|101867531|FG000|COMPLETED|Overall Study||170||
48625714|NCT00863707|101867532|FG001|COMPLETED|Overall Study||334||
48625715|NCT00863707|101867531|FG000|NOT COMPLETED|Overall Study||4||
48625716|NCT00863707|101867532|FG001|NOT COMPLETED|Overall Study||3||
48625717|NCT01067586|101867533|FG000|STARTED|Overall Study||359||
48625718|NCT01067586|101867533|FG000|COMPLETED|Overall Study||359||
48625719|NCT01067586|101867533|FG000|NOT COMPLETED|Overall Study||0||
48625720|NCT00541242|101867534|FG000|STARTED|Treatment Period 1||0||
48168041|NCT02667886|100735642|FG000|Received at Least 1 Dose of Study Drug|Dose Escalation and Expansion (Part C)||0||
48748606|NCT01156480|102169625|FG000|STARTED|Overall Study||0||
48748607|NCT01156480|102169626|FG001|STARTED|Overall Study||2||
48748608|NCT01156480|102169625|FG000|COMPLETED|Overall Study||0||
48748609|NCT01156480|102169626|FG001|COMPLETED|Overall Study||1||
48748610|NCT01156480|102169625|FG000|NOT COMPLETED|Overall Study||0||
48748611|NCT01156480|102169626|FG001|NOT COMPLETED|Overall Study||1||
48748612|NCT00945282|102169627|FG000|STARTED|Overall Study||6||
48748613|NCT00945282|102169628|FG001|STARTED|Overall Study||2||
48748614|NCT00945282|102169627|FG000|COMPLETED|Overall Study||6||
48748615|NCT00945282|102169628|FG001|COMPLETED|Overall Study||2||
48748616|NCT00945282|102169627|FG000|NOT COMPLETED|Overall Study||0||
48748617|NCT00945282|102169628|FG001|NOT COMPLETED|Overall Study||0||
48748618|NCT01623115|102169629|FG000|STARTED|Overall Study||163||
48748619|NCT01623115|102169630|FG001|STARTED|Overall Study||323||
48748620|NCT01623115|102169629|FG000|Treated|Overall Study||163||
48748621|NCT01623115|102169630|FG001|Treated|Overall Study||322||
48331565|NCT00662792|101141683|FG000|STARTED|Period 4||30||
48331566|NCT00662792|101141684|FG001|STARTED|Period 4||31||
48331567|NCT00662792|101141685|FG002|STARTED|Period 4||30||
48331568|NCT00662792|101141686|FG003|STARTED|Period 4||35||
48331569|NCT00662792|101141683|FG000|Treated|Period 4||30||
48331570|NCT00662792|101141684|FG001|Treated|Period 4||31||
48331571|NCT00662792|101141685|FG002|Treated|Period 4||30||
48331572|NCT00662792|101141686|FG003|Treated|Period 4||35||
48331573|NCT00662792|101141683|FG000|COMPLETED|Period 4||29|Not prematurely discontinued from study medication|
48331574|NCT00662792|101141684|FG001|COMPLETED|Period 4||30|Not prematurely discontinued from study medication|
48331575|NCT00662792|101141685|FG002|COMPLETED|Period 4||30|Not prematurely discontinued from study medication|
48331576|NCT00662792|101141686|FG003|COMPLETED|Period 4||34|Not prematurely discontinued from study medication|
48331577|NCT00662792|101141683|FG000|NOT COMPLETED|Period 4||1||
48331578|NCT00662792|101141684|FG001|NOT COMPLETED|Period 4||1||
48331579|NCT00662792|101141685|FG002|NOT COMPLETED|Period 4||0||
48331580|NCT00662792|101141686|FG003|NOT COMPLETED|Period 4||1||
48331581|NCT00493038|101141687|FG000|STARTED|Treatment||147||
48331582|NCT00493038|101141688|FG001|STARTED|Treatment||146||
48331583|NCT00493038|101141687|FG000|Randomization|Treatment||147||
48331584|NCT00493038|101141688|FG001|Randomization|Treatment||146||
48331585|NCT00493038|101141687|FG000|Treated With Study Medication|Treatment||145||
48331586|NCT00493038|101141688|FG001|Treated With Study Medication|Treatment||142||
48331587|NCT00493038|101141687|FG000|Test-of-Cure Visit|Treatment||123||
48331588|NCT00493038|101141688|FG001|Test-of-Cure Visit|Treatment||126||
48331589|NCT00493038|101141687|FG000|COMPLETED|Treatment||123||
48331590|NCT00493038|101141688|FG001|COMPLETED|Treatment||126||
48331591|NCT00493038|101141687|FG000|NOT COMPLETED|Treatment||24||
48331592|NCT00493038|101141688|FG001|NOT COMPLETED|Treatment||20||
48331593|NCT00493038|101141687|FG000|STARTED|Follow-up||123||
48331594|NCT00493038|101141688|FG001|STARTED|Follow-up||126||
48331595|NCT00493038|101141687|FG000|COMPLETED|Follow-up||122||
48331596|NCT00493038|101141688|FG001|COMPLETED|Follow-up||126||
48331597|NCT00493038|101141687|FG000|NOT COMPLETED|Follow-up||1||
48410856|NCT01563406|101337741|FG002|COMPLETED|Overall Study||30||
48410857|NCT01563406|101337742|FG003|COMPLETED|Overall Study||29||
48410858|NCT01563406|101337739|FG000|NOT COMPLETED|Overall Study||0||
48331598|NCT00493038|101141688|FG001|NOT COMPLETED|Follow-up||0||
48331599|NCT02831673|101141689|FG000|STARTED|Double-blind (Day 1 to Week 96)||359|Randomized|
48331600|NCT02831673|101141690|FG001|STARTED|Double-blind (Day 1 to Week 96)||360|Randomized|
48331601|NCT02831673|101141691|FG002|STARTED|Double-blind (Day 1 to Week 96)||0|Randomized|
48331602|NCT02831673|101141692|FG003|STARTED|Double-blind (Day 1 to Week 96)||0|Randomized|
48331603|NCT02831673|101141693|FG004|STARTED|Double-blind (Day 1 to Week 96)||0|Randomized|
48331604|NCT02831673|101141689|FG000|Intent to Treat Exposed|Double-blind (Day 1 to Week 96)||356||
48331605|NCT02831673|101141690|FG001|Intent to Treat Exposed|Double-blind (Day 1 to Week 96)||358||
48331606|NCT02831673|101141691|FG002|Intent to Treat Exposed|Double-blind (Day 1 to Week 96)||0||
48331607|NCT02831673|101141692|FG003|Intent to Treat Exposed|Double-blind (Day 1 to Week 96)||0||
48331608|NCT02831673|101141693|FG004|Intent to Treat Exposed|Double-blind (Day 1 to Week 96)||0||
48331609|NCT02831673|101141689|FG000|COMPLETED|Double-blind (Day 1 to Week 96)||301||
48331610|NCT02831673|101141690|FG001|COMPLETED|Double-blind (Day 1 to Week 96)||320||
48410859|NCT01563406|101337740|FG001|NOT COMPLETED|Overall Study||0||
48748622|NCT01623115|102169629|FG000|COMPLETED|Overall Study||130||
48748623|NCT01623115|102169630|FG001|COMPLETED|Overall Study||246||
48748624|NCT01623115|102169629|FG000|NOT COMPLETED|Overall Study||33||
48748625|NCT01623115|102169630|FG001|NOT COMPLETED|Overall Study||77||
48748626|NCT00296816|102169631|FG000|STARTED|Overall Study||132||
48748627|NCT00296816|102169631|FG000|COMPLETED|Overall Study||58||
48331611|NCT02831673|101141691|FG002|COMPLETED|Double-blind (Day 1 to Week 96)||0||
48331612|NCT02831673|101141692|FG003|COMPLETED|Double-blind (Day 1 to Week 96)||0||
48331613|NCT02831673|101141693|FG004|COMPLETED|Double-blind (Day 1 to Week 96)||0||
48331614|NCT02831673|101141689|FG000|NOT COMPLETED|Double-blind (Day 1 to Week 96)||58||
48331615|NCT02831673|101141690|FG001|NOT COMPLETED|Double-blind (Day 1 to Week 96)||40||
48331616|NCT02831673|101141691|FG002|NOT COMPLETED|Double-blind (Day 1 to Week 96)||0||
48331617|NCT02831673|101141692|FG003|NOT COMPLETED|Double-blind (Day 1 to Week 96)||0||
48331618|NCT02831673|101141693|FG004|NOT COMPLETED|Double-blind (Day 1 to Week 96)||0||
48748628|NCT00296816|102169631|FG000|NOT COMPLETED|Overall Study||74||
48331619|NCT02831673|101141689|FG000|STARTED|Open-label Phase (Week 96 to Week 148)||0||
48331620|NCT02831673|101141690|FG001|STARTED|Open-label Phase (Week 96 to Week 148)||0||
48331621|NCT02831673|101141691|FG002|STARTED|Open-label Phase (Week 96 to Week 148)||301||
48410860|NCT01563406|101337741|FG002|NOT COMPLETED|Overall Study||0||
48748629|NCT03192826|102169632|FG000|STARTED|Overall Study||27||
48331622|NCT02831673|101141692|FG003|STARTED|Open-label Phase (Week 96 to Week 148)||319||
48331623|NCT02831673|101141693|FG004|STARTED|Open-label Phase (Week 96 to Week 148)||0||
48331624|NCT02831673|101141689|FG000|COMPLETED|Open-label Phase (Week 96 to Week 148)||0||
48331625|NCT02831673|101141690|FG001|COMPLETED|Open-label Phase (Week 96 to Week 148)||0||
48410861|NCT01563406|101337742|FG003|NOT COMPLETED|Overall Study||0||
48410862|NCT02463227|101337743|FG000|STARTED|Overall Study||14||
48410863|NCT02463227|101337743|FG000|COMPLETED|Overall Study||14||
48410864|NCT02463227|101337743|FG000|NOT COMPLETED|Overall Study||0||
48410865|NCT01847560|101337744|FG000|STARTED|Overall Study||13464||
48625721|NCT00541242|101867535|FG001|STARTED|Treatment Period 1||586||
48331626|NCT02831673|101141691|FG002|COMPLETED|Open-label Phase (Week 96 to Week 148)||281||
48331627|NCT02831673|101141692|FG003|COMPLETED|Open-label Phase (Week 96 to Week 148)||294||
48331628|NCT02831673|101141693|FG004|COMPLETED|Open-label Phase (Week 96 to Week 148)||0||
48331629|NCT02831673|101141689|FG000|NOT COMPLETED|Open-label Phase (Week 96 to Week 148)||0||
48331630|NCT02831673|101141690|FG001|NOT COMPLETED|Open-label Phase (Week 96 to Week 148)||0||
48331631|NCT02831673|101141691|FG002|NOT COMPLETED|Open-label Phase (Week 96 to Week 148)||20||
48331632|NCT02831673|101141692|FG003|NOT COMPLETED|Open-label Phase (Week 96 to Week 148)||25||
48331633|NCT02831673|101141693|FG004|NOT COMPLETED|Open-label Phase (Week 96 to Week 148)||0||
48331634|NCT02831673|101141689|FG000|STARTED|Continuation Phase(Week 148 to Week 280)||0||
48331635|NCT02831673|101141690|FG001|STARTED|Continuation Phase(Week 148 to Week 280)||0||
48331636|NCT02831673|101141691|FG002|STARTED|Continuation Phase(Week 148 to Week 280)||0||
48331637|NCT02831673|101141692|FG003|STARTED|Continuation Phase(Week 148 to Week 280)||0||
48331638|NCT02831673|101141693|FG004|STARTED|Continuation Phase(Week 148 to Week 280)||233||
48331639|NCT02831673|101141689|FG000|COMPLETED|Continuation Phase(Week 148 to Week 280)||0||
48331640|NCT02831673|101141690|FG001|COMPLETED|Continuation Phase(Week 148 to Week 280)||0||
48331641|NCT02831673|101141691|FG002|COMPLETED|Continuation Phase(Week 148 to Week 280)||0||
48331642|NCT02831673|101141692|FG003|COMPLETED|Continuation Phase(Week 148 to Week 280)||0||
48331643|NCT02831673|101141693|FG004|COMPLETED|Continuation Phase(Week 148 to Week 280)||212||
48331644|NCT02831673|101141689|FG000|NOT COMPLETED|Continuation Phase(Week 148 to Week 280)||0||
48331645|NCT02831673|101141690|FG001|NOT COMPLETED|Continuation Phase(Week 148 to Week 280)||0||
48331646|NCT02831673|101141691|FG002|NOT COMPLETED|Continuation Phase(Week 148 to Week 280)||0||
48331647|NCT02831673|101141692|FG003|NOT COMPLETED|Continuation Phase(Week 148 to Week 280)||0||
48331648|NCT02831673|101141693|FG004|NOT COMPLETED|Continuation Phase(Week 148 to Week 280)||21||
48331649|NCT01422239|101141694|FG000|STARTED|Overall Study||14||
48331650|NCT01422239|101141695|FG001|STARTED|Overall Study||6||
48331651|NCT01422239|101141694|FG000|COMPLETED|Overall Study||10||
48331652|NCT01422239|101141695|FG001|COMPLETED|Overall Study||3||
48331653|NCT01422239|101141694|FG000|NOT COMPLETED|Overall Study||4||
48331654|NCT01422239|101141695|FG001|NOT COMPLETED|Overall Study||3||
48331655|NCT03988907|101141696|FG000|STARTED|Overall Study||8||
48331656|NCT03988907|101141697|FG001|STARTED|Overall Study||27||
48331657|NCT03988907|101141696|FG000|COMPLETED|Overall Study||8||
48331658|NCT03988907|101141697|FG001|COMPLETED|Overall Study||26||
48331659|NCT03988907|101141696|FG000|NOT COMPLETED|Overall Study||0||
48331660|NCT03988907|101141697|FG001|NOT COMPLETED|Overall Study||1||
48331661|NCT01142726|101141698|FG000|STARTED|Treatment Phase: Day 1 Through Month 12||119||
48331662|NCT01142726|101141699|FG001|STARTED|Treatment Phase: Day 1 Through Month 12||116||
48331663|NCT01142726|101141700|FG002|STARTED|Treatment Phase: Day 1 Through Month 12||116||
48331664|NCT01142726|101141698|FG000|COMPLETED|Treatment Phase: Day 1 Through Month 12||103||
48331665|NCT01142726|101141699|FG001|COMPLETED|Treatment Phase: Day 1 Through Month 12||91||
48410866|NCT01847560|101337745|FG001|STARTED|Overall Study||19955||
48410867|NCT01847560|101337746|FG002|STARTED|Overall Study||9731||
48410868|NCT01847560|101337747|FG003|STARTED|Overall Study||56655||
48410869|NCT01847560|101337748|FG004|STARTED|Overall Study||27731||
48410870|NCT01847560|101337749|FG005|STARTED|Overall Study||28343||
48410871|NCT01847560|101337750|FG006|STARTED|Overall Study||40971||
48410872|NCT01847560|101337751|FG007|STARTED|Overall Study||19829||
48331666|NCT01142726|101141700|FG002|COMPLETED|Treatment Phase: Day 1 Through Month 12||96||
48331667|NCT01142726|101141698|FG000|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||16||
48331668|NCT01142726|101141699|FG001|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||25||
48331669|NCT01142726|101141700|FG002|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||20||
48331670|NCT01142726|101141698|FG000|STARTED|Withdrawal Phase: Months 12 up to 24||84||
48331671|NCT01142726|101141699|FG001|STARTED|Withdrawal Phase: Months 12 up to 24||66||
48331672|NCT01142726|101141700|FG002|STARTED|Withdrawal Phase: Months 12 up to 24||75||
48331673|NCT01142726|101141698|FG000|COMPLETED|Withdrawal Phase: Months 12 up to 24||14||
48410873|NCT01847560|101337752|FG008|STARTED|Overall Study||77547||
48410874|NCT01847560|101337753|FG009|STARTED|Overall Study||39438||
48625722|NCT00541242|101867534|FG000|COMPLETED|Treatment Period 1||0||
48331674|NCT01142726|101141699|FG001|COMPLETED|Withdrawal Phase: Months 12 up to 24||10||
48331675|NCT01142726|101141700|FG002|COMPLETED|Withdrawal Phase: Months 12 up to 24||17||
48368084|NCT03032068|101230103|FG000|STARTED|Overall Study||10||
48410875|NCT01847560|101337744|FG000|COMPLETED|Overall Study||13464||
48410876|NCT01847560|101337745|FG001|COMPLETED|Overall Study||19955||
48331676|NCT01142726|101141698|FG000|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||70||
48331677|NCT01142726|101141699|FG001|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||56||
48331678|NCT01142726|101141700|FG002|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||58||
48331679|NCT01142726|101141698|FG000|STARTED|Re-Exposure Phase: Months 24 up to 30||55||
48331680|NCT01142726|101141699|FG001|STARTED|Re-Exposure Phase: Months 24 up to 30||48||
48331681|NCT01142726|101141700|FG002|STARTED|Re-Exposure Phase: Months 24 up to 30||43||
48331682|NCT01142726|101141698|FG000|COMPLETED|Re-Exposure Phase: Months 24 up to 30||54||
48331683|NCT01142726|101141699|FG001|COMPLETED|Re-Exposure Phase: Months 24 up to 30||46||
48331684|NCT01142726|101141700|FG002|COMPLETED|Re-Exposure Phase: Months 24 up to 30||40||
48331685|NCT01142726|101141698|FG000|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||1||
48331686|NCT01142726|101141699|FG001|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||2||
48331687|NCT01142726|101141700|FG002|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||3||
48410877|NCT01847560|101337746|FG002|COMPLETED|Overall Study||9731||
48410878|NCT01847560|101337747|FG003|COMPLETED|Overall Study||56655||
48410879|NCT01847560|101337748|FG004|COMPLETED|Overall Study||27731||
48410880|NCT01847560|101337749|FG005|COMPLETED|Overall Study||28343||
48410881|NCT01847560|101337750|FG006|COMPLETED|Overall Study||40971||
48410882|NCT01847560|101337751|FG007|COMPLETED|Overall Study||19829||
48410883|NCT01847560|101337752|FG008|COMPLETED|Overall Study||77547||
48410884|NCT01847560|101337753|FG009|COMPLETED|Overall Study||39438||
48410885|NCT01847560|101337744|FG000|NOT COMPLETED|Overall Study||0||
48410886|NCT01847560|101337745|FG001|NOT COMPLETED|Overall Study||0||
48410887|NCT01847560|101337746|FG002|NOT COMPLETED|Overall Study||0||
48410888|NCT01847560|101337747|FG003|NOT COMPLETED|Overall Study||0||
48410889|NCT01847560|101337748|FG004|NOT COMPLETED|Overall Study||0||
48410890|NCT01847560|101337749|FG005|NOT COMPLETED|Overall Study||0||
48410891|NCT01847560|101337750|FG006|NOT COMPLETED|Overall Study||0||
48748630|NCT03192826|102169633|FG001|STARTED|Overall Study||27||
48748631|NCT03192826|102169634|FG002|STARTED|Overall Study||25||
48748632|NCT03192826|102169632|FG000|COMPLETED|Overall Study||27||
48748633|NCT03192826|102169633|FG001|COMPLETED|Overall Study||27||
48748634|NCT03192826|102169634|FG002|COMPLETED|Overall Study||25||
48748635|NCT03192826|102169632|FG000|NOT COMPLETED|Overall Study||0||
48748636|NCT03192826|102169633|FG001|NOT COMPLETED|Overall Study||0||
48748637|NCT03192826|102169634|FG002|NOT COMPLETED|Overall Study||0||
48748638|NCT02324283|102169635|FG000|STARTED|Overall Study||40||
48748639|NCT02324283|102169636|FG001|STARTED|Overall Study||40||
48748640|NCT02324283|102169635|FG000|COMPLETED|Overall Study||40||
48748641|NCT02324283|102169636|FG001|COMPLETED|Overall Study||40||
48331688|NCT00686647|101141701|FG000|STARTED|Overall Study||93||
48331689|NCT00686647|101141701|FG000|COMPLETED|Overall Study||91||
48331690|NCT00686647|101141701|FG000|NOT COMPLETED|Overall Study||2||
48331691|NCT00865020|101141702|FG000|STARTED|Overall Study||414||
48331692|NCT00865020|101141703|FG001|STARTED|Overall Study||408||
48331693|NCT00865020|101141702|FG000|COMPLETED|Overall Study||365||
48331694|NCT00865020|101141703|FG001|COMPLETED|Overall Study||357||
48331695|NCT00865020|101141702|FG000|NOT COMPLETED|Overall Study||49||
48331696|NCT00865020|101141703|FG001|NOT COMPLETED|Overall Study||51||
48331697|NCT01017952|101141704|FG000|STARTED|4-week, Open-label Run-In Period||2092||
48331698|NCT01017952|101141705|FG001|STARTED|4-week, Open-label Run-In Period||0||
48331699|NCT01017952|101141706|FG002|STARTED|4-week, Open-label Run-In Period||0||
48331700|NCT01017952|101141707|FG003|STARTED|4-week, Open-label Run-In Period||0||
48331701|NCT01017952|101141708|FG004|STARTED|4-week, Open-label Run-In Period||0||
48331702|NCT01017952|101141704|FG000|COMPLETED|4-week, Open-label Run-In Period||1633||
48331703|NCT01017952|101141705|FG001|COMPLETED|4-week, Open-label Run-In Period||0||
48331704|NCT01017952|101141706|FG002|COMPLETED|4-week, Open-label Run-In Period||0||
48331705|NCT01017952|101141707|FG003|COMPLETED|4-week, Open-label Run-In Period||0||
48331706|NCT01017952|101141708|FG004|COMPLETED|4-week, Open-label Run-In Period||0||
48331707|NCT01017952|101141704|FG000|NOT COMPLETED|4-week, Open-label Run-In Period||459||
48410892|NCT01847560|101337751|FG007|NOT COMPLETED|Overall Study||0||
48748642|NCT02324283|102169635|FG000|NOT COMPLETED|Overall Study||0||
48410893|NCT01847560|101337752|FG008|NOT COMPLETED|Overall Study||0||
48410894|NCT01847560|101337753|FG009|NOT COMPLETED|Overall Study||0||
48410895|NCT02100813|101337754|FG000|STARTED|Overall Study||10||
48748643|NCT02324283|102169636|FG001|NOT COMPLETED|Overall Study||0||
48748644|NCT00496015|102169637|FG000|STARTED|Overall Study||178||
48748645|NCT00496015|102169638|FG001|STARTED|Overall Study||27||
48748646|NCT00496015|102169639|FG002|STARTED|Overall Study||172||
48748647|NCT00496015|102169640|FG003|STARTED|Overall Study||37||
48748648|NCT00496015|102169641|FG004|STARTED|Overall Study||336||
48748649|NCT00496015|102169637|FG000|COMPLETED|Overall Study||177||
48748650|NCT00496015|102169638|FG001|COMPLETED|Overall Study||27||
48331708|NCT01017952|101141705|FG001|NOT COMPLETED|4-week, Open-label Run-In Period||0||
48748651|NCT00496015|102169639|FG002|COMPLETED|Overall Study||172||
48748652|NCT00496015|102169640|FG003|COMPLETED|Overall Study||36||
48748653|NCT00496015|102169641|FG004|COMPLETED|Overall Study||336||
48748654|NCT00496015|102169637|FG000|NOT COMPLETED|Overall Study||1||
48748655|NCT00496015|102169638|FG001|NOT COMPLETED|Overall Study||0||
48748656|NCT00496015|102169639|FG002|NOT COMPLETED|Overall Study||0||
48748657|NCT00496015|102169640|FG003|NOT COMPLETED|Overall Study||1||
48748658|NCT00496015|102169641|FG004|NOT COMPLETED|Overall Study||0||
48748659|NCT00990106|102169642|FG000|STARTED|Overall Study||32||
48748660|NCT00990106|102169643|FG001|STARTED|Overall Study||35||
48748661|NCT00990106|102169642|FG000|COMPLETED|Overall Study||23||
48748662|NCT00990106|102169643|FG001|COMPLETED|Overall Study||23||
48748663|NCT00990106|102169642|FG000|NOT COMPLETED|Overall Study||9||
48748664|NCT00990106|102169643|FG001|NOT COMPLETED|Overall Study||12||
48748665|NCT01467505|102169644|FG000|STARTED|Overall Study||51||
48748666|NCT01467505|102169645|FG001|STARTED|Overall Study||10||
48331709|NCT01017952|101141706|FG002|NOT COMPLETED|4-week, Open-label Run-In Period||0||
48331710|NCT01017952|101141707|FG003|NOT COMPLETED|4-week, Open-label Run-In Period||0||
48331711|NCT01017952|101141708|FG004|NOT COMPLETED|4-week, Open-label Run-In Period||0||
48331712|NCT01017952|101141704|FG000|STARTED|52-week, Double-blind Treatment Period||0||
48331713|NCT01017952|101141705|FG001|STARTED|52-week, Double-blind Treatment Period||409||
48331714|NCT01017952|101141706|FG002|STARTED|52-week, Double-blind Treatment Period||412||
48331715|NCT01017952|101141707|FG003|STARTED|52-week, Double-blind Treatment Period||403||
48331716|NCT01017952|101141708|FG004|STARTED|52-week, Double-blind Treatment Period||409||
48331717|NCT01017952|101141704|FG000|Completed the Treatment Period|52-week, Double-blind Treatment Period||0||
48331718|NCT01017952|101141705|FG001|Completed the Treatment Period|52-week, Double-blind Treatment Period||285||
48331719|NCT01017952|101141706|FG002|Completed the Treatment Period|52-week, Double-blind Treatment Period||305||
48331720|NCT01017952|101141707|FG003|Completed the Treatment Period|52-week, Double-blind Treatment Period||293||
48331721|NCT01017952|101141708|FG004|Completed the Treatment Period|52-week, Double-blind Treatment Period||307||
48331722|NCT01017952|101141704|FG000|COMPLETED|52-week, Double-blind Treatment Period||0||
48331723|NCT01017952|101141705|FG001|COMPLETED|52-week, Double-blind Treatment Period||284||
48331724|NCT01017952|101141706|FG002|COMPLETED|52-week, Double-blind Treatment Period||303||
48331725|NCT01017952|101141707|FG003|COMPLETED|52-week, Double-blind Treatment Period||291||
48331726|NCT01017952|101141708|FG004|COMPLETED|52-week, Double-blind Treatment Period||306||
48331727|NCT01017952|101141704|FG000|NOT COMPLETED|52-week, Double-blind Treatment Period||0||
48331728|NCT01017952|101141705|FG001|NOT COMPLETED|52-week, Double-blind Treatment Period||125||
48331729|NCT01017952|101141706|FG002|NOT COMPLETED|52-week, Double-blind Treatment Period||109||
48331730|NCT01017952|101141707|FG003|NOT COMPLETED|52-week, Double-blind Treatment Period||112||
48331731|NCT01017952|101141708|FG004|NOT COMPLETED|52-week, Double-blind Treatment Period||103||
48331732|NCT02217566|101141709|FG000|STARTED|Overall Study||46||
48331733|NCT02217566|101141709|FG000|COMPLETED|Overall Study||35||
48331734|NCT02217566|101141709|FG000|NOT COMPLETED|Overall Study||11||
48331735|NCT02317562|101141710|FG000|STARTED|Overall Study||19||
48331736|NCT02317562|101141710|FG000|COMPLETED|Overall Study||5||
48331737|NCT02317562|101141710|FG000|NOT COMPLETED|Overall Study||14||
48331738|NCT01582308|101141711|FG000|STARTED|Period 1||2||
48331739|NCT01582308|101141712|FG001|STARTED|Period 1||2||
48331740|NCT01582308|101141713|FG002|STARTED|Period 1||2||
48331741|NCT01582308|101141714|FG003|STARTED|Period 1||2||
48331742|NCT01582308|101141715|FG004|STARTED|Period 1||3||
48331743|NCT01582308|101141716|FG005|STARTED|Period 1||2||
48331744|NCT01582308|101141717|FG006|STARTED|Period 1||3||
48331745|NCT01582308|101141718|FG007|STARTED|Period 1||2||
48331746|NCT01582308|101141719|FG008|STARTED|Period 1||2||
48331747|NCT01582308|101141720|FG009|STARTED|Period 1||2||
48331748|NCT01582308|101141711|FG000|COMPLETED|Period 1||2||
48331749|NCT01582308|101141712|FG001|COMPLETED|Period 1||2||
48331750|NCT01582308|101141713|FG002|COMPLETED|Period 1||2||
48331751|NCT01582308|101141714|FG003|COMPLETED|Period 1||2||
48331752|NCT01582308|101141715|FG004|COMPLETED|Period 1||3||
48331753|NCT01582308|101141716|FG005|COMPLETED|Period 1||2||
48331754|NCT01582308|101141717|FG006|COMPLETED|Period 1||2||
48331755|NCT01582308|101141718|FG007|COMPLETED|Period 1||2||
48331756|NCT01582308|101141719|FG008|COMPLETED|Period 1||2||
48748667|NCT01467505|102169644|FG000|COMPLETED|Overall Study||18||
48748668|NCT01467505|102169645|FG001|COMPLETED|Overall Study||7||
48748669|NCT01467505|102169644|FG000|NOT COMPLETED|Overall Study||33||
48748670|NCT01467505|102169645|FG001|NOT COMPLETED|Overall Study||3||
48748671|NCT04426318|102169646|FG000|STARTED|Overall Study||346||
48748672|NCT04426318|102169647|FG001|STARTED|Overall Study||320||
48748673|NCT04426318|102169646|FG000|Failed Attention Checks|Overall Study||4||
48331757|NCT01582308|101141720|FG009|COMPLETED|Period 1||2||
48331758|NCT01582308|101141711|FG000|NOT COMPLETED|Period 1||0||
48331759|NCT01582308|101141712|FG001|NOT COMPLETED|Period 1||0||
48331760|NCT01582308|101141713|FG002|NOT COMPLETED|Period 1||0||
48331761|NCT01582308|101141714|FG003|NOT COMPLETED|Period 1||0||
48331762|NCT01582308|101141715|FG004|NOT COMPLETED|Period 1||0||
48748674|NCT04426318|102169647|FG001|Failed Attention Checks|Overall Study||6||
48748675|NCT04426318|102169646|FG000|Downloaded HMP App|Overall Study||329||
48410896|NCT02100813|101337755|FG001|STARTED|Overall Study||11||
48410897|NCT02100813|101337756|FG002|STARTED|Overall Study||12||
48410898|NCT02100813|101337757|FG003|STARTED|Overall Study||12||
48410899|NCT02100813|101337758|FG004|STARTED|Overall Study||12||
48410900|NCT02100813|101337759|FG005|STARTED|Overall Study||32||
48410901|NCT02100813|101337760|FG006|STARTED|Overall Study||64||
48410902|NCT02100813|101337761|FG007|STARTED|Overall Study||67||
48410903|NCT02100813|101337754|FG000|COMPLETED|Overall Study||10||
48410904|NCT02100813|101337755|FG001|COMPLETED|Overall Study||11||
48410905|NCT02100813|101337756|FG002|COMPLETED|Overall Study||12||
48410906|NCT02100813|101337757|FG003|COMPLETED|Overall Study||12||
48410907|NCT02100813|101337758|FG004|COMPLETED|Overall Study||12||
48410908|NCT02100813|101337759|FG005|COMPLETED|Overall Study||32||
48410909|NCT02100813|101337760|FG006|COMPLETED|Overall Study||64||
48410910|NCT02100813|101337761|FG007|COMPLETED|Overall Study||66||
48410911|NCT02100813|101337754|FG000|NOT COMPLETED|Overall Study||0||
48410912|NCT02100813|101337755|FG001|NOT COMPLETED|Overall Study||0||
48410913|NCT02100813|101337756|FG002|NOT COMPLETED|Overall Study||0||
48410914|NCT02100813|101337757|FG003|NOT COMPLETED|Overall Study||0||
48410915|NCT02100813|101337758|FG004|NOT COMPLETED|Overall Study||0||
48410916|NCT02100813|101337759|FG005|NOT COMPLETED|Overall Study||0||
48410917|NCT02100813|101337760|FG006|NOT COMPLETED|Overall Study||0||
48410918|NCT02100813|101337761|FG007|NOT COMPLETED|Overall Study||1||
48410919|NCT01388491|101337762|FG000|STARTED|Overall Study||150||
48410920|NCT01388491|101337763|FG001|STARTED|Overall Study||143||
48410921|NCT01388491|101337762|FG000|Safety Population|Overall Study||145||
48410922|NCT01388491|101337763|FG001|Safety Population|Overall Study||142||
48410923|NCT01388491|101337762|FG000|Intent-to-Treat (ITT) Population|Overall Study||140||
48410924|NCT01388491|101337763|FG001|Intent-to-Treat (ITT) Population|Overall Study||136||
48625723|NCT00541242|101867535|FG001|COMPLETED|Treatment Period 1||586||
48625724|NCT00541242|101867534|FG000|NOT COMPLETED|Treatment Period 1||0||
48625725|NCT00541242|101867535|FG001|NOT COMPLETED|Treatment Period 1||0||
48625726|NCT00541242|101867534|FG000|STARTED|Treatment Period 2||270||
48625727|NCT00541242|101867535|FG001|STARTED|Treatment Period 2||273||
48625728|NCT00541242|101867534|FG000|COMPLETED|Treatment Period 2||261||
48625729|NCT00541242|101867535|FG001|COMPLETED|Treatment Period 2||266||
48625730|NCT00541242|101867534|FG000|NOT COMPLETED|Treatment Period 2||9||
48625731|NCT00541242|101867535|FG001|NOT COMPLETED|Treatment Period 2||7||
48625732|NCT01126099|101867536|FG000|STARTED|Double Blind Phase||11||
48625733|NCT01126099|101867537|FG001|STARTED|Double Blind Phase||9||
48625734|NCT01126099|101867536|FG000|COMPLETED|Double Blind Phase||7||
48625735|NCT01126099|101867537|FG001|COMPLETED|Double Blind Phase||7||
48625736|NCT01126099|101867536|FG000|NOT COMPLETED|Double Blind Phase||4||
48625737|NCT01126099|101867537|FG001|NOT COMPLETED|Double Blind Phase||2||
48331763|NCT01582308|101141716|FG005|NOT COMPLETED|Period 1||0||
48331764|NCT01582308|101141717|FG006|NOT COMPLETED|Period 1||1||
48331765|NCT01582308|101141718|FG007|NOT COMPLETED|Period 1||0||
48331766|NCT01582308|101141719|FG008|NOT COMPLETED|Period 1||0||
48331767|NCT01582308|101141720|FG009|NOT COMPLETED|Period 1||0||
48331768|NCT01582308|101141711|FG000|STARTED|10-day Washout Following Period 1||2||
48331769|NCT01582308|101141712|FG001|STARTED|10-day Washout Following Period 1||2||
48331770|NCT01582308|101141713|FG002|STARTED|10-day Washout Following Period 1||2||
48331771|NCT01582308|101141714|FG003|STARTED|10-day Washout Following Period 1||2||
48331772|NCT01582308|101141715|FG004|STARTED|10-day Washout Following Period 1||3||
48331773|NCT01582308|101141716|FG005|STARTED|10-day Washout Following Period 1||2||
48331774|NCT01582308|101141717|FG006|STARTED|10-day Washout Following Period 1||2||
48331775|NCT01582308|101141718|FG007|STARTED|10-day Washout Following Period 1||2||
48331776|NCT01582308|101141719|FG008|STARTED|10-day Washout Following Period 1||2||
48331777|NCT01582308|101141720|FG009|STARTED|10-day Washout Following Period 1||2||
48331778|NCT01582308|101141711|FG000|COMPLETED|10-day Washout Following Period 1||2||
48331779|NCT01582308|101141712|FG001|COMPLETED|10-day Washout Following Period 1||2||
48331780|NCT01582308|101141713|FG002|COMPLETED|10-day Washout Following Period 1||2||
48331781|NCT01582308|101141714|FG003|COMPLETED|10-day Washout Following Period 1||2||
48331782|NCT01582308|101141715|FG004|COMPLETED|10-day Washout Following Period 1||2||
48331783|NCT01582308|101141716|FG005|COMPLETED|10-day Washout Following Period 1||2||
48331784|NCT01582308|101141717|FG006|COMPLETED|10-day Washout Following Period 1||2||
48331785|NCT01582308|101141718|FG007|COMPLETED|10-day Washout Following Period 1||2||
48331786|NCT01582308|101141719|FG008|COMPLETED|10-day Washout Following Period 1||2||
48331787|NCT01582308|101141720|FG009|COMPLETED|10-day Washout Following Period 1||2||
48331788|NCT01582308|101141711|FG000|NOT COMPLETED|10-day Washout Following Period 1||0||
48331789|NCT01582308|101141712|FG001|NOT COMPLETED|10-day Washout Following Period 1||0||
48331790|NCT01582308|101141713|FG002|NOT COMPLETED|10-day Washout Following Period 1||0||
48331791|NCT01582308|101141714|FG003|NOT COMPLETED|10-day Washout Following Period 1||0||
48331792|NCT01582308|101141715|FG004|NOT COMPLETED|10-day Washout Following Period 1||1||
48331793|NCT01582308|101141716|FG005|NOT COMPLETED|10-day Washout Following Period 1||0||
48410925|NCT01388491|101337762|FG000|Per Protocol (PP) Population|Overall Study||125||
48410926|NCT01388491|101337763|FG001|Per Protocol (PP) Population|Overall Study||121||
48410927|NCT01388491|101337762|FG000|COMPLETED|Overall Study||116||
48410928|NCT01388491|101337763|FG001|COMPLETED|Overall Study||114||
48748676|NCT04426318|102169647|FG001|Downloaded HMP App|Overall Study||0||
48748677|NCT04426318|102169646|FG000|Completed T2 Assessment|Overall Study||281||
48748678|NCT04426318|102169647|FG001|Completed T2 Assessment|Overall Study||280||
48748679|NCT04426318|102169646|FG000|Completed T3 Assessment|Overall Study||261||
48748680|NCT04426318|102169647|FG001|Completed T3 Assessment|Overall Study||274||
48748681|NCT04426318|102169646|FG000|Completed T4 Assessment|Overall Study||261||
48748682|NCT04426318|102169647|FG001|Completed T4 Assessment|Overall Study||275||
48331794|NCT01582308|101141717|FG006|NOT COMPLETED|10-day Washout Following Period 1||0||
48331795|NCT01582308|101141718|FG007|NOT COMPLETED|10-day Washout Following Period 1||0||
48331796|NCT01582308|101141719|FG008|NOT COMPLETED|10-day Washout Following Period 1||0||
48331797|NCT01582308|101141720|FG009|NOT COMPLETED|10-day Washout Following Period 1||0||
48331798|NCT01582308|101141711|FG000|STARTED|Period 2||2||
48331799|NCT01582308|101141712|FG001|STARTED|Period 2||2||
48331800|NCT01582308|101141713|FG002|STARTED|Period 2||2||
48331801|NCT01582308|101141714|FG003|STARTED|Period 2||2||
48331802|NCT01582308|101141715|FG004|STARTED|Period 2||2||
48331803|NCT01582308|101141716|FG005|STARTED|Period 2||2||
48331804|NCT01582308|101141717|FG006|STARTED|Period 2||2||
48331805|NCT01582308|101141718|FG007|STARTED|Period 2||2||
48331806|NCT01582308|101141719|FG008|STARTED|Period 2||2||
48331807|NCT01582308|101141720|FG009|STARTED|Period 2||2||
48331808|NCT01582308|101141711|FG000|COMPLETED|Period 2||2||
48625738|NCT01126099|101867536|FG000|STARTED|Open-label Extension||5||
48625739|NCT01126099|101867537|FG001|STARTED|Open-label Extension||7||
48748683|NCT04426318|102169646|FG000|Completed T5 Assessment|Overall Study||284||
48748684|NCT04426318|102169647|FG001|Completed T5 Assessment|Overall Study||293||
48331809|NCT01582308|101141712|FG001|COMPLETED|Period 2||2||
48331810|NCT01582308|101141713|FG002|COMPLETED|Period 2||2||
48331811|NCT01582308|101141714|FG003|COMPLETED|Period 2||2||
48331812|NCT01582308|101141715|FG004|COMPLETED|Period 2||2||
48331813|NCT01582308|101141716|FG005|COMPLETED|Period 2||2||
48331814|NCT01582308|101141717|FG006|COMPLETED|Period 2||2||
48331815|NCT01582308|101141718|FG007|COMPLETED|Period 2||2||
48331816|NCT01582308|101141719|FG008|COMPLETED|Period 2||2||
48331817|NCT01582308|101141720|FG009|COMPLETED|Period 2||2||
48331818|NCT01582308|101141711|FG000|NOT COMPLETED|Period 2||0||
48331819|NCT01582308|101141712|FG001|NOT COMPLETED|Period 2||0||
48331820|NCT01582308|101141713|FG002|NOT COMPLETED|Period 2||0||
48331821|NCT01582308|101141714|FG003|NOT COMPLETED|Period 2||0||
48331822|NCT01582308|101141715|FG004|NOT COMPLETED|Period 2||0||
48331823|NCT01582308|101141716|FG005|NOT COMPLETED|Period 2||0||
48331824|NCT01582308|101141717|FG006|NOT COMPLETED|Period 2||0||
48625740|NCT01126099|101867536|FG000|COMPLETED|Open-label Extension||4||
48625741|NCT01126099|101867537|FG001|COMPLETED|Open-label Extension||6||
48625742|NCT01126099|101867536|FG000|NOT COMPLETED|Open-label Extension||1||
48331825|NCT01582308|101141718|FG007|NOT COMPLETED|Period 2||0||
48331826|NCT01582308|101141719|FG008|NOT COMPLETED|Period 2||0||
48331827|NCT01582308|101141720|FG009|NOT COMPLETED|Period 2||0||
48331828|NCT01582308|101141711|FG000|STARTED|10-day Washout Following Period 2||2||
48331829|NCT01582308|101141712|FG001|STARTED|10-day Washout Following Period 2||2||
48331830|NCT01582308|101141713|FG002|STARTED|10-day Washout Following Period 2||2||
48331831|NCT01582308|101141714|FG003|STARTED|10-day Washout Following Period 2||2||
48331832|NCT01582308|101141715|FG004|STARTED|10-day Washout Following Period 2||2||
48331833|NCT01582308|101141716|FG005|STARTED|10-day Washout Following Period 2||2||
48331834|NCT01582308|101141717|FG006|STARTED|10-day Washout Following Period 2||2||
48331835|NCT01582308|101141718|FG007|STARTED|10-day Washout Following Period 2||2||
48331836|NCT01582308|101141719|FG008|STARTED|10-day Washout Following Period 2||2||
48331837|NCT01582308|101141720|FG009|STARTED|10-day Washout Following Period 2||2||
48331838|NCT01582308|101141711|FG000|COMPLETED|10-day Washout Following Period 2||2||
48331839|NCT01582308|101141712|FG001|COMPLETED|10-day Washout Following Period 2||2||
48331840|NCT01582308|101141713|FG002|COMPLETED|10-day Washout Following Period 2||2||
48331841|NCT01582308|101141714|FG003|COMPLETED|10-day Washout Following Period 2||2||
48331842|NCT01582308|101141715|FG004|COMPLETED|10-day Washout Following Period 2||2||
48331843|NCT01582308|101141716|FG005|COMPLETED|10-day Washout Following Period 2||2||
48331844|NCT01582308|101141717|FG006|COMPLETED|10-day Washout Following Period 2||2||
48331845|NCT01582308|101141718|FG007|COMPLETED|10-day Washout Following Period 2||2||
48331846|NCT01582308|101141719|FG008|COMPLETED|10-day Washout Following Period 2||2||
48625743|NCT01126099|101867537|FG001|NOT COMPLETED|Open-label Extension||1||
48625744|NCT00747916|101867538|FG000|STARTED|Overall Study||3||
48625745|NCT00747916|101867538|FG000|COMPLETED|Overall Study||3||
48331847|NCT01582308|101141720|FG009|COMPLETED|10-day Washout Following Period 2||2||
48331848|NCT01582308|101141711|FG000|NOT COMPLETED|10-day Washout Following Period 2||0||
48331849|NCT01582308|101141712|FG001|NOT COMPLETED|10-day Washout Following Period 2||0||
48331850|NCT01582308|101141713|FG002|NOT COMPLETED|10-day Washout Following Period 2||0||
48331851|NCT01582308|101141714|FG003|NOT COMPLETED|10-day Washout Following Period 2||0||
48368085|NCT03032068|101230103|FG000|Preoperative Visit|Overall Study||10||
48748685|NCT04426318|102169646|FG000|Completed T6 Assessment|Overall Study||286||
48748686|NCT04426318|102169647|FG001|Completed T6 Assessment|Overall Study||293||
48625746|NCT00747916|101867538|FG000|NOT COMPLETED|Overall Study||0||
48625747|NCT00735709|101867539|FG000|STARTED|Overall Study||140||
48625748|NCT00735709|101867540|FG001|STARTED|Overall Study||140||
48625749|NCT00735709|101867541|FG002|STARTED|Overall Study||140||
48625750|NCT00735709|101867542|FG003|STARTED|Overall Study||140||
48625751|NCT00735709|101867539|FG000|Treated|Overall Study||140||
48625752|NCT00735709|101867540|FG001|Treated|Overall Study||140||
48625753|NCT00735709|101867541|FG002|Treated|Overall Study||140||
48625754|NCT00735709|101867542|FG003|Treated|Overall Study||139||
48625755|NCT00735709|101867539|FG000|COMPLETED|Overall Study||127||
48748687|NCT04426318|102169646|FG000|Final Intent to Treat Sample|Overall Study||344||
48748688|NCT04426318|102169647|FG001|Final Intent to Treat Sample|Overall Study||318||
48748689|NCT04426318|102169646|FG000|COMPLETED|Overall Study||344||
48748690|NCT04426318|102169647|FG001|COMPLETED|Overall Study||318||
48748691|NCT04426318|102169646|FG000|NOT COMPLETED|Overall Study||2||
48748692|NCT04426318|102169647|FG001|NOT COMPLETED|Overall Study||2||
48767673|NCT01656408|102222802|FG008|STARTED|Overall Study||18||
48767674|NCT01656408|102222803|FG009|STARTED|Overall Study||18||
48767675|NCT01656408|102222794|FG000|COMPLETED|Overall Study||7||
48767676|NCT01656408|102222795|FG001|COMPLETED|Overall Study||8||
48767677|NCT01656408|102222796|FG002|COMPLETED|Overall Study||6||
48767678|NCT01656408|102222797|FG003|COMPLETED|Overall Study||7||
48767679|NCT01656408|102222798|FG004|COMPLETED|Overall Study||8||
48767680|NCT01656408|102222799|FG005|COMPLETED|Overall Study||7||
48767681|NCT01656408|102222800|FG006|COMPLETED|Overall Study||9||
48767682|NCT01656408|102222801|FG007|COMPLETED|Overall Study||7||
48767683|NCT01656408|102222802|FG008|COMPLETED|Overall Study||16||
48767684|NCT01656408|102222803|FG009|COMPLETED|Overall Study||15||
48767685|NCT01656408|102222794|FG000|NOT COMPLETED|Overall Study||1||
48767686|NCT01656408|102222795|FG001|NOT COMPLETED|Overall Study||0||
48767687|NCT01656408|102222796|FG002|NOT COMPLETED|Overall Study||2||
48767688|NCT01656408|102222797|FG003|NOT COMPLETED|Overall Study||0||
48767689|NCT01656408|102222798|FG004|NOT COMPLETED|Overall Study||1||
48767690|NCT01656408|102222799|FG005|NOT COMPLETED|Overall Study||2||
48767691|NCT01656408|102222800|FG006|NOT COMPLETED|Overall Study||1||
48767692|NCT01656408|102222801|FG007|NOT COMPLETED|Overall Study||1||
48767693|NCT01656408|102222802|FG008|NOT COMPLETED|Overall Study||2||
48767694|NCT01656408|102222803|FG009|NOT COMPLETED|Overall Study||3||
48767695|NCT02267837|102222804|FG000|STARTED|Overall Study||11||
48767696|NCT02267837|102222805|FG001|STARTED|Overall Study||9||
48767697|NCT02267837|102222804|FG000|COMPLETED|Overall Study||11||
48767698|NCT02267837|102222805|FG001|COMPLETED|Overall Study||9||
48767699|NCT02267837|102222804|FG000|NOT COMPLETED|Overall Study||0||
48767700|NCT02267837|102222805|FG001|NOT COMPLETED|Overall Study||0||
48767701|NCT02556177|102222806|FG000|STARTED|Overall Study||325||
48767702|NCT02556177|102222807|FG001|STARTED|Overall Study||152||
48625756|NCT00735709|101867540|FG001|COMPLETED|Overall Study||127||
48625757|NCT00735709|101867541|FG002|COMPLETED|Overall Study||129||
48625758|NCT00735709|101867542|FG003|COMPLETED|Overall Study||122||
48625759|NCT00735709|101867539|FG000|NOT COMPLETED|Overall Study||13||
48625760|NCT00735709|101867540|FG001|NOT COMPLETED|Overall Study||13||
48625761|NCT00735709|101867541|FG002|NOT COMPLETED|Overall Study||11||
48625762|NCT00735709|101867542|FG003|NOT COMPLETED|Overall Study||18||
48625763|NCT02781324|101867543|FG000|STARTED|Overall Study||33||
48767703|NCT02556177|102222806|FG000|COMPLETED|Overall Study||42||
48767704|NCT02556177|102222807|FG001|COMPLETED|Overall Study||91||
48767705|NCT02556177|102222806|FG000|NOT COMPLETED|Overall Study||283||
48767706|NCT02556177|102222807|FG001|NOT COMPLETED|Overall Study||61||
48767707|NCT03856788|102222808|FG000|STARTED|Overall Study||23||
48767708|NCT03856788|102222809|FG001|STARTED|Overall Study||20||
48767709|NCT03856788|102222808|FG000|COMPLETED|Overall Study||21||
48767710|NCT03856788|102222809|FG001|COMPLETED|Overall Study||19||
48767711|NCT03856788|102222808|FG000|NOT COMPLETED|Overall Study||2||
48767712|NCT03856788|102222809|FG001|NOT COMPLETED|Overall Study||1||
48767713|NCT01112917|102222810|FG000|STARTED|Overall Study||96||
48767714|NCT01112917|102222811|FG001|STARTED|Overall Study||53||
48767715|NCT01112917|102222810|FG000|COMPLETED|Overall Study||89||
48625764|NCT02781324|101867544|FG001|STARTED|Overall Study||33||
48625765|NCT02781324|101867543|FG000|COMPLETED|Overall Study||31||
48625766|NCT02781324|101867544|FG001|COMPLETED|Overall Study||31||
48625767|NCT02781324|101867543|FG000|NOT COMPLETED|Overall Study||2||
48625768|NCT02781324|101867544|FG001|NOT COMPLETED|Overall Study||2||
48625769|NCT00746551|101867545|FG000|STARTED|At Gestational Age of 36 Weeks||40||
48625770|NCT00746551|101867546|FG001|STARTED|At Gestational Age of 36 Weeks||40||
48748693|NCT02055898|102172872|FG000|STARTED|First Intervention (5 Days)||7||
48748694|NCT02055898|102172873|FG001|STARTED|First Intervention (5 Days)||6||
48748695|NCT02055898|102172872|FG000|COMPLETED|First Intervention (5 Days)||5||
48748696|NCT02055898|102172873|FG001|COMPLETED|First Intervention (5 Days)||5||
48748697|NCT02055898|102172872|FG000|NOT COMPLETED|First Intervention (5 Days)||2||
48748698|NCT02055898|102172873|FG001|NOT COMPLETED|First Intervention (5 Days)||1||
48748699|NCT02055898|102172872|FG000|STARTED|Washout (at Least 14 Days)||5||
48748700|NCT02055898|102172873|FG001|STARTED|Washout (at Least 14 Days)||5||
48748701|NCT02055898|102172872|FG000|COMPLETED|Washout (at Least 14 Days)||5||
48748702|NCT02055898|102172873|FG001|COMPLETED|Washout (at Least 14 Days)||5||
48748703|NCT02055898|102172872|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0||
48748704|NCT02055898|102172873|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0||
48748705|NCT02055898|102172872|FG000|STARTED|Second Intervention (5 Days)||5||
48748706|NCT02055898|102172873|FG001|STARTED|Second Intervention (5 Days)||5||
48748707|NCT02055898|102172872|FG000|COMPLETED|Second Intervention (5 Days)||5||
48748708|NCT02055898|102172873|FG001|COMPLETED|Second Intervention (5 Days)||5||
48748709|NCT02055898|102172872|FG000|NOT COMPLETED|Second Intervention (5 Days)||0||
48748710|NCT02055898|102172873|FG001|NOT COMPLETED|Second Intervention (5 Days)||0||
48748711|NCT00230126|102172874|FG000|STARTED|Overall Study||30||
48748712|NCT00230126|102172875|FG001|STARTED|Overall Study||28||
48748713|NCT00230126|102172874|FG000|COMPLETED|Overall Study||28||
48748714|NCT00230126|102172875|FG001|COMPLETED|Overall Study||27||
48748715|NCT00230126|102172874|FG000|NOT COMPLETED|Overall Study||2||
48748716|NCT00230126|102172875|FG001|NOT COMPLETED|Overall Study||1||
48748717|NCT02451917|102172876|FG000|STARTED|First Intervention (24 Weeks)||16||
48748718|NCT02451917|102172877|FG001|STARTED|First Intervention (24 Weeks)||18||
48748719|NCT02451917|102172876|FG000|COMPLETED|First Intervention (24 Weeks)||14||
48748720|NCT02451917|102172877|FG001|COMPLETED|First Intervention (24 Weeks)||15||
48748721|NCT02451917|102172876|FG000|NOT COMPLETED|First Intervention (24 Weeks)||2||
48748722|NCT02451917|102172877|FG001|NOT COMPLETED|First Intervention (24 Weeks)||3||
48625771|NCT00746551|101867545|FG000|COMPLETED|At Gestational Age of 36 Weeks||38||
48625772|NCT00746551|101867546|FG001|COMPLETED|At Gestational Age of 36 Weeks||36||
48625773|NCT00746551|101867545|FG000|NOT COMPLETED|At Gestational Age of 36 Weeks||2||
48625774|NCT00746551|101867546|FG001|NOT COMPLETED|At Gestational Age of 36 Weeks||4||
48625775|NCT00746551|101867545|FG000|STARTED|At Delivery (GA of 39 Weeks)||40||
48625776|NCT00746551|101867546|FG001|STARTED|At Delivery (GA of 39 Weeks)||40||
48625777|NCT00746551|101867545|FG000|COMPLETED|At Delivery (GA of 39 Weeks)||25||
48625778|NCT00746551|101867546|FG001|COMPLETED|At Delivery (GA of 39 Weeks)||25||
48625779|NCT00746551|101867545|FG000|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15||
48625780|NCT00746551|101867546|FG001|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15||
48625781|NCT01204671|101867547|FG000|STARTED|Overall Study||1012||
48625782|NCT01204671|101867548|FG001|STARTED|Overall Study||1013||
48625783|NCT01204671|101867549|FG002|STARTED|Overall Study||1011||
48625784|NCT01204671|101867550|FG003|STARTED|Overall Study||1010||
48625785|NCT01204671|101867551|FG004|STARTED|Overall Study||610||
48625786|NCT01204671|101867547|FG000|COMPLETED|Overall Study||998||
48625787|NCT01204671|101867548|FG001|COMPLETED|Overall Study||998||
48625788|NCT01204671|101867549|FG002|COMPLETED|Overall Study||998||
48625789|NCT01204671|101867550|FG003|COMPLETED|Overall Study||997||
48625790|NCT01204671|101867551|FG004|COMPLETED|Overall Study||606||
48625791|NCT01204671|101867547|FG000|NOT COMPLETED|Overall Study||14||
48625792|NCT01204671|101867548|FG001|NOT COMPLETED|Overall Study||15||
48625793|NCT01204671|101867549|FG002|NOT COMPLETED|Overall Study||13||
48625794|NCT01204671|101867550|FG003|NOT COMPLETED|Overall Study||13||
48625795|NCT01204671|101867551|FG004|NOT COMPLETED|Overall Study||4||
48625796|NCT02572453|101867552|FG000|STARTED|Overall Study||1||
48625797|NCT02572453|101867553|FG001|STARTED|Overall Study||4||
48168042|NCT02667886|100735643|FG001|Received at Least 1 Dose of Study Drug|Dose Escalation and Expansion (Part C)||0||
48625798|NCT02572453|101867554|FG002|STARTED|Overall Study||20||
48625799|NCT02572453|101867552|FG000|COMPLETED|Overall Study||1||
48625800|NCT02572453|101867553|FG001|COMPLETED|Overall Study||4||
48625801|NCT02572453|101867554|FG002|COMPLETED|Overall Study||20||
48625802|NCT02572453|101867552|FG000|NOT COMPLETED|Overall Study||0||
48625803|NCT02572453|101867553|FG001|NOT COMPLETED|Overall Study||0||
48625804|NCT02572453|101867554|FG002|NOT COMPLETED|Overall Study||0||
48625805|NCT00552695|101867555|FG000|STARTED|Overall Study||22||
48625806|NCT00552695|101867556|FG001|STARTED|Overall Study||23||
48625807|NCT00552695|101867555|FG000|COMPLETED|Overall Study||22||
48625808|NCT00552695|101867556|FG001|COMPLETED|Overall Study||23||
48625809|NCT00552695|101867555|FG000|NOT COMPLETED|Overall Study||0||
48625810|NCT00552695|101867556|FG001|NOT COMPLETED|Overall Study||0||
48625811|NCT01575080|101867557|FG000|STARTED|Overall Study||102||
48625812|NCT01575080|101867557|FG000|COMPLETED|Overall Study||102||
48168043|NCT02667886|100735644|FG002|Received at Least 1 Dose of Study Drug|Dose Escalation and Expansion (Part C)||0||
48625813|NCT01575080|101867557|FG000|NOT COMPLETED|Overall Study||0||
48625814|NCT02124824|101867558|FG000|STARTED|Overall Study||15||
48625815|NCT02124824|101867559|FG001|STARTED|Overall Study||15||
48625816|NCT02124824|101867558|FG000|COMPLETED|Overall Study||15||
48625817|NCT02124824|101867559|FG001|COMPLETED|Overall Study||15||
48625818|NCT02124824|101867558|FG000|NOT COMPLETED|Overall Study||0||
48625819|NCT02124824|101867559|FG001|NOT COMPLETED|Overall Study||0||
48625820|NCT02247466|101867560|FG000|STARTED|Overall Study||19||
48625821|NCT02247466|101867561|FG001|STARTED|Overall Study||18||
48625822|NCT02247466|101867560|FG000|COMPLETED|Overall Study||19||
48625823|NCT02247466|101867561|FG001|COMPLETED|Overall Study||15||
48625824|NCT02247466|101867560|FG000|NOT COMPLETED|Overall Study||0||
48625825|NCT02247466|101867561|FG001|NOT COMPLETED|Overall Study||3||
48625826|NCT03585270|101867562|FG000|STARTED|Overall Study||203|Randomized Analysis Set|
48625827|NCT03585270|101867563|FG001|STARTED|Overall Study||206|Randomized Analysis Set|
48625828|NCT03585270|101867562|FG000|Not Treated|Overall Study||1|Participants were randomized but not treated|
48625829|NCT03585270|101867563|FG001|Not Treated|Overall Study||2|Participants were randomized but not treated|
48625830|NCT03585270|101867562|FG000|Started Treatment (Assigned Treatment Groups)|Overall Study||202|Full Analysis Set: all randomized participants who started study treatment, evaluated according to assigned treatment.|
48625831|NCT03585270|101867563|FG001|Started Treatment (Assigned Treatment Groups)|Overall Study||204|Full Analysis Set: all randomized participants who started study treatment, evaluated according to assigned treatment.|
48625832|NCT03585270|101867562|FG000|Started Treatment (Actual Treatment Received)|Overall Study||207|Safety Analysis Set: all randomized participants who started study treatment, evaluated according to the actual treatment received. Note that 5 participants randomized to placebo received at least 1 infusion of clazosentan and were analyzed as part of the clazosentan arm for this analysis set.|
48625833|NCT03585270|101867563|FG001|Started Treatment (Actual Treatment Received)|Overall Study||199|Safety Analysis Set: all randomized participants who started study treatment, evaluated according to the actual treatment received. Note that 5 participants randomized to placebo received at least 1 infusion of clazosentan and were analyzed as part of the clazosentan arm for this analysis set.|
48625834|NCT03585270|101867562|FG000|COMPLETED|Overall Study||187||
48625835|NCT03585270|101867563|FG001|COMPLETED|Overall Study||189||
48625836|NCT03585270|101867562|FG000|NOT COMPLETED|Overall Study||16||
48625837|NCT03585270|101867563|FG001|NOT COMPLETED|Overall Study||17||
48625838|NCT01035749|101867564|FG000|STARTED|Overall Study||66||
48625839|NCT01035749|101867565|FG001|STARTED|Overall Study||66||
48625840|NCT01035749|101867566|FG002|STARTED|Overall Study||68||
48625841|NCT01035749|101867567|FG003|STARTED|Overall Study||110||
48625842|NCT01035749|101867564|FG000|COMPLETED|Overall Study||66||
48625843|NCT01035749|101867565|FG001|COMPLETED|Overall Study||66||
48625844|NCT01035749|101867566|FG002|COMPLETED|Overall Study||68||
48625845|NCT01035749|101867567|FG003|COMPLETED|Overall Study||110||
48625846|NCT01035749|101867564|FG000|NOT COMPLETED|Overall Study||0||
48625847|NCT01035749|101867565|FG001|NOT COMPLETED|Overall Study||0||
48625848|NCT01035749|101867566|FG002|NOT COMPLETED|Overall Study||0||
48625849|NCT01035749|101867567|FG003|NOT COMPLETED|Overall Study||0||
48625850|NCT02084511|101867568|FG000|STARTED|Overall Study||20||
48625851|NCT02084511|101867569|FG001|STARTED|Overall Study||20||
48625852|NCT02084511|101867570|FG002|STARTED|Overall Study||20||
48625853|NCT02084511|101867571|FG003|STARTED|Overall Study||20||
48625854|NCT02084511|101867568|FG000|COMPLETED|Overall Study||20||
48625855|NCT02084511|101867569|FG001|COMPLETED|Overall Study||20||
48625856|NCT02084511|101867570|FG002|COMPLETED|Overall Study||20||
48625857|NCT02084511|101867571|FG003|COMPLETED|Overall Study||20||
48625858|NCT02084511|101867568|FG000|NOT COMPLETED|Overall Study||0||
48625859|NCT02084511|101867569|FG001|NOT COMPLETED|Overall Study||0||
48625860|NCT02084511|101867570|FG002|NOT COMPLETED|Overall Study||0||
48625861|NCT02084511|101867571|FG003|NOT COMPLETED|Overall Study||0||
48625862|NCT02115984|101867572|FG000|STARTED|Overall Study||57||
48625863|NCT02115984|101867573|FG001|STARTED|Overall Study||23||
48625864|NCT02115984|101867572|FG000|COMPLETED|Overall Study||51||
48625865|NCT02115984|101867573|FG001|COMPLETED|Overall Study||16||
48625866|NCT02115984|101867572|FG000|NOT COMPLETED|Overall Study||6||
48625867|NCT02115984|101867573|FG001|NOT COMPLETED|Overall Study||7||
48625868|NCT00465530|101867574|FG000|STARTED|Overall Study||21||
48625869|NCT00465530|101867575|FG001|STARTED|Overall Study||19||
48625870|NCT00465530|101867574|FG000|COMPLETED|Overall Study||19||
48625871|NCT00465530|101867575|FG001|COMPLETED|Overall Study||15||
48625872|NCT00465530|101867574|FG000|NOT COMPLETED|Overall Study||2||
48410929|NCT01388491|101337762|FG000|NOT COMPLETED|Overall Study||34||
48410930|NCT01388491|101337763|FG001|NOT COMPLETED|Overall Study||29||
48410931|NCT00683774|101337764|FG000|STARTED|Overall Study||11||
48410932|NCT00683774|101337765|FG001|STARTED|Overall Study||10||
48410933|NCT00683774|101337764|FG000|COMPLETED|Overall Study||8||
48410934|NCT00683774|101337765|FG001|COMPLETED|Overall Study||9||
48410935|NCT00683774|101337764|FG000|NOT COMPLETED|Overall Study||3||
48410936|NCT00683774|101337765|FG001|NOT COMPLETED|Overall Study||1||
48410937|NCT03148899|101337766|FG000|STARTED|Overall Study||16||
48625873|NCT00465530|101867575|FG001|NOT COMPLETED|Overall Study||4||
48625874|NCT02087774|101867576|FG000|STARTED|Overall Study||150||
48625875|NCT02087774|101867577|FG001|STARTED|Overall Study||150||
48625876|NCT02087774|101867576|FG000|COMPLETED|Overall Study||142||
48625877|NCT02087774|101867577|FG001|COMPLETED|Overall Study||130||
48625878|NCT02087774|101867576|FG000|NOT COMPLETED|Overall Study||8||
48625879|NCT02087774|101867577|FG001|NOT COMPLETED|Overall Study||20||
48168044|NCT02667886|100735645|FG003|Received at Least 1 Dose of Study Drug|Dose Escalation and Expansion (Part C)||0||
48410938|NCT03148899|101337767|FG001|STARTED|Overall Study||16||
48410939|NCT03148899|101337766|FG000|COMPLETED|Overall Study||16||
48410940|NCT03148899|101337767|FG001|COMPLETED|Overall Study||16||
48410941|NCT03148899|101337766|FG000|NOT COMPLETED|Overall Study||0||
48410942|NCT03148899|101337767|FG001|NOT COMPLETED|Overall Study||0||
48625880|NCT05770713|101867578|FG000|STARTED|Overall Study||48||
48625881|NCT05770713|101867578|FG000|COMPLETED|Overall Study||48||
48625882|NCT05770713|101867578|FG000|NOT COMPLETED|Overall Study||0||
48625883|NCT01200329|101867579|FG000|STARTED|Overall Study||81||
48625884|NCT01200329|101867579|FG000|COMPLETED|Overall Study||78||
48625885|NCT01200329|101867579|FG000|NOT COMPLETED|Overall Study||3||
48625886|NCT03368807|101867580|FG000|STARTED|Period 1 (Blinded CGM)||79||
48625887|NCT03368807|101867580|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Blinded CGM)||78||
48625888|NCT03368807|101867580|FG000|COMPLETED|Period 1 (Blinded CGM)||73||
48625889|NCT03368807|101867580|FG000|NOT COMPLETED|Period 1 (Blinded CGM)||6||
48625890|NCT03368807|101867580|FG000|STARTED|Period 2 (Unblinded CGM)||73||
48625891|NCT03368807|101867580|FG000|COMPLETED|Period 2 (Unblinded CGM)||73||
48625892|NCT03368807|101867580|FG000|NOT COMPLETED|Period 2 (Unblinded CGM)||0||
48625893|NCT01307956|101867581|FG000|STARTED|Overall Study||11||
48625894|NCT01307956|101867581|FG000|COMPLETED|Overall Study||11||
48625895|NCT01307956|101867581|FG000|NOT COMPLETED|Overall Study||0||
48188610|NCT00432159|100783284|FG002|NOT COMPLETED|Overall Study||4||
48410943|NCT03344562|101337768|FG000|STARTED|Overall Study||10||
48625896|NCT02812186|101867582|FG000|STARTED|Period 1||40||
48625897|NCT02812186|101867583|FG001|STARTED|Period 1||39||
48625898|NCT02812186|101867582|FG000|COMPLETED|Period 1||29||
48625899|NCT02812186|101867583|FG001|COMPLETED|Period 1||24||
48625900|NCT02812186|101867582|FG000|NOT COMPLETED|Period 1||11||
48625901|NCT02812186|101867583|FG001|NOT COMPLETED|Period 1||15||
48625902|NCT02812186|101867582|FG000|STARTED|Period 2||29||
48410944|NCT03344562|101337769|FG001|STARTED|Overall Study||9||
48331852|NCT01582308|101141715|FG004|NOT COMPLETED|10-day Washout Following Period 2||0||
48331853|NCT01582308|101141716|FG005|NOT COMPLETED|10-day Washout Following Period 2||0||
48331854|NCT01582308|101141717|FG006|NOT COMPLETED|10-day Washout Following Period 2||0||
48331855|NCT01582308|101141718|FG007|NOT COMPLETED|10-day Washout Following Period 2||0||
48331856|NCT01582308|101141719|FG008|NOT COMPLETED|10-day Washout Following Period 2||0||
48331857|NCT01582308|101141720|FG009|NOT COMPLETED|10-day Washout Following Period 2||0||
48331858|NCT01582308|101141711|FG000|STARTED|Period 3||2||
48410945|NCT03344562|101337768|FG000|COMPLETED|Overall Study||8||
48410946|NCT03344562|101337769|FG001|COMPLETED|Overall Study||9||
48410947|NCT03344562|101337768|FG000|NOT COMPLETED|Overall Study||2||
48410948|NCT03344562|101337769|FG001|NOT COMPLETED|Overall Study||0||
48410949|NCT03733132|101337770|FG000|STARTED|Overall Study||20||
48625903|NCT02812186|101867583|FG001|STARTED|Period 2||24||
48625904|NCT02812186|101867582|FG000|COMPLETED|Period 2||29||
48625905|NCT02812186|101867583|FG001|COMPLETED|Period 2||24||
48625906|NCT02812186|101867582|FG000|NOT COMPLETED|Period 2||0||
48625907|NCT02812186|101867583|FG001|NOT COMPLETED|Period 2||0||
48625908|NCT02654639|101867584|FG000|STARTED|Overall Study||4||
48625909|NCT02654639|101867584|FG000|COMPLETED|Overall Study||4||
48625910|NCT02654639|101867584|FG000|NOT COMPLETED|Overall Study||0||
48410950|NCT03733132|101337771|FG001|STARTED|Overall Study||20||
48410951|NCT03733132|101337770|FG000|COMPLETED|Overall Study||20||
48410952|NCT03733132|101337771|FG001|COMPLETED|Overall Study||20||
48625911|NCT02806713|101867585|FG000|STARTED|Overall Study||46||
48625912|NCT02806713|101867586|FG001|STARTED|Overall Study||46||
48625913|NCT02806713|101867585|FG000|COMPLETED|Overall Study||44||
48625914|NCT02806713|101867586|FG001|COMPLETED|Overall Study||44||
48625915|NCT02806713|101867585|FG000|NOT COMPLETED|Overall Study||2||
48625916|NCT02806713|101867586|FG001|NOT COMPLETED|Overall Study||2||
48625917|NCT02280252|101867587|FG000|STARTED|Overall Study||0||
48625918|NCT02280252|101867587|FG000|COMPLETED|Overall Study||0||
48625919|NCT02280252|101867587|FG000|NOT COMPLETED|Overall Study||0||
48625920|NCT00468585|101867588|FG000|STARTED|Overall Study||4||
48625921|NCT00468585|101867589|FG001|STARTED|Overall Study||3||
48625922|NCT00468585|101867590|FG002|STARTED|Overall Study||50||
48625923|NCT00468585|101867591|FG003|STARTED|Overall Study||6||
48625924|NCT00468585|101867588|FG000|COMPLETED|Overall Study||3||
48410953|NCT03733132|101337770|FG000|NOT COMPLETED|Overall Study||0||
48410954|NCT03733132|101337771|FG001|NOT COMPLETED|Overall Study||0||
48410955|NCT02177786|101337772|FG000|STARTED|Overall Study||81||
48410956|NCT02177786|101337773|FG001|STARTED|Overall Study||84||
48410957|NCT02177786|101337774|FG002|STARTED|Overall Study||84||
48410958|NCT02177786|101337775|FG003|STARTED|Overall Study||85||
48410959|NCT02177786|101337772|FG000|Randomized and Treated|Overall Study||81||
48410960|NCT02177786|101337773|FG001|Randomized and Treated|Overall Study||84||
48410961|NCT02177786|101337774|FG002|Randomized and Treated|Overall Study||83||
48410962|NCT02177786|101337775|FG003|Randomized and Treated|Overall Study||85||
48410963|NCT02177786|101337772|FG000|COMPLETED|Overall Study||75||
48410964|NCT02177786|101337773|FG001|COMPLETED|Overall Study||70||
48410965|NCT02177786|101337774|FG002|COMPLETED|Overall Study||66||
48410966|NCT02177786|101337775|FG003|COMPLETED|Overall Study||72||
48410967|NCT02177786|101337772|FG000|NOT COMPLETED|Overall Study||6||
48410968|NCT02177786|101337773|FG001|NOT COMPLETED|Overall Study||14||
48410969|NCT02177786|101337774|FG002|NOT COMPLETED|Overall Study||18||
48410970|NCT02177786|101337775|FG003|NOT COMPLETED|Overall Study||13||
48410971|NCT00402285|101337776|FG000|STARTED|Overall Study||29||
48410972|NCT00402285|101337777|FG001|STARTED|Overall Study||27||
48410973|NCT00402285|101337778|FG002|STARTED|Overall Study||28||
48410974|NCT00402285|101337776|FG000|COMPLETED|Overall Study||22||
48410975|NCT00402285|101337777|FG001|COMPLETED|Overall Study||21||
48410976|NCT00402285|101337778|FG002|COMPLETED|Overall Study||26||
48410977|NCT00402285|101337776|FG000|NOT COMPLETED|Overall Study||7||
48410978|NCT00402285|101337777|FG001|NOT COMPLETED|Overall Study||6||
48410979|NCT00402285|101337778|FG002|NOT COMPLETED|Overall Study||2||
48625925|NCT00468585|101867589|FG001|COMPLETED|Overall Study||3||
48331859|NCT01582308|101141712|FG001|STARTED|Period 3||2||
48410980|NCT04904640|101337779|FG000|STARTED|Overall Study||150||200
48410981|NCT04904640|101337779|FG000|COMPLETED|Overall Study||150||200
48410982|NCT04904640|101337779|FG000|NOT COMPLETED|Overall Study||0||0
48410983|NCT03261037|101337780|FG000|STARTED|Overall Study||68||
48410984|NCT03261037|101337781|FG001|STARTED|Overall Study||62||
48625926|NCT00468585|101867590|FG002|COMPLETED|Overall Study||45||
48625927|NCT00468585|101867591|FG003|COMPLETED|Overall Study||5||
48625928|NCT00468585|101867588|FG000|NOT COMPLETED|Overall Study||1||
48625929|NCT00468585|101867589|FG001|NOT COMPLETED|Overall Study||0||
48625930|NCT00468585|101867590|FG002|NOT COMPLETED|Overall Study||5||
48331860|NCT01582308|101141713|FG002|STARTED|Period 3||2||
48410985|NCT03261037|101337782|FG002|STARTED|Overall Study||9||
48625931|NCT00468585|101867591|FG003|NOT COMPLETED|Overall Study||1||
48410986|NCT03261037|101337783|FG003|STARTED|Overall Study||39||
48410987|NCT03261037|101337780|FG000|COMPLETED|Overall Study||64||
48410988|NCT03261037|101337781|FG001|COMPLETED|Overall Study||41||
48410989|NCT03261037|101337782|FG002|COMPLETED|Overall Study||9||
48625932|NCT03177395|101867592|FG000|STARTED|Overall Study||6||
48331861|NCT01582308|101141714|FG003|STARTED|Period 3||2||
48331862|NCT01582308|101141715|FG004|STARTED|Period 3||2||
48331863|NCT01582308|101141716|FG005|STARTED|Period 3||2||
48331864|NCT01582308|101141717|FG006|STARTED|Period 3||2||
48331865|NCT01582308|101141718|FG007|STARTED|Period 3||2||
48331866|NCT01582308|101141719|FG008|STARTED|Period 3||2||
48331867|NCT01582308|101141720|FG009|STARTED|Period 3||2||
48331868|NCT01582308|101141711|FG000|COMPLETED|Period 3||2||
48331869|NCT01582308|101141712|FG001|COMPLETED|Period 3||2||
48331870|NCT01582308|101141713|FG002|COMPLETED|Period 3||2||
48331871|NCT01582308|101141714|FG003|COMPLETED|Period 3||2||
48331872|NCT01582308|101141715|FG004|COMPLETED|Period 3||2||
48331873|NCT01582308|101141716|FG005|COMPLETED|Period 3||2||
48331874|NCT01582308|101141717|FG006|COMPLETED|Period 3||2||
48331875|NCT01582308|101141718|FG007|COMPLETED|Period 3||2||
48331876|NCT01582308|101141719|FG008|COMPLETED|Period 3||2||
48331877|NCT01582308|101141720|FG009|COMPLETED|Period 3||2||
48331878|NCT01582308|101141711|FG000|NOT COMPLETED|Period 3||0||
48331879|NCT01582308|101141712|FG001|NOT COMPLETED|Period 3||0||
48331880|NCT01582308|101141713|FG002|NOT COMPLETED|Period 3||0||
48331881|NCT01582308|101141714|FG003|NOT COMPLETED|Period 3||0||
48331882|NCT01582308|101141715|FG004|NOT COMPLETED|Period 3||0||
48331883|NCT01582308|101141716|FG005|NOT COMPLETED|Period 3||0||
48331884|NCT01582308|101141717|FG006|NOT COMPLETED|Period 3||0||
48331885|NCT01582308|101141718|FG007|NOT COMPLETED|Period 3||0||
48331886|NCT01582308|101141719|FG008|NOT COMPLETED|Period 3||0||
48331887|NCT01582308|101141720|FG009|NOT COMPLETED|Period 3||0||
48331888|NCT01582308|101141711|FG000|STARTED|10-day Washout Following Period 3||2||
48331889|NCT01582308|101141712|FG001|STARTED|10-day Washout Following Period 3||2||
48331890|NCT01582308|101141713|FG002|STARTED|10-day Washout Following Period 3||2||
48331891|NCT01582308|101141714|FG003|STARTED|10-day Washout Following Period 3||2||
48331892|NCT01582308|101141715|FG004|STARTED|10-day Washout Following Period 3||2||
48331893|NCT01582308|101141716|FG005|STARTED|10-day Washout Following Period 3||2||
48331894|NCT01582308|101141717|FG006|STARTED|10-day Washout Following Period 3||2||
48331895|NCT01582308|101141718|FG007|STARTED|10-day Washout Following Period 3||2||
48331896|NCT01582308|101141719|FG008|STARTED|10-day Washout Following Period 3||2||
48331897|NCT01582308|101141720|FG009|STARTED|10-day Washout Following Period 3||2||
48331898|NCT01582308|101141711|FG000|COMPLETED|10-day Washout Following Period 3||2||
48331899|NCT01582308|101141712|FG001|COMPLETED|10-day Washout Following Period 3||2||
48331900|NCT01582308|101141713|FG002|COMPLETED|10-day Washout Following Period 3||2||
48331901|NCT01582308|101141714|FG003|COMPLETED|10-day Washout Following Period 3||2||
48748723|NCT02451917|102172876|FG000|STARTED|Second Intervention (24 Weeks)||14||
48748724|NCT02451917|102172877|FG001|STARTED|Second Intervention (24 Weeks)||15||
48748725|NCT02451917|102172876|FG000|COMPLETED|Second Intervention (24 Weeks)||14||
48748726|NCT02451917|102172877|FG001|COMPLETED|Second Intervention (24 Weeks)||15||
48748727|NCT02451917|102172876|FG000|NOT COMPLETED|Second Intervention (24 Weeks)||0||
48331902|NCT01582308|101141715|FG004|COMPLETED|10-day Washout Following Period 3||2||
48331903|NCT01582308|101141716|FG005|COMPLETED|10-day Washout Following Period 3||2||
48331904|NCT01582308|101141717|FG006|COMPLETED|10-day Washout Following Period 3||2||
48331905|NCT01582308|101141718|FG007|COMPLETED|10-day Washout Following Period 3||2||
48331906|NCT01582308|101141719|FG008|COMPLETED|10-day Washout Following Period 3||2||
48331907|NCT01582308|101141720|FG009|COMPLETED|10-day Washout Following Period 3||2||
48331908|NCT01582308|101141711|FG000|NOT COMPLETED|10-day Washout Following Period 3||0||
48331909|NCT01582308|101141712|FG001|NOT COMPLETED|10-day Washout Following Period 3||0||
48331910|NCT01582308|101141713|FG002|NOT COMPLETED|10-day Washout Following Period 3||0||
48331911|NCT01582308|101141714|FG003|NOT COMPLETED|10-day Washout Following Period 3||0||
48331912|NCT01582308|101141715|FG004|NOT COMPLETED|10-day Washout Following Period 3||0||
48331913|NCT01582308|101141716|FG005|NOT COMPLETED|10-day Washout Following Period 3||0||
48331914|NCT01582308|101141717|FG006|NOT COMPLETED|10-day Washout Following Period 3||0||
48331915|NCT01582308|101141718|FG007|NOT COMPLETED|10-day Washout Following Period 3||0||
48331916|NCT01582308|101141719|FG008|NOT COMPLETED|10-day Washout Following Period 3||0||
48331917|NCT01582308|101141720|FG009|NOT COMPLETED|10-day Washout Following Period 3||0||
48331918|NCT01582308|101141711|FG000|STARTED|Period 4||2||
48331919|NCT01582308|101141712|FG001|STARTED|Period 4||2||
48410990|NCT03261037|101337783|FG003|COMPLETED|Overall Study||11||
48410991|NCT03261037|101337780|FG000|NOT COMPLETED|Overall Study||4||
48748728|NCT02451917|102172877|FG001|NOT COMPLETED|Second Intervention (24 Weeks)||0||
48748729|NCT01050634|102172878|FG000|STARTED|Overall Study||980||
48748730|NCT01050634|102172878|FG000|Received Treatment|Overall Study||924||
48748731|NCT01050634|102172878|FG000|COMPLETED|Overall Study||852||
48748732|NCT01050634|102172878|FG000|NOT COMPLETED|Overall Study||128||
48748733|NCT01176032|102172879|FG000|STARTED|Overall Study||37||
48748734|NCT01176032|102172880|FG001|STARTED|Overall Study||37||
48748735|NCT01176032|102172879|FG000|Intention-to-treat (ITT) Population|Overall Study||32||
48748736|NCT01176032|102172880|FG001|Intention-to-treat (ITT) Population|Overall Study||37||
48410992|NCT03261037|101337781|FG001|NOT COMPLETED|Overall Study||21||
48748737|NCT01176032|102172879|FG000|COMPLETED|Overall Study||31||
48748738|NCT01176032|102172880|FG001|COMPLETED|Overall Study||36||
48748739|NCT01176032|102172879|FG000|NOT COMPLETED|Overall Study||6||
48410993|NCT03261037|101337782|FG002|NOT COMPLETED|Overall Study||0||
48331920|NCT01582308|101141713|FG002|STARTED|Period 4||2||
48331921|NCT01582308|101141714|FG003|STARTED|Period 4||2||
48331922|NCT01582308|101141715|FG004|STARTED|Period 4||2||
48331923|NCT01582308|101141716|FG005|STARTED|Period 4||2||
48331924|NCT01582308|101141717|FG006|STARTED|Period 4||2||
48331925|NCT01582308|101141718|FG007|STARTED|Period 4||2||
48331926|NCT01582308|101141719|FG008|STARTED|Period 4||2||
48331927|NCT01582308|101141720|FG009|STARTED|Period 4||2||
48331928|NCT01582308|101141711|FG000|COMPLETED|Period 4||1||
48331929|NCT01582308|101141712|FG001|COMPLETED|Period 4||2||
48331930|NCT01582308|101141713|FG002|COMPLETED|Period 4||2||
48331931|NCT01582308|101141714|FG003|COMPLETED|Period 4||2||
48331932|NCT01582308|101141715|FG004|COMPLETED|Period 4||2||
48331933|NCT01582308|101141716|FG005|COMPLETED|Period 4||1||
48331934|NCT01582308|101141717|FG006|COMPLETED|Period 4||2||
48331935|NCT01582308|101141718|FG007|COMPLETED|Period 4||2||
48331936|NCT01582308|101141719|FG008|COMPLETED|Period 4||2||
48331937|NCT01582308|101141720|FG009|COMPLETED|Period 4||1||
48331938|NCT01582308|101141711|FG000|NOT COMPLETED|Period 4||1||
48331939|NCT01582308|101141712|FG001|NOT COMPLETED|Period 4||0||
48331940|NCT01582308|101141713|FG002|NOT COMPLETED|Period 4||0||
48331941|NCT01582308|101141714|FG003|NOT COMPLETED|Period 4||0||
48331942|NCT01582308|101141715|FG004|NOT COMPLETED|Period 4||0||
48331943|NCT01582308|101141716|FG005|NOT COMPLETED|Period 4||1||
48331944|NCT01582308|101141717|FG006|NOT COMPLETED|Period 4||0||
48331945|NCT01582308|101141718|FG007|NOT COMPLETED|Period 4||0||
48331946|NCT01582308|101141719|FG008|NOT COMPLETED|Period 4||0||
48331947|NCT01582308|101141720|FG009|NOT COMPLETED|Period 4||1||
48331948|NCT01582308|101141711|FG000|STARTED|10-day Washout Following Period 4||1||
48331949|NCT01582308|101141712|FG001|STARTED|10-day Washout Following Period 4||2||
48331950|NCT01582308|101141713|FG002|STARTED|10-day Washout Following Period 4||2||
48331951|NCT01582308|101141714|FG003|STARTED|10-day Washout Following Period 4||2||
48331952|NCT01582308|101141715|FG004|STARTED|10-day Washout Following Period 4||2||
48410994|NCT03261037|101337783|FG003|NOT COMPLETED|Overall Study||28||
48410995|NCT00621244|101337784|FG000|STARTED|Overall Study||86||
48410996|NCT00621244|101337785|FG001|STARTED|Overall Study||34||
48410997|NCT00621244|101337786|FG002|STARTED|Overall Study||33||
48410998|NCT00621244|101337787|FG003|STARTED|Overall Study||23||
48410999|NCT00621244|101337784|FG000|COMPLETED|Overall Study||0||
48411000|NCT00621244|101337785|FG001|COMPLETED|Overall Study||0||
48411001|NCT00621244|101337786|FG002|COMPLETED|Overall Study||0||
48411002|NCT00621244|101337787|FG003|COMPLETED|Overall Study||0||
48411003|NCT00621244|101337784|FG000|NOT COMPLETED|Overall Study||86||
48411004|NCT00621244|101337785|FG001|NOT COMPLETED|Overall Study||34||
48748740|NCT01176032|102172880|FG001|NOT COMPLETED|Overall Study||1||
48411005|NCT00621244|101337786|FG002|NOT COMPLETED|Overall Study||33||
48767716|NCT01112917|102222811|FG001|COMPLETED|Overall Study||38||
48331953|NCT01582308|101141716|FG005|STARTED|10-day Washout Following Period 4||1||
48331954|NCT01582308|101141717|FG006|STARTED|10-day Washout Following Period 4||2||
48331955|NCT01582308|101141718|FG007|STARTED|10-day Washout Following Period 4||2||
48331956|NCT01582308|101141719|FG008|STARTED|10-day Washout Following Period 4||2||
48331957|NCT01582308|101141720|FG009|STARTED|10-day Washout Following Period 4||1||
48331958|NCT01582308|101141711|FG000|COMPLETED|10-day Washout Following Period 4||1||
48331959|NCT01582308|101141712|FG001|COMPLETED|10-day Washout Following Period 4||2||
48331960|NCT01582308|101141713|FG002|COMPLETED|10-day Washout Following Period 4||2||
48331961|NCT01582308|101141714|FG003|COMPLETED|10-day Washout Following Period 4||2||
48411006|NCT00621244|101337787|FG003|NOT COMPLETED|Overall Study||23||
48411007|NCT03797144|101337788|FG000|STARTED|Enrollment||16||
48411008|NCT03797144|101337789|FG001|STARTED|Enrollment||11||
48411009|NCT03797144|101337788|FG000|COMPLETED|Enrollment||12||
48411010|NCT03797144|101337789|FG001|COMPLETED|Enrollment||10||
48411011|NCT03797144|101337788|FG000|NOT COMPLETED|Enrollment||4||
48411012|NCT03797144|101337789|FG001|NOT COMPLETED|Enrollment||1||
48411013|NCT03797144|101337788|FG000|STARTED|Surgery||12||
48411014|NCT03797144|101337789|FG001|STARTED|Surgery||10||
48411015|NCT03797144|101337788|FG000|COMPLETED|Surgery||11||
48411016|NCT03797144|101337789|FG001|COMPLETED|Surgery||10||
48411017|NCT03797144|101337788|FG000|NOT COMPLETED|Surgery||1||
48411018|NCT03797144|101337789|FG001|NOT COMPLETED|Surgery||0||
48411019|NCT03797144|101337788|FG000|STARTED|3 Month||11||
48411020|NCT03797144|101337789|FG001|STARTED|3 Month||10||
48331962|NCT01582308|101141715|FG004|COMPLETED|10-day Washout Following Period 4||2||
48331963|NCT01582308|101141716|FG005|COMPLETED|10-day Washout Following Period 4||1||
48331964|NCT01582308|101141717|FG006|COMPLETED|10-day Washout Following Period 4||2||
48331965|NCT01582308|101141718|FG007|COMPLETED|10-day Washout Following Period 4||2||
48331966|NCT01582308|101141719|FG008|COMPLETED|10-day Washout Following Period 4||2||
48411021|NCT03797144|101337788|FG000|COMPLETED|3 Month||9||
48411022|NCT03797144|101337789|FG001|COMPLETED|3 Month||10||
48331967|NCT01582308|101141720|FG009|COMPLETED|10-day Washout Following Period 4||1||
48331968|NCT01582308|101141711|FG000|NOT COMPLETED|10-day Washout Following Period 4||0||
48411023|NCT03797144|101337788|FG000|NOT COMPLETED|3 Month||2||
48411024|NCT03797144|101337789|FG001|NOT COMPLETED|3 Month||0||
48411025|NCT03797144|101337788|FG000|STARTED|12 Month||9||
48411026|NCT03797144|101337789|FG001|STARTED|12 Month||10||
48411027|NCT03797144|101337788|FG000|COMPLETED|12 Month||1||
48331969|NCT01582308|101141712|FG001|NOT COMPLETED|10-day Washout Following Period 4||0||
48331970|NCT01582308|101141713|FG002|NOT COMPLETED|10-day Washout Following Period 4||0||
48331971|NCT01582308|101141714|FG003|NOT COMPLETED|10-day Washout Following Period 4||0||
48748741|NCT03535974|102172881|FG000|STARTED|First Intervention Weeks 0-6 (V1-V2)||14||
48748742|NCT03535974|102172882|FG001|STARTED|First Intervention Weeks 0-6 (V1-V2)||19||
48748743|NCT03535974|102172883|FG002|STARTED|First Intervention Weeks 0-6 (V1-V2)||5||
48748744|NCT03535974|102172881|FG000|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||12||
48748745|NCT03535974|102172882|FG001|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||17||
48748746|NCT03535974|102172883|FG002|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||5||
48748747|NCT03535974|102172881|FG000|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||2||
48748748|NCT03535974|102172882|FG001|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||2||
48748749|NCT03535974|102172883|FG002|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||0||
48748750|NCT03535974|102172881|FG000|STARTED|Second Intervention Weeks 6-12 (V2-V3)||12||
48748751|NCT03535974|102172882|FG001|STARTED|Second Intervention Weeks 6-12 (V2-V3)||17||
48748752|NCT03535974|102172883|FG002|STARTED|Second Intervention Weeks 6-12 (V2-V3)||5||
48748753|NCT03535974|102172881|FG000|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||12||
48748754|NCT03535974|102172882|FG001|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||17||
48748755|NCT03535974|102172883|FG002|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||5||
48748756|NCT03535974|102172881|FG000|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0||
48748757|NCT03535974|102172882|FG001|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0||
48748758|NCT03535974|102172883|FG002|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0||
48748759|NCT01400698|102172884|FG000|STARTED|Overall Study||23||
48748760|NCT01400698|102172885|FG001|STARTED|Overall Study||23||
48748761|NCT01400698|102172886|FG002|STARTED|Overall Study||2||
48748762|NCT01400698|102172887|FG003|STARTED|Overall Study||14||
48748763|NCT01400698|102172888|FG004|STARTED|Overall Study||14||
48748764|NCT01400698|102172889|FG005|STARTED|Overall Study||15||
48748765|NCT01400698|102172884|FG000|COMPLETED|Overall Study||8||
48748766|NCT01400698|102172885|FG001|COMPLETED|Overall Study||12||
48748767|NCT01400698|102172886|FG002|COMPLETED|Overall Study||0||
48748768|NCT01400698|102172887|FG003|COMPLETED|Overall Study||6||
48748769|NCT01400698|102172888|FG004|COMPLETED|Overall Study||7||
48331972|NCT01582308|101141715|FG004|NOT COMPLETED|10-day Washout Following Period 4||0||
48625933|NCT03177395|101867593|FG001|STARTED|Overall Study||6||
48625934|NCT03177395|101867594|FG002|STARTED|Overall Study||6||
48625935|NCT03177395|101867595|FG003|STARTED|Overall Study||6||
48625936|NCT03177395|101867592|FG000|COMPLETED|Overall Study||6||
48625937|NCT03177395|101867593|FG001|COMPLETED|Overall Study||6||
48625938|NCT03177395|101867594|FG002|COMPLETED|Overall Study||6||
48625939|NCT03177395|101867595|FG003|COMPLETED|Overall Study||6||
48625940|NCT03177395|101867592|FG000|NOT COMPLETED|Overall Study||0||
48625941|NCT03177395|101867593|FG001|NOT COMPLETED|Overall Study||0||
48625942|NCT03177395|101867594|FG002|NOT COMPLETED|Overall Study||0||
48625943|NCT03177395|101867595|FG003|NOT COMPLETED|Overall Study||0||
48625944|NCT03641508|101867596|FG000|STARTED|First Injection||37||
48625945|NCT03641508|101867597|FG001|STARTED|First Injection||32||
48625946|NCT03641508|101867596|FG000|COMPLETED|First Injection||35||
48625947|NCT03641508|101867597|FG001|COMPLETED|First Injection||32||
48625948|NCT03641508|101867596|FG000|NOT COMPLETED|First Injection||2||
48625949|NCT03641508|101867597|FG001|NOT COMPLETED|First Injection||0||
48625950|NCT03641508|101867596|FG000|STARTED|Follow-up/Second Injection||2|Only those who had symptoms at the six-week follow-up received the second injection|
48625951|NCT03641508|101867597|FG001|STARTED|Follow-up/Second Injection||10|Only those who had symptoms at the six-week follow-up received the second injection|
48625952|NCT03641508|101867596|FG000|COMPLETED|Follow-up/Second Injection||2||
48625953|NCT03641508|101867597|FG001|COMPLETED|Follow-up/Second Injection||10||
48625954|NCT03641508|101867596|FG000|NOT COMPLETED|Follow-up/Second Injection||0||
48625955|NCT03641508|101867597|FG001|NOT COMPLETED|Follow-up/Second Injection||0||
48625956|NCT02772666|101867598|FG000|STARTED|O-Glas Then SFT||44||
48748770|NCT01400698|102172889|FG005|COMPLETED|Overall Study||9||
48748771|NCT01400698|102172884|FG000|NOT COMPLETED|Overall Study||15||
48748772|NCT01400698|102172885|FG001|NOT COMPLETED|Overall Study||11||
48625957|NCT02772666|101867598|FG000|COMPLETED|O-Glas Then SFT||44||
48625958|NCT02772666|101867598|FG000|NOT COMPLETED|O-Glas Then SFT||0||
48625959|NCT02772666|101867598|FG000|STARTED|SFT Then O-Glass||44||
48625960|NCT02772666|101867598|FG000|COMPLETED|SFT Then O-Glass||44||
48625961|NCT02772666|101867598|FG000|NOT COMPLETED|SFT Then O-Glass||0||
48625962|NCT01443858|101867599|FG000|STARTED|Overall Study||25||
48625963|NCT01443858|101867600|FG001|STARTED|Overall Study||25||
48625964|NCT01443858|101867601|FG002|STARTED|Overall Study||25||
48625965|NCT01443858|101867599|FG000|COMPLETED|Overall Study||10||
48625966|NCT01443858|101867600|FG001|COMPLETED|Overall Study||12||
48625967|NCT01443858|101867601|FG002|COMPLETED|Overall Study||18||
48625968|NCT01443858|101867599|FG000|NOT COMPLETED|Overall Study||15||
48625969|NCT01443858|101867600|FG001|NOT COMPLETED|Overall Study||13||
48625970|NCT01443858|101867601|FG002|NOT COMPLETED|Overall Study||7||
48625971|NCT05088772|101867602|FG000|STARTED|Overall Study||86||
48625972|NCT05088772|101867602|FG000|COMPLETED|Overall Study||86||
48625973|NCT05088772|101867602|FG000|NOT COMPLETED|Overall Study||0||
48625974|NCT00496769|101867603|FG000|STARTED|Double Blind||2807||
48625975|NCT00496769|101867604|FG001|STARTED|Double Blind||2791||
48625976|NCT00496769|101867605|FG002|STARTED|Double Blind||0||
48625977|NCT00496769|101867603|FG000|Received Treatment|Double Blind||2798||
48625978|NCT00496769|101867604|FG001|Received Treatment|Double Blind||2708||
48625979|NCT00496769|101867605|FG002|Received Treatment|Double Blind||0||
48625980|NCT00496769|101867603|FG000|COMPLETED|Double Blind||2249||
48625981|NCT00496769|101867604|FG001|COMPLETED|Double Blind||2142||
48625982|NCT00496769|101867605|FG002|COMPLETED|Double Blind||0||
48625983|NCT00496769|101867603|FG000|NOT COMPLETED|Double Blind||558||
48625984|NCT00496769|101867604|FG001|NOT COMPLETED|Double Blind||649||
48625985|NCT00496769|101867605|FG002|NOT COMPLETED|Double Blind||0||
48625986|NCT00496769|101867603|FG000|STARTED|Open Label||0||
48625987|NCT00496769|101867604|FG001|STARTED|Open Label||0||
48625988|NCT00496769|101867605|FG002|STARTED|Open Label||3275||
48625989|NCT00496769|101867603|FG000|COMPLETED|Open Label||0||
48625990|NCT00496769|101867604|FG001|COMPLETED|Open Label||0||
48625991|NCT00496769|101867605|FG002|COMPLETED|Open Label||2264||
48625992|NCT00496769|101867603|FG000|NOT COMPLETED|Open Label||0||
48625993|NCT00496769|101867604|FG001|NOT COMPLETED|Open Label||0||
48625994|NCT00496769|101867605|FG002|NOT COMPLETED|Open Label||1011||
48625995|NCT04418947|101867606|FG000|STARTED|Overall Study||1108||
48625996|NCT04418947|101867607|FG001|STARTED|Overall Study||1351||
48625997|NCT04418947|101867608|FG002|STARTED|Overall Study||1351||
48625998|NCT04418947|101867609|FG003|STARTED|Overall Study||3655||
48625999|NCT04418947|101867610|FG004|STARTED|Overall Study||3655||
48626000|NCT04418947|101867606|FG000|COMPLETED|Overall Study||1108||
48626001|NCT04418947|101867607|FG001|COMPLETED|Overall Study||1351||
48626002|NCT04418947|101867608|FG002|COMPLETED|Overall Study||1351||
48626003|NCT04418947|101867609|FG003|COMPLETED|Overall Study||3655||
48626004|NCT04418947|101867610|FG004|COMPLETED|Overall Study||3655||
48626005|NCT04418947|101867606|FG000|NOT COMPLETED|Overall Study||0||
48626006|NCT04418947|101867607|FG001|NOT COMPLETED|Overall Study||0||
48626007|NCT04418947|101867608|FG002|NOT COMPLETED|Overall Study||0||
48626008|NCT04418947|101867609|FG003|NOT COMPLETED|Overall Study||0||
48626009|NCT04418947|101867610|FG004|NOT COMPLETED|Overall Study||0||
48626010|NCT01733277|101867611|FG000|STARTED|Overall Study||25||
48626011|NCT01733277|101867612|FG001|STARTED|Overall Study||25||
48626012|NCT01733277|101867611|FG000|COMPLETED|Overall Study||25||
48626013|NCT01733277|101867612|FG001|COMPLETED|Overall Study||25||
48626014|NCT01733277|101867611|FG000|NOT COMPLETED|Overall Study||0||
48626015|NCT01733277|101867612|FG001|NOT COMPLETED|Overall Study||0||
48626016|NCT00702780|101867613|FG000|STARTED|Overall Study||37||
48626017|NCT00702780|101867614|FG001|STARTED|Overall Study||37||
48626018|NCT00702780|101867613|FG000|COMPLETED|Overall Study||28||
48626019|NCT00702780|101867614|FG001|COMPLETED|Overall Study||29||
48626020|NCT00702780|101867613|FG000|NOT COMPLETED|Overall Study||9||
48626021|NCT00702780|101867614|FG001|NOT COMPLETED|Overall Study||8||
48626022|NCT03368664|101867615|FG000|STARTED|Phase1: Prior DMT:Month -4 to Month 0||16||
48626023|NCT03368664|101867615|FG000|COMPLETED|Phase1: Prior DMT:Month -4 to Month 0||12||
48626024|NCT03368664|101867615|FG000|NOT COMPLETED|Phase1: Prior DMT:Month -4 to Month 0||4||
48626025|NCT03368664|101867615|FG000|STARTED|Phase2:AlemtuzumabTreatment:Month 0 to 8||11||
48626026|NCT03368664|101867615|FG000|Treated|Phase2:AlemtuzumabTreatment:Month 0 to 8||11||
48626027|NCT03368664|101867615|FG000|COMPLETED|Phase2:AlemtuzumabTreatment:Month 0 to 8||11||
48626028|NCT03368664|101867615|FG000|NOT COMPLETED|Phase2:AlemtuzumabTreatment:Month 0 to 8||0||
48626029|NCT03654417|101867616|FG000|STARTED|Overall Study||19||
48626030|NCT03654417|101867617|FG001|STARTED|Overall Study||18||
48626031|NCT03654417|101867616|FG000|COMPLETED|Overall Study||19||
48626032|NCT03654417|101867617|FG001|COMPLETED|Overall Study||18||
48626033|NCT03654417|101867616|FG000|NOT COMPLETED|Overall Study||0||
48626034|NCT03654417|101867617|FG001|NOT COMPLETED|Overall Study||0||
48626035|NCT00368251|101867618|FG000|STARTED|Overall Study||18||
48626036|NCT00368251|101867619|FG001|STARTED|Overall Study||20||
48626037|NCT00368251|101867620|FG002|STARTED|Overall Study||18||
48626038|NCT00368251|101867618|FG000|COMPLETED|Overall Study||17||
48626039|NCT00368251|101867619|FG001|COMPLETED|Overall Study||20||
48626040|NCT00368251|101867620|FG002|COMPLETED|Overall Study||17||
48331973|NCT01582308|101141716|FG005|NOT COMPLETED|10-day Washout Following Period 4||0||
48331974|NCT01582308|101141717|FG006|NOT COMPLETED|10-day Washout Following Period 4||0||
48331975|NCT01582308|101141718|FG007|NOT COMPLETED|10-day Washout Following Period 4||0||
48331976|NCT01582308|101141719|FG008|NOT COMPLETED|10-day Washout Following Period 4||0||
48331977|NCT01582308|101141720|FG009|NOT COMPLETED|10-day Washout Following Period 4||0||
48626041|NCT00368251|101867618|FG000|NOT COMPLETED|Overall Study||1||
48626042|NCT00368251|101867619|FG001|NOT COMPLETED|Overall Study||0||
48626043|NCT00368251|101867620|FG002|NOT COMPLETED|Overall Study||1||
48626044|NCT01776554|101867621|FG000|STARTED|Overall Study||332||
48626045|NCT01776554|101867622|FG001|STARTED|Overall Study||330||
48626046|NCT01776554|101867621|FG000|COMPLETED|Overall Study||315||
48626047|NCT01776554|101867622|FG001|COMPLETED|Overall Study||307||
48626048|NCT01776554|101867621|FG000|NOT COMPLETED|Overall Study||17||
48331978|NCT01582308|101141711|FG000|STARTED|Period 5||1||
48331979|NCT01582308|101141712|FG001|STARTED|Period 5||2||
48331980|NCT01582308|101141713|FG002|STARTED|Period 5||2||
48331981|NCT01582308|101141714|FG003|STARTED|Period 5||2||
48331982|NCT01582308|101141715|FG004|STARTED|Period 5||2||
48331983|NCT01582308|101141716|FG005|STARTED|Period 5||1||
48168045|NCT02667886|100735646|FG004|Received at Least 1 Dose of Study Drug|Dose Escalation and Expansion (Part C)||3||
48331984|NCT01582308|101141717|FG006|STARTED|Period 5||2||
48331985|NCT01582308|101141718|FG007|STARTED|Period 5||2||
48331986|NCT01582308|101141719|FG008|STARTED|Period 5||2||
48331987|NCT01582308|101141720|FG009|STARTED|Period 5||1||
48331988|NCT01582308|101141711|FG000|COMPLETED|Period 5||1||
48331989|NCT01582308|101141712|FG001|COMPLETED|Period 5||2||
48331990|NCT01582308|101141713|FG002|COMPLETED|Period 5||2||
48331991|NCT01582308|101141714|FG003|COMPLETED|Period 5||2||
48626049|NCT01776554|101867622|FG001|NOT COMPLETED|Overall Study||23||
48626050|NCT00072449|101867623|FG000|STARTED|Overall Study||12||
48168046|NCT02667886|100735642|FG000|COMPLETED|Dose Escalation and Expansion (Part C)||0||
48168047|NCT02667886|100735643|FG001|COMPLETED|Dose Escalation and Expansion (Part C)||0||
48331992|NCT01582308|101141715|FG004|COMPLETED|Period 5||2||
48331993|NCT01582308|101141716|FG005|COMPLETED|Period 5||1||
48331994|NCT01582308|101141717|FG006|COMPLETED|Period 5||2||
48331995|NCT01582308|101141718|FG007|COMPLETED|Period 5||2||
48626051|NCT00072449|101867623|FG000|COMPLETED|Overall Study||12||
48748773|NCT01400698|102172886|FG002|NOT COMPLETED|Overall Study||2||
48748774|NCT01400698|102172887|FG003|NOT COMPLETED|Overall Study||8||
48168048|NCT02667886|100735644|FG002|COMPLETED|Dose Escalation and Expansion (Part C)||0||
48331996|NCT01582308|101141719|FG008|COMPLETED|Period 5||2||
48331997|NCT01582308|101141720|FG009|COMPLETED|Period 5||1||
48748775|NCT01400698|102172888|FG004|NOT COMPLETED|Overall Study||7||
48748776|NCT01400698|102172889|FG005|NOT COMPLETED|Overall Study||6||
48748777|NCT03550378|102172890|FG000|STARTED|Overall Study||20||
48748778|NCT03550378|102172891|FG001|STARTED|Overall Study||21||
48331998|NCT01582308|101141711|FG000|NOT COMPLETED|Period 5||0||
48748779|NCT03550378|102172890|FG000|COMPLETED|Overall Study||20||
48748780|NCT03550378|102172891|FG001|COMPLETED|Overall Study||20||
48748781|NCT03550378|102172890|FG000|NOT COMPLETED|Overall Study||0||
48748782|NCT03550378|102172891|FG001|NOT COMPLETED|Overall Study||1||
48331999|NCT01582308|101141712|FG001|NOT COMPLETED|Period 5||0||
48626052|NCT00072449|101867623|FG000|NOT COMPLETED|Overall Study||0||
48168049|NCT02667886|100735645|FG003|COMPLETED|Dose Escalation and Expansion (Part C)||0||
48626053|NCT01115452|101867624|FG000|STARTED|Overall Study||32||
48626054|NCT01115452|101867624|FG000|COMPLETED|Overall Study||32||
48626055|NCT01115452|101867624|FG000|NOT COMPLETED|Overall Study||0||
48626056|NCT01814007|101867625|FG000|STARTED|Overall Study||35||
48626057|NCT01814007|101867625|FG000|COMPLETED|Overall Study||34||
48626058|NCT01814007|101867625|FG000|NOT COMPLETED|Overall Study||1||
48626059|NCT00728494|101867626|FG000|STARTED|Overall Study||60||
48626060|NCT00728494|101867627|FG001|STARTED|Overall Study||39||
48626061|NCT00728494|101867626|FG000|COMPLETED|Overall Study||51||
48626062|NCT00728494|101867627|FG001|COMPLETED|Overall Study||32||
48626063|NCT00728494|101867626|FG000|NOT COMPLETED|Overall Study||9||
48748783|NCT01454791|102172892|FG000|STARTED|Overall Study||20||
48332000|NCT01582308|101141713|FG002|NOT COMPLETED|Period 5||0||
48332001|NCT01582308|101141714|FG003|NOT COMPLETED|Period 5||0||
48626064|NCT00728494|101867627|FG001|NOT COMPLETED|Overall Study||7||
48626065|NCT00716456|101867628|FG000|STARTED|Overall Study||3||
48626066|NCT00716456|101867629|FG001|STARTED|Overall Study||5||
48626067|NCT00716456|101867630|FG002|STARTED|Overall Study||13||
48626068|NCT00716456|101867628|FG000|COMPLETED|Overall Study||3||
48626069|NCT00716456|101867629|FG001|COMPLETED|Overall Study||3||
48626070|NCT00716456|101867630|FG002|COMPLETED|Overall Study||13||
48626071|NCT00716456|101867628|FG000|NOT COMPLETED|Overall Study||0||
48332002|NCT01582308|101141715|FG004|NOT COMPLETED|Period 5||0||
48332003|NCT01582308|101141716|FG005|NOT COMPLETED|Period 5||0||
48332004|NCT01582308|101141717|FG006|NOT COMPLETED|Period 5||0||
48332005|NCT01582308|101141718|FG007|NOT COMPLETED|Period 5||0||
48626072|NCT00716456|101867629|FG001|NOT COMPLETED|Overall Study||2||
48626073|NCT00716456|101867630|FG002|NOT COMPLETED|Overall Study||0||
48626074|NCT05021640|101867631|FG000|STARTED|Overall Study||6||
48626075|NCT05021640|101867632|FG001|STARTED|Overall Study||6||
48626076|NCT05021640|101867633|FG002|STARTED|Overall Study||6||
48626077|NCT05021640|101867634|FG003|STARTED|Overall Study||6||
48626078|NCT05021640|101867635|FG004|STARTED|Overall Study||12||
48626079|NCT05021640|101867631|FG000|Safety Population|Overall Study||6||
48626080|NCT05021640|101867632|FG001|Safety Population|Overall Study||6||
48626081|NCT05021640|101867633|FG002|Safety Population|Overall Study||6||
48626082|NCT05021640|101867634|FG003|Safety Population|Overall Study||6||
48626083|NCT05021640|101867635|FG004|Safety Population|Overall Study||12||
48626084|NCT05021640|101867631|FG000|Pharmacodynamic Population|Overall Study||4||
48626085|NCT05021640|101867632|FG001|Pharmacodynamic Population|Overall Study||4||
48626086|NCT05021640|101867633|FG002|Pharmacodynamic Population|Overall Study||4||
48626087|NCT05021640|101867634|FG003|Pharmacodynamic Population|Overall Study||4||
48332006|NCT01582308|101141719|FG008|NOT COMPLETED|Period 5||0||
48332007|NCT01582308|101141720|FG009|NOT COMPLETED|Period 5||0||
48332008|NCT01999582|101141721|FG000|STARTED|Overall Study||7||
48626088|NCT05021640|101867635|FG004|Pharmacodynamic Population|Overall Study||8||
48626089|NCT05021640|101867631|FG000|COMPLETED|Overall Study||6||
48626090|NCT05021640|101867632|FG001|COMPLETED|Overall Study||6||
48626091|NCT05021640|101867633|FG002|COMPLETED|Overall Study||6||
48332009|NCT01999582|101141722|FG001|STARTED|Overall Study||7||
48332010|NCT01999582|101141723|FG002|STARTED|Overall Study||9||
48626092|NCT05021640|101867634|FG003|COMPLETED|Overall Study||6||
48626093|NCT05021640|101867635|FG004|COMPLETED|Overall Study||11||
48626094|NCT05021640|101867631|FG000|NOT COMPLETED|Overall Study||0||
48626095|NCT05021640|101867632|FG001|NOT COMPLETED|Overall Study||0||
48332011|NCT01999582|101141724|FG003|STARTED|Overall Study||9||
48626096|NCT05021640|101867633|FG002|NOT COMPLETED|Overall Study||0||
48626097|NCT05021640|101867634|FG003|NOT COMPLETED|Overall Study||0||
48332012|NCT01999582|101141725|FG004|STARTED|Overall Study||12||
48332013|NCT01999582|101141726|FG005|STARTED|Overall Study||6||
48332014|NCT01999582|101141721|FG000|COMPLETED|Overall Study||4||
48332015|NCT01999582|101141722|FG001|COMPLETED|Overall Study||4||
48332016|NCT01999582|101141723|FG002|COMPLETED|Overall Study||3||
48332017|NCT01999582|101141724|FG003|COMPLETED|Overall Study||6||
48748784|NCT01454791|102172893|FG001|STARTED|Overall Study||20||
48748785|NCT01454791|102172892|FG000|COMPLETED|Overall Study||20||
48748786|NCT01454791|102172893|FG001|COMPLETED|Overall Study||20||
48748787|NCT01454791|102172892|FG000|NOT COMPLETED|Overall Study||0||
48748788|NCT01454791|102172893|FG001|NOT COMPLETED|Overall Study||0||
48748789|NCT03901144|102172894|FG000|STARTED|Overall Study||50|Each participant used all three creams and had one area untreated, i.e. 4 treatment areas per subject. Total number of subjects was 50|50
48748790|NCT03901144|102172895|FG001|STARTED|Overall Study||50|Each participant used all three creams and had one area untreated, i.e. 4 treatment areas per subject. Total number of subjects was 50|50
48748791|NCT03901144|102172896|FG002|STARTED|Overall Study||50|Each participant used all three creams and had one area untreated, i.e. 4 treatment areas per subject. Total number of subjects was 50|50
48748792|NCT03901144|102172897|FG003|STARTED|Overall Study||50|Each participant used all three creams and had one area untreated, i.e. 4 treatment areas per subject. Total number of subjects was 50|50
48748793|NCT03901144|102172894|FG000|COMPLETED|Overall Study||49|Each participant used all three creams and had one area untreated, i.e. 4 treatment areas per subject. Total number of completed subjects was 49|49
48748794|NCT03901144|102172895|FG001|COMPLETED|Overall Study||49|Each participant used all three creams and had one area untreated, i.e. 4 treatment areas per subject. Total number of completed subjects was 49|49
48748795|NCT03901144|102172896|FG002|COMPLETED|Overall Study||49|Each participant used all three creams and had one area untreated, i.e. 4 treatment areas per subject. Total number of completed subjects was 49|49
48748796|NCT03901144|102172897|FG003|COMPLETED|Overall Study||49|Each participant used all three creams and had one area untreated, i.e. 4 treatment areas per subject. Total number of completed subjects was 49|49
48748797|NCT03901144|102172894|FG000|NOT COMPLETED|Overall Study||1||1
48748798|NCT03901144|102172895|FG001|NOT COMPLETED|Overall Study||1||1
48748799|NCT03901144|102172896|FG002|NOT COMPLETED|Overall Study||1||1
48748800|NCT03901144|102172897|FG003|NOT COMPLETED|Overall Study||1||1
48748801|NCT03880058|102172898|FG000|STARTED|Part A: Pre-abdominoplasty Injections||22||280
48748802|NCT03880058|102172898|FG000|Received SLI-F06|Part A: Pre-abdominoplasty Injections||22||140
48748803|NCT03880058|102172898|FG000|Received Control|Part A: Pre-abdominoplasty Injections||22||140
48748804|NCT03880058|102172898|FG000|COMPLETED|Part A: Pre-abdominoplasty Injections||22||280
48748805|NCT03880058|102172898|FG000|NOT COMPLETED|Part A: Pre-abdominoplasty Injections||0||0
48748806|NCT03880058|102172898|FG000|STARTED|Part B: Abdominoplasty Injections||21||21
48748807|NCT03880058|102172898|FG000|Received SLI-F06|Part B: Abdominoplasty Injections||21||21
48748808|NCT03880058|102172898|FG000|Received Control|Part B: Abdominoplasty Injections||21||21
48748809|NCT03880058|102172898|FG000|COMPLETED|Part B: Abdominoplasty Injections||21||21
48748810|NCT03880058|102172898|FG000|NOT COMPLETED|Part B: Abdominoplasty Injections||0||0
48748811|NCT00628030|102172899|FG000|STARTED|Baseline to Post-Assessment||92||
48748812|NCT00628030|102172900|FG001|STARTED|Baseline to Post-Assessment||92||
48748813|NCT00628030|102172899|FG000|COMPLETED|Baseline to Post-Assessment||59||
48748814|NCT00628030|102172900|FG001|COMPLETED|Baseline to Post-Assessment||63||
48748815|NCT00628030|102172899|FG000|NOT COMPLETED|Baseline to Post-Assessment||33||
48748816|NCT00628030|102172900|FG001|NOT COMPLETED|Baseline to Post-Assessment||29||
48748817|NCT00628030|102172899|FG000|STARTED|Post to 6 Month Follow-up||59||
48748818|NCT00628030|102172900|FG001|STARTED|Post to 6 Month Follow-up||63||
48748819|NCT00628030|102172899|FG000|COMPLETED|Post to 6 Month Follow-up||27||
48748820|NCT00628030|102172900|FG001|COMPLETED|Post to 6 Month Follow-up||33||
48748821|NCT00628030|102172899|FG000|NOT COMPLETED|Post to 6 Month Follow-up||32||
48748822|NCT00628030|102172900|FG001|NOT COMPLETED|Post to 6 Month Follow-up||30||
48748823|NCT00763386|102172901|FG000|STARTED|Overall Study||164||
48748824|NCT00763386|102172902|FG001|STARTED|Overall Study||167||
48748825|NCT00763386|102172901|FG000|COMPLETED|Overall Study||116||
48748826|NCT00763386|102172902|FG001|COMPLETED|Overall Study||127||
48748827|NCT00763386|102172901|FG000|NOT COMPLETED|Overall Study||48||
48748828|NCT00763386|102172902|FG001|NOT COMPLETED|Overall Study||40||
48748829|NCT01691794|102172903|FG000|STARTED|Overall Study||3||
48748830|NCT01691794|102172904|FG001|STARTED|Overall Study||33||
48748831|NCT01691794|102172905|FG002|STARTED|Overall Study||23||
48748832|NCT01691794|102172903|FG000|COMPLETED|Overall Study||2||
48748833|NCT01691794|102172904|FG001|COMPLETED|Overall Study||15||
48748834|NCT01691794|102172905|FG002|COMPLETED|Overall Study||13||
48748835|NCT01691794|102172903|FG000|NOT COMPLETED|Overall Study||1||
48748836|NCT01691794|102172904|FG001|NOT COMPLETED|Overall Study||18||
48748837|NCT01691794|102172905|FG002|NOT COMPLETED|Overall Study||10||
48748838|NCT00905450|102172906|FG000|STARTED|Overall Study||60||
48748839|NCT00905450|102172907|FG001|STARTED|Overall Study||28||
48748840|NCT00905450|102172908|FG002|STARTED|Overall Study||28||
48332018|NCT01999582|101141725|FG004|COMPLETED|Overall Study||10||
48332019|NCT01999582|101141726|FG005|COMPLETED|Overall Study||3||
48332020|NCT01999582|101141721|FG000|NOT COMPLETED|Overall Study||3||
48332021|NCT01999582|101141722|FG001|NOT COMPLETED|Overall Study||3||
48332022|NCT01999582|101141723|FG002|NOT COMPLETED|Overall Study||6||
48748841|NCT00905450|102172909|FG003|STARTED|Overall Study||60||
48748842|NCT00905450|102172910|FG004|STARTED|Overall Study||59||
48332023|NCT01999582|101141724|FG003|NOT COMPLETED|Overall Study||3||
48332024|NCT01999582|101141725|FG004|NOT COMPLETED|Overall Study||2||
48332025|NCT01999582|101141726|FG005|NOT COMPLETED|Overall Study||3||
48332026|NCT02549755|101141727|FG000|STARTED|Overall Study||1||
48332027|NCT02549755|101141727|FG000|COMPLETED|Overall Study||0||
48332028|NCT02549755|101141727|FG000|NOT COMPLETED|Overall Study||1||
48332029|NCT01815229|101141728|FG000|STARTED|Overall Study||13||
48748843|NCT00905450|102172911|FG005|STARTED|Overall Study||60||
48748844|NCT00905450|102172912|FG006|STARTED|Overall Study||60||
48748845|NCT00905450|102172913|FG007|STARTED|Overall Study||60||
48748846|NCT00905450|102172906|FG000|COMPLETED|Overall Study||59||
48168050|NCT02667886|100735646|FG004|COMPLETED|Dose Escalation and Expansion (Part C)||0||
48168051|NCT02667886|100735642|FG000|NOT COMPLETED|Dose Escalation and Expansion (Part C)||0||
48332030|NCT01815229|101141729|FG001|STARTED|Overall Study||18||
48748847|NCT00905450|102172907|FG001|COMPLETED|Overall Study||27||
48748848|NCT00905450|102172908|FG002|COMPLETED|Overall Study||28||
48748849|NCT00905450|102172909|FG003|COMPLETED|Overall Study||60||
48748850|NCT00905450|102172910|FG004|COMPLETED|Overall Study||59||
48748851|NCT00905450|102172911|FG005|COMPLETED|Overall Study||58||
48748852|NCT00905450|102172912|FG006|COMPLETED|Overall Study||58||
48748853|NCT00905450|102172913|FG007|COMPLETED|Overall Study||59||
48748854|NCT00905450|102172906|FG000|NOT COMPLETED|Overall Study||1||
48188611|NCT00432159|100783285|FG003|NOT COMPLETED|Overall Study||5||
48332031|NCT01815229|101141730|FG002|STARTED|Overall Study||51||
48748855|NCT00905450|102172907|FG001|NOT COMPLETED|Overall Study||1||
48748856|NCT00905450|102172908|FG002|NOT COMPLETED|Overall Study||0||
48748857|NCT00905450|102172909|FG003|NOT COMPLETED|Overall Study||0||
48748858|NCT00905450|102172910|FG004|NOT COMPLETED|Overall Study||0||
48748859|NCT00905450|102172911|FG005|NOT COMPLETED|Overall Study||2||
48748860|NCT00905450|102172912|FG006|NOT COMPLETED|Overall Study||2||
48748861|NCT00905450|102172913|FG007|NOT COMPLETED|Overall Study||1||
48748862|NCT02271698|102172914|FG000|STARTED|Overall Study||11||
48748863|NCT02271698|102172915|FG001|STARTED|Overall Study||10||
48748864|NCT02271698|102172916|FG002|STARTED|Overall Study||10||
48748865|NCT02271698|102172917|FG003|STARTED|Overall Study||11||
48748866|NCT02271698|102172914|FG000|COMPLETED|Overall Study||11||
48748867|NCT02271698|102172915|FG001|COMPLETED|Overall Study||10||
48748868|NCT02271698|102172916|FG002|COMPLETED|Overall Study||10||
48748869|NCT02271698|102172917|FG003|COMPLETED|Overall Study||11||
48748870|NCT02271698|102172914|FG000|NOT COMPLETED|Overall Study||0||
48748871|NCT02271698|102172915|FG001|NOT COMPLETED|Overall Study||0||
48748872|NCT02271698|102172916|FG002|NOT COMPLETED|Overall Study||0||
48748873|NCT02271698|102172917|FG003|NOT COMPLETED|Overall Study||0||
48748874|NCT01960140|102172918|FG000|STARTED|Period 1 (Days 1-2)||40||
48748875|NCT01960140|102172918|FG000|Received Simvastatin|Period 1 (Days 1-2)||40||
48748876|NCT01960140|102172918|FG000|COMPLETED|Period 1 (Days 1-2)||40||
48748877|NCT01960140|102172918|FG000|NOT COMPLETED|Period 1 (Days 1-2)||0||
48748878|NCT01960140|102172918|FG000|STARTED|Period 2 (Days 3-18)||40||
48748879|NCT01960140|102172918|FG000|Received At Least 1 Dose of Baricitinib|Period 2 (Days 3-18)||40||
48748880|NCT01960140|102172918|FG000|Received Simvastatin|Period 2 (Days 3-18)||38||
48748881|NCT01960140|102172918|FG000|COMPLETED|Period 2 (Days 3-18)||38||
48748882|NCT01960140|102172918|FG000|NOT COMPLETED|Period 2 (Days 3-18)||2||
48748883|NCT00395746|102172919|FG000|STARTED|Overall Study||88||
48748884|NCT00395746|102172920|FG001|STARTED|Overall Study||88||
48748885|NCT00395746|102172921|FG002|STARTED|Overall Study||88||
48748886|NCT00395746|102172919|FG000|COMPLETED|Overall Study||78||
48748887|NCT00395746|102172920|FG001|COMPLETED|Overall Study||84||
48748888|NCT00395746|102172921|FG002|COMPLETED|Overall Study||66||
48188612|NCT00432159|100783286|FG004|NOT COMPLETED|Overall Study||10||
48748889|NCT00395746|102172919|FG000|NOT COMPLETED|Overall Study||10||
48748890|NCT00395746|102172920|FG001|NOT COMPLETED|Overall Study||4||
48748891|NCT00395746|102172921|FG002|NOT COMPLETED|Overall Study||22||
48748892|NCT00688259|102172922|FG000|STARTED|Overall Study||44||
48748893|NCT00688259|102172923|FG001|STARTED|Overall Study||44||
48748894|NCT00688259|102172922|FG000|End to Active Treatment,|Overall Study||37|Approximately 6 months post-randomization|
48748895|NCT00688259|102172923|FG001|End to Active Treatment,|Overall Study||37|Approximately 6 months post-randomization|
48748896|NCT00688259|102172922|FG000|COMPLETED|Overall Study||37|6 month post treatment follow-up|
48748897|NCT00688259|102172923|FG001|COMPLETED|Overall Study||36|6 month post treatment follow-up|
48748898|NCT00688259|102172922|FG000|NOT COMPLETED|Overall Study||7||
48748899|NCT00688259|102172923|FG001|NOT COMPLETED|Overall Study||8||
48748900|NCT02374164|102172924|FG000|STARTED|Treatment Period 1||12||
48626098|NCT05021640|101867635|FG004|NOT COMPLETED|Overall Study||1||
48626099|NCT04347408|101867636|FG000|STARTED|Overall Study||992||
48626100|NCT04347408|101867636|FG000|COMPLETED|Overall Study||992||
48626101|NCT04347408|101867636|FG000|NOT COMPLETED|Overall Study||0||
48626102|NCT01162733|101867637|FG000|STARTED|Overall Study||49||
48626103|NCT01162733|101867638|FG001|STARTED|Overall Study||50||
48168052|NCT02667886|100735643|FG001|NOT COMPLETED|Dose Escalation and Expansion (Part C)||0||
48168053|NCT02667886|100735644|FG002|NOT COMPLETED|Dose Escalation and Expansion (Part C)||0||
48168054|NCT02667886|100735645|FG003|NOT COMPLETED|Dose Escalation and Expansion (Part C)||0||
48168055|NCT02667886|100735646|FG004|NOT COMPLETED|Dose Escalation and Expansion (Part C)||3||
48168056|NCT00979602|100735647|FG000|STARTED|Overall Study||2025||
48168057|NCT00979602|100735648|FG001|STARTED|Overall Study||2023||
48626104|NCT01162733|101867637|FG000|COMPLETED|Overall Study||22||
48626105|NCT01162733|101867638|FG001|COMPLETED|Overall Study||25||
48626106|NCT01162733|101867637|FG000|NOT COMPLETED|Overall Study||27||
48626107|NCT01162733|101867638|FG001|NOT COMPLETED|Overall Study||25||
48748901|NCT02374164|102172925|FG001|STARTED|Treatment Period 1||12||
48748902|NCT02374164|102172926|FG002|STARTED|Treatment Period 1||12||
48748903|NCT02374164|102172924|FG000|COMPLETED|Treatment Period 1||12||
48748904|NCT02374164|102172925|FG001|COMPLETED|Treatment Period 1||12||
48748905|NCT02374164|102172926|FG002|COMPLETED|Treatment Period 1||12||
48748906|NCT02374164|102172924|FG000|NOT COMPLETED|Treatment Period 1||0||
48748907|NCT02374164|102172925|FG001|NOT COMPLETED|Treatment Period 1||0||
48748908|NCT02374164|102172926|FG002|NOT COMPLETED|Treatment Period 1||0||
48168058|NCT00979602|100735647|FG000|COMPLETED|Overall Study||1880||
48168059|NCT00979602|100735648|FG001|COMPLETED|Overall Study||1890||
48168060|NCT00979602|100735647|FG000|NOT COMPLETED|Overall Study||145||
48168061|NCT00979602|100735648|FG001|NOT COMPLETED|Overall Study||133||
48168062|NCT03560258|100735649|FG000|STARTED|Overall Study||22||
48168063|NCT03560258|100735650|FG001|STARTED|Overall Study||11||
48168064|NCT03560258|100735651|FG002|STARTED|Overall Study||12||
48168065|NCT03560258|100735649|FG000|Received at Least 1 Dose of Treatment|Overall Study||22||
48168066|NCT03560258|100735650|FG001|Received at Least 1 Dose of Treatment|Overall Study||10||
48168067|NCT03560258|100735651|FG002|Received at Least 1 Dose of Treatment|Overall Study||12||
48168068|NCT03560258|100735649|FG000|COMPLETED|Overall Study||19||
48168069|NCT03560258|100735650|FG001|COMPLETED|Overall Study||10||
48168070|NCT03560258|100735651|FG002|COMPLETED|Overall Study||11||
48168071|NCT03560258|100735649|FG000|NOT COMPLETED|Overall Study||3||
48168072|NCT03560258|100735650|FG001|NOT COMPLETED|Overall Study||1||
48168073|NCT03560258|100735651|FG002|NOT COMPLETED|Overall Study||1||
48168074|NCT00674323|100735652|FG000|STARTED|Overall Study||19||
48168075|NCT00674323|100735653|FG001|STARTED|Overall Study||21||
48168076|NCT00674323|100735654|FG002|STARTED|Overall Study||21||
48168077|NCT00674323|100735652|FG000|COMPLETED|Overall Study||18||
48168078|NCT00674323|100735653|FG001|COMPLETED|Overall Study||20||
48626108|NCT01811732|101867639|FG000|STARTED|Overall Study||331||
48626109|NCT01811732|101867640|FG001|STARTED|Overall Study||329||
48626110|NCT01811732|101867639|FG000|COMPLETED|Overall Study||276|Completed the Late Follow-Up (LFU) Visit|
48626111|NCT01811732|101867640|FG001|COMPLETED|Overall Study||271|Completed the Late Follow-Up (LFU) Visit|
48626112|NCT01811732|101867639|FG000|NOT COMPLETED|Overall Study||55||
48626113|NCT01811732|101867640|FG001|NOT COMPLETED|Overall Study||58||
48626114|NCT00305162|101867641|FG000|STARTED|48 Hour Follow-up Period||4435||
48748909|NCT02374164|102172924|FG000|STARTED|Treatment Period 2||12||
48748910|NCT02374164|102172925|FG001|STARTED|Treatment Period 2||12||
48168079|NCT00674323|100735654|FG002|COMPLETED|Overall Study||21||
48168080|NCT00674323|100735652|FG000|NOT COMPLETED|Overall Study||1||
48168081|NCT00674323|100735653|FG001|NOT COMPLETED|Overall Study||1||
48626115|NCT00305162|101867642|FG001|STARTED|48 Hour Follow-up Period||4447||
48748911|NCT02374164|102172926|FG002|STARTED|Treatment Period 2||12||
48626116|NCT00305162|101867641|FG000|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period||3933||
48626117|NCT00305162|101867642|FG001|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period||3924||
48657127|NCT03745313|101943783|FG000|NOT COMPLETED|At 2 Year Follow-up||1||
48168082|NCT00674323|100735654|FG002|NOT COMPLETED|Overall Study||0||
48168083|NCT00010439|100735655|FG000|STARTED|Overall Study||10||
48168084|NCT00010439|100735655|FG000|6 Months|Overall Study||10||
48168085|NCT00010439|100735655|FG000|COMPLETED|Overall Study||10||
48168086|NCT00010439|100735655|FG000|NOT COMPLETED|Overall Study||0||
48168087|NCT01414426|100735656|FG000|STARTED|Overall Study||10||
48168088|NCT01414426|100735657|FG001|STARTED|Overall Study||10||
48168089|NCT01414426|100735656|FG000|COMPLETED|Overall Study||9||
48168090|NCT01414426|100735657|FG001|COMPLETED|Overall Study||8||
48168091|NCT01414426|100735656|FG000|NOT COMPLETED|Overall Study||1||
48168092|NCT01414426|100735657|FG001|NOT COMPLETED|Overall Study||2||
48168093|NCT01678443|100735658|FG000|STARTED|Overall Study||2||
48168094|NCT01678443|100735658|FG000|COMPLETED|Overall Study||2||
48168095|NCT01678443|100735658|FG000|NOT COMPLETED|Overall Study||0||
48168096|NCT00885352|100735659|FG000|STARTED|Overall Study||157||
48168097|NCT00885352|100735660|FG001|STARTED|Overall Study||156||
48168098|NCT00885352|100735659|FG000|COMPLETED|Overall Study||149||
48168099|NCT00885352|100735660|FG001|COMPLETED|Overall Study||136||
48168100|NCT00885352|100735659|FG000|NOT COMPLETED|Overall Study||8||
48168101|NCT00885352|100735660|FG001|NOT COMPLETED|Overall Study||20||
48168102|NCT00805493|100735661|FG000|STARTED|Overall Study||3||
48168103|NCT00805493|100735662|FG001|STARTED|Overall Study||2||
48168104|NCT00805493|100735663|FG002|STARTED|Overall Study||1||
48168105|NCT00805493|100735661|FG000|COMPLETED|Overall Study||1||
48168106|NCT00805493|100735662|FG001|COMPLETED|Overall Study||2||
48168107|NCT00805493|100735663|FG002|COMPLETED|Overall Study||0||
48168108|NCT00805493|100735661|FG000|NOT COMPLETED|Overall Study||2||
48168109|NCT00805493|100735662|FG001|NOT COMPLETED|Overall Study||0||
48168110|NCT00805493|100735663|FG002|NOT COMPLETED|Overall Study||1||
48168111|NCT00453479|100735664|FG000|STARTED|Overall Study||6||
48168112|NCT00453479|100735665|FG001|STARTED|Overall Study||9||
48168113|NCT00453479|100735666|FG002|STARTED|Overall Study||8||
48168114|NCT00453479|100735664|FG000|COMPLETED|Overall Study||6||
48168115|NCT00453479|100735665|FG001|COMPLETED|Overall Study||9||
48168116|NCT00453479|100735666|FG002|COMPLETED|Overall Study||8||
48168117|NCT00453479|100735664|FG000|NOT COMPLETED|Overall Study||0||
48168118|NCT00453479|100735665|FG001|NOT COMPLETED|Overall Study||0||
48168119|NCT00453479|100735666|FG002|NOT COMPLETED|Overall Study||0||
48168120|NCT02086162|100735667|FG000|STARTED|Overall Study||78||
48168121|NCT02086162|100735668|FG001|STARTED|Overall Study||84||
48168122|NCT02086162|100735667|FG000|COMPLETED|Overall Study||68||
48168123|NCT02086162|100735668|FG001|COMPLETED|Overall Study||77||
48168124|NCT02086162|100735667|FG000|NOT COMPLETED|Overall Study||10||
48168125|NCT02086162|100735668|FG001|NOT COMPLETED|Overall Study||7||
48168126|NCT01778946|100735669|FG000|STARTED|Overall Study||7||
48168127|NCT01778946|100735669|FG000|COMPLETED|Overall Study||4||
48168128|NCT01778946|100735669|FG000|NOT COMPLETED|Overall Study||3||
48168129|NCT00544544|100735670|FG000|STARTED|Overall Study||14||
48168130|NCT00544544|100735670|FG000|COMPLETED|Overall Study||11||
48168131|NCT00544544|100735670|FG000|NOT COMPLETED|Overall Study||3||
48168132|NCT03708588|100735671|FG000|STARTED|Overall Study||55||
48411028|NCT03797144|101337789|FG001|COMPLETED|12 Month||1||
48411029|NCT03797144|101337788|FG000|NOT COMPLETED|12 Month||8||
48626118|NCT00305162|101867641|FG000|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period||482||
48626119|NCT00305162|101867642|FG001|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period||507||
48626120|NCT00305162|101867641|FG000|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period||3889||
48626121|NCT00305162|101867642|FG001|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period||3865||
48626122|NCT00305162|101867641|FG000|Modified ITT (mITT): STEMI|48 Hour Follow-up Period||446||
48626123|NCT00305162|101867642|FG001|Modified ITT (mITT): STEMI|48 Hour Follow-up Period||447||
48626124|NCT00305162|101867641|FG000|Safety Population|48 Hour Follow-up Period||4374||
48626125|NCT00305162|101867642|FG001|Safety Population|48 Hour Follow-up Period||4365||
48626126|NCT00305162|101867641|FG000|COMPLETED|48 Hour Follow-up Period||4415||
48626127|NCT00305162|101867642|FG001|COMPLETED|48 Hour Follow-up Period||4431||
48626128|NCT00305162|101867641|FG000|NOT COMPLETED|48 Hour Follow-up Period||20||
48626129|NCT00305162|101867642|FG001|NOT COMPLETED|48 Hour Follow-up Period||16||
48626130|NCT00305162|101867641|FG000|STARTED|30-day Follow-up Period||4435||
48626131|NCT00305162|101867642|FG001|STARTED|30-day Follow-up Period||4447||
48168133|NCT03708588|100735672|FG001|STARTED|Overall Study||57||
48168134|NCT03708588|100735671|FG000|COMPLETED|Overall Study||46||
48626132|NCT00305162|101867641|FG000|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period||3902||
48626133|NCT00305162|101867642|FG001|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period||3883||
48168135|NCT03708588|100735672|FG001|COMPLETED|Overall Study||48||
48168136|NCT03708588|100735671|FG000|NOT COMPLETED|Overall Study||9||
48168137|NCT03708588|100735672|FG001|NOT COMPLETED|Overall Study||9||
48168138|NCT02207439|100735673|FG000|STARTED|Nelfinavir Lead-In||17||
48168139|NCT02207439|100735673|FG000|COMPLETED|Nelfinavir Lead-In||17||
48168140|NCT02207439|100735673|FG000|NOT COMPLETED|Nelfinavir Lead-In||0||
48168141|NCT02207439|100735673|FG000|STARTED|Chemoradiotherapy With Nelfinavir||17||
48168142|NCT02207439|100735673|FG000|COMPLETED|Chemoradiotherapy With Nelfinavir||17||
48168143|NCT02207439|100735673|FG000|NOT COMPLETED|Chemoradiotherapy With Nelfinavir||0||
48168144|NCT00308737|100735674|FG000|STARTED|Overall Study||938||
48168145|NCT00308737|100735675|FG001|STARTED|Overall Study||951||
48626134|NCT00305162|101867641|FG000|Intent-to-treat (ITT): STEMI|30-day Follow-up Period||471||
48626135|NCT00305162|101867642|FG001|Intent-to-treat (ITT): STEMI|30-day Follow-up Period||501||
48168146|NCT00308737|100735676|FG002|STARTED|Overall Study||164||
48168147|NCT00308737|100735674|FG000|COMPLETED|Overall Study||475||
48168148|NCT00308737|100735675|FG001|COMPLETED|Overall Study||662||
48168149|NCT00308737|100735676|FG002|COMPLETED|Overall Study||127||
48168150|NCT00308737|100735674|FG000|NOT COMPLETED|Overall Study||463||
48168151|NCT00308737|100735675|FG001|NOT COMPLETED|Overall Study||289||
48168152|NCT00308737|100735676|FG002|NOT COMPLETED|Overall Study||37||
48168153|NCT01306201|100735677|FG000|STARTED|Overall Study||63||
48168154|NCT01306201|100735677|FG000|COMPLETED|Overall Study||53||
48168155|NCT01306201|100735677|FG000|NOT COMPLETED|Overall Study||10||
48168156|NCT01821898|100735678|FG000|STARTED|Overall Study||2||
48168157|NCT01821898|100735679|FG001|STARTED|Overall Study||1||
48168158|NCT01821898|100735678|FG000|COMPLETED|Overall Study||0||
48168159|NCT01821898|100735679|FG001|COMPLETED|Overall Study||0||
48168160|NCT01821898|100735678|FG000|NOT COMPLETED|Overall Study||2||
48168161|NCT01821898|100735679|FG001|NOT COMPLETED|Overall Study||1||
48168162|NCT00672958|100735680|FG000|STARTED|Overall Study||300||
48168163|NCT00672958|100735681|FG001|STARTED|Overall Study||300||
48168164|NCT00672958|100735680|FG000|Safety Set|Overall Study||298||
48168165|NCT00672958|100735681|FG001|Safety Set|Overall Study||299||
48168166|NCT00672958|100735680|FG000|Full Analysis Set|Overall Study||286||
48168167|NCT00672958|100735681|FG001|Full Analysis Set|Overall Study||292||
48168168|NCT00672958|100735680|FG000|COMPLETED|Overall Study||236||
48168169|NCT00672958|100735681|FG001|COMPLETED|Overall Study||244||
48168170|NCT00672958|100735680|FG000|NOT COMPLETED|Overall Study||64||
48168171|NCT00672958|100735681|FG001|NOT COMPLETED|Overall Study||56||
48168172|NCT03800979|100735682|FG000|STARTED|Overall Study||19||
48168173|NCT03800979|100735682|FG000|COMPLETED|Overall Study||19||
48168174|NCT03800979|100735682|FG000|NOT COMPLETED|Overall Study||0||
48168175|NCT00315588|100735683|FG000|STARTED|Overall Study||7||
48168176|NCT00315588|100735683|FG000|COMPLETED|Overall Study||7||
48168177|NCT00315588|100735683|FG000|NOT COMPLETED|Overall Study||0||
48168178|NCT01302938|100735684|FG000|STARTED|Overall Study||12||
48168179|NCT01302938|100735685|FG001|STARTED|Overall Study||6||
48168180|NCT01302938|100735684|FG000|COMPLETED|Overall Study||10||
48168181|NCT01302938|100735685|FG001|COMPLETED|Overall Study||6||
48168182|NCT01302938|100735684|FG000|NOT COMPLETED|Overall Study||2||
48168183|NCT01302938|100735685|FG001|NOT COMPLETED|Overall Study||0||
48168184|NCT01916941|100735686|FG000|STARTED|Overall Study||18||
48168185|NCT01916941|100735687|FG001|STARTED|Overall Study||18||
48168186|NCT01916941|100735686|FG000|COMPLETED|Overall Study||13||
48168187|NCT01916941|100735687|FG001|COMPLETED|Overall Study||14||
48168188|NCT01916941|100735686|FG000|NOT COMPLETED|Overall Study||5||
48168189|NCT01916941|100735687|FG001|NOT COMPLETED|Overall Study||4||
48626136|NCT00305162|101867641|FG000|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period||3860||
48626137|NCT00305162|101867642|FG001|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period||3827||
48626138|NCT00305162|101867641|FG000|Modified ITT (mITT): STEMI|30-day Follow-up Period||438||
48168190|NCT03295266|100735688|FG000|STARTED|Overall Study||5||
48168191|NCT03295266|100735689|FG001|STARTED|Overall Study||4||
48168192|NCT03295266|100735688|FG000|COMPLETED|Overall Study||5||
48168193|NCT03295266|100735689|FG001|COMPLETED|Overall Study||4||
48168194|NCT03295266|100735688|FG000|NOT COMPLETED|Overall Study||0||
48168195|NCT03295266|100735689|FG001|NOT COMPLETED|Overall Study||0||
48168196|NCT02687412|100735690|FG000|STARTED|Overall Study||50||
48168197|NCT02687412|100735691|FG001|STARTED|Overall Study||57||
48168198|NCT02687412|100735690|FG000|COMPLETED|Overall Study||50||
48168199|NCT02687412|100735691|FG001|COMPLETED|Overall Study||57||
48168200|NCT02687412|100735690|FG000|NOT COMPLETED|Overall Study||0||
48168201|NCT02687412|100735691|FG001|NOT COMPLETED|Overall Study||0||
48168202|NCT02712398|100735692|FG000|STARTED|Overall Study||120||
48168203|NCT02712398|100735692|FG000|COMPLETED|Overall Study||83||
48168204|NCT02712398|100735692|FG000|NOT COMPLETED|Overall Study||37||
48168205|NCT02341287|100735693|FG000|STARTED|1st Intervention (2 Weeks)||7||
48168206|NCT02341287|100735694|FG001|STARTED|1st Intervention (2 Weeks)||6||
48168207|NCT02341287|100735693|FG000|COMPLETED|1st Intervention (2 Weeks)||7||
48168208|NCT02341287|100735694|FG001|COMPLETED|1st Intervention (2 Weeks)||6||
48168209|NCT02341287|100735693|FG000|NOT COMPLETED|1st Intervention (2 Weeks)||0||
48168210|NCT02341287|100735694|FG001|NOT COMPLETED|1st Intervention (2 Weeks)||0||
48168211|NCT02341287|100735693|FG000|STARTED|2nd Intervention (2 Weeks)||7||
48168212|NCT02341287|100735694|FG001|STARTED|2nd Intervention (2 Weeks)||6||
48168213|NCT02341287|100735693|FG000|COMPLETED|2nd Intervention (2 Weeks)||7||
48168214|NCT02341287|100735694|FG001|COMPLETED|2nd Intervention (2 Weeks)||6||
48168215|NCT02341287|100735693|FG000|NOT COMPLETED|2nd Intervention (2 Weeks)||0||
48168216|NCT02341287|100735694|FG001|NOT COMPLETED|2nd Intervention (2 Weeks)||0||
48168217|NCT02882711|100735695|FG000|STARTED|Overall Study||6||
48168218|NCT02882711|100735695|FG000|COMPLETED|Overall Study||2||
48168219|NCT02882711|100735695|FG000|NOT COMPLETED|Overall Study||4||
48168220|NCT01767935|100735696|FG000|STARTED|Overall Study||1||
48168221|NCT01767935|100735696|FG000|COMPLETED|Overall Study||1||
48168222|NCT01767935|100735696|FG000|NOT COMPLETED|Overall Study||0||
48168223|NCT00201864|100735697|FG000|STARTED|Overall Study||40||
48168224|NCT00201864|100735697|FG000|COMPLETED|Overall Study||40||
48168225|NCT00201864|100735697|FG000|NOT COMPLETED|Overall Study||0||
48168226|NCT00762021|100735698|FG000|STARTED|Overall Study||52||
48168227|NCT00762021|100735699|FG001|STARTED|Overall Study||52||
48168228|NCT00762021|100735698|FG000|COMPLETED|Overall Study||44||
48168229|NCT00762021|100735699|FG001|COMPLETED|Overall Study||44||
48168230|NCT00762021|100735698|FG000|NOT COMPLETED|Overall Study||8||
48168231|NCT00762021|100735699|FG001|NOT COMPLETED|Overall Study||8||
48168232|NCT03366220|100735700|FG000|STARTED|Overall Study||4||
48626139|NCT00305162|101867642|FG001|Modified ITT (mITT): STEMI|30-day Follow-up Period||444||
48626140|NCT00305162|101867641|FG000|COMPLETED|30-day Follow-up Period||4373||
48626141|NCT00305162|101867642|FG001|COMPLETED|30-day Follow-up Period||4384||
48626142|NCT00305162|101867641|FG000|NOT COMPLETED|30-day Follow-up Period||62||
48626143|NCT00305162|101867642|FG001|NOT COMPLETED|30-day Follow-up Period||63||
48626144|NCT00305162|101867641|FG000|STARTED|1 Year Follow-up Period||4435||
48168233|NCT03366220|100735701|FG001|STARTED|Overall Study||4||
48168234|NCT03366220|100735700|FG000|COMPLETED|Overall Study||4||
48168235|NCT03366220|100735701|FG001|COMPLETED|Overall Study||4||
48168236|NCT03366220|100735700|FG000|NOT COMPLETED|Overall Study||0||
48168237|NCT03366220|100735701|FG001|NOT COMPLETED|Overall Study||0||
48168238|NCT01112696|100735702|FG000|STARTED|Overall Study||100||
48168239|NCT01112696|100735702|FG000|COMPLETED|Overall Study||98||
48168240|NCT01112696|100735702|FG000|NOT COMPLETED|Overall Study||2||
48168241|NCT05258747|100735703|FG000|STARTED|First Period||35||
48168242|NCT05258747|100735704|FG001|STARTED|First Period||35||
48168243|NCT05258747|100735703|FG000|COMPLETED|First Period||35||
48168244|NCT05258747|100735704|FG001|COMPLETED|First Period||35||
48168245|NCT05258747|100735703|FG000|NOT COMPLETED|First Period||0||
48168246|NCT05258747|100735704|FG001|NOT COMPLETED|First Period||0||
48168247|NCT05258747|100735703|FG000|STARTED|Second Period||35||
48168248|NCT05258747|100735704|FG001|STARTED|Second Period||35||
48168249|NCT05258747|100735703|FG000|COMPLETED|Second Period||34||
48168250|NCT05258747|100735704|FG001|COMPLETED|Second Period||35||
48626145|NCT00305162|101867642|FG001|STARTED|1 Year Follow-up Period||4447||
48626146|NCT00305162|101867641|FG000|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period||3900||
48626147|NCT00305162|101867642|FG001|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period||3878||
48626148|NCT00305162|101867641|FG000|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period||480||
48626149|NCT00305162|101867642|FG001|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period||504||
48626150|NCT00305162|101867641|FG000|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period||3851||
48168251|NCT05258747|100735703|FG000|NOT COMPLETED|Second Period||1||
48168252|NCT05258747|100735704|FG001|NOT COMPLETED|Second Period||0||
48168253|NCT01027364|100735705|FG000|STARTED|Overall Study||63||
48168254|NCT01027364|100735706|FG001|STARTED|Overall Study||29||
48168255|NCT01027364|100735707|FG002|STARTED|Overall Study||27||
48168256|NCT01027364|100735708|FG003|STARTED|Overall Study||4||
48168257|NCT01027364|100735705|FG000|Enrolled in Sequential PK Subgroup|Overall Study||22||
48168258|NCT01027364|100735706|FG001|Enrolled in Sequential PK Subgroup|Overall Study||0||
48168259|NCT01027364|100735707|FG002|Enrolled in Sequential PK Subgroup|Overall Study||0||
48168260|NCT01027364|100735708|FG003|Enrolled in Sequential PK Subgroup|Overall Study||0||
48168261|NCT01027364|100735705|FG000|Joined Arm 4 for Surgery Then Returned|Overall Study||5||
48168262|NCT01027364|100735706|FG001|Joined Arm 4 for Surgery Then Returned|Overall Study||0||
48168263|NCT01027364|100735707|FG002|Joined Arm 4 for Surgery Then Returned|Overall Study||1||
48168264|NCT01027364|100735708|FG003|Joined Arm 4 for Surgery Then Returned|Overall Study||0||
48168265|NCT01027364|100735705|FG000|Started Arm 4 Then Joined Another Arm|Overall Study||2||
48168266|NCT01027364|100735706|FG001|Started Arm 4 Then Joined Another Arm|Overall Study||0||
48168267|NCT01027364|100735707|FG002|Started Arm 4 Then Joined Another Arm|Overall Study||0||
48168268|NCT01027364|100735708|FG003|Started Arm 4 Then Joined Another Arm|Overall Study||0||
48168269|NCT01027364|100735705|FG000|COMPLETED|Overall Study||59||
48168270|NCT01027364|100735706|FG001|COMPLETED|Overall Study||27||
48168271|NCT01027364|100735707|FG002|COMPLETED|Overall Study||26||
48168272|NCT01027364|100735708|FG003|COMPLETED|Overall Study||3||
48168273|NCT01027364|100735705|FG000|NOT COMPLETED|Overall Study||4||
48168274|NCT01027364|100735706|FG001|NOT COMPLETED|Overall Study||2||
48168275|NCT01027364|100735707|FG002|NOT COMPLETED|Overall Study||1||
48168276|NCT01027364|100735708|FG003|NOT COMPLETED|Overall Study||1||
48168277|NCT01375205|100735709|FG000|STARTED|Overall Study||54||
48626151|NCT00305162|101867642|FG001|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period||3818||
48626152|NCT00305162|101867641|FG000|Modified ITT (mITT): STEMI|1 Year Follow-up Period||446||
48626153|NCT00305162|101867642|FG001|Modified ITT (mITT): STEMI|1 Year Follow-up Period||444||
48626154|NCT00305162|101867641|FG000|COMPLETED|1 Year Follow-up Period||4380||
48168278|NCT01375205|100735710|FG001|STARTED|Overall Study||46||
48168279|NCT01375205|100735709|FG000|COMPLETED|Overall Study||33||
48168280|NCT01375205|100735710|FG001|COMPLETED|Overall Study||33||
48168281|NCT01375205|100735709|FG000|NOT COMPLETED|Overall Study||21||
48168282|NCT01375205|100735710|FG001|NOT COMPLETED|Overall Study||13||
48168283|NCT01913639|100735711|FG000|STARTED|Overall Study||39||
48168284|NCT01913639|100735711|FG000|COMPLETED|Overall Study||36||
48168285|NCT01913639|100735711|FG000|NOT COMPLETED|Overall Study||3||
48168286|NCT01719237|100735712|FG000|STARTED|Overall Study||30||
48168287|NCT01719237|100735713|FG001|STARTED|Overall Study||30||
48168288|NCT01719237|100735712|FG000|COMPLETED|Overall Study||30||
48168289|NCT01719237|100735713|FG001|COMPLETED|Overall Study||29||
48168290|NCT01719237|100735712|FG000|NOT COMPLETED|Overall Study||0||
48168291|NCT01719237|100735713|FG001|NOT COMPLETED|Overall Study||1||
48168292|NCT01862991|100735714|FG000|STARTED|Overall Study||24||
48168293|NCT01862991|100735715|FG001|STARTED|Overall Study||28||
48168294|NCT01862991|100735716|FG002|STARTED|Overall Study||28||
48168295|NCT01862991|100735714|FG000|COMPLETED|Overall Study||21||
48168296|NCT01862991|100735715|FG001|COMPLETED|Overall Study||27||
48168297|NCT01862991|100735716|FG002|COMPLETED|Overall Study||27||
48168298|NCT01862991|100735714|FG000|NOT COMPLETED|Overall Study||3||
48168299|NCT01862991|100735715|FG001|NOT COMPLETED|Overall Study||1||
48168300|NCT01862991|100735716|FG002|NOT COMPLETED|Overall Study||1||
48168301|NCT00957931|100735717|FG000|STARTED|Overall Study||6||
48168302|NCT00957931|100735717|FG000|COMPLETED|Overall Study||2||
48168303|NCT00957931|100735717|FG000|NOT COMPLETED|Overall Study||4||
48168304|NCT03283696|100735718|FG000|STARTED|Overall Study||16||
48168305|NCT03283696|100735719|FG001|STARTED|Overall Study||8||
48168306|NCT03283696|100735718|FG000|Received at Least 1 Dose of Study Drug|Overall Study||16||
48168307|NCT03283696|100735719|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8||
48332032|NCT01815229|101141728|FG000|COMPLETED|Overall Study||13||
48332033|NCT01815229|101141729|FG001|COMPLETED|Overall Study||18||
48332034|NCT01815229|101141730|FG002|COMPLETED|Overall Study||0||
48332035|NCT01815229|101141728|FG000|NOT COMPLETED|Overall Study||0||
48332036|NCT01815229|101141729|FG001|NOT COMPLETED|Overall Study||0||
48332037|NCT01815229|101141730|FG002|NOT COMPLETED|Overall Study||51||
48332038|NCT00954109|101141731|FG000|STARTED|Overall Study||11||
48332039|NCT00954109|101141731|FG000|COMPLETED|Overall Study||11||
48332040|NCT00954109|101141731|FG000|NOT COMPLETED|Overall Study||0||
48332041|NCT01133171|101141732|FG000|STARTED|Overall Study||25||
48332042|NCT01133171|101141733|FG001|STARTED|Overall Study||27||
48332043|NCT01133171|101141734|FG002|STARTED|Overall Study||25||
48332044|NCT01133171|101141732|FG000|COMPLETED|Overall Study||24||
48332045|NCT01133171|101141733|FG001|COMPLETED|Overall Study||25||
48332046|NCT01133171|101141734|FG002|COMPLETED|Overall Study||25||
48332047|NCT01133171|101141732|FG000|NOT COMPLETED|Overall Study||1||
48332048|NCT01133171|101141733|FG001|NOT COMPLETED|Overall Study||2||
48332049|NCT01133171|101141734|FG002|NOT COMPLETED|Overall Study||0||
48332050|NCT03504410|101141735|FG000|STARTED|Overall Study||98||
48168308|NCT03283696|100735718|FG000|COMPLETED|Overall Study||9||
48168309|NCT03283696|100735719|FG001|COMPLETED|Overall Study||2||
48168310|NCT03283696|100735718|FG000|NOT COMPLETED|Overall Study||7||
48168311|NCT03283696|100735719|FG001|NOT COMPLETED|Overall Study||6||
48168312|NCT00791323|100735720|FG000|STARTED|Overall Study||6||
48168313|NCT00791323|100735721|FG001|STARTED|Overall Study||3||
48168314|NCT00791323|100735720|FG000|COMPLETED|Overall Study||6||
48168315|NCT00791323|100735721|FG001|COMPLETED|Overall Study||3||
48168316|NCT00791323|100735720|FG000|NOT COMPLETED|Overall Study||0||
48168317|NCT00791323|100735721|FG001|NOT COMPLETED|Overall Study||0||
48168318|NCT04250337|100735722|FG000|STARTED|Overall Study||75||
48168319|NCT04250337|100735723|FG001|STARTED|Overall Study||153||
48168320|NCT04250337|100735722|FG000|Received at Least One Dose of Study Drug|Overall Study||75||
48168321|NCT04250337|100735723|FG001|Received at Least One Dose of Study Drug|Overall Study||153||
48168322|NCT04250337|100735722|FG000|COMPLETED|Overall Study||67||
48168323|NCT04250337|100735723|FG001|COMPLETED|Overall Study||142||
48168324|NCT04250337|100735722|FG000|NOT COMPLETED|Overall Study||8||
48168325|NCT04250337|100735723|FG001|NOT COMPLETED|Overall Study||11||
48168326|NCT00409786|100735724|FG000|STARTED|Overall Study||50||
48168327|NCT00409786|100735724|FG000|COMPLETED|Overall Study||47||
48168328|NCT00409786|100735724|FG000|NOT COMPLETED|Overall Study||3||
48168329|NCT02635724|100735725|FG000|STARTED|Overall Study||41||
48168330|NCT02635724|100735726|FG001|STARTED|Overall Study||26||
48168331|NCT02635724|100735727|FG002|STARTED|Overall Study||7||
48168332|NCT02635724|100735725|FG000|ITT Population|Overall Study||41|Intent-to-Treat (ITT) population included all enrolled subjects.|
48168333|NCT02635724|100735726|FG001|ITT Population|Overall Study||26|Intent-to-Treat (ITT) population included all enrolled subjects.|
48168334|NCT02635724|100735727|FG002|ITT Population|Overall Study||7|Intent-to-Treat (ITT) population included all enrolled subjects.|
48168335|NCT02635724|100735725|FG000|Safety Population|Overall Study||41|The safety population included all enrolled subjects who received any amount of study drug.|
48168336|NCT02635724|100735726|FG001|Safety Population|Overall Study||25|The safety population included all enrolled subjects who received any amount of study drug.|
48168337|NCT02635724|100735727|FG002|Safety Population|Overall Study||7|The safety population included all enrolled subjects who received any amount of study drug.|
48168338|NCT02635724|100735725|FG000|ITTI Population|Overall Study||28|Intent-to-Treat Infected (ITTI) population included all subjects who were enrolled, treated, and had influenza type A or B confirmed by PCR.|
48188613|NCT04524104|100783287|FG000|STARTED|Overall Study||42||
48332051|NCT03504410|101141736|FG001|STARTED|Overall Study||102||
48332052|NCT03504410|101141735|FG000|COMPLETED|Overall Study||11||
48332053|NCT03504410|101141736|FG001|COMPLETED|Overall Study||11||
48332054|NCT03504410|101141735|FG000|NOT COMPLETED|Overall Study||87||
48332055|NCT03504410|101141736|FG001|NOT COMPLETED|Overall Study||91||
48168339|NCT02635724|100735726|FG001|ITTI Population|Overall Study||19|Intent-to-Treat Infected (ITTI) population included all subjects who were enrolled, treated, and had influenza type A or B confirmed by PCR.|
48168340|NCT02635724|100735727|FG002|ITTI Population|Overall Study||5|Intent-to-Treat Infected (ITTI) population included all subjects who were enrolled, treated, and had influenza type A or B confirmed by PCR.|
48168341|NCT02635724|100735725|FG000|E-R Population|Overall Study||28|Exposure-Response (E-R) population included all subjects in the ITTI population who had a quantifiable peramivir concentration on Day 1 and had at least one post-baseline effectiveness assessment.|
48168342|NCT02635724|100735726|FG001|E-R Population|Overall Study||19|Exposure-Response (E-R) population included all subjects in the ITTI population who had a quantifiable peramivir concentration on Day 1 and had at least one post-baseline effectiveness assessment.|
48168343|NCT02635724|100735727|FG002|E-R Population|Overall Study||5|Exposure-Response (E-R) population included all subjects in the ITTI population who had a quantifiable peramivir concentration on Day 1 and had at least one post-baseline effectiveness assessment.|
48168344|NCT02635724|100735725|FG000|COMPLETED|Overall Study||41||
48168345|NCT02635724|100735726|FG001|COMPLETED|Overall Study||25||
48168346|NCT02635724|100735727|FG002|COMPLETED|Overall Study||7||
48168347|NCT02635724|100735725|FG000|NOT COMPLETED|Overall Study||0||
48168348|NCT02635724|100735726|FG001|NOT COMPLETED|Overall Study||1||
48168349|NCT02635724|100735727|FG002|NOT COMPLETED|Overall Study||0||
48168350|NCT01320735|100735728|FG000|STARTED|Overall Study||300||
48168351|NCT01320735|100735728|FG000|COMPLETED|Overall Study||194||
48168352|NCT01320735|100735728|FG000|NOT COMPLETED|Overall Study||106||
48168353|NCT04182880|100735729|FG000|STARTED|Overall Study||5||
48168354|NCT04182880|100735730|FG001|STARTED|Overall Study||15||
48168355|NCT04182880|100735729|FG000|COMPLETED|Overall Study||4||
48168356|NCT04182880|100735730|FG001|COMPLETED|Overall Study||15||
48168357|NCT04182880|100735729|FG000|NOT COMPLETED|Overall Study||1||
48168358|NCT04182880|100735730|FG001|NOT COMPLETED|Overall Study||0||
48168359|NCT00332605|100735731|FG000|STARTED|Overall Study||14||
48168360|NCT00332605|100735732|FG001|STARTED|Overall Study||14||
48168361|NCT00332605|100735733|FG002|STARTED|Overall Study||17||
48168362|NCT00332605|100735731|FG000|COMPLETED|Overall Study||12||
48168363|NCT00332605|100735732|FG001|COMPLETED|Overall Study||12||
48168364|NCT00332605|100735733|FG002|COMPLETED|Overall Study||9||
48168365|NCT00332605|100735731|FG000|NOT COMPLETED|Overall Study||2||
48168366|NCT00332605|100735732|FG001|NOT COMPLETED|Overall Study||2||
48168367|NCT00332605|100735733|FG002|NOT COMPLETED|Overall Study||8||
48168368|NCT00068380|100735734|FG000|STARTED|Overall Study||17||
48168369|NCT00068380|100735734|FG000|COMPLETED|Overall Study||12||
48168370|NCT00068380|100735734|FG000|NOT COMPLETED|Overall Study||5||
48168371|NCT03321006|100735735|FG000|STARTED|Overall Study||14||
48168372|NCT03321006|100735736|FG001|STARTED|Overall Study||11||
48168373|NCT03321006|100735735|FG000|COMPLETED|Overall Study||12||
48168374|NCT03321006|100735736|FG001|COMPLETED|Overall Study||11||
48168375|NCT03321006|100735735|FG000|NOT COMPLETED|Overall Study||2||
48168376|NCT03321006|100735736|FG001|NOT COMPLETED|Overall Study||0||
48168377|NCT01679301|100735737|FG000|STARTED|Screening Period||11||
48168378|NCT01679301|100735738|FG001|STARTED|Screening Period||0||
48168379|NCT01679301|100735739|FG002|STARTED|Screening Period||0||
48168380|NCT01679301|100735737|FG000|COMPLETED|Screening Period||8||
48168381|NCT01679301|100735738|FG001|COMPLETED|Screening Period||0||
48168382|NCT01679301|100735739|FG002|COMPLETED|Screening Period||0||
48168383|NCT01679301|100735737|FG000|NOT COMPLETED|Screening Period||3||
48168384|NCT01679301|100735738|FG001|NOT COMPLETED|Screening Period||0||
48168385|NCT01679301|100735739|FG002|NOT COMPLETED|Screening Period||0||
48168386|NCT01679301|100735737|FG000|STARTED|Study Period||0||
48168387|NCT01679301|100735738|FG001|STARTED|Study Period||4||
48332056|NCT01459705|101141737|FG000|STARTED|Overall Study||54||
48332057|NCT01459705|101141738|FG001|STARTED|Overall Study||54||
48168388|NCT01679301|100735739|FG002|STARTED|Study Period||4||
48168389|NCT01679301|100735737|FG000|COMPLETED|Study Period||0||
48168390|NCT01679301|100735738|FG001|COMPLETED|Study Period||4||
48168391|NCT01679301|100735739|FG002|COMPLETED|Study Period||4||
48168392|NCT01679301|100735737|FG000|NOT COMPLETED|Study Period||0||
48168393|NCT01679301|100735738|FG001|NOT COMPLETED|Study Period||0||
48168394|NCT01679301|100735739|FG002|NOT COMPLETED|Study Period||0||
48168395|NCT01346514|100735740|FG000|STARTED|Overall Study||91||
48168396|NCT01346514|100735741|FG001|STARTED|Overall Study||90||
48168397|NCT01346514|100735740|FG000|3 Month Assessment|Overall Study||83||
48168398|NCT01346514|100735741|FG001|3 Month Assessment|Overall Study||68||
48168399|NCT01346514|100735740|FG000|6 Month Assessment|Overall Study||74||
48168400|NCT01346514|100735741|FG001|6 Month Assessment|Overall Study||61||
48168401|NCT01346514|100735740|FG000|9 Month Assessment|Overall Study||67||
48168402|NCT01346514|100735741|FG001|9 Month Assessment|Overall Study||59||
48168403|NCT01346514|100735740|FG000|12 Month Assessment|Overall Study||62||
48168404|NCT01346514|100735741|FG001|12 Month Assessment|Overall Study||53||
48168405|NCT01346514|100735740|FG000|COMPLETED|Overall Study||62||
48168406|NCT01346514|100735741|FG001|COMPLETED|Overall Study||53||
48168407|NCT01346514|100735740|FG000|NOT COMPLETED|Overall Study||29||
48411030|NCT03797144|101337789|FG001|NOT COMPLETED|12 Month||9||
48411031|NCT03797144|101337788|FG000|STARTED|24 Month||1||
48411032|NCT03797144|101337789|FG001|STARTED|24 Month||1||
48168408|NCT01346514|100735741|FG001|NOT COMPLETED|Overall Study||37||
48168409|NCT02200939|100735742|FG000|STARTED|Overall Study||33||
48168410|NCT02200939|100735743|FG001|STARTED|Overall Study||115||
48168411|NCT02200939|100735742|FG000|COMPLETED|Overall Study||31||
48168412|NCT02200939|100735743|FG001|COMPLETED|Overall Study||104||
48168413|NCT02200939|100735742|FG000|NOT COMPLETED|Overall Study||2||
48168414|NCT02200939|100735743|FG001|NOT COMPLETED|Overall Study||11||
48168415|NCT01190215|100735744|FG000|STARTED|Up to Day 28||38||
48168416|NCT01190215|100735745|FG001|STARTED|Up to Day 28||39||
48168417|NCT01190215|100735744|FG000|COMPLETED|Up to Day 28||38||
48168418|NCT01190215|100735745|FG001|COMPLETED|Up to Day 28||39||
48168419|NCT01190215|100735744|FG000|NOT COMPLETED|Up to Day 28||0||
48168420|NCT01190215|100735745|FG001|NOT COMPLETED|Up to Day 28||0||
48168421|NCT01190215|100735744|FG000|STARTED|Up to Month 6||38||
48168422|NCT01190215|100735745|FG001|STARTED|Up to Month 6||39||
48168423|NCT01190215|100735744|FG000|COMPLETED|Up to Month 6||36||
48168424|NCT01190215|100735745|FG001|COMPLETED|Up to Month 6||39||
48168425|NCT01190215|100735744|FG000|NOT COMPLETED|Up to Month 6||2||
48168426|NCT01190215|100735745|FG001|NOT COMPLETED|Up to Month 6||0||
48168427|NCT00882921|100735746|FG000|STARTED|Overall Study||26||
48168428|NCT00882921|100735746|FG000|COMPLETED|Overall Study||15||
48168429|NCT00882921|100735746|FG000|NOT COMPLETED|Overall Study||11||
48168430|NCT01508013|100735747|FG000|STARTED|Overall Study||214||
48168431|NCT01508013|100735748|FG001|STARTED|Overall Study||229||
48168432|NCT01508013|100735747|FG000|COMPLETED|Overall Study||182||
48168433|NCT01508013|100735748|FG001|COMPLETED|Overall Study||206||
48168434|NCT01508013|100735747|FG000|NOT COMPLETED|Overall Study||32||
48168435|NCT01508013|100735748|FG001|NOT COMPLETED|Overall Study||23||
48168436|NCT02223754|100735749|FG000|STARTED|Period 1||163||
48168437|NCT02223754|100735750|FG001|STARTED|Period 1||159||
48168438|NCT02223754|100735749|FG000|COMPLETED|Period 1||159||
48168439|NCT02223754|100735750|FG001|COMPLETED|Period 1||144||
48168440|NCT02223754|100735749|FG000|NOT COMPLETED|Period 1||4||
48168441|NCT02223754|100735750|FG001|NOT COMPLETED|Period 1||15||
48168442|NCT02223754|100735749|FG000|STARTED|Period 2||159||
48168443|NCT02223754|100735750|FG001|STARTED|Period 2||144||
48168444|NCT02223754|100735749|FG000|COMPLETED|Period 2||156||
48168445|NCT02223754|100735750|FG001|COMPLETED|Period 2||141||
48168446|NCT02223754|100735749|FG000|NOT COMPLETED|Period 2||3||
48168447|NCT02223754|100735750|FG001|NOT COMPLETED|Period 2||3||
48168448|NCT01744860|100735751|FG000|STARTED|Overall Study||420||
48168449|NCT01744860|100735751|FG000|COMPLETED|Overall Study||420||
48168450|NCT01744860|100735751|FG000|NOT COMPLETED|Overall Study||0||
48168451|NCT02281760|100735752|FG000|STARTED|Overall Study||6||
48168452|NCT02281760|100735752|FG000|COMPLETED|Overall Study||5||
48168453|NCT02281760|100735752|FG000|NOT COMPLETED|Overall Study||1||
48168454|NCT01966796|100735753|FG000|STARTED|Overall Study||15||
48168455|NCT01966796|100735754|FG001|STARTED|Overall Study||51||
48168456|NCT01966796|100735755|FG002|STARTED|Overall Study||195||
48168457|NCT01966796|100735756|FG003|STARTED|Overall Study||269||
48168458|NCT01966796|100735753|FG000|COMPLETED|Overall Study||15||
48168459|NCT01966796|100735754|FG001|COMPLETED|Overall Study||51||
48168460|NCT01966796|100735755|FG002|COMPLETED|Overall Study||195||
48168461|NCT01966796|100735756|FG003|COMPLETED|Overall Study||269||
48168462|NCT01966796|100735753|FG000|NOT COMPLETED|Overall Study||0||
48168463|NCT01966796|100735754|FG001|NOT COMPLETED|Overall Study||0||
48168464|NCT01966796|100735755|FG002|NOT COMPLETED|Overall Study||0||
48168465|NCT01966796|100735756|FG003|NOT COMPLETED|Overall Study||0||
48168466|NCT02357810|100735757|FG000|STARTED|Registered and Started Treatment||178||
48168467|NCT02357810|100735757|FG000|Signed Consent|Registered and Started Treatment||178||
48168468|NCT02357810|100735757|FG000|Registered to Study|Registered and Started Treatment||152||
48168469|NCT02357810|100735757|FG000|Initiated Treatment on Study|Registered and Started Treatment||151||
48168470|NCT02357810|100735757|FG000|COMPLETED|Registered and Started Treatment||151||
48168471|NCT02357810|100735757|FG000|NOT COMPLETED|Registered and Started Treatment||27||
48168472|NCT02357810|100735757|FG000|STARTED|Reached 12 Weeks Response||151||
48168473|NCT02357810|100735757|FG000|Completed 4 Weeks/1 Cycle|Reached 12 Weeks Response||151||
48168474|NCT02357810|100735757|FG000|Reached 6 Week Response|Reached 12 Weeks Response||129|Patients assessed as having progression at 6 weeks, discontinue study treatment per protocol.|
48168475|NCT02357810|100735757|FG000|Reached 12 Weeks/3 Cycles|Reached 12 Weeks Response||95||
48168476|NCT02357810|100735757|FG000|COMPLETED|Reached 12 Weeks Response||95||
48168477|NCT02357810|100735757|FG000|NOT COMPLETED|Reached 12 Weeks Response||56||
48168478|NCT02357810|100735757|FG000|STARTED|12 Week Response and Further Treatment||95||
48168479|NCT02357810|100735757|FG000|Assessed for 12 Week Response|12 Week Response and Further Treatment||95|Patients assessed as having progression at 12 weeks, discontinue study treatment per protocol.|
48168480|NCT02357810|100735757|FG000|Went on to be Treated After Response|12 Week Response and Further Treatment||73|Patients continue treatment until progressive disease, toxicity or patient withdrawal.|
48168481|NCT02357810|100735757|FG000|COMPLETED|12 Week Response and Further Treatment||73||
48168482|NCT02357810|100735757|FG000|NOT COMPLETED|12 Week Response and Further Treatment||22||
48168483|NCT02357810|100735757|FG000|STARTED|Follow-up at Treatment Discontinuation||151|Follow-up= 2yrs for patients with progression/5yrs for patients without progression, or until death or reach date 10.12.21|
48168484|NCT02357810|100735757|FG000|COMPLETED|Follow-up at Treatment Discontinuation||144||
48168485|NCT02357810|100735757|FG000|NOT COMPLETED|Follow-up at Treatment Discontinuation||7||
48168486|NCT01517243|100735758|FG000|STARTED|Overall Study||19||
48168487|NCT01517243|100735758|FG000|COMPLETED|Overall Study||19||
48168488|NCT01517243|100735758|FG000|NOT COMPLETED|Overall Study||0||
48168489|NCT00981474|100735759|FG000|STARTED|Overall Study||228||
48168490|NCT00981474|100735760|FG001|STARTED|Overall Study||232||
48168491|NCT00981474|100735759|FG000|COMPLETED|Overall Study||228||
48168492|NCT00981474|100735760|FG001|COMPLETED|Overall Study||232||
48168493|NCT00981474|100735759|FG000|NOT COMPLETED|Overall Study||0||
48168494|NCT00981474|100735760|FG001|NOT COMPLETED|Overall Study||0||
48168495|NCT02139358|100735761|FG000|STARTED|Overall Study||15||
48168496|NCT02139358|100735761|FG000|COMPLETED|Overall Study||15||
48168497|NCT02139358|100735761|FG000|NOT COMPLETED|Overall Study||0||
48168498|NCT04296890|100735762|FG000|STARTED|Overall Study||106||
48168499|NCT04296890|100735762|FG000|INV Efficacy Evaluable Population|Overall Study||105||
48168500|NCT04296890|100735762|FG000|COMPLETED|Overall Study||38||
48168501|NCT04296890|100735762|FG000|NOT COMPLETED|Overall Study||68||
48168502|NCT02001974|100735763|FG000|STARTED|Run-in Period||4||
48168503|NCT02001974|100735764|FG001|STARTED|Run-in Period||3||
48168504|NCT02001974|100735765|FG002|STARTED|Run-in Period||26||
48168505|NCT02001974|100735763|FG000|COMPLETED|Run-in Period||4||
48168506|NCT02001974|100735764|FG001|COMPLETED|Run-in Period||3||
48168507|NCT02001974|100735765|FG002|COMPLETED|Run-in Period||26||
48168508|NCT02001974|100735763|FG000|NOT COMPLETED|Run-in Period||0||
48168509|NCT02001974|100735764|FG001|NOT COMPLETED|Run-in Period||0||
48168510|NCT02001974|100735765|FG002|NOT COMPLETED|Run-in Period||0||
48168511|NCT02001974|100735763|FG000|STARTED|Reparixin + Paclitaxel (28-day Cycles)||4||
48168512|NCT02001974|100735764|FG001|STARTED|Reparixin + Paclitaxel (28-day Cycles)||3||
48168513|NCT02001974|100735765|FG002|STARTED|Reparixin + Paclitaxel (28-day Cycles)||26||
48332058|NCT01459705|101141739|FG002|STARTED|Overall Study||54||
48332059|NCT01459705|101141737|FG000|COMPLETED|Overall Study||32||
48332060|NCT01459705|101141738|FG001|COMPLETED|Overall Study||30||
48332061|NCT01459705|101141739|FG002|COMPLETED|Overall Study||47||
48168514|NCT02001974|100735763|FG000|COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||0||
48168515|NCT02001974|100735764|FG001|COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||0||
48168516|NCT02001974|100735765|FG002|COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||0||
48168517|NCT02001974|100735763|FG000|NOT COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||4||
48168518|NCT02001974|100735764|FG001|NOT COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||3||
48168519|NCT02001974|100735765|FG002|NOT COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||26||
48168520|NCT00597714|100735766|FG000|STARTED|Overall Study||80||
48168521|NCT00597714|100735767|FG001|STARTED|Overall Study||57||
48168522|NCT00597714|100735768|FG002|STARTED|Overall Study||94||
48168523|NCT00597714|100735766|FG000|COMPLETED|Overall Study||24||
48168524|NCT00597714|100735767|FG001|COMPLETED|Overall Study||11||
48168525|NCT00597714|100735768|FG002|COMPLETED|Overall Study||84||
48168526|NCT00597714|100735766|FG000|NOT COMPLETED|Overall Study||56||
48168527|NCT00597714|100735767|FG001|NOT COMPLETED|Overall Study||46||
48168528|NCT00597714|100735768|FG002|NOT COMPLETED|Overall Study||10||
48168529|NCT02917577|100735769|FG000|STARTED|Overall Study||10||
48168530|NCT02917577|100735770|FG001|STARTED|Overall Study||9||
48168531|NCT02917577|100735769|FG000|COMPLETED|Overall Study||9||
48168532|NCT02917577|100735770|FG001|COMPLETED|Overall Study||7||
48168533|NCT02917577|100735769|FG000|NOT COMPLETED|Overall Study||1||
48168534|NCT02917577|100735770|FG001|NOT COMPLETED|Overall Study||2||
48168535|NCT01512745|100735771|FG000|STARTED|Overall Study||176||
48168536|NCT01512745|100735772|FG001|STARTED|Overall Study||91||
48168537|NCT01512745|100735771|FG000|COMPLETED|Overall Study||136||
48168538|NCT01512745|100735772|FG001|COMPLETED|Overall Study||71||
48168539|NCT01512745|100735771|FG000|NOT COMPLETED|Overall Study||40||
48168540|NCT01512745|100735772|FG001|NOT COMPLETED|Overall Study||20||
48168541|NCT01231503|100735773|FG000|STARTED|Overall Study||60||
48168542|NCT01231503|100735774|FG001|STARTED|Overall Study||59||
48168543|NCT01231503|100735775|FG002|STARTED|Overall Study||60||
48168544|NCT01231503|100735776|FG003|STARTED|Overall Study||60||
48168545|NCT01231503|100735777|FG004|STARTED|Overall Study||60||
48168546|NCT01231503|100735778|FG005|STARTED|Overall Study||60||
48168547|NCT01231503|100735779|FG006|STARTED|Overall Study||60||
48168548|NCT01231503|100735780|FG007|STARTED|Overall Study||60||
48168549|NCT01231503|100735773|FG000|COMPLETED|Overall Study||46||
48168550|NCT01231503|100735774|FG001|COMPLETED|Overall Study||46||
48168551|NCT01231503|100735775|FG002|COMPLETED|Overall Study||48||
48168552|NCT01231503|100735776|FG003|COMPLETED|Overall Study||52||
48168553|NCT01231503|100735777|FG004|COMPLETED|Overall Study||50||
48168554|NCT01231503|100735778|FG005|COMPLETED|Overall Study||44||
48168555|NCT01231503|100735779|FG006|COMPLETED|Overall Study||53||
48168556|NCT01231503|100735780|FG007|COMPLETED|Overall Study||52||
48168557|NCT01231503|100735773|FG000|NOT COMPLETED|Overall Study||14||
48168558|NCT01231503|100735774|FG001|NOT COMPLETED|Overall Study||13||
48332062|NCT01459705|101141737|FG000|NOT COMPLETED|Overall Study||22||
48411033|NCT03797144|101337788|FG000|COMPLETED|24 Month||0||
48168559|NCT01231503|100735775|FG002|NOT COMPLETED|Overall Study||12||
48168560|NCT01231503|100735776|FG003|NOT COMPLETED|Overall Study||8||
48168561|NCT01231503|100735777|FG004|NOT COMPLETED|Overall Study||10||
48168562|NCT01231503|100735778|FG005|NOT COMPLETED|Overall Study||16||
48168563|NCT01231503|100735779|FG006|NOT COMPLETED|Overall Study||7||
48168564|NCT01231503|100735780|FG007|NOT COMPLETED|Overall Study||8||
48168565|NCT01290822|100735781|FG000|STARTED|Overall Study||12||
48168566|NCT01290822|100735781|FG000|COMPLETED|Overall Study||1||
48168567|NCT01290822|100735781|FG000|NOT COMPLETED|Overall Study||11||
48168568|NCT02970032|100735782|FG000|STARTED|Standard Heparin Dose||20||
48168569|NCT02970032|100735782|FG000|COMPLETED|Standard Heparin Dose||20||
48168570|NCT02970032|100735782|FG000|NOT COMPLETED|Standard Heparin Dose||0||
48168571|NCT02970032|100735782|FG000|STARTED|Real Time Heparin Dose Adjustment||20||
48168572|NCT02970032|100735782|FG000|COMPLETED|Real Time Heparin Dose Adjustment||20||
48168573|NCT02970032|100735782|FG000|NOT COMPLETED|Real Time Heparin Dose Adjustment||0||
48332063|NCT01459705|101141738|FG001|NOT COMPLETED|Overall Study||24||
48332064|NCT01459705|101141739|FG002|NOT COMPLETED|Overall Study||7||
48332065|NCT00880893|101141740|FG000|STARTED|Overall Study||898||
48332066|NCT00880893|101141741|FG001|STARTED|Overall Study||300||
48332067|NCT00880893|101141740|FG000|COMPLETED|Overall Study||791||
48332068|NCT00880893|101141741|FG001|COMPLETED|Overall Study||255||
48332069|NCT00880893|101141740|FG000|NOT COMPLETED|Overall Study||107||
48332070|NCT00880893|101141741|FG001|NOT COMPLETED|Overall Study||45||
48332071|NCT00762515|101141742|FG000|STARTED|Overall Study||22||
48332072|NCT00762515|101141743|FG001|STARTED|Overall Study||22||
48332073|NCT00762515|101141742|FG000|COMPLETED|Overall Study||22||
48332074|NCT00762515|101141743|FG001|COMPLETED|Overall Study||22||
48332075|NCT00762515|101141742|FG000|NOT COMPLETED|Overall Study||0||
48332076|NCT00762515|101141743|FG001|NOT COMPLETED|Overall Study||0||
48411034|NCT03797144|101337789|FG001|COMPLETED|24 Month||0||
48411035|NCT03797144|101337788|FG000|NOT COMPLETED|24 Month||1||
48411036|NCT03797144|101337789|FG001|NOT COMPLETED|24 Month||1||
48748912|NCT02374164|102172924|FG000|COMPLETED|Treatment Period 2||12||
48748913|NCT02374164|102172925|FG001|COMPLETED|Treatment Period 2||12||
48748914|NCT02374164|102172926|FG002|COMPLETED|Treatment Period 2||12||
48168574|NCT00610701|100735783|FG000|STARTED|Overall Study||15||
48168575|NCT00610701|100735784|FG001|STARTED|Overall Study||20||
48168576|NCT00610701|100735783|FG000|COMPLETED|Overall Study||5||
48168577|NCT00610701|100735784|FG001|COMPLETED|Overall Study||9||
48168578|NCT00610701|100735783|FG000|NOT COMPLETED|Overall Study||10||
48168579|NCT00610701|100735784|FG001|NOT COMPLETED|Overall Study||11||
48168580|NCT02400437|100735785|FG000|STARTED|Overall Study||26||
48168581|NCT02400437|100735785|FG000|COMPLETED|Overall Study||26||
48168582|NCT02400437|100735785|FG000|NOT COMPLETED|Overall Study||0||
48168583|NCT02641249|100735786|FG000|STARTED|Overall Study||19||
48168584|NCT02641249|100735786|FG000|COMPLETED|Overall Study||15||
48168585|NCT02641249|100735786|FG000|NOT COMPLETED|Overall Study||4||
48168586|NCT02120664|100735787|FG000|STARTED|Overall Study||10||
48168587|NCT02120664|100735788|FG001|STARTED|Overall Study||4||
48168588|NCT02120664|100735789|FG002|STARTED|Overall Study||7||
48168589|NCT02120664|100735790|FG003|STARTED|Overall Study||4||
48168590|NCT02120664|100735791|FG004|STARTED|Overall Study||10||
48168591|NCT02120664|100735787|FG000|COMPLETED|Overall Study||10||
48168592|NCT02120664|100735788|FG001|COMPLETED|Overall Study||4||
48168593|NCT02120664|100735789|FG002|COMPLETED|Overall Study||7||
48332077|NCT03856255|101141744|FG000|STARTED|Overall Study||23||
48332078|NCT03856255|101141744|FG000|COMPLETED|Overall Study||23||
48332079|NCT03856255|101141744|FG000|NOT COMPLETED|Overall Study||0||
48332080|NCT05048719|101141745|FG000|STARTED|Overall Study||55||
48332081|NCT05048719|101141746|FG001|STARTED|Overall Study||51||
48332082|NCT05048719|101141747|FG002|STARTED|Overall Study||56||
48332083|NCT05048719|101141748|FG003|STARTED|Overall Study||47||
48411037|NCT00081263|101337790|FG000|STARTED|Overall Study||67||
48411038|NCT00081263|101337791|FG001|STARTED|Overall Study||63||
48748915|NCT02374164|102172924|FG000|NOT COMPLETED|Treatment Period 2||0||
48748916|NCT02374164|102172925|FG001|NOT COMPLETED|Treatment Period 2||0||
48748917|NCT02374164|102172926|FG002|NOT COMPLETED|Treatment Period 2||0||
48168594|NCT02120664|100735790|FG003|COMPLETED|Overall Study||3||
48168595|NCT02120664|100735791|FG004|COMPLETED|Overall Study||10||
48168596|NCT02120664|100735787|FG000|NOT COMPLETED|Overall Study||0||
48168597|NCT02120664|100735788|FG001|NOT COMPLETED|Overall Study||0||
48168598|NCT02120664|100735789|FG002|NOT COMPLETED|Overall Study||0||
48168599|NCT02120664|100735790|FG003|NOT COMPLETED|Overall Study||1||
48168600|NCT02120664|100735791|FG004|NOT COMPLETED|Overall Study||0||
48168601|NCT02778399|100735792|FG000|STARTED|Up to Week 12 Treatment Period||54||
48168602|NCT02778399|100735793|FG001|STARTED|Up to Week 12 Treatment Period||49||
48168603|NCT02778399|100735794|FG002|STARTED|Up to Week 12 Treatment Period||57||
48168604|NCT02778399|100735795|FG003|STARTED|Up to Week 12 Treatment Period||58||
48168605|NCT02778399|100735796|FG004|STARTED|Up to Week 12 Treatment Period||53||
48168606|NCT02778399|100735797|FG005|STARTED|Up to Week 12 Treatment Period||57||
48168607|NCT02778399|100735792|FG000|Included in SAFETY SET|Up to Week 12 Treatment Period||54||
48332084|NCT05048719|101141749|FG004|STARTED|Overall Study||27||
48332085|NCT05048719|101141750|FG005|STARTED|Overall Study||34||
48332086|NCT05048719|101141751|FG006|STARTED|Overall Study||31||
48332087|NCT05048719|101141752|FG007|STARTED|Overall Study||32||
48748918|NCT02374164|102172924|FG000|STARTED|Treatment Period 3||12||
48168608|NCT02778399|100735793|FG001|Included in SAFETY SET|Up to Week 12 Treatment Period||49||
48168609|NCT02778399|100735794|FG002|Included in SAFETY SET|Up to Week 12 Treatment Period||57||
48626155|NCT00305162|101867642|FG001|COMPLETED|1 Year Follow-up Period||4382||
48626156|NCT00305162|101867641|FG000|NOT COMPLETED|1 Year Follow-up Period||55||
48626157|NCT00305162|101867642|FG001|NOT COMPLETED|1 Year Follow-up Period||65||
48168610|NCT02778399|100735795|FG003|Included in SAFETY SET|Up to Week 12 Treatment Period||58||
48168611|NCT02778399|100735796|FG004|Included in SAFETY SET|Up to Week 12 Treatment Period||52||
48168612|NCT02778399|100735797|FG005|Included in SAFETY SET|Up to Week 12 Treatment Period||57||
48168613|NCT02778399|100735792|FG000|Included in FAS|Up to Week 12 Treatment Period||53||
48168614|NCT02778399|100735793|FG001|Included in FAS|Up to Week 12 Treatment Period||49||
48168615|NCT02778399|100735794|FG002|Included in FAS|Up to Week 12 Treatment Period||56||
48168616|NCT02778399|100735795|FG003|Included in FAS|Up to Week 12 Treatment Period||58||
48168617|NCT02778399|100735796|FG004|Included in FAS|Up to Week 12 Treatment Period||51||
48168618|NCT02778399|100735797|FG005|Included in FAS|Up to Week 12 Treatment Period||56||
48168619|NCT02778399|100735792|FG000|COMPLETED|Up to Week 12 Treatment Period||45||
48168620|NCT02778399|100735793|FG001|COMPLETED|Up to Week 12 Treatment Period||45||
48168621|NCT02778399|100735794|FG002|COMPLETED|Up to Week 12 Treatment Period||53||
48626158|NCT03885908|101867643|FG000|STARTED|Overall Study||11||
48626159|NCT03885908|101867644|FG001|STARTED|Overall Study||9||
48626160|NCT03885908|101867643|FG000|COMPLETED|Overall Study||8||
48626161|NCT03885908|101867644|FG001|COMPLETED|Overall Study||7||
48626162|NCT03885908|101867643|FG000|NOT COMPLETED|Overall Study||3||
48626163|NCT03885908|101867644|FG001|NOT COMPLETED|Overall Study||2||
48168622|NCT02778399|100735795|FG003|COMPLETED|Up to Week 12 Treatment Period||51||
48168623|NCT02778399|100735796|FG004|COMPLETED|Up to Week 12 Treatment Period||45||
48168624|NCT02778399|100735797|FG005|COMPLETED|Up to Week 12 Treatment Period||49||
48168625|NCT02778399|100735792|FG000|NOT COMPLETED|Up to Week 12 Treatment Period||9||
48168626|NCT02778399|100735793|FG001|NOT COMPLETED|Up to Week 12 Treatment Period||4||
48168627|NCT02778399|100735794|FG002|NOT COMPLETED|Up to Week 12 Treatment Period||4||
48168628|NCT02778399|100735795|FG003|NOT COMPLETED|Up to Week 12 Treatment Period||7||
48168629|NCT02778399|100735796|FG004|NOT COMPLETED|Up to Week 12 Treatment Period||8||
48168630|NCT02778399|100735797|FG005|NOT COMPLETED|Up to Week 12 Treatment Period||8||
48168631|NCT02778399|100735792|FG000|STARTED|Week 12 to Week 24 Treatment Period||45||
48168632|NCT02778399|100735793|FG001|STARTED|Week 12 to Week 24 Treatment Period||45||
48168633|NCT02778399|100735794|FG002|STARTED|Week 12 to Week 24 Treatment Period||53||
48168634|NCT02778399|100735795|FG003|STARTED|Week 12 to Week 24 Treatment Period||51||
48168635|NCT02778399|100735796|FG004|STARTED|Week 12 to Week 24 Treatment Period||45||
48168636|NCT02778399|100735797|FG005|STARTED|Week 12 to Week 24 Treatment Period||49||
48626164|NCT03143257|101867645|FG000|STARTED|Overall Study||71||
48626165|NCT03143257|101867645|FG000|COMPLETED|Overall Study||71||
48626166|NCT03143257|101867645|FG000|NOT COMPLETED|Overall Study||0||
48168637|NCT02778399|100735792|FG000|COMPLETED|Week 12 to Week 24 Treatment Period||37||
48168638|NCT02778399|100735793|FG001|COMPLETED|Week 12 to Week 24 Treatment Period||41||
48168639|NCT02778399|100735794|FG002|COMPLETED|Week 12 to Week 24 Treatment Period||48||
48168640|NCT02778399|100735795|FG003|COMPLETED|Week 12 to Week 24 Treatment Period||46||
48168641|NCT02778399|100735796|FG004|COMPLETED|Week 12 to Week 24 Treatment Period||39||
48168642|NCT02778399|100735797|FG005|COMPLETED|Week 12 to Week 24 Treatment Period||42||
48168643|NCT02778399|100735792|FG000|NOT COMPLETED|Week 12 to Week 24 Treatment Period||8||
48168644|NCT02778399|100735793|FG001|NOT COMPLETED|Week 12 to Week 24 Treatment Period||4||
48168645|NCT02778399|100735794|FG002|NOT COMPLETED|Week 12 to Week 24 Treatment Period||5||
48168646|NCT02778399|100735795|FG003|NOT COMPLETED|Week 12 to Week 24 Treatment Period||5||
48168647|NCT02778399|100735796|FG004|NOT COMPLETED|Week 12 to Week 24 Treatment Period||6||
48168648|NCT02778399|100735797|FG005|NOT COMPLETED|Week 12 to Week 24 Treatment Period||7||
48168649|NCT01381874|100735798|FG000|STARTED|Overall Study||102||
48168650|NCT01381874|100735799|FG001|STARTED|Overall Study||89||
48168651|NCT01381874|100735800|FG002|STARTED|Overall Study||106||
48168652|NCT01381874|100735798|FG000|Treated|Overall Study||102||
48168653|NCT01381874|100735799|FG001|Treated|Overall Study||87||
48168654|NCT01381874|100735800|FG002|Treated|Overall Study||104||
48168655|NCT01381874|100735798|FG000|COMPLETED|Overall Study||25||
48626167|NCT00764790|101867646|FG000|STARTED|Overall Study||1107||
48626168|NCT00764790|101867647|FG001|STARTED|Overall Study||1106||
48626169|NCT00764790|101867648|FG002|STARTED|Overall Study||1104||
48168656|NCT01381874|100735799|FG001|COMPLETED|Overall Study||26||
48168657|NCT01381874|100735800|FG002|COMPLETED|Overall Study||30||
48168658|NCT01381874|100735798|FG000|NOT COMPLETED|Overall Study||77||
48168659|NCT01381874|100735799|FG001|NOT COMPLETED|Overall Study||63||
48168660|NCT01381874|100735800|FG002|NOT COMPLETED|Overall Study||76||
48168661|NCT02756832|100735801|FG000|STARTED|Overall Study||1409||
48626170|NCT00764790|101867646|FG000|COMPLETED|Overall Study||1069||
48626171|NCT00764790|101867647|FG001|COMPLETED|Overall Study||1065||
48626172|NCT00764790|101867648|FG002|COMPLETED|Overall Study||1074||
48626173|NCT00764790|101867646|FG000|NOT COMPLETED|Overall Study||38||
48626174|NCT00764790|101867647|FG001|NOT COMPLETED|Overall Study||41||
48168662|NCT02756832|100735801|FG000|Received Therapy|Overall Study||1393||
48168663|NCT02756832|100735801|FG000|Included in Efficacy and Safety Analysis|Overall Study||1399||
48168664|NCT02756832|100735801|FG000|COMPLETED|Overall Study||1356||
48168665|NCT02756832|100735801|FG000|NOT COMPLETED|Overall Study||53||
48626175|NCT00764790|101867648|FG002|NOT COMPLETED|Overall Study||30||
48168666|NCT02401308|100735802|FG000|STARTED|Overall Study||0||
48168667|NCT02401308|100735803|FG001|STARTED|Overall Study||1||
48168668|NCT02401308|100735802|FG000|COMPLETED|Overall Study||0||
48168669|NCT02401308|100735803|FG001|COMPLETED|Overall Study||0||
48168670|NCT02401308|100735802|FG000|NOT COMPLETED|Overall Study||0||
48168671|NCT02401308|100735803|FG001|NOT COMPLETED|Overall Study||1||
48168672|NCT04651114|100735804|FG000|STARTED|Overall Study||38||
48168673|NCT04651114|100735804|FG000|COMPLETED|Overall Study||30||
48168674|NCT04651114|100735804|FG000|NOT COMPLETED|Overall Study||8||
48168675|NCT00245856|100735805|FG000|STARTED|Period One||28||
48168676|NCT00245856|100735806|FG001|STARTED|Period One||0||
48168677|NCT00245856|100735805|FG000|COMPLETED|Period One||28||
48168678|NCT00245856|100735806|FG001|COMPLETED|Period One||0||
48168679|NCT00245856|100735805|FG000|NOT COMPLETED|Period One||0||
48168680|NCT00245856|100735806|FG001|NOT COMPLETED|Period One||0||
48168681|NCT00245856|100735805|FG000|STARTED|Period Two||0||
48168682|NCT00245856|100735806|FG001|STARTED|Period Two||39||
48168683|NCT00245856|100735805|FG000|COMPLETED|Period Two||0||
48168684|NCT00245856|100735806|FG001|COMPLETED|Period Two||38||
48168685|NCT00245856|100735805|FG000|NOT COMPLETED|Period Two||0||
48168686|NCT00245856|100735806|FG001|NOT COMPLETED|Period Two||1||
48168687|NCT04613882|100735807|FG000|STARTED|First Intervention||14||23
48626176|NCT02169440|101867649|FG000|STARTED|Overall Study||10||
48626177|NCT02169440|101867650|FG001|STARTED|Overall Study||10||
48626178|NCT02169440|101867649|FG000|COMPLETED|Overall Study||10||
48626179|NCT02169440|101867650|FG001|COMPLETED|Overall Study||10||
48626180|NCT02169440|101867649|FG000|NOT COMPLETED|Overall Study||0||
48626181|NCT02169440|101867650|FG001|NOT COMPLETED|Overall Study||0||
48626182|NCT02154139|101867651|FG000|STARTED|Overall Study||651||
48626183|NCT02154139|101867651|FG000|COMPLETED|Overall Study||644||
48626184|NCT02154139|101867651|FG000|NOT COMPLETED|Overall Study||7||
48626185|NCT01257347|101867652|FG000|STARTED|Overall Study||12||
48626186|NCT01257347|101867653|FG001|STARTED|Overall Study||12||
48626187|NCT01257347|101867654|FG002|STARTED|Overall Study||35||
48626188|NCT01257347|101867655|FG003|STARTED|Overall Study||65||
48626189|NCT01257347|101867652|FG000|COMPLETED|Overall Study||12||
48626190|NCT01257347|101867653|FG001|COMPLETED|Overall Study||12||
48626191|NCT01257347|101867654|FG002|COMPLETED|Overall Study||35||
48626192|NCT01257347|101867655|FG003|COMPLETED|Overall Study||65||
48626193|NCT01257347|101867652|FG000|NOT COMPLETED|Overall Study||0||
48626194|NCT01257347|101867653|FG001|NOT COMPLETED|Overall Study||0||
48626195|NCT01257347|101867654|FG002|NOT COMPLETED|Overall Study||0||
48626196|NCT01257347|101867655|FG003|NOT COMPLETED|Overall Study||0||
48626197|NCT02100839|101867656|FG000|STARTED|Single Ascending Dose||24||
48168688|NCT04613882|100735808|FG001|STARTED|First Intervention||6||9
48168689|NCT04613882|100735809|FG002|STARTED|First Intervention||9||15
48168690|NCT04613882|100735810|FG003|STARTED|First Intervention||5||6
48168691|NCT04613882|100735811|FG004|STARTED|First Intervention||6||9
48168692|NCT04613882|100735812|FG005|STARTED|First Intervention||13||22
48168693|NCT04613882|100735807|FG000|COMPLETED|First Intervention||14||23
48168694|NCT04613882|100735808|FG001|COMPLETED|First Intervention||6||9
48168695|NCT04613882|100735809|FG002|COMPLETED|First Intervention||9||15
48168696|NCT04613882|100735810|FG003|COMPLETED|First Intervention||5||6
48168697|NCT04613882|100735811|FG004|COMPLETED|First Intervention||6||9
48168698|NCT04613882|100735812|FG005|COMPLETED|First Intervention||13||22
48168699|NCT04613882|100735807|FG000|NOT COMPLETED|First Intervention||0||0
48168700|NCT04613882|100735808|FG001|NOT COMPLETED|First Intervention||0||0
48168701|NCT04613882|100735809|FG002|NOT COMPLETED|First Intervention||0||0
48168702|NCT04613882|100735810|FG003|NOT COMPLETED|First Intervention||0||0
48168703|NCT04613882|100735811|FG004|NOT COMPLETED|First Intervention||0||0
48168704|NCT04613882|100735812|FG005|NOT COMPLETED|First Intervention||0||0
48168705|NCT04613882|100735807|FG000|STARTED|Second Intervention||14||23
48168706|NCT04613882|100735808|FG001|STARTED|Second Intervention||6||9
48168707|NCT04613882|100735809|FG002|STARTED|Second Intervention||9||15
48168708|NCT04613882|100735810|FG003|STARTED|Second Intervention||5||6
48168709|NCT04613882|100735811|FG004|STARTED|Second Intervention||6||9
48168710|NCT04613882|100735812|FG005|STARTED|Second Intervention||13||22
48168711|NCT04613882|100735807|FG000|COMPLETED|Second Intervention||14||23
48168712|NCT04613882|100735808|FG001|COMPLETED|Second Intervention||6||9
48168713|NCT04613882|100735809|FG002|COMPLETED|Second Intervention||9||15
48168714|NCT04613882|100735810|FG003|COMPLETED|Second Intervention||5||6
48168715|NCT04613882|100735811|FG004|COMPLETED|Second Intervention||6||9
48168716|NCT04613882|100735812|FG005|COMPLETED|Second Intervention||13||22
48626198|NCT02100839|101867657|FG001|STARTED|Single Ascending Dose||12||
48626199|NCT02100839|101867656|FG000|COMPLETED|Single Ascending Dose||24||
48626200|NCT02100839|101867657|FG001|COMPLETED|Single Ascending Dose||12||
48626201|NCT02100839|101867656|FG000|NOT COMPLETED|Single Ascending Dose||0||
48626202|NCT02100839|101867657|FG001|NOT COMPLETED|Single Ascending Dose||0||
48168717|NCT04613882|100735807|FG000|NOT COMPLETED|Second Intervention||0||0
48168718|NCT04613882|100735808|FG001|NOT COMPLETED|Second Intervention||0||0
48168719|NCT04613882|100735809|FG002|NOT COMPLETED|Second Intervention||0||0
48168720|NCT04613882|100735810|FG003|NOT COMPLETED|Second Intervention||0||0
48626203|NCT02100839|101867656|FG000|STARTED|Multiple Ascending Dose||13||
48626204|NCT02100839|101867657|FG001|STARTED|Multiple Ascending Dose||3||
48168721|NCT04613882|100735811|FG004|NOT COMPLETED|Second Intervention||0||0
48168722|NCT04613882|100735812|FG005|NOT COMPLETED|Second Intervention||0||0
48168723|NCT04613882|100735807|FG000|STARTED|Third Intervention||14||23
48168724|NCT04613882|100735808|FG001|STARTED|Third Intervention||6||9
48168725|NCT04613882|100735809|FG002|STARTED|Third Intervention||9||15
48168726|NCT04613882|100735810|FG003|STARTED|Third Intervention||5||6
48168727|NCT04613882|100735811|FG004|STARTED|Third Intervention||6||9
48168728|NCT04613882|100735812|FG005|STARTED|Third Intervention||13||22
48168729|NCT04613882|100735807|FG000|COMPLETED|Third Intervention||14||23
48168730|NCT04613882|100735808|FG001|COMPLETED|Third Intervention||6||9
48168731|NCT04613882|100735809|FG002|COMPLETED|Third Intervention||9||15
48168732|NCT04613882|100735810|FG003|COMPLETED|Third Intervention||5||6
48168733|NCT04613882|100735811|FG004|COMPLETED|Third Intervention||6||9
48168734|NCT04613882|100735812|FG005|COMPLETED|Third Intervention||13||22
48168735|NCT04613882|100735807|FG000|NOT COMPLETED|Third Intervention||0||0
48168736|NCT04613882|100735808|FG001|NOT COMPLETED|Third Intervention||0||0
48168737|NCT04613882|100735809|FG002|NOT COMPLETED|Third Intervention||0||0
48168738|NCT04613882|100735810|FG003|NOT COMPLETED|Third Intervention||0||0
48168739|NCT04613882|100735811|FG004|NOT COMPLETED|Third Intervention||0||0
48168740|NCT04613882|100735812|FG005|NOT COMPLETED|Third Intervention||0||0
48168741|NCT01535274|100735813|FG000|STARTED|Overall Study||28||
48168742|NCT01535274|100735814|FG001|STARTED|Overall Study||29||
48168743|NCT01535274|100735813|FG000|Received Propofol|Overall Study||28||
48168744|NCT01535274|100735814|FG001|Received Propofol|Overall Study||1||
48168745|NCT01535274|100735813|FG000|Received Desflurane|Overall Study||0||
48168746|NCT01535274|100735814|FG001|Received Desflurane|Overall Study||28||
48168747|NCT01535274|100735813|FG000|COMPLETED|Overall Study||28||
48168748|NCT01535274|100735814|FG001|COMPLETED|Overall Study||27||
48168749|NCT01535274|100735813|FG000|NOT COMPLETED|Overall Study||0||
48168750|NCT01535274|100735814|FG001|NOT COMPLETED|Overall Study||2||
48168751|NCT01370603|100735815|FG000|STARTED|Period 1||164||
48168752|NCT01370603|100735816|FG001|STARTED|Period 1||164||
48168753|NCT01370603|100735815|FG000|COMPLETED|Period 1||150||
48168754|NCT01370603|100735816|FG001|COMPLETED|Period 1||154||
48168755|NCT01370603|100735815|FG000|NOT COMPLETED|Period 1||14||
48168756|NCT01370603|100735816|FG001|NOT COMPLETED|Period 1||10||
48168757|NCT01370603|100735815|FG000|STARTED|Crossover Washout||150||
48168758|NCT01370603|100735816|FG001|STARTED|Crossover Washout||154||
48168759|NCT01370603|100735815|FG000|COMPLETED|Crossover Washout||141||
48168760|NCT01370603|100735816|FG001|COMPLETED|Crossover Washout||150||
48168761|NCT01370603|100735815|FG000|NOT COMPLETED|Crossover Washout||9||
48168762|NCT01370603|100735816|FG001|NOT COMPLETED|Crossover Washout||4||
48168763|NCT01370603|100735815|FG000|STARTED|Period 2||141||
48168764|NCT01370603|100735816|FG001|STARTED|Period 2||150||
48168765|NCT01370603|100735815|FG000|COMPLETED|Period 2||138||
48168766|NCT01370603|100735816|FG001|COMPLETED|Period 2||146||
48168767|NCT01370603|100735815|FG000|NOT COMPLETED|Period 2||3||
48168768|NCT01370603|100735816|FG001|NOT COMPLETED|Period 2||4||
48168769|NCT02080195|100735817|FG000|STARTED|Overall Study||1||
48168770|NCT02080195|100735817|FG000|COMPLETED|Overall Study||1||
48168771|NCT02080195|100735817|FG000|NOT COMPLETED|Overall Study||0||
48168772|NCT04581200|100735818|FG000|STARTED|Overall Study||29||
48168773|NCT04581200|100735819|FG001|STARTED|Overall Study||27||
48168774|NCT04581200|100735818|FG000|COMPLETED|Overall Study||23||
48168775|NCT04581200|100735819|FG001|COMPLETED|Overall Study||22||
48168776|NCT04581200|100735818|FG000|NOT COMPLETED|Overall Study||6||
48168777|NCT04581200|100735819|FG001|NOT COMPLETED|Overall Study||5||
48626205|NCT02100839|101867656|FG000|COMPLETED|Multiple Ascending Dose||9||
48626206|NCT02100839|101867657|FG001|COMPLETED|Multiple Ascending Dose||3||
48748919|NCT02374164|102172925|FG001|STARTED|Treatment Period 3||11||
48168778|NCT00989586|100735820|FG000|STARTED|Overall Study||18||
48168779|NCT00989586|100735821|FG001|STARTED|Overall Study||17||
48168780|NCT00989586|100735820|FG000|COMPLETED|Overall Study||18||
48168781|NCT00989586|100735821|FG001|COMPLETED|Overall Study||17||
48168782|NCT00989586|100735820|FG000|NOT COMPLETED|Overall Study||0||
48168783|NCT00989586|100735821|FG001|NOT COMPLETED|Overall Study||0||
48168784|NCT02387216|100735822|FG000|STARTED|Overall Study||103|One patient was inappropriately enrolled into the Sherloc study hence why 152 participants started and not 153|
48168785|NCT02387216|100735823|FG001|STARTED|Overall Study||49|One patient was inappropriately enrolled into the Sherloc study hence why 152 participants started and not 153|
48168786|NCT02387216|100735822|FG000|COMPLETED|Overall Study||3|Safety population: includes patients receiving at least one dose of study medication|
48168787|NCT02387216|100735823|FG001|COMPLETED|Overall Study||2|Safety population: includes patients receiving at least one dose of study medication|
48168788|NCT02387216|100735822|FG000|NOT COMPLETED|Overall Study||100||
48626207|NCT02100839|101867656|FG000|NOT COMPLETED|Multiple Ascending Dose||4||
48626208|NCT02100839|101867657|FG001|NOT COMPLETED|Multiple Ascending Dose||0||
48626209|NCT00830765|101867658|FG000|STARTED|Overall Study||73||
48626210|NCT00830765|101867659|FG001|STARTED|Overall Study||71||
48626211|NCT00830765|101867658|FG000|COMPLETED|Overall Study||70||
48168789|NCT02387216|100735823|FG001|NOT COMPLETED|Overall Study||47||
48168790|NCT02281526|100735824|FG000|STARTED|Overall Study||9||
48168791|NCT02281526|100735825|FG001|STARTED|Overall Study||8||
48168792|NCT02281526|100735824|FG000|COMPLETED|Overall Study||8||
48168793|NCT02281526|100735825|FG001|COMPLETED|Overall Study||8||
48168794|NCT02281526|100735824|FG000|NOT COMPLETED|Overall Study||1||
48168795|NCT02281526|100735825|FG001|NOT COMPLETED|Overall Study||0||
48168796|NCT03195465|100735826|FG000|STARTED|Overall Study||0||
48626212|NCT00830765|101867659|FG001|COMPLETED|Overall Study||69||
48626213|NCT00830765|101867658|FG000|NOT COMPLETED|Overall Study||3||
48626214|NCT00830765|101867659|FG001|NOT COMPLETED|Overall Study||2||
48626215|NCT02577640|101867660|FG000|STARTED|Dose Escalation Group 1||4||
48168797|NCT03195465|100735826|FG000|COMPLETED|Overall Study||0||
48168798|NCT03195465|100735826|FG000|NOT COMPLETED|Overall Study||0||
48168799|NCT02790073|100735827|FG000|STARTED|Overall Study||14||
48168800|NCT02790073|100735827|FG000|COMPLETED|Overall Study||11||
48168801|NCT02790073|100735827|FG000|NOT COMPLETED|Overall Study||3||
48168802|NCT00857805|100735828|FG000|STARTED|Overall Study||40||
48168803|NCT00857805|100735829|FG001|STARTED|Overall Study||36||
48168804|NCT00857805|100735828|FG000|COMPLETED|Overall Study||39||
48168805|NCT00857805|100735829|FG001|COMPLETED|Overall Study||35||
48168806|NCT00857805|100735828|FG000|NOT COMPLETED|Overall Study||1||
48168807|NCT00857805|100735829|FG001|NOT COMPLETED|Overall Study||1||
48168808|NCT02690077|100735830|FG000|STARTED|Overall Study||73||
48168809|NCT02690077|100735831|FG001|STARTED|Overall Study||76||
48332088|NCT05048719|101141753|FG008|STARTED|Overall Study||50||
48332089|NCT05048719|101141745|FG000|Received At Least One Dose of Study Drug|Overall Study||55||
48332090|NCT05048719|101141746|FG001|Received At Least One Dose of Study Drug|Overall Study||51||
48332091|NCT05048719|101141747|FG002|Received At Least One Dose of Study Drug|Overall Study||56||
48332092|NCT05048719|101141748|FG003|Received At Least One Dose of Study Drug|Overall Study||47||
48332093|NCT05048719|101141749|FG004|Received At Least One Dose of Study Drug|Overall Study||27||
48332094|NCT05048719|101141750|FG005|Received At Least One Dose of Study Drug|Overall Study||34||
48332095|NCT05048719|101141751|FG006|Received At Least One Dose of Study Drug|Overall Study||31||
48332096|NCT05048719|101141752|FG007|Received At Least One Dose of Study Drug|Overall Study||32||
48332097|NCT05048719|101141753|FG008|Received At Least One Dose of Study Drug|Overall Study||50||
48332098|NCT05048719|101141745|FG000|COMPLETED|Overall Study||51||
48332099|NCT05048719|101141746|FG001|COMPLETED|Overall Study||47||
48332100|NCT05048719|101141747|FG002|COMPLETED|Overall Study||50||
48332101|NCT05048719|101141748|FG003|COMPLETED|Overall Study||42||
48332102|NCT05048719|101141749|FG004|COMPLETED|Overall Study||25||
48411039|NCT00081263|101337790|FG000|COMPLETED|Overall Study||50||
48626216|NCT02577640|101867661|FG001|STARTED|Dose Escalation Group 1||0||
48626217|NCT02577640|101867662|FG002|STARTED|Dose Escalation Group 1||0||
48626218|NCT02577640|101867663|FG003|STARTED|Dose Escalation Group 1||0||
48626219|NCT02577640|101867660|FG000|COMPLETED|Dose Escalation Group 1||3||
48626220|NCT02577640|101867661|FG001|COMPLETED|Dose Escalation Group 1||0||
48168810|NCT02690077|100735830|FG000|COMPLETED|Overall Study||68||
48168811|NCT02690077|100735831|FG001|COMPLETED|Overall Study||61||
48168812|NCT02690077|100735830|FG000|NOT COMPLETED|Overall Study||5||
48168813|NCT02690077|100735831|FG001|NOT COMPLETED|Overall Study||15||
48168814|NCT00405353|100735832|FG000|STARTED|Overall Study||10||
48168815|NCT00405353|100735832|FG000|COMPLETED|Overall Study||10||
48168816|NCT00405353|100735832|FG000|NOT COMPLETED|Overall Study||0||
48168817|NCT00244374|100735833|FG000|STARTED|Pre-Randomization Cross-sectional Study||546||
48168818|NCT00244374|100735834|FG001|STARTED|Pre-Randomization Cross-sectional Study||0||
48626221|NCT02577640|101867662|FG002|COMPLETED|Dose Escalation Group 1||0||
48748920|NCT02374164|102172926|FG002|STARTED|Treatment Period 3||12||
48168819|NCT00244374|100735835|FG002|STARTED|Pre-Randomization Cross-sectional Study||0||
48168820|NCT00244374|100735836|FG003|STARTED|Pre-Randomization Cross-sectional Study||0||
48168821|NCT00244374|100735837|FG004|STARTED|Pre-Randomization Cross-sectional Study||0||
48168822|NCT00244374|100735833|FG000|COMPLETED|Pre-Randomization Cross-sectional Study||409||
48168823|NCT00244374|100735834|FG001|COMPLETED|Pre-Randomization Cross-sectional Study||0||
48188614|NCT04524104|100783288|FG001|STARTED|Overall Study||21||
48188615|NCT04524104|100783287|FG000|COMPLETED|Overall Study||40||
48188616|NCT04524104|100783288|FG001|COMPLETED|Overall Study||21||
48188617|NCT04524104|100783287|FG000|NOT COMPLETED|Overall Study||2||
48188618|NCT04524104|100783288|FG001|NOT COMPLETED|Overall Study||0||
48188619|NCT00761774|100783289|FG000|STARTED|Overall Study||108||
48188620|NCT00761774|100783289|FG000|COMPLETED|Overall Study||29||
48188621|NCT00761774|100783289|FG000|NOT COMPLETED|Overall Study||79||
48188622|NCT02802020|100783290|FG000|STARTED|Overall Study||67||
48188623|NCT02802020|100783290|FG000|COMPLETED|Overall Study||63||
48188624|NCT02802020|100783290|FG000|NOT COMPLETED|Overall Study||4||
48188625|NCT02906683|100783291|FG000|STARTED|Overall Study||85||
48188626|NCT02906683|100783292|FG001|STARTED|Overall Study||86||
48188627|NCT02906683|100783293|FG002|STARTED|Overall Study||85||
48188628|NCT02906683|100783291|FG000|COMPLETED|Overall Study||84||
48188629|NCT02906683|100783292|FG001|COMPLETED|Overall Study||81||
48188630|NCT02906683|100783293|FG002|COMPLETED|Overall Study||82||
48188631|NCT02906683|100783291|FG000|NOT COMPLETED|Overall Study||1||
48332103|NCT05048719|101141750|FG005|COMPLETED|Overall Study||30||
48332104|NCT05048719|101141751|FG006|COMPLETED|Overall Study||29||
48332105|NCT05048719|101141752|FG007|COMPLETED|Overall Study||29||
48332106|NCT05048719|101141753|FG008|COMPLETED|Overall Study||49||
48332107|NCT05048719|101141745|FG000|NOT COMPLETED|Overall Study||4||
48332108|NCT05048719|101141746|FG001|NOT COMPLETED|Overall Study||4||
48332109|NCT05048719|101141747|FG002|NOT COMPLETED|Overall Study||6||
48332110|NCT05048719|101141748|FG003|NOT COMPLETED|Overall Study||5||
48332111|NCT05048719|101141749|FG004|NOT COMPLETED|Overall Study||2||
48332112|NCT05048719|101141750|FG005|NOT COMPLETED|Overall Study||4||
48332113|NCT05048719|101141751|FG006|NOT COMPLETED|Overall Study||2||
48332114|NCT05048719|101141752|FG007|NOT COMPLETED|Overall Study||3||
48332115|NCT05048719|101141753|FG008|NOT COMPLETED|Overall Study||1||
48332116|NCT01580397|101141754|FG000|STARTED|Overall Study||14||
48332117|NCT01580397|101141754|FG000|COMPLETED|Overall Study||0||
48332118|NCT01580397|101141754|FG000|NOT COMPLETED|Overall Study||14||
48332119|NCT01292057|101141755|FG000|STARTED|Overall Study||49||
48332120|NCT01292057|101141756|FG001|STARTED|Overall Study||50||
48332121|NCT01292057|101141755|FG000|COMPLETED|Overall Study||47||
48332122|NCT01292057|101141756|FG001|COMPLETED|Overall Study||48||
48332123|NCT01292057|101141755|FG000|NOT COMPLETED|Overall Study||2||
48332124|NCT01292057|101141756|FG001|NOT COMPLETED|Overall Study||2||
48332125|NCT01405053|101141757|FG000|STARTED|Overall Study||25||
48411040|NCT00081263|101337791|FG001|COMPLETED|Overall Study||41||
48411041|NCT00081263|101337790|FG000|NOT COMPLETED|Overall Study||17||
48411042|NCT00081263|101337791|FG001|NOT COMPLETED|Overall Study||22||
48411043|NCT02181504|101337792|FG000|STARTED|Overall Study||10||
48411044|NCT02181504|101337793|FG001|STARTED|Overall Study||10||
48411045|NCT02181504|101337794|FG002|STARTED|Overall Study||5||
48168824|NCT00244374|100735835|FG002|COMPLETED|Pre-Randomization Cross-sectional Study||0||
48168825|NCT00244374|100735836|FG003|COMPLETED|Pre-Randomization Cross-sectional Study||0||
48168826|NCT00244374|100735837|FG004|COMPLETED|Pre-Randomization Cross-sectional Study||0||
48168827|NCT00244374|100735833|FG000|NOT COMPLETED|Pre-Randomization Cross-sectional Study||137||
48411046|NCT02181504|101337792|FG000|COMPLETED|Overall Study||9||
48411047|NCT02181504|101337793|FG001|COMPLETED|Overall Study||9||
48411048|NCT02181504|101337794|FG002|COMPLETED|Overall Study||4||
48748921|NCT02374164|102172924|FG000|COMPLETED|Treatment Period 3||12||
48748922|NCT02374164|102172925|FG001|COMPLETED|Treatment Period 3||11||
48748923|NCT02374164|102172926|FG002|COMPLETED|Treatment Period 3||12||
48748924|NCT02374164|102172924|FG000|NOT COMPLETED|Treatment Period 3||0||
48748925|NCT02374164|102172925|FG001|NOT COMPLETED|Treatment Period 3||0||
48748926|NCT02374164|102172926|FG002|NOT COMPLETED|Treatment Period 3||0||
48748927|NCT00443040|102172927|FG000|STARTED|Overall Study||14||
48748928|NCT00443040|102172928|FG001|STARTED|Overall Study||11||
48748929|NCT00443040|102172929|FG002|STARTED|Overall Study||10||
48748930|NCT00443040|102172927|FG000|COMPLETED|Overall Study||10||
48332126|NCT01405053|101141758|FG001|STARTED|Overall Study||12||
48411049|NCT02181504|101337792|FG000|NOT COMPLETED|Overall Study||1||
48411050|NCT02181504|101337793|FG001|NOT COMPLETED|Overall Study||1||
48411051|NCT02181504|101337794|FG002|NOT COMPLETED|Overall Study||1||
48411052|NCT01408732|101337795|FG000|STARTED|Overall Study||9||
48411053|NCT01408732|101337796|FG001|STARTED|Overall Study||9||
48411054|NCT01408732|101337795|FG000|COMPLETED|Overall Study||7||
48411055|NCT01408732|101337796|FG001|COMPLETED|Overall Study||7||
48411056|NCT01408732|101337795|FG000|NOT COMPLETED|Overall Study||2||
48411057|NCT01408732|101337796|FG001|NOT COMPLETED|Overall Study||2||
48411058|NCT01369069|101337797|FG000|STARTED|Overall Study||581||
48168828|NCT00244374|100735834|FG001|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0||
48332127|NCT01405053|101141757|FG000|COMPLETED|Overall Study||15||
48332128|NCT01405053|101141758|FG001|COMPLETED|Overall Study||4||
48411059|NCT01369069|101337798|FG001|STARTED|Overall Study||570||
48411060|NCT01369069|101337797|FG000|COMPLETED|Overall Study||564||
48748931|NCT00443040|102172928|FG001|COMPLETED|Overall Study||11||
48748932|NCT00443040|102172929|FG002|COMPLETED|Overall Study||9||
48168829|NCT00244374|100735835|FG002|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0||
48332129|NCT01405053|101141757|FG000|NOT COMPLETED|Overall Study||10||
48332130|NCT01405053|101141758|FG001|NOT COMPLETED|Overall Study||8||
48332131|NCT00429585|101141759|FG000|STARTED|Overall Study||52||
48332132|NCT00429585|101141760|FG001|STARTED|Overall Study||47||
48411061|NCT01369069|101337798|FG001|COMPLETED|Overall Study||554||
48411062|NCT01369069|101337797|FG000|NOT COMPLETED|Overall Study||17||
48411063|NCT01369069|101337798|FG001|NOT COMPLETED|Overall Study||16||
48411064|NCT01555541|101337799|FG000|STARTED|Salvage Response Assessment||19||
48411065|NCT01555541|101337799|FG000|COMPLETED|Salvage Response Assessment||19||
48411066|NCT01555541|101337799|FG000|NOT COMPLETED|Salvage Response Assessment||0||
48748933|NCT00443040|102172927|FG000|NOT COMPLETED|Overall Study||4||
48748934|NCT00443040|102172928|FG001|NOT COMPLETED|Overall Study||0||
48748935|NCT00443040|102172929|FG002|NOT COMPLETED|Overall Study||1||
48748936|NCT03923790|102172930|FG000|STARTED|Overall Study||42||
48748937|NCT03923790|102172931|FG001|STARTED|Overall Study||41||
48748938|NCT03923790|102172930|FG000|COMPLETED|Overall Study||27||
48748939|NCT03923790|102172931|FG001|COMPLETED|Overall Study||17||
48748940|NCT03923790|102172930|FG000|NOT COMPLETED|Overall Study||15||
48748941|NCT03923790|102172931|FG001|NOT COMPLETED|Overall Study||24||
48748942|NCT00429949|102172932|FG000|STARTED|Overall Study||21||
48748943|NCT00429949|102172932|FG000|COMPLETED|Overall Study||21||
48748944|NCT00429949|102172932|FG000|NOT COMPLETED|Overall Study||0||
48748945|NCT04737278|102172933|FG000|STARTED|Overall Study||28||
48748946|NCT04737278|102172934|FG001|STARTED|Overall Study||28||
48748947|NCT04737278|102172933|FG000|COMPLETED|Overall Study||24||
48332133|NCT00429585|101141759|FG000|COMPLETED|Overall Study||22||
48411067|NCT01555541|101337799|FG000|STARTED|OVA Treatment||19||
48411068|NCT01555541|101337799|FG000|COMPLETED|OVA Treatment||19||
48411069|NCT01555541|101337799|FG000|NOT COMPLETED|OVA Treatment||0||
48411070|NCT01555541|101337799|FG000|STARTED|Autologous Stem Cell Transplantation||12||
48411071|NCT01555541|101337799|FG000|COMPLETED|Autologous Stem Cell Transplantation||12||
48411072|NCT01555541|101337799|FG000|NOT COMPLETED|Autologous Stem Cell Transplantation||0||
48411073|NCT00736450|101337800|FG000|STARTED|Overall Study||37||
48411074|NCT00736450|101337800|FG000|COMPLETED|Overall Study||12||
48411075|NCT00736450|101337800|FG000|NOT COMPLETED|Overall Study||25||
48411076|NCT00809614|101337801|FG000|STARTED|Overall Study||28||
48748948|NCT04737278|102172934|FG001|COMPLETED|Overall Study||25||
48332134|NCT00429585|101141760|FG001|COMPLETED|Overall Study||27||
48332135|NCT00429585|101141759|FG000|NOT COMPLETED|Overall Study||30||
48332136|NCT00429585|101141760|FG001|NOT COMPLETED|Overall Study||20||
48332137|NCT00836433|101141761|FG000|STARTED|Overall Study||361||
48332138|NCT00836433|101141762|FG001|STARTED|Overall Study||328||
48332139|NCT00836433|101141761|FG000|COMPLETED|Overall Study||349||
48332140|NCT00836433|101141762|FG001|COMPLETED|Overall Study||321||
48332141|NCT00836433|101141761|FG000|NOT COMPLETED|Overall Study||12||
48332142|NCT00836433|101141762|FG001|NOT COMPLETED|Overall Study||7||
48332143|NCT02559687|101141763|FG000|STARTED|Overall Study||121||
48332144|NCT02559687|101141763|FG000|Received First Course of Pembrolizumab|Overall Study||121||
48332145|NCT02559687|101141763|FG000|Received Second Course of Pembrolizumab|Overall Study||1||
48332146|NCT02559687|101141763|FG000|COMPLETED|Overall Study||0||
48332147|NCT02559687|101141763|FG000|NOT COMPLETED|Overall Study||121||
48411077|NCT00809614|101337802|FG001|STARTED|Overall Study||14||
48411078|NCT00809614|101337801|FG000|Pharmacokinetic Safety Set|Overall Study||27||
48411079|NCT00809614|101337802|FG001|Pharmacokinetic Safety Set|Overall Study||14||
48411080|NCT00809614|101337801|FG000|Pharmacodynamic (PD) Set|Overall Study||24||
48748949|NCT04737278|102172933|FG000|NOT COMPLETED|Overall Study||4||
48748950|NCT04737278|102172934|FG001|NOT COMPLETED|Overall Study||3||
48332148|NCT03948178|101141764|FG000|STARTED|Overall Study||227||
48332149|NCT03948178|101141764|FG000|COMPLETED|Overall Study||0||
48332150|NCT03948178|101141764|FG000|NOT COMPLETED|Overall Study||227||
48332151|NCT04682405|101141765|FG000|STARTED|Overall Study||26||
48332152|NCT04682405|101141766|FG001|STARTED|Overall Study||25||
48332153|NCT04682405|101141765|FG000|COMPLETED|Overall Study||26||
48332154|NCT04682405|101141766|FG001|COMPLETED|Overall Study||24||
48332155|NCT04682405|101141765|FG000|NOT COMPLETED|Overall Study||0||
48332156|NCT04682405|101141766|FG001|NOT COMPLETED|Overall Study||1||
48332157|NCT01667471|101141767|FG000|STARTED|Overall Study||7||
48332158|NCT01667471|101141767|FG000|COMPLETED|Overall Study||7||
48411081|NCT00809614|101337802|FG001|Pharmacodynamic (PD) Set|Overall Study||13||
48411082|NCT00809614|101337801|FG000|COMPLETED|Overall Study||25||
48411083|NCT00809614|101337802|FG001|COMPLETED|Overall Study||10||
48411084|NCT00809614|101337801|FG000|NOT COMPLETED|Overall Study||3||
48748951|NCT01693029|102172935|FG000|STARTED|Overall Study||217|437 patients were randomized but 2 were excluded from analyses due to improper ICF signature process|
48748952|NCT01693029|102172936|FG001|STARTED|Overall Study||218|437 patients were randomized but 2 were excluded from analyses due to improper ICF signature process|
48332159|NCT01667471|101141767|FG000|NOT COMPLETED|Overall Study||0||
48411085|NCT00809614|101337802|FG001|NOT COMPLETED|Overall Study||4||
48332160|NCT01783678|101141768|FG000|STARTED|Overall Study||19||
48332161|NCT01783678|101141769|FG001|STARTED|Overall Study||112||
48332162|NCT01783678|101141770|FG002|STARTED|Overall Study||6||
48332163|NCT01783678|101141771|FG003|STARTED|Overall Study||58||
48332164|NCT01783678|101141772|FG004|STARTED|Overall Study||49||
48748953|NCT01693029|102172935|FG000|COMPLETED|Overall Study||173||
48332165|NCT01783678|101141773|FG005|STARTED|Overall Study||31||
48332166|NCT01783678|101141768|FG000|COMPLETED|Overall Study||17||
48332167|NCT01783678|101141769|FG001|COMPLETED|Overall Study||94||
48332168|NCT01783678|101141770|FG002|COMPLETED|Overall Study||5||
48332169|NCT01783678|101141771|FG003|COMPLETED|Overall Study||50||
48748954|NCT01693029|102172936|FG001|COMPLETED|Overall Study||161||
48748955|NCT01693029|102172935|FG000|NOT COMPLETED|Overall Study||44||
48748956|NCT01693029|102172936|FG001|NOT COMPLETED|Overall Study||57||
48748957|NCT02302365|102172937|FG000|STARTED|0-2 Hour Period||43||
48748958|NCT02302365|102172937|FG000|COMPLETED|0-2 Hour Period||41||
48748959|NCT02302365|102172937|FG000|NOT COMPLETED|0-2 Hour Period||2||
48748960|NCT02302365|102172937|FG000|STARTED|0-24 Hour Period||32||
48748961|NCT02302365|102172937|FG000|COMPLETED|0-24 Hour Period||32||
48748962|NCT02302365|102172937|FG000|NOT COMPLETED|0-24 Hour Period||0||
48748963|NCT02813889|102172938|FG000|STARTED|Overall Study||26||
48748964|NCT02813889|102172939|FG001|STARTED|Overall Study||10||
48748965|NCT02813889|102172938|FG000|COMPLETED|Overall Study||19||
48748966|NCT02813889|102172939|FG001|COMPLETED|Overall Study||10||
48748967|NCT02813889|102172938|FG000|NOT COMPLETED|Overall Study||7||
48332170|NCT01783678|101141772|FG004|COMPLETED|Overall Study||42||
48332171|NCT01783678|101141773|FG005|COMPLETED|Overall Study||26||
48626222|NCT02577640|101867663|FG003|COMPLETED|Dose Escalation Group 1||0||
48626223|NCT02577640|101867660|FG000|NOT COMPLETED|Dose Escalation Group 1||1||
48626224|NCT02577640|101867661|FG001|NOT COMPLETED|Dose Escalation Group 1||0||
48626225|NCT02577640|101867662|FG002|NOT COMPLETED|Dose Escalation Group 1||0||
48626226|NCT02577640|101867663|FG003|NOT COMPLETED|Dose Escalation Group 1||0||
48626227|NCT02577640|101867660|FG000|STARTED|Dose Escalation Group 2||0||
48626228|NCT02577640|101867661|FG001|STARTED|Dose Escalation Group 2||3||
48626229|NCT02577640|101867662|FG002|STARTED|Dose Escalation Group 2||0||
48626230|NCT02577640|101867663|FG003|STARTED|Dose Escalation Group 2||0||
48626231|NCT02577640|101867660|FG000|COMPLETED|Dose Escalation Group 2||0||
48626232|NCT02577640|101867661|FG001|COMPLETED|Dose Escalation Group 2||3||
48626233|NCT02577640|101867662|FG002|COMPLETED|Dose Escalation Group 2||0||
48626234|NCT02577640|101867663|FG003|COMPLETED|Dose Escalation Group 2||0||
48626235|NCT02577640|101867660|FG000|NOT COMPLETED|Dose Escalation Group 2||0||
48626236|NCT02577640|101867661|FG001|NOT COMPLETED|Dose Escalation Group 2||0||
48626237|NCT02577640|101867662|FG002|NOT COMPLETED|Dose Escalation Group 2||0||
48626238|NCT02577640|101867663|FG003|NOT COMPLETED|Dose Escalation Group 2||0||
48626239|NCT02577640|101867660|FG000|STARTED|Dose Escalation Group 3||0||
48626240|NCT02577640|101867661|FG001|STARTED|Dose Escalation Group 3||0||
48626241|NCT02577640|101867662|FG002|STARTED|Dose Escalation Group 3||3||
48626242|NCT02577640|101867663|FG003|STARTED|Dose Escalation Group 3||0||
48626243|NCT02577640|101867660|FG000|COMPLETED|Dose Escalation Group 3||0||
48626244|NCT02577640|101867661|FG001|COMPLETED|Dose Escalation Group 3||0||
48626245|NCT02577640|101867662|FG002|COMPLETED|Dose Escalation Group 3||3||
48626246|NCT02577640|101867663|FG003|COMPLETED|Dose Escalation Group 3||0||
48626247|NCT02577640|101867660|FG000|NOT COMPLETED|Dose Escalation Group 3||0||
48332172|NCT01783678|101141768|FG000|NOT COMPLETED|Overall Study||2||
48332173|NCT01783678|101141769|FG001|NOT COMPLETED|Overall Study||18||
48332174|NCT01783678|101141770|FG002|NOT COMPLETED|Overall Study||1||
48332175|NCT01783678|101141771|FG003|NOT COMPLETED|Overall Study||8||
48626248|NCT02577640|101867661|FG001|NOT COMPLETED|Dose Escalation Group 3||0||
48626249|NCT02577640|101867662|FG002|NOT COMPLETED|Dose Escalation Group 3||0||
48626250|NCT02577640|101867663|FG003|NOT COMPLETED|Dose Escalation Group 3||0||
48626251|NCT02577640|101867660|FG000|STARTED|Maximally Tolerated Dose||0||
48626252|NCT02577640|101867661|FG001|STARTED|Maximally Tolerated Dose||0||
48626253|NCT02577640|101867662|FG002|STARTED|Maximally Tolerated Dose||0||
48626254|NCT02577640|101867663|FG003|STARTED|Maximally Tolerated Dose||1||
48626255|NCT02577640|101867660|FG000|COMPLETED|Maximally Tolerated Dose||0||
48626256|NCT02577640|101867661|FG001|COMPLETED|Maximally Tolerated Dose||0||
48626257|NCT02577640|101867662|FG002|COMPLETED|Maximally Tolerated Dose||0||
48626258|NCT02577640|101867663|FG003|COMPLETED|Maximally Tolerated Dose||1||
48332176|NCT01783678|101141772|FG004|NOT COMPLETED|Overall Study||7||
48332177|NCT01783678|101141773|FG005|NOT COMPLETED|Overall Study||5||
48748968|NCT02813889|102172939|FG001|NOT COMPLETED|Overall Study||0||
48748969|NCT02531217|102172940|FG000|STARTED|Overall Study||9||
48748970|NCT02531217|102172940|FG000|Received at Least One Dose of Study Drug|Overall Study||9||
48748971|NCT02531217|102172940|FG000|COMPLETED|Overall Study||9||
48748972|NCT02531217|102172940|FG000|NOT COMPLETED|Overall Study||0||
48748973|NCT00796666|102172941|FG000|STARTED|Overall Study||67||
48748974|NCT00796666|102172942|FG001|STARTED|Overall Study||64||
48748975|NCT00796666|102172941|FG000|Treated|Overall Study||66||
48748976|NCT00796666|102172942|FG001|Treated|Overall Study||64||
48748977|NCT00796666|102172941|FG000|Randomized and Not Treated|Overall Study||1||
48748978|NCT00796666|102172942|FG001|Randomized and Not Treated|Overall Study||0||
48748979|NCT00796666|102172941|FG000|COMPLETED|Overall Study||0||
48748980|NCT00796666|102172942|FG001|COMPLETED|Overall Study||0||
48748981|NCT00796666|102172941|FG000|NOT COMPLETED|Overall Study||67||
48748982|NCT00796666|102172942|FG001|NOT COMPLETED|Overall Study||64||
48748983|NCT02525653|102172943|FG000|STARTED|Overall Study||40||
48748984|NCT02525653|102172943|FG000|COMPLETED|Overall Study||40||
48748985|NCT02525653|102172943|FG000|NOT COMPLETED|Overall Study||0||
48748986|NCT01441843|102172944|FG000|STARTED|Overall Study||200||
48748987|NCT01441843|102172945|FG001|STARTED|Overall Study||200||
48748988|NCT01441843|102172944|FG000|COMPLETED|Overall Study||188||
48748989|NCT01441843|102172945|FG001|COMPLETED|Overall Study||195||
48748990|NCT01441843|102172944|FG000|NOT COMPLETED|Overall Study||12||
48748991|NCT01441843|102172945|FG001|NOT COMPLETED|Overall Study||5||
48748992|NCT01177007|102172946|FG000|STARTED|Overall Study||50||
48748993|NCT01177007|102172946|FG000|Completed First Y90 Treatment|Overall Study||50|Patients completing this milestone were analyzed for survival, safety, and dose outcomes|
48748994|NCT01177007|102172946|FG000|Completed First Clinical and Imaging|Overall Study||43|Patients completing this milestones were assessed for image response outcomes|
48748995|NCT01177007|102172946|FG000|COMPLETED|Overall Study||12|Patients who completed all 12 months on protocol.|
48748996|NCT01177007|102172946|FG000|NOT COMPLETED|Overall Study||38||
48748997|NCT02038153|102172947|FG000|STARTED|Overall Study||3||
48748998|NCT02038153|102172947|FG000|COMPLETED|Overall Study||2||
48748999|NCT02038153|102172947|FG000|NOT COMPLETED|Overall Study||1||
48749000|NCT03649217|102172948|FG000|STARTED|Overall Study||23||
48749001|NCT03649217|102172948|FG000|COMPLETED|Overall Study||21||
48749002|NCT03649217|102172948|FG000|NOT COMPLETED|Overall Study||2||
48749003|NCT00117637|102172949|FG000|STARTED|First Intervention (Period 1)||97||
48749004|NCT00117637|102172950|FG001|STARTED|First Intervention (Period 1)||92||
48749005|NCT00117637|102172949|FG000|Subjects Received Treatment|First Intervention (Period 1)||97||
48749006|NCT00117637|102172950|FG001|Subjects Received Treatment|First Intervention (Period 1)||90||
48749007|NCT00117637|102172949|FG000|COMPLETED|First Intervention (Period 1)||79||
48749008|NCT00117637|102172950|FG001|COMPLETED|First Intervention (Period 1)||67||
48749009|NCT00117637|102172949|FG000|NOT COMPLETED|First Intervention (Period 1)||18||
48749010|NCT00117637|102172950|FG001|NOT COMPLETED|First Intervention (Period 1)||25||
48749011|NCT00117637|102172949|FG000|STARTED|Second Intervention (Period 2)||49||
48188632|NCT02906683|100783292|FG001|NOT COMPLETED|Overall Study||5||
48749012|NCT00117637|102172950|FG001|STARTED|Second Intervention (Period 2)||61||
48749013|NCT00117637|102172949|FG000|Subjects Received Treatment|Second Intervention (Period 2)||49||
48749014|NCT00117637|102172950|FG001|Subjects Received Treatment|Second Intervention (Period 2)||61||
48749015|NCT00117637|102172949|FG000|COMPLETED|Second Intervention (Period 2)||39||
48749016|NCT00117637|102172950|FG001|COMPLETED|Second Intervention (Period 2)||39||
48749017|NCT00117637|102172949|FG000|NOT COMPLETED|Second Intervention (Period 2)||10||
48749018|NCT00117637|102172950|FG001|NOT COMPLETED|Second Intervention (Period 2)||22||
48749019|NCT01962441|102172951|FG000|STARTED|Randomized Period||200||
48749020|NCT01962441|102172952|FG001|STARTED|Randomized Period||201||
48749021|NCT01962441|102172953|FG002|STARTED|Randomized Period||200||
48749022|NCT01962441|102172951|FG000|COMPLETED|Randomized Period||190||
48749023|NCT01962441|102172952|FG001|COMPLETED|Randomized Period||190||
48749024|NCT01962441|102172953|FG002|COMPLETED|Randomized Period||189||
48749025|NCT01962441|102172951|FG000|NOT COMPLETED|Randomized Period||10||
48749026|NCT01962441|102172952|FG001|NOT COMPLETED|Randomized Period||11||
48749027|NCT01962441|102172953|FG002|NOT COMPLETED|Randomized Period||11||
48749028|NCT01962441|102172951|FG000|STARTED|Retreatment Substudy||20||
48749029|NCT01962441|102172952|FG001|STARTED|Retreatment Substudy||10||
48749030|NCT01962441|102172953|FG002|STARTED|Retreatment Substudy||0||
48749031|NCT01962441|102172951|FG000|COMPLETED|Retreatment Substudy||18||
48749032|NCT01962441|102172952|FG001|COMPLETED|Retreatment Substudy||10||
48749033|NCT01962441|102172953|FG002|COMPLETED|Retreatment Substudy||0||
48749034|NCT01962441|102172951|FG000|NOT COMPLETED|Retreatment Substudy||2||
48749035|NCT01962441|102172952|FG001|NOT COMPLETED|Retreatment Substudy||0||
48749036|NCT01962441|102172953|FG002|NOT COMPLETED|Retreatment Substudy||0||
48749037|NCT00667888|102172954|FG000|STARTED|Overall Study||111||
48749038|NCT00667888|102172955|FG001|STARTED|Overall Study||111||
48749039|NCT00667888|102172954|FG000|COMPLETED|Overall Study||101||
48749040|NCT00667888|102172955|FG001|COMPLETED|Overall Study||102||
48749041|NCT00667888|102172954|FG000|NOT COMPLETED|Overall Study||10||
48749042|NCT00667888|102172955|FG001|NOT COMPLETED|Overall Study||9||
48749043|NCT02719171|102172956|FG000|STARTED|Overall Study||42||
48749044|NCT02719171|102172957|FG001|STARTED|Overall Study||42||
48749045|NCT02719171|102172958|FG002|STARTED|Overall Study||42||
48749046|NCT02719171|102172959|FG003|STARTED|Overall Study||39||
48749047|NCT02719171|102172960|FG004|STARTED|Overall Study||20||
48749048|NCT02719171|102172956|FG000|COMPLETED|Overall Study||41||
48749049|NCT02719171|102172957|FG001|COMPLETED|Overall Study||38||
48749050|NCT02719171|102172958|FG002|COMPLETED|Overall Study||39||
48749051|NCT02719171|102172959|FG003|COMPLETED|Overall Study||37||
48749052|NCT02719171|102172960|FG004|COMPLETED|Overall Study||18||
48749053|NCT02719171|102172956|FG000|NOT COMPLETED|Overall Study||1||
48749054|NCT02719171|102172957|FG001|NOT COMPLETED|Overall Study||4||
48749055|NCT02719171|102172958|FG002|NOT COMPLETED|Overall Study||3||
48749056|NCT02719171|102172959|FG003|NOT COMPLETED|Overall Study||2||
48749057|NCT02719171|102172960|FG004|NOT COMPLETED|Overall Study||2||
48749058|NCT01983228|102172961|FG000|STARTED|Overall Study||249||
48411086|NCT03442933|101337803|FG000|STARTED|Overall Study||20||
48411087|NCT03442933|101337804|FG001|STARTED|Overall Study||20||
48749059|NCT01983228|102172962|FG001|STARTED|Overall Study||251||
48749060|NCT01983228|102172961|FG000|COMPLETED|Overall Study||211||
48749061|NCT01983228|102172962|FG001|COMPLETED|Overall Study||189||
48749062|NCT01983228|102172961|FG000|NOT COMPLETED|Overall Study||38||
48749063|NCT01983228|102172962|FG001|NOT COMPLETED|Overall Study||62||
48749064|NCT00292942|102172963|FG000|STARTED|Overall Study||6||
48749065|NCT00292942|102172964|FG001|STARTED|Overall Study||6||
48749066|NCT00292942|102172965|FG002|STARTED|Overall Study||7||
48749067|NCT00292942|102172966|FG003|STARTED|Overall Study||7||
48749068|NCT00292942|102172963|FG000|COMPLETED|Overall Study||6||
48749069|NCT00292942|102172964|FG001|COMPLETED|Overall Study||6||
48749070|NCT00292942|102172965|FG002|COMPLETED|Overall Study||6||
48749071|NCT00292942|102172966|FG003|COMPLETED|Overall Study||6||
48749072|NCT00292942|102172963|FG000|NOT COMPLETED|Overall Study||0||
48749073|NCT00292942|102172964|FG001|NOT COMPLETED|Overall Study||0||
48749074|NCT00292942|102172965|FG002|NOT COMPLETED|Overall Study||1||
48749075|NCT00292942|102172966|FG003|NOT COMPLETED|Overall Study||1||
48749076|NCT04864639|102172967|FG000|STARTED|Overall Study||12||
48749077|NCT04864639|102172967|FG000|COMPLETED|Overall Study||10||
48749078|NCT04864639|102172967|FG000|NOT COMPLETED|Overall Study||2||
48749079|NCT04972786|102172968|FG000|STARTED|Baseline MRI Scan (1 Day)||11||
48749080|NCT04972786|102172969|FG001|STARTED|Baseline MRI Scan (1 Day)||10||
48749081|NCT04972786|102172968|FG000|COMPLETED|Baseline MRI Scan (1 Day)||11||
48749082|NCT04972786|102172969|FG001|COMPLETED|Baseline MRI Scan (1 Day)||10||
48749083|NCT04972786|102172968|FG000|NOT COMPLETED|Baseline MRI Scan (1 Day)||0||
48749084|NCT04972786|102172969|FG001|NOT COMPLETED|Baseline MRI Scan (1 Day)||0||
48749085|NCT04972786|102172968|FG000|STARTED|First Intervention (1 Day)||8||
48749086|NCT04972786|102172969|FG001|STARTED|First Intervention (1 Day)||5||
48749087|NCT04972786|102172968|FG000|COMPLETED|First Intervention (1 Day)||7||
48749088|NCT04972786|102172969|FG001|COMPLETED|First Intervention (1 Day)||5||
48749089|NCT04972786|102172968|FG000|NOT COMPLETED|First Intervention (1 Day)||1||
48749090|NCT04972786|102172969|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48749091|NCT04972786|102172968|FG000|STARTED|Washout (7 or More Days)||7||
48749092|NCT04972786|102172969|FG001|STARTED|Washout (7 or More Days)||5||
48332178|NCT03434379|101141774|FG000|STARTED|Global Period||165||
48332179|NCT03434379|101141775|FG001|STARTED|Global Period||336||
48749093|NCT04972786|102172968|FG000|COMPLETED|Washout (7 or More Days)||7||
48749094|NCT04972786|102172969|FG001|COMPLETED|Washout (7 or More Days)||5||
48749095|NCT04972786|102172968|FG000|NOT COMPLETED|Washout (7 or More Days)||0||
48749096|NCT04972786|102172969|FG001|NOT COMPLETED|Washout (7 or More Days)||0||
48749097|NCT04972786|102172968|FG000|STARTED|Second Intervention (1 Day)||7||
48749098|NCT04972786|102172969|FG001|STARTED|Second Intervention (1 Day)||5||
48749099|NCT04972786|102172968|FG000|COMPLETED|Second Intervention (1 Day)||7||
48749100|NCT04972786|102172969|FG001|COMPLETED|Second Intervention (1 Day)||5||
48749101|NCT04972786|102172968|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48749102|NCT04972786|102172969|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48749103|NCT01001975|102172970|FG000|STARTED|Overall Study||5||
48749104|NCT01001975|102172971|FG001|STARTED|Overall Study||5||
48749105|NCT01001975|102172970|FG000|COMPLETED|Overall Study||5||
48749106|NCT01001975|102172971|FG001|COMPLETED|Overall Study||5||
48749107|NCT01001975|102172970|FG000|NOT COMPLETED|Overall Study||0||
48749108|NCT01001975|102172971|FG001|NOT COMPLETED|Overall Study||0||
48332180|NCT03434379|101141776|FG002|STARTED|Global Period||0||
48332181|NCT03434379|101141777|FG003|STARTED|Global Period||0||
48332182|NCT03434379|101141774|FG000|COMPLETED|Global Period||0||
48332183|NCT03434379|101141775|FG001|COMPLETED|Global Period||0||
48332184|NCT03434379|101141776|FG002|COMPLETED|Global Period||0||
48332185|NCT03434379|101141777|FG003|COMPLETED|Global Period||0||
48332186|NCT03434379|101141774|FG000|NOT COMPLETED|Global Period||165||
48332187|NCT03434379|101141775|FG001|NOT COMPLETED|Global Period||336||
48332188|NCT03434379|101141776|FG002|NOT COMPLETED|Global Period||0||
48332189|NCT03434379|101141777|FG003|NOT COMPLETED|Global Period||0||
48332190|NCT03434379|101141774|FG000|STARTED|China Extension Period||0||
48332191|NCT03434379|101141775|FG001|STARTED|China Extension Period||0||
48332192|NCT03434379|101141776|FG002|STARTED|China Extension Period||61||
48332193|NCT03434379|101141777|FG003|STARTED|China Extension Period||133||
48332194|NCT03434379|101141774|FG000|COMPLETED|China Extension Period||0||
48332195|NCT03434379|101141775|FG001|COMPLETED|China Extension Period||0||
48332196|NCT03434379|101141776|FG002|COMPLETED|China Extension Period||0||
48332197|NCT03434379|101141777|FG003|COMPLETED|China Extension Period||0||
48332198|NCT03434379|101141774|FG000|NOT COMPLETED|China Extension Period||0||
48332199|NCT03434379|101141775|FG001|NOT COMPLETED|China Extension Period||0||
48332200|NCT03434379|101141776|FG002|NOT COMPLETED|China Extension Period||61||
48332201|NCT03434379|101141777|FG003|NOT COMPLETED|China Extension Period||133||
48332202|NCT01751971|101141778|FG000|STARTED|Overall Study||22||
48332203|NCT01751971|101141779|FG001|STARTED|Overall Study||25||
48332204|NCT01751971|101141778|FG000|COMPLETED|Overall Study||20||
48332205|NCT01751971|101141779|FG001|COMPLETED|Overall Study||24||
48332206|NCT01751971|101141778|FG000|NOT COMPLETED|Overall Study||2||
48332207|NCT01751971|101141779|FG001|NOT COMPLETED|Overall Study||1||
48332208|NCT01534676|101141780|FG000|STARTED|Overall Study||2||
48411088|NCT03442933|101337803|FG000|COMPLETED|Overall Study||20||
48749109|NCT03098641|102172972|FG000|STARTED|Overall Study||272||
48749110|NCT03098641|102172972|FG000|COMPLETED|Overall Study||220||
48749111|NCT03098641|102172972|FG000|NOT COMPLETED|Overall Study||52||
48749112|NCT01332123|102172973|FG000|STARTED|Overall Study||10||
48749113|NCT01332123|102172973|FG000|COMPLETED|Overall Study||10||
48749114|NCT01332123|102172973|FG000|NOT COMPLETED|Overall Study||0||
48749115|NCT03546621|102172974|FG000|STARTED|Overall Study||28||
48411089|NCT03442933|101337804|FG001|COMPLETED|Overall Study||20||
48749116|NCT03546621|102172975|FG001|STARTED|Overall Study||32||
48749117|NCT03546621|102172976|FG002|STARTED|Overall Study||30||
48749118|NCT03546621|102172977|FG003|STARTED|Overall Study||28||
48749119|NCT03546621|102172974|FG000|COMPLETED|Overall Study||28||
48332209|NCT01534676|101141781|FG001|STARTED|Overall Study||1||
48332210|NCT01534676|101141780|FG000|COMPLETED|Overall Study||0||
48332211|NCT01534676|101141781|FG001|COMPLETED|Overall Study||0||
48332212|NCT01534676|101141780|FG000|NOT COMPLETED|Overall Study||2||
48411090|NCT03442933|101337803|FG000|NOT COMPLETED|Overall Study||0||
48411091|NCT03442933|101337804|FG001|NOT COMPLETED|Overall Study||0||
48411092|NCT02057276|101337805|FG000|STARTED|Overall Study||0||
48749120|NCT03546621|102172975|FG001|COMPLETED|Overall Study||29||
48749121|NCT03546621|102172976|FG002|COMPLETED|Overall Study||28||
48332213|NCT01534676|101141781|FG001|NOT COMPLETED|Overall Study||1||
48332214|NCT01920711|101141782|FG000|STARTED|Overall Study||2419||
48332215|NCT01920711|101141783|FG001|STARTED|Overall Study||2403||
48332216|NCT01920711|101141782|FG000|COMPLETED|Overall Study||2055||
48332217|NCT01920711|101141783|FG001|COMPLETED|Overall Study||2030||
48332218|NCT01920711|101141782|FG000|NOT COMPLETED|Overall Study||364||
48332219|NCT01920711|101141783|FG001|NOT COMPLETED|Overall Study||373||
48332220|NCT00539695|101141784|FG000|STARTED|Overall Study||25||
48332221|NCT00539695|101141784|FG000|Evaluable Patients|Overall Study||22||
48411093|NCT02057276|101337806|FG001|STARTED|Overall Study||0||
48749122|NCT03546621|102172977|FG003|COMPLETED|Overall Study||25||
48749123|NCT03546621|102172974|FG000|NOT COMPLETED|Overall Study||0||
48749124|NCT03546621|102172975|FG001|NOT COMPLETED|Overall Study||3||
48749125|NCT03546621|102172976|FG002|NOT COMPLETED|Overall Study||2||
48749126|NCT03546621|102172977|FG003|NOT COMPLETED|Overall Study||3||
48749127|NCT03007966|102172978|FG000|STARTED|Overall Study||30||
48749128|NCT03007966|102172979|FG001|STARTED|Overall Study||30||
48749129|NCT03007966|102172978|FG000|COMPLETED|Overall Study||29||
48749130|NCT03007966|102172979|FG001|COMPLETED|Overall Study||30||
48749131|NCT03007966|102172978|FG000|NOT COMPLETED|Overall Study||1||
48749132|NCT03007966|102172979|FG001|NOT COMPLETED|Overall Study||0||
48749133|NCT00286442|102172980|FG000|STARTED|Overall Study||213||
48749134|NCT00286442|102172981|FG001|STARTED|Overall Study||210||
48749135|NCT00286442|102172982|FG002|STARTED|Overall Study||104||
48749136|NCT00286442|102172980|FG000|COMPLETED|Overall Study||176||
48749137|NCT00286442|102172981|FG001|COMPLETED|Overall Study||165||
48749138|NCT00286442|102172982|FG002|COMPLETED|Overall Study||72||
48749139|NCT00286442|102172980|FG000|NOT COMPLETED|Overall Study||37||
48749140|NCT00286442|102172981|FG001|NOT COMPLETED|Overall Study||45||
48749141|NCT00286442|102172982|FG002|NOT COMPLETED|Overall Study||32||
48749142|NCT01724866|102172983|FG000|STARTED|Overall Study||39||
48749143|NCT01724866|102172984|FG001|STARTED|Overall Study||37||
48749144|NCT01724866|102172985|FG002|STARTED|Overall Study||36||
48749145|NCT01724866|102172986|FG003|STARTED|Overall Study||36||
48749146|NCT01724866|102172983|FG000|Evaluable Population|Overall Study||39|The Evaluable Population included all randomized participants who had received either SPI-2012 or pegfilgrastim and had completed Cycle 1.|
48749147|NCT01724866|102172984|FG001|Evaluable Population|Overall Study||36|The Evaluable Population included all randomized participants who had received either SPI-2012 or pegfilgrastim and had completed Cycle 1.|
48749148|NCT01724866|102172985|FG002|Evaluable Population|Overall Study||36|The Evaluable Population included all randomized participants who had received either SPI-2012 or pegfilgrastim and had completed Cycle 1.|
48749149|NCT01724866|102172986|FG003|Evaluable Population|Overall Study||36|The Evaluable Population included all randomized participants who had received either SPI-2012 or pegfilgrastim and had completed Cycle 1.|
48749150|NCT01724866|102172983|FG000|COMPLETED|Overall Study||38||
48749151|NCT01724866|102172984|FG001|COMPLETED|Overall Study||32||
48749152|NCT01724866|102172985|FG002|COMPLETED|Overall Study||33||
48749153|NCT01724866|102172986|FG003|COMPLETED|Overall Study||35||
48749154|NCT01724866|102172983|FG000|NOT COMPLETED|Overall Study||1||
48749155|NCT01724866|102172984|FG001|NOT COMPLETED|Overall Study||5||
48749156|NCT01724866|102172985|FG002|NOT COMPLETED|Overall Study||3||
48749157|NCT01724866|102172986|FG003|NOT COMPLETED|Overall Study||1||
48749158|NCT00803283|102172987|FG000|STARTED|Overall Study||1||
48749159|NCT00803283|102172988|FG001|STARTED|Overall Study||1||
48749160|NCT00803283|102172987|FG000|COMPLETED|Overall Study||1||
48749161|NCT00803283|102172988|FG001|COMPLETED|Overall Study||1||
48749162|NCT00803283|102172987|FG000|NOT COMPLETED|Overall Study||0||
48749163|NCT00803283|102172988|FG001|NOT COMPLETED|Overall Study||0||
48332222|NCT00539695|101141784|FG000|COMPLETED|Overall Study||12||
48332223|NCT00539695|101141784|FG000|NOT COMPLETED|Overall Study||13||
48411094|NCT02057276|101337805|FG000|COMPLETED|Overall Study||0||
48749164|NCT00216671|102172989|FG000|STARTED|Overall Study||110||
48749165|NCT00216671|102172990|FG001|STARTED|Overall Study||110||
48749166|NCT00216671|102172989|FG000|COMPLETED|Overall Study||75||
48749167|NCT00216671|102172990|FG001|COMPLETED|Overall Study||60||
48749168|NCT00216671|102172989|FG000|NOT COMPLETED|Overall Study||35||
48749169|NCT00216671|102172990|FG001|NOT COMPLETED|Overall Study||50||
48749170|NCT03480152|102172991|FG000|STARTED|Phase I||3||
48749171|NCT03480152|102172992|FG001|STARTED|Phase I||2||
48749172|NCT03480152|102172993|FG002|STARTED|Phase I||0||
48749173|NCT03480152|102172991|FG000|Received Intervention|Phase I||2||
48749174|NCT03480152|102172992|FG001|Received Intervention|Phase I||2||
48749175|NCT03480152|102172993|FG002|Received Intervention|Phase I||0||
48749176|NCT03480152|102172991|FG000|COMPLETED|Phase I||2||
48411095|NCT02057276|101337806|FG001|COMPLETED|Overall Study||0||
48411096|NCT02057276|101337805|FG000|NOT COMPLETED|Overall Study||0||
48749177|NCT03480152|102172992|FG001|COMPLETED|Phase I||2||
48332224|NCT00931489|101141785|FG000|STARTED|Overall Study||40||
48332225|NCT00931489|101141786|FG001|STARTED|Overall Study||40||
48332226|NCT00931489|101141787|FG002|STARTED|Overall Study||5||
48168830|NCT00244374|100735836|FG003|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0||
48168831|NCT00244374|100735837|FG004|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0||
48168832|NCT00244374|100735833|FG000|STARTED|Evaluation for Vaccine Adherence Cohort||440||
48168833|NCT00244374|100735834|FG001|STARTED|Evaluation for Vaccine Adherence Cohort||0||
48168834|NCT00244374|100735835|FG002|STARTED|Evaluation for Vaccine Adherence Cohort||0||
48168835|NCT00244374|100735836|FG003|STARTED|Evaluation for Vaccine Adherence Cohort||0||
48626259|NCT02577640|101867660|FG000|NOT COMPLETED|Maximally Tolerated Dose||0||
48626260|NCT02577640|101867661|FG001|NOT COMPLETED|Maximally Tolerated Dose||0||
48626261|NCT02577640|101867662|FG002|NOT COMPLETED|Maximally Tolerated Dose||0||
48626262|NCT02577640|101867663|FG003|NOT COMPLETED|Maximally Tolerated Dose||0||
48626263|NCT02037893|101867664|FG000|STARTED|Overall Study||32||
48626264|NCT02037893|101867665|FG001|STARTED|Overall Study||25||
48626265|NCT02037893|101867666|FG002|STARTED|Overall Study||27||
48168836|NCT00244374|100735837|FG004|STARTED|Evaluation for Vaccine Adherence Cohort||0||
48168837|NCT00244374|100735833|FG000|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||217||
48168838|NCT00244374|100735834|FG001|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0||
48168839|NCT00244374|100735835|FG002|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0||
48168840|NCT00244374|100735836|FG003|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0||
48168841|NCT00244374|100735837|FG004|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0||
48168842|NCT00244374|100735833|FG000|COMPLETED|Evaluation for Vaccine Adherence Cohort||167||
48168843|NCT00244374|100735834|FG001|COMPLETED|Evaluation for Vaccine Adherence Cohort||0||
48168844|NCT00244374|100735835|FG002|COMPLETED|Evaluation for Vaccine Adherence Cohort||0||
48168845|NCT00244374|100735836|FG003|COMPLETED|Evaluation for Vaccine Adherence Cohort||0||
48168846|NCT00244374|100735837|FG004|COMPLETED|Evaluation for Vaccine Adherence Cohort||0||
48168847|NCT00244374|100735833|FG000|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||273||
48168848|NCT00244374|100735834|FG001|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0||
48168849|NCT00244374|100735835|FG002|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0||
48168850|NCT00244374|100735836|FG003|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0||
48168851|NCT00244374|100735837|FG004|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0||
48168852|NCT00244374|100735833|FG000|STARTED|Vaccine Adherence Cohort||0||
48168853|NCT00244374|100735834|FG001|STARTED|Vaccine Adherence Cohort||47||
48168854|NCT00244374|100735835|FG002|STARTED|Vaccine Adherence Cohort||43||
48168855|NCT00244374|100735836|FG003|STARTED|Vaccine Adherence Cohort||36||
48168856|NCT00244374|100735837|FG004|STARTED|Vaccine Adherence Cohort||41||
48168857|NCT00244374|100735833|FG000|COMPLETED|Vaccine Adherence Cohort||0||
48168858|NCT00244374|100735834|FG001|COMPLETED|Vaccine Adherence Cohort||47||
48168859|NCT00244374|100735835|FG002|COMPLETED|Vaccine Adherence Cohort||43||
48168860|NCT00244374|100735836|FG003|COMPLETED|Vaccine Adherence Cohort||36||
48168861|NCT00244374|100735837|FG004|COMPLETED|Vaccine Adherence Cohort||41||
48168862|NCT00244374|100735833|FG000|NOT COMPLETED|Vaccine Adherence Cohort||0||
48168863|NCT00244374|100735834|FG001|NOT COMPLETED|Vaccine Adherence Cohort||0||
48168864|NCT00244374|100735835|FG002|NOT COMPLETED|Vaccine Adherence Cohort||0||
48168865|NCT00244374|100735836|FG003|NOT COMPLETED|Vaccine Adherence Cohort||0||
48168866|NCT00244374|100735837|FG004|NOT COMPLETED|Vaccine Adherence Cohort||0||
48168867|NCT00708721|100735838|FG000|STARTED|Overall Study||2||
48168868|NCT00708721|100735839|FG001|STARTED|Overall Study||4||
48168869|NCT00708721|100735840|FG002|STARTED|Overall Study||3||
48168870|NCT00708721|100735841|FG003|STARTED|Overall Study||2||
48168871|NCT00708721|100735838|FG000|COMPLETED|Overall Study||2||
48168872|NCT00708721|100735839|FG001|COMPLETED|Overall Study||4||
48168873|NCT00708721|100735840|FG002|COMPLETED|Overall Study||3||
48749178|NCT03480152|102172993|FG002|COMPLETED|Phase I||0||
48749179|NCT03480152|102172991|FG000|NOT COMPLETED|Phase I||1||
48749180|NCT03480152|102172992|FG001|NOT COMPLETED|Phase I||0||
48749181|NCT03480152|102172993|FG002|NOT COMPLETED|Phase I||0||
48749182|NCT03480152|102172991|FG000|STARTED|Phase II||0||
48749183|NCT03480152|102172992|FG001|STARTED|Phase II||0||
48749184|NCT03480152|102172993|FG002|STARTED|Phase II||0||
48749185|NCT03480152|102172991|FG000|COMPLETED|Phase II||0||
48749186|NCT03480152|102172992|FG001|COMPLETED|Phase II||0||
48749187|NCT03480152|102172993|FG002|COMPLETED|Phase II||0||
48168874|NCT00708721|100735841|FG003|COMPLETED|Overall Study||2||
48168875|NCT00708721|100735838|FG000|NOT COMPLETED|Overall Study||0||
48168876|NCT00708721|100735839|FG001|NOT COMPLETED|Overall Study||0||
48168877|NCT00708721|100735840|FG002|NOT COMPLETED|Overall Study||0||
48168878|NCT00708721|100735841|FG003|NOT COMPLETED|Overall Study||0||
48168879|NCT00936481|100735842|FG000|STARTED|Overall Study||17||
48626266|NCT02037893|101867667|FG003|STARTED|Overall Study||28||
48626267|NCT02037893|101867664|FG000|COMPLETED|Overall Study||32||
48749188|NCT03480152|102172991|FG000|NOT COMPLETED|Phase II||0||
48749189|NCT03480152|102172992|FG001|NOT COMPLETED|Phase II||0||
48749190|NCT03480152|102172993|FG002|NOT COMPLETED|Phase II||0||
48749191|NCT03689582|102172994|FG000|STARTED|Overall Study||11||
48749192|NCT03689582|102172994|FG000|COMPLETED|Overall Study||11||
48749193|NCT03689582|102172994|FG000|NOT COMPLETED|Overall Study||0||
48168880|NCT00936481|100735843|FG001|STARTED|Overall Study||17||
48168881|NCT00936481|100735842|FG000|COMPLETED|Overall Study||17||
48168882|NCT00936481|100735843|FG001|COMPLETED|Overall Study||17||
48168883|NCT00936481|100735842|FG000|NOT COMPLETED|Overall Study||0||
48168884|NCT00936481|100735843|FG001|NOT COMPLETED|Overall Study||0||
48168885|NCT01923896|100735844|FG000|STARTED|Overall Study||8||
48168886|NCT01923896|100735845|FG001|STARTED|Overall Study||8||
48168887|NCT01923896|100735844|FG000|COMPLETED|Overall Study||7||
48168888|NCT01923896|100735845|FG001|COMPLETED|Overall Study||8||
48168889|NCT01923896|100735844|FG000|NOT COMPLETED|Overall Study||1||
48626268|NCT02037893|101867665|FG001|COMPLETED|Overall Study||25||
48626269|NCT02037893|101867666|FG002|COMPLETED|Overall Study||26||
48626270|NCT02037893|101867667|FG003|COMPLETED|Overall Study||28||
48626271|NCT02037893|101867664|FG000|NOT COMPLETED|Overall Study||0||
48626272|NCT02037893|101867665|FG001|NOT COMPLETED|Overall Study||0||
48626273|NCT02037893|101867666|FG002|NOT COMPLETED|Overall Study||1||
48626274|NCT02037893|101867667|FG003|NOT COMPLETED|Overall Study||0||
48626275|NCT00104052|101867668|FG000|STARTED|Overall Study||107||
48626276|NCT00104052|101867668|FG000|COMPLETED|Overall Study||78||
48626277|NCT00104052|101867668|FG000|NOT COMPLETED|Overall Study||29||
48626278|NCT03400449|101867669|FG000|STARTED|Overall Study||121||
48626279|NCT03400449|101867670|FG001|STARTED|Overall Study||119||
48626280|NCT03400449|101867669|FG000|COMPLETED|Overall Study||120||
48626281|NCT03400449|101867670|FG001|COMPLETED|Overall Study||119||
48626282|NCT03400449|101867669|FG000|NOT COMPLETED|Overall Study||1||
48626283|NCT03400449|101867670|FG001|NOT COMPLETED|Overall Study||0||
48626284|NCT01190891|101867671|FG000|STARTED|Overall Study||52||
48626285|NCT01190891|101867672|FG001|STARTED|Overall Study||52||
48626286|NCT01190891|101867671|FG000|COMPLETED|Overall Study||46||
48626287|NCT01190891|101867672|FG001|COMPLETED|Overall Study||52||
48626288|NCT01190891|101867671|FG000|NOT COMPLETED|Overall Study||6||
48626289|NCT01190891|101867672|FG001|NOT COMPLETED|Overall Study||0||
48626290|NCT01041859|101867673|FG000|STARTED|Open-Label Titration||459||
48626291|NCT01041859|101867674|FG001|STARTED|Open-Label Titration||0||
48626292|NCT01041859|101867675|FG002|STARTED|Open-Label Titration||0||
48626293|NCT01041859|101867673|FG000|COMPLETED|Open-Label Titration||358||
48626294|NCT01041859|101867674|FG001|COMPLETED|Open-Label Titration||0||
48626295|NCT01041859|101867675|FG002|COMPLETED|Open-Label Titration||0||
48626296|NCT01041859|101867673|FG000|NOT COMPLETED|Open-Label Titration||101||
48626297|NCT01041859|101867674|FG001|NOT COMPLETED|Open-Label Titration||0||
48168890|NCT01923896|100735845|FG001|NOT COMPLETED|Overall Study||0||
48168891|NCT01468532|100735846|FG000|STARTED|Overall Study||18||
48168892|NCT01468532|100735846|FG000|COMPLETED|Overall Study||18||
48168893|NCT01468532|100735846|FG000|NOT COMPLETED|Overall Study||0||
48168894|NCT00332332|100735847|FG000|STARTED|Overall Study||246||
48168895|NCT00332332|100735847|FG000|Received Study Medication|Overall Study||230||
48168896|NCT00332332|100735847|FG000|COMPLETED|Overall Study||178||
48168897|NCT00332332|100735847|FG000|NOT COMPLETED|Overall Study||68||
48168898|NCT00251927|100735848|FG000|STARTED|Overall Study||288||
48168899|NCT00251927|100735849|FG001|STARTED|Overall Study||266||
48168900|NCT00251927|100735848|FG000|COMPLETED|Overall Study||180||
48168901|NCT00251927|100735849|FG001|COMPLETED|Overall Study||192||
48168902|NCT00251927|100735848|FG000|NOT COMPLETED|Overall Study||108||
48168903|NCT00251927|100735849|FG001|NOT COMPLETED|Overall Study||74||
48332227|NCT00931489|101141788|FG003|STARTED|Overall Study||39||
48626298|NCT01041859|101867675|FG002|NOT COMPLETED|Open-Label Titration||0||
48626299|NCT01041859|101867673|FG000|STARTED|Double-Blind Maintenance||0||
48626300|NCT01041859|101867674|FG001|STARTED|Double-Blind Maintenance||166||
48626301|NCT01041859|101867675|FG002|STARTED|Double-Blind Maintenance||152||
48626302|NCT01041859|101867673|FG000|COMPLETED|Double-Blind Maintenance||0||
48626303|NCT01041859|101867674|FG001|COMPLETED|Double-Blind Maintenance||120||
48626304|NCT01041859|101867675|FG002|COMPLETED|Double-Blind Maintenance||107||
48626305|NCT01041859|101867673|FG000|NOT COMPLETED|Double-Blind Maintenance||0||
48626306|NCT01041859|101867674|FG001|NOT COMPLETED|Double-Blind Maintenance||46||
48626307|NCT01041859|101867675|FG002|NOT COMPLETED|Double-Blind Maintenance||45||
48626308|NCT02446691|101867676|FG000|STARTED|Overall Study||128||
48626309|NCT02446691|101867676|FG000|COMPLETED|Overall Study||117||
48168904|NCT01806740|100735850|FG000|STARTED|Overall Study||37||
48168905|NCT01806740|100735850|FG000|COMPLETED|Overall Study||31||
48168906|NCT01806740|100735850|FG000|NOT COMPLETED|Overall Study||6||
48168907|NCT01679236|100735851|FG000|STARTED|Overall Study||30||
48168908|NCT01679236|100735852|FG001|STARTED|Overall Study||25||
48332228|NCT00931489|101141789|FG004|STARTED|Overall Study||7||
48626310|NCT02446691|101867676|FG000|NOT COMPLETED|Overall Study||11||
48626311|NCT02611882|101867677|FG000|STARTED|Overall Study||75||
48626312|NCT02611882|101867678|FG001|STARTED|Overall Study||150||
48626313|NCT02611882|101867679|FG002|STARTED|Overall Study||0||
48626314|NCT02611882|101867677|FG000|Completed Surgery Per Protocol|Overall Study||42|Applies only to participants in the preRP group|
48626315|NCT02611882|101867678|FG001|Completed Surgery Per Protocol|Overall Study||0|Applies only to participants in the preRP group|
48168909|NCT01679236|100735851|FG000|COMPLETED|Overall Study||15||
48168910|NCT01679236|100735852|FG001|COMPLETED|Overall Study||10||
48168911|NCT01679236|100735851|FG000|NOT COMPLETED|Overall Study||15||
48168912|NCT01679236|100735852|FG001|NOT COMPLETED|Overall Study||15||
48168913|NCT03363659|100735853|FG000|STARTED|Overall Study||15||
48168914|NCT03363659|100735853|FG000|COMPLETED|Overall Study||12||
48626316|NCT02611882|101867679|FG002|Completed Surgery Per Protocol|Overall Study||0|Applies only to participants in the preRP group|
48168915|NCT03363659|100735853|FG000|NOT COMPLETED|Overall Study||3||
48168916|NCT00819403|100735854|FG000|STARTED|First Intervention (6 Weeks)||7||
48168917|NCT00819403|100735855|FG001|STARTED|First Intervention (6 Weeks)||8||
48168918|NCT00819403|100735854|FG000|COMPLETED|First Intervention (6 Weeks)||7||
48168919|NCT00819403|100735855|FG001|COMPLETED|First Intervention (6 Weeks)||8||
48168920|NCT00819403|100735854|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0||
48168921|NCT00819403|100735855|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0||
48168922|NCT00819403|100735854|FG000|STARTED|Washout (14 Days)||7||
48168923|NCT00819403|100735855|FG001|STARTED|Washout (14 Days)||8||
48168924|NCT00819403|100735854|FG000|COMPLETED|Washout (14 Days)||7||
48168925|NCT00819403|100735855|FG001|COMPLETED|Washout (14 Days)||8||
48168926|NCT00819403|100735854|FG000|NOT COMPLETED|Washout (14 Days)||0||
48168927|NCT00819403|100735855|FG001|NOT COMPLETED|Washout (14 Days)||0||
48168928|NCT00819403|100735854|FG000|STARTED|Second Intervention (6 Weeks)||7||
48168929|NCT00819403|100735855|FG001|STARTED|Second Intervention (6 Weeks)||8||
48168930|NCT00819403|100735854|FG000|COMPLETED|Second Intervention (6 Weeks)||7||
48168931|NCT00819403|100735855|FG001|COMPLETED|Second Intervention (6 Weeks)||8||
48168932|NCT00819403|100735854|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0||
48168933|NCT00819403|100735855|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0||
48168934|NCT00154310|100735856|FG000|STARTED|Overall Study||155||
48168935|NCT00154310|100735857|FG001|STARTED|Overall Study||145||
48168936|NCT00154310|100735856|FG000|COMPLETED|Overall Study||118||
48168937|NCT00154310|100735857|FG001|COMPLETED|Overall Study||117||
48168938|NCT00154310|100735856|FG000|NOT COMPLETED|Overall Study||37||
48168939|NCT00154310|100735857|FG001|NOT COMPLETED|Overall Study||28||
48168940|NCT02835846|100735858|FG000|STARTED|Overall Study||35||
48168941|NCT02835846|100735858|FG000|COMPLETED|Overall Study||24||
48168942|NCT02835846|100735858|FG000|NOT COMPLETED|Overall Study||11||
48168943|NCT02302066|100735859|FG000|STARTED|Overall Study||201||
48168944|NCT02302066|100735860|FG001|STARTED|Overall Study||398||
48168945|NCT02302066|100735861|FG002|STARTED|Overall Study||1002||
48168946|NCT02302066|100735862|FG003|STARTED|Overall Study||199||
48168947|NCT02302066|100735859|FG000|Safety Analysis Set|Overall Study||200||
48168948|NCT02302066|100735860|FG001|Safety Analysis Set|Overall Study||398||
48168949|NCT02302066|100735861|FG002|Safety Analysis Set|Overall Study||998||
48168950|NCT02302066|100735862|FG003|Safety Analysis Set|Overall Study||198||
48168951|NCT02302066|100735859|FG000|Immunogenicity Subset|Overall Study||92||
48332229|NCT00931489|101141785|FG000|COMPLETED|Overall Study||40||
48332230|NCT00931489|101141786|FG001|COMPLETED|Overall Study||40||
48332231|NCT00931489|101141787|FG002|COMPLETED|Overall Study||5||
48332232|NCT00931489|101141788|FG003|COMPLETED|Overall Study||39||
48332233|NCT00931489|101141789|FG004|COMPLETED|Overall Study||7||
48332234|NCT00931489|101141785|FG000|NOT COMPLETED|Overall Study||0||
48332235|NCT00931489|101141786|FG001|NOT COMPLETED|Overall Study||0||
48332236|NCT00931489|101141787|FG002|NOT COMPLETED|Overall Study||0||
48332237|NCT00931489|101141788|FG003|NOT COMPLETED|Overall Study||0||
48332238|NCT00931489|101141789|FG004|NOT COMPLETED|Overall Study||0||
48332239|NCT02863809|101141790|FG000|STARTED|Overall Study||34|Subjects randomized in the study groups|
48332240|NCT02863809|101141791|FG001|STARTED|Overall Study||34|Subjects randomized in the study groups|
48332241|NCT02863809|101141790|FG000|Screen Fail (Post Randomization)|Overall Study||1|Subject that did not meet eligibility criteria after the study randomization had occured.|
48332242|NCT02863809|101141791|FG001|Screen Fail (Post Randomization)|Overall Study||0|Subject that did not meet eligibility criteria after the study randomization had occured.|
48332243|NCT02863809|101141790|FG000|COMPLETED|Overall Study||24||
48332244|NCT02863809|101141791|FG001|COMPLETED|Overall Study||24||
48332245|NCT02863809|101141790|FG000|NOT COMPLETED|Overall Study||10||
48332246|NCT02863809|101141791|FG001|NOT COMPLETED|Overall Study||10||
48332247|NCT00929071|101141792|FG000|STARTED|Overall Study||10||
48332248|NCT00929071|101141792|FG000|COMPLETED|Overall Study||10||
48332249|NCT00929071|101141792|FG000|NOT COMPLETED|Overall Study||0||
48332250|NCT01298492|101141793|FG000|STARTED|Overall Study||268||
48332251|NCT01298492|101141793|FG000|COMPLETED|Overall Study||149||
48332252|NCT01298492|101141793|FG000|NOT COMPLETED|Overall Study||119||
48332253|NCT02643004|101141794|FG000|STARTED|First Intervention (One Week)||35||
48332254|NCT02643004|101141795|FG001|STARTED|First Intervention (One Week)||35||
48332255|NCT02643004|101141794|FG000|COMPLETED|First Intervention (One Week)||35||
48332256|NCT02643004|101141795|FG001|COMPLETED|First Intervention (One Week)||35||
48332257|NCT02643004|101141794|FG000|NOT COMPLETED|First Intervention (One Week)||0||
48332258|NCT02643004|101141795|FG001|NOT COMPLETED|First Intervention (One Week)||0||
48332259|NCT02643004|101141794|FG000|STARTED|Second Intervention (One Week)||35||
48332260|NCT02643004|101141795|FG001|STARTED|Second Intervention (One Week)||35||
48332261|NCT02643004|101141794|FG000|COMPLETED|Second Intervention (One Week)||35||
48168952|NCT02302066|100735860|FG001|Immunogenicity Subset|Overall Study||187||
48168953|NCT02302066|100735861|FG002|Immunogenicity Subset|Overall Study||192||
48168954|NCT02302066|100735862|FG003|Immunogenicity Subset|Overall Study||94||
48168955|NCT02302066|100735859|FG000|Per-Protocol Set (PPS)|Overall Study||83||
48168956|NCT02302066|100735860|FG001|Per-Protocol Set (PPS)|Overall Study||171||
48168957|NCT02302066|100735861|FG002|Per-Protocol Set (PPS)|Overall Study||174||
48168958|NCT02302066|100735862|FG003|Per-Protocol Set (PPS)|Overall Study||81||
48168959|NCT02302066|100735859|FG000|COMPLETED|Overall Study||168||
48168960|NCT02302066|100735860|FG001|COMPLETED|Overall Study||323||
48168961|NCT02302066|100735861|FG002|COMPLETED|Overall Study||830||
48168962|NCT02302066|100735862|FG003|COMPLETED|Overall Study||158||
48168963|NCT02302066|100735859|FG000|NOT COMPLETED|Overall Study||33||
48168964|NCT02302066|100735860|FG001|NOT COMPLETED|Overall Study||75||
48168965|NCT02302066|100735861|FG002|NOT COMPLETED|Overall Study||172||
48168966|NCT02302066|100735862|FG003|NOT COMPLETED|Overall Study||41||
48168967|NCT00684762|100735863|FG000|STARTED|First Intervention||16||
48168968|NCT00684762|100735864|FG001|STARTED|First Intervention||16||
48168969|NCT00684762|100735863|FG000|COMPLETED|First Intervention||16||
48168970|NCT00684762|100735864|FG001|COMPLETED|First Intervention||16||
48168971|NCT00684762|100735863|FG000|NOT COMPLETED|First Intervention||0||
48168972|NCT00684762|100735864|FG001|NOT COMPLETED|First Intervention||0||
48168973|NCT00684762|100735863|FG000|STARTED|Washout Period of 7 Days||16||
48168974|NCT00684762|100735864|FG001|STARTED|Washout Period of 7 Days||16||
48168975|NCT00684762|100735863|FG000|COMPLETED|Washout Period of 7 Days||14||
48168976|NCT00684762|100735864|FG001|COMPLETED|Washout Period of 7 Days||14||
48168977|NCT00684762|100735863|FG000|NOT COMPLETED|Washout Period of 7 Days||2||
48168978|NCT00684762|100735864|FG001|NOT COMPLETED|Washout Period of 7 Days||2||
48168979|NCT00684762|100735863|FG000|STARTED|Second Intervention||14||
48168980|NCT00684762|100735864|FG001|STARTED|Second Intervention||14||
48626317|NCT02611882|101867677|FG000|COMPLETED|Overall Study||42||
48626318|NCT02611882|101867678|FG001|COMPLETED|Overall Study||150||
48626319|NCT02611882|101867679|FG002|COMPLETED|Overall Study||0||
48626320|NCT02611882|101867677|FG000|NOT COMPLETED|Overall Study||33||
48626321|NCT02611882|101867678|FG001|NOT COMPLETED|Overall Study||0||
48626322|NCT02611882|101867679|FG002|NOT COMPLETED|Overall Study||0||
48626323|NCT01309386|101867680|FG000|STARTED|Overall Study||50||
48626324|NCT01309386|101867681|FG001|STARTED|Overall Study||50||
48168981|NCT00684762|100735863|FG000|COMPLETED|Second Intervention||14||
48168982|NCT00684762|100735864|FG001|COMPLETED|Second Intervention||14||
48168983|NCT00684762|100735863|FG000|NOT COMPLETED|Second Intervention||0||
48168984|NCT00684762|100735864|FG001|NOT COMPLETED|Second Intervention||0||
48168985|NCT03734991|100735865|FG000|STARTED|Overall Study||249||
48168986|NCT03734991|100735866|FG001|STARTED|Overall Study||127||
48168987|NCT03734991|100735865|FG000|Withdrawn Before Treatment|Overall Study||2||
48168988|NCT03734991|100735866|FG001|Withdrawn Before Treatment|Overall Study||3||
48168989|NCT03734991|100735865|FG000|Withdrawn Before TOC|Overall Study||59||
48168990|NCT03734991|100735866|FG001|Withdrawn Before TOC|Overall Study||41||
48168991|NCT03734991|100735865|FG000|Completed the TOC Visit|Overall Study||188||
48168992|NCT03734991|100735866|FG001|Completed the TOC Visit|Overall Study||83||
48168993|NCT03734991|100735865|FG000|Withdrawn At or After the TOC Visit|Overall Study||5||
48168994|NCT03734991|100735866|FG001|Withdrawn At or After the TOC Visit|Overall Study||3||
48168995|NCT03734991|100735865|FG000|COMPLETED|Overall Study||183||
48168996|NCT03734991|100735866|FG001|COMPLETED|Overall Study||80||
48168997|NCT03734991|100735865|FG000|NOT COMPLETED|Overall Study||66||
48168998|NCT03734991|100735866|FG001|NOT COMPLETED|Overall Study||47||
48168999|NCT02254421|100735867|FG000|STARTED|Overall Study||31||
48169000|NCT02254421|100735868|FG001|STARTED|Overall Study||29||
48169001|NCT02254421|100735867|FG000|COMPLETED|Overall Study||29||
48169002|NCT02254421|100735868|FG001|COMPLETED|Overall Study||26||
48169003|NCT02254421|100735867|FG000|NOT COMPLETED|Overall Study||2||
48169004|NCT02254421|100735868|FG001|NOT COMPLETED|Overall Study||3||
48169005|NCT01976364|100735869|FG000|STARTED|Main Study (36 Months)||686||
48169006|NCT01976364|100735870|FG001|STARTED|Main Study (36 Months)||0||
48169007|NCT01976364|100735871|FG002|STARTED|Main Study (36 Months)||0||
48169008|NCT01976364|100735869|FG000|COMPLETED|Main Study (36 Months)||465||
48169009|NCT01976364|100735870|FG001|COMPLETED|Main Study (36 Months)||0||
48169010|NCT01976364|100735871|FG002|COMPLETED|Main Study (36 Months)||0||
48169011|NCT01976364|100735869|FG000|NOT COMPLETED|Main Study (36 Months)||221||
48626325|NCT01309386|101867680|FG000|COMPLETED|Overall Study||28||
48626326|NCT01309386|101867681|FG001|COMPLETED|Overall Study||29||
48626327|NCT01309386|101867680|FG000|NOT COMPLETED|Overall Study||22||
48626328|NCT01309386|101867681|FG001|NOT COMPLETED|Overall Study||21||
48626329|NCT00010257|101867682|FG000|STARTED|Overall Study||25||
48626330|NCT00010257|101867683|FG001|STARTED|Overall Study||21||
48626331|NCT00010257|101867682|FG000|COMPLETED|Overall Study||24||
48169012|NCT01976364|100735870|FG001|NOT COMPLETED|Main Study (36 Months)||0||
48169013|NCT01976364|100735871|FG002|NOT COMPLETED|Main Study (36 Months)||0||
48169014|NCT01976364|100735869|FG000|STARTED|Sub-study (12 Months)||0||
48169015|NCT01976364|100735870|FG001|STARTED|Sub-study (12 Months)||89||
48169016|NCT01976364|100735871|FG002|STARTED|Sub-study (12 Months)||90||
48626332|NCT00010257|101867683|FG001|COMPLETED|Overall Study||21||
48626333|NCT00010257|101867682|FG000|NOT COMPLETED|Overall Study||1||
48626334|NCT00010257|101867683|FG001|NOT COMPLETED|Overall Study||0||
48169017|NCT01976364|100735869|FG000|COMPLETED|Sub-study (12 Months)||0||
48169018|NCT01976364|100735870|FG001|COMPLETED|Sub-study (12 Months)||83||
48169019|NCT01976364|100735871|FG002|COMPLETED|Sub-study (12 Months)||85||
48169020|NCT01976364|100735869|FG000|NOT COMPLETED|Sub-study (12 Months)||0||
48411097|NCT02057276|101337806|FG001|NOT COMPLETED|Overall Study||0||
48411098|NCT01245972|101337807|FG000|STARTED|Overall Study||7||
48411099|NCT01245972|101337808|FG001|STARTED|Overall Study||8||
48411100|NCT01245972|101337809|FG002|STARTED|Overall Study||8||
48411101|NCT01245972|101337807|FG000|COMPLETED|Overall Study||7||
48411102|NCT01245972|101337808|FG001|COMPLETED|Overall Study||8||
48411103|NCT01245972|101337809|FG002|COMPLETED|Overall Study||8||
48749194|NCT01300728|102172995|FG000|STARTED|Overall Study||26||
48749195|NCT01300728|102172996|FG001|STARTED|Overall Study||26||
48749196|NCT01300728|102172995|FG000|COMPLETED|Overall Study||24||
48749197|NCT01300728|102172996|FG001|COMPLETED|Overall Study||25||
48749198|NCT01300728|102172995|FG000|NOT COMPLETED|Overall Study||2||
48749199|NCT01300728|102172996|FG001|NOT COMPLETED|Overall Study||1||
48749200|NCT03795116|102172997|FG000|STARTED|Overall Study||10||10
48749201|NCT03795116|102172998|FG001|STARTED|Overall Study||10||10
48749202|NCT03795116|102172999|FG002|STARTED|Overall Study||10||10
48749203|NCT03795116|102173000|FG003|STARTED|Overall Study||10||10
48749204|NCT03795116|102173001|FG004|STARTED|Overall Study||10||10
48749205|NCT03795116|102173002|FG005|STARTED|Overall Study||10||10
48169021|NCT01976364|100735870|FG001|NOT COMPLETED|Sub-study (12 Months)||6||
48169022|NCT01976364|100735871|FG002|NOT COMPLETED|Sub-study (12 Months)||5||
48169023|NCT00545363|100735872|FG000|STARTED|Overall Study||358||
48411104|NCT01245972|101337807|FG000|NOT COMPLETED|Overall Study||0||
48411105|NCT01245972|101337808|FG001|NOT COMPLETED|Overall Study||0||
48411106|NCT01245972|101337809|FG002|NOT COMPLETED|Overall Study||0||
48411107|NCT02299206|101337810|FG000|STARTED|Overall Study||4||
48411108|NCT02299206|101337810|FG000|COMPLETED|Overall Study||2||
48411109|NCT02299206|101337810|FG000|NOT COMPLETED|Overall Study||2||
48749206|NCT03795116|102172997|FG000|COMPLETED|Overall Study||6||6
48749207|NCT03795116|102172998|FG001|COMPLETED|Overall Study||6||6
48749208|NCT03795116|102172999|FG002|COMPLETED|Overall Study||9||9
48749209|NCT03795116|102173000|FG003|COMPLETED|Overall Study||9||9
48749210|NCT03795116|102173001|FG004|COMPLETED|Overall Study||9||9
48749211|NCT03795116|102173002|FG005|COMPLETED|Overall Study||9||9
48749212|NCT03795116|102172997|FG000|NOT COMPLETED|Overall Study||4||4
48749213|NCT03795116|102172998|FG001|NOT COMPLETED|Overall Study||4||4
48749214|NCT03795116|102172999|FG002|NOT COMPLETED|Overall Study||1||1
48749215|NCT03795116|102173000|FG003|NOT COMPLETED|Overall Study||1||1
48749216|NCT03795116|102173001|FG004|NOT COMPLETED|Overall Study||1||1
48749217|NCT03795116|102173002|FG005|NOT COMPLETED|Overall Study||1||1
48749218|NCT01421017|102173003|FG000|STARTED|Overall Study||12||
48749219|NCT01421017|102173004|FG001|STARTED|Overall Study||12||
48749220|NCT01421017|102173005|FG002|STARTED|Overall Study||7||
48749221|NCT01421017|102173003|FG000|COMPLETED|Overall Study||10||
48749222|NCT01421017|102173004|FG001|COMPLETED|Overall Study||6||
48749223|NCT01421017|102173005|FG002|COMPLETED|Overall Study||4||
48749224|NCT01421017|102173003|FG000|NOT COMPLETED|Overall Study||2||
48749225|NCT01421017|102173004|FG001|NOT COMPLETED|Overall Study||6||
48749226|NCT01421017|102173005|FG002|NOT COMPLETED|Overall Study||3||
48749227|NCT01046565|102173006|FG000|STARTED|Overall Study||75||
48749228|NCT01046565|102173006|FG000|COMPLETED|Overall Study||66||
48749229|NCT01046565|102173006|FG000|NOT COMPLETED|Overall Study||9||
48749230|NCT01247324|102173007|FG000|STARTED|Overall Study||411||
48749231|NCT01247324|102173008|FG001|STARTED|Overall Study||410||
48749232|NCT01247324|102173007|FG000|Entered Open-Label Extension|Overall Study||326||
48767717|NCT01112917|102222810|FG000|NOT COMPLETED|Overall Study||7||
48169024|NCT00545363|100735873|FG001|STARTED|Overall Study||358||
48169025|NCT00545363|100735872|FG000|Treated|Overall Study||354||
48169026|NCT00545363|100735873|FG001|Treated|Overall Study||357||
48169027|NCT00545363|100735872|FG000|COMPLETED|Overall Study||339||
48169028|NCT00545363|100735873|FG001|COMPLETED|Overall Study||343||
48169029|NCT00545363|100735872|FG000|NOT COMPLETED|Overall Study||19||
48411110|NCT00518336|101337811|FG000|STARTED|Year 7||222||
48411111|NCT00518336|101337812|FG001|STARTED|Year 7||211||
48411112|NCT00518336|101337811|FG000|COMPLETED|Year 7||220||
48411113|NCT00518336|101337812|FG001|COMPLETED|Year 7||208||
48411114|NCT00518336|101337811|FG000|NOT COMPLETED|Year 7||2||
48626335|NCT03407313|101867684|FG000|STARTED|Overall Study||68||
48169030|NCT00545363|100735873|FG001|NOT COMPLETED|Overall Study||15||
48169031|NCT04559282|100735874|FG000|STARTED|Intervention 1 (Day 0)||8||
48169032|NCT04559282|100735875|FG001|STARTED|Intervention 1 (Day 0)||8||
48169033|NCT04559282|100735874|FG000|COMPLETED|Intervention 1 (Day 0)||8||
48169034|NCT04559282|100735875|FG001|COMPLETED|Intervention 1 (Day 0)||8||
48169035|NCT04559282|100735874|FG000|NOT COMPLETED|Intervention 1 (Day 0)||0||
48169036|NCT04559282|100735875|FG001|NOT COMPLETED|Intervention 1 (Day 0)||0||
48169037|NCT04559282|100735874|FG000|STARTED|Intervention 2 (Day 7)||8||
48169038|NCT04559282|100735875|FG001|STARTED|Intervention 2 (Day 7)||8||
48169039|NCT04559282|100735874|FG000|COMPLETED|Intervention 2 (Day 7)||8||
48169040|NCT04559282|100735875|FG001|COMPLETED|Intervention 2 (Day 7)||8||
48169041|NCT04559282|100735874|FG000|NOT COMPLETED|Intervention 2 (Day 7)||0||
48169042|NCT04559282|100735875|FG001|NOT COMPLETED|Intervention 2 (Day 7)||0||
48169043|NCT04559282|100735874|FG000|STARTED|Intervention 3 (Day 14)||8||
48169044|NCT04559282|100735875|FG001|STARTED|Intervention 3 (Day 14)||8||
48169045|NCT04559282|100735874|FG000|COMPLETED|Intervention 3 (Day 14)||8||
48169046|NCT04559282|100735875|FG001|COMPLETED|Intervention 3 (Day 14)||8||
48169047|NCT04559282|100735874|FG000|NOT COMPLETED|Intervention 3 (Day 14)||0||
48169048|NCT04559282|100735875|FG001|NOT COMPLETED|Intervention 3 (Day 14)||0||
48169049|NCT02354924|100735876|FG000|STARTED|Overall Study||40||
48169050|NCT02354924|100735877|FG001|STARTED|Overall Study||20||
48169051|NCT02354924|100735876|FG000|COMPLETED|Overall Study||40||
48411115|NCT00518336|101337812|FG001|NOT COMPLETED|Year 7||3||
48411116|NCT00518336|101337811|FG000|STARTED|Year 8||223||
48411117|NCT00518336|101337812|FG001|STARTED|Year 8||213||
48411118|NCT00518336|101337811|FG000|COMPLETED|Year 8||222||
48626336|NCT03407313|101867684|FG000|COMPLETED|Overall Study||66||
48626337|NCT03407313|101867684|FG000|NOT COMPLETED|Overall Study||2||
48626338|NCT02999789|101867685|FG000|STARTED|Overall Study||4||
48626339|NCT02999789|101867686|FG001|STARTED|Overall Study||3||
48626340|NCT02999789|101867685|FG000|COMPLETED|Overall Study||3||
48626341|NCT02999789|101867686|FG001|COMPLETED|Overall Study||0||
48626342|NCT02999789|101867685|FG000|NOT COMPLETED|Overall Study||1||
48411119|NCT00518336|101337812|FG001|COMPLETED|Year 8||211||
48411120|NCT00518336|101337811|FG000|NOT COMPLETED|Year 8||1||
48626343|NCT02999789|101867686|FG001|NOT COMPLETED|Overall Study||3||
48626344|NCT03555149|101867687|FG000|STARTED|Overall Study||24||
48626345|NCT03555149|101867688|FG001|STARTED|Overall Study||15||
48626346|NCT03555149|101867689|FG002|STARTED|Overall Study||15||
48169052|NCT02354924|100735877|FG001|COMPLETED|Overall Study||20||
48169053|NCT02354924|100735876|FG000|NOT COMPLETED|Overall Study||0||
48169054|NCT02354924|100735877|FG001|NOT COMPLETED|Overall Study||0||
48169055|NCT03679767|100735878|FG000|STARTED|Overall Study||35||
48169056|NCT03679767|100735879|FG001|STARTED|Overall Study||23||
48411121|NCT00518336|101337812|FG001|NOT COMPLETED|Year 8||2||
48411122|NCT00518336|101337811|FG000|STARTED|Year 9||224||
48626347|NCT03555149|101867690|FG003|STARTED|Overall Study||6||
48626348|NCT03555149|101867691|FG004|STARTED|Overall Study||4||
48626349|NCT03555149|101867692|FG005|STARTED|Overall Study||15||
48626350|NCT03555149|101867693|FG006|STARTED|Overall Study||15||
48169057|NCT03679767|100735880|FG002|STARTED|Overall Study||29||
48169058|NCT03679767|100735881|FG003|STARTED|Overall Study||34||
48169059|NCT03679767|100735878|FG000|COMPLETED|Overall Study||0||
48169060|NCT03679767|100735879|FG001|COMPLETED|Overall Study||0||
48169061|NCT03679767|100735880|FG002|COMPLETED|Overall Study||0||
48169062|NCT03679767|100735881|FG003|COMPLETED|Overall Study||0||
48169063|NCT03679767|100735878|FG000|NOT COMPLETED|Overall Study||35||
48169064|NCT03679767|100735879|FG001|NOT COMPLETED|Overall Study||23||
48169065|NCT03679767|100735880|FG002|NOT COMPLETED|Overall Study||29||
48626351|NCT03555149|101867694|FG007|STARTED|Overall Study||2||
48626352|NCT03555149|101867687|FG000|Received at Least One Dose of Study Treatment|Overall Study||19|Safety Population|
48626353|NCT03555149|101867688|FG001|Received at Least One Dose of Study Treatment|Overall Study||15|Safety Population|
48626354|NCT03555149|101867689|FG002|Received at Least One Dose of Study Treatment|Overall Study||15|Safety Population|
48169066|NCT03679767|100735881|FG003|NOT COMPLETED|Overall Study||34||
48169067|NCT01625923|100735882|FG000|STARTED|Overall Study||3||
48169068|NCT01625923|100735882|FG000|COMPLETED|Overall Study||3||
48169069|NCT01625923|100735882|FG000|NOT COMPLETED|Overall Study||0||
48169070|NCT01893827|100735883|FG000|STARTED|Overall Study||117||
48169071|NCT01893827|100735884|FG001|STARTED|Overall Study||120||
48169072|NCT01893827|100735883|FG000|COMPLETED|Overall Study||98||
48169073|NCT01893827|100735884|FG001|COMPLETED|Overall Study||94||
48169074|NCT01893827|100735883|FG000|NOT COMPLETED|Overall Study||19||
48169075|NCT01893827|100735884|FG001|NOT COMPLETED|Overall Study||26||
48169076|NCT02294474|100735885|FG000|STARTED|Overall Study||253||
48169077|NCT02294474|100735886|FG001|STARTED|Overall Study||252||
48169078|NCT02294474|100735885|FG000|COMPLETED|Overall Study||228||
48169079|NCT02294474|100735886|FG001|COMPLETED|Overall Study||230||
48169080|NCT02294474|100735885|FG000|NOT COMPLETED|Overall Study||25||
48169081|NCT02294474|100735886|FG001|NOT COMPLETED|Overall Study||22||
48169082|NCT00747123|100735887|FG000|STARTED|Overall Study||6||
48169083|NCT00747123|100735888|FG001|STARTED|Overall Study||8||
48169084|NCT00747123|100735889|FG002|STARTED|Overall Study||8||
48169085|NCT00747123|100735890|FG003|STARTED|Overall Study||8||
48169086|NCT00747123|100735887|FG000|COMPLETED|Overall Study||6||
48169087|NCT00747123|100735888|FG001|COMPLETED|Overall Study||6||
48169088|NCT00747123|100735889|FG002|COMPLETED|Overall Study||7||
48169089|NCT00747123|100735890|FG003|COMPLETED|Overall Study||7||
48169090|NCT00747123|100735887|FG000|NOT COMPLETED|Overall Study||0||
48169091|NCT00747123|100735888|FG001|NOT COMPLETED|Overall Study||2||
48169092|NCT00747123|100735889|FG002|NOT COMPLETED|Overall Study||1||
48169093|NCT00747123|100735890|FG003|NOT COMPLETED|Overall Study||1||
48169094|NCT03430063|100735891|FG000|STARTED|Overall Study||8|All randomized participants|
48169095|NCT03430063|100735892|FG001|STARTED|Overall Study||11|All randomized participants|
48169096|NCT03430063|100735893|FG002|STARTED|Overall Study||9|All randomized participants|
48169097|NCT03430063|100735891|FG000|Treated|Overall Study||8|All randomized participants who received any study treatment|
48169098|NCT03430063|100735892|FG001|Treated|Overall Study||11|All randomized participants who received any study treatment|
48169099|NCT03430063|100735893|FG002|Treated|Overall Study||8|All randomized participants who received any study treatment|
48169100|NCT03430063|100735891|FG000|COMPLETED|Overall Study||0|Completed study|
48169101|NCT03430063|100735892|FG001|COMPLETED|Overall Study||3|Completed study|
48169102|NCT03430063|100735893|FG002|COMPLETED|Overall Study||1|Completed study|
48169103|NCT03430063|100735891|FG000|NOT COMPLETED|Overall Study||8||
48169104|NCT03430063|100735892|FG001|NOT COMPLETED|Overall Study||8||
48169105|NCT03430063|100735893|FG002|NOT COMPLETED|Overall Study||8||
48169106|NCT01411501|100735894|FG000|STARTED|Overall Study||168||
48169107|NCT01411501|100735895|FG001|STARTED|Overall Study||172||
48169108|NCT01411501|100735896|FG002|STARTED|Overall Study||165||
48169109|NCT01411501|100735897|FG003|STARTED|Overall Study||170||
48169110|NCT01411501|100735894|FG000|COMPLETED|Overall Study||158||
48169111|NCT01411501|100735895|FG001|COMPLETED|Overall Study||166||
48169112|NCT01411501|100735896|FG002|COMPLETED|Overall Study||159||
48626355|NCT03555149|101867690|FG003|Received at Least One Dose of Study Treatment|Overall Study||6|Safety Population|
48626356|NCT03555149|101867691|FG004|Received at Least One Dose of Study Treatment|Overall Study||4|Safety Population|
48656963|NCT01340170|101943736|FG002|COMPLETED|Overall Study||3|ITT population|6
48169113|NCT01411501|100735897|FG003|COMPLETED|Overall Study||163||
48169114|NCT01411501|100735894|FG000|NOT COMPLETED|Overall Study||10||
48169115|NCT01411501|100735895|FG001|NOT COMPLETED|Overall Study||6||
48169116|NCT01411501|100735896|FG002|NOT COMPLETED|Overall Study||6||
48169117|NCT01411501|100735897|FG003|NOT COMPLETED|Overall Study||7||
48169118|NCT01932294|100735898|FG000|STARTED|Overall Study||171||
48169119|NCT01932294|100735898|FG000|COMPLETED|Overall Study||72||
48169120|NCT01932294|100735898|FG000|NOT COMPLETED|Overall Study||99||
48169121|NCT01582789|100735899|FG000|STARTED|First Intervention (14 Days)||34||
48169122|NCT01582789|100735900|FG001|STARTED|First Intervention (14 Days)||27||
48169123|NCT01582789|100735899|FG000|COMPLETED|First Intervention (14 Days)||34||
48169124|NCT01582789|100735900|FG001|COMPLETED|First Intervention (14 Days)||27||
48169125|NCT01582789|100735899|FG000|NOT COMPLETED|First Intervention (14 Days)||0||
48169126|NCT01582789|100735900|FG001|NOT COMPLETED|First Intervention (14 Days)||0||
48626357|NCT03555149|101867692|FG005|Received at Least One Dose of Study Treatment|Overall Study||15|Safety Population|
48626358|NCT03555149|101867693|FG006|Received at Least One Dose of Study Treatment|Overall Study||15|Safety Population|
48626359|NCT03555149|101867694|FG007|Received at Least One Dose of Study Treatment|Overall Study||2|Safety Population|
48626360|NCT03555149|101867687|FG000|COMPLETED|Overall Study||0||
48626361|NCT03555149|101867688|FG001|COMPLETED|Overall Study||0||
48626362|NCT03555149|101867689|FG002|COMPLETED|Overall Study||0||
48626363|NCT03555149|101867690|FG003|COMPLETED|Overall Study||0||
48626364|NCT03555149|101867691|FG004|COMPLETED|Overall Study||0||
48626365|NCT03555149|101867692|FG005|COMPLETED|Overall Study||0||
48169127|NCT01582789|100735899|FG000|STARTED|Second Intervention (14 Days)||34||
48169128|NCT01582789|100735900|FG001|STARTED|Second Intervention (14 Days)||27||
48169129|NCT01582789|100735899|FG000|COMPLETED|Second Intervention (14 Days)||33||
48169130|NCT01582789|100735900|FG001|COMPLETED|Second Intervention (14 Days)||27||
48169131|NCT01582789|100735899|FG000|NOT COMPLETED|Second Intervention (14 Days)||1||
48169132|NCT01582789|100735900|FG001|NOT COMPLETED|Second Intervention (14 Days)||0||
48169133|NCT00152971|100735901|FG000|STARTED|Overall Study||857||
48169134|NCT00152971|100735902|FG001|STARTED|Overall Study||871||
48169135|NCT00152971|100735903|FG002|STARTED|Overall Study||868||
48169136|NCT00152971|100735901|FG000|COMPLETED|Overall Study||806||
48169137|NCT00152971|100735902|FG001|COMPLETED|Overall Study||823||
48169138|NCT00152971|100735903|FG002|COMPLETED|Overall Study||819||
48169139|NCT00152971|100735901|FG000|NOT COMPLETED|Overall Study||51||
48169140|NCT00152971|100735902|FG001|NOT COMPLETED|Overall Study||48||
48169141|NCT00152971|100735903|FG002|NOT COMPLETED|Overall Study||49||
48626366|NCT03555149|101867693|FG006|COMPLETED|Overall Study||0||
48626367|NCT03555149|101867694|FG007|COMPLETED|Overall Study||0||
48626368|NCT03555149|101867687|FG000|NOT COMPLETED|Overall Study||24||
48626369|NCT03555149|101867688|FG001|NOT COMPLETED|Overall Study||15||
48626370|NCT03555149|101867689|FG002|NOT COMPLETED|Overall Study||15||
48626371|NCT03555149|101867690|FG003|NOT COMPLETED|Overall Study||6||
48626372|NCT03555149|101867691|FG004|NOT COMPLETED|Overall Study||4||
48626373|NCT03555149|101867692|FG005|NOT COMPLETED|Overall Study||15||
48626374|NCT03555149|101867693|FG006|NOT COMPLETED|Overall Study||15||
48169142|NCT00152971|100735901|FG000|STARTED|Treatment||857||
48169143|NCT00152971|100735902|FG001|STARTED|Treatment||871||
48169144|NCT00152971|100735903|FG002|STARTED|Treatment||868||
48169145|NCT00152971|100735901|FG000|COMPLETED|Treatment||786||
48169146|NCT00152971|100735902|FG001|COMPLETED|Treatment||808||
48169147|NCT00152971|100735903|FG002|COMPLETED|Treatment||788||
48169148|NCT00152971|100735901|FG000|NOT COMPLETED|Treatment||71||
48169149|NCT00152971|100735902|FG001|NOT COMPLETED|Treatment||63||
48169150|NCT00152971|100735903|FG002|NOT COMPLETED|Treatment||80||
48169151|NCT02012192|100735904|FG000|STARTED|Overall Study||90||
48169152|NCT02012192|100735905|FG001|STARTED|Overall Study||43||
48169153|NCT02012192|100735904|FG000|COMPLETED|Overall Study||63||
48169154|NCT02012192|100735905|FG001|COMPLETED|Overall Study||43||
48626375|NCT03555149|101867694|FG007|NOT COMPLETED|Overall Study||2||
48626376|NCT00521365|101867695|FG000|STARTED|Overall Study||88||
48626377|NCT00521365|101867695|FG000|Modified Intention to Treat (mITT)|Overall Study||88||
48626378|NCT00521365|101867695|FG000|Per Protocol (PP) Population|Overall Study||68||
48626379|NCT00521365|101867695|FG000|Safety Analysis Set|Overall Study||88||
48626380|NCT00521365|101867695|FG000|COMPLETED|Overall Study||68||
48626381|NCT00521365|101867695|FG000|NOT COMPLETED|Overall Study||20||
48626382|NCT03575702|101867696|FG000|STARTED|Overall Study||149||
48169155|NCT02012192|100735904|FG000|NOT COMPLETED|Overall Study||27||
48169156|NCT02012192|100735905|FG001|NOT COMPLETED|Overall Study||0||
48169157|NCT00675415|100735906|FG000|STARTED|Overall Study||132||
48169158|NCT00675415|100735907|FG001|STARTED|Overall Study||131||
48169159|NCT00675415|100735906|FG000|COMPLETED|Overall Study||124||
48169160|NCT00675415|100735907|FG001|COMPLETED|Overall Study||123||
48169161|NCT00675415|100735906|FG000|NOT COMPLETED|Overall Study||8||
48169162|NCT00675415|100735907|FG001|NOT COMPLETED|Overall Study||8||
48169163|NCT02611830|100735908|FG000|STARTED|OL Induction Phase||383||
48169164|NCT02611830|100735909|FG001|STARTED|OL Induction Phase||0||
48169165|NCT02611830|100735910|FG002|STARTED|OL Induction Phase||0||
48169166|NCT02611830|100735911|FG003|STARTED|OL Induction Phase||0||
48626383|NCT03575702|101867697|FG001|STARTED|Overall Study||150||
48169167|NCT02611830|100735908|FG000|COMPLETED|OL Induction Phase||353|Completers included randomized participants, or if not randomized, those who had Week 14 visit|
48169168|NCT02611830|100735909|FG001|COMPLETED|OL Induction Phase||0|Completers included randomized participants, or if not randomized, those who had Week 14 visit|
48169169|NCT02611830|100735910|FG002|COMPLETED|OL Induction Phase||0|Completers included randomized participants, or if not randomized, those who had Week 14 visit|
48169170|NCT02611830|100735911|FG003|COMPLETED|OL Induction Phase||0|Completers included randomized participants, or if not randomized, those who had Week 14 visit|
48169171|NCT02611830|100735908|FG000|NOT COMPLETED|OL Induction Phase||30||
48626384|NCT03575702|101867696|FG000|COMPLETED|Overall Study||143||
48626385|NCT03575702|101867697|FG001|COMPLETED|Overall Study||146||
48626386|NCT03575702|101867696|FG000|NOT COMPLETED|Overall Study||6||
48626387|NCT03575702|101867697|FG001|NOT COMPLETED|Overall Study||4||
48169172|NCT02611830|100735909|FG001|NOT COMPLETED|OL Induction Phase||0||
48169173|NCT02611830|100735910|FG002|NOT COMPLETED|OL Induction Phase||0||
48169174|NCT02611830|100735911|FG003|NOT COMPLETED|OL Induction Phase||0||
48169175|NCT02611830|100735908|FG000|STARTED|Maintenance Phase||0|Participants who achieved clinical response at Week 6 entered the maintenance phase.|
48169176|NCT02611830|100735909|FG001|STARTED|Maintenance Phase||56|Participants who achieved clinical response at Week 6 entered the maintenance phase.|
48169177|NCT02611830|100735910|FG002|STARTED|Maintenance Phase||106|Participants who achieved clinical response at Week 6 entered the maintenance phase.|
48169178|NCT02611830|100735911|FG003|STARTED|Maintenance Phase||54|Participants who achieved clinical response at Week 6 entered the maintenance phase.|
48169179|NCT02611830|100735908|FG000|COMPLETED|Maintenance Phase||0||
48169180|NCT02611830|100735909|FG001|COMPLETED|Maintenance Phase||20||
48169181|NCT02611830|100735910|FG002|COMPLETED|Maintenance Phase||75||
48169182|NCT02611830|100735911|FG003|COMPLETED|Maintenance Phase||39||
48169183|NCT02611830|100735908|FG000|NOT COMPLETED|Maintenance Phase||0||
48169184|NCT02611830|100735909|FG001|NOT COMPLETED|Maintenance Phase||36||
48169185|NCT02611830|100735910|FG002|NOT COMPLETED|Maintenance Phase||31||
48749233|NCT01247324|102173008|FG001|Entered Open-Label Extension|Overall Study||352||
48749234|NCT01247324|102173007|FG000|COMPLETED|Overall Study||226||
48749235|NCT01247324|102173008|FG001|COMPLETED|Overall Study||239||
48749236|NCT01247324|102173007|FG000|NOT COMPLETED|Overall Study||185||
48749237|NCT01247324|102173008|FG001|NOT COMPLETED|Overall Study||171||
48749238|NCT00271375|102173009|FG000|STARTED|Overall Study||114||
48169186|NCT02611830|100735911|FG003|NOT COMPLETED|Maintenance Phase||15||
48169187|NCT03447730|100735912|FG000|STARTED|Overall Study||6||
48169188|NCT03447730|100735913|FG001|STARTED|Overall Study||9||
48169189|NCT03447730|100735914|FG002|STARTED|Overall Study||8||
48332262|NCT02643004|101141795|FG001|COMPLETED|Second Intervention (One Week)||35||
48332263|NCT02643004|101141794|FG000|NOT COMPLETED|Second Intervention (One Week)||0||
48332264|NCT02643004|101141795|FG001|NOT COMPLETED|Second Intervention (One Week)||0||
48332265|NCT02165384|101141796|FG000|STARTED|Overall Study||199||
48332266|NCT02165384|101141796|FG000|COMPLETED|Overall Study||199||
48332267|NCT02165384|101141796|FG000|NOT COMPLETED|Overall Study||0||
48332268|NCT01543087|101141797|FG000|STARTED|Stage 1 (48 Months)||70||
48332269|NCT01543087|101141798|FG001|STARTED|Stage 1 (48 Months)||103||
48332270|NCT01543087|101141799|FG002|STARTED|Stage 1 (48 Months)||277||
48332271|NCT01543087|101141800|FG003|STARTED|Stage 1 (48 Months)||116||
48169190|NCT03447730|100735912|FG000|COMPLETED|Overall Study||6|Completed all 6 days of TID dosing|
48169191|NCT03447730|100735913|FG001|COMPLETED|Overall Study||7|Completed all 6 days of TID dosing|
48169192|NCT03447730|100735914|FG002|COMPLETED|Overall Study||8|Completed all 6 days of TID dosing|
48169193|NCT03447730|100735912|FG000|NOT COMPLETED|Overall Study||0||
48169194|NCT03447730|100735913|FG001|NOT COMPLETED|Overall Study||2||
48169195|NCT03447730|100735914|FG002|NOT COMPLETED|Overall Study||0||
48169196|NCT01155661|100735915|FG000|STARTED|Overall Study||608||
48169197|NCT01155661|100735915|FG000|COMPLETED|Overall Study||328||
48169198|NCT01155661|100735915|FG000|NOT COMPLETED|Overall Study||280||
48169199|NCT00591123|100735916|FG000|STARTED|Overall Study||38||
48169200|NCT00591123|100735916|FG000|COMPLETED|Overall Study||38||
48169201|NCT00591123|100735916|FG000|NOT COMPLETED|Overall Study||0||
48169202|NCT02367716|100735917|FG000|STARTED|Overall Study||121||
48169203|NCT02367716|100735917|FG000|COMPLETED|Overall Study||120||
48169204|NCT02367716|100735917|FG000|NOT COMPLETED|Overall Study||1||
48169205|NCT02608905|100735918|FG000|STARTED|Overall Study||7||
48169206|NCT02608905|100735919|FG001|STARTED|Overall Study||10||
48169207|NCT02608905|100735918|FG000|COMPLETED|Overall Study||5||
48169208|NCT02608905|100735919|FG001|COMPLETED|Overall Study||10||
48169209|NCT02608905|100735918|FG000|NOT COMPLETED|Overall Study||2||
48169210|NCT02608905|100735919|FG001|NOT COMPLETED|Overall Study||0||
48169211|NCT04112940|100735920|FG000|STARTED|Overall Study||12||
48169212|NCT04112940|100735920|FG000|COMPLETED|Overall Study||12||
48169213|NCT04112940|100735920|FG000|NOT COMPLETED|Overall Study||0||
48169214|NCT01678820|100735921|FG000|STARTED|Overall Study||100||
48169215|NCT01678820|100735922|FG001|STARTED|Overall Study||99||
48169216|NCT01678820|100735923|FG002|STARTED|Overall Study||100||
48332272|NCT01543087|101141801|FG004|STARTED|Stage 1 (48 Months)||86||
48332273|NCT01543087|101141802|FG005|STARTED|Stage 1 (48 Months)||46||
48749239|NCT00271375|102173010|FG001|STARTED|Overall Study||83||
48749240|NCT00271375|102173011|FG002|STARTED|Overall Study||57||
48749241|NCT00271375|102173009|FG000|COMPLETED|Overall Study||114||
48749242|NCT00271375|102173010|FG001|COMPLETED|Overall Study||83||
48749243|NCT00271375|102173011|FG002|COMPLETED|Overall Study||57||
48749244|NCT00271375|102173009|FG000|NOT COMPLETED|Overall Study||0||
48749245|NCT00271375|102173010|FG001|NOT COMPLETED|Overall Study||0||
48749246|NCT00271375|102173011|FG002|NOT COMPLETED|Overall Study||0||
48749247|NCT05298202|102173012|FG000|STARTED|Overall Study||6||
48749248|NCT05298202|102173013|FG001|STARTED|Overall Study||6||
48749249|NCT05298202|102173012|FG000|COMPLETED|Overall Study||6||
48749250|NCT05298202|102173013|FG001|COMPLETED|Overall Study||6||
48749251|NCT05298202|102173012|FG000|NOT COMPLETED|Overall Study||0||
48749252|NCT05298202|102173013|FG001|NOT COMPLETED|Overall Study||0||
48188633|NCT02906683|100783293|FG002|NOT COMPLETED|Overall Study||3||
48411123|NCT00518336|101337812|FG001|STARTED|Year 9||213||
48411124|NCT00518336|101337811|FG000|COMPLETED|Year 9||219||
48411125|NCT00518336|101337812|FG001|COMPLETED|Year 9||212||
48411126|NCT00518336|101337811|FG000|NOT COMPLETED|Year 9||5||
48411127|NCT00518336|101337812|FG001|NOT COMPLETED|Year 9||1||
48626388|NCT01172873|101867698|FG000|STARTED|Overall Study||11||
48626389|NCT01172873|101867699|FG001|STARTED|Overall Study||5||
48626390|NCT01172873|101867698|FG000|COMPLETED|Overall Study||8||
48749253|NCT00614380|102173014|FG000|STARTED|Overall Study||564||
48749254|NCT00614380|102173015|FG001|STARTED|Overall Study||206||
48411128|NCT00802880|101337813|FG000|STARTED|Overall Study||80||
48411129|NCT00802880|101337813|FG000|COMPLETED|Overall Study||80||
48411130|NCT00802880|101337813|FG000|NOT COMPLETED|Overall Study||0||
48411131|NCT01700140|101337814|FG000|STARTED|Overall Study||61||
48411132|NCT01700140|101337815|FG001|STARTED|Overall Study||66||
48626391|NCT01172873|101867699|FG001|COMPLETED|Overall Study||3||
48626392|NCT01172873|101867698|FG000|NOT COMPLETED|Overall Study||3||
48626393|NCT01172873|101867699|FG001|NOT COMPLETED|Overall Study||2||
48626394|NCT03593200|101867700|FG000|STARTED|Overall Study||4||
48626395|NCT03593200|101867700|FG000|COMPLETED|Overall Study||4|All subjects transitioned to an open-label extension study after Day 364.|
48626396|NCT03593200|101867700|FG000|NOT COMPLETED|Overall Study||0||
48626397|NCT01576575|101867701|FG000|STARTED|Buprenorphine Control||21||
48626398|NCT01576575|101867701|FG000|COMPLETED|Buprenorphine Control||18||
48626399|NCT01576575|101867701|FG000|NOT COMPLETED|Buprenorphine Control||3||
48626400|NCT01576575|101867701|FG000|STARTED|Buprenorphine + Rifampin||18||
48749255|NCT00614380|102173016|FG002|STARTED|Overall Study||25||
48749256|NCT00614380|102173017|FG003|STARTED|Overall Study||181||
48749257|NCT00614380|102173014|FG000|COMPLETED|Overall Study||529||
48749258|NCT00614380|102173015|FG001|COMPLETED|Overall Study||198||
48749259|NCT00614380|102173016|FG002|COMPLETED|Overall Study||24||
48749260|NCT00614380|102173017|FG003|COMPLETED|Overall Study||179||
48749261|NCT00614380|102173014|FG000|NOT COMPLETED|Overall Study||35||
48749262|NCT00614380|102173015|FG001|NOT COMPLETED|Overall Study||8||
48749263|NCT00614380|102173016|FG002|NOT COMPLETED|Overall Study||1||
48749264|NCT00614380|102173017|FG003|NOT COMPLETED|Overall Study||2||
48749265|NCT00423657|102173018|FG000|STARTED|Overall Study||342||
48749266|NCT00423657|102173019|FG001|STARTED|Overall Study||338||
48411133|NCT01700140|101337816|FG002|STARTED|Overall Study||62||
48169217|NCT01678820|100735921|FG000|Treated With Double-blind Study Drug|Overall Study||100||
48169218|NCT01678820|100735922|FG001|Treated With Double-blind Study Drug|Overall Study||97||
48169219|NCT01678820|100735923|FG002|Treated With Double-blind Study Drug|Overall Study||98||
48169220|NCT01678820|100735921|FG000|COMPLETED|Overall Study||38||
48169221|NCT01678820|100735922|FG001|COMPLETED|Overall Study||36||
48169222|NCT01678820|100735923|FG002|COMPLETED|Overall Study||43||
48169223|NCT01678820|100735921|FG000|NOT COMPLETED|Overall Study||62||
48169224|NCT01678820|100735922|FG001|NOT COMPLETED|Overall Study||63||
48169225|NCT01678820|100735923|FG002|NOT COMPLETED|Overall Study||57||
48169226|NCT03239873|100735924|FG000|STARTED|Overall Study||300||
48169227|NCT03239873|100735925|FG001|STARTED|Overall Study||300||
48749267|NCT00423657|102173018|FG000|COMPLETED|Overall Study||316||
48749268|NCT00423657|102173019|FG001|COMPLETED|Overall Study||313||
48749269|NCT00423657|102173018|FG000|NOT COMPLETED|Overall Study||26||
48749270|NCT00423657|102173019|FG001|NOT COMPLETED|Overall Study||25||
48749271|NCT03367858|102173020|FG000|STARTED|Intervention + Baseline Scan||101||
48749272|NCT03367858|102173021|FG001|STARTED|Intervention + Baseline Scan||103||
48169228|NCT03239873|100735924|FG000|Vaccination 1|Overall Study||299||
48169229|NCT03239873|100735925|FG001|Vaccination 1|Overall Study||300||
48332274|NCT01543087|101141797|FG000|Safety Population|Stage 1 (48 Months)||70|Participants who had at least 1 blood draw in this study.|
48332275|NCT01543087|101141798|FG001|Safety Population|Stage 1 (48 Months)||101|Participants who had at least 1 blood draw in this study.|
48332276|NCT01543087|101141799|FG002|Safety Population|Stage 1 (48 Months)||277|Participants who had at least 1 blood draw in this study.|
48332277|NCT01543087|101141800|FG003|Safety Population|Stage 1 (48 Months)||116|Participants who had at least 1 blood draw in this study.|
48332278|NCT01543087|101141801|FG004|Safety Population|Stage 1 (48 Months)||86|Participants who had at least 1 blood draw in this study.|
48332279|NCT01543087|101141802|FG005|Safety Population|Stage 1 (48 Months)||46|Participants who had at least 1 blood draw in this study.|
48332280|NCT01543087|101141797|FG000|COMPLETED|Stage 1 (48 Months)||56||
48332281|NCT01543087|101141798|FG001|COMPLETED|Stage 1 (48 Months)||93||
48749273|NCT03367858|102173020|FG000|COMPLETED|Intervention + Baseline Scan||97||
48749274|NCT03367858|102173021|FG001|COMPLETED|Intervention + Baseline Scan||101||
48749275|NCT03367858|102173020|FG000|NOT COMPLETED|Intervention + Baseline Scan||4||
48169230|NCT03239873|100735924|FG000|Vaccination 2|Overall Study||276||
48169231|NCT03239873|100735925|FG001|Vaccination 2|Overall Study||282||
48169232|NCT03239873|100735924|FG000|COMPLETED|Overall Study||268||
48169233|NCT03239873|100735925|FG001|COMPLETED|Overall Study||273||
48169234|NCT03239873|100735924|FG000|NOT COMPLETED|Overall Study||32||
48169235|NCT03239873|100735925|FG001|NOT COMPLETED|Overall Study||27||
48169236|NCT02396537|100735926|FG000|STARTED|Overall Study||40||
48169237|NCT02396537|100735927|FG001|STARTED|Overall Study||37||
48169238|NCT02396537|100735926|FG000|COMPLETED|Overall Study||40||
48169239|NCT02396537|100735927|FG001|COMPLETED|Overall Study||36||
48169240|NCT02396537|100735926|FG000|NOT COMPLETED|Overall Study||0||
48169241|NCT02396537|100735927|FG001|NOT COMPLETED|Overall Study||1||
48169242|NCT05033080|100735928|FG000|STARTED|Overall Study||202||
48169243|NCT05033080|100735929|FG001|STARTED|Overall Study||196||
48169244|NCT05033080|100735928|FG000|Pooled Analysis Set|Overall Study||491|The Pooled full analysis set (PFAS) included all randomized participants from this study (VX20-121-102) and from Study VX20-121-103 who carry the intended CFTR genotype and received at least 1dose of study drug during the Treatment Period.|
48169245|NCT05033080|100735929|FG001|Pooled Analysis Set|Overall Study||480|The Pooled full analysis set (PFAS) included all randomized participants from this study (VX20-121-102) and from Study VX20-121-103 who carry the intended CFTR genotype and received at least 1dose of study drug during the Treatment Period.|
48169246|NCT05033080|100735928|FG000|COMPLETED|Overall Study||191||
48169247|NCT05033080|100735929|FG001|COMPLETED|Overall Study||184||
48169248|NCT05033080|100735928|FG000|NOT COMPLETED|Overall Study||11||
48169249|NCT05033080|100735929|FG001|NOT COMPLETED|Overall Study||12||
48169250|NCT04485130|100735930|FG000|STARTED|Overall Study||7||
48169251|NCT04485130|100735931|FG001|STARTED|Overall Study||4||
48169252|NCT04485130|100735932|FG002|STARTED|Overall Study||0||
48169253|NCT04485130|100735933|FG003|STARTED|Overall Study||0||
48169254|NCT04485130|100735930|FG000|COMPLETED|Overall Study||7||
48169255|NCT04485130|100735931|FG001|COMPLETED|Overall Study||4||
48169256|NCT04485130|100735932|FG002|COMPLETED|Overall Study||0||
48169257|NCT04485130|100735933|FG003|COMPLETED|Overall Study||0||
48332282|NCT01543087|101141799|FG002|COMPLETED|Stage 1 (48 Months)||237||
48749276|NCT03367858|102173021|FG001|NOT COMPLETED|Intervention + Baseline Scan||2||
48749277|NCT03367858|102173020|FG000|STARTED|3 Month Follow Up||97||
48749278|NCT03367858|102173021|FG001|STARTED|3 Month Follow Up||101||
48749279|NCT03367858|102173020|FG000|COMPLETED|3 Month Follow Up||81||
48749280|NCT03367858|102173021|FG001|COMPLETED|3 Month Follow Up||87||
48749281|NCT03367858|102173020|FG000|NOT COMPLETED|3 Month Follow Up||16||
48749282|NCT03367858|102173021|FG001|NOT COMPLETED|3 Month Follow Up||14||
48749283|NCT03367858|102173020|FG000|STARTED|6 Month Follow Up||81||
48749284|NCT03367858|102173021|FG001|STARTED|6 Month Follow Up||87||
48749285|NCT03367858|102173020|FG000|COMPLETED|6 Month Follow Up||76||
48749286|NCT03367858|102173021|FG001|COMPLETED|6 Month Follow Up||84||
48749287|NCT03367858|102173020|FG000|NOT COMPLETED|6 Month Follow Up||5||
48749288|NCT03367858|102173021|FG001|NOT COMPLETED|6 Month Follow Up||3||
48169258|NCT04485130|100735930|FG000|NOT COMPLETED|Overall Study||0||
48749289|NCT03367858|102173020|FG000|STARTED|12 Month Follow Up||81||
48749290|NCT03367858|102173021|FG001|STARTED|12 Month Follow Up||87||
48749291|NCT03367858|102173020|FG000|COMPLETED|12 Month Follow Up||78||
48332283|NCT01543087|101141800|FG003|COMPLETED|Stage 1 (48 Months)||108||
48332284|NCT01543087|101141801|FG004|COMPLETED|Stage 1 (48 Months)||83||
48332285|NCT01543087|101141802|FG005|COMPLETED|Stage 1 (48 Months)||46||
48332286|NCT01543087|101141797|FG000|NOT COMPLETED|Stage 1 (48 Months)||14||
48332287|NCT01543087|101141798|FG001|NOT COMPLETED|Stage 1 (48 Months)||10||
48332288|NCT01543087|101141799|FG002|NOT COMPLETED|Stage 1 (48 Months)||40||
48411134|NCT01700140|101337814|FG000|COMPLETED|Overall Study||55||
48411135|NCT01700140|101337815|FG001|COMPLETED|Overall Study||57||
48411136|NCT01700140|101337816|FG002|COMPLETED|Overall Study||61||
48411137|NCT01700140|101337814|FG000|NOT COMPLETED|Overall Study||6||
48749292|NCT03367858|102173021|FG001|COMPLETED|12 Month Follow Up||83||
48749293|NCT03367858|102173020|FG000|NOT COMPLETED|12 Month Follow Up||3||
48749294|NCT03367858|102173021|FG001|NOT COMPLETED|12 Month Follow Up||4||
48749295|NCT01173016|102173022|FG000|STARTED|Overall Study||11||
48749296|NCT01173016|102173022|FG000|COMPLETED|Overall Study||10||
48749297|NCT01173016|102173022|FG000|NOT COMPLETED|Overall Study||1||
48749298|NCT04552769|102173023|FG000|STARTED|Overall Study||9||
48749299|NCT04552769|102173023|FG000|COMPLETED|Overall Study||9||
48749300|NCT04552769|102173023|FG000|NOT COMPLETED|Overall Study||0||
48749301|NCT01092728|102173024|FG000|STARTED|Overall Study||4||
48749302|NCT01092728|102173025|FG001|STARTED|Overall Study||14||
48749303|NCT01092728|102173024|FG000|COMPLETED|Overall Study||0||
48749304|NCT01092728|102173025|FG001|COMPLETED|Overall Study||0||
48749305|NCT01092728|102173024|FG000|NOT COMPLETED|Overall Study||4||
48749306|NCT01092728|102173025|FG001|NOT COMPLETED|Overall Study||14||
48749307|NCT02469623|102173026|FG000|STARTED|Overall Study||85||
48749308|NCT02469623|102173026|FG000|COMPLETED|Overall Study||72||
48749309|NCT02469623|102173026|FG000|NOT COMPLETED|Overall Study||13||
48749310|NCT03431441|102173027|FG000|STARTED|Overall Study||24|24|
48749311|NCT03431441|102173027|FG000|COMPLETED|Overall Study||19|19|
48749312|NCT03431441|102173027|FG000|NOT COMPLETED|Overall Study||5||
48411138|NCT01700140|101337815|FG001|NOT COMPLETED|Overall Study||9||
48411139|NCT01700140|101337816|FG002|NOT COMPLETED|Overall Study||1||
48169259|NCT04485130|100735931|FG001|NOT COMPLETED|Overall Study||0||
48169260|NCT04485130|100735932|FG002|NOT COMPLETED|Overall Study||0||
48332289|NCT01543087|101141800|FG003|NOT COMPLETED|Stage 1 (48 Months)||8||
48332290|NCT01543087|101141801|FG004|NOT COMPLETED|Stage 1 (48 Months)||3||
48332291|NCT01543087|101141802|FG005|NOT COMPLETED|Stage 1 (48 Months)||0||
48332292|NCT01543087|101141797|FG000|STARTED|Booster Stage (26 Months)||0||
48332293|NCT01543087|101141798|FG001|STARTED|Booster Stage (26 Months)||60||
48411140|NCT00794469|101337817|FG000|STARTED|Overall Study||21||
48411141|NCT00794469|101337817|FG000|COMPLETED|Overall Study||21||
48411142|NCT00794469|101337817|FG000|NOT COMPLETED|Overall Study||0||
48411143|NCT03140488|101337818|FG000|STARTED|Overall Study||35||
48749313|NCT02230566|102173028|FG000|STARTED|Overall Study||3||
48749314|NCT02230566|102173029|FG001|STARTED|Overall Study||3||
48749315|NCT02230566|102173030|FG002|STARTED|Overall Study||3||
48749316|NCT02230566|102173031|FG003|STARTED|Overall Study||3||
48749317|NCT02230566|102173028|FG000|COMPLETED|Overall Study||3||
48749318|NCT02230566|102173029|FG001|COMPLETED|Overall Study||3||
48749319|NCT02230566|102173030|FG002|COMPLETED|Overall Study||3||
48749320|NCT02230566|102173031|FG003|COMPLETED|Overall Study||3||
48749321|NCT02230566|102173028|FG000|NOT COMPLETED|Overall Study||0||
48749322|NCT02230566|102173029|FG001|NOT COMPLETED|Overall Study||0||
48749323|NCT02230566|102173030|FG002|NOT COMPLETED|Overall Study||0||
48749324|NCT02230566|102173031|FG003|NOT COMPLETED|Overall Study||0||
48749325|NCT00088530|102173032|FG000|STARTED|Overall Study||70||
48749326|NCT00088530|102173033|FG001|STARTED|Overall Study||70||
48749327|NCT00088530|102173032|FG000|COMPLETED|Overall Study||20||
48749328|NCT00088530|102173033|FG001|COMPLETED|Overall Study||16||
48749329|NCT00088530|102173032|FG000|NOT COMPLETED|Overall Study||50||
48749330|NCT00088530|102173033|FG001|NOT COMPLETED|Overall Study||54||
48749331|NCT04683835|102173034|FG000|STARTED|Overall Study||80||
48749332|NCT04683835|102173034|FG000|COMPLETED|Overall Study||80||
48749333|NCT04683835|102173034|FG000|NOT COMPLETED|Overall Study||0||
48749334|NCT03936608|102173035|FG000|STARTED|Overall Study||2||
48749335|NCT03936608|102173036|FG001|STARTED|Overall Study||2||
48749336|NCT03936608|102173035|FG000|COMPLETED|Overall Study||0||
48749337|NCT03936608|102173036|FG001|COMPLETED|Overall Study||0||
48749338|NCT03936608|102173035|FG000|NOT COMPLETED|Overall Study||2||
48749339|NCT03936608|102173036|FG001|NOT COMPLETED|Overall Study||2||
48749340|NCT01875159|102173037|FG000|STARTED|Overall Study||45||
48749341|NCT01875159|102173038|FG001|STARTED|Overall Study||53||
48749342|NCT01875159|102173037|FG000|COMPLETED|Overall Study||42||
48749343|NCT01875159|102173038|FG001|COMPLETED|Overall Study||53||
48749344|NCT01875159|102173037|FG000|NOT COMPLETED|Overall Study||3||
48749345|NCT01875159|102173038|FG001|NOT COMPLETED|Overall Study||0||
48749346|NCT02986711|102173039|FG000|STARTED|Overall Study||78||
48749347|NCT02986711|102173040|FG001|STARTED|Overall Study||80||
48749348|NCT02986711|102173039|FG000|COMPLETED|Overall Study||70||
48749349|NCT02986711|102173040|FG001|COMPLETED|Overall Study||70||
48749350|NCT02986711|102173039|FG000|NOT COMPLETED|Overall Study||8||
48749351|NCT02986711|102173040|FG001|NOT COMPLETED|Overall Study||10||
48169261|NCT04485130|100735933|FG003|NOT COMPLETED|Overall Study||0||
48169262|NCT00735644|100735934|FG000|STARTED|Overall Study||303||
48169263|NCT00735644|100735935|FG001|STARTED|Overall Study||300||
48169264|NCT00735644|100735936|FG002|STARTED|Overall Study||296||
48169265|NCT00735644|100735937|FG003|STARTED|Overall Study||199||
48169266|NCT00735644|100735938|FG004|STARTED|Overall Study||102||
48169267|NCT00735644|100735934|FG000|COMPLETED|Overall Study||303||
48169268|NCT00735644|100735935|FG001|COMPLETED|Overall Study||298||
48169269|NCT00735644|100735936|FG002|COMPLETED|Overall Study||295||
48169270|NCT00735644|100735937|FG003|COMPLETED|Overall Study||198||
48169271|NCT00735644|100735938|FG004|COMPLETED|Overall Study||102||
48169272|NCT00735644|100735934|FG000|NOT COMPLETED|Overall Study||0||
48169273|NCT00735644|100735935|FG001|NOT COMPLETED|Overall Study||2||
48169274|NCT00735644|100735936|FG002|NOT COMPLETED|Overall Study||1||
48169275|NCT00735644|100735937|FG003|NOT COMPLETED|Overall Study||1||
48169276|NCT00735644|100735938|FG004|NOT COMPLETED|Overall Study||0||
48169277|NCT03331185|100735939|FG000|STARTED|Overall Study||14||
48169278|NCT03331185|100735940|FG001|STARTED|Overall Study||12||
48169279|NCT03331185|100735939|FG000|COMPLETED|Overall Study||14||
48169280|NCT03331185|100735940|FG001|COMPLETED|Overall Study||12||
48332294|NCT01543087|101141799|FG002|STARTED|Booster Stage (26 Months)||92||
48332295|NCT01543087|101141800|FG003|STARTED|Booster Stage (26 Months)||64||
48332296|NCT01543087|101141801|FG004|STARTED|Booster Stage (26 Months)||56||
48332297|NCT01543087|101141802|FG005|STARTED|Booster Stage (26 Months)||32||
48332298|NCT01543087|101141797|FG000|Vaccinated|Booster Stage (26 Months)||0||
48332299|NCT01543087|101141798|FG001|Vaccinated|Booster Stage (26 Months)||59||
48332300|NCT01543087|101141799|FG002|Vaccinated|Booster Stage (26 Months)||92||
48332301|NCT01543087|101141800|FG003|Vaccinated|Booster Stage (26 Months)||64||
48332302|NCT01543087|101141801|FG004|Vaccinated|Booster Stage (26 Months)||54||
48332303|NCT01543087|101141802|FG005|Vaccinated|Booster Stage (26 Months)||32||
48332304|NCT01543087|101141797|FG000|COMPLETED|Booster Stage (26 Months)||0||
48332305|NCT01543087|101141798|FG001|COMPLETED|Booster Stage (26 Months)||59||
48411144|NCT03140488|101337819|FG001|STARTED|Overall Study||35||
48411145|NCT03140488|101337820|FG002|STARTED|Overall Study||35||
48749352|NCT00226590|102173041|FG000|STARTED|Overall Study||39||
48169281|NCT03331185|100735939|FG000|NOT COMPLETED|Overall Study||0||
48169282|NCT03331185|100735940|FG001|NOT COMPLETED|Overall Study||0||
48169283|NCT04229030|100739087|FG000|STARTED|Overall Study||20||125
48169284|NCT04229030|100739088|FG001|STARTED|Overall Study||18||109
48169285|NCT04229030|100739087|FG000|COMPLETED|Overall Study||20||125
48169286|NCT04229030|100739088|FG001|COMPLETED|Overall Study||18||109
48169287|NCT04229030|100739087|FG000|NOT COMPLETED|Overall Study||0||0
48169288|NCT04229030|100739088|FG001|NOT COMPLETED|Overall Study||0||0
48169289|NCT00299195|100739089|FG000|STARTED|Overall Study||30||
48169290|NCT00299195|100739090|FG001|STARTED|Overall Study||33||
48169291|NCT00299195|100739089|FG000|COMPLETED|Overall Study||30||
48169292|NCT00299195|100739090|FG001|COMPLETED|Overall Study||33||
48332306|NCT01543087|101141799|FG002|COMPLETED|Booster Stage (26 Months)||91||
48332307|NCT01543087|101141800|FG003|COMPLETED|Booster Stage (26 Months)||64||
48332308|NCT01543087|101141801|FG004|COMPLETED|Booster Stage (26 Months)||54||
48411146|NCT03140488|101337821|FG003|STARTED|Overall Study||35||
48411147|NCT03140488|101337818|FG000|COMPLETED|Overall Study||35||
48749353|NCT00226590|102173041|FG000|COMPLETED|Overall Study||39||
48749354|NCT00226590|102173041|FG000|NOT COMPLETED|Overall Study||0||
48749355|NCT04612725|102173042|FG000|STARTED|Overall Study||30||
48749356|NCT04612725|102173043|FG001|STARTED|Overall Study||29||
48749357|NCT04612725|102173044|FG002|STARTED|Overall Study||28||
48749358|NCT04612725|102173045|FG003|STARTED|Overall Study||28||
48749359|NCT04612725|102173046|FG004|STARTED|Overall Study||40||
48169293|NCT00299195|100739089|FG000|NOT COMPLETED|Overall Study||0||
48169294|NCT00299195|100739090|FG001|NOT COMPLETED|Overall Study||0||
48169295|NCT01045122|100739091|FG000|STARTED|Dexmedetomidine Then Propofol||5||
48169296|NCT01045122|100739092|FG001|STARTED|Dexmedetomidine Then Propofol||6||
48169297|NCT01045122|100739091|FG000|COMPLETED|Dexmedetomidine Then Propofol||5||
48169298|NCT01045122|100739092|FG001|COMPLETED|Dexmedetomidine Then Propofol||6||
48169299|NCT01045122|100739091|FG000|NOT COMPLETED|Dexmedetomidine Then Propofol||0||
48169300|NCT01045122|100739092|FG001|NOT COMPLETED|Dexmedetomidine Then Propofol||0||
48169301|NCT01045122|100739091|FG000|STARTED|Propofol Then Dexmedetomidine||5||
48169302|NCT01045122|100739092|FG001|STARTED|Propofol Then Dexmedetomidine||6||
48188634|NCT05257837|100783294|FG000|STARTED|Overall Study||58||
48332309|NCT01543087|101141802|FG005|COMPLETED|Booster Stage (26 Months)||32||
48332310|NCT01543087|101141797|FG000|NOT COMPLETED|Booster Stage (26 Months)||0||
48332311|NCT01543087|101141798|FG001|NOT COMPLETED|Booster Stage (26 Months)||1||
48332312|NCT01543087|101141799|FG002|NOT COMPLETED|Booster Stage (26 Months)||1||
48332313|NCT01543087|101141800|FG003|NOT COMPLETED|Booster Stage (26 Months)||0||
48332314|NCT01543087|101141801|FG004|NOT COMPLETED|Booster Stage (26 Months)||2||
48332315|NCT01543087|101141802|FG005|NOT COMPLETED|Booster Stage (26 Months)||0||
48332316|NCT02450487|101141803|FG000|STARTED|Overall Study||105||
48332317|NCT02450487|101141803|FG000|COMPLETED|Overall Study||102||
48332318|NCT02450487|101141803|FG000|NOT COMPLETED|Overall Study||3||
48332319|NCT00523991|101141804|FG000|STARTED|Overall Study||219||
48332320|NCT00523991|101141805|FG001|STARTED|Overall Study||238||
48332321|NCT00523991|101141804|FG000|COMPLETED|Overall Study||198||
48332322|NCT00523991|101141805|FG001|COMPLETED|Overall Study||211||
48332323|NCT00523991|101141804|FG000|NOT COMPLETED|Overall Study||21||
48332324|NCT00523991|101141805|FG001|NOT COMPLETED|Overall Study||27||
48332325|NCT03245450|101141806|FG000|STARTED|Overall Study||3||
48332326|NCT03245450|101141807|FG001|STARTED|Overall Study||4||
48626401|NCT01576575|101867701|FG000|COMPLETED|Buprenorphine + Rifampin||15||
48626402|NCT01576575|101867701|FG000|NOT COMPLETED|Buprenorphine + Rifampin||3||
48626403|NCT01576575|101867701|FG000|STARTED|Buprenorphine + Grapefruit||15||
48626404|NCT01576575|101867701|FG000|COMPLETED|Buprenorphine + Grapefruit||14||
48626405|NCT01576575|101867701|FG000|NOT COMPLETED|Buprenorphine + Grapefruit||1||
48626406|NCT01576575|101867701|FG000|STARTED|Buprenorphine + Ketoconazole||14||
48626407|NCT01576575|101867701|FG000|COMPLETED|Buprenorphine + Ketoconazole||14||
48626408|NCT01576575|101867701|FG000|NOT COMPLETED|Buprenorphine + Ketoconazole||0||
48626409|NCT04195594|101867702|FG000|STARTED|Overall Study||14||
48626410|NCT04195594|101867702|FG000|COMPLETED|Overall Study||11||
48626411|NCT04195594|101867702|FG000|NOT COMPLETED|Overall Study||3||
48626412|NCT01053156|101867703|FG000|STARTED|First Intervention (Week 1-12)||33||
48626413|NCT01053156|101867704|FG001|STARTED|First Intervention (Week 1-12)||33||
48626414|NCT01053156|101867703|FG000|COMPLETED|First Intervention (Week 1-12)||28||
48626415|NCT01053156|101867704|FG001|COMPLETED|First Intervention (Week 1-12)||27||
48626416|NCT01053156|101867703|FG000|NOT COMPLETED|First Intervention (Week 1-12)||5||
48626417|NCT01053156|101867704|FG001|NOT COMPLETED|First Intervention (Week 1-12)||6||
48626418|NCT01053156|101867703|FG000|STARTED|Second Intervention (Week 13-24)||28||
48626419|NCT01053156|101867704|FG001|STARTED|Second Intervention (Week 13-24)||27||
48626420|NCT01053156|101867703|FG000|COMPLETED|Second Intervention (Week 13-24)||26||
48626421|NCT01053156|101867704|FG001|COMPLETED|Second Intervention (Week 13-24)||22||
48626422|NCT01053156|101867703|FG000|NOT COMPLETED|Second Intervention (Week 13-24)||2||
48626423|NCT01053156|101867704|FG001|NOT COMPLETED|Second Intervention (Week 13-24)||5||
48626424|NCT02343224|101870815|FG000|STARTED|Overall Study||9||
48626425|NCT02343224|101870815|FG000|COMPLETED|Overall Study||0||
48626426|NCT02343224|101870815|FG000|NOT COMPLETED|Overall Study||9||
48626427|NCT00073918|101870816|FG000|STARTED|Overall Study||111||
48626428|NCT00073918|101870816|FG000|COMPLETED|Overall Study||107||
48626429|NCT00073918|101870816|FG000|NOT COMPLETED|Overall Study||4||
48626430|NCT01746862|101870817|FG000|STARTED|Overall Study||60||
48626431|NCT01746862|101870818|FG001|STARTED|Overall Study||30||
48626432|NCT01746862|101870817|FG000|Treated|Overall Study||59||
48626433|NCT01746862|101870818|FG001|Treated|Overall Study||30||
48626434|NCT01746862|101870817|FG000|COMPLETED|Overall Study||52||
48626435|NCT01746862|101870818|FG001|COMPLETED|Overall Study||27||
48626436|NCT01746862|101870817|FG000|NOT COMPLETED|Overall Study||8||
48332327|NCT03245450|101141808|FG002|STARTED|Overall Study||3||
48332328|NCT03245450|101141809|FG003|STARTED|Overall Study||3||
48332329|NCT03245450|101141810|FG004|STARTED|Overall Study||9||
48332330|NCT03245450|101141811|FG005|STARTED|Overall Study||9||
48332331|NCT03245450|101141812|FG006|STARTED|Overall Study||9||
48332332|NCT03245450|101141806|FG000|COMPLETED|Overall Study||0||
48332333|NCT03245450|101141807|FG001|COMPLETED|Overall Study||0||
48332334|NCT03245450|101141808|FG002|COMPLETED|Overall Study||0||
48332335|NCT03245450|101141809|FG003|COMPLETED|Overall Study||0||
48332336|NCT03245450|101141810|FG004|COMPLETED|Overall Study||0||
48332337|NCT03245450|101141811|FG005|COMPLETED|Overall Study||0||
48332338|NCT03245450|101141812|FG006|COMPLETED|Overall Study||0||
48332339|NCT03245450|101141806|FG000|NOT COMPLETED|Overall Study||3||
48332340|NCT03245450|101141807|FG001|NOT COMPLETED|Overall Study||4||
48332341|NCT03245450|101141808|FG002|NOT COMPLETED|Overall Study||3||
48332342|NCT03245450|101141809|FG003|NOT COMPLETED|Overall Study||3||
48332343|NCT03245450|101141810|FG004|NOT COMPLETED|Overall Study||9||
48332344|NCT03245450|101141811|FG005|NOT COMPLETED|Overall Study||9||
48626437|NCT01746862|101870818|FG001|NOT COMPLETED|Overall Study||3||
48626438|NCT02869789|101870819|FG000|STARTED|Overall Study||391||
48626439|NCT02869789|101870820|FG001|STARTED|Overall Study||198||
48626440|NCT02869789|101870821|FG002|STARTED|Overall Study||395||
48626441|NCT02869789|101870822|FG003|STARTED|Overall Study||57||
48626442|NCT02869789|101870819|FG000|COMPLETED|Overall Study||56||
48626443|NCT02869789|101870820|FG001|COMPLETED|Overall Study||16||
48626444|NCT02869789|101870821|FG002|COMPLETED|Overall Study||30||
48626445|NCT02869789|101870822|FG003|COMPLETED|Overall Study||12||
48332345|NCT03245450|101141812|FG006|NOT COMPLETED|Overall Study||9||
48332346|NCT01995071|101141813|FG000|STARTED|Overall Study||8|The safety population: all participants who received at least 1 dose of any study drug.|
48332347|NCT01995071|101141814|FG001|STARTED|Overall Study||8|The safety population: all participants who received at least 1 dose of any study drug.|
48626446|NCT02869789|101870819|FG000|NOT COMPLETED|Overall Study||335||
48626447|NCT02869789|101870820|FG001|NOT COMPLETED|Overall Study||182||
48332348|NCT01995071|101141815|FG002|STARTED|Overall Study||9|The safety population: all participants who received at least 1 dose of any study drug.|
48332349|NCT01995071|101141816|FG003|STARTED|Overall Study||8|The safety population: all participants who received at least 1 dose of any study drug.|
48332350|NCT01995071|101141817|FG004|STARTED|Overall Study||8|The safety population: all participants who received at least 1 dose of any study drug.|
48332351|NCT01995071|101141818|FG005|STARTED|Overall Study||8|The safety population: all participants who received at least 1 dose of any study drug.|
48332352|NCT01995071|101141819|FG006|STARTED|Overall Study||8|The safety population: all participants who received at least 1 dose of any study drug.|
48332353|NCT01995071|101141820|FG007|STARTED|Overall Study||8|The safety population: all participants who received at least 1 dose of any study drug.|
48332354|NCT01995071|101141821|FG008|STARTED|Overall Study||8|The safety population: all participants who received at least 1 dose of any study drug.|
48332355|NCT01995071|101141822|FG009|STARTED|Overall Study||8|The safety population: all participants who received at least 1 dose of any study drug.|
48332356|NCT01995071|101141823|FG010|STARTED|Overall Study||8|The safety population: all participants who received at least 1 dose of any study drug.|
48332357|NCT01995071|101141824|FG011|STARTED|Overall Study||0|The safety population: all participants who received at least 1 dose of any study drug.|
48332358|NCT01995071|101141813|FG000|COMPLETED|Overall Study||7||
48332359|NCT01995071|101141814|FG001|COMPLETED|Overall Study||8||
48332360|NCT01995071|101141815|FG002|COMPLETED|Overall Study||8||
48332361|NCT01995071|101141816|FG003|COMPLETED|Overall Study||8||
48332362|NCT01995071|101141817|FG004|COMPLETED|Overall Study||7||
48332363|NCT01995071|101141818|FG005|COMPLETED|Overall Study||8||
48332364|NCT01995071|101141819|FG006|COMPLETED|Overall Study||7||
48332365|NCT01995071|101141820|FG007|COMPLETED|Overall Study||6||
48332366|NCT01995071|101141821|FG008|COMPLETED|Overall Study||7||
48332367|NCT01995071|101141822|FG009|COMPLETED|Overall Study||8||
48332368|NCT01995071|101141823|FG010|COMPLETED|Overall Study||7||
48332369|NCT01995071|101141824|FG011|COMPLETED|Overall Study||0||
48332370|NCT01995071|101141813|FG000|NOT COMPLETED|Overall Study||1||
48332371|NCT01995071|101141814|FG001|NOT COMPLETED|Overall Study||0||
48332372|NCT01995071|101141815|FG002|NOT COMPLETED|Overall Study||1||
48332373|NCT01995071|101141816|FG003|NOT COMPLETED|Overall Study||0||
48332374|NCT01995071|101141817|FG004|NOT COMPLETED|Overall Study||1||
48332375|NCT01995071|101141818|FG005|NOT COMPLETED|Overall Study||0||
48332376|NCT01995071|101141819|FG006|NOT COMPLETED|Overall Study||1||
48332377|NCT01995071|101141820|FG007|NOT COMPLETED|Overall Study||2||
48411148|NCT03140488|101337819|FG001|COMPLETED|Overall Study||35||
48411149|NCT03140488|101337820|FG002|COMPLETED|Overall Study||35||
48411150|NCT03140488|101337821|FG003|COMPLETED|Overall Study||35||
48411151|NCT03140488|101337818|FG000|NOT COMPLETED|Overall Study||0||
48411152|NCT03140488|101337819|FG001|NOT COMPLETED|Overall Study||0||
48626448|NCT02869789|101870821|FG002|NOT COMPLETED|Overall Study||365||
48332378|NCT01995071|101141821|FG008|NOT COMPLETED|Overall Study||1||
48332379|NCT01995071|101141822|FG009|NOT COMPLETED|Overall Study||0||
48332380|NCT01995071|101141823|FG010|NOT COMPLETED|Overall Study||1||
48332381|NCT01995071|101141824|FG011|NOT COMPLETED|Overall Study||0||
48411153|NCT03140488|101337820|FG002|NOT COMPLETED|Overall Study||0||
48411154|NCT03140488|101337821|FG003|NOT COMPLETED|Overall Study||0||
48626449|NCT02869789|101870822|FG003|NOT COMPLETED|Overall Study||45||
48626450|NCT01290718|101870823|FG000|STARTED|Overall Study||4||
48626451|NCT01290718|101870823|FG000|COMPLETED|Overall Study||0||
48626452|NCT01290718|101870823|FG000|NOT COMPLETED|Overall Study||4||
48626453|NCT02121210|101870824|FG000|STARTED|Overall Study||65||
48626454|NCT02121210|101870825|FG001|STARTED|Overall Study||67||
48332382|NCT00391222|101141825|FG000|STARTED|Period II (Open-label Risperidone LAI)||0||
48332383|NCT00391222|101141826|FG001|STARTED|Period II (Open-label Risperidone LAI)||0||
48332384|NCT00391222|101141827|FG002|STARTED|Period II (Open-label Risperidone LAI)||0||
48332385|NCT00391222|101141828|FG003|STARTED|Period II (Open-label Risperidone LAI)||560||
48332386|NCT00391222|101141825|FG000|COMPLETED|Period II (Open-label Risperidone LAI)||0||
48411155|NCT00369928|101337822|FG000|STARTED|Overall Study||85||
48411156|NCT00369928|101337823|FG001|STARTED|Overall Study||85||
48411157|NCT00369928|101337824|FG002|STARTED|Overall Study||86||
48411158|NCT00369928|101337822|FG000|COMPLETED|Overall Study||77||
48626455|NCT02121210|101870824|FG000|COMPLETED|Overall Study||58||
48626456|NCT02121210|101870825|FG001|COMPLETED|Overall Study||58||
48626457|NCT02121210|101870824|FG000|NOT COMPLETED|Overall Study||7||
48626458|NCT02121210|101870825|FG001|NOT COMPLETED|Overall Study||9||
48626459|NCT02668640|101870826|FG000|STARTED|Overall Study||55||
48332387|NCT00391222|101141826|FG001|COMPLETED|Period II (Open-label Risperidone LAI)||0||
48332388|NCT00391222|101141827|FG002|COMPLETED|Period II (Open-label Risperidone LAI)||0||
48332389|NCT00391222|101141828|FG003|COMPLETED|Period II (Open-label Risperidone LAI)||398||
48332390|NCT00391222|101141825|FG000|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0||
48332391|NCT00391222|101141826|FG001|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0||
48332392|NCT00391222|101141827|FG002|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0||
48332393|NCT00391222|101141828|FG003|NOT COMPLETED|Period II (Open-label Risperidone LAI)||162||
48332394|NCT00391222|101141825|FG000|STARTED|Period III (Double-Blind Treatment)||132||
48332395|NCT00391222|101141826|FG001|STARTED|Period III (Double-Blind Treatment)||135||
48332396|NCT00391222|101141827|FG002|STARTED|Period III (Double-Blind Treatment)||131||
48332397|NCT00391222|101141828|FG003|STARTED|Period III (Double-Blind Treatment)||0||
48332398|NCT00391222|101141825|FG000|COMPLETED|Period III (Double-Blind Treatment)||104||
48332399|NCT00391222|101141826|FG001|COMPLETED|Period III (Double-Blind Treatment)||113||
48332400|NCT00391222|101141827|FG002|COMPLETED|Period III (Double-Blind Treatment)||108||
48332401|NCT00391222|101141828|FG003|COMPLETED|Period III (Double-Blind Treatment)||0||
48332402|NCT00391222|101141825|FG000|NOT COMPLETED|Period III (Double-Blind Treatment)||28||
48332403|NCT00391222|101141826|FG001|NOT COMPLETED|Period III (Double-Blind Treatment)||22||
48332404|NCT00391222|101141827|FG002|NOT COMPLETED|Period III (Double-Blind Treatment)||23||
48332405|NCT00391222|101141828|FG003|NOT COMPLETED|Period III (Double-Blind Treatment)||0||
48332406|NCT01162421|101141829|FG000|STARTED|Overall Study||37||
48332407|NCT01162421|101141830|FG001|STARTED|Overall Study||40||
48332408|NCT01162421|101141829|FG000|COMPLETED|Overall Study||29||
48332409|NCT01162421|101141830|FG001|COMPLETED|Overall Study||27||
48332410|NCT01162421|101141829|FG000|NOT COMPLETED|Overall Study||8||
48332411|NCT01162421|101141830|FG001|NOT COMPLETED|Overall Study||13||
48626460|NCT02668640|101870826|FG000|COMPLETED|Overall Study||41||
48332412|NCT01441570|101141831|FG000|STARTED|Overall Study||6||
48332413|NCT01441570|101141832|FG001|STARTED|Overall Study||5||
48332414|NCT01441570|101141831|FG000|COMPLETED|Overall Study||6||
48332415|NCT01441570|101141832|FG001|COMPLETED|Overall Study||5||
48332416|NCT01441570|101141831|FG000|NOT COMPLETED|Overall Study||0||
48332417|NCT01441570|101141832|FG001|NOT COMPLETED|Overall Study||0||
48332418|NCT02154087|101141833|FG000|STARTED|Overall Study||1||
48332419|NCT02154087|101141833|FG000|COMPLETED|Overall Study||0||
48332420|NCT02154087|101141833|FG000|NOT COMPLETED|Overall Study||1||
48332421|NCT01046877|101141834|FG000|STARTED|Overall Study||25||
48332422|NCT01046877|101141834|FG000|Completed on Schedule|Overall Study||6||
48332423|NCT01046877|101141834|FG000|Completed Study Late|Overall Study||1||
48332424|NCT01046877|101141834|FG000|COMPLETED|Overall Study||7||
48332425|NCT01046877|101141834|FG000|NOT COMPLETED|Overall Study||18||
48332426|NCT01847885|101141835|FG000|STARTED|Initial Enrollment (Consented)||88||
48332427|NCT01847885|101141836|FG001|STARTED|Initial Enrollment (Consented)||0||
48332428|NCT01847885|101141837|FG002|STARTED|Initial Enrollment (Consented)||0||
48332429|NCT01847885|101141835|FG000|Randomized|Initial Enrollment (Consented)||46|Subjects who signed a consent form, met all eligibility criteria, and were randomized.|
48332430|NCT01847885|101141836|FG001|Randomized|Initial Enrollment (Consented)||0|Subjects who signed a consent form, met all eligibility criteria, and were randomized.|
48332431|NCT01847885|101141837|FG002|Randomized|Initial Enrollment (Consented)||0|Subjects who signed a consent form, met all eligibility criteria, and were randomized.|
48332432|NCT01847885|101141835|FG000|Full Analysis Set|Initial Enrollment (Consented)||43|Subjects who were consented, randomized, and met all eligibility criteria prior to lead placement|
48332433|NCT01847885|101141836|FG001|Full Analysis Set|Initial Enrollment (Consented)||0|Subjects who were consented, randomized, and met all eligibility criteria prior to lead placement|
48332434|NCT01847885|101141837|FG002|Full Analysis Set|Initial Enrollment (Consented)||0|Subjects who were consented, randomized, and met all eligibility criteria prior to lead placement|
48332435|NCT01847885|101141835|FG000|Safety Set|Initial Enrollment (Consented)||41|Subjects who received a Lead.|
48332436|NCT01847885|101141836|FG001|Safety Set|Initial Enrollment (Consented)||0|Subjects who received a Lead.|
48332437|NCT01847885|101141837|FG002|Safety Set|Initial Enrollment (Consented)||0|Subjects who received a Lead.|
48332438|NCT01847885|101141835|FG000|Per Protocol Set|Initial Enrollment (Consented)||40|Subjects who received a Lead, had enough scores in the diary, and met eligibility through treatment.|
48332439|NCT01847885|101141836|FG001|Per Protocol Set|Initial Enrollment (Consented)||0|Subjects who received a Lead, had enough scores in the diary, and met eligibility through treatment.|
48332440|NCT01847885|101141837|FG002|Per Protocol Set|Initial Enrollment (Consented)||0|Subjects who received a Lead, had enough scores in the diary, and met eligibility through treatment.|
48332441|NCT01847885|101141835|FG000|COMPLETED|Initial Enrollment (Consented)||40||
48332442|NCT01847885|101141836|FG001|COMPLETED|Initial Enrollment (Consented)||0||
48332443|NCT01847885|101141837|FG002|COMPLETED|Initial Enrollment (Consented)||0||
48332444|NCT01847885|101141835|FG000|NOT COMPLETED|Initial Enrollment (Consented)||48||
48332445|NCT01847885|101141836|FG001|NOT COMPLETED|Initial Enrollment (Consented)||0||
48332446|NCT01847885|101141837|FG002|NOT COMPLETED|Initial Enrollment (Consented)||0||
48332447|NCT01847885|101141835|FG000|STARTED|Randomization||0||
48332448|NCT01847885|101141836|FG001|STARTED|Randomization||31||
48332449|NCT01847885|101141837|FG002|STARTED|Randomization||15||
48626461|NCT02668640|101870826|FG000|NOT COMPLETED|Overall Study||14||
48626462|NCT02351934|101870827|FG000|STARTED|Allocation||62||
48626463|NCT02351934|101870828|FG001|STARTED|Allocation||61||
48411159|NCT00369928|101337823|FG001|COMPLETED|Overall Study||69||
48411160|NCT00369928|101337824|FG002|COMPLETED|Overall Study||66||
48411161|NCT00369928|101337822|FG000|NOT COMPLETED|Overall Study||8||
48411162|NCT00369928|101337823|FG001|NOT COMPLETED|Overall Study||16||
48411163|NCT00369928|101337824|FG002|NOT COMPLETED|Overall Study||20||
48411164|NCT01166386|101337825|FG000|STARTED|Overall Study||82||
48411165|NCT01166386|101337826|FG001|STARTED|Overall Study||83||
48411166|NCT01166386|101337825|FG000|COMPLETED|Overall Study||79||
48411167|NCT01166386|101337826|FG001|COMPLETED|Overall Study||78||
48411168|NCT01166386|101337825|FG000|NOT COMPLETED|Overall Study||3||
48411169|NCT01166386|101337826|FG001|NOT COMPLETED|Overall Study||5||
48411170|NCT01572480|101337827|FG000|STARTED|Participants Enrolled||55||
48749360|NCT04612725|102173042|FG000|Completed the Treatment Period|Overall Study||26||
48749361|NCT04612725|102173043|FG001|Completed the Treatment Period|Overall Study||27||
48749362|NCT04612725|102173044|FG002|Completed the Treatment Period|Overall Study||25||
48749363|NCT04612725|102173045|FG003|Completed the Treatment Period|Overall Study||28||
48749364|NCT04612725|102173046|FG004|Completed the Treatment Period|Overall Study||37||
48749365|NCT04612725|102173042|FG000|Entered Extension Period|Overall Study||24||
48749366|NCT04612725|102173043|FG001|Entered Extension Period|Overall Study||26||
48749367|NCT04612725|102173044|FG002|Entered Extension Period|Overall Study||25||
48749368|NCT04612725|102173045|FG003|Entered Extension Period|Overall Study||28||
48749369|NCT04612725|102173046|FG004|Entered Extension Period|Overall Study||37||
48749370|NCT04612725|102173042|FG000|COMPLETED|Overall Study||16||
48749371|NCT04612725|102173043|FG001|COMPLETED|Overall Study||21||
48749372|NCT04612725|102173044|FG002|COMPLETED|Overall Study||20||
48749373|NCT04612725|102173045|FG003|COMPLETED|Overall Study||23||
48749374|NCT04612725|102173046|FG004|COMPLETED|Overall Study||24||
48749375|NCT04612725|102173042|FG000|NOT COMPLETED|Overall Study||14||
48749376|NCT04612725|102173043|FG001|NOT COMPLETED|Overall Study||8||
48749377|NCT04612725|102173044|FG002|NOT COMPLETED|Overall Study||8||
48749378|NCT04612725|102173045|FG003|NOT COMPLETED|Overall Study||5||
48749379|NCT04612725|102173046|FG004|NOT COMPLETED|Overall Study||16||
48749380|NCT04456634|102173047|FG000|STARTED|Overall Study||6||
48749381|NCT04456634|102173048|FG001|STARTED|Overall Study||2||
48749382|NCT04456634|102173047|FG000|COMPLETED|Overall Study||5||
48749383|NCT04456634|102173048|FG001|COMPLETED|Overall Study||2||
48749384|NCT04456634|102173047|FG000|NOT COMPLETED|Overall Study||1||
48749385|NCT04456634|102173048|FG001|NOT COMPLETED|Overall Study||0||
48749386|NCT04076540|102173049|FG000|STARTED|Cohort 1: Dose Level X||2|8|
48749387|NCT04076540|102173050|FG001|STARTED|Cohort 1: Dose Level X||6|8|
48749388|NCT04076540|102173051|FG002|STARTED|Cohort 1: Dose Level X||0|8|
48749389|NCT04076540|102173052|FG003|STARTED|Cohort 1: Dose Level X||0|8|
48749390|NCT04076540|102173053|FG004|STARTED|Cohort 1: Dose Level X||0|8|
48749391|NCT04076540|102173054|FG005|STARTED|Cohort 1: Dose Level X||0|8|
48749392|NCT04076540|102173055|FG006|STARTED|Cohort 1: Dose Level X||0|8|
48749393|NCT04076540|102173049|FG000|COMPLETED|Cohort 1: Dose Level X||2|8|
48749394|NCT04076540|102173050|FG001|COMPLETED|Cohort 1: Dose Level X||6|8|
48749395|NCT04076540|102173051|FG002|COMPLETED|Cohort 1: Dose Level X||0|8|
48749396|NCT04076540|102173052|FG003|COMPLETED|Cohort 1: Dose Level X||0|8|
48749397|NCT04076540|102173053|FG004|COMPLETED|Cohort 1: Dose Level X||0|8|
48749398|NCT04076540|102173054|FG005|COMPLETED|Cohort 1: Dose Level X||0|8|
48749399|NCT04076540|102173055|FG006|COMPLETED|Cohort 1: Dose Level X||0|8|
48749400|NCT04076540|102173049|FG000|NOT COMPLETED|Cohort 1: Dose Level X||0||
48749401|NCT04076540|102173050|FG001|NOT COMPLETED|Cohort 1: Dose Level X||0||
48749402|NCT04076540|102173051|FG002|NOT COMPLETED|Cohort 1: Dose Level X||0||
48749403|NCT04076540|102173052|FG003|NOT COMPLETED|Cohort 1: Dose Level X||0||
48749404|NCT04076540|102173053|FG004|NOT COMPLETED|Cohort 1: Dose Level X||0||
48749405|NCT04076540|102173054|FG005|NOT COMPLETED|Cohort 1: Dose Level X||0||
48749406|NCT04076540|102173055|FG006|NOT COMPLETED|Cohort 1: Dose Level X||0||
48749407|NCT04076540|102173049|FG000|STARTED|Cohort 2: Dose Level 3X||2|8|
48749408|NCT04076540|102173050|FG001|STARTED|Cohort 2: Dose Level 3X||0|8|
48749409|NCT04076540|102173051|FG002|STARTED|Cohort 2: Dose Level 3X||6|8|
48749410|NCT04076540|102173052|FG003|STARTED|Cohort 2: Dose Level 3X||0|8|
48749411|NCT04076540|102173053|FG004|STARTED|Cohort 2: Dose Level 3X||0|8|
48749412|NCT04076540|102173054|FG005|STARTED|Cohort 2: Dose Level 3X||0|8|
48749413|NCT04076540|102173055|FG006|STARTED|Cohort 2: Dose Level 3X||0|8|
48749414|NCT04076540|102173049|FG000|COMPLETED|Cohort 2: Dose Level 3X||2|8|
48749415|NCT04076540|102173050|FG001|COMPLETED|Cohort 2: Dose Level 3X||0|8|
48749416|NCT04076540|102173051|FG002|COMPLETED|Cohort 2: Dose Level 3X||6|8|
48411171|NCT01572480|101337827|FG000|COMPLETED|Participants Enrolled||54||
48411172|NCT01572480|101337827|FG000|NOT COMPLETED|Participants Enrolled||1||
48411173|NCT01572480|101337827|FG000|STARTED|Drug Administration||54||
48411174|NCT01572480|101337827|FG000|COMPLETED|Drug Administration||53||
48411175|NCT01572480|101337827|FG000|NOT COMPLETED|Drug Administration||1||
48749417|NCT04076540|102173052|FG003|COMPLETED|Cohort 2: Dose Level 3X||0|8|
48411176|NCT01572480|101337827|FG000|STARTED|Initiated Maintenance Therapy||53||
48411177|NCT01572480|101337827|FG000|COMPLETED|Initiated Maintenance Therapy||50||
48411178|NCT01572480|101337827|FG000|NOT COMPLETED|Initiated Maintenance Therapy||3||
48411179|NCT01572480|101337827|FG000|STARTED|Completed Maintenance Therapy||50||
48411180|NCT01572480|101337827|FG000|COMPLETED|Completed Maintenance Therapy||30||
48411181|NCT01572480|101337827|FG000|NOT COMPLETED|Completed Maintenance Therapy||20||
48411182|NCT00732472|101337828|FG000|STARTED|Overall Study||9||
48411183|NCT00732472|101337829|FG001|STARTED|Overall Study||10||
48411184|NCT00732472|101337830|FG002|STARTED|Overall Study||10||
48411185|NCT00732472|101337831|FG003|STARTED|Overall Study||9||
48411186|NCT00732472|101337828|FG000|COMPLETED|Overall Study||9||
48411187|NCT00732472|101337829|FG001|COMPLETED|Overall Study||7||
48411188|NCT00732472|101337830|FG002|COMPLETED|Overall Study||9||
48411189|NCT00732472|101337831|FG003|COMPLETED|Overall Study||6||
48411190|NCT00732472|101337828|FG000|NOT COMPLETED|Overall Study||0||
48411191|NCT00732472|101337829|FG001|NOT COMPLETED|Overall Study||3||
48411192|NCT00732472|101337830|FG002|NOT COMPLETED|Overall Study||1||
48411193|NCT00732472|101337831|FG003|NOT COMPLETED|Overall Study||3||
48411194|NCT00471276|101337832|FG000|STARTED|Overall Study||83||
48411195|NCT00471276|101337832|FG000|COMPLETED|Overall Study||0||
48411196|NCT00471276|101337832|FG000|NOT COMPLETED|Overall Study||83||
48411197|NCT02094612|101337833|FG000|STARTED|Overall Study||112||
48411198|NCT02094612|101337834|FG001|STARTED|Overall Study||95||
48411199|NCT02094612|101337833|FG000|1 Month Follow up|Overall Study||67||
48411200|NCT02094612|101337834|FG001|1 Month Follow up|Overall Study||50||
48411201|NCT02094612|101337833|FG000|3 Month Follow up|Overall Study||50||
48411202|NCT02094612|101337834|FG001|3 Month Follow up|Overall Study||43||
48411203|NCT02094612|101337833|FG000|6 Month Follow up|Overall Study||33||
48411204|NCT02094612|101337834|FG001|6 Month Follow up|Overall Study||25||
48411205|NCT02094612|101337833|FG000|COMPLETED|Overall Study||33||
48411206|NCT02094612|101337834|FG001|COMPLETED|Overall Study||25||
48411207|NCT02094612|101337833|FG000|NOT COMPLETED|Overall Study||79||
48411208|NCT02094612|101337834|FG001|NOT COMPLETED|Overall Study||70||
48411209|NCT00355615|101337835|FG000|STARTED|Randomized Double Blind Period||42||
48411210|NCT00355615|101337836|FG001|STARTED|Randomized Double Blind Period||44||
48411211|NCT00355615|101337837|FG002|STARTED|Randomized Double Blind Period||45||
48411212|NCT00355615|101337838|FG003|STARTED|Randomized Double Blind Period||46||
48411213|NCT00355615|101337839|FG004|STARTED|Randomized Double Blind Period||0||
48411214|NCT00355615|101337835|FG000|COMPLETED|Randomized Double Blind Period||41||
48411215|NCT00355615|101337836|FG001|COMPLETED|Randomized Double Blind Period||44||
48411216|NCT00355615|101337837|FG002|COMPLETED|Randomized Double Blind Period||44||
48411217|NCT00355615|101337838|FG003|COMPLETED|Randomized Double Blind Period||45||
48411218|NCT00355615|101337839|FG004|COMPLETED|Randomized Double Blind Period||0||
48411219|NCT00355615|101337835|FG000|NOT COMPLETED|Randomized Double Blind Period||1||
48411220|NCT00355615|101337836|FG001|NOT COMPLETED|Randomized Double Blind Period||0||
48411221|NCT00355615|101337837|FG002|NOT COMPLETED|Randomized Double Blind Period||1||
48411222|NCT00355615|101337838|FG003|NOT COMPLETED|Randomized Double Blind Period||1||
48411223|NCT00355615|101337839|FG004|NOT COMPLETED|Randomized Double Blind Period||0||
48411224|NCT00355615|101337835|FG000|STARTED|40-week Rosuvastatin Open Label Period||0||
48411225|NCT00355615|101337836|FG001|STARTED|40-week Rosuvastatin Open Label Period||0||
48411226|NCT00355615|101337837|FG002|STARTED|40-week Rosuvastatin Open Label Period||0||
48411227|NCT00355615|101337838|FG003|STARTED|40-week Rosuvastatin Open Label Period||0||
48411228|NCT00355615|101337839|FG004|STARTED|40-week Rosuvastatin Open Label Period||173||
48411229|NCT00355615|101337835|FG000|COMPLETED|40-week Rosuvastatin Open Label Period||0||
48411230|NCT00355615|101337836|FG001|COMPLETED|40-week Rosuvastatin Open Label Period||0||
48411231|NCT00355615|101337837|FG002|COMPLETED|40-week Rosuvastatin Open Label Period||0||
48411232|NCT00355615|101337838|FG003|COMPLETED|40-week Rosuvastatin Open Label Period||0||
48411233|NCT00355615|101337839|FG004|COMPLETED|40-week Rosuvastatin Open Label Period||164||
48411234|NCT00355615|101337835|FG000|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0||
48411235|NCT00355615|101337836|FG001|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0||
48411236|NCT00355615|101337837|FG002|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0||
48411237|NCT00355615|101337838|FG003|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0||
48411238|NCT00355615|101337839|FG004|NOT COMPLETED|40-week Rosuvastatin Open Label Period||9||
48411239|NCT01675141|101337840|FG000|STARTED|Overall Study||11||
48411240|NCT01675141|101337840|FG000|COMPLETED|Overall Study||0||
48411241|NCT01675141|101337840|FG000|NOT COMPLETED|Overall Study||11||
48411242|NCT00706264|101337841|FG000|STARTED|Overall Study||193||
48411243|NCT00706264|101337842|FG001|STARTED|Overall Study||192||
48411244|NCT00706264|101337841|FG000|COMPLETED|Overall Study||190||
48411245|NCT00706264|101337842|FG001|COMPLETED|Overall Study||190||
48411246|NCT00706264|101337841|FG000|NOT COMPLETED|Overall Study||3||
48411247|NCT00706264|101337842|FG001|NOT COMPLETED|Overall Study||2||
48411248|NCT05091918|101337843|FG000|STARTED|Overall Study||101||
48411249|NCT05091918|101337843|FG000|COMPLETED|Overall Study||19||
48411250|NCT05091918|101337843|FG000|NOT COMPLETED|Overall Study||82||
48411251|NCT02148952|101337844|FG000|STARTED|Assessing Eligibility and Consent||83166|This includes all women who registered for delivery.|60
48411252|NCT02148952|101337845|FG001|STARTED|Assessing Eligibility and Consent||80773|This includes all women who registered for delivery.|60
48411253|NCT02148952|101337844|FG000|COMPLETED|Assessing Eligibility and Consent||80063|This includes all women who were eligible for inclusion and consented to follow-up.|60
48439933|NCT01279265|101409987|FG001|STARTED|Overall Study||17||
48411254|NCT02148952|101337845|FG001|COMPLETED|Assessing Eligibility and Consent||77626|This includes all women who were eligible for inclusion and consented to follow-up.|60
48411255|NCT02148952|101337844|FG000|NOT COMPLETED|Assessing Eligibility and Consent||3103||0
48411256|NCT02148952|101337845|FG001|NOT COMPLETED|Assessing Eligibility and Consent||3147||0
48411257|NCT02148952|101337844|FG000|STARTED|Follow-Up||80063||60
48411258|NCT02148952|101337845|FG001|STARTED|Follow-Up||77626||60
48332450|NCT01847885|101141835|FG000|Full Analysis Set|Randomization||0||
48332451|NCT01847885|101141836|FG001|Full Analysis Set|Randomization||28||
48332452|NCT01847885|101141837|FG002|Full Analysis Set|Randomization||15||
48332453|NCT01847885|101141835|FG000|Safety Set|Randomization||0||
48411259|NCT02148952|101337844|FG000|COMPLETED|Follow-Up||79798||60
48332454|NCT01847885|101141836|FG001|Safety Set|Randomization||28||
48332455|NCT01847885|101141837|FG002|Safety Set|Randomization||13||
48411260|NCT02148952|101337845|FG001|COMPLETED|Follow-Up||77347||60
48411261|NCT02148952|101337844|FG000|NOT COMPLETED|Follow-Up||265||0
48411262|NCT02148952|101337845|FG001|NOT COMPLETED|Follow-Up||279||0
48411263|NCT01487863|101337846|FG000|STARTED|Overall Study||35||
48411264|NCT01487863|101337847|FG001|STARTED|Overall Study||34||
48411265|NCT01487863|101337846|FG000|Subjects Randomized (Efficacy Analysis)|Overall Study||35||
48411266|NCT01487863|101337847|FG001|Subjects Randomized (Efficacy Analysis)|Overall Study||34||
48411267|NCT01487863|101337846|FG000|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||35||
48411268|NCT01487863|101337847|FG001|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||34||
48411269|NCT01487863|101337846|FG000|COMPLETED|Overall Study||16||
48411270|NCT01487863|101337847|FG001|COMPLETED|Overall Study||15||
48411271|NCT01487863|101337846|FG000|NOT COMPLETED|Overall Study||19||
48411272|NCT01487863|101337847|FG001|NOT COMPLETED|Overall Study||19||
48411273|NCT00113555|101337848|FG000|STARTED|Overall Study||221||
48411274|NCT00113555|101337848|FG000|TREATED|Overall Study||162||
48411275|NCT00113555|101337848|FG000|COMPLETED|Overall Study||142||
48411276|NCT00113555|101337848|FG000|NOT COMPLETED|Overall Study||79||
48411277|NCT02935595|101337849|FG000|STARTED|Overall Study||5||
48411278|NCT02935595|101337849|FG000|COMPLETED|Overall Study||4||
48411279|NCT02935595|101337849|FG000|NOT COMPLETED|Overall Study||1||
48411280|NCT00397631|101337850|FG000|STARTED|Overall Study||261||
48411281|NCT00397631|101337851|FG001|STARTED|Overall Study||259||
48411282|NCT00397631|101337850|FG000|COMPLETED|Overall Study||231||
48411283|NCT00397631|101337851|FG001|COMPLETED|Overall Study||215||
48411284|NCT00397631|101337850|FG000|NOT COMPLETED|Overall Study||30||
48411285|NCT00397631|101337851|FG001|NOT COMPLETED|Overall Study||44||
48411286|NCT01594411|101337852|FG000|STARTED|Overall Study||251||
48411287|NCT01594411|101337852|FG000|COMPLETED|Overall Study||249||
48411288|NCT01594411|101337852|FG000|NOT COMPLETED|Overall Study||2||
48411289|NCT02058706|101337853|FG000|STARTED|Overall Study||35||
48411290|NCT02058706|101337854|FG001|STARTED|Overall Study||36||
48411291|NCT02058706|101337853|FG000|COMPLETED|Overall Study||35||
48411292|NCT02058706|101337854|FG001|COMPLETED|Overall Study||36||
48411293|NCT02058706|101337853|FG000|NOT COMPLETED|Overall Study||0||
48411294|NCT02058706|101337854|FG001|NOT COMPLETED|Overall Study||0||
48411295|NCT00901394|101337855|FG000|STARTED|Overall Study||21||
48411296|NCT00901394|101337856|FG001|STARTED|Overall Study||20||
48411297|NCT00901394|101337857|FG002|STARTED|Overall Study||22||
48411298|NCT00901394|101337855|FG000|COMPLETED|Overall Study||20||
48411299|NCT00901394|101337856|FG001|COMPLETED|Overall Study||19||
48411300|NCT00901394|101337857|FG002|COMPLETED|Overall Study||20||
48626464|NCT02351934|101870827|FG000|Received Allocation|Allocation||56||
48626465|NCT02351934|101870828|FG001|Received Allocation|Allocation||61||
48626466|NCT02351934|101870827|FG000|COMPLETED|Allocation||56||
48626467|NCT02351934|101870828|FG001|COMPLETED|Allocation||61||
48626468|NCT02351934|101870827|FG000|NOT COMPLETED|Allocation||6||
48626469|NCT02351934|101870828|FG001|NOT COMPLETED|Allocation||0||
48626470|NCT02351934|101870827|FG000|STARTED|Follow-Up||56||
48332456|NCT01847885|101141835|FG000|Per Protocol Set|Randomization||0||
48332457|NCT01847885|101141836|FG001|Per Protocol Set|Randomization||27||
48332458|NCT01847885|101141837|FG002|Per Protocol Set|Randomization||13||
48332459|NCT01847885|101141835|FG000|COMPLETED|Randomization||0||
48411301|NCT00901394|101337855|FG000|NOT COMPLETED|Overall Study||1||
48411302|NCT00901394|101337856|FG001|NOT COMPLETED|Overall Study||1||
48411303|NCT00901394|101337857|FG002|NOT COMPLETED|Overall Study||2||
48411304|NCT02274766|101337858|FG000|STARTED|Overall Study||39||
48411305|NCT02274766|101337859|FG001|STARTED|Overall Study||38||
48411306|NCT02274766|101337858|FG000|Received Study Drug|Overall Study||38||
48411307|NCT02274766|101337859|FG001|Received Study Drug|Overall Study||37||
48411308|NCT02274766|101337858|FG000|COMPLETED|Overall Study||35||
48411309|NCT02274766|101337859|FG001|COMPLETED|Overall Study||29||
48411310|NCT02274766|101337858|FG000|NOT COMPLETED|Overall Study||4||
48411311|NCT02274766|101337859|FG001|NOT COMPLETED|Overall Study||9||
48411312|NCT02447952|101337860|FG000|STARTED|Overall Study||25||
48411313|NCT02447952|101337860|FG000|COMPLETED|Overall Study||18||
48411314|NCT02447952|101337860|FG000|NOT COMPLETED|Overall Study||7||
48411315|NCT01359111|101337861|FG000|STARTED|Overall Study||20||
48411316|NCT01359111|101337861|FG000|COMPLETED|Overall Study||20||
48626471|NCT02351934|101870828|FG001|STARTED|Follow-Up||61||
48411317|NCT01359111|101337861|FG000|NOT COMPLETED|Overall Study||0||
48626472|NCT02351934|101870827|FG000|COMPLETED|Follow-Up||44||
48411318|NCT00957034|101337862|FG000|STARTED|Overall Study||6||
48411319|NCT00957034|101337863|FG001|STARTED|Overall Study||4||
48411320|NCT00957034|101337864|FG002|STARTED|Overall Study||7||
48411321|NCT00957034|101337862|FG000|COMPLETED|Overall Study||0||
48411322|NCT00957034|101337863|FG001|COMPLETED|Overall Study||0||
48411323|NCT00957034|101337864|FG002|COMPLETED|Overall Study||1||
48411324|NCT00957034|101337862|FG000|NOT COMPLETED|Overall Study||6||
48411325|NCT00957034|101337863|FG001|NOT COMPLETED|Overall Study||4||
48411326|NCT00957034|101337864|FG002|NOT COMPLETED|Overall Study||6||
48411327|NCT02449915|101337865|FG000|STARTED|Overall Study||35||
48411328|NCT02449915|101337866|FG001|STARTED|Overall Study||35||
48411329|NCT02449915|101337865|FG000|COMPLETED|Overall Study||33||
48411330|NCT02449915|101337866|FG001|COMPLETED|Overall Study||31||
48411331|NCT02449915|101337865|FG000|NOT COMPLETED|Overall Study||2||
48411332|NCT02449915|101337866|FG001|NOT COMPLETED|Overall Study||4||
48411333|NCT00958191|101337867|FG000|STARTED|Overall Study||221||240
48749418|NCT04076540|102173053|FG004|COMPLETED|Cohort 2: Dose Level 3X||0|8|
48749419|NCT04076540|102173054|FG005|COMPLETED|Cohort 2: Dose Level 3X||0|8|
48749420|NCT04076540|102173055|FG006|COMPLETED|Cohort 2: Dose Level 3X||0|8|
48749421|NCT04076540|102173049|FG000|NOT COMPLETED|Cohort 2: Dose Level 3X||0||
48749422|NCT04076540|102173050|FG001|NOT COMPLETED|Cohort 2: Dose Level 3X||0||
48749423|NCT04076540|102173051|FG002|NOT COMPLETED|Cohort 2: Dose Level 3X||0||
48749424|NCT04076540|102173052|FG003|NOT COMPLETED|Cohort 2: Dose Level 3X||0||
48749425|NCT04076540|102173053|FG004|NOT COMPLETED|Cohort 2: Dose Level 3X||0||
48749426|NCT04076540|102173054|FG005|NOT COMPLETED|Cohort 2: Dose Level 3X||0||
48749427|NCT04076540|102173055|FG006|NOT COMPLETED|Cohort 2: Dose Level 3X||0||
48749428|NCT04076540|102173049|FG000|STARTED|Cohort 3: Dose Level 9X||2|8|
48749429|NCT04076540|102173050|FG001|STARTED|Cohort 3: Dose Level 9X||0|8|
48749430|NCT04076540|102173051|FG002|STARTED|Cohort 3: Dose Level 9X||0|8|
48749431|NCT04076540|102173052|FG003|STARTED|Cohort 3: Dose Level 9X||6|8|
48749432|NCT04076540|102173053|FG004|STARTED|Cohort 3: Dose Level 9X||0|8|
48749433|NCT04076540|102173054|FG005|STARTED|Cohort 3: Dose Level 9X||0|8|
48749434|NCT04076540|102173055|FG006|STARTED|Cohort 3: Dose Level 9X||0|8|
48749435|NCT04076540|102173049|FG000|COMPLETED|Cohort 3: Dose Level 9X||2||
48749436|NCT04076540|102173050|FG001|COMPLETED|Cohort 3: Dose Level 9X||0||
48749437|NCT04076540|102173051|FG002|COMPLETED|Cohort 3: Dose Level 9X||0||
48749438|NCT04076540|102173052|FG003|COMPLETED|Cohort 3: Dose Level 9X||6||
48749439|NCT04076540|102173053|FG004|COMPLETED|Cohort 3: Dose Level 9X||0||
48411334|NCT00958191|101337867|FG000|COMPLETED|Overall Study||110|Complete/Not completed counts are based on participant status at the 5 yr primary outcome interval.|118
48411335|NCT00958191|101337867|FG000|NOT COMPLETED|Overall Study||111||122
48411336|NCT01670825|101337868|FG000|STARTED|Overall Study||42||
48411337|NCT01670825|101337869|FG001|STARTED|Overall Study||39||
48411338|NCT01670825|101337868|FG000|COMPLETED|Overall Study||42||
48411339|NCT01670825|101337869|FG001|COMPLETED|Overall Study||39||
48411340|NCT01670825|101337868|FG000|NOT COMPLETED|Overall Study||0||
48411341|NCT01670825|101337869|FG001|NOT COMPLETED|Overall Study||0||
48411342|NCT02483611|101337870|FG000|STARTED|Overall Study||16||
48411343|NCT02483611|101337871|FG001|STARTED|Overall Study||16||
48411344|NCT02483611|101337872|FG002|STARTED|Overall Study||16||
48411345|NCT02483611|101337870|FG000|COMPLETED|Overall Study||16||
48411346|NCT02483611|101337871|FG001|COMPLETED|Overall Study||16||
48626473|NCT02351934|101870828|FG001|COMPLETED|Follow-Up||51||
48411347|NCT02483611|101337872|FG002|COMPLETED|Overall Study||15||
48411348|NCT02483611|101337870|FG000|NOT COMPLETED|Overall Study||0||
48411349|NCT02483611|101337871|FG001|NOT COMPLETED|Overall Study||0||
48411350|NCT02483611|101337872|FG002|NOT COMPLETED|Overall Study||1||
48411351|NCT00985140|101337873|FG000|STARTED|Overall Study||15||
48411352|NCT00985140|101337873|FG000|COMPLETED|Overall Study||15||
48411353|NCT00985140|101337873|FG000|NOT COMPLETED|Overall Study||0||
48411354|NCT01646151|101337874|FG000|STARTED|Overall Study||2580||
48411355|NCT01646151|101337874|FG000|COMPLETED|Overall Study||2410||
48411356|NCT01646151|101337874|FG000|NOT COMPLETED|Overall Study||170||
48411357|NCT04840849|101337875|FG000|STARTED|Overall Study||18||
48626474|NCT02351934|101870827|FG000|NOT COMPLETED|Follow-Up||12||
48626475|NCT02351934|101870828|FG001|NOT COMPLETED|Follow-Up||10||
48626476|NCT02051296|101870829|FG000|STARTED|Overall Study||66||
48626477|NCT02051296|101870830|FG001|STARTED|Overall Study||65||
48626478|NCT02051296|101870829|FG000|Received Allocated Intervention|Overall Study||59||
48626479|NCT02051296|101870830|FG001|Received Allocated Intervention|Overall Study||58||
48626480|NCT02051296|101870829|FG000|COMPLETED|Overall Study||58||
48626481|NCT02051296|101870830|FG001|COMPLETED|Overall Study||56||
48626482|NCT02051296|101870829|FG000|NOT COMPLETED|Overall Study||8||
48626483|NCT02051296|101870830|FG001|NOT COMPLETED|Overall Study||9||
48626484|NCT02962427|101870831|FG000|STARTED|Overall Study||3||
48626485|NCT02962427|101870832|FG001|STARTED|Overall Study||1||
48626486|NCT02962427|101870831|FG000|COMPLETED|Overall Study||3||
48626487|NCT02962427|101870832|FG001|COMPLETED|Overall Study||1||
48626488|NCT02962427|101870831|FG000|NOT COMPLETED|Overall Study||0||
48626489|NCT02962427|101870832|FG001|NOT COMPLETED|Overall Study||0||
48626490|NCT01111565|101870833|FG000|STARTED|Phase B (Weeks 0 to 8)||137||
48749440|NCT04076540|102173054|FG005|COMPLETED|Cohort 3: Dose Level 9X||0||
48749441|NCT04076540|102173055|FG006|COMPLETED|Cohort 3: Dose Level 9X||0||
48749442|NCT04076540|102173049|FG000|NOT COMPLETED|Cohort 3: Dose Level 9X||0||
48749443|NCT04076540|102173050|FG001|NOT COMPLETED|Cohort 3: Dose Level 9X||0||
48749444|NCT04076540|102173051|FG002|NOT COMPLETED|Cohort 3: Dose Level 9X||0||
48749445|NCT04076540|102173052|FG003|NOT COMPLETED|Cohort 3: Dose Level 9X||0||
48749446|NCT04076540|102173053|FG004|NOT COMPLETED|Cohort 3: Dose Level 9X||0||
48749447|NCT04076540|102173054|FG005|NOT COMPLETED|Cohort 3: Dose Level 9X||0||
48749448|NCT04076540|102173055|FG006|NOT COMPLETED|Cohort 3: Dose Level 9X||0||
48749449|NCT04076540|102173049|FG000|STARTED|Cohort 4: Dose Level 20X||2|8|
48749450|NCT04076540|102173050|FG001|STARTED|Cohort 4: Dose Level 20X||0|8|
48749451|NCT04076540|102173051|FG002|STARTED|Cohort 4: Dose Level 20X||0|8|
48749452|NCT04076540|102173052|FG003|STARTED|Cohort 4: Dose Level 20X||0|8|
48749453|NCT04076540|102173053|FG004|STARTED|Cohort 4: Dose Level 20X||6|8|
48749454|NCT04076540|102173054|FG005|STARTED|Cohort 4: Dose Level 20X||0|8|
48749455|NCT04076540|102173055|FG006|STARTED|Cohort 4: Dose Level 20X||0|8|
48749456|NCT04076540|102173049|FG000|COMPLETED|Cohort 4: Dose Level 20X||2||
48749457|NCT04076540|102173050|FG001|COMPLETED|Cohort 4: Dose Level 20X||0||
48749458|NCT04076540|102173051|FG002|COMPLETED|Cohort 4: Dose Level 20X||0||
48749459|NCT04076540|102173052|FG003|COMPLETED|Cohort 4: Dose Level 20X||0||
48749460|NCT04076540|102173053|FG004|COMPLETED|Cohort 4: Dose Level 20X||6||
48749461|NCT04076540|102173054|FG005|COMPLETED|Cohort 4: Dose Level 20X||0||
48749462|NCT04076540|102173055|FG006|COMPLETED|Cohort 4: Dose Level 20X||0||
48749463|NCT04076540|102173049|FG000|NOT COMPLETED|Cohort 4: Dose Level 20X||0||
48749464|NCT04076540|102173050|FG001|NOT COMPLETED|Cohort 4: Dose Level 20X||0||
48749465|NCT04076540|102173051|FG002|NOT COMPLETED|Cohort 4: Dose Level 20X||0||
48749466|NCT04076540|102173052|FG003|NOT COMPLETED|Cohort 4: Dose Level 20X||0||
48749467|NCT04076540|102173053|FG004|NOT COMPLETED|Cohort 4: Dose Level 20X||0||
48749468|NCT04076540|102173054|FG005|NOT COMPLETED|Cohort 4: Dose Level 20X||0||
48749469|NCT04076540|102173055|FG006|NOT COMPLETED|Cohort 4: Dose Level 20X||0||
48749470|NCT04076540|102173049|FG000|STARTED|Cohort 5: Dose Level 40X||2||
48749471|NCT04076540|102173050|FG001|STARTED|Cohort 5: Dose Level 40X||0||
48749472|NCT04076540|102173051|FG002|STARTED|Cohort 5: Dose Level 40X||0||
48749473|NCT04076540|102173052|FG003|STARTED|Cohort 5: Dose Level 40X||0||
48749474|NCT04076540|102173053|FG004|STARTED|Cohort 5: Dose Level 40X||0||
48749475|NCT04076540|102173054|FG005|STARTED|Cohort 5: Dose Level 40X||6||
48749476|NCT04076540|102173055|FG006|STARTED|Cohort 5: Dose Level 40X||0||
48749477|NCT04076540|102173049|FG000|COMPLETED|Cohort 5: Dose Level 40X||2||
48749478|NCT04076540|102173050|FG001|COMPLETED|Cohort 5: Dose Level 40X||0||
48749479|NCT04076540|102173051|FG002|COMPLETED|Cohort 5: Dose Level 40X||0||
48749480|NCT04076540|102173052|FG003|COMPLETED|Cohort 5: Dose Level 40X||0||
48749481|NCT04076540|102173053|FG004|COMPLETED|Cohort 5: Dose Level 40X||0||
48749482|NCT04076540|102173054|FG005|COMPLETED|Cohort 5: Dose Level 40X||6||
48749483|NCT04076540|102173055|FG006|COMPLETED|Cohort 5: Dose Level 40X||0||
48749484|NCT04076540|102173049|FG000|NOT COMPLETED|Cohort 5: Dose Level 40X||0||
48749485|NCT04076540|102173050|FG001|NOT COMPLETED|Cohort 5: Dose Level 40X||0||
48749486|NCT04076540|102173051|FG002|NOT COMPLETED|Cohort 5: Dose Level 40X||0||
48749487|NCT04076540|102173052|FG003|NOT COMPLETED|Cohort 5: Dose Level 40X||0||
48749488|NCT04076540|102173053|FG004|NOT COMPLETED|Cohort 5: Dose Level 40X||0||
48749489|NCT04076540|102173054|FG005|NOT COMPLETED|Cohort 5: Dose Level 40X||0||
48749490|NCT04076540|102173055|FG006|NOT COMPLETED|Cohort 5: Dose Level 40X||0||
48626491|NCT01111565|101870834|FG001|STARTED|Phase B (Weeks 0 to 8)||0||
48626492|NCT01111565|101870835|FG002|STARTED|Phase B (Weeks 0 to 8)||0||
48626493|NCT01111565|101870836|FG003|STARTED|Phase B (Weeks 0 to 8)||0||
48626494|NCT01111565|101870837|FG004|STARTED|Phase B (Weeks 0 to 8)||0||
48626495|NCT01111565|101870833|FG000|COMPLETED|Phase B (Weeks 0 to 8)||71||
48626496|NCT01111565|101870834|FG001|COMPLETED|Phase B (Weeks 0 to 8)||0||
48626497|NCT01111565|101870835|FG002|COMPLETED|Phase B (Weeks 0 to 8)||0||
48626498|NCT01111565|101870836|FG003|COMPLETED|Phase B (Weeks 0 to 8)||0||
48626499|NCT01111565|101870837|FG004|COMPLETED|Phase B (Weeks 0 to 8)||0||
48626500|NCT01111565|101870833|FG000|NOT COMPLETED|Phase B (Weeks 0 to 8)||66||
48626501|NCT01111565|101870834|FG001|NOT COMPLETED|Phase B (Weeks 0 to 8)||0||
48626502|NCT01111565|101870835|FG002|NOT COMPLETED|Phase B (Weeks 0 to 8)||0||
48626503|NCT01111565|101870836|FG003|NOT COMPLETED|Phase B (Weeks 0 to 8)||0||
48749491|NCT04076540|102173049|FG000|STARTED|Cohort 6: Dose Level 80X||2||
48749492|NCT04076540|102173050|FG001|STARTED|Cohort 6: Dose Level 80X||0||
48749493|NCT04076540|102173051|FG002|STARTED|Cohort 6: Dose Level 80X||0||
48749494|NCT04076540|102173052|FG003|STARTED|Cohort 6: Dose Level 80X||0||
48749495|NCT04076540|102173053|FG004|STARTED|Cohort 6: Dose Level 80X||0||
48749496|NCT04076540|102173054|FG005|STARTED|Cohort 6: Dose Level 80X||0||
48749497|NCT04076540|102173055|FG006|STARTED|Cohort 6: Dose Level 80X||6||
48749498|NCT04076540|102173049|FG000|COMPLETED|Cohort 6: Dose Level 80X||2||
48749499|NCT04076540|102173050|FG001|COMPLETED|Cohort 6: Dose Level 80X||0||
48749500|NCT04076540|102173051|FG002|COMPLETED|Cohort 6: Dose Level 80X||0||
48749501|NCT04076540|102173052|FG003|COMPLETED|Cohort 6: Dose Level 80X||0||
48749502|NCT04076540|102173053|FG004|COMPLETED|Cohort 6: Dose Level 80X||0||
48749503|NCT04076540|102173054|FG005|COMPLETED|Cohort 6: Dose Level 80X||0||
48749504|NCT04076540|102173055|FG006|COMPLETED|Cohort 6: Dose Level 80X||6||
48749505|NCT04076540|102173049|FG000|NOT COMPLETED|Cohort 6: Dose Level 80X||0||
48749506|NCT04076540|102173050|FG001|NOT COMPLETED|Cohort 6: Dose Level 80X||0||
48749507|NCT04076540|102173051|FG002|NOT COMPLETED|Cohort 6: Dose Level 80X||0||
48749508|NCT04076540|102173052|FG003|NOT COMPLETED|Cohort 6: Dose Level 80X||0||
48749509|NCT04076540|102173053|FG004|NOT COMPLETED|Cohort 6: Dose Level 80X||0||
48749510|NCT04076540|102173054|FG005|NOT COMPLETED|Cohort 6: Dose Level 80X||0||
48749511|NCT04076540|102173055|FG006|NOT COMPLETED|Cohort 6: Dose Level 80X||0||
48749512|NCT00416624|102173056|FG000|STARTED|Overall Study||61||
48749513|NCT00416624|102173057|FG001|STARTED|Overall Study||60||
48749514|NCT00416624|102173058|FG002|STARTED|Overall Study||58||
48749515|NCT00416624|102173059|FG003|STARTED|Overall Study||57||
48749516|NCT00416624|102173056|FG000|COMPLETED|Overall Study||39||
48749517|NCT00416624|102173057|FG001|COMPLETED|Overall Study||33||
48749518|NCT00416624|102173058|FG002|COMPLETED|Overall Study||40||
48749519|NCT00416624|102173059|FG003|COMPLETED|Overall Study||40||
48332460|NCT01847885|101141836|FG001|COMPLETED|Randomization||27||
48332461|NCT01847885|101141837|FG002|COMPLETED|Randomization||13||
48332462|NCT01847885|101141835|FG000|NOT COMPLETED|Randomization||0||
48332463|NCT01847885|101141836|FG001|NOT COMPLETED|Randomization||4||
48332464|NCT01847885|101141837|FG002|NOT COMPLETED|Randomization||2||
48332465|NCT02867995|101141838|FG000|STARTED|Overall Study||9||
48332466|NCT02867995|101141839|FG001|STARTED|Overall Study||30||
48332467|NCT02867995|101141838|FG000|COMPLETED|Overall Study||9||
48332468|NCT02867995|101141839|FG001|COMPLETED|Overall Study||27||
48332469|NCT02867995|101141838|FG000|NOT COMPLETED|Overall Study||0||
48332470|NCT02867995|101141839|FG001|NOT COMPLETED|Overall Study||3||
48332471|NCT02526550|101141840|FG000|STARTED|Overall Study||50||
48749520|NCT00416624|102173056|FG000|NOT COMPLETED|Overall Study||22||
48749521|NCT00416624|102173057|FG001|NOT COMPLETED|Overall Study||27||
48749522|NCT00416624|102173058|FG002|NOT COMPLETED|Overall Study||18||
48749523|NCT00416624|102173059|FG003|NOT COMPLETED|Overall Study||17||
48749524|NCT00646646|102173060|FG000|STARTED|Overall Study||15||
48749525|NCT00646646|102173061|FG001|STARTED|Overall Study||15||
48749526|NCT00646646|102173062|FG002|STARTED|Overall Study||15||
48749527|NCT00646646|102173063|FG003|STARTED|Overall Study||20||
48749528|NCT00646646|102173060|FG000|COMPLETED|Overall Study||15||
48749529|NCT00646646|102173061|FG001|COMPLETED|Overall Study||15||
48749530|NCT00646646|102173062|FG002|COMPLETED|Overall Study||15||
48749531|NCT00646646|102173063|FG003|COMPLETED|Overall Study||20||
48749532|NCT00646646|102173060|FG000|NOT COMPLETED|Overall Study||0||
48749533|NCT00646646|102173061|FG001|NOT COMPLETED|Overall Study||0||
48749534|NCT00646646|102173062|FG002|NOT COMPLETED|Overall Study||0||
48749535|NCT00646646|102173063|FG003|NOT COMPLETED|Overall Study||0||
48749536|NCT01894607|102173064|FG000|STARTED|Overall Study||11||
48749537|NCT01894607|102173064|FG000|COMPLETED|Overall Study||10||
48749538|NCT01894607|102173064|FG000|NOT COMPLETED|Overall Study||1||
48749539|NCT02090426|102173065|FG000|STARTED|Overall Study||401||
48749540|NCT02090426|102173066|FG001|STARTED|Overall Study||399||
48749541|NCT02090426|102173065|FG000|Analysis Population|Overall Study||389|Subset of randomized participants that matched to discharge data in which we observe outcomes.|
48749542|NCT02090426|102173066|FG001|Analysis Population|Overall Study||393|Subset of randomized participants that matched to discharge data in which we observe outcomes.|
48749543|NCT02090426|102173065|FG000|COMPLETED|Overall Study||389||
48749544|NCT02090426|102173066|FG001|COMPLETED|Overall Study||393||
48749545|NCT02090426|102173065|FG000|NOT COMPLETED|Overall Study||12||
48749546|NCT02090426|102173066|FG001|NOT COMPLETED|Overall Study||6||
48749547|NCT01788566|102173067|FG000|STARTED|Overall Study||61||
48332472|NCT02526550|101141840|FG000|COMPLETED|Overall Study||49||
48332473|NCT02526550|101141840|FG000|NOT COMPLETED|Overall Study||1||
48332474|NCT01465659|101141841|FG000|STARTED|Completed 1 Cycle of Treatment||7||
48332475|NCT01465659|101141842|FG001|STARTED|Completed 1 Cycle of Treatment||5||
48332476|NCT01465659|101141843|FG002|STARTED|Completed 1 Cycle of Treatment||6||
48332477|NCT01465659|101141844|FG003|STARTED|Completed 1 Cycle of Treatment||11||
48332478|NCT01465659|101141841|FG000|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||7||
48332479|NCT01465659|101141842|FG001|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||4||
48332480|NCT01465659|101141843|FG002|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||6||
48332481|NCT01465659|101141844|FG003|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||11||
48332482|NCT01465659|101141841|FG000|COMPLETED|Completed 1 Cycle of Treatment||7||
48332483|NCT01465659|101141842|FG001|COMPLETED|Completed 1 Cycle of Treatment||4||
48332484|NCT01465659|101141843|FG002|COMPLETED|Completed 1 Cycle of Treatment||6||
48332485|NCT01465659|101141844|FG003|COMPLETED|Completed 1 Cycle of Treatment||10||
48749548|NCT01788566|102173067|FG000|COMPLETED|Overall Study||53||
48749549|NCT01788566|102173067|FG000|NOT COMPLETED|Overall Study||8||
48749550|NCT02462148|102173068|FG000|STARTED|Overall Study||37||
48749551|NCT02462148|102173069|FG001|STARTED|Overall Study||36||
48749552|NCT02462148|102173070|FG002|STARTED|Overall Study||12||
48749553|NCT02462148|102173068|FG000|COMPLETED|Overall Study||36||
48749554|NCT02462148|102173069|FG001|COMPLETED|Overall Study||36||
48749555|NCT02462148|102173070|FG002|COMPLETED|Overall Study||12||
48749556|NCT02462148|102173068|FG000|NOT COMPLETED|Overall Study||1||
48749557|NCT02462148|102173069|FG001|NOT COMPLETED|Overall Study||0||
48749558|NCT02462148|102173070|FG002|NOT COMPLETED|Overall Study||0||
48749559|NCT02152826|102173071|FG000|STARTED|Overall Study||45||
48749560|NCT02152826|102173072|FG001|STARTED|Overall Study||35||
48749561|NCT02152826|102173071|FG000|COMPLETED|Overall Study||44||
48749562|NCT02152826|102173072|FG001|COMPLETED|Overall Study||34||
48749563|NCT02152826|102173071|FG000|NOT COMPLETED|Overall Study||1||
48749564|NCT02152826|102173072|FG001|NOT COMPLETED|Overall Study||1||
48749565|NCT01917747|102173073|FG000|STARTED|Overall Study||60||
48749566|NCT01917747|102173074|FG001|STARTED|Overall Study||46||
48749567|NCT01917747|102173073|FG000|COMPLETED|Overall Study||41||
48749568|NCT01917747|102173074|FG001|COMPLETED|Overall Study||35||
48749569|NCT01917747|102173073|FG000|NOT COMPLETED|Overall Study||19||
48749570|NCT01917747|102173074|FG001|NOT COMPLETED|Overall Study||11||
48749571|NCT00141102|102173075|FG000|STARTED|Overall Study||2238||
48749572|NCT00141102|102173076|FG001|STARTED|Overall Study||2246||
48749573|NCT00141102|102173075|FG000|Received Treatment|Overall Study||2223||
48749574|NCT00141102|102173076|FG001|Received Treatment|Overall Study||2237||
48749575|NCT00141102|102173075|FG000|COMPLETED|Overall Study||1730||
48749576|NCT00141102|102173076|FG001|COMPLETED|Overall Study||1621||
48749577|NCT00141102|102173075|FG000|NOT COMPLETED|Overall Study||508||
48749578|NCT00141102|102173076|FG001|NOT COMPLETED|Overall Study||625||
48749579|NCT00833040|102173077|FG000|STARTED|Overall Study||6||
48749580|NCT00833040|102173078|FG001|STARTED|Overall Study||6||
48332486|NCT01465659|101141841|FG000|NOT COMPLETED|Completed 1 Cycle of Treatment||0||
48332487|NCT01465659|101141842|FG001|NOT COMPLETED|Completed 1 Cycle of Treatment||1||
48332488|NCT01465659|101141843|FG002|NOT COMPLETED|Completed 1 Cycle of Treatment||0||
48332489|NCT01465659|101141844|FG003|NOT COMPLETED|Completed 1 Cycle of Treatment||1||
48332490|NCT01465659|101141841|FG000|STARTED|Completed 2 Cycles/Reached 1st Response||7||
48332491|NCT01465659|101141842|FG001|STARTED|Completed 2 Cycles/Reached 1st Response||4||
48749581|NCT00833040|102173079|FG002|STARTED|Overall Study||6||
48749582|NCT00833040|102173080|FG003|STARTED|Overall Study||6||
48749583|NCT00833040|102173081|FG004|STARTED|Overall Study||5||
48749584|NCT00833040|102173082|FG005|STARTED|Overall Study||5||
48749585|NCT00833040|102173077|FG000|COMPLETED|Overall Study||6||
48749586|NCT00833040|102173078|FG001|COMPLETED|Overall Study||6||
48749587|NCT00833040|102173079|FG002|COMPLETED|Overall Study||6||
48749588|NCT00833040|102173080|FG003|COMPLETED|Overall Study||6||
48749589|NCT00833040|102173081|FG004|COMPLETED|Overall Study||5||
48749590|NCT00833040|102173082|FG005|COMPLETED|Overall Study||4||
48749591|NCT00833040|102173077|FG000|NOT COMPLETED|Overall Study||0||
48749592|NCT00833040|102173078|FG001|NOT COMPLETED|Overall Study||0||
48749593|NCT00833040|102173079|FG002|NOT COMPLETED|Overall Study||0||
48749594|NCT00833040|102173080|FG003|NOT COMPLETED|Overall Study||0||
48749595|NCT00833040|102173081|FG004|NOT COMPLETED|Overall Study||0||
48749596|NCT00833040|102173082|FG005|NOT COMPLETED|Overall Study||1||
48749597|NCT00730158|102173083|FG000|STARTED|Overall Study||17||
48749598|NCT00730158|102173084|FG001|STARTED|Overall Study||16||
48749599|NCT00730158|102173083|FG000|COMPLETED|Overall Study||16||
48749600|NCT00730158|102173084|FG001|COMPLETED|Overall Study||15||
48749601|NCT00730158|102173083|FG000|NOT COMPLETED|Overall Study||1||
48749602|NCT00730158|102173084|FG001|NOT COMPLETED|Overall Study||1||
48749603|NCT02754570|102173085|FG000|STARTED|Overall Study||27||
48749604|NCT02754570|102173085|FG000|Visits 1 and 2 (PGA Only)|Overall Study||27||
48749605|NCT02754570|102173085|FG000|Visit 3 (PGA + Pilocarpine)|Overall Study||27||
48749606|NCT02754570|102173085|FG000|COMPLETED|Overall Study||27||
48749607|NCT02754570|102173085|FG000|NOT COMPLETED|Overall Study||0||
48332492|NCT01465659|101141843|FG002|STARTED|Completed 2 Cycles/Reached 1st Response||6||
48332493|NCT01465659|101141844|FG003|STARTED|Completed 2 Cycles/Reached 1st Response||10||
48332494|NCT01465659|101141841|FG000|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||7||
48332495|NCT01465659|101141842|FG001|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||4||
48332496|NCT01465659|101141843|FG002|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||6||
48749608|NCT02855281|102173086|FG000|STARTED|Overall Study||50||
48749609|NCT02855281|102173086|FG000|COMPLETED|Overall Study||50||
48749610|NCT02855281|102173086|FG000|NOT COMPLETED|Overall Study||0||
48749611|NCT02103309|102173087|FG000|STARTED|Overall Study||20||
48749612|NCT02103309|102173088|FG001|STARTED|Overall Study||22||
48749613|NCT02103309|102173087|FG000|COMPLETED|Overall Study||20||
48749614|NCT02103309|102173088|FG001|COMPLETED|Overall Study||22||
48749615|NCT02103309|102173087|FG000|NOT COMPLETED|Overall Study||0||
48332497|NCT01465659|101141844|FG003|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||10||
48749616|NCT02103309|102173088|FG001|NOT COMPLETED|Overall Study||0||
48749617|NCT03633344|102173089|FG000|STARTED|Overall Study||120||
48332498|NCT01465659|101141841|FG000|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||7||
48749618|NCT03633344|102173090|FG001|STARTED|Overall Study||24||
48749619|NCT03633344|102173089|FG000|COMPLETED|Overall Study||120||
48749620|NCT03633344|102173090|FG001|COMPLETED|Overall Study||24||
48749621|NCT03633344|102173089|FG000|NOT COMPLETED|Overall Study||0||
48749622|NCT03633344|102173090|FG001|NOT COMPLETED|Overall Study||0||
48749623|NCT02981368|102173091|FG000|STARTED|Overall Study||268||
48749624|NCT02981368|102173092|FG001|STARTED|Overall Study||117||
48749625|NCT02981368|102173091|FG000|COMPLETED|Overall Study||248||
48332499|NCT01465659|101141842|FG001|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||4||
48332500|NCT01465659|101141843|FG002|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||6||
48332501|NCT01465659|101141844|FG003|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||10||
48749626|NCT02981368|102173092|FG001|COMPLETED|Overall Study||102||
48332502|NCT01465659|101141841|FG000|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||7||
48749627|NCT02981368|102173091|FG000|NOT COMPLETED|Overall Study||20||
48749628|NCT02981368|102173092|FG001|NOT COMPLETED|Overall Study||15||
48749629|NCT00904813|102173093|FG000|STARTED|Overall Study||129||
48749630|NCT00904813|102173094|FG001|STARTED|Overall Study||128||
48749631|NCT00904813|102173095|FG002|STARTED|Overall Study||128||
48411358|NCT04840849|101337876|FG001|STARTED|Overall Study||6||
48411359|NCT04840849|101337875|FG000|COMPLETED|Overall Study||18||
48411360|NCT04840849|101337876|FG001|COMPLETED|Overall Study||6||
48411361|NCT04840849|101337875|FG000|NOT COMPLETED|Overall Study||0||
48411362|NCT04840849|101337876|FG001|NOT COMPLETED|Overall Study||0||
48411363|NCT03196973|101337877|FG000|STARTED|Overall Study||197||
48411364|NCT03196973|101337878|FG001|STARTED|Overall Study||196||
48749632|NCT00904813|102173096|FG003|STARTED|Overall Study||228||
48749633|NCT00904813|102173097|FG004|STARTED|Overall Study||227||
48169303|NCT01045122|100739091|FG000|COMPLETED|Propofol Then Dexmedetomidine||5||
48332503|NCT01465659|101141842|FG001|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||4||
48332504|NCT01465659|101141843|FG002|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||4||
48332505|NCT01465659|101141844|FG003|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||10||
48332506|NCT01465659|101141841|FG000|COMPLETED|Completed 2 Cycles/Reached 1st Response||5||
48332507|NCT01465659|101141842|FG001|COMPLETED|Completed 2 Cycles/Reached 1st Response||4||
48332508|NCT01465659|101141843|FG002|COMPLETED|Completed 2 Cycles/Reached 1st Response||4||
48332509|NCT01465659|101141844|FG003|COMPLETED|Completed 2 Cycles/Reached 1st Response||9||
48332510|NCT01465659|101141841|FG000|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||2||
48411365|NCT03196973|101337879|FG002|STARTED|Overall Study||100||
48411366|NCT03196973|101337877|FG000|COMPLETED|Overall Study||188||
48411367|NCT03196973|101337878|FG001|COMPLETED|Overall Study||184||
48411368|NCT03196973|101337879|FG002|COMPLETED|Overall Study||95||
48411369|NCT03196973|101337877|FG000|NOT COMPLETED|Overall Study||9||
48749634|NCT00904813|102173093|FG000|COMPLETED|Overall Study||129||
48749635|NCT00904813|102173094|FG001|COMPLETED|Overall Study||128||
48749636|NCT00904813|102173095|FG002|COMPLETED|Overall Study||128||
48169304|NCT01045122|100739092|FG001|COMPLETED|Propofol Then Dexmedetomidine||6||
48169305|NCT01045122|100739091|FG000|NOT COMPLETED|Propofol Then Dexmedetomidine||0||
48169306|NCT01045122|100739092|FG001|NOT COMPLETED|Propofol Then Dexmedetomidine||0||
48169307|NCT00482274|100739093|FG000|STARTED|Overall Study||3||
48169308|NCT00482274|100739093|FG000|COMPLETED|Overall Study||2||
48169309|NCT00482274|100739093|FG000|NOT COMPLETED|Overall Study||1||
48169310|NCT04186403|100739094|FG000|STARTED|Overall Study||90||
48169311|NCT04186403|100739095|FG001|STARTED|Overall Study||111||
48169312|NCT04186403|100739094|FG000|Safety Sample|Overall Study||88|Safety sample included all participants who received at least 1 dose of investigational medicinal product (IMP).|
48169313|NCT04186403|100739095|FG001|Safety Sample|Overall Study||111|Safety sample included all participants who received at least 1 dose of investigational medicinal product (IMP).|
48169314|NCT04186403|100739094|FG000|COMPLETED|Overall Study||71||
48169315|NCT04186403|100739095|FG001|COMPLETED|Overall Study||92||
48169316|NCT04186403|100739094|FG000|NOT COMPLETED|Overall Study||19||
48169317|NCT04186403|100739095|FG001|NOT COMPLETED|Overall Study||19||
48169318|NCT04041440|100739096|FG000|STARTED|Overall Study||12||
48169319|NCT04041440|100739097|FG001|STARTED|Overall Study||22||
48169320|NCT04041440|100739096|FG000|COMPLETED|Overall Study||12||
48169321|NCT04041440|100739097|FG001|COMPLETED|Overall Study||20||
48169322|NCT04041440|100739096|FG000|NOT COMPLETED|Overall Study||0||
48169323|NCT04041440|100739097|FG001|NOT COMPLETED|Overall Study||2||
48169324|NCT03278886|100739098|FG000|STARTED|Overall Study||8||
48169325|NCT03278886|100739099|FG001|STARTED|Overall Study||3||
48169326|NCT03278886|100739098|FG000|COMPLETED|Overall Study||8||
48169327|NCT03278886|100739099|FG001|COMPLETED|Overall Study||2||
48169328|NCT03278886|100739098|FG000|NOT COMPLETED|Overall Study||0||
48332511|NCT01465659|101141842|FG001|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0||
48332512|NCT01465659|101141843|FG002|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||2||
48411370|NCT03196973|101337878|FG001|NOT COMPLETED|Overall Study||12||
48411371|NCT03196973|101337879|FG002|NOT COMPLETED|Overall Study||5||
48411372|NCT01836029|101337880|FG000|STARTED|Overall Study||100||
48411373|NCT01836029|101337881|FG001|STARTED|Overall Study||95||
48411374|NCT01836029|101337880|FG000|COMPLETED|Overall Study||100||
48626504|NCT01111565|101870837|FG004|NOT COMPLETED|Phase B (Weeks 0 to 8)||0||
48749637|NCT00904813|102173096|FG003|COMPLETED|Overall Study||228||
48749638|NCT00904813|102173097|FG004|COMPLETED|Overall Study||227||
48169329|NCT03278886|100739099|FG001|NOT COMPLETED|Overall Study||1||
48169330|NCT01086605|100739100|FG000|STARTED|Overall Study||24||
48749639|NCT00904813|102173093|FG000|NOT COMPLETED|Overall Study||0||
48169331|NCT01086605|100739101|FG001|STARTED|Overall Study||22||
48169332|NCT01086605|100739100|FG000|COMPLETED|Overall Study||24||
48169333|NCT01086605|100739101|FG001|COMPLETED|Overall Study||22||
48169334|NCT01086605|100739100|FG000|NOT COMPLETED|Overall Study||0||
48411375|NCT01836029|101337881|FG001|COMPLETED|Overall Study||95||
48749640|NCT00904813|102173094|FG001|NOT COMPLETED|Overall Study||0||
48749641|NCT00904813|102173095|FG002|NOT COMPLETED|Overall Study||0||
48749642|NCT00904813|102173096|FG003|NOT COMPLETED|Overall Study||0||
48749643|NCT00904813|102173097|FG004|NOT COMPLETED|Overall Study||0||
48749644|NCT00217425|102173098|FG000|STARTED|Overall Study||46||
48749645|NCT00217425|102173098|FG000|Treated|Overall Study||44||
48749646|NCT00217425|102173098|FG000|Eligible and Treated|Overall Study||39||
48749647|NCT00217425|102173098|FG000|COMPLETED|Overall Study||9||
48749648|NCT00217425|102173098|FG000|NOT COMPLETED|Overall Study||37||
48749649|NCT01392547|102173099|FG000|STARTED|Overall Study||72||
48749650|NCT01392547|102173099|FG000|COMPLETED|Overall Study||64||
48749651|NCT01392547|102173099|FG000|NOT COMPLETED|Overall Study||8||
48749652|NCT01239511|102173100|FG000|STARTED|Overall Study||47||
48749653|NCT01239511|102173101|FG001|STARTED|Overall Study||45||
48749654|NCT01239511|102173102|FG002|STARTED|Overall Study||47||
48749655|NCT01239511|102173103|FG003|STARTED|Overall Study||47||
48749656|NCT01239511|102173100|FG000|COMPLETED|Overall Study||46||
48749657|NCT01239511|102173101|FG001|COMPLETED|Overall Study||40||
48749658|NCT01239511|102173102|FG002|COMPLETED|Overall Study||43||
48749659|NCT01239511|102173103|FG003|COMPLETED|Overall Study||38||
48749660|NCT01239511|102173100|FG000|NOT COMPLETED|Overall Study||1||
48749661|NCT01239511|102173101|FG001|NOT COMPLETED|Overall Study||5||
48749662|NCT01239511|102173102|FG002|NOT COMPLETED|Overall Study||4||
48749663|NCT01239511|102173103|FG003|NOT COMPLETED|Overall Study||9||
48749664|NCT00681629|102173104|FG000|STARTED|Overall Study||5||
48749665|NCT00681629|102173105|FG001|STARTED|Overall Study||2||
48749666|NCT00681629|102173104|FG000|COMPLETED|Overall Study||0||
48749667|NCT00681629|102173105|FG001|COMPLETED|Overall Study||0||
48749668|NCT00681629|102173104|FG000|NOT COMPLETED|Overall Study||5||
48749669|NCT00681629|102173105|FG001|NOT COMPLETED|Overall Study||2||
48749670|NCT00895284|102173106|FG000|STARTED|Overall Study||3||
48749671|NCT00895284|102173107|FG001|STARTED|Overall Study||0||
48749672|NCT00895284|102173106|FG000|COMPLETED|Overall Study||3||
48749673|NCT00895284|102173107|FG001|COMPLETED|Overall Study||0||
48749674|NCT00895284|102173106|FG000|NOT COMPLETED|Overall Study||0||
48749675|NCT00895284|102173107|FG001|NOT COMPLETED|Overall Study||0||
48749676|NCT03951077|102173108|FG000|STARTED|Overall Study||27|Randomized|
48749677|NCT03951077|102173109|FG001|STARTED|Overall Study||18|Randomized|
48749678|NCT03951077|102173110|FG002|STARTED|Overall Study||18|Randomized|
48749679|NCT03951077|102173111|FG003|STARTED|Overall Study||18|Randomized|
48749680|NCT03951077|102173112|FG004|STARTED|Overall Study||19|Randomized|
48749681|NCT03951077|102173113|FG005|STARTED|Overall Study||18|Randomized|
48749682|NCT03951077|102173108|FG000|Randomized and Treated|Overall Study||26||
48749683|NCT03951077|102173109|FG001|Randomized and Treated|Overall Study||18||
48749684|NCT03951077|102173110|FG002|Randomized and Treated|Overall Study||17||
48749685|NCT03951077|102173111|FG003|Randomized and Treated|Overall Study||17||
48749686|NCT03951077|102173112|FG004|Randomized and Treated|Overall Study||18||
48749687|NCT03951077|102173113|FG005|Randomized and Treated|Overall Study||18||
48749688|NCT03951077|102173108|FG000|COMPLETED|Overall Study||9||
48749689|NCT03951077|102173109|FG001|COMPLETED|Overall Study||4||
48749690|NCT03951077|102173110|FG002|COMPLETED|Overall Study||5||
48749691|NCT03951077|102173111|FG003|COMPLETED|Overall Study||6||
48169335|NCT01086605|100739101|FG001|NOT COMPLETED|Overall Study||0||
48749692|NCT03951077|102173112|FG004|COMPLETED|Overall Study||3||
48169336|NCT03077620|100739102|FG000|STARTED|Overall Study||14||
48169337|NCT03077620|100739103|FG001|STARTED|Overall Study||14||
48169338|NCT03077620|100739104|FG002|STARTED|Overall Study||14||
48169339|NCT03077620|100739105|FG003|STARTED|Overall Study||6||
48169340|NCT03077620|100739102|FG000|COMPLETED|Overall Study||13||
48169341|NCT03077620|100739103|FG001|COMPLETED|Overall Study||13||
48169342|NCT03077620|100739104|FG002|COMPLETED|Overall Study||12||
48169343|NCT03077620|100739105|FG003|COMPLETED|Overall Study||6||
48169344|NCT03077620|100739102|FG000|NOT COMPLETED|Overall Study||1||
48169345|NCT03077620|100739103|FG001|NOT COMPLETED|Overall Study||1||
48749693|NCT03951077|102173113|FG005|COMPLETED|Overall Study||7||
48169346|NCT03077620|100739104|FG002|NOT COMPLETED|Overall Study||2||
48749694|NCT03951077|102173108|FG000|NOT COMPLETED|Overall Study||18||
48749695|NCT03951077|102173109|FG001|NOT COMPLETED|Overall Study||14||
48749696|NCT03951077|102173110|FG002|NOT COMPLETED|Overall Study||13||
48749697|NCT03951077|102173111|FG003|NOT COMPLETED|Overall Study||12||
48749698|NCT03951077|102173112|FG004|NOT COMPLETED|Overall Study||16||
48749699|NCT03951077|102173113|FG005|NOT COMPLETED|Overall Study||11||
48749700|NCT01377584|102173114|FG000|STARTED|Overall Study||8||
48749701|NCT01377584|102173115|FG001|STARTED|Overall Study||8||
48749702|NCT01377584|102173116|FG002|STARTED|Overall Study||10||
48749703|NCT01377584|102173117|FG003|STARTED|Overall Study||10||
48749704|NCT01377584|102173118|FG004|STARTED|Overall Study||12||
48749705|NCT01377584|102173119|FG005|STARTED|Overall Study||12||
48749706|NCT01377584|102173114|FG000|COMPLETED|Overall Study||5||
48749707|NCT01377584|102173115|FG001|COMPLETED|Overall Study||5||
48169347|NCT03077620|100739105|FG003|NOT COMPLETED|Overall Study||0||
48169348|NCT01676532|100739106|FG000|STARTED|Overall Study||127||
48169349|NCT01676532|100739106|FG000|COMPLETED|Overall Study||127||
48749708|NCT01377584|102173116|FG002|COMPLETED|Overall Study||6||
48749709|NCT01377584|102173117|FG003|COMPLETED|Overall Study||6||
48749710|NCT01377584|102173118|FG004|COMPLETED|Overall Study||9||
48749711|NCT01377584|102173119|FG005|COMPLETED|Overall Study||9||
48749712|NCT01377584|102173114|FG000|NOT COMPLETED|Overall Study||3||
48749713|NCT01377584|102173115|FG001|NOT COMPLETED|Overall Study||3||
48749714|NCT01377584|102173116|FG002|NOT COMPLETED|Overall Study||4||
48749715|NCT01377584|102173117|FG003|NOT COMPLETED|Overall Study||4||
48749716|NCT01377584|102173118|FG004|NOT COMPLETED|Overall Study||3||
48749717|NCT01377584|102173119|FG005|NOT COMPLETED|Overall Study||3||
48749718|NCT01020786|102173120|FG000|STARTED|Induction Period||109||
48749719|NCT01020786|102173120|FG000|COMPLETED|Induction Period||60||
48749720|NCT01020786|102173120|FG000|NOT COMPLETED|Induction Period||49||
48749721|NCT01020786|102173120|FG000|STARTED|Maintenance Period||60||
48749722|NCT01020786|102173120|FG000|COMPLETED|Maintenance Period||0||
48749723|NCT01020786|102173120|FG000|NOT COMPLETED|Maintenance Period||60||
48749724|NCT01422161|102173121|FG000|STARTED|Overall Study||10||
48749725|NCT01422161|102173122|FG001|STARTED|Overall Study||6||
48749726|NCT01422161|102173121|FG000|COMPLETED|Overall Study||10||
48749727|NCT01422161|102173122|FG001|COMPLETED|Overall Study||6||
48749728|NCT01422161|102173121|FG000|NOT COMPLETED|Overall Study||0||
48749729|NCT01422161|102173122|FG001|NOT COMPLETED|Overall Study||0||
48749730|NCT02752880|102173123|FG000|STARTED|Overall Study||23||
48749731|NCT02752880|102173124|FG001|STARTED|Overall Study||23||
48749732|NCT02752880|102173123|FG000|COMPLETED|Overall Study||21||
48749733|NCT02752880|102173124|FG001|COMPLETED|Overall Study||20||
48749734|NCT02752880|102173123|FG000|NOT COMPLETED|Overall Study||2||
48749735|NCT02752880|102173124|FG001|NOT COMPLETED|Overall Study||3||
48749736|NCT04023526|102173125|FG000|STARTED|Overall Study||51||
48749737|NCT04023526|102173126|FG001|STARTED|Overall Study||52||
48749738|NCT04023526|102173125|FG000|COMPLETED|Overall Study||46||
48749739|NCT04023526|102173126|FG001|COMPLETED|Overall Study||42||
48749740|NCT04023526|102173125|FG000|NOT COMPLETED|Overall Study||5||
48749741|NCT04023526|102173126|FG001|NOT COMPLETED|Overall Study||10||
48749742|NCT03174353|102173127|FG000|STARTED|Overall Study||114||
48749743|NCT03174353|102173127|FG000|COMPLETED|Overall Study||98||
48749744|NCT03174353|102173127|FG000|NOT COMPLETED|Overall Study||16||
48749745|NCT00960063|102173128|FG000|STARTED|Overall Study||1||
48749746|NCT00960063|102173129|FG001|STARTED|Overall Study||0||
48749747|NCT00960063|102173130|FG002|STARTED|Overall Study||3||
48749748|NCT00960063|102173128|FG000|COMPLETED|Overall Study||0||
48749749|NCT00960063|102173129|FG001|COMPLETED|Overall Study||0||
48749750|NCT00960063|102173130|FG002|COMPLETED|Overall Study||0||
48749751|NCT00960063|102173128|FG000|NOT COMPLETED|Overall Study||1||
48749752|NCT00960063|102173129|FG001|NOT COMPLETED|Overall Study||0||
48749753|NCT00960063|102173130|FG002|NOT COMPLETED|Overall Study||3||
48749754|NCT00953667|102173131|FG000|STARTED|Overall Study||400||
48749755|NCT00953667|102173131|FG000|COMPLETED|Overall Study||277||
48749756|NCT00953667|102173131|FG000|NOT COMPLETED|Overall Study||123||
48749757|NCT03347123|102173132|FG000|STARTED|Overall Study||5||
48749758|NCT03347123|102173133|FG001|STARTED|Overall Study||6||
48749759|NCT03347123|102173134|FG002|STARTED|Overall Study||0||
48749760|NCT03347123|102173135|FG003|STARTED|Overall Study||0||
48749761|NCT03347123|102173136|FG004|STARTED|Overall Study||0||
48749762|NCT03347123|102173137|FG005|STARTED|Overall Study||0||
48749763|NCT03347123|102173138|FG006|STARTED|Overall Study||0||
48749764|NCT03347123|102173132|FG000|COMPLETED|Overall Study||0||
48749765|NCT03347123|102173133|FG001|COMPLETED|Overall Study||0||
48749766|NCT03347123|102173134|FG002|COMPLETED|Overall Study||0||
48749767|NCT03347123|102173135|FG003|COMPLETED|Overall Study||0||
48749768|NCT03347123|102173136|FG004|COMPLETED|Overall Study||0||
48749769|NCT03347123|102173137|FG005|COMPLETED|Overall Study||0||
48749770|NCT03347123|102173138|FG006|COMPLETED|Overall Study||0||
48749771|NCT03347123|102173132|FG000|NOT COMPLETED|Overall Study||5||
48749772|NCT03347123|102173133|FG001|NOT COMPLETED|Overall Study||6||
48749773|NCT03347123|102173134|FG002|NOT COMPLETED|Overall Study||0||
48749774|NCT03347123|102173135|FG003|NOT COMPLETED|Overall Study||0||
48749775|NCT03347123|102173136|FG004|NOT COMPLETED|Overall Study||0||
48749776|NCT03347123|102173137|FG005|NOT COMPLETED|Overall Study||0||
48749777|NCT03347123|102173138|FG006|NOT COMPLETED|Overall Study||0||
48749778|NCT02960217|102173139|FG000|STARTED|Maintenance Phase: Treatment Period 1||22|Randomized and treated|
48749779|NCT02960217|102173140|FG001|STARTED|Maintenance Phase: Treatment Period 1||21|Randomized and treated|
48749780|NCT02960217|102173139|FG000|COMPLETED|Maintenance Phase: Treatment Period 1||21||
48749781|NCT02960217|102173140|FG001|COMPLETED|Maintenance Phase: Treatment Period 1||21||
48749782|NCT02960217|102173139|FG000|NOT COMPLETED|Maintenance Phase: Treatment Period 1||1||
48749783|NCT02960217|102173140|FG001|NOT COMPLETED|Maintenance Phase: Treatment Period 1||0||
48749784|NCT02960217|102173139|FG000|STARTED|Maintenance Phase: Crossover Washout||21||
48749785|NCT02960217|102173140|FG001|STARTED|Maintenance Phase: Crossover Washout||21||
48749786|NCT02960217|102173139|FG000|COMPLETED|Maintenance Phase: Crossover Washout||21||
48749787|NCT02960217|102173140|FG001|COMPLETED|Maintenance Phase: Crossover Washout||21||
48749788|NCT02960217|102173139|FG000|NOT COMPLETED|Maintenance Phase: Crossover Washout||0||
48749789|NCT02960217|102173140|FG001|NOT COMPLETED|Maintenance Phase: Crossover Washout||0||
48749790|NCT02960217|102173139|FG000|STARTED|Maintenance Phase: Treatment Period 2||21||
48749791|NCT02960217|102173140|FG001|STARTED|Maintenance Phase: Treatment Period 2||21||
48749792|NCT02960217|102173139|FG000|COMPLETED|Maintenance Phase: Treatment Period 2||20||
48749793|NCT02960217|102173140|FG001|COMPLETED|Maintenance Phase: Treatment Period 2||18||
48749794|NCT02960217|102173139|FG000|NOT COMPLETED|Maintenance Phase: Treatment Period 2||1||
48749795|NCT02960217|102173140|FG001|NOT COMPLETED|Maintenance Phase: Treatment Period 2||3||
48749796|NCT02960217|102173139|FG000|STARTED|Open-Label Extension Phase||20||
48749797|NCT02960217|102173140|FG001|STARTED|Open-Label Extension Phase||13||
48749798|NCT02960217|102173139|FG000|COMPLETED|Open-Label Extension Phase||0||
48749799|NCT02960217|102173140|FG001|COMPLETED|Open-Label Extension Phase||0||
48749800|NCT02960217|102173139|FG000|NOT COMPLETED|Open-Label Extension Phase||20||
48749801|NCT02960217|102173140|FG001|NOT COMPLETED|Open-Label Extension Phase||13||
48749802|NCT02675907|102173141|FG000|STARTED|Treatment Phase (48 Hours Post-Dose 1)||100||
48749803|NCT02675907|102173142|FG001|STARTED|Treatment Phase (48 Hours Post-Dose 1)||101||
48749804|NCT02675907|102173141|FG000|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||95||
48749805|NCT02675907|102173142|FG001|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||96||
48749806|NCT02675907|102173141|FG000|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5||
48749807|NCT02675907|102173142|FG001|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5||
48749808|NCT02675907|102173141|FG000|STARTED|Study Overall||100||
48749809|NCT02675907|102173142|FG001|STARTED|Study Overall||101||
48749810|NCT02675907|102173141|FG000|COMPLETED|Study Overall||97||
48749811|NCT02675907|102173142|FG001|COMPLETED|Study Overall||97||
48749812|NCT02675907|102173141|FG000|NOT COMPLETED|Study Overall||3||
48749813|NCT02675907|102173142|FG001|NOT COMPLETED|Study Overall||4||
48749814|NCT04309110|102173143|FG000|STARTED|Overall Study||20||
48749815|NCT04309110|102173144|FG001|STARTED|Overall Study||20||
48749816|NCT04309110|102173143|FG000|COMPLETED|Overall Study||20||
48749817|NCT04309110|102173144|FG001|COMPLETED|Overall Study||20||
48749818|NCT04309110|102173143|FG000|NOT COMPLETED|Overall Study||0||
48749819|NCT04309110|102173144|FG001|NOT COMPLETED|Overall Study||0||
48749820|NCT00503750|102173145|FG000|STARTED|Overall Study||27||
48749821|NCT00503750|102173145|FG000|COMPLETED|Overall Study||27||
48749822|NCT00503750|102173145|FG000|NOT COMPLETED|Overall Study||0||
48749823|NCT02748863|102173146|FG000|STARTED|Treatment Period 1||72||
48749824|NCT02748863|102173147|FG001|STARTED|Treatment Period 1||71||
48749825|NCT02748863|102173148|FG002|STARTED|Treatment Period 1||71||
48749826|NCT02748863|102173149|FG003|STARTED|Treatment Period 1||0||
48749827|NCT02748863|102173150|FG004|STARTED|Treatment Period 1||0||
48749828|NCT02748863|102173146|FG000|COMPLETED|Treatment Period 1||72||
48749829|NCT02748863|102173147|FG001|COMPLETED|Treatment Period 1||69||
48749830|NCT02748863|102173148|FG002|COMPLETED|Treatment Period 1||69||
48749831|NCT02748863|102173149|FG003|COMPLETED|Treatment Period 1||0||
48749832|NCT02748863|102173150|FG004|COMPLETED|Treatment Period 1||0||
48749833|NCT02748863|102173146|FG000|NOT COMPLETED|Treatment Period 1||0||
48749834|NCT02748863|102173147|FG001|NOT COMPLETED|Treatment Period 1||2||
48749835|NCT02748863|102173148|FG002|NOT COMPLETED|Treatment Period 1||2||
48749836|NCT02748863|102173149|FG003|NOT COMPLETED|Treatment Period 1||0||
48749837|NCT02748863|102173150|FG004|NOT COMPLETED|Treatment Period 1||0||
48749838|NCT02748863|102173146|FG000|STARTED|Treatment Period 2||72||
48749839|NCT02748863|102173147|FG001|STARTED|Treatment Period 2||69||
48749840|NCT02748863|102173148|FG002|STARTED|Treatment Period 2||0||
48749841|NCT02748863|102173149|FG003|STARTED|Treatment Period 2||34||
48749842|NCT02748863|102173150|FG004|STARTED|Treatment Period 2||34||
48749843|NCT02748863|102173146|FG000|COMPLETED|Treatment Period 2||67||
48749844|NCT02748863|102173147|FG001|COMPLETED|Treatment Period 2||66||
48749845|NCT02748863|102173148|FG002|COMPLETED|Treatment Period 2||0||
48749846|NCT02748863|102173149|FG003|COMPLETED|Treatment Period 2||32||
48749847|NCT02748863|102173150|FG004|COMPLETED|Treatment Period 2||33||
48749848|NCT02748863|102173146|FG000|NOT COMPLETED|Treatment Period 2||5||
48749849|NCT02748863|102173147|FG001|NOT COMPLETED|Treatment Period 2||3||
48749850|NCT02748863|102173148|FG002|NOT COMPLETED|Treatment Period 2||0||
48749851|NCT02748863|102173149|FG003|NOT COMPLETED|Treatment Period 2||2||
48749852|NCT02748863|102173150|FG004|NOT COMPLETED|Treatment Period 2||1||
48749853|NCT00551759|102173151|FG000|STARTED|Overall Study||22||
48749854|NCT00551759|102173151|FG000|Eligible and Began Treatment|Overall Study||21||
48749855|NCT00551759|102173151|FG000|Underwent Surgery|Overall Study||17||
48749856|NCT00551759|102173151|FG000|Received Adjuvant Therapy|Overall Study||12||
48749857|NCT00551759|102173151|FG000|COMPLETED|Overall Study||9||
48749858|NCT00551759|102173151|FG000|NOT COMPLETED|Overall Study||13||
48749859|NCT02485691|102173152|FG000|STARTED|Overall Study||129||
48749860|NCT02485691|102173153|FG001|STARTED|Overall Study||126||
48332513|NCT01465659|101141844|FG003|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||1||
48332514|NCT01465659|101141841|FG000|STARTED|Went on to Cycle 3 and Beyond||5||
48332515|NCT01465659|101141842|FG001|STARTED|Went on to Cycle 3 and Beyond||4||
48332516|NCT01465659|101141843|FG002|STARTED|Went on to Cycle 3 and Beyond||4||
48332517|NCT01465659|101141844|FG003|STARTED|Went on to Cycle 3 and Beyond||9||
48332518|NCT01465659|101141841|FG000|COMPLETED|Went on to Cycle 3 and Beyond||5||
48332519|NCT01465659|101141842|FG001|COMPLETED|Went on to Cycle 3 and Beyond||4||
48626505|NCT01111565|101870833|FG000|STARTED|Phase B + and Phase C (Weeks 9 to 14)||0||
48626506|NCT01111565|101870834|FG001|STARTED|Phase B + and Phase C (Weeks 9 to 14)||26||
48626507|NCT01111565|101870835|FG002|STARTED|Phase B + and Phase C (Weeks 9 to 14)||16||
48626508|NCT01111565|101870836|FG003|STARTED|Phase B + and Phase C (Weeks 9 to 14)||14||
48626509|NCT01111565|101870837|FG004|STARTED|Phase B + and Phase C (Weeks 9 to 14)||15||
48626510|NCT01111565|101870833|FG000|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||0||
48626511|NCT01111565|101870834|FG001|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||19||
48626512|NCT01111565|101870835|FG002|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||11||
48626513|NCT01111565|101870836|FG003|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||10||
48626514|NCT01111565|101870837|FG004|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||11||
48626515|NCT01111565|101870833|FG000|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||0||
48626516|NCT01111565|101870834|FG001|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||7||
48626517|NCT01111565|101870835|FG002|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||5||
48626518|NCT01111565|101870836|FG003|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||4||
48626519|NCT01111565|101870837|FG004|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||4||
48626520|NCT02792504|101870838|FG000|STARTED|Overall Study||669||
48626521|NCT02792504|101870838|FG000|Safety Analysis Set|Overall Study||639||
48332520|NCT01465659|101141843|FG002|COMPLETED|Went on to Cycle 3 and Beyond||4||
48332521|NCT01465659|101141844|FG003|COMPLETED|Went on to Cycle 3 and Beyond||9||
48332522|NCT01465659|101141841|FG000|NOT COMPLETED|Went on to Cycle 3 and Beyond||0||
48332523|NCT01465659|101141842|FG001|NOT COMPLETED|Went on to Cycle 3 and Beyond||0||
48332524|NCT01465659|101141843|FG002|NOT COMPLETED|Went on to Cycle 3 and Beyond||0||
48332525|NCT01465659|101141844|FG003|NOT COMPLETED|Went on to Cycle 3 and Beyond||0||
48626522|NCT02792504|101870838|FG000|Efficacy Analysis Set|Overall Study||390||
48626523|NCT02792504|101870838|FG000|COMPLETED|Overall Study||639||
48626524|NCT02792504|101870838|FG000|NOT COMPLETED|Overall Study||30||
48626525|NCT00483652|101870839|FG000|STARTED|Double-blind Treatment Period||120||
48626526|NCT00483652|101870840|FG001|STARTED|Double-blind Treatment Period||119||
48626527|NCT00483652|101870839|FG000|COMPLETED|Double-blind Treatment Period||113||
48749861|NCT02485691|102173152|FG000|Treated|Overall Study||126||
48749862|NCT02485691|102173153|FG001|Treated|Overall Study||124||
48749863|NCT02485691|102173152|FG000|COMPLETED|Overall Study||0||
48749864|NCT02485691|102173153|FG001|COMPLETED|Overall Study||0||
48749865|NCT02485691|102173152|FG000|NOT COMPLETED|Overall Study||129||
48169350|NCT01676532|100739106|FG000|NOT COMPLETED|Overall Study||0||
48169351|NCT04567693|100739107|FG000|STARTED|Overall Study||32||
48169352|NCT04567693|100739108|FG001|STARTED|Overall Study||31||
48332526|NCT01465659|101141841|FG000|STARTED|Completed Follow for 1 Year||7|Any patient that is treated with study drug goes into follow up after treatment discontinuation.|
48332527|NCT01465659|101141842|FG001|STARTED|Completed Follow for 1 Year||4|Any patient that is treated with study drug goes into follow up after treatment discontinuation.|
48332528|NCT01465659|101141843|FG002|STARTED|Completed Follow for 1 Year||6|Any patient that is treated with study drug goes into follow up after treatment discontinuation.|
48332529|NCT01465659|101141844|FG003|STARTED|Completed Follow for 1 Year||11|Any patient that is treated with study drug goes into follow up after treatment discontinuation.|
48332530|NCT01465659|101141841|FG000|COMPLETED|Completed Follow for 1 Year||1||
48332531|NCT01465659|101141842|FG001|COMPLETED|Completed Follow for 1 Year||1||
48332532|NCT01465659|101141843|FG002|COMPLETED|Completed Follow for 1 Year||4||
48332533|NCT01465659|101141844|FG003|COMPLETED|Completed Follow for 1 Year||7||
48169353|NCT04567693|100739109|FG002|STARTED|Overall Study||30||
48169354|NCT04567693|100739107|FG000|COMPLETED|Overall Study||30||
48169355|NCT04567693|100739108|FG001|COMPLETED|Overall Study||31||
48169356|NCT04567693|100739109|FG002|COMPLETED|Overall Study||24||
48169357|NCT04567693|100739107|FG000|NOT COMPLETED|Overall Study||2||
48169358|NCT04567693|100739108|FG001|NOT COMPLETED|Overall Study||0||
48169359|NCT04567693|100739109|FG002|NOT COMPLETED|Overall Study||6||
48169360|NCT01464021|100739110|FG000|STARTED|Overall Study||26||
48169361|NCT01464021|100739110|FG000|COMPLETED|Overall Study||0||
48169362|NCT01464021|100739110|FG000|NOT COMPLETED|Overall Study||26||
48169363|NCT04498247|100739111|FG000|STARTED|Overall Study||21||
48169364|NCT04498247|100739112|FG001|STARTED|Overall Study||80||
48169365|NCT04498247|100739113|FG002|STARTED|Overall Study||4||
48169366|NCT04498247|100739114|FG003|STARTED|Overall Study||81||
48169367|NCT04498247|100739115|FG004|STARTED|Overall Study||4||
48169368|NCT04498247|100739116|FG005|STARTED|Overall Study||20||
48169369|NCT04498247|100739117|FG006|STARTED|Overall Study||51||
48169370|NCT04498247|100739118|FG007|STARTED|Overall Study||2||
48169371|NCT04498247|100739111|FG000|Vaccination 1|Overall Study||20||
48169372|NCT04498247|100739112|FG001|Vaccination 1|Overall Study||80||
48169373|NCT04498247|100739113|FG002|Vaccination 1|Overall Study||4||
48169374|NCT04498247|100739114|FG003|Vaccination 1|Overall Study||81||
48169375|NCT04498247|100739115|FG004|Vaccination 1|Overall Study||4||
48169376|NCT04498247|100739116|FG005|Vaccination 1|Overall Study||20||
48169377|NCT04498247|100739117|FG006|Vaccination 1|Overall Study||51||
48169378|NCT04498247|100739118|FG007|Vaccination 1|Overall Study||2||
48626528|NCT00483652|101870840|FG001|COMPLETED|Double-blind Treatment Period||114||
48626529|NCT00483652|101870839|FG000|NOT COMPLETED|Double-blind Treatment Period||7||
48626530|NCT00483652|101870840|FG001|NOT COMPLETED|Double-blind Treatment Period||5||
48626531|NCT00483652|101870839|FG000|STARTED|Post-study Follow-up||113||
48626532|NCT00483652|101870840|FG001|STARTED|Post-study Follow-up||114||
48626533|NCT00483652|101870839|FG000|COMPLETED|Post-study Follow-up||113||
48626534|NCT00483652|101870840|FG001|COMPLETED|Post-study Follow-up||114||
48626535|NCT00483652|101870839|FG000|NOT COMPLETED|Post-study Follow-up||0||
48169379|NCT04498247|100739111|FG000|Vaccination 2|Overall Study||0||
48169380|NCT04498247|100739112|FG001|Vaccination 2|Overall Study||0||
48626536|NCT00483652|101870840|FG001|NOT COMPLETED|Post-study Follow-up||0||
48332534|NCT01465659|101141841|FG000|NOT COMPLETED|Completed Follow for 1 Year||6||
48332535|NCT01465659|101141842|FG001|NOT COMPLETED|Completed Follow for 1 Year||3||
48169381|NCT04498247|100739113|FG002|Vaccination 2|Overall Study||4||
48169382|NCT04498247|100739114|FG003|Vaccination 2|Overall Study||0||
48169383|NCT04498247|100739115|FG004|Vaccination 2|Overall Study||4||
48332536|NCT01465659|101141843|FG002|NOT COMPLETED|Completed Follow for 1 Year||2||
48169384|NCT04498247|100739116|FG005|Vaccination 2|Overall Study||0||
48332537|NCT01465659|101141844|FG003|NOT COMPLETED|Completed Follow for 1 Year||4||
48626537|NCT00643201|101870841|FG000|STARTED|Randomized, Completed 6 Months of Study||2691||
48749866|NCT02485691|102173153|FG001|NOT COMPLETED|Overall Study||126||
48749867|NCT01379183|102173154|FG000|STARTED|Overall Study||19||
48749868|NCT01379183|102173155|FG001|STARTED|Overall Study||21||
48169385|NCT04498247|100739117|FG006|Vaccination 2|Overall Study||0||
48169386|NCT04498247|100739118|FG007|Vaccination 2|Overall Study||2||
48169387|NCT04498247|100739111|FG000|COMPLETED|Overall Study||20||
48169388|NCT04498247|100739112|FG001|COMPLETED|Overall Study||68||
48169389|NCT04498247|100739113|FG002|COMPLETED|Overall Study||4||
48169390|NCT04498247|100739114|FG003|COMPLETED|Overall Study||70||
48169391|NCT04498247|100739115|FG004|COMPLETED|Overall Study||4||
48169392|NCT04498247|100739116|FG005|COMPLETED|Overall Study||20||
48169393|NCT04498247|100739117|FG006|COMPLETED|Overall Study||43||
48169394|NCT04498247|100739118|FG007|COMPLETED|Overall Study||2||
48169395|NCT04498247|100739111|FG000|NOT COMPLETED|Overall Study||1||
48169396|NCT04498247|100739112|FG001|NOT COMPLETED|Overall Study||12||
48169397|NCT04498247|100739113|FG002|NOT COMPLETED|Overall Study||0||
48169398|NCT04498247|100739114|FG003|NOT COMPLETED|Overall Study||11||
48169399|NCT04498247|100739115|FG004|NOT COMPLETED|Overall Study||0||
48626538|NCT00643201|101870842|FG001|STARTED|Randomized, Completed 6 Months of Study||2704||
48626539|NCT00643201|101870841|FG000|COMPLETED|Randomized, Completed 6 Months of Study||2314||
48626540|NCT00643201|101870842|FG001|COMPLETED|Randomized, Completed 6 Months of Study||2291||
48626541|NCT00643201|101870841|FG000|NOT COMPLETED|Randomized, Completed 6 Months of Study||377||
48169400|NCT04498247|100739116|FG005|NOT COMPLETED|Overall Study||0||
48169401|NCT04498247|100739117|FG006|NOT COMPLETED|Overall Study||8||
48169402|NCT04498247|100739118|FG007|NOT COMPLETED|Overall Study||0||
48169403|NCT02081456|100739119|FG000|STARTED|Overall Study||11||
48169404|NCT02081456|100739120|FG001|STARTED|Overall Study||12||
48169405|NCT02081456|100739119|FG000|COMPLETED|Overall Study||11||
48169406|NCT02081456|100739120|FG001|COMPLETED|Overall Study||12||
48169407|NCT02081456|100739119|FG000|NOT COMPLETED|Overall Study||0||
48169408|NCT02081456|100739120|FG001|NOT COMPLETED|Overall Study||0||
48169409|NCT05126459|100739121|FG000|STARTED|Overall Study||20||
48169410|NCT05126459|100739122|FG001|STARTED|Overall Study||20||
48169411|NCT05126459|100739123|FG002|STARTED|Overall Study||20||
48169412|NCT05126459|100739121|FG000|COMPLETED|Overall Study||20||
48169413|NCT05126459|100739122|FG001|COMPLETED|Overall Study||20||
48169414|NCT05126459|100739123|FG002|COMPLETED|Overall Study||20||
48169415|NCT05126459|100739121|FG000|NOT COMPLETED|Overall Study||0||
48169416|NCT05126459|100739122|FG001|NOT COMPLETED|Overall Study||0||
48169417|NCT05126459|100739123|FG002|NOT COMPLETED|Overall Study||0||
48169418|NCT03327402|100739124|FG000|STARTED|Overall Study||24||
48169419|NCT03327402|100739124|FG000|Rich PK Sampling Group|Overall Study||12||
48169420|NCT03327402|100739124|FG000|Sparse PK Sampling Group|Overall Study||12||
48169421|NCT03327402|100739124|FG000|COMPLETED|Overall Study||22||
48169422|NCT03327402|100739124|FG000|NOT COMPLETED|Overall Study||2||
48169423|NCT02841267|100739125|FG000|STARTED|Lead-in (Untreated)||4|Participants were observed for 16 weeks prior to treatment.|
48169424|NCT02841267|100739126|FG001|STARTED|Lead-in (Untreated)||7|Participants were observed for 16 weeks prior to treatment.|
48169425|NCT02841267|100739127|FG002|STARTED|Lead-in (Untreated)||8|Participants were observed for 16 weeks prior to treatment.|
48169426|NCT02841267|100739125|FG000|COMPLETED|Lead-in (Untreated)||4||
48169427|NCT02841267|100739126|FG001|COMPLETED|Lead-in (Untreated)||7||
48169428|NCT02841267|100739127|FG002|COMPLETED|Lead-in (Untreated)||8||
48169429|NCT02841267|100739125|FG000|NOT COMPLETED|Lead-in (Untreated)||0||
48169430|NCT02841267|100739126|FG001|NOT COMPLETED|Lead-in (Untreated)||0||
48169431|NCT02841267|100739127|FG002|NOT COMPLETED|Lead-in (Untreated)||0||
48169432|NCT02841267|100739125|FG000|STARTED|Treatment Period||4||
48169433|NCT02841267|100739126|FG001|STARTED|Treatment Period||7||
48169434|NCT02841267|100739127|FG002|STARTED|Treatment Period||8||
48169435|NCT02841267|100739125|FG000|COMPLETED|Treatment Period||4||
48169436|NCT02841267|100739126|FG001|COMPLETED|Treatment Period||7||
48169437|NCT02841267|100739127|FG002|COMPLETED|Treatment Period||8||
48169438|NCT02841267|100739125|FG000|NOT COMPLETED|Treatment Period||0||
48169439|NCT02841267|100739126|FG001|NOT COMPLETED|Treatment Period||0||
48169440|NCT02841267|100739127|FG002|NOT COMPLETED|Treatment Period||0||
48169441|NCT02841267|100739125|FG000|STARTED|Extension Study||4||
48169442|NCT02841267|100739126|FG001|STARTED|Extension Study||6||
48169443|NCT02841267|100739127|FG002|STARTED|Extension Study||6||
48169444|NCT02841267|100739125|FG000|COMPLETED|Extension Study||4||
48169445|NCT02841267|100739126|FG001|COMPLETED|Extension Study||6||
48626542|NCT00643201|101870842|FG001|NOT COMPLETED|Randomized, Completed 6 Months of Study||413||
48626543|NCT00643201|101870841|FG000|STARTED|Completed Study Follow Up||2617||
48626544|NCT00643201|101870842|FG001|STARTED|Completed Study Follow Up||2639||
48169446|NCT02841267|100739127|FG002|COMPLETED|Extension Study||6||
48169447|NCT02841267|100739125|FG000|NOT COMPLETED|Extension Study||0||
48169448|NCT02841267|100739126|FG001|NOT COMPLETED|Extension Study||0||
48169449|NCT02841267|100739127|FG002|NOT COMPLETED|Extension Study||0||
48169450|NCT00366301|100739128|FG000|STARTED|Overall Study||124||
48169451|NCT00366301|100739129|FG001|STARTED|Overall Study||126||
48169452|NCT00366301|100739130|FG002|STARTED|Overall Study||126||
48169453|NCT00366301|100739131|FG003|STARTED|Overall Study||124||
48169454|NCT00366301|100739128|FG000|Either 6W or 14W CRP Obtained|Overall Study||120||
48169455|NCT00366301|100739129|FG001|Either 6W or 14W CRP Obtained|Overall Study||124||
48169456|NCT00366301|100739130|FG002|Either 6W or 14W CRP Obtained|Overall Study||124||
48169457|NCT00366301|100739131|FG003|Either 6W or 14W CRP Obtained|Overall Study||119||
48169458|NCT00366301|100739128|FG000|COMPLETED|Overall Study||116||
48169459|NCT00366301|100739129|FG001|COMPLETED|Overall Study||120||
48169460|NCT00366301|100739130|FG002|COMPLETED|Overall Study||122||
48169461|NCT00366301|100739131|FG003|COMPLETED|Overall Study||116||
48169462|NCT00366301|100739128|FG000|NOT COMPLETED|Overall Study||8||
48169463|NCT00366301|100739129|FG001|NOT COMPLETED|Overall Study||6||
48169464|NCT00366301|100739130|FG002|NOT COMPLETED|Overall Study||4||
48169465|NCT00366301|100739131|FG003|NOT COMPLETED|Overall Study||8||
48169466|NCT01024959|100739132|FG000|STARTED|Overall Study||507||
48169467|NCT01024959|100739132|FG000|COMPLETED|Overall Study||466||
48169468|NCT01024959|100739132|FG000|NOT COMPLETED|Overall Study||41||
48169469|NCT00584701|100739133|FG000|STARTED|Active Risperidone||49||
48169470|NCT00584701|100739133|FG000|COMPLETED|Active Risperidone||46||
48169471|NCT00584701|100739133|FG000|NOT COMPLETED|Active Risperidone||3||
48169472|NCT00584701|100739133|FG000|STARTED|Follow-up||46||
48169473|NCT00584701|100739133|FG000|COMPLETED|Follow-up||34||
48169474|NCT00584701|100739133|FG000|NOT COMPLETED|Follow-up||12||
48169475|NCT01263106|100739134|FG000|STARTED|Period 1 (7 Days)||11||
48169476|NCT01263106|100739135|FG001|STARTED|Period 1 (7 Days)||10||
48169477|NCT01263106|100739134|FG000|COMPLETED|Period 1 (7 Days)||11||
48169478|NCT01263106|100739135|FG001|COMPLETED|Period 1 (7 Days)||10||
48169479|NCT01263106|100739134|FG000|NOT COMPLETED|Period 1 (7 Days)||0||
48169480|NCT01263106|100739135|FG001|NOT COMPLETED|Period 1 (7 Days)||0||
48169481|NCT01263106|100739134|FG000|STARTED|Washout (at Least 7 Days)||11||
48169482|NCT01263106|100739135|FG001|STARTED|Washout (at Least 7 Days)||10||
48169483|NCT01263106|100739134|FG000|COMPLETED|Washout (at Least 7 Days)||10||
48169484|NCT01263106|100739135|FG001|COMPLETED|Washout (at Least 7 Days)||9||
48169485|NCT01263106|100739134|FG000|NOT COMPLETED|Washout (at Least 7 Days)||1||
48626545|NCT00643201|101870841|FG000|COMPLETED|Completed Study Follow Up||2547||
48626546|NCT00643201|101870842|FG001|COMPLETED|Completed Study Follow Up||2560||
48626547|NCT00643201|101870841|FG000|NOT COMPLETED|Completed Study Follow Up||70||
48626548|NCT00643201|101870842|FG001|NOT COMPLETED|Completed Study Follow Up||79||
48626549|NCT02425306|101870843|FG000|STARTED|Overall Study||3||
48626550|NCT02425306|101870844|FG001|STARTED|Overall Study||7||
48626551|NCT02425306|101870845|FG002|STARTED|Overall Study||6||
48626552|NCT02425306|101870846|FG003|STARTED|Overall Study||32||
48626553|NCT02425306|101870843|FG000|COMPLETED|Overall Study||3||
48626554|NCT02425306|101870844|FG001|COMPLETED|Overall Study||6||
48626555|NCT02425306|101870845|FG002|COMPLETED|Overall Study||5||
48626556|NCT02425306|101870846|FG003|COMPLETED|Overall Study||18||
48626557|NCT02425306|101870843|FG000|NOT COMPLETED|Overall Study||0||
48626558|NCT02425306|101870844|FG001|NOT COMPLETED|Overall Study||1||
48626559|NCT02425306|101870845|FG002|NOT COMPLETED|Overall Study||1||
48626560|NCT02425306|101870846|FG003|NOT COMPLETED|Overall Study||14||
48626561|NCT00731822|101870847|FG000|STARTED|Overall Study||20||
48626562|NCT00731822|101870848|FG001|STARTED|Overall Study||40||
48626563|NCT00731822|101870847|FG000|COMPLETED|Overall Study||16||
48626564|NCT00731822|101870848|FG001|COMPLETED|Overall Study||39||
48626565|NCT00731822|101870847|FG000|NOT COMPLETED|Overall Study||4||
48626566|NCT00731822|101870848|FG001|NOT COMPLETED|Overall Study||1||
48626567|NCT00607243|101870849|FG000|STARTED|Initial Post-vaccination Period||82||
48626568|NCT00607243|101870850|FG001|STARTED|Initial Post-vaccination Period||41||
48626569|NCT00607243|101870849|FG000|COMPLETED|Initial Post-vaccination Period||82||
48626570|NCT00607243|101870850|FG001|COMPLETED|Initial Post-vaccination Period||41||
48626571|NCT00607243|101870849|FG000|NOT COMPLETED|Initial Post-vaccination Period||0||
48626572|NCT00607243|101870850|FG001|NOT COMPLETED|Initial Post-vaccination Period||0||
48626573|NCT00607243|101870849|FG000|STARTED|Telephone Safety Assessment Period||82||
48626574|NCT00607243|101870850|FG001|STARTED|Telephone Safety Assessment Period||41||
48626575|NCT00607243|101870849|FG000|COMPLETED|Telephone Safety Assessment Period||77||
48626576|NCT00607243|101870850|FG001|COMPLETED|Telephone Safety Assessment Period||39||
48626577|NCT00607243|101870849|FG000|NOT COMPLETED|Telephone Safety Assessment Period||5||
48626578|NCT00607243|101870850|FG001|NOT COMPLETED|Telephone Safety Assessment Period||2||
48626579|NCT03041441|101870851|FG000|STARTED|Overall Study||5||
48626580|NCT03041441|101870851|FG000|COMPLETED|Overall Study||3||
48626581|NCT03041441|101870851|FG000|NOT COMPLETED|Overall Study||2||
48626582|NCT00983372|101870852|FG000|STARTED|Colchicine Alone||24||
48169486|NCT01263106|100739135|FG001|NOT COMPLETED|Washout (at Least 7 Days)||1||
48169487|NCT01263106|100739134|FG000|STARTED|Period 2 (7 Days)||10||
48169488|NCT01263106|100739135|FG001|STARTED|Period 2 (7 Days)||9||
48169489|NCT01263106|100739134|FG000|COMPLETED|Period 2 (7 Days)||10||
48169490|NCT01263106|100739135|FG001|COMPLETED|Period 2 (7 Days)||9||
48169491|NCT01263106|100739134|FG000|NOT COMPLETED|Period 2 (7 Days)||0||
48169492|NCT01263106|100739135|FG001|NOT COMPLETED|Period 2 (7 Days)||0||
48169493|NCT02881008|100739136|FG000|STARTED|Overall Study||8||
48169494|NCT02881008|100739137|FG001|STARTED|Overall Study||8||
48169495|NCT02881008|100739138|FG002|STARTED|Overall Study||8||
48169496|NCT02881008|100739139|FG003|STARTED|Overall Study||8||
48626583|NCT00983372|101870852|FG000|COMPLETED|Colchicine Alone||24||
48626584|NCT00983372|101870852|FG000|NOT COMPLETED|Colchicine Alone||0||
48626585|NCT00983372|101870852|FG000|STARTED|14 Day Washout Period||24||
48626586|NCT00983372|101870852|FG000|COMPLETED|14 Day Washout Period||23||
48626587|NCT00983372|101870852|FG000|NOT COMPLETED|14 Day Washout Period||1||
48626588|NCT00983372|101870852|FG000|STARTED|Diltiazem ER Alone||23||
48169497|NCT02881008|100739140|FG004|STARTED|Overall Study||8||
48169498|NCT02881008|100739141|FG005|STARTED|Overall Study||8||
48169499|NCT02881008|100739136|FG000|COMPLETED|Overall Study||8||
48169500|NCT02881008|100739137|FG001|COMPLETED|Overall Study||8||
48169501|NCT02881008|100739138|FG002|COMPLETED|Overall Study||8||
48169502|NCT02881008|100739139|FG003|COMPLETED|Overall Study||8||
48169503|NCT02881008|100739140|FG004|COMPLETED|Overall Study||8||
48169504|NCT02881008|100739141|FG005|COMPLETED|Overall Study||8||
48169505|NCT02881008|100739136|FG000|NOT COMPLETED|Overall Study||0||
48169506|NCT02881008|100739137|FG001|NOT COMPLETED|Overall Study||0||
48169507|NCT02881008|100739138|FG002|NOT COMPLETED|Overall Study||0||
48169508|NCT02881008|100739139|FG003|NOT COMPLETED|Overall Study||0||
48169509|NCT02881008|100739140|FG004|NOT COMPLETED|Overall Study||0||
48169510|NCT02881008|100739141|FG005|NOT COMPLETED|Overall Study||0||
48169511|NCT01597505|100739142|FG000|STARTED|Overall Study||308||
48169512|NCT01597505|100739143|FG001|STARTED|Overall Study||298||
48169513|NCT01597505|100739142|FG000|Treated|Overall Study||305||
48169514|NCT01597505|100739143|FG001|Treated|Overall Study||286||
48169515|NCT01597505|100739142|FG000|COMPLETED|Overall Study||264||
48169516|NCT01597505|100739143|FG001|COMPLETED|Overall Study||265||
48169517|NCT01597505|100739142|FG000|NOT COMPLETED|Overall Study||44||
48169518|NCT01597505|100739143|FG001|NOT COMPLETED|Overall Study||33||
48169519|NCT04219618|100739144|FG000|STARTED|Overall Study||1||
48169520|NCT04219618|100739145|FG001|STARTED|Overall Study||1||
48169521|NCT04219618|100739144|FG000|COMPLETED|Overall Study||1||
48169522|NCT04219618|100739145|FG001|COMPLETED|Overall Study||1||
48169523|NCT04219618|100739144|FG000|NOT COMPLETED|Overall Study||0||
48169524|NCT04219618|100739145|FG001|NOT COMPLETED|Overall Study||0||
48169525|NCT00119262|100739146|FG000|STARTED|Overall Study||104||
48169526|NCT00119262|100739147|FG001|STARTED|Overall Study||122||
48169527|NCT00119262|100739146|FG000|Eligible|Overall Study||103||
48169528|NCT00119262|100739147|FG001|Eligible|Overall Study||120||
48332538|NCT00684957|101141845|FG000|STARTED|Overall Study||2||
48332539|NCT00684957|101141846|FG001|STARTED|Overall Study||3||
48332540|NCT00684957|101141845|FG000|COMPLETED|Overall Study||0||
48169529|NCT00119262|100739146|FG000|Treated|Overall Study||103||
48332541|NCT00684957|101141846|FG001|COMPLETED|Overall Study||2||
48332542|NCT00684957|101141845|FG000|NOT COMPLETED|Overall Study||2||
48332543|NCT00684957|101141846|FG001|NOT COMPLETED|Overall Study||1||
48332544|NCT01583374|101141847|FG000|STARTED|Placebo-controlled Phase (Week 0-24)||164||
48169530|NCT00119262|100739147|FG001|Treated|Overall Study||120||
48169531|NCT00119262|100739146|FG000|Eligible and Treated|Overall Study||102||
48169532|NCT00119262|100739147|FG001|Eligible and Treated|Overall Study||119||
48169533|NCT00119262|100739146|FG000|COMPLETED|Overall Study||58||
48169534|NCT00119262|100739147|FG001|COMPLETED|Overall Study||64||
48169535|NCT00119262|100739146|FG000|NOT COMPLETED|Overall Study||46||
48169536|NCT00119262|100739147|FG001|NOT COMPLETED|Overall Study||58||
48626589|NCT00983372|101870852|FG000|COMPLETED|Diltiazem ER Alone||20||
48626590|NCT00983372|101870852|FG000|NOT COMPLETED|Diltiazem ER Alone||3||
48626591|NCT00983372|101870852|FG000|STARTED|Colchicine With Diltiazem ER||20||
48626592|NCT00983372|101870852|FG000|COMPLETED|Colchicine With Diltiazem ER||20||
48626593|NCT00983372|101870852|FG000|NOT COMPLETED|Colchicine With Diltiazem ER||0||
48626594|NCT03006562|101870853|FG000|STARTED|Overall Study||251||
48626595|NCT03006562|101870854|FG001|STARTED|Overall Study||250||
48626596|NCT03006562|101870853|FG000|Voluntary Ultrasound at 30 Days|Overall Study||141||
48332545|NCT01583374|101141848|FG001|STARTED|Placebo-controlled Phase (Week 0-24)||163||
48332546|NCT01583374|101141849|FG002|STARTED|Placebo-controlled Phase (Week 0-24)||163||
48169537|NCT00423293|100739148|FG000|STARTED|Overall Study||63||
48169538|NCT00423293|100739148|FG000|COMPLETED|Overall Study||52||
48169539|NCT00423293|100739148|FG000|NOT COMPLETED|Overall Study||11||
48626597|NCT03006562|101870854|FG001|Voluntary Ultrasound at 30 Days|Overall Study||137||
48626598|NCT03006562|101870853|FG000|COMPLETED|Overall Study||251||
48749869|NCT01379183|102173154|FG000|COMPLETED|Overall Study||19||
48749870|NCT01379183|102173155|FG001|COMPLETED|Overall Study||21||
48749871|NCT01379183|102173154|FG000|NOT COMPLETED|Overall Study||0||
48749872|NCT01379183|102173155|FG001|NOT COMPLETED|Overall Study||0||
48169540|NCT02145078|100739149|FG000|STARTED|Overall Study||4||
48169541|NCT02145078|100739149|FG000|COMPLETED|Overall Study||0||
48169542|NCT02145078|100739149|FG000|NOT COMPLETED|Overall Study||4||
48169543|NCT01662531|100739150|FG000|STARTED|Overall Study||27||
48169544|NCT01662531|100739150|FG000|COMPLETED|Overall Study||27||
48749873|NCT04292535|102173156|FG000|STARTED|Overall Study||8||
48749874|NCT04292535|102173157|FG001|STARTED|Overall Study||8||
48749875|NCT04292535|102173158|FG002|STARTED|Overall Study||9||
48169545|NCT01662531|100739150|FG000|NOT COMPLETED|Overall Study||0||
48169546|NCT01051063|100739151|FG000|STARTED|Overall Study||12||
48169547|NCT01051063|100739152|FG001|STARTED|Overall Study||5||
48169548|NCT01051063|100739151|FG000|COMPLETED|Overall Study||2||
48169549|NCT01051063|100739152|FG001|COMPLETED|Overall Study||1||
48332547|NCT01583374|101141850|FG003|STARTED|Placebo-controlled Phase (Week 0-24)||0||
48332548|NCT01583374|101141851|FG004|STARTED|Placebo-controlled Phase (Week 0-24)||0||
48626599|NCT03006562|101870854|FG001|COMPLETED|Overall Study||249||
48749876|NCT04292535|102173159|FG003|STARTED|Overall Study||8||
48169550|NCT01051063|100739151|FG000|NOT COMPLETED|Overall Study||10||
48169551|NCT01051063|100739152|FG001|NOT COMPLETED|Overall Study||4||
48626600|NCT03006562|101870853|FG000|NOT COMPLETED|Overall Study||0||
48169552|NCT00562978|100739153|FG000|STARTED|Overall Study||6||
48169553|NCT00562978|100739154|FG001|STARTED|Overall Study||48||
48169554|NCT00562978|100739153|FG000|COMPLETED|Overall Study||5||
48169555|NCT00562978|100739154|FG001|COMPLETED|Overall Study||37||
48169556|NCT00562978|100739153|FG000|NOT COMPLETED|Overall Study||1||
48169557|NCT00562978|100739154|FG001|NOT COMPLETED|Overall Study||11||
48169558|NCT05082142|100739155|FG000|STARTED|Overall Study||55||
48169559|NCT05082142|100739156|FG001|STARTED|Overall Study||55||
48169560|NCT05082142|100739155|FG000|COMPLETED|Overall Study||55||
48169561|NCT05082142|100739156|FG001|COMPLETED|Overall Study||55||
48169562|NCT05082142|100739155|FG000|NOT COMPLETED|Overall Study||0||
48169563|NCT05082142|100739156|FG001|NOT COMPLETED|Overall Study||0||
48169564|NCT02721641|100739157|FG000|STARTED|Overall Study||69||
48169565|NCT02721641|100739157|FG000|COMPLETED|Overall Study||69||
48169566|NCT02721641|100739157|FG000|NOT COMPLETED|Overall Study||0||
48169567|NCT00318149|100739158|FG000|STARTED|Overall Study||75||
48169568|NCT00318149|100739159|FG001|STARTED|Overall Study||50||
48169569|NCT00318149|100739160|FG002|STARTED|Overall Study||75||
48626601|NCT03006562|101870854|FG001|NOT COMPLETED|Overall Study||1||
48626602|NCT02662569|101870855|FG000|STARTED|Overall Study||166||
48626603|NCT02662569|101870856|FG001|STARTED|Overall Study||161||
48626604|NCT02662569|101870857|FG002|STARTED|Overall Study||327||
48626605|NCT02662569|101870858|FG003|STARTED|Overall Study||332||
48749877|NCT04292535|102173160|FG004|STARTED|Overall Study||8||
48749878|NCT04292535|102173161|FG005|STARTED|Overall Study||9||
48749879|NCT04292535|102173162|FG006|STARTED|Overall Study||8||
48169570|NCT00318149|100739161|FG003|STARTED|Overall Study||75||
48169571|NCT00318149|100739162|FG004|STARTED|Overall Study||75||
48169572|NCT00318149|100739163|FG005|STARTED|Overall Study||75||
48169573|NCT00318149|100739158|FG000|COMPLETED|Overall Study||75||
48169574|NCT00318149|100739159|FG001|COMPLETED|Overall Study||50||
48169575|NCT00318149|100739160|FG002|COMPLETED|Overall Study||75||
48169576|NCT00318149|100739161|FG003|COMPLETED|Overall Study||75||
48169577|NCT00318149|100739162|FG004|COMPLETED|Overall Study||75||
48169578|NCT00318149|100739163|FG005|COMPLETED|Overall Study||73||
48169579|NCT00318149|100739158|FG000|NOT COMPLETED|Overall Study||0||
48169580|NCT00318149|100739159|FG001|NOT COMPLETED|Overall Study||0||
48169581|NCT00318149|100739160|FG002|NOT COMPLETED|Overall Study||0||
48169582|NCT00318149|100739161|FG003|NOT COMPLETED|Overall Study||0||
48749880|NCT04292535|102173163|FG007|STARTED|Overall Study||10||
48749881|NCT04292535|102173164|FG008|STARTED|Overall Study||8||
48749882|NCT04292535|102173165|FG009|STARTED|Overall Study||8||
48749883|NCT04292535|102173166|FG010|STARTED|Overall Study||7||
48749884|NCT04292535|102173167|FG011|STARTED|Overall Study||7||
48749885|NCT04292535|102173168|FG012|STARTED|Overall Study||9||
48749886|NCT04292535|102173169|FG013|STARTED|Overall Study||9||
48749887|NCT04292535|102173156|FG000|COMPLETED|Overall Study||8||
48169583|NCT00318149|100739162|FG004|NOT COMPLETED|Overall Study||0||
48169584|NCT00318149|100739163|FG005|NOT COMPLETED|Overall Study||2||
48169585|NCT04249219|100739164|FG000|STARTED|Overall Study||62||
48169586|NCT04249219|100739164|FG000|COMPLETED|Overall Study||62||
48626606|NCT02662569|101870855|FG000|Received Study Drug|Overall Study||164|Study drug defined as subcutaneous evolocumab or placebo to evolocumab|
48626607|NCT02662569|101870856|FG001|Received Study Drug|Overall Study||160|Study drug defined as subcutaneous evolocumab or placebo to evolocumab|
48626608|NCT02662569|101870857|FG002|Received Study Drug|Overall Study||325|Study drug defined as subcutaneous evolocumab or placebo to evolocumab|
48626609|NCT02662569|101870858|FG003|Received Study Drug|Overall Study||332|Study drug defined as subcutaneous evolocumab or placebo to evolocumab|
48626610|NCT02662569|101870855|FG000|COMPLETED|Overall Study||159||
48626611|NCT02662569|101870856|FG001|COMPLETED|Overall Study||160||
48626612|NCT02662569|101870857|FG002|COMPLETED|Overall Study||321||
48626613|NCT02662569|101870858|FG003|COMPLETED|Overall Study||328||
48626614|NCT02662569|101870855|FG000|NOT COMPLETED|Overall Study||7||
48626615|NCT02662569|101870856|FG001|NOT COMPLETED|Overall Study||1||
48626616|NCT02662569|101870857|FG002|NOT COMPLETED|Overall Study||6||
48169587|NCT04249219|100739164|FG000|NOT COMPLETED|Overall Study||0||
48169588|NCT01356667|100739165|FG000|STARTED|Overall Study||4||
48169589|NCT01356667|100739166|FG001|STARTED|Overall Study||6||
48169590|NCT01356667|100739165|FG000|COMPLETED|Overall Study||0||
48169591|NCT01356667|100739166|FG001|COMPLETED|Overall Study||0||
48169592|NCT01356667|100739165|FG000|NOT COMPLETED|Overall Study||4||
48169593|NCT01356667|100739166|FG001|NOT COMPLETED|Overall Study||6||
48169594|NCT01798186|100739167|FG000|STARTED|Overall Study||6||
48169595|NCT01798186|100739168|FG001|STARTED|Overall Study||6||
48169596|NCT01798186|100739169|FG002|STARTED|Overall Study||6||
48169597|NCT01798186|100739170|FG003|STARTED|Overall Study||8||
48169598|NCT01798186|100739167|FG000|COMPLETED|Overall Study||6||
48169599|NCT01798186|100739168|FG001|COMPLETED|Overall Study||6||
48169600|NCT01798186|100739169|FG002|COMPLETED|Overall Study||6||
48169601|NCT01798186|100739170|FG003|COMPLETED|Overall Study||8||
48169602|NCT01798186|100739167|FG000|NOT COMPLETED|Overall Study||0||
48169603|NCT01798186|100739168|FG001|NOT COMPLETED|Overall Study||0||
48169604|NCT01798186|100739169|FG002|NOT COMPLETED|Overall Study||0||
48169605|NCT01798186|100739170|FG003|NOT COMPLETED|Overall Study||0||
48169606|NCT04078035|100739171|FG000|STARTED|Session1||36||
48169607|NCT04078035|100739172|FG001|STARTED|Session1||36||
48169608|NCT04078035|100739171|FG000|COMPLETED|Session1||36||
48169609|NCT04078035|100739172|FG001|COMPLETED|Session1||36||
48169610|NCT04078035|100739171|FG000|NOT COMPLETED|Session1||0||
48169611|NCT04078035|100739172|FG001|NOT COMPLETED|Session1||0||
48169612|NCT04078035|100739171|FG000|STARTED|Session 2||36||
48169613|NCT04078035|100739172|FG001|STARTED|Session 2||36||
48169614|NCT04078035|100739171|FG000|COMPLETED|Session 2||25||
48169615|NCT04078035|100739172|FG001|COMPLETED|Session 2||27||
48169616|NCT04078035|100739171|FG000|NOT COMPLETED|Session 2||11||
48626617|NCT02662569|101870858|FG003|NOT COMPLETED|Overall Study||4||
48626618|NCT03072550|101870859|FG000|STARTED|Overall Study||26||
48626619|NCT03072550|101870859|FG000|COMPLETED|Overall Study||24||
48626620|NCT03072550|101870859|FG000|NOT COMPLETED|Overall Study||2||
48626621|NCT02089347|101870860|FG000|STARTED|Overall Study||356||
48626622|NCT02089347|101870861|FG001|STARTED|Overall Study||178||
48626623|NCT02089347|101870860|FG000|COMPLETED|Overall Study||355||
48626624|NCT02089347|101870861|FG001|COMPLETED|Overall Study||178||
48626625|NCT02089347|101870860|FG000|NOT COMPLETED|Overall Study||1||
48626626|NCT02089347|101870861|FG001|NOT COMPLETED|Overall Study||0||
48626627|NCT01178294|101870862|FG000|STARTED|Overall Study||29||
48626628|NCT01178294|101870862|FG000|COMPLETED|Overall Study||18||
48626629|NCT01178294|101870862|FG000|NOT COMPLETED|Overall Study||11||
48626630|NCT00286182|101870863|FG000|STARTED|Overall Study||28||
48626631|NCT00286182|101870864|FG001|STARTED|Overall Study||28||
48626632|NCT00286182|101870863|FG000|COMPLETED|Overall Study||23||
48626633|NCT00286182|101870864|FG001|COMPLETED|Overall Study||25||
48626634|NCT00286182|101870863|FG000|NOT COMPLETED|Overall Study||5||
48626635|NCT00286182|101870864|FG001|NOT COMPLETED|Overall Study||3||
48626636|NCT02659943|101870865|FG000|STARTED|Overall Study||3||
48626637|NCT02659943|101870866|FG001|STARTED|Overall Study||2||
48626638|NCT02659943|101870867|FG002|STARTED|Overall Study||1||
48626639|NCT02659943|101870868|FG003|STARTED|Overall Study||4||
48626640|NCT02659943|101870869|FG004|STARTED|Overall Study||2||
48626641|NCT02659943|101870870|FG005|STARTED|Overall Study||9||
48626642|NCT02659943|101870871|FG006|STARTED|Overall Study||6||
48626643|NCT02659943|101870865|FG000|COMPLETED|Overall Study||2||
48749888|NCT04292535|102173157|FG001|COMPLETED|Overall Study||8||
48169617|NCT04078035|100739172|FG001|NOT COMPLETED|Session 2||9||
48169618|NCT03501693|100739173|FG000|STARTED|First Reading Session||75||
48169619|NCT03501693|100739174|FG001|STARTED|First Reading Session||75||
48169620|NCT03501693|100739173|FG000|COMPLETED|First Reading Session||75||
48169621|NCT03501693|100739174|FG001|COMPLETED|First Reading Session||75||
48169622|NCT03501693|100739173|FG000|NOT COMPLETED|First Reading Session||0||
48169623|NCT03501693|100739174|FG001|NOT COMPLETED|First Reading Session||0||
48169624|NCT03501693|100739173|FG000|STARTED|4 Week Memory Washout Period||75||
48169625|NCT03501693|100739174|FG001|STARTED|4 Week Memory Washout Period||75||
48169626|NCT03501693|100739173|FG000|COMPLETED|4 Week Memory Washout Period||75||
48169627|NCT03501693|100739174|FG001|COMPLETED|4 Week Memory Washout Period||75||
48169628|NCT03501693|100739173|FG000|NOT COMPLETED|4 Week Memory Washout Period||0||
48169629|NCT03501693|100739174|FG001|NOT COMPLETED|4 Week Memory Washout Period||0||
48169630|NCT03501693|100739173|FG000|STARTED|Second Reading Session||75||
48169631|NCT03501693|100739174|FG001|STARTED|Second Reading Session||75||
48169632|NCT03501693|100739173|FG000|COMPLETED|Second Reading Session||75||
48169633|NCT03501693|100739174|FG001|COMPLETED|Second Reading Session||75||
48169634|NCT03501693|100739173|FG000|NOT COMPLETED|Second Reading Session||0||
48169635|NCT03501693|100739174|FG001|NOT COMPLETED|Second Reading Session||0||
48169636|NCT03428126|100739175|FG000|STARTED|Overall Study||29||
48169637|NCT03428126|100739175|FG000|COMPLETED|Overall Study||29||
48626644|NCT02659943|101870866|FG001|COMPLETED|Overall Study||0||
48626645|NCT02659943|101870867|FG002|COMPLETED|Overall Study||0||
48626646|NCT02659943|101870868|FG003|COMPLETED|Overall Study||1||
48626647|NCT02659943|101870869|FG004|COMPLETED|Overall Study||0||
48626648|NCT02659943|101870870|FG005|COMPLETED|Overall Study||4||
48626649|NCT02659943|101870871|FG006|COMPLETED|Overall Study||0||
48169638|NCT03428126|100739175|FG000|NOT COMPLETED|Overall Study||0||
48169639|NCT01291225|100739176|FG000|STARTED|Overall Study||151||
48169640|NCT01291225|100739177|FG001|STARTED|Overall Study||160||
48169641|NCT01291225|100739176|FG000|COMPLETED|Overall Study||66||
48169642|NCT01291225|100739177|FG001|COMPLETED|Overall Study||121||
48169643|NCT01291225|100739176|FG000|NOT COMPLETED|Overall Study||85||
48169644|NCT01291225|100739177|FG001|NOT COMPLETED|Overall Study||39||
48169645|NCT01930435|100739178|FG000|STARTED|Overall Study||20||
48169646|NCT01930435|100739178|FG000|COMPLETED|Overall Study||20||
48169647|NCT01930435|100739178|FG000|NOT COMPLETED|Overall Study||0||
48169648|NCT01107743|100739179|FG000|STARTED|Overall Study||1291||
48169649|NCT01107743|100739179|FG000|COMPLETED|Overall Study||1245||
48169650|NCT01107743|100739179|FG000|NOT COMPLETED|Overall Study||46||
48169651|NCT02305381|100739180|FG000|STARTED|Overall Study||132||
48169652|NCT02305381|100739181|FG001|STARTED|Overall Study||132||
48749889|NCT04292535|102173158|FG002|COMPLETED|Overall Study||9||
48169653|NCT02305381|100739182|FG002|STARTED|Overall Study||133||
48169654|NCT02305381|100739180|FG000|Exposed|Overall Study||132||
48169655|NCT02305381|100739181|FG001|Exposed|Overall Study||131||
48169656|NCT02305381|100739182|FG002|Exposed|Overall Study||133||
48169657|NCT02305381|100739180|FG000|Premature Discontinuation of Treatment|Overall Study||14||
48169658|NCT02305381|100739181|FG001|Premature Discontinuation of Treatment|Overall Study||16||
48169659|NCT02305381|100739182|FG002|Premature Discontinuation of Treatment|Overall Study||13||
48169660|NCT02305381|100739180|FG000|COMPLETED|Overall Study||127||
48169661|NCT02305381|100739181|FG001|COMPLETED|Overall Study||127||
48169662|NCT02305381|100739182|FG002|COMPLETED|Overall Study||126||
48169663|NCT02305381|100739180|FG000|NOT COMPLETED|Overall Study||5||
48332549|NCT01583374|101141852|FG005|STARTED|Placebo-controlled Phase (Week 0-24)||0||
48332550|NCT01583374|101141853|FG006|STARTED|Placebo-controlled Phase (Week 0-24)||0||
48332551|NCT01583374|101141854|FG007|STARTED|Placebo-controlled Phase (Week 0-24)||0||
48332552|NCT01583374|101141855|FG008|STARTED|Placebo-controlled Phase (Week 0-24)||0||
48332553|NCT01583374|101141847|FG000|Received Treatment|Placebo-controlled Phase (Week 0-24)||164||
48332554|NCT01583374|101141848|FG001|Received Treatment|Placebo-controlled Phase (Week 0-24)||163||
48749890|NCT04292535|102173159|FG003|COMPLETED|Overall Study||8||
48749891|NCT04292535|102173160|FG004|COMPLETED|Overall Study||8||
48749892|NCT04292535|102173161|FG005|COMPLETED|Overall Study||9||
48332555|NCT01583374|101141849|FG002|Received Treatment|Placebo-controlled Phase (Week 0-24)||163||
48332556|NCT01583374|101141850|FG003|Received Treatment|Placebo-controlled Phase (Week 0-24)||0||
48332557|NCT01583374|101141851|FG004|Received Treatment|Placebo-controlled Phase (Week 0-24)||0||
48332558|NCT01583374|101141852|FG005|Received Treatment|Placebo-controlled Phase (Week 0-24)||0||
48332559|NCT01583374|101141853|FG006|Received Treatment|Placebo-controlled Phase (Week 0-24)||0||
48332560|NCT01583374|101141854|FG007|Received Treatment|Placebo-controlled Phase (Week 0-24)||0||
48332561|NCT01583374|101141855|FG008|Received Treatment|Placebo-controlled Phase (Week 0-24)||0||
48626650|NCT02659943|101870865|FG000|NOT COMPLETED|Overall Study||1||
48626651|NCT02659943|101870866|FG001|NOT COMPLETED|Overall Study||2||
48626652|NCT02659943|101870867|FG002|NOT COMPLETED|Overall Study||1||
48626653|NCT02659943|101870868|FG003|NOT COMPLETED|Overall Study||3||
48626654|NCT02659943|101870869|FG004|NOT COMPLETED|Overall Study||2||
48626655|NCT02659943|101870870|FG005|NOT COMPLETED|Overall Study||5||
48626656|NCT02659943|101870871|FG006|NOT COMPLETED|Overall Study||6||
48626657|NCT02139540|101870872|FG000|STARTED|Overall Study||11||
48749893|NCT04292535|102173162|FG006|COMPLETED|Overall Study||8||
48626658|NCT02139540|101870873|FG001|STARTED|Overall Study||10||
48626659|NCT02139540|101870872|FG000|COMPLETED|Overall Study||10||
48626660|NCT02139540|101870873|FG001|COMPLETED|Overall Study||10||
48749894|NCT04292535|102173163|FG007|COMPLETED|Overall Study||8||
48749895|NCT04292535|102173164|FG008|COMPLETED|Overall Study||8||
48749896|NCT04292535|102173165|FG009|COMPLETED|Overall Study||8||
48749897|NCT04292535|102173166|FG010|COMPLETED|Overall Study||7||
48749898|NCT04292535|102173167|FG011|COMPLETED|Overall Study||6||
48749899|NCT04292535|102173168|FG012|COMPLETED|Overall Study||8||
48169664|NCT02305381|100739181|FG001|NOT COMPLETED|Overall Study||5||
48169665|NCT02305381|100739182|FG002|NOT COMPLETED|Overall Study||7||
48169666|NCT01306175|100739183|FG000|STARTED|First Intervention||20||
48169667|NCT01306175|100739183|FG000|COMPLETED|First Intervention||20||
48169668|NCT01306175|100739183|FG000|NOT COMPLETED|First Intervention||0||
48169669|NCT01306175|100739183|FG000|STARTED|Washout Period of at Least 14 Days||20||
48169670|NCT01306175|100739183|FG000|COMPLETED|Washout Period of at Least 14 Days||20||
48169671|NCT01306175|100739183|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||0||
48169672|NCT01306175|100739183|FG000|STARTED|Second Intervention||20||
48169673|NCT01306175|100739183|FG000|COMPLETED|Second Intervention||20||
48169674|NCT01306175|100739183|FG000|NOT COMPLETED|Second Intervention||0||
48169675|NCT01960790|100739184|FG000|STARTED|Overall Study||473||
48169676|NCT01960790|100739184|FG000|COMPLETED|Overall Study||462||
48169677|NCT01960790|100739184|FG000|NOT COMPLETED|Overall Study||11||
48169678|NCT02134210|100739185|FG000|STARTED|Part One: Weeks 0-12||260||
48749900|NCT04292535|102173169|FG013|COMPLETED|Overall Study||7||
48169679|NCT02134210|100739186|FG001|STARTED|Part One: Weeks 0-12||261||
48169680|NCT02134210|100739185|FG000|COMPLETED|Part One: Weeks 0-12||241||
48169681|NCT02134210|100739186|FG001|COMPLETED|Part One: Weeks 0-12||255||
48332562|NCT01583374|101141847|FG000|Completed Week 16|Placebo-controlled Phase (Week 0-24)||150||
48332563|NCT01583374|101141848|FG001|Completed Week 16|Placebo-controlled Phase (Week 0-24)||151||
48332564|NCT01583374|101141849|FG002|Completed Week 16|Placebo-controlled Phase (Week 0-24)||144||
48332565|NCT01583374|101141850|FG003|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0||
48332566|NCT01583374|101141851|FG004|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0||
48332567|NCT01583374|101141852|FG005|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0||
48332568|NCT01583374|101141853|FG006|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0||
48332569|NCT01583374|101141854|FG007|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0||
48332570|NCT01583374|101141855|FG008|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0||
48332571|NCT01583374|101141847|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||51||
48332572|NCT01583374|101141848|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||49||
48332573|NCT01583374|101141849|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||49||
48332574|NCT01583374|101141850|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0||
48332575|NCT01583374|101141851|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0||
48332576|NCT01583374|101141852|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0||
48332577|NCT01583374|101141853|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0||
48332578|NCT01583374|101141854|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0||
48332579|NCT01583374|101141855|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0||
48332580|NCT01583374|101141847|FG000|COMPLETED|Placebo-controlled Phase (Week 0-24)||145||
48332581|NCT01583374|101141848|FG001|COMPLETED|Placebo-controlled Phase (Week 0-24)||147||
48332582|NCT01583374|101141849|FG002|COMPLETED|Placebo-controlled Phase (Week 0-24)||138||
48332583|NCT01583374|101141850|FG003|COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
48332584|NCT01583374|101141851|FG004|COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
48332585|NCT01583374|101141852|FG005|COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
48332586|NCT01583374|101141853|FG006|COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
48332587|NCT01583374|101141854|FG007|COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
48332588|NCT01583374|101141855|FG008|COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
48332589|NCT01583374|101141847|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||19||
48332590|NCT01583374|101141848|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||16||
48332591|NCT01583374|101141849|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||25||
48332592|NCT01583374|101141850|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
48332593|NCT01583374|101141851|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
48332594|NCT01583374|101141852|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
48332595|NCT01583374|101141853|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
48749901|NCT04292535|102173156|FG000|NOT COMPLETED|Overall Study||0||
48749902|NCT04292535|102173157|FG001|NOT COMPLETED|Overall Study||0||
48749903|NCT04292535|102173158|FG002|NOT COMPLETED|Overall Study||0||
48749904|NCT04292535|102173159|FG003|NOT COMPLETED|Overall Study||0||
48749905|NCT04292535|102173160|FG004|NOT COMPLETED|Overall Study||0||
48749906|NCT04292535|102173161|FG005|NOT COMPLETED|Overall Study||0||
48332596|NCT01583374|101141854|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
48332597|NCT01583374|101141855|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
48332598|NCT01583374|101141847|FG000|STARTED|Extension Phase (Weeks 24 to 52)||0|9 participants who completed Week 24 did not continue in the extension phase.|
48332599|NCT01583374|101141848|FG001|STARTED|Extension Phase (Weeks 24 to 52)||74|9 participants who completed Week 24 did not continue in the extension phase.|
48332600|NCT01583374|101141849|FG002|STARTED|Extension Phase (Weeks 24 to 52)||65|9 participants who completed Week 24 did not continue in the extension phase.|
48332601|NCT01583374|101141850|FG003|STARTED|Extension Phase (Weeks 24 to 52)||47|9 participants who completed Week 24 did not continue in the extension phase.|
48332602|NCT01583374|101141851|FG004|STARTED|Extension Phase (Weeks 24 to 52)||91|9 participants who completed Week 24 did not continue in the extension phase.|
48332603|NCT01583374|101141852|FG005|STARTED|Extension Phase (Weeks 24 to 52)||48|9 participants who completed Week 24 did not continue in the extension phase.|
48332604|NCT01583374|101141853|FG006|STARTED|Extension Phase (Weeks 24 to 52)||48|9 participants who completed Week 24 did not continue in the extension phase.|
48332605|NCT01583374|101141854|FG007|STARTED|Extension Phase (Weeks 24 to 52)||25|9 participants who completed Week 24 did not continue in the extension phase.|
48332606|NCT01583374|101141855|FG008|STARTED|Extension Phase (Weeks 24 to 52)||23|9 participants who completed Week 24 did not continue in the extension phase.|
48332607|NCT01583374|101141847|FG000|COMPLETED|Extension Phase (Weeks 24 to 52)||0||
48411376|NCT01836029|101337880|FG000|NOT COMPLETED|Overall Study||0||
48411377|NCT01836029|101337881|FG001|NOT COMPLETED|Overall Study||0||
48749907|NCT04292535|102173162|FG006|NOT COMPLETED|Overall Study||0||
48749908|NCT04292535|102173163|FG007|NOT COMPLETED|Overall Study||2||
48749909|NCT04292535|102173164|FG008|NOT COMPLETED|Overall Study||0||
48749910|NCT04292535|102173165|FG009|NOT COMPLETED|Overall Study||0||
48749911|NCT04292535|102173166|FG010|NOT COMPLETED|Overall Study||0||
48749912|NCT04292535|102173167|FG011|NOT COMPLETED|Overall Study||1||
48169682|NCT02134210|100739185|FG000|NOT COMPLETED|Part One: Weeks 0-12||19||
48169683|NCT02134210|100739186|FG001|NOT COMPLETED|Part One: Weeks 0-12||6||
48169684|NCT02134210|100739185|FG000|STARTED|Part Two: Weeks 13-48||241||
48169685|NCT02134210|100739186|FG001|STARTED|Part Two: Weeks 13-48||255||
48332608|NCT01583374|101141848|FG001|COMPLETED|Extension Phase (Weeks 24 to 52)||69||
48332609|NCT01583374|101141849|FG002|COMPLETED|Extension Phase (Weeks 24 to 52)||61||
48332610|NCT01583374|101141850|FG003|COMPLETED|Extension Phase (Weeks 24 to 52)||41||
48332611|NCT01583374|101141851|FG004|COMPLETED|Extension Phase (Weeks 24 to 52)||85||
48332612|NCT01583374|101141852|FG005|COMPLETED|Extension Phase (Weeks 24 to 52)||43||
48332613|NCT01583374|101141853|FG006|COMPLETED|Extension Phase (Weeks 24 to 52)||43||
48332614|NCT01583374|101141854|FG007|COMPLETED|Extension Phase (Weeks 24 to 52)||22||
48332615|NCT01583374|101141855|FG008|COMPLETED|Extension Phase (Weeks 24 to 52)||21||
48332616|NCT01583374|101141847|FG000|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||0||
48332617|NCT01583374|101141848|FG001|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5||
48332618|NCT01583374|101141849|FG002|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||4||
48332619|NCT01583374|101141850|FG003|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||6||
48332620|NCT01583374|101141851|FG004|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||6||
48332621|NCT01583374|101141852|FG005|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5||
48332622|NCT01583374|101141853|FG006|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5||
48332623|NCT01583374|101141854|FG007|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||3||
48332624|NCT01583374|101141855|FG008|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||2||
48332625|NCT01583374|101141847|FG000|STARTED|Long-Term Extension Phase Weeks 52-260||0|24 participants who completed Week 52 did not continue in the Week 52-260 study period|
48332626|NCT01583374|101141848|FG001|STARTED|Long-Term Extension Phase Weeks 52-260||66|24 participants who completed Week 52 did not continue in the Week 52-260 study period|
48332627|NCT01583374|101141849|FG002|STARTED|Long-Term Extension Phase Weeks 52-260||61|24 participants who completed Week 52 did not continue in the Week 52-260 study period|
48332628|NCT01583374|101141850|FG003|STARTED|Long-Term Extension Phase Weeks 52-260||35|24 participants who completed Week 52 did not continue in the Week 52-260 study period|
48332629|NCT01583374|101141851|FG004|STARTED|Long-Term Extension Phase Weeks 52-260||81|24 participants who completed Week 52 did not continue in the Week 52-260 study period|
48332630|NCT01583374|101141852|FG005|STARTED|Long-Term Extension Phase Weeks 52-260||39|24 participants who completed Week 52 did not continue in the Week 52-260 study period|
48332631|NCT01583374|101141853|FG006|STARTED|Long-Term Extension Phase Weeks 52-260||38|24 participants who completed Week 52 did not continue in the Week 52-260 study period|
48332632|NCT01583374|101141854|FG007|STARTED|Long-Term Extension Phase Weeks 52-260||21|24 participants who completed Week 52 did not continue in the Week 52-260 study period|
48332633|NCT01583374|101141855|FG008|STARTED|Long-Term Extension Phase Weeks 52-260||20|24 participants who completed Week 52 did not continue in the Week 52-260 study period|
48411378|NCT00491751|101337882|FG000|STARTED|Overall Study||22||
48411379|NCT00491751|101337883|FG001|STARTED|Overall Study||44||
48411380|NCT00491751|101337884|FG002|STARTED|Overall Study||42||
48749913|NCT04292535|102173168|FG012|NOT COMPLETED|Overall Study||1||
48749914|NCT04292535|102173169|FG013|NOT COMPLETED|Overall Study||2||
48749915|NCT01332994|102173170|FG000|STARTED|Overall Study||519||
48749916|NCT01332994|102173170|FG000|Completed Week 16|Overall Study||463||
48749917|NCT01332994|102173170|FG000|Completed Week 32 (TCZ/TCZ)|Overall Study||200||
48749918|NCT01332994|102173170|FG000|Completed Week 32 (TCZ/RTX)|Overall Study||26||
48749919|NCT01332994|102173170|FG000|Completed Week 66 (TCZ/RTX)|Overall Study||25||
48411381|NCT00491751|101337882|FG000|COMPLETED|Overall Study||22||
48411382|NCT00491751|101337883|FG001|COMPLETED|Overall Study||44||
48411383|NCT00491751|101337884|FG002|COMPLETED|Overall Study||42||
48411384|NCT00491751|101337882|FG000|NOT COMPLETED|Overall Study||0||
48411385|NCT00491751|101337883|FG001|NOT COMPLETED|Overall Study||0||
48411386|NCT00491751|101337884|FG002|NOT COMPLETED|Overall Study||0||
48411387|NCT02159365|101337885|FG000|STARTED|Overall Study||70||
48411388|NCT02159365|101337885|FG000|COMPLETED|Overall Study||0||
48411389|NCT02159365|101337885|FG000|NOT COMPLETED|Overall Study||70||
48411390|NCT01642004|101337886|FG000|STARTED|Randomization||135|Started=Randomized|
48411391|NCT01642004|101337887|FG001|STARTED|Randomization||137|Started=Randomized|
48411392|NCT01642004|101337886|FG000|COMPLETED|Randomization||131|Completed= participants that received treatment|
48411393|NCT01642004|101337887|FG001|COMPLETED|Randomization||129|Completed= participants that received treatment|
48411394|NCT01642004|101337886|FG000|NOT COMPLETED|Randomization||4||
48411395|NCT01642004|101337887|FG001|NOT COMPLETED|Randomization||8||
48411396|NCT01642004|101337886|FG000|STARTED|Treatment||131||
48411397|NCT01642004|101337887|FG001|STARTED|Treatment||129||
48749920|NCT01332994|102173170|FG000|COMPLETED|Overall Study||448||
48749921|NCT01332994|102173170|FG000|NOT COMPLETED|Overall Study||71||
48749922|NCT02222610|102173171|FG000|STARTED|Baseline to W48||8||8
48749923|NCT02222610|102173172|FG001|STARTED|Baseline to W48||16||16
48749924|NCT02222610|102173173|FG002|STARTED|Baseline to W48||16||16
48749925|NCT02222610|102173171|FG000|COMPLETED|Baseline to W48||8||8
48749926|NCT02222610|102173172|FG001|COMPLETED|Baseline to W48||14||14
48749927|NCT02222610|102173173|FG002|COMPLETED|Baseline to W48||15||15
48749928|NCT02222610|102173171|FG000|NOT COMPLETED|Baseline to W48||0||0
48749929|NCT02222610|102173172|FG001|NOT COMPLETED|Baseline to W48||2||2
48749930|NCT02222610|102173173|FG002|NOT COMPLETED|Baseline to W48||1||1
48749931|NCT02222610|102173171|FG000|STARTED|Baseline to W104||8||8
48749932|NCT02222610|102173172|FG001|STARTED|Baseline to W104||16||16
48749933|NCT02222610|102173173|FG002|STARTED|Baseline to W104||16||16
48749934|NCT02222610|102173171|FG000|COMPLETED|Baseline to W104||8||8
48749935|NCT02222610|102173172|FG001|COMPLETED|Baseline to W104||11||11
48411398|NCT01642004|101337886|FG000|Participants Transitioned to Nivolumab|Treatment||0||
48411399|NCT01642004|101337887|FG001|Participants Transitioned to Nivolumab|Treatment||6||
48411400|NCT01642004|101337886|FG000|COMPLETED|Treatment||0|Completed = continue in the treatment period|
48411401|NCT01642004|101337887|FG001|COMPLETED|Treatment||0|Completed = continue in the treatment period|
48411402|NCT01642004|101337886|FG000|NOT COMPLETED|Treatment||131||
48332634|NCT01583374|101141847|FG000|COMPLETED|Long-Term Extension Phase Weeks 52-260||0||
48332635|NCT01583374|101141848|FG001|COMPLETED|Long-Term Extension Phase Weeks 52-260||40||
48332636|NCT01583374|101141849|FG002|COMPLETED|Long-Term Extension Phase Weeks 52-260||41||
48332637|NCT01583374|101141850|FG003|COMPLETED|Long-Term Extension Phase Weeks 52-260||22||
48332638|NCT01583374|101141851|FG004|COMPLETED|Long-Term Extension Phase Weeks 52-260||50||
48332639|NCT01583374|101141852|FG005|COMPLETED|Long-Term Extension Phase Weeks 52-260||22||
48332640|NCT01583374|101141853|FG006|COMPLETED|Long-Term Extension Phase Weeks 52-260||20||
48332641|NCT01583374|101141854|FG007|COMPLETED|Long-Term Extension Phase Weeks 52-260||12||
48332642|NCT01583374|101141855|FG008|COMPLETED|Long-Term Extension Phase Weeks 52-260||10||
48332643|NCT01583374|101141847|FG000|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||0||
48332644|NCT01583374|101141848|FG001|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||26||
48332645|NCT01583374|101141849|FG002|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||20||
48332646|NCT01583374|101141850|FG003|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||13||
48332647|NCT01583374|101141851|FG004|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||31||
48332648|NCT01583374|101141852|FG005|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||17||
48332649|NCT01583374|101141853|FG006|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||18||
48332650|NCT01583374|101141854|FG007|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||9||
48332651|NCT01583374|101141855|FG008|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||10||
48332652|NCT00794560|101141856|FG000|STARTED|Overall Study||36||
48332653|NCT00794560|101141857|FG001|STARTED|Overall Study||36||
48332654|NCT00794560|101141858|FG002|STARTED|Overall Study||44||
48332655|NCT00794560|101141859|FG003|STARTED|Overall Study||38||
48332656|NCT00794560|101141856|FG000|COMPLETED|Overall Study||33||
48332657|NCT00794560|101141857|FG001|COMPLETED|Overall Study||32||
48332658|NCT00794560|101141858|FG002|COMPLETED|Overall Study||40||
48332659|NCT00794560|101141859|FG003|COMPLETED|Overall Study||34||
48332660|NCT00794560|101141856|FG000|NOT COMPLETED|Overall Study||3||
48332661|NCT00794560|101141857|FG001|NOT COMPLETED|Overall Study||4||
48332662|NCT00794560|101141858|FG002|NOT COMPLETED|Overall Study||4||
48332663|NCT00794560|101141859|FG003|NOT COMPLETED|Overall Study||4||
48332664|NCT01145066|101141860|FG000|STARTED|Overall Study||26||
48332665|NCT01145066|101141861|FG001|STARTED|Overall Study||20||
48332666|NCT01145066|101141862|FG002|STARTED|Overall Study||25||
48332667|NCT01145066|101141860|FG000|COMPLETED|Overall Study||22||
48332668|NCT01145066|101141861|FG001|COMPLETED|Overall Study||16||
48332669|NCT01145066|101141862|FG002|COMPLETED|Overall Study||21||
48332670|NCT01145066|101141860|FG000|NOT COMPLETED|Overall Study||4||
48332671|NCT01145066|101141861|FG001|NOT COMPLETED|Overall Study||4||
48332672|NCT01145066|101141862|FG002|NOT COMPLETED|Overall Study||4||
48332673|NCT04631029|101141863|FG000|STARTED|Overall Study||3||
48332674|NCT04631029|101141863|FG000|COMPLETED|Overall Study||3||
48332675|NCT04631029|101141863|FG000|NOT COMPLETED|Overall Study||0||
48332676|NCT01158521|101141864|FG000|STARTED|Overall Study||25||
48332677|NCT01158521|101141864|FG000|COMPLETED|Overall Study||25||
48332678|NCT01158521|101141864|FG000|NOT COMPLETED|Overall Study||0||
48411403|NCT01642004|101337887|FG001|NOT COMPLETED|Treatment||129||
48411404|NCT05085327|101337888|FG000|STARTED|Overall Study||11||11
48749936|NCT02222610|102173173|FG002|COMPLETED|Baseline to W104||10||10
48749937|NCT02222610|102173171|FG000|NOT COMPLETED|Baseline to W104||0||0
48749938|NCT02222610|102173172|FG001|NOT COMPLETED|Baseline to W104||5||5
48332679|NCT01077973|101141865|FG000|STARTED|Overall Study||41||
48332680|NCT01077973|101141866|FG001|STARTED|Overall Study||79||
48332681|NCT01077973|101141867|FG002|STARTED|Overall Study||80||
48332682|NCT01077973|101141865|FG000|COMPLETED|Overall Study||41||
48332683|NCT01077973|101141866|FG001|COMPLETED|Overall Study||79||
48332684|NCT01077973|101141867|FG002|COMPLETED|Overall Study||80||
48332685|NCT01077973|101141865|FG000|NOT COMPLETED|Overall Study||0||
48332686|NCT01077973|101141866|FG001|NOT COMPLETED|Overall Study||0||
48332687|NCT01077973|101141867|FG002|NOT COMPLETED|Overall Study||0||
48332688|NCT02482675|101141868|FG000|STARTED|Overall Study||1||
48332689|NCT02482675|101141869|FG001|STARTED|Overall Study||1||
48332690|NCT02482675|101141870|FG002|STARTED|Overall Study||1||
48332691|NCT02482675|101141871|FG003|STARTED|Overall Study||1||
48411405|NCT05085327|101337888|FG000|CLM Original|Overall Study||11||11
48411406|NCT05085327|101337888|FG000|CLM Mint|Overall Study||10||10
48411407|NCT05085327|101337888|FG000|CLM Black Cherry|Overall Study||11||11
48749939|NCT02222610|102173173|FG002|NOT COMPLETED|Baseline to W104||6||6
48749940|NCT01859923|102177098|FG000|STARTED|Overall Study||7||
48749941|NCT01859923|102177099|FG001|STARTED|Overall Study||6||
48749942|NCT01859923|102177100|FG002|STARTED|Overall Study||12||
48749943|NCT01859923|102177101|FG003|STARTED|Overall Study||12||
48749944|NCT01859923|102177098|FG000|COMPLETED|Overall Study||7||
48749945|NCT01859923|102177099|FG001|COMPLETED|Overall Study||6||
48749946|NCT01859923|102177100|FG002|COMPLETED|Overall Study||11||
48411408|NCT05085327|101337888|FG000|SPF Standard|Overall Study||11||11
48411409|NCT05085327|101337888|FG000|COMPLETED|Overall Study||11||11
48411410|NCT05085327|101337888|FG000|NOT COMPLETED|Overall Study||0||0
48411411|NCT01266070|101337889|FG000|STARTED|Overall Study||6||
48411412|NCT01266070|101337889|FG000|COMPLETED|Overall Study||2||
48411413|NCT01266070|101337889|FG000|NOT COMPLETED|Overall Study||4||
48411414|NCT01726504|101337890|FG000|STARTED|Overall Study||536||
48411415|NCT01726504|101337891|FG001|STARTED|Overall Study||539||
48411416|NCT01726504|101337890|FG000|COMPLETED|Overall Study||524||
48411417|NCT01726504|101337891|FG001|COMPLETED|Overall Study||511||
48411418|NCT01726504|101337890|FG000|NOT COMPLETED|Overall Study||12||
48411419|NCT01726504|101337891|FG001|NOT COMPLETED|Overall Study||28||
48411420|NCT01938391|101337892|FG000|STARTED|Baseline||25||
48411421|NCT01938391|101337892|FG000|COMPLETED|Baseline||25||
48411422|NCT01938391|101337892|FG000|NOT COMPLETED|Baseline||0||
48411423|NCT01938391|101337892|FG000|STARTED|2 Week Follow up||25||
48411424|NCT01938391|101337892|FG000|COMPLETED|2 Week Follow up||25||
48411425|NCT01938391|101337892|FG000|NOT COMPLETED|2 Week Follow up||0||
48411426|NCT01938391|101337892|FG000|STARTED|6 Month Follow up||25||
48411427|NCT01938391|101337892|FG000|COMPLETED|6 Month Follow up||24||
48411428|NCT01938391|101337892|FG000|NOT COMPLETED|6 Month Follow up||1||
48626661|NCT02139540|101870872|FG000|NOT COMPLETED|Overall Study||1||
48626662|NCT02139540|101870873|FG001|NOT COMPLETED|Overall Study||0||
48626663|NCT01692119|101870874|FG000|STARTED|Overall Study||130||
48626664|NCT01692119|101870875|FG001|STARTED|Overall Study||128||
48626665|NCT01692119|101870874|FG000|COMPLETED|Overall Study||110||
48626666|NCT01692119|101870875|FG001|COMPLETED|Overall Study||127||
48749947|NCT01859923|102177101|FG003|COMPLETED|Overall Study||11||
48749948|NCT01859923|102177098|FG000|NOT COMPLETED|Overall Study||0||
48749949|NCT01859923|102177099|FG001|NOT COMPLETED|Overall Study||0||
48749950|NCT01859923|102177100|FG002|NOT COMPLETED|Overall Study||1||
48749951|NCT01859923|102177101|FG003|NOT COMPLETED|Overall Study||1||
48749952|NCT03641937|102177102|FG000|STARTED|Overall Study||10||
48749953|NCT03641937|102177102|FG000|COMPLETED|Overall Study||10||
48749954|NCT03641937|102177102|FG000|NOT COMPLETED|Overall Study||0||
48749955|NCT03507036|102177103|FG000|STARTED|Overall Study||20||
48749956|NCT03507036|102177103|FG000|COMPLETED|Overall Study||15||
48749957|NCT03507036|102177103|FG000|NOT COMPLETED|Overall Study||5||
48749958|NCT00769886|102177104|FG000|STARTED|Overall Study||36||72
48411429|NCT01938391|101337892|FG000|STARTED|12 Month Follow up||24||
48411430|NCT01938391|101337892|FG000|COMPLETED|12 Month Follow up||22||
48626667|NCT01692119|101870874|FG000|NOT COMPLETED|Overall Study||20||
48626668|NCT01692119|101870875|FG001|NOT COMPLETED|Overall Study||1||
48411431|NCT01938391|101337892|FG000|NOT COMPLETED|12 Month Follow up||2||
48411432|NCT02734849|101337893|FG000|STARTED|Overall Study||16||
48411433|NCT02734849|101337894|FG001|STARTED|Overall Study||14||
48411434|NCT02734849|101337895|FG002|STARTED|Overall Study||10||
48626669|NCT01165307|101870876|FG000|STARTED|Overall Study||33||
48626670|NCT01165307|101870877|FG001|STARTED|Overall Study||34||
48626671|NCT01165307|101870876|FG000|COMPLETED|Overall Study||19||
48626672|NCT01165307|101870877|FG001|COMPLETED|Overall Study||31||
48626673|NCT01165307|101870876|FG000|NOT COMPLETED|Overall Study||14||
48626674|NCT01165307|101870877|FG001|NOT COMPLETED|Overall Study||3||
48749959|NCT00769886|102177105|FG001|STARTED|Overall Study||36||72
48749960|NCT00769886|102177106|FG002|STARTED|Overall Study||35||70
48749961|NCT00769886|102177107|FG003|STARTED|Overall Study||37||74
48749962|NCT00769886|102177104|FG000|COMPLETED|Overall Study||31||62
48411435|NCT02734849|101337893|FG000|COMPLETED|Overall Study||12||
48411436|NCT02734849|101337894|FG001|COMPLETED|Overall Study||14||
48626675|NCT00885118|101870878|FG000|STARTED|Overall Study||21||
48749963|NCT00769886|102177105|FG001|COMPLETED|Overall Study||32||64
48749964|NCT00769886|102177106|FG002|COMPLETED|Overall Study||34||68
48749965|NCT00769886|102177107|FG003|COMPLETED|Overall Study||35||70
48749966|NCT00769886|102177104|FG000|NOT COMPLETED|Overall Study||5||10
48749967|NCT00769886|102177105|FG001|NOT COMPLETED|Overall Study||4||8
48749968|NCT00769886|102177106|FG002|NOT COMPLETED|Overall Study||1||2
48749969|NCT00769886|102177107|FG003|NOT COMPLETED|Overall Study||2||4
48749970|NCT02653326|102177108|FG000|STARTED|Overall Study||32||
48749971|NCT02653326|102177109|FG001|STARTED|Overall Study||34||
48411437|NCT02734849|101337895|FG002|COMPLETED|Overall Study||9||
48411438|NCT02734849|101337893|FG000|NOT COMPLETED|Overall Study||4||
48411439|NCT02734849|101337894|FG001|NOT COMPLETED|Overall Study||0||
48411440|NCT02734849|101337895|FG002|NOT COMPLETED|Overall Study||1||
48411441|NCT01620658|101337896|FG000|STARTED|Overall Study||59||
48411442|NCT01620658|101337897|FG001|STARTED|Overall Study||74||
48411443|NCT01620658|101337898|FG002|STARTED|Overall Study||64||
48411444|NCT01620658|101337896|FG000|COMPLETED|Overall Study||35||
48411445|NCT01620658|101337897|FG001|COMPLETED|Overall Study||45||
48411446|NCT01620658|101337898|FG002|COMPLETED|Overall Study||44||
48411447|NCT01620658|101337896|FG000|NOT COMPLETED|Overall Study||24||
48411448|NCT01620658|101337897|FG001|NOT COMPLETED|Overall Study||29||
48411449|NCT01620658|101337898|FG002|NOT COMPLETED|Overall Study||20||
48411450|NCT00893763|101337899|FG000|STARTED|Overall Study||157||
48411451|NCT00893763|101337900|FG001|STARTED|Overall Study||157||
48411452|NCT00893763|101337899|FG000|COMPLETED|Overall Study||47||
48411453|NCT00893763|101337900|FG001|COMPLETED|Overall Study||47||
48411454|NCT00893763|101337899|FG000|NOT COMPLETED|Overall Study||110||
48411455|NCT00893763|101337900|FG001|NOT COMPLETED|Overall Study||110||
48411456|NCT01326910|101337901|FG000|STARTED|Overall Study||45||
48411457|NCT01326910|101337902|FG001|STARTED|Overall Study||45||
48411458|NCT01326910|101337901|FG000|COMPLETED|Overall Study||41||
48411459|NCT01326910|101337902|FG001|COMPLETED|Overall Study||42||
48411460|NCT01326910|101337901|FG000|NOT COMPLETED|Overall Study||4||
48411461|NCT01326910|101337902|FG001|NOT COMPLETED|Overall Study||3||
48411462|NCT01076270|101337903|FG000|STARTED|Overall Study||1||
48411463|NCT01076270|101337903|FG000|COMPLETED|Overall Study||1||
48411464|NCT01076270|101337903|FG000|NOT COMPLETED|Overall Study||0||
48411465|NCT01994109|101337904|FG000|STARTED|Double-blind Phase (Part A)||63||
48411466|NCT01994109|101337905|FG001|STARTED|Double-blind Phase (Part A)||64||
48411467|NCT01994109|101337906|FG002|STARTED|Double-blind Phase (Part A)||60||
48411468|NCT01994109|101337907|FG003|STARTED|Double-blind Phase (Part A)||0||
48411469|NCT01994109|101337904|FG000|COMPLETED|Double-blind Phase (Part A)||62||
48411470|NCT01994109|101337905|FG001|COMPLETED|Double-blind Phase (Part A)||61||
48411471|NCT01994109|101337906|FG002|COMPLETED|Double-blind Phase (Part A)||53||
48411472|NCT01994109|101337907|FG003|COMPLETED|Double-blind Phase (Part A)||0||
48411473|NCT01994109|101337904|FG000|NOT COMPLETED|Double-blind Phase (Part A)||1||
48411474|NCT01994109|101337905|FG001|NOT COMPLETED|Double-blind Phase (Part A)||3||
48411475|NCT01994109|101337906|FG002|NOT COMPLETED|Double-blind Phase (Part A)||7||
48411476|NCT01994109|101337907|FG003|NOT COMPLETED|Double-blind Phase (Part A)||0||
48411477|NCT01994109|101337904|FG000|STARTED|Open-label Phase (Part B)||0||
48411478|NCT01994109|101337905|FG001|STARTED|Open-label Phase (Part B)||0||
48411479|NCT01994109|101337906|FG002|STARTED|Open-label Phase (Part B)||0||
48411480|NCT01994109|101337907|FG003|STARTED|Open-label Phase (Part B)||170||
48411481|NCT01994109|101337904|FG000|COMPLETED|Open-label Phase (Part B)||0||
48411482|NCT01994109|101337905|FG001|COMPLETED|Open-label Phase (Part B)||0||
48411483|NCT01994109|101337906|FG002|COMPLETED|Open-label Phase (Part B)||0||
48411484|NCT01994109|101337907|FG003|COMPLETED|Open-label Phase (Part B)||128||
48411485|NCT01994109|101337904|FG000|NOT COMPLETED|Open-label Phase (Part B)||0||
48749972|NCT02653326|102177108|FG000|COMPLETED|Overall Study||22||
48749973|NCT02653326|102177109|FG001|COMPLETED|Overall Study||27||
48411486|NCT01994109|101337905|FG001|NOT COMPLETED|Open-label Phase (Part B)||0||
48411487|NCT01994109|101337906|FG002|NOT COMPLETED|Open-label Phase (Part B)||0||
48411488|NCT01994109|101337907|FG003|NOT COMPLETED|Open-label Phase (Part B)||42||
48411489|NCT03595982|101337908|FG000|STARTED|Overall Study||3||
48411490|NCT03595982|101337909|FG001|STARTED|Overall Study||2||
48411491|NCT03595982|101337908|FG000|COMPLETED|Overall Study||3||
48411492|NCT03595982|101337909|FG001|COMPLETED|Overall Study||2||
48411493|NCT03595982|101337908|FG000|NOT COMPLETED|Overall Study||0||
48411494|NCT03595982|101337909|FG001|NOT COMPLETED|Overall Study||0||
48411495|NCT05592145|101337910|FG000|STARTED|Overall Study||38||
48411496|NCT05592145|101337910|FG000|COMPLETED|Overall Study||38||
48411497|NCT05592145|101337910|FG000|NOT COMPLETED|Overall Study||0||
48411498|NCT02254304|101341765|FG000|STARTED|Overall Study||89||
48411499|NCT02254304|101341766|FG001|STARTED|Overall Study||17||
48411500|NCT02254304|101341765|FG000|COMPLETED|Overall Study||75||
48411501|NCT02254304|101341766|FG001|COMPLETED|Overall Study||13||
48411502|NCT02254304|101341765|FG000|NOT COMPLETED|Overall Study||14||
48411503|NCT02254304|101341766|FG001|NOT COMPLETED|Overall Study||4||
48411504|NCT02871791|101341767|FG000|STARTED|Phase 1b||6||
48749974|NCT02653326|102177108|FG000|NOT COMPLETED|Overall Study||10||
48749975|NCT02653326|102177109|FG001|NOT COMPLETED|Overall Study||7||
48749976|NCT01137032|102177110|FG000|STARTED|Overall Study||19||
48749977|NCT01137032|102177110|FG000|COMPLETED|Overall Study||19||
48411505|NCT02871791|101341768|FG001|STARTED|Phase 1b||3||
48411506|NCT02871791|101341767|FG000|COMPLETED|Phase 1b||0||
48411507|NCT02871791|101341768|FG001|COMPLETED|Phase 1b||0||
48411508|NCT02871791|101341767|FG000|NOT COMPLETED|Phase 1b||6||
48411509|NCT02871791|101341768|FG001|NOT COMPLETED|Phase 1b||3||
48411510|NCT02871791|101341767|FG000|STARTED|Phase 2||32||
48411511|NCT02871791|101341768|FG001|STARTED|Phase 2||0||
48411512|NCT02871791|101341767|FG000|COMPLETED|Phase 2||29||
48749978|NCT01137032|102177110|FG000|NOT COMPLETED|Overall Study||0||
48749979|NCT01307319|102177111|FG000|STARTED|Overall Study||239||
48749980|NCT01307319|102177112|FG001|STARTED|Overall Study||242||
48749981|NCT01307319|102177113|FG002|STARTED|Overall Study||234||
48749982|NCT01307319|102177111|FG000|Safety Population|Overall Study||239||
48749983|NCT01307319|102177112|FG001|Safety Population|Overall Study||241||
48626676|NCT00885118|101870879|FG001|STARTED|Overall Study||19||
48626677|NCT00885118|101870880|FG002|STARTED|Overall Study||21||
48626678|NCT00885118|101870881|FG003|STARTED|Overall Study||20||
48626679|NCT00885118|101870882|FG004|STARTED|Overall Study||19||
48749984|NCT01307319|102177113|FG002|Safety Population|Overall Study||234||
48749985|NCT01307319|102177111|FG000|ITT Population|Overall Study||238||
48749986|NCT01307319|102177112|FG001|ITT Population|Overall Study||241||
48749987|NCT01307319|102177113|FG002|ITT Population|Overall Study||234||
48749988|NCT01307319|102177111|FG000|COMPLETED|Overall Study||235||
48749989|NCT01307319|102177112|FG001|COMPLETED|Overall Study||234||
48749990|NCT01307319|102177113|FG002|COMPLETED|Overall Study||227||
48749991|NCT01307319|102177111|FG000|NOT COMPLETED|Overall Study||4||
48749992|NCT01307319|102177112|FG001|NOT COMPLETED|Overall Study||8||
48749993|NCT01307319|102177113|FG002|NOT COMPLETED|Overall Study||7||
48749994|NCT03273673|102177114|FG000|STARTED|Overall Study||18||
48749995|NCT03273673|102177115|FG001|STARTED|Overall Study||22||
48749996|NCT03273673|102177114|FG000|COMPLETED|Overall Study||14||
48749997|NCT03273673|102177115|FG001|COMPLETED|Overall Study||22||
48749998|NCT03273673|102177114|FG000|NOT COMPLETED|Overall Study||4||
48626680|NCT00885118|101870878|FG000|COMPLETED|Overall Study||20||
48626681|NCT00885118|101870879|FG001|COMPLETED|Overall Study||19||
48626682|NCT00885118|101870880|FG002|COMPLETED|Overall Study||20||
48626683|NCT00885118|101870881|FG003|COMPLETED|Overall Study||20||
48626684|NCT00885118|101870882|FG004|COMPLETED|Overall Study||18||
48626685|NCT00885118|101870878|FG000|NOT COMPLETED|Overall Study||1||
48626686|NCT00885118|101870879|FG001|NOT COMPLETED|Overall Study||0||
48749999|NCT03273673|102177115|FG001|NOT COMPLETED|Overall Study||0||
48750000|NCT03125226|102177116|FG000|STARTED|Overall Study||12||
48750001|NCT03125226|102177116|FG000|COMPLETED|Overall Study||12||
48750002|NCT03125226|102177116|FG000|NOT COMPLETED|Overall Study||0||
48750003|NCT01814527|102177117|FG000|STARTED|Overall Study||29||
48750004|NCT01814527|102177118|FG001|STARTED|Overall Study||33||
48750005|NCT01814527|102177117|FG000|COMPLETED|Overall Study||23||
48750006|NCT01814527|102177118|FG001|COMPLETED|Overall Study||32||
48750007|NCT01814527|102177117|FG000|NOT COMPLETED|Overall Study||6||
48750008|NCT01814527|102177118|FG001|NOT COMPLETED|Overall Study||1||
48750009|NCT01290523|102177119|FG000|STARTED|Overall Study||14||
48626687|NCT00885118|101870880|FG002|NOT COMPLETED|Overall Study||1||
48626688|NCT00885118|101870881|FG003|NOT COMPLETED|Overall Study||0||
48626689|NCT00885118|101870882|FG004|NOT COMPLETED|Overall Study||1||
48626690|NCT00875810|101870883|FG000|STARTED|Overall Study||194||
48626691|NCT00875810|101870883|FG000|Implanted|Overall Study||190||
48626692|NCT00875810|101870883|FG000|Discharged|Overall Study||177||
48626693|NCT00875810|101870883|FG000|3 Months Follow up|Overall Study||175||
48750010|NCT01290523|102177119|FG000|COMPLETED|Overall Study||11||
48750011|NCT01290523|102177119|FG000|NOT COMPLETED|Overall Study||3||
48750012|NCT01141712|102177120|FG000|STARTED|Overall Study||43||
48750013|NCT01141712|102177120|FG000|COMPLETED|Overall Study||40||
48626694|NCT00875810|101870883|FG000|6 Months Follow up|Overall Study||80||
48750014|NCT01141712|102177120|FG000|NOT COMPLETED|Overall Study||3||
48750015|NCT02914639|102177121|FG000|STARTED|Overall Study||23||
48750016|NCT02914639|102177122|FG001|STARTED|Overall Study||21||
48750017|NCT02914639|102177121|FG000|COMPLETED|Overall Study||23||
48626695|NCT00875810|101870883|FG000|12 Months Follow up|Overall Study||112||
48750018|NCT02914639|102177122|FG001|COMPLETED|Overall Study||19||
48750019|NCT02914639|102177121|FG000|NOT COMPLETED|Overall Study||0||
48626696|NCT00875810|101870883|FG000|24 Months Follow up|Overall Study||148||
48626697|NCT00875810|101870883|FG000|COMPLETED|Overall Study||148||
48626698|NCT00875810|101870883|FG000|NOT COMPLETED|Overall Study||46||
48626699|NCT05002972|101870884|FG000|STARTED|Overall Study||63||
48626700|NCT05002972|101870884|FG000|COMPLETED|Overall Study||61||
48626701|NCT05002972|101870884|FG000|NOT COMPLETED|Overall Study||2||
48626702|NCT00975416|101870885|FG000|STARTED|Overall Study||14||
48626703|NCT00975416|101870886|FG001|STARTED|Overall Study||16||
48626704|NCT00975416|101870885|FG000|COMPLETED|Overall Study||11||
48626705|NCT00975416|101870886|FG001|COMPLETED|Overall Study||11||
48626706|NCT00975416|101870885|FG000|NOT COMPLETED|Overall Study||3||
48626707|NCT00975416|101870886|FG001|NOT COMPLETED|Overall Study||5||
48626708|NCT01118052|101870887|FG000|STARTED|Overall Study||22||
48626709|NCT01118052|101870887|FG000|COMPLETED|Overall Study||20||
48626710|NCT01118052|101870887|FG000|NOT COMPLETED|Overall Study||2||
48626711|NCT04644029|101870888|FG000|STARTED|Overall Study||364||
48626712|NCT04644029|101870889|FG001|STARTED|Overall Study||366||
48626713|NCT04644029|101870888|FG000|Treated Per Protocol Arm Design|Overall Study||362||
48626714|NCT04644029|101870889|FG001|Treated Per Protocol Arm Design|Overall Study||365||
48626715|NCT04644029|101870888|FG000|Received Open-Label FTC/TDF|Overall Study||343||
48626716|NCT04644029|101870889|FG001|Received Open-Label FTC/TDF|Overall Study||345||
48626717|NCT04644029|101870888|FG000|COMPLETED|Overall Study||0||
48626718|NCT04644029|101870889|FG001|COMPLETED|Overall Study||0||
48626719|NCT04644029|101870888|FG000|NOT COMPLETED|Overall Study||364||
48626720|NCT04644029|101870889|FG001|NOT COMPLETED|Overall Study||366||
48626721|NCT04773028|101870890|FG000|STARTED|Overall Study||24||
48750020|NCT02914639|102177122|FG001|NOT COMPLETED|Overall Study||2||
48750021|NCT02970981|102177123|FG000|STARTED|Overall Study||16||
48750022|NCT02970981|102177123|FG000|Received Intervention|Overall Study||16||
48750023|NCT02970981|102177123|FG000|Completed Induction Therapy (4 Cycles)|Overall Study||15||
48750024|NCT02970981|102177123|FG000|Completed Maintenance Therapy (48 Weeks)|Overall Study||14||
48750025|NCT02970981|102177123|FG000|COMPLETED|Overall Study||14||
48626722|NCT04773028|101870891|FG001|STARTED|Overall Study||24||
48626723|NCT04773028|101870890|FG000|COMPLETED|Overall Study||24||
48626724|NCT04773028|101870891|FG001|COMPLETED|Overall Study||24||
48626725|NCT04773028|101870890|FG000|NOT COMPLETED|Overall Study||0||
48626726|NCT04773028|101870891|FG001|NOT COMPLETED|Overall Study||0||
48626727|NCT02816723|101870892|FG000|STARTED|Overall Study||30||
48750026|NCT02970981|102177123|FG000|NOT COMPLETED|Overall Study||2||
48750027|NCT00626444|102177124|FG000|STARTED|Overall Study||2||
48750028|NCT00626444|102177124|FG000|COMPLETED|Overall Study||2||
48750029|NCT00626444|102177124|FG000|NOT COMPLETED|Overall Study||0||
48750030|NCT00985673|102177125|FG000|STARTED|Overall Study||102||
48626728|NCT02816723|101870893|FG001|STARTED|Overall Study||30||
48626729|NCT02816723|101870892|FG000|COMPLETED|Overall Study||24||
48626730|NCT02816723|101870893|FG001|COMPLETED|Overall Study||28||
48750031|NCT00985673|102177126|FG001|STARTED|Overall Study||104||
48750032|NCT00985673|102177127|FG002|STARTED|Overall Study||102||
48750033|NCT00985673|102177128|FG003|STARTED|Overall Study||100||
48750034|NCT00985673|102177129|FG004|STARTED|Overall Study||101||
48750035|NCT00985673|102177130|FG005|STARTED|Overall Study||102||
48750036|NCT00985673|102177125|FG000|COMPLETED|Overall Study||95||
48332692|NCT02482675|101141872|FG004|STARTED|Overall Study||1||
48626731|NCT02816723|101870892|FG000|NOT COMPLETED|Overall Study||6||
48626732|NCT02816723|101870893|FG001|NOT COMPLETED|Overall Study||2||
48750037|NCT00985673|102177126|FG001|COMPLETED|Overall Study||93||
48750038|NCT00985673|102177127|FG002|COMPLETED|Overall Study||90||
48750039|NCT00985673|102177128|FG003|COMPLETED|Overall Study||88||
48750040|NCT00985673|102177129|FG004|COMPLETED|Overall Study||93||
48750041|NCT00985673|102177130|FG005|COMPLETED|Overall Study||96||
48750042|NCT00985673|102177125|FG000|NOT COMPLETED|Overall Study||7||
48750043|NCT00985673|102177126|FG001|NOT COMPLETED|Overall Study||11||
48750044|NCT00985673|102177127|FG002|NOT COMPLETED|Overall Study||12||
48750045|NCT00985673|102177128|FG003|NOT COMPLETED|Overall Study||12||
48750046|NCT00985673|102177129|FG004|NOT COMPLETED|Overall Study||8||
48750047|NCT00985673|102177130|FG005|NOT COMPLETED|Overall Study||6||
48750048|NCT02005016|102177131|FG000|STARTED|Overall Study||46||
48750049|NCT02005016|102177131|FG000|COMPLETED|Overall Study||44||
48750050|NCT02005016|102177131|FG000|NOT COMPLETED|Overall Study||2||
48750051|NCT00791388|102177132|FG000|STARTED|Period 1 - 50 mg Dose Group||3||
48750052|NCT00791388|102177133|FG001|STARTED|Period 1 - 50 mg Dose Group||8||
48332693|NCT02482675|101141873|FG005|STARTED|Overall Study||1||
48332694|NCT02482675|101141874|FG006|STARTED|Overall Study||1||
48626733|NCT02414698|101870894|FG000|STARTED|Overall Study||3||
48626734|NCT02414698|101870895|FG001|STARTED|Overall Study||1||
48626735|NCT02414698|101870894|FG000|COMPLETED|Overall Study||3||
48626736|NCT02414698|101870895|FG001|COMPLETED|Overall Study||1||
48750053|NCT00791388|102177134|FG002|STARTED|Period 1 - 50 mg Dose Group||0||
48750054|NCT00791388|102177135|FG003|STARTED|Period 1 - 50 mg Dose Group||0||
48750055|NCT00791388|102177136|FG004|STARTED|Period 1 - 50 mg Dose Group||0||
48750056|NCT00791388|102177132|FG000|COMPLETED|Period 1 - 50 mg Dose Group||3||
48626737|NCT02414698|101870894|FG000|NOT COMPLETED|Overall Study||0||
48626738|NCT02414698|101870895|FG001|NOT COMPLETED|Overall Study||0||
48626739|NCT03342001|101870896|FG000|STARTED|Overall Study||11||
48626740|NCT03342001|101870896|FG000|COMPLETED|Overall Study||9||
48626741|NCT03342001|101870896|FG000|NOT COMPLETED|Overall Study||2||
48626742|NCT00685516|101870897|FG000|STARTED|Overall Study||42||
48626743|NCT00685516|101870898|FG001|STARTED|Overall Study||38||
48750057|NCT00791388|102177133|FG001|COMPLETED|Period 1 - 50 mg Dose Group||7||
48750058|NCT00791388|102177134|FG002|COMPLETED|Period 1 - 50 mg Dose Group||0||
48332695|NCT02482675|101141875|FG007|STARTED|Overall Study||1||
48332696|NCT02482675|101141876|FG008|STARTED|Overall Study||1||
48332697|NCT02482675|101141877|FG009|STARTED|Overall Study||1||
48626744|NCT00685516|101870899|FG002|STARTED|Overall Study||33||
48626745|NCT00685516|101870897|FG000|COMPLETED|Overall Study||34||
48626746|NCT00685516|101870898|FG001|COMPLETED|Overall Study||33||
48626747|NCT00685516|101870899|FG002|COMPLETED|Overall Study||26||
48626748|NCT00685516|101870897|FG000|NOT COMPLETED|Overall Study||8||
48626749|NCT00685516|101870898|FG001|NOT COMPLETED|Overall Study||5||
48626750|NCT00685516|101870899|FG002|NOT COMPLETED|Overall Study||7||
48626751|NCT02530437|101870900|FG000|STARTED|Overall Study||7||
48626752|NCT02530437|101870900|FG000|COMPLETED|Overall Study||7||
48626753|NCT02530437|101870900|FG000|NOT COMPLETED|Overall Study||0||
48750059|NCT00791388|102177135|FG003|COMPLETED|Period 1 - 50 mg Dose Group||0||
48750060|NCT00791388|102177136|FG004|COMPLETED|Period 1 - 50 mg Dose Group||0||
48750061|NCT00791388|102177132|FG000|NOT COMPLETED|Period 1 - 50 mg Dose Group||0||
48750062|NCT00791388|102177133|FG001|NOT COMPLETED|Period 1 - 50 mg Dose Group||1||
48750063|NCT00791388|102177134|FG002|NOT COMPLETED|Period 1 - 50 mg Dose Group||0||
48750064|NCT00791388|102177135|FG003|NOT COMPLETED|Period 1 - 50 mg Dose Group||0||
48750065|NCT00791388|102177136|FG004|NOT COMPLETED|Period 1 - 50 mg Dose Group||0||
48750066|NCT00791388|102177132|FG000|STARTED|Period 2 - 100 mg Dose Group||3||
48332698|NCT02482675|101141878|FG010|STARTED|Overall Study||1||
48626754|NCT00379834|101870901|FG000|STARTED|Overall Study||10||
48626755|NCT00379834|101870901|FG000|COMPLETED|Overall Study||8||
48750067|NCT00791388|102177133|FG001|STARTED|Period 2 - 100 mg Dose Group||0||
48750068|NCT00791388|102177134|FG002|STARTED|Period 2 - 100 mg Dose Group||8||
48750069|NCT00791388|102177135|FG003|STARTED|Period 2 - 100 mg Dose Group||0||
48750070|NCT00791388|102177136|FG004|STARTED|Period 2 - 100 mg Dose Group||0||
48750071|NCT00791388|102177132|FG000|COMPLETED|Period 2 - 100 mg Dose Group||2||
48750072|NCT00791388|102177133|FG001|COMPLETED|Period 2 - 100 mg Dose Group||0||
48169686|NCT02134210|100739185|FG000|COMPLETED|Part Two: Weeks 13-48||211||
48169687|NCT02134210|100739186|FG001|COMPLETED|Part Two: Weeks 13-48||227||
48169688|NCT02134210|100739185|FG000|NOT COMPLETED|Part Two: Weeks 13-48||30||
48169689|NCT02134210|100739186|FG001|NOT COMPLETED|Part Two: Weeks 13-48||28||
48169690|NCT00871403|100739187|FG000|STARTED|Combination Treatment Phase||9||
48169691|NCT00871403|100739188|FG001|STARTED|Combination Treatment Phase||62||
48169692|NCT00871403|100739189|FG002|STARTED|Combination Treatment Phase||35||
48169693|NCT00871403|100739187|FG000|COMPLETED|Combination Treatment Phase||0||
48169694|NCT00871403|100739188|FG001|COMPLETED|Combination Treatment Phase||13||
48169695|NCT00871403|100739189|FG002|COMPLETED|Combination Treatment Phase||23||
48169696|NCT00871403|100739187|FG000|NOT COMPLETED|Combination Treatment Phase||9||
48169697|NCT00871403|100739188|FG001|NOT COMPLETED|Combination Treatment Phase||49||
48169698|NCT00871403|100739189|FG002|NOT COMPLETED|Combination Treatment Phase||12||
48169699|NCT00871403|100739187|FG000|STARTED|Monotherapy Treatment Phase||0||
48169700|NCT00871403|100739188|FG001|STARTED|Monotherapy Treatment Phase||13||
48169701|NCT00871403|100739189|FG002|STARTED|Monotherapy Treatment Phase||1||
48169702|NCT00871403|100739187|FG000|COMPLETED|Monotherapy Treatment Phase||0||
48169703|NCT00871403|100739188|FG001|COMPLETED|Monotherapy Treatment Phase||0||
48626756|NCT00379834|101870901|FG000|NOT COMPLETED|Overall Study||2||
48626757|NCT02736617|101870902|FG000|STARTED|Treatment||10||
48626758|NCT02736617|101870902|FG000|COMPLETED|Treatment||7||
48626759|NCT02736617|101870902|FG000|NOT COMPLETED|Treatment||3||
48626760|NCT02736617|101870902|FG000|STARTED|Maintenance||7||
48626761|NCT02736617|101870902|FG000|COMPLETED|Maintenance||2||
48169704|NCT00871403|100739189|FG002|COMPLETED|Monotherapy Treatment Phase||0||
48169705|NCT00871403|100739187|FG000|NOT COMPLETED|Monotherapy Treatment Phase||0||
48332699|NCT02482675|101141879|FG011|STARTED|Overall Study||1||
48332700|NCT02482675|101141880|FG012|STARTED|Overall Study||1||
48332701|NCT02482675|101141881|FG013|STARTED|Overall Study||1||
48332702|NCT02482675|101141882|FG014|STARTED|Overall Study||1||
48332703|NCT02482675|101141883|FG015|STARTED|Overall Study||1||
48332704|NCT02482675|101141884|FG016|STARTED|Overall Study||1||
48332705|NCT02482675|101141885|FG017|STARTED|Overall Study||1||
48332706|NCT02482675|101141886|FG018|STARTED|Overall Study||1||
48332707|NCT02482675|101141887|FG019|STARTED|Overall Study||1||
48332708|NCT02482675|101141888|FG020|STARTED|Overall Study||1||
48332709|NCT02482675|101141889|FG021|STARTED|Overall Study||1||
48332710|NCT02482675|101141890|FG022|STARTED|Overall Study||1||
48332711|NCT02482675|101141868|FG000|COMPLETED|Overall Study||1||
48332712|NCT02482675|101141869|FG001|COMPLETED|Overall Study||1||
48332713|NCT02482675|101141870|FG002|COMPLETED|Overall Study||1||
48332714|NCT02482675|101141871|FG003|COMPLETED|Overall Study||1||
48332715|NCT02482675|101141872|FG004|COMPLETED|Overall Study||1||
48332716|NCT02482675|101141873|FG005|COMPLETED|Overall Study||1||
48332717|NCT02482675|101141874|FG006|COMPLETED|Overall Study||1||
48332718|NCT02482675|101141875|FG007|COMPLETED|Overall Study||1||
48332719|NCT02482675|101141876|FG008|COMPLETED|Overall Study||1||
48332720|NCT02482675|101141877|FG009|COMPLETED|Overall Study||1||
48332721|NCT02482675|101141878|FG010|COMPLETED|Overall Study||1||
48332722|NCT02482675|101141879|FG011|COMPLETED|Overall Study||1||
48332723|NCT02482675|101141880|FG012|COMPLETED|Overall Study||1||
48332724|NCT02482675|101141881|FG013|COMPLETED|Overall Study||1||
48332725|NCT02482675|101141882|FG014|COMPLETED|Overall Study||1||
48332726|NCT02482675|101141883|FG015|COMPLETED|Overall Study||1||
48332727|NCT02482675|101141884|FG016|COMPLETED|Overall Study||1||
48332728|NCT02482675|101141885|FG017|COMPLETED|Overall Study||1||
48332729|NCT02482675|101141886|FG018|COMPLETED|Overall Study||1||
48332730|NCT02482675|101141887|FG019|COMPLETED|Overall Study||1||
48332731|NCT02482675|101141888|FG020|COMPLETED|Overall Study||1||
48332732|NCT02482675|101141889|FG021|COMPLETED|Overall Study||1||
48332733|NCT02482675|101141890|FG022|COMPLETED|Overall Study||1||
48332734|NCT02482675|101141868|FG000|NOT COMPLETED|Overall Study||0||
48626762|NCT02736617|101870902|FG000|NOT COMPLETED|Maintenance||5||
48626763|NCT00617279|101870903|FG000|STARTED|Overall Study||14||
48626764|NCT00617279|101870904|FG001|STARTED|Overall Study||17||
48626765|NCT00617279|101870903|FG000|COMPLETED|Overall Study||0||
48626766|NCT00617279|101870904|FG001|COMPLETED|Overall Study||0||
48332735|NCT02482675|101141869|FG001|NOT COMPLETED|Overall Study||0||
48626767|NCT00617279|101870903|FG000|NOT COMPLETED|Overall Study||14||
48626768|NCT00617279|101870904|FG001|NOT COMPLETED|Overall Study||17||
48626769|NCT01764841|101870905|FG000|STARTED|Overall Study||141||
48169706|NCT00871403|100739188|FG001|NOT COMPLETED|Monotherapy Treatment Phase||13||
48169707|NCT00871403|100739189|FG002|NOT COMPLETED|Monotherapy Treatment Phase||1||
48169708|NCT03691948|100739190|FG000|STARTED|Overall Study||27||
48169709|NCT03691948|100739191|FG001|STARTED|Overall Study||33||
48169710|NCT03691948|100739190|FG000|COMPLETED|Overall Study||26||
48169711|NCT03691948|100739191|FG001|COMPLETED|Overall Study||30||
48169712|NCT03691948|100739190|FG000|NOT COMPLETED|Overall Study||1||
48169713|NCT03691948|100739191|FG001|NOT COMPLETED|Overall Study||3||
48169714|NCT02441946|100739192|FG000|STARTED|Cycle 1 Period 1 (2 Weeks)||74||
48332736|NCT02482675|101141870|FG002|NOT COMPLETED|Overall Study||0||
48411513|NCT02871791|101341768|FG001|COMPLETED|Phase 2||0||
48411514|NCT02871791|101341767|FG000|NOT COMPLETED|Phase 2||3||
48411515|NCT02871791|101341768|FG001|NOT COMPLETED|Phase 2||0||
48169715|NCT02441946|100739193|FG001|STARTED|Cycle 1 Period 1 (2 Weeks)||76||
48169716|NCT02441946|100739194|FG002|STARTED|Cycle 1 Period 1 (2 Weeks)||74||
48169717|NCT02441946|100739192|FG000|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74||
48169718|NCT02441946|100739193|FG001|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||75||
48169719|NCT02441946|100739194|FG002|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74||
48169720|NCT02441946|100739192|FG000|COMPLETED|Cycle 1 Period 1 (2 Weeks)||72||
48169721|NCT02441946|100739193|FG001|COMPLETED|Cycle 1 Period 1 (2 Weeks)||71||
48169722|NCT02441946|100739194|FG002|COMPLETED|Cycle 1 Period 1 (2 Weeks)||74||
48169723|NCT02441946|100739192|FG000|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||2||
48169724|NCT02441946|100739193|FG001|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||5||
48169725|NCT02441946|100739194|FG002|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0||
48169726|NCT02441946|100739192|FG000|STARTED|Cycle 2-5 Period 2 (14 Weeks)||217||
48169727|NCT02441946|100739193|FG001|STARTED|Cycle 2-5 Period 2 (14 Weeks)||0||
48169728|NCT02441946|100739194|FG002|STARTED|Cycle 2-5 Period 2 (14 Weeks)||0||
48169729|NCT02441946|100739192|FG000|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||217||
48169730|NCT02441946|100739193|FG001|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0||
48169731|NCT02441946|100739194|FG002|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0||
48169732|NCT02441946|100739192|FG000|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||5||
48169733|NCT02441946|100739193|FG001|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||0||
48169734|NCT02441946|100739194|FG002|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||0||
48169735|NCT02441946|100739192|FG000|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||190||
48169736|NCT02441946|100739193|FG001|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0||
48169737|NCT02441946|100739194|FG002|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0||
48169738|NCT02441946|100739192|FG000|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||27||
48169739|NCT02441946|100739193|FG001|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0||
48169740|NCT02441946|100739194|FG002|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0||
48169741|NCT02441946|100739192|FG000|STARTED|Extension Period (8 Weeks)||42||
48169742|NCT02441946|100739193|FG001|STARTED|Extension Period (8 Weeks)||0||
48169743|NCT02441946|100739194|FG002|STARTED|Extension Period (8 Weeks)||0||
48169744|NCT02441946|100739192|FG000|COMPLETED|Extension Period (8 Weeks)||40||
48169745|NCT02441946|100739193|FG001|COMPLETED|Extension Period (8 Weeks)||0||
48169746|NCT02441946|100739194|FG002|COMPLETED|Extension Period (8 Weeks)||0||
48169747|NCT02441946|100739192|FG000|NOT COMPLETED|Extension Period (8 Weeks)||2||
48169748|NCT02441946|100739193|FG001|NOT COMPLETED|Extension Period (8 Weeks)||0||
48169749|NCT02441946|100739194|FG002|NOT COMPLETED|Extension Period (8 Weeks)||0||
48169750|NCT00847301|100739195|FG000|STARTED|Overall Study||428||
48169751|NCT00847301|100739195|FG000|COMPLETED|Overall Study||374||
48169752|NCT00847301|100739195|FG000|NOT COMPLETED|Overall Study||54||
48169753|NCT02340520|100739196|FG000|STARTED|Overall Study||11||
48169754|NCT02340520|100739196|FG000|COMPLETED|Overall Study||8||
48169755|NCT02340520|100739196|FG000|NOT COMPLETED|Overall Study||3||
48169756|NCT04551196|100739197|FG000|STARTED|Overall Study||25||
48169757|NCT04551196|100739198|FG001|STARTED|Overall Study||25||
48169758|NCT04551196|100739197|FG000|COMPLETED|Overall Study||25||
48169759|NCT04551196|100739198|FG001|COMPLETED|Overall Study||25||
48169760|NCT04551196|100739197|FG000|NOT COMPLETED|Overall Study||0||
48169761|NCT04551196|100739198|FG001|NOT COMPLETED|Overall Study||0||
48169762|NCT04662671|100739199|FG000|STARTED|Overall Study||20||
48169763|NCT04662671|100739200|FG001|STARTED|Overall Study||11||
48169764|NCT04662671|100739199|FG000|COMPLETED|Overall Study||20||
48169765|NCT04662671|100739200|FG001|COMPLETED|Overall Study||11||
48169766|NCT04662671|100739199|FG000|NOT COMPLETED|Overall Study||0||
48169767|NCT04662671|100739200|FG001|NOT COMPLETED|Overall Study||0||
48169768|NCT02075021|100739201|FG000|STARTED|Overall Study||3||
48169769|NCT02075021|100739201|FG000|COMPLETED|Overall Study||3||
48169770|NCT02075021|100739201|FG000|NOT COMPLETED|Overall Study||0||
48169771|NCT00401102|100739202|FG000|STARTED|Overall Study||12||
48169772|NCT00401102|100739202|FG000|COMPLETED|Overall Study||5||
48169773|NCT00401102|100739202|FG000|NOT COMPLETED|Overall Study||7||
48169774|NCT00758160|100739203|FG000|STARTED|Overall Study||296||
48169775|NCT00758160|100739203|FG000|COMPLETED|Overall Study||230||
48169776|NCT00758160|100739203|FG000|NOT COMPLETED|Overall Study||66||
48169777|NCT02494921|100739204|FG000|STARTED|Phase 1b, Dose Level I||5||
48169778|NCT02494921|100739205|FG001|STARTED|Phase 1b, Dose Level I||0||
48169779|NCT02494921|100739206|FG002|STARTED|Phase 1b, Dose Level I||0||
48169780|NCT02494921|100739207|FG003|STARTED|Phase 1b, Dose Level I||0||
48169781|NCT02494921|100739208|FG004|STARTED|Phase 1b, Dose Level I||0||
48169782|NCT02494921|100739204|FG000|COMPLETED|Phase 1b, Dose Level I||3||
48169783|NCT02494921|100739205|FG001|COMPLETED|Phase 1b, Dose Level I||0||
48169784|NCT02494921|100739206|FG002|COMPLETED|Phase 1b, Dose Level I||0||
48169785|NCT02494921|100739207|FG003|COMPLETED|Phase 1b, Dose Level I||0||
48169786|NCT02494921|100739208|FG004|COMPLETED|Phase 1b, Dose Level I||0||
48169787|NCT02494921|100739204|FG000|NOT COMPLETED|Phase 1b, Dose Level I||2||
48169788|NCT02494921|100739205|FG001|NOT COMPLETED|Phase 1b, Dose Level I||0||
48169789|NCT02494921|100739206|FG002|NOT COMPLETED|Phase 1b, Dose Level I||0||
48169790|NCT02494921|100739207|FG003|NOT COMPLETED|Phase 1b, Dose Level I||0||
48169791|NCT02494921|100739208|FG004|NOT COMPLETED|Phase 1b, Dose Level I||0||
48169792|NCT02494921|100739204|FG000|STARTED|Phase 1b, Dose Level IA||0||
48169793|NCT02494921|100739205|FG001|STARTED|Phase 1b, Dose Level IA||4||
48169794|NCT02494921|100739206|FG002|STARTED|Phase 1b, Dose Level IA||0||
48169795|NCT02494921|100739207|FG003|STARTED|Phase 1b, Dose Level IA||0||
48169796|NCT02494921|100739208|FG004|STARTED|Phase 1b, Dose Level IA||0||
48169797|NCT02494921|100739204|FG000|COMPLETED|Phase 1b, Dose Level IA||0||
48169798|NCT02494921|100739205|FG001|COMPLETED|Phase 1b, Dose Level IA||3||
48169799|NCT02494921|100739206|FG002|COMPLETED|Phase 1b, Dose Level IA||0||
48169800|NCT02494921|100739207|FG003|COMPLETED|Phase 1b, Dose Level IA||0||
48169801|NCT02494921|100739208|FG004|COMPLETED|Phase 1b, Dose Level IA||0||
48169802|NCT02494921|100739204|FG000|NOT COMPLETED|Phase 1b, Dose Level IA||0||
48169803|NCT02494921|100739205|FG001|NOT COMPLETED|Phase 1b, Dose Level IA||1||
48169804|NCT02494921|100739206|FG002|NOT COMPLETED|Phase 1b, Dose Level IA||0||
48169805|NCT02494921|100739207|FG003|NOT COMPLETED|Phase 1b, Dose Level IA||0||
48169806|NCT02494921|100739208|FG004|NOT COMPLETED|Phase 1b, Dose Level IA||0||
48169807|NCT02494921|100739204|FG000|STARTED|Phase 1b, Dose Level IIC||0||
48169808|NCT02494921|100739205|FG001|STARTED|Phase 1b, Dose Level IIC||0||
48169809|NCT02494921|100739206|FG002|STARTED|Phase 1b, Dose Level IIC||4||
48169810|NCT02494921|100739207|FG003|STARTED|Phase 1b, Dose Level IIC||0||
48169811|NCT02494921|100739208|FG004|STARTED|Phase 1b, Dose Level IIC||0||
48169812|NCT02494921|100739204|FG000|COMPLETED|Phase 1b, Dose Level IIC||0||
48169813|NCT02494921|100739205|FG001|COMPLETED|Phase 1b, Dose Level IIC||0||
48169814|NCT02494921|100739206|FG002|COMPLETED|Phase 1b, Dose Level IIC||3||
48169815|NCT02494921|100739207|FG003|COMPLETED|Phase 1b, Dose Level IIC||0||
48169816|NCT02494921|100739208|FG004|COMPLETED|Phase 1b, Dose Level IIC||0||
48169817|NCT02494921|100739204|FG000|NOT COMPLETED|Phase 1b, Dose Level IIC||0||
48169818|NCT02494921|100739205|FG001|NOT COMPLETED|Phase 1b, Dose Level IIC||0||
48169819|NCT02494921|100739206|FG002|NOT COMPLETED|Phase 1b, Dose Level IIC||1||
48169820|NCT02494921|100739207|FG003|NOT COMPLETED|Phase 1b, Dose Level IIC||0||
48169821|NCT02494921|100739208|FG004|NOT COMPLETED|Phase 1b, Dose Level IIC||0||
48169822|NCT02494921|100739204|FG000|STARTED|Phase 1b, Dose Level IIIC, RP2D||0||
48169823|NCT02494921|100739205|FG001|STARTED|Phase 1b, Dose Level IIIC, RP2D||0||
48169824|NCT02494921|100739206|FG002|STARTED|Phase 1b, Dose Level IIIC, RP2D||0||
48169825|NCT02494921|100739207|FG003|STARTED|Phase 1b, Dose Level IIIC, RP2D||6||
48169826|NCT02494921|100739208|FG004|STARTED|Phase 1b, Dose Level IIIC, RP2D||0||
48169827|NCT02494921|100739204|FG000|COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0||
48332737|NCT02482675|101141871|FG003|NOT COMPLETED|Overall Study||0||
48169828|NCT02494921|100739205|FG001|COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0||
48169829|NCT02494921|100739206|FG002|COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0||
48169830|NCT02494921|100739207|FG003|COMPLETED|Phase 1b, Dose Level IIIC, RP2D||6||
48169831|NCT02494921|100739208|FG004|COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0||
48169832|NCT02494921|100739204|FG000|NOT COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0||
48169833|NCT02494921|100739205|FG001|NOT COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0||
48169834|NCT02494921|100739206|FG002|NOT COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0||
48169835|NCT02494921|100739207|FG003|NOT COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0||
48169836|NCT02494921|100739208|FG004|NOT COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0||
48169837|NCT02494921|100739204|FG000|STARTED|Phase 2, RP2D||0||
48169838|NCT02494921|100739205|FG001|STARTED|Phase 2, RP2D||0||
48169839|NCT02494921|100739206|FG002|STARTED|Phase 2, RP2D||0||
48169840|NCT02494921|100739207|FG003|STARTED|Phase 2, RP2D||0||
48169841|NCT02494921|100739208|FG004|STARTED|Phase 2, RP2D||24||
48332738|NCT02482675|101141872|FG004|NOT COMPLETED|Overall Study||0||
48169842|NCT02494921|100739204|FG000|COMPLETED|Phase 2, RP2D||0||
48169843|NCT02494921|100739205|FG001|COMPLETED|Phase 2, RP2D||0||
48169844|NCT02494921|100739206|FG002|COMPLETED|Phase 2, RP2D||0||
48169845|NCT02494921|100739207|FG003|COMPLETED|Phase 2, RP2D||0||
48169846|NCT02494921|100739208|FG004|COMPLETED|Phase 2, RP2D||24||
48169847|NCT02494921|100739204|FG000|NOT COMPLETED|Phase 2, RP2D||0||
48169848|NCT02494921|100739205|FG001|NOT COMPLETED|Phase 2, RP2D||0||
48332739|NCT02482675|101141873|FG005|NOT COMPLETED|Overall Study||0||
48332740|NCT02482675|101141874|FG006|NOT COMPLETED|Overall Study||0||
48332741|NCT02482675|101141875|FG007|NOT COMPLETED|Overall Study||0||
48169849|NCT02494921|100739206|FG002|NOT COMPLETED|Phase 2, RP2D||0||
48169850|NCT02494921|100739207|FG003|NOT COMPLETED|Phase 2, RP2D||0||
48332742|NCT02482675|101141876|FG008|NOT COMPLETED|Overall Study||0||
48332743|NCT02482675|101141877|FG009|NOT COMPLETED|Overall Study||0||
48332744|NCT02482675|101141878|FG010|NOT COMPLETED|Overall Study||0||
48332745|NCT02482675|101141879|FG011|NOT COMPLETED|Overall Study||0||
48332746|NCT02482675|101141880|FG012|NOT COMPLETED|Overall Study||0||
48332747|NCT02482675|101141881|FG013|NOT COMPLETED|Overall Study||0||
48169851|NCT02494921|100739208|FG004|NOT COMPLETED|Phase 2, RP2D||0||
48169852|NCT03015116|100739209|FG000|STARTED|Overall Study||38||
48169853|NCT03015116|100739210|FG001|STARTED|Overall Study||38||
48169854|NCT03015116|100739211|FG002|STARTED|Overall Study||38||
48169855|NCT03015116|100739209|FG000|COMPLETED|Overall Study||31||
48169856|NCT03015116|100739210|FG001|COMPLETED|Overall Study||36||
48169857|NCT03015116|100739211|FG002|COMPLETED|Overall Study||36||
48169858|NCT03015116|100739209|FG000|NOT COMPLETED|Overall Study||7||
48169859|NCT03015116|100739210|FG001|NOT COMPLETED|Overall Study||2||
48332748|NCT02482675|101141882|FG014|NOT COMPLETED|Overall Study||0||
48169860|NCT03015116|100739211|FG002|NOT COMPLETED|Overall Study||2||
48332749|NCT02482675|101141883|FG015|NOT COMPLETED|Overall Study||0||
48332750|NCT02482675|101141884|FG016|NOT COMPLETED|Overall Study||0||
48332751|NCT02482675|101141885|FG017|NOT COMPLETED|Overall Study||0||
48332752|NCT02482675|101141886|FG018|NOT COMPLETED|Overall Study||0||
48332753|NCT02482675|101141887|FG019|NOT COMPLETED|Overall Study||0||
48332754|NCT02482675|101141888|FG020|NOT COMPLETED|Overall Study||0||
48332755|NCT02482675|101141889|FG021|NOT COMPLETED|Overall Study||0||
48332756|NCT02482675|101141890|FG022|NOT COMPLETED|Overall Study||0||
48332757|NCT02362503|101141891|FG000|STARTED|Double-blind Period-Up to 8 Days||69||
48332758|NCT02362503|101141892|FG001|STARTED|Double-blind Period-Up to 8 Days||203||
48332759|NCT02362503|101141893|FG002|STARTED|Double-blind Period-Up to 8 Days||0||
48332760|NCT02362503|101141891|FG000|COMPLETED|Double-blind Period-Up to 8 Days||68||
48169861|NCT02397265|100739212|FG000|STARTED|First Intervention of Three||2||
48169862|NCT02397265|100739213|FG001|STARTED|First Intervention of Three||2||
48169863|NCT02397265|100739214|FG002|STARTED|First Intervention of Three||2||
48169864|NCT02397265|100739212|FG000|COMPLETED|First Intervention of Three||2||
48169865|NCT02397265|100739213|FG001|COMPLETED|First Intervention of Three||2||
48169866|NCT02397265|100739214|FG002|COMPLETED|First Intervention of Three||2||
48169867|NCT02397265|100739212|FG000|NOT COMPLETED|First Intervention of Three||0||
48169868|NCT02397265|100739213|FG001|NOT COMPLETED|First Intervention of Three||0||
48169869|NCT02397265|100739214|FG002|NOT COMPLETED|First Intervention of Three||0||
48169870|NCT02397265|100739212|FG000|STARTED|Second Intervention of Three||2||
48169871|NCT02397265|100739213|FG001|STARTED|Second Intervention of Three||2||
48169872|NCT02397265|100739214|FG002|STARTED|Second Intervention of Three||2||
48169873|NCT02397265|100739212|FG000|COMPLETED|Second Intervention of Three||2||
48169874|NCT02397265|100739213|FG001|COMPLETED|Second Intervention of Three||2||
48169875|NCT02397265|100739214|FG002|COMPLETED|Second Intervention of Three||2||
48169876|NCT02397265|100739212|FG000|NOT COMPLETED|Second Intervention of Three||0||
48169877|NCT02397265|100739213|FG001|NOT COMPLETED|Second Intervention of Three||0||
48169878|NCT02397265|100739214|FG002|NOT COMPLETED|Second Intervention of Three||0||
48169879|NCT02397265|100739212|FG000|STARTED|Third Intervention of Three||2||
48169880|NCT02397265|100739213|FG001|STARTED|Third Intervention of Three||2||
48169881|NCT02397265|100739214|FG002|STARTED|Third Intervention of Three||2||
48169882|NCT02397265|100739212|FG000|COMPLETED|Third Intervention of Three||2||
48169883|NCT02397265|100739213|FG001|COMPLETED|Third Intervention of Three||2||
48169884|NCT02397265|100739214|FG002|COMPLETED|Third Intervention of Three||2||
48169885|NCT02397265|100739212|FG000|NOT COMPLETED|Third Intervention of Three||0||
48169886|NCT02397265|100739213|FG001|NOT COMPLETED|Third Intervention of Three||0||
48169887|NCT02397265|100739214|FG002|NOT COMPLETED|Third Intervention of Three||0||
48169888|NCT02468934|100739215|FG000|STARTED|Overall Study||27||
48169889|NCT02468934|100739215|FG000|Enrolled/Received Leads|Overall Study||24|Subjects consented, met eligibility criteria, and continued with SPRINT Lead placement.|
48169890|NCT02468934|100739215|FG000|Underwent Total Knee Arthroplasty|Overall Study||20|Subjects consented, met eligibility criteria, received Leads, and underwent total knee arthroplasty.|
48169891|NCT02468934|100739215|FG000|COMPLETED|Overall Study||20||
48169892|NCT02468934|100739215|FG000|NOT COMPLETED|Overall Study||7||
48169893|NCT00708305|100739216|FG000|STARTED|Period 1||16||
48169894|NCT00708305|100739217|FG001|STARTED|Period 1||16||
48169895|NCT00708305|100739218|FG002|STARTED|Period 1||17||
48169896|NCT00708305|100739219|FG003|STARTED|Period 1||16||
48169897|NCT00708305|100739216|FG000|COMPLETED|Period 1||15||
48169898|NCT00708305|100739217|FG001|COMPLETED|Period 1||16||
48169899|NCT00708305|100739218|FG002|COMPLETED|Period 1||16||
48332761|NCT02362503|101141892|FG001|COMPLETED|Double-blind Period-Up to 8 Days||199||
48332762|NCT02362503|101141893|FG002|COMPLETED|Double-blind Period-Up to 8 Days||0||
48332763|NCT02362503|101141891|FG000|NOT COMPLETED|Double-blind Period-Up to 8 Days||1||
48332764|NCT02362503|101141892|FG001|NOT COMPLETED|Double-blind Period-Up to 8 Days||4||
48332765|NCT02362503|101141893|FG002|NOT COMPLETED|Double-blind Period-Up to 8 Days||0||
48332766|NCT02362503|101141891|FG000|STARTED|Open Label Period-Up to 96 Weeks||68||
48332767|NCT02362503|101141892|FG001|STARTED|Open Label Period-Up to 96 Weeks||199||
48332768|NCT02362503|101141893|FG002|STARTED|Open Label Period-Up to 96 Weeks||99||
48332769|NCT02362503|101141891|FG000|COMPLETED|Open Label Period-Up to 96 Weeks||0||
48332770|NCT02362503|101141892|FG001|COMPLETED|Open Label Period-Up to 96 Weeks||0||
48332771|NCT02362503|101141893|FG002|COMPLETED|Open Label Period-Up to 96 Weeks||0||
48332772|NCT02362503|101141891|FG000|NOT COMPLETED|Open Label Period-Up to 96 Weeks||68||
48332773|NCT02362503|101141892|FG001|NOT COMPLETED|Open Label Period-Up to 96 Weeks||199||
48332774|NCT02362503|101141893|FG002|NOT COMPLETED|Open Label Period-Up to 96 Weeks||99||
48332775|NCT03005054|101141894|FG000|STARTED|Overall Study||3||
48169900|NCT00708305|100739219|FG003|COMPLETED|Period 1||14||
48169901|NCT00708305|100739216|FG000|NOT COMPLETED|Period 1||1||
48169902|NCT00708305|100739217|FG001|NOT COMPLETED|Period 1||0||
48169903|NCT00708305|100739218|FG002|NOT COMPLETED|Period 1||1||
48169904|NCT00708305|100739219|FG003|NOT COMPLETED|Period 1||2||
48332776|NCT03005054|101141894|FG000|COMPLETED|Overall Study||3||
48332777|NCT03005054|101141894|FG000|NOT COMPLETED|Overall Study||0||
48169905|NCT00708305|100739216|FG000|STARTED|Period 2||15||
48169906|NCT00708305|100739217|FG001|STARTED|Period 2||15||
48169907|NCT00708305|100739218|FG002|STARTED|Period 2||16||
48169908|NCT00708305|100739219|FG003|STARTED|Period 2||15||
48169909|NCT00708305|100739216|FG000|COMPLETED|Period 2||14||
48169910|NCT00708305|100739217|FG001|COMPLETED|Period 2||13||
48169911|NCT00708305|100739218|FG002|COMPLETED|Period 2||16||
48169912|NCT00708305|100739219|FG003|COMPLETED|Period 2||14||
48169913|NCT00708305|100739216|FG000|NOT COMPLETED|Period 2||1||
48169914|NCT00708305|100739217|FG001|NOT COMPLETED|Period 2||2||
48169915|NCT00708305|100739218|FG002|NOT COMPLETED|Period 2||0||
48169916|NCT00708305|100739219|FG003|NOT COMPLETED|Period 2||1||
48169917|NCT00708305|100739216|FG000|STARTED|Period 3||15||
48169918|NCT00708305|100739217|FG001|STARTED|Period 3||14||
48169919|NCT00708305|100739218|FG002|STARTED|Period 3||14||
48169920|NCT00708305|100739219|FG003|STARTED|Period 3||14||
48169921|NCT00708305|100739216|FG000|COMPLETED|Period 3||14||
48169922|NCT00708305|100739217|FG001|COMPLETED|Period 3||12||
48169923|NCT00708305|100739218|FG002|COMPLETED|Period 3||14||
48169924|NCT00708305|100739219|FG003|COMPLETED|Period 3||14||
48169925|NCT00708305|100739216|FG000|NOT COMPLETED|Period 3||1||
48169926|NCT00708305|100739217|FG001|NOT COMPLETED|Period 3||2||
48169927|NCT00708305|100739218|FG002|NOT COMPLETED|Period 3||0||
48169928|NCT00708305|100739219|FG003|NOT COMPLETED|Period 3||0||
48169929|NCT00708305|100739216|FG000|STARTED|Period 4||12||
48169930|NCT00708305|100739217|FG001|STARTED|Period 4||14||
48169931|NCT00708305|100739218|FG002|STARTED|Period 4||14||
48169932|NCT00708305|100739219|FG003|STARTED|Period 4||14||
48169933|NCT00708305|100739216|FG000|COMPLETED|Period 4||12||
48169934|NCT00708305|100739217|FG001|COMPLETED|Period 4||14||
48169935|NCT00708305|100739218|FG002|COMPLETED|Period 4||14||
48332778|NCT04429061|101141895|FG000|STARTED|Overall Study||1019||23
48332779|NCT04429061|101141896|FG001|STARTED|Overall Study||1134||23
48332780|NCT04429061|101141895|FG000|School 1 and 2|Overall Study||38||1
48332781|NCT04429061|101141896|FG001|School 1 and 2|Overall Study||51||1
48332782|NCT04429061|101141895|FG000|School 3 and 4|Overall Study||37||1
48750073|NCT00791388|102177134|FG002|COMPLETED|Period 2 - 100 mg Dose Group||8||
48750074|NCT00791388|102177135|FG003|COMPLETED|Period 2 - 100 mg Dose Group||0||
48750075|NCT00791388|102177136|FG004|COMPLETED|Period 2 - 100 mg Dose Group||0||
48750076|NCT00791388|102177132|FG000|NOT COMPLETED|Period 2 - 100 mg Dose Group||1||
48750077|NCT00791388|102177133|FG001|NOT COMPLETED|Period 2 - 100 mg Dose Group||0||
48750078|NCT00791388|102177134|FG002|NOT COMPLETED|Period 2 - 100 mg Dose Group||0||
48169936|NCT00708305|100739219|FG003|COMPLETED|Period 4||14||
48169937|NCT00708305|100739216|FG000|NOT COMPLETED|Period 4||0||
48169938|NCT00708305|100739217|FG001|NOT COMPLETED|Period 4||0||
48169939|NCT00708305|100739218|FG002|NOT COMPLETED|Period 4||0||
48169940|NCT00708305|100739219|FG003|NOT COMPLETED|Period 4||0||
48169941|NCT03075501|100739220|FG000|STARTED|Overall Study||89||
48169942|NCT03075501|100739221|FG001|STARTED|Overall Study||44||
48169943|NCT03075501|100739220|FG000|COMPLETED|Overall Study||74||
48169944|NCT03075501|100739221|FG001|COMPLETED|Overall Study||35||
48169945|NCT03075501|100739220|FG000|NOT COMPLETED|Overall Study||15||
48169946|NCT03075501|100739221|FG001|NOT COMPLETED|Overall Study||9||
48332783|NCT04429061|101141896|FG001|School 3 and 4|Overall Study||46||1
48332784|NCT04429061|101141895|FG000|School 5 and 6|Overall Study||44||1
48332785|NCT04429061|101141896|FG001|School 5 and 6|Overall Study||50||1
48332786|NCT04429061|101141895|FG000|School 7 and 8|Overall Study||31||1
48332787|NCT04429061|101141896|FG001|School 7 and 8|Overall Study||53||1
48332788|NCT04429061|101141895|FG000|School 9 and 10|Overall Study||50||1
48332789|NCT04429061|101141896|FG001|School 9 and 10|Overall Study||50||1
48332790|NCT04429061|101141895|FG000|School 11 and 12|Overall Study||50||1
48332791|NCT04429061|101141896|FG001|School 11 and 12|Overall Study||50||1
48332792|NCT04429061|101141895|FG000|School 13 and 14|Overall Study||50||1
48332793|NCT04429061|101141896|FG001|School 13 and 14|Overall Study||50||1
48332794|NCT04429061|101141895|FG000|School 15 and 16|Overall Study||29||1
48332795|NCT04429061|101141896|FG001|School 15 and 16|Overall Study||50||1
48332796|NCT04429061|101141895|FG000|School 17 and 18|Overall Study||52||1
48332797|NCT04429061|101141896|FG001|School 17 and 18|Overall Study||48||1
48332798|NCT04429061|101141895|FG000|School 19 and 20|Overall Study||50||1
48332799|NCT04429061|101141896|FG001|School 19 and 20|Overall Study||47||1
48332800|NCT04429061|101141895|FG000|School 21 and 22|Overall Study||35||1
48332801|NCT04429061|101141896|FG001|School 21 and 22|Overall Study||51||1
48169947|NCT00077636|100739222|FG000|STARTED|Overall Study||736||
48169948|NCT00077636|100739223|FG001|STARTED|Overall Study||733||
48169949|NCT00077636|100739222|FG000|COMPLETED|Overall Study||692||
48169950|NCT00077636|100739223|FG001|COMPLETED|Overall Study||641||
48169951|NCT00077636|100739222|FG000|NOT COMPLETED|Overall Study||44||
48169952|NCT00077636|100739223|FG001|NOT COMPLETED|Overall Study||92||
48169953|NCT03853317|100739224|FG000|STARTED|Overall Study||9||
48169954|NCT03853317|100739224|FG000|COMPLETED|Overall Study||0||
48169955|NCT03853317|100739224|FG000|NOT COMPLETED|Overall Study||9||
48169956|NCT01844115|100739225|FG000|STARTED|Overall Study||202||
48169957|NCT01844115|100739226|FG001|STARTED|Overall Study||202||
48169958|NCT01844115|100739225|FG000|COMPLETED|Overall Study||163||
48169959|NCT01844115|100739226|FG001|COMPLETED|Overall Study||144||
48169960|NCT01844115|100739225|FG000|NOT COMPLETED|Overall Study||39||
48332802|NCT04429061|101141895|FG000|School 23 and 24|Overall Study||50||1
48332803|NCT04429061|101141896|FG001|School 23 and 24|Overall Study||51||1
48332804|NCT04429061|101141895|FG000|School 25 and 26|Overall Study||36||1
48332805|NCT04429061|101141896|FG001|School 25 and 26|Overall Study||48||1
48332806|NCT04429061|101141895|FG000|School 27 and 28|Overall Study||50||1
48332807|NCT04429061|101141896|FG001|School 27 and 28|Overall Study||40||1
48332808|NCT04429061|101141895|FG000|School 29 and 30|Overall Study||35||1
48332809|NCT04429061|101141896|FG001|School 29 and 30|Overall Study||51||1
48332810|NCT04429061|101141895|FG000|School 31 and 32|Overall Study||51||1
48169961|NCT01844115|100739226|FG001|NOT COMPLETED|Overall Study||58||
48169962|NCT02796963|100739227|FG000|STARTED|Overall Study||383||2
48169963|NCT02796963|100739228|FG001|STARTED|Overall Study||328||2
48169964|NCT02796963|100739229|FG002|STARTED|Overall Study||316||2
48169965|NCT02796963|100739230|FG003|STARTED|Overall Study||354||2
48169966|NCT02796963|100739227|FG000|First Follow up|Overall Study||293||2
48169967|NCT02796963|100739228|FG001|First Follow up|Overall Study||279||2
48169968|NCT02796963|100739229|FG002|First Follow up|Overall Study||257||2
48169969|NCT02796963|100739230|FG003|First Follow up|Overall Study||291||2
48169970|NCT02796963|100739227|FG000|Second Follow up|Overall Study||280||2
48169971|NCT02796963|100739228|FG001|Second Follow up|Overall Study||260||2
48169972|NCT02796963|100739229|FG002|Second Follow up|Overall Study||255||2
48169973|NCT02796963|100739230|FG003|Second Follow up|Overall Study||293||2
48169974|NCT02796963|100739227|FG000|Third Follow up|Overall Study||276||2
48169975|NCT02796963|100739228|FG001|Third Follow up|Overall Study||237||2
48169976|NCT02796963|100739229|FG002|Third Follow up|Overall Study||245||2
48169977|NCT02796963|100739230|FG003|Third Follow up|Overall Study||286||2
48169978|NCT02796963|100739227|FG000|Fourth Follow up|Overall Study||275||2
48169979|NCT02796963|100739228|FG001|Fourth Follow up|Overall Study||233||2
48169980|NCT02796963|100739229|FG002|Fourth Follow up|Overall Study||236||2
48169981|NCT02796963|100739230|FG003|Fourth Follow up|Overall Study||263||2
48169982|NCT02796963|100739227|FG000|HIV Sero Converted|Overall Study||19||2
48169983|NCT02796963|100739228|FG001|HIV Sero Converted|Overall Study||19||2
48169984|NCT02796963|100739229|FG002|HIV Sero Converted|Overall Study||11||2
48169985|NCT02796963|100739230|FG003|HIV Sero Converted|Overall Study||19||2
48169986|NCT02796963|100739227|FG000|COMPLETED|Overall Study||294||2
48169987|NCT02796963|100739228|FG001|COMPLETED|Overall Study||252||2
48169988|NCT02796963|100739229|FG002|COMPLETED|Overall Study||247||2
48169989|NCT02796963|100739230|FG003|COMPLETED|Overall Study||282||2
48169990|NCT02796963|100739227|FG000|NOT COMPLETED|Overall Study||89||0
48169991|NCT02796963|100739228|FG001|NOT COMPLETED|Overall Study||76||0
48169992|NCT02796963|100739229|FG002|NOT COMPLETED|Overall Study||69||0
48169993|NCT02796963|100739230|FG003|NOT COMPLETED|Overall Study||72||0
48169994|NCT02674490|100739231|FG000|STARTED|Overall Study||30|Randomized|
48169995|NCT02674490|100739232|FG001|STARTED|Overall Study||28|Randomized|
48169996|NCT02674490|100739231|FG000|Received at Least One Treatment Session (Modified Intent-to-treat Sample)|Overall Study||26||
48169997|NCT02674490|100739232|FG001|Received at Least One Treatment Session (Modified Intent-to-treat Sample)|Overall Study||25||
48169998|NCT02674490|100739231|FG000|COMPLETED|Overall Study||25|Completed 1 week follow-up|
48169999|NCT02674490|100739232|FG001|COMPLETED|Overall Study||21|Completed 1 week follow-up|
48170000|NCT02674490|100739231|FG000|NOT COMPLETED|Overall Study||5||
48170001|NCT02674490|100739232|FG001|NOT COMPLETED|Overall Study||7||
48170002|NCT00553202|100739233|FG000|STARTED|Overall Study||158||
48170003|NCT00553202|100739233|FG000|COMPLETED|Overall Study||90||
48170004|NCT00553202|100739233|FG000|NOT COMPLETED|Overall Study||68||
48170005|NCT01403441|100739234|FG000|STARTED|Overall Study||3||
48170006|NCT01403441|100739234|FG000|COMPLETED|Overall Study||3||
48170007|NCT01403441|100739234|FG000|NOT COMPLETED|Overall Study||0||
48170008|NCT02300285|100739235|FG000|STARTED|Overall Study||3||
48170009|NCT02300285|100739236|FG001|STARTED|Overall Study||3||
48170010|NCT02300285|100739235|FG000|COMPLETED|Overall Study||3||
48170011|NCT02300285|100739236|FG001|COMPLETED|Overall Study||3||
48170012|NCT02300285|100739235|FG000|NOT COMPLETED|Overall Study||0||
48170013|NCT02300285|100739236|FG001|NOT COMPLETED|Overall Study||0||
48170014|NCT03091673|100739237|FG000|STARTED|First Dose||31||
48170015|NCT03091673|100739238|FG001|STARTED|First Dose||0||
48170016|NCT03091673|100739237|FG000|COMPLETED|First Dose||31||
48170017|NCT03091673|100739238|FG001|COMPLETED|First Dose||0||
48170018|NCT03091673|100739237|FG000|NOT COMPLETED|First Dose||0||
48170019|NCT03091673|100739238|FG001|NOT COMPLETED|First Dose||0||
48170020|NCT03091673|100739237|FG000|STARTED|Second Dose||0||
48170021|NCT03091673|100739238|FG001|STARTED|Second Dose||11||
48170022|NCT03091673|100739237|FG000|COMPLETED|Second Dose||0||
48170023|NCT03091673|100739238|FG001|COMPLETED|Second Dose||11||
48170024|NCT03091673|100739237|FG000|NOT COMPLETED|Second Dose||0||
48332811|NCT04429061|101141896|FG001|School 31 and 32|Overall Study||54||1
48170025|NCT03091673|100739238|FG001|NOT COMPLETED|Second Dose||0||
48170026|NCT01183650|100739239|FG000|STARTED|Overall Study||12||
48170027|NCT01183650|100739240|FG001|STARTED|Overall Study||12||
48332812|NCT04429061|101141895|FG000|School 33 and 34|Overall Study||52||1
48170028|NCT01183650|100739239|FG000|COMPLETED|Overall Study||12||
48170029|NCT01183650|100739240|FG001|COMPLETED|Overall Study||12||
48170030|NCT01183650|100739239|FG000|NOT COMPLETED|Overall Study||0||
48170031|NCT01183650|100739240|FG001|NOT COMPLETED|Overall Study||0||
48170032|NCT04389333|100739241|FG000|STARTED|Overall Study||20||
48170033|NCT04389333|100739242|FG001|STARTED|Overall Study||20||
48170034|NCT04389333|100739241|FG000|COMPLETED|Overall Study||20||
48170035|NCT04389333|100739242|FG001|COMPLETED|Overall Study||20||
48170036|NCT04389333|100739241|FG000|NOT COMPLETED|Overall Study||0||
48170037|NCT04389333|100739242|FG001|NOT COMPLETED|Overall Study||0||
48170038|NCT00282815|100739243|FG000|STARTED|Overall Study||15||
48170039|NCT00282815|100739244|FG001|STARTED|Overall Study||17||
48170040|NCT00282815|100739243|FG000|COMPLETED|Overall Study||8||
48170041|NCT00282815|100739244|FG001|COMPLETED|Overall Study||11||
48170042|NCT00282815|100739243|FG000|NOT COMPLETED|Overall Study||7||
48170043|NCT00282815|100739244|FG001|NOT COMPLETED|Overall Study||6||
48170044|NCT00406419|100739245|FG000|STARTED|Overall Study||324||
48170045|NCT00406419|100739246|FG001|STARTED|Overall Study||344||
48170046|NCT00406419|100739247|FG002|STARTED|Overall Study||347||
48170047|NCT00406419|100739245|FG000|COMPLETED|Overall Study||0||
48170048|NCT00406419|100739246|FG001|COMPLETED|Overall Study||0||
48170049|NCT00406419|100739247|FG002|COMPLETED|Overall Study||0||
48170050|NCT00406419|100739245|FG000|NOT COMPLETED|Overall Study||324||
48170051|NCT00406419|100739246|FG001|NOT COMPLETED|Overall Study||344||
48170052|NCT00406419|100739247|FG002|NOT COMPLETED|Overall Study||347||
48170053|NCT01155830|100739248|FG000|STARTED|Overall Study||0||
48170054|NCT01155830|100739249|FG001|STARTED|Overall Study||0||
48170055|NCT01155830|100739250|FG002|STARTED|Overall Study||21||
48170056|NCT01155830|100739248|FG000|COMPLETED|Overall Study||0||
48170057|NCT01155830|100739249|FG001|COMPLETED|Overall Study||0||
48170058|NCT01155830|100739250|FG002|COMPLETED|Overall Study||21||
48170059|NCT01155830|100739248|FG000|NOT COMPLETED|Overall Study||0||
48170060|NCT01155830|100739249|FG001|NOT COMPLETED|Overall Study||0||
48170061|NCT01155830|100739250|FG002|NOT COMPLETED|Overall Study||0||
48170062|NCT00779584|100739251|FG000|STARTED|Overall Study||3||
48170063|NCT00779584|100739252|FG001|STARTED|Overall Study||3||
48170064|NCT00779584|100739253|FG002|STARTED|Overall Study||7||
48170065|NCT00779584|100739254|FG003|STARTED|Overall Study||6||
48170066|NCT00779584|100739255|FG004|STARTED|Overall Study||7||
48170067|NCT00779584|100739256|FG005|STARTED|Overall Study||6||
48170068|NCT00779584|100739257|FG006|STARTED|Overall Study||8||
48170069|NCT00779584|100739258|FG007|STARTED|Overall Study||3||
48170070|NCT00779584|100739259|FG008|STARTED|Overall Study||2||
48170071|NCT00779584|100739251|FG000|Treated|Overall Study||3||
48170072|NCT00779584|100739252|FG001|Treated|Overall Study||3||
48170073|NCT00779584|100739253|FG002|Treated|Overall Study||7||
48170074|NCT00779584|100739254|FG003|Treated|Overall Study||6||
48170075|NCT00779584|100739255|FG004|Treated|Overall Study||7||
48170076|NCT00779584|100739256|FG005|Treated|Overall Study||4||
48170077|NCT00779584|100739257|FG006|Treated|Overall Study||8||
48170078|NCT00779584|100739258|FG007|Treated|Overall Study||3||
48170079|NCT00779584|100739259|FG008|Treated|Overall Study||2||
48170080|NCT00779584|100739251|FG000|COMPLETED|Overall Study||0||
48170081|NCT00779584|100739252|FG001|COMPLETED|Overall Study||0||
48170082|NCT00779584|100739253|FG002|COMPLETED|Overall Study||0||
48332813|NCT04429061|101141896|FG001|School 33 and 34|Overall Study||52||1
48332814|NCT04429061|101141895|FG000|School 35 and 36|Overall Study||43||1
48332815|NCT04429061|101141896|FG001|School 35 and 36|Overall Study||42||1
48332816|NCT04429061|101141895|FG000|School 37 and 38|Overall Study||51||1
48332817|NCT04429061|101141896|FG001|School 37 and 38|Overall Study||45||1
48332818|NCT04429061|101141895|FG000|School 39 and 40|Overall Study||31||1
48332819|NCT04429061|101141896|FG001|School 39 and 40|Overall Study||52||1
48332820|NCT04429061|101141895|FG000|School 41 and 42|Overall Study||49||1
48411516|NCT02520141|101341769|FG000|STARTED|Overall Study||61||
48170083|NCT00779584|100739254|FG003|COMPLETED|Overall Study||0||
48170084|NCT00779584|100739255|FG004|COMPLETED|Overall Study||0||
48170085|NCT00779584|100739256|FG005|COMPLETED|Overall Study||0||
48170086|NCT00779584|100739257|FG006|COMPLETED|Overall Study||0||
48170087|NCT00779584|100739258|FG007|COMPLETED|Overall Study||0||
48170088|NCT00779584|100739259|FG008|COMPLETED|Overall Study||0||
48170089|NCT00779584|100739251|FG000|NOT COMPLETED|Overall Study||3||
48170090|NCT00779584|100739252|FG001|NOT COMPLETED|Overall Study||3||
48170091|NCT00779584|100739253|FG002|NOT COMPLETED|Overall Study||7||
48170092|NCT00779584|100739254|FG003|NOT COMPLETED|Overall Study||6||
48170093|NCT00779584|100739255|FG004|NOT COMPLETED|Overall Study||7||
48170094|NCT00779584|100739256|FG005|NOT COMPLETED|Overall Study||6||
48170095|NCT00779584|100739257|FG006|NOT COMPLETED|Overall Study||8||
48170096|NCT00779584|100739258|FG007|NOT COMPLETED|Overall Study||3||
48170097|NCT00779584|100739259|FG008|NOT COMPLETED|Overall Study||2||
48170098|NCT01121172|100739260|FG000|STARTED|Overall Study||90||
48170099|NCT01121172|100739261|FG001|STARTED|Overall Study||90||
48170100|NCT01121172|100739260|FG000|COMPLETED|Overall Study||90||
48170101|NCT01121172|100739261|FG001|COMPLETED|Overall Study||90||
48170102|NCT01121172|100739260|FG000|NOT COMPLETED|Overall Study||0||
48170103|NCT01121172|100739261|FG001|NOT COMPLETED|Overall Study||0||
48170104|NCT01478113|100739262|FG000|STARTED|Overall Study||2||
48170105|NCT01478113|100739263|FG001|STARTED|Overall Study||2||
48411517|NCT02520141|101341769|FG000|COMPLETED|Overall Study||60||
48411518|NCT02520141|101341769|FG000|NOT COMPLETED|Overall Study||1||
48750079|NCT00791388|102177135|FG003|NOT COMPLETED|Period 2 - 100 mg Dose Group||0||
48750080|NCT00791388|102177136|FG004|NOT COMPLETED|Period 2 - 100 mg Dose Group||0||
48750081|NCT00791388|102177132|FG000|STARTED|Period 3 - 200 mg Dose Group||3||
48750082|NCT00791388|102177133|FG001|STARTED|Period 3 - 200 mg Dose Group||0||
48750083|NCT00791388|102177134|FG002|STARTED|Period 3 - 200 mg Dose Group||0||
48750084|NCT00791388|102177135|FG003|STARTED|Period 3 - 200 mg Dose Group||8||
48750085|NCT00791388|102177136|FG004|STARTED|Period 3 - 200 mg Dose Group||0||
48750086|NCT00791388|102177132|FG000|COMPLETED|Period 3 - 200 mg Dose Group||3||
48750087|NCT00791388|102177133|FG001|COMPLETED|Period 3 - 200 mg Dose Group||0||
48750088|NCT00791388|102177134|FG002|COMPLETED|Period 3 - 200 mg Dose Group||0||
48170106|NCT01478113|100739262|FG000|COMPLETED|Overall Study||1||
48170107|NCT01478113|100739263|FG001|COMPLETED|Overall Study||1||
48170108|NCT01478113|100739262|FG000|NOT COMPLETED|Overall Study||1||
48170109|NCT01478113|100739263|FG001|NOT COMPLETED|Overall Study||1||
48750089|NCT00791388|102177135|FG003|COMPLETED|Period 3 - 200 mg Dose Group||8||
48750090|NCT00791388|102177136|FG004|COMPLETED|Period 3 - 200 mg Dose Group||0||
48170110|NCT04686279|100739264|FG000|STARTED|Overall Study||8||
48170111|NCT04686279|100739264|FG000|COMPLETED|Overall Study||8||
48170112|NCT04686279|100739264|FG000|NOT COMPLETED|Overall Study||0||
48170113|NCT02049710|100739265|FG000|STARTED|Overall Study||653||
48170114|NCT02049710|100739266|FG001|STARTED|Overall Study||664||
48170115|NCT02049710|100739265|FG000|COMPLETED|Overall Study||334||
48170116|NCT02049710|100739266|FG001|COMPLETED|Overall Study||340||
48170117|NCT02049710|100739265|FG000|NOT COMPLETED|Overall Study||319||
48170118|NCT02049710|100739266|FG001|NOT COMPLETED|Overall Study||324||
48170119|NCT00393523|100739267|FG000|STARTED|Overall Study||376||
48170120|NCT00393523|100739268|FG001|STARTED|Overall Study||375||
48170121|NCT00393523|100739269|FG002|STARTED|Overall Study||353||
48170122|NCT00393523|100739270|FG003|STARTED|Overall Study||354||
48170123|NCT00393523|100739271|FG004|STARTED|Overall Study||20||
48170124|NCT00393523|100739267|FG000|Vaccination Visit 1|Overall Study||374||
48170125|NCT00393523|100739268|FG001|Vaccination Visit 1|Overall Study||375||
48170126|NCT00393523|100739269|FG002|Vaccination Visit 1|Overall Study||349||
48170127|NCT00393523|100739270|FG003|Vaccination Visit 1|Overall Study||352||
48170128|NCT00393523|100739271|FG004|Vaccination Visit 1|Overall Study||20||
48170129|NCT00393523|100739267|FG000|COMPLETED|Overall Study||364||
48170130|NCT00393523|100739268|FG001|COMPLETED|Overall Study||366||
48170131|NCT00393523|100739269|FG002|COMPLETED|Overall Study||349||
48170132|NCT00393523|100739270|FG003|COMPLETED|Overall Study||348||
48170133|NCT00393523|100739271|FG004|COMPLETED|Overall Study||19||
48170134|NCT00393523|100739267|FG000|NOT COMPLETED|Overall Study||12||
48170135|NCT00393523|100739268|FG001|NOT COMPLETED|Overall Study||9||
48170136|NCT00393523|100739269|FG002|NOT COMPLETED|Overall Study||4||
48170137|NCT00393523|100739270|FG003|NOT COMPLETED|Overall Study||6||
48170138|NCT00393523|100739271|FG004|NOT COMPLETED|Overall Study||1||
48170139|NCT01254890|100739272|FG000|STARTED|Overall Study||3||
48170140|NCT01254890|100739273|FG001|STARTED|Overall Study||57||
48170141|NCT01254890|100739272|FG000|COMPLETED|Overall Study||2||
48170142|NCT01254890|100739273|FG001|COMPLETED|Overall Study||47||
48170143|NCT01254890|100739272|FG000|NOT COMPLETED|Overall Study||1||
48170144|NCT01254890|100739273|FG001|NOT COMPLETED|Overall Study||10||
48170145|NCT01532817|100739274|FG000|STARTED|Overall Study||30||
48170146|NCT01532817|100739274|FG000|COMPLETED|Overall Study||30||
48170147|NCT01532817|100739274|FG000|NOT COMPLETED|Overall Study||0||
48750091|NCT00791388|102177132|FG000|NOT COMPLETED|Period 3 - 200 mg Dose Group||0||
48170148|NCT03075904|100739275|FG000|STARTED|Overall Study||8||
48170149|NCT03075904|100739275|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8||
48170150|NCT03075904|100739275|FG000|COMPLETED|Overall Study||4|All 8 participants received all 5 weekly doses of ALXN1830 10 mg/kg in the Treatment Period.|
48170151|NCT03075904|100739275|FG000|NOT COMPLETED|Overall Study||4||
48170152|NCT01868035|100739276|FG000|STARTED|Overall Study||15||
48170153|NCT01868035|100739276|FG000|COMPLETED|Overall Study||8||
48170154|NCT01868035|100739276|FG000|NOT COMPLETED|Overall Study||7||
48170155|NCT00569803|100739277|FG000|STARTED|Overall Study||5||
48170156|NCT00569803|100739278|FG001|STARTED|Overall Study||5||
48411519|NCT02060903|101341770|FG000|STARTED|Overall Study||187||
48411520|NCT02060903|101341771|FG001|STARTED|Overall Study||192||
48411521|NCT02060903|101341770|FG000|COMPLETED|Overall Study||183||
48750092|NCT00791388|102177133|FG001|NOT COMPLETED|Period 3 - 200 mg Dose Group||0||
48750093|NCT00791388|102177134|FG002|NOT COMPLETED|Period 3 - 200 mg Dose Group||0||
48170157|NCT00569803|100739279|FG002|STARTED|Overall Study||5||
48170158|NCT00569803|100739280|FG003|STARTED|Overall Study||6||
48170159|NCT00569803|100739281|FG004|STARTED|Overall Study||5||
48411522|NCT02060903|101341771|FG001|COMPLETED|Overall Study||185||
48411523|NCT02060903|101341770|FG000|NOT COMPLETED|Overall Study||4||
48170160|NCT00569803|100739282|FG005|STARTED|Overall Study||5||
48170161|NCT00569803|100739283|FG006|STARTED|Overall Study||10||
48170162|NCT00569803|100739284|FG007|STARTED|Overall Study||6||
48170163|NCT00569803|100739277|FG000|COMPLETED|Overall Study||4||
48170164|NCT00569803|100739278|FG001|COMPLETED|Overall Study||5||
48170165|NCT00569803|100739279|FG002|COMPLETED|Overall Study||5||
48170166|NCT00569803|100739280|FG003|COMPLETED|Overall Study||5||
48170167|NCT00569803|100739281|FG004|COMPLETED|Overall Study||5||
48170168|NCT00569803|100739282|FG005|COMPLETED|Overall Study||5||
48170169|NCT00569803|100739283|FG006|COMPLETED|Overall Study||10||
48170170|NCT00569803|100739284|FG007|COMPLETED|Overall Study||5||
48170171|NCT00569803|100739277|FG000|NOT COMPLETED|Overall Study||1||
48170172|NCT00569803|100739278|FG001|NOT COMPLETED|Overall Study||0||
48170173|NCT00569803|100739279|FG002|NOT COMPLETED|Overall Study||0||
48170174|NCT00569803|100739280|FG003|NOT COMPLETED|Overall Study||1||
48170175|NCT00569803|100739281|FG004|NOT COMPLETED|Overall Study||0||
48170176|NCT00569803|100739282|FG005|NOT COMPLETED|Overall Study||0||
48170177|NCT00569803|100739283|FG006|NOT COMPLETED|Overall Study||0||
48170178|NCT00569803|100739284|FG007|NOT COMPLETED|Overall Study||1||
48170179|NCT00692406|100739285|FG000|STARTED|Overall Study||80||
48626770|NCT01764841|101870906|FG001|STARTED|Overall Study||137||
48626771|NCT01764841|101870907|FG002|STARTED|Overall Study||70||
48626772|NCT01764841|101870908|FG003|STARTED|Overall Study||68||
48626773|NCT01764841|101870905|FG000|Participants Received Treatment|Overall Study||141||
48626774|NCT01764841|101870906|FG001|Participants Received Treatment|Overall Study||136||
48750094|NCT00791388|102177135|FG003|NOT COMPLETED|Period 3 - 200 mg Dose Group||0||
48750095|NCT00791388|102177136|FG004|NOT COMPLETED|Period 3 - 200 mg Dose Group||0||
48750096|NCT00791388|102177132|FG000|STARTED|Period 4 - 400 mg Dose Group||4||
48750097|NCT00791388|102177133|FG001|STARTED|Period 4 - 400 mg Dose Group||0||
48750098|NCT00791388|102177134|FG002|STARTED|Period 4 - 400 mg Dose Group||0||
48750099|NCT00791388|102177135|FG003|STARTED|Period 4 - 400 mg Dose Group||0||
48170180|NCT00692406|100739285|FG000|COMPLETED|Overall Study||23||
48170181|NCT00692406|100739285|FG000|NOT COMPLETED|Overall Study||57||
48750100|NCT00791388|102177136|FG004|STARTED|Period 4 - 400 mg Dose Group||8||
48170182|NCT02101918|100739286|FG000|STARTED|Overall Study||22||
48170183|NCT02101918|100739286|FG000|COMPLETED|Overall Study||22||
48170184|NCT02101918|100739286|FG000|NOT COMPLETED|Overall Study||0||
48170185|NCT03777865|100739287|FG000|STARTED|Overall Study||100||
48750101|NCT00791388|102177132|FG000|COMPLETED|Period 4 - 400 mg Dose Group||4||
48170186|NCT03777865|100739287|FG000|COMPLETED|Overall Study||100||
48170187|NCT03777865|100739287|FG000|NOT COMPLETED|Overall Study||0||
48170188|NCT03893825|100739288|FG000|STARTED|Overall Study||174||
48170189|NCT03893825|100739289|FG001|STARTED|Overall Study||162||
48170190|NCT03893825|100739288|FG000|Received at Least 1 Dose of Study Drug|Overall Study||172||
48170191|NCT03893825|100739289|FG001|Received at Least 1 Dose of Study Drug|Overall Study||162||
48170192|NCT03893825|100739288|FG000|COMPLETED|Overall Study||135||
48626775|NCT01764841|101870907|FG002|Participants Received Treatment|Overall Study||69||
48626776|NCT01764841|101870908|FG003|Participants Received Treatment|Overall Study||68||
48626777|NCT01764841|101870905|FG000|COMPLETED|Overall Study||118||
48626778|NCT01764841|101870906|FG001|COMPLETED|Overall Study||111||
48626779|NCT01764841|101870907|FG002|COMPLETED|Overall Study||56||
48626780|NCT01764841|101870908|FG003|COMPLETED|Overall Study||49||
48626781|NCT01764841|101870905|FG000|NOT COMPLETED|Overall Study||23||
48626782|NCT01764841|101870906|FG001|NOT COMPLETED|Overall Study||26||
48626783|NCT01764841|101870907|FG002|NOT COMPLETED|Overall Study||14||
48626784|NCT01764841|101870908|FG003|NOT COMPLETED|Overall Study||19||
48626785|NCT01334086|101870909|FG000|STARTED|Overall Study||41||
48626786|NCT01334086|101870909|FG000|COMPLETED|Overall Study||41||
48626787|NCT01334086|101870909|FG000|NOT COMPLETED|Overall Study||0||
48626788|NCT02697071|101870910|FG000|STARTED|Overall Study||18||
48626789|NCT02697071|101870911|FG001|STARTED|Overall Study||16||
48626790|NCT02697071|101870910|FG000|COMPLETED|Overall Study||18||
48626791|NCT02697071|101870911|FG001|COMPLETED|Overall Study||16||
48626792|NCT02697071|101870910|FG000|NOT COMPLETED|Overall Study||0||
48626793|NCT02697071|101870911|FG001|NOT COMPLETED|Overall Study||0||
48626794|NCT01286129|101870912|FG000|STARTED|Overall Study||27||
48626795|NCT01286129|101870913|FG001|STARTED|Overall Study||18||
48626796|NCT01286129|101870912|FG000|COMPLETED|Overall Study||19||
48626797|NCT01286129|101870913|FG001|COMPLETED|Overall Study||13||
48626798|NCT01286129|101870912|FG000|NOT COMPLETED|Overall Study||8||
48626799|NCT01286129|101870913|FG001|NOT COMPLETED|Overall Study||5||
48626800|NCT01408706|101870914|FG000|STARTED|Overall Study||30||
48332821|NCT04429061|101141896|FG001|School 41 and 42|Overall Study||50||1
48626801|NCT01408706|101870915|FG001|STARTED|Overall Study||30||
48626802|NCT01408706|101870914|FG000|COMPLETED|Overall Study||29||
48626803|NCT01408706|101870915|FG001|COMPLETED|Overall Study||30||
48626804|NCT01408706|101870914|FG000|NOT COMPLETED|Overall Study||1||
48750102|NCT00791388|102177133|FG001|COMPLETED|Period 4 - 400 mg Dose Group||0||
48750103|NCT00791388|102177134|FG002|COMPLETED|Period 4 - 400 mg Dose Group||0||
48170193|NCT03893825|100739289|FG001|COMPLETED|Overall Study||122||
48170194|NCT03893825|100739288|FG000|NOT COMPLETED|Overall Study||39||
48332822|NCT04429061|101141895|FG000|School 43 and 44|Overall Study||52||1
48626805|NCT01408706|101870915|FG001|NOT COMPLETED|Overall Study||0||
48626806|NCT00111761|101870916|FG000|STARTED|Part 1||0||
48626807|NCT00111761|101870917|FG001|STARTED|Part 1||19||
48626808|NCT00111761|101870916|FG000|COMPLETED|Part 1||0||
48170195|NCT03893825|100739289|FG001|NOT COMPLETED|Overall Study||40||
48170196|NCT02247804|100739290|FG000|STARTED|Treatment Period 1||198||
48170197|NCT02247804|100739291|FG001|STARTED|Treatment Period 1||198||
48170198|NCT02247804|100739292|FG002|STARTED|Treatment Period 1||198||
48170199|NCT02247804|100739290|FG000|Received (Sham or Bimatoprost SR)|Treatment Period 1||193||
48170200|NCT02247804|100739291|FG001|Received (Sham or Bimatoprost SR)|Treatment Period 1||197||
48170201|NCT02247804|100739292|FG002|Received (Sham or Bimatoprost SR)|Treatment Period 1||197||
48170202|NCT02247804|100739290|FG000|COMPLETED|Treatment Period 1||176||
48170203|NCT02247804|100739291|FG001|COMPLETED|Treatment Period 1||194||
48170204|NCT02247804|100739292|FG002|COMPLETED|Treatment Period 1||190||
48170205|NCT02247804|100739290|FG000|NOT COMPLETED|Treatment Period 1||22||
48170206|NCT02247804|100739291|FG001|NOT COMPLETED|Treatment Period 1||4||
48170207|NCT02247804|100739292|FG002|NOT COMPLETED|Treatment Period 1||8||
48170208|NCT02247804|100739290|FG000|STARTED|Treatment Period 2||172|Started=received administration (Sham or Bimatoprost SR) in the cycle|
48170209|NCT02247804|100739291|FG001|STARTED|Treatment Period 2||191|Started=received administration (Sham or Bimatoprost SR) in the cycle|
48170210|NCT02247804|100739292|FG002|STARTED|Treatment Period 2||187|Started=received administration (Sham or Bimatoprost SR) in the cycle|
48170211|NCT02247804|100739290|FG000|COMPLETED|Treatment Period 2||164||
48170212|NCT02247804|100739291|FG001|COMPLETED|Treatment Period 2||186||
48170213|NCT02247804|100739292|FG002|COMPLETED|Treatment Period 2||179||
48170214|NCT02247804|100739290|FG000|NOT COMPLETED|Treatment Period 2||8||
48170215|NCT02247804|100739291|FG001|NOT COMPLETED|Treatment Period 2||5||
48170216|NCT02247804|100739292|FG002|NOT COMPLETED|Treatment Period 2||8||
48170217|NCT02247804|100739290|FG000|STARTED|Treatment Period 3||158|Started=received administration (Sham or Bimatoprost SR) in the cycle|
48170218|NCT02247804|100739291|FG001|STARTED|Treatment Period 3||183|Started=received administration (Sham or Bimatoprost SR) in the cycle|
48170219|NCT02247804|100739292|FG002|STARTED|Treatment Period 3||177|Started=received administration (Sham or Bimatoprost SR) in the cycle|
48170220|NCT02247804|100739290|FG000|COMPLETED|Treatment Period 3||147||
48170221|NCT02247804|100739291|FG001|COMPLETED|Treatment Period 3||173||
48170222|NCT02247804|100739292|FG002|COMPLETED|Treatment Period 3||167||
48170223|NCT02247804|100739290|FG000|NOT COMPLETED|Treatment Period 3||11||
48750104|NCT00791388|102177135|FG003|COMPLETED|Period 4 - 400 mg Dose Group||0||
48750105|NCT00791388|102177136|FG004|COMPLETED|Period 4 - 400 mg Dose Group||4||
48750106|NCT00791388|102177132|FG000|NOT COMPLETED|Period 4 - 400 mg Dose Group||0||
48750107|NCT00791388|102177133|FG001|NOT COMPLETED|Period 4 - 400 mg Dose Group||0||
48750108|NCT00791388|102177134|FG002|NOT COMPLETED|Period 4 - 400 mg Dose Group||0||
48750109|NCT00791388|102177135|FG003|NOT COMPLETED|Period 4 - 400 mg Dose Group||0||
48170224|NCT02247804|100739291|FG001|NOT COMPLETED|Treatment Period 3||10||
48170225|NCT02247804|100739292|FG002|NOT COMPLETED|Treatment Period 3||10||
48170226|NCT01348776|100739293|FG000|STARTED|Overall Study||87||
48170227|NCT01348776|100739293|FG000|COMPLETED|Overall Study||84||
48170228|NCT01348776|100739293|FG000|NOT COMPLETED|Overall Study||3||
48170229|NCT00147225|100739294|FG000|STARTED|Overall Study||7||
48170230|NCT00147225|100739295|FG001|STARTED|Overall Study||6||
48170231|NCT00147225|100739296|FG002|STARTED|Overall Study||8||
48170232|NCT00147225|100739297|FG003|STARTED|Overall Study||11||
48170233|NCT00147225|100739298|FG004|STARTED|Overall Study||11||
48170234|NCT00147225|100739299|FG005|STARTED|Overall Study||12||
48170235|NCT00147225|100739294|FG000|COMPLETED|Overall Study||6||
48170236|NCT00147225|100739295|FG001|COMPLETED|Overall Study||6||
48170237|NCT00147225|100739296|FG002|COMPLETED|Overall Study||6||
48170238|NCT00147225|100739297|FG003|COMPLETED|Overall Study||10||
48170239|NCT00147225|100739298|FG004|COMPLETED|Overall Study||10||
48170240|NCT00147225|100739299|FG005|COMPLETED|Overall Study||10||
48170241|NCT00147225|100739294|FG000|NOT COMPLETED|Overall Study||1||
48170242|NCT00147225|100739295|FG001|NOT COMPLETED|Overall Study||0||
48170243|NCT00147225|100739296|FG002|NOT COMPLETED|Overall Study||2||
48170244|NCT00147225|100739297|FG003|NOT COMPLETED|Overall Study||1||
48170245|NCT00147225|100739298|FG004|NOT COMPLETED|Overall Study||1||
48170246|NCT00147225|100739299|FG005|NOT COMPLETED|Overall Study||2||
48170247|NCT02593305|100739300|FG000|STARTED|Baseline 1||7||
48170248|NCT02593305|100739301|FG001|STARTED|Baseline 1||6||
48170249|NCT02593305|100739302|FG002|STARTED|Baseline 1||10||
48170250|NCT02593305|100739300|FG000|COMPLETED|Baseline 1||7||
48170251|NCT02593305|100739301|FG001|COMPLETED|Baseline 1||6||
48170252|NCT02593305|100739302|FG002|COMPLETED|Baseline 1||10||
48170253|NCT02593305|100739300|FG000|NOT COMPLETED|Baseline 1||0||
48170254|NCT02593305|100739301|FG001|NOT COMPLETED|Baseline 1||0||
48750110|NCT00791388|102177136|FG004|NOT COMPLETED|Period 4 - 400 mg Dose Group||4||
48750111|NCT03714178|102177137|FG000|STARTED|Overall Study||71||
48750112|NCT03714178|102177137|FG000|COMPLETED|Overall Study||71||
48750113|NCT03714178|102177137|FG000|NOT COMPLETED|Overall Study||0||
48750114|NCT00857285|102177138|FG000|STARTED|Overall Study||65||
48170255|NCT02593305|100739302|FG002|NOT COMPLETED|Baseline 1||0||
48170256|NCT02593305|100739300|FG000|STARTED|Post 1||7||
48170257|NCT02593305|100739301|FG001|STARTED|Post 1||6||
48170258|NCT02593305|100739302|FG002|STARTED|Post 1||10||
48170259|NCT02593305|100739300|FG000|COMPLETED|Post 1||7||
48170260|NCT02593305|100739301|FG001|COMPLETED|Post 1||6||
48170261|NCT02593305|100739302|FG002|COMPLETED|Post 1||0||
48170262|NCT02593305|100739300|FG000|NOT COMPLETED|Post 1||0||
48332823|NCT04429061|101141896|FG001|School 43 and 44|Overall Study||50||1
48750115|NCT00857285|102177139|FG001|STARTED|Overall Study||65||
48750116|NCT00857285|102177138|FG000|COMPLETED|Overall Study||53||
48750117|NCT00857285|102177139|FG001|COMPLETED|Overall Study||59||
48750118|NCT00857285|102177138|FG000|NOT COMPLETED|Overall Study||12||
48750119|NCT00857285|102177139|FG001|NOT COMPLETED|Overall Study||6||
48750120|NCT00597402|102177140|FG000|STARTED|Overall Study||125||
48750121|NCT00597402|102177140|FG000|COMPLETED|Overall Study||125||
48750122|NCT00597402|102177140|FG000|NOT COMPLETED|Overall Study||0||
48750123|NCT00527735|102177141|FG000|STARTED|Overall Study||113||
48750124|NCT00527735|102177142|FG001|STARTED|Overall Study||109||
48750125|NCT00527735|102177143|FG002|STARTED|Overall Study||109||
48750126|NCT00527735|102177141|FG000|COMPLETED|Overall Study||5||
48750127|NCT00527735|102177142|FG001|COMPLETED|Overall Study||2||
48750128|NCT00527735|102177143|FG002|COMPLETED|Overall Study||2||
48332824|NCT04429061|101141895|FG000|School 45 and 46|Overall Study||53||1
48332825|NCT04429061|101141896|FG001|School 45 and 46|Overall Study||53||1
48332826|NCT04429061|101141895|FG000|COMPLETED|Overall Study||954||23
48332827|NCT04429061|101141896|FG001|COMPLETED|Overall Study||1043||23
48332828|NCT04429061|101141895|FG000|NOT COMPLETED|Overall Study||65||0
48332829|NCT04429061|101141896|FG001|NOT COMPLETED|Overall Study||91||0
48332830|NCT00352105|101141897|FG000|STARTED|Overall Study||60||
48332831|NCT00352105|101141897|FG000|COMPLETED|Overall Study||20||
48750129|NCT00527735|102177141|FG000|NOT COMPLETED|Overall Study||108||
48750130|NCT00527735|102177142|FG001|NOT COMPLETED|Overall Study||107||
48750131|NCT00527735|102177143|FG002|NOT COMPLETED|Overall Study||107||
48332832|NCT00352105|101141897|FG000|NOT COMPLETED|Overall Study||40||
48332833|NCT01114529|101141898|FG000|STARTED|Completed Study Medication at Month 24||353||
48332834|NCT01114529|101141899|FG001|STARTED|Completed Study Medication at Month 24||231||
48332835|NCT01114529|101141900|FG002|STARTED|Completed Study Medication at Month 24||125||
48332836|NCT01114529|101141898|FG000|COMPLETED|Completed Study Medication at Month 24||229||
48332837|NCT01114529|101141899|FG001|COMPLETED|Completed Study Medication at Month 24||190||
48332838|NCT01114529|101141900|FG002|COMPLETED|Completed Study Medication at Month 24||93||
48332839|NCT01114529|101141898|FG000|NOT COMPLETED|Completed Study Medication at Month 24||124||
48332840|NCT01114529|101141899|FG001|NOT COMPLETED|Completed Study Medication at Month 24||41||
48332841|NCT01114529|101141900|FG002|NOT COMPLETED|Completed Study Medication at Month 24||32||
48332842|NCT01114529|101141898|FG000|STARTED|Completed Study Phase at Month 24||353||
48332843|NCT01114529|101141899|FG001|STARTED|Completed Study Phase at Month 24||231||
48332844|NCT01114529|101141900|FG002|STARTED|Completed Study Phase at Month 24||125||
48332845|NCT01114529|101141898|FG000|COMPLETED|Completed Study Phase at Month 24||313||
48332846|NCT01114529|101141899|FG001|COMPLETED|Completed Study Phase at Month 24||215||
48332847|NCT01114529|101141900|FG002|COMPLETED|Completed Study Phase at Month 24||111||
48332848|NCT01114529|101141898|FG000|NOT COMPLETED|Completed Study Phase at Month 24||40||
48411524|NCT02060903|101341771|FG001|NOT COMPLETED|Overall Study||7||
48750132|NCT02314052|102177144|FG000|STARTED|Cycle One||3||
48411525|NCT00205374|101341772|FG000|STARTED|Overall Study||10||
48411526|NCT00205374|101341773|FG001|STARTED|Overall Study||9||
48411527|NCT00205374|101341772|FG000|COMPLETED|Overall Study||10||
48411528|NCT00205374|101341773|FG001|COMPLETED|Overall Study||9||
48411529|NCT00205374|101341772|FG000|NOT COMPLETED|Overall Study||0||
48411530|NCT00205374|101341773|FG001|NOT COMPLETED|Overall Study||0||
48411531|NCT03733249|101341774|FG000|STARTED|Overall Study||184|Patients receiving HSCT graft (HSCT Safety population)|
48411532|NCT03733249|101341774|FG000|Patients Receiving Rivogenlecleucel (BPX-501 Safety Population)|Overall Study||171||
48411533|NCT03733249|101341774|FG000|Intent-to-Treat Population|Overall Study||142|Includes all patients treated with HSCT who received rivogenlecleucel at the dose of 1×10E6 cells/kg.|
48411534|NCT03733249|101341774|FG000|Patients Receiving at Least 1 Dose of Rimiducid|Overall Study||16||
48750133|NCT02314052|102177145|FG001|STARTED|Cycle One||3||
48750134|NCT02314052|102177146|FG002|STARTED|Cycle One||3||
48332849|NCT01114529|101141899|FG001|NOT COMPLETED|Completed Study Phase at Month 24||16||
48332850|NCT01114529|101141900|FG002|NOT COMPLETED|Completed Study Phase at Month 24||14||
48332851|NCT03042936|101141901|FG000|STARTED|Overall Study||33||
48332852|NCT03042936|101141901|FG000|COMPLETED|Overall Study||28||
48332853|NCT03042936|101141901|FG000|NOT COMPLETED|Overall Study||5||
48332854|NCT01022190|101141902|FG000|STARTED|Overall Study||42||
48332855|NCT01022190|101141902|FG000|COMPLETED|Overall Study||42||
48332856|NCT01022190|101141902|FG000|NOT COMPLETED|Overall Study||0||
48332857|NCT00328627|101141903|FG000|STARTED|Overall Study||129||
48750135|NCT02314052|102177147|FG003|STARTED|Cycle One||3||
48750136|NCT02314052|102177148|FG004|STARTED|Cycle One||6||
48750137|NCT02314052|102177149|FG005|STARTED|Cycle One||3||
48750138|NCT02314052|102177144|FG000|COMPLETED|Cycle One||3||
48750139|NCT02314052|102177145|FG001|COMPLETED|Cycle One||3||
48750140|NCT02314052|102177146|FG002|COMPLETED|Cycle One||3||
48750141|NCT02314052|102177147|FG003|COMPLETED|Cycle One||2||
48750142|NCT02314052|102177148|FG004|COMPLETED|Cycle One||6||
48750143|NCT02314052|102177149|FG005|COMPLETED|Cycle One||3||
48750144|NCT02314052|102177144|FG000|NOT COMPLETED|Cycle One||0||
48750145|NCT02314052|102177145|FG001|NOT COMPLETED|Cycle One||0||
48750146|NCT02314052|102177146|FG002|NOT COMPLETED|Cycle One||0||
48332858|NCT00328627|101141904|FG001|STARTED|Overall Study||128||
48332859|NCT00328627|101141905|FG002|STARTED|Overall Study||129||
48332860|NCT00328627|101141906|FG003|STARTED|Overall Study||130||
48750147|NCT02314052|102177147|FG003|NOT COMPLETED|Cycle One||1||
48750148|NCT02314052|102177148|FG004|NOT COMPLETED|Cycle One||0||
48750149|NCT02314052|102177149|FG005|NOT COMPLETED|Cycle One||0||
48750150|NCT02314052|102177144|FG000|STARTED|Cycle Two||3||
48750151|NCT02314052|102177145|FG001|STARTED|Cycle Two||3||
48750152|NCT02314052|102177146|FG002|STARTED|Cycle Two||3||
48750153|NCT02314052|102177147|FG003|STARTED|Cycle Two||2||
48750154|NCT02314052|102177148|FG004|STARTED|Cycle Two||6||
48750155|NCT02314052|102177149|FG005|STARTED|Cycle Two||3||
48750156|NCT02314052|102177144|FG000|COMPLETED|Cycle Two||3||
48750157|NCT02314052|102177145|FG001|COMPLETED|Cycle Two||2||
48332861|NCT00328627|101141907|FG004|STARTED|Overall Study||130||
48332862|NCT00328627|101141908|FG005|STARTED|Overall Study||130||
48332863|NCT00328627|101141909|FG006|STARTED|Overall Study||129||
48332864|NCT00328627|101141910|FG007|STARTED|Overall Study||130||
48332865|NCT00328627|101141911|FG008|STARTED|Overall Study||130||
48332866|NCT00328627|101141912|FG009|STARTED|Overall Study||129||
48332867|NCT00328627|101141913|FG010|STARTED|Overall Study||130||
48332868|NCT00328627|101141914|FG011|STARTED|Overall Study||130||
48332869|NCT00328627|101141903|FG000|Safety Set|Overall Study||129||
48332870|NCT00328627|101141904|FG001|Safety Set|Overall Study||128||
48332871|NCT00328627|101141905|FG002|Safety Set|Overall Study||129||
48332872|NCT00328627|101141906|FG003|Safety Set|Overall Study||129||
48332873|NCT00328627|101141907|FG004|Safety Set|Overall Study||130||
48332874|NCT00328627|101141908|FG005|Safety Set|Overall Study||130||
48332875|NCT00328627|101141909|FG006|Safety Set|Overall Study||129||
48332876|NCT00328627|101141910|FG007|Safety Set|Overall Study||130||
48332877|NCT00328627|101141911|FG008|Safety Set|Overall Study||130||
48332878|NCT00328627|101141912|FG009|Safety Set|Overall Study||129||
48332879|NCT00328627|101141913|FG010|Safety Set|Overall Study||130||
48332880|NCT00328627|101141914|FG011|Safety Set|Overall Study||130||
48332881|NCT00328627|101141903|FG000|COMPLETED|Overall Study||70||
48332882|NCT00328627|101141904|FG001|COMPLETED|Overall Study||97||
48332883|NCT00328627|101141905|FG002|COMPLETED|Overall Study||101||
48332884|NCT00328627|101141906|FG003|COMPLETED|Overall Study||93||
48332885|NCT00328627|101141907|FG004|COMPLETED|Overall Study||115||
48332886|NCT00328627|101141908|FG005|COMPLETED|Overall Study||110||
48332887|NCT00328627|101141909|FG006|COMPLETED|Overall Study||94||
48332888|NCT00328627|101141910|FG007|COMPLETED|Overall Study||116||
48332889|NCT00328627|101141911|FG008|COMPLETED|Overall Study||113||
48332890|NCT00328627|101141912|FG009|COMPLETED|Overall Study||97||
48332891|NCT00328627|101141913|FG010|COMPLETED|Overall Study||112||
48332892|NCT00328627|101141914|FG011|COMPLETED|Overall Study||114||
48332893|NCT00328627|101141903|FG000|NOT COMPLETED|Overall Study||59||
48332894|NCT00328627|101141904|FG001|NOT COMPLETED|Overall Study||31||
48332895|NCT00328627|101141905|FG002|NOT COMPLETED|Overall Study||28||
48332896|NCT00328627|101141906|FG003|NOT COMPLETED|Overall Study||37||
48332897|NCT00328627|101141907|FG004|NOT COMPLETED|Overall Study||15||
48332898|NCT00328627|101141908|FG005|NOT COMPLETED|Overall Study||20||
48332899|NCT00328627|101141909|FG006|NOT COMPLETED|Overall Study||35||
48332900|NCT00328627|101141910|FG007|NOT COMPLETED|Overall Study||14||
48332901|NCT00328627|101141911|FG008|NOT COMPLETED|Overall Study||17||
48332902|NCT00328627|101141912|FG009|NOT COMPLETED|Overall Study||32||
48332903|NCT00328627|101141913|FG010|NOT COMPLETED|Overall Study||18||
48332904|NCT00328627|101141914|FG011|NOT COMPLETED|Overall Study||16||
48332905|NCT01614093|101141915|FG000|STARTED|Overall Study||17||
48332906|NCT01614093|101141915|FG000|COMPLETED|Overall Study||16||
48750158|NCT02314052|102177146|FG002|COMPLETED|Cycle Two||2||
48750159|NCT02314052|102177147|FG003|COMPLETED|Cycle Two||1||
48750160|NCT02314052|102177148|FG004|COMPLETED|Cycle Two||2||
48750161|NCT02314052|102177149|FG005|COMPLETED|Cycle Two||3||
48750162|NCT02314052|102177144|FG000|NOT COMPLETED|Cycle Two||0||
48750163|NCT02314052|102177145|FG001|NOT COMPLETED|Cycle Two||1||
48750164|NCT02314052|102177146|FG002|NOT COMPLETED|Cycle Two||1||
48750165|NCT02314052|102177147|FG003|NOT COMPLETED|Cycle Two||1||
48750166|NCT02314052|102177148|FG004|NOT COMPLETED|Cycle Two||4||
48750167|NCT02314052|102177149|FG005|NOT COMPLETED|Cycle Two||0||
48750168|NCT02314052|102177144|FG000|STARTED|Cycle Three||3||
48750169|NCT02314052|102177145|FG001|STARTED|Cycle Three||2||
48332907|NCT01614093|101141915|FG000|NOT COMPLETED|Overall Study||1||
48332908|NCT03604445|101141916|FG000|STARTED|Overall Study||3||
48332909|NCT03604445|101141917|FG001|STARTED|Overall Study||3||
48332910|NCT03604445|101141918|FG002|STARTED|Overall Study||3||
48332911|NCT03604445|101141919|FG003|STARTED|Overall Study||3||
48332912|NCT03604445|101141920|FG004|STARTED|Overall Study||3||
48332913|NCT03604445|101141921|FG005|STARTED|Overall Study||6||
48332914|NCT03604445|101141922|FG006|STARTED|Overall Study||6||
48332915|NCT03604445|101141923|FG007|STARTED|Overall Study||7||
48332916|NCT03604445|101141924|FG008|STARTED|Overall Study||3||
48332917|NCT03604445|101141916|FG000|COMPLETED|Overall Study||3||
48332918|NCT03604445|101141917|FG001|COMPLETED|Overall Study||3||
48332919|NCT03604445|101141918|FG002|COMPLETED|Overall Study||3||
48750170|NCT02314052|102177146|FG002|STARTED|Cycle Three||2||
48750171|NCT02314052|102177147|FG003|STARTED|Cycle Three||1||
48750172|NCT02314052|102177148|FG004|STARTED|Cycle Three||2||
48332920|NCT03604445|101141919|FG003|COMPLETED|Overall Study||2||
48332921|NCT03604445|101141920|FG004|COMPLETED|Overall Study||3||
48332922|NCT03604445|101141921|FG005|COMPLETED|Overall Study||5||
48332923|NCT03604445|101141922|FG006|COMPLETED|Overall Study||5||
48332924|NCT03604445|101141923|FG007|COMPLETED|Overall Study||6||
48332925|NCT03604445|101141924|FG008|COMPLETED|Overall Study||1||
48332926|NCT03604445|101141916|FG000|NOT COMPLETED|Overall Study||0||
48332927|NCT03604445|101141917|FG001|NOT COMPLETED|Overall Study||0||
48332928|NCT03604445|101141918|FG002|NOT COMPLETED|Overall Study||0||
48332929|NCT03604445|101141919|FG003|NOT COMPLETED|Overall Study||1||
48332930|NCT03604445|101141920|FG004|NOT COMPLETED|Overall Study||0||
48332931|NCT03604445|101141921|FG005|NOT COMPLETED|Overall Study||1||
48332932|NCT03604445|101141922|FG006|NOT COMPLETED|Overall Study||1||
48332933|NCT03604445|101141923|FG007|NOT COMPLETED|Overall Study||1||
48332934|NCT03604445|101141924|FG008|NOT COMPLETED|Overall Study||2||
48332935|NCT02627495|101141925|FG000|STARTED|Overall Study||9||
48332936|NCT02627495|101141925|FG000|COMPLETED|Overall Study||5||
48332937|NCT02627495|101141925|FG000|NOT COMPLETED|Overall Study||4||
48332938|NCT02445586|101141926|FG000|STARTED|Overall Study||52|Intent-to-Treat (ITT) Population|
48332939|NCT02445586|101141926|FG000|Received at Least One Dose of Study Drug|Overall Study||52|Safety Population|
48332940|NCT02445586|101141926|FG000|COMPLETED|Overall Study||13||
48332941|NCT02445586|101141926|FG000|NOT COMPLETED|Overall Study||39||
48332942|NCT01459614|101141927|FG000|STARTED|Overall Study||29||
48332943|NCT01459614|101141928|FG001|STARTED|Overall Study||10||
48332944|NCT01459614|101141927|FG000|COMPLETED|Overall Study||28||
48332945|NCT01459614|101141928|FG001|COMPLETED|Overall Study||10||
48332946|NCT01459614|101141927|FG000|NOT COMPLETED|Overall Study||1||
48332947|NCT01459614|101141928|FG001|NOT COMPLETED|Overall Study||0||
48750173|NCT02314052|102177149|FG005|STARTED|Cycle Three||3||
48750174|NCT02314052|102177144|FG000|COMPLETED|Cycle Three||3||
48750175|NCT02314052|102177145|FG001|COMPLETED|Cycle Three||2||
48750176|NCT02314052|102177146|FG002|COMPLETED|Cycle Three||2||
48750177|NCT02314052|102177147|FG003|COMPLETED|Cycle Three||1||
48750178|NCT02314052|102177148|FG004|COMPLETED|Cycle Three||2||
48750179|NCT02314052|102177149|FG005|COMPLETED|Cycle Three||3||
48750180|NCT02314052|102177144|FG000|NOT COMPLETED|Cycle Three||0||
48750181|NCT02314052|102177145|FG001|NOT COMPLETED|Cycle Three||0||
48750182|NCT02314052|102177146|FG002|NOT COMPLETED|Cycle Three||0||
48750183|NCT02314052|102177147|FG003|NOT COMPLETED|Cycle Three||0||
48750184|NCT02314052|102177148|FG004|NOT COMPLETED|Cycle Three||0||
48750185|NCT02314052|102177149|FG005|NOT COMPLETED|Cycle Three||0||
48750186|NCT02314052|102177144|FG000|STARTED|Cycle Four||3||
48750187|NCT02314052|102177145|FG001|STARTED|Cycle Four||2||
48750188|NCT02314052|102177146|FG002|STARTED|Cycle Four||2||
48750189|NCT02314052|102177147|FG003|STARTED|Cycle Four||1||
48750190|NCT02314052|102177148|FG004|STARTED|Cycle Four||2||
48750191|NCT02314052|102177149|FG005|STARTED|Cycle Four||3||
48750192|NCT02314052|102177144|FG000|COMPLETED|Cycle Four||0||
48750193|NCT02314052|102177145|FG001|COMPLETED|Cycle Four||2||
48750194|NCT02314052|102177146|FG002|COMPLETED|Cycle Four||1||
48750195|NCT02314052|102177147|FG003|COMPLETED|Cycle Four||0||
48750196|NCT02314052|102177148|FG004|COMPLETED|Cycle Four||2||
48332948|NCT01699087|101141929|FG000|STARTED|Overall Study||176||
48332949|NCT01699087|101141929|FG000|Treated|Overall Study||161||
48332950|NCT01699087|101141929|FG000|COMPLETED|Overall Study||152||
48332951|NCT01699087|101141929|FG000|NOT COMPLETED|Overall Study||24||
48332952|NCT03759665|101141930|FG000|STARTED|Treatment With IB1001||30||
48332953|NCT03759665|101141930|FG000|COMPLETED|Treatment With IB1001||27||
48332954|NCT03759665|101141930|FG000|NOT COMPLETED|Treatment With IB1001||3||
48332955|NCT03759665|101141930|FG000|STARTED|Post-Treatment Washout||27||
48332956|NCT03759665|101141930|FG000|COMPLETED|Post-Treatment Washout||27||
48332957|NCT03759665|101141930|FG000|NOT COMPLETED|Post-Treatment Washout||0||
48332958|NCT02642094|101141931|FG000|STARTED|Overall Study||40||
48626809|NCT00111761|101870917|FG001|COMPLETED|Part 1||14||
48626810|NCT00111761|101870916|FG000|NOT COMPLETED|Part 1||0||
48626811|NCT00111761|101870917|FG001|NOT COMPLETED|Part 1||5||
48750197|NCT02314052|102177149|FG005|COMPLETED|Cycle Four||0||
48750198|NCT02314052|102177144|FG000|NOT COMPLETED|Cycle Four||3||
48332959|NCT02642094|101141932|FG001|STARTED|Overall Study||18||
48332960|NCT02642094|101141931|FG000|COMPLETED|Overall Study||38||
48332961|NCT02642094|101141932|FG001|COMPLETED|Overall Study||18||
48332962|NCT02642094|101141931|FG000|NOT COMPLETED|Overall Study||2||
48626812|NCT00111761|101870916|FG000|STARTED|Part 2||24||
48750199|NCT02314052|102177145|FG001|NOT COMPLETED|Cycle Four||0||
48626813|NCT00111761|101870917|FG001|STARTED|Part 2||0||
48626814|NCT00111761|101870916|FG000|COMPLETED|Part 2||16||
48626815|NCT00111761|101870917|FG001|COMPLETED|Part 2||0||
48626816|NCT00111761|101870916|FG000|NOT COMPLETED|Part 2||8||
48626817|NCT00111761|101870917|FG001|NOT COMPLETED|Part 2||0||
48750200|NCT02314052|102177146|FG002|NOT COMPLETED|Cycle Four||1||
48750201|NCT02314052|102177147|FG003|NOT COMPLETED|Cycle Four||1||
48626818|NCT02337062|101870918|FG000|STARTED|Overall Study||572||
48750202|NCT02314052|102177148|FG004|NOT COMPLETED|Cycle Four||0||
48750203|NCT02314052|102177149|FG005|NOT COMPLETED|Cycle Four||3||
48332963|NCT02642094|101141932|FG001|NOT COMPLETED|Overall Study||0||
48332964|NCT00553163|101141933|FG000|STARTED|Overall Study||16||
48332965|NCT00553163|101141934|FG001|STARTED|Overall Study||10||
48332966|NCT00553163|101141933|FG000|COMPLETED|Overall Study||16||
48332967|NCT00553163|101141934|FG001|COMPLETED|Overall Study||10||
48332968|NCT00553163|101141933|FG000|NOT COMPLETED|Overall Study||0||
48332969|NCT00553163|101141934|FG001|NOT COMPLETED|Overall Study||0||
48332970|NCT03473561|101141935|FG000|STARTED|Overall Study||31||
48332971|NCT03473561|101141935|FG000|COMPLETED|Overall Study||31||
48332972|NCT03473561|101141935|FG000|NOT COMPLETED|Overall Study||0||
48332973|NCT02793232|101141936|FG000|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2||
48332974|NCT02793232|101141937|FG001|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2||
48332975|NCT02793232|101141938|FG002|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2||
48332976|NCT02793232|101141939|FG003|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2||
48332977|NCT02793232|101141940|FG004|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||7||
48332978|NCT02793232|101141941|FG005|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||12||
48332979|NCT02793232|101141942|FG006|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||9||
48332980|NCT02793232|101141943|FG007|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2||
48332981|NCT02793232|101141944|FG008|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||8||
48332982|NCT02793232|101141936|FG000|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2||
48332983|NCT02793232|101141937|FG001|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2||
48332984|NCT02793232|101141938|FG002|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2||
48332985|NCT02793232|101141939|FG003|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2||
48332986|NCT02793232|101141940|FG004|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||6||
48332987|NCT02793232|101141941|FG005|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||12||
48332988|NCT02793232|101141942|FG006|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||8||
48332989|NCT02793232|101141943|FG007|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2||
48332990|NCT02793232|101141944|FG008|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||8||
48332991|NCT02793232|101141936|FG000|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0||
48332992|NCT02793232|101141937|FG001|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0||
48332993|NCT02793232|101141938|FG002|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0||
48332994|NCT02793232|101141939|FG003|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0||
48332995|NCT02793232|101141940|FG004|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||1||
48332996|NCT02793232|101141941|FG005|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0||
48332997|NCT02793232|101141942|FG006|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||1||
48332998|NCT02793232|101141943|FG007|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0||
48332999|NCT02793232|101141944|FG008|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0||
48333000|NCT02793232|101141936|FG000|STARTED|Washout Period 1(Part A:at Least 10days)||2||
48333001|NCT02793232|101141937|FG001|STARTED|Washout Period 1(Part A:at Least 10days)||2||
48333002|NCT02793232|101141938|FG002|STARTED|Washout Period 1(Part A:at Least 10days)||2||
48333003|NCT02793232|101141939|FG003|STARTED|Washout Period 1(Part A:at Least 10days)||2||
48333004|NCT02793232|101141940|FG004|STARTED|Washout Period 1(Part A:at Least 10days)||0||
48333005|NCT02793232|101141941|FG005|STARTED|Washout Period 1(Part A:at Least 10days)||0||
48333006|NCT02793232|101141942|FG006|STARTED|Washout Period 1(Part A:at Least 10days)||0||
48333007|NCT02793232|101141943|FG007|STARTED|Washout Period 1(Part A:at Least 10days)||0||
48333008|NCT02793232|101141944|FG008|STARTED|Washout Period 1(Part A:at Least 10days)||0||
48333009|NCT02793232|101141936|FG000|COMPLETED|Washout Period 1(Part A:at Least 10days)||2||
48333010|NCT02793232|101141937|FG001|COMPLETED|Washout Period 1(Part A:at Least 10days)||2||
48333011|NCT02793232|101141938|FG002|COMPLETED|Washout Period 1(Part A:at Least 10days)||2||
48333012|NCT02793232|101141939|FG003|COMPLETED|Washout Period 1(Part A:at Least 10days)||2||
48333013|NCT02793232|101141940|FG004|COMPLETED|Washout Period 1(Part A:at Least 10days)||0||
48333014|NCT02793232|101141941|FG005|COMPLETED|Washout Period 1(Part A:at Least 10days)||0||
48333015|NCT02793232|101141942|FG006|COMPLETED|Washout Period 1(Part A:at Least 10days)||0||
48333016|NCT02793232|101141943|FG007|COMPLETED|Washout Period 1(Part A:at Least 10days)||0||
48333017|NCT02793232|101141944|FG008|COMPLETED|Washout Period 1(Part A:at Least 10days)||0||
48333018|NCT02793232|101141936|FG000|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0||
48333019|NCT02793232|101141937|FG001|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0||
48333020|NCT02793232|101141938|FG002|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0||
48333021|NCT02793232|101141939|FG003|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0||
48333022|NCT02793232|101141940|FG004|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0||
48333023|NCT02793232|101141941|FG005|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0||
48333024|NCT02793232|101141942|FG006|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0||
48333025|NCT02793232|101141943|FG007|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0||
48333026|NCT02793232|101141944|FG008|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0||
48333027|NCT02793232|101141936|FG000|STARTED|Period 2 (Part A: 5 Days)||2||
48333028|NCT02793232|101141937|FG001|STARTED|Period 2 (Part A: 5 Days)||2||
48333029|NCT02793232|101141938|FG002|STARTED|Period 2 (Part A: 5 Days)||2||
48333030|NCT02793232|101141939|FG003|STARTED|Period 2 (Part A: 5 Days)||2||
48333031|NCT02793232|101141940|FG004|STARTED|Period 2 (Part A: 5 Days)||0||
48750204|NCT02314052|102177144|FG000|STARTED|Cycle Five||0||
48750205|NCT02314052|102177145|FG001|STARTED|Cycle Five||2||
48750206|NCT02314052|102177146|FG002|STARTED|Cycle Five||1||
48750207|NCT02314052|102177147|FG003|STARTED|Cycle Five||1||
48750208|NCT02314052|102177148|FG004|STARTED|Cycle Five||2||
48750209|NCT02314052|102177149|FG005|STARTED|Cycle Five||0||
48750210|NCT02314052|102177144|FG000|COMPLETED|Cycle Five||0||
48750211|NCT02314052|102177145|FG001|COMPLETED|Cycle Five||0||
48750212|NCT02314052|102177146|FG002|COMPLETED|Cycle Five||0||
48750213|NCT02314052|102177147|FG003|COMPLETED|Cycle Five||1||
48750214|NCT02314052|102177148|FG004|COMPLETED|Cycle Five||2||
48750215|NCT02314052|102177149|FG005|COMPLETED|Cycle Five||0||
48750216|NCT02314052|102177144|FG000|NOT COMPLETED|Cycle Five||0||
48750217|NCT02314052|102177145|FG001|NOT COMPLETED|Cycle Five||2||
48750218|NCT02314052|102177146|FG002|NOT COMPLETED|Cycle Five||1||
48750219|NCT02314052|102177147|FG003|NOT COMPLETED|Cycle Five||0||
48750220|NCT02314052|102177148|FG004|NOT COMPLETED|Cycle Five||0||
48411535|NCT03733249|101341774|FG000|COMPLETED|Overall Study||149||
48750221|NCT02314052|102177149|FG005|NOT COMPLETED|Cycle Five||0||
48750222|NCT02314052|102177144|FG000|STARTED|Cycles 6 -10.5||0||
48750223|NCT02314052|102177145|FG001|STARTED|Cycles 6 -10.5||0||
48750224|NCT02314052|102177146|FG002|STARTED|Cycles 6 -10.5||0||
48750225|NCT02314052|102177147|FG003|STARTED|Cycles 6 -10.5||1||
48333032|NCT02793232|101141941|FG005|STARTED|Period 2 (Part A: 5 Days)||0||
48333033|NCT02793232|101141942|FG006|STARTED|Period 2 (Part A: 5 Days)||0||
48333034|NCT02793232|101141943|FG007|STARTED|Period 2 (Part A: 5 Days)||0||
48333035|NCT02793232|101141944|FG008|STARTED|Period 2 (Part A: 5 Days)||0||
48333036|NCT02793232|101141936|FG000|COMPLETED|Period 2 (Part A: 5 Days)||2||
48333037|NCT02793232|101141937|FG001|COMPLETED|Period 2 (Part A: 5 Days)||2||
48333038|NCT02793232|101141938|FG002|COMPLETED|Period 2 (Part A: 5 Days)||2||
48626819|NCT02337062|101870919|FG001|STARTED|Overall Study||575||
48626820|NCT02337062|101870918|FG000|COMPLETED|Overall Study||555||
48626821|NCT02337062|101870919|FG001|COMPLETED|Overall Study||556||
48411536|NCT03733249|101341774|FG000|NOT COMPLETED|Overall Study||35||
48411537|NCT02074436|101341775|FG000|STARTED|Overall Study||15||
48411538|NCT02074436|101341776|FG001|STARTED|Overall Study||14||
48626822|NCT02337062|101870918|FG000|NOT COMPLETED|Overall Study||17||
48626823|NCT02337062|101870919|FG001|NOT COMPLETED|Overall Study||19||
48626824|NCT02481050|101870920|FG000|STARTED|Overall Study||58||
48626825|NCT02481050|101870920|FG000|COMPLETED|Overall Study||0||
48626826|NCT02481050|101870920|FG000|NOT COMPLETED|Overall Study||58||
48626827|NCT00706004|101870921|FG000|STARTED|Overall Study||9||
48626828|NCT00706004|101870921|FG000|COMPLETED|Overall Study||7||
48333039|NCT02793232|101141939|FG003|COMPLETED|Period 2 (Part A: 5 Days)||2||
48333040|NCT02793232|101141940|FG004|COMPLETED|Period 2 (Part A: 5 Days)||0||
48333041|NCT02793232|101141941|FG005|COMPLETED|Period 2 (Part A: 5 Days)||0||
48626829|NCT00706004|101870921|FG000|NOT COMPLETED|Overall Study||2||
48333042|NCT02793232|101141942|FG006|COMPLETED|Period 2 (Part A: 5 Days)||0||
48626830|NCT03122171|101870922|FG000|STARTED|Overall Study||6||
48750226|NCT02314052|102177148|FG004|STARTED|Cycles 6 -10.5||2||
48333043|NCT02793232|101141943|FG007|COMPLETED|Period 2 (Part A: 5 Days)||0||
48333044|NCT02793232|101141944|FG008|COMPLETED|Period 2 (Part A: 5 Days)||0||
48333045|NCT02793232|101141936|FG000|NOT COMPLETED|Period 2 (Part A: 5 Days)||0||
48333046|NCT02793232|101141937|FG001|NOT COMPLETED|Period 2 (Part A: 5 Days)||0||
48333047|NCT02793232|101141938|FG002|NOT COMPLETED|Period 2 (Part A: 5 Days)||0||
48333048|NCT02793232|101141939|FG003|NOT COMPLETED|Period 2 (Part A: 5 Days)||0||
48333049|NCT02793232|101141940|FG004|NOT COMPLETED|Period 2 (Part A: 5 Days)||0||
48333050|NCT02793232|101141941|FG005|NOT COMPLETED|Period 2 (Part A: 5 Days)||0||
48333051|NCT02793232|101141942|FG006|NOT COMPLETED|Period 2 (Part A: 5 Days)||0||
48333052|NCT02793232|101141943|FG007|NOT COMPLETED|Period 2 (Part A: 5 Days)||0||
48333053|NCT02793232|101141944|FG008|NOT COMPLETED|Period 2 (Part A: 5 Days)||0||
48333054|NCT02793232|101141936|FG000|STARTED|Washout Period 2(Part A:at Least 10days)||2||
48750227|NCT02314052|102177149|FG005|STARTED|Cycles 6 -10.5||0||
48750228|NCT02314052|102177144|FG000|COMPLETED|Cycles 6 -10.5||0||
48750229|NCT02314052|102177145|FG001|COMPLETED|Cycles 6 -10.5||0||
48750230|NCT02314052|102177146|FG002|COMPLETED|Cycles 6 -10.5||0||
48750231|NCT02314052|102177147|FG003|COMPLETED|Cycles 6 -10.5||1||
48750232|NCT02314052|102177148|FG004|COMPLETED|Cycles 6 -10.5||2||
48750233|NCT02314052|102177149|FG005|COMPLETED|Cycles 6 -10.5||0||
48750234|NCT02314052|102177144|FG000|NOT COMPLETED|Cycles 6 -10.5||0||
48750235|NCT02314052|102177145|FG001|NOT COMPLETED|Cycles 6 -10.5||0||
48750236|NCT02314052|102177146|FG002|NOT COMPLETED|Cycles 6 -10.5||0||
48333055|NCT02793232|101141937|FG001|STARTED|Washout Period 2(Part A:at Least 10days)||2||
48333056|NCT02793232|101141938|FG002|STARTED|Washout Period 2(Part A:at Least 10days)||2||
48333057|NCT02793232|101141939|FG003|STARTED|Washout Period 2(Part A:at Least 10days)||2||
48333058|NCT02793232|101141940|FG004|STARTED|Washout Period 2(Part A:at Least 10days)||0||
48411539|NCT02074436|101341775|FG000|COMPLETED|Overall Study||15||
48750237|NCT02314052|102177147|FG003|NOT COMPLETED|Cycles 6 -10.5||0||
48750238|NCT02314052|102177148|FG004|NOT COMPLETED|Cycles 6 -10.5||0||
48750239|NCT02314052|102177149|FG005|NOT COMPLETED|Cycles 6 -10.5||0||
48750240|NCT01664910|102177150|FG000|STARTED|Overall Study||4||
48750241|NCT01664910|102177151|FG001|STARTED|Overall Study||2||
48750242|NCT01664910|102177152|FG002|STARTED|Overall Study||21||
48750243|NCT01664910|102177150|FG000|COMPLETED|Overall Study||4||
48750244|NCT01664910|102177151|FG001|COMPLETED|Overall Study||2||
48750245|NCT01664910|102177152|FG002|COMPLETED|Overall Study||20||
48750246|NCT01664910|102177150|FG000|NOT COMPLETED|Overall Study||0||
48750247|NCT01664910|102177151|FG001|NOT COMPLETED|Overall Study||0||
48750248|NCT01664910|102177152|FG002|NOT COMPLETED|Overall Study||1||
48750249|NCT04664153|102177153|FG000|STARTED|Overall Study||34||
48750250|NCT04664153|102177154|FG001|STARTED|Overall Study||36||
48333059|NCT02793232|101141941|FG005|STARTED|Washout Period 2(Part A:at Least 10days)||0||
48333060|NCT02793232|101141942|FG006|STARTED|Washout Period 2(Part A:at Least 10days)||0||
48333061|NCT02793232|101141943|FG007|STARTED|Washout Period 2(Part A:at Least 10days)||0||
48333062|NCT02793232|101141944|FG008|STARTED|Washout Period 2(Part A:at Least 10days)||0||
48333063|NCT02793232|101141936|FG000|COMPLETED|Washout Period 2(Part A:at Least 10days)||2||
48333064|NCT02793232|101141937|FG001|COMPLETED|Washout Period 2(Part A:at Least 10days)||2||
48333065|NCT02793232|101141938|FG002|COMPLETED|Washout Period 2(Part A:at Least 10days)||2||
48333066|NCT02793232|101141939|FG003|COMPLETED|Washout Period 2(Part A:at Least 10days)||2||
48333067|NCT02793232|101141940|FG004|COMPLETED|Washout Period 2(Part A:at Least 10days)||0||
48333068|NCT02793232|101141941|FG005|COMPLETED|Washout Period 2(Part A:at Least 10days)||0||
48333069|NCT02793232|101141942|FG006|COMPLETED|Washout Period 2(Part A:at Least 10days)||0||
48333070|NCT02793232|101141943|FG007|COMPLETED|Washout Period 2(Part A:at Least 10days)||0||
48333071|NCT02793232|101141944|FG008|COMPLETED|Washout Period 2(Part A:at Least 10days)||0||
48333072|NCT02793232|101141936|FG000|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0||
48333073|NCT02793232|101141937|FG001|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0||
48333074|NCT02793232|101141938|FG002|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0||
48333075|NCT02793232|101141939|FG003|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0||
48333076|NCT02793232|101141940|FG004|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0||
48333077|NCT02793232|101141941|FG005|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0||
48333078|NCT02793232|101141942|FG006|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0||
48333079|NCT02793232|101141943|FG007|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0||
48333080|NCT02793232|101141944|FG008|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0||
48333081|NCT02793232|101141936|FG000|STARTED|Period 3 (Part A: 5 Days)||2||
48333082|NCT02793232|101141937|FG001|STARTED|Period 3 (Part A: 5 Days)||2||
48333083|NCT02793232|101141938|FG002|STARTED|Period 3 (Part A: 5 Days)||2||
48333084|NCT02793232|101141939|FG003|STARTED|Period 3 (Part A: 5 Days)||2||
48333085|NCT02793232|101141940|FG004|STARTED|Period 3 (Part A: 5 Days)||0||
48333086|NCT02793232|101141941|FG005|STARTED|Period 3 (Part A: 5 Days)||0||
48333087|NCT02793232|101141942|FG006|STARTED|Period 3 (Part A: 5 Days)||0||
48333088|NCT02793232|101141943|FG007|STARTED|Period 3 (Part A: 5 Days)||0||
48333089|NCT02793232|101141944|FG008|STARTED|Period 3 (Part A: 5 Days)||0||
48333090|NCT02793232|101141936|FG000|COMPLETED|Period 3 (Part A: 5 Days)||2||
48333091|NCT02793232|101141937|FG001|COMPLETED|Period 3 (Part A: 5 Days)||2||
48333092|NCT02793232|101141938|FG002|COMPLETED|Period 3 (Part A: 5 Days)||2||
48333093|NCT02793232|101141939|FG003|COMPLETED|Period 3 (Part A: 5 Days)||2||
48333094|NCT02793232|101141940|FG004|COMPLETED|Period 3 (Part A: 5 Days)||0||
48333095|NCT02793232|101141941|FG005|COMPLETED|Period 3 (Part A: 5 Days)||0||
48333096|NCT02793232|101141942|FG006|COMPLETED|Period 3 (Part A: 5 Days)||0||
48333097|NCT02793232|101141943|FG007|COMPLETED|Period 3 (Part A: 5 Days)||0||
48333098|NCT02793232|101141944|FG008|COMPLETED|Period 3 (Part A: 5 Days)||0||
48333099|NCT02793232|101141936|FG000|NOT COMPLETED|Period 3 (Part A: 5 Days)||0||
48333100|NCT02793232|101141937|FG001|NOT COMPLETED|Period 3 (Part A: 5 Days)||0||
48333101|NCT02793232|101141938|FG002|NOT COMPLETED|Period 3 (Part A: 5 Days)||0||
48333102|NCT02793232|101141939|FG003|NOT COMPLETED|Period 3 (Part A: 5 Days)||0||
48411540|NCT02074436|101341776|FG001|COMPLETED|Overall Study||14||
48411541|NCT02074436|101341775|FG000|NOT COMPLETED|Overall Study||0||
48411542|NCT02074436|101341776|FG001|NOT COMPLETED|Overall Study||0||
48333103|NCT02793232|101141940|FG004|NOT COMPLETED|Period 3 (Part A: 5 Days)||0||
48333104|NCT02793232|101141941|FG005|NOT COMPLETED|Period 3 (Part A: 5 Days)||0||
48333105|NCT02793232|101141942|FG006|NOT COMPLETED|Period 3 (Part A: 5 Days)||0||
48333106|NCT02793232|101141943|FG007|NOT COMPLETED|Period 3 (Part A: 5 Days)||0||
48333107|NCT02793232|101141944|FG008|NOT COMPLETED|Period 3 (Part A: 5 Days)||0||
48333108|NCT02793232|101141936|FG000|STARTED|Washout Period 3(Part A:at Least 10days)||2||
48333109|NCT02793232|101141937|FG001|STARTED|Washout Period 3(Part A:at Least 10days)||2||
48333110|NCT02793232|101141938|FG002|STARTED|Washout Period 3(Part A:at Least 10days)||2||
48333111|NCT02793232|101141939|FG003|STARTED|Washout Period 3(Part A:at Least 10days)||2||
48333112|NCT02793232|101141940|FG004|STARTED|Washout Period 3(Part A:at Least 10days)||0||
48333113|NCT02793232|101141941|FG005|STARTED|Washout Period 3(Part A:at Least 10days)||0||
48333114|NCT02793232|101141942|FG006|STARTED|Washout Period 3(Part A:at Least 10days)||0||
48333115|NCT02793232|101141943|FG007|STARTED|Washout Period 3(Part A:at Least 10days)||0||
48333116|NCT02793232|101141944|FG008|STARTED|Washout Period 3(Part A:at Least 10days)||0||
48333117|NCT02793232|101141936|FG000|COMPLETED|Washout Period 3(Part A:at Least 10days)||2||
48333118|NCT02793232|101141937|FG001|COMPLETED|Washout Period 3(Part A:at Least 10days)||2||
48333119|NCT02793232|101141938|FG002|COMPLETED|Washout Period 3(Part A:at Least 10days)||2||
48333120|NCT02793232|101141939|FG003|COMPLETED|Washout Period 3(Part A:at Least 10days)||2||
48333121|NCT02793232|101141940|FG004|COMPLETED|Washout Period 3(Part A:at Least 10days)||0||
48333122|NCT02793232|101141941|FG005|COMPLETED|Washout Period 3(Part A:at Least 10days)||0||
48333123|NCT02793232|101141942|FG006|COMPLETED|Washout Period 3(Part A:at Least 10days)||0||
48333124|NCT02793232|101141943|FG007|COMPLETED|Washout Period 3(Part A:at Least 10days)||0||
48333125|NCT02793232|101141944|FG008|COMPLETED|Washout Period 3(Part A:at Least 10days)||0||
48333126|NCT02793232|101141936|FG000|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0||
48333127|NCT02793232|101141937|FG001|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0||
48333128|NCT02793232|101141938|FG002|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0||
48333129|NCT02793232|101141939|FG003|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0||
48333130|NCT02793232|101141940|FG004|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0||
48333131|NCT02793232|101141941|FG005|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0||
48333132|NCT02793232|101141942|FG006|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0||
48333133|NCT02793232|101141943|FG007|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0||
48333134|NCT02793232|101141944|FG008|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0||
48333135|NCT02793232|101141936|FG000|STARTED|Period 4 (Part A: 5 Days)||2||
48333136|NCT02793232|101141937|FG001|STARTED|Period 4 (Part A: 5 Days)||2||
48333137|NCT02793232|101141938|FG002|STARTED|Period 4 (Part A: 5 Days)||2||
48333138|NCT02793232|101141939|FG003|STARTED|Period 4 (Part A: 5 Days)||2||
48333139|NCT02793232|101141940|FG004|STARTED|Period 4 (Part A: 5 Days)||0||
48333140|NCT02793232|101141941|FG005|STARTED|Period 4 (Part A: 5 Days)||0||
48333141|NCT02793232|101141942|FG006|STARTED|Period 4 (Part A: 5 Days)||0||
48333142|NCT02793232|101141943|FG007|STARTED|Period 4 (Part A: 5 Days)||0||
48333143|NCT02793232|101141944|FG008|STARTED|Period 4 (Part A: 5 Days)||0||
48333144|NCT02793232|101141936|FG000|COMPLETED|Period 4 (Part A: 5 Days)||2||
48333145|NCT02793232|101141937|FG001|COMPLETED|Period 4 (Part A: 5 Days)||2||
48333146|NCT02793232|101141938|FG002|COMPLETED|Period 4 (Part A: 5 Days)||2||
48333147|NCT02793232|101141939|FG003|COMPLETED|Period 4 (Part A: 5 Days)||2||
48333148|NCT02793232|101141940|FG004|COMPLETED|Period 4 (Part A: 5 Days)||0||
48333149|NCT02793232|101141941|FG005|COMPLETED|Period 4 (Part A: 5 Days)||0||
48333150|NCT02793232|101141942|FG006|COMPLETED|Period 4 (Part A: 5 Days)||0||
48333151|NCT02793232|101141943|FG007|COMPLETED|Period 4 (Part A: 5 Days)||0||
48333152|NCT02793232|101141944|FG008|COMPLETED|Period 4 (Part A: 5 Days)||0||
48333153|NCT02793232|101141936|FG000|NOT COMPLETED|Period 4 (Part A: 5 Days)||0||
48333154|NCT02793232|101141937|FG001|NOT COMPLETED|Period 4 (Part A: 5 Days)||0||
48333155|NCT02793232|101141938|FG002|NOT COMPLETED|Period 4 (Part A: 5 Days)||0||
48333156|NCT02793232|101141939|FG003|NOT COMPLETED|Period 4 (Part A: 5 Days)||0||
48333157|NCT02793232|101141940|FG004|NOT COMPLETED|Period 4 (Part A: 5 Days)||0||
48333158|NCT02793232|101141941|FG005|NOT COMPLETED|Period 4 (Part A: 5 Days)||0||
48333159|NCT02793232|101141942|FG006|NOT COMPLETED|Period 4 (Part A: 5 Days)||0||
48333160|NCT02793232|101141943|FG007|NOT COMPLETED|Period 4 (Part A: 5 Days)||0||
48333161|NCT02793232|101141944|FG008|NOT COMPLETED|Period 4 (Part A: 5 Days)||0||
48333162|NCT01227551|101141945|FG000|STARTED|Overall Study||57||
48333163|NCT01227551|101141945|FG000|COMPLETED|Overall Study||23||
48333164|NCT01227551|101141945|FG000|NOT COMPLETED|Overall Study||34||
48333165|NCT00105443|101141946|FG000|STARTED|Double-Blind Treatment||242||
48333166|NCT00105443|101141947|FG001|STARTED|Double-Blind Treatment||57||
48333167|NCT00105443|101141948|FG002|STARTED|Double-Blind Treatment||256||
48333168|NCT00105443|101141949|FG003|STARTED|Double-Blind Treatment||47||
48333169|NCT00105443|101141946|FG000|Received Treatment|Double-Blind Treatment||240||
48333170|NCT00105443|101141947|FG001|Received Treatment|Double-Blind Treatment||57||
48333171|NCT00105443|101141948|FG002|Received Treatment|Double-Blind Treatment||255||
48333172|NCT00105443|101141949|FG003|Received Treatment|Double-Blind Treatment||47||
48333173|NCT00105443|101141946|FG000|COMPLETED|Double-Blind Treatment||228||
48333174|NCT00105443|101141947|FG001|COMPLETED|Double-Blind Treatment||57||
48333175|NCT00105443|101141948|FG002|COMPLETED|Double-Blind Treatment||245||
48333176|NCT00105443|101141949|FG003|COMPLETED|Double-Blind Treatment||47||
48333177|NCT00105443|101141946|FG000|NOT COMPLETED|Double-Blind Treatment||14||
48333178|NCT00105443|101141947|FG001|NOT COMPLETED|Double-Blind Treatment||0||
48333179|NCT00105443|101141948|FG002|NOT COMPLETED|Double-Blind Treatment||11||
48333180|NCT00105443|101141949|FG003|NOT COMPLETED|Double-Blind Treatment||0||
48333181|NCT00105443|101141946|FG000|STARTED|Follow-up and/or Open Label Nexavar||228||
48333182|NCT00105443|101141947|FG001|STARTED|Follow-up and/or Open Label Nexavar||57||
48333183|NCT00105443|101141948|FG002|STARTED|Follow-up and/or Open Label Nexavar||245||
48333184|NCT00105443|101141949|FG003|STARTED|Follow-up and/or Open Label Nexavar||47||
48333185|NCT00105443|101141946|FG000|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||228||
48333186|NCT00105443|101141947|FG001|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0||
48333187|NCT00105443|101141948|FG002|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||245||
48333188|NCT00105443|101141949|FG003|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0||
48333189|NCT00105443|101141946|FG000|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0||
48333190|NCT00105443|101141947|FG001|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||47||
48333191|NCT00105443|101141948|FG002|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0||
48333192|NCT00105443|101141949|FG003|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||36||
48411543|NCT01950364|101341777|FG000|STARTED|Overall Study||10||
48411544|NCT01950364|101341778|FG001|STARTED|Overall Study||10||
48411545|NCT01950364|101341777|FG000|COMPLETED|Overall Study||0||
48411546|NCT01950364|101341778|FG001|COMPLETED|Overall Study||0||
48411547|NCT01950364|101341777|FG000|NOT COMPLETED|Overall Study||10||
48411548|NCT01950364|101341778|FG001|NOT COMPLETED|Overall Study||10||
48411549|NCT01183104|101341779|FG000|STARTED|Overall Study||153||
48411550|NCT01183104|101341780|FG001|STARTED|Overall Study||152||
48411551|NCT01183104|101341779|FG000|Received Study Drug|Overall Study||148|Analysis set of evaluation for safety|
48411552|NCT01183104|101341780|FG001|Received Study Drug|Overall Study||143|Analysis set of evaluation for safety|
48750251|NCT04664153|102177155|FG002|STARTED|Overall Study||17||
48750252|NCT04664153|102177156|FG003|STARTED|Overall Study||17||
48750253|NCT04664153|102177153|FG000|COMPLETED|Overall Study||27||
48750254|NCT04664153|102177154|FG001|COMPLETED|Overall Study||33||
48750255|NCT04664153|102177155|FG002|COMPLETED|Overall Study||13||
48750256|NCT04664153|102177156|FG003|COMPLETED|Overall Study||15||
48411553|NCT01183104|101341779|FG000|Continued Treatment for 12 Weeks|Overall Study||143|Analysis set of evaluation for efficacy; Per Protocol Set|
48411554|NCT01183104|101341780|FG001|Continued Treatment for 12 Weeks|Overall Study||129|Analysis set of evaluation for efficacy; Per Protocol Set|
48411555|NCT01183104|101341779|FG000|Completed 52-week Treatment|Overall Study||119||
48411556|NCT01183104|101341780|FG001|Completed 52-week Treatment|Overall Study||111||
48411557|NCT01183104|101341779|FG000|Enrolled in Extension Study|Overall Study||80||
48411558|NCT01183104|101341780|FG001|Enrolled in Extension Study|Overall Study||61||
48411559|NCT01183104|101341779|FG000|COMPLETED|Overall Study||76|104-week extension study|
48411560|NCT01183104|101341780|FG001|COMPLETED|Overall Study||60|104-week extension study|
48411561|NCT01183104|101341779|FG000|NOT COMPLETED|Overall Study||77||
48411562|NCT01183104|101341780|FG001|NOT COMPLETED|Overall Study||92||
48411563|NCT03032523|101341781|FG000|STARTED|Overall Study||15||
48411564|NCT03032523|101341782|FG001|STARTED|Overall Study||6||
48411565|NCT03032523|101341781|FG000|COMPLETED|Overall Study||12||
48411566|NCT03032523|101341782|FG001|COMPLETED|Overall Study||4||
48411567|NCT03032523|101341781|FG000|NOT COMPLETED|Overall Study||3||
48411568|NCT03032523|101341782|FG001|NOT COMPLETED|Overall Study||2||
48411569|NCT03619902|101341783|FG000|STARTED|Overall Study||8||
48411570|NCT03619902|101341783|FG000|COMPLETED|Overall Study||6||
48411571|NCT03619902|101341783|FG000|NOT COMPLETED|Overall Study||2||
48411572|NCT02871570|101341784|FG000|STARTED|Overall Study||8||
48626831|NCT03122171|101870922|FG000|COMPLETED|Overall Study||5||
48626832|NCT03122171|101870922|FG000|NOT COMPLETED|Overall Study||1||
48626833|NCT01802385|101870923|FG000|STARTED|Overall Study||231||
48626834|NCT01802385|101870924|FG001|STARTED|Overall Study||229||
48626835|NCT01802385|101870923|FG000|COMPLETED|Overall Study||125||
48626836|NCT01802385|101870924|FG001|COMPLETED|Overall Study||109||
48750257|NCT04664153|102177153|FG000|NOT COMPLETED|Overall Study||7||
48170263|NCT02593305|100739301|FG001|NOT COMPLETED|Post 1||0||
48411573|NCT02871570|101341785|FG001|STARTED|Overall Study||8||
48411574|NCT02871570|101341784|FG000|COMPLETED|Overall Study||8||
48411575|NCT02871570|101341785|FG001|COMPLETED|Overall Study||8||
48411576|NCT02871570|101341784|FG000|NOT COMPLETED|Overall Study||0||
48411577|NCT02871570|101341785|FG001|NOT COMPLETED|Overall Study||0||
48411578|NCT04589832|101341786|FG000|STARTED|Overall Study||6||
48411579|NCT04589832|101341786|FG000|COMPLETED|Overall Study||6||
48411580|NCT04589832|101341786|FG000|NOT COMPLETED|Overall Study||0||
48411581|NCT02892734|101341787|FG000|STARTED|Treatment on Study||3||
48411582|NCT02892734|101341787|FG000|Completed 1st Cycle/Response at 12 Weeks|Treatment on Study||1||
48411583|NCT02892734|101341787|FG000|Went on to Start Cycle 2|Treatment on Study||1||
48411584|NCT02892734|101341787|FG000|COMPLETED|Treatment on Study||1||
48411585|NCT02892734|101341787|FG000|NOT COMPLETED|Treatment on Study||2||
48411586|NCT02892734|101341787|FG000|STARTED|Follow up for 2 Years||3|All patients that are treated with at least one dose of study drug go into follow-up.|
48411587|NCT02892734|101341787|FG000|COMPLETED|Follow up for 2 Years||0||
48411588|NCT02892734|101341787|FG000|NOT COMPLETED|Follow up for 2 Years||3||
48411589|NCT02243306|101341788|FG000|STARTED|Overall Study||1||
48626837|NCT01802385|101870923|FG000|NOT COMPLETED|Overall Study||106||
48626838|NCT01802385|101870924|FG001|NOT COMPLETED|Overall Study||120||
48626839|NCT02127658|101870925|FG000|STARTED|Overall Study||7||
48626840|NCT02127658|101870926|FG001|STARTED|Overall Study||7||
48626841|NCT02127658|101870925|FG000|6 Week Follow-up|Overall Study||5||
48626842|NCT02127658|101870926|FG001|6 Week Follow-up|Overall Study||4||
48626843|NCT02127658|101870925|FG000|6 Month Follow-up|Overall Study||5||
48626844|NCT02127658|101870926|FG001|6 Month Follow-up|Overall Study||3||
48626845|NCT02127658|101870925|FG000|12 Month Follow-up|Overall Study||5||
48626846|NCT02127658|101870926|FG001|12 Month Follow-up|Overall Study||2||
48626847|NCT02127658|101870925|FG000|COMPLETED|Overall Study||5||
48626848|NCT02127658|101870926|FG001|COMPLETED|Overall Study||4||
48750258|NCT04664153|102177154|FG001|NOT COMPLETED|Overall Study||3||
48626849|NCT02127658|101870925|FG000|NOT COMPLETED|Overall Study||2||
48411590|NCT02243306|101341789|FG001|STARTED|Overall Study||7||
48411591|NCT02243306|101341788|FG000|COMPLETED|Overall Study||1||
48411592|NCT02243306|101341789|FG001|COMPLETED|Overall Study||4||
48626850|NCT02127658|101870926|FG001|NOT COMPLETED|Overall Study||3||
48750259|NCT04664153|102177155|FG002|NOT COMPLETED|Overall Study||4||
48750260|NCT04664153|102177156|FG003|NOT COMPLETED|Overall Study||2||
48750261|NCT00181363|102177157|FG000|STARTED|Overall Study||10||
48626851|NCT00368108|101870927|FG000|STARTED|Overall Study||251||
48626852|NCT00368108|101870928|FG001|STARTED|Overall Study||251||
48626853|NCT00368108|101870929|FG002|STARTED|Overall Study||250||
48626854|NCT00368108|101870927|FG000|COMPLETED|Overall Study||187||
48626855|NCT00368108|101870928|FG001|COMPLETED|Overall Study||198||
48626856|NCT00368108|101870929|FG002|COMPLETED|Overall Study||182||
48626857|NCT00368108|101870927|FG000|NOT COMPLETED|Overall Study||64||
48626858|NCT00368108|101870928|FG001|NOT COMPLETED|Overall Study||53||
48626859|NCT00368108|101870929|FG002|NOT COMPLETED|Overall Study||68||
48626860|NCT01339416|101870930|FG000|STARTED|Overall Study||8202||
48626861|NCT01339416|101870930|FG000|COMPLETED|Overall Study||8202||
48626862|NCT01339416|101870930|FG000|NOT COMPLETED|Overall Study||0||
48626863|NCT01723072|101870931|FG000|STARTED|Overall Study||44||
48626864|NCT01723072|101870932|FG001|STARTED|Overall Study||47||
48626865|NCT01723072|101870931|FG000|COMPLETED|Overall Study||33||
48626866|NCT01723072|101870932|FG001|COMPLETED|Overall Study||26||
48626867|NCT01723072|101870931|FG000|NOT COMPLETED|Overall Study||11||
48626868|NCT01723072|101870932|FG001|NOT COMPLETED|Overall Study||21||
48626869|NCT00171249|101870933|FG000|STARTED|Overall Study||77||
48626870|NCT00171249|101870934|FG001|STARTED|Overall Study||5||
48626871|NCT00171249|101870935|FG002|STARTED|Overall Study||5||
48626872|NCT00171249|101870936|FG003|STARTED|Overall Study||158||
48626873|NCT00171249|101870937|FG004|STARTED|Overall Study||3||
48626874|NCT00171249|101870938|FG005|STARTED|Overall Study||43||
48626875|NCT00171249|101870939|FG006|STARTED|Overall Study||2||
48626876|NCT00171249|101870933|FG000|Completed Part 1|Overall Study||50||
48626877|NCT00171249|101870934|FG001|Completed Part 1|Overall Study||0||
48626878|NCT00171249|101870935|FG002|Completed Part 1|Overall Study||1||
48626879|NCT00171249|101870936|FG003|Completed Part 1|Overall Study||125||
48626880|NCT00171249|101870937|FG004|Completed Part 1|Overall Study||2||
48626881|NCT00171249|101870938|FG005|Completed Part 1|Overall Study||6||
48626882|NCT00171249|101870939|FG006|Completed Part 1|Overall Study||0||
48626883|NCT00171249|101870933|FG000|COMPLETED|Overall Study||1||
48626884|NCT00171249|101870934|FG001|COMPLETED|Overall Study||0||
48626885|NCT00171249|101870935|FG002|COMPLETED|Overall Study||0||
48750262|NCT00181363|102177157|FG000|COMPLETED|Overall Study||10||
48750263|NCT00181363|102177157|FG000|NOT COMPLETED|Overall Study||0||
48750264|NCT04716426|102177158|FG000|STARTED|Overall Study||50||
48750265|NCT04716426|102177159|FG001|STARTED|Overall Study||50||
48750266|NCT04716426|102177158|FG000|COMPLETED|Overall Study||48||
48750267|NCT04716426|102177159|FG001|COMPLETED|Overall Study||49||
48750268|NCT04716426|102177158|FG000|NOT COMPLETED|Overall Study||2||
48750269|NCT04716426|102177159|FG001|NOT COMPLETED|Overall Study||1||
48750270|NCT01844388|102177160|FG000|STARTED|Overall Study||244||
48750271|NCT01844388|102177161|FG001|STARTED|Overall Study||121||
48750272|NCT01844388|102177160|FG000|COMPLETED|Overall Study||236||
48750273|NCT01844388|102177161|FG001|COMPLETED|Overall Study||114||
48750274|NCT01844388|102177160|FG000|NOT COMPLETED|Overall Study||8||
48750275|NCT01844388|102177161|FG001|NOT COMPLETED|Overall Study||7||
48750276|NCT03656939|102177162|FG000|STARTED|Overall Study||21240||
48750277|NCT03656939|102177162|FG000|Main Study Cohort|Overall Study||21240||
48750278|NCT03656939|102177162|FG000|Main Study Cohort: Participants Who Received Dose 1|Overall Study||20318||
48626886|NCT00171249|101870936|FG003|COMPLETED|Overall Study||6||
48626887|NCT00171249|101870937|FG004|COMPLETED|Overall Study||0||
48750279|NCT03656939|102177162|FG000|Main Study Cohort: Participants Who Received Dose 2|Overall Study||19387||
48750280|NCT03656939|102177162|FG000|Main Study Cohort: Participants Who Received Dose 3|Overall Study||18415||
48750281|NCT03656939|102177162|FG000|Main Study Cohort: Participants Who Received Dose 4|Overall Study||12944||
48750282|NCT03656939|102177162|FG000|Prospective Study Cohort|Overall Study||2300||
48750283|NCT03656939|102177162|FG000|Prospective Study Cohort: Participants Who Received Dose 1|Overall Study||2300||
48750284|NCT03656939|102177162|FG000|Prospective Study Cohort: Participants Who Received Dose 2|Overall Study||2203||
48750285|NCT03656939|102177162|FG000|Prospective Study Cohort: Participants Who Received Dose 3|Overall Study||2047||
48750286|NCT03656939|102177162|FG000|Prospective Study Cohort: Participants Who Received Dose 4|Overall Study||1291||
48750287|NCT03656939|102177162|FG000|COMPLETED|Overall Study||21240||
48750288|NCT03656939|102177162|FG000|NOT COMPLETED|Overall Study||0||
48750289|NCT03430791|102177163|FG000|STARTED|Overall Study||4||
48750290|NCT03430791|102177164|FG001|STARTED|Overall Study||0||
48170264|NCT02593305|100739302|FG002|NOT COMPLETED|Post 1||10||
48626888|NCT00171249|101870938|FG005|COMPLETED|Overall Study||0||
48626889|NCT00171249|101870939|FG006|COMPLETED|Overall Study||0||
48626890|NCT00171249|101870933|FG000|NOT COMPLETED|Overall Study||76||
48626891|NCT00171249|101870934|FG001|NOT COMPLETED|Overall Study||5||
48626892|NCT00171249|101870935|FG002|NOT COMPLETED|Overall Study||5||
48626893|NCT00171249|101870936|FG003|NOT COMPLETED|Overall Study||152||
48626894|NCT00171249|101870937|FG004|NOT COMPLETED|Overall Study||3||
48626895|NCT00171249|101870938|FG005|NOT COMPLETED|Overall Study||43||
48626896|NCT00171249|101870939|FG006|NOT COMPLETED|Overall Study||2||
48750291|NCT03430791|102177163|FG000|COMPLETED|Overall Study||4||
48750292|NCT03430791|102177164|FG001|COMPLETED|Overall Study||0||
48750293|NCT03430791|102177163|FG000|NOT COMPLETED|Overall Study||0||
48626897|NCT00349336|101870940|FG000|STARTED|Overall Study||32||
48626898|NCT00349336|101870941|FG001|STARTED|Overall Study||32||
48626899|NCT00349336|101870940|FG000|COMPLETED|Overall Study||19||
48626900|NCT00349336|101870941|FG001|COMPLETED|Overall Study||18||
48626901|NCT00349336|101870940|FG000|NOT COMPLETED|Overall Study||13||
48626902|NCT00349336|101870941|FG001|NOT COMPLETED|Overall Study||14||
48626903|NCT02517658|101870942|FG000|STARTED|Overall Study||33||
48626904|NCT02517658|101870943|FG001|STARTED|Overall Study||33||
48626905|NCT02517658|101870944|FG002|STARTED|Overall Study||33||
48626906|NCT02517658|101870942|FG000|COMPLETED|Overall Study||33||
48626907|NCT02517658|101870943|FG001|COMPLETED|Overall Study||33||
48626908|NCT02517658|101870944|FG002|COMPLETED|Overall Study||33||
48626909|NCT02517658|101870942|FG000|NOT COMPLETED|Overall Study||0||
48411593|NCT02243306|101341788|FG000|NOT COMPLETED|Overall Study||0||
48411594|NCT02243306|101341789|FG001|NOT COMPLETED|Overall Study||3||
48626910|NCT02517658|101870943|FG001|NOT COMPLETED|Overall Study||0||
48626911|NCT02517658|101870944|FG002|NOT COMPLETED|Overall Study||0||
48626912|NCT02880254|101870945|FG000|STARTED|Overall Study||13||
48626913|NCT02880254|101870946|FG001|STARTED|Overall Study||14||
48626914|NCT02880254|101870945|FG000|COMPLETED|Overall Study||4||
48626915|NCT02880254|101870946|FG001|COMPLETED|Overall Study||4||
48170265|NCT02593305|100739300|FG000|STARTED|Baseline 2||7||
48626916|NCT02880254|101870945|FG000|NOT COMPLETED|Overall Study||9||
48626917|NCT02880254|101870946|FG001|NOT COMPLETED|Overall Study||10||
48626918|NCT01690663|101870947|FG000|STARTED|Overall Study||23||
48170266|NCT02593305|100739301|FG001|STARTED|Baseline 2||6||
48170267|NCT02593305|100739302|FG002|STARTED|Baseline 2||0||
48170268|NCT02593305|100739300|FG000|COMPLETED|Baseline 2||7||
48170269|NCT02593305|100739301|FG001|COMPLETED|Baseline 2||6||
48170270|NCT02593305|100739302|FG002|COMPLETED|Baseline 2||0||
48170271|NCT02593305|100739300|FG000|NOT COMPLETED|Baseline 2||0||
48170272|NCT02593305|100739301|FG001|NOT COMPLETED|Baseline 2||0||
48170273|NCT02593305|100739302|FG002|NOT COMPLETED|Baseline 2||0||
48170274|NCT02593305|100739300|FG000|STARTED|Post 2||7||
48170275|NCT02593305|100739301|FG001|STARTED|Post 2||6||
48626919|NCT01690663|101870948|FG001|STARTED|Overall Study||20||
48626920|NCT01690663|101870949|FG002|STARTED|Overall Study||22||
48626921|NCT01690663|101870950|FG003|STARTED|Overall Study||24||
48626922|NCT01690663|101870947|FG000|COMPLETED|Overall Study||20||
48626923|NCT01690663|101870948|FG001|COMPLETED|Overall Study||17||
48626924|NCT01690663|101870949|FG002|COMPLETED|Overall Study||19||
48626925|NCT01690663|101870950|FG003|COMPLETED|Overall Study||20||
48750294|NCT03430791|102177164|FG001|NOT COMPLETED|Overall Study||0||
48750295|NCT03255902|102177165|FG000|STARTED|Overall Study||7||
48750296|NCT03255902|102177165|FG000|COMPLETED|Overall Study||5||
48750297|NCT03255902|102177165|FG000|NOT COMPLETED|Overall Study||2||
48750298|NCT02326064|102177166|FG000|STARTED|Overall Study||209||
48750299|NCT02326064|102177167|FG001|STARTED|Overall Study||12||
48750300|NCT02326064|102177166|FG000|COMPLETED|Overall Study||209||
48750301|NCT02326064|102177167|FG001|COMPLETED|Overall Study||12||
48750302|NCT02326064|102177166|FG000|NOT COMPLETED|Overall Study||0||
48750303|NCT02326064|102177167|FG001|NOT COMPLETED|Overall Study||0||
48750304|NCT01436526|102177168|FG000|STARTED|Period 1||14||
48750305|NCT01436526|102177169|FG001|STARTED|Period 1||14||
48750306|NCT01436526|102177168|FG000|Participants Received Treatment|Period 1||14||
48750307|NCT01436526|102177169|FG001|Participants Received Treatment|Period 1||14||
48750308|NCT01436526|102177168|FG000|COMPLETED|Period 1||14||
48750309|NCT01436526|102177169|FG001|COMPLETED|Period 1||14||
48750310|NCT01436526|102177168|FG000|NOT COMPLETED|Period 1||0||
48750311|NCT01436526|102177169|FG001|NOT COMPLETED|Period 1||0||
48750312|NCT01436526|102177168|FG000|STARTED|Period 2||13||
48750313|NCT01436526|102177169|FG001|STARTED|Period 2||13||
48750314|NCT01436526|102177168|FG000|Participants Received Treatment|Period 2||13||
48750315|NCT01436526|102177169|FG001|Participants Received Treatment|Period 2||13||
48750316|NCT01436526|102177168|FG000|COMPLETED|Period 2||13||
48750317|NCT01436526|102177169|FG001|COMPLETED|Period 2||13||
48750318|NCT01436526|102177168|FG000|NOT COMPLETED|Period 2||0||
48750319|NCT01436526|102177169|FG001|NOT COMPLETED|Period 2||0||
48750320|NCT04326920|102177170|FG000|STARTED|Overall Study||40||
48750321|NCT04326920|102177171|FG001|STARTED|Overall Study||41||
48750322|NCT04326920|102177170|FG000|COMPLETED|Overall Study||40||
48750323|NCT04326920|102177171|FG001|COMPLETED|Overall Study||39||
48170276|NCT02593305|100739302|FG002|STARTED|Post 2||0||
48170277|NCT02593305|100739300|FG000|COMPLETED|Post 2||7||
48626926|NCT01690663|101870947|FG000|NOT COMPLETED|Overall Study||3||
48626927|NCT01690663|101870948|FG001|NOT COMPLETED|Overall Study||3||
48626928|NCT01690663|101870949|FG002|NOT COMPLETED|Overall Study||3||
48626929|NCT01690663|101870950|FG003|NOT COMPLETED|Overall Study||4||
48626930|NCT02966834|101870951|FG000|STARTED|Main Study Period (Up to 12 Weeks)||36||
48626931|NCT02966834|101870952|FG001|STARTED|Main Study Period (Up to 12 Weeks)||16||
48626932|NCT02966834|101870953|FG002|STARTED|Main Study Period (Up to 12 Weeks)||23||
48626933|NCT02966834|101870954|FG003|STARTED|Main Study Period (Up to 12 Weeks)||27||
48626934|NCT02966834|101870955|FG004|STARTED|Main Study Period (Up to 12 Weeks)||23||
48626935|NCT02966834|101870956|FG005|STARTED|Main Study Period (Up to 12 Weeks)||22||
48626936|NCT02966834|101870951|FG000|COMPLETED|Main Study Period (Up to 12 Weeks)||35||
48626937|NCT02966834|101870952|FG001|COMPLETED|Main Study Period (Up to 12 Weeks)||16||
48750324|NCT04326920|102177170|FG000|NOT COMPLETED|Overall Study||0||
48750325|NCT04326920|102177171|FG001|NOT COMPLETED|Overall Study||2||
48750326|NCT01903460|102177172|FG000|STARTED|Overall Study||6||
48750327|NCT01903460|102177173|FG001|STARTED|Overall Study||8||
48750328|NCT01903460|102177174|FG002|STARTED|Overall Study||3||
48750329|NCT01903460|102177175|FG003|STARTED|Overall Study||3||
48170278|NCT02593305|100739301|FG001|COMPLETED|Post 2||6||
48170279|NCT02593305|100739302|FG002|COMPLETED|Post 2||0||
48626938|NCT02966834|101870953|FG002|COMPLETED|Main Study Period (Up to 12 Weeks)||19||
48626939|NCT02966834|101870954|FG003|COMPLETED|Main Study Period (Up to 12 Weeks)||19||
48750330|NCT01903460|102177172|FG000|COMPLETED|Overall Study||6||
48750331|NCT01903460|102177173|FG001|COMPLETED|Overall Study||8||
48750332|NCT01903460|102177174|FG002|COMPLETED|Overall Study||3||
48750333|NCT01903460|102177175|FG003|COMPLETED|Overall Study||2||
48750334|NCT01903460|102177172|FG000|NOT COMPLETED|Overall Study||0||
48750335|NCT01903460|102177173|FG001|NOT COMPLETED|Overall Study||0||
48750336|NCT01903460|102177174|FG002|NOT COMPLETED|Overall Study||0||
48750337|NCT01903460|102177175|FG003|NOT COMPLETED|Overall Study||1||
48750338|NCT00983307|102177176|FG000|STARTED|Overall Study||17||
48170280|NCT02593305|100739300|FG000|NOT COMPLETED|Post 2||0||
48170281|NCT02593305|100739301|FG001|NOT COMPLETED|Post 2||0||
48750339|NCT00983307|102177176|FG000|COMPLETED|Overall Study||17||
48170282|NCT02593305|100739302|FG002|NOT COMPLETED|Post 2||0||
48170283|NCT00985543|100739303|FG000|STARTED|Overall Study||22||
48626940|NCT02966834|101870955|FG004|COMPLETED|Main Study Period (Up to 12 Weeks)||22||
48626941|NCT02966834|101870956|FG005|COMPLETED|Main Study Period (Up to 12 Weeks)||17||
48626942|NCT02966834|101870951|FG000|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||1||
48626943|NCT02966834|101870952|FG001|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||0||
48626944|NCT02966834|101870953|FG002|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||4||
48626945|NCT02966834|101870954|FG003|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||8||
48626946|NCT02966834|101870955|FG004|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||1||
48626947|NCT02966834|101870956|FG005|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||5||
48626948|NCT02966834|101870951|FG000|STARTED|Final Study Period (Up to 4 Weeks)||35||
48626949|NCT02966834|101870952|FG001|STARTED|Final Study Period (Up to 4 Weeks)||16||
48626950|NCT02966834|101870953|FG002|STARTED|Final Study Period (Up to 4 Weeks)||19||
48750340|NCT00983307|102177176|FG000|NOT COMPLETED|Overall Study||0||
48750341|NCT02221869|102177177|FG000|STARTED|Overall Study||31||
48170284|NCT00985543|100739303|FG000|COMPLETED|Overall Study||22||
48170285|NCT00985543|100739303|FG000|NOT COMPLETED|Overall Study||0||
48170286|NCT03767634|100739304|FG000|STARTED|Overall Study||62145||
48656964|NCT01340170|101943734|FG000|NOT COMPLETED|Overall Study||3||4
48750342|NCT02221869|102177178|FG001|STARTED|Overall Study||32||
48750343|NCT02221869|102177179|FG002|STARTED|Overall Study||43||
48750344|NCT02221869|102177177|FG000|COMPLETED|Overall Study||30|Double-blind Period|
48750345|NCT02221869|102177178|FG001|COMPLETED|Overall Study||32|Double-blind Period|
48750346|NCT02221869|102177179|FG002|COMPLETED|Overall Study||33|Double-blind Period|
48750347|NCT02221869|102177177|FG000|NOT COMPLETED|Overall Study||1||
48750348|NCT02221869|102177178|FG001|NOT COMPLETED|Overall Study||0||
48750349|NCT02221869|102177179|FG002|NOT COMPLETED|Overall Study||10||
48750350|NCT00922623|102177180|FG000|STARTED|Overall Study||93||
48750351|NCT00922623|102177180|FG000|COMPLETED|Overall Study||88||
48750352|NCT00922623|102177180|FG000|NOT COMPLETED|Overall Study||5||
48750353|NCT01210716|102177181|FG000|STARTED|First TPE Procedure||20||
48750354|NCT01210716|102177182|FG001|STARTED|First TPE Procedure||17||
48750355|NCT01210716|102177181|FG000|COMPLETED|First TPE Procedure||18||
48750356|NCT01210716|102177182|FG001|COMPLETED|First TPE Procedure||15||
48750357|NCT01210716|102177181|FG000|NOT COMPLETED|First TPE Procedure||2||
48750358|NCT01210716|102177182|FG001|NOT COMPLETED|First TPE Procedure||2||
48750359|NCT01210716|102177181|FG000|STARTED|Second TPE Procedure||18||
48750360|NCT01210716|102177182|FG001|STARTED|Second TPE Procedure||15||
48750361|NCT01210716|102177181|FG000|COMPLETED|Second TPE Procedure||15||
48750362|NCT01210716|102177182|FG001|COMPLETED|Second TPE Procedure||15||
48750363|NCT01210716|102177181|FG000|NOT COMPLETED|Second TPE Procedure||3||
48750364|NCT01210716|102177182|FG001|NOT COMPLETED|Second TPE Procedure||0||
48750365|NCT04486235|102177183|FG000|STARTED|Overall Study||32||
48750366|NCT04486235|102177184|FG001|STARTED|Overall Study||30||
48750367|NCT04486235|102177183|FG000|Analysis|Overall Study||30||
48750368|NCT04486235|102177184|FG001|Analysis|Overall Study||30||
48750369|NCT04486235|102177183|FG000|COMPLETED|Overall Study||30||
48750370|NCT04486235|102177184|FG001|COMPLETED|Overall Study||30||
48750371|NCT04486235|102177183|FG000|NOT COMPLETED|Overall Study||2||
48750372|NCT04486235|102177184|FG001|NOT COMPLETED|Overall Study||0||
48750373|NCT01485094|102177185|FG000|STARTED|Overall Study||20||
48750374|NCT01485094|102177186|FG001|STARTED|Overall Study||20||
48750375|NCT01485094|102177187|FG002|STARTED|Overall Study||19||
48750376|NCT01485094|102177185|FG000|COMPLETED|Overall Study||17||
48750377|NCT01485094|102177186|FG001|COMPLETED|Overall Study||18||
48750378|NCT01485094|102177187|FG002|COMPLETED|Overall Study||18||
48750379|NCT01485094|102177185|FG000|NOT COMPLETED|Overall Study||3||
48750380|NCT01485094|102177186|FG001|NOT COMPLETED|Overall Study||2||
48750381|NCT01485094|102177187|FG002|NOT COMPLETED|Overall Study||1||
48750382|NCT04024891|102177188|FG000|STARTED|Overall Study||16||
48750383|NCT04024891|102177189|FG001|STARTED|Overall Study||16||
48750384|NCT04024891|102177188|FG000|COMPLETED|Overall Study||16||
48750385|NCT04024891|102177189|FG001|COMPLETED|Overall Study||15||
48750386|NCT04024891|102177188|FG000|NOT COMPLETED|Overall Study||0||
48750387|NCT04024891|102177189|FG001|NOT COMPLETED|Overall Study||1||
48750388|NCT00079040|102177190|FG000|STARTED|Overall Study||65||
48750389|NCT00079040|102177190|FG000|COMPLETED|Overall Study||63||
48750390|NCT00079040|102177190|FG000|NOT COMPLETED|Overall Study||2||
48750391|NCT01364584|102177191|FG000|STARTED|Overall Study||11||
48750392|NCT01364584|102177192|FG001|STARTED|Overall Study||12||
48750393|NCT01364584|102177191|FG000|COMPLETED|Overall Study||11||
48750394|NCT01364584|102177192|FG001|COMPLETED|Overall Study||12||
48750395|NCT01364584|102177191|FG000|NOT COMPLETED|Overall Study||0||
48750396|NCT01364584|102177192|FG001|NOT COMPLETED|Overall Study||0||
48750397|NCT03016312|102177193|FG000|STARTED|Overall Study||379||
48750398|NCT03016312|102177194|FG001|STARTED|Overall Study||380||
48750399|NCT03016312|102177193|FG000|Participants Received Treatment|Overall Study||375||
48750400|NCT03016312|102177194|FG001|Participants Received Treatment|Overall Study||375||
48170287|NCT03767634|100739305|FG001|STARTED|Overall Study||19080||
48170288|NCT03767634|100739306|FG002|STARTED|Overall Study||16282||
48750401|NCT03016312|102177193|FG000|COMPLETED|Overall Study||17||
48750402|NCT03016312|102177194|FG001|COMPLETED|Overall Study||10||
48750403|NCT03016312|102177193|FG000|NOT COMPLETED|Overall Study||362||
48170289|NCT03767634|100739304|FG000|COMPLETED|Overall Study||62145||
48170290|NCT03767634|100739305|FG001|COMPLETED|Overall Study||19080||
48170291|NCT03767634|100739306|FG002|COMPLETED|Overall Study||16282||
48333193|NCT00105443|101141946|FG000|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0||
48333194|NCT00105443|101141947|FG001|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||10||
48170292|NCT03767634|100739304|FG000|NOT COMPLETED|Overall Study||0||
48170293|NCT03767634|100739305|FG001|NOT COMPLETED|Overall Study||0||
48170294|NCT03767634|100739306|FG002|NOT COMPLETED|Overall Study||0||
48170295|NCT00517075|100739307|FG000|STARTED|Overall Study||0||
48170296|NCT00517075|100739308|FG001|STARTED|Overall Study||0||
48170297|NCT00517075|100739309|FG002|STARTED|Overall Study||0||
48626951|NCT02966834|101870954|FG003|STARTED|Final Study Period (Up to 4 Weeks)||19||
48626952|NCT02966834|101870955|FG004|STARTED|Final Study Period (Up to 4 Weeks)||21||
48626953|NCT02966834|101870956|FG005|STARTED|Final Study Period (Up to 4 Weeks)||17||
48626954|NCT02966834|101870951|FG000|COMPLETED|Final Study Period (Up to 4 Weeks)||35||
48626955|NCT02966834|101870952|FG001|COMPLETED|Final Study Period (Up to 4 Weeks)||16||
48626956|NCT02966834|101870953|FG002|COMPLETED|Final Study Period (Up to 4 Weeks)||19||
48626957|NCT02966834|101870954|FG003|COMPLETED|Final Study Period (Up to 4 Weeks)||19||
48626958|NCT02966834|101870955|FG004|COMPLETED|Final Study Period (Up to 4 Weeks)||21||
48626959|NCT02966834|101870956|FG005|COMPLETED|Final Study Period (Up to 4 Weeks)||17||
48626960|NCT02966834|101870951|FG000|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0||
48750404|NCT03016312|102177194|FG001|NOT COMPLETED|Overall Study||370||
48750405|NCT01072188|102177195|FG000|STARTED|Overall Study||22||
48170298|NCT00517075|100739310|FG003|STARTED|Overall Study||0||
48170299|NCT00517075|100739307|FG000|COMPLETED|Overall Study||0||
48170300|NCT00517075|100739308|FG001|COMPLETED|Overall Study||0||
48170301|NCT00517075|100739309|FG002|COMPLETED|Overall Study||0||
48170302|NCT00517075|100739310|FG003|COMPLETED|Overall Study||0||
48170303|NCT00517075|100739307|FG000|NOT COMPLETED|Overall Study||0||
48170304|NCT00517075|100739308|FG001|NOT COMPLETED|Overall Study||0||
48170305|NCT00517075|100739309|FG002|NOT COMPLETED|Overall Study||0||
48170306|NCT00517075|100739310|FG003|NOT COMPLETED|Overall Study||0||
48170307|NCT03661996|100739311|FG000|STARTED|Overall Study||162||
48170308|NCT03661996|100739312|FG001|STARTED|Overall Study||180||
48170309|NCT03661996|100739313|FG002|STARTED|Overall Study||176||
48170310|NCT03661996|100739314|FG003|STARTED|Overall Study||163||
48170311|NCT03661996|100739315|FG004|STARTED|Overall Study||173||
48170312|NCT03661996|100739311|FG000|Treated|Overall Study||162||
48170313|NCT03661996|100739312|FG001|Treated|Overall Study||179||
48170314|NCT03661996|100739313|FG002|Treated|Overall Study||175||
48170315|NCT03661996|100739314|FG003|Treated|Overall Study||160||
48170316|NCT03661996|100739315|FG004|Treated|Overall Study||172||
48333195|NCT00105443|101141948|FG002|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0||
48333196|NCT00105443|101141949|FG003|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||11||
48333197|NCT00105443|101141946|FG000|COMPLETED|Follow-up and/or Open Label Nexavar||0||
48750406|NCT01072188|102177196|FG001|STARTED|Overall Study||23||
48170317|NCT03661996|100739311|FG000|COMPLETED|Overall Study||150||
48170318|NCT03661996|100739312|FG001|COMPLETED|Overall Study||172||
48170319|NCT03661996|100739313|FG002|COMPLETED|Overall Study||170||
48170320|NCT03661996|100739314|FG003|COMPLETED|Overall Study||150||
48170321|NCT03661996|100739315|FG004|COMPLETED|Overall Study||159||
48170322|NCT03661996|100739311|FG000|NOT COMPLETED|Overall Study||12||
48170323|NCT03661996|100739312|FG001|NOT COMPLETED|Overall Study||8||
48170324|NCT03661996|100739313|FG002|NOT COMPLETED|Overall Study||6||
48170325|NCT03661996|100739314|FG003|NOT COMPLETED|Overall Study||13||
48170326|NCT03661996|100739315|FG004|NOT COMPLETED|Overall Study||14||
48333198|NCT00105443|101141947|FG001|COMPLETED|Follow-up and/or Open Label Nexavar||0||
48411595|NCT02094664|101341790|FG000|STARTED|Overall Study||16||
48626961|NCT02966834|101870952|FG001|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0||
48626962|NCT02966834|101870953|FG002|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0||
48626963|NCT02966834|101870954|FG003|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0||
48626964|NCT02966834|101870955|FG004|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0||
48626965|NCT02966834|101870956|FG005|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0||
48626966|NCT02966834|101870951|FG000|STARTED|Follow-up (Up to 4 Weeks)||35||
48750407|NCT01072188|102177195|FG000|COMPLETED|Overall Study||22||
48750408|NCT01072188|102177196|FG001|COMPLETED|Overall Study||23||
48170327|NCT02638623|100739316|FG000|STARTED|Overall Study||27||
48170328|NCT02638623|100739317|FG001|STARTED|Overall Study||25||
48170329|NCT02638623|100739316|FG000|COMPLETED|Overall Study||20||
48170330|NCT02638623|100739317|FG001|COMPLETED|Overall Study||19||
48170331|NCT02638623|100739316|FG000|NOT COMPLETED|Overall Study||7||
48170332|NCT02638623|100739317|FG001|NOT COMPLETED|Overall Study||6||
48170333|NCT00383240|100739318|FG000|STARTED|Overall Study||191||
48170334|NCT00383240|100739319|FG001|STARTED|Overall Study||192||
48170335|NCT00383240|100739320|FG002|STARTED|Overall Study||202||
48170336|NCT00383240|100739321|FG003|STARTED|Overall Study||196||
48170337|NCT00383240|100739318|FG000|COMPLETED|Overall Study||156||
48170338|NCT00383240|100739319|FG001|COMPLETED|Overall Study||159||
48170339|NCT00383240|100739320|FG002|COMPLETED|Overall Study||117||
48170340|NCT00383240|100739321|FG003|COMPLETED|Overall Study||119||
48626967|NCT02966834|101870952|FG001|STARTED|Follow-up (Up to 4 Weeks)||16||
48626968|NCT02966834|101870953|FG002|STARTED|Follow-up (Up to 4 Weeks)||23||
48626969|NCT02966834|101870954|FG003|STARTED|Follow-up (Up to 4 Weeks)||27||
48170341|NCT00383240|100739318|FG000|NOT COMPLETED|Overall Study||35||
48170342|NCT00383240|100739319|FG001|NOT COMPLETED|Overall Study||33||
48170343|NCT00383240|100739320|FG002|NOT COMPLETED|Overall Study||85||
48170344|NCT00383240|100739321|FG003|NOT COMPLETED|Overall Study||77||
48170345|NCT02914379|100739322|FG000|STARTED|Overall Study||6||
48170346|NCT02914379|100739322|FG000|COMPLETED|Overall Study||6||
48170347|NCT02914379|100739322|FG000|NOT COMPLETED|Overall Study||0||
48170348|NCT01112514|100739323|FG000|STARTED|Overall Study||4||
48170349|NCT01112514|100739323|FG000|COMPLETED|Overall Study||3||
48170350|NCT01112514|100739323|FG000|NOT COMPLETED|Overall Study||1||
48170351|NCT02289989|100739324|FG000|STARTED|Overall Study||0||
48170352|NCT02289989|100739325|FG001|STARTED|Overall Study||1||
48170353|NCT02289989|100739324|FG000|COMPLETED|Overall Study||0||
48170354|NCT02289989|100739325|FG001|COMPLETED|Overall Study||1||
48170355|NCT02289989|100739324|FG000|NOT COMPLETED|Overall Study||0||
48170356|NCT02289989|100739325|FG001|NOT COMPLETED|Overall Study||0||
48170357|NCT00983489|100739326|FG000|STARTED|Overall Study||511||
48170358|NCT00983489|100739327|FG001|STARTED|Overall Study||453||
48170359|NCT00983489|100739328|FG002|STARTED|Overall Study||447||
48170360|NCT00983489|100739326|FG000|COMPLETED|Overall Study||326||
48170361|NCT00983489|100739327|FG001|COMPLETED|Overall Study||168||
48170362|NCT00983489|100739328|FG002|COMPLETED|Overall Study||135||
48170363|NCT00983489|100739326|FG000|NOT COMPLETED|Overall Study||185||
48170364|NCT00983489|100739327|FG001|NOT COMPLETED|Overall Study||285||
48170365|NCT00983489|100739328|FG002|NOT COMPLETED|Overall Study||312||
48170366|NCT01671748|100739329|FG000|STARTED|4 Week run-in Phase||47||
48170367|NCT01671748|100739330|FG001|STARTED|4 Week run-in Phase||0||
48170368|NCT01671748|100739329|FG000|COMPLETED|4 Week run-in Phase||36||
48170369|NCT01671748|100739330|FG001|COMPLETED|4 Week run-in Phase||0||
48170370|NCT01671748|100739329|FG000|NOT COMPLETED|4 Week run-in Phase||11||
48170371|NCT01671748|100739330|FG001|NOT COMPLETED|4 Week run-in Phase||0||
48170372|NCT01671748|100739329|FG000|STARTED|12 Week Treatment Phase||19||
48170373|NCT01671748|100739330|FG001|STARTED|12 Week Treatment Phase||17||
48170374|NCT01671748|100739329|FG000|COMPLETED|12 Week Treatment Phase||19||
48170375|NCT01671748|100739330|FG001|COMPLETED|12 Week Treatment Phase||17||
48170376|NCT01671748|100739329|FG000|NOT COMPLETED|12 Week Treatment Phase||0||
48170377|NCT01671748|100739330|FG001|NOT COMPLETED|12 Week Treatment Phase||0||
48170378|NCT01129531|100739331|FG000|STARTED|Treatment Cycle 1||84||
48170379|NCT01129531|100739332|FG001|STARTED|Treatment Cycle 1||84||
48170380|NCT01129531|100739333|FG002|STARTED|Treatment Cycle 1||126||
48170381|NCT01129531|100739331|FG000|COMPLETED|Treatment Cycle 1||80||
48170382|NCT01129531|100739332|FG001|COMPLETED|Treatment Cycle 1||78||
48626970|NCT02966834|101870955|FG004|STARTED|Follow-up (Up to 4 Weeks)||22||
48626971|NCT02966834|101870956|FG005|STARTED|Follow-up (Up to 4 Weeks)||22||
48626972|NCT02966834|101870951|FG000|COMPLETED|Follow-up (Up to 4 Weeks)||35||
48626973|NCT02966834|101870952|FG001|COMPLETED|Follow-up (Up to 4 Weeks)||16||
48626974|NCT02966834|101870953|FG002|COMPLETED|Follow-up (Up to 4 Weeks)||22||
48626975|NCT02966834|101870954|FG003|COMPLETED|Follow-up (Up to 4 Weeks)||22||
48626976|NCT02966834|101870955|FG004|COMPLETED|Follow-up (Up to 4 Weeks)||22||
48626977|NCT02966834|101870956|FG005|COMPLETED|Follow-up (Up to 4 Weeks)||21||
48750409|NCT01072188|102177195|FG000|NOT COMPLETED|Overall Study||0||
48750410|NCT01072188|102177196|FG001|NOT COMPLETED|Overall Study||0||
48750411|NCT02201524|102177197|FG000|STARTED|Overall Study||14||
48750412|NCT02201524|102177198|FG001|STARTED|Overall Study||15||
48750413|NCT02201524|102177199|FG002|STARTED|Overall Study||16||
48750414|NCT02201524|102177200|FG003|STARTED|Overall Study||14||
48750415|NCT02201524|102177197|FG000|COMPLETED|Overall Study||12||
48750416|NCT02201524|102177198|FG001|COMPLETED|Overall Study||12||
48750417|NCT02201524|102177199|FG002|COMPLETED|Overall Study||12||
48750418|NCT02201524|102177200|FG003|COMPLETED|Overall Study||10||
48170383|NCT01129531|100739333|FG002|COMPLETED|Treatment Cycle 1||110||
48170384|NCT01129531|100739331|FG000|NOT COMPLETED|Treatment Cycle 1||4||
48170385|NCT01129531|100739332|FG001|NOT COMPLETED|Treatment Cycle 1||6||
48170386|NCT01129531|100739333|FG002|NOT COMPLETED|Treatment Cycle 1||16||
48170387|NCT01129531|100739331|FG000|STARTED|Treatment Cycle 2||94||
48170388|NCT01129531|100739332|FG001|STARTED|Treatment Cycle 2||95||
48170389|NCT01129531|100739333|FG002|STARTED|Treatment Cycle 2||79||
48170390|NCT01129531|100739331|FG000|COMPLETED|Treatment Cycle 2||88||
48170391|NCT01129531|100739332|FG001|COMPLETED|Treatment Cycle 2||92||
48170392|NCT01129531|100739333|FG002|COMPLETED|Treatment Cycle 2||74||
48170393|NCT01129531|100739331|FG000|NOT COMPLETED|Treatment Cycle 2||6||
48170394|NCT01129531|100739332|FG001|NOT COMPLETED|Treatment Cycle 2||3||
48170395|NCT01129531|100739333|FG002|NOT COMPLETED|Treatment Cycle 2||5||
48170396|NCT03879603|100739334|FG000|STARTED|Overall Study||5||
48170397|NCT03879603|100739335|FG001|STARTED|Overall Study||5||
48170398|NCT03879603|100739336|FG002|STARTED|Overall Study||5||
48170399|NCT03879603|100739337|FG003|STARTED|Overall Study||5||
48170400|NCT03879603|100739338|FG004|STARTED|Overall Study||5||
48170401|NCT03879603|100739339|FG005|STARTED|Overall Study||5||
48170402|NCT03879603|100739334|FG000|Received First Product Administration|Overall Study||5||
48170403|NCT03879603|100739335|FG001|Received First Product Administration|Overall Study||5||
48170404|NCT03879603|100739336|FG002|Received First Product Administration|Overall Study||5||
48170405|NCT03879603|100739337|FG003|Received First Product Administration|Overall Study||5||
48170406|NCT03879603|100739338|FG004|Received First Product Administration|Overall Study||5||
48170407|NCT03879603|100739339|FG005|Received First Product Administration|Overall Study||5||
48626978|NCT02966834|101870951|FG000|NOT COMPLETED|Follow-up (Up to 4 Weeks)||0||
48626979|NCT02966834|101870952|FG001|NOT COMPLETED|Follow-up (Up to 4 Weeks)||0||
48626980|NCT02966834|101870953|FG002|NOT COMPLETED|Follow-up (Up to 4 Weeks)||1||
48626981|NCT02966834|101870954|FG003|NOT COMPLETED|Follow-up (Up to 4 Weeks)||5||
48170408|NCT03879603|100739334|FG000|Received All Product Administrations|Overall Study||4||
48170409|NCT03879603|100739335|FG001|Received All Product Administrations|Overall Study||5||
48170410|NCT03879603|100739336|FG002|Received All Product Administrations|Overall Study||5||
48170411|NCT03879603|100739337|FG003|Received All Product Administrations|Overall Study||5||
48170412|NCT03879603|100739338|FG004|Received All Product Administrations|Overall Study||5||
48170413|NCT03879603|100739339|FG005|Received All Product Administrations|Overall Study||5||
48170414|NCT03879603|100739334|FG000|COMPLETED|Overall Study||5||
48170415|NCT03879603|100739335|FG001|COMPLETED|Overall Study||5||
48170416|NCT03879603|100739336|FG002|COMPLETED|Overall Study||5||
48170417|NCT03879603|100739337|FG003|COMPLETED|Overall Study||5||
48170418|NCT03879603|100739338|FG004|COMPLETED|Overall Study||5||
48170419|NCT03879603|100739339|FG005|COMPLETED|Overall Study||5||
48170420|NCT03879603|100739334|FG000|NOT COMPLETED|Overall Study||0||
48170421|NCT03879603|100739335|FG001|NOT COMPLETED|Overall Study||0||
48170422|NCT03879603|100739336|FG002|NOT COMPLETED|Overall Study||0||
48170423|NCT03879603|100739337|FG003|NOT COMPLETED|Overall Study||0||
48170424|NCT03879603|100739338|FG004|NOT COMPLETED|Overall Study||0||
48170425|NCT03879603|100739339|FG005|NOT COMPLETED|Overall Study||0||
48170426|NCT02796274|100739340|FG000|STARTED|Overall Study||219||438
48170427|NCT02796274|100739340|FG000|COMPLETED|Overall Study||219||438
48170428|NCT02796274|100739340|FG000|NOT COMPLETED|Overall Study||0||0
48170429|NCT02058290|100739341|FG000|STARTED|Overall Study||77||
48170430|NCT02058290|100739342|FG001|STARTED|Overall Study||45||
48170431|NCT02058290|100739341|FG000|COMPLETED|Overall Study||66||
48170432|NCT02058290|100739342|FG001|COMPLETED|Overall Study||36||
48170433|NCT02058290|100739341|FG000|NOT COMPLETED|Overall Study||11||
48170434|NCT02058290|100739342|FG001|NOT COMPLETED|Overall Study||9||
48170435|NCT00539643|100739343|FG000|STARTED|Overall Study||51||
48170436|NCT00539643|100739344|FG001|STARTED|Overall Study||50||
48170437|NCT00539643|100739343|FG000|COMPLETED|Overall Study||45||
48170438|NCT00539643|100739344|FG001|COMPLETED|Overall Study||47||
48170439|NCT00539643|100739343|FG000|NOT COMPLETED|Overall Study||6||
48170440|NCT00539643|100739344|FG001|NOT COMPLETED|Overall Study||3||
48170441|NCT01872949|100739345|FG000|STARTED|Overall Study||15||
48170442|NCT01872949|100739345|FG000|COMPLETED|Overall Study||4||
48170443|NCT01872949|100739345|FG000|NOT COMPLETED|Overall Study||11||
48170444|NCT03380780|100739346|FG000|STARTED|Overall Study||16||
48170445|NCT03380780|100739346|FG000|COMPLETED|Overall Study||16||
48170446|NCT03380780|100739346|FG000|NOT COMPLETED|Overall Study||0||
48170447|NCT01361620|100739347|FG000|STARTED|Overall Study||132||
48170448|NCT01361620|100739347|FG000|COMPLETED|Overall Study||132||
48170449|NCT01361620|100739347|FG000|NOT COMPLETED|Overall Study||0||
48170450|NCT02235701|100739348|FG000|STARTED|Overall Study||6||
48170451|NCT02235701|100739349|FG001|STARTED|Overall Study||64||
48170452|NCT02235701|100739348|FG000|COMPLETED|Overall Study||6|Completed defined as receiving at least one dose of study drug.|
48170453|NCT02235701|100739349|FG001|COMPLETED|Overall Study||64|Completed defined as receiving at least one dose of study drug.|
48170454|NCT02235701|100739348|FG000|NOT COMPLETED|Overall Study||0||
48170455|NCT02235701|100739349|FG001|NOT COMPLETED|Overall Study||0||
48170456|NCT03857841|100739350|FG000|STARTED|Overall Study||2||
48170457|NCT03857841|100739351|FG001|STARTED|Overall Study||0||
48626982|NCT02966834|101870955|FG004|NOT COMPLETED|Follow-up (Up to 4 Weeks)||0||
48626983|NCT02966834|101870956|FG005|NOT COMPLETED|Follow-up (Up to 4 Weeks)||1||
48626984|NCT00785356|101870957|FG000|STARTED|Overall Study||8||
48170458|NCT03857841|100739352|FG002|STARTED|Overall Study||0||
48170459|NCT03857841|100739353|FG003|STARTED|Overall Study||1||
48170460|NCT03857841|100739350|FG000|COMPLETED|Overall Study||0||
48170461|NCT03857841|100739351|FG001|COMPLETED|Overall Study||0||
48170462|NCT03857841|100739352|FG002|COMPLETED|Overall Study||0||
48170463|NCT03857841|100739353|FG003|COMPLETED|Overall Study||1||
48170464|NCT03857841|100739350|FG000|NOT COMPLETED|Overall Study||2||
48170465|NCT03857841|100739351|FG001|NOT COMPLETED|Overall Study||0||
48170466|NCT03857841|100739352|FG002|NOT COMPLETED|Overall Study||0||
48170467|NCT03857841|100739353|FG003|NOT COMPLETED|Overall Study||0||
48170468|NCT00220961|100739354|FG000|STARTED|Overall Study||299||
48170469|NCT00220961|100739355|FG001|STARTED|Overall Study||303||
48170470|NCT00220961|100739354|FG000|COMPLETED|Overall Study||228||
48170471|NCT00220961|100739355|FG001|COMPLETED|Overall Study||213||
48170472|NCT00220961|100739354|FG000|NOT COMPLETED|Overall Study||71||
48170473|NCT00220961|100739355|FG001|NOT COMPLETED|Overall Study||90||
48170474|NCT02440594|100739356|FG000|STARTED|Overall Study||509||
48626985|NCT00785356|101870957|FG000|COMPLETED|Overall Study||0||
48170475|NCT02440594|100739357|FG001|STARTED|Overall Study||509||
48170476|NCT02440594|100739358|FG002|STARTED|Overall Study||436||
48170477|NCT02440594|100739359|FG003|STARTED|Overall Study||429||
48170478|NCT02440594|100739360|FG004|STARTED|Overall Study||55||
48170479|NCT02440594|100739361|FG005|STARTED|Overall Study||54||
48170480|NCT02440594|100739362|FG006|STARTED|Overall Study||150||
48170481|NCT02440594|100739363|FG007|STARTED|Overall Study||290||
48170482|NCT02440594|100739356|FG000|COMPLETED|Overall Study||377|Completed numbers reflect number completing 2 or more follow-ups assessments|
48170483|NCT02440594|100739357|FG001|COMPLETED|Overall Study||401|Completed numbers reflect number completing 2 or more follow-ups assessments|
48170484|NCT02440594|100739358|FG002|COMPLETED|Overall Study||319|Completed numbers reflect number completing 2 or more follow-ups assessments|
48170485|NCT02440594|100739359|FG003|COMPLETED|Overall Study||340|Completed numbers reflect number completing 2 or more follow-ups assessments|
48170486|NCT02440594|100739360|FG004|COMPLETED|Overall Study||46|Completed numbers reflect number completing 2 or more follow-ups assessments|
48170487|NCT02440594|100739361|FG005|COMPLETED|Overall Study||47|Completed numbers reflect number completing 2 or more follow-ups assessments|
48411596|NCT02094664|101341791|FG001|STARTED|Overall Study||16||
48411597|NCT02094664|101341790|FG000|COMPLETED|Overall Study||16||
48411598|NCT02094664|101341791|FG001|COMPLETED|Overall Study||16||
48170488|NCT02440594|100739362|FG006|COMPLETED|Overall Study||113|Completed numbers reflect number completing 2 or more follow-ups assessments|
48170489|NCT02440594|100739363|FG007|COMPLETED|Overall Study||234|Completed numbers reflect number completing 2 or more follow-ups assessments|
48170490|NCT02440594|100739356|FG000|NOT COMPLETED|Overall Study||132||
48170491|NCT02440594|100739357|FG001|NOT COMPLETED|Overall Study||108||
48170492|NCT02440594|100739358|FG002|NOT COMPLETED|Overall Study||117||
48170493|NCT02440594|100739359|FG003|NOT COMPLETED|Overall Study||89||
48411599|NCT02094664|101341790|FG000|NOT COMPLETED|Overall Study||0||
48411600|NCT02094664|101341791|FG001|NOT COMPLETED|Overall Study||0||
48411601|NCT01855867|101341792|FG000|STARTED|Overall Study||100||
48411602|NCT01855867|101341792|FG000|COMPLETED|Overall Study||100||
48411603|NCT01855867|101341792|FG000|NOT COMPLETED|Overall Study||0||
48411604|NCT04193605|101341793|FG000|STARTED|Overall Study||24||
48411605|NCT04193605|101341794|FG001|STARTED|Overall Study||24||
48411606|NCT04193605|101341793|FG000|COMPLETED|Overall Study||21||
48750419|NCT02201524|102177197|FG000|NOT COMPLETED|Overall Study||2||
48750420|NCT02201524|102177198|FG001|NOT COMPLETED|Overall Study||3||
48750421|NCT02201524|102177199|FG002|NOT COMPLETED|Overall Study||4||
48750422|NCT02201524|102177200|FG003|NOT COMPLETED|Overall Study||4||
48750423|NCT02997501|102177201|FG000|STARTED|Overall Study||256|2016-12-27|
48750424|NCT02997501|102177201|FG000|COMPLETED|Overall Study||256|2017-09-30|
48750425|NCT02997501|102177201|FG000|NOT COMPLETED|Overall Study||0||
48750426|NCT02767271|102177202|FG000|STARTED|Overall Study||15||
48170494|NCT02440594|100739360|FG004|NOT COMPLETED|Overall Study||9||
48170495|NCT02440594|100739361|FG005|NOT COMPLETED|Overall Study||7||
48170496|NCT02440594|100739362|FG006|NOT COMPLETED|Overall Study||37||
48170497|NCT02440594|100739363|FG007|NOT COMPLETED|Overall Study||56||
48170498|NCT02285595|100739364|FG000|STARTED|Overall Study||69||
48170499|NCT02285595|100739364|FG000|COMPLETED|Overall Study||54||
48170500|NCT02285595|100739364|FG000|NOT COMPLETED|Overall Study||15||
48170501|NCT02388074|100739365|FG000|STARTED|Overall Study||25||
48170502|NCT02388074|100739365|FG000|COMPLETED|Overall Study||22||
48170503|NCT02388074|100739365|FG000|NOT COMPLETED|Overall Study||3||
48170504|NCT02959671|100739366|FG000|STARTED|Overall Study||34||
48170505|NCT02959671|100739366|FG000|COMPLETED|Overall Study||29||
48170506|NCT02959671|100739366|FG000|NOT COMPLETED|Overall Study||5||
48170507|NCT01234649|100739367|FG000|STARTED|Overall Study||78||
48170508|NCT01234649|100739368|FG001|STARTED|Overall Study||75||
48170509|NCT01234649|100739367|FG000|COMPLETED|Overall Study||35||
48411607|NCT04193605|101341794|FG001|COMPLETED|Overall Study||20||
48411608|NCT04193605|101341793|FG000|NOT COMPLETED|Overall Study||3||
48411609|NCT04193605|101341794|FG001|NOT COMPLETED|Overall Study||4||
48411610|NCT01736930|101341795|FG000|STARTED|Overall Study||20||
48411611|NCT01736930|101341795|FG000|COMPLETED|Overall Study||19||
48411612|NCT01736930|101341795|FG000|NOT COMPLETED|Overall Study||1||
48411613|NCT04124952|101341796|FG000|STARTED|Overall Study||30||
48411614|NCT04124952|101341796|FG000|COMPLETED|Overall Study||29||
48750427|NCT02767271|102177203|FG001|STARTED|Overall Study||15||
48750428|NCT02767271|102177202|FG000|Safety Population|Overall Study||15|Received at least 1 application of study drug.|
48767718|NCT01112917|102222811|FG001|NOT COMPLETED|Overall Study||15||
48626986|NCT00785356|101870957|FG000|NOT COMPLETED|Overall Study||8||
48626987|NCT03627832|101870958|FG000|STARTED|Overall Study||28||
48626988|NCT03627832|101870959|FG001|STARTED|Overall Study||28||
48626989|NCT03627832|101870958|FG000|COMPLETED|Overall Study||18||
48626990|NCT03627832|101870959|FG001|COMPLETED|Overall Study||27||
48626991|NCT03627832|101870958|FG000|NOT COMPLETED|Overall Study||10||
48626992|NCT03627832|101870959|FG001|NOT COMPLETED|Overall Study||1||
48626993|NCT04556760|101870960|FG000|STARTED|Treatment Period 1 (72 Hours)||14||
48626994|NCT04556760|101870961|FG001|STARTED|Treatment Period 1 (72 Hours)||14||
48626995|NCT04556760|101870962|FG002|STARTED|Treatment Period 1 (72 Hours)||5||
48626996|NCT04556760|101870963|FG003|STARTED|Treatment Period 1 (72 Hours)||4||
48333199|NCT00105443|101141948|FG002|COMPLETED|Follow-up and/or Open Label Nexavar||0||
48333200|NCT00105443|101141949|FG003|COMPLETED|Follow-up and/or Open Label Nexavar||0||
48333201|NCT00105443|101141946|FG000|NOT COMPLETED|Follow-up and/or Open Label Nexavar||228||
48333202|NCT00105443|101141947|FG001|NOT COMPLETED|Follow-up and/or Open Label Nexavar||57||
48333203|NCT00105443|101141948|FG002|NOT COMPLETED|Follow-up and/or Open Label Nexavar||245||
48626997|NCT04556760|101870964|FG004|STARTED|Treatment Period 1 (72 Hours)||4||
48626998|NCT04556760|101870965|FG005|STARTED|Treatment Period 1 (72 Hours)||5||
48170510|NCT01234649|100739368|FG001|COMPLETED|Overall Study||37||
48170511|NCT01234649|100739367|FG000|NOT COMPLETED|Overall Study||43||
48170512|NCT01234649|100739368|FG001|NOT COMPLETED|Overall Study||38||
48170513|NCT04278417|100739369|FG000|STARTED|Overall Study||347||
48626999|NCT04556760|101870960|FG000|COMPLETED|Treatment Period 1 (72 Hours)||14||
48627000|NCT04556760|101870961|FG001|COMPLETED|Treatment Period 1 (72 Hours)||13||
48627001|NCT04556760|101870962|FG002|COMPLETED|Treatment Period 1 (72 Hours)||5||
48170514|NCT04278417|100739370|FG001|STARTED|Overall Study||342||
48170515|NCT04278417|100739369|FG000|COMPLETED|Overall Study||286||
48170516|NCT04278417|100739370|FG001|COMPLETED|Overall Study||286||
48170517|NCT04278417|100739369|FG000|NOT COMPLETED|Overall Study||61||
48170518|NCT04278417|100739370|FG001|NOT COMPLETED|Overall Study||56||
48170519|NCT02307513|100739371|FG000|STARTED|Placebo Controlled Phase (Weeks 0-12)||103||
48170520|NCT02307513|100739372|FG001|STARTED|Placebo Controlled Phase (Weeks 0-12)||104||
48170521|NCT02307513|100739371|FG000|COMPLETED|Placebo Controlled Phase (Weeks 0-12)||83||
48170522|NCT02307513|100739372|FG001|COMPLETED|Placebo Controlled Phase (Weeks 0-12)||96||
48170523|NCT02307513|100739371|FG000|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-12)||20||
48170524|NCT02307513|100739372|FG001|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-12)||8||
48333204|NCT00105443|101141949|FG003|NOT COMPLETED|Follow-up and/or Open Label Nexavar||47||
48333205|NCT00883246|101141950|FG000|STARTED|Overall Study||799||
48333206|NCT00883246|101141950|FG000|COMPLETED|Overall Study||626||
48333207|NCT00883246|101141950|FG000|NOT COMPLETED|Overall Study||173||
48333208|NCT00983983|101141951|FG000|STARTED|Overall Study||8||
48170525|NCT02307513|100739371|FG000|STARTED|Active Treatment Phase (Weeks 13-64)||83||
48170526|NCT02307513|100739372|FG001|STARTED|Active Treatment Phase (Weeks 13-64)||95||
48170527|NCT02307513|100739371|FG000|COMPLETED|Active Treatment Phase (Weeks 13-64)||68||
48170528|NCT02307513|100739372|FG001|COMPLETED|Active Treatment Phase (Weeks 13-64)||75||
48170529|NCT02307513|100739371|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 13-64)||15||
48170530|NCT02307513|100739372|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 13-64)||20||
48170531|NCT02307513|100739371|FG000|STARTED|Long-term Extension||2|Only participants in Germany had the option to continue receiving apremilast 30 mg BID in the extension phase.|
48170532|NCT02307513|100739372|FG001|STARTED|Long-term Extension||0|Only participants in Germany had the option to continue receiving apremilast 30 mg BID in the extension phase.|
48170533|NCT02307513|100739371|FG000|COMPLETED|Long-term Extension||1||
48170534|NCT02307513|100739372|FG001|COMPLETED|Long-term Extension||0||
48170535|NCT02307513|100739371|FG000|NOT COMPLETED|Long-term Extension||1||
48170536|NCT02307513|100739372|FG001|NOT COMPLETED|Long-term Extension||0||
48170537|NCT00579982|100739373|FG000|STARTED|Overall Study||97||
48170538|NCT00579982|100739373|FG000|COMPLETED|Overall Study||89||
48170539|NCT00579982|100739373|FG000|NOT COMPLETED|Overall Study||8||
48170540|NCT00335725|100739374|FG000|STARTED|Overall Study||75||
48170541|NCT00335725|100739375|FG001|STARTED|Overall Study||76||
48170542|NCT00335725|100739374|FG000|COMPLETED|Overall Study||71||
48170543|NCT00335725|100739375|FG001|COMPLETED|Overall Study||71||
48170544|NCT00335725|100739374|FG000|NOT COMPLETED|Overall Study||4||
48170545|NCT00335725|100739375|FG001|NOT COMPLETED|Overall Study||5||
48170546|NCT01216293|100739376|FG000|STARTED|Main Study||42||
48170547|NCT01216293|100739377|FG001|STARTED|Main Study||38||
48170548|NCT01216293|100739378|FG002|STARTED|Main Study||35||
48170549|NCT01216293|100739376|FG000|Safety Set: Received Study Drug|Main Study||41||
48170550|NCT01216293|100739377|FG001|Safety Set: Received Study Drug|Main Study||38||
48170551|NCT01216293|100739378|FG002|Safety Set: Received Study Drug|Main Study||35||
48170552|NCT01216293|100739376|FG000|Randomized, Not Treated|Main Study||1||
48170553|NCT01216293|100739377|FG001|Randomized, Not Treated|Main Study||0||
48170554|NCT01216293|100739378|FG002|Randomized, Not Treated|Main Study||0||
48170555|NCT01216293|100739376|FG000|COMPLETED|Main Study||34||
48170556|NCT01216293|100739377|FG001|COMPLETED|Main Study||30||
48333209|NCT00983983|101141952|FG001|STARTED|Overall Study||9||
48333210|NCT00983983|101141953|FG002|STARTED|Overall Study||7||
48333211|NCT00983983|101141951|FG000|COMPLETED|Overall Study||6||
48627002|NCT04556760|101870963|FG003|COMPLETED|Treatment Period 1 (72 Hours)||3||
48627003|NCT04556760|101870964|FG004|COMPLETED|Treatment Period 1 (72 Hours)||4||
48627004|NCT04556760|101870965|FG005|COMPLETED|Treatment Period 1 (72 Hours)||5||
48170557|NCT01216293|100739378|FG002|COMPLETED|Main Study||29||
48170558|NCT01216293|100739376|FG000|NOT COMPLETED|Main Study||8||
48170559|NCT01216293|100739377|FG001|NOT COMPLETED|Main Study||8||
48170560|NCT01216293|100739378|FG002|NOT COMPLETED|Main Study||6||
48333212|NCT00983983|101141952|FG001|COMPLETED|Overall Study||8||
48333213|NCT00983983|101141953|FG002|COMPLETED|Overall Study||6||
48333214|NCT00983983|101141951|FG000|NOT COMPLETED|Overall Study||2||
48333215|NCT00983983|101141952|FG001|NOT COMPLETED|Overall Study||1||
48170561|NCT01216293|100739376|FG000|STARTED|Calcium Absorption Substudy||14||
48170562|NCT01216293|100739377|FG001|STARTED|Calcium Absorption Substudy||10||
48170563|NCT01216293|100739378|FG002|STARTED|Calcium Absorption Substudy||10||
48170564|NCT01216293|100739376|FG000|Safety Set: Received Study Drug|Calcium Absorption Substudy||14||
48188635|NCT05257837|100783295|FG001|STARTED|Overall Study||60||
48627005|NCT04556760|101870960|FG000|NOT COMPLETED|Treatment Period 1 (72 Hours)||0||
48627006|NCT04556760|101870961|FG001|NOT COMPLETED|Treatment Period 1 (72 Hours)||1||
48627007|NCT04556760|101870962|FG002|NOT COMPLETED|Treatment Period 1 (72 Hours)||0||
48170565|NCT01216293|100739377|FG001|Safety Set: Received Study Drug|Calcium Absorption Substudy||10||
48170566|NCT01216293|100739378|FG002|Safety Set: Received Study Drug|Calcium Absorption Substudy||10||
48170567|NCT01216293|100739376|FG000|COMPLETED|Calcium Absorption Substudy||12||
48170568|NCT01216293|100739377|FG001|COMPLETED|Calcium Absorption Substudy||8||
48170569|NCT01216293|100739378|FG002|COMPLETED|Calcium Absorption Substudy||10||
48170570|NCT01216293|100739376|FG000|NOT COMPLETED|Calcium Absorption Substudy||2||
48170571|NCT01216293|100739377|FG001|NOT COMPLETED|Calcium Absorption Substudy||2||
48170572|NCT01216293|100739378|FG002|NOT COMPLETED|Calcium Absorption Substudy||0||
48170573|NCT00592319|100739379|FG000|STARTED|Overall Study||2||
48170574|NCT00592319|100739380|FG001|STARTED|Overall Study||8||
48170575|NCT00592319|100739379|FG000|COMPLETED|Overall Study||2||
48170576|NCT00592319|100739380|FG001|COMPLETED|Overall Study||5||
48170577|NCT00592319|100739379|FG000|NOT COMPLETED|Overall Study||0||
48170578|NCT00592319|100739380|FG001|NOT COMPLETED|Overall Study||3||
48170579|NCT02936037|100739381|FG000|STARTED|Double-Blind Treatment Period||316||
48170580|NCT02936037|100739382|FG001|STARTED|Double-Blind Treatment Period||326||
48170581|NCT02936037|100739381|FG000|COMPLETED|Double-Blind Treatment Period||267||
48170582|NCT02936037|100739382|FG001|COMPLETED|Double-Blind Treatment Period||261||
48170583|NCT02936037|100739381|FG000|NOT COMPLETED|Double-Blind Treatment Period||49||
48170584|NCT02936037|100739382|FG001|NOT COMPLETED|Double-Blind Treatment Period||65||
48170585|NCT02936037|100739381|FG000|STARTED|Open Label Extension||0||
48170586|NCT02936037|100739382|FG001|STARTED|Open Label Extension||528||
48170587|NCT02936037|100739381|FG000|COMPLETED|Open Label Extension||0||
48170588|NCT02936037|100739382|FG001|COMPLETED|Open Label Extension||518||
48170589|NCT02936037|100739381|FG000|NOT COMPLETED|Open Label Extension||0||
48170590|NCT02936037|100739382|FG001|NOT COMPLETED|Open Label Extension||10||
48170591|NCT01515189|100739383|FG000|STARTED|Induction||365||
48170592|NCT01515189|100739384|FG001|STARTED|Induction||362||
48170593|NCT01515189|100739383|FG000|COMPLETED|Induction||128||
48170594|NCT01515189|100739384|FG001|COMPLETED|Induction||130||
48170595|NCT01515189|100739383|FG000|NOT COMPLETED|Induction||237||
48170596|NCT01515189|100739384|FG001|NOT COMPLETED|Induction||232||
48170597|NCT01515189|100739383|FG000|STARTED|First Re-Induction Phase||23||
48627008|NCT04556760|101870963|FG003|NOT COMPLETED|Treatment Period 1 (72 Hours)||1||
48627009|NCT04556760|101870964|FG004|NOT COMPLETED|Treatment Period 1 (72 Hours)||0||
48627010|NCT04556760|101870965|FG005|NOT COMPLETED|Treatment Period 1 (72 Hours)||0||
48627011|NCT04556760|101870960|FG000|STARTED|Washout Period (3 Weeks)||14||
48170598|NCT01515189|100739384|FG001|STARTED|First Re-Induction Phase||32||
48170599|NCT01515189|100739383|FG000|COMPLETED|First Re-Induction Phase||9||
48170600|NCT01515189|100739384|FG001|COMPLETED|First Re-Induction Phase||17||
48170601|NCT01515189|100739383|FG000|NOT COMPLETED|First Re-Induction Phase||14||
48170602|NCT01515189|100739384|FG001|NOT COMPLETED|First Re-Induction Phase||15||
48170603|NCT00152763|100739385|FG000|STARTED|Overall Study||77||
48170604|NCT00152763|100739386|FG001|STARTED|Overall Study||19||
48170605|NCT00152763|100739387|FG002|STARTED|Overall Study||20||
48170606|NCT00152763|100739388|FG003|STARTED|Overall Study||77||
48170607|NCT00152763|100739385|FG000|COMPLETED|Overall Study||67||
48170608|NCT00152763|100739386|FG001|COMPLETED|Overall Study||14||
48170609|NCT00152763|100739387|FG002|COMPLETED|Overall Study||16||
48170610|NCT00152763|100739388|FG003|COMPLETED|Overall Study||63||
48170611|NCT00152763|100739385|FG000|NOT COMPLETED|Overall Study||10||
48170612|NCT00152763|100739386|FG001|NOT COMPLETED|Overall Study||5||
48170613|NCT00152763|100739387|FG002|NOT COMPLETED|Overall Study||4||
48170614|NCT00152763|100739388|FG003|NOT COMPLETED|Overall Study||14||
48170615|NCT01709305|100739389|FG000|STARTED|Phase 1||5570||
48170616|NCT01709305|100739390|FG001|STARTED|Phase 1||0||
48170617|NCT01709305|100739391|FG002|STARTED|Phase 1||0||
48170618|NCT01709305|100739392|FG003|STARTED|Phase 1||0||
48170619|NCT01709305|100739393|FG004|STARTED|Phase 1||0||
48170620|NCT01709305|100739389|FG000|COMPLETED|Phase 1||4933||
48170621|NCT01709305|100739390|FG001|COMPLETED|Phase 1||0||
48170622|NCT01709305|100739391|FG002|COMPLETED|Phase 1||0||
48170623|NCT01709305|100739392|FG003|COMPLETED|Phase 1||0||
48170624|NCT01709305|100739393|FG004|COMPLETED|Phase 1||0||
48170625|NCT01709305|100739389|FG000|NOT COMPLETED|Phase 1||637||
48170626|NCT01709305|100739390|FG001|NOT COMPLETED|Phase 1||0||
48170627|NCT01709305|100739391|FG002|NOT COMPLETED|Phase 1||0||
48170628|NCT01709305|100739392|FG003|NOT COMPLETED|Phase 1||0||
48170629|NCT01709305|100739393|FG004|NOT COMPLETED|Phase 1||0||
48170630|NCT01709305|100739389|FG000|STARTED|Phase 2||0||
48170631|NCT01709305|100739390|FG001|STARTED|Phase 2||552||
48170632|NCT01709305|100739391|FG002|STARTED|Phase 2||550||
48170633|NCT01709305|100739392|FG003|STARTED|Phase 2||556||
48170634|NCT01709305|100739393|FG004|STARTED|Phase 2||554||
48170635|NCT01709305|100739389|FG000|COMPLETED|Phase 2||0||
48170636|NCT01709305|100739390|FG001|COMPLETED|Phase 2||500||
48170637|NCT01709305|100739391|FG002|COMPLETED|Phase 2||505||
48170638|NCT01709305|100739392|FG003|COMPLETED|Phase 2||508||
48333216|NCT00983983|101141953|FG002|NOT COMPLETED|Overall Study||1||
48333217|NCT01396005|101141954|FG000|STARTED|Overall Study||10||
48333218|NCT01396005|101141955|FG001|STARTED|Overall Study||11||
48333219|NCT01396005|101141954|FG000|COMPLETED|Overall Study||10||
48333220|NCT01396005|101141955|FG001|COMPLETED|Overall Study||9||
48333221|NCT01396005|101141954|FG000|NOT COMPLETED|Overall Study||0||
48333222|NCT01396005|101141955|FG001|NOT COMPLETED|Overall Study||2||
48333223|NCT02083380|101141956|FG000|STARTED|Overall Study||148||
48333224|NCT02083380|101141957|FG001|STARTED|Overall Study||151||
48333225|NCT02083380|101141958|FG002|STARTED|Overall Study||149||
48333226|NCT02083380|101141956|FG000|COMPLETED|Overall Study||57|Lack of Efficacy = Received rescue treatment therefore linked with the efficacy endpoint ACPR|
48333227|NCT02083380|101141957|FG001|COMPLETED|Overall Study||56|Lack of Efficacy = Received rescue treatment therefore linked with the efficacy endpoint ACPR|
48333228|NCT02083380|101141958|FG002|COMPLETED|Overall Study||65|Lack of Efficacy = Received rescue treatment therefore linked with the efficacy endpoint ACPR|
48627012|NCT04556760|101870961|FG001|STARTED|Washout Period (3 Weeks)||13||
48627013|NCT04556760|101870962|FG002|STARTED|Washout Period (3 Weeks)||5||
48627014|NCT04556760|101870963|FG003|STARTED|Washout Period (3 Weeks)||3||
48627015|NCT04556760|101870964|FG004|STARTED|Washout Period (3 Weeks)||4||
48627016|NCT04556760|101870965|FG005|STARTED|Washout Period (3 Weeks)||5||
48627017|NCT04556760|101870960|FG000|COMPLETED|Washout Period (3 Weeks)||14||
48750429|NCT02767271|102177203|FG001|Safety Population|Overall Study||15|Received at least 1 application of study drug.|
48750430|NCT02767271|102177202|FG000|Pharmacokinetic Pedis (PKP) Population|Overall Study||15|Participants with tinea pedis, received ≥1 dose of study drug, had at least 1 PK assessment.|
48333229|NCT02083380|101141956|FG000|NOT COMPLETED|Overall Study||91||
48333230|NCT02083380|101141957|FG001|NOT COMPLETED|Overall Study||95||
48333231|NCT02083380|101141958|FG002|NOT COMPLETED|Overall Study||84||
48333232|NCT01623271|101141959|FG000|STARTED|Overall Study||5||
48333233|NCT01623271|101141959|FG000|COMPLETED|Overall Study||3||
48333234|NCT01623271|101141959|FG000|NOT COMPLETED|Overall Study||2||
48333235|NCT00693160|101141960|FG000|STARTED|Overall Study||14||
48333236|NCT00693160|101141961|FG001|STARTED|Overall Study||16||
48333237|NCT00693160|101141960|FG000|COMPLETED|Overall Study||14||
48333238|NCT00693160|101141961|FG001|COMPLETED|Overall Study||16||
48333239|NCT00693160|101141960|FG000|NOT COMPLETED|Overall Study||0||
48333240|NCT00693160|101141961|FG001|NOT COMPLETED|Overall Study||0||
48333241|NCT00119158|101141962|FG000|STARTED|Active Treatment||45||
48333242|NCT00119158|101141963|FG001|STARTED|Active Treatment||45||
48333243|NCT00119158|101141962|FG000|COMPLETED|Active Treatment||45||
48333244|NCT00119158|101141963|FG001|COMPLETED|Active Treatment||45||
48333245|NCT00119158|101141962|FG000|NOT COMPLETED|Active Treatment||0||
48333246|NCT00119158|101141963|FG001|NOT COMPLETED|Active Treatment||0||
48333247|NCT00119158|101141962|FG000|STARTED|Placebo Treatment||45||
48333248|NCT00119158|101141963|FG001|STARTED|Placebo Treatment||45||
48333249|NCT00119158|101141962|FG000|COMPLETED|Placebo Treatment||45||
48333250|NCT00119158|101141963|FG001|COMPLETED|Placebo Treatment||45||
48333251|NCT00119158|101141962|FG000|NOT COMPLETED|Placebo Treatment||0||
48333252|NCT00119158|101141963|FG001|NOT COMPLETED|Placebo Treatment||0||
48333253|NCT01777581|101141964|FG000|STARTED|Overall Study||8||
48333254|NCT01777581|101141965|FG001|STARTED|Overall Study||5||
48627018|NCT04556760|101870961|FG001|COMPLETED|Washout Period (3 Weeks)||13||
48627019|NCT04556760|101870962|FG002|COMPLETED|Washout Period (3 Weeks)||5||
48627020|NCT04556760|101870963|FG003|COMPLETED|Washout Period (3 Weeks)||3||
48627021|NCT04556760|101870964|FG004|COMPLETED|Washout Period (3 Weeks)||4||
48627022|NCT04556760|101870965|FG005|COMPLETED|Washout Period (3 Weeks)||5||
48627023|NCT04556760|101870960|FG000|NOT COMPLETED|Washout Period (3 Weeks)||0||
48627024|NCT04556760|101870961|FG001|NOT COMPLETED|Washout Period (3 Weeks)||0||
48627025|NCT04556760|101870962|FG002|NOT COMPLETED|Washout Period (3 Weeks)||0||
48627026|NCT04556760|101870963|FG003|NOT COMPLETED|Washout Period (3 Weeks)||0||
48627027|NCT04556760|101870964|FG004|NOT COMPLETED|Washout Period (3 Weeks)||0||
48627028|NCT04556760|101870965|FG005|NOT COMPLETED|Washout Period (3 Weeks)||0||
48627029|NCT04556760|101870960|FG000|STARTED|Treatment Period 2 (72 Hours)||14||
48627030|NCT04556760|101870961|FG001|STARTED|Treatment Period 2 (72 Hours)||13||
48333255|NCT01777581|101141964|FG000|COMPLETED|Overall Study||5||
48333256|NCT01777581|101141965|FG001|COMPLETED|Overall Study||3||
48333257|NCT01777581|101141964|FG000|NOT COMPLETED|Overall Study||3||
48333258|NCT01777581|101141965|FG001|NOT COMPLETED|Overall Study||2||
48333259|NCT02004873|101141966|FG000|STARTED|Overall Study||725||
48333260|NCT02004873|101141966|FG000|Micra Implant Success|Overall Study||719||
48333261|NCT02004873|101141966|FG000|COMPLETED|Overall Study||301||
48333262|NCT02004873|101141966|FG000|NOT COMPLETED|Overall Study||424||
48333263|NCT02180893|101145430|FG000|STARTED|Overall Study||30||
48333264|NCT02180893|101145431|FG001|STARTED|Overall Study||30||
48333265|NCT02180893|101145430|FG000|COMPLETED|Overall Study||27||
48333266|NCT02180893|101145431|FG001|COMPLETED|Overall Study||23||
48333267|NCT02180893|101145430|FG000|NOT COMPLETED|Overall Study||3||
48333268|NCT02180893|101145431|FG001|NOT COMPLETED|Overall Study||7||
48333269|NCT01482910|101145432|FG000|STARTED|Overall Study||228||
48333270|NCT01482910|101145433|FG001|STARTED|Overall Study||76||
48333271|NCT01482910|101145432|FG000|Completed Week 28|Overall Study||216||
48333272|NCT01482910|101145433|FG001|Completed Week 28|Overall Study||71||
48333273|NCT01482910|101145432|FG000|COMPLETED|Overall Study||213||
48333274|NCT01482910|101145433|FG001|COMPLETED|Overall Study||67||
48333275|NCT01482910|101145432|FG000|NOT COMPLETED|Overall Study||15||
48333276|NCT01482910|101145433|FG001|NOT COMPLETED|Overall Study||9||
48333277|NCT02387359|101145434|FG000|STARTED|Overall Study||354||
48333278|NCT02387359|101145435|FG001|STARTED|Overall Study||351||
48333279|NCT02387359|101145436|FG002|STARTED|Overall Study||349||
48750431|NCT02767271|102177203|FG001|Pharmacokinetic Pedis (PKP) Population|Overall Study||0|Participants with tinea pedis, received ≥1 dose of study drug, had at least 1 PK assessment.|
48750432|NCT02767271|102177202|FG000|Pharmacokinetic Cruris (PKC) Population|Overall Study||0|Participants with tinea cruris, received ≥1 dose of study drug, had at least 1 PK assessment.|
48333280|NCT02387359|101145434|FG000|COMPLETED|Overall Study||295||
48333281|NCT02387359|101145435|FG001|COMPLETED|Overall Study||309||
48333282|NCT02387359|101145436|FG002|COMPLETED|Overall Study||293||
48333283|NCT02387359|101145434|FG000|NOT COMPLETED|Overall Study||59||
48333284|NCT02387359|101145435|FG001|NOT COMPLETED|Overall Study||42||
48333285|NCT02387359|101145436|FG002|NOT COMPLETED|Overall Study||56||
48333286|NCT00874250|101145437|FG000|STARTED|Overall Study||51||
48333287|NCT00874250|101145437|FG000|COMPLETED|Overall Study||0||
48333288|NCT00874250|101145437|FG000|NOT COMPLETED|Overall Study||51||
48333289|NCT04607733|101145438|FG000|STARTED|Overall Study||40||
48333290|NCT04607733|101145439|FG001|STARTED|Overall Study||39||
48333291|NCT04607733|101145440|FG002|STARTED|Overall Study||41||
48333292|NCT04607733|101145441|FG003|STARTED|Overall Study||40||
48333293|NCT04607733|101145442|FG004|STARTED|Overall Study||41||
48333294|NCT04607733|101145443|FG005|STARTED|Overall Study||39||
48333295|NCT04607733|101145438|FG000|Received at Least One Dose of Drug|Overall Study||40||
48333296|NCT04607733|101145439|FG001|Received at Least One Dose of Drug|Overall Study||39||
48333297|NCT04607733|101145440|FG002|Received at Least One Dose of Drug|Overall Study||41||
48333298|NCT04607733|101145441|FG003|Received at Least One Dose of Drug|Overall Study||40||
48333299|NCT04607733|101145442|FG004|Received at Least One Dose of Drug|Overall Study||41||
48333300|NCT04607733|101145443|FG005|Received at Least One Dose of Drug|Overall Study||39||
48333301|NCT04607733|101145438|FG000|COMPLETED|Overall Study||39||
48333302|NCT04607733|101145439|FG001|COMPLETED|Overall Study||39||
48333303|NCT04607733|101145440|FG002|COMPLETED|Overall Study||41||
48333304|NCT04607733|101145441|FG003|COMPLETED|Overall Study||39||
48333305|NCT04607733|101145442|FG004|COMPLETED|Overall Study||39||
48333306|NCT04607733|101145443|FG005|COMPLETED|Overall Study||39||
48333307|NCT04607733|101145438|FG000|NOT COMPLETED|Overall Study||1||
48333308|NCT04607733|101145439|FG001|NOT COMPLETED|Overall Study||0||
48333309|NCT04607733|101145440|FG002|NOT COMPLETED|Overall Study||0||
48333310|NCT04607733|101145441|FG003|NOT COMPLETED|Overall Study||1||
48333311|NCT04607733|101145442|FG004|NOT COMPLETED|Overall Study||2||
48333312|NCT04607733|101145443|FG005|NOT COMPLETED|Overall Study||0||
48333313|NCT02508194|101145444|FG000|STARTED|Overall Study||949||
48333314|NCT02508194|101145445|FG001|STARTED|Overall Study||951||
48333315|NCT02508194|101145444|FG000|COMPLETED|Overall Study||897||
48333316|NCT02508194|101145445|FG001|COMPLETED|Overall Study||907||
48333317|NCT02508194|101145444|FG000|NOT COMPLETED|Overall Study||52||
48333318|NCT02508194|101145445|FG001|NOT COMPLETED|Overall Study||44||
48333319|NCT02164422|101145446|FG000|STARTED|Overall Study||25||
48333320|NCT02164422|101145447|FG001|STARTED|Overall Study||22||
48333321|NCT02164422|101145448|FG002|STARTED|Overall Study||23||
48333322|NCT02164422|101145446|FG000|COMPLETED|Overall Study||24||
48333323|NCT02164422|101145447|FG001|COMPLETED|Overall Study||20||
48333324|NCT02164422|101145448|FG002|COMPLETED|Overall Study||23||
48333325|NCT02164422|101145446|FG000|NOT COMPLETED|Overall Study||1||
48333326|NCT02164422|101145447|FG001|NOT COMPLETED|Overall Study||2||
48333327|NCT02164422|101145448|FG002|NOT COMPLETED|Overall Study||0||
48333328|NCT02634580|101145449|FG000|STARTED|Double-blind Treatment Period||10||
48333329|NCT02634580|101145450|FG001|STARTED|Double-blind Treatment Period||11||
48333330|NCT02634580|101145451|FG002|STARTED|Double-blind Treatment Period||19||
48333331|NCT02634580|101145452|FG003|STARTED|Double-blind Treatment Period||21||
48333332|NCT02634580|101145449|FG000|COMPLETED|Double-blind Treatment Period||9|Completed double-blind treatment period|
48333333|NCT02634580|101145450|FG001|COMPLETED|Double-blind Treatment Period||11|Completed double-blind treatment period|
48333334|NCT02634580|101145451|FG002|COMPLETED|Double-blind Treatment Period||18|Completed double-blind treatment period|
48333335|NCT02634580|101145452|FG003|COMPLETED|Double-blind Treatment Period||20|Completed double-blind treatment period|
48333336|NCT02634580|101145449|FG000|NOT COMPLETED|Double-blind Treatment Period||1||
48333337|NCT02634580|101145450|FG001|NOT COMPLETED|Double-blind Treatment Period||0||
48333338|NCT02634580|101145451|FG002|NOT COMPLETED|Double-blind Treatment Period||1||
48333339|NCT02634580|101145452|FG003|NOT COMPLETED|Double-blind Treatment Period||1||
48333340|NCT02634580|101145449|FG000|STARTED|Open-label Extension Period||9||
48333341|NCT02634580|101145450|FG001|STARTED|Open-label Extension Period||11||
48333342|NCT02634580|101145451|FG002|STARTED|Open-label Extension Period||18||
48333343|NCT02634580|101145452|FG003|STARTED|Open-label Extension Period||21||
48627031|NCT04556760|101870962|FG002|STARTED|Treatment Period 2 (72 Hours)||5||
48627032|NCT04556760|101870963|FG003|STARTED|Treatment Period 2 (72 Hours)||3||
48333344|NCT02634580|101145449|FG000|Received Open-label Treatment|Open-label Extension Period||9||
48333345|NCT02634580|101145450|FG001|Received Open-label Treatment|Open-label Extension Period||11||
48333346|NCT02634580|101145451|FG002|Received Open-label Treatment|Open-label Extension Period||18||
48333347|NCT02634580|101145452|FG003|Received Open-label Treatment|Open-label Extension Period||20||
48333348|NCT02634580|101145449|FG000|COMPLETED|Open-label Extension Period||9|Completed study|
48333349|NCT02634580|101145450|FG001|COMPLETED|Open-label Extension Period||10|Completed study|
48333350|NCT02634580|101145451|FG002|COMPLETED|Open-label Extension Period||18|Completed study|
48333351|NCT02634580|101145452|FG003|COMPLETED|Open-label Extension Period||20|Completed study|
48333352|NCT02634580|101145449|FG000|NOT COMPLETED|Open-label Extension Period||0||
48333353|NCT02634580|101145450|FG001|NOT COMPLETED|Open-label Extension Period||1||
48333354|NCT02634580|101145451|FG002|NOT COMPLETED|Open-label Extension Period||0||
48333355|NCT02634580|101145452|FG003|NOT COMPLETED|Open-label Extension Period||1||
48333356|NCT00363038|101145453|FG000|STARTED|Overall Study||16||
48333357|NCT00363038|101145453|FG000|COMPLETED|Overall Study||16||
48333358|NCT00363038|101145453|FG000|NOT COMPLETED|Overall Study||0||
48333359|NCT02658812|101145454|FG000|STARTED|Overall Study||9||
48333360|NCT02658812|101145454|FG000|COMPLETED|Overall Study||0||
48333361|NCT02658812|101145454|FG000|NOT COMPLETED|Overall Study||9||
48333362|NCT00577993|101145455|FG000|STARTED|Overall Study||85||
48333363|NCT00577993|101145456|FG001|STARTED|Overall Study||90||
48333364|NCT00577993|101145457|FG002|STARTED|Overall Study||35||
48333365|NCT00577993|101145455|FG000|COMPLETED|Overall Study||78||
48333366|NCT00577993|101145456|FG001|COMPLETED|Overall Study||80||
48333367|NCT00577993|101145457|FG002|COMPLETED|Overall Study||32||
48333368|NCT00577993|101145455|FG000|NOT COMPLETED|Overall Study||7||
48333369|NCT00577993|101145456|FG001|NOT COMPLETED|Overall Study||10||
48333370|NCT00577993|101145457|FG002|NOT COMPLETED|Overall Study||3||
48333371|NCT04311086|101145458|FG000|STARTED|Overall Study||128||
48333372|NCT04311086|101145458|FG000|COMPLETED|Overall Study||56||
48333373|NCT04311086|101145458|FG000|NOT COMPLETED|Overall Study||72||
48333374|NCT01986062|101145459|FG000|STARTED|Overall Study||47||
48333375|NCT01986062|101145460|FG001|STARTED|Overall Study||50||
48333376|NCT01986062|101145459|FG000|COMPLETED|Overall Study||46||
48333377|NCT01986062|101145460|FG001|COMPLETED|Overall Study||49||
48333378|NCT01986062|101145459|FG000|NOT COMPLETED|Overall Study||1||
48333379|NCT01986062|101145460|FG001|NOT COMPLETED|Overall Study||1||
48333380|NCT04002310|101145461|FG000|STARTED|Overall Study||3||
48333381|NCT04002310|101145462|FG001|STARTED|Overall Study||3||
48333382|NCT04002310|101145463|FG002|STARTED|Overall Study||3||
48333383|NCT04002310|101145464|FG003|STARTED|Overall Study||6||
48333384|NCT04002310|101145465|FG004|STARTED|Overall Study||3||
48333385|NCT04002310|101145461|FG000|Treated|Overall Study||3||
48333386|NCT04002310|101145462|FG001|Treated|Overall Study||3||
48333387|NCT04002310|101145463|FG002|Treated|Overall Study||3||
48333388|NCT04002310|101145464|FG003|Treated|Overall Study||6||
48333389|NCT04002310|101145465|FG004|Treated|Overall Study||3||
48333390|NCT04002310|101145461|FG000|COMPLETED|Overall Study||3|Completed=Not prematurely discontinued from trial medication.|
48333391|NCT04002310|101145462|FG001|COMPLETED|Overall Study||3|Completed=Not prematurely discontinued from trial medication.|
48627033|NCT04556760|101870964|FG004|STARTED|Treatment Period 2 (72 Hours)||4||
48627034|NCT04556760|101870965|FG005|STARTED|Treatment Period 2 (72 Hours)||5||
48627035|NCT04556760|101870960|FG000|COMPLETED|Treatment Period 2 (72 Hours)||14||
48627036|NCT04556760|101870961|FG001|COMPLETED|Treatment Period 2 (72 Hours)||13||
48627037|NCT04556760|101870962|FG002|COMPLETED|Treatment Period 2 (72 Hours)||5||
48627038|NCT04556760|101870963|FG003|COMPLETED|Treatment Period 2 (72 Hours)||3||
48627039|NCT04556760|101870964|FG004|COMPLETED|Treatment Period 2 (72 Hours)||4||
48627040|NCT04556760|101870965|FG005|COMPLETED|Treatment Period 2 (72 Hours)||5||
48627041|NCT04556760|101870960|FG000|NOT COMPLETED|Treatment Period 2 (72 Hours)||0||
48627042|NCT04556760|101870961|FG001|NOT COMPLETED|Treatment Period 2 (72 Hours)||0||
48627043|NCT04556760|101870962|FG002|NOT COMPLETED|Treatment Period 2 (72 Hours)||0||
48627044|NCT04556760|101870963|FG003|NOT COMPLETED|Treatment Period 2 (72 Hours)||0||
48333392|NCT04002310|101145463|FG002|COMPLETED|Overall Study||3|Completed=Not prematurely discontinued from trial medication.|
48333393|NCT04002310|101145464|FG003|COMPLETED|Overall Study||6|Completed=Not prematurely discontinued from trial medication.|
48333394|NCT04002310|101145465|FG004|COMPLETED|Overall Study||2|Completed=Not prematurely discontinued from trial medication.|
48333395|NCT04002310|101145461|FG000|NOT COMPLETED|Overall Study||0||
48333396|NCT04002310|101145462|FG001|NOT COMPLETED|Overall Study||0||
48333397|NCT04002310|101145463|FG002|NOT COMPLETED|Overall Study||0||
48627045|NCT04556760|101870964|FG004|NOT COMPLETED|Treatment Period 2 (72 Hours)||0||
48627046|NCT04556760|101870965|FG005|NOT COMPLETED|Treatment Period 2 (72 Hours)||0||
48627047|NCT01811238|101870966|FG000|STARTED|Overall Study||240||
48627048|NCT01811238|101870966|FG000|Safety Set|Overall Study||220||
48333398|NCT04002310|101145464|FG003|NOT COMPLETED|Overall Study||0||
48333399|NCT04002310|101145465|FG004|NOT COMPLETED|Overall Study||1||
48333400|NCT01486199|101145466|FG000|STARTED|Baseline Study Day||10||
48333401|NCT01486199|101145467|FG001|STARTED|Baseline Study Day||10||
48333402|NCT01486199|101145466|FG000|COMPLETED|Baseline Study Day||10||
48333403|NCT01486199|101145467|FG001|COMPLETED|Baseline Study Day||9||
48333404|NCT01486199|101145466|FG000|NOT COMPLETED|Baseline Study Day||0||
48333405|NCT01486199|101145467|FG001|NOT COMPLETED|Baseline Study Day||1||
48333406|NCT01486199|101145466|FG000|STARTED|Two Year Period Between Study Days||10||
48333407|NCT01486199|101145467|FG001|STARTED|Two Year Period Between Study Days||0||
48333408|NCT01486199|101145466|FG000|COMPLETED|Two Year Period Between Study Days||9||
48333409|NCT01486199|101145467|FG001|COMPLETED|Two Year Period Between Study Days||0||
48333410|NCT01486199|101145466|FG000|NOT COMPLETED|Two Year Period Between Study Days||1||
48333411|NCT01486199|101145467|FG001|NOT COMPLETED|Two Year Period Between Study Days||0||
48333412|NCT01486199|101145466|FG000|STARTED|Study Day at t= 2 Years||9||
48333413|NCT01486199|101145467|FG001|STARTED|Study Day at t= 2 Years||0||
48333414|NCT01486199|101145466|FG000|COMPLETED|Study Day at t= 2 Years||9||
48333415|NCT01486199|101145467|FG001|COMPLETED|Study Day at t= 2 Years||0||
48333416|NCT01486199|101145466|FG000|NOT COMPLETED|Study Day at t= 2 Years||0||
48333417|NCT01486199|101145467|FG001|NOT COMPLETED|Study Day at t= 2 Years||0||
48627049|NCT01811238|101870966|FG000|ITT Set|Overall Study||209||
48627050|NCT01811238|101870966|FG000|PP Set|Overall Study||120||
48627051|NCT01811238|101870966|FG000|COMPLETED|Overall Study||159||
48333418|NCT00854828|101145468|FG000|STARTED|Overall Study||30|Baseline enrollment data collected and completed intervention.|
48627052|NCT01811238|101870966|FG000|NOT COMPLETED|Overall Study||81||
48627053|NCT00830128|101870967|FG000|STARTED|Overall Study||106||
48627054|NCT00830128|101870967|FG000|COMPLETED|Overall Study||87||
48627055|NCT00830128|101870967|FG000|NOT COMPLETED|Overall Study||19||
48627056|NCT03060473|101870968|FG000|STARTED|Overall Study||11||
48333419|NCT00854828|101145469|FG001|STARTED|Overall Study||33|Baseline enrollment data collected and completed intervention.|
48333420|NCT00854828|101145470|FG002|STARTED|Overall Study||112|Baseline enrollment data collected and completed intervention.|
48627057|NCT03060473|101870969|FG001|STARTED|Overall Study||10||
48627058|NCT03060473|101870968|FG000|COMPLETED|Overall Study||11||
48627059|NCT03060473|101870969|FG001|COMPLETED|Overall Study||10||
48627060|NCT03060473|101870968|FG000|NOT COMPLETED|Overall Study||0||
48627061|NCT03060473|101870969|FG001|NOT COMPLETED|Overall Study||0||
48627062|NCT03644017|101870970|FG000|STARTED|Overall Study||46||
48627063|NCT03644017|101870970|FG000|COMPLETED|Overall Study||39||
48627064|NCT03644017|101870970|FG000|NOT COMPLETED|Overall Study||7||
48627065|NCT00239720|101870971|FG000|STARTED|Overall Study||3||
48627066|NCT00239720|101870972|FG001|STARTED|Overall Study||1||
48627067|NCT00239720|101870971|FG000|COMPLETED|Overall Study||2||
48627068|NCT00239720|101870972|FG001|COMPLETED|Overall Study||0||
48627069|NCT00239720|101870971|FG000|NOT COMPLETED|Overall Study||1||
48627070|NCT00239720|101870972|FG001|NOT COMPLETED|Overall Study||1||
48627071|NCT01329198|101870973|FG000|STARTED|Overall Study||3||
48627072|NCT01329198|101870974|FG001|STARTED|Overall Study||2||
48627073|NCT01329198|101870973|FG000|COMPLETED|Overall Study||3||
48627074|NCT01329198|101870974|FG001|COMPLETED|Overall Study||2||
48627075|NCT01329198|101870973|FG000|NOT COMPLETED|Overall Study||0||
48627076|NCT01329198|101870974|FG001|NOT COMPLETED|Overall Study||0||
48627077|NCT00535613|101870975|FG000|STARTED|Overall Study||49||
48627078|NCT00535613|101870976|FG001|STARTED|Overall Study||50||
48627079|NCT00535613|101870975|FG000|COMPLETED|Overall Study||49||
48627080|NCT00535613|101870976|FG001|COMPLETED|Overall Study||50||
48627081|NCT00535613|101870975|FG000|NOT COMPLETED|Overall Study||0||
48627082|NCT00535613|101870976|FG001|NOT COMPLETED|Overall Study||0||
48627083|NCT02513550|101870977|FG000|STARTED|Double Blind Treatment Period||310||
48627084|NCT02513550|101870978|FG001|STARTED|Double Blind Treatment Period||306||
48627085|NCT02513550|101870979|FG002|STARTED|Double Blind Treatment Period||611||
48627086|NCT02513550|101870980|FG003|STARTED|Double Blind Treatment Period||9||
48627087|NCT02513550|101870981|FG004|STARTED|Double Blind Treatment Period||5||
48627088|NCT02513550|101870982|FG005|STARTED|Double Blind Treatment Period||16||
48333421|NCT00854828|101145471|FG003|STARTED|Overall Study||111|Baseline enrollment data collected and completed intervention.|
48333422|NCT00854828|101145468|FG000|3 Months Post Intervention|Overall Study||24||
48333423|NCT00854828|101145469|FG001|3 Months Post Intervention|Overall Study||32||
48333424|NCT00854828|101145470|FG002|3 Months Post Intervention|Overall Study||112||
48333425|NCT00854828|101145471|FG003|3 Months Post Intervention|Overall Study||106||
48333426|NCT00854828|101145468|FG000|12 Months Post Intervention|Overall Study||26||
48333427|NCT00854828|101145469|FG001|12 Months Post Intervention|Overall Study||32||
48333428|NCT00854828|101145470|FG002|12 Months Post Intervention|Overall Study||112||
48333429|NCT00854828|101145471|FG003|12 Months Post Intervention|Overall Study||101||
48333430|NCT00854828|101145468|FG000|24 Months Post Intervention|Overall Study||27||
48333431|NCT00854828|101145469|FG001|24 Months Post Intervention|Overall Study||31||
48333432|NCT00854828|101145470|FG002|24 Months Post Intervention|Overall Study||104||
48333433|NCT00854828|101145471|FG003|24 Months Post Intervention|Overall Study||94||
48333434|NCT00854828|101145468|FG000|COMPLETED|Overall Study||27||
48333435|NCT00854828|101145469|FG001|COMPLETED|Overall Study||31||
48333436|NCT00854828|101145470|FG002|COMPLETED|Overall Study||104||
48333437|NCT00854828|101145471|FG003|COMPLETED|Overall Study||94||
48333438|NCT00854828|101145468|FG000|NOT COMPLETED|Overall Study||3||
48333439|NCT00854828|101145469|FG001|NOT COMPLETED|Overall Study||2||
48333440|NCT00854828|101145470|FG002|NOT COMPLETED|Overall Study||8||
48333441|NCT00854828|101145471|FG003|NOT COMPLETED|Overall Study||17||
48411615|NCT04124952|101341796|FG000|NOT COMPLETED|Overall Study||1||
48411616|NCT00995215|101341797|FG000|STARTED|Overall Study||6||
48411617|NCT00995215|101341797|FG000|COMPLETED|Overall Study||6||
48627089|NCT02513550|101870977|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Period||310||
48333442|NCT00379795|101145472|FG000|STARTED|Overall Study||526||
48333443|NCT00379795|101145473|FG001|STARTED|Overall Study||74||
48333444|NCT00379795|101145474|FG002|STARTED|Overall Study||116||
48627090|NCT02513550|101870978|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Period||306||
48627091|NCT02513550|101870979|FG002|Received at Least One Dose of Study Drug|Double Blind Treatment Period||609||
48627092|NCT02513550|101870980|FG003|Received at Least One Dose of Study Drug|Double Blind Treatment Period||9||
48627093|NCT02513550|101870981|FG004|Received at Least One Dose of Study Drug|Double Blind Treatment Period||5||
48627094|NCT02513550|101870982|FG005|Received at Least One Dose of Study Drug|Double Blind Treatment Period||16||
48627095|NCT02513550|101870977|FG000|COMPLETED|Double Blind Treatment Period||274||
48627096|NCT02513550|101870978|FG001|COMPLETED|Double Blind Treatment Period||268||
48627097|NCT02513550|101870979|FG002|COMPLETED|Double Blind Treatment Period||537||
48627098|NCT02513550|101870980|FG003|COMPLETED|Double Blind Treatment Period||9||
48627099|NCT02513550|101870981|FG004|COMPLETED|Double Blind Treatment Period||4||
48750433|NCT02767271|102177203|FG001|Pharmacokinetic Cruris (PKC) Population|Overall Study||15|Participants with tinea cruris, received ≥1 dose of study drug, had at least 1 PK assessment.|
48750434|NCT02767271|102177202|FG000|COMPLETED|Overall Study||15||
48750435|NCT02767271|102177203|FG001|COMPLETED|Overall Study||15||
48750436|NCT02767271|102177202|FG000|NOT COMPLETED|Overall Study||0||
48750437|NCT02767271|102177203|FG001|NOT COMPLETED|Overall Study||0||
48750438|NCT00962208|102177204|FG000|STARTED|Overall Study||51||
48750439|NCT00962208|102177205|FG001|STARTED|Overall Study||51||
48750440|NCT00962208|102177204|FG000|COMPLETED|Overall Study||37||
48750441|NCT00962208|102177205|FG001|COMPLETED|Overall Study||41||
48750442|NCT00962208|102177204|FG000|NOT COMPLETED|Overall Study||14||
48750443|NCT00962208|102177205|FG001|NOT COMPLETED|Overall Study||10||
48750444|NCT00499681|102177206|FG000|STARTED|Overall Study||4||
48750445|NCT00499681|102177207|FG001|STARTED|Overall Study||2||
48750446|NCT00499681|102177206|FG000|COMPLETED|Overall Study||4||
48750447|NCT00499681|102177207|FG001|COMPLETED|Overall Study||0||
48750448|NCT00499681|102177206|FG000|NOT COMPLETED|Overall Study||0||
48750449|NCT00499681|102177207|FG001|NOT COMPLETED|Overall Study||2||
48750450|NCT02178995|102177208|FG000|STARTED|Double Blind||0||
48750451|NCT02178995|102177209|FG001|STARTED|Double Blind||16||
48750452|NCT02178995|102177210|FG002|STARTED|Double Blind||5||
48750453|NCT02178995|102177211|FG003|STARTED|Double Blind||6||
48750454|NCT02178995|102177212|FG004|STARTED|Double Blind||6||
48750455|NCT02178995|102177213|FG005|STARTED|Double Blind||6||
48750456|NCT02178995|102177214|FG006|STARTED|Double Blind||5||
48750457|NCT02178995|102177215|FG007|STARTED|Double Blind||6||
48750458|NCT02178995|102177216|FG008|STARTED|Double Blind||1||
48750459|NCT02178995|102177208|FG000|COMPLETED|Double Blind||0||
48750460|NCT02178995|102177209|FG001|COMPLETED|Double Blind||15||
48750461|NCT02178995|102177210|FG002|COMPLETED|Double Blind||5||
48750462|NCT02178995|102177211|FG003|COMPLETED|Double Blind||6||
48627100|NCT02513550|101870982|FG005|COMPLETED|Double Blind Treatment Period||15||
48627101|NCT02513550|101870977|FG000|NOT COMPLETED|Double Blind Treatment Period||36||
48627102|NCT02513550|101870978|FG001|NOT COMPLETED|Double Blind Treatment Period||38||
48627103|NCT02513550|101870979|FG002|NOT COMPLETED|Double Blind Treatment Period||74||
48627104|NCT02513550|101870980|FG003|NOT COMPLETED|Double Blind Treatment Period||0||
48627105|NCT02513550|101870981|FG004|NOT COMPLETED|Double Blind Treatment Period||1||
48627106|NCT02513550|101870982|FG005|NOT COMPLETED|Double Blind Treatment Period||1||
48750463|NCT02178995|102177212|FG004|COMPLETED|Double Blind||6||
48750464|NCT02178995|102177213|FG005|COMPLETED|Double Blind||5||
48750465|NCT02178995|102177214|FG006|COMPLETED|Double Blind||5||
48750466|NCT02178995|102177215|FG007|COMPLETED|Double Blind||4||
48750467|NCT02178995|102177216|FG008|COMPLETED|Double Blind||0||
48750468|NCT02178995|102177208|FG000|NOT COMPLETED|Double Blind||0||
48750469|NCT02178995|102177209|FG001|NOT COMPLETED|Double Blind||1||
48750470|NCT02178995|102177210|FG002|NOT COMPLETED|Double Blind||0||
48750471|NCT02178995|102177211|FG003|NOT COMPLETED|Double Blind||0||
48750472|NCT02178995|102177212|FG004|NOT COMPLETED|Double Blind||0||
48750473|NCT02178995|102177213|FG005|NOT COMPLETED|Double Blind||1||
48750474|NCT02178995|102177214|FG006|NOT COMPLETED|Double Blind||0||
48750475|NCT02178995|102177215|FG007|NOT COMPLETED|Double Blind||2||
48750476|NCT02178995|102177216|FG008|NOT COMPLETED|Double Blind||1||
48333445|NCT00379795|101145475|FG003|STARTED|Overall Study||74||
48333446|NCT00379795|101145476|FG004|STARTED|Overall Study||63||
48333447|NCT00379795|101145472|FG000|Received Ranibizumab in Extension Study|Overall Study||377||
48411618|NCT00995215|101341797|FG000|NOT COMPLETED|Overall Study||0||
48411619|NCT00952588|101341798|FG000|STARTED|Overall Study||48||
48750477|NCT02178995|102177208|FG000|STARTED|Open Label||30||
48750478|NCT02178995|102177209|FG001|STARTED|Open Label||14||
48750479|NCT02178995|102177210|FG002|STARTED|Open Label||0||
48750480|NCT02178995|102177211|FG003|STARTED|Open Label||0||
48750481|NCT02178995|102177212|FG004|STARTED|Open Label||0||
48750482|NCT02178995|102177213|FG005|STARTED|Open Label||0||
48750483|NCT02178995|102177214|FG006|STARTED|Open Label||0||
48750484|NCT02178995|102177215|FG007|STARTED|Open Label||0||
48750485|NCT02178995|102177216|FG008|STARTED|Open Label||0||
48750486|NCT02178995|102177208|FG000|COMPLETED|Open Label||28||
48750487|NCT02178995|102177209|FG001|COMPLETED|Open Label||14||
48750488|NCT02178995|102177210|FG002|COMPLETED|Open Label||0||
48750489|NCT02178995|102177211|FG003|COMPLETED|Open Label||0||
48750490|NCT02178995|102177212|FG004|COMPLETED|Open Label||0||
48750491|NCT02178995|102177213|FG005|COMPLETED|Open Label||0||
48333448|NCT00379795|101145473|FG001|Received Ranibizumab in Extension Study|Overall Study||41||
48333449|NCT00379795|101145474|FG002|Received Ranibizumab in Extension Study|Overall Study||113||
48333450|NCT00379795|101145475|FG003|Received Ranibizumab in Extension Study|Overall Study||55||
48333451|NCT00379795|101145476|FG004|Received Ranibizumab in Extension Study|Overall Study||0||
48333452|NCT00379795|101145472|FG000|COMPLETED|Overall Study||50||
48333453|NCT00379795|101145473|FG001|COMPLETED|Overall Study||23||
48333454|NCT00379795|101145474|FG002|COMPLETED|Overall Study||23||
48411620|NCT00952588|101341799|FG001|STARTED|Overall Study||26||
48627107|NCT02513550|101870977|FG000|STARTED|Post-Treatment Follow-up Period||285||
48750492|NCT02178995|102177214|FG006|COMPLETED|Open Label||0||
48750493|NCT02178995|102177215|FG007|COMPLETED|Open Label||0||
48411621|NCT00952588|101341798|FG000|COMPLETED|Overall Study||12||
48411622|NCT00952588|101341799|FG001|COMPLETED|Overall Study||2||
48411623|NCT00952588|101341798|FG000|NOT COMPLETED|Overall Study||36||
48627108|NCT02513550|101870978|FG001|STARTED|Post-Treatment Follow-up Period||283||
48627109|NCT02513550|101870979|FG002|STARTED|Post-Treatment Follow-up Period||559||
48627110|NCT02513550|101870980|FG003|STARTED|Post-Treatment Follow-up Period||9||
48411624|NCT00952588|101341799|FG001|NOT COMPLETED|Overall Study||24||
48627111|NCT02513550|101870981|FG004|STARTED|Post-Treatment Follow-up Period||4||
48627112|NCT02513550|101870982|FG005|STARTED|Post-Treatment Follow-up Period||15||
48627113|NCT02513550|101870977|FG000|COMPLETED|Post-Treatment Follow-up Period||254||
48627114|NCT02513550|101870978|FG001|COMPLETED|Post-Treatment Follow-up Period||244||
48627115|NCT02513550|101870979|FG002|COMPLETED|Post-Treatment Follow-up Period||496||
48627116|NCT02513550|101870980|FG003|COMPLETED|Post-Treatment Follow-up Period||9||
48627117|NCT02513550|101870981|FG004|COMPLETED|Post-Treatment Follow-up Period||4||
48627118|NCT02513550|101870982|FG005|COMPLETED|Post-Treatment Follow-up Period||15||
48627119|NCT02513550|101870977|FG000|NOT COMPLETED|Post-Treatment Follow-up Period||31||
48627120|NCT02513550|101870978|FG001|NOT COMPLETED|Post-Treatment Follow-up Period||39||
48627121|NCT02513550|101870979|FG002|NOT COMPLETED|Post-Treatment Follow-up Period||63||
48627122|NCT02513550|101870980|FG003|NOT COMPLETED|Post-Treatment Follow-up Period||0||
48627123|NCT02513550|101870981|FG004|NOT COMPLETED|Post-Treatment Follow-up Period||0||
48627124|NCT02513550|101870982|FG005|NOT COMPLETED|Post-Treatment Follow-up Period||0||
48627125|NCT00086190|101870983|FG000|STARTED|Overall Study||42||
48627126|NCT00086190|101870984|FG001|STARTED|Overall Study||34||
48627127|NCT00086190|101870985|FG002|STARTED|Overall Study||39||
48627128|NCT00086190|101870983|FG000|COMPLETED|Overall Study||34||
48627129|NCT00086190|101870984|FG001|COMPLETED|Overall Study||30||
48627130|NCT00086190|101870985|FG002|COMPLETED|Overall Study||33||
48411625|NCT02176005|101341800|FG000|STARTED|Overall Study||14||
48411626|NCT02176005|101341801|FG001|STARTED|Overall Study||14||
48411627|NCT02176005|101341802|FG002|STARTED|Overall Study||8||
48750494|NCT02178995|102177216|FG008|COMPLETED|Open Label||0||
48750495|NCT02178995|102177208|FG000|NOT COMPLETED|Open Label||2||
48750496|NCT02178995|102177209|FG001|NOT COMPLETED|Open Label||0||
48750497|NCT02178995|102177210|FG002|NOT COMPLETED|Open Label||0||
48750498|NCT02178995|102177211|FG003|NOT COMPLETED|Open Label||0||
48750499|NCT02178995|102177212|FG004|NOT COMPLETED|Open Label||0||
48750500|NCT02178995|102177213|FG005|NOT COMPLETED|Open Label||0||
48750501|NCT02178995|102177214|FG006|NOT COMPLETED|Open Label||0||
48750502|NCT02178995|102177215|FG007|NOT COMPLETED|Open Label||0||
48750503|NCT02178995|102177216|FG008|NOT COMPLETED|Open Label||0||
48750504|NCT00851357|102177217|FG000|STARTED|Overall Study||1200||
48750505|NCT00851357|102177218|FG001|STARTED|Overall Study||1201||
48750506|NCT00851357|102177219|FG002|STARTED|Overall Study||1799||
48750507|NCT00851357|102177217|FG000|COMPLETED|Overall Study||1200||
48750508|NCT00851357|102177218|FG001|COMPLETED|Overall Study||1201||
48750509|NCT00851357|102177219|FG002|COMPLETED|Overall Study||1799||
48750510|NCT00851357|102177217|FG000|NOT COMPLETED|Overall Study||0||
48750511|NCT00851357|102177218|FG001|NOT COMPLETED|Overall Study||0||
48750512|NCT00851357|102177219|FG002|NOT COMPLETED|Overall Study||0||
48750513|NCT02111447|102177220|FG000|STARTED|Overall Study||0||
48750514|NCT02111447|102177221|FG001|STARTED|Overall Study||5||
48750515|NCT02111447|102177222|FG002|STARTED|Overall Study||1||
48750516|NCT02111447|102177223|FG003|STARTED|Overall Study||0||
48750517|NCT02111447|102177220|FG000|COMPLETED|Overall Study||0||
48750518|NCT02111447|102177221|FG001|COMPLETED|Overall Study||5||
48750519|NCT02111447|102177222|FG002|COMPLETED|Overall Study||1||
48750520|NCT02111447|102177223|FG003|COMPLETED|Overall Study||0||
48750521|NCT02111447|102177220|FG000|NOT COMPLETED|Overall Study||0||
48750522|NCT02111447|102177221|FG001|NOT COMPLETED|Overall Study||0||
48750523|NCT02111447|102177222|FG002|NOT COMPLETED|Overall Study||0||
48750524|NCT02111447|102177223|FG003|NOT COMPLETED|Overall Study||0||
48750525|NCT03310723|102177224|FG000|STARTED|Overall Study||20||
48750526|NCT03310723|102177225|FG001|STARTED|Overall Study||20||
48750527|NCT03310723|102177224|FG000|COMPLETED|Overall Study||20|Discontinued|
48750528|NCT03310723|102177225|FG001|COMPLETED|Overall Study||17|Discontinued|
48750529|NCT03310723|102177224|FG000|NOT COMPLETED|Overall Study||0||
48750530|NCT03310723|102177225|FG001|NOT COMPLETED|Overall Study||3||
48750531|NCT02794207|102177226|FG000|STARTED|Overall Study||32||
48750532|NCT02794207|102177227|FG001|STARTED|Overall Study||54||
48750533|NCT02794207|102177226|FG000|COMPLETED|Overall Study||32||
48750534|NCT02794207|102177227|FG001|COMPLETED|Overall Study||54||
48750535|NCT02794207|102177226|FG000|NOT COMPLETED|Overall Study||0||
48750536|NCT02794207|102177227|FG001|NOT COMPLETED|Overall Study||0||
48750537|NCT00227721|102177228|FG000|STARTED|Overall Study||30||
48750538|NCT00227721|102177228|FG000|COMPLETED|Overall Study||29||
48750539|NCT00227721|102177228|FG000|NOT COMPLETED|Overall Study||1||
48750540|NCT02898454|102177229|FG000|STARTED|Overall Study||153|Randomized population|
48750541|NCT02898454|102177230|FG001|STARTED|Overall Study||145|Randomized population|
48750542|NCT02898454|102177231|FG002|STARTED|Overall Study||150|Randomized population|
48750543|NCT02898454|102177229|FG000|Intent-to-Treat (ITT) Population|Overall Study||153|Randomized participants who were analyzed according to treatment group allocated by randomization.|
48750544|NCT02898454|102177230|FG001|Intent-to-Treat (ITT) Population|Overall Study||145|Randomized participants who were analyzed according to treatment group allocated by randomization.|
48750545|NCT02898454|102177231|FG002|Intent-to-Treat (ITT) Population|Overall Study||150|Randomized participants who were analyzed according to treatment group allocated by randomization.|
48750546|NCT02898454|102177229|FG000|Treated|Overall Study||152||
48750547|NCT02898454|102177230|FG001|Treated|Overall Study||145||
48750548|NCT02898454|102177231|FG002|Treated|Overall Study||150||
48750549|NCT02898454|102177229|FG000|Safety Population|Overall Study||150||
48750550|NCT02898454|102177230|FG001|Safety Population|Overall Study||148||
48750551|NCT02898454|102177231|FG002|Safety Population|Overall Study||149||
48750552|NCT02898454|102177229|FG000|COMPLETED|Overall Study||136||
48750553|NCT02898454|102177230|FG001|COMPLETED|Overall Study||140||
48750554|NCT02898454|102177231|FG002|COMPLETED|Overall Study||144||
48750555|NCT02898454|102177229|FG000|NOT COMPLETED|Overall Study||17||
48750556|NCT02898454|102177230|FG001|NOT COMPLETED|Overall Study||5||
48750557|NCT02898454|102177231|FG002|NOT COMPLETED|Overall Study||6||
48750558|NCT02539797|102177232|FG000|STARTED|Overall Study||12||
48750559|NCT02539797|102177233|FG001|STARTED|Overall Study||13||
48750560|NCT02539797|102177234|FG002|STARTED|Overall Study||13||
48750561|NCT02539797|102177232|FG000|COMPLETED|Overall Study||12||
48750562|NCT02539797|102177233|FG001|COMPLETED|Overall Study||12||
48750563|NCT02539797|102177234|FG002|COMPLETED|Overall Study||13||
48750564|NCT02539797|102177232|FG000|NOT COMPLETED|Overall Study||0||
48750565|NCT02539797|102177233|FG001|NOT COMPLETED|Overall Study||1||
48750566|NCT02539797|102177234|FG002|NOT COMPLETED|Overall Study||0||
48750567|NCT02123134|102177235|FG000|STARTED|Overall Study||28||
48750568|NCT02123134|102177236|FG001|STARTED|Overall Study||27||
48750569|NCT02123134|102177235|FG000|COMPLETED|Overall Study||25||
48750570|NCT02123134|102177236|FG001|COMPLETED|Overall Study||24||
48750571|NCT02123134|102177235|FG000|NOT COMPLETED|Overall Study||3||
48750572|NCT02123134|102177236|FG001|NOT COMPLETED|Overall Study||3||
48750573|NCT03691909|102177237|FG000|STARTED|Overall Study||15||
48750574|NCT03691909|102177237|FG000|Per Protocol Population Day 1|Overall Study||15||
48750575|NCT03691909|102177237|FG000|Per Protocol Population Week 1|Overall Study||15||
48750576|NCT03691909|102177237|FG000|Per Protocol Population Week 4|Overall Study||14||
48750577|NCT03691909|102177237|FG000|Per Protocol Population Week 8|Overall Study||13||
48750578|NCT03691909|102177237|FG000|Per Protocol Population Week 12|Overall Study||15||
48750579|NCT03691909|102177237|FG000|Per Protocol Population Week 26|Overall Study||14||
48750580|NCT03691909|102177237|FG000|Per Protocol Population Week 52|Overall Study||13||
48750581|NCT03691909|102177237|FG000|COMPLETED|Overall Study||15||
48750582|NCT03691909|102177237|FG000|NOT COMPLETED|Overall Study||0||
48750583|NCT01420861|102177238|FG000|STARTED|Overall Study||18||
48627131|NCT00086190|101870983|FG000|NOT COMPLETED|Overall Study||8||
48627132|NCT00086190|101870984|FG001|NOT COMPLETED|Overall Study||4||
48627133|NCT00086190|101870985|FG002|NOT COMPLETED|Overall Study||6||
48627134|NCT00402831|101870986|FG000|STARTED|Overall Study||202||
48627135|NCT00402831|101870987|FG001|STARTED|Overall Study||203||
48627136|NCT00402831|101870986|FG000|ProQuad® Dose 1 (Day 1)|Overall Study||202||
48627137|NCT00402831|101870987|FG001|ProQuad® Dose 1 (Day 1)|Overall Study||203||
48627138|NCT00402831|101870986|FG000|ProQuad® Dose 1 (Day 30)|Overall Study||202||
48627139|NCT00402831|101870987|FG001|ProQuad® Dose 1 (Day 30)|Overall Study||203||
48627140|NCT00402831|101870986|FG000|COMPLETED|Overall Study||201||
48627141|NCT00402831|101870987|FG001|COMPLETED|Overall Study||200||
48627142|NCT00402831|101870986|FG000|NOT COMPLETED|Overall Study||1||
48627143|NCT00402831|101870987|FG001|NOT COMPLETED|Overall Study||3||
48627144|NCT01525589|101870988|FG000|STARTED|Overall Study||56||
48627145|NCT01525589|101870989|FG001|STARTED|Overall Study||20||
48627146|NCT01525589|101870990|FG002|STARTED|Overall Study||35||
48627147|NCT01525589|101870988|FG000|COMPLETED|Overall Study||0||
48627148|NCT01525589|101870989|FG001|COMPLETED|Overall Study||0||
48627149|NCT01525589|101870990|FG002|COMPLETED|Overall Study||0||
48627150|NCT01525589|101870988|FG000|NOT COMPLETED|Overall Study||56||
48627151|NCT01525589|101870989|FG001|NOT COMPLETED|Overall Study||20||
48627152|NCT01525589|101870990|FG002|NOT COMPLETED|Overall Study||35||
48627153|NCT04074265|101870991|FG000|STARTED|Overall Study||17||
48627154|NCT04074265|101870992|FG001|STARTED|Overall Study||17||
48750584|NCT01420861|102177238|FG000|Randomized|Overall Study||11||
48750585|NCT01420861|102177238|FG000|Treated|Overall Study||9||
48750586|NCT01420861|102177238|FG000|COMPLETED|Overall Study||0||
48750587|NCT01420861|102177238|FG000|NOT COMPLETED|Overall Study||18||
48750588|NCT00982735|102177239|FG000|STARTED|Overall Study||987||
48750589|NCT00982735|102177239|FG000|COMPLETED|Overall Study||757||
48750590|NCT00982735|102177239|FG000|NOT COMPLETED|Overall Study||230||
48750591|NCT03180385|102177240|FG000|STARTED|Overall Study||0||
48750592|NCT03180385|102177241|FG001|STARTED|Overall Study||2||
48750593|NCT03180385|102177240|FG000|COMPLETED|Overall Study||0||
48750594|NCT03180385|102177241|FG001|COMPLETED|Overall Study||2||
48750595|NCT03180385|102177240|FG000|NOT COMPLETED|Overall Study||0||
48627155|NCT04074265|101870991|FG000|COMPLETED|Overall Study||17||
48627156|NCT04074265|101870992|FG001|COMPLETED|Overall Study||17||
48627157|NCT04074265|101870991|FG000|NOT COMPLETED|Overall Study||0||
48627158|NCT04074265|101870992|FG001|NOT COMPLETED|Overall Study||0||
48627159|NCT02027025|101870993|FG000|STARTED|Overall Study||48||
48627160|NCT02027025|101870994|FG001|STARTED|Overall Study||47||
48627161|NCT02027025|101870995|FG002|STARTED|Overall Study||47||
48627162|NCT02027025|101870993|FG000|COMPLETED|Overall Study||47||
48627163|NCT02027025|101870994|FG001|COMPLETED|Overall Study||42||
48627164|NCT02027025|101870995|FG002|COMPLETED|Overall Study||46||
48627165|NCT02027025|101870993|FG000|NOT COMPLETED|Overall Study||1||
48627166|NCT02027025|101870994|FG001|NOT COMPLETED|Overall Study||5||
48627167|NCT02027025|101870995|FG002|NOT COMPLETED|Overall Study||1||
48627168|NCT04789304|101870996|FG000|STARTED|Overall Study||6|Treated|
48627169|NCT04789304|101870997|FG001|STARTED|Overall Study||8|Treated|
48627170|NCT04789304|101870998|FG002|STARTED|Overall Study||8|Treated|
48627171|NCT04789304|101870999|FG003|STARTED|Overall Study||8|Treated|
48627172|NCT04789304|101870996|FG000|COMPLETED|Overall Study||6||
48627173|NCT04789304|101870997|FG001|COMPLETED|Overall Study||8||
48627174|NCT04789304|101870998|FG002|COMPLETED|Overall Study||8||
48627175|NCT04789304|101870999|FG003|COMPLETED|Overall Study||8||
48627176|NCT04789304|101870996|FG000|NOT COMPLETED|Overall Study||0||
48627177|NCT04789304|101870997|FG001|NOT COMPLETED|Overall Study||0||
48627178|NCT04789304|101870998|FG002|NOT COMPLETED|Overall Study||0||
48627179|NCT04789304|101870999|FG003|NOT COMPLETED|Overall Study||0||
48627180|NCT01305811|101871000|FG000|STARTED|Overall Study||52||
48627181|NCT01305811|101871001|FG001|STARTED|Overall Study||52||
48627182|NCT01305811|101871000|FG000|COMPLETED|Overall Study||44||
48627183|NCT01305811|101871001|FG001|COMPLETED|Overall Study||41||
48627184|NCT01305811|101871000|FG000|NOT COMPLETED|Overall Study||8||
48627185|NCT01305811|101871001|FG001|NOT COMPLETED|Overall Study||11||
48627186|NCT01206465|101871002|FG000|STARTED|Overall Study||3||
48627187|NCT01206465|101871003|FG001|STARTED|Overall Study||6||
48627188|NCT01206465|101871004|FG002|STARTED|Overall Study||6||
48627189|NCT01206465|101871005|FG003|STARTED|Overall Study||6||
48627190|NCT01206465|101871006|FG004|STARTED|Overall Study||6||
48627191|NCT01206465|101871002|FG000|COMPLETED|Overall Study||3||
48627192|NCT01206465|101871003|FG001|COMPLETED|Overall Study||6||
48627193|NCT01206465|101871004|FG002|COMPLETED|Overall Study||6||
48627194|NCT01206465|101871005|FG003|COMPLETED|Overall Study||6||
48627195|NCT01206465|101871006|FG004|COMPLETED|Overall Study||6||
48627196|NCT01206465|101871002|FG000|NOT COMPLETED|Overall Study||0||
48627197|NCT01206465|101871003|FG001|NOT COMPLETED|Overall Study||0||
48627198|NCT01206465|101871004|FG002|NOT COMPLETED|Overall Study||0||
48627199|NCT01206465|101871005|FG003|NOT COMPLETED|Overall Study||0||
48333455|NCT00379795|101145475|FG003|COMPLETED|Overall Study||6||
48333456|NCT00379795|101145476|FG004|COMPLETED|Overall Study||14||
48333457|NCT00379795|101145472|FG000|NOT COMPLETED|Overall Study||476||
48750596|NCT03180385|102177241|FG001|NOT COMPLETED|Overall Study||0||
48750597|NCT04368260|102177242|FG000|STARTED|Overall Study||40||
48627200|NCT01206465|101871006|FG004|NOT COMPLETED|Overall Study||0||
48627201|NCT03292016|101871007|FG000|STARTED|First Intervention||1||
48627202|NCT03292016|101871008|FG001|STARTED|First Intervention||1||
48627203|NCT03292016|101871009|FG002|STARTED|First Intervention||2||
48627204|NCT03292016|101871010|FG003|STARTED|First Intervention||1||
48627205|NCT03292016|101871011|FG004|STARTED|First Intervention||1||
48627206|NCT03292016|101871012|FG005|STARTED|First Intervention||2||
48627207|NCT03292016|101871007|FG000|COMPLETED|First Intervention||1||
48627208|NCT03292016|101871008|FG001|COMPLETED|First Intervention||1||
48627209|NCT03292016|101871009|FG002|COMPLETED|First Intervention||2||
48627210|NCT03292016|101871010|FG003|COMPLETED|First Intervention||1||
48627211|NCT03292016|101871011|FG004|COMPLETED|First Intervention||1||
48627212|NCT03292016|101871012|FG005|COMPLETED|First Intervention||2||
48627213|NCT03292016|101871007|FG000|NOT COMPLETED|First Intervention||0||
48627214|NCT03292016|101871008|FG001|NOT COMPLETED|First Intervention||0||
48627215|NCT03292016|101871009|FG002|NOT COMPLETED|First Intervention||0||
48627216|NCT03292016|101871010|FG003|NOT COMPLETED|First Intervention||0||
48627217|NCT03292016|101871011|FG004|NOT COMPLETED|First Intervention||0||
48627218|NCT03292016|101871012|FG005|NOT COMPLETED|First Intervention||0||
48627219|NCT03292016|101871007|FG000|STARTED|First Washout||1||
48627220|NCT03292016|101871008|FG001|STARTED|First Washout||1||
48627221|NCT03292016|101871009|FG002|STARTED|First Washout||2||
48627222|NCT03292016|101871010|FG003|STARTED|First Washout||1||
48627223|NCT03292016|101871011|FG004|STARTED|First Washout||1||
48627224|NCT03292016|101871012|FG005|STARTED|First Washout||2||
48627225|NCT03292016|101871007|FG000|COMPLETED|First Washout||1||
48627226|NCT03292016|101871008|FG001|COMPLETED|First Washout||1||
48627227|NCT03292016|101871009|FG002|COMPLETED|First Washout||2||
48627228|NCT03292016|101871010|FG003|COMPLETED|First Washout||1||
48627229|NCT03292016|101871011|FG004|COMPLETED|First Washout||1||
48627230|NCT03292016|101871012|FG005|COMPLETED|First Washout||2||
48750598|NCT04368260|102177242|FG000|COMPLETED|Overall Study||40||
48750599|NCT04368260|102177242|FG000|NOT COMPLETED|Overall Study||0||
48333458|NCT00379795|101145473|FG001|NOT COMPLETED|Overall Study||51||
48333459|NCT00379795|101145474|FG002|NOT COMPLETED|Overall Study||93||
48333460|NCT00379795|101145475|FG003|NOT COMPLETED|Overall Study||68||
48333461|NCT00379795|101145476|FG004|NOT COMPLETED|Overall Study||49||
48333462|NCT02902120|101145477|FG000|STARTED|Overall Study||21||
48333463|NCT02902120|101145477|FG000|COMPLETED|Overall Study||20||
48750600|NCT03110471|102177243|FG000|STARTED|Overall Study||30||
48627231|NCT03292016|101871007|FG000|NOT COMPLETED|First Washout||0||
48627232|NCT03292016|101871008|FG001|NOT COMPLETED|First Washout||0||
48627233|NCT03292016|101871009|FG002|NOT COMPLETED|First Washout||0||
48627234|NCT03292016|101871010|FG003|NOT COMPLETED|First Washout||0||
48627235|NCT03292016|101871011|FG004|NOT COMPLETED|First Washout||0||
48627236|NCT03292016|101871012|FG005|NOT COMPLETED|First Washout||0||
48627237|NCT03292016|101871007|FG000|STARTED|Second Intervention||1||
48627238|NCT03292016|101871008|FG001|STARTED|Second Intervention||1||
48627239|NCT03292016|101871009|FG002|STARTED|Second Intervention||2||
48627240|NCT03292016|101871010|FG003|STARTED|Second Intervention||1||
48627241|NCT03292016|101871011|FG004|STARTED|Second Intervention||1||
48627242|NCT03292016|101871012|FG005|STARTED|Second Intervention||2||
48627243|NCT03292016|101871007|FG000|COMPLETED|Second Intervention||1||
48627244|NCT03292016|101871008|FG001|COMPLETED|Second Intervention||1||
48627245|NCT03292016|101871009|FG002|COMPLETED|Second Intervention||2||
48627246|NCT03292016|101871010|FG003|COMPLETED|Second Intervention||1||
48627247|NCT03292016|101871011|FG004|COMPLETED|Second Intervention||1||
48627248|NCT03292016|101871012|FG005|COMPLETED|Second Intervention||2||
48627249|NCT03292016|101871007|FG000|NOT COMPLETED|Second Intervention||0||
48627250|NCT03292016|101871008|FG001|NOT COMPLETED|Second Intervention||0||
48627251|NCT03292016|101871009|FG002|NOT COMPLETED|Second Intervention||0||
48627252|NCT03292016|101871010|FG003|NOT COMPLETED|Second Intervention||0||
48627253|NCT03292016|101871011|FG004|NOT COMPLETED|Second Intervention||0||
48627254|NCT03292016|101871012|FG005|NOT COMPLETED|Second Intervention||0||
48627255|NCT03292016|101871007|FG000|STARTED|Second Washout||1||
48627256|NCT03292016|101871008|FG001|STARTED|Second Washout||1||
48627257|NCT03292016|101871009|FG002|STARTED|Second Washout||2||
48627258|NCT03292016|101871010|FG003|STARTED|Second Washout||1||
48627259|NCT03292016|101871011|FG004|STARTED|Second Washout||1||
48627260|NCT03292016|101871012|FG005|STARTED|Second Washout||2||
48627261|NCT03292016|101871007|FG000|COMPLETED|Second Washout||1||
48627262|NCT03292016|101871008|FG001|COMPLETED|Second Washout||0||
48627263|NCT03292016|101871009|FG002|COMPLETED|Second Washout||2||
48627264|NCT03292016|101871010|FG003|COMPLETED|Second Washout||1||
48627265|NCT03292016|101871011|FG004|COMPLETED|Second Washout||1||
48627266|NCT03292016|101871012|FG005|COMPLETED|Second Washout||2||
48627267|NCT03292016|101871007|FG000|NOT COMPLETED|Second Washout||0||
48627268|NCT03292016|101871008|FG001|NOT COMPLETED|Second Washout||1||
48627269|NCT03292016|101871009|FG002|NOT COMPLETED|Second Washout||0||
48627270|NCT03292016|101871010|FG003|NOT COMPLETED|Second Washout||0||
48627271|NCT03292016|101871011|FG004|NOT COMPLETED|Second Washout||0||
48627272|NCT03292016|101871012|FG005|NOT COMPLETED|Second Washout||0||
48627273|NCT03292016|101871007|FG000|STARTED|Third Intervention||1||
48627274|NCT03292016|101871008|FG001|STARTED|Third Intervention||0||
48627275|NCT03292016|101871009|FG002|STARTED|Third Intervention||2||
48627276|NCT03292016|101871010|FG003|STARTED|Third Intervention||1||
48627277|NCT03292016|101871011|FG004|STARTED|Third Intervention||1||
48627278|NCT03292016|101871012|FG005|STARTED|Third Intervention||2||
48627279|NCT03292016|101871007|FG000|COMPLETED|Third Intervention||1||
48627280|NCT03292016|101871008|FG001|COMPLETED|Third Intervention||0||
48627281|NCT03292016|101871009|FG002|COMPLETED|Third Intervention||2||
48627282|NCT03292016|101871010|FG003|COMPLETED|Third Intervention||1||
48627283|NCT03292016|101871011|FG004|COMPLETED|Third Intervention||1||
48627284|NCT03292016|101871012|FG005|COMPLETED|Third Intervention||2||
48627285|NCT03292016|101871007|FG000|NOT COMPLETED|Third Intervention||0||
48627286|NCT03292016|101871008|FG001|NOT COMPLETED|Third Intervention||0||
48627287|NCT03292016|101871009|FG002|NOT COMPLETED|Third Intervention||0||
48627288|NCT03292016|101871010|FG003|NOT COMPLETED|Third Intervention||0||
48627289|NCT03292016|101871011|FG004|NOT COMPLETED|Third Intervention||0||
48627290|NCT03292016|101871012|FG005|NOT COMPLETED|Third Intervention||0||
48627291|NCT04176224|101871013|FG000|STARTED|Overall Study||9||
48627292|NCT04176224|101871013|FG000|COMPLETED|Overall Study||9||
48627293|NCT04176224|101871013|FG000|NOT COMPLETED|Overall Study||0||
48627294|NCT02683109|101871014|FG000|STARTED|Overall Study||110||
48627295|NCT02683109|101871015|FG001|STARTED|Overall Study||111||
48627296|NCT02683109|101871014|FG000|COMPLETED|Overall Study||109||
48627297|NCT02683109|101871015|FG001|COMPLETED|Overall Study||111||
48627298|NCT02683109|101871014|FG000|NOT COMPLETED|Overall Study||1||
48627299|NCT02683109|101871015|FG001|NOT COMPLETED|Overall Study||0||
48627300|NCT03704064|101871016|FG000|STARTED|Overall Study||52||
48627301|NCT03704064|101871017|FG001|STARTED|Overall Study||53||
48627302|NCT03704064|101871016|FG000|Week 20|Overall Study||44||
48627303|NCT03704064|101871017|FG001|Week 20|Overall Study||46||
48627304|NCT03704064|101871016|FG000|Week 46|Overall Study||44||
48627305|NCT03704064|101871017|FG001|Week 46|Overall Study||46||
48627306|NCT03704064|101871016|FG000|Week 72|Overall Study||42||
48627307|NCT03704064|101871017|FG001|Week 72|Overall Study||47||
48627308|NCT03704064|101871016|FG000|COMPLETED|Overall Study||42||
48627309|NCT03704064|101871017|FG001|COMPLETED|Overall Study||47||
48627310|NCT03704064|101871016|FG000|NOT COMPLETED|Overall Study||10||
48627311|NCT03704064|101871017|FG001|NOT COMPLETED|Overall Study||6||
48627312|NCT03049501|101871018|FG000|STARTED|Overall Study||123||
48627313|NCT03049501|101871019|FG001|STARTED|Overall Study||121||
48627314|NCT03049501|101871018|FG000|6 Month Follow up|Overall Study||107||
48627315|NCT03049501|101871019|FG001|6 Month Follow up|Overall Study||91||
48627316|NCT03049501|101871018|FG000|12 Month Follow up|Overall Study||101||
48750601|NCT03110471|102177244|FG001|STARTED|Overall Study||30||
48750602|NCT03110471|102177243|FG000|COMPLETED|Overall Study||30||
48750603|NCT03110471|102177244|FG001|COMPLETED|Overall Study||30||
48750604|NCT03110471|102177243|FG000|NOT COMPLETED|Overall Study||0||
48750605|NCT03110471|102177244|FG001|NOT COMPLETED|Overall Study||0||
48750606|NCT01300234|102177245|FG000|STARTED|Overall Study||257||
48750607|NCT01300234|102177246|FG001|STARTED|Overall Study||255||
48411628|NCT02176005|101341803|FG003|STARTED|Overall Study||8||
48411629|NCT02176005|101341800|FG000|COMPLETED|Overall Study||14||
48411630|NCT02176005|101341801|FG001|COMPLETED|Overall Study||14||
48627317|NCT03049501|101871019|FG001|12 Month Follow up|Overall Study||92||
48627318|NCT03049501|101871018|FG000|COMPLETED|Overall Study||101||
48627319|NCT03049501|101871019|FG001|COMPLETED|Overall Study||92||
48627320|NCT03049501|101871018|FG000|NOT COMPLETED|Overall Study||22||
48627321|NCT03049501|101871019|FG001|NOT COMPLETED|Overall Study||29||
48627322|NCT00094445|101871020|FG000|STARTED|Overall Study||50||
48627323|NCT00094445|101871020|FG000|COMPLETED|Overall Study||44||
48627324|NCT00094445|101871020|FG000|NOT COMPLETED|Overall Study||6||
48627325|NCT02204917|101871021|FG000|STARTED|Overall Study||31||
48627326|NCT02204917|101871021|FG000|COMPLETED|Overall Study||30||
48627327|NCT02204917|101871021|FG000|NOT COMPLETED|Overall Study||1||
48627328|NCT03415152|101871022|FG000|STARTED|Overall Study||3000||
48627329|NCT03415152|101871022|FG000|COMPLETED|Overall Study||1975||
48627330|NCT03415152|101871022|FG000|NOT COMPLETED|Overall Study||1025||
48627331|NCT01669434|101871023|FG000|STARTED|Overall Study||146||
48627332|NCT01669434|101871024|FG001|STARTED|Overall Study||145||
48627333|NCT01669434|101871023|FG000|COMPLETED|Overall Study||137||
48627334|NCT01669434|101871024|FG001|COMPLETED|Overall Study||138||
48627335|NCT01669434|101871023|FG000|NOT COMPLETED|Overall Study||9||
48627336|NCT01669434|101871024|FG001|NOT COMPLETED|Overall Study||7||
48627337|NCT00869960|101871025|FG000|STARTED|Overall Study||24||
48627338|NCT00869960|101871025|FG000|COMPLETED|Overall Study||22||
48627339|NCT00869960|101871025|FG000|NOT COMPLETED|Overall Study||2||
48627340|NCT02801331|101871026|FG000|STARTED|Overall Study||105|mITT-reflects treatment received|
48627341|NCT02801331|101871027|FG001|STARTED|Overall Study||103|mITT-reflects treatment received|
48627342|NCT02801331|101871026|FG000|COMPLETED|Overall Study||94|Completed hospitalization at respective site (does not include post-hospitalization followup)|
48627343|NCT02801331|101871027|FG001|COMPLETED|Overall Study||87|Completed hospitalization at respective site (does not include post-hospitalization followup)|
48627344|NCT02801331|101871026|FG000|NOT COMPLETED|Overall Study||11||
48627345|NCT02801331|101871027|FG001|NOT COMPLETED|Overall Study||16||
48627346|NCT01326871|101871028|FG000|STARTED|Overall Study||3||
48627347|NCT01326871|101871029|FG001|STARTED|Overall Study||49||
48627348|NCT01326871|101871030|FG002|STARTED|Overall Study||16||
48750608|NCT01300234|102177245|FG000|COMPLETED|Overall Study||229||
48750609|NCT01300234|102177246|FG001|COMPLETED|Overall Study||228||
48750610|NCT01300234|102177245|FG000|NOT COMPLETED|Overall Study||28||
48627349|NCT01326871|101871028|FG000|COMPLETED|Overall Study||3||
48627350|NCT01326871|101871029|FG001|COMPLETED|Overall Study||21||
48627351|NCT01326871|101871030|FG002|COMPLETED|Overall Study||1||
48627352|NCT01326871|101871028|FG000|NOT COMPLETED|Overall Study||0||
48627353|NCT01326871|101871029|FG001|NOT COMPLETED|Overall Study||28||
48627354|NCT01326871|101871030|FG002|NOT COMPLETED|Overall Study||15||
48627355|NCT00721799|101871031|FG000|STARTED|Overall Study||33||
48627356|NCT00721799|101871031|FG000|Recieved FLT PET Scan 1|Overall Study||26||
48627357|NCT00721799|101871031|FG000|Received FLT PET Scan #2|Overall Study||25||
48750611|NCT01300234|102177246|FG001|NOT COMPLETED|Overall Study||27||
48750612|NCT00526292|102177247|FG000|STARTED|Overall Study||6||
48750613|NCT00526292|102177247|FG000|COMPLETED|Overall Study||6||
48750614|NCT00526292|102177247|FG000|NOT COMPLETED|Overall Study||0||
48750615|NCT03050801|102177248|FG000|STARTED|Experiment 1||3||
48750616|NCT03050801|102177249|FG001|STARTED|Experiment 1||13||
48411631|NCT02176005|101341802|FG002|COMPLETED|Overall Study||8||
48411632|NCT02176005|101341803|FG003|COMPLETED|Overall Study||8||
48411633|NCT02176005|101341800|FG000|NOT COMPLETED|Overall Study||0||
48411634|NCT02176005|101341801|FG001|NOT COMPLETED|Overall Study||0||
48411635|NCT02176005|101341802|FG002|NOT COMPLETED|Overall Study||0||
48411636|NCT02176005|101341803|FG003|NOT COMPLETED|Overall Study||0||
48627358|NCT00721799|101871031|FG000|COMPLETED|Overall Study||25||
48627359|NCT00721799|101871031|FG000|NOT COMPLETED|Overall Study||8||
48627360|NCT03684408|101871032|FG000|STARTED|Overall Study||10||
48627361|NCT03684408|101871033|FG001|STARTED|Overall Study||16||
48627362|NCT03684408|101871034|FG002|STARTED|Overall Study||12||
48627363|NCT03684408|101871032|FG000|COMPLETED|Overall Study||9||
48627364|NCT03684408|101871033|FG001|COMPLETED|Overall Study||15||
48627365|NCT03684408|101871034|FG002|COMPLETED|Overall Study||12||
48627366|NCT03684408|101871032|FG000|NOT COMPLETED|Overall Study||1||
48627367|NCT03684408|101871033|FG001|NOT COMPLETED|Overall Study||1||
48627368|NCT03684408|101871034|FG002|NOT COMPLETED|Overall Study||0||
48627369|NCT02791269|101871035|FG000|STARTED|Overall Study||4||
48627370|NCT02791269|101871036|FG001|STARTED|Overall Study||20||
48627371|NCT02791269|101871035|FG000|COMPLETED|Overall Study||4||
48627372|NCT02791269|101871036|FG001|COMPLETED|Overall Study||19||
48627373|NCT02791269|101871035|FG000|NOT COMPLETED|Overall Study||0||
48750617|NCT03050801|102177250|FG002|STARTED|Experiment 1||8||
48333464|NCT02902120|101145477|FG000|NOT COMPLETED|Overall Study||1||
48333465|NCT02653768|101145478|FG000|STARTED|3-Month Follow-Up||230||
48333466|NCT02653768|101145479|FG001|STARTED|3-Month Follow-Up||115||
48333467|NCT02653768|101145478|FG000|COMPLETED|3-Month Follow-Up||164||
48333468|NCT02653768|101145479|FG001|COMPLETED|3-Month Follow-Up||100||
48333469|NCT02653768|101145478|FG000|NOT COMPLETED|3-Month Follow-Up||66||
48333470|NCT02653768|101145479|FG001|NOT COMPLETED|3-Month Follow-Up||15||
48333471|NCT02653768|101145478|FG000|STARTED|6-Month Follow-Up||209||
48333472|NCT02653768|101145479|FG001|STARTED|6-Month Follow-Up||113||
48333473|NCT02653768|101145478|FG000|COMPLETED|6-Month Follow-Up||164||
48333474|NCT02653768|101145479|FG001|COMPLETED|6-Month Follow-Up||100||
48333475|NCT02653768|101145478|FG000|NOT COMPLETED|6-Month Follow-Up||45||
48333476|NCT02653768|101145479|FG001|NOT COMPLETED|6-Month Follow-Up||13||
48333477|NCT02653768|101145478|FG000|STARTED|9-Month Follow-Up (Primary)||196||
48333478|NCT02653768|101145479|FG001|STARTED|9-Month Follow-Up (Primary)||111||
48333479|NCT02653768|101145478|FG000|COMPLETED|9-Month Follow-Up (Primary)||163||
48333480|NCT02653768|101145479|FG001|COMPLETED|9-Month Follow-Up (Primary)||95||
48333481|NCT02653768|101145478|FG000|NOT COMPLETED|9-Month Follow-Up (Primary)||33||
48333482|NCT02653768|101145479|FG001|NOT COMPLETED|9-Month Follow-Up (Primary)||16||
48333483|NCT00573794|101145480|FG000|STARTED|Overall Study||585|ITT-1: All subjects who received ≥1 dose of study drug excluding 7 subjects at noncompliant sites.|
48333484|NCT00573794|101145480|FG000|COMPLETED|Overall Study||255||
48333485|NCT00573794|101145480|FG000|NOT COMPLETED|Overall Study||330||
48333486|NCT02615990|101145481|FG000|STARTED|Overall Study||1||
48333487|NCT02615990|101145482|FG001|STARTED|Overall Study||1||
48333488|NCT02615990|101145481|FG000|COMPLETED|Overall Study||0||
48333489|NCT02615990|101145482|FG001|COMPLETED|Overall Study||0||
48333490|NCT02615990|101145481|FG000|NOT COMPLETED|Overall Study||1||
48333491|NCT02615990|101145482|FG001|NOT COMPLETED|Overall Study||1||
48333492|NCT04391959|101145483|FG000|STARTED|Overall Study||16||
48333493|NCT04391959|101145484|FG001|STARTED|Overall Study||15||
48627374|NCT02791269|101871036|FG001|NOT COMPLETED|Overall Study||1||
48627375|NCT00909844|101871037|FG000|STARTED|Overall Study||35||
48627376|NCT00909844|101871037|FG000|COMPLETED|Overall Study||31||
48627377|NCT00909844|101871037|FG000|NOT COMPLETED|Overall Study||4||
48627378|NCT01386606|101871038|FG000|STARTED|Overall Study||16||
48627379|NCT01386606|101871039|FG001|STARTED|Overall Study||14||
48627380|NCT01386606|101871040|FG002|STARTED|Overall Study||16||
48627381|NCT01386606|101871041|FG003|STARTED|Overall Study||14||
48627382|NCT01386606|101871038|FG000|COMPLETED|Overall Study||12||
48627383|NCT01386606|101871039|FG001|COMPLETED|Overall Study||10||
48627384|NCT01386606|101871040|FG002|COMPLETED|Overall Study||13||
48627385|NCT01386606|101871041|FG003|COMPLETED|Overall Study||13||
48627386|NCT01386606|101871038|FG000|NOT COMPLETED|Overall Study||4||
48627387|NCT01386606|101871039|FG001|NOT COMPLETED|Overall Study||4||
48627388|NCT01386606|101871040|FG002|NOT COMPLETED|Overall Study||3||
48627389|NCT01386606|101871041|FG003|NOT COMPLETED|Overall Study||1||
48627390|NCT02067858|101871042|FG000|STARTED|Overall Study||6||
48627391|NCT02067858|101871042|FG000|COMPLETED|Overall Study||6||
48627392|NCT02067858|101871042|FG000|NOT COMPLETED|Overall Study||0||
48627393|NCT01899911|101871043|FG000|STARTED|Overall Study||12||
48627394|NCT01899911|101871043|FG000|COMPLETED|Overall Study||12||
48627395|NCT01899911|101871043|FG000|NOT COMPLETED|Overall Study||0||
48170639|NCT01709305|100739393|FG004|COMPLETED|Phase 2||507||
48333494|NCT04391959|101145483|FG000|COMPLETED|Overall Study||15||
48333495|NCT04391959|101145484|FG001|COMPLETED|Overall Study||10||
48333496|NCT04391959|101145483|FG000|NOT COMPLETED|Overall Study||1||
48333497|NCT04391959|101145484|FG001|NOT COMPLETED|Overall Study||5||
48333498|NCT01500057|101145485|FG000|STARTED|Overall Study||31||
48333499|NCT01500057|101145486|FG001|STARTED|Overall Study||35||
48333500|NCT01500057|101145485|FG000|COMPLETED|Overall Study||25||
48333501|NCT01500057|101145486|FG001|COMPLETED|Overall Study||31||
48333502|NCT01500057|101145485|FG000|NOT COMPLETED|Overall Study||6||
48333503|NCT01500057|101145486|FG001|NOT COMPLETED|Overall Study||4||
48627396|NCT03712280|101871044|FG000|STARTED|Overall Study||12|Participants randomized|
48627397|NCT03712280|101871045|FG001|STARTED|Overall Study||12|Participants randomized|
48627398|NCT03712280|101871046|FG002|STARTED|Overall Study||13|Participants randomized|
48627399|NCT03712280|101871047|FG003|STARTED|Overall Study||13|Participants randomized|
48627400|NCT03712280|101871044|FG000|Safety Population|Overall Study||12|All participants randomized and treated|
48627401|NCT03712280|101871045|FG001|Safety Population|Overall Study||11|All participants randomized and treated|
48627402|NCT03712280|101871046|FG002|Safety Population|Overall Study||13|All participants randomized and treated|
48627403|NCT03712280|101871047|FG003|Safety Population|Overall Study||12|All participants randomized and treated|
48333504|NCT01870739|101145487|FG000|STARTED|Single Drug Treatment (12 Weeks)||57||
48333505|NCT01870739|101145488|FG001|STARTED|Single Drug Treatment (12 Weeks)||57||
48333506|NCT01870739|101145487|FG000|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||57||
48627404|NCT03712280|101871044|FG000|Modified Intent to Treat Population|Overall Study||12||
48627405|NCT03712280|101871045|FG001|Modified Intent to Treat Population|Overall Study||11||
48627406|NCT03712280|101871046|FG002|Modified Intent to Treat Population|Overall Study||13||
48627407|NCT03712280|101871047|FG003|Modified Intent to Treat Population|Overall Study||12||
48627408|NCT03712280|101871044|FG000|Completed 5 Day Treatment|Overall Study||11||
48627409|NCT03712280|101871045|FG001|Completed 5 Day Treatment|Overall Study||11||
48627410|NCT03712280|101871046|FG002|Completed 5 Day Treatment|Overall Study||12||
48627411|NCT03712280|101871047|FG003|Completed 5 Day Treatment|Overall Study||12||
48627412|NCT03712280|101871044|FG000|COMPLETED|Overall Study||11||
48627413|NCT03712280|101871045|FG001|COMPLETED|Overall Study||11||
48627414|NCT03712280|101871046|FG002|COMPLETED|Overall Study||12||
48627415|NCT03712280|101871047|FG003|COMPLETED|Overall Study||12||
48627416|NCT03712280|101871044|FG000|NOT COMPLETED|Overall Study||1||
48627417|NCT03712280|101871045|FG001|NOT COMPLETED|Overall Study||1||
48627418|NCT03712280|101871046|FG002|NOT COMPLETED|Overall Study||1||
48627419|NCT03712280|101871047|FG003|NOT COMPLETED|Overall Study||1||
48627420|NCT02666222|101871048|FG000|STARTED|Overall Study||51||
48627421|NCT02666222|101871048|FG000|COMPLETED|Overall Study||49||
48627422|NCT02666222|101871048|FG000|NOT COMPLETED|Overall Study||2||
48627423|NCT04161391|101871049|FG000|STARTED|Overall Study||4||
48627424|NCT04161391|101871050|FG001|STARTED|Overall Study||4||
48627425|NCT04161391|101871051|FG002|STARTED|Overall Study||4||
48627426|NCT04161391|101871052|FG003|STARTED|Overall Study||8||
48627427|NCT04161391|101871053|FG004|STARTED|Overall Study||3||
48627428|NCT04161391|101871054|FG005|STARTED|Overall Study||3||
48627429|NCT04161391|101871055|FG006|STARTED|Overall Study||7||
48627430|NCT04161391|101871056|FG007|STARTED|Overall Study||6||
48627431|NCT04161391|101871057|FG008|STARTED|Overall Study||2||
48627432|NCT04161391|101871049|FG000|COMPLETED|Overall Study||0||
48627433|NCT04161391|101871050|FG001|COMPLETED|Overall Study||0||
48627434|NCT04161391|101871051|FG002|COMPLETED|Overall Study||0||
48627435|NCT04161391|101871052|FG003|COMPLETED|Overall Study||0||
48627436|NCT04161391|101871053|FG004|COMPLETED|Overall Study||0||
48627437|NCT04161391|101871054|FG005|COMPLETED|Overall Study||0||
48627438|NCT04161391|101871055|FG006|COMPLETED|Overall Study||0||
48627439|NCT04161391|101871056|FG007|COMPLETED|Overall Study||0||
48627440|NCT04161391|101871057|FG008|COMPLETED|Overall Study||0||
48627441|NCT04161391|101871049|FG000|NOT COMPLETED|Overall Study||4||
48627442|NCT04161391|101871050|FG001|NOT COMPLETED|Overall Study||4||
48627443|NCT04161391|101871051|FG002|NOT COMPLETED|Overall Study||4||
48627444|NCT04161391|101871052|FG003|NOT COMPLETED|Overall Study||8||
48627445|NCT04161391|101871053|FG004|NOT COMPLETED|Overall Study||3||
48627446|NCT04161391|101871054|FG005|NOT COMPLETED|Overall Study||3||
48627447|NCT04161391|101871055|FG006|NOT COMPLETED|Overall Study||7||
48627448|NCT04161391|101871056|FG007|NOT COMPLETED|Overall Study||6||
48627449|NCT04161391|101871057|FG008|NOT COMPLETED|Overall Study||2||
48627450|NCT00492297|101871058|FG000|STARTED|Treatment||83||
48627451|NCT00492297|101871058|FG000|First Stage of Simon Optimal Design|Treatment||32||
48750618|NCT03050801|102177251|FG003|STARTED|Experiment 1||0||
48333507|NCT01870739|101145488|FG001|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||56||
48333508|NCT01870739|101145487|FG000|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||57||
48333509|NCT01870739|101145488|FG001|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||56||
48333510|NCT01870739|101145487|FG000|COMPLETED|Single Drug Treatment (12 Weeks)||54||
48333511|NCT01870739|101145488|FG001|COMPLETED|Single Drug Treatment (12 Weeks)||53||
48333512|NCT01870739|101145487|FG000|NOT COMPLETED|Single Drug Treatment (12 Weeks)||3||
48627452|NCT00492297|101871058|FG000|Second Stage of Simon Optimal Design|Treatment||51||
48627453|NCT00492297|101871058|FG000|COMPLETED|Treatment||78||
48333513|NCT01870739|101145488|FG001|NOT COMPLETED|Single Drug Treatment (12 Weeks)||4||
48333514|NCT01870739|101145487|FG000|STARTED|Add-on Period (40 Weeks)||54||
48333515|NCT01870739|101145488|FG001|STARTED|Add-on Period (40 Weeks)||53||
48333516|NCT01870739|101145487|FG000|COMPLETED|Add-on Period (40 Weeks)||51||
48333517|NCT01870739|101145488|FG001|COMPLETED|Add-on Period (40 Weeks)||51||
48333518|NCT01870739|101145487|FG000|NOT COMPLETED|Add-on Period (40 Weeks)||3||
48333519|NCT01870739|101145488|FG001|NOT COMPLETED|Add-on Period (40 Weeks)||2||
48627454|NCT00492297|101871058|FG000|NOT COMPLETED|Treatment||5||
48627455|NCT00492297|101871058|FG000|STARTED|Active Follow-up 30(+4) Days Duration||78||
48627456|NCT00492297|101871058|FG000|COMPLETED|Active Follow-up 30(+4) Days Duration||59||
48627457|NCT00492297|101871058|FG000|NOT COMPLETED|Active Follow-up 30(+4) Days Duration||19||
48627458|NCT00492297|101871058|FG000|STARTED|Survival Only Follow-up||59||
48627459|NCT00492297|101871058|FG000|COMPLETED|Survival Only Follow-up||0||
48333520|NCT01943565|101145489|FG000|STARTED|Overall Study||11||
48333521|NCT01943565|101145490|FG001|STARTED|Overall Study||9||
48411637|NCT00846027|101341804|FG000|STARTED|Overall Study||90||
48627460|NCT00492297|101871058|FG000|NOT COMPLETED|Survival Only Follow-up||59||
48627461|NCT01483118|101871059|FG000|STARTED|Overall Study||23||
48627462|NCT01483118|101871060|FG001|STARTED|Overall Study||22||
48627463|NCT01483118|101871059|FG000|Completed 3 Months|Overall Study||15||
48627464|NCT01483118|101871060|FG001|Completed 3 Months|Overall Study||11||
48627465|NCT01483118|101871059|FG000|COMPLETED|Overall Study||11|(entire 6 months)|
48627466|NCT01483118|101871060|FG001|COMPLETED|Overall Study||6|(entire 6 months)|
48333522|NCT01943565|101145491|FG002|STARTED|Overall Study||9||
48333523|NCT01943565|101145489|FG000|COMPLETED|Overall Study||11||
48333524|NCT01943565|101145490|FG001|COMPLETED|Overall Study||9||
48333525|NCT01943565|101145491|FG002|COMPLETED|Overall Study||9||
48333526|NCT01943565|101145489|FG000|NOT COMPLETED|Overall Study||0||
48333527|NCT01943565|101145490|FG001|NOT COMPLETED|Overall Study||0||
48333528|NCT01943565|101145491|FG002|NOT COMPLETED|Overall Study||0||
48333529|NCT00494143|101145492|FG000|STARTED|Overall Study||1||
48750619|NCT03050801|102177252|FG004|STARTED|Experiment 1||0||
48750620|NCT03050801|102177253|FG005|STARTED|Experiment 1||0||
48750621|NCT03050801|102177248|FG000|COMPLETED|Experiment 1||3||
48750622|NCT03050801|102177249|FG001|COMPLETED|Experiment 1||6||
48750623|NCT03050801|102177250|FG002|COMPLETED|Experiment 1||6||
48750624|NCT03050801|102177251|FG003|COMPLETED|Experiment 1||0||
48750625|NCT03050801|102177252|FG004|COMPLETED|Experiment 1||0||
48750626|NCT03050801|102177253|FG005|COMPLETED|Experiment 1||0||
48750627|NCT03050801|102177248|FG000|NOT COMPLETED|Experiment 1||0||
48750628|NCT03050801|102177249|FG001|NOT COMPLETED|Experiment 1||7||
48750629|NCT03050801|102177250|FG002|NOT COMPLETED|Experiment 1||2||
48750630|NCT03050801|102177251|FG003|NOT COMPLETED|Experiment 1||0||
48750631|NCT03050801|102177252|FG004|NOT COMPLETED|Experiment 1||0||
48750632|NCT03050801|102177253|FG005|NOT COMPLETED|Experiment 1||0||
48750633|NCT03050801|102177248|FG000|STARTED|Experiment 2||0||
48750634|NCT03050801|102177249|FG001|STARTED|Experiment 2||0||
48750635|NCT03050801|102177250|FG002|STARTED|Experiment 2||0||
48750636|NCT03050801|102177251|FG003|STARTED|Experiment 2||21||
48750637|NCT03050801|102177252|FG004|STARTED|Experiment 2||19||
48750638|NCT03050801|102177253|FG005|STARTED|Experiment 2||4||
48750639|NCT03050801|102177248|FG000|COMPLETED|Experiment 2||0||
48750640|NCT03050801|102177249|FG001|COMPLETED|Experiment 2||0||
48750641|NCT03050801|102177250|FG002|COMPLETED|Experiment 2||0||
48750642|NCT03050801|102177251|FG003|COMPLETED|Experiment 2||15||
48750643|NCT03050801|102177252|FG004|COMPLETED|Experiment 2||15||
48750644|NCT03050801|102177253|FG005|COMPLETED|Experiment 2||2||
48750645|NCT03050801|102177248|FG000|NOT COMPLETED|Experiment 2||0||
48750646|NCT03050801|102177249|FG001|NOT COMPLETED|Experiment 2||0||
48750647|NCT03050801|102177250|FG002|NOT COMPLETED|Experiment 2||0||
48750648|NCT03050801|102177251|FG003|NOT COMPLETED|Experiment 2||6||
48750649|NCT03050801|102177252|FG004|NOT COMPLETED|Experiment 2||4||
48750650|NCT03050801|102177253|FG005|NOT COMPLETED|Experiment 2||2||
48750651|NCT02744092|102177254|FG000|STARTED|Enrolled & Received Selected Treatment||335||
48750652|NCT02744092|102177255|FG001|STARTED|Enrolled & Received Selected Treatment||336||
48750653|NCT02744092|102177256|FG002|STARTED|Enrolled & Received Selected Treatment||108||
48750654|NCT02744092|102177257|FG003|STARTED|Enrolled & Received Selected Treatment||32||
48750655|NCT02744092|102177254|FG000|Received Assigned Treatment (Apixaban)|Enrolled & Received Selected Treatment||193||
48750656|NCT02744092|102177255|FG001|Received Assigned Treatment (Apixaban)|Enrolled & Received Selected Treatment||0||
48750657|NCT02744092|102177256|FG002|Received Assigned Treatment (Apixaban)|Enrolled & Received Selected Treatment||57||
48750658|NCT02744092|102177257|FG003|Received Assigned Treatment (Apixaban)|Enrolled & Received Selected Treatment||0||
48750659|NCT02744092|102177254|FG000|Received Assigned Treatment (Rivaroxaban)|Enrolled & Received Selected Treatment||122||
48750660|NCT02744092|102177255|FG001|Received Assigned Treatment (Rivaroxaban)|Enrolled & Received Selected Treatment||0||
48750661|NCT02744092|102177256|FG002|Received Assigned Treatment (Rivaroxaban)|Enrolled & Received Selected Treatment||48||
48750662|NCT02744092|102177257|FG003|Received Assigned Treatment (Rivaroxaban)|Enrolled & Received Selected Treatment||0||
48750663|NCT02744092|102177254|FG000|Received Assigned Treatment (Dabigatran)|Enrolled & Received Selected Treatment||9||
48333530|NCT00494143|101145493|FG001|STARTED|Overall Study||2||
48333531|NCT00494143|101145494|FG002|STARTED|Overall Study||3||
48333532|NCT00494143|101145495|FG003|STARTED|Overall Study||0||
48333533|NCT00494143|101145496|FG004|STARTED|Overall Study||1||
48333534|NCT00494143|101145497|FG005|STARTED|Overall Study||0||
48750664|NCT02744092|102177255|FG001|Received Assigned Treatment (Dabigatran)|Enrolled & Received Selected Treatment||0||
48333535|NCT00494143|101145492|FG000|COMPLETED|Overall Study||1||
48333536|NCT00494143|101145493|FG001|COMPLETED|Overall Study||2||
48333537|NCT00494143|101145494|FG002|COMPLETED|Overall Study||3||
48333538|NCT00494143|101145495|FG003|COMPLETED|Overall Study||0||
48333539|NCT00494143|101145496|FG004|COMPLETED|Overall Study||1||
48333540|NCT00494143|101145497|FG005|COMPLETED|Overall Study||0||
48627467|NCT01483118|101871059|FG000|NOT COMPLETED|Overall Study||12||
48627468|NCT01483118|101871060|FG001|NOT COMPLETED|Overall Study||16||
48627469|NCT02984982|101871061|FG000|STARTED|Overall Study||102||
48627470|NCT02984982|101871062|FG001|STARTED|Overall Study||104||
48627471|NCT02984982|101871061|FG000|Treated|Overall Study||102||
48627472|NCT02984982|101871062|FG001|Treated|Overall Study||103||
48627473|NCT02984982|101871061|FG000|COMPLETED|Overall Study||94||
48627474|NCT02984982|101871062|FG001|COMPLETED|Overall Study||94||
48627475|NCT02984982|101871061|FG000|NOT COMPLETED|Overall Study||8||
48627476|NCT02984982|101871062|FG001|NOT COMPLETED|Overall Study||10||
48627477|NCT01674725|101871063|FG000|STARTED|Overall Study||92||
48627478|NCT01674725|101871064|FG001|STARTED|Overall Study||95||
48627479|NCT01674725|101871063|FG000|COMPLETED|Overall Study||89||
48627480|NCT01674725|101871064|FG001|COMPLETED|Overall Study||94||
48627481|NCT01674725|101871063|FG000|NOT COMPLETED|Overall Study||3||
48627482|NCT01674725|101871064|FG001|NOT COMPLETED|Overall Study||1||
48627483|NCT01867008|101871065|FG000|STARTED|Overall Study||55||
48627484|NCT01867008|101871065|FG000|COMPLETED|Overall Study||54||
48627485|NCT01867008|101871065|FG000|NOT COMPLETED|Overall Study||1||
48627486|NCT03652818|101871066|FG000|STARTED|Overall Study||24||
48627487|NCT03652818|101871067|FG001|STARTED|Overall Study||23||
48627488|NCT03652818|101871068|FG002|STARTED|Overall Study||22||
48627489|NCT03652818|101871069|FG003|STARTED|Overall Study||23||
48627490|NCT03652818|101871070|FG004|STARTED|Overall Study||23||
48627491|NCT03652818|101871066|FG000|COMPLETED|Overall Study||22||
48627492|NCT03652818|101871067|FG001|COMPLETED|Overall Study||22||
48627493|NCT03652818|101871068|FG002|COMPLETED|Overall Study||20||
48627494|NCT03652818|101871069|FG003|COMPLETED|Overall Study||22||
48627495|NCT03652818|101871070|FG004|COMPLETED|Overall Study||22||
48627496|NCT03652818|101871066|FG000|NOT COMPLETED|Overall Study||2||
48627497|NCT03652818|101871067|FG001|NOT COMPLETED|Overall Study||1||
48627498|NCT03652818|101871068|FG002|NOT COMPLETED|Overall Study||2||
48627499|NCT03652818|101871069|FG003|NOT COMPLETED|Overall Study||1||
48627500|NCT03652818|101871070|FG004|NOT COMPLETED|Overall Study||1||
48627501|NCT01928771|101871071|FG000|STARTED|Overall Study||400||
48627502|NCT01928771|101871072|FG001|STARTED|Overall Study||398||
48627503|NCT01928771|101871073|FG002|STARTED|Overall Study||407||
48627504|NCT01928771|101871071|FG000|Received Treatment|Overall Study||399||
48627505|NCT01928771|101871072|FG001|Received Treatment|Overall Study||398||
48627506|NCT01928771|101871073|FG002|Received Treatment|Overall Study||407||
48627507|NCT01928771|101871071|FG000|COMPLETED|Overall Study||354||
48627508|NCT01928771|101871072|FG001|COMPLETED|Overall Study||358||
48627509|NCT01928771|101871073|FG002|COMPLETED|Overall Study||367||
48627510|NCT01928771|101871071|FG000|NOT COMPLETED|Overall Study||46||
48627511|NCT01928771|101871072|FG001|NOT COMPLETED|Overall Study||40||
48627512|NCT01928771|101871073|FG002|NOT COMPLETED|Overall Study||40||
48627513|NCT01232283|101871074|FG000|STARTED|Placebo Controlled Phase (Weeks 0-16)||275||
48627514|NCT01232283|101871075|FG001|STARTED|Placebo Controlled Phase (Weeks 0-16)||138||
48627515|NCT01232283|101871076|FG002|STARTED|Placebo Controlled Phase (Weeks 0-16)||0||
48627516|NCT01232283|101871077|FG003|STARTED|Placebo Controlled Phase (Weeks 0-16)||0||
48627517|NCT01232283|101871078|FG004|STARTED|Placebo Controlled Phase (Weeks 0-16)||0||
48627518|NCT01232283|101871079|FG005|STARTED|Placebo Controlled Phase (Weeks 0-16)||0||
48627519|NCT01232283|101871080|FG006|STARTED|Placebo Controlled Phase (Weeks 0-16)||0||
48627520|NCT01232283|101871081|FG007|STARTED|Placebo Controlled Phase (Weeks 0-16)||0||
48627521|NCT01232283|101871082|FG008|STARTED|Placebo Controlled Phase (Weeks 0-16)||0||
48627522|NCT01232283|101871083|FG009|STARTED|Placebo Controlled Phase (Weeks 0-16)||0||
48627523|NCT01232283|101871074|FG000|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||272||
48627524|NCT01232283|101871075|FG001|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||136||
48627525|NCT01232283|101871076|FG002|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0||
48627526|NCT01232283|101871077|FG003|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0||
48627527|NCT01232283|101871078|FG004|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0||
48627528|NCT01232283|101871079|FG005|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0||
48627529|NCT01232283|101871080|FG006|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0||
48627530|NCT01232283|101871081|FG007|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0||
48627531|NCT01232283|101871082|FG008|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0||
48627532|NCT01232283|101871083|FG009|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0||
48627533|NCT01232283|101871074|FG000|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||239||
48627534|NCT01232283|101871075|FG001|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||112||
48627535|NCT01232283|101871076|FG002|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0||
48627536|NCT01232283|101871077|FG003|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0||
48627537|NCT01232283|101871078|FG004|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0||
48627538|NCT01232283|101871079|FG005|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0||
48627539|NCT01232283|101871080|FG006|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0||
48627540|NCT01232283|101871081|FG007|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0||
48627541|NCT01232283|101871082|FG008|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0||
48627542|NCT01232283|101871083|FG009|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0||
48627543|NCT01232283|101871074|FG000|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||36||
48656965|NCT01340170|101943735|FG001|NOT COMPLETED|Overall Study||7||8
48627544|NCT01232283|101871075|FG001|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||26||
48627545|NCT01232283|101871076|FG002|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0||
48627546|NCT01232283|101871077|FG003|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0||
48627547|NCT01232283|101871078|FG004|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0||
48627548|NCT01232283|101871079|FG005|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0||
48750665|NCT02744092|102177256|FG002|Received Assigned Treatment (Dabigatran)|Enrolled & Received Selected Treatment||2||
48750666|NCT02744092|102177257|FG003|Received Assigned Treatment (Dabigatran)|Enrolled & Received Selected Treatment||0||
48750667|NCT02744092|102177254|FG000|Received Assigned Treatment (Edoxaban)|Enrolled & Received Selected Treatment||6||
48170640|NCT01709305|100739389|FG000|NOT COMPLETED|Phase 2||0||
48170641|NCT01709305|100739390|FG001|NOT COMPLETED|Phase 2||52||
48170642|NCT01709305|100739391|FG002|NOT COMPLETED|Phase 2||45||
48170643|NCT01709305|100739392|FG003|NOT COMPLETED|Phase 2||48||
48170644|NCT01709305|100739393|FG004|NOT COMPLETED|Phase 2||47||
48170645|NCT02960763|100739394|FG000|STARTED|Step 1||211||
48170646|NCT02960763|100739395|FG001|STARTED|Step 1||206||
48750668|NCT02744092|102177255|FG001|Received Assigned Treatment (Edoxaban)|Enrolled & Received Selected Treatment||0||
48750669|NCT02744092|102177256|FG002|Received Assigned Treatment (Edoxaban)|Enrolled & Received Selected Treatment||0||
48750670|NCT02744092|102177257|FG003|Received Assigned Treatment (Edoxaban)|Enrolled & Received Selected Treatment||0||
48170647|NCT02960763|100739396|FG002|STARTED|Step 1||202||
48170648|NCT02960763|100739397|FG003|STARTED|Step 1||0||
48170649|NCT02960763|100739398|FG004|STARTED|Step 1||0||
48170650|NCT02960763|100739394|FG000|COMPLETED|Step 1||192|"Step 1 only includes: Aripiprazole Augmentation Bupropion Augmentation Switch to Bupropion"|
48170651|NCT02960763|100739395|FG001|COMPLETED|Step 1||188|"Step 1 only includes: Aripiprazole Augmentation Bupropion Augmentation Switch to Bupropion"|
48170652|NCT02960763|100739396|FG002|COMPLETED|Step 1||174|"Step 1 only includes: Aripiprazole Augmentation Bupropion Augmentation Switch to Bupropion"|
48170653|NCT02960763|100739397|FG003|COMPLETED|Step 1||0|"Step 1 only includes: Aripiprazole Augmentation Bupropion Augmentation Switch to Bupropion"|
48170654|NCT02960763|100739398|FG004|COMPLETED|Step 1||0|"Step 1 only includes: Aripiprazole Augmentation Bupropion Augmentation Switch to Bupropion"|
48170655|NCT02960763|100739394|FG000|NOT COMPLETED|Step 1||19||
48170656|NCT02960763|100739395|FG001|NOT COMPLETED|Step 1||18||
48170657|NCT02960763|100739396|FG002|NOT COMPLETED|Step 1||28||
48170658|NCT02960763|100739397|FG003|NOT COMPLETED|Step 1||0||
48170659|NCT02960763|100739398|FG004|NOT COMPLETED|Step 1||0||
48170660|NCT02960763|100739394|FG000|STARTED|Step 2||0||
48170661|NCT02960763|100739395|FG001|STARTED|Step 2||0||
48170662|NCT02960763|100739396|FG002|STARTED|Step 2||0||
48170663|NCT02960763|100739397|FG003|STARTED|Step 2||127||
48170664|NCT02960763|100739398|FG004|STARTED|Step 2||121||
48170665|NCT02960763|100739394|FG000|People Who Participated in Step 1 and Continued to Participate in Step 2|Step 2||43||
48170666|NCT02960763|100739395|FG001|People Who Participated in Step 1 and Continued to Participate in Step 2|Step 2||44||
48170667|NCT02960763|100739396|FG002|People Who Participated in Step 1 and Continued to Participate in Step 2|Step 2||38||
48170668|NCT02960763|100739397|FG003|People Who Participated in Step 1 and Continued to Participate in Step 2|Step 2||0||
48170669|NCT02960763|100739398|FG004|People Who Participated in Step 1 and Continued to Participate in Step 2|Step 2||0||
48170670|NCT02960763|100739394|FG000|People Who Began Step 2 Without Having Participated in Step 1|Step 2||0||
48170671|NCT02960763|100739395|FG001|People Who Began Step 2 Without Having Participated in Step 1|Step 2||0||
48170672|NCT02960763|100739396|FG002|People Who Began Step 2 Without Having Participated in Step 1|Step 2||0||
48170673|NCT02960763|100739397|FG003|People Who Began Step 2 Without Having Participated in Step 1|Step 2||63||
48170674|NCT02960763|100739398|FG004|People Who Began Step 2 Without Having Participated in Step 1|Step 2||60||
48170675|NCT02960763|100739394|FG000|COMPLETED|Step 2||0|"Step 2 only includes: Lithium Augmentation Switch to Nortriptyline"|
48170676|NCT02960763|100739395|FG001|COMPLETED|Step 2||0|"Step 2 only includes: Lithium Augmentation Switch to Nortriptyline"|
48170677|NCT02960763|100739396|FG002|COMPLETED|Step 2||0|"Step 2 only includes: Lithium Augmentation Switch to Nortriptyline"|
48170678|NCT02960763|100739397|FG003|COMPLETED|Step 2||116|"Step 2 only includes: Lithium Augmentation Switch to Nortriptyline"|
48170679|NCT02960763|100739398|FG004|COMPLETED|Step 2||116|"Step 2 only includes: Lithium Augmentation Switch to Nortriptyline"|
48170680|NCT02960763|100739394|FG000|NOT COMPLETED|Step 2||0||
48170681|NCT02960763|100739395|FG001|NOT COMPLETED|Step 2||0||
48170682|NCT02960763|100739396|FG002|NOT COMPLETED|Step 2||0||
48170683|NCT02960763|100739397|FG003|NOT COMPLETED|Step 2||11||
48170684|NCT02960763|100739398|FG004|NOT COMPLETED|Step 2||5||
48411638|NCT00846027|101341804|FG000|Received Treatment|Overall Study||83||
48627549|NCT01232283|101871080|FG006|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0||
48627550|NCT01232283|101871081|FG007|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0||
48750671|NCT02744092|102177254|FG000|Received Assigned Treatment (Enoxaparin)|Enrolled & Received Selected Treatment||0||
48750672|NCT02744092|102177255|FG001|Received Assigned Treatment (Enoxaparin)|Enrolled & Received Selected Treatment||277||
48767719|NCT00494676|102222812|FG000|STARTED|Allocation||37||
48333541|NCT00494143|101145492|FG000|NOT COMPLETED|Overall Study||0||
48333542|NCT00494143|101145493|FG001|NOT COMPLETED|Overall Study||0||
48333543|NCT00494143|101145494|FG002|NOT COMPLETED|Overall Study||0||
48333544|NCT00494143|101145495|FG003|NOT COMPLETED|Overall Study||0||
48333545|NCT00494143|101145496|FG004|NOT COMPLETED|Overall Study||0||
48333546|NCT00494143|101145497|FG005|NOT COMPLETED|Overall Study||0||
48333547|NCT03104725|101145498|FG000|STARTED|Overall Study||2||
48333548|NCT03104725|101145499|FG001|STARTED|Overall Study||4||
48333549|NCT03104725|101145498|FG000|COMPLETED|Overall Study||2||
48333550|NCT03104725|101145499|FG001|COMPLETED|Overall Study||4||
48333551|NCT03104725|101145498|FG000|NOT COMPLETED|Overall Study||0||
48333552|NCT03104725|101145499|FG001|NOT COMPLETED|Overall Study||0||
48333553|NCT01390259|101145500|FG000|STARTED|Overall Study||5||
48333554|NCT01390259|101145501|FG001|STARTED|Overall Study||6||
48333555|NCT01390259|101145500|FG000|COMPLETED|Overall Study||5||
48333556|NCT01390259|101145501|FG001|COMPLETED|Overall Study||6||
48333557|NCT01390259|101145500|FG000|NOT COMPLETED|Overall Study||0||
48333558|NCT01390259|101145501|FG001|NOT COMPLETED|Overall Study||0||
48333559|NCT02721355|101145502|FG000|STARTED|Overall Study||42||
48333560|NCT02721355|101145503|FG001|STARTED|Overall Study||42||
48333561|NCT02721355|101145502|FG000|COMPLETED|Overall Study||36||
48333562|NCT02721355|101145503|FG001|COMPLETED|Overall Study||41||
48333563|NCT02721355|101145502|FG000|NOT COMPLETED|Overall Study||6||
48333564|NCT02721355|101145503|FG001|NOT COMPLETED|Overall Study||1||
48333565|NCT00772629|101145504|FG000|STARTED|Overall Study||17||
48333566|NCT00772629|101145505|FG001|STARTED|Overall Study||1||
48333567|NCT00772629|101145504|FG000|COMPLETED|Overall Study||16||
48333568|NCT00772629|101145505|FG001|COMPLETED|Overall Study||1||
48333569|NCT00772629|101145504|FG000|NOT COMPLETED|Overall Study||1||
48333570|NCT00772629|101145505|FG001|NOT COMPLETED|Overall Study||0||
48333571|NCT00477165|101145506|FG000|STARTED|Overall Study||27||
48333572|NCT00477165|101145507|FG001|STARTED|Overall Study||27||
48333573|NCT00477165|101145506|FG000|COMPLETED|Overall Study||20||
48333574|NCT00477165|101145507|FG001|COMPLETED|Overall Study||25||
48333575|NCT00477165|101145506|FG000|NOT COMPLETED|Overall Study||7||
48333576|NCT00477165|101145507|FG001|NOT COMPLETED|Overall Study||2||
48333577|NCT02486757|101145508|FG000|STARTED|Overall Study||6||
48333578|NCT02486757|101145508|FG000|COMPLETED|Overall Study||5||
48333579|NCT02486757|101145508|FG000|NOT COMPLETED|Overall Study||1||
48333580|NCT00559507|101145509|FG000|STARTED|Overall Study||12||
48333581|NCT00559507|101145509|FG000|COMPLETED|Overall Study||9||
48333582|NCT00559507|101145509|FG000|NOT COMPLETED|Overall Study||3||
48333583|NCT02810964|101145510|FG000|STARTED|Placebo Run-In Phase (2 Weeks)||32||
48627551|NCT01232283|101871082|FG008|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0||
48627552|NCT01232283|101871083|FG009|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0||
48627553|NCT01232283|101871074|FG000|STARTED|Maintenance Phase (Weeks16-32)||0||
48627554|NCT01232283|101871075|FG001|STARTED|Maintenance Phase (Weeks16-32)||0||
48627555|NCT01232283|101871076|FG002|STARTED|Maintenance Phase (Weeks16-32)||234||
48333584|NCT02810964|101145511|FG001|STARTED|Placebo Run-In Phase (2 Weeks)||32||
48333585|NCT02810964|101145510|FG000|COMPLETED|Placebo Run-In Phase (2 Weeks)||32||
48333586|NCT02810964|101145511|FG001|COMPLETED|Placebo Run-In Phase (2 Weeks)||32||
48333587|NCT02810964|101145510|FG000|NOT COMPLETED|Placebo Run-In Phase (2 Weeks)||0||
48333588|NCT02810964|101145511|FG001|NOT COMPLETED|Placebo Run-In Phase (2 Weeks)||0||
48333589|NCT02810964|101145510|FG000|STARTED|Double-Blind Treatment Phase (16 Weeks)||32||
48333590|NCT02810964|101145511|FG001|STARTED|Double-Blind Treatment Phase (16 Weeks)||32||
48333591|NCT02810964|101145510|FG000|COMPLETED|Double-Blind Treatment Phase (16 Weeks)||29||
48333592|NCT02810964|101145511|FG001|COMPLETED|Double-Blind Treatment Phase (16 Weeks)||29||
48627556|NCT01232283|101871077|FG003|STARTED|Maintenance Phase (Weeks16-32)||108||
48627557|NCT01232283|101871078|FG004|STARTED|Maintenance Phase (Weeks16-32)||0||
48767720|NCT00494676|102222813|FG001|STARTED|Allocation||36||
48333593|NCT02810964|101145510|FG000|NOT COMPLETED|Double-Blind Treatment Phase (16 Weeks)||3||
48627558|NCT01232283|101871079|FG005|STARTED|Maintenance Phase (Weeks16-32)||0||
48627559|NCT01232283|101871080|FG006|STARTED|Maintenance Phase (Weeks16-32)||0||
48627560|NCT01232283|101871081|FG007|STARTED|Maintenance Phase (Weeks16-32)||0||
48333594|NCT02810964|101145511|FG001|NOT COMPLETED|Double-Blind Treatment Phase (16 Weeks)||3||
48333595|NCT01243320|101145512|FG000|STARTED|10ppm Oral Silver (3 Days)||36||
48333596|NCT01243320|101145512|FG000|COMPLETED|10ppm Oral Silver (3 Days)||36||
48333597|NCT01243320|101145512|FG000|NOT COMPLETED|10ppm Oral Silver (3 Days)||0||
48333598|NCT01243320|101145512|FG000|STARTED|10ppm Oral Silver (7 Days)||36||
48333599|NCT01243320|101145512|FG000|COMPLETED|10ppm Oral Silver (7 Days)||36||
48333600|NCT01243320|101145512|FG000|NOT COMPLETED|10ppm Oral Silver (7 Days)||0||
48333601|NCT01243320|101145512|FG000|STARTED|10ppm Oral Silver (14 Days)||36||
48627561|NCT01232283|101871082|FG008|STARTED|Maintenance Phase (Weeks16-32)||0||
48627562|NCT01232283|101871083|FG009|STARTED|Maintenance Phase (Weeks16-32)||0||
48627563|NCT01232283|101871074|FG000|COMPLETED|Maintenance Phase (Weeks16-32)||0||
48627564|NCT01232283|101871075|FG001|COMPLETED|Maintenance Phase (Weeks16-32)||0||
48627565|NCT01232283|101871076|FG002|COMPLETED|Maintenance Phase (Weeks16-32)||194||
48627566|NCT01232283|101871077|FG003|COMPLETED|Maintenance Phase (Weeks16-32)||100||
48627567|NCT01232283|101871078|FG004|COMPLETED|Maintenance Phase (Weeks16-32)||0||
48750673|NCT02744092|102177256|FG002|Received Assigned Treatment (Enoxaparin)|Enrolled & Received Selected Treatment||0||
48750674|NCT02744092|102177257|FG003|Received Assigned Treatment (Enoxaparin)|Enrolled & Received Selected Treatment||24||
48750675|NCT02744092|102177254|FG000|Received Assigned Treatment (Fondaparinux)|Enrolled & Received Selected Treatment||0||
48750676|NCT02744092|102177255|FG001|Received Assigned Treatment (Fondaparinux)|Enrolled & Received Selected Treatment||23||
48750677|NCT02744092|102177256|FG002|Received Assigned Treatment (Fondaparinux)|Enrolled & Received Selected Treatment||0||
48750678|NCT02744092|102177257|FG003|Received Assigned Treatment (Fondaparinux)|Enrolled & Received Selected Treatment||6||
48750679|NCT02744092|102177254|FG000|Received Assigned Treatment (Dalteparin)|Enrolled & Received Selected Treatment||0||
48750680|NCT02744092|102177255|FG001|Received Assigned Treatment (Dalteparin)|Enrolled & Received Selected Treatment||8||
48750681|NCT02744092|102177256|FG002|Received Assigned Treatment (Dalteparin)|Enrolled & Received Selected Treatment||0||
48750682|NCT02744092|102177257|FG003|Received Assigned Treatment (Dalteparin)|Enrolled & Received Selected Treatment||0||
48750683|NCT02744092|102177254|FG000|Did Not Receive Assigned/Selected Treatment|Enrolled & Received Selected Treatment||5||
48750684|NCT02744092|102177255|FG001|Did Not Receive Assigned/Selected Treatment|Enrolled & Received Selected Treatment||28||
48750685|NCT02744092|102177256|FG002|Did Not Receive Assigned/Selected Treatment|Enrolled & Received Selected Treatment||1||
48750686|NCT02744092|102177257|FG003|Did Not Receive Assigned/Selected Treatment|Enrolled & Received Selected Treatment||2||
48750687|NCT02744092|102177254|FG000|COMPLETED|Enrolled & Received Selected Treatment||330||
48750688|NCT02744092|102177255|FG001|COMPLETED|Enrolled & Received Selected Treatment||308||
48750689|NCT02744092|102177256|FG002|COMPLETED|Enrolled & Received Selected Treatment||107||
48333602|NCT01243320|101145512|FG000|COMPLETED|10ppm Oral Silver (14 Days)||36||
48333603|NCT01243320|101145512|FG000|NOT COMPLETED|10ppm Oral Silver (14 Days)||0||
48333604|NCT01243320|101145512|FG000|STARTED|Washout (3 Days)||36||
48333605|NCT01243320|101145512|FG000|COMPLETED|Washout (3 Days)||36||
48333606|NCT01243320|101145512|FG000|NOT COMPLETED|Washout (3 Days)||0||
48333607|NCT01243320|101145512|FG000|STARTED|32ppm Oral Silver (14 Days)||24||
48333608|NCT01243320|101145512|FG000|COMPLETED|32ppm Oral Silver (14 Days)||24||
48333609|NCT01243320|101145512|FG000|NOT COMPLETED|32ppm Oral Silver (14 Days)||0||
48333610|NCT00466310|101145513|FG000|STARTED|Overall Study||20||
48627568|NCT01232283|101871079|FG005|COMPLETED|Maintenance Phase (Weeks16-32)||0||
48627569|NCT01232283|101871080|FG006|COMPLETED|Maintenance Phase (Weeks16-32)||0||
48627570|NCT01232283|101871081|FG007|COMPLETED|Maintenance Phase (Weeks16-32)||0||
48627571|NCT01232283|101871082|FG008|COMPLETED|Maintenance Phase (Weeks16-32)||0||
48627572|NCT01232283|101871083|FG009|COMPLETED|Maintenance Phase (Weeks16-32)||0||
48627573|NCT01232283|101871074|FG000|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0||
48627574|NCT01232283|101871075|FG001|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0||
48627575|NCT01232283|101871076|FG002|NOT COMPLETED|Maintenance Phase (Weeks16-32)||40||
48627576|NCT01232283|101871077|FG003|NOT COMPLETED|Maintenance Phase (Weeks16-32)||8||
48627577|NCT01232283|101871078|FG004|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0||
48627578|NCT01232283|101871079|FG005|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0||
48627579|NCT01232283|101871080|FG006|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0||
48627580|NCT01232283|101871081|FG007|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0||
48627581|NCT01232283|101871082|FG008|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0||
48750690|NCT02744092|102177257|FG003|COMPLETED|Enrolled & Received Selected Treatment||30||
48333611|NCT00466310|101145514|FG001|STARTED|Overall Study||20||
48333612|NCT00466310|101145515|FG002|STARTED|Overall Study||31||
48333613|NCT00466310|101145513|FG000|COMPLETED|Overall Study||20||
48333614|NCT00466310|101145514|FG001|COMPLETED|Overall Study||20||
48333615|NCT00466310|101145515|FG002|COMPLETED|Overall Study||31||
48333616|NCT00466310|101145513|FG000|NOT COMPLETED|Overall Study||0||
48333617|NCT00466310|101145514|FG001|NOT COMPLETED|Overall Study||0||
48333618|NCT00466310|101145515|FG002|NOT COMPLETED|Overall Study||0||
48750691|NCT02744092|102177254|FG000|NOT COMPLETED|Enrolled & Received Selected Treatment||5||
48767721|NCT00494676|102222812|FG000|COMPLETED|Allocation||35||
48333619|NCT02163434|101145516|FG000|STARTED|Overall Study||15||
48333620|NCT02163434|101145517|FG001|STARTED|Overall Study||16||
48333621|NCT02163434|101145516|FG000|COMPLETED|Overall Study||12||
48333622|NCT02163434|101145517|FG001|COMPLETED|Overall Study||9||
48333623|NCT02163434|101145516|FG000|NOT COMPLETED|Overall Study||3||
48333624|NCT02163434|101145517|FG001|NOT COMPLETED|Overall Study||7||
48333625|NCT02574637|101145518|FG000|STARTED|Double-blind Period||5||
48333626|NCT02574637|101145519|FG001|STARTED|Double-blind Period||5||
48333627|NCT02574637|101145520|FG002|STARTED|Double-blind Period||9||
48333628|NCT02574637|101145521|FG003|STARTED|Double-blind Period||7||
48627582|NCT01232283|101871083|FG009|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0||
48627583|NCT01232283|101871074|FG000|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0||
48627584|NCT01232283|101871075|FG001|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0||
48627585|NCT01232283|101871076|FG002|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0||
48627586|NCT01232283|101871077|FG003|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0||
48627587|NCT01232283|101871078|FG004|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||62||
48333629|NCT02574637|101145522|FG004|STARTED|Double-blind Period||3||
48333630|NCT02574637|101145523|FG005|STARTED|Double-blind Period||0||
48750692|NCT02744092|102177255|FG001|NOT COMPLETED|Enrolled & Received Selected Treatment||28||
48750693|NCT02744092|102177256|FG002|NOT COMPLETED|Enrolled & Received Selected Treatment||1||
48750694|NCT02744092|102177257|FG003|NOT COMPLETED|Enrolled & Received Selected Treatment||2||
48750695|NCT02744092|102177254|FG000|STARTED|6-Month Clinical Outcomes(Chart Review)||330||
48411639|NCT00846027|101341804|FG000|COMPLETED|Overall Study||0||
48411640|NCT00846027|101341804|FG000|NOT COMPLETED|Overall Study||90||
48411641|NCT01875874|101341805|FG000|STARTED|Overall Study||8||
48411642|NCT01875874|101341805|FG000|COMPLETED|Overall Study||5||
48411643|NCT01875874|101341805|FG000|NOT COMPLETED|Overall Study||3||
48411644|NCT04315298|101341806|FG000|STARTED|Overall Study||90|Randomized and Treated|
48750696|NCT02744092|102177255|FG001|STARTED|6-Month Clinical Outcomes(Chart Review)||308||
48333631|NCT02574637|101145524|FG006|STARTED|Double-blind Period||0||
48333632|NCT02574637|101145525|FG007|STARTED|Double-blind Period||0||
48333633|NCT02574637|101145526|FG008|STARTED|Double-blind Period||0||
48333634|NCT02574637|101145527|FG009|STARTED|Double-blind Period||0||
48333635|NCT02574637|101145518|FG000|COMPLETED|Double-blind Period||2||
48333636|NCT02574637|101145519|FG001|COMPLETED|Double-blind Period||4||
48333637|NCT02574637|101145520|FG002|COMPLETED|Double-blind Period||2||
48333638|NCT02574637|101145521|FG003|COMPLETED|Double-blind Period||3||
48333639|NCT02574637|101145522|FG004|COMPLETED|Double-blind Period||1||
48333640|NCT02574637|101145523|FG005|COMPLETED|Double-blind Period||0||
48333641|NCT02574637|101145524|FG006|COMPLETED|Double-blind Period||0||
48333642|NCT02574637|101145525|FG007|COMPLETED|Double-blind Period||0||
48333643|NCT02574637|101145526|FG008|COMPLETED|Double-blind Period||0||
48333644|NCT02574637|101145527|FG009|COMPLETED|Double-blind Period||0||
48333645|NCT02574637|101145518|FG000|NOT COMPLETED|Double-blind Period||3||
48333646|NCT02574637|101145519|FG001|NOT COMPLETED|Double-blind Period||1||
48333647|NCT02574637|101145520|FG002|NOT COMPLETED|Double-blind Period||7||
48333648|NCT02574637|101145521|FG003|NOT COMPLETED|Double-blind Period||4||
48333649|NCT02574637|101145522|FG004|NOT COMPLETED|Double-blind Period||2||
48333650|NCT02574637|101145523|FG005|NOT COMPLETED|Double-blind Period||0||
48333651|NCT02574637|101145524|FG006|NOT COMPLETED|Double-blind Period||0||
48333652|NCT02574637|101145525|FG007|NOT COMPLETED|Double-blind Period||0||
48333653|NCT02574637|101145526|FG008|NOT COMPLETED|Double-blind Period||0||
48333654|NCT02574637|101145527|FG009|NOT COMPLETED|Double-blind Period||0||
48333655|NCT02574637|101145518|FG000|STARTED|Open-label (OL) Period||0||
48333656|NCT02574637|101145519|FG001|STARTED|Open-label (OL) Period||0||
48333657|NCT02574637|101145520|FG002|STARTED|Open-label (OL) Period||0||
48333658|NCT02574637|101145521|FG003|STARTED|Open-label (OL) Period||0||
48333659|NCT02574637|101145522|FG004|STARTED|Open-label (OL) Period||0||
48333660|NCT02574637|101145523|FG005|STARTED|Open-label (OL) Period||2||
48333661|NCT02574637|101145524|FG006|STARTED|Open-label (OL) Period||3||
48333662|NCT02574637|101145525|FG007|STARTED|Open-label (OL) Period||2||
48333663|NCT02574637|101145526|FG008|STARTED|Open-label (OL) Period||3||
48333664|NCT02574637|101145527|FG009|STARTED|Open-label (OL) Period||1||
48333665|NCT02574637|101145518|FG000|COMPLETED|Open-label (OL) Period||0||
48333666|NCT02574637|101145519|FG001|COMPLETED|Open-label (OL) Period||0||
48411645|NCT04315298|101341807|FG001|STARTED|Overall Study||187|Randomized and Treated|
48411646|NCT04315298|101341808|FG002|STARTED|Overall Study||180|Randomized and Treated|
48411647|NCT04315298|101341809|FG003|STARTED|Overall Study||170|Randomized and Treated|
48411648|NCT04315298|101341810|FG004|STARTED|Overall Study||242|Randomized and Treated|
48411649|NCT04315298|101341811|FG005|STARTED|Overall Study||338|Randomized and Treated|
48411650|NCT04315298|101341812|FG006|STARTED|Overall Study||70|Randomized and Treated|
48411651|NCT04315298|101341813|FG007|STARTED|Overall Study||140|Randomized and Treated|
48750697|NCT02744092|102177256|FG002|STARTED|6-Month Clinical Outcomes(Chart Review)||107||
48750698|NCT02744092|102177257|FG003|STARTED|6-Month Clinical Outcomes(Chart Review)||30||
48750699|NCT02744092|102177254|FG000|COMPLETED|6-Month Clinical Outcomes(Chart Review)||330||
48750700|NCT02744092|102177255|FG001|COMPLETED|6-Month Clinical Outcomes(Chart Review)||308||
48750701|NCT02744092|102177256|FG002|COMPLETED|6-Month Clinical Outcomes(Chart Review)||107||
48750702|NCT02744092|102177257|FG003|COMPLETED|6-Month Clinical Outcomes(Chart Review)||30||
48750703|NCT02744092|102177254|FG000|NOT COMPLETED|6-Month Clinical Outcomes(Chart Review)||0||
48750704|NCT02744092|102177255|FG001|NOT COMPLETED|6-Month Clinical Outcomes(Chart Review)||0||
48750705|NCT02744092|102177256|FG002|NOT COMPLETED|6-Month Clinical Outcomes(Chart Review)||0||
48750706|NCT02744092|102177257|FG003|NOT COMPLETED|6-Month Clinical Outcomes(Chart Review)||0||
48750707|NCT02744092|102177254|FG000|STARTED|3-Month Patient-Reported Outcomes Survey||330||
48750708|NCT02744092|102177255|FG001|STARTED|3-Month Patient-Reported Outcomes Survey||308||
48750709|NCT02744092|102177256|FG002|STARTED|3-Month Patient-Reported Outcomes Survey||107||
48750710|NCT02744092|102177257|FG003|STARTED|3-Month Patient-Reported Outcomes Survey||30||
48750711|NCT02744092|102177254|FG000|Approached for 3-month Survey|3-Month Patient-Reported Outcomes Survey||295||
48750712|NCT02744092|102177255|FG001|Approached for 3-month Survey|3-Month Patient-Reported Outcomes Survey||280||
48750713|NCT02744092|102177256|FG002|Approached for 3-month Survey|3-Month Patient-Reported Outcomes Survey||99||
48750714|NCT02744092|102177257|FG003|Approached for 3-month Survey|3-Month Patient-Reported Outcomes Survey||26||
48750715|NCT02744092|102177254|FG000|COMPLETED|3-Month Patient-Reported Outcomes Survey||212||
48750716|NCT02744092|102177255|FG001|COMPLETED|3-Month Patient-Reported Outcomes Survey||197||
48750717|NCT02744092|102177256|FG002|COMPLETED|3-Month Patient-Reported Outcomes Survey||77||
48750718|NCT02744092|102177257|FG003|COMPLETED|3-Month Patient-Reported Outcomes Survey||16||
48750719|NCT02744092|102177254|FG000|NOT COMPLETED|3-Month Patient-Reported Outcomes Survey||118||
48750720|NCT02744092|102177255|FG001|NOT COMPLETED|3-Month Patient-Reported Outcomes Survey||111||
48750721|NCT02744092|102177256|FG002|NOT COMPLETED|3-Month Patient-Reported Outcomes Survey||30||
48750722|NCT02744092|102177257|FG003|NOT COMPLETED|3-Month Patient-Reported Outcomes Survey||14||
48750723|NCT02744092|102177254|FG000|STARTED|6-Month Patient-Reported Outcomes Survey||330|All patients were eligible to be included in the 6-month survey, regardless of whether or not they completed the 3-month survey.|
48750724|NCT02744092|102177255|FG001|STARTED|6-Month Patient-Reported Outcomes Survey||308|All patients were eligible to be included in the 6-month survey, regardless of whether or not they completed the 3-month survey.|
48750725|NCT02744092|102177256|FG002|STARTED|6-Month Patient-Reported Outcomes Survey||107|All patients were eligible to be included in the 6-month survey, regardless of whether or not they completed the 3-month survey.|
48750726|NCT02744092|102177257|FG003|STARTED|6-Month Patient-Reported Outcomes Survey||30|All patients were eligible to be included in the 6-month survey, regardless of whether or not they completed the 3-month survey.|
48750727|NCT02744092|102177254|FG000|Approached for 6-month Survey|6-Month Patient-Reported Outcomes Survey||262||
48750728|NCT02744092|102177255|FG001|Approached for 6-month Survey|6-Month Patient-Reported Outcomes Survey||253||
48750729|NCT02744092|102177256|FG002|Approached for 6-month Survey|6-Month Patient-Reported Outcomes Survey||89||
48750730|NCT02744092|102177257|FG003|Approached for 6-month Survey|6-Month Patient-Reported Outcomes Survey||21||
48750731|NCT02744092|102177254|FG000|COMPLETED|6-Month Patient-Reported Outcomes Survey||191||
48750732|NCT02744092|102177255|FG001|COMPLETED|6-Month Patient-Reported Outcomes Survey||177||
48750733|NCT02744092|102177256|FG002|COMPLETED|6-Month Patient-Reported Outcomes Survey||75||
48170685|NCT01566630|100739399|FG000|STARTED|Overall Study||2||
48170686|NCT01566630|100739400|FG001|STARTED|Overall Study||1||
48170687|NCT01566630|100739399|FG000|COMPLETED|Overall Study||2||
48170688|NCT01566630|100739400|FG001|COMPLETED|Overall Study||1||
48750734|NCT02744092|102177257|FG003|COMPLETED|6-Month Patient-Reported Outcomes Survey||12||
48750735|NCT02744092|102177254|FG000|NOT COMPLETED|6-Month Patient-Reported Outcomes Survey||139||
48750736|NCT02744092|102177255|FG001|NOT COMPLETED|6-Month Patient-Reported Outcomes Survey||131||
48750737|NCT02744092|102177256|FG002|NOT COMPLETED|6-Month Patient-Reported Outcomes Survey||32||
48170689|NCT01566630|100739399|FG000|NOT COMPLETED|Overall Study||0||
48170690|NCT01566630|100739400|FG001|NOT COMPLETED|Overall Study||0||
48170691|NCT02887989|100739401|FG000|STARTED|Overall Study||70||
48170692|NCT02887989|100739402|FG001|STARTED|Overall Study||70||
48170693|NCT02887989|100739401|FG000|COMPLETED|Overall Study||61||
48170694|NCT02887989|100739402|FG001|COMPLETED|Overall Study||59||
48170695|NCT02887989|100739401|FG000|NOT COMPLETED|Overall Study||9||
48170696|NCT02887989|100739402|FG001|NOT COMPLETED|Overall Study||11||
48170697|NCT00390455|100739403|FG000|STARTED|Overall Study||148||
48170698|NCT00390455|100739404|FG001|STARTED|Overall Study||147||
48170699|NCT00390455|100739403|FG000|COMPLETED|Overall Study||116||
48170700|NCT00390455|100739404|FG001|COMPLETED|Overall Study||124||
48170701|NCT00390455|100739403|FG000|NOT COMPLETED|Overall Study||32||
48170702|NCT00390455|100739404|FG001|NOT COMPLETED|Overall Study||23||
48170703|NCT01381952|100739405|FG000|STARTED|Overall Study||20||
48170704|NCT01381952|100739405|FG000|Collected Dose and Image Information|Overall Study||20||
48170705|NCT01381952|100739405|FG000|COMPLETED|Overall Study||20||
48170706|NCT01381952|100739405|FG000|NOT COMPLETED|Overall Study||0||
48170707|NCT01588990|100739406|FG000|STARTED|Phase A||128||
48170708|NCT01588990|100739406|FG000|COMPLETED|Phase A||58||
48170709|NCT01588990|100739406|FG000|NOT COMPLETED|Phase A||70||
48170710|NCT01588990|100739406|FG000|STARTED|Phase B||53||
48170711|NCT01588990|100739406|FG000|COMPLETED|Phase B||37||
48170712|NCT01588990|100739406|FG000|NOT COMPLETED|Phase B||16||
48170713|NCT01719224|100739407|FG000|STARTED|Intervention 1: Sleeping Position 1||18||
48170714|NCT01719224|100739408|FG001|STARTED|Intervention 1: Sleeping Position 1||18||
48170715|NCT01719224|100739407|FG000|COMPLETED|Intervention 1: Sleeping Position 1||14||
48170716|NCT01719224|100739408|FG001|COMPLETED|Intervention 1: Sleeping Position 1||16||
48170717|NCT01719224|100739407|FG000|NOT COMPLETED|Intervention 1: Sleeping Position 1||4||
48170718|NCT01719224|100739408|FG001|NOT COMPLETED|Intervention 1: Sleeping Position 1||2||
48170719|NCT01719224|100739407|FG000|STARTED|Intervention 2: Position Change(At 3.5h)||14||
48170720|NCT01719224|100739408|FG001|STARTED|Intervention 2: Position Change(At 3.5h)||16||
48627588|NCT01232283|101871079|FG005|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||61||
48627589|NCT01232283|101871080|FG006|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||58||
48627590|NCT01232283|101871081|FG007|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||96||
48627591|NCT01232283|101871082|FG008|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0||
48627592|NCT01232283|101871083|FG009|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0||
48627593|NCT01232283|101871074|FG000|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0||
48627594|NCT01232283|101871075|FG001|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0||
48627595|NCT01232283|101871076|FG002|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0||
48627596|NCT01232283|101871077|FG003|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0||
48627597|NCT01232283|101871078|FG004|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0||
48627598|NCT01232283|101871079|FG005|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0||
48627599|NCT01232283|101871080|FG006|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||28||
48627600|NCT01232283|101871081|FG007|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||17||
48627601|NCT01232283|101871082|FG008|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0||
48750738|NCT02744092|102177257|FG003|NOT COMPLETED|6-Month Patient-Reported Outcomes Survey||18||
48750739|NCT02859246|102177258|FG000|STARTED|Overall Study||15||
48750740|NCT02859246|102177258|FG000|COMPLETED|Overall Study||10||
48750741|NCT02859246|102177258|FG000|NOT COMPLETED|Overall Study||5||
48750742|NCT04290039|102177259|FG000|STARTED|Period 1 (Visit 1; Day 1)||5||
48750743|NCT04290039|102177260|FG001|STARTED|Period 1 (Visit 1; Day 1)||5||
48750744|NCT04290039|102177261|FG002|STARTED|Period 1 (Visit 1; Day 1)||5||
48170721|NCT01719224|100739407|FG000|COMPLETED|Intervention 2: Position Change(At 3.5h)||14||
48170722|NCT01719224|100739408|FG001|COMPLETED|Intervention 2: Position Change(At 3.5h)||16||
48170723|NCT01719224|100739407|FG000|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0||
48170724|NCT01719224|100739408|FG001|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0||
48170725|NCT01048606|100739409|FG000|STARTED|Overall Study||28||
48170726|NCT01048606|100739410|FG001|STARTED|Overall Study||15||
48170727|NCT01048606|100739411|FG002|STARTED|Overall Study||26||
48170728|NCT01048606|100739412|FG003|STARTED|Overall Study||10||
48170729|NCT01048606|100739409|FG000|COMPLETED|Overall Study||16||
48170730|NCT01048606|100739410|FG001|COMPLETED|Overall Study||8||
48170731|NCT01048606|100739411|FG002|COMPLETED|Overall Study||16||
48170732|NCT01048606|100739412|FG003|COMPLETED|Overall Study||5||
48170733|NCT01048606|100739409|FG000|NOT COMPLETED|Overall Study||12||
48170734|NCT01048606|100739410|FG001|NOT COMPLETED|Overall Study||7||
48170735|NCT01048606|100739411|FG002|NOT COMPLETED|Overall Study||10||
48170736|NCT01048606|100739412|FG003|NOT COMPLETED|Overall Study||5||
48170737|NCT02366936|100739413|FG000|STARTED|Overall Study||32||
48170738|NCT02366936|100739413|FG000|COMPLETED|Overall Study||24||
48170739|NCT02366936|100739413|FG000|NOT COMPLETED|Overall Study||8||
48170740|NCT01468896|100739414|FG000|STARTED|Overall Study||6||
48170741|NCT01468896|100739415|FG001|STARTED|Overall Study||17||
48170742|NCT01468896|100739414|FG000|COMPLETED|Overall Study||6||
48170743|NCT01468896|100739415|FG001|COMPLETED|Overall Study||17||
48170744|NCT01468896|100739414|FG000|NOT COMPLETED|Overall Study||0||
48170745|NCT01468896|100739415|FG001|NOT COMPLETED|Overall Study||0||
48170746|NCT04091360|100739416|FG000|STARTED|Part A (R, PC, PG) Single Dose||6||
48170747|NCT04091360|100739417|FG001|STARTED|Part A (R, PC, PG) Single Dose||7||
48170748|NCT04091360|100739418|FG002|STARTED|Part A (R, PC, PG) Single Dose||6||
48170749|NCT04091360|100739419|FG003|STARTED|Part A (R, PC, PG) Single Dose||7||
48170750|NCT04091360|100739420|FG004|STARTED|Part A (R, PC, PG) Single Dose||7||
48170751|NCT04091360|100739421|FG005|STARTED|Part A (R, PC, PG) Single Dose||7||
48170752|NCT04091360|100739422|FG006|STARTED|Part A (R, PC, PG) Single Dose||0||
48170753|NCT04091360|100739423|FG007|STARTED|Part A (R, PC, PG) Single Dose||0||
48170754|NCT04091360|100739424|FG008|STARTED|Part A (R, PC, PG) Single Dose||0||
48170755|NCT04091360|100739425|FG009|STARTED|Part A (R, PC, PG) Single Dose||0||
48411652|NCT04315298|101341814|FG008|STARTED|Overall Study||137|Randomized and Treated|
48170756|NCT04091360|100739416|FG000|COMPLETED|Part A (R, PC, PG) Single Dose||6||
48170757|NCT04091360|100739417|FG001|COMPLETED|Part A (R, PC, PG) Single Dose||7||
48170758|NCT04091360|100739418|FG002|COMPLETED|Part A (R, PC, PG) Single Dose||6||
48170759|NCT04091360|100739419|FG003|COMPLETED|Part A (R, PC, PG) Single Dose||7||
48170760|NCT04091360|100739420|FG004|COMPLETED|Part A (R, PC, PG) Single Dose||7||
48170761|NCT04091360|100739421|FG005|COMPLETED|Part A (R, PC, PG) Single Dose||7||
48170762|NCT04091360|100739422|FG006|COMPLETED|Part A (R, PC, PG) Single Dose||0||
48170763|NCT04091360|100739423|FG007|COMPLETED|Part A (R, PC, PG) Single Dose||0||
48170764|NCT04091360|100739424|FG008|COMPLETED|Part A (R, PC, PG) Single Dose||0||
48170765|NCT04091360|100739425|FG009|COMPLETED|Part A (R, PC, PG) Single Dose||0||
48170766|NCT04091360|100739416|FG000|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
48170767|NCT04091360|100739417|FG001|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
48170768|NCT04091360|100739418|FG002|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
48170769|NCT04091360|100739419|FG003|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
48170770|NCT04091360|100739420|FG004|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
48170771|NCT04091360|100739421|FG005|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
48170772|NCT04091360|100739422|FG006|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
48170773|NCT04091360|100739423|FG007|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
48170774|NCT04091360|100739424|FG008|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
48170775|NCT04091360|100739425|FG009|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
48170776|NCT04091360|100739416|FG000|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
48170777|NCT04091360|100739417|FG001|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
48170778|NCT04091360|100739418|FG002|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
48170779|NCT04091360|100739419|FG003|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
48170780|NCT04091360|100739420|FG004|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
48170781|NCT04091360|100739421|FG005|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
48170782|NCT04091360|100739422|FG006|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||8||
48170783|NCT04091360|100739423|FG007|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||7||
48170784|NCT04091360|100739424|FG008|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||7||
48170785|NCT04091360|100739425|FG009|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||6||
48170786|NCT04091360|100739416|FG000|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
48170787|NCT04091360|100739417|FG001|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
48170788|NCT04091360|100739418|FG002|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
48170789|NCT04091360|100739419|FG003|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
48170790|NCT04091360|100739420|FG004|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
48170791|NCT04091360|100739421|FG005|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
48170792|NCT04091360|100739422|FG006|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||6||
48170793|NCT04091360|100739423|FG007|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||6||
48170794|NCT04091360|100739424|FG008|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||6||
48170795|NCT04091360|100739425|FG009|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||4||
48170796|NCT04091360|100739416|FG000|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
48170797|NCT04091360|100739417|FG001|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
48170798|NCT04091360|100739418|FG002|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
48170799|NCT04091360|100739419|FG003|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
48170800|NCT04091360|100739420|FG004|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
48170801|NCT04091360|100739421|FG005|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
48170802|NCT04091360|100739422|FG006|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||2||
48170803|NCT04091360|100739423|FG007|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||1||
48170804|NCT04091360|100739424|FG008|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||1||
48170805|NCT04091360|100739425|FG009|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||2||
48170806|NCT00810082|100739426|FG000|STARTED|Overall Study||34||
48170807|NCT00810082|100739427|FG001|STARTED|Overall Study||31||
48170808|NCT00810082|100739426|FG000|COMPLETED|Overall Study||34||
48170809|NCT00810082|100739427|FG001|COMPLETED|Overall Study||27||
48170810|NCT00810082|100739426|FG000|NOT COMPLETED|Overall Study||0||
48170811|NCT00810082|100739427|FG001|NOT COMPLETED|Overall Study||4||
48170812|NCT04192630|100742358|FG000|STARTED|Overall Study||194||
48170813|NCT04192630|100742359|FG001|STARTED|Overall Study||196||
48170814|NCT04192630|100742358|FG000|COMPLETED|Overall Study||187||
48170815|NCT04192630|100742359|FG001|COMPLETED|Overall Study||193||
48170816|NCT04192630|100742358|FG000|NOT COMPLETED|Overall Study||7||
48170817|NCT04192630|100742359|FG001|NOT COMPLETED|Overall Study||3||
48411653|NCT04315298|101341815|FG009|STARTED|Overall Study||46|Randomized and Treated|
48411654|NCT04315298|101341816|FG010|STARTED|Overall Study||95|Randomized and Treated|
48411655|NCT04315298|101341817|FG011|STARTED|Overall Study||92|Randomized and Treated|
48170818|NCT00235443|100742360|FG000|STARTED|Overall Study||11||
48170819|NCT00235443|100742361|FG001|STARTED|Overall Study||57||
48170820|NCT00235443|100742362|FG002|STARTED|Overall Study||85||
48170821|NCT00235443|100742363|FG003|STARTED|Overall Study||205||
48170822|NCT00235443|100742364|FG004|STARTED|Overall Study||39||
48170823|NCT00235443|100742365|FG005|STARTED|Overall Study||54||
48170824|NCT00235443|100742360|FG000|COMPLETED|Overall Study||3||
48170825|NCT00235443|100742361|FG001|COMPLETED|Overall Study||19||
48170826|NCT00235443|100742362|FG002|COMPLETED|Overall Study||23||
48170827|NCT00235443|100742363|FG003|COMPLETED|Overall Study||108||
48170828|NCT00235443|100742364|FG004|COMPLETED|Overall Study||9||
48170829|NCT00235443|100742365|FG005|COMPLETED|Overall Study||9||
48170830|NCT00235443|100742360|FG000|NOT COMPLETED|Overall Study||8||
48170831|NCT00235443|100742361|FG001|NOT COMPLETED|Overall Study||38||
48170832|NCT00235443|100742362|FG002|NOT COMPLETED|Overall Study||62||
48170833|NCT00235443|100742363|FG003|NOT COMPLETED|Overall Study||97||
48170834|NCT00235443|100742364|FG004|NOT COMPLETED|Overall Study||30||
48170835|NCT00235443|100742365|FG005|NOT COMPLETED|Overall Study||45||
48170836|NCT00734214|100742366|FG000|STARTED|Overall Study||128||
48170837|NCT00734214|100742367|FG001|STARTED|Overall Study||130||
48170838|NCT00734214|100742366|FG000|COMPLETED|Overall Study||124||
48170839|NCT00734214|100742367|FG001|COMPLETED|Overall Study||126||
48170840|NCT00734214|100742366|FG000|NOT COMPLETED|Overall Study||4||
48170841|NCT00734214|100742367|FG001|NOT COMPLETED|Overall Study||4||
48170842|NCT03771157|100742368|FG000|STARTED|Overall Study||32||
48170843|NCT03771157|100742368|FG000|COMPLETED|Overall Study||31||
48170844|NCT03771157|100742368|FG000|NOT COMPLETED|Overall Study||1||
48170845|NCT02318719|100742369|FG000|STARTED|Double-blind Phase||304||
48411656|NCT04315298|101341818|FG012|STARTED|Overall Study||8|Randomized and Treated|
48411657|NCT04315298|101341819|FG013|STARTED|Overall Study||12|Randomized and Treated|
48411658|NCT04315298|101341820|FG014|STARTED|Overall Study||15|Randomized and Treated|
48750745|NCT04290039|102177259|FG000|COMPLETED|Period 1 (Visit 1; Day 1)||5||
48170846|NCT02318719|100742370|FG001|STARTED|Double-blind Phase||153||
48170847|NCT02318719|100742371|FG002|STARTED|Double-blind Phase||153||
48170848|NCT02318719|100742372|FG003|STARTED|Double-blind Phase||155||
48170849|NCT02318719|100742373|FG004|STARTED|Double-blind Phase||0||
48170850|NCT02318719|100742369|FG000|Did Not Receive Treatment|Double-blind Phase||1||
48170851|NCT02318719|100742370|FG001|Did Not Receive Treatment|Double-blind Phase||1||
48170852|NCT02318719|100742371|FG002|Did Not Receive Treatment|Double-blind Phase||0||
48170853|NCT02318719|100742372|FG003|Did Not Receive Treatment|Double-blind Phase||0||
48170854|NCT02318719|100742373|FG004|Did Not Receive Treatment|Double-blind Phase||0||
48170855|NCT02318719|100742369|FG000|COMPLETED|Double-blind Phase||266||
48750746|NCT04290039|102177260|FG001|COMPLETED|Period 1 (Visit 1; Day 1)||5||
48750747|NCT04290039|102177261|FG002|COMPLETED|Period 1 (Visit 1; Day 1)||5||
48170856|NCT02318719|100742370|FG001|COMPLETED|Double-blind Phase||137||
48170857|NCT02318719|100742371|FG002|COMPLETED|Double-blind Phase||128||
48170858|NCT02318719|100742372|FG003|COMPLETED|Double-blind Phase||140||
48170859|NCT02318719|100742373|FG004|COMPLETED|Double-blind Phase||0||
48170860|NCT02318719|100742369|FG000|NOT COMPLETED|Double-blind Phase||38||
48170861|NCT02318719|100742370|FG001|NOT COMPLETED|Double-blind Phase||16||
48170862|NCT02318719|100742371|FG002|NOT COMPLETED|Double-blind Phase||25||
48170863|NCT02318719|100742372|FG003|NOT COMPLETED|Double-blind Phase||15||
48170864|NCT02318719|100742373|FG004|NOT COMPLETED|Double-blind Phase||0||
48170865|NCT02318719|100742369|FG000|STARTED|Open-label Extension Phase||0||
48750748|NCT04290039|102177259|FG000|NOT COMPLETED|Period 1 (Visit 1; Day 1)||0||
48170866|NCT02318719|100742370|FG001|STARTED|Open-label Extension Phase||0||
48170867|NCT02318719|100742371|FG002|STARTED|Open-label Extension Phase||0||
48170868|NCT02318719|100742372|FG003|STARTED|Open-label Extension Phase||0||
48170869|NCT02318719|100742373|FG004|STARTED|Open-label Extension Phase||239||
48170870|NCT02318719|100742369|FG000|COMPLETED|Open-label Extension Phase||0||
48170871|NCT02318719|100742370|FG001|COMPLETED|Open-label Extension Phase||0||
48170872|NCT02318719|100742371|FG002|COMPLETED|Open-label Extension Phase||0||
48170873|NCT02318719|100742372|FG003|COMPLETED|Open-label Extension Phase||0||
48170874|NCT02318719|100742373|FG004|COMPLETED|Open-label Extension Phase||184||
48170875|NCT02318719|100742369|FG000|NOT COMPLETED|Open-label Extension Phase||0||
48170876|NCT02318719|100742370|FG001|NOT COMPLETED|Open-label Extension Phase||0||
48170877|NCT02318719|100742371|FG002|NOT COMPLETED|Open-label Extension Phase||0||
48170878|NCT02318719|100742372|FG003|NOT COMPLETED|Open-label Extension Phase||0||
48170879|NCT02318719|100742373|FG004|NOT COMPLETED|Open-label Extension Phase||55||
48170880|NCT00240526|100742374|FG000|STARTED|Year 15||19||
48170881|NCT00240526|100742375|FG001|STARTED|Year 15||19||
48170882|NCT00240526|100742376|FG002|STARTED|Year 15||14||
48411659|NCT04315298|101341821|FG015|STARTED|Overall Study||15|Randomized and Treated|
48411660|NCT04315298|101341822|FG016|STARTED|Overall Study||16|Randomized and Treated|
48411661|NCT04315298|101341823|FG017|STARTED|Overall Study||6|Randomized and Treated|
48750749|NCT04290039|102177260|FG001|NOT COMPLETED|Period 1 (Visit 1; Day 1)||0||
48170883|NCT00240526|100742377|FG003|STARTED|Year 15||21||
48170884|NCT00240526|100742374|FG000|COMPLETED|Year 15||19||
48170885|NCT00240526|100742375|FG001|COMPLETED|Year 15||19||
48170886|NCT00240526|100742376|FG002|COMPLETED|Year 15||14||
48170887|NCT00240526|100742377|FG003|COMPLETED|Year 15||21||
48170888|NCT00240526|100742374|FG000|NOT COMPLETED|Year 15||0||
48170889|NCT00240526|100742375|FG001|NOT COMPLETED|Year 15||0||
48170890|NCT00240526|100742376|FG002|NOT COMPLETED|Year 15||0||
48170891|NCT00240526|100742377|FG003|NOT COMPLETED|Year 15||0||
48170892|NCT00240526|100742374|FG000|STARTED|Year 16||17||
48170893|NCT00240526|100742375|FG001|STARTED|Year 16||19||
48170894|NCT00240526|100742376|FG002|STARTED|Year 16||16||
48170895|NCT00240526|100742377|FG003|STARTED|Year 16||22||
48333667|NCT02574637|101145520|FG002|COMPLETED|Open-label (OL) Period||0||
48627602|NCT01232283|101871083|FG009|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0||
48627603|NCT01232283|101871074|FG000|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0||
48627604|NCT01232283|101871075|FG001|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0||
48627605|NCT01232283|101871076|FG002|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0||
48750750|NCT04290039|102177261|FG002|NOT COMPLETED|Period 1 (Visit 1; Day 1)||0||
48750751|NCT04290039|102177259|FG000|STARTED|Period 2 (Visit 2; Day 8)||5||
48750752|NCT04290039|102177260|FG001|STARTED|Period 2 (Visit 2; Day 8)||5||
48750753|NCT04290039|102177261|FG002|STARTED|Period 2 (Visit 2; Day 8)||5||
48750754|NCT04290039|102177259|FG000|COMPLETED|Period 2 (Visit 2; Day 8)||5||
48750755|NCT04290039|102177260|FG001|COMPLETED|Period 2 (Visit 2; Day 8)||5||
48750756|NCT04290039|102177261|FG002|COMPLETED|Period 2 (Visit 2; Day 8)||5||
48750757|NCT04290039|102177259|FG000|NOT COMPLETED|Period 2 (Visit 2; Day 8)||0||
48750758|NCT04290039|102177260|FG001|NOT COMPLETED|Period 2 (Visit 2; Day 8)||0||
48750759|NCT04290039|102177261|FG002|NOT COMPLETED|Period 2 (Visit 2; Day 8)||0||
48750760|NCT04290039|102177259|FG000|STARTED|Period 3 (Visit 3; Day 15)||5||
48750761|NCT04290039|102177260|FG001|STARTED|Period 3 (Visit 3; Day 15)||4||
48627606|NCT01232283|101871077|FG003|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0||
48627607|NCT01232283|101871078|FG004|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||50||
48627608|NCT01232283|101871079|FG005|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||56||
48627609|NCT01232283|101871080|FG006|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||41||
48627610|NCT01232283|101871081|FG007|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||84||
48627611|NCT01232283|101871082|FG008|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0||
48627612|NCT01232283|101871083|FG009|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0||
48627613|NCT01232283|101871074|FG000|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0||
48750762|NCT04290039|102177261|FG002|STARTED|Period 3 (Visit 3; Day 15)||5||
48750763|NCT04290039|102177259|FG000|COMPLETED|Period 3 (Visit 3; Day 15)||5||
48750764|NCT04290039|102177260|FG001|COMPLETED|Period 3 (Visit 3; Day 15)||4||
48750765|NCT04290039|102177261|FG002|COMPLETED|Period 3 (Visit 3; Day 15)||5||
48750766|NCT04290039|102177259|FG000|NOT COMPLETED|Period 3 (Visit 3; Day 15)||0||
48750767|NCT04290039|102177260|FG001|NOT COMPLETED|Period 3 (Visit 3; Day 15)||0||
48750768|NCT04290039|102177261|FG002|NOT COMPLETED|Period 3 (Visit 3; Day 15)||0||
48170896|NCT00240526|100742374|FG000|COMPLETED|Year 16||17||
48170897|NCT00240526|100742375|FG001|COMPLETED|Year 16||19||
48170898|NCT00240526|100742376|FG002|COMPLETED|Year 16||16||
48170899|NCT00240526|100742377|FG003|COMPLETED|Year 16||22||
48333668|NCT02574637|101145521|FG003|COMPLETED|Open-label (OL) Period||0||
48750769|NCT01121146|102177262|FG000|STARTED|Overall Study||116||
48170900|NCT00240526|100742374|FG000|NOT COMPLETED|Year 16||0||
48170901|NCT00240526|100742375|FG001|NOT COMPLETED|Year 16||0||
48170902|NCT00240526|100742376|FG002|NOT COMPLETED|Year 16||0||
48627614|NCT01232283|101871075|FG001|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0||
48627615|NCT01232283|101871076|FG002|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0||
48627616|NCT01232283|101871077|FG003|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0||
48656966|NCT01340170|101943736|FG002|NOT COMPLETED|Overall Study||0||0
48750770|NCT01121146|102177263|FG001|STARTED|Overall Study||114||
48333669|NCT02574637|101145522|FG004|COMPLETED|Open-label (OL) Period||0||
48170903|NCT00240526|100742377|FG003|NOT COMPLETED|Year 16||0||
48170904|NCT00240526|100742374|FG000|STARTED|Year 17||19||
48750771|NCT01121146|102177262|FG000|COMPLETED|Overall Study||90||
48750772|NCT01121146|102177263|FG001|COMPLETED|Overall Study||72||
48750773|NCT01121146|102177262|FG000|NOT COMPLETED|Overall Study||26||
48170905|NCT00240526|100742375|FG001|STARTED|Year 17||17||
48170906|NCT00240526|100742376|FG002|STARTED|Year 17||13||
48170907|NCT00240526|100742377|FG003|STARTED|Year 17||20||
48170908|NCT00240526|100742374|FG000|COMPLETED|Year 17||19||
48170909|NCT00240526|100742375|FG001|COMPLETED|Year 17||17||
48170910|NCT00240526|100742376|FG002|COMPLETED|Year 17||13||
48170911|NCT00240526|100742377|FG003|COMPLETED|Year 17||20||
48627617|NCT01232283|101871078|FG004|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12||
48627618|NCT01232283|101871079|FG005|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||5||
48627619|NCT01232283|101871080|FG006|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||17||
48627620|NCT01232283|101871081|FG007|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12||
48627621|NCT01232283|101871082|FG008|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0||
48627622|NCT01232283|101871083|FG009|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0||
48170912|NCT00240526|100742374|FG000|NOT COMPLETED|Year 17||0||
48170913|NCT00240526|100742375|FG001|NOT COMPLETED|Year 17||0||
48170914|NCT00240526|100742376|FG002|NOT COMPLETED|Year 17||0||
48170915|NCT00240526|100742377|FG003|NOT COMPLETED|Year 17||0||
48170916|NCT00240526|100742374|FG000|STARTED|Year 18||16||
48170917|NCT00240526|100742375|FG001|STARTED|Year 18||17||
48170918|NCT00240526|100742376|FG002|STARTED|Year 18||14||
48170919|NCT00240526|100742377|FG003|STARTED|Year 18||20||
48170920|NCT00240526|100742374|FG000|COMPLETED|Year 18||16||
48170921|NCT00240526|100742375|FG001|COMPLETED|Year 18||17||
48170922|NCT00240526|100742376|FG002|COMPLETED|Year 18||14||
48170923|NCT00240526|100742377|FG003|COMPLETED|Year 18||20||
48170924|NCT00240526|100742374|FG000|NOT COMPLETED|Year 18||0||
48170925|NCT00240526|100742375|FG001|NOT COMPLETED|Year 18||0||
48170926|NCT00240526|100742376|FG002|NOT COMPLETED|Year 18||0||
48170927|NCT00240526|100742377|FG003|NOT COMPLETED|Year 18||0||
48170928|NCT00240526|100742374|FG000|STARTED|Year 19||17||
48170929|NCT00240526|100742375|FG001|STARTED|Year 19||16||
48170930|NCT00240526|100742376|FG002|STARTED|Year 19||12||
48170931|NCT00240526|100742377|FG003|STARTED|Year 19||18||
48170932|NCT00240526|100742374|FG000|COMPLETED|Year 19||17||
48627623|NCT01232283|101871074|FG000|STARTED|Long-Term Extension Phase (Weeks 52-260)||0||
48627624|NCT01232283|101871075|FG001|STARTED|Long-Term Extension Phase (Weeks 52-260)||0||
48627625|NCT01232283|101871076|FG002|STARTED|Long-Term Extension Phase (Weeks 52-260)||0||
48627626|NCT01232283|101871077|FG003|STARTED|Long-Term Extension Phase (Weeks 52-260)||0||
48627627|NCT01232283|101871078|FG004|STARTED|Long-Term Extension Phase (Weeks 52-260)||0||
48627628|NCT01232283|101871079|FG005|STARTED|Long-Term Extension Phase (Weeks 52-260)||0||
48627629|NCT01232283|101871080|FG006|STARTED|Long-Term Extension Phase (Weeks 52-260)||0||
48750774|NCT01121146|102177263|FG001|NOT COMPLETED|Overall Study||42||
48750775|NCT01096316|102177264|FG000|STARTED|Overall Study||102||
48750776|NCT01096316|102177265|FG001|STARTED|Overall Study||103||
48750777|NCT01096316|102177264|FG000|COMPLETED|Overall Study||87||
48750778|NCT01096316|102177265|FG001|COMPLETED|Overall Study||94||
48750779|NCT01096316|102177264|FG000|NOT COMPLETED|Overall Study||15||
48750780|NCT01096316|102177265|FG001|NOT COMPLETED|Overall Study||9||
48750781|NCT00601835|102177266|FG000|STARTED|Overall Study||2950||
48750782|NCT00601835|102177267|FG001|STARTED|Overall Study||700||
48170933|NCT00240526|100742375|FG001|COMPLETED|Year 19||16||
48170934|NCT00240526|100742376|FG002|COMPLETED|Year 19||12||
48170935|NCT00240526|100742377|FG003|COMPLETED|Year 19||18||
48627630|NCT01232283|101871081|FG007|STARTED|Long-Term Extension Phase (Weeks 52-260)||0||
48750783|NCT00601835|102177266|FG000|COMPLETED|Overall Study||2890||
48750784|NCT00601835|102177267|FG001|COMPLETED|Overall Study||686||
48750785|NCT00601835|102177266|FG000|NOT COMPLETED|Overall Study||60||
48750786|NCT00601835|102177267|FG001|NOT COMPLETED|Overall Study||14||
48750787|NCT00973752|102177268|FG000|STARTED|Overall Study||30||
48750788|NCT00973752|102177268|FG000|COMPLETED|Overall Study||30||
48750789|NCT00973752|102177268|FG000|NOT COMPLETED|Overall Study||0||
48170936|NCT00240526|100742374|FG000|NOT COMPLETED|Year 19||0||
48170937|NCT00240526|100742375|FG001|NOT COMPLETED|Year 19||0||
48627631|NCT01232283|101871082|FG008|STARTED|Long-Term Extension Phase (Weeks 52-260)||137||
48627632|NCT01232283|101871083|FG009|STARTED|Long-Term Extension Phase (Weeks 52-260)||80||
48627633|NCT01232283|101871074|FG000|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0||
48656967|NCT03735979|101943737|FG000|STARTED|Overall Study||59||
48750790|NCT02519023|102177269|FG000|STARTED|Overall Study||49||
48170938|NCT00240526|100742376|FG002|NOT COMPLETED|Year 19||0||
48170939|NCT00240526|100742377|FG003|NOT COMPLETED|Year 19||0||
48170940|NCT00240526|100742374|FG000|STARTED|Year 20||19||
48750791|NCT02519023|102177270|FG001|STARTED|Overall Study||38||
48750792|NCT02519023|102177269|FG000|COMPLETED|Overall Study||31||
48170941|NCT00240526|100742375|FG001|STARTED|Year 20||17||
48170942|NCT00240526|100742376|FG002|STARTED|Year 20||13||
48170943|NCT00240526|100742377|FG003|STARTED|Year 20||20||
48170944|NCT00240526|100742374|FG000|COMPLETED|Year 20||19||
48170945|NCT00240526|100742375|FG001|COMPLETED|Year 20||17||
48750793|NCT02519023|102177270|FG001|COMPLETED|Overall Study||31||
48170946|NCT00240526|100742376|FG002|COMPLETED|Year 20||13||
48170947|NCT00240526|100742377|FG003|COMPLETED|Year 20||20||
48170948|NCT00240526|100742374|FG000|NOT COMPLETED|Year 20||0||
48750794|NCT02519023|102177269|FG000|NOT COMPLETED|Overall Study||18||
48750795|NCT02519023|102177270|FG001|NOT COMPLETED|Overall Study||7||
48750796|NCT03999515|102177271|FG000|STARTED|Overall Study||3||
48750797|NCT03999515|102177271|FG000|COMPLETED|Overall Study||3||
48750798|NCT03999515|102177271|FG000|NOT COMPLETED|Overall Study||0||
48750799|NCT02526277|102177272|FG000|STARTED|Overall Study||8||
48627634|NCT01232283|101871075|FG001|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0||
48627635|NCT01232283|101871076|FG002|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0||
48411662|NCT04315298|101341824|FG018|STARTED|Overall Study||2|Randomized and Treated|
48411663|NCT04315298|101341806|FG000|COMPLETED|Overall Study||61||
48411664|NCT04315298|101341807|FG001|COMPLETED|Overall Study||117||
48627636|NCT01232283|101871077|FG003|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0||
48627637|NCT01232283|101871078|FG004|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0||
48627638|NCT01232283|101871079|FG005|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0||
48627639|NCT01232283|101871080|FG006|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0||
48627640|NCT01232283|101871081|FG007|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0||
48627641|NCT01232283|101871082|FG008|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||29||
48627642|NCT01232283|101871083|FG009|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||19||
48627643|NCT01232283|101871074|FG000|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0||
48627644|NCT01232283|101871075|FG001|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0||
48627645|NCT01232283|101871076|FG002|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0||
48170949|NCT00240526|100742375|FG001|NOT COMPLETED|Year 20||0||
48170950|NCT00240526|100742376|FG002|NOT COMPLETED|Year 20||0||
48170951|NCT00240526|100742377|FG003|NOT COMPLETED|Year 20||0||
48750800|NCT02526277|102177273|FG001|STARTED|Overall Study||6||
48750801|NCT02526277|102177274|FG002|STARTED|Overall Study||7||
48750802|NCT02526277|102177275|FG003|STARTED|Overall Study||7||
48750803|NCT02526277|102177272|FG000|COMPLETED|Overall Study||8||
48170952|NCT02430818|100742378|FG000|STARTED|Overall Study||7||
48170953|NCT02430818|100742379|FG001|STARTED|Overall Study||6||
48170954|NCT02430818|100742378|FG000|COMPLETED|Overall Study||7||
48170955|NCT02430818|100742379|FG001|COMPLETED|Overall Study||6||
48170956|NCT02430818|100742378|FG000|NOT COMPLETED|Overall Study||0||
48411665|NCT04315298|101341808|FG002|COMPLETED|Overall Study||125||
48411666|NCT04315298|101341809|FG003|COMPLETED|Overall Study||101||
48627646|NCT01232283|101871077|FG003|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0||
48627647|NCT01232283|101871078|FG004|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0||
48627648|NCT01232283|101871079|FG005|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0||
48627649|NCT01232283|101871080|FG006|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0||
48627650|NCT01232283|101871081|FG007|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0||
48627651|NCT01232283|101871082|FG008|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||108||
48627652|NCT01232283|101871083|FG009|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||61||
48627653|NCT01123655|101871084|FG000|STARTED|Overall Study||10||
48627654|NCT01123655|101871085|FG001|STARTED|Overall Study||4||
48627655|NCT01123655|101871086|FG002|STARTED|Overall Study||8||
48627656|NCT01123655|101871084|FG000|COMPLETED|Overall Study||9||
48627657|NCT01123655|101871085|FG001|COMPLETED|Overall Study||3||
48627658|NCT01123655|101871086|FG002|COMPLETED|Overall Study||7||
48627659|NCT01123655|101871084|FG000|NOT COMPLETED|Overall Study||1||
48750804|NCT02526277|102177273|FG001|COMPLETED|Overall Study||6||
48750805|NCT02526277|102177274|FG002|COMPLETED|Overall Study||7||
48750806|NCT02526277|102177275|FG003|COMPLETED|Overall Study||7||
48750807|NCT02526277|102177272|FG000|NOT COMPLETED|Overall Study||0||
48750808|NCT02526277|102177273|FG001|NOT COMPLETED|Overall Study||0||
48750809|NCT02526277|102177274|FG002|NOT COMPLETED|Overall Study||0||
48750810|NCT02526277|102177275|FG003|NOT COMPLETED|Overall Study||0||
48170957|NCT02430818|100742379|FG001|NOT COMPLETED|Overall Study||0||
48170958|NCT03959592|100742380|FG000|STARTED|Overall Study||3||
48170959|NCT03959592|100742381|FG001|STARTED|Overall Study||5||
48170960|NCT03959592|100742380|FG000|COMPLETED|Overall Study||3||
48170961|NCT03959592|100742381|FG001|COMPLETED|Overall Study||5||
48170962|NCT03959592|100742380|FG000|NOT COMPLETED|Overall Study||0||
48170963|NCT03959592|100742381|FG001|NOT COMPLETED|Overall Study||0||
48170964|NCT02384317|100742382|FG000|STARTED|Overall Study||7||
48170965|NCT02384317|100742382|FG000|COMPLETED|Overall Study||7||
48170966|NCT02384317|100742382|FG000|NOT COMPLETED|Overall Study||0||
48750811|NCT01451723|102177276|FG000|STARTED|Overall Study||6||
48170967|NCT04105972|100742383|FG000|STARTED|Overall Study||88||
48170968|NCT04105972|100742384|FG001|STARTED|Overall Study||87||
48170969|NCT04105972|100742383|FG000|COMPLETED|Overall Study||86||
48170970|NCT04105972|100742384|FG001|COMPLETED|Overall Study||86||
48170971|NCT04105972|100742383|FG000|NOT COMPLETED|Overall Study||2||
48170972|NCT04105972|100742384|FG001|NOT COMPLETED|Overall Study||1||
48170973|NCT01827254|100742385|FG000|STARTED|Overall Study||61||
48411667|NCT04315298|101341810|FG004|COMPLETED|Overall Study||157||
48411668|NCT04315298|101341811|FG005|COMPLETED|Overall Study||209||
48411669|NCT04315298|101341812|FG006|COMPLETED|Overall Study||52||
48411670|NCT04315298|101341813|FG007|COMPLETED|Overall Study||111||
48411671|NCT04315298|101341814|FG008|COMPLETED|Overall Study||101||
48411672|NCT04315298|101341815|FG009|COMPLETED|Overall Study||29||
48627660|NCT01123655|101871085|FG001|NOT COMPLETED|Overall Study||1||
48627661|NCT01123655|101871086|FG002|NOT COMPLETED|Overall Study||1||
48627662|NCT00001305|101871087|FG000|STARTED|Overall Study||42||
48627663|NCT00001305|101871087|FG000|COMPLETED|Overall Study||42||
48627664|NCT00001305|101871087|FG000|NOT COMPLETED|Overall Study||0||
48627665|NCT03307174|101871088|FG000|STARTED|Overall Study||60||
48627666|NCT03307174|101871089|FG001|STARTED|Overall Study||60||
48627667|NCT03307174|101871088|FG000|COMPLETED|Overall Study||46||
48627668|NCT03307174|101871089|FG001|COMPLETED|Overall Study||53||
48627669|NCT03307174|101871088|FG000|NOT COMPLETED|Overall Study||14||
48627670|NCT03307174|101871089|FG001|NOT COMPLETED|Overall Study||7||
48627671|NCT03353792|101871090|FG000|STARTED|Overall Study||4||
48627672|NCT03353792|101871091|FG001|STARTED|Overall Study||3||
48627673|NCT03353792|101871090|FG000|COMPLETED|Overall Study||2||
48627674|NCT03353792|101871091|FG001|COMPLETED|Overall Study||3||
48627675|NCT03353792|101871090|FG000|NOT COMPLETED|Overall Study||2||
48627676|NCT03353792|101871091|FG001|NOT COMPLETED|Overall Study||0||
48627677|NCT00461734|101871092|FG000|STARTED|Overall Study||120||
48627678|NCT00461734|101871093|FG001|STARTED|Overall Study||120||
48627679|NCT00461734|101871092|FG000|COMPLETED|Overall Study||62||
48170974|NCT01827254|100742385|FG000|Evaluable Population|Overall Study||52||
48170975|NCT01827254|100742385|FG000|COMPLETED|Overall Study||2||
48170976|NCT01827254|100742385|FG000|NOT COMPLETED|Overall Study||59||
48170977|NCT01267253|100742386|FG000|STARTED|Overall Study||31||
48170978|NCT01267253|100742386|FG000|COMPLETED|Overall Study||28||
48170979|NCT01267253|100742386|FG000|NOT COMPLETED|Overall Study||3||
48170980|NCT01642082|100742387|FG000|STARTED|Overall Study||28||
48170981|NCT01642082|100742387|FG000|COMPLETED|Overall Study||28||
48170982|NCT01642082|100742387|FG000|NOT COMPLETED|Overall Study||0||
48170983|NCT01493960|100742388|FG000|STARTED|Overall Study||87||
48170984|NCT01493960|100742389|FG001|STARTED|Overall Study||44||
48170985|NCT01493960|100742388|FG000|Received Study Drug|Overall Study||87||
48170986|NCT01493960|100742389|FG001|Received Study Drug|Overall Study||43||
48170987|NCT01493960|100742388|FG000|COMPLETED|Overall Study||55||
48333670|NCT02574637|101145523|FG005|COMPLETED|Open-label (OL) Period||0||
48627680|NCT00461734|101871093|FG001|COMPLETED|Overall Study||60||
48627681|NCT00461734|101871092|FG000|NOT COMPLETED|Overall Study||58||
48627682|NCT00461734|101871093|FG001|NOT COMPLETED|Overall Study||60||
48627683|NCT00846365|101871094|FG000|STARTED|Overall Study||372||
48627684|NCT00846365|101871095|FG001|STARTED|Overall Study||357||
48627685|NCT00846365|101871096|FG002|STARTED|Overall Study||356||
48627686|NCT00846365|101871094|FG000|COMPLETED|Overall Study||317||
48627687|NCT00846365|101871095|FG001|COMPLETED|Overall Study||308||
48627688|NCT00846365|101871096|FG002|COMPLETED|Overall Study||323||
48627689|NCT00846365|101871094|FG000|NOT COMPLETED|Overall Study||55||
48627690|NCT00846365|101871095|FG001|NOT COMPLETED|Overall Study||49||
48627691|NCT00846365|101871096|FG002|NOT COMPLETED|Overall Study||33||
48627692|NCT01832766|101871097|FG000|STARTED|First Intervention||7||
48627693|NCT01832766|101871098|FG001|STARTED|First Intervention||6||
48627694|NCT01832766|101871097|FG000|COMPLETED|First Intervention||7||
48627695|NCT01832766|101871098|FG001|COMPLETED|First Intervention||6||
48627696|NCT01832766|101871097|FG000|NOT COMPLETED|First Intervention||0||
48627697|NCT01832766|101871098|FG001|NOT COMPLETED|First Intervention||0||
48627698|NCT01832766|101871097|FG000|STARTED|Washout||7||
48333671|NCT02574637|101145524|FG006|COMPLETED|Open-label (OL) Period||1||
48627699|NCT01832766|101871098|FG001|STARTED|Washout||6||
48627700|NCT01832766|101871097|FG000|COMPLETED|Washout||7||
48627701|NCT01832766|101871098|FG001|COMPLETED|Washout||5||
48170988|NCT01493960|100742389|FG001|COMPLETED|Overall Study||26||
48170989|NCT01493960|100742388|FG000|NOT COMPLETED|Overall Study||32||
48170990|NCT01493960|100742389|FG001|NOT COMPLETED|Overall Study||18||
48333672|NCT02574637|101145525|FG007|COMPLETED|Open-label (OL) Period||1||
48333673|NCT02574637|101145526|FG008|COMPLETED|Open-label (OL) Period||1||
48333674|NCT02574637|101145527|FG009|COMPLETED|Open-label (OL) Period||0||
48333675|NCT02574637|101145518|FG000|NOT COMPLETED|Open-label (OL) Period||0||
48627702|NCT01832766|101871097|FG000|NOT COMPLETED|Washout||0||
48627703|NCT01832766|101871098|FG001|NOT COMPLETED|Washout||1||
48627704|NCT01832766|101871097|FG000|STARTED|Second Intervention||7||
48627705|NCT01832766|101871098|FG001|STARTED|Second Intervention||5||
48627706|NCT01832766|101871097|FG000|COMPLETED|Second Intervention||7||
48627707|NCT01832766|101871098|FG001|COMPLETED|Second Intervention||5||
48627708|NCT01832766|101871097|FG000|NOT COMPLETED|Second Intervention||0||
48627709|NCT01832766|101871098|FG001|NOT COMPLETED|Second Intervention||0||
48627710|NCT01850641|101871099|FG000|STARTED|Overall Study||35||
48627711|NCT01850641|101871099|FG000|COMPLETED|Overall Study||30||
48627712|NCT01850641|101871099|FG000|NOT COMPLETED|Overall Study||5||
48627713|NCT01079780|101871100|FG000|STARTED|Overall Study||70||
48627714|NCT01079780|101871101|FG001|STARTED|Overall Study||16||
48627715|NCT01079780|101871102|FG002|STARTED|Overall Study||50||
48627716|NCT01079780|101871100|FG000|Started Protocol Therapy|Overall Study||69||
48170991|NCT04422639|100742390|FG000|STARTED|Overall Study||1||
48170992|NCT04422639|100742391|FG001|STARTED|Overall Study||2||
48170993|NCT04422639|100742390|FG000|COMPLETED|Overall Study||0||
48627717|NCT01079780|101871101|FG001|Started Protocol Therapy|Overall Study||16||
48627718|NCT01079780|101871102|FG002|Started Protocol Therapy|Overall Study||48||
48170994|NCT04422639|100742391|FG001|COMPLETED|Overall Study||0||
48170995|NCT04422639|100742390|FG000|NOT COMPLETED|Overall Study||1||
48170996|NCT04422639|100742391|FG001|NOT COMPLETED|Overall Study||2||
48170997|NCT02969031|100742392|FG000|STARTED|Enrolled and Randomized||73||
48170998|NCT02969031|100742393|FG001|STARTED|Enrolled and Randomized||75||
48170999|NCT02969031|100742392|FG000|COMPLETED|Enrolled and Randomized||73||
48171000|NCT02969031|100742393|FG001|COMPLETED|Enrolled and Randomized||75||
48171001|NCT02969031|100742392|FG000|NOT COMPLETED|Enrolled and Randomized||0||
48627719|NCT01079780|101871100|FG000|Treated Patients With Toxicity Data Available|Overall Study||68||
48627720|NCT01079780|101871101|FG001|Treated Patients With Toxicity Data Available|Overall Study||16||
48627721|NCT01079780|101871102|FG002|Treated Patients With Toxicity Data Available|Overall Study||48||
48171002|NCT02969031|100742393|FG001|NOT COMPLETED|Enrolled and Randomized||0||
48171003|NCT02969031|100742392|FG000|STARTED|Collection of Baseline Surveys||73||
48171004|NCT02969031|100742393|FG001|STARTED|Collection of Baseline Surveys||75||
48171005|NCT02969031|100742392|FG000|COMPLETED|Collection of Baseline Surveys||34||
48171006|NCT02969031|100742393|FG001|COMPLETED|Collection of Baseline Surveys||23||
48171007|NCT02969031|100742392|FG000|NOT COMPLETED|Collection of Baseline Surveys||39||
48171008|NCT02969031|100742393|FG001|NOT COMPLETED|Collection of Baseline Surveys||52||
48171009|NCT02969031|100742392|FG000|STARTED|Collection of Baseline Recordings||34||
48171010|NCT02969031|100742393|FG001|STARTED|Collection of Baseline Recordings||23||
48171011|NCT02969031|100742392|FG000|COMPLETED|Collection of Baseline Recordings||22||
48171012|NCT02969031|100742393|FG001|COMPLETED|Collection of Baseline Recordings||18||
48171013|NCT02969031|100742392|FG000|NOT COMPLETED|Collection of Baseline Recordings||12||
48171014|NCT02969031|100742393|FG001|NOT COMPLETED|Collection of Baseline Recordings||5||
48171015|NCT02969031|100742392|FG000|STARTED|Completed Intervention||22||
48171016|NCT02969031|100742393|FG001|STARTED|Completed Intervention||18||
48171017|NCT02969031|100742392|FG000|COMPLETED|Completed Intervention||15||
48171018|NCT02969031|100742393|FG001|COMPLETED|Completed Intervention||14||
48171019|NCT02969031|100742392|FG000|NOT COMPLETED|Completed Intervention||7||
48171020|NCT02969031|100742393|FG001|NOT COMPLETED|Completed Intervention||4||
48171021|NCT02969031|100742392|FG000|STARTED|Collection of Follow-Up Surveys||15||
48171022|NCT02969031|100742393|FG001|STARTED|Collection of Follow-Up Surveys||14||
48171023|NCT02969031|100742392|FG000|COMPLETED|Collection of Follow-Up Surveys||15||
48171024|NCT02969031|100742393|FG001|COMPLETED|Collection of Follow-Up Surveys||12||
48171025|NCT02969031|100742392|FG000|NOT COMPLETED|Collection of Follow-Up Surveys||0||
48171026|NCT02969031|100742393|FG001|NOT COMPLETED|Collection of Follow-Up Surveys||2||
48171027|NCT02969031|100742392|FG000|STARTED|Collection of Follow-Up Recordings||15||
48171028|NCT02969031|100742393|FG001|STARTED|Collection of Follow-Up Recordings||12||
48171029|NCT02969031|100742392|FG000|COMPLETED|Collection of Follow-Up Recordings||15||
48171030|NCT02969031|100742393|FG001|COMPLETED|Collection of Follow-Up Recordings||12||
48171031|NCT02969031|100742392|FG000|NOT COMPLETED|Collection of Follow-Up Recordings||0||
48171032|NCT02969031|100742393|FG001|NOT COMPLETED|Collection of Follow-Up Recordings||0||
48171033|NCT02969031|100742392|FG000|STARTED|Completed and Analyzed||15||
48171034|NCT02969031|100742393|FG001|STARTED|Completed and Analyzed||12||
48171035|NCT02969031|100742392|FG000|COMPLETED|Completed and Analyzed||15||
48171036|NCT02969031|100742393|FG001|COMPLETED|Completed and Analyzed||12||
48171037|NCT02969031|100742392|FG000|NOT COMPLETED|Completed and Analyzed||0||
48171038|NCT02969031|100742393|FG001|NOT COMPLETED|Completed and Analyzed||0||
48171039|NCT02010697|100742394|FG000|STARTED|Overall Study||1044||
48171040|NCT02010697|100742395|FG001|STARTED|Overall Study||1038||
48171041|NCT02010697|100742396|FG002|STARTED|Overall Study||1043||
48171042|NCT02010697|100742394|FG000|COMPLETED|Overall Study||1044||
48171043|NCT02010697|100742395|FG001|COMPLETED|Overall Study||1038||
48171044|NCT02010697|100742396|FG002|COMPLETED|Overall Study||1043||
48171045|NCT02010697|100742394|FG000|NOT COMPLETED|Overall Study||0||
48627722|NCT01079780|101871100|FG000|Eligible and Treated|Overall Study||62||
48627723|NCT01079780|101871101|FG001|Eligible and Treated|Overall Study||16||
48627724|NCT01079780|101871102|FG002|Eligible and Treated|Overall Study||45||
48627725|NCT01079780|101871100|FG000|Analyzable Patients for Efficacy Analysis|Overall Study||44||
48627726|NCT01079780|101871101|FG001|Analyzable Patients for Efficacy Analysis|Overall Study||0||
48627727|NCT01079780|101871102|FG002|Analyzable Patients for Efficacy Analysis|Overall Study||45||
48627728|NCT01079780|101871100|FG000|COMPLETED|Overall Study||0||
48171046|NCT02010697|100742395|FG001|NOT COMPLETED|Overall Study||0||
48171047|NCT02010697|100742396|FG002|NOT COMPLETED|Overall Study||0||
48171048|NCT03599986|100742397|FG000|STARTED|Overall Study||398||
48171049|NCT03599986|100742397|FG000|COMPLETED|Overall Study||366||
48171050|NCT03599986|100742397|FG000|NOT COMPLETED|Overall Study||32||
48171051|NCT01598428|100742398|FG000|STARTED|Overall Study||20||
48627729|NCT01079780|101871101|FG001|COMPLETED|Overall Study||0||
48171052|NCT01598428|100742398|FG000|COMPLETED|Overall Study||20||
48171053|NCT01598428|100742398|FG000|NOT COMPLETED|Overall Study||0||
48171054|NCT01630590|100742399|FG000|STARTED|Overall Study||62||
48171055|NCT01630590|100742399|FG000|COMPLETED|Overall Study||5||
48171056|NCT01630590|100742399|FG000|NOT COMPLETED|Overall Study||57||
48627730|NCT01079780|101871102|FG002|COMPLETED|Overall Study||0||
48627731|NCT01079780|101871100|FG000|NOT COMPLETED|Overall Study||70||
48627732|NCT01079780|101871101|FG001|NOT COMPLETED|Overall Study||16||
48171057|NCT01596283|100742400|FG000|STARTED|Overall Study||69||
48171058|NCT01596283|100742401|FG001|STARTED|Overall Study||66||
48171059|NCT01596283|100742400|FG000|COMPLETED|Overall Study||69||
48171060|NCT01596283|100742401|FG001|COMPLETED|Overall Study||66||
48171061|NCT01596283|100742400|FG000|NOT COMPLETED|Overall Study||0||
48171062|NCT01596283|100742401|FG001|NOT COMPLETED|Overall Study||0||
48171063|NCT02132533|100742402|FG000|STARTED|Overall Study||46||
48171064|NCT02132533|100742403|FG001|STARTED|Overall Study||42||
48171065|NCT02132533|100742402|FG000|COMPLETED|Overall Study||46||
48171066|NCT02132533|100742403|FG001|COMPLETED|Overall Study||42||
48171067|NCT02132533|100742402|FG000|NOT COMPLETED|Overall Study||0||
48171068|NCT02132533|100742403|FG001|NOT COMPLETED|Overall Study||0||
48171069|NCT00125593|100742404|FG000|STARTED|Overall Study||4650||
48171070|NCT00125593|100742405|FG001|STARTED|Overall Study||4620||
48171071|NCT00125593|100742404|FG000|COMPLETED|Overall Study||4549||
48171072|NCT00125593|100742405|FG001|COMPLETED|Overall Study||4517||
48171073|NCT00125593|100742404|FG000|NOT COMPLETED|Overall Study||101||
48171074|NCT00125593|100742405|FG001|NOT COMPLETED|Overall Study||103||
48171075|NCT00098254|100742406|FG000|STARTED|Overall Study||37||
48171076|NCT00098254|100742406|FG000|COMPLETED|Overall Study||34||
48171077|NCT00098254|100742406|FG000|NOT COMPLETED|Overall Study||3||
48171078|NCT02906202|100742407|FG000|STARTED|Overall Study||24||
48171079|NCT02906202|100742407|FG000|Transplant Population|Overall Study||23||
48171080|NCT02906202|100742407|FG000|COMPLETED|Overall Study||23||
48171081|NCT02906202|100742407|FG000|NOT COMPLETED|Overall Study||1||
48171082|NCT01613027|100742408|FG000|STARTED|Overall Study||135||
48171083|NCT01613027|100742408|FG000|COMPLETED|Overall Study||127||
48333676|NCT02574637|101145519|FG001|NOT COMPLETED|Open-label (OL) Period||0||
48333677|NCT02574637|101145520|FG002|NOT COMPLETED|Open-label (OL) Period||0||
48333678|NCT02574637|101145521|FG003|NOT COMPLETED|Open-label (OL) Period||0||
48333679|NCT02574637|101145522|FG004|NOT COMPLETED|Open-label (OL) Period||0||
48171084|NCT01613027|100742408|FG000|NOT COMPLETED|Overall Study||8||
48171085|NCT02354859|100742409|FG000|STARTED|Overall Study||60|Treated, defined as randomized and started on study drug (IV gallium or placebo)|
48171086|NCT02354859|100742410|FG001|STARTED|Overall Study||59|Treated, defined as randomized and started on study drug (IV gallium or placebo)|
48171087|NCT02354859|100742409|FG000|COMPLETED|Overall Study||60|Completed last study visit (Day 56)|
48171088|NCT02354859|100742410|FG001|COMPLETED|Overall Study||57|Completed last study visit (Day 56)|
48171089|NCT02354859|100742409|FG000|NOT COMPLETED|Overall Study||0||
48171090|NCT02354859|100742410|FG001|NOT COMPLETED|Overall Study||2||
48171091|NCT01097915|100742411|FG000|STARTED|Overall Study||50||
48171092|NCT01097915|100742412|FG001|STARTED|Overall Study||70||
48171093|NCT01097915|100742413|FG002|STARTED|Overall Study||50||
48171094|NCT01097915|100742411|FG000|COMPLETED|Overall Study||27||
48171095|NCT01097915|100742412|FG001|COMPLETED|Overall Study||28||
48171096|NCT01097915|100742413|FG002|COMPLETED|Overall Study||20||
48171097|NCT01097915|100742411|FG000|NOT COMPLETED|Overall Study||23||
48171098|NCT01097915|100742412|FG001|NOT COMPLETED|Overall Study||42||
48171099|NCT01097915|100742413|FG002|NOT COMPLETED|Overall Study||30||
48171100|NCT01382940|100742414|FG000|STARTED|Overall Study||351||
48171101|NCT01382940|100742414|FG000|Received Day 1 Infusion|Overall Study||351||
48333680|NCT02574637|101145523|FG005|NOT COMPLETED|Open-label (OL) Period||2||
48333681|NCT02574637|101145524|FG006|NOT COMPLETED|Open-label (OL) Period||2||
48333682|NCT02574637|101145525|FG007|NOT COMPLETED|Open-label (OL) Period||1||
48333683|NCT02574637|101145526|FG008|NOT COMPLETED|Open-label (OL) Period||2||
48333684|NCT02574637|101145527|FG009|NOT COMPLETED|Open-label (OL) Period||1||
48333685|NCT01116544|101145528|FG000|STARTED|Overall Study||23||
48333686|NCT01116544|101145529|FG001|STARTED|Overall Study||23||
48333687|NCT01116544|101145528|FG000|COMPLETED|Overall Study||21||
48333688|NCT01116544|101145529|FG001|COMPLETED|Overall Study||22||
48333689|NCT01116544|101145528|FG000|NOT COMPLETED|Overall Study||2||
48333690|NCT01116544|101145529|FG001|NOT COMPLETED|Overall Study||1||
48411673|NCT04315298|101341816|FG010|COMPLETED|Overall Study||53||
48171102|NCT01382940|100742414|FG000|Received Day 15 Infusions|Overall Study||341||
48171103|NCT01382940|100742414|FG000|Received Day 168 Infusion|Overall Study||290||
48171104|NCT01382940|100742414|FG000|Received Day 182 Infusion|Overall Study||278||
48171105|NCT01382940|100742414|FG000|COMPLETED|Overall Study||278||
48171106|NCT01382940|100742414|FG000|NOT COMPLETED|Overall Study||73||
48171107|NCT03119610|100742415|FG000|STARTED|Overall Study||13||
48171108|NCT03119610|100742416|FG001|STARTED|Overall Study||10||
48171109|NCT03119610|100742415|FG000|COMPLETED|Overall Study||12||
48411674|NCT04315298|101341817|FG011|COMPLETED|Overall Study||51||
48171110|NCT03119610|100742416|FG001|COMPLETED|Overall Study||9||
48171111|NCT03119610|100742415|FG000|NOT COMPLETED|Overall Study||1||
48171112|NCT03119610|100742416|FG001|NOT COMPLETED|Overall Study||1||
48171113|NCT01463293|100742417|FG000|STARTED|Overall Study||74||
48171114|NCT01463293|100742418|FG001|STARTED|Overall Study||79||
48171115|NCT01463293|100742419|FG002|STARTED|Overall Study||71||
48171116|NCT01463293|100742417|FG000|COMPLETED|Overall Study||68||
48171117|NCT01463293|100742418|FG001|COMPLETED|Overall Study||63||
48171118|NCT01463293|100742419|FG002|COMPLETED|Overall Study||59||
48171119|NCT01463293|100742417|FG000|NOT COMPLETED|Overall Study||6||
48171120|NCT01463293|100742418|FG001|NOT COMPLETED|Overall Study||16||
48171121|NCT01463293|100742419|FG002|NOT COMPLETED|Overall Study||12||
48171122|NCT01432015|100742420|FG000|STARTED|Overall Study||10||
48171123|NCT01432015|100742421|FG001|STARTED|Overall Study||10||
48171124|NCT01432015|100742420|FG000|COMPLETED|Overall Study||10||
48171125|NCT01432015|100742421|FG001|COMPLETED|Overall Study||10||
48171126|NCT01432015|100742420|FG000|NOT COMPLETED|Overall Study||0||
48171127|NCT01432015|100742421|FG001|NOT COMPLETED|Overall Study||0||
48171128|NCT01544582|100742422|FG000|STARTED|Screening/Eligibility||713||
48627733|NCT01079780|101871102|FG002|NOT COMPLETED|Overall Study||50||
48750812|NCT01451723|102177277|FG001|STARTED|Overall Study||5||
48750813|NCT01451723|102177276|FG000|COMPLETED|Overall Study||0||
48750814|NCT01451723|102177277|FG001|COMPLETED|Overall Study||0||
48750815|NCT01451723|102177276|FG000|NOT COMPLETED|Overall Study||6||
48750816|NCT01451723|102177277|FG001|NOT COMPLETED|Overall Study||5||
48750817|NCT02872116|102177278|FG000|STARTED|Pre-Treatment||789|= Randomized|
48750818|NCT02872116|102177279|FG001|STARTED|Pre-Treatment||833|= Randomized|
48750819|NCT02872116|102177280|FG002|STARTED|Pre-Treatment||409|= Randomized|
48171129|NCT01544582|100742423|FG001|STARTED|Screening/Eligibility||0||
48171130|NCT01544582|100742424|FG002|STARTED|Screening/Eligibility||0||
48171131|NCT01544582|100742425|FG003|STARTED|Screening/Eligibility||0||
48171132|NCT01544582|100742422|FG000|Analysis Population|Screening/Eligibility||679||
48171133|NCT01544582|100742423|FG001|Analysis Population|Screening/Eligibility||0||
48171134|NCT01544582|100742424|FG002|Analysis Population|Screening/Eligibility||0||
48171135|NCT01544582|100742425|FG003|Analysis Population|Screening/Eligibility||0||
48627734|NCT01042795|101871103|FG000|STARTED|Dosing Period - 16 Weeks of Daily Doses||7||
48627735|NCT01042795|101871103|FG000|COMPLETED|Dosing Period - 16 Weeks of Daily Doses||2||
48627736|NCT01042795|101871103|FG000|NOT COMPLETED|Dosing Period - 16 Weeks of Daily Doses||5||
48627737|NCT01042795|101871103|FG000|STARTED|Follow up - 22 Months After Drug Start||2||
48627738|NCT01042795|101871103|FG000|COMPLETED|Follow up - 22 Months After Drug Start||0||
48627739|NCT01042795|101871103|FG000|NOT COMPLETED|Follow up - 22 Months After Drug Start||2||
48627740|NCT00116688|101871104|FG000|STARTED|Overall Study||292||
48627741|NCT00116688|101871105|FG001|STARTED|Overall Study||21||
48627742|NCT00116688|101871104|FG000|Received Study Medication|Overall Study||291||
48627743|NCT00116688|101871105|FG001|Received Study Medication|Overall Study||20||
48627744|NCT00116688|101871104|FG000|COMPLETED|Overall Study||200||
48627745|NCT00116688|101871105|FG001|COMPLETED|Overall Study||17||
48627746|NCT00116688|101871104|FG000|NOT COMPLETED|Overall Study||92||
48627747|NCT00116688|101871105|FG001|NOT COMPLETED|Overall Study||4||
48627748|NCT00315341|101871106|FG000|STARTED|Overall Study||740||
48627749|NCT00315341|101871107|FG001|STARTED|Overall Study||529||
48627750|NCT00315341|101871106|FG000|COMPLETED|Overall Study||340||
48627751|NCT00315341|101871107|FG001|COMPLETED|Overall Study||391||
48627752|NCT00315341|101871106|FG000|NOT COMPLETED|Overall Study||400||
48627753|NCT00315341|101871107|FG001|NOT COMPLETED|Overall Study||138||
48627754|NCT04264208|101871108|FG000|STARTED|Pre-HDR Scan Sequence||1||
48627755|NCT04264208|101871109|FG001|STARTED|Pre-HDR Scan Sequence||2||
48627756|NCT04264208|101871108|FG000|Received First Scan in Sequence|Pre-HDR Scan Sequence||1||
48627757|NCT04264208|101871109|FG001|Received First Scan in Sequence|Pre-HDR Scan Sequence||2||
48627758|NCT04264208|101871108|FG000|Received Second Scan in Sequence|Pre-HDR Scan Sequence||0||
48627759|NCT04264208|101871109|FG001|Received Second Scan in Sequence|Pre-HDR Scan Sequence||1||
48627760|NCT04264208|101871108|FG000|COMPLETED|Pre-HDR Scan Sequence||1||
48627761|NCT04264208|101871109|FG001|COMPLETED|Pre-HDR Scan Sequence||2||
48627762|NCT04264208|101871108|FG000|NOT COMPLETED|Pre-HDR Scan Sequence||0||
48627763|NCT04264208|101871109|FG001|NOT COMPLETED|Pre-HDR Scan Sequence||0||
48627764|NCT04264208|101871108|FG000|STARTED|HDR Treatment at 2 Months||1||
48627765|NCT04264208|101871109|FG001|STARTED|HDR Treatment at 2 Months||2||
48627766|NCT04264208|101871108|FG000|COMPLETED|HDR Treatment at 2 Months||1||
48627767|NCT04264208|101871109|FG001|COMPLETED|HDR Treatment at 2 Months||2||
48627768|NCT04264208|101871108|FG000|NOT COMPLETED|HDR Treatment at 2 Months||0||
48627769|NCT04264208|101871109|FG001|NOT COMPLETED|HDR Treatment at 2 Months||0||
48627770|NCT04264208|101871108|FG000|STARTED|Post-HDR Scan Sequence at 10 Months||1||
48627771|NCT04264208|101871109|FG001|STARTED|Post-HDR Scan Sequence at 10 Months||2||
48627772|NCT04264208|101871108|FG000|Received First Scan in Sequence|Post-HDR Scan Sequence at 10 Months||0||
48627773|NCT04264208|101871109|FG001|Received First Scan in Sequence|Post-HDR Scan Sequence at 10 Months||1||
48627774|NCT04264208|101871108|FG000|Received Second Scan in Sequence|Post-HDR Scan Sequence at 10 Months||0||
48750820|NCT02872116|102177278|FG000|COMPLETED|Pre-Treatment||782|= Moving to treatment period|
48750821|NCT02872116|102177279|FG001|COMPLETED|Pre-Treatment||806|= Moving to treatment period|
48750822|NCT02872116|102177280|FG002|COMPLETED|Pre-Treatment||403|= Moving to treatment period|
48750823|NCT02872116|102177278|FG000|NOT COMPLETED|Pre-Treatment||7||
48171136|NCT01544582|100742422|FG000|COMPLETED|Screening/Eligibility||679||
48171137|NCT01544582|100742423|FG001|COMPLETED|Screening/Eligibility||0||
48171138|NCT01544582|100742424|FG002|COMPLETED|Screening/Eligibility||0||
48171139|NCT01544582|100742425|FG003|COMPLETED|Screening/Eligibility||0||
48171140|NCT01544582|100742422|FG000|NOT COMPLETED|Screening/Eligibility||34||
48333691|NCT02475655|101145530|FG000|STARTED|Overall Study||40||
48171141|NCT01544582|100742423|FG001|NOT COMPLETED|Screening/Eligibility||0||
48627775|NCT04264208|101871109|FG001|Received Second Scan in Sequence|Post-HDR Scan Sequence at 10 Months||1||
48627776|NCT04264208|101871108|FG000|COMPLETED|Post-HDR Scan Sequence at 10 Months||1||
48627777|NCT04264208|101871109|FG001|COMPLETED|Post-HDR Scan Sequence at 10 Months||2||
48627778|NCT04264208|101871108|FG000|NOT COMPLETED|Post-HDR Scan Sequence at 10 Months||0||
48627779|NCT04264208|101871109|FG001|NOT COMPLETED|Post-HDR Scan Sequence at 10 Months||0||
48627780|NCT00087178|101871110|FG000|STARTED|Overall Study||1361||
48627781|NCT00087178|101871111|FG001|STARTED|Overall Study||1361||
48627782|NCT00087178|101871110|FG000|COMPLETED|Overall Study||1355||
48627783|NCT00087178|101871111|FG001|COMPLETED|Overall Study||1343||
48627784|NCT00087178|101871110|FG000|NOT COMPLETED|Overall Study||6||
48627785|NCT00087178|101871111|FG001|NOT COMPLETED|Overall Study||18||
48627786|NCT03191799|101871112|FG000|STARTED|Overall Study||195|Intent-to-Treat (ITT) Population|
48627787|NCT03191799|101871112|FG000|Received at Least One Dose of Emicizumab|Overall Study||193|Safety Population|
48627788|NCT03191799|101871112|FG000|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2||
48627789|NCT03191799|101871112|FG000|COMPLETED|Overall Study||186||
48627790|NCT03191799|101871112|FG000|NOT COMPLETED|Overall Study||9||
48627791|NCT01107925|101871113|FG000|STARTED|Period 1-Randomization up Through Day 12||34||
48627792|NCT01107925|101871114|FG001|STARTED|Period 1-Randomization up Through Day 12||0||
48627793|NCT01107925|101871115|FG002|STARTED|Period 1-Randomization up Through Day 12||0||
48627794|NCT01107925|101871116|FG003|STARTED|Period 1-Randomization up Through Day 12||0||
48627795|NCT01107925|101871117|FG004|STARTED|Period 1-Randomization up Through Day 12||38||
48627796|NCT01107925|101871118|FG005|STARTED|Period 1-Randomization up Through Day 12||0||
48627797|NCT01107925|101871113|FG000|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||34||
48627798|NCT01107925|101871114|FG001|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0||
48627799|NCT01107925|101871115|FG002|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0||
48627800|NCT01107925|101871116|FG003|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0||
48333692|NCT02475655|101145531|FG001|STARTED|Overall Study||20||
48333693|NCT02475655|101145530|FG000|COMPLETED|Overall Study||40||
48333694|NCT02475655|101145531|FG001|COMPLETED|Overall Study||19||
48333695|NCT02475655|101145530|FG000|NOT COMPLETED|Overall Study||0||
48333696|NCT02475655|101145531|FG001|NOT COMPLETED|Overall Study||1||
48333697|NCT00648167|101145532|FG000|STARTED|Overall Study||55||
48333698|NCT00648167|101145532|FG000|Start Dose 4.5 g/Day|Overall Study||34||
48333699|NCT00648167|101145532|FG000|Start Dose 6 g/Day|Overall Study||21||
48333700|NCT00648167|101145532|FG000|COMPLETED|Overall Study||48||
48333701|NCT00648167|101145532|FG000|NOT COMPLETED|Overall Study||7||
48333702|NCT04926779|101145533|FG000|STARTED|Overall Study||185||
48333703|NCT04926779|101145533|FG000|COMPLETED|Overall Study||185||
48333704|NCT04926779|101145533|FG000|NOT COMPLETED|Overall Study||0||
48333705|NCT02600507|101145534|FG000|STARTED|Overall Study||176||
48333706|NCT02600507|101145535|FG001|STARTED|Overall Study||177||
48333707|NCT02600507|101145536|FG002|STARTED|Overall Study||175||
48333708|NCT02600507|101145534|FG000|COMPLETED|Overall Study||147||
48333709|NCT02600507|101145535|FG001|COMPLETED|Overall Study||133||
48333710|NCT02600507|101145536|FG002|COMPLETED|Overall Study||150||
48333711|NCT02600507|101145534|FG000|NOT COMPLETED|Overall Study||29||
48333712|NCT02600507|101145535|FG001|NOT COMPLETED|Overall Study||44||
48333713|NCT02600507|101145536|FG002|NOT COMPLETED|Overall Study||25||
48333714|NCT03790280|101145537|FG000|STARTED|Overall Study||8||
48333715|NCT03790280|101145538|FG001|STARTED|Overall Study||9||
48333716|NCT03790280|101145537|FG000|COMPLETED|Overall Study||7||
48411675|NCT04315298|101341818|FG012|COMPLETED|Overall Study||5||
48627801|NCT01107925|101871117|FG004|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||38||
48627802|NCT01107925|101871118|FG005|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0||
48627803|NCT01107925|101871113|FG000|COMPLETED|Period 1-Randomization up Through Day 12||33||
48627804|NCT01107925|101871114|FG001|COMPLETED|Period 1-Randomization up Through Day 12||0||
48627805|NCT01107925|101871115|FG002|COMPLETED|Period 1-Randomization up Through Day 12||0||
48627806|NCT01107925|101871116|FG003|COMPLETED|Period 1-Randomization up Through Day 12||0||
48627807|NCT01107925|101871117|FG004|COMPLETED|Period 1-Randomization up Through Day 12||37||
48627808|NCT01107925|101871118|FG005|COMPLETED|Period 1-Randomization up Through Day 12||0||
48627809|NCT01107925|101871113|FG000|NOT COMPLETED|Period 1-Randomization up Through Day 12||1||
48627810|NCT01107925|101871114|FG001|NOT COMPLETED|Period 1-Randomization up Through Day 12||0||
48750824|NCT02872116|102177279|FG001|NOT COMPLETED|Pre-Treatment||27||
48750825|NCT02872116|102177280|FG002|NOT COMPLETED|Pre-Treatment||6||
48333717|NCT03790280|101145538|FG001|COMPLETED|Overall Study||9||
48333718|NCT03790280|101145537|FG000|NOT COMPLETED|Overall Study||1||
48333719|NCT03790280|101145538|FG001|NOT COMPLETED|Overall Study||0||
48333720|NCT00540579|101145539|FG000|STARTED|Overall Study||23||
48333721|NCT00540579|101145539|FG000|COMPLETED|Overall Study||23||
48333722|NCT00540579|101145539|FG000|NOT COMPLETED|Overall Study||0||
48333723|NCT01480297|101145540|FG000|STARTED|Overall Study||8||
48333724|NCT01480297|101145540|FG000|COMPLETED|Overall Study||8||
48333725|NCT01480297|101145540|FG000|NOT COMPLETED|Overall Study||0||
48333726|NCT01583894|101145541|FG000|STARTED|Overall Study||828||
48333727|NCT01583894|101145541|FG000|COMPLETED|Overall Study||813||
48333728|NCT01583894|101145541|FG000|NOT COMPLETED|Overall Study||15||
48333729|NCT00700180|101145542|FG000|STARTED|Overall Study||154||
48333730|NCT00700180|101145543|FG001|STARTED|Overall Study||149||
48333731|NCT00700180|101145542|FG000|COMPLETED|Overall Study||0||
48333732|NCT00700180|101145543|FG001|COMPLETED|Overall Study||0||
48333733|NCT00700180|101145542|FG000|NOT COMPLETED|Overall Study||154||
48333734|NCT00700180|101145543|FG001|NOT COMPLETED|Overall Study||149||
48333735|NCT00044512|101145544|FG000|STARTED|Treatment||137||
48333736|NCT00044512|101145544|FG000|COMPLETED|Treatment||137||
48333737|NCT00044512|101145544|FG000|NOT COMPLETED|Treatment||0||
48333738|NCT00044512|101145544|FG000|STARTED|Follow Up||137||
48333739|NCT00044512|101145544|FG000|COMPLETED|Follow Up||135||
48333740|NCT00044512|101145544|FG000|NOT COMPLETED|Follow Up||2||
48333741|NCT01761266|101145545|FG000|STARTED|Overall Study||478||
48333742|NCT01761266|101145546|FG001|STARTED|Overall Study||476||
48333743|NCT01761266|101145545|FG000|Treated|Overall Study||476||
48333744|NCT01761266|101145546|FG001|Treated|Overall Study||475||
48333745|NCT01761266|101145545|FG000|COMPLETED|Overall Study||0||
48333746|NCT01761266|101145546|FG001|COMPLETED|Overall Study||0||
48333747|NCT01761266|101145545|FG000|NOT COMPLETED|Overall Study||478||
48333748|NCT01761266|101145546|FG001|NOT COMPLETED|Overall Study||476||
48333749|NCT01164722|101145547|FG000|STARTED|Overall Study||60||
48333750|NCT01164722|101145548|FG001|STARTED|Overall Study||60||
48333751|NCT01164722|101145547|FG000|COMPLETED|Overall Study||42||
48333752|NCT01164722|101145548|FG001|COMPLETED|Overall Study||45||
48333753|NCT01164722|101145547|FG000|NOT COMPLETED|Overall Study||18||
48333754|NCT01164722|101145548|FG001|NOT COMPLETED|Overall Study||15||
48333755|NCT02599961|101145549|FG000|STARTED|Overall Study||15||
48333756|NCT02599961|101145549|FG000|COMPLETED|Overall Study||0||
48333757|NCT02599961|101145549|FG000|NOT COMPLETED|Overall Study||15||
48333758|NCT01557166|101145550|FG000|STARTED|Overall Study||180||
48333759|NCT01557166|101145551|FG001|STARTED|Overall Study||179||
48333760|NCT01557166|101145550|FG000|Exposed|Overall Study||176||
48627811|NCT01107925|101871115|FG002|NOT COMPLETED|Period 1-Randomization up Through Day 12||0||
48627812|NCT01107925|101871116|FG003|NOT COMPLETED|Period 1-Randomization up Through Day 12||0||
48333761|NCT01557166|101145551|FG001|Exposed|Overall Study||179||
48333762|NCT01557166|101145550|FG000|COMPLETED|Overall Study||134||
48333763|NCT01557166|101145551|FG001|COMPLETED|Overall Study||142||
48333764|NCT01557166|101145550|FG000|NOT COMPLETED|Overall Study||46||
48333765|NCT01557166|101145551|FG001|NOT COMPLETED|Overall Study||37||
48333766|NCT00684515|101145552|FG000|STARTED|Overall Study||33||
48333767|NCT00684515|101145553|FG001|STARTED|Overall Study||29||
48333768|NCT00684515|101145554|FG002|STARTED|Overall Study||28||
48333769|NCT00684515|101145552|FG000|COMPLETED|Overall Study||29||
48333770|NCT00684515|101145553|FG001|COMPLETED|Overall Study||26||
48333771|NCT00684515|101145554|FG002|COMPLETED|Overall Study||27||
48333772|NCT00684515|101145552|FG000|NOT COMPLETED|Overall Study||4||
48333773|NCT00684515|101145553|FG001|NOT COMPLETED|Overall Study||3||
48333774|NCT00684515|101145554|FG002|NOT COMPLETED|Overall Study||1||
48333775|NCT01827384|101145555|FG000|STARTED|Overall Study||13||
48333776|NCT01827384|101145556|FG001|STARTED|Overall Study||1||
48333777|NCT01827384|101145557|FG002|STARTED|Overall Study||9||
48333778|NCT01827384|101145558|FG003|STARTED|Overall Study||1||
48333779|NCT01827384|101145559|FG004|STARTED|Overall Study||1||
48333780|NCT01827384|101145560|FG005|STARTED|Overall Study||22||
48333781|NCT01827384|101145561|FG006|STARTED|Overall Study||2||
48333782|NCT01827384|101145562|FG007|STARTED|Overall Study||1||
48333783|NCT01827384|101145563|FG008|STARTED|Overall Study||2||
48333784|NCT01827384|101145564|FG009|STARTED|Overall Study||15||
48333785|NCT01827384|101145565|FG010|STARTED|Overall Study||7||
48333786|NCT01827384|101145566|FG011|STARTED|Overall Study||1||
48333787|NCT01827384|101145567|FG012|STARTED|Overall Study||2||
48333788|NCT01827384|101145568|FG013|STARTED|Overall Study||131||
48333789|NCT01827384|101145555|FG000|COMPLETED|Overall Study||13||
48333790|NCT01827384|101145556|FG001|COMPLETED|Overall Study||1||
48627813|NCT01107925|101871117|FG004|NOT COMPLETED|Period 1-Randomization up Through Day 12||1||
48627814|NCT01107925|101871118|FG005|NOT COMPLETED|Period 1-Randomization up Through Day 12||0||
48333791|NCT01827384|101145557|FG002|COMPLETED|Overall Study||9||
48333792|NCT01827384|101145558|FG003|COMPLETED|Overall Study||1||
48333793|NCT01827384|101145559|FG004|COMPLETED|Overall Study||1||
48333794|NCT01827384|101145560|FG005|COMPLETED|Overall Study||22||
48333795|NCT01827384|101145561|FG006|COMPLETED|Overall Study||2||
48333796|NCT01827384|101145562|FG007|COMPLETED|Overall Study||1||
48333797|NCT01827384|101145563|FG008|COMPLETED|Overall Study||2||
48333798|NCT01827384|101145564|FG009|COMPLETED|Overall Study||15||
48333799|NCT01827384|101145565|FG010|COMPLETED|Overall Study||7||
48333800|NCT01827384|101145566|FG011|COMPLETED|Overall Study||1||
48333801|NCT01827384|101145567|FG012|COMPLETED|Overall Study||2||
48627815|NCT01107925|101871113|FG000|STARTED|Period 2||0||
48627816|NCT01107925|101871114|FG001|STARTED|Period 2||16||
48333802|NCT01827384|101145568|FG013|COMPLETED|Overall Study||0||
48333803|NCT01827384|101145555|FG000|NOT COMPLETED|Overall Study||0||
48333804|NCT01827384|101145556|FG001|NOT COMPLETED|Overall Study||0||
48333805|NCT01827384|101145557|FG002|NOT COMPLETED|Overall Study||0||
48411676|NCT04315298|101341819|FG013|COMPLETED|Overall Study||8||
48333806|NCT01827384|101145558|FG003|NOT COMPLETED|Overall Study||0||
48333807|NCT01827384|101145559|FG004|NOT COMPLETED|Overall Study||0||
48333808|NCT01827384|101145560|FG005|NOT COMPLETED|Overall Study||0||
48333809|NCT01827384|101145561|FG006|NOT COMPLETED|Overall Study||0||
48333810|NCT01827384|101145562|FG007|NOT COMPLETED|Overall Study||0||
48333811|NCT01827384|101145563|FG008|NOT COMPLETED|Overall Study||0||
48333812|NCT01827384|101145564|FG009|NOT COMPLETED|Overall Study||0||
48333813|NCT01827384|101145565|FG010|NOT COMPLETED|Overall Study||0||
48333814|NCT01827384|101145566|FG011|NOT COMPLETED|Overall Study||0||
48333815|NCT01827384|101145567|FG012|NOT COMPLETED|Overall Study||0||
48333816|NCT01827384|101145568|FG013|NOT COMPLETED|Overall Study||131||
48333817|NCT03472560|101145569|FG000|STARTED|Overall Study||41||
48333818|NCT03472560|101145570|FG001|STARTED|Overall Study||20||
48333819|NCT03472560|101145569|FG000|COMPLETED|Overall Study||0||
48333820|NCT03472560|101145570|FG001|COMPLETED|Overall Study||0||
48333821|NCT03472560|101145569|FG000|NOT COMPLETED|Overall Study||41||
48333822|NCT03472560|101145570|FG001|NOT COMPLETED|Overall Study||20||
48333823|NCT01407926|101145571|FG000|STARTED|Overall Study||142||
48333824|NCT01407926|101145571|FG000|COMPLETED|Overall Study||87||
48333825|NCT01407926|101145571|FG000|NOT COMPLETED|Overall Study||55||
48333826|NCT01014585|101145572|FG000|STARTED|Overall Study||51||
48333827|NCT01014585|101145573|FG001|STARTED|Overall Study||100||
48333828|NCT01014585|101145574|FG002|STARTED|Overall Study||60||
48333829|NCT01014585|101145575|FG003|STARTED|Overall Study||129||
48333830|NCT01014585|101145572|FG000|COMPLETED|Overall Study||31||
48333831|NCT01014585|101145573|FG001|COMPLETED|Overall Study||75||
48333832|NCT01014585|101145574|FG002|COMPLETED|Overall Study||37||
48333833|NCT01014585|101145575|FG003|COMPLETED|Overall Study||99||
48333834|NCT01014585|101145572|FG000|NOT COMPLETED|Overall Study||20||
48333835|NCT01014585|101145573|FG001|NOT COMPLETED|Overall Study||25||
48333836|NCT01014585|101145574|FG002|NOT COMPLETED|Overall Study||23||
48333837|NCT01014585|101145575|FG003|NOT COMPLETED|Overall Study||30||
48333838|NCT01363986|101145576|FG000|STARTED|Overall Study||3||
48333839|NCT01363986|101145576|FG000|COMPLETED|Overall Study||2||
48333840|NCT01363986|101145576|FG000|NOT COMPLETED|Overall Study||1||
48333841|NCT02356562|101145577|FG000|STARTED|Overall Study||22||
48333842|NCT02356562|101145578|FG001|STARTED|Overall Study||7||
48333843|NCT02356562|101145577|FG000|COMPLETED|Overall Study||20||
48333844|NCT02356562|101145578|FG001|COMPLETED|Overall Study||6||
48333845|NCT02356562|101145577|FG000|NOT COMPLETED|Overall Study||2||
48333846|NCT02356562|101145578|FG001|NOT COMPLETED|Overall Study||1||
48333847|NCT00355394|101145579|FG000|STARTED|Overall Study||15||
48333848|NCT00355394|101145580|FG001|STARTED|Overall Study||16||
48333849|NCT00355394|101145579|FG000|COMPLETED|Overall Study||15||
48333850|NCT00355394|101145580|FG001|COMPLETED|Overall Study||16||
48333851|NCT00355394|101145579|FG000|NOT COMPLETED|Overall Study||0||
48333852|NCT00355394|101145580|FG001|NOT COMPLETED|Overall Study||0||
48333853|NCT02623335|101145581|FG000|STARTED|Overall Study||223||
48333854|NCT02623335|101145582|FG001|STARTED|Overall Study||223||
48333855|NCT02623335|101145581|FG000|T0 Audio Recording (Day of Consultation)|Overall Study||223||
48333856|NCT02623335|101145582|FG001|T0 Audio Recording (Day of Consultation)|Overall Study||222||
48333857|NCT02623335|101145581|FG000|T1 Survey (24-48 Hours)|Overall Study||216||
48333858|NCT02623335|101145582|FG001|T1 Survey (24-48 Hours)|Overall Study||214||
48333859|NCT02623335|101145581|FG000|T2 Survey (6-8 Weeks)|Overall Study||199||
48333860|NCT02623335|101145582|FG001|T2 Survey (6-8 Weeks)|Overall Study||192||
48333861|NCT02623335|101145581|FG000|T3 Survey (12-14 Weeks)|Overall Study||196||
48333862|NCT02623335|101145582|FG001|T3 Survey (12-14 Weeks)|Overall Study||187||
48333863|NCT02623335|101145581|FG000|COMPLETED|Overall Study||196||
48333864|NCT02623335|101145582|FG001|COMPLETED|Overall Study||187||
48750826|NCT02872116|102177278|FG000|STARTED|Treatment||782|Treated|
48333865|NCT02623335|101145581|FG000|NOT COMPLETED|Overall Study||27||
48333866|NCT02623335|101145582|FG001|NOT COMPLETED|Overall Study||36||
48333867|NCT00486278|101145583|FG000|STARTED|Overall Study||51||
48333868|NCT00486278|101145583|FG000|COMPLETED|Overall Study||42||
48333869|NCT00486278|101145583|FG000|NOT COMPLETED|Overall Study||9||
48333870|NCT00197054|101145584|FG000|STARTED|Overall Study||85||
48333871|NCT00197054|101145585|FG001|STARTED|Overall Study||85||
48333872|NCT00197054|101145586|FG002|STARTED|Overall Study||85||
48333873|NCT00197054|101145584|FG000|COMPLETED|Overall Study||68||
48333874|NCT00197054|101145585|FG001|COMPLETED|Overall Study||64||
48333875|NCT00197054|101145586|FG002|COMPLETED|Overall Study||73||
48333876|NCT00197054|101145584|FG000|NOT COMPLETED|Overall Study||17||
48333877|NCT00197054|101145585|FG001|NOT COMPLETED|Overall Study||21||
48333878|NCT00197054|101145586|FG002|NOT COMPLETED|Overall Study||12||
48333879|NCT00343512|101145587|FG000|STARTED|Overall Study||34||
48333880|NCT00343512|101145587|FG000|COMPLETED|Overall Study||32||
48333881|NCT00343512|101145587|FG000|NOT COMPLETED|Overall Study||2||
48333882|NCT02602223|101145588|FG000|STARTED|Overall Study||9||
48333883|NCT02602223|101145588|FG000|COMPLETED|Overall Study||9||
48333884|NCT02602223|101145588|FG000|NOT COMPLETED|Overall Study||0||
48333885|NCT00500682|101145589|FG000|STARTED|Overall Study||510||
48333886|NCT00500682|101145590|FG001|STARTED|Overall Study||510||
48333887|NCT00500682|101145589|FG000|COMPLETED|Overall Study||204||
48333888|NCT00500682|101145590|FG001|COMPLETED|Overall Study||223||
48333889|NCT00500682|101145589|FG000|NOT COMPLETED|Overall Study||306||
48333890|NCT00500682|101145590|FG001|NOT COMPLETED|Overall Study||287||
48750827|NCT02872116|102177279|FG001|STARTED|Treatment||806|Treated|
48750828|NCT02872116|102177280|FG002|STARTED|Treatment||403|Treated|
48750829|NCT02872116|102177278|FG000|COMPLETED|Treatment||623|Continuing in the study|
48750830|NCT02872116|102177279|FG001|COMPLETED|Treatment||653|Continuing in the study|
48750831|NCT02872116|102177280|FG002|COMPLETED|Treatment||319|Continuing in the study|
48750832|NCT02872116|102177278|FG000|NOT COMPLETED|Treatment||159||
48750833|NCT02872116|102177279|FG001|NOT COMPLETED|Treatment||153||
48750834|NCT02872116|102177280|FG002|NOT COMPLETED|Treatment||84||
48171142|NCT01544582|100742424|FG002|NOT COMPLETED|Screening/Eligibility||0||
48171143|NCT01544582|100742425|FG003|NOT COMPLETED|Screening/Eligibility||0||
48171144|NCT01544582|100742422|FG000|STARTED|Analysis Population||0||
48171145|NCT01544582|100742423|FG001|STARTED|Analysis Population||298||
48171146|NCT01544582|100742424|FG002|STARTED|Analysis Population||307||
48171147|NCT01544582|100742425|FG003|STARTED|Analysis Population||74||
48171148|NCT01544582|100742422|FG000|COMPLETED|Analysis Population||0||
48171149|NCT01544582|100742423|FG001|COMPLETED|Analysis Population||180||
48171150|NCT01544582|100742424|FG002|COMPLETED|Analysis Population||205||
48171151|NCT01544582|100742425|FG003|COMPLETED|Analysis Population||35||
48171152|NCT01544582|100742422|FG000|NOT COMPLETED|Analysis Population||0||
48171153|NCT01544582|100742423|FG001|NOT COMPLETED|Analysis Population||118||
48171154|NCT01544582|100742424|FG002|NOT COMPLETED|Analysis Population||102||
48171155|NCT01544582|100742425|FG003|NOT COMPLETED|Analysis Population||39||
48171156|NCT03487718|100742426|FG000|STARTED|Overall Study||12||
48171157|NCT03487718|100742427|FG001|STARTED|Overall Study||15||
48171158|NCT03487718|100742426|FG000|COMPLETED|Overall Study||11||
48171159|NCT03487718|100742427|FG001|COMPLETED|Overall Study||11||
48171160|NCT03487718|100742426|FG000|NOT COMPLETED|Overall Study||1||
48171161|NCT03487718|100742427|FG001|NOT COMPLETED|Overall Study||4||
48171162|NCT01146574|100742428|FG000|STARTED|Overall Study||1||
48171163|NCT01146574|100742429|FG001|STARTED|Overall Study||6||
48171164|NCT01146574|100742430|FG002|STARTED|Overall Study||11||
48171165|NCT01146574|100742431|FG003|STARTED|Overall Study||9||
48171166|NCT01146574|100742432|FG004|STARTED|Overall Study||8||
48171167|NCT01146574|100742433|FG005|STARTED|Overall Study||9||
48171168|NCT01146574|100742434|FG006|STARTED|Overall Study||6||
48171169|NCT01146574|100742428|FG000|COMPLETED|Overall Study||1||
48171170|NCT01146574|100742429|FG001|COMPLETED|Overall Study||5||
48171171|NCT01146574|100742430|FG002|COMPLETED|Overall Study||5||
48171172|NCT01146574|100742431|FG003|COMPLETED|Overall Study||7||
48171173|NCT01146574|100742432|FG004|COMPLETED|Overall Study||6||
48171174|NCT01146574|100742433|FG005|COMPLETED|Overall Study||8||
48171175|NCT01146574|100742434|FG006|COMPLETED|Overall Study||5||
48171176|NCT01146574|100742428|FG000|NOT COMPLETED|Overall Study||0||
48171177|NCT01146574|100742429|FG001|NOT COMPLETED|Overall Study||1||
48171178|NCT01146574|100742430|FG002|NOT COMPLETED|Overall Study||6||
48171179|NCT01146574|100742431|FG003|NOT COMPLETED|Overall Study||2||
48171180|NCT01146574|100742432|FG004|NOT COMPLETED|Overall Study||2||
48171181|NCT01146574|100742433|FG005|NOT COMPLETED|Overall Study||1||
48171182|NCT01146574|100742434|FG006|NOT COMPLETED|Overall Study||1||
48171183|NCT00064025|100742435|FG000|STARTED|Overall Study||75||
48171184|NCT00064025|100742435|FG000|COMPLETED|Overall Study||68||
48171185|NCT00064025|100742435|FG000|NOT COMPLETED|Overall Study||7||
48171186|NCT03285295|100742436|FG000|STARTED|Alinity s HBsAg||17095||
48171187|NCT03285295|100742437|FG001|STARTED|Alinity s HBsAg||438||
48171188|NCT03285295|100742438|FG002|STARTED|Alinity s HBsAg||403||
48171189|NCT03285295|100742439|FG003|STARTED|Alinity s HBsAg||0||
48171190|NCT03285295|100742440|FG004|STARTED|Alinity s HBsAg||51||
48171191|NCT03285295|100742436|FG000|COMPLETED|Alinity s HBsAg||16993||
48750835|NCT03634085|102177281|FG000|STARTED|Overall Study||8||
48750836|NCT03634085|102177282|FG001|STARTED|Overall Study||8||
48750837|NCT03634085|102177281|FG000|Period 1|Overall Study||8||
48750838|NCT03634085|102177282|FG001|Period 1|Overall Study||8||
48171192|NCT03285295|100742437|FG001|COMPLETED|Alinity s HBsAg||432||
48171193|NCT03285295|100742438|FG002|COMPLETED|Alinity s HBsAg||403||
48171194|NCT03285295|100742439|FG003|COMPLETED|Alinity s HBsAg||0||
48171195|NCT03285295|100742440|FG004|COMPLETED|Alinity s HBsAg||51||
48171196|NCT03285295|100742436|FG000|NOT COMPLETED|Alinity s HBsAg||102||
48171197|NCT03285295|100742437|FG001|NOT COMPLETED|Alinity s HBsAg||6||
48171198|NCT03285295|100742438|FG002|NOT COMPLETED|Alinity s HBsAg||0||
48171199|NCT03285295|100742439|FG003|NOT COMPLETED|Alinity s HBsAg||0||
48171200|NCT03285295|100742440|FG004|NOT COMPLETED|Alinity s HBsAg||0||
48171201|NCT03285295|100742436|FG000|STARTED|Alinity s HBsAg Confirmatory||8||
48171202|NCT03285295|100742437|FG001|STARTED|Alinity s HBsAg Confirmatory||432||
48171203|NCT03285295|100742438|FG002|STARTED|Alinity s HBsAg Confirmatory||3||
48171204|NCT03285295|100742439|FG003|STARTED|Alinity s HBsAg Confirmatory||0||
48171205|NCT03285295|100742440|FG004|STARTED|Alinity s HBsAg Confirmatory||0||
48750839|NCT03634085|102177281|FG000|Period 2|Overall Study||8||
48750840|NCT03634085|102177282|FG001|Period 2|Overall Study||8||
48750841|NCT03634085|102177281|FG000|Period 3|Overall Study||8||
48750842|NCT03634085|102177282|FG001|Period 3|Overall Study||8||
48171206|NCT03285295|100742436|FG000|COMPLETED|Alinity s HBsAg Confirmatory||8||
48171207|NCT03285295|100742437|FG001|COMPLETED|Alinity s HBsAg Confirmatory||432||
48750843|NCT03634085|102177281|FG000|Period 4|Overall Study||8||
48750844|NCT03634085|102177282|FG001|Period 4|Overall Study||0||
48171208|NCT03285295|100742438|FG002|COMPLETED|Alinity s HBsAg Confirmatory||3||
48411677|NCT04315298|101341820|FG014|COMPLETED|Overall Study||9||
48411678|NCT04315298|101341821|FG015|COMPLETED|Overall Study||9||
48411679|NCT04315298|101341822|FG016|COMPLETED|Overall Study||13||
48750845|NCT03634085|102177281|FG000|COMPLETED|Overall Study||7||
48750846|NCT03634085|102177282|FG001|COMPLETED|Overall Study||6||
48750847|NCT03634085|102177281|FG000|NOT COMPLETED|Overall Study||1||
48750848|NCT03634085|102177282|FG001|NOT COMPLETED|Overall Study||2||
48750849|NCT01217944|102177283|FG000|STARTED|Overall Study||106||
48750850|NCT01217944|102177284|FG001|STARTED|Overall Study||116||
48750851|NCT01217944|102177285|FG002|STARTED|Overall Study||55||
48750852|NCT01217944|102177283|FG000|Completed 3 Months|Overall Study||105||
48750853|NCT01217944|102177284|FG001|Completed 3 Months|Overall Study||116||
48750854|NCT01217944|102177285|FG002|Completed 3 Months|Overall Study||55||
48750855|NCT01217944|102177283|FG000|Completed 6 Months|Overall Study||103||
48750856|NCT01217944|102177284|FG001|Completed 6 Months|Overall Study||116||
48750857|NCT01217944|102177285|FG002|Completed 6 Months|Overall Study||55||
48750858|NCT01217944|102177283|FG000|COMPLETED|Overall Study||100||
48750859|NCT01217944|102177284|FG001|COMPLETED|Overall Study||112||
48750860|NCT01217944|102177285|FG002|COMPLETED|Overall Study||55||
48750861|NCT01217944|102177283|FG000|NOT COMPLETED|Overall Study||6||
48750862|NCT01217944|102177284|FG001|NOT COMPLETED|Overall Study||4||
48750863|NCT01217944|102177285|FG002|NOT COMPLETED|Overall Study||0||
48750864|NCT00467740|102177286|FG000|STARTED|Overall Study||54||
48750865|NCT00467740|102177287|FG001|STARTED|Overall Study||61||
48750866|NCT00467740|102177288|FG002|STARTED|Overall Study||60||
48750867|NCT00467740|102177289|FG003|STARTED|Overall Study||60||
48750868|NCT00467740|102177290|FG004|STARTED|Overall Study||61||
48750869|NCT00467740|102177286|FG000|COMPLETED|Overall Study||53||
48750870|NCT00467740|102177287|FG001|COMPLETED|Overall Study||58||
48750871|NCT00467740|102177288|FG002|COMPLETED|Overall Study||58||
48750872|NCT00467740|102177289|FG003|COMPLETED|Overall Study||59||
48750873|NCT00467740|102177290|FG004|COMPLETED|Overall Study||61||
48750874|NCT00467740|102177286|FG000|NOT COMPLETED|Overall Study||1||
48750875|NCT00467740|102177287|FG001|NOT COMPLETED|Overall Study||3||
48750876|NCT00467740|102177288|FG002|NOT COMPLETED|Overall Study||2||
48750877|NCT00467740|102177289|FG003|NOT COMPLETED|Overall Study||1||
48750878|NCT00467740|102177290|FG004|NOT COMPLETED|Overall Study||0||
48750879|NCT02868554|102177291|FG000|STARTED|Overall Study||10||
48750880|NCT02868554|102177292|FG001|STARTED|Overall Study||12||
48750881|NCT02868554|102177293|FG002|STARTED|Overall Study||12||
48750882|NCT02868554|102177291|FG000|COMPLETED|Overall Study||7||
48750883|NCT02868554|102177292|FG001|COMPLETED|Overall Study||12||
48750884|NCT02868554|102177293|FG002|COMPLETED|Overall Study||11||
48750885|NCT02868554|102177291|FG000|NOT COMPLETED|Overall Study||3||
48750886|NCT02868554|102177292|FG001|NOT COMPLETED|Overall Study||0||
48750887|NCT02868554|102177293|FG002|NOT COMPLETED|Overall Study||1||
48750888|NCT01173601|102177294|FG000|STARTED|Confirmation (CF) Phase, 3 Weeks||1416||
48750889|NCT01173601|102177295|FG001|STARTED|Confirmation (CF) Phase, 3 Weeks||0||
48750890|NCT01173601|102177296|FG002|STARTED|Confirmation (CF) Phase, 3 Weeks||0||
48750891|NCT01173601|102177297|FG003|STARTED|Confirmation (CF) Phase, 3 Weeks||0||
48171209|NCT03285295|100742439|FG003|COMPLETED|Alinity s HBsAg Confirmatory||0||
48171210|NCT03285295|100742440|FG004|COMPLETED|Alinity s HBsAg Confirmatory||0||
48750892|NCT01173601|102177298|FG004|STARTED|Confirmation (CF) Phase, 3 Weeks||0||
48750893|NCT01173601|102177294|FG000|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||21||
48750894|NCT01173601|102177295|FG001|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0||
48750895|NCT01173601|102177296|FG002|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0||
48750896|NCT01173601|102177297|FG003|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0||
48750897|NCT01173601|102177298|FG004|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0||
48411680|NCT04315298|101341823|FG017|COMPLETED|Overall Study||5||
48411681|NCT04315298|101341824|FG018|COMPLETED|Overall Study||2||
48750898|NCT01173601|102177294|FG000|COMPLETED|Confirmation (CF) Phase, 3 Weeks||1328||
48750899|NCT01173601|102177295|FG001|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
48750900|NCT01173601|102177296|FG002|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
48750901|NCT01173601|102177297|FG003|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
48750902|NCT01173601|102177298|FG004|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
48750903|NCT01173601|102177294|FG000|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88||
48750904|NCT01173601|102177295|FG001|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
48750905|NCT01173601|102177296|FG002|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
48750906|NCT01173601|102177297|FG003|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
48767722|NCT00494676|102222813|FG001|COMPLETED|Allocation||32||
48171211|NCT03285295|100742436|FG000|NOT COMPLETED|Alinity s HBsAg Confirmatory||0||
48171212|NCT03285295|100742437|FG001|NOT COMPLETED|Alinity s HBsAg Confirmatory||0||
48188636|NCT05257837|100783296|FG002|STARTED|Overall Study||58||
48411682|NCT04315298|101341806|FG000|NOT COMPLETED|Overall Study||29||
48411683|NCT04315298|101341807|FG001|NOT COMPLETED|Overall Study||70||
48750907|NCT01173601|102177298|FG004|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
48750908|NCT01173601|102177294|FG000|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0||
48333891|NCT03875950|101145591|FG000|STARTED|Overall Study||125||
48333892|NCT03875950|101145592|FG001|STARTED|Overall Study||107||
48333893|NCT03875950|101145591|FG000|COMPLETED|Overall Study||125||
48750909|NCT01173601|102177295|FG001|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231||
48750910|NCT01173601|102177296|FG002|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230||
48750911|NCT01173601|102177297|FG003|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||240||
48750912|NCT01173601|102177298|FG004|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||627||
48333894|NCT03875950|101145592|FG001|COMPLETED|Overall Study||107||
48333895|NCT03875950|101145591|FG000|NOT COMPLETED|Overall Study||0||
48333896|NCT03875950|101145592|FG001|NOT COMPLETED|Overall Study||0||
48333897|NCT00482014|101145593|FG000|STARTED|Overall Study||9||
48333898|NCT00482014|101145594|FG001|STARTED|Overall Study||13||
48750913|NCT01173601|102177294|FG000|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0||
48750914|NCT01173601|102177295|FG001|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||100||
48750915|NCT01173601|102177296|FG002|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||107||
48333899|NCT00482014|101145595|FG002|STARTED|Overall Study||46||
48333900|NCT00482014|101145596|FG003|STARTED|Overall Study||52||
48333901|NCT00482014|101145593|FG000|COMPLETED|Overall Study||2||
48333902|NCT00482014|101145594|FG001|COMPLETED|Overall Study||7||
48333903|NCT00482014|101145595|FG002|COMPLETED|Overall Study||35||
48333904|NCT00482014|101145596|FG003|COMPLETED|Overall Study||29||
48333905|NCT00482014|101145593|FG000|NOT COMPLETED|Overall Study||7||
48333906|NCT00482014|101145594|FG001|NOT COMPLETED|Overall Study||6||
48333907|NCT00482014|101145595|FG002|NOT COMPLETED|Overall Study||11||
48333908|NCT00482014|101145596|FG003|NOT COMPLETED|Overall Study||23||
48333909|NCT02587338|101145597|FG000|STARTED|Overall Study||20||
48333910|NCT02587338|101145598|FG001|STARTED|Overall Study||18||
48333911|NCT02587338|101145597|FG000|COMPLETED|Overall Study||20||
48333912|NCT02587338|101145598|FG001|COMPLETED|Overall Study||18||
48333913|NCT02587338|101145597|FG000|NOT COMPLETED|Overall Study||0||
48333914|NCT02587338|101145598|FG001|NOT COMPLETED|Overall Study||0||
48333915|NCT00217087|101145599|FG000|STARTED|Overall Study||36||
48333916|NCT00217087|101145600|FG001|STARTED|Overall Study||37||
48333917|NCT00217087|101145599|FG000|COMPLETED|Overall Study||25||
48333918|NCT00217087|101145600|FG001|COMPLETED|Overall Study||17||
48333919|NCT00217087|101145599|FG000|NOT COMPLETED|Overall Study||11||
48333920|NCT00217087|101145600|FG001|NOT COMPLETED|Overall Study||20||
48333921|NCT01988090|101145601|FG000|STARTED|Start Treament After Randomization||46||
48333922|NCT01988090|101145602|FG001|STARTED|Start Treament After Randomization||47||
48333923|NCT01988090|101145601|FG000|COMPLETED|Start Treament After Randomization||44|Complete 12 weeks treatment|
48333924|NCT01988090|101145602|FG001|COMPLETED|Start Treament After Randomization||43|Complete 12 weeks treatment|
48333925|NCT01988090|101145601|FG000|NOT COMPLETED|Start Treament After Randomization||2||
48333926|NCT01988090|101145602|FG001|NOT COMPLETED|Start Treament After Randomization||4||
48333927|NCT01988090|101145601|FG000|STARTED|Complete Study After Start||44||
48333928|NCT01988090|101145602|FG001|STARTED|Complete Study After Start||43||
48333929|NCT01988090|101145601|FG000|COMPLETED|Complete Study After Start||41||
48333930|NCT01988090|101145602|FG001|COMPLETED|Complete Study After Start||42||
48333931|NCT01988090|101145601|FG000|NOT COMPLETED|Complete Study After Start||3||
48333932|NCT01988090|101145602|FG001|NOT COMPLETED|Complete Study After Start||1||
48333933|NCT00626093|101145603|FG000|STARTED|Overall Study||77||
48333934|NCT00626093|101145603|FG000|COMPLETED|Overall Study||54||
48411684|NCT04315298|101341808|FG002|NOT COMPLETED|Overall Study||55||
48750916|NCT01173601|102177297|FG003|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0||
48750917|NCT01173601|102177298|FG004|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0||
48750918|NCT01173601|102177294|FG000|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0||
48333935|NCT00626093|101145603|FG000|NOT COMPLETED|Overall Study||23||
48333936|NCT03438045|101145604|FG000|STARTED|Overall Study||75||
48333937|NCT03438045|101145604|FG000|COMPLETED|Overall Study||75||
48333938|NCT03438045|101145604|FG000|NOT COMPLETED|Overall Study||0||
48333939|NCT00820755|101145605|FG000|STARTED|Period 1: Combination Therapy Phase||583||
48333940|NCT00820755|101145606|FG001|STARTED|Period 1: Combination Therapy Phase||0||
48333941|NCT00820755|101145607|FG002|STARTED|Period 1: Combination Therapy Phase||0||
48333942|NCT00820755|101145605|FG000|COMPLETED|Period 1: Combination Therapy Phase||313||
48333943|NCT00820755|101145606|FG001|COMPLETED|Period 1: Combination Therapy Phase||0||
48333944|NCT00820755|101145607|FG002|COMPLETED|Period 1: Combination Therapy Phase||0||
48333945|NCT00820755|101145605|FG000|NOT COMPLETED|Period 1: Combination Therapy Phase||270||
48333946|NCT00820755|101145606|FG001|NOT COMPLETED|Period 1: Combination Therapy Phase||0||
48333947|NCT00820755|101145607|FG002|NOT COMPLETED|Period 1: Combination Therapy Phase||0||
48333948|NCT00820755|101145605|FG000|STARTED|Period 2: Maintenance Therapy Phase||0||
48333949|NCT00820755|101145606|FG001|STARTED|Period 2: Maintenance Therapy Phase||157||
48333950|NCT00820755|101145607|FG002|STARTED|Period 2: Maintenance Therapy Phase||154||
48333951|NCT00820755|101145605|FG000|COMPLETED|Period 2: Maintenance Therapy Phase||0||
48333952|NCT00820755|101145606|FG001|COMPLETED|Period 2: Maintenance Therapy Phase||112||
48171213|NCT03285295|100742438|FG002|NOT COMPLETED|Alinity s HBsAg Confirmatory||0||
48171214|NCT03285295|100742439|FG003|NOT COMPLETED|Alinity s HBsAg Confirmatory||0||
48171215|NCT03285295|100742440|FG004|NOT COMPLETED|Alinity s HBsAg Confirmatory||0||
48171216|NCT03285295|100742436|FG000|STARTED|Alinity s HBsAg Follow-Up||0||
48171217|NCT03285295|100742437|FG001|STARTED|Alinity s HBsAg Follow-Up||0||
48171218|NCT03285295|100742438|FG002|STARTED|Alinity s HBsAg Follow-Up||0||
48171219|NCT03285295|100742439|FG003|STARTED|Alinity s HBsAg Follow-Up||0||
48171220|NCT03285295|100742440|FG004|STARTED|Alinity s HBsAg Follow-Up||0||
48171221|NCT03285295|100742436|FG000|COMPLETED|Alinity s HBsAg Follow-Up||0||
48171222|NCT03285295|100742437|FG001|COMPLETED|Alinity s HBsAg Follow-Up||0||
48171223|NCT03285295|100742438|FG002|COMPLETED|Alinity s HBsAg Follow-Up||0||
48750919|NCT01173601|102177295|FG001|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||100||
48750920|NCT01173601|102177296|FG002|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||108||
48750921|NCT01173601|102177297|FG003|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||221||
48750922|NCT01173601|102177298|FG004|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||586||
48750923|NCT01173601|102177294|FG000|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0||
48171224|NCT03285295|100742439|FG003|COMPLETED|Alinity s HBsAg Follow-Up||0||
48171225|NCT03285295|100742440|FG004|COMPLETED|Alinity s HBsAg Follow-Up||0||
48171226|NCT03285295|100742436|FG000|NOT COMPLETED|Alinity s HBsAg Follow-Up||0||
48171227|NCT03285295|100742437|FG001|NOT COMPLETED|Alinity s HBsAg Follow-Up||0||
48171228|NCT03285295|100742438|FG002|NOT COMPLETED|Alinity s HBsAg Follow-Up||0||
48171229|NCT03285295|100742439|FG003|NOT COMPLETED|Alinity s HBsAg Follow-Up||0||
48171230|NCT03285295|100742440|FG004|NOT COMPLETED|Alinity s HBsAg Follow-Up||0||
48333953|NCT00820755|101145607|FG002|COMPLETED|Period 2: Maintenance Therapy Phase||109||
48750924|NCT01173601|102177295|FG001|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196||
48171231|NCT03285295|100742436|FG000|STARTED|Alinity s HTLV I/II||15968||
48171232|NCT03285295|100742437|FG001|STARTED|Alinity s HTLV I/II||706||
48171233|NCT03285295|100742438|FG002|STARTED|Alinity s HTLV I/II||502||
48171234|NCT03285295|100742439|FG003|STARTED|Alinity s HTLV I/II||509||
48171235|NCT03285295|100742440|FG004|STARTED|Alinity s HTLV I/II||0||
48171236|NCT03285295|100742436|FG000|COMPLETED|Alinity s HTLV I/II||15877||
48171237|NCT03285295|100742437|FG001|COMPLETED|Alinity s HTLV I/II||706||
48171238|NCT03285295|100742438|FG002|COMPLETED|Alinity s HTLV I/II||502||
48171239|NCT03285295|100742439|FG003|COMPLETED|Alinity s HTLV I/II||509||
48171240|NCT03285295|100742440|FG004|COMPLETED|Alinity s HTLV I/II||0||
48171241|NCT03285295|100742436|FG000|NOT COMPLETED|Alinity s HTLV I/II||91||
48171242|NCT03285295|100742437|FG001|NOT COMPLETED|Alinity s HTLV I/II||0||
48171243|NCT03285295|100742438|FG002|NOT COMPLETED|Alinity s HTLV I/II||0||
48171244|NCT03285295|100742439|FG003|NOT COMPLETED|Alinity s HTLV I/II||0||
48171245|NCT03285295|100742440|FG004|NOT COMPLETED|Alinity s HTLV I/II||0||
48171246|NCT03285295|100742436|FG000|STARTED|Alinity s HTLV I/II Follow-Up||12||
48171247|NCT03285295|100742437|FG001|STARTED|Alinity s HTLV I/II Follow-Up||0||
48171248|NCT03285295|100742438|FG002|STARTED|Alinity s HTLV I/II Follow-Up||0||
48171249|NCT03285295|100742439|FG003|STARTED|Alinity s HTLV I/II Follow-Up||0||
48171250|NCT03285295|100742440|FG004|STARTED|Alinity s HTLV I/II Follow-Up||0||
48171251|NCT03285295|100742436|FG000|COMPLETED|Alinity s HTLV I/II Follow-Up||8||
48171252|NCT03285295|100742437|FG001|COMPLETED|Alinity s HTLV I/II Follow-Up||0||
48171253|NCT03285295|100742438|FG002|COMPLETED|Alinity s HTLV I/II Follow-Up||0||
48333954|NCT00820755|101145605|FG000|NOT COMPLETED|Period 2: Maintenance Therapy Phase||0||
48333955|NCT00820755|101145606|FG001|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45||
48333956|NCT00820755|101145607|FG002|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45||
48333957|NCT00532480|101145608|FG000|STARTED|Overall Study||10||
48333958|NCT00532480|101145608|FG000|COMPLETED|Overall Study||7||
48333959|NCT00532480|101145608|FG000|NOT COMPLETED|Overall Study||3||
48333960|NCT00168831|101145609|FG000|STARTED|Overall Study||338||
48171254|NCT03285295|100742439|FG003|COMPLETED|Alinity s HTLV I/II Follow-Up||0||
48171255|NCT03285295|100742440|FG004|COMPLETED|Alinity s HTLV I/II Follow-Up||0||
48171256|NCT03285295|100742436|FG000|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||4||
48171257|NCT03285295|100742437|FG001|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0||
48171258|NCT03285295|100742438|FG002|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0||
48171259|NCT03285295|100742439|FG003|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0||
48333961|NCT00168831|101145610|FG001|STARTED|Overall Study||335||
48333962|NCT00168831|101145611|FG002|STARTED|Overall Study||334||
48333963|NCT00168831|101145609|FG000|COMPLETED|Overall Study||278||
48333964|NCT00168831|101145610|FG001|COMPLETED|Overall Study||254||
48333965|NCT00168831|101145611|FG002|COMPLETED|Overall Study||220||
48333966|NCT00168831|101145609|FG000|NOT COMPLETED|Overall Study||60||
48333967|NCT00168831|101145610|FG001|NOT COMPLETED|Overall Study||81||
48411685|NCT04315298|101341809|FG003|NOT COMPLETED|Overall Study||69||
48411686|NCT04315298|101341810|FG004|NOT COMPLETED|Overall Study||85||
48411687|NCT04315298|101341811|FG005|NOT COMPLETED|Overall Study||129||
48411688|NCT04315298|101341812|FG006|NOT COMPLETED|Overall Study||18||
48411689|NCT04315298|101341813|FG007|NOT COMPLETED|Overall Study||29||
48411690|NCT04315298|101341814|FG008|NOT COMPLETED|Overall Study||36||
48411691|NCT04315298|101341815|FG009|NOT COMPLETED|Overall Study||17||
48411692|NCT04315298|101341816|FG010|NOT COMPLETED|Overall Study||42||
48627817|NCT01107925|101871115|FG002|STARTED|Period 2||17||
48627818|NCT01107925|101871116|FG003|STARTED|Period 2||20||
48627819|NCT01107925|101871117|FG004|STARTED|Period 2||0||
48627820|NCT01107925|101871118|FG005|STARTED|Period 2||17||
48627821|NCT01107925|101871113|FG000|Took at Least 1 Dose of Study Drug|Period 2||0||
48627822|NCT01107925|101871114|FG001|Took at Least 1 Dose of Study Drug|Period 2||16||
48627823|NCT01107925|101871115|FG002|Took at Least 1 Dose of Study Drug|Period 2||17||
48627824|NCT01107925|101871116|FG003|Took at Least 1 Dose of Study Drug|Period 2||20||
48627825|NCT01107925|101871117|FG004|Took at Least 1 Dose of Study Drug|Period 2||0||
48627826|NCT01107925|101871118|FG005|Took at Least 1 Dose of Study Drug|Period 2||17||
48627827|NCT01107925|101871113|FG000|COMPLETED|Period 2||0||
48627828|NCT01107925|101871114|FG001|COMPLETED|Period 2||15||
48627829|NCT01107925|101871115|FG002|COMPLETED|Period 2||17||
48627830|NCT01107925|101871116|FG003|COMPLETED|Period 2||20||
48627831|NCT01107925|101871117|FG004|COMPLETED|Period 2||0||
48627832|NCT01107925|101871118|FG005|COMPLETED|Period 2||16||
48627833|NCT01107925|101871113|FG000|NOT COMPLETED|Period 2||0||
48627834|NCT01107925|101871114|FG001|NOT COMPLETED|Period 2||1||
48627835|NCT01107925|101871115|FG002|NOT COMPLETED|Period 2||0||
48627836|NCT01107925|101871116|FG003|NOT COMPLETED|Period 2||0||
48627837|NCT01107925|101871117|FG004|NOT COMPLETED|Period 2||0||
48627838|NCT01107925|101871118|FG005|NOT COMPLETED|Period 2||1||
48627839|NCT01107925|101871113|FG000|STARTED|Period 3||0||
48627840|NCT01107925|101871114|FG001|STARTED|Period 3||17||
48627841|NCT01107925|101871115|FG002|STARTED|Period 3||15||
48627842|NCT01107925|101871116|FG003|STARTED|Period 3||16||
48627843|NCT01107925|101871117|FG004|STARTED|Period 3||0||
48627844|NCT01107925|101871118|FG005|STARTED|Period 3||20||
48627845|NCT01107925|101871113|FG000|Took at Least 1 Dose of Study Drug|Period 3||0||
48627846|NCT01107925|101871114|FG001|Took at Least 1 Dose of Study Drug|Period 3||17||
48627847|NCT01107925|101871115|FG002|Took at Least 1 Dose of Study Drug|Period 3||15||
48627848|NCT01107925|101871116|FG003|Took at Least 1 Dose of Study Drug|Period 3||16||
48627849|NCT01107925|101871117|FG004|Took at Least 1 Dose of Study Drug|Period 3||0||
48627850|NCT01107925|101871118|FG005|Took at Least 1 Dose of Study Drug|Period 3||20||
48627851|NCT01107925|101871113|FG000|COMPLETED|Period 3||0||
48627852|NCT01107925|101871114|FG001|COMPLETED|Period 3||17||
48627853|NCT01107925|101871115|FG002|COMPLETED|Period 3||15||
48627854|NCT01107925|101871116|FG003|COMPLETED|Period 3||16||
48627855|NCT01107925|101871117|FG004|COMPLETED|Period 3||0||
48333968|NCT00168831|101145611|FG002|NOT COMPLETED|Overall Study||114||
48333969|NCT02340663|101145612|FG000|STARTED|Overall Study||35||
48333970|NCT02340663|101145613|FG001|STARTED|Overall Study||32||
48333971|NCT02340663|101145612|FG000|Clinical Exam, Impressions|Overall Study||35||
48333972|NCT02340663|101145613|FG001|Clinical Exam, Impressions|Overall Study||32||
48333973|NCT02340663|101145612|FG000|Splint Delivery, Assessments|Overall Study||33||
48333974|NCT02340663|101145613|FG001|Splint Delivery, Assessments|Overall Study||31||
48333975|NCT02340663|101145612|FG000|1 Week Follow-up, Assessments|Overall Study||33||
48411693|NCT04315298|101341817|FG011|NOT COMPLETED|Overall Study||41||
48411694|NCT04315298|101341818|FG012|NOT COMPLETED|Overall Study||3||
48411695|NCT04315298|101341819|FG013|NOT COMPLETED|Overall Study||4||
48411696|NCT04315298|101341820|FG014|NOT COMPLETED|Overall Study||6||
48627856|NCT01107925|101871118|FG005|COMPLETED|Period 3||20||
48627857|NCT01107925|101871113|FG000|NOT COMPLETED|Period 3||0||
48627858|NCT01107925|101871114|FG001|NOT COMPLETED|Period 3||0||
48627859|NCT01107925|101871115|FG002|NOT COMPLETED|Period 3||0||
48333976|NCT02340663|101145613|FG001|1 Week Follow-up, Assessments|Overall Study||31||
48627860|NCT01107925|101871116|FG003|NOT COMPLETED|Period 3||0||
48627861|NCT01107925|101871117|FG004|NOT COMPLETED|Period 3||0||
48627862|NCT01107925|101871118|FG005|NOT COMPLETED|Period 3||0||
48627863|NCT02732639|101871119|FG000|STARTED|Overall Study||31||
48627864|NCT02732639|101871119|FG000|COMPLETED|Overall Study||30||
48627865|NCT02732639|101871119|FG000|NOT COMPLETED|Overall Study||1||
48627866|NCT01981616|101871120|FG000|STARTED|Overall Study||64||
48627867|NCT01981616|101871121|FG001|STARTED|Overall Study||63||
48333977|NCT02340663|101145612|FG000|4 Month Follow-up, Assessments|Overall Study||30||
48411697|NCT04315298|101341821|FG015|NOT COMPLETED|Overall Study||6||
48411698|NCT04315298|101341822|FG016|NOT COMPLETED|Overall Study||3||
48411699|NCT04315298|101341823|FG017|NOT COMPLETED|Overall Study||1||
48411700|NCT04315298|101341824|FG018|NOT COMPLETED|Overall Study||0||
48627868|NCT01981616|101871120|FG000|COMPLETED|Overall Study||63||
48627869|NCT01981616|101871121|FG001|COMPLETED|Overall Study||62||
48627870|NCT01981616|101871120|FG000|NOT COMPLETED|Overall Study||1||
48627871|NCT01981616|101871121|FG001|NOT COMPLETED|Overall Study||1||
48627872|NCT03499795|101871122|FG000|STARTED|Overall Study||23||
48627873|NCT03499795|101871122|FG000|Safety Population|Overall Study||23|Safety population included all participants who received at least 1 dose of VGX-3100+EP.|
48627874|NCT03499795|101871122|FG000|Modified Intent-to-treat (mITT) Population|Overall Study||23|mITT population included all participants who received at least 1 dose of VGX-3100+EP.|
48627875|NCT03499795|101871122|FG000|COMPLETED|Overall Study||21||
48627876|NCT03499795|101871122|FG000|NOT COMPLETED|Overall Study||2||
48627877|NCT00972621|101871123|FG000|STARTED|Overall Study||200||
48627878|NCT00972621|101871124|FG001|STARTED|Overall Study||200||
48171260|NCT03285295|100742440|FG004|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0||
48171261|NCT03285295|100742436|FG000|STARTED|Alinity s Anti-HCV||17095||
48171262|NCT03285295|100742437|FG001|STARTED|Alinity s Anti-HCV||402||
48171263|NCT03285295|100742438|FG002|STARTED|Alinity s Anti-HCV||407||
48171264|NCT03285295|100742439|FG003|STARTED|Alinity s Anti-HCV||0||
48171265|NCT03285295|100742440|FG004|STARTED|Alinity s Anti-HCV||0||
48171266|NCT03285295|100742436|FG000|COMPLETED|Alinity s Anti-HCV||16999||
48171267|NCT03285295|100742437|FG001|COMPLETED|Alinity s Anti-HCV||402||
48627879|NCT00972621|101871123|FG000|COMPLETED|Overall Study||200||
48627880|NCT00972621|101871124|FG001|COMPLETED|Overall Study||199||
48627881|NCT00972621|101871123|FG000|NOT COMPLETED|Overall Study||0||
48627882|NCT00972621|101871124|FG001|NOT COMPLETED|Overall Study||1||
48627883|NCT00193375|101871125|FG000|STARTED|Overall Study||60||
48627884|NCT00193375|101871125|FG000|COMPLETED|Overall Study||41||
48627885|NCT00193375|101871125|FG000|NOT COMPLETED|Overall Study||19||
48627886|NCT02449434|101871126|FG000|STARTED|Overall Study||300||
48627887|NCT02449434|101871127|FG001|STARTED|Overall Study||300||
48627888|NCT02449434|101871126|FG000|COMPLETED|Overall Study||300||
48627889|NCT02449434|101871127|FG001|COMPLETED|Overall Study||300||
48171268|NCT03285295|100742438|FG002|COMPLETED|Alinity s Anti-HCV||407||
48171269|NCT03285295|100742439|FG003|COMPLETED|Alinity s Anti-HCV||0||
48171270|NCT03285295|100742440|FG004|COMPLETED|Alinity s Anti-HCV||0||
48171271|NCT03285295|100742436|FG000|NOT COMPLETED|Alinity s Anti-HCV||96||
48171272|NCT03285295|100742437|FG001|NOT COMPLETED|Alinity s Anti-HCV||0||
48171273|NCT03285295|100742438|FG002|NOT COMPLETED|Alinity s Anti-HCV||0||
48171274|NCT03285295|100742439|FG003|NOT COMPLETED|Alinity s Anti-HCV||0||
48171275|NCT03285295|100742440|FG004|NOT COMPLETED|Alinity s Anti-HCV||0||
48171276|NCT03285295|100742436|FG000|STARTED|Alinity s Anti-HCV Follow-Up||20||
48171277|NCT03285295|100742437|FG001|STARTED|Alinity s Anti-HCV Follow-Up||0||
48627890|NCT02449434|101871126|FG000|NOT COMPLETED|Overall Study||0||
48627891|NCT02449434|101871127|FG001|NOT COMPLETED|Overall Study||0||
48627892|NCT01894906|101871128|FG000|STARTED|Overall Study||6||
48627893|NCT01894906|101871129|FG001|STARTED|Overall Study||6||
48627894|NCT01894906|101871128|FG000|Treatment A|Overall Study||6||
48627895|NCT01894906|101871129|FG001|Treatment A|Overall Study||6||
48627896|NCT01894906|101871128|FG000|Treatment B|Overall Study||6||
48627897|NCT01894906|101871129|FG001|Treatment B|Overall Study||6||
48627898|NCT01894906|101871128|FG000|Treatment C|Overall Study||6||
48627899|NCT01894906|101871129|FG001|Treatment C|Overall Study||6||
48627900|NCT01894906|101871128|FG000|Treatment D|Overall Study||6||
48750925|NCT01173601|102177296|FG002|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||197||
48750926|NCT01173601|102177297|FG003|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||210||
48750927|NCT01173601|102177298|FG004|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||559||
48750928|NCT01173601|102177294|FG000|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0||
48750929|NCT01173601|102177295|FG001|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35||
48750930|NCT01173601|102177296|FG002|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33||
48750931|NCT01173601|102177297|FG003|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||30||
48750932|NCT01173601|102177298|FG004|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||68||
48750933|NCT01631435|102177299|FG000|STARTED|Overall Study||75||
48627901|NCT01894906|101871129|FG001|Treatment D|Overall Study||6||
48627902|NCT01894906|101871128|FG000|Treatment E|Overall Study||6||
48627903|NCT01894906|101871129|FG001|Treatment E|Overall Study||6||
48627904|NCT01894906|101871128|FG000|Treatment F|Overall Study||6||
48627905|NCT01894906|101871129|FG001|Treatment F|Overall Study||6||
48627906|NCT01894906|101871128|FG000|COMPLETED|Overall Study||6||
48627907|NCT01894906|101871129|FG001|COMPLETED|Overall Study||6||
48627908|NCT01894906|101871128|FG000|NOT COMPLETED|Overall Study||0||
48627909|NCT01894906|101871129|FG001|NOT COMPLETED|Overall Study||0||
48627910|NCT01929889|101871130|FG000|STARTED|Overall Study||8||
48627911|NCT01929889|101871130|FG000|COMPLETED|Overall Study||3||
48627912|NCT01929889|101871130|FG000|NOT COMPLETED|Overall Study||5||
48627913|NCT02431299|101871131|FG000|STARTED|Overall Study||236||
48627914|NCT02431299|101871132|FG001|STARTED|Overall Study||63||
48627915|NCT02431299|101871131|FG000|COMPLETED|Overall Study||183||
48627916|NCT02431299|101871132|FG001|COMPLETED|Overall Study||62||
48627917|NCT02431299|101871131|FG000|NOT COMPLETED|Overall Study||53||
48627918|NCT02431299|101871132|FG001|NOT COMPLETED|Overall Study||1||
48627919|NCT00161213|101874296|FG000|STARTED|Overall Study||44||
48627920|NCT00161213|101874296|FG000|COMPLETED|Overall Study||42||
48750934|NCT01631435|102177299|FG000|COMPLETED|Overall Study||66||
48750935|NCT01631435|102177299|FG000|NOT COMPLETED|Overall Study||9||
48750936|NCT01790594|102177300|FG000|STARTED|Overall Study||22||
48750937|NCT01790594|102177301|FG001|STARTED|Overall Study||21||
48750938|NCT01790594|102177302|FG002|STARTED|Overall Study||3||
48750939|NCT01790594|102177300|FG000|COMPLETED|Overall Study||17||
48750940|NCT01790594|102177301|FG001|COMPLETED|Overall Study||18||
48750941|NCT01790594|102177302|FG002|COMPLETED|Overall Study||0||
48627921|NCT00161213|101874296|FG000|NOT COMPLETED|Overall Study||2||
48750942|NCT01790594|102177300|FG000|NOT COMPLETED|Overall Study||5||
48750943|NCT01790594|102177301|FG001|NOT COMPLETED|Overall Study||3||
48750944|NCT01790594|102177302|FG002|NOT COMPLETED|Overall Study||3||
48750945|NCT00660192|102177303|FG000|STARTED|Overall Study||12||
48750946|NCT00660192|102177304|FG001|STARTED|Overall Study||13||
48750947|NCT00660192|102177303|FG000|COMPLETED|Overall Study||10||
48750948|NCT00660192|102177304|FG001|COMPLETED|Overall Study||10||
48750949|NCT00660192|102177303|FG000|NOT COMPLETED|Overall Study||2||
48750950|NCT00660192|102177304|FG001|NOT COMPLETED|Overall Study||3||
48750951|NCT00556075|102177305|FG000|STARTED|Overall Study||22||
48750952|NCT00556075|102177306|FG001|STARTED|Overall Study||22||
48750953|NCT00556075|102177307|FG002|STARTED|Overall Study||23||
48750954|NCT00556075|102177305|FG000|COMPLETED|Overall Study||9||
48750955|NCT00556075|102177306|FG001|COMPLETED|Overall Study||13||
48750956|NCT00556075|102177307|FG002|COMPLETED|Overall Study||15||
48750957|NCT00556075|102177305|FG000|NOT COMPLETED|Overall Study||13||
48750958|NCT00556075|102177306|FG001|NOT COMPLETED|Overall Study||9||
48750959|NCT00556075|102177307|FG002|NOT COMPLETED|Overall Study||8||
48750960|NCT01129622|102177308|FG000|STARTED|Overall Study||16||
48750961|NCT01129622|102177308|FG000|COMPLETED|Overall Study||14||
48750962|NCT01129622|102177308|FG000|NOT COMPLETED|Overall Study||2||
48750963|NCT01410890|102177309|FG000|STARTED|Overall Study||10||
48750964|NCT01410890|102177310|FG001|STARTED|Overall Study||11||
48750965|NCT01410890|102177309|FG000|Treated|Overall Study||10||
48750966|NCT01410890|102177310|FG001|Treated|Overall Study||10||
48627922|NCT04232839|101874297|FG000|STARTED|Treatment Period 1 + Washout||2||
48627923|NCT04232839|101874298|FG001|STARTED|Treatment Period 1 + Washout||2||
48627924|NCT04232839|101874299|FG002|STARTED|Treatment Period 1 + Washout||2||
48750967|NCT01410890|102177309|FG000|COMPLETED|Overall Study||10||
48750968|NCT01410890|102177310|FG001|COMPLETED|Overall Study||10||
48750969|NCT01410890|102177309|FG000|NOT COMPLETED|Overall Study||0||
48750970|NCT01410890|102177310|FG001|NOT COMPLETED|Overall Study||1||
48750971|NCT03836625|102177311|FG000|STARTED|Overall Study||99||
48750972|NCT03836625|102177312|FG001|STARTED|Overall Study||101||
48750973|NCT03836625|102177311|FG000|COMPLETED|Overall Study||84||
48171278|NCT03285295|100742438|FG002|STARTED|Alinity s Anti-HCV Follow-Up||0||
48171279|NCT03285295|100742439|FG003|STARTED|Alinity s Anti-HCV Follow-Up||0||
48750974|NCT03836625|102177312|FG001|COMPLETED|Overall Study||89||
48750975|NCT03836625|102177311|FG000|NOT COMPLETED|Overall Study||15||
48750976|NCT03836625|102177312|FG001|NOT COMPLETED|Overall Study||12||
48750977|NCT01389882|102177313|FG000|STARTED|Overall Study||13||
48171280|NCT03285295|100742440|FG004|STARTED|Alinity s Anti-HCV Follow-Up||0||
48171281|NCT03285295|100742436|FG000|COMPLETED|Alinity s Anti-HCV Follow-Up||2||
48171282|NCT03285295|100742437|FG001|COMPLETED|Alinity s Anti-HCV Follow-Up||0||
48171283|NCT03285295|100742438|FG002|COMPLETED|Alinity s Anti-HCV Follow-Up||0||
48171284|NCT03285295|100742439|FG003|COMPLETED|Alinity s Anti-HCV Follow-Up||0||
48171285|NCT03285295|100742440|FG004|COMPLETED|Alinity s Anti-HCV Follow-Up||0||
48171286|NCT03285295|100742436|FG000|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||18||
48750978|NCT01389882|102177314|FG001|STARTED|Overall Study||11||
48750979|NCT01389882|102177313|FG000|COMPLETED|Overall Study||12||
48750980|NCT01389882|102177314|FG001|COMPLETED|Overall Study||7||
48171287|NCT03285295|100742437|FG001|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0||
48171288|NCT03285295|100742438|FG002|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0||
48171289|NCT03285295|100742439|FG003|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0||
48750981|NCT01389882|102177313|FG000|NOT COMPLETED|Overall Study||1||
48750982|NCT01389882|102177314|FG001|NOT COMPLETED|Overall Study||4||
48171290|NCT03285295|100742440|FG004|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0||
48750983|NCT00322881|102177315|FG000|STARTED|Overall Study||12||
48750984|NCT00322881|102177315|FG000|COMPLETED|Overall Study||7||
48750985|NCT00322881|102177315|FG000|NOT COMPLETED|Overall Study||5||
48750986|NCT03137992|102177316|FG000|STARTED|Period 1 (Visit 2)||62|Three of the 377 participants enrolled and randomized did not receive any treatment.|
48171291|NCT03285295|100742436|FG000|STARTED|Alinity s HIV Ag/Ab Combo||17095||
48171292|NCT03285295|100742437|FG001|STARTED|Alinity s HIV Ag/Ab Combo||1336||
48171293|NCT03285295|100742438|FG002|STARTED|Alinity s HIV Ag/Ab Combo||605||
48171294|NCT03285295|100742439|FG003|STARTED|Alinity s HIV Ag/Ab Combo||535||
48171295|NCT03285295|100742440|FG004|STARTED|Alinity s HIV Ag/Ab Combo||0||
48171296|NCT03285295|100742436|FG000|COMPLETED|Alinity s HIV Ag/Ab Combo||16996||
48171297|NCT03285295|100742437|FG001|COMPLETED|Alinity s HIV Ag/Ab Combo||1336||
48171298|NCT03285295|100742438|FG002|COMPLETED|Alinity s HIV Ag/Ab Combo||605||
48171299|NCT03285295|100742439|FG003|COMPLETED|Alinity s HIV Ag/Ab Combo||535||
48171300|NCT03285295|100742440|FG004|COMPLETED|Alinity s HIV Ag/Ab Combo||0||
48171301|NCT03285295|100742436|FG000|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||99||
48171302|NCT03285295|100742437|FG001|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0||
48171303|NCT03285295|100742438|FG002|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0||
48171304|NCT03285295|100742439|FG003|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0||
48171305|NCT03285295|100742440|FG004|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0||
48750987|NCT03137992|102177317|FG001|STARTED|Period 1 (Visit 2)||63|Three of the 377 participants enrolled and randomized did not receive any treatment.|
48750988|NCT03137992|102177318|FG002|STARTED|Period 1 (Visit 2)||63|Three of the 377 participants enrolled and randomized did not receive any treatment.|
48750989|NCT03137992|102177319|FG003|STARTED|Period 1 (Visit 2)||63|Three of the 377 participants enrolled and randomized did not receive any treatment.|
48750990|NCT03137992|102177320|FG004|STARTED|Period 1 (Visit 2)||62|Three of the 377 participants enrolled and randomized did not receive any treatment.|
48750991|NCT03137992|102177321|FG005|STARTED|Period 1 (Visit 2)||61|Three of the 377 participants enrolled and randomized did not receive any treatment.|
48750992|NCT03137992|102177316|FG000|COMPLETED|Period 1 (Visit 2)||62|One subject randomized to Sequence A received treatment P in period 1 (visit 2)|
48750993|NCT03137992|102177317|FG001|COMPLETED|Period 1 (Visit 2)||63|One subject randomized to Sequence A received treatment P in period 1 (visit 2)|
48750994|NCT03137992|102177318|FG002|COMPLETED|Period 1 (Visit 2)||63|One subject randomized to Sequence A received treatment P in period 1 (visit 2)|
48171306|NCT03285295|100742436|FG000|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||15||
48171307|NCT03285295|100742437|FG001|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0||
48171308|NCT03285295|100742438|FG002|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0||
48171309|NCT03285295|100742439|FG003|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0||
48171310|NCT03285295|100742440|FG004|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0||
48171311|NCT03285295|100742436|FG000|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||4||
48171312|NCT03285295|100742437|FG001|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0||
48171313|NCT03285295|100742438|FG002|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0||
48171314|NCT03285295|100742439|FG003|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0||
48171315|NCT03285295|100742440|FG004|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0||
48171316|NCT03285295|100742436|FG000|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||11||
48750995|NCT03137992|102177319|FG003|COMPLETED|Period 1 (Visit 2)||63|One subject randomized to Sequence A received treatment P in period 1 (visit 2)|
48767723|NCT00494676|102222812|FG000|NOT COMPLETED|Allocation||2||
48171317|NCT03285295|100742437|FG001|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0||
48171318|NCT03285295|100742438|FG002|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0||
48171319|NCT03285295|100742439|FG003|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0||
48171320|NCT03285295|100742440|FG004|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0||
48171321|NCT03285295|100742436|FG000|STARTED|Alinity s Anti-HBc||15968||
48171322|NCT03285295|100742437|FG001|STARTED|Alinity s Anti-HBc||405||
48171323|NCT03285295|100742438|FG002|STARTED|Alinity s Anti-HBc||403||
48171324|NCT03285295|100742439|FG003|STARTED|Alinity s Anti-HBc||0||
48171325|NCT03285295|100742440|FG004|STARTED|Alinity s Anti-HBc||0||
48171326|NCT03285295|100742436|FG000|COMPLETED|Alinity s Anti-HBc||15877||
48171327|NCT03285295|100742437|FG001|COMPLETED|Alinity s Anti-HBc||404||
48171328|NCT03285295|100742438|FG002|COMPLETED|Alinity s Anti-HBc||403||
48171329|NCT03285295|100742439|FG003|COMPLETED|Alinity s Anti-HBc||0||
48171330|NCT03285295|100742440|FG004|COMPLETED|Alinity s Anti-HBc||0||
48171331|NCT03285295|100742436|FG000|NOT COMPLETED|Alinity s Anti-HBc||91||
48171332|NCT03285295|100742437|FG001|NOT COMPLETED|Alinity s Anti-HBc||1||
48171333|NCT03285295|100742438|FG002|NOT COMPLETED|Alinity s Anti-HBc||0||
48171334|NCT03285295|100742439|FG003|NOT COMPLETED|Alinity s Anti-HBc||0||
48171335|NCT03285295|100742440|FG004|NOT COMPLETED|Alinity s Anti-HBc||0||
48627925|NCT04232839|101874300|FG003|STARTED|Treatment Period 1 + Washout||3||
48627926|NCT04232839|101874301|FG004|STARTED|Treatment Period 1 + Washout||2||
48627927|NCT04232839|101874302|FG005|STARTED|Treatment Period 1 + Washout||2||
48627928|NCT04232839|101874303|FG006|STARTED|Treatment Period 1 + Washout||3||
48627929|NCT04232839|101874304|FG007|STARTED|Treatment Period 1 + Washout||3||
48627930|NCT04232839|101874305|FG008|STARTED|Treatment Period 1 + Washout||2||
48627931|NCT04232839|101874306|FG009|STARTED|Treatment Period 1 + Washout||3||
48627932|NCT04232839|101874297|FG000|COMPLETED|Treatment Period 1 + Washout||2||
48627933|NCT04232839|101874298|FG001|COMPLETED|Treatment Period 1 + Washout||2||
48627934|NCT04232839|101874299|FG002|COMPLETED|Treatment Period 1 + Washout||2||
48627935|NCT04232839|101874300|FG003|COMPLETED|Treatment Period 1 + Washout||3||
48627936|NCT04232839|101874301|FG004|COMPLETED|Treatment Period 1 + Washout||2||
48627937|NCT04232839|101874302|FG005|COMPLETED|Treatment Period 1 + Washout||2||
48627938|NCT04232839|101874303|FG006|COMPLETED|Treatment Period 1 + Washout||3||
48627939|NCT04232839|101874304|FG007|COMPLETED|Treatment Period 1 + Washout||3||
48171336|NCT03285295|100742436|FG000|STARTED|Alinity s Anti-HBc Follow-Up||16||
48171337|NCT03285295|100742437|FG001|STARTED|Alinity s Anti-HBc Follow-Up||0||
48171338|NCT03285295|100742438|FG002|STARTED|Alinity s Anti-HBc Follow-Up||0||
48627940|NCT04232839|101874305|FG008|COMPLETED|Treatment Period 1 + Washout||2||
48627941|NCT04232839|101874306|FG009|COMPLETED|Treatment Period 1 + Washout||3||
48627942|NCT04232839|101874297|FG000|NOT COMPLETED|Treatment Period 1 + Washout||0||
48627943|NCT04232839|101874298|FG001|NOT COMPLETED|Treatment Period 1 + Washout||0||
48627944|NCT04232839|101874299|FG002|NOT COMPLETED|Treatment Period 1 + Washout||0||
48627945|NCT04232839|101874300|FG003|NOT COMPLETED|Treatment Period 1 + Washout||0||
48750996|NCT03137992|102177320|FG004|COMPLETED|Period 1 (Visit 2)||62|One subject randomized to Sequence A received treatment P in period 1 (visit 2)|
48750997|NCT03137992|102177321|FG005|COMPLETED|Period 1 (Visit 2)||61|One subject randomized to Sequence A received treatment P in period 1 (visit 2)|
48171339|NCT03285295|100742439|FG003|STARTED|Alinity s Anti-HBc Follow-Up||0||
48171340|NCT03285295|100742440|FG004|STARTED|Alinity s Anti-HBc Follow-Up||0||
48627946|NCT04232839|101874301|FG004|NOT COMPLETED|Treatment Period 1 + Washout||0||
48627947|NCT04232839|101874302|FG005|NOT COMPLETED|Treatment Period 1 + Washout||0||
48750998|NCT03137992|102177316|FG000|NOT COMPLETED|Period 1 (Visit 2)||0||
48171341|NCT03285295|100742436|FG000|COMPLETED|Alinity s Anti-HBc Follow-Up||2||
48171342|NCT03285295|100742437|FG001|COMPLETED|Alinity s Anti-HBc Follow-Up||0||
48171343|NCT03285295|100742438|FG002|COMPLETED|Alinity s Anti-HBc Follow-Up||0||
48171344|NCT03285295|100742439|FG003|COMPLETED|Alinity s Anti-HBc Follow-Up||0||
48171345|NCT03285295|100742440|FG004|COMPLETED|Alinity s Anti-HBc Follow-Up||0||
48171346|NCT03285295|100742436|FG000|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||14||
48171347|NCT03285295|100742437|FG001|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0||
48171348|NCT03285295|100742438|FG002|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0||
48627948|NCT04232839|101874303|FG006|NOT COMPLETED|Treatment Period 1 + Washout||0||
48627949|NCT04232839|101874304|FG007|NOT COMPLETED|Treatment Period 1 + Washout||0||
48627950|NCT04232839|101874305|FG008|NOT COMPLETED|Treatment Period 1 + Washout||0||
48627951|NCT04232839|101874306|FG009|NOT COMPLETED|Treatment Period 1 + Washout||0||
48627952|NCT04232839|101874297|FG000|STARTED|Treatment Period 2 + Washout||2||
48627953|NCT04232839|101874298|FG001|STARTED|Treatment Period 2 + Washout||2||
48627954|NCT04232839|101874299|FG002|STARTED|Treatment Period 2 + Washout||2||
48627955|NCT04232839|101874300|FG003|STARTED|Treatment Period 2 + Washout||3||
48627956|NCT04232839|101874301|FG004|STARTED|Treatment Period 2 + Washout||2||
48627957|NCT04232839|101874302|FG005|STARTED|Treatment Period 2 + Washout||2||
48627958|NCT04232839|101874303|FG006|STARTED|Treatment Period 2 + Washout||3||
48627959|NCT04232839|101874304|FG007|STARTED|Treatment Period 2 + Washout||3||
48627960|NCT04232839|101874305|FG008|STARTED|Treatment Period 2 + Washout||2||
48750999|NCT03137992|102177317|FG001|NOT COMPLETED|Period 1 (Visit 2)||0||
48171349|NCT03285295|100742439|FG003|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0||
48171350|NCT03285295|100742440|FG004|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0||
48171351|NCT03285295|100742436|FG000|STARTED|Alinity s Chagas||16023||
48171352|NCT03285295|100742437|FG001|STARTED|Alinity s Chagas||320||
48171353|NCT03285295|100742438|FG002|STARTED|Alinity s Chagas||0||
48171354|NCT03285295|100742439|FG003|STARTED|Alinity s Chagas||615||
48171355|NCT03285295|100742440|FG004|STARTED|Alinity s Chagas||0||
48171356|NCT03285295|100742436|FG000|COMPLETED|Alinity s Chagas||15804||
48171357|NCT03285295|100742437|FG001|COMPLETED|Alinity s Chagas||320||
48171358|NCT03285295|100742438|FG002|COMPLETED|Alinity s Chagas||0||
48627961|NCT04232839|101874306|FG009|STARTED|Treatment Period 2 + Washout||3||
48627962|NCT04232839|101874297|FG000|COMPLETED|Treatment Period 2 + Washout||2||
48333978|NCT02340663|101145613|FG001|4 Month Follow-up, Assessments|Overall Study||31||
48333979|NCT02340663|101145612|FG000|COMPLETED|Overall Study||30||
48333980|NCT02340663|101145613|FG001|COMPLETED|Overall Study||31||
48333981|NCT02340663|101145612|FG000|NOT COMPLETED|Overall Study||5||
48333982|NCT02340663|101145613|FG001|NOT COMPLETED|Overall Study||1||
48333983|NCT03683394|101145614|FG000|STARTED|Overall Study||82||
48333984|NCT03683394|101145615|FG001|STARTED|Overall Study||90||
48333985|NCT03683394|101145614|FG000|COMPLETED|Overall Study||68||
48333986|NCT03683394|101145615|FG001|COMPLETED|Overall Study||81||
48627963|NCT04232839|101874298|FG001|COMPLETED|Treatment Period 2 + Washout||2||
48627964|NCT04232839|101874299|FG002|COMPLETED|Treatment Period 2 + Washout||2||
48627965|NCT04232839|101874300|FG003|COMPLETED|Treatment Period 2 + Washout||3||
48627966|NCT04232839|101874301|FG004|COMPLETED|Treatment Period 2 + Washout||2||
48627967|NCT04232839|101874302|FG005|COMPLETED|Treatment Period 2 + Washout||2||
48627968|NCT04232839|101874303|FG006|COMPLETED|Treatment Period 2 + Washout||3||
48627969|NCT04232839|101874304|FG007|COMPLETED|Treatment Period 2 + Washout||3||
48627970|NCT04232839|101874305|FG008|COMPLETED|Treatment Period 2 + Washout||2||
48627971|NCT04232839|101874306|FG009|COMPLETED|Treatment Period 2 + Washout||3||
48171359|NCT03285295|100742439|FG003|COMPLETED|Alinity s Chagas||615||
48171360|NCT03285295|100742440|FG004|COMPLETED|Alinity s Chagas||0||
48171361|NCT03285295|100742436|FG000|NOT COMPLETED|Alinity s Chagas||219||
48171362|NCT03285295|100742437|FG001|NOT COMPLETED|Alinity s Chagas||0||
48171363|NCT03285295|100742438|FG002|NOT COMPLETED|Alinity s Chagas||0||
48171364|NCT03285295|100742439|FG003|NOT COMPLETED|Alinity s Chagas||0||
48171365|NCT03285295|100742440|FG004|NOT COMPLETED|Alinity s Chagas||0||
48171366|NCT03285295|100742436|FG000|STARTED|Alinity s Chagas Follow-Up||14||
48171367|NCT03285295|100742437|FG001|STARTED|Alinity s Chagas Follow-Up||0||
48333987|NCT03683394|101145614|FG000|NOT COMPLETED|Overall Study||14||
48333988|NCT03683394|101145615|FG001|NOT COMPLETED|Overall Study||9||
48333989|NCT00535925|101145616|FG000|STARTED|Overall Study||188||
48333990|NCT00535925|101145617|FG001|STARTED|Overall Study||207||
48333991|NCT00535925|101145616|FG000|COMPLETED|Overall Study||169||
48333992|NCT00535925|101145617|FG001|COMPLETED|Overall Study||199||
48333993|NCT00535925|101145616|FG000|NOT COMPLETED|Overall Study||19||
48333994|NCT00535925|101145617|FG001|NOT COMPLETED|Overall Study||8||
48333995|NCT00841763|101145618|FG000|STARTED|Overall Study||2691||
48333996|NCT00841763|101145619|FG001|STARTED|Overall Study||681||
48627972|NCT04232839|101874297|FG000|NOT COMPLETED|Treatment Period 2 + Washout||0||
48627973|NCT04232839|101874298|FG001|NOT COMPLETED|Treatment Period 2 + Washout||0||
48627974|NCT04232839|101874299|FG002|NOT COMPLETED|Treatment Period 2 + Washout||0||
48627975|NCT04232839|101874300|FG003|NOT COMPLETED|Treatment Period 2 + Washout||0||
48627976|NCT04232839|101874301|FG004|NOT COMPLETED|Treatment Period 2 + Washout||0||
48627977|NCT04232839|101874302|FG005|NOT COMPLETED|Treatment Period 2 + Washout||0||
48627978|NCT04232839|101874303|FG006|NOT COMPLETED|Treatment Period 2 + Washout||0||
48627979|NCT04232839|101874304|FG007|NOT COMPLETED|Treatment Period 2 + Washout||0||
48627980|NCT04232839|101874305|FG008|NOT COMPLETED|Treatment Period 2 + Washout||0||
48627981|NCT04232839|101874306|FG009|NOT COMPLETED|Treatment Period 2 + Washout||0||
48627982|NCT04232839|101874297|FG000|STARTED|Treatment Period 3 + Washout||2||
48627983|NCT04232839|101874298|FG001|STARTED|Treatment Period 3 + Washout||2||
48627984|NCT04232839|101874299|FG002|STARTED|Treatment Period 3 + Washout||2||
48627985|NCT04232839|101874300|FG003|STARTED|Treatment Period 3 + Washout||3||
48627986|NCT04232839|101874301|FG004|STARTED|Treatment Period 3 + Washout||2||
48627987|NCT04232839|101874302|FG005|STARTED|Treatment Period 3 + Washout||2||
48171368|NCT03285295|100742438|FG002|STARTED|Alinity s Chagas Follow-Up||0||
48171369|NCT03285295|100742439|FG003|STARTED|Alinity s Chagas Follow-Up||0||
48171370|NCT03285295|100742440|FG004|STARTED|Alinity s Chagas Follow-Up||0||
48171371|NCT03285295|100742436|FG000|COMPLETED|Alinity s Chagas Follow-Up||1||
48171372|NCT03285295|100742437|FG001|COMPLETED|Alinity s Chagas Follow-Up||0||
48171373|NCT03285295|100742438|FG002|COMPLETED|Alinity s Chagas Follow-Up||0||
48171374|NCT03285295|100742439|FG003|COMPLETED|Alinity s Chagas Follow-Up||0||
48171375|NCT03285295|100742440|FG004|COMPLETED|Alinity s Chagas Follow-Up||0||
48171376|NCT03285295|100742436|FG000|NOT COMPLETED|Alinity s Chagas Follow-Up||13||
48333997|NCT00841763|101145620|FG002|STARTED|Overall Study||219||
48333998|NCT00841763|101145621|FG003|STARTED|Overall Study||56||
48333999|NCT00841763|101145618|FG000|COMPLETED|Overall Study||2529||
48334000|NCT00841763|101145619|FG001|COMPLETED|Overall Study||624||
48334001|NCT00841763|101145620|FG002|COMPLETED|Overall Study||211||
48334002|NCT00841763|101145621|FG003|COMPLETED|Overall Study||53||
48334003|NCT00841763|101145618|FG000|NOT COMPLETED|Overall Study||162||
48334004|NCT00841763|101145619|FG001|NOT COMPLETED|Overall Study||57||
48334005|NCT00841763|101145620|FG002|NOT COMPLETED|Overall Study||8||
48334006|NCT00841763|101145621|FG003|NOT COMPLETED|Overall Study||3||
48171377|NCT03285295|100742437|FG001|NOT COMPLETED|Alinity s Chagas Follow-Up||0||
48171378|NCT03285295|100742438|FG002|NOT COMPLETED|Alinity s Chagas Follow-Up||0||
48334007|NCT01968460|101145622|FG000|STARTED|Overall Study||49||
48334008|NCT01968460|101145623|FG001|STARTED|Overall Study||50||
48334009|NCT01968460|101145624|FG002|STARTED|Overall Study||50||
48171379|NCT03285295|100742439|FG003|NOT COMPLETED|Alinity s Chagas Follow-Up||0||
48171380|NCT03285295|100742440|FG004|NOT COMPLETED|Alinity s Chagas Follow-Up||0||
48171381|NCT00514046|100742441|FG000|STARTED|Overall Study||5||
48171382|NCT00514046|100742442|FG001|STARTED|Overall Study||1||
48171383|NCT00514046|100742443|FG002|STARTED|Overall Study||5||
48171384|NCT00514046|100742444|FG003|STARTED|Overall Study||1||
48171385|NCT00514046|100742445|FG004|STARTED|Overall Study||1||
48171386|NCT00514046|100742446|FG005|STARTED|Overall Study||1||
48171387|NCT00514046|100742447|FG006|STARTED|Overall Study||1||
48171388|NCT00514046|100742448|FG007|STARTED|Overall Study||1||
48171389|NCT00514046|100742449|FG008|STARTED|Overall Study||1||
48171390|NCT00514046|100742441|FG000|COMPLETED|Overall Study||2||
48171391|NCT00514046|100742442|FG001|COMPLETED|Overall Study||0||
48171392|NCT00514046|100742443|FG002|COMPLETED|Overall Study||0||
48171393|NCT00514046|100742444|FG003|COMPLETED|Overall Study||1||
48171394|NCT00514046|100742445|FG004|COMPLETED|Overall Study||0||
48171395|NCT00514046|100742446|FG005|COMPLETED|Overall Study||0||
48171396|NCT00514046|100742447|FG006|COMPLETED|Overall Study||1||
48171397|NCT00514046|100742448|FG007|COMPLETED|Overall Study||0||
48171398|NCT00514046|100742449|FG008|COMPLETED|Overall Study||0||
48171399|NCT00514046|100742441|FG000|NOT COMPLETED|Overall Study||3||
48171400|NCT00514046|100742442|FG001|NOT COMPLETED|Overall Study||1||
48171401|NCT00514046|100742443|FG002|NOT COMPLETED|Overall Study||5||
48171402|NCT00514046|100742444|FG003|NOT COMPLETED|Overall Study||0||
48171403|NCT00514046|100742445|FG004|NOT COMPLETED|Overall Study||1||
48171404|NCT00514046|100742446|FG005|NOT COMPLETED|Overall Study||1||
48171405|NCT00514046|100742447|FG006|NOT COMPLETED|Overall Study||0||
48171406|NCT00514046|100742448|FG007|NOT COMPLETED|Overall Study||1||
48171407|NCT00514046|100742449|FG008|NOT COMPLETED|Overall Study||1||
48171408|NCT02009696|100742450|FG000|STARTED|Overall Study||221||
48171409|NCT02009696|100742450|FG000|COMPLETED|Overall Study||219||
48171410|NCT02009696|100742450|FG000|NOT COMPLETED|Overall Study||2||
48171411|NCT02406209|100742451|FG000|STARTED|Overall Study||15||
48171412|NCT02406209|100742452|FG001|STARTED|Overall Study||16||
48171413|NCT02406209|100742453|FG002|STARTED|Overall Study||14||
48171414|NCT02406209|100742451|FG000|COMPLETED|Overall Study||7||
48171415|NCT02406209|100742452|FG001|COMPLETED|Overall Study||7||
48171416|NCT02406209|100742453|FG002|COMPLETED|Overall Study||6||
48171417|NCT02406209|100742451|FG000|NOT COMPLETED|Overall Study||8||
48171418|NCT02406209|100742452|FG001|NOT COMPLETED|Overall Study||9||
48171419|NCT02406209|100742453|FG002|NOT COMPLETED|Overall Study||8||
48171420|NCT03292146|100742454|FG000|STARTED|Baseline to 12 Months||20||
48171421|NCT03292146|100742455|FG001|STARTED|Baseline to 12 Months||10||
48171422|NCT03292146|100742454|FG000|COMPLETED|Baseline to 12 Months||18||
48171423|NCT03292146|100742455|FG001|COMPLETED|Baseline to 12 Months||9||
48171424|NCT03292146|100742454|FG000|NOT COMPLETED|Baseline to 12 Months||2||
48171425|NCT03292146|100742455|FG001|NOT COMPLETED|Baseline to 12 Months||1||
48171426|NCT03292146|100742454|FG000|STARTED|12 Months to 24 Months||18||
48171427|NCT03292146|100742455|FG001|STARTED|12 Months to 24 Months||9||
48171428|NCT03292146|100742454|FG000|COMPLETED|12 Months to 24 Months||15||
48171429|NCT03292146|100742455|FG001|COMPLETED|12 Months to 24 Months||6||
48171430|NCT03292146|100742454|FG000|NOT COMPLETED|12 Months to 24 Months||3||
48171431|NCT03292146|100742455|FG001|NOT COMPLETED|12 Months to 24 Months||3||
48171432|NCT00405704|100742456|FG000|STARTED|Overall Study||302||
48171433|NCT00405704|100742457|FG001|STARTED|Overall Study||305||
48171434|NCT00405704|100742456|FG000|Completed Outcome Renal Scan|Overall Study||227||
48171435|NCT00405704|100742457|FG001|Completed Outcome Renal Scan|Overall Study||235||
48171436|NCT00405704|100742456|FG000|Completed Assessments for New Scarring|Overall Study||220||
48171437|NCT00405704|100742457|FG001|Completed Assessments for New Scarring|Overall Study||227||
48171438|NCT00405704|100742456|FG000|Outcome Stool Assessed|Overall Study||203||
48171439|NCT00405704|100742457|FG001|Outcome Stool Assessed|Overall Study||210||
48171440|NCT00405704|100742456|FG000|Recurrent UTI With E. Coli|Overall Study||30||
48171441|NCT00405704|100742457|FG001|Recurrent UTI With E. Coli|Overall Study||57||
48171442|NCT00405704|100742456|FG000|Recurrent UTI With TMP-SMZ Panel|Overall Study||38||
48171443|NCT00405704|100742457|FG001|Recurrent UTI With TMP-SMZ Panel|Overall Study||69||
48171444|NCT00405704|100742456|FG000|COMPLETED|Overall Study||261||
48171445|NCT00405704|100742457|FG001|COMPLETED|Overall Study||259||
48171446|NCT00405704|100742456|FG000|NOT COMPLETED|Overall Study||41||
48171447|NCT00405704|100742457|FG001|NOT COMPLETED|Overall Study||46||
48171448|NCT04076020|100742458|FG000|STARTED|Overall Study||135||
48171449|NCT04076020|100742459|FG001|STARTED|Overall Study||135||
48171450|NCT04076020|100742458|FG000|COMPLETED|Overall Study||119||
48171451|NCT04076020|100742459|FG001|COMPLETED|Overall Study||121||
48171452|NCT04076020|100742458|FG000|NOT COMPLETED|Overall Study||16||
48171453|NCT04076020|100742459|FG001|NOT COMPLETED|Overall Study||14||
48171454|NCT00924469|100742460|FG000|STARTED|Overall Study||30||
48171455|NCT00924469|100742461|FG001|STARTED|Overall Study||28||
48171456|NCT00924469|100742460|FG000|COMPLETED|Overall Study||28||
48171457|NCT00924469|100742461|FG001|COMPLETED|Overall Study||26||
48171458|NCT00924469|100742460|FG000|NOT COMPLETED|Overall Study||2||
48171459|NCT00924469|100742461|FG001|NOT COMPLETED|Overall Study||2||
48171460|NCT01973491|100742462|FG000|STARTED|Baseline Control Period (8 Weeks)||37||
48171461|NCT01973491|100742462|FG000|COMPLETED|Baseline Control Period (8 Weeks)||19||
48171462|NCT01973491|100742462|FG000|NOT COMPLETED|Baseline Control Period (8 Weeks)||18||
48171463|NCT01973491|100742462|FG000|STARTED|Titration Period(4 Weeks)||19||
48171464|NCT01973491|100742462|FG000|COMPLETED|Titration Period(4 Weeks)||19||
48171465|NCT01973491|100742462|FG000|NOT COMPLETED|Titration Period(4 Weeks)||0||
48171466|NCT01973491|100742462|FG000|STARTED|Treatment Period (16 Weeks)||19||
48171467|NCT01973491|100742462|FG000|COMPLETED|Treatment Period (16 Weeks)||18||
48171468|NCT01973491|100742462|FG000|NOT COMPLETED|Treatment Period (16 Weeks)||1||
48171469|NCT02413190|100742463|FG000|STARTED|Overall Study||94||
48171470|NCT02413190|100742463|FG000|COMPLETED|Overall Study||94||
48171471|NCT02413190|100742463|FG000|NOT COMPLETED|Overall Study||0||
48171472|NCT02951351|100742464|FG000|STARTED|Overall Study||19||
48171473|NCT02951351|100742465|FG001|STARTED|Overall Study||17||
48171474|NCT02951351|100742464|FG000|COMPLETED|Overall Study||19||
48171475|NCT02951351|100742465|FG001|COMPLETED|Overall Study||17||
48171476|NCT02951351|100742464|FG000|NOT COMPLETED|Overall Study||0||
48171477|NCT02951351|100742465|FG001|NOT COMPLETED|Overall Study||0||
48171478|NCT02693834|100742466|FG000|STARTED|Baseline Measurement||12||
48171479|NCT02693834|100742467|FG001|STARTED|Baseline Measurement||11||
48171480|NCT02693834|100742466|FG000|COMPLETED|Baseline Measurement||10||
48171481|NCT02693834|100742467|FG001|COMPLETED|Baseline Measurement||11||
48171482|NCT02693834|100742466|FG000|NOT COMPLETED|Baseline Measurement||2||
48171483|NCT02693834|100742467|FG001|NOT COMPLETED|Baseline Measurement||0||
48171484|NCT02693834|100742466|FG000|STARTED|Week 1 Practice||10||
48171485|NCT02693834|100742467|FG001|STARTED|Week 1 Practice||11||
48171486|NCT02693834|100742466|FG000|COMPLETED|Week 1 Practice||10||
48171487|NCT02693834|100742467|FG001|COMPLETED|Week 1 Practice||11||
48171488|NCT02693834|100742466|FG000|NOT COMPLETED|Week 1 Practice||0||
48171489|NCT02693834|100742467|FG001|NOT COMPLETED|Week 1 Practice||0||
48171490|NCT02693834|100742466|FG000|STARTED|Week 2 Practice||10||
48171491|NCT02693834|100742467|FG001|STARTED|Week 2 Practice||11||
48171492|NCT02693834|100742466|FG000|COMPLETED|Week 2 Practice||10||
48171493|NCT02693834|100742467|FG001|COMPLETED|Week 2 Practice||10||
48171494|NCT02693834|100742466|FG000|NOT COMPLETED|Week 2 Practice||0||
48171495|NCT02693834|100742467|FG001|NOT COMPLETED|Week 2 Practice||1||
48171496|NCT03954158|100742468|FG000|STARTED|Overall Study||20||
48171497|NCT03954158|100742469|FG001|STARTED|Overall Study||21||
48171498|NCT03954158|100742470|FG002|STARTED|Overall Study||20||
48171499|NCT03954158|100742471|FG003|STARTED|Overall Study||20||
48171500|NCT03954158|100742468|FG000|COMPLETED|Overall Study||20||
48171501|NCT03954158|100742469|FG001|COMPLETED|Overall Study||21||
48171502|NCT03954158|100742470|FG002|COMPLETED|Overall Study||20||
48171503|NCT03954158|100742471|FG003|COMPLETED|Overall Study||20||
48171504|NCT03954158|100742468|FG000|NOT COMPLETED|Overall Study||0||
48171505|NCT03954158|100742469|FG001|NOT COMPLETED|Overall Study||0||
48171506|NCT03954158|100742470|FG002|NOT COMPLETED|Overall Study||0||
48171507|NCT03954158|100742471|FG003|NOT COMPLETED|Overall Study||0||
48171508|NCT01912781|100742472|FG000|STARTED|Overall Study||71||
48171509|NCT01912781|100742473|FG001|STARTED|Overall Study||35||
48171510|NCT01912781|100742472|FG000|COMPLETED|Overall Study||69||
48171511|NCT01912781|100742473|FG001|COMPLETED|Overall Study||35||
48171512|NCT01912781|100742472|FG000|NOT COMPLETED|Overall Study||2||
48171513|NCT01912781|100742473|FG001|NOT COMPLETED|Overall Study||0||
48171514|NCT02293837|100742474|FG000|STARTED|Overall Study||54||
48171515|NCT02293837|100742475|FG001|STARTED|Overall Study||27||
48171516|NCT02293837|100742476|FG002|STARTED|Overall Study||35||
48171517|NCT02293837|100742477|FG003|STARTED|Overall Study||20||
48171518|NCT02293837|100742474|FG000|COMPLETED|Overall Study||51||
48171519|NCT02293837|100742475|FG001|COMPLETED|Overall Study||23||
48171520|NCT02293837|100742476|FG002|COMPLETED|Overall Study||31||
48171521|NCT02293837|100742477|FG003|COMPLETED|Overall Study||19||
48171522|NCT02293837|100742474|FG000|NOT COMPLETED|Overall Study||3||
48171523|NCT02293837|100742475|FG001|NOT COMPLETED|Overall Study||4||
48171524|NCT02293837|100742476|FG002|NOT COMPLETED|Overall Study||4||
48171525|NCT02293837|100742477|FG003|NOT COMPLETED|Overall Study||1||
48171526|NCT01311362|100742478|FG000|STARTED|Ambrisentan Single Dose||20||
48171527|NCT01311362|100742478|FG000|COMPLETED|Ambrisentan Single Dose||20||
48171528|NCT01311362|100742478|FG000|NOT COMPLETED|Ambrisentan Single Dose||0||
48171529|NCT01311362|100742478|FG000|STARTED|Ambrisentan Steady-state||20||
48171530|NCT01311362|100742478|FG000|COMPLETED|Ambrisentan Steady-state||20||
48171531|NCT01311362|100742478|FG000|NOT COMPLETED|Ambrisentan Steady-state||0||
48171532|NCT01311362|100742478|FG000|STARTED|Ambrisentan and SJW||20||
48171533|NCT01311362|100742478|FG000|COMPLETED|Ambrisentan and SJW||20||
48171534|NCT01311362|100742478|FG000|NOT COMPLETED|Ambrisentan and SJW||0||
48171535|NCT00227760|100742479|FG000|STARTED|Overall Study||44||
48171536|NCT00227760|100742479|FG000|COMPLETED|Overall Study||44||
48171537|NCT00227760|100742479|FG000|NOT COMPLETED|Overall Study||0||
48171538|NCT01560260|100742480|FG000|STARTED|Overall Study||20||
48171539|NCT01560260|100742480|FG000|COMPLETED|Overall Study||20||
48411701|NCT01426009|101341825|FG000|STARTED|Period 1-First Intervention (7 Days)||139||
48171540|NCT01560260|100742480|FG000|NOT COMPLETED|Overall Study||0||
48171541|NCT03462706|100742481|FG000|STARTED|Overall Study||60||
48171542|NCT03462706|100742482|FG001|STARTED|Overall Study||63||
48751000|NCT03137992|102177318|FG002|NOT COMPLETED|Period 1 (Visit 2)||0||
48751001|NCT03137992|102177319|FG003|NOT COMPLETED|Period 1 (Visit 2)||0||
48751002|NCT03137992|102177320|FG004|NOT COMPLETED|Period 1 (Visit 2)||0||
48171543|NCT03462706|100742483|FG002|STARTED|Overall Study||58||
48171544|NCT03462706|100742484|FG003|STARTED|Overall Study||57||
48171545|NCT03462706|100742481|FG000|COMPLETED|Overall Study||59||
48751003|NCT03137992|102177321|FG005|NOT COMPLETED|Period 1 (Visit 2)||0||
48751004|NCT03137992|102177316|FG000|STARTED|Washout Period 1||62||
48751005|NCT03137992|102177317|FG001|STARTED|Washout Period 1||63||
48751006|NCT03137992|102177318|FG002|STARTED|Washout Period 1||63||
48751007|NCT03137992|102177319|FG003|STARTED|Washout Period 1||63||
48751008|NCT03137992|102177320|FG004|STARTED|Washout Period 1||62||
48751009|NCT03137992|102177321|FG005|STARTED|Washout Period 1||61||
48751010|NCT03137992|102177316|FG000|COMPLETED|Washout Period 1||59||
48751011|NCT03137992|102177317|FG001|COMPLETED|Washout Period 1||59||
48751012|NCT03137992|102177318|FG002|COMPLETED|Washout Period 1||61||
48751013|NCT03137992|102177319|FG003|COMPLETED|Washout Period 1||63||
48751014|NCT03137992|102177320|FG004|COMPLETED|Washout Period 1||60||
48751015|NCT03137992|102177321|FG005|COMPLETED|Washout Period 1||59||
48751016|NCT03137992|102177316|FG000|NOT COMPLETED|Washout Period 1||3||
48751017|NCT03137992|102177317|FG001|NOT COMPLETED|Washout Period 1||4||
48751018|NCT03137992|102177318|FG002|NOT COMPLETED|Washout Period 1||2||
48171546|NCT03462706|100742482|FG001|COMPLETED|Overall Study||63||
48171547|NCT03462706|100742483|FG002|COMPLETED|Overall Study||57||
48171548|NCT03462706|100742484|FG003|COMPLETED|Overall Study||56||
48171549|NCT03462706|100742481|FG000|NOT COMPLETED|Overall Study||1||
48171550|NCT03462706|100742482|FG001|NOT COMPLETED|Overall Study||0||
48171551|NCT03462706|100742483|FG002|NOT COMPLETED|Overall Study||1||
48171552|NCT03462706|100742484|FG003|NOT COMPLETED|Overall Study||1||
48171553|NCT04536571|100742485|FG000|STARTED|First Intervention||11||
48171554|NCT04536571|100742486|FG001|STARTED|First Intervention||16||
48171555|NCT04536571|100742485|FG000|COMPLETED|First Intervention||11||
48171556|NCT04536571|100742486|FG001|COMPLETED|First Intervention||16||
48171557|NCT04536571|100742485|FG000|NOT COMPLETED|First Intervention||0||
48171558|NCT04536571|100742486|FG001|NOT COMPLETED|First Intervention||0||
48171559|NCT04536571|100742485|FG000|STARTED|Second Intervention||11||
48171560|NCT04536571|100742486|FG001|STARTED|Second Intervention||16||
48171561|NCT04536571|100742485|FG000|COMPLETED|Second Intervention||11||
48171562|NCT04536571|100742486|FG001|COMPLETED|Second Intervention||16||
48171563|NCT04536571|100742485|FG000|NOT COMPLETED|Second Intervention||0||
48171564|NCT04536571|100742486|FG001|NOT COMPLETED|Second Intervention||0||
48171565|NCT01200030|100742487|FG000|STARTED|Overall Study||12||
48171566|NCT01200030|100742488|FG001|STARTED|Overall Study||13||
48171567|NCT01200030|100742489|FG002|STARTED|Overall Study||12||
48171568|NCT01200030|100742487|FG000|COMPLETED|Overall Study||12||
48171569|NCT01200030|100742488|FG001|COMPLETED|Overall Study||13||
48171570|NCT01200030|100742489|FG002|COMPLETED|Overall Study||12||
48171571|NCT01200030|100742487|FG000|NOT COMPLETED|Overall Study||0||
48171572|NCT01200030|100742488|FG001|NOT COMPLETED|Overall Study||0||
48171573|NCT01200030|100742489|FG002|NOT COMPLETED|Overall Study||0||
48171574|NCT01414413|100742490|FG000|STARTED|Overall Study||8194||
48171575|NCT01414413|100742491|FG001|STARTED|Overall Study||8466||
48171576|NCT01414413|100742490|FG000|COMPLETED|Overall Study||8194||
48171577|NCT01414413|100742491|FG001|COMPLETED|Overall Study||8466||
48171578|NCT01414413|100742490|FG000|NOT COMPLETED|Overall Study||0||
48171579|NCT01414413|100742491|FG001|NOT COMPLETED|Overall Study||0||
48171580|NCT02153359|100742492|FG000|STARTED|Intervention 1 (1 Month)||11||
48171581|NCT02153359|100742493|FG001|STARTED|Intervention 1 (1 Month)||12||
48171582|NCT02153359|100742492|FG000|COMPLETED|Intervention 1 (1 Month)||11||
48171583|NCT02153359|100742493|FG001|COMPLETED|Intervention 1 (1 Month)||12||
48171584|NCT02153359|100742492|FG000|NOT COMPLETED|Intervention 1 (1 Month)||0||
48171585|NCT02153359|100742493|FG001|NOT COMPLETED|Intervention 1 (1 Month)||0||
48171586|NCT02153359|100742492|FG000|STARTED|Washout (at Least 1 Month)||11||
48171587|NCT02153359|100742493|FG001|STARTED|Washout (at Least 1 Month)||12||
48171588|NCT02153359|100742492|FG000|COMPLETED|Washout (at Least 1 Month)||11||
48171589|NCT02153359|100742493|FG001|COMPLETED|Washout (at Least 1 Month)||12||
48171590|NCT02153359|100742492|FG000|NOT COMPLETED|Washout (at Least 1 Month)||0||
48171591|NCT02153359|100742493|FG001|NOT COMPLETED|Washout (at Least 1 Month)||0||
48171592|NCT02153359|100742492|FG000|STARTED|Intervention 2 (1 Month)||11||
48171593|NCT02153359|100742493|FG001|STARTED|Intervention 2 (1 Month)||12||
48171594|NCT02153359|100742492|FG000|COMPLETED|Intervention 2 (1 Month)||11||
48171595|NCT02153359|100742493|FG001|COMPLETED|Intervention 2 (1 Month)||10||
48171596|NCT02153359|100742492|FG000|NOT COMPLETED|Intervention 2 (1 Month)||0||
48171597|NCT02153359|100742493|FG001|NOT COMPLETED|Intervention 2 (1 Month)||2||
48171598|NCT00291655|100742494|FG000|STARTED|Overall Study||130||
48751019|NCT03137992|102177319|FG003|NOT COMPLETED|Washout Period 1||0||
48751020|NCT03137992|102177320|FG004|NOT COMPLETED|Washout Period 1||2||
48751021|NCT03137992|102177321|FG005|NOT COMPLETED|Washout Period 1||2||
48751022|NCT03137992|102177316|FG000|STARTED|Period 2 (Visit 3)||59||
48751023|NCT03137992|102177317|FG001|STARTED|Period 2 (Visit 3)||59||
48751024|NCT03137992|102177318|FG002|STARTED|Period 2 (Visit 3)||61||
48751025|NCT03137992|102177319|FG003|STARTED|Period 2 (Visit 3)||63||
48171599|NCT00291655|100742494|FG000|COMPLETED|Overall Study||115||
48171600|NCT00291655|100742494|FG000|NOT COMPLETED|Overall Study||15||
48171601|NCT01536145|100742495|FG000|STARTED|Overall Study||3||
48171602|NCT01536145|100742496|FG001|STARTED|Overall Study||4||
48171603|NCT01536145|100742497|FG002|STARTED|Overall Study||3||
48171604|NCT01536145|100742498|FG003|STARTED|Overall Study||3||
48171605|NCT01536145|100742499|FG004|STARTED|Overall Study||4||
48171606|NCT01536145|100742500|FG005|STARTED|Overall Study||3||
48171607|NCT01536145|100742501|FG006|STARTED|Overall Study||3||
48171608|NCT01536145|100742502|FG007|STARTED|Overall Study||4||
48171609|NCT01536145|100742503|FG008|STARTED|Overall Study||3||
48171610|NCT01536145|100742504|FG009|STARTED|Overall Study||7||
48171611|NCT01536145|100742505|FG010|STARTED|Overall Study||10||
48171612|NCT01536145|100742495|FG000|COMPLETED|Overall Study||0||
48171613|NCT01536145|100742496|FG001|COMPLETED|Overall Study||0||
48171614|NCT01536145|100742497|FG002|COMPLETED|Overall Study||1||
48171615|NCT01536145|100742498|FG003|COMPLETED|Overall Study||1||
48171616|NCT01536145|100742499|FG004|COMPLETED|Overall Study||2||
48171617|NCT01536145|100742500|FG005|COMPLETED|Overall Study||0||
48171618|NCT01536145|100742501|FG006|COMPLETED|Overall Study||1||
48171619|NCT01536145|100742502|FG007|COMPLETED|Overall Study||0||
48171620|NCT01536145|100742503|FG008|COMPLETED|Overall Study||0||
48171621|NCT01536145|100742504|FG009|COMPLETED|Overall Study||1||
48171622|NCT01536145|100742505|FG010|COMPLETED|Overall Study||0||
48171623|NCT01536145|100742495|FG000|NOT COMPLETED|Overall Study||3||
48171624|NCT01536145|100742496|FG001|NOT COMPLETED|Overall Study||4||
48171625|NCT01536145|100742497|FG002|NOT COMPLETED|Overall Study||2||
48171626|NCT01536145|100742498|FG003|NOT COMPLETED|Overall Study||2||
48171627|NCT01536145|100742499|FG004|NOT COMPLETED|Overall Study||2||
48171628|NCT01536145|100742500|FG005|NOT COMPLETED|Overall Study||3||
48171629|NCT01536145|100742501|FG006|NOT COMPLETED|Overall Study||2||
48171630|NCT01536145|100742502|FG007|NOT COMPLETED|Overall Study||4||
48171631|NCT01536145|100742503|FG008|NOT COMPLETED|Overall Study||3||
48171632|NCT01536145|100742504|FG009|NOT COMPLETED|Overall Study||6||
48171633|NCT01536145|100742505|FG010|NOT COMPLETED|Overall Study||10||
48171634|NCT00350701|100742506|FG000|STARTED|Overall Study||17||
48627988|NCT04232839|101874303|FG006|STARTED|Treatment Period 3 + Washout||3||
48627989|NCT04232839|101874304|FG007|STARTED|Treatment Period 3 + Washout||3||
48627990|NCT04232839|101874305|FG008|STARTED|Treatment Period 3 + Washout||2||
48627991|NCT04232839|101874306|FG009|STARTED|Treatment Period 3 + Washout||3||
48627992|NCT04232839|101874297|FG000|COMPLETED|Treatment Period 3 + Washout||2||
48627993|NCT04232839|101874298|FG001|COMPLETED|Treatment Period 3 + Washout||2||
48627994|NCT04232839|101874299|FG002|COMPLETED|Treatment Period 3 + Washout||2||
48627995|NCT04232839|101874300|FG003|COMPLETED|Treatment Period 3 + Washout||3||
48627996|NCT04232839|101874301|FG004|COMPLETED|Treatment Period 3 + Washout||2||
48627997|NCT04232839|101874302|FG005|COMPLETED|Treatment Period 3 + Washout||2||
48171635|NCT00350701|100742507|FG001|STARTED|Overall Study||17||
48171636|NCT00350701|100742508|FG002|STARTED|Overall Study||15||
48171637|NCT00350701|100742506|FG000|COMPLETED|Overall Study||17||
48171638|NCT00350701|100742507|FG001|COMPLETED|Overall Study||17||
48171639|NCT00350701|100742508|FG002|COMPLETED|Overall Study||15||
48171640|NCT00350701|100742506|FG000|NOT COMPLETED|Overall Study||0||
48171641|NCT00350701|100742507|FG001|NOT COMPLETED|Overall Study||0||
48171642|NCT00350701|100742508|FG002|NOT COMPLETED|Overall Study||0||
48171643|NCT04110366|100742509|FG000|STARTED|Overall Study||40||
48171644|NCT04110366|100742510|FG001|STARTED|Overall Study||8||
48171645|NCT04110366|100742509|FG000|COMPLETED|Overall Study||40||
48171646|NCT04110366|100742510|FG001|COMPLETED|Overall Study||8||
48171647|NCT04110366|100742509|FG000|NOT COMPLETED|Overall Study||0||
48171648|NCT04110366|100742510|FG001|NOT COMPLETED|Overall Study||0||
48171649|NCT00210119|100742511|FG000|STARTED|Overall Study||19||
48171650|NCT00210119|100742511|FG000|COMPLETED|Overall Study||17||
48171651|NCT00210119|100742511|FG000|NOT COMPLETED|Overall Study||2||
48171652|NCT00630058|100742512|FG000|STARTED|Overall Study||10||
48171653|NCT00630058|100742513|FG001|STARTED|Overall Study||10||
48171654|NCT00630058|100742512|FG000|COMPLETED|Overall Study||6||
48171655|NCT00630058|100742513|FG001|COMPLETED|Overall Study||6||
48171656|NCT00630058|100742512|FG000|NOT COMPLETED|Overall Study||4||
48171657|NCT00630058|100742513|FG001|NOT COMPLETED|Overall Study||4||
48171658|NCT03377790|100742514|FG000|STARTED|Overall Study||160||
48171659|NCT03377790|100742515|FG001|STARTED|Overall Study||106||
48171660|NCT03377790|100742514|FG000|COMPLETED|Overall Study||150||
48171661|NCT03377790|100742515|FG001|COMPLETED|Overall Study||100||
48171662|NCT03377790|100742514|FG000|NOT COMPLETED|Overall Study||10||
48171663|NCT03377790|100742515|FG001|NOT COMPLETED|Overall Study||6||
48171664|NCT01035333|100742516|FG000|STARTED|Overall Study||19||
48171665|NCT01035333|100742516|FG000|COMPLETED|Overall Study||9||
48171666|NCT01035333|100742516|FG000|NOT COMPLETED|Overall Study||10||
48171667|NCT01022073|100742517|FG000|STARTED|Overall Study||86||
48171668|NCT01022073|100742518|FG001|STARTED|Overall Study||70||
48171669|NCT01022073|100742517|FG000|COMPLETED|Overall Study||67||
48171670|NCT01022073|100742518|FG001|COMPLETED|Overall Study||52||
48171671|NCT01022073|100742517|FG000|NOT COMPLETED|Overall Study||19||
48171672|NCT01022073|100742518|FG001|NOT COMPLETED|Overall Study||18||
48171673|NCT04827134|100742519|FG000|STARTED|Treatment Period 1 (1 Day)||8||
48171674|NCT04827134|100742520|FG001|STARTED|Treatment Period 1 (1 Day)||8||
48627998|NCT04232839|101874303|FG006|COMPLETED|Treatment Period 3 + Washout||3||
48627999|NCT04232839|101874304|FG007|COMPLETED|Treatment Period 3 + Washout||3||
48628000|NCT04232839|101874305|FG008|COMPLETED|Treatment Period 3 + Washout||2||
48628001|NCT04232839|101874306|FG009|COMPLETED|Treatment Period 3 + Washout||3||
48628002|NCT04232839|101874297|FG000|NOT COMPLETED|Treatment Period 3 + Washout||0||
48171675|NCT04827134|100742521|FG002|STARTED|Treatment Period 1 (1 Day)||8||
48171676|NCT04827134|100742522|FG003|STARTED|Treatment Period 1 (1 Day)||9||
48171677|NCT04827134|100742519|FG000|COMPLETED|Treatment Period 1 (1 Day)||8||
48171678|NCT04827134|100742520|FG001|COMPLETED|Treatment Period 1 (1 Day)||8||
48171679|NCT04827134|100742521|FG002|COMPLETED|Treatment Period 1 (1 Day)||7||
48171680|NCT04827134|100742522|FG003|COMPLETED|Treatment Period 1 (1 Day)||9||
48171681|NCT04827134|100742519|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
48171682|NCT04827134|100742520|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
48171683|NCT04827134|100742521|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||1||
48171684|NCT04827134|100742522|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
48171685|NCT04827134|100742519|FG000|STARTED|Washout Period (up to 7 Days)||8||
48171686|NCT04827134|100742520|FG001|STARTED|Washout Period (up to 7 Days)||8||
48171687|NCT04827134|100742521|FG002|STARTED|Washout Period (up to 7 Days)||7||
48171688|NCT04827134|100742522|FG003|STARTED|Washout Period (up to 7 Days)||9||
48171689|NCT04827134|100742519|FG000|COMPLETED|Washout Period (up to 7 Days)||8||
48171690|NCT04827134|100742520|FG001|COMPLETED|Washout Period (up to 7 Days)||8||
48171691|NCT04827134|100742521|FG002|COMPLETED|Washout Period (up to 7 Days)||7||
48171692|NCT04827134|100742522|FG003|COMPLETED|Washout Period (up to 7 Days)||9||
48171693|NCT04827134|100742519|FG000|NOT COMPLETED|Washout Period (up to 7 Days)||0||
48171694|NCT04827134|100742520|FG001|NOT COMPLETED|Washout Period (up to 7 Days)||0||
48171695|NCT04827134|100742521|FG002|NOT COMPLETED|Washout Period (up to 7 Days)||0||
48171696|NCT04827134|100742522|FG003|NOT COMPLETED|Washout Period (up to 7 Days)||0||
48171697|NCT04827134|100742519|FG000|STARTED|Treatment Period 2 (1 Day)||8||
48171698|NCT04827134|100742520|FG001|STARTED|Treatment Period 2 (1 Day)||8||
48628003|NCT04232839|101874298|FG001|NOT COMPLETED|Treatment Period 3 + Washout||0||
48628004|NCT04232839|101874299|FG002|NOT COMPLETED|Treatment Period 3 + Washout||0||
48628005|NCT04232839|101874300|FG003|NOT COMPLETED|Treatment Period 3 + Washout||0||
48171699|NCT04827134|100742521|FG002|STARTED|Treatment Period 2 (1 Day)||7||
48171700|NCT04827134|100742522|FG003|STARTED|Treatment Period 2 (1 Day)||9||
48334010|NCT01968460|101145622|FG000|COMPLETED|Overall Study||43||
48334011|NCT01968460|101145623|FG001|COMPLETED|Overall Study||45||
48334012|NCT01968460|101145624|FG002|COMPLETED|Overall Study||48||
48628006|NCT04232839|101874301|FG004|NOT COMPLETED|Treatment Period 3 + Washout||0||
48628007|NCT04232839|101874302|FG005|NOT COMPLETED|Treatment Period 3 + Washout||0||
48628008|NCT04232839|101874303|FG006|NOT COMPLETED|Treatment Period 3 + Washout||0||
48628009|NCT04232839|101874304|FG007|NOT COMPLETED|Treatment Period 3 + Washout||0||
48628010|NCT04232839|101874305|FG008|NOT COMPLETED|Treatment Period 3 + Washout||0||
48628011|NCT04232839|101874306|FG009|NOT COMPLETED|Treatment Period 3 + Washout||0||
48628012|NCT04232839|101874297|FG000|STARTED|Treatment Period 4 + Washout||2||
48628013|NCT04232839|101874298|FG001|STARTED|Treatment Period 4 + Washout||2||
48628014|NCT04232839|101874299|FG002|STARTED|Treatment Period 4 + Washout||2||
48628015|NCT04232839|101874300|FG003|STARTED|Treatment Period 4 + Washout||3||
48628016|NCT04232839|101874301|FG004|STARTED|Treatment Period 4 + Washout||2||
48628017|NCT04232839|101874302|FG005|STARTED|Treatment Period 4 + Washout||2||
48628018|NCT04232839|101874303|FG006|STARTED|Treatment Period 4 + Washout||3||
48628019|NCT04232839|101874304|FG007|STARTED|Treatment Period 4 + Washout||3||
48628020|NCT04232839|101874305|FG008|STARTED|Treatment Period 4 + Washout||2||
48628021|NCT04232839|101874306|FG009|STARTED|Treatment Period 4 + Washout||3||
48628022|NCT04232839|101874297|FG000|COMPLETED|Treatment Period 4 + Washout||2||
48628023|NCT04232839|101874298|FG001|COMPLETED|Treatment Period 4 + Washout||2||
48628024|NCT04232839|101874299|FG002|COMPLETED|Treatment Period 4 + Washout||2||
48171701|NCT04827134|100742519|FG000|COMPLETED|Treatment Period 2 (1 Day)||8||
48171702|NCT04827134|100742520|FG001|COMPLETED|Treatment Period 2 (1 Day)||8||
48171703|NCT04827134|100742521|FG002|COMPLETED|Treatment Period 2 (1 Day)||7||
48171704|NCT04827134|100742522|FG003|COMPLETED|Treatment Period 2 (1 Day)||9||
48171705|NCT04827134|100742519|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
48171706|NCT04827134|100742520|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
48171707|NCT04827134|100742521|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
48171708|NCT04827134|100742522|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
48171709|NCT00452413|100742523|FG000|STARTED|Overall Study||4||
48171710|NCT00452413|100742524|FG001|STARTED|Overall Study||12||
48171711|NCT00452413|100742525|FG002|STARTED|Overall Study||49||
48188637|NCT05257837|100783297|FG003|STARTED|Overall Study||50||
48334013|NCT01968460|101145622|FG000|NOT COMPLETED|Overall Study||6||
48171712|NCT00452413|100742523|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4||
48171713|NCT00452413|100742524|FG001|Received at Least 1 Dose of Study Drug|Overall Study||12||
48171714|NCT00452413|100742525|FG002|Received at Least 1 Dose of Study Drug|Overall Study||49||
48171715|NCT00452413|100742523|FG000|COMPLETED|Overall Study||0||
48171716|NCT00452413|100742524|FG001|COMPLETED|Overall Study||0||
48171717|NCT00452413|100742525|FG002|COMPLETED|Overall Study||0||
48171718|NCT00452413|100742523|FG000|NOT COMPLETED|Overall Study||4||
48171719|NCT00452413|100742524|FG001|NOT COMPLETED|Overall Study||12||
48171720|NCT00452413|100742525|FG002|NOT COMPLETED|Overall Study||49||
48171721|NCT00519636|100742526|FG000|STARTED|Treatment Period 1||91||
48171722|NCT00519636|100742527|FG001|STARTED|Treatment Period 1||86||
48334014|NCT01968460|101145623|FG001|NOT COMPLETED|Overall Study||5||
48334015|NCT01968460|101145624|FG002|NOT COMPLETED|Overall Study||2||
48334016|NCT01656434|101145625|FG000|STARTED|Overall Study||2553||
48334017|NCT01656434|101145626|FG001|STARTED|Overall Study||620||
48334018|NCT01656434|101145625|FG000|Treated|Overall Study||2466||
48334019|NCT01656434|101145626|FG001|Treated|Overall Study||604||
48334020|NCT01656434|101145625|FG000|COMPLETED|Overall Study||152||
48334021|NCT01656434|101145626|FG001|COMPLETED|Overall Study||40||
48334022|NCT01656434|101145625|FG000|NOT COMPLETED|Overall Study||2401||
48334023|NCT01656434|101145626|FG001|NOT COMPLETED|Overall Study||580||
48334024|NCT02513329|101145627|FG000|STARTED|Overall Study||20||
48334025|NCT02513329|101145628|FG001|STARTED|Overall Study||17||
48334026|NCT02513329|101145627|FG000|COMPLETED|Overall Study||15|6 months after intervention follow up period|
48334027|NCT02513329|101145628|FG001|COMPLETED|Overall Study||15|6 months after intervention follow up period|
48334028|NCT02513329|101145627|FG000|NOT COMPLETED|Overall Study||5||
48334029|NCT02513329|101145628|FG001|NOT COMPLETED|Overall Study||2||
48334030|NCT05325775|101145629|FG000|STARTED|Overall Study||12||
48334031|NCT05325775|101145630|FG001|STARTED|Overall Study||12||
48334032|NCT05325775|101145631|FG002|STARTED|Overall Study||12||
48334033|NCT05325775|101145632|FG003|STARTED|Overall Study||13||
48334034|NCT05325775|101145629|FG000|COMPLETED|Overall Study||12||
48334035|NCT05325775|101145630|FG001|COMPLETED|Overall Study||12||
48334036|NCT05325775|101145631|FG002|COMPLETED|Overall Study||12||
48334037|NCT05325775|101145632|FG003|COMPLETED|Overall Study||13||
48334038|NCT05325775|101145629|FG000|NOT COMPLETED|Overall Study||0||
48334039|NCT05325775|101145630|FG001|NOT COMPLETED|Overall Study||0||
48334040|NCT05325775|101145631|FG002|NOT COMPLETED|Overall Study||0||
48334041|NCT05325775|101145632|FG003|NOT COMPLETED|Overall Study||0||
48334042|NCT05162066|101145633|FG000|STARTED|Overall Study||2||
48334043|NCT05162066|101145634|FG001|STARTED|Overall Study||0||
48334044|NCT05162066|101145635|FG002|STARTED|Overall Study||0||
48334045|NCT05162066|101145633|FG000|COMPLETED|Overall Study||0||
48334046|NCT05162066|101145634|FG001|COMPLETED|Overall Study||0||
48171723|NCT00519636|100742528|FG002|STARTED|Treatment Period 1||90||
48171724|NCT00519636|100742529|FG003|STARTED|Treatment Period 1||93||
48171725|NCT00519636|100742526|FG000|COMPLETED|Treatment Period 1||89||
48171726|NCT00519636|100742527|FG001|COMPLETED|Treatment Period 1||86||
48171727|NCT00519636|100742528|FG002|COMPLETED|Treatment Period 1||89||
48171728|NCT00519636|100742529|FG003|COMPLETED|Treatment Period 1||93||
48171729|NCT00519636|100742526|FG000|NOT COMPLETED|Treatment Period 1||2||
48171730|NCT00519636|100742527|FG001|NOT COMPLETED|Treatment Period 1||0||
48171731|NCT00519636|100742528|FG002|NOT COMPLETED|Treatment Period 1||1||
48171732|NCT00519636|100742529|FG003|NOT COMPLETED|Treatment Period 1||0||
48171733|NCT00519636|100742526|FG000|STARTED|Washout Period||89||
48171734|NCT00519636|100742527|FG001|STARTED|Washout Period||86||
48171735|NCT00519636|100742528|FG002|STARTED|Washout Period||89||
48171736|NCT00519636|100742529|FG003|STARTED|Washout Period||93||
48171737|NCT00519636|100742526|FG000|COMPLETED|Washout Period||69||
48171738|NCT00519636|100742527|FG001|COMPLETED|Washout Period||72||
48171739|NCT00519636|100742528|FG002|COMPLETED|Washout Period||75||
48171740|NCT00519636|100742529|FG003|COMPLETED|Washout Period||88||
48171741|NCT00519636|100742526|FG000|NOT COMPLETED|Washout Period||20||
48171742|NCT00519636|100742527|FG001|NOT COMPLETED|Washout Period||14||
48171743|NCT00519636|100742528|FG002|NOT COMPLETED|Washout Period||14||
48171744|NCT00519636|100742529|FG003|NOT COMPLETED|Washout Period||5||
48171745|NCT00519636|100742526|FG000|STARTED|Treatment Period 2||69||
48171746|NCT00519636|100742527|FG001|STARTED|Treatment Period 2||72||
48171747|NCT00519636|100742528|FG002|STARTED|Treatment Period 2||75||
48171748|NCT00519636|100742529|FG003|STARTED|Treatment Period 2||88||
48171749|NCT00519636|100742526|FG000|COMPLETED|Treatment Period 2||69||
48171750|NCT00519636|100742527|FG001|COMPLETED|Treatment Period 2||71||
48171751|NCT00519636|100742528|FG002|COMPLETED|Treatment Period 2||74||
48171752|NCT00519636|100742529|FG003|COMPLETED|Treatment Period 2||86||
48171753|NCT00519636|100742526|FG000|NOT COMPLETED|Treatment Period 2||0||
48171754|NCT00519636|100742527|FG001|NOT COMPLETED|Treatment Period 2||1||
48171755|NCT00519636|100742528|FG002|NOT COMPLETED|Treatment Period 2||1||
48334047|NCT05162066|101145635|FG002|COMPLETED|Overall Study||0||
48334048|NCT05162066|101145633|FG000|NOT COMPLETED|Overall Study||2||
48334049|NCT05162066|101145634|FG001|NOT COMPLETED|Overall Study||0||
48334050|NCT05162066|101145635|FG002|NOT COMPLETED|Overall Study||0||
48334051|NCT03213366|101145636|FG000|STARTED|Overall Study||81||7
48171756|NCT00519636|100742529|FG003|NOT COMPLETED|Treatment Period 2||2||
48171757|NCT00519636|100742526|FG000|STARTED|Post Study Period||69||
48171758|NCT00519636|100742527|FG001|STARTED|Post Study Period||71||
48171759|NCT00519636|100742528|FG002|STARTED|Post Study Period||74||
48171760|NCT00519636|100742529|FG003|STARTED|Post Study Period||86||
48171761|NCT00519636|100742526|FG000|COMPLETED|Post Study Period||69||
48171762|NCT00519636|100742527|FG001|COMPLETED|Post Study Period||71||
48171763|NCT00519636|100742528|FG002|COMPLETED|Post Study Period||74||
48171764|NCT00519636|100742529|FG003|COMPLETED|Post Study Period||85||
48171765|NCT00519636|100742526|FG000|NOT COMPLETED|Post Study Period||0||
48171766|NCT00519636|100742527|FG001|NOT COMPLETED|Post Study Period||0||
48171767|NCT00519636|100742528|FG002|NOT COMPLETED|Post Study Period||0||
48171768|NCT00519636|100742529|FG003|NOT COMPLETED|Post Study Period||1||
48171769|NCT02299258|100742530|FG000|STARTED|Overall Study||32||
48171770|NCT02299258|100742531|FG001|STARTED|Overall Study||31||
48171771|NCT02299258|100742530|FG000|COMPLETED|Overall Study||31||
48171772|NCT02299258|100742531|FG001|COMPLETED|Overall Study||30||
48171773|NCT02299258|100742530|FG000|NOT COMPLETED|Overall Study||1||
48171774|NCT02299258|100742531|FG001|NOT COMPLETED|Overall Study||1||
48171775|NCT00674115|100742532|FG000|STARTED|First Intervention||14||
48171776|NCT00674115|100742533|FG001|STARTED|First Intervention||16||
48171777|NCT00674115|100742534|FG002|STARTED|First Intervention||14||
48334052|NCT03213366|101145637|FG001|STARTED|Overall Study||71||5
48334053|NCT03213366|101145636|FG000|COMPLETED|Overall Study||72||5
48334054|NCT03213366|101145637|FG001|COMPLETED|Overall Study||67||5
48334055|NCT03213366|101145636|FG000|NOT COMPLETED|Overall Study||9||2
48334056|NCT03213366|101145637|FG001|NOT COMPLETED|Overall Study||4||0
48334057|NCT01064167|101145638|FG000|STARTED|Overall Study||130||
48334058|NCT01064167|101145639|FG001|STARTED|Overall Study||130||
48334059|NCT01064167|101145638|FG000|COMPLETED|Overall Study||116||
48334060|NCT01064167|101145639|FG001|COMPLETED|Overall Study||115||
48171778|NCT00674115|100742535|FG003|STARTED|First Intervention||16||
48171779|NCT00674115|100742532|FG000|COMPLETED|First Intervention||14||
48171780|NCT00674115|100742533|FG001|COMPLETED|First Intervention||16||
48171781|NCT00674115|100742534|FG002|COMPLETED|First Intervention||14||
48171782|NCT00674115|100742535|FG003|COMPLETED|First Intervention||16||
48171783|NCT00674115|100742532|FG000|NOT COMPLETED|First Intervention||0||
48171784|NCT00674115|100742533|FG001|NOT COMPLETED|First Intervention||0||
48171785|NCT00674115|100742534|FG002|NOT COMPLETED|First Intervention||0||
48171786|NCT00674115|100742535|FG003|NOT COMPLETED|First Intervention||0||
48171787|NCT00674115|100742532|FG000|STARTED|Washout Period of 2 Weeks||14||
48171788|NCT00674115|100742533|FG001|STARTED|Washout Period of 2 Weeks||16||
48171789|NCT00674115|100742534|FG002|STARTED|Washout Period of 2 Weeks||14||
48171790|NCT00674115|100742535|FG003|STARTED|Washout Period of 2 Weeks||16||
48171791|NCT00674115|100742532|FG000|COMPLETED|Washout Period of 2 Weeks||14||
48171792|NCT00674115|100742533|FG001|COMPLETED|Washout Period of 2 Weeks||16||
48171793|NCT00674115|100742534|FG002|COMPLETED|Washout Period of 2 Weeks||14||
48171794|NCT00674115|100742535|FG003|COMPLETED|Washout Period of 2 Weeks||16||
48171795|NCT00674115|100742532|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0||
48334061|NCT01064167|101145638|FG000|NOT COMPLETED|Overall Study||14||
48334062|NCT01064167|101145639|FG001|NOT COMPLETED|Overall Study||15||
48334063|NCT03036527|101145640|FG000|STARTED|Overall Study||8||
48334064|NCT03036527|101145641|FG001|STARTED|Overall Study||12||
48334065|NCT03036527|101145642|FG002|STARTED|Overall Study||10||
48334066|NCT03036527|101145643|FG003|STARTED|Overall Study||10||
48334067|NCT03036527|101145640|FG000|COMPLETED|Overall Study||8||
48334068|NCT03036527|101145641|FG001|COMPLETED|Overall Study||12||
48334069|NCT03036527|101145642|FG002|COMPLETED|Overall Study||10||
48334070|NCT03036527|101145643|FG003|COMPLETED|Overall Study||10||
48334071|NCT03036527|101145640|FG000|NOT COMPLETED|Overall Study||0||
48334072|NCT03036527|101145641|FG001|NOT COMPLETED|Overall Study||0||
48628025|NCT04232839|101874300|FG003|COMPLETED|Treatment Period 4 + Washout||3||
48628026|NCT04232839|101874301|FG004|COMPLETED|Treatment Period 4 + Washout||2||
48171796|NCT00674115|100742533|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0||
48171797|NCT00674115|100742534|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0||
48171798|NCT00674115|100742535|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0||
48171799|NCT00674115|100742532|FG000|STARTED|Second Intervention||14||
48171800|NCT00674115|100742533|FG001|STARTED|Second Intervention||16||
48171801|NCT00674115|100742534|FG002|STARTED|Second Intervention||14||
48171802|NCT00674115|100742535|FG003|STARTED|Second Intervention||16||
48171803|NCT00674115|100742532|FG000|COMPLETED|Second Intervention||14||
48171804|NCT00674115|100742533|FG001|COMPLETED|Second Intervention||16||
48171805|NCT00674115|100742534|FG002|COMPLETED|Second Intervention||14||
48171806|NCT00674115|100742535|FG003|COMPLETED|Second Intervention||16||
48171807|NCT00674115|100742532|FG000|NOT COMPLETED|Second Intervention||0||
48171808|NCT00674115|100742533|FG001|NOT COMPLETED|Second Intervention||0||
48171809|NCT00674115|100742534|FG002|NOT COMPLETED|Second Intervention||0||
48334073|NCT03036527|101145642|FG002|NOT COMPLETED|Overall Study||0||
48334074|NCT03036527|101145643|FG003|NOT COMPLETED|Overall Study||0||
48334075|NCT03094195|101145644|FG000|STARTED|Double-Blind Treatment Period (DB)||43||
48334076|NCT03094195|101145645|FG001|STARTED|Double-Blind Treatment Period (DB)||43||
48334077|NCT03094195|101145646|FG002|STARTED|Double-Blind Treatment Period (DB)||43||
48334078|NCT03094195|101145647|FG003|STARTED|Double-Blind Treatment Period (DB)||0||
48334079|NCT03094195|101145648|FG004|STARTED|Double-Blind Treatment Period (DB)||0||
48751026|NCT03137992|102177320|FG004|STARTED|Period 2 (Visit 3)||60||
48751027|NCT03137992|102177321|FG005|STARTED|Period 2 (Visit 3)||59||
48751028|NCT03137992|102177316|FG000|COMPLETED|Period 2 (Visit 3)||56||
48751029|NCT03137992|102177317|FG001|COMPLETED|Period 2 (Visit 3)||52||
48751030|NCT03137992|102177318|FG002|COMPLETED|Period 2 (Visit 3)||58||
48751031|NCT03137992|102177319|FG003|COMPLETED|Period 2 (Visit 3)||58||
48751032|NCT03137992|102177320|FG004|COMPLETED|Period 2 (Visit 3)||56||
48751033|NCT03137992|102177321|FG005|COMPLETED|Period 2 (Visit 3)||51||
48751034|NCT03137992|102177316|FG000|NOT COMPLETED|Period 2 (Visit 3)||3||
48751035|NCT03137992|102177317|FG001|NOT COMPLETED|Period 2 (Visit 3)||7||
48751036|NCT03137992|102177318|FG002|NOT COMPLETED|Period 2 (Visit 3)||3||
48751037|NCT03137992|102177319|FG003|NOT COMPLETED|Period 2 (Visit 3)||5||
48751038|NCT03137992|102177320|FG004|NOT COMPLETED|Period 2 (Visit 3)||4||
48751039|NCT03137992|102177321|FG005|NOT COMPLETED|Period 2 (Visit 3)||8||
48751040|NCT03137992|102177316|FG000|STARTED|Washout Period 2||56||
48751041|NCT03137992|102177317|FG001|STARTED|Washout Period 2||52||
48751042|NCT03137992|102177318|FG002|STARTED|Washout Period 2||58||
48751043|NCT03137992|102177319|FG003|STARTED|Washout Period 2||58||
48751044|NCT03137992|102177320|FG004|STARTED|Washout Period 2||56||
48751045|NCT03137992|102177321|FG005|STARTED|Washout Period 2||51||
48751046|NCT03137992|102177316|FG000|COMPLETED|Washout Period 2||54||
48751047|NCT03137992|102177317|FG001|COMPLETED|Washout Period 2||50||
48751048|NCT03137992|102177318|FG002|COMPLETED|Washout Period 2||58||
48751049|NCT03137992|102177319|FG003|COMPLETED|Washout Period 2||57||
48751050|NCT03137992|102177320|FG004|COMPLETED|Washout Period 2||53||
48751051|NCT03137992|102177321|FG005|COMPLETED|Washout Period 2||50||
48751052|NCT03137992|102177316|FG000|NOT COMPLETED|Washout Period 2||2||
48751053|NCT03137992|102177317|FG001|NOT COMPLETED|Washout Period 2||2||
48171810|NCT00674115|100742535|FG003|NOT COMPLETED|Second Intervention||0||
48171811|NCT00674115|100742532|FG000|STARTED|Washout Period of 2 Weeks||14||
48171812|NCT00674115|100742533|FG001|STARTED|Washout Period of 2 Weeks||16||
48171813|NCT00674115|100742534|FG002|STARTED|Washout Period of 2 Weeks||0||
48171814|NCT00674115|100742535|FG003|STARTED|Washout Period of 2 Weeks||0||
48171815|NCT00674115|100742532|FG000|COMPLETED|Washout Period of 2 Weeks||14||
48171816|NCT00674115|100742533|FG001|COMPLETED|Washout Period of 2 Weeks||16||
48171817|NCT00674115|100742534|FG002|COMPLETED|Washout Period of 2 Weeks||0||
48171818|NCT00674115|100742535|FG003|COMPLETED|Washout Period of 2 Weeks||0||
48751054|NCT03137992|102177318|FG002|NOT COMPLETED|Washout Period 2||0||
48751055|NCT03137992|102177319|FG003|NOT COMPLETED|Washout Period 2||1||
48751056|NCT03137992|102177320|FG004|NOT COMPLETED|Washout Period 2||3||
48751057|NCT03137992|102177321|FG005|NOT COMPLETED|Washout Period 2||1||
48751058|NCT03137992|102177316|FG000|STARTED|Period 3 (Visit 04)||54||
48751059|NCT03137992|102177317|FG001|STARTED|Period 3 (Visit 04)||50||
48751060|NCT03137992|102177318|FG002|STARTED|Period 3 (Visit 04)||58||
48751061|NCT03137992|102177319|FG003|STARTED|Period 3 (Visit 04)||57||
48751062|NCT03137992|102177320|FG004|STARTED|Period 3 (Visit 04)||53||
48751063|NCT03137992|102177321|FG005|STARTED|Period 3 (Visit 04)||50||
48751064|NCT03137992|102177316|FG000|COMPLETED|Period 3 (Visit 04)||48||
48171819|NCT00674115|100742532|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0||
48171820|NCT00674115|100742533|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0||
48171821|NCT00674115|100742534|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0||
48171822|NCT00674115|100742535|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0||
48171823|NCT00674115|100742532|FG000|STARTED|Third Intervention||14||
48171824|NCT00674115|100742533|FG001|STARTED|Third Intervention||16||
48171825|NCT00674115|100742534|FG002|STARTED|Third Intervention||0||
48171826|NCT00674115|100742535|FG003|STARTED|Third Intervention||0||
48171827|NCT00674115|100742532|FG000|COMPLETED|Third Intervention||14||
48171828|NCT00674115|100742533|FG001|COMPLETED|Third Intervention||16||
48171829|NCT00674115|100742534|FG002|COMPLETED|Third Intervention||0||
48171830|NCT00674115|100742535|FG003|COMPLETED|Third Intervention||0||
48171831|NCT00674115|100742532|FG000|NOT COMPLETED|Third Intervention||0||
48171832|NCT00674115|100742533|FG001|NOT COMPLETED|Third Intervention||0||
48171833|NCT00674115|100742534|FG002|NOT COMPLETED|Third Intervention||0||
48171834|NCT00674115|100742535|FG003|NOT COMPLETED|Third Intervention||0||
48171835|NCT04397523|100742536|FG000|STARTED|Overall Study||200||
48171836|NCT04397523|100742536|FG000|COMPLETED|Overall Study||189||
48171837|NCT04397523|100742536|FG000|NOT COMPLETED|Overall Study||11||
48334080|NCT03094195|101145649|FG005|STARTED|Double-Blind Treatment Period (DB)||0||
48751065|NCT03137992|102177317|FG001|COMPLETED|Period 3 (Visit 04)||48||
48751066|NCT03137992|102177318|FG002|COMPLETED|Period 3 (Visit 04)||55||
48751067|NCT03137992|102177319|FG003|COMPLETED|Period 3 (Visit 04)||57||
48171838|NCT01266447|100742537|FG000|STARTED|Overall Study||27||
48171839|NCT01266447|100742537|FG000|COMPLETED|Overall Study||27||
48171840|NCT01266447|100742537|FG000|NOT COMPLETED|Overall Study||0||
48171841|NCT01289041|100742538|FG000|STARTED|Overall Study||70||
48171842|NCT01289041|100742538|FG000|COMPLETED|Overall Study||0||
48439934|NCT01279265|101409986|FG000|COMPLETED|Overall Study||9||
48751068|NCT03137992|102177320|FG004|COMPLETED|Period 3 (Visit 04)||50||
48751069|NCT03137992|102177321|FG005|COMPLETED|Period 3 (Visit 04)||47||
48411702|NCT01426009|101341825|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23||
48411703|NCT01426009|101341825|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||24||
48411704|NCT01426009|101341825|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||22||
48411705|NCT01426009|101341825|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23||
48411706|NCT01426009|101341825|FG000|Ipratropium Bromide|Period 1-First Intervention (7 Days)||23||
48411707|NCT01426009|101341825|FG000|Placebo|Period 1-First Intervention (7 Days)||24||
48411708|NCT01426009|101341825|FG000|COMPLETED|Period 1-First Intervention (7 Days)||137||
48411709|NCT01426009|101341825|FG000|NOT COMPLETED|Period 1-First Intervention (7 Days)||2||
48411710|NCT01426009|101341825|FG000|STARTED|Washout 1||137||
48411711|NCT01426009|101341825|FG000|COMPLETED|Washout 1||135||
48411712|NCT01426009|101341825|FG000|NOT COMPLETED|Washout 1||2||
48411713|NCT01426009|101341825|FG000|STARTED|Period 2-Second Intervention (7 Days)||135||
48411714|NCT01426009|101341825|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||22||
48411715|NCT01426009|101341825|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24||
48411716|NCT01426009|101341825|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24||
48411717|NCT01426009|101341825|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||23||
48411718|NCT01426009|101341825|FG000|Ipratropium Bromide|Period 2-Second Intervention (7 Days)||21||
48411719|NCT01426009|101341825|FG000|Placebo|Period 2-Second Intervention (7 Days)||21||
48411720|NCT01426009|101341825|FG000|COMPLETED|Period 2-Second Intervention (7 Days)||130||
48411721|NCT01426009|101341825|FG000|NOT COMPLETED|Period 2-Second Intervention (7 Days)||5||
48751070|NCT03137992|102177316|FG000|NOT COMPLETED|Period 3 (Visit 04)||6||
48751071|NCT03137992|102177317|FG001|NOT COMPLETED|Period 3 (Visit 04)||2||
48334081|NCT03094195|101145650|FG006|STARTED|Double-Blind Treatment Period (DB)||0||
48334082|NCT03094195|101145651|FG007|STARTED|Double-Blind Treatment Period (DB)||0||
48334083|NCT03094195|101145644|FG000|COMPLETED|Double-Blind Treatment Period (DB)||28|Study completers completed the treatment phase regardless of completion of study treatment.|
48334084|NCT03094195|101145645|FG001|COMPLETED|Double-Blind Treatment Period (DB)||30|Study completers completed the treatment phase regardless of completion of study treatment.|
48334085|NCT03094195|101145646|FG002|COMPLETED|Double-Blind Treatment Period (DB)||29|Study completers completed the treatment phase regardless of completion of study treatment.|
48334086|NCT03094195|101145647|FG003|COMPLETED|Double-Blind Treatment Period (DB)||0|Study completers completed the treatment phase regardless of completion of study treatment.|
48334087|NCT03094195|101145648|FG004|COMPLETED|Double-Blind Treatment Period (DB)||0|Study completers completed the treatment phase regardless of completion of study treatment.|
48334088|NCT03094195|101145649|FG005|COMPLETED|Double-Blind Treatment Period (DB)||0|Study completers completed the treatment phase regardless of completion of study treatment.|
48334089|NCT03094195|101145650|FG006|COMPLETED|Double-Blind Treatment Period (DB)||0|Study completers completed the treatment phase regardless of completion of study treatment.|
48334090|NCT03094195|101145651|FG007|COMPLETED|Double-Blind Treatment Period (DB)||0|Study completers completed the treatment phase regardless of completion of study treatment.|
48334091|NCT03094195|101145644|FG000|NOT COMPLETED|Double-Blind Treatment Period (DB)||15||
48334092|NCT03094195|101145645|FG001|NOT COMPLETED|Double-Blind Treatment Period (DB)||13||
48334093|NCT03094195|101145646|FG002|NOT COMPLETED|Double-Blind Treatment Period (DB)||14||
48334094|NCT03094195|101145647|FG003|NOT COMPLETED|Double-Blind Treatment Period (DB)||0||
48334095|NCT03094195|101145648|FG004|NOT COMPLETED|Double-Blind Treatment Period (DB)||0||
48334096|NCT03094195|101145649|FG005|NOT COMPLETED|Double-Blind Treatment Period (DB)||0||
48334097|NCT03094195|101145650|FG006|NOT COMPLETED|Double-Blind Treatment Period (DB)||0||
48334098|NCT03094195|101145651|FG007|NOT COMPLETED|Double-Blind Treatment Period (DB)||0||
48334099|NCT03094195|101145644|FG000|STARTED|Treatment Withdrawal Period (TW)||0||
48334100|NCT03094195|101145645|FG001|STARTED|Treatment Withdrawal Period (TW)||0||
48334101|NCT03094195|101145646|FG002|STARTED|Treatment Withdrawal Period (TW)||0||
48334102|NCT03094195|101145647|FG003|STARTED|Treatment Withdrawal Period (TW)||13||
48334103|NCT03094195|101145648|FG004|STARTED|Treatment Withdrawal Period (TW)||13||
48334104|NCT03094195|101145649|FG005|STARTED|Treatment Withdrawal Period (TW)||15||
48334105|NCT03094195|101145650|FG006|STARTED|Treatment Withdrawal Period (TW)||13||
48334106|NCT03094195|101145651|FG007|STARTED|Treatment Withdrawal Period (TW)||26||
48334107|NCT03094195|101145644|FG000|COMPLETED|Treatment Withdrawal Period (TW)||0||
48334108|NCT03094195|101145645|FG001|COMPLETED|Treatment Withdrawal Period (TW)||0||
48334109|NCT03094195|101145646|FG002|COMPLETED|Treatment Withdrawal Period (TW)||0||
48334110|NCT03094195|101145647|FG003|COMPLETED|Treatment Withdrawal Period (TW)||13||
48334111|NCT03094195|101145648|FG004|COMPLETED|Treatment Withdrawal Period (TW)||13||
48334112|NCT03094195|101145649|FG005|COMPLETED|Treatment Withdrawal Period (TW)||15||
48334113|NCT03094195|101145650|FG006|COMPLETED|Treatment Withdrawal Period (TW)||13||
48334114|NCT03094195|101145651|FG007|COMPLETED|Treatment Withdrawal Period (TW)||26||
48334115|NCT03094195|101145644|FG000|NOT COMPLETED|Treatment Withdrawal Period (TW)||0||
48334116|NCT03094195|101145645|FG001|NOT COMPLETED|Treatment Withdrawal Period (TW)||0||
48334117|NCT03094195|101145646|FG002|NOT COMPLETED|Treatment Withdrawal Period (TW)||0||
48334118|NCT03094195|101145647|FG003|NOT COMPLETED|Treatment Withdrawal Period (TW)||0||
48334119|NCT03094195|101145648|FG004|NOT COMPLETED|Treatment Withdrawal Period (TW)||0||
48411722|NCT01426009|101341825|FG000|STARTED|Washout 2||130||
48411723|NCT01426009|101341825|FG000|COMPLETED|Washout 2||129||
48411724|NCT01426009|101341825|FG000|NOT COMPLETED|Washout 2||1||
48411725|NCT01426009|101341825|FG000|STARTED|Period 3-Third Intervention (7 Days)||129||
48411726|NCT01426009|101341825|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||19||
48411727|NCT01426009|101341825|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||23||
48411728|NCT01426009|101341825|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||22||
48628027|NCT04232839|101874302|FG005|COMPLETED|Treatment Period 4 + Washout||2||
48628028|NCT04232839|101874303|FG006|COMPLETED|Treatment Period 4 + Washout||3||
48628029|NCT04232839|101874304|FG007|COMPLETED|Treatment Period 4 + Washout||3||
48751072|NCT03137992|102177318|FG002|NOT COMPLETED|Period 3 (Visit 04)||3||
48751073|NCT03137992|102177319|FG003|NOT COMPLETED|Period 3 (Visit 04)||0||
48751074|NCT03137992|102177320|FG004|NOT COMPLETED|Period 3 (Visit 04)||3||
48751075|NCT03137992|102177321|FG005|NOT COMPLETED|Period 3 (Visit 04)||3||
48751076|NCT03137992|102177316|FG000|STARTED|Part 2 (Open-label Extension)||22|Part 2 of the study enrolled a subset of 125 (from select investigational centers) participants who had successfully completed Part 1 of the study and who met the continuation criteria.|
48334120|NCT03094195|101145649|FG005|NOT COMPLETED|Treatment Withdrawal Period (TW)||0||
48334121|NCT03094195|101145650|FG006|NOT COMPLETED|Treatment Withdrawal Period (TW)||0||
48334122|NCT03094195|101145651|FG007|NOT COMPLETED|Treatment Withdrawal Period (TW)||0||
48334123|NCT03056573|101145652|FG000|STARTED|Overall Study||45||
48334124|NCT03056573|101145653|FG001|STARTED|Overall Study||19||
48334125|NCT03056573|101145652|FG000|COMPLETED|Overall Study||40||
48334126|NCT03056573|101145653|FG001|COMPLETED|Overall Study||14||
48334127|NCT03056573|101145652|FG000|NOT COMPLETED|Overall Study||5||
48334128|NCT03056573|101145653|FG001|NOT COMPLETED|Overall Study||5||
48334129|NCT00654498|101145654|FG000|STARTED|Overall Study||203||
48334130|NCT00654498|101145655|FG001|STARTED|Overall Study||103||
48334131|NCT00654498|101145654|FG000|COMPLETED|Overall Study||189||
48334132|NCT00654498|101145655|FG001|COMPLETED|Overall Study||91||
48334133|NCT00654498|101145654|FG000|NOT COMPLETED|Overall Study||14||
48334134|NCT00654498|101145655|FG001|NOT COMPLETED|Overall Study||12||
48334135|NCT02396732|101145656|FG000|STARTED|Overall Study||14||
48334136|NCT02396732|101145657|FG001|STARTED|Overall Study||17||
48334137|NCT02396732|101145656|FG000|COMPLETED|Overall Study||14||
48334138|NCT02396732|101145657|FG001|COMPLETED|Overall Study||17||
48334139|NCT02396732|101145656|FG000|NOT COMPLETED|Overall Study||0||
48334140|NCT02396732|101145657|FG001|NOT COMPLETED|Overall Study||0||
48334141|NCT01110395|101145658|FG000|STARTED|Overall Study||15||
48334142|NCT01110395|101145658|FG000|COMPLETED|Overall Study||15||
48334143|NCT01110395|101145658|FG000|NOT COMPLETED|Overall Study||0||
48334144|NCT00880256|101145659|FG000|STARTED|Overall Study||93||
48334145|NCT00880256|101145659|FG000|COMPLETED|Overall Study||65||
48628030|NCT04232839|101874305|FG008|COMPLETED|Treatment Period 4 + Washout||2||
48628031|NCT04232839|101874306|FG009|COMPLETED|Treatment Period 4 + Washout||3||
48628032|NCT04232839|101874297|FG000|NOT COMPLETED|Treatment Period 4 + Washout||0||
48628033|NCT04232839|101874298|FG001|NOT COMPLETED|Treatment Period 4 + Washout||0||
48751077|NCT03137992|102177317|FG001|STARTED|Part 2 (Open-label Extension)||17|Part 2 of the study enrolled a subset of 125 (from select investigational centers) participants who had successfully completed Part 1 of the study and who met the continuation criteria.|
48751078|NCT03137992|102177318|FG002|STARTED|Part 2 (Open-label Extension)||21|Part 2 of the study enrolled a subset of 125 (from select investigational centers) participants who had successfully completed Part 1 of the study and who met the continuation criteria.|
48767724|NCT00494676|102222813|FG001|NOT COMPLETED|Allocation||4||
48171843|NCT01289041|100742538|FG000|NOT COMPLETED|Overall Study||70||
48334146|NCT00880256|101145659|FG000|NOT COMPLETED|Overall Study||28||
48334147|NCT02582957|101145660|FG000|STARTED|Overall Study||261||
48628034|NCT04232839|101874299|FG002|NOT COMPLETED|Treatment Period 4 + Washout||0||
48628035|NCT04232839|101874300|FG003|NOT COMPLETED|Treatment Period 4 + Washout||0||
48628036|NCT04232839|101874301|FG004|NOT COMPLETED|Treatment Period 4 + Washout||0||
48628037|NCT04232839|101874302|FG005|NOT COMPLETED|Treatment Period 4 + Washout||0||
48628038|NCT04232839|101874303|FG006|NOT COMPLETED|Treatment Period 4 + Washout||0||
48628039|NCT04232839|101874304|FG007|NOT COMPLETED|Treatment Period 4 + Washout||0||
48628040|NCT04232839|101874305|FG008|NOT COMPLETED|Treatment Period 4 + Washout||0||
48628041|NCT04232839|101874306|FG009|NOT COMPLETED|Treatment Period 4 + Washout||0||
48628042|NCT04232839|101874297|FG000|STARTED|Treatment Period 5 + Washout||2||
48334148|NCT02582957|101145661|FG001|STARTED|Overall Study||263||
48334149|NCT02582957|101145660|FG000|COMPLETED|Overall Study||259||
48334150|NCT02582957|101145661|FG001|COMPLETED|Overall Study||261||
48334151|NCT02582957|101145660|FG000|NOT COMPLETED|Overall Study||2||
48334152|NCT02582957|101145661|FG001|NOT COMPLETED|Overall Study||2||
48334153|NCT01627860|101145662|FG000|STARTED|Overall Study||35||
48334154|NCT01627860|101145663|FG001|STARTED|Overall Study||20||
48334155|NCT01627860|101145662|FG000|COMPLETED|Overall Study||23||
48411729|NCT01426009|101341825|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||20||
48411730|NCT01426009|101341825|FG000|Ipratropium Bromide|Period 3-Third Intervention (7 Days)||23||
48411731|NCT01426009|101341825|FG000|Placebo|Period 3-Third Intervention (7 Days)||22||
48411732|NCT01426009|101341825|FG000|COMPLETED|Period 3-Third Intervention (7 Days)||129||
48411733|NCT01426009|101341825|FG000|NOT COMPLETED|Period 3-Third Intervention (7 Days)||0||
48334156|NCT01627860|101145663|FG001|COMPLETED|Overall Study||14||
48334157|NCT01627860|101145662|FG000|NOT COMPLETED|Overall Study||12||
48334158|NCT01627860|101145663|FG001|NOT COMPLETED|Overall Study||6||
48751079|NCT03137992|102177319|FG003|STARTED|Part 2 (Open-label Extension)||25|Part 2 of the study enrolled a subset of 125 (from select investigational centers) participants who had successfully completed Part 1 of the study and who met the continuation criteria.|
48751080|NCT03137992|102177320|FG004|STARTED|Part 2 (Open-label Extension)||18|Part 2 of the study enrolled a subset of 125 (from select investigational centers) participants who had successfully completed Part 1 of the study and who met the continuation criteria.|
48751081|NCT03137992|102177321|FG005|STARTED|Part 2 (Open-label Extension)||22|Part 2 of the study enrolled a subset of 125 (from select investigational centers) participants who had successfully completed Part 1 of the study and who met the continuation criteria.|
48751082|NCT03137992|102177316|FG000|COMPLETED|Part 2 (Open-label Extension)||20||
48751083|NCT03137992|102177317|FG001|COMPLETED|Part 2 (Open-label Extension)||17||
48751084|NCT03137992|102177318|FG002|COMPLETED|Part 2 (Open-label Extension)||20||
48751085|NCT03137992|102177319|FG003|COMPLETED|Part 2 (Open-label Extension)||24||
48751086|NCT03137992|102177320|FG004|COMPLETED|Part 2 (Open-label Extension)||18||
48751087|NCT03137992|102177321|FG005|COMPLETED|Part 2 (Open-label Extension)||21||
48751088|NCT03137992|102177316|FG000|NOT COMPLETED|Part 2 (Open-label Extension)||2||
48411734|NCT01426009|101341825|FG000|STARTED|Washout 3||129||
48411735|NCT01426009|101341825|FG000|COMPLETED|Washout 3||128||
48411736|NCT01426009|101341825|FG000|NOT COMPLETED|Washout 3||1||
48411737|NCT01426009|101341825|FG000|STARTED|Period 4-Fourth Intervention (7 Days)||128||
48411738|NCT01426009|101341825|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||10||
48411739|NCT01426009|101341825|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||7||
48411740|NCT01426009|101341825|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||8||
48411741|NCT01426009|101341825|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||9||
48411742|NCT01426009|101341825|FG000|Ipratropium Bromide|Period 4-Fourth Intervention (7 Days)||8||
48411743|NCT01426009|101341825|FG000|Tiotropium Bromide|Period 4-Fourth Intervention (7 Days)||76||
48411744|NCT01426009|101341825|FG000|Placebo|Period 4-Fourth Intervention (7 Days)||10||
48411745|NCT01426009|101341825|FG000|COMPLETED|Period 4-Fourth Intervention (7 Days)||127||
48751089|NCT03137992|102177317|FG001|NOT COMPLETED|Part 2 (Open-label Extension)||0||
48751090|NCT03137992|102177318|FG002|NOT COMPLETED|Part 2 (Open-label Extension)||1||
48751091|NCT03137992|102177319|FG003|NOT COMPLETED|Part 2 (Open-label Extension)||1||
48767725|NCT00494676|102222812|FG000|STARTED|First Intervention||35||
48411746|NCT01426009|101341825|FG000|NOT COMPLETED|Period 4-Fourth Intervention (7 Days)||1||
48411747|NCT01426009|101341825|FG000|STARTED|Washout 4||127||
48411748|NCT01426009|101341825|FG000|COMPLETED|Washout 4||126||
48411749|NCT01426009|101341825|FG000|NOT COMPLETED|Washout 4||1||
48411750|NCT04476108|101341826|FG000|STARTED|Overall Study||84||
48411751|NCT04476108|101341827|FG001|STARTED|Overall Study||41||
48411752|NCT04476108|101341826|FG000|Received at Least 1 Dose of Study Drug|Overall Study||83||
48411753|NCT04476108|101341827|FG001|Received at Least 1 Dose of Study Drug|Overall Study||41||
48411754|NCT04476108|101341826|FG000|COMPLETED|Overall Study||76||
48411755|NCT04476108|101341827|FG001|COMPLETED|Overall Study||38||
48411756|NCT04476108|101341826|FG000|NOT COMPLETED|Overall Study||8||
48411757|NCT04476108|101341827|FG001|NOT COMPLETED|Overall Study||3||
48411758|NCT02139280|101341828|FG000|STARTED|Overall Study||34||
48411759|NCT02139280|101341829|FG001|STARTED|Overall Study||20||
48411760|NCT02139280|101341828|FG000|COMPLETED|Overall Study||32||
48411761|NCT02139280|101341829|FG001|COMPLETED|Overall Study||20||
48411762|NCT02139280|101341828|FG000|NOT COMPLETED|Overall Study||2||
48411763|NCT02139280|101341829|FG001|NOT COMPLETED|Overall Study||0||
48411764|NCT00636506|101341830|FG000|STARTED|Overall Study||76||
48411765|NCT00636506|101341830|FG000|COMPLETED|Overall Study||60||
48411766|NCT00636506|101341830|FG000|NOT COMPLETED|Overall Study||16||
48411767|NCT01836549|101341831|FG000|STARTED|Overall Study||1||
48411768|NCT01836549|101341832|FG001|STARTED|Overall Study||1||
48411769|NCT01836549|101341833|FG002|STARTED|Overall Study||1||
48411770|NCT01836549|101341834|FG003|STARTED|Overall Study||9||
48411771|NCT01836549|101341835|FG004|STARTED|Overall Study||18||
48411772|NCT01836549|101341836|FG005|STARTED|Overall Study||4||
48411773|NCT01836549|101341837|FG006|STARTED|Overall Study||9||
48411774|NCT01836549|101341831|FG000|COMPLETED|Overall Study||1||
48411775|NCT01836549|101341832|FG001|COMPLETED|Overall Study||1||
48411776|NCT01836549|101341833|FG002|COMPLETED|Overall Study||0||
48411777|NCT01836549|101341834|FG003|COMPLETED|Overall Study||8||
48411778|NCT01836549|101341835|FG004|COMPLETED|Overall Study||18||
48411779|NCT01836549|101341836|FG005|COMPLETED|Overall Study||4||
48411780|NCT01836549|101341837|FG006|COMPLETED|Overall Study||8||
48411781|NCT01836549|101341831|FG000|NOT COMPLETED|Overall Study||0||
48411782|NCT01836549|101341832|FG001|NOT COMPLETED|Overall Study||0||
48411783|NCT01836549|101341833|FG002|NOT COMPLETED|Overall Study||1||
48411784|NCT01836549|101341834|FG003|NOT COMPLETED|Overall Study||1||
48411785|NCT01836549|101341835|FG004|NOT COMPLETED|Overall Study||0||
48411786|NCT01836549|101341836|FG005|NOT COMPLETED|Overall Study||0||
48411787|NCT01836549|101341837|FG006|NOT COMPLETED|Overall Study||1||
48411788|NCT02573012|101341838|FG000|STARTED|Overall Study||131||
48411789|NCT02573012|101341839|FG001|STARTED|Overall Study||128||
48411790|NCT02573012|101341838|FG000|COMPLETED|Overall Study||116||
48411791|NCT02573012|101341839|FG001|COMPLETED|Overall Study||113||
48411792|NCT02573012|101341838|FG000|NOT COMPLETED|Overall Study||15||
48411793|NCT02573012|101341839|FG001|NOT COMPLETED|Overall Study||15||
48411794|NCT04043416|101341840|FG000|STARTED|Campaign 1||14||
48628043|NCT04232839|101874298|FG001|STARTED|Treatment Period 5 + Washout||2||
48628044|NCT04232839|101874299|FG002|STARTED|Treatment Period 5 + Washout||2||
48628045|NCT04232839|101874300|FG003|STARTED|Treatment Period 5 + Washout||3||
48628046|NCT04232839|101874301|FG004|STARTED|Treatment Period 5 + Washout||2||
48628047|NCT04232839|101874302|FG005|STARTED|Treatment Period 5 + Washout||2||
48628048|NCT04232839|101874303|FG006|STARTED|Treatment Period 5 + Washout||3||
48628049|NCT04232839|101874304|FG007|STARTED|Treatment Period 5 + Washout||3||
48628050|NCT04232839|101874305|FG008|STARTED|Treatment Period 5 + Washout||2||
48628051|NCT04232839|101874306|FG009|STARTED|Treatment Period 5 + Washout||3||
48628052|NCT04232839|101874297|FG000|COMPLETED|Treatment Period 5 + Washout||2||
48628053|NCT04232839|101874298|FG001|COMPLETED|Treatment Period 5 + Washout||2||
48628054|NCT04232839|101874299|FG002|COMPLETED|Treatment Period 5 + Washout||2||
48628055|NCT04232839|101874300|FG003|COMPLETED|Treatment Period 5 + Washout||3||
48628056|NCT04232839|101874301|FG004|COMPLETED|Treatment Period 5 + Washout||2||
48628057|NCT04232839|101874302|FG005|COMPLETED|Treatment Period 5 + Washout||2||
48628058|NCT04232839|101874303|FG006|COMPLETED|Treatment Period 5 + Washout||3||
48628059|NCT04232839|101874304|FG007|COMPLETED|Treatment Period 5 + Washout||3||
48628060|NCT04232839|101874305|FG008|COMPLETED|Treatment Period 5 + Washout||2||
48628061|NCT04232839|101874306|FG009|COMPLETED|Treatment Period 5 + Washout||3||
48628062|NCT04232839|101874297|FG000|NOT COMPLETED|Treatment Period 5 + Washout||0||
48628063|NCT04232839|101874298|FG001|NOT COMPLETED|Treatment Period 5 + Washout||0||
48628064|NCT04232839|101874299|FG002|NOT COMPLETED|Treatment Period 5 + Washout||0||
48628065|NCT04232839|101874300|FG003|NOT COMPLETED|Treatment Period 5 + Washout||0||
48628066|NCT04232839|101874301|FG004|NOT COMPLETED|Treatment Period 5 + Washout||0||
48628067|NCT04232839|101874302|FG005|NOT COMPLETED|Treatment Period 5 + Washout||0||
48628068|NCT04232839|101874303|FG006|NOT COMPLETED|Treatment Period 5 + Washout||0||
48628069|NCT04232839|101874304|FG007|NOT COMPLETED|Treatment Period 5 + Washout||0||
48628070|NCT04232839|101874305|FG008|NOT COMPLETED|Treatment Period 5 + Washout||0||
48628071|NCT04232839|101874306|FG009|NOT COMPLETED|Treatment Period 5 + Washout||0||
48628072|NCT04232839|101874297|FG000|STARTED|Treatment Period 6||2||
48628073|NCT04232839|101874298|FG001|STARTED|Treatment Period 6||2||
48628074|NCT04232839|101874299|FG002|STARTED|Treatment Period 6||2||
48628075|NCT04232839|101874300|FG003|STARTED|Treatment Period 6||3||
48628076|NCT04232839|101874301|FG004|STARTED|Treatment Period 6||2||
48628077|NCT04232839|101874302|FG005|STARTED|Treatment Period 6||2||
48628078|NCT04232839|101874303|FG006|STARTED|Treatment Period 6||3||
48411795|NCT04043416|101341841|FG001|STARTED|Campaign 1||14||
48411796|NCT04043416|101341840|FG000|COMPLETED|Campaign 1||14||
48411797|NCT04043416|101341841|FG001|COMPLETED|Campaign 1||14||
48411798|NCT04043416|101341840|FG000|NOT COMPLETED|Campaign 1||0||
48411799|NCT04043416|101341841|FG001|NOT COMPLETED|Campaign 1||0||
48411800|NCT04043416|101341840|FG000|STARTED|Washout||14||
48411801|NCT04043416|101341841|FG001|STARTED|Washout||14||
48411802|NCT04043416|101341840|FG000|COMPLETED|Washout||14||
48411803|NCT04043416|101341841|FG001|COMPLETED|Washout||13||
48411804|NCT04043416|101341840|FG000|NOT COMPLETED|Washout||0||
48411805|NCT04043416|101341841|FG001|NOT COMPLETED|Washout||1||
48411806|NCT04043416|101341840|FG000|STARTED|Campaign 2||14||
48628079|NCT04232839|101874304|FG007|STARTED|Treatment Period 6||3||
48751092|NCT03137992|102177320|FG004|NOT COMPLETED|Part 2 (Open-label Extension)||0||
48751093|NCT03137992|102177321|FG005|NOT COMPLETED|Part 2 (Open-label Extension)||1||
48751094|NCT02721875|102177322|FG000|STARTED|Overall Study||1||
48751095|NCT02721875|102177323|FG001|STARTED|Overall Study||0||
48751096|NCT02721875|102177322|FG000|COMPLETED|Overall Study||0||
48751097|NCT02721875|102177323|FG001|COMPLETED|Overall Study||0||
48751098|NCT02721875|102177322|FG000|NOT COMPLETED|Overall Study||1||
48751099|NCT02721875|102177323|FG001|NOT COMPLETED|Overall Study||0||
48751100|NCT02051452|102177324|FG000|STARTED|Overall Study||16||
48751101|NCT02051452|102177325|FG001|STARTED|Overall Study||16||
48751102|NCT02051452|102177324|FG000|COMPLETED|Overall Study||16||
48751103|NCT02051452|102177325|FG001|COMPLETED|Overall Study||16||
48628080|NCT04232839|101874305|FG008|STARTED|Treatment Period 6||2||
48628081|NCT04232839|101874306|FG009|STARTED|Treatment Period 6||3||
48628082|NCT04232839|101874297|FG000|COMPLETED|Treatment Period 6||2||
48628083|NCT04232839|101874298|FG001|COMPLETED|Treatment Period 6||2||
48751104|NCT02051452|102177324|FG000|NOT COMPLETED|Overall Study||0||
48751105|NCT02051452|102177325|FG001|NOT COMPLETED|Overall Study||0||
48751106|NCT00099372|102177326|FG000|STARTED|Enrolled in Extended CARE Trial||104||
48751107|NCT00099372|102177327|FG001|STARTED|Enrolled in Extended CARE Trial||111||
48751108|NCT00099372|102177326|FG000|COMPLETED|Enrolled in Extended CARE Trial||104||
48751109|NCT00099372|102177327|FG001|COMPLETED|Enrolled in Extended CARE Trial||111||
48751110|NCT00099372|102177326|FG000|NOT COMPLETED|Enrolled in Extended CARE Trial||0||
48751111|NCT00099372|102177327|FG001|NOT COMPLETED|Enrolled in Extended CARE Trial||0||
48751112|NCT00099372|102177326|FG000|STARTED|Followed up 5 Years After Index Surgery||104||
48751113|NCT00099372|102177327|FG001|STARTED|Followed up 5 Years After Index Surgery||111||
48751114|NCT00099372|102177326|FG000|COMPLETED|Followed up 5 Years After Index Surgery||89||
48751115|NCT00099372|102177327|FG001|COMPLETED|Followed up 5 Years After Index Surgery||92||
48751116|NCT00099372|102177326|FG000|NOT COMPLETED|Followed up 5 Years After Index Surgery||15||
48751117|NCT00099372|102177327|FG001|NOT COMPLETED|Followed up 5 Years After Index Surgery||19||
48751118|NCT00099372|102177326|FG000|STARTED|Followed up 7 Years After Index Surgery||89||
48751119|NCT00099372|102177327|FG001|STARTED|Followed up 7 Years After Index Surgery||92||
48751120|NCT00099372|102177326|FG000|COMPLETED|Followed up 7 Years After Index Surgery||66||
48751121|NCT00099372|102177327|FG001|COMPLETED|Followed up 7 Years After Index Surgery||60||
48751122|NCT00099372|102177326|FG000|NOT COMPLETED|Followed up 7 Years After Index Surgery||23||
48751123|NCT00099372|102177327|FG001|NOT COMPLETED|Followed up 7 Years After Index Surgery||32||
48411807|NCT04043416|101341841|FG001|STARTED|Campaign 2||13||
48411808|NCT04043416|101341840|FG000|COMPLETED|Campaign 2||14||
48628084|NCT04232839|101874299|FG002|COMPLETED|Treatment Period 6||2||
48628085|NCT04232839|101874300|FG003|COMPLETED|Treatment Period 6||3||
48628086|NCT04232839|101874301|FG004|COMPLETED|Treatment Period 6||2||
48628087|NCT04232839|101874302|FG005|COMPLETED|Treatment Period 6||2||
48628088|NCT04232839|101874303|FG006|COMPLETED|Treatment Period 6||3||
48628089|NCT04232839|101874304|FG007|COMPLETED|Treatment Period 6||3||
48628090|NCT04232839|101874305|FG008|COMPLETED|Treatment Period 6||2||
48628091|NCT04232839|101874306|FG009|COMPLETED|Treatment Period 6||3||
48628092|NCT04232839|101874297|FG000|NOT COMPLETED|Treatment Period 6||0||
48628093|NCT04232839|101874298|FG001|NOT COMPLETED|Treatment Period 6||0||
48751124|NCT02349633|102177328|FG000|STARTED|Overall Study||4||
48751125|NCT02349633|102177329|FG001|STARTED|Overall Study||3||
48751126|NCT02349633|102177330|FG002|STARTED|Overall Study||4||
48751127|NCT02349633|102177331|FG003|STARTED|Overall Study||4||
48751128|NCT02349633|102177332|FG004|STARTED|Overall Study||3||
48751129|NCT02349633|102177333|FG005|STARTED|Overall Study||4||
48751130|NCT02349633|102177334|FG006|STARTED|Overall Study||4||
48751131|NCT02349633|102177335|FG007|STARTED|Overall Study||29||
48751132|NCT02349633|102177336|FG008|STARTED|Overall Study||5||
48751133|NCT02349633|102177337|FG009|STARTED|Overall Study||5||
48751134|NCT02349633|102177338|FG010|STARTED|Overall Study||0||
48751135|NCT02349633|102177339|FG011|STARTED|Overall Study||0||
48751136|NCT02349633|102177340|FG012|STARTED|Overall Study||0||
48751137|NCT02349633|102177341|FG013|STARTED|Overall Study||0||
48751138|NCT02349633|102177328|FG000|COMPLETED|Overall Study||4||
48751139|NCT02349633|102177329|FG001|COMPLETED|Overall Study||2||
48751140|NCT02349633|102177330|FG002|COMPLETED|Overall Study||4||
48751141|NCT02349633|102177331|FG003|COMPLETED|Overall Study||2||
48751142|NCT02349633|102177332|FG004|COMPLETED|Overall Study||1||
48751143|NCT02349633|102177333|FG005|COMPLETED|Overall Study||3||
48751144|NCT02349633|102177334|FG006|COMPLETED|Overall Study||3||
48751145|NCT02349633|102177335|FG007|COMPLETED|Overall Study||13||
48751146|NCT02349633|102177336|FG008|COMPLETED|Overall Study||3||
48751147|NCT02349633|102177337|FG009|COMPLETED|Overall Study||0||
48751148|NCT02349633|102177338|FG010|COMPLETED|Overall Study||0||
48751149|NCT02349633|102177339|FG011|COMPLETED|Overall Study||0||
48751150|NCT02349633|102177340|FG012|COMPLETED|Overall Study||0||
48751151|NCT02349633|102177341|FG013|COMPLETED|Overall Study||0||
48751152|NCT02349633|102177328|FG000|NOT COMPLETED|Overall Study||0||
48751153|NCT02349633|102177329|FG001|NOT COMPLETED|Overall Study||1||
48751154|NCT02349633|102177330|FG002|NOT COMPLETED|Overall Study||0||
48751155|NCT02349633|102177331|FG003|NOT COMPLETED|Overall Study||2||
48751156|NCT02349633|102177332|FG004|NOT COMPLETED|Overall Study||2||
48751157|NCT02349633|102177333|FG005|NOT COMPLETED|Overall Study||1||
48751158|NCT02349633|102177334|FG006|NOT COMPLETED|Overall Study||1||
48751159|NCT02349633|102177335|FG007|NOT COMPLETED|Overall Study||16||
48171844|NCT05150587|100742539|FG000|STARTED|Overall Study||70||
48411809|NCT04043416|101341841|FG001|COMPLETED|Campaign 2||13||
48751160|NCT02349633|102177336|FG008|NOT COMPLETED|Overall Study||2||
48751161|NCT02349633|102177337|FG009|NOT COMPLETED|Overall Study||5||
48751162|NCT02349633|102177338|FG010|NOT COMPLETED|Overall Study||0||
48751163|NCT02349633|102177339|FG011|NOT COMPLETED|Overall Study||0||
48751164|NCT02349633|102177340|FG012|NOT COMPLETED|Overall Study||0||
48171845|NCT05150587|100742540|FG001|STARTED|Overall Study||80||
48411810|NCT04043416|101341840|FG000|NOT COMPLETED|Campaign 2||0||
48411811|NCT04043416|101341841|FG001|NOT COMPLETED|Campaign 2||0||
48411812|NCT01362049|101341842|FG000|STARTED|Follow-Up at 7 Weeks||26|Subjects who signed consent forms|
48411813|NCT01362049|101341843|FG001|STARTED|Follow-Up at 7 Weeks||19|Subjects who signed consent forms|
48751165|NCT02349633|102177341|FG013|NOT COMPLETED|Overall Study||0||
48751166|NCT02138890|102177342|FG000|STARTED|Overall Study||31|Subjects were followed up for 12 months and if they consent, for a long term follow-up of 5 years.|
48751167|NCT02138890|102177343|FG001|STARTED|Overall Study||15|Subjects were followed up for 12 months and if they consent, for a long term follow-up of 5 years.|
48171846|NCT05150587|100742541|FG002|STARTED|Overall Study||66||
48751168|NCT02138890|102177342|FG000|COMPLETED|Overall Study||30||
48751169|NCT02138890|102177343|FG001|COMPLETED|Overall Study||15||
48751170|NCT02138890|102177342|FG000|NOT COMPLETED|Overall Study||1||
48751171|NCT02138890|102177343|FG001|NOT COMPLETED|Overall Study||0||
48751172|NCT01091675|102177344|FG000|STARTED|Overall Study||57||
48751173|NCT01091675|102177344|FG000|COMPLETED|Overall Study||23||
48751174|NCT01091675|102177344|FG000|NOT COMPLETED|Overall Study||34||
48751175|NCT02159066|102177345|FG000|STARTED|Part I||75||
48751176|NCT02159066|102177346|FG001|STARTED|Part I||83||
48751177|NCT02159066|102177347|FG002|STARTED|Part I||0||
48751178|NCT02159066|102177348|FG003|STARTED|Part I||0||
48751179|NCT02159066|102177349|FG004|STARTED|Part I||0||
48171847|NCT05150587|100742539|FG000|"Number of Participants Included in the Full Analysis Set"|Overall Study||65||
48171848|NCT05150587|100742540|FG001|"Number of Participants Included in the Full Analysis Set"|Overall Study||76||
48171849|NCT05150587|100742541|FG002|"Number of Participants Included in the Full Analysis Set"|Overall Study||63||
48171850|NCT05150587|100742539|FG000|COMPLETED|Overall Study||64||
48171851|NCT05150587|100742540|FG001|COMPLETED|Overall Study||73||
48171852|NCT05150587|100742541|FG002|COMPLETED|Overall Study||60||
48171853|NCT05150587|100742539|FG000|NOT COMPLETED|Overall Study||6||
48171854|NCT05150587|100742540|FG001|NOT COMPLETED|Overall Study||7||
48171855|NCT05150587|100742541|FG002|NOT COMPLETED|Overall Study||6||
48171856|NCT04785326|100742542|FG000|STARTED|Period 1 (Week 1 to 28)||299||
48171857|NCT04785326|100742543|FG001|STARTED|Period 1 (Week 1 to 28)||299||
48171858|NCT04785326|100742544|FG002|STARTED|Period 1 (Week 1 to 28)||0||
48171859|NCT04785326|100742542|FG000|COMPLETED|Period 1 (Week 1 to 28)||268||
48171860|NCT04785326|100742543|FG001|COMPLETED|Period 1 (Week 1 to 28)||263||
48171861|NCT04785326|100742544|FG002|COMPLETED|Period 1 (Week 1 to 28)||0||
48171862|NCT04785326|100742542|FG000|NOT COMPLETED|Period 1 (Week 1 to 28)||31||
48171863|NCT04785326|100742543|FG001|NOT COMPLETED|Period 1 (Week 1 to 28)||36||
48171864|NCT04785326|100742544|FG002|NOT COMPLETED|Period 1 (Week 1 to 28)||0||
48171865|NCT04785326|100742542|FG000|STARTED|Period 2 (Week 28 to 52)||268||
48171866|NCT04785326|100742543|FG001|STARTED|Period 2 (Week 28 to 52)||132||
48171867|NCT04785326|100742544|FG002|STARTED|Period 2 (Week 28 to 52)||131||
48171868|NCT04785326|100742542|FG000|COMPLETED|Period 2 (Week 28 to 52)||258||
48171869|NCT04785326|100742543|FG001|COMPLETED|Period 2 (Week 28 to 52)||130||
48171870|NCT04785326|100742544|FG002|COMPLETED|Period 2 (Week 28 to 52)||124||
48171871|NCT04785326|100742542|FG000|NOT COMPLETED|Period 2 (Week 28 to 52)||10||
48171872|NCT04785326|100742543|FG001|NOT COMPLETED|Period 2 (Week 28 to 52)||2||
48171873|NCT04785326|100742544|FG002|NOT COMPLETED|Period 2 (Week 28 to 52)||7||
48751180|NCT02159066|102177350|FG005|STARTED|Part I||0||
48751181|NCT02159066|102177345|FG000|COMPLETED|Part I||0||
48171874|NCT01213173|100742545|FG000|STARTED|Overall Study||125||
48171875|NCT01213173|100742546|FG001|STARTED|Overall Study||126||
48171876|NCT01213173|100742545|FG000|Patients Included in Safety Population|Overall Study||139||
48171877|NCT01213173|100742546|FG001|Patients Included in Safety Population|Overall Study||112||
48171878|NCT01213173|100742545|FG000|Patients Included in ITT Population|Overall Study||116||
48171879|NCT01213173|100742546|FG001|Patients Included in ITT Population|Overall Study||115||
48171880|NCT01213173|100742545|FG000|Patients Included in PP Population|Overall Study||102||
48171881|NCT01213173|100742546|FG001|Patients Included in PP Population|Overall Study||89||
48171882|NCT01213173|100742545|FG000|COMPLETED|Overall Study||113||
48171883|NCT01213173|100742546|FG001|COMPLETED|Overall Study||110||
48751182|NCT02159066|102177346|FG001|COMPLETED|Part I||4||
48751183|NCT02159066|102177347|FG002|COMPLETED|Part I||0||
48751184|NCT02159066|102177348|FG003|COMPLETED|Part I||0||
48751185|NCT02159066|102177349|FG004|COMPLETED|Part I||0||
48751186|NCT02159066|102177350|FG005|COMPLETED|Part I||0||
48171884|NCT01213173|100742545|FG000|NOT COMPLETED|Overall Study||12||
48171885|NCT01213173|100742546|FG001|NOT COMPLETED|Overall Study||16||
48171886|NCT01811940|100742547|FG000|STARTED|Overall Study||64||
48171887|NCT01811940|100742548|FG001|STARTED|Overall Study||63||
48171888|NCT01811940|100742547|FG000|COMPLETED|Overall Study||42||
48171889|NCT01811940|100742548|FG001|COMPLETED|Overall Study||37||
48171890|NCT01811940|100742547|FG000|NOT COMPLETED|Overall Study||22||
48171891|NCT01811940|100742548|FG001|NOT COMPLETED|Overall Study||26||
48171892|NCT02186509|100742549|FG000|STARTED|Overall Study||17||
48171893|NCT02186509|100742549|FG000|COMPLETED|Overall Study||17||
48171894|NCT02186509|100742549|FG000|NOT COMPLETED|Overall Study||0||
48628094|NCT04232839|101874299|FG002|NOT COMPLETED|Treatment Period 6||0||
48628095|NCT04232839|101874300|FG003|NOT COMPLETED|Treatment Period 6||0||
48628096|NCT04232839|101874301|FG004|NOT COMPLETED|Treatment Period 6||0||
48628097|NCT04232839|101874302|FG005|NOT COMPLETED|Treatment Period 6||0||
48628098|NCT04232839|101874303|FG006|NOT COMPLETED|Treatment Period 6||0||
48628099|NCT04232839|101874304|FG007|NOT COMPLETED|Treatment Period 6||0||
48628100|NCT04232839|101874305|FG008|NOT COMPLETED|Treatment Period 6||0||
48628101|NCT04232839|101874306|FG009|NOT COMPLETED|Treatment Period 6||0||
48628102|NCT03106077|101874307|FG000|STARTED|Overall Study||96||
48628103|NCT03106077|101874308|FG001|STARTED|Overall Study||0||
48628104|NCT03106077|101874307|FG000|COMPLETED|Overall Study||2||
48628105|NCT03106077|101874308|FG001|COMPLETED|Overall Study||0||
48628106|NCT03106077|101874307|FG000|NOT COMPLETED|Overall Study||94||
48628107|NCT03106077|101874308|FG001|NOT COMPLETED|Overall Study||0||
48628108|NCT03316586|101874309|FG000|STARTED|Overall Study||18||
48171895|NCT00003458|100742550|FG000|STARTED|Overall Study||34||
48171896|NCT00003458|100742550|FG000|COMPLETED|Overall Study||30||
48171897|NCT00003458|100742550|FG000|NOT COMPLETED|Overall Study||4||
48171898|NCT02138747|100742551|FG000|STARTED|Treatment Period 1||156||
48171899|NCT02138747|100742552|FG001|STARTED|Treatment Period 1||157||
48171900|NCT02138747|100742553|FG002|STARTED|Treatment Period 1||31||
48171901|NCT02138747|100742554|FG003|STARTED|Treatment Period 1||32||
48171902|NCT02138747|100742551|FG000|COMPLETED|Treatment Period 1||136||
48171903|NCT02138747|100742552|FG001|COMPLETED|Treatment Period 1||132||
48171904|NCT02138747|100742553|FG002|COMPLETED|Treatment Period 1||27||
48171905|NCT02138747|100742554|FG003|COMPLETED|Treatment Period 1||28||
48171906|NCT02138747|100742551|FG000|NOT COMPLETED|Treatment Period 1||20||
48171907|NCT02138747|100742552|FG001|NOT COMPLETED|Treatment Period 1||25||
48171908|NCT02138747|100742553|FG002|NOT COMPLETED|Treatment Period 1||4||
48171909|NCT02138747|100742554|FG003|NOT COMPLETED|Treatment Period 1||4||
48171910|NCT02138747|100742551|FG000|STARTED|Treatment Period 2||138||
48171911|NCT02138747|100742552|FG001|STARTED|Treatment Period 2||132||
48171912|NCT02138747|100742553|FG002|STARTED|Treatment Period 2||26||
48171913|NCT02138747|100742554|FG003|STARTED|Treatment Period 2||27||
48171914|NCT02138747|100742551|FG000|COMPLETED|Treatment Period 2||121||
48171915|NCT02138747|100742552|FG001|COMPLETED|Treatment Period 2||125||
48171916|NCT02138747|100742553|FG002|COMPLETED|Treatment Period 2||24||
48171917|NCT02138747|100742554|FG003|COMPLETED|Treatment Period 2||24||
48171918|NCT02138747|100742551|FG000|NOT COMPLETED|Treatment Period 2||17||
48171919|NCT02138747|100742552|FG001|NOT COMPLETED|Treatment Period 2||7||
48171920|NCT02138747|100742553|FG002|NOT COMPLETED|Treatment Period 2||2||
48171921|NCT02138747|100742554|FG003|NOT COMPLETED|Treatment Period 2||3||
48171922|NCT04362137|100742555|FG000|STARTED|Overall Study||287|Randomized participants.|
48171923|NCT04362137|100742556|FG001|STARTED|Overall Study||145|Randomized participants.|
48171924|NCT04362137|100742555|FG000|Safety Set|Overall Study||281|The Safety Set included all participants who received at least one dose of double-blind treatment.|
48171925|NCT04362137|100742556|FG001|Safety Set|Overall Study||143|The Safety Set included all participants who received at least one dose of double-blind treatment.|
48171926|NCT04362137|100742555|FG000|COMPLETED|Overall Study||269||
48171927|NCT04362137|100742556|FG001|COMPLETED|Overall Study||139||
48628109|NCT03316586|101874309|FG000|COMPLETED|Overall Study||0||
48628110|NCT03316586|101874309|FG000|NOT COMPLETED|Overall Study||18||
48628111|NCT03234465|101874310|FG000|STARTED|Overall Study||100||
48628112|NCT03234465|101874311|FG001|STARTED|Overall Study||100||
48628113|NCT03234465|101874310|FG000|COMPLETED|Overall Study||67||
48628114|NCT03234465|101874311|FG001|COMPLETED|Overall Study||60||
48628115|NCT03234465|101874310|FG000|NOT COMPLETED|Overall Study||33||
48628116|NCT03234465|101874311|FG001|NOT COMPLETED|Overall Study||40||
48628117|NCT01447888|101874312|FG000|STARTED|Overall Study||45||
48628118|NCT01447888|101874313|FG001|STARTED|Overall Study||55||
48171928|NCT04362137|100742555|FG000|NOT COMPLETED|Overall Study||18||
48171929|NCT04362137|100742556|FG001|NOT COMPLETED|Overall Study||6||
48628119|NCT01447888|101874312|FG000|COMPLETED|Overall Study||45||
48628120|NCT01447888|101874313|FG001|COMPLETED|Overall Study||55||
48628121|NCT01447888|101874312|FG000|NOT COMPLETED|Overall Study||0||
48628122|NCT01447888|101874313|FG001|NOT COMPLETED|Overall Study||0||
48171930|NCT00195715|100742557|FG000|STARTED|Overall Study||777||
48171931|NCT00195715|100742557|FG000|COMPLETED|Overall Study||400||
48171932|NCT00195715|100742557|FG000|NOT COMPLETED|Overall Study||377||
48628123|NCT00896493|101874314|FG000|STARTED|Overall Study||38||
48628124|NCT00896493|101874314|FG000|Completed Assigned Treatment|Overall Study||35||
48628125|NCT00896493|101874314|FG000|COMPLETED|Overall Study||35||
48171933|NCT01987830|100742558|FG000|STARTED|Overall Study||13||
48411814|NCT01362049|101341844|FG002|STARTED|Follow-Up at 7 Weeks||32|Subjects who signed consent forms|
48411815|NCT01362049|101341845|FG003|STARTED|Follow-Up at 7 Weeks||25|Subjects who signed consent forms|
48411816|NCT01362049|101341842|FG000|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||26||
48411817|NCT01362049|101341843|FG001|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||18||
48411818|NCT01362049|101341844|FG002|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||32||
48411819|NCT01362049|101341845|FG003|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||25||
48411820|NCT01362049|101341842|FG000|COMPLETED|Follow-Up at 7 Weeks||23||
48411821|NCT01362049|101341843|FG001|COMPLETED|Follow-Up at 7 Weeks||16||
48411822|NCT01362049|101341844|FG002|COMPLETED|Follow-Up at 7 Weeks||30||
48411823|NCT01362049|101341845|FG003|COMPLETED|Follow-Up at 7 Weeks||24||
48411824|NCT01362049|101341842|FG000|NOT COMPLETED|Follow-Up at 7 Weeks||3||
48411825|NCT01362049|101341843|FG001|NOT COMPLETED|Follow-Up at 7 Weeks||3||
48171934|NCT01987830|100742558|FG000|COMPLETED|Overall Study||12||
48171935|NCT01987830|100742558|FG000|NOT COMPLETED|Overall Study||1||
48171936|NCT02608489|100742559|FG000|STARTED|Overall Study||43||
48411826|NCT01362049|101341844|FG002|NOT COMPLETED|Follow-Up at 7 Weeks||2||
48411827|NCT01362049|101341845|FG003|NOT COMPLETED|Follow-Up at 7 Weeks||1||
48411828|NCT01362049|101341842|FG000|STARTED|Follow-Up at 52 Weeks (12 Months)||23||
48411829|NCT01362049|101341843|FG001|STARTED|Follow-Up at 52 Weeks (12 Months)||16||
48411830|NCT01362049|101341844|FG002|STARTED|Follow-Up at 52 Weeks (12 Months)||30||
48411831|NCT01362049|101341845|FG003|STARTED|Follow-Up at 52 Weeks (12 Months)||24||
48411832|NCT01362049|101341842|FG000|COMPLETED|Follow-Up at 52 Weeks (12 Months)||18||
48411833|NCT01362049|101341843|FG001|COMPLETED|Follow-Up at 52 Weeks (12 Months)||13||
48411834|NCT01362049|101341844|FG002|COMPLETED|Follow-Up at 52 Weeks (12 Months)||28||
48411835|NCT01362049|101341845|FG003|COMPLETED|Follow-Up at 52 Weeks (12 Months)||21||
48411836|NCT01362049|101341842|FG000|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||5||
48411837|NCT01362049|101341843|FG001|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3||
48628126|NCT00896493|101874314|FG000|NOT COMPLETED|Overall Study||3||
48628127|NCT01317940|101874315|FG000|STARTED|Overall Study||19||
48628128|NCT01317940|101874316|FG001|STARTED|Overall Study||10||
48628129|NCT01317940|101874317|FG002|STARTED|Overall Study||20||
48171937|NCT02608489|100742560|FG001|STARTED|Overall Study||43||
48171938|NCT02608489|100742559|FG000|COMPLETED|Overall Study||30||
48171939|NCT02608489|100742560|FG001|COMPLETED|Overall Study||33||
48171940|NCT02608489|100742559|FG000|NOT COMPLETED|Overall Study||13||
48171941|NCT02608489|100742560|FG001|NOT COMPLETED|Overall Study||10||
48171942|NCT05284019|100742561|FG000|STARTED|Overall Study||3||
48171943|NCT05284019|100742562|FG001|STARTED|Overall Study||2||
48171944|NCT05284019|100742563|FG002|STARTED|Overall Study||2||
48171945|NCT05284019|100742564|FG003|STARTED|Overall Study||8||
48171946|NCT05284019|100742565|FG004|STARTED|Overall Study||17||
48171947|NCT05284019|100742561|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
48171948|NCT05284019|100742562|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2||
48171949|NCT05284019|100742563|FG002|Received at Least 1 Dose of Study Drug|Overall Study||2||
48628130|NCT01317940|101874318|FG003|STARTED|Overall Study||6||
48628131|NCT01317940|101874319|FG004|STARTED|Overall Study||13||
48171950|NCT05284019|100742564|FG003|Received at Least 1 Dose of Study Drug|Overall Study||8||
48171951|NCT05284019|100742565|FG004|Received at Least 1 Dose of Study Drug|Overall Study||16||
48171952|NCT05284019|100742561|FG000|COMPLETED|Overall Study||0||
48171953|NCT05284019|100742562|FG001|COMPLETED|Overall Study||0||
48171954|NCT05284019|100742563|FG002|COMPLETED|Overall Study||0||
48171955|NCT05284019|100742564|FG003|COMPLETED|Overall Study||0||
48171956|NCT05284019|100742565|FG004|COMPLETED|Overall Study||0||
48171957|NCT05284019|100742561|FG000|NOT COMPLETED|Overall Study||3||
48171958|NCT05284019|100742562|FG001|NOT COMPLETED|Overall Study||2||
48171959|NCT05284019|100742563|FG002|NOT COMPLETED|Overall Study||2||
48411838|NCT01362049|101341844|FG002|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||2||
48628132|NCT01317940|101874320|FG005|STARTED|Overall Study||4||
48628133|NCT01317940|101874315|FG000|COMPLETED|Overall Study||18||
48628134|NCT01317940|101874316|FG001|COMPLETED|Overall Study||10||
48628135|NCT01317940|101874317|FG002|COMPLETED|Overall Study||15||
48171960|NCT05284019|100742564|FG003|NOT COMPLETED|Overall Study||8||
48171961|NCT05284019|100742565|FG004|NOT COMPLETED|Overall Study||17||
48171962|NCT02559609|100742566|FG000|STARTED|Overall Study||50||
48171963|NCT02559609|100742567|FG001|STARTED|Overall Study||65||
48411839|NCT01362049|101341845|FG003|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3||
48411840|NCT03378973|101341846|FG000|STARTED|Overall Study||4||
48171964|NCT02559609|100742568|FG002|STARTED|Overall Study||58||
48171965|NCT02559609|100742569|FG003|STARTED|Overall Study||67||
48171966|NCT02559609|100742566|FG000|COMPLETED|Overall Study||50||
48171967|NCT02559609|100742567|FG001|COMPLETED|Overall Study||64||
48171968|NCT02559609|100742568|FG002|COMPLETED|Overall Study||58||
48171969|NCT02559609|100742569|FG003|COMPLETED|Overall Study||67||
48171970|NCT02559609|100742566|FG000|NOT COMPLETED|Overall Study||0||
48171971|NCT02559609|100742567|FG001|NOT COMPLETED|Overall Study||1||
48628136|NCT01317940|101874318|FG003|COMPLETED|Overall Study||5||
48628137|NCT01317940|101874319|FG004|COMPLETED|Overall Study||12||
48628138|NCT01317940|101874320|FG005|COMPLETED|Overall Study||4||
48171972|NCT02559609|100742568|FG002|NOT COMPLETED|Overall Study||0||
48171973|NCT02559609|100742569|FG003|NOT COMPLETED|Overall Study||0||
48171974|NCT03926065|100742570|FG000|STARTED|Study Week 1||11||
48171975|NCT03926065|100742571|FG001|STARTED|Study Week 1||9||
48171976|NCT03926065|100742572|FG002|STARTED|Study Week 1||14||
48171977|NCT03926065|100742573|FG003|STARTED|Study Week 1||18||
48171978|NCT03926065|100742574|FG004|STARTED|Study Week 1||15||
48171979|NCT03926065|100742570|FG000|COMPLETED|Study Week 1||11||
48171980|NCT03926065|100742571|FG001|COMPLETED|Study Week 1||9||
48171981|NCT03926065|100742572|FG002|COMPLETED|Study Week 1||14||
48171982|NCT03926065|100742573|FG003|COMPLETED|Study Week 1||18||
48171983|NCT03926065|100742574|FG004|COMPLETED|Study Week 1||15||
48171984|NCT03926065|100742570|FG000|NOT COMPLETED|Study Week 1||0||
48171985|NCT03926065|100742571|FG001|NOT COMPLETED|Study Week 1||0||
48171986|NCT03926065|100742572|FG002|NOT COMPLETED|Study Week 1||0||
48171987|NCT03926065|100742573|FG003|NOT COMPLETED|Study Week 1||0||
48171988|NCT03926065|100742574|FG004|NOT COMPLETED|Study Week 1||0||
48171989|NCT03926065|100742570|FG000|STARTED|Study Week 2||11||
48171990|NCT03926065|100742571|FG001|STARTED|Study Week 2||9||
48171991|NCT03926065|100742572|FG002|STARTED|Study Week 2||14||
48171992|NCT03926065|100742573|FG003|STARTED|Study Week 2||18||
48171993|NCT03926065|100742574|FG004|STARTED|Study Week 2||15||
48171994|NCT03926065|100742570|FG000|COMPLETED|Study Week 2||11||
48171995|NCT03926065|100742571|FG001|COMPLETED|Study Week 2||9||
48171996|NCT03926065|100742572|FG002|COMPLETED|Study Week 2||14||
48334159|NCT04418765|101145664|FG000|STARTED|Placebo-controlled Period (24 Weeks)||299||
48334160|NCT04418765|101145665|FG001|STARTED|Placebo-controlled Period (24 Weeks)||299||
48334161|NCT04418765|101145666|FG002|STARTED|Placebo-controlled Period (24 Weeks)||294||
48334162|NCT04418765|101145664|FG000|Received at Least 1 Dose of Study Drug|Placebo-controlled Period (24 Weeks)||298||
48334163|NCT04418765|101145665|FG001|Received at Least 1 Dose of Study Drug|Placebo-controlled Period (24 Weeks)||299||
48411841|NCT03378973|101341847|FG001|STARTED|Overall Study||3||
48628139|NCT01317940|101874315|FG000|NOT COMPLETED|Overall Study||1||
48628140|NCT01317940|101874316|FG001|NOT COMPLETED|Overall Study||0||
48628141|NCT01317940|101874317|FG002|NOT COMPLETED|Overall Study||5||
48628142|NCT01317940|101874318|FG003|NOT COMPLETED|Overall Study||1||
48628143|NCT01317940|101874319|FG004|NOT COMPLETED|Overall Study||1||
48628144|NCT01317940|101874320|FG005|NOT COMPLETED|Overall Study||0||
48628145|NCT01001429|101874321|FG000|STARTED|Overall Study||39||
48628146|NCT01001429|101874322|FG001|STARTED|Overall Study||38||
48628147|NCT01001429|101874321|FG000|COMPLETED|Overall Study||39||
48628148|NCT01001429|101874322|FG001|COMPLETED|Overall Study||37||
48628149|NCT01001429|101874321|FG000|NOT COMPLETED|Overall Study||0||
48628150|NCT01001429|101874322|FG001|NOT COMPLETED|Overall Study||1||
48628151|NCT01103323|101874323|FG000|STARTED|Without/Before Drug Switch||505||
48628152|NCT01103323|101874324|FG001|STARTED|Without/Before Drug Switch||255||
48628153|NCT01103323|101874323|FG000|Participants Received Treatment|Without/Before Drug Switch||500||
48628154|NCT01103323|101874324|FG001|Participants Received Treatment|Without/Before Drug Switch||253||
48628155|NCT01103323|101874323|FG000|COMPLETED|Without/Before Drug Switch||429||
48628156|NCT01103323|101874324|FG001|COMPLETED|Without/Before Drug Switch||237||
48628157|NCT01103323|101874323|FG000|NOT COMPLETED|Without/Before Drug Switch||76||
48628158|NCT01103323|101874324|FG001|NOT COMPLETED|Without/Before Drug Switch||18||
48628159|NCT01103323|101874323|FG000|STARTED|Switched From Placebo to Regorafenib||0||
48628160|NCT01103323|101874324|FG001|STARTED|Switched From Placebo to Regorafenib||4||
48628161|NCT01103323|101874323|FG000|COMPLETED|Switched From Placebo to Regorafenib||0||
48628162|NCT01103323|101874324|FG001|COMPLETED|Switched From Placebo to Regorafenib||3||
48628163|NCT01103323|101874323|FG000|NOT COMPLETED|Switched From Placebo to Regorafenib||0||
48628164|NCT01103323|101874324|FG001|NOT COMPLETED|Switched From Placebo to Regorafenib||1||
48628165|NCT01884597|101874325|FG000|STARTED|Overall Study||5||
48628166|NCT01884597|101874326|FG001|STARTED|Overall Study||3||
48171997|NCT03926065|100742573|FG003|COMPLETED|Study Week 2||18||
48171998|NCT03926065|100742574|FG004|COMPLETED|Study Week 2||15||
48171999|NCT03926065|100742570|FG000|NOT COMPLETED|Study Week 2||0||
48172000|NCT03926065|100742571|FG001|NOT COMPLETED|Study Week 2||0||
48172001|NCT03926065|100742572|FG002|NOT COMPLETED|Study Week 2||0||
48172002|NCT03926065|100742573|FG003|NOT COMPLETED|Study Week 2||0||
48628167|NCT01884597|101874327|FG002|STARTED|Overall Study||16||
48628168|NCT01884597|101874325|FG000|COMPLETED|Overall Study||4||
48172003|NCT03926065|100742574|FG004|NOT COMPLETED|Study Week 2||0||
48172004|NCT03926065|100742570|FG000|STARTED|Study Week 3||11||
48172005|NCT03926065|100742571|FG001|STARTED|Study Week 3||9||
48172006|NCT03926065|100742572|FG002|STARTED|Study Week 3||14||
48172007|NCT03926065|100742573|FG003|STARTED|Study Week 3||18||
48172008|NCT03926065|100742574|FG004|STARTED|Study Week 3||15||
48172009|NCT03926065|100742570|FG000|COMPLETED|Study Week 3||11||
48628169|NCT01884597|101874326|FG001|COMPLETED|Overall Study||2||
48628170|NCT01884597|101874327|FG002|COMPLETED|Overall Study||15||
48172010|NCT03926065|100742571|FG001|COMPLETED|Study Week 3||9||
48172011|NCT03926065|100742572|FG002|COMPLETED|Study Week 3||14||
48172012|NCT03926065|100742573|FG003|COMPLETED|Study Week 3||18||
48172013|NCT03926065|100742574|FG004|COMPLETED|Study Week 3||15||
48172014|NCT03926065|100742570|FG000|NOT COMPLETED|Study Week 3||0||
48172015|NCT03926065|100742571|FG001|NOT COMPLETED|Study Week 3||0||
48172016|NCT03926065|100742572|FG002|NOT COMPLETED|Study Week 3||0||
48172017|NCT03926065|100742573|FG003|NOT COMPLETED|Study Week 3||0||
48172018|NCT03926065|100742574|FG004|NOT COMPLETED|Study Week 3||0||
48172019|NCT03926065|100742570|FG000|STARTED|Study Week 4||11||
48172020|NCT03926065|100742571|FG001|STARTED|Study Week 4||9||
48172021|NCT03926065|100742572|FG002|STARTED|Study Week 4||14||
48172022|NCT03926065|100742573|FG003|STARTED|Study Week 4||18||
48172023|NCT03926065|100742574|FG004|STARTED|Study Week 4||15||
48172024|NCT03926065|100742570|FG000|COMPLETED|Study Week 4||11||
48172025|NCT03926065|100742571|FG001|COMPLETED|Study Week 4||9||
48172026|NCT03926065|100742572|FG002|COMPLETED|Study Week 4||14||
48172027|NCT03926065|100742573|FG003|COMPLETED|Study Week 4||18||
48172028|NCT03926065|100742574|FG004|COMPLETED|Study Week 4||15||
48172029|NCT03926065|100742570|FG000|NOT COMPLETED|Study Week 4||0||
48172030|NCT03926065|100742571|FG001|NOT COMPLETED|Study Week 4||0||
48172031|NCT03926065|100742572|FG002|NOT COMPLETED|Study Week 4||0||
48172032|NCT03926065|100742573|FG003|NOT COMPLETED|Study Week 4||0||
48172033|NCT03926065|100742574|FG004|NOT COMPLETED|Study Week 4||0||
48172034|NCT01486615|100742575|FG000|STARTED|Overall Study||20||
48172035|NCT01486615|100742576|FG001|STARTED|Overall Study||20||
48172036|NCT01486615|100742577|FG002|STARTED|Overall Study||20||
48172037|NCT01486615|100742578|FG003|STARTED|Overall Study||20||
48172038|NCT01486615|100742575|FG000|COMPLETED|Overall Study||20||
48172039|NCT01486615|100742576|FG001|COMPLETED|Overall Study||19||
48172040|NCT01486615|100742577|FG002|COMPLETED|Overall Study||18||
48172041|NCT01486615|100742578|FG003|COMPLETED|Overall Study||18||
48172042|NCT01486615|100742575|FG000|NOT COMPLETED|Overall Study||0||
48172043|NCT01486615|100742576|FG001|NOT COMPLETED|Overall Study||1||
48172044|NCT01486615|100742577|FG002|NOT COMPLETED|Overall Study||2||
48172045|NCT01486615|100742578|FG003|NOT COMPLETED|Overall Study||2||
48172046|NCT01794117|100742579|FG000|STARTED|Overall Study||1||
48172047|NCT01794117|100742580|FG001|STARTED|Overall Study||3||
48172048|NCT01794117|100742581|FG002|STARTED|Overall Study||2||
48172049|NCT01794117|100742582|FG003|STARTED|Overall Study||12||
48172050|NCT01794117|100742579|FG000|COMPLETED|Overall Study||0||
48172051|NCT01794117|100742580|FG001|COMPLETED|Overall Study||0||
48172052|NCT01794117|100742581|FG002|COMPLETED|Overall Study||2||
48172053|NCT01794117|100742582|FG003|COMPLETED|Overall Study||12||
48172054|NCT01794117|100742579|FG000|NOT COMPLETED|Overall Study||1||
48172055|NCT01794117|100742580|FG001|NOT COMPLETED|Overall Study||3||
48172056|NCT01794117|100742581|FG002|NOT COMPLETED|Overall Study||0||
48172057|NCT01794117|100742582|FG003|NOT COMPLETED|Overall Study||0||
48172058|NCT01458990|100742583|FG000|STARTED|Overall Study||45||
48172059|NCT01458990|100742584|FG001|STARTED|Overall Study||15||
48172060|NCT01458990|100742583|FG000|COMPLETED|Overall Study||45||
48172061|NCT01458990|100742584|FG001|COMPLETED|Overall Study||15||
48172062|NCT01458990|100742583|FG000|NOT COMPLETED|Overall Study||0||
48172063|NCT01458990|100742584|FG001|NOT COMPLETED|Overall Study||0||
48172064|NCT00543400|100742585|FG000|STARTED|Overall Study||151||
48172065|NCT00543400|100742586|FG001|STARTED|Overall Study||44||
48172066|NCT00543400|100742587|FG002|STARTED|Overall Study||152||
48334164|NCT04418765|101145666|FG002|Received at Least 1 Dose of Study Drug|Placebo-controlled Period (24 Weeks)||294||
48334165|NCT04418765|101145664|FG000|COMPLETED|Placebo-controlled Period (24 Weeks)||293||
48334166|NCT04418765|101145665|FG001|COMPLETED|Placebo-controlled Period (24 Weeks)||288||
48334167|NCT04418765|101145666|FG002|COMPLETED|Placebo-controlled Period (24 Weeks)||284||
48334168|NCT04418765|101145664|FG000|NOT COMPLETED|Placebo-controlled Period (24 Weeks)||6||
48334169|NCT04418765|101145665|FG001|NOT COMPLETED|Placebo-controlled Period (24 Weeks)||11||
48334170|NCT04418765|101145666|FG002|NOT COMPLETED|Placebo-controlled Period (24 Weeks)||10||
48334171|NCT04418765|101145664|FG000|STARTED|Extension Period (48 Weeks)||0||
48411842|NCT03378973|101341846|FG000|COMPLETED|Overall Study||4||
48172067|NCT00543400|100742588|FG003|STARTED|Overall Study||156||
48172068|NCT00543400|100742585|FG000|COMPLETED|Overall Study||146||
48172069|NCT00543400|100742586|FG001|COMPLETED|Overall Study||43||
48172070|NCT00543400|100742587|FG002|COMPLETED|Overall Study||148||
48172071|NCT00543400|100742588|FG003|COMPLETED|Overall Study||151||
48172072|NCT00543400|100742585|FG000|NOT COMPLETED|Overall Study||5||
48172073|NCT00543400|100742586|FG001|NOT COMPLETED|Overall Study||1||
48172074|NCT00543400|100742587|FG002|NOT COMPLETED|Overall Study||4||
48172075|NCT00543400|100742588|FG003|NOT COMPLETED|Overall Study||5||
48172076|NCT02104830|100742589|FG000|STARTED|Overall Study||42||
48172077|NCT02104830|100742590|FG001|STARTED|Overall Study||43||
48172078|NCT02104830|100742591|FG002|STARTED|Overall Study||43||
48172079|NCT02104830|100742589|FG000|COMPLETED|Overall Study||38||
48172080|NCT02104830|100742590|FG001|COMPLETED|Overall Study||36||
48172081|NCT02104830|100742591|FG002|COMPLETED|Overall Study||36||
48172082|NCT02104830|100742589|FG000|NOT COMPLETED|Overall Study||4||
48172083|NCT02104830|100742590|FG001|NOT COMPLETED|Overall Study||7||
48172084|NCT02104830|100742591|FG002|NOT COMPLETED|Overall Study||7||
48172085|NCT03154359|100742592|FG000|STARTED|Overall Study||42||
48172086|NCT03154359|100742592|FG000|6 Weeks|Overall Study||29||
48172087|NCT03154359|100742592|FG000|18 Weeks|Overall Study||20||
48172088|NCT03154359|100742592|FG000|COMPLETED|Overall Study||20||
48172089|NCT03154359|100742592|FG000|NOT COMPLETED|Overall Study||22||
48172090|NCT03396432|100742593|FG000|STARTED|Overall Study||283||
48172091|NCT03396432|100742594|FG001|STARTED|Overall Study||283||
48172092|NCT03396432|100742593|FG000|COMPLETED|Overall Study||274||
48172093|NCT03396432|100742594|FG001|COMPLETED|Overall Study||277||
48172094|NCT03396432|100742593|FG000|NOT COMPLETED|Overall Study||9||
48172095|NCT03396432|100742594|FG001|NOT COMPLETED|Overall Study||6||
48172096|NCT01850082|100742595|FG000|STARTED|Overall Study||576||
48172097|NCT01850082|100742596|FG001|STARTED|Overall Study||574||
48172098|NCT01850082|100742595|FG000|COMPLETED|Overall Study||576||
48172099|NCT01850082|100742596|FG001|COMPLETED|Overall Study||574||
48172100|NCT01850082|100742595|FG000|NOT COMPLETED|Overall Study||0||
48172101|NCT01850082|100742596|FG001|NOT COMPLETED|Overall Study||0||
48172102|NCT02780622|100742597|FG000|STARTED|Treatment Period 1||10||
48172103|NCT02780622|100742598|FG001|STARTED|Treatment Period 1||10||
48172104|NCT02780622|100742597|FG000|COMPLETED|Treatment Period 1||10||
48172105|NCT02780622|100742598|FG001|COMPLETED|Treatment Period 1||10||
48172106|NCT02780622|100742597|FG000|NOT COMPLETED|Treatment Period 1||0||
48172107|NCT02780622|100742598|FG001|NOT COMPLETED|Treatment Period 1||0||
48172108|NCT02780622|100742597|FG000|STARTED|Treatment Period 2||10||
48172109|NCT02780622|100742598|FG001|STARTED|Treatment Period 2||10||
48172110|NCT02780622|100742597|FG000|COMPLETED|Treatment Period 2||10||
48411843|NCT03378973|101341847|FG001|COMPLETED|Overall Study||3||
48411844|NCT03378973|101341846|FG000|NOT COMPLETED|Overall Study||0||
48411845|NCT03378973|101341847|FG001|NOT COMPLETED|Overall Study||0||
48172111|NCT02780622|100742598|FG001|COMPLETED|Treatment Period 2||10||
48172112|NCT02780622|100742597|FG000|NOT COMPLETED|Treatment Period 2||0||
48172113|NCT02780622|100742598|FG001|NOT COMPLETED|Treatment Period 2||0||
48172114|NCT01265823|100742599|FG000|STARTED|Overall Study||150||
48172115|NCT01265823|100742599|FG000|COMPLETED|Overall Study||143||
48172116|NCT01265823|100742599|FG000|NOT COMPLETED|Overall Study||7||
48172117|NCT01756560|100742600|FG000|STARTED|Overall Study||2||
48172118|NCT01756560|100742601|FG001|STARTED|Overall Study||0||
48172119|NCT01756560|100742600|FG000|COMPLETED|Overall Study||0||
48172120|NCT01756560|100742601|FG001|COMPLETED|Overall Study||0||
48172121|NCT01756560|100742600|FG000|NOT COMPLETED|Overall Study||2||
48172122|NCT01756560|100742601|FG001|NOT COMPLETED|Overall Study||0||
48172123|NCT02133924|100742602|FG000|STARTED|Overall Study||76||
48172124|NCT02133924|100742602|FG000|COMPLETED|Overall Study||34||
48172125|NCT02133924|100742602|FG000|NOT COMPLETED|Overall Study||42||
48172126|NCT03406702|100742603|FG000|STARTED|Overall Study||7||
48172127|NCT03406702|100742603|FG000|COMPLETED|Overall Study||6||
48172128|NCT03406702|100742603|FG000|NOT COMPLETED|Overall Study||1||
48172129|NCT01950273|100742604|FG000|STARTED|Overall Study||49||
48172130|NCT01950273|100742605|FG001|STARTED|Overall Study||46||
48172131|NCT01950273|100742604|FG000|COMPLETED|Overall Study||45||
48172132|NCT01950273|100742605|FG001|COMPLETED|Overall Study||46||
48172133|NCT01950273|100742604|FG000|NOT COMPLETED|Overall Study||4||
48172134|NCT01950273|100742605|FG001|NOT COMPLETED|Overall Study||0||
48172135|NCT03662360|100742606|FG000|STARTED|Overall Study||16||
48172136|NCT03662360|100742607|FG001|STARTED|Overall Study||16||
48172137|NCT03662360|100742606|FG000|COMPLETED|Overall Study||16||
48172138|NCT03662360|100742607|FG001|COMPLETED|Overall Study||14||
48172139|NCT03662360|100742606|FG000|NOT COMPLETED|Overall Study||0||
48172140|NCT03662360|100742607|FG001|NOT COMPLETED|Overall Study||2||
48172141|NCT03545113|100742608|FG000|STARTED|Overall Study||23||
48172142|NCT03545113|100742609|FG001|STARTED|Overall Study||21||
48172143|NCT03545113|100742608|FG000|COMPLETED|Overall Study||18||
48172144|NCT03545113|100742609|FG001|COMPLETED|Overall Study||21||
48411846|NCT01376908|101341848|FG000|STARTED|Overall Study||27||
48411847|NCT01376908|101341849|FG001|STARTED|Overall Study||29||
48172145|NCT03545113|100742608|FG000|NOT COMPLETED|Overall Study||5||
48172146|NCT03545113|100742609|FG001|NOT COMPLETED|Overall Study||0||
48172147|NCT01015807|100742610|FG000|STARTED|Overall Study||30||
48172148|NCT01015807|100742611|FG001|STARTED|Overall Study||30||
48172149|NCT01015807|100742612|FG002|STARTED|Overall Study||30||
48172150|NCT01015807|100742610|FG000|COMPLETED|Overall Study||30||
48172151|NCT01015807|100742611|FG001|COMPLETED|Overall Study||30||
48172152|NCT01015807|100742612|FG002|COMPLETED|Overall Study||30||
48172153|NCT01015807|100742610|FG000|NOT COMPLETED|Overall Study||0||
48411848|NCT01376908|101341848|FG000|COMPLETED|Overall Study||25||
48411849|NCT01376908|101341849|FG001|COMPLETED|Overall Study||26||
48411850|NCT01376908|101341848|FG000|NOT COMPLETED|Overall Study||2||
48411851|NCT01376908|101341849|FG001|NOT COMPLETED|Overall Study||3||
48411852|NCT01981096|101341850|FG000|STARTED|Overall Study||20||
48172154|NCT01015807|100742611|FG001|NOT COMPLETED|Overall Study||0||
48172155|NCT01015807|100742612|FG002|NOT COMPLETED|Overall Study||0||
48172156|NCT04711460|100742613|FG000|STARTED|Overall Study||32||
48172157|NCT04711460|100742614|FG001|STARTED|Overall Study||32||
48172158|NCT04711460|100742615|FG002|STARTED|Overall Study||26||
48172159|NCT04711460|100742616|FG003|STARTED|Overall Study||26||
48172160|NCT04711460|100742613|FG000|COMPLETED|Overall Study||32||
48172161|NCT04711460|100742614|FG001|COMPLETED|Overall Study||32||
48172162|NCT04711460|100742615|FG002|COMPLETED|Overall Study||26||
48172163|NCT04711460|100742616|FG003|COMPLETED|Overall Study||26||
48172164|NCT04711460|100742613|FG000|NOT COMPLETED|Overall Study||0||
48172165|NCT04711460|100742614|FG001|NOT COMPLETED|Overall Study||0||
48172166|NCT04711460|100742615|FG002|NOT COMPLETED|Overall Study||0||
48334172|NCT04418765|101145665|FG001|STARTED|Extension Period (48 Weeks)||433||
48334173|NCT04418765|101145666|FG002|STARTED|Extension Period (48 Weeks)||432||
48334174|NCT04418765|101145664|FG000|Received at Least 1 Dose of Study Drug|Extension Period (48 Weeks)||0||
48334175|NCT04418765|101145665|FG001|Received at Least 1 Dose of Study Drug|Extension Period (48 Weeks)||433||
48334176|NCT04418765|101145666|FG002|Received at Least 1 Dose of Study Drug|Extension Period (48 Weeks)||432||
48334177|NCT04418765|101145664|FG000|COMPLETED|Extension Period (48 Weeks)||0||
48334178|NCT04418765|101145665|FG001|COMPLETED|Extension Period (48 Weeks)||392||
48334179|NCT04418765|101145666|FG002|COMPLETED|Extension Period (48 Weeks)||390||
48334180|NCT04418765|101145664|FG000|NOT COMPLETED|Extension Period (48 Weeks)||0||
48334181|NCT04418765|101145665|FG001|NOT COMPLETED|Extension Period (48 Weeks)||41||
48334182|NCT04418765|101145666|FG002|NOT COMPLETED|Extension Period (48 Weeks)||42||
48334183|NCT03099707|101145667|FG000|STARTED|Overall Study||43||
48334184|NCT03099707|101145668|FG001|STARTED|Overall Study||41||
48628171|NCT01884597|101874325|FG000|NOT COMPLETED|Overall Study||1||
48628172|NCT01884597|101874326|FG001|NOT COMPLETED|Overall Study||1||
48628173|NCT01884597|101874327|FG002|NOT COMPLETED|Overall Study||1||
48628174|NCT02771275|101874328|FG000|STARTED|Overall Study||13|Received the Harpoon Medical Device.|
48628175|NCT02771275|101874328|FG000|COMPLETED|Overall Study||9||
48628176|NCT02771275|101874328|FG000|NOT COMPLETED|Overall Study||4||
48628177|NCT02737722|101874329|FG000|STARTED|Overall Study||8||
48628178|NCT02737722|101874330|FG001|STARTED|Overall Study||8||
48172167|NCT04711460|100742616|FG003|NOT COMPLETED|Overall Study||0||
48172168|NCT01728805|100742617|FG000|STARTED|Randomization Period||186||
48172169|NCT01728805|100742618|FG001|STARTED|Randomization Period||186||
48172170|NCT01728805|100742619|FG002|STARTED|Randomization Period||0||
48172171|NCT01728805|100742617|FG000|COMPLETED|Randomization Period||186||
48172172|NCT01728805|100742618|FG001|COMPLETED|Randomization Period||186||
48172173|NCT01728805|100742619|FG002|COMPLETED|Randomization Period||0||
48172174|NCT01728805|100742617|FG000|NOT COMPLETED|Randomization Period||0||
48172175|NCT01728805|100742618|FG001|NOT COMPLETED|Randomization Period||0||
48172176|NCT01728805|100742619|FG002|NOT COMPLETED|Randomization Period||0||
48334185|NCT03099707|101145667|FG000|COMPLETED|Overall Study||43||
48334186|NCT03099707|101145668|FG001|COMPLETED|Overall Study||37||
48334187|NCT03099707|101145667|FG000|NOT COMPLETED|Overall Study||0||
48334188|NCT03099707|101145668|FG001|NOT COMPLETED|Overall Study||4||
48334189|NCT02769728|101145669|FG000|STARTED|Overall Study||10||
48334190|NCT02769728|101145669|FG000|Implantation of the Endobarrier Device|Overall Study||10||
48334191|NCT02769728|101145669|FG000|COMPLETED|Overall Study||10||
48172177|NCT01728805|100742617|FG000|STARTED|Crossover Period||0||
48172178|NCT01728805|100742618|FG001|STARTED|Crossover Period||0||
48172179|NCT01728805|100742619|FG002|STARTED|Crossover Period||136||
48172180|NCT01728805|100742617|FG000|COMPLETED|Crossover Period||0||
48334192|NCT02769728|101145669|FG000|NOT COMPLETED|Overall Study||0||
48334193|NCT03167073|101145670|FG000|STARTED|Overall Study||85||
48334194|NCT03167073|101145671|FG001|STARTED|Overall Study||85||
48628179|NCT02737722|101874331|FG002|STARTED|Overall Study||8||
48628180|NCT02737722|101874332|FG003|STARTED|Overall Study||6||
48628181|NCT02737722|101874329|FG000|COMPLETED|Overall Study||8||
48628182|NCT02737722|101874330|FG001|COMPLETED|Overall Study||8||
48628183|NCT02737722|101874331|FG002|COMPLETED|Overall Study||7||
48628184|NCT02737722|101874332|FG003|COMPLETED|Overall Study||6||
48172181|NCT01728805|100742618|FG001|COMPLETED|Crossover Period||0||
48172182|NCT01728805|100742619|FG002|COMPLETED|Crossover Period||136||
48172183|NCT01728805|100742617|FG000|NOT COMPLETED|Crossover Period||0||
48172184|NCT01728805|100742618|FG001|NOT COMPLETED|Crossover Period||0||
48172185|NCT01728805|100742619|FG002|NOT COMPLETED|Crossover Period||0||
48334195|NCT03167073|101145670|FG000|COMPLETED|Overall Study||84||
48334196|NCT03167073|101145671|FG001|COMPLETED|Overall Study||85||
48334197|NCT03167073|101145670|FG000|NOT COMPLETED|Overall Study||1||
48334198|NCT03167073|101145671|FG001|NOT COMPLETED|Overall Study||0||
48334199|NCT00291551|101145672|FG000|STARTED|Overall Study||39||
48334200|NCT00291551|101145672|FG000|COMPLETED|Overall Study||26||
48628185|NCT02737722|101874329|FG000|NOT COMPLETED|Overall Study||0||
48628186|NCT02737722|101874330|FG001|NOT COMPLETED|Overall Study||0||
48628187|NCT02737722|101874331|FG002|NOT COMPLETED|Overall Study||1||
48628188|NCT02737722|101874332|FG003|NOT COMPLETED|Overall Study||0||
48628189|NCT03880474|101874333|FG000|STARTED|Overall Study||1077||
48628190|NCT03880474|101874334|FG001|STARTED|Overall Study||1075||
48628191|NCT03880474|101874333|FG000|COMPLETED|Overall Study||1054||
48628192|NCT03880474|101874334|FG001|COMPLETED|Overall Study||1055||
48628193|NCT03880474|101874333|FG000|NOT COMPLETED|Overall Study||23||
48172186|NCT02023879|100742620|FG000|STARTED|Period 1: 24-Week Double-blind Treatment||58||
48334201|NCT00291551|101145672|FG000|NOT COMPLETED|Overall Study||13||
48334202|NCT03036293|101145673|FG000|STARTED|Overall Study||127||
48334203|NCT03036293|101145674|FG001|STARTED|Overall Study||67||
48334204|NCT03036293|101145675|FG002|STARTED|Overall Study||131||
48334205|NCT03036293|101145676|FG003|STARTED|Overall Study||65||
48334206|NCT03036293|101145673|FG000|COMPLETED|Overall Study||126||
48334207|NCT03036293|101145674|FG001|COMPLETED|Overall Study||64||
48334208|NCT03036293|101145675|FG002|COMPLETED|Overall Study||130||
48334209|NCT03036293|101145676|FG003|COMPLETED|Overall Study||64||
48334210|NCT03036293|101145673|FG000|NOT COMPLETED|Overall Study||1||
48334211|NCT03036293|101145674|FG001|NOT COMPLETED|Overall Study||3||
48334212|NCT03036293|101145675|FG002|NOT COMPLETED|Overall Study||1||
48334213|NCT03036293|101145676|FG003|NOT COMPLETED|Overall Study||1||
48334214|NCT02604940|101145677|FG000|STARTED|Overall Study||26||
48334215|NCT02604940|101145678|FG001|STARTED|Overall Study||20||
48334216|NCT02604940|101145677|FG000|COMPLETED|Overall Study||26||
48334217|NCT02604940|101145678|FG001|COMPLETED|Overall Study||20||
48334218|NCT02604940|101145677|FG000|NOT COMPLETED|Overall Study||0||
48334219|NCT02604940|101145678|FG001|NOT COMPLETED|Overall Study||0||
48334220|NCT04580290|101145679|FG000|STARTED|Overall Study||88||
48334221|NCT04580290|101145680|FG001|STARTED|Overall Study||32||
48334222|NCT04580290|101145679|FG000|COMPLETED|Overall Study||88||
48334223|NCT04580290|101145680|FG001|COMPLETED|Overall Study||32||
48334224|NCT04580290|101145679|FG000|NOT COMPLETED|Overall Study||0||
48334225|NCT04580290|101145680|FG001|NOT COMPLETED|Overall Study||0||
48334226|NCT03382574|101145681|FG000|STARTED|Overall Study||0||
48334227|NCT03382574|101145681|FG000|COMPLETED|Overall Study||0||
48334228|NCT03382574|101145681|FG000|NOT COMPLETED|Overall Study||0||
48334229|NCT04541004|101145682|FG000|STARTED|Overall Study||253||
48334230|NCT04541004|101145682|FG000|COMPLETED|Overall Study||251||
48334231|NCT04541004|101145682|FG000|NOT COMPLETED|Overall Study||2||
48334232|NCT00331409|101145683|FG000|STARTED|Overall Study||19||
48334233|NCT00331409|101145683|FG000|COMPLETED|Overall Study||15||
48334234|NCT00331409|101145683|FG000|NOT COMPLETED|Overall Study||4||
48334235|NCT01636466|101145684|FG000|STARTED|Overall Study||1||
48334236|NCT01636466|101145685|FG001|STARTED|Overall Study||0||
48334237|NCT01636466|101145684|FG000|COMPLETED|Overall Study||0||
48334238|NCT01636466|101145685|FG001|COMPLETED|Overall Study||0||
48334239|NCT01636466|101145684|FG000|NOT COMPLETED|Overall Study||1||
48334240|NCT01636466|101145685|FG001|NOT COMPLETED|Overall Study||0||
48334241|NCT02944448|101145686|FG000|STARTED|Overall Study||316||
48334242|NCT02944448|101145687|FG001|STARTED|Overall Study||160||
48334243|NCT02944448|101145686|FG000|COMPLETED|Overall Study||227||
48334244|NCT02944448|101145687|FG001|COMPLETED|Overall Study||136||
48334245|NCT02944448|101145686|FG000|NOT COMPLETED|Overall Study||89||
48334246|NCT02944448|101145687|FG001|NOT COMPLETED|Overall Study||24||
48334247|NCT04142983|101145688|FG000|STARTED|Overall Study||110||
48334248|NCT04142983|101145688|FG000|Treatment Population|Overall Study||100||
48334249|NCT04142983|101145688|FG000|COMPLETED|Overall Study||11||
48334250|NCT04142983|101145688|FG000|NOT COMPLETED|Overall Study||99||
48334251|NCT00330187|101145689|FG000|STARTED|Overall Study||37||
48334252|NCT00330187|101145690|FG001|STARTED|Overall Study||36||
48334253|NCT00330187|101145691|FG002|STARTED|Overall Study||29||
48334254|NCT00330187|101145692|FG003|STARTED|Overall Study||32||
48334255|NCT00330187|101145689|FG000|COMPLETED|Overall Study||17||
48334256|NCT00330187|101145690|FG001|COMPLETED|Overall Study||18||
48334257|NCT00330187|101145691|FG002|COMPLETED|Overall Study||11||
48334258|NCT00330187|101145692|FG003|COMPLETED|Overall Study||18||
48334259|NCT00330187|101145689|FG000|NOT COMPLETED|Overall Study||20||
48334260|NCT00330187|101145690|FG001|NOT COMPLETED|Overall Study||18||
48334261|NCT00330187|101145691|FG002|NOT COMPLETED|Overall Study||18||
48334262|NCT00330187|101145692|FG003|NOT COMPLETED|Overall Study||14||
48334263|NCT01925209|101145693|FG000|STARTED|Treatment Epoch||63||
48334264|NCT01925209|101145694|FG001|STARTED|Treatment Epoch||63||
48334265|NCT01925209|101145695|FG002|STARTED|Treatment Epoch||63||
48334266|NCT01925209|101145696|FG003|STARTED|Treatment Epoch||62||
48334267|NCT01925209|101145693|FG000|Full Analysis Set|Treatment Epoch||63||
48334268|NCT01925209|101145694|FG001|Full Analysis Set|Treatment Epoch||63||
48334269|NCT01925209|101145695|FG002|Full Analysis Set|Treatment Epoch||63||
48334270|NCT01925209|101145696|FG003|Full Analysis Set|Treatment Epoch||62||
48334271|NCT01925209|101145693|FG000|COMPLETED|Treatment Epoch||54||
48334272|NCT01925209|101145694|FG001|COMPLETED|Treatment Epoch||55||
48334273|NCT01925209|101145695|FG002|COMPLETED|Treatment Epoch||56||
48334274|NCT01925209|101145696|FG003|COMPLETED|Treatment Epoch||57||
48334275|NCT01925209|101145693|FG000|NOT COMPLETED|Treatment Epoch||9||
48334276|NCT01925209|101145694|FG001|NOT COMPLETED|Treatment Epoch||8||
48334277|NCT01925209|101145695|FG002|NOT COMPLETED|Treatment Epoch||7||
48334278|NCT01925209|101145696|FG003|NOT COMPLETED|Treatment Epoch||5||
48334279|NCT01925209|101145693|FG000|STARTED|Maintenance Treatment Epoch||49||
48334280|NCT01925209|101145694|FG001|STARTED|Maintenance Treatment Epoch||46||
48334281|NCT01925209|101145695|FG002|STARTED|Maintenance Treatment Epoch||52||
48334282|NCT01925209|101145696|FG003|STARTED|Maintenance Treatment Epoch||50||
48334283|NCT01925209|101145693|FG000|COMPLETED|Maintenance Treatment Epoch||49||
48334284|NCT01925209|101145694|FG001|COMPLETED|Maintenance Treatment Epoch||45||
48334285|NCT01925209|101145695|FG002|COMPLETED|Maintenance Treatment Epoch||50||
48334286|NCT01925209|101145696|FG003|COMPLETED|Maintenance Treatment Epoch||48||
48334287|NCT01925209|101145693|FG000|NOT COMPLETED|Maintenance Treatment Epoch||0||
48334288|NCT01925209|101145694|FG001|NOT COMPLETED|Maintenance Treatment Epoch||1||
48334289|NCT01925209|101145695|FG002|NOT COMPLETED|Maintenance Treatment Epoch||2||
48334290|NCT01925209|101145696|FG003|NOT COMPLETED|Maintenance Treatment Epoch||2||
48334291|NCT01925209|101145693|FG000|STARTED|Follow-up||57||
48334292|NCT01925209|101145694|FG001|STARTED|Follow-up||61||
48334293|NCT01925209|101145695|FG002|STARTED|Follow-up||56||
48334294|NCT01925209|101145696|FG003|STARTED|Follow-up||58||
48334295|NCT01925209|101145693|FG000|COMPLETED|Follow-up||56||
48334296|NCT01925209|101145694|FG001|COMPLETED|Follow-up||55||
48334297|NCT01925209|101145695|FG002|COMPLETED|Follow-up||55||
48334298|NCT01925209|101145696|FG003|COMPLETED|Follow-up||54||
48334299|NCT01925209|101145693|FG000|NOT COMPLETED|Follow-up||1||
48334300|NCT01925209|101145694|FG001|NOT COMPLETED|Follow-up||6||
48334301|NCT01925209|101145695|FG002|NOT COMPLETED|Follow-up||1||
48334302|NCT01925209|101145696|FG003|NOT COMPLETED|Follow-up||4||
48334303|NCT00272987|101145697|FG000|STARTED|Overall Study||29||
48334304|NCT00272987|101145698|FG001|STARTED|Overall Study||14||
48334305|NCT00272987|101145699|FG002|STARTED|Overall Study||20||
48334306|NCT00272987|101145697|FG000|COMPLETED|Overall Study||20||
48334307|NCT00272987|101145698|FG001|COMPLETED|Overall Study||10||
48334308|NCT00272987|101145699|FG002|COMPLETED|Overall Study||9||
48334309|NCT00272987|101145697|FG000|NOT COMPLETED|Overall Study||9||
48334310|NCT00272987|101145698|FG001|NOT COMPLETED|Overall Study||4||
48334311|NCT00272987|101145699|FG002|NOT COMPLETED|Overall Study||11||
48334312|NCT04660643|101145700|FG000|STARTED|Open-label Lead-in Period (Week 0 - 36)||783||
48334313|NCT04660643|101145701|FG001|STARTED|Open-label Lead-in Period (Week 0 - 36)||0||
48334314|NCT04660643|101145702|FG002|STARTED|Open-label Lead-in Period (Week 0 - 36)||0||
48334315|NCT04660643|101145700|FG000|Received at Least 1 Dose of Study Drug|Open-label Lead-in Period (Week 0 - 36)||782||
48334316|NCT04660643|101145701|FG001|Received at Least 1 Dose of Study Drug|Open-label Lead-in Period (Week 0 - 36)||0||
48334317|NCT04660643|101145702|FG002|Received at Least 1 Dose of Study Drug|Open-label Lead-in Period (Week 0 - 36)||0||
48334318|NCT04660643|101145700|FG000|Completed 36-weeks of Treatment (i.e., Reaching and Tolerating the MTD at Week 36)|Open-label Lead-in Period (Week 0 - 36)||670|Eligible for randomization.|
48334319|NCT04660643|101145701|FG001|Completed 36-weeks of Treatment (i.e., Reaching and Tolerating the MTD at Week 36)|Open-label Lead-in Period (Week 0 - 36)||0|Eligible for randomization.|
48334320|NCT04660643|101145702|FG002|Completed 36-weeks of Treatment (i.e., Reaching and Tolerating the MTD at Week 36)|Open-label Lead-in Period (Week 0 - 36)||0|Eligible for randomization.|
48334321|NCT04660643|101145700|FG000|COMPLETED|Open-label Lead-in Period (Week 0 - 36)||671|All enrolled participants with a non-missing body weight measurement at week 36, regardless of treatment discontinuation were considered as lead-in period completers.|
48334322|NCT04660643|101145701|FG001|COMPLETED|Open-label Lead-in Period (Week 0 - 36)||0|All enrolled participants with a non-missing body weight measurement at week 36, regardless of treatment discontinuation were considered as lead-in period completers.|
48334323|NCT04660643|101145702|FG002|COMPLETED|Open-label Lead-in Period (Week 0 - 36)||0|All enrolled participants with a non-missing body weight measurement at week 36, regardless of treatment discontinuation were considered as lead-in period completers.|
48334324|NCT04660643|101145700|FG000|NOT COMPLETED|Open-label Lead-in Period (Week 0 - 36)||112||
48334325|NCT04660643|101145701|FG001|NOT COMPLETED|Open-label Lead-in Period (Week 0 - 36)||0||
48334326|NCT04660643|101145702|FG002|NOT COMPLETED|Open-label Lead-in Period (Week 0 - 36)||0||
48334327|NCT04660643|101145700|FG000|STARTED|Double-blind Study Period (Week 36 - 92)||0||
48334328|NCT04660643|101145701|FG001|STARTED|Double-blind Study Period (Week 36 - 92)||335||
48334329|NCT04660643|101145702|FG002|STARTED|Double-blind Study Period (Week 36 - 92)||335||
48334330|NCT04660643|101145700|FG000|Received at Least 1 Dose of Study Drug|Double-blind Study Period (Week 36 - 92)||0||
48334331|NCT04660643|101145701|FG001|Received at Least 1 Dose of Study Drug|Double-blind Study Period (Week 36 - 92)||335||
48334332|NCT04660643|101145702|FG002|Received at Least 1 Dose of Study Drug|Double-blind Study Period (Week 36 - 92)||335||
48334333|NCT04660643|101145700|FG000|COMPLETED|Double-blind Study Period (Week 36 - 92)||0||
48334334|NCT04660643|101145701|FG001|COMPLETED|Double-blind Study Period (Week 36 - 92)||290||
48334335|NCT04660643|101145702|FG002|COMPLETED|Double-blind Study Period (Week 36 - 92)||310||
48334336|NCT04660643|101145700|FG000|NOT COMPLETED|Double-blind Study Period (Week 36 - 92)||0||
48334337|NCT04660643|101145701|FG001|NOT COMPLETED|Double-blind Study Period (Week 36 - 92)||45||
48334338|NCT04660643|101145702|FG002|NOT COMPLETED|Double-blind Study Period (Week 36 - 92)||25||
48334339|NCT01882907|101145703|FG000|STARTED|Overall Study||117|The patients who were screening failure and didn't taking investigational product are excluded.|
48334340|NCT01882907|101145704|FG001|STARTED|Overall Study||111|The patients who were screening failure and didn't taking investigational product are excluded.|
48334341|NCT01882907|101145703|FG000|COMPLETED|Overall Study||103||
48334342|NCT01882907|101145704|FG001|COMPLETED|Overall Study||83||
48334343|NCT01882907|101145703|FG000|NOT COMPLETED|Overall Study||14||
48334344|NCT01882907|101145704|FG001|NOT COMPLETED|Overall Study||28||
48334345|NCT00703664|101145705|FG000|STARTED|Overall Study||22||
48411853|NCT01981096|101341851|FG001|STARTED|Overall Study||20||
48411854|NCT01981096|101341850|FG000|Post-treatment|Overall Study||17||
48334346|NCT00703664|101145706|FG001|STARTED|Overall Study||4||
48334347|NCT00703664|101145707|FG002|STARTED|Overall Study||39||
48334348|NCT00703664|101145705|FG000|COMPLETED|Overall Study||22||
48334349|NCT00703664|101145706|FG001|COMPLETED|Overall Study||4||
48411855|NCT01981096|101341851|FG001|Post-treatment|Overall Study||19||
48411856|NCT01981096|101341850|FG000|COMPLETED|Overall Study||17||
48411857|NCT01981096|101341851|FG001|COMPLETED|Overall Study||19||
48411858|NCT01981096|101341850|FG000|NOT COMPLETED|Overall Study||3||
48411859|NCT01981096|101341851|FG001|NOT COMPLETED|Overall Study||1||
48411860|NCT01646346|101341852|FG000|STARTED|Overall Study||46||
48334350|NCT00703664|101145707|FG002|COMPLETED|Overall Study||39||
48334351|NCT00703664|101145705|FG000|NOT COMPLETED|Overall Study||0||
48334352|NCT00703664|101145706|FG001|NOT COMPLETED|Overall Study||0||
48334353|NCT00703664|101145707|FG002|NOT COMPLETED|Overall Study||0||
48334354|NCT00524537|101145708|FG000|STARTED|Overall Study||5025||
48334355|NCT00524537|101145708|FG000|Discontinued|Overall Study||2811||
48334356|NCT00524537|101145708|FG000|Re-enrolled|Overall Study||339||
48334357|NCT00524537|101145708|FG000|Discontinued After Re-enrollment|Overall Study||102||
48334358|NCT00524537|101145708|FG000|COMPLETED|Overall Study||2451||
48334359|NCT00524537|101145708|FG000|NOT COMPLETED|Overall Study||2574||
48334360|NCT01963481|101145709|FG000|STARTED|Overall Study||23||
48334361|NCT01963481|101145709|FG000|COMPLETED|Overall Study||23||
48334362|NCT01963481|101145709|FG000|NOT COMPLETED|Overall Study||0||
48334363|NCT02499029|101145710|FG000|STARTED|Overall Study||18||
48334364|NCT02499029|101145711|FG001|STARTED|Overall Study||17||
48334365|NCT02499029|101145710|FG000|COMPLETED|Overall Study||13||
48334366|NCT02499029|101145711|FG001|COMPLETED|Overall Study||14||
48334367|NCT02499029|101145710|FG000|NOT COMPLETED|Overall Study||5||
48334368|NCT02499029|101145711|FG001|NOT COMPLETED|Overall Study||3||
48334369|NCT01997463|101145712|FG000|STARTED|Overall Study||192||
48334370|NCT01997463|101145713|FG001|STARTED|Overall Study||250||
48334371|NCT01997463|101145712|FG000|COMPLETED|Overall Study||107||
48334372|NCT01997463|101145713|FG001|COMPLETED|Overall Study||147||
48334373|NCT01997463|101145712|FG000|NOT COMPLETED|Overall Study||85||
48334374|NCT01997463|101145713|FG001|NOT COMPLETED|Overall Study||103||
48411861|NCT01646346|101341852|FG000|COMPLETED|Overall Study||46||
48411862|NCT01646346|101341852|FG000|NOT COMPLETED|Overall Study||0||
48411863|NCT03180294|101341853|FG000|STARTED|Overall Study||79||
48751187|NCT02159066|102177345|FG000|NOT COMPLETED|Part I||75||
48751188|NCT02159066|102177346|FG001|NOT COMPLETED|Part I||79||
48751189|NCT02159066|102177347|FG002|NOT COMPLETED|Part I||0||
48751190|NCT02159066|102177348|FG003|NOT COMPLETED|Part I||0||
48751191|NCT02159066|102177349|FG004|NOT COMPLETED|Part I||0||
48751192|NCT02159066|102177350|FG005|NOT COMPLETED|Part I||0||
48751193|NCT02159066|102177345|FG000|STARTED|Part II||0||
48751194|NCT02159066|102177346|FG001|STARTED|Part II||0||
48751195|NCT02159066|102177347|FG002|STARTED|Part II||38||
48751196|NCT02159066|102177348|FG003|STARTED|Part II||1||
48751197|NCT02159066|102177349|FG004|STARTED|Part II||13||
48751198|NCT02159066|102177350|FG005|STARTED|Part II||6||
48751199|NCT02159066|102177345|FG000|COMPLETED|Part II||0||
48751200|NCT02159066|102177346|FG001|COMPLETED|Part II||0||
48751201|NCT02159066|102177347|FG002|COMPLETED|Part II||0||
48751202|NCT02159066|102177348|FG003|COMPLETED|Part II||0||
48751203|NCT02159066|102177349|FG004|COMPLETED|Part II||0||
48751204|NCT02159066|102177350|FG005|COMPLETED|Part II||0||
48751205|NCT02159066|102177345|FG000|NOT COMPLETED|Part II||0||
48334375|NCT02082678|101145714|FG000|STARTED|Overall Study||35||
48334376|NCT02082678|101145715|FG001|STARTED|Overall Study||35||
48334377|NCT02082678|101145714|FG000|COMPLETED|Overall Study||23||
48334378|NCT02082678|101145715|FG001|COMPLETED|Overall Study||21||
48334379|NCT02082678|101145714|FG000|NOT COMPLETED|Overall Study||12||
48334380|NCT02082678|101145715|FG001|NOT COMPLETED|Overall Study||14||
48334381|NCT00763321|101145716|FG000|STARTED|Open-label Period||285||
48334382|NCT00763321|101145717|FG001|STARTED|Open-label Period||0||
48334383|NCT00763321|101145718|FG002|STARTED|Open-label Period||0||
48411864|NCT03180294|101341854|FG001|STARTED|Overall Study||74||
48411865|NCT03180294|101341855|FG002|STARTED|Overall Study||77||
48411866|NCT03180294|101341853|FG000|Eligible Population|Overall Study||79||
48751206|NCT02159066|102177346|FG001|NOT COMPLETED|Part II||0||
48751207|NCT02159066|102177347|FG002|NOT COMPLETED|Part II||38||
48751208|NCT02159066|102177348|FG003|NOT COMPLETED|Part II||1||
48751209|NCT02159066|102177349|FG004|NOT COMPLETED|Part II||13||
48751210|NCT02159066|102177350|FG005|NOT COMPLETED|Part II||6||
48751211|NCT04055675|102177351|FG000|STARTED|Overall Study||96||
48751212|NCT04055675|102177352|FG001|STARTED|Overall Study||104||
48751213|NCT04055675|102177351|FG000|COMPLETED|Overall Study||96||
48751214|NCT04055675|102177352|FG001|COMPLETED|Overall Study||104||
48751215|NCT04055675|102177351|FG000|NOT COMPLETED|Overall Study||0||
48751216|NCT04055675|102177352|FG001|NOT COMPLETED|Overall Study||0||
48751217|NCT02525471|102177353|FG000|STARTED|Overall Study||24||
48751218|NCT02525471|102177353|FG000|Randomized/Treated|Overall Study||16||
48751219|NCT02525471|102177353|FG000|COMPLETED|Overall Study||13||
48334384|NCT00763321|101145716|FG000|COMPLETED|Open-label Period||222||
48334385|NCT00763321|101145717|FG001|COMPLETED|Open-label Period||0||
48334386|NCT00763321|101145718|FG002|COMPLETED|Open-label Period||0||
48334387|NCT00763321|101145716|FG000|NOT COMPLETED|Open-label Period||63||
48334388|NCT00763321|101145717|FG001|NOT COMPLETED|Open-label Period||0||
48334389|NCT00763321|101145718|FG002|NOT COMPLETED|Open-label Period||0||
48334390|NCT00763321|101145716|FG000|STARTED|Double-blind Period||0||
48751220|NCT02525471|102177353|FG000|NOT COMPLETED|Overall Study||11||
48751221|NCT03410628|102177354|FG000|STARTED|Overall Study||21||
48751222|NCT03410628|102177354|FG000|COMPLETED|Overall Study||15||
48751223|NCT03410628|102177354|FG000|NOT COMPLETED|Overall Study||6||
48751224|NCT03788057|102177355|FG000|STARTED|Overall Study||58||
48751225|NCT03788057|102177355|FG000|COMPLETED|Overall Study||52||
48751226|NCT03788057|102177355|FG000|NOT COMPLETED|Overall Study||6||
48411867|NCT03180294|101341854|FG001|Eligible Population|Overall Study||74||
48411868|NCT03180294|101341855|FG002|Eligible Population|Overall Study||77||
48411869|NCT03180294|101341853|FG000|Adverse Event Population|Overall Study||77|Eligible participants with adverse event data who started study treatment.|
48411870|NCT03180294|101341854|FG001|Adverse Event Population|Overall Study||73|Eligible participants with adverse event data who started study treatment.|
48411871|NCT03180294|101341855|FG002|Adverse Event Population|Overall Study||76|Eligible participants with adverse event data who started study treatment.|
48411872|NCT03180294|101341853|FG000|COMPLETED|Overall Study||79|Participants contributing data to results are considered to have completed the study.|
48411873|NCT03180294|101341854|FG001|COMPLETED|Overall Study||74|Participants contributing data to results are considered to have completed the study.|
48411874|NCT03180294|101341855|FG002|COMPLETED|Overall Study||77|Participants contributing data to results are considered to have completed the study.|
48411875|NCT03180294|101341853|FG000|NOT COMPLETED|Overall Study||0||
48411876|NCT03180294|101341854|FG001|NOT COMPLETED|Overall Study||0||
48411877|NCT03180294|101341855|FG002|NOT COMPLETED|Overall Study||0||
48628194|NCT03880474|101874334|FG001|NOT COMPLETED|Overall Study||20||
48628195|NCT02271451|101874335|FG000|STARTED|Overall Study||7||
48628196|NCT02271451|101874336|FG001|STARTED|Overall Study||8||
48628197|NCT02271451|101874335|FG000|COMPLETED|Overall Study||7||
48628198|NCT02271451|101874336|FG001|COMPLETED|Overall Study||7||
48628199|NCT02271451|101874335|FG000|NOT COMPLETED|Overall Study||0||
48628200|NCT02271451|101874336|FG001|NOT COMPLETED|Overall Study||1||
48628201|NCT03608826|101874337|FG000|STARTED|Overall Study||12||
48628202|NCT03608826|101874337|FG000|COMPLETED|Overall Study||2||
48628203|NCT03608826|101874337|FG000|NOT COMPLETED|Overall Study||10||
48628204|NCT01003106|101874338|FG000|STARTED|Baseline to Month 6||22||
48628205|NCT01003106|101874339|FG001|STARTED|Baseline to Month 6||20||
48628206|NCT01003106|101874340|FG002|STARTED|Baseline to Month 6||0||
48628207|NCT01003106|101874341|FG003|STARTED|Baseline to Month 6||0||
48628208|NCT01003106|101874342|FG004|STARTED|Baseline to Month 6||19||
48628209|NCT01003106|101874343|FG005|STARTED|Baseline to Month 6||20||
48628210|NCT01003106|101874344|FG006|STARTED|Baseline to Month 6||0||
48411878|NCT04098016|101341856|FG000|STARTED|Overall Study||54||
48411879|NCT04098016|101341856|FG000|COMPLETED|Overall Study||48||
48411880|NCT04098016|101341856|FG000|NOT COMPLETED|Overall Study||6||
48411881|NCT03227692|101341857|FG000|STARTED|Overall Study||47||
48411882|NCT03227692|101341858|FG001|STARTED|Overall Study||46||
48411883|NCT03227692|101341857|FG000|COMPLETED|Overall Study||42||
48411884|NCT03227692|101341858|FG001|COMPLETED|Overall Study||41||
48628211|NCT01003106|101874345|FG007|STARTED|Baseline to Month 6||0||
48628212|NCT01003106|101874338|FG000|COMPLETED|Baseline to Month 6||22||
48628213|NCT01003106|101874339|FG001|COMPLETED|Baseline to Month 6||20||
48628214|NCT01003106|101874340|FG002|COMPLETED|Baseline to Month 6||0||
48628215|NCT01003106|101874341|FG003|COMPLETED|Baseline to Month 6||0||
48751227|NCT03473236|102177356|FG000|STARTED|Overall Study||10||
48751228|NCT03473236|102177357|FG001|STARTED|Overall Study||6||
48751229|NCT03473236|102177358|FG002|STARTED|Overall Study||6||
48751230|NCT03473236|102177359|FG003|STARTED|Overall Study||6||
48751231|NCT03473236|102177360|FG004|STARTED|Overall Study||6||
48751232|NCT03473236|102177361|FG005|STARTED|Overall Study||7||
48751233|NCT03473236|102177362|FG006|STARTED|Overall Study||6||
48751234|NCT03473236|102177363|FG007|STARTED|Overall Study||6||
48751235|NCT03473236|102177364|FG008|STARTED|Overall Study||7||
48411885|NCT03227692|101341857|FG000|NOT COMPLETED|Overall Study||5||
48411886|NCT03227692|101341858|FG001|NOT COMPLETED|Overall Study||5||
48411887|NCT02993783|101341859|FG000|STARTED|Overall Study||8||
48411888|NCT02993783|101341860|FG001|STARTED|Overall Study||9||
48411889|NCT02993783|101341859|FG000|COMPLETED|Overall Study||2||
48411890|NCT02993783|101341860|FG001|COMPLETED|Overall Study||0||
48751236|NCT03473236|102177365|FG009|STARTED|Overall Study||6||
48751237|NCT03473236|102177356|FG000|COMPLETED|Overall Study||10||
48751238|NCT03473236|102177357|FG001|COMPLETED|Overall Study||6||
48751239|NCT03473236|102177358|FG002|COMPLETED|Overall Study||6||
48751240|NCT03473236|102177359|FG003|COMPLETED|Overall Study||6||
48751241|NCT03473236|102177360|FG004|COMPLETED|Overall Study||6||
48751242|NCT03473236|102177361|FG005|COMPLETED|Overall Study||6||
48751243|NCT03473236|102177362|FG006|COMPLETED|Overall Study||6||
48751244|NCT03473236|102177363|FG007|COMPLETED|Overall Study||6||
48751245|NCT03473236|102177364|FG008|COMPLETED|Overall Study||6||
48751246|NCT03473236|102177365|FG009|COMPLETED|Overall Study||6||
48751247|NCT03473236|102177356|FG000|NOT COMPLETED|Overall Study||0||
48751248|NCT03473236|102177357|FG001|NOT COMPLETED|Overall Study||0||
48751249|NCT03473236|102177358|FG002|NOT COMPLETED|Overall Study||0||
48751250|NCT03473236|102177359|FG003|NOT COMPLETED|Overall Study||0||
48751251|NCT03473236|102177360|FG004|NOT COMPLETED|Overall Study||0||
48751252|NCT03473236|102177361|FG005|NOT COMPLETED|Overall Study||1||
48751253|NCT03473236|102177362|FG006|NOT COMPLETED|Overall Study||0||
48751254|NCT03473236|102177363|FG007|NOT COMPLETED|Overall Study||0||
48751255|NCT03473236|102177364|FG008|NOT COMPLETED|Overall Study||1||
48751256|NCT03473236|102177365|FG009|NOT COMPLETED|Overall Study||0||
48751257|NCT03865446|102177366|FG000|STARTED|Overall Study||8||
48751258|NCT03865446|102177367|FG001|STARTED|Overall Study||8||
48751259|NCT03865446|102177366|FG000|COMPLETED|Overall Study||8||
48751260|NCT03865446|102177367|FG001|COMPLETED|Overall Study||8||
48411891|NCT02993783|101341859|FG000|NOT COMPLETED|Overall Study||6||
48751261|NCT03865446|102177366|FG000|NOT COMPLETED|Overall Study||0||
48751262|NCT03865446|102177367|FG001|NOT COMPLETED|Overall Study||0||
48751263|NCT01132807|102177368|FG000|STARTED|Initial ABVD Treatment (2 Cycles)||15||
48751264|NCT01132807|102177369|FG001|STARTED|Initial ABVD Treatment (2 Cycles)||135||
48188638|NCT05257837|100783294|FG000|COMPLETED|Overall Study||54||
48411892|NCT02993783|101341860|FG001|NOT COMPLETED|Overall Study||9||
48751265|NCT01132807|102177370|FG002|STARTED|Initial ABVD Treatment (2 Cycles)||14||
48751266|NCT01132807|102177368|FG000|COMPLETED|Initial ABVD Treatment (2 Cycles)||0||
48751267|NCT01132807|102177369|FG001|COMPLETED|Initial ABVD Treatment (2 Cycles)||135||
48628216|NCT01003106|101874342|FG004|COMPLETED|Baseline to Month 6||19||
48628217|NCT01003106|101874343|FG005|COMPLETED|Baseline to Month 6||20||
48628218|NCT01003106|101874344|FG006|COMPLETED|Baseline to Month 6||0||
48628219|NCT01003106|101874345|FG007|COMPLETED|Baseline to Month 6||0||
48628220|NCT01003106|101874338|FG000|NOT COMPLETED|Baseline to Month 6||0||
48628221|NCT01003106|101874339|FG001|NOT COMPLETED|Baseline to Month 6||0||
48628222|NCT01003106|101874340|FG002|NOT COMPLETED|Baseline to Month 6||0||
48628223|NCT01003106|101874341|FG003|NOT COMPLETED|Baseline to Month 6||0||
48628224|NCT01003106|101874342|FG004|NOT COMPLETED|Baseline to Month 6||0||
48628225|NCT01003106|101874343|FG005|NOT COMPLETED|Baseline to Month 6||0||
48628226|NCT01003106|101874344|FG006|NOT COMPLETED|Baseline to Month 6||0||
48628227|NCT01003106|101874345|FG007|NOT COMPLETED|Baseline to Month 6||0||
48628228|NCT01003106|101874338|FG000|STARTED|Month 6-Month 36||0||
48628229|NCT01003106|101874339|FG001|STARTED|Month 6-Month 36||0||
48628230|NCT01003106|101874340|FG002|STARTED|Month 6-Month 36||19||
48628231|NCT01003106|101874341|FG003|STARTED|Month 6-Month 36||20||
48628232|NCT01003106|101874342|FG004|STARTED|Month 6-Month 36||0||
48628233|NCT01003106|101874343|FG005|STARTED|Month 6-Month 36||0||
48628234|NCT01003106|101874344|FG006|STARTED|Month 6-Month 36||20||
48628235|NCT01003106|101874345|FG007|STARTED|Month 6-Month 36||18||
48628236|NCT01003106|101874338|FG000|COMPLETED|Month 6-Month 36||0||
48628237|NCT01003106|101874339|FG001|COMPLETED|Month 6-Month 36||0||
48628238|NCT01003106|101874340|FG002|COMPLETED|Month 6-Month 36||18||
48628239|NCT01003106|101874341|FG003|COMPLETED|Month 6-Month 36||20||
48628240|NCT01003106|101874342|FG004|COMPLETED|Month 6-Month 36||0||
48628241|NCT01003106|101874343|FG005|COMPLETED|Month 6-Month 36||0||
48628242|NCT01003106|101874344|FG006|COMPLETED|Month 6-Month 36||19||
48628243|NCT01003106|101874345|FG007|COMPLETED|Month 6-Month 36||18||
48628244|NCT01003106|101874338|FG000|NOT COMPLETED|Month 6-Month 36||0||
48628245|NCT01003106|101874339|FG001|NOT COMPLETED|Month 6-Month 36||0||
48628246|NCT01003106|101874340|FG002|NOT COMPLETED|Month 6-Month 36||1||
48628247|NCT01003106|101874341|FG003|NOT COMPLETED|Month 6-Month 36||0||
48628248|NCT01003106|101874342|FG004|NOT COMPLETED|Month 6-Month 36||0||
48628249|NCT01003106|101874343|FG005|NOT COMPLETED|Month 6-Month 36||0||
48628250|NCT01003106|101874344|FG006|NOT COMPLETED|Month 6-Month 36||1||
48628251|NCT01003106|101874345|FG007|NOT COMPLETED|Month 6-Month 36||0||
48628252|NCT03163446|101874346|FG000|STARTED|Overall Study||73||
48751268|NCT01132807|102177370|FG002|COMPLETED|Initial ABVD Treatment (2 Cycles)||14||
48751269|NCT01132807|102177368|FG000|NOT COMPLETED|Initial ABVD Treatment (2 Cycles)||15||
48751270|NCT01132807|102177369|FG001|NOT COMPLETED|Initial ABVD Treatment (2 Cycles)||0||
48751271|NCT01132807|102177370|FG002|NOT COMPLETED|Initial ABVD Treatment (2 Cycles)||0||
48751272|NCT01132807|102177368|FG000|STARTED|Post-Cycle 2 PET Assessment||0||
48751273|NCT01132807|102177369|FG001|STARTED|Post-Cycle 2 PET Assessment||135||
48751274|NCT01132807|102177370|FG002|STARTED|Post-Cycle 2 PET Assessment||14||
48751275|NCT01132807|102177368|FG000|COMPLETED|Post-Cycle 2 PET Assessment||0||
48751276|NCT01132807|102177369|FG001|COMPLETED|Post-Cycle 2 PET Assessment||135||
48751277|NCT01132807|102177370|FG002|COMPLETED|Post-Cycle 2 PET Assessment||14||
48751278|NCT01132807|102177368|FG000|NOT COMPLETED|Post-Cycle 2 PET Assessment||0||
48751279|NCT01132807|102177369|FG001|NOT COMPLETED|Post-Cycle 2 PET Assessment||0||
48751280|NCT01132807|102177370|FG002|NOT COMPLETED|Post-Cycle 2 PET Assessment||0||
48751281|NCT01488045|102177371|FG000|STARTED|Overall Study||145||
48751282|NCT01488045|102177372|FG001|STARTED|Overall Study||144||
48751283|NCT01488045|102177371|FG000|COMPLETED|Overall Study||136||
48751284|NCT01488045|102177372|FG001|COMPLETED|Overall Study||126||
48751285|NCT01488045|102177371|FG000|NOT COMPLETED|Overall Study||9||
48751286|NCT01488045|102177372|FG001|NOT COMPLETED|Overall Study||18||
48751287|NCT00859547|102177373|FG000|STARTED|Overall Study||30||
48751288|NCT00859547|102177373|FG000|COMPLETED|Overall Study||28||
48751289|NCT00859547|102177373|FG000|NOT COMPLETED|Overall Study||2||
48751290|NCT00647296|102177374|FG000|STARTED|Part 1: 12-week Double-Blind Treatment||27||
48751291|NCT00647296|102177375|FG001|STARTED|Part 1: 12-week Double-Blind Treatment||23||
48751292|NCT00647296|102177376|FG002|STARTED|Part 1: 12-week Double-Blind Treatment||26||
48751293|NCT00647296|102177377|FG003|STARTED|Part 1: 12-week Double-Blind Treatment||26||
48751294|NCT00647296|102177374|FG000|COMPLETED|Part 1: 12-week Double-Blind Treatment||26||
48628253|NCT03163446|101874347|FG001|STARTED|Overall Study||48||
48628254|NCT03163446|101874346|FG000|COMPLETED|Overall Study||45||
48628255|NCT03163446|101874347|FG001|COMPLETED|Overall Study||31||
48628256|NCT03163446|101874346|FG000|NOT COMPLETED|Overall Study||28||
48628257|NCT03163446|101874347|FG001|NOT COMPLETED|Overall Study||17||
48628258|NCT01701245|101874348|FG000|STARTED|Overall Study||49||
48628259|NCT01701245|101874349|FG001|STARTED|Overall Study||48||
48628260|NCT01701245|101874348|FG000|FAS Unmatched Data|Overall Study||48||
48628261|NCT01701245|101874349|FG001|FAS Unmatched Data|Overall Study||45||
48628262|NCT01701245|101874348|FG000|FAS Matched Data|Overall Study||42||
48628263|NCT01701245|101874349|FG001|FAS Matched Data|Overall Study||32||
48628264|NCT01701245|101874348|FG000|COMPLETED|Overall Study||37||
48751295|NCT00647296|102177375|FG001|COMPLETED|Part 1: 12-week Double-Blind Treatment||22||
48751296|NCT00647296|102177376|FG002|COMPLETED|Part 1: 12-week Double-Blind Treatment||26||
48751297|NCT00647296|102177377|FG003|COMPLETED|Part 1: 12-week Double-Blind Treatment||24||
48751298|NCT00647296|102177374|FG000|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||1||
48751299|NCT00647296|102177375|FG001|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||1||
48628265|NCT01701245|101874349|FG001|COMPLETED|Overall Study||33||
48628266|NCT01701245|101874348|FG000|NOT COMPLETED|Overall Study||12||
48628267|NCT01701245|101874349|FG001|NOT COMPLETED|Overall Study||15||
48751300|NCT00647296|102177376|FG002|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||0||
48751301|NCT00647296|102177377|FG003|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||2||
48751302|NCT00647296|102177374|FG000|STARTED|Part 2: 4-week Placebo Washout||97||
48751303|NCT00647296|102177375|FG001|STARTED|Part 2: 4-week Placebo Washout||0||
48751304|NCT00647296|102177376|FG002|STARTED|Part 2: 4-week Placebo Washout||0||
48751305|NCT00647296|102177377|FG003|STARTED|Part 2: 4-week Placebo Washout||0||
48751306|NCT00647296|102177374|FG000|COMPLETED|Part 2: 4-week Placebo Washout||92||
48751307|NCT00647296|102177375|FG001|COMPLETED|Part 2: 4-week Placebo Washout||0||
48751308|NCT00647296|102177376|FG002|COMPLETED|Part 2: 4-week Placebo Washout||0||
48751309|NCT00647296|102177377|FG003|COMPLETED|Part 2: 4-week Placebo Washout||0||
48751310|NCT00647296|102177374|FG000|NOT COMPLETED|Part 2: 4-week Placebo Washout||5||
48751311|NCT00647296|102177375|FG001|NOT COMPLETED|Part 2: 4-week Placebo Washout||0||
48751312|NCT00647296|102177376|FG002|NOT COMPLETED|Part 2: 4-week Placebo Washout||0||
48767726|NCT00494676|102222813|FG001|STARTED|First Intervention||32||
48628268|NCT01548404|101874350|FG000|STARTED|Overall Study||54||
48751313|NCT00647296|102177377|FG003|NOT COMPLETED|Part 2: 4-week Placebo Washout||0||
48751314|NCT00647296|102177374|FG000|STARTED|Part 2: 76-week Double-Blind Treatment||0||
48751315|NCT00647296|102177375|FG001|STARTED|Part 2: 76-week Double-Blind Treatment||48||
48751316|NCT00647296|102177376|FG002|STARTED|Part 2: 76-week Double-Blind Treatment||0||
48751317|NCT00647296|102177377|FG003|STARTED|Part 2: 76-week Double-Blind Treatment||44||
48751318|NCT00647296|102177374|FG000|COMPLETED|Part 2: 76-week Double-Blind Treatment||0||
48751319|NCT00647296|102177375|FG001|COMPLETED|Part 2: 76-week Double-Blind Treatment||33||
48751320|NCT00647296|102177376|FG002|COMPLETED|Part 2: 76-week Double-Blind Treatment||0||
48751321|NCT00647296|102177377|FG003|COMPLETED|Part 2: 76-week Double-Blind Treatment||30||
48751322|NCT00647296|102177374|FG000|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||0||
48751323|NCT00647296|102177375|FG001|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||15||
48751324|NCT00647296|102177376|FG002|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||0||
48751325|NCT00647296|102177377|FG003|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||14||
48751326|NCT01600885|102177378|FG000|STARTED|First Period||10||
48751327|NCT01600885|102177379|FG001|STARTED|First Period||9||
48751328|NCT01600885|102177378|FG000|COMPLETED|First Period||8||
48751329|NCT01600885|102177379|FG001|COMPLETED|First Period||8||
48751330|NCT01600885|102177378|FG000|NOT COMPLETED|First Period||2||
48751331|NCT01600885|102177379|FG001|NOT COMPLETED|First Period||1||
48751332|NCT01600885|102177378|FG000|STARTED|Wash Out Period||8||
48751333|NCT01600885|102177379|FG001|STARTED|Wash Out Period||8||
48751334|NCT01600885|102177378|FG000|COMPLETED|Wash Out Period||8||
48751335|NCT01600885|102177379|FG001|COMPLETED|Wash Out Period||8||
48751336|NCT01600885|102177378|FG000|NOT COMPLETED|Wash Out Period||0||
48751337|NCT01600885|102177379|FG001|NOT COMPLETED|Wash Out Period||0||
48751338|NCT01600885|102177378|FG000|STARTED|Second Period||8||
48751339|NCT01600885|102177379|FG001|STARTED|Second Period||8||
48751340|NCT01600885|102177378|FG000|COMPLETED|Second Period||8||
48751341|NCT01600885|102177379|FG001|COMPLETED|Second Period||8||
48751342|NCT01600885|102177378|FG000|NOT COMPLETED|Second Period||0||
48751343|NCT01600885|102177379|FG001|NOT COMPLETED|Second Period||0||
48751344|NCT01650558|102177380|FG000|STARTED|Overall Study||500||
48751345|NCT01650558|102177381|FG001|STARTED|Overall Study||500||
48751346|NCT01650558|102177382|FG002|STARTED|Overall Study||499||
48751347|NCT01650558|102177380|FG000|COMPLETED|Overall Study||417||
48751348|NCT01650558|102177381|FG001|COMPLETED|Overall Study||408||
48751349|NCT01650558|102177382|FG002|COMPLETED|Overall Study||424||
48751350|NCT01650558|102177380|FG000|NOT COMPLETED|Overall Study||83||
48751351|NCT01650558|102177381|FG001|NOT COMPLETED|Overall Study||92||
48751352|NCT01650558|102177382|FG002|NOT COMPLETED|Overall Study||75||
48751353|NCT02372877|102177383|FG000|STARTED|Overall Study||83||
48751354|NCT02372877|102177383|FG000|COMPLETED|Overall Study||59||
48751355|NCT02372877|102177383|FG000|NOT COMPLETED|Overall Study||24||
48751356|NCT01329263|102177384|FG000|STARTED|Overall Study||15||
48751357|NCT01329263|102177385|FG001|STARTED|Overall Study||45||
48751358|NCT01329263|102177384|FG000|Completed Period 1 Own Menthol|Overall Study||15||
48751359|NCT01329263|102177385|FG001|Completed Period 1 Own Menthol|Overall Study||45||
48751360|NCT01329263|102177384|FG000|Completed Period 2 Own or CCrush Menthol|Overall Study||10||
48751361|NCT01329263|102177385|FG001|Completed Period 2 Own or CCrush Menthol|Overall Study||30||
48751362|NCT01329263|102177384|FG000|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||10||
48751363|NCT01329263|102177385|FG001|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||22||
48751364|NCT01329263|102177384|FG000|COMPLETED|Overall Study||10||
48751365|NCT01329263|102177385|FG001|COMPLETED|Overall Study||22||
48751366|NCT01329263|102177384|FG000|NOT COMPLETED|Overall Study||5||
48751367|NCT01329263|102177385|FG001|NOT COMPLETED|Overall Study||23||
48751368|NCT00914186|102177386|FG000|STARTED|Overall Study||31||
48751369|NCT00914186|102177387|FG001|STARTED|Overall Study||30||
48751370|NCT00914186|102177388|FG002|STARTED|Overall Study||31||
48751371|NCT00914186|102177389|FG003|STARTED|Overall Study||30||
48751372|NCT00914186|102177386|FG000|COMPLETED|Overall Study||28||
48751373|NCT00914186|102177387|FG001|COMPLETED|Overall Study||28||
48751374|NCT00914186|102177388|FG002|COMPLETED|Overall Study||29||
48751375|NCT00914186|102177389|FG003|COMPLETED|Overall Study||20||
48751376|NCT00914186|102177386|FG000|NOT COMPLETED|Overall Study||3||
48751377|NCT00914186|102177387|FG001|NOT COMPLETED|Overall Study||2||
48751378|NCT00914186|102177388|FG002|NOT COMPLETED|Overall Study||2||
48751379|NCT00914186|102177389|FG003|NOT COMPLETED|Overall Study||10||
48751380|NCT01232868|102177390|FG000|STARTED|Overall Study||22||
48751381|NCT01232868|102177391|FG001|STARTED|Overall Study||44||
48751382|NCT01232868|102177390|FG000|COMPLETED|Overall Study||20||
48751383|NCT01232868|102177391|FG001|COMPLETED|Overall Study||40||
48751384|NCT01232868|102177390|FG000|NOT COMPLETED|Overall Study||2||
48751385|NCT01232868|102177391|FG001|NOT COMPLETED|Overall Study||4||
48751386|NCT00404651|102177392|FG000|STARTED|Overall Study||340||
48751387|NCT00404651|102177393|FG001|STARTED|Overall Study||343||
48751388|NCT00404651|102177394|FG002|STARTED|Overall Study||339||
48751389|NCT00404651|102177395|FG003|STARTED|Overall Study||167||
48751390|NCT00404651|102177392|FG000|COMPLETED|Overall Study||301||
48751391|NCT00404651|102177393|FG001|COMPLETED|Overall Study||315||
48751392|NCT00404651|102177394|FG002|COMPLETED|Overall Study||294||
48751393|NCT00404651|102177395|FG003|COMPLETED|Overall Study||146||
48751394|NCT00404651|102177392|FG000|NOT COMPLETED|Overall Study||39||
48751395|NCT00404651|102177393|FG001|NOT COMPLETED|Overall Study||28||
48751396|NCT00404651|102177394|FG002|NOT COMPLETED|Overall Study||45||
48751397|NCT00404651|102177395|FG003|NOT COMPLETED|Overall Study||21||
48751398|NCT04875013|102177396|FG000|STARTED|Overall Study||13||
48751399|NCT04875013|102177396|FG000|Post-treatment Assessment|Overall Study||13||
48751400|NCT04875013|102177396|FG000|COMPLETED|Overall Study||9||
48751401|NCT04875013|102177396|FG000|NOT COMPLETED|Overall Study||4||
48751402|NCT00965081|102177397|FG000|STARTED|Overall Study||155||
48751403|NCT00965081|102177398|FG001|STARTED|Overall Study||153||
48751404|NCT00965081|102177397|FG000|COMPLETED|Overall Study||121||
48751405|NCT00965081|102177398|FG001|COMPLETED|Overall Study||110||
48751406|NCT00965081|102177397|FG000|NOT COMPLETED|Overall Study||34||
48751407|NCT00965081|102177398|FG001|NOT COMPLETED|Overall Study||43||
48751408|NCT05470387|102177399|FG000|STARTED|Overall Study||13||
48751409|NCT05470387|102177400|FG001|STARTED|Overall Study||10||
48751410|NCT05470387|102177399|FG000|COMPLETED|Overall Study||13||
48751411|NCT05470387|102177400|FG001|COMPLETED|Overall Study||7||
48751412|NCT05470387|102177399|FG000|NOT COMPLETED|Overall Study||0||
48751413|NCT05470387|102177400|FG001|NOT COMPLETED|Overall Study||3||
48751414|NCT01893801|102177401|FG000|STARTED|Overall Study||25||
48751415|NCT01893801|102177401|FG000|COMPLETED|Overall Study||25||
48751416|NCT01893801|102177401|FG000|NOT COMPLETED|Overall Study||0||
48751417|NCT00687401|102177402|FG000|STARTED|Overall Study||159||
48751418|NCT00687401|102177402|FG000|COMPLETED|Overall Study||129||
48751419|NCT00687401|102177402|FG000|NOT COMPLETED|Overall Study||30||
48751420|NCT02922725|102177403|FG000|STARTED|Overall Study||12||
48751421|NCT02922725|102177404|FG001|STARTED|Overall Study||12||
48751422|NCT02922725|102177405|FG002|STARTED|Overall Study||8||
48751423|NCT02922725|102177403|FG000|COMPLETED|Overall Study||11||
48751424|NCT02922725|102177404|FG001|COMPLETED|Overall Study||12||
48751425|NCT02922725|102177405|FG002|COMPLETED|Overall Study||8||
48751426|NCT02922725|102177403|FG000|NOT COMPLETED|Overall Study||1||
48751427|NCT02922725|102177404|FG001|NOT COMPLETED|Overall Study||0||
48751428|NCT02922725|102177405|FG002|NOT COMPLETED|Overall Study||0||
48751429|NCT02785185|102177406|FG000|STARTED|Overall Study||60||
48751430|NCT02785185|102177407|FG001|STARTED|Overall Study||57||
48751431|NCT02785185|102177408|FG002|STARTED|Overall Study||17||
48411893|NCT01671605|101341861|FG000|STARTED|Overall Study||72||
48411894|NCT01671605|101341862|FG001|STARTED|Overall Study||31||
48411895|NCT01671605|101341861|FG000|COMPLETED|Overall Study||72||
48411896|NCT01671605|101341862|FG001|COMPLETED|Overall Study||31||
48411897|NCT01671605|101341861|FG000|NOT COMPLETED|Overall Study||0||
48411898|NCT01671605|101341862|FG001|NOT COMPLETED|Overall Study||0||
48751432|NCT02785185|102177409|FG003|STARTED|Overall Study||16||
48751433|NCT02785185|102177406|FG000|COMPLETED|Overall Study||59||
48751434|NCT02785185|102177407|FG001|COMPLETED|Overall Study||56||
48751435|NCT02785185|102177408|FG002|COMPLETED|Overall Study||15||
48751436|NCT02785185|102177409|FG003|COMPLETED|Overall Study||16||
48751437|NCT02785185|102177406|FG000|NOT COMPLETED|Overall Study||1||
48751438|NCT02785185|102177407|FG001|NOT COMPLETED|Overall Study||1||
48751439|NCT02785185|102177408|FG002|NOT COMPLETED|Overall Study||2||
48751440|NCT02785185|102177409|FG003|NOT COMPLETED|Overall Study||0||
48751441|NCT03683173|102177410|FG000|STARTED|Enrolled and Completed Baseline Survey||627||7
48751442|NCT03683173|102177411|FG001|STARTED|Enrolled and Completed Baseline Survey||614||7
48751443|NCT03683173|102177410|FG000|COMPLETED|Enrolled and Completed Baseline Survey||627||7
48751444|NCT03683173|102177411|FG001|COMPLETED|Enrolled and Completed Baseline Survey||614||7
48751445|NCT03683173|102177410|FG000|NOT COMPLETED|Enrolled and Completed Baseline Survey||0||0
48751446|NCT03683173|102177411|FG001|NOT COMPLETED|Enrolled and Completed Baseline Survey||0||0
48751447|NCT03683173|102177410|FG000|STARTED|Completed Follow-up||627||7
48751448|NCT03683173|102177411|FG001|STARTED|Completed Follow-up||614||7
48751449|NCT03683173|102177410|FG000|COMPLETED|Completed Follow-up||240||7
48751450|NCT03683173|102177411|FG001|COMPLETED|Completed Follow-up||238||7
48751451|NCT03683173|102177410|FG000|NOT COMPLETED|Completed Follow-up||387||0
48751452|NCT03683173|102177411|FG001|NOT COMPLETED|Completed Follow-up||376||0
48751453|NCT03790111|102180735|FG000|STARTED|Overall Study||53||
48751454|NCT03790111|102180735|FG000|COMPLETED|Overall Study||0||
48751455|NCT03790111|102180735|FG000|NOT COMPLETED|Overall Study||53||
48751456|NCT01216202|102180736|FG000|STARTED|Overall Study||101|Included in the study|
48751457|NCT01216202|102180737|FG001|STARTED|Overall Study||77|Included in the study|
48751458|NCT01216202|102180736|FG000|Analysed at Baseline|Overall Study||93||
48751459|NCT01216202|102180737|FG001|Analysed at Baseline|Overall Study||75||
48751460|NCT01216202|102180736|FG000|Analysed After RT|Overall Study||79||
48751461|NCT01216202|102180737|FG001|Analysed After RT|Overall Study||0||
48751462|NCT01216202|102180736|FG000|COMPLETED|Overall Study||79|Analysed at baseline|
48751463|NCT01216202|102180737|FG001|COMPLETED|Overall Study||75|Analysed at baseline|
48751464|NCT01216202|102180736|FG000|NOT COMPLETED|Overall Study||22||
48751465|NCT01216202|102180737|FG001|NOT COMPLETED|Overall Study||2||
48411899|NCT01017549|101341863|FG000|STARTED|Eligibility Through 6 Month Follow-up||44||
48411900|NCT01017549|101341863|FG000|COMPLETED|Eligibility Through 6 Month Follow-up||43||
48411901|NCT01017549|101341863|FG000|NOT COMPLETED|Eligibility Through 6 Month Follow-up||1||
48751466|NCT00248495|102180738|FG000|STARTED|Overall Study||38||
48751467|NCT00248495|102180738|FG000|COMPLETED|Overall Study||37||
48751468|NCT00248495|102180738|FG000|NOT COMPLETED|Overall Study||1||
48751469|NCT01419795|102180739|FG000|STARTED|Overall Study||3||
48751470|NCT01419795|102180740|FG001|STARTED|Overall Study||0||
48751471|NCT01419795|102180739|FG000|COMPLETED|Overall Study||3||
48751472|NCT01419795|102180740|FG001|COMPLETED|Overall Study||0||
48751473|NCT01419795|102180739|FG000|NOT COMPLETED|Overall Study||0||
48751474|NCT01419795|102180740|FG001|NOT COMPLETED|Overall Study||0||
48751475|NCT00564681|102180741|FG000|STARTED|Overall Study||117||
48411902|NCT01017549|101341863|FG000|STARTED|One-year Follow-up||43||
48411903|NCT01017549|101341863|FG000|COMPLETED|One-year Follow-up||36||
48751476|NCT00564681|102180742|FG001|STARTED|Overall Study||61||
48172187|NCT02023879|100742621|FG001|STARTED|Period 1: 24-Week Double-blind Treatment||116||
48172188|NCT02023879|100742622|FG002|STARTED|Period 1: 24-Week Double-blind Treatment||59||
48172189|NCT02023879|100742620|FG000|Treated|Period 1: 24-Week Double-blind Treatment||58||
48172190|NCT02023879|100742621|FG001|Treated|Period 1: 24-Week Double-blind Treatment||115||
48172191|NCT02023879|100742622|FG002|Treated|Period 1: 24-Week Double-blind Treatment||58||
48172192|NCT02023879|100742620|FG000|COMPLETED|Period 1: 24-Week Double-blind Treatment||54||
48172193|NCT02023879|100742621|FG001|COMPLETED|Period 1: 24-Week Double-blind Treatment||107||
48172194|NCT02023879|100742622|FG002|COMPLETED|Period 1: 24-Week Double-blind Treatment||50||
48172195|NCT02023879|100742620|FG000|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||4||
48172196|NCT02023879|100742621|FG001|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||9||
48172197|NCT02023879|100742622|FG002|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||9||
48188639|NCT05257837|100783295|FG001|COMPLETED|Overall Study||58||
48411904|NCT01017549|101341863|FG000|NOT COMPLETED|One-year Follow-up||7||
48411905|NCT01017549|101341863|FG000|STARTED|5 Year Follow-up||36||
48411906|NCT01017549|101341863|FG000|COMPLETED|5 Year Follow-up||24||
48411907|NCT01017549|101341863|FG000|NOT COMPLETED|5 Year Follow-up||12||
48411908|NCT01263470|101341864|FG000|STARTED|Overall Study||75||
48411909|NCT01263470|101341865|FG001|STARTED|Overall Study||79||
48411910|NCT01263470|101341866|FG002|STARTED|Overall Study||84||
48411911|NCT01263470|101341867|FG003|STARTED|Overall Study||80||
48411912|NCT01263470|101341868|FG004|STARTED|Overall Study||79||
48411913|NCT01263470|101341869|FG005|STARTED|Overall Study||83||
48411914|NCT01263470|101341864|FG000|COMPLETED|Overall Study||73||
48411915|NCT01263470|101341865|FG001|COMPLETED|Overall Study||74||
48411916|NCT01263470|101341866|FG002|COMPLETED|Overall Study||80||
48411917|NCT01263470|101341867|FG003|COMPLETED|Overall Study||77||
48411918|NCT01263470|101341868|FG004|COMPLETED|Overall Study||76||
48411919|NCT01263470|101341869|FG005|COMPLETED|Overall Study||78||
48411920|NCT01263470|101341864|FG000|NOT COMPLETED|Overall Study||2||
48411921|NCT01263470|101341865|FG001|NOT COMPLETED|Overall Study||5||
48411922|NCT01263470|101341866|FG002|NOT COMPLETED|Overall Study||4||
48411923|NCT01263470|101341867|FG003|NOT COMPLETED|Overall Study||3||
48411924|NCT01263470|101341868|FG004|NOT COMPLETED|Overall Study||3||
48411925|NCT01263470|101341869|FG005|NOT COMPLETED|Overall Study||5||
48411926|NCT03726749|101341870|FG000|STARTED|Overall Study||30||
48411927|NCT03726749|101341870|FG000|COMPLETED|Overall Study||30||
48411928|NCT03726749|101341870|FG000|NOT COMPLETED|Overall Study||0||
48411929|NCT04785144|101341871|FG000|STARTED|Overall Study||25||
48411930|NCT04785144|101341872|FG001|STARTED|Overall Study||23||
48411931|NCT04785144|101341873|FG002|STARTED|Overall Study||5||
48411932|NCT04785144|101341874|FG003|STARTED|Overall Study||6||
48411933|NCT04785144|101341875|FG004|STARTED|Overall Study||12||
48411934|NCT04785144|101341876|FG005|STARTED|Overall Study||13||
48411935|NCT04785144|101341877|FG006|STARTED|Overall Study||13||
48411936|NCT04785144|101341878|FG007|STARTED|Overall Study||12||
48411937|NCT04785144|101341879|FG008|STARTED|Overall Study||13||
48411938|NCT04785144|101341880|FG009|STARTED|Overall Study||13||
48411939|NCT04785144|101341871|FG000|COMPLETED|Overall Study||20||
48411940|NCT04785144|101341872|FG001|COMPLETED|Overall Study||22||
48411941|NCT04785144|101341873|FG002|COMPLETED|Overall Study||5||
48411942|NCT04785144|101341874|FG003|COMPLETED|Overall Study||6||
48411943|NCT04785144|101341875|FG004|COMPLETED|Overall Study||11||
48411944|NCT04785144|101341876|FG005|COMPLETED|Overall Study||9||
48411945|NCT04785144|101341877|FG006|COMPLETED|Overall Study||9||
48411946|NCT04785144|101341878|FG007|COMPLETED|Overall Study||10||
48411947|NCT04785144|101341879|FG008|COMPLETED|Overall Study||8||
48411948|NCT04785144|101341880|FG009|COMPLETED|Overall Study||10||
48411949|NCT04785144|101341871|FG000|NOT COMPLETED|Overall Study||5||
48411950|NCT04785144|101341872|FG001|NOT COMPLETED|Overall Study||1||
48411951|NCT04785144|101341873|FG002|NOT COMPLETED|Overall Study||0||
48411952|NCT04785144|101341874|FG003|NOT COMPLETED|Overall Study||0||
48411953|NCT04785144|101341875|FG004|NOT COMPLETED|Overall Study||1||
48411954|NCT04785144|101341876|FG005|NOT COMPLETED|Overall Study||4||
48411955|NCT04785144|101341877|FG006|NOT COMPLETED|Overall Study||4||
48411956|NCT04785144|101341878|FG007|NOT COMPLETED|Overall Study||2||
48411957|NCT04785144|101341879|FG008|NOT COMPLETED|Overall Study||5||
48411958|NCT04785144|101341880|FG009|NOT COMPLETED|Overall Study||3||
48411959|NCT04210232|101341881|FG000|STARTED|Overall Study||54||
48411960|NCT04210232|101341881|FG000|COMPLETED|Overall Study||54||
48411961|NCT04210232|101341881|FG000|NOT COMPLETED|Overall Study||0||
48411962|NCT01012037|101341882|FG000|STARTED|Overall Study||44||
48411963|NCT01012037|101341883|FG001|STARTED|Overall Study||223||
48411964|NCT01012037|101341884|FG002|STARTED|Overall Study||224||
48411965|NCT01012037|101341882|FG000|COMPLETED|Overall Study||43||
48411966|NCT01012037|101341883|FG001|COMPLETED|Overall Study||207||
48172198|NCT02023879|100742620|FG000|STARTED|Extension Open Label Treatment||51||
48172199|NCT02023879|100742621|FG001|STARTED|Extension Open Label Treatment||106||
48172200|NCT02023879|100742622|FG002|STARTED|Extension Open Label Treatment||48||
48172201|NCT02023879|100742620|FG000|COMPLETED|Extension Open Label Treatment||46||
48172202|NCT02023879|100742621|FG001|COMPLETED|Extension Open Label Treatment||89||
48172203|NCT02023879|100742622|FG002|COMPLETED|Extension Open Label Treatment||43||
48172204|NCT02023879|100742620|FG000|NOT COMPLETED|Extension Open Label Treatment||5||
48172205|NCT02023879|100742621|FG001|NOT COMPLETED|Extension Open Label Treatment||17||
48172206|NCT02023879|100742622|FG002|NOT COMPLETED|Extension Open Label Treatment||5||
48172207|NCT05197257|100742623|FG000|STARTED|Overall Study||39||
48172208|NCT05197257|100742623|FG000|COMPLETED|Overall Study||39||
48172209|NCT05197257|100742623|FG000|NOT COMPLETED|Overall Study||0||
48172210|NCT01380990|100742624|FG000|STARTED|Overall Study||20||
48172211|NCT01380990|100742625|FG001|STARTED|Overall Study||16||
48172212|NCT01380990|100742624|FG000|COMPLETED|Overall Study||19||
48172213|NCT01380990|100742625|FG001|COMPLETED|Overall Study||15||
48172214|NCT01380990|100742624|FG000|NOT COMPLETED|Overall Study||1||
48172215|NCT01380990|100742625|FG001|NOT COMPLETED|Overall Study||1||
48172216|NCT03758118|100742626|FG000|STARTED|Overall Study||20||
48172217|NCT03758118|100742627|FG001|STARTED|Overall Study||20||
48172218|NCT03758118|100742626|FG000|COMPLETED|Overall Study||19||
48172219|NCT03758118|100742627|FG001|COMPLETED|Overall Study||17||
48172220|NCT03758118|100742626|FG000|NOT COMPLETED|Overall Study||1||
48172221|NCT03758118|100742627|FG001|NOT COMPLETED|Overall Study||3||
48172222|NCT03384953|100742628|FG000|STARTED|Overall Study||91||
48172223|NCT03384953|100742629|FG001|STARTED|Overall Study||12||
48172224|NCT03384953|100742628|FG000|Completed Treatment|Overall Study||68||
48172225|NCT03384953|100742629|FG001|Completed Treatment|Overall Study||6||
48172226|NCT03384953|100742628|FG000|COMPLETED|Overall Study||51||
48172227|NCT03384953|100742629|FG001|COMPLETED|Overall Study||4||
48172228|NCT03384953|100742628|FG000|NOT COMPLETED|Overall Study||40||
48172229|NCT03384953|100742629|FG001|NOT COMPLETED|Overall Study||8||
48172230|NCT00130793|100742630|FG000|STARTED|Overall Study||183||
48172231|NCT00130793|100742631|FG001|STARTED|Overall Study||185||
48172232|NCT00130793|100742630|FG000|Vaccinated|Overall Study||182||
48172233|NCT00130793|100742631|FG001|Vaccinated|Overall Study||185||
48172234|NCT00130793|100742630|FG000|COMPLETED|Overall Study||180||
48172235|NCT00130793|100742631|FG001|COMPLETED|Overall Study||181||
48172236|NCT00130793|100742630|FG000|NOT COMPLETED|Overall Study||3||
48172237|NCT00130793|100742631|FG001|NOT COMPLETED|Overall Study||4||
48172238|NCT02444988|100742632|FG000|STARTED|Overall Study||2646||
48172239|NCT02444988|100742633|FG001|STARTED|Overall Study||2735||
48172240|NCT02444988|100742632|FG000|COMPLETED|Overall Study||2646||
48172241|NCT02444988|100742633|FG001|COMPLETED|Overall Study||2735||
48172242|NCT02444988|100742632|FG000|NOT COMPLETED|Overall Study||0||
48172243|NCT02444988|100742633|FG001|NOT COMPLETED|Overall Study||0||
48172244|NCT00525603|100742634|FG000|STARTED|Overall Study||60||
48172245|NCT00525603|100742634|FG000|COMPLETED|Overall Study||60||
48172246|NCT00525603|100742634|FG000|NOT COMPLETED|Overall Study||0||
48172247|NCT00459303|100742635|FG000|STARTED|Overall Study||20||
48172248|NCT00459303|100742635|FG000|COMPLETED|Overall Study||20||
48172249|NCT00459303|100742635|FG000|NOT COMPLETED|Overall Study||0||
48172250|NCT00936221|100742636|FG000|STARTED|Overall Study||45||
48172251|NCT00936221|100742637|FG001|STARTED|Overall Study||46||
48172252|NCT00936221|100742636|FG000|Received Treatment|Overall Study||44||
48411967|NCT01012037|101341884|FG002|COMPLETED|Overall Study||214||
48411968|NCT01012037|101341882|FG000|NOT COMPLETED|Overall Study||1||
48411969|NCT01012037|101341883|FG001|NOT COMPLETED|Overall Study||16||
48411970|NCT01012037|101341884|FG002|NOT COMPLETED|Overall Study||10||
48628269|NCT01548404|101874351|FG001|STARTED|Overall Study||55||
48172253|NCT00936221|100742637|FG001|Received Treatment|Overall Study||45||
48172254|NCT00936221|100742636|FG000|COMPLETED|Overall Study||44||
48172255|NCT00936221|100742637|FG001|COMPLETED|Overall Study||45||
48172256|NCT00936221|100742636|FG000|NOT COMPLETED|Overall Study||1||
48172257|NCT00936221|100742637|FG001|NOT COMPLETED|Overall Study||1||
48172258|NCT03856996|100742638|FG000|STARTED|Overall Study||15||
48172259|NCT03856996|100742639|FG001|STARTED|Overall Study||15||
48172260|NCT03856996|100742638|FG000|COMPLETED|Overall Study||12||
48172261|NCT03856996|100742639|FG001|COMPLETED|Overall Study||13||
48411971|NCT02045979|101341885|FG000|STARTED|Overall Study||108||
48172262|NCT03856996|100742638|FG000|NOT COMPLETED|Overall Study||3||
48172263|NCT03856996|100742639|FG001|NOT COMPLETED|Overall Study||2||
48172264|NCT01590771|100742640|FG000|STARTED|Overall Study||249||
48172265|NCT01590771|100742641|FG001|STARTED|Overall Study||249||
48172266|NCT01590771|100742640|FG000|COMPLETED|Overall Study||230||
48172267|NCT01590771|100742641|FG001|COMPLETED|Overall Study||210||
48172268|NCT01590771|100742640|FG000|NOT COMPLETED|Overall Study||19||
48411972|NCT02045979|101341886|FG001|STARTED|Overall Study||108||
48628270|NCT01548404|101874350|FG000|COMPLETED|Overall Study||24||
48172269|NCT01590771|100742641|FG001|NOT COMPLETED|Overall Study||39||
48172270|NCT00572624|100742642|FG000|STARTED|Overall Study||37||
48172271|NCT00572624|100742643|FG001|STARTED|Overall Study||14||
48172272|NCT00572624|100742642|FG000|COMPLETED|Overall Study||20||
48172273|NCT00572624|100742643|FG001|COMPLETED|Overall Study||10||
48172274|NCT00572624|100742642|FG000|NOT COMPLETED|Overall Study||17||
48172275|NCT00572624|100742643|FG001|NOT COMPLETED|Overall Study||4||
48172276|NCT00636792|100742644|FG000|STARTED|Overall Study||73||
48172277|NCT00636792|100742644|FG000|COMPLETED|Overall Study||40||
48172278|NCT00636792|100742644|FG000|NOT COMPLETED|Overall Study||33||
48172279|NCT04764929|100742645|FG000|STARTED|Overall Study||5||
48172280|NCT04764929|100742645|FG000|COMPLETED|Overall Study||5||
48172281|NCT04764929|100742645|FG000|NOT COMPLETED|Overall Study||0||
48172282|NCT04161807|100742646|FG000|STARTED|Overall Study||42||
48172283|NCT04161807|100742646|FG000|COMPLETED|Overall Study||38||
48172284|NCT04161807|100742646|FG000|NOT COMPLETED|Overall Study||4||
48172285|NCT01805882|100742647|FG000|STARTED|Overall Study||20||
48172286|NCT01805882|100742648|FG001|STARTED|Overall Study||20||
48172287|NCT01805882|100742649|FG002|STARTED|Overall Study||20||
48172288|NCT01805882|100742650|FG003|STARTED|Overall Study||34||
48172289|NCT01805882|100742651|FG004|STARTED|Overall Study||14||
48172290|NCT01805882|100742652|FG005|STARTED|Overall Study||21||
48172291|NCT01805882|100742653|FG006|STARTED|Overall Study||50||
48172292|NCT01805882|100742654|FG007|STARTED|Overall Study||25||
48172293|NCT01805882|100742655|FG008|STARTED|Overall Study||25||
48172294|NCT01805882|100742647|FG000|COMPLETED|Overall Study||20||
48172295|NCT01805882|100742648|FG001|COMPLETED|Overall Study||20||
48172296|NCT01805882|100742649|FG002|COMPLETED|Overall Study||19||
48172297|NCT01805882|100742650|FG003|COMPLETED|Overall Study||32||
48172298|NCT01805882|100742651|FG004|COMPLETED|Overall Study||14||
48172299|NCT01805882|100742652|FG005|COMPLETED|Overall Study||20||
48172300|NCT01805882|100742653|FG006|COMPLETED|Overall Study||48||
48172301|NCT01805882|100742654|FG007|COMPLETED|Overall Study||25||
48172302|NCT01805882|100742655|FG008|COMPLETED|Overall Study||24||
48172303|NCT01805882|100742647|FG000|NOT COMPLETED|Overall Study||0||
48172304|NCT01805882|100742648|FG001|NOT COMPLETED|Overall Study||0||
48172305|NCT01805882|100742649|FG002|NOT COMPLETED|Overall Study||1||
48172306|NCT01805882|100742650|FG003|NOT COMPLETED|Overall Study||2||
48172307|NCT01805882|100742651|FG004|NOT COMPLETED|Overall Study||0||
48172308|NCT01805882|100742652|FG005|NOT COMPLETED|Overall Study||1||
48172309|NCT01805882|100742653|FG006|NOT COMPLETED|Overall Study||2||
48172310|NCT01805882|100742654|FG007|NOT COMPLETED|Overall Study||0||
48172311|NCT01805882|100742655|FG008|NOT COMPLETED|Overall Study||1||
48628271|NCT01548404|101874351|FG001|COMPLETED|Overall Study||41||
48628272|NCT01548404|101874350|FG000|NOT COMPLETED|Overall Study||30||
48628273|NCT01548404|101874351|FG001|NOT COMPLETED|Overall Study||14||
48628274|NCT03054428|101874352|FG000|STARTED|Overall Study||85||
48628275|NCT03054428|101874353|FG001|STARTED|Overall Study||84||
48628276|NCT03054428|101874354|FG002|STARTED|Overall Study||82||
48628277|NCT03054428|101874352|FG000|Completed Wk 16 End of Treatment (EOT)|Overall Study||80||
48628278|NCT03054428|101874353|FG001|Completed Wk 16 End of Treatment (EOT)|Overall Study||81||
48628279|NCT03054428|101874354|FG002|Completed Wk 16 End of Treatment (EOT)|Overall Study||79||
48628280|NCT03054428|101874352|FG000|Completed Week 28 (End of Study)|Overall Study||2||
48628281|NCT03054428|101874353|FG001|Completed Week 28 (End of Study)|Overall Study||4||
48628282|NCT03054428|101874354|FG002|Completed Week 28 (End of Study)|Overall Study||3||
48628283|NCT03054428|101874352|FG000|COMPLETED|Overall Study||2||
48628284|NCT03054428|101874353|FG001|COMPLETED|Overall Study||4||
48172312|NCT02452866|100742656|FG000|STARTED|Overall Study||325||
48172313|NCT02452866|100742656|FG000|COMPLETED|Overall Study||321||
48172314|NCT02452866|100742656|FG000|NOT COMPLETED|Overall Study||4||
48172315|NCT02359019|100742657|FG000|STARTED|Overall Study||45||
48172316|NCT02359019|100742657|FG000|COMPLETED|Overall Study||45||
48628285|NCT03054428|101874354|FG002|COMPLETED|Overall Study||3||
48628286|NCT03054428|101874352|FG000|NOT COMPLETED|Overall Study||83||
48628287|NCT03054428|101874353|FG001|NOT COMPLETED|Overall Study||80||
48628288|NCT03054428|101874354|FG002|NOT COMPLETED|Overall Study||79||
48172317|NCT02359019|100742657|FG000|NOT COMPLETED|Overall Study||0||
48172318|NCT02224482|100742658|FG000|STARTED|Overall Study||214||
48172319|NCT02224482|100742659|FG001|STARTED|Overall Study||217||
48172320|NCT02224482|100742658|FG000|COMPLETED|Overall Study||63||
48172321|NCT02224482|100742659|FG001|COMPLETED|Overall Study||57||
48172322|NCT02224482|100742658|FG000|NOT COMPLETED|Overall Study||151||
48172323|NCT02224482|100742659|FG001|NOT COMPLETED|Overall Study||160||
48172324|NCT00258440|100746157|FG000|STARTED|Overall Study||1||
48172325|NCT00258440|100746158|FG001|STARTED|Overall Study||0||
48172326|NCT00258440|100746159|FG002|STARTED|Overall Study||6||
48172327|NCT00258440|100746157|FG000|COMPLETED|Overall Study||1||
48172328|NCT00258440|100746158|FG001|COMPLETED|Overall Study||0||
48172329|NCT00258440|100746159|FG002|COMPLETED|Overall Study||5||
48172330|NCT00258440|100746157|FG000|NOT COMPLETED|Overall Study||0||
48172331|NCT00258440|100746158|FG001|NOT COMPLETED|Overall Study||0||
48172332|NCT00258440|100746159|FG002|NOT COMPLETED|Overall Study||1||
48172333|NCT00996580|100746160|FG000|STARTED|Overall Study||3597||
48628289|NCT00381628|101874355|FG000|STARTED|Overall Study||18||
48172334|NCT00996580|100746160|FG000|Pregnancy Intent-to-Treat Population|Overall Study||3019||
48172335|NCT00996580|100746160|FG000|COMPLETED|Overall Study||2144||
48172336|NCT00996580|100746160|FG000|NOT COMPLETED|Overall Study||1453||
48628290|NCT00381628|101874356|FG001|STARTED|Overall Study||27||
48628291|NCT00381628|101874357|FG002|STARTED|Overall Study||0||
48628292|NCT00381628|101874358|FG003|STARTED|Overall Study||14||
48628293|NCT00381628|101874355|FG000|COMPLETED|Overall Study||18||
48628294|NCT00381628|101874356|FG001|COMPLETED|Overall Study||27||
48628295|NCT00381628|101874357|FG002|COMPLETED|Overall Study||0||
48628296|NCT00381628|101874358|FG003|COMPLETED|Overall Study||14||
48628297|NCT00381628|101874355|FG000|NOT COMPLETED|Overall Study||0||
48628298|NCT00381628|101874356|FG001|NOT COMPLETED|Overall Study||0||
48628299|NCT00381628|101874357|FG002|NOT COMPLETED|Overall Study||0||
48628300|NCT00381628|101874358|FG003|NOT COMPLETED|Overall Study||0||
48628301|NCT02524119|101874359|FG000|STARTED|Overall Study||5||
48628302|NCT02524119|101874359|FG000|COMPLETED|Overall Study||5||
48628303|NCT02524119|101874359|FG000|NOT COMPLETED|Overall Study||0||
48628304|NCT00427934|101874360|FG000|STARTED|Overall Study||8||
48628305|NCT00427934|101874361|FG001|STARTED|Overall Study||8||
48628306|NCT00427934|101874362|FG002|STARTED|Overall Study||78||
48628307|NCT00427934|101874363|FG003|STARTED|Overall Study||34||
48628308|NCT00427934|101874360|FG000|Treated|Overall Study||8||
48628309|NCT00427934|101874361|FG001|Treated|Overall Study||8||
48628310|NCT00427934|101874362|FG002|Treated|Overall Study||77||
48628311|NCT00427934|101874363|FG003|Treated|Overall Study||33||
48628312|NCT00427934|101874360|FG000|COMPLETED|Overall Study||7||
48628313|NCT00427934|101874361|FG001|COMPLETED|Overall Study||8||
48172337|NCT01923428|100746161|FG000|STARTED|Overall Study||88||
48172338|NCT01923428|100746162|FG001|STARTED|Overall Study||89||
48172339|NCT01923428|100746163|FG002|STARTED|Overall Study||89||
48172340|NCT01923428|100746164|FG003|STARTED|Overall Study||90||
48172341|NCT01923428|100746161|FG000|COMPLETED|Overall Study||69||
48172342|NCT01923428|100746162|FG001|COMPLETED|Overall Study||77||
48172343|NCT01923428|100746163|FG002|COMPLETED|Overall Study||78||
48172344|NCT01923428|100746164|FG003|COMPLETED|Overall Study||80||
48172345|NCT01923428|100746161|FG000|NOT COMPLETED|Overall Study||19||
48172346|NCT01923428|100746162|FG001|NOT COMPLETED|Overall Study||12||
48172347|NCT01923428|100746163|FG002|NOT COMPLETED|Overall Study||11||
48172348|NCT01923428|100746164|FG003|NOT COMPLETED|Overall Study||10||
48172349|NCT01170884|100746165|FG000|STARTED|Overall Study||59||
48172350|NCT01170884|100746166|FG001|STARTED|Overall Study||62||
48172351|NCT01170884|100746165|FG000|COMPLETED|Overall Study||54||
48172352|NCT01170884|100746166|FG001|COMPLETED|Overall Study||60||
48172353|NCT01170884|100746165|FG000|NOT COMPLETED|Overall Study||5||
48172354|NCT01170884|100746166|FG001|NOT COMPLETED|Overall Study||2||
48172355|NCT04789577|100746167|FG000|STARTED|Overall Study||121||
48172356|NCT04789577|100746168|FG001|STARTED|Overall Study||116||
48172357|NCT04789577|100746169|FG002|STARTED|Overall Study||119||
48172358|NCT04789577|100746170|FG003|STARTED|Overall Study||119||
48172359|NCT04789577|100746171|FG004|STARTED|Overall Study||117||
48172360|NCT04789577|100746172|FG005|STARTED|Overall Study||121||
48172361|NCT04789577|100746173|FG006|STARTED|Overall Study||120||
48172362|NCT04789577|100746167|FG000|COMPLETED|Overall Study||113||
48172363|NCT04789577|100746168|FG001|COMPLETED|Overall Study||103||
48172364|NCT04789577|100746169|FG002|COMPLETED|Overall Study||111||
48172365|NCT04789577|100746170|FG003|COMPLETED|Overall Study||105||
48172366|NCT04789577|100746171|FG004|COMPLETED|Overall Study||108||
48172367|NCT04789577|100746172|FG005|COMPLETED|Overall Study||107||
48172368|NCT04789577|100746173|FG006|COMPLETED|Overall Study||109||
48172369|NCT04789577|100746167|FG000|NOT COMPLETED|Overall Study||8||
48172370|NCT04789577|100746168|FG001|NOT COMPLETED|Overall Study||13||
48628314|NCT00427934|101874362|FG002|COMPLETED|Overall Study||55||
48628315|NCT00427934|101874363|FG003|COMPLETED|Overall Study||19||
48628316|NCT00427934|101874360|FG000|NOT COMPLETED|Overall Study||1||
48628317|NCT00427934|101874361|FG001|NOT COMPLETED|Overall Study||0||
48628318|NCT00427934|101874362|FG002|NOT COMPLETED|Overall Study||23||
48172371|NCT04789577|100746169|FG002|NOT COMPLETED|Overall Study||8||
48172372|NCT04789577|100746170|FG003|NOT COMPLETED|Overall Study||14||
48172373|NCT04789577|100746171|FG004|NOT COMPLETED|Overall Study||9||
48172374|NCT04789577|100746172|FG005|NOT COMPLETED|Overall Study||14||
48172375|NCT04789577|100746173|FG006|NOT COMPLETED|Overall Study||11||
48172376|NCT01500746|100746174|FG000|STARTED|Overall Study||4||
48172377|NCT01500746|100746175|FG001|STARTED|Overall Study||4||
48172378|NCT01500746|100746174|FG000|COMPLETED|Overall Study||4||
48172379|NCT01500746|100746175|FG001|COMPLETED|Overall Study||4||
48172380|NCT01500746|100746174|FG000|NOT COMPLETED|Overall Study||0||
48172381|NCT01500746|100746175|FG001|NOT COMPLETED|Overall Study||0||
48172382|NCT01719900|100746176|FG000|STARTED|Overall Study||29||
48172383|NCT01719900|100746177|FG001|STARTED|Overall Study||24||
48172384|NCT01719900|100746176|FG000|COMPLETED|Overall Study||22||
48628319|NCT00427934|101874363|FG003|NOT COMPLETED|Overall Study||15||
48628320|NCT00217490|101874364|FG000|STARTED|Overall Study||154||
48628321|NCT00217490|101874365|FG001|STARTED|Overall Study||153||
48628322|NCT00217490|101874366|FG002|STARTED|Overall Study||155||
48628323|NCT00217490|101874367|FG003|STARTED|Overall Study||153||
48628324|NCT00217490|101874364|FG000|COMPLETED|Overall Study||137||
48628325|NCT00217490|101874365|FG001|COMPLETED|Overall Study||128||
48172385|NCT01719900|100746177|FG001|COMPLETED|Overall Study||22||
48172386|NCT01719900|100746176|FG000|NOT COMPLETED|Overall Study||7||
48172387|NCT01719900|100746177|FG001|NOT COMPLETED|Overall Study||2||
48172388|NCT01763788|100746178|FG000|STARTED|Overall Study||3||
48172389|NCT01763788|100746179|FG001|STARTED|Overall Study||6||
48172390|NCT01763788|100746180|FG002|STARTED|Overall Study||91||
48172391|NCT01763788|100746181|FG003|STARTED|Overall Study||92||
48172392|NCT01763788|100746178|FG000|Received at Least 1dose of Study Drug|Overall Study||3||
48172393|NCT01763788|100746179|FG001|Received at Least 1dose of Study Drug|Overall Study||6||
48172394|NCT01763788|100746180|FG002|Received at Least 1dose of Study Drug|Overall Study||90||
48411973|NCT02045979|101341887|FG002|STARTED|Overall Study||108||
48411974|NCT02045979|101341885|FG000|COMPLETED|Overall Study||106||
48411975|NCT02045979|101341886|FG001|COMPLETED|Overall Study||107||
48411976|NCT02045979|101341887|FG002|COMPLETED|Overall Study||107||
48411977|NCT02045979|101341885|FG000|NOT COMPLETED|Overall Study||2||
48172395|NCT01763788|100746181|FG003|Received at Least 1dose of Study Drug|Overall Study||91||
48172396|NCT01763788|100746178|FG000|COMPLETED|Overall Study||3||
48172397|NCT01763788|100746179|FG001|COMPLETED|Overall Study||6||
48172398|NCT01763788|100746180|FG002|COMPLETED|Overall Study||90||
48172399|NCT01763788|100746181|FG003|COMPLETED|Overall Study||92||
48172400|NCT01763788|100746178|FG000|NOT COMPLETED|Overall Study||0||
48172401|NCT01763788|100746179|FG001|NOT COMPLETED|Overall Study||0||
48172402|NCT01763788|100746180|FG002|NOT COMPLETED|Overall Study||1||
48172403|NCT01763788|100746181|FG003|NOT COMPLETED|Overall Study||0||
48172404|NCT00183456|100746182|FG000|STARTED|Overall Study||85||
48172405|NCT00183456|100746183|FG001|STARTED|Overall Study||84||
48172406|NCT00183456|100746184|FG002|STARTED|Overall Study||329||
48172407|NCT00183456|100746185|FG003|STARTED|Overall Study||248||
48172408|NCT00183456|100746182|FG000|6 Month Follow-up|Overall Study||74||
48172409|NCT00183456|100746183|FG001|6 Month Follow-up|Overall Study||77||
48172410|NCT00183456|100746184|FG002|6 Month Follow-up|Overall Study||278||
48172411|NCT00183456|100746185|FG003|6 Month Follow-up|Overall Study||175||
48172412|NCT00183456|100746182|FG000|12 Month Follow-up|Overall Study||76||
48172413|NCT00183456|100746183|FG001|12 Month Follow-up|Overall Study||74||
48172414|NCT00183456|100746184|FG002|12 Month Follow-up|Overall Study||267||
48172415|NCT00183456|100746185|FG003|12 Month Follow-up|Overall Study||186||
48628326|NCT00217490|101874366|FG002|COMPLETED|Overall Study||131||
48628327|NCT00217490|101874367|FG003|COMPLETED|Overall Study||130||
48628328|NCT00217490|101874364|FG000|NOT COMPLETED|Overall Study||17||
48628329|NCT00217490|101874365|FG001|NOT COMPLETED|Overall Study||25||
48628330|NCT00217490|101874366|FG002|NOT COMPLETED|Overall Study||24||
48628331|NCT00217490|101874367|FG003|NOT COMPLETED|Overall Study||23||
48628332|NCT03642990|101874368|FG000|STARTED|300 mg/Day for One Week||5||
48628333|NCT03642990|101874368|FG000|COMPLETED|300 mg/Day for One Week||4||
48628334|NCT03642990|101874368|FG000|NOT COMPLETED|300 mg/Day for One Week||1||
48628335|NCT03642990|101874368|FG000|STARTED|1000 mg/Day for Weeks 2-12||4||
48628336|NCT03642990|101874368|FG000|COMPLETED|1000 mg/Day for Weeks 2-12||0||
48628337|NCT03642990|101874368|FG000|NOT COMPLETED|1000 mg/Day for Weeks 2-12||4||
48628338|NCT01294423|101874369|FG000|STARTED|Overall Study||86||
48628339|NCT01294423|101874370|FG001|STARTED|Overall Study||88||
48628340|NCT01294423|101874371|FG002|STARTED|Overall Study||87||
48628341|NCT01294423|101874369|FG000|COMPLETED|Overall Study||81||
48628342|NCT01294423|101874370|FG001|COMPLETED|Overall Study||79||
48628343|NCT01294423|101874371|FG002|COMPLETED|Overall Study||79||
48628344|NCT01294423|101874369|FG000|NOT COMPLETED|Overall Study||5||
48628345|NCT01294423|101874370|FG001|NOT COMPLETED|Overall Study||9||
48628346|NCT01294423|101874371|FG002|NOT COMPLETED|Overall Study||8||
48628347|NCT01604785|101874372|FG000|STARTED|Overall Study||37||
48628348|NCT01604785|101874373|FG001|STARTED|Overall Study||37||
48628349|NCT01604785|101874372|FG000|COMPLETED|Overall Study||30||
48628350|NCT01604785|101874373|FG001|COMPLETED|Overall Study||36||
48628351|NCT01604785|101874372|FG000|NOT COMPLETED|Overall Study||7||
48628352|NCT01604785|101874373|FG001|NOT COMPLETED|Overall Study||1||
48628353|NCT00563290|101874374|FG000|STARTED|Overall Study||3||
48172416|NCT00183456|100746182|FG000|18 Month Follow-up|Overall Study||80||
48172417|NCT00183456|100746183|FG001|18 Month Follow-up|Overall Study||81||
48172418|NCT00183456|100746184|FG002|18 Month Follow-up|Overall Study||303||
48172419|NCT00183456|100746185|FG003|18 Month Follow-up|Overall Study||207||
48172420|NCT00183456|100746182|FG000|COMPLETED|Overall Study||82||
48172421|NCT00183456|100746183|FG001|COMPLETED|Overall Study||83||
48172422|NCT00183456|100746184|FG002|COMPLETED|Overall Study||313||
48172423|NCT00183456|100746185|FG003|COMPLETED|Overall Study||220||
48172424|NCT00183456|100746182|FG000|NOT COMPLETED|Overall Study||3||
48172425|NCT00183456|100746183|FG001|NOT COMPLETED|Overall Study||1||
48172426|NCT00183456|100746184|FG002|NOT COMPLETED|Overall Study||16||
48172427|NCT00183456|100746185|FG003|NOT COMPLETED|Overall Study||28||
48334391|NCT00763321|101145717|FG001|STARTED|Double-blind Period||109||
48628354|NCT00563290|101874375|FG001|STARTED|Overall Study||4||
48172428|NCT03714022|100746186|FG000|STARTED|Overall Study||70||
48172429|NCT03714022|100746187|FG001|STARTED|Overall Study||70||
48411978|NCT02045979|101341886|FG001|NOT COMPLETED|Overall Study||1||
48411979|NCT02045979|101341887|FG002|NOT COMPLETED|Overall Study||1||
48628355|NCT00563290|101874374|FG000|COMPLETED|Overall Study||3||
48628356|NCT00563290|101874375|FG001|COMPLETED|Overall Study||4||
48628357|NCT00563290|101874374|FG000|NOT COMPLETED|Overall Study||0||
48751477|NCT00564681|102180743|FG002|STARTED|Overall Study||43||
48751478|NCT00564681|102180744|FG003|STARTED|Overall Study||21||
48751479|NCT00564681|102180741|FG000|COMPLETED|Overall Study||106||
48751480|NCT00564681|102180742|FG001|COMPLETED|Overall Study||58||
48751481|NCT00564681|102180743|FG002|COMPLETED|Overall Study||40||
48751482|NCT00564681|102180744|FG003|COMPLETED|Overall Study||19||
48751483|NCT00564681|102180741|FG000|NOT COMPLETED|Overall Study||11||
48172430|NCT03714022|100746186|FG000|COMPLETED|Overall Study||66||
48172431|NCT03714022|100746187|FG001|COMPLETED|Overall Study||67||
48172432|NCT03714022|100746186|FG000|NOT COMPLETED|Overall Study||4||
48172433|NCT03714022|100746187|FG001|NOT COMPLETED|Overall Study||3||
48172434|NCT00594906|100746188|FG000|STARTED|Overall Study||7||
48172435|NCT00594906|100746189|FG001|STARTED|Overall Study||3||
48172436|NCT00594906|100746188|FG000|COMPLETED|Overall Study||6||
48628358|NCT00563290|101874375|FG001|NOT COMPLETED|Overall Study||0||
48628359|NCT00192114|101874376|FG000|STARTED|Overall Study||28||
48628360|NCT00192114|101874376|FG000|Received at Least 1 Dose of Study Drug|Overall Study||28||
48628361|NCT00192114|101874376|FG000|COMPLETED|Overall Study||4||
48628362|NCT00192114|101874376|FG000|NOT COMPLETED|Overall Study||24||
48628363|NCT03613493|101874377|FG000|STARTED|Overall Study||10||
48628364|NCT03613493|101874378|FG001|STARTED|Overall Study||75||
48172437|NCT00594906|100746189|FG001|COMPLETED|Overall Study||1||
48172438|NCT00594906|100746188|FG000|NOT COMPLETED|Overall Study||1||
48172439|NCT00594906|100746189|FG001|NOT COMPLETED|Overall Study||2||
48172440|NCT02368002|100746190|FG000|STARTED|Stage 1 Intervention (Up to 20 Weeks)||233||
48172441|NCT02368002|100746191|FG001|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0||
48172442|NCT02368002|100746192|FG002|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0||
48172443|NCT02368002|100746193|FG003|STARTED|Stage 1 Intervention (Up to 20 Weeks)||235||
48172444|NCT02368002|100746194|FG004|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0||
48172445|NCT02368002|100746195|FG005|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0||
48172446|NCT02368002|100746190|FG000|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||228||
48172447|NCT02368002|100746191|FG001|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0||
48172448|NCT02368002|100746192|FG002|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0||
48172449|NCT02368002|100746193|FG003|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||214||
48172450|NCT02368002|100746194|FG004|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0||
48172451|NCT02368002|100746195|FG005|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0||
48172452|NCT02368002|100746190|FG000|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||5||
48172453|NCT02368002|100746191|FG001|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0||
48172454|NCT02368002|100746192|FG002|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0||
48172455|NCT02368002|100746193|FG003|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||21||
48172456|NCT02368002|100746194|FG004|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0||
48172457|NCT02368002|100746195|FG005|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0||
48172458|NCT02368002|100746190|FG000|STARTED|Stage 2 Intervention (Up to 17 Weeks)||88||
48172459|NCT02368002|100746191|FG001|STARTED|Stage 2 Intervention (Up to 17 Weeks)||70||
48172460|NCT02368002|100746192|FG002|STARTED|Stage 2 Intervention (Up to 17 Weeks)||70||
48172461|NCT02368002|100746193|FG003|STARTED|Stage 2 Intervention (Up to 17 Weeks)||0||
48172462|NCT02368002|100746194|FG004|STARTED|Stage 2 Intervention (Up to 17 Weeks)||0||
48172463|NCT02368002|100746195|FG005|STARTED|Stage 2 Intervention (Up to 17 Weeks)||0||
48172464|NCT02368002|100746190|FG000|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||86||
48172465|NCT02368002|100746191|FG001|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||60||
48172466|NCT02368002|100746192|FG002|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||64||
48172467|NCT02368002|100746193|FG003|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0||
48172468|NCT02368002|100746194|FG004|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0||
48172469|NCT02368002|100746195|FG005|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0||
48172470|NCT02368002|100746190|FG000|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||2||
48172471|NCT02368002|100746191|FG001|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||10||
48628365|NCT03613493|101874379|FG002|STARTED|Overall Study||0||
48628366|NCT03613493|101874380|FG003|STARTED|Overall Study||90||
48628367|NCT03613493|101874377|FG000|Enrollment Criteria Met|Overall Study||10||
48628368|NCT03613493|101874378|FG001|Enrollment Criteria Met|Overall Study||74||
48751484|NCT00564681|102180742|FG001|NOT COMPLETED|Overall Study||3||
48751485|NCT00564681|102180743|FG002|NOT COMPLETED|Overall Study||3||
48751486|NCT00564681|102180744|FG003|NOT COMPLETED|Overall Study||2||
48751487|NCT03271424|102180745|FG000|STARTED|November 2015||20||
48172472|NCT02368002|100746192|FG002|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||6||
48172473|NCT02368002|100746193|FG003|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0||
48172474|NCT02368002|100746194|FG004|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0||
48172475|NCT02368002|100746195|FG005|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0||
48172476|NCT02368002|100746190|FG000|STARTED|Stage 2 Intervention (Up to 13 Weeks)||0||
48172477|NCT02368002|100746191|FG001|STARTED|Stage 2 Intervention (Up to 13 Weeks)||0||
48172478|NCT02368002|100746192|FG002|STARTED|Stage 2 Intervention (Up to 13 Weeks)||0||
48751488|NCT03271424|102180746|FG001|STARTED|November 2015||0||
48628369|NCT03613493|101874379|FG002|Enrollment Criteria Met|Overall Study||0||
48628370|NCT03613493|101874380|FG003|Enrollment Criteria Met|Overall Study||89||
48628371|NCT03613493|101874377|FG000|COMPLETED|Overall Study||10||
48411980|NCT01215786|101341888|FG000|STARTED|Overall Study||21||
48172479|NCT02368002|100746193|FG003|STARTED|Stage 2 Intervention (Up to 13 Weeks)||95||
48172480|NCT02368002|100746194|FG004|STARTED|Stage 2 Intervention (Up to 13 Weeks)||57||
48172481|NCT02368002|100746195|FG005|STARTED|Stage 2 Intervention (Up to 13 Weeks)||62||
48172482|NCT02368002|100746190|FG000|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0||
48172483|NCT02368002|100746191|FG001|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0||
48172484|NCT02368002|100746192|FG002|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0||
48172485|NCT02368002|100746193|FG003|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||94||
48172486|NCT02368002|100746194|FG004|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||53||
48172487|NCT02368002|100746195|FG005|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||59||
48172488|NCT02368002|100746190|FG000|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0||
48172489|NCT02368002|100746191|FG001|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0||
48172490|NCT02368002|100746192|FG002|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0||
48172491|NCT02368002|100746193|FG003|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||1||
48172492|NCT02368002|100746194|FG004|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||4||
48172493|NCT02368002|100746195|FG005|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||3||
48172494|NCT01563978|100746196|FG000|STARTED|Overall Study||68||
48172495|NCT01563978|100746197|FG001|STARTED|Overall Study||67||
48172496|NCT01563978|100746196|FG000|Randomised But Did Not Receive Treatment|Overall Study||0||
48172497|NCT01563978|100746197|FG001|Randomised But Did Not Receive Treatment|Overall Study||0||
48751489|NCT03271424|102180747|FG002|STARTED|November 2015||0||
48751490|NCT03271424|102180745|FG000|COMPLETED|November 2015||20||
48751491|NCT03271424|102180746|FG001|COMPLETED|November 2015||0||
48172498|NCT01563978|100746196|FG000|COMPLETED|Overall Study||64||
48172499|NCT01563978|100746197|FG001|COMPLETED|Overall Study||65||
48172500|NCT01563978|100746196|FG000|NOT COMPLETED|Overall Study||4||
48172501|NCT01563978|100746197|FG001|NOT COMPLETED|Overall Study||2||
48172502|NCT03151395|100746198|FG000|STARTED|Overall Study||197||
48172503|NCT03151395|100746198|FG000|COMPLETED|Overall Study||182||
48334392|NCT00763321|101145718|FG002|STARTED|Double-blind Period||113||
48334393|NCT00763321|101145716|FG000|COMPLETED|Double-blind Period||0||
48334394|NCT00763321|101145717|FG001|COMPLETED|Double-blind Period||88||
48334395|NCT00763321|101145718|FG002|COMPLETED|Double-blind Period||84||
48411981|NCT01215786|101341889|FG001|STARTED|Overall Study||19||
48411982|NCT01215786|101341890|FG002|STARTED|Overall Study||10||
48411983|NCT01215786|101341888|FG000|COMPLETED|Overall Study||21||
48411984|NCT01215786|101341889|FG001|COMPLETED|Overall Study||19||
48411985|NCT01215786|101341890|FG002|COMPLETED|Overall Study||10||
48411986|NCT01215786|101341888|FG000|NOT COMPLETED|Overall Study||0||
48411987|NCT01215786|101341889|FG001|NOT COMPLETED|Overall Study||0||
48411988|NCT01215786|101341890|FG002|NOT COMPLETED|Overall Study||0||
48751492|NCT03271424|102180747|FG002|COMPLETED|November 2015||0||
48751493|NCT03271424|102180745|FG000|NOT COMPLETED|November 2015||0||
48751494|NCT03271424|102180746|FG001|NOT COMPLETED|November 2015||0||
48751495|NCT03271424|102180747|FG002|NOT COMPLETED|November 2015||0||
48172504|NCT03151395|100746198|FG000|NOT COMPLETED|Overall Study||15||
48172505|NCT01234766|100746199|FG000|STARTED|Overall Study||39||
48172506|NCT01234766|100746199|FG000|COMPLETED|Overall Study||35||
48172507|NCT01234766|100746199|FG000|NOT COMPLETED|Overall Study||4||
48172508|NCT00582491|100746200|FG000|STARTED|Overall Study||11||
48172509|NCT00582491|100746201|FG001|STARTED|Overall Study||10||
48172510|NCT00582491|100746200|FG000|COMPLETED|Overall Study||10||
48172511|NCT00582491|100746201|FG001|COMPLETED|Overall Study||10||
48172512|NCT00582491|100746200|FG000|NOT COMPLETED|Overall Study||1||
48172513|NCT00582491|100746201|FG001|NOT COMPLETED|Overall Study||0||
48172514|NCT00951509|100746202|FG000|STARTED|Overall Study||31||
48172515|NCT00951509|100746202|FG000|Driving Condition 1|Overall Study||29||
48172516|NCT00951509|100746202|FG000|Driving Condition 2|Overall Study||29||
48172517|NCT00951509|100746202|FG000|Driving Condition 3|Overall Study||25||
48172518|NCT00951509|100746202|FG000|Driving Condition 4|Overall Study||28||
48172519|NCT00951509|100746202|FG000|Driving Condition 5|Overall Study||30||
48172520|NCT00951509|100746202|FG000|COMPLETED|Overall Study||29||
48172521|NCT00951509|100746202|FG000|NOT COMPLETED|Overall Study||2||
48172522|NCT00216320|100746203|FG000|STARTED|Phase 1 (Weeks 0 - 6)||43||
48172523|NCT00216320|100746204|FG001|STARTED|Phase 1 (Weeks 0 - 6)||39||
48172524|NCT00216320|100746205|FG002|STARTED|Phase 1 (Weeks 0 - 6)||30||
48172525|NCT00216320|100746203|FG000|COMPLETED|Phase 1 (Weeks 0 - 6)||43||
48172526|NCT00216320|100746204|FG001|COMPLETED|Phase 1 (Weeks 0 - 6)||35||
48172527|NCT00216320|100746205|FG002|COMPLETED|Phase 1 (Weeks 0 - 6)||25||
48172528|NCT00216320|100746203|FG000|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||0||
48172529|NCT00216320|100746204|FG001|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||4||
48334396|NCT00763321|101145716|FG000|NOT COMPLETED|Double-blind Period||0||
48411989|NCT03607994|101341891|FG000|STARTED|Overall Study||10||
48751496|NCT03271424|102180745|FG000|STARTED|December 2015||0||
48334397|NCT00763321|101145717|FG001|NOT COMPLETED|Double-blind Period||21||
48334398|NCT00763321|101145718|FG002|NOT COMPLETED|Double-blind Period||29||
48334399|NCT00624520|101145719|FG000|STARTED|Overall Study||56||
48334400|NCT00624520|101145720|FG001|STARTED|Overall Study||47||
48334401|NCT00624520|101145719|FG000|COMPLETED|Overall Study||44||
48334402|NCT00624520|101145720|FG001|COMPLETED|Overall Study||39||
48334403|NCT00624520|101145719|FG000|NOT COMPLETED|Overall Study||12||
48334404|NCT00624520|101145720|FG001|NOT COMPLETED|Overall Study||8||
48334405|NCT01791855|101145721|FG000|STARTED|Overall Study||8||
48334406|NCT01791855|101145722|FG001|STARTED|Overall Study||9||
48334407|NCT01791855|101145723|FG002|STARTED|Overall Study||8||
48334408|NCT01791855|101145724|FG003|STARTED|Overall Study||7||
48334409|NCT01791855|101145721|FG000|Treated|Overall Study||8||
48334410|NCT01791855|101145722|FG001|Treated|Overall Study||8||
48334411|NCT01791855|101145723|FG002|Treated|Overall Study||8||
48334412|NCT01791855|101145724|FG003|Treated|Overall Study||7||
48334413|NCT01791855|101145721|FG000|COMPLETED|Overall Study||8||
48334414|NCT01791855|101145722|FG001|COMPLETED|Overall Study||8||
48334415|NCT01791855|101145723|FG002|COMPLETED|Overall Study||8||
48334416|NCT01791855|101145724|FG003|COMPLETED|Overall Study||6||
48334417|NCT01791855|101145721|FG000|NOT COMPLETED|Overall Study||0||
48334418|NCT01791855|101145722|FG001|NOT COMPLETED|Overall Study||1||
48334419|NCT01791855|101145723|FG002|NOT COMPLETED|Overall Study||0||
48334420|NCT01791855|101145724|FG003|NOT COMPLETED|Overall Study||1||
48334421|NCT00679952|101145725|FG000|STARTED|Overall Study||86||
48334422|NCT00679952|101145726|FG001|STARTED|Overall Study||82||
48334423|NCT00679952|101145725|FG000|COMPLETED|Overall Study||86||
48334424|NCT00679952|101145726|FG001|COMPLETED|Overall Study||82||
48334425|NCT00679952|101145725|FG000|NOT COMPLETED|Overall Study||0||
48334426|NCT00679952|101145726|FG001|NOT COMPLETED|Overall Study||0||
48334427|NCT02605642|101145727|FG000|STARTED|Overall Study||227||
48334428|NCT02605642|101145728|FG001|STARTED|Overall Study||107||
48334429|NCT02605642|101145727|FG000|Safety Set|Overall Study||221|Included all participants who received at least 1 dose of CT- P13 during study observation period|
48334430|NCT02605642|101145728|FG001|Safety Set|Overall Study||107|Included all participants who received at least 1 dose of CT- P13 during study observation period|
48334431|NCT02605642|101145727|FG000|COMPLETED|Overall Study||131||
48334432|NCT02605642|101145728|FG001|COMPLETED|Overall Study||86||
48334433|NCT02605642|101145727|FG000|NOT COMPLETED|Overall Study||96||
48411990|NCT03607994|101341892|FG001|STARTED|Overall Study||12||
48411991|NCT03607994|101341891|FG000|COMPLETED|Overall Study||9||
48411992|NCT03607994|101341892|FG001|COMPLETED|Overall Study||11||
48411993|NCT03607994|101341891|FG000|NOT COMPLETED|Overall Study||1||
48411994|NCT03607994|101341892|FG001|NOT COMPLETED|Overall Study||1||
48628372|NCT03613493|101874378|FG001|COMPLETED|Overall Study||73||
48628373|NCT03613493|101874379|FG002|COMPLETED|Overall Study||0||
48628374|NCT03613493|101874380|FG003|COMPLETED|Overall Study||83||
48628375|NCT03613493|101874377|FG000|NOT COMPLETED|Overall Study||0||
48628376|NCT03613493|101874378|FG001|NOT COMPLETED|Overall Study||2||
48628377|NCT03613493|101874379|FG002|NOT COMPLETED|Overall Study||0||
48628378|NCT03613493|101874380|FG003|NOT COMPLETED|Overall Study||7||
48628379|NCT02461693|101874381|FG000|STARTED|Overall Study||103||
48628380|NCT02461693|101874382|FG001|STARTED|Overall Study||102||
48628381|NCT02461693|101874381|FG000|COMPLETED|Overall Study||103||
48628382|NCT02461693|101874382|FG001|COMPLETED|Overall Study||102||
48628383|NCT02461693|101874381|FG000|NOT COMPLETED|Overall Study||0||
48628384|NCT02461693|101874382|FG001|NOT COMPLETED|Overall Study||0||
48334434|NCT02605642|101145728|FG001|NOT COMPLETED|Overall Study||21||
48334435|NCT01700192|101145729|FG000|STARTED|Overall Study||741||
48334436|NCT01700192|101145730|FG001|STARTED|Overall Study||741||
48334437|NCT01700192|101145729|FG000|Treated|Overall Study||740||
48334438|NCT01700192|101145730|FG001|Treated|Overall Study||741||
48334439|NCT01700192|101145729|FG000|All Participants as Treated (APaT)|Overall Study||743||
48334440|NCT01700192|101145730|FG001|All Participants as Treated (APaT)|Overall Study||738||
48334441|NCT01700192|101145729|FG000|COMPLETED|Overall Study||561||
48334442|NCT01700192|101145730|FG001|COMPLETED|Overall Study||613||
48334443|NCT01700192|101145729|FG000|NOT COMPLETED|Overall Study||180||
48334444|NCT01700192|101145730|FG001|NOT COMPLETED|Overall Study||128||
48334445|NCT01331304|101145731|FG000|STARTED|Overall Study||240||
48334446|NCT01331304|101145732|FG001|STARTED|Overall Study||242||
48334447|NCT01331304|101145731|FG000|COMPLETED|Overall Study||182||
48334448|NCT01331304|101145732|FG001|COMPLETED|Overall Study||182||
48411995|NCT01142791|101341893|FG000|STARTED|Overall Study||115||
48628385|NCT00687908|101874383|FG000|STARTED|Overall Study||123||
48628386|NCT00687908|101874384|FG001|STARTED|Overall Study||120||
48628387|NCT00687908|101874383|FG000|COMPLETED|Overall Study||105||
48334449|NCT01331304|101145731|FG000|NOT COMPLETED|Overall Study||58||
48334450|NCT01331304|101145732|FG001|NOT COMPLETED|Overall Study||60||
48334451|NCT02532855|101145733|FG000|STARTED|Overall Study||307||
48334452|NCT02532855|101145734|FG001|STARTED|Overall Study||307||
48334453|NCT02532855|101145733|FG000|Treated|Overall Study||307||
48334454|NCT02532855|101145734|FG001|Treated|Overall Study||306||
48334455|NCT02532855|101145733|FG000|COMPLETED|Overall Study||299||
48411996|NCT01142791|101341894|FG001|STARTED|Overall Study||6||
48411997|NCT01142791|101341893|FG000|Safety|Overall Study||115||
48334456|NCT02532855|101145734|FG001|COMPLETED|Overall Study||296||
48334457|NCT02532855|101145733|FG000|NOT COMPLETED|Overall Study||8||
48334458|NCT02532855|101145734|FG001|NOT COMPLETED|Overall Study||11||
48334459|NCT01192347|101145735|FG000|STARTED|Overall Study||175||
48334460|NCT01192347|101145735|FG000|COMPLETED|Overall Study||163||
48334461|NCT01192347|101145735|FG000|NOT COMPLETED|Overall Study||12||
48334462|NCT00769119|101145736|FG000|STARTED|Overall Study||22||
48334463|NCT00769119|101145737|FG001|STARTED|Overall Study||16||
48334464|NCT00769119|101145736|FG000|COMPLETED|Overall Study||20||
48334465|NCT00769119|101145737|FG001|COMPLETED|Overall Study||13||
48334466|NCT00769119|101145736|FG000|NOT COMPLETED|Overall Study||2||
48334467|NCT00769119|101145737|FG001|NOT COMPLETED|Overall Study||3||
48334468|NCT03345472|101145738|FG000|STARTED|Implant to 3 Months||103||
48334469|NCT03345472|101145738|FG000|COMPLETED|Implant to 3 Months||99||
48334470|NCT03345472|101145738|FG000|NOT COMPLETED|Implant to 3 Months||4||
48334471|NCT03345472|101145738|FG000|STARTED|3 Months to 12 Months||99||
48334472|NCT03345472|101145738|FG000|COMPLETED|3 Months to 12 Months||91||
48628388|NCT00687908|101874384|FG001|COMPLETED|Overall Study||78||
48628389|NCT00687908|101874383|FG000|NOT COMPLETED|Overall Study||18||
48628390|NCT00687908|101874384|FG001|NOT COMPLETED|Overall Study||42||
48628391|NCT00848497|101874385|FG000|STARTED|Overall Study||2||
48628392|NCT00848497|101874386|FG001|STARTED|Overall Study||1||
48628393|NCT00848497|101874385|FG000|COMPLETED|Overall Study||0||
48628394|NCT00848497|101874386|FG001|COMPLETED|Overall Study||0||
48628395|NCT00848497|101874385|FG000|NOT COMPLETED|Overall Study||2||
48628396|NCT00848497|101874386|FG001|NOT COMPLETED|Overall Study||1||
48628397|NCT02063672|101874387|FG000|STARTED|Overall Study||53||
48628398|NCT02063672|101874388|FG001|STARTED|Overall Study||29||
48628399|NCT02063672|101874387|FG000|COMPLETED|Overall Study||18||
48628400|NCT02063672|101874388|FG001|COMPLETED|Overall Study||7||
48172530|NCT00216320|100746205|FG002|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||5||
48172531|NCT00216320|100746203|FG000|STARTED|Phase 2 (Weeks 6 -12)||43||
48172532|NCT00216320|100746204|FG001|STARTED|Phase 2 (Weeks 6 -12)||35||
48172533|NCT00216320|100746205|FG002|STARTED|Phase 2 (Weeks 6 -12)||25||
48172534|NCT00216320|100746203|FG000|COMPLETED|Phase 2 (Weeks 6 -12)||38||
48172535|NCT00216320|100746204|FG001|COMPLETED|Phase 2 (Weeks 6 -12)||31||
48628401|NCT02063672|101874387|FG000|NOT COMPLETED|Overall Study||35||
48628402|NCT02063672|101874388|FG001|NOT COMPLETED|Overall Study||22||
48628403|NCT01302899|101874389|FG000|STARTED|Period 1 (Day 1 to End of Week 6)||4||
48628404|NCT01302899|101874390|FG001|STARTED|Period 1 (Day 1 to End of Week 6)||4||
48628405|NCT01302899|101874389|FG000|COMPLETED|Period 1 (Day 1 to End of Week 6)||4||
48628406|NCT01302899|101874390|FG001|COMPLETED|Period 1 (Day 1 to End of Week 6)||4||
48628407|NCT01302899|101874389|FG000|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0||
48628408|NCT01302899|101874390|FG001|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0||
48628409|NCT01302899|101874389|FG000|STARTED|Period 2 (Weeks 7 to 12)||4||
48628410|NCT01302899|101874390|FG001|STARTED|Period 2 (Weeks 7 to 12)||4||
48628411|NCT01302899|101874389|FG000|COMPLETED|Period 2 (Weeks 7 to 12)||3||
48628412|NCT01302899|101874390|FG001|COMPLETED|Period 2 (Weeks 7 to 12)||3||
48628413|NCT01302899|101874389|FG000|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1||
48628414|NCT01302899|101874390|FG001|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1||
48628415|NCT01302899|101874389|FG000|STARTED|Period 3 (Weeks 13 to 18)||3||
48628416|NCT01302899|101874390|FG001|STARTED|Period 3 (Weeks 13 to 18)||3||
48628417|NCT01302899|101874389|FG000|COMPLETED|Period 3 (Weeks 13 to 18)||3||
48628418|NCT01302899|101874390|FG001|COMPLETED|Period 3 (Weeks 13 to 18)||3||
48751497|NCT03271424|102180746|FG001|STARTED|December 2015||35||
48751498|NCT03271424|102180747|FG002|STARTED|December 2015||0||
48751499|NCT03271424|102180745|FG000|COMPLETED|December 2015||0||
48751500|NCT03271424|102180746|FG001|COMPLETED|December 2015||35||
48172536|NCT00216320|100746205|FG002|COMPLETED|Phase 2 (Weeks 6 -12)||24||
48172537|NCT00216320|100746203|FG000|NOT COMPLETED|Phase 2 (Weeks 6 -12)||5||
48172538|NCT00216320|100746204|FG001|NOT COMPLETED|Phase 2 (Weeks 6 -12)||4||
48172539|NCT00216320|100746205|FG002|NOT COMPLETED|Phase 2 (Weeks 6 -12)||1||
48172540|NCT02066532|100746206|FG000|STARTED|Phase I||9||
48172541|NCT02066532|100746207|FG001|STARTED|Phase I||1||
48172542|NCT02066532|100746208|FG002|STARTED|Phase I||0||
48334473|NCT03345472|101145738|FG000|NOT COMPLETED|3 Months to 12 Months||8||
48334474|NCT02787850|101145739|FG000|STARTED|Overall Study||10||
48334475|NCT02787850|101145740|FG001|STARTED|Overall Study||10||
48334476|NCT02787850|101145739|FG000|COMPLETED|Overall Study||10||
48334477|NCT02787850|101145740|FG001|COMPLETED|Overall Study||9||
48334478|NCT02787850|101145739|FG000|NOT COMPLETED|Overall Study||0||
48334479|NCT02787850|101145740|FG001|NOT COMPLETED|Overall Study||1||
48334480|NCT04663945|101145741|FG000|STARTED|Overall Study||29||
48334481|NCT04663945|101145742|FG001|STARTED|Overall Study||15||
48334482|NCT04663945|101145741|FG000|Week 6 Evaluation|Overall Study||28||
48334483|NCT04663945|101145742|FG001|Week 6 Evaluation|Overall Study||13||
48334484|NCT04663945|101145741|FG000|Week 12 Evaluation|Overall Study||28||
48334485|NCT04663945|101145742|FG001|Week 12 Evaluation|Overall Study||12||
48334486|NCT04663945|101145741|FG000|COMPLETED|Overall Study||28||
48334487|NCT04663945|101145742|FG001|COMPLETED|Overall Study||12||
48334488|NCT04663945|101145741|FG000|NOT COMPLETED|Overall Study||1||
48334489|NCT04663945|101145742|FG001|NOT COMPLETED|Overall Study||3||
48628419|NCT01302899|101874389|FG000|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0||
48628420|NCT01302899|101874390|FG001|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0||
48628421|NCT01302899|101874389|FG000|STARTED|Period 4 (Weeks 19 to 26)||3||
48628422|NCT01302899|101874390|FG001|STARTED|Period 4 (Weeks 19 to 26)||3||
48628423|NCT01302899|101874389|FG000|COMPLETED|Period 4 (Weeks 19 to 26)||3||
48628424|NCT01302899|101874390|FG001|COMPLETED|Period 4 (Weeks 19 to 26)||3||
48628425|NCT01302899|101874389|FG000|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0||
48628426|NCT01302899|101874390|FG001|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0||
48628427|NCT03964207|101874391|FG000|STARTED|First Treatment||37|Randomized|
48628428|NCT03964207|101874392|FG001|STARTED|First Treatment||35|Randomized|
48628429|NCT03964207|101874391|FG000|Treated|First Treatment||36||
48334490|NCT02161562|101148182|FG000|STARTED|Overall Study||178||
48334491|NCT02161562|101148183|FG001|STARTED|Overall Study||136||
48334492|NCT02161562|101148182|FG000|COMPLETED|Overall Study||152||
48334493|NCT02161562|101148183|FG001|COMPLETED|Overall Study||119||
48334494|NCT02161562|101148182|FG000|NOT COMPLETED|Overall Study||26||
48334495|NCT02161562|101148183|FG001|NOT COMPLETED|Overall Study||17||
48334496|NCT00356031|101148184|FG000|STARTED|Overall Study||20||
48334497|NCT00356031|101148184|FG000|COMPLETED|Overall Study||20||
48334498|NCT00356031|101148184|FG000|NOT COMPLETED|Overall Study||0||
48334499|NCT01469000|101148185|FG000|STARTED|Overall Study||129||
48334500|NCT01469000|101148186|FG001|STARTED|Overall Study||66||
48334501|NCT01469000|101148185|FG000|Received at Least 1 Dose of Study Drug|Overall Study||126||
48334502|NCT01469000|101148186|FG001|Received at Least 1 Dose of Study Drug|Overall Study||65||
48334503|NCT01469000|101148185|FG000|COMPLETED|Overall Study||109||
48334504|NCT01469000|101148186|FG001|COMPLETED|Overall Study||62||
48334505|NCT01469000|101148185|FG000|NOT COMPLETED|Overall Study||20||
48334506|NCT01469000|101148186|FG001|NOT COMPLETED|Overall Study||4||
48334507|NCT01649947|101148187|FG000|STARTED|Overall Study||12||
48334508|NCT01649947|101148188|FG001|STARTED|Overall Study||20||
48411998|NCT01142791|101341894|FG001|Safety|Overall Study||6||
48411999|NCT01142791|101341893|FG000|COMPLETED|Overall Study||108||
48412000|NCT01142791|101341894|FG001|COMPLETED|Overall Study||0||
48412001|NCT01142791|101341893|FG000|NOT COMPLETED|Overall Study||7||
48412002|NCT01142791|101341894|FG001|NOT COMPLETED|Overall Study||6||
48412003|NCT01579162|101341895|FG000|STARTED|Overall Study||16||
48412004|NCT01579162|101341896|FG001|STARTED|Overall Study||8||
48628430|NCT03964207|101874392|FG001|Treated|First Treatment||35||
48628431|NCT03964207|101874391|FG000|COMPLETED|First Treatment||34||
48628432|NCT03964207|101874392|FG001|COMPLETED|First Treatment||33||
48628433|NCT03964207|101874391|FG000|NOT COMPLETED|First Treatment||3||
48628434|NCT03964207|101874392|FG001|NOT COMPLETED|First Treatment||2||
48628435|NCT03964207|101874391|FG000|STARTED|Second Treatment||34||
48628436|NCT03964207|101874392|FG001|STARTED|Second Treatment||33||
48628437|NCT03964207|101874391|FG000|COMPLETED|Second Treatment||33||
48628438|NCT03964207|101874392|FG001|COMPLETED|Second Treatment||30||
48628439|NCT03964207|101874391|FG000|NOT COMPLETED|Second Treatment||1||
48751501|NCT03271424|102180747|FG002|COMPLETED|December 2015||0||
48751502|NCT03271424|102180745|FG000|NOT COMPLETED|December 2015||0||
48751503|NCT03271424|102180746|FG001|NOT COMPLETED|December 2015||0||
48751504|NCT03271424|102180747|FG002|NOT COMPLETED|December 2015||0||
48751505|NCT03271424|102180745|FG000|STARTED|April-May 2016||0||
48751506|NCT03271424|102180746|FG001|STARTED|April-May 2016||0||
48334509|NCT01649947|101148187|FG000|COMPLETED|Overall Study||0||
48334510|NCT01649947|101148188|FG001|COMPLETED|Overall Study||2||
48334511|NCT01649947|101148187|FG000|NOT COMPLETED|Overall Study||12||
48334512|NCT01649947|101148188|FG001|NOT COMPLETED|Overall Study||18||
48334513|NCT01535365|101148189|FG000|STARTED|Overall Study||31||
48334514|NCT01535365|101148190|FG001|STARTED|Overall Study||29||
48334515|NCT01535365|101148189|FG000|COMPLETED|Overall Study||31||
48334516|NCT01535365|101148190|FG001|COMPLETED|Overall Study||29||
48334517|NCT01535365|101148189|FG000|NOT COMPLETED|Overall Study||0||
48334518|NCT01535365|101148190|FG001|NOT COMPLETED|Overall Study||0||
48334519|NCT00141765|101148191|FG000|STARTED|Overall Study||25||
48334520|NCT00141765|101148191|FG000|COMPLETED|Overall Study||25||
48334521|NCT00141765|101148191|FG000|NOT COMPLETED|Overall Study||0||
48334522|NCT01652287|101148192|FG000|STARTED|Overall Study||31||
48334523|NCT01652287|101148193|FG001|STARTED|Overall Study||31||
48334524|NCT01652287|101148192|FG000|COMPLETED|Overall Study||29||
48334525|NCT01652287|101148193|FG001|COMPLETED|Overall Study||31||
48334526|NCT01652287|101148192|FG000|NOT COMPLETED|Overall Study||2||
48334527|NCT01652287|101148193|FG001|NOT COMPLETED|Overall Study||0||
48334528|NCT03126760|101148194|FG000|STARTED|Overall Study||18||
48334529|NCT03126760|101148195|FG001|STARTED|Overall Study||17||
48334530|NCT03126760|101148194|FG000|Modified Intent to Treat (mITT)|Overall Study||18|All participants who received study treatment|
48412005|NCT01579162|101341897|FG002|STARTED|Overall Study||8||
48751507|NCT03271424|102180747|FG002|STARTED|April-May 2016||40||
48751508|NCT03271424|102180745|FG000|COMPLETED|April-May 2016||0||
48751509|NCT03271424|102180746|FG001|COMPLETED|April-May 2016||0||
48751510|NCT03271424|102180747|FG002|COMPLETED|April-May 2016||40||
48751511|NCT03271424|102180745|FG000|NOT COMPLETED|April-May 2016||0||
48751512|NCT03271424|102180746|FG001|NOT COMPLETED|April-May 2016||0||
48412006|NCT01579162|101341898|FG003|STARTED|Overall Study||8||
48412007|NCT01579162|101341899|FG004|STARTED|Overall Study||8||
48412008|NCT01579162|101341895|FG000|COMPLETED|Overall Study||16||
48628440|NCT03964207|101874392|FG001|NOT COMPLETED|Second Treatment||3||
48628441|NCT00578903|101874393|FG000|STARTED|Overall Study||22||
48628442|NCT00578903|101874393|FG000|COMPLETED|Overall Study||22||
48628443|NCT00578903|101874393|FG000|NOT COMPLETED|Overall Study||0||
48628444|NCT01715831|101874394|FG000|STARTED|Overall Study||26||
48628445|NCT01715831|101874394|FG000|COMPLETED|Overall Study||25||
48628446|NCT01715831|101874394|FG000|NOT COMPLETED|Overall Study||1||
48628447|NCT03074500|101874395|FG000|STARTED|Overall Study||11||
48628448|NCT03074500|101874396|FG001|STARTED|Overall Study||11||
48628449|NCT03074500|101874397|FG002|STARTED|Overall Study||11||
48628450|NCT03074500|101874395|FG000|COMPLETED|Overall Study||10||
48628451|NCT03074500|101874396|FG001|COMPLETED|Overall Study||10||
48628452|NCT03074500|101874397|FG002|COMPLETED|Overall Study||10||
48628453|NCT03074500|101874395|FG000|NOT COMPLETED|Overall Study||1||
48628454|NCT03074500|101874396|FG001|NOT COMPLETED|Overall Study||1||
48628455|NCT03074500|101874397|FG002|NOT COMPLETED|Overall Study||1||
48628456|NCT01863771|101874398|FG000|STARTED|Induction Phase||144||
48628457|NCT01863771|101874399|FG001|STARTED|Induction Phase||0||
48628458|NCT01863771|101874400|FG002|STARTED|Induction Phase||0||
48628459|NCT01863771|101874401|FG003|STARTED|Induction Phase||0||
48628460|NCT01863771|101874398|FG000|COMPLETED|Induction Phase||123||
48628461|NCT01863771|101874399|FG001|COMPLETED|Induction Phase||0||
48628462|NCT01863771|101874400|FG002|COMPLETED|Induction Phase||0||
48628463|NCT01863771|101874401|FG003|COMPLETED|Induction Phase||0||
48628464|NCT01863771|101874398|FG000|NOT COMPLETED|Induction Phase||21||
48628465|NCT01863771|101874399|FG001|NOT COMPLETED|Induction Phase||0||
48628466|NCT01863771|101874400|FG002|NOT COMPLETED|Induction Phase||0||
48628467|NCT01863771|101874401|FG003|NOT COMPLETED|Induction Phase||0||
48628468|NCT01863771|101874398|FG000|STARTED|Maintenance Phase||0||
48628469|NCT01863771|101874399|FG001|STARTED|Maintenance Phase||32||
48628470|NCT01863771|101874400|FG002|STARTED|Maintenance Phase||31||
48628471|NCT01863771|101874401|FG003|STARTED|Maintenance Phase||60||
48628472|NCT01863771|101874398|FG000|COMPLETED|Maintenance Phase||0||
48628473|NCT01863771|101874399|FG001|COMPLETED|Maintenance Phase||27||
48628474|NCT01863771|101874400|FG002|COMPLETED|Maintenance Phase||19||
48628475|NCT01863771|101874401|FG003|COMPLETED|Maintenance Phase||17||
48628476|NCT01863771|101874398|FG000|NOT COMPLETED|Maintenance Phase||0||
48628477|NCT01863771|101874399|FG001|NOT COMPLETED|Maintenance Phase||5||
48628478|NCT01863771|101874400|FG002|NOT COMPLETED|Maintenance Phase||12||
48628479|NCT01863771|101874401|FG003|NOT COMPLETED|Maintenance Phase||43||
48628480|NCT00289211|101874402|FG000|STARTED|Overall Study||36||
48628481|NCT00289211|101874403|FG001|STARTED|Overall Study||35||
48628482|NCT00289211|101874404|FG002|STARTED|Overall Study||12||
48628483|NCT00289211|101874402|FG000|COMPLETED|Overall Study||36||
48628484|NCT00289211|101874403|FG001|COMPLETED|Overall Study||34||
48628485|NCT00289211|101874404|FG002|COMPLETED|Overall Study||2||
48628486|NCT00289211|101874402|FG000|NOT COMPLETED|Overall Study||0||
48628487|NCT00289211|101874403|FG001|NOT COMPLETED|Overall Study||1||
48628488|NCT00289211|101874404|FG002|NOT COMPLETED|Overall Study||10||
48628489|NCT00666237|101874405|FG000|STARTED|Overall Study||125||
48628490|NCT00666237|101874406|FG001|STARTED|Overall Study||117||
48628491|NCT00666237|101874405|FG000|COMPLETED|Overall Study||91||
48628492|NCT00666237|101874406|FG001|COMPLETED|Overall Study||87||
48628493|NCT00666237|101874405|FG000|NOT COMPLETED|Overall Study||34||
48628494|NCT00666237|101874406|FG001|NOT COMPLETED|Overall Study||30||
48628495|NCT03248037|101874407|FG000|STARTED|Overall Study||95||95
48628496|NCT03248037|101874408|FG001|STARTED|Overall Study||96||96
48628497|NCT03248037|101874407|FG000|COMPLETED|Overall Study||74||74
48628498|NCT03248037|101874408|FG001|COMPLETED|Overall Study||87||87
48628499|NCT03248037|101874407|FG000|NOT COMPLETED|Overall Study||21||21
48628500|NCT03248037|101874408|FG001|NOT COMPLETED|Overall Study||9||9
48628501|NCT03074695|101874409|FG000|STARTED|Overall Study||70||
48628502|NCT03074695|101874410|FG001|STARTED|Overall Study||71||
48628503|NCT03074695|101874409|FG000|COMPLETED|Overall Study||66||
48628504|NCT03074695|101874410|FG001|COMPLETED|Overall Study||66||
48628505|NCT03074695|101874409|FG000|NOT COMPLETED|Overall Study||4||
48628506|NCT03074695|101874410|FG001|NOT COMPLETED|Overall Study||5||
48628507|NCT02394769|101874411|FG000|STARTED|Overall Study||60||
48628508|NCT02394769|101874412|FG001|STARTED|Overall Study||60||
48628509|NCT02394769|101874413|FG002|STARTED|Overall Study||60||
48628510|NCT02394769|101874411|FG000|COMPLETED|Overall Study||58||
48628511|NCT02394769|101874412|FG001|COMPLETED|Overall Study||57||
48412009|NCT01579162|101341896|FG001|COMPLETED|Overall Study||8||
48412010|NCT01579162|101341897|FG002|COMPLETED|Overall Study||8||
48412011|NCT01579162|101341898|FG003|COMPLETED|Overall Study||8||
48412012|NCT01579162|101341899|FG004|COMPLETED|Overall Study||8||
48412013|NCT01579162|101341895|FG000|NOT COMPLETED|Overall Study||0||
48412014|NCT01579162|101341896|FG001|NOT COMPLETED|Overall Study||0||
48412015|NCT01579162|101341897|FG002|NOT COMPLETED|Overall Study||0||
48412016|NCT01579162|101341898|FG003|NOT COMPLETED|Overall Study||0||
48412017|NCT01579162|101341899|FG004|NOT COMPLETED|Overall Study||0||
48628512|NCT02394769|101874413|FG002|COMPLETED|Overall Study||54||
48751513|NCT03271424|102180747|FG002|NOT COMPLETED|April-May 2016||0||
48751514|NCT00528957|102180748|FG000|STARTED|Randomized Phase (Baseline to Week 48)||48||
48751515|NCT00528957|102180749|FG001|STARTED|Randomized Phase (Baseline to Week 48)||49||
48334531|NCT03126760|101148195|FG001|Modified Intent to Treat (mITT)|Overall Study||17|All participants who received study treatment|
48334532|NCT03126760|101148194|FG000|Completed Treatment|Overall Study||17||
48334533|NCT03126760|101148195|FG001|Completed Treatment|Overall Study||17||
48334534|NCT03126760|101148194|FG000|COMPLETED|Overall Study||18||
48334535|NCT03126760|101148195|FG001|COMPLETED|Overall Study||17||
48334536|NCT03126760|101148194|FG000|NOT COMPLETED|Overall Study||0||
48334537|NCT03126760|101148195|FG001|NOT COMPLETED|Overall Study||0||
48334538|NCT00112905|101148196|FG000|STARTED|Overall Study||27||
48334539|NCT00112905|101148196|FG000|Eligible and Treated|Overall Study||22||
48334540|NCT00112905|101148196|FG000|COMPLETED|Overall Study||15||
48334541|NCT00112905|101148196|FG000|NOT COMPLETED|Overall Study||12||
48334542|NCT00090545|101148197|FG000|STARTED|Overall Study||22||
48334543|NCT00090545|101148198|FG001|STARTED|Overall Study||24||
48334544|NCT00090545|101148197|FG000|COMPLETED|Overall Study||0||
48334545|NCT00090545|101148198|FG001|COMPLETED|Overall Study||0||
48334546|NCT00090545|101148197|FG000|NOT COMPLETED|Overall Study||22||
48334547|NCT00090545|101148198|FG001|NOT COMPLETED|Overall Study||24||
48334548|NCT02049944|101148199|FG000|STARTED|Overall Study||30||
48751516|NCT00528957|102180748|FG000|COMPLETED|Randomized Phase (Baseline to Week 48)||44||
48751517|NCT00528957|102180749|FG001|COMPLETED|Randomized Phase (Baseline to Week 48)||48||
48751518|NCT00528957|102180748|FG000|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||4||
48751519|NCT00528957|102180749|FG001|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||1||
48751520|NCT00528957|102180748|FG000|STARTED|First Extension (Week 48 to Week 144)||38||
48751521|NCT00528957|102180749|FG001|STARTED|First Extension (Week 48 to Week 144)||41||
48751522|NCT00528957|102180748|FG000|COMPLETED|First Extension (Week 48 to Week 144)||35||
48751523|NCT00528957|102180749|FG001|COMPLETED|First Extension (Week 48 to Week 144)||40||
48751524|NCT00528957|102180748|FG000|NOT COMPLETED|First Extension (Week 48 to Week 144)||3||
48751525|NCT00528957|102180749|FG001|NOT COMPLETED|First Extension (Week 48 to Week 144)||1||
48751526|NCT00528957|102180748|FG000|STARTED|Second Extension (Week 144 to Week 240)||34||
48751527|NCT00528957|102180749|FG001|STARTED|Second Extension (Week 144 to Week 240)||40||
48751528|NCT00528957|102180748|FG000|COMPLETED|Second Extension (Week 144 to Week 240)||27||
48751529|NCT00528957|102180749|FG001|COMPLETED|Second Extension (Week 144 to Week 240)||37||
48751530|NCT00528957|102180748|FG000|NOT COMPLETED|Second Extension (Week 144 to Week 240)||7||
48751531|NCT00528957|102180749|FG001|NOT COMPLETED|Second Extension (Week 144 to Week 240)||3||
48751532|NCT00528957|102180748|FG000|STARTED|Third Extension (Week 240 to Week 336)||27||
48751533|NCT00528957|102180749|FG001|STARTED|Third Extension (Week 240 to Week 336)||37||
48751534|NCT00528957|102180748|FG000|COMPLETED|Third Extension (Week 240 to Week 336)||21||
48751535|NCT00528957|102180749|FG001|COMPLETED|Third Extension (Week 240 to Week 336)||27||
48751536|NCT00528957|102180748|FG000|NOT COMPLETED|Third Extension (Week 240 to Week 336)||6||
48751537|NCT00528957|102180749|FG001|NOT COMPLETED|Third Extension (Week 240 to Week 336)||10||
48751538|NCT00528957|102180748|FG000|STARTED|Long-Term Extension (Week 336 and On)||19||
48751539|NCT00528957|102180749|FG001|STARTED|Long-Term Extension (Week 336 and On)||25||
48751540|NCT00528957|102180748|FG000|COMPLETED|Long-Term Extension (Week 336 and On)||9||
48751541|NCT00528957|102180749|FG001|COMPLETED|Long-Term Extension (Week 336 and On)||8||
48751542|NCT00528957|102180748|FG000|NOT COMPLETED|Long-Term Extension (Week 336 and On)||10||
48751543|NCT00528957|102180749|FG001|NOT COMPLETED|Long-Term Extension (Week 336 and On)||17||
48751544|NCT01969708|102180750|FG000|STARTED|Overall Study||180||
48751545|NCT01969708|102180751|FG001|STARTED|Overall Study||182||
48751546|NCT01969708|102180750|FG000|COMPLETED|Overall Study||175||
48751547|NCT01969708|102180751|FG001|COMPLETED|Overall Study||173||
48751548|NCT01969708|102180750|FG000|NOT COMPLETED|Overall Study||5||
48172543|NCT02066532|100746209|FG003|STARTED|Phase I||0||
48172544|NCT02066532|100746206|FG000|COMPLETED|Phase I||9||
48334549|NCT02049944|101148199|FG000|Obese (BMI 30-40kg/m^2)|Overall Study||14||
48334550|NCT02049944|101148199|FG000|Extremely Obese (BMI >40kg/m^2)|Overall Study||14||
48334551|NCT02049944|101148199|FG000|COMPLETED|Overall Study||28||
48334552|NCT02049944|101148199|FG000|NOT COMPLETED|Overall Study||2||
48334553|NCT01639833|101148200|FG000|STARTED|Overall Study||45||
48334554|NCT01639833|101148201|FG001|STARTED|Overall Study||45||
48334555|NCT01639833|101148200|FG000|COMPLETED|Overall Study||39||
48334556|NCT01639833|101148201|FG001|COMPLETED|Overall Study||41||
48334557|NCT01639833|101148200|FG000|NOT COMPLETED|Overall Study||6||
48334558|NCT01639833|101148201|FG001|NOT COMPLETED|Overall Study||4||
48334559|NCT01813890|101148202|FG000|STARTED|Overall Study||20||
48334560|NCT01813890|101148203|FG001|STARTED|Overall Study||21||
48334561|NCT01813890|101148204|FG002|STARTED|Overall Study||19||
48334562|NCT01813890|101148202|FG000|COMPLETED|Overall Study||11||
48334563|NCT01813890|101148203|FG001|COMPLETED|Overall Study||17||
48334564|NCT01813890|101148204|FG002|COMPLETED|Overall Study||13||
48334565|NCT01813890|101148202|FG000|NOT COMPLETED|Overall Study||9||
48334566|NCT01813890|101148203|FG001|NOT COMPLETED|Overall Study||4||
48334567|NCT01813890|101148204|FG002|NOT COMPLETED|Overall Study||6||
48334568|NCT01688050|101148205|FG000|STARTED|Overall Study||50||
48334569|NCT01688050|101148205|FG000|5-Year|Overall Study||22||
48412018|NCT02590406|101341900|FG000|STARTED|Overall Study||25||
48412019|NCT02590406|101341901|FG001|STARTED|Overall Study||25||
48412020|NCT02590406|101341900|FG000|COMPLETED|Overall Study||24||
48412021|NCT02590406|101341901|FG001|COMPLETED|Overall Study||24||
48412022|NCT02590406|101341900|FG000|NOT COMPLETED|Overall Study||1||
48412023|NCT02590406|101341901|FG001|NOT COMPLETED|Overall Study||1||
48412024|NCT01646255|101341902|FG000|STARTED|Overall Study||172||
48412025|NCT01646255|101341903|FG001|STARTED|Overall Study||174||
48412026|NCT01646255|101341902|FG000|COMPLETED|Overall Study||151||
48412027|NCT01646255|101341903|FG001|COMPLETED|Overall Study||160||
48412028|NCT01646255|101341902|FG000|NOT COMPLETED|Overall Study||21||
48412029|NCT01646255|101341903|FG001|NOT COMPLETED|Overall Study||14||
48412030|NCT00589602|101341904|FG000|STARTED|Overall Study||13||
48412031|NCT00589602|101341904|FG000|COMPLETED|Overall Study||12||
48412032|NCT00589602|101341904|FG000|NOT COMPLETED|Overall Study||1||
48412033|NCT02658149|101341905|FG000|STARTED|Overall Study||50||
48412034|NCT02658149|101341906|FG001|STARTED|Overall Study||50||
48412035|NCT02658149|101341905|FG000|COMPLETED|Overall Study||49||
48412036|NCT02658149|101341906|FG001|COMPLETED|Overall Study||50||
48412037|NCT02658149|101341905|FG000|NOT COMPLETED|Overall Study||1||
48412038|NCT02658149|101341906|FG001|NOT COMPLETED|Overall Study||0||
48412039|NCT03662789|101341907|FG000|STARTED|Overall Study||52||
48412040|NCT03662789|101341908|FG001|STARTED|Overall Study||50||
48412041|NCT03662789|101341907|FG000|COMPLETED|Overall Study||47||
48412042|NCT03662789|101341908|FG001|COMPLETED|Overall Study||43||
48412043|NCT03662789|101341907|FG000|NOT COMPLETED|Overall Study||5||
48412044|NCT03662789|101341908|FG001|NOT COMPLETED|Overall Study||7||
48412045|NCT00354484|101341909|FG000|STARTED|Overall Study||142||
48412046|NCT00354484|101341910|FG001|STARTED|Overall Study||147||
48412047|NCT00354484|101341909|FG000|COMPLETED|Overall Study||138||
48412048|NCT00354484|101341910|FG001|COMPLETED|Overall Study||144||
48412049|NCT00354484|101341909|FG000|NOT COMPLETED|Overall Study||4||
48412050|NCT00354484|101341910|FG001|NOT COMPLETED|Overall Study||3||
48412051|NCT00112840|101341911|FG000|STARTED|Overall Study||8||
48412052|NCT00112840|101341912|FG001|STARTED|Overall Study||6||
48412053|NCT00112840|101341913|FG002|STARTED|Overall Study||46||
48412054|NCT00112840|101341911|FG000|COMPLETED|Overall Study||6||
48412055|NCT00112840|101341912|FG001|COMPLETED|Overall Study||6||
48412056|NCT00112840|101341913|FG002|COMPLETED|Overall Study||40||
48412057|NCT00112840|101341911|FG000|NOT COMPLETED|Overall Study||2||
48412058|NCT00112840|101341912|FG001|NOT COMPLETED|Overall Study||0||
48412059|NCT00112840|101341913|FG002|NOT COMPLETED|Overall Study||6||
48412060|NCT02618512|101341914|FG000|STARTED|Overall Study||3||
48412061|NCT02618512|101341914|FG000|COMPLETED|Overall Study||3||
48412062|NCT02618512|101341914|FG000|NOT COMPLETED|Overall Study||0||
48412063|NCT01469637|101341915|FG000|STARTED|First Intervention||22||
48412064|NCT01469637|101341916|FG001|STARTED|First Intervention||22||
48412065|NCT01469637|101341915|FG000|COMPLETED|First Intervention||22||
48334570|NCT01688050|101148205|FG000|COMPLETED|Overall Study||19||
48334571|NCT01688050|101148205|FG000|NOT COMPLETED|Overall Study||31||
48334572|NCT01239160|101148206|FG000|STARTED|Overall Study||114|"Of the 238 patients started, 64 APCD and 66 SPCD had reached the 12 week visit milestone at the time of the outcome analysis reported below. Results presented include 130 subjects who had completed the 12 week follow up (or who withdrew within 12 weeks) prior to the 26Oct2011 dataset."|
48412066|NCT01469637|101341916|FG001|COMPLETED|First Intervention||21||
48412067|NCT01469637|101341915|FG000|NOT COMPLETED|First Intervention||0||
48412068|NCT01469637|101341916|FG001|NOT COMPLETED|First Intervention||1||
48412069|NCT01469637|101341915|FG000|STARTED|Second Intervention||22||
48412070|NCT01469637|101341916|FG001|STARTED|Second Intervention||21||
48628513|NCT02394769|101874411|FG000|NOT COMPLETED|Overall Study||2||
48334573|NCT01239160|101148207|FG001|STARTED|Overall Study||114|"Of the 238 patients started, 64 APCD and 66 SPCD had reached the 12 week visit milestone at the time of the outcome analysis reported below. Results presented include 130 subjects who had completed the 12 week follow up (or who withdrew within 12 weeks) prior to the 26Oct2011 dataset."|
48334574|NCT01239160|101148208|FG002|STARTED|Overall Study||10|"Of the 238 patients started, 64 APCD and 66 SPCD had reached the 12 week visit milestone at the time of the outcome analysis reported below. Results presented include 130 subjects who had completed the 12 week follow up (or who withdrew within 12 weeks) prior to the 26Oct2011 dataset."|
48628514|NCT02394769|101874412|FG001|NOT COMPLETED|Overall Study||3||
48334575|NCT01239160|101148206|FG000|COMPLETED|Overall Study||89||
48334576|NCT01239160|101148207|FG001|COMPLETED|Overall Study||95||
48334577|NCT01239160|101148208|FG002|COMPLETED|Overall Study||0||
48412071|NCT01469637|101341915|FG000|COMPLETED|Second Intervention||21||
48412072|NCT01469637|101341916|FG001|COMPLETED|Second Intervention||21||
48412073|NCT01469637|101341915|FG000|NOT COMPLETED|Second Intervention||1||
48412074|NCT01469637|101341916|FG001|NOT COMPLETED|Second Intervention||0||
48412075|NCT03979495|101341917|FG000|STARTED|Overall Study||2702||11
48412076|NCT03979495|101341918|FG001|STARTED|Overall Study||3254||11
48412077|NCT03979495|101341919|FG002|STARTED|Overall Study||2569||11
48628515|NCT02394769|101874413|FG002|NOT COMPLETED|Overall Study||6||
48628516|NCT01968421|101874414|FG000|STARTED|Overall Study||99||
48412078|NCT03979495|101341920|FG003|STARTED|Overall Study||3455||11
48412079|NCT03979495|101341917|FG000|COMPLETED|Overall Study||2702||11
48412080|NCT03979495|101341918|FG001|COMPLETED|Overall Study||3254||11
48412081|NCT03979495|101341919|FG002|COMPLETED|Overall Study||2569||11
48412082|NCT03979495|101341920|FG003|COMPLETED|Overall Study||3455||11
48412083|NCT03979495|101341917|FG000|NOT COMPLETED|Overall Study||0||0
48412084|NCT03979495|101341918|FG001|NOT COMPLETED|Overall Study||0||0
48412085|NCT03979495|101341919|FG002|NOT COMPLETED|Overall Study||0||0
48412086|NCT03979495|101341920|FG003|NOT COMPLETED|Overall Study||0||0
48412087|NCT00537810|101341921|FG000|STARTED|Overall Study||26||
48628517|NCT01968421|101874415|FG001|STARTED|Overall Study||97||
48628518|NCT01968421|101874414|FG000|Starting Trial|Overall Study||99|starting to recuit first subject|
48628519|NCT01968421|101874415|FG001|Starting Trial|Overall Study||97|starting to recuit first subject|
48628520|NCT01968421|101874414|FG000|COMPLETED|Overall Study||99||
48628521|NCT01968421|101874415|FG001|COMPLETED|Overall Study||97||
48628522|NCT01968421|101874414|FG000|NOT COMPLETED|Overall Study||0||
48628523|NCT01968421|101874415|FG001|NOT COMPLETED|Overall Study||0||
48628524|NCT03504917|101874416|FG000|STARTED|Blinded Treatment Period||163|ITT Population|
48628525|NCT03504917|101874417|FG001|STARTED|Blinded Treatment Period||158|ITT Population|
48628526|NCT03504917|101874416|FG000|COMPLETED|Blinded Treatment Period||103|ITT Population|
48628527|NCT03504917|101874417|FG001|COMPLETED|Blinded Treatment Period||102|ITT Population|
48628528|NCT03504917|101874416|FG000|NOT COMPLETED|Blinded Treatment Period||60||
48628529|NCT03504917|101874417|FG001|NOT COMPLETED|Blinded Treatment Period||56||
48628530|NCT03504917|101874416|FG000|STARTED|Open Label Extension Treatment Period||100|ITT Population, 63 and 61 Participants did not continue in open-label extension in Balovaptan and Placebo Arms respectively.|
48628531|NCT03504917|101874417|FG001|STARTED|Open Label Extension Treatment Period||97|ITT Population, 63 and 61 Participants did not continue in open-label extension in Balovaptan and Placebo Arms respectively.|
48628532|NCT03504917|101874416|FG000|COMPLETED|Open Label Extension Treatment Period||0|ITT Population|
48751549|NCT01969708|102180751|FG001|NOT COMPLETED|Overall Study||9||
48751550|NCT00101686|102180752|FG000|STARTED|Overall Study||71||
48751551|NCT00101686|102180753|FG001|STARTED|Overall Study||73||
48751552|NCT00101686|102180754|FG002|STARTED|Overall Study||69||
48751553|NCT00101686|102180755|FG003|STARTED|Overall Study||72||
48751554|NCT00101686|102180756|FG004|STARTED|Overall Study||73||
48751555|NCT00101686|102180757|FG005|STARTED|Overall Study||72||
48751556|NCT00101686|102180758|FG006|STARTED|Overall Study||27||
48751557|NCT00101686|102180759|FG007|STARTED|Overall Study||30||
48751558|NCT00101686|102180760|FG008|STARTED|Overall Study||30||
48751559|NCT00101686|102180761|FG009|STARTED|Overall Study||30||
48751560|NCT00101686|102180752|FG000|Received Treatment|Overall Study||70||
48751561|NCT00101686|102180753|FG001|Received Treatment|Overall Study||67||
48751562|NCT00101686|102180754|FG002|Received Treatment|Overall Study||67||
48751563|NCT00101686|102180755|FG003|Received Treatment|Overall Study||70||
48751564|NCT00101686|102180756|FG004|Received Treatment|Overall Study||71||
48751565|NCT00101686|102180757|FG005|Received Treatment|Overall Study||70||
48751566|NCT00101686|102180758|FG006|Received Treatment|Overall Study||27||
48751567|NCT00101686|102180759|FG007|Received Treatment|Overall Study||29||
48751568|NCT00101686|102180760|FG008|Received Treatment|Overall Study||30||
48751569|NCT00101686|102180761|FG009|Received Treatment|Overall Study||29||
48751570|NCT00101686|102180752|FG000|COMPLETED|Overall Study||0||
48751571|NCT00101686|102180753|FG001|COMPLETED|Overall Study||0||
48751572|NCT00101686|102180754|FG002|COMPLETED|Overall Study||0||
48751573|NCT00101686|102180755|FG003|COMPLETED|Overall Study||0||
48751574|NCT00101686|102180756|FG004|COMPLETED|Overall Study||0||
48751575|NCT00101686|102180757|FG005|COMPLETED|Overall Study||0||
48751576|NCT00101686|102180758|FG006|COMPLETED|Overall Study||0||
48751577|NCT00101686|102180759|FG007|COMPLETED|Overall Study||0||
48751578|NCT00101686|102180760|FG008|COMPLETED|Overall Study||0||
48751579|NCT00101686|102180761|FG009|COMPLETED|Overall Study||0||
48751580|NCT00101686|102180752|FG000|NOT COMPLETED|Overall Study||71||
48751581|NCT00101686|102180753|FG001|NOT COMPLETED|Overall Study||73||
48751582|NCT00101686|102180754|FG002|NOT COMPLETED|Overall Study||69||
48751583|NCT00101686|102180755|FG003|NOT COMPLETED|Overall Study||72||
48751584|NCT00101686|102180756|FG004|NOT COMPLETED|Overall Study||73||
48751585|NCT00101686|102180757|FG005|NOT COMPLETED|Overall Study||72||
48751586|NCT00101686|102180758|FG006|NOT COMPLETED|Overall Study||27||
48751587|NCT00101686|102180759|FG007|NOT COMPLETED|Overall Study||30||
48751588|NCT00101686|102180760|FG008|NOT COMPLETED|Overall Study||30||
48412088|NCT00537810|101341922|FG001|STARTED|Overall Study||27||
48751589|NCT00101686|102180761|FG009|NOT COMPLETED|Overall Study||30||
48751590|NCT05261386|102180762|FG000|STARTED|Overall Study||32||
48751591|NCT05261386|102180763|FG001|STARTED|Overall Study||31||
48751592|NCT05261386|102180764|FG002|STARTED|Overall Study||32||
48751593|NCT05261386|102180762|FG000|COMPLETED|Overall Study||32||
48751594|NCT05261386|102180763|FG001|COMPLETED|Overall Study||30||
48412089|NCT00537810|101341923|FG002|STARTED|Overall Study||25||
48412090|NCT00537810|101341924|FG003|STARTED|Overall Study||26||
48628533|NCT03504917|101874417|FG001|COMPLETED|Open Label Extension Treatment Period||0|ITT Population|
48628534|NCT03504917|101874416|FG000|NOT COMPLETED|Open Label Extension Treatment Period||100||
48628535|NCT03504917|101874417|FG001|NOT COMPLETED|Open Label Extension Treatment Period||97||
48628536|NCT01155570|101874418|FG000|STARTED|Overall Study||734||
48628537|NCT01155570|101874418|FG000|Efficacy Analysis Population|Overall Study||708||
48628538|NCT01155570|101874418|FG000|COMPLETED|Overall Study||592||
48628539|NCT01155570|101874418|FG000|NOT COMPLETED|Overall Study||142||
48628540|NCT02814526|101874419|FG000|STARTED|Overall Study||148||
48628541|NCT02814526|101874420|FG001|STARTED|Overall Study||148||
48628542|NCT02814526|101874419|FG000|COMPLETED|Overall Study||115|Completed = number of participants randomized to AX or SBR and completed 12 months of supervised exercise sessions|
48628543|NCT02814526|101874420|FG001|COMPLETED|Overall Study||118|Completed = number of participants randomized to AX or SBR and completed 12 months of supervised exercise sessions|
48628544|NCT02814526|101874419|FG000|NOT COMPLETED|Overall Study||33||
48628545|NCT02814526|101874420|FG001|NOT COMPLETED|Overall Study||30||
48628546|NCT00997334|101874421|FG000|STARTED|Overall Study||60||
48628547|NCT00997334|101874421|FG000|Eligible for Repeat Biopsy|Overall Study||44||
48628548|NCT00997334|101874421|FG000|Evaluable|Overall Study||35||
48628549|NCT00997334|101874421|FG000|COMPLETED|Overall Study||35||
48628550|NCT00997334|101874421|FG000|NOT COMPLETED|Overall Study||25||
48751595|NCT05261386|102180764|FG002|COMPLETED|Overall Study||32||
48751596|NCT05261386|102180762|FG000|NOT COMPLETED|Overall Study||0||
48751597|NCT05261386|102180763|FG001|NOT COMPLETED|Overall Study||1||
48751598|NCT05261386|102180764|FG002|NOT COMPLETED|Overall Study||0||
48751599|NCT02796677|102180765|FG000|STARTED|Overall Study||317|All participants in the screened population who were randomized to a treatment group in the study.|
48751600|NCT02796677|102180766|FG001|STARTED|Overall Study||478|All participants in the screened population who were randomized to a treatment group in the study.|
48751601|NCT02796677|102180767|FG002|STARTED|Overall Study||320|All participants in the screened population who were randomized to a treatment group in the study.|
48767727|NCT00494676|102222812|FG000|COMPLETED|First Intervention||34||
48628551|NCT03836586|101874422|FG000|STARTED|Overall Study||5||
48628552|NCT03836586|101874423|FG001|STARTED|Overall Study||5||
48628553|NCT03836586|101874422|FG000|COMPLETED|Overall Study||5||
48628554|NCT03836586|101874423|FG001|COMPLETED|Overall Study||5||
48628555|NCT03836586|101874422|FG000|NOT COMPLETED|Overall Study||0||
48628556|NCT03836586|101874423|FG001|NOT COMPLETED|Overall Study||0||
48628557|NCT04159714|101874424|FG000|STARTED|Overall Study||1||
48628558|NCT04159714|101874425|FG001|STARTED|Overall Study||0||
48628559|NCT04159714|101874424|FG000|COMPLETED|Overall Study||1||
48628560|NCT04159714|101874425|FG001|COMPLETED|Overall Study||0||
48628561|NCT04159714|101874424|FG000|NOT COMPLETED|Overall Study||0||
48628562|NCT04159714|101874425|FG001|NOT COMPLETED|Overall Study||0||
48628563|NCT02879318|101874426|FG000|STARTED|Overall Study||61||
48628564|NCT02879318|101874427|FG001|STARTED|Overall Study||119||
48628565|NCT02879318|101874426|FG000|COMPLETED|Overall Study||61||
48628566|NCT02879318|101874427|FG001|COMPLETED|Overall Study||119||
48628567|NCT02879318|101874426|FG000|NOT COMPLETED|Overall Study||0||
48628568|NCT02879318|101874427|FG001|NOT COMPLETED|Overall Study||0||
48751602|NCT02796677|102180768|FG003|STARTED|Overall Study||479|All participants in the screened population who were randomized to a treatment group in the study.|
48751603|NCT02796677|102180765|FG000|Completed Treatment and Follow-up|Overall Study||279|Participants who completed the study treatment and the study, and attend to the follow-up contact|
48751604|NCT02796677|102180766|FG001|Completed Treatment and Follow-up|Overall Study||405|Participants who completed the study treatment and the study, and attend to the follow-up contact|
48751605|NCT02796677|102180767|FG002|Completed Treatment and Follow-up|Overall Study||267|Participants who completed the study treatment and the study, and attend to the follow-up contact|
48751606|NCT02796677|102180768|FG003|Completed Treatment and Follow-up|Overall Study||403|Participants who completed the study treatment and the study, and attend to the follow-up contact|
48751607|NCT02796677|102180765|FG000|COMPLETED|Overall Study||279|Participants who completed the study treatment and the study|
48751608|NCT02796677|102180766|FG001|COMPLETED|Overall Study||405|Participants who completed the study treatment and the study|
48751609|NCT02796677|102180767|FG002|COMPLETED|Overall Study||267|Participants who completed the study treatment and the study|
48172545|NCT02066532|100746207|FG001|COMPLETED|Phase I||1||
48751610|NCT02796677|102180768|FG003|COMPLETED|Overall Study||405|Participants who completed the study treatment and the study|
48751611|NCT02796677|102180765|FG000|NOT COMPLETED|Overall Study||38||
48751612|NCT02796677|102180766|FG001|NOT COMPLETED|Overall Study||73||
48751613|NCT02796677|102180767|FG002|NOT COMPLETED|Overall Study||53||
48751614|NCT02796677|102180768|FG003|NOT COMPLETED|Overall Study||74||
48751615|NCT03349723|102180769|FG000|STARTED|Overall Study||6|Started are the Treated|
48751616|NCT03349723|102180770|FG001|STARTED|Overall Study||6|Started are the Treated|
48751617|NCT03349723|102180771|FG002|STARTED|Overall Study||6|Started are the Treated|
48751618|NCT03349723|102180772|FG003|STARTED|Overall Study||6|Started are the Treated|
48334578|NCT01239160|101148206|FG000|NOT COMPLETED|Overall Study||25||
48628569|NCT01578772|101874428|FG000|STARTED|Overall Study||17||
48628570|NCT01578772|101874428|FG000|COMPLETED|Overall Study||17||
48628571|NCT01578772|101874428|FG000|NOT COMPLETED|Overall Study||0||
48628572|NCT01411852|101874429|FG000|STARTED|Prehospital Intervention Phase||95||
48751619|NCT03349723|102180773|FG004|STARTED|Overall Study||6|Started are the Treated|
48172546|NCT02066532|100746208|FG002|COMPLETED|Phase I||0||
48628573|NCT01411852|101874430|FG001|STARTED|Prehospital Intervention Phase||96||
48628574|NCT01411852|101874429|FG000|COMPLETED|Prehospital Intervention Phase||83||
48172547|NCT02066532|100746209|FG003|COMPLETED|Phase I||0||
48172548|NCT02066532|100746206|FG000|NOT COMPLETED|Phase I||0||
48172549|NCT02066532|100746207|FG001|NOT COMPLETED|Phase I||0||
48172550|NCT02066532|100746208|FG002|NOT COMPLETED|Phase I||0||
48172551|NCT02066532|100746209|FG003|NOT COMPLETED|Phase I||0||
48172552|NCT02066532|100746206|FG000|STARTED|Phase II||27||
48172553|NCT02066532|100746207|FG001|STARTED|Phase II||0||
48172554|NCT02066532|100746208|FG002|STARTED|Phase II||0||
48172555|NCT02066532|100746209|FG003|STARTED|Phase II||0||
48172556|NCT02066532|100746206|FG000|COMPLETED|Phase II||26||
48172557|NCT02066532|100746207|FG001|COMPLETED|Phase II||0||
48628575|NCT01411852|101874430|FG001|COMPLETED|Prehospital Intervention Phase||89||
48172558|NCT02066532|100746208|FG002|COMPLETED|Phase II||0||
48172559|NCT02066532|100746209|FG003|COMPLETED|Phase II||0||
48172560|NCT02066532|100746206|FG000|NOT COMPLETED|Phase II||1||
48172561|NCT02066532|100746207|FG001|NOT COMPLETED|Phase II||0||
48172562|NCT02066532|100746208|FG002|NOT COMPLETED|Phase II||0||
48172563|NCT02066532|100746209|FG003|NOT COMPLETED|Phase II||0||
48172564|NCT02378402|100746210|FG000|STARTED|Overall Study||25||
48172565|NCT02378402|100746211|FG001|STARTED|Overall Study||25||
48172566|NCT02378402|100746212|FG002|STARTED|Overall Study||21||
48334579|NCT01239160|101148207|FG001|NOT COMPLETED|Overall Study||19||
48172567|NCT02378402|100746210|FG000|COMPLETED|Overall Study||25||
48628576|NCT01411852|101874429|FG000|NOT COMPLETED|Prehospital Intervention Phase||12||
48628577|NCT01411852|101874430|FG001|NOT COMPLETED|Prehospital Intervention Phase||7||
48628578|NCT01411852|101874429|FG000|STARTED|Hospital Intervention Phase||83||
48751620|NCT03349723|102180774|FG005|STARTED|Overall Study||6|Started are the Treated|
48751621|NCT03349723|102180775|FG006|STARTED|Overall Study||6|Started are the Treated|
48751622|NCT03349723|102180776|FG007|STARTED|Overall Study||14|Started are the Treated|
48751623|NCT03349723|102180769|FG000|COMPLETED|Overall Study||6||
48751624|NCT03349723|102180770|FG001|COMPLETED|Overall Study||6||
48751625|NCT03349723|102180771|FG002|COMPLETED|Overall Study||6||
48172568|NCT02378402|100746211|FG001|COMPLETED|Overall Study||23||
48334580|NCT01239160|101148208|FG002|NOT COMPLETED|Overall Study||10||
48628579|NCT01411852|101874430|FG001|STARTED|Hospital Intervention Phase||89||
48628580|NCT01411852|101874429|FG000|COMPLETED|Hospital Intervention Phase||59||
48628581|NCT01411852|101874430|FG001|COMPLETED|Hospital Intervention Phase||71||
48172569|NCT02378402|100746212|FG002|COMPLETED|Overall Study||21||
48172570|NCT02378402|100746210|FG000|NOT COMPLETED|Overall Study||0||
48172571|NCT02378402|100746211|FG001|NOT COMPLETED|Overall Study||2||
48172572|NCT02378402|100746212|FG002|NOT COMPLETED|Overall Study||0||
48172573|NCT02045433|100746213|FG000|STARTED|Overall Study||16||
48172574|NCT02045433|100746213|FG000|COMPLETED|Overall Study||15||
48172575|NCT02045433|100746213|FG000|NOT COMPLETED|Overall Study||1||
48172576|NCT01250119|100746214|FG000|STARTED|Diagnostic Phase||688||
48172577|NCT01250119|100746215|FG001|STARTED|Diagnostic Phase||0||
48172578|NCT01250119|100746214|FG000|COMPLETED|Diagnostic Phase||575||
48172579|NCT01250119|100746215|FG001|COMPLETED|Diagnostic Phase||0||
48172580|NCT01250119|100746214|FG000|NOT COMPLETED|Diagnostic Phase||113||
48172581|NCT01250119|100746215|FG001|NOT COMPLETED|Diagnostic Phase||0||
48172582|NCT01250119|100746214|FG000|STARTED|Treatment Phase||0||
48172583|NCT01250119|100746215|FG001|STARTED|Treatment Phase||41||
48172584|NCT01250119|100746214|FG000|COMPLETED|Treatment Phase||0||
48172585|NCT01250119|100746215|FG001|COMPLETED|Treatment Phase||0||
48172586|NCT01250119|100746214|FG000|NOT COMPLETED|Treatment Phase||0||
48172587|NCT01250119|100746215|FG001|NOT COMPLETED|Treatment Phase||41||
48172588|NCT02211534|100746216|FG000|STARTED|Overall Study||24||
48172589|NCT02211534|100746217|FG001|STARTED|Overall Study||11||
48172590|NCT02211534|100746216|FG000|COMPLETED|Overall Study||11||
48172591|NCT02211534|100746217|FG001|COMPLETED|Overall Study||6||
48172592|NCT02211534|100746216|FG000|NOT COMPLETED|Overall Study||13||
48172593|NCT02211534|100746217|FG001|NOT COMPLETED|Overall Study||5||
48172594|NCT01863043|100746218|FG000|STARTED|Overall Study||74||
48172595|NCT01863043|100746219|FG001|STARTED|Overall Study||72||
48172596|NCT01863043|100746218|FG000|COMPLETED|Overall Study||61||
48172597|NCT01863043|100746219|FG001|COMPLETED|Overall Study||60||
48172598|NCT01863043|100746218|FG000|NOT COMPLETED|Overall Study||13||
48172599|NCT01863043|100746219|FG001|NOT COMPLETED|Overall Study||12||
48172600|NCT00423852|100746220|FG000|STARTED|Overall Study||26||
48172601|NCT00423852|100746220|FG000|COMPLETED|Overall Study||23||
48172602|NCT00423852|100746220|FG000|NOT COMPLETED|Overall Study||3||
48172603|NCT01984424|100746221|FG000|STARTED|Overall Study||73||
48172604|NCT01984424|100746222|FG001|STARTED|Overall Study||145||
48172605|NCT01984424|100746221|FG000|COMPLETED|Overall Study||70||
48172606|NCT01984424|100746222|FG001|COMPLETED|Overall Study||138||
48172607|NCT01984424|100746221|FG000|NOT COMPLETED|Overall Study||3||
48172608|NCT01984424|100746222|FG001|NOT COMPLETED|Overall Study||7||
48172609|NCT02494206|100746223|FG000|STARTED|Overall Study||9||
48172610|NCT02494206|100746223|FG000|COMPLETED|Overall Study||7||
48172611|NCT02494206|100746223|FG000|NOT COMPLETED|Overall Study||2||
48172612|NCT04205929|100746224|FG000|STARTED|Overall Study||29||
48172613|NCT04205929|100746225|FG001|STARTED|Overall Study||29||
48172614|NCT04205929|100746224|FG000|COMPLETED|Overall Study||28||
48172615|NCT04205929|100746225|FG001|COMPLETED|Overall Study||26||
48172616|NCT04205929|100746224|FG000|NOT COMPLETED|Overall Study||1||
48172617|NCT04205929|100746225|FG001|NOT COMPLETED|Overall Study||3||
48172618|NCT02204293|100746226|FG000|STARTED|Core Study Part I||19||
48172619|NCT02204293|100746227|FG001|STARTED|Core Study Part I||17||
48172620|NCT02204293|100746228|FG002|STARTED|Core Study Part I||0||
48172621|NCT02204293|100746229|FG003|STARTED|Core Study Part I||0||
48172622|NCT02204293|100746230|FG004|STARTED|Core Study Part I||0||
48172623|NCT02204293|100746231|FG005|STARTED|Core Study Part I||0||
48172624|NCT02204293|100746226|FG000|Intention-to-treat Population|Core Study Part I||18||
48172625|NCT02204293|100746227|FG001|Intention-to-treat Population|Core Study Part I||17||
48334581|NCT02272686|101148209|FG000|STARTED|Overall Study||1||
48172626|NCT02204293|100746228|FG002|Intention-to-treat Population|Core Study Part I||0||
48172627|NCT02204293|100746229|FG003|Intention-to-treat Population|Core Study Part I||0||
48172628|NCT02204293|100746230|FG004|Intention-to-treat Population|Core Study Part I||0||
48172629|NCT02204293|100746231|FG005|Intention-to-treat Population|Core Study Part I||0||
48172630|NCT02204293|100746226|FG000|Safety Population|Core Study Part I||20||
48172631|NCT02204293|100746227|FG001|Safety Population|Core Study Part I||15||
48172632|NCT02204293|100746228|FG002|Safety Population|Core Study Part I||0||
48172633|NCT02204293|100746229|FG003|Safety Population|Core Study Part I||0||
48172634|NCT02204293|100746230|FG004|Safety Population|Core Study Part I||0||
48172635|NCT02204293|100746231|FG005|Safety Population|Core Study Part I||0||
48172636|NCT02204293|100746226|FG000|COMPLETED|Core Study Part I||17||
48172637|NCT02204293|100746227|FG001|COMPLETED|Core Study Part I||14||
48172638|NCT02204293|100746228|FG002|COMPLETED|Core Study Part I||0||
48172639|NCT02204293|100746229|FG003|COMPLETED|Core Study Part I||0||
48172640|NCT02204293|100746230|FG004|COMPLETED|Core Study Part I||0||
48172641|NCT02204293|100746231|FG005|COMPLETED|Core Study Part I||0||
48172642|NCT02204293|100746226|FG000|NOT COMPLETED|Core Study Part I||2||
48172643|NCT02204293|100746227|FG001|NOT COMPLETED|Core Study Part I||3||
48172644|NCT02204293|100746228|FG002|NOT COMPLETED|Core Study Part I||0||
48172645|NCT02204293|100746229|FG003|NOT COMPLETED|Core Study Part I||0||
48172646|NCT02204293|100746230|FG004|NOT COMPLETED|Core Study Part I||0||
48172647|NCT02204293|100746231|FG005|NOT COMPLETED|Core Study Part I||0||
48172648|NCT02204293|100746226|FG000|STARTED|Core Study Part 2||0||
48172649|NCT02204293|100746227|FG001|STARTED|Core Study Part 2||0||
48172650|NCT02204293|100746228|FG002|STARTED|Core Study Part 2||12||
48334582|NCT02272686|101148209|FG000|COMPLETED|Overall Study||1||
48334583|NCT02272686|101148209|FG000|NOT COMPLETED|Overall Study||0||
48334584|NCT01641939|101148210|FG000|STARTED|Overall Study||117||
48628582|NCT01411852|101874429|FG000|NOT COMPLETED|Hospital Intervention Phase||24||
48628583|NCT01411852|101874430|FG001|NOT COMPLETED|Hospital Intervention Phase||18||
48628584|NCT03311555|101874431|FG000|STARTED|Overall Study||39||
48628585|NCT03311555|101874431|FG000|COMPLETED|Overall Study||38||
48334585|NCT01641939|101148211|FG001|STARTED|Overall Study||228||
48334586|NCT01641939|101148212|FG002|STARTED|Overall Study||70||
48334587|NCT01641939|101148210|FG000|Stage 1|Overall Study||37||
48334588|NCT01641939|101148211|FG001|Stage 1|Overall Study||75||
48334589|NCT01641939|101148212|FG002|Stage 1|Overall Study||70||
48334590|NCT01641939|101148210|FG000|Stage 2|Overall Study||80||
48334591|NCT01641939|101148211|FG001|Stage 2|Overall Study||153||
48334592|NCT01641939|101148212|FG002|Stage 2|Overall Study||0||
48334593|NCT01641939|101148210|FG000|COMPLETED|Overall Study||0||
48334594|NCT01641939|101148211|FG001|COMPLETED|Overall Study||0||
48334595|NCT01641939|101148212|FG002|COMPLETED|Overall Study||0||
48334596|NCT01641939|101148210|FG000|NOT COMPLETED|Overall Study||117||
48334597|NCT01641939|101148211|FG001|NOT COMPLETED|Overall Study||228||
48334598|NCT01641939|101148212|FG002|NOT COMPLETED|Overall Study||70||
48334599|NCT03969888|101148213|FG000|STARTED|Overall Study||6||
48334600|NCT03969888|101148214|FG001|STARTED|Overall Study||7||
48334601|NCT03969888|101148215|FG002|STARTED|Overall Study||5||
48334602|NCT03969888|101148216|FG003|STARTED|Overall Study||12||
48334603|NCT03969888|101148217|FG004|STARTED|Overall Study||11||
48334604|NCT03969888|101148218|FG005|STARTED|Overall Study||12||
48334605|NCT03969888|101148219|FG006|STARTED|Overall Study||14||
48334606|NCT03969888|101148220|FG007|STARTED|Overall Study||11||
48334607|NCT03969888|101148213|FG000|COMPLETED|Overall Study||6||
48334608|NCT03969888|101148214|FG001|COMPLETED|Overall Study||7||
48334609|NCT03969888|101148215|FG002|COMPLETED|Overall Study||4||
48334610|NCT03969888|101148216|FG003|COMPLETED|Overall Study||12||
48334611|NCT03969888|101148217|FG004|COMPLETED|Overall Study||11||
48334612|NCT03969888|101148218|FG005|COMPLETED|Overall Study||12||
48334613|NCT03969888|101148219|FG006|COMPLETED|Overall Study||13||
48334614|NCT03969888|101148220|FG007|COMPLETED|Overall Study||10||
48334615|NCT03969888|101148213|FG000|NOT COMPLETED|Overall Study||0||
48334616|NCT03969888|101148214|FG001|NOT COMPLETED|Overall Study||0||
48334617|NCT03969888|101148215|FG002|NOT COMPLETED|Overall Study||1||
48334618|NCT03969888|101148216|FG003|NOT COMPLETED|Overall Study||0||
48334619|NCT03969888|101148217|FG004|NOT COMPLETED|Overall Study||0||
48334620|NCT03969888|101148218|FG005|NOT COMPLETED|Overall Study||0||
48334621|NCT03969888|101148219|FG006|NOT COMPLETED|Overall Study||1||
48334622|NCT03969888|101148220|FG007|NOT COMPLETED|Overall Study||1||
48412091|NCT00537810|101341921|FG000|COMPLETED|Overall Study||20||
48628586|NCT03311555|101874431|FG000|NOT COMPLETED|Overall Study||1||
48628587|NCT01787552|101874432|FG000|STARTED|Overall Study||8||
48628588|NCT01787552|101874433|FG001|STARTED|Overall Study||10||
48751626|NCT03349723|102180772|FG003|COMPLETED|Overall Study||6||
48751627|NCT03349723|102180773|FG004|COMPLETED|Overall Study||6||
48751628|NCT03349723|102180774|FG005|COMPLETED|Overall Study||6||
48751629|NCT03349723|102180775|FG006|COMPLETED|Overall Study||6||
48751630|NCT03349723|102180776|FG007|COMPLETED|Overall Study||14||
48751631|NCT03349723|102180769|FG000|NOT COMPLETED|Overall Study||0||
48751632|NCT03349723|102180770|FG001|NOT COMPLETED|Overall Study||0||
48751633|NCT03349723|102180771|FG002|NOT COMPLETED|Overall Study||0||
48751634|NCT03349723|102180772|FG003|NOT COMPLETED|Overall Study||0||
48751635|NCT03349723|102180773|FG004|NOT COMPLETED|Overall Study||0||
48334623|NCT01235962|101148221|FG000|STARTED|Overall Study||198||
48334624|NCT01235962|101148222|FG001|STARTED|Overall Study||205||
48751636|NCT03349723|102180774|FG005|NOT COMPLETED|Overall Study||0||
48334625|NCT01235962|101148223|FG002|STARTED|Overall Study||571||
48751637|NCT03349723|102180775|FG006|NOT COMPLETED|Overall Study||0||
48334626|NCT01235962|101148224|FG003|STARTED|Overall Study||564||
48334627|NCT01235962|101148221|FG000|Prem. Withdrawn = Did Not Complete Study|Overall Study||46||
48334628|NCT01235962|101148222|FG001|Prem. Withdrawn = Did Not Complete Study|Overall Study||35||
48334629|NCT01235962|101148223|FG002|Prem. Withdrawn = Did Not Complete Study|Overall Study||118||
48412092|NCT00537810|101341922|FG001|COMPLETED|Overall Study||14||
48334630|NCT01235962|101148224|FG003|Prem. Withdrawn = Did Not Complete Study|Overall Study||86||
48628589|NCT01787552|101874434|FG002|STARTED|Overall Study||5||
48628590|NCT01787552|101874435|FG003|STARTED|Overall Study||27||
48628591|NCT01787552|101874432|FG000|COMPLETED|Overall Study||0||
48628592|NCT01787552|101874433|FG001|COMPLETED|Overall Study||1||
48172651|NCT02204293|100746229|FG003|STARTED|Core Study Part 2||4||
48172652|NCT02204293|100746230|FG004|STARTED|Core Study Part 2||7||
48172653|NCT02204293|100746231|FG005|STARTED|Core Study Part 2||0||
48172654|NCT02204293|100746226|FG000|Safety Population|Core Study Part 2||0||
48172655|NCT02204293|100746227|FG001|Safety Population|Core Study Part 2||0||
48172656|NCT02204293|100746228|FG002|Safety Population|Core Study Part 2||14||
48172657|NCT02204293|100746229|FG003|Safety Population|Core Study Part 2||2||
48172658|NCT02204293|100746230|FG004|Safety Population|Core Study Part 2||7||
48172659|NCT02204293|100746231|FG005|Safety Population|Core Study Part 2||0||
48172660|NCT02204293|100746226|FG000|COMPLETED|Core Study Part 2||0||
48172661|NCT02204293|100746227|FG001|COMPLETED|Core Study Part 2||0||
48172662|NCT02204293|100746228|FG002|COMPLETED|Core Study Part 2||12||
48172663|NCT02204293|100746229|FG003|COMPLETED|Core Study Part 2||4||
48172664|NCT02204293|100746230|FG004|COMPLETED|Core Study Part 2||7||
48172665|NCT02204293|100746231|FG005|COMPLETED|Core Study Part 2||0||
48172666|NCT02204293|100746226|FG000|NOT COMPLETED|Core Study Part 2||0||
48172667|NCT02204293|100746227|FG001|NOT COMPLETED|Core Study Part 2||0||
48172668|NCT02204293|100746228|FG002|NOT COMPLETED|Core Study Part 2||0||
48172669|NCT02204293|100746229|FG003|NOT COMPLETED|Core Study Part 2||0||
48172670|NCT02204293|100746230|FG004|NOT COMPLETED|Core Study Part 2||0||
48172671|NCT02204293|100746231|FG005|NOT COMPLETED|Core Study Part 2||0||
48172672|NCT02204293|100746226|FG000|STARTED|LTE Phase||0|Participants who achieved remission entered LTE Phase.|
48172673|NCT02204293|100746227|FG001|STARTED|LTE Phase||0|Participants who achieved remission entered LTE Phase.|
48172674|NCT02204293|100746228|FG002|STARTED|LTE Phase||0|Participants who achieved remission entered LTE Phase.|
48172675|NCT02204293|100746229|FG003|STARTED|LTE Phase||0|Participants who achieved remission entered LTE Phase.|
48172676|NCT02204293|100746230|FG004|STARTED|LTE Phase||0|Participants who achieved remission entered LTE Phase.|
48172677|NCT02204293|100746231|FG005|STARTED|LTE Phase||7|Participants who achieved remission entered LTE Phase.|
48172678|NCT02204293|100746226|FG000|COMPLETED|LTE Phase||0||
48172679|NCT02204293|100746227|FG001|COMPLETED|LTE Phase||0||
48172680|NCT02204293|100746228|FG002|COMPLETED|LTE Phase||0||
48172681|NCT02204293|100746229|FG003|COMPLETED|LTE Phase||0||
48172682|NCT02204293|100746230|FG004|COMPLETED|LTE Phase||0||
48172683|NCT02204293|100746231|FG005|COMPLETED|LTE Phase||0||
48172684|NCT02204293|100746226|FG000|NOT COMPLETED|LTE Phase||0||
48172685|NCT02204293|100746227|FG001|NOT COMPLETED|LTE Phase||0||
48172686|NCT02204293|100746228|FG002|NOT COMPLETED|LTE Phase||0||
48172687|NCT02204293|100746229|FG003|NOT COMPLETED|LTE Phase||0||
48172688|NCT02204293|100746230|FG004|NOT COMPLETED|LTE Phase||0||
48172689|NCT02204293|100746231|FG005|NOT COMPLETED|LTE Phase||7||
48172690|NCT01018563|100746232|FG000|STARTED|Overall Study||2||
48172691|NCT01018563|100746233|FG001|STARTED|Overall Study||1||
48172692|NCT01018563|100746232|FG000|COMPLETED|Overall Study||0||
48172693|NCT01018563|100746233|FG001|COMPLETED|Overall Study||0||
48172694|NCT01018563|100746232|FG000|NOT COMPLETED|Overall Study||2||
48172695|NCT01018563|100746233|FG001|NOT COMPLETED|Overall Study||1||
48172696|NCT01284140|100746234|FG000|STARTED|Randomization and Intervention||11||
48172697|NCT01284140|100746235|FG001|STARTED|Randomization and Intervention||11||
48172698|NCT01284140|100746234|FG000|COMPLETED|Randomization and Intervention||11||
48172699|NCT01284140|100746235|FG001|COMPLETED|Randomization and Intervention||11||
48172700|NCT01284140|100746234|FG000|NOT COMPLETED|Randomization and Intervention||0||
48172701|NCT01284140|100746235|FG001|NOT COMPLETED|Randomization and Intervention||0||
48172702|NCT01284140|100746234|FG000|STARTED|Subjects With Paired 24hr Collections||11||
48172703|NCT01284140|100746235|FG001|STARTED|Subjects With Paired 24hr Collections||11||
48172704|NCT01284140|100746234|FG000|COMPLETED|Subjects With Paired 24hr Collections||6||
48172705|NCT01284140|100746235|FG001|COMPLETED|Subjects With Paired 24hr Collections||5||
48172706|NCT01284140|100746234|FG000|NOT COMPLETED|Subjects With Paired 24hr Collections||5||
48172707|NCT01284140|100746235|FG001|NOT COMPLETED|Subjects With Paired 24hr Collections||6||
48172708|NCT00852137|100746236|FG000|STARTED|Overall Study||13||
48172709|NCT00852137|100746237|FG001|STARTED|Overall Study||3||
48172710|NCT00852137|100746236|FG000|COMPLETED|Overall Study||13||
48172711|NCT00852137|100746237|FG001|COMPLETED|Overall Study||3||
48628593|NCT01787552|101874434|FG002|COMPLETED|Overall Study||0||
48628594|NCT01787552|101874435|FG003|COMPLETED|Overall Study||0||
48172712|NCT00852137|100746236|FG000|NOT COMPLETED|Overall Study||0||
48172713|NCT00852137|100746237|FG001|NOT COMPLETED|Overall Study||0||
48172714|NCT01108510|100746238|FG000|STARTED|Overall Study||349||
48172715|NCT01108510|100746239|FG001|STARTED|Overall Study||349||
48172716|NCT01108510|100746238|FG000|COMPLETED|Overall Study||70||
48172717|NCT01108510|100746239|FG001|COMPLETED|Overall Study||81||
48172718|NCT01108510|100746238|FG000|NOT COMPLETED|Overall Study||279||
48172719|NCT01108510|100746239|FG001|NOT COMPLETED|Overall Study||268||
48172720|NCT02802319|100746240|FG000|STARTED|Overall Study||22||
48172721|NCT02802319|100746241|FG001|STARTED|Overall Study||22||
48172722|NCT02802319|100746240|FG000|COMPLETED|Overall Study||20||
48172723|NCT02802319|100746241|FG001|COMPLETED|Overall Study||17||
48172724|NCT02802319|100746240|FG000|NOT COMPLETED|Overall Study||2||
48172725|NCT02802319|100746241|FG001|NOT COMPLETED|Overall Study||5||
48628595|NCT01787552|101874432|FG000|NOT COMPLETED|Overall Study||8||
48172726|NCT01017653|100746242|FG000|STARTED|Overall Study||16||
48172727|NCT01017653|100746242|FG000|COMPLETED|Overall Study||16||
48172728|NCT01017653|100746242|FG000|NOT COMPLETED|Overall Study||0||
48172729|NCT04867785|100746243|FG000|STARTED|Overall Study||45||
48172730|NCT04867785|100746244|FG001|STARTED|Overall Study||46||
48172731|NCT04867785|100746245|FG002|STARTED|Overall Study||47||
48172732|NCT04867785|100746246|FG003|STARTED|Overall Study||23||
48172733|NCT04867785|100746247|FG004|STARTED|Overall Study||24||
48172734|NCT04867785|100746248|FG005|STARTED|Overall Study||26||
48172735|NCT04867785|100746249|FG006|STARTED|Overall Study||24||
48172736|NCT04867785|100746250|FG007|STARTED|Overall Study||46||
48172737|NCT04867785|100746243|FG000|Received at Least 1 Dose of Study Drug|Overall Study||45||
48172738|NCT04867785|100746244|FG001|Received at Least 1 Dose of Study Drug|Overall Study||46||
48172739|NCT04867785|100746245|FG002|Received at Least 1 Dose of Study Drug|Overall Study||47||
48172740|NCT04867785|100746246|FG003|Received at Least 1 Dose of Study Drug|Overall Study||23||
48172741|NCT04867785|100746247|FG004|Received at Least 1 Dose of Study Drug|Overall Study||24||
48172742|NCT04867785|100746248|FG005|Received at Least 1 Dose of Study Drug|Overall Study||26||
48172743|NCT04867785|100746249|FG006|Received at Least 1 Dose of Study Drug|Overall Study||24||
48172744|NCT04867785|100746250|FG007|Received at Least 1 Dose of Study Drug|Overall Study||46||
48172745|NCT04867785|100746243|FG000|COMPLETED|Overall Study||34||
48172746|NCT04867785|100746244|FG001|COMPLETED|Overall Study||40||
48172747|NCT04867785|100746245|FG002|COMPLETED|Overall Study||41||
48172748|NCT04867785|100746246|FG003|COMPLETED|Overall Study||19||
48172749|NCT04867785|100746247|FG004|COMPLETED|Overall Study||21||
48172750|NCT04867785|100746248|FG005|COMPLETED|Overall Study||25||
48412093|NCT00537810|101341923|FG002|COMPLETED|Overall Study||21||
48412094|NCT00537810|101341924|FG003|COMPLETED|Overall Study||22||
48412095|NCT00537810|101341921|FG000|NOT COMPLETED|Overall Study||6||
48412096|NCT00537810|101341922|FG001|NOT COMPLETED|Overall Study||13||
48412097|NCT00537810|101341923|FG002|NOT COMPLETED|Overall Study||4||
48412098|NCT00537810|101341924|FG003|NOT COMPLETED|Overall Study||4||
48412099|NCT03701061|101341925|FG000|STARTED|Overall Study||9||
48412100|NCT03701061|101341926|FG001|STARTED|Overall Study||3||
48628596|NCT01787552|101874433|FG001|NOT COMPLETED|Overall Study||9||
48628597|NCT01787552|101874434|FG002|NOT COMPLETED|Overall Study||5||
48172751|NCT04867785|100746249|FG006|COMPLETED|Overall Study||22||
48172752|NCT04867785|100746250|FG007|COMPLETED|Overall Study||35||
48172753|NCT04867785|100746243|FG000|NOT COMPLETED|Overall Study||11||
48172754|NCT04867785|100746244|FG001|NOT COMPLETED|Overall Study||6||
48172755|NCT04867785|100746245|FG002|NOT COMPLETED|Overall Study||6||
48172756|NCT04867785|100746246|FG003|NOT COMPLETED|Overall Study||4||
48172757|NCT04867785|100746247|FG004|NOT COMPLETED|Overall Study||3||
48172758|NCT04867785|100746248|FG005|NOT COMPLETED|Overall Study||1||
48172759|NCT04867785|100746249|FG006|NOT COMPLETED|Overall Study||2||
48172760|NCT04867785|100746250|FG007|NOT COMPLETED|Overall Study||11||
48172761|NCT01004250|100746251|FG000|STARTED|Induction Therapy Period||109||
48172762|NCT01004250|100746251|FG000|Received at Least One Dose of Study Drug|Induction Therapy Period||109||
48172763|NCT01004250|100746251|FG000|Death (Any Cause) or Disease Progression|Induction Therapy Period||21||
48172764|NCT01004250|100746251|FG000|COMPLETED|Induction Therapy Period||94||
48172765|NCT01004250|100746251|FG000|NOT COMPLETED|Induction Therapy Period||15||
48412101|NCT03701061|101341925|FG000|COMPLETED|Overall Study||9||
48412102|NCT03701061|101341926|FG001|COMPLETED|Overall Study||3||
48412103|NCT03701061|101341925|FG000|NOT COMPLETED|Overall Study||0||
48412104|NCT03701061|101341926|FG001|NOT COMPLETED|Overall Study||0||
48628598|NCT01787552|101874435|FG003|NOT COMPLETED|Overall Study||27||
48412105|NCT03083470|101341927|FG000|STARTED|Overall Study||6||
48628599|NCT02785939|101874436|FG000|STARTED|Overall Study||31||
48628600|NCT02785939|101874437|FG001|STARTED|Overall Study||10||
48628601|NCT02785939|101874436|FG000|Participants Re-registered to Palbociclib After Progression on Docetaxel|Overall Study||0||
48751638|NCT03349723|102180776|FG007|NOT COMPLETED|Overall Study||0||
48172766|NCT01004250|100746251|FG000|STARTED|Maintenance Therapy Period||72||
48172767|NCT01004250|100746251|FG000|Death (Any Cause) or Disease Progression|Maintenance Therapy Period||46||
48172768|NCT01004250|100746251|FG000|COMPLETED|Maintenance Therapy Period||46||
48172769|NCT01004250|100746251|FG000|NOT COMPLETED|Maintenance Therapy Period||26||
48172770|NCT01004250|100746251|FG000|STARTED|Follow-Up (FU) Period||101||
48172771|NCT01004250|100746251|FG000|COMPLETED|Follow-Up (FU) Period||100||
48172772|NCT01004250|100746251|FG000|NOT COMPLETED|Follow-Up (FU) Period||1||
48172773|NCT03548064|100746252|FG000|STARTED|Overall Study||12||
48172774|NCT03548064|100746253|FG001|STARTED|Overall Study||12||
48172775|NCT03548064|100746254|FG002|STARTED|Overall Study||6||
48172776|NCT03548064|100746255|FG003|STARTED|Overall Study||12||
48172777|NCT03548064|100746256|FG004|STARTED|Overall Study||12||
48172778|NCT03548064|100746257|FG005|STARTED|Overall Study||6||
48172779|NCT03548064|100746258|FG006|STARTED|Overall Study||12||
48172780|NCT03548064|100746259|FG007|STARTED|Overall Study||3||
48412106|NCT03083470|101341928|FG001|STARTED|Overall Study||6||
48412107|NCT03083470|101341929|FG002|STARTED|Overall Study||6||
48412108|NCT03083470|101341930|FG003|STARTED|Overall Study||6||
48412109|NCT03083470|101341931|FG004|STARTED|Overall Study||9||
48412110|NCT03083470|101341927|FG000|COMPLETED|Overall Study||6||
48628602|NCT02785939|101874437|FG001|Participants Re-registered to Palbociclib After Progression on Docetaxel|Overall Study||1||
48628603|NCT02785939|101874436|FG000|COMPLETED|Overall Study||0|Re-registered participant did not complete palbociclib treatment due to progression|
48628604|NCT02785939|101874437|FG001|COMPLETED|Overall Study||0|Re-registered participant did not complete palbociclib treatment due to progression|
48628605|NCT02785939|101874436|FG000|NOT COMPLETED|Overall Study||31||
48628606|NCT02785939|101874437|FG001|NOT COMPLETED|Overall Study||10||
48628607|NCT01132508|101874438|FG000|STARTED|Overall Study||33||
48172781|NCT03548064|100746252|FG000|COMPLETED|Overall Study||12||
48172782|NCT03548064|100746253|FG001|COMPLETED|Overall Study||12||
48172783|NCT03548064|100746254|FG002|COMPLETED|Overall Study||6||
48172784|NCT03548064|100746255|FG003|COMPLETED|Overall Study||11||
48172785|NCT03548064|100746256|FG004|COMPLETED|Overall Study||0||
48172786|NCT03548064|100746257|FG005|COMPLETED|Overall Study||3||
48172787|NCT03548064|100746258|FG006|COMPLETED|Overall Study||12||
48172788|NCT03548064|100746259|FG007|COMPLETED|Overall Study||3||
48172789|NCT03548064|100746252|FG000|NOT COMPLETED|Overall Study||0||
48172790|NCT03548064|100746253|FG001|NOT COMPLETED|Overall Study||0||
48172791|NCT03548064|100746254|FG002|NOT COMPLETED|Overall Study||0||
48172792|NCT03548064|100746255|FG003|NOT COMPLETED|Overall Study||1||
48172793|NCT03548064|100746256|FG004|NOT COMPLETED|Overall Study||12||
48172794|NCT03548064|100746257|FG005|NOT COMPLETED|Overall Study||3||
48172795|NCT03548064|100746258|FG006|NOT COMPLETED|Overall Study||0||
48172796|NCT03548064|100746259|FG007|NOT COMPLETED|Overall Study||0||
48172797|NCT00479089|100746260|FG000|STARTED|Overall Study||25||
48172798|NCT00479089|100746261|FG001|STARTED|Overall Study||25||
48172799|NCT00479089|100746260|FG000|COMPLETED|Overall Study||25||
48172800|NCT00479089|100746261|FG001|COMPLETED|Overall Study||25||
48172801|NCT00479089|100746260|FG000|NOT COMPLETED|Overall Study||0||
48172802|NCT00479089|100746261|FG001|NOT COMPLETED|Overall Study||0||
48172803|NCT01290536|100746262|FG000|STARTED|Overall Study||42||
48172804|NCT01290536|100746262|FG000|COMPLETED|Overall Study||42||
48172805|NCT01290536|100746262|FG000|NOT COMPLETED|Overall Study||0||
48172806|NCT01242176|100746263|FG000|STARTED|First Intervention||12||
48172807|NCT01242176|100746264|FG001|STARTED|First Intervention||12||
48172808|NCT01242176|100746263|FG000|COMPLETED|First Intervention||12||
48172809|NCT01242176|100746264|FG001|COMPLETED|First Intervention||12||
48628608|NCT01132508|101874438|FG000|Treated at Baseline|Overall Study||33||
48628609|NCT01132508|101874438|FG000|6 Weeks|Overall Study||33||
48628610|NCT01132508|101874438|FG000|12 Weeks|Overall Study||33||
48628611|NCT01132508|101874438|FG000|26 Weeks|Overall Study||33||
48628612|NCT01132508|101874438|FG000|52 Weeks|Overall Study||30||
48628613|NCT01132508|101874438|FG000|78 Weeks|Overall Study||28||
48628614|NCT01132508|101874438|FG000|104 Weeks|Overall Study||27||
48628615|NCT01132508|101874438|FG000|COMPLETED|Overall Study||24||
48172810|NCT01242176|100746263|FG000|NOT COMPLETED|First Intervention||0||
48172811|NCT01242176|100746264|FG001|NOT COMPLETED|First Intervention||0||
48172812|NCT01242176|100746263|FG000|STARTED|Washout Period of 7 Days||12||
48172813|NCT01242176|100746264|FG001|STARTED|Washout Period of 7 Days||12||
48172814|NCT01242176|100746263|FG000|COMPLETED|Washout Period of 7 Days||11||
48172815|NCT01242176|100746264|FG001|COMPLETED|Washout Period of 7 Days||10||
48628616|NCT01132508|101874438|FG000|NOT COMPLETED|Overall Study||9||
48172816|NCT01242176|100746263|FG000|NOT COMPLETED|Washout Period of 7 Days||1||
48172817|NCT01242176|100746264|FG001|NOT COMPLETED|Washout Period of 7 Days||2||
48172818|NCT01242176|100746263|FG000|STARTED|Second Intervention||11||
48172819|NCT01242176|100746264|FG001|STARTED|Second Intervention||10||
48172820|NCT01242176|100746263|FG000|COMPLETED|Second Intervention||11||
48172821|NCT01242176|100746264|FG001|COMPLETED|Second Intervention||10||
48172822|NCT01242176|100746263|FG000|NOT COMPLETED|Second Intervention||0||
48172823|NCT01242176|100746264|FG001|NOT COMPLETED|Second Intervention||0||
48172824|NCT02765490|100746265|FG000|STARTED|Overall Study||183||
48172825|NCT02765490|100746266|FG001|STARTED|Overall Study||182||
48172826|NCT02765490|100746265|FG000|COMPLETED|Overall Study||182||
48172827|NCT02765490|100746266|FG001|COMPLETED|Overall Study||179||
48172828|NCT02765490|100746265|FG000|NOT COMPLETED|Overall Study||1||
48172829|NCT02765490|100746266|FG001|NOT COMPLETED|Overall Study||3||
48172830|NCT01586338|100746267|FG000|STARTED|Overall Study||237||
48628617|NCT02391337|101874439|FG000|STARTED|Baseline||80||
48628618|NCT02391337|101874440|FG001|STARTED|Baseline||81||
48628619|NCT02391337|101874439|FG000|COMPLETED|Baseline||80||
48628620|NCT02391337|101874440|FG001|COMPLETED|Baseline||81||
48628621|NCT02391337|101874439|FG000|NOT COMPLETED|Baseline||0||
48628622|NCT02391337|101874440|FG001|NOT COMPLETED|Baseline||0||
48628623|NCT02391337|101874439|FG000|STARTED|6 Months Follow-up||80||
48628624|NCT02391337|101874440|FG001|STARTED|6 Months Follow-up||81||
48628625|NCT02391337|101874439|FG000|COMPLETED|6 Months Follow-up||74||
48172831|NCT01586338|100746267|FG000|COMPLETED|Overall Study||229||
48172832|NCT01586338|100746267|FG000|NOT COMPLETED|Overall Study||8||
48172833|NCT03117517|100746268|FG000|STARTED|Overall Study||53||
48172834|NCT03117517|100746269|FG001|STARTED|Overall Study||53||
48172835|NCT03117517|100746268|FG000|COMPLETED|Overall Study||48||
48172836|NCT03117517|100746269|FG001|COMPLETED|Overall Study||49||
48172837|NCT03117517|100746268|FG000|NOT COMPLETED|Overall Study||5||
48172838|NCT03117517|100746269|FG001|NOT COMPLETED|Overall Study||4||
48172839|NCT04848662|100746270|FG000|STARTED|Period 1 (First Treatment Intervention)||6||
48172840|NCT04848662|100746271|FG001|STARTED|Period 1 (First Treatment Intervention)||6||
48172841|NCT04848662|100746270|FG000|COMPLETED|Period 1 (First Treatment Intervention)||6||
48172842|NCT04848662|100746271|FG001|COMPLETED|Period 1 (First Treatment Intervention)||6||
48172843|NCT04848662|100746270|FG000|NOT COMPLETED|Period 1 (First Treatment Intervention)||0||
48172844|NCT04848662|100746271|FG001|NOT COMPLETED|Period 1 (First Treatment Intervention)||0||
48172845|NCT04848662|100746270|FG000|STARTED|Period 2 (Second Treatment Intervention)||6||
48172846|NCT04848662|100746271|FG001|STARTED|Period 2 (Second Treatment Intervention)||6||
48172847|NCT04848662|100746270|FG000|COMPLETED|Period 2 (Second Treatment Intervention)||5||
48172848|NCT04848662|100746271|FG001|COMPLETED|Period 2 (Second Treatment Intervention)||6||
48172849|NCT04848662|100746270|FG000|NOT COMPLETED|Period 2 (Second Treatment Intervention)||1||
48172850|NCT04848662|100746271|FG001|NOT COMPLETED|Period 2 (Second Treatment Intervention)||0||
48172851|NCT01703702|100746272|FG000|STARTED|Overall Study||308||
48172852|NCT01703702|100746273|FG001|STARTED|Overall Study||310||
48172853|NCT01703702|100746272|FG000|COMPLETED|Overall Study||272||
48172854|NCT01703702|100746273|FG001|COMPLETED|Overall Study||288||
48172855|NCT01703702|100746272|FG000|NOT COMPLETED|Overall Study||36||
48172856|NCT01703702|100746273|FG001|NOT COMPLETED|Overall Study||22||
48172857|NCT03452176|100746274|FG000|STARTED|Overall Study||11||
48172858|NCT03452176|100746275|FG001|STARTED|Overall Study||11||
48172859|NCT03452176|100746274|FG000|COMPLETED|Overall Study||11||
48172860|NCT03452176|100746275|FG001|COMPLETED|Overall Study||11||
48172861|NCT03452176|100746274|FG000|NOT COMPLETED|Overall Study||0||
48172862|NCT03452176|100746275|FG001|NOT COMPLETED|Overall Study||0||
48172863|NCT00773955|100746276|FG000|STARTED|Overall Study||15||
48751639|NCT00849940|102180777|FG000|STARTED|Overall Study||72||
48751640|NCT00849940|102180777|FG000|COMPLETED|Overall Study||68||
48751641|NCT00849940|102180777|FG000|NOT COMPLETED|Overall Study||4||
48751642|NCT00528112|102180778|FG000|STARTED|Treatment up to 3 Years||1432||
48751643|NCT00528112|102180779|FG001|STARTED|Treatment up to 3 Years||1453||
48751644|NCT00528112|102180778|FG000|Participants Received Treatment|Treatment up to 3 Years||1432||
48751645|NCT00528112|102180779|FG001|Participants Received Treatment|Treatment up to 3 Years||1452||
48751646|NCT00528112|102180778|FG000|COMPLETED|Treatment up to 3 Years||819||
48751647|NCT00528112|102180779|FG001|COMPLETED|Treatment up to 3 Years||870||
48751648|NCT00528112|102180778|FG000|NOT COMPLETED|Treatment up to 3 Years||613||
48751649|NCT00528112|102180779|FG001|NOT COMPLETED|Treatment up to 3 Years||583||
48751650|NCT00528112|102180778|FG000|STARTED|Extension Phase||0||
48751651|NCT00528112|102180779|FG001|STARTED|Extension Phase||707||
48172864|NCT00773955|100746276|FG000|COMPLETED|Overall Study||15||
48172865|NCT00773955|100746276|FG000|NOT COMPLETED|Overall Study||0||
48172866|NCT01421589|100746277|FG000|STARTED|Overall Study||15||
48172867|NCT01421589|100746277|FG000|COMPLETED|Overall Study||15||
48172868|NCT01421589|100746277|FG000|NOT COMPLETED|Overall Study||0||
48172869|NCT04880161|100746278|FG000|STARTED|Overall Study||16||
48172870|NCT04880161|100746279|FG001|STARTED|Overall Study||16||
48172871|NCT04880161|100746278|FG000|COMPLETED|Overall Study||14||
48172872|NCT04880161|100746279|FG001|COMPLETED|Overall Study||13||
48172873|NCT04880161|100746278|FG000|NOT COMPLETED|Overall Study||2||
48172874|NCT04880161|100746279|FG001|NOT COMPLETED|Overall Study||3||
48172875|NCT02757521|100746280|FG000|STARTED|Overall Study||1||
48172876|NCT02757521|100746281|FG001|STARTED|Overall Study||0||
48172877|NCT02757521|100746280|FG000|COMPLETED|Overall Study||0||
48172878|NCT02757521|100746281|FG001|COMPLETED|Overall Study||0||
48172879|NCT02757521|100746280|FG000|NOT COMPLETED|Overall Study||1||
48172880|NCT02757521|100746281|FG001|NOT COMPLETED|Overall Study||0||
48172881|NCT04542226|100746282|FG000|STARTED|Overall Study||81||
48172882|NCT04542226|100746282|FG000|COMPLETED|Overall Study||81||
48172883|NCT04542226|100746282|FG000|NOT COMPLETED|Overall Study||0||
48172884|NCT02855164|100746283|FG000|STARTED|Parts A + B (Randomized Set)||14||
48172885|NCT02855164|100746284|FG001|STARTED|Parts A + B (Randomized Set)||16||
48172886|NCT02855164|100746285|FG002|STARTED|Parts A + B (Randomized Set)||37||
48172887|NCT02855164|100746286|FG003|STARTED|Parts A + B (Randomized Set)||85||
48172888|NCT02855164|100746287|FG004|STARTED|Parts A + B (Randomized Set)||46||
48172889|NCT02855164|100746288|FG005|STARTED|Parts A + B (Randomized Set)||0||
48172890|NCT02855164|100746289|FG006|STARTED|Parts A + B (Randomized Set)||0||
48172891|NCT02855164|100746290|FG007|STARTED|Parts A + B (Randomized Set)||0||
48172892|NCT02855164|100746283|FG000|COMPLETED|Parts A + B (Randomized Set)||14||
48172893|NCT02855164|100746284|FG001|COMPLETED|Parts A + B (Randomized Set)||16||
48172894|NCT02855164|100746285|FG002|COMPLETED|Parts A + B (Randomized Set)||36||
48172895|NCT02855164|100746286|FG003|COMPLETED|Parts A + B (Randomized Set)||77||
48172896|NCT02855164|100746287|FG004|COMPLETED|Parts A + B (Randomized Set)||45||
48172897|NCT02855164|100746288|FG005|COMPLETED|Parts A + B (Randomized Set)||0||
48172898|NCT02855164|100746289|FG006|COMPLETED|Parts A + B (Randomized Set)||0||
48172899|NCT02855164|100746290|FG007|COMPLETED|Parts A + B (Randomized Set)||0||
48172900|NCT02855164|100746283|FG000|NOT COMPLETED|Parts A + B (Randomized Set)||0||
48172901|NCT02855164|100746284|FG001|NOT COMPLETED|Parts A + B (Randomized Set)||0||
48188640|NCT05257837|100783296|FG002|COMPLETED|Overall Study||54||
48751652|NCT00528112|102180778|FG000|COMPLETED|Extension Phase||0||
48751653|NCT00528112|102180779|FG001|COMPLETED|Extension Phase||550||
48172902|NCT02855164|100746285|FG002|NOT COMPLETED|Parts A + B (Randomized Set)||1||
48172903|NCT02855164|100746286|FG003|NOT COMPLETED|Parts A + B (Randomized Set)||8||
48172904|NCT02855164|100746287|FG004|NOT COMPLETED|Parts A + B (Randomized Set)||1||
48172905|NCT02855164|100746288|FG005|NOT COMPLETED|Parts A + B (Randomized Set)||0||
48172906|NCT02855164|100746289|FG006|NOT COMPLETED|Parts A + B (Randomized Set)||0||
48172907|NCT02855164|100746290|FG007|NOT COMPLETED|Parts A + B (Randomized Set)||0||
48172908|NCT02855164|100746283|FG000|STARTED|Part C (Randomized Set)||0||
48172909|NCT02855164|100746284|FG001|STARTED|Part C (Randomized Set)||0||
48172910|NCT02855164|100746285|FG002|STARTED|Part C (Randomized Set)||0||
48172911|NCT02855164|100746286|FG003|STARTED|Part C (Randomized Set)||0||
48172912|NCT02855164|100746287|FG004|STARTED|Part C (Randomized Set)||0||
48172913|NCT02855164|100746288|FG005|STARTED|Part C (Randomized Set)||50||
48172914|NCT02855164|100746289|FG006|STARTED|Part C (Randomized Set)||51||
48172915|NCT02855164|100746290|FG007|STARTED|Part C (Randomized Set)||51||
48172916|NCT02855164|100746283|FG000|COMPLETED|Part C (Randomized Set)||0||
48172917|NCT02855164|100746284|FG001|COMPLETED|Part C (Randomized Set)||0||
48172918|NCT02855164|100746285|FG002|COMPLETED|Part C (Randomized Set)||0||
48172919|NCT02855164|100746286|FG003|COMPLETED|Part C (Randomized Set)||0||
48172920|NCT02855164|100746287|FG004|COMPLETED|Part C (Randomized Set)||0||
48172921|NCT02855164|100746288|FG005|COMPLETED|Part C (Randomized Set)||38||
48172922|NCT02855164|100746289|FG006|COMPLETED|Part C (Randomized Set)||37||
48172923|NCT02855164|100746290|FG007|COMPLETED|Part C (Randomized Set)||44||
48172924|NCT02855164|100746283|FG000|NOT COMPLETED|Part C (Randomized Set)||0||
48172925|NCT02855164|100746284|FG001|NOT COMPLETED|Part C (Randomized Set)||0||
48172926|NCT02855164|100746285|FG002|NOT COMPLETED|Part C (Randomized Set)||0||
48172927|NCT02855164|100746286|FG003|NOT COMPLETED|Part C (Randomized Set)||0||
48172928|NCT02855164|100746287|FG004|NOT COMPLETED|Part C (Randomized Set)||0||
48172929|NCT02855164|100746288|FG005|NOT COMPLETED|Part C (Randomized Set)||12||
48172930|NCT02855164|100746289|FG006|NOT COMPLETED|Part C (Randomized Set)||14||
48172931|NCT02855164|100746290|FG007|NOT COMPLETED|Part C (Randomized Set)||7||
48172932|NCT03029247|100746291|FG000|STARTED|Acute Challenge 1 (Day 1)||45||
48172933|NCT03029247|100746292|FG001|STARTED|Acute Challenge 1 (Day 1)||43||
48172934|NCT03029247|100746291|FG000|COMPLETED|Acute Challenge 1 (Day 1)||45||
48172935|NCT03029247|100746292|FG001|COMPLETED|Acute Challenge 1 (Day 1)||43||
48172936|NCT03029247|100746291|FG000|NOT COMPLETED|Acute Challenge 1 (Day 1)||0||
48172937|NCT03029247|100746292|FG001|NOT COMPLETED|Acute Challenge 1 (Day 1)||0||
48172938|NCT03029247|100746291|FG000|STARTED|Hgb Maintenance Phase (8 Weeks)||45||
48172939|NCT03029247|100746292|FG001|STARTED|Hgb Maintenance Phase (8 Weeks)||43||
48172940|NCT03029247|100746291|FG000|COMPLETED|Hgb Maintenance Phase (8 Weeks)||32||
48172941|NCT03029247|100746292|FG001|COMPLETED|Hgb Maintenance Phase (8 Weeks)||36||
48172942|NCT03029247|100746291|FG000|NOT COMPLETED|Hgb Maintenance Phase (8 Weeks)||13||
48172943|NCT03029247|100746292|FG001|NOT COMPLETED|Hgb Maintenance Phase (8 Weeks)||7||
48172944|NCT03029247|100746291|FG000|STARTED|Acute Challenge 2 (Day 57)||32||
48172945|NCT03029247|100746292|FG001|STARTED|Acute Challenge 2 (Day 57)||36||
48172946|NCT03029247|100746291|FG000|COMPLETED|Acute Challenge 2 (Day 57)||32||
48172947|NCT03029247|100746292|FG001|COMPLETED|Acute Challenge 2 (Day 57)||36||
48172948|NCT03029247|100746291|FG000|NOT COMPLETED|Acute Challenge 2 (Day 57)||0||
48172949|NCT03029247|100746292|FG001|NOT COMPLETED|Acute Challenge 2 (Day 57)||0||
48172950|NCT03029247|100746291|FG000|STARTED|Follow-up Period (14 Days)||32||
48172951|NCT03029247|100746292|FG001|STARTED|Follow-up Period (14 Days)||36||
48172952|NCT03029247|100746291|FG000|COMPLETED|Follow-up Period (14 Days)||32||
48172953|NCT03029247|100746292|FG001|COMPLETED|Follow-up Period (14 Days)||36||
48172954|NCT03029247|100746291|FG000|NOT COMPLETED|Follow-up Period (14 Days)||0||
48172955|NCT03029247|100746292|FG001|NOT COMPLETED|Follow-up Period (14 Days)||0||
48172956|NCT00641186|100746293|FG000|STARTED|Overall Study||30||
48628626|NCT02391337|101874440|FG001|COMPLETED|6 Months Follow-up||76||
48628627|NCT02391337|101874439|FG000|NOT COMPLETED|6 Months Follow-up||6||
48628628|NCT02391337|101874440|FG001|NOT COMPLETED|6 Months Follow-up||5||
48628629|NCT02391337|101874439|FG000|STARTED|12 Months Follow-up||74||
48628630|NCT02391337|101874440|FG001|STARTED|12 Months Follow-up||76||
48628631|NCT02391337|101874439|FG000|COMPLETED|12 Months Follow-up||72||
48628632|NCT02391337|101874440|FG001|COMPLETED|12 Months Follow-up||73||
48628633|NCT02391337|101874439|FG000|NOT COMPLETED|12 Months Follow-up||2||
48628634|NCT02391337|101874440|FG001|NOT COMPLETED|12 Months Follow-up||3||
48334631|NCT01235962|101148221|FG000|All Deaths|Overall Study||43||
48628635|NCT00744939|101874441|FG000|STARTED|Overall Study||168||
48628636|NCT00744939|101874441|FG000|Treatment Received|Overall Study||141||
48628637|NCT00744939|101874441|FG000|COMPLETED|Overall Study||77||
48628638|NCT00744939|101874441|FG000|NOT COMPLETED|Overall Study||91||
48628639|NCT01965327|101874442|FG000|STARTED|Overall Study||12||
48628640|NCT01965327|101874442|FG000|COMPLETED|Overall Study||10||
48628641|NCT01965327|101874442|FG000|NOT COMPLETED|Overall Study||2||
48628642|NCT00069264|101874443|FG000|STARTED|Overall Study||32||
48628643|NCT00069264|101874443|FG000|COMPLETED|Overall Study||0||
48334632|NCT01235962|101148222|FG001|All Deaths|Overall Study||46||
48412111|NCT03083470|101341928|FG001|COMPLETED|Overall Study||6||
48334633|NCT01235962|101148223|FG002|All Deaths|Overall Study||102||
48172957|NCT00641186|100746293|FG000|COMPLETED|Overall Study||27||
48172958|NCT00641186|100746293|FG000|NOT COMPLETED|Overall Study||3||
48172959|NCT03897205|100746294|FG000|STARTED|Overall Study||19||
48172960|NCT03897205|100746295|FG001|STARTED|Overall Study||10||
48172961|NCT03897205|100746294|FG000|COMPLETED|Overall Study||17||
48172962|NCT03897205|100746295|FG001|COMPLETED|Overall Study||10||
48172963|NCT03897205|100746294|FG000|NOT COMPLETED|Overall Study||2||
48172964|NCT03897205|100746295|FG001|NOT COMPLETED|Overall Study||0||
48172965|NCT01989598|100746296|FG000|STARTED|Overall Study||25||
48172966|NCT01989598|100746296|FG000|Dual Therapy With Trametinib and GSK2141795|Overall Study||12||
48172967|NCT01989598|100746296|FG000|COMPLETED|Overall Study||25||
48172968|NCT01989598|100746296|FG000|NOT COMPLETED|Overall Study||0||
48172969|NCT01354106|100746297|FG000|STARTED|Overall Study||26||
48172970|NCT01354106|100746297|FG000|COMPLETED|Overall Study||24||
48172971|NCT01354106|100746297|FG000|NOT COMPLETED|Overall Study||2||
48172972|NCT00519896|100746298|FG000|STARTED|Overall Study||35||
48172973|NCT00519896|100746298|FG000|COMPLETED|Overall Study||33||
48172974|NCT00519896|100746298|FG000|NOT COMPLETED|Overall Study||2||
48172975|NCT00817804|100746299|FG000|STARTED|Overall Study||1||
48172976|NCT00817804|100746300|FG001|STARTED|Overall Study||2||
48172977|NCT00817804|100746299|FG000|COMPLETED|Overall Study||1||
48172978|NCT00817804|100746300|FG001|COMPLETED|Overall Study||2||
48172979|NCT00817804|100746299|FG000|NOT COMPLETED|Overall Study||0||
48172980|NCT00817804|100746300|FG001|NOT COMPLETED|Overall Study||0||
48172981|NCT02105636|100746301|FG000|STARTED|Pre-Treatment||240|Started = Randomized|
48172982|NCT02105636|100746302|FG001|STARTED|Pre-Treatment||121|Started = Randomized|
48172983|NCT02105636|100746301|FG000|COMPLETED|Pre-Treatment||236|Completed = Entering treatment|
48172984|NCT02105636|100746302|FG001|COMPLETED|Pre-Treatment||111|Completed = Entering treatment|
48172985|NCT02105636|100746301|FG000|NOT COMPLETED|Pre-Treatment||4||
48172986|NCT02105636|100746302|FG001|NOT COMPLETED|Pre-Treatment||10||
48172987|NCT02105636|100746301|FG000|STARTED|Treatment||236||
48172988|NCT02105636|100746302|FG001|STARTED|Treatment||111||
48172989|NCT02105636|100746301|FG000|COMPLETED|Treatment||1||
48172990|NCT02105636|100746302|FG001|COMPLETED|Treatment||0||
48172991|NCT02105636|100746301|FG000|NOT COMPLETED|Treatment||235||
48172992|NCT02105636|100746302|FG001|NOT COMPLETED|Treatment||111||
48172993|NCT01473381|100746303|FG000|STARTED|Overall Study||290||
48172994|NCT01473381|100746304|FG001|STARTED|Overall Study||292||
48172995|NCT01473381|100746305|FG002|STARTED|Overall Study||291||
48172996|NCT01473381|100746306|FG003|STARTED|Overall Study||289||
48172997|NCT01473381|100746303|FG000|Safety Population|Overall Study||281||
48172998|NCT01473381|100746304|FG001|Safety Population|Overall Study||288||
48172999|NCT01473381|100746305|FG002|Safety Population|Overall Study||287||
48173000|NCT01473381|100746306|FG003|Safety Population|Overall Study||282||
48173001|NCT01473381|100746303|FG000|COMPLETED|Overall Study||210||
48173002|NCT01473381|100746304|FG001|COMPLETED|Overall Study||199||
48173003|NCT01473381|100746305|FG002|COMPLETED|Overall Study||189||
48173004|NCT01473381|100746306|FG003|COMPLETED|Overall Study||200||
48173005|NCT01473381|100746303|FG000|NOT COMPLETED|Overall Study||80||
48173006|NCT01473381|100746304|FG001|NOT COMPLETED|Overall Study||93||
48173007|NCT01473381|100746305|FG002|NOT COMPLETED|Overall Study||102||
48173008|NCT01473381|100746306|FG003|NOT COMPLETED|Overall Study||89||
48173009|NCT02274649|100746307|FG000|STARTED|Overall Study||101||
48173010|NCT02274649|100746308|FG001|STARTED|Overall Study||93||
48173011|NCT02274649|100746307|FG000|COMPLETED|Overall Study||77||
48173012|NCT02274649|100746308|FG001|COMPLETED|Overall Study||81||
48173013|NCT02274649|100746307|FG000|NOT COMPLETED|Overall Study||24||
48173014|NCT02274649|100746308|FG001|NOT COMPLETED|Overall Study||12||
48173015|NCT00661258|100746309|FG000|STARTED|Overall Study||34||
48173016|NCT00661258|100746310|FG001|STARTED|Overall Study||34||
48173017|NCT00661258|100746309|FG000|COMPLETED|Overall Study||31||
48334634|NCT01235962|101148224|FG003|All Deaths|Overall Study||104||
48173018|NCT00661258|100746310|FG001|COMPLETED|Overall Study||33||
48173019|NCT00661258|100746309|FG000|NOT COMPLETED|Overall Study||3||
48173020|NCT00661258|100746310|FG001|NOT COMPLETED|Overall Study||1||
48173021|NCT01617005|100746311|FG000|STARTED|Overall Study||50||
48173022|NCT01617005|100746311|FG000|COMPLETED|Overall Study||48||
48173023|NCT01617005|100746311|FG000|NOT COMPLETED|Overall Study||2||
48173024|NCT04048759|100746312|FG000|STARTED|Overall Study||34||
48173025|NCT04048759|100746313|FG001|STARTED|Overall Study||32||
48173026|NCT04048759|100746314|FG002|STARTED|Overall Study||15||
48173027|NCT04048759|100746312|FG000|6 Month Assessment|Overall Study||34||
48173028|NCT04048759|100746313|FG001|6 Month Assessment|Overall Study||32||
48173029|NCT04048759|100746314|FG002|6 Month Assessment|Overall Study||15||
48173030|NCT04048759|100746312|FG000|12 Month Assessment|Overall Study||34||
48173031|NCT04048759|100746313|FG001|12 Month Assessment|Overall Study||32||
48173032|NCT04048759|100746314|FG002|12 Month Assessment|Overall Study||15||
48173033|NCT04048759|100746312|FG000|COMPLETED|Overall Study||34||
48173034|NCT04048759|100746313|FG001|COMPLETED|Overall Study||32||
48173035|NCT04048759|100746314|FG002|COMPLETED|Overall Study||15||
48173036|NCT04048759|100746312|FG000|NOT COMPLETED|Overall Study||0||
48368086|NCT03032068|101230103|FG000|Postoperative Home Care Visit 1|Overall Study||10||
48173037|NCT04048759|100746313|FG001|NOT COMPLETED|Overall Study||0||
48173038|NCT04048759|100746314|FG002|NOT COMPLETED|Overall Study||0||
48173039|NCT03687450|100746315|FG000|STARTED|Overall Study||38||
48173040|NCT03687450|100746316|FG001|STARTED|Overall Study||18||
48173041|NCT03687450|100746315|FG000|Post-Program Follow-Up|Overall Study||28||
48173042|NCT03687450|100746316|FG001|Post-Program Follow-Up|Overall Study||15||
48173043|NCT03687450|100746315|FG000|Two-month Follow-up|Overall Study||26||
48173044|NCT03687450|100746316|FG001|Two-month Follow-up|Overall Study||16||
48173045|NCT03687450|100746315|FG000|COMPLETED|Overall Study||26||
48173046|NCT03687450|100746316|FG001|COMPLETED|Overall Study||16||
48173047|NCT03687450|100746315|FG000|NOT COMPLETED|Overall Study||12||
48173048|NCT03687450|100746316|FG001|NOT COMPLETED|Overall Study||2||
48173049|NCT04248465|100746317|FG000|STARTED|Randomized-Controlled Period||255||
48173050|NCT04248465|100746318|FG001|STARTED|Randomized-Controlled Period||127||
48173051|NCT04248465|100746317|FG000|Received at Least 1 Dose of Study Drug|Randomized-Controlled Period||255||
48173052|NCT04248465|100746318|FG001|Received at Least 1 Dose of Study Drug|Randomized-Controlled Period||127||
48173053|NCT04248465|100746317|FG000|COMPLETED|Randomized-Controlled Period||15||
48173054|NCT04248465|100746318|FG001|COMPLETED|Randomized-Controlled Period||5||
48173055|NCT04248465|100746317|FG000|NOT COMPLETED|Randomized-Controlled Period||240||
48173056|NCT04248465|100746318|FG001|NOT COMPLETED|Randomized-Controlled Period||122||
48173057|NCT04248465|100746317|FG000|STARTED|Open-label Extension Period||14||
48173058|NCT04248465|100746318|FG001|STARTED|Open-label Extension Period||5||
48751654|NCT00528112|102180778|FG000|NOT COMPLETED|Extension Phase||0||
48751655|NCT00528112|102180779|FG001|NOT COMPLETED|Extension Phase||157||
48751656|NCT02735239|102180780|FG000|STARTED|Overall Study||12|All Subjects who received at least one dose of study treatment.|
48173059|NCT04248465|100746317|FG000|Received at Least 1 Dose of Study Drug|Open-label Extension Period||14||
48173060|NCT04248465|100746318|FG001|Received at Least 1 Dose of Study Drug|Open-label Extension Period||5||
48173061|NCT04248465|100746317|FG000|COMPLETED|Open-label Extension Period||0||
48173062|NCT04248465|100746318|FG001|COMPLETED|Open-label Extension Period||0||
48173063|NCT04248465|100746317|FG000|NOT COMPLETED|Open-label Extension Period||14||
48173064|NCT04248465|100746318|FG001|NOT COMPLETED|Open-label Extension Period||5||
48173065|NCT01539863|100746319|FG000|STARTED|Overall Study||166||
48173066|NCT01539863|100746320|FG001|STARTED|Overall Study||162||
48173067|NCT01539863|100746319|FG000|COMPLETED|Overall Study||161||
48173068|NCT01539863|100746320|FG001|COMPLETED|Overall Study||158||
48173069|NCT01539863|100746319|FG000|NOT COMPLETED|Overall Study||5||
48173070|NCT01539863|100746320|FG001|NOT COMPLETED|Overall Study||4||
48173071|NCT00798486|100746321|FG000|STARTED|Overall Study||110||
48173072|NCT00798486|100746321|FG000|COMPLETED|Overall Study||110||
48173073|NCT00798486|100746321|FG000|NOT COMPLETED|Overall Study||0||
48173074|NCT03662997|100746322|FG000|STARTED|Overall Study||11||
48173075|NCT03662997|100746323|FG001|STARTED|Overall Study||10||
48173076|NCT03662997|100746324|FG002|STARTED|Overall Study||11||
48173077|NCT03662997|100746325|FG003|STARTED|Overall Study||8||
48173078|NCT03662997|100746322|FG000|COMPLETED|Overall Study||11||
48173079|NCT03662997|100746323|FG001|COMPLETED|Overall Study||8||
48173080|NCT03662997|100746324|FG002|COMPLETED|Overall Study||11||
48173081|NCT03662997|100746325|FG003|COMPLETED|Overall Study||8||
48173082|NCT03662997|100746322|FG000|NOT COMPLETED|Overall Study||0||
48173083|NCT03662997|100746323|FG001|NOT COMPLETED|Overall Study||2||
48173084|NCT03662997|100746324|FG002|NOT COMPLETED|Overall Study||0||
48173085|NCT03662997|100746325|FG003|NOT COMPLETED|Overall Study||0||
48173086|NCT04204772|100746326|FG000|STARTED|Overall Study||3||
48173087|NCT04204772|100746327|FG001|STARTED|Overall Study||3||
48173088|NCT04204772|100746328|FG002|STARTED|Overall Study||3||
48173089|NCT04204772|100746329|FG003|STARTED|Overall Study||3||
48173090|NCT04204772|100746326|FG000|COMPLETED|Overall Study||3||
48334635|NCT01235962|101148221|FG000|COMPLETED|Overall Study||152|Completed means dead or completed survival follow-up until the study completed.|
48334636|NCT01235962|101148222|FG001|COMPLETED|Overall Study||170|Completed means dead or completed survival follow-up until the study completed.|
48751657|NCT02735239|102180781|FG001|STARTED|Overall Study||5|All Subjects who received at least one dose of study treatment.|
48751658|NCT02735239|102180782|FG002|STARTED|Overall Study||21|All Subjects who received at least one dose of study treatment.|
48751659|NCT02735239|102180783|FG003|STARTED|Overall Study||11|All Subjects who received at least one dose of study treatment.|
48751660|NCT02735239|102180784|FG004|STARTED|Overall Study||9|All Subjects who received at least one dose of study treatment.|
48751661|NCT02735239|102180785|FG005|STARTED|Overall Study||15|All Subjects who received at least one dose of study treatment.|
48751662|NCT02735239|102180780|FG000|COMPLETED|Overall Study||8|All subjects who completed protocol specified treatment. For Cohorts C and D/D2 this includes subjects who completed pre-surgery treatment.|
48751663|NCT02735239|102180781|FG001|COMPLETED|Overall Study||2|All subjects who completed protocol specified treatment. For Cohorts C and D/D2 this includes subjects who completed pre-surgery treatment.|
48334637|NCT01235962|101148223|FG002|COMPLETED|Overall Study||453|Completed means dead or completed survival follow-up until the study completed.|
48412112|NCT03083470|101341929|FG002|COMPLETED|Overall Study||6||
48412113|NCT03083470|101341930|FG003|COMPLETED|Overall Study||6||
48173091|NCT04204772|100746327|FG001|COMPLETED|Overall Study||3||
48173092|NCT04204772|100746328|FG002|COMPLETED|Overall Study||3||
48173093|NCT04204772|100746329|FG003|COMPLETED|Overall Study||3||
48173094|NCT04204772|100746326|FG000|NOT COMPLETED|Overall Study||0||
48173095|NCT04204772|100746327|FG001|NOT COMPLETED|Overall Study||0||
48173096|NCT04204772|100746328|FG002|NOT COMPLETED|Overall Study||0||
48173097|NCT04204772|100746329|FG003|NOT COMPLETED|Overall Study||0||
48173098|NCT01567943|100746330|FG000|STARTED|Overall Study||40||
48173099|NCT01567943|100746331|FG001|STARTED|Overall Study||39||
48173100|NCT01567943|100746332|FG002|STARTED|Overall Study||44||
48173101|NCT01567943|100746330|FG000|COMPLETED|Overall Study||26||
48173102|NCT01567943|100746331|FG001|COMPLETED|Overall Study||29||
48173103|NCT01567943|100746332|FG002|COMPLETED|Overall Study||44||
48173104|NCT01567943|100746330|FG000|NOT COMPLETED|Overall Study||14||
48173105|NCT01567943|100746331|FG001|NOT COMPLETED|Overall Study||10||
48173106|NCT01567943|100746332|FG002|NOT COMPLETED|Overall Study||0||
48173107|NCT01258660|100746333|FG000|STARTED|Overall Study||86||
48173108|NCT01258660|100746334|FG001|STARTED|Overall Study||86||
48173109|NCT01258660|100746333|FG000|Received Treatment|Overall Study||79||
48173110|NCT01258660|100746334|FG001|Received Treatment|Overall Study||82||
48173111|NCT01258660|100746333|FG000|Completed Treatment|Overall Study||79||
48173112|NCT01258660|100746334|FG001|Completed Treatment|Overall Study||81||
48173113|NCT01258660|100746333|FG000|COMPLETED|Overall Study||75||
48173114|NCT01258660|100746334|FG001|COMPLETED|Overall Study||75||
48173115|NCT01258660|100746333|FG000|NOT COMPLETED|Overall Study||11||
48173116|NCT01258660|100746334|FG001|NOT COMPLETED|Overall Study||11||
48173117|NCT02397460|100746335|FG000|STARTED|Treatment Period 1||7||
48173118|NCT02397460|100746336|FG001|STARTED|Treatment Period 1||7||
48173119|NCT02397460|100746337|FG002|STARTED|Treatment Period 1||6||
48173120|NCT02397460|100746338|FG003|STARTED|Treatment Period 1||6||
48173121|NCT02397460|100746339|FG004|STARTED|Treatment Period 1||6||
48173122|NCT02397460|100746340|FG005|STARTED|Treatment Period 1||6||
48173123|NCT02397460|100746341|FG006|STARTED|Treatment Period 1||6||
48173124|NCT02397460|100746342|FG007|STARTED|Treatment Period 1||6||
48173125|NCT02397460|100746335|FG000|COMPLETED|Treatment Period 1||7||
48173126|NCT02397460|100746336|FG001|COMPLETED|Treatment Period 1||7||
48173127|NCT02397460|100746337|FG002|COMPLETED|Treatment Period 1||6||
48173128|NCT02397460|100746338|FG003|COMPLETED|Treatment Period 1||6||
48173129|NCT02397460|100746339|FG004|COMPLETED|Treatment Period 1||6||
48173130|NCT02397460|100746340|FG005|COMPLETED|Treatment Period 1||6||
48173131|NCT02397460|100746341|FG006|COMPLETED|Treatment Period 1||6||
48173132|NCT02397460|100746342|FG007|COMPLETED|Treatment Period 1||6||
48173133|NCT02397460|100746335|FG000|NOT COMPLETED|Treatment Period 1||0||
48751664|NCT02735239|102180782|FG002|COMPLETED|Overall Study||13|All subjects who completed protocol specified treatment. For Cohorts C and D/D2 this includes subjects who completed pre-surgery treatment.|
48751665|NCT02735239|102180783|FG003|COMPLETED|Overall Study||11|All subjects who completed protocol specified treatment. For Cohorts C and D/D2 this includes subjects who completed pre-surgery treatment.|
48751666|NCT02735239|102180784|FG004|COMPLETED|Overall Study||9|All subjects who completed protocol specified treatment. For Cohorts C and D/D2 this includes subjects who completed pre-surgery treatment.|
48173134|NCT02397460|100746336|FG001|NOT COMPLETED|Treatment Period 1||0||
48173135|NCT02397460|100746337|FG002|NOT COMPLETED|Treatment Period 1||0||
48173136|NCT02397460|100746338|FG003|NOT COMPLETED|Treatment Period 1||0||
48173137|NCT02397460|100746339|FG004|NOT COMPLETED|Treatment Period 1||0||
48173138|NCT02397460|100746340|FG005|NOT COMPLETED|Treatment Period 1||0||
48173139|NCT02397460|100746341|FG006|NOT COMPLETED|Treatment Period 1||0||
48173140|NCT02397460|100746342|FG007|NOT COMPLETED|Treatment Period 1||0||
48173141|NCT02397460|100746335|FG000|STARTED|Treatment Period 2||7||
48173142|NCT02397460|100746336|FG001|STARTED|Treatment Period 2||7||
48173143|NCT02397460|100746337|FG002|STARTED|Treatment Period 2||6||
48173144|NCT02397460|100746338|FG003|STARTED|Treatment Period 2||6||
48173145|NCT02397460|100746339|FG004|STARTED|Treatment Period 2||6||
48173146|NCT02397460|100746340|FG005|STARTED|Treatment Period 2||6||
48173147|NCT02397460|100746341|FG006|STARTED|Treatment Period 2||6||
48173148|NCT02397460|100746342|FG007|STARTED|Treatment Period 2||6||
48173149|NCT02397460|100746335|FG000|COMPLETED|Treatment Period 2||7||
48173150|NCT02397460|100746336|FG001|COMPLETED|Treatment Period 2||7||
48173151|NCT02397460|100746337|FG002|COMPLETED|Treatment Period 2||6||
48173152|NCT02397460|100746338|FG003|COMPLETED|Treatment Period 2||6||
48173153|NCT02397460|100746339|FG004|COMPLETED|Treatment Period 2||6||
48173154|NCT02397460|100746340|FG005|COMPLETED|Treatment Period 2||6||
48173155|NCT02397460|100746341|FG006|COMPLETED|Treatment Period 2||6||
48173156|NCT02397460|100746342|FG007|COMPLETED|Treatment Period 2||5||
48173157|NCT02397460|100746335|FG000|NOT COMPLETED|Treatment Period 2||0||
48173158|NCT02397460|100746336|FG001|NOT COMPLETED|Treatment Period 2||0||
48173159|NCT02397460|100746337|FG002|NOT COMPLETED|Treatment Period 2||0||
48173160|NCT02397460|100746338|FG003|NOT COMPLETED|Treatment Period 2||0||
48173161|NCT02397460|100746339|FG004|NOT COMPLETED|Treatment Period 2||0||
48173162|NCT02397460|100746340|FG005|NOT COMPLETED|Treatment Period 2||0||
48173163|NCT02397460|100746341|FG006|NOT COMPLETED|Treatment Period 2||0||
48173164|NCT02397460|100746342|FG007|NOT COMPLETED|Treatment Period 2||1||
48173165|NCT02397460|100746335|FG000|STARTED|Treatment Period 3||7||
48173166|NCT02397460|100746336|FG001|STARTED|Treatment Period 3||7||
48173167|NCT02397460|100746337|FG002|STARTED|Treatment Period 3||6||
48751667|NCT02735239|102180785|FG005|COMPLETED|Overall Study||13|All subjects who completed protocol specified treatment. For Cohorts C and D/D2 this includes subjects who completed pre-surgery treatment.|
48173168|NCT02397460|100746338|FG003|STARTED|Treatment Period 3||6||
48173169|NCT02397460|100746339|FG004|STARTED|Treatment Period 3||6||
48173170|NCT02397460|100746340|FG005|STARTED|Treatment Period 3||6||
48173171|NCT02397460|100746341|FG006|STARTED|Treatment Period 3||6||
48173172|NCT02397460|100746342|FG007|STARTED|Treatment Period 3||5||
48173173|NCT02397460|100746335|FG000|COMPLETED|Treatment Period 3||7||
48173174|NCT02397460|100746336|FG001|COMPLETED|Treatment Period 3||7||
48173175|NCT02397460|100746337|FG002|COMPLETED|Treatment Period 3||6||
48173176|NCT02397460|100746338|FG003|COMPLETED|Treatment Period 3||6||
48173177|NCT02397460|100746339|FG004|COMPLETED|Treatment Period 3||6||
48173178|NCT02397460|100746340|FG005|COMPLETED|Treatment Period 3||6||
48173179|NCT02397460|100746341|FG006|COMPLETED|Treatment Period 3||6||
48173180|NCT02397460|100746342|FG007|COMPLETED|Treatment Period 3||5||
48173181|NCT02397460|100746335|FG000|NOT COMPLETED|Treatment Period 3||0||
48173182|NCT02397460|100746336|FG001|NOT COMPLETED|Treatment Period 3||0||
48173183|NCT02397460|100746337|FG002|NOT COMPLETED|Treatment Period 3||0||
48173184|NCT02397460|100746338|FG003|NOT COMPLETED|Treatment Period 3||0||
48173185|NCT02397460|100746339|FG004|NOT COMPLETED|Treatment Period 3||0||
48173186|NCT02397460|100746340|FG005|NOT COMPLETED|Treatment Period 3||0||
48173187|NCT02397460|100746341|FG006|NOT COMPLETED|Treatment Period 3||0||
48173188|NCT02397460|100746342|FG007|NOT COMPLETED|Treatment Period 3||0||
48173189|NCT02397460|100746335|FG000|STARTED|Treatment Period 4||7||
48173190|NCT02397460|100746336|FG001|STARTED|Treatment Period 4||7||
48173191|NCT02397460|100746337|FG002|STARTED|Treatment Period 4||6||
48173192|NCT02397460|100746338|FG003|STARTED|Treatment Period 4||6||
48173193|NCT02397460|100746339|FG004|STARTED|Treatment Period 4||6||
48173194|NCT02397460|100746340|FG005|STARTED|Treatment Period 4||6||
48173195|NCT02397460|100746341|FG006|STARTED|Treatment Period 4||6||
48173196|NCT02397460|100746342|FG007|STARTED|Treatment Period 4||5||
48173197|NCT02397460|100746335|FG000|COMPLETED|Treatment Period 4||7||
48173198|NCT02397460|100746336|FG001|COMPLETED|Treatment Period 4||6||
48173199|NCT02397460|100746337|FG002|COMPLETED|Treatment Period 4||6||
48173200|NCT02397460|100746338|FG003|COMPLETED|Treatment Period 4||6||
48173201|NCT02397460|100746339|FG004|COMPLETED|Treatment Period 4||5||
48173202|NCT02397460|100746340|FG005|COMPLETED|Treatment Period 4||6||
48173203|NCT02397460|100746341|FG006|COMPLETED|Treatment Period 4||6||
48628644|NCT00069264|101874443|FG000|NOT COMPLETED|Overall Study||32||
48628645|NCT02903446|101874444|FG000|STARTED|Overall Study||10||
48628646|NCT02903446|101874445|FG001|STARTED|Overall Study||10||
48628647|NCT02903446|101874444|FG000|COMPLETED|Overall Study||10||
48173204|NCT02397460|100746342|FG007|COMPLETED|Treatment Period 4||5||
48173205|NCT02397460|100746335|FG000|NOT COMPLETED|Treatment Period 4||0||
48173206|NCT02397460|100746336|FG001|NOT COMPLETED|Treatment Period 4||1||
48173207|NCT02397460|100746337|FG002|NOT COMPLETED|Treatment Period 4||0||
48173208|NCT02397460|100746338|FG003|NOT COMPLETED|Treatment Period 4||0||
48173209|NCT02397460|100746339|FG004|NOT COMPLETED|Treatment Period 4||1||
48173210|NCT02397460|100746340|FG005|NOT COMPLETED|Treatment Period 4||0||
48334638|NCT01235962|101148224|FG003|COMPLETED|Overall Study||478|Completed means dead or completed survival follow-up until the study completed.|
48334639|NCT01235962|101148221|FG000|NOT COMPLETED|Overall Study||46||
48334640|NCT01235962|101148222|FG001|NOT COMPLETED|Overall Study||35||
48334641|NCT01235962|101148223|FG002|NOT COMPLETED|Overall Study||118||
48334642|NCT01235962|101148224|FG003|NOT COMPLETED|Overall Study||86||
48334643|NCT02319044|101148225|FG000|STARTED|Overall Study||133||
48628648|NCT02903446|101874445|FG001|COMPLETED|Overall Study||10||
48173211|NCT02397460|100746341|FG006|NOT COMPLETED|Treatment Period 4||0||
48173212|NCT02397460|100746342|FG007|NOT COMPLETED|Treatment Period 4||0||
48173213|NCT01088529|100746343|FG000|STARTED|Overall Study||44||
48173214|NCT01088529|100746344|FG001|STARTED|Overall Study||22||
48173215|NCT01088529|100746343|FG000|Received Treatment|Overall Study||44||
48628649|NCT02903446|101874444|FG000|NOT COMPLETED|Overall Study||0||
48628650|NCT02903446|101874445|FG001|NOT COMPLETED|Overall Study||0||
48628651|NCT01529606|101874446|FG000|STARTED|Overall Study||55||
48628652|NCT01529606|101874447|FG001|STARTED|Overall Study||47||
48628653|NCT01529606|101874446|FG000|COMPLETED|Overall Study||34||
48173216|NCT01088529|100746344|FG001|Received Treatment|Overall Study||21||
48628654|NCT01529606|101874447|FG001|COMPLETED|Overall Study||29||
48628655|NCT01529606|101874446|FG000|NOT COMPLETED|Overall Study||21||
48628656|NCT01529606|101874447|FG001|NOT COMPLETED|Overall Study||18||
48628657|NCT03435055|101874448|FG000|STARTED|Screening||21||
48628658|NCT03435055|101874448|FG000|COMPLETED|Screening||19||
48173217|NCT01088529|100746343|FG000|COMPLETED|Overall Study||44||
48173218|NCT01088529|100746344|FG001|COMPLETED|Overall Study||21||
48173219|NCT01088529|100746343|FG000|NOT COMPLETED|Overall Study||0||
48173220|NCT01088529|100746344|FG001|NOT COMPLETED|Overall Study||1||
48173221|NCT00089895|100746345|FG000|STARTED|Overall Study||4722||
48173222|NCT00089895|100746346|FG001|STARTED|Overall Study||4684||
48173223|NCT00089895|100746345|FG000|COMPLETED|Overall Study||4687||
48334644|NCT02319044|101148226|FG001|STARTED|Overall Study||67||
48334645|NCT02319044|101148227|FG002|STARTED|Overall Study||67||
48628659|NCT03435055|101874448|FG000|NOT COMPLETED|Screening||2||
48628660|NCT03435055|101874448|FG000|STARTED|Received Intervention||19||
48628661|NCT03435055|101874448|FG000|COMPLETED|Received Intervention||16||
48334646|NCT02319044|101148225|FG000|COMPLETED|Overall Study||11||
48334647|NCT02319044|101148226|FG001|COMPLETED|Overall Study||7||
48334648|NCT02319044|101148227|FG002|COMPLETED|Overall Study||0||
48334649|NCT02319044|101148225|FG000|NOT COMPLETED|Overall Study||122||
48334650|NCT02319044|101148226|FG001|NOT COMPLETED|Overall Study||60||
48334651|NCT02319044|101148227|FG002|NOT COMPLETED|Overall Study||67||
48334652|NCT02963376|101148228|FG000|STARTED|Overall Study||6||
48334653|NCT02963376|101148229|FG001|STARTED|Overall Study||2||
48334654|NCT02963376|101148230|FG002|STARTED|Overall Study||6||
48334655|NCT02963376|101148231|FG003|STARTED|Overall Study||2||
48334656|NCT02963376|101148232|FG004|STARTED|Overall Study||6||
48334657|NCT02963376|101148233|FG005|STARTED|Overall Study||2||
48334658|NCT02963376|101148228|FG000|COMPLETED|Overall Study||6||
48334659|NCT02963376|101148229|FG001|COMPLETED|Overall Study||2||
48334660|NCT02963376|101148230|FG002|COMPLETED|Overall Study||6||
48334661|NCT02963376|101148231|FG003|COMPLETED|Overall Study||2||
48334662|NCT02963376|101148232|FG004|COMPLETED|Overall Study||6||
48334663|NCT02963376|101148233|FG005|COMPLETED|Overall Study||2||
48334664|NCT02963376|101148228|FG000|NOT COMPLETED|Overall Study||0||
48334665|NCT02963376|101148229|FG001|NOT COMPLETED|Overall Study||0||
48334666|NCT02963376|101148230|FG002|NOT COMPLETED|Overall Study||0||
48334667|NCT02963376|101148231|FG003|NOT COMPLETED|Overall Study||0||
48334668|NCT02963376|101148232|FG004|NOT COMPLETED|Overall Study||0||
48334669|NCT02963376|101148233|FG005|NOT COMPLETED|Overall Study||0||
48334670|NCT04957290|101148234|FG000|STARTED|Overall Study||4||
48334671|NCT04957290|101148235|FG001|STARTED|Overall Study||7||
48334672|NCT04957290|101148236|FG002|STARTED|Overall Study||10||
48334673|NCT04957290|101148237|FG003|STARTED|Overall Study||0||
48334674|NCT04957290|101148238|FG004|STARTED|Overall Study||0||
48334675|NCT04957290|101148239|FG005|STARTED|Overall Study||0||
48334676|NCT04957290|101148234|FG000|COMPLETED|Overall Study||0||
48334677|NCT04957290|101148235|FG001|COMPLETED|Overall Study||0||
48334678|NCT04957290|101148236|FG002|COMPLETED|Overall Study||0||
48334679|NCT04957290|101148237|FG003|COMPLETED|Overall Study||0||
48334680|NCT04957290|101148238|FG004|COMPLETED|Overall Study||0||
48334681|NCT04957290|101148239|FG005|COMPLETED|Overall Study||0||
48334682|NCT04957290|101148234|FG000|NOT COMPLETED|Overall Study||4||
48334683|NCT04957290|101148235|FG001|NOT COMPLETED|Overall Study||7||
48334684|NCT04957290|101148236|FG002|NOT COMPLETED|Overall Study||10||
48334685|NCT04957290|101148237|FG003|NOT COMPLETED|Overall Study||0||
48334686|NCT04957290|101148238|FG004|NOT COMPLETED|Overall Study||0||
48334687|NCT04957290|101148239|FG005|NOT COMPLETED|Overall Study||0||
48334688|NCT00448708|101148240|FG000|STARTED|Overall Study||112||
48334689|NCT00448708|101148241|FG001|STARTED|Overall Study||110||
48334690|NCT00448708|101148240|FG000|COMPLETED|Overall Study||77||
48334691|NCT00448708|101148241|FG001|COMPLETED|Overall Study||79||
48334692|NCT00448708|101148240|FG000|NOT COMPLETED|Overall Study||35||
48334693|NCT00448708|101148241|FG001|NOT COMPLETED|Overall Study||31||
48334694|NCT04599062|101148242|FG000|STARTED|Overall Study||6||
48334695|NCT04599062|101148243|FG001|STARTED|Overall Study||2||
48334696|NCT04599062|101148242|FG000|COMPLETED|Overall Study||5||
48334697|NCT04599062|101148243|FG001|COMPLETED|Overall Study||2||
48334698|NCT04599062|101148242|FG000|NOT COMPLETED|Overall Study||1||
48334699|NCT04599062|101148243|FG001|NOT COMPLETED|Overall Study||0||
48334700|NCT00433329|101148244|FG000|STARTED|Overall Study||100||
48334701|NCT00433329|101148244|FG000|COMPLETED|Overall Study||79||
48334702|NCT00433329|101148244|FG000|NOT COMPLETED|Overall Study||21||
48334703|NCT03961360|101148245|FG000|STARTED|Overall Study||110||
48334704|NCT03961360|101148246|FG001|STARTED|Overall Study||110||
48334705|NCT03961360|101148245|FG000|COMPLETED|Overall Study||107||
48334706|NCT03961360|101148246|FG001|COMPLETED|Overall Study||102||
48334707|NCT03961360|101148245|FG000|NOT COMPLETED|Overall Study||3||
48334708|NCT03961360|101148246|FG001|NOT COMPLETED|Overall Study||8||
48334709|NCT02908880|101148247|FG000|STARTED|Overall Study||263||
48334710|NCT02908880|101148247|FG000|COMPLETED|Overall Study||236||
48334711|NCT02908880|101148247|FG000|NOT COMPLETED|Overall Study||27||
48412114|NCT03083470|101341931|FG004|COMPLETED|Overall Study||7||
48412115|NCT03083470|101341927|FG000|NOT COMPLETED|Overall Study||0||
48334712|NCT03705793|101148248|FG000|STARTED|Overall Study||27||
48334713|NCT03705793|101148249|FG001|STARTED|Overall Study||26||
48334714|NCT03705793|101148248|FG000|COMPLETED|Overall Study||22||
48334715|NCT03705793|101148249|FG001|COMPLETED|Overall Study||21||
48334716|NCT03705793|101148248|FG000|NOT COMPLETED|Overall Study||5||
48334717|NCT03705793|101148249|FG001|NOT COMPLETED|Overall Study||5||
48412116|NCT03083470|101341928|FG001|NOT COMPLETED|Overall Study||0||
48412117|NCT03083470|101341929|FG002|NOT COMPLETED|Overall Study||0||
48412118|NCT03083470|101341930|FG003|NOT COMPLETED|Overall Study||0||
48334718|NCT00704262|101148250|FG000|STARTED|Overall Study||33||
48334719|NCT00704262|101148250|FG000|COMPLETED|Overall Study||31||
48334720|NCT00704262|101148250|FG000|NOT COMPLETED|Overall Study||2||
48334721|NCT02631538|101148251|FG000|STARTED|Treatment Period (Up to Week 52)||13||
48334722|NCT02631538|101148252|FG001|STARTED|Treatment Period (Up to Week 52)||24||
48334723|NCT02631538|101148253|FG002|STARTED|Treatment Period (Up to Week 52)||24||
48334724|NCT02631538|101148254|FG003|STARTED|Treatment Period (Up to Week 52)||25||
48334725|NCT02631538|101148251|FG000|COMPLETED|Treatment Period (Up to Week 52)||9||
48334726|NCT02631538|101148252|FG001|COMPLETED|Treatment Period (Up to Week 52)||17||
48334727|NCT02631538|101148253|FG002|COMPLETED|Treatment Period (Up to Week 52)||19||
48334728|NCT02631538|101148254|FG003|COMPLETED|Treatment Period (Up to Week 52)||17||
48334729|NCT02631538|101148251|FG000|NOT COMPLETED|Treatment Period (Up to Week 52)||4||
48334730|NCT02631538|101148252|FG001|NOT COMPLETED|Treatment Period (Up to Week 52)||7||
48334731|NCT02631538|101148253|FG002|NOT COMPLETED|Treatment Period (Up to Week 52)||5||
48334732|NCT02631538|101148254|FG003|NOT COMPLETED|Treatment Period (Up to Week 52)||8||
48334733|NCT02631538|101148251|FG000|STARTED|General Follow-up (GFU) (Up to Week 68)||9||
48334734|NCT02631538|101148252|FG001|STARTED|General Follow-up (GFU) (Up to Week 68)||17||
48334735|NCT02631538|101148253|FG002|STARTED|General Follow-up (GFU) (Up to Week 68)||19||
48334736|NCT02631538|101148254|FG003|STARTED|General Follow-up (GFU) (Up to Week 68)||17||
48334737|NCT02631538|101148251|FG000|COMPLETED|General Follow-up (GFU) (Up to Week 68)||8||
48334738|NCT02631538|101148252|FG001|COMPLETED|General Follow-up (GFU) (Up to Week 68)||17||
48334739|NCT02631538|101148253|FG002|COMPLETED|General Follow-up (GFU) (Up to Week 68)||19||
48334740|NCT02631538|101148254|FG003|COMPLETED|General Follow-up (GFU) (Up to Week 68)||16||
48334741|NCT02631538|101148251|FG000|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||1||
48334742|NCT02631538|101148252|FG001|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||0||
48334743|NCT02631538|101148253|FG002|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||0||
48334744|NCT02631538|101148254|FG003|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||1||
48334745|NCT00494091|101148255|FG000|STARTED|Overall Study||6||
48334746|NCT00494091|101148256|FG001|STARTED|Overall Study||76||
48334747|NCT00494091|101148255|FG000|COMPLETED|Overall Study||0||
48334748|NCT00494091|101148256|FG001|COMPLETED|Overall Study||0||
48334749|NCT00494091|101148255|FG000|NOT COMPLETED|Overall Study||6||
48334750|NCT00494091|101148256|FG001|NOT COMPLETED|Overall Study||76||
48334751|NCT03450083|101148257|FG000|STARTED|Overall Study||12||
48334752|NCT03450083|101148258|FG001|STARTED|Overall Study||12||
48334753|NCT03450083|101148257|FG000|COMPLETED|Overall Study||12||
48334754|NCT03450083|101148258|FG001|COMPLETED|Overall Study||12||
48334755|NCT03450083|101148257|FG000|NOT COMPLETED|Overall Study||0||
48334756|NCT03450083|101148258|FG001|NOT COMPLETED|Overall Study||0||
48334757|NCT01637142|101148259|FG000|STARTED|Treatment Period 1||18||
48334758|NCT01637142|101148259|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||18||
48334759|NCT01637142|101148259|FG000|COMPLETED|Treatment Period 1||18||
48334760|NCT01637142|101148259|FG000|NOT COMPLETED|Treatment Period 1||0||
48334761|NCT01637142|101148259|FG000|STARTED|Washout Period (at Least 3 Days)||18||
48334762|NCT01637142|101148259|FG000|COMPLETED|Washout Period (at Least 3 Days)||17||
48334763|NCT01637142|101148259|FG000|NOT COMPLETED|Washout Period (at Least 3 Days)||1||
48334764|NCT01637142|101148259|FG000|STARTED|Treatment Period 2||17||
48334765|NCT01637142|101148259|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||17||
48334766|NCT01637142|101148259|FG000|COMPLETED|Treatment Period 2||17||
48334767|NCT01637142|101148259|FG000|NOT COMPLETED|Treatment Period 2||0||
48334768|NCT00999908|101148260|FG000|STARTED|Treatment Period 1||19||
48334769|NCT00999908|101148261|FG001|STARTED|Treatment Period 1||16||
48628662|NCT03435055|101874448|FG000|NOT COMPLETED|Received Intervention||3||
48628663|NCT00266708|101874449|FG000|STARTED|Overall Study||20|Randomize|
48628664|NCT00266708|101874450|FG001|STARTED|Overall Study||22|Randomize|
48628665|NCT00266708|101874449|FG000|COMPLETED|Overall Study||16||
48628666|NCT00266708|101874450|FG001|COMPLETED|Overall Study||13||
48628667|NCT00266708|101874449|FG000|NOT COMPLETED|Overall Study||4||
48628668|NCT00266708|101874450|FG001|NOT COMPLETED|Overall Study||9||
48628669|NCT02219256|101874451|FG000|STARTED|Overall Study||12||
48628670|NCT02219256|101874452|FG001|STARTED|Overall Study||4||
48628671|NCT02219256|101874453|FG002|STARTED|Overall Study||4||
48628672|NCT02219256|101874454|FG003|STARTED|Overall Study||4||
48628673|NCT02219256|101874455|FG004|STARTED|Overall Study||6||
48334770|NCT00999908|101148262|FG002|STARTED|Treatment Period 1||19||
48334771|NCT00999908|101148260|FG000|COMPLETED|Treatment Period 1||17||
48628674|NCT02219256|101874456|FG005|STARTED|Overall Study||6||
48628675|NCT02219256|101874457|FG006|STARTED|Overall Study||6||
48628676|NCT02219256|101874458|FG007|STARTED|Overall Study||8||
48628677|NCT02219256|101874459|FG008|STARTED|Overall Study||6||
48628678|NCT02219256|101874460|FG009|STARTED|Overall Study||6||
48628679|NCT02219256|101874461|FG010|STARTED|Overall Study||6||
48628680|NCT02219256|101874462|FG011|STARTED|Overall Study||6||
48628681|NCT02219256|101874451|FG000|COMPLETED|Overall Study||12||
48628682|NCT02219256|101874452|FG001|COMPLETED|Overall Study||4||
48628683|NCT02219256|101874453|FG002|COMPLETED|Overall Study||4||
48628684|NCT02219256|101874454|FG003|COMPLETED|Overall Study||4||
48334772|NCT00999908|101148261|FG001|COMPLETED|Treatment Period 1||16||
48334773|NCT00999908|101148262|FG002|COMPLETED|Treatment Period 1||19||
48334774|NCT00999908|101148260|FG000|NOT COMPLETED|Treatment Period 1||2||
48334775|NCT00999908|101148261|FG001|NOT COMPLETED|Treatment Period 1||0||
48334776|NCT00999908|101148262|FG002|NOT COMPLETED|Treatment Period 1||0||
48628685|NCT02219256|101874455|FG004|COMPLETED|Overall Study||6||
48628686|NCT02219256|101874456|FG005|COMPLETED|Overall Study||6||
48334777|NCT00999908|101148260|FG000|STARTED|Treatment Period 2||17||
48334778|NCT00999908|101148261|FG001|STARTED|Treatment Period 2||16||
48628687|NCT02219256|101874457|FG006|COMPLETED|Overall Study||6||
48751668|NCT02735239|102180780|FG000|NOT COMPLETED|Overall Study||4||
48751669|NCT02735239|102180781|FG001|NOT COMPLETED|Overall Study||3||
48751670|NCT02735239|102180782|FG002|NOT COMPLETED|Overall Study||8||
48751671|NCT02735239|102180783|FG003|NOT COMPLETED|Overall Study||0||
48751672|NCT02735239|102180784|FG004|NOT COMPLETED|Overall Study||0||
48751673|NCT02735239|102180785|FG005|NOT COMPLETED|Overall Study||2||
48751674|NCT01643668|102180786|FG000|STARTED|Overall Study||34||
48751675|NCT01643668|102180786|FG000|COMPLETED|Overall Study||33||
48751676|NCT01643668|102180786|FG000|NOT COMPLETED|Overall Study||1||
48751677|NCT01350999|102180787|FG000|STARTED|Overall Study||165||
48751678|NCT01350999|102180788|FG001|STARTED|Overall Study||171||
48751679|NCT01350999|102180789|FG002|STARTED|Overall Study||167||
48751680|NCT01350999|102180787|FG000|Treated|Overall Study||165||
48751681|NCT01350999|102180788|FG001|Treated|Overall Study||171||
48751682|NCT01350999|102180789|FG002|Treated|Overall Study||167||
48751683|NCT01350999|102180787|FG000|COMPLETED|Overall Study||157||
48751684|NCT01350999|102180788|FG001|COMPLETED|Overall Study||157||
48751685|NCT01350999|102180789|FG002|COMPLETED|Overall Study||146||
48751686|NCT01350999|102180787|FG000|NOT COMPLETED|Overall Study||8||
48751687|NCT01350999|102180788|FG001|NOT COMPLETED|Overall Study||14||
48751688|NCT01350999|102180789|FG002|NOT COMPLETED|Overall Study||21||
48751689|NCT02738008|102180790|FG000|STARTED|Overall Study||1||
48751690|NCT02738008|102180791|FG001|STARTED|Overall Study||6||
48751691|NCT02738008|102180792|FG002|STARTED|Overall Study||5||
48751692|NCT02738008|102180790|FG000|COMPLETED|Overall Study||0||
48751693|NCT02738008|102180791|FG001|COMPLETED|Overall Study||0||
48751694|NCT02738008|102180792|FG002|COMPLETED|Overall Study||0||
48751695|NCT02738008|102180790|FG000|NOT COMPLETED|Overall Study||1||
48751696|NCT02738008|102180791|FG001|NOT COMPLETED|Overall Study||6||
48751697|NCT02738008|102180792|FG002|NOT COMPLETED|Overall Study||5||
48751698|NCT00844844|102180793|FG000|STARTED|Screening Period||17||
48751699|NCT00844844|102180793|FG000|COMPLETED|Screening Period||17||
48751700|NCT00844844|102180793|FG000|NOT COMPLETED|Screening Period||0||
48751701|NCT00844844|102180793|FG000|STARTED|Treatment Period (26 Weeks)||17||
48751702|NCT00844844|102180793|FG000|COMPLETED|Treatment Period (26 Weeks)||15||
48751703|NCT00844844|102180793|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||2||
48751704|NCT00844844|102180793|FG000|STARTED|Extension Treatment Period||13||
48751705|NCT00844844|102180793|FG000|COMPLETED|Extension Treatment Period||11||
48751706|NCT00844844|102180793|FG000|NOT COMPLETED|Extension Treatment Period||2||
48751707|NCT00844844|102180793|FG000|STARTED|Post Treatment Period||6||
48751708|NCT00844844|102180793|FG000|COMPLETED|Post Treatment Period||5||
48751709|NCT00844844|102180793|FG000|NOT COMPLETED|Post Treatment Period||1||
48751710|NCT04673214|102180794|FG000|STARTED|Overall Study||67||
48751711|NCT04673214|102180795|FG001|STARTED|Overall Study||47||
48751712|NCT04673214|102180794|FG000|Lost to Follow up|Overall Study||2||
48751713|NCT04673214|102180795|FG001|Lost to Follow up|Overall Study||1||
48751714|NCT04673214|102180794|FG000|COMPLETED|Overall Study||65|Analyzed|
48751715|NCT04673214|102180795|FG001|COMPLETED|Overall Study||46|Analyzed|
48751716|NCT04673214|102180794|FG000|NOT COMPLETED|Overall Study||2||
48751717|NCT04673214|102180795|FG001|NOT COMPLETED|Overall Study||1||
48751718|NCT00961311|102180796|FG000|STARTED|Overall Study||51||
48751719|NCT00961311|102180796|FG000|COMPLETED|Overall Study||51||
48751720|NCT00961311|102180796|FG000|NOT COMPLETED|Overall Study||0||
48751721|NCT01602224|102180797|FG000|STARTED|Overall Study||74||
48751722|NCT01602224|102180798|FG001|STARTED|Overall Study||74||
48751723|NCT01602224|102180799|FG002|STARTED|Overall Study||72||
48751724|NCT01602224|102180797|FG000|Received at Least 1 Dose of Study Drug|Overall Study||73||
48751725|NCT01602224|102180798|FG001|Received at Least 1 Dose of Study Drug|Overall Study||74||
48751726|NCT01602224|102180799|FG002|Received at Least 1 Dose of Study Drug|Overall Study||72||
48751727|NCT01602224|102180797|FG000|COMPLETED|Overall Study||66||
48751728|NCT01602224|102180798|FG001|COMPLETED|Overall Study||66||
48751729|NCT01602224|102180799|FG002|COMPLETED|Overall Study||66||
48751730|NCT01602224|102180797|FG000|NOT COMPLETED|Overall Study||8||
48751731|NCT01602224|102180798|FG001|NOT COMPLETED|Overall Study||8||
48751732|NCT01602224|102180799|FG002|NOT COMPLETED|Overall Study||6||
48751733|NCT02511379|102180800|FG000|STARTED|Overall Study||14||
48751734|NCT02511379|102180800|FG000|COMPLETED|Overall Study||14||
48751735|NCT02511379|102180800|FG000|NOT COMPLETED|Overall Study||0||
48751736|NCT01329978|102180801|FG000|STARTED|Sofosbuvir+PEG+RBV Treatment Period||52||
48751737|NCT01329978|102180802|FG001|STARTED|Sofosbuvir+PEG+RBV Treatment Period||125||
48751738|NCT01329978|102180803|FG002|STARTED|Sofosbuvir+PEG+RBV Treatment Period||155||
48751739|NCT01329978|102180804|FG003|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0||
48751740|NCT01329978|102180805|FG004|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0||
48751741|NCT01329978|102180801|FG000|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||48||
48751742|NCT01329978|102180802|FG001|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||112||
48751743|NCT01329978|102180803|FG002|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||150||
48751744|NCT01329978|102180804|FG003|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0||
48751745|NCT01329978|102180805|FG004|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0||
48751746|NCT01329978|102180801|FG000|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||4||
48751747|NCT01329978|102180802|FG001|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||13||
48751748|NCT01329978|102180803|FG002|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||5||
48751749|NCT01329978|102180804|FG003|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0||
48751750|NCT01329978|102180805|FG004|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0||
48751751|NCT01329978|102180801|FG000|STARTED|Rerandomization Treatment Period||0||
48751752|NCT01329978|102180802|FG001|STARTED|Rerandomization Treatment Period||0||
48751753|NCT01329978|102180803|FG002|STARTED|Rerandomization Treatment Period||0||
48751754|NCT01329978|102180804|FG003|STARTED|Rerandomization Treatment Period||75||
48751755|NCT01329978|102180805|FG004|STARTED|Rerandomization Treatment Period||75||
48751756|NCT01329978|102180801|FG000|COMPLETED|Rerandomization Treatment Period||0||
48751757|NCT01329978|102180802|FG001|COMPLETED|Rerandomization Treatment Period||0||
48751758|NCT01329978|102180803|FG002|COMPLETED|Rerandomization Treatment Period||0||
48751759|NCT01329978|102180804|FG003|COMPLETED|Rerandomization Treatment Period||70||
48751760|NCT01329978|102180805|FG004|COMPLETED|Rerandomization Treatment Period||71||
48751761|NCT01329978|102180801|FG000|NOT COMPLETED|Rerandomization Treatment Period||0||
48751762|NCT01329978|102180802|FG001|NOT COMPLETED|Rerandomization Treatment Period||0||
48751763|NCT01329978|102180803|FG002|NOT COMPLETED|Rerandomization Treatment Period||0||
48751764|NCT01329978|102180804|FG003|NOT COMPLETED|Rerandomization Treatment Period||5||
48751765|NCT01329978|102180805|FG004|NOT COMPLETED|Rerandomization Treatment Period||4||
48751766|NCT00539981|102180806|FG000|STARTED|Overall Study||2344||
48751767|NCT00539981|102180807|FG001|STARTED|Overall Study||2304||
48751768|NCT00539981|102180806|FG000|COMPLETED|Overall Study||2049||
48751769|NCT00539981|102180807|FG001|COMPLETED|Overall Study||2022||
48751770|NCT00539981|102180806|FG000|NOT COMPLETED|Overall Study||295||
48751771|NCT00539981|102180807|FG001|NOT COMPLETED|Overall Study||282||
48751772|NCT02978417|102180808|FG000|STARTED|Overall Study||5||
48751773|NCT02978417|102180809|FG001|STARTED|Overall Study||5||
48751774|NCT02978417|102180808|FG000|COMPLETED|Overall Study||3||
48751775|NCT02978417|102180809|FG001|COMPLETED|Overall Study||3||
48751776|NCT02978417|102180808|FG000|NOT COMPLETED|Overall Study||2||
48751777|NCT02978417|102180809|FG001|NOT COMPLETED|Overall Study||2||
48751778|NCT01255423|102180810|FG000|STARTED|Overall Study||104||
48751779|NCT01255423|102180811|FG001|STARTED|Overall Study||102||
48751780|NCT01255423|102180810|FG000|COMPLETED|Overall Study||101||
48751781|NCT01255423|102180811|FG001|COMPLETED|Overall Study||99||
48751782|NCT01255423|102180810|FG000|NOT COMPLETED|Overall Study||3||
48751783|NCT01255423|102180811|FG001|NOT COMPLETED|Overall Study||3||
48334779|NCT00999908|101148262|FG002|STARTED|Treatment Period 2||19||
48334780|NCT00999908|101148260|FG000|COMPLETED|Treatment Period 2||16||
48334781|NCT00999908|101148261|FG001|COMPLETED|Treatment Period 2||16||
48334782|NCT00999908|101148262|FG002|COMPLETED|Treatment Period 2||19||
48334783|NCT00999908|101148260|FG000|NOT COMPLETED|Treatment Period 2||1||
48751784|NCT02309944|102180812|FG000|STARTED|Overall Study||38||
48751785|NCT02309944|102180813|FG001|STARTED|Overall Study||43||
48751786|NCT02309944|102180812|FG000|COMPLETED|Overall Study||38||
48751787|NCT02309944|102180813|FG001|COMPLETED|Overall Study||43||
48334784|NCT00999908|101148261|FG001|NOT COMPLETED|Treatment Period 2||0||
48334785|NCT00999908|101148262|FG002|NOT COMPLETED|Treatment Period 2||0||
48334786|NCT00999908|101148260|FG000|STARTED|Treatment Period 3||16||
48334787|NCT00999908|101148261|FG001|STARTED|Treatment Period 3||16||
48334788|NCT00999908|101148262|FG002|STARTED|Treatment Period 3||19||
48334789|NCT00999908|101148260|FG000|COMPLETED|Treatment Period 3||16||
48334790|NCT00999908|101148261|FG001|COMPLETED|Treatment Period 3||16||
48334791|NCT00999908|101148262|FG002|COMPLETED|Treatment Period 3||19||
48334792|NCT00999908|101148260|FG000|NOT COMPLETED|Treatment Period 3||0||
48334793|NCT00999908|101148261|FG001|NOT COMPLETED|Treatment Period 3||0||
48334794|NCT00999908|101148262|FG002|NOT COMPLETED|Treatment Period 3||0||
48334795|NCT02549339|101148263|FG000|STARTED|3-day Treatment and 8-week Follow-up||205||
48334796|NCT02549339|101148264|FG001|STARTED|3-day Treatment and 8-week Follow-up||104||
48334797|NCT02549339|101148263|FG000|Treated|3-day Treatment and 8-week Follow-up||202||
48334798|NCT02549339|101148264|FG001|Treated|3-day Treatment and 8-week Follow-up||104||
48334799|NCT02549339|101148263|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||201||
48334800|NCT02549339|101148264|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||99||
48334801|NCT02549339|101148263|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||4||
48334802|NCT02549339|101148264|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||5||
48751788|NCT02309944|102180812|FG000|NOT COMPLETED|Overall Study||0||
48751789|NCT02309944|102180813|FG001|NOT COMPLETED|Overall Study||0||
48751790|NCT03084796|102180814|FG000|STARTED|Overall Study||121||
48751791|NCT03084796|102180815|FG001|STARTED|Overall Study||123||
48751792|NCT03084796|102180816|FG002|STARTED|Overall Study||122||
48751793|NCT03084796|102180817|FG003|STARTED|Overall Study||123||
48751794|NCT03084796|102180818|FG004|STARTED|Overall Study||121||
48751795|NCT03084796|102180819|FG005|STARTED|Overall Study||123||
48751796|NCT03084796|102180814|FG000|COMPLETED|Overall Study||114||
48751797|NCT03084796|102180815|FG001|COMPLETED|Overall Study||113||
48751798|NCT03084796|102180816|FG002|COMPLETED|Overall Study||110||
48751799|NCT03084796|102180817|FG003|COMPLETED|Overall Study||119||
48751800|NCT03084796|102180818|FG004|COMPLETED|Overall Study||110||
48751801|NCT03084796|102180819|FG005|COMPLETED|Overall Study||116||
48334803|NCT02549339|101148263|FG000|STARTED|12-month Follow-up||201||
48628688|NCT02219256|101874458|FG007|COMPLETED|Overall Study||8||
48628689|NCT02219256|101874459|FG008|COMPLETED|Overall Study||6||
48334804|NCT02549339|101148264|FG001|STARTED|12-month Follow-up||98||
48334805|NCT02549339|101148263|FG000|COMPLETED|12-month Follow-up||192||
48334806|NCT02549339|101148264|FG001|COMPLETED|12-month Follow-up||87||
48334807|NCT02549339|101148263|FG000|NOT COMPLETED|12-month Follow-up||9||
48334808|NCT02549339|101148264|FG001|NOT COMPLETED|12-month Follow-up||11||
48334809|NCT03468309|101148265|FG000|STARTED|Overall Study||53||
48334810|NCT03468309|101148265|FG000|COMPLETED|Overall Study||47||
48334811|NCT03468309|101148265|FG000|NOT COMPLETED|Overall Study||6||
48334812|NCT01724528|101148266|FG000|STARTED|Overall Study||173||
48334813|NCT01724528|101148267|FG001|STARTED|Overall Study||173||
48334814|NCT01724528|101148266|FG000|COMPLETED|Overall Study||169||
48334815|NCT01724528|101148267|FG001|COMPLETED|Overall Study||170||
48334816|NCT01724528|101148266|FG000|NOT COMPLETED|Overall Study||4||
48334817|NCT01724528|101148267|FG001|NOT COMPLETED|Overall Study||3||
48334818|NCT00868101|101148268|FG000|STARTED|Overall Study||12||
48334819|NCT00868101|101148269|FG001|STARTED|Overall Study||10||
48334820|NCT00868101|101148268|FG000|COMPLETED|Overall Study||12||
48334821|NCT00868101|101148269|FG001|COMPLETED|Overall Study||10||
48334822|NCT00868101|101148268|FG000|NOT COMPLETED|Overall Study||0||
48334823|NCT00868101|101148269|FG001|NOT COMPLETED|Overall Study||0||
48334824|NCT02419508|101148270|FG000|STARTED|Overall Study||96||
48628690|NCT02219256|101874460|FG009|COMPLETED|Overall Study||6||
48334825|NCT02419508|101148271|FG001|STARTED|Overall Study||92||
48334826|NCT02419508|101148270|FG000|Full Analysis Set|Overall Study||95||
48334827|NCT02419508|101148271|FG001|Full Analysis Set|Overall Study||92||
48334828|NCT02419508|101148270|FG000|Safety Analysis Set|Overall Study||95||
48334829|NCT02419508|101148271|FG001|Safety Analysis Set|Overall Study||92||
48334830|NCT02419508|101148270|FG000|COMPLETED|Overall Study||86||
48628691|NCT02219256|101874461|FG010|COMPLETED|Overall Study||6||
48628692|NCT02219256|101874462|FG011|COMPLETED|Overall Study||6||
48628693|NCT02219256|101874451|FG000|NOT COMPLETED|Overall Study||0||
48628694|NCT02219256|101874452|FG001|NOT COMPLETED|Overall Study||0||
48628695|NCT02219256|101874453|FG002|NOT COMPLETED|Overall Study||0||
48628696|NCT02219256|101874454|FG003|NOT COMPLETED|Overall Study||0||
48628697|NCT02219256|101874455|FG004|NOT COMPLETED|Overall Study||0||
48628698|NCT02219256|101874456|FG005|NOT COMPLETED|Overall Study||0||
48628699|NCT02219256|101874457|FG006|NOT COMPLETED|Overall Study||0||
48628700|NCT02219256|101874458|FG007|NOT COMPLETED|Overall Study||0||
48628701|NCT02219256|101874459|FG008|NOT COMPLETED|Overall Study||0||
48628702|NCT02219256|101874460|FG009|NOT COMPLETED|Overall Study||0||
48628703|NCT02219256|101874461|FG010|NOT COMPLETED|Overall Study||0||
48628704|NCT02219256|101874462|FG011|NOT COMPLETED|Overall Study||0||
48628705|NCT02233530|101874463|FG000|STARTED|Overall Study||8||
48628706|NCT02233530|101874463|FG000|COMPLETED|Overall Study||8||
48628707|NCT02233530|101874463|FG000|NOT COMPLETED|Overall Study||0||
48628708|NCT01287936|101874464|FG000|STARTED|Overall Study||6||
48628709|NCT01287936|101874465|FG001|STARTED|Overall Study||6||
48628710|NCT01287936|101874466|FG002|STARTED|Overall Study||6||
48334831|NCT02419508|101148271|FG001|COMPLETED|Overall Study||88||
48334832|NCT02419508|101148270|FG000|NOT COMPLETED|Overall Study||10||
48334833|NCT02419508|101148271|FG001|NOT COMPLETED|Overall Study||4||
48334834|NCT03760484|101148272|FG000|STARTED|Overall Study||4||
48334835|NCT03760484|101148272|FG000|COMPLETED|Overall Study||4||
48334836|NCT03760484|101148272|FG000|NOT COMPLETED|Overall Study||0||
48628711|NCT01287936|101874464|FG000|COMPLETED|Overall Study||6||
48628712|NCT01287936|101874465|FG001|COMPLETED|Overall Study||5||
48628713|NCT01287936|101874466|FG002|COMPLETED|Overall Study||5||
48628714|NCT01287936|101874464|FG000|NOT COMPLETED|Overall Study||0||
48628715|NCT01287936|101874465|FG001|NOT COMPLETED|Overall Study||1||
48628716|NCT01287936|101874466|FG002|NOT COMPLETED|Overall Study||1||
48334837|NCT00661271|101148273|FG000|STARTED|Overall Study||48||
48334838|NCT00661271|101148274|FG001|STARTED|Overall Study||45||
48334839|NCT00661271|101148273|FG000|COMPLETED|Overall Study||20||
48334840|NCT00661271|101148274|FG001|COMPLETED|Overall Study||20||
48334841|NCT00661271|101148273|FG000|NOT COMPLETED|Overall Study||28||
48628717|NCT02643693|101874467|FG000|STARTED|Overall Study||4||
48628718|NCT02643693|101874468|FG001|STARTED|Overall Study||4||
48628719|NCT02643693|101874469|FG002|STARTED|Overall Study||4||
48628720|NCT02643693|101874470|FG003|STARTED|Overall Study||4||
48628721|NCT02643693|101874471|FG004|STARTED|Overall Study||4||
48628722|NCT02643693|101874472|FG005|STARTED|Overall Study||4||
48628723|NCT02643693|101874467|FG000|COMPLETED|Overall Study||2||
48628724|NCT02643693|101874468|FG001|COMPLETED|Overall Study||2||
48628725|NCT02643693|101874469|FG002|COMPLETED|Overall Study||3||
48628726|NCT02643693|101874470|FG003|COMPLETED|Overall Study||4||
48628727|NCT02643693|101874471|FG004|COMPLETED|Overall Study||4||
48334842|NCT00661271|101148274|FG001|NOT COMPLETED|Overall Study||25||
48334843|NCT03474679|101148275|FG000|STARTED|Overall Study||19||
48334844|NCT03474679|101148275|FG000|COMPLETED|Overall Study||11||
48334845|NCT03474679|101148275|FG000|NOT COMPLETED|Overall Study||8||
48334846|NCT02769624|101148276|FG000|STARTED|Overall Study||7||
48334847|NCT02769624|101148277|FG001|STARTED|Overall Study||8||
48334848|NCT02769624|101148276|FG000|COMPLETED|Overall Study||7||
48628728|NCT02643693|101874472|FG005|COMPLETED|Overall Study||3||
48751802|NCT03084796|102180814|FG000|NOT COMPLETED|Overall Study||7||
48751803|NCT03084796|102180815|FG001|NOT COMPLETED|Overall Study||10||
48751804|NCT03084796|102180816|FG002|NOT COMPLETED|Overall Study||12||
48751805|NCT03084796|102180817|FG003|NOT COMPLETED|Overall Study||4||
48751806|NCT03084796|102180818|FG004|NOT COMPLETED|Overall Study||11||
48751807|NCT03084796|102180819|FG005|NOT COMPLETED|Overall Study||7||
48751808|NCT00964496|102180820|FG000|STARTED|Overall Study||28||
48751809|NCT00964496|102180821|FG001|STARTED|Overall Study||27||
48751810|NCT00964496|102180820|FG000|COMPLETED|Overall Study||26||
48751811|NCT00964496|102180821|FG001|COMPLETED|Overall Study||26||
48751812|NCT00964496|102180820|FG000|NOT COMPLETED|Overall Study||2||
48751813|NCT00964496|102180821|FG001|NOT COMPLETED|Overall Study||1||
48751814|NCT00659061|102180822|FG000|STARTED|Overall Study||308||
48751815|NCT00659061|102180823|FG001|STARTED|Overall Study||302||
48751816|NCT00659061|102180822|FG000|COMPLETED|Overall Study||287||
48751817|NCT00659061|102180823|FG001|COMPLETED|Overall Study||287||
48751818|NCT00659061|102180822|FG000|NOT COMPLETED|Overall Study||21||
48334849|NCT02769624|101148277|FG001|COMPLETED|Overall Study||7||
48334850|NCT02769624|101148276|FG000|NOT COMPLETED|Overall Study||0||
48334851|NCT02769624|101148277|FG001|NOT COMPLETED|Overall Study||1||
48334852|NCT02026063|101148278|FG000|STARTED|Overall Study||22||
48628729|NCT02643693|101874467|FG000|NOT COMPLETED|Overall Study||2||
48628730|NCT02643693|101874468|FG001|NOT COMPLETED|Overall Study||2||
48628731|NCT02643693|101874469|FG002|NOT COMPLETED|Overall Study||1||
48628732|NCT02643693|101874470|FG003|NOT COMPLETED|Overall Study||0||
48334853|NCT02026063|101148279|FG001|STARTED|Overall Study||102||
48334854|NCT02026063|101148278|FG000|COMPLETED|Overall Study||13||
48334855|NCT02026063|101148279|FG001|COMPLETED|Overall Study||53||
48334856|NCT02026063|101148278|FG000|NOT COMPLETED|Overall Study||9||
48334857|NCT02026063|101148279|FG001|NOT COMPLETED|Overall Study||49||
48334858|NCT01613326|101148280|FG000|STARTED|Overall Study||327||
48334859|NCT01613326|101148281|FG001|STARTED|Overall Study||330||
48334860|NCT01613326|101148280|FG000|COMPLETED|Overall Study||314||
48334861|NCT01613326|101148281|FG001|COMPLETED|Overall Study||316||
48334862|NCT01613326|101148280|FG000|NOT COMPLETED|Overall Study||13||
48334863|NCT01613326|101148281|FG001|NOT COMPLETED|Overall Study||14||
48334864|NCT00584870|101148282|FG000|STARTED|Overall Study||88||
48334865|NCT00584870|101148283|FG001|STARTED|Overall Study||89||
48334866|NCT00584870|101148284|FG002|STARTED|Overall Study||43||
48334867|NCT00584870|101148282|FG000|Treated|Overall Study||88||
48628733|NCT02643693|101874471|FG004|NOT COMPLETED|Overall Study||0||
48628734|NCT02643693|101874472|FG005|NOT COMPLETED|Overall Study||1||
48628735|NCT00003537|101874473|FG000|STARTED|Overall Study||19||
48628736|NCT00003537|101874473|FG000|COMPLETED|Overall Study||18||
48628737|NCT00003537|101874473|FG000|NOT COMPLETED|Overall Study||1||
48628738|NCT00677898|101874474|FG000|STARTED|Overall Study||119||
48628739|NCT00677898|101874475|FG001|STARTED|Overall Study||120||
48628740|NCT00677898|101874474|FG000|COMPLETED|Overall Study||99||
48628741|NCT00677898|101874475|FG001|COMPLETED|Overall Study||102||
48628742|NCT00677898|101874474|FG000|NOT COMPLETED|Overall Study||20||
48334868|NCT00584870|101148283|FG001|Treated|Overall Study||88||
48334869|NCT00584870|101148284|FG002|Treated|Overall Study||41||
48334870|NCT00584870|101148282|FG000|COMPLETED|Overall Study||59||
48628743|NCT00677898|101874475|FG001|NOT COMPLETED|Overall Study||18||
48628744|NCT03810183|101874476|FG000|STARTED|Overall Study||6||
48628745|NCT03810183|101874477|FG001|STARTED|Overall Study||3||
48628746|NCT03810183|101874476|FG000|COMPLETED|Overall Study||4||
48628747|NCT03810183|101874477|FG001|COMPLETED|Overall Study||2||
48173224|NCT00089895|100746346|FG001|COMPLETED|Overall Study||4642||
48334871|NCT00584870|101148283|FG001|COMPLETED|Overall Study||64||
48628748|NCT03810183|101874476|FG000|NOT COMPLETED|Overall Study||2||
48628749|NCT03810183|101874477|FG001|NOT COMPLETED|Overall Study||1||
48628750|NCT01035138|101874478|FG000|STARTED|Overall Study||73||
48628751|NCT01035138|101874479|FG001|STARTED|Overall Study||60||
48628752|NCT01035138|101874480|FG002|STARTED|Overall Study||47||
48628753|NCT01035138|101874478|FG000|COMPLETED|Overall Study||0||
48628754|NCT01035138|101874479|FG001|COMPLETED|Overall Study||0||
48751819|NCT00659061|102180823|FG001|NOT COMPLETED|Overall Study||15||
48751820|NCT03149055|102180824|FG000|STARTED|Overall Study||99||
48751821|NCT03149055|102180824|FG000|COMPLETED|Overall Study||95||
48751822|NCT03149055|102180824|FG000|NOT COMPLETED|Overall Study||4||
48751823|NCT00475670|102180825|FG000|STARTED|Overall Study||3||
48334872|NCT00584870|101148284|FG002|COMPLETED|Overall Study||25||
48751824|NCT00475670|102180826|FG001|STARTED|Overall Study||41||
48334873|NCT00584870|101148282|FG000|NOT COMPLETED|Overall Study||29||
48334874|NCT00584870|101148283|FG001|NOT COMPLETED|Overall Study||25||
48334875|NCT00584870|101148284|FG002|NOT COMPLETED|Overall Study||18||
48334876|NCT02322710|101148285|FG000|STARTED|Overall Study||105|Patients randomized|
48334877|NCT02322710|101148286|FG001|STARTED|Overall Study||99|Patients randomized|
48628755|NCT01035138|101874480|FG002|COMPLETED|Overall Study||0||
48628756|NCT01035138|101874478|FG000|NOT COMPLETED|Overall Study||73||
48628757|NCT01035138|101874479|FG001|NOT COMPLETED|Overall Study||60||
48628758|NCT01035138|101874480|FG002|NOT COMPLETED|Overall Study||47||
48628759|NCT00597272|101874481|FG000|STARTED|Overall Study||1||
48334878|NCT02322710|101148285|FG000|Safety Population|Overall Study||105||
48334879|NCT02322710|101148286|FG001|Safety Population|Overall Study||99||
48334880|NCT02322710|101148285|FG000|Full Analysis Population|Overall Study||105|No efficacy assessment post-baseline (N=1)|
48334881|NCT02322710|101148286|FG001|Full Analysis Population|Overall Study||98|No efficacy assessment post-baseline (N=1)|
48334882|NCT02322710|101148285|FG000|COMPLETED|Overall Study||85|Per protocol population|
48334883|NCT02322710|101148286|FG001|COMPLETED|Overall Study||73|Per protocol population|
48334884|NCT02322710|101148285|FG000|NOT COMPLETED|Overall Study||20||
48334885|NCT02322710|101148286|FG001|NOT COMPLETED|Overall Study||26||
48334886|NCT00621504|101148287|FG000|STARTED|Overall Study||299||
48334887|NCT00621504|101148288|FG001|STARTED|Overall Study||307||
48334888|NCT00621504|101148287|FG000|COMPLETED|Overall Study||273||
48334889|NCT00621504|101148288|FG001|COMPLETED|Overall Study||282||
48334890|NCT00621504|101148287|FG000|NOT COMPLETED|Overall Study||26||
48334891|NCT00621504|101148288|FG001|NOT COMPLETED|Overall Study||25||
48334892|NCT01639872|101148289|FG000|STARTED|Overall Study||24||
48334893|NCT01639872|101148290|FG001|STARTED|Overall Study||25||
48334894|NCT01639872|101148289|FG000|COMPLETED|Overall Study||14||
48334895|NCT01639872|101148290|FG001|COMPLETED|Overall Study||20||
48334896|NCT01639872|101148289|FG000|NOT COMPLETED|Overall Study||10||
48334897|NCT01639872|101148290|FG001|NOT COMPLETED|Overall Study||5||
48334898|NCT02631200|101148291|FG000|STARTED|First Period||17||
48334899|NCT02631200|101148292|FG001|STARTED|First Period||19||
48334900|NCT02631200|101148291|FG000|COMPLETED|First Period||10||
48334901|NCT02631200|101148292|FG001|COMPLETED|First Period||12||
48334902|NCT02631200|101148291|FG000|NOT COMPLETED|First Period||7||
48334903|NCT02631200|101148292|FG001|NOT COMPLETED|First Period||7||
48334904|NCT02631200|101148291|FG000|STARTED|Deferred Period||0|This was a deferred entry randomised controlled trial in which patients and their nominated surrogate were allocated in a 1:1 ratio to either immediate or deferred entry groups. Participants in the deferred entry group had outcomes measured contemporaneously with the immediate entry group but received the intervention 12 weeks after baseline data collection. They were then followed up until 24 weeks.|
48334905|NCT02631200|101148292|FG001|STARTED|Deferred Period||12|This was a deferred entry randomised controlled trial in which patients and their nominated surrogate were allocated in a 1:1 ratio to either immediate or deferred entry groups. Participants in the deferred entry group had outcomes measured contemporaneously with the immediate entry group but received the intervention 12 weeks after baseline data collection. They were then followed up until 24 weeks.|
48334906|NCT02631200|101148291|FG000|COMPLETED|Deferred Period||0||
48334907|NCT02631200|101148292|FG001|COMPLETED|Deferred Period||7||
48334908|NCT02631200|101148291|FG000|NOT COMPLETED|Deferred Period||0||
48334909|NCT02631200|101148292|FG001|NOT COMPLETED|Deferred Period||5||
48334910|NCT00876993|101148293|FG000|STARTED|Overall Study||5|Began at Dose Level (DL) 1, next was DL 0 (de-escalation), followed by DL1, DL 2, finished at DL 1.|
48334911|NCT00876993|101148294|FG001|STARTED|Overall Study||6|Began at Dose Level (DL) 1, next was DL 0 (de-escalation), followed by DL1, DL 2, finished at DL 1.|
48334912|NCT00876993|101148295|FG002|STARTED|Overall Study||5|Began at Dose Level (DL) 1, next was DL 0 (de-escalation), followed by DL1, DL 2, finished at DL 1.|
48334913|NCT00876993|101148296|FG003|STARTED|Overall Study||5|Began at Dose Level (DL) 1, next was DL 0 (de-escalation), followed by DL1, DL 2, finished at DL 1.|
48334914|NCT00876993|101148297|FG004|STARTED|Overall Study||5|Began at Dose Level (DL) 1, next was DL 0 (de-escalation), followed by DL1, DL 2, finished at DL 1.|
48334915|NCT00876993|101148293|FG000|COMPLETED|Overall Study||4||
48334916|NCT00876993|101148294|FG001|COMPLETED|Overall Study||6||
48334917|NCT00876993|101148295|FG002|COMPLETED|Overall Study||3||
48334918|NCT00876993|101148296|FG003|COMPLETED|Overall Study||5||
48334919|NCT00876993|101148297|FG004|COMPLETED|Overall Study||3||
48334920|NCT00876993|101148293|FG000|NOT COMPLETED|Overall Study||1||
48334921|NCT00876993|101148294|FG001|NOT COMPLETED|Overall Study||0||
48334922|NCT00876993|101148295|FG002|NOT COMPLETED|Overall Study||2||
48334923|NCT00876993|101148296|FG003|NOT COMPLETED|Overall Study||0||
48334924|NCT00876993|101148297|FG004|NOT COMPLETED|Overall Study||2||
48334925|NCT00634569|101148298|FG000|STARTED|Overall Study||14||
48334926|NCT00634569|101148299|FG001|STARTED|Overall Study||10||
48334927|NCT00634569|101148298|FG000|COMPLETED|Overall Study||14||
48334928|NCT00634569|101148299|FG001|COMPLETED|Overall Study||5||
48334929|NCT00634569|101148298|FG000|NOT COMPLETED|Overall Study||0||
48334930|NCT00634569|101148299|FG001|NOT COMPLETED|Overall Study||5||
48334931|NCT01044966|101148300|FG000|STARTED|Induction Phase||12||
48334932|NCT01044966|101148300|FG000|COMPLETED|Induction Phase||12||
48334933|NCT01044966|101148300|FG000|NOT COMPLETED|Induction Phase||0||
48334934|NCT01044966|101148300|FG000|STARTED|Consolidation Phase||12||
48334935|NCT01044966|101148300|FG000|COMPLETED|Consolidation Phase||2||
48334936|NCT01044966|101148300|FG000|NOT COMPLETED|Consolidation Phase||10||
48334937|NCT00689572|101148301|FG000|STARTED|Overall Study||53||
48334938|NCT00689572|101148302|FG001|STARTED|Overall Study||55||
48334939|NCT00689572|101148301|FG000|COMPLETED|Overall Study||39||
48334940|NCT00689572|101148302|FG001|COMPLETED|Overall Study||34||
48334941|NCT00689572|101148301|FG000|NOT COMPLETED|Overall Study||14||
48334942|NCT00689572|101148302|FG001|NOT COMPLETED|Overall Study||21||
48334943|NCT02479802|101148303|FG000|STARTED|Overall Study||13||
48334944|NCT02479802|101148303|FG000|COMPLETED|Overall Study||11||
48334945|NCT02479802|101148303|FG000|NOT COMPLETED|Overall Study||2||
48334946|NCT03887130|101148304|FG000|STARTED|Overall Study||51||
48334947|NCT03887130|101148305|FG001|STARTED|Overall Study||50||
48334948|NCT03887130|101148306|FG002|STARTED|Overall Study||51||
48334949|NCT03887130|101148304|FG000|COMPLETED|Overall Study||0||
48628760|NCT00597272|101874482|FG001|STARTED|Overall Study||1||
48628761|NCT00597272|101874483|FG002|STARTED|Overall Study||10||
48628762|NCT00597272|101874484|FG003|STARTED|Overall Study||1||
48628763|NCT00597272|101874485|FG004|STARTED|Overall Study||1||
48628764|NCT00597272|101874486|FG005|STARTED|Overall Study||10||
48628765|NCT00597272|101874487|FG006|STARTED|Overall Study||10||
48628766|NCT00597272|101874481|FG000|COMPLETED|Overall Study||1||
48173225|NCT00089895|100746345|FG000|NOT COMPLETED|Overall Study||35||
48173226|NCT00089895|100746346|FG001|NOT COMPLETED|Overall Study||42||
48173227|NCT02207374|100746347|FG000|STARTED|Overall Study||239||
48173228|NCT02207374|100746348|FG001|STARTED|Overall Study||241||
48173229|NCT02207374|100746349|FG002|STARTED|Overall Study||121||
48173230|NCT02207374|100746347|FG000|Exposed|Overall Study||239||
48173231|NCT02207374|100746348|FG001|Exposed|Overall Study||241||
48173232|NCT02207374|100746349|FG002|Exposed|Overall Study||120||
48173233|NCT02207374|100746347|FG000|COMPLETED|Overall Study||233||
48173234|NCT02207374|100746348|FG001|COMPLETED|Overall Study||231||
48173235|NCT02207374|100746349|FG002|COMPLETED|Overall Study||115||
48173236|NCT02207374|100746347|FG000|NOT COMPLETED|Overall Study||6||
48173237|NCT02207374|100746348|FG001|NOT COMPLETED|Overall Study||10||
48173238|NCT02207374|100746349|FG002|NOT COMPLETED|Overall Study||6||
48173239|NCT03249376|100746350|FG000|STARTED|Overall Study||188||
48173240|NCT03249376|100746351|FG001|STARTED|Overall Study||189||
48173241|NCT03249376|100746350|FG000|COMPLETED|Overall Study||167||
48173242|NCT03249376|100746351|FG001|COMPLETED|Overall Study||166||
48173243|NCT03249376|100746350|FG000|NOT COMPLETED|Overall Study||21||
48173244|NCT03249376|100746351|FG001|NOT COMPLETED|Overall Study||23||
48173245|NCT02341144|100746352|FG000|STARTED|Overall Study||30||
48173246|NCT02341144|100746353|FG001|STARTED|Overall Study||31||
48173247|NCT02341144|100746352|FG000|COMPLETED|Overall Study||28||
48173248|NCT02341144|100746353|FG001|COMPLETED|Overall Study||30||
48173249|NCT02341144|100746352|FG000|NOT COMPLETED|Overall Study||2||
48173250|NCT02341144|100746353|FG001|NOT COMPLETED|Overall Study||1||
48173251|NCT00472186|100746354|FG000|STARTED|Overall Study||2||
48173252|NCT00472186|100746355|FG001|STARTED|Overall Study||0||
48173253|NCT00472186|100746354|FG000|COMPLETED|Overall Study||1||
48173254|NCT00472186|100746355|FG001|COMPLETED|Overall Study||0||
48173255|NCT00472186|100746354|FG000|NOT COMPLETED|Overall Study||1||
48173256|NCT00472186|100746355|FG001|NOT COMPLETED|Overall Study||0||
48173257|NCT04684641|100746356|FG000|STARTED|Overall Study||4||
48173258|NCT04684641|100746357|FG001|STARTED|Overall Study||4||
48173259|NCT04684641|100746356|FG000|COMPLETED|Overall Study||4||
48173260|NCT04684641|100746357|FG001|COMPLETED|Overall Study||2||
48173261|NCT04684641|100746356|FG000|NOT COMPLETED|Overall Study||0||
48173262|NCT04684641|100746357|FG001|NOT COMPLETED|Overall Study||2||
48173263|NCT01486758|100746358|FG000|STARTED|Overall Study||20||
48173264|NCT01486758|100746359|FG001|STARTED|Overall Study||20||
48173265|NCT01486758|100746358|FG000|COMPLETED|Overall Study||20||
48173266|NCT01486758|100746359|FG001|COMPLETED|Overall Study||19||
48173267|NCT01486758|100746358|FG000|NOT COMPLETED|Overall Study||0||
48173268|NCT01486758|100746359|FG001|NOT COMPLETED|Overall Study||1||
48173269|NCT00649389|100746360|FG000|STARTED|Overall Study||628||
48173270|NCT00649389|100746361|FG001|STARTED|Overall Study||637||
48173271|NCT00649389|100746362|FG002|STARTED|Overall Study||600||
48173272|NCT00649389|100746363|FG003|STARTED|Overall Study||627||
48173273|NCT00649389|100746360|FG000|COMPLETED|Overall Study||557||
48173274|NCT00649389|100746361|FG001|COMPLETED|Overall Study||531||
48173275|NCT00649389|100746362|FG002|COMPLETED|Overall Study||512||
48173276|NCT00649389|100746363|FG003|COMPLETED|Overall Study||516||
48173277|NCT00649389|100746360|FG000|NOT COMPLETED|Overall Study||71||
48173278|NCT00649389|100746361|FG001|NOT COMPLETED|Overall Study||106||
48173279|NCT00649389|100746362|FG002|NOT COMPLETED|Overall Study||88||
48173280|NCT00649389|100746363|FG003|NOT COMPLETED|Overall Study||111||
48173281|NCT02162992|100746364|FG000|STARTED|Overall Study||51||
48173282|NCT02162992|100746365|FG001|STARTED|Overall Study||100||
48173283|NCT02162992|100746364|FG000|COMPLETED|Overall Study||46||
48173284|NCT02162992|100746365|FG001|COMPLETED|Overall Study||99||
48173285|NCT02162992|100746364|FG000|NOT COMPLETED|Overall Study||5||
48334950|NCT03887130|101148305|FG001|COMPLETED|Overall Study||0||
48334951|NCT03887130|101148306|FG002|COMPLETED|Overall Study||0||
48628767|NCT00597272|101874482|FG001|COMPLETED|Overall Study||1||
48628768|NCT00597272|101874483|FG002|COMPLETED|Overall Study||10||
48173286|NCT02162992|100746365|FG001|NOT COMPLETED|Overall Study||1||
48173287|NCT00584805|100746366|FG000|STARTED|Overall Study||138||
48173288|NCT00584805|100746366|FG000|COMPLETED|Overall Study||39||
48173289|NCT00584805|100746366|FG000|NOT COMPLETED|Overall Study||99||
48173290|NCT00566943|100746367|FG000|STARTED|Overall Study||52||
48334952|NCT03887130|101148304|FG000|NOT COMPLETED|Overall Study||51||
48334953|NCT03887130|101148305|FG001|NOT COMPLETED|Overall Study||50||
48173291|NCT00566943|100746368|FG001|STARTED|Overall Study||49||
48173292|NCT00566943|100746367|FG000|COMPLETED|Overall Study||52||
48173293|NCT00566943|100746368|FG001|COMPLETED|Overall Study||49||
48173294|NCT00566943|100746367|FG000|NOT COMPLETED|Overall Study||0||
48173295|NCT00566943|100746368|FG001|NOT COMPLETED|Overall Study||0||
48173296|NCT00653263|100746369|FG000|STARTED|Overall Study||8||
48173297|NCT00653263|100746369|FG000|COMPLETED|Overall Study||6||
48173298|NCT00653263|100746369|FG000|NOT COMPLETED|Overall Study||2||
48173299|NCT01987596|100746370|FG000|STARTED|Overall Study||12||
48173300|NCT01987596|100746371|FG001|STARTED|Overall Study||11||
48173301|NCT01987596|100746370|FG000|COMPLETED|Overall Study||11||
48173302|NCT01987596|100746371|FG001|COMPLETED|Overall Study||10||
48173303|NCT01987596|100746370|FG000|NOT COMPLETED|Overall Study||1||
48173304|NCT01987596|100746371|FG001|NOT COMPLETED|Overall Study||1||
48173305|NCT00474929|100746372|FG000|STARTED|Overall Study||6||
48173306|NCT00474929|100746373|FG001|STARTED|Overall Study||6||
48173307|NCT00474929|100746374|FG002|STARTED|Overall Study||7||
48173308|NCT00474929|100746375|FG003|STARTED|Overall Study||7||
48173309|NCT00474929|100746376|FG004|STARTED|Overall Study||77||
48173310|NCT00474929|100746372|FG000|COMPLETED|Overall Study||6||
48173311|NCT00474929|100746373|FG001|COMPLETED|Overall Study||5||
48628769|NCT00597272|101874484|FG003|COMPLETED|Overall Study||1||
48628770|NCT00597272|101874485|FG004|COMPLETED|Overall Study||1||
48628771|NCT00597272|101874486|FG005|COMPLETED|Overall Study||10||
48628772|NCT00597272|101874487|FG006|COMPLETED|Overall Study||10||
48628773|NCT00597272|101874481|FG000|NOT COMPLETED|Overall Study||0||
48628774|NCT00597272|101874482|FG001|NOT COMPLETED|Overall Study||0||
48628775|NCT00597272|101874483|FG002|NOT COMPLETED|Overall Study||0||
48628776|NCT00597272|101874484|FG003|NOT COMPLETED|Overall Study||0||
48628777|NCT00597272|101874485|FG004|NOT COMPLETED|Overall Study||0||
48173312|NCT00474929|100746374|FG002|COMPLETED|Overall Study||5||
48173313|NCT00474929|100746375|FG003|COMPLETED|Overall Study||5||
48173314|NCT00474929|100746376|FG004|COMPLETED|Overall Study||77||
48173315|NCT00474929|100746372|FG000|NOT COMPLETED|Overall Study||0||
48173316|NCT00474929|100746373|FG001|NOT COMPLETED|Overall Study||1||
48173317|NCT00474929|100746374|FG002|NOT COMPLETED|Overall Study||2||
48173318|NCT00474929|100746375|FG003|NOT COMPLETED|Overall Study||2||
48173319|NCT00474929|100746376|FG004|NOT COMPLETED|Overall Study||0||
48173320|NCT01232465|100746377|FG000|STARTED|Overall Study||337||
48173321|NCT01232465|100746378|FG001|STARTED|Overall Study||402||
48173322|NCT01232465|100746377|FG000|COMPLETED|Overall Study||337||
48173323|NCT01232465|100746378|FG001|COMPLETED|Overall Study||402||
48173324|NCT01232465|100746377|FG000|NOT COMPLETED|Overall Study||0||
48173325|NCT01232465|100746378|FG001|NOT COMPLETED|Overall Study||0||
48628778|NCT00597272|101874486|FG005|NOT COMPLETED|Overall Study||0||
48628779|NCT00597272|101874487|FG006|NOT COMPLETED|Overall Study||0||
48628780|NCT00843492|101874488|FG000|STARTED|Overall Study||622||
48173326|NCT03039543|100746379|FG000|STARTED|Overall Study||54||
48173327|NCT03039543|100746380|FG001|STARTED|Overall Study||54||
48173328|NCT03039543|100746379|FG000|COMPLETED|Overall Study||53||
48173329|NCT03039543|100746380|FG001|COMPLETED|Overall Study||51||
48173330|NCT03039543|100746379|FG000|NOT COMPLETED|Overall Study||1||
48173331|NCT03039543|100746380|FG001|NOT COMPLETED|Overall Study||3||
48173332|NCT00976482|100746381|FG000|STARTED|Overall Study||1745||
48173333|NCT00976482|100746381|FG000|Eligible for Last Follow up|Overall Study||1487||
48173334|NCT00976482|100746381|FG000|COMPLETED|Overall Study||1486||
48173335|NCT00976482|100746381|FG000|NOT COMPLETED|Overall Study||259||
48173336|NCT00924560|100746382|FG000|STARTED|Overall Study||458||
48173337|NCT00924560|100746383|FG001|STARTED|Overall Study||448||
48173338|NCT00924560|100746384|FG002|STARTED|Overall Study||455||
48173339|NCT00924560|100746382|FG000|Received Treatment|Overall Study||422||
48173340|NCT00924560|100746383|FG001|Received Treatment|Overall Study||411||
48173341|NCT00924560|100746384|FG002|Received Treatment|Overall Study||0||
48173342|NCT00924560|100746382|FG000|COMPLETED|Overall Study||247||
48173343|NCT00924560|100746383|FG001|COMPLETED|Overall Study||240||
48173344|NCT00924560|100746384|FG002|COMPLETED|Overall Study||372||
48173345|NCT00924560|100746382|FG000|NOT COMPLETED|Overall Study||211||
48173346|NCT00924560|100746383|FG001|NOT COMPLETED|Overall Study||208||
48173347|NCT00924560|100746384|FG002|NOT COMPLETED|Overall Study||83||
48173348|NCT01010477|100746385|FG000|STARTED|Overall Study||27||
48173349|NCT01010477|100746386|FG001|STARTED|Overall Study||25||
48628781|NCT00843492|101874489|FG001|STARTED|Overall Study||621||
48173350|NCT01010477|100746385|FG000|COMPLETED|Overall Study||21||
48173351|NCT01010477|100746386|FG001|COMPLETED|Overall Study||22||
48173352|NCT01010477|100746385|FG000|NOT COMPLETED|Overall Study||6||
48173353|NCT01010477|100746386|FG001|NOT COMPLETED|Overall Study||3||
48173354|NCT01317875|100746387|FG000|STARTED|Overall Study||5||
48173355|NCT01317875|100746388|FG001|STARTED|Overall Study||3||
48173356|NCT01317875|100746389|FG002|STARTED|Overall Study||20||
48751825|NCT00475670|102180825|FG000|COMPLETED|Overall Study||0||
48751826|NCT00475670|102180826|FG001|COMPLETED|Overall Study||0||
48751827|NCT00475670|102180825|FG000|NOT COMPLETED|Overall Study||3||
48751828|NCT00475670|102180826|FG001|NOT COMPLETED|Overall Study||41||
48751829|NCT05413668|102180827|FG000|STARTED|Overall Study||6||
48751830|NCT05413668|102180828|FG001|STARTED|Overall Study||6||
48751831|NCT05413668|102180829|FG002|STARTED|Overall Study||6||
48751832|NCT05413668|102180830|FG003|STARTED|Overall Study||6||
48751833|NCT05413668|102180831|FG004|STARTED|Overall Study||8||
48751834|NCT05413668|102180827|FG000|Dosed|Overall Study||6||
48751835|NCT05413668|102180828|FG001|Dosed|Overall Study||6||
48751836|NCT05413668|102180829|FG002|Dosed|Overall Study||6||
48751837|NCT05413668|102180830|FG003|Dosed|Overall Study||6||
48751838|NCT05413668|102180831|FG004|Dosed|Overall Study||8||
48751839|NCT05413668|102180827|FG000|COMPLETED|Overall Study||6||
48751840|NCT05413668|102180828|FG001|COMPLETED|Overall Study||6||
48751841|NCT05413668|102180829|FG002|COMPLETED|Overall Study||6||
48751842|NCT05413668|102180830|FG003|COMPLETED|Overall Study||6||
48751843|NCT05413668|102180831|FG004|COMPLETED|Overall Study||8||
48751844|NCT05413668|102180827|FG000|NOT COMPLETED|Overall Study||0||
48751845|NCT05413668|102180828|FG001|NOT COMPLETED|Overall Study||0||
48751846|NCT05413668|102180829|FG002|NOT COMPLETED|Overall Study||0||
48751847|NCT05413668|102180830|FG003|NOT COMPLETED|Overall Study||0||
48751848|NCT05413668|102180831|FG004|NOT COMPLETED|Overall Study||0||
48751849|NCT04258423|102180832|FG000|STARTED|Overall Study||2||
48751850|NCT04258423|102180833|FG001|STARTED|Overall Study||2||
48751851|NCT04258423|102180832|FG000|COMPLETED|Overall Study||0||
48751852|NCT04258423|102180833|FG001|COMPLETED|Overall Study||0||
48751853|NCT04258423|102180832|FG000|NOT COMPLETED|Overall Study||2||
48751854|NCT04258423|102180833|FG001|NOT COMPLETED|Overall Study||2||
48751855|NCT02519439|102180834|FG000|STARTED|Overall Study||26||
48751856|NCT02519439|102180834|FG000|COMPLETED|Overall Study||5||
48751857|NCT02519439|102180834|FG000|NOT COMPLETED|Overall Study||21||
48751858|NCT00681044|102180835|FG000|STARTED|Overall Study||4||
48751859|NCT00681044|102180835|FG000|COMPLETED|Overall Study||4||
48751860|NCT00681044|102180835|FG000|NOT COMPLETED|Overall Study||0||
48751861|NCT00558246|102180836|FG000|STARTED|Overall Study||79||
48751862|NCT00558246|102180836|FG000|COMPLETED|Overall Study||79||
48751863|NCT00558246|102180836|FG000|NOT COMPLETED|Overall Study||0||
48751864|NCT02888106|102180837|FG000|STARTED|Overall Study||15||
48751865|NCT02888106|102180838|FG001|STARTED|Overall Study||15||
48751866|NCT02888106|102180839|FG002|STARTED|Overall Study||15||
48751867|NCT02888106|102180840|FG003|STARTED|Overall Study||15||
48751868|NCT02888106|102180841|FG004|STARTED|Overall Study||15||
48751869|NCT02888106|102180842|FG005|STARTED|Overall Study||15||
48751870|NCT02888106|102180837|FG000|COMPLETED|Overall Study||10||
48751871|NCT02888106|102180838|FG001|COMPLETED|Overall Study||13||
48751872|NCT02888106|102180839|FG002|COMPLETED|Overall Study||15||
48751873|NCT02888106|102180840|FG003|COMPLETED|Overall Study||13||
48751874|NCT02888106|102180841|FG004|COMPLETED|Overall Study||14||
48173357|NCT01317875|100746390|FG003|STARTED|Overall Study||4||
48173358|NCT01317875|100746391|FG004|STARTED|Overall Study||12||
48173359|NCT01317875|100746392|FG005|STARTED|Overall Study||3||
48173360|NCT01317875|100746393|FG006|STARTED|Overall Study||4||
48173361|NCT01317875|100746394|FG007|STARTED|Overall Study||18||
48173362|NCT01317875|100746395|FG008|STARTED|Overall Study||0||
48173363|NCT01317875|100746396|FG009|STARTED|Overall Study||0||
48173364|NCT01317875|100746387|FG000|COMPLETED|Overall Study||2||
48173365|NCT01317875|100746388|FG001|COMPLETED|Overall Study||1||
48173366|NCT01317875|100746389|FG002|COMPLETED|Overall Study||11||
48173367|NCT01317875|100746390|FG003|COMPLETED|Overall Study||2||
48173368|NCT01317875|100746391|FG004|COMPLETED|Overall Study||3||
48751875|NCT02888106|102180842|FG005|COMPLETED|Overall Study||14||
48751876|NCT02888106|102180837|FG000|NOT COMPLETED|Overall Study||5||
48751877|NCT02888106|102180838|FG001|NOT COMPLETED|Overall Study||2||
48751878|NCT02888106|102180839|FG002|NOT COMPLETED|Overall Study||0||
48751879|NCT02888106|102180840|FG003|NOT COMPLETED|Overall Study||2||
48751880|NCT02888106|102180841|FG004|NOT COMPLETED|Overall Study||1||
48173369|NCT01317875|100746392|FG005|COMPLETED|Overall Study||1||
48173370|NCT01317875|100746393|FG006|COMPLETED|Overall Study||2||
48173371|NCT01317875|100746394|FG007|COMPLETED|Overall Study||3||
48751881|NCT02888106|102180842|FG005|NOT COMPLETED|Overall Study||1||
48751882|NCT02362321|102180843|FG000|STARTED|Overall Study||10||
48751883|NCT02362321|102180844|FG001|STARTED|Overall Study||10||
48751884|NCT02362321|102180843|FG000|COMPLETED|Overall Study||6||
48751885|NCT02362321|102180844|FG001|COMPLETED|Overall Study||10||
48751886|NCT02362321|102180843|FG000|NOT COMPLETED|Overall Study||4||
48173372|NCT01317875|100746395|FG008|COMPLETED|Overall Study||0||
48173373|NCT01317875|100746396|FG009|COMPLETED|Overall Study||0||
48173374|NCT01317875|100746387|FG000|NOT COMPLETED|Overall Study||3||
48173375|NCT01317875|100746388|FG001|NOT COMPLETED|Overall Study||2||
48173376|NCT01317875|100746389|FG002|NOT COMPLETED|Overall Study||9||
48173377|NCT01317875|100746390|FG003|NOT COMPLETED|Overall Study||2||
48173378|NCT01317875|100746391|FG004|NOT COMPLETED|Overall Study||9||
48173379|NCT01317875|100746392|FG005|NOT COMPLETED|Overall Study||2||
48173380|NCT01317875|100746393|FG006|NOT COMPLETED|Overall Study||2||
48173381|NCT01317875|100746394|FG007|NOT COMPLETED|Overall Study||15||
48173382|NCT01317875|100746395|FG008|NOT COMPLETED|Overall Study||0||
48173383|NCT01317875|100746396|FG009|NOT COMPLETED|Overall Study||0||
48173384|NCT02609659|100746397|FG000|STARTED|Overall Study||105||
48173385|NCT02609659|100746397|FG000|COMPLETED|Overall Study||97||
48173386|NCT02609659|100746397|FG000|NOT COMPLETED|Overall Study||8||
48173387|NCT01432535|100746398|FG000|STARTED|Overall Study||12||
48173388|NCT01432535|100746399|FG001|STARTED|Overall Study||7||
48173389|NCT01432535|100746400|FG002|STARTED|Overall Study||6||
48173390|NCT01432535|100746398|FG000|COMPLETED|Overall Study||12||
48173391|NCT01432535|100746399|FG001|COMPLETED|Overall Study||7||
48173392|NCT01432535|100746400|FG002|COMPLETED|Overall Study||6||
48173393|NCT01432535|100746398|FG000|NOT COMPLETED|Overall Study||0||
48173394|NCT01432535|100746399|FG001|NOT COMPLETED|Overall Study||0||
48173395|NCT01432535|100746400|FG002|NOT COMPLETED|Overall Study||0||
48173396|NCT01272882|100746401|FG000|STARTED|Overall Study||13||
48173397|NCT01272882|100746401|FG000|COMPLETED|Overall Study||13||
48173398|NCT01272882|100746401|FG000|NOT COMPLETED|Overall Study||0||
48173399|NCT03358329|100746402|FG000|STARTED|Overall Study||50||
48173400|NCT03358329|100746402|FG000|COMPLETED|Overall Study||46||
48173401|NCT03358329|100746402|FG000|NOT COMPLETED|Overall Study||4||
48173402|NCT02838628|100746403|FG000|STARTED|Treatment and Follow-up Period||84||
48173403|NCT02838628|100746404|FG001|STARTED|Treatment and Follow-up Period||84||
48173404|NCT02838628|100746403|FG000|COMPLETED|Treatment and Follow-up Period||84||
48173405|NCT02838628|100746404|FG001|COMPLETED|Treatment and Follow-up Period||84||
48173406|NCT02838628|100746403|FG000|NOT COMPLETED|Treatment and Follow-up Period||0||
48173407|NCT02838628|100746404|FG001|NOT COMPLETED|Treatment and Follow-up Period||0||
48173408|NCT02838628|100746403|FG000|STARTED|Recurrence Follow-up Period||36|Participants who achieved 100% AK clearance at Day 57 visit entered the recurrence follow-up period.|
48173409|NCT02838628|100746404|FG001|STARTED|Recurrence Follow-up Period||27|Participants who achieved 100% AK clearance at Day 57 visit entered the recurrence follow-up period.|
48173410|NCT02838628|100746403|FG000|COMPLETED|Recurrence Follow-up Period||16||
48173411|NCT02838628|100746404|FG001|COMPLETED|Recurrence Follow-up Period||10||
48173412|NCT02838628|100746403|FG000|NOT COMPLETED|Recurrence Follow-up Period||20||
48173413|NCT02838628|100746404|FG001|NOT COMPLETED|Recurrence Follow-up Period||17||
48173414|NCT00735449|100746405|FG000|STARTED|Overall Study||102||
48173415|NCT00735449|100746406|FG001|STARTED|Overall Study||102||
48173416|NCT00735449|100746405|FG000|COMPLETED|Overall Study||95||
48173417|NCT00735449|100746406|FG001|COMPLETED|Overall Study||96||
48173418|NCT00735449|100746405|FG000|NOT COMPLETED|Overall Study||7||
48173419|NCT00735449|100746406|FG001|NOT COMPLETED|Overall Study||6||
48173420|NCT00886262|100746407|FG000|STARTED|Overall Study||8||
48173421|NCT00886262|100746408|FG001|STARTED|Overall Study||10||
48173422|NCT00886262|100746407|FG000|COMPLETED|Overall Study||8||
48173423|NCT00886262|100746408|FG001|COMPLETED|Overall Study||7||
48173424|NCT00886262|100746407|FG000|NOT COMPLETED|Overall Study||0||
48173425|NCT00886262|100746408|FG001|NOT COMPLETED|Overall Study||3||
48173426|NCT02571439|100746409|FG000|STARTED|Overall Study||20||
48173427|NCT02571439|100746410|FG001|STARTED|Overall Study||21||
48334954|NCT03887130|101148306|FG002|NOT COMPLETED|Overall Study||51||
48334955|NCT05098041|101148307|FG000|STARTED|Period 1 (1 Day)||15||
48334956|NCT05098041|101148307|FG000|COMPLETED|Period 1 (1 Day)||14||
48628782|NCT00843492|101874488|FG000|COMPLETED|Overall Study||614||
48173428|NCT02571439|100746409|FG000|COMPLETED|Overall Study||20||
48173429|NCT02571439|100746410|FG001|COMPLETED|Overall Study||21||
48173430|NCT02571439|100746409|FG000|NOT COMPLETED|Overall Study||0||
48173431|NCT02571439|100746410|FG001|NOT COMPLETED|Overall Study||0||
48173432|NCT01225822|100746411|FG000|STARTED|Overall Study||389||
48173433|NCT01225822|100746412|FG001|STARTED|Overall Study||390||
48173434|NCT01225822|100746413|FG002|STARTED|Overall Study||393||
48173435|NCT01225822|100746414|FG003|STARTED|Overall Study||385||
48173436|NCT01225822|100746415|FG004|STARTED|Overall Study||392||
48173437|NCT01225822|100746411|FG000|COMPLETED|Overall Study||351||
48173438|NCT01225822|100746412|FG001|COMPLETED|Overall Study||334||
48173439|NCT01225822|100746413|FG002|COMPLETED|Overall Study||355||
48173440|NCT01225822|100746414|FG003|COMPLETED|Overall Study||333||
48173441|NCT01225822|100746415|FG004|COMPLETED|Overall Study||361||
48628783|NCT00843492|101874489|FG001|COMPLETED|Overall Study||607||
48173442|NCT01225822|100746411|FG000|NOT COMPLETED|Overall Study||38||
48173443|NCT01225822|100746412|FG001|NOT COMPLETED|Overall Study||56||
48173444|NCT01225822|100746413|FG002|NOT COMPLETED|Overall Study||38||
48173445|NCT01225822|100746414|FG003|NOT COMPLETED|Overall Study||52||
48173446|NCT01225822|100746415|FG004|NOT COMPLETED|Overall Study||31||
48173447|NCT03354637|100746416|FG000|STARTED|Double-blind Period||43||
48334957|NCT05098041|101148307|FG000|NOT COMPLETED|Period 1 (1 Day)||1||
48173448|NCT03354637|100746417|FG001|STARTED|Double-blind Period||44||
48173449|NCT03354637|100746418|FG002|STARTED|Double-blind Period||42||
48173450|NCT03354637|100746416|FG000|COMPLETED|Double-blind Period||26||
48173451|NCT03354637|100746417|FG001|COMPLETED|Double-blind Period||31||
48173452|NCT03354637|100746418|FG002|COMPLETED|Double-blind Period||35||
48173453|NCT03354637|100746416|FG000|NOT COMPLETED|Double-blind Period||17||
48173454|NCT03354637|100746417|FG001|NOT COMPLETED|Double-blind Period||13||
48173455|NCT03354637|100746418|FG002|NOT COMPLETED|Double-blind Period||7||
48173456|NCT03354637|100746416|FG000|STARTED|Open Label Extension||0|Subjects entering the Open Label Extension period all received ATI-50002 0.46% Topical Solution.|
48173457|NCT03354637|100746417|FG001|STARTED|Open Label Extension||0|Subjects entering the Open Label Extension period all received ATI-50002 0.46% Topical Solution.|
48173458|NCT03354637|100746418|FG002|STARTED|Open Label Extension||61|Subjects entering the Open Label Extension period all received ATI-50002 0.46% Topical Solution.|
48173459|NCT03354637|100746416|FG000|COMPLETED|Open Label Extension||0||
48173460|NCT03354637|100746417|FG001|COMPLETED|Open Label Extension||0||
48751887|NCT02362321|102180844|FG001|NOT COMPLETED|Overall Study||0||
48751888|NCT03642873|102180845|FG000|STARTED|First Intervention (1 Day)||4||
48751889|NCT03642873|102180846|FG001|STARTED|First Intervention (1 Day)||4||
48751890|NCT03642873|102180847|FG002|STARTED|First Intervention (1 Day)||4||
48751891|NCT03642873|102180848|FG003|STARTED|First Intervention (1 Day)||4||
48751892|NCT03642873|102180849|FG004|STARTED|First Intervention (1 Day)||4||
48173461|NCT03354637|100746418|FG002|COMPLETED|Open Label Extension||33||
48173462|NCT03354637|100746416|FG000|NOT COMPLETED|Open Label Extension||0||
48173463|NCT03354637|100746417|FG001|NOT COMPLETED|Open Label Extension||0||
48173464|NCT03354637|100746418|FG002|NOT COMPLETED|Open Label Extension||28||
48173465|NCT01927731|100746419|FG000|STARTED|Overall Study||6||
48173466|NCT01927731|100746420|FG001|STARTED|Overall Study||42||
48334958|NCT05098041|101148307|FG000|STARTED|Washout Period (4 Days)||14||
48334959|NCT05098041|101148307|FG000|COMPLETED|Washout Period (4 Days)||14||
48334960|NCT05098041|101148307|FG000|NOT COMPLETED|Washout Period (4 Days)||0||
48334961|NCT05098041|101148307|FG000|STARTED|Period 2 (13 Days)||14||
48334962|NCT05098041|101148307|FG000|COMPLETED|Period 2 (13 Days)||14||
48334963|NCT05098041|101148307|FG000|NOT COMPLETED|Period 2 (13 Days)||0||
48334964|NCT03439033|101148308|FG000|STARTED|Overall Study||273||
48334965|NCT03439033|101148308|FG000|Participants With Biochemical Reoccurrence at Baseline|Overall Study||114||
48334966|NCT03439033|101148308|FG000|PSMA PET/MRI|Overall Study||108||
48751893|NCT03642873|102180850|FG005|STARTED|First Intervention (1 Day)||4||
48751894|NCT03642873|102180845|FG000|COMPLETED|First Intervention (1 Day)||4||
48751895|NCT03642873|102180846|FG001|COMPLETED|First Intervention (1 Day)||4||
48751896|NCT03642873|102180847|FG002|COMPLETED|First Intervention (1 Day)||4||
48751897|NCT03642873|102180848|FG003|COMPLETED|First Intervention (1 Day)||4||
48751898|NCT03642873|102180849|FG004|COMPLETED|First Intervention (1 Day)||4||
48751899|NCT03642873|102180850|FG005|COMPLETED|First Intervention (1 Day)||4||
48751900|NCT03642873|102180845|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48751901|NCT03642873|102180846|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48751902|NCT03642873|102180847|FG002|NOT COMPLETED|First Intervention (1 Day)||0||
48751903|NCT03642873|102180848|FG003|NOT COMPLETED|First Intervention (1 Day)||0||
48751904|NCT03642873|102180849|FG004|NOT COMPLETED|First Intervention (1 Day)||0||
48751905|NCT03642873|102180850|FG005|NOT COMPLETED|First Intervention (1 Day)||0||
48751906|NCT03642873|102180845|FG000|STARTED|Washout (7 Days)||4||
48751907|NCT03642873|102180846|FG001|STARTED|Washout (7 Days)||4||
48751908|NCT03642873|102180847|FG002|STARTED|Washout (7 Days)||4||
48751909|NCT03642873|102180848|FG003|STARTED|Washout (7 Days)||4||
48751910|NCT03642873|102180849|FG004|STARTED|Washout (7 Days)||4||
48751911|NCT03642873|102180850|FG005|STARTED|Washout (7 Days)||4||
48751912|NCT03642873|102180845|FG000|COMPLETED|Washout (7 Days)||4||
48751913|NCT03642873|102180846|FG001|COMPLETED|Washout (7 Days)||4||
48751914|NCT03642873|102180847|FG002|COMPLETED|Washout (7 Days)||4||
48334967|NCT03439033|101148308|FG000|PSMA PET/CT|Overall Study||1||
48334968|NCT03439033|101148308|FG000|PSMA Multiple PET/MRI|Overall Study||0||
48334969|NCT03439033|101148308|FG000|COMPLETED|Overall Study||109||
48751915|NCT03642873|102180848|FG003|COMPLETED|Washout (7 Days)||4||
48751916|NCT03642873|102180849|FG004|COMPLETED|Washout (7 Days)||4||
48751917|NCT03642873|102180850|FG005|COMPLETED|Washout (7 Days)||4||
48751918|NCT03642873|102180845|FG000|NOT COMPLETED|Washout (7 Days)||0||
48751919|NCT03642873|102180846|FG001|NOT COMPLETED|Washout (7 Days)||0||
48173467|NCT01927731|100746419|FG000|COMPLETED|Overall Study||3||
48173468|NCT01927731|100746420|FG001|COMPLETED|Overall Study||32||
48173469|NCT01927731|100746419|FG000|NOT COMPLETED|Overall Study||3||
48173470|NCT01927731|100746420|FG001|NOT COMPLETED|Overall Study||10||
48334970|NCT03439033|101148308|FG000|NOT COMPLETED|Overall Study||164||
48334971|NCT00087646|101148309|FG000|STARTED|Overall Study||317||
48334972|NCT00087646|101148310|FG001|STARTED|Overall Study||156||
48334973|NCT00087646|101148311|FG002|STARTED|Overall Study||156||
48751920|NCT03642873|102180847|FG002|NOT COMPLETED|Washout (7 Days)||0||
48751921|NCT03642873|102180848|FG003|NOT COMPLETED|Washout (7 Days)||0||
48751922|NCT03642873|102180849|FG004|NOT COMPLETED|Washout (7 Days)||0||
48173471|NCT00180713|100746421|FG000|STARTED|Overall Study||23||
48173472|NCT00180713|100746422|FG001|STARTED|Overall Study||19||
48173473|NCT00180713|100746421|FG000|COMPLETED|Overall Study||18||
48173474|NCT00180713|100746422|FG001|COMPLETED|Overall Study||16||
48173475|NCT00180713|100746421|FG000|NOT COMPLETED|Overall Study||5||
48173476|NCT00180713|100746422|FG001|NOT COMPLETED|Overall Study||3||
48173477|NCT01213043|100746423|FG000|STARTED|Treatment Period 1||15||
48173478|NCT01213043|100746424|FG001|STARTED|Treatment Period 1||15||
48173479|NCT01213043|100746423|FG000|COMPLETED|Treatment Period 1||15||
48173480|NCT01213043|100746424|FG001|COMPLETED|Treatment Period 1||15||
48173481|NCT01213043|100746423|FG000|NOT COMPLETED|Treatment Period 1||0||
48173482|NCT01213043|100746424|FG001|NOT COMPLETED|Treatment Period 1||0||
48173483|NCT01213043|100746423|FG000|STARTED|Washout Period||15||
48173484|NCT01213043|100746424|FG001|STARTED|Washout Period||15||
48173485|NCT01213043|100746423|FG000|COMPLETED|Washout Period||15||
48173486|NCT01213043|100746424|FG001|COMPLETED|Washout Period||15||
48173487|NCT01213043|100746423|FG000|NOT COMPLETED|Washout Period||0||
48173488|NCT01213043|100746424|FG001|NOT COMPLETED|Washout Period||0||
48173489|NCT01213043|100746423|FG000|STARTED|Treatment Period 2||15||
48173490|NCT01213043|100746424|FG001|STARTED|Treatment Period 2||15||
48173491|NCT01213043|100746423|FG000|COMPLETED|Treatment Period 2||15||
48173492|NCT01213043|100746424|FG001|COMPLETED|Treatment Period 2||15||
48173493|NCT01213043|100746423|FG000|NOT COMPLETED|Treatment Period 2||0||
48173494|NCT01213043|100746424|FG001|NOT COMPLETED|Treatment Period 2||0||
48173495|NCT01213043|100746423|FG000|STARTED|Follow-up||15||
48173496|NCT01213043|100746424|FG001|STARTED|Follow-up||15||
48173497|NCT01213043|100746423|FG000|COMPLETED|Follow-up||15||
48173498|NCT01213043|100746424|FG001|COMPLETED|Follow-up||15||
48173499|NCT01213043|100746423|FG000|NOT COMPLETED|Follow-up||0||
48173500|NCT01213043|100746424|FG001|NOT COMPLETED|Follow-up||0||
48173501|NCT03321513|100746425|FG000|STARTED|Overall Study||158||158
48173502|NCT03321513|100746426|FG001|STARTED|Overall Study||154||154
48173503|NCT03321513|100746425|FG000|COMPLETED|Overall Study||132||132
48173504|NCT03321513|100746426|FG001|COMPLETED|Overall Study||128||128
48173505|NCT03321513|100746425|FG000|NOT COMPLETED|Overall Study||26||26
48173506|NCT03321513|100746426|FG001|NOT COMPLETED|Overall Study||26||26
48173507|NCT02596022|100746427|FG000|STARTED|Overall Study||10||
48173508|NCT02596022|100746428|FG001|STARTED|Overall Study||8||
48173509|NCT02596022|100746427|FG000|COMPLETED|Overall Study||10||
48173510|NCT02596022|100746428|FG001|COMPLETED|Overall Study||8||
48412119|NCT03083470|101341931|FG004|NOT COMPLETED|Overall Study||2||
48628784|NCT00843492|101874488|FG000|NOT COMPLETED|Overall Study||8||
48628785|NCT00843492|101874489|FG001|NOT COMPLETED|Overall Study||14||
48628786|NCT02097732|101874490|FG000|STARTED|Overall Study||1||
48628787|NCT02097732|101874491|FG001|STARTED|Overall Study||3||
48628788|NCT02097732|101874490|FG000|COMPLETED|Overall Study||1||
48412120|NCT02582151|101341932|FG000|STARTED|Overall Study||14||
48412121|NCT02582151|101341933|FG001|STARTED|Overall Study||16||
48412122|NCT02582151|101341932|FG000|COMPLETED|Overall Study||12||
48412123|NCT02582151|101341933|FG001|COMPLETED|Overall Study||16||
48412124|NCT02582151|101341932|FG000|NOT COMPLETED|Overall Study||2||
48628789|NCT02097732|101874491|FG001|COMPLETED|Overall Study||3||
48628790|NCT02097732|101874490|FG000|NOT COMPLETED|Overall Study||0||
48628791|NCT02097732|101874491|FG001|NOT COMPLETED|Overall Study||0||
48628792|NCT02988661|101874492|FG000|STARTED|Overall Study||168||
48628793|NCT02988661|101874493|FG001|STARTED|Overall Study||531||
48628794|NCT02988661|101874492|FG000|COMPLETED|Overall Study||165||
48628795|NCT02988661|101874493|FG001|COMPLETED|Overall Study||447||
48628796|NCT02988661|101874492|FG000|NOT COMPLETED|Overall Study||3||
48628797|NCT02988661|101874493|FG001|NOT COMPLETED|Overall Study||84||
48628798|NCT01474486|101874494|FG000|STARTED|Overall Study||28||
48628799|NCT01474486|101874494|FG000|Treated|Overall Study||22||
48628800|NCT01474486|101874494|FG000|COMPLETED|Overall Study||20||
48628801|NCT01474486|101874494|FG000|NOT COMPLETED|Overall Study||8||
48628802|NCT00686972|101874495|FG000|STARTED|Overall Study||51||
48628803|NCT00686972|101874495|FG000|COMPLETED|Overall Study||0||
48628804|NCT00686972|101874495|FG000|NOT COMPLETED|Overall Study||51||
48173511|NCT02596022|100746427|FG000|NOT COMPLETED|Overall Study||0||
48173512|NCT02596022|100746428|FG001|NOT COMPLETED|Overall Study||0||
48412125|NCT02582151|101341933|FG001|NOT COMPLETED|Overall Study||0||
48412126|NCT02239562|101341934|FG000|STARTED|Overall Study||6||
48628805|NCT01387269|101874496|FG000|STARTED|Overall Study||323||
48628806|NCT01387269|101874497|FG001|STARTED|Overall Study||161||
48628807|NCT01387269|101874496|FG000|ITT Population|Overall Study||323||
48628808|NCT01387269|101874497|FG001|ITT Population|Overall Study||161||
48628809|NCT01387269|101874496|FG000|MITT Population|Overall Study||284||
48173513|NCT04249336|100746429|FG000|STARTED|Overall Study||35||
48173514|NCT04249336|100746430|FG001|STARTED|Overall Study||35||
48173515|NCT04249336|100746431|FG002|STARTED|Overall Study||35||
48173516|NCT04249336|100746432|FG003|STARTED|Overall Study||35||
48628810|NCT01387269|101874497|FG001|MITT Population|Overall Study||141||
48628811|NCT01387269|101874496|FG000|Safety Population|Overall Study||320||
48173517|NCT04249336|100746429|FG000|Per Protocol Population Day 3|Overall Study||32||
48173518|NCT04249336|100746430|FG001|Per Protocol Population Day 3|Overall Study||32||
48173519|NCT04249336|100746431|FG002|Per Protocol Population Day 3|Overall Study||32||
48173520|NCT04249336|100746432|FG003|Per Protocol Population Day 3|Overall Study||32||
48173521|NCT04249336|100746429|FG000|Per Protocol Population Week 4|Overall Study||33||
48628812|NCT01387269|101874497|FG001|Safety Population|Overall Study||161||
48173522|NCT04249336|100746430|FG001|Per Protocol Population Week 4|Overall Study||35||
48173523|NCT04249336|100746431|FG002|Per Protocol Population Week 4|Overall Study||33||
48173524|NCT04249336|100746432|FG003|Per Protocol Population Week 4|Overall Study||34||
48173525|NCT04249336|100746429|FG000|COMPLETED|Overall Study||32|Out of 35 participants per group, 32 completed the 4-week clinical trial after lost to follow up and statistically analyzed for primary outcome measure.|
48173526|NCT04249336|100746430|FG001|COMPLETED|Overall Study||32|Out of 35 participants per group, 32 completed the 4-week clinical trial after lost to follow up and statistically analyzed for primary outcome measure.|
48173527|NCT04249336|100746431|FG002|COMPLETED|Overall Study||32|Out of 35 participants per group, 32 completed the 4-week clinical trial after lost to follow up and statistically analyzed for primary outcome measure.|
48173528|NCT04249336|100746432|FG003|COMPLETED|Overall Study||32|Out of 35 participants per group, 32 completed the 4-week clinical trial after lost to follow up and statistically analyzed for primary outcome measure.|
48173529|NCT04249336|100746429|FG000|NOT COMPLETED|Overall Study||3||
48173530|NCT04249336|100746430|FG001|NOT COMPLETED|Overall Study||3||
48173531|NCT04249336|100746431|FG002|NOT COMPLETED|Overall Study||3||
48334974|NCT00087646|101148312|FG003|STARTED|Overall Study||313||
48334975|NCT00087646|101148309|FG000|COMPLETED|Overall Study||182||
48334976|NCT00087646|101148310|FG001|COMPLETED|Overall Study||114||
48334977|NCT00087646|101148311|FG002|COMPLETED|Overall Study||91||
48334978|NCT00087646|101148312|FG003|COMPLETED|Overall Study||229||
48334979|NCT00087646|101148309|FG000|NOT COMPLETED|Overall Study||135||
48334980|NCT00087646|101148310|FG001|NOT COMPLETED|Overall Study||42||
48628813|NCT01387269|101874496|FG000|COMPLETED|Overall Study||231|A patient was considered to have completed the study if the patient completed Week 12/Day 85 Visit.|
48334981|NCT00087646|101148311|FG002|NOT COMPLETED|Overall Study||65||
48334982|NCT00087646|101148312|FG003|NOT COMPLETED|Overall Study||84||
48334983|NCT04137783|101148313|FG000|STARTED|Overall Study||7||
48334984|NCT04137783|101148314|FG001|STARTED|Overall Study||10||
48334985|NCT04137783|101148315|FG002|STARTED|Overall Study||22||
48334986|NCT04137783|101148313|FG000|COMPLETED|Overall Study||7||
48334987|NCT04137783|101148314|FG001|COMPLETED|Overall Study||10||
48334988|NCT04137783|101148315|FG002|COMPLETED|Overall Study||22||
48334989|NCT04137783|101148313|FG000|NOT COMPLETED|Overall Study||0||
48334990|NCT04137783|101148314|FG001|NOT COMPLETED|Overall Study||0||
48334991|NCT04137783|101148315|FG002|NOT COMPLETED|Overall Study||0||
48334992|NCT02814565|101148316|FG000|STARTED|Overall Study||90||
48334993|NCT02814565|101148317|FG001|STARTED|Overall Study||90||
48334994|NCT02814565|101148316|FG000|COMPLETED|Overall Study||89||
48334995|NCT02814565|101148317|FG001|COMPLETED|Overall Study||88||
48334996|NCT02814565|101148316|FG000|NOT COMPLETED|Overall Study||1||
48334997|NCT02814565|101148317|FG001|NOT COMPLETED|Overall Study||2||
48334998|NCT00647556|101148318|FG000|STARTED|Overall Study||15||
48334999|NCT00647556|101148319|FG001|STARTED|Overall Study||15||
48335000|NCT00647556|101148318|FG000|COMPLETED|Overall Study||12||
48335001|NCT00647556|101148319|FG001|COMPLETED|Overall Study||13||
48335002|NCT00647556|101148318|FG000|NOT COMPLETED|Overall Study||3||
48335003|NCT00647556|101148319|FG001|NOT COMPLETED|Overall Study||2||
48335004|NCT01602341|101148320|FG000|STARTED|Overall Study||44||
48335005|NCT01602341|101148321|FG001|STARTED|Overall Study||42||
48335006|NCT01602341|101148320|FG000|COMPLETED|Overall Study||44||
48335007|NCT01602341|101148321|FG001|COMPLETED|Overall Study||41||
48335008|NCT01602341|101148320|FG000|NOT COMPLETED|Overall Study||0||
48335009|NCT01602341|101148321|FG001|NOT COMPLETED|Overall Study||1||
48335010|NCT03208231|101148322|FG000|STARTED|Overall Study||30||
48335011|NCT03208231|101148323|FG001|STARTED|Overall Study||31||
48335012|NCT03208231|101148322|FG000|Evaluable|Overall Study||30|One infant in No-VRC01 arm did not return to the clinic after Week 0. This infant was not included in analyses of outcome measures.|
48335013|NCT03208231|101148323|FG001|Evaluable|Overall Study||30|One infant in No-VRC01 arm did not return to the clinic after Week 0. This infant was not included in analyses of outcome measures.|
48335014|NCT03208231|101148322|FG000|COMPLETED|Overall Study||28||
48335015|NCT03208231|101148323|FG001|COMPLETED|Overall Study||28||
48335016|NCT03208231|101148322|FG000|NOT COMPLETED|Overall Study||2||
48335017|NCT03208231|101148323|FG001|NOT COMPLETED|Overall Study||3||
48335018|NCT03219866|101148324|FG000|STARTED|Overall Study||21||
48656968|NCT03735979|101943738|FG001|STARTED|Overall Study||227||
48656969|NCT03735979|101943739|FG002|STARTED|Overall Study||228||
48751923|NCT03642873|102180850|FG005|NOT COMPLETED|Washout (7 Days)||0||
48173532|NCT04249336|100746432|FG003|NOT COMPLETED|Overall Study||3||
48173533|NCT01097395|100746433|FG000|STARTED|Overall Study||17||
48335019|NCT03219866|101148325|FG001|STARTED|Overall Study||19||
48335020|NCT03219866|101148324|FG000|COMPLETED|Overall Study||21||
48335021|NCT03219866|101148325|FG001|COMPLETED|Overall Study||19||
48335022|NCT03219866|101148324|FG000|NOT COMPLETED|Overall Study||0||
48335023|NCT03219866|101148325|FG001|NOT COMPLETED|Overall Study||0||
48335024|NCT01078805|101148326|FG000|STARTED|Overall Study||4167||
48335025|NCT01078805|101148326|FG000|Took at Least 1 Dose of Study Drug|Overall Study||4085||
48335026|NCT01078805|101148326|FG000|Modified Intent-To-Treat|Overall Study||3720||
48335027|NCT01078805|101148326|FG000|COMPLETED|Overall Study||2117||
48335028|NCT01078805|101148326|FG000|NOT COMPLETED|Overall Study||2050||
48335029|NCT05425563|101148327|FG000|STARTED|Overall Study||133||
48335030|NCT05425563|101148327|FG000|COMPLETED|Overall Study||116||
48335031|NCT05425563|101148327|FG000|NOT COMPLETED|Overall Study||17||
48335032|NCT02771522|101148328|FG000|STARTED|Overall Study||30|Patients attending baseline visit at de-bond and imaged with Calcivis System|119
48335033|NCT02771522|101148328|FG000|COMPLETED|Overall Study||22|Patients attending final visit at 8 weeks post de-bond and imaged with Calcivis System|87
48335034|NCT02771522|101148328|FG000|NOT COMPLETED|Overall Study||8||32
48335035|NCT00492973|101148329|FG000|STARTED|Overall Study||37||
48335036|NCT00492973|101148330|FG001|STARTED|Overall Study||39||
48335037|NCT00492973|101148329|FG000|COMPLETED|Overall Study||37||
48335038|NCT00492973|101148330|FG001|COMPLETED|Overall Study||38||
48335039|NCT00492973|101148329|FG000|NOT COMPLETED|Overall Study||0||
48335040|NCT00492973|101148330|FG001|NOT COMPLETED|Overall Study||1||
48335041|NCT01012492|101148331|FG000|STARTED|Overall Study||10||
48335042|NCT01012492|101148331|FG000|COMPLETED|Overall Study||10||
48335043|NCT01012492|101148331|FG000|NOT COMPLETED|Overall Study||0||
48335044|NCT01014403|101148332|FG000|STARTED|Overall Study||34||
48335045|NCT01014403|101148333|FG001|STARTED|Overall Study||28||
48335046|NCT01014403|101148332|FG000|COMPLETED|Overall Study||34||
48335047|NCT01014403|101148333|FG001|COMPLETED|Overall Study||28||
48335048|NCT01014403|101148332|FG000|NOT COMPLETED|Overall Study||0||
48335049|NCT01014403|101148333|FG001|NOT COMPLETED|Overall Study||0||
48335050|NCT00288574|101148334|FG000|STARTED|Overall Study||49||
48335051|NCT00288574|101148335|FG001|STARTED|Overall Study||44||
48335052|NCT00288574|101148334|FG000|COMPLETED|Overall Study||49||
48335053|NCT00288574|101148335|FG001|COMPLETED|Overall Study||44||
48335054|NCT00288574|101148334|FG000|NOT COMPLETED|Overall Study||0||
48335055|NCT00288574|101148335|FG001|NOT COMPLETED|Overall Study||0||
48335056|NCT03436615|101148336|FG000|STARTED|Overall Study||47||
48335057|NCT03436615|101148337|FG001|STARTED|Overall Study||48||
48335058|NCT03436615|101148338|FG002|STARTED|Overall Study||47||
48335059|NCT03436615|101148339|FG003|STARTED|Overall Study||48||
48335060|NCT03436615|101148340|FG004|STARTED|Overall Study||66||
48335061|NCT03436615|101148336|FG000|COMPLETED|Overall Study||38||
48335062|NCT03436615|101148337|FG001|COMPLETED|Overall Study||40||
48335063|NCT03436615|101148338|FG002|COMPLETED|Overall Study||39||
48335064|NCT03436615|101148339|FG003|COMPLETED|Overall Study||43||
48335065|NCT03436615|101148340|FG004|COMPLETED|Overall Study||61||
48335066|NCT03436615|101148336|FG000|NOT COMPLETED|Overall Study||9||
48335067|NCT03436615|101148337|FG001|NOT COMPLETED|Overall Study||8||
48335068|NCT03436615|101148338|FG002|NOT COMPLETED|Overall Study||8||
48335069|NCT03436615|101148339|FG003|NOT COMPLETED|Overall Study||5||
48335070|NCT03436615|101148340|FG004|NOT COMPLETED|Overall Study||5||
48335071|NCT00479154|101148341|FG000|STARTED|Overall Study||3||
48335072|NCT00479154|101148342|FG001|STARTED|Overall Study||3||
48335073|NCT00479154|101148341|FG000|COMPLETED|Overall Study||3||
48335074|NCT00479154|101148342|FG001|COMPLETED|Overall Study||3||
48335075|NCT00479154|101148341|FG000|NOT COMPLETED|Overall Study||0||
48335076|NCT00479154|101148342|FG001|NOT COMPLETED|Overall Study||0||
48335077|NCT03522441|101148343|FG000|STARTED|Overall Study||450||
48335078|NCT03522441|101148344|FG001|STARTED|Overall Study||450||
48335079|NCT03522441|101148345|FG002|STARTED|Overall Study||225||
48335080|NCT03522441|101148343|FG000|COMPLETED|Overall Study||424||
48335081|NCT03522441|101148344|FG001|COMPLETED|Overall Study||431||
48335082|NCT03522441|101148345|FG002|COMPLETED|Overall Study||214||
48335083|NCT03522441|101148343|FG000|NOT COMPLETED|Overall Study||26||
48335084|NCT03522441|101148344|FG001|NOT COMPLETED|Overall Study||19||
48335085|NCT03522441|101148345|FG002|NOT COMPLETED|Overall Study||11||
48628814|NCT01387269|101874497|FG001|COMPLETED|Overall Study||121|A patient was considered to have completed the study if the patient completed Week 12/Day 85 Visit.|
48628815|NCT01387269|101874496|FG000|NOT COMPLETED|Overall Study||92||
48628816|NCT01387269|101874497|FG001|NOT COMPLETED|Overall Study||40||
48628817|NCT04350593|101874498|FG000|STARTED|Overall Study||625||
48628818|NCT04350593|101874499|FG001|STARTED|Overall Study||625||
48628819|NCT04350593|101874498|FG000|COMPLETED|Overall Study||617||
48628820|NCT04350593|101874499|FG001|COMPLETED|Overall Study||620||
48628821|NCT04350593|101874498|FG000|NOT COMPLETED|Overall Study||8||
48628822|NCT04350593|101874499|FG001|NOT COMPLETED|Overall Study||5||
48628823|NCT02078817|101874500|FG000|STARTED|Overall Study||14||
48751924|NCT03642873|102180845|FG000|STARTED|Second Intervention (1 Day)||4||
48335086|NCT02354703|101148346|FG000|STARTED|Overall Study||12||
48335087|NCT02354703|101148347|FG001|STARTED|Overall Study||34||
48335088|NCT02354703|101148348|FG002|STARTED|Overall Study||39||
48335089|NCT02354703|101148349|FG003|STARTED|Overall Study||10||
48335090|NCT02354703|101148346|FG000|COMPLETED|Overall Study||9||
48335091|NCT02354703|101148347|FG001|COMPLETED|Overall Study||26||
48335092|NCT02354703|101148348|FG002|COMPLETED|Overall Study||28||
48335093|NCT02354703|101148349|FG003|COMPLETED|Overall Study||7||
48628824|NCT02078817|101874500|FG000|COMPLETED|Overall Study||13||
48335094|NCT02354703|101148346|FG000|NOT COMPLETED|Overall Study||3||
48335095|NCT02354703|101148347|FG001|NOT COMPLETED|Overall Study||8||
48335096|NCT02354703|101148348|FG002|NOT COMPLETED|Overall Study||11||
48335097|NCT02354703|101148349|FG003|NOT COMPLETED|Overall Study||3||
48335098|NCT00616109|101148350|FG000|STARTED|Overall Study||16||
48335099|NCT00616109|101148350|FG000|COMPLETED|Overall Study||16||
48751925|NCT03642873|102180846|FG001|STARTED|Second Intervention (1 Day)||4||
48751926|NCT03642873|102180847|FG002|STARTED|Second Intervention (1 Day)||4||
48751927|NCT03642873|102180848|FG003|STARTED|Second Intervention (1 Day)||4||
48751928|NCT03642873|102180849|FG004|STARTED|Second Intervention (1 Day)||4||
48751929|NCT03642873|102180850|FG005|STARTED|Second Intervention (1 Day)||4||
48751930|NCT03642873|102180845|FG000|COMPLETED|Second Intervention (1 Day)||4||
48751931|NCT03642873|102180846|FG001|COMPLETED|Second Intervention (1 Day)||4||
48751932|NCT03642873|102180847|FG002|COMPLETED|Second Intervention (1 Day)||4||
48751933|NCT03642873|102180848|FG003|COMPLETED|Second Intervention (1 Day)||4||
48751934|NCT03642873|102180849|FG004|COMPLETED|Second Intervention (1 Day)||4||
48751935|NCT03642873|102180850|FG005|COMPLETED|Second Intervention (1 Day)||4||
48751936|NCT03642873|102180845|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48751937|NCT03642873|102180846|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48751938|NCT03642873|102180847|FG002|NOT COMPLETED|Second Intervention (1 Day)||0||
48751939|NCT03642873|102180848|FG003|NOT COMPLETED|Second Intervention (1 Day)||0||
48751940|NCT03642873|102180849|FG004|NOT COMPLETED|Second Intervention (1 Day)||0||
48751941|NCT03642873|102180850|FG005|NOT COMPLETED|Second Intervention (1 Day)||0||
48751942|NCT03642873|102180845|FG000|STARTED|Washout (7 Days)||4||
48751943|NCT03642873|102180846|FG001|STARTED|Washout (7 Days)||4||
48751944|NCT03642873|102180847|FG002|STARTED|Washout (7 Days)||4||
48751945|NCT03642873|102180848|FG003|STARTED|Washout (7 Days)||4||
48751946|NCT03642873|102180849|FG004|STARTED|Washout (7 Days)||4||
48751947|NCT03642873|102180850|FG005|STARTED|Washout (7 Days)||4||
48751948|NCT03642873|102180845|FG000|COMPLETED|Washout (7 Days)||4||
48751949|NCT03642873|102180846|FG001|COMPLETED|Washout (7 Days)||4||
48751950|NCT03642873|102180847|FG002|COMPLETED|Washout (7 Days)||4||
48751951|NCT03642873|102180848|FG003|COMPLETED|Washout (7 Days)||4||
48751952|NCT03642873|102180849|FG004|COMPLETED|Washout (7 Days)||4||
48751953|NCT03642873|102180850|FG005|COMPLETED|Washout (7 Days)||4||
48751954|NCT03642873|102180845|FG000|NOT COMPLETED|Washout (7 Days)||0||
48751955|NCT03642873|102180846|FG001|NOT COMPLETED|Washout (7 Days)||0||
48751956|NCT03642873|102180847|FG002|NOT COMPLETED|Washout (7 Days)||0||
48751957|NCT03642873|102180848|FG003|NOT COMPLETED|Washout (7 Days)||0||
48751958|NCT03642873|102180849|FG004|NOT COMPLETED|Washout (7 Days)||0||
48751959|NCT03642873|102180850|FG005|NOT COMPLETED|Washout (7 Days)||0||
48751960|NCT03642873|102180845|FG000|STARTED|Third Intervention (1 Day)||4||
48751961|NCT03642873|102180846|FG001|STARTED|Third Intervention (1 Day)||4||
48751962|NCT03642873|102180847|FG002|STARTED|Third Intervention (1 Day)||4||
48751963|NCT03642873|102180848|FG003|STARTED|Third Intervention (1 Day)||4||
48751964|NCT03642873|102180849|FG004|STARTED|Third Intervention (1 Day)||4||
48751965|NCT03642873|102180850|FG005|STARTED|Third Intervention (1 Day)||4||
48335100|NCT00616109|101148350|FG000|NOT COMPLETED|Overall Study||0||
48335101|NCT03624946|101148351|FG000|STARTED|Overall Study||19||
48335102|NCT03624946|101148352|FG001|STARTED|Overall Study||11||
48335103|NCT03624946|101148351|FG000|COMPLETED|Overall Study||19||
48628825|NCT02078817|101874500|FG000|NOT COMPLETED|Overall Study||1||
48628826|NCT03238417|101874501|FG000|STARTED|Overall||1330||7
48628827|NCT03238417|101874502|FG001|STARTED|Overall||2632||14
48628828|NCT03238417|101874501|FG000|COMPLETED|Overall||327||7
48628829|NCT03238417|101874502|FG001|COMPLETED|Overall||644||14
48628830|NCT03238417|101874501|FG000|NOT COMPLETED|Overall||1003||0
48628831|NCT03238417|101874502|FG001|NOT COMPLETED|Overall||1988||0
48628832|NCT03238417|101874501|FG000|STARTED|Baseline||513||7
48628833|NCT03238417|101874502|FG001|STARTED|Baseline||934||14
48628834|NCT03238417|101874501|FG000|COMPLETED|Baseline||124||7
48628835|NCT03238417|101874502|FG001|COMPLETED|Baseline||217||14
48628836|NCT03238417|101874501|FG000|NOT COMPLETED|Baseline||389||0
48628837|NCT03238417|101874502|FG001|NOT COMPLETED|Baseline||717||0
48628838|NCT03238417|101874501|FG000|STARTED|12-month||400||7
48628839|NCT03238417|101874502|FG001|STARTED|12-month||911||14
48628840|NCT03238417|101874501|FG000|COMPLETED|12-month||81||7
48628841|NCT03238417|101874502|FG001|COMPLETED|12-month||205||14
48628842|NCT03238417|101874501|FG000|NOT COMPLETED|12-month||319||0
48628843|NCT03238417|101874502|FG001|NOT COMPLETED|12-month||706||0
48628844|NCT03238417|101874501|FG000|STARTED|24-month||417||7
48628845|NCT03238417|101874502|FG001|STARTED|24-month||847||14
48751966|NCT03642873|102180845|FG000|COMPLETED|Third Intervention (1 Day)||4||
48751967|NCT03642873|102180846|FG001|COMPLETED|Third Intervention (1 Day)||4||
48751968|NCT03642873|102180847|FG002|COMPLETED|Third Intervention (1 Day)||4||
48751969|NCT03642873|102180848|FG003|COMPLETED|Third Intervention (1 Day)||4||
48751970|NCT03642873|102180849|FG004|COMPLETED|Third Intervention (1 Day)||3||
48751971|NCT03642873|102180850|FG005|COMPLETED|Third Intervention (1 Day)||4||
48751972|NCT03642873|102180845|FG000|NOT COMPLETED|Third Intervention (1 Day)||0||
48751973|NCT03642873|102180846|FG001|NOT COMPLETED|Third Intervention (1 Day)||0||
48628846|NCT03238417|101874501|FG000|COMPLETED|24-month||122||7
48628847|NCT03238417|101874502|FG001|COMPLETED|24-month||222||14
48628848|NCT03238417|101874501|FG000|NOT COMPLETED|24-month||295||0
48628849|NCT03238417|101874502|FG001|NOT COMPLETED|24-month||625||0
48628850|NCT02674516|101874503|FG000|STARTED|Overall Study||17||
48751974|NCT03642873|102180847|FG002|NOT COMPLETED|Third Intervention (1 Day)||0||
48751975|NCT03642873|102180848|FG003|NOT COMPLETED|Third Intervention (1 Day)||0||
48412127|NCT02239562|101341935|FG001|STARTED|Overall Study||6||
48412128|NCT02239562|101341936|FG002|STARTED|Overall Study||6||
48412129|NCT02239562|101341937|FG003|STARTED|Overall Study||6||
48412130|NCT02239562|101341938|FG004|STARTED|Overall Study||6||
48412131|NCT02239562|101341939|FG005|STARTED|Overall Study||6||
48412132|NCT02239562|101341934|FG000|COMPLETED|Overall Study||6||
48412133|NCT02239562|101341935|FG001|COMPLETED|Overall Study||6||
48412134|NCT02239562|101341936|FG002|COMPLETED|Overall Study||6||
48412135|NCT02239562|101341937|FG003|COMPLETED|Overall Study||6||
48412136|NCT02239562|101341938|FG004|COMPLETED|Overall Study||6||
48412137|NCT02239562|101341939|FG005|COMPLETED|Overall Study||6||
48412138|NCT02239562|101341934|FG000|NOT COMPLETED|Overall Study||0||
48412139|NCT02239562|101341935|FG001|NOT COMPLETED|Overall Study||0||
48412140|NCT02239562|101341936|FG002|NOT COMPLETED|Overall Study||0||
48412141|NCT02239562|101341937|FG003|NOT COMPLETED|Overall Study||0||
48628851|NCT02674516|101874504|FG001|STARTED|Overall Study||15||
48628852|NCT02674516|101874503|FG000|COMPLETED|Overall Study||13||
48628853|NCT02674516|101874504|FG001|COMPLETED|Overall Study||11||
48628854|NCT02674516|101874503|FG000|NOT COMPLETED|Overall Study||4||
48628855|NCT02674516|101874504|FG001|NOT COMPLETED|Overall Study||4||
48628856|NCT03519009|101874505|FG000|STARTED|Period 1, Phase 1||0||
48628857|NCT03519009|101874506|FG001|STARTED|Period 1, Phase 1||0||
48628858|NCT03519009|101874507|FG002|STARTED|Period 1, Phase 1||152||
48628859|NCT03519009|101874505|FG000|COMPLETED|Period 1, Phase 1||0||
48628860|NCT03519009|101874506|FG001|COMPLETED|Period 1, Phase 1||0||
48628861|NCT03519009|101874507|FG002|COMPLETED|Period 1, Phase 1||119||
48628862|NCT03519009|101874505|FG000|NOT COMPLETED|Period 1, Phase 1||0||
48628863|NCT03519009|101874506|FG001|NOT COMPLETED|Period 1, Phase 1||0||
48628864|NCT03519009|101874507|FG002|NOT COMPLETED|Period 1, Phase 1||33||
48628865|NCT03519009|101874505|FG000|STARTED|Period 2, Phase 2||62||
48628866|NCT03519009|101874506|FG001|STARTED|Period 2, Phase 2||57||
48628867|NCT03519009|101874507|FG002|STARTED|Period 2, Phase 2||0||
48628868|NCT03519009|101874505|FG000|COMPLETED|Period 2, Phase 2||62||
48628869|NCT03519009|101874506|FG001|COMPLETED|Period 2, Phase 2||57||
48628870|NCT03519009|101874507|FG002|COMPLETED|Period 2, Phase 2||0||
48628871|NCT03519009|101874505|FG000|NOT COMPLETED|Period 2, Phase 2||0||
48628872|NCT03519009|101874506|FG001|NOT COMPLETED|Period 2, Phase 2||0||
48628873|NCT03519009|101874507|FG002|NOT COMPLETED|Period 2, Phase 2||0||
48628874|NCT03103503|101874508|FG000|STARTED|Overall Study||901||
48628875|NCT03103503|101874508|FG000|COMPLETED|Overall Study||0||
48628876|NCT03103503|101874508|FG000|NOT COMPLETED|Overall Study||901||
48628877|NCT00794664|101874509|FG000|STARTED|Treatment Period||19||
48628878|NCT00794664|101874510|FG001|STARTED|Treatment Period||39||
48628879|NCT00794664|101874509|FG000|COMPLETED|Treatment Period||18||
48628880|NCT00794664|101874510|FG001|COMPLETED|Treatment Period||27||
48412142|NCT02239562|101341938|FG004|NOT COMPLETED|Overall Study||0||
48412143|NCT02239562|101341939|FG005|NOT COMPLETED|Overall Study||0||
48412144|NCT00698139|101341940|FG000|STARTED|Overall Study||1||
48412145|NCT00698139|101341941|FG001|STARTED|Overall Study||1||
48412146|NCT00698139|101341942|FG002|STARTED|Overall Study||1||
48412147|NCT00698139|101341940|FG000|2nd Visit|Overall Study||1||
48412148|NCT00698139|101341941|FG001|2nd Visit|Overall Study||1||
48412149|NCT00698139|101341942|FG002|2nd Visit|Overall Study||0||
48412150|NCT00698139|101341940|FG000|COMPLETED|Overall Study||1||
48412151|NCT00698139|101341941|FG001|COMPLETED|Overall Study||1||
48412152|NCT00698139|101341942|FG002|COMPLETED|Overall Study||1||
48412153|NCT00698139|101341940|FG000|NOT COMPLETED|Overall Study||0||
48412154|NCT00698139|101341941|FG001|NOT COMPLETED|Overall Study||0||
48412155|NCT00698139|101341942|FG002|NOT COMPLETED|Overall Study||0||
48412156|NCT00364611|101341943|FG000|STARTED|Overall Study||52||
48412157|NCT00364611|101341944|FG001|STARTED|Overall Study||21||
48412158|NCT00364611|101341943|FG000|TREATED (SAFTEY POPULATION)|Overall Study||52||
48628881|NCT00794664|101874509|FG000|NOT COMPLETED|Treatment Period||1||
48628882|NCT00794664|101874510|FG001|NOT COMPLETED|Treatment Period||12||
48628883|NCT00794664|101874509|FG000|STARTED|Follow-up Period||16||
48628884|NCT00794664|101874510|FG001|STARTED|Follow-up Period||33||
48751976|NCT03642873|102180849|FG004|NOT COMPLETED|Third Intervention (1 Day)||1||
48412159|NCT00364611|101341944|FG001|TREATED (SAFTEY POPULATION)|Overall Study||20||
48412160|NCT00364611|101341943|FG000|COMPLETED|Overall Study||1||
48412161|NCT00364611|101341944|FG001|COMPLETED|Overall Study||0||
48412162|NCT00364611|101341943|FG000|NOT COMPLETED|Overall Study||51||
48412163|NCT00364611|101341944|FG001|NOT COMPLETED|Overall Study||21||
48412164|NCT00697255|101341945|FG000|STARTED|Stage 1a||5||
48412165|NCT00697255|101341946|FG001|STARTED|Stage 1a||0||
48412166|NCT00697255|101341945|FG000|COMPLETED|Stage 1a||2||
48412167|NCT00697255|101341946|FG001|COMPLETED|Stage 1a||0||
48628885|NCT00794664|101874509|FG000|COMPLETED|Follow-up Period||15||
48628886|NCT00794664|101874510|FG001|COMPLETED|Follow-up Period||28||
48628887|NCT00794664|101874509|FG000|NOT COMPLETED|Follow-up Period||1||
48628888|NCT00794664|101874510|FG001|NOT COMPLETED|Follow-up Period||5||
48628889|NCT02119299|101874511|FG000|STARTED|Overall Study||76||
48767728|NCT00494676|102222813|FG001|COMPLETED|First Intervention||29||
48628890|NCT02119299|101874511|FG000|COMPLETED|Overall Study||67||
48751977|NCT03642873|102180850|FG005|NOT COMPLETED|Third Intervention (1 Day)||0||
48751978|NCT01404039|102180851|FG000|STARTED|Overall Study||5||
48751979|NCT01404039|102180852|FG001|STARTED|Overall Study||5||
48751980|NCT01404039|102180853|FG002|STARTED|Overall Study||5||
48751981|NCT01404039|102180854|FG003|STARTED|Overall Study||10||
48751982|NCT01404039|102180855|FG004|STARTED|Overall Study||10||
48751983|NCT01404039|102180856|FG005|STARTED|Overall Study||10||
48751984|NCT01404039|102180857|FG006|STARTED|Overall Study||10||
48751985|NCT01404039|102180858|FG007|STARTED|Overall Study||15||
48751986|NCT01404039|102180859|FG008|STARTED|Overall Study||15||
48751987|NCT01404039|102180860|FG009|STARTED|Overall Study||15||
48751988|NCT01404039|102180861|FG010|STARTED|Overall Study||15||
48751989|NCT01404039|102180862|FG011|STARTED|Overall Study||0||
48751990|NCT01404039|102180863|FG012|STARTED|Overall Study||0||
48751991|NCT01404039|102180851|FG000|COMPLETED|Overall Study||4||
48751992|NCT01404039|102180852|FG001|COMPLETED|Overall Study||5||
48751993|NCT01404039|102180853|FG002|COMPLETED|Overall Study||5||
48751994|NCT01404039|102180854|FG003|COMPLETED|Overall Study||10||
48751995|NCT01404039|102180855|FG004|COMPLETED|Overall Study||10||
48751996|NCT01404039|102180856|FG005|COMPLETED|Overall Study||10||
48751997|NCT01404039|102180857|FG006|COMPLETED|Overall Study||10||
48751998|NCT01404039|102180858|FG007|COMPLETED|Overall Study||15||
48751999|NCT01404039|102180859|FG008|COMPLETED|Overall Study||15||
48752000|NCT01404039|102180860|FG009|COMPLETED|Overall Study||14||
48752001|NCT01404039|102180861|FG010|COMPLETED|Overall Study||14||
48752002|NCT01404039|102180862|FG011|COMPLETED|Overall Study||0||
48752003|NCT01404039|102180863|FG012|COMPLETED|Overall Study||0||
48752004|NCT01404039|102180851|FG000|NOT COMPLETED|Overall Study||1||
48752005|NCT01404039|102180852|FG001|NOT COMPLETED|Overall Study||0||
48752006|NCT01404039|102180853|FG002|NOT COMPLETED|Overall Study||0||
48752007|NCT01404039|102180854|FG003|NOT COMPLETED|Overall Study||0||
48752008|NCT01404039|102180855|FG004|NOT COMPLETED|Overall Study||0||
48752009|NCT01404039|102180856|FG005|NOT COMPLETED|Overall Study||0||
48752010|NCT01404039|102180857|FG006|NOT COMPLETED|Overall Study||0||
48752011|NCT01404039|102180858|FG007|NOT COMPLETED|Overall Study||0||
48752012|NCT01404039|102180859|FG008|NOT COMPLETED|Overall Study||0||
48752013|NCT01404039|102180860|FG009|NOT COMPLETED|Overall Study||1||
48752014|NCT01404039|102180861|FG010|NOT COMPLETED|Overall Study||1||
48752015|NCT01404039|102180862|FG011|NOT COMPLETED|Overall Study||0||
48752016|NCT01404039|102180863|FG012|NOT COMPLETED|Overall Study||0||
48752017|NCT01139814|102180864|FG000|STARTED|Overall Study||181||
48752018|NCT01139814|102180864|FG000|COMPLETED|Overall Study||181||
48752019|NCT01139814|102180864|FG000|NOT COMPLETED|Overall Study||0||
48752020|NCT02903160|102180865|FG000|STARTED|Overall Study||40||
48752021|NCT02903160|102180865|FG000|COMPLETED|Overall Study||33||
48752022|NCT02903160|102180865|FG000|NOT COMPLETED|Overall Study||7||
48752023|NCT00644358|102180866|FG000|STARTED|Overall Study||616||
48752024|NCT00644358|102180866|FG000|COMPLETED|Overall Study||254||
48752025|NCT00644358|102180866|FG000|NOT COMPLETED|Overall Study||362||
48752026|NCT01366872|102180867|FG000|STARTED|Overall Study||50||
48752027|NCT01366872|102180867|FG000|COMPLETED|Overall Study||50||
48752028|NCT01366872|102180867|FG000|NOT COMPLETED|Overall Study||0||
48752029|NCT00657540|102180868|FG000|STARTED|Overall Study||29||
48752030|NCT00657540|102180869|FG001|STARTED|Overall Study||31||
48752031|NCT00657540|102180868|FG000|COMPLETED|Overall Study||28||
48752032|NCT00657540|102180869|FG001|COMPLETED|Overall Study||27||
48752033|NCT00657540|102180868|FG000|NOT COMPLETED|Overall Study||1||
48752034|NCT00657540|102180869|FG001|NOT COMPLETED|Overall Study||4||
48752035|NCT00672555|102180870|FG000|STARTED|Overall Study||70||
48752036|NCT00672555|102180870|FG000|COMPLETED|Overall Study||64||
48752037|NCT00672555|102180870|FG000|NOT COMPLETED|Overall Study||6||
48752038|NCT01339689|102180871|FG000|STARTED|Overall Study||59||
48752039|NCT01339689|102180872|FG001|STARTED|Overall Study||53||
48752040|NCT01339689|102180871|FG000|COMPLETED|Overall Study||42||
48752041|NCT01339689|102180872|FG001|COMPLETED|Overall Study||44||
48752042|NCT01339689|102180871|FG000|NOT COMPLETED|Overall Study||17||
48752043|NCT01339689|102180872|FG001|NOT COMPLETED|Overall Study||9||
48752044|NCT01945021|102180873|FG000|STARTED|Overall Study||127||
48752045|NCT01945021|102180873|FG000|Safety Population|Overall Study||127||
48752046|NCT01945021|102180873|FG000|Response Evaluable Population|Overall Study||127||
48752047|NCT01945021|102180873|FG000|Patient Reported Outcome Evaluable|Overall Study||123||
48752048|NCT01945021|102180873|FG000|COMPLETED|Overall Study||44||
48752049|NCT01945021|102180873|FG000|NOT COMPLETED|Overall Study||83||
48752050|NCT01590979|102180874|FG000|STARTED|Overall Study||27||
48752051|NCT01590979|102180875|FG001|STARTED|Overall Study||27||
48752052|NCT01590979|102180874|FG000|COMPLETED|Overall Study||27||
48752053|NCT01590979|102180875|FG001|COMPLETED|Overall Study||27||
48752054|NCT01590979|102180874|FG000|NOT COMPLETED|Overall Study||0||
48752055|NCT01590979|102180875|FG001|NOT COMPLETED|Overall Study||0||
48752056|NCT00702702|102180876|FG000|STARTED|Overall Study||56||
48173534|NCT01097395|100746434|FG001|STARTED|Overall Study||18||
48173535|NCT01097395|100746433|FG000|COMPLETED|Overall Study||14||
48173536|NCT01097395|100746434|FG001|COMPLETED|Overall Study||14||
48173537|NCT01097395|100746433|FG000|NOT COMPLETED|Overall Study||3||
48173538|NCT01097395|100746434|FG001|NOT COMPLETED|Overall Study||4||
48335104|NCT03624946|101148352|FG001|COMPLETED|Overall Study||10||
48335105|NCT03624946|101148351|FG000|NOT COMPLETED|Overall Study||0||
48335106|NCT03624946|101148352|FG001|NOT COMPLETED|Overall Study||1||
48335107|NCT01337973|101148353|FG000|STARTED|Overall Study||60||
48335108|NCT01337973|101148354|FG001|STARTED|Overall Study||60||
48335109|NCT01337973|101148355|FG002|STARTED|Overall Study||60||
48335110|NCT01337973|101148353|FG000|COMPLETED|Overall Study||44||
48335111|NCT01337973|101148354|FG001|COMPLETED|Overall Study||45||
48628891|NCT02119299|101874511|FG000|NOT COMPLETED|Overall Study||9||
48628892|NCT02659501|101874512|FG000|STARTED|Overall Study||12||
48628893|NCT02659501|101874513|FG001|STARTED|Overall Study||12||
48628894|NCT02659501|101874512|FG000|COMPLETED|Overall Study||12||
48628895|NCT02659501|101874513|FG001|COMPLETED|Overall Study||12||
48628896|NCT02659501|101874512|FG000|NOT COMPLETED|Overall Study||0||
48628897|NCT02659501|101874513|FG001|NOT COMPLETED|Overall Study||0||
48628898|NCT01255163|101874514|FG000|STARTED|Overall Study||13||
48628899|NCT01255163|101874515|FG001|STARTED|Overall Study||14||
48628900|NCT01255163|101874514|FG000|COMPLETED|Overall Study||9||
48628901|NCT01255163|101874515|FG001|COMPLETED|Overall Study||9||
48628902|NCT01255163|101874514|FG000|NOT COMPLETED|Overall Study||4||
48628903|NCT01255163|101874515|FG001|NOT COMPLETED|Overall Study||5||
48628904|NCT02295644|101874516|FG000|STARTED|Overall Study||7||
48628905|NCT02295644|101874517|FG001|STARTED|Overall Study||7||
48628906|NCT02295644|101874518|FG002|STARTED|Overall Study||7||
48628907|NCT02295644|101874519|FG003|STARTED|Overall Study||7||
48628908|NCT02295644|101874516|FG000|COMPLETED|Overall Study||7||
48628909|NCT02295644|101874517|FG001|COMPLETED|Overall Study||7||
48628910|NCT02295644|101874518|FG002|COMPLETED|Overall Study||6||
48628911|NCT02295644|101874519|FG003|COMPLETED|Overall Study||5||
48628912|NCT02295644|101874516|FG000|NOT COMPLETED|Overall Study||0||
48628913|NCT02295644|101874517|FG001|NOT COMPLETED|Overall Study||0||
48628914|NCT02295644|101874518|FG002|NOT COMPLETED|Overall Study||1||
48628915|NCT02295644|101874519|FG003|NOT COMPLETED|Overall Study||2||
48628916|NCT00915590|101874520|FG000|STARTED|Overall Study||5||
48628917|NCT00915590|101874521|FG001|STARTED|Overall Study||5||
48628918|NCT00915590|101874520|FG000|COMPLETED|Overall Study||3||
48628919|NCT00915590|101874521|FG001|COMPLETED|Overall Study||4||
48628920|NCT00915590|101874520|FG000|NOT COMPLETED|Overall Study||2||
48628921|NCT00915590|101874521|FG001|NOT COMPLETED|Overall Study||1||
48628922|NCT02965924|101874522|FG000|STARTED|Overall Study||20||
48628923|NCT02965924|101874522|FG000|COMPLETED|Overall Study||20||
48628924|NCT02965924|101874522|FG000|NOT COMPLETED|Overall Study||0||
48628925|NCT02273167|101874523|FG000|STARTED|Overall Study||283||
48628926|NCT02273167|101874524|FG001|STARTED|Overall Study||283||
48628927|NCT02273167|101874525|FG002|STARTED|Overall Study||283||
48628928|NCT02273167|101874523|FG000|COMPLETED|Overall Study||259||
48628929|NCT02273167|101874524|FG001|COMPLETED|Overall Study||260||
48173539|NCT02917265|100746435|FG000|STARTED|Overall Study||5|11.2015|
48173540|NCT02917265|100746436|FG001|STARTED|Overall Study||2|11.2015|
48335112|NCT01337973|101148355|FG002|COMPLETED|Overall Study||49||
48335113|NCT01337973|101148353|FG000|NOT COMPLETED|Overall Study||16||
48335114|NCT01337973|101148354|FG001|NOT COMPLETED|Overall Study||15||
48335115|NCT01337973|101148355|FG002|NOT COMPLETED|Overall Study||11||
48628930|NCT02273167|101874525|FG002|COMPLETED|Overall Study||262||
48628931|NCT02273167|101874523|FG000|NOT COMPLETED|Overall Study||24||
48628932|NCT02273167|101874524|FG001|NOT COMPLETED|Overall Study||23||
48628933|NCT02273167|101874525|FG002|NOT COMPLETED|Overall Study||21||
48628934|NCT01433159|101874526|FG000|STARTED|Overall Study||9||
48628935|NCT01433159|101874527|FG001|STARTED|Overall Study||10||
48628936|NCT01433159|101874526|FG000|COMPLETED|Overall Study||7||
48173541|NCT02917265|100746435|FG000|COMPLETED|Overall Study||3|5.2017|
48173542|NCT02917265|100746436|FG001|COMPLETED|Overall Study||2|5.2017|
48628937|NCT01433159|101874527|FG001|COMPLETED|Overall Study||9||
48628938|NCT01433159|101874526|FG000|NOT COMPLETED|Overall Study||2||
48628939|NCT01433159|101874527|FG001|NOT COMPLETED|Overall Study||1||
48628940|NCT00466817|101874528|FG000|STARTED|Overall Study||49||
48628941|NCT00466817|101874529|FG001|STARTED|Overall Study||47||
48173543|NCT02917265|100746435|FG000|NOT COMPLETED|Overall Study||2||
48335116|NCT04269395|101148356|FG000|STARTED|Overall Study||87||
48335117|NCT04269395|101148357|FG001|STARTED|Overall Study||38||
48628942|NCT00466817|101874528|FG000|COMPLETED|Overall Study||44||
48628943|NCT00466817|101874529|FG001|COMPLETED|Overall Study||43||
48628944|NCT00466817|101874528|FG000|NOT COMPLETED|Overall Study||5||
48628945|NCT00466817|101874529|FG001|NOT COMPLETED|Overall Study||4||
48628946|NCT00473655|101874530|FG000|STARTED|Overall Study||111||
48628947|NCT00473655|101874531|FG001|STARTED|Overall Study||112||
48628948|NCT00473655|101874532|FG002|STARTED|Overall Study||111||
48752057|NCT00702702|102180876|FG000|COMPLETED|Overall Study||0||
48173544|NCT02917265|100746436|FG001|NOT COMPLETED|Overall Study||0||
48173545|NCT00305864|100746437|FG000|STARTED|Overall Study||7||
48173546|NCT00305864|100746438|FG001|STARTED|Overall Study||10||
48173547|NCT00305864|100746439|FG002|STARTED|Overall Study||7||
48173548|NCT00305864|100746440|FG003|STARTED|Overall Study||94||
48173549|NCT00305864|100746437|FG000|COMPLETED|Overall Study||7||
48173550|NCT00305864|100746438|FG001|COMPLETED|Overall Study||9||
48173551|NCT00305864|100746439|FG002|COMPLETED|Overall Study||6||
48173552|NCT00305864|100746440|FG003|COMPLETED|Overall Study||81||
48173553|NCT00305864|100746437|FG000|NOT COMPLETED|Overall Study||0||
48173554|NCT00305864|100746438|FG001|NOT COMPLETED|Overall Study||1||
48173555|NCT00305864|100746439|FG002|NOT COMPLETED|Overall Study||1||
48173556|NCT00305864|100746440|FG003|NOT COMPLETED|Overall Study||13||
48173557|NCT04666922|100746441|FG000|STARTED|Overall Study||6||
48173558|NCT04666922|100746442|FG001|STARTED|Overall Study||6||
48173559|NCT04666922|100746443|FG002|STARTED|Overall Study||6||
48173560|NCT04666922|100746444|FG003|STARTED|Overall Study||6||
48173561|NCT04666922|100746445|FG004|STARTED|Overall Study||6||
48173562|NCT04666922|100746446|FG005|STARTED|Overall Study||6||
48173563|NCT04666922|100746447|FG006|STARTED|Overall Study||12||
48173564|NCT04666922|100746441|FG000|COMPLETED|Overall Study||5||
48173565|NCT04666922|100746442|FG001|COMPLETED|Overall Study||6||
48173566|NCT04666922|100746443|FG002|COMPLETED|Overall Study||6||
48173567|NCT04666922|100746444|FG003|COMPLETED|Overall Study||6||
48173568|NCT04666922|100746445|FG004|COMPLETED|Overall Study||6||
48173569|NCT04666922|100746446|FG005|COMPLETED|Overall Study||6||
48173570|NCT04666922|100746447|FG006|COMPLETED|Overall Study||12||
48173571|NCT04666922|100746441|FG000|NOT COMPLETED|Overall Study||1||
48173572|NCT04666922|100746442|FG001|NOT COMPLETED|Overall Study||0||
48173573|NCT04666922|100746443|FG002|NOT COMPLETED|Overall Study||0||
48173574|NCT04666922|100746444|FG003|NOT COMPLETED|Overall Study||0||
48412168|NCT00697255|101341945|FG000|NOT COMPLETED|Stage 1a||3||
48412169|NCT00697255|101341946|FG001|NOT COMPLETED|Stage 1a||0||
48412170|NCT00697255|101341945|FG000|STARTED|Stage 1b||0||
48412171|NCT00697255|101341946|FG001|STARTED|Stage 1b||3||
48412172|NCT00697255|101341945|FG000|COMPLETED|Stage 1b||0||
48412173|NCT00697255|101341946|FG001|COMPLETED|Stage 1b||1||
48628949|NCT00473655|101874530|FG000|COMPLETED|Overall Study||102||
48628950|NCT00473655|101874531|FG001|COMPLETED|Overall Study||107||
48628951|NCT00473655|101874532|FG002|COMPLETED|Overall Study||103||
48628952|NCT00473655|101874530|FG000|NOT COMPLETED|Overall Study||9||
48628953|NCT00473655|101874531|FG001|NOT COMPLETED|Overall Study||5||
48628954|NCT00473655|101874532|FG002|NOT COMPLETED|Overall Study||8||
48628955|NCT03538041|101874533|FG000|STARTED|12-Week Treatment Period||10||
48628956|NCT03538041|101874534|FG001|STARTED|12-Week Treatment Period||15||
48628957|NCT03538041|101874533|FG000|COMPLETED|12-Week Treatment Period||9||
48628958|NCT03538041|101874534|FG001|COMPLETED|12-Week Treatment Period||13||
48628959|NCT03538041|101874533|FG000|NOT COMPLETED|12-Week Treatment Period||1||
48628960|NCT03538041|101874534|FG001|NOT COMPLETED|12-Week Treatment Period||2||
48752058|NCT00702702|102180876|FG000|NOT COMPLETED|Overall Study||56||
48628961|NCT03538041|101874533|FG000|STARTED|Treatment Extension Period||7||
48628962|NCT03538041|101874534|FG001|STARTED|Treatment Extension Period||10||
48628963|NCT03538041|101874533|FG000|COMPLETED|Treatment Extension Period||0||
48628964|NCT03538041|101874534|FG001|COMPLETED|Treatment Extension Period||0||
48628965|NCT03538041|101874533|FG000|NOT COMPLETED|Treatment Extension Period||7||
48628966|NCT03538041|101874534|FG001|NOT COMPLETED|Treatment Extension Period||10||
48628967|NCT02420639|101874535|FG000|STARTED|Overall Study||12||
48628968|NCT02420639|101874535|FG000|COMPLETED|Overall Study||12||
48173575|NCT04666922|100746445|FG004|NOT COMPLETED|Overall Study||0||
48173576|NCT04666922|100746446|FG005|NOT COMPLETED|Overall Study||0||
48173577|NCT04666922|100746447|FG006|NOT COMPLETED|Overall Study||0||
48628969|NCT02420639|101874535|FG000|NOT COMPLETED|Overall Study||0||
48628970|NCT03207399|101874536|FG000|STARTED|Overall Study||1||
48628971|NCT03207399|101874536|FG000|COMPLETED|Overall Study||1||
48628972|NCT03207399|101874536|FG000|NOT COMPLETED|Overall Study||0||
48173578|NCT00744237|100746448|FG000|STARTED|Overall Study||83||
48173579|NCT00744237|100746449|FG001|STARTED|Overall Study||73||
48173580|NCT00744237|100746450|FG002|STARTED|Overall Study||74||
48173581|NCT00744237|100746448|FG000|COMPLETED|Overall Study||56||
48173582|NCT00744237|100746449|FG001|COMPLETED|Overall Study||46||
48173583|NCT00744237|100746450|FG002|COMPLETED|Overall Study||59||
48173584|NCT00744237|100746448|FG000|NOT COMPLETED|Overall Study||27||
48173585|NCT00744237|100746449|FG001|NOT COMPLETED|Overall Study||27||
48173586|NCT00744237|100746450|FG002|NOT COMPLETED|Overall Study||15||
48173587|NCT02584855|100746451|FG000|STARTED|Open-Label Treatment Period||394||
48173588|NCT02584855|100746452|FG001|STARTED|Open-Label Treatment Period||0||
48173589|NCT02584855|100746453|FG002|STARTED|Open-Label Treatment Period||0||
48173590|NCT02584855|100746454|FG003|STARTED|Open-Label Treatment Period||0||
48173591|NCT02584855|100746455|FG004|STARTED|Open-Label Treatment Period||0||
48173592|NCT02584855|100746456|FG005|STARTED|Open-Label Treatment Period||0||
48173593|NCT02584855|100746451|FG000|Received at Least One Dose of Study Drug|Open-Label Treatment Period||394||
48173594|NCT02584855|100746452|FG001|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0||
48752059|NCT02732600|102180877|FG000|STARTED|Overall Study||3525||13
48173595|NCT02584855|100746453|FG002|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0||
48173596|NCT02584855|100746454|FG003|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0||
48173597|NCT02584855|100746455|FG004|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0||
48173598|NCT02584855|100746456|FG005|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0||
48173599|NCT02584855|100746451|FG000|Met Randomization Criteria|Open-Label Treatment Period||158||
48173600|NCT02584855|100746452|FG001|Met Randomization Criteria|Open-Label Treatment Period||0||
48173601|NCT02584855|100746453|FG002|Met Randomization Criteria|Open-Label Treatment Period||0||
48173602|NCT02584855|100746454|FG003|Met Randomization Criteria|Open-Label Treatment Period||0||
48173603|NCT02584855|100746455|FG004|Met Randomization Criteria|Open-Label Treatment Period||0||
48173604|NCT02584855|100746456|FG005|Met Randomization Criteria|Open-Label Treatment Period||0||
48173605|NCT02584855|100746451|FG000|Non-randomized|Open-Label Treatment Period||133||
48173606|NCT02584855|100746452|FG001|Non-randomized|Open-Label Treatment Period||0||
48173607|NCT02584855|100746453|FG002|Non-randomized|Open-Label Treatment Period||0||
48173608|NCT02584855|100746454|FG003|Non-randomized|Open-Label Treatment Period||0||
48173609|NCT02584855|100746455|FG004|Non-randomized|Open-Label Treatment Period||0||
48173610|NCT02584855|100746456|FG005|Non-randomized|Open-Label Treatment Period||0||
48173611|NCT02584855|100746451|FG000|COMPLETED|Open-Label Treatment Period||291||
48173612|NCT02584855|100746452|FG001|COMPLETED|Open-Label Treatment Period||0||
48173613|NCT02584855|100746453|FG002|COMPLETED|Open-Label Treatment Period||0||
48173614|NCT02584855|100746454|FG003|COMPLETED|Open-Label Treatment Period||0||
48173615|NCT02584855|100746455|FG004|COMPLETED|Open-Label Treatment Period||0||
48173616|NCT02584855|100746456|FG005|COMPLETED|Open-Label Treatment Period||0||
48752060|NCT02732600|102180878|FG001|STARTED|Overall Study||2091||12
48752061|NCT02732600|102180877|FG000|Sub-set of Sites Newly Delivering PS Services|Overall Study||899||12
48752062|NCT02732600|102180878|FG001|Sub-set of Sites Newly Delivering PS Services|Overall Study||1484||11
48752063|NCT02732600|102180877|FG000|Veteran Baseline Veteran (Sub-set of 23 Sites)|Overall Study||118||12
48752064|NCT02732600|102180878|FG001|Veteran Baseline Veteran (Sub-set of 23 Sites)|Overall Study||145||11
48752065|NCT02732600|102180877|FG000|Veteran 6-months (Sub-set 23 Sites)|Overall Study||70||12
48752066|NCT02732600|102180878|FG001|Veteran 6-months (Sub-set 23 Sites)|Overall Study||84||11
48752067|NCT02732600|102180877|FG000|Veteran 1-year (Sub-set 23 Sites)|Overall Study||54||12
48752068|NCT02732600|102180878|FG001|Veteran 1-year (Sub-set 23 Sites)|Overall Study||71||11
48752069|NCT02732600|102180877|FG000|Peer Specialist Responses at 6-months (All 25 Sites)|Overall Study||12||13
48752070|NCT02732600|102180878|FG001|Peer Specialist Responses at 6-months (All 25 Sites)|Overall Study||14||12
48752071|NCT02732600|102180877|FG000|Peer Specialist Responses at 1-year (All 25 Sites)|Overall Study||5||13
48752072|NCT02732600|102180878|FG001|Peer Specialist Responses at 1-year (All 25 Sites)|Overall Study||12||12
48752073|NCT02732600|102180877|FG000|Supervisor Responses 6-months (All 25 Sites)|Overall Study||10||13
48752074|NCT02732600|102180878|FG001|Supervisor Responses 6-months (All 25 Sites)|Overall Study||21||12
48752075|NCT02732600|102180877|FG000|Supervisor 1-year (All 25 Sites)|Overall Study||6||13
48752076|NCT02732600|102180878|FG001|Supervisor 1-year (All 25 Sites)|Overall Study||10||12
48752077|NCT02732600|102180877|FG000|COMPLETED|Overall Study||100|These are the number of Veterans (across all 25 sites) who completed surveys|13
48752078|NCT02732600|102180878|FG001|COMPLETED|Overall Study||113|These are the number of Veterans (across all 25 sites) who completed surveys|12
48173617|NCT02584855|100746451|FG000|NOT COMPLETED|Open-Label Treatment Period||103||
48173618|NCT02584855|100746452|FG001|NOT COMPLETED|Open-Label Treatment Period||0||
48173619|NCT02584855|100746453|FG002|NOT COMPLETED|Open-Label Treatment Period||0||
48173620|NCT02584855|100746454|FG003|NOT COMPLETED|Open-Label Treatment Period||0||
48173621|NCT02584855|100746455|FG004|NOT COMPLETED|Open-Label Treatment Period||0||
48173622|NCT02584855|100746456|FG005|NOT COMPLETED|Open-Label Treatment Period||0||
48752079|NCT02732600|102180877|FG000|NOT COMPLETED|Overall Study||3425||0
48173623|NCT02584855|100746451|FG000|STARTED|Double-Blind Withdrawal Period||0||
48173624|NCT02584855|100746452|FG001|STARTED|Double-Blind Withdrawal Period||133||
48173625|NCT02584855|100746453|FG002|STARTED|Double-Blind Withdrawal Period||79||
48173626|NCT02584855|100746454|FG003|STARTED|Double-Blind Withdrawal Period||79||
48173627|NCT02584855|100746455|FG004|STARTED|Double-Blind Withdrawal Period||0||
48173628|NCT02584855|100746456|FG005|STARTED|Double-Blind Withdrawal Period||0||
48173629|NCT02584855|100746451|FG000|Relapsed|Double-Blind Withdrawal Period||0||
48173630|NCT02584855|100746452|FG001|Relapsed|Double-Blind Withdrawal Period||0||
48173631|NCT02584855|100746453|FG002|Relapsed|Double-Blind Withdrawal Period||67||
48173632|NCT02584855|100746454|FG003|Relapsed|Double-Blind Withdrawal Period||30||
48173633|NCT02584855|100746455|FG004|Relapsed|Double-Blind Withdrawal Period||0||
48173634|NCT02584855|100746456|FG005|Relapsed|Double-Blind Withdrawal Period||0||
48335118|NCT04269395|101148356|FG000|COMPLETED|Overall Study||73||
48752080|NCT02732600|102180878|FG001|NOT COMPLETED|Overall Study||1978||0
48752081|NCT00531284|102180879|FG000|STARTED|Overall Study||3||
48752082|NCT00531284|102180880|FG001|STARTED|Overall Study||4||
48752083|NCT00531284|102180881|FG002|STARTED|Overall Study||7||
48752084|NCT00531284|102180882|FG003|STARTED|Overall Study||65||
48173635|NCT02584855|100746451|FG000|COMPLETED|Double-Blind Withdrawal Period||0||
48173636|NCT02584855|100746452|FG001|COMPLETED|Double-Blind Withdrawal Period||118||
48173637|NCT02584855|100746453|FG002|COMPLETED|Double-Blind Withdrawal Period||77||
48173638|NCT02584855|100746454|FG003|COMPLETED|Double-Blind Withdrawal Period||78||
48173639|NCT02584855|100746455|FG004|COMPLETED|Double-Blind Withdrawal Period||0||
48173640|NCT02584855|100746456|FG005|COMPLETED|Double-Blind Withdrawal Period||0||
48173641|NCT02584855|100746451|FG000|NOT COMPLETED|Double-Blind Withdrawal Period||0||
48173642|NCT02584855|100746452|FG001|NOT COMPLETED|Double-Blind Withdrawal Period||15||
48173643|NCT02584855|100746453|FG002|NOT COMPLETED|Double-Blind Withdrawal Period||2||
48173644|NCT02584855|100746454|FG003|NOT COMPLETED|Double-Blind Withdrawal Period||1||
48173645|NCT02584855|100746455|FG004|NOT COMPLETED|Double-Blind Withdrawal Period||0||
48173646|NCT02584855|100746456|FG005|NOT COMPLETED|Double-Blind Withdrawal Period||0||
48173647|NCT02584855|100746451|FG000|STARTED|Post Treatment Follow-up Period||0||
48173648|NCT02584855|100746452|FG001|STARTED|Post Treatment Follow-up Period||0||
48173649|NCT02584855|100746453|FG002|STARTED|Post Treatment Follow-up Period||0||
48173650|NCT02584855|100746454|FG003|STARTED|Post Treatment Follow-up Period||0||
48173651|NCT02584855|100746455|FG004|STARTED|Post Treatment Follow-up Period||355||
48173652|NCT02584855|100746456|FG005|STARTED|Post Treatment Follow-up Period||12||
48173653|NCT02584855|100746451|FG000|COMPLETED|Post Treatment Follow-up Period||0||
48173654|NCT02584855|100746452|FG001|COMPLETED|Post Treatment Follow-up Period||0||
48173655|NCT02584855|100746453|FG002|COMPLETED|Post Treatment Follow-up Period||0||
48173656|NCT02584855|100746454|FG003|COMPLETED|Post Treatment Follow-up Period||0||
48173657|NCT02584855|100746455|FG004|COMPLETED|Post Treatment Follow-up Period||347||
48173658|NCT02584855|100746456|FG005|COMPLETED|Post Treatment Follow-up Period||12||
48752085|NCT00531284|102180883|FG004|STARTED|Overall Study||6||
48752086|NCT00531284|102180884|FG005|STARTED|Overall Study||7||
48752087|NCT00531284|102180885|FG006|STARTED|Overall Study||6||
48752088|NCT00531284|102180886|FG007|STARTED|Overall Study||10||
48752089|NCT00531284|102180887|FG008|STARTED|Overall Study||11||
48752090|NCT00531284|102180888|FG009|STARTED|Overall Study||4||
48752091|NCT00531284|102180889|FG010|STARTED|Overall Study||3||
48752092|NCT00531284|102180890|FG011|STARTED|Overall Study||24||
48752093|NCT00531284|102180891|FG012|STARTED|Overall Study||2||
48752094|NCT00531284|102180892|FG013|STARTED|Overall Study||3||
48752095|NCT00531284|102180893|FG014|STARTED|Overall Study||7||
48752096|NCT00531284|102180894|FG015|STARTED|Overall Study||14||
48752097|NCT00531284|102180895|FG016|STARTED|Overall Study||8||
48752098|NCT00531284|102180879|FG000|COMPLETED|Overall Study||0||
48752099|NCT00531284|102180880|FG001|COMPLETED|Overall Study||0||
48752100|NCT00531284|102180881|FG002|COMPLETED|Overall Study||1||
48752101|NCT00531284|102180882|FG003|COMPLETED|Overall Study||2||
48752102|NCT00531284|102180883|FG004|COMPLETED|Overall Study||0||
48752103|NCT00531284|102180884|FG005|COMPLETED|Overall Study||0||
48752104|NCT00531284|102180885|FG006|COMPLETED|Overall Study||0||
48752105|NCT00531284|102180886|FG007|COMPLETED|Overall Study||0||
48752106|NCT00531284|102180887|FG008|COMPLETED|Overall Study||0||
48752107|NCT00531284|102180888|FG009|COMPLETED|Overall Study||0||
48752108|NCT00531284|102180889|FG010|COMPLETED|Overall Study||0||
48752109|NCT00531284|102180890|FG011|COMPLETED|Overall Study||0||
48752110|NCT00531284|102180891|FG012|COMPLETED|Overall Study||0||
48752111|NCT00531284|102180892|FG013|COMPLETED|Overall Study||0||
48173659|NCT02584855|100746451|FG000|NOT COMPLETED|Post Treatment Follow-up Period||0||
48173660|NCT02584855|100746452|FG001|NOT COMPLETED|Post Treatment Follow-up Period||0||
48173661|NCT02584855|100746453|FG002|NOT COMPLETED|Post Treatment Follow-up Period||0||
48173662|NCT02584855|100746454|FG003|NOT COMPLETED|Post Treatment Follow-up Period||0||
48173663|NCT02584855|100746455|FG004|NOT COMPLETED|Post Treatment Follow-up Period||8||
48173664|NCT02584855|100746456|FG005|NOT COMPLETED|Post Treatment Follow-up Period||0||
48173665|NCT02406885|100746457|FG000|STARTED|Overall Study||17||
48173666|NCT02406885|100746458|FG001|STARTED|Overall Study||16||
48173667|NCT02406885|100746457|FG000|COMPLETED|Overall Study||14||
48173668|NCT02406885|100746458|FG001|COMPLETED|Overall Study||14||
48173669|NCT02406885|100746457|FG000|NOT COMPLETED|Overall Study||3||
48752112|NCT00531284|102180893|FG014|COMPLETED|Overall Study||3||
48752113|NCT00531284|102180894|FG015|COMPLETED|Overall Study||2||
48752114|NCT00531284|102180895|FG016|COMPLETED|Overall Study||0||
48752115|NCT00531284|102180879|FG000|NOT COMPLETED|Overall Study||3||
48752116|NCT00531284|102180880|FG001|NOT COMPLETED|Overall Study||4||
48173670|NCT02406885|100746458|FG001|NOT COMPLETED|Overall Study||2||
48173671|NCT03225846|100746459|FG000|STARTED|Overall Study||22||
48173672|NCT03225846|100746460|FG001|STARTED|Overall Study||9||
48173673|NCT03225846|100746461|FG002|STARTED|Overall Study||12||
48173674|NCT03225846|100746462|FG003|STARTED|Overall Study||15||
48173675|NCT03225846|100746463|FG004|STARTED|Overall Study||8||
48752117|NCT00531284|102180881|FG002|NOT COMPLETED|Overall Study||6||
48752118|NCT00531284|102180882|FG003|NOT COMPLETED|Overall Study||63||
48752119|NCT00531284|102180883|FG004|NOT COMPLETED|Overall Study||6||
48752120|NCT00531284|102180884|FG005|NOT COMPLETED|Overall Study||7||
48752121|NCT00531284|102180885|FG006|NOT COMPLETED|Overall Study||6||
48752122|NCT00531284|102180886|FG007|NOT COMPLETED|Overall Study||10||
48752123|NCT00531284|102180887|FG008|NOT COMPLETED|Overall Study||11||
48752124|NCT00531284|102180888|FG009|NOT COMPLETED|Overall Study||4||
48752125|NCT00531284|102180889|FG010|NOT COMPLETED|Overall Study||3||
48752126|NCT00531284|102180890|FG011|NOT COMPLETED|Overall Study||24||
48752127|NCT00531284|102180891|FG012|NOT COMPLETED|Overall Study||2||
48752128|NCT00531284|102180892|FG013|NOT COMPLETED|Overall Study||3||
48752129|NCT00531284|102180893|FG014|NOT COMPLETED|Overall Study||4||
48173676|NCT03225846|100746464|FG005|STARTED|Overall Study||9||
48173677|NCT03225846|100746465|FG006|STARTED|Overall Study||13||
48173678|NCT03225846|100746459|FG000|Single Dose Period Only|Overall Study||6||
48173679|NCT03225846|100746460|FG001|Single Dose Period Only|Overall Study||3||
48173680|NCT03225846|100746461|FG002|Single Dose Period Only|Overall Study||4||
48173681|NCT03225846|100746462|FG003|Single Dose Period Only|Overall Study||7||
48173682|NCT03225846|100746463|FG004|Single Dose Period Only|Overall Study||8||
48173683|NCT03225846|100746464|FG005|Single Dose Period Only|Overall Study||0||
48173684|NCT03225846|100746465|FG006|Single Dose Period Only|Overall Study||4||
48173685|NCT03225846|100746459|FG000|Multiple Dose Period Only|Overall Study||3||
48173686|NCT03225846|100746460|FG001|Multiple Dose Period Only|Overall Study||0||
48173687|NCT03225846|100746461|FG002|Multiple Dose Period Only|Overall Study||3||
48173688|NCT03225846|100746462|FG003|Multiple Dose Period Only|Overall Study||6||
48173689|NCT03225846|100746463|FG004|Multiple Dose Period Only|Overall Study||0||
48173690|NCT03225846|100746464|FG005|Multiple Dose Period Only|Overall Study||0||
48173691|NCT03225846|100746465|FG006|Multiple Dose Period Only|Overall Study||4||
48173692|NCT03225846|100746459|FG000|Single Dose and Multiple Dose|Overall Study||13||
48173693|NCT03225846|100746460|FG001|Single Dose and Multiple Dose|Overall Study||6||
48173694|NCT03225846|100746461|FG002|Single Dose and Multiple Dose|Overall Study||5||
48173695|NCT03225846|100746462|FG003|Single Dose and Multiple Dose|Overall Study||2||
48173696|NCT03225846|100746463|FG004|Single Dose and Multiple Dose|Overall Study||0||
48173697|NCT03225846|100746464|FG005|Single Dose and Multiple Dose|Overall Study||9||
48173698|NCT03225846|100746465|FG006|Single Dose and Multiple Dose|Overall Study||5||
48173699|NCT03225846|100746459|FG000|COMPLETED|Overall Study||22||
48173700|NCT03225846|100746460|FG001|COMPLETED|Overall Study||7||
48173701|NCT03225846|100746461|FG002|COMPLETED|Overall Study||11||
48173702|NCT03225846|100746462|FG003|COMPLETED|Overall Study||15||
48173703|NCT03225846|100746463|FG004|COMPLETED|Overall Study||8||
48173704|NCT03225846|100746464|FG005|COMPLETED|Overall Study||9||
48173705|NCT03225846|100746465|FG006|COMPLETED|Overall Study||6||
48173706|NCT03225846|100746459|FG000|NOT COMPLETED|Overall Study||0||
48173707|NCT03225846|100746460|FG001|NOT COMPLETED|Overall Study||2||
48173708|NCT03225846|100746461|FG002|NOT COMPLETED|Overall Study||1||
48173709|NCT03225846|100746462|FG003|NOT COMPLETED|Overall Study||0||
48173710|NCT03225846|100746463|FG004|NOT COMPLETED|Overall Study||0||
48173711|NCT03225846|100746464|FG005|NOT COMPLETED|Overall Study||0||
48173712|NCT03225846|100746465|FG006|NOT COMPLETED|Overall Study||7||
48173713|NCT02134119|100746466|FG000|STARTED|Overall Study||30||
48173714|NCT02134119|100746467|FG001|STARTED|Overall Study||15||
48173715|NCT02134119|100746466|FG000|COMPLETED|Overall Study||30||
48173716|NCT02134119|100746467|FG001|COMPLETED|Overall Study||15||
48173717|NCT02134119|100746466|FG000|NOT COMPLETED|Overall Study||0||
48173718|NCT02134119|100746467|FG001|NOT COMPLETED|Overall Study||0||
48173719|NCT02821832|100746468|FG000|STARTED|Overall Study||251||
48173720|NCT02821832|100746469|FG001|STARTED|Overall Study||154||
48173721|NCT02821832|100746470|FG002|STARTED|Overall Study||141||
48173722|NCT02821832|100746468|FG000|COMPLETED|Overall Study||186||
48173723|NCT02821832|100746469|FG001|COMPLETED|Overall Study||106||
48173724|NCT02821832|100746470|FG002|COMPLETED|Overall Study||109||
48173725|NCT02821832|100746468|FG000|NOT COMPLETED|Overall Study||65||
48173726|NCT02821832|100746469|FG001|NOT COMPLETED|Overall Study||48||
48173727|NCT02821832|100746470|FG002|NOT COMPLETED|Overall Study||32||
48173728|NCT02223065|100746471|FG000|STARTED|Overall Study||18||
48173729|NCT02223065|100746472|FG001|STARTED|Overall Study||18||
48173730|NCT02223065|100746471|FG000|COMPLETED|Overall Study||18||
48173731|NCT02223065|100746472|FG001|COMPLETED|Overall Study||18||
48173732|NCT02223065|100746471|FG000|NOT COMPLETED|Overall Study||0||
48173733|NCT02223065|100746472|FG001|NOT COMPLETED|Overall Study||0||
48173734|NCT01355419|100746473|FG000|STARTED|Overall Study||150||
48173735|NCT01355419|100746473|FG000|COMPLETED|Overall Study||142||
48173736|NCT01355419|100746473|FG000|NOT COMPLETED|Overall Study||8||
48173737|NCT00107744|100746474|FG000|STARTED|Intervention 1 (8 Weeks)||117||
48173738|NCT00107744|100746475|FG001|STARTED|Intervention 1 (8 Weeks)||117||
48173739|NCT00107744|100746476|FG002|STARTED|Intervention 1 (8 Weeks)||118||
48173740|NCT00107744|100746474|FG000|COMPLETED|Intervention 1 (8 Weeks)||101||
48173741|NCT00107744|100746475|FG001|COMPLETED|Intervention 1 (8 Weeks)||104||
48173742|NCT00107744|100746476|FG002|COMPLETED|Intervention 1 (8 Weeks)||101||
48173743|NCT00107744|100746474|FG000|NOT COMPLETED|Intervention 1 (8 Weeks)||16||
48173744|NCT00107744|100746475|FG001|NOT COMPLETED|Intervention 1 (8 Weeks)||13||
48173745|NCT00107744|100746476|FG002|NOT COMPLETED|Intervention 1 (8 Weeks)||17||
48173746|NCT00107744|100746474|FG000|STARTED|Intervention 2 (8 Weeks)||101||
48173747|NCT00107744|100746475|FG001|STARTED|Intervention 2 (8 Weeks)||104||
48173748|NCT00107744|100746476|FG002|STARTED|Intervention 2 (8 Weeks)||101||
48173749|NCT00107744|100746474|FG000|COMPLETED|Intervention 2 (8 Weeks)||93||
48752130|NCT00531284|102180894|FG015|NOT COMPLETED|Overall Study||12||
48752131|NCT00531284|102180895|FG016|NOT COMPLETED|Overall Study||8||
48173750|NCT00107744|100746475|FG001|COMPLETED|Intervention 2 (8 Weeks)||92||
48173751|NCT00107744|100746476|FG002|COMPLETED|Intervention 2 (8 Weeks)||88||
48173752|NCT00107744|100746474|FG000|NOT COMPLETED|Intervention 2 (8 Weeks)||8||
48173753|NCT00107744|100746475|FG001|NOT COMPLETED|Intervention 2 (8 Weeks)||12||
48173754|NCT00107744|100746476|FG002|NOT COMPLETED|Intervention 2 (8 Weeks)||13||
48173755|NCT00107744|100746474|FG000|STARTED|Intervention 3 (8 Weeks)||93||
48173756|NCT00107744|100746475|FG001|STARTED|Intervention 3 (8 Weeks)||92||
48173757|NCT00107744|100746476|FG002|STARTED|Intervention 3 (8 Weeks)||88||
48173758|NCT00107744|100746474|FG000|COMPLETED|Intervention 3 (8 Weeks)||93||
48173759|NCT00107744|100746475|FG001|COMPLETED|Intervention 3 (8 Weeks)||92||
48173760|NCT00107744|100746476|FG002|COMPLETED|Intervention 3 (8 Weeks)||88||
48173761|NCT00107744|100746474|FG000|NOT COMPLETED|Intervention 3 (8 Weeks)||0||
48173762|NCT00107744|100746475|FG001|NOT COMPLETED|Intervention 3 (8 Weeks)||0||
48173763|NCT00107744|100746476|FG002|NOT COMPLETED|Intervention 3 (8 Weeks)||0||
48173764|NCT00518713|100746477|FG000|STARTED|Overall Study||58||
48173765|NCT00518713|100746478|FG001|STARTED|Overall Study||62||
48173766|NCT00518713|100746479|FG002|STARTED|Overall Study||59||
48173767|NCT00518713|100746480|FG003|STARTED|Overall Study||59||
48173768|NCT00518713|100746477|FG000|Modified Intent-to-Treat Population|Overall Study||53||
48173769|NCT00518713|100746478|FG001|Modified Intent-to-Treat Population|Overall Study||58||
48173770|NCT00518713|100746479|FG002|Modified Intent-to-Treat Population|Overall Study||49||
48173771|NCT00518713|100746480|FG003|Modified Intent-to-Treat Population|Overall Study||57||
48173772|NCT00518713|100746477|FG000|COMPLETED|Overall Study||50||
48173773|NCT00518713|100746478|FG001|COMPLETED|Overall Study||45||
48173774|NCT00518713|100746479|FG002|COMPLETED|Overall Study||41||
48173775|NCT00518713|100746480|FG003|COMPLETED|Overall Study||41||
48173776|NCT00518713|100746477|FG000|NOT COMPLETED|Overall Study||8||
48173777|NCT00518713|100746478|FG001|NOT COMPLETED|Overall Study||17||
48173778|NCT00518713|100746479|FG002|NOT COMPLETED|Overall Study||18||
48173779|NCT00518713|100746480|FG003|NOT COMPLETED|Overall Study||18||
48173780|NCT00779558|100746481|FG000|STARTED|Overall Study||57||
48173781|NCT00779558|100746482|FG001|STARTED|Overall Study||44||
48173782|NCT00779558|100746481|FG000|COMPLETED|Overall Study||53||
48173783|NCT00779558|100746482|FG001|COMPLETED|Overall Study||37||
48173784|NCT00779558|100746481|FG000|NOT COMPLETED|Overall Study||4||
48173785|NCT00779558|100746482|FG001|NOT COMPLETED|Overall Study||7||
48173786|NCT01304082|100746483|FG000|STARTED|Overall Study||3||
48173787|NCT01304082|100746484|FG001|STARTED|Overall Study||2||
48173788|NCT01304082|100746485|FG002|STARTED|Overall Study||11||
48173789|NCT01304082|100746486|FG003|STARTED|Overall Study||8||
48173790|NCT01304082|100746487|FG004|STARTED|Overall Study||5||
48173791|NCT01304082|100746483|FG000|First Intervention|Overall Study||3||
48173792|NCT01304082|100746484|FG001|First Intervention|Overall Study||2||
48173793|NCT01304082|100746485|FG002|First Intervention|Overall Study||11||
48173794|NCT01304082|100746486|FG003|First Intervention|Overall Study||8||
48173795|NCT01304082|100746487|FG004|First Intervention|Overall Study||5||
48173796|NCT01304082|100746483|FG000|Second Intervention|Overall Study||3||
48173797|NCT01304082|100746484|FG001|Second Intervention|Overall Study||2||
48173798|NCT01304082|100746485|FG002|Second Intervention|Overall Study||11||
48173799|NCT01304082|100746486|FG003|Second Intervention|Overall Study||8||
48173800|NCT01304082|100746487|FG004|Second Intervention|Overall Study||5||
48173801|NCT01304082|100746483|FG000|Third Intervention|Overall Study||3||
48173802|NCT01304082|100746484|FG001|Third Intervention|Overall Study||2||
48173803|NCT01304082|100746485|FG002|Third Intervention|Overall Study||11||
48173804|NCT01304082|100746486|FG003|Third Intervention|Overall Study||8||
48173805|NCT01304082|100746487|FG004|Third Intervention|Overall Study||5||
48173806|NCT01304082|100746483|FG000|COMPLETED|Overall Study||3||
48173807|NCT01304082|100746484|FG001|COMPLETED|Overall Study||2||
48173808|NCT01304082|100746485|FG002|COMPLETED|Overall Study||11||
48173809|NCT01304082|100746486|FG003|COMPLETED|Overall Study||8||
48173810|NCT01304082|100746487|FG004|COMPLETED|Overall Study||5||
48173811|NCT01304082|100746483|FG000|NOT COMPLETED|Overall Study||0||
48173812|NCT01304082|100746484|FG001|NOT COMPLETED|Overall Study||0||
48173813|NCT01304082|100746485|FG002|NOT COMPLETED|Overall Study||0||
48173814|NCT01304082|100746486|FG003|NOT COMPLETED|Overall Study||0||
48173815|NCT01304082|100746487|FG004|NOT COMPLETED|Overall Study||0||
48412174|NCT00697255|101341945|FG000|NOT COMPLETED|Stage 1b||0||
48628973|NCT02669849|101874537|FG000|STARTED|Overall Study||29||
48628974|NCT02669849|101874538|FG001|STARTED|Overall Study||6||
48412175|NCT00697255|101341946|FG001|NOT COMPLETED|Stage 1b||2||
48628975|NCT02669849|101874539|FG002|STARTED|Overall Study||32||
48628976|NCT02669849|101874537|FG000|COMPLETED|Overall Study||11||
48173816|NCT00962585|100746488|FG000|STARTED|Overall Study||43||
48173817|NCT00962585|100746489|FG001|STARTED|Overall Study||42||
48173818|NCT00962585|100746490|FG002|STARTED|Overall Study||42||
48173819|NCT00962585|100746491|FG003|STARTED|Overall Study||42||
48173820|NCT00962585|100746488|FG000|COMPLETED|Overall Study||37||
48173821|NCT00962585|100746489|FG001|COMPLETED|Overall Study||40||
48173822|NCT00962585|100746490|FG002|COMPLETED|Overall Study||39||
48173823|NCT00962585|100746491|FG003|COMPLETED|Overall Study||42||
48173824|NCT00962585|100746488|FG000|NOT COMPLETED|Overall Study||6||
48412176|NCT02809846|101341947|FG000|STARTED|Overall Study||17||
48412177|NCT02809846|101341948|FG001|STARTED|Overall Study||16||
48628977|NCT02669849|101874538|FG001|COMPLETED|Overall Study||4||
48173825|NCT00962585|100746489|FG001|NOT COMPLETED|Overall Study||2||
48173826|NCT00962585|100746490|FG002|NOT COMPLETED|Overall Study||3||
48173827|NCT00962585|100746491|FG003|NOT COMPLETED|Overall Study||0||
48173828|NCT01782963|100746492|FG000|STARTED|Overall Study||50||
48173829|NCT01782963|100746492|FG000|COMPLETED|Overall Study||50||
48173830|NCT01782963|100746492|FG000|NOT COMPLETED|Overall Study||0||
48173831|NCT03228017|100746493|FG000|STARTED|Overall Study||45||
48173832|NCT03228017|100746494|FG001|STARTED|Overall Study||18||
48335119|NCT04269395|101148357|FG001|COMPLETED|Overall Study||28||
48752132|NCT00113841|102180896|FG000|STARTED|Overall Study||16||
48752133|NCT00113841|102180897|FG001|STARTED|Overall Study||17||
48752134|NCT00113841|102180896|FG000|COMPLETED|Overall Study||15||
48752135|NCT00113841|102180897|FG001|COMPLETED|Overall Study||15||
48752136|NCT00113841|102180896|FG000|NOT COMPLETED|Overall Study||1||
48752137|NCT00113841|102180897|FG001|NOT COMPLETED|Overall Study||2||
48752138|NCT02542865|102180898|FG000|STARTED|Overall Study||462|Participants randomized to the treatment arms|
48752139|NCT02542865|102180899|FG001|STARTED|Overall Study||462|Participants randomized to the treatment arms|
48752140|NCT02542865|102180898|FG000|Treated|Overall Study||460|2 participants withdrew their consent before starting the treatment.|
48752141|NCT02542865|102180899|FG001|Treated|Overall Study||462|2 participants withdrew their consent before starting the treatment.|
48752142|NCT02542865|102180898|FG000|COMPLETED|Overall Study||445||
48752143|NCT02542865|102180899|FG001|COMPLETED|Overall Study||462||
48752144|NCT02542865|102180898|FG000|NOT COMPLETED|Overall Study||17||
48752145|NCT02542865|102180899|FG001|NOT COMPLETED|Overall Study||0||
48752146|NCT02153632|102180900|FG000|STARTED|Overall Study||45||
48752147|NCT02153632|102180901|FG001|STARTED|Overall Study||46||
48752148|NCT02153632|102180902|FG002|STARTED|Overall Study||44||
48752149|NCT02153632|102180900|FG000|COMPLETED|Overall Study||27||
48752150|NCT02153632|102180901|FG001|COMPLETED|Overall Study||27||
48752151|NCT02153632|102180902|FG002|COMPLETED|Overall Study||25||
48752152|NCT02153632|102180900|FG000|NOT COMPLETED|Overall Study||18||
48173833|NCT03228017|100746493|FG000|COMPLETED|Overall Study||45||
48173834|NCT03228017|100746494|FG001|COMPLETED|Overall Study||18||
48335120|NCT04269395|101148356|FG000|NOT COMPLETED|Overall Study||14||
48752153|NCT02153632|102180901|FG001|NOT COMPLETED|Overall Study||19||
48752154|NCT02153632|102180902|FG002|NOT COMPLETED|Overall Study||19||
48752155|NCT00683878|102180903|FG000|STARTED|Overall Study||139||
48335121|NCT04269395|101148357|FG001|NOT COMPLETED|Overall Study||10||
48335122|NCT00731874|101148358|FG000|STARTED|Overall Study||10||
48335123|NCT00731874|101148359|FG001|STARTED|Overall Study||13||
48335124|NCT00731874|101148358|FG000|COMPLETED|Overall Study||10||
48335125|NCT00731874|101148359|FG001|COMPLETED|Overall Study||13||
48335126|NCT00731874|101148358|FG000|NOT COMPLETED|Overall Study||0||
48335127|NCT00731874|101148359|FG001|NOT COMPLETED|Overall Study||0||
48335128|NCT01734655|101148360|FG000|STARTED|Overall Study||40||
48335129|NCT01734655|101148360|FG000|COMPLETED|Overall Study||40||
48335130|NCT01734655|101148360|FG000|NOT COMPLETED|Overall Study||0||
48335131|NCT02288273|101148361|FG000|STARTED|Overall Study||61||
48335132|NCT02288273|101148362|FG001|STARTED|Overall Study||56||
48335133|NCT02288273|101148361|FG000|COMPLETED|Overall Study||53||
48335134|NCT02288273|101148362|FG001|COMPLETED|Overall Study||48||
48335135|NCT02288273|101148361|FG000|NOT COMPLETED|Overall Study||8||
48335136|NCT02288273|101148362|FG001|NOT COMPLETED|Overall Study||8||
48335137|NCT01658657|101148363|FG000|STARTED|Overall Study||7||
48335138|NCT01658657|101148364|FG001|STARTED|Overall Study||10||
48335139|NCT01658657|101148363|FG000|COMPLETED|Overall Study||4||
48335140|NCT01658657|101148364|FG001|COMPLETED|Overall Study||7||
48335141|NCT01658657|101148363|FG000|NOT COMPLETED|Overall Study||3||
48173835|NCT03228017|100746493|FG000|NOT COMPLETED|Overall Study||0||
48335142|NCT01658657|101148364|FG001|NOT COMPLETED|Overall Study||3||
48335143|NCT02194439|101148365|FG000|STARTED|Overall Study||415||
48335144|NCT02194439|101148365|FG000|COMPLETED|Overall Study||415||
48335145|NCT02194439|101148365|FG000|NOT COMPLETED|Overall Study||0||
48335146|NCT02471716|101148366|FG000|STARTED|Overall Study||3||
48335147|NCT02471716|101148367|FG001|STARTED|Overall Study||3||
48752156|NCT00683878|102180904|FG001|STARTED|Overall Study||141||
48173836|NCT03228017|100746494|FG001|NOT COMPLETED|Overall Study||0||
48173837|NCT02572817|100746495|FG000|STARTED|Overall Study||91||
48173838|NCT02572817|100746496|FG001|STARTED|Overall Study||47||
48335148|NCT02471716|101148368|FG002|STARTED|Overall Study||3||
48335149|NCT02471716|101148369|FG003|STARTED|Overall Study||33||
48335150|NCT02471716|101148370|FG004|STARTED|Overall Study||24||
48335151|NCT02471716|101148366|FG000|COMPLETED|Overall Study||3||
48335152|NCT02471716|101148367|FG001|COMPLETED|Overall Study||2||
48335153|NCT02471716|101148368|FG002|COMPLETED|Overall Study||3||
48335154|NCT02471716|101148369|FG003|COMPLETED|Overall Study||18||
48335155|NCT02471716|101148370|FG004|COMPLETED|Overall Study||8||
48335156|NCT02471716|101148366|FG000|NOT COMPLETED|Overall Study||0||
48335157|NCT02471716|101148367|FG001|NOT COMPLETED|Overall Study||1||
48335158|NCT02471716|101148368|FG002|NOT COMPLETED|Overall Study||0||
48335159|NCT02471716|101148369|FG003|NOT COMPLETED|Overall Study||15||
48335160|NCT02471716|101148370|FG004|NOT COMPLETED|Overall Study||16||
48752157|NCT00683878|102180905|FG002|STARTED|Overall Study||140||
48335161|NCT02017574|101148371|FG000|STARTED|Overall Study||12||
48752158|NCT00683878|102180903|FG000|COMPLETED|Overall Study||116||
48752159|NCT00683878|102180904|FG001|COMPLETED|Overall Study||125||
48752160|NCT00683878|102180905|FG002|COMPLETED|Overall Study||126||
48752161|NCT00683878|102180903|FG000|NOT COMPLETED|Overall Study||23||
48752162|NCT00683878|102180904|FG001|NOT COMPLETED|Overall Study||16||
48752163|NCT00683878|102180905|FG002|NOT COMPLETED|Overall Study||14||
48752164|NCT02513563|102180906|FG000|STARTED|Overall Study||42||
48752165|NCT02513563|102180906|FG000|COMPLETED|Overall Study||33||
48752166|NCT02513563|102180906|FG000|NOT COMPLETED|Overall Study||9||
48752167|NCT03935126|102180907|FG000|STARTED|Overall Study||3||
48752168|NCT03935126|102180907|FG000|COMPLETED|Overall Study||0||
48752169|NCT03935126|102180907|FG000|NOT COMPLETED|Overall Study||3||
48752170|NCT03831477|102180908|FG000|STARTED|Overall Study||15||
48752171|NCT03831477|102180908|FG000|COMPLETED|Overall Study||13||
48752172|NCT03831477|102180908|FG000|NOT COMPLETED|Overall Study||2||
48752173|NCT02314936|102180909|FG000|STARTED|Overall Study||48||
48752174|NCT02314936|102180910|FG001|STARTED|Overall Study||48||
48752175|NCT02314936|102180911|FG002|STARTED|Overall Study||48||
48752176|NCT02314936|102180912|FG003|STARTED|Overall Study||48||
48752177|NCT02314936|102180909|FG000|COMPLETED|Overall Study||48||
48752178|NCT02314936|102180910|FG001|COMPLETED|Overall Study||48||
48752179|NCT02314936|102180911|FG002|COMPLETED|Overall Study||46||
48752180|NCT02314936|102180912|FG003|COMPLETED|Overall Study||48||
48752181|NCT02314936|102180909|FG000|NOT COMPLETED|Overall Study||0||
48752182|NCT02314936|102180910|FG001|NOT COMPLETED|Overall Study||0||
48752183|NCT02314936|102180911|FG002|NOT COMPLETED|Overall Study||2||
48752184|NCT02314936|102180912|FG003|NOT COMPLETED|Overall Study||0||
48752185|NCT00152503|102180913|FG000|STARTED|Overall Study||59||
48752186|NCT00152503|102180913|FG000|COMPLETED|Overall Study||55||
48752187|NCT00152503|102180913|FG000|NOT COMPLETED|Overall Study||4||
48752188|NCT02609308|102180914|FG000|STARTED|Overall Study||10||
48752189|NCT02609308|102180915|FG001|STARTED|Overall Study||11||
48752190|NCT02609308|102180914|FG000|COMPLETED|Overall Study||10||
48752191|NCT02609308|102180915|FG001|COMPLETED|Overall Study||11||
48752192|NCT02609308|102180914|FG000|NOT COMPLETED|Overall Study||0||
48752193|NCT02609308|102180915|FG001|NOT COMPLETED|Overall Study||0||
48752194|NCT00498940|102180916|FG000|STARTED|Overall Study||30||
48752195|NCT00498940|102180917|FG001|STARTED|Overall Study||31||
48752196|NCT00498940|102180916|FG000|COMPLETED|Overall Study||30||
48752197|NCT00498940|102180917|FG001|COMPLETED|Overall Study||31||
48752198|NCT00498940|102180916|FG000|NOT COMPLETED|Overall Study||0||
48752199|NCT00498940|102180917|FG001|NOT COMPLETED|Overall Study||0||
48752200|NCT01147666|102180918|FG000|STARTED|Dosing Period 1: 6-Week Treatment||12||
48752201|NCT01147666|102180919|FG001|STARTED|Dosing Period 1: 6-Week Treatment||12||
48752202|NCT01147666|102180920|FG002|STARTED|Dosing Period 1: 6-Week Treatment||12||
48752203|NCT01147666|102180921|FG003|STARTED|Dosing Period 1: 6-Week Treatment||12||
48752204|NCT01147666|102180922|FG004|STARTED|Dosing Period 1: 6-Week Treatment||12||
48752205|NCT01147666|102180923|FG005|STARTED|Dosing Period 1: 6-Week Treatment||12||
48752206|NCT01147666|102180924|FG006|STARTED|Dosing Period 1: 6-Week Treatment||12||
48752207|NCT01147666|102180925|FG007|STARTED|Dosing Period 1: 6-Week Treatment||12||
48752208|NCT01147666|102180926|FG008|STARTED|Dosing Period 1: 6-Week Treatment||2||
48752209|NCT01147666|102180927|FG009|STARTED|Dosing Period 1: 6-Week Treatment||10||
48752210|NCT01147666|102180928|FG010|STARTED|Dosing Period 1: 6-Week Treatment||36||
48752211|NCT01147666|102180929|FG011|STARTED|Dosing Period 1: 6-Week Treatment||4||
48752212|NCT01147666|102180930|FG012|STARTED|Dosing Period 1: 6-Week Treatment||5||
48752213|NCT01147666|102180931|FG013|STARTED|Dosing Period 1: 6-Week Treatment||4||
48752214|NCT01147666|102180932|FG014|STARTED|Dosing Period 1: 6-Week Treatment||4||
48752215|NCT01147666|102180918|FG000|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12||
48752216|NCT01147666|102180919|FG001|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12||
48752217|NCT01147666|102180920|FG002|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12||
48752218|NCT01147666|102180921|FG003|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12||
48752219|NCT01147666|102180922|FG004|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12||
48752220|NCT01147666|102180923|FG005|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12||
48752221|NCT01147666|102180924|FG006|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12||
48752222|NCT01147666|102180925|FG007|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12||
48752223|NCT01147666|102180926|FG008|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||2||
48752224|NCT01147666|102180927|FG009|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||10||
48752225|NCT01147666|102180928|FG010|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||36||
48752226|NCT01147666|102180929|FG011|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||4||
48752227|NCT01147666|102180930|FG012|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||5||
48752228|NCT01147666|102180931|FG013|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||4||
48752229|NCT01147666|102180932|FG014|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||4||
48752230|NCT01147666|102180918|FG000|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||9|Received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
48767729|NCT00494676|102222812|FG000|NOT COMPLETED|First Intervention||1||
48752231|NCT01147666|102180919|FG001|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||10|Received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
48752232|NCT01147666|102180920|FG002|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||9|Received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
48752233|NCT01147666|102180921|FG003|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||11|Received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
48752234|NCT01147666|102180922|FG004|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||11|Received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
48752235|NCT01147666|102180923|FG005|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||11|Received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
48752236|NCT01147666|102180924|FG006|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||11|Received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
48752237|NCT01147666|102180925|FG007|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||10|Received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
48752238|NCT01147666|102180926|FG008|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||2|Received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
48752239|NCT01147666|102180927|FG009|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||10|Received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
48752240|NCT01147666|102180928|FG010|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||31|Received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
48752241|NCT01147666|102180929|FG011|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||1|Received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
48752242|NCT01147666|102180930|FG012|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||3|Received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
48752243|NCT01147666|102180931|FG013|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||4|Received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
48752244|NCT01147666|102180932|FG014|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||3|Received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
48752245|NCT01147666|102180918|FG000|COMPLETED|Dosing Period 1: 6-Week Treatment||10||
48752246|NCT01147666|102180919|FG001|COMPLETED|Dosing Period 1: 6-Week Treatment||10||
48752247|NCT01147666|102180920|FG002|COMPLETED|Dosing Period 1: 6-Week Treatment||11||
48752248|NCT01147666|102180921|FG003|COMPLETED|Dosing Period 1: 6-Week Treatment||10||
48752249|NCT01147666|102180922|FG004|COMPLETED|Dosing Period 1: 6-Week Treatment||7||
48752250|NCT01147666|102180923|FG005|COMPLETED|Dosing Period 1: 6-Week Treatment||9||
48752251|NCT01147666|102180924|FG006|COMPLETED|Dosing Period 1: 6-Week Treatment||9||
48752252|NCT01147666|102180925|FG007|COMPLETED|Dosing Period 1: 6-Week Treatment||9||
48173839|NCT02572817|100746495|FG000|COMPLETED|Overall Study||82||
48173840|NCT02572817|100746496|FG001|COMPLETED|Overall Study||41||
48173841|NCT02572817|100746495|FG000|NOT COMPLETED|Overall Study||9||
48173842|NCT02572817|100746496|FG001|NOT COMPLETED|Overall Study||6||
48173843|NCT00910520|100746497|FG000|STARTED|Treatment Cycle 1||277||
48173844|NCT00910520|100746498|FG001|STARTED|Treatment Cycle 1||271||
48173845|NCT00910520|100746497|FG000|COMPLETED|Treatment Cycle 1||257||
48173846|NCT00910520|100746498|FG001|COMPLETED|Treatment Cycle 1||247||
48173847|NCT00910520|100746497|FG000|NOT COMPLETED|Treatment Cycle 1||20||
48173848|NCT00910520|100746498|FG001|NOT COMPLETED|Treatment Cycle 1||24||
48335162|NCT02017574|101148372|FG001|STARTED|Overall Study||12||
48335163|NCT02017574|101148371|FG000|COMPLETED|Overall Study||12||
48335164|NCT02017574|101148372|FG001|COMPLETED|Overall Study||12||
48173849|NCT00910520|100746497|FG000|STARTED|Treatment Cycle 2||163||
48173850|NCT00910520|100746498|FG001|STARTED|Treatment Cycle 2||223||
48173851|NCT00910520|100746497|FG000|COMPLETED|Treatment Cycle 2||156||
48173852|NCT00910520|100746498|FG001|COMPLETED|Treatment Cycle 2||215||
48173853|NCT00910520|100746497|FG000|NOT COMPLETED|Treatment Cycle 2||7||
48335165|NCT02017574|101148371|FG000|NOT COMPLETED|Overall Study||0||
48335166|NCT02017574|101148372|FG001|NOT COMPLETED|Overall Study||0||
48335167|NCT00305578|101148373|FG000|STARTED|Overall Study||15||
48335168|NCT00305578|101148374|FG001|STARTED|Overall Study||14||
48335169|NCT00305578|101148373|FG000|COMPLETED|Overall Study||12||
48335170|NCT00305578|101148374|FG001|COMPLETED|Overall Study||12||
48335171|NCT00305578|101148373|FG000|NOT COMPLETED|Overall Study||3||
48335172|NCT00305578|101148374|FG001|NOT COMPLETED|Overall Study||2||
48335173|NCT02629159|101148375|FG000|STARTED|Overall Study||651||
48173854|NCT00910520|100746498|FG001|NOT COMPLETED|Treatment Cycle 2||8||
48173855|NCT00904150|100746499|FG000|STARTED|Saliva Samples (DNA)||285||
48173856|NCT00904150|100746500|FG001|STARTED|Saliva Samples (DNA)||300||
48173857|NCT00904150|100746499|FG000|COMPLETED|Saliva Samples (DNA)||282||
48173858|NCT00904150|100746500|FG001|COMPLETED|Saliva Samples (DNA)||155||
48173859|NCT00904150|100746499|FG000|NOT COMPLETED|Saliva Samples (DNA)||3||
48173860|NCT00904150|100746500|FG001|NOT COMPLETED|Saliva Samples (DNA)||145||
48173861|NCT00904150|100746499|FG000|STARTED|Blood Samples (RNA): Follicular Phase||37||
48173862|NCT00904150|100746500|FG001|STARTED|Blood Samples (RNA): Follicular Phase||32||
48173863|NCT00904150|100746499|FG000|COMPLETED|Blood Samples (RNA): Follicular Phase||37||
48173864|NCT00904150|100746500|FG001|COMPLETED|Blood Samples (RNA): Follicular Phase||32||
48173865|NCT00904150|100746499|FG000|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0||
48173866|NCT00904150|100746500|FG001|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0||
48173867|NCT00904150|100746499|FG000|STARTED|Blood Samples (RNA): Luteal Phase||34||
48173868|NCT00904150|100746500|FG001|STARTED|Blood Samples (RNA): Luteal Phase||30||
48173869|NCT00904150|100746499|FG000|COMPLETED|Blood Samples (RNA): Luteal Phase||34||
48173870|NCT00904150|100746500|FG001|COMPLETED|Blood Samples (RNA): Luteal Phase||30||
48173871|NCT00904150|100746499|FG000|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0||
48173872|NCT00904150|100746500|FG001|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0||
48173873|NCT01034579|100746501|FG000|STARTED|Overall Study||158||
48335174|NCT02629159|101148376|FG001|STARTED|Overall Study||327||
48335175|NCT02629159|101148377|FG002|STARTED|Overall Study||651||
48335176|NCT02629159|101148375|FG000|Received Assigned Study Drug|Overall Study||651||
48335177|NCT02629159|101148376|FG001|Received Assigned Study Drug|Overall Study||327||
48335178|NCT02629159|101148377|FG002|Received Assigned Study Drug|Overall Study||650||
48173874|NCT01034579|100746502|FG001|STARTED|Overall Study||166||
48173875|NCT01034579|100746501|FG000|COMPLETED|Overall Study||158||
48173876|NCT01034579|100746502|FG001|COMPLETED|Overall Study||166||
48173877|NCT01034579|100746501|FG000|NOT COMPLETED|Overall Study||0||
48173878|NCT01034579|100746502|FG001|NOT COMPLETED|Overall Study||0||
48173879|NCT00547911|100746503|FG000|STARTED|Overall Study||2||
48173880|NCT00547911|100746504|FG001|STARTED|Overall Study||2||
48173881|NCT00547911|100746505|FG002|STARTED|Overall Study||2||
48173882|NCT00547911|100746506|FG003|STARTED|Overall Study||2||
48173883|NCT00547911|100746507|FG004|STARTED|Overall Study||3||
48173884|NCT00547911|100746508|FG005|STARTED|Overall Study||3||
48173885|NCT00547911|100746503|FG000|COMPLETED|Overall Study||2||
48173886|NCT00547911|100746504|FG001|COMPLETED|Overall Study||2||
48173887|NCT00547911|100746505|FG002|COMPLETED|Overall Study||2||
48173888|NCT00547911|100746506|FG003|COMPLETED|Overall Study||1||
48173889|NCT00547911|100746507|FG004|COMPLETED|Overall Study||3||
48173890|NCT00547911|100746508|FG005|COMPLETED|Overall Study||3||
48173891|NCT00547911|100746503|FG000|NOT COMPLETED|Overall Study||0||
48173892|NCT00547911|100746504|FG001|NOT COMPLETED|Overall Study||0||
48173893|NCT00547911|100746505|FG002|NOT COMPLETED|Overall Study||0||
48173894|NCT00547911|100746506|FG003|NOT COMPLETED|Overall Study||1||
48173895|NCT00547911|100746507|FG004|NOT COMPLETED|Overall Study||0||
48173896|NCT00547911|100746508|FG005|NOT COMPLETED|Overall Study||0||
48173897|NCT02550873|100746509|FG000|STARTED|Randomized Double Blind||78|Number of patients randomized|
48173898|NCT02550873|100746510|FG001|STARTED|Randomized Double Blind||39|Number of patients randomized|
48173899|NCT02550873|100746511|FG002|STARTED|Randomized Double Blind||0|Number of patients randomized|
48173900|NCT02550873|100746509|FG000|Received Treatment|Randomized Double Blind||77||
48173901|NCT02550873|100746510|FG001|Received Treatment|Randomized Double Blind||39||
48173902|NCT02550873|100746511|FG002|Received Treatment|Randomized Double Blind||0||
48173903|NCT02550873|100746509|FG000|Continue to Open Label Extension|Randomized Double Blind||74||
48173904|NCT02550873|100746510|FG001|Continue to Open Label Extension|Randomized Double Blind||37||
48173905|NCT02550873|100746511|FG002|Continue to Open Label Extension|Randomized Double Blind||0||
48173906|NCT02550873|100746509|FG000|COMPLETED|Randomized Double Blind||74||
48173907|NCT02550873|100746510|FG001|COMPLETED|Randomized Double Blind||37||
48173908|NCT02550873|100746511|FG002|COMPLETED|Randomized Double Blind||0||
48173909|NCT02550873|100746509|FG000|NOT COMPLETED|Randomized Double Blind||4||
48173910|NCT02550873|100746510|FG001|NOT COMPLETED|Randomized Double Blind||2||
48335179|NCT02629159|101148375|FG000|Completed Week 14 on Study Drug|Overall Study||620||
48335180|NCT02629159|101148376|FG001|Completed Week 14 on Study Drug|Overall Study||300||
48335181|NCT02629159|101148377|FG002|Completed Week 14 on Study Drug|Overall Study||620||
48173911|NCT02550873|100746511|FG002|NOT COMPLETED|Randomized Double Blind||0||
48173912|NCT02550873|100746509|FG000|STARTED|Open Label Extension||0||
48173913|NCT02550873|100746510|FG001|STARTED|Open Label Extension||0||
48173914|NCT02550873|100746511|FG002|STARTED|Open Label Extension||111||
48173915|NCT02550873|100746509|FG000|COMPLETED|Open Label Extension||0||
48173916|NCT02550873|100746510|FG001|COMPLETED|Open Label Extension||0||
48173917|NCT02550873|100746511|FG002|COMPLETED|Open Label Extension||0||
48173918|NCT02550873|100746509|FG000|NOT COMPLETED|Open Label Extension||0||
48335182|NCT02629159|101148375|FG000|Rescued at Week 14|Overall Study||231||
48335183|NCT02629159|101148376|FG001|Rescued at Week 14|Overall Study||56||
48173919|NCT02550873|100746510|FG001|NOT COMPLETED|Open Label Extension||0||
48173920|NCT02550873|100746511|FG002|NOT COMPLETED|Open Label Extension||111||
48173921|NCT01448421|100746512|FG000|STARTED|Overall Study||37||
48173922|NCT01448421|100746512|FG000|COMPLETED|Overall Study||37||
48173923|NCT01448421|100746512|FG000|NOT COMPLETED|Overall Study||0||
48173924|NCT01133860|100746513|FG000|STARTED|Overall Study||12||
48173925|NCT01133860|100746513|FG000|COMPLETED|Overall Study||12||
48173926|NCT01133860|100746513|FG000|NOT COMPLETED|Overall Study||0||
48173927|NCT02783820|100746514|FG000|STARTED|Overall Study||6||
48173928|NCT02783820|100746515|FG001|STARTED|Overall Study||6||
48173929|NCT02783820|100746516|FG002|STARTED|Overall Study||6||
48173930|NCT02783820|100746517|FG003|STARTED|Overall Study||6||
48173931|NCT02783820|100746514|FG000|COMPLETED|Overall Study||6||
48173932|NCT02783820|100746515|FG001|COMPLETED|Overall Study||6||
48173933|NCT02783820|100746516|FG002|COMPLETED|Overall Study||6||
48173934|NCT02783820|100746517|FG003|COMPLETED|Overall Study||6||
48173935|NCT02783820|100746514|FG000|NOT COMPLETED|Overall Study||0||
48173936|NCT02783820|100746515|FG001|NOT COMPLETED|Overall Study||0||
48173937|NCT02783820|100746516|FG002|NOT COMPLETED|Overall Study||0||
48173938|NCT02783820|100746517|FG003|NOT COMPLETED|Overall Study||0||
48173939|NCT03387514|100746518|FG000|STARTED|Overall Study||5||
48173940|NCT03387514|100746518|FG000|PET 1|Overall Study||5||
48173941|NCT03387514|100746518|FG000|Tissue Samples|Overall Study||4||
48412178|NCT02809846|101341947|FG000|COMPLETED|Overall Study||8||
48412179|NCT02809846|101341948|FG001|COMPLETED|Overall Study||9||
48752253|NCT01147666|102180926|FG008|COMPLETED|Dosing Period 1: 6-Week Treatment||2||
48173942|NCT03387514|100746518|FG000|PET 2A|Overall Study||0||
48173943|NCT03387514|100746518|FG000|PET 2B|Overall Study||0||
48173944|NCT03387514|100746518|FG000|PET 3A|Overall Study||0||
48173945|NCT03387514|100746518|FG000|PET 3B|Overall Study||0||
48173946|NCT03387514|100746518|FG000|PET 4|Overall Study||0||
48173947|NCT03387514|100746518|FG000|COMPLETED|Overall Study||0||
48173948|NCT03387514|100746518|FG000|NOT COMPLETED|Overall Study||5||
48173949|NCT02684903|100746519|FG000|STARTED|Overall Study||168||
48173950|NCT02684903|100746520|FG001|STARTED|Overall Study||240||
48173951|NCT02684903|100746519|FG000|COMPLETED|Overall Study||133||
48173952|NCT02684903|100746520|FG001|COMPLETED|Overall Study||193||
48173953|NCT02684903|100746519|FG000|NOT COMPLETED|Overall Study||35||
48173954|NCT02684903|100746520|FG001|NOT COMPLETED|Overall Study||47||
48335184|NCT02629159|101148377|FG002|Rescued at Week 14|Overall Study||78||
48335185|NCT02629159|101148375|FG000|Rescued at Week 18|Overall Study||48||
48335186|NCT02629159|101148376|FG001|Rescued at Week 18|Overall Study||14||
48335187|NCT02629159|101148377|FG002|Rescued at Week 18|Overall Study||29||
48335188|NCT02629159|101148375|FG000|Rescued at Week 22|Overall Study||26||
48335189|NCT02629159|101148376|FG001|Rescued at Week 22|Overall Study||7||
48335190|NCT02629159|101148377|FG002|Rescued at Week 22|Overall Study||18||
48335191|NCT02629159|101148375|FG000|COMPLETED|Overall Study||595|Participants who completed Week 26|
48335192|NCT02629159|101148376|FG001|COMPLETED|Overall Study||288|Participants who completed Week 26|
48335193|NCT02629159|101148377|FG002|COMPLETED|Overall Study||600|Participants who completed Week 26|
48335194|NCT02629159|101148375|FG000|NOT COMPLETED|Overall Study||56||
48335195|NCT02629159|101148376|FG001|NOT COMPLETED|Overall Study||39||
48335196|NCT02629159|101148377|FG002|NOT COMPLETED|Overall Study||51||
48335197|NCT03898063|101148378|FG000|STARTED|Overall Study||74||
48335198|NCT03898063|101148379|FG001|STARTED|Overall Study||74||
48335199|NCT03898063|101148378|FG000|COMPLETED|Overall Study||64||
48335200|NCT03898063|101148379|FG001|COMPLETED|Overall Study||66||
48335201|NCT03898063|101148378|FG000|NOT COMPLETED|Overall Study||10||
48335202|NCT03898063|101148379|FG001|NOT COMPLETED|Overall Study||8||
48335203|NCT02614079|101148380|FG000|STARTED|Overall Study||6||
48335204|NCT02614079|101148380|FG000|COMPLETED|Overall Study||5||
48335205|NCT02614079|101148380|FG000|NOT COMPLETED|Overall Study||1||
48335206|NCT00928421|101148381|FG000|STARTED|Overall Study||16||
48335207|NCT00928421|101148381|FG000|Treated With Study Drug|Overall Study||16||
48335208|NCT00928421|101148381|FG000|COMPLETED|Overall Study||16||
48412180|NCT02809846|101341947|FG000|NOT COMPLETED|Overall Study||9||
48412181|NCT02809846|101341948|FG001|NOT COMPLETED|Overall Study||7||
48412182|NCT02954952|101341949|FG000|STARTED|Overall Study||36||
48412183|NCT02954952|101341950|FG001|STARTED|Overall Study||5||
48752254|NCT01147666|102180927|FG009|COMPLETED|Dosing Period 1: 6-Week Treatment||8||
48752255|NCT01147666|102180928|FG010|COMPLETED|Dosing Period 1: 6-Week Treatment||33||
48752256|NCT01147666|102180929|FG011|COMPLETED|Dosing Period 1: 6-Week Treatment||2||
48752257|NCT01147666|102180930|FG012|COMPLETED|Dosing Period 1: 6-Week Treatment||1||
48173955|NCT01254565|100746521|FG000|STARTED|Overall Study||5||
48173956|NCT01254565|100746522|FG001|STARTED|Overall Study||7||
48173957|NCT01254565|100746523|FG002|STARTED|Overall Study||21||
48173958|NCT01254565|100746524|FG003|STARTED|Overall Study||21||
48335209|NCT00928421|101148381|FG000|NOT COMPLETED|Overall Study||0||
48335210|NCT02516670|101148382|FG000|STARTED|Overall Study||34||
48173959|NCT01254565|100746525|FG004|STARTED|Overall Study||16||
48173960|NCT01254565|100746526|FG005|STARTED|Overall Study||17||
48335211|NCT02516670|101148383|FG001|STARTED|Overall Study||16||
48412184|NCT02954952|101341951|FG002|STARTED|Overall Study||3||
48173961|NCT01254565|100746521|FG000|Received Treatment|Overall Study||4||
48173962|NCT01254565|100746522|FG001|Received Treatment|Overall Study||6||
48173963|NCT01254565|100746523|FG002|Received Treatment|Overall Study||21||
48173964|NCT01254565|100746524|FG003|Received Treatment|Overall Study||21||
48173965|NCT01254565|100746525|FG004|Received Treatment|Overall Study||13||
48173966|NCT01254565|100746526|FG005|Received Treatment|Overall Study||13||
48173967|NCT01254565|100746521|FG000|COMPLETED|Overall Study||4||
48173968|NCT01254565|100746522|FG001|COMPLETED|Overall Study||6||
48173969|NCT01254565|100746523|FG002|COMPLETED|Overall Study||21||
48173970|NCT01254565|100746524|FG003|COMPLETED|Overall Study||20||
48173971|NCT01254565|100746525|FG004|COMPLETED|Overall Study||12||
48173972|NCT01254565|100746526|FG005|COMPLETED|Overall Study||13||
48173973|NCT01254565|100746521|FG000|NOT COMPLETED|Overall Study||1||
48173974|NCT01254565|100746522|FG001|NOT COMPLETED|Overall Study||1||
48173975|NCT01254565|100746523|FG002|NOT COMPLETED|Overall Study||0||
48173976|NCT01254565|100746524|FG003|NOT COMPLETED|Overall Study||1||
48173977|NCT01254565|100746525|FG004|NOT COMPLETED|Overall Study||4||
48173978|NCT01254565|100746526|FG005|NOT COMPLETED|Overall Study||4||
48173979|NCT00871351|100746527|FG000|STARTED|Overall Study||47||
48173980|NCT00871351|100746528|FG001|STARTED|Overall Study||46||
48173981|NCT00871351|100746529|FG002|STARTED|Overall Study||32||
48173982|NCT00871351|100746527|FG000|COMPLETED|Overall Study||43||
48335212|NCT02516670|101148382|FG000|COMPLETED|Overall Study||34||
48335213|NCT02516670|101148383|FG001|COMPLETED|Overall Study||16||
48335214|NCT02516670|101148382|FG000|NOT COMPLETED|Overall Study||0||
48335215|NCT02516670|101148383|FG001|NOT COMPLETED|Overall Study||0||
48335216|NCT01558063|101148384|FG000|STARTED|Overall Study||5||
48335217|NCT01558063|101148385|FG001|STARTED|Overall Study||6||
48335218|NCT01558063|101148386|FG002|STARTED|Overall Study||8||
48335219|NCT01558063|101148387|FG003|STARTED|Overall Study||5||
48335220|NCT01558063|101148388|FG004|STARTED|Overall Study||9||
48173983|NCT00871351|100746528|FG001|COMPLETED|Overall Study||45||
48173984|NCT00871351|100746529|FG002|COMPLETED|Overall Study||32||
48173985|NCT00871351|100746527|FG000|NOT COMPLETED|Overall Study||4||
48173986|NCT00871351|100746528|FG001|NOT COMPLETED|Overall Study||1||
48173987|NCT00871351|100746529|FG002|NOT COMPLETED|Overall Study||0||
48173988|NCT00932646|100746530|FG000|STARTED|Overall Study||25||
48173989|NCT00932646|100746531|FG001|STARTED|Overall Study||25||
48335221|NCT01558063|101148389|FG005|STARTED|Overall Study||5||
48335222|NCT01558063|101148384|FG000|COMPLETED|Overall Study||5||
48335223|NCT01558063|101148385|FG001|COMPLETED|Overall Study||6||
48335224|NCT01558063|101148386|FG002|COMPLETED|Overall Study||8||
48173990|NCT00932646|100746532|FG002|STARTED|Overall Study||25||
48173991|NCT00932646|100746533|FG003|STARTED|Overall Study||25||
48173992|NCT00932646|100746530|FG000|COMPLETED|Overall Study||20||
48173993|NCT00932646|100746531|FG001|COMPLETED|Overall Study||22||
48173994|NCT00932646|100746532|FG002|COMPLETED|Overall Study||21||
48173995|NCT00932646|100746533|FG003|COMPLETED|Overall Study||24||
48173996|NCT00932646|100746530|FG000|NOT COMPLETED|Overall Study||5||
48173997|NCT00932646|100746531|FG001|NOT COMPLETED|Overall Study||3||
48173998|NCT00932646|100746532|FG002|NOT COMPLETED|Overall Study||4||
48173999|NCT00932646|100746533|FG003|NOT COMPLETED|Overall Study||1||
48174000|NCT02491892|100746534|FG000|STARTED|Overall Study||41||
48174001|NCT02491892|100746535|FG001|STARTED|Overall Study||38||
48174002|NCT02491892|100746534|FG000|Treated|Overall Study||41||
48174003|NCT02491892|100746535|FG001|Treated|Overall Study||37||
48174004|NCT02491892|100746534|FG000|COMPLETED|Overall Study||0||
48174005|NCT02491892|100746535|FG001|COMPLETED|Overall Study||0||
48174006|NCT02491892|100746534|FG000|NOT COMPLETED|Overall Study||41||
48174007|NCT02491892|100746535|FG001|NOT COMPLETED|Overall Study||38||
48174008|NCT01342887|100746536|FG000|STARTED|Overall Study||6||
48174009|NCT01342887|100746536|FG000|COMPLETED|Overall Study||4||
48174010|NCT01342887|100746536|FG000|NOT COMPLETED|Overall Study||2||
48174011|NCT02512510|100749831|FG000|STARTED|Overall Study||205||
48174012|NCT02512510|100749832|FG001|STARTED|Overall Study||197||
48174013|NCT02512510|100749833|FG002|STARTED|Overall Study||209||
48174014|NCT02512510|100749831|FG000|COMPLETED|Overall Study||163||
48174015|NCT02512510|100749832|FG001|COMPLETED|Overall Study||162||
48174016|NCT02512510|100749833|FG002|COMPLETED|Overall Study||157||
48174017|NCT02512510|100749831|FG000|NOT COMPLETED|Overall Study||42||
48174018|NCT02512510|100749832|FG001|NOT COMPLETED|Overall Study||35||
48335225|NCT01558063|101148387|FG003|COMPLETED|Overall Study||5||
48335226|NCT01558063|101148388|FG004|COMPLETED|Overall Study||9||
48335227|NCT01558063|101148389|FG005|COMPLETED|Overall Study||5||
48335228|NCT01558063|101148384|FG000|NOT COMPLETED|Overall Study||0||
48335229|NCT01558063|101148385|FG001|NOT COMPLETED|Overall Study||0||
48335230|NCT01558063|101148386|FG002|NOT COMPLETED|Overall Study||0||
48174019|NCT02512510|100749833|FG002|NOT COMPLETED|Overall Study||52||
48174020|NCT00238420|100749834|FG000|STARTED|Overall Study||22||
48174021|NCT00238420|100749835|FG001|STARTED|Overall Study||48||
48174022|NCT00238420|100749834|FG000|COMPLETED|Overall Study||21||
48174023|NCT00238420|100749835|FG001|COMPLETED|Overall Study||47||
48174024|NCT00238420|100749834|FG000|NOT COMPLETED|Overall Study||1||
48174025|NCT00238420|100749835|FG001|NOT COMPLETED|Overall Study||1||
48174026|NCT04343222|100749836|FG000|STARTED|Overall Study||16||
48174027|NCT04343222|100749837|FG001|STARTED|Overall Study||15||
48174028|NCT04343222|100749838|FG002|STARTED|Overall Study||15||
48335231|NCT01558063|101148387|FG003|NOT COMPLETED|Overall Study||0||
48335232|NCT01558063|101148388|FG004|NOT COMPLETED|Overall Study||0||
48174029|NCT04343222|100749836|FG000|COMPLETED|Overall Study||16||
48174030|NCT04343222|100749837|FG001|COMPLETED|Overall Study||15||
48174031|NCT04343222|100749838|FG002|COMPLETED|Overall Study||15||
48412185|NCT02954952|101341949|FG000|COMPLETED|Overall Study||35||
48412186|NCT02954952|101341950|FG001|COMPLETED|Overall Study||4||
48412187|NCT02954952|101341951|FG002|COMPLETED|Overall Study||3||
48412188|NCT02954952|101341949|FG000|NOT COMPLETED|Overall Study||1||
48412189|NCT02954952|101341950|FG001|NOT COMPLETED|Overall Study||1||
48412190|NCT02954952|101341951|FG002|NOT COMPLETED|Overall Study||0||
48412191|NCT03138798|101341952|FG000|STARTED|Overall Study||173||
48174032|NCT04343222|100749836|FG000|NOT COMPLETED|Overall Study||0||
48174033|NCT04343222|100749837|FG001|NOT COMPLETED|Overall Study||0||
48174034|NCT04343222|100749838|FG002|NOT COMPLETED|Overall Study||0||
48174035|NCT02788006|100749839|FG000|STARTED|Overall Study||43||
48174036|NCT02788006|100749839|FG000|COMPLETED|Overall Study||42||
48174037|NCT02788006|100749839|FG000|NOT COMPLETED|Overall Study||1||
48174038|NCT00000143|100749840|FG000|STARTED|Overall Study||31||
48174039|NCT00000143|100749841|FG001|STARTED|Overall Study||30||
48174040|NCT00000143|100749840|FG000|COMPLETED|Overall Study||31||
48174041|NCT00000143|100749841|FG001|COMPLETED|Overall Study||30||
48174042|NCT00000143|100749840|FG000|NOT COMPLETED|Overall Study||0||
48174043|NCT00000143|100749841|FG001|NOT COMPLETED|Overall Study||0||
48174044|NCT01591460|100749842|FG000|STARTED|Overall Study||165||
48174045|NCT01591460|100749842|FG000|COMPLETED|Overall Study||139||
48174046|NCT01591460|100749842|FG000|NOT COMPLETED|Overall Study||26||
48174047|NCT04694482|100749843|FG000|STARTED|Overall Study||200||
48174048|NCT04694482|100749844|FG001|STARTED|Overall Study||70||
48174049|NCT04694482|100749843|FG000|COMPLETED|Overall Study||166||
48174050|NCT04694482|100749844|FG001|COMPLETED|Overall Study||57||
48174051|NCT04694482|100749843|FG000|NOT COMPLETED|Overall Study||34||
48174052|NCT04694482|100749844|FG001|NOT COMPLETED|Overall Study||13||
48174053|NCT00675506|100749845|FG000|STARTED|Overall Study||31||
48174054|NCT00675506|100749846|FG001|STARTED|Overall Study||29||
48174055|NCT00675506|100749845|FG000|Received Intervention|Overall Study||29||
48174056|NCT00675506|100749846|FG001|Received Intervention|Overall Study||29||
48174057|NCT00675506|100749845|FG000|COMPLETED|Overall Study||19||
48174058|NCT00675506|100749846|FG001|COMPLETED|Overall Study||17||
48174059|NCT00675506|100749845|FG000|NOT COMPLETED|Overall Study||12||
48174060|NCT00675506|100749846|FG001|NOT COMPLETED|Overall Study||12||
48174061|NCT00791921|100749847|FG000|STARTED|Overall Study||116||
48174062|NCT00791921|100749848|FG001|STARTED|Overall Study||114||
48174063|NCT00791921|100749847|FG000|COMPLETED|Overall Study||82||
48174064|NCT00791921|100749848|FG001|COMPLETED|Overall Study||18||
48174065|NCT00791921|100749847|FG000|NOT COMPLETED|Overall Study||34||
48174066|NCT00791921|100749848|FG001|NOT COMPLETED|Overall Study||96||
48174067|NCT04445155|100749849|FG000|STARTED|Overall Study||68||
48174068|NCT04445155|100749850|FG001|STARTED|Overall Study||5||
48174069|NCT04445155|100749851|FG002|STARTED|Overall Study||16||
48174070|NCT04445155|100749852|FG003|STARTED|Overall Study||0||
48174071|NCT04445155|100749849|FG000|COMPLETED|Overall Study||33||
48174072|NCT04445155|100749850|FG001|COMPLETED|Overall Study||3||
48174073|NCT04445155|100749851|FG002|COMPLETED|Overall Study||13||
48174074|NCT04445155|100749852|FG003|COMPLETED|Overall Study||0||
48174075|NCT04445155|100749849|FG000|NOT COMPLETED|Overall Study||35||
48174076|NCT04445155|100749850|FG001|NOT COMPLETED|Overall Study||2||
48174077|NCT04445155|100749851|FG002|NOT COMPLETED|Overall Study||3||
48174078|NCT04445155|100749852|FG003|NOT COMPLETED|Overall Study||0||
48174079|NCT00453310|100749853|FG000|STARTED|Overall Study||10||
48174080|NCT00453310|100749853|FG000|COMPLETED|Overall Study||0||
48412192|NCT03138798|101341953|FG001|STARTED|Overall Study||175||
48412193|NCT03138798|101341952|FG000|Randomized But Did Not Meet Eligibility|Overall Study||6||
48412194|NCT03138798|101341953|FG001|Randomized But Did Not Meet Eligibility|Overall Study||4||
48412195|NCT03138798|101341952|FG000|COMPLETED|Overall Study||167||
48412196|NCT03138798|101341953|FG001|COMPLETED|Overall Study||171||
48412197|NCT03138798|101341952|FG000|NOT COMPLETED|Overall Study||6||
48412198|NCT03138798|101341953|FG001|NOT COMPLETED|Overall Study||4||
48412199|NCT00435929|101341954|FG000|STARTED|Overall Study||7||
48412200|NCT00435929|101341955|FG001|STARTED|Overall Study||9||
48412201|NCT00435929|101341954|FG000|COMPLETED|Overall Study||7||
48412202|NCT00435929|101341955|FG001|COMPLETED|Overall Study||9||
48412203|NCT00435929|101341954|FG000|NOT COMPLETED|Overall Study||0||
48174081|NCT00453310|100749853|FG000|NOT COMPLETED|Overall Study||10||
48174082|NCT04297241|100749854|FG000|STARTED|Overall Study||20||
48174083|NCT04297241|100749854|FG000|COMPLETED|Overall Study||15||
48174084|NCT04297241|100749854|FG000|NOT COMPLETED|Overall Study||5||
48174085|NCT02649322|100749855|FG000|STARTED|Overall Study||58||
48174086|NCT02649322|100749856|FG001|STARTED|Overall Study||57||
48174087|NCT02649322|100749855|FG000|COMPLETED|Overall Study||58||
48174088|NCT02649322|100749856|FG001|COMPLETED|Overall Study||57||
48174089|NCT02649322|100749855|FG000|NOT COMPLETED|Overall Study||0||
48412204|NCT00435929|101341955|FG001|NOT COMPLETED|Overall Study||0||
48412205|NCT01635244|101341956|FG000|STARTED|Overall Study||18||
48412206|NCT01635244|101341957|FG001|STARTED|Overall Study||22||
48412207|NCT01635244|101341958|FG002|STARTED|Overall Study||20||
48412208|NCT01635244|101341956|FG000|COMPLETED|Overall Study||17||
48335233|NCT01558063|101148389|FG005|NOT COMPLETED|Overall Study||0||
48335234|NCT00522795|101148390|FG000|STARTED|Overall Study||40||
48335235|NCT00522795|101148390|FG000|COMPLETED|Overall Study||40||
48412209|NCT01635244|101341957|FG001|COMPLETED|Overall Study||21||
48628978|NCT02669849|101874539|FG002|COMPLETED|Overall Study||8||
48628979|NCT02669849|101874537|FG000|NOT COMPLETED|Overall Study||18||
48628980|NCT02669849|101874538|FG001|NOT COMPLETED|Overall Study||2||
48174090|NCT02649322|100749856|FG001|NOT COMPLETED|Overall Study||0||
48174091|NCT02222896|100749857|FG000|STARTED|Abdomen||253||253
48174092|NCT02222896|100749858|FG001|STARTED|Abdomen||48||48
48174093|NCT02222896|100749859|FG002|STARTED|Abdomen||253||253
48174094|NCT02222896|100749857|FG000|COMPLETED|Abdomen||219|completed number is lower as some participants did not qualify for treatment day baseline|219
48174095|NCT02222896|100749858|FG001|COMPLETED|Abdomen||38|completed number is lower as some participants did not qualify for treatment day baseline|38
48174096|NCT02222896|100749859|FG002|COMPLETED|Abdomen||221|completed number is lower as some participants did not qualify for treatment day baseline|221
48174097|NCT02222896|100749857|FG000|NOT COMPLETED|Abdomen||34||34
48174098|NCT02222896|100749858|FG001|NOT COMPLETED|Abdomen||10||10
48174099|NCT02222896|100749859|FG002|NOT COMPLETED|Abdomen||32||32
48174100|NCT02222896|100749857|FG000|STARTED|Groin||254||254
48174101|NCT02222896|100749858|FG001|STARTED|Groin||48||48
48174102|NCT02222896|100749859|FG002|STARTED|Groin||250||250
48174103|NCT02222896|100749857|FG000|COMPLETED|Groin||211|completed number is lower as some participants did not qualify for treatment day baseline|211
48174104|NCT02222896|100749858|FG001|COMPLETED|Groin||39|completed number is lower as some participants did not qualify for treatment day baseline|39
48174105|NCT02222896|100749859|FG002|COMPLETED|Groin||210|completed number is lower as some participants did not qualify for treatment day baseline|210
48174106|NCT02222896|100749857|FG000|NOT COMPLETED|Groin||43||43
48174107|NCT02222896|100749858|FG001|NOT COMPLETED|Groin||9||9
48174108|NCT02222896|100749859|FG002|NOT COMPLETED|Groin||40||40
48174109|NCT00981825|100749860|FG000|STARTED|First Intervention||11||
48174110|NCT00981825|100749861|FG001|STARTED|First Intervention||11||
48174111|NCT00981825|100749860|FG000|COMPLETED|First Intervention||11||
48174112|NCT00981825|100749861|FG001|COMPLETED|First Intervention||11||
48628981|NCT02669849|101874539|FG002|NOT COMPLETED|Overall Study||24||
48628982|NCT00113607|101874540|FG000|STARTED|Overall Study||335||
48628983|NCT00113607|101874541|FG001|STARTED|Overall Study||337||
48628984|NCT00113607|101874540|FG000|COMPLETED|Overall Study||0||
48628985|NCT00113607|101874541|FG001|COMPLETED|Overall Study||0||
48628986|NCT00113607|101874540|FG000|NOT COMPLETED|Overall Study||335||
48628987|NCT00113607|101874541|FG001|NOT COMPLETED|Overall Study||337||
48628988|NCT00843466|101874542|FG000|STARTED|Overall Study||24||
48628989|NCT00843466|101874543|FG001|STARTED|Overall Study||18||
48628990|NCT00843466|101874542|FG000|COMPLETED|Overall Study||24||
48628991|NCT00843466|101874543|FG001|COMPLETED|Overall Study||18||
48628992|NCT00843466|101874542|FG000|NOT COMPLETED|Overall Study||0||
48628993|NCT00843466|101874543|FG001|NOT COMPLETED|Overall Study||0||
48628994|NCT03439137|101874544|FG000|STARTED|Overall Study||162||
48628995|NCT03439137|101874545|FG001|STARTED|Overall Study||161||
48628996|NCT03439137|101874544|FG000|COMPLETED|Overall Study||120||
48628997|NCT03439137|101874545|FG001|COMPLETED|Overall Study||135||
48628998|NCT03439137|101874544|FG000|NOT COMPLETED|Overall Study||42||
48174113|NCT00981825|100749860|FG000|NOT COMPLETED|First Intervention||0||
48174114|NCT00981825|100749861|FG001|NOT COMPLETED|First Intervention||0||
48174115|NCT00981825|100749860|FG000|STARTED|Washout After 1st Intervention||11||
48174116|NCT00981825|100749861|FG001|STARTED|Washout After 1st Intervention||11||
48174117|NCT00981825|100749860|FG000|COMPLETED|Washout After 1st Intervention||11||
48174118|NCT00981825|100749861|FG001|COMPLETED|Washout After 1st Intervention||11||
48174119|NCT00981825|100749860|FG000|NOT COMPLETED|Washout After 1st Intervention||0||
48174120|NCT00981825|100749861|FG001|NOT COMPLETED|Washout After 1st Intervention||0||
48174121|NCT00981825|100749860|FG000|STARTED|Second Intervention||11||
48335236|NCT00522795|101148390|FG000|NOT COMPLETED|Overall Study||0||
48335237|NCT00469612|101148391|FG000|STARTED|Overall Study||2||
48335238|NCT00469612|101148392|FG001|STARTED|Overall Study||0||
48335239|NCT00469612|101148391|FG000|COMPLETED|Overall Study||0||
48335240|NCT00469612|101148392|FG001|COMPLETED|Overall Study||0||
48335241|NCT00469612|101148391|FG000|NOT COMPLETED|Overall Study||2||
48628999|NCT03439137|101874545|FG001|NOT COMPLETED|Overall Study||26||
48629000|NCT00856180|101874546|FG000|STARTED|Overall Study||20||
48629001|NCT00856180|101874546|FG000|COMPLETED|Overall Study||0||
48629002|NCT00856180|101874546|FG000|NOT COMPLETED|Overall Study||20||
48629003|NCT01004939|101874547|FG000|STARTED|Overall Study||120||
48629004|NCT01004939|101874547|FG000|COMPLETED|Overall Study||120||
48629005|NCT01004939|101874547|FG000|NOT COMPLETED|Overall Study||0||
48335242|NCT00469612|101148392|FG001|NOT COMPLETED|Overall Study||0||
48335243|NCT03222349|101148393|FG000|STARTED|Overall Study||11||
48412210|NCT01635244|101341958|FG002|COMPLETED|Overall Study||18||
48629006|NCT00000575|101874548|FG000|STARTED|Overall Study||311||
48629007|NCT00000575|101874549|FG001|STARTED|Overall Study||312||
48629008|NCT00000575|101874550|FG002|STARTED|Overall Study||418||
48629009|NCT00000575|101874548|FG000|COMPLETED|Overall Study||311||
48629010|NCT00000575|101874549|FG001|COMPLETED|Overall Study||312||
48629011|NCT00000575|101874550|FG002|COMPLETED|Overall Study||418||
48629012|NCT00000575|101874548|FG000|NOT COMPLETED|Overall Study||0||
48629013|NCT00000575|101874549|FG001|NOT COMPLETED|Overall Study||0||
48629014|NCT00000575|101874550|FG002|NOT COMPLETED|Overall Study||0||
48629015|NCT02863666|101874551|FG000|STARTED|Overall Study||673||
48629016|NCT02863666|101874551|FG000|COMPLETED|Overall Study||673||
48335244|NCT03222349|101148394|FG001|STARTED|Overall Study||13||
48335245|NCT03222349|101148393|FG000|COMPLETED|Overall Study||3||
48335246|NCT03222349|101148394|FG001|COMPLETED|Overall Study||6||
48335247|NCT03222349|101148393|FG000|NOT COMPLETED|Overall Study||8||
48335248|NCT03222349|101148394|FG001|NOT COMPLETED|Overall Study||7||
48335249|NCT02981069|101148395|FG000|STARTED|Acute Portion of Study||25||
48629017|NCT02863666|101874551|FG000|NOT COMPLETED|Overall Study||0||
48629018|NCT01652690|101874552|FG000|STARTED|Overall Study||300||
48629019|NCT01652690|101874553|FG001|STARTED|Overall Study||300||
48629020|NCT01652690|101874552|FG000|COMPLETED|Overall Study||265||
48629021|NCT01652690|101874553|FG001|COMPLETED|Overall Study||279||
48629022|NCT01652690|101874552|FG000|NOT COMPLETED|Overall Study||35||
48335250|NCT02981069|101148396|FG001|STARTED|Acute Portion of Study||25||
48335251|NCT02981069|101148397|FG002|STARTED|Acute Portion of Study||25||
48335252|NCT02981069|101148398|FG003|STARTED|Acute Portion of Study||15||
48629023|NCT01652690|101874553|FG001|NOT COMPLETED|Overall Study||21||
48629024|NCT00427908|101874554|FG000|STARTED|Primary Phase||229||
48629025|NCT00427908|101874555|FG001|STARTED|Primary Phase||231||
48629026|NCT00427908|101874556|FG002|STARTED|Primary Phase||75||
48629027|NCT00427908|101874557|FG003|STARTED|Primary Phase||78||
48629028|NCT00427908|101874554|FG000|COMPLETED|Primary Phase||224||
48629029|NCT00427908|101874555|FG001|COMPLETED|Primary Phase||228||
48629030|NCT00427908|101874556|FG002|COMPLETED|Primary Phase||72||
48629031|NCT00427908|101874557|FG003|COMPLETED|Primary Phase||78||
48629032|NCT00427908|101874554|FG000|NOT COMPLETED|Primary Phase||5||
48629033|NCT00427908|101874555|FG001|NOT COMPLETED|Primary Phase||3||
48629034|NCT00427908|101874556|FG002|NOT COMPLETED|Primary Phase||3||
48629035|NCT00427908|101874557|FG003|NOT COMPLETED|Primary Phase||0||
48629036|NCT00427908|101874554|FG000|STARTED|Persistence Phase Year 1||222||
48629037|NCT00427908|101874555|FG001|STARTED|Persistence Phase Year 1||221||
48335253|NCT02981069|101148395|FG000|COMPLETED|Acute Portion of Study||25||
48335254|NCT02981069|101148396|FG001|COMPLETED|Acute Portion of Study||25||
48335255|NCT02981069|101148397|FG002|COMPLETED|Acute Portion of Study||25||
48335256|NCT02981069|101148398|FG003|COMPLETED|Acute Portion of Study||15||
48335257|NCT02981069|101148395|FG000|NOT COMPLETED|Acute Portion of Study||0||
48335258|NCT02981069|101148396|FG001|NOT COMPLETED|Acute Portion of Study||0||
48335259|NCT02981069|101148397|FG002|NOT COMPLETED|Acute Portion of Study||0||
48412211|NCT01635244|101341956|FG000|NOT COMPLETED|Overall Study||1||
48412212|NCT01635244|101341957|FG001|NOT COMPLETED|Overall Study||1||
48412213|NCT01635244|101341958|FG002|NOT COMPLETED|Overall Study||2||
48412214|NCT01389076|101341959|FG000|STARTED|Overall Study||22||
48412215|NCT01389076|101341959|FG000|COMPLETED|Overall Study||22||
48412216|NCT01389076|101341959|FG000|NOT COMPLETED|Overall Study||0||
48629038|NCT00427908|101874556|FG002|STARTED|Persistence Phase Year 1||71||
48629039|NCT00427908|101874557|FG003|STARTED|Persistence Phase Year 1||78||
48629040|NCT00427908|101874554|FG000|COMPLETED|Persistence Phase Year 1||222||
48629041|NCT00427908|101874555|FG001|COMPLETED|Persistence Phase Year 1||221||
48629042|NCT00427908|101874556|FG002|COMPLETED|Persistence Phase Year 1||71||
48629043|NCT00427908|101874557|FG003|COMPLETED|Persistence Phase Year 1||78||
48629044|NCT00427908|101874554|FG000|NOT COMPLETED|Persistence Phase Year 1||0||
48629045|NCT00427908|101874555|FG001|NOT COMPLETED|Persistence Phase Year 1||0||
48629046|NCT00427908|101874556|FG002|NOT COMPLETED|Persistence Phase Year 1||0||
48629047|NCT00427908|101874557|FG003|NOT COMPLETED|Persistence Phase Year 1||0||
48629048|NCT00427908|101874554|FG000|STARTED|Persistence Phase Year 2||208||
48629049|NCT00427908|101874555|FG001|STARTED|Persistence Phase Year 2||215||
48629050|NCT00427908|101874556|FG002|STARTED|Persistence Phase Year 2||53||
48629051|NCT00427908|101874557|FG003|STARTED|Persistence Phase Year 2||61||
48629052|NCT00427908|101874554|FG000|COMPLETED|Persistence Phase Year 2||208||
48629053|NCT00427908|101874555|FG001|COMPLETED|Persistence Phase Year 2||215||
48335260|NCT02981069|101148398|FG003|NOT COMPLETED|Acute Portion of Study||0||
48412217|NCT03330106|101341960|FG000|STARTED|Part A||22||
48412218|NCT03330106|101341961|FG001|STARTED|Part A||22||
48412219|NCT03330106|101341962|FG002|STARTED|Part A||0||
48412220|NCT03330106|101341963|FG003|STARTED|Part A||0||
48412221|NCT03330106|101341960|FG000|COMPLETED|Part A||18||
48412222|NCT03330106|101341961|FG001|COMPLETED|Part A||17||
48629054|NCT00427908|101874556|FG002|COMPLETED|Persistence Phase Year 2||53||
48629055|NCT00427908|101874557|FG003|COMPLETED|Persistence Phase Year 2||61||
48629056|NCT00427908|101874554|FG000|NOT COMPLETED|Persistence Phase Year 2||0||
48629057|NCT00427908|101874555|FG001|NOT COMPLETED|Persistence Phase Year 2||0||
48629058|NCT00427908|101874556|FG002|NOT COMPLETED|Persistence Phase Year 2||0||
48629059|NCT00427908|101874557|FG003|NOT COMPLETED|Persistence Phase Year 2||0||
48629060|NCT00427908|101874554|FG000|STARTED|Persistence Phase Year 3||185||
48368087|NCT03032068|101230103|FG000|Postoperative Home Care Visit 2|Overall Study||10||
48368088|NCT03032068|101230103|FG000|Postoperative Home Care Visit 3|Overall Study||10||
48412223|NCT03330106|101341962|FG002|COMPLETED|Part A||0||
48412224|NCT03330106|101341963|FG003|COMPLETED|Part A||0||
48412225|NCT03330106|101341960|FG000|NOT COMPLETED|Part A||4||
48412226|NCT03330106|101341961|FG001|NOT COMPLETED|Part A||5||
48412227|NCT03330106|101341962|FG002|NOT COMPLETED|Part A||0||
48412228|NCT03330106|101341963|FG003|NOT COMPLETED|Part A||0||
48412229|NCT03330106|101341960|FG000|STARTED|Part B||0|Participants who completed Part A were randomized in Part B to receive pevonedistat in combination with standard of care agents, either docetaxel or carboplatin+paclitaxel, as recommended by the Investigator.|
48412230|NCT03330106|101341961|FG001|STARTED|Part B||0|Participants who completed Part A were randomized in Part B to receive pevonedistat in combination with standard of care agents, either docetaxel or carboplatin+paclitaxel, as recommended by the Investigator.|
48412231|NCT03330106|101341962|FG002|STARTED|Part B||23|Participants who completed Part A were randomized in Part B to receive pevonedistat in combination with standard of care agents, either docetaxel or carboplatin+paclitaxel, as recommended by the Investigator.|
48412232|NCT03330106|101341963|FG003|STARTED|Part B||12|Participants who completed Part A were randomized in Part B to receive pevonedistat in combination with standard of care agents, either docetaxel or carboplatin+paclitaxel, as recommended by the Investigator.|
48412233|NCT03330106|101341960|FG000|COMPLETED|Part B||0||
48412234|NCT03330106|101341961|FG001|COMPLETED|Part B||0||
48412235|NCT03330106|101341962|FG002|COMPLETED|Part B||5||
48412236|NCT03330106|101341963|FG003|COMPLETED|Part B||4||
48412237|NCT03330106|101341960|FG000|NOT COMPLETED|Part B||0||
48412238|NCT03330106|101341961|FG001|NOT COMPLETED|Part B||0||
48412239|NCT03330106|101341962|FG002|NOT COMPLETED|Part B||18||
48412240|NCT03330106|101341963|FG003|NOT COMPLETED|Part B||8||
48752258|NCT01147666|102180931|FG013|COMPLETED|Dosing Period 1: 6-Week Treatment||3||
48752259|NCT01147666|102180932|FG014|COMPLETED|Dosing Period 1: 6-Week Treatment||0||
48752260|NCT01147666|102180918|FG000|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2||
48752261|NCT01147666|102180919|FG001|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2||
48752262|NCT01147666|102180920|FG002|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||1||
48752263|NCT01147666|102180921|FG003|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2||
48752264|NCT01147666|102180922|FG004|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||5||
48752265|NCT01147666|102180923|FG005|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||3||
48752266|NCT01147666|102180924|FG006|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||3||
48752267|NCT01147666|102180925|FG007|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||3||
48752268|NCT01147666|102180926|FG008|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||0||
48752269|NCT01147666|102180927|FG009|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2||
48412241|NCT04474366|101341964|FG000|STARTED|Overall Study||23||
48412242|NCT04474366|101341965|FG001|STARTED|Overall Study||27||
48412243|NCT04474366|101341964|FG000|COMPLETED|Overall Study||21||
48412244|NCT04474366|101341965|FG001|COMPLETED|Overall Study||22||
48412245|NCT04474366|101341964|FG000|NOT COMPLETED|Overall Study||2||
48412246|NCT04474366|101341965|FG001|NOT COMPLETED|Overall Study||5||
48412247|NCT01355224|101341966|FG000|STARTED|Overall Study||198||
48412248|NCT01355224|101341967|FG001|STARTED|Overall Study||203||
48412249|NCT01355224|101341968|FG002|STARTED|Overall Study||196||
48412250|NCT01355224|101341969|FG003|STARTED|Overall Study||201||
48412251|NCT01355224|101341966|FG000|Competed Baseline|Overall Study||191||
48412252|NCT01355224|101341967|FG001|Competed Baseline|Overall Study||200||
48412253|NCT01355224|101341968|FG002|Competed Baseline|Overall Study||193||
48412254|NCT01355224|101341969|FG003|Competed Baseline|Overall Study||193||
48629061|NCT00427908|101874555|FG001|STARTED|Persistence Phase Year 3||201||
48629062|NCT00427908|101874556|FG002|STARTED|Persistence Phase Year 3||38||
48629063|NCT00427908|101874557|FG003|STARTED|Persistence Phase Year 3||38||
48629064|NCT00427908|101874554|FG000|COMPLETED|Persistence Phase Year 3||185||
48629065|NCT00427908|101874555|FG001|COMPLETED|Persistence Phase Year 3||201||
48629066|NCT00427908|101874556|FG002|COMPLETED|Persistence Phase Year 3||38||
48629067|NCT00427908|101874557|FG003|COMPLETED|Persistence Phase Year 3||38||
48629068|NCT00427908|101874554|FG000|NOT COMPLETED|Persistence Phase Year 3||0||
48629069|NCT00427908|101874555|FG001|NOT COMPLETED|Persistence Phase Year 3||0||
48629070|NCT00427908|101874556|FG002|NOT COMPLETED|Persistence Phase Year 3||0||
48629071|NCT00427908|101874557|FG003|NOT COMPLETED|Persistence Phase Year 3||0||
48629072|NCT00427908|101874554|FG000|STARTED|Persistence Phase Year 4||165||
48629073|NCT00427908|101874555|FG001|STARTED|Persistence Phase Year 4||192||
48629074|NCT00427908|101874556|FG002|STARTED|Persistence Phase Year 4||34||
48629075|NCT00427908|101874557|FG003|STARTED|Persistence Phase Year 4||32||
48629076|NCT00427908|101874554|FG000|COMPLETED|Persistence Phase Year 4||165||
48629077|NCT00427908|101874555|FG001|COMPLETED|Persistence Phase Year 4||192||
48752270|NCT01147666|102180928|FG010|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||3||
48752271|NCT01147666|102180929|FG011|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2||
48752272|NCT01147666|102180930|FG012|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||4||
48752273|NCT01147666|102180931|FG013|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||1||
48752274|NCT01147666|102180932|FG014|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||4||
48752275|NCT01147666|102180918|FG000|STARTED|Dosing Period 2: 19-Week Treatment||0||
48174122|NCT00981825|100749861|FG001|STARTED|Second Intervention||11||
48629078|NCT00427908|101874556|FG002|COMPLETED|Persistence Phase Year 4||34||
48752276|NCT01147666|102180919|FG001|STARTED|Dosing Period 2: 19-Week Treatment||0||
48752277|NCT01147666|102180920|FG002|STARTED|Dosing Period 2: 19-Week Treatment||0||
48752278|NCT01147666|102180921|FG003|STARTED|Dosing Period 2: 19-Week Treatment||7||
48752279|NCT01147666|102180922|FG004|STARTED|Dosing Period 2: 19-Week Treatment||12||
48767730|NCT00494676|102222813|FG001|NOT COMPLETED|First Intervention||3||
48752280|NCT01147666|102180923|FG005|STARTED|Dosing Period 2: 19-Week Treatment||12||
48752281|NCT01147666|102180924|FG006|STARTED|Dosing Period 2: 19-Week Treatment||12||
48752282|NCT01147666|102180925|FG007|STARTED|Dosing Period 2: 19-Week Treatment||12||
48752283|NCT01147666|102180926|FG008|STARTED|Dosing Period 2: 19-Week Treatment||2||
48752284|NCT01147666|102180927|FG009|STARTED|Dosing Period 2: 19-Week Treatment||10||
48752285|NCT01147666|102180928|FG010|STARTED|Dosing Period 2: 19-Week Treatment||23||
48752286|NCT01147666|102180929|FG011|STARTED|Dosing Period 2: 19-Week Treatment||0||
48752287|NCT01147666|102180930|FG012|STARTED|Dosing Period 2: 19-Week Treatment||5||
48752288|NCT01147666|102180931|FG013|STARTED|Dosing Period 2: 19-Week Treatment||3||
48752289|NCT01147666|102180932|FG014|STARTED|Dosing Period 2: 19-Week Treatment||3||
48752290|NCT01147666|102180918|FG000|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||0||
48752291|NCT01147666|102180919|FG001|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||0||
48752292|NCT01147666|102180920|FG002|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||0||
48752293|NCT01147666|102180921|FG003|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||7||
48752294|NCT01147666|102180922|FG004|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||12||
48752295|NCT01147666|102180923|FG005|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||12||
48752296|NCT01147666|102180924|FG006|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||12||
48752297|NCT01147666|102180925|FG007|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||12||
48752298|NCT01147666|102180926|FG008|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||2||
48752299|NCT01147666|102180927|FG009|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||10||
48752300|NCT01147666|102180928|FG010|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||23||
48335261|NCT02981069|101148395|FG000|STARTED|16 Week Drug Administration Period||25|Since subjects are Type 2 diabetics, there was no placebo arm for this portion of the study. Only 3 arms of the study were conducted: (i) Byetta/Bydureon, (ii) Dapagliflozin (iii) Byetta/Bydureon plus Dapagliflozin.|
48335262|NCT02981069|101148396|FG001|STARTED|16 Week Drug Administration Period||25|Since subjects are Type 2 diabetics, there was no placebo arm for this portion of the study. Only 3 arms of the study were conducted: (i) Byetta/Bydureon, (ii) Dapagliflozin (iii) Byetta/Bydureon plus Dapagliflozin.|
48335263|NCT02981069|101148397|FG002|STARTED|16 Week Drug Administration Period||25|Since subjects are Type 2 diabetics, there was no placebo arm for this portion of the study. Only 3 arms of the study were conducted: (i) Byetta/Bydureon, (ii) Dapagliflozin (iii) Byetta/Bydureon plus Dapagliflozin.|
48335264|NCT02981069|101148398|FG003|STARTED|16 Week Drug Administration Period||0|Since subjects are Type 2 diabetics, there was no placebo arm for this portion of the study. Only 3 arms of the study were conducted: (i) Byetta/Bydureon, (ii) Dapagliflozin (iii) Byetta/Bydureon plus Dapagliflozin.|
48335265|NCT02981069|101148395|FG000|COMPLETED|16 Week Drug Administration Period||25||
48335266|NCT02981069|101148396|FG001|COMPLETED|16 Week Drug Administration Period||25||
48335267|NCT02981069|101148397|FG002|COMPLETED|16 Week Drug Administration Period||25||
48335268|NCT02981069|101148398|FG003|COMPLETED|16 Week Drug Administration Period||0||
48335269|NCT02981069|101148395|FG000|NOT COMPLETED|16 Week Drug Administration Period||0||
48335270|NCT02981069|101148396|FG001|NOT COMPLETED|16 Week Drug Administration Period||0||
48335271|NCT02981069|101148397|FG002|NOT COMPLETED|16 Week Drug Administration Period||0||
48335272|NCT02981069|101148398|FG003|NOT COMPLETED|16 Week Drug Administration Period||0||
48335273|NCT01242644|101148399|FG000|STARTED|Overall Study||16||
48335274|NCT01242644|101148400|FG001|STARTED|Overall Study||17||
48335275|NCT01242644|101148401|FG002|STARTED|Overall Study||15||
48335276|NCT01242644|101148399|FG000|COMPLETED|Overall Study||16||
48335277|NCT01242644|101148400|FG001|COMPLETED|Overall Study||17||
48335278|NCT01242644|101148401|FG002|COMPLETED|Overall Study||15||
48335279|NCT01242644|101148399|FG000|NOT COMPLETED|Overall Study||0||
48335280|NCT01242644|101148400|FG001|NOT COMPLETED|Overall Study||0||
48335281|NCT01242644|101148401|FG002|NOT COMPLETED|Overall Study||0||
48335282|NCT00836355|101148402|FG000|STARTED|Overall Study||0||
48335283|NCT00836355|101148403|FG001|STARTED|Overall Study||4||
48335284|NCT00836355|101148404|FG002|STARTED|Overall Study||0||
48335285|NCT00836355|101148405|FG003|STARTED|Overall Study||2||
48335286|NCT00836355|101148402|FG000|COMPLETED|Overall Study||0||
48335287|NCT00836355|101148403|FG001|COMPLETED|Overall Study||4||
48335288|NCT00836355|101148404|FG002|COMPLETED|Overall Study||0||
48335289|NCT00836355|101148405|FG003|COMPLETED|Overall Study||2||
48335290|NCT00836355|101148402|FG000|NOT COMPLETED|Overall Study||0||
48412255|NCT01355224|101341966|FG000|COMPLETED|Overall Study||167||
48412256|NCT01355224|101341967|FG001|COMPLETED|Overall Study||180||
48412257|NCT01355224|101341968|FG002|COMPLETED|Overall Study||177||
48412258|NCT01355224|101341969|FG003|COMPLETED|Overall Study||172||
48752301|NCT01147666|102180929|FG011|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||0||
48752302|NCT01147666|102180930|FG012|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||5||
48752303|NCT01147666|102180931|FG013|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||3||
48752304|NCT01147666|102180932|FG014|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||3||
48752305|NCT01147666|102180918|FG000|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||0|Participants randomized designated to receive 19 weeks of study medication and had received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
48412259|NCT01355224|101341966|FG000|NOT COMPLETED|Overall Study||31||
48752306|NCT01147666|102180919|FG001|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||0|Participants randomized designated to receive 19 weeks of study medication and had received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
48752307|NCT01147666|102180920|FG002|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||0|Participants randomized designated to receive 19 weeks of study medication and had received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
48752308|NCT01147666|102180921|FG003|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||6|Participants randomized designated to receive 19 weeks of study medication and had received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
48752309|NCT01147666|102180922|FG004|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||11|Participants randomized designated to receive 19 weeks of study medication and had received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
48752310|NCT01147666|102180923|FG005|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||11|Participants randomized designated to receive 19 weeks of study medication and had received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
48752311|NCT01147666|102180924|FG006|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||11|Participants randomized designated to receive 19 weeks of study medication and had received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
48752312|NCT01147666|102180925|FG007|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||10|Participants randomized designated to receive 19 weeks of study medication and had received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
48752313|NCT01147666|102180926|FG008|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||2|Participants randomized designated to receive 19 weeks of study medication and had received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
48752314|NCT01147666|102180927|FG009|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||10|Participants randomized designated to receive 19 weeks of study medication and had received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
48752315|NCT01147666|102180928|FG010|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||22|Participants randomized designated to receive 19 weeks of study medication and had received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
48767731|NCT00494676|102222812|FG000|STARTED|Second Intervention||34||
48335291|NCT00836355|101148403|FG001|NOT COMPLETED|Overall Study||0||
48335292|NCT00836355|101148404|FG002|NOT COMPLETED|Overall Study||0||
48335293|NCT00836355|101148405|FG003|NOT COMPLETED|Overall Study||0||
48335294|NCT01445769|101148406|FG000|STARTED|Overall Study||45||
48335295|NCT01445769|101148406|FG000|COMPLETED|Overall Study||37||
48412260|NCT01355224|101341967|FG001|NOT COMPLETED|Overall Study||23||
48335296|NCT01445769|101148406|FG000|NOT COMPLETED|Overall Study||8||
48335297|NCT00632853|101148407|FG000|STARTED|Overall Study||313||
48335298|NCT00632853|101148408|FG001|STARTED|Overall Study||325||
48412261|NCT01355224|101341968|FG002|NOT COMPLETED|Overall Study||19||
48629079|NCT00427908|101874557|FG003|COMPLETED|Persistence Phase Year 4||32||
48629080|NCT00427908|101874554|FG000|NOT COMPLETED|Persistence Phase Year 4||0||
48629081|NCT00427908|101874555|FG001|NOT COMPLETED|Persistence Phase Year 4||0||
48629082|NCT00427908|101874556|FG002|NOT COMPLETED|Persistence Phase Year 4||0||
48629083|NCT00427908|101874557|FG003|NOT COMPLETED|Persistence Phase Year 4||0||
48629084|NCT00427908|101874554|FG000|STARTED|Persistence Phase Year 5||52||
48629085|NCT00427908|101874555|FG001|STARTED|Persistence Phase Year 5||99||
48629086|NCT00427908|101874556|FG002|STARTED|Persistence Phase Year 5||12||
48629087|NCT00427908|101874557|FG003|STARTED|Persistence Phase Year 5||13||
48629088|NCT00427908|101874554|FG000|COMPLETED|Persistence Phase Year 5||52||
48629089|NCT00427908|101874555|FG001|COMPLETED|Persistence Phase Year 5||99||
48629090|NCT00427908|101874556|FG002|COMPLETED|Persistence Phase Year 5||12||
48629091|NCT00427908|101874557|FG003|COMPLETED|Persistence Phase Year 5||13||
48629092|NCT00427908|101874554|FG000|NOT COMPLETED|Persistence Phase Year 5||0||
48629093|NCT00427908|101874555|FG001|NOT COMPLETED|Persistence Phase Year 5||0||
48629094|NCT00427908|101874556|FG002|NOT COMPLETED|Persistence Phase Year 5||0||
48629095|NCT00427908|101874557|FG003|NOT COMPLETED|Persistence Phase Year 5||0||
48629096|NCT03456245|101874558|FG000|STARTED|Overall Study||205||
48629097|NCT03456245|101874558|FG000|COMPLETED|Overall Study||190||
48335299|NCT00632853|101148409|FG002|STARTED|Overall Study||93||
48335300|NCT00632853|101148407|FG000|COMPLETED|Overall Study||313||
48412262|NCT01355224|101341969|FG003|NOT COMPLETED|Overall Study||29||
48412263|NCT02178592|101341970|FG000|STARTED|Randomized Phase (Up to Week 52)||69||
48412264|NCT02178592|101341971|FG001|STARTED|Randomized Phase (Up to Week 52)||44||
48412265|NCT02178592|101341970|FG000|COMPLETED|Randomized Phase (Up to Week 52)||50||
48412266|NCT02178592|101341971|FG001|COMPLETED|Randomized Phase (Up to Week 52)||35||
48629098|NCT03456245|101874558|FG000|NOT COMPLETED|Overall Study||15||
48629099|NCT01774981|101874559|FG000|STARTED|Overall Study||3||
48335301|NCT00632853|101148408|FG001|COMPLETED|Overall Study||325||
48335302|NCT00632853|101148409|FG002|COMPLETED|Overall Study||93||
48335303|NCT00632853|101148407|FG000|NOT COMPLETED|Overall Study||0||
48335304|NCT00632853|101148408|FG001|NOT COMPLETED|Overall Study||0||
48335305|NCT00632853|101148409|FG002|NOT COMPLETED|Overall Study||0||
48335306|NCT02651428|101148410|FG000|STARTED|Overall Study||403||
48335307|NCT02651428|101148411|FG001|STARTED|Overall Study||403||
48335308|NCT02651428|101148410|FG000|COMPLETED|Overall Study||359||
48335309|NCT02651428|101148411|FG001|COMPLETED|Overall Study||359||
48335310|NCT02651428|101148410|FG000|NOT COMPLETED|Overall Study||44||
48335311|NCT02651428|101148411|FG001|NOT COMPLETED|Overall Study||44||
48752316|NCT01147666|102180929|FG011|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||0|Participants randomized designated to receive 19 weeks of study medication and had received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
48752317|NCT01147666|102180930|FG012|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||3|Participants randomized designated to receive 19 weeks of study medication and had received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
48752318|NCT01147666|102180931|FG013|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||3|Participants randomized designated to receive 19 weeks of study medication and had received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
48752319|NCT01147666|102180932|FG014|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||2|Participants randomized designated to receive 19 weeks of study medication and had received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
48752320|NCT01147666|102180918|FG000|COMPLETED|Dosing Period 2: 19-Week Treatment||0||
48752321|NCT01147666|102180919|FG001|COMPLETED|Dosing Period 2: 19-Week Treatment||0||
48752322|NCT01147666|102180920|FG002|COMPLETED|Dosing Period 2: 19-Week Treatment||0||
48752323|NCT01147666|102180921|FG003|COMPLETED|Dosing Period 2: 19-Week Treatment||5||
48752324|NCT01147666|102180922|FG004|COMPLETED|Dosing Period 2: 19-Week Treatment||7||
48335312|NCT00742469|101148412|FG000|STARTED|Overall Study||106||
48335313|NCT00742469|101148413|FG001|STARTED|Overall Study||104||
48335314|NCT00742469|101148412|FG000|COMPLETED|Overall Study||88||
48335315|NCT00742469|101148413|FG001|COMPLETED|Overall Study||69||
48335316|NCT00742469|101148412|FG000|NOT COMPLETED|Overall Study||18||
48335317|NCT00742469|101148413|FG001|NOT COMPLETED|Overall Study||35||
48335318|NCT03118297|101148414|FG000|STARTED|Overall Study||32||
48335319|NCT03118297|101148415|FG001|STARTED|Overall Study||33||
48335320|NCT03118297|101148414|FG000|COMPLETED|Overall Study||32||
48335321|NCT03118297|101148415|FG001|COMPLETED|Overall Study||31||
48335322|NCT03118297|101148414|FG000|NOT COMPLETED|Overall Study||0||
48335323|NCT03118297|101148415|FG001|NOT COMPLETED|Overall Study||2||
48335324|NCT00847587|101148416|FG000|STARTED|Overall Study||35||
48335325|NCT00847587|101148417|FG001|STARTED|Overall Study||34||
48335326|NCT00847587|101148416|FG000|COMPLETED|Overall Study||34||
48335327|NCT00847587|101148417|FG001|COMPLETED|Overall Study||34||
48335328|NCT00847587|101148416|FG000|NOT COMPLETED|Overall Study||1||
48335329|NCT00847587|101148417|FG001|NOT COMPLETED|Overall Study||0||
48335330|NCT03887299|101148418|FG000|STARTED|Overall Study||77||
48335331|NCT03887299|101148419|FG001|STARTED|Overall Study||77||
48335332|NCT03887299|101148418|FG000|COMPLETED|Overall Study||77||
48174123|NCT00981825|100749860|FG000|COMPLETED|Second Intervention||11||
48335333|NCT03887299|101148419|FG001|COMPLETED|Overall Study||77||
48335334|NCT03887299|101148418|FG000|NOT COMPLETED|Overall Study||0||
48335335|NCT03887299|101148419|FG001|NOT COMPLETED|Overall Study||0||
48335336|NCT01327651|101148420|FG000|STARTED|Self-administered Dosing Period||60|Week 6 (Randomization visit)|
48335337|NCT01327651|101148421|FG001|STARTED|Self-administered Dosing Period||59|Week 6 (Randomization visit)|
48335338|NCT01327651|101148422|FG002|STARTED|Self-administered Dosing Period||60|Week 6 (Randomization visit)|
48335339|NCT01327651|101148423|FG003|STARTED|Self-administered Dosing Period||60|Week 6 (Randomization visit)|
48752325|NCT01147666|102180923|FG005|COMPLETED|Dosing Period 2: 19-Week Treatment||9||
48752326|NCT01147666|102180924|FG006|COMPLETED|Dosing Period 2: 19-Week Treatment||9||
48752327|NCT01147666|102180925|FG007|COMPLETED|Dosing Period 2: 19-Week Treatment||9||
48752328|NCT01147666|102180926|FG008|COMPLETED|Dosing Period 2: 19-Week Treatment||2||
48752329|NCT01147666|102180927|FG009|COMPLETED|Dosing Period 2: 19-Week Treatment||8||
48752330|NCT01147666|102180928|FG010|COMPLETED|Dosing Period 2: 19-Week Treatment||21||
48752331|NCT01147666|102180929|FG011|COMPLETED|Dosing Period 2: 19-Week Treatment||0||
48752332|NCT01147666|102180930|FG012|COMPLETED|Dosing Period 2: 19-Week Treatment||1||
48752333|NCT01147666|102180931|FG013|COMPLETED|Dosing Period 2: 19-Week Treatment||2||
48752334|NCT01147666|102180932|FG014|COMPLETED|Dosing Period 2: 19-Week Treatment||0||
48174124|NCT00981825|100749861|FG001|COMPLETED|Second Intervention||11||
48174125|NCT00981825|100749860|FG000|NOT COMPLETED|Second Intervention||0||
48174126|NCT00981825|100749861|FG001|NOT COMPLETED|Second Intervention||0||
48174127|NCT02597933|100749862|FG000|STARTED|Overall Study||290||
48174128|NCT02597933|100749863|FG001|STARTED|Overall Study||290||
48174129|NCT02597933|100749862|FG000|Treated Patients|Overall Study||288||
48174130|NCT02597933|100749863|FG001|Treated Patients|Overall Study||288||
48174131|NCT02597933|100749862|FG000|COMPLETED|Overall Study||252||
48412267|NCT02178592|101341970|FG000|NOT COMPLETED|Randomized Phase (Up to Week 52)||19||
48412268|NCT02178592|101341971|FG001|NOT COMPLETED|Randomized Phase (Up to Week 52)||9||
48629100|NCT01774981|101874560|FG001|STARTED|Overall Study||4||
48629101|NCT01774981|101874561|FG002|STARTED|Overall Study||4||
48629102|NCT01774981|101874562|FG003|STARTED|Overall Study||4||
48412269|NCT02178592|101341970|FG000|STARTED|OLE Phase (Week 52 to Week 252)||47||
48412270|NCT02178592|101341971|FG001|STARTED|OLE Phase (Week 52 to Week 252)||19||
48412271|NCT02178592|101341970|FG000|COMPLETED|OLE Phase (Week 52 to Week 252)||35||
48629103|NCT01774981|101874563|FG004|STARTED|Overall Study||6||
48629104|NCT01774981|101874564|FG005|STARTED|Overall Study||14||
48629105|NCT01774981|101874565|FG006|STARTED|Overall Study||13||
48629106|NCT01774981|101874566|FG007|STARTED|Overall Study||12||
48629107|NCT01774981|101874559|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
48629108|NCT01774981|101874560|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4||
48629109|NCT01774981|101874561|FG002|Received at Least 1 Dose of Study Drug|Overall Study||4||
48629110|NCT01774981|101874562|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4||
48629111|NCT01774981|101874563|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6||
48629112|NCT01774981|101874564|FG005|Received at Least 1 Dose of Study Drug|Overall Study||14||
48629113|NCT01774981|101874565|FG006|Received at Least 1 Dose of Study Drug|Overall Study||13||
48629114|NCT01774981|101874566|FG007|Received at Least 1 Dose of Study Drug|Overall Study||12||
48629115|NCT01774981|101874559|FG000|COMPLETED|Overall Study||3||
48629116|NCT01774981|101874560|FG001|COMPLETED|Overall Study||4||
48629117|NCT01774981|101874561|FG002|COMPLETED|Overall Study||4||
48752335|NCT01147666|102180918|FG000|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0||
48752336|NCT01147666|102180919|FG001|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0||
48752337|NCT01147666|102180920|FG002|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0||
48752338|NCT01147666|102180921|FG003|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||2||
48752339|NCT01147666|102180922|FG004|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||5||
48752340|NCT01147666|102180923|FG005|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||3||
48752341|NCT01147666|102180924|FG006|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||3||
48752342|NCT01147666|102180925|FG007|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||3||
48752343|NCT01147666|102180926|FG008|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0||
48174132|NCT02597933|100749863|FG001|COMPLETED|Overall Study||239||
48174133|NCT02597933|100749862|FG000|NOT COMPLETED|Overall Study||38||
48412272|NCT02178592|101341971|FG001|COMPLETED|OLE Phase (Week 52 to Week 252)||16||
48412273|NCT02178592|101341970|FG000|NOT COMPLETED|OLE Phase (Week 52 to Week 252)||12||
48412274|NCT02178592|101341971|FG001|NOT COMPLETED|OLE Phase (Week 52 to Week 252)||3||
48412275|NCT03427528|101341972|FG000|STARTED|Overall Study||30||
48629118|NCT01774981|101874562|FG003|COMPLETED|Overall Study||4||
48752344|NCT01147666|102180927|FG009|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||2||
48412276|NCT03427528|101341973|FG001|STARTED|Overall Study||30||
48412277|NCT03427528|101341972|FG000|COMPLETED|Overall Study||17||
48629119|NCT01774981|101874563|FG004|COMPLETED|Overall Study||5||
48629120|NCT01774981|101874564|FG005|COMPLETED|Overall Study||13||
48629121|NCT01774981|101874565|FG006|COMPLETED|Overall Study||13||
48752345|NCT01147666|102180928|FG010|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||2||
48752346|NCT01147666|102180929|FG011|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0||
48752347|NCT01147666|102180930|FG012|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||4||
48629122|NCT01774981|101874566|FG007|COMPLETED|Overall Study||11||
48629123|NCT01774981|101874559|FG000|NOT COMPLETED|Overall Study||0||
48629124|NCT01774981|101874560|FG001|NOT COMPLETED|Overall Study||0||
48629125|NCT01774981|101874561|FG002|NOT COMPLETED|Overall Study||0||
48629126|NCT01774981|101874562|FG003|NOT COMPLETED|Overall Study||0||
48629127|NCT01774981|101874563|FG004|NOT COMPLETED|Overall Study||1||
48629128|NCT01774981|101874564|FG005|NOT COMPLETED|Overall Study||1||
48629129|NCT01774981|101874565|FG006|NOT COMPLETED|Overall Study||0||
48629130|NCT01774981|101874566|FG007|NOT COMPLETED|Overall Study||1||
48629131|NCT00141817|101874567|FG000|STARTED|Overall Study||7||
48629132|NCT00141817|101874568|FG001|STARTED|Overall Study||10||
48629133|NCT00141817|101874569|FG002|STARTED|Overall Study||11||
48629134|NCT00141817|101874570|FG003|STARTED|Overall Study||13||
48629135|NCT00141817|101874567|FG000|COMPLETED|Overall Study||6||
48629136|NCT00141817|101874568|FG001|COMPLETED|Overall Study||10||
48629137|NCT00141817|101874569|FG002|COMPLETED|Overall Study||10||
48629138|NCT00141817|101874570|FG003|COMPLETED|Overall Study||13||
48174134|NCT02597933|100749863|FG001|NOT COMPLETED|Overall Study||51||
48174135|NCT01568827|100749864|FG000|STARTED|First Intervention (6 Days)||5||
48174136|NCT01568827|100749865|FG001|STARTED|First Intervention (6 Days)||5||
48629139|NCT00141817|101874567|FG000|NOT COMPLETED|Overall Study||1||
48629140|NCT00141817|101874568|FG001|NOT COMPLETED|Overall Study||0||
48629141|NCT00141817|101874569|FG002|NOT COMPLETED|Overall Study||1||
48629142|NCT00141817|101874570|FG003|NOT COMPLETED|Overall Study||0||
48629143|NCT02834975|101874571|FG000|STARTED|Overall Study||26||
48629144|NCT02834975|101874571|FG000|COMPLETED|Overall Study||21||
48629145|NCT02834975|101874571|FG000|NOT COMPLETED|Overall Study||5||
48174137|NCT01568827|100749864|FG000|COMPLETED|First Intervention (6 Days)||5||
48174138|NCT01568827|100749865|FG001|COMPLETED|First Intervention (6 Days)||5||
48174139|NCT01568827|100749864|FG000|NOT COMPLETED|First Intervention (6 Days)||0||
48174140|NCT01568827|100749865|FG001|NOT COMPLETED|First Intervention (6 Days)||0||
48174141|NCT01568827|100749864|FG000|STARTED|Washout (2 Days)||5||
48174142|NCT01568827|100749865|FG001|STARTED|Washout (2 Days)||5||
48174143|NCT01568827|100749864|FG000|COMPLETED|Washout (2 Days)||5||
48174144|NCT01568827|100749865|FG001|COMPLETED|Washout (2 Days)||5||
48174145|NCT01568827|100749864|FG000|NOT COMPLETED|Washout (2 Days)||0||
48174146|NCT01568827|100749865|FG001|NOT COMPLETED|Washout (2 Days)||0||
48174147|NCT01568827|100749864|FG000|STARTED|Intervention 2 (5 Days)||5||
48174148|NCT01568827|100749865|FG001|STARTED|Intervention 2 (5 Days)||5||
48174149|NCT01568827|100749864|FG000|COMPLETED|Intervention 2 (5 Days)||5||
48412278|NCT03427528|101341973|FG001|COMPLETED|Overall Study||23||
48629146|NCT00447083|101874572|FG000|STARTED|Phase I||10||
48629147|NCT00447083|101874573|FG001|STARTED|Phase I||9||
48629148|NCT00447083|101874574|FG002|STARTED|Phase I||0||
48752348|NCT01147666|102180931|FG013|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||1||
48752349|NCT01147666|102180932|FG014|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||3||
48752350|NCT00883779|102180933|FG000|STARTED|Primary Study Treatment Phase||225||
48752351|NCT00883779|102180934|FG001|STARTED|Primary Study Treatment Phase||226||
48752352|NCT00883779|102180933|FG000|COMPLETED|Primary Study Treatment Phase||120||
48752353|NCT00883779|102180934|FG001|COMPLETED|Primary Study Treatment Phase||140||
48174150|NCT01568827|100749865|FG001|COMPLETED|Intervention 2 (5 Days)||5||
48174151|NCT01568827|100749864|FG000|NOT COMPLETED|Intervention 2 (5 Days)||0||
48174152|NCT01568827|100749865|FG001|NOT COMPLETED|Intervention 2 (5 Days)||0||
48174153|NCT01168674|100749866|FG000|STARTED|Overall Study||25||
48174154|NCT01168674|100749867|FG001|STARTED|Overall Study||24||
48174155|NCT01168674|100749866|FG000|COMPLETED|Overall Study||25||
48174156|NCT01168674|100749867|FG001|COMPLETED|Overall Study||24||
48174157|NCT01168674|100749866|FG000|NOT COMPLETED|Overall Study||0||
48174158|NCT01168674|100749867|FG001|NOT COMPLETED|Overall Study||0||
48412279|NCT03427528|101341972|FG000|NOT COMPLETED|Overall Study||13||
48412280|NCT03427528|101341973|FG001|NOT COMPLETED|Overall Study||7||
48412281|NCT02306148|101341974|FG000|STARTED|Overall Study||61||
48629149|NCT00447083|101874575|FG003|STARTED|Phase I||0||
48629150|NCT00447083|101874572|FG000|COMPLETED|Phase I||10||
48629151|NCT00447083|101874573|FG001|COMPLETED|Phase I||9||
48629152|NCT00447083|101874574|FG002|COMPLETED|Phase I||0||
48629153|NCT00447083|101874575|FG003|COMPLETED|Phase I||0||
48752354|NCT00883779|102180933|FG000|NOT COMPLETED|Primary Study Treatment Phase||105||
48174159|NCT02501759|100749868|FG000|STARTED|Overall Study||2||
48174160|NCT02501759|100749868|FG000|COMPLETED|Overall Study||1||
48629154|NCT00447083|101874572|FG000|NOT COMPLETED|Phase I||0||
48629155|NCT00447083|101874573|FG001|NOT COMPLETED|Phase I||0||
48629156|NCT00447083|101874574|FG002|NOT COMPLETED|Phase I||0||
48629157|NCT00447083|101874575|FG003|NOT COMPLETED|Phase I||0||
48629158|NCT00447083|101874572|FG000|STARTED|Phase II||0||
48174161|NCT02501759|100749868|FG000|NOT COMPLETED|Overall Study||1||
48174162|NCT03204695|100749869|FG000|STARTED|Overall Study||27||
48174163|NCT03204695|100749869|FG000|Treated: Intent-to-treat (ITT) Analysis Set|Overall Study||24||
48174164|NCT03204695|100749869|FG000|COMPLETED|Overall Study||23||
48174165|NCT03204695|100749869|FG000|NOT COMPLETED|Overall Study||4||
48174166|NCT01533714|100749870|FG000|STARTED|Overall Study||10||
48174167|NCT01533714|100749871|FG001|STARTED|Overall Study||15||
48174168|NCT01533714|100749872|FG002|STARTED|Overall Study||11||
48174169|NCT01533714|100749873|FG003|STARTED|Overall Study||15||
48174170|NCT01533714|100749874|FG004|STARTED|Overall Study||28||
48174171|NCT01533714|100749875|FG005|STARTED|Overall Study||24||
48174172|NCT01533714|100749870|FG000|COMPLETED|Overall Study||10||
48174173|NCT01533714|100749871|FG001|COMPLETED|Overall Study||12||
48174174|NCT01533714|100749872|FG002|COMPLETED|Overall Study||7||
48174175|NCT01533714|100749873|FG003|COMPLETED|Overall Study||11||
48174176|NCT01533714|100749874|FG004|COMPLETED|Overall Study||21||
48174177|NCT01533714|100749875|FG005|COMPLETED|Overall Study||21||
48174178|NCT01533714|100749870|FG000|NOT COMPLETED|Overall Study||0||
48174179|NCT01533714|100749871|FG001|NOT COMPLETED|Overall Study||3||
48174180|NCT01533714|100749872|FG002|NOT COMPLETED|Overall Study||4||
48174181|NCT01533714|100749873|FG003|NOT COMPLETED|Overall Study||4||
48174182|NCT01533714|100749874|FG004|NOT COMPLETED|Overall Study||7||
48174183|NCT01533714|100749875|FG005|NOT COMPLETED|Overall Study||3||
48174184|NCT00313911|100749876|FG000|STARTED|Overall Study||1422||
48174185|NCT00313911|100749877|FG001|STARTED|Overall Study||711||
48174186|NCT00313911|100749876|FG000|COMPLETED|Overall Study||1328||
48174187|NCT00313911|100749877|FG001|COMPLETED|Overall Study||670||
48174188|NCT00313911|100749876|FG000|NOT COMPLETED|Overall Study||94||
48174189|NCT00313911|100749877|FG001|NOT COMPLETED|Overall Study||41||
48174190|NCT01003184|100749878|FG000|STARTED|Overall Study||111||
48174191|NCT01003184|100749879|FG001|STARTED|Overall Study||111||
48174192|NCT01003184|100749878|FG000|Full Analysis Set (FAS)|Overall Study||111||
48174193|NCT01003184|100749879|FG001|Full Analysis Set (FAS)|Overall Study||105||
48174194|NCT01003184|100749878|FG000|COMPLETED|Overall Study||92||
48174195|NCT01003184|100749879|FG001|COMPLETED|Overall Study||99||
48174196|NCT01003184|100749878|FG000|NOT COMPLETED|Overall Study||19||
48174197|NCT01003184|100749879|FG001|NOT COMPLETED|Overall Study||12||
48174198|NCT02875561|100749880|FG000|STARTED|Overall Study||19||
48174199|NCT02875561|100749881|FG001|STARTED|Overall Study||28||
48629159|NCT00447083|101874573|FG001|STARTED|Phase II||0||
48629160|NCT00447083|101874574|FG002|STARTED|Phase II||8||
48174200|NCT02875561|100749880|FG000|COMPLETED|Overall Study||19||
48174201|NCT02875561|100749881|FG001|COMPLETED|Overall Study||28||
48174202|NCT02875561|100749880|FG000|NOT COMPLETED|Overall Study||0||
48174203|NCT02875561|100749881|FG001|NOT COMPLETED|Overall Study||0||
48174204|NCT05022602|100749882|FG000|STARTED|Overall Study||38||
48174205|NCT05022602|100749882|FG000|COMPLETED|Overall Study||38||
48174206|NCT05022602|100749882|FG000|NOT COMPLETED|Overall Study||0||
48174207|NCT01582880|100749883|FG000|STARTED|Overall Study||1||
48174208|NCT01582880|100749883|FG000|COMPLETED|Overall Study||1||
48174209|NCT01582880|100749883|FG000|NOT COMPLETED|Overall Study||0||
48174210|NCT02165904|100749884|FG000|STARTED|Overall Study||10||
48174211|NCT02165904|100749884|FG000|COMPLETED|Overall Study||10||
48174212|NCT02165904|100749884|FG000|NOT COMPLETED|Overall Study||0||
48174213|NCT02374593|100749885|FG000|STARTED|Overall Study||24||
48174214|NCT02374593|100749886|FG001|STARTED|Overall Study||44||
48174215|NCT02374593|100749885|FG000|COMPLETED|Overall Study||22||
48174216|NCT02374593|100749886|FG001|COMPLETED|Overall Study||44||
48174217|NCT02374593|100749885|FG000|NOT COMPLETED|Overall Study||2||
48174218|NCT02374593|100749886|FG001|NOT COMPLETED|Overall Study||0||
48174219|NCT00925782|100749887|FG000|STARTED|Pretreatment (Day -30 to Day -3)||12||
48174220|NCT00925782|100749888|FG001|STARTED|Pretreatment (Day -30 to Day -3)||12||
48174221|NCT00925782|100749887|FG000|COMPLETED|Pretreatment (Day -30 to Day -3)||12||
48174222|NCT00925782|100749888|FG001|COMPLETED|Pretreatment (Day -30 to Day -3)||12||
48174223|NCT00925782|100749887|FG000|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0||
48174224|NCT00925782|100749888|FG001|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0||
48174225|NCT00925782|100749887|FG000|STARTED|Study Period (Day -3 to Day 0)||12||
48174226|NCT00925782|100749888|FG001|STARTED|Study Period (Day -3 to Day 0)||12||
48174227|NCT00925782|100749887|FG000|COMPLETED|Study Period (Day -3 to Day 0)||12||
48174228|NCT00925782|100749888|FG001|COMPLETED|Study Period (Day -3 to Day 0)||12||
48174229|NCT00925782|100749887|FG000|NOT COMPLETED|Study Period (Day -3 to Day 0)||0||
48174230|NCT00925782|100749888|FG001|NOT COMPLETED|Study Period (Day -3 to Day 0)||0||
48174231|NCT00925782|100749887|FG000|STARTED|Follow-up(Day +1 to Date of Engraftment)||12||
48174232|NCT00925782|100749888|FG001|STARTED|Follow-up(Day +1 to Date of Engraftment)||12||
48174233|NCT00925782|100749887|FG000|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12||
48174234|NCT00925782|100749888|FG001|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12||
48174235|NCT00925782|100749887|FG000|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0||
48174236|NCT00925782|100749888|FG001|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0||
48629161|NCT00447083|101874575|FG003|STARTED|Phase II||8||
48174237|NCT00363896|100749889|FG000|STARTED|Overall Study||627||
48174238|NCT00363896|100749890|FG001|STARTED|Overall Study||216||
48629162|NCT00447083|101874572|FG000|COMPLETED|Phase II||0||
48629163|NCT00447083|101874573|FG001|COMPLETED|Phase II||0||
48629164|NCT00447083|101874574|FG002|COMPLETED|Phase II||7||
48629165|NCT00447083|101874575|FG003|COMPLETED|Phase II||7||
48629166|NCT00447083|101874572|FG000|NOT COMPLETED|Phase II||0||
48629167|NCT00447083|101874573|FG001|NOT COMPLETED|Phase II||0||
48629168|NCT00447083|101874574|FG002|NOT COMPLETED|Phase II||1||
48629169|NCT00447083|101874575|FG003|NOT COMPLETED|Phase II||1||
48629170|NCT00262119|101874576|FG000|STARTED|Overall Study||385||
48629171|NCT00262119|101874577|FG001|STARTED|Overall Study||398||
48629172|NCT00262119|101874578|FG002|STARTED|Overall Study||383||
48629173|NCT00262119|101874576|FG000|COMPLETED|Overall Study||327||
48629174|NCT00262119|101874577|FG001|COMPLETED|Overall Study||328||
48629175|NCT00262119|101874578|FG002|COMPLETED|Overall Study||325||
48629176|NCT00262119|101874576|FG000|NOT COMPLETED|Overall Study||58||
48629177|NCT00262119|101874577|FG001|NOT COMPLETED|Overall Study||70||
48629178|NCT00262119|101874578|FG002|NOT COMPLETED|Overall Study||58||
48629179|NCT01924533|101874579|FG000|STARTED|Overall Study||263||
48629180|NCT01924533|101874580|FG001|STARTED|Overall Study||262||
48629181|NCT01924533|101874579|FG000|COMPLETED|Overall Study||74||
48629182|NCT01924533|101874580|FG001|COMPLETED|Overall Study||57||
48629183|NCT01924533|101874579|FG000|NOT COMPLETED|Overall Study||189||
48629184|NCT01924533|101874580|FG001|NOT COMPLETED|Overall Study||205||
48629185|NCT02873975|101874581|FG000|STARTED|Overall Study||8||
48629186|NCT02873975|101874582|FG001|STARTED|Overall Study||10||
48335340|NCT01327651|101148424|FG004|STARTED|Self-administered Dosing Period||59|Week 6 (Randomization visit)|
48335341|NCT01327651|101148425|FG005|STARTED|Self-administered Dosing Period||59|Week 6 (Randomization visit)|
48335342|NCT01327651|101148426|FG006|STARTED|Self-administered Dosing Period||59|Week 6 (Randomization visit)|
48335343|NCT01327651|101148427|FG007|STARTED|Self-administered Dosing Period||60|Week 6 (Randomization visit)|
48335344|NCT01327651|101148428|FG008|STARTED|Self-administered Dosing Period||60|Week 6 (Randomization visit)|
48335345|NCT01327651|101148420|FG000|Week 10|Self-administered Dosing Period||59||
48335346|NCT01327651|101148421|FG001|Week 10|Self-administered Dosing Period||58||
48335347|NCT01327651|101148422|FG002|Week 10|Self-administered Dosing Period||60||
48335348|NCT01327651|101148423|FG003|Week 10|Self-administered Dosing Period||60||
48335349|NCT01327651|101148424|FG004|Week 10|Self-administered Dosing Period||59||
48335350|NCT01327651|101148425|FG005|Week 10|Self-administered Dosing Period||59||
48335351|NCT01327651|101148426|FG006|Week 10|Self-administered Dosing Period||57||
48335352|NCT01327651|101148427|FG007|Week 10|Self-administered Dosing Period||57||
48335353|NCT01327651|101148428|FG008|Week 10|Self-administered Dosing Period||56||
48335354|NCT01327651|101148420|FG000|Week 14|Self-administered Dosing Period||59||
48335355|NCT01327651|101148421|FG001|Week 14|Self-administered Dosing Period||55||
48335356|NCT01327651|101148422|FG002|Week 14|Self-administered Dosing Period||57||
48335357|NCT01327651|101148423|FG003|Week 14|Self-administered Dosing Period||60||
48335358|NCT01327651|101148424|FG004|Week 14|Self-administered Dosing Period||58||
48335359|NCT01327651|101148425|FG005|Week 14|Self-administered Dosing Period||59||
48335360|NCT01327651|101148426|FG006|Week 14|Self-administered Dosing Period||54||
48335361|NCT01327651|101148427|FG007|Week 14|Self-administered Dosing Period||51||
48335362|NCT01327651|101148428|FG008|Week 14|Self-administered Dosing Period||54||
48335363|NCT01327651|101148420|FG000|Week 18|Self-administered Dosing Period||57||
48335364|NCT01327651|101148421|FG001|Week 18|Self-administered Dosing Period||56||
48335365|NCT01327651|101148422|FG002|Week 18|Self-administered Dosing Period||56||
48335366|NCT01327651|101148423|FG003|Week 18|Self-administered Dosing Period||60||
48629187|NCT02873975|101874583|FG002|STARTED|Overall Study||9||
48629188|NCT02873975|101874581|FG000|COMPLETED|Overall Study||8||
48629189|NCT02873975|101874582|FG001|COMPLETED|Overall Study||10||
48629190|NCT02873975|101874583|FG002|COMPLETED|Overall Study||9||
48629191|NCT02873975|101874581|FG000|NOT COMPLETED|Overall Study||0||
48629192|NCT02873975|101874582|FG001|NOT COMPLETED|Overall Study||0||
48629193|NCT02873975|101874583|FG002|NOT COMPLETED|Overall Study||0||
48629194|NCT04753034|101874584|FG000|STARTED|Overall Study||31||
48335367|NCT01327651|101148424|FG004|Week 18|Self-administered Dosing Period||57||
48335368|NCT01327651|101148425|FG005|Week 18|Self-administered Dosing Period||59||
48335369|NCT01327651|101148426|FG006|Week 18|Self-administered Dosing Period||53||
48335370|NCT01327651|101148427|FG007|Week 18|Self-administered Dosing Period||49||
48335371|NCT01327651|101148428|FG008|Week 18|Self-administered Dosing Period||53||
48335372|NCT01327651|101148420|FG000|Week 22|Self-administered Dosing Period||59||
48629195|NCT04753034|101874585|FG001|STARTED|Overall Study||32||
48629196|NCT04753034|101874584|FG000|COMPLETED|Overall Study||29||
48629197|NCT04753034|101874585|FG001|COMPLETED|Overall Study||31||
48629198|NCT04753034|101874584|FG000|NOT COMPLETED|Overall Study||2||
48629199|NCT04753034|101874585|FG001|NOT COMPLETED|Overall Study||1||
48629200|NCT01186770|101874586|FG000|STARTED|Overall Study||201||
48629201|NCT01186770|101874587|FG001|STARTED|Overall Study||202||
48629202|NCT01186770|101874588|FG002|STARTED|Overall Study||200||
48629203|NCT01186770|101874589|FG003|STARTED|Overall Study||201||
48752355|NCT00883779|102180934|FG001|NOT COMPLETED|Primary Study Treatment Phase||86||
48752356|NCT00883779|102180933|FG000|STARTED|Post-Study Treatment Phase||112||
48752357|NCT00883779|102180934|FG001|STARTED|Post-Study Treatment Phase||135||
48412282|NCT02306148|101341975|FG001|STARTED|Overall Study||57||
48412283|NCT02306148|101341974|FG000|COMPLETED|Overall Study||48||
48412284|NCT02306148|101341975|FG001|COMPLETED|Overall Study||47||
48412285|NCT02306148|101341974|FG000|NOT COMPLETED|Overall Study||13||
48412286|NCT02306148|101341975|FG001|NOT COMPLETED|Overall Study||10||
48412287|NCT00715949|101341976|FG000|STARTED|Overall Study||120||
48412288|NCT00715949|101341976|FG000|COMPLETED|Overall Study||116||
48412289|NCT00715949|101341976|FG000|NOT COMPLETED|Overall Study||4||
48412290|NCT04490499|101341977|FG000|STARTED|Overall Study||207||
48412291|NCT04490499|101341977|FG000|Vaccinated|Overall Study||205||
48412292|NCT04490499|101341977|FG000|COMPLETED|Overall Study||205||
48412293|NCT04490499|101341977|FG000|NOT COMPLETED|Overall Study||2||
48629204|NCT01186770|101874586|FG000|Intent-to-treat (ITT Population)|Overall Study||201|Received at least 1 dose of study drug|
48629205|NCT01186770|101874587|FG001|Intent-to-treat (ITT Population)|Overall Study||201|Received at least 1 dose of study drug|
48629206|NCT01186770|101874588|FG002|Intent-to-treat (ITT Population)|Overall Study||200|Received at least 1 dose of study drug|
48629207|NCT01186770|101874589|FG003|Intent-to-treat (ITT Population)|Overall Study||201|Received at least 1 dose of study drug|
48629208|NCT01186770|101874586|FG000|COMPLETED|Overall Study||160||
48629209|NCT01186770|101874587|FG001|COMPLETED|Overall Study||156||
48629210|NCT01186770|101874588|FG002|COMPLETED|Overall Study||148||
48752358|NCT00883779|102180933|FG000|COMPLETED|Post-Study Treatment Phase||0||
48752359|NCT00883779|102180934|FG001|COMPLETED|Post-Study Treatment Phase||0||
48752360|NCT00883779|102180933|FG000|NOT COMPLETED|Post-Study Treatment Phase||112||
48752361|NCT00883779|102180934|FG001|NOT COMPLETED|Post-Study Treatment Phase||135||
48174239|NCT00363896|100749889|FG000|COMPLETED|Overall Study||538||
48174240|NCT00363896|100749890|FG001|COMPLETED|Overall Study||169||
48174241|NCT00363896|100749889|FG000|NOT COMPLETED|Overall Study||89||
48174242|NCT00363896|100749890|FG001|NOT COMPLETED|Overall Study||47||
48174243|NCT00556374|100749891|FG000|STARTED|Overall Study||1709||
48174244|NCT00556374|100749892|FG001|STARTED|Overall Study||1711||
48174245|NCT00556374|100749891|FG000|Received Study Drug in the Double-blind Phase|Overall Study||1699||
48174246|NCT00556374|100749892|FG001|Received Study Drug in the Double-blind Phase|Overall Study||1700||
48174247|NCT00556374|100749891|FG000|Continued Into the Open-Label Phase|Overall Study||268||
48174248|NCT00556374|100749892|FG001|Continued Into the Open-Label Phase|Overall Study||3||
48174249|NCT00556374|100749891|FG000|Safety Analysis Set|Overall Study||1690||
48174250|NCT00556374|100749892|FG001|Safety Analysis Set|Overall Study||1709||
48174251|NCT00556374|100749891|FG000|COMPLETED|Overall Study||1242||
48174252|NCT00556374|100749892|FG001|COMPLETED|Overall Study||1362||
48174253|NCT00556374|100749891|FG000|NOT COMPLETED|Overall Study||467||
48174254|NCT00556374|100749892|FG001|NOT COMPLETED|Overall Study||349||
48174255|NCT01404611|100749893|FG000|STARTED|Overall Study||112||
48174256|NCT01404611|100749894|FG001|STARTED|Overall Study||108||
48174257|NCT01404611|100749895|FG002|STARTED|Overall Study||111||
48174258|NCT01404611|100749893|FG000|COMPLETED|Overall Study||104||
48174259|NCT01404611|100749894|FG001|COMPLETED|Overall Study||89||
48174260|NCT01404611|100749895|FG002|COMPLETED|Overall Study||106||
48174261|NCT01404611|100749893|FG000|NOT COMPLETED|Overall Study||8||
48174262|NCT01404611|100749894|FG001|NOT COMPLETED|Overall Study||19||
48412294|NCT00362297|101341978|FG000|STARTED|Treatment 1 (Initial Drug Assignment)||16||
48412295|NCT00362297|101341979|FG001|STARTED|Treatment 1 (Initial Drug Assignment)||15||
48412296|NCT00362297|101341978|FG000|COMPLETED|Treatment 1 (Initial Drug Assignment)||16||
48412297|NCT00362297|101341979|FG001|COMPLETED|Treatment 1 (Initial Drug Assignment)||11||
48412298|NCT00362297|101341978|FG000|NOT COMPLETED|Treatment 1 (Initial Drug Assignment)||0||
48412299|NCT00362297|101341979|FG001|NOT COMPLETED|Treatment 1 (Initial Drug Assignment)||4||
48412300|NCT00362297|101341978|FG000|STARTED|Treatment 2||16||
48412301|NCT00362297|101341979|FG001|STARTED|Treatment 2||11||
48412302|NCT00362297|101341978|FG000|COMPLETED|Treatment 2||16||
48412303|NCT00362297|101341979|FG001|COMPLETED|Treatment 2||11||
48412304|NCT00362297|101341978|FG000|NOT COMPLETED|Treatment 2||0||
48412305|NCT00362297|101341979|FG001|NOT COMPLETED|Treatment 2||0||
48412306|NCT01332851|101341980|FG000|STARTED|Overall Study||124||
48412307|NCT01332851|101341981|FG001|STARTED|Overall Study||123||
48412308|NCT01332851|101341980|FG000|Completed Intervention|Overall Study||107|Intent-to-treat: we attempted to retain all participants, regardless of intervention completion.|
48629211|NCT01186770|101874589|FG003|COMPLETED|Overall Study||143||
48629212|NCT01186770|101874586|FG000|NOT COMPLETED|Overall Study||41||
48629213|NCT01186770|101874587|FG001|NOT COMPLETED|Overall Study||46||
48629214|NCT01186770|101874588|FG002|NOT COMPLETED|Overall Study||52||
48629215|NCT01186770|101874589|FG003|NOT COMPLETED|Overall Study||58||
48629216|NCT01420536|101874590|FG000|STARTED|Period 1 (30 Days)||22||
48174263|NCT01404611|100749895|FG002|NOT COMPLETED|Overall Study||5||
48174264|NCT05593211|100749896|FG000|STARTED|Overall Study||31||
48174265|NCT05593211|100749896|FG000|COMPLETED|Overall Study||30||
48174266|NCT05593211|100749896|FG000|NOT COMPLETED|Overall Study||1||
48752362|NCT00883779|102180933|FG000|STARTED|Off-study Phase||209||
48174267|NCT01053637|100749897|FG000|STARTED|Overall Study||43||
48174268|NCT01053637|100749898|FG001|STARTED|Overall Study||42||
48629217|NCT01420536|101874591|FG001|STARTED|Period 1 (30 Days)||22||
48629218|NCT01420536|101874590|FG000|COMPLETED|Period 1 (30 Days)||19||
48629219|NCT01420536|101874591|FG001|COMPLETED|Period 1 (30 Days)||22||
48174269|NCT01053637|100749897|FG000|COMPLETED|Overall Study||43||
48174270|NCT01053637|100749898|FG001|COMPLETED|Overall Study||42||
48174271|NCT01053637|100749897|FG000|NOT COMPLETED|Overall Study||0||
48174272|NCT01053637|100749898|FG001|NOT COMPLETED|Overall Study||0||
48174273|NCT03056859|100749899|FG000|STARTED|Overall Study||20||
48174274|NCT03056859|100749899|FG000|COMPLETED|Overall Study||20||
48174275|NCT03056859|100749899|FG000|NOT COMPLETED|Overall Study||0||
48174276|NCT02111213|100749900|FG000|STARTED|Overall Study||122||
48174277|NCT02111213|100749901|FG001|STARTED|Overall Study||123||
48174278|NCT02111213|100749900|FG000|COMPLETED|Overall Study||116||
48174279|NCT02111213|100749901|FG001|COMPLETED|Overall Study||117||
48174280|NCT02111213|100749900|FG000|NOT COMPLETED|Overall Study||6||
48174281|NCT02111213|100749901|FG001|NOT COMPLETED|Overall Study||6||
48174282|NCT01003639|100749902|FG000|STARTED|Overall Study||86||
48174283|NCT01003639|100749903|FG001|STARTED|Overall Study||79||
48174284|NCT01003639|100749902|FG000|COMPLETED|Overall Study||69||
48174285|NCT01003639|100749903|FG001|COMPLETED|Overall Study||57||
48174286|NCT01003639|100749902|FG000|NOT COMPLETED|Overall Study||17||
48174287|NCT01003639|100749903|FG001|NOT COMPLETED|Overall Study||22||
48174288|NCT02979626|100749904|FG000|STARTED|Overall Study||313||
48174289|NCT02979626|100749905|FG001|STARTED|Overall Study||98||
48174290|NCT02979626|100749904|FG000|COMPLETED|Overall Study||313||
48174291|NCT02979626|100749905|FG001|COMPLETED|Overall Study||98||
48174292|NCT02979626|100749904|FG000|NOT COMPLETED|Overall Study||0||
48174293|NCT02979626|100749905|FG001|NOT COMPLETED|Overall Study||0||
48174294|NCT00856934|100749906|FG000|STARTED|Overall Study||15||
48174295|NCT00856934|100749907|FG001|STARTED|Overall Study||15||
48174296|NCT00856934|100749908|FG002|STARTED|Overall Study||15||
48174297|NCT00856934|100749906|FG000|COMPLETED|Overall Study||15||
48174298|NCT00856934|100749907|FG001|COMPLETED|Overall Study||15||
48174299|NCT00856934|100749908|FG002|COMPLETED|Overall Study||15||
48174300|NCT00856934|100749906|FG000|NOT COMPLETED|Overall Study||0||
48174301|NCT00856934|100749907|FG001|NOT COMPLETED|Overall Study||0||
48174302|NCT00856934|100749908|FG002|NOT COMPLETED|Overall Study||0||
48629220|NCT01420536|101874590|FG000|NOT COMPLETED|Period 1 (30 Days)||3||
48629221|NCT01420536|101874591|FG001|NOT COMPLETED|Period 1 (30 Days)||0||
48629222|NCT01420536|101874590|FG000|STARTED|Period 2 (30 Days)||19||
48629223|NCT01420536|101874591|FG001|STARTED|Period 2 (30 Days)||22||
48629224|NCT01420536|101874590|FG000|COMPLETED|Period 2 (30 Days)||19||
48629225|NCT01420536|101874591|FG001|COMPLETED|Period 2 (30 Days)||22||
48629226|NCT01420536|101874590|FG000|NOT COMPLETED|Period 2 (30 Days)||0||
48629227|NCT01420536|101874591|FG001|NOT COMPLETED|Period 2 (30 Days)||0||
48629228|NCT00855218|101874592|FG000|STARTED|Overall Study||154||
48629229|NCT00855218|101874593|FG001|STARTED|Overall Study||153||
48629230|NCT00855218|101874592|FG000|Participants Received Treatment|Overall Study||153||
48629231|NCT00855218|101874593|FG001|Participants Received Treatment|Overall Study||151||
48629232|NCT00855218|101874592|FG000|COMPLETED|Overall Study||0||
48629233|NCT00855218|101874593|FG001|COMPLETED|Overall Study||0||
48629234|NCT00855218|101874592|FG000|NOT COMPLETED|Overall Study||154||
48629235|NCT00855218|101874593|FG001|NOT COMPLETED|Overall Study||153||
48174303|NCT04908683|100749909|FG000|STARTED|Overall Study||16817||
48174304|NCT04908683|100749910|FG001|STARTED|Overall Study||8419||
48174305|NCT04908683|100749909|FG000|Randomized and Vaccinated|Overall Study||16709||
48174306|NCT04908683|100749910|FG001|Randomized and Vaccinated|Overall Study||8367||
48174307|NCT04908683|100749909|FG000|COMPLETED|Overall Study||124||
48174308|NCT04908683|100749910|FG001|COMPLETED|Overall Study||59||
48174309|NCT04908683|100749909|FG000|NOT COMPLETED|Overall Study||16693||
48174310|NCT04908683|100749910|FG001|NOT COMPLETED|Overall Study||8360||
48174311|NCT02137538|100749911|FG000|STARTED|Overall Study||39||
48174312|NCT02137538|100749912|FG001|STARTED|Overall Study||40||
48174313|NCT02137538|100749911|FG000|COMPLETED|Overall Study||23||
48174314|NCT02137538|100749912|FG001|COMPLETED|Overall Study||26||
48174315|NCT02137538|100749911|FG000|NOT COMPLETED|Overall Study||16||
48174316|NCT02137538|100749912|FG001|NOT COMPLETED|Overall Study||14||
48174317|NCT02415998|100749913|FG000|STARTED|Overall Study||25||
48174318|NCT02415998|100749913|FG000|COMPLETED|Overall Study||20||
48174319|NCT02415998|100749913|FG000|NOT COMPLETED|Overall Study||5||
48174320|NCT03051659|100749914|FG000|STARTED|Treatment Period||44||
48174321|NCT03051659|100749915|FG001|STARTED|Treatment Period||46||
48174322|NCT03051659|100749914|FG000|COMPLETED|Treatment Period||44||
48174323|NCT03051659|100749915|FG001|COMPLETED|Treatment Period||44||
48174324|NCT03051659|100749914|FG000|NOT COMPLETED|Treatment Period||0||
48174325|NCT03051659|100749915|FG001|NOT COMPLETED|Treatment Period||2||
48174326|NCT03051659|100749914|FG000|STARTED|Survival Follow-up||44||
48174327|NCT03051659|100749915|FG001|STARTED|Survival Follow-up||44||
48174328|NCT03051659|100749914|FG000|COMPLETED|Survival Follow-up||21||
48174329|NCT03051659|100749915|FG001|COMPLETED|Survival Follow-up||22||
48629236|NCT02076100|101874594|FG000|STARTED|Overall Study||3||
48629237|NCT02076100|101874595|FG001|STARTED|Overall Study||3||
48629238|NCT02076100|101874596|FG002|STARTED|Overall Study||3||
48174330|NCT03051659|100749914|FG000|NOT COMPLETED|Survival Follow-up||23||
48174331|NCT03051659|100749915|FG001|NOT COMPLETED|Survival Follow-up||22||
48174332|NCT03765762|100749916|FG000|STARTED|Overall Study||18||
48174333|NCT03765762|100749917|FG001|STARTED|Overall Study||8||
48174334|NCT03765762|100749916|FG000|COMPLETED|Overall Study||18||
48174335|NCT03765762|100749917|FG001|COMPLETED|Overall Study||8||
48174336|NCT03765762|100749916|FG000|NOT COMPLETED|Overall Study||0||
48174337|NCT03765762|100749917|FG001|NOT COMPLETED|Overall Study||0||
48174338|NCT02240589|100749918|FG000|STARTED|Overall Study||5||
48174339|NCT02240589|100749919|FG001|STARTED|Overall Study||6||
48174340|NCT02240589|100749918|FG000|COMPLETED|Overall Study||3||
48174341|NCT02240589|100749919|FG001|COMPLETED|Overall Study||4||
48174342|NCT02240589|100749918|FG000|NOT COMPLETED|Overall Study||2||
48174343|NCT02240589|100749919|FG001|NOT COMPLETED|Overall Study||2||
48174344|NCT01757067|100749920|FG000|STARTED|Overall Study||2|The study was closed due to low enrollment.|
48174345|NCT01757067|100749921|FG001|STARTED|Overall Study||1|The study was closed due to low enrollment.|
48174346|NCT01757067|100749920|FG000|COMPLETED|Overall Study||2|The study was closed due to low enrollment.|
48174347|NCT01757067|100749921|FG001|COMPLETED|Overall Study||1|The study was closed due to low enrollment.|
48174348|NCT01757067|100749920|FG000|NOT COMPLETED|Overall Study||0||
48174349|NCT01757067|100749921|FG001|NOT COMPLETED|Overall Study||0||
48174350|NCT03688711|100749922|FG000|STARTED|Overall Study||34|Randomized|
48629239|NCT02076100|101874597|FG003|STARTED|Overall Study||3||
48629240|NCT02076100|101874598|FG004|STARTED|Overall Study||3||
48629241|NCT02076100|101874599|FG005|STARTED|Overall Study||3||
48174351|NCT03688711|100749923|FG001|STARTED|Overall Study||11|Randomized|
48174352|NCT03688711|100749922|FG000|COMPLETED|Overall Study||34||
48174353|NCT03688711|100749923|FG001|COMPLETED|Overall Study||10||
48174354|NCT03688711|100749922|FG000|NOT COMPLETED|Overall Study||0||
48174355|NCT03688711|100749923|FG001|NOT COMPLETED|Overall Study||1||
48174356|NCT03898180|100749924|FG000|STARTED|Overall Study||245||
48174357|NCT03898180|100749925|FG001|STARTED|Overall Study||242||
48174358|NCT03898180|100749924|FG000|Treated|Overall Study||241||
48174359|NCT03898180|100749925|FG001|Treated|Overall Study||242||
48174360|NCT03898180|100749924|FG000|COMPLETED|Overall Study||0||
48174361|NCT03898180|100749925|FG001|COMPLETED|Overall Study||0||
48174362|NCT03898180|100749924|FG000|NOT COMPLETED|Overall Study||245||
48174363|NCT03898180|100749925|FG001|NOT COMPLETED|Overall Study||242||
48174364|NCT00845871|100749926|FG000|STARTED|Run-in Period||65||
48174365|NCT00845871|100749926|FG000|COMPLETED|Run-in Period||65||
48174366|NCT00845871|100749926|FG000|NOT COMPLETED|Run-in Period||0||
48174367|NCT00845871|100749926|FG000|STARTED|Assessment Period||65||
48174368|NCT00845871|100749926|FG000|COMPLETED|Assessment Period||58||
48174369|NCT00845871|100749926|FG000|NOT COMPLETED|Assessment Period||7||
48174370|NCT01556763|100749927|FG000|STARTED|Overall Study||4||
48174371|NCT01556763|100749928|FG001|STARTED|Overall Study||9||
48174372|NCT01556763|100749929|FG002|STARTED|Overall Study||8||
48174373|NCT01556763|100749927|FG000|COMPLETED|Overall Study||4||
48174374|NCT01556763|100749928|FG001|COMPLETED|Overall Study||8||
48174375|NCT01556763|100749929|FG002|COMPLETED|Overall Study||8||
48174376|NCT01556763|100749927|FG000|NOT COMPLETED|Overall Study||0||
48174377|NCT01556763|100749928|FG001|NOT COMPLETED|Overall Study||1||
48174378|NCT01556763|100749929|FG002|NOT COMPLETED|Overall Study||0||
48174379|NCT04170296|100749930|FG000|STARTED|Overall Study||81||
48174380|NCT04170296|100749931|FG001|STARTED|Overall Study||72||
48174381|NCT04170296|100749930|FG000|COMPLETED|Overall Study||73||
48174382|NCT04170296|100749931|FG001|COMPLETED|Overall Study||68||
48174383|NCT04170296|100749930|FG000|NOT COMPLETED|Overall Study||8||
48174384|NCT04170296|100749931|FG001|NOT COMPLETED|Overall Study||4||
48174385|NCT00839917|100749932|FG000|STARTED|Overall Study||13||
48174386|NCT00839917|100749933|FG001|STARTED|Overall Study||17||
48174387|NCT00839917|100749932|FG000|COMPLETED|Overall Study||12||
48174388|NCT00839917|100749933|FG001|COMPLETED|Overall Study||16||
48174389|NCT00839917|100749932|FG000|NOT COMPLETED|Overall Study||1||
48174390|NCT00839917|100749933|FG001|NOT COMPLETED|Overall Study||1||
48174391|NCT04320615|100749934|FG000|STARTED|Overall Study||144||
48174392|NCT04320615|100749935|FG001|STARTED|Overall Study||294||
48174393|NCT04320615|100749934|FG000|COMPLETED|Overall Study||96||
48174394|NCT04320615|100749935|FG001|COMPLETED|Overall Study||190||
48174395|NCT04320615|100749934|FG000|NOT COMPLETED|Overall Study||48||
48174396|NCT04320615|100749935|FG001|NOT COMPLETED|Overall Study||104||
48174397|NCT02746575|100749936|FG000|STARTED|Overall Study||70||
48174398|NCT02746575|100749936|FG000|COMPLETED|Overall Study||20||
48174399|NCT02746575|100749936|FG000|NOT COMPLETED|Overall Study||50||
48174400|NCT00309608|100749937|FG000|STARTED|Overall Study||71||
48174401|NCT00309608|100749938|FG001|STARTED|Overall Study||65||
48174402|NCT00309608|100749939|FG002|STARTED|Overall Study||66||
48174403|NCT00309608|100749940|FG003|STARTED|Overall Study||66||
48174404|NCT00309608|100749941|FG004|STARTED|Overall Study||65||
48174405|NCT00309608|100749937|FG000|COMPLETED|Overall Study||57||
48174406|NCT00309608|100749938|FG001|COMPLETED|Overall Study||52||
48174407|NCT00309608|100749939|FG002|COMPLETED|Overall Study||56||
48174408|NCT00309608|100749940|FG003|COMPLETED|Overall Study||60||
48174409|NCT00309608|100749941|FG004|COMPLETED|Overall Study||61||
48174410|NCT00309608|100749937|FG000|NOT COMPLETED|Overall Study||14||
48629242|NCT02076100|101874600|FG006|STARTED|Overall Study||4||
48174411|NCT00309608|100749938|FG001|NOT COMPLETED|Overall Study||13||
48174412|NCT00309608|100749939|FG002|NOT COMPLETED|Overall Study||10||
48174413|NCT00309608|100749940|FG003|NOT COMPLETED|Overall Study||6||
48174414|NCT00309608|100749941|FG004|NOT COMPLETED|Overall Study||4||
48174415|NCT01700673|100749942|FG000|STARTED|Overall Study||1||
48174416|NCT01700673|100749943|FG001|STARTED|Overall Study||23||
48174417|NCT01700673|100749944|FG002|STARTED|Overall Study||1||
48174418|NCT01700673|100749942|FG000|COMPLETED|Overall Study||1||
48174419|NCT01700673|100749943|FG001|COMPLETED|Overall Study||17||
48174420|NCT01700673|100749944|FG002|COMPLETED|Overall Study||1||
48174421|NCT01700673|100749942|FG000|NOT COMPLETED|Overall Study||0||
48174422|NCT01700673|100749943|FG001|NOT COMPLETED|Overall Study||6||
48174423|NCT01700673|100749944|FG002|NOT COMPLETED|Overall Study||0||
48174424|NCT03306043|100749945|FG000|STARTED|Overall Study||102||
48174425|NCT03306043|100749945|FG000|COMPLETED|Overall Study||98||
48174426|NCT03306043|100749945|FG000|NOT COMPLETED|Overall Study||4||
48174427|NCT02341456|100749946|FG000|STARTED|Overall Study||7||
48174428|NCT02341456|100749947|FG001|STARTED|Overall Study||6||
48174429|NCT02341456|100749948|FG002|STARTED|Overall Study||6||
48174430|NCT02341456|100749946|FG000|COMPLETED|Overall Study||3||
48174431|NCT02341456|100749947|FG001|COMPLETED|Overall Study||0||
48174432|NCT02341456|100749948|FG002|COMPLETED|Overall Study||2||
48174433|NCT02341456|100749946|FG000|NOT COMPLETED|Overall Study||4||
48174434|NCT02341456|100749947|FG001|NOT COMPLETED|Overall Study||6||
48174435|NCT02341456|100749948|FG002|NOT COMPLETED|Overall Study||4||
48174436|NCT00429494|100749949|FG000|STARTED|Overall Study||59||
48174437|NCT00429494|100749949|FG000|COMPLETED|Overall Study||44||
48174438|NCT00429494|100749949|FG000|NOT COMPLETED|Overall Study||15||
48174439|NCT00552786|100749950|FG000|STARTED|First Intervention||25||
48335373|NCT01327651|101148421|FG001|Week 22|Self-administered Dosing Period||56||
48335374|NCT01327651|101148422|FG002|Week 22|Self-administered Dosing Period||55||
48335375|NCT01327651|101148423|FG003|Week 22|Self-administered Dosing Period||58||
48174440|NCT00552786|100749951|FG001|STARTED|First Intervention||28||
48174441|NCT00552786|100749950|FG000|Medication and Hearing Evaluation|First Intervention||25||
48174442|NCT00552786|100749951|FG001|Medication and Hearing Evaluation|First Intervention||28||
48174443|NCT00552786|100749950|FG000|COMPLETED|First Intervention||25||
48174444|NCT00552786|100749951|FG001|COMPLETED|First Intervention||28||
48174445|NCT00552786|100749950|FG000|NOT COMPLETED|First Intervention||0||
48174446|NCT00552786|100749951|FG001|NOT COMPLETED|First Intervention||0||
48174447|NCT00552786|100749950|FG000|STARTED|Washout Period of 2 Weeks||25||
48174448|NCT00552786|100749951|FG001|STARTED|Washout Period of 2 Weeks||28||
48174449|NCT00552786|100749950|FG000|COMPLETED|Washout Period of 2 Weeks||25||
48174450|NCT00552786|100749951|FG001|COMPLETED|Washout Period of 2 Weeks||28||
48174451|NCT00552786|100749950|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0||
48174452|NCT00552786|100749951|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0||
48174453|NCT00552786|100749950|FG000|STARTED|Second Intervention||25||
48174454|NCT00552786|100749951|FG001|STARTED|Second Intervention||28||
48174455|NCT00552786|100749950|FG000|COMPLETED|Second Intervention||25||
48629243|NCT02076100|101874594|FG000|COMPLETED|Overall Study||3||
48629244|NCT02076100|101874595|FG001|COMPLETED|Overall Study||3||
48174456|NCT00552786|100749951|FG001|COMPLETED|Second Intervention||28||
48335376|NCT01327651|101148424|FG004|Week 22|Self-administered Dosing Period||56||
48335377|NCT01327651|101148425|FG005|Week 22|Self-administered Dosing Period||59||
48335378|NCT01327651|101148426|FG006|Week 22|Self-administered Dosing Period||50||
48629245|NCT02076100|101874596|FG002|COMPLETED|Overall Study||3||
48174457|NCT00552786|100749950|FG000|NOT COMPLETED|Second Intervention||0||
48174458|NCT00552786|100749951|FG001|NOT COMPLETED|Second Intervention||0||
48174459|NCT01216176|100749952|FG000|STARTED|Overall Study||12||
48174460|NCT01216176|100749953|FG001|STARTED|Overall Study||39||
48174461|NCT01216176|100749954|FG002|STARTED|Overall Study||20||
48174462|NCT01216176|100749952|FG000|COMPLETED|Overall Study||12||
48174463|NCT01216176|100749953|FG001|COMPLETED|Overall Study||31||
48174464|NCT01216176|100749954|FG002|COMPLETED|Overall Study||19||
48174465|NCT01216176|100749952|FG000|NOT COMPLETED|Overall Study||0||
48335379|NCT01327651|101148427|FG007|Week 22|Self-administered Dosing Period||50||
48335380|NCT01327651|101148428|FG008|Week 22|Self-administered Dosing Period||51||
48629246|NCT02076100|101874597|FG003|COMPLETED|Overall Study||3||
48174466|NCT01216176|100749953|FG001|NOT COMPLETED|Overall Study||8||
48174467|NCT01216176|100749954|FG002|NOT COMPLETED|Overall Study||1||
48174468|NCT00706784|100749955|FG000|STARTED|Overall Study||3||
48174469|NCT00706784|100749956|FG001|STARTED|Overall Study||3||
48174470|NCT00706784|100749955|FG000|COMPLETED|Overall Study||3||
48174471|NCT00706784|100749956|FG001|COMPLETED|Overall Study||3||
48174472|NCT00706784|100749955|FG000|NOT COMPLETED|Overall Study||0||
48174473|NCT00706784|100749956|FG001|NOT COMPLETED|Overall Study||0||
48174474|NCT01288781|100749957|FG000|STARTED|Overall Study||11||
48629247|NCT02076100|101874598|FG004|COMPLETED|Overall Study||3||
48412309|NCT01332851|101341981|FG001|Completed Intervention|Overall Study||110|Intent-to-treat: we attempted to retain all participants, regardless of intervention completion.|
48412310|NCT01332851|101341980|FG000|Completed Follow up 1|Overall Study||116|Attempted to retain all participants regardless of intervention completion|
48412311|NCT01332851|101341981|FG001|Completed Follow up 1|Overall Study||112|Attempted to retain all participants regardless of intervention completion|
48412312|NCT01332851|101341980|FG000|Completed Follow up 2|Overall Study||111|Attempted to retain all participants regardless of intervention and/or follow up 1 completion|
48412313|NCT01332851|101341981|FG001|Completed Follow up 2|Overall Study||111|Attempted to retain all participants regardless of intervention and/or follow up 1 completion|
48629248|NCT02076100|101874599|FG005|COMPLETED|Overall Study||3||
48629249|NCT02076100|101874600|FG006|COMPLETED|Overall Study||4||
48629250|NCT02076100|101874594|FG000|NOT COMPLETED|Overall Study||0||
48629251|NCT02076100|101874595|FG001|NOT COMPLETED|Overall Study||0||
48629252|NCT02076100|101874596|FG002|NOT COMPLETED|Overall Study||0||
48629253|NCT02076100|101874597|FG003|NOT COMPLETED|Overall Study||0||
48629254|NCT02076100|101874598|FG004|NOT COMPLETED|Overall Study||0||
48629255|NCT02076100|101874599|FG005|NOT COMPLETED|Overall Study||0||
48629256|NCT02076100|101874600|FG006|NOT COMPLETED|Overall Study||0||
48629257|NCT02008526|101874601|FG000|STARTED|Overall Study||94||
48629258|NCT02008526|101874602|FG001|STARTED|Overall Study||99||
48629259|NCT02008526|101874603|FG002|STARTED|Overall Study||93||
48629260|NCT02008526|101874601|FG000|COMPLETED|Overall Study||86||
48629261|NCT02008526|101874602|FG001|COMPLETED|Overall Study||85||
48629262|NCT02008526|101874603|FG002|COMPLETED|Overall Study||84||
48629263|NCT02008526|101874601|FG000|NOT COMPLETED|Overall Study||8||
48629264|NCT02008526|101874602|FG001|NOT COMPLETED|Overall Study||14||
48629265|NCT02008526|101874603|FG002|NOT COMPLETED|Overall Study||9||
48629266|NCT05379920|101874604|FG000|STARTED|Overall Study||17||
48629267|NCT05379920|101874605|FG001|STARTED|Overall Study||15||
48629268|NCT05379920|101874606|FG002|STARTED|Overall Study||15||
48629269|NCT05379920|101874607|FG003|STARTED|Overall Study||13||
48629270|NCT05379920|101874604|FG000|COMPLETED|Overall Study||17||
48629271|NCT05379920|101874605|FG001|COMPLETED|Overall Study||10||
48629272|NCT05379920|101874606|FG002|COMPLETED|Overall Study||15||
48629273|NCT05379920|101874607|FG003|COMPLETED|Overall Study||13||
48629274|NCT05379920|101874604|FG000|NOT COMPLETED|Overall Study||0||
48629275|NCT05379920|101874605|FG001|NOT COMPLETED|Overall Study||5||
48629276|NCT05379920|101874606|FG002|NOT COMPLETED|Overall Study||0||
48629277|NCT05379920|101874607|FG003|NOT COMPLETED|Overall Study||0||
48629278|NCT01020123|101874608|FG000|STARTED|Main Period||93||
48629279|NCT01020123|101874609|FG001|STARTED|Main Period||91||
48629280|NCT01020123|101874610|FG002|STARTED|Main Period||52||
48629281|NCT01020123|101874611|FG003|STARTED|Main Period||40||
48629282|NCT01020123|101874612|FG004|STARTED|Main Period||88||
48629283|NCT01020123|101874613|FG005|STARTED|Main Period||94||
48629284|NCT01020123|101874614|FG006|STARTED|Main Period||72||
48629285|NCT01020123|101874608|FG000|COMPLETED|Main Period||76||
48629286|NCT01020123|101874609|FG001|COMPLETED|Main Period||77||
48629287|NCT01020123|101874610|FG002|COMPLETED|Main Period||44||
48629288|NCT01020123|101874611|FG003|COMPLETED|Main Period||33||
48629289|NCT01020123|101874612|FG004|COMPLETED|Main Period||77||
48629290|NCT01020123|101874613|FG005|COMPLETED|Main Period||83||
48629291|NCT01020123|101874614|FG006|COMPLETED|Main Period||61||
48629292|NCT01020123|101874608|FG000|NOT COMPLETED|Main Period||17||
48629293|NCT01020123|101874609|FG001|NOT COMPLETED|Main Period||14||
48629294|NCT01020123|101874610|FG002|NOT COMPLETED|Main Period||8||
48629295|NCT01020123|101874611|FG003|NOT COMPLETED|Main Period||7||
48629296|NCT01020123|101874612|FG004|NOT COMPLETED|Main Period||11||
48629297|NCT01020123|101874613|FG005|NOT COMPLETED|Main Period||11||
48629298|NCT01020123|101874614|FG006|NOT COMPLETED|Main Period||11||
48629299|NCT01020123|101874608|FG000|STARTED|Extention Period||40||
48629300|NCT01020123|101874609|FG001|STARTED|Extention Period||35||
48629301|NCT01020123|101874610|FG002|STARTED|Extention Period||19||
48629302|NCT01020123|101874611|FG003|STARTED|Extention Period||13||
48629303|NCT01020123|101874612|FG004|STARTED|Extention Period||31||
48412314|NCT01332851|101341980|FG000|Completed Follow up 3|Overall Study||113|Attempted to retain all participants regardless of intervention and/or follow up 1 \& 2 completion|
48412315|NCT01332851|101341981|FG001|Completed Follow up 3|Overall Study||110|Attempted to retain all participants regardless of intervention and/or follow up 1 \& 2 completion|
48412316|NCT01332851|101341980|FG000|COMPLETED|Overall Study||113||
48412317|NCT01332851|101341981|FG001|COMPLETED|Overall Study||110||
48412318|NCT01332851|101341980|FG000|NOT COMPLETED|Overall Study||11||
48629304|NCT01020123|101874613|FG005|STARTED|Extention Period||38||
48629305|NCT01020123|101874614|FG006|STARTED|Extention Period||19||
48629306|NCT01020123|101874608|FG000|COMPLETED|Extention Period||37||
48629307|NCT01020123|101874609|FG001|COMPLETED|Extention Period||33||
48629308|NCT01020123|101874610|FG002|COMPLETED|Extention Period||17||
48629309|NCT01020123|101874611|FG003|COMPLETED|Extention Period||12||
48629310|NCT01020123|101874612|FG004|COMPLETED|Extention Period||31||
48629311|NCT01020123|101874613|FG005|COMPLETED|Extention Period||36||
48629312|NCT01020123|101874614|FG006|COMPLETED|Extention Period||18||
48629313|NCT01020123|101874608|FG000|NOT COMPLETED|Extention Period||3||
48629314|NCT01020123|101874609|FG001|NOT COMPLETED|Extention Period||2||
48629315|NCT01020123|101874610|FG002|NOT COMPLETED|Extention Period||2||
48629316|NCT01020123|101874611|FG003|NOT COMPLETED|Extention Period||1||
48629317|NCT01020123|101874612|FG004|NOT COMPLETED|Extention Period||0||
48629318|NCT01020123|101874613|FG005|NOT COMPLETED|Extention Period||2||
48629319|NCT01020123|101874614|FG006|NOT COMPLETED|Extention Period||1||
48629320|NCT03087058|101874615|FG000|STARTED|Overall Study||14||
48629321|NCT03087058|101874616|FG001|STARTED|Overall Study||9||
48629322|NCT03087058|101874617|FG002|STARTED|Overall Study||0||
48629323|NCT03087058|101874615|FG000|COMPLETED|Overall Study||12||
48629324|NCT03087058|101874616|FG001|COMPLETED|Overall Study||9||
48629325|NCT03087058|101874617|FG002|COMPLETED|Overall Study||0||
48629326|NCT03087058|101874615|FG000|NOT COMPLETED|Overall Study||2||
48629327|NCT03087058|101874616|FG001|NOT COMPLETED|Overall Study||0||
48629328|NCT03087058|101874617|FG002|NOT COMPLETED|Overall Study||0||
48629329|NCT03084237|101874618|FG000|STARTED|Overall Study||325||
48752363|NCT00883779|102180934|FG001|STARTED|Off-study Phase||202||
48752364|NCT00883779|102180933|FG000|COMPLETED|Off-study Phase||0||
48752365|NCT00883779|102180934|FG001|COMPLETED|Off-study Phase||0||
48752366|NCT00883779|102180933|FG000|NOT COMPLETED|Off-study Phase||209||
48752367|NCT00883779|102180934|FG001|NOT COMPLETED|Off-study Phase||202||
48752368|NCT02920892|102180935|FG000|STARTED|Placebo Lead-In Period||110||
48752369|NCT02920892|102180936|FG001|STARTED|Placebo Lead-In Period||0||
48629330|NCT03084237|101874619|FG001|STARTED|Overall Study||327||
48629331|NCT03084237|101874618|FG000|COMPLETED|Overall Study||155||
48629332|NCT03084237|101874619|FG001|COMPLETED|Overall Study||137||
48629333|NCT03084237|101874618|FG000|NOT COMPLETED|Overall Study||170||
48629334|NCT03084237|101874619|FG001|NOT COMPLETED|Overall Study||190||
48629335|NCT02443623|101874620|FG000|STARTED|Overall Study||3032||
48629336|NCT02443623|101874620|FG000|COMPLETED|Overall Study||2788||
48629337|NCT02443623|101874620|FG000|NOT COMPLETED|Overall Study||244||
48629338|NCT02111200|101874621|FG000|STARTED|Overall Study||3||
48629339|NCT02111200|101874622|FG001|STARTED|Overall Study||2||
48629340|NCT02111200|101874623|FG002|STARTED|Overall Study||1||
48629341|NCT02111200|101874624|FG003|STARTED|Overall Study||1||
48629342|NCT02111200|101874621|FG000|COMPLETED|Overall Study||3||
48629343|NCT02111200|101874622|FG001|COMPLETED|Overall Study||2||
48629344|NCT02111200|101874623|FG002|COMPLETED|Overall Study||1||
48629345|NCT02111200|101874624|FG003|COMPLETED|Overall Study||1||
48629346|NCT02111200|101874621|FG000|NOT COMPLETED|Overall Study||0||
48629347|NCT02111200|101874622|FG001|NOT COMPLETED|Overall Study||0||
48629348|NCT02111200|101874623|FG002|NOT COMPLETED|Overall Study||0||
48629349|NCT02111200|101874624|FG003|NOT COMPLETED|Overall Study||0||
48629350|NCT03362944|101874625|FG000|STARTED|First Intervention||8||
48629351|NCT03362944|101874626|FG001|STARTED|First Intervention||8||
48629352|NCT03362944|101874625|FG000|COMPLETED|First Intervention||8||
48629353|NCT03362944|101874626|FG001|COMPLETED|First Intervention||8||
48629354|NCT03362944|101874625|FG000|NOT COMPLETED|First Intervention||0||
48629355|NCT03362944|101874626|FG001|NOT COMPLETED|First Intervention||0||
48629356|NCT03362944|101874625|FG000|STARTED|Single Week Washout Period||8||
48629357|NCT03362944|101874626|FG001|STARTED|Single Week Washout Period||8||
48629358|NCT03362944|101874625|FG000|COMPLETED|Single Week Washout Period||8||
48752370|NCT02920892|102180937|FG002|STARTED|Placebo Lead-In Period||0||
48752371|NCT02920892|102180935|FG000|COMPLETED|Placebo Lead-In Period||99||
48752372|NCT02920892|102180936|FG001|COMPLETED|Placebo Lead-In Period||0||
48752373|NCT02920892|102180937|FG002|COMPLETED|Placebo Lead-In Period||0||
48752374|NCT02920892|102180935|FG000|NOT COMPLETED|Placebo Lead-In Period||11||
48752375|NCT02920892|102180936|FG001|NOT COMPLETED|Placebo Lead-In Period||0||
48752376|NCT02920892|102180937|FG002|NOT COMPLETED|Placebo Lead-In Period||0||
48752377|NCT02920892|102180935|FG000|STARTED|Placebo-Controlled Period||0||
48752378|NCT02920892|102180936|FG001|STARTED|Placebo-Controlled Period||49||
48752379|NCT02920892|102180937|FG002|STARTED|Placebo-Controlled Period||50||
48752380|NCT02920892|102180935|FG000|COMPLETED|Placebo-Controlled Period||0||
48752381|NCT02920892|102180936|FG001|COMPLETED|Placebo-Controlled Period||46||
48629359|NCT03362944|101874626|FG001|COMPLETED|Single Week Washout Period||8||
48629360|NCT03362944|101874625|FG000|NOT COMPLETED|Single Week Washout Period||0||
48629361|NCT03362944|101874626|FG001|NOT COMPLETED|Single Week Washout Period||0||
48629362|NCT03362944|101874625|FG000|STARTED|Second Intervention||8||
48629363|NCT03362944|101874626|FG001|STARTED|Second Intervention||8||
48629364|NCT03362944|101874625|FG000|COMPLETED|Second Intervention||8||
48629365|NCT03362944|101874626|FG001|COMPLETED|Second Intervention||8||
48629366|NCT03362944|101874625|FG000|NOT COMPLETED|Second Intervention||0||
48629367|NCT03362944|101874626|FG001|NOT COMPLETED|Second Intervention||0||
48752382|NCT02920892|102180937|FG002|COMPLETED|Placebo-Controlled Period||43||
48752383|NCT02920892|102180935|FG000|NOT COMPLETED|Placebo-Controlled Period||0||
48752384|NCT02920892|102180936|FG001|NOT COMPLETED|Placebo-Controlled Period||3||
48752385|NCT02920892|102180937|FG002|NOT COMPLETED|Placebo-Controlled Period||7||
48629368|NCT00869414|101874627|FG000|STARTED|Overall Study||0||
48629369|NCT00869414|101874628|FG001|STARTED|Overall Study||0||
48629370|NCT00869414|101874629|FG002|STARTED|Overall Study||0||
48629371|NCT00869414|101874627|FG000|COMPLETED|Overall Study||0||
48629372|NCT00869414|101874628|FG001|COMPLETED|Overall Study||0||
48629373|NCT00869414|101874629|FG002|COMPLETED|Overall Study||0||
48629374|NCT00869414|101874627|FG000|NOT COMPLETED|Overall Study||0||
48629375|NCT00869414|101874628|FG001|NOT COMPLETED|Overall Study||0||
48629376|NCT00869414|101874629|FG002|NOT COMPLETED|Overall Study||0||
48629377|NCT03194334|101874630|FG000|STARTED|0-3 Months||10||
48629378|NCT03194334|101874631|FG001|STARTED|0-3 Months||15||
48629379|NCT03194334|101874632|FG002|STARTED|0-3 Months||15||
48629380|NCT03194334|101874630|FG000|COMPLETED|0-3 Months||10||
48629381|NCT03194334|101874631|FG001|COMPLETED|0-3 Months||15||
48629382|NCT03194334|101874632|FG002|COMPLETED|0-3 Months||14||
48335381|NCT01327651|101148420|FG000|Week 26|Self-administered Dosing Period||58||
48335382|NCT01327651|101148421|FG001|Week 26|Self-administered Dosing Period||56||
48335383|NCT01327651|101148422|FG002|Week 26|Self-administered Dosing Period||53||
48335384|NCT01327651|101148423|FG003|Week 26|Self-administered Dosing Period||57||
48335385|NCT01327651|101148424|FG004|Week 26|Self-administered Dosing Period||56||
48335386|NCT01327651|101148425|FG005|Week 26|Self-administered Dosing Period||58||
48335387|NCT01327651|101148426|FG006|Week 26|Self-administered Dosing Period||50||
48335388|NCT01327651|101148427|FG007|Week 26|Self-administered Dosing Period||51||
48335389|NCT01327651|101148428|FG008|Week 26|Self-administered Dosing Period||49||
48335390|NCT01327651|101148420|FG000|COMPLETED|Self-administered Dosing Period||56|Week 30|
48335391|NCT01327651|101148421|FG001|COMPLETED|Self-administered Dosing Period||56|Week 30|
48335392|NCT01327651|101148422|FG002|COMPLETED|Self-administered Dosing Period||56|Week 30|
48335393|NCT01327651|101148423|FG003|COMPLETED|Self-administered Dosing Period||57|Week 30|
48335394|NCT01327651|101148424|FG004|COMPLETED|Self-administered Dosing Period||56|Week 30|
48335395|NCT01327651|101148425|FG005|COMPLETED|Self-administered Dosing Period||59|Week 30|
48335396|NCT01327651|101148426|FG006|COMPLETED|Self-administered Dosing Period||49|Week 30|
48335397|NCT01327651|101148427|FG007|COMPLETED|Self-administered Dosing Period||50|Week 30|
48335398|NCT01327651|101148428|FG008|COMPLETED|Self-administered Dosing Period||49|Week 30|
48629383|NCT03194334|101874630|FG000|NOT COMPLETED|0-3 Months||0||
48629384|NCT03194334|101874631|FG001|NOT COMPLETED|0-3 Months||0||
48629385|NCT03194334|101874632|FG002|NOT COMPLETED|0-3 Months||1||
48629386|NCT03194334|101874630|FG000|STARTED|3-6 Months||10||
48629387|NCT03194334|101874631|FG001|STARTED|3-6 Months||15||
48629388|NCT03194334|101874632|FG002|STARTED|3-6 Months||14||
48629389|NCT03194334|101874630|FG000|COMPLETED|3-6 Months||10||
48629390|NCT03194334|101874631|FG001|COMPLETED|3-6 Months||15||
48629391|NCT03194334|101874632|FG002|COMPLETED|3-6 Months||14||
48629392|NCT03194334|101874630|FG000|NOT COMPLETED|3-6 Months||0||
48629393|NCT03194334|101874631|FG001|NOT COMPLETED|3-6 Months||0||
48629394|NCT03194334|101874632|FG002|NOT COMPLETED|3-6 Months||0||
48629395|NCT01898403|101878403|FG000|STARTED|Overall Study||50||
48335399|NCT01327651|101148420|FG000|NOT COMPLETED|Self-administered Dosing Period||4||
48335400|NCT01327651|101148421|FG001|NOT COMPLETED|Self-administered Dosing Period||3||
48335401|NCT01327651|101148422|FG002|NOT COMPLETED|Self-administered Dosing Period||4||
48335402|NCT01327651|101148423|FG003|NOT COMPLETED|Self-administered Dosing Period||3||
48335403|NCT01327651|101148424|FG004|NOT COMPLETED|Self-administered Dosing Period||3||
48335404|NCT01327651|101148425|FG005|NOT COMPLETED|Self-administered Dosing Period||0||
48335405|NCT01327651|101148426|FG006|NOT COMPLETED|Self-administered Dosing Period||10||
48335406|NCT01327651|101148427|FG007|NOT COMPLETED|Self-administered Dosing Period||10||
48335407|NCT01327651|101148428|FG008|NOT COMPLETED|Self-administered Dosing Period||11||
48335408|NCT01327651|101148420|FG000|STARTED|Post Study Follow-up||56|Week 30|
48335409|NCT01327651|101148421|FG001|STARTED|Post Study Follow-up||56|Week 30|
48335410|NCT01327651|101148422|FG002|STARTED|Post Study Follow-up||56|Week 30|
48335411|NCT01327651|101148423|FG003|STARTED|Post Study Follow-up||57|Week 30|
48335412|NCT01327651|101148424|FG004|STARTED|Post Study Follow-up||56|Week 30|
48335413|NCT01327651|101148425|FG005|STARTED|Post Study Follow-up||59|Week 30|
48335414|NCT01327651|101148426|FG006|STARTED|Post Study Follow-up||49|Week 30|
48335415|NCT01327651|101148427|FG007|STARTED|Post Study Follow-up||50|Week 30|
48335416|NCT01327651|101148428|FG008|STARTED|Post Study Follow-up||49|Week 30|
48335417|NCT01327651|101148420|FG000|COMPLETED|Post Study Follow-up||56|Week 34|
48335418|NCT01327651|101148421|FG001|COMPLETED|Post Study Follow-up||55|Week 34|
48335419|NCT01327651|101148422|FG002|COMPLETED|Post Study Follow-up||55|Week 34|
48335420|NCT01327651|101148423|FG003|COMPLETED|Post Study Follow-up||57|Week 34|
48335421|NCT01327651|101148424|FG004|COMPLETED|Post Study Follow-up||56|Week 34|
48335422|NCT01327651|101148425|FG005|COMPLETED|Post Study Follow-up||59|Week 34|
48629396|NCT01898403|101878403|FG000|COMPLETED|Overall Study||50||
48629397|NCT01898403|101878403|FG000|NOT COMPLETED|Overall Study||0||
48629398|NCT01535118|101878404|FG000|STARTED|Overall Study||2765||
48629399|NCT01535118|101878404|FG000|COMPLETED|Overall Study||2765||
48629400|NCT01535118|101878404|FG000|NOT COMPLETED|Overall Study||0||
48629401|NCT04539275|101878405|FG000|STARTED|Overall Study||35||
48335423|NCT01327651|101148426|FG006|COMPLETED|Post Study Follow-up||45|Week 34|
48412319|NCT01332851|101341981|FG001|NOT COMPLETED|Overall Study||13||
48629402|NCT04539275|101878406|FG001|STARTED|Overall Study||40||
48629403|NCT04539275|101878405|FG000|Received Study Product|Overall Study||32||
48629404|NCT04539275|101878406|FG001|Received Study Product|Overall Study||40||
48629405|NCT04539275|101878405|FG000|COMPLETED|Overall Study||29||
48629406|NCT04539275|101878406|FG001|COMPLETED|Overall Study||35||
48629407|NCT04539275|101878405|FG000|NOT COMPLETED|Overall Study||6||
48629408|NCT04539275|101878406|FG001|NOT COMPLETED|Overall Study||5||
48629409|NCT02951312|101878407|FG000|STARTED|Study Part 1||6||
48629410|NCT02951312|101878408|FG001|STARTED|Study Part 1||6||
48629411|NCT02951312|101878409|FG002|STARTED|Study Part 1||0||
48629412|NCT02951312|101878410|FG003|STARTED|Study Part 1||0||
48629413|NCT02951312|101878407|FG000|COMPLETED|Study Part 1||6||
48629414|NCT02951312|101878408|FG001|COMPLETED|Study Part 1||6||
48335424|NCT01327651|101148427|FG007|COMPLETED|Post Study Follow-up||49|Week 34|
48335425|NCT01327651|101148428|FG008|COMPLETED|Post Study Follow-up||47|Week 34|
48335426|NCT01327651|101148420|FG000|NOT COMPLETED|Post Study Follow-up||0||
48335427|NCT01327651|101148421|FG001|NOT COMPLETED|Post Study Follow-up||1||
48335428|NCT01327651|101148422|FG002|NOT COMPLETED|Post Study Follow-up||1||
48335429|NCT01327651|101148423|FG003|NOT COMPLETED|Post Study Follow-up||0||
48335430|NCT01327651|101148424|FG004|NOT COMPLETED|Post Study Follow-up||0||
48335431|NCT01327651|101148425|FG005|NOT COMPLETED|Post Study Follow-up||0||
48335432|NCT01327651|101148426|FG006|NOT COMPLETED|Post Study Follow-up||4||
48335433|NCT01327651|101148427|FG007|NOT COMPLETED|Post Study Follow-up||1||
48335434|NCT01327651|101148428|FG008|NOT COMPLETED|Post Study Follow-up||2||
48335435|NCT01289015|101148429|FG000|STARTED|Overall Study||571||
48335436|NCT01289015|101148430|FG001|STARTED|Overall Study||284||
48335437|NCT01289015|101148429|FG000|COMPLETED|Overall Study||472||
48335438|NCT01289015|101148430|FG001|COMPLETED|Overall Study||230||
48629415|NCT02951312|101878409|FG002|COMPLETED|Study Part 1||0||
48629416|NCT02951312|101878410|FG003|COMPLETED|Study Part 1||0||
48629417|NCT02951312|101878407|FG000|NOT COMPLETED|Study Part 1||0||
48629418|NCT02951312|101878408|FG001|NOT COMPLETED|Study Part 1||0||
48629419|NCT02951312|101878409|FG002|NOT COMPLETED|Study Part 1||0||
48629420|NCT02951312|101878410|FG003|NOT COMPLETED|Study Part 1||0||
48752386|NCT02920892|102180935|FG000|STARTED|Open-Label Extension (OLE) Period||0||
48752387|NCT02920892|102180936|FG001|STARTED|Open-Label Extension (OLE) Period||46||
48752388|NCT02920892|102180937|FG002|STARTED|Open-Label Extension (OLE) Period||43||
48752389|NCT02920892|102180935|FG000|COMPLETED|Open-Label Extension (OLE) Period||0||
48752390|NCT02920892|102180936|FG001|COMPLETED|Open-Label Extension (OLE) Period||37||
48752391|NCT02920892|102180937|FG002|COMPLETED|Open-Label Extension (OLE) Period||39||
48335439|NCT01289015|101148429|FG000|NOT COMPLETED|Overall Study||99||
48335440|NCT01289015|101148430|FG001|NOT COMPLETED|Overall Study||54||
48335441|NCT02055404|101148431|FG000|STARTED|Overall Study||3||
48335442|NCT02055404|101148431|FG000|COMPLETED|Overall Study||3||
48335443|NCT02055404|101148431|FG000|NOT COMPLETED|Overall Study||0||
48335444|NCT03261531|101148432|FG000|STARTED|Overall Study||7||
48335445|NCT03261531|101148432|FG000|COMPLETED|Overall Study||3||
48335446|NCT03261531|101148432|FG000|NOT COMPLETED|Overall Study||4||
48335447|NCT01015833|101148433|FG000|STARTED|Overall Study||180||
48335448|NCT01015833|101148434|FG001|STARTED|Overall Study||176||
48335449|NCT01015833|101148433|FG000|COMPLETED|Overall Study||167||
48335450|NCT01015833|101148434|FG001|COMPLETED|Overall Study||171||
48335451|NCT01015833|101148433|FG000|NOT COMPLETED|Overall Study||13||
48335452|NCT01015833|101148434|FG001|NOT COMPLETED|Overall Study||5||
48335453|NCT00440505|101148435|FG000|STARTED|First Intervention||5||
48335454|NCT00440505|101148436|FG001|STARTED|First Intervention||2||
48335455|NCT00440505|101148437|FG002|STARTED|First Intervention||1||
48335456|NCT00440505|101148438|FG003|STARTED|First Intervention||2||
48335457|NCT00440505|101148439|FG004|STARTED|First Intervention||5||
48335458|NCT00440505|101148440|FG005|STARTED|First Intervention||5||
48412320|NCT02010567|101341982|FG000|STARTED|Overall Study||3||
48412321|NCT02010567|101341983|FG001|STARTED|Overall Study||6||
48412322|NCT02010567|101341984|FG002|STARTED|Overall Study||14||
48412323|NCT02010567|101341985|FG003|STARTED|Overall Study||3||
48629421|NCT02951312|101878407|FG000|STARTED|Study Part 2||0||
48629422|NCT02951312|101878408|FG001|STARTED|Study Part 2||0||
48629423|NCT02951312|101878409|FG002|STARTED|Study Part 2||6||
48629424|NCT02951312|101878410|FG003|STARTED|Study Part 2||6||
48629425|NCT02951312|101878407|FG000|COMPLETED|Study Part 2||0||
48629426|NCT02951312|101878408|FG001|COMPLETED|Study Part 2||0||
48752392|NCT02920892|102180935|FG000|NOT COMPLETED|Open-Label Extension (OLE) Period||0||
48752393|NCT02920892|102180936|FG001|NOT COMPLETED|Open-Label Extension (OLE) Period||9||
48752394|NCT02920892|102180937|FG002|NOT COMPLETED|Open-Label Extension (OLE) Period||4||
48752395|NCT03798717|102180938|FG000|STARTED|Overall Study||4||
48752396|NCT03798717|102180939|FG001|STARTED|Overall Study||3||
48629427|NCT02951312|101878409|FG002|COMPLETED|Study Part 2||6||
48629428|NCT02951312|101878410|FG003|COMPLETED|Study Part 2||6||
48629429|NCT02951312|101878407|FG000|NOT COMPLETED|Study Part 2||0||
48752397|NCT03798717|102180940|FG002|STARTED|Overall Study||3||
48335459|NCT00440505|101148435|FG000|COMPLETED|First Intervention||5||
48335460|NCT00440505|101148436|FG001|COMPLETED|First Intervention||2||
48335461|NCT00440505|101148437|FG002|COMPLETED|First Intervention||1||
48335462|NCT00440505|101148438|FG003|COMPLETED|First Intervention||2||
48412324|NCT02010567|101341986|FG004|STARTED|Overall Study||6||
48412325|NCT02010567|101341982|FG000|COMPLETED|Overall Study||3||
48629430|NCT02951312|101878408|FG001|NOT COMPLETED|Study Part 2||0||
48629431|NCT02951312|101878409|FG002|NOT COMPLETED|Study Part 2||0||
48629432|NCT02951312|101878410|FG003|NOT COMPLETED|Study Part 2||0||
48629433|NCT01075048|101878411|FG000|STARTED|Overall Study||9||
48752398|NCT03798717|102180941|FG003|STARTED|Overall Study||4||
48752399|NCT03798717|102180942|FG004|STARTED|Overall Study||3||
48752400|NCT03798717|102180943|FG005|STARTED|Overall Study||3||
48752401|NCT03798717|102180938|FG000|COMPLETED|Overall Study||2||
48752402|NCT03798717|102180939|FG001|COMPLETED|Overall Study||2||
48752403|NCT03798717|102180940|FG002|COMPLETED|Overall Study||2||
48752404|NCT03798717|102180941|FG003|COMPLETED|Overall Study||2||
48752405|NCT03798717|102180942|FG004|COMPLETED|Overall Study||2||
48752406|NCT03798717|102180943|FG005|COMPLETED|Overall Study||2||
48752407|NCT03798717|102180938|FG000|NOT COMPLETED|Overall Study||2||
48629434|NCT01075048|101878412|FG001|STARTED|Overall Study||60||
48629435|NCT01075048|101878413|FG002|STARTED|Overall Study||62||
48629436|NCT01075048|101878411|FG000|Did Not Receive Treatment|Overall Study||0||
48629437|NCT01075048|101878412|FG001|Did Not Receive Treatment|Overall Study||1||
48629438|NCT01075048|101878413|FG002|Did Not Receive Treatment|Overall Study||0||
48629439|NCT01075048|101878411|FG000|COMPLETED|Overall Study||0||
48629440|NCT01075048|101878412|FG001|COMPLETED|Overall Study||0||
48629441|NCT01075048|101878413|FG002|COMPLETED|Overall Study||0||
48629442|NCT01075048|101878411|FG000|NOT COMPLETED|Overall Study||9||
48629443|NCT01075048|101878412|FG001|NOT COMPLETED|Overall Study||60||
48629444|NCT01075048|101878413|FG002|NOT COMPLETED|Overall Study||62||
48629445|NCT04919317|101878414|FG000|STARTED|Hospitalization and Wound Follow-up||26||
48629446|NCT04919317|101878415|FG001|STARTED|Hospitalization and Wound Follow-up||30||
48629447|NCT04919317|101878414|FG000|COMPLETED|Hospitalization and Wound Follow-up||26||
48752408|NCT03798717|102180939|FG001|NOT COMPLETED|Overall Study||1||
48335463|NCT00440505|101148439|FG004|COMPLETED|First Intervention||5||
48335464|NCT00440505|101148440|FG005|COMPLETED|First Intervention||5||
48335465|NCT00440505|101148435|FG000|NOT COMPLETED|First Intervention||0||
48335466|NCT00440505|101148436|FG001|NOT COMPLETED|First Intervention||0||
48335467|NCT00440505|101148437|FG002|NOT COMPLETED|First Intervention||0||
48335468|NCT00440505|101148438|FG003|NOT COMPLETED|First Intervention||0||
48335469|NCT00440505|101148439|FG004|NOT COMPLETED|First Intervention||0||
48335470|NCT00440505|101148440|FG005|NOT COMPLETED|First Intervention||0||
48629448|NCT04919317|101878415|FG001|COMPLETED|Hospitalization and Wound Follow-up||25||
48752409|NCT03798717|102180940|FG002|NOT COMPLETED|Overall Study||1||
48752410|NCT03798717|102180941|FG003|NOT COMPLETED|Overall Study||2||
48335471|NCT00440505|101148435|FG000|STARTED|Second Intervention||5||
48335472|NCT00440505|101148436|FG001|STARTED|Second Intervention||2||
48335473|NCT00440505|101148437|FG002|STARTED|Second Intervention||1||
48335474|NCT00440505|101148438|FG003|STARTED|Second Intervention||2||
48335475|NCT00440505|101148439|FG004|STARTED|Second Intervention||5||
48335476|NCT00440505|101148440|FG005|STARTED|Second Intervention||5||
48335477|NCT00440505|101148435|FG000|COMPLETED|Second Intervention||5||
48335478|NCT00440505|101148436|FG001|COMPLETED|Second Intervention||2||
48335479|NCT00440505|101148437|FG002|COMPLETED|Second Intervention||1||
48335480|NCT00440505|101148438|FG003|COMPLETED|Second Intervention||2||
48335481|NCT00440505|101148439|FG004|COMPLETED|Second Intervention||5||
48335482|NCT00440505|101148440|FG005|COMPLETED|Second Intervention||5||
48335483|NCT00440505|101148435|FG000|NOT COMPLETED|Second Intervention||0||
48335484|NCT00440505|101148436|FG001|NOT COMPLETED|Second Intervention||0||
48335485|NCT00440505|101148437|FG002|NOT COMPLETED|Second Intervention||0||
48335486|NCT00440505|101148438|FG003|NOT COMPLETED|Second Intervention||0||
48335487|NCT00440505|101148439|FG004|NOT COMPLETED|Second Intervention||0||
48335488|NCT00440505|101148440|FG005|NOT COMPLETED|Second Intervention||0||
48335489|NCT00440505|101148435|FG000|STARTED|Third Intervention||5||
48335490|NCT00440505|101148436|FG001|STARTED|Third Intervention||2||
48335491|NCT00440505|101148437|FG002|STARTED|Third Intervention||1||
48335492|NCT00440505|101148438|FG003|STARTED|Third Intervention||2||
48752411|NCT03798717|102180942|FG004|NOT COMPLETED|Overall Study||1||
48335493|NCT00440505|101148439|FG004|STARTED|Third Intervention||5||
48335494|NCT00440505|101148440|FG005|STARTED|Third Intervention||5||
48335495|NCT00440505|101148435|FG000|COMPLETED|Third Intervention||5||
48335496|NCT00440505|101148436|FG001|COMPLETED|Third Intervention||2||
48752412|NCT03798717|102180943|FG005|NOT COMPLETED|Overall Study||1||
48335497|NCT00440505|101148437|FG002|COMPLETED|Third Intervention||1||
48335498|NCT00440505|101148438|FG003|COMPLETED|Third Intervention||1||
48335499|NCT00440505|101148439|FG004|COMPLETED|Third Intervention||5||
48335500|NCT00440505|101148440|FG005|COMPLETED|Third Intervention||5||
48335501|NCT00440505|101148435|FG000|NOT COMPLETED|Third Intervention||0||
48335502|NCT00440505|101148436|FG001|NOT COMPLETED|Third Intervention||0||
48335503|NCT00440505|101148437|FG002|NOT COMPLETED|Third Intervention||0||
48629449|NCT04919317|101878414|FG000|NOT COMPLETED|Hospitalization and Wound Follow-up||0||
48629450|NCT04919317|101878415|FG001|NOT COMPLETED|Hospitalization and Wound Follow-up||5||
48629451|NCT04919317|101878414|FG000|STARTED|SF-36 Quality of Life Survey Completion||26||
48752413|NCT03186209|102180944|FG000|STARTED|Overall Study||348|All Participants Randomized|
48752414|NCT03186209|102180945|FG001|STARTED|Overall Study||347|All Participants Randomized|
48752415|NCT03186209|102180944|FG000|Dosed|Overall Study||348|Full Analysis Set|
48335504|NCT00440505|101148438|FG003|NOT COMPLETED|Third Intervention||1||
48335505|NCT00440505|101148439|FG004|NOT COMPLETED|Third Intervention||0||
48335506|NCT00440505|101148440|FG005|NOT COMPLETED|Third Intervention||0||
48335507|NCT01276236|101148441|FG000|STARTED|Overall Study||13||
48412326|NCT02010567|101341983|FG001|COMPLETED|Overall Study||6||
48412327|NCT02010567|101341984|FG002|COMPLETED|Overall Study||13||
48752416|NCT03186209|102180945|FG001|Dosed|Overall Study||347|Full Analysis Set|
48752417|NCT03186209|102180944|FG000|COMPLETED|Overall Study||331|study|
48752418|NCT03186209|102180945|FG001|COMPLETED|Overall Study||321|study|
48752419|NCT03186209|102180944|FG000|NOT COMPLETED|Overall Study||17||
48412328|NCT02010567|101341985|FG003|COMPLETED|Overall Study||3||
48412329|NCT02010567|101341986|FG004|COMPLETED|Overall Study||5||
48412330|NCT02010567|101341982|FG000|NOT COMPLETED|Overall Study||0||
48412331|NCT02010567|101341983|FG001|NOT COMPLETED|Overall Study||0||
48752420|NCT03186209|102180945|FG001|NOT COMPLETED|Overall Study||26||
48752421|NCT03605667|102180946|FG000|STARTED|Randomization Phase (Weeks 1 Through 48)||178||
48752422|NCT03605667|102180947|FG001|STARTED|Randomization Phase (Weeks 1 Through 48)||172||
48752423|NCT03605667|102180946|FG000|COMPLETED|Randomization Phase (Weeks 1 Through 48)||130||
48752424|NCT03605667|102180947|FG001|COMPLETED|Randomization Phase (Weeks 1 Through 48)||133||
48752425|NCT03605667|102180946|FG000|NOT COMPLETED|Randomization Phase (Weeks 1 Through 48)||48||
48752426|NCT03605667|102180947|FG001|NOT COMPLETED|Randomization Phase (Weeks 1 Through 48)||39||
48752427|NCT03605667|102180946|FG000|STARTED|OLE Phase (48 Weeks)||90||
48752428|NCT03605667|102180947|FG001|STARTED|OLE Phase (48 Weeks)||104||
48752429|NCT03605667|102180946|FG000|COMPLETED|OLE Phase (48 Weeks)||35||
48752430|NCT03605667|102180947|FG001|COMPLETED|OLE Phase (48 Weeks)||24||
48752431|NCT03605667|102180946|FG000|NOT COMPLETED|OLE Phase (48 Weeks)||55||
48752432|NCT03605667|102180947|FG001|NOT COMPLETED|OLE Phase (48 Weeks)||80||
48752433|NCT02119871|102180948|FG000|STARTED|Overall Study||10||
48752434|NCT02119871|102180949|FG001|STARTED|Overall Study||10||
48752435|NCT02119871|102180948|FG000|COMPLETED|Overall Study||10||
48752436|NCT02119871|102180949|FG001|COMPLETED|Overall Study||10||
48752437|NCT02119871|102180948|FG000|NOT COMPLETED|Overall Study||0||
48752438|NCT02119871|102180949|FG001|NOT COMPLETED|Overall Study||0||
48752439|NCT03679975|102180950|FG000|STARTED|Overall Study||9||
48752440|NCT03679975|102180950|FG000|COMPLETED|Overall Study||9||
48752441|NCT03679975|102180950|FG000|NOT COMPLETED|Overall Study||0||
48752442|NCT00960375|102180951|FG000|STARTED|Overall Study||92||
48752443|NCT00960375|102180952|FG001|STARTED|Overall Study||87||
48752444|NCT00960375|102180951|FG000|COMPLETED|Overall Study||72||
48752445|NCT00960375|102180952|FG001|COMPLETED|Overall Study||65||
48752446|NCT00960375|102180951|FG000|NOT COMPLETED|Overall Study||20||
48752447|NCT00960375|102180952|FG001|NOT COMPLETED|Overall Study||22||
48752448|NCT02527681|102180953|FG000|STARTED|Overall Study||15||
48752449|NCT02527681|102180953|FG000|COMPLETED|Overall Study||15||
48752450|NCT02527681|102180953|FG000|NOT COMPLETED|Overall Study||0||
48752451|NCT00321789|102180954|FG000|STARTED|Overall Study||127||
48752452|NCT00321789|102180955|FG001|STARTED|Overall Study||128||
48752453|NCT00321789|102180954|FG000|COMPLETED|Overall Study||112||
48752454|NCT00321789|102180955|FG001|COMPLETED|Overall Study||112||
48752455|NCT00321789|102180954|FG000|NOT COMPLETED|Overall Study||15||
48752456|NCT00321789|102180955|FG001|NOT COMPLETED|Overall Study||16||
48752457|NCT01838317|102180956|FG000|STARTED|Overall Study||9||
48752458|NCT01838317|102180957|FG001|STARTED|Overall Study||5||
48752459|NCT01838317|102180956|FG000|COMPLETED|Overall Study||9||
48752460|NCT01838317|102180957|FG001|COMPLETED|Overall Study||5||
48752461|NCT01838317|102180956|FG000|NOT COMPLETED|Overall Study||0||
48752462|NCT01838317|102180957|FG001|NOT COMPLETED|Overall Study||0||
48752463|NCT00419393|102180958|FG000|STARTED|Overall Study||190||
48752464|NCT00419393|102180958|FG000|COMPLETED|Overall Study||166||
48752465|NCT00419393|102180958|FG000|NOT COMPLETED|Overall Study||24||
48752466|NCT01506271|102180959|FG000|STARTED|Overall Study||118||
48752467|NCT01506271|102180960|FG001|STARTED|Overall Study||116||
48752468|NCT01506271|102180961|FG002|STARTED|Overall Study||117||
48752469|NCT01506271|102180959|FG000|Treated|Overall Study||117||
48752470|NCT01506271|102180960|FG001|Treated|Overall Study||116||
48752471|NCT01506271|102180961|FG002|Treated|Overall Study||114||
48752472|NCT01506271|102180959|FG000|COMPLETED|Overall Study||114||
48752473|NCT01506271|102180960|FG001|COMPLETED|Overall Study||109||
48412332|NCT02010567|101341984|FG002|NOT COMPLETED|Overall Study||1||
48752474|NCT01506271|102180961|FG002|COMPLETED|Overall Study||114||
48752475|NCT01506271|102180959|FG000|NOT COMPLETED|Overall Study||4||
48752476|NCT01506271|102180960|FG001|NOT COMPLETED|Overall Study||7||
48752477|NCT01506271|102180961|FG002|NOT COMPLETED|Overall Study||3||
48752478|NCT00214045|102180962|FG000|STARTED|Overall Study||18||
48752479|NCT00214045|102180963|FG001|STARTED|Overall Study||18||
48752480|NCT00214045|102180962|FG000|COMPLETED|Overall Study||18||
48752481|NCT00214045|102180963|FG001|COMPLETED|Overall Study||18||
48752482|NCT00214045|102180962|FG000|NOT COMPLETED|Overall Study||0||
48752483|NCT00214045|102180963|FG001|NOT COMPLETED|Overall Study||0||
48752484|NCT00657046|102180964|FG000|STARTED|Overall Study||30||
48752485|NCT00657046|102180965|FG001|STARTED|Overall Study||32||
48752486|NCT00657046|102180966|FG002|STARTED|Overall Study||23||
48752487|NCT00657046|102180964|FG000|Had at Least 1 Post Baseline Visit|Overall Study||30||
48412333|NCT02010567|101341985|FG003|NOT COMPLETED|Overall Study||0||
48412334|NCT02010567|101341986|FG004|NOT COMPLETED|Overall Study||1||
48412335|NCT00381706|101341987|FG000|STARTED|Overall Study||82||
48412336|NCT00381706|101341988|FG001|STARTED|Overall Study||83||
48412337|NCT00381706|101341989|FG002|STARTED|Overall Study||80||
48412338|NCT00381706|101341987|FG000|COMPLETED|Overall Study||75||
48412339|NCT00381706|101341988|FG001|COMPLETED|Overall Study||81||
48412340|NCT00381706|101341989|FG002|COMPLETED|Overall Study||79||
48629452|NCT04919317|101878415|FG001|STARTED|SF-36 Quality of Life Survey Completion||25||
48629453|NCT04919317|101878414|FG000|COMPLETED|SF-36 Quality of Life Survey Completion||14||
48752488|NCT00657046|102180965|FG001|Had at Least 1 Post Baseline Visit|Overall Study||31||
48752489|NCT00657046|102180966|FG002|Had at Least 1 Post Baseline Visit|Overall Study||23||
48752490|NCT00657046|102180964|FG000|Had Visits up to Visit 18|Overall Study||28||
48629454|NCT04919317|101878415|FG001|COMPLETED|SF-36 Quality of Life Survey Completion||19||
48629455|NCT04919317|101878414|FG000|NOT COMPLETED|SF-36 Quality of Life Survey Completion||12||
48629456|NCT04919317|101878415|FG001|NOT COMPLETED|SF-36 Quality of Life Survey Completion||6||
48752491|NCT00657046|102180965|FG001|Had Visits up to Visit 18|Overall Study||30||
48752492|NCT00657046|102180966|FG002|Had Visits up to Visit 18|Overall Study||23||
48752493|NCT00657046|102180964|FG000|COMPLETED|Overall Study||26||
48629457|NCT04006145|101878416|FG000|STARTED|Overall Study||23||
48629458|NCT04006145|101878417|FG001|STARTED|Overall Study||24||
48629459|NCT04006145|101878416|FG000|Received Treatment|Overall Study||23||
48629460|NCT04006145|101878417|FG001|Received Treatment|Overall Study||24||
48629461|NCT04006145|101878416|FG000|COMPLETED|Overall Study||22||
48752494|NCT00657046|102180965|FG001|COMPLETED|Overall Study||29||
48752495|NCT00657046|102180966|FG002|COMPLETED|Overall Study||21||
48752496|NCT00657046|102180964|FG000|NOT COMPLETED|Overall Study||4||
48335508|NCT01276236|101148441|FG000|Week 36 Visit|Overall Study||13||
48335509|NCT01276236|101148441|FG000|Week 56 Visit|Overall Study||9||
48335510|NCT01276236|101148441|FG000|Week 76 Visit|Overall Study||8||
48335511|NCT01276236|101148441|FG000|COMPLETED|Overall Study||7||
48335512|NCT01276236|101148441|FG000|NOT COMPLETED|Overall Study||6||
48335513|NCT00699348|101148442|FG000|STARTED|Overall Study||351||
48335514|NCT00699348|101148442|FG000|COMPLETED|Overall Study||261||
48335515|NCT00699348|101148442|FG000|NOT COMPLETED|Overall Study||90||
48412341|NCT00381706|101341987|FG000|NOT COMPLETED|Overall Study||7||
48412342|NCT00381706|101341988|FG001|NOT COMPLETED|Overall Study||2||
48412343|NCT00381706|101341989|FG002|NOT COMPLETED|Overall Study||1||
48412344|NCT00088595|101341990|FG000|STARTED|Overall Study||45||
48752497|NCT00657046|102180965|FG001|NOT COMPLETED|Overall Study||3||
48335516|NCT01228903|101148443|FG000|STARTED|Overall Study||41||
48412345|NCT00088595|101341990|FG000|COMPLETED|Overall Study||17||
48412346|NCT00088595|101341990|FG000|NOT COMPLETED|Overall Study||28||
48412347|NCT02545049|101341991|FG000|STARTED|Overall Study||3723|Randomized|
48412348|NCT02545049|101341992|FG001|STARTED|Overall Study||3714|Randomized|
48439935|NCT01279265|101409987|FG001|COMPLETED|Overall Study||11||
48629462|NCT04006145|101878417|FG001|COMPLETED|Overall Study||21||
48629463|NCT04006145|101878416|FG000|NOT COMPLETED|Overall Study||1||
48752498|NCT00657046|102180966|FG002|NOT COMPLETED|Overall Study||2||
48752499|NCT00614575|102180967|FG000|STARTED|Overall Study||1089||
48752500|NCT00614575|102180967|FG000|COMPLETED|Overall Study||861||
48752501|NCT00614575|102180967|FG000|NOT COMPLETED|Overall Study||228||
48174475|NCT01288781|100749958|FG001|STARTED|Overall Study||12||
48174476|NCT01288781|100749957|FG000|COMPLETED|Overall Study||11||
48335517|NCT01228903|101148444|FG001|STARTED|Overall Study||39||
48335518|NCT01228903|101148443|FG000|COMPLETED|Overall Study||36||
48335519|NCT01228903|101148444|FG001|COMPLETED|Overall Study||34||
48335520|NCT01228903|101148443|FG000|NOT COMPLETED|Overall Study||5||
48629464|NCT04006145|101878417|FG001|NOT COMPLETED|Overall Study||3||
48629465|NCT00001566|101878418|FG000|STARTED|Overall Study||42||
48629466|NCT00001566|101878418|FG000|Completed Immunotherapy|Overall Study||23||
48629467|NCT00001566|101878418|FG000|COMPLETED|Overall Study||23||
48629468|NCT00001566|101878418|FG000|NOT COMPLETED|Overall Study||19||
48629469|NCT00297167|101878419|FG000|STARTED|First Double-blind Intervention Period||17||
48629470|NCT00297167|101878420|FG001|STARTED|First Double-blind Intervention Period||16||
48629471|NCT00297167|101878421|FG002|STARTED|First Double-blind Intervention Period||0||
48629472|NCT00297167|101878419|FG000|COMPLETED|First Double-blind Intervention Period||17||
48629473|NCT00297167|101878420|FG001|COMPLETED|First Double-blind Intervention Period||16||
48629474|NCT00297167|101878421|FG002|COMPLETED|First Double-blind Intervention Period||0||
48629475|NCT00297167|101878419|FG000|NOT COMPLETED|First Double-blind Intervention Period||0||
48629476|NCT00297167|101878420|FG001|NOT COMPLETED|First Double-blind Intervention Period||0||
48629477|NCT00297167|101878421|FG002|NOT COMPLETED|First Double-blind Intervention Period||0||
48629478|NCT00297167|101878419|FG000|STARTED|Open-label Dose Normalization Period 1||0||
48629479|NCT00297167|101878420|FG001|STARTED|Open-label Dose Normalization Period 1||0||
48629480|NCT00297167|101878421|FG002|STARTED|Open-label Dose Normalization Period 1||33||
48629481|NCT00297167|101878419|FG000|COMPLETED|Open-label Dose Normalization Period 1||0||
48629482|NCT00297167|101878420|FG001|COMPLETED|Open-label Dose Normalization Period 1||0||
48629483|NCT00297167|101878421|FG002|COMPLETED|Open-label Dose Normalization Period 1||32||
48629484|NCT00297167|101878419|FG000|NOT COMPLETED|Open-label Dose Normalization Period 1||0||
48629485|NCT00297167|101878420|FG001|NOT COMPLETED|Open-label Dose Normalization Period 1||0||
48629486|NCT00297167|101878421|FG002|NOT COMPLETED|Open-label Dose Normalization Period 1||1||
48629487|NCT00297167|101878419|FG000|STARTED|Second Double-blind Intervention Period||17||
48629488|NCT00297167|101878420|FG001|STARTED|Second Double-blind Intervention Period||15||
48629489|NCT00297167|101878421|FG002|STARTED|Second Double-blind Intervention Period||0||
48629490|NCT00297167|101878419|FG000|COMPLETED|Second Double-blind Intervention Period||16||
48174477|NCT01288781|100749958|FG001|COMPLETED|Overall Study||12||
48335521|NCT01228903|101148444|FG001|NOT COMPLETED|Overall Study||5||
48335522|NCT00264004|101148445|FG000|STARTED|Overall Study||30||
48335523|NCT00264004|101148446|FG001|STARTED|Overall Study||32||
48335524|NCT00264004|101148447|FG002|STARTED|Overall Study||30||
48335525|NCT00264004|101148448|FG003|STARTED|Overall Study||34||
48335526|NCT00264004|101148445|FG000|COMPLETED|Overall Study||13||
48335527|NCT00264004|101148446|FG001|COMPLETED|Overall Study||21||
48335528|NCT00264004|101148447|FG002|COMPLETED|Overall Study||16||
48335529|NCT00264004|101148448|FG003|COMPLETED|Overall Study||19||
48335530|NCT00264004|101148445|FG000|NOT COMPLETED|Overall Study||17||
48335531|NCT00264004|101148446|FG001|NOT COMPLETED|Overall Study||11||
48335532|NCT00264004|101148447|FG002|NOT COMPLETED|Overall Study||14||
48335533|NCT00264004|101148448|FG003|NOT COMPLETED|Overall Study||15||
48335534|NCT01916629|101148449|FG000|STARTED|Overall Study||7||
48335535|NCT01916629|101148450|FG001|STARTED|Overall Study||5||
48335536|NCT01916629|101148449|FG000|COMPLETED|Overall Study||7||
48335537|NCT01916629|101148450|FG001|COMPLETED|Overall Study||5||
48335538|NCT01916629|101148449|FG000|NOT COMPLETED|Overall Study||0||
48335539|NCT01916629|101148450|FG001|NOT COMPLETED|Overall Study||0||
48335540|NCT02307682|101148451|FG000|STARTED|Overall Study||360|All randomized subjects|
48335541|NCT02307682|101148452|FG001|STARTED|Overall Study||361|All randomized subjects|
48335542|NCT02307682|101148453|FG002|STARTED|Overall Study||361|All randomized subjects|
48335543|NCT02307682|101148451|FG000|Randomized and Treated|Overall Study||358||
48335544|NCT02307682|101148452|FG001|Randomized and Treated|Overall Study||360||
48335545|NCT02307682|101148453|FG002|Randomized and Treated|Overall Study||360||
48335546|NCT02307682|101148451|FG000|COMPLETED|Overall Study||310||
48335547|NCT02307682|101148452|FG001|COMPLETED|Overall Study||304||
48335548|NCT02307682|101148453|FG002|COMPLETED|Overall Study||297||
48335549|NCT02307682|101148451|FG000|NOT COMPLETED|Overall Study||50||
48335550|NCT02307682|101148452|FG001|NOT COMPLETED|Overall Study||57||
48335551|NCT02307682|101148453|FG002|NOT COMPLETED|Overall Study||64||
48335552|NCT00289107|101148454|FG000|STARTED|Overall Study||77||
48335553|NCT00289107|101148455|FG001|STARTED|Overall Study||72||
48335554|NCT00289107|101148454|FG000|COMPLETED|Overall Study||24||
48335555|NCT00289107|101148455|FG001|COMPLETED|Overall Study||28||
48335556|NCT00289107|101148454|FG000|NOT COMPLETED|Overall Study||53||
48335557|NCT00289107|101148455|FG001|NOT COMPLETED|Overall Study||44||
48335558|NCT00454805|101148456|FG000|STARTED|Overall Study||31||
48335559|NCT00454805|101148457|FG001|STARTED|Overall Study||31||
48335560|NCT00454805|101148456|FG000|COMPLETED|Overall Study||5||
48335561|NCT00454805|101148457|FG001|COMPLETED|Overall Study||8||
48629491|NCT00297167|101878420|FG001|COMPLETED|Second Double-blind Intervention Period||15||
48335562|NCT00454805|101148456|FG000|NOT COMPLETED|Overall Study||26||
48629492|NCT00297167|101878421|FG002|COMPLETED|Second Double-blind Intervention Period||0||
48629493|NCT00297167|101878419|FG000|NOT COMPLETED|Second Double-blind Intervention Period||1||
48629494|NCT00297167|101878420|FG001|NOT COMPLETED|Second Double-blind Intervention Period||0||
48629495|NCT00297167|101878421|FG002|NOT COMPLETED|Second Double-blind Intervention Period||0||
48629496|NCT00297167|101878419|FG000|STARTED|Open-label Dose Normalization Period 2||0||
48629497|NCT00297167|101878420|FG001|STARTED|Open-label Dose Normalization Period 2||0||
48629498|NCT00297167|101878421|FG002|STARTED|Open-label Dose Normalization Period 2||31||
48752502|NCT02639494|102180968|FG000|STARTED|Overall Study||20||
48752503|NCT02639494|102180968|FG000|COMPLETED|Overall Study||20||
48752504|NCT02639494|102180968|FG000|NOT COMPLETED|Overall Study||0||
48752505|NCT00942903|102180969|FG000|STARTED|Overall Study||20||
48335563|NCT00454805|101148457|FG001|NOT COMPLETED|Overall Study||23||
48335564|NCT00382993|101148458|FG000|STARTED|Migraine Attack 1 (Period 1)||84||
48752506|NCT00942903|102180969|FG000|COMPLETED|Overall Study||20||
48752507|NCT00942903|102180969|FG000|NOT COMPLETED|Overall Study||0||
48752508|NCT01884077|102180970|FG000|STARTED|Overall Study||8||
48752509|NCT01884077|102180971|FG001|STARTED|Overall Study||11||
48752510|NCT01884077|102180970|FG000|COMPLETED|Overall Study||0||
48752511|NCT01884077|102180971|FG001|COMPLETED|Overall Study||1||
48752512|NCT01884077|102180970|FG000|NOT COMPLETED|Overall Study||8||
48752513|NCT01884077|102180971|FG001|NOT COMPLETED|Overall Study||10||
48752514|NCT02040623|102180972|FG000|STARTED|Overall Study||11||
48752515|NCT02040623|102180973|FG001|STARTED|Overall Study||12||
48752516|NCT02040623|102180974|FG002|STARTED|Overall Study||12||
48752517|NCT02040623|102180972|FG000|COMPLETED|Overall Study||7||
48752518|NCT02040623|102180973|FG001|COMPLETED|Overall Study||6||
48752519|NCT02040623|102180974|FG002|COMPLETED|Overall Study||10||
48752520|NCT02040623|102180972|FG000|NOT COMPLETED|Overall Study||4||
48752521|NCT02040623|102180973|FG001|NOT COMPLETED|Overall Study||6||
48752522|NCT02040623|102180974|FG002|NOT COMPLETED|Overall Study||2||
48335565|NCT00382993|101148459|FG001|STARTED|Migraine Attack 1 (Period 1)||85||
48335566|NCT00382993|101148458|FG000|COMPLETED|Migraine Attack 1 (Period 1)||70||
48335567|NCT00382993|101148459|FG001|COMPLETED|Migraine Attack 1 (Period 1)||67||
48335568|NCT00382993|101148458|FG000|NOT COMPLETED|Migraine Attack 1 (Period 1)||14||
48335569|NCT00382993|101148459|FG001|NOT COMPLETED|Migraine Attack 1 (Period 1)||18||
48335570|NCT00382993|101148458|FG000|STARTED|Migraine Attack 2 (Period 2)||70||
48335571|NCT00382993|101148459|FG001|STARTED|Migraine Attack 2 (Period 2)||67||
48439936|NCT01279265|101409986|FG000|NOT COMPLETED|Overall Study||4||
48629499|NCT00297167|101878419|FG000|COMPLETED|Open-label Dose Normalization Period 2||0||
48629500|NCT00297167|101878420|FG001|COMPLETED|Open-label Dose Normalization Period 2||0||
48629501|NCT00297167|101878421|FG002|COMPLETED|Open-label Dose Normalization Period 2||31||
48629502|NCT00297167|101878419|FG000|NOT COMPLETED|Open-label Dose Normalization Period 2||0||
48629503|NCT00297167|101878420|FG001|NOT COMPLETED|Open-label Dose Normalization Period 2||0||
48629504|NCT00297167|101878421|FG002|NOT COMPLETED|Open-label Dose Normalization Period 2||0||
48629505|NCT02378662|101878422|FG000|STARTED|Overall Study||2||
48752523|NCT03309878|102180975|FG000|STARTED|Overall Study||4||
48752524|NCT03309878|102180976|FG001|STARTED|Overall Study||4||
48752525|NCT03309878|102180977|FG002|STARTED|Overall Study||0||
48752526|NCT03309878|102180978|FG003|STARTED|Overall Study||0||
48752527|NCT03309878|102180975|FG000|COMPLETED|Overall Study||1||
48752528|NCT03309878|102180976|FG001|COMPLETED|Overall Study||2||
48752529|NCT03309878|102180977|FG002|COMPLETED|Overall Study||0||
48752530|NCT03309878|102180978|FG003|COMPLETED|Overall Study||0||
48752531|NCT03309878|102180975|FG000|NOT COMPLETED|Overall Study||3||
48752532|NCT03309878|102180976|FG001|NOT COMPLETED|Overall Study||2||
48752533|NCT03309878|102180977|FG002|NOT COMPLETED|Overall Study||0||
48752534|NCT03309878|102180978|FG003|NOT COMPLETED|Overall Study||0||
48629506|NCT02378662|101878423|FG001|STARTED|Overall Study||0||
48752535|NCT00468299|102180979|FG000|STARTED|Overall Study||9||
48174478|NCT01288781|100749957|FG000|NOT COMPLETED|Overall Study||0||
48174479|NCT01288781|100749958|FG001|NOT COMPLETED|Overall Study||0||
48174480|NCT01447849|100749959|FG000|STARTED|First Intervention||10||
48174481|NCT01447849|100749960|FG001|STARTED|First Intervention||10||
48174482|NCT01447849|100749961|FG002|STARTED|First Intervention||10||
48174483|NCT01447849|100749962|FG003|STARTED|First Intervention||10||
48174484|NCT01447849|100749959|FG000|COMPLETED|First Intervention||10||
48174485|NCT01447849|100749960|FG001|COMPLETED|First Intervention||10||
48174486|NCT01447849|100749961|FG002|COMPLETED|First Intervention||10||
48174487|NCT01447849|100749962|FG003|COMPLETED|First Intervention||10||
48174488|NCT01447849|100749959|FG000|NOT COMPLETED|First Intervention||0||
48174489|NCT01447849|100749960|FG001|NOT COMPLETED|First Intervention||0||
48412349|NCT02545049|101341991|FG000|Treated|Overall Study||3683|One partcipant was randomized to placebo but received finerenone.|
48412350|NCT02545049|101341992|FG001|Treated|Overall Study||3658|One partcipant was randomized to placebo but received finerenone.|
48412351|NCT02545049|101341991|FG000|Included in FAS|Overall Study||3686|85 participants were prospectively excluded from the analyses because of critical GCP violations|
48412352|NCT02545049|101341992|FG001|Included in FAS|Overall Study||3666|85 participants were prospectively excluded from the analyses because of critical GCP violations|
48439937|NCT01279265|101409987|FG001|NOT COMPLETED|Overall Study||6||
48439938|NCT04936334|101409988|FG000|STARTED|Overall Study||51||102
48439939|NCT04936334|101409988|FG000|COMPLETED|Overall Study||50||100
48629507|NCT02378662|101878422|FG000|Harvesting|Overall Study||2||
48629508|NCT02378662|101878423|FG001|Harvesting|Overall Study||0||
48629509|NCT02378662|101878422|FG000|Implantation|Overall Study||2||
48629510|NCT02378662|101878423|FG001|Implantation|Overall Study||0||
48629511|NCT02378662|101878422|FG000|COMPLETED|Overall Study||0||
48629512|NCT02378662|101878423|FG001|COMPLETED|Overall Study||0||
48629513|NCT02378662|101878422|FG000|NOT COMPLETED|Overall Study||2||
48629514|NCT02378662|101878423|FG001|NOT COMPLETED|Overall Study||0||
48629515|NCT01589315|101878424|FG000|STARTED|Overall Study||17||
48629516|NCT01589315|101878424|FG000|COMPLETED|Overall Study||16||
48629517|NCT01589315|101878424|FG000|NOT COMPLETED|Overall Study||1||
48629518|NCT03886272|101878425|FG000|STARTED|Period 1||7||
48629519|NCT03886272|101878426|FG001|STARTED|Period 1||7||
48629520|NCT03886272|101878427|FG002|STARTED|Period 1||7||
48629521|NCT03886272|101878428|FG003|STARTED|Period 1||7||
48629522|NCT03886272|101878429|FG004|STARTED|Period 1||5||
48629523|NCT03886272|101878430|FG005|STARTED|Period 1||5||
48629524|NCT03886272|101878431|FG006|STARTED|Period 1||5||
48629525|NCT03886272|101878425|FG000|COMPLETED|Period 1||7||
48629526|NCT03886272|101878426|FG001|COMPLETED|Period 1||7||
48629527|NCT03886272|101878427|FG002|COMPLETED|Period 1||7||
48629528|NCT03886272|101878428|FG003|COMPLETED|Period 1||7||
48629529|NCT03886272|101878429|FG004|COMPLETED|Period 1||5||
48629530|NCT03886272|101878430|FG005|COMPLETED|Period 1||4||
48629531|NCT03886272|101878431|FG006|COMPLETED|Period 1||5||
48629532|NCT03886272|101878425|FG000|NOT COMPLETED|Period 1||0||
48629533|NCT03886272|101878426|FG001|NOT COMPLETED|Period 1||0||
48629534|NCT03886272|101878427|FG002|NOT COMPLETED|Period 1||0||
48629535|NCT03886272|101878428|FG003|NOT COMPLETED|Period 1||0||
48629536|NCT03886272|101878429|FG004|NOT COMPLETED|Period 1||0||
48629537|NCT03886272|101878430|FG005|NOT COMPLETED|Period 1||1||
48629538|NCT03886272|101878431|FG006|NOT COMPLETED|Period 1||0||
48629539|NCT03886272|101878425|FG000|STARTED|Period 2||7||
48174490|NCT01447849|100749961|FG002|NOT COMPLETED|First Intervention||0||
48174491|NCT01447849|100749962|FG003|NOT COMPLETED|First Intervention||0||
48174492|NCT01447849|100749959|FG000|STARTED|Washout Period for 1 Week||10||
48174493|NCT01447849|100749960|FG001|STARTED|Washout Period for 1 Week||10||
48174494|NCT01447849|100749961|FG002|STARTED|Washout Period for 1 Week||10||
48174495|NCT01447849|100749962|FG003|STARTED|Washout Period for 1 Week||10||
48174496|NCT01447849|100749959|FG000|COMPLETED|Washout Period for 1 Week||10||
48174497|NCT01447849|100749960|FG001|COMPLETED|Washout Period for 1 Week||10||
48174498|NCT01447849|100749961|FG002|COMPLETED|Washout Period for 1 Week||10||
48174499|NCT01447849|100749962|FG003|COMPLETED|Washout Period for 1 Week||10||
48174500|NCT01447849|100749959|FG000|NOT COMPLETED|Washout Period for 1 Week||0||
48174501|NCT01447849|100749960|FG001|NOT COMPLETED|Washout Period for 1 Week||0||
48174502|NCT01447849|100749961|FG002|NOT COMPLETED|Washout Period for 1 Week||0||
48174503|NCT01447849|100749962|FG003|NOT COMPLETED|Washout Period for 1 Week||0||
48174504|NCT01447849|100749959|FG000|STARTED|Second Intervention||10||
48174505|NCT01447849|100749960|FG001|STARTED|Second Intervention||10||
48174506|NCT01447849|100749961|FG002|STARTED|Second Intervention||10||
48174507|NCT01447849|100749962|FG003|STARTED|Second Intervention||10||
48629540|NCT03886272|101878426|FG001|STARTED|Period 2||7||
48629541|NCT03886272|101878427|FG002|STARTED|Period 2||7||
48629542|NCT03886272|101878428|FG003|STARTED|Period 2||7||
48629543|NCT03886272|101878429|FG004|STARTED|Period 2||5||
48629544|NCT03886272|101878430|FG005|STARTED|Period 2||4||
48629545|NCT03886272|101878431|FG006|STARTED|Period 2||5||
48629546|NCT03886272|101878425|FG000|COMPLETED|Period 2||7||
48629547|NCT03886272|101878426|FG001|COMPLETED|Period 2||7||
48629548|NCT03886272|101878427|FG002|COMPLETED|Period 2||7||
48174508|NCT01447849|100749959|FG000|COMPLETED|Second Intervention||10||
48174509|NCT01447849|100749960|FG001|COMPLETED|Second Intervention||10||
48174510|NCT01447849|100749961|FG002|COMPLETED|Second Intervention||10||
48174511|NCT01447849|100749962|FG003|COMPLETED|Second Intervention||10||
48174512|NCT01447849|100749959|FG000|NOT COMPLETED|Second Intervention||0||
48174513|NCT01447849|100749960|FG001|NOT COMPLETED|Second Intervention||0||
48174514|NCT01447849|100749961|FG002|NOT COMPLETED|Second Intervention||0||
48174515|NCT01447849|100749962|FG003|NOT COMPLETED|Second Intervention||0||
48174516|NCT01706965|100749963|FG000|STARTED|Overall Study||14||
48174517|NCT01706965|100749964|FG001|STARTED|Overall Study||13||
48174518|NCT01706965|100749963|FG000|COMPLETED|Overall Study||13||
48174519|NCT01706965|100749964|FG001|COMPLETED|Overall Study||12||
48174520|NCT01706965|100749963|FG000|NOT COMPLETED|Overall Study||1||
48174521|NCT01706965|100749964|FG001|NOT COMPLETED|Overall Study||1||
48174522|NCT01406717|100749965|FG000|STARTED|Overall Study||180||
48174523|NCT01406717|100749966|FG001|STARTED|Overall Study||180||
48174524|NCT01406717|100749965|FG000|COMPLETED|Overall Study||137||
48629549|NCT03886272|101878428|FG003|COMPLETED|Period 2||7||
48629550|NCT03886272|101878429|FG004|COMPLETED|Period 2||5||
48629551|NCT03886272|101878430|FG005|COMPLETED|Period 2||4||
48629552|NCT03886272|101878431|FG006|COMPLETED|Period 2||5||
48629553|NCT03886272|101878425|FG000|NOT COMPLETED|Period 2||0||
48629554|NCT03886272|101878426|FG001|NOT COMPLETED|Period 2||0||
48629555|NCT03886272|101878427|FG002|NOT COMPLETED|Period 2||0||
48629556|NCT03886272|101878428|FG003|NOT COMPLETED|Period 2||0||
48752536|NCT00468299|102180980|FG001|STARTED|Overall Study||8||
48752537|NCT00468299|102180979|FG000|COMPLETED|Overall Study||9||
48752538|NCT00468299|102180980|FG001|COMPLETED|Overall Study||7||
48752539|NCT00468299|102180979|FG000|NOT COMPLETED|Overall Study||0||
48174525|NCT01406717|100749966|FG001|COMPLETED|Overall Study||149||
48174526|NCT01406717|100749965|FG000|NOT COMPLETED|Overall Study||43||
48174527|NCT01406717|100749966|FG001|NOT COMPLETED|Overall Study||31||
48174528|NCT02913521|100749967|FG000|STARTED|Overall Study||316||
48174529|NCT02913521|100749968|FG001|STARTED|Overall Study||312||
48174530|NCT02913521|100749969|FG002|STARTED|Overall Study||306||
48174531|NCT02913521|100749967|FG000|COMPLETED|Overall Study||263||
48174532|NCT02913521|100749968|FG001|COMPLETED|Overall Study||262||
48174533|NCT02913521|100749969|FG002|COMPLETED|Overall Study||261||
48174534|NCT02913521|100749967|FG000|NOT COMPLETED|Overall Study||53||
48174535|NCT02913521|100749968|FG001|NOT COMPLETED|Overall Study||50||
48174536|NCT02913521|100749969|FG002|NOT COMPLETED|Overall Study||45||
48174537|NCT01807221|100749970|FG000|STARTED|Overall Study||224||
48174538|NCT01807221|100749971|FG001|STARTED|Overall Study||173||
48174539|NCT01807221|100749972|FG002|STARTED|Overall Study||165||
48174540|NCT01807221|100749973|FG003|STARTED|Overall Study||169||
48174541|NCT01807221|100749974|FG004|STARTED|Overall Study||170||
48174542|NCT01807221|100749975|FG005|STARTED|Overall Study||165||
48174543|NCT01807221|100749970|FG000|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||221||
48174544|NCT01807221|100749971|FG001|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||172||
48174545|NCT01807221|100749972|FG002|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||163||
48174546|NCT01807221|100749973|FG003|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||167||
48174547|NCT01807221|100749974|FG004|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||169||
48174548|NCT01807221|100749975|FG005|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||163||
48174549|NCT01807221|100749970|FG000|COMPLETED|Overall Study||144||
48174550|NCT01807221|100749971|FG001|COMPLETED|Overall Study||121||
48174551|NCT01807221|100749972|FG002|COMPLETED|Overall Study||122||
48629557|NCT03886272|101878429|FG004|NOT COMPLETED|Period 2||0||
48752540|NCT00468299|102180980|FG001|NOT COMPLETED|Overall Study||1||
48752541|NCT00333775|102180981|FG000|STARTED|Overall Study||241||
48752542|NCT00333775|102180982|FG001|STARTED|Overall Study||248||
48752543|NCT00333775|102180983|FG002|STARTED|Overall Study||247||
48752544|NCT00333775|102180981|FG000|Received Treatment|Overall Study||238||
48174552|NCT01807221|100749973|FG003|COMPLETED|Overall Study||123||
48174553|NCT01807221|100749974|FG004|COMPLETED|Overall Study||134||
48335572|NCT00382993|101148458|FG000|COMPLETED|Migraine Attack 2 (Period 2)||68||
48629558|NCT03886272|101878430|FG005|NOT COMPLETED|Period 2||0||
48629559|NCT03886272|101878431|FG006|NOT COMPLETED|Period 2||0||
48629560|NCT03886272|101878425|FG000|STARTED|Period 3||0||
48629561|NCT03886272|101878426|FG001|STARTED|Period 3||0||
48629562|NCT03886272|101878427|FG002|STARTED|Period 3||0||
48629563|NCT03886272|101878428|FG003|STARTED|Period 3||0||
48752545|NCT00333775|102180982|FG001|Received Treatment|Overall Study||247||
48752546|NCT00333775|102180983|FG002|Received Treatment|Overall Study||245||
48752547|NCT00333775|102180981|FG000|COMPLETED|Overall Study||0||
48174554|NCT01807221|100749975|FG005|COMPLETED|Overall Study||124||
48174555|NCT01807221|100749970|FG000|NOT COMPLETED|Overall Study||80||
48174556|NCT01807221|100749971|FG001|NOT COMPLETED|Overall Study||52||
48174557|NCT01807221|100749972|FG002|NOT COMPLETED|Overall Study||43||
48174558|NCT01807221|100749973|FG003|NOT COMPLETED|Overall Study||46||
48174559|NCT01807221|100749974|FG004|NOT COMPLETED|Overall Study||36||
48629564|NCT03886272|101878429|FG004|STARTED|Period 3||5||
48629565|NCT03886272|101878430|FG005|STARTED|Period 3||4||
48629566|NCT03886272|101878431|FG006|STARTED|Period 3||5||
48752548|NCT00333775|102180982|FG001|COMPLETED|Overall Study||0||
48752549|NCT00333775|102180983|FG002|COMPLETED|Overall Study||0||
48752550|NCT00333775|102180981|FG000|NOT COMPLETED|Overall Study||241||
48174560|NCT01807221|100749975|FG005|NOT COMPLETED|Overall Study||41||
48174561|NCT03121534|100749976|FG000|STARTED|Overall Study||9||
48174562|NCT03121534|100749976|FG000|COMPLETED|Overall Study||9||
48174563|NCT03121534|100749976|FG000|NOT COMPLETED|Overall Study||0||
48174564|NCT01830881|100749977|FG000|STARTED|Overall Study||62||
48174565|NCT01830881|100749978|FG001|STARTED|Overall Study||62||
48174566|NCT01830881|100749977|FG000|COMPLETED|Overall Study||62||
48174567|NCT01830881|100749978|FG001|COMPLETED|Overall Study||61||
48174568|NCT01830881|100749977|FG000|NOT COMPLETED|Overall Study||0||
48174569|NCT01830881|100749978|FG001|NOT COMPLETED|Overall Study||1||
48174570|NCT03748979|100749979|FG000|STARTED|Overall Study||6||
48174571|NCT03748979|100749980|FG001|STARTED|Overall Study||6||
48174572|NCT03748979|100749981|FG002|STARTED|Overall Study||6||
48174573|NCT03748979|100749982|FG003|STARTED|Overall Study||6||
48174574|NCT03748979|100749983|FG004|STARTED|Overall Study||4||
48174575|NCT03748979|100749984|FG005|STARTED|Overall Study||4||
48174576|NCT03748979|100749985|FG006|STARTED|Overall Study||5||
48174577|NCT03748979|100749986|FG007|STARTED|Overall Study||5||
48174578|NCT03748979|100749987|FG008|STARTED|Overall Study||4||
48174579|NCT03748979|100749988|FG009|STARTED|Overall Study||5||
48174580|NCT03748979|100749989|FG010|STARTED|Overall Study||6||
48174581|NCT03748979|100749979|FG000|COMPLETED|Overall Study||6||
48174582|NCT03748979|100749980|FG001|COMPLETED|Overall Study||6||
48174583|NCT03748979|100749981|FG002|COMPLETED|Overall Study||6||
48174584|NCT03748979|100749982|FG003|COMPLETED|Overall Study||6||
48174585|NCT03748979|100749983|FG004|COMPLETED|Overall Study||4||
48174586|NCT03748979|100749984|FG005|COMPLETED|Overall Study||4||
48174587|NCT03748979|100749985|FG006|COMPLETED|Overall Study||5||
48174588|NCT03748979|100749986|FG007|COMPLETED|Overall Study||5||
48174589|NCT03748979|100749987|FG008|COMPLETED|Overall Study||4||
48174590|NCT03748979|100749988|FG009|COMPLETED|Overall Study||5||
48174591|NCT03748979|100749989|FG010|COMPLETED|Overall Study||6||
48174592|NCT03748979|100749979|FG000|NOT COMPLETED|Overall Study||0||
48174593|NCT03748979|100749980|FG001|NOT COMPLETED|Overall Study||0||
48174594|NCT03748979|100749981|FG002|NOT COMPLETED|Overall Study||0||
48174595|NCT03748979|100749982|FG003|NOT COMPLETED|Overall Study||0||
48174596|NCT03748979|100749983|FG004|NOT COMPLETED|Overall Study||0||
48174597|NCT03748979|100749984|FG005|NOT COMPLETED|Overall Study||0||
48174598|NCT03748979|100749985|FG006|NOT COMPLETED|Overall Study||0||
48174599|NCT03748979|100749986|FG007|NOT COMPLETED|Overall Study||0||
48174600|NCT03748979|100749987|FG008|NOT COMPLETED|Overall Study||0||
48174601|NCT03748979|100749988|FG009|NOT COMPLETED|Overall Study||0||
48174602|NCT03748979|100749989|FG010|NOT COMPLETED|Overall Study||0||
48174603|NCT00785538|100749990|FG000|STARTED|PK Period||7||
48174604|NCT00785538|100749991|FG001|STARTED|PK Period||1||
48174605|NCT00785538|100749992|FG002|STARTED|PK Period||1||
48174606|NCT00785538|100749993|FG003|STARTED|PK Period||0||
48174607|NCT00785538|100749990|FG000|COMPLETED|PK Period||7||
48174608|NCT00785538|100749991|FG001|COMPLETED|PK Period||1||
48174609|NCT00785538|100749992|FG002|COMPLETED|PK Period||1||
48174610|NCT00785538|100749993|FG003|COMPLETED|PK Period||0||
48174611|NCT00785538|100749990|FG000|NOT COMPLETED|PK Period||0||
48174612|NCT00785538|100749991|FG001|NOT COMPLETED|PK Period||0||
48335573|NCT00382993|101148459|FG001|COMPLETED|Migraine Attack 2 (Period 2)||63||
48335574|NCT00382993|101148458|FG000|NOT COMPLETED|Migraine Attack 2 (Period 2)||2||
48335575|NCT00382993|101148459|FG001|NOT COMPLETED|Migraine Attack 2 (Period 2)||4||
48335576|NCT03326141|101148460|FG000|STARTED|Overall Study||78||
48335577|NCT03326141|101148461|FG001|STARTED|Overall Study||78||
48629567|NCT03886272|101878425|FG000|COMPLETED|Period 3||0||
48629568|NCT03886272|101878426|FG001|COMPLETED|Period 3||0||
48629569|NCT03886272|101878427|FG002|COMPLETED|Period 3||0||
48629570|NCT03886272|101878428|FG003|COMPLETED|Period 3||0||
48629571|NCT03886272|101878429|FG004|COMPLETED|Period 3||5||
48629572|NCT03886272|101878430|FG005|COMPLETED|Period 3||4||
48174613|NCT00785538|100749992|FG002|NOT COMPLETED|PK Period||0||
48629573|NCT03886272|101878431|FG006|COMPLETED|Period 3||5||
48174614|NCT00785538|100749993|FG003|NOT COMPLETED|PK Period||0||
48174615|NCT00785538|100749990|FG000|STARTED|Treatment Period||7||
48174616|NCT00785538|100749991|FG001|STARTED|Treatment Period||9||
48174617|NCT00785538|100749992|FG002|STARTED|Treatment Period||6||
48335578|NCT03326141|101148462|FG002|STARTED|Overall Study||76||
48335579|NCT03326141|101148463|FG003|STARTED|Overall Study||77||
48629574|NCT03886272|101878425|FG000|NOT COMPLETED|Period 3||0||
48174618|NCT00785538|100749993|FG003|STARTED|Treatment Period||2||
48174619|NCT00785538|100749990|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||7||
48174620|NCT00785538|100749991|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||9||
48174621|NCT00785538|100749992|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||6||
48174622|NCT00785538|100749993|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||2||
48174623|NCT00785538|100749990|FG000|COMPLETED|Treatment Period||6||
48174624|NCT00785538|100749991|FG001|COMPLETED|Treatment Period||7||
48174625|NCT00785538|100749992|FG002|COMPLETED|Treatment Period||4||
48174626|NCT00785538|100749993|FG003|COMPLETED|Treatment Period||1||
48174627|NCT00785538|100749990|FG000|NOT COMPLETED|Treatment Period||1||
48174628|NCT00785538|100749991|FG001|NOT COMPLETED|Treatment Period||2||
48629575|NCT03886272|101878426|FG001|NOT COMPLETED|Period 3||0||
48174629|NCT00785538|100749992|FG002|NOT COMPLETED|Treatment Period||2||
48174630|NCT00785538|100749993|FG003|NOT COMPLETED|Treatment Period||1||
48174631|NCT01248962|100749994|FG000|STARTED|Overall Study||74||
48174632|NCT01248962|100749995|FG001|STARTED|Overall Study||72||
48174633|NCT01248962|100749994|FG000|COMPLETED|Overall Study||58||
48174634|NCT01248962|100749995|FG001|COMPLETED|Overall Study||56||
48174635|NCT01248962|100749994|FG000|NOT COMPLETED|Overall Study||16||
48174636|NCT01248962|100749995|FG001|NOT COMPLETED|Overall Study||16||
48174637|NCT00557622|100749996|FG000|STARTED|4-Week Run-in Phase||5||
48174638|NCT00557622|100749997|FG001|STARTED|4-Week Run-in Phase||0||
48174639|NCT00557622|100749996|FG000|COMPLETED|4-Week Run-in Phase||3||
48174640|NCT00557622|100749997|FG001|COMPLETED|4-Week Run-in Phase||0||
48174641|NCT00557622|100749996|FG000|NOT COMPLETED|4-Week Run-in Phase||2||
48174642|NCT00557622|100749997|FG001|NOT COMPLETED|4-Week Run-in Phase||0||
48174643|NCT00557622|100749996|FG000|STARTED|12-Week Treatment Phase||1||
48174644|NCT00557622|100749997|FG001|STARTED|12-Week Treatment Phase||2||
48174645|NCT00557622|100749996|FG000|COMPLETED|12-Week Treatment Phase||1||
48174646|NCT00557622|100749997|FG001|COMPLETED|12-Week Treatment Phase||1||
48174647|NCT00557622|100749996|FG000|NOT COMPLETED|12-Week Treatment Phase||0||
48174648|NCT00557622|100749997|FG001|NOT COMPLETED|12-Week Treatment Phase||1||
48174649|NCT02413684|100749998|FG000|STARTED|Overall Study||53||
48174650|NCT02413684|100749998|FG000|COMPLETED|Overall Study||40||
48174651|NCT02413684|100749998|FG000|NOT COMPLETED|Overall Study||13||
48174652|NCT00127413|100749999|FG000|STARTED|Overall Study||12||
48174653|NCT00127413|100750000|FG001|STARTED|Overall Study||10||
48174654|NCT00127413|100750001|FG002|STARTED|Overall Study||13||
48174655|NCT00127413|100750002|FG003|STARTED|Overall Study||7||
48174656|NCT00127413|100749999|FG000|COMPLETED|Overall Study||6||
48174657|NCT00127413|100750000|FG001|COMPLETED|Overall Study||6||
48174658|NCT00127413|100750001|FG002|COMPLETED|Overall Study||5||
48174659|NCT00127413|100750002|FG003|COMPLETED|Overall Study||5||
48174660|NCT00127413|100749999|FG000|NOT COMPLETED|Overall Study||6||
48174661|NCT00127413|100750000|FG001|NOT COMPLETED|Overall Study||4||
48174662|NCT00127413|100750001|FG002|NOT COMPLETED|Overall Study||8||
48174663|NCT00127413|100750002|FG003|NOT COMPLETED|Overall Study||2||
48174664|NCT01749501|100750003|FG000|STARTED|Overall Study||22||
48174665|NCT01749501|100750004|FG001|STARTED|Overall Study||23||
48174666|NCT01749501|100750003|FG000|COMPLETED|Overall Study||22||
48174667|NCT01749501|100750004|FG001|COMPLETED|Overall Study||23||
48174668|NCT01749501|100750003|FG000|NOT COMPLETED|Overall Study||0||
48174669|NCT01749501|100750004|FG001|NOT COMPLETED|Overall Study||0||
48174670|NCT01368211|100750005|FG000|STARTED|First Platelets Transfusion||8||
48174671|NCT01368211|100750006|FG001|STARTED|First Platelets Transfusion||7||
48629576|NCT03886272|101878427|FG002|NOT COMPLETED|Period 3||0||
48174672|NCT01368211|100750005|FG000|COMPLETED|First Platelets Transfusion||8||
48174673|NCT01368211|100750006|FG001|COMPLETED|First Platelets Transfusion||7||
48174674|NCT01368211|100750005|FG000|NOT COMPLETED|First Platelets Transfusion||0||
48174675|NCT01368211|100750006|FG001|NOT COMPLETED|First Platelets Transfusion||0||
48174676|NCT01368211|100750005|FG000|STARTED|Second Platelets Transfusion||8||
48174677|NCT01368211|100750006|FG001|STARTED|Second Platelets Transfusion||7||
48174678|NCT01368211|100750005|FG000|COMPLETED|Second Platelets Transfusion||7||
48174679|NCT01368211|100750006|FG001|COMPLETED|Second Platelets Transfusion||5||
48174680|NCT01368211|100750005|FG000|NOT COMPLETED|Second Platelets Transfusion||1||
48174681|NCT01368211|100750006|FG001|NOT COMPLETED|Second Platelets Transfusion||2||
48174682|NCT03567993|100750007|FG000|STARTED|Overall Study||378||
48174683|NCT03567993|100750008|FG001|STARTED|Overall Study||372||
48174684|NCT03567993|100750007|FG000|COMPLETED|Overall Study||372||
48174685|NCT03567993|100750008|FG001|COMPLETED|Overall Study||369||
48174686|NCT03567993|100750007|FG000|NOT COMPLETED|Overall Study||6||
48174687|NCT03567993|100750008|FG001|NOT COMPLETED|Overall Study||3||
48174688|NCT00007475|100750009|FG000|STARTED|Overall Study||12||
48174689|NCT00007475|100750010|FG001|STARTED|Overall Study||1||
48174690|NCT00007475|100750011|FG002|STARTED|Overall Study||2||
48174691|NCT00007475|100750012|FG003|STARTED|Overall Study||0||
48174692|NCT00007475|100750009|FG000|FSGS Permeability Factor (FPF) Assayed|Overall Study||0||
48335580|NCT03326141|101148460|FG000|COMPLETED|Overall Study||77||
48629577|NCT03886272|101878428|FG003|NOT COMPLETED|Period 3||0||
48629578|NCT03886272|101878429|FG004|NOT COMPLETED|Period 3||0||
48629579|NCT03886272|101878430|FG005|NOT COMPLETED|Period 3||0||
48629580|NCT03886272|101878431|FG006|NOT COMPLETED|Period 3||0||
48629581|NCT00296244|101878432|FG000|STARTED|Overall Study||20||
48629582|NCT00296244|101878433|FG001|STARTED|Overall Study||20||
48174693|NCT00007475|100750010|FG001|FSGS Permeability Factor (FPF) Assayed|Overall Study||1||
48174694|NCT00007475|100750011|FG002|FSGS Permeability Factor (FPF) Assayed|Overall Study||2||
48174695|NCT00007475|100750012|FG003|FSGS Permeability Factor (FPF) Assayed|Overall Study||0||
48174696|NCT00007475|100750009|FG000|Initial Transplant|Overall Study||12||
48174697|NCT00007475|100750010|FG001|Initial Transplant|Overall Study||1||
48174698|NCT00007475|100750011|FG002|Initial Transplant|Overall Study||2||
48174699|NCT00007475|100750012|FG003|Initial Transplant|Overall Study||0||
48174700|NCT00007475|100750009|FG000|Post-initial Transplant Proteinuria|Overall Study||12||
48174701|NCT00007475|100750010|FG001|Post-initial Transplant Proteinuria|Overall Study||1||
48629583|NCT00296244|101878432|FG000|COMPLETED|Overall Study||20||
48174702|NCT00007475|100750011|FG002|Post-initial Transplant Proteinuria|Overall Study||2||
48174703|NCT00007475|100750012|FG003|Post-initial Transplant Proteinuria|Overall Study||0||
48174704|NCT00007475|100750009|FG000|Initial Plasma Exchange|Overall Study||12||
48174705|NCT00007475|100750010|FG001|Initial Plasma Exchange|Overall Study||1||
48174706|NCT00007475|100750011|FG002|Initial Plasma Exchange|Overall Study||2||
48174707|NCT00007475|100750012|FG003|Initial Plasma Exchange|Overall Study||0||
48174708|NCT00007475|100750009|FG000|Initiate Cyclophosphamide|Overall Study||12||
48174709|NCT00007475|100750010|FG001|Initiate Cyclophosphamide|Overall Study||1||
48174710|NCT00007475|100750011|FG002|Initiate Cyclophosphamide|Overall Study||2||
48174711|NCT00007475|100750012|FG003|Initiate Cyclophosphamide|Overall Study||0||
48174712|NCT00007475|100750009|FG000|COMPLETED|Overall Study||8||
48174713|NCT00007475|100750010|FG001|COMPLETED|Overall Study||1||
48335581|NCT03326141|101148461|FG001|COMPLETED|Overall Study||76||
48412353|NCT02545049|101341991|FG000|COMPLETED|Overall Study||3681|Participants (except those with critical GCP violations) were followed up regardless of having started treatment or not, and study completion is independent of administration of study treatment. A participant included in the FAS was considered as having completed the study if there was a contact with the participant after the end-of-study (EOS) notification or if the participant died.|
48412354|NCT02545049|101341992|FG001|COMPLETED|Overall Study||3653|Participants (except those with critical GCP violations) were followed up regardless of having started treatment or not, and study completion is independent of administration of study treatment. A participant included in the FAS was considered as having completed the study if there was a contact with the participant after the end-of-study (EOS) notification or if the participant died.|
48412355|NCT02545049|101341991|FG000|NOT COMPLETED|Overall Study||42||
48412356|NCT02545049|101341992|FG001|NOT COMPLETED|Overall Study||61||
48412357|NCT00424099|101341993|FG000|STARTED|Overall Study||45||
48412358|NCT00424099|101341994|FG001|STARTED|Overall Study||47||
48412359|NCT00424099|101341995|FG002|STARTED|Overall Study||50||
48412360|NCT00424099|101341996|FG003|STARTED|Overall Study||48||
48412361|NCT00424099|101341993|FG000|COMPLETED|Overall Study||38||
48629584|NCT00296244|101878433|FG001|COMPLETED|Overall Study||19||
48629585|NCT00296244|101878432|FG000|NOT COMPLETED|Overall Study||0||
48629586|NCT00296244|101878433|FG001|NOT COMPLETED|Overall Study||1||
48629587|NCT04821063|101878434|FG000|STARTED|Period 1 (1 Day)||1||
48629588|NCT04821063|101878435|FG001|STARTED|Period 1 (1 Day)||1||
48629589|NCT04821063|101878436|FG002|STARTED|Period 1 (1 Day)||2||
48629590|NCT04821063|101878437|FG003|STARTED|Period 1 (1 Day)||3||
48752551|NCT00333775|102180982|FG001|NOT COMPLETED|Overall Study||248||
48752552|NCT00333775|102180983|FG002|NOT COMPLETED|Overall Study||247||
48752553|NCT02422498|102180984|FG000|STARTED|Overall Study||49||
48752554|NCT02422498|102180984|FG000|COMPLETED|Overall Study||45||
48752555|NCT02422498|102180984|FG000|NOT COMPLETED|Overall Study||4||
48752556|NCT01026012|102180985|FG000|STARTED|Overall Study||40||
48752557|NCT01026012|102180985|FG000|COMPLETED|Overall Study||40||
48752558|NCT01026012|102180985|FG000|NOT COMPLETED|Overall Study||0||
48752559|NCT01283555|102180986|FG000|STARTED|First Intervention||13||
48752560|NCT01283555|102180987|FG001|STARTED|First Intervention||12||
48752561|NCT01283555|102180986|FG000|COMPLETED|First Intervention||13||
48629591|NCT04821063|101878438|FG004|STARTED|Period 1 (1 Day)||3||
48629592|NCT04821063|101878439|FG005|STARTED|Period 1 (1 Day)||3||
48629593|NCT04821063|101878440|FG006|STARTED|Period 1 (1 Day)||3||
48629594|NCT04821063|101878441|FG007|STARTED|Period 1 (1 Day)||3||
48629595|NCT04821063|101878442|FG008|STARTED|Period 1 (1 Day)||3||
48629596|NCT04821063|101878443|FG009|STARTED|Period 1 (1 Day)||3||
48629597|NCT04821063|101878444|FG010|STARTED|Period 1 (1 Day)||3||
48629598|NCT04821063|101878445|FG011|STARTED|Period 1 (1 Day)||3||
48752562|NCT01283555|102180987|FG001|COMPLETED|First Intervention||12||
48752563|NCT01283555|102180986|FG000|NOT COMPLETED|First Intervention||0||
48752564|NCT01283555|102180987|FG001|NOT COMPLETED|First Intervention||0||
48752565|NCT01283555|102180986|FG000|STARTED|Washout Period of at Least 21 Days||13||
48752566|NCT01283555|102180987|FG001|STARTED|Washout Period of at Least 21 Days||12||
48752567|NCT01283555|102180986|FG000|COMPLETED|Washout Period of at Least 21 Days||13||
48752568|NCT01283555|102180987|FG001|COMPLETED|Washout Period of at Least 21 Days||12||
48752569|NCT01283555|102180986|FG000|NOT COMPLETED|Washout Period of at Least 21 Days||0||
48752570|NCT01283555|102180987|FG001|NOT COMPLETED|Washout Period of at Least 21 Days||0||
48752571|NCT01283555|102180986|FG000|STARTED|Second Intervention||13||
48752572|NCT01283555|102180987|FG001|STARTED|Second Intervention||12||
48752573|NCT01283555|102180986|FG000|COMPLETED|Second Intervention||13||
48174714|NCT00007475|100750011|FG002|COMPLETED|Overall Study||2||
48174715|NCT00007475|100750012|FG003|COMPLETED|Overall Study||0||
48174716|NCT00007475|100750009|FG000|NOT COMPLETED|Overall Study||4||
48174717|NCT00007475|100750010|FG001|NOT COMPLETED|Overall Study||0||
48174718|NCT00007475|100750011|FG002|NOT COMPLETED|Overall Study||0||
48174719|NCT00007475|100750012|FG003|NOT COMPLETED|Overall Study||0||
48174720|NCT00358150|100750013|FG000|STARTED|Overall Study||26||
48174721|NCT00358150|100750013|FG000|COMPLETED|Overall Study||19||
48174722|NCT00358150|100750013|FG000|NOT COMPLETED|Overall Study||7||
48174723|NCT01993823|100750014|FG000|STARTED|Overall Study||95||
48174724|NCT01993823|100750015|FG001|STARTED|Overall Study||95||
48629599|NCT04821063|101878434|FG000|COMPLETED|Period 1 (1 Day)||1||
48629600|NCT04821063|101878435|FG001|COMPLETED|Period 1 (1 Day)||1||
48629601|NCT04821063|101878436|FG002|COMPLETED|Period 1 (1 Day)||2||
48629602|NCT04821063|101878437|FG003|COMPLETED|Period 1 (1 Day)||3||
48629603|NCT04821063|101878438|FG004|COMPLETED|Period 1 (1 Day)||3||
48629604|NCT04821063|101878439|FG005|COMPLETED|Period 1 (1 Day)||3||
48629605|NCT04821063|101878440|FG006|COMPLETED|Period 1 (1 Day)||3||
48629606|NCT04821063|101878441|FG007|COMPLETED|Period 1 (1 Day)||3||
48629607|NCT04821063|101878442|FG008|COMPLETED|Period 1 (1 Day)||3||
48629608|NCT04821063|101878443|FG009|COMPLETED|Period 1 (1 Day)||3||
48629609|NCT04821063|101878444|FG010|COMPLETED|Period 1 (1 Day)||3||
48629610|NCT04821063|101878445|FG011|COMPLETED|Period 1 (1 Day)||3||
48629611|NCT04821063|101878434|FG000|NOT COMPLETED|Period 1 (1 Day)||0||
48629612|NCT04821063|101878435|FG001|NOT COMPLETED|Period 1 (1 Day)||0||
48629613|NCT04821063|101878436|FG002|NOT COMPLETED|Period 1 (1 Day)||0||
48629614|NCT04821063|101878437|FG003|NOT COMPLETED|Period 1 (1 Day)||0||
48629615|NCT04821063|101878438|FG004|NOT COMPLETED|Period 1 (1 Day)||0||
48629616|NCT04821063|101878439|FG005|NOT COMPLETED|Period 1 (1 Day)||0||
48629617|NCT04821063|101878440|FG006|NOT COMPLETED|Period 1 (1 Day)||0||
48629618|NCT04821063|101878441|FG007|NOT COMPLETED|Period 1 (1 Day)||0||
48629619|NCT04821063|101878442|FG008|NOT COMPLETED|Period 1 (1 Day)||0||
48629620|NCT04821063|101878443|FG009|NOT COMPLETED|Period 1 (1 Day)||0||
48629621|NCT04821063|101878444|FG010|NOT COMPLETED|Period 1 (1 Day)||0||
48629622|NCT04821063|101878445|FG011|NOT COMPLETED|Period 1 (1 Day)||0||
48629623|NCT04821063|101878434|FG000|STARTED|Washout Period (7 Days )||1||
48629624|NCT04821063|101878435|FG001|STARTED|Washout Period (7 Days )||1||
48629625|NCT04821063|101878436|FG002|STARTED|Washout Period (7 Days )||2||
48752574|NCT01283555|102180987|FG001|COMPLETED|Second Intervention||12||
48752575|NCT01283555|102180986|FG000|NOT COMPLETED|Second Intervention||0||
48752576|NCT01283555|102180987|FG001|NOT COMPLETED|Second Intervention||0||
48752577|NCT00265564|102180988|FG000|STARTED|Overall Study||59||
48752578|NCT00265564|102180989|FG001|STARTED|Overall Study||58||
48752579|NCT00265564|102180988|FG000|COMPLETED|Overall Study||49||
48752580|NCT00265564|102180989|FG001|COMPLETED|Overall Study||49||
48629626|NCT04821063|101878437|FG003|STARTED|Washout Period (7 Days )||3||
48629627|NCT04821063|101878438|FG004|STARTED|Washout Period (7 Days )||3||
48629628|NCT04821063|101878439|FG005|STARTED|Washout Period (7 Days )||3||
48629629|NCT04821063|101878440|FG006|STARTED|Washout Period (7 Days )||3||
48629630|NCT04821063|101878441|FG007|STARTED|Washout Period (7 Days )||3||
48629631|NCT04821063|101878442|FG008|STARTED|Washout Period (7 Days )||3||
48629632|NCT04821063|101878443|FG009|STARTED|Washout Period (7 Days )||3||
48629633|NCT04821063|101878444|FG010|STARTED|Washout Period (7 Days )||3||
48629634|NCT04821063|101878445|FG011|STARTED|Washout Period (7 Days )||3||
48629635|NCT04821063|101878434|FG000|COMPLETED|Washout Period (7 Days )||1||
48629636|NCT04821063|101878435|FG001|COMPLETED|Washout Period (7 Days )||1||
48629637|NCT04821063|101878436|FG002|COMPLETED|Washout Period (7 Days )||2||
48629638|NCT04821063|101878437|FG003|COMPLETED|Washout Period (7 Days )||3||
48629639|NCT04821063|101878438|FG004|COMPLETED|Washout Period (7 Days )||3||
48629640|NCT04821063|101878439|FG005|COMPLETED|Washout Period (7 Days )||3||
48629641|NCT04821063|101878440|FG006|COMPLETED|Washout Period (7 Days )||3||
48629642|NCT04821063|101878441|FG007|COMPLETED|Washout Period (7 Days )||3||
48629643|NCT04821063|101878442|FG008|COMPLETED|Washout Period (7 Days )||3||
48629644|NCT04821063|101878443|FG009|COMPLETED|Washout Period (7 Days )||3||
48629645|NCT04821063|101878444|FG010|COMPLETED|Washout Period (7 Days )||3||
48629646|NCT04821063|101878445|FG011|COMPLETED|Washout Period (7 Days )||3||
48629647|NCT04821063|101878434|FG000|NOT COMPLETED|Washout Period (7 Days )||0||
48629648|NCT04821063|101878435|FG001|NOT COMPLETED|Washout Period (7 Days )||0||
48629649|NCT04821063|101878436|FG002|NOT COMPLETED|Washout Period (7 Days )||0||
48629650|NCT04821063|101878437|FG003|NOT COMPLETED|Washout Period (7 Days )||0||
48629651|NCT04821063|101878438|FG004|NOT COMPLETED|Washout Period (7 Days )||0||
48629652|NCT04821063|101878439|FG005|NOT COMPLETED|Washout Period (7 Days )||0||
48174725|NCT01993823|100750014|FG000|COMPLETED|Overall Study||88||
48629653|NCT04821063|101878440|FG006|NOT COMPLETED|Washout Period (7 Days )||0||
48752581|NCT00265564|102180988|FG000|NOT COMPLETED|Overall Study||10||
48752582|NCT00265564|102180989|FG001|NOT COMPLETED|Overall Study||9||
48335582|NCT03326141|101148462|FG002|COMPLETED|Overall Study||74||
48335583|NCT03326141|101148463|FG003|COMPLETED|Overall Study||75||
48335584|NCT03326141|101148460|FG000|NOT COMPLETED|Overall Study||1||
48335585|NCT03326141|101148461|FG001|NOT COMPLETED|Overall Study||2||
48335586|NCT03326141|101148462|FG002|NOT COMPLETED|Overall Study||2||
48335587|NCT03326141|101148463|FG003|NOT COMPLETED|Overall Study||2||
48335588|NCT02425098|101148464|FG000|STARTED|Overall Study||176||
48335589|NCT02425098|101148465|FG001|STARTED|Overall Study||175||
48335590|NCT02425098|101148464|FG000|COMPLETED|Overall Study||163||
48335591|NCT02425098|101148465|FG001|COMPLETED|Overall Study||159||
48335592|NCT02425098|101148464|FG000|NOT COMPLETED|Overall Study||13||
48335593|NCT02425098|101148465|FG001|NOT COMPLETED|Overall Study||16||
48335594|NCT03128957|101148466|FG000|STARTED|Overall Study||10||
48335595|NCT03128957|101148466|FG000|COMPLETED|Overall Study||10||
48335596|NCT03128957|101148466|FG000|NOT COMPLETED|Overall Study||0||
48335597|NCT02615743|101148467|FG000|STARTED|Overall Study||21||
48335598|NCT02615743|101148468|FG001|STARTED|Overall Study||20||
48335599|NCT02615743|101148467|FG000|COMPLETED|Overall Study||15||
48335600|NCT02615743|101148468|FG001|COMPLETED|Overall Study||17||
48335601|NCT02615743|101148467|FG000|NOT COMPLETED|Overall Study||6||
48335602|NCT02615743|101148468|FG001|NOT COMPLETED|Overall Study||3||
48335603|NCT00604968|101148469|FG000|STARTED|Overall Study||25||
48335604|NCT00604968|101148469|FG000|COMPLETED|Overall Study||25||
48335605|NCT00604968|101148469|FG000|NOT COMPLETED|Overall Study||0||
48629654|NCT04821063|101878441|FG007|NOT COMPLETED|Washout Period (7 Days )||0||
48335606|NCT01818297|101148470|FG000|STARTED|Blinded Phase (Randomization - 3 Months)||32||
48335607|NCT01818297|101148471|FG001|STARTED|Blinded Phase (Randomization - 3 Months)||30||
48412362|NCT00424099|101341994|FG001|COMPLETED|Overall Study||31||
48412363|NCT00424099|101341995|FG002|COMPLETED|Overall Study||38||
48412364|NCT00424099|101341996|FG003|COMPLETED|Overall Study||35||
48629655|NCT04821063|101878442|FG008|NOT COMPLETED|Washout Period (7 Days )||0||
48629656|NCT04821063|101878443|FG009|NOT COMPLETED|Washout Period (7 Days )||0||
48629657|NCT04821063|101878444|FG010|NOT COMPLETED|Washout Period (7 Days )||0||
48629658|NCT04821063|101878445|FG011|NOT COMPLETED|Washout Period (7 Days )||0||
48629659|NCT04821063|101878434|FG000|STARTED|Period 2 (1 Day)||1||
48629660|NCT04821063|101878435|FG001|STARTED|Period 2 (1 Day)||1||
48629661|NCT04821063|101878436|FG002|STARTED|Period 2 (1 Day)||2||
48629662|NCT04821063|101878437|FG003|STARTED|Period 2 (1 Day)||3||
48629663|NCT04821063|101878438|FG004|STARTED|Period 2 (1 Day)||3||
48629664|NCT04821063|101878439|FG005|STARTED|Period 2 (1 Day)||3||
48629665|NCT04821063|101878440|FG006|STARTED|Period 2 (1 Day)||3||
48629666|NCT04821063|101878441|FG007|STARTED|Period 2 (1 Day)||3||
48629667|NCT04821063|101878442|FG008|STARTED|Period 2 (1 Day)||3||
48629668|NCT04821063|101878443|FG009|STARTED|Period 2 (1 Day)||3||
48629669|NCT04821063|101878444|FG010|STARTED|Period 2 (1 Day)||3||
48629670|NCT04821063|101878445|FG011|STARTED|Period 2 (1 Day)||3||
48629671|NCT04821063|101878434|FG000|COMPLETED|Period 2 (1 Day)||1||
48629672|NCT04821063|101878435|FG001|COMPLETED|Period 2 (1 Day)||1||
48629673|NCT04821063|101878436|FG002|COMPLETED|Period 2 (1 Day)||2||
48629674|NCT04821063|101878437|FG003|COMPLETED|Period 2 (1 Day)||3||
48629675|NCT04821063|101878438|FG004|COMPLETED|Period 2 (1 Day)||3||
48629676|NCT04821063|101878439|FG005|COMPLETED|Period 2 (1 Day)||3||
48629677|NCT04821063|101878440|FG006|COMPLETED|Period 2 (1 Day)||3||
48629678|NCT04821063|101878441|FG007|COMPLETED|Period 2 (1 Day)||3||
48629679|NCT04821063|101878442|FG008|COMPLETED|Period 2 (1 Day)||3||
48629680|NCT04821063|101878443|FG009|COMPLETED|Period 2 (1 Day)||3||
48629681|NCT04821063|101878444|FG010|COMPLETED|Period 2 (1 Day)||3||
48629682|NCT04821063|101878445|FG011|COMPLETED|Period 2 (1 Day)||3||
48629683|NCT04821063|101878434|FG000|NOT COMPLETED|Period 2 (1 Day)||0||
48629684|NCT04821063|101878435|FG001|NOT COMPLETED|Period 2 (1 Day)||0||
48629685|NCT04821063|101878436|FG002|NOT COMPLETED|Period 2 (1 Day)||0||
48629686|NCT04821063|101878437|FG003|NOT COMPLETED|Period 2 (1 Day)||0||
48335608|NCT01818297|101148470|FG000|Week 1|Blinded Phase (Randomization - 3 Months)||32||
48335609|NCT01818297|101148471|FG001|Week 1|Blinded Phase (Randomization - 3 Months)||30||
48335610|NCT01818297|101148470|FG000|Week 6|Blinded Phase (Randomization - 3 Months)||32||
48335611|NCT01818297|101148471|FG001|Week 6|Blinded Phase (Randomization - 3 Months)||29||
48752583|NCT01033240|102180990|FG000|STARTED|Overall Study||55||
48752584|NCT01033240|102180991|FG001|STARTED|Overall Study||53||
48752585|NCT01033240|102180992|FG002|STARTED|Overall Study||55||
48752586|NCT01033240|102180990|FG000|COMPLETED|Overall Study||6||
48752587|NCT01033240|102180991|FG001|COMPLETED|Overall Study||3||
48752588|NCT01033240|102180992|FG002|COMPLETED|Overall Study||2||
48752589|NCT01033240|102180990|FG000|NOT COMPLETED|Overall Study||49||
48752590|NCT01033240|102180991|FG001|NOT COMPLETED|Overall Study||50||
48174726|NCT01993823|100750015|FG001|COMPLETED|Overall Study||79||
48174727|NCT01993823|100750014|FG000|NOT COMPLETED|Overall Study||7||
48174728|NCT01993823|100750015|FG001|NOT COMPLETED|Overall Study||16||
48335612|NCT01818297|101148470|FG000|COMPLETED|Blinded Phase (Randomization - 3 Months)||32||
48412365|NCT00424099|101341993|FG000|NOT COMPLETED|Overall Study||7||
48752591|NCT01033240|102180992|FG002|NOT COMPLETED|Overall Study||53||
48752592|NCT00866177|102180993|FG000|STARTED|Overall Study||167||
48752593|NCT00866177|102180993|FG000|COMPLETED|Overall Study||15||
48752594|NCT00866177|102180993|FG000|NOT COMPLETED|Overall Study||152||
48752595|NCT03043534|102180994|FG000|STARTED|Overall Study||15||
48752596|NCT03043534|102180995|FG001|STARTED|Overall Study||14||
48752597|NCT03043534|102180994|FG000|COMPLETED|Overall Study||15||
48752598|NCT03043534|102180995|FG001|COMPLETED|Overall Study||14||
48752599|NCT03043534|102180994|FG000|NOT COMPLETED|Overall Study||0||
48752600|NCT03043534|102180995|FG001|NOT COMPLETED|Overall Study||0||
48752601|NCT03057496|102180996|FG000|STARTED|Overall Study||49||
48752602|NCT03057496|102180996|FG000|Started Home-use Trial|Overall Study||36||
48752603|NCT03057496|102180996|FG000|COMPLETED|Overall Study||31||
48752604|NCT03057496|102180996|FG000|NOT COMPLETED|Overall Study||18||
48752605|NCT00350025|102180997|FG000|STARTED|Overall Study||11||
48752606|NCT00350025|102180998|FG001|STARTED|Overall Study||30||
48752607|NCT00350025|102180997|FG000|COMPLETED|Overall Study||11||
48752608|NCT00350025|102180998|FG001|COMPLETED|Overall Study||28||
48752609|NCT00350025|102180997|FG000|NOT COMPLETED|Overall Study||0||
48752610|NCT00350025|102180998|FG001|NOT COMPLETED|Overall Study||2||
48752611|NCT03052101|102180999|FG000|STARTED|Overall Study||94||
48752612|NCT03052101|102180999|FG000|COMPLETED|Overall Study||94||
48752613|NCT03052101|102180999|FG000|NOT COMPLETED|Overall Study||0||
48752614|NCT03905096|102181000|FG000|STARTED|Period 1 for Trial Part 1 and 2||18||
48752615|NCT03905096|102181001|FG001|STARTED|Period 1 for Trial Part 1 and 2||14||
48752616|NCT03905096|102181000|FG000|COMPLETED|Period 1 for Trial Part 1 and 2||18||
48752617|NCT03905096|102181001|FG001|COMPLETED|Period 1 for Trial Part 1 and 2||14||
48752618|NCT03905096|102181000|FG000|NOT COMPLETED|Period 1 for Trial Part 1 and 2||0||
48752619|NCT03905096|102181001|FG001|NOT COMPLETED|Period 1 for Trial Part 1 and 2||0||
48752620|NCT03905096|102181000|FG000|STARTED|Period 2 for Trial Part 1 and 2||18||
48752621|NCT03905096|102181001|FG001|STARTED|Period 2 for Trial Part 1 and 2||14||
48752622|NCT03905096|102181000|FG000|COMPLETED|Period 2 for Trial Part 1 and 2||17||
48752623|NCT03905096|102181001|FG001|COMPLETED|Period 2 for Trial Part 1 and 2||14||
48752624|NCT03905096|102181000|FG000|NOT COMPLETED|Period 2 for Trial Part 1 and 2||1||
48752625|NCT03905096|102181001|FG001|NOT COMPLETED|Period 2 for Trial Part 1 and 2||0||
48752626|NCT01277744|102181002|FG000|STARTED|Overall Study||22||
48752627|NCT01277744|102181002|FG000|COMPLETED|Overall Study||20||
48752628|NCT01277744|102181002|FG000|NOT COMPLETED|Overall Study||2||
48335613|NCT01818297|101148471|FG001|COMPLETED|Blinded Phase (Randomization - 3 Months)||29||
48412366|NCT00424099|101341994|FG001|NOT COMPLETED|Overall Study||16||
48412367|NCT00424099|101341995|FG002|NOT COMPLETED|Overall Study||12||
48752629|NCT00561652|102181003|FG000|STARTED|Overall Study||10||
48752630|NCT00561652|102181004|FG001|STARTED|Overall Study||20||
48752631|NCT00561652|102181003|FG000|COMPLETED|Overall Study||10||
48752632|NCT00561652|102181004|FG001|COMPLETED|Overall Study||19||
48752633|NCT00561652|102181003|FG000|NOT COMPLETED|Overall Study||0||
48752634|NCT00561652|102181004|FG001|NOT COMPLETED|Overall Study||1||
48752635|NCT02690181|102181005|FG000|STARTED|Overall Study||14||
48752636|NCT02690181|102181006|FG001|STARTED|Overall Study||14||
48752637|NCT02690181|102181007|FG002|STARTED|Overall Study||15||
48752638|NCT02690181|102181008|FG003|STARTED|Overall Study||10||
48752639|NCT02690181|102181009|FG004|STARTED|Overall Study||6||
48752640|NCT02690181|102181010|FG005|STARTED|Overall Study||21||
48752641|NCT02690181|102181005|FG000|COMPLETED|Overall Study||14||
48752642|NCT02690181|102181006|FG001|COMPLETED|Overall Study||14||
48752643|NCT02690181|102181007|FG002|COMPLETED|Overall Study||15||
48752644|NCT02690181|102181008|FG003|COMPLETED|Overall Study||10||
48752645|NCT02690181|102181009|FG004|COMPLETED|Overall Study||6||
48752646|NCT02690181|102181010|FG005|COMPLETED|Overall Study||21||
48752647|NCT02690181|102181005|FG000|NOT COMPLETED|Overall Study||0||
48752648|NCT02690181|102181006|FG001|NOT COMPLETED|Overall Study||0||
48752649|NCT02690181|102181007|FG002|NOT COMPLETED|Overall Study||0||
48752650|NCT02690181|102181008|FG003|NOT COMPLETED|Overall Study||0||
48752651|NCT02690181|102181009|FG004|NOT COMPLETED|Overall Study||0||
48174729|NCT01275196|100750016|FG000|STARTED|Overall Study||133||
48174730|NCT01275196|100750017|FG001|STARTED|Overall Study||134||
48174731|NCT01275196|100750016|FG000|Intended to Continue Into Extension|Overall Study||112||
48412368|NCT00424099|101341996|FG003|NOT COMPLETED|Overall Study||13||
48412369|NCT00394277|101341997|FG000|STARTED|Overall Study||195||
48412370|NCT00394277|101341998|FG001|STARTED|Overall Study||196||
48412371|NCT00394277|101341999|FG002|STARTED|Overall Study||393||
48412372|NCT00394277|101342000|FG003|STARTED|Overall Study||391||
48412373|NCT00394277|101341997|FG000|COMPLETED|Overall Study||137||
48412374|NCT00394277|101341998|FG001|COMPLETED|Overall Study||136||
48412375|NCT00394277|101341999|FG002|COMPLETED|Overall Study||273||
48412376|NCT00394277|101342000|FG003|COMPLETED|Overall Study||266||
48412377|NCT00394277|101341997|FG000|NOT COMPLETED|Overall Study||58||
48412378|NCT00394277|101341998|FG001|NOT COMPLETED|Overall Study||60||
48412379|NCT00394277|101341999|FG002|NOT COMPLETED|Overall Study||120||
48412380|NCT00394277|101342000|FG003|NOT COMPLETED|Overall Study||125||
48412381|NCT03685643|101342001|FG000|STARTED|Overall Study||290||
48412382|NCT03685643|101342002|FG001|STARTED|Overall Study||288||
48412383|NCT03685643|101342001|FG000|COMPLETED|Overall Study||276||
48174732|NCT01275196|100750017|FG001|Intended to Continue Into Extension|Overall Study||113||
48335614|NCT01818297|101148470|FG000|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||0||
48335615|NCT01818297|101148471|FG001|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||1||
48335616|NCT01818297|101148470|FG000|STARTED|Open Label Phase (3-12 Months)||32||
48335617|NCT01818297|101148471|FG001|STARTED|Open Label Phase (3-12 Months)||29||
48335618|NCT01818297|101148470|FG000|COMPLETED|Open Label Phase (3-12 Months)||14||
48335619|NCT01818297|101148471|FG001|COMPLETED|Open Label Phase (3-12 Months)||19||
48335620|NCT01818297|101148470|FG000|NOT COMPLETED|Open Label Phase (3-12 Months)||18||
48335621|NCT01818297|101148471|FG001|NOT COMPLETED|Open Label Phase (3-12 Months)||10||
48335622|NCT00820573|101148472|FG000|STARTED|Overall Study||4||
48335623|NCT00820573|101148473|FG001|STARTED|Overall Study||4||
48412384|NCT03685643|101342002|FG001|COMPLETED|Overall Study||266||
48412385|NCT03685643|101342001|FG000|NOT COMPLETED|Overall Study||14||
48412386|NCT03685643|101342002|FG001|NOT COMPLETED|Overall Study||22||
48412387|NCT04921969|101342003|FG000|STARTED|VC Period (Day 1 to Week 8)||65||
48412388|NCT04921969|101342004|FG001|STARTED|VC Period (Day 1 to Week 8)||134||
48412389|NCT04921969|101342005|FG002|STARTED|VC Period (Day 1 to Week 8)||131||
48412390|NCT04921969|101342006|FG003|STARTED|VC Period (Day 1 to Week 8)||0||
48412391|NCT04921969|101342007|FG004|STARTED|VC Period (Day 1 to Week 8)||0||
48412392|NCT04921969|101342008|FG005|STARTED|VC Period (Day 1 to Week 8)||0||
48412393|NCT04921969|101342009|FG006|STARTED|VC Period (Day 1 to Week 8)||0||
48412394|NCT04921969|101342003|FG000|COMPLETED|VC Period (Day 1 to Week 8)||49||
48412395|NCT04921969|101342004|FG001|COMPLETED|VC Period (Day 1 to Week 8)||120||
48412396|NCT04921969|101342005|FG002|COMPLETED|VC Period (Day 1 to Week 8)||115||
48412397|NCT04921969|101342006|FG003|COMPLETED|VC Period (Day 1 to Week 8)||0||
48412398|NCT04921969|101342007|FG004|COMPLETED|VC Period (Day 1 to Week 8)||0||
48412399|NCT04921969|101342008|FG005|COMPLETED|VC Period (Day 1 to Week 8)||0||
48412400|NCT04921969|101342009|FG006|COMPLETED|VC Period (Day 1 to Week 8)||0||
48412401|NCT04921969|101342003|FG000|NOT COMPLETED|VC Period (Day 1 to Week 8)||16||
48412402|NCT04921969|101342004|FG001|NOT COMPLETED|VC Period (Day 1 to Week 8)||14||
48412403|NCT04921969|101342005|FG002|NOT COMPLETED|VC Period (Day 1 to Week 8)||16||
48412404|NCT04921969|101342006|FG003|NOT COMPLETED|VC Period (Day 1 to Week 8)||0||
48412405|NCT04921969|101342007|FG004|NOT COMPLETED|VC Period (Day 1 to Week 8)||0||
48412406|NCT04921969|101342008|FG005|NOT COMPLETED|VC Period (Day 1 to Week 8)||0||
48412407|NCT04921969|101342009|FG006|NOT COMPLETED|VC Period (Day 1 to Week 8)||0||
48335624|NCT00820573|101148474|FG002|STARTED|Overall Study||4||
48335625|NCT00820573|101148475|FG003|STARTED|Overall Study||4||
48335626|NCT00820573|101148472|FG000|COMPLETED|Overall Study||4||
48335627|NCT00820573|101148473|FG001|COMPLETED|Overall Study||4||
48335628|NCT00820573|101148474|FG002|COMPLETED|Overall Study||4||
48412408|NCT04921969|101342003|FG000|STARTED|LTS Period (Weeks 8 to 52)||0||
48412409|NCT04921969|101342004|FG001|STARTED|LTS Period (Weeks 8 to 52)||0||
48412410|NCT04921969|101342005|FG002|STARTED|LTS Period (Weeks 8 to 52)||0||
48174733|NCT01275196|100750016|FG000|COMPLETED|Overall Study||113||
48412411|NCT04921969|101342006|FG003|STARTED|LTS Period (Weeks 8 to 52)||25||
48335629|NCT00820573|101148475|FG003|COMPLETED|Overall Study||4||
48335630|NCT00820573|101148472|FG000|NOT COMPLETED|Overall Study||0||
48174734|NCT01275196|100750017|FG001|COMPLETED|Overall Study||113||
48174735|NCT01275196|100750016|FG000|NOT COMPLETED|Overall Study||20||
48174736|NCT01275196|100750017|FG001|NOT COMPLETED|Overall Study||21||
48174737|NCT01468922|100750018|FG000|STARTED|Overall Study||3||
48174738|NCT01468922|100750019|FG001|STARTED|Overall Study||3||
48174739|NCT01468922|100750020|FG002|STARTED|Overall Study||2||
48174740|NCT01468922|100750021|FG003|STARTED|Overall Study||1||
48174741|NCT01468922|100750022|FG004|STARTED|Overall Study||4||
48174742|NCT01468922|100750023|FG005|STARTED|Overall Study||1||
48335631|NCT00820573|101148473|FG001|NOT COMPLETED|Overall Study||0||
48335632|NCT00820573|101148474|FG002|NOT COMPLETED|Overall Study||0||
48335633|NCT00820573|101148475|FG003|NOT COMPLETED|Overall Study||0||
48335634|NCT01370460|101148476|FG000|STARTED|Overall Study||50||
48629687|NCT04821063|101878438|FG004|NOT COMPLETED|Period 2 (1 Day)||0||
48629688|NCT04821063|101878439|FG005|NOT COMPLETED|Period 2 (1 Day)||0||
48629689|NCT04821063|101878440|FG006|NOT COMPLETED|Period 2 (1 Day)||0||
48629690|NCT04821063|101878441|FG007|NOT COMPLETED|Period 2 (1 Day)||0||
48629691|NCT04821063|101878442|FG008|NOT COMPLETED|Period 2 (1 Day)||0||
48629692|NCT04821063|101878443|FG009|NOT COMPLETED|Period 2 (1 Day)||0||
48629693|NCT04821063|101878444|FG010|NOT COMPLETED|Period 2 (1 Day)||0||
48629694|NCT04821063|101878445|FG011|NOT COMPLETED|Period 2 (1 Day)||0||
48629695|NCT04821063|101878434|FG000|STARTED|Washout Period (7 Days)||1||
48629696|NCT04821063|101878435|FG001|STARTED|Washout Period (7 Days)||1||
48629697|NCT04821063|101878436|FG002|STARTED|Washout Period (7 Days)||2||
48629698|NCT04821063|101878437|FG003|STARTED|Washout Period (7 Days)||3||
48629699|NCT04821063|101878438|FG004|STARTED|Washout Period (7 Days)||3||
48629700|NCT04821063|101878439|FG005|STARTED|Washout Period (7 Days)||3||
48629701|NCT04821063|101878440|FG006|STARTED|Washout Period (7 Days)||3||
48629702|NCT04821063|101878441|FG007|STARTED|Washout Period (7 Days)||3||
48629703|NCT04821063|101878442|FG008|STARTED|Washout Period (7 Days)||3||
48629704|NCT04821063|101878443|FG009|STARTED|Washout Period (7 Days)||3||
48629705|NCT04821063|101878444|FG010|STARTED|Washout Period (7 Days)||3||
48629706|NCT04821063|101878445|FG011|STARTED|Washout Period (7 Days)||3||
48629707|NCT04821063|101878434|FG000|COMPLETED|Washout Period (7 Days)||1||
48629708|NCT04821063|101878435|FG001|COMPLETED|Washout Period (7 Days)||1||
48629709|NCT04821063|101878436|FG002|COMPLETED|Washout Period (7 Days)||2||
48629710|NCT04821063|101878437|FG003|COMPLETED|Washout Period (7 Days)||3||
48629711|NCT04821063|101878438|FG004|COMPLETED|Washout Period (7 Days)||3||
48629712|NCT04821063|101878439|FG005|COMPLETED|Washout Period (7 Days)||3||
48629713|NCT04821063|101878440|FG006|COMPLETED|Washout Period (7 Days)||3||
48629714|NCT04821063|101878441|FG007|COMPLETED|Washout Period (7 Days)||3||
48629715|NCT04821063|101878442|FG008|COMPLETED|Washout Period (7 Days)||3||
48629716|NCT04821063|101878443|FG009|COMPLETED|Washout Period (7 Days)||3||
48629717|NCT04821063|101878444|FG010|COMPLETED|Washout Period (7 Days)||3||
48752652|NCT02690181|102181010|FG005|NOT COMPLETED|Overall Study||0||
48629718|NCT04821063|101878445|FG011|COMPLETED|Washout Period (7 Days)||3||
48629719|NCT04821063|101878434|FG000|NOT COMPLETED|Washout Period (7 Days)||0||
48752653|NCT03332459|102181011|FG000|STARTED|Overall Study||3||
48752654|NCT03332459|102181012|FG001|STARTED|Overall Study||1||
48752655|NCT03332459|102181013|FG002|STARTED|Overall Study||3||
48335635|NCT01370460|101148477|FG001|STARTED|Overall Study||51||
48335636|NCT01370460|101148476|FG000|COMPLETED|Overall Study||50||
48335637|NCT01370460|101148477|FG001|COMPLETED|Overall Study||51||
48335638|NCT01370460|101148476|FG000|NOT COMPLETED|Overall Study||0||
48629720|NCT04821063|101878435|FG001|NOT COMPLETED|Washout Period (7 Days)||0||
48752656|NCT03332459|102181011|FG000|COMPLETED|Overall Study||3||
48752657|NCT03332459|102181012|FG001|COMPLETED|Overall Study||1||
48752658|NCT03332459|102181013|FG002|COMPLETED|Overall Study||3||
48752659|NCT03332459|102181011|FG000|NOT COMPLETED|Overall Study||0||
48752660|NCT03332459|102181012|FG001|NOT COMPLETED|Overall Study||0||
48752661|NCT03332459|102181013|FG002|NOT COMPLETED|Overall Study||0||
48752662|NCT01746368|102181014|FG000|STARTED|Overall Study||33||
48752663|NCT01746368|102181015|FG001|STARTED|Overall Study||17||
48335639|NCT01370460|101148477|FG001|NOT COMPLETED|Overall Study||0||
48629721|NCT04821063|101878436|FG002|NOT COMPLETED|Washout Period (7 Days)||0||
48752664|NCT01746368|102181014|FG000|Recieved Allocated Intervention|Overall Study||31||
48752665|NCT01746368|102181015|FG001|Recieved Allocated Intervention|Overall Study||8||
48752666|NCT01746368|102181014|FG000|Assessment Completed|Overall Study||31||
48174743|NCT01468922|100750024|FG006|STARTED|Overall Study||1||
48174744|NCT01468922|100750025|FG007|STARTED|Overall Study||16||
48174745|NCT01468922|100750026|FG008|STARTED|Overall Study||1||
48174746|NCT01468922|100750018|FG000|COMPLETED|Overall Study||1||
48174747|NCT01468922|100750019|FG001|COMPLETED|Overall Study||3||
48629722|NCT04821063|101878437|FG003|NOT COMPLETED|Washout Period (7 Days)||0||
48629723|NCT04821063|101878438|FG004|NOT COMPLETED|Washout Period (7 Days)||0||
48629724|NCT04821063|101878439|FG005|NOT COMPLETED|Washout Period (7 Days)||0||
48629725|NCT04821063|101878440|FG006|NOT COMPLETED|Washout Period (7 Days)||0||
48174748|NCT01468922|100750020|FG002|COMPLETED|Overall Study||2||
48174749|NCT01468922|100750021|FG003|COMPLETED|Overall Study||1||
48335640|NCT00939692|101151856|FG000|STARTED|Period 1 - First Intervention - 5 Days||13||
48629726|NCT04821063|101878441|FG007|NOT COMPLETED|Washout Period (7 Days)||0||
48752667|NCT01746368|102181015|FG001|Assessment Completed|Overall Study||16||
48752668|NCT01746368|102181014|FG000|Analyzed for AD Completion Rate|Overall Study||32||
48629727|NCT04821063|101878442|FG008|NOT COMPLETED|Washout Period (7 Days)||0||
48629728|NCT04821063|101878443|FG009|NOT COMPLETED|Washout Period (7 Days)||0||
48629729|NCT04821063|101878444|FG010|NOT COMPLETED|Washout Period (7 Days)||0||
48629730|NCT04821063|101878445|FG011|NOT COMPLETED|Washout Period (7 Days)||0||
48629731|NCT04821063|101878434|FG000|STARTED|Period 3 (1 Day)||1||
48629732|NCT04821063|101878435|FG001|STARTED|Period 3 (1 Day)||1||
48629733|NCT04821063|101878436|FG002|STARTED|Period 3 (1 Day)||2||
48629734|NCT04821063|101878437|FG003|STARTED|Period 3 (1 Day)||3||
48629735|NCT04821063|101878438|FG004|STARTED|Period 3 (1 Day)||3||
48412412|NCT04921969|101342007|FG004|STARTED|LTS Period (Weeks 8 to 52)||24||
48412413|NCT04921969|101342008|FG005|STARTED|LTS Period (Weeks 8 to 52)||119||
48412414|NCT04921969|101342009|FG006|STARTED|LTS Period (Weeks 8 to 52)||114||
48412415|NCT04921969|101342003|FG000|COMPLETED|LTS Period (Weeks 8 to 52)||0||
48412416|NCT04921969|101342004|FG001|COMPLETED|LTS Period (Weeks 8 to 52)||0||
48629736|NCT04821063|101878439|FG005|STARTED|Period 3 (1 Day)||3||
48629737|NCT04821063|101878440|FG006|STARTED|Period 3 (1 Day)||3||
48629738|NCT04821063|101878441|FG007|STARTED|Period 3 (1 Day)||3||
48629739|NCT04821063|101878442|FG008|STARTED|Period 3 (1 Day)||3||
48629740|NCT04821063|101878443|FG009|STARTED|Period 3 (1 Day)||3||
48629741|NCT04821063|101878444|FG010|STARTED|Period 3 (1 Day)||3||
48629742|NCT04821063|101878445|FG011|STARTED|Period 3 (1 Day)||3||
48629743|NCT04821063|101878434|FG000|COMPLETED|Period 3 (1 Day)||1||
48629744|NCT04821063|101878435|FG001|COMPLETED|Period 3 (1 Day)||1||
48629745|NCT04821063|101878436|FG002|COMPLETED|Period 3 (1 Day)||2||
48629746|NCT04821063|101878437|FG003|COMPLETED|Period 3 (1 Day)||3||
48412417|NCT04921969|101342005|FG002|COMPLETED|LTS Period (Weeks 8 to 52)||0||
48412418|NCT04921969|101342006|FG003|COMPLETED|LTS Period (Weeks 8 to 52)||5||
48412419|NCT04921969|101342007|FG004|COMPLETED|LTS Period (Weeks 8 to 52)||8||
48412420|NCT04921969|101342008|FG005|COMPLETED|LTS Period (Weeks 8 to 52)||28||
48412421|NCT04921969|101342009|FG006|COMPLETED|LTS Period (Weeks 8 to 52)||33||
48412422|NCT04921969|101342003|FG000|NOT COMPLETED|LTS Period (Weeks 8 to 52)||0||
48412423|NCT04921969|101342004|FG001|NOT COMPLETED|LTS Period (Weeks 8 to 52)||0||
48412424|NCT04921969|101342005|FG002|NOT COMPLETED|LTS Period (Weeks 8 to 52)||0||
48412425|NCT04921969|101342006|FG003|NOT COMPLETED|LTS Period (Weeks 8 to 52)||20||
48629747|NCT04821063|101878438|FG004|COMPLETED|Period 3 (1 Day)||3||
48629748|NCT04821063|101878439|FG005|COMPLETED|Period 3 (1 Day)||3||
48629749|NCT04821063|101878440|FG006|COMPLETED|Period 3 (1 Day)||3||
48629750|NCT04821063|101878441|FG007|COMPLETED|Period 3 (1 Day)||3||
48629751|NCT04821063|101878442|FG008|COMPLETED|Period 3 (1 Day)||3||
48629752|NCT04821063|101878443|FG009|COMPLETED|Period 3 (1 Day)||3||
48629753|NCT04821063|101878444|FG010|COMPLETED|Period 3 (1 Day)||3||
48629754|NCT04821063|101878445|FG011|COMPLETED|Period 3 (1 Day)||3||
48629755|NCT04821063|101878434|FG000|NOT COMPLETED|Period 3 (1 Day)||0||
48629756|NCT04821063|101878435|FG001|NOT COMPLETED|Period 3 (1 Day)||0||
48629757|NCT04821063|101878436|FG002|NOT COMPLETED|Period 3 (1 Day)||0||
48629758|NCT04821063|101878437|FG003|NOT COMPLETED|Period 3 (1 Day)||0||
48629759|NCT04821063|101878438|FG004|NOT COMPLETED|Period 3 (1 Day)||0||
48629760|NCT04821063|101878439|FG005|NOT COMPLETED|Period 3 (1 Day)||0||
48629761|NCT04821063|101878440|FG006|NOT COMPLETED|Period 3 (1 Day)||0||
48752669|NCT01746368|102181015|FG001|Analyzed for AD Completion Rate|Overall Study||17||
48752670|NCT01746368|102181014|FG000|Analyzed for Satisfaction|Overall Study||30||
48752671|NCT01746368|102181015|FG001|Analyzed for Satisfaction|Overall Study||16||
48752672|NCT01746368|102181014|FG000|COMPLETED|Overall Study||31||
48752673|NCT01746368|102181015|FG001|COMPLETED|Overall Study||16||
48752674|NCT01746368|102181014|FG000|NOT COMPLETED|Overall Study||2||
48752675|NCT01746368|102181015|FG001|NOT COMPLETED|Overall Study||1||
48752676|NCT02520726|102181016|FG000|STARTED|Overall Study||3||
48752677|NCT02520726|102181017|FG001|STARTED|Overall Study||2||
48752678|NCT02520726|102181016|FG000|COMPLETED|Overall Study||0||
48752679|NCT02520726|102181017|FG001|COMPLETED|Overall Study||0||
48629762|NCT04821063|101878441|FG007|NOT COMPLETED|Period 3 (1 Day)||0||
48629763|NCT04821063|101878442|FG008|NOT COMPLETED|Period 3 (1 Day)||0||
48752680|NCT02520726|102181016|FG000|NOT COMPLETED|Overall Study||3||
48174750|NCT01468922|100750022|FG004|COMPLETED|Overall Study||2||
48629764|NCT04821063|101878443|FG009|NOT COMPLETED|Period 3 (1 Day)||0||
48629765|NCT04821063|101878444|FG010|NOT COMPLETED|Period 3 (1 Day)||0||
48629766|NCT04821063|101878445|FG011|NOT COMPLETED|Period 3 (1 Day)||0||
48629767|NCT04821063|101878434|FG000|STARTED|Washout Period 3 (7 Days)||1||
48629768|NCT04821063|101878435|FG001|STARTED|Washout Period 3 (7 Days)||1||
48629769|NCT04821063|101878436|FG002|STARTED|Washout Period 3 (7 Days)||2||
48629770|NCT04821063|101878437|FG003|STARTED|Washout Period 3 (7 Days)||3||
48629771|NCT04821063|101878438|FG004|STARTED|Washout Period 3 (7 Days)||3||
48629772|NCT04821063|101878439|FG005|STARTED|Washout Period 3 (7 Days)||3||
48629773|NCT04821063|101878440|FG006|STARTED|Washout Period 3 (7 Days)||3||
48629774|NCT04821063|101878441|FG007|STARTED|Washout Period 3 (7 Days)||3||
48629775|NCT04821063|101878442|FG008|STARTED|Washout Period 3 (7 Days)||3||
48629776|NCT04821063|101878443|FG009|STARTED|Washout Period 3 (7 Days)||3||
48629777|NCT04821063|101878444|FG010|STARTED|Washout Period 3 (7 Days)||3||
48629778|NCT04821063|101878445|FG011|STARTED|Washout Period 3 (7 Days)||3||
48629779|NCT04821063|101878434|FG000|COMPLETED|Washout Period 3 (7 Days)||1||
48629780|NCT04821063|101878435|FG001|COMPLETED|Washout Period 3 (7 Days)||1||
48629781|NCT04821063|101878436|FG002|COMPLETED|Washout Period 3 (7 Days)||2||
48629782|NCT04821063|101878437|FG003|COMPLETED|Washout Period 3 (7 Days)||3||
48629783|NCT04821063|101878438|FG004|COMPLETED|Washout Period 3 (7 Days)||3||
48629784|NCT04821063|101878439|FG005|COMPLETED|Washout Period 3 (7 Days)||3||
48629785|NCT04821063|101878440|FG006|COMPLETED|Washout Period 3 (7 Days)||3||
48629786|NCT04821063|101878441|FG007|COMPLETED|Washout Period 3 (7 Days)||3||
48629787|NCT04821063|101878442|FG008|COMPLETED|Washout Period 3 (7 Days)||3||
48629788|NCT04821063|101878443|FG009|COMPLETED|Washout Period 3 (7 Days)||3||
48629789|NCT04821063|101878444|FG010|COMPLETED|Washout Period 3 (7 Days)||3||
48629790|NCT04821063|101878445|FG011|COMPLETED|Washout Period 3 (7 Days)||3||
48629791|NCT04821063|101878434|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48629792|NCT04821063|101878435|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48629793|NCT04821063|101878436|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48629794|NCT04821063|101878437|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48629795|NCT04821063|101878438|FG004|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48174751|NCT01468922|100750023|FG005|COMPLETED|Overall Study||1||
48752681|NCT02520726|102181017|FG001|NOT COMPLETED|Overall Study||2||
48752682|NCT00918385|102181018|FG000|STARTED|Monotherapy||14||
48752683|NCT00918385|102181019|FG001|STARTED|Monotherapy||17||
48752684|NCT00918385|102181018|FG000|COMPLETED|Monotherapy||12||
48174752|NCT01468922|100750024|FG006|COMPLETED|Overall Study||1||
48335641|NCT00939692|101151857|FG001|STARTED|Period 1 - First Intervention - 5 Days||13||
48335642|NCT00939692|101151856|FG000|COMPLETED|Period 1 - First Intervention - 5 Days||12||
48335643|NCT00939692|101151857|FG001|COMPLETED|Period 1 - First Intervention - 5 Days||13||
48335644|NCT00939692|101151856|FG000|NOT COMPLETED|Period 1 - First Intervention - 5 Days||1||
48335645|NCT00939692|101151857|FG001|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0||
48335646|NCT00939692|101151856|FG000|STARTED|Period 2 - Second Intervent - 5 Days||12||
48335647|NCT00939692|101151857|FG001|STARTED|Period 2 - Second Intervent - 5 Days||13||
48335648|NCT00939692|101151856|FG000|COMPLETED|Period 2 - Second Intervent - 5 Days||12||
48335649|NCT00939692|101151857|FG001|COMPLETED|Period 2 - Second Intervent - 5 Days||12||
48335650|NCT00939692|101151856|FG000|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||0||
48335651|NCT00939692|101151857|FG001|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||1||
48335652|NCT02847598|101151858|FG000|STARTED|Overall Study||56||
48335653|NCT02847598|101151859|FG001|STARTED|Overall Study||6||
48335654|NCT02847598|101151860|FG002|STARTED|Overall Study||6||
48335655|NCT02847598|101151861|FG003|STARTED|Overall Study||64||
48335656|NCT02847598|101151862|FG004|STARTED|Overall Study||33||
48629796|NCT04821063|101878439|FG005|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48629797|NCT04821063|101878440|FG006|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48629798|NCT04821063|101878441|FG007|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48629799|NCT04821063|101878442|FG008|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48629800|NCT04821063|101878443|FG009|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48174753|NCT01468922|100750025|FG007|COMPLETED|Overall Study||12||
48174754|NCT01468922|100750026|FG008|COMPLETED|Overall Study||0||
48174755|NCT01468922|100750018|FG000|NOT COMPLETED|Overall Study||2||
48174756|NCT01468922|100750019|FG001|NOT COMPLETED|Overall Study||0||
48174757|NCT01468922|100750020|FG002|NOT COMPLETED|Overall Study||0||
48174758|NCT01468922|100750021|FG003|NOT COMPLETED|Overall Study||0||
48629801|NCT04821063|101878444|FG010|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48629802|NCT04821063|101878445|FG011|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48629803|NCT04821063|101878434|FG000|STARTED|Period 4 (1 Day)||1||
48629804|NCT04821063|101878435|FG001|STARTED|Period 4 (1 Day)||1||
48629805|NCT04821063|101878436|FG002|STARTED|Period 4 (1 Day)||2||
48752685|NCT00918385|102181019|FG001|COMPLETED|Monotherapy||11||
48335657|NCT02847598|101151863|FG005|STARTED|Overall Study||26||
48335658|NCT02847598|101151864|FG006|STARTED|Overall Study||25||
48629806|NCT04821063|101878437|FG003|STARTED|Period 4 (1 Day)||3||
48629807|NCT04821063|101878438|FG004|STARTED|Period 4 (1 Day)||3||
48629808|NCT04821063|101878439|FG005|STARTED|Period 4 (1 Day)||3||
48335659|NCT02847598|101151865|FG007|STARTED|Overall Study||48||
48335660|NCT02847598|101151858|FG000|COMPLETED|Overall Study||51||
48335661|NCT02847598|101151859|FG001|COMPLETED|Overall Study||6||
48335662|NCT02847598|101151860|FG002|COMPLETED|Overall Study||6||
48335663|NCT02847598|101151861|FG003|COMPLETED|Overall Study||60||
48335664|NCT02847598|101151862|FG004|COMPLETED|Overall Study||30||
48335665|NCT02847598|101151863|FG005|COMPLETED|Overall Study||23||
48335666|NCT02847598|101151864|FG006|COMPLETED|Overall Study||23||
48335667|NCT02847598|101151865|FG007|COMPLETED|Overall Study||44||
48335668|NCT02847598|101151858|FG000|NOT COMPLETED|Overall Study||5||
48629809|NCT04821063|101878440|FG006|STARTED|Period 4 (1 Day)||3||
48629810|NCT04821063|101878441|FG007|STARTED|Period 4 (1 Day)||3||
48629811|NCT04821063|101878442|FG008|STARTED|Period 4 (1 Day)||3||
48629812|NCT04821063|101878443|FG009|STARTED|Period 4 (1 Day)||3||
48629813|NCT04821063|101878444|FG010|STARTED|Period 4 (1 Day)||3||
48629814|NCT04821063|101878445|FG011|STARTED|Period 4 (1 Day)||3||
48629815|NCT04821063|101878434|FG000|COMPLETED|Period 4 (1 Day)||1||
48629816|NCT04821063|101878435|FG001|COMPLETED|Period 4 (1 Day)||1||
48752686|NCT00918385|102181018|FG000|NOT COMPLETED|Monotherapy||2||
48752687|NCT00918385|102181019|FG001|NOT COMPLETED|Monotherapy||6||
48752688|NCT00918385|102181018|FG000|STARTED|Combination Nilutamide and Dasatinib||12||
48752689|NCT00918385|102181019|FG001|STARTED|Combination Nilutamide and Dasatinib||11||
48752690|NCT00918385|102181018|FG000|COMPLETED|Combination Nilutamide and Dasatinib||6||
48752691|NCT00918385|102181019|FG001|COMPLETED|Combination Nilutamide and Dasatinib||3||
48335669|NCT02847598|101151859|FG001|NOT COMPLETED|Overall Study||0||
48629817|NCT04821063|101878436|FG002|COMPLETED|Period 4 (1 Day)||2||
48174759|NCT01468922|100750022|FG004|NOT COMPLETED|Overall Study||2||
48629818|NCT04821063|101878437|FG003|COMPLETED|Period 4 (1 Day)||3||
48629819|NCT04821063|101878438|FG004|COMPLETED|Period 4 (1 Day)||3||
48629820|NCT04821063|101878439|FG005|COMPLETED|Period 4 (1 Day)||3||
48629821|NCT04821063|101878440|FG006|COMPLETED|Period 4 (1 Day)||3||
48629822|NCT04821063|101878441|FG007|COMPLETED|Period 4 (1 Day)||3||
48629823|NCT04821063|101878442|FG008|COMPLETED|Period 4 (1 Day)||3||
48629824|NCT04821063|101878443|FG009|COMPLETED|Period 4 (1 Day)||3||
48629825|NCT04821063|101878444|FG010|COMPLETED|Period 4 (1 Day)||3||
48629826|NCT04821063|101878445|FG011|COMPLETED|Period 4 (1 Day)||3||
48629827|NCT04821063|101878434|FG000|NOT COMPLETED|Period 4 (1 Day)||0||
48629828|NCT04821063|101878435|FG001|NOT COMPLETED|Period 4 (1 Day)||0||
48629829|NCT04821063|101878436|FG002|NOT COMPLETED|Period 4 (1 Day)||0||
48629830|NCT04821063|101878437|FG003|NOT COMPLETED|Period 4 (1 Day)||0||
48629831|NCT04821063|101878438|FG004|NOT COMPLETED|Period 4 (1 Day)||0||
48629832|NCT04821063|101878439|FG005|NOT COMPLETED|Period 4 (1 Day)||0||
48629833|NCT04821063|101878440|FG006|NOT COMPLETED|Period 4 (1 Day)||0||
48629834|NCT04821063|101878441|FG007|NOT COMPLETED|Period 4 (1 Day)||0||
48629835|NCT04821063|101878442|FG008|NOT COMPLETED|Period 4 (1 Day)||0||
48629836|NCT04821063|101878443|FG009|NOT COMPLETED|Period 4 (1 Day)||0||
48629837|NCT04821063|101878444|FG010|NOT COMPLETED|Period 4 (1 Day)||0||
48629838|NCT04821063|101878445|FG011|NOT COMPLETED|Period 4 (1 Day)||0||
48629839|NCT00879658|101878446|FG000|STARTED|Overall Study||50||
48629840|NCT00879658|101878447|FG001|STARTED|Overall Study||49||
48629841|NCT00879658|101878448|FG002|STARTED|Overall Study||43||
48629842|NCT00879658|101878449|FG003|STARTED|Overall Study||46||
48629843|NCT00879658|101878450|FG004|STARTED|Overall Study||42||
48629844|NCT00879658|101878451|FG005|STARTED|Overall Study||51||
48629845|NCT00879658|101878452|FG006|STARTED|Overall Study||16||
48629846|NCT00879658|101878446|FG000|COMPLETED|Overall Study||35||
48629847|NCT00879658|101878447|FG001|COMPLETED|Overall Study||44||
48629848|NCT00879658|101878448|FG002|COMPLETED|Overall Study||36||
48174760|NCT01468922|100750023|FG005|NOT COMPLETED|Overall Study||0||
48174761|NCT01468922|100750024|FG006|NOT COMPLETED|Overall Study||0||
48174762|NCT01468922|100750025|FG007|NOT COMPLETED|Overall Study||4||
48174763|NCT01468922|100750026|FG008|NOT COMPLETED|Overall Study||1||
48174764|NCT02258464|100750027|FG000|STARTED|Overall Study||49|Participants randomized in the study|
48174765|NCT02258464|100750028|FG001|STARTED|Overall Study||50|Participants randomized in the study|
48174766|NCT02258464|100750027|FG000|COMPLETED|Overall Study||32|Participants completed treatment of Radium 223/Placebo|
48174767|NCT02258464|100750028|FG001|COMPLETED|Overall Study||25|Participants completed treatment of Radium 223/Placebo|
48174768|NCT02258464|100750027|FG000|NOT COMPLETED|Overall Study||17||
48174769|NCT02258464|100750028|FG001|NOT COMPLETED|Overall Study||25||
48174770|NCT03549234|100750029|FG000|STARTED|Overall Study||50||
48174771|NCT03549234|100750030|FG001|STARTED|Overall Study||50||
48174772|NCT03549234|100750029|FG000|COMPLETED|Overall Study||50||
48174773|NCT03549234|100750030|FG001|COMPLETED|Overall Study||50||
48174774|NCT03549234|100750029|FG000|NOT COMPLETED|Overall Study||0||
48174775|NCT03549234|100750030|FG001|NOT COMPLETED|Overall Study||0||
48174776|NCT00715741|100750031|FG000|STARTED|Overall Study||25||
48174777|NCT00715741|100750032|FG001|STARTED|Overall Study||25||
48174778|NCT00715741|100750033|FG002|STARTED|Overall Study||25||
48174779|NCT00715741|100750034|FG003|STARTED|Overall Study||25||
48174780|NCT00715741|100750031|FG000|COMPLETED|Overall Study||25||
48174781|NCT00715741|100750032|FG001|COMPLETED|Overall Study||25||
48174782|NCT00715741|100750033|FG002|COMPLETED|Overall Study||25||
48174783|NCT00715741|100750034|FG003|COMPLETED|Overall Study||25||
48174784|NCT00715741|100750031|FG000|NOT COMPLETED|Overall Study||0||
48174785|NCT00715741|100750032|FG001|NOT COMPLETED|Overall Study||0||
48174786|NCT00715741|100750033|FG002|NOT COMPLETED|Overall Study||0||
48174787|NCT00715741|100750034|FG003|NOT COMPLETED|Overall Study||0||
48174788|NCT00917267|100750035|FG000|STARTED|Overall Study||346||
48174789|NCT00917267|100750036|FG001|STARTED|Overall Study||345||
48174790|NCT00917267|100750035|FG000|Intent to Treat (ITT)|Overall Study||340||
48174791|NCT00917267|100750036|FG001|Intent to Treat (ITT)|Overall Study||338||
48174792|NCT00917267|100750035|FG000|COMPLETED|Overall Study||307||
48174793|NCT00917267|100750036|FG001|COMPLETED|Overall Study||266||
48174794|NCT00917267|100750035|FG000|NOT COMPLETED|Overall Study||39||
48629849|NCT00879658|101878449|FG003|COMPLETED|Overall Study||42||
48629850|NCT00879658|101878450|FG004|COMPLETED|Overall Study||40||
48629851|NCT00879658|101878451|FG005|COMPLETED|Overall Study||50||
48629852|NCT00879658|101878452|FG006|COMPLETED|Overall Study||16||
48629853|NCT00879658|101878446|FG000|NOT COMPLETED|Overall Study||15||
48629854|NCT00879658|101878447|FG001|NOT COMPLETED|Overall Study||5||
48629855|NCT00879658|101878448|FG002|NOT COMPLETED|Overall Study||7||
48174795|NCT00917267|100750036|FG001|NOT COMPLETED|Overall Study||79||
48174796|NCT02769065|100750037|FG000|STARTED|Overall Study||17||
48174797|NCT02769065|100750038|FG001|STARTED|Overall Study||6||
48174798|NCT02769065|100750039|FG002|STARTED|Overall Study||6||
48174799|NCT02769065|100750040|FG003|STARTED|Overall Study||6||
48629856|NCT00879658|101878449|FG003|NOT COMPLETED|Overall Study||4||
48629857|NCT00879658|101878450|FG004|NOT COMPLETED|Overall Study||2||
48629858|NCT00879658|101878451|FG005|NOT COMPLETED|Overall Study||1||
48629859|NCT00879658|101878452|FG006|NOT COMPLETED|Overall Study||0||
48629860|NCT04896216|101878453|FG000|STARTED|Overall Study||30||9
48174800|NCT02769065|100750041|FG004|STARTED|Overall Study||6||
48174801|NCT02769065|100750042|FG005|STARTED|Overall Study||6||
48174802|NCT02769065|100750043|FG006|STARTED|Overall Study||7||
48174803|NCT02769065|100750044|FG007|STARTED|Overall Study||6||
48174804|NCT02769065|100750045|FG008|STARTED|Overall Study||6||
48174805|NCT02769065|100750046|FG009|STARTED|Overall Study||6||
48174806|NCT02769065|100750047|FG010|STARTED|Overall Study||6||
48174807|NCT02769065|100750048|FG011|STARTED|Overall Study||6||
48174808|NCT02769065|100750049|FG012|STARTED|Overall Study||6||
48174809|NCT02769065|100750050|FG013|STARTED|Overall Study||6||
48174810|NCT02769065|100750051|FG014|STARTED|Overall Study||6||
48174811|NCT02769065|100750052|FG015|STARTED|Overall Study||3||
48174812|NCT02769065|100750053|FG016|STARTED|Overall Study||5||
48174813|NCT02769065|100750054|FG017|STARTED|Overall Study||5||
48174814|NCT02769065|100750055|FG018|STARTED|Overall Study||5||
48174815|NCT02769065|100750056|FG019|STARTED|Overall Study||0||
48174816|NCT02769065|100750057|FG020|STARTED|Overall Study||4||
48174817|NCT02769065|100750058|FG021|STARTED|Overall Study||4||
48174818|NCT02769065|100750059|FG022|STARTED|Overall Study||4||
48174819|NCT02769065|100750060|FG023|STARTED|Overall Study||6||
48174820|NCT02769065|100750061|FG024|STARTED|Overall Study||6||
48174821|NCT02769065|100750062|FG025|STARTED|Overall Study||9||
48174822|NCT02769065|100750063|FG026|STARTED|Overall Study||9||
48174823|NCT02769065|100750064|FG027|STARTED|Overall Study||5||
48174824|NCT02769065|100750065|FG028|STARTED|Overall Study||6||
48174825|NCT02769065|100750066|FG029|STARTED|Overall Study||6||
48174826|NCT02769065|100750037|FG000|COMPLETED|Overall Study||16||
48174827|NCT02769065|100750038|FG001|COMPLETED|Overall Study||6||
48174828|NCT02769065|100750039|FG002|COMPLETED|Overall Study||6||
48174829|NCT02769065|100750040|FG003|COMPLETED|Overall Study||6||
48174830|NCT02769065|100750041|FG004|COMPLETED|Overall Study||6||
48174831|NCT02769065|100750042|FG005|COMPLETED|Overall Study||6||
48174832|NCT02769065|100750043|FG006|COMPLETED|Overall Study||6||
48174833|NCT02769065|100750044|FG007|COMPLETED|Overall Study||6||
48174834|NCT02769065|100750045|FG008|COMPLETED|Overall Study||6||
48174835|NCT02769065|100750046|FG009|COMPLETED|Overall Study||6||
48174836|NCT02769065|100750047|FG010|COMPLETED|Overall Study||5||
48174837|NCT02769065|100750048|FG011|COMPLETED|Overall Study||6||
48174838|NCT02769065|100750049|FG012|COMPLETED|Overall Study||6||
48174839|NCT02769065|100750050|FG013|COMPLETED|Overall Study||6||
48174840|NCT02769065|100750051|FG014|COMPLETED|Overall Study||6||
48174841|NCT02769065|100750052|FG015|COMPLETED|Overall Study||3||
48174842|NCT02769065|100750053|FG016|COMPLETED|Overall Study||5||
48174843|NCT02769065|100750054|FG017|COMPLETED|Overall Study||5||
48174844|NCT02769065|100750055|FG018|COMPLETED|Overall Study||5||
48174845|NCT02769065|100750056|FG019|COMPLETED|Overall Study||0||
48174846|NCT02769065|100750057|FG020|COMPLETED|Overall Study||4||
48174847|NCT02769065|100750058|FG021|COMPLETED|Overall Study||4||
48174848|NCT02769065|100750059|FG022|COMPLETED|Overall Study||4||
48174849|NCT02769065|100750060|FG023|COMPLETED|Overall Study||6||
48174850|NCT02769065|100750061|FG024|COMPLETED|Overall Study||6||
48174851|NCT02769065|100750062|FG025|COMPLETED|Overall Study||9||
48174852|NCT02769065|100750063|FG026|COMPLETED|Overall Study||9||
48174853|NCT02769065|100750064|FG027|COMPLETED|Overall Study||5||
48174854|NCT02769065|100750065|FG028|COMPLETED|Overall Study||6||
48174855|NCT02769065|100750066|FG029|COMPLETED|Overall Study||6||
48174856|NCT02769065|100750037|FG000|NOT COMPLETED|Overall Study||1||
48174857|NCT02769065|100750038|FG001|NOT COMPLETED|Overall Study||0||
48174858|NCT02769065|100750039|FG002|NOT COMPLETED|Overall Study||0||
48174859|NCT02769065|100750040|FG003|NOT COMPLETED|Overall Study||0||
48174860|NCT02769065|100750041|FG004|NOT COMPLETED|Overall Study||0||
48174861|NCT02769065|100750042|FG005|NOT COMPLETED|Overall Study||0||
48174862|NCT02769065|100750043|FG006|NOT COMPLETED|Overall Study||1||
48629861|NCT04896216|101878454|FG001|STARTED|Overall Study||29||8
48629862|NCT04896216|101878453|FG000|COMPLETED|Overall Study||27||9
48629863|NCT04896216|101878454|FG001|COMPLETED|Overall Study||18||7
48174863|NCT02769065|100750044|FG007|NOT COMPLETED|Overall Study||0||
48174864|NCT02769065|100750045|FG008|NOT COMPLETED|Overall Study||0||
48174865|NCT02769065|100750046|FG009|NOT COMPLETED|Overall Study||0||
48174866|NCT02769065|100750047|FG010|NOT COMPLETED|Overall Study||1||
48174867|NCT02769065|100750048|FG011|NOT COMPLETED|Overall Study||0||
48174868|NCT02769065|100750049|FG012|NOT COMPLETED|Overall Study||0||
48174869|NCT02769065|100750050|FG013|NOT COMPLETED|Overall Study||0||
48174870|NCT02769065|100750051|FG014|NOT COMPLETED|Overall Study||0||
48174871|NCT02769065|100750052|FG015|NOT COMPLETED|Overall Study||0||
48174872|NCT02769065|100750053|FG016|NOT COMPLETED|Overall Study||0||
48174873|NCT02769065|100750054|FG017|NOT COMPLETED|Overall Study||0||
48174874|NCT02769065|100750055|FG018|NOT COMPLETED|Overall Study||0||
48174875|NCT02769065|100750056|FG019|NOT COMPLETED|Overall Study||0||
48174876|NCT02769065|100750057|FG020|NOT COMPLETED|Overall Study||0||
48174877|NCT02769065|100750058|FG021|NOT COMPLETED|Overall Study||0||
48174878|NCT02769065|100750059|FG022|NOT COMPLETED|Overall Study||0||
48174879|NCT02769065|100750060|FG023|NOT COMPLETED|Overall Study||0||
48174880|NCT02769065|100750061|FG024|NOT COMPLETED|Overall Study||0||
48174881|NCT02769065|100750062|FG025|NOT COMPLETED|Overall Study||0||
48629864|NCT04896216|101878453|FG000|NOT COMPLETED|Overall Study||3||0
48174882|NCT02769065|100750063|FG026|NOT COMPLETED|Overall Study||0||
48174883|NCT02769065|100750064|FG027|NOT COMPLETED|Overall Study||0||
48174884|NCT02769065|100750065|FG028|NOT COMPLETED|Overall Study||0||
48174885|NCT02769065|100750066|FG029|NOT COMPLETED|Overall Study||0||
48174886|NCT01865617|100750067|FG000|STARTED|Overall Study||39||
48174887|NCT01865617|100750068|FG001|STARTED|Overall Study||5||
48174888|NCT01865617|100750069|FG002|STARTED|Overall Study||2||
48174889|NCT01865617|100750070|FG003|STARTED|Overall Study||1||
48174890|NCT01865617|100750071|FG004|STARTED|Overall Study||18||
48174891|NCT01865617|100750072|FG005|STARTED|Overall Study||5||
48174892|NCT01865617|100750073|FG006|STARTED|Overall Study||22||
48174893|NCT01865617|100750074|FG007|STARTED|Overall Study||1||
48174894|NCT01865617|100750075|FG008|STARTED|Overall Study||20||
48174895|NCT01865617|100750076|FG009|STARTED|Overall Study||5||
48174896|NCT01865617|100750077|FG010|STARTED|Overall Study||49||
48174897|NCT01865617|100750078|FG011|STARTED|Overall Study||10||
48174898|NCT01865617|100750079|FG012|STARTED|Overall Study||20||
48174899|NCT01865617|100750067|FG000|COMPLETED|Overall Study||9||
48174900|NCT01865617|100750068|FG001|COMPLETED|Overall Study||2||
48174901|NCT01865617|100750069|FG002|COMPLETED|Overall Study||1||
48174902|NCT01865617|100750070|FG003|COMPLETED|Overall Study||0||
48174903|NCT01865617|100750071|FG004|COMPLETED|Overall Study||11||
48174904|NCT01865617|100750072|FG005|COMPLETED|Overall Study||4||
48174905|NCT01865617|100750073|FG006|COMPLETED|Overall Study||10||
48174906|NCT01865617|100750074|FG007|COMPLETED|Overall Study||0||
48174907|NCT01865617|100750075|FG008|COMPLETED|Overall Study||9||
48174908|NCT01865617|100750076|FG009|COMPLETED|Overall Study||2||
48174909|NCT01865617|100750077|FG010|COMPLETED|Overall Study||17||
48174910|NCT01865617|100750078|FG011|COMPLETED|Overall Study||4||
48174911|NCT01865617|100750079|FG012|COMPLETED|Overall Study||7||
48174912|NCT01865617|100750067|FG000|NOT COMPLETED|Overall Study||30||
48174913|NCT01865617|100750068|FG001|NOT COMPLETED|Overall Study||3||
48174914|NCT01865617|100750069|FG002|NOT COMPLETED|Overall Study||1||
48174915|NCT01865617|100750070|FG003|NOT COMPLETED|Overall Study||1||
48174916|NCT01865617|100750071|FG004|NOT COMPLETED|Overall Study||7||
48174917|NCT01865617|100750072|FG005|NOT COMPLETED|Overall Study||1||
48174918|NCT01865617|100750073|FG006|NOT COMPLETED|Overall Study||12||
48174919|NCT01865617|100750074|FG007|NOT COMPLETED|Overall Study||1||
48174920|NCT01865617|100750075|FG008|NOT COMPLETED|Overall Study||11||
48174921|NCT01865617|100750076|FG009|NOT COMPLETED|Overall Study||3||
48174922|NCT01865617|100750077|FG010|NOT COMPLETED|Overall Study||32||
48174923|NCT01865617|100750078|FG011|NOT COMPLETED|Overall Study||6||
48174924|NCT01865617|100750079|FG012|NOT COMPLETED|Overall Study||13||
48174925|NCT02922985|100750080|FG000|STARTED|Overall Study||60||
48174926|NCT02922985|100750081|FG001|STARTED|Overall Study||60||
48174927|NCT02922985|100750080|FG000|COMPLETED|Overall Study||60||
48174928|NCT02922985|100750081|FG001|COMPLETED|Overall Study||60||
48174929|NCT02922985|100750080|FG000|NOT COMPLETED|Overall Study||0||
48174930|NCT02922985|100750081|FG001|NOT COMPLETED|Overall Study||0||
48174931|NCT00976703|100750082|FG000|STARTED|Overall Study||99||
48174932|NCT00976703|100750083|FG001|STARTED|Overall Study||98||
48174933|NCT00976703|100750082|FG000|COMPLETED|Overall Study||96||
48174934|NCT00976703|100750083|FG001|COMPLETED|Overall Study||95||
48174935|NCT00976703|100750082|FG000|NOT COMPLETED|Overall Study||3||
48174936|NCT00976703|100750083|FG001|NOT COMPLETED|Overall Study||3||
48174937|NCT01812005|100750084|FG000|STARTED|Overall Study||1||
48174938|NCT01812005|100750085|FG001|STARTED|Overall Study||13||
48174939|NCT01812005|100750084|FG000|COMPLETED|Overall Study||1||
48174940|NCT01812005|100750085|FG001|COMPLETED|Overall Study||13||
48174941|NCT01812005|100750084|FG000|NOT COMPLETED|Overall Study||0||
48174942|NCT01812005|100750085|FG001|NOT COMPLETED|Overall Study||0||
48174943|NCT00284089|100750086|FG000|STARTED|Single Dose Phase||6||
48174944|NCT00284089|100750087|FG001|STARTED|Single Dose Phase||6||
48174945|NCT00284089|100750088|FG002|STARTED|Single Dose Phase||0||
48174946|NCT00284089|100750089|FG003|STARTED|Single Dose Phase||0||
48174947|NCT00284089|100750086|FG000|COMPLETED|Single Dose Phase||6||
48174948|NCT00284089|100750087|FG001|COMPLETED|Single Dose Phase||6||
48174949|NCT00284089|100750088|FG002|COMPLETED|Single Dose Phase||0||
48174950|NCT00284089|100750089|FG003|COMPLETED|Single Dose Phase||0||
48174951|NCT00284089|100750086|FG000|NOT COMPLETED|Single Dose Phase||0||
48174952|NCT00284089|100750087|FG001|NOT COMPLETED|Single Dose Phase||0||
48174953|NCT00284089|100750088|FG002|NOT COMPLETED|Single Dose Phase||0||
48174954|NCT00284089|100750089|FG003|NOT COMPLETED|Single Dose Phase||0||
48174955|NCT00284089|100750086|FG000|STARTED|Multiple Dose Phase||5||
48174956|NCT00284089|100750087|FG001|STARTED|Multiple Dose Phase||6||
48174957|NCT00284089|100750088|FG002|STARTED|Multiple Dose Phase||35||
48174958|NCT00284089|100750089|FG003|STARTED|Multiple Dose Phase||41||
48174959|NCT00284089|100750086|FG000|COMPLETED|Multiple Dose Phase||4||
48174960|NCT00284089|100750087|FG001|COMPLETED|Multiple Dose Phase||6||
48174961|NCT00284089|100750088|FG002|COMPLETED|Multiple Dose Phase||31||
48174962|NCT00284089|100750089|FG003|COMPLETED|Multiple Dose Phase||37||
48174963|NCT00284089|100750086|FG000|NOT COMPLETED|Multiple Dose Phase||1||
48174964|NCT00284089|100750087|FG001|NOT COMPLETED|Multiple Dose Phase||0||
48174965|NCT00284089|100750088|FG002|NOT COMPLETED|Multiple Dose Phase||4||
48174966|NCT00284089|100750089|FG003|NOT COMPLETED|Multiple Dose Phase||4||
48174967|NCT00284089|100750086|FG000|STARTED|Extension Phase||3||
48174968|NCT00284089|100750087|FG001|STARTED|Extension Phase||6||
48174969|NCT00284089|100750088|FG002|STARTED|Extension Phase||28||
48174970|NCT00284089|100750089|FG003|STARTED|Extension Phase||33||
48174971|NCT00284089|100750086|FG000|COMPLETED|Extension Phase||1||
48174972|NCT00284089|100750087|FG001|COMPLETED|Extension Phase||6||
48174973|NCT00284089|100750088|FG002|COMPLETED|Extension Phase||22||
48174974|NCT00284089|100750089|FG003|COMPLETED|Extension Phase||21||
48174975|NCT00284089|100750086|FG000|NOT COMPLETED|Extension Phase||2||
48174976|NCT00284089|100750087|FG001|NOT COMPLETED|Extension Phase||0||
48174977|NCT00284089|100750088|FG002|NOT COMPLETED|Extension Phase||6||
48174978|NCT00284089|100750089|FG003|NOT COMPLETED|Extension Phase||12||
48174979|NCT00895843|100750090|FG000|STARTED|Overall Study||60||
48174980|NCT00895843|100750091|FG001|STARTED|Overall Study||62||
48174981|NCT00895843|100750090|FG000|COMPLETED|Overall Study||48||
48174982|NCT00895843|100750091|FG001|COMPLETED|Overall Study||50||
48174983|NCT00895843|100750090|FG000|NOT COMPLETED|Overall Study||12||
48174984|NCT00895843|100750091|FG001|NOT COMPLETED|Overall Study||12||
48174985|NCT00593320|100750092|FG000|STARTED|Overall Study||1||
48174986|NCT00593320|100750093|FG001|STARTED|Overall Study||1||
48174987|NCT00593320|100750092|FG000|COMPLETED|Overall Study||1||
48174988|NCT00593320|100750093|FG001|COMPLETED|Overall Study||1||
48174989|NCT00593320|100750092|FG000|NOT COMPLETED|Overall Study||0||
48174990|NCT00593320|100750093|FG001|NOT COMPLETED|Overall Study||0||
48174991|NCT03810313|100750094|FG000|STARTED|Overall Study||247||
48174992|NCT03810313|100750095|FG001|STARTED|Overall Study||246||
48174993|NCT03810313|100750094|FG000|COMPLETED|Overall Study||66||
48174994|NCT03810313|100750095|FG001|COMPLETED|Overall Study||70||
48174995|NCT03810313|100750094|FG000|NOT COMPLETED|Overall Study||181||
48174996|NCT03810313|100750095|FG001|NOT COMPLETED|Overall Study||176||
48174997|NCT01775930|100750096|FG000|STARTED|Overall Study||10||
48174998|NCT01775930|100750096|FG000|COMPLETED|Overall Study||9||
48174999|NCT01775930|100750096|FG000|NOT COMPLETED|Overall Study||1||
48175000|NCT01226979|100750097|FG000|STARTED|Overall Study||16||
48175001|NCT01226979|100750097|FG000|COMPLETED|Overall Study||16||
48175002|NCT01226979|100750097|FG000|NOT COMPLETED|Overall Study||0||
48175003|NCT02443103|100750098|FG000|STARTED|Overall Study||4||
48175004|NCT02443103|100750098|FG000|COMPLETED|Overall Study||1||
48175005|NCT02443103|100750098|FG000|NOT COMPLETED|Overall Study||3||
48335670|NCT02847598|101151860|FG002|NOT COMPLETED|Overall Study||0||
48335671|NCT02847598|101151861|FG003|NOT COMPLETED|Overall Study||4||
48335672|NCT02847598|101151862|FG004|NOT COMPLETED|Overall Study||3||
48335673|NCT02847598|101151863|FG005|NOT COMPLETED|Overall Study||3||
48629865|NCT04896216|101878454|FG001|NOT COMPLETED|Overall Study||11||1
48629866|NCT01316614|101878455|FG000|STARTED|Overall Study||137||
48629867|NCT01316614|101878455|FG000|COMPLETED|Overall Study||100||
48629868|NCT01316614|101878455|FG000|NOT COMPLETED|Overall Study||37||
48629869|NCT02845674|101878456|FG000|STARTED|Overall Study||129||
48629870|NCT02845674|101878457|FG001|STARTED|Overall Study||129||
48629871|NCT02845674|101878456|FG000|COMPLETED|Overall Study||111||
48629872|NCT02845674|101878457|FG001|COMPLETED|Overall Study||79||
48629873|NCT02845674|101878456|FG000|NOT COMPLETED|Overall Study||18||
48629874|NCT02845674|101878457|FG001|NOT COMPLETED|Overall Study||50||
48629875|NCT02100124|101878458|FG000|STARTED|Overall Study||329||
48629876|NCT02100124|101878459|FG001|STARTED|Overall Study||329||
48175006|NCT01342029|100750099|FG000|STARTED|Period 1||70||
48175007|NCT01342029|100750100|FG001|STARTED|Period 1||72||
48175008|NCT01342029|100750099|FG000|Dropout|Period 1||3||
48175009|NCT01342029|100750100|FG001|Dropout|Period 1||1||
48175010|NCT01342029|100750099|FG000|COMPLETED|Period 1||67||
48175011|NCT01342029|100750100|FG001|COMPLETED|Period 1||71||
48175012|NCT01342029|100750099|FG000|NOT COMPLETED|Period 1||3||
48175013|NCT01342029|100750100|FG001|NOT COMPLETED|Period 1||1||
48175014|NCT01342029|100750099|FG000|STARTED|Washout||67||
48175015|NCT01342029|100750100|FG001|STARTED|Washout||71||
48175016|NCT01342029|100750099|FG000|COMPLETED|Washout||67||
48175017|NCT01342029|100750100|FG001|COMPLETED|Washout||67||
48175018|NCT01342029|100750099|FG000|NOT COMPLETED|Washout||0||
48175019|NCT01342029|100750100|FG001|NOT COMPLETED|Washout||4||
48175020|NCT01342029|100750099|FG000|STARTED|Period 2||67||
48175021|NCT01342029|100750100|FG001|STARTED|Period 2||67||
48175022|NCT01342029|100750099|FG000|Dropout|Period 2||2||
48175023|NCT01342029|100750100|FG001|Dropout|Period 2||0||
48175024|NCT01342029|100750099|FG000|COMPLETED|Period 2||65||
48175025|NCT01342029|100750100|FG001|COMPLETED|Period 2||67||
48175026|NCT01342029|100750099|FG000|NOT COMPLETED|Period 2||2||
48175027|NCT01342029|100750100|FG001|NOT COMPLETED|Period 2||0||
48175028|NCT02337478|100750101|FG000|STARTED|Overall Study||5||
48175029|NCT02337478|100750101|FG000|COMPLETED|Overall Study||0||
48175030|NCT02337478|100750101|FG000|NOT COMPLETED|Overall Study||5||
48175031|NCT01886963|100750102|FG000|STARTED|Overall Study||57||
48175032|NCT01886963|100750103|FG001|STARTED|Overall Study||58||
48175033|NCT01886963|100750102|FG000|2 Week Follow Up|Overall Study||55||
48175034|NCT01886963|100750103|FG001|2 Week Follow Up|Overall Study||55||
48175035|NCT01886963|100750102|FG000|4 Week Follow Up|Overall Study||50||
48629877|NCT02100124|101878460|FG002|STARTED|Overall Study||326||
48629878|NCT02100124|101878458|FG000|COMPLETED|Overall Study||323||
48175036|NCT01886963|100750103|FG001|4 Week Follow Up|Overall Study||51||
48175037|NCT01886963|100750102|FG000|12 Week Follow Up|Overall Study||46||
48175038|NCT01886963|100750103|FG001|12 Week Follow Up|Overall Study||49||
48175039|NCT01886963|100750102|FG000|COMPLETED|Overall Study||46||
48175040|NCT01886963|100750103|FG001|COMPLETED|Overall Study||49||
48175041|NCT01886963|100750102|FG000|NOT COMPLETED|Overall Study||11||
48175042|NCT01886963|100750103|FG001|NOT COMPLETED|Overall Study||9||
48175043|NCT01077362|100750104|FG000|STARTED|Overall Study||104||
48175044|NCT01077362|100750105|FG001|STARTED|Overall Study||103||
48175045|NCT01077362|100750106|FG002|STARTED|Overall Study||105||
48175046|NCT01077362|100750104|FG000|COMPLETED|Overall Study||73||
48175047|NCT01077362|100750105|FG001|COMPLETED|Overall Study||84||
48175048|NCT01077362|100750106|FG002|COMPLETED|Overall Study||81||
48175049|NCT01077362|100750104|FG000|NOT COMPLETED|Overall Study||31||
48175050|NCT01077362|100750105|FG001|NOT COMPLETED|Overall Study||19||
48175051|NCT01077362|100750106|FG002|NOT COMPLETED|Overall Study||24||
48175052|NCT02731313|100750107|FG000|STARTED|Overall Study||367||
48175053|NCT02731313|100750107|FG000|COMPLETED|Overall Study||367||
48175054|NCT02731313|100750107|FG000|NOT COMPLETED|Overall Study||0||
48175055|NCT05764239|100750108|FG000|STARTED|DEP (Part 1)||35||
48175056|NCT05764239|100750108|FG000|Completed DEP|DEP (Part 1)||17||
48175057|NCT05764239|100750108|FG000|COMPLETED|DEP (Part 1)||0|Completed study|
48175058|NCT05764239|100750108|FG000|NOT COMPLETED|DEP (Part 1)||35||
48335674|NCT02847598|101151864|FG006|NOT COMPLETED|Overall Study||2||
48412426|NCT04921969|101342007|FG004|NOT COMPLETED|LTS Period (Weeks 8 to 52)||16||
48412427|NCT04921969|101342008|FG005|NOT COMPLETED|LTS Period (Weeks 8 to 52)||91||
48412428|NCT04921969|101342009|FG006|NOT COMPLETED|LTS Period (Weeks 8 to 52)||81||
48335675|NCT02847598|101151865|FG007|NOT COMPLETED|Overall Study||4||
48335676|NCT03687502|101151866|FG000|STARTED|Overall Study||37||
48335677|NCT03687502|101151866|FG000|COMPLETED|Overall Study||35||
48335678|NCT03687502|101151866|FG000|NOT COMPLETED|Overall Study||2||
48335679|NCT00626743|101151867|FG000|STARTED|Treatment Period 1||6||
48335680|NCT00626743|101151868|FG001|STARTED|Treatment Period 1||7||
48335681|NCT00626743|101151867|FG000|COMPLETED|Treatment Period 1||6||
48335682|NCT00626743|101151868|FG001|COMPLETED|Treatment Period 1||6||
48335683|NCT00626743|101151867|FG000|NOT COMPLETED|Treatment Period 1||0||
48335684|NCT00626743|101151868|FG001|NOT COMPLETED|Treatment Period 1||1||
48335685|NCT00626743|101151867|FG000|STARTED|Wash-out Period of 6 Days||6||
48335686|NCT00626743|101151868|FG001|STARTED|Wash-out Period of 6 Days||6||
48335687|NCT00626743|101151867|FG000|COMPLETED|Wash-out Period of 6 Days||6||
48335688|NCT00626743|101151868|FG001|COMPLETED|Wash-out Period of 6 Days||6||
48335689|NCT00626743|101151867|FG000|NOT COMPLETED|Wash-out Period of 6 Days||0||
48335690|NCT00626743|101151868|FG001|NOT COMPLETED|Wash-out Period of 6 Days||0||
48335691|NCT00626743|101151867|FG000|STARTED|Treatment Period 2||6||
48335692|NCT00626743|101151868|FG001|STARTED|Treatment Period 2||6||
48335693|NCT00626743|101151867|FG000|COMPLETED|Treatment Period 2||6||
48335694|NCT00626743|101151868|FG001|COMPLETED|Treatment Period 2||6||
48335695|NCT00626743|101151867|FG000|NOT COMPLETED|Treatment Period 2||0||
48335696|NCT00626743|101151868|FG001|NOT COMPLETED|Treatment Period 2||0||
48335697|NCT01757717|101151869|FG000|STARTED|Overall Study||3||
48335698|NCT01757717|101151869|FG000|COMPLETED|Overall Study||3||
48335699|NCT01757717|101151869|FG000|NOT COMPLETED|Overall Study||0||
48335700|NCT00413959|101151870|FG000|STARTED|Overall Study||12||
48335701|NCT00413959|101151870|FG000|COMPLETED|Overall Study||11||
48335702|NCT00413959|101151870|FG000|NOT COMPLETED|Overall Study||1||
48335703|NCT02154425|101151871|FG000|STARTED|Screening Period||18||
48335704|NCT02154425|101151871|FG000|COMPLETED|Screening Period||17||
48335705|NCT02154425|101151871|FG000|NOT COMPLETED|Screening Period||1||
48335706|NCT02154425|101151871|FG000|STARTED|Sampling Period||17||
48335707|NCT02154425|101151871|FG000|COMPLETED|Sampling Period||17||
48335708|NCT02154425|101151871|FG000|NOT COMPLETED|Sampling Period||0||
48335709|NCT02504554|101151872|FG000|STARTED|Overall Study||12||
48335710|NCT02504554|101151873|FG001|STARTED|Overall Study||6||
48335711|NCT02504554|101151872|FG000|COMPLETED|Overall Study||12||
48335712|NCT02504554|101151873|FG001|COMPLETED|Overall Study||6||
48412429|NCT03644173|101342010|FG000|STARTED|Participants at Last Visit (Pre-surveys)||37||
48439940|NCT04936334|101409988|FG000|NOT COMPLETED|Overall Study||1||2
48175059|NCT05764239|100750108|FG000|STARTED|RWP (Part 2, SYNB1934v1)||9||
48175060|NCT05764239|100750108|FG000|Completed RWP|RWP (Part 2, SYNB1934v1)||9||
48175061|NCT05764239|100750108|FG000|COMPLETED|RWP (Part 2, SYNB1934v1)||0|Completed study|
48175062|NCT05764239|100750108|FG000|NOT COMPLETED|RWP (Part 2, SYNB1934v1)||9||
48175063|NCT05764239|100750108|FG000|STARTED|RWP (Part 2, Placebo)||8||
48175064|NCT05764239|100750108|FG000|Completed RWP|RWP (Part 2, Placebo)||8||
48175065|NCT05764239|100750108|FG000|COMPLETED|RWP (Part 2, Placebo)||0|Completed Study|
48175066|NCT05764239|100750108|FG000|NOT COMPLETED|RWP (Part 2, Placebo)||8||
48175067|NCT05764239|100750108|FG000|STARTED|OLE (Part 3)||10||
48175068|NCT05764239|100750108|FG000|COMPLETED|OLE (Part 3)||0|Completed OLE and/or study|
48175069|NCT05764239|100750108|FG000|NOT COMPLETED|OLE (Part 3)||10||
48175070|NCT00432835|100750109|FG000|STARTED|Overall Study||28||
48175071|NCT00432835|100750110|FG001|STARTED|Overall Study||30||
48335713|NCT02504554|101151872|FG000|NOT COMPLETED|Overall Study||0||
48335714|NCT02504554|101151873|FG001|NOT COMPLETED|Overall Study||0||
48335715|NCT04451707|101151874|FG000|STARTED|Overall Study||67||
48335716|NCT04451707|101151874|FG000|COMPLETED|Overall Study||67||
48335717|NCT04451707|101151874|FG000|NOT COMPLETED|Overall Study||0||
48335718|NCT04178772|101151875|FG000|STARTED|Overall Study||27||
48335719|NCT04178772|101151875|FG000|COMPLETED|Overall Study||19||
48335720|NCT04178772|101151875|FG000|NOT COMPLETED|Overall Study||8||
48335721|NCT05501600|101151876|FG000|STARTED|Overall Study||30||
48335722|NCT05501600|101151876|FG000|COMPLETED|Overall Study||27||
48335723|NCT05501600|101151876|FG000|NOT COMPLETED|Overall Study||3||
48335724|NCT02167945|101151877|FG000|STARTED|Overall Study||615||
48335725|NCT02167945|101151877|FG000|COMPLETED|Overall Study||366||
48335726|NCT02167945|101151877|FG000|NOT COMPLETED|Overall Study||249||
48335727|NCT04130802|101151878|FG000|STARTED|Overall Study||51||
48335728|NCT04130802|101151879|FG001|STARTED|Overall Study||51||
48335729|NCT04130802|101151880|FG002|STARTED|Overall Study||51||
48335730|NCT04130802|101151878|FG000|COMPLETED|Overall Study||50||
48629879|NCT02100124|101878459|FG001|COMPLETED|Overall Study||318||
48629880|NCT02100124|101878460|FG002|COMPLETED|Overall Study||323||
48629881|NCT02100124|101878458|FG000|NOT COMPLETED|Overall Study||6||
48629882|NCT02100124|101878459|FG001|NOT COMPLETED|Overall Study||11||
48629883|NCT02100124|101878460|FG002|NOT COMPLETED|Overall Study||3||
48629884|NCT00830219|101878461|FG000|STARTED|First Intervention||23||
48629885|NCT00830219|101878462|FG001|STARTED|First Intervention||23||
48629886|NCT00830219|101878461|FG000|COMPLETED|First Intervention||23||
48629887|NCT00830219|101878462|FG001|COMPLETED|First Intervention||23||
48335731|NCT04130802|101151879|FG001|COMPLETED|Overall Study||50||
48335732|NCT04130802|101151880|FG002|COMPLETED|Overall Study||48||
48335733|NCT04130802|101151878|FG000|NOT COMPLETED|Overall Study||1||
48335734|NCT04130802|101151879|FG001|NOT COMPLETED|Overall Study||1||
48335735|NCT04130802|101151880|FG002|NOT COMPLETED|Overall Study||3||
48629888|NCT00830219|101878461|FG000|NOT COMPLETED|First Intervention||0||
48629889|NCT00830219|101878462|FG001|NOT COMPLETED|First Intervention||0||
48629890|NCT00830219|101878461|FG000|STARTED|Washout of 7 Days||23||
48629891|NCT00830219|101878462|FG001|STARTED|Washout of 7 Days||23||
48629892|NCT00830219|101878461|FG000|COMPLETED|Washout of 7 Days||22||
48335736|NCT00070941|101151881|FG000|STARTED|Overall Study||12||
48335737|NCT00070941|101151882|FG001|STARTED|Overall Study||11||
48335738|NCT00070941|101151883|FG002|STARTED|Overall Study||6||
48335739|NCT00070941|101151881|FG000|COMPLETED|Overall Study||2||
48335740|NCT00070941|101151882|FG001|COMPLETED|Overall Study||3||
48335741|NCT00070941|101151883|FG002|COMPLETED|Overall Study||2||
48335742|NCT00070941|101151881|FG000|NOT COMPLETED|Overall Study||10||
48335743|NCT00070941|101151882|FG001|NOT COMPLETED|Overall Study||8||
48335744|NCT00070941|101151883|FG002|NOT COMPLETED|Overall Study||4||
48335745|NCT01871090|101151884|FG000|STARTED|Overall Study||35||
48335746|NCT01871090|101151885|FG001|STARTED|Overall Study||48||
48335747|NCT01871090|101151884|FG000|COMPLETED|Overall Study||33||
48335748|NCT01871090|101151885|FG001|COMPLETED|Overall Study||25||
48335749|NCT01871090|101151884|FG000|NOT COMPLETED|Overall Study||2||
48335750|NCT01871090|101151885|FG001|NOT COMPLETED|Overall Study||23||
48335751|NCT03575104|101151886|FG000|STARTED|Overall Study||307||
48335752|NCT03575104|101151887|FG001|STARTED|Overall Study||309||
48335753|NCT03575104|101151888|FG002|STARTED|Overall Study||308||
48335754|NCT03575104|101151886|FG000|COMPLETED|Overall Study||283||
48335755|NCT03575104|101151887|FG001|COMPLETED|Overall Study||280||
48335756|NCT03575104|101151888|FG002|COMPLETED|Overall Study||286||
48335757|NCT03575104|101151886|FG000|NOT COMPLETED|Overall Study||24||
48335758|NCT03575104|101151887|FG001|NOT COMPLETED|Overall Study||29||
48335759|NCT03575104|101151888|FG002|NOT COMPLETED|Overall Study||22||
48335760|NCT01703858|101151889|FG000|STARTED|Overall Study||5||
48629893|NCT00830219|101878462|FG001|COMPLETED|Washout of 7 Days||22||
48629894|NCT00830219|101878461|FG000|NOT COMPLETED|Washout of 7 Days||1||
48629895|NCT00830219|101878462|FG001|NOT COMPLETED|Washout of 7 Days||1||
48335761|NCT01703858|101151890|FG001|STARTED|Overall Study||5||
48335762|NCT01703858|101151891|FG002|STARTED|Overall Study||5||
48629896|NCT00830219|101878461|FG000|STARTED|Second Intervention||22||
48629897|NCT00830219|101878462|FG001|STARTED|Second Intervention||22||
48335763|NCT01703858|101151889|FG000|COMPLETED|Overall Study||5||
48335764|NCT01703858|101151890|FG001|COMPLETED|Overall Study||4||
48335765|NCT01703858|101151891|FG002|COMPLETED|Overall Study||5||
48335766|NCT01703858|101151889|FG000|NOT COMPLETED|Overall Study||0||
48335767|NCT01703858|101151890|FG001|NOT COMPLETED|Overall Study||1||
48335768|NCT01703858|101151891|FG002|NOT COMPLETED|Overall Study||0||
48335769|NCT02679469|101151892|FG000|STARTED|Overall Study||7||
48335770|NCT02679469|101151892|FG000|COMPLETED|Overall Study||7||
48335771|NCT02679469|101151892|FG000|NOT COMPLETED|Overall Study||0||
48335772|NCT03980938|101151893|FG000|STARTED|Treatment Period 1||7||
48335773|NCT03980938|101151894|FG001|STARTED|Treatment Period 1||8||
48335774|NCT03980938|101151893|FG000|COMPLETED|Treatment Period 1||6||
48335775|NCT03980938|101151894|FG001|COMPLETED|Treatment Period 1||7||
48335776|NCT03980938|101151893|FG000|NOT COMPLETED|Treatment Period 1||1||
48335777|NCT03980938|101151894|FG001|NOT COMPLETED|Treatment Period 1||1||
48629898|NCT00830219|101878461|FG000|COMPLETED|Second Intervention||22||
48629899|NCT00830219|101878462|FG001|COMPLETED|Second Intervention||22||
48629900|NCT00830219|101878461|FG000|NOT COMPLETED|Second Intervention||0||
48335778|NCT03980938|101151893|FG000|STARTED|Treatment Period 2||3|"The study was halted in March 2020 due to COVID-19 pandemic and eventually terminated without resuming any study activities. At this time 5 participants had started Treatment Period 2.~2 participants were in Treatment Period 1 and 8 participants were in the Washout Period, thus 10 participants never started Treatment Period 2."|
48335779|NCT03980938|101151894|FG001|STARTED|Treatment Period 2||2|"The study was halted in March 2020 due to COVID-19 pandemic and eventually terminated without resuming any study activities. At this time 5 participants had started Treatment Period 2.~2 participants were in Treatment Period 1 and 8 participants were in the Washout Period, thus 10 participants never started Treatment Period 2."|
48335780|NCT03980938|101151893|FG000|COMPLETED|Treatment Period 2||1||
48335781|NCT03980938|101151894|FG001|COMPLETED|Treatment Period 2||0||
48335782|NCT03980938|101151893|FG000|NOT COMPLETED|Treatment Period 2||2||
48335783|NCT03980938|101151894|FG001|NOT COMPLETED|Treatment Period 2||2||
48629901|NCT00830219|101878462|FG001|NOT COMPLETED|Second Intervention||0||
48629902|NCT02532036|101878463|FG000|STARTED|Overall Study||2||
48629903|NCT02532036|101878464|FG001|STARTED|Overall Study||0||
48629904|NCT02532036|101878463|FG000|COMPLETED|Overall Study||2||
48629905|NCT02532036|101878464|FG001|COMPLETED|Overall Study||0||
48629906|NCT02532036|101878463|FG000|NOT COMPLETED|Overall Study||0||
48629907|NCT02532036|101878464|FG001|NOT COMPLETED|Overall Study||0||
48629908|NCT02075125|101878465|FG000|STARTED|Overall Study||19||
48629909|NCT02075125|101878466|FG001|STARTED|Overall Study||20||
48629910|NCT02075125|101878465|FG000|COMPLETED|Overall Study||19||
48629911|NCT02075125|101878466|FG001|COMPLETED|Overall Study||19||
48629912|NCT02075125|101878465|FG000|NOT COMPLETED|Overall Study||0||
48629913|NCT02075125|101878466|FG001|NOT COMPLETED|Overall Study||1||
48629914|NCT01545336|101878467|FG000|STARTED|Overall Study||12||
48629915|NCT01545336|101878468|FG001|STARTED|Overall Study||6||
48335784|NCT02296242|101151895|FG000|STARTED|Overall Study||5||
48335785|NCT02296242|101151896|FG001|STARTED|Overall Study||6||
48335786|NCT02296242|101151897|FG002|STARTED|Overall Study||7||
48335787|NCT02296242|101151898|FG003|STARTED|Overall Study||14||
48335788|NCT02296242|101151899|FG004|STARTED|Overall Study||21||
48335789|NCT02296242|101151895|FG000|COMPLETED|Overall Study||0||
48335790|NCT02296242|101151896|FG001|COMPLETED|Overall Study||0||
48335791|NCT02296242|101151897|FG002|COMPLETED|Overall Study||0||
48335792|NCT02296242|101151898|FG003|COMPLETED|Overall Study||0||
48335793|NCT02296242|101151899|FG004|COMPLETED|Overall Study||0||
48629916|NCT01545336|101878467|FG000|COMPLETED|Overall Study||12||
48629917|NCT01545336|101878468|FG001|COMPLETED|Overall Study||6||
48629918|NCT01545336|101878467|FG000|NOT COMPLETED|Overall Study||0||
48335794|NCT02296242|101151895|FG000|NOT COMPLETED|Overall Study||5||
48335795|NCT02296242|101151896|FG001|NOT COMPLETED|Overall Study||6||
48629919|NCT01545336|101878468|FG001|NOT COMPLETED|Overall Study||0||
48629920|NCT02709746|101878469|FG000|STARTED|Phase A (Single-blind Treatment Period)||784||
48629921|NCT02709746|101878470|FG001|STARTED|Phase A (Single-blind Treatment Period)||0||
48629922|NCT02709746|101878471|FG002|STARTED|Phase A (Single-blind Treatment Period)||0||
48752692|NCT00918385|102181018|FG000|NOT COMPLETED|Combination Nilutamide and Dasatinib||6||
48752693|NCT00918385|102181019|FG001|NOT COMPLETED|Combination Nilutamide and Dasatinib||8||
48752694|NCT00447226|102181020|FG000|STARTED|12-Week Open-label Phase||0||
48752695|NCT00447226|102181021|FG001|STARTED|12-Week Open-label Phase||32||
48752696|NCT00447226|102181020|FG000|COMPLETED|12-Week Open-label Phase||0||
48752697|NCT00447226|102181021|FG001|COMPLETED|12-Week Open-label Phase||7||
48629923|NCT02709746|101878472|FG003|STARTED|Phase A (Single-blind Treatment Period)||0||
48629924|NCT02709746|101878473|FG004|STARTED|Phase A (Single-blind Treatment Period)||0||
48629925|NCT02709746|101878469|FG000|COMPLETED|Phase A (Single-blind Treatment Period)||616||
48629926|NCT02709746|101878470|FG001|COMPLETED|Phase A (Single-blind Treatment Period)||0||
48629927|NCT02709746|101878471|FG002|COMPLETED|Phase A (Single-blind Treatment Period)||0||
48629928|NCT02709746|101878472|FG003|COMPLETED|Phase A (Single-blind Treatment Period)||0||
48335796|NCT02296242|101151897|FG002|NOT COMPLETED|Overall Study||7||
48335797|NCT02296242|101151898|FG003|NOT COMPLETED|Overall Study||14||
48335798|NCT02296242|101151899|FG004|NOT COMPLETED|Overall Study||21||
48335799|NCT00605085|101151900|FG000|STARTED|Overall Study||2012||
48629929|NCT02709746|101878473|FG004|COMPLETED|Phase A (Single-blind Treatment Period)||0||
48629930|NCT02709746|101878469|FG000|NOT COMPLETED|Phase A (Single-blind Treatment Period)||168||
48629931|NCT02709746|101878470|FG001|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0||
48629932|NCT02709746|101878471|FG002|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0||
48629933|NCT02709746|101878472|FG003|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0||
48629934|NCT02709746|101878473|FG004|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0||
48629935|NCT02709746|101878469|FG000|STARTED|Phase B (Double-blind Treatment Period)||0||
48629936|NCT02709746|101878470|FG001|STARTED|Phase B (Double-blind Treatment Period)||147||
48752698|NCT00447226|102181020|FG000|NOT COMPLETED|12-Week Open-label Phase||0||
48752699|NCT00447226|102181021|FG001|NOT COMPLETED|12-Week Open-label Phase||25||
48752700|NCT00447226|102181020|FG000|STARTED|Double-blind Phase||4||
48752701|NCT00447226|102181021|FG001|STARTED|Double-blind Phase||3||
48752702|NCT00447226|102181020|FG000|COMPLETED|Double-blind Phase||0||
48752703|NCT00447226|102181021|FG001|COMPLETED|Double-blind Phase||0||
48752704|NCT00447226|102181020|FG000|NOT COMPLETED|Double-blind Phase||4||
48752705|NCT00447226|102181021|FG001|NOT COMPLETED|Double-blind Phase||3||
48752706|NCT00702468|102181022|FG000|STARTED|Overall Study||18||
48752707|NCT00702468|102181023|FG001|STARTED|Overall Study||18||
48335800|NCT00605085|101151901|FG001|STARTED|Overall Study||663||
48335801|NCT00605085|101151900|FG000|COMPLETED|Overall Study||1962||
48629937|NCT02709746|101878471|FG002|STARTED|Phase B (Double-blind Treatment Period)||162||
48629938|NCT02709746|101878472|FG003|STARTED|Phase B (Double-blind Treatment Period)||153||
48629939|NCT02709746|101878473|FG004|STARTED|Phase B (Double-blind Treatment Period)||154||
48629940|NCT02709746|101878469|FG000|COMPLETED|Phase B (Double-blind Treatment Period)||0||
48629941|NCT02709746|101878470|FG001|COMPLETED|Phase B (Double-blind Treatment Period)||126||
48629942|NCT02709746|101878471|FG002|COMPLETED|Phase B (Double-blind Treatment Period)||140||
48629943|NCT02709746|101878472|FG003|COMPLETED|Phase B (Double-blind Treatment Period)||138||
48629944|NCT02709746|101878473|FG004|COMPLETED|Phase B (Double-blind Treatment Period)||138||
48629945|NCT02709746|101878469|FG000|NOT COMPLETED|Phase B (Double-blind Treatment Period)||0||
48629946|NCT02709746|101878470|FG001|NOT COMPLETED|Phase B (Double-blind Treatment Period)||21||
48335802|NCT00605085|101151901|FG001|COMPLETED|Overall Study||638||
48335803|NCT00605085|101151900|FG000|NOT COMPLETED|Overall Study||50||
48335804|NCT00605085|101151901|FG001|NOT COMPLETED|Overall Study||25||
48335805|NCT00821678|101151902|FG000|STARTED|Overall Study||133||
48335806|NCT00821678|101151903|FG001|STARTED|Overall Study||132||
48335807|NCT00821678|101151902|FG000|COMPLETED|Overall Study||112||
48335808|NCT00821678|101151903|FG001|COMPLETED|Overall Study||118||
48335809|NCT00821678|101151902|FG000|NOT COMPLETED|Overall Study||21||
48335810|NCT00821678|101151903|FG001|NOT COMPLETED|Overall Study||14||
48335811|NCT00110019|101151904|FG000|STARTED|Overall Study||410||
48335812|NCT00110019|101151905|FG001|STARTED|Overall Study||413||
48335813|NCT00110019|101151904|FG000|Eligible|Overall Study||395||
48335814|NCT00110019|101151905|FG001|Eligible|Overall Study||398||
48335815|NCT00110019|101151904|FG000|Treated|Overall Study||393||
48335816|NCT00110019|101151905|FG001|Treated|Overall Study||397||
48335817|NCT00110019|101151904|FG000|COMPLETED|Overall Study||4||
48335818|NCT00110019|101151905|FG001|COMPLETED|Overall Study||0||
48335819|NCT00110019|101151904|FG000|NOT COMPLETED|Overall Study||406||
48335820|NCT00110019|101151905|FG001|NOT COMPLETED|Overall Study||413||
48335821|NCT01893567|101151906|FG000|STARTED|Overall Study||28||
48335822|NCT01893567|101151906|FG000|COMPLETED|Overall Study||28||
48335823|NCT01893567|101151906|FG000|NOT COMPLETED|Overall Study||0||
48335824|NCT01260454|101151907|FG000|STARTED|Overall Study||6||
48335825|NCT01260454|101151907|FG000|COMPLETED|Overall Study||6||
48335826|NCT01260454|101151907|FG000|NOT COMPLETED|Overall Study||0||
48335827|NCT01554579|101151908|FG000|STARTED|Overall Study||86||
48335828|NCT01554579|101151909|FG001|STARTED|Overall Study||85||
48335829|NCT01554579|101151908|FG000|COMPLETED|Overall Study||76||
48335830|NCT01554579|101151909|FG001|COMPLETED|Overall Study||58||
48335831|NCT01554579|101151908|FG000|NOT COMPLETED|Overall Study||10||
48335832|NCT01554579|101151909|FG001|NOT COMPLETED|Overall Study||27||
48335833|NCT02546986|101151910|FG000|STARTED|Treatment Period||51||
48629947|NCT02709746|101878471|FG002|NOT COMPLETED|Phase B (Double-blind Treatment Period)||22||
48629948|NCT02709746|101878472|FG003|NOT COMPLETED|Phase B (Double-blind Treatment Period)||15||
48629949|NCT02709746|101878473|FG004|NOT COMPLETED|Phase B (Double-blind Treatment Period)||16||
48629950|NCT02592824|101878474|FG000|STARTED|Overall Study||155||
48629951|NCT02592824|101878475|FG001|STARTED|Overall Study||159||
48629952|NCT02592824|101878474|FG000|COMPLETED|Overall Study||148||
48629953|NCT02592824|101878475|FG001|COMPLETED|Overall Study||155||
48629954|NCT02592824|101878474|FG000|NOT COMPLETED|Overall Study||7||
48629955|NCT02592824|101878475|FG001|NOT COMPLETED|Overall Study||4||
48629956|NCT03558516|101878476|FG000|STARTED|Overall Study||40||
48629957|NCT03558516|101878477|FG001|STARTED|Overall Study||40||
48629958|NCT03558516|101878476|FG000|COMPLETED|Overall Study||38||
48629959|NCT03558516|101878477|FG001|COMPLETED|Overall Study||38||
48335834|NCT02546986|101151911|FG001|STARTED|Treatment Period||49||
48335835|NCT02546986|101151910|FG000|COMPLETED|Treatment Period||0|Completed = Not applicable according to the study design|
48335836|NCT02546986|101151911|FG001|COMPLETED|Treatment Period||0|Completed = Not applicable according to the study design|
48629960|NCT03558516|101878476|FG000|NOT COMPLETED|Overall Study||2||
48629961|NCT03558516|101878477|FG001|NOT COMPLETED|Overall Study||2||
48752708|NCT00702468|102181022|FG000|COMPLETED|Overall Study||15||
48335837|NCT02546986|101151910|FG000|NOT COMPLETED|Treatment Period||51||
48752709|NCT00702468|102181023|FG001|COMPLETED|Overall Study||2||
48752710|NCT00702468|102181022|FG000|NOT COMPLETED|Overall Study||3||
48752711|NCT00702468|102181023|FG001|NOT COMPLETED|Overall Study||16||
48752712|NCT05075746|102181024|FG000|STARTED|Overall Study||157||192
48752713|NCT05075746|102181025|FG001|STARTED|Overall Study||145||191
48752714|NCT05075746|102181024|FG000|COMPLETED|Overall Study||157||192
48335838|NCT02546986|101151911|FG001|NOT COMPLETED|Treatment Period||49||
48335839|NCT02546986|101151910|FG000|STARTED|Survival Follow-Up Phase||36||
48335840|NCT02546986|101151911|FG001|STARTED|Survival Follow-Up Phase||35||
48335841|NCT02546986|101151910|FG000|COMPLETED|Survival Follow-Up Phase||0|Participants remained in follow-up until withdrawal of consent, death or lost to follow-up|
48752715|NCT05075746|102181025|FG001|COMPLETED|Overall Study||145||191
48335842|NCT02546986|101151911|FG001|COMPLETED|Survival Follow-Up Phase||0|Participants remained in follow-up until withdrawal of consent, death or lost to follow-up|
48335843|NCT02546986|101151910|FG000|NOT COMPLETED|Survival Follow-Up Phase||36||
48335844|NCT02546986|101151911|FG001|NOT COMPLETED|Survival Follow-Up Phase||35||
48335845|NCT01318122|101151912|FG000|STARTED|Enrolled - Long-Term Extension Study||106||
48335846|NCT01318122|101151913|FG001|STARTED|Enrolled - Long-Term Extension Study||110||
48752716|NCT05075746|102181024|FG000|NOT COMPLETED|Overall Study||0||0
48752717|NCT05075746|102181025|FG001|NOT COMPLETED|Overall Study||0||0
48752718|NCT01342913|102181026|FG000|STARTED|2-week Run-in Period||702||
48752719|NCT01342913|102181027|FG001|STARTED|2-week Run-in Period||0||
48752720|NCT01342913|102181028|FG002|STARTED|2-week Run-in Period||0||
48752721|NCT01342913|102181026|FG000|COMPLETED|2-week Run-in Period||528||
48752722|NCT01342913|102181027|FG001|COMPLETED|2-week Run-in Period||0||
48752723|NCT01342913|102181028|FG002|COMPLETED|2-week Run-in Period||0||
48752724|NCT01342913|102181026|FG000|NOT COMPLETED|2-week Run-in Period||174||
48752725|NCT01342913|102181027|FG001|NOT COMPLETED|2-week Run-in Period||0||
48752726|NCT01342913|102181028|FG002|NOT COMPLETED|2-week Run-in Period||0||
48752727|NCT01342913|102181026|FG000|STARTED|Double-Blind Treatment Period||0||
48752728|NCT01342913|102181027|FG001|STARTED|Double-Blind Treatment Period||262||
48752729|NCT01342913|102181028|FG002|STARTED|Double-Blind Treatment Period||266||
48752730|NCT01342913|102181026|FG000|COMPLETED|Double-Blind Treatment Period||0||
48752731|NCT01342913|102181027|FG001|COMPLETED|Double-Blind Treatment Period||246||
48335847|NCT01318122|101151914|FG002|STARTED|Enrolled - Long-Term Extension Study||57||
48335848|NCT01318122|101151915|FG003|STARTED|Enrolled - Long-Term Extension Study||53||
48335849|NCT01318122|101151912|FG000|COMPLETED|Enrolled - Long-Term Extension Study||105||
48335850|NCT01318122|101151913|FG001|COMPLETED|Enrolled - Long-Term Extension Study||110||
48335851|NCT01318122|101151914|FG002|COMPLETED|Enrolled - Long-Term Extension Study||55||
48335852|NCT01318122|101151915|FG003|COMPLETED|Enrolled - Long-Term Extension Study||52||
48335853|NCT01318122|101151912|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||1||
48335854|NCT01318122|101151913|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
48335855|NCT01318122|101151914|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||2||
48335856|NCT01318122|101151915|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||1||
48335857|NCT01318122|101151912|FG000|STARTED|Entered - Long-Term Extension Study||105||
48335858|NCT01318122|101151913|FG001|STARTED|Entered - Long-Term Extension Study||110||
48335859|NCT01318122|101151914|FG002|STARTED|Entered - Long-Term Extension Study||55||
48335860|NCT01318122|101151915|FG003|STARTED|Entered - Long-Term Extension Study||52||
48335861|NCT01318122|101151912|FG000|COMPLETED|Entered - Long-Term Extension Study||96||
48335862|NCT01318122|101151913|FG001|COMPLETED|Entered - Long-Term Extension Study||99||
48335863|NCT01318122|101151914|FG002|COMPLETED|Entered - Long-Term Extension Study||49||
48335864|NCT01318122|101151915|FG003|COMPLETED|Entered - Long-Term Extension Study||48||
48335865|NCT01318122|101151912|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||9||
48335866|NCT01318122|101151913|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||11||
48335867|NCT01318122|101151914|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||6||
48335868|NCT01318122|101151915|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||4||
48335869|NCT03595280|101151916|FG000|STARTED|Overall Study||119||
48335870|NCT03595280|101151917|FG001|STARTED|Overall Study||117||
48335871|NCT03595280|101151918|FG002|STARTED|Overall Study||113||
48335872|NCT03595280|101151916|FG000|COMPLETED|Overall Study||113||
48335873|NCT03595280|101151917|FG001|COMPLETED|Overall Study||108||
48335874|NCT03595280|101151918|FG002|COMPLETED|Overall Study||98||
48335875|NCT03595280|101151916|FG000|NOT COMPLETED|Overall Study||6||
48752732|NCT01342913|102181028|FG002|COMPLETED|Double-Blind Treatment Period||243||
48752733|NCT01342913|102181026|FG000|NOT COMPLETED|Double-Blind Treatment Period||0||
48752734|NCT01342913|102181027|FG001|NOT COMPLETED|Double-Blind Treatment Period||16||
48752735|NCT01342913|102181028|FG002|NOT COMPLETED|Double-Blind Treatment Period||23||
48752736|NCT03324776|102181029|FG000|STARTED|Overall Study||20||
48752737|NCT03324776|102181029|FG000|COMPLETED|Overall Study||20||
48752738|NCT03324776|102181029|FG000|NOT COMPLETED|Overall Study||0||
48752739|NCT00689390|102181030|FG000|STARTED|Overall Study||1907||
48752740|NCT00689390|102181031|FG001|STARTED|Overall Study||47||
48752741|NCT00689390|102181030|FG000|COMPLETED|Overall Study||1481||
48752742|NCT00689390|102181031|FG001|COMPLETED|Overall Study||37||
48752743|NCT00689390|102181030|FG000|NOT COMPLETED|Overall Study||426||
48752744|NCT00689390|102181031|FG001|NOT COMPLETED|Overall Study||10||
48752745|NCT02694744|102181032|FG000|STARTED|Overall Study||57||
48752746|NCT02694744|102181033|FG001|STARTED|Overall Study||57||
48752747|NCT02694744|102181032|FG000|Safety Population|Overall Study||57|Safety Population: All subjects who have taken at least one dose of patiromer.|
48752748|NCT02694744|102181033|FG001|Safety Population|Overall Study||56|Safety Population: All subjects who have taken at least one dose of patiromer.|
48752749|NCT02694744|102181032|FG000|ITT|Overall Study||57|Two randomized participates from Group 2 were excluded from the analyses for the ITT population.|
48752750|NCT02694744|102181033|FG001|ITT|Overall Study||55|Two randomized participates from Group 2 were excluded from the analyses for the ITT population.|
48752751|NCT02694744|102181032|FG000|COMPLETED|Overall Study||51||
48752752|NCT02694744|102181033|FG001|COMPLETED|Overall Study||52||
48752753|NCT02694744|102181032|FG000|NOT COMPLETED|Overall Study||6||
48752754|NCT02694744|102181033|FG001|NOT COMPLETED|Overall Study||5||
48335876|NCT03595280|101151917|FG001|NOT COMPLETED|Overall Study||9||
48335877|NCT03595280|101151918|FG002|NOT COMPLETED|Overall Study||15||
48335878|NCT03256045|101151919|FG000|STARTED|Overall Study||9||
48335879|NCT03256045|101151919|FG000|COMPLETED|Overall Study||9||
48335880|NCT03256045|101151919|FG000|NOT COMPLETED|Overall Study||0||
48335881|NCT03686969|101151920|FG000|STARTED|Overall Study||1||
48335882|NCT03686969|101151921|FG001|STARTED|Overall Study||0||
48335883|NCT03686969|101151920|FG000|COMPLETED|Overall Study||0||
48335884|NCT03686969|101151921|FG001|COMPLETED|Overall Study||0||
48335885|NCT03686969|101151920|FG000|NOT COMPLETED|Overall Study||1||
48335886|NCT03686969|101151921|FG001|NOT COMPLETED|Overall Study||0||
48335887|NCT03932799|101151922|FG000|STARTED|Overall Study||4632||
48335888|NCT03932799|101151923|FG001|STARTED|Overall Study||779||
48335889|NCT03932799|101151922|FG000|COMPLETED|Overall Study||4632||
48335890|NCT03932799|101151923|FG001|COMPLETED|Overall Study||779||
48335891|NCT03932799|101151922|FG000|NOT COMPLETED|Overall Study||0||
48335892|NCT03932799|101151923|FG001|NOT COMPLETED|Overall Study||0||
48335893|NCT00944034|101151924|FG000|STARTED|Overall Study||188||
48335894|NCT00944034|101151925|FG001|STARTED|Overall Study||157||
48335895|NCT00944034|101151926|FG002|STARTED|Overall Study||152||
48335896|NCT00944034|101151927|FG003|STARTED|Overall Study||174||
48335897|NCT00944034|101151928|FG004|STARTED|Overall Study||164||
48335898|NCT00944034|101151929|FG005|STARTED|Overall Study||143||
48335899|NCT00944034|101151930|FG006|STARTED|Overall Study||106||
48335900|NCT00944034|101151931|FG007|STARTED|Overall Study||78||
48335901|NCT00944034|101151932|FG008|STARTED|Overall Study||73||
48335902|NCT00944034|101151933|FG009|STARTED|Overall Study||246||
48335903|NCT00944034|101151934|FG010|STARTED|Overall Study||51||
48335904|NCT00944034|101151935|FG011|STARTED|Overall Study||56||
48335905|NCT00944034|101151924|FG000|COMPLETED|Overall Study||183||
48335906|NCT00944034|101151925|FG001|COMPLETED|Overall Study||150||
48335907|NCT00944034|101151926|FG002|COMPLETED|Overall Study||143||
48335908|NCT00944034|101151927|FG003|COMPLETED|Overall Study||170||
48335909|NCT00944034|101151928|FG004|COMPLETED|Overall Study||150||
48335910|NCT00944034|101151929|FG005|COMPLETED|Overall Study||123||
48335911|NCT00944034|101151930|FG006|COMPLETED|Overall Study||102||
48335912|NCT00944034|101151931|FG007|COMPLETED|Overall Study||73||
48335913|NCT00944034|101151932|FG008|COMPLETED|Overall Study||63||
48335914|NCT00944034|101151933|FG009|COMPLETED|Overall Study||236||
48335915|NCT00944034|101151934|FG010|COMPLETED|Overall Study||50||
48335916|NCT00944034|101151935|FG011|COMPLETED|Overall Study||52||
48335917|NCT00944034|101151924|FG000|NOT COMPLETED|Overall Study||5||
48335918|NCT00944034|101151925|FG001|NOT COMPLETED|Overall Study||7||
48335919|NCT00944034|101151926|FG002|NOT COMPLETED|Overall Study||9||
48335920|NCT00944034|101151927|FG003|NOT COMPLETED|Overall Study||4||
48335921|NCT00944034|101151928|FG004|NOT COMPLETED|Overall Study||14||
48335922|NCT00944034|101151929|FG005|NOT COMPLETED|Overall Study||20||
48335923|NCT00944034|101151930|FG006|NOT COMPLETED|Overall Study||4||
48335924|NCT00944034|101151931|FG007|NOT COMPLETED|Overall Study||5||
48335925|NCT00944034|101151932|FG008|NOT COMPLETED|Overall Study||10||
48335926|NCT00944034|101151933|FG009|NOT COMPLETED|Overall Study||10||
48335927|NCT00944034|101151934|FG010|NOT COMPLETED|Overall Study||1||
48335928|NCT00944034|101151935|FG011|NOT COMPLETED|Overall Study||4||
48335929|NCT03122431|101151936|FG000|STARTED|Overall Study||41||
48335930|NCT03122431|101151937|FG001|STARTED|Overall Study||32||
48335931|NCT03122431|101151938|FG002|STARTED|Overall Study||20||
48335932|NCT03122431|101151936|FG000|COMPLETED|Overall Study||41||
48335933|NCT03122431|101151937|FG001|COMPLETED|Overall Study||32||
48335934|NCT03122431|101151938|FG002|COMPLETED|Overall Study||9||
48335935|NCT03122431|101151936|FG000|NOT COMPLETED|Overall Study||0||
48335936|NCT03122431|101151937|FG001|NOT COMPLETED|Overall Study||0||
48335937|NCT03122431|101151938|FG002|NOT COMPLETED|Overall Study||11||
48335938|NCT02024971|101151939|FG000|STARTED|Overall Study||1103||
48335939|NCT02024971|101151939|FG000|Safety Analysis Set|Overall Study||1067||
48335940|NCT02024971|101151939|FG000|COMPLETED|Overall Study||1067||
48335941|NCT02024971|101151939|FG000|NOT COMPLETED|Overall Study||36||
48335942|NCT00282841|101151940|FG000|STARTED|Overall Study||61||
48335943|NCT00282841|101151940|FG000|COMPLETED|Overall Study||61||
48335944|NCT00282841|101151940|FG000|NOT COMPLETED|Overall Study||0||
48335945|NCT03786432|101151941|FG000|STARTED|Overall Study||13||
48335946|NCT03786432|101151941|FG000|Completed 12 Month Visit|Overall Study||8||
48335947|NCT03786432|101151941|FG000|Completed 12 Month CT Scan|Overall Study||7||
48335948|NCT03786432|101151941|FG000|COMPLETED|Overall Study||7||
48335949|NCT03786432|101151941|FG000|NOT COMPLETED|Overall Study||6||
48335950|NCT02849639|101151942|FG000|STARTED|Overall Study||44||
48335951|NCT02849639|101151943|FG001|STARTED|Overall Study||46||
48335952|NCT02849639|101151942|FG000|COMPLETED|Overall Study||41||
48335953|NCT02849639|101151943|FG001|COMPLETED|Overall Study||44||
48335954|NCT02849639|101151942|FG000|NOT COMPLETED|Overall Study||3||
48335955|NCT02849639|101151943|FG001|NOT COMPLETED|Overall Study||2||
48335956|NCT00568555|101151944|FG000|STARTED|Overall Study||16||
48335957|NCT00568555|101151945|FG001|STARTED|Overall Study||15||
48335958|NCT00568555|101151944|FG000|COMPLETED|Overall Study||15||
48335959|NCT00568555|101151945|FG001|COMPLETED|Overall Study||14||
48335960|NCT00568555|101151944|FG000|NOT COMPLETED|Overall Study||1||
48335961|NCT00568555|101151945|FG001|NOT COMPLETED|Overall Study||1||
48335962|NCT03715426|101151946|FG000|STARTED|Overall Study||133||
48335963|NCT03715426|101151947|FG001|STARTED|Overall Study||117||
48335964|NCT03715426|101151946|FG000|1-Month Follow-Up Survey|Overall Study||113||
48335965|NCT03715426|101151947|FG001|1-Month Follow-Up Survey|Overall Study||97||
48335966|NCT03715426|101151946|FG000|4-Month Follow-Up Survey|Overall Study||112||
48335967|NCT03715426|101151947|FG001|4-Month Follow-Up Survey|Overall Study||92||
48335968|NCT03715426|101151946|FG000|COMPLETED|Overall Study||112||
48335969|NCT03715426|101151947|FG001|COMPLETED|Overall Study||92||
48335970|NCT03715426|101151946|FG000|NOT COMPLETED|Overall Study||21||
48335971|NCT03715426|101151947|FG001|NOT COMPLETED|Overall Study||25||
48335972|NCT03640832|101151948|FG000|STARTED|Overall Study||44||
48335973|NCT03640832|101151949|FG001|STARTED|Overall Study||46||
48335974|NCT03640832|101151948|FG000|COMPLETED|Overall Study||44||
48335975|NCT03640832|101151949|FG001|COMPLETED|Overall Study||46||
48335976|NCT03640832|101151948|FG000|NOT COMPLETED|Overall Study||0||
48335977|NCT03640832|101151949|FG001|NOT COMPLETED|Overall Study||0||
48335978|NCT03303911|101151950|FG000|STARTED|Overall Study||13||
48335979|NCT03303911|101151951|FG001|STARTED|Overall Study||13||
48335980|NCT03303911|101151950|FG000|COMPLETED|Overall Study||13||
48335981|NCT03303911|101151951|FG001|COMPLETED|Overall Study||13||
48335982|NCT03303911|101151950|FG000|NOT COMPLETED|Overall Study||0||
48335983|NCT03303911|101151951|FG001|NOT COMPLETED|Overall Study||0||
48335984|NCT00602355|101151952|FG000|STARTED|Overall Study||53||
48335985|NCT00602355|101151953|FG001|STARTED|Overall Study||56||
48335986|NCT00602355|101151954|FG002|STARTED|Overall Study||53||
48335987|NCT00602355|101151952|FG000|COMPLETED|Overall Study||44||
48335988|NCT00602355|101151953|FG001|COMPLETED|Overall Study||38||
48335989|NCT00602355|101151954|FG002|COMPLETED|Overall Study||43||
48335990|NCT00602355|101151952|FG000|NOT COMPLETED|Overall Study||9||
48335991|NCT00602355|101151953|FG001|NOT COMPLETED|Overall Study||18||
48335992|NCT00602355|101151954|FG002|NOT COMPLETED|Overall Study||10||
48335993|NCT01441063|101151955|FG000|STARTED|Tocilizumab Alone||8||
48335994|NCT01441063|101151955|FG000|COMPLETED|Tocilizumab Alone||5||
48335995|NCT01441063|101151955|FG000|NOT COMPLETED|Tocilizumab Alone||3||
48335996|NCT01441063|101151955|FG000|STARTED|Tocilizumab + Zidovudine /Valganciclovir||3||
48335997|NCT01441063|101151955|FG000|COMPLETED|Tocilizumab + Zidovudine /Valganciclovir||2||
48335998|NCT01441063|101151955|FG000|NOT COMPLETED|Tocilizumab + Zidovudine /Valganciclovir||1||
48335999|NCT00996203|101151956|FG000|STARTED|Overall Study||201||
48336000|NCT00996203|101151956|FG000|COMPLETED|Overall Study||194||
48336001|NCT00996203|101151956|FG000|NOT COMPLETED|Overall Study||7||
48336002|NCT00384241|101151957|FG000|STARTED|Overall Study||500||
48336003|NCT00384241|101151958|FG001|STARTED|Overall Study||599||
48336004|NCT00384241|101151957|FG000|COMPLETED|Overall Study||500||
48336005|NCT00384241|101151958|FG001|COMPLETED|Overall Study||599||
48336006|NCT00384241|101151957|FG000|NOT COMPLETED|Overall Study||0||
48336007|NCT00384241|101151958|FG001|NOT COMPLETED|Overall Study||0||
48336008|NCT00723788|101151959|FG000|STARTED|Overall Study||21||
48336009|NCT00723788|101151959|FG000|COMPLETED|Overall Study||21||
48336010|NCT00723788|101151959|FG000|NOT COMPLETED|Overall Study||0||
48336011|NCT00600015|101151960|FG000|STARTED|Overall Study||111||
48336012|NCT00600015|101151961|FG001|STARTED|Overall Study||55||
48336013|NCT00600015|101151960|FG000|COMPLETED|Overall Study||51||
48336014|NCT00600015|101151961|FG001|COMPLETED|Overall Study||20||
48336015|NCT00600015|101151960|FG000|NOT COMPLETED|Overall Study||60||
48336016|NCT00600015|101151961|FG001|NOT COMPLETED|Overall Study||35||
48336017|NCT04428411|101151962|FG000|STARTED|Overall Study||486||
48336018|NCT04428411|101151962|FG000|Participants With Difficult to Treat Sites|Overall Study||397||
48336019|NCT04428411|101151962|FG000|Participants Without Difficulty to Treat Sites|Overall Study||89||
48336020|NCT04428411|101151962|FG000|Participants Adherent to Treatment|Overall Study||417||
48336021|NCT04428411|101151962|FG000|Participants Not Adherent to Treatment|Overall Study||69||
48336022|NCT04428411|101151962|FG000|COMPLETED|Overall Study||372||
48336023|NCT04428411|101151962|FG000|NOT COMPLETED|Overall Study||114||
48336024|NCT01565980|101151963|FG000|STARTED|Overall Study||20||
48336025|NCT01565980|101151964|FG001|STARTED|Overall Study||20||
48336026|NCT01565980|101151963|FG000|COMPLETED|Overall Study||16||
48336027|NCT01565980|101151964|FG001|COMPLETED|Overall Study||16||
48336028|NCT01565980|101151963|FG000|NOT COMPLETED|Overall Study||4||
48336029|NCT01565980|101151964|FG001|NOT COMPLETED|Overall Study||4||
48336030|NCT04270760|101151965|FG000|STARTED|Overall Study||58||
48336031|NCT04270760|101151966|FG001|STARTED|Overall Study||58||
48336032|NCT04270760|101151967|FG002|STARTED|Overall Study||56||
48336033|NCT04270760|101151968|FG003|STARTED|Overall Study||55||
48336034|NCT04270760|101151969|FG004|STARTED|Overall Study||54||
48336035|NCT04270760|101151965|FG000|Entered Extended Safety Follow-up Period|Overall Study||57||
48336036|NCT04270760|101151966|FG001|Entered Extended Safety Follow-up Period|Overall Study||57||
48336037|NCT04270760|101151967|FG002|Entered Extended Safety Follow-up Period|Overall Study||54||
48336038|NCT04270760|101151968|FG003|Entered Extended Safety Follow-up Period|Overall Study||55||
48336039|NCT04270760|101151969|FG004|Entered Extended Safety Follow-up Period|Overall Study||53||
48336040|NCT04270760|101151965|FG000|COMPLETED|Overall Study||57||
48336041|NCT04270760|101151966|FG001|COMPLETED|Overall Study||55||
48336042|NCT04270760|101151967|FG002|COMPLETED|Overall Study||52||
48752755|NCT01308736|102181034|FG000|STARTED|Overall Study||31||
48752756|NCT01308736|102181035|FG001|STARTED|Overall Study||32||
48752757|NCT01308736|102181034|FG000|COMPLETED|Overall Study||25||
48752758|NCT01308736|102181035|FG001|COMPLETED|Overall Study||27||
48752759|NCT01308736|102181034|FG000|NOT COMPLETED|Overall Study||6||
48752760|NCT01308736|102181035|FG001|NOT COMPLETED|Overall Study||5||
48752761|NCT00317473|102181036|FG000|STARTED|Overall Study||30||
48175072|NCT00432835|100750109|FG000|Completed 1st Intervention|Overall Study||22||
48175073|NCT00432835|100750110|FG001|Completed 1st Intervention|Overall Study||23||
48175074|NCT00432835|100750109|FG000|Completed 2nd Intervention|Overall Study||22||
48175075|NCT00432835|100750110|FG001|Completed 2nd Intervention|Overall Study||23||
48175076|NCT00432835|100750109|FG000|COMPLETED|Overall Study||22||
48752762|NCT00317473|102181037|FG001|STARTED|Overall Study||15||
48752763|NCT00317473|102181038|FG002|STARTED|Overall Study||30||
48752764|NCT00317473|102181039|FG003|STARTED|Overall Study||15||
48752765|NCT00317473|102181040|FG004|STARTED|Overall Study||30||
48752766|NCT00317473|102181041|FG005|STARTED|Overall Study||15||
48752767|NCT00317473|102181036|FG000|COMPLETED|Overall Study||26||
48175077|NCT00432835|100750110|FG001|COMPLETED|Overall Study||23||
48175078|NCT00432835|100750109|FG000|NOT COMPLETED|Overall Study||6||
48175079|NCT00432835|100750110|FG001|NOT COMPLETED|Overall Study||7||
48175080|NCT02334527|100750111|FG000|STARTED|Overall Study||12||
48175081|NCT02334527|100750111|FG000|COMPLETED|Overall Study||12||
48175082|NCT02334527|100750111|FG000|NOT COMPLETED|Overall Study||0||
48175083|NCT04081298|100750112|FG000|STARTED|Overall Study||20||
48175084|NCT04081298|100750112|FG000|COMPLETED|Overall Study||19||
48175085|NCT04081298|100750112|FG000|NOT COMPLETED|Overall Study||1||
48175086|NCT01644474|100750113|FG000|STARTED|Overall Study||51||
48175087|NCT01644474|100750114|FG001|STARTED|Overall Study||52||
48175088|NCT01644474|100750113|FG000|Treated|Overall Study||51||
48175089|NCT01644474|100750114|FG001|Treated|Overall Study||52||
48175090|NCT01644474|100750113|FG000|COMPLETED|Overall Study||44||
48175091|NCT01644474|100750114|FG001|COMPLETED|Overall Study||44||
48175092|NCT01644474|100750113|FG000|NOT COMPLETED|Overall Study||7||
48175093|NCT01644474|100750114|FG001|NOT COMPLETED|Overall Study||8||
48175094|NCT04140890|100750115|FG000|STARTED|Overall Study||9||
48175095|NCT04140890|100750116|FG001|STARTED|Overall Study||12||
48175096|NCT04140890|100750115|FG000|COMPLETED|Overall Study||9||
48175097|NCT04140890|100750116|FG001|COMPLETED|Overall Study||11||
48175098|NCT04140890|100750115|FG000|NOT COMPLETED|Overall Study||0||
48175099|NCT04140890|100750116|FG001|NOT COMPLETED|Overall Study||1||
48175100|NCT03525574|100750117|FG000|STARTED|Overall Study||507||
48175101|NCT03525574|100750118|FG001|STARTED|Overall Study||3||
48175102|NCT03525574|100750117|FG000|Open-Label Safety Set (OL-SS)|Overall Study||506||
48175103|NCT03525574|100750118|FG001|Open-Label Safety Set (OL-SS)|Overall Study||0||
48175104|NCT03525574|100750117|FG000|OL-FAS 102/105|Overall Study||399||
48175105|NCT03525574|100750118|FG001|OL-FAS 102/105|Overall Study||0||
48175106|NCT03525574|100750117|FG000|OL-FAS 103/105|Overall Study||107||
48412430|NCT03644173|101342010|FG000|COMPLETED|Participants at Last Visit (Pre-surveys)||16||
48412431|NCT03644173|101342010|FG000|NOT COMPLETED|Participants at Last Visit (Pre-surveys)||21||
48412432|NCT03644173|101342010|FG000|STARTED|Participants at the 1-month Follow up||16||
48412433|NCT03644173|101342010|FG000|COMPLETED|Participants at the 1-month Follow up||12||
48412434|NCT03644173|101342010|FG000|NOT COMPLETED|Participants at the 1-month Follow up||4||
48412435|NCT03644173|101342010|FG000|STARTED|Participants at the 3-month Follow up||12||
48412436|NCT03644173|101342010|FG000|COMPLETED|Participants at the 3-month Follow up||10||
48439941|NCT04993339|101409989|FG000|STARTED|Overall Study||14||
48752768|NCT00317473|102181037|FG001|COMPLETED|Overall Study||12||
48752769|NCT00317473|102181038|FG002|COMPLETED|Overall Study||27||
48752770|NCT00317473|102181039|FG003|COMPLETED|Overall Study||13||
48752771|NCT00317473|102181040|FG004|COMPLETED|Overall Study||22||
48752772|NCT00317473|102181041|FG005|COMPLETED|Overall Study||12||
48752773|NCT00317473|102181036|FG000|NOT COMPLETED|Overall Study||4||
48752774|NCT00317473|102181037|FG001|NOT COMPLETED|Overall Study||3||
48752775|NCT00317473|102181038|FG002|NOT COMPLETED|Overall Study||3||
48752776|NCT00317473|102181039|FG003|NOT COMPLETED|Overall Study||2||
48752777|NCT00317473|102181040|FG004|NOT COMPLETED|Overall Study||8||
48752778|NCT00317473|102181041|FG005|NOT COMPLETED|Overall Study||3||
48752779|NCT01478971|102181042|FG000|STARTED|Standard of Care Period||184||
48752780|NCT01478971|102181042|FG000|Received Treatment|Standard of Care Period||178||
48752781|NCT01478971|102181042|FG000|COMPLETED|Standard of Care Period||159||
48752782|NCT01478971|102181042|FG000|NOT COMPLETED|Standard of Care Period||25||
48752783|NCT01478971|102181042|FG000|STARTED|Peginesatide Treatment Period||157||
48752784|NCT01478971|102181042|FG000|COMPLETED|Peginesatide Treatment Period||143||
48752785|NCT01478971|102181042|FG000|NOT COMPLETED|Peginesatide Treatment Period||14||
48752786|NCT00855959|102181043|FG000|STARTED|Overall Study||108||
48175107|NCT03525574|100750118|FG001|OL-FAS 103/105|Overall Study||0||
48175108|NCT03525574|100750117|FG000|Cumulative Triple Combination (TC) Efficacy Set 102/105|Overall Study||400||
48175109|NCT03525574|100750118|FG001|Cumulative Triple Combination (TC) Efficacy Set 102/105|Overall Study||3||
48175110|NCT03525574|100750117|FG000|Cumulative TC Efficacy Set 103/105|Overall Study||107||
48175111|NCT03525574|100750118|FG001|Cumulative TC Efficacy Set 103/105|Overall Study||0||
48175112|NCT03525574|100750117|FG000|COMPLETED|Overall Study||354||
48175113|NCT03525574|100750118|FG001|COMPLETED|Overall Study||0||
48175114|NCT03525574|100750117|FG000|NOT COMPLETED|Overall Study||153||
48175115|NCT03525574|100750118|FG001|NOT COMPLETED|Overall Study||3||
48175116|NCT01405794|100750119|FG000|STARTED|First Dose Placebo (14 Days)||12||
48175117|NCT01405794|100750119|FG000|COMPLETED|First Dose Placebo (14 Days)||12||
48175118|NCT01405794|100750119|FG000|NOT COMPLETED|First Dose Placebo (14 Days)||0||
48175119|NCT01405794|100750119|FG000|STARTED|72 hr Washout||12||
48175120|NCT01405794|100750119|FG000|COMPLETED|72 hr Washout||12||
48175121|NCT01405794|100750119|FG000|NOT COMPLETED|72 hr Washout||0||
48175122|NCT01405794|100750119|FG000|STARTED|Second Dose 32ppm Oral Silver (14 Days)||12||
48175123|NCT01405794|100750119|FG000|COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||12||
48175124|NCT01405794|100750119|FG000|NOT COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||0||
48175125|NCT02357043|100750120|FG000|STARTED|Overall Study||368||
48175126|NCT02357043|100750120|FG000|COMPLETED|Overall Study||368||
48175127|NCT02357043|100750120|FG000|NOT COMPLETED|Overall Study||0||
48175128|NCT03410914|100750121|FG000|STARTED|Overall Study||52||
48175129|NCT03410914|100750121|FG000|COMPLETED|Overall Study||52||
48175130|NCT03410914|100750121|FG000|NOT COMPLETED|Overall Study||0||
48175131|NCT02762981|100750122|FG000|STARTED|Overall Study||17||
48175132|NCT02762981|100750123|FG001|STARTED|Overall Study||40||
48175133|NCT02762981|100750124|FG002|STARTED|Overall Study||7||
48175134|NCT02762981|100750125|FG003|STARTED|Overall Study||16||
48175135|NCT02762981|100750126|FG004|STARTED|Overall Study||5||
48175136|NCT02762981|100750122|FG000|COMPLETED|Overall Study||0||
48175137|NCT02762981|100750123|FG001|COMPLETED|Overall Study||0||
48175138|NCT02762981|100750124|FG002|COMPLETED|Overall Study||0||
48175139|NCT02762981|100750125|FG003|COMPLETED|Overall Study||0||
48175140|NCT02762981|100750126|FG004|COMPLETED|Overall Study||0||
48629962|NCT02860988|101878478|FG000|STARTED|Overall Study||201||
48752787|NCT00855959|102181043|FG000|Patients Who Received Pulmicort Respules|Overall Study||105||
48752788|NCT00855959|102181043|FG000|COMPLETED|Overall Study||99||
48752789|NCT00855959|102181043|FG000|NOT COMPLETED|Overall Study||9||
48752790|NCT04349072|102181044|FG000|STARTED|Randomization Period||56||
48175141|NCT02762981|100750122|FG000|NOT COMPLETED|Overall Study||17||
48175142|NCT02762981|100750123|FG001|NOT COMPLETED|Overall Study||40||
48175143|NCT02762981|100750124|FG002|NOT COMPLETED|Overall Study||7||
48175144|NCT02762981|100750125|FG003|NOT COMPLETED|Overall Study||16||
48175145|NCT02762981|100750126|FG004|NOT COMPLETED|Overall Study||5||
48175146|NCT02265224|100750127|FG000|STARTED|Overall Study||48||
48175147|NCT02265224|100750127|FG000|COMPLETED|Overall Study||48||
48175148|NCT02265224|100750127|FG000|NOT COMPLETED|Overall Study||0||
48175149|NCT01159535|100750128|FG000|STARTED|Overall Study||103||
48175150|NCT01159535|100750129|FG001|STARTED|Overall Study||88||
48175151|NCT01159535|100750130|FG002|STARTED|Overall Study||95||
48175152|NCT01159535|100750128|FG000|COMPLETED|Overall Study||79||
48629963|NCT02860988|101878479|FG001|STARTED|Overall Study||200||
48629964|NCT02860988|101878478|FG000|COMPLETED|Overall Study||117||
48629965|NCT02860988|101878479|FG001|COMPLETED|Overall Study||94||
48629966|NCT02860988|101878478|FG000|NOT COMPLETED|Overall Study||84||
48629967|NCT02860988|101878479|FG001|NOT COMPLETED|Overall Study||106||
48629968|NCT05310877|101878480|FG000|STARTED|Overall Study||7||
48629969|NCT05310877|101878480|FG000|COMPLETED|Overall Study||6||
48629970|NCT05310877|101878480|FG000|NOT COMPLETED|Overall Study||1||
48629971|NCT01922934|101878481|FG000|STARTED|Eligible Patients||428||
48629972|NCT01922934|101878482|FG001|STARTED|Eligible Patients||4302||
48629973|NCT01922934|101878481|FG000|COMPLETED|Eligible Patients||375||
48629974|NCT01922934|101878482|FG001|COMPLETED|Eligible Patients||4214||
48629975|NCT01922934|101878481|FG000|NOT COMPLETED|Eligible Patients||53||
48629976|NCT01922934|101878482|FG001|NOT COMPLETED|Eligible Patients||88||
48629977|NCT01922934|101878481|FG000|STARTED|Visit 0 - Patient Contacted & Consented||375||
48629978|NCT01922934|101878482|FG001|STARTED|Visit 0 - Patient Contacted & Consented||4214||
48629979|NCT01922934|101878481|FG000|COMPLETED|Visit 0 - Patient Contacted & Consented||140||
48629980|NCT01922934|101878482|FG001|COMPLETED|Visit 0 - Patient Contacted & Consented||4214||
48629981|NCT01922934|101878481|FG000|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||235||
48629982|NCT01922934|101878482|FG001|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||0||
48629983|NCT01922934|101878481|FG000|STARTED|Visit 1- Weight Measured||140||
48629984|NCT01922934|101878482|FG001|STARTED|Visit 1- Weight Measured||4214||
48629985|NCT01922934|101878481|FG000|COMPLETED|Visit 1- Weight Measured||119||
48629986|NCT01922934|101878482|FG001|COMPLETED|Visit 1- Weight Measured||2930||
48629987|NCT01922934|101878481|FG000|NOT COMPLETED|Visit 1- Weight Measured||21||
48629988|NCT01922934|101878482|FG001|NOT COMPLETED|Visit 1- Weight Measured||1284||
48629989|NCT01922934|101878481|FG000|STARTED|Visit 12 / Final Visits||119||
48629990|NCT01922934|101878482|FG001|STARTED|Visit 12 / Final Visits||2930||
48629991|NCT01922934|101878481|FG000|COMPLETED|Visit 12 / Final Visits||113||
48752791|NCT04349072|102181045|FG001|STARTED|Randomization Period||56||
48752792|NCT04349072|102181044|FG000|COMPLETED|Randomization Period||56||
48752793|NCT04349072|102181045|FG001|COMPLETED|Randomization Period||55||
48752794|NCT04349072|102181044|FG000|NOT COMPLETED|Randomization Period||0||
48752795|NCT04349072|102181045|FG001|NOT COMPLETED|Randomization Period||1||
48752796|NCT04349072|102181044|FG000|STARTED|Treatment Period||56||
48752797|NCT04349072|102181045|FG001|STARTED|Treatment Period||55||
48752798|NCT04349072|102181044|FG000|Discontinued Treatment During the Placebo-controlled Period (Day 1 to Week 16)|Treatment Period||2||
48752799|NCT04349072|102181045|FG001|Discontinued Treatment During the Placebo-controlled Period (Day 1 to Week 16)|Treatment Period||3||
48752800|NCT04349072|102181044|FG000|COMPLETED|Treatment Period||52|Ongoing treatment|
48752801|NCT04349072|102181045|FG001|COMPLETED|Treatment Period||45|Ongoing treatment|
48752802|NCT04349072|102181044|FG000|NOT COMPLETED|Treatment Period||4||
48752803|NCT04349072|102181045|FG001|NOT COMPLETED|Treatment Period||10||
48752804|NCT00453154|102181046|FG000|STARTED|Combination Chemotherapy||12||
48752805|NCT00453154|102181047|FG001|STARTED|Combination Chemotherapy||144||
48752806|NCT00453154|102181048|FG002|STARTED|Combination Chemotherapy||0||
48752807|NCT00453154|102181049|FG003|STARTED|Combination Chemotherapy||0||
48752808|NCT00453154|102181046|FG000|COMPLETED|Combination Chemotherapy||12||
48752809|NCT00453154|102181047|FG001|COMPLETED|Combination Chemotherapy||95||
48752810|NCT00453154|102181048|FG002|COMPLETED|Combination Chemotherapy||0||
48752811|NCT00453154|102181049|FG003|COMPLETED|Combination Chemotherapy||0||
48752812|NCT00453154|102181046|FG000|NOT COMPLETED|Combination Chemotherapy||0||
48752813|NCT00453154|102181047|FG001|NOT COMPLETED|Combination Chemotherapy||49||
48752814|NCT00453154|102181048|FG002|NOT COMPLETED|Combination Chemotherapy||0||
48752815|NCT00453154|102181049|FG003|NOT COMPLETED|Combination Chemotherapy||0||
48752816|NCT00453154|102181046|FG000|STARTED|Double BIind Maintenance||0||
48752817|NCT00453154|102181047|FG001|STARTED|Double BIind Maintenance||0||
48752818|NCT00453154|102181048|FG002|STARTED|Double BIind Maintenance||46||
48752819|NCT00453154|102181049|FG003|STARTED|Double BIind Maintenance||49||
48752820|NCT00453154|102181046|FG000|COMPLETED|Double BIind Maintenance||0||
48752821|NCT00453154|102181047|FG001|COMPLETED|Double BIind Maintenance||0||
48752822|NCT00453154|102181048|FG002|COMPLETED|Double BIind Maintenance||0||
48175153|NCT01159535|100750129|FG001|COMPLETED|Overall Study||64||
48175154|NCT01159535|100750130|FG002|COMPLETED|Overall Study||64||
48175155|NCT01159535|100750128|FG000|NOT COMPLETED|Overall Study||24||
48175156|NCT01159535|100750129|FG001|NOT COMPLETED|Overall Study||24||
48175157|NCT01159535|100750130|FG002|NOT COMPLETED|Overall Study||31||
48175158|NCT03632434|100750131|FG000|STARTED|Overall Study||26||
48175159|NCT03632434|100750131|FG000|COMPLETED|Overall Study||24||
48175160|NCT03632434|100750131|FG000|NOT COMPLETED|Overall Study||2||
48175161|NCT01266993|100750132|FG000|STARTED|Persistence Phase (Month 32-44)||199||
48175162|NCT01266993|100750133|FG001|STARTED|Persistence Phase (Month 32-44)||72||
48175163|NCT01266993|100750132|FG000|COMPLETED|Persistence Phase (Month 32-44)||199||
48175164|NCT01266993|100750133|FG001|COMPLETED|Persistence Phase (Month 32-44)||72||
48175165|NCT01266993|100750132|FG000|NOT COMPLETED|Persistence Phase (Month 32-44)||0||
48175166|NCT01266993|100750133|FG001|NOT COMPLETED|Persistence Phase (Month 32-44)||0||
48175167|NCT01266993|100750132|FG000|STARTED|Persistence Phase (Month 44-56)||193||
48175168|NCT01266993|100750133|FG001|STARTED|Persistence Phase (Month 44-56)||68||
48175169|NCT01266993|100750132|FG000|COMPLETED|Persistence Phase (Month 44-56)||193||
48752823|NCT00453154|102181049|FG003|COMPLETED|Double BIind Maintenance||0||
48752824|NCT00453154|102181046|FG000|NOT COMPLETED|Double BIind Maintenance||0||
48752825|NCT00453154|102181047|FG001|NOT COMPLETED|Double BIind Maintenance||0||
48752826|NCT00453154|102181048|FG002|NOT COMPLETED|Double BIind Maintenance||46||
48752827|NCT00453154|102181049|FG003|NOT COMPLETED|Double BIind Maintenance||49||
48752828|NCT00453154|102181046|FG000|STARTED|Open Label Sunitinib Crossover||0||
48752829|NCT00453154|102181047|FG001|STARTED|Open Label Sunitinib Crossover||0||
48752830|NCT00453154|102181048|FG002|STARTED|Open Label Sunitinib Crossover||18||
48752831|NCT00453154|102181049|FG003|STARTED|Open Label Sunitinib Crossover||0||
48752832|NCT00453154|102181046|FG000|COMPLETED|Open Label Sunitinib Crossover||0||
48752833|NCT00453154|102181047|FG001|COMPLETED|Open Label Sunitinib Crossover||0||
48752834|NCT00453154|102181048|FG002|COMPLETED|Open Label Sunitinib Crossover||18||
48752835|NCT00453154|102181049|FG003|COMPLETED|Open Label Sunitinib Crossover||0||
48752836|NCT00453154|102181046|FG000|NOT COMPLETED|Open Label Sunitinib Crossover||0||
48752837|NCT00453154|102181047|FG001|NOT COMPLETED|Open Label Sunitinib Crossover||0||
48752838|NCT00453154|102181048|FG002|NOT COMPLETED|Open Label Sunitinib Crossover||0||
48752839|NCT00453154|102181049|FG003|NOT COMPLETED|Open Label Sunitinib Crossover||0||
48752840|NCT03812380|102181050|FG000|STARTED|Overall Study||22||
48752841|NCT03812380|102181051|FG001|STARTED|Overall Study||22||
48752842|NCT03812380|102181050|FG000|COMPLETED|Overall Study||0||
48752843|NCT03812380|102181051|FG001|COMPLETED|Overall Study||1||
48752844|NCT03812380|102181050|FG000|NOT COMPLETED|Overall Study||22||
48752845|NCT03812380|102181051|FG001|NOT COMPLETED|Overall Study||21||
48752846|NCT01636765|102181052|FG000|STARTED|Overall Study||104||
48752847|NCT01636765|102181052|FG000|COMPLETED|Overall Study||104||
48752848|NCT01636765|102181052|FG000|NOT COMPLETED|Overall Study||0||
48752849|NCT01018030|102181053|FG000|STARTED|Overall Study||246||
48752850|NCT01018030|102181054|FG001|STARTED|Overall Study||243||
48175170|NCT01266993|100750133|FG001|COMPLETED|Persistence Phase (Month 44-56)||68||
48175171|NCT01266993|100750132|FG000|NOT COMPLETED|Persistence Phase (Month 44-56)||0||
48175172|NCT01266993|100750133|FG001|NOT COMPLETED|Persistence Phase (Month 44-56)||0||
48175173|NCT01266993|100750132|FG000|STARTED|Persistence Phase (Month 56-68)||193||
48175174|NCT01266993|100750133|FG001|STARTED|Persistence Phase (Month 56-68)||67||
48175175|NCT01266993|100750132|FG000|COMPLETED|Persistence Phase (Month 56-68)||193||
48175176|NCT01266993|100750133|FG001|COMPLETED|Persistence Phase (Month 56-68)||67||
48175177|NCT01266993|100750132|FG000|NOT COMPLETED|Persistence Phase (Month 56-68)||0||
48175178|NCT01266993|100750133|FG001|NOT COMPLETED|Persistence Phase (Month 56-68)||0||
48175179|NCT01266993|100750132|FG000|STARTED|Booster Phase (Month 68-69)||179||
48175180|NCT01266993|100750133|FG001|STARTED|Booster Phase (Month 68-69)||62||
48175181|NCT01266993|100750132|FG000|COMPLETED|Booster Phase (Month 68-69)||174||
48175182|NCT01266993|100750133|FG001|COMPLETED|Booster Phase (Month 68-69)||60||
48175183|NCT01266993|100750132|FG000|NOT COMPLETED|Booster Phase (Month 68-69)||5||
48175184|NCT01266993|100750133|FG001|NOT COMPLETED|Booster Phase (Month 68-69)||2||
48175185|NCT00110513|100750134|FG000|STARTED|Overall Study||18||
48175186|NCT00110513|100750134|FG000|COMPLETED|Overall Study||18||
48175187|NCT00110513|100750134|FG000|NOT COMPLETED|Overall Study||0||
48175188|NCT01193582|100750135|FG000|STARTED|Vaccination Series||100||
48175189|NCT01193582|100750136|FG001|STARTED|Vaccination Series||101||
48175190|NCT01193582|100750137|FG002|STARTED|Vaccination Series||125||
48175191|NCT01193582|100750138|FG003|STARTED|Vaccination Series||180||
48175192|NCT01193582|100750135|FG000|Vaccinated Dose 1|Vaccination Series||100||
48175193|NCT01193582|100750136|FG001|Vaccinated Dose 1|Vaccination Series||100||
48175194|NCT01193582|100750137|FG002|Vaccinated Dose 1|Vaccination Series||125||
48175195|NCT01193582|100750138|FG003|Vaccinated Dose 1|Vaccination Series||180||
48175196|NCT01193582|100750135|FG000|Vaccinated Dose 2|Vaccination Series||92||
48175197|NCT01193582|100750136|FG001|Vaccinated Dose 2|Vaccination Series||91||
48175198|NCT01193582|100750137|FG002|Vaccinated Dose 2|Vaccination Series||118||
48175199|NCT01193582|100750138|FG003|Vaccinated Dose 2|Vaccination Series||0||
48175200|NCT01193582|100750135|FG000|Vaccinated Dose 3|Vaccination Series||90||
48175201|NCT01193582|100750136|FG001|Vaccinated Dose 3|Vaccination Series||89||
48175202|NCT01193582|100750137|FG002|Vaccinated Dose 3|Vaccination Series||0||
48175203|NCT01193582|100750138|FG003|Vaccinated Dose 3|Vaccination Series||0||
48175204|NCT01193582|100750135|FG000|Vaccinated Dose 4|Vaccination Series||90||
48175205|NCT01193582|100750136|FG001|Vaccinated Dose 4|Vaccination Series||0||
48175206|NCT01193582|100750137|FG002|Vaccinated Dose 4|Vaccination Series||0||
48175207|NCT01193582|100750138|FG003|Vaccinated Dose 4|Vaccination Series||0||
48175208|NCT01193582|100750135|FG000|COMPLETED|Vaccination Series||89||
48175209|NCT01193582|100750136|FG001|COMPLETED|Vaccination Series||88||
48175210|NCT01193582|100750137|FG002|COMPLETED|Vaccination Series||117||
48175211|NCT01193582|100750138|FG003|COMPLETED|Vaccination Series||177||
48175212|NCT01193582|100750135|FG000|NOT COMPLETED|Vaccination Series||11||
48175213|NCT01193582|100750136|FG001|NOT COMPLETED|Vaccination Series||13||
48175214|NCT01193582|100750137|FG002|NOT COMPLETED|Vaccination Series||8||
48175215|NCT01193582|100750138|FG003|NOT COMPLETED|Vaccination Series||3||
48175216|NCT01193582|100750135|FG000|STARTED|12 Month Follow-up||89||
48175217|NCT01193582|100750136|FG001|STARTED|12 Month Follow-up||88||
48175218|NCT01193582|100750137|FG002|STARTED|12 Month Follow-up||117||
48175219|NCT01193582|100750138|FG003|STARTED|12 Month Follow-up||177||
48175220|NCT01193582|100750135|FG000|COMPLETED|12 Month Follow-up||83||
48175221|NCT01193582|100750136|FG001|COMPLETED|12 Month Follow-up||88||
48175222|NCT01193582|100750137|FG002|COMPLETED|12 Month Follow-up||113||
48175223|NCT01193582|100750138|FG003|COMPLETED|12 Month Follow-up||166||
48175224|NCT01193582|100750135|FG000|NOT COMPLETED|12 Month Follow-up||6||
48175225|NCT01193582|100750136|FG001|NOT COMPLETED|12 Month Follow-up||0||
48175226|NCT01193582|100750137|FG002|NOT COMPLETED|12 Month Follow-up||4||
48175227|NCT01193582|100750138|FG003|NOT COMPLETED|12 Month Follow-up||11||
48175228|NCT02538679|100750139|FG000|STARTED|Overall Study||24||
48175229|NCT02538679|100750140|FG001|STARTED|Overall Study||54||
48175230|NCT02538679|100750141|FG002|STARTED|Overall Study||49||
48175231|NCT02538679|100750139|FG000|COMPLETED|Overall Study||21||
48175232|NCT02538679|100750140|FG001|COMPLETED|Overall Study||45||
48175233|NCT02538679|100750141|FG002|COMPLETED|Overall Study||41||
48175234|NCT02538679|100750139|FG000|NOT COMPLETED|Overall Study||3||
48175235|NCT02538679|100750140|FG001|NOT COMPLETED|Overall Study||9||
48175236|NCT02538679|100750141|FG002|NOT COMPLETED|Overall Study||8||
48175237|NCT01026909|100750142|FG000|STARTED|Overall Study||1||
48175238|NCT01026909|100750143|FG001|STARTED|Overall Study||2||
48175239|NCT01026909|100750142|FG000|COMPLETED|Overall Study||1||
48175240|NCT01026909|100750143|FG001|COMPLETED|Overall Study||2||
48175241|NCT01026909|100750142|FG000|NOT COMPLETED|Overall Study||0||
48175242|NCT01026909|100750143|FG001|NOT COMPLETED|Overall Study||0||
48175243|NCT02038764|100750144|FG000|STARTED|Overall Study||7||
48175244|NCT02038764|100750145|FG001|STARTED|Overall Study||8||
48175245|NCT02038764|100750146|FG002|STARTED|Overall Study||9||
48336043|NCT04270760|101151968|FG003|COMPLETED|Overall Study||55||
48175246|NCT02038764|100750147|FG003|STARTED|Overall Study||5||
48175247|NCT02038764|100750148|FG004|STARTED|Overall Study||8||
48175248|NCT02038764|100750144|FG000|COMPLETED|Overall Study||6||
48175249|NCT02038764|100750145|FG001|COMPLETED|Overall Study||7||
48175250|NCT02038764|100750146|FG002|COMPLETED|Overall Study||7||
48175251|NCT02038764|100750147|FG003|COMPLETED|Overall Study||5||
48175252|NCT02038764|100750148|FG004|COMPLETED|Overall Study||7||
48175253|NCT02038764|100750144|FG000|NOT COMPLETED|Overall Study||1||
48175254|NCT02038764|100750145|FG001|NOT COMPLETED|Overall Study||1||
48175255|NCT02038764|100750146|FG002|NOT COMPLETED|Overall Study||2||
48175256|NCT02038764|100750147|FG003|NOT COMPLETED|Overall Study||0||
48175257|NCT02038764|100750148|FG004|NOT COMPLETED|Overall Study||1||
48175258|NCT00859508|100750149|FG000|STARTED|Overall Study||68||
48175259|NCT00859508|100750150|FG001|STARTED|Overall Study||37||
48175260|NCT00859508|100750149|FG000|COMPLETED|Overall Study||62||
48336044|NCT04270760|101151969|FG004|COMPLETED|Overall Study||53||
48336045|NCT04270760|101151965|FG000|NOT COMPLETED|Overall Study||1||
48336046|NCT04270760|101151966|FG001|NOT COMPLETED|Overall Study||3||
48336047|NCT04270760|101151967|FG002|NOT COMPLETED|Overall Study||4||
48336048|NCT04270760|101151968|FG003|NOT COMPLETED|Overall Study||0||
48336049|NCT04270760|101151969|FG004|NOT COMPLETED|Overall Study||1||
48336050|NCT01592760|101151970|FG000|STARTED|Perioperative to Discharge||90||
48336051|NCT01592760|101151971|FG001|STARTED|Perioperative to Discharge||90||
48336052|NCT01592760|101151972|FG002|STARTED|Perioperative to Discharge||45||
48336053|NCT01592760|101151970|FG000|COMPLETED|Perioperative to Discharge||90||
48336054|NCT01592760|101151971|FG001|COMPLETED|Perioperative to Discharge||90||
48336055|NCT01592760|101151972|FG002|COMPLETED|Perioperative to Discharge||45||
48336056|NCT01592760|101151970|FG000|NOT COMPLETED|Perioperative to Discharge||0||
48336057|NCT01592760|101151971|FG001|NOT COMPLETED|Perioperative to Discharge||0||
48336058|NCT01592760|101151972|FG002|NOT COMPLETED|Perioperative to Discharge||0||
48336059|NCT01592760|101151970|FG000|STARTED|24-hour Follow-Up||90||
48336060|NCT01592760|101151971|FG001|STARTED|24-hour Follow-Up||90||
48336061|NCT01592760|101151972|FG002|STARTED|24-hour Follow-Up||45||
48629992|NCT01922934|101878482|FG001|COMPLETED|Visit 12 / Final Visits||2640||
48175261|NCT00859508|100750150|FG001|COMPLETED|Overall Study||37||
48175262|NCT00859508|100750149|FG000|NOT COMPLETED|Overall Study||6||
48175263|NCT00859508|100750150|FG001|NOT COMPLETED|Overall Study||0||
48175264|NCT00445263|100750151|FG000|STARTED|Overall Study||83||
48175265|NCT00445263|100750152|FG001|STARTED|Overall Study||87||
48175266|NCT00445263|100750151|FG000|COMPLETED|Overall Study||83||
48175267|NCT00445263|100750152|FG001|COMPLETED|Overall Study||86||
48175268|NCT00445263|100750151|FG000|NOT COMPLETED|Overall Study||0||
48175269|NCT00445263|100750152|FG001|NOT COMPLETED|Overall Study||1||
48175270|NCT01778062|100750153|FG000|STARTED|Overall Study||68||
48175271|NCT01778062|100750154|FG001|STARTED|Overall Study||68||
48175272|NCT01778062|100750153|FG000|Safety Set|Overall Study||68||
48175273|NCT01778062|100750154|FG001|Safety Set|Overall Study||68||
48175274|NCT01778062|100750153|FG000|Intent to Treat (ITT)|Overall Study||68||
48175275|NCT01778062|100750154|FG001|Intent to Treat (ITT)|Overall Study||67||
48175276|NCT01778062|100750153|FG000|COMPLETED|Overall Study||62||
48175277|NCT01778062|100750154|FG001|COMPLETED|Overall Study||57||
48175278|NCT01778062|100750153|FG000|NOT COMPLETED|Overall Study||6||
48175279|NCT01778062|100750154|FG001|NOT COMPLETED|Overall Study||11||
48175280|NCT00855868|100750155|FG000|STARTED|Overall Study||13||
48175281|NCT00855868|100750156|FG001|STARTED|Overall Study||15||
48175282|NCT00855868|100750155|FG000|COMPLETED|Overall Study||12||
48175283|NCT00855868|100750156|FG001|COMPLETED|Overall Study||14||
48175284|NCT00855868|100750155|FG000|NOT COMPLETED|Overall Study||1||
48175285|NCT00855868|100750156|FG001|NOT COMPLETED|Overall Study||1||
48175286|NCT01395043|100750157|FG000|STARTED|Overall Study||15||
48175287|NCT01395043|100750157|FG000|COMPLETED|Overall Study||15||
48175288|NCT01395043|100750157|FG000|NOT COMPLETED|Overall Study||0||
48175289|NCT01551303|100750158|FG000|STARTED|Overall Study||25||
48175290|NCT01551303|100750159|FG001|STARTED|Overall Study||22||
48629993|NCT01922934|101878481|FG000|NOT COMPLETED|Visit 12 / Final Visits||6||
48629994|NCT01922934|101878482|FG001|NOT COMPLETED|Visit 12 / Final Visits||290||
48629995|NCT02074514|101878483|FG000|STARTED|Overall Study||59||
48629996|NCT02074514|101878484|FG001|STARTED|Overall Study||58||
48175291|NCT01551303|100750158|FG000|COMPLETED|Overall Study||21||
48175292|NCT01551303|100750159|FG001|COMPLETED|Overall Study||15||
48175293|NCT01551303|100750158|FG000|NOT COMPLETED|Overall Study||4||
48175294|NCT01551303|100750159|FG001|NOT COMPLETED|Overall Study||7||
48175295|NCT03017235|100753688|FG000|STARTED|Overall Study||456||
48175296|NCT03017235|100753689|FG001|STARTED|Overall Study||461||
48336062|NCT01592760|101151970|FG000|COMPLETED|24-hour Follow-Up||86||
48175297|NCT03017235|100753688|FG000|COMPLETED|Overall Study||444||
48175298|NCT03017235|100753689|FG001|COMPLETED|Overall Study||447||
48175299|NCT03017235|100753688|FG000|NOT COMPLETED|Overall Study||12||
48175300|NCT03017235|100753689|FG001|NOT COMPLETED|Overall Study||14||
48336063|NCT01592760|101151971|FG001|COMPLETED|24-hour Follow-Up||87||
48336064|NCT01592760|101151972|FG002|COMPLETED|24-hour Follow-Up||43||
48629997|NCT02074514|101878483|FG000|COMPLETED|Overall Study||56||
48175301|NCT00854295|100753690|FG000|STARTED|Overall Study||106||
48175302|NCT00854295|100753691|FG001|STARTED|Overall Study||14||
48175303|NCT00854295|100753692|FG002|STARTED|Overall Study||77||
48175304|NCT00854295|100753693|FG003|STARTED|Overall Study||69||
48175305|NCT00854295|100753690|FG000|COMPLETED|Overall Study||65||
48175306|NCT00854295|100753691|FG001|COMPLETED|Overall Study||8||
48175307|NCT00854295|100753692|FG002|COMPLETED|Overall Study||54||
48175308|NCT00854295|100753693|FG003|COMPLETED|Overall Study||44||
48175309|NCT00854295|100753690|FG000|NOT COMPLETED|Overall Study||41||
48175310|NCT00854295|100753691|FG001|NOT COMPLETED|Overall Study||6||
48175311|NCT00854295|100753692|FG002|NOT COMPLETED|Overall Study||23||
48175312|NCT00854295|100753693|FG003|NOT COMPLETED|Overall Study||25||
48175313|NCT03912220|100753694|FG000|STARTED|Overall Study||26||
48175314|NCT03912220|100753695|FG001|STARTED|Overall Study||19||
48175315|NCT03912220|100753694|FG000|COMPLETED|Overall Study||26||
48175316|NCT03912220|100753695|FG001|COMPLETED|Overall Study||19||
48175317|NCT03912220|100753694|FG000|NOT COMPLETED|Overall Study||0||
48175318|NCT03912220|100753695|FG001|NOT COMPLETED|Overall Study||0||
48175319|NCT01868074|100753696|FG000|STARTED|Overall Study||36||
48175320|NCT01868074|100753697|FG001|STARTED|Overall Study||36||
48175321|NCT01868074|100753696|FG000|COMPLETED|Overall Study||29||
48175322|NCT01868074|100753697|FG001|COMPLETED|Overall Study||32||
48175323|NCT01868074|100753696|FG000|NOT COMPLETED|Overall Study||7||
48175324|NCT01868074|100753697|FG001|NOT COMPLETED|Overall Study||4||
48175325|NCT03698864|100753698|FG000|STARTED|Overall Study||12||
48175326|NCT03698864|100753698|FG000|COMPLETED|Overall Study||10||
48175327|NCT03698864|100753698|FG000|NOT COMPLETED|Overall Study||2||
48175328|NCT01614574|100753699|FG000|STARTED|Overall Study||6||
48175329|NCT01614574|100753699|FG000|COMPLETED|Overall Study||6||
48175330|NCT01614574|100753699|FG000|NOT COMPLETED|Overall Study||0||
48175331|NCT00453102|100753700|FG000|STARTED|Overall Study||18||
48175332|NCT00453102|100753700|FG000|COMPLETED|Overall Study||16||
48175333|NCT00453102|100753700|FG000|NOT COMPLETED|Overall Study||2||
48175334|NCT00759772|100753701|FG000|STARTED|Overall Study||12||
48175335|NCT00759772|100753702|FG001|STARTED|Overall Study||11||
48175336|NCT00759772|100753701|FG000|COMPLETED|Overall Study||12||
48175337|NCT00759772|100753702|FG001|COMPLETED|Overall Study||11||
48175338|NCT00759772|100753701|FG000|NOT COMPLETED|Overall Study||0||
48175339|NCT00759772|100753702|FG001|NOT COMPLETED|Overall Study||0||
48175340|NCT03629990|100753703|FG000|STARTED|Overall Study||53||
48175341|NCT03629990|100753704|FG001|STARTED|Overall Study||51||
48175342|NCT03629990|100753703|FG000|COMPLETED|Overall Study||26||
48175343|NCT03629990|100753704|FG001|COMPLETED|Overall Study||29||
48175344|NCT03629990|100753703|FG000|NOT COMPLETED|Overall Study||27||
48175345|NCT03629990|100753704|FG001|NOT COMPLETED|Overall Study||22||
48175346|NCT02144519|100753705|FG000|STARTED|Year 1||895||10
48175347|NCT02144519|100753706|FG001|STARTED|Year 1||870||10
48175348|NCT02144519|100753705|FG000|COMPLETED|Year 1||895||10
48175349|NCT02144519|100753706|FG001|COMPLETED|Year 1||870||10
48175350|NCT02144519|100753705|FG000|NOT COMPLETED|Year 1||0||0
48175351|NCT02144519|100753706|FG001|NOT COMPLETED|Year 1||0||0
48175352|NCT02144519|100753705|FG000|STARTED|Year 2||763||10
48175353|NCT02144519|100753706|FG001|STARTED|Year 2||864||10
48175354|NCT02144519|100753705|FG000|COMPLETED|Year 2||763||10
48175355|NCT02144519|100753706|FG001|COMPLETED|Year 2||864||10
48175356|NCT02144519|100753705|FG000|NOT COMPLETED|Year 2||0||0
48175357|NCT02144519|100753706|FG001|NOT COMPLETED|Year 2||0||0
48175358|NCT02144519|100753705|FG000|STARTED|Year 3||894||10
48175359|NCT02144519|100753706|FG001|STARTED|Year 3||760||10
48175360|NCT02144519|100753705|FG000|COMPLETED|Year 3||894||10
48175361|NCT02144519|100753706|FG001|COMPLETED|Year 3||760||10
48175362|NCT02144519|100753705|FG000|NOT COMPLETED|Year 3||0||0
48175363|NCT02144519|100753706|FG001|NOT COMPLETED|Year 3||0||0
48175364|NCT04448236|100753707|FG000|STARTED|Overall Study||27||
48175365|NCT04448236|100753708|FG001|STARTED|Overall Study||26||
48175366|NCT04448236|100753707|FG000|COMPLETED|Overall Study||20||
48175367|NCT04448236|100753708|FG001|COMPLETED|Overall Study||25||
48175368|NCT04448236|100753707|FG000|NOT COMPLETED|Overall Study||7||
48175369|NCT04448236|100753708|FG001|NOT COMPLETED|Overall Study||1||
48175370|NCT03621982|100753709|FG000|STARTED|Overall Study||3||
48175371|NCT03621982|100753710|FG001|STARTED|Overall Study||5||
48175372|NCT03621982|100753711|FG002|STARTED|Overall Study||5||
48175373|NCT03621982|100753712|FG003|STARTED|Overall Study||5||
48175374|NCT03621982|100753713|FG004|STARTED|Overall Study||8||
48175375|NCT03621982|100753714|FG005|STARTED|Overall Study||7||
48175376|NCT03621982|100753715|FG006|STARTED|Overall Study||8||
48175377|NCT03621982|100753716|FG007|STARTED|Overall Study||3||
48175378|NCT03621982|100753717|FG008|STARTED|Overall Study||1||
48175379|NCT03621982|100753718|FG009|STARTED|Overall Study||4||
48175380|NCT03621982|100753719|FG010|STARTED|Overall Study||10||
48175381|NCT03621982|100753720|FG011|STARTED|Overall Study||9||
48175382|NCT03621982|100753721|FG012|STARTED|Overall Study||4||
48175383|NCT03621982|100753722|FG013|STARTED|Overall Study||6||
48175384|NCT03621982|100753709|FG000|COMPLETED|Overall Study||0||
48175385|NCT03621982|100753710|FG001|COMPLETED|Overall Study||1||
48175386|NCT03621982|100753711|FG002|COMPLETED|Overall Study||0||
48175387|NCT03621982|100753712|FG003|COMPLETED|Overall Study||1||
48175388|NCT03621982|100753713|FG004|COMPLETED|Overall Study||0||
48175389|NCT03621982|100753714|FG005|COMPLETED|Overall Study||2||
48175390|NCT03621982|100753715|FG006|COMPLETED|Overall Study||0||
48175391|NCT03621982|100753716|FG007|COMPLETED|Overall Study||0||
48175392|NCT03621982|100753717|FG008|COMPLETED|Overall Study||0||
48175393|NCT03621982|100753718|FG009|COMPLETED|Overall Study||0||
48175394|NCT03621982|100753719|FG010|COMPLETED|Overall Study||0||
48175395|NCT03621982|100753720|FG011|COMPLETED|Overall Study||0||
48175396|NCT03621982|100753721|FG012|COMPLETED|Overall Study||0||
48175397|NCT03621982|100753722|FG013|COMPLETED|Overall Study||0||
48175398|NCT03621982|100753709|FG000|NOT COMPLETED|Overall Study||3||
48175399|NCT03621982|100753710|FG001|NOT COMPLETED|Overall Study||4||
48175400|NCT03621982|100753711|FG002|NOT COMPLETED|Overall Study||5||
48175401|NCT03621982|100753712|FG003|NOT COMPLETED|Overall Study||4||
48175402|NCT03621982|100753713|FG004|NOT COMPLETED|Overall Study||8||
48175403|NCT03621982|100753714|FG005|NOT COMPLETED|Overall Study||5||
48175404|NCT03621982|100753715|FG006|NOT COMPLETED|Overall Study||8||
48175405|NCT03621982|100753716|FG007|NOT COMPLETED|Overall Study||3||
48175406|NCT03621982|100753717|FG008|NOT COMPLETED|Overall Study||1||
48175407|NCT03621982|100753718|FG009|NOT COMPLETED|Overall Study||4||
48175408|NCT03621982|100753719|FG010|NOT COMPLETED|Overall Study||10||
48175409|NCT03621982|100753720|FG011|NOT COMPLETED|Overall Study||9||
48175410|NCT03621982|100753721|FG012|NOT COMPLETED|Overall Study||4||
48175411|NCT03621982|100753722|FG013|NOT COMPLETED|Overall Study||6||
48175412|NCT01990820|100753723|FG000|STARTED|Overall Study||13||
48175413|NCT01990820|100753724|FG001|STARTED|Overall Study||12||
48175414|NCT01990820|100753723|FG000|COMPLETED|Overall Study||13||
48175415|NCT01990820|100753724|FG001|COMPLETED|Overall Study||12||
48175416|NCT01990820|100753723|FG000|NOT COMPLETED|Overall Study||0||
48175417|NCT01990820|100753724|FG001|NOT COMPLETED|Overall Study||0||
48175418|NCT02444234|100753725|FG000|STARTED|First Intervention (3 Days)||6||
48175419|NCT02444234|100753726|FG001|STARTED|First Intervention (3 Days)||5||
48175420|NCT02444234|100753725|FG000|COMPLETED|First Intervention (3 Days)||6||
48175421|NCT02444234|100753726|FG001|COMPLETED|First Intervention (3 Days)||5||
48175422|NCT02444234|100753725|FG000|NOT COMPLETED|First Intervention (3 Days)||0||
48175423|NCT02444234|100753726|FG001|NOT COMPLETED|First Intervention (3 Days)||0||
48175424|NCT02444234|100753725|FG000|STARTED|Washout (2 Day Minimum)||6||
48175425|NCT02444234|100753726|FG001|STARTED|Washout (2 Day Minimum)||5||
48175426|NCT02444234|100753725|FG000|COMPLETED|Washout (2 Day Minimum)||6||
48175427|NCT02444234|100753726|FG001|COMPLETED|Washout (2 Day Minimum)||5||
48175428|NCT02444234|100753725|FG000|NOT COMPLETED|Washout (2 Day Minimum)||0||
48175429|NCT02444234|100753726|FG001|NOT COMPLETED|Washout (2 Day Minimum)||0||
48175430|NCT02444234|100753725|FG000|STARTED|Second Intervention (3 Days)||6||
48175431|NCT02444234|100753726|FG001|STARTED|Second Intervention (3 Days)||5||
48175432|NCT02444234|100753725|FG000|COMPLETED|Second Intervention (3 Days)||6||
48175433|NCT02444234|100753726|FG001|COMPLETED|Second Intervention (3 Days)||5||
48175434|NCT02444234|100753725|FG000|NOT COMPLETED|Second Intervention (3 Days)||0||
48629998|NCT02074514|101878484|FG001|COMPLETED|Overall Study||54||
48629999|NCT02074514|101878483|FG000|NOT COMPLETED|Overall Study||3||
48630000|NCT02074514|101878484|FG001|NOT COMPLETED|Overall Study||4||
48630001|NCT01670292|101878485|FG000|STARTED|Overall Study||82||
48630002|NCT01670292|101878485|FG000|COMPLETED|Overall Study||68||
48630003|NCT01670292|101878485|FG000|NOT COMPLETED|Overall Study||14||
48630004|NCT01603277|101878486|FG000|STARTED|Overall Study||78||
48630005|NCT01603277|101878487|FG001|STARTED|Overall Study||82||
48630006|NCT01603277|101878486|FG000|COMPLETED|Overall Study||64||
48630007|NCT01603277|101878487|FG001|COMPLETED|Overall Study||64||
48630008|NCT01603277|101878486|FG000|NOT COMPLETED|Overall Study||14||
48630009|NCT01603277|101878487|FG001|NOT COMPLETED|Overall Study||18||
48630010|NCT02000921|101878488|FG000|STARTED|Overall Study||27||
48630011|NCT02000921|101878489|FG001|STARTED|Overall Study||53||
48630012|NCT02000921|101878490|FG002|STARTED|Overall Study||56||
48175435|NCT02444234|100753726|FG001|NOT COMPLETED|Second Intervention (3 Days)||0||
48175436|NCT02353832|100753727|FG000|STARTED|Overall Study||44||
48175437|NCT02353832|100753727|FG000|COMPLETED|Overall Study||42||
48175438|NCT02353832|100753727|FG000|NOT COMPLETED|Overall Study||2||
48630013|NCT02000921|101878488|FG000|COMPLETED|Overall Study||22||
48630014|NCT02000921|101878489|FG001|COMPLETED|Overall Study||37||
48630015|NCT02000921|101878490|FG002|COMPLETED|Overall Study||46||
48630016|NCT02000921|101878488|FG000|NOT COMPLETED|Overall Study||5||
48630017|NCT02000921|101878489|FG001|NOT COMPLETED|Overall Study||16||
48630018|NCT02000921|101878490|FG002|NOT COMPLETED|Overall Study||10||
48630019|NCT01285518|101878491|FG000|STARTED|Overall Study||10||
48630020|NCT01285518|101878492|FG001|STARTED|Overall Study||10||
48630021|NCT01285518|101878493|FG002|STARTED|Overall Study||10||
48630022|NCT01285518|101878494|FG003|STARTED|Overall Study||10||
48752851|NCT01018030|102181055|FG002|STARTED|Overall Study||252||
48175439|NCT01622348|100753728|FG000|STARTED|Overall Study||15||
48175440|NCT01622348|100753729|FG001|STARTED|Overall Study||14||
48175441|NCT01622348|100753730|FG002|STARTED|Overall Study||15||
48175442|NCT01622348|100753728|FG000|COMPLETED|Overall Study||14||
48175443|NCT01622348|100753729|FG001|COMPLETED|Overall Study||14||
48175444|NCT01622348|100753730|FG002|COMPLETED|Overall Study||14||
48175445|NCT01622348|100753728|FG000|NOT COMPLETED|Overall Study||1||
48630023|NCT01285518|101878495|FG004|STARTED|Overall Study||10||
48630024|NCT01285518|101878496|FG005|STARTED|Overall Study||10||
48630025|NCT01285518|101878497|FG006|STARTED|Overall Study||10||
48630026|NCT01285518|101878498|FG007|STARTED|Overall Study||14||
48630027|NCT01285518|101878491|FG000|COMPLETED|Overall Study||10||
48630028|NCT01285518|101878492|FG001|COMPLETED|Overall Study||10||
48630029|NCT01285518|101878493|FG002|COMPLETED|Overall Study||10||
48630030|NCT01285518|101878494|FG003|COMPLETED|Overall Study||10||
48630031|NCT01285518|101878495|FG004|COMPLETED|Overall Study||10||
48630032|NCT01285518|101878496|FG005|COMPLETED|Overall Study||9||
48752852|NCT01018030|102181053|FG000|COMPLETED|Overall Study||227||
48752853|NCT01018030|102181054|FG001|COMPLETED|Overall Study||232||
48752854|NCT01018030|102181055|FG002|COMPLETED|Overall Study||239||
48752855|NCT01018030|102181053|FG000|NOT COMPLETED|Overall Study||19||
48752856|NCT01018030|102181054|FG001|NOT COMPLETED|Overall Study||11||
48752857|NCT01018030|102181055|FG002|NOT COMPLETED|Overall Study||13||
48752858|NCT03224130|102181056|FG000|STARTED|Overall Study||483||
48175446|NCT01622348|100753729|FG001|NOT COMPLETED|Overall Study||0||
48175447|NCT01622348|100753730|FG002|NOT COMPLETED|Overall Study||1||
48412437|NCT03644173|101342010|FG000|NOT COMPLETED|Participants at the 3-month Follow up||2||
48412438|NCT03483012|101342011|FG000|STARTED|Overall Study||6||
48412439|NCT03483012|101342011|FG000|COMPLETED|Overall Study||0||
48412440|NCT03483012|101342011|FG000|NOT COMPLETED|Overall Study||6||
48412441|NCT02599324|101342012|FG000|STARTED|Phase 1b||3||
48412442|NCT02599324|101342013|FG001|STARTED|Phase 1b||7||
48412443|NCT02599324|101342014|FG002|STARTED|Phase 1b||4||
48412444|NCT02599324|101342015|FG003|STARTED|Phase 1b||10||
48412445|NCT02599324|101342016|FG004|STARTED|Phase 1b||21||
48412446|NCT02599324|101342017|FG005|STARTED|Phase 1b||8||
48412447|NCT02599324|101342018|FG006|STARTED|Phase 1b||12||
48412448|NCT02599324|101342019|FG007|STARTED|Phase 1b||10||
48630033|NCT01285518|101878497|FG006|COMPLETED|Overall Study||10||
48630034|NCT01285518|101878498|FG007|COMPLETED|Overall Study||14||
48630035|NCT01285518|101878491|FG000|NOT COMPLETED|Overall Study||0||
48630036|NCT01285518|101878492|FG001|NOT COMPLETED|Overall Study||0||
48630037|NCT01285518|101878493|FG002|NOT COMPLETED|Overall Study||0||
48630038|NCT01285518|101878494|FG003|NOT COMPLETED|Overall Study||0||
48175448|NCT00950937|100753731|FG000|STARTED|Overall Study||14||
48175449|NCT00950937|100753732|FG001|STARTED|Overall Study||14||
48175450|NCT00950937|100753731|FG000|COMPLETED|Overall Study||14||
48175451|NCT00950937|100753732|FG001|COMPLETED|Overall Study||14||
48175452|NCT00950937|100753731|FG000|NOT COMPLETED|Overall Study||0||
48175453|NCT00950937|100753732|FG001|NOT COMPLETED|Overall Study||0||
48175454|NCT04436796|100753733|FG000|STARTED|Overall Study||19||
48175455|NCT04436796|100753734|FG001|STARTED|Overall Study||16||
48175456|NCT04436796|100753733|FG000|COMPLETED|Overall Study||19||
48175457|NCT04436796|100753734|FG001|COMPLETED|Overall Study||16||
48175458|NCT04436796|100753733|FG000|NOT COMPLETED|Overall Study||0||
48175459|NCT04436796|100753734|FG001|NOT COMPLETED|Overall Study||0||
48175460|NCT02213055|100753735|FG000|STARTED|Overall Study||97||
48175461|NCT02213055|100753736|FG001|STARTED|Overall Study||0||
48175462|NCT02213055|100753735|FG000|COMPLETED|Overall Study||58||
48175463|NCT02213055|100753736|FG001|COMPLETED|Overall Study||0||
48175464|NCT02213055|100753735|FG000|NOT COMPLETED|Overall Study||39||
48175465|NCT02213055|100753736|FG001|NOT COMPLETED|Overall Study||0||
48175466|NCT01087723|100753737|FG000|STARTED|Overall Study||1089||
48175467|NCT01087723|100753738|FG001|STARTED|Overall Study||1109||
48175468|NCT01087723|100753737|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1099||
48175469|NCT01087723|100753738|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1094||
48412449|NCT02599324|101342020|FG008|STARTED|Phase 1b||17||
48412450|NCT02599324|101342012|FG000|COMPLETED|Phase 1b||3||
48412451|NCT02599324|101342013|FG001|COMPLETED|Phase 1b||7||
48412452|NCT02599324|101342014|FG002|COMPLETED|Phase 1b||4||
48752859|NCT03224130|102181057|FG001|STARTED|Overall Study||483||
48412453|NCT02599324|101342015|FG003|COMPLETED|Phase 1b||10||
48412454|NCT02599324|101342016|FG004|COMPLETED|Phase 1b||21||
48412455|NCT02599324|101342017|FG005|COMPLETED|Phase 1b||8||
48412456|NCT02599324|101342018|FG006|COMPLETED|Phase 1b||12||
48412457|NCT02599324|101342019|FG007|COMPLETED|Phase 1b||10||
48412458|NCT02599324|101342020|FG008|COMPLETED|Phase 1b||17||
48412459|NCT02599324|101342012|FG000|NOT COMPLETED|Phase 1b||0||
48412460|NCT02599324|101342013|FG001|NOT COMPLETED|Phase 1b||0||
48412461|NCT02599324|101342014|FG002|NOT COMPLETED|Phase 1b||0||
48752860|NCT03224130|102181056|FG000|COMPLETED|Overall Study||483||
48175470|NCT01087723|100753737|FG000|COMPLETED|Overall Study||1075||
48175471|NCT01087723|100753738|FG001|COMPLETED|Overall Study||1089||
48412462|NCT02599324|101342015|FG003|NOT COMPLETED|Phase 1b||0||
48412463|NCT02599324|101342016|FG004|NOT COMPLETED|Phase 1b||0||
48412464|NCT02599324|101342017|FG005|NOT COMPLETED|Phase 1b||0||
48175472|NCT01087723|100753737|FG000|NOT COMPLETED|Overall Study||14||
48175473|NCT01087723|100753738|FG001|NOT COMPLETED|Overall Study||20||
48175474|NCT02006420|100753739|FG000|STARTED|Overall Study||24||
48412465|NCT02599324|101342018|FG006|NOT COMPLETED|Phase 1b||0||
48412466|NCT02599324|101342019|FG007|NOT COMPLETED|Phase 1b||0||
48412467|NCT02599324|101342020|FG008|NOT COMPLETED|Phase 1b||0||
48630039|NCT01285518|101878495|FG004|NOT COMPLETED|Overall Study||0||
48752861|NCT03224130|102181057|FG001|COMPLETED|Overall Study||482||
48752862|NCT03224130|102181056|FG000|NOT COMPLETED|Overall Study||0||
48175475|NCT02006420|100753740|FG001|STARTED|Overall Study||21||
48175476|NCT02006420|100753739|FG000|COMPLETED|Overall Study||24||
48175477|NCT02006420|100753740|FG001|COMPLETED|Overall Study||21||
48175478|NCT02006420|100753739|FG000|NOT COMPLETED|Overall Study||0||
48175479|NCT02006420|100753740|FG001|NOT COMPLETED|Overall Study||0||
48175480|NCT02726399|100753741|FG000|STARTED|Overall Study||7||
48412468|NCT02599324|101342012|FG000|STARTED|Phase 2 (RP2D)||0|Entered Phase 2 and received at least 1 dose of study medication.|
48412469|NCT02599324|101342013|FG001|STARTED|Phase 2 (RP2D)||38|Entered Phase 2 and received at least 1 dose of study medication.|
48752863|NCT03224130|102181057|FG001|NOT COMPLETED|Overall Study||1||
48752864|NCT00057863|102181058|FG000|STARTED|Overall Study||35||
48752865|NCT00057863|102181058|FG000|COMPLETED|Overall Study||32||
48752866|NCT00057863|102181058|FG000|NOT COMPLETED|Overall Study||3||
48175481|NCT02726399|100753741|FG000|COMPLETED|Overall Study||0||
48175482|NCT02726399|100753741|FG000|NOT COMPLETED|Overall Study||7||
48175483|NCT03289481|100753742|FG000|STARTED|Overall Study||6||
48175484|NCT03289481|100753743|FG001|STARTED|Overall Study||7||
48175485|NCT03289481|100753742|FG000|COMPLETED|Overall Study||4||
48175486|NCT03289481|100753743|FG001|COMPLETED|Overall Study||5||
48175487|NCT03289481|100753742|FG000|NOT COMPLETED|Overall Study||2||
48175488|NCT03289481|100753743|FG001|NOT COMPLETED|Overall Study||2||
48175489|NCT01992549|100753744|FG000|STARTED|Overall Study||48||
48175490|NCT01992549|100753744|FG000|SAF Population|Overall Study||48|SAF population = study population of patients in safety analysis|
48175491|NCT01992549|100753744|FG000|ITT Population|Overall Study||47|ITT population = intent-to-treat population|
48175492|NCT01992549|100753744|FG000|PROPH Population|Overall Study||47|PROPH population = study population of patients receiving prophylaxis|
48175493|NCT01992549|100753744|FG000|BLEED Population|Overall Study||29|BLEED population = study population of Bleeding Events (BEs)|
48175494|NCT01992549|100753744|FG000|SURG Population|Overall Study||3|SURG population = study population of patients undergoing surgery treated with Human-cl rhFVIII|
48175495|NCT01992549|100753744|FG000|COMPLETED|Overall Study||44||
48175496|NCT01992549|100753744|FG000|NOT COMPLETED|Overall Study||4||
48175497|NCT01638468|100753745|FG000|STARTED|Overall Study||7||
48175498|NCT01638468|100753745|FG000|COMPLETED|Overall Study||7||
48175499|NCT01638468|100753745|FG000|NOT COMPLETED|Overall Study||0||
48175500|NCT03796013|100753746|FG000|STARTED|Period 1||14||
48175501|NCT03796013|100753747|FG001|STARTED|Period 1||14||
48175502|NCT03796013|100753746|FG000|COMPLETED|Period 1||14||
48752867|NCT02407223|102181059|FG000|STARTED|Overall Study||116||
48752868|NCT02407223|102181060|FG001|STARTED|Overall Study||118||
48752869|NCT02407223|102181061|FG002|STARTED|Overall Study||122||
48175503|NCT03796013|100753747|FG001|COMPLETED|Period 1||14||
48175504|NCT03796013|100753746|FG000|NOT COMPLETED|Period 1||0||
48175505|NCT03796013|100753747|FG001|NOT COMPLETED|Period 1||0||
48175506|NCT03796013|100753746|FG000|STARTED|Period 2||14||
48175507|NCT03796013|100753747|FG001|STARTED|Period 2||14||
48175508|NCT03796013|100753746|FG000|COMPLETED|Period 2||14||
48175509|NCT03796013|100753747|FG001|COMPLETED|Period 2||14||
48175510|NCT03796013|100753746|FG000|NOT COMPLETED|Period 2||0||
48175511|NCT03796013|100753747|FG001|NOT COMPLETED|Period 2||0||
48175512|NCT01962025|100753748|FG000|STARTED|Overall Study||8||
48412470|NCT02599324|101342014|FG002|STARTED|Phase 2 (RP2D)||0|Entered Phase 2 and received at least 1 dose of study medication.|
48439942|NCT04993339|101409990|FG001|STARTED|Overall Study||12||
48752870|NCT02407223|102181059|FG000|Early Escape at Week 16|Overall Study||22||
48752871|NCT02407223|102181060|FG001|Early Escape at Week 16|Overall Study||0||
48752872|NCT02407223|102181061|FG002|Early Escape at Week 16|Overall Study||0||
48752873|NCT02407223|102181059|FG000|Cross Over at Week 24|Overall Study||60||
48752874|NCT02407223|102181060|FG001|Cross Over at Week 24|Overall Study||0||
48752875|NCT02407223|102181061|FG002|Cross Over at Week 24|Overall Study||0||
48175513|NCT01962025|100753749|FG001|STARTED|Overall Study||6||
48175514|NCT01962025|100753748|FG000|COMPLETED|Overall Study||8||
48175515|NCT01962025|100753749|FG001|COMPLETED|Overall Study||6||
48175516|NCT01962025|100753748|FG000|NOT COMPLETED|Overall Study||0||
48175517|NCT01962025|100753749|FG001|NOT COMPLETED|Overall Study||0||
48175518|NCT01848834|100753750|FG000|STARTED|Overall Study||32||
48175519|NCT01848834|100753751|FG001|STARTED|Overall Study||61||
48175520|NCT01848834|100753752|FG002|STARTED|Overall Study||33||
48175521|NCT01848834|100753753|FG003|STARTED|Overall Study||39||
48175522|NCT01848834|100753754|FG004|STARTED|Overall Study||132||
48175523|NCT01848834|100753750|FG000|Treated|Overall Study||32||
48175524|NCT01848834|100753751|FG001|Treated|Overall Study||60||
48175525|NCT01848834|100753752|FG002|Treated|Overall Study||33||
48175526|NCT01848834|100753753|FG003|Treated|Overall Study||39||
48175527|NCT01848834|100753754|FG004|Treated|Overall Study||132||
48175528|NCT01848834|100753750|FG000|COMPLETED|Overall Study||13||
48175529|NCT01848834|100753751|FG001|COMPLETED|Overall Study||13||
48175530|NCT01848834|100753752|FG002|COMPLETED|Overall Study||9||
48175531|NCT01848834|100753753|FG003|COMPLETED|Overall Study||13||
48175532|NCT01848834|100753754|FG004|COMPLETED|Overall Study||38||
48175533|NCT01848834|100753750|FG000|NOT COMPLETED|Overall Study||19||
48175534|NCT01848834|100753751|FG001|NOT COMPLETED|Overall Study||48||
48175535|NCT01848834|100753752|FG002|NOT COMPLETED|Overall Study||24||
48175536|NCT01848834|100753753|FG003|NOT COMPLETED|Overall Study||26||
48175537|NCT01848834|100753754|FG004|NOT COMPLETED|Overall Study||94||
48336065|NCT01592760|101151970|FG000|NOT COMPLETED|24-hour Follow-Up||4||
48336066|NCT01592760|101151971|FG001|NOT COMPLETED|24-hour Follow-Up||3||
48336067|NCT01592760|101151972|FG002|NOT COMPLETED|24-hour Follow-Up||2||
48336068|NCT00883675|101151973|FG000|STARTED|Overall Study||133||
48336069|NCT00883675|101151973|FG000|COMPLETED|Overall Study||133||
48630040|NCT01285518|101878496|FG005|NOT COMPLETED|Overall Study||1||
48630041|NCT01285518|101878497|FG006|NOT COMPLETED|Overall Study||0||
48630042|NCT01285518|101878498|FG007|NOT COMPLETED|Overall Study||0||
48630043|NCT01249131|101878499|FG000|STARTED|First Intervention||3||
48630044|NCT01249131|101878500|FG001|STARTED|First Intervention||3||
48630045|NCT01249131|101878501|FG002|STARTED|First Intervention||4||
48630046|NCT01249131|101878502|FG003|STARTED|First Intervention||3||
48630047|NCT01249131|101878503|FG004|STARTED|First Intervention||3||
48630048|NCT01249131|101878504|FG005|STARTED|First Intervention||4||
48630049|NCT01249131|101878499|FG000|COMPLETED|First Intervention||3||
48630050|NCT01249131|101878500|FG001|COMPLETED|First Intervention||3||
48630051|NCT01249131|101878501|FG002|COMPLETED|First Intervention||4||
48630052|NCT01249131|101878502|FG003|COMPLETED|First Intervention||3||
48630053|NCT01249131|101878503|FG004|COMPLETED|First Intervention||3||
48630054|NCT01249131|101878504|FG005|COMPLETED|First Intervention||4||
48175538|NCT04548531|100753755|FG000|STARTED|Intervention Period||400||
48175539|NCT04548531|100753756|FG001|STARTED|Intervention Period||400||
48175540|NCT04548531|100753755|FG000|COMPLETED|Intervention Period||399||
48175541|NCT04548531|100753756|FG001|COMPLETED|Intervention Period||399||
48175542|NCT04548531|100753755|FG000|NOT COMPLETED|Intervention Period||1||
48175543|NCT04548531|100753756|FG001|NOT COMPLETED|Intervention Period||1||
48175544|NCT04548531|100753755|FG000|STARTED|8-week Follow-up Survey||252||
48175545|NCT04548531|100753756|FG001|STARTED|8-week Follow-up Survey||252||
48175546|NCT04548531|100753755|FG000|COMPLETED|8-week Follow-up Survey||124||
48175547|NCT04548531|100753756|FG001|COMPLETED|8-week Follow-up Survey||119||
48175548|NCT04548531|100753755|FG000|NOT COMPLETED|8-week Follow-up Survey||128||
48175549|NCT04548531|100753756|FG001|NOT COMPLETED|8-week Follow-up Survey||133||
48175550|NCT03125941|100753757|FG000|STARTED|Overall Study||65||
48175551|NCT03125941|100753758|FG001|STARTED|Overall Study||65||
48175552|NCT03125941|100753757|FG000|Post-randomization Exclusion|Overall Study||1||
48175553|NCT03125941|100753758|FG001|Post-randomization Exclusion|Overall Study||2||
48175554|NCT03125941|100753757|FG000|COMPLETED|Overall Study||64||
48175555|NCT03125941|100753758|FG001|COMPLETED|Overall Study||63||
48175556|NCT03125941|100753757|FG000|NOT COMPLETED|Overall Study||1||
48175557|NCT03125941|100753758|FG001|NOT COMPLETED|Overall Study||2||
48175558|NCT00663962|100753759|FG000|STARTED|Overall Study||7||
48175559|NCT00663962|100753760|FG001|STARTED|Overall Study||8||
48175560|NCT00663962|100753759|FG000|COMPLETED|Overall Study||6||
48175561|NCT00663962|100753760|FG001|COMPLETED|Overall Study||8||
48336070|NCT00883675|101151973|FG000|NOT COMPLETED|Overall Study||0||
48336071|NCT02065453|101151974|FG000|STARTED|Overall Study||27||
48630055|NCT01249131|101878499|FG000|NOT COMPLETED|First Intervention||0||
48630056|NCT01249131|101878500|FG001|NOT COMPLETED|First Intervention||0||
48175562|NCT00663962|100753759|FG000|NOT COMPLETED|Overall Study||1||
48175563|NCT00663962|100753760|FG001|NOT COMPLETED|Overall Study||0||
48175564|NCT00871819|100753761|FG000|STARTED|Overall Study||20||
48175565|NCT00871819|100753761|FG000|COMPLETED|Overall Study||20||
48175566|NCT00871819|100753761|FG000|NOT COMPLETED|Overall Study||0||
48175567|NCT00832338|100753762|FG000|STARTED|Overall Study||23||
48175568|NCT00832338|100753762|FG000|COMPLETED|Overall Study||23||
48175569|NCT00832338|100753762|FG000|NOT COMPLETED|Overall Study||0||
48175570|NCT00245011|100753763|FG000|STARTED|Overall Study||11||
48336072|NCT02065453|101151975|FG001|STARTED|Overall Study||25||
48630057|NCT01249131|101878501|FG002|NOT COMPLETED|First Intervention||0||
48336073|NCT02065453|101151974|FG000|COMPLETED|Overall Study||24||
48630058|NCT01249131|101878502|FG003|NOT COMPLETED|First Intervention||0||
48630059|NCT01249131|101878503|FG004|NOT COMPLETED|First Intervention||0||
48336074|NCT02065453|101151975|FG001|COMPLETED|Overall Study||21||
48336075|NCT02065453|101151974|FG000|NOT COMPLETED|Overall Study||3||
48336076|NCT02065453|101151975|FG001|NOT COMPLETED|Overall Study||4||
48336077|NCT00364689|101151976|FG000|STARTED|Overall Study||13||
48336078|NCT00364689|101151976|FG000|COMPLETED|Overall Study||12||
48336079|NCT00364689|101151976|FG000|NOT COMPLETED|Overall Study||1||
48336080|NCT02404103|101151977|FG000|STARTED|Overall Study||14||
48336081|NCT02404103|101151978|FG001|STARTED|Overall Study||12||
48412471|NCT02599324|101342015|FG003|STARTED|Phase 2 (RP2D)||55|Entered Phase 2 and received at least 1 dose of study medication.|
48412472|NCT02599324|101342016|FG004|STARTED|Phase 2 (RP2D)||31|Entered Phase 2 and received at least 1 dose of study medication.|
48439943|NCT04993339|101409989|FG000|COMPLETED|Overall Study||11||
48752876|NCT02407223|102181059|FG000|Qualified Re-randomization at Week 52|Overall Study||0||
48752877|NCT02407223|102181060|FG001|Qualified Re-randomization at Week 52|Overall Study||3||
48752878|NCT02407223|102181061|FG002|Qualified Re-randomization at Week 52|Overall Study||2||
48752879|NCT02407223|102181059|FG000|COMPLETED|Overall Study||0||
48752880|NCT02407223|102181060|FG001|COMPLETED|Overall Study||0||
48752881|NCT02407223|102181061|FG002|COMPLETED|Overall Study||0||
48752882|NCT02407223|102181059|FG000|NOT COMPLETED|Overall Study||116||
48752883|NCT02407223|102181060|FG001|NOT COMPLETED|Overall Study||118||
48752884|NCT02407223|102181061|FG002|NOT COMPLETED|Overall Study||122||
48752885|NCT01302483|102181062|FG000|STARTED|Overall Study||30||
48752886|NCT01302483|102181063|FG001|STARTED|Overall Study||15||
48752887|NCT01302483|102181062|FG000|COMPLETED|Overall Study||30||
48752888|NCT01302483|102181063|FG001|COMPLETED|Overall Study||15||
48752889|NCT01302483|102181062|FG000|NOT COMPLETED|Overall Study||0||
48752890|NCT01302483|102181063|FG001|NOT COMPLETED|Overall Study||0||
48752891|NCT01590264|102181064|FG000|STARTED|Overall Study||5||
48752892|NCT01590264|102181064|FG000|COMPLETED|Overall Study||5||
48175571|NCT00245011|100753763|FG000|COMPLETED|Overall Study||10||
48175572|NCT00245011|100753763|FG000|NOT COMPLETED|Overall Study||1||
48175573|NCT00883103|100753764|FG000|STARTED|Overall Study||69||
48175574|NCT00883103|100753765|FG001|STARTED|Overall Study||68||
48175575|NCT00883103|100753764|FG000|COMPLETED|Overall Study||69||
48175576|NCT00883103|100753765|FG001|COMPLETED|Overall Study||68||
48175577|NCT00883103|100753764|FG000|NOT COMPLETED|Overall Study||0||
48175578|NCT00883103|100753765|FG001|NOT COMPLETED|Overall Study||0||
48175579|NCT02136498|100753766|FG000|STARTED|Overall Study||33||
48175580|NCT02136498|100753767|FG001|STARTED|Overall Study||33||
48175581|NCT02136498|100753766|FG000|COMPLETED|Overall Study||33||
48175582|NCT02136498|100753767|FG001|COMPLETED|Overall Study||33||
48175583|NCT02136498|100753766|FG000|NOT COMPLETED|Overall Study||0||
48175584|NCT02136498|100753767|FG001|NOT COMPLETED|Overall Study||0||
48175585|NCT03518658|100753768|FG000|STARTED|Overall Study||257||
48175586|NCT03518658|100753769|FG001|STARTED|Overall Study||128607||
48175587|NCT03518658|100753768|FG000|COMPLETED|Overall Study||206||
48175588|NCT03518658|100753769|FG001|COMPLETED|Overall Study||128607||
48175589|NCT03518658|100753768|FG000|NOT COMPLETED|Overall Study||51||
48175590|NCT03518658|100753769|FG001|NOT COMPLETED|Overall Study||0||
48175591|NCT01464255|100753770|FG000|STARTED|Overall Study||25||
48175592|NCT01464255|100753771|FG001|STARTED|Overall Study||25||
48175593|NCT01464255|100753770|FG000|COMPLETED|Overall Study||25||
48175594|NCT01464255|100753771|FG001|COMPLETED|Overall Study||24||
48175595|NCT01464255|100753770|FG000|NOT COMPLETED|Overall Study||0||
48175596|NCT01464255|100753771|FG001|NOT COMPLETED|Overall Study||1||
48175597|NCT00252590|100753772|FG000|STARTED|Overall Study||35||
48175598|NCT00252590|100753773|FG001|STARTED|Overall Study||30||
48175599|NCT00252590|100753774|FG002|STARTED|Overall Study||34||
48175600|NCT00252590|100753772|FG000|COMPLETED|Overall Study||33||
48175601|NCT00252590|100753773|FG001|COMPLETED|Overall Study||28||
48175602|NCT00252590|100753774|FG002|COMPLETED|Overall Study||31||
48175603|NCT00252590|100753772|FG000|NOT COMPLETED|Overall Study||2||
48175604|NCT00252590|100753773|FG001|NOT COMPLETED|Overall Study||2||
48175605|NCT00252590|100753774|FG002|NOT COMPLETED|Overall Study||3||
48175606|NCT04022889|100753775|FG000|STARTED|Stage 1: Period 1||9|Consented Subjects|
48175607|NCT04022889|100753776|FG001|STARTED|Stage 1: Period 1||6|Consented Subjects|
48175608|NCT04022889|100753777|FG002|STARTED|Stage 1: Period 1||0|Consented Subjects|
48175609|NCT04022889|100753775|FG000|Met Screening Criteria|Stage 1: Period 1||9||
48336082|NCT02404103|101151977|FG000|COMPLETED|Overall Study||10||
48175610|NCT04022889|100753776|FG001|Met Screening Criteria|Stage 1: Period 1||6||
48336083|NCT02404103|101151978|FG001|COMPLETED|Overall Study||9||
48752893|NCT01590264|102181064|FG000|NOT COMPLETED|Overall Study||0||
48336084|NCT02404103|101151977|FG000|NOT COMPLETED|Overall Study||4||
48752894|NCT01500772|102181065|FG000|STARTED|Overall Study||6||
48752895|NCT01500772|102181065|FG000|COMPLETED|Overall Study||0||
48752896|NCT01500772|102181065|FG000|NOT COMPLETED|Overall Study||6||
48752897|NCT04590014|102181066|FG000|STARTED|Overall Study||2||
48175611|NCT04022889|100753777|FG002|Met Screening Criteria|Stage 1: Period 1||0||
48175612|NCT04022889|100753775|FG000|Successful Apheresis Collection|Stage 1: Period 1||8||
48175613|NCT04022889|100753776|FG001|Successful Apheresis Collection|Stage 1: Period 1||6||
48175614|NCT04022889|100753777|FG002|Successful Apheresis Collection|Stage 1: Period 1||0||
48188641|NCT05257837|100783297|FG003|COMPLETED|Overall Study||50||
48175615|NCT04022889|100753775|FG000|Completed 7-days Storage of Test Platelet Component|Stage 1: Period 1||7||
48175616|NCT04022889|100753776|FG001|Completed 7-days Storage of Test Platelet Component|Stage 1: Period 1||6||
48175617|NCT04022889|100753777|FG002|Completed 7-days Storage of Test Platelet Component|Stage 1: Period 1||0||
48175618|NCT04022889|100753775|FG000|Completed Post Infusion Sampling|Stage 1: Period 1||7||
48175619|NCT04022889|100753776|FG001|Completed Post Infusion Sampling|Stage 1: Period 1||6||
48175620|NCT04022889|100753777|FG002|Completed Post Infusion Sampling|Stage 1: Period 1||0||
48175621|NCT04022889|100753775|FG000|COMPLETED|Stage 1: Period 1||7||
48175622|NCT04022889|100753776|FG001|COMPLETED|Stage 1: Period 1||6||
48175623|NCT04022889|100753777|FG002|COMPLETED|Stage 1: Period 1||0||
48175624|NCT04022889|100753775|FG000|NOT COMPLETED|Stage 1: Period 1||2||
48175625|NCT04022889|100753776|FG001|NOT COMPLETED|Stage 1: Period 1||0||
48175626|NCT04022889|100753777|FG002|NOT COMPLETED|Stage 1: Period 1||0||
48175627|NCT04022889|100753775|FG000|STARTED|Stage 1: Period 2||7||
48175628|NCT04022889|100753776|FG001|STARTED|Stage 1: Period 2||6||
48175629|NCT04022889|100753777|FG002|STARTED|Stage 1: Period 2||0||
48336085|NCT02404103|101151978|FG001|NOT COMPLETED|Overall Study||3||
48336086|NCT03312517|101151979|FG000|STARTED|Overall Study||2||
48336087|NCT03312517|101151980|FG001|STARTED|Overall Study||2||
48336088|NCT03312517|101151981|FG002|STARTED|Overall Study||2||
48336089|NCT03312517|101151982|FG003|STARTED|Overall Study||2||
48336090|NCT03312517|101151983|FG004|STARTED|Overall Study||2||
48336091|NCT03312517|101151984|FG005|STARTED|Overall Study||2||
48336092|NCT03312517|101151979|FG000|COMPLETED|Overall Study||2||
48336093|NCT03312517|101151980|FG001|COMPLETED|Overall Study||2||
48336094|NCT03312517|101151981|FG002|COMPLETED|Overall Study||2||
48336095|NCT03312517|101151982|FG003|COMPLETED|Overall Study||2||
48336096|NCT03312517|101151983|FG004|COMPLETED|Overall Study||2||
48336097|NCT03312517|101151984|FG005|COMPLETED|Overall Study||2||
48336098|NCT03312517|101151979|FG000|NOT COMPLETED|Overall Study||0||
48336099|NCT03312517|101151980|FG001|NOT COMPLETED|Overall Study||0||
48336100|NCT03312517|101151981|FG002|NOT COMPLETED|Overall Study||0||
48336101|NCT03312517|101151982|FG003|NOT COMPLETED|Overall Study||0||
48336102|NCT03312517|101151983|FG004|NOT COMPLETED|Overall Study||0||
48336103|NCT03312517|101151984|FG005|NOT COMPLETED|Overall Study||0||
48336104|NCT00305942|101151985|FG000|STARTED|Overall Study||61||
48336105|NCT00305942|101151985|FG000|COMPLETED|Overall Study||23||
48336106|NCT00305942|101151985|FG000|NOT COMPLETED|Overall Study||38||
48336107|NCT00556426|101151986|FG000|STARTED|Overall Study||100||
48336108|NCT00556426|101151986|FG000|COMPLETED|Overall Study||91||
48336109|NCT00556426|101151986|FG000|NOT COMPLETED|Overall Study||9||
48336110|NCT00109473|101151987|FG000|STARTED|Baseline (0 Through 12 Weeks)||10||
48336111|NCT00109473|101151988|FG001|STARTED|Baseline (0 Through 12 Weeks)||10||
48336112|NCT00109473|101151987|FG000|Analyzed|Baseline (0 Through 12 Weeks)||10||
48175630|NCT04022889|100753775|FG000|Met Screening Criteria|Stage 1: Period 2||7||
48175631|NCT04022889|100753776|FG001|Met Screening Criteria|Stage 1: Period 2||6||
48175632|NCT04022889|100753777|FG002|Met Screening Criteria|Stage 1: Period 2||0||
48175633|NCT04022889|100753775|FG000|Successful Apheresis Collection|Stage 1: Period 2||7||
48175634|NCT04022889|100753776|FG001|Successful Apheresis Collection|Stage 1: Period 2||6||
48175635|NCT04022889|100753777|FG002|Successful Apheresis Collection|Stage 1: Period 2||0||
48175636|NCT04022889|100753775|FG000|Completed 7-days Storage of Test Platelet Component|Stage 1: Period 2||7||
48175637|NCT04022889|100753776|FG001|Completed 7-days Storage of Test Platelet Component|Stage 1: Period 2||6||
48175638|NCT04022889|100753777|FG002|Completed 7-days Storage of Test Platelet Component|Stage 1: Period 2||0||
48175639|NCT04022889|100753775|FG000|Completed Post Infusion Sampling|Stage 1: Period 2||6||
48175640|NCT04022889|100753776|FG001|Completed Post Infusion Sampling|Stage 1: Period 2||5||
48175641|NCT04022889|100753777|FG002|Completed Post Infusion Sampling|Stage 1: Period 2||0||
48175642|NCT04022889|100753775|FG000|COMPLETED|Stage 1: Period 2||6||
48175643|NCT04022889|100753776|FG001|COMPLETED|Stage 1: Period 2||5||
48175644|NCT04022889|100753777|FG002|COMPLETED|Stage 1: Period 2||0||
48175645|NCT04022889|100753775|FG000|NOT COMPLETED|Stage 1: Period 2||1||
48175646|NCT04022889|100753776|FG001|NOT COMPLETED|Stage 1: Period 2||1||
48175647|NCT04022889|100753777|FG002|NOT COMPLETED|Stage 1: Period 2||0||
48175648|NCT04022889|100753775|FG000|STARTED|Stage 2||7||
48175649|NCT04022889|100753776|FG001|STARTED|Stage 2||6||
48175650|NCT04022889|100753777|FG002|STARTED|Stage 2||22||
48175651|NCT04022889|100753775|FG000|Met Screening Criteria|Stage 2||7||
48336113|NCT00109473|101151988|FG001|Analyzed|Baseline (0 Through 12 Weeks)||10||
48336114|NCT00109473|101151987|FG000|COMPLETED|Baseline (0 Through 12 Weeks)||10||
48336115|NCT00109473|101151988|FG001|COMPLETED|Baseline (0 Through 12 Weeks)||9||
48336116|NCT00109473|101151987|FG000|NOT COMPLETED|Baseline (0 Through 12 Weeks)||0||
48336117|NCT00109473|101151988|FG001|NOT COMPLETED|Baseline (0 Through 12 Weeks)||1||
48336118|NCT00109473|101151987|FG000|STARTED|Week 12 to Week 24||10||
48336119|NCT00109473|101151988|FG001|STARTED|Week 12 to Week 24||9||
48336120|NCT00109473|101151987|FG000|Analyzed|Week 12 to Week 24||9||
48336121|NCT00109473|101151988|FG001|Analyzed|Week 12 to Week 24||9||
48336122|NCT00109473|101151987|FG000|COMPLETED|Week 12 to Week 24||9||
48336123|NCT00109473|101151988|FG001|COMPLETED|Week 12 to Week 24||9||
48336124|NCT00109473|101151987|FG000|NOT COMPLETED|Week 12 to Week 24||1||
48336125|NCT00109473|101151988|FG001|NOT COMPLETED|Week 12 to Week 24||0||
48336126|NCT00109473|101151987|FG000|STARTED|52 Week Extension Phase||9||
48336127|NCT00109473|101151988|FG001|STARTED|52 Week Extension Phase||8||
48336128|NCT00109473|101151987|FG000|Analyzed|52 Week Extension Phase||9||
48336129|NCT00109473|101151988|FG001|Analyzed|52 Week Extension Phase||8||
48336130|NCT00109473|101151987|FG000|COMPLETED|52 Week Extension Phase||5||
48336131|NCT00109473|101151988|FG001|COMPLETED|52 Week Extension Phase||3||
48336132|NCT00109473|101151987|FG000|NOT COMPLETED|52 Week Extension Phase||4||
48336133|NCT00109473|101151988|FG001|NOT COMPLETED|52 Week Extension Phase||5||
48336134|NCT00374803|101151989|FG000|STARTED|Overall Study||22||
48336135|NCT00374803|101151990|FG001|STARTED|Overall Study||23||
48336136|NCT00374803|101151989|FG000|COMPLETED|Overall Study||22||
48336137|NCT00374803|101151990|FG001|COMPLETED|Overall Study||23||
48336138|NCT00374803|101151989|FG000|NOT COMPLETED|Overall Study||0||
48336139|NCT00374803|101151990|FG001|NOT COMPLETED|Overall Study||0||
48336140|NCT01144598|101151991|FG000|STARTED|Overall Study||356||
48336141|NCT01144598|101151991|FG000|Analysis Population|Overall Study||356||
48336142|NCT01144598|101151991|FG000|COMPLETED|Overall Study||356||
48336143|NCT01144598|101151991|FG000|NOT COMPLETED|Overall Study||0||
48336144|NCT01622569|101151992|FG000|STARTED|Double-Blind Treatment Phase (Wks 1-16)||82||
48336145|NCT01622569|101151993|FG001|STARTED|Double-Blind Treatment Phase (Wks 1-16)||81||
48336146|NCT01622569|101151994|FG002|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80||
48336147|NCT01622569|101151995|FG003|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80||
48336148|NCT01622569|101151992|FG000|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||70||
48336149|NCT01622569|101151993|FG001|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||75||
48336150|NCT01622569|101151994|FG002|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||71||
48336151|NCT01622569|101151995|FG003|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||76||
48336152|NCT01622569|101151992|FG000|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||12||
48336153|NCT01622569|101151993|FG001|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||6||
48336154|NCT01622569|101151994|FG002|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||9||
48336155|NCT01622569|101151995|FG003|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||4||
48336156|NCT01622569|101151992|FG000|STARTED|Open-Label Extension Phase (Wks 17-24)||68||
48336157|NCT01622569|101151993|FG001|STARTED|Open-Label Extension Phase (Wks 17-24)||72||
48336158|NCT01622569|101151994|FG002|STARTED|Open-Label Extension Phase (Wks 17-24)||67||
48336159|NCT01622569|101151995|FG003|STARTED|Open-Label Extension Phase (Wks 17-24)||75||
48336160|NCT01622569|101151992|FG000|COMPLETED|Open-Label Extension Phase (Wks 17-24)||67||
48336161|NCT01622569|101151993|FG001|COMPLETED|Open-Label Extension Phase (Wks 17-24)||70||
48336162|NCT01622569|101151994|FG002|COMPLETED|Open-Label Extension Phase (Wks 17-24)||64||
48336163|NCT01622569|101151995|FG003|COMPLETED|Open-Label Extension Phase (Wks 17-24)||73||
48336164|NCT01622569|101151992|FG000|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1||
48336165|NCT01622569|101151993|FG001|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2||
48336166|NCT01622569|101151994|FG002|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||3||
48336167|NCT01622569|101151995|FG003|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2||
48336168|NCT03269344|101151996|FG000|STARTED|Overall Study||33||
48336169|NCT03269344|101151997|FG001|STARTED|Overall Study||32||
48336170|NCT03269344|101151996|FG000|COMPLETED|Overall Study||29||
48336171|NCT03269344|101151997|FG001|COMPLETED|Overall Study||29||
48336172|NCT03269344|101151996|FG000|NOT COMPLETED|Overall Study||4||
48336173|NCT03269344|101151997|FG001|NOT COMPLETED|Overall Study||3||
48336174|NCT01097304|101151998|FG000|STARTED|Overall Study||36||
48336175|NCT01097304|101151998|FG000|COMPLETED|Overall Study||29||
48336176|NCT01097304|101151998|FG000|NOT COMPLETED|Overall Study||7||
48336177|NCT02344225|101151999|FG000|STARTED|Overall Study||6||
48336178|NCT02344225|101152000|FG001|STARTED|Overall Study||3||
48336179|NCT02344225|101152001|FG002|STARTED|Overall Study||5||
48336180|NCT02344225|101151999|FG000|COMPLETED|Overall Study||6||
48336181|NCT02344225|101152000|FG001|COMPLETED|Overall Study||3||
48336182|NCT02344225|101152001|FG002|COMPLETED|Overall Study||5||
48336183|NCT02344225|101151999|FG000|NOT COMPLETED|Overall Study||0||
48336184|NCT02344225|101152000|FG001|NOT COMPLETED|Overall Study||0||
48336185|NCT02344225|101152001|FG002|NOT COMPLETED|Overall Study||0||
48336186|NCT02093702|101152002|FG000|STARTED|Overall Study||2||
48336187|NCT02093702|101152003|FG001|STARTED|Overall Study||3||
48336188|NCT02093702|101152002|FG000|COMPLETED|Overall Study||2||
48336189|NCT02093702|101152003|FG001|COMPLETED|Overall Study||3||
48336190|NCT02093702|101152002|FG000|NOT COMPLETED|Overall Study||0||
48336191|NCT02093702|101152003|FG001|NOT COMPLETED|Overall Study||0||
48336192|NCT02901431|101152004|FG000|STARTED|PK Part||12||
48336193|NCT02901431|101152005|FG001|STARTED|PK Part||11||
48336194|NCT02901431|101152006|FG002|STARTED|PK Part||15||
48336195|NCT02901431|101152007|FG003|STARTED|PK Part||0||
48336196|NCT02901431|101152008|FG004|STARTED|PK Part||0||
48336197|NCT02901431|101152009|FG005|STARTED|PK Part||0||
48336198|NCT02901431|101152010|FG006|STARTED|PK Part||0||
48336199|NCT02901431|101152011|FG007|STARTED|PK Part||0||
48336200|NCT02901431|101152012|FG008|STARTED|PK Part||0||
48336201|NCT02901431|101152013|FG009|STARTED|PK Part||0||
48336202|NCT02901431|101152014|FG010|STARTED|PK Part||0||
48336203|NCT02901431|101152015|FG011|STARTED|PK Part||0||
48336204|NCT02901431|101152016|FG012|STARTED|PK Part||0||
48336205|NCT02901431|101152004|FG000|COMPLETED|PK Part||5||
48336206|NCT02901431|101152005|FG001|COMPLETED|PK Part||5||
48336207|NCT02901431|101152006|FG002|COMPLETED|PK Part||6||
48336208|NCT02901431|101152007|FG003|COMPLETED|PK Part||0||
48336209|NCT02901431|101152008|FG004|COMPLETED|PK Part||0||
48336210|NCT02901431|101152009|FG005|COMPLETED|PK Part||0||
48336211|NCT02901431|101152010|FG006|COMPLETED|PK Part||0||
48336212|NCT02901431|101152011|FG007|COMPLETED|PK Part||0||
48336213|NCT02901431|101152012|FG008|COMPLETED|PK Part||0||
48336214|NCT02901431|101152013|FG009|COMPLETED|PK Part||0||
48336215|NCT02901431|101152014|FG010|COMPLETED|PK Part||0||
48336216|NCT02901431|101152015|FG011|COMPLETED|PK Part||0||
48336217|NCT02901431|101152016|FG012|COMPLETED|PK Part||0||
48336218|NCT02901431|101152004|FG000|NOT COMPLETED|PK Part||7||
48336219|NCT02901431|101152005|FG001|NOT COMPLETED|PK Part||6||
48336220|NCT02901431|101152006|FG002|NOT COMPLETED|PK Part||9||
48336221|NCT02901431|101152007|FG003|NOT COMPLETED|PK Part||0||
48336222|NCT02901431|101152008|FG004|NOT COMPLETED|PK Part||0||
48336223|NCT02901431|101152009|FG005|NOT COMPLETED|PK Part||0||
48336224|NCT02901431|101152010|FG006|NOT COMPLETED|PK Part||0||
48336225|NCT02901431|101152011|FG007|NOT COMPLETED|PK Part||0||
48336226|NCT02901431|101152012|FG008|NOT COMPLETED|PK Part||0||
48336227|NCT02901431|101152013|FG009|NOT COMPLETED|PK Part||0||
48336228|NCT02901431|101152014|FG010|NOT COMPLETED|PK Part||0||
48336229|NCT02901431|101152015|FG011|NOT COMPLETED|PK Part||0||
48336230|NCT02901431|101152016|FG012|NOT COMPLETED|PK Part||0||
48336231|NCT02901431|101152004|FG000|STARTED|Main Treatment Part||0||
48336232|NCT02901431|101152005|FG001|STARTED|Main Treatment Part||0||
48336233|NCT02901431|101152006|FG002|STARTED|Main Treatment Part||0||
48336234|NCT02901431|101152007|FG003|STARTED|Main Treatment Part||112||
48336235|NCT02901431|101152008|FG004|STARTED|Main Treatment Part||57||
48336236|NCT02901431|101152009|FG005|STARTED|Main Treatment Part||66||
48336237|NCT02901431|101152010|FG006|STARTED|Main Treatment Part||66||
48336238|NCT02901431|101152011|FG007|STARTED|Main Treatment Part||7||
48336239|NCT02901431|101152012|FG008|STARTED|Main Treatment Part||0||
48336240|NCT02901431|101152013|FG009|STARTED|Main Treatment Part||0||
48336241|NCT02901431|101152014|FG010|STARTED|Main Treatment Part||0||
48336242|NCT02901431|101152015|FG011|STARTED|Main Treatment Part||0||
48336243|NCT02901431|101152016|FG012|STARTED|Main Treatment Part||0||
48336244|NCT02901431|101152004|FG000|COMPLETED|Main Treatment Part||0||
48336245|NCT02901431|101152005|FG001|COMPLETED|Main Treatment Part||0||
48336246|NCT02901431|101152006|FG002|COMPLETED|Main Treatment Part||0||
48336247|NCT02901431|101152007|FG003|COMPLETED|Main Treatment Part||86||
48336248|NCT02901431|101152008|FG004|COMPLETED|Main Treatment Part||50||
48336249|NCT02901431|101152009|FG005|COMPLETED|Main Treatment Part||54||
48336250|NCT02901431|101152010|FG006|COMPLETED|Main Treatment Part||55||
48336251|NCT02901431|101152011|FG007|COMPLETED|Main Treatment Part||7||
48336252|NCT02901431|101152012|FG008|COMPLETED|Main Treatment Part||0||
48336253|NCT02901431|101152013|FG009|COMPLETED|Main Treatment Part||0||
48336254|NCT02901431|101152014|FG010|COMPLETED|Main Treatment Part||0||
48336255|NCT02901431|101152015|FG011|COMPLETED|Main Treatment Part||0||
48336256|NCT02901431|101152016|FG012|COMPLETED|Main Treatment Part||0||
48336257|NCT02901431|101152004|FG000|NOT COMPLETED|Main Treatment Part||0||
48336258|NCT02901431|101152005|FG001|NOT COMPLETED|Main Treatment Part||0||
48336259|NCT02901431|101152006|FG002|NOT COMPLETED|Main Treatment Part||0||
48336260|NCT02901431|101152007|FG003|NOT COMPLETED|Main Treatment Part||26||
48336261|NCT02901431|101152008|FG004|NOT COMPLETED|Main Treatment Part||7||
48336262|NCT02901431|101152009|FG005|NOT COMPLETED|Main Treatment Part||12||
48336263|NCT02901431|101152010|FG006|NOT COMPLETED|Main Treatment Part||11||
48336264|NCT02901431|101152011|FG007|NOT COMPLETED|Main Treatment Part||0||
48336265|NCT02901431|101152012|FG008|NOT COMPLETED|Main Treatment Part||0||
48336266|NCT02901431|101152013|FG009|NOT COMPLETED|Main Treatment Part||0||
48336267|NCT02901431|101152014|FG010|NOT COMPLETED|Main Treatment Part||0||
48336268|NCT02901431|101152015|FG011|NOT COMPLETED|Main Treatment Part||0||
48336269|NCT02901431|101152016|FG012|NOT COMPLETED|Main Treatment Part||0||
48336270|NCT02901431|101152004|FG000|STARTED|Open Label Part||0||
48336271|NCT02901431|101152005|FG001|STARTED|Open Label Part||0||
48336272|NCT02901431|101152006|FG002|STARTED|Open Label Part||0||
48336273|NCT02901431|101152007|FG003|STARTED|Open Label Part||0||
48336274|NCT02901431|101152008|FG004|STARTED|Open Label Part||0||
48336275|NCT02901431|101152009|FG005|STARTED|Open Label Part||0||
48336276|NCT02901431|101152010|FG006|STARTED|Open Label Part||0||
48336277|NCT02901431|101152011|FG007|STARTED|Open Label Part||0||
48336278|NCT02901431|101152012|FG008|STARTED|Open Label Part||68||
48336279|NCT02901431|101152013|FG009|STARTED|Open Label Part||35||
48336280|NCT02901431|101152014|FG010|STARTED|Open Label Part||40||
48336281|NCT02901431|101152015|FG011|STARTED|Open Label Part||46||
48336282|NCT02901431|101152016|FG012|STARTED|Open Label Part||5||
48336283|NCT02901431|101152004|FG000|COMPLETED|Open Label Part||0||
48336284|NCT02901431|101152005|FG001|COMPLETED|Open Label Part||0||
48336285|NCT02901431|101152006|FG002|COMPLETED|Open Label Part||0||
48336286|NCT02901431|101152007|FG003|COMPLETED|Open Label Part||0||
48336287|NCT02901431|101152008|FG004|COMPLETED|Open Label Part||0||
48336288|NCT02901431|101152009|FG005|COMPLETED|Open Label Part||0||
48439944|NCT04993339|101409990|FG001|COMPLETED|Overall Study||10||
48336289|NCT02901431|101152010|FG006|COMPLETED|Open Label Part||0||
48336290|NCT02901431|101152011|FG007|COMPLETED|Open Label Part||0||
48336291|NCT02901431|101152012|FG008|COMPLETED|Open Label Part||20||
48336292|NCT02901431|101152013|FG009|COMPLETED|Open Label Part||11||
48336293|NCT02901431|101152014|FG010|COMPLETED|Open Label Part||11||
48336294|NCT02901431|101152015|FG011|COMPLETED|Open Label Part||7||
48336295|NCT02901431|101152016|FG012|COMPLETED|Open Label Part||2||
48336296|NCT02901431|101152004|FG000|NOT COMPLETED|Open Label Part||0||
48336297|NCT02901431|101152005|FG001|NOT COMPLETED|Open Label Part||0||
48336298|NCT02901431|101152006|FG002|NOT COMPLETED|Open Label Part||0||
48336299|NCT02901431|101152007|FG003|NOT COMPLETED|Open Label Part||0||
48336300|NCT02901431|101152008|FG004|NOT COMPLETED|Open Label Part||0||
48336301|NCT02901431|101152009|FG005|NOT COMPLETED|Open Label Part||0||
48336302|NCT02901431|101152010|FG006|NOT COMPLETED|Open Label Part||0||
48336303|NCT02901431|101152011|FG007|NOT COMPLETED|Open Label Part||0||
48336304|NCT02901431|101152012|FG008|NOT COMPLETED|Open Label Part||48||
48336305|NCT02901431|101152013|FG009|NOT COMPLETED|Open Label Part||24||
48336306|NCT02901431|101152014|FG010|NOT COMPLETED|Open Label Part||29||
48336307|NCT02901431|101152015|FG011|NOT COMPLETED|Open Label Part||39||
48336308|NCT02901431|101152016|FG012|NOT COMPLETED|Open Label Part||3||
48336309|NCT03075085|101152017|FG000|STARTED|Overall Study||352||5
48336310|NCT03075085|101152018|FG001|STARTED|Overall Study||344||4
48336311|NCT03075085|101152017|FG000|COMPLETED|Overall Study||247||5
48336312|NCT03075085|101152018|FG001|COMPLETED|Overall Study||232||4
48336313|NCT03075085|101152017|FG000|NOT COMPLETED|Overall Study||105||0
48336314|NCT03075085|101152018|FG001|NOT COMPLETED|Overall Study||112||0
48336315|NCT03183128|101152019|FG000|STARTED|Overall Study||89|"Started represents the number of participants assigned to each arm. Note: The number of participants who actually received SER-109 was 90, and those who actually received Placebo was 92."|
48336316|NCT03183128|101152020|FG001|STARTED|Overall Study||93|"Started represents the number of participants assigned to each arm. Note: The number of participants who actually received SER-109 was 90, and those who actually received Placebo was 92."|
48336317|NCT03183128|101152019|FG000|Completed 8-Week Follow-up|Overall Study||84||
48336318|NCT03183128|101152020|FG001|Completed 8-Week Follow-up|Overall Study||65||
48336319|NCT03183128|101152019|FG000|COMPLETED|Overall Study||77|Completed 24-Week Follow-up|
48336320|NCT03183128|101152020|FG001|COMPLETED|Overall Study||56|Completed 24-Week Follow-up|
48336321|NCT03183128|101152019|FG000|NOT COMPLETED|Overall Study||12||
48336322|NCT03183128|101152020|FG001|NOT COMPLETED|Overall Study||37||
48336323|NCT01934140|101152021|FG000|STARTED|Persistence Phase (Year 6-10)||235||
48336324|NCT01934140|101152022|FG001|STARTED|Persistence Phase (Year 6-10)||76||
48336325|NCT01934140|101152021|FG000|COMPLETED|Persistence Phase (Year 6-10)||152||
48336326|NCT01934140|101152022|FG001|COMPLETED|Persistence Phase (Year 6-10)||51||
48336327|NCT01934140|101152021|FG000|NOT COMPLETED|Persistence Phase (Year 6-10)||83||
48336328|NCT01934140|101152022|FG001|NOT COMPLETED|Persistence Phase (Year 6-10)||25||
48336329|NCT01934140|101152021|FG000|STARTED|Booster Phase (6 Months)||164||
48336330|NCT01934140|101152022|FG001|STARTED|Booster Phase (6 Months)||56||
48336331|NCT01934140|101152021|FG000|Vaccinated|Booster Phase (6 Months)||164||
48336332|NCT01934140|101152022|FG001|Vaccinated|Booster Phase (6 Months)||56||
48336333|NCT01934140|101152021|FG000|COMPLETED|Booster Phase (6 Months)||159||
48336334|NCT01934140|101152022|FG001|COMPLETED|Booster Phase (6 Months)||53||
48336335|NCT01934140|101152021|FG000|NOT COMPLETED|Booster Phase (6 Months)||5||
48336336|NCT01934140|101152022|FG001|NOT COMPLETED|Booster Phase (6 Months)||3||
48336337|NCT01154933|101152023|FG000|STARTED|Exenatide 5 mcg||12||
48336338|NCT01154933|101152024|FG001|STARTED|Exenatide 5 mcg||12||
48336339|NCT01154933|101152023|FG000|COMPLETED|Exenatide 5 mcg||12||
48336340|NCT01154933|101152024|FG001|COMPLETED|Exenatide 5 mcg||12||
48336341|NCT01154933|101152023|FG000|NOT COMPLETED|Exenatide 5 mcg||0||
48336342|NCT01154933|101152024|FG001|NOT COMPLETED|Exenatide 5 mcg||0||
48336343|NCT01154933|101152023|FG000|STARTED|Exenatide 10 mcg||12||
48336344|NCT01154933|101152024|FG001|STARTED|Exenatide 10 mcg||12||
48336345|NCT01154933|101152023|FG000|COMPLETED|Exenatide 10 mcg||12||
48336346|NCT01154933|101152024|FG001|COMPLETED|Exenatide 10 mcg||12||
48336347|NCT01154933|101152023|FG000|NOT COMPLETED|Exenatide 10 mcg||0||
48630060|NCT01249131|101878504|FG005|NOT COMPLETED|First Intervention||0||
48630061|NCT01249131|101878499|FG000|STARTED|Washout Period of 10 Days||3||
48630062|NCT01249131|101878500|FG001|STARTED|Washout Period of 10 Days||3||
48630063|NCT01249131|101878501|FG002|STARTED|Washout Period of 10 Days||4||
48336348|NCT01154933|101152024|FG001|NOT COMPLETED|Exenatide 10 mcg||0||
48336349|NCT00159432|101152025|FG000|STARTED|Overall Study||63||
48336350|NCT00159432|101152025|FG000|COMPLETED|Overall Study||53||
48336351|NCT00159432|101152025|FG000|NOT COMPLETED|Overall Study||10||
48336352|NCT03639948|101152026|FG000|STARTED|Overall Study||115||
48336353|NCT03639948|101152026|FG000|COMPLETED|Overall Study||115||
48336354|NCT03639948|101152026|FG000|NOT COMPLETED|Overall Study||0||
48336355|NCT01439945|101152027|FG000|STARTED|Double-Blind Treatment Phase||97||
48630064|NCT01249131|101878502|FG003|STARTED|Washout Period of 10 Days||3||
48336356|NCT01439945|101152028|FG001|STARTED|Double-Blind Treatment Phase||96||
48336357|NCT01439945|101152029|FG002|STARTED|Double-Blind Treatment Phase||48||
48336358|NCT01439945|101152030|FG003|STARTED|Double-Blind Treatment Phase||48||
48630065|NCT01249131|101878503|FG004|STARTED|Washout Period of 10 Days||3||
48630066|NCT01249131|101878504|FG005|STARTED|Washout Period of 10 Days||4||
48630067|NCT01249131|101878499|FG000|COMPLETED|Washout Period of 10 Days||3||
48630068|NCT01249131|101878500|FG001|COMPLETED|Washout Period of 10 Days||3||
48657128|NCT04419389|101943784|FG000|STARTED|Overall Study||1||
48175652|NCT04022889|100753776|FG001|Met Screening Criteria|Stage 2||6||
48175653|NCT04022889|100753777|FG002|Met Screening Criteria|Stage 2||19||
48175654|NCT04022889|100753775|FG000|Successful Apheresis Collection|Stage 2||7||
48175655|NCT04022889|100753776|FG001|Successful Apheresis Collection|Stage 2||6||
48175656|NCT04022889|100753777|FG002|Successful Apheresis Collection|Stage 2||15||
48175657|NCT04022889|100753775|FG000|Completed 7-days Storage of Test Platelet Component|Stage 2||7||
48175658|NCT04022889|100753776|FG001|Completed 7-days Storage of Test Platelet Component|Stage 2||6||
48175659|NCT04022889|100753777|FG002|Completed 7-days Storage of Test Platelet Component|Stage 2||14||
48175660|NCT04022889|100753775|FG000|Completed Post Infusion Sampling|Stage 2||6||
48175661|NCT04022889|100753776|FG001|Completed Post Infusion Sampling|Stage 2||6||
48175662|NCT04022889|100753777|FG002|Completed Post Infusion Sampling|Stage 2||14||
48175663|NCT04022889|100753775|FG000|COMPLETED|Stage 2||6||
48175664|NCT04022889|100753776|FG001|COMPLETED|Stage 2||6||
48175665|NCT04022889|100753777|FG002|COMPLETED|Stage 2||14||
48175666|NCT04022889|100753775|FG000|NOT COMPLETED|Stage 2||1||
48175667|NCT04022889|100753776|FG001|NOT COMPLETED|Stage 2||0||
48175668|NCT04022889|100753777|FG002|NOT COMPLETED|Stage 2||8||
48175669|NCT02670538|100753778|FG000|STARTED|Overall Study||167||
48175670|NCT02670538|100753779|FG001|STARTED|Overall Study||168||
48175671|NCT02670538|100753780|FG002|STARTED|Overall Study||158||
48175672|NCT02670538|100753778|FG000|Safety Population : Received Study Drug|Overall Study||165||
48175673|NCT02670538|100753779|FG001|Safety Population : Received Study Drug|Overall Study||167||
48175674|NCT02670538|100753780|FG002|Safety Population : Received Study Drug|Overall Study||158||
48175675|NCT02670538|100753778|FG000|Intent-to-Treat Population|Overall Study||163||
48175676|NCT02670538|100753779|FG001|Intent-to-Treat Population|Overall Study||162||
48175677|NCT02670538|100753780|FG002|Intent-to-Treat Population|Overall Study||153||
48175678|NCT02670538|100753778|FG000|COMPLETED|Overall Study||135||
48175679|NCT02670538|100753779|FG001|COMPLETED|Overall Study||136||
48175680|NCT02670538|100753780|FG002|COMPLETED|Overall Study||128||
48175681|NCT02670538|100753778|FG000|NOT COMPLETED|Overall Study||32||
48175682|NCT02670538|100753779|FG001|NOT COMPLETED|Overall Study||32||
48175683|NCT02670538|100753780|FG002|NOT COMPLETED|Overall Study||30||
48175684|NCT01554982|100753781|FG000|STARTED|Overall Study||168||
48630069|NCT01249131|101878501|FG002|COMPLETED|Washout Period of 10 Days||4||
48630070|NCT01249131|101878502|FG003|COMPLETED|Washout Period of 10 Days||3||
48630071|NCT01249131|101878503|FG004|COMPLETED|Washout Period of 10 Days||2||
48630072|NCT01249131|101878504|FG005|COMPLETED|Washout Period of 10 Days||4||
48630073|NCT01249131|101878499|FG000|NOT COMPLETED|Washout Period of 10 Days||0||
48175685|NCT01554982|100753781|FG000|Received Drug|Overall Study||166||
48175686|NCT01554982|100753781|FG000|COMPLETED|Overall Study||125||
48175687|NCT01554982|100753781|FG000|NOT COMPLETED|Overall Study||43||
48175688|NCT04466618|100753782|FG000|STARTED|Overall Study||12||
48175689|NCT04466618|100753783|FG001|STARTED|Overall Study||11||
48175690|NCT04466618|100753782|FG000|COMPLETED|Overall Study||12||
48175691|NCT04466618|100753783|FG001|COMPLETED|Overall Study||10||
48175692|NCT04466618|100753782|FG000|NOT COMPLETED|Overall Study||0||
48175693|NCT04466618|100753783|FG001|NOT COMPLETED|Overall Study||1||
48175694|NCT02835443|100753784|FG000|STARTED|Overall Study||12||
48175695|NCT02835443|100753784|FG000|COMPLETED|Overall Study||12||
48175696|NCT02835443|100753784|FG000|NOT COMPLETED|Overall Study||0||
48175697|NCT02036515|100753785|FG000|STARTED|Overall Study||156||
48175698|NCT02036515|100753786|FG001|STARTED|Overall Study||155||
48175699|NCT02036515|100753787|FG002|STARTED|Overall Study||153||
48175700|NCT02036515|100753785|FG000|Treated|Overall Study||156||
48175701|NCT02036515|100753786|FG001|Treated|Overall Study||153||
48175702|NCT02036515|100753787|FG002|Treated|Overall Study||153||
48630074|NCT01249131|101878500|FG001|NOT COMPLETED|Washout Period of 10 Days||0||
48630075|NCT01249131|101878501|FG002|NOT COMPLETED|Washout Period of 10 Days||0||
48630076|NCT01249131|101878502|FG003|NOT COMPLETED|Washout Period of 10 Days||0||
48175703|NCT02036515|100753785|FG000|COMPLETED|Overall Study||151||
48175704|NCT02036515|100753786|FG001|COMPLETED|Overall Study||143||
48175705|NCT02036515|100753787|FG002|COMPLETED|Overall Study||139||
48175706|NCT02036515|100753785|FG000|NOT COMPLETED|Overall Study||5||
48175707|NCT02036515|100753786|FG001|NOT COMPLETED|Overall Study||12||
48175708|NCT02036515|100753787|FG002|NOT COMPLETED|Overall Study||14||
48175709|NCT03050398|100753788|FG000|STARTED|Overall Study||8||
48175710|NCT03050398|100753788|FG000|COMPLETED|Overall Study||0||
48630077|NCT01249131|101878503|FG004|NOT COMPLETED|Washout Period of 10 Days||1||
48630078|NCT01249131|101878504|FG005|NOT COMPLETED|Washout Period of 10 Days||0||
48175711|NCT03050398|100753788|FG000|NOT COMPLETED|Overall Study||8||
48175712|NCT01454830|100753789|FG000|STARTED|Overall Study||61||
48175713|NCT01454830|100753790|FG001|STARTED|Overall Study||57||
48175714|NCT01454830|100753789|FG000|COMPLETED|Overall Study||30||
48175715|NCT01454830|100753790|FG001|COMPLETED|Overall Study||30||
48630079|NCT01249131|101878499|FG000|STARTED|Second Intervention||3||
48630080|NCT01249131|101878500|FG001|STARTED|Second Intervention||3||
48175716|NCT01454830|100753789|FG000|NOT COMPLETED|Overall Study||31||
48175717|NCT01454830|100753790|FG001|NOT COMPLETED|Overall Study||27||
48175718|NCT01722318|100753791|FG000|STARTED|Overall Study||86||
48175719|NCT01722318|100753792|FG001|STARTED|Overall Study||85||
48175720|NCT01722318|100753793|FG002|STARTED|Overall Study||86||
48336359|NCT01439945|101152027|FG000|COMPLETED|Double-Blind Treatment Phase||93||
48336360|NCT01439945|101152028|FG001|COMPLETED|Double-Blind Treatment Phase||91||
48336361|NCT01439945|101152029|FG002|COMPLETED|Double-Blind Treatment Phase||45||
48336362|NCT01439945|101152030|FG003|COMPLETED|Double-Blind Treatment Phase||46||
48336363|NCT01439945|101152027|FG000|NOT COMPLETED|Double-Blind Treatment Phase||4||
48336364|NCT01439945|101152028|FG001|NOT COMPLETED|Double-Blind Treatment Phase||5||
48336365|NCT01439945|101152029|FG002|NOT COMPLETED|Double-Blind Treatment Phase||3||
48336366|NCT01439945|101152030|FG003|NOT COMPLETED|Double-Blind Treatment Phase||2||
48336367|NCT01439945|101152027|FG000|STARTED|Optional Continuation Phase||72||
48336368|NCT01439945|101152028|FG001|STARTED|Optional Continuation Phase||44||
48336369|NCT01439945|101152029|FG002|STARTED|Optional Continuation Phase||0||
48336370|NCT01439945|101152030|FG003|STARTED|Optional Continuation Phase||0||
48336371|NCT01439945|101152027|FG000|COMPLETED|Optional Continuation Phase||72||
48336372|NCT01439945|101152028|FG001|COMPLETED|Optional Continuation Phase||44||
48336373|NCT01439945|101152029|FG002|COMPLETED|Optional Continuation Phase||0||
48336374|NCT01439945|101152030|FG003|COMPLETED|Optional Continuation Phase||0||
48336375|NCT01439945|101152027|FG000|NOT COMPLETED|Optional Continuation Phase||0||
48336376|NCT01439945|101152028|FG001|NOT COMPLETED|Optional Continuation Phase||0||
48336377|NCT01439945|101152029|FG002|NOT COMPLETED|Optional Continuation Phase||0||
48336378|NCT01439945|101152030|FG003|NOT COMPLETED|Optional Continuation Phase||0||
48336379|NCT00481065|101152031|FG000|STARTED|Overall Study||51||
48336380|NCT00481065|101152032|FG001|STARTED|Overall Study||50||
48336381|NCT00481065|101152033|FG002|STARTED|Overall Study||51||
48336382|NCT00481065|101152034|FG003|STARTED|Overall Study||52||
48336383|NCT00481065|101152035|FG004|STARTED|Overall Study||51||
48336384|NCT00481065|101152036|FG005|STARTED|Overall Study||51||
48336385|NCT00481065|101152037|FG006|STARTED|Overall Study||50||
48336386|NCT00481065|101152038|FG007|STARTED|Overall Study||49||
48336387|NCT00481065|101152031|FG000|COMPLETED|Overall Study||29||
48336388|NCT00481065|101152032|FG001|COMPLETED|Overall Study||33||
48336389|NCT00481065|101152033|FG002|COMPLETED|Overall Study||32||
48336390|NCT00481065|101152034|FG003|COMPLETED|Overall Study||37||
48336391|NCT00481065|101152035|FG004|COMPLETED|Overall Study||28||
48336392|NCT00481065|101152036|FG005|COMPLETED|Overall Study||27||
48336393|NCT00481065|101152037|FG006|COMPLETED|Overall Study||34||
48336394|NCT00481065|101152038|FG007|COMPLETED|Overall Study||30||
48336395|NCT00481065|101152031|FG000|NOT COMPLETED|Overall Study||22||
48336396|NCT00481065|101152032|FG001|NOT COMPLETED|Overall Study||17||
48336397|NCT00481065|101152033|FG002|NOT COMPLETED|Overall Study||19||
48336398|NCT00481065|101152034|FG003|NOT COMPLETED|Overall Study||15||
48336399|NCT00481065|101152035|FG004|NOT COMPLETED|Overall Study||23||
48336400|NCT00481065|101152036|FG005|NOT COMPLETED|Overall Study||24||
48336401|NCT00481065|101152037|FG006|NOT COMPLETED|Overall Study||16||
48336402|NCT00481065|101152038|FG007|NOT COMPLETED|Overall Study||19||
48336403|NCT00598975|101152039|FG000|STARTED|Overall Study||12||
48336404|NCT00598975|101152040|FG001|STARTED|Overall Study||6||
48336405|NCT00598975|101152039|FG000|Completed Cycle 1|Overall Study||12||
48336406|NCT00598975|101152040|FG001|Completed Cycle 1|Overall Study||6||
48336407|NCT00598975|101152039|FG000|COMPLETED|Overall Study||0||
48336408|NCT00598975|101152040|FG001|COMPLETED|Overall Study||0||
48336409|NCT00598975|101152039|FG000|NOT COMPLETED|Overall Study||12||
48336410|NCT00598975|101152040|FG001|NOT COMPLETED|Overall Study||6||
48336411|NCT02817087|101152041|FG000|STARTED|Overall Study||16||
48336412|NCT02817087|101152042|FG001|STARTED|Overall Study||15||
48336413|NCT02817087|101152041|FG000|COMPLETED|Overall Study||14||
48336414|NCT02817087|101152042|FG001|COMPLETED|Overall Study||15||
48336415|NCT02817087|101152041|FG000|NOT COMPLETED|Overall Study||2||
48336416|NCT02817087|101152042|FG001|NOT COMPLETED|Overall Study||0||
48752898|NCT04590014|102181067|FG001|STARTED|Overall Study||3||
48752899|NCT04590014|102181066|FG000|COMPLETED|Overall Study||1||
48752900|NCT04590014|102181067|FG001|COMPLETED|Overall Study||3||
48752901|NCT04590014|102181066|FG000|NOT COMPLETED|Overall Study||1||
48752902|NCT04590014|102181067|FG001|NOT COMPLETED|Overall Study||0||
48752903|NCT00474955|102181068|FG000|STARTED|Overall Study||27||
48752904|NCT00474955|102181068|FG000|COMPLETED|Overall Study||19||
48336417|NCT00860158|101152043|FG000|STARTED|Overall Study||1||
48336418|NCT00860158|101152043|FG000|COMPLETED|Overall Study||0||
48336419|NCT00860158|101152043|FG000|NOT COMPLETED|Overall Study||1||
48336420|NCT00898222|101152044|FG000|STARTED|Overall Study||4||
48336421|NCT00898222|101152044|FG000|COMPLETED|Overall Study||4||
48336422|NCT00898222|101152044|FG000|NOT COMPLETED|Overall Study||0||
48336423|NCT01178138|101152045|FG000|STARTED|Overall Study||24||
48336424|NCT01178138|101152045|FG000|Completed 6 Sessions|Overall Study||1||
48336425|NCT01178138|101152045|FG000|Completed 5 Sessions|Overall Study||1||
48336426|NCT01178138|101152045|FG000|Completed 3 Sessions|Overall Study||1||
48336427|NCT01178138|101152045|FG000|COMPLETED|Overall Study||1||
48752905|NCT00474955|102181068|FG000|NOT COMPLETED|Overall Study||8||
48336428|NCT01178138|101152045|FG000|NOT COMPLETED|Overall Study||23||
48336429|NCT01194440|101152046|FG000|STARTED|Baseline (First Dose)||59||
48336430|NCT01194440|101152046|FG000|COMPLETED|Baseline (First Dose)||52||
48752906|NCT02413918|102181069|FG000|STARTED|Overall Study||41||
48752907|NCT02413918|102181069|FG000|COMPLETED|Overall Study||16||
48412473|NCT02599324|101342017|FG005|STARTED|Phase 2 (RP2D)||0|Entered Phase 2 and received at least 1 dose of study medication.|
48412474|NCT02599324|101342018|FG006|STARTED|Phase 2 (RP2D)||44|Entered Phase 2 and received at least 1 dose of study medication.|
48412475|NCT02599324|101342019|FG007|STARTED|Phase 2 (RP2D)||33|Entered Phase 2 and received at least 1 dose of study medication.|
48412476|NCT02599324|101342020|FG008|STARTED|Phase 2 (RP2D)||13|Entered Phase 2 and received at least 1 dose of study medication.|
48412477|NCT02599324|101342012|FG000|Continued From Phase 1b|Phase 2 (RP2D)||0||
48412478|NCT02599324|101342013|FG001|Continued From Phase 1b|Phase 2 (RP2D)||6||
48412479|NCT02599324|101342014|FG002|Continued From Phase 1b|Phase 2 (RP2D)||0||
48412480|NCT02599324|101342015|FG003|Continued From Phase 1b|Phase 2 (RP2D)||6||
48412481|NCT02599324|101342016|FG004|Continued From Phase 1b|Phase 2 (RP2D)||6||
48412482|NCT02599324|101342017|FG005|Continued From Phase 1b|Phase 2 (RP2D)||0||
48412483|NCT02599324|101342018|FG006|Continued From Phase 1b|Phase 2 (RP2D)||6||
48412484|NCT02599324|101342019|FG007|Continued From Phase 1b|Phase 2 (RP2D)||8||
48412485|NCT02599324|101342020|FG008|Continued From Phase 1b|Phase 2 (RP2D)||12||
48412486|NCT02599324|101342012|FG000|Enrolled in Phase 2|Phase 2 (RP2D)||0||
48412487|NCT02599324|101342013|FG001|Enrolled in Phase 2|Phase 2 (RP2D)||32||
48412488|NCT02599324|101342014|FG002|Enrolled in Phase 2|Phase 2 (RP2D)||0||
48412489|NCT02599324|101342015|FG003|Enrolled in Phase 2|Phase 2 (RP2D)||49||
48412490|NCT02599324|101342016|FG004|Enrolled in Phase 2|Phase 2 (RP2D)||25||
48412491|NCT02599324|101342017|FG005|Enrolled in Phase 2|Phase 2 (RP2D)||0||
48412492|NCT02599324|101342018|FG006|Enrolled in Phase 2|Phase 2 (RP2D)||39||
48412493|NCT02599324|101342019|FG007|Enrolled in Phase 2|Phase 2 (RP2D)||25||
48752908|NCT02413918|102181069|FG000|NOT COMPLETED|Overall Study||25||
48752909|NCT00981149|102181070|FG000|STARTED|Overall Study||12||
48752910|NCT00981149|102181071|FG001|STARTED|Overall Study||12||
48752911|NCT00981149|102181070|FG000|COMPLETED|Overall Study||10||
48752912|NCT00981149|102181071|FG001|COMPLETED|Overall Study||9||
48752913|NCT00981149|102181070|FG000|NOT COMPLETED|Overall Study||2||
48752914|NCT00981149|102181071|FG001|NOT COMPLETED|Overall Study||3||
48752915|NCT02753946|102181072|FG000|STARTED|Overall Study||233|465 were randomized but 1 randomized patient had adverse event prior to dosing|
48752916|NCT02753946|102181073|FG001|STARTED|Overall Study||231|465 were randomized but 1 randomized patient had adverse event prior to dosing|
48752917|NCT02753946|102181072|FG000|COMPLETED|Overall Study||219||
48752918|NCT02753946|102181073|FG001|COMPLETED|Overall Study||222||
48752919|NCT02753946|102181072|FG000|NOT COMPLETED|Overall Study||14||
48752920|NCT02753946|102181073|FG001|NOT COMPLETED|Overall Study||9||
48752921|NCT04142034|102181074|FG000|STARTED|Recruitment Period||535||
48752922|NCT04142034|102181075|FG001|STARTED|Recruitment Period||23||
48752923|NCT04142034|102181076|FG002|STARTED|Recruitment Period||0||
48752924|NCT04142034|102181077|FG003|STARTED|Recruitment Period||0||
48752925|NCT04142034|102181074|FG000|COMPLETED|Recruitment Period||99||
48752926|NCT04142034|102181075|FG001|COMPLETED|Recruitment Period||5||
48752927|NCT04142034|102181076|FG002|COMPLETED|Recruitment Period||0||
48752928|NCT04142034|102181077|FG003|COMPLETED|Recruitment Period||0||
48752929|NCT04142034|102181074|FG000|NOT COMPLETED|Recruitment Period||436||
48752930|NCT04142034|102181075|FG001|NOT COMPLETED|Recruitment Period||18||
48752931|NCT04142034|102181076|FG002|NOT COMPLETED|Recruitment Period||0||
48752932|NCT04142034|102181077|FG003|NOT COMPLETED|Recruitment Period||0||
48412494|NCT02599324|101342020|FG008|Enrolled in Phase 2|Phase 2 (RP2D)||1||
48412495|NCT02599324|101342012|FG000|Enrolled and Treated in Phase 2|Phase 2 (RP2D)||0||
48412496|NCT02599324|101342013|FG001|Enrolled and Treated in Phase 2|Phase 2 (RP2D)||32||
48412497|NCT02599324|101342014|FG002|Enrolled and Treated in Phase 2|Phase 2 (RP2D)||0||
48412498|NCT02599324|101342015|FG003|Enrolled and Treated in Phase 2|Phase 2 (RP2D)||49||
48412499|NCT02599324|101342016|FG004|Enrolled and Treated in Phase 2|Phase 2 (RP2D)||25||
48412500|NCT02599324|101342017|FG005|Enrolled and Treated in Phase 2|Phase 2 (RP2D)||0||
48412501|NCT02599324|101342018|FG006|Enrolled and Treated in Phase 2|Phase 2 (RP2D)||38||
48752933|NCT04142034|102181074|FG000|STARTED|Intervention Period||0||
48752934|NCT04142034|102181075|FG001|STARTED|Intervention Period||0||
48752935|NCT04142034|102181076|FG002|STARTED|Intervention Period||52||
48752936|NCT04142034|102181077|FG003|STARTED|Intervention Period||52||
48752937|NCT04142034|102181074|FG000|COMPLETED|Intervention Period||0||
48752938|NCT04142034|102181075|FG001|COMPLETED|Intervention Period||0||
48752939|NCT04142034|102181076|FG002|COMPLETED|Intervention Period||45||
48412502|NCT02599324|101342019|FG007|Enrolled and Treated in Phase 2|Phase 2 (RP2D)||25||
48412503|NCT02599324|101342020|FG008|Enrolled and Treated in Phase 2|Phase 2 (RP2D)||1||
48412504|NCT02599324|101342012|FG000|COMPLETED|Phase 2 (RP2D)||0|Off Study|
48412505|NCT02599324|101342013|FG001|COMPLETED|Phase 2 (RP2D)||38|Off Study|
48412506|NCT02599324|101342014|FG002|COMPLETED|Phase 2 (RP2D)||0|Off Study|
48412507|NCT02599324|101342015|FG003|COMPLETED|Phase 2 (RP2D)||55|Off Study|
48412508|NCT02599324|101342016|FG004|COMPLETED|Phase 2 (RP2D)||31|Off Study|
48412509|NCT02599324|101342017|FG005|COMPLETED|Phase 2 (RP2D)||0|Off Study|
48412510|NCT02599324|101342018|FG006|COMPLETED|Phase 2 (RP2D)||44|Off Study|
48412511|NCT02599324|101342019|FG007|COMPLETED|Phase 2 (RP2D)||33|Off Study|
48412512|NCT02599324|101342020|FG008|COMPLETED|Phase 2 (RP2D)||13|Off Study|
48752940|NCT04142034|102181077|FG003|COMPLETED|Intervention Period||50||
48752941|NCT04142034|102181074|FG000|NOT COMPLETED|Intervention Period||0||
48752942|NCT04142034|102181075|FG001|NOT COMPLETED|Intervention Period||0||
48752943|NCT04142034|102181076|FG002|NOT COMPLETED|Intervention Period||7||
48752944|NCT04142034|102181077|FG003|NOT COMPLETED|Intervention Period||2||
48752945|NCT01731912|102184366|FG000|STARTED|Overall Study||16||
48412513|NCT02599324|101342012|FG000|NOT COMPLETED|Phase 2 (RP2D)||0||
48412514|NCT02599324|101342013|FG001|NOT COMPLETED|Phase 2 (RP2D)||0||
48752946|NCT01731912|102184366|FG000|COMPLETED|Overall Study||14||
48752947|NCT01731912|102184366|FG000|NOT COMPLETED|Overall Study||2||
48752948|NCT00464698|102184367|FG000|STARTED|Period 1: 30 mg||20||
48752949|NCT00464698|102184367|FG000|COMPLETED|Period 1: 30 mg||17||
48752950|NCT00464698|102184367|FG000|NOT COMPLETED|Period 1: 30 mg||3||
48752951|NCT00464698|102184367|FG000|STARTED|Period 2: 60 mg||17||
48752952|NCT00464698|102184367|FG000|COMPLETED|Period 2: 60 mg||17||
48412515|NCT02599324|101342014|FG002|NOT COMPLETED|Phase 2 (RP2D)||0||
48412516|NCT02599324|101342015|FG003|NOT COMPLETED|Phase 2 (RP2D)||0||
48412517|NCT02599324|101342016|FG004|NOT COMPLETED|Phase 2 (RP2D)||0||
48412518|NCT02599324|101342017|FG005|NOT COMPLETED|Phase 2 (RP2D)||0||
48412519|NCT02599324|101342018|FG006|NOT COMPLETED|Phase 2 (RP2D)||0||
48412520|NCT02599324|101342019|FG007|NOT COMPLETED|Phase 2 (RP2D)||0||
48412521|NCT02599324|101342020|FG008|NOT COMPLETED|Phase 2 (RP2D)||0||
48412522|NCT02468804|101342021|FG000|STARTED|Overall Study||37||
48412523|NCT02468804|101342022|FG001|STARTED|Overall Study||58||
48412524|NCT02468804|101342021|FG000|COMPLETED|Overall Study||36||
48412525|NCT02468804|101342022|FG001|COMPLETED|Overall Study||50||
48412526|NCT02468804|101342021|FG000|NOT COMPLETED|Overall Study||1||
48412527|NCT02468804|101342022|FG001|NOT COMPLETED|Overall Study||8||
48412528|NCT02875366|101342023|FG000|STARTED|Overall Study||36||
48412529|NCT02875366|101342024|FG001|STARTED|Overall Study||34||
48412530|NCT02875366|101342023|FG000|COMPLETED|Overall Study||36||
48412531|NCT02875366|101342024|FG001|COMPLETED|Overall Study||31||
48412532|NCT02875366|101342023|FG000|NOT COMPLETED|Overall Study||0||
48412533|NCT02875366|101342024|FG001|NOT COMPLETED|Overall Study||3||
48412534|NCT00608894|101342025|FG000|STARTED|Overall Study||7||
48412535|NCT00608894|101342026|FG001|STARTED|Overall Study||6||
48412536|NCT00608894|101342025|FG000|COMPLETED|Overall Study||7||
48412537|NCT00608894|101342026|FG001|COMPLETED|Overall Study||4||
48412538|NCT00608894|101342025|FG000|NOT COMPLETED|Overall Study||0||
48412539|NCT00608894|101342026|FG001|NOT COMPLETED|Overall Study||2||
48412540|NCT02463331|101342027|FG000|STARTED|Overall Study||26||
48412541|NCT02463331|101342028|FG001|STARTED|Overall Study||31||
48412542|NCT02463331|101342027|FG000|COMPLETED|Overall Study||10||
48412543|NCT02463331|101342028|FG001|COMPLETED|Overall Study||25||
48412544|NCT02463331|101342027|FG000|NOT COMPLETED|Overall Study||16||
48412545|NCT02463331|101342028|FG001|NOT COMPLETED|Overall Study||6||
48752953|NCT00464698|102184367|FG000|NOT COMPLETED|Period 2: 60 mg||0||
48752954|NCT00464698|102184367|FG000|STARTED|Period 3: 120mg||14||
48752955|NCT00464698|102184367|FG000|COMPLETED|Period 3: 120mg||12||
48752956|NCT00464698|102184367|FG000|NOT COMPLETED|Period 3: 120mg||2||
48630081|NCT01249131|101878501|FG002|STARTED|Second Intervention||4||
48752957|NCT03174184|102184368|FG000|STARTED|Overall Study||32||
48752958|NCT03174184|102184369|FG001|STARTED|Overall Study||20||
48752959|NCT03174184|102184370|FG002|STARTED|Overall Study||17||
48752960|NCT03174184|102184371|FG003|STARTED|Overall Study||15||
48752961|NCT03174184|102184372|FG004|STARTED|Overall Study||14||
48752962|NCT03174184|102184373|FG005|STARTED|Overall Study||14||
48752963|NCT03174184|102184368|FG000|COMPLETED|Overall Study||23||
48752964|NCT03174184|102184369|FG001|COMPLETED|Overall Study||15||
48752965|NCT03174184|102184370|FG002|COMPLETED|Overall Study||12||
48752966|NCT03174184|102184371|FG003|COMPLETED|Overall Study||12||
48752967|NCT03174184|102184372|FG004|COMPLETED|Overall Study||12||
48752968|NCT03174184|102184373|FG005|COMPLETED|Overall Study||12||
48752969|NCT03174184|102184368|FG000|NOT COMPLETED|Overall Study||9||
48412546|NCT04957745|101342029|FG000|STARTED|Overall Study||13||
48412547|NCT04957745|101342029|FG000|COMPLETED|Overall Study||13||
48412548|NCT04957745|101342029|FG000|NOT COMPLETED|Overall Study||0||
48412549|NCT04021706|101342030|FG000|STARTED|Overall Study||17||
48412550|NCT04021706|101342031|FG001|STARTED|Overall Study||15||
48412551|NCT04021706|101342030|FG000|COMPLETED|Overall Study||13||
48412552|NCT04021706|101342031|FG001|COMPLETED|Overall Study||13||
48752970|NCT03174184|102184369|FG001|NOT COMPLETED|Overall Study||5||
48752971|NCT03174184|102184370|FG002|NOT COMPLETED|Overall Study||5||
48630082|NCT01249131|101878502|FG003|STARTED|Second Intervention||3||
48630083|NCT01249131|101878503|FG004|STARTED|Second Intervention||2||
48630084|NCT01249131|101878504|FG005|STARTED|Second Intervention||4||
48630085|NCT01249131|101878499|FG000|COMPLETED|Second Intervention||3||
48630086|NCT01249131|101878500|FG001|COMPLETED|Second Intervention||3||
48630087|NCT01249131|101878501|FG002|COMPLETED|Second Intervention||4||
48630088|NCT01249131|101878502|FG003|COMPLETED|Second Intervention||3||
48630089|NCT01249131|101878503|FG004|COMPLETED|Second Intervention||2||
48630090|NCT01249131|101878504|FG005|COMPLETED|Second Intervention||4||
48412553|NCT04021706|101342030|FG000|NOT COMPLETED|Overall Study||4||
48412554|NCT04021706|101342031|FG001|NOT COMPLETED|Overall Study||2||
48412555|NCT00403390|101342032|FG000|STARTED|Overall Study||16||
48336431|NCT01194440|101152046|FG000|NOT COMPLETED|Baseline (First Dose)||7||
48336432|NCT01194440|101152046|FG000|STARTED|6-months (2nd Dose)||52||
48336433|NCT01194440|101152046|FG000|COMPLETED|6-months (2nd Dose)||48||
48336434|NCT01194440|101152046|FG000|NOT COMPLETED|6-months (2nd Dose)||4||
48336435|NCT00845195|101152047|FG000|STARTED|Overall Study||75||
48336436|NCT00845195|101152048|FG001|STARTED|Overall Study||75||
48336437|NCT00845195|101152047|FG000|COMPLETED|Overall Study||75||
48336438|NCT00845195|101152048|FG001|COMPLETED|Overall Study||75||
48336439|NCT00845195|101152047|FG000|NOT COMPLETED|Overall Study||0||
48412556|NCT00403390|101342033|FG001|STARTED|Overall Study||18||
48412557|NCT00403390|101342032|FG000|COMPLETED|Overall Study||13||
48630091|NCT01249131|101878499|FG000|NOT COMPLETED|Second Intervention||0||
48630092|NCT01249131|101878500|FG001|NOT COMPLETED|Second Intervention||0||
48630093|NCT01249131|101878501|FG002|NOT COMPLETED|Second Intervention||0||
48630094|NCT01249131|101878502|FG003|NOT COMPLETED|Second Intervention||0||
48630095|NCT01249131|101878503|FG004|NOT COMPLETED|Second Intervention||0||
48630096|NCT01249131|101878504|FG005|NOT COMPLETED|Second Intervention||0||
48630097|NCT01249131|101878499|FG000|STARTED|Washout Period of 10 Days||3||
48630098|NCT01249131|101878500|FG001|STARTED|Washout Period of 10 Days||3||
48630099|NCT01249131|101878501|FG002|STARTED|Washout Period of 10 Days||4||
48412558|NCT00403390|101342033|FG001|COMPLETED|Overall Study||18||
48630100|NCT01249131|101878502|FG003|STARTED|Washout Period of 10 Days||3||
48630101|NCT01249131|101878503|FG004|STARTED|Washout Period of 10 Days||2||
48630102|NCT01249131|101878504|FG005|STARTED|Washout Period of 10 Days||4||
48630103|NCT01249131|101878499|FG000|COMPLETED|Washout Period of 10 Days||3||
48630104|NCT01249131|101878500|FG001|COMPLETED|Washout Period of 10 Days||3||
48630105|NCT01249131|101878501|FG002|COMPLETED|Washout Period of 10 Days||4||
48630106|NCT01249131|101878502|FG003|COMPLETED|Washout Period of 10 Days||3||
48752972|NCT03174184|102184371|FG003|NOT COMPLETED|Overall Study||3||
48752973|NCT03174184|102184372|FG004|NOT COMPLETED|Overall Study||2||
48752974|NCT03174184|102184373|FG005|NOT COMPLETED|Overall Study||2||
48752975|NCT00467077|102184374|FG000|STARTED|Overall Study||21||
48752976|NCT00467077|102184374|FG000|COMPLETED|Overall Study||21||
48752977|NCT00467077|102184374|FG000|NOT COMPLETED|Overall Study||0||
48752978|NCT01582061|102184375|FG000|STARTED|Overall Study||49||
48752979|NCT01582061|102184376|FG001|STARTED|Overall Study||55||
48752980|NCT01582061|102184375|FG000|COMPLETED|Overall Study||21||
48752981|NCT01582061|102184376|FG001|COMPLETED|Overall Study||19||
48752982|NCT01582061|102184375|FG000|NOT COMPLETED|Overall Study||28||
48752983|NCT01582061|102184376|FG001|NOT COMPLETED|Overall Study||36||
48752984|NCT02831764|102184377|FG000|STARTED|Double-blind Phase (Day1 to Week 96)||360||
48752985|NCT02831764|102184378|FG001|STARTED|Double-blind Phase (Day1 to Week 96)||362||
48752986|NCT02831764|102184379|FG002|STARTED|Double-blind Phase (Day1 to Week 96)||0||
48752987|NCT02831764|102184380|FG003|STARTED|Double-blind Phase (Day1 to Week 96)||0||
48752988|NCT02831764|102184381|FG004|STARTED|Double-blind Phase (Day1 to Week 96)||0||
48752989|NCT02831764|102184377|FG000|Intent-to-Treat Exposed|Double-blind Phase (Day1 to Week 96)||360||
48752990|NCT02831764|102184378|FG001|Intent-to-Treat Exposed|Double-blind Phase (Day1 to Week 96)||359||
48752991|NCT02831764|102184379|FG002|Intent-to-Treat Exposed|Double-blind Phase (Day1 to Week 96)||0||
48752992|NCT02831764|102184380|FG003|Intent-to-Treat Exposed|Double-blind Phase (Day1 to Week 96)||0||
48752993|NCT02831764|102184381|FG004|Intent-to-Treat Exposed|Double-blind Phase (Day1 to Week 96)||0||
48752994|NCT02831764|102184377|FG000|COMPLETED|Double-blind Phase (Day1 to Week 96)||319||
48752995|NCT02831764|102184378|FG001|COMPLETED|Double-blind Phase (Day1 to Week 96)||327||
48336440|NCT00845195|101152048|FG001|NOT COMPLETED|Overall Study||0||
48336441|NCT00592475|101152049|FG000|STARTED|Overall Study||6||
48336442|NCT00592475|101152050|FG001|STARTED|Overall Study||9||
48336443|NCT00592475|101152051|FG002|STARTED|Overall Study||5||
48412559|NCT00403390|101342032|FG000|NOT COMPLETED|Overall Study||3||
48412560|NCT00403390|101342033|FG001|NOT COMPLETED|Overall Study||0||
48630107|NCT01249131|101878503|FG004|COMPLETED|Washout Period of 10 Days||2||
48630108|NCT01249131|101878504|FG005|COMPLETED|Washout Period of 10 Days||4||
48630109|NCT01249131|101878499|FG000|NOT COMPLETED|Washout Period of 10 Days||0||
48630110|NCT01249131|101878500|FG001|NOT COMPLETED|Washout Period of 10 Days||0||
48630111|NCT01249131|101878501|FG002|NOT COMPLETED|Washout Period of 10 Days||0||
48630112|NCT01249131|101878502|FG003|NOT COMPLETED|Washout Period of 10 Days||0||
48630113|NCT01249131|101878503|FG004|NOT COMPLETED|Washout Period of 10 Days||0||
48630114|NCT01249131|101878504|FG005|NOT COMPLETED|Washout Period of 10 Days||0||
48630115|NCT01249131|101878499|FG000|STARTED|Third Intervention||3||
48630116|NCT01249131|101878500|FG001|STARTED|Third Intervention||3||
48630117|NCT01249131|101878501|FG002|STARTED|Third Intervention||4||
48630118|NCT01249131|101878502|FG003|STARTED|Third Intervention||3||
48630119|NCT01249131|101878503|FG004|STARTED|Third Intervention||2||
48630120|NCT01249131|101878504|FG005|STARTED|Third Intervention||4||
48630121|NCT01249131|101878499|FG000|COMPLETED|Third Intervention||3||
48630122|NCT01249131|101878500|FG001|COMPLETED|Third Intervention||3||
48630123|NCT01249131|101878501|FG002|COMPLETED|Third Intervention||4||
48630124|NCT01249131|101878502|FG003|COMPLETED|Third Intervention||3||
48630125|NCT01249131|101878503|FG004|COMPLETED|Third Intervention||2||
48630126|NCT01249131|101878504|FG005|COMPLETED|Third Intervention||4||
48630127|NCT01249131|101878499|FG000|NOT COMPLETED|Third Intervention||0||
48630128|NCT01249131|101878500|FG001|NOT COMPLETED|Third Intervention||0||
48630129|NCT01249131|101878501|FG002|NOT COMPLETED|Third Intervention||0||
48630130|NCT01249131|101878502|FG003|NOT COMPLETED|Third Intervention||0||
48630131|NCT01249131|101878503|FG004|NOT COMPLETED|Third Intervention||0||
48630132|NCT01249131|101878504|FG005|NOT COMPLETED|Third Intervention||0||
48630133|NCT03903172|101878505|FG000|STARTED|Overall Study||54||
48630134|NCT03903172|101878506|FG001|STARTED|Overall Study||51||
48630135|NCT03903172|101878505|FG000|COMPLETED|Overall Study||50||
48630136|NCT03903172|101878506|FG001|COMPLETED|Overall Study||50||
48630137|NCT03903172|101878505|FG000|NOT COMPLETED|Overall Study||4||
48630138|NCT03903172|101878506|FG001|NOT COMPLETED|Overall Study||1||
48630139|NCT01268267|101878507|FG000|STARTED|Overall Study||94||
48630140|NCT01268267|101878507|FG000|COMPLETED|Overall Study||93||
48630141|NCT01268267|101878507|FG000|NOT COMPLETED|Overall Study||1||
48630142|NCT00977197|101878508|FG000|STARTED|Overall Study||41||
48630143|NCT00977197|101878509|FG001|STARTED|Overall Study||44||
48630144|NCT00977197|101878508|FG000|COMPLETED|Overall Study||32||
48630145|NCT00977197|101878509|FG001|COMPLETED|Overall Study||35||
48630146|NCT00977197|101878508|FG000|NOT COMPLETED|Overall Study||9||
48630147|NCT00977197|101878509|FG001|NOT COMPLETED|Overall Study||9||
48630148|NCT00943436|101878510|FG000|STARTED|Exercise Session: 45 Minutes of Activity||10||
48630149|NCT00943436|101878511|FG001|STARTED|Exercise Session: 45 Minutes of Activity||10||
48630150|NCT00943436|101878510|FG000|COMPLETED|Exercise Session: 45 Minutes of Activity||10||
48630151|NCT00943436|101878511|FG001|COMPLETED|Exercise Session: 45 Minutes of Activity||10||
48630152|NCT00943436|101878510|FG000|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0||
48630153|NCT00943436|101878511|FG001|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0||
48630154|NCT00943436|101878510|FG000|STARTED|Rest Session: 45 Minutes of Reading||10||
48630155|NCT00943436|101878511|FG001|STARTED|Rest Session: 45 Minutes of Reading||10||
48630156|NCT00943436|101878510|FG000|COMPLETED|Rest Session: 45 Minutes of Reading||10||
48630157|NCT00943436|101878511|FG001|COMPLETED|Rest Session: 45 Minutes of Reading||10||
48630158|NCT00943436|101878510|FG000|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0||
48630159|NCT00943436|101878511|FG001|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0||
48630160|NCT02756910|101878512|FG000|STARTED|Overall Study||80||
48630161|NCT02756910|101878512|FG000|COMPLETED|Overall Study||80||
48630162|NCT02756910|101878512|FG000|NOT COMPLETED|Overall Study||0||
48630163|NCT01125098|101878513|FG000|STARTED|Overall Study||91||
48630164|NCT01125098|101878514|FG001|STARTED|Overall Study||90||
48630165|NCT01125098|101878513|FG000|COMPLETED|Overall Study||88||
48630166|NCT01125098|101878514|FG001|COMPLETED|Overall Study||90||
48630167|NCT01125098|101878513|FG000|NOT COMPLETED|Overall Study||3||
48630168|NCT01125098|101878514|FG001|NOT COMPLETED|Overall Study||0||
48630169|NCT00526474|101878515|FG000|STARTED|Overall Study||13224||
48630170|NCT00526474|101878516|FG001|STARTED|Overall Study||13225||
48630171|NCT00526474|101878515|FG000|Received Study Drug|Overall Study||13166||
48630172|NCT00526474|101878516|FG001|Received Study Drug|Overall Study||13186||
48630173|NCT00526474|101878515|FG000|COMPLETED|Overall Study||12932||
48630174|NCT00526474|101878516|FG001|COMPLETED|Overall Study||12953||
48630175|NCT00526474|101878515|FG000|NOT COMPLETED|Overall Study||292||
48630176|NCT00526474|101878516|FG001|NOT COMPLETED|Overall Study||272||
48630177|NCT03720119|101878517|FG000|STARTED|Overall Study||78||
48630178|NCT03720119|101878517|FG000|COMPLETED|Overall Study||69||
48630179|NCT03720119|101878517|FG000|NOT COMPLETED|Overall Study||9||
48630180|NCT01621009|101878518|FG000|STARTED|Overall Study||113||
48630181|NCT01621009|101878519|FG001|STARTED|Overall Study||116||
48630182|NCT01621009|101878520|FG002|STARTED|Overall Study||121||
48630183|NCT01621009|101878521|FG003|STARTED|Overall Study||113||
48630184|NCT01621009|101878518|FG000|COMPLETED|Overall Study||70||
48630185|NCT01621009|101878519|FG001|COMPLETED|Overall Study||65||
48630186|NCT01621009|101878520|FG002|COMPLETED|Overall Study||58||
48630187|NCT01621009|101878521|FG003|COMPLETED|Overall Study||60||
48630188|NCT01621009|101878518|FG000|NOT COMPLETED|Overall Study||43||
48630189|NCT01621009|101878519|FG001|NOT COMPLETED|Overall Study||51||
48630190|NCT01621009|101878520|FG002|NOT COMPLETED|Overall Study||63||
48630191|NCT01621009|101878521|FG003|NOT COMPLETED|Overall Study||53||
48630192|NCT02431598|101878522|FG000|STARTED|Overall Study||6||
48630193|NCT02431598|101878523|FG001|STARTED|Overall Study||9||
48630194|NCT02431598|101878524|FG002|STARTED|Overall Study||9||
48630195|NCT02431598|101878525|FG003|STARTED|Overall Study||7||
48175721|NCT01722318|100753794|FG003|STARTED|Overall Study||85||
48175722|NCT01722318|100753795|FG004|STARTED|Overall Study||86||
48175723|NCT01722318|100753791|FG000|COMPLETED|Overall Study||72||
48175724|NCT01722318|100753792|FG001|COMPLETED|Overall Study||65||
48752996|NCT02831764|102184379|FG002|COMPLETED|Double-blind Phase (Day1 to Week 96)||0||
48630196|NCT02431598|101878526|FG004|STARTED|Overall Study||7||
48630197|NCT02431598|101878527|FG005|STARTED|Overall Study||6||
48630198|NCT02431598|101878522|FG000|COMPLETED|Overall Study||6||
48630199|NCT02431598|101878523|FG001|COMPLETED|Overall Study||9||
48630200|NCT02431598|101878524|FG002|COMPLETED|Overall Study||9||
48630201|NCT02431598|101878525|FG003|COMPLETED|Overall Study||7||
48630202|NCT02431598|101878526|FG004|COMPLETED|Overall Study||7||
48630203|NCT02431598|101878527|FG005|COMPLETED|Overall Study||6||
48630204|NCT02431598|101878522|FG000|NOT COMPLETED|Overall Study||0||
48630205|NCT02431598|101878523|FG001|NOT COMPLETED|Overall Study||0||
48630206|NCT02431598|101878524|FG002|NOT COMPLETED|Overall Study||0||
48630207|NCT02431598|101878525|FG003|NOT COMPLETED|Overall Study||0||
48630208|NCT02431598|101878526|FG004|NOT COMPLETED|Overall Study||0||
48630209|NCT02431598|101878527|FG005|NOT COMPLETED|Overall Study||0||
48630210|NCT02465450|101878528|FG000|STARTED|Treatment Period 1||26||
48630211|NCT02465450|101878529|FG001|STARTED|Treatment Period 1||24||
48630212|NCT02465450|101878530|FG002|STARTED|Treatment Period 1||35||
48630213|NCT02465450|101878531|FG003|STARTED|Treatment Period 1||0||
48752997|NCT02831764|102184380|FG003|COMPLETED|Double-blind Phase (Day1 to Week 96)||0||
48752998|NCT02831764|102184381|FG004|COMPLETED|Double-blind Phase (Day1 to Week 96)||0||
48752999|NCT02831764|102184377|FG000|NOT COMPLETED|Double-blind Phase (Day1 to Week 96)||41||
48753000|NCT02831764|102184378|FG001|NOT COMPLETED|Double-blind Phase (Day1 to Week 96)||35||
48753001|NCT02831764|102184379|FG002|NOT COMPLETED|Double-blind Phase (Day1 to Week 96)||0||
48753002|NCT02831764|102184380|FG003|NOT COMPLETED|Double-blind Phase (Day1 to Week 96)||0||
48753003|NCT02831764|102184381|FG004|NOT COMPLETED|Double-blind Phase (Day1 to Week 96)||0||
48753004|NCT02831764|102184377|FG000|STARTED|Open-label Phase (Week 96 to Week 148)||0||
48175725|NCT01722318|100753793|FG002|COMPLETED|Overall Study||66||
48175726|NCT01722318|100753794|FG003|COMPLETED|Overall Study||65||
48175727|NCT01722318|100753795|FG004|COMPLETED|Overall Study||68||
48175728|NCT01722318|100753791|FG000|NOT COMPLETED|Overall Study||14||
48175729|NCT01722318|100753792|FG001|NOT COMPLETED|Overall Study||20||
48175730|NCT01722318|100753793|FG002|NOT COMPLETED|Overall Study||20||
48175731|NCT01722318|100753794|FG003|NOT COMPLETED|Overall Study||20||
48412561|NCT02355665|101342034|FG000|STARTED|Overall Study||601||
48630214|NCT02465450|101878532|FG004|STARTED|Treatment Period 1||0||
48753005|NCT02831764|102184378|FG001|STARTED|Open-label Phase (Week 96 to Week 148)||0||
48753006|NCT02831764|102184379|FG002|STARTED|Open-label Phase (Week 96 to Week 148)||319||
48753007|NCT02831764|102184380|FG003|STARTED|Open-label Phase (Week 96 to Week 148)||327||
48753008|NCT02831764|102184381|FG004|STARTED|Open-label Phase (Week 96 to Week 148)||0||
48753009|NCT02831764|102184377|FG000|COMPLETED|Open-label Phase (Week 96 to Week 148)||0||
48753010|NCT02831764|102184378|FG001|COMPLETED|Open-label Phase (Week 96 to Week 148)||0||
48753011|NCT02831764|102184379|FG002|COMPLETED|Open-label Phase (Week 96 to Week 148)||301||
48753012|NCT02831764|102184380|FG003|COMPLETED|Open-label Phase (Week 96 to Week 148)||300||
48753013|NCT02831764|102184381|FG004|COMPLETED|Open-label Phase (Week 96 to Week 148)||0||
48753014|NCT02831764|102184377|FG000|NOT COMPLETED|Open-label Phase (Week 96 to Week 148)||0||
48753015|NCT02831764|102184378|FG001|NOT COMPLETED|Open-label Phase (Week 96 to Week 148)||0||
48753016|NCT02831764|102184379|FG002|NOT COMPLETED|Open-label Phase (Week 96 to Week 148)||18||
48753017|NCT02831764|102184380|FG003|NOT COMPLETED|Open-label Phase (Week 96 to Week 148)||27||
48753018|NCT02831764|102184381|FG004|NOT COMPLETED|Open-label Phase (Week 96 to Week 148)||0||
48630215|NCT02465450|101878533|FG005|STARTED|Treatment Period 1||0||
48630216|NCT02465450|101878528|FG000|COMPLETED|Treatment Period 1||24||
48630217|NCT02465450|101878529|FG001|COMPLETED|Treatment Period 1||23||
48630218|NCT02465450|101878530|FG002|COMPLETED|Treatment Period 1||34||
48630219|NCT02465450|101878531|FG003|COMPLETED|Treatment Period 1||0||
48630220|NCT02465450|101878532|FG004|COMPLETED|Treatment Period 1||0||
48630221|NCT02465450|101878533|FG005|COMPLETED|Treatment Period 1||0||
48630222|NCT02465450|101878528|FG000|NOT COMPLETED|Treatment Period 1||2||
48630223|NCT02465450|101878529|FG001|NOT COMPLETED|Treatment Period 1||1||
48630224|NCT02465450|101878530|FG002|NOT COMPLETED|Treatment Period 1||1||
48753019|NCT02831764|102184377|FG000|STARTED|Continuation Phase(Week 148 to Week 280)||0||
48175732|NCT01722318|100753795|FG004|NOT COMPLETED|Overall Study||18||
48175733|NCT00840996|100753796|FG000|STARTED|Overall Study||58||
48175734|NCT00840996|100753797|FG001|STARTED|Overall Study||58||
48175735|NCT00840996|100753796|FG000|COMPLETED|Overall Study||57||
48175736|NCT00840996|100753797|FG001|COMPLETED|Overall Study||58||
48175737|NCT00840996|100753796|FG000|NOT COMPLETED|Overall Study||1||
48175738|NCT00840996|100753797|FG001|NOT COMPLETED|Overall Study||0||
48175739|NCT01254305|100753798|FG000|STARTED|Overall Study||93||
48175740|NCT01254305|100753799|FG001|STARTED|Overall Study||90||
48175741|NCT01254305|100753800|FG002|STARTED|Overall Study||79||
48175742|NCT01254305|100753798|FG000|Safety Population|Overall Study||89||
48175743|NCT01254305|100753799|FG001|Safety Population|Overall Study||85||
48175744|NCT01254305|100753800|FG002|Safety Population|Overall Study||77||
48175745|NCT01254305|100753798|FG000|COMPLETED|Overall Study||71||
48175746|NCT01254305|100753799|FG001|COMPLETED|Overall Study||72||
48175747|NCT01254305|100753800|FG002|COMPLETED|Overall Study||62||
48175748|NCT01254305|100753798|FG000|NOT COMPLETED|Overall Study||22||
48412562|NCT02355665|101342035|FG001|STARTED|Overall Study||597||
48412563|NCT02355665|101342034|FG000|COMPLETED|Overall Study||352||
48412564|NCT02355665|101342035|FG001|COMPLETED|Overall Study||365||
48412565|NCT02355665|101342034|FG000|NOT COMPLETED|Overall Study||249||
48412566|NCT02355665|101342035|FG001|NOT COMPLETED|Overall Study||232||
48412567|NCT01662986|101342036|FG000|STARTED|Overall Study||40||
48412568|NCT01662986|101342037|FG001|STARTED|Overall Study||39||
48412569|NCT01662986|101342036|FG000|COMPLETED|Overall Study||22||
48412570|NCT01662986|101342037|FG001|COMPLETED|Overall Study||26||
48412571|NCT01662986|101342036|FG000|NOT COMPLETED|Overall Study||18||
48412572|NCT01662986|101342037|FG001|NOT COMPLETED|Overall Study||13||
48412573|NCT02782364|101342038|FG000|STARTED|Overall Study||18||
48412574|NCT02782364|101342039|FG001|STARTED|Overall Study||18||
48412575|NCT02782364|101342038|FG000|COMPLETED|Overall Study||18||
48175749|NCT01254305|100753799|FG001|NOT COMPLETED|Overall Study||18||
48175750|NCT01254305|100753800|FG002|NOT COMPLETED|Overall Study||17||
48175751|NCT00229619|100753801|FG000|STARTED|Overall Study||11||
48175752|NCT00229619|100753801|FG000|COMPLETED|Overall Study||11||
48175753|NCT00229619|100753801|FG000|NOT COMPLETED|Overall Study||0||
48175754|NCT01614847|100753802|FG000|STARTED|Day 1||4||
48175755|NCT01614847|100753803|FG001|STARTED|Day 1||4||
48175756|NCT01614847|100753802|FG000|COMPLETED|Day 1||4||
48175757|NCT01614847|100753803|FG001|COMPLETED|Day 1||4||
48175758|NCT01614847|100753802|FG000|NOT COMPLETED|Day 1||0||
48175759|NCT01614847|100753803|FG001|NOT COMPLETED|Day 1||0||
48175760|NCT01614847|100753802|FG000|STARTED|Day 2 (24 Hours Later)||4||
48175761|NCT01614847|100753803|FG001|STARTED|Day 2 (24 Hours Later)||4||
48175762|NCT01614847|100753802|FG000|COMPLETED|Day 2 (24 Hours Later)||4||
48175763|NCT01614847|100753803|FG001|COMPLETED|Day 2 (24 Hours Later)||4||
48175764|NCT01614847|100753802|FG000|NOT COMPLETED|Day 2 (24 Hours Later)||0||
48336444|NCT00592475|101152049|FG000|COMPLETED|Overall Study||6||
48336445|NCT00592475|101152050|FG001|COMPLETED|Overall Study||9||
48336446|NCT00592475|101152051|FG002|COMPLETED|Overall Study||5||
48336447|NCT00592475|101152049|FG000|NOT COMPLETED|Overall Study||0||
48336448|NCT00592475|101152050|FG001|NOT COMPLETED|Overall Study||0||
48336449|NCT00592475|101152051|FG002|NOT COMPLETED|Overall Study||0||
48336450|NCT01542645|101152052|FG000|STARTED|Overall Study||82||
48336451|NCT01542645|101152053|FG001|STARTED|Overall Study||82||
48336452|NCT01542645|101152052|FG000|COMPLETED|Overall Study||77||
48336453|NCT01542645|101152053|FG001|COMPLETED|Overall Study||79||
48336454|NCT01542645|101152052|FG000|NOT COMPLETED|Overall Study||5||
48336455|NCT01542645|101152053|FG001|NOT COMPLETED|Overall Study||3||
48336456|NCT01551979|101152054|FG000|STARTED|Overall Study||10||
48336457|NCT01551979|101152055|FG001|STARTED|Overall Study||7||
48336458|NCT01551979|101152054|FG000|Last Day of Treatment (After 5 Days)|Overall Study||10||
48336459|NCT01551979|101152055|FG001|Last Day of Treatment (After 5 Days)|Overall Study||7||
48336460|NCT01551979|101152054|FG000|1 Week Post Treatment|Overall Study||10||
48336461|NCT01551979|101152055|FG001|1 Week Post Treatment|Overall Study||6||
48336462|NCT01551979|101152054|FG000|COMPLETED|Overall Study||8||
48336463|NCT01551979|101152055|FG001|COMPLETED|Overall Study||5||
48336464|NCT01551979|101152054|FG000|NOT COMPLETED|Overall Study||2||
48336465|NCT01551979|101152055|FG001|NOT COMPLETED|Overall Study||2||
48336466|NCT02685709|101152056|FG000|STARTED|Run-in Phase||146||
48336467|NCT02685709|101152057|FG001|STARTED|Run-in Phase||0||
48336468|NCT02685709|101152058|FG002|STARTED|Run-in Phase||0||
48412576|NCT02782364|101342039|FG001|COMPLETED|Overall Study||18||
48412577|NCT02782364|101342038|FG000|NOT COMPLETED|Overall Study||0||
48412578|NCT02782364|101342039|FG001|NOT COMPLETED|Overall Study||0||
48412579|NCT00394654|101342040|FG000|STARTED|Overall Study||15||
48412580|NCT00394654|101342041|FG001|STARTED|Overall Study||15||
48412581|NCT00394654|101342040|FG000|COMPLETED|Overall Study||13||
48412582|NCT00394654|101342041|FG001|COMPLETED|Overall Study||15||
48412583|NCT00394654|101342040|FG000|NOT COMPLETED|Overall Study||2||
48412584|NCT00394654|101342041|FG001|NOT COMPLETED|Overall Study||0||
48412585|NCT00442611|101342042|FG000|STARTED|Overall Study||7||
48175765|NCT01614847|100753803|FG001|NOT COMPLETED|Day 2 (24 Hours Later)||0||
48175766|NCT01900054|100753804|FG000|STARTED|Overall Study||58||
48175767|NCT01900054|100753804|FG000|COMPLETED|Overall Study||56||
48336469|NCT02685709|101152059|FG003|STARTED|Run-in Phase||0||
48336470|NCT02685709|101152056|FG000|COMPLETED|Run-in Phase||116||
48336471|NCT02685709|101152057|FG001|COMPLETED|Run-in Phase||0||
48630225|NCT02465450|101878531|FG003|NOT COMPLETED|Treatment Period 1||0||
48175768|NCT01900054|100753804|FG000|NOT COMPLETED|Overall Study||2||
48175769|NCT03864926|100753805|FG000|STARTED|Overall Study||50||
48175770|NCT03864926|100753806|FG001|STARTED|Overall Study||50||
48175771|NCT03864926|100753805|FG000|COMPLETED|Overall Study||50||
48336472|NCT02685709|101152058|FG002|COMPLETED|Run-in Phase||0||
48336473|NCT02685709|101152059|FG003|COMPLETED|Run-in Phase||0||
48412586|NCT00442611|101342043|FG001|STARTED|Overall Study||3||
48412587|NCT00442611|101342042|FG000|COMPLETED|Overall Study||6||
48412588|NCT00442611|101342043|FG001|COMPLETED|Overall Study||3||
48412589|NCT00442611|101342042|FG000|NOT COMPLETED|Overall Study||1||
48412590|NCT00442611|101342043|FG001|NOT COMPLETED|Overall Study||0||
48412591|NCT01784211|101342044|FG000|STARTED|Part A (Days 1-15)||38||
48412592|NCT01784211|101342045|FG001|STARTED|Part A (Days 1-15)||38||
48412593|NCT01784211|101342046|FG002|STARTED|Part A (Days 1-15)||0||
48412594|NCT01784211|101342047|FG003|STARTED|Part A (Days 1-15)||0||
48412595|NCT01784211|101342048|FG004|STARTED|Part A (Days 1-15)||0||
48412596|NCT01784211|101342049|FG005|STARTED|Part A (Days 1-15)||0||
48412597|NCT01784211|101342044|FG000|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||37||
48412598|NCT01784211|101342045|FG001|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||38||
48412599|NCT01784211|101342046|FG002|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0||
48412600|NCT01784211|101342047|FG003|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0||
48412601|NCT01784211|101342048|FG004|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0||
48412602|NCT01784211|101342049|FG005|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0||
48412603|NCT01784211|101342044|FG000|Entered Part B|Part A (Days 1-15)||19||
48412604|NCT01784211|101342045|FG001|Entered Part B|Part A (Days 1-15)||21||
48412605|NCT01784211|101342046|FG002|Entered Part B|Part A (Days 1-15)||0||
48412606|NCT01784211|101342047|FG003|Entered Part B|Part A (Days 1-15)||0||
48412607|NCT01784211|101342048|FG004|Entered Part B|Part A (Days 1-15)||0||
48412608|NCT01784211|101342049|FG005|Entered Part B|Part A (Days 1-15)||0||
48412609|NCT01784211|101342044|FG000|COMPLETED|Part A (Days 1-15)||35||
48412610|NCT01784211|101342045|FG001|COMPLETED|Part A (Days 1-15)||36||
48412611|NCT01784211|101342046|FG002|COMPLETED|Part A (Days 1-15)||0||
48412612|NCT01784211|101342047|FG003|COMPLETED|Part A (Days 1-15)||0||
48412613|NCT01784211|101342048|FG004|COMPLETED|Part A (Days 1-15)||0||
48412614|NCT01784211|101342049|FG005|COMPLETED|Part A (Days 1-15)||0||
48412615|NCT01784211|101342044|FG000|NOT COMPLETED|Part A (Days 1-15)||3||
48630226|NCT02465450|101878532|FG004|NOT COMPLETED|Treatment Period 1||0||
48630227|NCT02465450|101878533|FG005|NOT COMPLETED|Treatment Period 1||0||
48630228|NCT02465450|101878528|FG000|STARTED|Treatment Period 2||0||
48412616|NCT01784211|101342045|FG001|NOT COMPLETED|Part A (Days 1-15)||2||
48412617|NCT01784211|101342046|FG002|NOT COMPLETED|Part A (Days 1-15)||0||
48412618|NCT01784211|101342047|FG003|NOT COMPLETED|Part A (Days 1-15)||0||
48412619|NCT01784211|101342048|FG004|NOT COMPLETED|Part A (Days 1-15)||0||
48412620|NCT01784211|101342049|FG005|NOT COMPLETED|Part A (Days 1-15)||0||
48412621|NCT01784211|101342044|FG000|STARTED|Part B (Days 16-21)||0||
48412622|NCT01784211|101342045|FG001|STARTED|Part B (Days 16-21)||0||
48412623|NCT01784211|101342046|FG002|STARTED|Part B (Days 16-21)||10||
48412624|NCT01784211|101342047|FG003|STARTED|Part B (Days 16-21)||9||
48412625|NCT01784211|101342048|FG004|STARTED|Part B (Days 16-21)||11||
48412626|NCT01784211|101342049|FG005|STARTED|Part B (Days 16-21)||10||
48412627|NCT01784211|101342044|FG000|COMPLETED|Part B (Days 16-21)||0||
48412628|NCT01784211|101342045|FG001|COMPLETED|Part B (Days 16-21)||0||
48412629|NCT01784211|101342046|FG002|COMPLETED|Part B (Days 16-21)||10||
48412630|NCT01784211|101342047|FG003|COMPLETED|Part B (Days 16-21)||9||
48412631|NCT01784211|101342048|FG004|COMPLETED|Part B (Days 16-21)||11||
48412632|NCT01784211|101342049|FG005|COMPLETED|Part B (Days 16-21)||10||
48412633|NCT01784211|101342044|FG000|NOT COMPLETED|Part B (Days 16-21)||0||
48412634|NCT01784211|101342045|FG001|NOT COMPLETED|Part B (Days 16-21)||0||
48630229|NCT02465450|101878529|FG001|STARTED|Treatment Period 2||0||
48630230|NCT02465450|101878530|FG002|STARTED|Treatment Period 2||0||
48630231|NCT02465450|101878531|FG003|STARTED|Treatment Period 2||30||
48630232|NCT02465450|101878532|FG004|STARTED|Treatment Period 2||28||
48753020|NCT02831764|102184378|FG001|STARTED|Continuation Phase(Week 148 to Week 280)||0||
48412635|NCT01784211|101342046|FG002|NOT COMPLETED|Part B (Days 16-21)||0||
48412636|NCT01784211|101342047|FG003|NOT COMPLETED|Part B (Days 16-21)||0||
48412637|NCT01784211|101342048|FG004|NOT COMPLETED|Part B (Days 16-21)||0||
48412638|NCT01784211|101342049|FG005|NOT COMPLETED|Part B (Days 16-21)||0||
48412639|NCT02087241|101342050|FG000|STARTED|Overall Study||3||
48412640|NCT02087241|101342051|FG001|STARTED|Overall Study||3||
48412641|NCT02087241|101342052|FG002|STARTED|Overall Study||1||
48412642|NCT02087241|101342053|FG003|STARTED|Overall Study||7||
48412643|NCT02087241|101342050|FG000|COMPLETED|Overall Study||0||
48412644|NCT02087241|101342051|FG001|COMPLETED|Overall Study||0||
48412645|NCT02087241|101342052|FG002|COMPLETED|Overall Study||0||
48412646|NCT02087241|101342053|FG003|COMPLETED|Overall Study||0||
48412647|NCT02087241|101342050|FG000|NOT COMPLETED|Overall Study||3||
48412648|NCT02087241|101342051|FG001|NOT COMPLETED|Overall Study||3||
48412649|NCT02087241|101342052|FG002|NOT COMPLETED|Overall Study||1||
48412650|NCT02087241|101342053|FG003|NOT COMPLETED|Overall Study||7||
48412651|NCT02005211|101342054|FG000|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6||
48412652|NCT02005211|101342055|FG001|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6||
48412653|NCT02005211|101342056|FG002|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6||
48412654|NCT02005211|101342057|FG003|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6||
48630233|NCT02465450|101878533|FG005|STARTED|Treatment Period 2||23||
48753021|NCT02831764|102184379|FG002|STARTED|Continuation Phase(Week 148 to Week 280)||0||
48630234|NCT02465450|101878528|FG000|COMPLETED|Treatment Period 2||0||
48412655|NCT02005211|101342058|FG004|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0||
48412656|NCT02005211|101342059|FG005|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0||
48412657|NCT02005211|101342060|FG006|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0||
48412658|NCT02005211|101342054|FG000|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6||
48412659|NCT02005211|101342055|FG001|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6||
48412660|NCT02005211|101342056|FG002|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6||
48753022|NCT02831764|102184380|FG003|STARTED|Continuation Phase(Week 148 to Week 280)||0||
48753023|NCT02831764|102184381|FG004|STARTED|Continuation Phase(Week 148 to Week 280)||252||
48753024|NCT02831764|102184377|FG000|COMPLETED|Continuation Phase(Week 148 to Week 280)||0||
48753025|NCT02831764|102184378|FG001|COMPLETED|Continuation Phase(Week 148 to Week 280)||0||
48753026|NCT02831764|102184379|FG002|COMPLETED|Continuation Phase(Week 148 to Week 280)||0||
48753027|NCT02831764|102184380|FG003|COMPLETED|Continuation Phase(Week 148 to Week 280)||0||
48630235|NCT02465450|101878529|FG001|COMPLETED|Treatment Period 2||0||
48630236|NCT02465450|101878530|FG002|COMPLETED|Treatment Period 2||0||
48630237|NCT02465450|101878531|FG003|COMPLETED|Treatment Period 2||27||
48630238|NCT02465450|101878532|FG004|COMPLETED|Treatment Period 2||24||
48630239|NCT02465450|101878533|FG005|COMPLETED|Treatment Period 2||23||
48630240|NCT02465450|101878528|FG000|NOT COMPLETED|Treatment Period 2||0||
48753028|NCT02831764|102184381|FG004|COMPLETED|Continuation Phase(Week 148 to Week 280)||239||
48753029|NCT02831764|102184377|FG000|NOT COMPLETED|Continuation Phase(Week 148 to Week 280)||0||
48753030|NCT02831764|102184378|FG001|NOT COMPLETED|Continuation Phase(Week 148 to Week 280)||0||
48175772|NCT03864926|100753806|FG001|COMPLETED|Overall Study||48||
48175773|NCT03864926|100753805|FG000|NOT COMPLETED|Overall Study||0||
48175774|NCT03864926|100753806|FG001|NOT COMPLETED|Overall Study||2||
48175775|NCT01700348|100753807|FG000|STARTED|Overall Study||116||
48412661|NCT02005211|101342057|FG003|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6||
48412662|NCT02005211|101342058|FG004|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0||
48412663|NCT02005211|101342059|FG005|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0||
48412664|NCT02005211|101342060|FG006|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0||
48412665|NCT02005211|101342054|FG000|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0||
48412666|NCT02005211|101342055|FG001|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0||
48412667|NCT02005211|101342056|FG002|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0||
48412668|NCT02005211|101342057|FG003|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0||
48412669|NCT02005211|101342058|FG004|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0||
48412670|NCT02005211|101342059|FG005|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0||
48412671|NCT02005211|101342060|FG006|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0||
48630241|NCT02465450|101878529|FG001|NOT COMPLETED|Treatment Period 2||0||
48630242|NCT02465450|101878530|FG002|NOT COMPLETED|Treatment Period 2||0||
48630243|NCT02465450|101878531|FG003|NOT COMPLETED|Treatment Period 2||3||
48630244|NCT02465450|101878532|FG004|NOT COMPLETED|Treatment Period 2||4||
48753031|NCT02831764|102184379|FG002|NOT COMPLETED|Continuation Phase(Week 148 to Week 280)||0||
48753032|NCT02831764|102184380|FG003|NOT COMPLETED|Continuation Phase(Week 148 to Week 280)||0||
48175776|NCT01700348|100753807|FG000|COMPLETED|Overall Study||93||
48175777|NCT01700348|100753807|FG000|NOT COMPLETED|Overall Study||23||
48175778|NCT01729728|100753808|FG000|STARTED|Overall Study||21||
48175779|NCT01729728|100753809|FG001|STARTED|Overall Study||28||
48175780|NCT01729728|100753810|FG002|STARTED|Overall Study||17||
48175781|NCT01729728|100753808|FG000|COMPLETED|Overall Study||20||
48630245|NCT02465450|101878533|FG005|NOT COMPLETED|Treatment Period 2||0||
48630246|NCT00641563|101878534|FG000|STARTED|Infusion 1||5||
48630247|NCT00641563|101878535|FG001|STARTED|Infusion 1||5||
48175782|NCT01729728|100753809|FG001|COMPLETED|Overall Study||22||
48175783|NCT01729728|100753810|FG002|COMPLETED|Overall Study||16||
48175784|NCT01729728|100753808|FG000|NOT COMPLETED|Overall Study||1||
48175785|NCT01729728|100753809|FG001|NOT COMPLETED|Overall Study||6||
48412672|NCT02005211|101342054|FG000|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0||
48412673|NCT02005211|101342055|FG001|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0||
48412674|NCT02005211|101342056|FG002|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0||
48412675|NCT02005211|101342057|FG003|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0||
48412676|NCT02005211|101342058|FG004|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6||
48412677|NCT02005211|101342059|FG005|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6||
48412678|NCT02005211|101342060|FG006|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||4||
48412679|NCT02005211|101342054|FG000|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0||
48630248|NCT00641563|101878534|FG000|COMPLETED|Infusion 1||5||
48630249|NCT00641563|101878535|FG001|COMPLETED|Infusion 1||5||
48175786|NCT01729728|100753810|FG002|NOT COMPLETED|Overall Study||1||
48175787|NCT02087150|100753811|FG000|STARTED|Overall Study||81||
48175788|NCT02087150|100753812|FG001|STARTED|Overall Study||162||
48175789|NCT02087150|100753813|FG002|STARTED|Overall Study||80||
48175790|NCT02087150|100753811|FG000|Had a Lead-in or Randomized ETBC Proc|Overall Study||80||
48175791|NCT02087150|100753812|FG001|Had a Lead-in or Randomized ETBC Proc|Overall Study||149||
48175792|NCT02087150|100753813|FG002|Had a Lead-in or Randomized ETBC Proc|Overall Study||0||
48630250|NCT00641563|101878534|FG000|NOT COMPLETED|Infusion 1||0||
48630251|NCT00641563|101878535|FG001|NOT COMPLETED|Infusion 1||0||
48630252|NCT00641563|101878534|FG000|STARTED|Infusion 2||5||
48175793|NCT02087150|100753811|FG000|Received a Crossover MM ETBC Procedure|Overall Study||0||
48175794|NCT02087150|100753812|FG001|Received a Crossover MM ETBC Procedure|Overall Study||0||
48175795|NCT02087150|100753813|FG002|Received a Crossover MM ETBC Procedure|Overall Study||70||
48175796|NCT02087150|100753811|FG000|COMPLETED|Overall Study||71||
48175797|NCT02087150|100753812|FG001|COMPLETED|Overall Study||128||
48175798|NCT02087150|100753813|FG002|COMPLETED|Overall Study||69||
48175799|NCT02087150|100753811|FG000|NOT COMPLETED|Overall Study||10||
48175800|NCT02087150|100753812|FG001|NOT COMPLETED|Overall Study||34||
48630253|NCT00641563|101878535|FG001|STARTED|Infusion 2||5||
48630254|NCT00641563|101878534|FG000|COMPLETED|Infusion 2||5||
48630255|NCT00641563|101878535|FG001|COMPLETED|Infusion 2||5||
48175801|NCT02087150|100753813|FG002|NOT COMPLETED|Overall Study||11||
48175802|NCT00850720|100753814|FG000|STARTED|Overall Study||0||
48630256|NCT00641563|101878534|FG000|NOT COMPLETED|Infusion 2||0||
48630257|NCT00641563|101878535|FG001|NOT COMPLETED|Infusion 2||0||
48630258|NCT00183339|101878536|FG000|STARTED|Overall Study||10||
48630259|NCT00183339|101878537|FG001|STARTED|Overall Study||8||
48630260|NCT00183339|101878536|FG000|COMPLETED|Overall Study||4||
48630261|NCT00183339|101878537|FG001|COMPLETED|Overall Study||4||
48630262|NCT00183339|101878536|FG000|NOT COMPLETED|Overall Study||6||
48630263|NCT00183339|101878537|FG001|NOT COMPLETED|Overall Study||4||
48630264|NCT01699750|101878538|FG000|STARTED|Overall Study||34||
48630265|NCT01699750|101878539|FG001|STARTED|Overall Study||36||
48630266|NCT01699750|101878538|FG000|COMPLETED|Overall Study||34||
48630267|NCT01699750|101878539|FG001|COMPLETED|Overall Study||33||
48630268|NCT01699750|101878538|FG000|NOT COMPLETED|Overall Study||0||
48630269|NCT01699750|101878539|FG001|NOT COMPLETED|Overall Study||3||
48630270|NCT00611806|101878540|FG000|STARTED|Overall Study||94||
48630271|NCT00611806|101878541|FG001|STARTED|Overall Study||46||
48630272|NCT00611806|101878540|FG000|COMPLETED|Overall Study||78||
48630273|NCT00611806|101878541|FG001|COMPLETED|Overall Study||43||
48630274|NCT00611806|101878540|FG000|NOT COMPLETED|Overall Study||16||
48753033|NCT02831764|102184381|FG004|NOT COMPLETED|Continuation Phase(Week 148 to Week 280)||13||
48753034|NCT00074165|102184382|FG000|STARTED|Overall Study||17||
48630275|NCT00611806|101878541|FG001|NOT COMPLETED|Overall Study||3||
48630276|NCT04584788|101878542|FG000|STARTED|Overall Study||37||
48630277|NCT04584788|101878542|FG000|COMPLETED|Overall Study||25||
48753035|NCT00074165|102184382|FG000|COMPLETED|Overall Study||17||
48753036|NCT00074165|102184382|FG000|NOT COMPLETED|Overall Study||0||
48753037|NCT00311766|102184383|FG000|STARTED|Overall Study||8||
48175803|NCT00850720|100753814|FG000|COMPLETED|Overall Study||0||
48175804|NCT00850720|100753814|FG000|NOT COMPLETED|Overall Study||0||
48175805|NCT05418777|100753815|FG000|STARTED|Overall Study||1||
48175806|NCT05418777|100753816|FG001|STARTED|Overall Study||0||
48175807|NCT05418777|100753815|FG000|COMPLETED|Overall Study||1||
48175808|NCT05418777|100753816|FG001|COMPLETED|Overall Study||0||
48175809|NCT05418777|100753815|FG000|NOT COMPLETED|Overall Study||0||
48175810|NCT05418777|100753816|FG001|NOT COMPLETED|Overall Study||0||
48175811|NCT01734850|100753817|FG000|STARTED|Overall Study||4||
48175812|NCT01734850|100753818|FG001|STARTED|Overall Study||4||
48175813|NCT01734850|100753819|FG002|STARTED|Overall Study||5||
48175814|NCT01734850|100753817|FG000|COMPLETED|Overall Study||1||
48175815|NCT01734850|100753818|FG001|COMPLETED|Overall Study||2||
48175816|NCT01734850|100753819|FG002|COMPLETED|Overall Study||1||
48336474|NCT02685709|101152056|FG000|NOT COMPLETED|Run-in Phase||30||
48336475|NCT02685709|101152057|FG001|NOT COMPLETED|Run-in Phase||0||
48336476|NCT02685709|101152058|FG002|NOT COMPLETED|Run-in Phase||0||
48336477|NCT02685709|101152059|FG003|NOT COMPLETED|Run-in Phase||0||
48336478|NCT02685709|101152056|FG000|STARTED|RCT Phase||0||
48336479|NCT02685709|101152057|FG001|STARTED|RCT Phase||55||
48336480|NCT02685709|101152058|FG002|STARTED|RCT Phase||37||
48175817|NCT01734850|100753817|FG000|NOT COMPLETED|Overall Study||3||
48175818|NCT01734850|100753818|FG001|NOT COMPLETED|Overall Study||2||
48175819|NCT01734850|100753819|FG002|NOT COMPLETED|Overall Study||4||
48175820|NCT04374500|100753820|FG000|STARTED|Overall Study||10|Recruitment and study procedures in all protocols were performed in 2006|
48175821|NCT04374500|100753821|FG001|STARTED|Overall Study||10|Recruitment and study procedures in all protocols were performed in 2006|
48175822|NCT04374500|100753822|FG002|STARTED|Overall Study||83|Recruitment and study procedures in all protocols were performed in 2006|
48175823|NCT04374500|100753820|FG000|COMPLETED|Overall Study||10||
48175824|NCT04374500|100753821|FG001|COMPLETED|Overall Study||10||
48175825|NCT04374500|100753822|FG002|COMPLETED|Overall Study||83||
48175826|NCT04374500|100753820|FG000|NOT COMPLETED|Overall Study||0||
48175827|NCT04374500|100753821|FG001|NOT COMPLETED|Overall Study||0||
48336481|NCT02685709|101152059|FG003|STARTED|RCT Phase||0||
48336482|NCT02685709|101152056|FG000|COMPLETED|RCT Phase||0||
48336483|NCT02685709|101152057|FG001|COMPLETED|RCT Phase||54||
48336484|NCT02685709|101152058|FG002|COMPLETED|RCT Phase||35||
48630278|NCT04584788|101878542|FG000|NOT COMPLETED|Overall Study||12||
48630279|NCT02452047|101878543|FG000|STARTED|Overall Study||31||
48630280|NCT02452047|101878544|FG001|STARTED|Overall Study||16||
48630281|NCT02452047|101878545|FG002|STARTED|Overall Study||3||
48630282|NCT02452047|101878543|FG000|COMPLETED|Overall Study||27||
48630283|NCT02452047|101878544|FG001|COMPLETED|Overall Study||11||
48753038|NCT00311766|102184384|FG001|STARTED|Overall Study||22||
48412680|NCT02005211|101342055|FG001|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0||
48412681|NCT02005211|101342056|FG002|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0||
48412682|NCT02005211|101342057|FG003|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0||
48412683|NCT02005211|101342058|FG004|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||5||
48412684|NCT02005211|101342059|FG005|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||6||
48412685|NCT02005211|101342060|FG006|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||4||
48630284|NCT02452047|101878545|FG002|COMPLETED|Overall Study||1||
48630285|NCT02452047|101878543|FG000|NOT COMPLETED|Overall Study||4||
48630286|NCT02452047|101878544|FG001|NOT COMPLETED|Overall Study||5||
48630287|NCT02452047|101878545|FG002|NOT COMPLETED|Overall Study||2||
48630288|NCT02133508|101878546|FG000|STARTED|Overall Study||156||
48630289|NCT02133508|101878546|FG000|COMPLETED|Overall Study||141||
48630290|NCT02133508|101878546|FG000|NOT COMPLETED|Overall Study||15||
48630291|NCT00834041|101878547|FG000|STARTED|Overall Study||19||
48630292|NCT00834041|101878548|FG001|STARTED|Overall Study||20||
48630293|NCT00834041|101878547|FG000|COMPLETED|Overall Study||18||
48630294|NCT00834041|101878548|FG001|COMPLETED|Overall Study||19||
48630295|NCT00834041|101878547|FG000|NOT COMPLETED|Overall Study||1||
48630296|NCT00834041|101878548|FG001|NOT COMPLETED|Overall Study||1||
48630297|NCT00288912|101878549|FG000|STARTED|Overall Study||175||
48630298|NCT00288912|101878550|FG001|STARTED|Overall Study||174||
48630299|NCT00288912|101878551|FG002|STARTED|Overall Study||174||
48630300|NCT00288912|101878549|FG000|COMPLETED|Overall Study||158||
48630301|NCT00288912|101878550|FG001|COMPLETED|Overall Study||157||
48630302|NCT00288912|101878551|FG002|COMPLETED|Overall Study||146||
48630303|NCT00288912|101878549|FG000|NOT COMPLETED|Overall Study||17||
48630304|NCT00288912|101878550|FG001|NOT COMPLETED|Overall Study||17||
48630305|NCT00288912|101878551|FG002|NOT COMPLETED|Overall Study||28||
48412686|NCT02005211|101342054|FG000|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0||
48412687|NCT02005211|101342055|FG001|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0||
48412688|NCT02005211|101342056|FG002|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0||
48412689|NCT02005211|101342057|FG003|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0||
48412690|NCT02005211|101342058|FG004|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||1||
48412691|NCT02005211|101342059|FG005|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0||
48412692|NCT02005211|101342060|FG006|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0||
48630306|NCT00549393|101878552|FG000|STARTED|Period 1 (6 Months)||1319||
48630307|NCT00549393|101878553|FG001|STARTED|Period 1 (6 Months)||1199||
48630308|NCT00549393|101878552|FG000|Per Protocol|Period 1 (6 Months)||880||
48630309|NCT00549393|101878553|FG001|Per Protocol|Period 1 (6 Months)||1199||
48630310|NCT00549393|101878552|FG000|COMPLETED|Period 1 (6 Months)||1319||
48630311|NCT00549393|101878553|FG001|COMPLETED|Period 1 (6 Months)||1199||
48630312|NCT00549393|101878552|FG000|NOT COMPLETED|Period 1 (6 Months)||0||
48630313|NCT00549393|101878553|FG001|NOT COMPLETED|Period 1 (6 Months)||0||
48630314|NCT00549393|101878552|FG000|STARTED|Period 2 Washout (2 Weeks)||0||
48630315|NCT00549393|101878553|FG001|STARTED|Period 2 Washout (2 Weeks)||0||
48630316|NCT00549393|101878552|FG000|COMPLETED|Period 2 Washout (2 Weeks)||0||
48630317|NCT00549393|101878553|FG001|COMPLETED|Period 2 Washout (2 Weeks)||0||
48630318|NCT00549393|101878552|FG000|NOT COMPLETED|Period 2 Washout (2 Weeks)||0||
48630319|NCT00549393|101878553|FG001|NOT COMPLETED|Period 2 Washout (2 Weeks)||0||
48630320|NCT00549393|101878552|FG000|STARTED|Period 3 (6 Months)||1103||
48630321|NCT00549393|101878553|FG001|STARTED|Period 3 (6 Months)||1326||
48630322|NCT00549393|101878552|FG000|Per Protocol|Period 3 (6 Months)||667||
48630323|NCT00549393|101878553|FG001|Per Protocol|Period 3 (6 Months)||1326||
48630324|NCT00549393|101878552|FG000|COMPLETED|Period 3 (6 Months)||1103||
48630325|NCT00549393|101878553|FG001|COMPLETED|Period 3 (6 Months)||1326||
48630326|NCT00549393|101878552|FG000|NOT COMPLETED|Period 3 (6 Months)||0||
48630327|NCT00549393|101878553|FG001|NOT COMPLETED|Period 3 (6 Months)||0||
48630328|NCT00572832|101878554|FG000|STARTED|Overall Study||100||
48630329|NCT00572832|101878555|FG001|STARTED|Overall Study||100||
48630330|NCT00572832|101878554|FG000|COMPLETED|Overall Study||100||
48630331|NCT00572832|101878555|FG001|COMPLETED|Overall Study||88||
48412693|NCT02274311|101342061|FG000|STARTED|Three Months of Clomiphene Treatment||16||
48412694|NCT02274311|101342061|FG000|COMPLETED|Three Months of Clomiphene Treatment||16||
48412695|NCT02274311|101342061|FG000|NOT COMPLETED|Three Months of Clomiphene Treatment||0||
48412696|NCT02274311|101342061|FG000|STARTED|Three Months of Clomiphene Wash-out||16||
48412697|NCT02274311|101342061|FG000|COMPLETED|Three Months of Clomiphene Wash-out||15||
48412698|NCT02274311|101342061|FG000|NOT COMPLETED|Three Months of Clomiphene Wash-out||1||
48412699|NCT03630185|101342062|FG000|STARTED|Overall Study||4||
48630332|NCT00572832|101878554|FG000|NOT COMPLETED|Overall Study||0||
48630333|NCT00572832|101878555|FG001|NOT COMPLETED|Overall Study||12||
48630334|NCT00597818|101878556|FG000|STARTED|Overall Study||30||
48630335|NCT00597818|101878557|FG001|STARTED|Overall Study||30||
48630336|NCT00597818|101878558|FG002|STARTED|Overall Study||31||
48630337|NCT00597818|101878559|FG003|STARTED|Overall Study||30||
48630338|NCT00597818|101878556|FG000|COMPLETED|Overall Study||12||
48630339|NCT00597818|101878557|FG001|COMPLETED|Overall Study||14||
48630340|NCT00597818|101878558|FG002|COMPLETED|Overall Study||12||
48630341|NCT00597818|101878559|FG003|COMPLETED|Overall Study||20||
48630342|NCT00597818|101878556|FG000|NOT COMPLETED|Overall Study||18||
48630343|NCT00597818|101878557|FG001|NOT COMPLETED|Overall Study||16||
48630344|NCT00597818|101878558|FG002|NOT COMPLETED|Overall Study||19||
48630345|NCT00597818|101878559|FG003|NOT COMPLETED|Overall Study||10||
48630346|NCT00595361|101878560|FG000|STARTED|Overall Study||12||
48630347|NCT00595361|101878561|FG001|STARTED|Overall Study||18||
48336485|NCT02685709|101152059|FG003|COMPLETED|RCT Phase||0||
48336486|NCT02685709|101152056|FG000|NOT COMPLETED|RCT Phase||0||
48336487|NCT02685709|101152057|FG001|NOT COMPLETED|RCT Phase||1||
48336488|NCT02685709|101152058|FG002|NOT COMPLETED|RCT Phase||2||
48336489|NCT02685709|101152059|FG003|NOT COMPLETED|RCT Phase||0||
48336490|NCT02685709|101152056|FG000|STARTED|Combination Phase||0||
48336491|NCT02685709|101152057|FG001|STARTED|Combination Phase||0||
48336492|NCT02685709|101152058|FG002|STARTED|Combination Phase||0||
48336493|NCT02685709|101152059|FG003|STARTED|Combination Phase||14||
48336494|NCT02685709|101152056|FG000|COMPLETED|Combination Phase||0||
48336495|NCT02685709|101152057|FG001|COMPLETED|Combination Phase||0||
48336496|NCT02685709|101152058|FG002|COMPLETED|Combination Phase||0||
48336497|NCT02685709|101152059|FG003|COMPLETED|Combination Phase||8||
48336498|NCT02685709|101152056|FG000|NOT COMPLETED|Combination Phase||0||
48336499|NCT02685709|101152057|FG001|NOT COMPLETED|Combination Phase||0||
48336500|NCT02685709|101152058|FG002|NOT COMPLETED|Combination Phase||0||
48336501|NCT02685709|101152059|FG003|NOT COMPLETED|Combination Phase||6||
48336502|NCT01307930|101152060|FG000|STARTED|Overall Study||20||
48336503|NCT01307930|101152060|FG000|COMPLETED|Overall Study||18||
48336504|NCT01307930|101152060|FG000|NOT COMPLETED|Overall Study||2||
48336505|NCT00441545|101152061|FG000|STARTED|First Intervention||95||
48336506|NCT00441545|101152062|FG001|STARTED|First Intervention||87||
48336507|NCT00441545|101152061|FG000|COMPLETED|First Intervention||77||
48336508|NCT00441545|101152062|FG001|COMPLETED|First Intervention||75||
48336509|NCT00441545|101152061|FG000|NOT COMPLETED|First Intervention||18||
48336510|NCT00441545|101152062|FG001|NOT COMPLETED|First Intervention||12||
48336511|NCT00441545|101152061|FG000|STARTED|Washout||77||
48336512|NCT00441545|101152062|FG001|STARTED|Washout||75||
48336513|NCT00441545|101152061|FG000|COMPLETED|Washout||77||
48336514|NCT00441545|101152062|FG001|COMPLETED|Washout||75||
48336515|NCT00441545|101152061|FG000|NOT COMPLETED|Washout||0||
48336516|NCT00441545|101152062|FG001|NOT COMPLETED|Washout||0||
48336517|NCT00441545|101152061|FG000|STARTED|Second Intervention||77||
48336518|NCT00441545|101152062|FG001|STARTED|Second Intervention||75||
48336519|NCT00441545|101152061|FG000|COMPLETED|Second Intervention||65||
48336520|NCT00441545|101152062|FG001|COMPLETED|Second Intervention||68||
48336521|NCT00441545|101152061|FG000|NOT COMPLETED|Second Intervention||12||
48336522|NCT00441545|101152062|FG001|NOT COMPLETED|Second Intervention||7||
48336523|NCT01106040|101152063|FG000|STARTED|Overall Study||163||
48336524|NCT01106040|101152063|FG000|COMPLETED|Overall Study||152||
48336525|NCT01106040|101152063|FG000|NOT COMPLETED|Overall Study||11||
48336526|NCT01461044|101152064|FG000|STARTED|Overall Study||150||
48336527|NCT01461044|101152065|FG001|STARTED|Overall Study||77||
48336528|NCT01461044|101152064|FG000|Participants Alive at Inclusion|Overall Study||127||
48336529|NCT01461044|101152065|FG001|Participants Alive at Inclusion|Overall Study||58||
48336530|NCT01461044|101152064|FG000|COMPLETED|Overall Study||80||
48336531|NCT01461044|101152065|FG001|COMPLETED|Overall Study||37||
48336532|NCT01461044|101152064|FG000|NOT COMPLETED|Overall Study||70||
48336533|NCT01461044|101152065|FG001|NOT COMPLETED|Overall Study||40||
48336534|NCT00122135|101152066|FG000|STARTED|Overall Study||60||
48336535|NCT00122135|101152067|FG001|STARTED|Overall Study||60||
48336536|NCT00122135|101152066|FG000|COMPLETED|Overall Study||57||
48336537|NCT00122135|101152067|FG001|COMPLETED|Overall Study||60||
48336538|NCT00122135|101152066|FG000|NOT COMPLETED|Overall Study||3||
48336539|NCT00122135|101152067|FG001|NOT COMPLETED|Overall Study||0||
48336540|NCT01957137|101152068|FG000|STARTED|Randomized Portion||30||
48336541|NCT01957137|101152068|FG000|Continuous Stimulation|Randomized Portion||29||
48336542|NCT01957137|101152068|FG000|Cycling Parameter #1|Randomized Portion||30||
48630348|NCT00595361|101878560|FG000|COMPLETED|Overall Study||12||
48336543|NCT01957137|101152068|FG000|Cycling Parameter #2|Randomized Portion||28||
48336544|NCT01957137|101152068|FG000|Cycling Parameter #3|Randomized Portion||28||
48336545|NCT01957137|101152068|FG000|COMPLETED|Randomized Portion||28||
48336546|NCT01957137|101152068|FG000|NOT COMPLETED|Randomized Portion||2||
48336547|NCT01957137|101152068|FG000|STARTED|No Stimulation||28||
48336548|NCT01957137|101152068|FG000|COMPLETED|No Stimulation||28||
48630349|NCT00595361|101878561|FG001|COMPLETED|Overall Study||18||
48630350|NCT00595361|101878560|FG000|NOT COMPLETED|Overall Study||0||
48630351|NCT00595361|101878561|FG001|NOT COMPLETED|Overall Study||0||
48630352|NCT03183908|101878562|FG000|STARTED|Overall Study||378|Full Analysis Population 2|
48657129|NCT04419389|101943784|FG000|COMPLETED|Overall Study||0||
48336549|NCT01957137|101152068|FG000|NOT COMPLETED|No Stimulation||0||
48336550|NCT01001702|101152069|FG000|STARTED|Overall Study||85||
48336551|NCT01001702|101152069|FG000|COMPLETED|Overall Study||13||
48336552|NCT01001702|101152069|FG000|NOT COMPLETED|Overall Study||72||
48336553|NCT03336502|101152070|FG000|STARTED|Overall Study||30|70|
48336554|NCT03336502|101152071|FG001|STARTED|Overall Study||40|70|
48336555|NCT03336502|101152070|FG000|COMPLETED|Overall Study||26|57|
48336556|NCT03336502|101152071|FG001|COMPLETED|Overall Study||31|57|
48336557|NCT03336502|101152070|FG000|NOT COMPLETED|Overall Study||4||
48336558|NCT03336502|101152071|FG001|NOT COMPLETED|Overall Study||9||
48336559|NCT01046695|101152072|FG000|STARTED|Overall Study||20||
48336560|NCT01046695|101152073|FG001|STARTED|Overall Study||22||
48336561|NCT01046695|101152072|FG000|COMPLETED|Overall Study||20||
48336562|NCT01046695|101152073|FG001|COMPLETED|Overall Study||20||
48336563|NCT01046695|101152072|FG000|NOT COMPLETED|Overall Study||0||
48336564|NCT01046695|101152073|FG001|NOT COMPLETED|Overall Study||2||
48336565|NCT02654002|101152074|FG000|STARTED|Overall Study||12||
48336566|NCT02654002|101152075|FG001|STARTED|Overall Study||12||
48336567|NCT02654002|101152076|FG002|STARTED|Overall Study||12||
48753039|NCT00311766|102184383|FG000|COMPLETED|Overall Study||8||
48753040|NCT00311766|102184384|FG001|COMPLETED|Overall Study||17||
48753041|NCT00311766|102184383|FG000|NOT COMPLETED|Overall Study||0||
48753042|NCT00311766|102184384|FG001|NOT COMPLETED|Overall Study||5||
48753043|NCT02587221|102184385|FG000|STARTED|Overall Study||3394||
48753044|NCT02587221|102184386|FG001|STARTED|Overall Study||3396||
48336568|NCT02654002|101152077|FG003|STARTED|Overall Study||12||
48336569|NCT02654002|101152078|FG004|STARTED|Overall Study||12||
48336570|NCT02654002|101152079|FG005|STARTED|Overall Study||12||
48336571|NCT02654002|101152080|FG006|STARTED|Overall Study||12||
48336572|NCT02654002|101152081|FG007|STARTED|Overall Study||12||
48336573|NCT02654002|101152082|FG008|STARTED|Overall Study||24||
48336574|NCT02654002|101152074|FG000|COMPLETED|Overall Study||12||
48336575|NCT02654002|101152075|FG001|COMPLETED|Overall Study||12||
48336576|NCT02654002|101152076|FG002|COMPLETED|Overall Study||12||
48336577|NCT02654002|101152077|FG003|COMPLETED|Overall Study||12||
48336578|NCT02654002|101152078|FG004|COMPLETED|Overall Study||12||
48336579|NCT02654002|101152079|FG005|COMPLETED|Overall Study||11||
48336580|NCT02654002|101152080|FG006|COMPLETED|Overall Study||11||
48336581|NCT02654002|101152081|FG007|COMPLETED|Overall Study||11||
48412700|NCT03630185|101342063|FG001|STARTED|Overall Study||4||
48412701|NCT03630185|101342062|FG000|30 Day Follow up|Overall Study||1||
48412702|NCT03630185|101342063|FG001|30 Day Follow up|Overall Study||1||
48412703|NCT03630185|101342062|FG000|90 Day Follow up|Overall Study||0||
48412704|NCT03630185|101342063|FG001|90 Day Follow up|Overall Study||1||
48412705|NCT03630185|101342062|FG000|6 Month Follow up|Overall Study||0||
48412706|NCT03630185|101342063|FG001|6 Month Follow up|Overall Study||0||
48412707|NCT03630185|101342062|FG000|COMPLETED|Overall Study||0||
48412708|NCT03630185|101342063|FG001|COMPLETED|Overall Study||0||
48412709|NCT03630185|101342062|FG000|NOT COMPLETED|Overall Study||4||
48412710|NCT03630185|101342063|FG001|NOT COMPLETED|Overall Study||4||
48412711|NCT02828644|101342064|FG000|STARTED|Overall Study||88||
48412712|NCT02828644|101342065|FG001|STARTED|Overall Study||87||
48412713|NCT02828644|101342064|FG000|COMPLETED|Overall Study||65||
48412714|NCT02828644|101342065|FG001|COMPLETED|Overall Study||65||
48412715|NCT02828644|101342064|FG000|NOT COMPLETED|Overall Study||23||
48412716|NCT02828644|101342065|FG001|NOT COMPLETED|Overall Study||22||
48753045|NCT02587221|102184385|FG000|Treated|Overall Study||3379||
48336582|NCT02654002|101152082|FG008|COMPLETED|Overall Study||24||
48336583|NCT02654002|101152074|FG000|NOT COMPLETED|Overall Study||0||
48336584|NCT02654002|101152075|FG001|NOT COMPLETED|Overall Study||0||
48336585|NCT02654002|101152076|FG002|NOT COMPLETED|Overall Study||0||
48336586|NCT02654002|101152077|FG003|NOT COMPLETED|Overall Study||0||
48336587|NCT02654002|101152078|FG004|NOT COMPLETED|Overall Study||0||
48336588|NCT02654002|101152079|FG005|NOT COMPLETED|Overall Study||1||
48336589|NCT02654002|101152080|FG006|NOT COMPLETED|Overall Study||1||
48336590|NCT02654002|101152081|FG007|NOT COMPLETED|Overall Study||1||
48412717|NCT00994890|101342066|FG000|STARTED|Overall Study||231||
48412718|NCT00994890|101342067|FG001|STARTED|Overall Study||222||
48412719|NCT00994890|101342068|FG002|STARTED|Overall Study||226||
48412720|NCT00994890|101342066|FG000|Treated|Overall Study||230||
48412721|NCT00994890|101342067|FG001|Treated|Overall Study||222||
48412722|NCT00994890|101342068|FG002|Treated|Overall Study||226||
48412723|NCT00994890|101342066|FG000|COMPLETED|Overall Study||0||
48412724|NCT00994890|101342067|FG001|COMPLETED|Overall Study||0||
48412725|NCT00994890|101342068|FG002|COMPLETED|Overall Study||0||
48412726|NCT00994890|101342066|FG000|NOT COMPLETED|Overall Study||231||
48412727|NCT00994890|101342067|FG001|NOT COMPLETED|Overall Study||222||
48412728|NCT00994890|101342068|FG002|NOT COMPLETED|Overall Study||226||
48753046|NCT02587221|102184386|FG001|Treated|Overall Study||3382||
48336591|NCT02654002|101152082|FG008|NOT COMPLETED|Overall Study||0||
48753047|NCT02587221|102184385|FG000|COMPLETED|Overall Study||3263||
48336592|NCT01833130|101152083|FG000|STARTED|Overall Study||25||
48336593|NCT01833130|101152084|FG001|STARTED|Overall Study||27||
48336594|NCT01833130|101152083|FG000|COMPLETED|Overall Study||15||
48336595|NCT01833130|101152084|FG001|COMPLETED|Overall Study||8||
48336596|NCT01833130|101152083|FG000|NOT COMPLETED|Overall Study||10||
48336597|NCT01833130|101152084|FG001|NOT COMPLETED|Overall Study||19||
48336598|NCT00560755|101152085|FG000|STARTED|Overall Study||3388||
48412729|NCT01603615|101342069|FG000|STARTED|Overall Study||220||
48412730|NCT01603615|101342069|FG000|Safety Population (Treated)|Overall Study||213||
48412731|NCT01603615|101342069|FG000|COMPLETED|Overall Study||186||
48336599|NCT00560755|101152085|FG000|ProQuad® Dose 1 and Dose 2|Overall Study||3346||
48336600|NCT00560755|101152085|FG000|COMPLETED|Overall Study||3328||
48336601|NCT00560755|101152085|FG000|NOT COMPLETED|Overall Study||60||
48412732|NCT01603615|101342069|FG000|NOT COMPLETED|Overall Study||34||
48412733|NCT00312728|101342070|FG000|STARTED|Overall Study||115||
48412734|NCT00312728|101342070|FG000|COMPLETED|Overall Study||5||
48412735|NCT00312728|101342070|FG000|NOT COMPLETED|Overall Study||110||
48412736|NCT02516306|101342071|FG000|STARTED|Period 1: Day 1 - 7||50||
48412737|NCT02516306|101342072|FG001|STARTED|Period 1: Day 1 - 7||25||
48412738|NCT02516306|101342071|FG000|COMPLETED|Period 1: Day 1 - 7||50||
48412739|NCT02516306|101342072|FG001|COMPLETED|Period 1: Day 1 - 7||25||
48412740|NCT02516306|101342071|FG000|NOT COMPLETED|Period 1: Day 1 - 7||0||
48412741|NCT02516306|101342072|FG001|NOT COMPLETED|Period 1: Day 1 - 7||0||
48412742|NCT02516306|101342071|FG000|STARTED|Period 2: Day 8 - 91||50||
48630353|NCT03183908|101878563|FG001|STARTED|Overall Study||379|Full Analysis Population 2|
48630354|NCT03183908|101878562|FG000|COMPLETED|Overall Study||378|Full Analysis Population 1|
48630355|NCT03183908|101878563|FG001|COMPLETED|Overall Study||377|Full Analysis Population 1|
48336602|NCT02183519|101152086|FG000|STARTED|Overall Study||28||
48336603|NCT02183519|101152087|FG001|STARTED|Overall Study||16||
48336604|NCT02183519|101152086|FG000|COMPLETED|Overall Study||25||
48336605|NCT02183519|101152087|FG001|COMPLETED|Overall Study||13||
48336606|NCT02183519|101152086|FG000|NOT COMPLETED|Overall Study||3||
48336607|NCT02183519|101152087|FG001|NOT COMPLETED|Overall Study||3||
48336608|NCT01072409|101152088|FG000|STARTED|Overall Study||45||
48336609|NCT01072409|101152088|FG000|COMPLETED|Overall Study||38||
48336610|NCT01072409|101152088|FG000|NOT COMPLETED|Overall Study||7||
48336611|NCT00805740|101152089|FG000|STARTED|Overall Study||28||
48336612|NCT00805740|101152090|FG001|STARTED|Overall Study||13||
48336613|NCT00805740|101152089|FG000|Treated|Overall Study||26||
48336614|NCT00805740|101152090|FG001|Treated|Overall Study||13||
48336615|NCT00805740|101152089|FG000|COMPLETED|Overall Study||17||
48336616|NCT00805740|101152090|FG001|COMPLETED|Overall Study||9||
48336617|NCT00805740|101152089|FG000|NOT COMPLETED|Overall Study||11||
48336618|NCT00805740|101152090|FG001|NOT COMPLETED|Overall Study||4||
48336619|NCT00440726|101152091|FG000|STARTED|Phase 1||4||
48336620|NCT00440726|101152092|FG001|STARTED|Phase 1||6||
48336621|NCT00440726|101152093|FG002|STARTED|Phase 1||0||
48336622|NCT00440726|101152091|FG000|COMPLETED|Phase 1||3||
48336623|NCT00440726|101152092|FG001|COMPLETED|Phase 1||5||
48336624|NCT00440726|101152093|FG002|COMPLETED|Phase 1||0||
48336625|NCT00440726|101152091|FG000|NOT COMPLETED|Phase 1||1||
48336626|NCT00440726|101152092|FG001|NOT COMPLETED|Phase 1||1||
48336627|NCT00440726|101152093|FG002|NOT COMPLETED|Phase 1||0||
48336628|NCT00440726|101152091|FG000|STARTED|Phase 2||0||
48336629|NCT00440726|101152092|FG001|STARTED|Phase 2||0||
48336630|NCT00440726|101152093|FG002|STARTED|Phase 2||22||
48336631|NCT00440726|101152091|FG000|COMPLETED|Phase 2||0||
48336632|NCT00440726|101152092|FG001|COMPLETED|Phase 2||0||
48336633|NCT00440726|101152093|FG002|COMPLETED|Phase 2||20||
48336634|NCT00440726|101152091|FG000|NOT COMPLETED|Phase 2||0||
48336635|NCT00440726|101152092|FG001|NOT COMPLETED|Phase 2||0||
48336636|NCT00440726|101152093|FG002|NOT COMPLETED|Phase 2||2||
48336637|NCT03711604|101152094|FG000|STARTED|Overall Study||17||
48336638|NCT03711604|101152094|FG000|COMPLETED|Overall Study||17||
48630356|NCT03183908|101878562|FG000|NOT COMPLETED|Overall Study||0||
48630357|NCT03183908|101878563|FG001|NOT COMPLETED|Overall Study||2||
48630358|NCT01663623|101878564|FG000|STARTED|Overall Study||52||
48630359|NCT01663623|101878565|FG001|STARTED|Overall Study||53||
48630360|NCT01663623|101878564|FG000|COMPLETED|Overall Study||40||
48630361|NCT01663623|101878565|FG001|COMPLETED|Overall Study||33||
48630362|NCT01663623|101878564|FG000|NOT COMPLETED|Overall Study||12||
48630363|NCT01663623|101878565|FG001|NOT COMPLETED|Overall Study||20||
48336639|NCT03711604|101152094|FG000|NOT COMPLETED|Overall Study||0||
48336640|NCT01859247|101152095|FG000|STARTED|Overall Study||1||
48336641|NCT01859247|101152096|FG001|STARTED|Overall Study||1||
48336642|NCT01859247|101152097|FG002|STARTED|Overall Study||1||
48336643|NCT01859247|101152098|FG003|STARTED|Overall Study||1||
48412743|NCT02516306|101342072|FG001|STARTED|Period 2: Day 8 - 91||25||
48630364|NCT04889040|101878566|FG000|STARTED|Overall Study||73||
48630365|NCT04889040|101878567|FG001|STARTED|Overall Study||143||
48630366|NCT04889040|101878566|FG000|Received Treatment|Overall Study||71||
48336644|NCT01859247|101152099|FG004|STARTED|Overall Study||1||
48336645|NCT01859247|101152100|FG005|STARTED|Overall Study||1||
48336646|NCT01859247|101152101|FG006|STARTED|Overall Study||1||
48336647|NCT01859247|101152102|FG007|STARTED|Overall Study||1||
48336648|NCT01859247|101152095|FG000|COMPLETED|Overall Study||1||
48336649|NCT01859247|101152096|FG001|COMPLETED|Overall Study||1||
48336650|NCT01859247|101152097|FG002|COMPLETED|Overall Study||1||
48336651|NCT01859247|101152098|FG003|COMPLETED|Overall Study||1||
48336652|NCT01859247|101152099|FG004|COMPLETED|Overall Study||1||
48336653|NCT01859247|101152100|FG005|COMPLETED|Overall Study||1||
48336654|NCT01859247|101152101|FG006|COMPLETED|Overall Study||1||
48336655|NCT01859247|101152102|FG007|COMPLETED|Overall Study||1||
48336656|NCT01859247|101152095|FG000|NOT COMPLETED|Overall Study||0||
48412744|NCT02516306|101342071|FG000|COMPLETED|Period 2: Day 8 - 91||49||
48630367|NCT04889040|101878567|FG001|Received Treatment|Overall Study||141||
48336657|NCT01859247|101152096|FG001|NOT COMPLETED|Overall Study||0||
48336658|NCT01859247|101152097|FG002|NOT COMPLETED|Overall Study||0||
48336659|NCT01859247|101152098|FG003|NOT COMPLETED|Overall Study||0||
48336660|NCT01859247|101152099|FG004|NOT COMPLETED|Overall Study||0||
48336661|NCT01859247|101152100|FG005|NOT COMPLETED|Overall Study||0||
48336662|NCT01859247|101152101|FG006|NOT COMPLETED|Overall Study||0||
48336663|NCT01859247|101152102|FG007|NOT COMPLETED|Overall Study||0||
48336664|NCT04640766|101152103|FG000|STARTED|Overall Study||9||
48336665|NCT04640766|101152103|FG000|COMPLETED|Overall Study||7||
48336666|NCT04640766|101152103|FG000|NOT COMPLETED|Overall Study||2||
48336667|NCT02320487|101152104|FG000|STARTED|Overall Study||102||
48336668|NCT02320487|101152104|FG000|COMPLETED|Overall Study||81||
48336669|NCT02320487|101152104|FG000|NOT COMPLETED|Overall Study||21||
48336670|NCT00802685|101152105|FG000|STARTED|Overall Study||54||
48336671|NCT00802685|101152106|FG001|STARTED|Overall Study||51||
48336672|NCT00802685|101152105|FG000|COMPLETED|Overall Study||54||
48336673|NCT00802685|101152106|FG001|COMPLETED|Overall Study||51||
48630368|NCT04889040|101878566|FG000|COMPLETED|Overall Study||68||
48630369|NCT04889040|101878567|FG001|COMPLETED|Overall Study||138||
48630370|NCT04889040|101878566|FG000|NOT COMPLETED|Overall Study||5||
48630371|NCT04889040|101878567|FG001|NOT COMPLETED|Overall Study||5||
48630372|NCT04275336|101878568|FG000|STARTED|Overall Study||120||
48630373|NCT04275336|101878569|FG001|STARTED|Overall Study||118||
48336674|NCT00802685|101152105|FG000|NOT COMPLETED|Overall Study||0||
48336675|NCT00802685|101152106|FG001|NOT COMPLETED|Overall Study||0||
48336676|NCT03555266|101152107|FG000|STARTED|Overall Study||32||
48336677|NCT03555266|101152108|FG001|STARTED|Overall Study||31||
48336678|NCT03555266|101152107|FG000|COMPLETED|Overall Study||26||
48336679|NCT03555266|101152108|FG001|COMPLETED|Overall Study||27||
48336680|NCT03555266|101152107|FG000|NOT COMPLETED|Overall Study||6||
48336681|NCT03555266|101152108|FG001|NOT COMPLETED|Overall Study||4||
48336682|NCT00653861|101152109|FG000|STARTED|Overall Study||72||
48336683|NCT00653861|101152109|FG000|COMPLETED|Overall Study||72||
48336684|NCT00653861|101152109|FG000|NOT COMPLETED|Overall Study||0||
48336685|NCT04033419|101152110|FG000|STARTED|Overall Study||51||
48336686|NCT04033419|101152110|FG000|COMPLETED|Overall Study||45||
48336687|NCT04033419|101152110|FG000|NOT COMPLETED|Overall Study||6||
48336688|NCT00165958|101152111|FG000|STARTED|Overall Study||19||
48336689|NCT00165958|101152112|FG001|STARTED|Overall Study||21||
48336690|NCT00165958|101152111|FG000|COMPLETED|Overall Study||18||
48336691|NCT00165958|101152112|FG001|COMPLETED|Overall Study||19||
48412745|NCT02516306|101342072|FG001|COMPLETED|Period 2: Day 8 - 91||23||
48412746|NCT02516306|101342071|FG000|NOT COMPLETED|Period 2: Day 8 - 91||1||
48412747|NCT02516306|101342072|FG001|NOT COMPLETED|Period 2: Day 8 - 91||2||
48412748|NCT03523715|101342073|FG000|STARTED|Overall Study||38||
48412749|NCT03523715|101342074|FG001|STARTED|Overall Study||39||
48412750|NCT03523715|101342073|FG000|COMPLETED|Overall Study||26||
48412751|NCT03523715|101342074|FG001|COMPLETED|Overall Study||23||
48412752|NCT03523715|101342073|FG000|NOT COMPLETED|Overall Study||12||
48412753|NCT03523715|101342074|FG001|NOT COMPLETED|Overall Study||16||
48412754|NCT00083616|101342075|FG000|STARTED|Overall Study||185||
48412755|NCT00083616|101342075|FG000|Received Study Medication|Overall Study||182||
48412756|NCT00083616|101342075|FG000|COMPLETED|Overall Study||154||
48412757|NCT00083616|101342075|FG000|NOT COMPLETED|Overall Study||31||
48412758|NCT03323086|101342076|FG000|STARTED|Overall Study||26||
48412759|NCT03323086|101342077|FG001|STARTED|Overall Study||22||
48753048|NCT02587221|102184386|FG001|COMPLETED|Overall Study||3273||
48336692|NCT00165958|101152111|FG000|NOT COMPLETED|Overall Study||1||
48336693|NCT00165958|101152112|FG001|NOT COMPLETED|Overall Study||2||
48336694|NCT01734317|101152113|FG000|STARTED|Overall Study||10||
48412760|NCT03323086|101342076|FG000|COMPLETED|Overall Study||23||
48412761|NCT03323086|101342077|FG001|COMPLETED|Overall Study||20||
48412762|NCT03323086|101342076|FG000|NOT COMPLETED|Overall Study||3||
48412763|NCT03323086|101342077|FG001|NOT COMPLETED|Overall Study||2||
48412764|NCT01051856|101342078|FG000|STARTED|Overall Study||33||
48412765|NCT01051856|101342079|FG001|STARTED|Overall Study||35||
48412766|NCT01051856|101342078|FG000|COMPLETED|Overall Study||32||
48412767|NCT01051856|101342079|FG001|COMPLETED|Overall Study||35||
48412768|NCT01051856|101342078|FG000|NOT COMPLETED|Overall Study||1||
48630374|NCT04275336|101878570|FG002|STARTED|Overall Study||116||
48630375|NCT04275336|101878568|FG000|COMPLETED|Overall Study||103||
48630376|NCT04275336|101878569|FG001|COMPLETED|Overall Study||96||
48630377|NCT04275336|101878570|FG002|COMPLETED|Overall Study||100||
48630378|NCT04275336|101878568|FG000|NOT COMPLETED|Overall Study||17||
48630379|NCT04275336|101878569|FG001|NOT COMPLETED|Overall Study||22||
48336695|NCT01734317|101152113|FG000|COMPLETED|Overall Study||10||
48630380|NCT04275336|101878570|FG002|NOT COMPLETED|Overall Study||16||
48336696|NCT01734317|101152113|FG000|NOT COMPLETED|Overall Study||0||
48336697|NCT00666926|101152114|FG000|STARTED|Overall Study||2||
48336698|NCT00666926|101152115|FG001|STARTED|Overall Study||4||
48412769|NCT01051856|101342079|FG001|NOT COMPLETED|Overall Study||0||
48412770|NCT01766986|101342080|FG000|STARTED|Overall Study||41||
48412771|NCT01766986|101342081|FG001|STARTED|Overall Study||51||
48412772|NCT01766986|101342082|FG002|STARTED|Overall Study||38||
48412773|NCT01766986|101342080|FG000|COMPLETED|Overall Study||41||
48412774|NCT01766986|101342081|FG001|COMPLETED|Overall Study||51||
48412775|NCT01766986|101342082|FG002|COMPLETED|Overall Study||38||
48412776|NCT01766986|101342080|FG000|NOT COMPLETED|Overall Study||0||
48412777|NCT01766986|101342081|FG001|NOT COMPLETED|Overall Study||0||
48412778|NCT01766986|101342082|FG002|NOT COMPLETED|Overall Study||0||
48412779|NCT00362440|101342083|FG000|STARTED|Overall Study||5||
48412780|NCT00362440|101342084|FG001|STARTED|Overall Study||4||
48412781|NCT00362440|101342083|FG000|COMPLETED|Overall Study||3||
48412782|NCT00362440|101342084|FG001|COMPLETED|Overall Study||3||
48412783|NCT00362440|101342083|FG000|NOT COMPLETED|Overall Study||2||
48412784|NCT00362440|101342084|FG001|NOT COMPLETED|Overall Study||1||
48412785|NCT01227252|101342085|FG000|STARTED|Overall Study||12||
48412786|NCT01227252|101342086|FG001|STARTED|Overall Study||10||
48412787|NCT01227252|101342087|FG002|STARTED|Overall Study||10||
48412788|NCT01227252|101342088|FG003|STARTED|Overall Study||10||
48412789|NCT01227252|101342085|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12||
48412790|NCT01227252|101342086|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10||
48412791|NCT01227252|101342087|FG002|Received at Least 1 Dose of Study Drug|Overall Study||10||
48412792|NCT01227252|101342088|FG003|Received at Least 1 Dose of Study Drug|Overall Study||10||
48412793|NCT01227252|101342085|FG000|COMPLETED|Overall Study||12||
48412794|NCT01227252|101342086|FG001|COMPLETED|Overall Study||7||
48412795|NCT01227252|101342087|FG002|COMPLETED|Overall Study||10||
48412796|NCT01227252|101342088|FG003|COMPLETED|Overall Study||10||
48336699|NCT00666926|101152116|FG002|STARTED|Overall Study||3||
48336700|NCT00666926|101152117|FG003|STARTED|Overall Study||4||
48336701|NCT00666926|101152118|FG004|STARTED|Overall Study||3||
48336702|NCT00666926|101152119|FG005|STARTED|Overall Study||4||
48336703|NCT00666926|101152120|FG006|STARTED|Overall Study||4||
48336704|NCT00666926|101152121|FG007|STARTED|Overall Study||1||
48336705|NCT00666926|101152122|FG008|STARTED|Overall Study||3||
48336706|NCT00666926|101152123|FG009|STARTED|Overall Study||10||
48336707|NCT00666926|101152124|FG010|STARTED|Overall Study||6||
48336708|NCT00666926|101152125|FG011|STARTED|Overall Study||33||
48336709|NCT00666926|101152126|FG012|STARTED|Overall Study||3||
48336710|NCT00666926|101152127|FG013|STARTED|Overall Study||4||
48336711|NCT00666926|101152128|FG014|STARTED|Overall Study||7||
48336712|NCT00666926|101152129|FG015|STARTED|Overall Study||8||
48336713|NCT00666926|101152114|FG000|COMPLETED|Overall Study||0||
48336714|NCT00666926|101152115|FG001|COMPLETED|Overall Study||0||
48336715|NCT00666926|101152116|FG002|COMPLETED|Overall Study||0||
48336716|NCT00666926|101152117|FG003|COMPLETED|Overall Study||0||
48336717|NCT00666926|101152118|FG004|COMPLETED|Overall Study||0||
48336718|NCT00666926|101152119|FG005|COMPLETED|Overall Study||0||
48336719|NCT00666926|101152120|FG006|COMPLETED|Overall Study||0||
48336720|NCT00666926|101152121|FG007|COMPLETED|Overall Study||0||
48412797|NCT01227252|101342085|FG000|NOT COMPLETED|Overall Study||0||
48412798|NCT01227252|101342086|FG001|NOT COMPLETED|Overall Study||3||
48412799|NCT01227252|101342087|FG002|NOT COMPLETED|Overall Study||0||
48336721|NCT00666926|101152122|FG008|COMPLETED|Overall Study||0||
48412800|NCT01227252|101342088|FG003|NOT COMPLETED|Overall Study||0||
48336722|NCT00666926|101152123|FG009|COMPLETED|Overall Study||0||
48336723|NCT00666926|101152124|FG010|COMPLETED|Overall Study||0||
48336724|NCT00666926|101152125|FG011|COMPLETED|Overall Study||0||
48336725|NCT00666926|101152126|FG012|COMPLETED|Overall Study||0||
48336726|NCT00666926|101152127|FG013|COMPLETED|Overall Study||0||
48336727|NCT00666926|101152128|FG014|COMPLETED|Overall Study||0||
48336728|NCT00666926|101152129|FG015|COMPLETED|Overall Study||0||
48336729|NCT00666926|101152114|FG000|NOT COMPLETED|Overall Study||2||
48336730|NCT00666926|101152115|FG001|NOT COMPLETED|Overall Study||4||
48412801|NCT01997892|101342089|FG000|STARTED|Overall Study||1027||
48336731|NCT00666926|101152116|FG002|NOT COMPLETED|Overall Study||3||
48336732|NCT00666926|101152117|FG003|NOT COMPLETED|Overall Study||4||
48336733|NCT00666926|101152118|FG004|NOT COMPLETED|Overall Study||3||
48336734|NCT00666926|101152119|FG005|NOT COMPLETED|Overall Study||4||
48412802|NCT01997892|101342089|FG000|Received Darbepoetin Alfa|Overall Study||987||
48412803|NCT01997892|101342089|FG000|COMPLETED|Overall Study||959||
48336735|NCT00666926|101152120|FG006|NOT COMPLETED|Overall Study||4||
48336736|NCT00666926|101152121|FG007|NOT COMPLETED|Overall Study||1||
48336737|NCT00666926|101152122|FG008|NOT COMPLETED|Overall Study||3||
48336738|NCT00666926|101152123|FG009|NOT COMPLETED|Overall Study||10||
48336739|NCT00666926|101152124|FG010|NOT COMPLETED|Overall Study||6||
48336740|NCT00666926|101152125|FG011|NOT COMPLETED|Overall Study||33||
48336741|NCT00666926|101152126|FG012|NOT COMPLETED|Overall Study||3||
48630381|NCT00251758|101878571|FG000|STARTED|Overall Study||292||
48630382|NCT00251758|101878572|FG001|STARTED|Overall Study||312||
48630383|NCT00251758|101878573|FG002|STARTED|Overall Study||304||
48630384|NCT00251758|101878571|FG000|COMPLETED|Overall Study||264||
48630385|NCT00251758|101878572|FG001|COMPLETED|Overall Study||285||
48630386|NCT00251758|101878573|FG002|COMPLETED|Overall Study||277||
48630387|NCT00251758|101878571|FG000|NOT COMPLETED|Overall Study||28||
48630388|NCT00251758|101878572|FG001|NOT COMPLETED|Overall Study||27||
48630389|NCT00251758|101878573|FG002|NOT COMPLETED|Overall Study||27||
48630390|NCT00853762|101878574|FG000|STARTED|Overall Study||16||
48630391|NCT00853762|101878575|FG001|STARTED|Overall Study||19||
48630392|NCT00853762|101878576|FG002|STARTED|Overall Study||17||
48630393|NCT00853762|101878577|FG003|STARTED|Overall Study||22||
48630394|NCT00853762|101878574|FG000|COMPLETED|Overall Study||0||
48630395|NCT00853762|101878575|FG001|COMPLETED|Overall Study||0||
48630396|NCT00853762|101878576|FG002|COMPLETED|Overall Study||0||
48630397|NCT00853762|101878577|FG003|COMPLETED|Overall Study||0||
48630398|NCT00853762|101878574|FG000|NOT COMPLETED|Overall Study||16||
48630399|NCT00853762|101878575|FG001|NOT COMPLETED|Overall Study||19||
48630400|NCT00853762|101878576|FG002|NOT COMPLETED|Overall Study||17||
48630401|NCT00853762|101878577|FG003|NOT COMPLETED|Overall Study||22||
48630402|NCT01718483|101878578|FG000|STARTED|Overall Study||191||
48630403|NCT01718483|101878579|FG001|STARTED|Overall Study||192||
48630404|NCT01718483|101878578|FG000|Treated|Overall Study||187||
48630405|NCT01718483|101878579|FG001|Treated|Overall Study||192||
48630406|NCT01718483|101878578|FG000|COMPLETED|Overall Study||157||
48630407|NCT01718483|101878579|FG001|COMPLETED|Overall Study||158||
48630408|NCT01718483|101878578|FG000|NOT COMPLETED|Overall Study||34||
48630409|NCT01718483|101878579|FG001|NOT COMPLETED|Overall Study||34||
48753049|NCT02587221|102184385|FG000|NOT COMPLETED|Overall Study||131||
48753050|NCT02587221|102184386|FG001|NOT COMPLETED|Overall Study||123||
48753051|NCT00948064|102184387|FG000|STARTED|Phase I||31||
48753052|NCT00948064|102184388|FG001|STARTED|Phase I||0||
48753053|NCT00948064|102184389|FG002|STARTED|Phase I||0||
48753054|NCT00948064|102184387|FG000|COMPLETED|Phase I||30||
48753055|NCT00948064|102184388|FG001|COMPLETED|Phase I||0||
48753056|NCT00948064|102184389|FG002|COMPLETED|Phase I||0||
48753057|NCT00948064|102184387|FG000|NOT COMPLETED|Phase I||1||
48753058|NCT00948064|102184388|FG001|NOT COMPLETED|Phase I||0||
48753059|NCT00948064|102184389|FG002|NOT COMPLETED|Phase I||0||
48753060|NCT00948064|102184387|FG000|STARTED|Phase II||0||
48630410|NCT03261999|101878580|FG000|STARTED|Overall Study||144||
48753061|NCT00948064|102184388|FG001|STARTED|Phase II||52||
48753062|NCT00948064|102184389|FG002|STARTED|Phase II||27||
48753063|NCT00948064|102184387|FG000|COMPLETED|Phase II||0||
48753064|NCT00948064|102184388|FG001|COMPLETED|Phase II||51||
48753065|NCT00948064|102184389|FG002|COMPLETED|Phase II||26||
48753066|NCT00948064|102184387|FG000|NOT COMPLETED|Phase II||0||
48753067|NCT00948064|102184388|FG001|NOT COMPLETED|Phase II||1||
48753068|NCT00948064|102184389|FG002|NOT COMPLETED|Phase II||1||
48753069|NCT00713609|102184390|FG000|STARTED|Overall Study||106||
48753070|NCT00713609|102184391|FG001|STARTED|Overall Study||105||
48753071|NCT00713609|102184392|FG002|STARTED|Overall Study||107||
48753072|NCT00713609|102184393|FG003|STARTED|Overall Study||108||
48753073|NCT00713609|102184394|FG004|STARTED|Overall Study||106||
48753074|NCT00713609|102184395|FG005|STARTED|Overall Study||55||
48753075|NCT00713609|102184390|FG000|COMPLETED|Overall Study||85||
48753076|NCT00713609|102184391|FG001|COMPLETED|Overall Study||90||
48753077|NCT00713609|102184392|FG002|COMPLETED|Overall Study||92||
48753078|NCT00713609|102184393|FG003|COMPLETED|Overall Study||99||
48753079|NCT00713609|102184394|FG004|COMPLETED|Overall Study||87||
48753080|NCT00713609|102184395|FG005|COMPLETED|Overall Study||47||
48753081|NCT00713609|102184390|FG000|NOT COMPLETED|Overall Study||21||
48753082|NCT00713609|102184391|FG001|NOT COMPLETED|Overall Study||15||
48630411|NCT03261999|101878580|FG000|ITT|Overall Study||144||
48630412|NCT03261999|101878580|FG000|PP|Overall Study||132||
48630413|NCT03261999|101878580|FG000|COMPLETED|Overall Study||129||
48630414|NCT03261999|101878580|FG000|NOT COMPLETED|Overall Study||15||
48630415|NCT00320086|101878581|FG000|STARTED|Overall Study||91||
48630416|NCT00320086|101878582|FG001|STARTED|Overall Study||112||
48630417|NCT00320086|101878581|FG000|COMPLETED|Overall Study||91||
48630418|NCT00320086|101878582|FG001|COMPLETED|Overall Study||112||
48753083|NCT00713609|102184392|FG002|NOT COMPLETED|Overall Study||15||
48753084|NCT00713609|102184393|FG003|NOT COMPLETED|Overall Study||9||
48753085|NCT00713609|102184394|FG004|NOT COMPLETED|Overall Study||19||
48753086|NCT00713609|102184395|FG005|NOT COMPLETED|Overall Study||8||
48753087|NCT03755206|102184396|FG000|STARTED|Overall Study||24||
48630419|NCT00320086|101878581|FG000|NOT COMPLETED|Overall Study||0||
48753088|NCT03755206|102184396|FG000|COMPLETED|Overall Study||24||
48753089|NCT03755206|102184396|FG000|NOT COMPLETED|Overall Study||0||
48753090|NCT01650298|102184397|FG000|STARTED|Overall Study||16||
48630420|NCT00320086|101878582|FG001|NOT COMPLETED|Overall Study||0||
48630421|NCT01244477|101878583|FG000|STARTED|Overall Study||38||
48630422|NCT01244477|101878584|FG001|STARTED|Overall Study||23||
48630423|NCT01244477|101878583|FG000|COMPLETED|Overall Study||18||
48630424|NCT01244477|101878584|FG001|COMPLETED|Overall Study||20||
48630425|NCT01244477|101878583|FG000|NOT COMPLETED|Overall Study||20||
48630426|NCT01244477|101878584|FG001|NOT COMPLETED|Overall Study||3||
48630427|NCT00906243|101878585|FG000|STARTED|Overall Study||6||
48630428|NCT00906243|101878585|FG000|COMPLETED|Overall Study||6||
48630429|NCT00906243|101878585|FG000|NOT COMPLETED|Overall Study||0||
48630430|NCT00323063|101878586|FG000|STARTED|Overall Study||26||
48630431|NCT00323063|101878587|FG001|STARTED|Overall Study||23||
48630432|NCT00323063|101878586|FG000|COMPLETED|Overall Study||24||
48630433|NCT00323063|101878587|FG001|COMPLETED|Overall Study||23||
48630434|NCT00323063|101878586|FG000|NOT COMPLETED|Overall Study||2||
48630435|NCT00323063|101878587|FG001|NOT COMPLETED|Overall Study||0||
48630436|NCT01317641|101878588|FG000|STARTED|Overall Study||4||
48630437|NCT01317641|101878589|FG001|STARTED|Overall Study||7||
48630438|NCT01317641|101878590|FG002|STARTED|Overall Study||3||
48630439|NCT01317641|101878591|FG003|STARTED|Overall Study||4||
48630440|NCT01317641|101878592|FG004|STARTED|Overall Study||3||
48630441|NCT01317641|101878593|FG005|STARTED|Overall Study||3||
48630442|NCT01317641|101878594|FG006|STARTED|Overall Study||38||
48630443|NCT01317641|101878595|FG007|STARTED|Overall Study||38||
48630444|NCT01317641|101878596|FG008|STARTED|Overall Study||36||
48630445|NCT01317641|101878588|FG000|COMPLETED|Overall Study||3||
48630446|NCT01317641|101878589|FG001|COMPLETED|Overall Study||6||
48630447|NCT01317641|101878590|FG002|COMPLETED|Overall Study||3||
48630448|NCT01317641|101878591|FG003|COMPLETED|Overall Study||3||
48630449|NCT01317641|101878592|FG004|COMPLETED|Overall Study||3||
48630450|NCT01317641|101878593|FG005|COMPLETED|Overall Study||3||
48630451|NCT01317641|101878594|FG006|COMPLETED|Overall Study||35||
48630452|NCT01317641|101878595|FG007|COMPLETED|Overall Study||33||
48630453|NCT01317641|101878596|FG008|COMPLETED|Overall Study||31||
48630454|NCT01317641|101878588|FG000|NOT COMPLETED|Overall Study||1||
48630455|NCT01317641|101878589|FG001|NOT COMPLETED|Overall Study||1||
48630456|NCT01317641|101878590|FG002|NOT COMPLETED|Overall Study||0||
48630457|NCT01317641|101878591|FG003|NOT COMPLETED|Overall Study||1||
48630458|NCT01317641|101878592|FG004|NOT COMPLETED|Overall Study||0||
48630459|NCT01317641|101878593|FG005|NOT COMPLETED|Overall Study||0||
48630460|NCT01317641|101878594|FG006|NOT COMPLETED|Overall Study||3||
48630461|NCT01317641|101878595|FG007|NOT COMPLETED|Overall Study||5||
48630462|NCT01317641|101878596|FG008|NOT COMPLETED|Overall Study||5||
48630463|NCT01586195|101878597|FG000|STARTED|Overall Study||31||
48630464|NCT01586195|101878597|FG000|COMPLETED|Overall Study||5||
48630465|NCT01586195|101878597|FG000|NOT COMPLETED|Overall Study||26||
48630466|NCT03042546|101878598|FG000|STARTED|Overall Study||0||
48630467|NCT03042546|101878599|FG001|STARTED|Overall Study||0||
48630468|NCT03042546|101878600|FG002|STARTED|Overall Study||0||
48630469|NCT03042546|101878598|FG000|COMPLETED|Overall Study||0||
48630470|NCT03042546|101878599|FG001|COMPLETED|Overall Study||0||
48630471|NCT03042546|101878600|FG002|COMPLETED|Overall Study||0||
48630472|NCT03042546|101878598|FG000|NOT COMPLETED|Overall Study||0||
48630473|NCT03042546|101878599|FG001|NOT COMPLETED|Overall Study||0||
48336742|NCT00666926|101152127|FG013|NOT COMPLETED|Overall Study||4||
48630474|NCT03042546|101878600|FG002|NOT COMPLETED|Overall Study||0||
48630475|NCT02147301|101878601|FG000|STARTED|Overall Study||17||
48630476|NCT02147301|101878601|FG000|COMPLETED|Overall Study||17||
48630477|NCT02147301|101878601|FG000|NOT COMPLETED|Overall Study||0||
48630478|NCT00947544|101878602|FG000|STARTED|Switch-Over Period (2 Weeks)||11||
48630479|NCT00947544|101878603|FG001|STARTED|Switch-Over Period (2 Weeks)||0||
48630480|NCT00947544|101878602|FG000|COMPLETED|Switch-Over Period (2 Weeks)||11||
48630481|NCT00947544|101878603|FG001|COMPLETED|Switch-Over Period (2 Weeks)||0||
48630482|NCT00947544|101878602|FG000|NOT COMPLETED|Switch-Over Period (2 Weeks)||0||
48630483|NCT00947544|101878603|FG001|NOT COMPLETED|Switch-Over Period (2 Weeks)||0||
48630484|NCT00947544|101878602|FG000|STARTED|Safety-Extension Period (12 Months)||11||
48630485|NCT00947544|101878603|FG001|STARTED|Safety-Extension Period (12 Months)||6||
48630486|NCT00947544|101878602|FG000|COMPLETED|Safety-Extension Period (12 Months)||10||
48630487|NCT00947544|101878603|FG001|COMPLETED|Safety-Extension Period (12 Months)||6||
48630488|NCT00947544|101878602|FG000|NOT COMPLETED|Safety-Extension Period (12 Months)||1||
48630489|NCT00947544|101878603|FG001|NOT COMPLETED|Safety-Extension Period (12 Months)||0||
48630490|NCT04076917|101878604|FG000|STARTED|Overall Study||84||
48630491|NCT04076917|101878604|FG000|COMPLETED|Overall Study||15||
48630492|NCT04076917|101878604|FG000|NOT COMPLETED|Overall Study||69||
48630493|NCT02265965|101878605|FG000|STARTED|Overall Study||7||
48630494|NCT02265965|101878606|FG001|STARTED|Overall Study||11||
48630495|NCT02265965|101878605|FG000|COMPLETED|Overall Study||7||
48630496|NCT02265965|101878606|FG001|COMPLETED|Overall Study||11||
48336743|NCT00666926|101152128|FG014|NOT COMPLETED|Overall Study||7||
48630497|NCT02265965|101878605|FG000|NOT COMPLETED|Overall Study||0||
48630498|NCT02265965|101878606|FG001|NOT COMPLETED|Overall Study||0||
48630499|NCT00296517|101878607|FG000|STARTED|Dose Level 1 - Week 1||159||
48630500|NCT00296517|101878608|FG001|STARTED|Dose Level 1 - Week 1||166||
48630501|NCT00296517|101878607|FG000|COMPLETED|Dose Level 1 - Week 1||159||
48630502|NCT00296517|101878608|FG001|COMPLETED|Dose Level 1 - Week 1||166||
48630503|NCT00296517|101878607|FG000|NOT COMPLETED|Dose Level 1 - Week 1||0||
48630504|NCT00296517|101878608|FG001|NOT COMPLETED|Dose Level 1 - Week 1||0||
48630505|NCT00296517|101878607|FG000|STARTED|Dose Level 2 - Week 2||159||
48630506|NCT00296517|101878608|FG001|STARTED|Dose Level 2 - Week 2||166||
48630507|NCT00296517|101878607|FG000|COMPLETED|Dose Level 2 - Week 2||157||
48630508|NCT00296517|101878608|FG001|COMPLETED|Dose Level 2 - Week 2||161||
48630509|NCT00296517|101878607|FG000|NOT COMPLETED|Dose Level 2 - Week 2||2||
48630510|NCT00296517|101878608|FG001|NOT COMPLETED|Dose Level 2 - Week 2||5||
48630511|NCT00296517|101878607|FG000|STARTED|Dose Level 3 - Weeks 3-12||157||
48630512|NCT00296517|101878608|FG001|STARTED|Dose Level 3 - Weeks 3-12||161||
48630513|NCT00296517|101878607|FG000|COMPLETED|Dose Level 3 - Weeks 3-12||112||
48630514|NCT00296517|101878608|FG001|COMPLETED|Dose Level 3 - Weeks 3-12||99||
48630515|NCT00296517|101878607|FG000|NOT COMPLETED|Dose Level 3 - Weeks 3-12||45||
48630516|NCT00296517|101878608|FG001|NOT COMPLETED|Dose Level 3 - Weeks 3-12||62||
48630517|NCT02139397|101878609|FG000|STARTED|Overall Study||3||
48630518|NCT02139397|101878610|FG001|STARTED|Overall Study||7||
48630519|NCT02139397|101878611|FG002|STARTED|Overall Study||6||
48630520|NCT02139397|101878612|FG003|STARTED|Overall Study||0||
48630521|NCT02139397|101878609|FG000|COMPLETED|Overall Study||3||
48630522|NCT02139397|101878610|FG001|COMPLETED|Overall Study||7||
48630523|NCT02139397|101878611|FG002|COMPLETED|Overall Study||6||
48630524|NCT02139397|101878612|FG003|COMPLETED|Overall Study||0||
48630525|NCT02139397|101878609|FG000|NOT COMPLETED|Overall Study||0||
48630526|NCT02139397|101878610|FG001|NOT COMPLETED|Overall Study||0||
48630527|NCT02139397|101878611|FG002|NOT COMPLETED|Overall Study||0||
48630528|NCT02139397|101878612|FG003|NOT COMPLETED|Overall Study||0||
48630529|NCT03159143|101878613|FG000|STARTED|Overall Study||22||
48630530|NCT03159143|101878613|FG000|COMPLETED|Overall Study||22||
48630531|NCT03159143|101878613|FG000|NOT COMPLETED|Overall Study||0||
48630532|NCT02240667|101878614|FG000|STARTED|Overall Study||771||
48412804|NCT01997892|101342089|FG000|NOT COMPLETED|Overall Study||68||
48412805|NCT01610414|101342090|FG000|STARTED|Study Start - Month 13||922||
48412806|NCT01610414|101342091|FG001|STARTED|Study Start - Month 13||924||
48630533|NCT02240667|101878615|FG001|STARTED|Overall Study||650||
48630534|NCT02240667|101878614|FG000|COMPLETED|Overall Study||771||
48630535|NCT02240667|101878615|FG001|COMPLETED|Overall Study||650||
48630536|NCT02240667|101878614|FG000|NOT COMPLETED|Overall Study||0||
48630537|NCT02240667|101878615|FG001|NOT COMPLETED|Overall Study||0||
48630538|NCT03736967|101878616|FG000|STARTED|Overall Study||51||
48630539|NCT03736967|101878617|FG001|STARTED|Overall Study||52||
48630540|NCT03736967|101878618|FG002|STARTED|Overall Study||51||
48630541|NCT03736967|101878619|FG003|STARTED|Overall Study||52||
48630542|NCT03736967|101878616|FG000|Treated|Overall Study||50||
48630543|NCT03736967|101878617|FG001|Treated|Overall Study||52||
48412807|NCT01610414|101342090|FG000|COMPLETED|Study Start - Month 13||807||
48412808|NCT01610414|101342091|FG001|COMPLETED|Study Start - Month 13||795||
48412809|NCT01610414|101342090|FG000|NOT COMPLETED|Study Start - Month 13||115||
48412810|NCT01610414|101342091|FG001|NOT COMPLETED|Study Start - Month 13||129||
48412811|NCT01610414|101342090|FG000|STARTED|Month 13 - Month 25||922||
48630544|NCT03736967|101878618|FG002|Treated|Overall Study||51||
48630545|NCT03736967|101878619|FG003|Treated|Overall Study||52||
48630546|NCT03736967|101878616|FG000|COMPLETED|Overall Study||20||
48630547|NCT03736967|101878617|FG001|COMPLETED|Overall Study||24||
48630548|NCT03736967|101878618|FG002|COMPLETED|Overall Study||27||
48630549|NCT03736967|101878619|FG003|COMPLETED|Overall Study||22||
48630550|NCT03736967|101878616|FG000|NOT COMPLETED|Overall Study||31||
48630551|NCT03736967|101878617|FG001|NOT COMPLETED|Overall Study||28||
48630552|NCT03736967|101878618|FG002|NOT COMPLETED|Overall Study||24||
48630553|NCT03736967|101878619|FG003|NOT COMPLETED|Overall Study||30||
48630554|NCT01878799|101878620|FG000|STARTED|Overall Study||37||
48630555|NCT01878799|101878621|FG001|STARTED|Overall Study||13||
48630556|NCT01878799|101878620|FG000|COMPLETED|Overall Study||36||
48630557|NCT01878799|101878621|FG001|COMPLETED|Overall Study||13||
48630558|NCT01878799|101878620|FG000|NOT COMPLETED|Overall Study||1||
48630559|NCT01878799|101878621|FG001|NOT COMPLETED|Overall Study||0||
48630560|NCT03363906|101878622|FG000|STARTED|Period 1 (Reference or Test)||15||
48630561|NCT03363906|101878623|FG001|STARTED|Period 1 (Reference or Test)||12||
48630562|NCT03363906|101878622|FG000|Received at Least One Dose of Study Drug|Period 1 (Reference or Test)||15||
48630563|NCT03363906|101878623|FG001|Received at Least One Dose of Study Drug|Period 1 (Reference or Test)||11||
48630564|NCT03363906|101878622|FG000|COMPLETED|Period 1 (Reference or Test)||14||
48630565|NCT03363906|101878623|FG001|COMPLETED|Period 1 (Reference or Test)||10||
48630566|NCT03363906|101878622|FG000|NOT COMPLETED|Period 1 (Reference or Test)||1||
48630567|NCT03363906|101878623|FG001|NOT COMPLETED|Period 1 (Reference or Test)||2||
48630568|NCT03363906|101878622|FG000|STARTED|Period 2 (Test or Reference)||14||
48630569|NCT03363906|101878623|FG001|STARTED|Period 2 (Test or Reference)||10||
48630570|NCT03363906|101878622|FG000|Received at Least One Dose of Study Drug|Period 2 (Test or Reference)||12||
48630571|NCT03363906|101878623|FG001|Received at Least One Dose of Study Drug|Period 2 (Test or Reference)||9||
48630572|NCT03363906|101878622|FG000|COMPLETED|Period 2 (Test or Reference)||10||
48630573|NCT03363906|101878623|FG001|COMPLETED|Period 2 (Test or Reference)||9||
48630574|NCT03363906|101878622|FG000|NOT COMPLETED|Period 2 (Test or Reference)||4||
48630575|NCT03363906|101878623|FG001|NOT COMPLETED|Period 2 (Test or Reference)||1||
48630576|NCT00942786|101878624|FG000|STARTED|Overall Study||297||
48630577|NCT00942786|101878624|FG000|COMPLETED|Overall Study||297||
48630578|NCT00942786|101878624|FG000|NOT COMPLETED|Overall Study||0||
48630579|NCT03424148|101878625|FG000|STARTED|Overall Study||10||
48630580|NCT03424148|101878625|FG000|COMPLETED|Overall Study||8||
48630581|NCT03424148|101878625|FG000|NOT COMPLETED|Overall Study||2||
48630582|NCT03805841|101878626|FG000|STARTED|Overall Study||11||
48630583|NCT03805841|101878627|FG001|STARTED|Overall Study||22||
48630584|NCT03805841|101878628|FG002|STARTED|Overall Study||8||
48630585|NCT03805841|101878626|FG000|COMPLETED|Overall Study||6||
48630586|NCT03805841|101878627|FG001|COMPLETED|Overall Study||12||
48630587|NCT03805841|101878628|FG002|COMPLETED|Overall Study||5||
48630588|NCT03805841|101878626|FG000|NOT COMPLETED|Overall Study||5||
48630589|NCT03805841|101878627|FG001|NOT COMPLETED|Overall Study||10||
48630590|NCT03805841|101878628|FG002|NOT COMPLETED|Overall Study||3||
48630591|NCT03181308|101878629|FG000|STARTED|Overall Study||3||
48630592|NCT03181308|101878630|FG001|STARTED|Overall Study||8||
48630593|NCT03181308|101878629|FG000|COMPLETED|Overall Study||3||
48630594|NCT03181308|101878630|FG001|COMPLETED|Overall Study||8||
48630595|NCT03181308|101878629|FG000|NOT COMPLETED|Overall Study||0||
48630596|NCT03181308|101878630|FG001|NOT COMPLETED|Overall Study||0||
48630597|NCT00386334|101878631|FG000|STARTED|Double Blind Period||194||
48630598|NCT00386334|101878632|FG001|STARTED|Double Blind Period||194||
48336744|NCT00666926|101152129|FG015|NOT COMPLETED|Overall Study||8||
48336745|NCT02883244|101152130|FG000|STARTED|Overall Study||24||
48336746|NCT02883244|101152131|FG001|STARTED|Overall Study||26||
48336747|NCT02883244|101152130|FG000|COMPLETED|Overall Study||24||
48336748|NCT02883244|101152131|FG001|COMPLETED|Overall Study||25||
48336749|NCT02883244|101152130|FG000|NOT COMPLETED|Overall Study||0||
48336750|NCT02883244|101152131|FG001|NOT COMPLETED|Overall Study||1||
48336751|NCT04082663|101152132|FG000|STARTED|Overall Study||20||
48630599|NCT00386334|101878631|FG000|COMPLETED|Double Blind Period||148||
48630600|NCT00386334|101878632|FG001|COMPLETED|Double Blind Period||147||
48336752|NCT04082663|101152132|FG000|COMPLETED|Overall Study||13||
48336753|NCT04082663|101152132|FG000|NOT COMPLETED|Overall Study||7||
48336754|NCT00132730|101152133|FG000|STARTED|Period I - Placebo Run-in (Base)||150||
48630601|NCT00386334|101878631|FG000|NOT COMPLETED|Double Blind Period||46||
48630602|NCT00386334|101878632|FG001|NOT COMPLETED|Double Blind Period||47||
48630603|NCT00386334|101878631|FG000|STARTED|Follow up:2 Week Placebo, 2 Week no Drug||146||
48630604|NCT00386334|101878632|FG001|STARTED|Follow up:2 Week Placebo, 2 Week no Drug||145||
48630605|NCT00386334|101878631|FG000|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||143||
48630606|NCT00386334|101878632|FG001|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||144||
48630607|NCT00386334|101878631|FG000|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||3||
48630608|NCT00386334|101878632|FG001|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||1||
48630609|NCT04585919|101878633|FG000|STARTED|Usual Care||7|Number of community health center staff|1
48630610|NCT04585919|101878634|FG001|STARTED|Usual Care||6|Number of community health center staff|1
48630611|NCT04585919|101878635|FG002|STARTED|Usual Care||9|Number of community health center staff|1
48630612|NCT04585919|101878636|FG003|STARTED|Usual Care||4|Number of community health center staff|1
48753091|NCT01650298|102184398|FG001|STARTED|Overall Study||48||
48753092|NCT01650298|102184397|FG000|COMPLETED|Overall Study||11||
48753093|NCT01650298|102184398|FG001|COMPLETED|Overall Study||42||
48753094|NCT01650298|102184397|FG000|NOT COMPLETED|Overall Study||5||
48630613|NCT04585919|101878633|FG000|Number of Patients|Usual Care||5947|Patients are not enrolled|1
48630614|NCT04585919|101878634|FG001|Number of Patients|Usual Care||7652|Patients are not enrolled|1
48630615|NCT04585919|101878635|FG002|Number of Patients|Usual Care||7311|Patients are not enrolled|1
48630616|NCT04585919|101878636|FG003|Number of Patients|Usual Care||6317|Patients are not enrolled|1
48630617|NCT04585919|101878633|FG000|COMPLETED|Usual Care||7||1
48630618|NCT04585919|101878634|FG001|COMPLETED|Usual Care||6||1
48630619|NCT04585919|101878635|FG002|COMPLETED|Usual Care||9||1
48630620|NCT04585919|101878636|FG003|COMPLETED|Usual Care||4||1
48630621|NCT04585919|101878633|FG000|NOT COMPLETED|Usual Care||0||0
48630622|NCT04585919|101878634|FG001|NOT COMPLETED|Usual Care||0||0
48630623|NCT04585919|101878635|FG002|NOT COMPLETED|Usual Care||0||0
48630624|NCT04585919|101878636|FG003|NOT COMPLETED|Usual Care||0||0
48630625|NCT04585919|101878633|FG000|STARTED|Paired Outreach||7|Number of community health center staff|1
48630626|NCT04585919|101878634|FG001|STARTED|Paired Outreach||6|Number of community health center staff|1
48630627|NCT04585919|101878635|FG002|STARTED|Paired Outreach||9|Number of community health center staff|1
48630628|NCT04585919|101878636|FG003|STARTED|Paired Outreach||4|Number of community health center staff|1
48630629|NCT04585919|101878633|FG000|Number of Patients|Paired Outreach||6453|Patients are not enrolled|1
48630630|NCT04585919|101878634|FG001|Number of Patients|Paired Outreach||13401|Patients are not enrolled|1
48630631|NCT04585919|101878635|FG002|Number of Patients|Paired Outreach||7272|Patients are not enrolled|1
48630632|NCT04585919|101878636|FG003|Number of Patients|Paired Outreach||6254|Patients are not enrolled|1
48630633|NCT04585919|101878633|FG000|COMPLETED|Paired Outreach||7||1
48630634|NCT04585919|101878634|FG001|COMPLETED|Paired Outreach||6||1
48630635|NCT04585919|101878635|FG002|COMPLETED|Paired Outreach||9||1
48630636|NCT04585919|101878636|FG003|COMPLETED|Paired Outreach||4||1
48630637|NCT04585919|101878633|FG000|NOT COMPLETED|Paired Outreach||0||0
48630638|NCT04585919|101878634|FG001|NOT COMPLETED|Paired Outreach||0||0
48630639|NCT04585919|101878635|FG002|NOT COMPLETED|Paired Outreach||0||0
48630640|NCT04585919|101878636|FG003|NOT COMPLETED|Paired Outreach||0||0
48630641|NCT02858401|101878637|FG000|STARTED|Overall Study||6||
48630642|NCT02858401|101878638|FG001|STARTED|Overall Study||6||
48630643|NCT02858401|101878639|FG002|STARTED|Overall Study||6||
48630644|NCT02858401|101878640|FG003|STARTED|Overall Study||6||
48630645|NCT02858401|101878641|FG004|STARTED|Overall Study||6||
48753095|NCT01650298|102184398|FG001|NOT COMPLETED|Overall Study||6||
48753096|NCT04999839|102184399|FG000|STARTED|Overall Study||52||
48753097|NCT04999839|102184400|FG001|STARTED|Overall Study||50||
48753098|NCT04999839|102184401|FG002|STARTED|Overall Study||52||
48753099|NCT04999839|102184402|FG003|STARTED|Overall Study||53||
48630646|NCT02858401|101878642|FG005|STARTED|Overall Study||6||
48630647|NCT02858401|101878643|FG006|STARTED|Overall Study||12||
48630648|NCT02858401|101878637|FG000|COMPLETED|Overall Study||6||
48630649|NCT02858401|101878638|FG001|COMPLETED|Overall Study||5||
48630650|NCT02858401|101878639|FG002|COMPLETED|Overall Study||6||
48630651|NCT02858401|101878640|FG003|COMPLETED|Overall Study||6||
48630652|NCT02858401|101878641|FG004|COMPLETED|Overall Study||6||
48630653|NCT02858401|101878642|FG005|COMPLETED|Overall Study||5||
48630654|NCT02858401|101878643|FG006|COMPLETED|Overall Study||12||
48630655|NCT02858401|101878637|FG000|NOT COMPLETED|Overall Study||0||
48630656|NCT02858401|101878638|FG001|NOT COMPLETED|Overall Study||1||
48753100|NCT04999839|102184403|FG004|STARTED|Overall Study||52||
48630657|NCT02858401|101878639|FG002|NOT COMPLETED|Overall Study||0||
48630658|NCT02858401|101878640|FG003|NOT COMPLETED|Overall Study||0||
48630659|NCT02858401|101878641|FG004|NOT COMPLETED|Overall Study||0||
48630660|NCT02858401|101878642|FG005|NOT COMPLETED|Overall Study||1||
48630661|NCT02858401|101878643|FG006|NOT COMPLETED|Overall Study||0||
48630662|NCT02184208|101878644|FG000|STARTED|Overall Study||278||
48175828|NCT04374500|100753822|FG002|NOT COMPLETED|Overall Study||0||
48175829|NCT03580356|100753823|FG000|STARTED|Treatment Period||307||
48175830|NCT03580356|100753824|FG001|STARTED|Treatment Period||16||
48175831|NCT03580356|100753825|FG002|STARTED|Treatment Period||304||
48175832|NCT03580356|100753826|FG003|STARTED|Treatment Period||19||
48175833|NCT03580356|100753827|FG004|STARTED|Treatment Period||309||
48630663|NCT02184208|101878644|FG000|COMPLETED|Overall Study||222||
48630664|NCT02184208|101878644|FG000|NOT COMPLETED|Overall Study||56||
48630665|NCT00626639|101878645|FG000|STARTED|Overall Study||2||
48630666|NCT00626639|101878646|FG001|STARTED|Overall Study||3||
48753101|NCT04999839|102184399|FG000|COMPLETED|Overall Study||43||
48753102|NCT04999839|102184400|FG001|COMPLETED|Overall Study||42||
48753103|NCT04999839|102184401|FG002|COMPLETED|Overall Study||45||
48175834|NCT03580356|100753828|FG005|STARTED|Treatment Period||14||
48175835|NCT03580356|100753829|FG006|STARTED|Treatment Period||103||
48175836|NCT03580356|100753830|FG007|STARTED|Treatment Period||6||
48412812|NCT01610414|101342091|FG001|STARTED|Month 13 - Month 25||924||
48175837|NCT03580356|100753823|FG000|Randomized Set (RAN)|Treatment Period||307||
48175838|NCT03580356|100753824|FG001|Randomized Set (RAN)|Treatment Period||16||
48175839|NCT03580356|100753825|FG002|Randomized Set (RAN)|Treatment Period||304||
48175840|NCT03580356|100753826|FG003|Randomized Set (RAN)|Treatment Period||19||
48175841|NCT03580356|100753827|FG004|Randomized Set (RAN)|Treatment Period||309||
48175842|NCT03580356|100753828|FG005|Randomized Set (RAN)|Treatment Period||14||
48175843|NCT03580356|100753829|FG006|Randomized Set (RAN)|Treatment Period||103||
48175844|NCT03580356|100753830|FG007|Randomized Set (RAN)|Treatment Period||6||
48175845|NCT03580356|100753823|FG000|Safety Set (SAF)|Treatment Period||304||
48175846|NCT03580356|100753824|FG001|Safety Set (SAF)|Treatment Period||16||
48175847|NCT03580356|100753825|FG002|Safety Set (SAF)|Treatment Period||306||
48175848|NCT03580356|100753826|FG003|Safety Set (SAF)|Treatment Period||19||
48175849|NCT03580356|100753827|FG004|Safety Set (SAF)|Treatment Period||307||
48175850|NCT03580356|100753828|FG005|Safety Set (SAF)|Treatment Period||14||
48175851|NCT03580356|100753829|FG006|Safety Set (SAF)|Treatment Period||103||
48175852|NCT03580356|100753830|FG007|Safety Set (SAF)|Treatment Period||6||
48175853|NCT03580356|100753823|FG000|Full Analysis Set (FAS)|Treatment Period||307||
48175854|NCT03580356|100753824|FG001|Full Analysis Set (FAS)|Treatment Period||16||
48175855|NCT03580356|100753825|FG002|Full Analysis Set (FAS)|Treatment Period||303||
48175856|NCT03580356|100753826|FG003|Full Analysis Set (FAS)|Treatment Period||19||
48175857|NCT03580356|100753827|FG004|Full Analysis Set (FAS)|Treatment Period||307||
48175858|NCT03580356|100753828|FG005|Full Analysis Set (FAS)|Treatment Period||14||
48175859|NCT03580356|100753829|FG006|Full Analysis Set (FAS)|Treatment Period||103||
48175860|NCT03580356|100753830|FG007|Full Analysis Set (FAS)|Treatment Period||6||
48336755|NCT00132730|101152134|FG001|STARTED|Period I - Placebo Run-in (Base)||148||
48336756|NCT00132730|101152135|FG002|STARTED|Period I - Placebo Run-in (Base)||153||
48336757|NCT00132730|101152136|FG003|STARTED|Period I - Placebo Run-in (Base)||153||
48336758|NCT00132730|101152137|FG004|STARTED|Period I - Placebo Run-in (Base)||0||
48336759|NCT00132730|101152138|FG005|STARTED|Period I - Placebo Run-in (Base)||0||
48336760|NCT00132730|101152133|FG000|COMPLETED|Period I - Placebo Run-in (Base)||150||
48336761|NCT00132730|101152134|FG001|COMPLETED|Period I - Placebo Run-in (Base)||148||
48336762|NCT00132730|101152135|FG002|COMPLETED|Period I - Placebo Run-in (Base)||153||
48412813|NCT01610414|101342090|FG000|COMPLETED|Month 13 - Month 25||857||
48412814|NCT01610414|101342091|FG001|COMPLETED|Month 13 - Month 25||854||
48630667|NCT00626639|101878645|FG000|COMPLETED|Overall Study||0||
48630668|NCT00626639|101878646|FG001|COMPLETED|Overall Study||1||
48753104|NCT04999839|102184402|FG003|COMPLETED|Overall Study||46||
48175861|NCT03580356|100753823|FG000|COMPLETED|Treatment Period||269||
48175862|NCT03580356|100753824|FG001|COMPLETED|Treatment Period||15||
48175863|NCT03580356|100753825|FG002|COMPLETED|Treatment Period||259||
48175864|NCT03580356|100753826|FG003|COMPLETED|Treatment Period||17||
48175865|NCT03580356|100753827|FG004|COMPLETED|Treatment Period||263||
48175866|NCT03580356|100753828|FG005|COMPLETED|Treatment Period||13||
48175867|NCT03580356|100753829|FG006|COMPLETED|Treatment Period||82||
48175868|NCT03580356|100753830|FG007|COMPLETED|Treatment Period||6||
48175869|NCT03580356|100753823|FG000|NOT COMPLETED|Treatment Period||38||
48175870|NCT03580356|100753824|FG001|NOT COMPLETED|Treatment Period||1||
48175871|NCT03580356|100753825|FG002|NOT COMPLETED|Treatment Period||45||
48630669|NCT00626639|101878645|FG000|NOT COMPLETED|Overall Study||2||
48630670|NCT00626639|101878646|FG001|NOT COMPLETED|Overall Study||2||
48630671|NCT01225549|101878647|FG000|STARTED|Period 1 - First Treatment Period||1||
48630672|NCT01225549|101878648|FG001|STARTED|Period 1 - First Treatment Period||4||
48630673|NCT01225549|101878649|FG002|STARTED|Period 1 - First Treatment Period||3||
48630674|NCT01225549|101878650|FG003|STARTED|Period 1 - First Treatment Period||1||
48630675|NCT01225549|101878651|FG004|STARTED|Period 1 - First Treatment Period||1||
48753105|NCT04999839|102184403|FG004|COMPLETED|Overall Study||47||
48753106|NCT04999839|102184399|FG000|NOT COMPLETED|Overall Study||9||
48630676|NCT01225549|101878652|FG005|STARTED|Period 1 - First Treatment Period||1||
48630677|NCT01225549|101878653|FG006|STARTED|Period 1 - First Treatment Period||3||
48630678|NCT01225549|101878654|FG007|STARTED|Period 1 - First Treatment Period||1||
48630679|NCT01225549|101878655|FG008|STARTED|Period 1 - First Treatment Period||4||
48630680|NCT01225549|101878656|FG009|STARTED|Period 1 - First Treatment Period||1||
48630681|NCT01225549|101878647|FG000|COMPLETED|Period 1 - First Treatment Period||1||
48630682|NCT01225549|101878648|FG001|COMPLETED|Period 1 - First Treatment Period||4||
48630683|NCT01225549|101878649|FG002|COMPLETED|Period 1 - First Treatment Period||3||
48630684|NCT01225549|101878650|FG003|COMPLETED|Period 1 - First Treatment Period||1||
48630685|NCT01225549|101878651|FG004|COMPLETED|Period 1 - First Treatment Period||1||
48175872|NCT03580356|100753826|FG003|NOT COMPLETED|Treatment Period||2||
48175873|NCT03580356|100753827|FG004|NOT COMPLETED|Treatment Period||46||
48175874|NCT03580356|100753828|FG005|NOT COMPLETED|Treatment Period||1||
48175875|NCT03580356|100753829|FG006|NOT COMPLETED|Treatment Period||21||
48175876|NCT03580356|100753830|FG007|NOT COMPLETED|Treatment Period||0||
48175877|NCT03580356|100753823|FG000|STARTED|Post-treatment Follow Up Period||272|Entered post-treatment follow up period|
48175878|NCT03580356|100753824|FG001|STARTED|Post-treatment Follow Up Period||15|Entered post-treatment follow up period|
48175879|NCT03580356|100753825|FG002|STARTED|Post-treatment Follow Up Period||275|Entered post-treatment follow up period|
48175880|NCT03580356|100753826|FG003|STARTED|Post-treatment Follow Up Period||18|Entered post-treatment follow up period|
48175881|NCT03580356|100753827|FG004|STARTED|Post-treatment Follow Up Period||265|Entered post-treatment follow up period|
48175882|NCT03580356|100753828|FG005|STARTED|Post-treatment Follow Up Period||13|Entered post-treatment follow up period|
48175883|NCT03580356|100753829|FG006|STARTED|Post-treatment Follow Up Period||89|Entered post-treatment follow up period|
48175884|NCT03580356|100753830|FG007|STARTED|Post-treatment Follow Up Period||6|Entered post-treatment follow up period|
48175885|NCT03580356|100753823|FG000|COMPLETED|Post-treatment Follow Up Period||260||
48175886|NCT03580356|100753824|FG001|COMPLETED|Post-treatment Follow Up Period||15||
48175887|NCT03580356|100753825|FG002|COMPLETED|Post-treatment Follow Up Period||256||
48175888|NCT03580356|100753826|FG003|COMPLETED|Post-treatment Follow Up Period||17||
48336763|NCT00132730|101152136|FG003|COMPLETED|Period I - Placebo Run-in (Base)||153||
48630686|NCT01225549|101878652|FG005|COMPLETED|Period 1 - First Treatment Period||1||
48630687|NCT01225549|101878653|FG006|COMPLETED|Period 1 - First Treatment Period||3||
48630688|NCT01225549|101878654|FG007|COMPLETED|Period 1 - First Treatment Period||1||
48630689|NCT01225549|101878655|FG008|COMPLETED|Period 1 - First Treatment Period||4||
48630690|NCT01225549|101878656|FG009|COMPLETED|Period 1 - First Treatment Period||1||
48630691|NCT01225549|101878647|FG000|NOT COMPLETED|Period 1 - First Treatment Period||0||
48630692|NCT01225549|101878648|FG001|NOT COMPLETED|Period 1 - First Treatment Period||0||
48630693|NCT01225549|101878649|FG002|NOT COMPLETED|Period 1 - First Treatment Period||0||
48630694|NCT01225549|101878650|FG003|NOT COMPLETED|Period 1 - First Treatment Period||0||
48175889|NCT03580356|100753827|FG004|COMPLETED|Post-treatment Follow Up Period||259||
48175890|NCT03580356|100753828|FG005|COMPLETED|Post-treatment Follow Up Period||13||
48175891|NCT03580356|100753829|FG006|COMPLETED|Post-treatment Follow Up Period||82||
48175892|NCT03580356|100753830|FG007|COMPLETED|Post-treatment Follow Up Period||5||
48175893|NCT03580356|100753823|FG000|NOT COMPLETED|Post-treatment Follow Up Period||12||
48175894|NCT03580356|100753824|FG001|NOT COMPLETED|Post-treatment Follow Up Period||0||
48175895|NCT03580356|100753825|FG002|NOT COMPLETED|Post-treatment Follow Up Period||19||
48175896|NCT03580356|100753826|FG003|NOT COMPLETED|Post-treatment Follow Up Period||1||
48175897|NCT03580356|100753827|FG004|NOT COMPLETED|Post-treatment Follow Up Period||6||
48175898|NCT03580356|100753828|FG005|NOT COMPLETED|Post-treatment Follow Up Period||0||
48175899|NCT03580356|100753829|FG006|NOT COMPLETED|Post-treatment Follow Up Period||7||
48175900|NCT03580356|100753830|FG007|NOT COMPLETED|Post-treatment Follow Up Period||1||
48175901|NCT04934137|100753831|FG000|STARTED|Overall Study||23|Includes only participants who completed the baseline data collection, prior to intervention periods.|
48175902|NCT04934137|100753832|FG001|STARTED|Overall Study||23|Includes only participants who completed the baseline data collection, prior to intervention periods.|
48188642|NCT05257837|100783294|FG000|NOT COMPLETED|Overall Study||4||
48188643|NCT05257837|100783295|FG001|NOT COMPLETED|Overall Study||2||
48336764|NCT00132730|101152137|FG004|COMPLETED|Period I - Placebo Run-in (Base)||0||
48336765|NCT00132730|101152138|FG005|COMPLETED|Period I - Placebo Run-in (Base)||0||
48336766|NCT00132730|101152133|FG000|NOT COMPLETED|Period I - Placebo Run-in (Base)||0||
48336767|NCT00132730|101152134|FG001|NOT COMPLETED|Period I - Placebo Run-in (Base)||0||
48336768|NCT00132730|101152135|FG002|NOT COMPLETED|Period I - Placebo Run-in (Base)||0||
48336769|NCT00132730|101152136|FG003|NOT COMPLETED|Period I - Placebo Run-in (Base)||0||
48336770|NCT00132730|101152137|FG004|NOT COMPLETED|Period I - Placebo Run-in (Base)||0||
48336771|NCT00132730|101152138|FG005|NOT COMPLETED|Period I - Placebo Run-in (Base)||0||
48336772|NCT00132730|101152133|FG000|STARTED|Period II - 12-week Treatment (Base)||150||
48336773|NCT00132730|101152134|FG001|STARTED|Period II - 12-week Treatment (Base)||148||
48336774|NCT00132730|101152135|FG002|STARTED|Period II - 12-week Treatment (Base)||153||
48336775|NCT00132730|101152136|FG003|STARTED|Period II - 12-week Treatment (Base)||153||
48336776|NCT00132730|101152137|FG004|STARTED|Period II - 12-week Treatment (Base)||0||
48630695|NCT01225549|101878651|FG004|NOT COMPLETED|Period 1 - First Treatment Period||0||
48657130|NCT04419389|101943784|FG000|NOT COMPLETED|Overall Study||1||
48412815|NCT01610414|101342090|FG000|NOT COMPLETED|Month 13 - Month 25||65||
48412816|NCT01610414|101342091|FG001|NOT COMPLETED|Month 13 - Month 25||70||
48412817|NCT01610414|101342090|FG000|STARTED|After Month 25||922||
48412818|NCT01610414|101342091|FG001|STARTED|After Month 25||924||
48412819|NCT01610414|101342090|FG000|COMPLETED|After Month 25||874||
48412820|NCT01610414|101342091|FG001|COMPLETED|After Month 25||871||
48175903|NCT04934137|100753831|FG000|Completed Baseline and Both Interventions|Overall Study||15|"Includes participants who completed at least baseline and 2 intervention periods. This milestone should occur time-wise after the Completed milestone, but for analysis purposes it has been added as clarifying information per the comments. Participants who completed baseline and at least 1 intervention period are included as Completed and were analyzed."|
48175904|NCT04934137|100753832|FG001|Completed Baseline and Both Interventions|Overall Study||14|"Includes participants who completed at least baseline and 2 intervention periods. This milestone should occur time-wise after the Completed milestone, but for analysis purposes it has been added as clarifying information per the comments. Participants who completed baseline and at least 1 intervention period are included as Completed and were analyzed."|
48175905|NCT04934137|100753831|FG000|COMPLETED|Overall Study||21|Includes participants who completed at least baseline and 1 intervention period.|
48175906|NCT04934137|100753832|FG001|COMPLETED|Overall Study||20|Includes participants who completed at least baseline and 1 intervention period.|
48412821|NCT01610414|101342090|FG000|NOT COMPLETED|After Month 25||48||
48175907|NCT04934137|100753831|FG000|NOT COMPLETED|Overall Study||2||
48175908|NCT04934137|100753832|FG001|NOT COMPLETED|Overall Study||3||
48175909|NCT03745794|100753833|FG000|STARTED|Overall Study||52||
48175910|NCT03745794|100753834|FG001|STARTED|Overall Study||54||
48175911|NCT03745794|100753833|FG000|COMPLETED|Overall Study||52||
48175912|NCT03745794|100753834|FG001|COMPLETED|Overall Study||53||
48175913|NCT03745794|100753833|FG000|NOT COMPLETED|Overall Study||0||
48175914|NCT03745794|100753834|FG001|NOT COMPLETED|Overall Study||1||
48175915|NCT03008122|100753835|FG000|STARTED|Overall Study||36||
48175916|NCT03008122|100753836|FG001|STARTED|Overall Study||45||
48175917|NCT03008122|100753837|FG002|STARTED|Overall Study||10||
48175918|NCT03008122|100753835|FG000|COMPLETED|Overall Study||26||
48175919|NCT03008122|100753836|FG001|COMPLETED|Overall Study||32||
48175920|NCT03008122|100753837|FG002|COMPLETED|Overall Study||6||
48175921|NCT03008122|100753835|FG000|NOT COMPLETED|Overall Study||10||
48175922|NCT03008122|100753836|FG001|NOT COMPLETED|Overall Study||13||
48175923|NCT03008122|100753837|FG002|NOT COMPLETED|Overall Study||4||
48175924|NCT00654329|100753838|FG000|STARTED|Overall Study||23||
48412822|NCT01610414|101342091|FG001|NOT COMPLETED|After Month 25||53||
48412823|NCT00908050|101342092|FG000|STARTED|Overall Study||10||
48412824|NCT00908050|101342093|FG001|STARTED|Overall Study||13||
48412825|NCT00908050|101342092|FG000|COMPLETED|Overall Study||10||
48412826|NCT00908050|101342093|FG001|COMPLETED|Overall Study||13||
48175925|NCT00654329|100753839|FG001|STARTED|Overall Study||28||
48175926|NCT00654329|100753840|FG002|STARTED|Overall Study||23||
48175927|NCT00654329|100753841|FG003|STARTED|Overall Study||27||
48175928|NCT00654329|100753838|FG000|COMPLETED|Overall Study||23||
48175929|NCT00654329|100753839|FG001|COMPLETED|Overall Study||28||
48175930|NCT00654329|100753840|FG002|COMPLETED|Overall Study||23||
48175931|NCT00654329|100753841|FG003|COMPLETED|Overall Study||27||
48175932|NCT00654329|100753838|FG000|NOT COMPLETED|Overall Study||0||
48175933|NCT00654329|100753839|FG001|NOT COMPLETED|Overall Study||0||
48175934|NCT00654329|100753840|FG002|NOT COMPLETED|Overall Study||0||
48175935|NCT00654329|100753841|FG003|NOT COMPLETED|Overall Study||0||
48175936|NCT01165840|100753842|FG000|STARTED|Overall Study||36||
48175937|NCT01165840|100753842|FG000|COMPLETED|Overall Study||36||
48175938|NCT01165840|100753842|FG000|NOT COMPLETED|Overall Study||0||
48175939|NCT02632786|100753843|FG000|STARTED|Overall Study||66||
48175940|NCT02632786|100753844|FG001|STARTED|Overall Study||63||
48175941|NCT02632786|100753843|FG000|Informed Consent Obtained|Overall Study||66||
48175942|NCT02632786|100753844|FG001|Informed Consent Obtained|Overall Study||63||
48412827|NCT00908050|101342092|FG000|NOT COMPLETED|Overall Study||0||
48412828|NCT00908050|101342093|FG001|NOT COMPLETED|Overall Study||0||
48412829|NCT01250899|101342094|FG000|STARTED|Overall Study||40||
48412830|NCT01250899|101342095|FG001|STARTED|Overall Study||82||
48412831|NCT01250899|101342094|FG000|COMPLETED|Overall Study||40||
48412832|NCT01250899|101342095|FG001|COMPLETED|Overall Study||82||
48412833|NCT01250899|101342094|FG000|NOT COMPLETED|Overall Study||0||
48412834|NCT01250899|101342095|FG001|NOT COMPLETED|Overall Study||0||
48175943|NCT02632786|100753843|FG000|Randomized and Dosed|Overall Study||66||
48175944|NCT02632786|100753844|FG001|Randomized and Dosed|Overall Study||63||
48175945|NCT02632786|100753843|FG000|COMPLETED|Overall Study||55||
48175946|NCT02632786|100753844|FG001|COMPLETED|Overall Study||56||
48175947|NCT02632786|100753843|FG000|NOT COMPLETED|Overall Study||11||
48175948|NCT02632786|100753844|FG001|NOT COMPLETED|Overall Study||7||
48412835|NCT02735044|101345708|FG000|STARTED|Overall Study||233||
48630696|NCT01225549|101878652|FG005|NOT COMPLETED|Period 1 - First Treatment Period||0||
48630697|NCT01225549|101878653|FG006|NOT COMPLETED|Period 1 - First Treatment Period||0||
48630698|NCT01225549|101878654|FG007|NOT COMPLETED|Period 1 - First Treatment Period||0||
48630699|NCT01225549|101878655|FG008|NOT COMPLETED|Period 1 - First Treatment Period||0||
48630700|NCT01225549|101878656|FG009|NOT COMPLETED|Period 1 - First Treatment Period||0||
48630701|NCT01225549|101878647|FG000|STARTED|Period 2 - Washout||1||
48630702|NCT01225549|101878648|FG001|STARTED|Period 2 - Washout||4||
48630703|NCT01225549|101878649|FG002|STARTED|Period 2 - Washout||3||
48630704|NCT01225549|101878650|FG003|STARTED|Period 2 - Washout||1||
48630705|NCT01225549|101878651|FG004|STARTED|Period 2 - Washout||1||
48630706|NCT01225549|101878652|FG005|STARTED|Period 2 - Washout||1||
48630707|NCT01225549|101878653|FG006|STARTED|Period 2 - Washout||3||
48175949|NCT00849680|100753845|FG000|STARTED|Overall Study||27||
48175950|NCT00849680|100753846|FG001|STARTED|Overall Study||13||
48175951|NCT00849680|100753847|FG002|STARTED|Overall Study||42||
48175952|NCT00849680|100753848|FG003|STARTED|Overall Study||42||
48175953|NCT00849680|100753849|FG004|STARTED|Overall Study||42||
48175954|NCT00849680|100753850|FG005|STARTED|Overall Study||42||
48175955|NCT00849680|100753851|FG006|STARTED|Overall Study||78||
48175956|NCT00849680|100753852|FG007|STARTED|Overall Study||31||
48175957|NCT00849680|100753845|FG000|COMPLETED|Overall Study||16||
48175958|NCT00849680|100753846|FG001|COMPLETED|Overall Study||10||
48175959|NCT00849680|100753847|FG002|COMPLETED|Overall Study||27||
48175960|NCT00849680|100753848|FG003|COMPLETED|Overall Study||28||
48175961|NCT00849680|100753849|FG004|COMPLETED|Overall Study||32||
48175962|NCT00849680|100753850|FG005|COMPLETED|Overall Study||27||
48175963|NCT00849680|100753851|FG006|COMPLETED|Overall Study||61||
48175964|NCT00849680|100753852|FG007|COMPLETED|Overall Study||23||
48336777|NCT00132730|101152138|FG005|STARTED|Period II - 12-week Treatment (Base)||0||
48336778|NCT00132730|101152133|FG000|COMPLETED|Period II - 12-week Treatment (Base)||127||
48336779|NCT00132730|101152134|FG001|COMPLETED|Period II - 12-week Treatment (Base)||133||
48336780|NCT00132730|101152135|FG002|COMPLETED|Period II - 12-week Treatment (Base)||135||
48336781|NCT00132730|101152136|FG003|COMPLETED|Period II - 12-week Treatment (Base)||131||
48336782|NCT00132730|101152137|FG004|COMPLETED|Period II - 12-week Treatment (Base)||0||
48336783|NCT00132730|101152138|FG005|COMPLETED|Period II - 12-week Treatment (Base)||0||
48336784|NCT00132730|101152133|FG000|NOT COMPLETED|Period II - 12-week Treatment (Base)||23||
48336785|NCT00132730|101152134|FG001|NOT COMPLETED|Period II - 12-week Treatment (Base)||15||
48336786|NCT00132730|101152135|FG002|NOT COMPLETED|Period II - 12-week Treatment (Base)||18||
48336787|NCT00132730|101152136|FG003|NOT COMPLETED|Period II - 12-week Treatment (Base)||22||
48412836|NCT02735044|101345709|FG001|STARTED|Overall Study||230||
48175965|NCT00849680|100753845|FG000|NOT COMPLETED|Overall Study||11||
48175966|NCT00849680|100753846|FG001|NOT COMPLETED|Overall Study||3||
48412837|NCT02735044|101345708|FG000|Treated|Overall Study||233||
48412838|NCT02735044|101345709|FG001|Treated|Overall Study||228||
48630708|NCT01225549|101878654|FG007|STARTED|Period 2 - Washout||1||
48630709|NCT01225549|101878655|FG008|STARTED|Period 2 - Washout||4||
48175967|NCT00849680|100753847|FG002|NOT COMPLETED|Overall Study||15||
48175968|NCT00849680|100753848|FG003|NOT COMPLETED|Overall Study||14||
48175969|NCT00849680|100753849|FG004|NOT COMPLETED|Overall Study||10||
48175970|NCT00849680|100753850|FG005|NOT COMPLETED|Overall Study||15||
48175971|NCT00849680|100753851|FG006|NOT COMPLETED|Overall Study||17||
48175972|NCT00849680|100753852|FG007|NOT COMPLETED|Overall Study||8||
48175973|NCT00249496|100753853|FG000|STARTED|Overall Study||24||
48175974|NCT00249496|100753854|FG001|STARTED|Overall Study||27||
48175975|NCT00249496|100753853|FG000|COMPLETED|Overall Study||24||
48175976|NCT00249496|100753854|FG001|COMPLETED|Overall Study||26||
48175977|NCT00249496|100753853|FG000|NOT COMPLETED|Overall Study||0||
48175978|NCT00249496|100753854|FG001|NOT COMPLETED|Overall Study||1||
48175979|NCT01364727|100753855|FG000|STARTED|Overall Study||35||
48175980|NCT01364727|100753855|FG000|COMPLETED|Overall Study||33||
48175981|NCT01364727|100753855|FG000|NOT COMPLETED|Overall Study||2||
48175982|NCT00154063|100753856|FG000|STARTED|Overall Study||104||
48175983|NCT00154063|100753857|FG001|STARTED|Overall Study||102||
48175984|NCT00154063|100753856|FG000|COMPLETED|Overall Study||92||
48175985|NCT00154063|100753857|FG001|COMPLETED|Overall Study||80||
48175986|NCT00154063|100753856|FG000|NOT COMPLETED|Overall Study||12||
48175987|NCT00154063|100753857|FG001|NOT COMPLETED|Overall Study||22||
48175988|NCT00786474|100753858|FG000|STARTED|Overall Study||950||
48175989|NCT00786474|100753859|FG001|STARTED|Overall Study||934||
48175990|NCT00786474|100753858|FG000|COMPLETED|Overall Study||913||
48175991|NCT00786474|100753859|FG001|COMPLETED|Overall Study||891||
48175992|NCT00786474|100753858|FG000|NOT COMPLETED|Overall Study||37||
48175993|NCT00786474|100753859|FG001|NOT COMPLETED|Overall Study||43||
48175994|NCT01927718|100753860|FG000|STARTED|Overall Study||10||
48175995|NCT01927718|100753860|FG000|COMPLETED|Overall Study||10||
48175996|NCT01927718|100753860|FG000|NOT COMPLETED|Overall Study||0||
48175997|NCT04957732|100753861|FG000|STARTED|Overall Study||19||
48175998|NCT04957732|100753862|FG001|STARTED|Overall Study||16||
48175999|NCT04957732|100753861|FG000|COMPLETED|Overall Study||18||
48176000|NCT04957732|100753862|FG001|COMPLETED|Overall Study||12||
48176001|NCT04957732|100753861|FG000|NOT COMPLETED|Overall Study||1||
48176002|NCT04957732|100753862|FG001|NOT COMPLETED|Overall Study||4||
48176003|NCT00312858|100753863|FG000|STARTED|Overall Study||330||
48176004|NCT00312858|100753864|FG001|STARTED|Overall Study||323||
48176005|NCT00312858|100753863|FG000|Visit 1|Overall Study||330||
48630710|NCT01225549|101878656|FG009|STARTED|Period 2 - Washout||1||
48176006|NCT00312858|100753864|FG001|Visit 1|Overall Study||323||
48630711|NCT01225549|101878647|FG000|COMPLETED|Period 2 - Washout||1||
48630712|NCT01225549|101878648|FG001|COMPLETED|Period 2 - Washout||4||
48630713|NCT01225549|101878649|FG002|COMPLETED|Period 2 - Washout||3||
48630714|NCT01225549|101878650|FG003|COMPLETED|Period 2 - Washout||1||
48630715|NCT01225549|101878651|FG004|COMPLETED|Period 2 - Washout||1||
48630716|NCT01225549|101878652|FG005|COMPLETED|Period 2 - Washout||1||
48630717|NCT01225549|101878653|FG006|COMPLETED|Period 2 - Washout||3||
48630718|NCT01225549|101878654|FG007|COMPLETED|Period 2 - Washout||1||
48630719|NCT01225549|101878655|FG008|COMPLETED|Period 2 - Washout||4||
48630720|NCT01225549|101878656|FG009|COMPLETED|Period 2 - Washout||1||
48630721|NCT01225549|101878647|FG000|NOT COMPLETED|Period 2 - Washout||0||
48630722|NCT01225549|101878648|FG001|NOT COMPLETED|Period 2 - Washout||0||
48630723|NCT01225549|101878649|FG002|NOT COMPLETED|Period 2 - Washout||0||
48630724|NCT01225549|101878650|FG003|NOT COMPLETED|Period 2 - Washout||0||
48630725|NCT01225549|101878651|FG004|NOT COMPLETED|Period 2 - Washout||0||
48630726|NCT01225549|101878652|FG005|NOT COMPLETED|Period 2 - Washout||0||
48630727|NCT01225549|101878653|FG006|NOT COMPLETED|Period 2 - Washout||0||
48630728|NCT01225549|101878654|FG007|NOT COMPLETED|Period 2 - Washout||0||
48176007|NCT00312858|100753863|FG000|Visit 2|Overall Study||305||
48176008|NCT00312858|100753864|FG001|Visit 2|Overall Study||294||
48176009|NCT00312858|100753863|FG000|Visit 3|Overall Study||273||
48176010|NCT00312858|100753864|FG001|Visit 3|Overall Study||261||
48176011|NCT00312858|100753863|FG000|Visit 4|Overall Study||262||
48176012|NCT00312858|100753864|FG001|Visit 4|Overall Study||240||
48176013|NCT00312858|100753863|FG000|COMPLETED|Overall Study||262||
48336788|NCT00132730|101152137|FG004|NOT COMPLETED|Period II - 12-week Treatment (Base)||0||
48630729|NCT01225549|101878655|FG008|NOT COMPLETED|Period 2 - Washout||0||
48176014|NCT00312858|100753864|FG001|COMPLETED|Overall Study||230||
48176015|NCT00312858|100753863|FG000|NOT COMPLETED|Overall Study||68||
48176016|NCT00312858|100753864|FG001|NOT COMPLETED|Overall Study||93||
48176017|NCT03040687|100753865|FG000|STARTED|Overall Study||20||
48176018|NCT03040687|100753866|FG001|STARTED|Overall Study||20||
48176019|NCT03040687|100753867|FG002|STARTED|Overall Study||20||
48176020|NCT03040687|100753865|FG000|COMPLETED|Overall Study||19||
48176021|NCT03040687|100753866|FG001|COMPLETED|Overall Study||20||
48176022|NCT03040687|100753867|FG002|COMPLETED|Overall Study||20||
48630730|NCT01225549|101878656|FG009|NOT COMPLETED|Period 2 - Washout||0||
48630731|NCT01225549|101878647|FG000|STARTED|Period 3 - Second Treatment Period||1||
48630732|NCT01225549|101878648|FG001|STARTED|Period 3 - Second Treatment Period||4||
48176023|NCT03040687|100753865|FG000|NOT COMPLETED|Overall Study||1||
48176024|NCT03040687|100753866|FG001|NOT COMPLETED|Overall Study||0||
48176025|NCT03040687|100753867|FG002|NOT COMPLETED|Overall Study||0||
48176026|NCT00214903|100753868|FG000|STARTED|Overall Study||10043||
48176027|NCT00214903|100753869|FG001|STARTED|Overall Study||13384||
48176028|NCT00214903|100753870|FG002|STARTED|Overall Study||4113||
48176029|NCT00214903|100753871|FG003|STARTED|Overall Study||3057||
48630733|NCT01225549|101878649|FG002|STARTED|Period 3 - Second Treatment Period||3||
48176030|NCT00214903|100753868|FG000|COMPLETED|Overall Study||10043||
48176031|NCT00214903|100753869|FG001|COMPLETED|Overall Study||13384||
48176032|NCT00214903|100753870|FG002|COMPLETED|Overall Study||4113||
48176033|NCT00214903|100753871|FG003|COMPLETED|Overall Study||3057||
48176034|NCT00214903|100753868|FG000|NOT COMPLETED|Overall Study||0||
48176035|NCT00214903|100753869|FG001|NOT COMPLETED|Overall Study||0||
48176036|NCT00214903|100753870|FG002|NOT COMPLETED|Overall Study||0||
48176037|NCT00214903|100753871|FG003|NOT COMPLETED|Overall Study||0||
48176038|NCT00794820|100753872|FG000|STARTED|Overall Study||66||
48176039|NCT00794820|100753872|FG000|COMPLETED|Overall Study||50||
48176040|NCT00794820|100753872|FG000|NOT COMPLETED|Overall Study||16||
48176041|NCT03604263|100753873|FG000|STARTED|Overall Study||17||
48176042|NCT03604263|100753873|FG000|COMPLETED|Overall Study||15||
48176043|NCT03604263|100753873|FG000|NOT COMPLETED|Overall Study||2||
48176044|NCT00211237|100753874|FG000|STARTED|Baseline||70||
48176045|NCT00211237|100753875|FG001|STARTED|Baseline||64||
48176046|NCT00211237|100753876|FG002|STARTED|Baseline||0||
48176047|NCT00211237|100753874|FG000|COMPLETED|Baseline||68||
48176048|NCT00211237|100753875|FG001|COMPLETED|Baseline||61||
48176049|NCT00211237|100753876|FG002|COMPLETED|Baseline||0||
48176050|NCT00211237|100753874|FG000|NOT COMPLETED|Baseline||2||
48176051|NCT00211237|100753875|FG001|NOT COMPLETED|Baseline||3||
48176052|NCT00211237|100753876|FG002|NOT COMPLETED|Baseline||0||
48176053|NCT00211237|100753874|FG000|STARTED|1 Month||68||
48176054|NCT00211237|100753875|FG001|STARTED|1 Month||61||
48176055|NCT00211237|100753876|FG002|STARTED|1 Month||0||
48176056|NCT00211237|100753874|FG000|COMPLETED|1 Month||65||
48176057|NCT00211237|100753875|FG001|COMPLETED|1 Month||52||
48176058|NCT00211237|100753876|FG002|COMPLETED|1 Month||0||
48176059|NCT00211237|100753874|FG000|NOT COMPLETED|1 Month||3||
48176060|NCT00211237|100753875|FG001|NOT COMPLETED|1 Month||9||
48176061|NCT00211237|100753876|FG002|NOT COMPLETED|1 Month||0||
48176062|NCT00211237|100753874|FG000|STARTED|3 Months||65||
48176063|NCT00211237|100753875|FG001|STARTED|3 Months||18||
48176064|NCT00211237|100753876|FG002|STARTED|3 Months||34||
48176065|NCT00211237|100753874|FG000|COMPLETED|3 Months||57||
48176066|NCT00211237|100753875|FG001|COMPLETED|3 Months||14||
48176067|NCT00211237|100753876|FG002|COMPLETED|3 Months||33||
48176068|NCT00211237|100753874|FG000|NOT COMPLETED|3 Months||8||
48753107|NCT04999839|102184400|FG001|NOT COMPLETED|Overall Study||8||
48753108|NCT04999839|102184401|FG002|NOT COMPLETED|Overall Study||7||
48753109|NCT04999839|102184402|FG003|NOT COMPLETED|Overall Study||7||
48753110|NCT04999839|102184403|FG004|NOT COMPLETED|Overall Study||5||
48753111|NCT00399516|102184404|FG000|STARTED|Overall Study||21||
48753112|NCT00399516|102184404|FG000|COMPLETED|Overall Study||19||
48753113|NCT00399516|102184404|FG000|NOT COMPLETED|Overall Study||2||
48176069|NCT00211237|100753875|FG001|NOT COMPLETED|3 Months||4||
48176070|NCT00211237|100753876|FG002|NOT COMPLETED|3 Months||1||
48176071|NCT00211237|100753874|FG000|STARTED|6 Months||57||
48176072|NCT00211237|100753875|FG001|STARTED|6 Months||11||
48176073|NCT00211237|100753876|FG002|STARTED|6 Months||36||
48176074|NCT00211237|100753874|FG000|COMPLETED|6 Months||49||
48176075|NCT00211237|100753875|FG001|COMPLETED|6 Months||9||
48176076|NCT00211237|100753876|FG002|COMPLETED|6 Months||33||
48176077|NCT00211237|100753874|FG000|NOT COMPLETED|6 Months||8||
48176078|NCT00211237|100753875|FG001|NOT COMPLETED|6 Months||2||
48176079|NCT00211237|100753876|FG002|NOT COMPLETED|6 Months||3||
48176080|NCT00211237|100753874|FG000|STARTED|12 Months||49||
48176081|NCT00211237|100753875|FG001|STARTED|12 Months||8||
48336789|NCT00132730|101152138|FG005|NOT COMPLETED|Period II - 12-week Treatment (Base)||0||
48336790|NCT00132730|101152133|FG000|STARTED|Period III - Blinded Extension (EXT1)||0||
48336791|NCT00132730|101152134|FG001|STARTED|Period III - Blinded Extension (EXT1)||0||
48336792|NCT00132730|101152135|FG002|STARTED|Period III - Blinded Extension (EXT1)||317||
48336793|NCT00132730|101152136|FG003|STARTED|Period III - Blinded Extension (EXT1)||107||
48412839|NCT02735044|101345708|FG000|COMPLETED|Overall Study||217||
48176082|NCT00211237|100753876|FG002|STARTED|12 Months||34||
48176083|NCT00211237|100753874|FG000|COMPLETED|12 Months||40||
48176084|NCT00211237|100753875|FG001|COMPLETED|12 Months||6||
48176085|NCT00211237|100753876|FG002|COMPLETED|12 Months||28||
48176086|NCT00211237|100753874|FG000|NOT COMPLETED|12 Months||9||
48176087|NCT00211237|100753875|FG001|NOT COMPLETED|12 Months||2||
48176088|NCT00211237|100753876|FG002|NOT COMPLETED|12 Months||6||
48412840|NCT02735044|101345709|FG001|COMPLETED|Overall Study||207||
48176089|NCT01115491|100753877|FG000|STARTED|Overall Study||32||
48176090|NCT01115491|100753877|FG000|COMPLETED|Overall Study||2||
48176091|NCT01115491|100753877|FG000|NOT COMPLETED|Overall Study||30||
48176092|NCT00065468|100753878|FG000|STARTED|Overall Study||207||
48176093|NCT00065468|100753879|FG001|STARTED|Overall Study||209||
48176094|NCT00065468|100753880|FG002|STARTED|Overall Study||210||
48753114|NCT01808196|102184405|FG000|STARTED|Overall Study||6||
48753115|NCT01808196|102184405|FG000|COMPLETED|Overall Study||5||
48753116|NCT01808196|102184405|FG000|NOT COMPLETED|Overall Study||1||
48176095|NCT00065468|100753878|FG000|Received Treatment|Overall Study||200||
48176096|NCT00065468|100753879|FG001|Received Treatment|Overall Study||208||
48176097|NCT00065468|100753880|FG002|Received Treatment|Overall Study||208||
48176098|NCT00065468|100753878|FG000|COMPLETED|Overall Study||0||
48176099|NCT00065468|100753879|FG001|COMPLETED|Overall Study||0||
48336794|NCT00132730|101152137|FG004|STARTED|Period III - Blinded Extension (EXT1)||0||
48336795|NCT00132730|101152138|FG005|STARTED|Period III - Blinded Extension (EXT1)||0||
48336796|NCT00132730|101152133|FG000|COMPLETED|Period III - Blinded Extension (EXT1)||0||
48336797|NCT00132730|101152134|FG001|COMPLETED|Period III - Blinded Extension (EXT1)||0||
48336798|NCT00132730|101152135|FG002|COMPLETED|Period III - Blinded Extension (EXT1)||235||
48336799|NCT00132730|101152136|FG003|COMPLETED|Period III - Blinded Extension (EXT1)||82||
48336800|NCT00132730|101152137|FG004|COMPLETED|Period III - Blinded Extension (EXT1)||0||
48336801|NCT00132730|101152138|FG005|COMPLETED|Period III - Blinded Extension (EXT1)||0||
48336802|NCT00132730|101152133|FG000|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0||
48336803|NCT00132730|101152134|FG001|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0||
48336804|NCT00132730|101152135|FG002|NOT COMPLETED|Period III - Blinded Extension (EXT1)||82||
48336805|NCT00132730|101152136|FG003|NOT COMPLETED|Period III - Blinded Extension (EXT1)||25||
48336806|NCT00132730|101152137|FG004|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0||
48336807|NCT00132730|101152138|FG005|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0||
48336808|NCT00132730|101152133|FG000|STARTED|Period IV - Open-label Extension (EXT2)||0||
48336809|NCT00132730|101152134|FG001|STARTED|Period IV - Open-label Extension (EXT2)||0||
48336810|NCT00132730|101152135|FG002|STARTED|Period IV - Open-label Extension (EXT2)||0||
48336811|NCT00132730|101152136|FG003|STARTED|Period IV - Open-label Extension (EXT2)||0||
48336812|NCT00132730|101152137|FG004|STARTED|Period IV - Open-label Extension (EXT2)||187||
48753117|NCT01890343|102184406|FG000|STARTED|Overall Study||8||
48753118|NCT01890343|102184407|FG001|STARTED|Overall Study||10||
48753119|NCT01890343|102184408|FG002|STARTED|Overall Study||10||
48753120|NCT01890343|102184406|FG000|COMPLETED|Overall Study||8||
48753121|NCT01890343|102184407|FG001|COMPLETED|Overall Study||10||
48753122|NCT01890343|102184408|FG002|COMPLETED|Overall Study||10||
48753123|NCT01890343|102184406|FG000|NOT COMPLETED|Overall Study||0||
48336813|NCT00132730|101152138|FG005|STARTED|Period IV - Open-label Extension (EXT2)||71||
48336814|NCT00132730|101152133|FG000|COMPLETED|Period IV - Open-label Extension (EXT2)||0||
48336815|NCT00132730|101152134|FG001|COMPLETED|Period IV - Open-label Extension (EXT2)||0||
48753124|NCT01890343|102184407|FG001|NOT COMPLETED|Overall Study||0||
48753125|NCT01890343|102184408|FG002|NOT COMPLETED|Overall Study||0||
48753126|NCT01045460|102184409|FG000|STARTED|Overall Study||17||
48753127|NCT01045460|102184410|FG001|STARTED|Overall Study||18||
48753128|NCT01045460|102184409|FG000|COMPLETED|Overall Study||11||
48753129|NCT01045460|102184410|FG001|COMPLETED|Overall Study||15||
48753130|NCT01045460|102184409|FG000|NOT COMPLETED|Overall Study||6||
48753131|NCT01045460|102184410|FG001|NOT COMPLETED|Overall Study||3||
48753132|NCT01469221|102184411|FG000|STARTED|Open Label Phase||0||
48336816|NCT00132730|101152135|FG002|COMPLETED|Period IV - Open-label Extension (EXT2)||0||
48336817|NCT00132730|101152136|FG003|COMPLETED|Period IV - Open-label Extension (EXT2)||0||
48336818|NCT00132730|101152137|FG004|COMPLETED|Period IV - Open-label Extension (EXT2)||8||
48336819|NCT00132730|101152138|FG005|COMPLETED|Period IV - Open-label Extension (EXT2)||3||
48753133|NCT01469221|102184412|FG001|STARTED|Open Label Phase||0||
48753134|NCT01469221|102184413|FG002|STARTED|Open Label Phase||47||
48753135|NCT01469221|102184411|FG000|COMPLETED|Open Label Phase||0||
48753136|NCT01469221|102184412|FG001|COMPLETED|Open Label Phase||0||
48753137|NCT01469221|102184413|FG002|COMPLETED|Open Label Phase||44||
48753138|NCT01469221|102184411|FG000|NOT COMPLETED|Open Label Phase||0||
48753139|NCT01469221|102184412|FG001|NOT COMPLETED|Open Label Phase||0||
48753140|NCT01469221|102184413|FG002|NOT COMPLETED|Open Label Phase||3||
48753141|NCT01469221|102184411|FG000|STARTED|Double Blind Phase||14||
48753142|NCT01469221|102184412|FG001|STARTED|Double Blind Phase||17||
48753143|NCT01469221|102184413|FG002|STARTED|Double Blind Phase||0||
48753144|NCT01469221|102184411|FG000|COMPLETED|Double Blind Phase||0||
48753145|NCT01469221|102184412|FG001|COMPLETED|Double Blind Phase||0||
48753146|NCT01469221|102184413|FG002|COMPLETED|Double Blind Phase||0||
48753147|NCT01469221|102184411|FG000|NOT COMPLETED|Double Blind Phase||14||
48753148|NCT01469221|102184412|FG001|NOT COMPLETED|Double Blind Phase||17||
48753149|NCT01469221|102184413|FG002|NOT COMPLETED|Double Blind Phase||0||
48753150|NCT02542046|102184414|FG000|STARTED|Overall Study||300||
48753151|NCT02542046|102184415|FG001|STARTED|Overall Study||300||
48753152|NCT02542046|102184416|FG002|STARTED|Overall Study||300||
48753153|NCT02542046|102184414|FG000|COMPLETED|Overall Study||300||
48753154|NCT02542046|102184415|FG001|COMPLETED|Overall Study||300||
48753155|NCT02542046|102184416|FG002|COMPLETED|Overall Study||300||
48753156|NCT02542046|102184414|FG000|NOT COMPLETED|Overall Study||0||
48753157|NCT02542046|102184415|FG001|NOT COMPLETED|Overall Study||0||
48753158|NCT02542046|102184416|FG002|NOT COMPLETED|Overall Study||0||
48753159|NCT00668148|102184417|FG000|STARTED|Overall Study||113||
48753160|NCT00668148|102184417|FG000|Received at Least 1 Dose of Study Drug|Overall Study||111||
48753161|NCT00668148|102184417|FG000|COMPLETED|Overall Study||103||
48753162|NCT00668148|102184417|FG000|NOT COMPLETED|Overall Study||10||
48753163|NCT03111875|102184418|FG000|STARTED|Overall Study||2529||
48753164|NCT03111875|102184419|FG001|STARTED|Overall Study||2527||
48753165|NCT03111875|102184418|FG000|COMPLETED|Overall Study||2506||
48336820|NCT00132730|101152133|FG000|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0||
48336821|NCT00132730|101152134|FG001|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0||
48336822|NCT00132730|101152135|FG002|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0||
48336823|NCT00132730|101152136|FG003|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0||
48336824|NCT00132730|101152137|FG004|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||179||
48336825|NCT00132730|101152138|FG005|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||68||
48336826|NCT00132730|101152133|FG000|STARTED|Period V - Open-label Extension (EXT2)||0||
48336827|NCT00132730|101152134|FG001|STARTED|Period V - Open-label Extension (EXT2)||0||
48336828|NCT00132730|101152135|FG002|STARTED|Period V - Open-label Extension (EXT2)||0||
48336829|NCT00132730|101152136|FG003|STARTED|Period V - Open-label Extension (EXT2)||0||
48336830|NCT00132730|101152137|FG004|STARTED|Period V - Open-label Extension (EXT2)||7||
48336831|NCT00132730|101152138|FG005|STARTED|Period V - Open-label Extension (EXT2)||2||
48336832|NCT00132730|101152133|FG000|COMPLETED|Period V - Open-label Extension (EXT2)||0||
48336833|NCT00132730|101152134|FG001|COMPLETED|Period V - Open-label Extension (EXT2)||0||
48336834|NCT00132730|101152135|FG002|COMPLETED|Period V - Open-label Extension (EXT2)||0||
48336835|NCT00132730|101152136|FG003|COMPLETED|Period V - Open-label Extension (EXT2)||0||
48336836|NCT00132730|101152137|FG004|COMPLETED|Period V - Open-label Extension (EXT2)||0||
48336837|NCT00132730|101152138|FG005|COMPLETED|Period V - Open-label Extension (EXT2)||0||
48336838|NCT00132730|101152133|FG000|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0||
48336839|NCT00132730|101152134|FG001|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0||
48336840|NCT00132730|101152135|FG002|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0||
48336841|NCT00132730|101152136|FG003|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0||
48336842|NCT00132730|101152137|FG004|NOT COMPLETED|Period V - Open-label Extension (EXT2)||7||
48336843|NCT00132730|101152138|FG005|NOT COMPLETED|Period V - Open-label Extension (EXT2)||2||
48336844|NCT01975922|101152139|FG000|STARTED|Overall Study||45||
48336845|NCT01975922|101152140|FG001|STARTED|Overall Study||52||
48336846|NCT01975922|101152139|FG000|COMPLETED|Overall Study||45||
48336847|NCT01975922|101152140|FG001|COMPLETED|Overall Study||43||
48336848|NCT01975922|101152139|FG000|NOT COMPLETED|Overall Study||0||
48336849|NCT01975922|101152140|FG001|NOT COMPLETED|Overall Study||9||
48336850|NCT03064490|101152141|FG000|STARTED|Overall Study||35||
48336851|NCT03064490|101152141|FG000|COMPLETED|Overall Study||30||
48336852|NCT03064490|101152141|FG000|NOT COMPLETED|Overall Study||5||
48336853|NCT03118596|101152142|FG000|STARTED|Overall Study||90||
48336854|NCT03118596|101152143|FG001|STARTED|Overall Study||90||
48336855|NCT03118596|101152142|FG000|Treated|Overall Study||2||
48336856|NCT03118596|101152143|FG001|Treated|Overall Study||0||
48336857|NCT03118596|101152142|FG000|Failed|Overall Study||0||
48336858|NCT03118596|101152143|FG001|Failed|Overall Study||4||
48336859|NCT03118596|101152142|FG000|COMPLETED|Overall Study||90||
48336860|NCT03118596|101152143|FG001|COMPLETED|Overall Study||86||
48336861|NCT03118596|101152142|FG000|NOT COMPLETED|Overall Study||0||
48336862|NCT03118596|101152143|FG001|NOT COMPLETED|Overall Study||4||
48336863|NCT01790048|101152144|FG000|STARTED|Overall Study||1156||
48336864|NCT01790048|101152145|FG001|STARTED|Overall Study||1103||
48336865|NCT01790048|101152144|FG000|COMPLETED|Overall Study||1144||
48336866|NCT01790048|101152145|FG001|COMPLETED|Overall Study||1086||
48336867|NCT01790048|101152144|FG000|NOT COMPLETED|Overall Study||12||
48336868|NCT01790048|101152145|FG001|NOT COMPLETED|Overall Study||17||
48336869|NCT01931059|101152146|FG000|STARTED|Day 1||6||
48336870|NCT01931059|101152147|FG001|STARTED|Day 1||5||
48336871|NCT01931059|101152146|FG000|COMPLETED|Day 1||6||
48336872|NCT01931059|101152147|FG001|COMPLETED|Day 1||4||
48753166|NCT03111875|102184419|FG001|COMPLETED|Overall Study||2507||
48336873|NCT01931059|101152146|FG000|NOT COMPLETED|Day 1||0||
48336874|NCT01931059|101152147|FG001|NOT COMPLETED|Day 1||1||
48336875|NCT01931059|101152146|FG000|STARTED|Day2||6||
48336876|NCT01931059|101152147|FG001|STARTED|Day2||4||
48336877|NCT01931059|101152146|FG000|COMPLETED|Day2||6||
48336878|NCT01931059|101152147|FG001|COMPLETED|Day2||4||
48336879|NCT01931059|101152146|FG000|NOT COMPLETED|Day2||0||
48336880|NCT01931059|101152147|FG001|NOT COMPLETED|Day2||0||
48753167|NCT03111875|102184418|FG000|NOT COMPLETED|Overall Study||23||
48753168|NCT03111875|102184419|FG001|NOT COMPLETED|Overall Study||20||
48336881|NCT01931059|101152146|FG000|STARTED|Day3||6||
48336882|NCT01931059|101152147|FG001|STARTED|Day3||4||
48336883|NCT01931059|101152146|FG000|COMPLETED|Day3||5||
48336884|NCT01931059|101152147|FG001|COMPLETED|Day3||4||
48336885|NCT01931059|101152146|FG000|NOT COMPLETED|Day3||1||
48336886|NCT01931059|101152147|FG001|NOT COMPLETED|Day3||0||
48336887|NCT01869647|101152148|FG000|STARTED|Overall Study||66||
48336888|NCT01869647|101152149|FG001|STARTED|Overall Study||136||
48336889|NCT01869647|101152150|FG002|STARTED|Overall Study||62||
48336890|NCT01869647|101152148|FG000|COMPLETED|Overall Study||65||
48336891|NCT01869647|101152149|FG001|COMPLETED|Overall Study||130||
48336892|NCT01869647|101152150|FG002|COMPLETED|Overall Study||62||
48753169|NCT02987231|102184420|FG000|STARTED|Overall Study||30||
48753170|NCT02987231|102184421|FG001|STARTED|Overall Study||30||
48753171|NCT02987231|102184420|FG000|COMPLETED|Overall Study||30||
48753172|NCT02987231|102184421|FG001|COMPLETED|Overall Study||30||
48753173|NCT02987231|102184420|FG000|NOT COMPLETED|Overall Study||0||
48336893|NCT01869647|101152148|FG000|NOT COMPLETED|Overall Study||1||
48336894|NCT01869647|101152149|FG001|NOT COMPLETED|Overall Study||6||
48336895|NCT01869647|101152150|FG002|NOT COMPLETED|Overall Study||0||
48336896|NCT02624492|101152151|FG000|STARTED|Overall Study||5||
48336897|NCT02624492|101152152|FG001|STARTED|Overall Study||8||
48336898|NCT02624492|101152153|FG002|STARTED|Overall Study||8||
48336899|NCT02624492|101152151|FG000|COMPLETED|Overall Study||3||
48336900|NCT02624492|101152152|FG001|COMPLETED|Overall Study||4||
48412841|NCT02735044|101345708|FG000|NOT COMPLETED|Overall Study||16||
48412842|NCT02735044|101345709|FG001|NOT COMPLETED|Overall Study||23||
48412843|NCT00443534|101345710|FG000|STARTED|Overall Study||123||
48412844|NCT00443534|101345710|FG000|Treated|Overall Study||122||
48412845|NCT00443534|101345710|FG000|COMPLETED|Overall Study||0||
48630734|NCT01225549|101878650|FG003|STARTED|Period 3 - Second Treatment Period||1||
48630735|NCT01225549|101878651|FG004|STARTED|Period 3 - Second Treatment Period||1||
48630736|NCT01225549|101878652|FG005|STARTED|Period 3 - Second Treatment Period||1||
48630737|NCT01225549|101878653|FG006|STARTED|Period 3 - Second Treatment Period||3||
48630738|NCT01225549|101878654|FG007|STARTED|Period 3 - Second Treatment Period||1||
48630739|NCT01225549|101878655|FG008|STARTED|Period 3 - Second Treatment Period||4||
48630740|NCT01225549|101878656|FG009|STARTED|Period 3 - Second Treatment Period||1||
48630741|NCT01225549|101878647|FG000|COMPLETED|Period 3 - Second Treatment Period||1||
48630742|NCT01225549|101878648|FG001|COMPLETED|Period 3 - Second Treatment Period||4||
48630743|NCT01225549|101878649|FG002|COMPLETED|Period 3 - Second Treatment Period||3||
48630744|NCT01225549|101878650|FG003|COMPLETED|Period 3 - Second Treatment Period||1||
48630745|NCT01225549|101878651|FG004|COMPLETED|Period 3 - Second Treatment Period||1||
48753174|NCT02987231|102184421|FG001|NOT COMPLETED|Overall Study||0||
48753175|NCT01791244|102184422|FG000|STARTED|Overall Study||46||
48753176|NCT01791244|102184423|FG001|STARTED|Overall Study||47||
48753177|NCT01791244|102184422|FG000|Intent to Treat (ITT)|Overall Study||38||
48753178|NCT01791244|102184423|FG001|Intent to Treat (ITT)|Overall Study||39||
48753179|NCT01791244|102184422|FG000|COMPLETED|Overall Study||31||
48176100|NCT00065468|100753880|FG002|COMPLETED|Overall Study||0||
48176101|NCT00065468|100753878|FG000|NOT COMPLETED|Overall Study||207||
48176102|NCT00065468|100753879|FG001|NOT COMPLETED|Overall Study||209||
48176103|NCT00065468|100753880|FG002|NOT COMPLETED|Overall Study||210||
48176104|NCT02406261|100753881|FG000|STARTED|Period 1||50||
48176105|NCT02406261|100753882|FG001|STARTED|Period 1||32||
48176106|NCT02406261|100753881|FG000|Received at Least One Dose of Study Drug|Period 1||50||
48176107|NCT02406261|100753882|FG001|Received at Least One Dose of Study Drug|Period 1||32||
48176108|NCT02406261|100753881|FG000|COMPLETED|Period 1||47||
48176109|NCT02406261|100753882|FG001|COMPLETED|Period 1||32||
48176110|NCT02406261|100753881|FG000|NOT COMPLETED|Period 1||3||
48176111|NCT02406261|100753882|FG001|NOT COMPLETED|Period 1||0||
48176112|NCT02406261|100753881|FG000|STARTED|Period 2||0||
48176113|NCT02406261|100753882|FG001|STARTED|Period 2||32||
48176114|NCT02406261|100753881|FG000|COMPLETED|Period 2||0||
48176115|NCT02406261|100753882|FG001|COMPLETED|Period 2||29||
48176116|NCT02406261|100753881|FG000|NOT COMPLETED|Period 2||0||
48176117|NCT02406261|100753882|FG001|NOT COMPLETED|Period 2||3||
48176118|NCT02141659|100753883|FG000|STARTED|Overall Study||3||
48176119|NCT02141659|100753884|FG001|STARTED|Overall Study||4||
48176120|NCT02141659|100753885|FG002|STARTED|Overall Study||3||
48176121|NCT02141659|100753886|FG003|STARTED|Overall Study||3||
48176122|NCT02141659|100753887|FG004|STARTED|Overall Study||15||
48176123|NCT02141659|100753888|FG005|STARTED|Overall Study||15||
48176124|NCT02141659|100753883|FG000|COMPLETED|Overall Study||3||
48176125|NCT02141659|100753884|FG001|COMPLETED|Overall Study||3||
48176126|NCT02141659|100753885|FG002|COMPLETED|Overall Study||3||
48176127|NCT02141659|100753886|FG003|COMPLETED|Overall Study||3||
48176128|NCT02141659|100753887|FG004|COMPLETED|Overall Study||13||
48176129|NCT02141659|100753888|FG005|COMPLETED|Overall Study||13||
48176130|NCT02141659|100753883|FG000|NOT COMPLETED|Overall Study||0||
48176131|NCT02141659|100753884|FG001|NOT COMPLETED|Overall Study||1||
48176132|NCT02141659|100753885|FG002|NOT COMPLETED|Overall Study||0||
48176133|NCT02141659|100753886|FG003|NOT COMPLETED|Overall Study||0||
48176134|NCT02141659|100753887|FG004|NOT COMPLETED|Overall Study||2||
48176135|NCT02141659|100753888|FG005|NOT COMPLETED|Overall Study||2||
48176136|NCT02459080|100753889|FG000|STARTED|Overall Study||212||
48176137|NCT02459080|100753890|FG001|STARTED|Overall Study||198||
48176138|NCT02459080|100753891|FG002|STARTED|Overall Study||209||
48176139|NCT02459080|100753889|FG000|COMPLETED|Overall Study||168||
48336901|NCT02624492|101152153|FG002|COMPLETED|Overall Study||3||
48336902|NCT02624492|101152151|FG000|NOT COMPLETED|Overall Study||2||
48336903|NCT02624492|101152152|FG001|NOT COMPLETED|Overall Study||4||
48336904|NCT02624492|101152153|FG002|NOT COMPLETED|Overall Study||5||
48753180|NCT01791244|102184423|FG001|COMPLETED|Overall Study||29||
48176140|NCT02459080|100753890|FG001|COMPLETED|Overall Study||158||
48176141|NCT02459080|100753891|FG002|COMPLETED|Overall Study||151||
48336905|NCT03905863|101152154|FG000|STARTED|Overall Study||64||
48336906|NCT03905863|101152155|FG001|STARTED|Overall Study||81||
48753181|NCT01791244|102184422|FG000|NOT COMPLETED|Overall Study||15||
48753182|NCT01791244|102184423|FG001|NOT COMPLETED|Overall Study||18||
48753183|NCT01071044|102184424|FG000|STARTED|Overall Study||15||
48630746|NCT01225549|101878652|FG005|COMPLETED|Period 3 - Second Treatment Period||1||
48630747|NCT01225549|101878653|FG006|COMPLETED|Period 3 - Second Treatment Period||3||
48630748|NCT01225549|101878654|FG007|COMPLETED|Period 3 - Second Treatment Period||1||
48630749|NCT01225549|101878655|FG008|COMPLETED|Period 3 - Second Treatment Period||4||
48176142|NCT02459080|100753889|FG000|NOT COMPLETED|Overall Study||44||
48176143|NCT02459080|100753890|FG001|NOT COMPLETED|Overall Study||40||
48176144|NCT02459080|100753891|FG002|NOT COMPLETED|Overall Study||58||
48630750|NCT01225549|101878656|FG009|COMPLETED|Period 3 - Second Treatment Period||1||
48630751|NCT01225549|101878647|FG000|NOT COMPLETED|Period 3 - Second Treatment Period||0||
48630752|NCT01225549|101878648|FG001|NOT COMPLETED|Period 3 - Second Treatment Period||0||
48630753|NCT01225549|101878649|FG002|NOT COMPLETED|Period 3 - Second Treatment Period||0||
48630754|NCT01225549|101878650|FG003|NOT COMPLETED|Period 3 - Second Treatment Period||0||
48630755|NCT01225549|101878651|FG004|NOT COMPLETED|Period 3 - Second Treatment Period||0||
48630756|NCT01225549|101878652|FG005|NOT COMPLETED|Period 3 - Second Treatment Period||0||
48630757|NCT01225549|101878653|FG006|NOT COMPLETED|Period 3 - Second Treatment Period||0||
48630758|NCT01225549|101878654|FG007|NOT COMPLETED|Period 3 - Second Treatment Period||0||
48630759|NCT01225549|101878655|FG008|NOT COMPLETED|Period 3 - Second Treatment Period||0||
48630760|NCT01225549|101878656|FG009|NOT COMPLETED|Period 3 - Second Treatment Period||0||
48753184|NCT01071044|102184425|FG001|STARTED|Overall Study||11||
48630761|NCT01225549|101878647|FG000|STARTED|Period 4 - Washout||1||
48630762|NCT01225549|101878648|FG001|STARTED|Period 4 - Washout||4||
48630763|NCT01225549|101878649|FG002|STARTED|Period 4 - Washout||3||
48630764|NCT01225549|101878650|FG003|STARTED|Period 4 - Washout||1||
48630765|NCT01225549|101878651|FG004|STARTED|Period 4 - Washout||1||
48630766|NCT01225549|101878652|FG005|STARTED|Period 4 - Washout||1||
48630767|NCT01225549|101878653|FG006|STARTED|Period 4 - Washout||3||
48630768|NCT01225549|101878654|FG007|STARTED|Period 4 - Washout||1||
48630769|NCT01225549|101878655|FG008|STARTED|Period 4 - Washout||4||
48630770|NCT01225549|101878656|FG009|STARTED|Period 4 - Washout||1||
48630771|NCT01225549|101878647|FG000|COMPLETED|Period 4 - Washout||1||
48630772|NCT01225549|101878648|FG001|COMPLETED|Period 4 - Washout||3||
48630773|NCT01225549|101878649|FG002|COMPLETED|Period 4 - Washout||3||
48630774|NCT01225549|101878650|FG003|COMPLETED|Period 4 - Washout||1||
48630775|NCT01225549|101878651|FG004|COMPLETED|Period 4 - Washout||1||
48336907|NCT03905863|101152154|FG000|COMPLETED|Overall Study||59||
48336908|NCT03905863|101152155|FG001|COMPLETED|Overall Study||69||
48336909|NCT03905863|101152154|FG000|NOT COMPLETED|Overall Study||5||
48336910|NCT03905863|101152155|FG001|NOT COMPLETED|Overall Study||12||
48336911|NCT01360645|101152156|FG000|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||824||
48336912|NCT01360645|101152157|FG001|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0||
48336913|NCT01360645|101152158|FG002|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0||
48336914|NCT01360645|101152159|FG003|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0||
48336915|NCT01360645|101152156|FG000|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||710||
48753185|NCT01071044|102184424|FG000|COMPLETED|Overall Study||13||
48753186|NCT01071044|102184425|FG001|COMPLETED|Overall Study||11||
48753187|NCT01071044|102184424|FG000|NOT COMPLETED|Overall Study||2||
48753188|NCT01071044|102184425|FG001|NOT COMPLETED|Overall Study||0||
48753189|NCT03206216|102184426|FG000|STARTED|Overall Study||0||
48176145|NCT01129336|100753892|FG000|STARTED|Overall Study||15||
48176146|NCT01129336|100753893|FG001|STARTED|Overall Study||29||
48176147|NCT01129336|100753892|FG000|Completed Treatment|Overall Study||1||
48176148|NCT01129336|100753893|FG001|Completed Treatment|Overall Study||3||
48336916|NCT01360645|101152157|FG001|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0||
48336917|NCT01360645|101152158|FG002|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0||
48336918|NCT01360645|101152159|FG003|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0||
48336919|NCT01360645|101152156|FG000|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||114||
48336920|NCT01360645|101152157|FG001|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0||
48336921|NCT01360645|101152158|FG002|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0||
48336922|NCT01360645|101152159|FG003|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0||
48336923|NCT01360645|101152156|FG000|STARTED|Phase B (6 Weeks)||0||
48336924|NCT01360645|101152157|FG001|STARTED|Phase B (6 Weeks)||188||
48630776|NCT01225549|101878652|FG005|COMPLETED|Period 4 - Washout||1||
48630777|NCT01225549|101878653|FG006|COMPLETED|Period 4 - Washout||3||
48630778|NCT01225549|101878654|FG007|COMPLETED|Period 4 - Washout||1||
48753190|NCT03206216|102184427|FG001|STARTED|Overall Study||1||
48753191|NCT03206216|102184426|FG000|COMPLETED|Overall Study||0||
48753192|NCT03206216|102184427|FG001|COMPLETED|Overall Study||0||
48753193|NCT03206216|102184426|FG000|NOT COMPLETED|Overall Study||0||
48753194|NCT03206216|102184427|FG001|NOT COMPLETED|Overall Study||1||
48753195|NCT02322281|102184428|FG000|STARTED|Overall Study||53||
48753196|NCT02322281|102184429|FG001|STARTED|Overall Study||22||
48753197|NCT02322281|102184430|FG002|STARTED|Overall Study||74||
48753198|NCT02322281|102184428|FG000|Crossed Over to Rociletinib 500 mg BID|Overall Study||0||
48753199|NCT02322281|102184429|FG001|Crossed Over to Rociletinib 500 mg BID|Overall Study||0||
48753200|NCT02322281|102184430|FG002|Crossed Over to Rociletinib 500 mg BID|Overall Study||36||
48753201|NCT02322281|102184428|FG000|Crossed Over to Rociletinib 625 mg BID|Overall Study||0||
48767732|NCT00494676|102222813|FG001|STARTED|Second Intervention||29||
48630779|NCT01225549|101878655|FG008|COMPLETED|Period 4 - Washout||4||
48630780|NCT01225549|101878656|FG009|COMPLETED|Period 4 - Washout||1||
48630781|NCT01225549|101878647|FG000|NOT COMPLETED|Period 4 - Washout||0||
48630782|NCT01225549|101878648|FG001|NOT COMPLETED|Period 4 - Washout||1||
48630783|NCT01225549|101878649|FG002|NOT COMPLETED|Period 4 - Washout||0||
48630784|NCT01225549|101878650|FG003|NOT COMPLETED|Period 4 - Washout||0||
48753202|NCT02322281|102184429|FG001|Crossed Over to Rociletinib 625 mg BID|Overall Study||0||
48753203|NCT02322281|102184430|FG002|Crossed Over to Rociletinib 625 mg BID|Overall Study||3||
48753204|NCT02322281|102184428|FG000|COMPLETED|Overall Study||0||
48753205|NCT02322281|102184429|FG001|COMPLETED|Overall Study||0||
48753206|NCT02322281|102184430|FG002|COMPLETED|Overall Study||0||
48753207|NCT02322281|102184428|FG000|NOT COMPLETED|Overall Study||53||
48753208|NCT02322281|102184429|FG001|NOT COMPLETED|Overall Study||22||
48753209|NCT02322281|102184430|FG002|NOT COMPLETED|Overall Study||74||
48753210|NCT02656017|102184431|FG000|STARTED|Overall Study||49||
48176149|NCT01129336|100753892|FG000|COMPLETED|Overall Study||3||
48176150|NCT01129336|100753893|FG001|COMPLETED|Overall Study||13||
48176151|NCT01129336|100753892|FG000|NOT COMPLETED|Overall Study||12||
48176152|NCT01129336|100753893|FG001|NOT COMPLETED|Overall Study||16||
48176153|NCT03382600|100753894|FG000|STARTED|Overall Study||54||
48176154|NCT03382600|100753895|FG001|STARTED|Overall Study||46||
48176155|NCT03382600|100753894|FG000|COMPLETED|Overall Study||0||
48176156|NCT03382600|100753895|FG001|COMPLETED|Overall Study||0||
48176157|NCT03382600|100753894|FG000|NOT COMPLETED|Overall Study||54||
48176158|NCT03382600|100753895|FG001|NOT COMPLETED|Overall Study||46||
48176159|NCT01912222|100753896|FG000|STARTED|Part A: Pharmacokinetic Period||13||
48176160|NCT01912222|100753897|FG001|STARTED|Part A: Pharmacokinetic Period||15||
48630785|NCT01225549|101878651|FG004|NOT COMPLETED|Period 4 - Washout||0||
48630786|NCT01225549|101878652|FG005|NOT COMPLETED|Period 4 - Washout||0||
48630787|NCT01225549|101878653|FG006|NOT COMPLETED|Period 4 - Washout||0||
48753211|NCT02656017|102184432|FG001|STARTED|Overall Study||48||
48630788|NCT01225549|101878654|FG007|NOT COMPLETED|Period 4 - Washout||0||
48176161|NCT01912222|100753898|FG002|STARTED|Part A: Pharmacokinetic Period||20||
48176162|NCT01912222|100753896|FG000|COMPLETED|Part A: Pharmacokinetic Period||12||
48176163|NCT01912222|100753897|FG001|COMPLETED|Part A: Pharmacokinetic Period||13||
48176164|NCT01912222|100753898|FG002|COMPLETED|Part A: Pharmacokinetic Period||18||
48176165|NCT01912222|100753896|FG000|NOT COMPLETED|Part A: Pharmacokinetic Period||1||
48176166|NCT01912222|100753897|FG001|NOT COMPLETED|Part A: Pharmacokinetic Period||2||
48176167|NCT01912222|100753898|FG002|NOT COMPLETED|Part A: Pharmacokinetic Period||2||
48176168|NCT01912222|100753896|FG000|STARTED|Part B: Treatment Period||13||
48176169|NCT01912222|100753897|FG001|STARTED|Part B: Treatment Period||15||
48630789|NCT01225549|101878655|FG008|NOT COMPLETED|Period 4 - Washout||0||
48630790|NCT01225549|101878656|FG009|NOT COMPLETED|Period 4 - Washout||0||
48630791|NCT01225549|101878647|FG000|STARTED|Period 5 - Third Treatment Period||1||
48630792|NCT01225549|101878648|FG001|STARTED|Period 5 - Third Treatment Period||3||
48630793|NCT01225549|101878649|FG002|STARTED|Period 5 - Third Treatment Period||3||
48630794|NCT01225549|101878650|FG003|STARTED|Period 5 - Third Treatment Period||1||
48753212|NCT02656017|102184431|FG000|COMPLETED|Overall Study||40||
48753213|NCT02656017|102184432|FG001|COMPLETED|Overall Study||42||
48753214|NCT02656017|102184431|FG000|NOT COMPLETED|Overall Study||9||
48753215|NCT02656017|102184432|FG001|NOT COMPLETED|Overall Study||6||
48753216|NCT00510835|102184433|FG000|STARTED|Overall Study||445||
48753217|NCT00510835|102184434|FG001|STARTED|Overall Study||448||
48753218|NCT00510835|102184435|FG002|STARTED|Overall Study||458||
48753219|NCT00510835|102184433|FG000|COMPLETED|Overall Study||439||
48753220|NCT00510835|102184434|FG001|COMPLETED|Overall Study||446||
48753221|NCT00510835|102184435|FG002|COMPLETED|Overall Study||456||
48753222|NCT00510835|102184433|FG000|NOT COMPLETED|Overall Study||6||
48753223|NCT00510835|102184434|FG001|NOT COMPLETED|Overall Study||2||
48753224|NCT00510835|102184435|FG002|NOT COMPLETED|Overall Study||2||
48753225|NCT01428258|102184436|FG000|STARTED|Intervention 1||17||
48753226|NCT01428258|102184437|FG001|STARTED|Intervention 1||15||
48753227|NCT01428258|102184436|FG000|COMPLETED|Intervention 1||15||
48753228|NCT01428258|102184437|FG001|COMPLETED|Intervention 1||15||
48753229|NCT01428258|102184436|FG000|NOT COMPLETED|Intervention 1||2||
48753230|NCT01428258|102184437|FG001|NOT COMPLETED|Intervention 1||0||
48753231|NCT01428258|102184436|FG000|STARTED|Intervention 2||15||
48753232|NCT01428258|102184437|FG001|STARTED|Intervention 2||15||
48753233|NCT01428258|102184436|FG000|COMPLETED|Intervention 2||15||
48753234|NCT01428258|102184437|FG001|COMPLETED|Intervention 2||15||
48176170|NCT01912222|100753898|FG002|STARTED|Part B: Treatment Period||20||
48176171|NCT01912222|100753896|FG000|COMPLETED|Part B: Treatment Period||0||
48176172|NCT01912222|100753897|FG001|COMPLETED|Part B: Treatment Period||0||
48176173|NCT01912222|100753898|FG002|COMPLETED|Part B: Treatment Period||0||
48176174|NCT01912222|100753896|FG000|NOT COMPLETED|Part B: Treatment Period||13||
48176175|NCT01912222|100753897|FG001|NOT COMPLETED|Part B: Treatment Period||15||
48176176|NCT01912222|100753898|FG002|NOT COMPLETED|Part B: Treatment Period||20||
48176177|NCT01079143|100753899|FG000|STARTED|Overall Study||36||
48176178|NCT01079143|100753900|FG001|STARTED|Overall Study||60||
48176179|NCT01079143|100753901|FG002|STARTED|Overall Study||39||
48176180|NCT01079143|100753902|FG003|STARTED|Overall Study||59||
48176181|NCT01079143|100753899|FG000|Exposed|Overall Study||36||
48176182|NCT01079143|100753900|FG001|Exposed|Overall Study||60||
48176183|NCT01079143|100753901|FG002|Exposed|Overall Study||39||
48176184|NCT01079143|100753902|FG003|Exposed|Overall Study||59||
48176185|NCT01079143|100753899|FG000|Month 3 (M3) Biopsies|Overall Study||36||
48176186|NCT01079143|100753900|FG001|Month 3 (M3) Biopsies|Overall Study||59||
48176187|NCT01079143|100753901|FG002|Month 3 (M3) Biopsies|Overall Study||39||
48176188|NCT01079143|100753902|FG003|Month 3 (M3) Biopsies|Overall Study||59||
48176189|NCT01079143|100753899|FG000|Month 12 (M12) Biopsies|Overall Study||26||
48176190|NCT01079143|100753900|FG001|Month 12 (M12) Biopsies|Overall Study||43||
48176191|NCT01079143|100753901|FG002|Month 12 (M12) Biopsies|Overall Study||32||
48176192|NCT01079143|100753902|FG003|Month 12 (M12) Biopsies|Overall Study||53||
48176193|NCT01079143|100753899|FG000|M3 and M12 Biopsies|Overall Study||26||
48176194|NCT01079143|100753900|FG001|M3 and M12 Biopsies|Overall Study||43||
48176195|NCT01079143|100753901|FG002|M3 and M12 Biopsies|Overall Study||32||
48176196|NCT01079143|100753902|FG003|M3 and M12 Biopsies|Overall Study||53||
48336925|NCT01360645|101152158|FG002|STARTED|Phase B (6 Weeks)||191||
48336926|NCT01360645|101152159|FG003|STARTED|Phase B (6 Weeks)||0||
48630795|NCT01225549|101878651|FG004|STARTED|Period 5 - Third Treatment Period||1||
48630796|NCT01225549|101878652|FG005|STARTED|Period 5 - Third Treatment Period||1||
48630797|NCT01225549|101878653|FG006|STARTED|Period 5 - Third Treatment Period||3||
48630798|NCT01225549|101878654|FG007|STARTED|Period 5 - Third Treatment Period||1||
48630799|NCT01225549|101878655|FG008|STARTED|Period 5 - Third Treatment Period||4||
48630800|NCT01225549|101878656|FG009|STARTED|Period 5 - Third Treatment Period||1||
48630801|NCT01225549|101878647|FG000|COMPLETED|Period 5 - Third Treatment Period||1||
48753235|NCT01428258|102184436|FG000|NOT COMPLETED|Intervention 2||0||
48753236|NCT01428258|102184437|FG001|NOT COMPLETED|Intervention 2||0||
48753237|NCT01848158|102184438|FG000|STARTED|Overall Study||10||
48176197|NCT01079143|100753899|FG000|COMPLETED|Overall Study||27||
48176198|NCT01079143|100753900|FG001|COMPLETED|Overall Study||43||
48176199|NCT01079143|100753901|FG002|COMPLETED|Overall Study||34||
48176200|NCT01079143|100753902|FG003|COMPLETED|Overall Study||54||
48176201|NCT01079143|100753899|FG000|NOT COMPLETED|Overall Study||9||
48176202|NCT01079143|100753900|FG001|NOT COMPLETED|Overall Study||17||
48176203|NCT01079143|100753901|FG002|NOT COMPLETED|Overall Study||5||
48176204|NCT01079143|100753902|FG003|NOT COMPLETED|Overall Study||5||
48176205|NCT00462644|100753903|FG000|STARTED|Overall Study||18||
48176206|NCT00462644|100753904|FG001|STARTED|Overall Study||12||
48176207|NCT00462644|100753903|FG000|COMPLETED|Overall Study||18||
48176208|NCT00462644|100753904|FG001|COMPLETED|Overall Study||12||
48176209|NCT00462644|100753903|FG000|NOT COMPLETED|Overall Study||0||
48176210|NCT00462644|100753904|FG001|NOT COMPLETED|Overall Study||0||
48176211|NCT01097460|100753905|FG000|STARTED|Overall Study||16||
48176212|NCT01097460|100753905|FG000|COMPLETED|Overall Study||16||
48176213|NCT01097460|100753905|FG000|NOT COMPLETED|Overall Study||0||
48176214|NCT03317379|100753906|FG000|STARTED|Overall Study||20||
48176215|NCT03317379|100753907|FG001|STARTED|Overall Study||18||
48176216|NCT03317379|100753908|FG002|STARTED|Overall Study||22||
48176217|NCT03317379|100753906|FG000|Completed Intervention|Overall Study||16|Completed intervention defined as participated in intervention for at least 20 weeks (out of 6 months)|
48176218|NCT03317379|100753907|FG001|Completed Intervention|Overall Study||6|Completed intervention defined as participated in intervention for at least 20 weeks (out of 6 months)|
48176219|NCT03317379|100753908|FG002|Completed Intervention|Overall Study||0|Completed intervention defined as participated in intervention for at least 20 weeks (out of 6 months)|
48176220|NCT03317379|100753906|FG000|COMPLETED|Overall Study||20|Completion defined as completion of at least one follow-up study interval|
48176221|NCT03317379|100753907|FG001|COMPLETED|Overall Study||15|Completion defined as completion of at least one follow-up study interval|
48188644|NCT05257837|100783296|FG002|NOT COMPLETED|Overall Study||4||
48336927|NCT01360645|101152156|FG000|COMPLETED|Phase B (6 Weeks)||0||
48630802|NCT01225549|101878648|FG001|COMPLETED|Period 5 - Third Treatment Period||3||
48630803|NCT01225549|101878649|FG002|COMPLETED|Period 5 - Third Treatment Period||3||
48753238|NCT01848158|102184439|FG001|STARTED|Overall Study||7||
48753239|NCT01848158|102184438|FG000|COMPLETED|Overall Study||10||
48753240|NCT01848158|102184439|FG001|COMPLETED|Overall Study||7||
48753241|NCT01848158|102184438|FG000|NOT COMPLETED|Overall Study||0||
48753242|NCT01848158|102184439|FG001|NOT COMPLETED|Overall Study||0||
48753243|NCT00499486|102184440|FG000|STARTED|Overall Study||47||
48753244|NCT00499486|102184440|FG000|COMPLETED|Overall Study||31||
48753245|NCT00499486|102184440|FG000|NOT COMPLETED|Overall Study||16||
48753246|NCT01620060|102184441|FG000|STARTED|Overall Study||105||
48176222|NCT03317379|100753908|FG002|COMPLETED|Overall Study||20|Completion defined as completion of at least one follow-up study interval|
48176223|NCT03317379|100753906|FG000|NOT COMPLETED|Overall Study||0||
48176224|NCT03317379|100753907|FG001|NOT COMPLETED|Overall Study||3||
48176225|NCT03317379|100753908|FG002|NOT COMPLETED|Overall Study||2||
48176226|NCT05033743|100753909|FG000|STARTED|Overall Study||24||
48176227|NCT05033743|100753909|FG000|COMPLETED|Overall Study||20||
48176228|NCT05033743|100753909|FG000|NOT COMPLETED|Overall Study||4||
48176229|NCT02372058|100753910|FG000|STARTED|Overall Study||103||
48176230|NCT02372058|100753910|FG000|COMPLETED|Overall Study||100||
48176231|NCT02372058|100753910|FG000|NOT COMPLETED|Overall Study||3||
48176232|NCT03299062|100753911|FG000|STARTED|Overall Study||4||
48176233|NCT03299062|100753912|FG001|STARTED|Overall Study||5||
48176234|NCT03299062|100753911|FG000|COMPLETED|Overall Study||4||
48176235|NCT03299062|100753912|FG001|COMPLETED|Overall Study||5||
48176236|NCT03299062|100753911|FG000|NOT COMPLETED|Overall Study||0||
48176237|NCT03299062|100753912|FG001|NOT COMPLETED|Overall Study||0||
48176238|NCT02590068|100753913|FG000|STARTED|Overall Study||0||
48176239|NCT02590068|100753914|FG001|STARTED|Overall Study||14||
48176240|NCT02590068|100753913|FG000|COMPLETED|Overall Study||0||
48176241|NCT02590068|100753914|FG001|COMPLETED|Overall Study||14||
48176242|NCT02590068|100753913|FG000|NOT COMPLETED|Overall Study||0||
48176243|NCT02590068|100753914|FG001|NOT COMPLETED|Overall Study||0||
48176244|NCT02533258|100753915|FG000|STARTED|Overall Study||13||
48176245|NCT02533258|100753915|FG000|COMPLETED|Overall Study||5||
48176246|NCT02533258|100753915|FG000|NOT COMPLETED|Overall Study||8||
48176247|NCT04039503|100753916|FG000|STARTED|Overall Study||116||
48176248|NCT04039503|100753917|FG001|STARTED|Overall Study||119||
48176249|NCT04039503|100753918|FG002|STARTED|Overall Study||120||
48176250|NCT04039503|100753919|FG003|STARTED|Overall Study||120||
48176251|NCT04039503|100753916|FG000|Received at Least One Dose of Study Drug|Overall Study||116||
48176252|NCT04039503|100753917|FG001|Received at Least One Dose of Study Drug|Overall Study||119||
48176253|NCT04039503|100753918|FG002|Received at Least One Dose of Study Drug|Overall Study||120||
48176254|NCT04039503|100753919|FG003|Received at Least One Dose of Study Drug|Overall Study||120||
48176255|NCT04039503|100753916|FG000|COMPLETED|Overall Study||109||
48176256|NCT04039503|100753917|FG001|COMPLETED|Overall Study||115||
48176257|NCT04039503|100753918|FG002|COMPLETED|Overall Study||110||
48176258|NCT04039503|100753919|FG003|COMPLETED|Overall Study||117||
48176259|NCT04039503|100753916|FG000|NOT COMPLETED|Overall Study||7||
48176260|NCT04039503|100753917|FG001|NOT COMPLETED|Overall Study||4||
48176261|NCT04039503|100753918|FG002|NOT COMPLETED|Overall Study||10||
48176262|NCT04039503|100753919|FG003|NOT COMPLETED|Overall Study||3||
48176263|NCT00975221|100753920|FG000|STARTED|Titration Phase (Weeks 1-12)||34||
48176264|NCT00975221|100753921|FG001|STARTED|Titration Phase (Weeks 1-12)||33||
48176265|NCT00975221|100753920|FG000|Received Study Drug|Titration Phase (Weeks 1-12)||34||
48176266|NCT00975221|100753921|FG001|Received Study Drug|Titration Phase (Weeks 1-12)||33||
48176267|NCT00975221|100753920|FG000|COMPLETED|Titration Phase (Weeks 1-12)||31||
48176268|NCT00975221|100753921|FG001|COMPLETED|Titration Phase (Weeks 1-12)||29||
48176269|NCT00975221|100753920|FG000|NOT COMPLETED|Titration Phase (Weeks 1-12)||3||
48176270|NCT00975221|100753921|FG001|NOT COMPLETED|Titration Phase (Weeks 1-12)||4||
48176271|NCT00975221|100753920|FG000|STARTED|Efficacy Assessment Phase (Weeks 13-28)||30||
48176272|NCT00975221|100753921|FG001|STARTED|Efficacy Assessment Phase (Weeks 13-28)||29||
48176273|NCT00975221|100753920|FG000|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||30||
48176274|NCT00975221|100753921|FG001|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||28||
48176275|NCT00975221|100753920|FG000|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||0||
48176276|NCT00975221|100753921|FG001|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||1||
48176277|NCT00975221|100753920|FG000|STARTED|Open-label Extension Phase (Weeks 29-52)||29||
48176278|NCT00975221|100753921|FG001|STARTED|Open-label Extension Phase (Weeks 29-52)||28||
48176279|NCT00975221|100753920|FG000|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27||
48176280|NCT00975221|100753921|FG001|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27||
48176281|NCT00975221|100753920|FG000|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||2||
48176282|NCT00975221|100753921|FG001|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||1||
48176283|NCT04475848|100753922|FG000|STARTED|Overall Study||6||
48176284|NCT04475848|100753923|FG001|STARTED|Overall Study||6||
48176285|NCT04475848|100753924|FG002|STARTED|Overall Study||6||
48176286|NCT04475848|100753925|FG003|STARTED|Overall Study||6||
48176287|NCT04475848|100753926|FG004|STARTED|Overall Study||6||
48176288|NCT04475848|100753927|FG005|STARTED|Overall Study||6||
48176289|NCT04475848|100753928|FG006|STARTED|Overall Study||10||
48176290|NCT04475848|100753929|FG007|STARTED|Overall Study||2||
48176291|NCT04475848|100753930|FG008|STARTED|Overall Study||6||
48176292|NCT04475848|100753931|FG009|STARTED|Overall Study||6||
48176293|NCT04475848|100753932|FG010|STARTED|Overall Study||6||
48176294|NCT04475848|100753933|FG011|STARTED|Overall Study||6||
48176295|NCT04475848|100753934|FG012|STARTED|Overall Study||16||
48176296|NCT04475848|100753922|FG000|COMPLETED|Overall Study||6||
48176297|NCT04475848|100753923|FG001|COMPLETED|Overall Study||6||
48176298|NCT04475848|100753924|FG002|COMPLETED|Overall Study||6||
48176299|NCT04475848|100753925|FG003|COMPLETED|Overall Study||6||
48176300|NCT04475848|100753926|FG004|COMPLETED|Overall Study||6||
48176301|NCT04475848|100753927|FG005|COMPLETED|Overall Study||6||
48176302|NCT04475848|100753928|FG006|COMPLETED|Overall Study||10||
48176303|NCT04475848|100753929|FG007|COMPLETED|Overall Study||2||
48176304|NCT04475848|100753930|FG008|COMPLETED|Overall Study||6||
48176305|NCT04475848|100753931|FG009|COMPLETED|Overall Study||6||
48176306|NCT04475848|100753932|FG010|COMPLETED|Overall Study||6||
48176307|NCT04475848|100753933|FG011|COMPLETED|Overall Study||6||
48176308|NCT04475848|100753934|FG012|COMPLETED|Overall Study||16||
48176309|NCT04475848|100753922|FG000|NOT COMPLETED|Overall Study||0||
48176310|NCT04475848|100753923|FG001|NOT COMPLETED|Overall Study||0||
48176311|NCT04475848|100753924|FG002|NOT COMPLETED|Overall Study||0||
48176312|NCT04475848|100753925|FG003|NOT COMPLETED|Overall Study||0||
48176313|NCT04475848|100753926|FG004|NOT COMPLETED|Overall Study||0||
48176314|NCT04475848|100753927|FG005|NOT COMPLETED|Overall Study||0||
48176315|NCT04475848|100753928|FG006|NOT COMPLETED|Overall Study||0||
48176316|NCT04475848|100753929|FG007|NOT COMPLETED|Overall Study||0||
48630804|NCT01225549|101878650|FG003|COMPLETED|Period 5 - Third Treatment Period||1||
48630805|NCT01225549|101878651|FG004|COMPLETED|Period 5 - Third Treatment Period||1||
48630806|NCT01225549|101878652|FG005|COMPLETED|Period 5 - Third Treatment Period||1||
48630807|NCT01225549|101878653|FG006|COMPLETED|Period 5 - Third Treatment Period||3||
48630808|NCT01225549|101878654|FG007|COMPLETED|Period 5 - Third Treatment Period||1||
48630809|NCT01225549|101878655|FG008|COMPLETED|Period 5 - Third Treatment Period||4||
48630810|NCT01225549|101878656|FG009|COMPLETED|Period 5 - Third Treatment Period||1||
48630811|NCT01225549|101878647|FG000|NOT COMPLETED|Period 5 - Third Treatment Period||0||
48630812|NCT01225549|101878648|FG001|NOT COMPLETED|Period 5 - Third Treatment Period||0||
48630813|NCT01225549|101878649|FG002|NOT COMPLETED|Period 5 - Third Treatment Period||0||
48176317|NCT04475848|100753930|FG008|NOT COMPLETED|Overall Study||0||
48176318|NCT04475848|100753931|FG009|NOT COMPLETED|Overall Study||0||
48176319|NCT04475848|100753932|FG010|NOT COMPLETED|Overall Study||0||
48176320|NCT04475848|100753933|FG011|NOT COMPLETED|Overall Study||0||
48176321|NCT04475848|100753934|FG012|NOT COMPLETED|Overall Study||0||
48176322|NCT03990363|100753935|FG000|STARTED|Overall Study||172||
48176323|NCT03990363|100753936|FG001|STARTED|Overall Study||172||
48176324|NCT03990363|100753937|FG002|STARTED|Overall Study||173||
48176325|NCT03990363|100753938|FG003|STARTED|Overall Study||171||
48176326|NCT03990363|100753939|FG004|STARTED|Overall Study||173||
48176327|NCT03990363|100753935|FG000|Switch Dose|Overall Study||0|As per Protocol Version 5.0, 37 participants from 3 mg dose (ie, Low Dose group) were switched to 24 mg at Visit 9. Participants received Verinurad 24 mg and Allopurinol 300 mg.|
48176328|NCT03990363|100753936|FG001|Switch Dose|Overall Study||0|As per Protocol Version 5.0, 37 participants from 3 mg dose (ie, Low Dose group) were switched to 24 mg at Visit 9. Participants received Verinurad 24 mg and Allopurinol 300 mg.|
48176329|NCT03990363|100753937|FG002|Switch Dose|Overall Study||37|As per Protocol Version 5.0, 37 participants from 3 mg dose (ie, Low Dose group) were switched to 24 mg at Visit 9. Participants received Verinurad 24 mg and Allopurinol 300 mg.|
48176330|NCT03990363|100753938|FG003|Switch Dose|Overall Study||0|As per Protocol Version 5.0, 37 participants from 3 mg dose (ie, Low Dose group) were switched to 24 mg at Visit 9. Participants received Verinurad 24 mg and Allopurinol 300 mg.|
48176331|NCT03990363|100753939|FG004|Switch Dose|Overall Study||0|As per Protocol Version 5.0, 37 participants from 3 mg dose (ie, Low Dose group) were switched to 24 mg at Visit 9. Participants received Verinurad 24 mg and Allopurinol 300 mg.|
48176332|NCT03990363|100753935|FG000|COMPLETED|Overall Study||137||
48176333|NCT03990363|100753936|FG001|COMPLETED|Overall Study||143||
48176334|NCT03990363|100753937|FG002|COMPLETED|Overall Study||131||
48176335|NCT03990363|100753938|FG003|COMPLETED|Overall Study||145||
48176336|NCT03990363|100753939|FG004|COMPLETED|Overall Study||147||
48176337|NCT03990363|100753935|FG000|NOT COMPLETED|Overall Study||35||
48176338|NCT03990363|100753936|FG001|NOT COMPLETED|Overall Study||29||
48176339|NCT03990363|100753937|FG002|NOT COMPLETED|Overall Study||42||
48176340|NCT03990363|100753938|FG003|NOT COMPLETED|Overall Study||26||
48176341|NCT03990363|100753939|FG004|NOT COMPLETED|Overall Study||26||
48176342|NCT02019602|100753940|FG000|STARTED|Screening Period||21||
48176343|NCT02019602|100753941|FG001|STARTED|Screening Period||16||
48176344|NCT02019602|100753940|FG000|COMPLETED|Screening Period||16||
48630814|NCT01225549|101878650|FG003|NOT COMPLETED|Period 5 - Third Treatment Period||0||
48630815|NCT01225549|101878651|FG004|NOT COMPLETED|Period 5 - Third Treatment Period||0||
48630816|NCT01225549|101878652|FG005|NOT COMPLETED|Period 5 - Third Treatment Period||0||
48630817|NCT01225549|101878653|FG006|NOT COMPLETED|Period 5 - Third Treatment Period||0||
48630818|NCT01225549|101878654|FG007|NOT COMPLETED|Period 5 - Third Treatment Period||0||
48630819|NCT01225549|101878655|FG008|NOT COMPLETED|Period 5 - Third Treatment Period||0||
48630820|NCT01225549|101878656|FG009|NOT COMPLETED|Period 5 - Third Treatment Period||0||
48630821|NCT01225549|101878647|FG000|STARTED|Period 6 - Washout||1||
48630822|NCT01225549|101878648|FG001|STARTED|Period 6 - Washout||3||
48630823|NCT01225549|101878649|FG002|STARTED|Period 6 - Washout||3||
48630824|NCT01225549|101878650|FG003|STARTED|Period 6 - Washout||1||
48630825|NCT01225549|101878651|FG004|STARTED|Period 6 - Washout||1||
48630826|NCT01225549|101878652|FG005|STARTED|Period 6 - Washout||1||
48630827|NCT01225549|101878653|FG006|STARTED|Period 6 - Washout||3||
48630828|NCT01225549|101878654|FG007|STARTED|Period 6 - Washout||1||
48630829|NCT01225549|101878655|FG008|STARTED|Period 6 - Washout||4||
48630830|NCT01225549|101878656|FG009|STARTED|Period 6 - Washout||1||
48412846|NCT00443534|101345710|FG000|NOT COMPLETED|Overall Study||123||
48412847|NCT00098865|101345711|FG000|STARTED|Overall Study||15||
48412848|NCT00098865|101345711|FG000|COMPLETED|Overall Study||6||
48753247|NCT01620060|102184441|FG000|COMPLETED|Overall Study||90||
48176345|NCT02019602|100753941|FG001|COMPLETED|Screening Period||16||
48176346|NCT02019602|100753940|FG000|NOT COMPLETED|Screening Period||5||
48176347|NCT02019602|100753941|FG001|NOT COMPLETED|Screening Period||0||
48176348|NCT02019602|100753940|FG000|STARTED|Sampling Period||16||
48176349|NCT02019602|100753941|FG001|STARTED|Sampling Period||16||
48176350|NCT02019602|100753940|FG000|COMPLETED|Sampling Period||16||
48176351|NCT02019602|100753941|FG001|COMPLETED|Sampling Period||16||
48176352|NCT02019602|100753940|FG000|NOT COMPLETED|Sampling Period||0||
48176353|NCT02019602|100753941|FG001|NOT COMPLETED|Sampling Period||0||
48753248|NCT01620060|102184441|FG000|NOT COMPLETED|Overall Study||15||
48753249|NCT02269124|102184442|FG000|STARTED|Overall Study||21|Completion of each of the six survey rounds is defined here as completing at least one of the five surveys for the given time point.|
48753250|NCT02269124|102184443|FG001|STARTED|Overall Study||16|Completion of each of the six survey rounds is defined here as completing at least one of the five surveys for the given time point.|
48176354|NCT01033773|100753942|FG000|STARTED|Overall Study||86||
48176355|NCT01033773|100753942|FG000|COMPLETED|Overall Study||51||
48176356|NCT01033773|100753942|FG000|NOT COMPLETED|Overall Study||35||
48176357|NCT01840319|100753943|FG000|STARTED|Overall Study||156||
48176358|NCT01840319|100753943|FG000|COMPLETED|Overall Study||156||
48176359|NCT01840319|100753943|FG000|NOT COMPLETED|Overall Study||0||
48176360|NCT00267111|100753944|FG000|STARTED|Overall Study||55||
48176361|NCT00267111|100753945|FG001|STARTED|Overall Study||55||
48176362|NCT00267111|100753944|FG000|COMPLETED|Overall Study||55||
48176363|NCT00267111|100753945|FG001|COMPLETED|Overall Study||55||
48176364|NCT00267111|100753944|FG000|NOT COMPLETED|Overall Study||0||
48176365|NCT00267111|100753945|FG001|NOT COMPLETED|Overall Study||0||
48176366|NCT00627042|100753946|FG000|STARTED|Overall Study||42||
48176367|NCT00627042|100753946|FG000|Received at Least 1 Dose of Study Drug|Overall Study||42||
48176368|NCT00627042|100753946|FG000|COMPLETED|Overall Study||40||
48176369|NCT00627042|100753946|FG000|NOT COMPLETED|Overall Study||2||
48176370|NCT02029040|100753947|FG000|STARTED|Overall Study||27||
48176371|NCT02029040|100753948|FG001|STARTED|Overall Study||25||
48176372|NCT02029040|100753947|FG000|COMPLETED|Overall Study||27||
48176373|NCT02029040|100753948|FG001|COMPLETED|Overall Study||25||
48176374|NCT02029040|100753947|FG000|NOT COMPLETED|Overall Study||0||
48176375|NCT02029040|100753948|FG001|NOT COMPLETED|Overall Study||0||
48176376|NCT00988351|100753949|FG000|STARTED|Overall Study||78||
48176377|NCT00988351|100753950|FG001|STARTED|Overall Study||78||
48176378|NCT00988351|100753949|FG000|CPAP Titration|Overall Study||78||
48176379|NCT00988351|100753950|FG001|CPAP Titration|Overall Study||78||
48176380|NCT00988351|100753949|FG000|PAP Setup|Overall Study||70||
48176381|NCT00988351|100753950|FG001|PAP Setup|Overall Study||78||
48176382|NCT00988351|100753949|FG000|Clinic Visit|Overall Study||64||
48176383|NCT00988351|100753950|FG001|Clinic Visit|Overall Study||69||
48176384|NCT00988351|100753949|FG000|Using CPAP or APAP|Overall Study||59||
48176385|NCT00988351|100753950|FG001|Using CPAP or APAP|Overall Study||66||
48176386|NCT00988351|100753949|FG000|COMPLETED|Overall Study||59||
48176387|NCT00988351|100753950|FG001|COMPLETED|Overall Study||66||
48176388|NCT00988351|100753949|FG000|NOT COMPLETED|Overall Study||19||
48176389|NCT00988351|100753950|FG001|NOT COMPLETED|Overall Study||12||
48176390|NCT00872430|100753951|FG000|STARTED|First Intervention||10||
48176391|NCT00872430|100753952|FG001|STARTED|First Intervention||10||
48176392|NCT00872430|100753951|FG000|COMPLETED|First Intervention||10||
48176393|NCT00872430|100753952|FG001|COMPLETED|First Intervention||10||
48176394|NCT00872430|100753951|FG000|NOT COMPLETED|First Intervention||0||
48176395|NCT00872430|100753952|FG001|NOT COMPLETED|First Intervention||0||
48176396|NCT00872430|100753951|FG000|STARTED|Washout Period||10||
48176397|NCT00872430|100753952|FG001|STARTED|Washout Period||10||
48176398|NCT00872430|100753951|FG000|COMPLETED|Washout Period||10||
48176399|NCT00872430|100753952|FG001|COMPLETED|Washout Period||10||
48176400|NCT00872430|100753951|FG000|NOT COMPLETED|Washout Period||0||
48176401|NCT00872430|100753952|FG001|NOT COMPLETED|Washout Period||0||
48176402|NCT00872430|100753951|FG000|STARTED|Second Intervention||10||
48176403|NCT00872430|100753952|FG001|STARTED|Second Intervention||10||
48176404|NCT00872430|100753951|FG000|COMPLETED|Second Intervention||10||
48176405|NCT00872430|100753952|FG001|COMPLETED|Second Intervention||10||
48176406|NCT00872430|100753951|FG000|NOT COMPLETED|Second Intervention||0||
48176407|NCT00872430|100753952|FG001|NOT COMPLETED|Second Intervention||0||
48176408|NCT04781647|100753953|FG000|STARTED|Overall Study||20||
48412849|NCT00098865|101345711|FG000|NOT COMPLETED|Overall Study||9||
48412850|NCT00836953|101345712|FG000|STARTED|Overall Study||33||
48412851|NCT00836953|101345712|FG000|COMPLETED|Overall Study||31||
48176409|NCT04781647|100753954|FG001|STARTED|Overall Study||17||
48176410|NCT04781647|100753955|FG002|STARTED|Overall Study||17||
48412852|NCT00836953|101345712|FG000|NOT COMPLETED|Overall Study||2||
48176411|NCT04781647|100753953|FG000|COMPLETED|Overall Study||6||
48176412|NCT04781647|100753954|FG001|COMPLETED|Overall Study||5||
48767733|NCT00494676|102222812|FG000|COMPLETED|Second Intervention||33||
48767734|NCT00494676|102222813|FG001|COMPLETED|Second Intervention||28||
48176413|NCT04781647|100753955|FG002|COMPLETED|Overall Study||6||
48176414|NCT04781647|100753953|FG000|NOT COMPLETED|Overall Study||14||
48176415|NCT04781647|100753954|FG001|NOT COMPLETED|Overall Study||12||
48176416|NCT04781647|100753955|FG002|NOT COMPLETED|Overall Study||11||
48176417|NCT01313923|100753956|FG000|STARTED|Overall Study||3||
48176418|NCT01313923|100753956|FG000|COMPLETED|Overall Study||0||
48176419|NCT01313923|100753956|FG000|NOT COMPLETED|Overall Study||3||
48176420|NCT02250521|100753957|FG000|STARTED|Overall Study||100||
48176421|NCT02250521|100753957|FG000|COMPLETED|Overall Study||99||
48176422|NCT02250521|100753957|FG000|NOT COMPLETED|Overall Study||1||
48176423|NCT00548041|100753958|FG000|STARTED|Overall Study||100||
48176424|NCT00548041|100753958|FG000|COMPLETED|Overall Study||100||
48176425|NCT00548041|100753958|FG000|NOT COMPLETED|Overall Study||0||
48176426|NCT01267825|100753959|FG000|STARTED|Overall Study||1||
48176427|NCT01267825|100753960|FG001|STARTED|Overall Study||0||
48176428|NCT01267825|100753959|FG000|COMPLETED|Overall Study||0||
48176429|NCT01267825|100753960|FG001|COMPLETED|Overall Study||0||
48176430|NCT01267825|100753959|FG000|NOT COMPLETED|Overall Study||1||
48176431|NCT01267825|100753960|FG001|NOT COMPLETED|Overall Study||0||
48176432|NCT01818141|100753961|FG000|STARTED|Overall Study||18||
48176433|NCT01818141|100753962|FG001|STARTED|Overall Study||16||
48176434|NCT01818141|100753961|FG000|COMPLETED|Overall Study||15||
48176435|NCT01818141|100753962|FG001|COMPLETED|Overall Study||13||
48176436|NCT01818141|100753961|FG000|NOT COMPLETED|Overall Study||3||
48176437|NCT01818141|100753962|FG001|NOT COMPLETED|Overall Study||3||
48176438|NCT00393094|100753963|FG000|STARTED|Period1Bevacizumab & Irinotecan Patients||31||
48176439|NCT00393094|100753963|FG000|COMPLETED|Period1Bevacizumab & Irinotecan Patients||30||
48176440|NCT00393094|100753963|FG000|NOT COMPLETED|Period1Bevacizumab & Irinotecan Patients||1||
48176441|NCT00393094|100753963|FG000|STARTED|Disease Progression After Trtmt: Onstudy||30||
48176442|NCT00393094|100753963|FG000|COMPLETED|Disease Progression After Trtmt: Onstudy||29||
48176443|NCT00393094|100753963|FG000|NOT COMPLETED|Disease Progression After Trtmt: Onstudy||1||
48176444|NCT03958630|100753964|FG000|STARTED|Overall Study||6||
48176445|NCT03958630|100753965|FG001|STARTED|Overall Study||3||
48176446|NCT03958630|100753966|FG002|STARTED|Overall Study||4||
48176447|NCT03958630|100753964|FG000|COMPLETED|Overall Study||6||
48630831|NCT01225549|101878647|FG000|COMPLETED|Period 6 - Washout||1||
48630832|NCT01225549|101878648|FG001|COMPLETED|Period 6 - Washout||3||
48630833|NCT01225549|101878649|FG002|COMPLETED|Period 6 - Washout||3||
48630834|NCT01225549|101878650|FG003|COMPLETED|Period 6 - Washout||0||
48176448|NCT03958630|100753965|FG001|COMPLETED|Overall Study||3||
48176449|NCT03958630|100753966|FG002|COMPLETED|Overall Study||2||
48176450|NCT03958630|100753964|FG000|NOT COMPLETED|Overall Study||0||
48176451|NCT03958630|100753965|FG001|NOT COMPLETED|Overall Study||0||
48176452|NCT03958630|100753966|FG002|NOT COMPLETED|Overall Study||2||
48176453|NCT02500979|100753967|FG000|STARTED|Period 1||16|(Randomized Analysis Set)|
48176454|NCT02500979|100753968|FG001|STARTED|Period 1||17|(Randomized Analysis Set)|
48176455|NCT02500979|100753967|FG000|COMPLETED|Period 1||12|Number of subjects that entered Period 2|
48176456|NCT02500979|100753968|FG001|COMPLETED|Period 1||16|Number of subjects that entered Period 2|
48176457|NCT02500979|100753967|FG000|NOT COMPLETED|Period 1||4||
48176458|NCT02500979|100753968|FG001|NOT COMPLETED|Period 1||1||
48176459|NCT02500979|100753967|FG000|STARTED|Period 2||12|(Randomized Analysis Set)|
48176460|NCT02500979|100753968|FG001|STARTED|Period 2||16|(Randomized Analysis Set)|
48176461|NCT02500979|100753967|FG000|COMPLETED|Period 2||11|Completed Period 2|
48176462|NCT02500979|100753968|FG001|COMPLETED|Period 2||16|Completed Period 2|
48176463|NCT02500979|100753967|FG000|NOT COMPLETED|Period 2||1||
48176464|NCT02500979|100753968|FG001|NOT COMPLETED|Period 2||0||
48176465|NCT00993317|100753969|FG000|STARTED|Overall Study||42||
48630835|NCT01225549|101878651|FG004|COMPLETED|Period 6 - Washout||1||
48630836|NCT01225549|101878652|FG005|COMPLETED|Period 6 - Washout||1||
48630837|NCT01225549|101878653|FG006|COMPLETED|Period 6 - Washout||3||
48176466|NCT00993317|100753970|FG001|STARTED|Overall Study||85||
48176467|NCT00993317|100753969|FG000|COMPLETED|Overall Study||21||
48176468|NCT00993317|100753970|FG001|COMPLETED|Overall Study||60||
48176469|NCT00993317|100753969|FG000|NOT COMPLETED|Overall Study||21||
48176470|NCT00993317|100753970|FG001|NOT COMPLETED|Overall Study||25||
48176471|NCT02091869|100753971|FG000|STARTED|Overall Study||17||
48176472|NCT02091869|100753972|FG001|STARTED|Overall Study||17||
48630838|NCT01225549|101878654|FG007|COMPLETED|Period 6 - Washout||1||
48630839|NCT01225549|101878655|FG008|COMPLETED|Period 6 - Washout||4||
48630840|NCT01225549|101878656|FG009|COMPLETED|Period 6 - Washout||1||
48176473|NCT02091869|100753971|FG000|COMPLETED|Overall Study||17||
48176474|NCT02091869|100753972|FG001|COMPLETED|Overall Study||14||
48176475|NCT02091869|100753971|FG000|NOT COMPLETED|Overall Study||0||
48176476|NCT02091869|100753972|FG001|NOT COMPLETED|Overall Study||3||
48176477|NCT04276090|100753973|FG000|STARTED|Overall Study||17||
48176478|NCT04276090|100753974|FG001|STARTED|Overall Study||4||
48176479|NCT04276090|100753973|FG000|COMPLETED|Overall Study||16||
48176480|NCT04276090|100753974|FG001|COMPLETED|Overall Study||4||
48176481|NCT04276090|100753973|FG000|NOT COMPLETED|Overall Study||1||
48176482|NCT04276090|100753974|FG001|NOT COMPLETED|Overall Study||0||
48630841|NCT01225549|101878647|FG000|NOT COMPLETED|Period 6 - Washout||0||
48176483|NCT02310126|100753975|FG000|STARTED|Period 1 (15 Minutes)||94||
48176484|NCT02310126|100753976|FG001|STARTED|Period 1 (15 Minutes)||97||
48176485|NCT02310126|100753975|FG000|Hyperopes|Period 1 (15 Minutes)||38||
48176486|NCT02310126|100753976|FG001|Hyperopes|Period 1 (15 Minutes)||33||
48176487|NCT02310126|100753975|FG000|Myopes|Period 1 (15 Minutes)||56||
48176488|NCT02310126|100753976|FG001|Myopes|Period 1 (15 Minutes)||64||
48176489|NCT02310126|100753975|FG000|COMPLETED|Period 1 (15 Minutes)||94||
48176490|NCT02310126|100753976|FG001|COMPLETED|Period 1 (15 Minutes)||95||
48176491|NCT02310126|100753975|FG000|NOT COMPLETED|Period 1 (15 Minutes)||0||
48176492|NCT02310126|100753976|FG001|NOT COMPLETED|Period 1 (15 Minutes)||2||
48176493|NCT02310126|100753975|FG000|STARTED|Period 2 (15 Minutes)||94||
48176494|NCT02310126|100753976|FG001|STARTED|Period 2 (15 Minutes)||95||
48176495|NCT02310126|100753975|FG000|Hyperopes|Period 2 (15 Minutes)||38||
48176496|NCT02310126|100753976|FG001|Hyperopes|Period 2 (15 Minutes)||32||
48176497|NCT02310126|100753975|FG000|Myopes|Period 2 (15 Minutes)||56||
48176498|NCT02310126|100753976|FG001|Myopes|Period 2 (15 Minutes)||63||
48176499|NCT02310126|100753975|FG000|COMPLETED|Period 2 (15 Minutes)||94||
48176500|NCT02310126|100753976|FG001|COMPLETED|Period 2 (15 Minutes)||95||
48176501|NCT02310126|100753975|FG000|NOT COMPLETED|Period 2 (15 Minutes)||0||
48176502|NCT02310126|100753976|FG001|NOT COMPLETED|Period 2 (15 Minutes)||0||
48176503|NCT00287469|100753977|FG000|STARTED|Overall Study||1000||
48176504|NCT00287469|100753978|FG001|STARTED|Overall Study||1000||
48176505|NCT00287469|100753977|FG000|COMPLETED|Overall Study||780||
48176506|NCT00287469|100753978|FG001|COMPLETED|Overall Study||786||
48176507|NCT00287469|100753977|FG000|NOT COMPLETED|Overall Study||220||
48176508|NCT00287469|100753978|FG001|NOT COMPLETED|Overall Study||214||
48176509|NCT00574990|100753979|FG000|STARTED|Overall Study||12||
48176510|NCT00574990|100753980|FG001|STARTED|Overall Study||19||
48176511|NCT00574990|100753981|FG002|STARTED|Overall Study||8||
48176512|NCT00574990|100753979|FG000|COMPLETED|Overall Study||12||
48176513|NCT00574990|100753980|FG001|COMPLETED|Overall Study||19||
48176514|NCT00574990|100753981|FG002|COMPLETED|Overall Study||8||
48176515|NCT00574990|100753979|FG000|NOT COMPLETED|Overall Study||0||
48176516|NCT00574990|100753980|FG001|NOT COMPLETED|Overall Study||0||
48176517|NCT00574990|100753981|FG002|NOT COMPLETED|Overall Study||0||
48176518|NCT02044419|100753982|FG000|STARTED|First Intervention||11||
48176519|NCT02044419|100753983|FG001|STARTED|First Intervention||10||
48176520|NCT02044419|100753984|FG002|STARTED|First Intervention||11||
48176521|NCT02044419|100753982|FG000|COMPLETED|First Intervention||11||
48176522|NCT02044419|100753983|FG001|COMPLETED|First Intervention||9||
48176523|NCT02044419|100753984|FG002|COMPLETED|First Intervention||10||
48176524|NCT02044419|100753982|FG000|NOT COMPLETED|First Intervention||0||
48176525|NCT02044419|100753983|FG001|NOT COMPLETED|First Intervention||1||
48176526|NCT02044419|100753984|FG002|NOT COMPLETED|First Intervention||1||
48176527|NCT02044419|100753982|FG000|STARTED|Second Intervention||11||
48176528|NCT02044419|100753983|FG001|STARTED|Second Intervention||9||
48176529|NCT02044419|100753984|FG002|STARTED|Second Intervention||10||
48176530|NCT02044419|100753982|FG000|COMPLETED|Second Intervention||11||
48176531|NCT02044419|100753983|FG001|COMPLETED|Second Intervention||9||
48176532|NCT02044419|100753984|FG002|COMPLETED|Second Intervention||10||
48176533|NCT02044419|100753982|FG000|NOT COMPLETED|Second Intervention||0||
48630842|NCT01225549|101878648|FG001|NOT COMPLETED|Period 6 - Washout||0||
48630843|NCT01225549|101878649|FG002|NOT COMPLETED|Period 6 - Washout||0||
48630844|NCT01225549|101878650|FG003|NOT COMPLETED|Period 6 - Washout||1||
48630845|NCT01225549|101878651|FG004|NOT COMPLETED|Period 6 - Washout||0||
48630846|NCT01225549|101878652|FG005|NOT COMPLETED|Period 6 - Washout||0||
48630847|NCT01225549|101878653|FG006|NOT COMPLETED|Period 6 - Washout||0||
48630848|NCT01225549|101878654|FG007|NOT COMPLETED|Period 6 - Washout||0||
48630849|NCT01225549|101878655|FG008|NOT COMPLETED|Period 6 - Washout||0||
48630850|NCT01225549|101878656|FG009|NOT COMPLETED|Period 6 - Washout||0||
48630851|NCT01225549|101878647|FG000|STARTED|Period 7 - Fourth Treatment Period||1||
48630852|NCT01225549|101878648|FG001|STARTED|Period 7 - Fourth Treatment Period||3||
48630853|NCT01225549|101878649|FG002|STARTED|Period 7 - Fourth Treatment Period||3||
48630854|NCT01225549|101878650|FG003|STARTED|Period 7 - Fourth Treatment Period||0||
48630855|NCT01225549|101878651|FG004|STARTED|Period 7 - Fourth Treatment Period||1||
48176534|NCT02044419|100753983|FG001|NOT COMPLETED|Second Intervention||0||
48176535|NCT02044419|100753984|FG002|NOT COMPLETED|Second Intervention||0||
48630856|NCT01225549|101878652|FG005|STARTED|Period 7 - Fourth Treatment Period||1||
48753251|NCT02269124|102184442|FG000|Completed Survey Round 1 (Arm 1, 0 Weeks)|Overall Study||20|Survey Round 1 was administered 0 weeks into the study, corresponding to the beginning of the first treatment arm. Round 1 represents the first of six survey rounds overall.|
48176536|NCT02044419|100753982|FG000|STARTED|Third Intervention||11||
48176537|NCT02044419|100753983|FG001|STARTED|Third Intervention||9||
48176538|NCT02044419|100753984|FG002|STARTED|Third Intervention||10||
48176539|NCT02044419|100753982|FG000|COMPLETED|Third Intervention||11||
48176540|NCT02044419|100753983|FG001|COMPLETED|Third Intervention||9||
48176541|NCT02044419|100753984|FG002|COMPLETED|Third Intervention||10||
48176542|NCT02044419|100753982|FG000|NOT COMPLETED|Third Intervention||0||
48176543|NCT02044419|100753983|FG001|NOT COMPLETED|Third Intervention||0||
48176544|NCT02044419|100753984|FG002|NOT COMPLETED|Third Intervention||0||
48657131|NCT00063362|101943785|FG000|STARTED|Overall Study||23||
48753252|NCT02269124|102184443|FG001|Completed Survey Round 1 (Arm 1, 0 Weeks)|Overall Study||14|Survey Round 1 was administered 0 weeks into the study, corresponding to the beginning of the first treatment arm. Round 1 represents the first of six survey rounds overall.|
48753253|NCT02269124|102184442|FG000|Completed Survey Round 2 (Arm 1, 6 Weeks)|Overall Study||17|Survey Round 2 was administered 6 weeks into the study, corresponding to the halfway point within the first treatment arm. Round 2 represents the second of six survey rounds overall.|
48753254|NCT02269124|102184443|FG001|Completed Survey Round 2 (Arm 1, 6 Weeks)|Overall Study||13|Survey Round 2 was administered 6 weeks into the study, corresponding to the halfway point within the first treatment arm. Round 2 represents the second of six survey rounds overall.|
48767735|NCT00494676|102222812|FG000|NOT COMPLETED|Second Intervention||1||
48176545|NCT02241720|100753985|FG000|STARTED|Overall Study||5||
48176546|NCT02241720|100753985|FG000|COMPLETED|Overall Study||1||
48176547|NCT02241720|100753985|FG000|NOT COMPLETED|Overall Study||4||
48176548|NCT02774265|100753986|FG000|STARTED|Overall Study||164||
48176549|NCT02774265|100753987|FG001|STARTED|Overall Study||165||
48176550|NCT02774265|100753986|FG000|COMPLETED|Overall Study||151||
48176551|NCT02774265|100753987|FG001|COMPLETED|Overall Study||159||
48176552|NCT02774265|100753986|FG000|NOT COMPLETED|Overall Study||13||
48176553|NCT02774265|100753987|FG001|NOT COMPLETED|Overall Study||6||
48176554|NCT04800757|100753988|FG000|STARTED|Overall Study||113||10
48176555|NCT04800757|100753989|FG001|STARTED|Overall Study||102||10
48176556|NCT04800757|100753990|FG002|STARTED|Overall Study||110||10
48176557|NCT04800757|100753988|FG000|Completed Baseline Assessment|Overall Study||112||10
48176558|NCT04800757|100753989|FG001|Completed Baseline Assessment|Overall Study||100||10
48176559|NCT04800757|100753990|FG002|Completed Baseline Assessment|Overall Study||106||10
48176560|NCT04800757|100753988|FG000|Completed Post-Intervention Assessment|Overall Study||91||10
48176561|NCT04800757|100753989|FG001|Completed Post-Intervention Assessment|Overall Study||82||10
48176562|NCT04800757|100753990|FG002|Completed Post-Intervention Assessment|Overall Study||75||10
48176563|NCT04800757|100753988|FG000|COMPLETED|Overall Study||91||10
48176564|NCT04800757|100753989|FG001|COMPLETED|Overall Study||82||10
48176565|NCT04800757|100753990|FG002|COMPLETED|Overall Study||75||10
48176566|NCT04800757|100753988|FG000|NOT COMPLETED|Overall Study||22||0
48176567|NCT04800757|100753989|FG001|NOT COMPLETED|Overall Study||20||0
48176568|NCT04800757|100753990|FG002|NOT COMPLETED|Overall Study||35||0
48176569|NCT03881059|100753991|FG000|STARTED|Treatment Period - Part A||66||
48176570|NCT03881059|100753992|FG001|STARTED|Treatment Period - Part A||70||
48176571|NCT03881059|100753993|FG002|STARTED|Treatment Period - Part A||67||
48176572|NCT03881059|100753991|FG000|COMPLETED|Treatment Period - Part A||58||
48176573|NCT03881059|100753992|FG001|COMPLETED|Treatment Period - Part A||63||
48176574|NCT03881059|100753993|FG002|COMPLETED|Treatment Period - Part A||59||
48176575|NCT03881059|100753991|FG000|NOT COMPLETED|Treatment Period - Part A||8||
48176576|NCT03881059|100753992|FG001|NOT COMPLETED|Treatment Period - Part A||7||
48176577|NCT03881059|100753993|FG002|NOT COMPLETED|Treatment Period - Part A||8||
48176578|NCT03881059|100753991|FG000|STARTED|Treatment Period - Part B||55|Participation in Part B was optional. Some of the participants who completed Part A decided not to continue in Part B|
48176579|NCT03881059|100753992|FG001|STARTED|Treatment Period - Part B||60|Participation in Part B was optional. Some of the participants who completed Part A decided not to continue in Part B|
48176580|NCT03881059|100753993|FG002|STARTED|Treatment Period - Part B||58|Participation in Part B was optional. Some of the participants who completed Part A decided not to continue in Part B|
48176581|NCT03881059|100753991|FG000|Participants Maintaining Same Treatment as in Part A|Treatment Period - Part B||0||
48176582|NCT03881059|100753992|FG001|Participants Maintaining Same Treatment as in Part A|Treatment Period - Part B||13||
48176583|NCT03881059|100753993|FG002|Participants Maintaining Same Treatment as in Part A|Treatment Period - Part B||16||
48176584|NCT03881059|100753991|FG000|Participants Treated With Ustekinumab in Part B|Treatment Period - Part B||55||
48176585|NCT03881059|100753992|FG001|Participants Treated With Ustekinumab in Part B|Treatment Period - Part B||47||
48176586|NCT03881059|100753993|FG002|Participants Treated With Ustekinumab in Part B|Treatment Period - Part B||42||
48176587|NCT03881059|100753991|FG000|COMPLETED|Treatment Period - Part B||47||
48176588|NCT03881059|100753992|FG001|COMPLETED|Treatment Period - Part B||54||
48176589|NCT03881059|100753993|FG002|COMPLETED|Treatment Period - Part B||47||
48176590|NCT03881059|100753991|FG000|NOT COMPLETED|Treatment Period - Part B||8||
48176591|NCT03881059|100753992|FG001|NOT COMPLETED|Treatment Period - Part B||6||
48176592|NCT03881059|100753993|FG002|NOT COMPLETED|Treatment Period - Part B||11||
48176593|NCT00451217|100753994|FG000|STARTED|Overall Study||49||
48176594|NCT00451217|100753995|FG001|STARTED|Overall Study||49||
48176595|NCT00451217|100753996|FG002|STARTED|Overall Study||51||
48176596|NCT00451217|100753997|FG003|STARTED|Overall Study||49||
48176597|NCT00451217|100753994|FG000|Treated|Overall Study||48||
48176598|NCT00451217|100753995|FG001|Treated|Overall Study||48||
48176599|NCT00451217|100753996|FG002|Treated|Overall Study||48||
48176600|NCT00451217|100753997|FG003|Treated|Overall Study||45||
48176601|NCT00451217|100753994|FG000|COMPLETED|Overall Study||47||
48176602|NCT00451217|100753995|FG001|COMPLETED|Overall Study||47||
48176603|NCT00451217|100753996|FG002|COMPLETED|Overall Study||47||
48176604|NCT00451217|100753997|FG003|COMPLETED|Overall Study||44||
48176605|NCT00451217|100753994|FG000|NOT COMPLETED|Overall Study||2||
48176606|NCT00451217|100753995|FG001|NOT COMPLETED|Overall Study||2||
48176607|NCT00451217|100753996|FG002|NOT COMPLETED|Overall Study||4||
48767736|NCT00494676|102222813|FG001|NOT COMPLETED|Second Intervention||1||
48176608|NCT00451217|100753997|FG003|NOT COMPLETED|Overall Study||5||
48176609|NCT02743793|100753998|FG000|STARTED|Overall Study||5||
48176610|NCT02743793|100753999|FG001|STARTED|Overall Study||36||
48176611|NCT02743793|100753998|FG000|COMPLETED|Overall Study||0||
48176612|NCT02743793|100753999|FG001|COMPLETED|Overall Study||0||
48176613|NCT02743793|100753998|FG000|NOT COMPLETED|Overall Study||5||
48176614|NCT02743793|100753999|FG001|NOT COMPLETED|Overall Study||36||
48176615|NCT01515345|100754000|FG000|STARTED|Overall Study||665||
48176616|NCT01515345|100754001|FG001|STARTED|Overall Study||343||
48176617|NCT01515345|100754000|FG000|COMPLETED|Overall Study||664||
48176618|NCT01515345|100754001|FG001|COMPLETED|Overall Study||343||
48176619|NCT01515345|100754000|FG000|NOT COMPLETED|Overall Study||1||
48176620|NCT01515345|100754001|FG001|NOT COMPLETED|Overall Study||0||
48176621|NCT03047174|100754002|FG000|STARTED|Overall Study||28||
48176622|NCT03047174|100754003|FG001|STARTED|Overall Study||29||
48176623|NCT03047174|100754002|FG000|COMPLETED|Overall Study||9||
48176624|NCT03047174|100754003|FG001|COMPLETED|Overall Study||27||
48176625|NCT03047174|100754002|FG000|NOT COMPLETED|Overall Study||19||
48176626|NCT03047174|100754003|FG001|NOT COMPLETED|Overall Study||2||
48176627|NCT04537897|100754004|FG000|STARTED|Overall Study||10||
48176628|NCT04537897|100754005|FG001|STARTED|Overall Study||8||
48176629|NCT04537897|100754006|FG002|STARTED|Overall Study||8||
48176630|NCT04537897|100754007|FG003|STARTED|Overall Study||8||
48176631|NCT04537897|100754008|FG004|STARTED|Overall Study||8||
48176632|NCT04537897|100754009|FG005|STARTED|Overall Study||8||
48176633|NCT04537897|100754010|FG006|STARTED|Overall Study||4||
48176634|NCT04537897|100754011|FG007|STARTED|Overall Study||8||
48176635|NCT04537897|100754012|FG008|STARTED|Overall Study||8||
48176636|NCT04537897|100754004|FG000|COMPLETED|Overall Study||10|"Completed = not prematurely discontinued from trial medication."|
48176637|NCT04537897|100754005|FG001|COMPLETED|Overall Study||7|"Completed = not prematurely discontinued from trial medication."|
48176638|NCT04537897|100754006|FG002|COMPLETED|Overall Study||8|"Completed = not prematurely discontinued from trial medication."|
48176639|NCT04537897|100754007|FG003|COMPLETED|Overall Study||7|"Completed = not prematurely discontinued from trial medication."|
48176640|NCT04537897|100754008|FG004|COMPLETED|Overall Study||8|"Completed = not prematurely discontinued from trial medication."|
48176641|NCT04537897|100754009|FG005|COMPLETED|Overall Study||8|"Completed = not prematurely discontinued from trial medication."|
48176642|NCT04537897|100754010|FG006|COMPLETED|Overall Study||3|"Completed = not prematurely discontinued from trial medication."|
48176643|NCT04537897|100754011|FG007|COMPLETED|Overall Study||8|"Completed = not prematurely discontinued from trial medication."|
48176644|NCT04537897|100754012|FG008|COMPLETED|Overall Study||8|"Completed = not prematurely discontinued from trial medication."|
48176645|NCT04537897|100754004|FG000|NOT COMPLETED|Overall Study||0||
48176646|NCT04537897|100754005|FG001|NOT COMPLETED|Overall Study||1||
48176647|NCT04537897|100754006|FG002|NOT COMPLETED|Overall Study||0||
48176648|NCT04537897|100754007|FG003|NOT COMPLETED|Overall Study||1||
48176649|NCT04537897|100754008|FG004|NOT COMPLETED|Overall Study||0||
48176650|NCT04537897|100754009|FG005|NOT COMPLETED|Overall Study||0||
48176651|NCT04537897|100754010|FG006|NOT COMPLETED|Overall Study||1||
48176652|NCT04537897|100754011|FG007|NOT COMPLETED|Overall Study||0||
48176653|NCT04537897|100754012|FG008|NOT COMPLETED|Overall Study||0||
48176654|NCT02032173|100754013|FG000|STARTED|Overall Study||31||
48176655|NCT02032173|100754013|FG000|Included Population - Main Group|Overall Study||31|Included population with evaluable patients at specific time points|
48176656|NCT02032173|100754013|FG000|Rescue Group|Overall Study||1|Participants who did not meet the pre-defined criteria were moved to Rescue Group|
48176657|NCT02032173|100754013|FG000|COMPLETED|Overall Study||0||
48176658|NCT02032173|100754013|FG000|NOT COMPLETED|Overall Study||31||
48176659|NCT01680458|100754014|FG000|STARTED|Overall Study||30||
48176660|NCT01680458|100754014|FG000|COMPLETED|Overall Study||27||
48176661|NCT01680458|100754014|FG000|NOT COMPLETED|Overall Study||3||
48767737|NCT01520506|102222814|FG000|STARTED|Overall Study||50||
48176662|NCT00183443|100757471|FG000|STARTED|Overall Study||24||
48176663|NCT00183443|100757472|FG001|STARTED|Overall Study||26||
48176664|NCT00183443|100757473|FG002|STARTED|Overall Study||25||
48176665|NCT00183443|100757471|FG000|COMPLETED|Overall Study||24||
48176666|NCT00183443|100757472|FG001|COMPLETED|Overall Study||26||
48176667|NCT00183443|100757473|FG002|COMPLETED|Overall Study||25||
48176668|NCT00183443|100757471|FG000|NOT COMPLETED|Overall Study||0||
48176669|NCT00183443|100757472|FG001|NOT COMPLETED|Overall Study||0||
48176670|NCT00183443|100757473|FG002|NOT COMPLETED|Overall Study||0||
48767738|NCT01520506|102222814|FG000|COMPLETED|Overall Study||44||
48176671|NCT00547105|100757474|FG000|STARTED|Overall Study||24||
48176672|NCT00547105|100757474|FG000|COMPLETED|Overall Study||24||
48176673|NCT00547105|100757474|FG000|NOT COMPLETED|Overall Study||0||
48176674|NCT02248961|100757475|FG000|STARTED|Overall Study||89||
48767739|NCT01520506|102222814|FG000|NOT COMPLETED|Overall Study||6||
48176675|NCT02248961|100757476|FG001|STARTED|Overall Study||90||
48176676|NCT02248961|100757475|FG000|COMPLETED|Overall Study||86||
48176677|NCT02248961|100757476|FG001|COMPLETED|Overall Study||88||
48176678|NCT02248961|100757475|FG000|NOT COMPLETED|Overall Study||3||
48176679|NCT02248961|100757476|FG001|NOT COMPLETED|Overall Study||2||
48176680|NCT01785628|100757477|FG000|STARTED|Overall Study||15||
48412853|NCT00533780|101345713|FG000|STARTED|Overall Study||51||
48176681|NCT01785628|100757478|FG001|STARTED|Overall Study||15||
48176682|NCT01785628|100757477|FG000|COMPLETED|Overall Study||13||
48176683|NCT01785628|100757478|FG001|COMPLETED|Overall Study||12||
48176684|NCT01785628|100757477|FG000|NOT COMPLETED|Overall Study||2||
48176685|NCT01785628|100757478|FG001|NOT COMPLETED|Overall Study||3||
48176686|NCT03786094|100757479|FG000|STARTED|Overall Study||219||
48176687|NCT03786094|100757480|FG001|STARTED|Overall Study||213||
48753255|NCT02269124|102184442|FG000|Completed Survey Round 3 (Arm 1, 12 Weeks)|Overall Study||17|Survey Round 3 was administered 12 weeks into the study, corresponding to the last measures during the first treatment arm. Survey Round 3 was administered shortly before the subject had ended the first treatment arm, while Survey Round 4 was administered shortly after the subject initiated the second treatment arm. Round 3 represents the third of six survey rounds overall.|
48767740|NCT02141295|102222815|FG000|STARTED|Overall Study||8||
48767741|NCT02141295|102222816|FG001|STARTED|Overall Study||94||
48176688|NCT03786094|100757479|FG000|Overall Population (2nd Line+)|Overall Study||219||
48176689|NCT03786094|100757480|FG001|Overall Population (2nd Line+)|Overall Study||213||
48176690|NCT03786094|100757479|FG000|3rd Line+ Population|Overall Study||175||
48176691|NCT03786094|100757480|FG001|3rd Line+ Population|Overall Study||173||
48176692|NCT03786094|100757479|FG000|COMPLETED|Overall Study||10||
48176693|NCT03786094|100757480|FG001|COMPLETED|Overall Study||11||
48176694|NCT03786094|100757479|FG000|NOT COMPLETED|Overall Study||209||
48176695|NCT03786094|100757480|FG001|NOT COMPLETED|Overall Study||202||
48412854|NCT00533780|101345713|FG000|COMPLETED|Overall Study||51||
48412855|NCT00533780|101345713|FG000|NOT COMPLETED|Overall Study||0||
48412856|NCT01030757|101345714|FG000|STARTED|Overall Study||2||
48630857|NCT01225549|101878653|FG006|STARTED|Period 7 - Fourth Treatment Period||3||
48630858|NCT01225549|101878654|FG007|STARTED|Period 7 - Fourth Treatment Period||1||
48630859|NCT01225549|101878655|FG008|STARTED|Period 7 - Fourth Treatment Period||4||
48630860|NCT01225549|101878656|FG009|STARTED|Period 7 - Fourth Treatment Period||1||
48630861|NCT01225549|101878647|FG000|COMPLETED|Period 7 - Fourth Treatment Period||1||
48630862|NCT01225549|101878648|FG001|COMPLETED|Period 7 - Fourth Treatment Period||3||
48630863|NCT01225549|101878649|FG002|COMPLETED|Period 7 - Fourth Treatment Period||3||
48630864|NCT01225549|101878650|FG003|COMPLETED|Period 7 - Fourth Treatment Period||0||
48630865|NCT01225549|101878651|FG004|COMPLETED|Period 7 - Fourth Treatment Period||1||
48176696|NCT02550132|100757481|FG000|STARTED|Overall Study||25||
48176697|NCT02550132|100757481|FG000|COMPLETED|Overall Study||25||
48630866|NCT01225549|101878652|FG005|COMPLETED|Period 7 - Fourth Treatment Period||1||
48630867|NCT01225549|101878653|FG006|COMPLETED|Period 7 - Fourth Treatment Period||3||
48630868|NCT01225549|101878654|FG007|COMPLETED|Period 7 - Fourth Treatment Period||1||
48176698|NCT02550132|100757481|FG000|NOT COMPLETED|Overall Study||0||
48176699|NCT02392767|100757482|FG000|STARTED|Overall Study||12||
48176700|NCT02392767|100757483|FG001|STARTED|Overall Study||13||
48176701|NCT02392767|100757482|FG000|COMPLETED|Overall Study||12||
48176702|NCT02392767|100757483|FG001|COMPLETED|Overall Study||13||
48176703|NCT02392767|100757482|FG000|NOT COMPLETED|Overall Study||0||
48176704|NCT02392767|100757483|FG001|NOT COMPLETED|Overall Study||0||
48176705|NCT00655551|100757484|FG000|STARTED|All Periods Combined||25||
48176706|NCT00655551|100757485|FG001|STARTED|All Periods Combined||50||
48176707|NCT00655551|100757486|FG002|STARTED|All Periods Combined||25||
48176708|NCT00655551|100757484|FG000|COMPLETED|All Periods Combined||25||
48176709|NCT00655551|100757485|FG001|COMPLETED|All Periods Combined||47||
48176710|NCT00655551|100757486|FG002|COMPLETED|All Periods Combined||21||
48176711|NCT00655551|100757484|FG000|NOT COMPLETED|All Periods Combined||0||
48176712|NCT00655551|100757485|FG001|NOT COMPLETED|All Periods Combined||3||
48176713|NCT00655551|100757486|FG002|NOT COMPLETED|All Periods Combined||4||
48176714|NCT00655551|100757484|FG000|STARTED|Period 1 (up to 7 Days)||25||
48176715|NCT00655551|100757485|FG001|STARTED|Period 1 (up to 7 Days)||0||
48176716|NCT00655551|100757486|FG002|STARTED|Period 1 (up to 7 Days)||0||
48176717|NCT00655551|100757484|FG000|COMPLETED|Period 1 (up to 7 Days)||25||
48176718|NCT00655551|100757485|FG001|COMPLETED|Period 1 (up to 7 Days)||0||
48176719|NCT00655551|100757486|FG002|COMPLETED|Period 1 (up to 7 Days)||0||
48412857|NCT01030757|101345714|FG000|COMPLETED|Overall Study||2||
48630869|NCT01225549|101878655|FG008|COMPLETED|Period 7 - Fourth Treatment Period||4||
48630870|NCT01225549|101878656|FG009|COMPLETED|Period 7 - Fourth Treatment Period||1||
48630871|NCT01225549|101878647|FG000|NOT COMPLETED|Period 7 - Fourth Treatment Period||0||
48630872|NCT01225549|101878648|FG001|NOT COMPLETED|Period 7 - Fourth Treatment Period||0||
48630873|NCT01225549|101878649|FG002|NOT COMPLETED|Period 7 - Fourth Treatment Period||0||
48767742|NCT02141295|102222817|FG002|STARTED|Overall Study||95||
48176720|NCT00655551|100757484|FG000|NOT COMPLETED|Period 1 (up to 7 Days)||0||
48176721|NCT00655551|100757485|FG001|NOT COMPLETED|Period 1 (up to 7 Days)||0||
48176722|NCT00655551|100757486|FG002|NOT COMPLETED|Period 1 (up to 7 Days)||0||
48176723|NCT00655551|100757484|FG000|STARTED|Period 2 (up to 7 Days)||0||
48176724|NCT00655551|100757485|FG001|STARTED|Period 2 (up to 7 Days)||25||
48176725|NCT00655551|100757486|FG002|STARTED|Period 2 (up to 7 Days)||0||
48176726|NCT00655551|100757484|FG000|COMPLETED|Period 2 (up to 7 Days)||0||
48412858|NCT01030757|101345714|FG000|NOT COMPLETED|Overall Study||0||
48176727|NCT00655551|100757485|FG001|COMPLETED|Period 2 (up to 7 Days)||24||
48412859|NCT03315702|101345715|FG000|STARTED|Overall Study||52||
48412860|NCT03315702|101345715|FG000|COMPLETED|Overall Study||52||
48412861|NCT03315702|101345715|FG000|NOT COMPLETED|Overall Study||0||
48412862|NCT02203916|101345716|FG000|STARTED|Overall Study||65||
48412863|NCT02203916|101345717|FG001|STARTED|Overall Study||132||
48412864|NCT02203916|101345718|FG002|STARTED|Overall Study||131||
48412865|NCT02203916|101345716|FG000|Full Analysis Set (FAS)|Overall Study||65||
48412866|NCT02203916|101345717|FG001|Full Analysis Set (FAS)|Overall Study||132||
48412867|NCT02203916|101345718|FG002|Full Analysis Set (FAS)|Overall Study||130||
48412868|NCT02203916|101345716|FG000|Safety Analysis Set (SAS)|Overall Study||65||
48412869|NCT02203916|101345717|FG001|Safety Analysis Set (SAS)|Overall Study||132||
48412870|NCT02203916|101345718|FG002|Safety Analysis Set (SAS)|Overall Study||130||
48176728|NCT00655551|100757486|FG002|COMPLETED|Period 2 (up to 7 Days)||0||
48176729|NCT00655551|100757484|FG000|NOT COMPLETED|Period 2 (up to 7 Days)||0||
48176730|NCT00655551|100757485|FG001|NOT COMPLETED|Period 2 (up to 7 Days)||1||
48412871|NCT02203916|101345716|FG000|COMPLETED|Overall Study||57||
48412872|NCT02203916|101345717|FG001|COMPLETED|Overall Study||122||
48412873|NCT02203916|101345718|FG002|COMPLETED|Overall Study||120||
48412874|NCT02203916|101345716|FG000|NOT COMPLETED|Overall Study||8||
48176731|NCT00655551|100757486|FG002|NOT COMPLETED|Period 2 (up to 7 Days)||0||
48176732|NCT00655551|100757484|FG000|STARTED|Period 3 (up to 7 Days)||0||
48176733|NCT00655551|100757485|FG001|STARTED|Period 3 (up to 7 Days)||0||
48176734|NCT00655551|100757486|FG002|STARTED|Period 3 (up to 7 Days)||25||
48412875|NCT02203916|101345717|FG001|NOT COMPLETED|Overall Study||10||
48412876|NCT02203916|101345718|FG002|NOT COMPLETED|Overall Study||11||
48412877|NCT00671515|101345719|FG000|STARTED|Phase 1||23||
48412878|NCT00671515|101345719|FG000|COMPLETED|Phase 1||20||
48412879|NCT00671515|101345719|FG000|NOT COMPLETED|Phase 1||3||
48630874|NCT01225549|101878650|FG003|NOT COMPLETED|Period 7 - Fourth Treatment Period||0||
48630875|NCT01225549|101878651|FG004|NOT COMPLETED|Period 7 - Fourth Treatment Period||0||
48630876|NCT01225549|101878652|FG005|NOT COMPLETED|Period 7 - Fourth Treatment Period||0||
48630877|NCT01225549|101878653|FG006|NOT COMPLETED|Period 7 - Fourth Treatment Period||0||
48630878|NCT01225549|101878654|FG007|NOT COMPLETED|Period 7 - Fourth Treatment Period||0||
48630879|NCT01225549|101878655|FG008|NOT COMPLETED|Period 7 - Fourth Treatment Period||0||
48412880|NCT00671515|101345719|FG000|STARTED|Phase 2||13||
48412881|NCT00671515|101345719|FG000|COMPLETED|Phase 2||9||
48412882|NCT00671515|101345719|FG000|NOT COMPLETED|Phase 2||4||
48630880|NCT01225549|101878656|FG009|NOT COMPLETED|Period 7 - Fourth Treatment Period||0||
48630881|NCT00565864|101878657|FG000|STARTED|Overall Study||58||
48630882|NCT00565864|101878658|FG001|STARTED|Overall Study||59||
48630883|NCT00565864|101878659|FG002|STARTED|Overall Study||56||
48630884|NCT00565864|101878657|FG000|COMPLETED|Overall Study||46||
48630885|NCT00565864|101878658|FG001|COMPLETED|Overall Study||47||
48630886|NCT00565864|101878659|FG002|COMPLETED|Overall Study||45||
48630887|NCT00565864|101878657|FG000|NOT COMPLETED|Overall Study||12||
48630888|NCT00565864|101878658|FG001|NOT COMPLETED|Overall Study||12||
48630889|NCT00565864|101878659|FG002|NOT COMPLETED|Overall Study||11||
48630890|NCT01930539|101878660|FG000|STARTED|Overall Study||5||
48630891|NCT01930539|101878661|FG001|STARTED|Overall Study||6||
48630892|NCT01930539|101878660|FG000|COMPLETED|Overall Study||3||
48630893|NCT01930539|101878661|FG001|COMPLETED|Overall Study||4||
48176735|NCT00655551|100757484|FG000|COMPLETED|Period 3 (up to 7 Days)||0||
48176736|NCT00655551|100757485|FG001|COMPLETED|Period 3 (up to 7 Days)||0||
48176737|NCT00655551|100757486|FG002|COMPLETED|Period 3 (up to 7 Days)||21||
48176738|NCT00655551|100757484|FG000|NOT COMPLETED|Period 3 (up to 7 Days)||0||
48176739|NCT00655551|100757485|FG001|NOT COMPLETED|Period 3 (up to 7 Days)||0||
48176740|NCT00655551|100757486|FG002|NOT COMPLETED|Period 3 (up to 7 Days)||4||
48176741|NCT00655551|100757484|FG000|STARTED|Period 4 (up to 7 Days)||0||
48176742|NCT00655551|100757485|FG001|STARTED|Period 4 (up to 7 Days)||25||
48176743|NCT00655551|100757486|FG002|STARTED|Period 4 (up to 7 Days)||0||
48176744|NCT00655551|100757484|FG000|COMPLETED|Period 4 (up to 7 Days)||0||
48176745|NCT00655551|100757485|FG001|COMPLETED|Period 4 (up to 7 Days)||23||
48176746|NCT00655551|100757486|FG002|COMPLETED|Period 4 (up to 7 Days)||0||
48176747|NCT00655551|100757484|FG000|NOT COMPLETED|Period 4 (up to 7 Days)||0||
48176748|NCT00655551|100757485|FG001|NOT COMPLETED|Period 4 (up to 7 Days)||2||
48176749|NCT00655551|100757486|FG002|NOT COMPLETED|Period 4 (up to 7 Days)||0||
48176750|NCT04213989|100757487|FG000|STARTED|Overall Study||18||
48412883|NCT01657253|101345720|FG000|STARTED|Overall Study||93||
48412884|NCT01657253|101345721|FG001|STARTED|Overall Study||90||
48412885|NCT01657253|101345720|FG000|COMPLETED|Overall Study||76||
48412886|NCT01657253|101345721|FG001|COMPLETED|Overall Study||72||
48412887|NCT01657253|101345720|FG000|NOT COMPLETED|Overall Study||17||
48630894|NCT01930539|101878660|FG000|NOT COMPLETED|Overall Study||2||
48630895|NCT01930539|101878661|FG001|NOT COMPLETED|Overall Study||2||
48767743|NCT02141295|102222815|FG000|COMPLETED|Overall Study||2||
48412888|NCT01657253|101345721|FG001|NOT COMPLETED|Overall Study||18||
48176751|NCT04213989|100757488|FG001|STARTED|Overall Study||18||
48176752|NCT04213989|100757487|FG000|COMPLETED|Overall Study||14||
48176753|NCT04213989|100757488|FG001|COMPLETED|Overall Study||12||
48176754|NCT04213989|100757487|FG000|NOT COMPLETED|Overall Study||4||
48412889|NCT02367859|101345722|FG000|STARTED|Overall Study||1||
48412890|NCT02367859|101345722|FG000|COMPLETED|Overall Study||1||
48412891|NCT02367859|101345722|FG000|NOT COMPLETED|Overall Study||0||
48412892|NCT02390362|101345723|FG000|STARTED|Overall Study||1||
48176755|NCT04213989|100757488|FG001|NOT COMPLETED|Overall Study||6||
48176756|NCT00736073|100757489|FG000|STARTED|Overall Study||34||
48176757|NCT00736073|100757490|FG001|STARTED|Overall Study||39||
48176758|NCT00736073|100757489|FG000|COMPLETED|Overall Study||34||
48176759|NCT00736073|100757490|FG001|COMPLETED|Overall Study||39||
48176760|NCT00736073|100757489|FG000|NOT COMPLETED|Overall Study||0||
48176761|NCT00736073|100757490|FG001|NOT COMPLETED|Overall Study||0||
48176762|NCT01603420|100757491|FG000|STARTED|Overall Study||1||
48176763|NCT01603420|100757492|FG001|STARTED|Overall Study||1||
48176764|NCT01603420|100757491|FG000|COMPLETED|Overall Study||1||
48176765|NCT01603420|100757492|FG001|COMPLETED|Overall Study||1||
48176766|NCT01603420|100757491|FG000|NOT COMPLETED|Overall Study||0||
48176767|NCT01603420|100757492|FG001|NOT COMPLETED|Overall Study||0||
48176768|NCT01450787|100757493|FG000|STARTED|Overall Study||38||
48176769|NCT01450787|100757494|FG001|STARTED|Overall Study||25||
48176770|NCT01450787|100757493|FG000|COMPLETED|Overall Study||38||
48176771|NCT01450787|100757494|FG001|COMPLETED|Overall Study||25||
48176772|NCT01450787|100757493|FG000|NOT COMPLETED|Overall Study||0||
48176773|NCT01450787|100757494|FG001|NOT COMPLETED|Overall Study||0||
48176774|NCT01130883|100757495|FG000|STARTED|Overall Study||3130||
48176775|NCT01130883|100757495|FG000|Participants Analyzed|Overall Study||3128||
48176776|NCT01130883|100757495|FG000|COMPLETED|Overall Study||3120||
48176777|NCT01130883|100757495|FG000|NOT COMPLETED|Overall Study||10||
48412893|NCT02390362|101345724|FG001|STARTED|Overall Study||2||
48412894|NCT02390362|101345723|FG000|COMPLETED|Overall Study||1||
48412895|NCT02390362|101345724|FG001|COMPLETED|Overall Study||1||
48753256|NCT02269124|102184443|FG001|Completed Survey Round 3 (Arm 1, 12 Weeks)|Overall Study||11|Survey Round 3 was administered 12 weeks into the study, corresponding to the last measures during the first treatment arm. Survey Round 3 was administered shortly before the subject had ended the first treatment arm, while Survey Round 4 was administered shortly after the subject initiated the second treatment arm. Round 3 represents the third of six survey rounds overall.|
48753257|NCT02269124|102184442|FG000|Completed Survey Round 4 (Arm 2, 12 Weeks)|Overall Study||11|Survey Round 4 was administered 12 weeks into the study, corresponding to the first measures during the second treatment arm. Survey Round 4 was administered shortly after the subject had initiated the second treatment arm, while Survey Round 3 was administered shortly before the subject ended the first treatment arm. Round 4 represents the fourth of six survey rounds overall.|
48753258|NCT02269124|102184443|FG001|Completed Survey Round 4 (Arm 2, 12 Weeks)|Overall Study||8|Survey Round 4 was administered 12 weeks into the study, corresponding to the first measures during the second treatment arm. Survey Round 4 was administered shortly after the subject had initiated the second treatment arm, while Survey Round 3 was administered shortly before the subject ended the first treatment arm. Round 4 represents the fourth of six survey rounds overall.|
48753259|NCT02269124|102184442|FG000|Completed Survey Round 5 (Arm 2, 18 Weeks)|Overall Study||16|Survey Round 5 was administered 18 weeks into the study, corresponding to the halfway point within the second treatment arm. Round 5 represents the fifth of six survey rounds overall.|
48753260|NCT02269124|102184443|FG001|Completed Survey Round 5 (Arm 2, 18 Weeks)|Overall Study||10|Survey Round 5 was administered 18 weeks into the study, corresponding to the halfway point within the second treatment arm. Round 5 represents the fifth of six survey rounds overall.|
48176778|NCT01448044|100757496|FG000|STARTED|Treatment Period||82||
48176779|NCT01448044|100757497|FG001|STARTED|Treatment Period||42||
48176780|NCT01448044|100757496|FG000|COMPLETED|Treatment Period||59||
48176781|NCT01448044|100757497|FG001|COMPLETED|Treatment Period||26||
48176782|NCT01448044|100757496|FG000|NOT COMPLETED|Treatment Period||23||
48176783|NCT01448044|100757497|FG001|NOT COMPLETED|Treatment Period||16||
48176784|NCT01448044|100757496|FG000|STARTED|Follow Up Period||77||
48753261|NCT02269124|102184442|FG000|Completed Survey Round 6 (Arm 2, 24 Weeks)|Overall Study||14|Survey Round 6 was administered 24 weeks into the study, corresponding to the last measures in the second treatment arm. Round 6 represents the sixth of six survey rounds overall.|
48753262|NCT02269124|102184443|FG001|Completed Survey Round 6 (Arm 2, 24 Weeks)|Overall Study||10|Survey Round 6 was administered 24 weeks into the study, corresponding to the last measures in the second treatment arm. Round 6 represents the sixth of six survey rounds overall.|
48753263|NCT02269124|102184442|FG000|COMPLETED|Overall Study||20|Overall completion is defined here as completing at least one survey.|
48753264|NCT02269124|102184443|FG001|COMPLETED|Overall Study||14|Overall completion is defined here as completing at least one survey.|
48753265|NCT02269124|102184442|FG000|NOT COMPLETED|Overall Study||1||
48753266|NCT02269124|102184443|FG001|NOT COMPLETED|Overall Study||2||
48753267|NCT00291135|102184444|FG000|STARTED|Overall Study||42||
48753268|NCT00291135|102184444|FG000|COMPLETED|Overall Study||42||
48753269|NCT00291135|102184444|FG000|NOT COMPLETED|Overall Study||0||
48753270|NCT01777308|102184445|FG000|STARTED|Overall Study||119||
48753271|NCT01777308|102184446|FG001|STARTED|Overall Study||37||
48176785|NCT01448044|100757497|FG001|STARTED|Follow Up Period||40||
48412896|NCT02390362|101345723|FG000|NOT COMPLETED|Overall Study||0||
48412897|NCT02390362|101345724|FG001|NOT COMPLETED|Overall Study||1||
48412898|NCT03303625|101345725|FG000|STARTED|Overall Study||8||
48176786|NCT01448044|100757496|FG000|COMPLETED|Follow Up Period||65||
48176787|NCT01448044|100757497|FG001|COMPLETED|Follow Up Period||26||
48176788|NCT01448044|100757496|FG000|NOT COMPLETED|Follow Up Period||12||
48176789|NCT01448044|100757497|FG001|NOT COMPLETED|Follow Up Period||14||
48176790|NCT00967018|100757498|FG000|STARTED|Overall Study||77||
48176791|NCT00967018|100757498|FG000|COMPLETED|Overall Study||56||
48176792|NCT00967018|100757498|FG000|NOT COMPLETED|Overall Study||21||
48176793|NCT03653416|100757499|FG000|STARTED|Overall Study||52||
48336928|NCT01360645|101152157|FG001|COMPLETED|Phase B (6 Weeks)||174||
48336929|NCT01360645|101152158|FG002|COMPLETED|Phase B (6 Weeks)||178||
48336930|NCT01360645|101152159|FG003|COMPLETED|Phase B (6 Weeks)||0||
48336931|NCT01360645|101152156|FG000|NOT COMPLETED|Phase B (6 Weeks)||0||
48336932|NCT01360645|101152157|FG001|NOT COMPLETED|Phase B (6 Weeks)||14||
48336933|NCT01360645|101152158|FG002|NOT COMPLETED|Phase B (6 Weeks)||13||
48336934|NCT01360645|101152159|FG003|NOT COMPLETED|Phase B (6 Weeks)||0||
48630896|NCT01466361|101878662|FG000|STARTED|Overall Study||52||
48630897|NCT01466361|101878663|FG001|STARTED|Overall Study||34||
48630898|NCT01466361|101878664|FG002|STARTED|Overall Study||60||
48630899|NCT01466361|101878665|FG003|STARTED|Overall Study||41||
48630900|NCT01466361|101878662|FG000|COMPLETED|Overall Study||52||
48630901|NCT01466361|101878663|FG001|COMPLETED|Overall Study||34||
48630902|NCT01466361|101878664|FG002|COMPLETED|Overall Study||60||
48630903|NCT01466361|101878665|FG003|COMPLETED|Overall Study||41||
48630904|NCT01466361|101878662|FG000|NOT COMPLETED|Overall Study||0||
48630905|NCT01466361|101878663|FG001|NOT COMPLETED|Overall Study||0||
48630906|NCT01466361|101878664|FG002|NOT COMPLETED|Overall Study||0||
48630907|NCT01466361|101878665|FG003|NOT COMPLETED|Overall Study||0||
48336935|NCT01360645|101152156|FG000|STARTED|Phase A+||0||
48336936|NCT01360645|101152157|FG001|STARTED|Phase A+||0||
48336937|NCT01360645|101152158|FG002|STARTED|Phase A+||0||
48336938|NCT01360645|101152159|FG003|STARTED|Phase A+||331||
48336939|NCT01360645|101152156|FG000|COMPLETED|Phase A+||0||
48336940|NCT01360645|101152157|FG001|COMPLETED|Phase A+||0||
48336941|NCT01360645|101152158|FG002|COMPLETED|Phase A+||0||
48336942|NCT01360645|101152159|FG003|COMPLETED|Phase A+||307||
48336943|NCT01360645|101152156|FG000|NOT COMPLETED|Phase A+||0||
48336944|NCT01360645|101152157|FG001|NOT COMPLETED|Phase A+||0||
48336945|NCT01360645|101152158|FG002|NOT COMPLETED|Phase A+||0||
48336946|NCT01360645|101152159|FG003|NOT COMPLETED|Phase A+||24||
48336947|NCT01493180|101152160|FG000|STARTED|Overall Study||51||
48336948|NCT01493180|101152161|FG001|STARTED|Overall Study||51||
48336949|NCT01493180|101152160|FG000|COMPLETED|Overall Study||48||
48336950|NCT01493180|101152161|FG001|COMPLETED|Overall Study||49||
48336951|NCT01493180|101152160|FG000|NOT COMPLETED|Overall Study||3||
48336952|NCT01493180|101152161|FG001|NOT COMPLETED|Overall Study||2||
48336953|NCT01983787|101152162|FG000|STARTED|Overall Study||10||
48336954|NCT01983787|101152162|FG000|COMPLETED|Overall Study||10||
48336955|NCT01983787|101152162|FG000|NOT COMPLETED|Overall Study||0||
48336956|NCT02452762|101152163|FG000|STARTED|Overall Study||45||
48336957|NCT02452762|101152164|FG001|STARTED|Overall Study||22||
48336958|NCT02452762|101152163|FG000|COMPLETED|Overall Study||40||
48336959|NCT02452762|101152164|FG001|COMPLETED|Overall Study||19||
48336960|NCT02452762|101152163|FG000|NOT COMPLETED|Overall Study||5||
48336961|NCT02452762|101152164|FG001|NOT COMPLETED|Overall Study||3||
48336962|NCT02052557|101152165|FG000|STARTED|Overall Study||26||
48336963|NCT02052557|101152166|FG001|STARTED|Overall Study||25||
48630908|NCT02783898|101878666|FG000|STARTED|Overall Study||125||
48630909|NCT02783898|101878667|FG001|STARTED|Overall Study||117||
48630910|NCT02783898|101878666|FG000|COMPLETED|Overall Study||124||
48630911|NCT02783898|101878667|FG001|COMPLETED|Overall Study||116||
48630912|NCT02783898|101878666|FG000|NOT COMPLETED|Overall Study||1||
48336964|NCT02052557|101152165|FG000|COMPLETED|Overall Study||26||
48336965|NCT02052557|101152166|FG001|COMPLETED|Overall Study||25||
48336966|NCT02052557|101152165|FG000|NOT COMPLETED|Overall Study||0||
48336967|NCT02052557|101152166|FG001|NOT COMPLETED|Overall Study||0||
48336968|NCT05655377|101152167|FG000|STARTED|Overall Study||9||
48336969|NCT05655377|101152167|FG000|COMPLETED|Overall Study||7||
48336970|NCT05655377|101152167|FG000|NOT COMPLETED|Overall Study||2||
48336971|NCT01668654|101152168|FG000|STARTED|Overall Study||4||
48336972|NCT01668654|101152168|FG000|COMPLETED|Overall Study||0||
48630913|NCT02783898|101878667|FG001|NOT COMPLETED|Overall Study||1||
48630914|NCT00284856|101878668|FG000|STARTED|Overall Study||347||
48630915|NCT00284856|101878669|FG001|STARTED|Overall Study||336||
48630916|NCT00284856|101878670|FG002|STARTED|Overall Study||336||
48753272|NCT01777308|102184445|FG000|Completed up to Month 73|Overall Study||118||
48630917|NCT00284856|101878668|FG000|COMPLETED|Overall Study||296||
48630918|NCT00284856|101878669|FG001|COMPLETED|Overall Study||286||
48630919|NCT00284856|101878670|FG002|COMPLETED|Overall Study||276||
48336973|NCT01668654|101152168|FG000|NOT COMPLETED|Overall Study||4||
48336974|NCT00772447|101152169|FG000|STARTED|Overall Study||131||
48336975|NCT00772447|101152170|FG001|STARTED|Overall Study||134||
48336976|NCT00772447|101152169|FG000|COMPLETED|Overall Study||111||
48336977|NCT00772447|101152170|FG001|COMPLETED|Overall Study||110||
48336978|NCT00772447|101152169|FG000|NOT COMPLETED|Overall Study||20||
48336979|NCT00772447|101152170|FG001|NOT COMPLETED|Overall Study||24||
48336980|NCT01481896|101152171|FG000|STARTED|Overall Study||126||
48336981|NCT01481896|101152171|FG000|Min 4.75 yr Follow-up, Revised or Dead|Overall Study||114||
48336982|NCT01481896|101152171|FG000|COMPLETED|Overall Study||114||
48336983|NCT01481896|101152171|FG000|NOT COMPLETED|Overall Study||12||
48336984|NCT00200850|101152172|FG000|STARTED|Overall Study||10||
48336985|NCT00200850|101152173|FG001|STARTED|Overall Study||10||
48336986|NCT00200850|101152174|FG002|STARTED|Overall Study||11||
48336987|NCT00200850|101152172|FG000|COMPLETED|Overall Study||7||
48336988|NCT00200850|101152173|FG001|COMPLETED|Overall Study||9||
48336989|NCT00200850|101152174|FG002|COMPLETED|Overall Study||5||
48336990|NCT00200850|101152172|FG000|NOT COMPLETED|Overall Study||3||
48336991|NCT00200850|101152173|FG001|NOT COMPLETED|Overall Study||1||
48336992|NCT00200850|101152174|FG002|NOT COMPLETED|Overall Study||6||
48336993|NCT01239355|101152175|FG000|STARTED|Overall Study||15||
48336994|NCT01239355|101152175|FG000|COMPLETED|Overall Study||15||
48336995|NCT01239355|101152175|FG000|NOT COMPLETED|Overall Study||0||
48336996|NCT02298933|101152176|FG000|STARTED|Overall Study||10||
48336997|NCT02298933|101152176|FG000|COMPLETED|Overall Study||10||
48336998|NCT02298933|101152176|FG000|NOT COMPLETED|Overall Study||0||
48336999|NCT02762513|101152177|FG000|STARTED|Overall Study||28|Started study treatment with axitinib|
48337000|NCT02762513|101152177|FG000|COMPLETED|Overall Study||28|Completed at least one 28-day cycle of treatment with axitinib.|
48337001|NCT02762513|101152177|FG000|NOT COMPLETED|Overall Study||0||
48337002|NCT00481845|101152178|FG000|STARTED|Overall Study||1||
48630920|NCT00284856|101878668|FG000|NOT COMPLETED|Overall Study||51||
48630921|NCT00284856|101878669|FG001|NOT COMPLETED|Overall Study||50||
48630922|NCT00284856|101878670|FG002|NOT COMPLETED|Overall Study||60||
48630923|NCT01235377|101878671|FG000|STARTED|Overall Study||11||
48630924|NCT01235377|101878672|FG001|STARTED|Overall Study||9||
48630925|NCT01235377|101878671|FG000|COMPLETED|Overall Study||10||
48630926|NCT01235377|101878672|FG001|COMPLETED|Overall Study||8||
48630927|NCT01235377|101878671|FG000|NOT COMPLETED|Overall Study||1||
48630928|NCT01235377|101878672|FG001|NOT COMPLETED|Overall Study||1||
48630929|NCT04678284|101878673|FG000|STARTED|Overall Study||10||
48630930|NCT04678284|101878673|FG000|COMPLETED|Overall Study||10||
48630931|NCT04678284|101878673|FG000|NOT COMPLETED|Overall Study||0||
48630932|NCT01181167|101878674|FG000|STARTED|Overall Study||307||
48630933|NCT01181167|101878675|FG001|STARTED|Overall Study||303||
48630934|NCT01181167|101878674|FG000|Efficacy Analysis Population|Overall Study||255||
48630935|NCT01181167|101878675|FG001|Efficacy Analysis Population|Overall Study||248||
48630936|NCT01181167|101878674|FG000|COMPLETED|Overall Study||284||
48630937|NCT01181167|101878675|FG001|COMPLETED|Overall Study||271||
48630938|NCT01181167|101878674|FG000|NOT COMPLETED|Overall Study||23||
48176794|NCT03653416|100757500|FG001|STARTED|Overall Study||47||
48337003|NCT00481845|101152179|FG001|STARTED|Overall Study||0||
48337004|NCT00481845|101152178|FG000|COMPLETED|Overall Study||1||
48630939|NCT01181167|101878675|FG001|NOT COMPLETED|Overall Study||32||
48630940|NCT02709317|101878676|FG000|STARTED|Overall Study||50||
48630941|NCT02709317|101878677|FG001|STARTED|Overall Study||58||
48630942|NCT02709317|101878676|FG000|COMPLETED|Overall Study||18||
48630943|NCT02709317|101878677|FG001|COMPLETED|Overall Study||31||
48630944|NCT02709317|101878676|FG000|NOT COMPLETED|Overall Study||32||
48630945|NCT02709317|101878677|FG001|NOT COMPLETED|Overall Study||27||
48630946|NCT02014272|101878678|FG000|STARTED|Intervention Period 1||14||
48630947|NCT02014272|101878679|FG001|STARTED|Intervention Period 1||14||
48630948|NCT02014272|101878678|FG000|COMPLETED|Intervention Period 1||13||
48630949|NCT02014272|101878679|FG001|COMPLETED|Intervention Period 1||13||
48630950|NCT02014272|101878678|FG000|NOT COMPLETED|Intervention Period 1||1||
48337005|NCT00481845|101152179|FG001|COMPLETED|Overall Study||0||
48337006|NCT00481845|101152178|FG000|NOT COMPLETED|Overall Study||0||
48337007|NCT00481845|101152179|FG001|NOT COMPLETED|Overall Study||0||
48337008|NCT00888238|101152180|FG000|STARTED|First Period of Treatment Intervention||4||
48630951|NCT02014272|101878679|FG001|NOT COMPLETED|Intervention Period 1||1||
48630952|NCT02014272|101878678|FG000|STARTED|Washout Period 1 (7 Days)||13||
48630953|NCT02014272|101878679|FG001|STARTED|Washout Period 1 (7 Days)||13||
48630954|NCT02014272|101878678|FG000|COMPLETED|Washout Period 1 (7 Days)||13||
48630955|NCT02014272|101878679|FG001|COMPLETED|Washout Period 1 (7 Days)||13||
48630956|NCT02014272|101878678|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48630957|NCT02014272|101878679|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48630958|NCT02014272|101878678|FG000|STARTED|Intervention Period 2||13||
48630959|NCT02014272|101878679|FG001|STARTED|Intervention Period 2||13||
48630960|NCT02014272|101878678|FG000|COMPLETED|Intervention Period 2||13||
48630961|NCT02014272|101878679|FG001|COMPLETED|Intervention Period 2||13||
48630962|NCT02014272|101878678|FG000|NOT COMPLETED|Intervention Period 2||0||
48337009|NCT00888238|101152181|FG001|STARTED|First Period of Treatment Intervention||4||
48337010|NCT00888238|101152182|FG002|STARTED|First Period of Treatment Intervention||4||
48337011|NCT00888238|101152180|FG000|COMPLETED|First Period of Treatment Intervention||4||
48337012|NCT00888238|101152181|FG001|COMPLETED|First Period of Treatment Intervention||4||
48176795|NCT03653416|100757499|FG000|COMPLETED|Overall Study||46||
48337013|NCT00888238|101152182|FG002|COMPLETED|First Period of Treatment Intervention||4||
48337014|NCT00888238|101152180|FG000|NOT COMPLETED|First Period of Treatment Intervention||0||
48337015|NCT00888238|101152181|FG001|NOT COMPLETED|First Period of Treatment Intervention||0||
48337016|NCT00888238|101152182|FG002|NOT COMPLETED|First Period of Treatment Intervention||0||
48337017|NCT00888238|101152180|FG000|STARTED|Washout Period After Period 1||4||
48337018|NCT00888238|101152181|FG001|STARTED|Washout Period After Period 1||4||
48337019|NCT00888238|101152182|FG002|STARTED|Washout Period After Period 1||4||
48337020|NCT00888238|101152180|FG000|COMPLETED|Washout Period After Period 1||4||
48337021|NCT00888238|101152181|FG001|COMPLETED|Washout Period After Period 1||4||
48337022|NCT00888238|101152182|FG002|COMPLETED|Washout Period After Period 1||4||
48337023|NCT00888238|101152180|FG000|NOT COMPLETED|Washout Period After Period 1||0||
48337024|NCT00888238|101152181|FG001|NOT COMPLETED|Washout Period After Period 1||0||
48337025|NCT00888238|101152182|FG002|NOT COMPLETED|Washout Period After Period 1||0||
48337026|NCT00888238|101152180|FG000|STARTED|Second Period of Treatment Intervention||4||
48337027|NCT00888238|101152181|FG001|STARTED|Second Period of Treatment Intervention||4||
48337028|NCT00888238|101152182|FG002|STARTED|Second Period of Treatment Intervention||4||
48337029|NCT00888238|101152180|FG000|COMPLETED|Second Period of Treatment Intervention||4||
48412899|NCT03303625|101345726|FG001|STARTED|Overall Study||4||
48412900|NCT03303625|101345727|FG002|STARTED|Overall Study||24||
48412901|NCT03303625|101345728|FG003|STARTED|Overall Study||12||
48412902|NCT03303625|101345725|FG000|COMPLETED|Overall Study||6||
48412903|NCT03303625|101345726|FG001|COMPLETED|Overall Study||4||
48412904|NCT03303625|101345727|FG002|COMPLETED|Overall Study||24||
48412905|NCT03303625|101345728|FG003|COMPLETED|Overall Study||12||
48412906|NCT03303625|101345725|FG000|NOT COMPLETED|Overall Study||2||
48412907|NCT03303625|101345726|FG001|NOT COMPLETED|Overall Study||0||
48630963|NCT02014272|101878679|FG001|NOT COMPLETED|Intervention Period 2||0||
48630964|NCT02153918|101878680|FG000|STARTED|Overall Study||27||
48630965|NCT02153918|101878680|FG000|COMPLETED|Overall Study||26||
48630966|NCT02153918|101878680|FG000|NOT COMPLETED|Overall Study||1||
48630967|NCT01901185|101878681|FG000|STARTED|Overall Study||77||
48630968|NCT01901185|101878681|FG000|Received Etanercept With Autoinjector A|Overall Study||75||
48630969|NCT01901185|101878681|FG000|COMPLETED|Overall Study||75||
48630970|NCT01901185|101878681|FG000|NOT COMPLETED|Overall Study||2||
48630971|NCT00857506|101878682|FG000|STARTED|Overall Study||31||
48630972|NCT00857506|101878683|FG001|STARTED|Overall Study||52||
48630973|NCT00857506|101878684|FG002|STARTED|Overall Study||69||
48630974|NCT00857506|101878682|FG000|COMPLETED|Overall Study||16||
48630975|NCT00857506|101878683|FG001|COMPLETED|Overall Study||37||
48630976|NCT00857506|101878684|FG002|COMPLETED|Overall Study||51||
48630977|NCT00857506|101878682|FG000|NOT COMPLETED|Overall Study||15||
48630978|NCT00857506|101878683|FG001|NOT COMPLETED|Overall Study||15||
48630979|NCT00857506|101878684|FG002|NOT COMPLETED|Overall Study||18||
48630980|NCT00472420|101878685|FG000|STARTED|Induction Treatment Period||48||
48630981|NCT00472420|101878685|FG000|COMPLETED|Induction Treatment Period||32||
48630982|NCT00472420|101878685|FG000|NOT COMPLETED|Induction Treatment Period||16||
48630983|NCT00472420|101878685|FG000|STARTED|Follow-up Period||32||
48630984|NCT00472420|101878685|FG000|COMPLETED|Follow-up Period||15||
48630985|NCT00472420|101878685|FG000|NOT COMPLETED|Follow-up Period||17||
48630986|NCT01248416|101878686|FG000|STARTED|Overall Study||25||
48630987|NCT01248416|101878687|FG001|STARTED|Overall Study||25||
48630988|NCT01248416|101878688|FG002|STARTED|Overall Study||26||
48630989|NCT01248416|101878686|FG000|COMPLETED|Overall Study||21||
48630990|NCT01248416|101878687|FG001|COMPLETED|Overall Study||25||
48630991|NCT01248416|101878688|FG002|COMPLETED|Overall Study||25||
48630992|NCT01248416|101878686|FG000|NOT COMPLETED|Overall Study||4||
48630993|NCT01248416|101878687|FG001|NOT COMPLETED|Overall Study||0||
48630994|NCT01248416|101878688|FG002|NOT COMPLETED|Overall Study||1||
48630995|NCT03477162|101878689|FG000|STARTED|Overall Study||17||
48630996|NCT03477162|101878690|FG001|STARTED|Overall Study||1||
48630997|NCT03477162|101878689|FG000|COMPLETED|Overall Study||14||
48337030|NCT00888238|101152181|FG001|COMPLETED|Second Period of Treatment Intervention||4||
48412908|NCT03303625|101345727|FG002|NOT COMPLETED|Overall Study||0||
48412909|NCT03303625|101345728|FG003|NOT COMPLETED|Overall Study||0||
48412910|NCT01034709|101345729|FG000|STARTED|Overall Study||53||
48412911|NCT01034709|101345730|FG001|STARTED|Overall Study||58||
48412912|NCT01034709|101345729|FG000|COMPLETED|Overall Study||44||
48630998|NCT03477162|101878690|FG001|COMPLETED|Overall Study||1||
48630999|NCT03477162|101878689|FG000|NOT COMPLETED|Overall Study||3||
48631000|NCT03477162|101878690|FG001|NOT COMPLETED|Overall Study||0||
48631001|NCT03638323|101878691|FG000|STARTED|Overall Study||38||
48631002|NCT03638323|101878691|FG000|COMPLETED|Overall Study||37||
48631003|NCT03638323|101878691|FG000|NOT COMPLETED|Overall Study||1||
48631004|NCT00465179|101878692|FG000|STARTED|Overall Study||57||
48631005|NCT00465179|101878692|FG000|COMPLETED|Overall Study||4||
48631006|NCT00465179|101878692|FG000|NOT COMPLETED|Overall Study||53||
48631007|NCT03513952|101878693|FG000|STARTED|Overall Study||19||
48631008|NCT03513952|101878694|FG001|STARTED|Overall Study||21||
48631009|NCT03513952|101878695|FG002|STARTED|Overall Study||7||
48631010|NCT03513952|101878693|FG000|COMPLETED|Overall Study||3|Completed Study Treatment (up to 2 years)|
48753273|NCT01777308|102184446|FG001|Completed up to Month 73|Overall Study||37||
48753274|NCT01777308|102184445|FG000|COMPLETED|Overall Study||105|Completed up to Month 96|
48753275|NCT01777308|102184446|FG001|COMPLETED|Overall Study||34|Completed up to Month 96|
48753276|NCT01777308|102184445|FG000|NOT COMPLETED|Overall Study||14||
48753277|NCT01777308|102184446|FG001|NOT COMPLETED|Overall Study||3||
48753278|NCT01069484|102184447|FG000|STARTED|Overall Study||87||
48337031|NCT00888238|101152182|FG002|COMPLETED|Second Period of Treatment Intervention||4||
48337032|NCT00888238|101152180|FG000|NOT COMPLETED|Second Period of Treatment Intervention||0||
48337033|NCT00888238|101152181|FG001|NOT COMPLETED|Second Period of Treatment Intervention||0||
48337034|NCT00888238|101152182|FG002|NOT COMPLETED|Second Period of Treatment Intervention||0||
48337035|NCT00888238|101152180|FG000|STARTED|Washout Period After Period 2||4||
48337036|NCT00888238|101152181|FG001|STARTED|Washout Period After Period 2||4||
48412913|NCT01034709|101345730|FG001|COMPLETED|Overall Study||42||
48412914|NCT01034709|101345729|FG000|NOT COMPLETED|Overall Study||9||
48412915|NCT01034709|101345730|FG001|NOT COMPLETED|Overall Study||16||
48412916|NCT00780676|101345731|FG000|STARTED|Overall Study||9||
48412917|NCT00780676|101345732|FG001|STARTED|Overall Study||8||
48412918|NCT00780676|101345733|FG002|STARTED|Overall Study||13||
48412919|NCT00780676|101345734|FG003|STARTED|Overall Study||0||
48412920|NCT00780676|101345735|FG004|STARTED|Overall Study||0||
48412921|NCT00780676|101345731|FG000|COMPLETED|Overall Study||9||
48412922|NCT00780676|101345732|FG001|COMPLETED|Overall Study||8||
48412923|NCT00780676|101345733|FG002|COMPLETED|Overall Study||13||
48412924|NCT00780676|101345734|FG003|COMPLETED|Overall Study||0||
48412925|NCT00780676|101345735|FG004|COMPLETED|Overall Study||0||
48337037|NCT00888238|101152182|FG002|STARTED|Washout Period After Period 2||4||
48337038|NCT00888238|101152180|FG000|COMPLETED|Washout Period After Period 2||4||
48412926|NCT00780676|101345731|FG000|NOT COMPLETED|Overall Study||0||
48412927|NCT00780676|101345732|FG001|NOT COMPLETED|Overall Study||0||
48412928|NCT00780676|101345733|FG002|NOT COMPLETED|Overall Study||0||
48412929|NCT00780676|101345734|FG003|NOT COMPLETED|Overall Study||0||
48631011|NCT03513952|101878694|FG001|COMPLETED|Overall Study||2|Completed Study Treatment (up to 2 years)|
48631012|NCT03513952|101878695|FG002|COMPLETED|Overall Study||0|Completed Study Treatment (up to 2 years)|
48631013|NCT03513952|101878693|FG000|NOT COMPLETED|Overall Study||16||
48631014|NCT03513952|101878694|FG001|NOT COMPLETED|Overall Study||19||
48631015|NCT03513952|101878695|FG002|NOT COMPLETED|Overall Study||7||
48631016|NCT01933594|101878696|FG000|STARTED|Overall Study||12||
48631017|NCT01933594|101878697|FG001|STARTED|Overall Study||12||
48631018|NCT01933594|101878698|FG002|STARTED|Overall Study||12||
48631019|NCT01933594|101878699|FG003|STARTED|Overall Study||7||
48631020|NCT01933594|101878700|FG004|STARTED|Overall Study||13||
48631021|NCT01933594|101878701|FG005|STARTED|Overall Study||3||
48631022|NCT01933594|101878696|FG000|COMPLETED|Overall Study||11||
48631023|NCT01933594|101878697|FG001|COMPLETED|Overall Study||12||
48631024|NCT01933594|101878698|FG002|COMPLETED|Overall Study||12||
48631025|NCT01933594|101878699|FG003|COMPLETED|Overall Study||7||
48631026|NCT01933594|101878700|FG004|COMPLETED|Overall Study||11||
48631027|NCT01933594|101878701|FG005|COMPLETED|Overall Study||3||
48631028|NCT01933594|101878696|FG000|NOT COMPLETED|Overall Study||1||
48631029|NCT01933594|101878697|FG001|NOT COMPLETED|Overall Study||0||
48631030|NCT01933594|101878698|FG002|NOT COMPLETED|Overall Study||0||
48753279|NCT01069484|102184448|FG001|STARTED|Overall Study||88||
48412930|NCT00780676|101345735|FG004|NOT COMPLETED|Overall Study||0||
48412931|NCT01624974|101345736|FG000|STARTED|Period III of Treatment (4 Weeks)||54||
48412932|NCT01624974|101345737|FG001|STARTED|Period III of Treatment (4 Weeks)||53||
48412933|NCT01624974|101345736|FG000|COMPLETED|Period III of Treatment (4 Weeks)||47||
48412934|NCT01624974|101345737|FG001|COMPLETED|Period III of Treatment (4 Weeks)||45||
48412935|NCT01624974|101345736|FG000|NOT COMPLETED|Period III of Treatment (4 Weeks)||7||
48753280|NCT01069484|102184447|FG000|COMPLETED|Overall Study||75||
48753281|NCT01069484|102184448|FG001|COMPLETED|Overall Study||85||
48412936|NCT01624974|101345737|FG001|NOT COMPLETED|Period III of Treatment (4 Weeks)||8||
48412937|NCT01624974|101345736|FG000|STARTED|Period IV Washout (4 Weeks)||47||
48631031|NCT01933594|101878699|FG003|NOT COMPLETED|Overall Study||0||
48631032|NCT01933594|101878700|FG004|NOT COMPLETED|Overall Study||2||
48753282|NCT01069484|102184447|FG000|NOT COMPLETED|Overall Study||12||
48753283|NCT01069484|102184448|FG001|NOT COMPLETED|Overall Study||3||
48412938|NCT01624974|101345737|FG001|STARTED|Period IV Washout (4 Weeks)||45||
48412939|NCT01624974|101345736|FG000|COMPLETED|Period IV Washout (4 Weeks)||44||
48412940|NCT01624974|101345737|FG001|COMPLETED|Period IV Washout (4 Weeks)||42||
48412941|NCT01624974|101345736|FG000|NOT COMPLETED|Period IV Washout (4 Weeks)||3||
48412942|NCT01624974|101345737|FG001|NOT COMPLETED|Period IV Washout (4 Weeks)||3||
48412943|NCT01624974|101345736|FG000|STARTED|Period V of Treatment (4 Weeks)||44||
48753284|NCT01702844|102184449|FG000|STARTED|Overall Study||42||
48753285|NCT01702844|102184449|FG000|Disease Progression|Overall Study||23||
48753286|NCT01702844|102184449|FG000|COMPLETED|Overall Study||23||
48753287|NCT01702844|102184449|FG000|NOT COMPLETED|Overall Study||19||
48753288|NCT02051764|102184450|FG000|STARTED|Overall Study||16||
48753289|NCT02051764|102184451|FG001|STARTED|Overall Study||28||
48753290|NCT02051764|102184450|FG000|COMPLETED|Overall Study||16||
48753291|NCT02051764|102184451|FG001|COMPLETED|Overall Study||21||
48753292|NCT02051764|102184450|FG000|NOT COMPLETED|Overall Study||0||
48753293|NCT02051764|102184451|FG001|NOT COMPLETED|Overall Study||7||
48753294|NCT03760029|102184452|FG000|STARTED|Overall Study||99||
48753295|NCT03760029|102184453|FG001|STARTED|Overall Study||177||
48753296|NCT03760029|102184454|FG002|STARTED|Overall Study||36||
48753297|NCT03760029|102184452|FG000|COMPLETED|Overall Study||91||
48753298|NCT03760029|102184453|FG001|COMPLETED|Overall Study||166||
48753299|NCT03760029|102184454|FG002|COMPLETED|Overall Study||33||
48753300|NCT03760029|102184452|FG000|NOT COMPLETED|Overall Study||8||
48753301|NCT03760029|102184453|FG001|NOT COMPLETED|Overall Study||11||
48753302|NCT03760029|102184454|FG002|NOT COMPLETED|Overall Study||3||
48753303|NCT00414635|102184455|FG000|STARTED|Overall Study||30||
48753304|NCT00414635|102184456|FG001|STARTED|Overall Study||30||
48753305|NCT00414635|102184455|FG000|COMPLETED|Overall Study||25||
48753306|NCT00414635|102184456|FG001|COMPLETED|Overall Study||28||
48753307|NCT00414635|102184455|FG000|NOT COMPLETED|Overall Study||5||
48753308|NCT00414635|102184456|FG001|NOT COMPLETED|Overall Study||2||
48753309|NCT02344108|102184457|FG000|STARTED|Overall Study||42||
48753310|NCT02344108|102184457|FG000|COMPLETED|Overall Study||42||
48753311|NCT02344108|102184457|FG000|NOT COMPLETED|Overall Study||0||
48753312|NCT03623243|102184458|FG000|STARTED|Overall Study||185||
48753313|NCT03623243|102184458|FG000|Safety Set|Overall Study||185|Safety set included all participants who received at least one dose of study treatment.|
48753314|NCT03623243|102184458|FG000|COMPLETED|Overall Study||146||
48753315|NCT03623243|102184458|FG000|NOT COMPLETED|Overall Study||39||
48753316|NCT01405768|102184459|FG000|STARTED|Overall Study||28||
48753317|NCT01405768|102184460|FG001|STARTED|Overall Study||28||
48753318|NCT01405768|102184459|FG000|COMPLETED|Overall Study||24||
48753319|NCT01405768|102184460|FG001|COMPLETED|Overall Study||28||
48412944|NCT01624974|101345737|FG001|STARTED|Period V of Treatment (4 Weeks)||42||
48412945|NCT01624974|101345736|FG000|COMPLETED|Period V of Treatment (4 Weeks)||39||
48631033|NCT01933594|101878701|FG005|NOT COMPLETED|Overall Study||0||
48631034|NCT04066374|101878702|FG000|STARTED|Overall Study||10||
48631035|NCT04066374|101878702|FG000|COMPLETED|Overall Study||10||
48631036|NCT04066374|101878702|FG000|NOT COMPLETED|Overall Study||0||
48631037|NCT03895801|101878703|FG000|STARTED|Overall Study||18||
48631038|NCT03895801|101878704|FG001|STARTED|Overall Study||24||
48631039|NCT03895801|101878705|FG002|STARTED|Overall Study||15||
48631040|NCT03895801|101878703|FG000|COMPLETED|Overall Study||16||
48631041|NCT03895801|101878704|FG001|COMPLETED|Overall Study||22||
48631042|NCT03895801|101878705|FG002|COMPLETED|Overall Study||13||
48631043|NCT03895801|101878703|FG000|NOT COMPLETED|Overall Study||2||
48631044|NCT03895801|101878704|FG001|NOT COMPLETED|Overall Study||2||
48631045|NCT03895801|101878705|FG002|NOT COMPLETED|Overall Study||2||
48631046|NCT03176771|101878706|FG000|STARTED|Double-Blind Placebo-Controlled Period||85||
48631047|NCT03176771|101878707|FG001|STARTED|Double-Blind Placebo-Controlled Period||86||
48631048|NCT03176771|101878708|FG002|STARTED|Double-Blind Placebo-Controlled Period||85||
48631049|NCT03176771|101878709|FG003|STARTED|Double-Blind Placebo-Controlled Period||0||
48631050|NCT03176771|101878710|FG004|STARTED|Double-Blind Placebo-Controlled Period||0||
48631051|NCT03176771|101878706|FG000|COMPLETED|Double-Blind Placebo-Controlled Period||80||
48631052|NCT03176771|101878707|FG001|COMPLETED|Double-Blind Placebo-Controlled Period||71||
48631053|NCT03176771|101878708|FG002|COMPLETED|Double-Blind Placebo-Controlled Period||60||
48753320|NCT01405768|102184459|FG000|NOT COMPLETED|Overall Study||4||
48753321|NCT01405768|102184460|FG001|NOT COMPLETED|Overall Study||0||
48753322|NCT03741088|102184461|FG000|STARTED|Overall Study||8||11
48753323|NCT03741088|102184461|FG000|COMPLETED|Overall Study||5||6
48753324|NCT03741088|102184461|FG000|NOT COMPLETED|Overall Study||3||5
48753325|NCT05736874|102184462|FG000|STARTED|Overall Study||715||
48753326|NCT05736874|102184463|FG001|STARTED|Overall Study||692||
48753327|NCT05736874|102184462|FG000|COMPLETED|Overall Study||656||
48753328|NCT05736874|102184463|FG001|COMPLETED|Overall Study||621||
48753329|NCT05736874|102184462|FG000|NOT COMPLETED|Overall Study||59||
48753330|NCT05736874|102184463|FG001|NOT COMPLETED|Overall Study||71||
48753331|NCT02552966|102184464|FG000|STARTED|Overall Study||20||
48753332|NCT02552966|102184464|FG000|COMPLETED|Overall Study||15||
48753333|NCT02552966|102184464|FG000|NOT COMPLETED|Overall Study||5||
48753334|NCT01927497|102184465|FG000|STARTED|Overall Study||50||
48753335|NCT01927497|102184466|FG001|STARTED|Overall Study||54||
48753336|NCT01927497|102184465|FG000|COMPLETED|Overall Study||48||
48631054|NCT03176771|101878709|FG003|COMPLETED|Double-Blind Placebo-Controlled Period||0||
48631055|NCT03176771|101878710|FG004|COMPLETED|Double-Blind Placebo-Controlled Period||0||
48631056|NCT03176771|101878706|FG000|NOT COMPLETED|Double-Blind Placebo-Controlled Period||5||
48631057|NCT03176771|101878707|FG001|NOT COMPLETED|Double-Blind Placebo-Controlled Period||15||
48631058|NCT03176771|101878708|FG002|NOT COMPLETED|Double-Blind Placebo-Controlled Period||25||
48753337|NCT01927497|102184466|FG001|COMPLETED|Overall Study||53||
48337039|NCT00888238|101152181|FG001|COMPLETED|Washout Period After Period 2||4||
48337040|NCT00888238|101152182|FG002|COMPLETED|Washout Period After Period 2||3||
48337041|NCT00888238|101152180|FG000|NOT COMPLETED|Washout Period After Period 2||0||
48753338|NCT01927497|102184465|FG000|NOT COMPLETED|Overall Study||2||
48753339|NCT01927497|102184466|FG001|NOT COMPLETED|Overall Study||1||
48753340|NCT03449758|102184467|FG000|STARTED|Overall Study||84|Enrolled and treated.|
48753341|NCT03449758|102184467|FG000|COMPLETED|Overall Study||65||
48337042|NCT00888238|101152181|FG001|NOT COMPLETED|Washout Period After Period 2||0||
48337043|NCT00888238|101152182|FG002|NOT COMPLETED|Washout Period After Period 2||1||
48337044|NCT00888238|101152180|FG000|STARTED|Third Period of Treatment Intervention||4||
48337045|NCT00888238|101152181|FG001|STARTED|Third Period of Treatment Intervention||4||
48337046|NCT00888238|101152182|FG002|STARTED|Third Period of Treatment Intervention||3||
48337047|NCT00888238|101152180|FG000|COMPLETED|Third Period of Treatment Intervention||4||
48337048|NCT00888238|101152181|FG001|COMPLETED|Third Period of Treatment Intervention||4||
48753342|NCT03449758|102184467|FG000|NOT COMPLETED|Overall Study||19||
48753343|NCT03811340|102184468|FG000|STARTED|Overall Study||1105||
48753344|NCT03811340|102184468|FG000|COMPLETED|Overall Study||1015||
48753345|NCT03811340|102184468|FG000|NOT COMPLETED|Overall Study||90||
48753346|NCT03776864|102184469|FG000|STARTED|Overall Study||6||
48753347|NCT03776864|102184469|FG000|COMPLETED|Overall Study||6||
48753348|NCT03776864|102184469|FG000|NOT COMPLETED|Overall Study||0||
48753349|NCT02193776|102184470|FG000|STARTED|Overall Study||59||
48753350|NCT02193776|102184471|FG001|STARTED|Overall Study||60||
48753351|NCT02193776|102184472|FG002|STARTED|Overall Study||61||
48337049|NCT00888238|101152182|FG002|COMPLETED|Third Period of Treatment Intervention||3||
48337050|NCT00888238|101152180|FG000|NOT COMPLETED|Third Period of Treatment Intervention||0||
48337051|NCT00888238|101152181|FG001|NOT COMPLETED|Third Period of Treatment Intervention||0||
48337052|NCT00888238|101152182|FG002|NOT COMPLETED|Third Period of Treatment Intervention||0||
48337053|NCT01821300|101152183|FG000|STARTED|Overall Study||154||
48337054|NCT01821300|101152184|FG001|STARTED|Overall Study||103||
48337055|NCT01821300|101152183|FG000|COMPLETED|Overall Study||154||
48337056|NCT01821300|101152184|FG001|COMPLETED|Overall Study||103||
48337057|NCT01821300|101152183|FG000|NOT COMPLETED|Overall Study||0||
48337058|NCT01821300|101152184|FG001|NOT COMPLETED|Overall Study||0||
48337059|NCT04173741|101152185|FG000|STARTED|Overall Study||23||
48337060|NCT04173741|101152186|FG001|STARTED|Overall Study||23||
48337061|NCT04173741|101152185|FG000|COMPLETED|Overall Study||22||
48337062|NCT04173741|101152186|FG001|COMPLETED|Overall Study||22||
48337063|NCT04173741|101152185|FG000|NOT COMPLETED|Overall Study||1||
48337064|NCT04173741|101152186|FG001|NOT COMPLETED|Overall Study||1||
48337065|NCT01284114|101152187|FG000|STARTED|Overall Study||23||
48337066|NCT01284114|101152187|FG000|COMPLETED|Overall Study||19||
48337067|NCT01284114|101152187|FG000|NOT COMPLETED|Overall Study||4||
48337068|NCT00510809|101152188|FG000|STARTED|Overall Study||18||
48337069|NCT00510809|101152189|FG001|STARTED|Overall Study||18||
48337070|NCT00510809|101152190|FG002|STARTED|Overall Study||18||
48337071|NCT00510809|101152188|FG000|COMPLETED|Overall Study||18||
48337072|NCT00510809|101152189|FG001|COMPLETED|Overall Study||18||
48337073|NCT00510809|101152190|FG002|COMPLETED|Overall Study||18||
48337074|NCT00510809|101152188|FG000|NOT COMPLETED|Overall Study||0||
48337075|NCT00510809|101152189|FG001|NOT COMPLETED|Overall Study||0||
48337076|NCT00510809|101152190|FG002|NOT COMPLETED|Overall Study||0||
48337077|NCT00400400|101152191|FG000|STARTED|Overall Study||200||
48631059|NCT03176771|101878709|FG003|NOT COMPLETED|Double-Blind Placebo-Controlled Period||0||
48631060|NCT03176771|101878710|FG004|NOT COMPLETED|Double-Blind Placebo-Controlled Period||0||
48631061|NCT03176771|101878706|FG000|STARTED|Double-Blind Extension Period||0||
48631062|NCT03176771|101878707|FG001|STARTED|Double-Blind Extension Period||0||
48753352|NCT02193776|102184473|FG003|STARTED|Overall Study||60||
48753353|NCT02193776|102184470|FG000|Completed Day 70 Follow-up|Overall Study||54||
48753354|NCT02193776|102184471|FG001|Completed Day 70 Follow-up|Overall Study||56||
48753355|NCT02193776|102184472|FG002|Completed Day 70 Follow-up|Overall Study||60||
48753356|NCT02193776|102184473|FG003|Completed Day 70 Follow-up|Overall Study||60||
48753357|NCT02193776|102184470|FG000|Completed Day 140 Follow-up|Overall Study||52||
48753358|NCT02193776|102184471|FG001|Completed Day 140 Follow-up|Overall Study||52||
48337078|NCT00400400|101152192|FG001|STARTED|Overall Study||200||
48337079|NCT00400400|101152191|FG000|Intent-to-Treat Population|Overall Study||199||
48337080|NCT00400400|101152192|FG001|Intent-to-Treat Population|Overall Study||197||
48337081|NCT00400400|101152191|FG000|COMPLETED|Overall Study||186||
48337082|NCT00400400|101152192|FG001|COMPLETED|Overall Study||185||
48337083|NCT00400400|101152191|FG000|NOT COMPLETED|Overall Study||14||
48337084|NCT00400400|101152192|FG001|NOT COMPLETED|Overall Study||15||
48753359|NCT02193776|102184472|FG002|Completed Day 140 Follow-up|Overall Study||58||
48753360|NCT02193776|102184473|FG003|Completed Day 140 Follow-up|Overall Study||58||
48337085|NCT03806127|101152193|FG000|STARTED|Overall Study||111||
48337086|NCT03806127|101152194|FG001|STARTED|Overall Study||111||
48337087|NCT03806127|101152193|FG000|COMPLETED|Overall Study||90||
48337088|NCT03806127|101152194|FG001|COMPLETED|Overall Study||99||
48337089|NCT03806127|101152193|FG000|NOT COMPLETED|Overall Study||21||
48337090|NCT03806127|101152194|FG001|NOT COMPLETED|Overall Study||12||
48337091|NCT01412957|101152195|FG000|STARTED|Overall Study||189||
48337092|NCT01412957|101152196|FG001|STARTED|Overall Study||188||
48412946|NCT01624974|101345737|FG001|COMPLETED|Period V of Treatment (4 Weeks)||42||
48412947|NCT01624974|101345736|FG000|NOT COMPLETED|Period V of Treatment (4 Weeks)||5||
48412948|NCT01624974|101345737|FG001|NOT COMPLETED|Period V of Treatment (4 Weeks)||0||
48412949|NCT02079311|101345738|FG000|STARTED|Overall Study||28||
48412950|NCT02079311|101345739|FG001|STARTED|Overall Study||27||
48412951|NCT02079311|101345738|FG000|COMPLETED|Overall Study||28||
48631063|NCT03176771|101878708|FG002|STARTED|Double-Blind Extension Period||0||
48631064|NCT03176771|101878709|FG003|STARTED|Double-Blind Extension Period||112||
48631065|NCT03176771|101878710|FG004|STARTED|Double-Blind Extension Period||99||
48631066|NCT03176771|101878706|FG000|COMPLETED|Double-Blind Extension Period||0||
48631067|NCT03176771|101878707|FG001|COMPLETED|Double-Blind Extension Period||0||
48631068|NCT03176771|101878708|FG002|COMPLETED|Double-Blind Extension Period||0||
48631069|NCT03176771|101878709|FG003|COMPLETED|Double-Blind Extension Period||67||
48631070|NCT03176771|101878710|FG004|COMPLETED|Double-Blind Extension Period||50||
48631071|NCT03176771|101878706|FG000|NOT COMPLETED|Double-Blind Extension Period||0||
48631072|NCT03176771|101878707|FG001|NOT COMPLETED|Double-Blind Extension Period||0||
48631073|NCT03176771|101878708|FG002|NOT COMPLETED|Double-Blind Extension Period||0||
48631074|NCT03176771|101878709|FG003|NOT COMPLETED|Double-Blind Extension Period||45||
48631075|NCT03176771|101878710|FG004|NOT COMPLETED|Double-Blind Extension Period||49||
48631076|NCT02029417|101878711|FG000|STARTED|Overall Study||2||
48631077|NCT02029417|101878711|FG000|COMPLETED|Overall Study||0||
48631078|NCT02029417|101878711|FG000|NOT COMPLETED|Overall Study||2||
48631079|NCT02330341|101878712|FG000|STARTED|Overall Study||12||
48631080|NCT02330341|101878713|FG001|STARTED|Overall Study||12||
48753361|NCT02193776|102184470|FG000|COMPLETED|Overall Study||51|Completed Treatment|
48753362|NCT02193776|102184471|FG001|COMPLETED|Overall Study||53|Completed Treatment|
48753363|NCT02193776|102184472|FG002|COMPLETED|Overall Study||59|Completed Treatment|
48753364|NCT02193776|102184473|FG003|COMPLETED|Overall Study||58|Completed Treatment|
48753365|NCT02193776|102184470|FG000|NOT COMPLETED|Overall Study||8||
48753366|NCT02193776|102184471|FG001|NOT COMPLETED|Overall Study||7||
48753367|NCT02193776|102184472|FG002|NOT COMPLETED|Overall Study||2||
48753368|NCT02193776|102184473|FG003|NOT COMPLETED|Overall Study||2||
48753369|NCT01005251|102184474|FG000|STARTED|Overall Study||134||
48753370|NCT01005251|102184475|FG001|STARTED|Overall Study||125||
48753371|NCT01005251|102184476|FG002|STARTED|Overall Study||136||
48753372|NCT01005251|102184477|FG003|STARTED|Overall Study||126||
48753373|NCT01005251|102184478|FG004|STARTED|Overall Study||140||
48753374|NCT01005251|102184474|FG000|COMPLETED|Overall Study||121||
48753375|NCT01005251|102184475|FG001|COMPLETED|Overall Study||109||
48753376|NCT01005251|102184476|FG002|COMPLETED|Overall Study||114||
48753377|NCT01005251|102184477|FG003|COMPLETED|Overall Study||114||
48753378|NCT01005251|102184478|FG004|COMPLETED|Overall Study||122||
48753379|NCT01005251|102184474|FG000|NOT COMPLETED|Overall Study||13||
48753380|NCT01005251|102184475|FG001|NOT COMPLETED|Overall Study||16||
48753381|NCT01005251|102184476|FG002|NOT COMPLETED|Overall Study||22||
48753382|NCT01005251|102184477|FG003|NOT COMPLETED|Overall Study||12||
48753383|NCT01005251|102184478|FG004|NOT COMPLETED|Overall Study||18||
48753384|NCT00666666|102184479|FG000|STARTED|Overall Study||55||
48337093|NCT01412957|101152195|FG000|COMPLETED|Overall Study||40||
48337094|NCT01412957|101152196|FG001|COMPLETED|Overall Study||31||
48337095|NCT01412957|101152195|FG000|NOT COMPLETED|Overall Study||149||
48631081|NCT02330341|101878712|FG000|COMPLETED|Overall Study||12||
48631082|NCT02330341|101878713|FG001|COMPLETED|Overall Study||11||
48631083|NCT02330341|101878712|FG000|NOT COMPLETED|Overall Study||0||
48631084|NCT02330341|101878713|FG001|NOT COMPLETED|Overall Study||1||
48631085|NCT04236284|101878714|FG000|STARTED|Overall Study||21||
48631086|NCT04236284|101878714|FG000|Completed tDCS|Overall Study||16||
48753385|NCT00666666|102184479|FG000|COMPLETED|Overall Study||55||
48753386|NCT00666666|102184479|FG000|NOT COMPLETED|Overall Study||0||
48753387|NCT01009060|102184480|FG000|STARTED|Overall Study||25||
48753388|NCT01009060|102184481|FG001|STARTED|Overall Study||25||
48753389|NCT01009060|102184480|FG000|COMPLETED|Overall Study||21||
48753390|NCT01009060|102184481|FG001|COMPLETED|Overall Study||20||
48753391|NCT01009060|102184480|FG000|NOT COMPLETED|Overall Study||4||
48753392|NCT01009060|102184481|FG001|NOT COMPLETED|Overall Study||5||
48753393|NCT02918617|102184482|FG000|STARTED|Overall Study||21||
48753394|NCT02918617|102184483|FG001|STARTED|Overall Study||20||
48753395|NCT02918617|102184484|FG002|STARTED|Overall Study||22||
48753396|NCT02918617|102184485|FG003|STARTED|Overall Study||22||
48753397|NCT02918617|102184486|FG004|STARTED|Overall Study||24||
48753398|NCT02918617|102184487|FG005|STARTED|Overall Study||20||
48753399|NCT02918617|102184488|FG006|STARTED|Overall Study||22||
48753400|NCT02918617|102184489|FG007|STARTED|Overall Study||26||
48337096|NCT01412957|101152196|FG001|NOT COMPLETED|Overall Study||157||
48337097|NCT02388568|101152197|FG000|STARTED|Overall Study||69||
48337098|NCT02388568|101152198|FG001|STARTED|Overall Study||68||
48337099|NCT02388568|101152197|FG000|COMPLETED|Overall Study||59||
48337100|NCT02388568|101152198|FG001|COMPLETED|Overall Study||53||
48337101|NCT02388568|101152197|FG000|NOT COMPLETED|Overall Study||10||
48337102|NCT02388568|101152198|FG001|NOT COMPLETED|Overall Study||15||
48337103|NCT01539980|101152199|FG000|STARTED|Overall Study||30||
48337104|NCT01539980|101152199|FG000|COMPLETED|Overall Study||30||
48337105|NCT01539980|101152199|FG000|NOT COMPLETED|Overall Study||0||
48337106|NCT01099202|101152200|FG000|STARTED|Overall Study||55||
48337107|NCT01099202|101152201|FG001|STARTED|Overall Study||54||
48337108|NCT01099202|101152200|FG000|COMPLETED|Overall Study||55||
48337109|NCT01099202|101152201|FG001|COMPLETED|Overall Study||54||
48337110|NCT01099202|101152200|FG000|NOT COMPLETED|Overall Study||0||
48337111|NCT01099202|101152201|FG001|NOT COMPLETED|Overall Study||0||
48337112|NCT01764633|101152202|FG000|STARTED|Overall Study||13780||
48337113|NCT01764633|101152203|FG001|STARTED|Overall Study||13784||
48337114|NCT01764633|101152202|FG000|Received Treatment|Overall Study||13756||
48337115|NCT01764633|101152203|FG001|Received Treatment|Overall Study||13769||
48337116|NCT01764633|101152202|FG000|COMPLETED|Overall Study||13662||
48337117|NCT01764633|101152203|FG001|COMPLETED|Overall Study||13691||
48337118|NCT01764633|101152202|FG000|NOT COMPLETED|Overall Study||118||
48337119|NCT01764633|101152203|FG001|NOT COMPLETED|Overall Study||93||
48337120|NCT02630953|101156366|FG000|STARTED|6 Month Assessment||97||
48337121|NCT02630953|101156367|FG001|STARTED|6 Month Assessment||102||
48337122|NCT02630953|101156366|FG000|COMPLETED|6 Month Assessment||83||
48337123|NCT02630953|101156367|FG001|COMPLETED|6 Month Assessment||70||
48337124|NCT02630953|101156366|FG000|NOT COMPLETED|6 Month Assessment||14||
48337125|NCT02630953|101156367|FG001|NOT COMPLETED|6 Month Assessment||32||
48337126|NCT02630953|101156366|FG000|STARTED|12 Month Assessment||97||
48337127|NCT02630953|101156367|FG001|STARTED|12 Month Assessment||102||
48337128|NCT02630953|101156366|FG000|COMPLETED|12 Month Assessment||73||
48337129|NCT02630953|101156367|FG001|COMPLETED|12 Month Assessment||64||
48337130|NCT02630953|101156366|FG000|NOT COMPLETED|12 Month Assessment||24||
48337131|NCT02630953|101156367|FG001|NOT COMPLETED|12 Month Assessment||38||
48337132|NCT03365778|101156368|FG000|STARTED|Overall Study||16||
48337133|NCT03365778|101156369|FG001|STARTED|Overall Study||17||
48337134|NCT03365778|101156370|FG002|STARTED|Overall Study||53||
48337135|NCT03365778|101156368|FG000|COMPLETED|Overall Study||16||
48337136|NCT03365778|101156369|FG001|COMPLETED|Overall Study||17||
48337137|NCT03365778|101156370|FG002|COMPLETED|Overall Study||53||
48337138|NCT03365778|101156368|FG000|NOT COMPLETED|Overall Study||0||
48337139|NCT03365778|101156369|FG001|NOT COMPLETED|Overall Study||0||
48337140|NCT03365778|101156370|FG002|NOT COMPLETED|Overall Study||0||
48337141|NCT01662440|101156371|FG000|STARTED|Overall Study||167||
48337142|NCT01662440|101156372|FG001|STARTED|Overall Study||217||
48337143|NCT01662440|101156373|FG002|STARTED|Overall Study||221||
48337144|NCT01662440|101156374|FG003|STARTED|Overall Study||56||
48337145|NCT01662440|101156371|FG000|COMPLETED|Overall Study||158||
48337146|NCT01662440|101156372|FG001|COMPLETED|Overall Study||211||
48337147|NCT01662440|101156373|FG002|COMPLETED|Overall Study||215||
48337148|NCT01662440|101156374|FG003|COMPLETED|Overall Study||52||
48337149|NCT01662440|101156371|FG000|NOT COMPLETED|Overall Study||9||
48337150|NCT01662440|101156372|FG001|NOT COMPLETED|Overall Study||6||
48337151|NCT01662440|101156373|FG002|NOT COMPLETED|Overall Study||6||
48337152|NCT01662440|101156374|FG003|NOT COMPLETED|Overall Study||4||
48337153|NCT01885000|101156375|FG000|STARTED|Overall Study||48||
48337154|NCT01885000|101156376|FG001|STARTED|Overall Study||44||
48337155|NCT01885000|101156375|FG000|COMPLETED|Overall Study||46||
48337156|NCT01885000|101156376|FG001|COMPLETED|Overall Study||42||
48337157|NCT01885000|101156375|FG000|NOT COMPLETED|Overall Study||2||
48337158|NCT01885000|101156376|FG001|NOT COMPLETED|Overall Study||2||
48337159|NCT01936389|101156377|FG000|STARTED|Overall Study||5||
48337160|NCT01936389|101156378|FG001|STARTED|Overall Study||5||
48337161|NCT01936389|101156377|FG000|COMPLETED|Overall Study||4||
48337162|NCT01936389|101156378|FG001|COMPLETED|Overall Study||5||
48337163|NCT01936389|101156377|FG000|NOT COMPLETED|Overall Study||1||
48337164|NCT01936389|101156378|FG001|NOT COMPLETED|Overall Study||0||
48337165|NCT01966770|101156379|FG000|STARTED|Overall Study||20||
48337166|NCT01966770|101156379|FG000|COMPLETED|Overall Study||20||
48337167|NCT01966770|101156379|FG000|NOT COMPLETED|Overall Study||0||
48337168|NCT03603002|101156380|FG000|STARTED|Overall Study||6||
48337169|NCT03603002|101156380|FG000|COMPLETED|Overall Study||6||
48337170|NCT03603002|101156380|FG000|NOT COMPLETED|Overall Study||0||
48337171|NCT01291017|101156381|FG000|STARTED|Overall Study||19||
48337172|NCT01291017|101156381|FG000|COMPLETED|Overall Study||14||
48337173|NCT01291017|101156381|FG000|NOT COMPLETED|Overall Study||5||
48337174|NCT00464204|101156382|FG000|STARTED|Overall Study||100||
48337175|NCT00464204|101156383|FG001|STARTED|Overall Study||96||
48337176|NCT00464204|101156382|FG000|Completed Treatment|Overall Study||81||
48337177|NCT00464204|101156383|FG001|Completed Treatment|Overall Study||83||
48337178|NCT00464204|101156382|FG000|Day 30 Follow-up Performed|Overall Study||89||
48337179|NCT00464204|101156383|FG001|Day 30 Follow-up Performed|Overall Study||83||
48412952|NCT02079311|101345739|FG001|COMPLETED|Overall Study||26||
48753401|NCT02918617|102184490|FG008|STARTED|Overall Study||26||
48176796|NCT03653416|100757500|FG001|COMPLETED|Overall Study||46||
48631087|NCT04236284|101878714|FG000|Completed Prolonged Exposure Therapy|Overall Study||14||
48631088|NCT04236284|101878714|FG000|COMPLETED|Overall Study||14||
48631089|NCT04236284|101878714|FG000|NOT COMPLETED|Overall Study||7||
48631090|NCT02147626|101878715|FG000|STARTED|Overall Study||75||
48631091|NCT02147626|101878716|FG001|STARTED|Overall Study||76||
48631092|NCT02147626|101878715|FG000|COMPLETED|Overall Study||70||
48631093|NCT02147626|101878716|FG001|COMPLETED|Overall Study||69||
48631094|NCT02147626|101878715|FG000|NOT COMPLETED|Overall Study||5||
48631095|NCT02147626|101878716|FG001|NOT COMPLETED|Overall Study||7||
48631096|NCT02111083|101878717|FG000|STARTED|First Intervention (1 Day)||19||
48631097|NCT02111083|101878718|FG001|STARTED|First Intervention (1 Day)||19||
48631098|NCT02111083|101878717|FG000|COMPLETED|First Intervention (1 Day)||19||
48631099|NCT02111083|101878718|FG001|COMPLETED|First Intervention (1 Day)||19||
48631100|NCT02111083|101878717|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48631101|NCT02111083|101878718|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48631102|NCT02111083|101878717|FG000|STARTED|Interval Between Dosing (7-8 Days)||19||
48631103|NCT02111083|101878718|FG001|STARTED|Interval Between Dosing (7-8 Days)||19||
48631104|NCT02111083|101878717|FG000|COMPLETED|Interval Between Dosing (7-8 Days)||19||
48631105|NCT02111083|101878718|FG001|COMPLETED|Interval Between Dosing (7-8 Days)||19||
48631106|NCT02111083|101878717|FG000|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0||
48753402|NCT02918617|102184482|FG000|COMPLETED|Overall Study||20||
48176797|NCT03653416|100757499|FG000|NOT COMPLETED|Overall Study||6||
48176798|NCT03653416|100757500|FG001|NOT COMPLETED|Overall Study||1||
48176799|NCT02218489|100757501|FG000|STARTED|Overall Study||101||
48176800|NCT02218489|100757502|FG001|STARTED|Overall Study||104||
48176801|NCT02218489|100757501|FG000|COMPLETED|Overall Study||96||
48176802|NCT02218489|100757502|FG001|COMPLETED|Overall Study||101||
48176803|NCT02218489|100757501|FG000|NOT COMPLETED|Overall Study||5||
48176804|NCT02218489|100757502|FG001|NOT COMPLETED|Overall Study||3||
48176805|NCT00118144|100757503|FG000|STARTED|Overall Study||42||
48176806|NCT00118144|100757503|FG000|COMPLETED|Overall Study||41||
48176807|NCT00118144|100757503|FG000|NOT COMPLETED|Overall Study||1||
48176808|NCT04241575|100757504|FG000|STARTED|Overall Study||533||
48176809|NCT04241575|100757505|FG001|STARTED|Overall Study||528||
48176810|NCT04241575|100757504|FG000|COMPLETED|Overall Study||533||
48176811|NCT04241575|100757505|FG001|COMPLETED|Overall Study||528||
48176812|NCT04241575|100757504|FG000|NOT COMPLETED|Overall Study||0||
48176813|NCT04241575|100757505|FG001|NOT COMPLETED|Overall Study||0||
48176814|NCT01649596|100757506|FG000|STARTED|Overall Study||46||
48176815|NCT01649596|100757507|FG001|STARTED|Overall Study||48||
48176816|NCT01649596|100757506|FG000|COMPLETED|Overall Study||46||
48176817|NCT01649596|100757507|FG001|COMPLETED|Overall Study||48||
48176818|NCT01649596|100757506|FG000|NOT COMPLETED|Overall Study||0||
48176819|NCT01649596|100757507|FG001|NOT COMPLETED|Overall Study||0||
48176820|NCT01060020|100757508|FG000|STARTED|Overall Study||20||
48176821|NCT01060020|100757508|FG000|COMPLETED|Overall Study||20||
48631107|NCT02111083|101878718|FG001|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0||
48631108|NCT02111083|101878717|FG000|STARTED|Second Intervention (1 Day)||19||
48631109|NCT02111083|101878718|FG001|STARTED|Second Intervention (1 Day)||19||
48631110|NCT02111083|101878717|FG000|COMPLETED|Second Intervention (1 Day)||19||
48631111|NCT02111083|101878718|FG001|COMPLETED|Second Intervention (1 Day)||19||
48631112|NCT02111083|101878717|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48631113|NCT02111083|101878718|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48631114|NCT02111083|101878717|FG000|STARTED|Interval Between Dosing (7-8 Days)||19||
48631115|NCT02111083|101878718|FG001|STARTED|Interval Between Dosing (7-8 Days)||19||
48631116|NCT02111083|101878717|FG000|COMPLETED|Interval Between Dosing (7-8 Days)||19||
48631117|NCT02111083|101878718|FG001|COMPLETED|Interval Between Dosing (7-8 Days)||19||
48631118|NCT02111083|101878717|FG000|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0||
48631119|NCT02111083|101878718|FG001|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0||
48631120|NCT02111083|101878717|FG000|STARTED|Third Intervention (1 Day)||19||
48631121|NCT02111083|101878718|FG001|STARTED|Third Intervention (1 Day)||19||
48753403|NCT02918617|102184483|FG001|COMPLETED|Overall Study||20||
48753404|NCT02918617|102184484|FG002|COMPLETED|Overall Study||19||
48176822|NCT01060020|100757508|FG000|NOT COMPLETED|Overall Study||0||
48176823|NCT01225835|100757509|FG000|STARTED|Overall Study||62||
48176824|NCT01225835|100757510|FG001|STARTED|Overall Study||62||
48176825|NCT01225835|100757509|FG000|Per Protocol Population|Overall Study||48||
48176826|NCT01225835|100757510|FG001|Per Protocol Population|Overall Study||58||
48176827|NCT01225835|100757509|FG000|COMPLETED|Overall Study||55||
48176828|NCT01225835|100757510|FG001|COMPLETED|Overall Study||59||
48176829|NCT01225835|100757509|FG000|NOT COMPLETED|Overall Study||7||
48176830|NCT01225835|100757510|FG001|NOT COMPLETED|Overall Study||3||
48176831|NCT01542541|100757511|FG000|STARTED|Overall Study||38||
48176832|NCT01542541|100757512|FG001|STARTED|Overall Study||30||
48176833|NCT01542541|100757511|FG000|COMPLETED|Overall Study||30||
48176834|NCT01542541|100757512|FG001|COMPLETED|Overall Study||30||
48176835|NCT01542541|100757511|FG000|NOT COMPLETED|Overall Study||8||
48176836|NCT01542541|100757512|FG001|NOT COMPLETED|Overall Study||0||
48176837|NCT01235975|100757513|FG000|STARTED|Overall Study||274||
48176838|NCT01235975|100757514|FG001|STARTED|Overall Study||95||
48176839|NCT01235975|100757513|FG000|COMPLETED|Overall Study||257||
48176840|NCT01235975|100757514|FG001|COMPLETED|Overall Study||88||
48176841|NCT01235975|100757513|FG000|NOT COMPLETED|Overall Study||17||
48176842|NCT01235975|100757514|FG001|NOT COMPLETED|Overall Study||7||
48176843|NCT02404493|100757515|FG000|STARTED|Overall Study||17||
48176844|NCT02404493|100757516|FG001|STARTED|Overall Study||6||
48176845|NCT02404493|100757515|FG000|COMPLETED|Overall Study||16||
48176846|NCT02404493|100757516|FG001|COMPLETED|Overall Study||5||
48176847|NCT02404493|100757515|FG000|NOT COMPLETED|Overall Study||1||
48176848|NCT02404493|100757516|FG001|NOT COMPLETED|Overall Study||1||
48176849|NCT00859131|100757517|FG000|STARTED|Overall Study||102||
48176850|NCT00859131|100757518|FG001|STARTED|Overall Study||98||
48176851|NCT00859131|100757517|FG000|COMPLETED|Overall Study||102||
48176852|NCT00859131|100757518|FG001|COMPLETED|Overall Study||98||
48176853|NCT00859131|100757517|FG000|NOT COMPLETED|Overall Study||0||
48176854|NCT00859131|100757518|FG001|NOT COMPLETED|Overall Study||0||
48176855|NCT00422799|100757519|FG000|STARTED|Overall Study||63||
48176856|NCT00422799|100757519|FG000|COMPLETED|Overall Study||50||
48176857|NCT00422799|100757519|FG000|NOT COMPLETED|Overall Study||13||
48176858|NCT01449721|100757520|FG000|STARTED|Overall Study||112||
48176859|NCT01449721|100757521|FG001|STARTED|Overall Study||30||
48176860|NCT01449721|100757520|FG000|COMPLETED|Overall Study||112||
48176861|NCT01449721|100757521|FG001|COMPLETED|Overall Study||28||
48176862|NCT01449721|100757520|FG000|NOT COMPLETED|Overall Study||0||
48176863|NCT01449721|100757521|FG001|NOT COMPLETED|Overall Study||2||
48176864|NCT04447820|100757522|FG000|STARTED|Overall Study||32||
48412953|NCT02079311|101345738|FG000|NOT COMPLETED|Overall Study||0||
48412954|NCT02079311|101345739|FG001|NOT COMPLETED|Overall Study||1||
48753405|NCT02918617|102184485|FG003|COMPLETED|Overall Study||22||
48753406|NCT02918617|102184486|FG004|COMPLETED|Overall Study||24||
48753407|NCT02918617|102184487|FG005|COMPLETED|Overall Study||20||
48753408|NCT02918617|102184488|FG006|COMPLETED|Overall Study||22||
48176865|NCT04447820|100757523|FG001|STARTED|Overall Study||32||
48176866|NCT04447820|100757524|FG002|STARTED|Overall Study||32||
48176867|NCT04447820|100757522|FG000|COMPLETED|Overall Study||31||
48753409|NCT02918617|102184489|FG007|COMPLETED|Overall Study||25||
48753410|NCT02918617|102184490|FG008|COMPLETED|Overall Study||26||
48753411|NCT02918617|102184482|FG000|NOT COMPLETED|Overall Study||1||
48753412|NCT02918617|102184483|FG001|NOT COMPLETED|Overall Study||0||
48753413|NCT02918617|102184484|FG002|NOT COMPLETED|Overall Study||3||
48753414|NCT02918617|102184485|FG003|NOT COMPLETED|Overall Study||0||
48753415|NCT02918617|102184486|FG004|NOT COMPLETED|Overall Study||0||
48176868|NCT04447820|100757523|FG001|COMPLETED|Overall Study||31||
48176869|NCT04447820|100757524|FG002|COMPLETED|Overall Study||29||
48176870|NCT04447820|100757522|FG000|NOT COMPLETED|Overall Study||1||
48176871|NCT04447820|100757523|FG001|NOT COMPLETED|Overall Study||1||
48176872|NCT04447820|100757524|FG002|NOT COMPLETED|Overall Study||3||
48176873|NCT01751113|100757525|FG000|STARTED|Treatment Period 1 (4 Weeks)||8||
48176874|NCT01751113|100757526|FG001|STARTED|Treatment Period 1 (4 Weeks)||8||
48176875|NCT01751113|100757527|FG002|STARTED|Treatment Period 1 (4 Weeks)||9||
48176876|NCT01751113|100757528|FG003|STARTED|Treatment Period 1 (4 Weeks)||9||
48176877|NCT01751113|100757529|FG004|STARTED|Treatment Period 1 (4 Weeks)||9||
48176878|NCT01751113|100757530|FG005|STARTED|Treatment Period 1 (4 Weeks)||10||
48176879|NCT01751113|100757525|FG000|COMPLETED|Treatment Period 1 (4 Weeks)||8||
48176880|NCT01751113|100757526|FG001|COMPLETED|Treatment Period 1 (4 Weeks)||8||
48176881|NCT01751113|100757527|FG002|COMPLETED|Treatment Period 1 (4 Weeks)||9||
48176882|NCT01751113|100757528|FG003|COMPLETED|Treatment Period 1 (4 Weeks)||8||
48176883|NCT01751113|100757529|FG004|COMPLETED|Treatment Period 1 (4 Weeks)||8||
48176884|NCT01751113|100757530|FG005|COMPLETED|Treatment Period 1 (4 Weeks)||10||
48176885|NCT01751113|100757525|FG000|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0||
48176886|NCT01751113|100757526|FG001|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0||
48176887|NCT01751113|100757527|FG002|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0||
48176888|NCT01751113|100757528|FG003|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1||
48176889|NCT01751113|100757529|FG004|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1||
48176890|NCT01751113|100757530|FG005|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0||
48176891|NCT01751113|100757525|FG000|STARTED|Washout Period 1 (2 Weeks)||8||
48176892|NCT01751113|100757526|FG001|STARTED|Washout Period 1 (2 Weeks)||8||
48176893|NCT01751113|100757527|FG002|STARTED|Washout Period 1 (2 Weeks)||9||
48753416|NCT02918617|102184487|FG005|NOT COMPLETED|Overall Study||0||
48753417|NCT02918617|102184488|FG006|NOT COMPLETED|Overall Study||0||
48753418|NCT02918617|102184489|FG007|NOT COMPLETED|Overall Study||1||
48753419|NCT02918617|102184490|FG008|NOT COMPLETED|Overall Study||0||
48753420|NCT03324607|102184491|FG000|STARTED|Overall Study||20||
48753421|NCT03324607|102184491|FG000|COMPLETED|Overall Study||20||
48753422|NCT03324607|102184491|FG000|NOT COMPLETED|Overall Study||0||
48753423|NCT03550118|102184492|FG000|STARTED|Overall Study||15||
48753424|NCT03550118|102184493|FG001|STARTED|Overall Study||13||
48753425|NCT03550118|102184494|FG002|STARTED|Overall Study||12||
48753426|NCT03550118|102184495|FG003|STARTED|Overall Study||13||
48753427|NCT03550118|102184496|FG004|STARTED|Overall Study||7||
48176894|NCT01751113|100757528|FG003|STARTED|Washout Period 1 (2 Weeks)||8||
48176895|NCT01751113|100757529|FG004|STARTED|Washout Period 1 (2 Weeks)||8||
48176896|NCT01751113|100757530|FG005|STARTED|Washout Period 1 (2 Weeks)||10||
48176897|NCT01751113|100757525|FG000|COMPLETED|Washout Period 1 (2 Weeks)||8||
48176898|NCT01751113|100757526|FG001|COMPLETED|Washout Period 1 (2 Weeks)||8||
48176899|NCT01751113|100757527|FG002|COMPLETED|Washout Period 1 (2 Weeks)||9||
48176900|NCT01751113|100757528|FG003|COMPLETED|Washout Period 1 (2 Weeks)||8||
48176901|NCT01751113|100757529|FG004|COMPLETED|Washout Period 1 (2 Weeks)||8||
48176902|NCT01751113|100757530|FG005|COMPLETED|Washout Period 1 (2 Weeks)||10||
48176903|NCT01751113|100757525|FG000|NOT COMPLETED|Washout Period 1 (2 Weeks)||0||
48176904|NCT01751113|100757526|FG001|NOT COMPLETED|Washout Period 1 (2 Weeks)||0||
48176905|NCT01751113|100757527|FG002|NOT COMPLETED|Washout Period 1 (2 Weeks)||0||
48176906|NCT01751113|100757528|FG003|NOT COMPLETED|Washout Period 1 (2 Weeks)||0||
48176907|NCT01751113|100757529|FG004|NOT COMPLETED|Washout Period 1 (2 Weeks)||0||
48176908|NCT01751113|100757530|FG005|NOT COMPLETED|Washout Period 1 (2 Weeks)||0||
48176909|NCT01751113|100757525|FG000|STARTED|Treatment Period 2 (4 Weeks)||8||
48176910|NCT01751113|100757526|FG001|STARTED|Treatment Period 2 (4 Weeks)||8||
48176911|NCT01751113|100757527|FG002|STARTED|Treatment Period 2 (4 Weeks)||9||
48176912|NCT01751113|100757528|FG003|STARTED|Treatment Period 2 (4 Weeks)||8||
48176913|NCT01751113|100757529|FG004|STARTED|Treatment Period 2 (4 Weeks)||8||
48176914|NCT01751113|100757530|FG005|STARTED|Treatment Period 2 (4 Weeks)||10||
48176915|NCT01751113|100757525|FG000|COMPLETED|Treatment Period 2 (4 Weeks)||8||
48176916|NCT01751113|100757526|FG001|COMPLETED|Treatment Period 2 (4 Weeks)||8||
48176917|NCT01751113|100757527|FG002|COMPLETED|Treatment Period 2 (4 Weeks)||9||
48176918|NCT01751113|100757528|FG003|COMPLETED|Treatment Period 2 (4 Weeks)||8||
48176919|NCT01751113|100757529|FG004|COMPLETED|Treatment Period 2 (4 Weeks)||8||
48337180|NCT00464204|101156382|FG000|Day 90 Follow-up Performed|Overall Study||69||
48337181|NCT00464204|101156383|FG001|Day 90 Follow-up Performed|Overall Study||74||
48337182|NCT00464204|101156382|FG000|Withdrawal Due to Discharge From ICU|Overall Study||18||
48337183|NCT00464204|101156383|FG001|Withdrawal Due to Discharge From ICU|Overall Study||11||
48337184|NCT00464204|101156382|FG000|COMPLETED|Overall Study||51||
48337185|NCT00464204|101156383|FG001|COMPLETED|Overall Study||64||
48337186|NCT00464204|101156382|FG000|NOT COMPLETED|Overall Study||49||
48337187|NCT00464204|101156383|FG001|NOT COMPLETED|Overall Study||32||
48337188|NCT02481505|101156384|FG000|STARTED|Overall Study||15||
48337189|NCT02481505|101156385|FG001|STARTED|Overall Study||15||
48337190|NCT02481505|101156386|FG002|STARTED|Overall Study||15||
48337191|NCT02481505|101156384|FG000|COMPLETED|Overall Study||15||
48337192|NCT02481505|101156385|FG001|COMPLETED|Overall Study||15||
48337193|NCT02481505|101156386|FG002|COMPLETED|Overall Study||15||
48337194|NCT02481505|101156384|FG000|NOT COMPLETED|Overall Study||0||
48337195|NCT02481505|101156385|FG001|NOT COMPLETED|Overall Study||0||
48337196|NCT02481505|101156386|FG002|NOT COMPLETED|Overall Study||0||
48337197|NCT03430986|101156387|FG000|STARTED|24-week Control Period||42||
48337198|NCT03430986|101156388|FG001|STARTED|24-week Control Period||122||
48337199|NCT03430986|101156387|FG000|Treated as Randomized|24-week Control Period||42||
48337200|NCT03430986|101156388|FG001|Treated as Randomized|24-week Control Period||120||
48337201|NCT03430986|101156387|FG000|COMPLETED|24-week Control Period||34||
48337202|NCT03430986|101156388|FG001|COMPLETED|24-week Control Period||118||
48337203|NCT03430986|101156387|FG000|NOT COMPLETED|24-week Control Period||8||
48337204|NCT03430986|101156388|FG001|NOT COMPLETED|24-week Control Period||4||
48337205|NCT03430986|101156387|FG000|STARTED|24-week Post-Control Period||31||
48337206|NCT03430986|101156388|FG001|STARTED|24-week Post-Control Period||118||
48337207|NCT03430986|101156387|FG000|COMPLETED|24-week Post-Control Period||30||
48337208|NCT03430986|101156388|FG001|COMPLETED|24-week Post-Control Period||116||
48337209|NCT03430986|101156387|FG000|NOT COMPLETED|24-week Post-Control Period||1||
48337210|NCT03430986|101156388|FG001|NOT COMPLETED|24-week Post-Control Period||2||
48337211|NCT01877564|101156389|FG000|STARTED|Overall Study||6||
48337212|NCT01877564|101156390|FG001|STARTED|Overall Study||4||
48337213|NCT01877564|101156389|FG000|COMPLETED|Overall Study||6||
48337214|NCT01877564|101156390|FG001|COMPLETED|Overall Study||4||
48176920|NCT01751113|100757530|FG005|COMPLETED|Treatment Period 2 (4 Weeks)||10||
48337215|NCT01877564|101156389|FG000|NOT COMPLETED|Overall Study||0||
48337216|NCT01877564|101156390|FG001|NOT COMPLETED|Overall Study||0||
48176921|NCT01751113|100757525|FG000|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0||
48176922|NCT01751113|100757526|FG001|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0||
48176923|NCT01751113|100757527|FG002|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0||
48176924|NCT01751113|100757528|FG003|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0||
48176925|NCT01751113|100757529|FG004|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0||
48337217|NCT03682120|101156391|FG000|STARTED|Overall Study||105||
48337218|NCT03682120|101156392|FG001|STARTED|Overall Study||105||
48337219|NCT03682120|101156393|FG002|STARTED|Overall Study||105||
48337220|NCT03682120|101156394|FG003|STARTED|Overall Study||57||
48176926|NCT01751113|100757530|FG005|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0||
48337221|NCT03682120|101156391|FG000|COMPLETED|Overall Study||92||
48337222|NCT03682120|101156392|FG001|COMPLETED|Overall Study||97||
48753428|NCT03550118|102184497|FG005|STARTED|Overall Study||14||
48176927|NCT01751113|100757525|FG000|STARTED|Washout Period 2 (2 Weeks)||8||
48176928|NCT01751113|100757526|FG001|STARTED|Washout Period 2 (2 Weeks)||8||
48176929|NCT01751113|100757527|FG002|STARTED|Washout Period 2 (2 Weeks)||9||
48176930|NCT01751113|100757528|FG003|STARTED|Washout Period 2 (2 Weeks)||8||
48176931|NCT01751113|100757529|FG004|STARTED|Washout Period 2 (2 Weeks)||8||
48176932|NCT01751113|100757530|FG005|STARTED|Washout Period 2 (2 Weeks)||10||
48176933|NCT01751113|100757525|FG000|COMPLETED|Washout Period 2 (2 Weeks)||8||
48337223|NCT03682120|101156393|FG002|COMPLETED|Overall Study||97||
48337224|NCT03682120|101156394|FG003|COMPLETED|Overall Study||55||
48337225|NCT03682120|101156391|FG000|NOT COMPLETED|Overall Study||13||
48337226|NCT03682120|101156392|FG001|NOT COMPLETED|Overall Study||8||
48753429|NCT03550118|102184498|FG006|STARTED|Overall Study||12||
48176934|NCT01751113|100757526|FG001|COMPLETED|Washout Period 2 (2 Weeks)||8||
48176935|NCT01751113|100757527|FG002|COMPLETED|Washout Period 2 (2 Weeks)||9||
48176936|NCT01751113|100757528|FG003|COMPLETED|Washout Period 2 (2 Weeks)||8||
48176937|NCT01751113|100757529|FG004|COMPLETED|Washout Period 2 (2 Weeks)||8||
48176938|NCT01751113|100757530|FG005|COMPLETED|Washout Period 2 (2 Weeks)||10||
48176939|NCT01751113|100757525|FG000|NOT COMPLETED|Washout Period 2 (2 Weeks)||0||
48176940|NCT01751113|100757526|FG001|NOT COMPLETED|Washout Period 2 (2 Weeks)||0||
48176941|NCT01751113|100757527|FG002|NOT COMPLETED|Washout Period 2 (2 Weeks)||0||
48176942|NCT01751113|100757528|FG003|NOT COMPLETED|Washout Period 2 (2 Weeks)||0||
48176943|NCT01751113|100757529|FG004|NOT COMPLETED|Washout Period 2 (2 Weeks)||0||
48176944|NCT01751113|100757530|FG005|NOT COMPLETED|Washout Period 2 (2 Weeks)||0||
48176945|NCT01751113|100757525|FG000|STARTED|Treatment Period 3 (4 Weeks)||8||
48176946|NCT01751113|100757526|FG001|STARTED|Treatment Period 3 (4 Weeks)||8||
48176947|NCT01751113|100757527|FG002|STARTED|Treatment Period 3 (4 Weeks)||9||
48753430|NCT03550118|102184499|FG007|STARTED|Overall Study||18||
48753431|NCT03550118|102184492|FG000|COMPLETED|Overall Study||10||
48176948|NCT01751113|100757528|FG003|STARTED|Treatment Period 3 (4 Weeks)||8||
48176949|NCT01751113|100757529|FG004|STARTED|Treatment Period 3 (4 Weeks)||8||
48176950|NCT01751113|100757530|FG005|STARTED|Treatment Period 3 (4 Weeks)||10||
48176951|NCT01751113|100757525|FG000|COMPLETED|Treatment Period 3 (4 Weeks)||8||
48176952|NCT01751113|100757526|FG001|COMPLETED|Treatment Period 3 (4 Weeks)||8||
48176953|NCT01751113|100757527|FG002|COMPLETED|Treatment Period 3 (4 Weeks)||9||
48176954|NCT01751113|100757528|FG003|COMPLETED|Treatment Period 3 (4 Weeks)||8||
48176955|NCT01751113|100757529|FG004|COMPLETED|Treatment Period 3 (4 Weeks)||8||
48176956|NCT01751113|100757530|FG005|COMPLETED|Treatment Period 3 (4 Weeks)||9||
48176957|NCT01751113|100757525|FG000|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0||
48176958|NCT01751113|100757526|FG001|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0||
48176959|NCT01751113|100757527|FG002|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0||
48176960|NCT01751113|100757528|FG003|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0||
48176961|NCT01751113|100757529|FG004|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0||
48176962|NCT01751113|100757530|FG005|NOT COMPLETED|Treatment Period 3 (4 Weeks)||1||
48176963|NCT01896115|100757531|FG000|STARTED|Overall Study||16||
48176964|NCT01896115|100757532|FG001|STARTED|Overall Study||24||
48176965|NCT01896115|100757531|FG000|Phase 1 Short PW|Overall Study||15||
48176966|NCT01896115|100757532|FG001|Phase 1 Short PW|Overall Study||0||
48176967|NCT01896115|100757531|FG000|Phase 1 Conventional PW|Overall Study||15||
48176968|NCT01896115|100757532|FG001|Phase 1 Conventional PW|Overall Study||0||
48176969|NCT01896115|100757531|FG000|Phase 1 Dorsal Steering|Overall Study||15||
48176970|NCT01896115|100757532|FG001|Phase 1 Dorsal Steering|Overall Study||0||
48176971|NCT01896115|100757531|FG000|Phase 1 Ventral Steering|Overall Study||15||
48176972|NCT01896115|100757532|FG001|Phase 1 Ventral Steering|Overall Study||0||
48176973|NCT01896115|100757531|FG000|Phase 2 Single Contact|Overall Study||0||
48176974|NCT01896115|100757532|FG001|Phase 2 Single Contact|Overall Study||24||
48176975|NCT01896115|100757531|FG000|Phase 2 Steering|Overall Study||0||
48176976|NCT01896115|100757532|FG001|Phase 2 Steering|Overall Study||24||
48176977|NCT01896115|100757531|FG000|COMPLETED|Overall Study||15||
48176978|NCT01896115|100757532|FG001|COMPLETED|Overall Study||24||
48176979|NCT01896115|100757531|FG000|NOT COMPLETED|Overall Study||1||
48176980|NCT01896115|100757532|FG001|NOT COMPLETED|Overall Study||0||
48176981|NCT01394250|100757533|FG000|STARTED|Randomization and IV Placement Attempt||134||
48176982|NCT01394250|100757534|FG001|STARTED|Randomization and IV Placement Attempt||134||
48176983|NCT01394250|100757533|FG000|COMPLETED|Randomization and IV Placement Attempt||120||
48337227|NCT03682120|101156393|FG002|NOT COMPLETED|Overall Study||8||
48337228|NCT03682120|101156394|FG003|NOT COMPLETED|Overall Study||2||
48337229|NCT00741156|101156395|FG000|STARTED|Overall Study||12||
48337230|NCT00741156|101156395|FG000|COMPLETED|Overall Study||12||
48337231|NCT00741156|101156395|FG000|NOT COMPLETED|Overall Study||0||
48337232|NCT02557178|101156396|FG000|STARTED|Overall Study||72||
48337233|NCT02557178|101156397|FG001|STARTED|Overall Study||74||
48176984|NCT01394250|100757534|FG001|COMPLETED|Randomization and IV Placement Attempt||121||
48176985|NCT01394250|100757533|FG000|NOT COMPLETED|Randomization and IV Placement Attempt||14||
48337234|NCT02557178|101156396|FG000|COMPLETED|Overall Study||56||
48337235|NCT02557178|101156397|FG001|COMPLETED|Overall Study||63||
48753432|NCT03550118|102184493|FG001|COMPLETED|Overall Study||12||
48753433|NCT03550118|102184494|FG002|COMPLETED|Overall Study||10||
48753434|NCT03550118|102184495|FG003|COMPLETED|Overall Study||12||
48176986|NCT01394250|100757534|FG001|NOT COMPLETED|Randomization and IV Placement Attempt||13||
48176987|NCT01394250|100757533|FG000|STARTED|Successful IV Placement & Follow-Up||120||
48176988|NCT01394250|100757534|FG001|STARTED|Successful IV Placement & Follow-Up||121||
48176989|NCT01394250|100757533|FG000|COMPLETED|Successful IV Placement & Follow-Up||114||
48176990|NCT01394250|100757534|FG001|COMPLETED|Successful IV Placement & Follow-Up||110||
48176991|NCT01394250|100757533|FG000|NOT COMPLETED|Successful IV Placement & Follow-Up||6||
48176992|NCT01394250|100757534|FG001|NOT COMPLETED|Successful IV Placement & Follow-Up||11||
48176993|NCT00767104|100757535|FG000|STARTED|Overall Study||20||
48176994|NCT00767104|100757536|FG001|STARTED|Overall Study||20||
48176995|NCT00767104|100757535|FG000|COMPLETED|Overall Study||19||
48176996|NCT00767104|100757536|FG001|COMPLETED|Overall Study||18||
48176997|NCT00767104|100757535|FG000|NOT COMPLETED|Overall Study||1||
48176998|NCT00767104|100757536|FG001|NOT COMPLETED|Overall Study||2||
48176999|NCT01189890|100757537|FG000|STARTED|Overall Study||241||
48177000|NCT01189890|100757538|FG001|STARTED|Overall Study||239||
48177001|NCT01189890|100757537|FG000|COMPLETED|Overall Study||204||
48177002|NCT01189890|100757538|FG001|COMPLETED|Overall Study||200||
48177003|NCT01189890|100757537|FG000|NOT COMPLETED|Overall Study||37||
48177004|NCT01189890|100757538|FG001|NOT COMPLETED|Overall Study||39||
48177005|NCT01799720|100757539|FG000|STARTED|Overall Study||20||
48177006|NCT01799720|100757540|FG001|STARTED|Overall Study||18||
48177007|NCT01799720|100757541|FG002|STARTED|Overall Study||19||
48177008|NCT01799720|100757539|FG000|Began the Treatment|Overall Study||20||
48177009|NCT01799720|100757540|FG001|Began the Treatment|Overall Study||18||
48177010|NCT01799720|100757541|FG002|Began the Treatment|Overall Study||19||
48177011|NCT01799720|100757539|FG000|Began the Treatment and Finished it|Overall Study||17||
48177012|NCT01799720|100757540|FG001|Began the Treatment and Finished it|Overall Study||17||
48177013|NCT01799720|100757541|FG002|Began the Treatment and Finished it|Overall Study||18||
48177014|NCT01799720|100757539|FG000|COMPLETED|Overall Study||17||
48177015|NCT01799720|100757540|FG001|COMPLETED|Overall Study||17||
48177016|NCT01799720|100757541|FG002|COMPLETED|Overall Study||18||
48177017|NCT01799720|100757539|FG000|NOT COMPLETED|Overall Study||3||
48177018|NCT01799720|100757540|FG001|NOT COMPLETED|Overall Study||1||
48177019|NCT01799720|100757541|FG002|NOT COMPLETED|Overall Study||1||
48177020|NCT03171168|100757542|FG000|STARTED|Overall Study||17||
48177021|NCT03171168|100757543|FG001|STARTED|Overall Study||37||
48177022|NCT03171168|100757542|FG000|COMPLETED|Overall Study||10||
48177023|NCT03171168|100757543|FG001|COMPLETED|Overall Study||19||
48177024|NCT03171168|100757542|FG000|NOT COMPLETED|Overall Study||7||
48177025|NCT03171168|100757543|FG001|NOT COMPLETED|Overall Study||18||
48177026|NCT01875861|100757544|FG000|STARTED|Pre-implementation||4779||6
48177027|NCT01875861|100757545|FG001|STARTED|Pre-implementation||3714||6
48177028|NCT01875861|100757544|FG000|COMPLETED|Pre-implementation||4779||6
48177029|NCT01875861|100757545|FG001|COMPLETED|Pre-implementation||3714||6
48177030|NCT01875861|100757544|FG000|NOT COMPLETED|Pre-implementation||0||0
48177031|NCT01875861|100757545|FG001|NOT COMPLETED|Pre-implementation||0||0
48177032|NCT01875861|100757544|FG000|STARTED|Implementation||4546|The number of patients within each period is independent of the number in other periods.|6
48753435|NCT03550118|102184496|FG004|COMPLETED|Overall Study||6||
48753436|NCT03550118|102184497|FG005|COMPLETED|Overall Study||12||
48753437|NCT03550118|102184498|FG006|COMPLETED|Overall Study||12||
48753438|NCT03550118|102184499|FG007|COMPLETED|Overall Study||12||
48177033|NCT01875861|100757545|FG001|STARTED|Implementation||3444|The number of patients within each period is independent of the number in other periods.|6
48177034|NCT01875861|100757544|FG000|COMPLETED|Implementation||4546||6
48177035|NCT01875861|100757545|FG001|COMPLETED|Implementation||3444||6
48177036|NCT01875861|100757544|FG000|NOT COMPLETED|Implementation||0||0
48177037|NCT01875861|100757545|FG001|NOT COMPLETED|Implementation||0||0
48177038|NCT01875861|100757544|FG000|STARTED|Sustainability||4306||6
48177039|NCT01875861|100757545|FG001|STARTED|Sustainability||3444||6
48177040|NCT01875861|100757544|FG000|COMPLETED|Sustainability||4306||6
48177041|NCT01875861|100757545|FG001|COMPLETED|Sustainability||3444||6
48177042|NCT01875861|100757544|FG000|NOT COMPLETED|Sustainability||0||0
48177043|NCT01875861|100757545|FG001|NOT COMPLETED|Sustainability||0||0
48177044|NCT02733042|100757546|FG000|STARTED|Overall Study||3||
48177045|NCT02733042|100757547|FG001|STARTED|Overall Study||3||
48177046|NCT02733042|100757548|FG002|STARTED|Overall Study||8||
48177047|NCT02733042|100757549|FG003|STARTED|Overall Study||3||
48337236|NCT02557178|101156396|FG000|NOT COMPLETED|Overall Study||16||
48177048|NCT02733042|100757550|FG004|STARTED|Overall Study||4||
48177049|NCT02733042|100757551|FG005|STARTED|Overall Study||3||
48177050|NCT02733042|100757552|FG006|STARTED|Overall Study||1||
48177051|NCT02733042|100757553|FG007|STARTED|Overall Study||4||
48177052|NCT02733042|100757554|FG008|STARTED|Overall Study||5||
48177053|NCT02733042|100757555|FG009|STARTED|Overall Study||10||
48177054|NCT02733042|100757556|FG010|STARTED|Overall Study||10||
48177055|NCT02733042|100757557|FG011|STARTED|Overall Study||10||
48177056|NCT02733042|100757558|FG012|STARTED|Overall Study||10||
48177057|NCT02733042|100757559|FG013|STARTED|Overall Study||5||
48177058|NCT02733042|100757560|FG014|STARTED|Overall Study||5||
48753439|NCT03550118|102184492|FG000|NOT COMPLETED|Overall Study||5||
48753440|NCT03550118|102184493|FG001|NOT COMPLETED|Overall Study||1||
48177059|NCT02733042|100757561|FG015|STARTED|Overall Study||10||
48177060|NCT02733042|100757562|FG016|STARTED|Overall Study||2||
48177061|NCT02733042|100757563|FG017|STARTED|Overall Study||5||
48177062|NCT02733042|100757564|FG018|STARTED|Overall Study||5||
48177063|NCT02733042|100757546|FG000|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||3||
48177064|NCT02733042|100757547|FG001|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||3||
48177065|NCT02733042|100757548|FG002|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||6||
48177066|NCT02733042|100757549|FG003|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||3||
48177067|NCT02733042|100757550|FG004|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||2||
48177068|NCT02733042|100757551|FG005|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||2||
48177069|NCT02733042|100757552|FG006|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||0||
48177070|NCT02733042|100757553|FG007|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||4||
48177071|NCT02733042|100757554|FG008|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||4||
48177072|NCT02733042|100757555|FG009|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||4||
48177073|NCT02733042|100757556|FG010|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||5||
48177074|NCT02733042|100757557|FG011|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||9||
48177075|NCT02733042|100757558|FG012|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||9||
48177076|NCT02733042|100757559|FG013|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||4||
48177077|NCT02733042|100757560|FG014|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||1||
48177078|NCT02733042|100757561|FG015|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||5||
48177079|NCT02733042|100757562|FG016|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||0||
48177080|NCT02733042|100757563|FG017|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||3||
48177081|NCT02733042|100757564|FG018|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||2||
48177082|NCT02733042|100757546|FG000|COMPLETED|Overall Study||0||
48177083|NCT02733042|100757547|FG001|COMPLETED|Overall Study||1||
48177084|NCT02733042|100757548|FG002|COMPLETED|Overall Study||1||
48177085|NCT02733042|100757549|FG003|COMPLETED|Overall Study||0||
48177086|NCT02733042|100757550|FG004|COMPLETED|Overall Study||1||
48177087|NCT02733042|100757551|FG005|COMPLETED|Overall Study||0||
48177088|NCT02733042|100757552|FG006|COMPLETED|Overall Study||0||
48177089|NCT02733042|100757553|FG007|COMPLETED|Overall Study||1||
48177090|NCT02733042|100757554|FG008|COMPLETED|Overall Study||0||
48177091|NCT02733042|100757555|FG009|COMPLETED|Overall Study||6||
48177092|NCT02733042|100757556|FG010|COMPLETED|Overall Study||4||
48177093|NCT02733042|100757557|FG011|COMPLETED|Overall Study||4||
48177094|NCT02733042|100757558|FG012|COMPLETED|Overall Study||1||
48177095|NCT02733042|100757559|FG013|COMPLETED|Overall Study||1||
48177096|NCT02733042|100757560|FG014|COMPLETED|Overall Study||0||
48177097|NCT02733042|100757561|FG015|COMPLETED|Overall Study||0||
48177098|NCT02733042|100757562|FG016|COMPLETED|Overall Study||0||
48177099|NCT02733042|100757563|FG017|COMPLETED|Overall Study||0||
48177100|NCT02733042|100757564|FG018|COMPLETED|Overall Study||1||
48177101|NCT02733042|100757546|FG000|NOT COMPLETED|Overall Study||3||
48177102|NCT02733042|100757547|FG001|NOT COMPLETED|Overall Study||2||
48177103|NCT02733042|100757548|FG002|NOT COMPLETED|Overall Study||7||
48177104|NCT02733042|100757549|FG003|NOT COMPLETED|Overall Study||3||
48177105|NCT02733042|100757550|FG004|NOT COMPLETED|Overall Study||3||
48177106|NCT02733042|100757551|FG005|NOT COMPLETED|Overall Study||3||
48177107|NCT02733042|100757552|FG006|NOT COMPLETED|Overall Study||1||
48177108|NCT02733042|100757553|FG007|NOT COMPLETED|Overall Study||3||
48177109|NCT02733042|100757554|FG008|NOT COMPLETED|Overall Study||5||
48177110|NCT02733042|100757555|FG009|NOT COMPLETED|Overall Study||4||
48177111|NCT02733042|100757556|FG010|NOT COMPLETED|Overall Study||6||
48177112|NCT02733042|100757557|FG011|NOT COMPLETED|Overall Study||6||
48177113|NCT02733042|100757558|FG012|NOT COMPLETED|Overall Study||9||
48177114|NCT02733042|100757559|FG013|NOT COMPLETED|Overall Study||4||
48177115|NCT02733042|100757560|FG014|NOT COMPLETED|Overall Study||5||
48177116|NCT02733042|100757561|FG015|NOT COMPLETED|Overall Study||10||
48177117|NCT02733042|100757562|FG016|NOT COMPLETED|Overall Study||2||
48177118|NCT02733042|100757563|FG017|NOT COMPLETED|Overall Study||5||
48177119|NCT02733042|100757564|FG018|NOT COMPLETED|Overall Study||4||
48177120|NCT03428815|100757565|FG000|STARTED|Overall Study||17||
48177121|NCT03428815|100757566|FG001|STARTED|Overall Study||19||
48177122|NCT03428815|100757565|FG000|COMPLETED|Overall Study||7||
48177123|NCT03428815|100757566|FG001|COMPLETED|Overall Study||14||
48177124|NCT03428815|100757565|FG000|NOT COMPLETED|Overall Study||10||
48177125|NCT03428815|100757566|FG001|NOT COMPLETED|Overall Study||5||
48177126|NCT00963989|100757567|FG000|STARTED|Overall Study||146||
48177127|NCT00963989|100757567|FG000|COMPLETED|Overall Study||127||
48177128|NCT00963989|100757567|FG000|NOT COMPLETED|Overall Study||19||
48177129|NCT01822353|100757568|FG000|STARTED|Overall Study||10||
48177130|NCT01822353|100757569|FG001|STARTED|Overall Study||9||
48177131|NCT01822353|100757570|FG002|STARTED|Overall Study||4||
48177132|NCT01822353|100757568|FG000|COMPLETED|Overall Study||6||
48177133|NCT01822353|100757569|FG001|COMPLETED|Overall Study||4||
48177134|NCT01822353|100757570|FG002|COMPLETED|Overall Study||3||
48177135|NCT01822353|100757568|FG000|NOT COMPLETED|Overall Study||4||
48177136|NCT01822353|100757569|FG001|NOT COMPLETED|Overall Study||5||
48177137|NCT01822353|100757570|FG002|NOT COMPLETED|Overall Study||1||
48177138|NCT00249249|100757571|FG000|STARTED|Overall Study||321||
48177139|NCT00249249|100757572|FG001|STARTED|Overall Study||103||
48177140|NCT00249249|100757573|FG002|STARTED|Overall Study||303||
48177141|NCT00249249|100757574|FG003|STARTED|Overall Study||103||
48177142|NCT00249249|100757571|FG000|Safety Population|Overall Study||316||
48177143|NCT00249249|100757572|FG001|Safety Population|Overall Study||102||
48177144|NCT00249249|100757573|FG002|Safety Population|Overall Study||300||
48177145|NCT00249249|100757574|FG003|Safety Population|Overall Study||103||
48177146|NCT00249249|100757571|FG000|COMPLETED|Overall Study||301||
48177147|NCT00249249|100757572|FG001|COMPLETED|Overall Study||98||
48177148|NCT00249249|100757573|FG002|COMPLETED|Overall Study||288||
48177149|NCT00249249|100757574|FG003|COMPLETED|Overall Study||100||
48177150|NCT00249249|100757571|FG000|NOT COMPLETED|Overall Study||20||
48177151|NCT00249249|100757572|FG001|NOT COMPLETED|Overall Study||5||
48177152|NCT00249249|100757573|FG002|NOT COMPLETED|Overall Study||15||
48177153|NCT00249249|100757574|FG003|NOT COMPLETED|Overall Study||3||
48177154|NCT00209274|100757575|FG000|STARTED|Overall Study||184||
48177155|NCT00209274|100757576|FG001|STARTED|Overall Study||95||
48177156|NCT00209274|100757575|FG000|COMPLETED|Overall Study||113||
48177157|NCT00209274|100757576|FG001|COMPLETED|Overall Study||48||
48177158|NCT00209274|100757575|FG000|NOT COMPLETED|Overall Study||71||
48177159|NCT00209274|100757576|FG001|NOT COMPLETED|Overall Study||47||
48177160|NCT01804816|100757577|FG000|STARTED|No Acupuncture (Initial 5 Weeks)||14||
48177161|NCT01804816|100757577|FG000|COMPLETED|No Acupuncture (Initial 5 Weeks)||11|Completed all study procedures.|
48177162|NCT01804816|100757577|FG000|NOT COMPLETED|No Acupuncture (Initial 5 Weeks)||3||
48177163|NCT01804816|100757577|FG000|STARTED|Acupuncture (Second 5 Weeks)||11||
48177164|NCT01804816|100757577|FG000|COMPLETED|Acupuncture (Second 5 Weeks)||10||
48177165|NCT01804816|100757577|FG000|NOT COMPLETED|Acupuncture (Second 5 Weeks)||1||
48177166|NCT03722264|100757578|FG000|STARTED|Overall Study||12||
48177167|NCT03722264|100757578|FG000|COMPLETED|Overall Study||9||
48177168|NCT03722264|100757578|FG000|NOT COMPLETED|Overall Study||3||
48177169|NCT01009047|100757579|FG000|STARTED|Overall Study||113||
48177170|NCT01009047|100757580|FG001|STARTED|Overall Study||115||
48177171|NCT01009047|100757579|FG000|COMPLETED|Overall Study||85||
48177172|NCT01009047|100757580|FG001|COMPLETED|Overall Study||89||
48177173|NCT01009047|100757579|FG000|NOT COMPLETED|Overall Study||28||
48177174|NCT01009047|100757580|FG001|NOT COMPLETED|Overall Study||26||
48177175|NCT01047475|100757581|FG000|STARTED|Overall Study||34||
48177176|NCT01047475|100757582|FG001|STARTED|Overall Study||38||
48177177|NCT01047475|100757581|FG000|COMPLETED|Overall Study||29||
48177178|NCT01047475|100757582|FG001|COMPLETED|Overall Study||31||
48177179|NCT01047475|100757581|FG000|NOT COMPLETED|Overall Study||5||
48177180|NCT01047475|100757582|FG001|NOT COMPLETED|Overall Study||7||
48177181|NCT01752413|100757583|FG000|STARTED|Overall Study||170||
48177182|NCT01752413|100757584|FG001|STARTED|Overall Study||27||
48177183|NCT01752413|100757583|FG000|COMPLETED|Overall Study||58||
48177184|NCT01752413|100757584|FG001|COMPLETED|Overall Study||6||
48177185|NCT01752413|100757583|FG000|NOT COMPLETED|Overall Study||112||
48177186|NCT01752413|100757584|FG001|NOT COMPLETED|Overall Study||21||
48177187|NCT02169895|100757585|FG000|STARTED|Overall Study||4||
48177188|NCT02169895|100757586|FG001|STARTED|Overall Study||4||
48177189|NCT02169895|100757587|FG002|STARTED|Overall Study||4||
48177190|NCT02169895|100757588|FG003|STARTED|Overall Study||4||
48177191|NCT02169895|100757585|FG000|25 mg BIA 9-1067|Overall Study||4||
48177192|NCT02169895|100757586|FG001|25 mg BIA 9-1067|Overall Study||4||
48177193|NCT02169895|100757587|FG002|25 mg BIA 9-1067|Overall Study||4||
48177194|NCT02169895|100757588|FG003|25 mg BIA 9-1067|Overall Study||4||
48177195|NCT02169895|100757585|FG000|50 mg BIA 9-1067|Overall Study||4||
48177196|NCT02169895|100757586|FG001|50 mg BIA 9-1067|Overall Study||4||
48177197|NCT02169895|100757587|FG002|50 mg BIA 9-1067|Overall Study||4||
48177198|NCT02169895|100757588|FG003|50 mg BIA 9-1067|Overall Study||4||
48177199|NCT02169895|100757585|FG000|100 mg BIA 9-1067|Overall Study||4||
48177200|NCT02169895|100757586|FG001|100 mg BIA 9-1067|Overall Study||4||
48177201|NCT02169895|100757587|FG002|100 mg BIA 9-1067|Overall Study||4||
48177202|NCT02169895|100757588|FG003|100 mg BIA 9-1067|Overall Study||2||
48177203|NCT02169895|100757585|FG000|Placebo|Overall Study||4||
48177204|NCT02169895|100757586|FG001|Placebo|Overall Study||4||
48177205|NCT02169895|100757587|FG002|Placebo|Overall Study||4||
48177206|NCT02169895|100757588|FG003|Placebo|Overall Study||4||
48177207|NCT02169895|100757585|FG000|COMPLETED|Overall Study||4||
48177208|NCT02169895|100757586|FG001|COMPLETED|Overall Study||4||
48177209|NCT02169895|100757587|FG002|COMPLETED|Overall Study||4||
48177210|NCT02169895|100757588|FG003|COMPLETED|Overall Study||2||
48177211|NCT02169895|100757585|FG000|NOT COMPLETED|Overall Study||0||
48177212|NCT02169895|100757586|FG001|NOT COMPLETED|Overall Study||0||
48631122|NCT02111083|101878717|FG000|COMPLETED|Third Intervention (1 Day)||19||
48631123|NCT02111083|101878718|FG001|COMPLETED|Third Intervention (1 Day)||19||
48177213|NCT02169895|100757587|FG002|NOT COMPLETED|Overall Study||0||
48177214|NCT02169895|100757588|FG003|NOT COMPLETED|Overall Study||2||
48177215|NCT02846558|100757589|FG000|STARTED|Overall Study||15||
48177216|NCT02846558|100757590|FG001|STARTED|Overall Study||12||
48177217|NCT02846558|100757591|FG002|STARTED|Overall Study||14||
48177218|NCT02846558|100757592|FG003|STARTED|Overall Study||13||
48177219|NCT02846558|100757589|FG000|Baseline Study Visit|Overall Study||10||
48177220|NCT02846558|100757590|FG001|Baseline Study Visit|Overall Study||9||
48337237|NCT02557178|101156397|FG001|NOT COMPLETED|Overall Study||11||
48631124|NCT02111083|101878717|FG000|NOT COMPLETED|Third Intervention (1 Day)||0||
48631125|NCT02111083|101878718|FG001|NOT COMPLETED|Third Intervention (1 Day)||0||
48631126|NCT02111083|101878717|FG000|STARTED|Interval Between Dosing (7-8 Days)||19||
48631127|NCT02111083|101878718|FG001|STARTED|Interval Between Dosing (7-8 Days)||19||
48631128|NCT02111083|101878717|FG000|COMPLETED|Interval Between Dosing (7-8 Days)||18||
48631129|NCT02111083|101878718|FG001|COMPLETED|Interval Between Dosing (7-8 Days)||18||
48631130|NCT02111083|101878717|FG000|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1||
48631131|NCT02111083|101878718|FG001|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1||
48631132|NCT02111083|101878717|FG000|STARTED|Fourth Intervention (1 Day)||18||
48631133|NCT02111083|101878718|FG001|STARTED|Fourth Intervention (1 Day)||18||
48753441|NCT03550118|102184494|FG002|NOT COMPLETED|Overall Study||2||
48753442|NCT03550118|102184495|FG003|NOT COMPLETED|Overall Study||1||
48753443|NCT03550118|102184496|FG004|NOT COMPLETED|Overall Study||1||
48753444|NCT03550118|102184497|FG005|NOT COMPLETED|Overall Study||2||
48753445|NCT03550118|102184498|FG006|NOT COMPLETED|Overall Study||0||
48753446|NCT03550118|102184499|FG007|NOT COMPLETED|Overall Study||6||
48753447|NCT02559622|102184500|FG000|STARTED|Overall Study||48||
48753448|NCT02559622|102184501|FG001|STARTED|Overall Study||54||
48753449|NCT02559622|102184502|FG002|STARTED|Overall Study||26||
48753450|NCT02559622|102184503|FG003|STARTED|Overall Study||23||
48753451|NCT02559622|102184500|FG000|COMPLETED|Overall Study||47||
48753452|NCT02559622|102184501|FG001|COMPLETED|Overall Study||49||
48753453|NCT02559622|102184502|FG002|COMPLETED|Overall Study||24||
48753454|NCT02559622|102184503|FG003|COMPLETED|Overall Study||20||
48753455|NCT02559622|102184500|FG000|NOT COMPLETED|Overall Study||1||
48753456|NCT02559622|102184501|FG001|NOT COMPLETED|Overall Study||5||
48753457|NCT02559622|102184502|FG002|NOT COMPLETED|Overall Study||2||
48177221|NCT02846558|100757591|FG002|Baseline Study Visit|Overall Study||14||
48177222|NCT02846558|100757592|FG003|Baseline Study Visit|Overall Study||12||
48177223|NCT02846558|100757589|FG000|3 Month Study Visit|Overall Study||7||
48177224|NCT02846558|100757590|FG001|3 Month Study Visit|Overall Study||8||
48177225|NCT02846558|100757591|FG002|3 Month Study Visit|Overall Study||12||
48177226|NCT02846558|100757592|FG003|3 Month Study Visit|Overall Study||11||
48177227|NCT02846558|100757589|FG000|COMPLETED|Overall Study||7||
48177228|NCT02846558|100757590|FG001|COMPLETED|Overall Study||8||
48177229|NCT02846558|100757591|FG002|COMPLETED|Overall Study||12||
48177230|NCT02846558|100757592|FG003|COMPLETED|Overall Study||11||
48337238|NCT03633084|101156398|FG000|STARTED|Overall Study||3||
48337239|NCT03633084|101156399|FG001|STARTED|Overall Study||3||
48337240|NCT03633084|101156400|FG002|STARTED|Overall Study||3||
48337241|NCT03633084|101156398|FG000|COMPLETED|Overall Study||3||
48631134|NCT02111083|101878717|FG000|COMPLETED|Fourth Intervention (1 Day)||18||
48631135|NCT02111083|101878718|FG001|COMPLETED|Fourth Intervention (1 Day)||18||
48631136|NCT02111083|101878717|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0||
48631137|NCT02111083|101878718|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0||
48631138|NCT01719653|101878719|FG000|STARTED|Overall Study||209||
48631139|NCT01719653|101878720|FG001|STARTED|Overall Study||213||
48631140|NCT01719653|101878721|FG002|STARTED|Overall Study||218||
48177231|NCT02846558|100757589|FG000|NOT COMPLETED|Overall Study||8||
48177232|NCT02846558|100757590|FG001|NOT COMPLETED|Overall Study||4||
48177233|NCT02846558|100757591|FG002|NOT COMPLETED|Overall Study||2||
48177234|NCT02846558|100757592|FG003|NOT COMPLETED|Overall Study||2||
48177235|NCT00050089|100757593|FG000|STARTED|Overall Study||106||
48337242|NCT03633084|101156399|FG001|COMPLETED|Overall Study||3||
48631141|NCT01719653|101878722|FG003|STARTED|Overall Study||218||
48337243|NCT03633084|101156400|FG002|COMPLETED|Overall Study||3||
48337244|NCT03633084|101156398|FG000|NOT COMPLETED|Overall Study||0||
48631142|NCT01719653|101878723|FG004|STARTED|Overall Study||221||
48631143|NCT01719653|101878719|FG000|COMPLETED|Overall Study||200||
48631144|NCT01719653|101878720|FG001|COMPLETED|Overall Study||200||
48631145|NCT01719653|101878721|FG002|COMPLETED|Overall Study||200||
48631146|NCT01719653|101878722|FG003|COMPLETED|Overall Study||200||
48631147|NCT01719653|101878723|FG004|COMPLETED|Overall Study||200||
48631148|NCT01719653|101878719|FG000|NOT COMPLETED|Overall Study||9||
48631149|NCT01719653|101878720|FG001|NOT COMPLETED|Overall Study||13||
48753458|NCT02559622|102184503|FG003|NOT COMPLETED|Overall Study||3||
48177236|NCT00050089|100757594|FG001|STARTED|Overall Study||98||
48177237|NCT00050089|100757595|FG002|STARTED|Overall Study||86||
48177238|NCT00050089|100757596|FG003|STARTED|Overall Study||78||
48177239|NCT00050089|100757593|FG000|Baseline|Overall Study||91||
48753459|NCT02648204|102184504|FG000|STARTED|Overall Study||301||
48337245|NCT03633084|101156399|FG001|NOT COMPLETED|Overall Study||0||
48631150|NCT01719653|101878721|FG002|NOT COMPLETED|Overall Study||18||
48631151|NCT01719653|101878722|FG003|NOT COMPLETED|Overall Study||18||
48631152|NCT01719653|101878723|FG004|NOT COMPLETED|Overall Study||21||
48631153|NCT00076570|101878724|FG000|STARTED|Overall Study||15||
48631154|NCT00076570|101878725|FG001|STARTED|Overall Study||16||
48631155|NCT00076570|101878724|FG000|COMPLETED|Overall Study||7||
48631156|NCT00076570|101878725|FG001|COMPLETED|Overall Study||8||
48631157|NCT00076570|101878724|FG000|NOT COMPLETED|Overall Study||8||
48631158|NCT00076570|101878725|FG001|NOT COMPLETED|Overall Study||8||
48631159|NCT00321763|101878726|FG000|STARTED|Overall Study||850||
48631160|NCT00321763|101878727|FG001|STARTED|Overall Study||850||
48631161|NCT00321763|101878728|FG002|STARTED|Overall Study||854||
48753460|NCT02648204|102184505|FG001|STARTED|Overall Study||300||
48753461|NCT02648204|102184506|FG002|STARTED|Overall Study||300||
48337246|NCT03633084|101156400|FG002|NOT COMPLETED|Overall Study||0||
48631162|NCT00321763|101878729|FG003|STARTED|Overall Study||570||
48631163|NCT00321763|101878726|FG000|COMPLETED|Overall Study||844||
48631164|NCT00321763|101878727|FG001|COMPLETED|Overall Study||848||
48631165|NCT00321763|101878728|FG002|COMPLETED|Overall Study||848||
48631166|NCT00321763|101878729|FG003|COMPLETED|Overall Study||565||
48631167|NCT00321763|101878726|FG000|NOT COMPLETED|Overall Study||6||
48631168|NCT00321763|101878727|FG001|NOT COMPLETED|Overall Study||2||
48753462|NCT02648204|102184507|FG003|STARTED|Overall Study||300||
48753463|NCT02648204|102184504|FG000|Exposed|Overall Study||301||
48753464|NCT02648204|102184505|FG001|Exposed|Overall Study||300||
48753465|NCT02648204|102184506|FG002|Exposed|Overall Study||299||
48337247|NCT03176316|101156401|FG000|STARTED|Overall Study||53||
48337248|NCT03176316|101156401|FG000|COMPLETED|Overall Study||53||
48177240|NCT00050089|100757594|FG001|Baseline|Overall Study||84||
48177241|NCT00050089|100757595|FG002|Baseline|Overall Study||86||
48337249|NCT03176316|101156401|FG000|NOT COMPLETED|Overall Study||0||
48337250|NCT00167245|101156402|FG000|STARTED|Overall Study||83||
48337251|NCT00167245|101156403|FG001|STARTED|Overall Study||87||
48337252|NCT00167245|101156402|FG000|COMPLETED|Overall Study||54||
48337253|NCT00167245|101156403|FG001|COMPLETED|Overall Study||46||
48337254|NCT00167245|101156402|FG000|NOT COMPLETED|Overall Study||29||
48337255|NCT00167245|101156403|FG001|NOT COMPLETED|Overall Study||41||
48337256|NCT03501966|101156404|FG000|STARTED|Overall Study||2||
48337257|NCT03501966|101156405|FG001|STARTED|Overall Study||2||
48337258|NCT03501966|101156406|FG002|STARTED|Overall Study||3||
48337259|NCT03501966|101156404|FG000|COMPLETED|Overall Study||0||
48337260|NCT03501966|101156405|FG001|COMPLETED|Overall Study||0||
48337261|NCT03501966|101156406|FG002|COMPLETED|Overall Study||0||
48337262|NCT03501966|101156404|FG000|NOT COMPLETED|Overall Study||2||
48753466|NCT02648204|102184507|FG003|Exposed|Overall Study||299||
48753467|NCT02648204|102184504|FG000|COMPLETED|Overall Study||279||
48753468|NCT02648204|102184505|FG001|COMPLETED|Overall Study||279||
48177242|NCT00050089|100757596|FG003|Baseline|Overall Study||78||
48177243|NCT00050089|100757593|FG000|COMPLETED|Overall Study||106||
48177244|NCT00050089|100757594|FG001|COMPLETED|Overall Study||98||
48337263|NCT03501966|101156405|FG001|NOT COMPLETED|Overall Study||2||
48337264|NCT03501966|101156406|FG002|NOT COMPLETED|Overall Study||3||
48337265|NCT00132041|101156407|FG000|STARTED|Baseline||51||
48337266|NCT00132041|101156407|FG000|Eligible|Baseline||45||
48337267|NCT00132041|101156407|FG000|COMPLETED|Baseline||45||
48337268|NCT00132041|101156407|FG000|NOT COMPLETED|Baseline||6||
48337269|NCT00132041|101156407|FG000|STARTED|3 Months Post Ablation||45||
48337270|NCT00132041|101156407|FG000|COMPLETED|3 Months Post Ablation||42||
48337271|NCT00132041|101156407|FG000|NOT COMPLETED|3 Months Post Ablation||3||
48337272|NCT00132041|101156407|FG000|STARTED|6 Months Post Ablation||42||
48337273|NCT00132041|101156407|FG000|COMPLETED|6 Months Post Ablation||32||
48337274|NCT00132041|101156407|FG000|NOT COMPLETED|6 Months Post Ablation||10||
48337275|NCT00132041|101156407|FG000|STARTED|9 Months Post Ablation||32||
48337276|NCT00132041|101156407|FG000|COMPLETED|9 Months Post Ablation||30||
48337277|NCT00132041|101156407|FG000|NOT COMPLETED|9 Months Post Ablation||2||
48337278|NCT00132041|101156407|FG000|STARTED|12 Months Post Ablation||30||
48337279|NCT00132041|101156407|FG000|COMPLETED|12 Months Post Ablation||26||
48337280|NCT00132041|101156407|FG000|NOT COMPLETED|12 Months Post Ablation||4||
48337281|NCT00132041|101156407|FG000|STARTED|15 Months Post Ablation||26||
48337282|NCT00132041|101156407|FG000|COMPLETED|15 Months Post Ablation||18||
48337283|NCT00132041|101156407|FG000|NOT COMPLETED|15 Months Post Ablation||8||
48631169|NCT00321763|101878728|FG002|NOT COMPLETED|Overall Study||6||
48631170|NCT00321763|101878729|FG003|NOT COMPLETED|Overall Study||5||
48631171|NCT01218308|101878730|FG000|STARTED|Overall Study||2584||
48631172|NCT01218308|101878731|FG001|STARTED|Overall Study||2584||
48631173|NCT01218308|101878730|FG000|COMPLETED|Overall Study||2481||
48631174|NCT01218308|101878731|FG001|COMPLETED|Overall Study||2464||
48631175|NCT01218308|101878730|FG000|NOT COMPLETED|Overall Study||103||
48177245|NCT00050089|100757595|FG002|COMPLETED|Overall Study||86||
48631176|NCT01218308|101878731|FG001|NOT COMPLETED|Overall Study||120||
48631177|NCT02701634|101881470|FG000|STARTED|Overall Study||33||
48631178|NCT02701634|101881471|FG001|STARTED|Overall Study||33||
48631179|NCT02701634|101881470|FG000|COMPLETED|Overall Study||1||
48753469|NCT02648204|102184506|FG002|COMPLETED|Overall Study||287||
48337284|NCT00132041|101156407|FG000|STARTED|18 Months Post Ablation||18||
48337285|NCT00132041|101156407|FG000|COMPLETED|18 Months Post Ablation||12||
48337286|NCT00132041|101156407|FG000|NOT COMPLETED|18 Months Post Ablation||6||
48337287|NCT02809833|101156408|FG000|STARTED|Overall Study||850||
48337288|NCT02809833|101156408|FG000|COMPLETED|Overall Study||550||
48337289|NCT02809833|101156408|FG000|NOT COMPLETED|Overall Study||300||
48337290|NCT04557384|101156409|FG000|STARTED|Overall Study||3||
48337291|NCT04557384|101156409|FG000|Received At Least 1 Dose of Study Drug|Overall Study||3||
48337292|NCT04557384|101156409|FG000|COMPLETED|Overall Study||1||
48337293|NCT04557384|101156409|FG000|NOT COMPLETED|Overall Study||2||
48337294|NCT02111564|101156410|FG000|STARTED|Overall Study||6007||
48337295|NCT02111564|101156411|FG001|STARTED|Overall Study||6012||
48337296|NCT02111564|101156410|FG000|Treated|Overall Study||5982||
48337297|NCT02111564|101156411|FG001|Treated|Overall Study||5980||
48337298|NCT02111564|101156410|FG000|COMPLETED|Overall Study||5876||
48337299|NCT02111564|101156411|FG001|COMPLETED|Overall Study||5869||
48337300|NCT02111564|101156410|FG000|NOT COMPLETED|Overall Study||131||
48337301|NCT02111564|101156411|FG001|NOT COMPLETED|Overall Study||143||
48337302|NCT00741819|101156412|FG000|STARTED|Overall Study||73||
48337303|NCT00741819|101156412|FG000|COMPLETED|Overall Study||65||
48337304|NCT00741819|101156412|FG000|NOT COMPLETED|Overall Study||8||
48337305|NCT02688647|101156413|FG000|STARTED|Initial Treatment Period (24 Weeks)||52||
48337306|NCT02688647|101156414|FG001|STARTED|Initial Treatment Period (24 Weeks)||24||
48337307|NCT02688647|101156413|FG000|Treated|Initial Treatment Period (24 Weeks)||51||
48337308|NCT02688647|101156414|FG001|Treated|Initial Treatment Period (24 Weeks)||24||
48337309|NCT02688647|101156413|FG000|COMPLETED|Initial Treatment Period (24 Weeks)||51||
48337310|NCT02688647|101156414|FG001|COMPLETED|Initial Treatment Period (24 Weeks)||18||
48337311|NCT02688647|101156413|FG000|NOT COMPLETED|Initial Treatment Period (24 Weeks)||1||
48337312|NCT02688647|101156414|FG001|NOT COMPLETED|Initial Treatment Period (24 Weeks)||6||
48337313|NCT02688647|101156413|FG000|STARTED|Post Switch Treatment Period (72 Weeks)||51||
48337314|NCT02688647|101156414|FG001|STARTED|Post Switch Treatment Period (72 Weeks)||17||
48337315|NCT02688647|101156413|FG000|COMPLETED|Post Switch Treatment Period (72 Weeks)||23||
48337316|NCT02688647|101156414|FG001|COMPLETED|Post Switch Treatment Period (72 Weeks)||3||
48337317|NCT02688647|101156413|FG000|NOT COMPLETED|Post Switch Treatment Period (72 Weeks)||28||
48337318|NCT02688647|101156414|FG001|NOT COMPLETED|Post Switch Treatment Period (72 Weeks)||14||
48337319|NCT02363478|101156415|FG000|STARTED|Overall Study||30||
48337320|NCT02363478|101156415|FG000|COMPLETED|Overall Study||22||
48337321|NCT02363478|101156415|FG000|NOT COMPLETED|Overall Study||8||
48337322|NCT00709956|101156416|FG000|STARTED|Overall Study||33||
48337323|NCT00709956|101156417|FG001|STARTED|Overall Study||37||
48337324|NCT00709956|101156416|FG000|Double-blind Crossover-period|Overall Study||31||
48337325|NCT00709956|101156417|FG001|Double-blind Crossover-period|Overall Study||33||
48337326|NCT00709956|101156416|FG000|COMPLETED|Overall Study||30||
48337327|NCT00709956|101156417|FG001|COMPLETED|Overall Study||33||
48337328|NCT00709956|101156416|FG000|NOT COMPLETED|Overall Study||3||
48337329|NCT00709956|101156417|FG001|NOT COMPLETED|Overall Study||4||
48337330|NCT02292771|101156418|FG000|STARTED|Overall Study||47||
48337331|NCT02292771|101156419|FG001|STARTED|Overall Study||50||
48337332|NCT02292771|101156418|FG000|COMPLETED|Overall Study||43||
48337333|NCT02292771|101156419|FG001|COMPLETED|Overall Study||48||
48337334|NCT02292771|101156418|FG000|NOT COMPLETED|Overall Study||4||
48337335|NCT02292771|101156419|FG001|NOT COMPLETED|Overall Study||2||
48337336|NCT03609619|101156420|FG000|STARTED|Overall Study||54||
48337337|NCT03609619|101156421|FG001|STARTED|Overall Study||55||
48337338|NCT03609619|101156420|FG000|COMPLETED|Overall Study||44||
48337339|NCT03609619|101156421|FG001|COMPLETED|Overall Study||49||
48337340|NCT03609619|101156420|FG000|NOT COMPLETED|Overall Study||10||
48337341|NCT03609619|101156421|FG001|NOT COMPLETED|Overall Study||6||
48337342|NCT00701714|101156422|FG000|STARTED|Treatment Period (up to 1 Year)||174||
48337343|NCT00701714|101156423|FG001|STARTED|Treatment Period (up to 1 Year)||163||
48337344|NCT00701714|101156422|FG000|COMPLETED|Treatment Period (up to 1 Year)||37||
48337345|NCT00701714|101156423|FG001|COMPLETED|Treatment Period (up to 1 Year)||29||
48337346|NCT00701714|101156422|FG000|NOT COMPLETED|Treatment Period (up to 1 Year)||137||
48337347|NCT00701714|101156423|FG001|NOT COMPLETED|Treatment Period (up to 1 Year)||134||
48337348|NCT00701714|101156422|FG000|STARTED|Safety Follow-up Period (6 Months)||151||
48337349|NCT00701714|101156423|FG001|STARTED|Safety Follow-up Period (6 Months)||119||
48337350|NCT00701714|101156422|FG000|COMPLETED|Safety Follow-up Period (6 Months)||144||
48337351|NCT00701714|101156423|FG001|COMPLETED|Safety Follow-up Period (6 Months)||112||
48337352|NCT00701714|101156422|FG000|NOT COMPLETED|Safety Follow-up Period (6 Months)||7||
48337353|NCT00701714|101156423|FG001|NOT COMPLETED|Safety Follow-up Period (6 Months)||7||
48337354|NCT02597855|101156424|FG000|STARTED|Overall Study||18||
48337355|NCT02597855|101156425|FG001|STARTED|Overall Study||14||
48337356|NCT02597855|101156424|FG000|COMPLETED|Overall Study||16||
48337357|NCT02597855|101156425|FG001|COMPLETED|Overall Study||13||
48337358|NCT02597855|101156424|FG000|NOT COMPLETED|Overall Study||2||
48337359|NCT02597855|101156425|FG001|NOT COMPLETED|Overall Study||1||
48337360|NCT04415073|101156426|FG000|STARTED|Overall Study||0||
48337361|NCT04415073|101156427|FG001|STARTED|Overall Study||0||
48337362|NCT04415073|101156426|FG000|COMPLETED|Overall Study||0||
48337363|NCT04415073|101156427|FG001|COMPLETED|Overall Study||0||
48337364|NCT04415073|101156426|FG000|NOT COMPLETED|Overall Study||0||
48337365|NCT04415073|101156427|FG001|NOT COMPLETED|Overall Study||0||
48337366|NCT00257010|101156428|FG000|STARTED|Overall Study||447||
48337367|NCT00257010|101156428|FG000|COMPLETED|Overall Study||319||
48337368|NCT00257010|101156428|FG000|NOT COMPLETED|Overall Study||128||
48337369|NCT03538743|101156429|FG000|STARTED|Overall Study||25||
48337370|NCT03538743|101156430|FG001|STARTED|Overall Study||9||
48337371|NCT03538743|101156431|FG002|STARTED|Overall Study||9||
48337372|NCT03538743|101156432|FG003|STARTED|Overall Study||10||
48337373|NCT03538743|101156433|FG004|STARTED|Overall Study||9||
48337374|NCT03538743|101156434|FG005|STARTED|Overall Study||9||
48337375|NCT03538743|101156435|FG006|STARTED|Overall Study||9||
48337376|NCT03538743|101156436|FG007|STARTED|Overall Study||8||
48337377|NCT03538743|101156437|FG008|STARTED|Overall Study||10||
48337378|NCT03538743|101156429|FG000|Received Treatment|Overall Study||25||
48337379|NCT03538743|101156430|FG001|Received Treatment|Overall Study||9||
48337380|NCT03538743|101156431|FG002|Received Treatment|Overall Study||9||
48337381|NCT03538743|101156432|FG003|Received Treatment|Overall Study||10||
48337382|NCT03538743|101156433|FG004|Received Treatment|Overall Study||9||
48337383|NCT03538743|101156434|FG005|Received Treatment|Overall Study||9||
48337384|NCT03538743|101156435|FG006|Received Treatment|Overall Study||9||
48337385|NCT03538743|101156436|FG007|Received Treatment|Overall Study||8||
48337386|NCT03538743|101156437|FG008|Received Treatment|Overall Study||10||
48337387|NCT03538743|101156429|FG000|COMPLETED|Overall Study||25||
48337388|NCT03538743|101156430|FG001|COMPLETED|Overall Study||9||
48337389|NCT03538743|101156431|FG002|COMPLETED|Overall Study||8||
48337390|NCT03538743|101156432|FG003|COMPLETED|Overall Study||8||
48337391|NCT03538743|101156433|FG004|COMPLETED|Overall Study||9||
48337392|NCT03538743|101156434|FG005|COMPLETED|Overall Study||9||
48337393|NCT03538743|101156435|FG006|COMPLETED|Overall Study||9||
48337394|NCT03538743|101156436|FG007|COMPLETED|Overall Study||8||
48337395|NCT03538743|101156437|FG008|COMPLETED|Overall Study||7||
48337396|NCT03538743|101156429|FG000|NOT COMPLETED|Overall Study||0||
48337397|NCT03538743|101156430|FG001|NOT COMPLETED|Overall Study||0||
48337398|NCT03538743|101156431|FG002|NOT COMPLETED|Overall Study||1||
48337399|NCT03538743|101156432|FG003|NOT COMPLETED|Overall Study||2||
48337400|NCT03538743|101156433|FG004|NOT COMPLETED|Overall Study||0||
48337401|NCT03538743|101156434|FG005|NOT COMPLETED|Overall Study||0||
48337402|NCT03538743|101156435|FG006|NOT COMPLETED|Overall Study||0||
48337403|NCT03538743|101156436|FG007|NOT COMPLETED|Overall Study||0||
48337404|NCT03538743|101156437|FG008|NOT COMPLETED|Overall Study||3||
48337405|NCT03446885|101156438|FG000|STARTED|Overall Study||12||
48337406|NCT03446885|101156439|FG001|STARTED|Overall Study||10||
48337407|NCT03446885|101156438|FG000|COMPLETED|Overall Study||10||
48337408|NCT03446885|101156439|FG001|COMPLETED|Overall Study||10||
48337409|NCT03446885|101156438|FG000|NOT COMPLETED|Overall Study||2||
48337410|NCT03446885|101156439|FG001|NOT COMPLETED|Overall Study||0||
48337411|NCT02894840|101156440|FG000|STARTED|Overall Study||20||
48337412|NCT02894840|101156441|FG001|STARTED|Overall Study||20||
48337413|NCT02894840|101156442|FG002|STARTED|Overall Study||200||
48337414|NCT02894840|101156443|FG003|STARTED|Overall Study||100||
48631180|NCT02701634|101881471|FG001|COMPLETED|Overall Study||2||
48337415|NCT02894840|101156440|FG000|COMPLETED|Overall Study||19||
48337416|NCT02894840|101156441|FG001|COMPLETED|Overall Study||20||
48337417|NCT02894840|101156442|FG002|COMPLETED|Overall Study||197||
48337418|NCT02894840|101156443|FG003|COMPLETED|Overall Study||100||
48337419|NCT02894840|101156440|FG000|NOT COMPLETED|Overall Study||1||
48337420|NCT02894840|101156441|FG001|NOT COMPLETED|Overall Study||0||
48337421|NCT02894840|101156442|FG002|NOT COMPLETED|Overall Study||3||
48337422|NCT02894840|101156443|FG003|NOT COMPLETED|Overall Study||0||
48337423|NCT04684420|101156444|FG000|STARTED|Treatment Period 1 (Day 1)||24||
48337424|NCT04684420|101156445|FG001|STARTED|Treatment Period 1 (Day 1)||24||
48337425|NCT04684420|101156446|FG002|STARTED|Treatment Period 1 (Day 1)||17||
48337426|NCT04684420|101156447|FG003|STARTED|Treatment Period 1 (Day 1)||16||
48337427|NCT04684420|101156444|FG000|COMPLETED|Treatment Period 1 (Day 1)||24||
48337428|NCT04684420|101156445|FG001|COMPLETED|Treatment Period 1 (Day 1)||23||
48337429|NCT04684420|101156446|FG002|COMPLETED|Treatment Period 1 (Day 1)||15||
48337430|NCT04684420|101156447|FG003|COMPLETED|Treatment Period 1 (Day 1)||15||
48337431|NCT04684420|101156444|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48337432|NCT04684420|101156445|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||1||
48337433|NCT04684420|101156446|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||2||
48337434|NCT04684420|101156447|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||1||
48337435|NCT04684420|101156444|FG000|STARTED|Period 2(Day 8 up to 3 Months)||24||
48337436|NCT04684420|101156445|FG001|STARTED|Period 2(Day 8 up to 3 Months)||23||
48337437|NCT04684420|101156446|FG002|STARTED|Period 2(Day 8 up to 3 Months)||15||
48337438|NCT04684420|101156447|FG003|STARTED|Period 2(Day 8 up to 3 Months)||15||
48337439|NCT04684420|101156444|FG000|COMPLETED|Period 2(Day 8 up to 3 Months)||24||
48337440|NCT04684420|101156445|FG001|COMPLETED|Period 2(Day 8 up to 3 Months)||23||
48337441|NCT04684420|101156446|FG002|COMPLETED|Period 2(Day 8 up to 3 Months)||15||
48337442|NCT04684420|101156447|FG003|COMPLETED|Period 2(Day 8 up to 3 Months)||15||
48337443|NCT04684420|101156444|FG000|NOT COMPLETED|Period 2(Day 8 up to 3 Months)||0||
48337444|NCT04684420|101156445|FG001|NOT COMPLETED|Period 2(Day 8 up to 3 Months)||0||
48337445|NCT04684420|101156446|FG002|NOT COMPLETED|Period 2(Day 8 up to 3 Months)||0||
48337446|NCT04684420|101156447|FG003|NOT COMPLETED|Period 2(Day 8 up to 3 Months)||0||
48337447|NCT01641120|101156448|FG000|STARTED|25 Gauge Needle Weeks 1, 4, 5||20||
48337448|NCT01641120|101156448|FG000|COMPLETED|25 Gauge Needle Weeks 1, 4, 5||20||
48337449|NCT01641120|101156448|FG000|NOT COMPLETED|25 Gauge Needle Weeks 1, 4, 5||0||
48337450|NCT01641120|101156448|FG000|STARTED|30 Gauge Needle Weeks 2 and 3||20||
48337451|NCT01641120|101156448|FG000|COMPLETED|30 Gauge Needle Weeks 2 and 3||20||
48337452|NCT01641120|101156448|FG000|NOT COMPLETED|30 Gauge Needle Weeks 2 and 3||0||
48337453|NCT03093155|101156449|FG000|STARTED|Overall Study||38||
48337454|NCT03093155|101156450|FG001|STARTED|Overall Study||40||
48337455|NCT03093155|101156449|FG000|Patients Completing Treatment|Overall Study||37||
48337456|NCT03093155|101156450|FG001|Patients Completing Treatment|Overall Study||39||
48337457|NCT03093155|101156449|FG000|Patients Requiring Dose Reduction|Overall Study||21||
48337458|NCT03093155|101156450|FG001|Patients Requiring Dose Reduction|Overall Study||25||
48337459|NCT03093155|101156449|FG000|COMPLETED|Overall Study||37||
48337460|NCT03093155|101156450|FG001|COMPLETED|Overall Study||39||
48337461|NCT03093155|101156449|FG000|NOT COMPLETED|Overall Study||1||
48337462|NCT03093155|101156450|FG001|NOT COMPLETED|Overall Study||1||
48337463|NCT03634800|101156451|FG000|STARTED|Overall Study||6||
48337464|NCT03634800|101156451|FG000|COMPLETED|Overall Study||0||
48337465|NCT03634800|101156451|FG000|NOT COMPLETED|Overall Study||6||
48337466|NCT02058147|101156452|FG000|STARTED|Overall Study||469||
48337467|NCT02058147|101156453|FG001|STARTED|Overall Study||467||
48337468|NCT02058147|101156454|FG002|STARTED|Overall Study||234||
48337469|NCT02058147|101156452|FG000|Treated|Overall Study||469||
48337470|NCT02058147|101156453|FG001|Treated|Overall Study||467||
48337471|NCT02058147|101156454|FG002|Treated|Overall Study||233||
48337472|NCT02058147|101156452|FG000|COMPLETED|Overall Study||440||
48337473|NCT02058147|101156453|FG001|COMPLETED|Overall Study||440||
48337474|NCT02058147|101156454|FG002|COMPLETED|Overall Study||205||
48337475|NCT02058147|101156452|FG000|NOT COMPLETED|Overall Study||29||
48337476|NCT02058147|101156453|FG001|NOT COMPLETED|Overall Study||27||
48337477|NCT02058147|101156454|FG002|NOT COMPLETED|Overall Study||29||
48337478|NCT00643994|101156455|FG000|STARTED|Overall Study||310|Received CyberKnife 36.25 Gy delivered in 5 fractions of 7.25 Gy per fraction|
48337479|NCT00643994|101156455|FG000|10-yr Follow up|Overall Study||69|optional extension per protocol amendment|
48337480|NCT00643994|101156455|FG000|COMPLETED|Overall Study||214|Completed required 5-year follow up|
48337481|NCT00643994|101156455|FG000|NOT COMPLETED|Overall Study||96||
48337482|NCT03543410|101156456|FG000|STARTED|Overall Study||113||
48337483|NCT03543410|101156457|FG001|STARTED|Overall Study||114||
48337484|NCT03543410|101156458|FG002|STARTED|Overall Study||114||
48337485|NCT03543410|101156456|FG000|COMPLETED|Overall Study||92||
48337486|NCT03543410|101156457|FG001|COMPLETED|Overall Study||101||
48337487|NCT03543410|101156458|FG002|COMPLETED|Overall Study||99||
48337488|NCT03543410|101156456|FG000|NOT COMPLETED|Overall Study||21||
48337489|NCT03543410|101156457|FG001|NOT COMPLETED|Overall Study||13||
48337490|NCT03543410|101156458|FG002|NOT COMPLETED|Overall Study||15||
48337491|NCT01725750|101156459|FG000|STARTED|Overall Study||44||
48337492|NCT01725750|101156460|FG001|STARTED|Overall Study||44||
48337493|NCT01725750|101156459|FG000|COMPLETED|Overall Study||42||
48337494|NCT01725750|101156460|FG001|COMPLETED|Overall Study||34||
48337495|NCT01725750|101156459|FG000|NOT COMPLETED|Overall Study||2||
48337496|NCT01725750|101156460|FG001|NOT COMPLETED|Overall Study||10||
48337497|NCT02796755|101156461|FG000|STARTED|Overall Study||15||
48337498|NCT02796755|101156462|FG001|STARTED|Overall Study||15||
48337499|NCT02796755|101156461|FG000|COMPLETED|Overall Study||13||
48337500|NCT02796755|101156462|FG001|COMPLETED|Overall Study||15||
48337501|NCT02796755|101156461|FG000|NOT COMPLETED|Overall Study||2||
48337502|NCT02796755|101156462|FG001|NOT COMPLETED|Overall Study||0||
48337503|NCT01671345|101156463|FG000|STARTED|Overall Study||77||
48337504|NCT01671345|101156464|FG001|STARTED|Overall Study||92||
48337505|NCT01671345|101156463|FG000|COMPLETED|Overall Study||64||
48337506|NCT01671345|101156464|FG001|COMPLETED|Overall Study||83||
48337507|NCT01671345|101156463|FG000|NOT COMPLETED|Overall Study||13||
48337508|NCT01671345|101156464|FG001|NOT COMPLETED|Overall Study||9||
48337509|NCT01651780|101156465|FG000|STARTED|Overall Study||405||
48337510|NCT01651780|101156466|FG001|STARTED|Overall Study||398||
48412955|NCT01914510|101345740|FG000|STARTED|Overall Study||40||
48412956|NCT01914510|101345740|FG000|COMPLETED|Overall Study||38||
48412957|NCT01914510|101345740|FG000|NOT COMPLETED|Overall Study||2||
48337511|NCT01651780|101156465|FG000|Intent-To-Treat (ITT) Population|Overall Study||404||
48412958|NCT01241318|101345741|FG000|STARTED|Overall Study||19629||
48412959|NCT01241318|101345742|FG001|STARTED|Overall Study||20050||
48412960|NCT01241318|101345741|FG000|Liveborn Infant|Overall Study||18510||
48412961|NCT01241318|101345742|FG001|Liveborn Infant|Overall Study||19346||
48337512|NCT01651780|101156466|FG001|Intent-To-Treat (ITT) Population|Overall Study||398||
48337513|NCT01651780|101156465|FG000|Received at Least 1 Dose of Study Drug|Overall Study||393||
48337514|NCT01651780|101156466|FG001|Received at Least 1 Dose of Study Drug|Overall Study||394||
48337515|NCT01651780|101156465|FG000|BRAVO 2 Feasibility Cohort|Overall Study||65||
48337516|NCT01651780|101156466|FG001|BRAVO 2 Feasibility Cohort|Overall Study||0||
48337517|NCT01651780|101156465|FG000|COMPLETED|Overall Study||394||
48337518|NCT01651780|101156466|FG001|COMPLETED|Overall Study||388||
48337519|NCT01651780|101156465|FG000|NOT COMPLETED|Overall Study||11||
48337520|NCT01651780|101156466|FG001|NOT COMPLETED|Overall Study||10||
48337521|NCT00809328|101156467|FG000|STARTED|Overall Study||102||
48337522|NCT00809328|101156467|FG000|COMPLETED|Overall Study||73||
48337523|NCT00809328|101156467|FG000|NOT COMPLETED|Overall Study||29||
48337524|NCT03902080|101156468|FG000|STARTED|Overall Study||551||
48337525|NCT03902080|101156469|FG001|STARTED|Overall Study||554||
48337526|NCT03902080|101156468|FG000|Received at Least 1 Dose of Double-blind Medication|Overall Study||551||
48337527|NCT03902080|101156469|FG001|Received at Least 1 Dose of Double-blind Medication|Overall Study||553||
48337528|NCT03902080|101156468|FG000|COMPLETED|Overall Study||484||
48337529|NCT03902080|101156469|FG001|COMPLETED|Overall Study||481||
48337530|NCT03902080|101156468|FG000|NOT COMPLETED|Overall Study||67||
48337531|NCT03902080|101156469|FG001|NOT COMPLETED|Overall Study||73||
48337532|NCT04167345|101156470|FG000|STARTED|Overall Study||10||
48337533|NCT04167345|101156471|FG001|STARTED|Overall Study||4||
48337534|NCT04167345|101156472|FG002|STARTED|Overall Study||3||
48337535|NCT04167345|101156473|FG003|STARTED|Overall Study||13||
48337536|NCT04167345|101156474|FG004|STARTED|Overall Study||18||
48337537|NCT04167345|101156470|FG000|COMPLETED|Overall Study||9||
48337538|NCT04167345|101156471|FG001|COMPLETED|Overall Study||3||
48337539|NCT04167345|101156472|FG002|COMPLETED|Overall Study||3||
48337540|NCT04167345|101156473|FG003|COMPLETED|Overall Study||13||
48337541|NCT04167345|101156474|FG004|COMPLETED|Overall Study||18||
48337542|NCT04167345|101156470|FG000|NOT COMPLETED|Overall Study||1||
48337543|NCT04167345|101156471|FG001|NOT COMPLETED|Overall Study||1||
48337544|NCT04167345|101156472|FG002|NOT COMPLETED|Overall Study||0||
48337545|NCT04167345|101156473|FG003|NOT COMPLETED|Overall Study||0||
48337546|NCT04167345|101156474|FG004|NOT COMPLETED|Overall Study||0||
48337547|NCT00630331|101156475|FG000|STARTED|Overall Study||3828||
48337548|NCT00630331|101156476|FG001|STARTED|Overall Study||3676||
48337549|NCT00630331|101156477|FG002|STARTED|Overall Study||3900||
48337550|NCT00630331|101156475|FG000|COMPLETED|Overall Study||3622||
48337551|NCT00630331|101156476|FG001|COMPLETED|Overall Study||3510||
48337552|NCT00630331|101156477|FG002|COMPLETED|Overall Study||3712||
48337553|NCT00630331|101156475|FG000|NOT COMPLETED|Overall Study||206||
48337554|NCT00630331|101156476|FG001|NOT COMPLETED|Overall Study||166||
48337555|NCT00630331|101156477|FG002|NOT COMPLETED|Overall Study||188||
48337556|NCT03828487|101156478|FG000|STARTED|Overall Study||8||
48337557|NCT03828487|101156478|FG000|COMPLETED|Overall Study||7||
48337558|NCT03828487|101156478|FG000|NOT COMPLETED|Overall Study||1||
48337559|NCT02554929|101156479|FG000|STARTED|Overall Study||46||
48337560|NCT02554929|101156480|FG001|STARTED|Overall Study||44||
48337561|NCT02554929|101156479|FG000|Per Protocol Received Intervention|Overall Study||44||
48337562|NCT02554929|101156480|FG001|Per Protocol Received Intervention|Overall Study||36||
48337563|NCT02554929|101156479|FG000|Per Protocol Post-Intervention|Overall Study||42||
48337564|NCT02554929|101156480|FG001|Per Protocol Post-Intervention|Overall Study||36||
48337565|NCT02554929|101156479|FG000|Per Protocol 6 Month Follow-up|Overall Study||40||
48337566|NCT02554929|101156480|FG001|Per Protocol 6 Month Follow-up|Overall Study||32||
48337567|NCT02554929|101156479|FG000|COMPLETED|Overall Study||40||
48337568|NCT02554929|101156480|FG001|COMPLETED|Overall Study||32||
48337569|NCT02554929|101156479|FG000|NOT COMPLETED|Overall Study||6||
48337570|NCT02554929|101156480|FG001|NOT COMPLETED|Overall Study||12||
48337571|NCT03313050|101156481|FG000|STARTED|Stage 1: 6 Months||34||
48337572|NCT03313050|101156482|FG001|STARTED|Stage 1: 6 Months||32||
48337573|NCT03313050|101156483|FG002|STARTED|Stage 1: 6 Months||0||
48337574|NCT03313050|101156484|FG003|STARTED|Stage 1: 6 Months||0||
48337575|NCT03313050|101156481|FG000|Vaccinated|Stage 1: 6 Months||34||
48337576|NCT03313050|101156482|FG001|Vaccinated|Stage 1: 6 Months||32||
48337577|NCT03313050|101156483|FG002|Vaccinated|Stage 1: 6 Months||0||
48337578|NCT03313050|101156484|FG003|Vaccinated|Stage 1: 6 Months||0||
48337579|NCT03313050|101156481|FG000|COMPLETED|Stage 1: 6 Months||34||
48337580|NCT03313050|101156482|FG001|COMPLETED|Stage 1: 6 Months||32||
48337581|NCT03313050|101156483|FG002|COMPLETED|Stage 1: 6 Months||0||
48337582|NCT03313050|101156484|FG003|COMPLETED|Stage 1: 6 Months||0||
48337583|NCT03313050|101156481|FG000|NOT COMPLETED|Stage 1: 6 Months||0||
48337584|NCT03313050|101156482|FG001|NOT COMPLETED|Stage 1: 6 Months||0||
48337585|NCT03313050|101156483|FG002|NOT COMPLETED|Stage 1: 6 Months||0||
48337586|NCT03313050|101156484|FG003|NOT COMPLETED|Stage 1: 6 Months||0||
48337587|NCT03313050|101156481|FG000|STARTED|Stage 2: 12 Months||0||
48337588|NCT03313050|101156482|FG001|STARTED|Stage 2: 12 Months||0||
48337589|NCT03313050|101156483|FG002|STARTED|Stage 2: 12 Months||221||
48337590|NCT03313050|101156484|FG003|STARTED|Stage 2: 12 Months||224||
48337591|NCT03313050|101156481|FG000|Vaccinated|Stage 2: 12 Months||0||
48337592|NCT03313050|101156482|FG001|Vaccinated|Stage 2: 12 Months||0||
48412962|NCT01241318|101345741|FG000|COMPLETED|Overall Study||18450||
48337593|NCT03313050|101156483|FG002|Vaccinated|Stage 2: 12 Months||221||
48337594|NCT03313050|101156484|FG003|Vaccinated|Stage 2: 12 Months||223||
48337595|NCT03313050|101156481|FG000|COMPLETED|Stage 2: 12 Months||0||
48337596|NCT03313050|101156482|FG001|COMPLETED|Stage 2: 12 Months||0||
48337597|NCT03313050|101156483|FG002|COMPLETED|Stage 2: 12 Months||210||
48337598|NCT03313050|101156484|FG003|COMPLETED|Stage 2: 12 Months||204||
48337599|NCT03313050|101156481|FG000|NOT COMPLETED|Stage 2: 12 Months||0||
48337600|NCT03313050|101156482|FG001|NOT COMPLETED|Stage 2: 12 Months||0||
48337601|NCT03313050|101156483|FG002|NOT COMPLETED|Stage 2: 12 Months||11||
48337602|NCT03313050|101156484|FG003|NOT COMPLETED|Stage 2: 12 Months||20||
48337603|NCT02690194|101156485|FG000|STARTED|Overall Study||17||
48337604|NCT02690194|101156486|FG001|STARTED|Overall Study||18||
48337605|NCT02690194|101156487|FG002|STARTED|Overall Study||19||
48337606|NCT02690194|101156485|FG000|COMPLETED|Overall Study||16||
48337607|NCT02690194|101156486|FG001|COMPLETED|Overall Study||14||
48337608|NCT02690194|101156487|FG002|COMPLETED|Overall Study||19||
48337609|NCT02690194|101156485|FG000|NOT COMPLETED|Overall Study||1||
48337610|NCT02690194|101156486|FG001|NOT COMPLETED|Overall Study||4||
48337611|NCT02690194|101156487|FG002|NOT COMPLETED|Overall Study||0||
48337612|NCT04276207|101156488|FG000|STARTED|Period 1||15||
48337613|NCT04276207|101156489|FG001|STARTED|Period 1||17||
48337614|NCT04276207|101156488|FG000|Received at Least One Dose of Study Drug|Period 1||15||
48337615|NCT04276207|101156489|FG001|Received at Least One Dose of Study Drug|Period 1||17||
48337616|NCT04276207|101156488|FG000|COMPLETED|Period 1||15||
48337617|NCT04276207|101156489|FG001|COMPLETED|Period 1||16||
48337618|NCT04276207|101156488|FG000|NOT COMPLETED|Period 1||0||
48337619|NCT04276207|101156489|FG001|NOT COMPLETED|Period 1||1||
48337620|NCT04276207|101156488|FG000|STARTED|Washout (3- 14 Days)||15||
48337621|NCT04276207|101156489|FG001|STARTED|Washout (3- 14 Days)||16||
48337622|NCT04276207|101156488|FG000|COMPLETED|Washout (3- 14 Days)||15||
48337623|NCT04276207|101156489|FG001|COMPLETED|Washout (3- 14 Days)||16||
48337624|NCT04276207|101156488|FG000|NOT COMPLETED|Washout (3- 14 Days)||0||
48337625|NCT04276207|101156489|FG001|NOT COMPLETED|Washout (3- 14 Days)||0||
48337626|NCT04276207|101156488|FG000|STARTED|Period 2||15||
48337627|NCT04276207|101156489|FG001|STARTED|Period 2||16||
48337628|NCT04276207|101156488|FG000|COMPLETED|Period 2||15||
48337629|NCT04276207|101156489|FG001|COMPLETED|Period 2||16||
48337630|NCT04276207|101156488|FG000|NOT COMPLETED|Period 2||0||
48337631|NCT04276207|101156489|FG001|NOT COMPLETED|Period 2||0||
48337632|NCT00374244|101156490|FG000|STARTED|Overall Study||14||
48337633|NCT00374244|101156491|FG001|STARTED|Overall Study||14||
48337634|NCT00374244|101156490|FG000|COMPLETED|Overall Study||14||
48337635|NCT00374244|101156491|FG001|COMPLETED|Overall Study||14||
48337636|NCT00374244|101156490|FG000|NOT COMPLETED|Overall Study||0||
48337637|NCT00374244|101156491|FG001|NOT COMPLETED|Overall Study||0||
48337638|NCT00706030|101156492|FG000|STARTED|Overall Study||6||
48337639|NCT00706030|101156493|FG001|STARTED|Overall Study||6||
48337640|NCT00706030|101156494|FG002|STARTED|Overall Study||64||
48337641|NCT00706030|101156495|FG003|STARTED|Overall Study||16||
48337642|NCT00706030|101156492|FG000|Treated|Overall Study||6||
48337643|NCT00706030|101156493|FG001|Treated|Overall Study||6||
48337644|NCT00706030|101156494|FG002|Treated|Overall Study||64||
48337645|NCT00706030|101156495|FG003|Treated|Overall Study||15||
48337646|NCT00706030|101156492|FG000|COMPLETED|Overall Study||0||
48337647|NCT00706030|101156493|FG001|COMPLETED|Overall Study||0||
48337648|NCT00706030|101156494|FG002|COMPLETED|Overall Study||4||
48337649|NCT00706030|101156495|FG003|COMPLETED|Overall Study||0||
48337650|NCT00706030|101156492|FG000|NOT COMPLETED|Overall Study||6||
48337651|NCT00706030|101156493|FG001|NOT COMPLETED|Overall Study||6||
48337652|NCT00706030|101156494|FG002|NOT COMPLETED|Overall Study||60||
48337653|NCT00706030|101156495|FG003|NOT COMPLETED|Overall Study||16||
48337654|NCT01275222|101156496|FG000|STARTED|Phase l by Treatment||13||
48337655|NCT01275222|101156497|FG001|STARTED|Phase l by Treatment||13||
48337656|NCT01275222|101156498|FG002|STARTED|Phase l by Treatment||5||
48337657|NCT01275222|101156499|FG003|STARTED|Phase l by Treatment||11||
48337658|NCT01275222|101156500|FG004|STARTED|Phase l by Treatment||0||
48337659|NCT01275222|101156501|FG005|STARTED|Phase l by Treatment||0||
48337660|NCT01275222|101156496|FG000|COMPLETED|Phase l by Treatment||0||
48337661|NCT01275222|101156497|FG001|COMPLETED|Phase l by Treatment||0||
48337662|NCT01275222|101156498|FG002|COMPLETED|Phase l by Treatment||0||
48337663|NCT01275222|101156499|FG003|COMPLETED|Phase l by Treatment||0||
48337664|NCT01275222|101156500|FG004|COMPLETED|Phase l by Treatment||0||
48337665|NCT01275222|101156501|FG005|COMPLETED|Phase l by Treatment||0||
48337666|NCT01275222|101156496|FG000|NOT COMPLETED|Phase l by Treatment||13||
48337667|NCT01275222|101156497|FG001|NOT COMPLETED|Phase l by Treatment||13||
48337668|NCT01275222|101156498|FG002|NOT COMPLETED|Phase l by Treatment||5||
48337669|NCT01275222|101156499|FG003|NOT COMPLETED|Phase l by Treatment||11||
48337670|NCT01275222|101156500|FG004|NOT COMPLETED|Phase l by Treatment||0||
48337671|NCT01275222|101156501|FG005|NOT COMPLETED|Phase l by Treatment||0||
48337672|NCT01275222|101156496|FG000|STARTED|Phase ll by Stratum||0||
48337673|NCT01275222|101156497|FG001|STARTED|Phase ll by Stratum||0||
48412963|NCT01241318|101345742|FG001|COMPLETED|Overall Study||19308||
48337674|NCT01275222|101156498|FG002|STARTED|Phase ll by Stratum||0||
48337675|NCT01275222|101156499|FG003|STARTED|Phase ll by Stratum||0||
48337676|NCT01275222|101156500|FG004|STARTED|Phase ll by Stratum||28||
48337677|NCT01275222|101156501|FG005|STARTED|Phase ll by Stratum||47||
48337678|NCT01275222|101156496|FG000|COMPLETED|Phase ll by Stratum||0||
48337679|NCT01275222|101156497|FG001|COMPLETED|Phase ll by Stratum||0||
48337680|NCT01275222|101156498|FG002|COMPLETED|Phase ll by Stratum||0||
48337681|NCT01275222|101156499|FG003|COMPLETED|Phase ll by Stratum||0||
48337682|NCT01275222|101156500|FG004|COMPLETED|Phase ll by Stratum||0||
48337683|NCT01275222|101156501|FG005|COMPLETED|Phase ll by Stratum||1||
48337684|NCT01275222|101156496|FG000|NOT COMPLETED|Phase ll by Stratum||0||
48337685|NCT01275222|101156497|FG001|NOT COMPLETED|Phase ll by Stratum||0||
48337686|NCT01275222|101156498|FG002|NOT COMPLETED|Phase ll by Stratum||0||
48337687|NCT01275222|101156499|FG003|NOT COMPLETED|Phase ll by Stratum||0||
48337688|NCT01275222|101156500|FG004|NOT COMPLETED|Phase ll by Stratum||28||
48337689|NCT01275222|101156501|FG005|NOT COMPLETED|Phase ll by Stratum||46||
48337690|NCT00578643|101156502|FG000|STARTED|Overall Study||15||
48337691|NCT00578643|101156502|FG000|COMPLETED|Overall Study||13||
48337692|NCT00578643|101156502|FG000|NOT COMPLETED|Overall Study||2||
48337693|NCT01946516|101156503|FG000|STARTED|Overall Study||3051||
48337694|NCT01946516|101156503|FG000|Evaluated for HBV Status|Overall Study||3050||
48337695|NCT01946516|101156503|FG000|Evaluated for HCV Status|Overall Study||2990||
48337696|NCT01946516|101156503|FG000|Evaluated for HIV Status|Overall Study||3045||
48337697|NCT01946516|101156503|FG000|COMPLETED|Overall Study||3051||
48337698|NCT01946516|101156503|FG000|NOT COMPLETED|Overall Study||0||
48337699|NCT03603652|101156504|FG000|STARTED|Overall Study||10||
48337700|NCT03603652|101156504|FG000|COMPLETED|Overall Study||8||
48337701|NCT03603652|101156504|FG000|NOT COMPLETED|Overall Study||2||
48337702|NCT00331006|101156505|FG000|STARTED|Screening Phase||23||
48337703|NCT00331006|101156505|FG000|COMPLETED|Screening Phase||16||
48337704|NCT00331006|101156505|FG000|NOT COMPLETED|Screening Phase||7||
48337705|NCT00331006|101156505|FG000|STARTED|Treatment Phase||16||
48337706|NCT00331006|101156505|FG000|COMPLETED|Treatment Phase||15||
48337707|NCT00331006|101156505|FG000|NOT COMPLETED|Treatment Phase||1||
48337708|NCT00331006|101156505|FG000|STARTED|Follow-Up Phase I||15||
48337709|NCT00331006|101156505|FG000|COMPLETED|Follow-Up Phase I||14||
48337710|NCT00331006|101156505|FG000|NOT COMPLETED|Follow-Up Phase I||1||
48337711|NCT00331006|101156505|FG000|STARTED|Follow-Up Phase II||14||
48337712|NCT00331006|101156505|FG000|COMPLETED|Follow-Up Phase II||11||
48337713|NCT00331006|101156505|FG000|NOT COMPLETED|Follow-Up Phase II||3||
48337714|NCT01087541|101156506|FG000|STARTED|Overall Study||3307||
48337715|NCT01087541|101156507|FG001|STARTED|Overall Study||3523||
48337716|NCT01087541|101156506|FG000|COMPLETED|Overall Study||3307||
48337717|NCT01087541|101156507|FG001|COMPLETED|Overall Study||3523||
48337718|NCT01087541|101156506|FG000|NOT COMPLETED|Overall Study||0||
48337719|NCT01087541|101156507|FG001|NOT COMPLETED|Overall Study||0||
48337720|NCT04162210|101156508|FG000|STARTED|Overall Study||218|Intent-to Treat (ITT) population included all randomized participants whether or not randomized treatment was administered.|
48337721|NCT04162210|101156509|FG001|STARTED|Overall Study||107|Intent-to Treat (ITT) population included all randomized participants whether or not randomized treatment was administered.|
48337722|NCT04162210|101156508|FG000|Safety Population|Overall Study||217|All randomized participants who took at least 1 dose of study intervention.|
48337723|NCT04162210|101156509|FG001|Safety Population|Overall Study||102|All randomized participants who took at least 1 dose of study intervention.|
48337724|NCT04162210|101156508|FG000|COMPLETED|Overall Study||84||
48337725|NCT04162210|101156509|FG001|COMPLETED|Overall Study||38||
48337726|NCT04162210|101156508|FG000|NOT COMPLETED|Overall Study||134||
48337727|NCT04162210|101156509|FG001|NOT COMPLETED|Overall Study||69||
48337728|NCT00946309|101156510|FG000|STARTED|Overall Study||22||
48337729|NCT00946309|101156511|FG001|STARTED|Overall Study||23||
48337730|NCT00946309|101156510|FG000|COMPLETED|Overall Study||21||
48337731|NCT00946309|101156511|FG001|COMPLETED|Overall Study||19||
48337732|NCT00946309|101156510|FG000|NOT COMPLETED|Overall Study||1||
48337733|NCT00946309|101156511|FG001|NOT COMPLETED|Overall Study||4||
48753470|NCT02648204|102184507|FG003|COMPLETED|Overall Study||284||
48753471|NCT02648204|102184504|FG000|NOT COMPLETED|Overall Study||22||
48753472|NCT02648204|102184505|FG001|NOT COMPLETED|Overall Study||21||
48753473|NCT02648204|102184506|FG002|NOT COMPLETED|Overall Study||13||
48753474|NCT02648204|102184507|FG003|NOT COMPLETED|Overall Study||16||
48337734|NCT02720757|101156512|FG000|STARTED|Overall Study||132||
48337735|NCT02720757|101156512|FG000|COMPLETED|Overall Study||114||
48337736|NCT02720757|101156512|FG000|NOT COMPLETED|Overall Study||18||
48337737|NCT03881007|101156513|FG000|STARTED|First 3 Months||172||
48337738|NCT03881007|101156514|FG001|STARTED|First 3 Months||171||
48337739|NCT03881007|101156513|FG000|COMPLETED|First 3 Months||121||
48337740|NCT03881007|101156514|FG001|COMPLETED|First 3 Months||119||
48337741|NCT03881007|101156513|FG000|NOT COMPLETED|First 3 Months||51||
48337742|NCT03881007|101156514|FG001|NOT COMPLETED|First 3 Months||52||
48337743|NCT03881007|101156513|FG000|STARTED|Last 3 Months||121||
48337744|NCT03881007|101156514|FG001|STARTED|Last 3 Months||119||
48337745|NCT03881007|101156513|FG000|COMPLETED|Last 3 Months||77||
48337746|NCT03881007|101156514|FG001|COMPLETED|Last 3 Months||74||
48337747|NCT03881007|101156513|FG000|NOT COMPLETED|Last 3 Months||44||
48337748|NCT03881007|101156514|FG001|NOT COMPLETED|Last 3 Months||45||
48337749|NCT01214044|101156515|FG000|STARTED|Visit 1: Screening and Consent, Washout||31||
48337750|NCT01214044|101156515|FG000|COMPLETED|Visit 1: Screening and Consent, Washout||19||
48753475|NCT05135871|102184508|FG000|STARTED|Overall Study||13||
48753476|NCT05135871|102184509|FG001|STARTED|Overall Study||12||
48412964|NCT01241318|101345741|FG000|NOT COMPLETED|Overall Study||1179||
48753477|NCT05135871|102184510|FG002|STARTED|Overall Study||12||
48337751|NCT01214044|101156515|FG000|NOT COMPLETED|Visit 1: Screening and Consent, Washout||12||
48337752|NCT01214044|101156515|FG000|STARTED|Visit 2: End Washout & Start Placebo||19||
48337753|NCT01214044|101156515|FG000|COMPLETED|Visit 2: End Washout & Start Placebo||17||
48337754|NCT01214044|101156515|FG000|NOT COMPLETED|Visit 2: End Washout & Start Placebo||2||
48337755|NCT01214044|101156515|FG000|STARTED|Visits 3-5: Escitalopram 10 mg Daily||17||
48337756|NCT01214044|101156515|FG000|COMPLETED|Visits 3-5: Escitalopram 10 mg Daily||14||
48337757|NCT01214044|101156515|FG000|NOT COMPLETED|Visits 3-5: Escitalopram 10 mg Daily||3||
48337758|NCT01214044|101156515|FG000|STARTED|Visits 6-11: Escitalopram 20 mg Daily||14||
48337759|NCT01214044|101156515|FG000|COMPLETED|Visits 6-11: Escitalopram 20 mg Daily||10||
48337760|NCT01214044|101156515|FG000|NOT COMPLETED|Visits 6-11: Escitalopram 20 mg Daily||4||
48337761|NCT00713219|101156516|FG000|STARTED|Overall Study||14||
48337762|NCT00713219|101156516|FG000|COMPLETED|Overall Study||12||
48337763|NCT00713219|101156516|FG000|NOT COMPLETED|Overall Study||2||
48337764|NCT02549716|101156517|FG000|STARTED|Overall Study||1||
48337765|NCT02549716|101156518|FG001|STARTED|Overall Study||2||
48337766|NCT02549716|101156517|FG000|COMPLETED|Overall Study||1||
48337767|NCT02549716|101156518|FG001|COMPLETED|Overall Study||2||
48337768|NCT02549716|101156517|FG000|NOT COMPLETED|Overall Study||0||
48337769|NCT02549716|101156518|FG001|NOT COMPLETED|Overall Study||0||
48337770|NCT02932787|101156519|FG000|STARTED|Overall Study||22||
48337771|NCT02932787|101156520|FG001|STARTED|Overall Study||9||
48337772|NCT02932787|101156519|FG000|COMPLETED|Overall Study||22||
48337773|NCT02932787|101156520|FG001|COMPLETED|Overall Study||9||
48337774|NCT02932787|101156519|FG000|NOT COMPLETED|Overall Study||0||
48412965|NCT01241318|101345742|FG001|NOT COMPLETED|Overall Study||742||
48753478|NCT05135871|102184511|FG003|STARTED|Overall Study||8||
48753479|NCT05135871|102184508|FG000|COMPLETED|Overall Study||12||
48753480|NCT05135871|102184509|FG001|COMPLETED|Overall Study||12||
48753481|NCT05135871|102184510|FG002|COMPLETED|Overall Study||12||
48753482|NCT05135871|102184511|FG003|COMPLETED|Overall Study||8||
48753483|NCT05135871|102184508|FG000|NOT COMPLETED|Overall Study||1||
48753484|NCT05135871|102184509|FG001|NOT COMPLETED|Overall Study||0||
48753485|NCT05135871|102184510|FG002|NOT COMPLETED|Overall Study||0||
48753486|NCT05135871|102184511|FG003|NOT COMPLETED|Overall Study||0||
48753487|NCT00001959|102184512|FG000|STARTED|Overall Study||21||
48753488|NCT00001959|102184512|FG000|COMPLETED|Overall Study||18||
48753489|NCT00001959|102184512|FG000|NOT COMPLETED|Overall Study||3||
48753490|NCT04233008|102184513|FG000|STARTED|Overall Study||89||
48753491|NCT04233008|102184514|FG001|STARTED|Overall Study||89||
48753492|NCT04233008|102184513|FG000|COMPLETED|Overall Study||89||
48753493|NCT04233008|102184514|FG001|COMPLETED|Overall Study||89||
48753494|NCT04233008|102184513|FG000|NOT COMPLETED|Overall Study||0||
48753495|NCT04233008|102184514|FG001|NOT COMPLETED|Overall Study||0||
48753496|NCT00231777|102184515|FG000|STARTED|Overall Study||170||
48753497|NCT00231777|102184516|FG001|STARTED|Overall Study||46||
48753498|NCT00231777|102184515|FG000|COMPLETED|Overall Study||164||
48753499|NCT00231777|102184516|FG001|COMPLETED|Overall Study||44||
48753500|NCT00231777|102184515|FG000|NOT COMPLETED|Overall Study||6||
48753501|NCT00231777|102184516|FG001|NOT COMPLETED|Overall Study||2||
48753502|NCT02240485|102184517|FG000|STARTED|3 Months Post-admission||44||
48753503|NCT02240485|102184518|FG001|STARTED|3 Months Post-admission||36||
48753504|NCT02240485|102184517|FG000|COMPLETED|3 Months Post-admission||41||
48753505|NCT02240485|102184518|FG001|COMPLETED|3 Months Post-admission||30||
48753506|NCT02240485|102184517|FG000|NOT COMPLETED|3 Months Post-admission||3||
48753507|NCT02240485|102184518|FG001|NOT COMPLETED|3 Months Post-admission||6||
48753508|NCT02240485|102184517|FG000|STARTED|9 Months Post-admission||41||
48753509|NCT02240485|102184518|FG001|STARTED|9 Months Post-admission||30||
48753510|NCT02240485|102184517|FG000|COMPLETED|9 Months Post-admission||38||
48753511|NCT02240485|102184518|FG001|COMPLETED|9 Months Post-admission||26||
48753512|NCT02240485|102184517|FG000|NOT COMPLETED|9 Months Post-admission||3||
48337775|NCT02932787|101156520|FG001|NOT COMPLETED|Overall Study||0||
48337776|NCT01656772|101156521|FG000|STARTED|Overall Study||43||
48337777|NCT01656772|101156522|FG001|STARTED|Overall Study||77||
48337778|NCT01656772|101156521|FG000|COMPLETED|Overall Study||43||
48337779|NCT01656772|101156522|FG001|COMPLETED|Overall Study||77||
48337780|NCT01656772|101156521|FG000|NOT COMPLETED|Overall Study||0||
48337781|NCT01656772|101156522|FG001|NOT COMPLETED|Overall Study||0||
48337782|NCT00705263|101156523|FG000|STARTED|Overall Study||110||
48337783|NCT00705263|101156523|FG000|COMPLETED|Overall Study||108||
48337784|NCT00705263|101156523|FG000|NOT COMPLETED|Overall Study||2||
48337785|NCT00332709|101156524|FG000|STARTED|Overall Study||40||
48337786|NCT00332709|101156525|FG001|STARTED|Overall Study||41||
48337787|NCT00332709|101156524|FG000|COMPLETED|Overall Study||24||
48412966|NCT02531633|101345743|FG000|STARTED|Part A (52 Weeks)||42||
48753513|NCT02240485|102184518|FG001|NOT COMPLETED|9 Months Post-admission||4||
48753514|NCT02240485|102184517|FG000|STARTED|18 Months Post-admission||38||
48753515|NCT02240485|102184518|FG001|STARTED|18 Months Post-admission||26||
48753516|NCT02240485|102184517|FG000|COMPLETED|18 Months Post-admission||35||
48753517|NCT02240485|102184518|FG001|COMPLETED|18 Months Post-admission||21||
48753518|NCT02240485|102184517|FG000|NOT COMPLETED|18 Months Post-admission||3||
48753519|NCT02240485|102184518|FG001|NOT COMPLETED|18 Months Post-admission||5||
48753520|NCT00112736|102184519|FG000|STARTED|Overall Study||22||
48753521|NCT00112736|102184520|FG001|STARTED|Overall Study||47||
48753522|NCT00112736|102184519|FG000|COMPLETED|Overall Study||21||
48753523|NCT00112736|102184520|FG001|COMPLETED|Overall Study||47||
48753524|NCT00112736|102184519|FG000|NOT COMPLETED|Overall Study||1||
48753525|NCT00112736|102184520|FG001|NOT COMPLETED|Overall Study||0||
48753526|NCT02467179|102184521|FG000|STARTED|Overall Study||25||
48753527|NCT02467179|102184522|FG001|STARTED|Overall Study||25||
48753528|NCT02467179|102184521|FG000|COMPLETED|Overall Study||25||
48753529|NCT02467179|102184522|FG001|COMPLETED|Overall Study||25||
48753530|NCT02467179|102184521|FG000|NOT COMPLETED|Overall Study||0||
48753531|NCT02467179|102184522|FG001|NOT COMPLETED|Overall Study||0||
48753532|NCT02952365|102184523|FG000|STARTED|Overall Study||2||2
48753533|NCT02952365|102184523|FG000|COMPLETED|Overall Study||2||2
48753534|NCT02952365|102184523|FG000|NOT COMPLETED|Overall Study||0||0
48753535|NCT03557970|102184524|FG000|STARTED|Overall Study||1||
48412967|NCT02531633|101345744|FG001|STARTED|Part A (52 Weeks)||39||
48412968|NCT02531633|101345745|FG002|STARTED|Part A (52 Weeks)||26||
48412969|NCT02531633|101345746|FG003|STARTED|Part A (52 Weeks)||27||
48412970|NCT02531633|101345747|FG004|STARTED|Part A (52 Weeks)||27||
48412971|NCT02531633|101345748|FG005|STARTED|Part A (52 Weeks)||0||
48412972|NCT02531633|101345749|FG006|STARTED|Part A (52 Weeks)||0||
48412973|NCT02531633|101345750|FG007|STARTED|Part A (52 Weeks)||0||
48412974|NCT02531633|101345751|FG008|STARTED|Part A (52 Weeks)||0||
48412975|NCT02531633|101345752|FG009|STARTED|Part A (52 Weeks)||0||
48753536|NCT03557970|102184525|FG001|STARTED|Overall Study||2||
48753537|NCT03557970|102184524|FG000|COMPLETED|Overall Study||0||
48753538|NCT03557970|102184525|FG001|COMPLETED|Overall Study||0||
48753539|NCT03557970|102184524|FG000|NOT COMPLETED|Overall Study||1||
48753540|NCT03557970|102184525|FG001|NOT COMPLETED|Overall Study||2||
48753541|NCT01962792|102184526|FG000|STARTED|Overall Study||3||
48753542|NCT01962792|102184527|FG001|STARTED|Overall Study||5||
48753543|NCT01962792|102184528|FG002|STARTED|Overall Study||17||
48753544|NCT01962792|102184529|FG003|STARTED|Overall Study||59||
48753545|NCT01962792|102184526|FG000|COMPLETED|Overall Study||3||
48753546|NCT01962792|102184527|FG001|COMPLETED|Overall Study||5||
48753547|NCT01962792|102184528|FG002|COMPLETED|Overall Study||17||
48753548|NCT01962792|102184529|FG003|COMPLETED|Overall Study||59||
48753549|NCT01962792|102184526|FG000|NOT COMPLETED|Overall Study||0||
48753550|NCT01962792|102184527|FG001|NOT COMPLETED|Overall Study||0||
48753551|NCT01962792|102184528|FG002|NOT COMPLETED|Overall Study||0||
48753552|NCT01962792|102184529|FG003|NOT COMPLETED|Overall Study||0||
48753553|NCT02660788|102184530|FG000|STARTED|Overall Study||2749||
48753554|NCT02660788|102184531|FG001|STARTED|Overall Study||2749||
48753555|NCT02660788|102184530|FG000|COMPLETED|Overall Study||2749||
48753556|NCT02660788|102184531|FG001|COMPLETED|Overall Study||2749||
48753557|NCT02660788|102184530|FG000|NOT COMPLETED|Overall Study||0||
48753558|NCT02660788|102184531|FG001|NOT COMPLETED|Overall Study||0||
48753559|NCT03212326|102184532|FG000|STARTED|Overall Study||24||
48753560|NCT03212326|102184532|FG000|COMPLETED|Overall Study||20||
48753561|NCT03212326|102184532|FG000|NOT COMPLETED|Overall Study||4||
48753562|NCT04247347|102184533|FG000|STARTED|Overall Study||28||
48753563|NCT04247347|102184534|FG001|STARTED|Overall Study||28||
48753564|NCT04247347|102184535|FG002|STARTED|Overall Study||29||
48753565|NCT04247347|102184533|FG000|Received Intervention|Overall Study||26||
48753566|NCT04247347|102184534|FG001|Received Intervention|Overall Study||27||
48753567|NCT04247347|102184535|FG002|Received Intervention|Overall Study||26||
48753568|NCT04247347|102184533|FG000|COMPLETED|Overall Study||25||
48753569|NCT04247347|102184534|FG001|COMPLETED|Overall Study||24||
48177246|NCT00050089|100757596|FG003|COMPLETED|Overall Study||78||
48177247|NCT00050089|100757593|FG000|NOT COMPLETED|Overall Study||0||
48412976|NCT02531633|101345743|FG000|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||1|2 Participants completed Part A then withdrew. They are counted again in withdrawals|
48439945|NCT04993339|101409989|FG000|NOT COMPLETED|Overall Study||3||
48631181|NCT02701634|101881470|FG000|NOT COMPLETED|Overall Study||32||
48753570|NCT04247347|102184535|FG002|COMPLETED|Overall Study||25||
48753571|NCT04247347|102184533|FG000|NOT COMPLETED|Overall Study||3||
48753572|NCT04247347|102184534|FG001|NOT COMPLETED|Overall Study||4||
48753573|NCT04247347|102184535|FG002|NOT COMPLETED|Overall Study||4||
48753574|NCT01576341|102184536|FG000|STARTED|Overall Study||417||
48753575|NCT01576341|102184536|FG000|COMPLETED|Overall Study||324||
48753576|NCT01576341|102184536|FG000|NOT COMPLETED|Overall Study||93||
48753577|NCT01519323|102184537|FG000|STARTED|Overall Study||3||
48753578|NCT01519323|102184538|FG001|STARTED|Overall Study||3||
48753579|NCT01519323|102184537|FG000|COMPLETED|Overall Study||0||
48753580|NCT01519323|102184538|FG001|COMPLETED|Overall Study||0||
48753581|NCT01519323|102184537|FG000|NOT COMPLETED|Overall Study||3||
48753582|NCT01519323|102184538|FG001|NOT COMPLETED|Overall Study||3||
48753583|NCT02682381|102184539|FG000|STARTED|Overall Study||24||
48753584|NCT02682381|102184540|FG001|STARTED|Overall Study||26||
48753585|NCT02682381|102184541|FG002|STARTED|Overall Study||9||
48753586|NCT02682381|102184539|FG000|COMPLETED|Overall Study||24||
48753587|NCT02682381|102184540|FG001|COMPLETED|Overall Study||26||
48753588|NCT02682381|102184541|FG002|COMPLETED|Overall Study||9||
48753589|NCT02682381|102184539|FG000|NOT COMPLETED|Overall Study||0||
48753590|NCT02682381|102184540|FG001|NOT COMPLETED|Overall Study||0||
48753591|NCT02682381|102184541|FG002|NOT COMPLETED|Overall Study||0||
48753592|NCT02855203|102184542|FG000|STARTED|Overall Study||30||
48753593|NCT02855203|102184542|FG000|COMPLETED|Overall Study||30||
48753594|NCT02855203|102184542|FG000|NOT COMPLETED|Overall Study||0||
48753595|NCT01814774|102184543|FG000|STARTED|Overall Study||48||
48753596|NCT01814774|102184543|FG000|COMPLETED|Overall Study||48||
48753597|NCT01814774|102184543|FG000|NOT COMPLETED|Overall Study||0||
48753598|NCT04046328|102184544|FG000|STARTED|First Intervention (14 Days)||6||
48753599|NCT04046328|102184545|FG001|STARTED|First Intervention (14 Days)||7||
48753600|NCT04046328|102184544|FG000|COMPLETED|First Intervention (14 Days)||6||
48753601|NCT04046328|102184545|FG001|COMPLETED|First Intervention (14 Days)||7||
48753602|NCT04046328|102184544|FG000|NOT COMPLETED|First Intervention (14 Days)||0||
48753603|NCT04046328|102184545|FG001|NOT COMPLETED|First Intervention (14 Days)||0||
48753604|NCT04046328|102184544|FG000|STARTED|Washout (14 Days)||6||
48753605|NCT04046328|102184545|FG001|STARTED|Washout (14 Days)||7||
48337788|NCT00332709|101156525|FG001|COMPLETED|Overall Study||21||
48337789|NCT00332709|101156524|FG000|NOT COMPLETED|Overall Study||16||
48337790|NCT00332709|101156525|FG001|NOT COMPLETED|Overall Study||20||
48337791|NCT02382133|101156526|FG000|STARTED|Overall Study||43||
48337792|NCT02382133|101156526|FG000|COMPLETED|Overall Study||10||
48337793|NCT02382133|101156526|FG000|NOT COMPLETED|Overall Study||33||
48337794|NCT02468648|101156527|FG000|STARTED|Overall Study||72||
48337795|NCT02468648|101156527|FG000|COMPLETED|Overall Study||71||
48337796|NCT02468648|101156527|FG000|NOT COMPLETED|Overall Study||1||
48631182|NCT02701634|101881471|FG001|NOT COMPLETED|Overall Study||31||
48631183|NCT03306199|101881472|FG000|STARTED|Overall Study||82||
48631184|NCT03306199|101881472|FG000|COMPLETED|Overall Study||67||
48631185|NCT03306199|101881472|FG000|NOT COMPLETED|Overall Study||15||
48337797|NCT04373460|101156528|FG000|STARTED|Overall Study||610||
48631186|NCT00748241|101881473|FG000|STARTED|Overall Study||19||
48631187|NCT00748241|101881473|FG000|COMPLETED|Overall Study||11||
48337798|NCT04373460|101156529|FG001|STARTED|Overall Study||615||
48337799|NCT04373460|101156528|FG000|COMPLETED|Overall Study||592||
48337800|NCT04373460|101156529|FG001|COMPLETED|Overall Study||589||
48337801|NCT04373460|101156528|FG000|NOT COMPLETED|Overall Study||18||
48631188|NCT00748241|101881473|FG000|NOT COMPLETED|Overall Study||8||
48631189|NCT01033136|101881474|FG000|STARTED|Baseline Assessment||36||
48631190|NCT01033136|101881475|FG001|STARTED|Baseline Assessment||32||
48631191|NCT01033136|101881474|FG000|COMPLETED|Baseline Assessment||30||
48631192|NCT01033136|101881475|FG001|COMPLETED|Baseline Assessment||26||
48631193|NCT01033136|101881474|FG000|NOT COMPLETED|Baseline Assessment||6||
48631194|NCT01033136|101881475|FG001|NOT COMPLETED|Baseline Assessment||6||
48631195|NCT01033136|101881474|FG000|STARTED|Post-Treatment (1 Week)||30||
48631196|NCT01033136|101881475|FG001|STARTED|Post-Treatment (1 Week)||26||
48631197|NCT01033136|101881474|FG000|COMPLETED|Post-Treatment (1 Week)||16||
48631198|NCT01033136|101881475|FG001|COMPLETED|Post-Treatment (1 Week)||15||
48631199|NCT01033136|101881474|FG000|NOT COMPLETED|Post-Treatment (1 Week)||14||
48631200|NCT01033136|101881475|FG001|NOT COMPLETED|Post-Treatment (1 Week)||11||
48631201|NCT01033136|101881474|FG000|STARTED|Follow-Up (3 Month)||16||
48631202|NCT01033136|101881475|FG001|STARTED|Follow-Up (3 Month)||15||
48631203|NCT01033136|101881474|FG000|COMPLETED|Follow-Up (3 Month)||14||
48631204|NCT01033136|101881475|FG001|COMPLETED|Follow-Up (3 Month)||13||
48631205|NCT01033136|101881474|FG000|NOT COMPLETED|Follow-Up (3 Month)||2||
48631206|NCT01033136|101881475|FG001|NOT COMPLETED|Follow-Up (3 Month)||2||
48631207|NCT02936999|101881476|FG000|STARTED|Overall Study||8||
48631208|NCT02936999|101881476|FG000|COMPLETED|Overall Study||8||
48631209|NCT02936999|101881476|FG000|NOT COMPLETED|Overall Study||0||
48631210|NCT00505921|101881477|FG000|STARTED|Overall Study||27||
48631211|NCT00505921|101881477|FG000|COMPLETED|Overall Study||18||
48631212|NCT00505921|101881477|FG000|NOT COMPLETED|Overall Study||9||
48631213|NCT01900444|101881478|FG000|STARTED|Overall Study||119||
48631214|NCT01900444|101881478|FG000|COMPLETED|Overall Study||116||
48631215|NCT01900444|101881478|FG000|NOT COMPLETED|Overall Study||3||
48631216|NCT03563222|101881479|FG000|STARTED|Overall Study||1||
48753606|NCT04046328|102184544|FG000|COMPLETED|Washout (14 Days)||6||
48753607|NCT04046328|102184545|FG001|COMPLETED|Washout (14 Days)||7||
48337802|NCT04373460|101156529|FG001|NOT COMPLETED|Overall Study||26||
48337803|NCT02808390|101156530|FG000|STARTED|Overall Study||4||
48337804|NCT02808390|101156531|FG001|STARTED|Overall Study||8||
48337805|NCT02808390|101156532|FG002|STARTED|Overall Study||7||
48337806|NCT02808390|101156530|FG000|COMPLETED|Overall Study||2||
48337807|NCT02808390|101156531|FG001|COMPLETED|Overall Study||2||
48337808|NCT02808390|101156532|FG002|COMPLETED|Overall Study||4||
48337809|NCT02808390|101156530|FG000|NOT COMPLETED|Overall Study||2||
48631217|NCT03563222|101881480|FG001|STARTED|Overall Study||0||
48631218|NCT03563222|101881479|FG000|COMPLETED|Overall Study||1||
48631219|NCT03563222|101881480|FG001|COMPLETED|Overall Study||0||
48631220|NCT03563222|101881479|FG000|NOT COMPLETED|Overall Study||0||
48631221|NCT03563222|101881480|FG001|NOT COMPLETED|Overall Study||0||
48631222|NCT02765035|101881481|FG000|STARTED|First Intervention (90 Days)||5||
48337810|NCT02808390|101156531|FG001|NOT COMPLETED|Overall Study||6||
48631223|NCT02765035|101881482|FG001|STARTED|First Intervention (90 Days)||8||
48177248|NCT00050089|100757594|FG001|NOT COMPLETED|Overall Study||0||
48177249|NCT00050089|100757595|FG002|NOT COMPLETED|Overall Study||0||
48177250|NCT00050089|100757596|FG003|NOT COMPLETED|Overall Study||0||
48177251|NCT03749460|100757597|FG000|STARTED|Overall Study||20||
48177252|NCT03749460|100757597|FG000|COMPLETED|Overall Study||20||
48177253|NCT03749460|100757597|FG000|NOT COMPLETED|Overall Study||0||
48177254|NCT04642469|100757598|FG000|STARTED|Overall Study||15||
48177255|NCT04642469|100757599|FG001|STARTED|Overall Study||15||
48177256|NCT04642469|100757598|FG000|COMPLETED|Overall Study||0||
48177257|NCT04642469|100757599|FG001|COMPLETED|Overall Study||1||
48177258|NCT04642469|100757598|FG000|NOT COMPLETED|Overall Study||15||
48177259|NCT04642469|100757599|FG001|NOT COMPLETED|Overall Study||14||
48753608|NCT04046328|102184544|FG000|NOT COMPLETED|Washout (14 Days)||0||
48753609|NCT04046328|102184545|FG001|NOT COMPLETED|Washout (14 Days)||0||
48753610|NCT04046328|102184544|FG000|STARTED|Second Intervention (14 Days)||6||
48753611|NCT04046328|102184545|FG001|STARTED|Second Intervention (14 Days)||7||
48753612|NCT04046328|102184544|FG000|COMPLETED|Second Intervention (14 Days)||6||
48753613|NCT04046328|102184545|FG001|COMPLETED|Second Intervention (14 Days)||7||
48753614|NCT04046328|102184544|FG000|NOT COMPLETED|Second Intervention (14 Days)||0||
48753615|NCT04046328|102184545|FG001|NOT COMPLETED|Second Intervention (14 Days)||0||
48753616|NCT00763412|102184546|FG000|STARTED|Overall Study||8||
48753617|NCT00763412|102184547|FG001|STARTED|Overall Study||8||
48753618|NCT00763412|102184546|FG000|COMPLETED|Overall Study||4||
48753619|NCT00763412|102184547|FG001|COMPLETED|Overall Study||4||
48753620|NCT00763412|102184546|FG000|NOT COMPLETED|Overall Study||4||
48753621|NCT00763412|102184547|FG001|NOT COMPLETED|Overall Study||4||
48753622|NCT04801420|102184548|FG000|STARTED|Overall Study||208||
48753623|NCT04801420|102184549|FG001|STARTED|Overall Study||209||
48753624|NCT04801420|102184550|FG002|STARTED|Overall Study||208||
48753625|NCT04801420|102184548|FG000|COMPLETED|Overall Study||0||
48753626|NCT04801420|102184549|FG001|COMPLETED|Overall Study||0||
48753627|NCT04801420|102184550|FG002|COMPLETED|Overall Study||0||
48753628|NCT04801420|102184548|FG000|NOT COMPLETED|Overall Study||208||
48753629|NCT04801420|102184549|FG001|NOT COMPLETED|Overall Study||209||
48753630|NCT04801420|102184550|FG002|NOT COMPLETED|Overall Study||208||
48753631|NCT03617172|102184551|FG000|STARTED|Overall Study||3||
48753632|NCT03617172|102184552|FG001|STARTED|Overall Study||3||
48753633|NCT03617172|102184551|FG000|COMPLETED|Overall Study||2||
48753634|NCT03617172|102184552|FG001|COMPLETED|Overall Study||3||
48753635|NCT03617172|102184551|FG000|NOT COMPLETED|Overall Study||1||
48753636|NCT03617172|102184552|FG001|NOT COMPLETED|Overall Study||0||
48753637|NCT01319981|102184553|FG000|STARTED|Overall Study||15||
48753638|NCT01319981|102184554|FG001|STARTED|Overall Study||16||
48753639|NCT01319981|102184553|FG000|COMPLETED|Overall Study||15||
48753640|NCT01319981|102184554|FG001|COMPLETED|Overall Study||16||
48753641|NCT01319981|102184553|FG000|NOT COMPLETED|Overall Study||0||
48753642|NCT01319981|102184554|FG001|NOT COMPLETED|Overall Study||0||
48753643|NCT03913221|102184555|FG000|STARTED|Low Dose Cohort||9||
48753644|NCT03913221|102184556|FG001|STARTED|Low Dose Cohort||0||
48753645|NCT03913221|102184555|FG000|COMPLETED|Low Dose Cohort||9||
48753646|NCT03913221|102184556|FG001|COMPLETED|Low Dose Cohort||0||
48753647|NCT03913221|102184555|FG000|NOT COMPLETED|Low Dose Cohort||0||
48753648|NCT03913221|102184556|FG001|NOT COMPLETED|Low Dose Cohort||0||
48753649|NCT03913221|102184555|FG000|STARTED|High Dose Cohort||0||
48753650|NCT03913221|102184556|FG001|STARTED|High Dose Cohort||8||
48753651|NCT03913221|102184555|FG000|COMPLETED|High Dose Cohort||0||
48753652|NCT03913221|102184556|FG001|COMPLETED|High Dose Cohort||8||
48753653|NCT03913221|102184555|FG000|NOT COMPLETED|High Dose Cohort||0||
48753654|NCT03913221|102184556|FG001|NOT COMPLETED|High Dose Cohort||0||
48753655|NCT00388349|102184557|FG000|STARTED|Phase I Dose Escalation||3||
48753656|NCT00388349|102184558|FG001|STARTED|Phase I Dose Escalation||4||
48753657|NCT00388349|102184557|FG000|COMPLETED|Phase I Dose Escalation||3||
48753658|NCT00388349|102184558|FG001|COMPLETED|Phase I Dose Escalation||1||
48177260|NCT04157686|100757600|FG000|STARTED|Overall Study||55||
48177261|NCT04157686|100757601|FG001|STARTED|Overall Study||56||
48177262|NCT04157686|100757602|FG002|STARTED|Overall Study||118||
48753659|NCT00388349|102184557|FG000|NOT COMPLETED|Phase I Dose Escalation||0||
48753660|NCT00388349|102184558|FG001|NOT COMPLETED|Phase I Dose Escalation||3||
48753661|NCT00388349|102184557|FG000|STARTED|Phase 2 Dose Expansion||139||
48177263|NCT04157686|100757603|FG003|STARTED|Overall Study||116||
48177264|NCT04157686|100757604|FG004|STARTED|Overall Study||108||
48177265|NCT04157686|100757605|FG005|STARTED|Overall Study||128||
48177266|NCT04157686|100757606|FG006|STARTED|Overall Study||123||
48753662|NCT00388349|102184558|FG001|STARTED|Phase 2 Dose Expansion||0||
48753663|NCT00388349|102184557|FG000|COMPLETED|Phase 2 Dose Expansion||139|# pts @ 1250 mg/m\^2 Gemzar in Phase 2 doesn't include the 4 pts @ 1500 mg/m2 Gemzar in Phase 1.|
48753664|NCT00388349|102184558|FG001|COMPLETED|Phase 2 Dose Expansion||0|# pts @ 1250 mg/m\^2 Gemzar in Phase 2 doesn't include the 4 pts @ 1500 mg/m2 Gemzar in Phase 1.|
48753665|NCT00388349|102184557|FG000|NOT COMPLETED|Phase 2 Dose Expansion||0||
48753666|NCT00388349|102184558|FG001|NOT COMPLETED|Phase 2 Dose Expansion||0||
48753667|NCT01083849|102184559|FG000|STARTED|Overall Study||121||
48177267|NCT04157686|100757607|FG007|STARTED|Overall Study||253||
48177268|NCT04157686|100757600|FG000|COMPLETED|Overall Study||43||
48177269|NCT04157686|100757601|FG001|COMPLETED|Overall Study||41||
48177270|NCT04157686|100757602|FG002|COMPLETED|Overall Study||89||
48177271|NCT04157686|100757603|FG003|COMPLETED|Overall Study||87||
48177272|NCT04157686|100757604|FG004|COMPLETED|Overall Study||83||
48177273|NCT04157686|100757605|FG005|COMPLETED|Overall Study||106||
48177274|NCT04157686|100757606|FG006|COMPLETED|Overall Study||92||
48177275|NCT04157686|100757607|FG007|COMPLETED|Overall Study||218||
48177276|NCT04157686|100757600|FG000|NOT COMPLETED|Overall Study||12||
48177277|NCT04157686|100757601|FG001|NOT COMPLETED|Overall Study||15||
48177278|NCT04157686|100757602|FG002|NOT COMPLETED|Overall Study||29||
48177279|NCT04157686|100757603|FG003|NOT COMPLETED|Overall Study||29||
48177280|NCT04157686|100757604|FG004|NOT COMPLETED|Overall Study||25||
48177281|NCT04157686|100757605|FG005|NOT COMPLETED|Overall Study||22||
48177282|NCT04157686|100757606|FG006|NOT COMPLETED|Overall Study||31||
48177283|NCT04157686|100757607|FG007|NOT COMPLETED|Overall Study||35||
48177284|NCT01576055|100757608|FG000|STARTED|Overall Study||197||
48177285|NCT01576055|100757609|FG001|STARTED|Overall Study||70||
48177286|NCT01576055|100757608|FG000|COMPLETED|Overall Study||178||
48177287|NCT01576055|100757609|FG001|COMPLETED|Overall Study||64||
48177288|NCT01576055|100757608|FG000|NOT COMPLETED|Overall Study||19||
48177289|NCT01576055|100757609|FG001|NOT COMPLETED|Overall Study||6||
48177290|NCT01448525|100757610|FG000|STARTED|Overall Study||44||
48177291|NCT01448525|100757611|FG001|STARTED|Overall Study||44||
48177292|NCT01448525|100757610|FG000|COMPLETED|Overall Study||43||
48177293|NCT01448525|100757611|FG001|COMPLETED|Overall Study||42||
48412977|NCT02531633|101345744|FG001|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0|2 Participants completed Part A then withdrew. They are counted again in withdrawals|
48412978|NCT02531633|101345745|FG002|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||1|2 Participants completed Part A then withdrew. They are counted again in withdrawals|
48412979|NCT02531633|101345746|FG003|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0|2 Participants completed Part A then withdrew. They are counted again in withdrawals|
48753668|NCT01083849|102184560|FG001|STARTED|Overall Study||638||
48753669|NCT01083849|102184559|FG000|COMPLETED|Overall Study||61||
48753670|NCT01083849|102184560|FG001|COMPLETED|Overall Study||527||
48753671|NCT01083849|102184559|FG000|NOT COMPLETED|Overall Study||60||
48753672|NCT01083849|102184560|FG001|NOT COMPLETED|Overall Study||111||
48753673|NCT01535040|102184561|FG000|STARTED|Overall Study||65||
48753674|NCT01535040|102184562|FG001|STARTED|Overall Study||65||
48753675|NCT01535040|102184561|FG000|COMPLETED|Overall Study||35||
48412980|NCT02531633|101345747|FG004|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0|2 Participants completed Part A then withdrew. They are counted again in withdrawals|
48631224|NCT02765035|101881481|FG000|COMPLETED|First Intervention (90 Days)||4||
48631225|NCT02765035|101881482|FG001|COMPLETED|First Intervention (90 Days)||7||
48631226|NCT02765035|101881481|FG000|NOT COMPLETED|First Intervention (90 Days)||1||
48631227|NCT02765035|101881482|FG001|NOT COMPLETED|First Intervention (90 Days)||1||
48631228|NCT02765035|101881481|FG000|STARTED|Second Intervention (30 Days)||4||
48631229|NCT02765035|101881482|FG001|STARTED|Second Intervention (30 Days)||7||
48631230|NCT02765035|101881481|FG000|COMPLETED|Second Intervention (30 Days)||2||
48631231|NCT02765035|101881482|FG001|COMPLETED|Second Intervention (30 Days)||5||
48631232|NCT02765035|101881481|FG000|NOT COMPLETED|Second Intervention (30 Days)||2||
48631233|NCT02765035|101881482|FG001|NOT COMPLETED|Second Intervention (30 Days)||2||
48631234|NCT00827567|101881483|FG000|STARTED|Overall Study||4||
48631235|NCT00827567|101881483|FG000|COMPLETED|Overall Study||0||
48631236|NCT00827567|101881483|FG000|NOT COMPLETED|Overall Study||4||
48631237|NCT00921024|101881484|FG000|STARTED|Overall Study||85||
48753676|NCT01535040|102184562|FG001|COMPLETED|Overall Study||44||
48753677|NCT01535040|102184561|FG000|NOT COMPLETED|Overall Study||30||
48753678|NCT01535040|102184562|FG001|NOT COMPLETED|Overall Study||21||
48753679|NCT02336282|102184563|FG000|STARTED|Overall Study||33||
48177294|NCT01448525|100757610|FG000|NOT COMPLETED|Overall Study||1||
48177295|NCT01448525|100757611|FG001|NOT COMPLETED|Overall Study||2||
48177296|NCT02329600|100757612|FG000|STARTED|Overall Study||10||
48177297|NCT02329600|100757613|FG001|STARTED|Overall Study||15||
48177298|NCT02329600|100757614|FG002|STARTED|Overall Study||15||
48177299|NCT02329600|100757612|FG000|COMPLETED|Overall Study||10||
48177300|NCT02329600|100757613|FG001|COMPLETED|Overall Study||15||
48753680|NCT02336282|102184563|FG000|COMPLETED|Overall Study||28||
48753681|NCT02336282|102184563|FG000|NOT COMPLETED|Overall Study||5||
48753682|NCT00189098|102184564|FG000|STARTED|Overall Study||51||
48753683|NCT00189098|102184565|FG001|STARTED|Overall Study||50||
48753684|NCT00189098|102184564|FG000|COMPLETED|Overall Study||46||
48177301|NCT02329600|100757614|FG002|COMPLETED|Overall Study||15||
48177302|NCT02329600|100757612|FG000|NOT COMPLETED|Overall Study||0||
48177303|NCT02329600|100757613|FG001|NOT COMPLETED|Overall Study||0||
48177304|NCT02329600|100757614|FG002|NOT COMPLETED|Overall Study||0||
48177305|NCT01816763|100757615|FG000|STARTED|Overall Study||195||
48177306|NCT01816763|100757616|FG001|STARTED|Overall Study||194||
48177307|NCT01816763|100757617|FG002|STARTED|Overall Study||180||
48177308|NCT01816763|100757615|FG000|COMPLETED|Overall Study||191||
48177309|NCT01816763|100757616|FG001|COMPLETED|Overall Study||179||
48177310|NCT01816763|100757617|FG002|COMPLETED|Overall Study||169||
48177311|NCT01816763|100757615|FG000|NOT COMPLETED|Overall Study||4||
48177312|NCT01816763|100757616|FG001|NOT COMPLETED|Overall Study||15||
48177313|NCT01816763|100757617|FG002|NOT COMPLETED|Overall Study||11||
48177314|NCT02593539|100757618|FG000|STARTED|Overall Study||5||
48177315|NCT02593539|100757618|FG000|COMPLETED|Overall Study||4||
48177316|NCT02593539|100757618|FG000|NOT COMPLETED|Overall Study||1||
48177317|NCT02411591|100757619|FG000|STARTED|Overall Study||3||
48177318|NCT02411591|100757620|FG001|STARTED|Overall Study||57||
48177319|NCT02411591|100757621|FG002|STARTED|Overall Study||6||
48177320|NCT02411591|100757619|FG000|Part A|Overall Study||3||
48177321|NCT02411591|100757620|FG001|Part A|Overall Study||6||
48177322|NCT02411591|100757621|FG002|Part A|Overall Study||6||
48177323|NCT02411591|100757619|FG000|Expansion Cohort Part B|Overall Study||0||
48177324|NCT02411591|100757620|FG001|Expansion Cohort Part B|Overall Study||51||
48177325|NCT02411591|100757621|FG002|Expansion Cohort Part B|Overall Study||0||
48177326|NCT02411591|100757619|FG000|Progressive Disease|Overall Study||3||
48177327|NCT02411591|100757620|FG001|Progressive Disease|Overall Study||42||
48177328|NCT02411591|100757621|FG002|Progressive Disease|Overall Study||3||
48177329|NCT02411591|100757619|FG000|Death|Overall Study||0||
48177330|NCT02411591|100757620|FG001|Death|Overall Study||2||
48177331|NCT02411591|100757621|FG002|Death|Overall Study||0||
48177332|NCT02411591|100757619|FG000|COMPLETED|Overall Study||3||
48177333|NCT02411591|100757620|FG001|COMPLETED|Overall Study||47||
48177334|NCT02411591|100757621|FG002|COMPLETED|Overall Study||3||
48177335|NCT02411591|100757619|FG000|NOT COMPLETED|Overall Study||0||
48177336|NCT02411591|100757620|FG001|NOT COMPLETED|Overall Study||10||
48177337|NCT02411591|100757621|FG002|NOT COMPLETED|Overall Study||3||
48177338|NCT01349660|100757622|FG000|STARTED|Overall Study||6||
48177339|NCT01349660|100757623|FG001|STARTED|Overall Study||6||
48177340|NCT01349660|100757624|FG002|STARTED|Overall Study||76||
48177341|NCT01349660|100757622|FG000|COMPLETED|Overall Study||0||
48177342|NCT01349660|100757623|FG001|COMPLETED|Overall Study||0||
48177343|NCT01349660|100757624|FG002|COMPLETED|Overall Study||0||
48177344|NCT01349660|100757622|FG000|NOT COMPLETED|Overall Study||6||
48177345|NCT01349660|100757623|FG001|NOT COMPLETED|Overall Study||6||
48177346|NCT01349660|100757624|FG002|NOT COMPLETED|Overall Study||76||
48177347|NCT02531295|100757625|FG000|STARTED|Overall Study||2||
48177348|NCT02531295|100757626|FG001|STARTED|Overall Study||0||
48177349|NCT02531295|100757627|FG002|STARTED|Overall Study||1||
48177350|NCT02531295|100757628|FG003|STARTED|Overall Study||0||
48177351|NCT02531295|100757629|FG004|STARTED|Overall Study||0||
48177352|NCT02531295|100757630|FG005|STARTED|Overall Study||2||
48177353|NCT02531295|100757625|FG000|COMPLETED|Overall Study||2||
48177354|NCT02531295|100757626|FG001|COMPLETED|Overall Study||0||
48177355|NCT02531295|100757627|FG002|COMPLETED|Overall Study||1||
48177356|NCT02531295|100757628|FG003|COMPLETED|Overall Study||0||
48177357|NCT02531295|100757629|FG004|COMPLETED|Overall Study||0||
48177358|NCT02531295|100757630|FG005|COMPLETED|Overall Study||1||
48177359|NCT02531295|100757625|FG000|NOT COMPLETED|Overall Study||0||
48177360|NCT02531295|100757626|FG001|NOT COMPLETED|Overall Study||0||
48177361|NCT02531295|100757627|FG002|NOT COMPLETED|Overall Study||0||
48177362|NCT02531295|100757628|FG003|NOT COMPLETED|Overall Study||0||
48177363|NCT02531295|100757629|FG004|NOT COMPLETED|Overall Study||0||
48177364|NCT02531295|100757630|FG005|NOT COMPLETED|Overall Study||1||
48177365|NCT02325713|100757631|FG000|STARTED|Intervention Period 1 (2 Days)||2||
48177366|NCT02325713|100757632|FG001|STARTED|Intervention Period 1 (2 Days)||2||
48177367|NCT02325713|100757633|FG002|STARTED|Intervention Period 1 (2 Days)||2||
48177368|NCT02325713|100757634|FG003|STARTED|Intervention Period 1 (2 Days)||2||
48177369|NCT02325713|100757635|FG004|STARTED|Intervention Period 1 (2 Days)||2||
48177370|NCT02325713|100757636|FG005|STARTED|Intervention Period 1 (2 Days)||2||
48177371|NCT02325713|100757637|FG006|STARTED|Intervention Period 1 (2 Days)||2||
48177372|NCT02325713|100757638|FG007|STARTED|Intervention Period 1 (2 Days)||2||
48177373|NCT02325713|100757639|FG008|STARTED|Intervention Period 1 (2 Days)||2||
48177374|NCT02325713|100757640|FG009|STARTED|Intervention Period 1 (2 Days)||2||
48177375|NCT02325713|100757641|FG010|STARTED|Intervention Period 1 (2 Days)||2||
48177376|NCT02325713|100757642|FG011|STARTED|Intervention Period 1 (2 Days)||2||
48177377|NCT02325713|100757643|FG012|STARTED|Intervention Period 1 (2 Days)||2||
48177378|NCT02325713|100757644|FG013|STARTED|Intervention Period 1 (2 Days)||2||
48177379|NCT02325713|100757645|FG014|STARTED|Intervention Period 1 (2 Days)||2||
48177380|NCT02325713|100757646|FG015|STARTED|Intervention Period 1 (2 Days)||2||
48177381|NCT02325713|100757631|FG000|COMPLETED|Intervention Period 1 (2 Days)||2||
48177382|NCT02325713|100757632|FG001|COMPLETED|Intervention Period 1 (2 Days)||2||
48177383|NCT02325713|100757633|FG002|COMPLETED|Intervention Period 1 (2 Days)||2||
48177384|NCT02325713|100757634|FG003|COMPLETED|Intervention Period 1 (2 Days)||2||
48177385|NCT02325713|100757635|FG004|COMPLETED|Intervention Period 1 (2 Days)||2||
48177386|NCT02325713|100757636|FG005|COMPLETED|Intervention Period 1 (2 Days)||2||
48177387|NCT02325713|100757637|FG006|COMPLETED|Intervention Period 1 (2 Days)||2||
48177388|NCT02325713|100757638|FG007|COMPLETED|Intervention Period 1 (2 Days)||2||
48177389|NCT02325713|100757639|FG008|COMPLETED|Intervention Period 1 (2 Days)||2||
48177390|NCT02325713|100757640|FG009|COMPLETED|Intervention Period 1 (2 Days)||2||
48177391|NCT02325713|100757641|FG010|COMPLETED|Intervention Period 1 (2 Days)||1||
48177392|NCT02325713|100757642|FG011|COMPLETED|Intervention Period 1 (2 Days)||2||
48177393|NCT02325713|100757643|FG012|COMPLETED|Intervention Period 1 (2 Days)||2||
48177394|NCT02325713|100757644|FG013|COMPLETED|Intervention Period 1 (2 Days)||2||
48177395|NCT02325713|100757645|FG014|COMPLETED|Intervention Period 1 (2 Days)||2||
48177396|NCT02325713|100757646|FG015|COMPLETED|Intervention Period 1 (2 Days)||2||
48177397|NCT02325713|100757631|FG000|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
48177398|NCT02325713|100757632|FG001|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
48177399|NCT02325713|100757633|FG002|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
48177400|NCT02325713|100757634|FG003|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
48177401|NCT02325713|100757635|FG004|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
48177402|NCT02325713|100757636|FG005|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
48177403|NCT02325713|100757637|FG006|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
48177404|NCT02325713|100757638|FG007|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
48177405|NCT02325713|100757639|FG008|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
48177406|NCT02325713|100757640|FG009|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
48177407|NCT02325713|100757641|FG010|NOT COMPLETED|Intervention Period 1 (2 Days)||1||
48177408|NCT02325713|100757642|FG011|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
48177409|NCT02325713|100757643|FG012|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
48177410|NCT02325713|100757644|FG013|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
48177411|NCT02325713|100757645|FG014|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
48177412|NCT02325713|100757646|FG015|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
48177413|NCT02325713|100757631|FG000|STARTED|Intervention Period 2 (2 Days)||2||
48177414|NCT02325713|100757632|FG001|STARTED|Intervention Period 2 (2 Days)||2||
48177415|NCT02325713|100757633|FG002|STARTED|Intervention Period 2 (2 Days)||2||
48177416|NCT02325713|100757634|FG003|STARTED|Intervention Period 2 (2 Days)||2||
48177417|NCT02325713|100757635|FG004|STARTED|Intervention Period 2 (2 Days)||2||
48177418|NCT02325713|100757636|FG005|STARTED|Intervention Period 2 (2 Days)||2||
48177419|NCT02325713|100757637|FG006|STARTED|Intervention Period 2 (2 Days)||2||
48177420|NCT02325713|100757638|FG007|STARTED|Intervention Period 2 (2 Days)||2||
48177421|NCT02325713|100757639|FG008|STARTED|Intervention Period 2 (2 Days)||2||
48177422|NCT02325713|100757640|FG009|STARTED|Intervention Period 2 (2 Days)||2||
48177423|NCT02325713|100757641|FG010|STARTED|Intervention Period 2 (2 Days)||1||
48177424|NCT02325713|100757642|FG011|STARTED|Intervention Period 2 (2 Days)||2||
48177425|NCT02325713|100757643|FG012|STARTED|Intervention Period 2 (2 Days)||2||
48337811|NCT02808390|101156532|FG002|NOT COMPLETED|Overall Study||3||
48631238|NCT00921024|101881485|FG001|STARTED|Overall Study||42||
48177426|NCT02325713|100757644|FG013|STARTED|Intervention Period 2 (2 Days)||2||
48337812|NCT01497262|101156533|FG000|STARTED|Overall Study||162||
48337813|NCT01497262|101156533|FG000|COMPLETED|Overall Study||151||
48337814|NCT01497262|101156533|FG000|NOT COMPLETED|Overall Study||11||
48177427|NCT02325713|100757645|FG014|STARTED|Intervention Period 2 (2 Days)||2||
48177428|NCT02325713|100757646|FG015|STARTED|Intervention Period 2 (2 Days)||2||
48177429|NCT02325713|100757631|FG000|COMPLETED|Intervention Period 2 (2 Days)||1||
48177430|NCT02325713|100757632|FG001|COMPLETED|Intervention Period 2 (2 Days)||2||
48177431|NCT02325713|100757633|FG002|COMPLETED|Intervention Period 2 (2 Days)||2||
48177432|NCT02325713|100757634|FG003|COMPLETED|Intervention Period 2 (2 Days)||2||
48177433|NCT02325713|100757635|FG004|COMPLETED|Intervention Period 2 (2 Days)||2||
48177434|NCT02325713|100757636|FG005|COMPLETED|Intervention Period 2 (2 Days)||2||
48177435|NCT02325713|100757637|FG006|COMPLETED|Intervention Period 2 (2 Days)||2||
48177436|NCT02325713|100757638|FG007|COMPLETED|Intervention Period 2 (2 Days)||2||
48177437|NCT02325713|100757639|FG008|COMPLETED|Intervention Period 2 (2 Days)||2||
48177438|NCT02325713|100757640|FG009|COMPLETED|Intervention Period 2 (2 Days)||2||
48177439|NCT02325713|100757641|FG010|COMPLETED|Intervention Period 2 (2 Days)||1||
48177440|NCT02325713|100757642|FG011|COMPLETED|Intervention Period 2 (2 Days)||2||
48177441|NCT02325713|100757643|FG012|COMPLETED|Intervention Period 2 (2 Days)||2||
48177442|NCT02325713|100757644|FG013|COMPLETED|Intervention Period 2 (2 Days)||2||
48177443|NCT02325713|100757645|FG014|COMPLETED|Intervention Period 2 (2 Days)||2||
48177444|NCT02325713|100757646|FG015|COMPLETED|Intervention Period 2 (2 Days)||2||
48177445|NCT02325713|100757631|FG000|NOT COMPLETED|Intervention Period 2 (2 Days)||1||
48177446|NCT02325713|100757632|FG001|NOT COMPLETED|Intervention Period 2 (2 Days)||0||
48177447|NCT02325713|100757633|FG002|NOT COMPLETED|Intervention Period 2 (2 Days)||0||
48177448|NCT02325713|100757634|FG003|NOT COMPLETED|Intervention Period 2 (2 Days)||0||
48177449|NCT02325713|100757635|FG004|NOT COMPLETED|Intervention Period 2 (2 Days)||0||
48177450|NCT02325713|100757636|FG005|NOT COMPLETED|Intervention Period 2 (2 Days)||0||
48177451|NCT02325713|100757637|FG006|NOT COMPLETED|Intervention Period 2 (2 Days)||0||
48177452|NCT02325713|100757638|FG007|NOT COMPLETED|Intervention Period 2 (2 Days)||0||
48177453|NCT02325713|100757639|FG008|NOT COMPLETED|Intervention Period 2 (2 Days)||0||
48177454|NCT02325713|100757640|FG009|NOT COMPLETED|Intervention Period 2 (2 Days)||0||
48337815|NCT01171820|101156534|FG000|STARTED|Overall Study||106||
48337816|NCT01171820|101156535|FG001|STARTED|Overall Study||218||
48337817|NCT01171820|101156534|FG000|COMPLETED|Overall Study||100||
48439946|NCT04993339|101409990|FG001|NOT COMPLETED|Overall Study||2||
48631239|NCT00921024|101881484|FG000|COMPLETED|Overall Study||81||
48631240|NCT00921024|101881485|FG001|COMPLETED|Overall Study||39||
48631241|NCT00921024|101881484|FG000|NOT COMPLETED|Overall Study||4||
48631242|NCT00921024|101881485|FG001|NOT COMPLETED|Overall Study||3||
48631243|NCT01579214|101881486|FG000|STARTED|Overall Study||45||
48631244|NCT01579214|101881487|FG001|STARTED|Overall Study||138||
48177455|NCT02325713|100757641|FG010|NOT COMPLETED|Intervention Period 2 (2 Days)||0||
48177456|NCT02325713|100757642|FG011|NOT COMPLETED|Intervention Period 2 (2 Days)||0||
48177457|NCT02325713|100757643|FG012|NOT COMPLETED|Intervention Period 2 (2 Days)||0||
48177458|NCT02325713|100757644|FG013|NOT COMPLETED|Intervention Period 2 (2 Days)||0||
48177459|NCT02325713|100757645|FG014|NOT COMPLETED|Intervention Period 2 (2 Days)||0||
48177460|NCT02325713|100757646|FG015|NOT COMPLETED|Intervention Period 2 (2 Days)||0||
48177461|NCT02325713|100757631|FG000|STARTED|Intervention Period 3 (2 Days)||1||
48177462|NCT02325713|100757632|FG001|STARTED|Intervention Period 3 (2 Days)||2||
48177463|NCT02325713|100757633|FG002|STARTED|Intervention Period 3 (2 Days)||2||
48177464|NCT02325713|100757634|FG003|STARTED|Intervention Period 3 (2 Days)||2||
48177465|NCT02325713|100757635|FG004|STARTED|Intervention Period 3 (2 Days)||2||
48177466|NCT02325713|100757636|FG005|STARTED|Intervention Period 3 (2 Days)||2||
48177467|NCT02325713|100757637|FG006|STARTED|Intervention Period 3 (2 Days)||2||
48177468|NCT02325713|100757638|FG007|STARTED|Intervention Period 3 (2 Days)||2||
48177469|NCT02325713|100757639|FG008|STARTED|Intervention Period 3 (2 Days)||2||
48177470|NCT02325713|100757640|FG009|STARTED|Intervention Period 3 (2 Days)||2||
48177471|NCT02325713|100757641|FG010|STARTED|Intervention Period 3 (2 Days)||1||
48631245|NCT01579214|101881486|FG000|COMPLETED|Overall Study||45||
48631246|NCT01579214|101881487|FG001|COMPLETED|Overall Study||138||
48631247|NCT01579214|101881486|FG000|NOT COMPLETED|Overall Study||0||
48631248|NCT01579214|101881487|FG001|NOT COMPLETED|Overall Study||0||
48631249|NCT00243243|101881488|FG000|STARTED|Overall Study||10||
48753685|NCT00189098|102184565|FG001|COMPLETED|Overall Study||44||
48177472|NCT02325713|100757642|FG011|STARTED|Intervention Period 3 (2 Days)||2||
48177473|NCT02325713|100757643|FG012|STARTED|Intervention Period 3 (2 Days)||2||
48177474|NCT02325713|100757644|FG013|STARTED|Intervention Period 3 (2 Days)||2||
48177475|NCT02325713|100757645|FG014|STARTED|Intervention Period 3 (2 Days)||2||
48177476|NCT02325713|100757646|FG015|STARTED|Intervention Period 3 (2 Days)||2||
48177477|NCT02325713|100757631|FG000|COMPLETED|Intervention Period 3 (2 Days)||1||
48177478|NCT02325713|100757632|FG001|COMPLETED|Intervention Period 3 (2 Days)||2||
48177479|NCT02325713|100757633|FG002|COMPLETED|Intervention Period 3 (2 Days)||2||
48177480|NCT02325713|100757634|FG003|COMPLETED|Intervention Period 3 (2 Days)||2||
48177481|NCT02325713|100757635|FG004|COMPLETED|Intervention Period 3 (2 Days)||2||
48177482|NCT02325713|100757636|FG005|COMPLETED|Intervention Period 3 (2 Days)||2||
48177483|NCT02325713|100757637|FG006|COMPLETED|Intervention Period 3 (2 Days)||2||
48177484|NCT02325713|100757638|FG007|COMPLETED|Intervention Period 3 (2 Days)||2||
48177485|NCT02325713|100757639|FG008|COMPLETED|Intervention Period 3 (2 Days)||2||
48177486|NCT02325713|100757640|FG009|COMPLETED|Intervention Period 3 (2 Days)||1||
48177487|NCT02325713|100757641|FG010|COMPLETED|Intervention Period 3 (2 Days)||1||
48177488|NCT02325713|100757642|FG011|COMPLETED|Intervention Period 3 (2 Days)||2||
48177489|NCT02325713|100757643|FG012|COMPLETED|Intervention Period 3 (2 Days)||2||
48177490|NCT02325713|100757644|FG013|COMPLETED|Intervention Period 3 (2 Days)||2||
48177491|NCT02325713|100757645|FG014|COMPLETED|Intervention Period 3 (2 Days)||2||
48177492|NCT02325713|100757646|FG015|COMPLETED|Intervention Period 3 (2 Days)||2||
48177493|NCT02325713|100757631|FG000|NOT COMPLETED|Intervention Period 3 (2 Days)||0||
48177494|NCT02325713|100757632|FG001|NOT COMPLETED|Intervention Period 3 (2 Days)||0||
48177495|NCT02325713|100757633|FG002|NOT COMPLETED|Intervention Period 3 (2 Days)||0||
48177496|NCT02325713|100757634|FG003|NOT COMPLETED|Intervention Period 3 (2 Days)||0||
48177497|NCT02325713|100757635|FG004|NOT COMPLETED|Intervention Period 3 (2 Days)||0||
48177498|NCT02325713|100757636|FG005|NOT COMPLETED|Intervention Period 3 (2 Days)||0||
48177499|NCT02325713|100757637|FG006|NOT COMPLETED|Intervention Period 3 (2 Days)||0||
48177500|NCT02325713|100757638|FG007|NOT COMPLETED|Intervention Period 3 (2 Days)||0||
48177501|NCT02325713|100757639|FG008|NOT COMPLETED|Intervention Period 3 (2 Days)||0||
48177502|NCT02325713|100757640|FG009|NOT COMPLETED|Intervention Period 3 (2 Days)||1||
48337818|NCT01171820|101156535|FG001|COMPLETED|Overall Study||212||
48337819|NCT01171820|101156534|FG000|NOT COMPLETED|Overall Study||6||
48337820|NCT01171820|101156535|FG001|NOT COMPLETED|Overall Study||6||
48337821|NCT03757988|101156536|FG000|STARTED|Overall Study||17||
48337822|NCT03757988|101156536|FG000|COMPLETED|Overall Study||16||
48337823|NCT03757988|101156536|FG000|NOT COMPLETED|Overall Study||1||
48337824|NCT01390909|101156537|FG000|STARTED|Overall Study||3454||
48631250|NCT00243243|101881489|FG001|STARTED|Overall Study||10||
48631251|NCT00243243|101881488|FG000|COMPLETED|Overall Study||10||
48631252|NCT00243243|101881489|FG001|COMPLETED|Overall Study||10||
48631253|NCT00243243|101881488|FG000|NOT COMPLETED|Overall Study||0||
48631254|NCT00243243|101881489|FG001|NOT COMPLETED|Overall Study||0||
48631255|NCT01712178|101881490|FG000|STARTED|Overall Study||50||
48631256|NCT01712178|101881491|FG001|STARTED|Overall Study||50||
48631257|NCT01712178|101881490|FG000|COMPLETED|Overall Study||49||
48631258|NCT01712178|101881491|FG001|COMPLETED|Overall Study||47||
48631259|NCT01712178|101881490|FG000|NOT COMPLETED|Overall Study||1||
48631260|NCT01712178|101881491|FG001|NOT COMPLETED|Overall Study||3||
48753686|NCT00189098|102184564|FG000|NOT COMPLETED|Overall Study||5||
48177503|NCT02325713|100757641|FG010|NOT COMPLETED|Intervention Period 3 (2 Days)||0||
48177504|NCT02325713|100757642|FG011|NOT COMPLETED|Intervention Period 3 (2 Days)||0||
48177505|NCT02325713|100757643|FG012|NOT COMPLETED|Intervention Period 3 (2 Days)||0||
48177506|NCT02325713|100757644|FG013|NOT COMPLETED|Intervention Period 3 (2 Days)||0||
48177507|NCT02325713|100757645|FG014|NOT COMPLETED|Intervention Period 3 (2 Days)||0||
48177508|NCT02325713|100757646|FG015|NOT COMPLETED|Intervention Period 3 (2 Days)||0||
48177509|NCT02325713|100757631|FG000|STARTED|Intervention Period 4 (2 Days)||1||
48177510|NCT02325713|100757632|FG001|STARTED|Intervention Period 4 (2 Days)||2||
48177511|NCT02325713|100757633|FG002|STARTED|Intervention Period 4 (2 Days)||2||
48177512|NCT02325713|100757634|FG003|STARTED|Intervention Period 4 (2 Days)||2||
48177513|NCT02325713|100757635|FG004|STARTED|Intervention Period 4 (2 Days)||2||
48177514|NCT02325713|100757636|FG005|STARTED|Intervention Period 4 (2 Days)||2||
48177515|NCT02325713|100757637|FG006|STARTED|Intervention Period 4 (2 Days)||2||
48177516|NCT02325713|100757638|FG007|STARTED|Intervention Period 4 (2 Days)||2||
48177517|NCT02325713|100757639|FG008|STARTED|Intervention Period 4 (2 Days)||2||
48177518|NCT02325713|100757640|FG009|STARTED|Intervention Period 4 (2 Days)||1||
48177519|NCT02325713|100757641|FG010|STARTED|Intervention Period 4 (2 Days)||1||
48177520|NCT02325713|100757642|FG011|STARTED|Intervention Period 4 (2 Days)||2||
48177521|NCT02325713|100757643|FG012|STARTED|Intervention Period 4 (2 Days)||2||
48177522|NCT02325713|100757644|FG013|STARTED|Intervention Period 4 (2 Days)||2||
48177523|NCT02325713|100757645|FG014|STARTED|Intervention Period 4 (2 Days)||2||
48177524|NCT02325713|100757646|FG015|STARTED|Intervention Period 4 (2 Days)||2||
48177525|NCT02325713|100757631|FG000|COMPLETED|Intervention Period 4 (2 Days)||1||
48177526|NCT02325713|100757632|FG001|COMPLETED|Intervention Period 4 (2 Days)||2||
48177527|NCT02325713|100757633|FG002|COMPLETED|Intervention Period 4 (2 Days)||2||
48177528|NCT02325713|100757634|FG003|COMPLETED|Intervention Period 4 (2 Days)||2||
48177529|NCT02325713|100757635|FG004|COMPLETED|Intervention Period 4 (2 Days)||2||
48177530|NCT02325713|100757636|FG005|COMPLETED|Intervention Period 4 (2 Days)||2||
48177531|NCT02325713|100757637|FG006|COMPLETED|Intervention Period 4 (2 Days)||2||
48177532|NCT02325713|100757638|FG007|COMPLETED|Intervention Period 4 (2 Days)||2||
48177533|NCT02325713|100757639|FG008|COMPLETED|Intervention Period 4 (2 Days)||2||
48177534|NCT02325713|100757640|FG009|COMPLETED|Intervention Period 4 (2 Days)||1||
48177535|NCT02325713|100757641|FG010|COMPLETED|Intervention Period 4 (2 Days)||1||
48177536|NCT02325713|100757642|FG011|COMPLETED|Intervention Period 4 (2 Days)||2||
48177537|NCT02325713|100757643|FG012|COMPLETED|Intervention Period 4 (2 Days)||2||
48177538|NCT02325713|100757644|FG013|COMPLETED|Intervention Period 4 (2 Days)||2||
48753687|NCT00189098|102184565|FG001|NOT COMPLETED|Overall Study||6||
48753688|NCT01743469|102184566|FG000|STARTED|Active Treatment Phase||53||
48177539|NCT02325713|100757645|FG014|COMPLETED|Intervention Period 4 (2 Days)||2||
48177540|NCT02325713|100757646|FG015|COMPLETED|Intervention Period 4 (2 Days)||2||
48177541|NCT02325713|100757631|FG000|NOT COMPLETED|Intervention Period 4 (2 Days)||0||
48177542|NCT02325713|100757632|FG001|NOT COMPLETED|Intervention Period 4 (2 Days)||0||
48177543|NCT02325713|100757633|FG002|NOT COMPLETED|Intervention Period 4 (2 Days)||0||
48177544|NCT02325713|100757634|FG003|NOT COMPLETED|Intervention Period 4 (2 Days)||0||
48177545|NCT02325713|100757635|FG004|NOT COMPLETED|Intervention Period 4 (2 Days)||0||
48177546|NCT02325713|100757636|FG005|NOT COMPLETED|Intervention Period 4 (2 Days)||0||
48177547|NCT02325713|100757637|FG006|NOT COMPLETED|Intervention Period 4 (2 Days)||0||
48177548|NCT02325713|100757638|FG007|NOT COMPLETED|Intervention Period 4 (2 Days)||0||
48177549|NCT02325713|100757639|FG008|NOT COMPLETED|Intervention Period 4 (2 Days)||0||
48177550|NCT02325713|100757640|FG009|NOT COMPLETED|Intervention Period 4 (2 Days)||0||
48177551|NCT02325713|100757641|FG010|NOT COMPLETED|Intervention Period 4 (2 Days)||0||
48337825|NCT01390909|101156538|FG001|STARTED|Overall Study||3552||
48337826|NCT01390909|101156539|FG002|STARTED|Overall Study||3552||
48337827|NCT01390909|101156540|FG003|STARTED|Overall Study||602||
48337828|NCT01390909|101156541|FG004|STARTED|Overall Study||613||
48337829|NCT01390909|101156542|FG005|STARTED|Overall Study||613||
48337830|NCT01390909|101156537|FG000|Participants in Subgroup|Overall Study||0||
48337831|NCT01390909|101156538|FG001|Participants in Subgroup|Overall Study||3454||
48412981|NCT02531633|101345748|FG005|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0|2 Participants completed Part A then withdrew. They are counted again in withdrawals|
48177552|NCT02325713|100757642|FG011|NOT COMPLETED|Intervention Period 4 (2 Days)||0||
48177553|NCT02325713|100757643|FG012|NOT COMPLETED|Intervention Period 4 (2 Days)||0||
48337832|NCT01390909|101156539|FG002|Participants in Subgroup|Overall Study||0||
48177554|NCT02325713|100757644|FG013|NOT COMPLETED|Intervention Period 4 (2 Days)||0||
48177555|NCT02325713|100757645|FG014|NOT COMPLETED|Intervention Period 4 (2 Days)||0||
48177556|NCT02325713|100757646|FG015|NOT COMPLETED|Intervention Period 4 (2 Days)||0||
48337833|NCT01390909|101156540|FG003|Participants in Subgroup|Overall Study||0||
48177557|NCT00247624|100757647|FG000|STARTED|Overall Study||30||
48177558|NCT00247624|100757648|FG001|STARTED|Overall Study||30||
48177559|NCT00247624|100757647|FG000|COMPLETED|Overall Study||25||
48177560|NCT00247624|100757648|FG001|COMPLETED|Overall Study||26||
48177561|NCT00247624|100757647|FG000|NOT COMPLETED|Overall Study||5||
48177562|NCT00247624|100757648|FG001|NOT COMPLETED|Overall Study||4||
48177563|NCT02471404|100757649|FG000|STARTED|Overall Study||314||
48177564|NCT02471404|100757650|FG001|STARTED|Overall Study||312||
48177565|NCT02471404|100757651|FG002|STARTED|Overall Study||313||
48177566|NCT02471404|100757649|FG000|COMPLETED|Overall Study||281||
48177567|NCT02471404|100757650|FG001|COMPLETED|Overall Study||298||
48177568|NCT02471404|100757651|FG002|COMPLETED|Overall Study||288||
48177569|NCT02471404|100757649|FG000|NOT COMPLETED|Overall Study||33||
48177570|NCT02471404|100757650|FG001|NOT COMPLETED|Overall Study||14||
48177571|NCT02471404|100757651|FG002|NOT COMPLETED|Overall Study||25||
48177572|NCT04747275|100757652|FG000|STARTED|Overall Study||2||
48177573|NCT04747275|100757653|FG001|STARTED|Overall Study||4||
48177574|NCT04747275|100757652|FG000|COMPLETED|Overall Study||2||
48177575|NCT04747275|100757653|FG001|COMPLETED|Overall Study||3||
48177576|NCT04747275|100757652|FG000|NOT COMPLETED|Overall Study||0||
48177577|NCT04747275|100757653|FG001|NOT COMPLETED|Overall Study||1||
48177578|NCT01163747|100757654|FG000|STARTED|Overall Study||31||
48177579|NCT01163747|100757655|FG001|STARTED|Overall Study||60||
48177580|NCT01163747|100757654|FG000|Per Protocol Population|Overall Study||27||
48177581|NCT01163747|100757655|FG001|Per Protocol Population|Overall Study||54||
48177582|NCT01163747|100757654|FG000|COMPLETED|Overall Study||25||
48177583|NCT01163747|100757655|FG001|COMPLETED|Overall Study||49||
48177584|NCT01163747|100757654|FG000|NOT COMPLETED|Overall Study||6||
48177585|NCT01163747|100757655|FG001|NOT COMPLETED|Overall Study||11||
48753689|NCT01743469|102184567|FG001|STARTED|Active Treatment Phase||55||
48753690|NCT01743469|102184568|FG002|STARTED|Active Treatment Phase||38||
48753691|NCT01743469|102184569|FG003|STARTED|Active Treatment Phase||21||
48753692|NCT01743469|102184566|FG000|COMPLETED|Active Treatment Phase||0||
48753693|NCT01743469|102184567|FG001|COMPLETED|Active Treatment Phase||0||
48753694|NCT01743469|102184568|FG002|COMPLETED|Active Treatment Phase||0||
48753695|NCT01743469|102184569|FG003|COMPLETED|Active Treatment Phase||0||
48753696|NCT01743469|102184566|FG000|NOT COMPLETED|Active Treatment Phase||53||
48753697|NCT01743469|102184567|FG001|NOT COMPLETED|Active Treatment Phase||55||
48753698|NCT01743469|102184568|FG002|NOT COMPLETED|Active Treatment Phase||38||
48177586|NCT02878213|100757656|FG000|STARTED|Overall Study||39||
48177587|NCT02878213|100757656|FG000|COMPLETED|Overall Study||36||
48177588|NCT02878213|100757656|FG000|NOT COMPLETED|Overall Study||3||
48177589|NCT02982720|100757657|FG000|STARTED|Overall Study||4||
48177590|NCT02982720|100757657|FG000|COMPLETED|Overall Study||0||
48177591|NCT02982720|100757657|FG000|NOT COMPLETED|Overall Study||4||
48177592|NCT02228525|100757658|FG000|STARTED|Overall Study||25||
48177593|NCT02228525|100757658|FG000|COMPLETED|Overall Study||25||
48177594|NCT02228525|100757658|FG000|NOT COMPLETED|Overall Study||0||
48177595|NCT00358215|100757659|FG000|STARTED|Overall Study||1142||
48177596|NCT00358215|100757660|FG001|STARTED|Overall Study||1136||
48177597|NCT00358215|100757659|FG000|Received Investigational Product|Overall Study||1140||
48177598|NCT00358215|100757660|FG001|Received Investigational Product|Overall Study||1133||
48177599|NCT00358215|100757659|FG000|COMPLETED|Overall Study||463||
48177600|NCT00358215|100757660|FG001|COMPLETED|Overall Study||484||
48177601|NCT00358215|100757659|FG000|NOT COMPLETED|Overall Study||679||
48177602|NCT00358215|100757660|FG001|NOT COMPLETED|Overall Study||652||
48177603|NCT02791490|100757661|FG000|STARTED|Overall Study||229||
48177604|NCT02791490|100757662|FG001|STARTED|Overall Study||229||
48177605|NCT02791490|100757661|FG000|COMPLETED|Overall Study||226||
48177606|NCT02791490|100757662|FG001|COMPLETED|Overall Study||221||
48177607|NCT02791490|100757661|FG000|NOT COMPLETED|Overall Study||3||
48177608|NCT02791490|100757662|FG001|NOT COMPLETED|Overall Study||8||
48177609|NCT00867490|100757663|FG000|STARTED|Phase 1 - Candesartan+HCTZ||186||
48177610|NCT00867490|100757663|FG000|COMPLETED|Phase 1 - Candesartan+HCTZ||176||
48177611|NCT00867490|100757663|FG000|NOT COMPLETED|Phase 1 - Candesartan+HCTZ||10||
48177612|NCT00867490|100757663|FG000|STARTED|Phase 2 - Aliskiren+HCTZ||123||
48177613|NCT00867490|100757663|FG000|COMPLETED|Phase 2 - Aliskiren+HCTZ||120||
48177614|NCT00867490|100757663|FG000|NOT COMPLETED|Phase 2 - Aliskiren+HCTZ||3||
48177615|NCT00867490|100757663|FG000|STARTED|Phase 3 - Aliskiren+HCTZ+Amlodipine||61||
48177616|NCT00867490|100757663|FG000|COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||61||
48177617|NCT00867490|100757663|FG000|NOT COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||0||
48177618|NCT02040090|100757664|FG000|STARTED|Overall Study||59||
48177619|NCT02040090|100757665|FG001|STARTED|Overall Study||59||
48177620|NCT02040090|100757664|FG000|COMPLETED|Overall Study||56||
48177621|NCT02040090|100757665|FG001|COMPLETED|Overall Study||57||
48177622|NCT02040090|100757664|FG000|NOT COMPLETED|Overall Study||3||
48177623|NCT02040090|100757665|FG001|NOT COMPLETED|Overall Study||2||
48177624|NCT00502996|100757666|FG000|STARTED|Overall Study||232||
48177625|NCT00502996|100757666|FG000|COMPLETED|Overall Study||188||
48177626|NCT00502996|100757666|FG000|NOT COMPLETED|Overall Study||44||
48177627|NCT02836613|100757667|FG000|STARTED|Overall Study||80||
48177628|NCT02836613|100757668|FG001|STARTED|Overall Study||80||
48177629|NCT02836613|100757667|FG000|COMPLETED|Overall Study||79||
48177630|NCT02836613|100757668|FG001|COMPLETED|Overall Study||77||
48177631|NCT02836613|100757667|FG000|NOT COMPLETED|Overall Study||1||
48177632|NCT02836613|100757668|FG001|NOT COMPLETED|Overall Study||3||
48177633|NCT00787722|100757669|FG000|STARTED|Overall Study||13||
48177634|NCT00787722|100757669|FG000|COMPLETED|Overall Study||12||
48753699|NCT01743469|102184569|FG003|NOT COMPLETED|Active Treatment Phase||21||
48767744|NCT02141295|102222816|FG001|COMPLETED|Overall Study||0||
48412982|NCT02531633|101345749|FG006|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0|2 Participants completed Part A then withdrew. They are counted again in withdrawals|
48412983|NCT02531633|101345750|FG007|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0|2 Participants completed Part A then withdrew. They are counted again in withdrawals|
48412984|NCT02531633|101345751|FG008|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0|2 Participants completed Part A then withdrew. They are counted again in withdrawals|
48631261|NCT00336544|101881492|FG000|STARTED|Overall Study||261||
48631262|NCT00336544|101881493|FG001|STARTED|Overall Study||260||
48631263|NCT00336544|101881492|FG000|COMPLETED|Overall Study||242||
48631264|NCT00336544|101881493|FG001|COMPLETED|Overall Study||238||
48631265|NCT00336544|101881492|FG000|NOT COMPLETED|Overall Study||19||
48631266|NCT00336544|101881493|FG001|NOT COMPLETED|Overall Study||22||
48631267|NCT01240746|101881494|FG000|STARTED|Overall Study||736||
48631268|NCT01240746|101881495|FG001|STARTED|Overall Study||725||
48631269|NCT01240746|101881496|FG002|STARTED|Overall Study||2902||
48631270|NCT01240746|101881494|FG000|COMPLETED|Overall Study||677||
48631271|NCT01240746|101881495|FG001|COMPLETED|Overall Study||677||
48631272|NCT01240746|101881496|FG002|COMPLETED|Overall Study||2659||
48631273|NCT01240746|101881494|FG000|NOT COMPLETED|Overall Study||59||
48631274|NCT01240746|101881495|FG001|NOT COMPLETED|Overall Study||48||
48631275|NCT01240746|101881496|FG002|NOT COMPLETED|Overall Study||243||
48631276|NCT00848016|101881497|FG000|STARTED|Overall Study||29||
48631277|NCT00848016|101881497|FG000|COMPLETED|Overall Study||29||
48631278|NCT00848016|101881497|FG000|NOT COMPLETED|Overall Study||0||
48631279|NCT00641056|101881498|FG000|STARTED|Overall Study||233||
48631280|NCT00641056|101881499|FG001|STARTED|Overall Study||234||
48631281|NCT00641056|101881498|FG000|Intent to Treat (ITT)|Overall Study||233||
48631282|NCT00641056|101881499|FG001|Intent to Treat (ITT)|Overall Study||223||
48631283|NCT00641056|101881498|FG000|COMPLETED|Overall Study||204||
48753700|NCT01743469|102184566|FG000|STARTED|Follow-up Period - Post-Treatment||51|Entered into follow-up after last treatment with study drug|
48753701|NCT01743469|102184567|FG001|STARTED|Follow-up Period - Post-Treatment||53|Entered into follow-up after last treatment with study drug|
48753702|NCT01743469|102184568|FG002|STARTED|Follow-up Period - Post-Treatment||37|Entered into follow-up after last treatment with study drug|
48753703|NCT01743469|102184569|FG003|STARTED|Follow-up Period - Post-Treatment||21|Entered into follow-up after last treatment with study drug|
48753704|NCT01743469|102184566|FG000|COMPLETED|Follow-up Period - Post-Treatment||6||
48753705|NCT01743469|102184567|FG001|COMPLETED|Follow-up Period - Post-Treatment||5||
48753706|NCT01743469|102184568|FG002|COMPLETED|Follow-up Period - Post-Treatment||14||
48753707|NCT01743469|102184569|FG003|COMPLETED|Follow-up Period - Post-Treatment||5||
48753708|NCT01743469|102184566|FG000|NOT COMPLETED|Follow-up Period - Post-Treatment||45||
48753709|NCT01743469|102184567|FG001|NOT COMPLETED|Follow-up Period - Post-Treatment||48||
48753710|NCT01743469|102184568|FG002|NOT COMPLETED|Follow-up Period - Post-Treatment||23||
48753711|NCT01743469|102184569|FG003|NOT COMPLETED|Follow-up Period - Post-Treatment||16||
48753712|NCT00189540|102184570|FG000|STARTED|Overall Study||21||
48753713|NCT00189540|102184571|FG001|STARTED|Overall Study||6||
48753714|NCT00189540|102184570|FG000|COMPLETED|Overall Study||14||
48753715|NCT00189540|102184571|FG001|COMPLETED|Overall Study||5||
48753716|NCT00189540|102184570|FG000|NOT COMPLETED|Overall Study||7||
48753717|NCT00189540|102184571|FG001|NOT COMPLETED|Overall Study||1||
48631284|NCT00641056|101881499|FG001|COMPLETED|Overall Study||209||
48631285|NCT00641056|101881498|FG000|NOT COMPLETED|Overall Study||29||
48631286|NCT00641056|101881499|FG001|NOT COMPLETED|Overall Study||25||
48337834|NCT01390909|101156541|FG004|Participants in Subgroup|Overall Study||602||
48337835|NCT01390909|101156542|FG005|Participants in Subgroup|Overall Study||0||
48337836|NCT01390909|101156537|FG000|COMPLETED|Overall Study||3454||
48337837|NCT01390909|101156538|FG001|COMPLETED|Overall Study||3552||
48337838|NCT01390909|101156539|FG002|COMPLETED|Overall Study||3552||
48337839|NCT01390909|101156540|FG003|COMPLETED|Overall Study||602||
48337840|NCT01390909|101156541|FG004|COMPLETED|Overall Study||613||
48337841|NCT01390909|101156542|FG005|COMPLETED|Overall Study||613||
48337842|NCT01390909|101156537|FG000|NOT COMPLETED|Overall Study||0||
48337843|NCT01390909|101156538|FG001|NOT COMPLETED|Overall Study||0||
48337844|NCT01390909|101156539|FG002|NOT COMPLETED|Overall Study||0||
48337845|NCT01390909|101156540|FG003|NOT COMPLETED|Overall Study||0||
48337846|NCT01390909|101156541|FG004|NOT COMPLETED|Overall Study||0||
48337847|NCT01390909|101156542|FG005|NOT COMPLETED|Overall Study||0||
48337848|NCT01175005|101156543|FG000|STARTED|Overall Study||62||
48337849|NCT01175005|101156543|FG000|COMPLETED|Overall Study||62||
48337850|NCT01175005|101156543|FG000|NOT COMPLETED|Overall Study||0||
48337851|NCT02848833|101156544|FG000|STARTED|Overall Study||3368||
48337852|NCT02848833|101156544|FG000|COMPLETED|Overall Study||3231|All Participants whose case report forms (CRFs) were retrieved during the re-examination period and who did not violate the inclusion/exclusion criteria.|
48337853|NCT02848833|101156544|FG000|NOT COMPLETED|Overall Study||137||
48337854|NCT01824979|101156545|FG000|STARTED|Overall Study||50||
48337855|NCT01824979|101156546|FG001|STARTED|Overall Study||50||
48337856|NCT01824979|101156545|FG000|COMPLETED|Overall Study||37||
48337857|NCT01824979|101156546|FG001|COMPLETED|Overall Study||37||
48337858|NCT01824979|101156545|FG000|NOT COMPLETED|Overall Study||13||
48337859|NCT01824979|101156546|FG001|NOT COMPLETED|Overall Study||13||
48337860|NCT02078219|101156547|FG000|STARTED|Overall Study||41||
48337861|NCT02078219|101156548|FG001|STARTED|Overall Study||40||
48337862|NCT02078219|101156549|FG002|STARTED|Overall Study||41||
48337863|NCT02078219|101156550|FG003|STARTED|Overall Study||41||
48337864|NCT02078219|101156551|FG004|STARTED|Overall Study||41||
48337865|NCT02078219|101156547|FG000|COMPLETED|Overall Study||38||
48337866|NCT02078219|101156548|FG001|COMPLETED|Overall Study||36||
48337867|NCT02078219|101156549|FG002|COMPLETED|Overall Study||35||
48337868|NCT02078219|101156550|FG003|COMPLETED|Overall Study||37||
48337869|NCT02078219|101156551|FG004|COMPLETED|Overall Study||39||
48337870|NCT02078219|101156547|FG000|NOT COMPLETED|Overall Study||3||
48337871|NCT02078219|101156548|FG001|NOT COMPLETED|Overall Study||4||
48337872|NCT02078219|101156549|FG002|NOT COMPLETED|Overall Study||6||
48337873|NCT02078219|101156550|FG003|NOT COMPLETED|Overall Study||4||
48337874|NCT02078219|101156551|FG004|NOT COMPLETED|Overall Study||2||
48337875|NCT01570244|101156552|FG000|STARTED|Microgynon||16||
48337876|NCT01570244|101156552|FG000|COMPLETED|Microgynon||16||
48337877|NCT01570244|101156552|FG000|NOT COMPLETED|Microgynon||0||
48337878|NCT01570244|101156552|FG000|STARTED|Microgynon+Faldaprevir||16||
48337879|NCT01570244|101156552|FG000|COMPLETED|Microgynon+Faldaprevir||15||
48337880|NCT01570244|101156552|FG000|NOT COMPLETED|Microgynon+Faldaprevir||1||
48337881|NCT02063035|101156553|FG000|STARTED|Overall Study||12||
48337882|NCT02063035|101156554|FG001|STARTED|Overall Study||17||
48337883|NCT02063035|101156553|FG000|COMPLETED|Overall Study||12||
48337884|NCT02063035|101156554|FG001|COMPLETED|Overall Study||17||
48337885|NCT02063035|101156553|FG000|NOT COMPLETED|Overall Study||0||
48337886|NCT02063035|101156554|FG001|NOT COMPLETED|Overall Study||0||
48337887|NCT04866290|101156555|FG000|STARTED|Enrolled and Completion of TACE Cycle 1||105||
48337888|NCT04866290|101156555|FG000|COMPLETED|Enrolled and Completion of TACE Cycle 1||105||
48337889|NCT04866290|101156555|FG000|NOT COMPLETED|Enrolled and Completion of TACE Cycle 1||0||
48337890|NCT04866290|101156555|FG000|STARTED|Completion of TACE Cycle 2||105||
48412985|NCT02531633|101345752|FG009|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0|2 Participants completed Part A then withdrew. They are counted again in withdrawals|
48412986|NCT02531633|101345743|FG000|COMPLETED|Part A (52 Weeks)||8|Completed Part A and entered Part B|
48412987|NCT02531633|101345744|FG001|COMPLETED|Part A (52 Weeks)||5|Completed Part A and entered Part B|
48412988|NCT02531633|101345745|FG002|COMPLETED|Part A (52 Weeks)||4|Completed Part A and entered Part B|
48412989|NCT02531633|101345746|FG003|COMPLETED|Part A (52 Weeks)||5|Completed Part A and entered Part B|
48631287|NCT01004614|101881500|FG000|STARTED|First Intervention||12||
48337891|NCT04866290|101156555|FG000|COMPLETED|Completion of TACE Cycle 2||58||
48337892|NCT04866290|101156555|FG000|NOT COMPLETED|Completion of TACE Cycle 2||47||
48337893|NCT02633371|101156556|FG000|STARTED|Overall Study||10||
48337894|NCT02633371|101156556|FG000|COMPLETED|Overall Study||7||
48337895|NCT02633371|101156556|FG000|NOT COMPLETED|Overall Study||3||
48337896|NCT01811147|101156557|FG000|STARTED|Overall Study||51||
48337897|NCT01811147|101156558|FG001|STARTED|Overall Study||56||
48337898|NCT01811147|101156559|FG002|STARTED|Overall Study||49||
48412990|NCT02531633|101345747|FG004|COMPLETED|Part A (52 Weeks)||4|Completed Part A and entered Part B|
48412991|NCT02531633|101345748|FG005|COMPLETED|Part A (52 Weeks)||0|Completed Part A and entered Part B|
48337899|NCT01811147|101156560|FG003|STARTED|Overall Study||33||
48337900|NCT01811147|101156557|FG000|COMPLETED|Overall Study||15||
48337901|NCT01811147|101156558|FG001|COMPLETED|Overall Study||11||
48337902|NCT01811147|101156559|FG002|COMPLETED|Overall Study||6||
48337903|NCT01811147|101156560|FG003|COMPLETED|Overall Study||4||
48337904|NCT01811147|101156557|FG000|NOT COMPLETED|Overall Study||36||
48337905|NCT01811147|101156558|FG001|NOT COMPLETED|Overall Study||45||
48337906|NCT01811147|101156559|FG002|NOT COMPLETED|Overall Study||43||
48337907|NCT01811147|101156560|FG003|NOT COMPLETED|Overall Study||29||
48337908|NCT01790503|101156561|FG000|STARTED|Overall Study||3||
48337909|NCT01790503|101156562|FG001|STARTED|Overall Study||1||
48337910|NCT01790503|101156563|FG002|STARTED|Overall Study||1||
48753718|NCT00003468|102184572|FG000|STARTED|Overall Study||11||
48753719|NCT00003468|102184572|FG000|COMPLETED|Overall Study||9||
48753720|NCT00003468|102184572|FG000|NOT COMPLETED|Overall Study||2||
48753721|NCT03416868|102184573|FG000|STARTED|Overall Study||39||
48337911|NCT01790503|101156564|FG003|STARTED|Overall Study||2||
48337912|NCT01790503|101156565|FG004|STARTED|Overall Study||5||
48337913|NCT01790503|101156566|FG005|STARTED|Overall Study||5||
48337914|NCT01790503|101156567|FG006|STARTED|Overall Study||1||
48337915|NCT01790503|101156568|FG007|STARTED|Overall Study||1||
48337916|NCT01790503|101156569|FG008|STARTED|Overall Study||3||
48337917|NCT01790503|101156570|FG009|STARTED|Overall Study||27||
48337918|NCT01790503|101156571|FG010|STARTED|Overall Study||16||
48337919|NCT01790503|101156561|FG000|COMPLETED|Overall Study||0||
48337920|NCT01790503|101156562|FG001|COMPLETED|Overall Study||0||
48337921|NCT01790503|101156563|FG002|COMPLETED|Overall Study||0||
48337922|NCT01790503|101156564|FG003|COMPLETED|Overall Study||0||
48337923|NCT01790503|101156565|FG004|COMPLETED|Overall Study||0||
48337924|NCT01790503|101156566|FG005|COMPLETED|Overall Study||0||
48337925|NCT01790503|101156567|FG006|COMPLETED|Overall Study||0||
48337926|NCT01790503|101156568|FG007|COMPLETED|Overall Study||0||
48337927|NCT01790503|101156569|FG008|COMPLETED|Overall Study||0||
48337928|NCT01790503|101156570|FG009|COMPLETED|Overall Study||1||
48337929|NCT01790503|101156571|FG010|COMPLETED|Overall Study||0||
48337930|NCT01790503|101156561|FG000|NOT COMPLETED|Overall Study||3||
48337931|NCT01790503|101156562|FG001|NOT COMPLETED|Overall Study||1||
48337932|NCT01790503|101156563|FG002|NOT COMPLETED|Overall Study||1||
48337933|NCT01790503|101156564|FG003|NOT COMPLETED|Overall Study||2||
48337934|NCT01790503|101156565|FG004|NOT COMPLETED|Overall Study||5||
48337935|NCT01790503|101156566|FG005|NOT COMPLETED|Overall Study||5||
48337936|NCT01790503|101156567|FG006|NOT COMPLETED|Overall Study||1||
48337937|NCT01790503|101156568|FG007|NOT COMPLETED|Overall Study||1||
48337938|NCT01790503|101156569|FG008|NOT COMPLETED|Overall Study||3||
48337939|NCT01790503|101156570|FG009|NOT COMPLETED|Overall Study||26||
48337940|NCT01790503|101156571|FG010|NOT COMPLETED|Overall Study||16||
48337941|NCT01467492|101156572|FG000|STARTED|Overall Study||83||
48337942|NCT01467492|101156573|FG001|STARTED|Overall Study||38||
48337943|NCT01467492|101156572|FG000|COMPLETED|Overall Study||61||
48337944|NCT01467492|101156573|FG001|COMPLETED|Overall Study||25||
48337945|NCT01467492|101156572|FG000|NOT COMPLETED|Overall Study||22||
48337946|NCT01467492|101156573|FG001|NOT COMPLETED|Overall Study||13||
48337947|NCT02266433|101156574|FG000|STARTED|Overall Study||127||
48337948|NCT02266433|101156575|FG001|STARTED|Overall Study||118||
48337949|NCT02266433|101156574|FG000|COMPLETED|Overall Study||68||
48337950|NCT02266433|101156575|FG001|COMPLETED|Overall Study||65||
48337951|NCT02266433|101156574|FG000|NOT COMPLETED|Overall Study||59||
48337952|NCT02266433|101156575|FG001|NOT COMPLETED|Overall Study||53||
48337953|NCT02803164|101156576|FG000|STARTED|Overall Study||10||
48337954|NCT02803164|101156577|FG001|STARTED|Overall Study||11||
48337955|NCT02803164|101156576|FG000|COMPLETED|Overall Study||10||
48337956|NCT02803164|101156577|FG001|COMPLETED|Overall Study||11||
48337957|NCT02803164|101156576|FG000|NOT COMPLETED|Overall Study||0||
48337958|NCT02803164|101156577|FG001|NOT COMPLETED|Overall Study||0||
48337959|NCT04870671|101156578|FG000|STARTED|Overall Study||7||
48337960|NCT04870671|101156579|FG001|STARTED|Overall Study||7||
48337961|NCT04870671|101156578|FG000|COMPLETED|Overall Study||7||
48337962|NCT04870671|101156579|FG001|COMPLETED|Overall Study||7||
48337963|NCT04870671|101156578|FG000|NOT COMPLETED|Overall Study||0||
48337964|NCT04870671|101156579|FG001|NOT COMPLETED|Overall Study||0||
48337965|NCT01262976|101156580|FG000|STARTED|Up to Month 2||40||
48337966|NCT01262976|101156581|FG001|STARTED|Up to Month 2||40||
48337967|NCT01262976|101156582|FG002|STARTED|Up to Month 2||40||
48753722|NCT03416868|102184573|FG000|COMPLETED|Overall Study||36||
48753723|NCT03416868|102184573|FG000|NOT COMPLETED|Overall Study||3||
48753724|NCT01755234|102184574|FG000|STARTED|Overall Study||45||
48753725|NCT01755234|102184575|FG001|STARTED|Overall Study||45||
48753726|NCT01755234|102184574|FG000|COMPLETED|Overall Study||30||
48753727|NCT01755234|102184575|FG001|COMPLETED|Overall Study||37||
48753728|NCT01755234|102184574|FG000|NOT COMPLETED|Overall Study||15||
48753729|NCT01755234|102184575|FG001|NOT COMPLETED|Overall Study||8||
48753730|NCT02994238|102184576|FG000|STARTED|Overall Study||125||
48337968|NCT01262976|101156583|FG003|STARTED|Up to Month 2||40||
48337969|NCT01262976|101156584|FG004|STARTED|Up to Month 2||40||
48337970|NCT01262976|101156585|FG005|STARTED|Up to Month 2||40||
48753731|NCT02994238|102184577|FG001|STARTED|Overall Study||127||
48753732|NCT02994238|102184576|FG000|COMPLETED|Overall Study||125||
48753733|NCT02994238|102184577|FG001|COMPLETED|Overall Study||127||
48337971|NCT01262976|101156580|FG000|COMPLETED|Up to Month 2||37||
48337972|NCT01262976|101156581|FG001|COMPLETED|Up to Month 2||39||
48337973|NCT01262976|101156582|FG002|COMPLETED|Up to Month 2||39||
48337974|NCT01262976|101156583|FG003|COMPLETED|Up to Month 2||38||
48337975|NCT01262976|101156584|FG004|COMPLETED|Up to Month 2||38||
48337976|NCT01262976|101156585|FG005|COMPLETED|Up to Month 2||36||
48337977|NCT01262976|101156580|FG000|NOT COMPLETED|Up to Month 2||3||
48337978|NCT01262976|101156581|FG001|NOT COMPLETED|Up to Month 2||1||
48337979|NCT01262976|101156582|FG002|NOT COMPLETED|Up to Month 2||1||
48337980|NCT01262976|101156583|FG003|NOT COMPLETED|Up to Month 2||2||
48337981|NCT01262976|101156584|FG004|NOT COMPLETED|Up to Month 2||2||
48337982|NCT01262976|101156585|FG005|NOT COMPLETED|Up to Month 2||4||
48337983|NCT01262976|101156580|FG000|STARTED|Up to Month 7||40||
48337984|NCT01262976|101156581|FG001|STARTED|Up to Month 7||40||
48337985|NCT01262976|101156582|FG002|STARTED|Up to Month 7||40||
48337986|NCT01262976|101156583|FG003|STARTED|Up to Month 7||40||
48337987|NCT01262976|101156584|FG004|STARTED|Up to Month 7||40||
48337988|NCT01262976|101156585|FG005|STARTED|Up to Month 7||40||
48337989|NCT01262976|101156580|FG000|COMPLETED|Up to Month 7||35||
48337990|NCT01262976|101156581|FG001|COMPLETED|Up to Month 7||40||
48337991|NCT01262976|101156582|FG002|COMPLETED|Up to Month 7||34||
48337992|NCT01262976|101156583|FG003|COMPLETED|Up to Month 7||34||
48337993|NCT01262976|101156584|FG004|COMPLETED|Up to Month 7||38||
48337994|NCT01262976|101156585|FG005|COMPLETED|Up to Month 7||36||
48337995|NCT01262976|101156580|FG000|NOT COMPLETED|Up to Month 7||5||
48337996|NCT01262976|101156581|FG001|NOT COMPLETED|Up to Month 7||0||
48337997|NCT01262976|101156582|FG002|NOT COMPLETED|Up to Month 7||6||
48337998|NCT01262976|101156583|FG003|NOT COMPLETED|Up to Month 7||6||
48337999|NCT01262976|101156584|FG004|NOT COMPLETED|Up to Month 7||2||
48338000|NCT01262976|101156585|FG005|NOT COMPLETED|Up to Month 7||4||
48338001|NCT01262976|101156580|FG000|STARTED|Up to Year 1||40||
48338002|NCT01262976|101156581|FG001|STARTED|Up to Year 1||40||
48338003|NCT01262976|101156582|FG002|STARTED|Up to Year 1||40||
48338004|NCT01262976|101156583|FG003|STARTED|Up to Year 1||40||
48338005|NCT01262976|101156584|FG004|STARTED|Up to Year 1||40||
48338006|NCT01262976|101156585|FG005|STARTED|Up to Year 1||40||
48338007|NCT01262976|101156580|FG000|COMPLETED|Up to Year 1||31||
48338008|NCT01262976|101156581|FG001|COMPLETED|Up to Year 1||39||
48338009|NCT01262976|101156582|FG002|COMPLETED|Up to Year 1||37||
48338010|NCT01262976|101156583|FG003|COMPLETED|Up to Year 1||36||
48338011|NCT01262976|101156584|FG004|COMPLETED|Up to Year 1||29||
48338012|NCT01262976|101156585|FG005|COMPLETED|Up to Year 1||31||
48338013|NCT01262976|101156580|FG000|NOT COMPLETED|Up to Year 1||9||
48338014|NCT01262976|101156581|FG001|NOT COMPLETED|Up to Year 1||1||
48338015|NCT01262976|101156582|FG002|NOT COMPLETED|Up to Year 1||3||
48338016|NCT01262976|101156583|FG003|NOT COMPLETED|Up to Year 1||4||
48631288|NCT01004614|101881501|FG001|STARTED|First Intervention||12||
48631289|NCT01004614|101881502|FG002|STARTED|First Intervention||12||
48631290|NCT01004614|101881503|FG003|STARTED|First Intervention||12||
48631291|NCT01004614|101881500|FG000|COMPLETED|First Intervention||12||
48631292|NCT01004614|101881501|FG001|COMPLETED|First Intervention||12||
48631293|NCT01004614|101881502|FG002|COMPLETED|First Intervention||12||
48631294|NCT01004614|101881503|FG003|COMPLETED|First Intervention||12||
48631295|NCT01004614|101881500|FG000|NOT COMPLETED|First Intervention||0||
48631296|NCT01004614|101881501|FG001|NOT COMPLETED|First Intervention||0||
48631297|NCT01004614|101881502|FG002|NOT COMPLETED|First Intervention||0||
48631298|NCT01004614|101881503|FG003|NOT COMPLETED|First Intervention||0||
48631299|NCT01004614|101881500|FG000|STARTED|Washout||12||
48753734|NCT02994238|102184576|FG000|NOT COMPLETED|Overall Study||0||
48753735|NCT02994238|102184577|FG001|NOT COMPLETED|Overall Study||0||
48753736|NCT02174731|102184578|FG000|STARTED|Overall Study||1051|Randomized and included in the analysis|
48753737|NCT02174731|102184579|FG001|STARTED|Overall Study||1055|Randomized and included in the analysis|
48338017|NCT01262976|101156584|FG004|NOT COMPLETED|Up to Year 1||11||
48338018|NCT01262976|101156585|FG005|NOT COMPLETED|Up to Year 1||9||
48338019|NCT01262976|101156580|FG000|STARTED|Up to Year 2||40||
48338020|NCT01262976|101156581|FG001|STARTED|Up to Year 2||40||
48338021|NCT01262976|101156582|FG002|STARTED|Up to Year 2||40||
48338022|NCT01262976|101156583|FG003|STARTED|Up to Year 2||40||
48338023|NCT01262976|101156584|FG004|STARTED|Up to Year 2||40||
48338024|NCT01262976|101156585|FG005|STARTED|Up to Year 2||40||
48338025|NCT01262976|101156580|FG000|COMPLETED|Up to Year 2||35||
48338026|NCT01262976|101156581|FG001|COMPLETED|Up to Year 2||39||
48338027|NCT01262976|101156582|FG002|COMPLETED|Up to Year 2||35||
48338028|NCT01262976|101156583|FG003|COMPLETED|Up to Year 2||36||
48338029|NCT01262976|101156584|FG004|COMPLETED|Up to Year 2||36||
48338030|NCT01262976|101156585|FG005|COMPLETED|Up to Year 2||35||
48338031|NCT01262976|101156580|FG000|NOT COMPLETED|Up to Year 2||5||
48631300|NCT01004614|101881501|FG001|STARTED|Washout||12||
48631301|NCT01004614|101881502|FG002|STARTED|Washout||12||
48631302|NCT01004614|101881503|FG003|STARTED|Washout||12||
48631303|NCT01004614|101881500|FG000|COMPLETED|Washout||12||
48631304|NCT01004614|101881501|FG001|COMPLETED|Washout||11||
48631305|NCT01004614|101881502|FG002|COMPLETED|Washout||12||
48631306|NCT01004614|101881503|FG003|COMPLETED|Washout||12||
48631307|NCT01004614|101881500|FG000|NOT COMPLETED|Washout||0||
48631308|NCT01004614|101881501|FG001|NOT COMPLETED|Washout||1||
48338032|NCT01262976|101156581|FG001|NOT COMPLETED|Up to Year 2||1||
48338033|NCT01262976|101156582|FG002|NOT COMPLETED|Up to Year 2||5||
48631309|NCT01004614|101881502|FG002|NOT COMPLETED|Washout||0||
48338034|NCT01262976|101156583|FG003|NOT COMPLETED|Up to Year 2||4||
48338035|NCT01262976|101156584|FG004|NOT COMPLETED|Up to Year 2||4||
48338036|NCT01262976|101156585|FG005|NOT COMPLETED|Up to Year 2||5||
48338037|NCT01262976|101156580|FG000|STARTED|Up to Year 3||40||
48338038|NCT01262976|101156581|FG001|STARTED|Up to Year 3||40||
48338039|NCT01262976|101156582|FG002|STARTED|Up to Year 3||40||
48338040|NCT01262976|101156583|FG003|STARTED|Up to Year 3||40||
48338041|NCT01262976|101156584|FG004|STARTED|Up to Year 3||40||
48338042|NCT01262976|101156585|FG005|STARTED|Up to Year 3||40||
48338043|NCT01262976|101156580|FG000|COMPLETED|Up to Year 3||34||
48631310|NCT01004614|101881503|FG003|NOT COMPLETED|Washout||0||
48631311|NCT01004614|101881500|FG000|STARTED|Second Intervention||12||
48631312|NCT01004614|101881501|FG001|STARTED|Second Intervention||11||
48631313|NCT01004614|101881502|FG002|STARTED|Second Intervention||12||
48338044|NCT01262976|101156581|FG001|COMPLETED|Up to Year 3||38||
48412992|NCT02531633|101345749|FG006|COMPLETED|Part A (52 Weeks)||0|Completed Part A and entered Part B|
48631314|NCT01004614|101881503|FG003|STARTED|Second Intervention||12||
48631315|NCT01004614|101881500|FG000|COMPLETED|Second Intervention||12||
48631316|NCT01004614|101881501|FG001|COMPLETED|Second Intervention||11||
48631317|NCT01004614|101881502|FG002|COMPLETED|Second Intervention||12||
48753738|NCT02174731|102184578|FG000|Received Treatment|Overall Study||1048||
48753739|NCT02174731|102184579|FG001|Received Treatment|Overall Study||1053||
48631318|NCT01004614|101881503|FG003|COMPLETED|Second Intervention||12||
48631319|NCT01004614|101881500|FG000|NOT COMPLETED|Second Intervention||0||
48631320|NCT01004614|101881501|FG001|NOT COMPLETED|Second Intervention||0||
48631321|NCT01004614|101881502|FG002|NOT COMPLETED|Second Intervention||0||
48631322|NCT01004614|101881503|FG003|NOT COMPLETED|Second Intervention||0||
48631323|NCT01192178|101881504|FG000|STARTED|Overall Study||171||
48631324|NCT01192178|101881505|FG001|STARTED|Overall Study||168||
48631325|NCT01192178|101881504|FG000|COMPLETED|Overall Study||147||
48631326|NCT01192178|101881505|FG001|COMPLETED|Overall Study||145||
48631327|NCT01192178|101881504|FG000|NOT COMPLETED|Overall Study||24||
48631328|NCT01192178|101881505|FG001|NOT COMPLETED|Overall Study||23||
48753740|NCT02174731|102184578|FG000|COMPLETED|Overall Study||982|Completed the study|
48753741|NCT02174731|102184579|FG001|COMPLETED|Overall Study||990|Completed the study|
48753742|NCT02174731|102184578|FG000|NOT COMPLETED|Overall Study||69||
48753743|NCT02174731|102184579|FG001|NOT COMPLETED|Overall Study||65||
48753744|NCT00097500|102184580|FG000|STARTED|On-drug Period (Week 0 to Week 52)||36||
48753745|NCT00097500|102184581|FG001|STARTED|On-drug Period (Week 0 to Week 52)||33||
48753746|NCT00097500|102184580|FG000|COMPLETED|On-drug Period (Week 0 to Week 52)||30||
48753747|NCT00097500|102184581|FG001|COMPLETED|On-drug Period (Week 0 to Week 52)||30||
48753748|NCT00097500|102184580|FG000|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||6||
48753749|NCT00097500|102184581|FG001|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||3||
48753750|NCT00097500|102184580|FG000|STARTED|Off-drug Period (Week 52 to Week 64)||30||
48753751|NCT00097500|102184581|FG001|STARTED|Off-drug Period (Week 52 to Week 64)||30||
48753752|NCT00097500|102184580|FG000|COMPLETED|Off-drug Period (Week 52 to Week 64)||25||
48753753|NCT00097500|102184581|FG001|COMPLETED|Off-drug Period (Week 52 to Week 64)||26||
48753754|NCT00097500|102184580|FG000|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||5||
48753755|NCT00097500|102184581|FG001|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||4||
48753756|NCT03095651|102184582|FG000|STARTED|Overall Study||6||
48753757|NCT03095651|102184583|FG001|STARTED|Overall Study||6||
48753758|NCT03095651|102184584|FG002|STARTED|Overall Study||0||
48753759|NCT03095651|102184585|FG003|STARTED|Overall Study||4||
48753760|NCT03095651|102184586|FG004|STARTED|Overall Study||0||
48753761|NCT03095651|102184587|FG005|STARTED|Overall Study||7||
48753762|NCT03095651|102184588|FG006|STARTED|Overall Study||6||
48753763|NCT03095651|102184589|FG007|STARTED|Overall Study||4||
48753764|NCT03095651|102184582|FG000|COMPLETED|Overall Study||5||
48753765|NCT03095651|102184583|FG001|COMPLETED|Overall Study||5||
48753766|NCT03095651|102184584|FG002|COMPLETED|Overall Study||0||
48753767|NCT03095651|102184585|FG003|COMPLETED|Overall Study||3||
48753768|NCT03095651|102184586|FG004|COMPLETED|Overall Study||0||
48338045|NCT01262976|101156582|FG002|COMPLETED|Up to Year 3||33||
48338046|NCT01262976|101156583|FG003|COMPLETED|Up to Year 3||35||
48753769|NCT03095651|102184587|FG005|COMPLETED|Overall Study||6||
48338047|NCT01262976|101156584|FG004|COMPLETED|Up to Year 3||38||
48338048|NCT01262976|101156585|FG005|COMPLETED|Up to Year 3||36||
48338049|NCT01262976|101156580|FG000|NOT COMPLETED|Up to Year 3||6||
48631329|NCT00720499|101881506|FG000|STARTED|Treatment Period 1 (4 Weeks)||69||
48631330|NCT00720499|101881507|FG001|STARTED|Treatment Period 1 (4 Weeks)||72||
48631331|NCT00720499|101881506|FG000|COMPLETED|Treatment Period 1 (4 Weeks)||66||
48631332|NCT00720499|101881507|FG001|COMPLETED|Treatment Period 1 (4 Weeks)||70||
48631333|NCT00720499|101881506|FG000|NOT COMPLETED|Treatment Period 1 (4 Weeks)||3||
48631334|NCT00720499|101881507|FG001|NOT COMPLETED|Treatment Period 1 (4 Weeks)||2||
48631335|NCT00720499|101881506|FG000|STARTED|Washout Period (2 Weeks)||66||
48631336|NCT00720499|101881507|FG001|STARTED|Washout Period (2 Weeks)||70||
48631337|NCT00720499|101881506|FG000|COMPLETED|Washout Period (2 Weeks)||66||
48631338|NCT00720499|101881507|FG001|COMPLETED|Washout Period (2 Weeks)||70||
48631339|NCT00720499|101881506|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0||
48631340|NCT00720499|101881507|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0||
48631341|NCT00720499|101881506|FG000|STARTED|Treatment Period 2 (4 Weeks)||66||
48631342|NCT00720499|101881507|FG001|STARTED|Treatment Period 2 (4 Weeks)||70||
48631343|NCT00720499|101881506|FG000|COMPLETED|Treatment Period 2 (4 Weeks)||64||
48631344|NCT00720499|101881507|FG001|COMPLETED|Treatment Period 2 (4 Weeks)||67||
48631345|NCT00720499|101881506|FG000|NOT COMPLETED|Treatment Period 2 (4 Weeks)||2||
48631346|NCT00720499|101881507|FG001|NOT COMPLETED|Treatment Period 2 (4 Weeks)||3||
48753770|NCT03095651|102184588|FG006|COMPLETED|Overall Study||6||
48753771|NCT03095651|102184589|FG007|COMPLETED|Overall Study||4||
48753772|NCT03095651|102184582|FG000|NOT COMPLETED|Overall Study||1||
48753773|NCT03095651|102184583|FG001|NOT COMPLETED|Overall Study||1||
48753774|NCT03095651|102184584|FG002|NOT COMPLETED|Overall Study||0||
48753775|NCT03095651|102184585|FG003|NOT COMPLETED|Overall Study||1||
48753776|NCT03095651|102184586|FG004|NOT COMPLETED|Overall Study||0||
48753777|NCT03095651|102184587|FG005|NOT COMPLETED|Overall Study||1||
48753778|NCT03095651|102184588|FG006|NOT COMPLETED|Overall Study||0||
48753779|NCT03095651|102184589|FG007|NOT COMPLETED|Overall Study||0||
48753780|NCT00287222|102184590|FG000|STARTED|Overall Study||21||
48753781|NCT00287222|102184590|FG000|COMPLETED|Overall Study||21||
48753782|NCT00287222|102184590|FG000|NOT COMPLETED|Overall Study||0||
48753783|NCT01476722|102184591|FG000|STARTED|Overall Study||125||
48753784|NCT01476722|102184591|FG000|COMPLETED|Overall Study||124||
48753785|NCT01476722|102184591|FG000|NOT COMPLETED|Overall Study||1||
48753786|NCT04643808|102184592|FG000|STARTED|Overall Study||14||
48753787|NCT04643808|102184593|FG001|STARTED|Overall Study||21||
48753788|NCT04643808|102184592|FG000|COMPLETED|Overall Study||14||
48753789|NCT04643808|102184593|FG001|COMPLETED|Overall Study||21||
48753790|NCT04643808|102184592|FG000|NOT COMPLETED|Overall Study||0||
48753791|NCT04643808|102184593|FG001|NOT COMPLETED|Overall Study||0||
48753792|NCT04097431|102184594|FG000|STARTED|Overall Study||0|Only Study 3 was a clinic trial. Zero out of the 30 enrolled individuals was assigned to any Arm/Group for the purposes of intervention or data collection on intervention. Zero participants received intervention in this study.|
48753793|NCT04097431|102184594|FG000|COMPLETED|Overall Study||0|Only Study 3 was a clinic trial. Zero out of the 30 enrolled individuals was assigned to any Arm/Group for the purposes of intervention or data collection on intervention. Zero participants received intervention in this study.|
48753794|NCT04097431|102184594|FG000|NOT COMPLETED|Overall Study||0||
48753795|NCT03040141|102184595|FG000|STARTED|Overall Study||29||
48753796|NCT03040141|102184596|FG001|STARTED|Overall Study||30||
48753797|NCT03040141|102184597|FG002|STARTED|Overall Study||30||
48753798|NCT03040141|102184595|FG000|COMPLETED|Overall Study||25||
48631347|NCT00737178|101881508|FG000|STARTED|Overall Study||71||
48631348|NCT00737178|101881509|FG001|STARTED|Overall Study||85||
48631349|NCT00737178|101881508|FG000|COMPLETED|Overall Study||66||
48631350|NCT00737178|101881509|FG001|COMPLETED|Overall Study||76||
48631351|NCT00737178|101881508|FG000|NOT COMPLETED|Overall Study||5||
48631352|NCT00737178|101881509|FG001|NOT COMPLETED|Overall Study||9||
48753799|NCT03040141|102184596|FG001|COMPLETED|Overall Study||24||
48753800|NCT03040141|102184597|FG002|COMPLETED|Overall Study||24||
48753801|NCT03040141|102184595|FG000|NOT COMPLETED|Overall Study||4||
48753802|NCT03040141|102184596|FG001|NOT COMPLETED|Overall Study||6||
48753803|NCT03040141|102184597|FG002|NOT COMPLETED|Overall Study||6||
48753804|NCT00829738|102184598|FG000|STARTED|Overall Study||4188||
48753805|NCT00829738|102184598|FG000|COMPLETED|Overall Study||4180||
48753806|NCT00829738|102184598|FG000|NOT COMPLETED|Overall Study||8||
48753807|NCT03305666|102184599|FG000|STARTED|Overall Study||18||
48753808|NCT03305666|102184600|FG001|STARTED|Overall Study||18||
48631353|NCT03353220|101881510|FG000|STARTED|First Intervention (7 Days) - Phase 1||14||
48631354|NCT03353220|101881511|FG001|STARTED|First Intervention (7 Days) - Phase 1||16||
48631355|NCT03353220|101881510|FG000|COMPLETED|First Intervention (7 Days) - Phase 1||14||
48631356|NCT03353220|101881511|FG001|COMPLETED|First Intervention (7 Days) - Phase 1||16||
48631357|NCT03353220|101881510|FG000|NOT COMPLETED|First Intervention (7 Days) - Phase 1||0||
48753809|NCT03305666|102184599|FG000|COMPLETED|Overall Study||16||
48753810|NCT03305666|102184600|FG001|COMPLETED|Overall Study||18||
48753811|NCT03305666|102184599|FG000|NOT COMPLETED|Overall Study||2||
48753812|NCT03305666|102184600|FG001|NOT COMPLETED|Overall Study||0||
48753813|NCT00659802|102184601|FG000|STARTED|Overall Study||74||
48753814|NCT00659802|102184602|FG001|STARTED|Overall Study||75||
48753815|NCT00659802|102184603|FG002|STARTED|Overall Study||75||
48753816|NCT00659802|102184601|FG000|COMPLETED|Overall Study||59||
48753817|NCT00659802|102184602|FG001|COMPLETED|Overall Study||57||
48412993|NCT02531633|101345750|FG007|COMPLETED|Part A (52 Weeks)||0|Completed Part A and entered Part B|
48412994|NCT02531633|101345751|FG008|COMPLETED|Part A (52 Weeks)||0|Completed Part A and entered Part B|
48631358|NCT03353220|101881511|FG001|NOT COMPLETED|First Intervention (7 Days) - Phase 1||0||
48631359|NCT03353220|101881510|FG000|STARTED|Washout (3 Weeks) - Phase 1||14||
48631360|NCT03353220|101881511|FG001|STARTED|Washout (3 Weeks) - Phase 1||16||
48631361|NCT03353220|101881510|FG000|COMPLETED|Washout (3 Weeks) - Phase 1||14||
48631362|NCT03353220|101881511|FG001|COMPLETED|Washout (3 Weeks) - Phase 1||16||
48631363|NCT03353220|101881510|FG000|NOT COMPLETED|Washout (3 Weeks) - Phase 1||0||
48338050|NCT01262976|101156581|FG001|NOT COMPLETED|Up to Year 3||2||
48338051|NCT01262976|101156582|FG002|NOT COMPLETED|Up to Year 3||7||
48338052|NCT01262976|101156583|FG003|NOT COMPLETED|Up to Year 3||5||
48338053|NCT01262976|101156584|FG004|NOT COMPLETED|Up to Year 3||2||
48338054|NCT01262976|101156585|FG005|NOT COMPLETED|Up to Year 3||4||
48338055|NCT00536172|101156586|FG000|STARTED|Overall Study||74||
48338056|NCT00536172|101156587|FG001|STARTED|Overall Study||74||
48338057|NCT00536172|101156586|FG000|COMPLETED|Overall Study||60||
48338058|NCT00536172|101156587|FG001|COMPLETED|Overall Study||65||
48338059|NCT00536172|101156586|FG000|NOT COMPLETED|Overall Study||14||
48338060|NCT00536172|101156587|FG001|NOT COMPLETED|Overall Study||9||
48338061|NCT01041248|101156588|FG000|STARTED|Overall Study||1||
48338062|NCT01041248|101156588|FG000|COMPLETED|Overall Study||1||
48338063|NCT01041248|101156588|FG000|NOT COMPLETED|Overall Study||0||
48338064|NCT00576979|101156589|FG000|STARTED|Overall Study||3||
48338065|NCT00576979|101156590|FG001|STARTED|Overall Study||3||
48338066|NCT00576979|101156591|FG002|STARTED|Overall Study||9||
48338067|NCT00576979|101156592|FG003|STARTED|Overall Study||6||
48338068|NCT00576979|101156593|FG004|STARTED|Overall Study||6||
48338069|NCT00576979|101156594|FG005|STARTED|Overall Study||6||
48338070|NCT00576979|101156595|FG006|STARTED|Overall Study||6||
48338071|NCT00576979|101156596|FG007|STARTED|Overall Study||6||
48338072|NCT00576979|101156597|FG008|STARTED|Overall Study||6||
48338073|NCT00576979|101156589|FG000|COMPLETED|Overall Study||3||
48338074|NCT00576979|101156590|FG001|COMPLETED|Overall Study||3||
48338075|NCT00576979|101156591|FG002|COMPLETED|Overall Study||9||
48338076|NCT00576979|101156592|FG003|COMPLETED|Overall Study||6||
48338077|NCT00576979|101156593|FG004|COMPLETED|Overall Study||6||
48338078|NCT00576979|101156594|FG005|COMPLETED|Overall Study||6||
48338079|NCT00576979|101156595|FG006|COMPLETED|Overall Study||6||
48338080|NCT00576979|101156596|FG007|COMPLETED|Overall Study||6||
48338081|NCT00576979|101156597|FG008|COMPLETED|Overall Study||6||
48338082|NCT00576979|101156589|FG000|NOT COMPLETED|Overall Study||0||
48338083|NCT00576979|101156590|FG001|NOT COMPLETED|Overall Study||0||
48338084|NCT00576979|101156591|FG002|NOT COMPLETED|Overall Study||0||
48338085|NCT00576979|101156592|FG003|NOT COMPLETED|Overall Study||0||
48631364|NCT03353220|101881511|FG001|NOT COMPLETED|Washout (3 Weeks) - Phase 1||0||
48631365|NCT03353220|101881510|FG000|STARTED|Second Intervention (7 Days) - Phase 1||14||
48338086|NCT00576979|101156593|FG004|NOT COMPLETED|Overall Study||0||
48338087|NCT00576979|101156594|FG005|NOT COMPLETED|Overall Study||0||
48338088|NCT00576979|101156595|FG006|NOT COMPLETED|Overall Study||0||
48338089|NCT00576979|101156596|FG007|NOT COMPLETED|Overall Study||0||
48338090|NCT00576979|101156597|FG008|NOT COMPLETED|Overall Study||0||
48631366|NCT03353220|101881511|FG001|STARTED|Second Intervention (7 Days) - Phase 1||16||
48631367|NCT03353220|101881510|FG000|COMPLETED|Second Intervention (7 Days) - Phase 1||14||
48338091|NCT01163786|101156598|FG000|STARTED|Treatment With Bortezomib||17||
48338092|NCT01163786|101156598|FG000|Completed 1st Cycle|Treatment With Bortezomib||17||
48338093|NCT01163786|101156598|FG000|Completed 2nd Cycle|Treatment With Bortezomib||14||
48338094|NCT01163786|101156598|FG000|COMPLETED|Treatment With Bortezomib||14||
48338095|NCT01163786|101156598|FG000|NOT COMPLETED|Treatment With Bortezomib||3||
48338096|NCT01163786|101156598|FG000|STARTED|Completed Follow up (Visit 9 and 10)||14||
48753818|NCT00659802|102184603|FG002|COMPLETED|Overall Study||64||
48753819|NCT00659802|102184601|FG000|NOT COMPLETED|Overall Study||15||
48753820|NCT00659802|102184602|FG001|NOT COMPLETED|Overall Study||18||
48753821|NCT00659802|102184603|FG002|NOT COMPLETED|Overall Study||11||
48753822|NCT01285401|102184604|FG000|STARTED|Overall Study||115||
48177635|NCT00787722|100757669|FG000|NOT COMPLETED|Overall Study||1||
48177636|NCT01995357|100757670|FG000|STARTED|Period 1||4||
48177637|NCT01995357|100757671|FG001|STARTED|Period 1||3||
48177638|NCT01995357|100757672|FG002|STARTED|Period 1||4||
48177639|NCT01995357|100757673|FG003|STARTED|Period 1||3||
48177640|NCT01995357|100757674|FG004|STARTED|Period 1||4||
48177641|NCT01995357|100757675|FG005|STARTED|Period 1||4||
48177642|NCT01995357|100757670|FG000|COMPLETED|Period 1||4||
48177643|NCT01995357|100757671|FG001|COMPLETED|Period 1||3||
48177644|NCT01995357|100757672|FG002|COMPLETED|Period 1||4||
48177645|NCT01995357|100757673|FG003|COMPLETED|Period 1||3||
48177646|NCT01995357|100757674|FG004|COMPLETED|Period 1||4||
48177647|NCT01995357|100757675|FG005|COMPLETED|Period 1||4||
48177648|NCT01995357|100757670|FG000|NOT COMPLETED|Period 1||0||
48177649|NCT01995357|100757671|FG001|NOT COMPLETED|Period 1||0||
48177650|NCT01995357|100757672|FG002|NOT COMPLETED|Period 1||0||
48177651|NCT01995357|100757673|FG003|NOT COMPLETED|Period 1||0||
48177652|NCT01995357|100757674|FG004|NOT COMPLETED|Period 1||0||
48177653|NCT01995357|100757675|FG005|NOT COMPLETED|Period 1||0||
48177654|NCT01995357|100757670|FG000|STARTED|Period 2||4||
48177655|NCT01995357|100757671|FG001|STARTED|Period 2||3||
48177656|NCT01995357|100757672|FG002|STARTED|Period 2||4||
48177657|NCT01995357|100757673|FG003|STARTED|Period 2||3||
48177658|NCT01995357|100757674|FG004|STARTED|Period 2||4||
48177659|NCT01995357|100757675|FG005|STARTED|Period 2||4||
48177660|NCT01995357|100757670|FG000|COMPLETED|Period 2||4||
48177661|NCT01995357|100757671|FG001|COMPLETED|Period 2||3||
48177662|NCT01995357|100757672|FG002|COMPLETED|Period 2||4||
48177663|NCT01995357|100757673|FG003|COMPLETED|Period 2||3||
48338097|NCT01163786|101156598|FG000|Completed Week 12 Follow up (Visit 9)|Completed Follow up (Visit 9 and 10)||14||
48338098|NCT01163786|101156598|FG000|Completed Week 18 Follow up (Visit 10)|Completed Follow up (Visit 9 and 10)||13||
48338099|NCT01163786|101156598|FG000|COMPLETED|Completed Follow up (Visit 9 and 10)||13||
48338100|NCT01163786|101156598|FG000|NOT COMPLETED|Completed Follow up (Visit 9 and 10)||1||
48338101|NCT00214461|101156599|FG000|STARTED|Overall Study||12||
48338102|NCT00214461|101156600|FG001|STARTED|Overall Study||12||
48338103|NCT00214461|101156601|FG002|STARTED|Overall Study||12||
48338104|NCT00214461|101156602|FG003|STARTED|Overall Study||12||
48338105|NCT00214461|101156599|FG000|COMPLETED|Overall Study||12||
48338106|NCT00214461|101156600|FG001|COMPLETED|Overall Study||12||
48753823|NCT01285401|102184605|FG001|STARTED|Overall Study||117||
48753824|NCT01285401|102184604|FG000|Treated|Overall Study||113||
48177664|NCT01995357|100757674|FG004|COMPLETED|Period 2||4||
48177665|NCT01995357|100757675|FG005|COMPLETED|Period 2||4||
48177666|NCT01995357|100757670|FG000|NOT COMPLETED|Period 2||0||
48177667|NCT01995357|100757671|FG001|NOT COMPLETED|Period 2||0||
48177668|NCT01995357|100757672|FG002|NOT COMPLETED|Period 2||0||
48177669|NCT01995357|100757673|FG003|NOT COMPLETED|Period 2||0||
48177670|NCT01995357|100757674|FG004|NOT COMPLETED|Period 2||0||
48177671|NCT01995357|100757675|FG005|NOT COMPLETED|Period 2||0||
48177672|NCT01995357|100757670|FG000|STARTED|Period 3||4||
48177673|NCT01995357|100757671|FG001|STARTED|Period 3||3||
48177674|NCT01995357|100757672|FG002|STARTED|Period 3||4||
48177675|NCT01995357|100757673|FG003|STARTED|Period 3||3||
48753825|NCT01285401|102184605|FG001|Treated|Overall Study||116||
48753826|NCT01285401|102184604|FG000|COMPLETED|Overall Study||98||
48753827|NCT01285401|102184605|FG001|COMPLETED|Overall Study||88||
48753828|NCT01285401|102184604|FG000|NOT COMPLETED|Overall Study||17||
48177676|NCT01995357|100757674|FG004|STARTED|Period 3||4||
48177677|NCT01995357|100757675|FG005|STARTED|Period 3||4||
48753829|NCT01285401|102184605|FG001|NOT COMPLETED|Overall Study||29||
48177678|NCT01995357|100757670|FG000|COMPLETED|Period 3||4||
48177679|NCT01995357|100757671|FG001|COMPLETED|Period 3||3||
48177680|NCT01995357|100757672|FG002|COMPLETED|Period 3||4||
48177681|NCT01995357|100757673|FG003|COMPLETED|Period 3||3||
48177682|NCT01995357|100757674|FG004|COMPLETED|Period 3||4||
48177683|NCT01995357|100757675|FG005|COMPLETED|Period 3||4||
48177684|NCT01995357|100757670|FG000|NOT COMPLETED|Period 3||0||
48177685|NCT01995357|100757671|FG001|NOT COMPLETED|Period 3||0||
48177686|NCT01995357|100757672|FG002|NOT COMPLETED|Period 3||0||
48177687|NCT01995357|100757673|FG003|NOT COMPLETED|Period 3||0||
48177688|NCT01995357|100757674|FG004|NOT COMPLETED|Period 3||0||
48177689|NCT01995357|100757675|FG005|NOT COMPLETED|Period 3||0||
48177690|NCT01995357|100757670|FG000|STARTED|Period 4||4||
48177691|NCT01995357|100757671|FG001|STARTED|Period 4||3||
48177692|NCT01995357|100757672|FG002|STARTED|Period 4||4||
48177693|NCT01995357|100757673|FG003|STARTED|Period 4||3||
48177694|NCT01995357|100757674|FG004|STARTED|Period 4||4||
48177695|NCT01995357|100757675|FG005|STARTED|Period 4||4||
48177696|NCT01995357|100757670|FG000|COMPLETED|Period 4||4||
48177697|NCT01995357|100757671|FG001|COMPLETED|Period 4||3||
48177698|NCT01995357|100757672|FG002|COMPLETED|Period 4||4||
48177699|NCT01995357|100757673|FG003|COMPLETED|Period 4||3||
48631368|NCT03353220|101881511|FG001|COMPLETED|Second Intervention (7 Days) - Phase 1||16||
48631369|NCT03353220|101881510|FG000|NOT COMPLETED|Second Intervention (7 Days) - Phase 1||0||
48631370|NCT03353220|101881511|FG001|NOT COMPLETED|Second Intervention (7 Days) - Phase 1||0||
48631371|NCT03353220|101881510|FG000|STARTED|Third Intervention (6 Months) - Phase 2||14||
48631372|NCT03353220|101881511|FG001|STARTED|Third Intervention (6 Months) - Phase 2||16||
48631373|NCT03353220|101881510|FG000|COMPLETED|Third Intervention (6 Months) - Phase 2||10||
48631374|NCT03353220|101881511|FG001|COMPLETED|Third Intervention (6 Months) - Phase 2||9||
48753830|NCT00997035|102184606|FG000|STARTED|3-week Followup Visit||121||
48753831|NCT00997035|102184607|FG001|STARTED|3-week Followup Visit||119||
48753832|NCT00997035|102184606|FG000|COMPLETED|3-week Followup Visit||112||
48177700|NCT01995357|100757674|FG004|COMPLETED|Period 4||4||
48177701|NCT01995357|100757675|FG005|COMPLETED|Period 4||4||
48177702|NCT01995357|100757670|FG000|NOT COMPLETED|Period 4||0||
48177703|NCT01995357|100757671|FG001|NOT COMPLETED|Period 4||0||
48177704|NCT01995357|100757672|FG002|NOT COMPLETED|Period 4||0||
48177705|NCT01995357|100757673|FG003|NOT COMPLETED|Period 4||0||
48177706|NCT01995357|100757674|FG004|NOT COMPLETED|Period 4||0||
48177707|NCT01995357|100757675|FG005|NOT COMPLETED|Period 4||0||
48177708|NCT01995357|100757670|FG000|STARTED|Period 5||4||
48177709|NCT01995357|100757671|FG001|STARTED|Period 5||3||
48177710|NCT01995357|100757672|FG002|STARTED|Period 5||4||
48177711|NCT01995357|100757673|FG003|STARTED|Period 5||3||
48177712|NCT01995357|100757674|FG004|STARTED|Period 5||4||
48177713|NCT01995357|100757675|FG005|STARTED|Period 5||4||
48177714|NCT01995357|100757670|FG000|COMPLETED|Period 5||2||
48177715|NCT01995357|100757671|FG001|COMPLETED|Period 5||3||
48177716|NCT01995357|100757672|FG002|COMPLETED|Period 5||3||
48177717|NCT01995357|100757673|FG003|COMPLETED|Period 5||3||
48177718|NCT01995357|100757674|FG004|COMPLETED|Period 5||4||
48177719|NCT01995357|100757675|FG005|COMPLETED|Period 5||4||
48177720|NCT01995357|100757670|FG000|NOT COMPLETED|Period 5||2||
48177721|NCT01995357|100757671|FG001|NOT COMPLETED|Period 5||0||
48177722|NCT01995357|100757672|FG002|NOT COMPLETED|Period 5||1||
48177723|NCT01995357|100757673|FG003|NOT COMPLETED|Period 5||0||
48177724|NCT01995357|100757674|FG004|NOT COMPLETED|Period 5||0||
48177725|NCT01995357|100757675|FG005|NOT COMPLETED|Period 5||0||
48177726|NCT01651936|100757676|FG000|STARTED|Base Study||30||
48177727|NCT01651936|100757677|FG001|STARTED|Base Study||26||
48177728|NCT01651936|100757678|FG002|STARTED|Base Study||0||
48177729|NCT01651936|100757676|FG000|COMPLETED|Base Study||3||
48631375|NCT03353220|101881510|FG000|NOT COMPLETED|Third Intervention (6 Months) - Phase 2||4||
48631376|NCT03353220|101881511|FG001|NOT COMPLETED|Third Intervention (6 Months) - Phase 2||7||
48631377|NCT00501631|101881512|FG000|STARTED|Part A (Double-blind Period)||152||
48631378|NCT00501631|101881513|FG001|STARTED|Part A (Double-blind Period)||148||
48631379|NCT00501631|101881512|FG000|COMPLETED|Part A (Double-blind Period)||90||
48631380|NCT00501631|101881513|FG001|COMPLETED|Part A (Double-blind Period)||99||
48631381|NCT00501631|101881512|FG000|NOT COMPLETED|Part A (Double-blind Period)||62||
48631382|NCT00501631|101881513|FG001|NOT COMPLETED|Part A (Double-blind Period)||49||
48753833|NCT00997035|102184607|FG001|COMPLETED|3-week Followup Visit||113||
48753834|NCT00997035|102184606|FG000|NOT COMPLETED|3-week Followup Visit||9||
48753835|NCT00997035|102184607|FG001|NOT COMPLETED|3-week Followup Visit||6||
48177730|NCT01651936|100757677|FG001|COMPLETED|Base Study||1||
48177731|NCT01651936|100757678|FG002|COMPLETED|Base Study||0||
48177732|NCT01651936|100757676|FG000|NOT COMPLETED|Base Study||27||
48177733|NCT01651936|100757677|FG001|NOT COMPLETED|Base Study||25||
48177734|NCT01651936|100757678|FG002|NOT COMPLETED|Base Study||0||
48177735|NCT01651936|100757676|FG000|STARTED|Extension Study||0||
48177736|NCT01651936|100757677|FG001|STARTED|Extension Study||0||
48177737|NCT01651936|100757678|FG002|STARTED|Extension Study||14||
48177738|NCT01651936|100757676|FG000|COMPLETED|Extension Study||0||
48177739|NCT01651936|100757677|FG001|COMPLETED|Extension Study||0||
48177740|NCT01651936|100757678|FG002|COMPLETED|Extension Study||0||
48177741|NCT01651936|100757676|FG000|NOT COMPLETED|Extension Study||0||
48177742|NCT01651936|100757677|FG001|NOT COMPLETED|Extension Study||0||
48177743|NCT01651936|100757678|FG002|NOT COMPLETED|Extension Study||14||
48177744|NCT02102464|100757679|FG000|STARTED|Randomized Study||29||58
48177745|NCT02102464|100757680|FG001|STARTED|Randomized Study||26||52
48177746|NCT02102464|100757681|FG002|STARTED|Randomized Study||0||0
48177747|NCT02102464|100757679|FG000|COMPLETED|Randomized Study||29||58
48177748|NCT02102464|100757680|FG001|COMPLETED|Randomized Study||25||50
48177749|NCT02102464|100757681|FG002|COMPLETED|Randomized Study||0||0
48177750|NCT02102464|100757679|FG000|NOT COMPLETED|Randomized Study||0||0
48177751|NCT02102464|100757680|FG001|NOT COMPLETED|Randomized Study||1||2
48631383|NCT00501631|101881512|FG000|STARTED|Part B (Open-label Period)||90||
48631384|NCT00501631|101881513|FG001|STARTED|Part B (Open-label Period)||99||
48631385|NCT00501631|101881512|FG000|COMPLETED|Part B (Open-label Period)||37||
48177752|NCT02102464|100757681|FG002|NOT COMPLETED|Randomized Study||0||0
48177753|NCT02102464|100757679|FG000|STARTED|Crossover LipiFlow Treatment of Control||0||0
48177754|NCT02102464|100757680|FG001|STARTED|Crossover LipiFlow Treatment of Control||0||0
48177755|NCT02102464|100757681|FG002|STARTED|Crossover LipiFlow Treatment of Control||25||50
48177756|NCT02102464|100757679|FG000|COMPLETED|Crossover LipiFlow Treatment of Control||0||0
48177757|NCT02102464|100757680|FG001|COMPLETED|Crossover LipiFlow Treatment of Control||0||0
48177758|NCT02102464|100757681|FG002|COMPLETED|Crossover LipiFlow Treatment of Control||25||50
48177759|NCT02102464|100757679|FG000|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0||0
48177760|NCT02102464|100757680|FG001|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0||0
48177761|NCT02102464|100757681|FG002|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0||0
48177762|NCT01951092|100757682|FG000|STARTED|Overall Study||32||
48177763|NCT01951092|100757682|FG000|COMPLETED|Overall Study||20||
48177764|NCT01951092|100757682|FG000|NOT COMPLETED|Overall Study||12||
48177765|NCT03638635|100757683|FG000|STARTED|Initial Hospitalization||39||
48177766|NCT03638635|100757684|FG001|STARTED|Initial Hospitalization||24||
48177767|NCT03638635|100757683|FG000|COMPLETED|Initial Hospitalization||39||
48177768|NCT03638635|100757684|FG001|COMPLETED|Initial Hospitalization||22||
48177769|NCT03638635|100757683|FG000|NOT COMPLETED|Initial Hospitalization||0||
48177770|NCT03638635|100757684|FG001|NOT COMPLETED|Initial Hospitalization||2||
48177771|NCT03638635|100757683|FG000|STARTED|Follow-Up (30 Days After Discharge)||39||
48177772|NCT03638635|100757684|FG001|STARTED|Follow-Up (30 Days After Discharge)||22||
48177773|NCT03638635|100757683|FG000|COMPLETED|Follow-Up (30 Days After Discharge)||0||
48177774|NCT03638635|100757684|FG001|COMPLETED|Follow-Up (30 Days After Discharge)||0||
48177775|NCT03638635|100757683|FG000|NOT COMPLETED|Follow-Up (30 Days After Discharge)||39||
48177776|NCT03638635|100757684|FG001|NOT COMPLETED|Follow-Up (30 Days After Discharge)||22||
48177777|NCT02169219|100757685|FG000|STARTED|Overall Study||20||
48177778|NCT02169219|100757685|FG000|COMPLETED|Overall Study||14||
48177779|NCT02169219|100757685|FG000|NOT COMPLETED|Overall Study||6||
48177780|NCT00305682|100757686|FG000|STARTED|Overall Study||98||
48177781|NCT00305682|100757687|FG001|STARTED|Overall Study||71||
48177782|NCT00305682|100757688|FG002|STARTED|Overall Study||7||
48177783|NCT00305682|100757689|FG003|STARTED|Overall Study||34||
48177784|NCT00305682|100757690|FG004|STARTED|Overall Study||39||
48631386|NCT00501631|101881513|FG001|COMPLETED|Part B (Open-label Period)||48||
48631387|NCT00501631|101881512|FG000|NOT COMPLETED|Part B (Open-label Period)||53||
48631388|NCT00501631|101881513|FG001|NOT COMPLETED|Part B (Open-label Period)||51||
48177785|NCT00305682|100757691|FG005|STARTED|Overall Study||35||
48177786|NCT00305682|100757686|FG000|COMPLETED|Overall Study||98||
48177787|NCT00305682|100757687|FG001|COMPLETED|Overall Study||71||
48177788|NCT00305682|100757688|FG002|COMPLETED|Overall Study||7||
48177789|NCT00305682|100757689|FG003|COMPLETED|Overall Study||34||
48177790|NCT00305682|100757690|FG004|COMPLETED|Overall Study||39||
48177791|NCT00305682|100757691|FG005|COMPLETED|Overall Study||35||
48177792|NCT00305682|100757686|FG000|NOT COMPLETED|Overall Study||0||
48177793|NCT00305682|100757687|FG001|NOT COMPLETED|Overall Study||0||
48177794|NCT00305682|100757688|FG002|NOT COMPLETED|Overall Study||0||
48177795|NCT00305682|100757689|FG003|NOT COMPLETED|Overall Study||0||
48177796|NCT00305682|100757690|FG004|NOT COMPLETED|Overall Study||0||
48177797|NCT00305682|100757691|FG005|NOT COMPLETED|Overall Study||0||
48753836|NCT00997035|102184606|FG000|STARTED|3-month Follow-up Visit||112||
48753837|NCT00997035|102184607|FG001|STARTED|3-month Follow-up Visit||113||
48753838|NCT00997035|102184606|FG000|COMPLETED|3-month Follow-up Visit||100||
48753839|NCT00997035|102184607|FG001|COMPLETED|3-month Follow-up Visit||107||
48177798|NCT04176133|100757692|FG000|STARTED|Overall Study||20||
48177799|NCT04176133|100757693|FG001|STARTED|Overall Study||19||
48177800|NCT04176133|100757694|FG002|STARTED|Overall Study||6||
48631389|NCT00888654|101881514|FG000|STARTED|Overall Study||41||
48631390|NCT00888654|101881514|FG000|COMPLETED|Overall Study||31||
48631391|NCT00888654|101881514|FG000|NOT COMPLETED|Overall Study||10||
48631392|NCT01426581|101881515|FG000|STARTED|Overall Study||62||
48631393|NCT01426581|101881516|FG001|STARTED|Overall Study||58||
48631394|NCT01426581|101881515|FG000|COMPLETED|Overall Study||62||
48631395|NCT01426581|101881516|FG001|COMPLETED|Overall Study||58||
48177801|NCT04176133|100757695|FG003|STARTED|Overall Study||16||
48177802|NCT04176133|100757692|FG000|COMPLETED|Overall Study||20||
48177803|NCT04176133|100757693|FG001|COMPLETED|Overall Study||19||
48177804|NCT04176133|100757694|FG002|COMPLETED|Overall Study||6||
48177805|NCT04176133|100757695|FG003|COMPLETED|Overall Study||16||
48177806|NCT04176133|100757692|FG000|NOT COMPLETED|Overall Study||0||
48177807|NCT04176133|100757693|FG001|NOT COMPLETED|Overall Study||0||
48177808|NCT04176133|100757694|FG002|NOT COMPLETED|Overall Study||0||
48338107|NCT00214461|101156601|FG002|COMPLETED|Overall Study||10||
48753840|NCT00997035|102184606|FG000|NOT COMPLETED|3-month Follow-up Visit||12||
48177809|NCT04176133|100757695|FG003|NOT COMPLETED|Overall Study||0||
48177810|NCT03935217|100757696|FG000|STARTED|Overall Study||74||
48753841|NCT00997035|102184607|FG001|NOT COMPLETED|3-month Follow-up Visit||6||
48177811|NCT03935217|100757697|FG001|STARTED|Overall Study||73||
48177812|NCT03935217|100757696|FG000|COMPLETED|Overall Study||73||
48177813|NCT03935217|100757697|FG001|COMPLETED|Overall Study||70||
48338108|NCT00214461|101156602|FG003|COMPLETED|Overall Study||11||
48338109|NCT00214461|101156599|FG000|NOT COMPLETED|Overall Study||0||
48338110|NCT00214461|101156600|FG001|NOT COMPLETED|Overall Study||0||
48412995|NCT02531633|101345752|FG009|COMPLETED|Part A (52 Weeks)||0|Completed Part A and entered Part B|
48631396|NCT01426581|101881515|FG000|NOT COMPLETED|Overall Study||0||
48631397|NCT01426581|101881516|FG001|NOT COMPLETED|Overall Study||0||
48631398|NCT02495389|101881517|FG000|STARTED|Overall Study||84||
48412996|NCT02531633|101345743|FG000|NOT COMPLETED|Part A (52 Weeks)||34||
48412997|NCT02531633|101345744|FG001|NOT COMPLETED|Part A (52 Weeks)||34||
48412998|NCT02531633|101345745|FG002|NOT COMPLETED|Part A (52 Weeks)||22||
48412999|NCT02531633|101345746|FG003|NOT COMPLETED|Part A (52 Weeks)||22||
48413000|NCT02531633|101345747|FG004|NOT COMPLETED|Part A (52 Weeks)||23||
48413001|NCT02531633|101345748|FG005|NOT COMPLETED|Part A (52 Weeks)||0||
48753842|NCT02973100|102184608|FG000|STARTED|Overall Study||82||
48753843|NCT02973100|102184609|FG001|STARTED|Overall Study||81||
48753844|NCT02973100|102184610|FG002|STARTED|Overall Study||79||
48753845|NCT02973100|102184611|FG003|STARTED|Overall Study||76||
48753846|NCT02973100|102184608|FG000|Received at Least 1 Dose of Study Drug|Overall Study||81||
48753847|NCT02973100|102184609|FG001|Received at Least 1 Dose of Study Drug|Overall Study||81||
48753848|NCT02973100|102184610|FG002|Received at Least 1 Dose of Study Drug|Overall Study||79||
48753849|NCT02973100|102184611|FG003|Received at Least 1 Dose of Study Drug|Overall Study||76||
48753850|NCT02973100|102184608|FG000|COMPLETED|Overall Study||75||
48753851|NCT02973100|102184609|FG001|COMPLETED|Overall Study||73||
48753852|NCT02973100|102184610|FG002|COMPLETED|Overall Study||75||
48753853|NCT02973100|102184611|FG003|COMPLETED|Overall Study||69||
48753854|NCT02973100|102184608|FG000|NOT COMPLETED|Overall Study||7||
48753855|NCT02973100|102184609|FG001|NOT COMPLETED|Overall Study||8||
48753856|NCT02973100|102184610|FG002|NOT COMPLETED|Overall Study||4||
48753857|NCT02973100|102184611|FG003|NOT COMPLETED|Overall Study||7||
48753858|NCT04439136|102184612|FG000|STARTED|Overall Study||40||
48753859|NCT04439136|102184612|FG000|Eligible|Overall Study||39||
48753860|NCT04439136|102184612|FG000|Eligible and Started Protocol Therapy|Overall Study||37|One patient ineligible, 2 patients never started treatment. This is the primary analysis population.|
48753861|NCT04439136|102184612|FG000|Reported Adverse Events Data|Overall Study||37|Excluding two who did not receive afatinib treatment and one who was not assessed for toxicity|
48413002|NCT02531633|101345749|FG006|NOT COMPLETED|Part A (52 Weeks)||0||
48631399|NCT02495389|101881517|FG000|COMPLETED|Overall Study||44||
48631400|NCT02495389|101881517|FG000|NOT COMPLETED|Overall Study||40||
48631401|NCT03703895|101881518|FG000|STARTED|Overall Study||15||
48631402|NCT03703895|101881519|FG001|STARTED|Overall Study||5||
48753862|NCT04439136|102184612|FG000|COMPLETED|Overall Study||0|Treatment continued until disease progression or intolerability.|
48753863|NCT04439136|102184612|FG000|NOT COMPLETED|Overall Study||40||
48753864|NCT01419769|102184613|FG000|STARTED|Overall Study||33||
48753865|NCT01419769|102184613|FG000|COMPLETED|Overall Study||29||
48753866|NCT01419769|102184613|FG000|NOT COMPLETED|Overall Study||4||
48753867|NCT00768989|102184614|FG000|STARTED|Prior to Week 24||63||
48753868|NCT00768989|102184615|FG001|STARTED|Prior to Week 24||30||
48753869|NCT00768989|102184614|FG000|COMPLETED|Prior to Week 24||59||
48753870|NCT00768989|102184615|FG001|COMPLETED|Prior to Week 24||27||
48753871|NCT00768989|102184614|FG000|NOT COMPLETED|Prior to Week 24||4||
48753872|NCT00768989|102184615|FG001|NOT COMPLETED|Prior to Week 24||3||
48753873|NCT00768989|102184614|FG000|STARTED|Week 24 to Prior to Week 36||59||
48753874|NCT00768989|102184615|FG001|STARTED|Week 24 to Prior to Week 36||27||
48753875|NCT00768989|102184614|FG000|COMPLETED|Week 24 to Prior to Week 36||51||
48177814|NCT03935217|100757696|FG000|NOT COMPLETED|Overall Study||1||
48338111|NCT00214461|101156601|FG002|NOT COMPLETED|Overall Study||2||
48338112|NCT00214461|101156602|FG003|NOT COMPLETED|Overall Study||1||
48338113|NCT03075163|101156603|FG000|STARTED|Overall Study||150||
48338114|NCT03075163|101156604|FG001|STARTED|Overall Study||150||
48177815|NCT03935217|100757697|FG001|NOT COMPLETED|Overall Study||3||
48177816|NCT02065570|100757698|FG000|STARTED|Induction Study||206||
48338115|NCT03075163|101156603|FG000|COMPLETED|Overall Study||12||
48177817|NCT02065570|100757699|FG001|STARTED|Induction Study||308||
48177818|NCT02065570|100757700|FG002|STARTED|Induction Study||0||
48177819|NCT02065570|100757701|FG003|STARTED|Induction Study||0||
48177820|NCT02065570|100757698|FG000|COMPLETED|Induction Study||192||
48338116|NCT03075163|101156604|FG001|COMPLETED|Overall Study||12||
48413003|NCT02531633|101345750|FG007|NOT COMPLETED|Part A (52 Weeks)||0||
48631403|NCT03703895|101881518|FG000|COMPLETED|Overall Study||15||
48631404|NCT03703895|101881519|FG001|COMPLETED|Overall Study||5||
48177821|NCT02065570|100757699|FG001|COMPLETED|Induction Study||287||
48631405|NCT03703895|101881518|FG000|NOT COMPLETED|Overall Study||0||
48631406|NCT03703895|101881519|FG001|NOT COMPLETED|Overall Study||0||
48338117|NCT03075163|101156603|FG000|NOT COMPLETED|Overall Study||138||
48338118|NCT03075163|101156604|FG001|NOT COMPLETED|Overall Study||138||
48338119|NCT01916980|101156605|FG000|STARTED|Overall Study||65||
48631407|NCT03863353|101881520|FG000|STARTED|Overall Study||282||
48631408|NCT03863353|101881521|FG001|STARTED|Overall Study||221||
48413004|NCT02531633|101345751|FG008|NOT COMPLETED|Part A (52 Weeks)||0||
48413005|NCT02531633|101345752|FG009|NOT COMPLETED|Part A (52 Weeks)||0||
48413006|NCT02531633|101345743|FG000|STARTED|Part B (104 Weeks)||0||
48413007|NCT02531633|101345744|FG001|STARTED|Part B (104 Weeks)||0||
48413008|NCT02531633|101345745|FG002|STARTED|Part B (104 Weeks)||0||
48177822|NCT02065570|100757700|FG002|COMPLETED|Induction Study||0||
48177823|NCT02065570|100757701|FG003|COMPLETED|Induction Study||0||
48177824|NCT02065570|100757698|FG000|NOT COMPLETED|Induction Study||14||
48177825|NCT02065570|100757699|FG001|NOT COMPLETED|Induction Study||21||
48413009|NCT02531633|101345746|FG003|STARTED|Part B (104 Weeks)||0||
48413010|NCT02531633|101345747|FG004|STARTED|Part B (104 Weeks)||0||
48413011|NCT02531633|101345748|FG005|STARTED|Part B (104 Weeks)||8||
48413012|NCT02531633|101345749|FG006|STARTED|Part B (104 Weeks)||5||
48413013|NCT02531633|101345750|FG007|STARTED|Part B (104 Weeks)||4||
48413014|NCT02531633|101345751|FG008|STARTED|Part B (104 Weeks)||5||
48413015|NCT02531633|101345752|FG009|STARTED|Part B (104 Weeks)||4||
48413016|NCT02531633|101345743|FG000|COMPLETED|Part B (104 Weeks)||0||
48413017|NCT02531633|101345744|FG001|COMPLETED|Part B (104 Weeks)||0||
48631409|NCT03863353|101881520|FG000|COMPLETED|Overall Study||258||
48631410|NCT03863353|101881521|FG001|COMPLETED|Overall Study||201||
48631411|NCT03863353|101881520|FG000|NOT COMPLETED|Overall Study||24||
48631412|NCT03863353|101881521|FG001|NOT COMPLETED|Overall Study||20||
48631413|NCT01324102|101881522|FG000|STARTED|Overall Study||11||
48631414|NCT01324102|101881523|FG001|STARTED|Overall Study||12||
48631415|NCT01324102|101881522|FG000|COMPLETED|Overall Study||10||
48631416|NCT01324102|101881523|FG001|COMPLETED|Overall Study||6||
48631417|NCT01324102|101881522|FG000|NOT COMPLETED|Overall Study||1||
48631418|NCT01324102|101881523|FG001|NOT COMPLETED|Overall Study||6||
48631419|NCT00385840|101881524|FG000|STARTED|Overall Study||133||
48631420|NCT00385840|101881525|FG001|STARTED|Overall Study||545||
48631421|NCT00385840|101881524|FG000|COMPLETED|Overall Study||129||
48631422|NCT00385840|101881525|FG001|COMPLETED|Overall Study||531||
48631423|NCT00385840|101881524|FG000|NOT COMPLETED|Overall Study||4||
48631424|NCT00385840|101881525|FG001|NOT COMPLETED|Overall Study||14||
48631425|NCT02631941|101881526|FG000|STARTED|Overall Study||9||
48631426|NCT02631941|101881527|FG001|STARTED|Overall Study||10||
48631427|NCT02631941|101881528|FG002|STARTED|Overall Study||9||
48631428|NCT02631941|101881529|FG003|STARTED|Overall Study||9||
48631429|NCT02631941|101881530|FG004|STARTED|Overall Study||9||
48631430|NCT02631941|101881531|FG005|STARTED|Overall Study||8||
48631431|NCT02631941|101881532|FG006|STARTED|Overall Study||9||
48631432|NCT02631941|101881533|FG007|STARTED|Overall Study||9||
48631433|NCT02631941|101881534|FG008|STARTED|Overall Study||10||
48631434|NCT02631941|101881535|FG009|STARTED|Overall Study||9||
48631435|NCT02631941|101881526|FG000|A|Overall Study||9||
48631436|NCT02631941|101881527|FG001|A|Overall Study||8||
48177826|NCT02065570|100757700|FG002|NOT COMPLETED|Induction Study||0||
48177827|NCT02065570|100757701|FG003|NOT COMPLETED|Induction Study||0||
48177828|NCT02065570|100757698|FG000|STARTED|Maintenance Study||0||
48413018|NCT02531633|101345745|FG002|COMPLETED|Part B (104 Weeks)||0||
48413019|NCT02531633|101345746|FG003|COMPLETED|Part B (104 Weeks)||0||
48413020|NCT02531633|101345747|FG004|COMPLETED|Part B (104 Weeks)||0||
48631437|NCT02631941|101881528|FG002|A|Overall Study||9||
48631438|NCT02631941|101881529|FG003|A|Overall Study||9||
48631439|NCT02631941|101881530|FG004|A|Overall Study||9||
48631440|NCT02631941|101881531|FG005|A|Overall Study||8||
48631441|NCT02631941|101881532|FG006|A|Overall Study||9||
48631442|NCT02631941|101881533|FG007|A|Overall Study||9||
48631443|NCT02631941|101881534|FG008|A|Overall Study||9||
48631444|NCT02631941|101881535|FG009|A|Overall Study||9||
48631445|NCT02631941|101881526|FG000|B1|Overall Study||9||
48631446|NCT02631941|101881527|FG001|B1|Overall Study||10||
48631447|NCT02631941|101881528|FG002|B1|Overall Study||9||
48631448|NCT02631941|101881529|FG003|B1|Overall Study||9||
48631449|NCT02631941|101881530|FG004|B1|Overall Study||8||
48631450|NCT02631941|101881531|FG005|B1|Overall Study||8||
48631451|NCT02631941|101881532|FG006|B1|Overall Study||9||
48631452|NCT02631941|101881533|FG007|B1|Overall Study||9||
48631453|NCT02631941|101881534|FG008|B1|Overall Study||10||
48631454|NCT02631941|101881535|FG009|B1|Overall Study||9||
48631455|NCT02631941|101881526|FG000|B2|Overall Study||9||
48631456|NCT02631941|101881527|FG001|B2|Overall Study||8||
48631457|NCT02631941|101881528|FG002|B2|Overall Study||9||
48631458|NCT02631941|101881529|FG003|B2|Overall Study||9||
48631459|NCT02631941|101881530|FG004|B2|Overall Study||9||
48631460|NCT02631941|101881531|FG005|B2|Overall Study||8||
48631461|NCT02631941|101881532|FG006|B2|Overall Study||9||
48631462|NCT02631941|101881533|FG007|B2|Overall Study||9||
48631463|NCT02631941|101881534|FG008|B2|Overall Study||9||
48631464|NCT02631941|101881535|FG009|B2|Overall Study||9||
48631465|NCT02631941|101881526|FG000|C|Overall Study||9||
48631466|NCT02631941|101881527|FG001|C|Overall Study||8||
48631467|NCT02631941|101881528|FG002|C|Overall Study||9||
48631468|NCT02631941|101881529|FG003|C|Overall Study||9||
48631469|NCT02631941|101881530|FG004|C|Overall Study||8||
48631470|NCT02631941|101881531|FG005|C|Overall Study||8||
48631471|NCT02631941|101881532|FG006|C|Overall Study||9||
48631472|NCT02631941|101881533|FG007|C|Overall Study||8||
48631473|NCT02631941|101881534|FG008|C|Overall Study||9||
48753876|NCT00768989|102184615|FG001|COMPLETED|Week 24 to Prior to Week 36||27||
48753877|NCT00768989|102184614|FG000|NOT COMPLETED|Week 24 to Prior to Week 36||8||
48753878|NCT00768989|102184615|FG001|NOT COMPLETED|Week 24 to Prior to Week 36||0||
48753879|NCT00768989|102184614|FG000|STARTED|On or After Week 36||51||
48753880|NCT00768989|102184615|FG001|STARTED|On or After Week 36||27||
48753881|NCT00768989|102184614|FG000|COMPLETED|On or After Week 36||0||
48753882|NCT00768989|102184615|FG001|COMPLETED|On or After Week 36||0||
48753883|NCT00768989|102184614|FG000|NOT COMPLETED|On or After Week 36||51||
48753884|NCT00768989|102184615|FG001|NOT COMPLETED|On or After Week 36||27||
48753885|NCT04472611|102184616|FG000|STARTED|Overall Study||125||
48753886|NCT04472611|102184617|FG001|STARTED|Overall Study||125||
48753887|NCT04472611|102184616|FG000|COMPLETED|Overall Study||122||
48753888|NCT04472611|102184617|FG001|COMPLETED|Overall Study||125||
48753889|NCT04472611|102184616|FG000|NOT COMPLETED|Overall Study||3||
48753890|NCT04472611|102184617|FG001|NOT COMPLETED|Overall Study||0||
48753891|NCT03600909|102184618|FG000|STARTED|Overall Study||0||
48753892|NCT03600909|102184619|FG001|STARTED|Overall Study||3||
48753893|NCT03600909|102184620|FG002|STARTED|Overall Study||0||
48753894|NCT03600909|102184618|FG000|COMPLETED|Overall Study||0||
48753895|NCT03600909|102184619|FG001|COMPLETED|Overall Study||0||
48753896|NCT03600909|102184620|FG002|COMPLETED|Overall Study||0||
48753897|NCT03600909|102184618|FG000|NOT COMPLETED|Overall Study||0||
48753898|NCT03600909|102184619|FG001|NOT COMPLETED|Overall Study||3||
48753899|NCT03600909|102184620|FG002|NOT COMPLETED|Overall Study||0||
48753900|NCT03922581|102184621|FG000|STARTED|Overall Study||44||
48753901|NCT03922581|102184622|FG001|STARTED|Overall Study||36||
48753902|NCT03922581|102184621|FG000|Started In-Person Intervention|Overall Study||18|Participants enrolled between September 2018 and March 2020|
48753903|NCT03922581|102184622|FG001|Started In-Person Intervention|Overall Study||16|Participants enrolled between September 2018 and March 2020|
48753904|NCT03922581|102184621|FG000|In-Person Intervention Participants Completing the Post-Intervention Assessment|Overall Study||11|Participants enrolled between September 2018 and March 2020|
48753905|NCT03922581|102184622|FG001|In-Person Intervention Participants Completing the Post-Intervention Assessment|Overall Study||15|Participants enrolled between September 2018 and March 2020|
48753906|NCT03922581|102184621|FG000|In-Person Intervention Participants Completing the Follow-up Assessment 1 Month After Intervention|Overall Study||10|Participants enrolled between September 2018 and March 2020|
48753907|NCT03922581|102184622|FG001|In-Person Intervention Participants Completing the Follow-up Assessment 1 Month After Intervention|Overall Study||14|Participants enrolled between September 2018 and March 2020|
48753908|NCT03922581|102184621|FG000|Started Virtual Intervention|Overall Study||26|Participants enrolled after study re-opened in September 2020|
48753909|NCT03922581|102184622|FG001|Started Virtual Intervention|Overall Study||20|Participants enrolled after study re-opened in September 2020|
48753910|NCT03922581|102184621|FG000|Virtual Intervention Participants Completing the Post-Intervention Assessment|Overall Study||14|Participants enrolled after study re-opened in September 2020|
48753911|NCT03922581|102184622|FG001|Virtual Intervention Participants Completing the Post-Intervention Assessment|Overall Study||18|Participants enrolled after study re-opened in September 2020|
48753912|NCT03922581|102184621|FG000|Virtual Intervention Participants Completing the Follow-up Assessment 1 Month After Intervention|Overall Study||12|Participants enrolled after study re-opened in September 2020|
48753913|NCT03922581|102184622|FG001|Virtual Intervention Participants Completing the Follow-up Assessment 1 Month After Intervention|Overall Study||12|Participants enrolled after study re-opened in September 2020|
48753914|NCT03922581|102184621|FG000|COMPLETED|Overall Study||22||
48753915|NCT03922581|102184622|FG001|COMPLETED|Overall Study||26||
48753916|NCT03922581|102184621|FG000|NOT COMPLETED|Overall Study||22||
48753917|NCT03922581|102184622|FG001|NOT COMPLETED|Overall Study||10||
48753918|NCT02016781|102184623|FG000|STARTED|Interim Look for Primary Analysis||260|Interim look uses data cutoff as of February 18, 2020|
48753919|NCT02016781|102184624|FG001|STARTED|Interim Look for Primary Analysis||124|Interim look uses data cutoff as of February 18, 2020|
48753920|NCT02016781|102184623|FG000|COMPLETED|Interim Look for Primary Analysis||187|Patients completed 3 years of follow up or died.|
48753921|NCT02016781|102184624|FG001|COMPLETED|Interim Look for Primary Analysis||100|Patients completed 3 years of follow up or died.|
48753922|NCT02016781|102184623|FG000|NOT COMPLETED|Interim Look for Primary Analysis||73||
48753923|NCT02016781|102184624|FG001|NOT COMPLETED|Interim Look for Primary Analysis||24||
48753924|NCT02016781|102184623|FG000|STARTED|Final Database Lock||261|Final database lock was on May 24, 2022. One patient was categorized in the non-HCT arm at interim analysis data look. The site corrected data to assign this patient to HCT arm after interim analysis data cutoff date and confirmed that the patient did receive transplant. Patients missing visits or data was unable to be obtained are categorized as not completing the study due to missing data.|
48753925|NCT02016781|102184624|FG001|STARTED|Final Database Lock||123|Final database lock was on May 24, 2022. One patient was categorized in the non-HCT arm at interim analysis data look. The site corrected data to assign this patient to HCT arm after interim analysis data cutoff date and confirmed that the patient did receive transplant. Patients missing visits or data was unable to be obtained are categorized as not completing the study due to missing data.|
48753926|NCT02016781|102184623|FG000|COMPLETED|Final Database Lock||248||
48753927|NCT02016781|102184624|FG001|COMPLETED|Final Database Lock||115||
48753928|NCT02016781|102184623|FG000|NOT COMPLETED|Final Database Lock||13||
48753929|NCT02016781|102184624|FG001|NOT COMPLETED|Final Database Lock||8||
48753930|NCT02021565|102184625|FG000|STARTED|Baseline Through Intervention||72||
48753931|NCT02021565|102184626|FG001|STARTED|Baseline Through Intervention||54||
48753932|NCT02021565|102184625|FG000|Caregivers|Baseline Through Intervention||36||
48753933|NCT02021565|102184626|FG001|Caregivers|Baseline Through Intervention||27||
48753934|NCT02021565|102184625|FG000|Care Recipients|Baseline Through Intervention||36||
48753935|NCT02021565|102184626|FG001|Care Recipients|Baseline Through Intervention||27||
48753936|NCT02021565|102184625|FG000|COMPLETED|Baseline Through Intervention||60||
48177829|NCT02065570|100757699|FG001|STARTED|Maintenance Study||0||
48177830|NCT02065570|100757700|FG002|STARTED|Maintenance Study||109||
48177831|NCT02065570|100757701|FG003|STARTED|Maintenance Study||109||
48177832|NCT02065570|100757698|FG000|COMPLETED|Maintenance Study||0||
48177833|NCT02065570|100757699|FG001|COMPLETED|Maintenance Study||0||
48177834|NCT02065570|100757700|FG002|COMPLETED|Maintenance Study||87||
48177835|NCT02065570|100757701|FG003|COMPLETED|Maintenance Study||90||
48177836|NCT02065570|100757698|FG000|NOT COMPLETED|Maintenance Study||0||
48753937|NCT02021565|102184626|FG001|COMPLETED|Baseline Through Intervention||36||
48753938|NCT02021565|102184625|FG000|NOT COMPLETED|Baseline Through Intervention||12||
48753939|NCT02021565|102184626|FG001|NOT COMPLETED|Baseline Through Intervention||18||
48753940|NCT02021565|102184625|FG000|STARTED|3-month Follow-up||60||
48753941|NCT02021565|102184626|FG001|STARTED|3-month Follow-up||36||
48753942|NCT02021565|102184625|FG000|Caregivers|3-month Follow-up||30||
48753943|NCT02021565|102184626|FG001|Caregivers|3-month Follow-up||18||
48753944|NCT02021565|102184625|FG000|Care Recipients|3-month Follow-up||30||
48753945|NCT02021565|102184626|FG001|Care Recipients|3-month Follow-up||18||
48753946|NCT02021565|102184625|FG000|COMPLETED|3-month Follow-up||50||
48753947|NCT02021565|102184626|FG001|COMPLETED|3-month Follow-up||34||
48753948|NCT02021565|102184625|FG000|NOT COMPLETED|3-month Follow-up||10||
48753949|NCT02021565|102184626|FG001|NOT COMPLETED|3-month Follow-up||2||
48177837|NCT02065570|100757699|FG001|NOT COMPLETED|Maintenance Study||0||
48177838|NCT02065570|100757700|FG002|NOT COMPLETED|Maintenance Study||22||
48177839|NCT02065570|100757701|FG003|NOT COMPLETED|Maintenance Study||19||
48177840|NCT01439087|100757702|FG000|STARTED|Overall Study||2||
48177841|NCT01439087|100757702|FG000|COMPLETED|Overall Study||2||
48177842|NCT01439087|100757702|FG000|NOT COMPLETED|Overall Study||0||
48177843|NCT02753530|100757703|FG000|STARTED|Overall Study||74||
48177844|NCT02753530|100757704|FG001|STARTED|Overall Study||78||
48177845|NCT02753530|100757703|FG000|COMPLETED|Overall Study||62||
48177846|NCT02753530|100757704|FG001|COMPLETED|Overall Study||72||
48177847|NCT02753530|100757703|FG000|NOT COMPLETED|Overall Study||12||
48177848|NCT02753530|100757704|FG001|NOT COMPLETED|Overall Study||6||
48177849|NCT00581113|100757705|FG000|STARTED|Overall Study||4||
48338120|NCT01916980|101156606|FG001|STARTED|Overall Study||29||
48338121|NCT01916980|101156605|FG000|COMPLETED|Overall Study||58||
48338122|NCT01916980|101156606|FG001|COMPLETED|Overall Study||25||
48338123|NCT01916980|101156605|FG000|NOT COMPLETED|Overall Study||7||
48338124|NCT01916980|101156606|FG001|NOT COMPLETED|Overall Study||4||
48177850|NCT00581113|100757706|FG001|STARTED|Overall Study||4||
48177851|NCT00581113|100757705|FG000|COMPLETED|Overall Study||4||
48177852|NCT00581113|100757706|FG001|COMPLETED|Overall Study||3||
48338125|NCT03136107|101156607|FG000|STARTED|Overall Study||26||
48338126|NCT03136107|101156607|FG000|Test Product|Overall Study||26||
48338127|NCT03136107|101156607|FG000|Reference Product|Overall Study||26||
48338128|NCT03136107|101156607|FG000|Negative Control|Overall Study||26||
48338129|NCT03136107|101156607|FG000|COMPLETED|Overall Study||25||
48338130|NCT03136107|101156607|FG000|NOT COMPLETED|Overall Study||1||
48753950|NCT00651924|102184627|FG000|STARTED|Overall Study||18||
48753951|NCT00651924|102184628|FG001|STARTED|Overall Study||9||
48753952|NCT00651924|102184627|FG000|COMPLETED|Overall Study||18||
48753953|NCT00651924|102184628|FG001|COMPLETED|Overall Study||2||
48753954|NCT00651924|102184627|FG000|NOT COMPLETED|Overall Study||0||
48753955|NCT00651924|102184628|FG001|NOT COMPLETED|Overall Study||7||
48753956|NCT01166139|102184629|FG000|STARTED|Overall Study||10||
48753957|NCT01166139|102184629|FG000|COMPLETED|Overall Study||7||
48753958|NCT01166139|102184629|FG000|NOT COMPLETED|Overall Study||3||
48753959|NCT01784991|102184630|FG000|STARTED|Overall Study||0||
48177853|NCT00581113|100757705|FG000|NOT COMPLETED|Overall Study||0||
48177854|NCT00581113|100757706|FG001|NOT COMPLETED|Overall Study||1||
48177855|NCT01425632|100757707|FG000|STARTED|Overall Study||161||
48177856|NCT01425632|100757708|FG001|STARTED|Overall Study||166||
48177857|NCT01425632|100757709|FG002|STARTED|Overall Study||163||
48177858|NCT01425632|100757707|FG000|COMPLETED|Overall Study||160||
48338131|NCT03120832|101156608|FG000|STARTED|Overall Study||3||
48753960|NCT01784991|102184631|FG001|STARTED|Overall Study||0||
48753961|NCT01784991|102184630|FG000|COMPLETED|Overall Study||0||
48753962|NCT01784991|102184631|FG001|COMPLETED|Overall Study||0||
48753963|NCT01784991|102184630|FG000|NOT COMPLETED|Overall Study||0||
48753964|NCT01784991|102184631|FG001|NOT COMPLETED|Overall Study||0||
48753965|NCT01415882|102184632|FG000|STARTED|Overall Study||33||
48177859|NCT01425632|100757708|FG001|COMPLETED|Overall Study||165||
48177860|NCT01425632|100757709|FG002|COMPLETED|Overall Study||159||
48177861|NCT01425632|100757707|FG000|NOT COMPLETED|Overall Study||1||
48177862|NCT01425632|100757708|FG001|NOT COMPLETED|Overall Study||1||
48177863|NCT01425632|100757709|FG002|NOT COMPLETED|Overall Study||4||
48177864|NCT04716413|100757710|FG000|STARTED|Overall Study||3||
48177865|NCT04716413|100757711|FG001|STARTED|Overall Study||0||
48177866|NCT04716413|100757710|FG000|COMPLETED|Overall Study||3||
48177867|NCT04716413|100757711|FG001|COMPLETED|Overall Study||0||
48177868|NCT04716413|100757710|FG000|NOT COMPLETED|Overall Study||0||
48177869|NCT04716413|100757711|FG001|NOT COMPLETED|Overall Study||0||
48177870|NCT00788255|100757712|FG000|STARTED|Overall Study||25||
48177871|NCT00788255|100757712|FG000|Oxytocin Infusion 1: 22.5 μU/mL|Overall Study||25||
48177872|NCT00788255|100757712|FG000|Oxytocin Infusion 2: 30.1μU/mL|Overall Study||25||
48177873|NCT00788255|100757712|FG000|Oxytocin Infusion 3: 32.9μU/mL|Overall Study||25||
48177874|NCT00788255|100757712|FG000|Oxytocin: 0 μU/mL|Overall Study||25||
48177875|NCT00788255|100757712|FG000|COMPLETED|Overall Study||25||
48177876|NCT00788255|100757712|FG000|NOT COMPLETED|Overall Study||0||
48177877|NCT02226172|100757713|FG000|STARTED|Overall Study||21||
48177878|NCT02226172|100757713|FG000|COMPLETED|Overall Study||4||
48177879|NCT02226172|100757713|FG000|NOT COMPLETED|Overall Study||17||
48177880|NCT03262701|100757714|FG000|STARTED|Overall Study||14||
48177881|NCT03262701|100757715|FG001|STARTED|Overall Study||17||
48177882|NCT03262701|100757716|FG002|STARTED|Overall Study||9||
48177883|NCT03262701|100757714|FG000|COMPLETED|Overall Study||11||
48177884|NCT03262701|100757715|FG001|COMPLETED|Overall Study||13||
48177885|NCT03262701|100757716|FG002|COMPLETED|Overall Study||8||
48177886|NCT03262701|100757714|FG000|NOT COMPLETED|Overall Study||3||
48177887|NCT03262701|100757715|FG001|NOT COMPLETED|Overall Study||4||
48177888|NCT03262701|100757716|FG002|NOT COMPLETED|Overall Study||1||
48177889|NCT05221749|100757717|FG000|STARTED|Overall Study||25||
48177890|NCT05221749|100757718|FG001|STARTED|Overall Study||25||
48177891|NCT05221749|100757717|FG000|COMPLETED|Overall Study||23||
48177892|NCT05221749|100757718|FG001|COMPLETED|Overall Study||22||
48177893|NCT05221749|100757717|FG000|NOT COMPLETED|Overall Study||2||
48177894|NCT05221749|100757718|FG001|NOT COMPLETED|Overall Study||3||
48177895|NCT00398398|100757719|FG000|STARTED|Overall Study||44||
48177896|NCT00398398|100757719|FG000|COMPLETED|Overall Study||44||
48177897|NCT00398398|100757719|FG000|NOT COMPLETED|Overall Study||0||
48177898|NCT03000673|100757720|FG000|STARTED|Overall Study||7||
48177899|NCT03000673|100757721|FG001|STARTED|Overall Study||9||
48177900|NCT03000673|100757722|FG002|STARTED|Overall Study||7||
48177901|NCT03000673|100757723|FG003|STARTED|Overall Study||9||
48177902|NCT03000673|100757720|FG000|COMPLETED|Overall Study||6||
48177903|NCT03000673|100757721|FG001|COMPLETED|Overall Study||9||
48177904|NCT03000673|100757722|FG002|COMPLETED|Overall Study||7||
48177905|NCT03000673|100757723|FG003|COMPLETED|Overall Study||9||
48177906|NCT03000673|100757720|FG000|NOT COMPLETED|Overall Study||1||
48177907|NCT03000673|100757721|FG001|NOT COMPLETED|Overall Study||0||
48338132|NCT03120832|101156609|FG001|STARTED|Overall Study||3||
48338133|NCT03120832|101156610|FG002|STARTED|Overall Study||6||
48338134|NCT03120832|101156608|FG000|COMPLETED|Overall Study||3||
48338135|NCT03120832|101156609|FG001|COMPLETED|Overall Study||3||
48338136|NCT03120832|101156610|FG002|COMPLETED|Overall Study||6||
48338137|NCT03120832|101156608|FG000|NOT COMPLETED|Overall Study||0||
48338138|NCT03120832|101156609|FG001|NOT COMPLETED|Overall Study||0||
48338139|NCT03120832|101156610|FG002|NOT COMPLETED|Overall Study||0||
48338140|NCT03950973|101156611|FG000|STARTED|Overall Study||301||
48177908|NCT03000673|100757722|FG002|NOT COMPLETED|Overall Study||0||
48177909|NCT03000673|100757723|FG003|NOT COMPLETED|Overall Study||0||
48177910|NCT01815736|100757724|FG000|STARTED|Randomized Treatment Phase-Up to Week 96||963||
48177911|NCT01815736|100757725|FG001|STARTED|Randomized Treatment Phase-Up to Week 96||480||
48177912|NCT01815736|100757724|FG000|COMPLETED|Randomized Treatment Phase-Up to Week 96||914||
48177913|NCT01815736|100757725|FG001|COMPLETED|Randomized Treatment Phase-Up to Week 96||445||
48338141|NCT03950973|101156612|FG001|STARTED|Overall Study||299||
48338142|NCT03950973|101156611|FG000|Follow Up 1 Completion|Overall Study||206|Completed next data collection timepoint (Follow-Up 1)|
48338143|NCT03950973|101156612|FG001|Follow Up 1 Completion|Overall Study||258|Completed next data collection timepoint (Follow-Up 1)|
48338144|NCT03950973|101156611|FG000|Follow Up 2 Completion|Overall Study||196|Completed final data collection timepoint (Follow-Up 2)|
48338145|NCT03950973|101156612|FG001|Follow Up 2 Completion|Overall Study||239|Completed final data collection timepoint (Follow-Up 2)|
48177914|NCT01815736|100757724|FG000|NOT COMPLETED|Randomized Treatment Phase-Up to Week 96||49||
48177915|NCT01815736|100757725|FG001|NOT COMPLETED|Randomized Treatment Phase-Up to Week 96||35||
48177916|NCT01815736|100757724|FG000|STARTED|Extension Treatment Phase- After Week 96||905||
48177917|NCT01815736|100757725|FG001|STARTED|Extension Treatment Phase- After Week 96||424||
48177918|NCT01815736|100757724|FG000|COMPLETED|Extension Treatment Phase- After Week 96||854||
48177919|NCT01815736|100757725|FG001|COMPLETED|Extension Treatment Phase- After Week 96||398||
48177920|NCT01815736|100757724|FG000|NOT COMPLETED|Extension Treatment Phase- After Week 96||51||
48413021|NCT02531633|101345748|FG005|COMPLETED|Part B (104 Weeks)||0||
48177921|NCT01815736|100757725|FG001|NOT COMPLETED|Extension Treatment Phase- After Week 96||26||
48177922|NCT04430335|100757726|FG000|STARTED|Overall Study||8||
48177923|NCT04430335|100757726|FG000|COMPLETED|Overall Study||7||
48177924|NCT04430335|100757726|FG000|NOT COMPLETED|Overall Study||1||
48177925|NCT02589392|100757727|FG000|STARTED|Overall Study||60||
48177926|NCT02589392|100757728|FG001|STARTED|Overall Study||60||
48413022|NCT02531633|101345749|FG006|COMPLETED|Part B (104 Weeks)||0||
48413023|NCT02531633|101345750|FG007|COMPLETED|Part B (104 Weeks)||0||
48413024|NCT02531633|101345751|FG008|COMPLETED|Part B (104 Weeks)||0||
48413025|NCT02531633|101345752|FG009|COMPLETED|Part B (104 Weeks)||0||
48413026|NCT02531633|101345743|FG000|NOT COMPLETED|Part B (104 Weeks)||0||
48413027|NCT02531633|101345744|FG001|NOT COMPLETED|Part B (104 Weeks)||0||
48413028|NCT02531633|101345745|FG002|NOT COMPLETED|Part B (104 Weeks)||0||
48413029|NCT02531633|101345746|FG003|NOT COMPLETED|Part B (104 Weeks)||0||
48413030|NCT02531633|101345747|FG004|NOT COMPLETED|Part B (104 Weeks)||0||
48413031|NCT02531633|101345748|FG005|NOT COMPLETED|Part B (104 Weeks)||8||
48413032|NCT02531633|101345749|FG006|NOT COMPLETED|Part B (104 Weeks)||5||
48413033|NCT02531633|101345750|FG007|NOT COMPLETED|Part B (104 Weeks)||4||
48413034|NCT02531633|101345751|FG008|NOT COMPLETED|Part B (104 Weeks)||5||
48413035|NCT02531633|101345752|FG009|NOT COMPLETED|Part B (104 Weeks)||4||
48413036|NCT00407420|101345753|FG000|STARTED|Overall Study||54||
48413037|NCT00407420|101345754|FG001|STARTED|Overall Study||52||
48413038|NCT00407420|101345753|FG000|COMPLETED|Overall Study||45||
48413039|NCT00407420|101345754|FG001|COMPLETED|Overall Study||46||
48413040|NCT00407420|101345753|FG000|NOT COMPLETED|Overall Study||9||
48413041|NCT00407420|101345754|FG001|NOT COMPLETED|Overall Study||6||
48413042|NCT01948791|101345755|FG000|STARTED|Overall Study||222||
48413043|NCT01948791|101345755|FG000|COMPLETED|Overall Study||151||
48413044|NCT01948791|101345755|FG000|NOT COMPLETED|Overall Study||71||
48413045|NCT00405275|101345756|FG000|STARTED|Overall Study||178||
48413046|NCT00405275|101345757|FG001|STARTED|Overall Study||175||
48413047|NCT00405275|101345756|FG000|24 Weeks (Total)|Overall Study||163||
48413048|NCT00405275|101345757|FG001|24 Weeks (Total)|Overall Study||165||
48413049|NCT00405275|101345756|FG000|24 Week (no Switch)|Overall Study||119||
48413050|NCT00405275|101345757|FG001|24 Week (no Switch)|Overall Study||121||
48413051|NCT00405275|101345756|FG000|24 Week (Switch)|Overall Study||44||
48413052|NCT00405275|101345757|FG001|24 Week (Switch)|Overall Study||44||
48413053|NCT00405275|101345756|FG000|COMPLETED|Overall Study||155||
48413054|NCT00405275|101345757|FG001|COMPLETED|Overall Study||156||
48413055|NCT00405275|101345756|FG000|NOT COMPLETED|Overall Study||23||
48413056|NCT00405275|101345757|FG001|NOT COMPLETED|Overall Study||19||
48413057|NCT00366444|101345758|FG000|STARTED|Overall Study||102||
48413058|NCT00366444|101345759|FG001|STARTED|Overall Study||99||
48413059|NCT00366444|101345758|FG000|COMPLETED|Overall Study||101||
48413060|NCT00366444|101345759|FG001|COMPLETED|Overall Study||97||
48413061|NCT00366444|101345758|FG000|NOT COMPLETED|Overall Study||1||
48413062|NCT00366444|101345759|FG001|NOT COMPLETED|Overall Study||2||
48413063|NCT01289028|101345760|FG000|STARTED|Overall Study||125||
48413064|NCT01289028|101345760|FG000|COMPLETED|Overall Study||42||
48413065|NCT01289028|101345760|FG000|NOT COMPLETED|Overall Study||83||
48413066|NCT00252499|101345761|FG000|STARTED|Overall Study||5||
48413067|NCT00252499|101345762|FG001|STARTED|Overall Study||2||
48413068|NCT00252499|101345763|FG002|STARTED|Overall Study||6||
48413069|NCT00252499|101345761|FG000|COMPLETED|Overall Study||4||
48413070|NCT00252499|101345762|FG001|COMPLETED|Overall Study||2||
48413071|NCT00252499|101345763|FG002|COMPLETED|Overall Study||6||
48413072|NCT00252499|101345761|FG000|NOT COMPLETED|Overall Study||1||
48413073|NCT00252499|101345762|FG001|NOT COMPLETED|Overall Study||0||
48413074|NCT00252499|101345763|FG002|NOT COMPLETED|Overall Study||0||
48413075|NCT01731600|101345764|FG000|STARTED|Overall Study||34||
48413076|NCT01731600|101345765|FG001|STARTED|Overall Study||34||
48413077|NCT01731600|101345764|FG000|COMPLETED|Overall Study||28||
48413078|NCT01731600|101345765|FG001|COMPLETED|Overall Study||34||
48413079|NCT01731600|101345764|FG000|NOT COMPLETED|Overall Study||6||
48413080|NCT01731600|101345765|FG001|NOT COMPLETED|Overall Study||0||
48413081|NCT03742271|101345766|FG000|STARTED|Overall Study||127||
48413082|NCT03742271|101345766|FG000|COMPLETED|Overall Study||115||
48413083|NCT03742271|101345766|FG000|NOT COMPLETED|Overall Study||12||
48413084|NCT00414973|101345767|FG000|STARTED|Overall Study||218||
48413085|NCT00414973|101345768|FG001|STARTED|Overall Study||109||
48413086|NCT00414973|101345769|FG002|STARTED|Overall Study||24||
48413087|NCT00414973|101345770|FG003|STARTED|Overall Study||11||
48413088|NCT00414973|101345767|FG000|COMPLETED|Overall Study||190||
48413089|NCT00414973|101345768|FG001|COMPLETED|Overall Study||99||
48413090|NCT00414973|101345769|FG002|COMPLETED|Overall Study||21||
48413091|NCT00414973|101345770|FG003|COMPLETED|Overall Study||11||
48413092|NCT00414973|101345767|FG000|NOT COMPLETED|Overall Study||28||
48413093|NCT00414973|101345768|FG001|NOT COMPLETED|Overall Study||10||
48413094|NCT00414973|101345769|FG002|NOT COMPLETED|Overall Study||3||
48413095|NCT00414973|101345770|FG003|NOT COMPLETED|Overall Study||0||
48413096|NCT02471586|101345771|FG000|STARTED|Overall Study||158||
48413097|NCT02471586|101345772|FG001|STARTED|Overall Study||146||
48413098|NCT02471586|101345773|FG002|STARTED|Overall Study||146||
48413099|NCT02471586|101345771|FG000|COMPLETED|Overall Study||153||
48413100|NCT02471586|101345772|FG001|COMPLETED|Overall Study||136||
48413101|NCT02471586|101345773|FG002|COMPLETED|Overall Study||142||
48413102|NCT02471586|101345771|FG000|NOT COMPLETED|Overall Study||5||
48413103|NCT02471586|101345772|FG001|NOT COMPLETED|Overall Study||10||
48413104|NCT02471586|101345773|FG002|NOT COMPLETED|Overall Study||4||
48413105|NCT00631969|101345774|FG000|STARTED|Overall Study||186||
48413106|NCT00631969|101345775|FG001|STARTED|Overall Study||176||
48413107|NCT00631969|101345774|FG000|Received Treatment|Overall Study||184||
48413108|NCT00631969|101345775|FG001|Received Treatment|Overall Study||174||
48413109|NCT00631969|101345774|FG000|COMPLETED|Overall Study||171||
48413110|NCT00631969|101345775|FG001|COMPLETED|Overall Study||155||
48413111|NCT00631969|101345774|FG000|NOT COMPLETED|Overall Study||15||
48631474|NCT02631941|101881535|FG009|C|Overall Study||9||
48631475|NCT02631941|101881526|FG000|D|Overall Study||9||
48631476|NCT02631941|101881527|FG001|D|Overall Study||8||
48631477|NCT02631941|101881528|FG002|D|Overall Study||9||
48631478|NCT02631941|101881529|FG003|D|Overall Study||9||
48631479|NCT02631941|101881530|FG004|D|Overall Study||8||
48631480|NCT02631941|101881531|FG005|D|Overall Study||8||
48631481|NCT02631941|101881532|FG006|D|Overall Study||9||
48753966|NCT01415882|102184633|FG001|STARTED|Overall Study||36||
48177927|NCT02589392|100757727|FG000|COMPLETED|Overall Study||54||
48177928|NCT02589392|100757728|FG001|COMPLETED|Overall Study||54||
48177929|NCT02589392|100757727|FG000|NOT COMPLETED|Overall Study||6||
48177930|NCT02589392|100757728|FG001|NOT COMPLETED|Overall Study||6||
48177931|NCT01736358|100757729|FG000|STARTED|Overall Study||25||
48177932|NCT01736358|100757730|FG001|STARTED|Overall Study||25||
48177933|NCT01736358|100757729|FG000|COMPLETED|Overall Study||20||
48177934|NCT01736358|100757730|FG001|COMPLETED|Overall Study||23||
48177935|NCT01736358|100757729|FG000|NOT COMPLETED|Overall Study||5||
48177936|NCT01736358|100757730|FG001|NOT COMPLETED|Overall Study||2||
48177937|NCT00197028|100757731|FG000|STARTED|Overall Study||107||
48177938|NCT00197028|100757732|FG001|STARTED|Overall Study||107||
48177939|NCT00197028|100757731|FG000|COMPLETED|Overall Study||91||
48177940|NCT00197028|100757732|FG001|COMPLETED|Overall Study||86||
48631482|NCT02631941|101881533|FG007|D|Overall Study||9||
48631483|NCT02631941|101881534|FG008|D|Overall Study||9||
48753967|NCT01415882|102184634|FG002|STARTED|Overall Study||35||
48753968|NCT01415882|102184635|FG003|STARTED|Overall Study||37||
48177941|NCT00197028|100757731|FG000|NOT COMPLETED|Overall Study||16||
48177942|NCT00197028|100757732|FG001|NOT COMPLETED|Overall Study||21||
48338146|NCT03950973|101156611|FG000|COMPLETED|Overall Study||196||
48338147|NCT03950973|101156612|FG001|COMPLETED|Overall Study||239||
48631484|NCT02631941|101881535|FG009|D|Overall Study||9||
48631485|NCT02631941|101881526|FG000|COMPLETED|Overall Study||9||
48631486|NCT02631941|101881527|FG001|COMPLETED|Overall Study||8||
48631487|NCT02631941|101881528|FG002|COMPLETED|Overall Study||9||
48631488|NCT02631941|101881529|FG003|COMPLETED|Overall Study||9||
48338148|NCT03950973|101156611|FG000|NOT COMPLETED|Overall Study||105||
48631489|NCT02631941|101881530|FG004|COMPLETED|Overall Study||8||
48631490|NCT02631941|101881531|FG005|COMPLETED|Overall Study||8||
48753969|NCT01415882|102184636|FG004|STARTED|Overall Study||24||
48753970|NCT01415882|102184632|FG000|COMPLETED|Overall Study||32||
48753971|NCT01415882|102184633|FG001|COMPLETED|Overall Study||35||
48753972|NCT01415882|102184634|FG002|COMPLETED|Overall Study||35||
48753973|NCT01415882|102184635|FG003|COMPLETED|Overall Study||33||
48753974|NCT01415882|102184636|FG004|COMPLETED|Overall Study||24||
48753975|NCT01415882|102184632|FG000|NOT COMPLETED|Overall Study||1||
48753976|NCT01415882|102184633|FG001|NOT COMPLETED|Overall Study||1||
48753977|NCT01415882|102184634|FG002|NOT COMPLETED|Overall Study||0||
48753978|NCT01415882|102184635|FG003|NOT COMPLETED|Overall Study||4||
48753979|NCT01415882|102184636|FG004|NOT COMPLETED|Overall Study||0||
48753980|NCT01292135|102184637|FG000|STARTED|Overall Study||3||
48753981|NCT01292135|102184638|FG001|STARTED|Overall Study||30||
48753982|NCT01292135|102184637|FG000|COMPLETED|Overall Study||3||
48753983|NCT01292135|102184638|FG001|COMPLETED|Overall Study||21||
48753984|NCT01292135|102184637|FG000|NOT COMPLETED|Overall Study||0||
48177943|NCT01155388|100757733|FG000|STARTED|Overall Study||8|Data are for the combined AMAG-FER-CKD-251 and AMAG-FER-CKD-252 studies.|
48177944|NCT01155388|100757734|FG001|STARTED|Overall Study||6|Data are for the combined AMAG-FER-CKD-251 and AMAG-FER-CKD-252 studies.|
48338149|NCT03950973|101156612|FG001|NOT COMPLETED|Overall Study||60||
48338150|NCT03033745|101156613|FG000|STARTED|Overall Study||15||
48338151|NCT03033745|101156614|FG001|STARTED|Overall Study||18||
48338152|NCT03033745|101156615|FG002|STARTED|Overall Study||16||
48338153|NCT03033745|101156613|FG000|COMPLETED|Overall Study||14||
48338154|NCT03033745|101156614|FG001|COMPLETED|Overall Study||17||
48338155|NCT03033745|101156615|FG002|COMPLETED|Overall Study||14||
48338156|NCT03033745|101156613|FG000|NOT COMPLETED|Overall Study||1||
48338157|NCT03033745|101156614|FG001|NOT COMPLETED|Overall Study||1||
48338158|NCT03033745|101156615|FG002|NOT COMPLETED|Overall Study||2||
48338159|NCT00360399|101156616|FG000|STARTED|Overall Study||114||
48338160|NCT00360399|101156617|FG001|STARTED|Overall Study||115||
48338161|NCT00360399|101156618|FG002|STARTED|Overall Study||115||
48753985|NCT01292135|102184638|FG001|NOT COMPLETED|Overall Study||9||
48338162|NCT00360399|101156616|FG000|Had Post-randomization Assessment|Overall Study||105||
48338163|NCT00360399|101156617|FG001|Had Post-randomization Assessment|Overall Study||106||
48338164|NCT00360399|101156618|FG002|Had Post-randomization Assessment|Overall Study||105||
48338165|NCT00360399|101156616|FG000|COMPLETED|Overall Study||86||
48338166|NCT00360399|101156617|FG001|COMPLETED|Overall Study||79||
48413112|NCT00631969|101345775|FG001|NOT COMPLETED|Overall Study||21||
48413113|NCT03675685|101345776|FG000|STARTED|Overall Study||12||
48631491|NCT02631941|101881532|FG006|COMPLETED|Overall Study||9||
48753986|NCT01273766|102187606|FG000|STARTED|Overall Study||4||
48177945|NCT01155388|100757733|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8||
48177946|NCT01155388|100757734|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
48177947|NCT01155388|100757733|FG000|COMPLETED|Overall Study||7||
48177948|NCT01155388|100757734|FG001|COMPLETED|Overall Study||6||
48177949|NCT01155388|100757733|FG000|NOT COMPLETED|Overall Study||1||
48177950|NCT01155388|100757734|FG001|NOT COMPLETED|Overall Study||0||
48177951|NCT00919893|100757735|FG000|STARTED|Overall Study||70||
48177952|NCT00919893|100757736|FG001|STARTED|Overall Study||69||
48177953|NCT00919893|100757735|FG000|COMPLETED|Overall Study||51||
48177954|NCT00919893|100757736|FG001|COMPLETED|Overall Study||60||
48177955|NCT00919893|100757735|FG000|NOT COMPLETED|Overall Study||19||
48177956|NCT00919893|100757736|FG001|NOT COMPLETED|Overall Study||9||
48177957|NCT00474175|100757737|FG000|STARTED|Overall Study||115||
48177958|NCT00474175|100757738|FG001|STARTED|Overall Study||233||
48413114|NCT03675685|101345776|FG000|COMPLETED|Overall Study||12||
48753987|NCT01273766|102187607|FG001|STARTED|Overall Study||7||
48753988|NCT01273766|102187608|FG002|STARTED|Overall Study||5||
48753989|NCT01273766|102187606|FG000|COMPLETED|Overall Study||4||
48753990|NCT01273766|102187607|FG001|COMPLETED|Overall Study||7||
48753991|NCT01273766|102187608|FG002|COMPLETED|Overall Study||5||
48753992|NCT01273766|102187606|FG000|NOT COMPLETED|Overall Study||0||
48753993|NCT01273766|102187607|FG001|NOT COMPLETED|Overall Study||0||
48753994|NCT01273766|102187608|FG002|NOT COMPLETED|Overall Study||0||
48177959|NCT00474175|100757739|FG002|STARTED|Overall Study||229||
48177960|NCT00474175|100757737|FG000|Treated|Overall Study||115||
48177961|NCT00474175|100757738|FG001|Treated|Overall Study||233||
48177962|NCT00474175|100757739|FG002|Treated|Overall Study||228||
48177963|NCT00474175|100757737|FG000|COMPLETED|Overall Study||114||
48177964|NCT00474175|100757738|FG001|COMPLETED|Overall Study||226||
48177965|NCT00474175|100757739|FG002|COMPLETED|Overall Study||225||
48177966|NCT00474175|100757737|FG000|NOT COMPLETED|Overall Study||1||
48177967|NCT00474175|100757738|FG001|NOT COMPLETED|Overall Study||7||
48177968|NCT00474175|100757739|FG002|NOT COMPLETED|Overall Study||4||
48177969|NCT01182727|100757740|FG000|STARTED|Overall Study||10||
48177970|NCT01182727|100757740|FG000|COMPLETED|Overall Study||10||
48177971|NCT01182727|100757740|FG000|NOT COMPLETED|Overall Study||0||
48177972|NCT02551744|100757741|FG000|STARTED|Overall Study||50||
48177973|NCT02551744|100757742|FG001|STARTED|Overall Study||51||
48177974|NCT02551744|100757741|FG000|COMPLETED|Overall Study||50||
48177975|NCT02551744|100757742|FG001|COMPLETED|Overall Study||51||
48753995|NCT00426166|102187609|FG000|STARTED|Overall Study||13||
48753996|NCT00426166|102187610|FG001|STARTED|Overall Study||14||
48753997|NCT00426166|102187609|FG000|COMPLETED|Overall Study||13||
48753998|NCT00426166|102187610|FG001|COMPLETED|Overall Study||14||
48753999|NCT00426166|102187609|FG000|NOT COMPLETED|Overall Study||0||
48177976|NCT02551744|100757741|FG000|NOT COMPLETED|Overall Study||0||
48177977|NCT02551744|100757742|FG001|NOT COMPLETED|Overall Study||0||
48177978|NCT01952301|100757743|FG000|STARTED|Overall Study||30||
48177979|NCT01952301|100757743|FG000|COMPLETED|Overall Study||30||
48177980|NCT01952301|100757743|FG000|NOT COMPLETED|Overall Study||0||
48177981|NCT00570661|100757744|FG000|STARTED|Overall Study||17||
48177982|NCT00570661|100757744|FG000|COMPLETED|Overall Study||10||
48338167|NCT00360399|101156618|FG002|COMPLETED|Overall Study||69||
48338168|NCT00360399|101156616|FG000|NOT COMPLETED|Overall Study||28||
48338169|NCT00360399|101156617|FG001|NOT COMPLETED|Overall Study||36||
48338170|NCT00360399|101156618|FG002|NOT COMPLETED|Overall Study||46||
48338171|NCT02307916|101156619|FG000|STARTED|Overall Study||42||
48338172|NCT02307916|101156620|FG001|STARTED|Overall Study||15||
48338173|NCT02307916|101156619|FG000|COMPLETED|Overall Study||40||
48338174|NCT02307916|101156620|FG001|COMPLETED|Overall Study||14||
48338175|NCT02307916|101156619|FG000|NOT COMPLETED|Overall Study||2||
48413115|NCT03675685|101345776|FG000|NOT COMPLETED|Overall Study||0||
48754000|NCT00426166|102187610|FG001|NOT COMPLETED|Overall Study||0||
48754001|NCT00473434|102187611|FG000|STARTED|Overall Study||64||
48177983|NCT00570661|100757744|FG000|NOT COMPLETED|Overall Study||7||
48177984|NCT03541642|100757745|FG000|STARTED|Overall Study||19||
48177985|NCT03541642|100757746|FG001|STARTED|Overall Study||16||
48754002|NCT00473434|102187611|FG000|COMPLETED|Overall Study||32||
48754003|NCT00473434|102187611|FG000|NOT COMPLETED|Overall Study||32||
48177986|NCT03541642|100757745|FG000|1-month|Overall Study||3||
48177987|NCT03541642|100757746|FG001|1-month|Overall Study||4||
48177988|NCT03541642|100757745|FG000|3-month|Overall Study||1||
48177989|NCT03541642|100757746|FG001|3-month|Overall Study||3||
48177990|NCT03541642|100757745|FG000|3-month Follow-up|Overall Study||1||
48177991|NCT03541642|100757746|FG001|3-month Follow-up|Overall Study||1||
48177992|NCT03541642|100757745|FG000|COMPLETED|Overall Study||1||
48177993|NCT03541642|100757746|FG001|COMPLETED|Overall Study||1||
48177994|NCT03541642|100757745|FG000|NOT COMPLETED|Overall Study||18||
48338176|NCT02307916|101156620|FG001|NOT COMPLETED|Overall Study||1||
48338177|NCT01808612|101156621|FG000|STARTED|Treatment Period||169||
48338178|NCT01808612|101156622|FG001|STARTED|Treatment Period||84||
48413116|NCT02202161|101345777|FG000|STARTED|Overall Study||13||
48413117|NCT02202161|101345778|FG001|STARTED|Overall Study||5||
48413118|NCT02202161|101345779|FG002|STARTED|Overall Study||5||
48413119|NCT02202161|101345780|FG003|STARTED|Overall Study||9||
48177995|NCT03541642|100757746|FG001|NOT COMPLETED|Overall Study||15||
48177996|NCT01466764|100757747|FG000|STARTED|Overall Study||5||
48631492|NCT02631941|101881533|FG007|COMPLETED|Overall Study||8||
48631493|NCT02631941|101881534|FG008|COMPLETED|Overall Study||9||
48631494|NCT02631941|101881535|FG009|COMPLETED|Overall Study||9||
48413120|NCT02202161|101345781|FG004|STARTED|Overall Study||9||
48413121|NCT02202161|101345782|FG005|STARTED|Overall Study||10||
48413122|NCT02202161|101345783|FG006|STARTED|Overall Study||13||
48413123|NCT02202161|101345784|FG007|STARTED|Overall Study||6||
48413124|NCT02202161|101345777|FG000|COMPLETED|Overall Study||12||
48413125|NCT02202161|101345778|FG001|COMPLETED|Overall Study||4||
48413126|NCT02202161|101345779|FG002|COMPLETED|Overall Study||5||
48754004|NCT02399215|102187612|FG000|STARTED|Overall Study||32||
48754005|NCT02399215|102187612|FG000|COMPLETED|Overall Study||30||
48177997|NCT01466764|100757748|FG001|STARTED|Overall Study||5||
48177998|NCT01466764|100757747|FG000|COMPLETED|Overall Study||5||
48177999|NCT01466764|100757748|FG001|COMPLETED|Overall Study||5||
48338179|NCT01808612|101156623|FG002|STARTED|Treatment Period||260||
48338180|NCT01808612|101156621|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||168||
48338181|NCT01808612|101156622|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||83||
48338182|NCT01808612|101156623|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||259||
48338183|NCT01808612|101156621|FG000|COMPLETED|Treatment Period||154||
48338184|NCT01808612|101156622|FG001|COMPLETED|Treatment Period||77||
48338185|NCT01808612|101156623|FG002|COMPLETED|Treatment Period||246||
48338186|NCT01808612|101156621|FG000|NOT COMPLETED|Treatment Period||15||
48338187|NCT01808612|101156622|FG001|NOT COMPLETED|Treatment Period||7||
48338188|NCT01808612|101156623|FG002|NOT COMPLETED|Treatment Period||14||
48338189|NCT01808612|101156621|FG000|STARTED|Discontinuation Period||87||
48338190|NCT01808612|101156622|FG001|STARTED|Discontinuation Period||38||
48338191|NCT01808612|101156623|FG002|STARTED|Discontinuation Period||145||
48338192|NCT01808612|101156621|FG000|COMPLETED|Discontinuation Period||85||
48338193|NCT01808612|101156622|FG001|COMPLETED|Discontinuation Period||37||
48338194|NCT01808612|101156623|FG002|COMPLETED|Discontinuation Period||145||
48338195|NCT01808612|101156621|FG000|NOT COMPLETED|Discontinuation Period||2||
48338196|NCT01808612|101156622|FG001|NOT COMPLETED|Discontinuation Period||1||
48338197|NCT01808612|101156623|FG002|NOT COMPLETED|Discontinuation Period||0||
48338198|NCT01528787|101156624|FG000|STARTED|Overall Study||22||
48338199|NCT01528787|101156625|FG001|STARTED|Overall Study||21||
48338200|NCT01528787|101156626|FG002|STARTED|Overall Study||19||
48338201|NCT01528787|101156627|FG003|STARTED|Overall Study||23||
48338202|NCT01528787|101156624|FG000|COMPLETED|Overall Study||22||
48338203|NCT01528787|101156625|FG001|COMPLETED|Overall Study||21||
48338204|NCT01528787|101156626|FG002|COMPLETED|Overall Study||18||
48413127|NCT02202161|101345780|FG003|COMPLETED|Overall Study||9||
48413128|NCT02202161|101345781|FG004|COMPLETED|Overall Study||8||
48413129|NCT02202161|101345782|FG005|COMPLETED|Overall Study||9||
48631495|NCT02631941|101881526|FG000|NOT COMPLETED|Overall Study||0||
48631496|NCT02631941|101881527|FG001|NOT COMPLETED|Overall Study||2||
48631497|NCT02631941|101881528|FG002|NOT COMPLETED|Overall Study||0||
48631498|NCT02631941|101881529|FG003|NOT COMPLETED|Overall Study||0||
48631499|NCT02631941|101881530|FG004|NOT COMPLETED|Overall Study||1||
48631500|NCT02631941|101881531|FG005|NOT COMPLETED|Overall Study||0||
48631501|NCT02631941|101881532|FG006|NOT COMPLETED|Overall Study||0||
48754006|NCT02399215|102187612|FG000|NOT COMPLETED|Overall Study||2||
48754007|NCT01766440|102187613|FG000|STARTED|Overall Study||18||
48754008|NCT01766440|102187613|FG000|COMPLETED|Overall Study||17||
48754009|NCT01766440|102187613|FG000|NOT COMPLETED|Overall Study||1||
48754010|NCT01468558|102187614|FG000|STARTED|Overall Study||24||
48178000|NCT01466764|100757747|FG000|NOT COMPLETED|Overall Study||0||
48338205|NCT01528787|101156627|FG003|COMPLETED|Overall Study||22||
48338206|NCT01528787|101156624|FG000|NOT COMPLETED|Overall Study||0||
48338207|NCT01528787|101156625|FG001|NOT COMPLETED|Overall Study||0||
48338208|NCT01528787|101156626|FG002|NOT COMPLETED|Overall Study||1||
48338209|NCT01528787|101156627|FG003|NOT COMPLETED|Overall Study||1||
48338210|NCT02542072|101156628|FG000|STARTED|First Intervention (1 Month)||44||
48754011|NCT01468558|102187614|FG000|COMPLETED|Overall Study||22||
48754012|NCT01468558|102187614|FG000|NOT COMPLETED|Overall Study||2||
48178001|NCT01466764|100757748|FG001|NOT COMPLETED|Overall Study||0||
48178002|NCT02697006|100757749|FG000|STARTED|Overall Study||34||
48338211|NCT02542072|101156629|FG001|STARTED|First Intervention (1 Month)||46||
48338212|NCT02542072|101156628|FG000|COMPLETED|First Intervention (1 Month)||39||
48413130|NCT02202161|101345783|FG006|COMPLETED|Overall Study||13||
48413131|NCT02202161|101345784|FG007|COMPLETED|Overall Study||0||
48413132|NCT02202161|101345777|FG000|NOT COMPLETED|Overall Study||1||
48413133|NCT02202161|101345778|FG001|NOT COMPLETED|Overall Study||1||
48413134|NCT02202161|101345779|FG002|NOT COMPLETED|Overall Study||0||
48413135|NCT02202161|101345780|FG003|NOT COMPLETED|Overall Study||0||
48413136|NCT02202161|101345781|FG004|NOT COMPLETED|Overall Study||1||
48413137|NCT02202161|101345782|FG005|NOT COMPLETED|Overall Study||1||
48413138|NCT02202161|101345783|FG006|NOT COMPLETED|Overall Study||0||
48631502|NCT02631941|101881533|FG007|NOT COMPLETED|Overall Study||1||
48631503|NCT02631941|101881534|FG008|NOT COMPLETED|Overall Study||1||
48754013|NCT01260493|102187615|FG000|STARTED|Overall Study||92||
48413139|NCT02202161|101345784|FG007|NOT COMPLETED|Overall Study||6||
48413140|NCT00764322|101345785|FG000|STARTED|Overall Study||500||
48413141|NCT00764322|101345785|FG000|COMPLETED|Overall Study||480||
48413142|NCT00764322|101345785|FG000|NOT COMPLETED|Overall Study||20||
48413143|NCT02067806|101345786|FG000|STARTED|Overall Study||394||
48413144|NCT02067806|101345786|FG000|COMPLETED|Overall Study||387||
48413145|NCT02067806|101345786|FG000|NOT COMPLETED|Overall Study||7||
48413146|NCT01693562|101345787|FG000|STARTED|Escalation Phase||4||
48413147|NCT01693562|101345788|FG001|STARTED|Escalation Phase||4||
48754014|NCT01260493|102187616|FG001|STARTED|Overall Study||89||
48754015|NCT01260493|102187615|FG000|COMPLETED|Overall Study||76||
48754016|NCT01260493|102187616|FG001|COMPLETED|Overall Study||85||
48754017|NCT01260493|102187615|FG000|NOT COMPLETED|Overall Study||16||
48754018|NCT01260493|102187616|FG001|NOT COMPLETED|Overall Study||4||
48754019|NCT04177706|102187617|FG000|STARTED|Overall Study||11||
48338213|NCT02542072|101156629|FG001|COMPLETED|First Intervention (1 Month)||43||
48338214|NCT02542072|101156628|FG000|NOT COMPLETED|First Intervention (1 Month)||5||
48338215|NCT02542072|101156629|FG001|NOT COMPLETED|First Intervention (1 Month)||3||
48338216|NCT02542072|101156628|FG000|STARTED|Second Intervention (1 Month)||39||
48338217|NCT02542072|101156629|FG001|STARTED|Second Intervention (1 Month)||43||
48338218|NCT02542072|101156628|FG000|COMPLETED|Second Intervention (1 Month)||37||
48338219|NCT02542072|101156629|FG001|COMPLETED|Second Intervention (1 Month)||43||
48338220|NCT02542072|101156628|FG000|NOT COMPLETED|Second Intervention (1 Month)||2||
48338221|NCT02542072|101156629|FG001|NOT COMPLETED|Second Intervention (1 Month)||0||
48338222|NCT01273064|101156630|FG000|STARTED|Overall Study||23||
48338223|NCT01273064|101156631|FG001|STARTED|Overall Study||30||
48338224|NCT01273064|101156632|FG002|STARTED|Overall Study||31||
48338225|NCT01273064|101156633|FG003|STARTED|Overall Study||20||
48338226|NCT01273064|101156634|FG004|STARTED|Overall Study||10||
48338227|NCT01273064|101156630|FG000|COMPLETED|Overall Study||0||
48338228|NCT01273064|101156631|FG001|COMPLETED|Overall Study||0||
48338229|NCT01273064|101156632|FG002|COMPLETED|Overall Study||0||
48338230|NCT01273064|101156633|FG003|COMPLETED|Overall Study||0||
48338231|NCT01273064|101156634|FG004|COMPLETED|Overall Study||0||
48338232|NCT01273064|101156630|FG000|NOT COMPLETED|Overall Study||23||
48338233|NCT01273064|101156631|FG001|NOT COMPLETED|Overall Study||30||
48413148|NCT01693562|101345789|FG002|STARTED|Escalation Phase||3||
48413149|NCT01693562|101345790|FG003|STARTED|Escalation Phase||3||
48413150|NCT01693562|101345791|FG004|STARTED|Escalation Phase||6||
48413151|NCT01693562|101345792|FG005|STARTED|Escalation Phase||7||
48413152|NCT01693562|101345793|FG006|STARTED|Escalation Phase||0||
48413153|NCT01693562|101345794|FG007|STARTED|Escalation Phase||0||
48413154|NCT01693562|101345795|FG008|STARTED|Escalation Phase||0||
48754020|NCT04177706|102187618|FG001|STARTED|Overall Study||10||
48754021|NCT04177706|102187617|FG000|COMPLETED|Overall Study||6||
48754022|NCT04177706|102187618|FG001|COMPLETED|Overall Study||5||
48754023|NCT04177706|102187617|FG000|NOT COMPLETED|Overall Study||5||
48754024|NCT04177706|102187618|FG001|NOT COMPLETED|Overall Study||5||
48754025|NCT03582215|102187619|FG000|STARTED|Overall Study||6||
48754026|NCT03582215|102187620|FG001|STARTED|Overall Study||6||
48754027|NCT03582215|102187621|FG002|STARTED|Overall Study||6||
48754028|NCT03582215|102187622|FG003|STARTED|Overall Study||6||
48338234|NCT01273064|101156632|FG002|NOT COMPLETED|Overall Study||31||
48338235|NCT01273064|101156633|FG003|NOT COMPLETED|Overall Study||20||
48338236|NCT01273064|101156634|FG004|NOT COMPLETED|Overall Study||10||
48338237|NCT03739528|101156635|FG000|STARTED|Overall Study||403||
48754029|NCT03582215|102187623|FG004|STARTED|Overall Study||12||
48754030|NCT03582215|102187624|FG005|STARTED|Overall Study||12||
48754031|NCT03582215|102187625|FG006|STARTED|Overall Study||12||
48754032|NCT03582215|102187626|FG007|STARTED|Overall Study||12||
48754033|NCT03582215|102187619|FG000|COMPLETED|Overall Study||5||
48338238|NCT03739528|101156636|FG001|STARTED|Overall Study||405||
48338239|NCT03739528|101156635|FG000|Received at Least One Treatment|Overall Study||395||
48338240|NCT03739528|101156636|FG001|Received at Least One Treatment|Overall Study||393||
48338241|NCT03739528|101156635|FG000|COMPLETED|Overall Study||388||
48338242|NCT03739528|101156636|FG001|COMPLETED|Overall Study||388||
48338243|NCT03739528|101156635|FG000|NOT COMPLETED|Overall Study||15||
48338244|NCT03739528|101156636|FG001|NOT COMPLETED|Overall Study||17||
48338245|NCT01852084|101156637|FG000|STARTED|Overall Study||79||
48338246|NCT01852084|101156638|FG001|STARTED|Overall Study||80||
48338247|NCT01852084|101156639|FG002|STARTED|Overall Study||20||
48338248|NCT01852084|101156640|FG003|STARTED|Overall Study||12||
48338249|NCT01852084|101156637|FG000|COMPLETED|Overall Study||79||
48338250|NCT01852084|101156638|FG001|COMPLETED|Overall Study||80||
48338251|NCT01852084|101156639|FG002|COMPLETED|Overall Study||18||
48413155|NCT01693562|101345796|FG009|STARTED|Escalation Phase||0||
48413156|NCT01693562|101345797|FG010|STARTED|Escalation Phase||0||
48413157|NCT01693562|101345798|FG011|STARTED|Escalation Phase||0||
48413158|NCT01693562|101345799|FG012|STARTED|Escalation Phase||0||
48413159|NCT01693562|101345800|FG013|STARTED|Escalation Phase||0||
48413160|NCT01693562|101345801|FG014|STARTED|Escalation Phase||0||
48413161|NCT01693562|101345802|FG015|STARTED|Escalation Phase||0||
48413162|NCT01693562|101345803|FG016|STARTED|Escalation Phase||0||
48413163|NCT01693562|101345804|FG017|STARTED|Escalation Phase||0||
48754034|NCT03582215|102187620|FG001|COMPLETED|Overall Study||6||
48413164|NCT01693562|101345805|FG018|STARTED|Escalation Phase||0||
48413165|NCT01693562|101345806|FG019|STARTED|Escalation Phase||0||
48413166|NCT01693562|101345807|FG020|STARTED|Escalation Phase||0||
48413167|NCT01693562|101345808|FG021|STARTED|Escalation Phase||0||
48413168|NCT01693562|101345809|FG022|STARTED|Escalation Phase||0||
48413169|NCT01693562|101345787|FG000|COMPLETED|Escalation Phase||0||
48413170|NCT01693562|101345788|FG001|COMPLETED|Escalation Phase||0||
48413171|NCT01693562|101345789|FG002|COMPLETED|Escalation Phase||0||
48413172|NCT01693562|101345790|FG003|COMPLETED|Escalation Phase||0||
48413173|NCT01693562|101345791|FG004|COMPLETED|Escalation Phase||0||
48413174|NCT01693562|101345792|FG005|COMPLETED|Escalation Phase||0||
48413175|NCT01693562|101345793|FG006|COMPLETED|Escalation Phase||0||
48413176|NCT01693562|101345794|FG007|COMPLETED|Escalation Phase||0||
48413177|NCT01693562|101345795|FG008|COMPLETED|Escalation Phase||0||
48413178|NCT01693562|101345796|FG009|COMPLETED|Escalation Phase||0||
48413179|NCT01693562|101345797|FG010|COMPLETED|Escalation Phase||0||
48413180|NCT01693562|101345798|FG011|COMPLETED|Escalation Phase||0||
48413181|NCT01693562|101345799|FG012|COMPLETED|Escalation Phase||0||
48338252|NCT01852084|101156640|FG003|COMPLETED|Overall Study||12||
48338253|NCT01852084|101156637|FG000|NOT COMPLETED|Overall Study||0||
48338254|NCT01852084|101156638|FG001|NOT COMPLETED|Overall Study||0||
48338255|NCT01852084|101156639|FG002|NOT COMPLETED|Overall Study||2||
48338256|NCT01852084|101156640|FG003|NOT COMPLETED|Overall Study||0||
48338257|NCT03562663|101156641|FG000|STARTED|Overall Study||41||
48338258|NCT03562663|101156642|FG001|STARTED|Overall Study||41||
48338259|NCT03562663|101156641|FG000|COMPLETED|Overall Study||34||
48338260|NCT03562663|101156642|FG001|COMPLETED|Overall Study||35||
48338261|NCT03562663|101156641|FG000|NOT COMPLETED|Overall Study||7||
48338262|NCT03562663|101156642|FG001|NOT COMPLETED|Overall Study||6||
48338263|NCT01354028|101156643|FG000|STARTED|Overall Study||15||
48338264|NCT01354028|101156644|FG001|STARTED|Overall Study||15||
48338265|NCT01354028|101156643|FG000|COMPLETED|Overall Study||13||
48338266|NCT01354028|101156644|FG001|COMPLETED|Overall Study||10||
48338267|NCT01354028|101156643|FG000|NOT COMPLETED|Overall Study||2||
48338268|NCT01354028|101156644|FG001|NOT COMPLETED|Overall Study||5||
48338269|NCT00510276|101156645|FG000|STARTED|Acute Double-Blind Phase||220||
48338270|NCT00510276|101156646|FG001|STARTED|Acute Double-Blind Phase||225||
48338271|NCT00510276|101156645|FG000|COMPLETED|Acute Double-Blind Phase||115||
48338272|NCT00510276|101156646|FG001|COMPLETED|Acute Double-Blind Phase||130||
48338273|NCT00510276|101156645|FG000|NOT COMPLETED|Acute Double-Blind Phase||105||
48338274|NCT00510276|101156646|FG001|NOT COMPLETED|Acute Double-Blind Phase||95||
48338275|NCT00510276|101156645|FG000|STARTED|Extension Open-Label Phase||111||
48338276|NCT00510276|101156646|FG001|STARTED|Extension Open-Label Phase||129||
48338277|NCT00510276|101156645|FG000|COMPLETED|Extension Open-Label Phase||78||
48338278|NCT00510276|101156646|FG001|COMPLETED|Extension Open-Label Phase||81||
48338279|NCT00510276|101156645|FG000|NOT COMPLETED|Extension Open-Label Phase||33||
48338280|NCT00510276|101156646|FG001|NOT COMPLETED|Extension Open-Label Phase||48||
48338281|NCT02303431|101156647|FG000|STARTED|Overall Study||8||
48338282|NCT02303431|101156648|FG001|STARTED|Overall Study||7||
48338283|NCT02303431|101156649|FG002|STARTED|Overall Study||7||
48338284|NCT02303431|101156650|FG003|STARTED|Overall Study||6||
48338285|NCT02303431|101156651|FG004|STARTED|Overall Study||7||
48338286|NCT02303431|101156652|FG005|STARTED|Overall Study||6||
48338287|NCT02303431|101156653|FG006|STARTED|Overall Study||7||
48338288|NCT02303431|101156654|FG007|STARTED|Overall Study||6||
48338289|NCT02303431|101156655|FG008|STARTED|Overall Study||6||
48338290|NCT02303431|101156656|FG009|STARTED|Overall Study||6||
48338291|NCT02303431|101156647|FG000|COMPLETED|Overall Study||8||
48338292|NCT02303431|101156648|FG001|COMPLETED|Overall Study||7||
48338293|NCT02303431|101156649|FG002|COMPLETED|Overall Study||7||
48338294|NCT02303431|101156650|FG003|COMPLETED|Overall Study||6||
48338295|NCT02303431|101156651|FG004|COMPLETED|Overall Study||7||
48338296|NCT02303431|101156652|FG005|COMPLETED|Overall Study||6||
48338297|NCT02303431|101156653|FG006|COMPLETED|Overall Study||7||
48338298|NCT02303431|101156654|FG007|COMPLETED|Overall Study||6||
48338299|NCT02303431|101156655|FG008|COMPLETED|Overall Study||6||
48338300|NCT02303431|101156656|FG009|COMPLETED|Overall Study||6||
48338301|NCT02303431|101156647|FG000|NOT COMPLETED|Overall Study||0||
48338302|NCT02303431|101156648|FG001|NOT COMPLETED|Overall Study||0||
48338303|NCT02303431|101156649|FG002|NOT COMPLETED|Overall Study||0||
48338304|NCT02303431|101156650|FG003|NOT COMPLETED|Overall Study||0||
48338305|NCT02303431|101156651|FG004|NOT COMPLETED|Overall Study||0||
48338306|NCT02303431|101156652|FG005|NOT COMPLETED|Overall Study||0||
48413182|NCT01693562|101345800|FG013|COMPLETED|Escalation Phase||0||
48413183|NCT01693562|101345801|FG014|COMPLETED|Escalation Phase||0||
48413184|NCT01693562|101345802|FG015|COMPLETED|Escalation Phase||0||
48338307|NCT02303431|101156653|FG006|NOT COMPLETED|Overall Study||0||
48338308|NCT02303431|101156654|FG007|NOT COMPLETED|Overall Study||0||
48338309|NCT02303431|101156655|FG008|NOT COMPLETED|Overall Study||0||
48338310|NCT02303431|101156656|FG009|NOT COMPLETED|Overall Study||0||
48338311|NCT02435914|101156657|FG000|STARTED|Overall Study||58||
48413185|NCT01693562|101345803|FG016|COMPLETED|Escalation Phase||0||
48338312|NCT02435914|101156658|FG001|STARTED|Overall Study||59||
48338313|NCT02435914|101156659|FG002|STARTED|Overall Study||60||
48338314|NCT02435914|101156660|FG003|STARTED|Overall Study||59||
48338315|NCT02435914|101156657|FG000|COMPLETED|Overall Study||57||
48338316|NCT02435914|101156658|FG001|COMPLETED|Overall Study||58||
48338317|NCT02435914|101156659|FG002|COMPLETED|Overall Study||59||
48338318|NCT02435914|101156660|FG003|COMPLETED|Overall Study||59||
48338319|NCT02435914|101156657|FG000|NOT COMPLETED|Overall Study||1||
48338320|NCT02435914|101156658|FG001|NOT COMPLETED|Overall Study||1||
48338321|NCT02435914|101156659|FG002|NOT COMPLETED|Overall Study||1||
48338322|NCT02435914|101156660|FG003|NOT COMPLETED|Overall Study||0||
48338323|NCT03357393|101156661|FG000|STARTED|Overall Study||50||
48338324|NCT03357393|101156662|FG001|STARTED|Overall Study||50||
48338325|NCT03357393|101156663|FG002|STARTED|Overall Study||50||
48338326|NCT03357393|101156661|FG000|COMPLETED|Overall Study||50||
48338327|NCT03357393|101156662|FG001|COMPLETED|Overall Study||50||
48338328|NCT03357393|101156663|FG002|COMPLETED|Overall Study||50||
48338329|NCT03357393|101156661|FG000|NOT COMPLETED|Overall Study||0||
48413186|NCT01693562|101345804|FG017|COMPLETED|Escalation Phase||0||
48413187|NCT01693562|101345805|FG018|COMPLETED|Escalation Phase||0||
48413188|NCT01693562|101345806|FG019|COMPLETED|Escalation Phase||0||
48413189|NCT01693562|101345807|FG020|COMPLETED|Escalation Phase||0||
48413190|NCT01693562|101345808|FG021|COMPLETED|Escalation Phase||0||
48413191|NCT01693562|101345809|FG022|COMPLETED|Escalation Phase||0||
48413192|NCT01693562|101345787|FG000|NOT COMPLETED|Escalation Phase||4||
48338330|NCT03357393|101156662|FG001|NOT COMPLETED|Overall Study||0||
48338331|NCT03357393|101156663|FG002|NOT COMPLETED|Overall Study||0||
48413193|NCT01693562|101345788|FG001|NOT COMPLETED|Escalation Phase||4||
48413194|NCT01693562|101345789|FG002|NOT COMPLETED|Escalation Phase||3||
48413195|NCT01693562|101345790|FG003|NOT COMPLETED|Escalation Phase||3||
48413196|NCT01693562|101345791|FG004|NOT COMPLETED|Escalation Phase||6||
48413197|NCT01693562|101345792|FG005|NOT COMPLETED|Escalation Phase||7||
48413198|NCT01693562|101345793|FG006|NOT COMPLETED|Escalation Phase||0||
48413199|NCT01693562|101345794|FG007|NOT COMPLETED|Escalation Phase||0||
48413200|NCT01693562|101345795|FG008|NOT COMPLETED|Escalation Phase||0||
48413201|NCT01693562|101345796|FG009|NOT COMPLETED|Escalation Phase||0||
48413202|NCT01693562|101345797|FG010|NOT COMPLETED|Escalation Phase||0||
48413203|NCT01693562|101345798|FG011|NOT COMPLETED|Escalation Phase||0||
48413204|NCT01693562|101345799|FG012|NOT COMPLETED|Escalation Phase||0||
48413205|NCT01693562|101345800|FG013|NOT COMPLETED|Escalation Phase||0||
48413206|NCT01693562|101345801|FG014|NOT COMPLETED|Escalation Phase||0||
48413207|NCT01693562|101345802|FG015|NOT COMPLETED|Escalation Phase||0||
48338332|NCT00364182|101156664|FG000|STARTED|First Intervention||3||
48338333|NCT00364182|101156665|FG001|STARTED|First Intervention||22||
48338334|NCT00364182|101156666|FG002|STARTED|First Intervention||25||
48413208|NCT01693562|101345803|FG016|NOT COMPLETED|Escalation Phase||0||
48413209|NCT01693562|101345804|FG017|NOT COMPLETED|Escalation Phase||0||
48413210|NCT01693562|101345805|FG018|NOT COMPLETED|Escalation Phase||0||
48413211|NCT01693562|101345806|FG019|NOT COMPLETED|Escalation Phase||0||
48413212|NCT01693562|101345807|FG020|NOT COMPLETED|Escalation Phase||0||
48413213|NCT01693562|101345808|FG021|NOT COMPLETED|Escalation Phase||0||
48413214|NCT01693562|101345809|FG022|NOT COMPLETED|Escalation Phase||0||
48413215|NCT01693562|101345787|FG000|STARTED|Exploration Phase||0||
48413216|NCT01693562|101345788|FG001|STARTED|Exploration Phase||0||
48413217|NCT01693562|101345789|FG002|STARTED|Exploration Phase||0||
48413218|NCT01693562|101345790|FG003|STARTED|Exploration Phase||0||
48413219|NCT01693562|101345791|FG004|STARTED|Exploration Phase||0||
48413220|NCT01693562|101345792|FG005|STARTED|Exploration Phase||0||
48413221|NCT01693562|101345793|FG006|STARTED|Exploration Phase||21||
48413222|NCT01693562|101345794|FG007|STARTED|Exploration Phase||0||
48413223|NCT01693562|101345795|FG008|STARTED|Exploration Phase||0||
48413224|NCT01693562|101345796|FG009|STARTED|Exploration Phase||0||
48413225|NCT01693562|101345797|FG010|STARTED|Exploration Phase||0||
48413226|NCT01693562|101345798|FG011|STARTED|Exploration Phase||0||
48338335|NCT00364182|101156664|FG000|COMPLETED|First Intervention||0||
48338336|NCT00364182|101156665|FG001|COMPLETED|First Intervention||22||
48413227|NCT01693562|101345799|FG012|STARTED|Exploration Phase||0||
48338337|NCT00364182|101156666|FG002|COMPLETED|First Intervention||25||
48338338|NCT00364182|101156664|FG000|NOT COMPLETED|First Intervention||3||
48338339|NCT00364182|101156665|FG001|NOT COMPLETED|First Intervention||0||
48338340|NCT00364182|101156666|FG002|NOT COMPLETED|First Intervention||0||
48338341|NCT00364182|101156664|FG000|STARTED|Second Intervention||0||
48413228|NCT01693562|101345800|FG013|STARTED|Exploration Phase||0||
48413229|NCT01693562|101345801|FG014|STARTED|Exploration Phase||0||
48413230|NCT01693562|101345802|FG015|STARTED|Exploration Phase||0||
48338342|NCT00364182|101156665|FG001|STARTED|Second Intervention||22||
48338343|NCT00364182|101156666|FG002|STARTED|Second Intervention||25||
48338344|NCT00364182|101156664|FG000|Randomized|Second Intervention||0||
48338345|NCT00364182|101156665|FG001|Randomized|Second Intervention||22||
48338346|NCT00364182|101156666|FG002|Randomized|Second Intervention||25||
48338347|NCT00364182|101156664|FG000|COMPLETED|Second Intervention||0||
48338348|NCT00364182|101156665|FG001|COMPLETED|Second Intervention||20||
48338349|NCT00364182|101156666|FG002|COMPLETED|Second Intervention||23||
48338350|NCT00364182|101156664|FG000|NOT COMPLETED|Second Intervention||0||
48338351|NCT00364182|101156665|FG001|NOT COMPLETED|Second Intervention||2||
48338352|NCT00364182|101156666|FG002|NOT COMPLETED|Second Intervention||2||
48338353|NCT00364182|101156664|FG000|STARTED|Third Intervention||0||
48338354|NCT00364182|101156665|FG001|STARTED|Third Intervention||20||
48338355|NCT00364182|101156666|FG002|STARTED|Third Intervention||23||
48413231|NCT01693562|101345803|FG016|STARTED|Exploration Phase||0||
48413232|NCT01693562|101345804|FG017|STARTED|Exploration Phase||0||
48413233|NCT01693562|101345805|FG018|STARTED|Exploration Phase||0||
48413234|NCT01693562|101345806|FG019|STARTED|Exploration Phase||0||
48413235|NCT01693562|101345807|FG020|STARTED|Exploration Phase||0||
48413236|NCT01693562|101345808|FG021|STARTED|Exploration Phase||0||
48413237|NCT01693562|101345809|FG022|STARTED|Exploration Phase||0||
48413238|NCT01693562|101345787|FG000|COMPLETED|Exploration Phase||0||
48413239|NCT01693562|101345788|FG001|COMPLETED|Exploration Phase||0||
48413240|NCT01693562|101345789|FG002|COMPLETED|Exploration Phase||0||
48413241|NCT01693562|101345790|FG003|COMPLETED|Exploration Phase||0||
48413242|NCT01693562|101345791|FG004|COMPLETED|Exploration Phase||0||
48413243|NCT01693562|101345792|FG005|COMPLETED|Exploration Phase||0||
48413244|NCT01693562|101345793|FG006|COMPLETED|Exploration Phase||0||
48413245|NCT01693562|101345794|FG007|COMPLETED|Exploration Phase||0||
48338356|NCT00364182|101156664|FG000|COMPLETED|Third Intervention||0||
48338357|NCT00364182|101156665|FG001|COMPLETED|Third Intervention||19||
48338358|NCT00364182|101156666|FG002|COMPLETED|Third Intervention||22||
48413246|NCT01693562|101345795|FG008|COMPLETED|Exploration Phase||0||
48413247|NCT01693562|101345796|FG009|COMPLETED|Exploration Phase||0||
48413248|NCT01693562|101345797|FG010|COMPLETED|Exploration Phase||0||
48413249|NCT01693562|101345798|FG011|COMPLETED|Exploration Phase||0||
48413250|NCT01693562|101345799|FG012|COMPLETED|Exploration Phase||0||
48413251|NCT01693562|101345800|FG013|COMPLETED|Exploration Phase||0||
48413252|NCT01693562|101345801|FG014|COMPLETED|Exploration Phase||0||
48413253|NCT01693562|101345802|FG015|COMPLETED|Exploration Phase||0||
48413254|NCT01693562|101345803|FG016|COMPLETED|Exploration Phase||0||
48413255|NCT01693562|101345804|FG017|COMPLETED|Exploration Phase||0||
48413256|NCT01693562|101345805|FG018|COMPLETED|Exploration Phase||0||
48413257|NCT01693562|101345806|FG019|COMPLETED|Exploration Phase||0||
48413258|NCT01693562|101345807|FG020|COMPLETED|Exploration Phase||0||
48413259|NCT01693562|101345808|FG021|COMPLETED|Exploration Phase||0||
48413260|NCT01693562|101345809|FG022|COMPLETED|Exploration Phase||0||
48413261|NCT01693562|101345787|FG000|NOT COMPLETED|Exploration Phase||0||
48413262|NCT01693562|101345788|FG001|NOT COMPLETED|Exploration Phase||0||
48413263|NCT01693562|101345789|FG002|NOT COMPLETED|Exploration Phase||0||
48413264|NCT01693562|101345790|FG003|NOT COMPLETED|Exploration Phase||0||
48413265|NCT01693562|101345791|FG004|NOT COMPLETED|Exploration Phase||0||
48413266|NCT01693562|101345792|FG005|NOT COMPLETED|Exploration Phase||0||
48413267|NCT01693562|101345793|FG006|NOT COMPLETED|Exploration Phase||21||
48413268|NCT01693562|101345794|FG007|NOT COMPLETED|Exploration Phase||0||
48413269|NCT01693562|101345795|FG008|NOT COMPLETED|Exploration Phase||0||
48413270|NCT01693562|101345796|FG009|NOT COMPLETED|Exploration Phase||0||
48413271|NCT01693562|101345797|FG010|NOT COMPLETED|Exploration Phase||0||
48413272|NCT01693562|101345798|FG011|NOT COMPLETED|Exploration Phase||0||
48413273|NCT01693562|101345799|FG012|NOT COMPLETED|Exploration Phase||0||
48413274|NCT01693562|101345800|FG013|NOT COMPLETED|Exploration Phase||0||
48413275|NCT01693562|101345801|FG014|NOT COMPLETED|Exploration Phase||0||
48413276|NCT01693562|101345802|FG015|NOT COMPLETED|Exploration Phase||0||
48413277|NCT01693562|101345803|FG016|NOT COMPLETED|Exploration Phase||0||
48413278|NCT01693562|101345804|FG017|NOT COMPLETED|Exploration Phase||0||
48413279|NCT01693562|101345805|FG018|NOT COMPLETED|Exploration Phase||0||
48413280|NCT01693562|101345806|FG019|NOT COMPLETED|Exploration Phase||0||
48413281|NCT01693562|101345807|FG020|NOT COMPLETED|Exploration Phase||0||
48413282|NCT01693562|101345808|FG021|NOT COMPLETED|Exploration Phase||0||
48338359|NCT00364182|101156664|FG000|NOT COMPLETED|Third Intervention||0||
48338360|NCT00364182|101156665|FG001|NOT COMPLETED|Third Intervention||1||
48338361|NCT00364182|101156666|FG002|NOT COMPLETED|Third Intervention||1||
48338362|NCT00364182|101156664|FG000|STARTED|Fourth Intervention||0||
48413283|NCT01693562|101345809|FG022|NOT COMPLETED|Exploration Phase||0||
48413284|NCT01693562|101345787|FG000|STARTED|Expansion Phase||0||
48338363|NCT00364182|101156665|FG001|STARTED|Fourth Intervention||19||
48338364|NCT00364182|101156666|FG002|STARTED|Fourth Intervention||22||
48338365|NCT00364182|101156664|FG000|COMPLETED|Fourth Intervention||0||
48413285|NCT01693562|101345788|FG001|STARTED|Expansion Phase||0||
48413286|NCT01693562|101345789|FG002|STARTED|Expansion Phase||0||
48413287|NCT01693562|101345790|FG003|STARTED|Expansion Phase||0||
48413288|NCT01693562|101345791|FG004|STARTED|Expansion Phase||0||
48338366|NCT00364182|101156665|FG001|COMPLETED|Fourth Intervention||19||
48338367|NCT00364182|101156666|FG002|COMPLETED|Fourth Intervention||22||
48338368|NCT00364182|101156664|FG000|NOT COMPLETED|Fourth Intervention||0||
48338369|NCT00364182|101156665|FG001|NOT COMPLETED|Fourth Intervention||0||
48338370|NCT00364182|101156666|FG002|NOT COMPLETED|Fourth Intervention||0||
48338371|NCT02211261|101156667|FG000|STARTED|Overall Study||9||
48338372|NCT02211261|101156668|FG001|STARTED|Overall Study||6||
48338373|NCT02211261|101156669|FG002|STARTED|Overall Study||6||
48338374|NCT02211261|101156670|FG003|STARTED|Overall Study||6||
48338375|NCT02211261|101156671|FG004|STARTED|Overall Study||9||
48338376|NCT02211261|101156672|FG005|STARTED|Overall Study||2||
48338377|NCT02211261|101156673|FG006|STARTED|Overall Study||6||
48338378|NCT02211261|101156674|FG007|STARTED|Overall Study||8||
48338379|NCT02211261|101156675|FG008|STARTED|Overall Study||8||
48338380|NCT02211261|101156676|FG009|STARTED|Overall Study||16||
48338381|NCT02211261|101156677|FG010|STARTED|Overall Study||8||
48338382|NCT02211261|101156667|FG000|COMPLETED|Overall Study||9||
48338383|NCT02211261|101156668|FG001|COMPLETED|Overall Study||6||
48338384|NCT02211261|101156669|FG002|COMPLETED|Overall Study||5||
48338385|NCT02211261|101156670|FG003|COMPLETED|Overall Study||6||
48338386|NCT02211261|101156671|FG004|COMPLETED|Overall Study||7||
48338387|NCT02211261|101156672|FG005|COMPLETED|Overall Study||1||
48338388|NCT02211261|101156673|FG006|COMPLETED|Overall Study||6||
48338389|NCT02211261|101156674|FG007|COMPLETED|Overall Study||7||
48338390|NCT02211261|101156675|FG008|COMPLETED|Overall Study||8||
48338391|NCT02211261|101156676|FG009|COMPLETED|Overall Study||14||
48338392|NCT02211261|101156677|FG010|COMPLETED|Overall Study||8||
48338393|NCT02211261|101156667|FG000|NOT COMPLETED|Overall Study||0||
48338394|NCT02211261|101156668|FG001|NOT COMPLETED|Overall Study||0||
48338395|NCT02211261|101156669|FG002|NOT COMPLETED|Overall Study||1||
48338396|NCT02211261|101156670|FG003|NOT COMPLETED|Overall Study||0||
48338397|NCT02211261|101156671|FG004|NOT COMPLETED|Overall Study||2||
48338398|NCT02211261|101156672|FG005|NOT COMPLETED|Overall Study||1||
48338399|NCT02211261|101156673|FG006|NOT COMPLETED|Overall Study||0||
48338400|NCT02211261|101156674|FG007|NOT COMPLETED|Overall Study||1||
48338401|NCT02211261|101156675|FG008|NOT COMPLETED|Overall Study||0||
48338402|NCT02211261|101156676|FG009|NOT COMPLETED|Overall Study||2||
48338403|NCT02211261|101156677|FG010|NOT COMPLETED|Overall Study||0||
48338404|NCT01323478|101156678|FG000|STARTED|Overall Study||71||
48338405|NCT01323478|101156678|FG000|COMPLETED|Overall Study||47||
48338406|NCT01323478|101156678|FG000|NOT COMPLETED|Overall Study||24||
48338407|NCT03446456|101156679|FG000|STARTED|Overall Study||20||
48338408|NCT03446456|101156680|FG001|STARTED|Overall Study||20||
48338409|NCT03446456|101156679|FG000|COMPLETED|Overall Study||16||
48338410|NCT03446456|101156680|FG001|COMPLETED|Overall Study||16||
48338411|NCT03446456|101156679|FG000|NOT COMPLETED|Overall Study||4||
48338412|NCT03446456|101156680|FG001|NOT COMPLETED|Overall Study||4||
48338413|NCT01872338|101156681|FG000|STARTED|Overall Study||66||
48338414|NCT01872338|101156682|FG001|STARTED|Overall Study||69||
48338415|NCT01872338|101156681|FG000|COMPLETED|Overall Study||46||
48338416|NCT01872338|101156682|FG001|COMPLETED|Overall Study||69||
48338417|NCT01872338|101156681|FG000|NOT COMPLETED|Overall Study||20||
48338418|NCT01872338|101156682|FG001|NOT COMPLETED|Overall Study||0||
48338419|NCT04258579|101156683|FG000|STARTED|Overall Study||40||
48338420|NCT04258579|101156683|FG000|COMPLETED|Overall Study||27||
48338421|NCT04258579|101156683|FG000|NOT COMPLETED|Overall Study||13||
48338422|NCT00631137|101156684|FG000|STARTED|Overall Study||1||
48338423|NCT00631137|101156685|FG001|STARTED|Overall Study||0||
48338424|NCT00631137|101156684|FG000|COMPLETED|Overall Study||0||
48338425|NCT00631137|101156685|FG001|COMPLETED|Overall Study||0||
48338426|NCT00631137|101156684|FG000|NOT COMPLETED|Overall Study||1||
48338427|NCT00631137|101156685|FG001|NOT COMPLETED|Overall Study||0||
48338428|NCT01795547|101156686|FG000|STARTED|Overall Study||148||
48338429|NCT01795547|101156687|FG001|STARTED|Overall Study||147||
48338430|NCT01795547|101156686|FG000|COMPLETED|Overall Study||100||
48338431|NCT01795547|101156687|FG001|COMPLETED|Overall Study||83||
48338432|NCT01795547|101156686|FG000|NOT COMPLETED|Overall Study||48||
48338433|NCT01795547|101156687|FG001|NOT COMPLETED|Overall Study||64||
48338434|NCT02844998|101156688|FG000|STARTED|Overall Study||42||
48338435|NCT02844998|101156689|FG001|STARTED|Overall Study||39||
48338436|NCT02844998|101156690|FG002|STARTED|Overall Study||39||
48338437|NCT02844998|101156688|FG000|COMPLETED|Overall Study||35||
48338438|NCT02844998|101156689|FG001|COMPLETED|Overall Study||35||
48338439|NCT02844998|101156690|FG002|COMPLETED|Overall Study||35||
48338440|NCT02844998|101156688|FG000|NOT COMPLETED|Overall Study||7||
48338441|NCT02844998|101156689|FG001|NOT COMPLETED|Overall Study||4||
48338442|NCT02844998|101156690|FG002|NOT COMPLETED|Overall Study||4||
48338443|NCT02400255|101156691|FG000|STARTED|Overall Study||22||
48338444|NCT02400255|101156692|FG001|STARTED|Overall Study||5||
48338445|NCT02400255|101156693|FG002|STARTED|Overall Study||1||
48338446|NCT02400255|101156694|FG003|STARTED|Overall Study||2||
48338447|NCT02400255|101156691|FG000|COMPLETED|Overall Study||5||
48338448|NCT02400255|101156692|FG001|COMPLETED|Overall Study||1||
48338449|NCT02400255|101156693|FG002|COMPLETED|Overall Study||0||
48338450|NCT02400255|101156694|FG003|COMPLETED|Overall Study||0||
48338451|NCT02400255|101156691|FG000|NOT COMPLETED|Overall Study||17||
48338452|NCT02400255|101156692|FG001|NOT COMPLETED|Overall Study||4||
48338453|NCT02400255|101156693|FG002|NOT COMPLETED|Overall Study||1||
48338454|NCT02400255|101156694|FG003|NOT COMPLETED|Overall Study||2||
48338455|NCT04451330|101156695|FG000|STARTED|Overall Study||133||
48338456|NCT04451330|101156696|FG001|STARTED|Overall Study||69||
48338457|NCT04451330|101156695|FG000|COMPLETED|Overall Study||123||
48338458|NCT04451330|101156696|FG001|COMPLETED|Overall Study||65||
48338459|NCT04451330|101156695|FG000|NOT COMPLETED|Overall Study||10||
48338460|NCT04451330|101156696|FG001|NOT COMPLETED|Overall Study||4||
48338461|NCT01438008|101156697|FG000|STARTED|Overall Study||4||
48338462|NCT01438008|101156698|FG001|STARTED|Overall Study||5||
48338463|NCT01438008|101156697|FG000|COMPLETED|Overall Study||4||
48338464|NCT01438008|101156698|FG001|COMPLETED|Overall Study||5||
48338465|NCT01438008|101156697|FG000|NOT COMPLETED|Overall Study||0||
48338466|NCT01438008|101156698|FG001|NOT COMPLETED|Overall Study||0||
48338467|NCT00584233|101156699|FG000|STARTED|Overall Study||75||
48338468|NCT00584233|101156699|FG000|COMPLETED|Overall Study||57||
48338469|NCT00584233|101156699|FG000|NOT COMPLETED|Overall Study||18||
48338470|NCT02118792|101156700|FG000|STARTED|Overall Study||514||
48338471|NCT02118792|101156701|FG001|STARTED|Overall Study||250||
48338472|NCT02118792|101156700|FG000|Treated|Overall Study||513||
48338473|NCT02118792|101156701|FG001|Treated|Overall Study||250||
48338474|NCT02118792|101156700|FG000|COMPLETED|Overall Study||483||
48338475|NCT02118792|101156701|FG001|COMPLETED|Overall Study||213||
48338476|NCT02118792|101156700|FG000|NOT COMPLETED|Overall Study||31||
48338477|NCT02118792|101156701|FG001|NOT COMPLETED|Overall Study||37||
48338478|NCT01110252|101156702|FG000|STARTED|Pre-procedure (Stem Cells Infusion)||4||
48338479|NCT01110252|101156702|FG000|COMPLETED|Pre-procedure (Stem Cells Infusion)||4||
48338480|NCT01110252|101156702|FG000|NOT COMPLETED|Pre-procedure (Stem Cells Infusion)||0||
48338481|NCT01110252|101156702|FG000|STARTED|Post-procedure (Stem Cells Infusion)||4||
48338482|NCT01110252|101156702|FG000|COMPLETED|Post-procedure (Stem Cells Infusion)||4||
48338483|NCT01110252|101156702|FG000|NOT COMPLETED|Post-procedure (Stem Cells Infusion)||0||
48338484|NCT00254410|101156703|FG000|STARTED|Overall Study||30||
48338485|NCT00254410|101156703|FG000|COMPLETED|Overall Study||30||
48338486|NCT00254410|101156703|FG000|NOT COMPLETED|Overall Study||0||
48338487|NCT00756938|101156704|FG000|STARTED|12-week Base Study||33||
48338488|NCT00756938|101156705|FG001|STARTED|12-week Base Study||34||
48338489|NCT00756938|101156706|FG002|STARTED|12-week Base Study||34||
48338490|NCT00756938|101156707|FG003|STARTED|12-week Base Study||0||
48338491|NCT00756938|101156704|FG000|COMPLETED|12-week Base Study||31||
48338492|NCT00756938|101156705|FG001|COMPLETED|12-week Base Study||34||
48338493|NCT00756938|101156706|FG002|COMPLETED|12-week Base Study||32||
48338494|NCT00756938|101156707|FG003|COMPLETED|12-week Base Study||0||
48338495|NCT00756938|101156704|FG000|NOT COMPLETED|12-week Base Study||2||
48338496|NCT00756938|101156705|FG001|NOT COMPLETED|12-week Base Study||0||
48338497|NCT00756938|101156706|FG002|NOT COMPLETED|12-week Base Study||2||
48338498|NCT00756938|101156707|FG003|NOT COMPLETED|12-week Base Study||0||
48338499|NCT00756938|101156704|FG000|STARTED|Optional Extension||0||
48338500|NCT00756938|101156705|FG001|STARTED|Optional Extension||0||
48338501|NCT00756938|101156706|FG002|STARTED|Optional Extension||0||
48338502|NCT00756938|101156707|FG003|STARTED|Optional Extension||90||
48338503|NCT00756938|101156704|FG000|COMPLETED|Optional Extension||0||
48338504|NCT00756938|101156705|FG001|COMPLETED|Optional Extension||0||
48338505|NCT00756938|101156706|FG002|COMPLETED|Optional Extension||0||
48338506|NCT00756938|101156707|FG003|COMPLETED|Optional Extension||53||
48338507|NCT00756938|101156704|FG000|NOT COMPLETED|Optional Extension||0||
48338508|NCT00756938|101156705|FG001|NOT COMPLETED|Optional Extension||0||
48338509|NCT00756938|101156706|FG002|NOT COMPLETED|Optional Extension||0||
48338510|NCT00756938|101156707|FG003|NOT COMPLETED|Optional Extension||37||
48338511|NCT03543085|101156708|FG000|STARTED|Overall Study||10||
48338512|NCT03543085|101156708|FG000|COMPLETED|Overall Study||10||
48338513|NCT03543085|101156708|FG000|NOT COMPLETED|Overall Study||0||
48338514|NCT02238847|101156709|FG000|STARTED|Overall Study||59||
48338515|NCT02238847|101156710|FG001|STARTED|Overall Study||60||
48338516|NCT02238847|101156709|FG000|COMPLETED|Overall Study||37||
48338517|NCT02238847|101156710|FG001|COMPLETED|Overall Study||36||
48338518|NCT02238847|101156709|FG000|NOT COMPLETED|Overall Study||22||
48338519|NCT02238847|101156710|FG001|NOT COMPLETED|Overall Study||24||
48338520|NCT00848120|101156711|FG000|STARTED|Overall Study||29||
48338521|NCT00848120|101156711|FG000|COMPLETED|Overall Study||28||
48338522|NCT00848120|101156711|FG000|NOT COMPLETED|Overall Study||1||
48338523|NCT03382509|101156712|FG000|STARTED|Overall Study||8|Started are treated|
48338524|NCT03382509|101156713|FG001|STARTED|Overall Study||8|Started are treated|
48338525|NCT03382509|101156712|FG000|COMPLETED|Overall Study||8||
48338526|NCT03382509|101156713|FG001|COMPLETED|Overall Study||8||
48338527|NCT03382509|101156712|FG000|NOT COMPLETED|Overall Study||0||
48338528|NCT03382509|101156713|FG001|NOT COMPLETED|Overall Study||0||
48338529|NCT01629615|101156714|FG000|STARTED|Overall Study||50||
48338530|NCT01629615|101156714|FG000|COMPLETED|Overall Study||50||
48338531|NCT01629615|101156714|FG000|NOT COMPLETED|Overall Study||0||
48338532|NCT02324270|101156715|FG000|STARTED|Overall Study||218||
48338533|NCT02324270|101156716|FG001|STARTED|Overall Study||219||
48338534|NCT02324270|101156717|FG002|STARTED|Overall Study||221||
48338535|NCT02324270|101156715|FG000|Safety Population|Overall Study||214||
48338536|NCT02324270|101156716|FG001|Safety Population|Overall Study||216||
48338537|NCT02324270|101156717|FG002|Safety Population|Overall Study||217||
48338538|NCT02324270|101156715|FG000|mITT Population|Overall Study||214||
48338539|NCT02324270|101156716|FG001|mITT Population|Overall Study||216||
48338540|NCT02324270|101156717|FG002|mITT Population|Overall Study||217||
48338541|NCT02324270|101156715|FG000|PP Population|Overall Study||180||
48338542|NCT02324270|101156716|FG001|PP Population|Overall Study||177||
48338543|NCT02324270|101156717|FG002|PP Population|Overall Study||171||
48338544|NCT02324270|101156715|FG000|COMPLETED|Overall Study||213||
48338545|NCT02324270|101156716|FG001|COMPLETED|Overall Study||212||
48338546|NCT02324270|101156717|FG002|COMPLETED|Overall Study||216||
48338547|NCT02324270|101156715|FG000|NOT COMPLETED|Overall Study||5||
48338548|NCT02324270|101156716|FG001|NOT COMPLETED|Overall Study||7||
48338549|NCT02324270|101156717|FG002|NOT COMPLETED|Overall Study||5||
48338550|NCT04436276|101156718|FG000|STARTED|Overall Study||77||
48631504|NCT02631941|101881535|FG009|NOT COMPLETED|Overall Study||0||
48631505|NCT01868646|101881536|FG000|STARTED|Overall Study||76||
48631506|NCT01868646|101881537|FG001|STARTED|Overall Study||72||
48631507|NCT01868646|101881536|FG000|COMPLETED|Overall Study||73||
48631508|NCT01868646|101881537|FG001|COMPLETED|Overall Study||67||
48631509|NCT01868646|101881536|FG000|NOT COMPLETED|Overall Study||3||
48338551|NCT04436276|101156719|FG001|STARTED|Overall Study||75||
48338552|NCT04436276|101156720|FG002|STARTED|Overall Study||75||
48338553|NCT04436276|101156721|FG003|STARTED|Overall Study||73||
48338554|NCT04436276|101156722|FG004|STARTED|Overall Study||77||
48338555|NCT04436276|101156723|FG005|STARTED|Overall Study||5||
48178003|NCT02697006|100757750|FG001|STARTED|Overall Study||13||
48631510|NCT01868646|101881537|FG001|NOT COMPLETED|Overall Study||5||
48631511|NCT02411643|101881538|FG000|STARTED|Overall Study||2||
48631512|NCT02411643|101881538|FG000|COMPLETED|Overall Study||2||
48338556|NCT04436276|101156724|FG006|STARTED|Overall Study||5||
48178004|NCT02697006|100757749|FG000|COMPLETED|Overall Study||31||
48338557|NCT04436276|101156725|FG007|STARTED|Overall Study||5||
48338558|NCT04436276|101156726|FG008|STARTED|Overall Study||5||
48338559|NCT04436276|101156727|FG009|STARTED|Overall Study||5||
48338560|NCT04436276|101156728|FG010|STARTED|Overall Study||58||
48631513|NCT02411643|101881538|FG000|NOT COMPLETED|Overall Study||0||
48631514|NCT00587067|101881539|FG000|STARTED|Overall Study||34||
48631515|NCT00587067|101881539|FG000|COMPLETED|Overall Study||34||
48631516|NCT00587067|101881539|FG000|NOT COMPLETED|Overall Study||0||
48631517|NCT02579629|101881540|FG000|STARTED|Overall Study||22||
48631518|NCT02579629|101881541|FG001|STARTED|Overall Study||20||
48631519|NCT02579629|101881542|FG002|STARTED|Overall Study||22||
48631520|NCT02579629|101881540|FG000|COMPLETED|Overall Study||20||
48631521|NCT02579629|101881541|FG001|COMPLETED|Overall Study||19||
48631522|NCT02579629|101881542|FG002|COMPLETED|Overall Study||20||
48631523|NCT02579629|101881540|FG000|NOT COMPLETED|Overall Study||2||
48631524|NCT02579629|101881541|FG001|NOT COMPLETED|Overall Study||1||
48631525|NCT02579629|101881542|FG002|NOT COMPLETED|Overall Study||2||
48631526|NCT01548599|101881543|FG000|STARTED|Overall Study||72||
48631527|NCT01548599|101881544|FG001|STARTED|Overall Study||68||
48631528|NCT01548599|101881543|FG000|COMPLETED|Overall Study||66||
48631529|NCT01548599|101881544|FG001|COMPLETED|Overall Study||66||
48631530|NCT01548599|101881543|FG000|NOT COMPLETED|Overall Study||6||
48631531|NCT01548599|101881544|FG001|NOT COMPLETED|Overall Study||2||
48631532|NCT05052580|101881545|FG000|STARTED|Overall Study||4733||
48631533|NCT05052580|101881545|FG000|COMPLETED|Overall Study||3489||
48631534|NCT05052580|101881545|FG000|NOT COMPLETED|Overall Study||1244||
48631535|NCT01349595|101881546|FG000|STARTED|Overall Study||2||
48631536|NCT01349595|101881547|FG001|STARTED|Overall Study||2||
48631537|NCT01349595|101881546|FG000|COMPLETED|Overall Study||0||
48754035|NCT03582215|102187621|FG002|COMPLETED|Overall Study||6||
48754036|NCT03582215|102187622|FG003|COMPLETED|Overall Study||6||
48754037|NCT03582215|102187623|FG004|COMPLETED|Overall Study||12||
48754038|NCT03582215|102187624|FG005|COMPLETED|Overall Study||12||
48754039|NCT03582215|102187625|FG006|COMPLETED|Overall Study||10||
48754040|NCT03582215|102187626|FG007|COMPLETED|Overall Study||10||
48754041|NCT03582215|102187619|FG000|NOT COMPLETED|Overall Study||1||
48754042|NCT03582215|102187620|FG001|NOT COMPLETED|Overall Study||0||
48754043|NCT03582215|102187621|FG002|NOT COMPLETED|Overall Study||0||
48754044|NCT03582215|102187622|FG003|NOT COMPLETED|Overall Study||0||
48754045|NCT03582215|102187623|FG004|NOT COMPLETED|Overall Study||0||
48754046|NCT03582215|102187624|FG005|NOT COMPLETED|Overall Study||0||
48754047|NCT03582215|102187625|FG006|NOT COMPLETED|Overall Study||2||
48754048|NCT03582215|102187626|FG007|NOT COMPLETED|Overall Study||2||
48631538|NCT01349595|101881547|FG001|COMPLETED|Overall Study||0||
48631539|NCT01349595|101881546|FG000|NOT COMPLETED|Overall Study||2||
48631540|NCT01349595|101881547|FG001|NOT COMPLETED|Overall Study||2||
48631541|NCT00505635|101881548|FG000|STARTED|Overall Study||5||
48631542|NCT00505635|101881548|FG000|COMPLETED|Overall Study||5||
48631543|NCT00505635|101881548|FG000|NOT COMPLETED|Overall Study||0||
48631544|NCT04901624|101881549|FG000|STARTED|Overall Study||626||172
48631545|NCT04901624|101881550|FG001|STARTED|Overall Study||550||162
48631546|NCT04901624|101881551|FG002|STARTED|Overall Study||539||153
48631547|NCT04901624|101881552|FG003|STARTED|Overall Study||449||138
48754049|NCT02646826|102187627|FG000|STARTED|Overall Study||21||
48754050|NCT02646826|102187628|FG001|STARTED|Overall Study||22||
48754051|NCT02646826|102187629|FG002|STARTED|Overall Study||21||
48754052|NCT02646826|102187630|FG003|STARTED|Overall Study||22||
48754053|NCT02646826|102187627|FG000|COMPLETED|Overall Study||19||
48754054|NCT02646826|102187628|FG001|COMPLETED|Overall Study||22||
48754055|NCT02646826|102187629|FG002|COMPLETED|Overall Study||20||
48754056|NCT02646826|102187630|FG003|COMPLETED|Overall Study||21||
48631548|NCT04901624|101881549|FG000|Wave 1 Attendance|Overall Study||308||85
48631549|NCT04901624|101881550|FG001|Wave 1 Attendance|Overall Study||285||82
48754057|NCT02646826|102187627|FG000|NOT COMPLETED|Overall Study||2||
48754058|NCT02646826|102187628|FG001|NOT COMPLETED|Overall Study||0||
48754059|NCT02646826|102187629|FG002|NOT COMPLETED|Overall Study||1||
48754060|NCT02646826|102187630|FG003|NOT COMPLETED|Overall Study||1||
48754061|NCT00989911|102187631|FG000|STARTED|Overall Study||10||
48631550|NCT04901624|101881551|FG002|Wave 1 Attendance|Overall Study||286||78
48631551|NCT04901624|101881552|FG003|Wave 1 Attendance|Overall Study||203||62
48631552|NCT04901624|101881549|FG000|Wave 2 Attendance|Overall Study||123||35
48631553|NCT04901624|101881550|FG001|Wave 2 Attendance|Overall Study||84||24
48631554|NCT04901624|101881551|FG002|Wave 2 Attendance|Overall Study||129||38
48631555|NCT04901624|101881552|FG003|Wave 2 Attendance|Overall Study||78||26
48631556|NCT04901624|101881549|FG000|COMPLETED|Overall Study||123||35
48631557|NCT04901624|101881550|FG001|COMPLETED|Overall Study||84||24
48631558|NCT04901624|101881551|FG002|COMPLETED|Overall Study||129||38
48631559|NCT04901624|101881552|FG003|COMPLETED|Overall Study||78||26
48631560|NCT04901624|101881549|FG000|NOT COMPLETED|Overall Study||503||137
48631561|NCT04901624|101881550|FG001|NOT COMPLETED|Overall Study||466||138
48631562|NCT04901624|101881551|FG002|NOT COMPLETED|Overall Study||410||115
48631563|NCT04901624|101881552|FG003|NOT COMPLETED|Overall Study||371||112
48631564|NCT01496456|101881553|FG000|STARTED|Overall Study||17||
48631565|NCT01496456|101881553|FG000|Baseline|Overall Study||16||
48631566|NCT01496456|101881553|FG000|1-yr Recall|Overall Study||12||
48631567|NCT01496456|101881553|FG000|2-yr Recall|Overall Study||10||
48631568|NCT01496456|101881553|FG000|3-yr Final Recall|Overall Study||9||
48754062|NCT00989911|102187631|FG000|COMPLETED|Overall Study||7||
48754063|NCT00989911|102187631|FG000|NOT COMPLETED|Overall Study||3||
48754064|NCT02723773|102187632|FG000|STARTED|Overall Study||7289||
48754065|NCT02723773|102187633|FG001|STARTED|Overall Study||61||
48754066|NCT02723773|102187634|FG002|STARTED|Overall Study||60||
48754067|NCT02723773|102187635|FG003|STARTED|Overall Study||119||
48754068|NCT02723773|102187632|FG000|COMPLETED|Overall Study||5570||
48754069|NCT02723773|102187633|FG001|COMPLETED|Overall Study||52||
48754070|NCT02723773|102187634|FG002|COMPLETED|Overall Study||51||
48754071|NCT02723773|102187635|FG003|COMPLETED|Overall Study||97||
48754072|NCT02723773|102187632|FG000|NOT COMPLETED|Overall Study||1719||
48754073|NCT02723773|102187633|FG001|NOT COMPLETED|Overall Study||9||
48754074|NCT02723773|102187634|FG002|NOT COMPLETED|Overall Study||9||
48754075|NCT02723773|102187635|FG003|NOT COMPLETED|Overall Study||22||
48754076|NCT00642356|102187636|FG000|STARTED|Overall Study||7||
48754077|NCT00642356|102187637|FG001|STARTED|Overall Study||7||
48754078|NCT00642356|102187636|FG000|COMPLETED|Overall Study||5||
48754079|NCT00642356|102187637|FG001|COMPLETED|Overall Study||4||
48754080|NCT00642356|102187636|FG000|NOT COMPLETED|Overall Study||2||
48754081|NCT00642356|102187637|FG001|NOT COMPLETED|Overall Study||3||
48754082|NCT00472108|102187638|FG000|STARTED|Overall Study||33||45
48754083|NCT00472108|102187639|FG001|STARTED|Overall Study||32||41
48754084|NCT00472108|102187638|FG000|COMPLETED|Overall Study||33||41
48754085|NCT00472108|102187639|FG001|COMPLETED|Overall Study||31||39
48754086|NCT00472108|102187638|FG000|NOT COMPLETED|Overall Study||0||4
48754087|NCT00472108|102187639|FG001|NOT COMPLETED|Overall Study||1||2
48754088|NCT04388111|102187640|FG000|STARTED|Overall Study||33||
48754089|NCT04388111|102187641|FG001|STARTED|Overall Study||32||
48754090|NCT04388111|102187640|FG000|COMPLETED|Overall Study||24||
48754091|NCT04388111|102187641|FG001|COMPLETED|Overall Study||24||
48631569|NCT01496456|101881553|FG000|COMPLETED|Overall Study||9||
48631570|NCT01496456|101881553|FG000|NOT COMPLETED|Overall Study||8||
48631571|NCT02897349|101881554|FG000|STARTED|Overall Study||102|Started are randomized/ treated|
48631572|NCT02897349|101881555|FG001|STARTED|Overall Study||104|Started are randomized/ treated|
48631573|NCT02897349|101881554|FG000|COMPLETED|Overall Study||97||
48631574|NCT02897349|101881555|FG001|COMPLETED|Overall Study||98||
48631575|NCT02897349|101881554|FG000|NOT COMPLETED|Overall Study||5||
48631576|NCT02897349|101881555|FG001|NOT COMPLETED|Overall Study||6||
48631577|NCT01641042|101881556|FG000|STARTED|Overall Study||43||
48631578|NCT01641042|101881557|FG001|STARTED|Overall Study||43||
48631579|NCT01641042|101881556|FG000|COMPLETED|Overall Study||43||
48631580|NCT01641042|101881557|FG001|COMPLETED|Overall Study||43||
48631581|NCT01641042|101881556|FG000|NOT COMPLETED|Overall Study||0||
48631582|NCT01641042|101881557|FG001|NOT COMPLETED|Overall Study||0||
48631583|NCT00499122|101881558|FG000|STARTED|Overall Study||41||
48631584|NCT00499122|101881558|FG000|COMPLETED|Overall Study||39||
48631585|NCT00499122|101881558|FG000|NOT COMPLETED|Overall Study||2||
48631586|NCT03506477|101881559|FG000|STARTED|Overall Study||20||
48631587|NCT03506477|101881560|FG001|STARTED|Overall Study||5||
48631588|NCT03506477|101881559|FG000|COMPLETED|Overall Study||19||
48754092|NCT04388111|102187640|FG000|NOT COMPLETED|Overall Study||9||
48754093|NCT04388111|102187641|FG001|NOT COMPLETED|Overall Study||8||
48754094|NCT01609348|102187642|FG000|STARTED|Overall Study||3||
48754095|NCT01609348|102187643|FG001|STARTED|Overall Study||2||
48754096|NCT01609348|102187642|FG000|COMPLETED|Overall Study||3||
48754097|NCT01609348|102187643|FG001|COMPLETED|Overall Study||2||
48754098|NCT01609348|102187642|FG000|NOT COMPLETED|Overall Study||0||
48754099|NCT01609348|102187643|FG001|NOT COMPLETED|Overall Study||0||
48754100|NCT01611792|102187644|FG000|STARTED|Initial Period: Time 0||29||
48754101|NCT01611792|102187645|FG001|STARTED|Initial Period: Time 0||29||
48754102|NCT01611792|102187644|FG000|COMPLETED|Initial Period: Time 0||17||
48754103|NCT01611792|102187645|FG001|COMPLETED|Initial Period: Time 0||20||
48413289|NCT01693562|101345792|FG005|STARTED|Expansion Phase||0||
48413290|NCT01693562|101345793|FG006|STARTED|Expansion Phase||0||
48631589|NCT03506477|101881560|FG001|COMPLETED|Overall Study||5||
48631590|NCT03506477|101881559|FG000|NOT COMPLETED|Overall Study||1||
48631591|NCT03506477|101881560|FG001|NOT COMPLETED|Overall Study||0||
48631592|NCT05252858|101881561|FG000|STARTED|Overall Study||38||
48754104|NCT01611792|102187644|FG000|NOT COMPLETED|Initial Period: Time 0||12||
48754105|NCT01611792|102187645|FG001|NOT COMPLETED|Initial Period: Time 0||9||
48754106|NCT01611792|102187644|FG000|STARTED|Follow-up: at 11 Weeks||17||
48754107|NCT01611792|102187645|FG001|STARTED|Follow-up: at 11 Weeks||20||
48754108|NCT01611792|102187644|FG000|COMPLETED|Follow-up: at 11 Weeks||17||
48754109|NCT01611792|102187645|FG001|COMPLETED|Follow-up: at 11 Weeks||20||
48754110|NCT01611792|102187644|FG000|NOT COMPLETED|Follow-up: at 11 Weeks||0||
48754111|NCT01611792|102187645|FG001|NOT COMPLETED|Follow-up: at 11 Weeks||0||
48754112|NCT01611792|102187644|FG000|STARTED|Followup: at 6 Months||17||
48631593|NCT05252858|101881562|FG001|STARTED|Overall Study||31||
48754113|NCT01611792|102187645|FG001|STARTED|Followup: at 6 Months||20||
48754114|NCT01611792|102187644|FG000|COMPLETED|Followup: at 6 Months||11||
48754115|NCT01611792|102187645|FG001|COMPLETED|Followup: at 6 Months||7||
48754116|NCT01611792|102187644|FG000|NOT COMPLETED|Followup: at 6 Months||6||
48754117|NCT01611792|102187645|FG001|NOT COMPLETED|Followup: at 6 Months||13||
48754118|NCT03371836|102187646|FG000|STARTED|Overall Study||20||
48754119|NCT03371836|102187646|FG000|COMPLETED|Overall Study||18||
48754120|NCT03371836|102187646|FG000|NOT COMPLETED|Overall Study||2||
48754121|NCT01188772|102187647|FG000|STARTED|Overall Study||48||
48754122|NCT01188772|102187648|FG001|STARTED|Overall Study||48||
48631594|NCT05252858|101881561|FG000|COMPLETED|Overall Study||38||
48754123|NCT01188772|102187649|FG002|STARTED|Overall Study||26||
48754124|NCT01188772|102187650|FG003|STARTED|Overall Study||25||
48754125|NCT01188772|102187647|FG000|Randomized and Treated|Overall Study||48||
48754126|NCT01188772|102187648|FG001|Randomized and Treated|Overall Study||47||
48754127|NCT01188772|102187649|FG002|Randomized and Treated|Overall Study||26||
48754128|NCT01188772|102187650|FG003|Randomized and Treated|Overall Study||25||
48754129|NCT01188772|102187647|FG000|COMPLETED|Overall Study||43||
48754130|NCT01188772|102187648|FG001|COMPLETED|Overall Study||45||
48754131|NCT01188772|102187649|FG002|COMPLETED|Overall Study||15||
48754132|NCT01188772|102187650|FG003|COMPLETED|Overall Study||24||
48754133|NCT01188772|102187647|FG000|NOT COMPLETED|Overall Study||5||
48754134|NCT01188772|102187648|FG001|NOT COMPLETED|Overall Study||3||
48754135|NCT01188772|102187649|FG002|NOT COMPLETED|Overall Study||11||
48754136|NCT01188772|102187650|FG003|NOT COMPLETED|Overall Study||1||
48754137|NCT00591006|102187651|FG000|STARTED|Overall Study||1||
48754138|NCT00591006|102187652|FG001|STARTED|Overall Study||0||
48754139|NCT00591006|102187653|FG002|STARTED|Overall Study||1||
48754140|NCT00591006|102187654|FG003|STARTED|Overall Study||1||
48754141|NCT00591006|102187655|FG004|STARTED|Overall Study||1||
48754142|NCT00591006|102187656|FG005|STARTED|Overall Study||0||
48754143|NCT00591006|102187657|FG006|STARTED|Overall Study||1||
48754144|NCT00591006|102187658|FG007|STARTED|Overall Study||0||
48754145|NCT00591006|102187659|FG008|STARTED|Overall Study||1||
48754146|NCT00591006|102187660|FG009|STARTED|Overall Study||1||
48754147|NCT00591006|102187661|FG010|STARTED|Overall Study||0||
48754148|NCT00591006|102187662|FG011|STARTED|Overall Study||1||
48754149|NCT00591006|102187663|FG012|STARTED|Overall Study||1||
48631595|NCT05252858|101881562|FG001|COMPLETED|Overall Study||31||
48631596|NCT05252858|101881561|FG000|NOT COMPLETED|Overall Study||0||
48631597|NCT05252858|101881562|FG001|NOT COMPLETED|Overall Study||0||
48631598|NCT02105324|101881563|FG000|STARTED|Period 1||9||
48631599|NCT02105324|101881564|FG001|STARTED|Period 1||10||
48631600|NCT02105324|101881563|FG000|COMPLETED|Period 1||9||
48631601|NCT02105324|101881564|FG001|COMPLETED|Period 1||10||
48631602|NCT02105324|101881563|FG000|NOT COMPLETED|Period 1||0||
48631603|NCT02105324|101881564|FG001|NOT COMPLETED|Period 1||0||
48631604|NCT02105324|101881563|FG000|STARTED|Period 2||9||
48631605|NCT02105324|101881564|FG001|STARTED|Period 2||10||
48631606|NCT02105324|101881563|FG000|COMPLETED|Period 2||9||
48631607|NCT02105324|101881564|FG001|COMPLETED|Period 2||10||
48754150|NCT00591006|102187664|FG013|STARTED|Overall Study||2||
48754151|NCT00591006|102187665|FG014|STARTED|Overall Study||0||
48754152|NCT00591006|102187666|FG015|STARTED|Overall Study||1||
48754153|NCT00591006|102187667|FG016|STARTED|Overall Study||0||
48754154|NCT00591006|102187668|FG017|STARTED|Overall Study||1||
48754155|NCT00591006|102187669|FG018|STARTED|Overall Study||0||
48754156|NCT00591006|102187670|FG019|STARTED|Overall Study||1||
48754157|NCT00591006|102187671|FG020|STARTED|Overall Study||0||
48754158|NCT00591006|102187672|FG021|STARTED|Overall Study||1||
48754159|NCT00591006|102187673|FG022|STARTED|Overall Study||1||
48754160|NCT00591006|102187674|FG023|STARTED|Overall Study||1||
48754161|NCT00591006|102187651|FG000|Treatment #2|Overall Study||1||
48754162|NCT00591006|102187652|FG001|Treatment #2|Overall Study||0||
48413291|NCT01693562|101345794|FG007|STARTED|Expansion Phase||62||
48413292|NCT01693562|101345795|FG008|STARTED|Expansion Phase||22||
48631608|NCT02105324|101881563|FG000|NOT COMPLETED|Period 2||0||
48631609|NCT02105324|101881564|FG001|NOT COMPLETED|Period 2||0||
48631610|NCT01201863|101881565|FG000|STARTED|Overall Study||12||
48631611|NCT01201863|101881566|FG001|STARTED|Overall Study||10||
48631612|NCT01201863|101881567|FG002|STARTED|Overall Study||24||
48631613|NCT01201863|101881565|FG000|COMPLETED|Overall Study||11||
48631614|NCT01201863|101881566|FG001|COMPLETED|Overall Study||6||
48631615|NCT01201863|101881567|FG002|COMPLETED|Overall Study||18||
48178005|NCT02697006|100757750|FG001|COMPLETED|Overall Study||9||
48413293|NCT01693562|101345796|FG009|STARTED|Expansion Phase||304||
48413294|NCT01693562|101345797|FG010|STARTED|Expansion Phase||40||
48631616|NCT01201863|101881565|FG000|NOT COMPLETED|Overall Study||1||
48631617|NCT01201863|101881566|FG001|NOT COMPLETED|Overall Study||4||
48631618|NCT01201863|101881567|FG002|NOT COMPLETED|Overall Study||6||
48631619|NCT00922636|101881568|FG000|STARTED|Overall Study||36||
48631620|NCT00922636|101881569|FG001|STARTED|Overall Study||78||
48631621|NCT00922636|101881570|FG002|STARTED|Overall Study||76||
48631622|NCT00922636|101881571|FG003|STARTED|Overall Study||75||
48631623|NCT00922636|101881572|FG004|STARTED|Overall Study||75||
48631624|NCT00922636|101881568|FG000|Entered Optional Taper Phase|Overall Study||4||
48754163|NCT00591006|102187653|FG002|Treatment #2|Overall Study||1||
48754164|NCT00591006|102187654|FG003|Treatment #2|Overall Study||1||
48754165|NCT00591006|102187655|FG004|Treatment #2|Overall Study||1||
48754166|NCT00591006|102187656|FG005|Treatment #2|Overall Study||0||
48754167|NCT00591006|102187657|FG006|Treatment #2|Overall Study||1||
48754168|NCT00591006|102187658|FG007|Treatment #2|Overall Study||0||
48754169|NCT00591006|102187659|FG008|Treatment #2|Overall Study||1||
48178006|NCT02697006|100757749|FG000|NOT COMPLETED|Overall Study||3||
48178007|NCT02697006|100757750|FG001|NOT COMPLETED|Overall Study||4||
48413295|NCT01693562|101345798|FG011|STARTED|Expansion Phase||21||
48413296|NCT01693562|101345799|FG012|STARTED|Expansion Phase||24||
48631625|NCT00922636|101881569|FG001|Entered Optional Taper Phase|Overall Study||10||
48631626|NCT00922636|101881570|FG002|Entered Optional Taper Phase|Overall Study||15||
48631627|NCT00922636|101881571|FG003|Entered Optional Taper Phase|Overall Study||7||
48631628|NCT00922636|101881572|FG004|Entered Optional Taper Phase|Overall Study||12||
48631629|NCT00922636|101881568|FG000|COMPLETED|Overall Study||29||
48631630|NCT00922636|101881569|FG001|COMPLETED|Overall Study||62||
48631631|NCT00922636|101881570|FG002|COMPLETED|Overall Study||56||
48631632|NCT00922636|101881571|FG003|COMPLETED|Overall Study||58||
48631633|NCT00922636|101881572|FG004|COMPLETED|Overall Study||59||
48631634|NCT00922636|101881568|FG000|NOT COMPLETED|Overall Study||7||
48631635|NCT00922636|101881569|FG001|NOT COMPLETED|Overall Study||16||
48754170|NCT00591006|102187660|FG009|Treatment #2|Overall Study||1||
48754171|NCT00591006|102187661|FG010|Treatment #2|Overall Study||0||
48754172|NCT00591006|102187662|FG011|Treatment #2|Overall Study||1||
48754173|NCT00591006|102187663|FG012|Treatment #2|Overall Study||1||
48754174|NCT00591006|102187664|FG013|Treatment #2|Overall Study||2||
48754175|NCT00591006|102187665|FG014|Treatment #2|Overall Study||0||
48754176|NCT00591006|102187666|FG015|Treatment #2|Overall Study||0||
48754177|NCT00591006|102187667|FG016|Treatment #2|Overall Study||0||
48754178|NCT00591006|102187668|FG017|Treatment #2|Overall Study||1||
48754179|NCT00591006|102187669|FG018|Treatment #2|Overall Study||0||
48413297|NCT01693562|101345800|FG013|STARTED|Expansion Phase||51||
48631636|NCT00922636|101881570|FG002|NOT COMPLETED|Overall Study||20||
48631637|NCT00922636|101881571|FG003|NOT COMPLETED|Overall Study||17||
48631638|NCT00922636|101881572|FG004|NOT COMPLETED|Overall Study||16||
48631639|NCT00062166|101881573|FG000|STARTED|Overall Study||340||
48631640|NCT00062166|101881573|FG000|COMPLETED|Overall Study||334||
48631641|NCT00062166|101881573|FG000|NOT COMPLETED|Overall Study||6||
48754180|NCT00591006|102187670|FG019|Treatment #2|Overall Study||1||
48754181|NCT00591006|102187671|FG020|Treatment #2|Overall Study||0||
48754182|NCT00591006|102187672|FG021|Treatment #2|Overall Study||1||
48754183|NCT00591006|102187673|FG022|Treatment #2|Overall Study||1||
48754184|NCT00591006|102187674|FG023|Treatment #2|Overall Study||1||
48754185|NCT00591006|102187651|FG000|Treatment #3|Overall Study||1||
48754186|NCT00591006|102187652|FG001|Treatment #3|Overall Study||0||
48631642|NCT02426684|101881574|FG000|STARTED|Overall Study||17||
48631643|NCT02426684|101881574|FG000|COMPLETED|Overall Study||16||
48631644|NCT02426684|101881574|FG000|NOT COMPLETED|Overall Study||1||
48631645|NCT04474483|101881575|FG000|STARTED|Overall Study||3||
48631646|NCT04474483|101881576|FG001|STARTED|Overall Study||5||
48631647|NCT04474483|101881575|FG000|COMPLETED|Overall Study||1||
48631648|NCT04474483|101881576|FG001|COMPLETED|Overall Study||3||
48754187|NCT00591006|102187653|FG002|Treatment #3|Overall Study||1||
48754188|NCT00591006|102187654|FG003|Treatment #3|Overall Study||1||
48754189|NCT00591006|102187655|FG004|Treatment #3|Overall Study||1||
48754190|NCT00591006|102187656|FG005|Treatment #3|Overall Study||0||
48754191|NCT00591006|102187657|FG006|Treatment #3|Overall Study||1||
48754192|NCT00591006|102187658|FG007|Treatment #3|Overall Study||0||
48754193|NCT00591006|102187659|FG008|Treatment #3|Overall Study||1||
48754194|NCT00591006|102187660|FG009|Treatment #3|Overall Study||1||
48754195|NCT00591006|102187661|FG010|Treatment #3|Overall Study||0||
48754196|NCT00591006|102187662|FG011|Treatment #3|Overall Study||1||
48754197|NCT00591006|102187663|FG012|Treatment #3|Overall Study||1||
48754198|NCT00591006|102187664|FG013|Treatment #3|Overall Study||2||
48754199|NCT00591006|102187665|FG014|Treatment #3|Overall Study||0||
48754200|NCT00591006|102187666|FG015|Treatment #3|Overall Study||0||
48754201|NCT00591006|102187667|FG016|Treatment #3|Overall Study||0||
48754202|NCT00591006|102187668|FG017|Treatment #3|Overall Study||1||
48754203|NCT00591006|102187669|FG018|Treatment #3|Overall Study||0||
48754204|NCT00591006|102187670|FG019|Treatment #3|Overall Study||1||
48754205|NCT00591006|102187671|FG020|Treatment #3|Overall Study||0||
48754206|NCT00591006|102187672|FG021|Treatment #3|Overall Study||1||
48754207|NCT00591006|102187673|FG022|Treatment #3|Overall Study||1||
48754208|NCT00591006|102187674|FG023|Treatment #3|Overall Study||1||
48754209|NCT00591006|102187651|FG000|Treatment #4|Overall Study||1||
48754210|NCT00591006|102187652|FG001|Treatment #4|Overall Study||0||
48754211|NCT00591006|102187653|FG002|Treatment #4|Overall Study||1||
48754212|NCT00591006|102187654|FG003|Treatment #4|Overall Study||1||
48754213|NCT00591006|102187655|FG004|Treatment #4|Overall Study||1||
48754214|NCT00591006|102187656|FG005|Treatment #4|Overall Study||0||
48754215|NCT00591006|102187657|FG006|Treatment #4|Overall Study||1||
48754216|NCT00591006|102187658|FG007|Treatment #4|Overall Study||0||
48754217|NCT00591006|102187659|FG008|Treatment #4|Overall Study||1||
48754218|NCT00591006|102187660|FG009|Treatment #4|Overall Study||1||
48178008|NCT00549822|100757751|FG000|STARTED|Overall Study||3||
48178009|NCT00549822|100757751|FG000|COMPLETED|Overall Study||3||
48178010|NCT00549822|100757751|FG000|NOT COMPLETED|Overall Study||0||
48178011|NCT00729690|100757752|FG000|STARTED|Overall Study||16||
48178012|NCT00729690|100757753|FG001|STARTED|Overall Study||16||
48178013|NCT00729690|100757754|FG002|STARTED|Overall Study||16||
48178014|NCT00729690|100757752|FG000|COMPLETED|Overall Study||16||
48178015|NCT00729690|100757753|FG001|COMPLETED|Overall Study||14||
48178016|NCT00729690|100757754|FG002|COMPLETED|Overall Study||14||
48178017|NCT00729690|100757752|FG000|NOT COMPLETED|Overall Study||0||
48178018|NCT00729690|100757753|FG001|NOT COMPLETED|Overall Study||2||
48178019|NCT00729690|100757754|FG002|NOT COMPLETED|Overall Study||2||
48178020|NCT01928225|100757755|FG000|STARTED|Overall Study||90||
48178021|NCT01928225|100757756|FG001|STARTED|Overall Study||90||
48178022|NCT01928225|100757755|FG000|COMPLETED|Overall Study||87||
48178023|NCT01928225|100757756|FG001|COMPLETED|Overall Study||87||
48178024|NCT01928225|100757755|FG000|NOT COMPLETED|Overall Study||3||
48178025|NCT01928225|100757756|FG001|NOT COMPLETED|Overall Study||3||
48631649|NCT04474483|101881575|FG000|NOT COMPLETED|Overall Study||2||
48631650|NCT04474483|101881576|FG001|NOT COMPLETED|Overall Study||2||
48631651|NCT01218802|101881577|FG000|STARTED|Overall Study||72||
48631652|NCT01218802|101881578|FG001|STARTED|Overall Study||75||
48631653|NCT01218802|101881577|FG000|COMPLETED|Overall Study||62||
48631654|NCT01218802|101881578|FG001|COMPLETED|Overall Study||57||
48631655|NCT01218802|101881577|FG000|NOT COMPLETED|Overall Study||10||
48631656|NCT01218802|101881578|FG001|NOT COMPLETED|Overall Study||18||
48631657|NCT03040726|101881579|FG000|STARTED|Overall Study||31||
48631658|NCT03040726|101881580|FG001|STARTED|Overall Study||15||
48631659|NCT03040726|101881579|FG000|Started Placebo run-in Phase|Overall Study||31||
48631660|NCT03040726|101881580|FG001|Started Placebo run-in Phase|Overall Study||15||
48631661|NCT03040726|101881579|FG000|Started Blinded Phase|Overall Study||22||
48631662|NCT03040726|101881580|FG001|Started Blinded Phase|Overall Study||11||
48631663|NCT03040726|101881579|FG000|COMPLETED|Overall Study||21||
48631664|NCT03040726|101881580|FG001|COMPLETED|Overall Study||9||
48631665|NCT03040726|101881579|FG000|NOT COMPLETED|Overall Study||10||
48631666|NCT03040726|101881580|FG001|NOT COMPLETED|Overall Study||6||
48631667|NCT02466399|101881581|FG000|STARTED|Overall Study||53||
48631668|NCT02466399|101881582|FG001|STARTED|Overall Study||27||
48631669|NCT02466399|101881581|FG000|COMPLETED|Overall Study||51||
48631670|NCT02466399|101881582|FG001|COMPLETED|Overall Study||27||
48631671|NCT02466399|101881581|FG000|NOT COMPLETED|Overall Study||2||
48754219|NCT00591006|102187661|FG010|Treatment #4|Overall Study||0||
48754220|NCT00591006|102187662|FG011|Treatment #4|Overall Study||1||
48178026|NCT04131959|100757757|FG000|STARTED|Overall Study||5||
48178027|NCT04131959|100757757|FG000|COMPLETED|Overall Study||5||
48178028|NCT04131959|100757757|FG000|NOT COMPLETED|Overall Study||0||
48178029|NCT00798174|100757758|FG000|STARTED|Overall Study||16||
48178030|NCT00798174|100757759|FG001|STARTED|Overall Study||16||
48178031|NCT00798174|100757758|FG000|COMPLETED|Overall Study||12||
48178032|NCT00798174|100757759|FG001|COMPLETED|Overall Study||13||
48178033|NCT00798174|100757758|FG000|NOT COMPLETED|Overall Study||4||
48178034|NCT00798174|100757759|FG001|NOT COMPLETED|Overall Study||3||
48178035|NCT03230864|100757760|FG000|STARTED|Prospective Confirmation (PC) Period||68||
48178036|NCT03230864|100757761|FG001|STARTED|Prospective Confirmation (PC) Period||51||
48178037|NCT03230864|100757762|FG002|STARTED|Prospective Confirmation (PC) Period||0||
48178038|NCT03230864|100757763|FG003|STARTED|Prospective Confirmation (PC) Period||0||
48338561|NCT04436276|101156729|FG011|STARTED|Overall Study||29||
48631672|NCT02466399|101881582|FG001|NOT COMPLETED|Overall Study||0||
48631673|NCT01677286|101881583|FG000|STARTED|Overall Study||25||
48178039|NCT03230864|100757760|FG000|COMPLETED|Prospective Confirmation (PC) Period||36||
48178040|NCT03230864|100757761|FG001|COMPLETED|Prospective Confirmation (PC) Period||32||
48178041|NCT03230864|100757762|FG002|COMPLETED|Prospective Confirmation (PC) Period||0||
48178042|NCT03230864|100757763|FG003|COMPLETED|Prospective Confirmation (PC) Period||0||
48178043|NCT03230864|100757760|FG000|NOT COMPLETED|Prospective Confirmation (PC) Period||32||
48338562|NCT04436276|101156730|FG012|STARTED|Overall Study||32||
48178044|NCT03230864|100757761|FG001|NOT COMPLETED|Prospective Confirmation (PC) Period||19||
48338563|NCT04436276|101156731|FG013|STARTED|Overall Study||17||
48178045|NCT03230864|100757762|FG002|NOT COMPLETED|Prospective Confirmation (PC) Period||0||
48178046|NCT03230864|100757763|FG003|NOT COMPLETED|Prospective Confirmation (PC) Period||0||
48178047|NCT03230864|100757760|FG000|STARTED|Double Blind Treatment (DBT) Period||0||
48178048|NCT03230864|100757761|FG001|STARTED|Double Blind Treatment (DBT) Period||0||
48178049|NCT03230864|100757762|FG002|STARTED|Double Blind Treatment (DBT) Period||35||
48631674|NCT01677286|101881583|FG000|COMPLETED|Overall Study||14||
48631675|NCT01677286|101881583|FG000|NOT COMPLETED|Overall Study||11||
48631676|NCT05277207|101881584|FG000|STARTED|Overall Study||15||
48631677|NCT05277207|101881585|FG001|STARTED|Overall Study||15||
48631678|NCT05277207|101881584|FG000|COMPLETED|Overall Study||15||
48631679|NCT05277207|101881585|FG001|COMPLETED|Overall Study||15||
48631680|NCT05277207|101881584|FG000|NOT COMPLETED|Overall Study||0||
48631681|NCT05277207|101881585|FG001|NOT COMPLETED|Overall Study||0||
48631682|NCT04081688|101881586|FG000|STARTED|Overall Study||16||
48631683|NCT04081688|101881586|FG000|COMPLETED|Overall Study||16||
48631684|NCT04081688|101881586|FG000|NOT COMPLETED|Overall Study||0||
48631685|NCT01547715|101881587|FG000|STARTED|Overall Study||60||
48631686|NCT01547715|101881588|FG001|STARTED|Overall Study||60||
48631687|NCT01547715|101881589|FG002|STARTED|Overall Study||60||
48338564|NCT04436276|101156732|FG014|STARTED|Overall Study||62||
48338565|NCT04436276|101156733|FG015|STARTED|Overall Study||30||
48338566|NCT04436276|101156734|FG016|STARTED|Overall Study||28||
48338567|NCT04436276|101156735|FG017|STARTED|Overall Study||15||
48338568|NCT04436276|101156736|FG018|STARTED|Overall Study||81||
48338569|NCT04436276|101156737|FG019|STARTED|Overall Study||80||
48338570|NCT04436276|101156738|FG020|STARTED|Overall Study||82||
48338571|NCT04436276|101156739|FG021|STARTED|Overall Study||79||
48338572|NCT04436276|101156740|FG022|STARTED|Overall Study||81||
48338573|NCT04436276|101156718|FG000|Dose 1|Overall Study||77||
48338574|NCT04436276|101156719|FG001|Dose 1|Overall Study||75||
48338575|NCT04436276|101156720|FG002|Dose 1|Overall Study||75||
48338576|NCT04436276|101156721|FG003|Dose 1|Overall Study||73||
48338577|NCT04436276|101156722|FG004|Dose 1|Overall Study||77||
48338578|NCT04436276|101156723|FG005|Dose 1|Overall Study||5||
48338579|NCT04436276|101156724|FG006|Dose 1|Overall Study||5||
48338580|NCT04436276|101156725|FG007|Dose 1|Overall Study||5||
48338581|NCT04436276|101156726|FG008|Dose 1|Overall Study||5||
48338582|NCT04436276|101156727|FG009|Dose 1|Overall Study||5||
48338583|NCT04436276|101156728|FG010|Dose 1|Overall Study||58||
48338584|NCT04436276|101156729|FG011|Dose 1|Overall Study||29||
48338585|NCT04436276|101156730|FG012|Dose 1|Overall Study||32||
48338586|NCT04436276|101156731|FG013|Dose 1|Overall Study||17||
48338587|NCT04436276|101156732|FG014|Dose 1|Overall Study||62||
48338588|NCT04436276|101156733|FG015|Dose 1|Overall Study||30||
48338589|NCT04436276|101156734|FG016|Dose 1|Overall Study||28||
48338590|NCT04436276|101156735|FG017|Dose 1|Overall Study||15||
48338591|NCT04436276|101156736|FG018|Dose 1|Overall Study||81||
48338592|NCT04436276|101156737|FG019|Dose 1|Overall Study||80||
48338593|NCT04436276|101156738|FG020|Dose 1|Overall Study||82||
48338594|NCT04436276|101156739|FG021|Dose 1|Overall Study||79||
48338595|NCT04436276|101156740|FG022|Dose 1|Overall Study||81||
48338596|NCT04436276|101156718|FG000|Dose 2|Overall Study||74||
48338597|NCT04436276|101156719|FG001|Dose 2|Overall Study||74||
48338598|NCT04436276|101156720|FG002|Dose 2|Overall Study||74||
48338599|NCT04436276|101156721|FG003|Dose 2|Overall Study||67||
48338600|NCT04436276|101156722|FG004|Dose 2|Overall Study||74||
48338601|NCT04436276|101156723|FG005|Dose 2|Overall Study||4||
48338602|NCT04436276|101156724|FG006|Dose 2|Overall Study||5||
48338603|NCT04436276|101156725|FG007|Dose 2|Overall Study||5||
48338604|NCT04436276|101156726|FG008|Dose 2|Overall Study||5||
48338605|NCT04436276|101156727|FG009|Dose 2|Overall Study||5||
48338606|NCT04436276|101156728|FG010|Dose 2|Overall Study||0||
48338607|NCT04436276|101156729|FG011|Dose 2|Overall Study||0||
48338608|NCT04436276|101156730|FG012|Dose 2|Overall Study||0||
48338609|NCT04436276|101156731|FG013|Dose 2|Overall Study||0||
48338610|NCT04436276|101156732|FG014|Dose 2|Overall Study||56||
48338611|NCT04436276|101156733|FG015|Dose 2|Overall Study||29||
48338612|NCT04436276|101156734|FG016|Dose 2|Overall Study||27||
48338613|NCT04436276|101156735|FG017|Dose 2|Overall Study||14||
48338614|NCT04436276|101156736|FG018|Dose 2|Overall Study||77||
48338615|NCT04436276|101156737|FG019|Dose 2|Overall Study||80||
48338616|NCT04436276|101156738|FG020|Dose 2|Overall Study||80||
48338617|NCT04436276|101156739|FG021|Dose 2|Overall Study||78||
48338618|NCT04436276|101156740|FG022|Dose 2|Overall Study||79||
48338619|NCT04436276|101156718|FG000|Ad Hoc Booster Dose|Overall Study||6||
48338620|NCT04436276|101156719|FG001|Ad Hoc Booster Dose|Overall Study||8||
48338621|NCT04436276|101156720|FG002|Ad Hoc Booster Dose|Overall Study||7||
48338622|NCT04436276|101156721|FG003|Ad Hoc Booster Dose|Overall Study||7||
48338623|NCT04436276|101156722|FG004|Ad Hoc Booster Dose|Overall Study||0||
48631688|NCT01547715|101881587|FG000|COMPLETED|Overall Study||60||
48631689|NCT01547715|101881588|FG001|COMPLETED|Overall Study||60||
48631690|NCT01547715|101881589|FG002|COMPLETED|Overall Study||60||
48631691|NCT01547715|101881587|FG000|NOT COMPLETED|Overall Study||0||
48631692|NCT01547715|101881588|FG001|NOT COMPLETED|Overall Study||0||
48631693|NCT01547715|101881589|FG002|NOT COMPLETED|Overall Study||0||
48338624|NCT04436276|101156723|FG005|Ad Hoc Booster Dose|Overall Study||1||
48338625|NCT04436276|101156724|FG006|Ad Hoc Booster Dose|Overall Study||2||
48338626|NCT04436276|101156725|FG007|Ad Hoc Booster Dose|Overall Study||2||
48338627|NCT04436276|101156726|FG008|Ad Hoc Booster Dose|Overall Study||0||
48338628|NCT04436276|101156727|FG009|Ad Hoc Booster Dose|Overall Study||0||
48338629|NCT04436276|101156728|FG010|Ad Hoc Booster Dose|Overall Study||4||
48631694|NCT01607658|101881590|FG000|STARTED|Overall Study||65||
48338630|NCT04436276|101156729|FG011|Ad Hoc Booster Dose|Overall Study||0||
48338631|NCT04436276|101156730|FG012|Ad Hoc Booster Dose|Overall Study||0||
48338632|NCT04436276|101156731|FG013|Ad Hoc Booster Dose|Overall Study||0||
48338633|NCT04436276|101156732|FG014|Ad Hoc Booster Dose|Overall Study||7||
48338634|NCT04436276|101156733|FG015|Ad Hoc Booster Dose|Overall Study||0||
48338635|NCT04436276|101156734|FG016|Ad Hoc Booster Dose|Overall Study||0||
48338636|NCT04436276|101156735|FG017|Ad Hoc Booster Dose|Overall Study||0||
48631695|NCT01607658|101881591|FG001|STARTED|Overall Study||67||
48338637|NCT04436276|101156736|FG018|Ad Hoc Booster Dose|Overall Study||11||
48338638|NCT04436276|101156737|FG019|Ad Hoc Booster Dose|Overall Study||15||
48338639|NCT04436276|101156738|FG020|Ad Hoc Booster Dose|Overall Study||14||
48338640|NCT04436276|101156739|FG021|Ad Hoc Booster Dose|Overall Study||9||
48338641|NCT04436276|101156740|FG022|Ad Hoc Booster Dose|Overall Study||0||
48338642|NCT04436276|101156718|FG000|Post Booster 1 Dose|Overall Study||0||
48338643|NCT04436276|101156719|FG001|Post Booster 1 Dose|Overall Study||0||
48338644|NCT04436276|101156720|FG002|Post Booster 1 Dose|Overall Study||0||
48338645|NCT04436276|101156721|FG003|Post Booster 1 Dose|Overall Study||0||
48338646|NCT04436276|101156722|FG004|Post Booster 1 Dose|Overall Study||0||
48338647|NCT04436276|101156723|FG005|Post Booster 1 Dose|Overall Study||0||
48338648|NCT04436276|101156724|FG006|Post Booster 1 Dose|Overall Study||0||
48338649|NCT04436276|101156725|FG007|Post Booster 1 Dose|Overall Study||0||
48338650|NCT04436276|101156726|FG008|Post Booster 1 Dose|Overall Study||0||
48338651|NCT04436276|101156727|FG009|Post Booster 1 Dose|Overall Study||0||
48338652|NCT04436276|101156728|FG010|Post Booster 1 Dose|Overall Study||42||
48338653|NCT04436276|101156729|FG011|Post Booster 1 Dose|Overall Study||19||
48338654|NCT04436276|101156730|FG012|Post Booster 1 Dose|Overall Study||20||
48338655|NCT04436276|101156731|FG013|Post Booster 1 Dose|Overall Study||1||
48338656|NCT04436276|101156732|FG014|Post Booster 1 Dose|Overall Study||45||
48338657|NCT04436276|101156733|FG015|Post Booster 1 Dose|Overall Study||21||
48338658|NCT04436276|101156734|FG016|Post Booster 1 Dose|Overall Study||20||
48338659|NCT04436276|101156735|FG017|Post Booster 1 Dose|Overall Study||0||
48338660|NCT04436276|101156736|FG018|Post Booster 1 Dose|Overall Study||0||
48338661|NCT04436276|101156737|FG019|Post Booster 1 Dose|Overall Study||0||
48338662|NCT04436276|101156738|FG020|Post Booster 1 Dose|Overall Study||0||
48338663|NCT04436276|101156739|FG021|Post Booster 1 Dose|Overall Study||0||
48338664|NCT04436276|101156740|FG022|Post Booster 1 Dose|Overall Study||0||
48338665|NCT04436276|101156718|FG000|Post Booster 2 Dose|Overall Study||0||
48338666|NCT04436276|101156719|FG001|Post Booster 2 Dose|Overall Study||0||
48338667|NCT04436276|101156720|FG002|Post Booster 2 Dose|Overall Study||0||
48338668|NCT04436276|101156721|FG003|Post Booster 2 Dose|Overall Study||0||
48338669|NCT04436276|101156722|FG004|Post Booster 2 Dose|Overall Study||0||
48338670|NCT04436276|101156723|FG005|Post Booster 2 Dose|Overall Study||0||
48338671|NCT04436276|101156724|FG006|Post Booster 2 Dose|Overall Study||0||
48338672|NCT04436276|101156725|FG007|Post Booster 2 Dose|Overall Study||0||
48338673|NCT04436276|101156726|FG008|Post Booster 2 Dose|Overall Study||0||
48338674|NCT04436276|101156727|FG009|Post Booster 2 Dose|Overall Study||0||
48338675|NCT04436276|101156728|FG010|Post Booster 2 Dose|Overall Study||19||
48338676|NCT04436276|101156729|FG011|Post Booster 2 Dose|Overall Study||13||
48338677|NCT04436276|101156730|FG012|Post Booster 2 Dose|Overall Study||10||
48338678|NCT04436276|101156731|FG013|Post Booster 2 Dose|Overall Study||0||
48338679|NCT04436276|101156732|FG014|Post Booster 2 Dose|Overall Study||8||
48338680|NCT04436276|101156733|FG015|Post Booster 2 Dose|Overall Study||3||
48338681|NCT04436276|101156734|FG016|Post Booster 2 Dose|Overall Study||5||
48338682|NCT04436276|101156735|FG017|Post Booster 2 Dose|Overall Study||0||
48338683|NCT04436276|101156736|FG018|Post Booster 2 Dose|Overall Study||0||
48338684|NCT04436276|101156737|FG019|Post Booster 2 Dose|Overall Study||0||
48338685|NCT04436276|101156738|FG020|Post Booster 2 Dose|Overall Study||0||
48338686|NCT04436276|101156739|FG021|Post Booster 2 Dose|Overall Study||0||
48338687|NCT04436276|101156740|FG022|Post Booster 2 Dose|Overall Study||0||
48338688|NCT04436276|101156718|FG000|COMPLETED|Overall Study||48||
48338689|NCT04436276|101156719|FG001|COMPLETED|Overall Study||49||
48338690|NCT04436276|101156720|FG002|COMPLETED|Overall Study||42||
48338691|NCT04436276|101156721|FG003|COMPLETED|Overall Study||39||
48338692|NCT04436276|101156722|FG004|COMPLETED|Overall Study||36||
48338693|NCT04436276|101156723|FG005|COMPLETED|Overall Study||3||
48338694|NCT04436276|101156724|FG006|COMPLETED|Overall Study||5||
48338695|NCT04436276|101156725|FG007|COMPLETED|Overall Study||4||
48338696|NCT04436276|101156726|FG008|COMPLETED|Overall Study||4||
48338697|NCT04436276|101156727|FG009|COMPLETED|Overall Study||4||
48338698|NCT04436276|101156728|FG010|COMPLETED|Overall Study||33||
48338699|NCT04436276|101156729|FG011|COMPLETED|Overall Study||15||
48338700|NCT04436276|101156730|FG012|COMPLETED|Overall Study||14||
48338701|NCT04436276|101156731|FG013|COMPLETED|Overall Study||7||
48338702|NCT04436276|101156732|FG014|COMPLETED|Overall Study||31||
48338703|NCT04436276|101156733|FG015|COMPLETED|Overall Study||16||
48338704|NCT04436276|101156734|FG016|COMPLETED|Overall Study||15||
48338705|NCT04436276|101156735|FG017|COMPLETED|Overall Study||5||
48338706|NCT04436276|101156736|FG018|COMPLETED|Overall Study||65||
48338707|NCT04436276|101156737|FG019|COMPLETED|Overall Study||53||
48338708|NCT04436276|101156738|FG020|COMPLETED|Overall Study||53||
48338709|NCT04436276|101156739|FG021|COMPLETED|Overall Study||57||
48338710|NCT04436276|101156740|FG022|COMPLETED|Overall Study||6||
48338711|NCT04436276|101156718|FG000|NOT COMPLETED|Overall Study||29||
48338712|NCT04436276|101156719|FG001|NOT COMPLETED|Overall Study||26||
48338713|NCT04436276|101156720|FG002|NOT COMPLETED|Overall Study||33||
48338714|NCT04436276|101156721|FG003|NOT COMPLETED|Overall Study||34||
48338715|NCT04436276|101156722|FG004|NOT COMPLETED|Overall Study||41||
48338716|NCT04436276|101156723|FG005|NOT COMPLETED|Overall Study||2||
48338717|NCT04436276|101156724|FG006|NOT COMPLETED|Overall Study||0||
48338718|NCT04436276|101156725|FG007|NOT COMPLETED|Overall Study||1||
48338719|NCT04436276|101156726|FG008|NOT COMPLETED|Overall Study||1||
48338720|NCT04436276|101156727|FG009|NOT COMPLETED|Overall Study||1||
48338721|NCT04436276|101156728|FG010|NOT COMPLETED|Overall Study||25||
48338722|NCT04436276|101156729|FG011|NOT COMPLETED|Overall Study||14||
48338723|NCT04436276|101156730|FG012|NOT COMPLETED|Overall Study||18||
48338724|NCT04436276|101156731|FG013|NOT COMPLETED|Overall Study||10||
48338725|NCT04436276|101156732|FG014|NOT COMPLETED|Overall Study||31||
48338726|NCT04436276|101156733|FG015|NOT COMPLETED|Overall Study||14||
48338727|NCT04436276|101156734|FG016|NOT COMPLETED|Overall Study||13||
48338728|NCT04436276|101156735|FG017|NOT COMPLETED|Overall Study||10||
48338729|NCT04436276|101156736|FG018|NOT COMPLETED|Overall Study||16||
48338730|NCT04436276|101156737|FG019|NOT COMPLETED|Overall Study||27||
48338731|NCT04436276|101156738|FG020|NOT COMPLETED|Overall Study||29||
48338732|NCT04436276|101156739|FG021|NOT COMPLETED|Overall Study||22||
48338733|NCT04436276|101156740|FG022|NOT COMPLETED|Overall Study||75||
48338734|NCT00622895|101156741|FG000|STARTED|Overall Study||3||
48338735|NCT00622895|101156741|FG000|COMPLETED|Overall Study||3||
48338736|NCT00622895|101156741|FG000|NOT COMPLETED|Overall Study||0||
48338737|NCT00792298|101156742|FG000|STARTED|Treatment Period 1||31||
48338738|NCT00792298|101156743|FG001|STARTED|Treatment Period 1||32||
48338739|NCT00792298|101156744|FG002|STARTED|Treatment Period 1||33||
48338740|NCT00792298|101156745|FG003|STARTED|Treatment Period 1||32||
48338741|NCT00792298|101156746|FG004|STARTED|Treatment Period 1||32||
48338742|NCT00792298|101156747|FG005|STARTED|Treatment Period 1||32||
48338743|NCT00792298|101156748|FG006|STARTED|Treatment Period 1||31||
48338744|NCT00792298|101156749|FG007|STARTED|Treatment Period 1||31||
48338745|NCT00792298|101156742|FG000|COMPLETED|Treatment Period 1||30||
48338746|NCT00792298|101156743|FG001|COMPLETED|Treatment Period 1||31||
48338747|NCT00792298|101156744|FG002|COMPLETED|Treatment Period 1||31||
48338748|NCT00792298|101156745|FG003|COMPLETED|Treatment Period 1||28||
48338749|NCT00792298|101156746|FG004|COMPLETED|Treatment Period 1||32||
48338750|NCT00792298|101156747|FG005|COMPLETED|Treatment Period 1||29||
48338751|NCT00792298|101156748|FG006|COMPLETED|Treatment Period 1||27||
48338752|NCT00792298|101156749|FG007|COMPLETED|Treatment Period 1||30||
48338753|NCT00792298|101156742|FG000|NOT COMPLETED|Treatment Period 1||1||
48338754|NCT00792298|101156743|FG001|NOT COMPLETED|Treatment Period 1||1||
48338755|NCT00792298|101156744|FG002|NOT COMPLETED|Treatment Period 1||2||
48338756|NCT00792298|101156745|FG003|NOT COMPLETED|Treatment Period 1||4||
48338757|NCT00792298|101156746|FG004|NOT COMPLETED|Treatment Period 1||0||
48338758|NCT00792298|101156747|FG005|NOT COMPLETED|Treatment Period 1||3||
48338759|NCT00792298|101156748|FG006|NOT COMPLETED|Treatment Period 1||4||
48338760|NCT00792298|101156749|FG007|NOT COMPLETED|Treatment Period 1||1||
48338761|NCT00792298|101156742|FG000|STARTED|Washout||30||
48338762|NCT00792298|101156743|FG001|STARTED|Washout||31||
48338763|NCT00792298|101156744|FG002|STARTED|Washout||32||
48338764|NCT00792298|101156745|FG003|STARTED|Washout||28||
48338765|NCT00792298|101156746|FG004|STARTED|Washout||32||
48338766|NCT00792298|101156747|FG005|STARTED|Washout||29||
48338767|NCT00792298|101156748|FG006|STARTED|Washout||29||
48338768|NCT00792298|101156749|FG007|STARTED|Washout||30||
48338769|NCT00792298|101156742|FG000|COMPLETED|Washout||30||
48338770|NCT00792298|101156743|FG001|COMPLETED|Washout||31||
48338771|NCT00792298|101156744|FG002|COMPLETED|Washout||31||
48338772|NCT00792298|101156745|FG003|COMPLETED|Washout||28||
48338773|NCT00792298|101156746|FG004|COMPLETED|Washout||32||
48338774|NCT00792298|101156747|FG005|COMPLETED|Washout||27||
48338775|NCT00792298|101156748|FG006|COMPLETED|Washout||29||
48338776|NCT00792298|101156749|FG007|COMPLETED|Washout||30||
48338777|NCT00792298|101156742|FG000|NOT COMPLETED|Washout||0||
48338778|NCT00792298|101156743|FG001|NOT COMPLETED|Washout||0||
48338779|NCT00792298|101156744|FG002|NOT COMPLETED|Washout||1||
48338780|NCT00792298|101156745|FG003|NOT COMPLETED|Washout||0||
48338781|NCT00792298|101156746|FG004|NOT COMPLETED|Washout||0||
48338782|NCT00792298|101156747|FG005|NOT COMPLETED|Washout||2||
48338783|NCT00792298|101156748|FG006|NOT COMPLETED|Washout||0||
48338784|NCT00792298|101156749|FG007|NOT COMPLETED|Washout||0||
48338785|NCT00792298|101156742|FG000|STARTED|Treatment Period 2||30||
48338786|NCT00792298|101156743|FG001|STARTED|Treatment Period 2||31||
48338787|NCT00792298|101156744|FG002|STARTED|Treatment Period 2||31||
48338788|NCT00792298|101156745|FG003|STARTED|Treatment Period 2||28||
48338789|NCT00792298|101156746|FG004|STARTED|Treatment Period 2||32||
48338790|NCT00792298|101156747|FG005|STARTED|Treatment Period 2||27||
48338791|NCT00792298|101156748|FG006|STARTED|Treatment Period 2||29||
48338792|NCT00792298|101156749|FG007|STARTED|Treatment Period 2||30||
48338793|NCT00792298|101156742|FG000|COMPLETED|Treatment Period 2||29||
48338794|NCT00792298|101156743|FG001|COMPLETED|Treatment Period 2||30||
48338795|NCT00792298|101156744|FG002|COMPLETED|Treatment Period 2||30||
48338796|NCT00792298|101156745|FG003|COMPLETED|Treatment Period 2||26||
48338797|NCT00792298|101156746|FG004|COMPLETED|Treatment Period 2||30||
48338798|NCT00792298|101156747|FG005|COMPLETED|Treatment Period 2||27||
48338799|NCT00792298|101156748|FG006|COMPLETED|Treatment Period 2||28||
48338800|NCT00792298|101156749|FG007|COMPLETED|Treatment Period 2||28||
48338801|NCT00792298|101156742|FG000|NOT COMPLETED|Treatment Period 2||1||
48338802|NCT00792298|101156743|FG001|NOT COMPLETED|Treatment Period 2||1||
48338803|NCT00792298|101156744|FG002|NOT COMPLETED|Treatment Period 2||1||
48338804|NCT00792298|101156745|FG003|NOT COMPLETED|Treatment Period 2||2||
48338805|NCT00792298|101156746|FG004|NOT COMPLETED|Treatment Period 2||2||
48338806|NCT00792298|101156747|FG005|NOT COMPLETED|Treatment Period 2||0||
48338807|NCT00792298|101156748|FG006|NOT COMPLETED|Treatment Period 2||1||
48413298|NCT01693562|101345801|FG014|STARTED|Expansion Phase||40||
48631696|NCT01607658|101881592|FG002|STARTED|Overall Study||58||
48631697|NCT01607658|101881593|FG003|STARTED|Overall Study||63||
48631698|NCT01607658|101881590|FG000|COMPLETED|Overall Study||56||
48631699|NCT01607658|101881591|FG001|COMPLETED|Overall Study||56||
48631700|NCT01607658|101881592|FG002|COMPLETED|Overall Study||47||
48631701|NCT01607658|101881593|FG003|COMPLETED|Overall Study||52||
48631702|NCT01607658|101881590|FG000|NOT COMPLETED|Overall Study||9||
48631703|NCT01607658|101881591|FG001|NOT COMPLETED|Overall Study||11||
48631704|NCT01607658|101881592|FG002|NOT COMPLETED|Overall Study||11||
48631705|NCT01607658|101881593|FG003|NOT COMPLETED|Overall Study||11||
48338808|NCT00792298|101156749|FG007|NOT COMPLETED|Treatment Period 2||2||
48338809|NCT03057366|101156750|FG000|STARTED|Part A||8||
48338810|NCT03057366|101156751|FG001|STARTED|Part A||0||
48338811|NCT03057366|101156752|FG002|STARTED|Part A||0||
48338812|NCT03057366|101156750|FG000|COMPLETED|Part A||8||
48338813|NCT03057366|101156751|FG001|COMPLETED|Part A||0||
48631706|NCT00781950|101881594|FG000|STARTED|Overall Study||52||
48631707|NCT00781950|101881595|FG001|STARTED|Overall Study||58||
48631708|NCT00781950|101881594|FG000|COMPLETED|Overall Study||41||
48631709|NCT00781950|101881595|FG001|COMPLETED|Overall Study||45||
48338814|NCT03057366|101156752|FG002|COMPLETED|Part A||0||
48338815|NCT03057366|101156750|FG000|NOT COMPLETED|Part A||0||
48338816|NCT03057366|101156751|FG001|NOT COMPLETED|Part A||0||
48413299|NCT01693562|101345802|FG015|STARTED|Expansion Phase||31||
48413300|NCT01693562|101345803|FG016|STARTED|Expansion Phase||201||
48413301|NCT01693562|101345804|FG017|STARTED|Expansion Phase||20||
48413302|NCT01693562|101345805|FG018|STARTED|Expansion Phase||47||
48413303|NCT01693562|101345806|FG019|STARTED|Expansion Phase||20||
48631710|NCT00781950|101881594|FG000|NOT COMPLETED|Overall Study||11||
48413304|NCT01693562|101345807|FG020|STARTED|Expansion Phase||21||
48413305|NCT01693562|101345808|FG021|STARTED|Expansion Phase||62||
48413306|NCT01693562|101345809|FG022|STARTED|Expansion Phase||10||
48413307|NCT01693562|101345787|FG000|COMPLETED|Expansion Phase||0||
48413308|NCT01693562|101345788|FG001|COMPLETED|Expansion Phase||0||
48754221|NCT00591006|102187663|FG012|Treatment #4|Overall Study||1||
48754222|NCT00591006|102187664|FG013|Treatment #4|Overall Study||2||
48754223|NCT00591006|102187665|FG014|Treatment #4|Overall Study||0||
48754224|NCT00591006|102187666|FG015|Treatment #4|Overall Study||0||
48754225|NCT00591006|102187667|FG016|Treatment #4|Overall Study||0||
48754226|NCT00591006|102187668|FG017|Treatment #4|Overall Study||1||
48754227|NCT00591006|102187669|FG018|Treatment #4|Overall Study||0||
48754228|NCT00591006|102187670|FG019|Treatment #4|Overall Study||1||
48413309|NCT01693562|101345789|FG002|COMPLETED|Expansion Phase||0||
48413310|NCT01693562|101345790|FG003|COMPLETED|Expansion Phase||0||
48413311|NCT01693562|101345791|FG004|COMPLETED|Expansion Phase||0||
48413312|NCT01693562|101345792|FG005|COMPLETED|Expansion Phase||0||
48413313|NCT01693562|101345793|FG006|COMPLETED|Expansion Phase||0||
48413314|NCT01693562|101345794|FG007|COMPLETED|Expansion Phase||0||
48413315|NCT01693562|101345795|FG008|COMPLETED|Expansion Phase||0||
48413316|NCT01693562|101345796|FG009|COMPLETED|Expansion Phase||4||
48413317|NCT01693562|101345797|FG010|COMPLETED|Expansion Phase||0||
48754229|NCT00591006|102187671|FG020|Treatment #4|Overall Study||0||
48178050|NCT03230864|100757763|FG003|STARTED|Double Blind Treatment (DBT) Period||33||
48178051|NCT03230864|100757760|FG000|COMPLETED|Double Blind Treatment (DBT) Period||0||
48631711|NCT00781950|101881595|FG001|NOT COMPLETED|Overall Study||13||
48631712|NCT00551369|101881596|FG000|STARTED|Overall Study||33||
48631713|NCT00551369|101881596|FG000|COMPLETED|Overall Study||26||
48631714|NCT00551369|101881596|FG000|NOT COMPLETED|Overall Study||7||
48338817|NCT03057366|101156752|FG002|NOT COMPLETED|Part A||0||
48338818|NCT03057366|101156750|FG000|STARTED|Part B||0||
48338819|NCT03057366|101156751|FG001|STARTED|Part B||5||
48338820|NCT03057366|101156752|FG002|STARTED|Part B||2||
48338821|NCT03057366|101156750|FG000|COMPLETED|Part B||0||
48338822|NCT03057366|101156751|FG001|COMPLETED|Part B||5||
48338823|NCT03057366|101156752|FG002|COMPLETED|Part B||2||
48338824|NCT03057366|101156750|FG000|NOT COMPLETED|Part B||0||
48338825|NCT03057366|101156751|FG001|NOT COMPLETED|Part B||0||
48338826|NCT03057366|101156752|FG002|NOT COMPLETED|Part B||0||
48338827|NCT02385279|101156753|FG000|STARTED|Overall Study||703||
48338828|NCT02385279|101156754|FG001|STARTED|Overall Study||695||
48338829|NCT02385279|101156753|FG000|COMPLETED|Overall Study||676||
48338830|NCT02385279|101156754|FG001|COMPLETED|Overall Study||677||
48338831|NCT02385279|101156753|FG000|NOT COMPLETED|Overall Study||27||
48338832|NCT02385279|101156754|FG001|NOT COMPLETED|Overall Study||18||
48338833|NCT02770521|101159909|FG000|STARTED|Period One||4||
48338834|NCT02770521|101159910|FG001|STARTED|Period One||4||
48338835|NCT02770521|101159911|FG002|STARTED|Period One||2||
48338836|NCT02770521|101159912|FG003|STARTED|Period One||2||
48338837|NCT02770521|101159913|FG004|STARTED|Period One||2||
48338838|NCT02770521|101159914|FG005|STARTED|Period One||9||
48338839|NCT02770521|101159909|FG000|Received Study Drug|Period One||4||
48338840|NCT02770521|101159910|FG001|Received Study Drug|Period One||4||
48338841|NCT02770521|101159911|FG002|Received Study Drug|Period One||2||
48338842|NCT02770521|101159912|FG003|Received Study Drug|Period One||2||
48338843|NCT02770521|101159913|FG004|Received Study Drug|Period One||2||
48338844|NCT02770521|101159914|FG005|Received Study Drug|Period One||9||
48338845|NCT02770521|101159909|FG000|COMPLETED|Period One||4||
48338846|NCT02770521|101159910|FG001|COMPLETED|Period One||4||
48338847|NCT02770521|101159911|FG002|COMPLETED|Period One||2||
48631715|NCT00957359|101881597|FG000|STARTED|Overall Study||14||
48631716|NCT00957359|101881598|FG001|STARTED|Overall Study||15||
48631717|NCT00957359|101881597|FG000|COMPLETED|Overall Study||14||
48338848|NCT02770521|101159912|FG003|COMPLETED|Period One||2||
48338849|NCT02770521|101159913|FG004|COMPLETED|Period One||2||
48631718|NCT00957359|101881598|FG001|COMPLETED|Overall Study||15||
48338850|NCT02770521|101159914|FG005|COMPLETED|Period One||9||
48338851|NCT02770521|101159909|FG000|NOT COMPLETED|Period One||0||
48338852|NCT02770521|101159910|FG001|NOT COMPLETED|Period One||0||
48631719|NCT00957359|101881597|FG000|NOT COMPLETED|Overall Study||0||
48631720|NCT00957359|101881598|FG001|NOT COMPLETED|Overall Study||0||
48631721|NCT00976339|101881599|FG000|STARTED|Overall Study||10||
48631722|NCT00976339|101881600|FG001|STARTED|Overall Study||10||
48631723|NCT00976339|101881599|FG000|COMPLETED|Overall Study||10||
48631724|NCT00976339|101881600|FG001|COMPLETED|Overall Study||10||
48631725|NCT00976339|101881599|FG000|NOT COMPLETED|Overall Study||0||
48631726|NCT00976339|101881600|FG001|NOT COMPLETED|Overall Study||0||
48631727|NCT01052948|101881601|FG000|STARTED|Overall Study||27812||
48338853|NCT02770521|101159911|FG002|NOT COMPLETED|Period One||0||
48338854|NCT02770521|101159912|FG003|NOT COMPLETED|Period One||0||
48338855|NCT02770521|101159913|FG004|NOT COMPLETED|Period One||0||
48338856|NCT02770521|101159914|FG005|NOT COMPLETED|Period One||0||
48338857|NCT02770521|101159909|FG000|STARTED|Period Two||4||
48338858|NCT02770521|101159910|FG001|STARTED|Period Two||4||
48338859|NCT02770521|101159911|FG002|STARTED|Period Two||2||
48338860|NCT02770521|101159912|FG003|STARTED|Period Two||2||
48338861|NCT02770521|101159913|FG004|STARTED|Period Two||2||
48413318|NCT01693562|101345798|FG011|COMPLETED|Expansion Phase||0||
48631728|NCT01052948|101881602|FG001|STARTED|Overall Study||14669||
48631729|NCT01052948|101881603|FG002|STARTED|Overall Study||15147||
48631730|NCT01052948|101881604|FG003|STARTED|Overall Study||29311||
48631731|NCT01052948|101881601|FG000|COMPLETED|Overall Study||27812||
48631732|NCT01052948|101881602|FG001|COMPLETED|Overall Study||14669||
48631733|NCT01052948|101881603|FG002|COMPLETED|Overall Study||15147||
48631734|NCT01052948|101881604|FG003|COMPLETED|Overall Study||29311||
48338862|NCT02770521|101159914|FG005|STARTED|Period Two||9||
48338863|NCT02770521|101159909|FG000|Received Study Drug|Period Two||4||
48338864|NCT02770521|101159910|FG001|Received Study Drug|Period Two||4||
48338865|NCT02770521|101159911|FG002|Received Study Drug|Period Two||2||
48338866|NCT02770521|101159912|FG003|Received Study Drug|Period Two||2||
48338867|NCT02770521|101159913|FG004|Received Study Drug|Period Two||2||
48338868|NCT02770521|101159914|FG005|Received Study Drug|Period Two||9||
48338869|NCT02770521|101159909|FG000|COMPLETED|Period Two||4||
48631735|NCT01052948|101881601|FG000|NOT COMPLETED|Overall Study||0||
48631736|NCT01052948|101881602|FG001|NOT COMPLETED|Overall Study||0||
48631737|NCT01052948|101881603|FG002|NOT COMPLETED|Overall Study||0||
48631738|NCT01052948|101881604|FG003|NOT COMPLETED|Overall Study||0||
48631739|NCT01977846|101881605|FG000|STARTED|Total Study - Retrospective||251||
48631740|NCT01977846|101881606|FG001|STARTED|Total Study - Retrospective||0||
48631741|NCT01977846|101881605|FG000|COMPLETED|Total Study - Retrospective||251||
48631742|NCT01977846|101881606|FG001|COMPLETED|Total Study - Retrospective||0||
48631743|NCT01977846|101881605|FG000|NOT COMPLETED|Total Study - Retrospective||0||
48631744|NCT01977846|101881606|FG001|NOT COMPLETED|Total Study - Retrospective||0||
48631745|NCT01977846|101881605|FG000|STARTED|Total Study - Prospective||0||
48631746|NCT01977846|101881606|FG001|STARTED|Total Study - Prospective||259||
48631747|NCT01977846|101881605|FG000|COMPLETED|Total Study - Prospective||0||
48631748|NCT01977846|101881606|FG001|COMPLETED|Total Study - Prospective||230||
48631749|NCT01977846|101881605|FG000|NOT COMPLETED|Total Study - Prospective||0||
48631750|NCT01977846|101881606|FG001|NOT COMPLETED|Total Study - Prospective||29||
48178052|NCT03230864|100757761|FG001|COMPLETED|Double Blind Treatment (DBT) Period||0||
48178053|NCT03230864|100757762|FG002|COMPLETED|Double Blind Treatment (DBT) Period||27||
48178054|NCT03230864|100757763|FG003|COMPLETED|Double Blind Treatment (DBT) Period||31||
48178055|NCT03230864|100757760|FG000|NOT COMPLETED|Double Blind Treatment (DBT) Period||0||
48178056|NCT03230864|100757761|FG001|NOT COMPLETED|Double Blind Treatment (DBT) Period||0||
48178057|NCT03230864|100757762|FG002|NOT COMPLETED|Double Blind Treatment (DBT) Period||8||
48754230|NCT00591006|102187672|FG021|Treatment #4|Overall Study||1||
48754231|NCT00591006|102187673|FG022|Treatment #4|Overall Study||0||
48754232|NCT00591006|102187674|FG023|Treatment #4|Overall Study||0||
48754233|NCT00591006|102187651|FG000|COMPLETED|Overall Study||1||
48754234|NCT00591006|102187652|FG001|COMPLETED|Overall Study||0||
48754235|NCT00591006|102187653|FG002|COMPLETED|Overall Study||1||
48178058|NCT03230864|100757763|FG003|NOT COMPLETED|Double Blind Treatment (DBT) Period||2||
48178059|NCT02269943|100757764|FG000|STARTED|Treatment Period||6||
48178060|NCT02269943|100757765|FG001|STARTED|Treatment Period||30||
48178061|NCT02269943|100757764|FG000|Investigational Product (IP) Stopped|Treatment Period||6|IP stopped due to disease progression, consent withdrawal, AE, discontinued at physician's decision|
48178062|NCT02269943|100757765|FG001|Investigational Product (IP) Stopped|Treatment Period||30|IP stopped due to disease progression, consent withdrawal, AE, discontinued at physician's decision|
48178063|NCT02269943|100757764|FG000|COMPLETED|Treatment Period||0||
48178064|NCT02269943|100757765|FG001|COMPLETED|Treatment Period||0||
48178065|NCT02269943|100757764|FG000|NOT COMPLETED|Treatment Period||6||
48178066|NCT02269943|100757765|FG001|NOT COMPLETED|Treatment Period||30||
48178067|NCT02269943|100757764|FG000|STARTED|Follow-Up Survival Period||5||
48178068|NCT02269943|100757765|FG001|STARTED|Follow-Up Survival Period||26||
48178069|NCT02269943|100757764|FG000|COMPLETED|Follow-Up Survival Period||0||
48178070|NCT02269943|100757765|FG001|COMPLETED|Follow-Up Survival Period||0||
48178071|NCT02269943|100757764|FG000|NOT COMPLETED|Follow-Up Survival Period||5||
48178072|NCT02269943|100757765|FG001|NOT COMPLETED|Follow-Up Survival Period||26||
48178073|NCT01378520|100757766|FG000|STARTED|First Intervention (Day 2-3)||10||
48178074|NCT01378520|100757767|FG001|STARTED|First Intervention (Day 2-3)||10||
48178075|NCT01378520|100757766|FG000|COMPLETED|First Intervention (Day 2-3)||10||
48178076|NCT01378520|100757767|FG001|COMPLETED|First Intervention (Day 2-3)||10||
48178077|NCT01378520|100757766|FG000|NOT COMPLETED|First Intervention (Day 2-3)||0||
48178078|NCT01378520|100757767|FG001|NOT COMPLETED|First Intervention (Day 2-3)||0||
48178079|NCT01378520|100757766|FG000|STARTED|Second Intervention (Day 4-6)||10||
48178080|NCT01378520|100757767|FG001|STARTED|Second Intervention (Day 4-6)||10||
48178081|NCT01378520|100757766|FG000|COMPLETED|Second Intervention (Day 4-6)||10||
48178082|NCT01378520|100757767|FG001|COMPLETED|Second Intervention (Day 4-6)||10||
48178083|NCT01378520|100757766|FG000|NOT COMPLETED|Second Intervention (Day 4-6)||0||
48178084|NCT01378520|100757767|FG001|NOT COMPLETED|Second Intervention (Day 4-6)||0||
48178085|NCT00289770|100757768|FG000|STARTED|Year 11||37||
48631751|NCT00106002|101881607|FG000|STARTED|Overall Study||37||
48178086|NCT00289770|100757768|FG000|COMPLETED|Year 11||37||
48178087|NCT00289770|100757768|FG000|NOT COMPLETED|Year 11||0||
48178088|NCT00289770|100757768|FG000|STARTED|Year 12||40||
48178089|NCT00289770|100757768|FG000|COMPLETED|Year 12||40||
48178090|NCT00289770|100757768|FG000|NOT COMPLETED|Year 12||0||
48338870|NCT02770521|101159910|FG001|COMPLETED|Period Two||4||
48631752|NCT00106002|101881607|FG000|COMPLETED|Overall Study||35||
48178091|NCT00289770|100757768|FG000|STARTED|Year 13||37||
48178092|NCT00289770|100757768|FG000|COMPLETED|Year 13||37||
48338871|NCT02770521|101159911|FG002|COMPLETED|Period Two||2||
48631753|NCT00106002|101881607|FG000|NOT COMPLETED|Overall Study||2||
48631754|NCT01162343|101881608|FG000|STARTED|Overall Study||498||
48754236|NCT00591006|102187654|FG003|COMPLETED|Overall Study||1||
48178093|NCT00289770|100757768|FG000|NOT COMPLETED|Year 13||0||
48178094|NCT00289770|100757768|FG000|STARTED|Year 14||43||
48631755|NCT01162343|101881608|FG000|COMPLETED|Overall Study||406||
48631756|NCT01162343|101881608|FG000|NOT COMPLETED|Overall Study||92||
48631757|NCT04018066|101881609|FG000|STARTED|Overall Study||34||
48754237|NCT00591006|102187655|FG004|COMPLETED|Overall Study||1||
48754238|NCT00591006|102187656|FG005|COMPLETED|Overall Study||0||
48754239|NCT00591006|102187657|FG006|COMPLETED|Overall Study||1||
48631758|NCT04018066|101881609|FG000|COMPLETED|Overall Study||30||
48631759|NCT04018066|101881609|FG000|NOT COMPLETED|Overall Study||4||
48631760|NCT03279458|101881610|FG000|STARTED|Overall Study||40||
48631761|NCT03279458|101881610|FG000|COMPLETED|Overall Study||40|The milestone was met if the participant was able to complete the breathing exercise.|
48631762|NCT03279458|101881610|FG000|NOT COMPLETED|Overall Study||0||
48631763|NCT03409744|101881611|FG000|STARTED|Overall Study||116||
48631764|NCT03409744|101881611|FG000|COMPLETED|Overall Study||106||
48631765|NCT03409744|101881611|FG000|NOT COMPLETED|Overall Study||10||
48631766|NCT01036802|101881612|FG000|STARTED|Overall Study||2||
48631767|NCT01036802|101881613|FG001|STARTED|Overall Study||1||
48631768|NCT01036802|101881612|FG000|COMPLETED|Overall Study||2||
48631769|NCT01036802|101881613|FG001|COMPLETED|Overall Study||1||
48631770|NCT01036802|101881612|FG000|NOT COMPLETED|Overall Study||0||
48631771|NCT01036802|101881613|FG001|NOT COMPLETED|Overall Study||0||
48631772|NCT03250273|101881614|FG000|STARTED|Overall Study||13||
48631773|NCT03250273|101881615|FG001|STARTED|Overall Study||30||
48631774|NCT03250273|101881614|FG000|COMPLETED|Overall Study||11||
48631775|NCT03250273|101881615|FG001|COMPLETED|Overall Study||18||
48631776|NCT03250273|101881614|FG000|NOT COMPLETED|Overall Study||2||
48631777|NCT03250273|101881615|FG001|NOT COMPLETED|Overall Study||12||
48631778|NCT02737358|101881616|FG000|STARTED|Overall Study||55||
48631779|NCT02737358|101881617|FG001|STARTED|Overall Study||59||
48631780|NCT02737358|101881616|FG000|COMPLETED|Overall Study||46||
48631781|NCT02737358|101881617|FG001|COMPLETED|Overall Study||44||
48631782|NCT02737358|101881616|FG000|NOT COMPLETED|Overall Study||9||
48631783|NCT02737358|101881617|FG001|NOT COMPLETED|Overall Study||15||
48631784|NCT05412134|101881618|FG000|STARTED|Overall Study||14||
48631785|NCT05412134|101881619|FG001|STARTED|Overall Study||13||
48631786|NCT05412134|101881618|FG000|COMPLETED|Overall Study||12||
48631787|NCT05412134|101881619|FG001|COMPLETED|Overall Study||13||
48631788|NCT05412134|101881618|FG000|NOT COMPLETED|Overall Study||2||
48631789|NCT05412134|101881619|FG001|NOT COMPLETED|Overall Study||0||
48631790|NCT03072186|101881620|FG000|STARTED|Overall Study||23||
48631791|NCT03072186|101881620|FG000|COMPLETED|Overall Study||17||
48631792|NCT03072186|101881620|FG000|NOT COMPLETED|Overall Study||6||
48631793|NCT03817528|101881621|FG000|STARTED|Overall Study||4||
48631794|NCT03817528|101881621|FG000|COMPLETED|Overall Study||1||
48631795|NCT03817528|101881621|FG000|NOT COMPLETED|Overall Study||3||
48631796|NCT01451372|101881622|FG000|STARTED|Overall Study||69||
48631797|NCT01451372|101881622|FG000|COMPLETED|Overall Study||69||
48631798|NCT01451372|101881622|FG000|NOT COMPLETED|Overall Study||0||
48631799|NCT02020941|101881623|FG000|STARTED|Overall Study||10||
48631800|NCT02020941|101881623|FG000|COMPLETED|Overall Study||2||
48631801|NCT02020941|101881623|FG000|NOT COMPLETED|Overall Study||8||
48631802|NCT02439164|101881624|FG000|STARTED|Overall Study||18||
48631803|NCT02439164|101881625|FG001|STARTED|Overall Study||18||
48631804|NCT02439164|101881624|FG000|COMPLETED|Overall Study||18||
48631805|NCT02439164|101881625|FG001|COMPLETED|Overall Study||18||
48631806|NCT02439164|101881624|FG000|NOT COMPLETED|Overall Study||0||
48631807|NCT02439164|101881625|FG001|NOT COMPLETED|Overall Study||0||
48631808|NCT02787499|101881626|FG000|STARTED|Overall Study||423||
48631809|NCT02787499|101881627|FG001|STARTED|Overall Study||417||
48631810|NCT02787499|101881626|FG000|COMPLETED|Overall Study||423||
48631811|NCT02787499|101881627|FG001|COMPLETED|Overall Study||417||
48754240|NCT00591006|102187658|FG007|COMPLETED|Overall Study||0||
48754241|NCT00591006|102187659|FG008|COMPLETED|Overall Study||1||
48754242|NCT00591006|102187660|FG009|COMPLETED|Overall Study||1||
48754243|NCT00591006|102187661|FG010|COMPLETED|Overall Study||0||
48754244|NCT00591006|102187662|FG011|COMPLETED|Overall Study||1||
48754245|NCT00591006|102187663|FG012|COMPLETED|Overall Study||1||
48754246|NCT00591006|102187664|FG013|COMPLETED|Overall Study||2||
48754247|NCT00591006|102187665|FG014|COMPLETED|Overall Study||0||
48754248|NCT00591006|102187666|FG015|COMPLETED|Overall Study||0||
48754249|NCT00591006|102187667|FG016|COMPLETED|Overall Study||0||
48754250|NCT00591006|102187668|FG017|COMPLETED|Overall Study||1||
48631812|NCT02787499|101881626|FG000|NOT COMPLETED|Overall Study||0||
48631813|NCT02787499|101881627|FG001|NOT COMPLETED|Overall Study||0||
48631814|NCT04596319|101881628|FG000|STARTED|Overall Study||3||
48631815|NCT04596319|101881629|FG001|STARTED|Overall Study||3||
48631816|NCT04596319|101881630|FG002|STARTED|Overall Study||2||
48631817|NCT04596319|101881631|FG003|STARTED|Overall Study||3||
48631818|NCT04596319|101881632|FG004|STARTED|Overall Study||10||
48631819|NCT04596319|101881633|FG005|STARTED|Overall Study||3||
48631820|NCT04596319|101881634|FG006|STARTED|Overall Study||5||
48631821|NCT04596319|101881628|FG000|COMPLETED|Overall Study||3||
48631822|NCT04596319|101881629|FG001|COMPLETED|Overall Study||3||
48631823|NCT04596319|101881630|FG002|COMPLETED|Overall Study||2||
48631824|NCT04596319|101881631|FG003|COMPLETED|Overall Study||3||
48631825|NCT04596319|101881632|FG004|COMPLETED|Overall Study||10||
48631826|NCT04596319|101881633|FG005|COMPLETED|Overall Study||3||
48754251|NCT00591006|102187669|FG018|COMPLETED|Overall Study||0||
48754252|NCT00591006|102187670|FG019|COMPLETED|Overall Study||1||
48754253|NCT00591006|102187671|FG020|COMPLETED|Overall Study||0||
48754254|NCT00591006|102187672|FG021|COMPLETED|Overall Study||1||
48754255|NCT00591006|102187673|FG022|COMPLETED|Overall Study||0||
48754256|NCT00591006|102187674|FG023|COMPLETED|Overall Study||0||
48754257|NCT00591006|102187651|FG000|NOT COMPLETED|Overall Study||0||
48178095|NCT00289770|100757768|FG000|COMPLETED|Year 14||43||
48631827|NCT04596319|101881634|FG006|COMPLETED|Overall Study||5||
48631828|NCT04596319|101881628|FG000|NOT COMPLETED|Overall Study||0||
48631829|NCT04596319|101881629|FG001|NOT COMPLETED|Overall Study||0||
48631830|NCT04596319|101881630|FG002|NOT COMPLETED|Overall Study||0||
48631831|NCT04596319|101881631|FG003|NOT COMPLETED|Overall Study||0||
48631832|NCT04596319|101881632|FG004|NOT COMPLETED|Overall Study||0||
48631833|NCT04596319|101881633|FG005|NOT COMPLETED|Overall Study||0||
48631834|NCT04596319|101881634|FG006|NOT COMPLETED|Overall Study||0||
48631835|NCT00722020|101881635|FG000|STARTED|Overall Study||19||
48178096|NCT00289770|100757768|FG000|NOT COMPLETED|Year 14||0||
48178097|NCT00289770|100757768|FG000|STARTED|Year 15||50||
48178098|NCT00289770|100757768|FG000|COMPLETED|Year 15||49||
48178099|NCT00289770|100757768|FG000|NOT COMPLETED|Year 15||1||
48178100|NCT01644396|100757769|FG000|STARTED|Overall Study||50||
48178101|NCT01644396|100757769|FG000|COMPLETED|Overall Study||50||
48178102|NCT01644396|100757769|FG000|NOT COMPLETED|Overall Study||0||
48178103|NCT03664739|100757770|FG000|STARTED|Overall Study||306||
48413319|NCT01693562|101345799|FG012|COMPLETED|Expansion Phase||1||
48413320|NCT01693562|101345800|FG013|COMPLETED|Expansion Phase||0||
48413321|NCT01693562|101345801|FG014|COMPLETED|Expansion Phase||0||
48413322|NCT01693562|101345802|FG015|COMPLETED|Expansion Phase||0||
48413323|NCT01693562|101345803|FG016|COMPLETED|Expansion Phase||4||
48413324|NCT01693562|101345804|FG017|COMPLETED|Expansion Phase||0||
48178104|NCT03664739|100757771|FG001|STARTED|Overall Study||302||
48178105|NCT03664739|100757770|FG000|COMPLETED|Overall Study||256||
48178106|NCT03664739|100757771|FG001|COMPLETED|Overall Study||270||
48178107|NCT03664739|100757770|FG000|NOT COMPLETED|Overall Study||50||
48178108|NCT03664739|100757771|FG001|NOT COMPLETED|Overall Study||32||
48178109|NCT02667444|100757772|FG000|STARTED|Overall Study||664||
48178110|NCT02667444|100757773|FG001|STARTED|Overall Study||666||
48178111|NCT02667444|100757772|FG000|COMPLETED|Overall Study||576||
48178112|NCT02667444|100757773|FG001|COMPLETED|Overall Study||574||
48178113|NCT02667444|100757772|FG000|NOT COMPLETED|Overall Study||88||
48178114|NCT02667444|100757773|FG001|NOT COMPLETED|Overall Study||92||
48178115|NCT03486899|100757774|FG000|STARTED|Overall Study||49||
48178116|NCT03486899|100757775|FG001|STARTED|Overall Study||50||
48178117|NCT03486899|100757776|FG002|STARTED|Overall Study||49||
48178118|NCT03486899|100757777|FG003|STARTED|Overall Study||49||
48178119|NCT03486899|100757774|FG000|COMPLETED|Overall Study||41||
48178120|NCT03486899|100757775|FG001|COMPLETED|Overall Study||39||
48178121|NCT03486899|100757776|FG002|COMPLETED|Overall Study||41||
48178122|NCT03486899|100757777|FG003|COMPLETED|Overall Study||39||
48178123|NCT03486899|100757774|FG000|NOT COMPLETED|Overall Study||8||
48178124|NCT03486899|100757775|FG001|NOT COMPLETED|Overall Study||11||
48178125|NCT03486899|100757776|FG002|NOT COMPLETED|Overall Study||8||
48178126|NCT03486899|100757777|FG003|NOT COMPLETED|Overall Study||10||
48413325|NCT01693562|101345805|FG018|COMPLETED|Expansion Phase||0||
48413326|NCT01693562|101345806|FG019|COMPLETED|Expansion Phase||0||
48413327|NCT01693562|101345807|FG020|COMPLETED|Expansion Phase||0||
48413328|NCT01693562|101345808|FG021|COMPLETED|Expansion Phase||0||
48631836|NCT00722020|101881636|FG001|STARTED|Overall Study||24||
48631837|NCT00722020|101881635|FG000|COMPLETED|Overall Study||19||
48631838|NCT00722020|101881636|FG001|COMPLETED|Overall Study||24||
48631839|NCT00722020|101881635|FG000|NOT COMPLETED|Overall Study||0||
48631840|NCT00722020|101881636|FG001|NOT COMPLETED|Overall Study||0||
48631841|NCT00606008|101881637|FG000|STARTED|Overall Study||30||
48631842|NCT00606008|101881637|FG000|COMPLETED|Overall Study||25||
48754258|NCT00591006|102187652|FG001|NOT COMPLETED|Overall Study||0||
48754259|NCT00591006|102187653|FG002|NOT COMPLETED|Overall Study||0||
48754260|NCT00591006|102187654|FG003|NOT COMPLETED|Overall Study||0||
48178127|NCT00550173|100757778|FG000|STARTED|Overall Study||81||
48178128|NCT00550173|100757779|FG001|STARTED|Overall Study||82||
48178129|NCT00550173|100757780|FG002|STARTED|Overall Study||84||
48413329|NCT01693562|101345809|FG022|COMPLETED|Expansion Phase||0||
48413330|NCT01693562|101345787|FG000|NOT COMPLETED|Expansion Phase||0||
48413331|NCT01693562|101345788|FG001|NOT COMPLETED|Expansion Phase||0||
48413332|NCT01693562|101345789|FG002|NOT COMPLETED|Expansion Phase||0||
48413333|NCT01693562|101345790|FG003|NOT COMPLETED|Expansion Phase||0||
48413334|NCT01693562|101345791|FG004|NOT COMPLETED|Expansion Phase||0||
48178130|NCT00550173|100757778|FG000|Qualified Participants|Overall Study||78||
48413335|NCT01693562|101345792|FG005|NOT COMPLETED|Expansion Phase||0||
48413336|NCT01693562|101345793|FG006|NOT COMPLETED|Expansion Phase||0||
48413337|NCT01693562|101345794|FG007|NOT COMPLETED|Expansion Phase||62||
48631843|NCT00606008|101881637|FG000|NOT COMPLETED|Overall Study||5||
48631844|NCT02366871|101881638|FG000|STARTED|Overall Study||204||
48631845|NCT02366871|101881639|FG001|STARTED|Overall Study||196||
48631846|NCT02366871|101881638|FG000|COMPLETED|Overall Study||204||
48631847|NCT02366871|101881639|FG001|COMPLETED|Overall Study||196||
48631848|NCT02366871|101881638|FG000|NOT COMPLETED|Overall Study||0||
48631849|NCT02366871|101881639|FG001|NOT COMPLETED|Overall Study||0||
48178131|NCT00550173|100757779|FG001|Qualified Participants|Overall Study||82||
48178132|NCT00550173|100757780|FG002|Qualified Participants|Overall Study||80||
48754261|NCT00591006|102187655|FG004|NOT COMPLETED|Overall Study||0||
48631850|NCT01664091|101881640|FG000|STARTED|Overall Study||32||
48631851|NCT01664091|101881640|FG000|COMPLETED|Overall Study||26||
48631852|NCT01664091|101881640|FG000|NOT COMPLETED|Overall Study||6||
48631853|NCT03108482|101881641|FG000|STARTED|Overall Study||183|Safety Analysis Set (Study Treatments as actually received)|
48631854|NCT03108482|101881642|FG001|STARTED|Overall Study||183|Safety Analysis Set (Study Treatments as actually received)|
48631855|NCT03108482|101881643|FG002|STARTED|Overall Study||182|Safety Analysis Set (Study Treatments as actually received)|
48631856|NCT03108482|101881644|FG003|STARTED|Overall Study||89|Safety Analysis Set (Study Treatments as actually received)|
48631857|NCT03108482|101881641|FG000|COMPLETED|Overall Study||183||
48631858|NCT03108482|101881642|FG001|COMPLETED|Overall Study||179||
48178133|NCT00550173|100757778|FG000|Not Discontinued at 18 Months|Overall Study||9||
48178134|NCT00550173|100757779|FG001|Not Discontinued at 18 Months|Overall Study||19||
48178135|NCT00550173|100757780|FG002|Not Discontinued at 18 Months|Overall Study||11||
48178136|NCT00550173|100757778|FG000|COMPLETED|Overall Study||9||
48178137|NCT00550173|100757779|FG001|COMPLETED|Overall Study||19||
48178138|NCT00550173|100757780|FG002|COMPLETED|Overall Study||11||
48178139|NCT00550173|100757778|FG000|NOT COMPLETED|Overall Study||72||
48178140|NCT00550173|100757779|FG001|NOT COMPLETED|Overall Study||63||
48178141|NCT00550173|100757780|FG002|NOT COMPLETED|Overall Study||73||
48178142|NCT03044353|100757781|FG000|STARTED|Overall Study||6||
48178143|NCT03044353|100757782|FG001|STARTED|Overall Study||1||
48178144|NCT03044353|100757783|FG002|STARTED|Overall Study||0||
48178145|NCT03044353|100757781|FG000|COMPLETED|Overall Study||6||
48178146|NCT03044353|100757782|FG001|COMPLETED|Overall Study||0||
48178147|NCT03044353|100757783|FG002|COMPLETED|Overall Study||0||
48178148|NCT03044353|100757781|FG000|NOT COMPLETED|Overall Study||0||
48178149|NCT03044353|100757782|FG001|NOT COMPLETED|Overall Study||1||
48178150|NCT03044353|100757783|FG002|NOT COMPLETED|Overall Study||0||
48178151|NCT01971580|100757784|FG000|STARTED|Overall Study||14||
48178152|NCT01971580|100757785|FG001|STARTED|Overall Study||14||
48178153|NCT01971580|100757784|FG000|COMPLETED|Overall Study||10||
48178154|NCT01971580|100757785|FG001|COMPLETED|Overall Study||9||
48178155|NCT01971580|100757784|FG000|NOT COMPLETED|Overall Study||4||
48178156|NCT01971580|100757785|FG001|NOT COMPLETED|Overall Study||5||
48178157|NCT04057820|100757786|FG000|STARTED|Period 1||27||4
48178158|NCT04057820|100757787|FG001|STARTED|Period 1||0||0
48178159|NCT04057820|100757788|FG002|STARTED|Period 1||8||2
48178160|NCT04057820|100757789|FG003|STARTED|Period 1||0||0
48338872|NCT02770521|101159912|FG003|COMPLETED|Period Two||2||
48338873|NCT02770521|101159913|FG004|COMPLETED|Period Two||2||
48338874|NCT02770521|101159914|FG005|COMPLETED|Period Two||9||
48338875|NCT02770521|101159909|FG000|NOT COMPLETED|Period Two||0||
48338876|NCT02770521|101159910|FG001|NOT COMPLETED|Period Two||0||
48338877|NCT02770521|101159911|FG002|NOT COMPLETED|Period Two||0||
48338878|NCT02770521|101159912|FG003|NOT COMPLETED|Period Two||0||
48338879|NCT02770521|101159913|FG004|NOT COMPLETED|Period Two||0||
48338880|NCT02770521|101159914|FG005|NOT COMPLETED|Period Two||0||
48338881|NCT02770521|101159909|FG000|STARTED|Period Three||0||
48413338|NCT01693562|101345795|FG008|NOT COMPLETED|Expansion Phase||22||
48631859|NCT03108482|101881643|FG002|COMPLETED|Overall Study||180||
48631860|NCT03108482|101881644|FG003|COMPLETED|Overall Study||86||
48631861|NCT03108482|101881641|FG000|NOT COMPLETED|Overall Study||0||
48631862|NCT03108482|101881642|FG001|NOT COMPLETED|Overall Study||4||
48631863|NCT03108482|101881643|FG002|NOT COMPLETED|Overall Study||2||
48631864|NCT03108482|101881644|FG003|NOT COMPLETED|Overall Study||3||
48631865|NCT02364557|101881645|FG000|STARTED|Overall Study||68||
48631866|NCT02364557|101881646|FG001|STARTED|Overall Study||61||
48631867|NCT02364557|101881645|FG000|Eligible Population|Overall Study||65||
48631868|NCT02364557|101881646|FG001|Eligible Population|Overall Study||60||
48631869|NCT02364557|101881645|FG000|AE Population|Overall Study||62|Eligible and received systemic therapy and/or ablation.|
48631870|NCT02364557|101881646|FG001|AE Population|Overall Study||57|Eligible and received systemic therapy and/or ablation.|
48178161|NCT04057820|100757790|FG004|STARTED|Period 1||23||3
48178162|NCT04057820|100757791|FG005|STARTED|Period 1||0||0
48338882|NCT02770521|101159910|FG001|STARTED|Period Three||0||
48338883|NCT02770521|101159911|FG002|STARTED|Period Three||2||
48338884|NCT02770521|101159912|FG003|STARTED|Period Three||2||
48338885|NCT02770521|101159913|FG004|STARTED|Period Three||2||
48338886|NCT02770521|101159914|FG005|STARTED|Period Three||9||
48338887|NCT02770521|101159909|FG000|Received Study Drug|Period Three||0||
48413339|NCT01693562|101345796|FG009|NOT COMPLETED|Expansion Phase||300||
48413340|NCT01693562|101345797|FG010|NOT COMPLETED|Expansion Phase||40||
48631871|NCT02364557|101881645|FG000|Circulating Tumor Cells (CTC) Population|Overall Study||36|Eligible with blood collection consent and baseline CTC data|
48631872|NCT02364557|101881646|FG001|Circulating Tumor Cells (CTC) Population|Overall Study||26|Eligible with blood collection consent and baseline CTC data|
48631873|NCT02364557|101881645|FG000|COMPLETED|Overall Study||65|Participants contributing data to results are considered to have completed the study.|
48631874|NCT02364557|101881646|FG001|COMPLETED|Overall Study||60|Participants contributing data to results are considered to have completed the study.|
48178163|NCT04057820|100757792|FG006|STARTED|Period 1||23||3
48178164|NCT04057820|100757793|FG007|STARTED|Period 1||0||0
48413341|NCT01693562|101345798|FG011|NOT COMPLETED|Expansion Phase||21||
48413342|NCT01693562|101345799|FG012|NOT COMPLETED|Expansion Phase||23||
48631875|NCT02364557|101881645|FG000|NOT COMPLETED|Overall Study||3||
48631876|NCT02364557|101881646|FG001|NOT COMPLETED|Overall Study||1||
48631877|NCT05630196|101881647|FG000|STARTED|Overall Study||91||
48631878|NCT05630196|101881648|FG001|STARTED|Overall Study||47||
48631879|NCT05630196|101881647|FG000|Received at Least One Dose of Study Drug|Overall Study||91||
48631880|NCT05630196|101881648|FG001|Received at Least One Dose of Study Drug|Overall Study||46||
48631881|NCT05630196|101881647|FG000|COMPLETED|Overall Study||82||
48178165|NCT04057820|100757794|FG008|STARTED|Period 1||41||4
48178166|NCT04057820|100757795|FG009|STARTED|Period 1||0||0
48178167|NCT04057820|100757796|FG010|STARTED|Period 1||27||4
48178168|NCT04057820|100757797|FG011|STARTED|Period 1||0||0
48178169|NCT04057820|100757798|FG012|STARTED|Period 1||16||3
48178170|NCT04057820|100757799|FG013|STARTED|Period 1||0||0
48178171|NCT04057820|100757800|FG014|STARTED|Period 1||20||3
48178172|NCT04057820|100757801|FG015|STARTED|Period 1||0||0
48178173|NCT04057820|100757786|FG000|COMPLETED|Period 1||27||4
48178174|NCT04057820|100757787|FG001|COMPLETED|Period 1||0||0
48178175|NCT04057820|100757788|FG002|COMPLETED|Period 1||8||2
48178176|NCT04057820|100757789|FG003|COMPLETED|Period 1||0||0
48178177|NCT04057820|100757790|FG004|COMPLETED|Period 1||23||3
48178178|NCT04057820|100757791|FG005|COMPLETED|Period 1||0||0
48178179|NCT04057820|100757792|FG006|COMPLETED|Period 1||23||3
48178180|NCT04057820|100757793|FG007|COMPLETED|Period 1||0||0
48178181|NCT04057820|100757794|FG008|COMPLETED|Period 1||41||4
48178182|NCT04057820|100757795|FG009|COMPLETED|Period 1||0||0
48178183|NCT04057820|100757796|FG010|COMPLETED|Period 1||27||4
48178184|NCT04057820|100757797|FG011|COMPLETED|Period 1||0||0
48413343|NCT01693562|101345800|FG013|NOT COMPLETED|Expansion Phase||51||
48413344|NCT01693562|101345801|FG014|NOT COMPLETED|Expansion Phase||40||
48413345|NCT01693562|101345802|FG015|NOT COMPLETED|Expansion Phase||31||
48413346|NCT01693562|101345803|FG016|NOT COMPLETED|Expansion Phase||197||
48413347|NCT01693562|101345804|FG017|NOT COMPLETED|Expansion Phase||20||
48413348|NCT01693562|101345805|FG018|NOT COMPLETED|Expansion Phase||47||
48413349|NCT01693562|101345806|FG019|NOT COMPLETED|Expansion Phase||20||
48413350|NCT01693562|101345807|FG020|NOT COMPLETED|Expansion Phase||21||
48413351|NCT01693562|101345808|FG021|NOT COMPLETED|Expansion Phase||62||
48413352|NCT01693562|101345809|FG022|NOT COMPLETED|Expansion Phase||10||
48413353|NCT02869451|101345810|FG000|STARTED|Overall Study||5||
48413354|NCT02869451|101345810|FG000|COMPLETED|Overall Study||5||
48413355|NCT02869451|101345810|FG000|NOT COMPLETED|Overall Study||0||
48413356|NCT01308853|101345811|FG000|STARTED|Overall Study||24||
48413357|NCT01308853|101345811|FG000|COMPLETED|Overall Study||20||
48413358|NCT01308853|101345811|FG000|NOT COMPLETED|Overall Study||4||
48413359|NCT01009333|101345812|FG000|STARTED|Week 1||2||
48413360|NCT01009333|101345813|FG001|STARTED|Week 1||3||
48413361|NCT01009333|101345814|FG002|STARTED|Week 1||2||
48413362|NCT01009333|101345815|FG003|STARTED|Week 1||2||
48413363|NCT01009333|101345816|FG004|STARTED|Week 1||2||
48413364|NCT01009333|101345817|FG005|STARTED|Week 1||2||
48413365|NCT01009333|101345812|FG000|COMPLETED|Week 1||2||
48413366|NCT01009333|101345813|FG001|COMPLETED|Week 1||3||
48413367|NCT01009333|101345814|FG002|COMPLETED|Week 1||2||
48413368|NCT01009333|101345815|FG003|COMPLETED|Week 1||2||
48413369|NCT01009333|101345816|FG004|COMPLETED|Week 1||2||
48413370|NCT01009333|101345817|FG005|COMPLETED|Week 1||2||
48413371|NCT01009333|101345812|FG000|NOT COMPLETED|Week 1||0||
48413372|NCT01009333|101345813|FG001|NOT COMPLETED|Week 1||0||
48178185|NCT04057820|100757798|FG012|COMPLETED|Period 1||16||3
48178186|NCT04057820|100757799|FG013|COMPLETED|Period 1||0||0
48178187|NCT04057820|100757800|FG014|COMPLETED|Period 1||20||3
48413373|NCT01009333|101345814|FG002|NOT COMPLETED|Week 1||0||
48413374|NCT01009333|101345815|FG003|NOT COMPLETED|Week 1||0||
48631882|NCT05630196|101881648|FG001|COMPLETED|Overall Study||38||
48631883|NCT05630196|101881647|FG000|NOT COMPLETED|Overall Study||9||
48631884|NCT05630196|101881648|FG001|NOT COMPLETED|Overall Study||9||
48631885|NCT00619827|101881649|FG000|STARTED|Overall Study||45||
48631886|NCT00619827|101881650|FG001|STARTED|Overall Study||44||
48631887|NCT00619827|101881649|FG000|COMPLETED|Overall Study||42||
48631888|NCT00619827|101881650|FG001|COMPLETED|Overall Study||40||
48631889|NCT00619827|101881649|FG000|NOT COMPLETED|Overall Study||3||
48631890|NCT00619827|101881650|FG001|NOT COMPLETED|Overall Study||4||
48631891|NCT04796415|101881651|FG000|STARTED|Overall Study||49|Completed OASIS at starting date; eligible Home Health Care patients and initial Call|
48631892|NCT04796415|101881651|FG000|Session #1|Overall Study||35||
48631893|NCT04796415|101881651|FG000|Session #2|Overall Study||25||
48178188|NCT04057820|100757801|FG015|COMPLETED|Period 1||0||0
48178189|NCT04057820|100757786|FG000|NOT COMPLETED|Period 1||0||0
48413375|NCT01009333|101345816|FG004|NOT COMPLETED|Week 1||0||
48413376|NCT01009333|101345817|FG005|NOT COMPLETED|Week 1||0||
48178190|NCT04057820|100757787|FG001|NOT COMPLETED|Period 1||0||0
48413377|NCT01009333|101345812|FG000|STARTED|Week 2||2||
48178191|NCT04057820|100757788|FG002|NOT COMPLETED|Period 1||0||0
48178192|NCT04057820|100757789|FG003|NOT COMPLETED|Period 1||0||0
48413378|NCT01009333|101345813|FG001|STARTED|Week 2||2||
48413379|NCT01009333|101345814|FG002|STARTED|Week 2||2||
48413380|NCT01009333|101345815|FG003|STARTED|Week 2||2||
48631894|NCT04796415|101881651|FG000|Session #3|Overall Study||21||
48178193|NCT04057820|100757790|FG004|NOT COMPLETED|Period 1||0||0
48178194|NCT04057820|100757791|FG005|NOT COMPLETED|Period 1||0||0
48178195|NCT04057820|100757792|FG006|NOT COMPLETED|Period 1||0||0
48178196|NCT04057820|100757793|FG007|NOT COMPLETED|Period 1||0||0
48178197|NCT04057820|100757794|FG008|NOT COMPLETED|Period 1||0||0
48178198|NCT04057820|100757795|FG009|NOT COMPLETED|Period 1||0||0
48178199|NCT04057820|100757796|FG010|NOT COMPLETED|Period 1||0||0
48631895|NCT04796415|101881651|FG000|Session #4|Overall Study||19||
48631896|NCT04796415|101881651|FG000|Session #5|Overall Study||19||
48631897|NCT04796415|101881651|FG000|Session #6|Overall Study||18||
48178200|NCT04057820|100757797|FG011|NOT COMPLETED|Period 1||0||0
48178201|NCT04057820|100757798|FG012|NOT COMPLETED|Period 1||0||0
48178202|NCT04057820|100757799|FG013|NOT COMPLETED|Period 1||0||0
48178203|NCT04057820|100757800|FG014|NOT COMPLETED|Period 1||0||0
48178204|NCT04057820|100757801|FG015|NOT COMPLETED|Period 1||0||0
48178205|NCT04057820|100757786|FG000|STARTED|Period 2||0||0
48178206|NCT04057820|100757787|FG001|STARTED|Period 2||0||0
48178207|NCT04057820|100757788|FG002|STARTED|Period 2||5||2
48178208|NCT04057820|100757789|FG003|STARTED|Period 2||0||0
48178209|NCT04057820|100757790|FG004|STARTED|Period 2||11||3
48178210|NCT04057820|100757791|FG005|STARTED|Period 2||0||0
48178211|NCT04057820|100757792|FG006|STARTED|Period 2||12||3
48178212|NCT04057820|100757793|FG007|STARTED|Period 2||0||0
48178213|NCT04057820|100757794|FG008|STARTED|Period 2||47||4
48178214|NCT04057820|100757795|FG009|STARTED|Period 2||0||0
48178215|NCT04057820|100757796|FG010|STARTED|Period 2||17||4
48178216|NCT04057820|100757797|FG011|STARTED|Period 2||0||0
48178217|NCT04057820|100757798|FG012|STARTED|Period 2||10||3
48178218|NCT04057820|100757799|FG013|STARTED|Period 2||0||0
48178219|NCT04057820|100757800|FG014|STARTED|Period 2||18||3
48178220|NCT04057820|100757801|FG015|STARTED|Period 2||0||0
48178221|NCT04057820|100757786|FG000|COMPLETED|Period 2||0||0
48178222|NCT04057820|100757787|FG001|COMPLETED|Period 2||0||0
48178223|NCT04057820|100757788|FG002|COMPLETED|Period 2||5||2
48178224|NCT04057820|100757789|FG003|COMPLETED|Period 2||0||0
48178225|NCT04057820|100757790|FG004|COMPLETED|Period 2||11||3
48178226|NCT04057820|100757791|FG005|COMPLETED|Period 2||0||0
48178227|NCT04057820|100757792|FG006|COMPLETED|Period 2||12||3
48178228|NCT04057820|100757793|FG007|COMPLETED|Period 2||0||0
48178229|NCT04057820|100757794|FG008|COMPLETED|Period 2||47||4
48178230|NCT04057820|100757795|FG009|COMPLETED|Period 2||0||0
48178231|NCT04057820|100757796|FG010|COMPLETED|Period 2||17||4
48178232|NCT04057820|100757797|FG011|COMPLETED|Period 2||0||0
48178233|NCT04057820|100757798|FG012|COMPLETED|Period 2||10||3
48178234|NCT04057820|100757799|FG013|COMPLETED|Period 2||0||0
48178235|NCT04057820|100757800|FG014|COMPLETED|Period 2||18||3
48178236|NCT04057820|100757801|FG015|COMPLETED|Period 2||0||0
48178237|NCT04057820|100757786|FG000|NOT COMPLETED|Period 2||0||0
48178238|NCT04057820|100757787|FG001|NOT COMPLETED|Period 2||0||0
48178239|NCT04057820|100757788|FG002|NOT COMPLETED|Period 2||0||0
48178240|NCT04057820|100757789|FG003|NOT COMPLETED|Period 2||0||0
48178241|NCT04057820|100757790|FG004|NOT COMPLETED|Period 2||0||0
48178242|NCT04057820|100757791|FG005|NOT COMPLETED|Period 2||0||0
48178243|NCT04057820|100757792|FG006|NOT COMPLETED|Period 2||0||0
48178244|NCT04057820|100757793|FG007|NOT COMPLETED|Period 2||0||0
48178245|NCT04057820|100757794|FG008|NOT COMPLETED|Period 2||0||0
48631898|NCT04796415|101881651|FG000|COMPLETED|Overall Study||18||
48631899|NCT04796415|101881651|FG000|NOT COMPLETED|Overall Study||31||
48631900|NCT00490035|101881652|FG000|STARTED|Overall Study||100||
48631901|NCT00490035|101881653|FG001|STARTED|Overall Study||99||
48631902|NCT00490035|101881654|FG002|STARTED|Overall Study||100||
48631903|NCT00490035|101881655|FG003|STARTED|Overall Study||100||
48631904|NCT00490035|101881652|FG000|COMPLETED|Overall Study||92||
48631905|NCT00490035|101881653|FG001|COMPLETED|Overall Study||93||
48631906|NCT00490035|101881654|FG002|COMPLETED|Overall Study||88||
48631907|NCT00490035|101881655|FG003|COMPLETED|Overall Study||94||
48631908|NCT00490035|101881652|FG000|NOT COMPLETED|Overall Study||8||
48178246|NCT04057820|100757795|FG009|NOT COMPLETED|Period 2||0||0
48178247|NCT04057820|100757796|FG010|NOT COMPLETED|Period 2||0||0
48178248|NCT04057820|100757797|FG011|NOT COMPLETED|Period 2||0||0
48178249|NCT04057820|100757798|FG012|NOT COMPLETED|Period 2||0||0
48178250|NCT04057820|100757799|FG013|NOT COMPLETED|Period 2||0||0
48178251|NCT04057820|100757800|FG014|NOT COMPLETED|Period 2||0||0
48178252|NCT04057820|100757801|FG015|NOT COMPLETED|Period 2||0||0
48178253|NCT04057820|100757786|FG000|STARTED|Period 3||0||0
48178254|NCT04057820|100757787|FG001|STARTED|Period 3||25||4
48178255|NCT04057820|100757788|FG002|STARTED|Period 3||0||0
48178256|NCT04057820|100757789|FG003|STARTED|Period 3||0||0
48178257|NCT04057820|100757790|FG004|STARTED|Period 3||7||3
48178258|NCT04057820|100757791|FG005|STARTED|Period 3||0||0
48178259|NCT04057820|100757792|FG006|STARTED|Period 3||19||3
48178260|NCT04057820|100757793|FG007|STARTED|Period 3||0||0
48178261|NCT04057820|100757794|FG008|STARTED|Period 3||32||4
48178262|NCT04057820|100757795|FG009|STARTED|Period 3||0||0
48631909|NCT00490035|101881653|FG001|NOT COMPLETED|Overall Study||6||
48631910|NCT00490035|101881654|FG002|NOT COMPLETED|Overall Study||12||
48754262|NCT00591006|102187656|FG005|NOT COMPLETED|Overall Study||0||
48754263|NCT00591006|102187657|FG006|NOT COMPLETED|Overall Study||0||
48754264|NCT00591006|102187658|FG007|NOT COMPLETED|Overall Study||0||
48754265|NCT00591006|102187659|FG008|NOT COMPLETED|Overall Study||0||
48754266|NCT00591006|102187660|FG009|NOT COMPLETED|Overall Study||0||
48178263|NCT04057820|100757796|FG010|STARTED|Period 3||15||4
48178264|NCT04057820|100757797|FG011|STARTED|Period 3||0||0
48178265|NCT04057820|100757798|FG012|STARTED|Period 3||22||3
48178266|NCT04057820|100757799|FG013|STARTED|Period 3||0||0
48178267|NCT04057820|100757800|FG014|STARTED|Period 3||24||3
48178268|NCT04057820|100757801|FG015|STARTED|Period 3||0||0
48178269|NCT04057820|100757786|FG000|COMPLETED|Period 3||0||0
48178270|NCT04057820|100757787|FG001|COMPLETED|Period 3||25||4
48178271|NCT04057820|100757788|FG002|COMPLETED|Period 3||0||0
48178272|NCT04057820|100757789|FG003|COMPLETED|Period 3||0||0
48178273|NCT04057820|100757790|FG004|COMPLETED|Period 3||7||3
48178274|NCT04057820|100757791|FG005|COMPLETED|Period 3||0||0
48178275|NCT04057820|100757792|FG006|COMPLETED|Period 3||19||3
48178276|NCT04057820|100757793|FG007|COMPLETED|Period 3||0||0
48178277|NCT04057820|100757794|FG008|COMPLETED|Period 3||32||4
48178278|NCT04057820|100757795|FG009|COMPLETED|Period 3||0||0
48178279|NCT04057820|100757796|FG010|COMPLETED|Period 3||15||4
48178280|NCT04057820|100757797|FG011|COMPLETED|Period 3||0||0
48178281|NCT04057820|100757798|FG012|COMPLETED|Period 3||22||3
48178282|NCT04057820|100757799|FG013|COMPLETED|Period 3||0||0
48178283|NCT04057820|100757800|FG014|COMPLETED|Period 3||24||3
48178284|NCT04057820|100757801|FG015|COMPLETED|Period 3||0||0
48178285|NCT04057820|100757786|FG000|NOT COMPLETED|Period 3||0||0
48178286|NCT04057820|100757787|FG001|NOT COMPLETED|Period 3||0||0
48178287|NCT04057820|100757788|FG002|NOT COMPLETED|Period 3||0||0
48178288|NCT04057820|100757789|FG003|NOT COMPLETED|Period 3||0||0
48178289|NCT04057820|100757790|FG004|NOT COMPLETED|Period 3||0||0
48178290|NCT04057820|100757791|FG005|NOT COMPLETED|Period 3||0||0
48178291|NCT04057820|100757792|FG006|NOT COMPLETED|Period 3||0||0
48178292|NCT04057820|100757793|FG007|NOT COMPLETED|Period 3||0||0
48178293|NCT04057820|100757794|FG008|NOT COMPLETED|Period 3||0||0
48338888|NCT02770521|101159910|FG001|Received Study Drug|Period Three||0||
48338889|NCT02770521|101159911|FG002|Received Study Drug|Period Three||2||
48338890|NCT02770521|101159912|FG003|Received Study Drug|Period Three||2||
48338891|NCT02770521|101159913|FG004|Received Study Drug|Period Three||2||
48178294|NCT04057820|100757795|FG009|NOT COMPLETED|Period 3||0||0
48178295|NCT04057820|100757796|FG010|NOT COMPLETED|Period 3||0||0
48178296|NCT04057820|100757797|FG011|NOT COMPLETED|Period 3||0||0
48178297|NCT04057820|100757798|FG012|NOT COMPLETED|Period 3||0||0
48178298|NCT04057820|100757799|FG013|NOT COMPLETED|Period 3||0||0
48178299|NCT04057820|100757800|FG014|NOT COMPLETED|Period 3||0||0
48178300|NCT04057820|100757801|FG015|NOT COMPLETED|Period 3||0||0
48178301|NCT04057820|100757786|FG000|STARTED|Period 4||0||0
48178302|NCT04057820|100757787|FG001|STARTED|Period 4||22||4
48178303|NCT04057820|100757788|FG002|STARTED|Period 4||0||0
48178304|NCT04057820|100757789|FG003|STARTED|Period 4||8||2
48178305|NCT04057820|100757790|FG004|STARTED|Period 4||0||0
48178306|NCT04057820|100757791|FG005|STARTED|Period 4||0||0
48178307|NCT04057820|100757792|FG006|STARTED|Period 4||16||3
48178308|NCT04057820|100757793|FG007|STARTED|Period 4||0||0
48178309|NCT04057820|100757794|FG008|STARTED|Period 4||33||4
48338892|NCT02770521|101159914|FG005|Received Study Drug|Period Three||9||
48338893|NCT02770521|101159909|FG000|COMPLETED|Period Three||0||
48338894|NCT02770521|101159910|FG001|COMPLETED|Period Three||0||
48754267|NCT00591006|102187661|FG010|NOT COMPLETED|Overall Study||0||
48754268|NCT00591006|102187662|FG011|NOT COMPLETED|Overall Study||0||
48754269|NCT00591006|102187663|FG012|NOT COMPLETED|Overall Study||0||
48754270|NCT00591006|102187664|FG013|NOT COMPLETED|Overall Study||0||
48178310|NCT04057820|100757795|FG009|STARTED|Period 4||0||0
48178311|NCT04057820|100757796|FG010|STARTED|Period 4||19||4
48178312|NCT04057820|100757797|FG011|STARTED|Period 4||0||0
48178313|NCT04057820|100757798|FG012|STARTED|Period 4||19||3
48178314|NCT04057820|100757799|FG013|STARTED|Period 4||0||0
48178315|NCT04057820|100757800|FG014|STARTED|Period 4||22||3
48178316|NCT04057820|100757801|FG015|STARTED|Period 4||0||0
48338895|NCT02770521|101159911|FG002|COMPLETED|Period Three||2||
48338896|NCT02770521|101159912|FG003|COMPLETED|Period Three||2||
48338897|NCT02770521|101159913|FG004|COMPLETED|Period Three||2||
48178317|NCT04057820|100757786|FG000|COMPLETED|Period 4||0||0
48338898|NCT02770521|101159914|FG005|COMPLETED|Period Three||9||
48338899|NCT02770521|101159909|FG000|NOT COMPLETED|Period Three||0||
48338900|NCT02770521|101159910|FG001|NOT COMPLETED|Period Three||0||
48178318|NCT04057820|100757787|FG001|COMPLETED|Period 4||22||4
48178319|NCT04057820|100757788|FG002|COMPLETED|Period 4||0||0
48338901|NCT02770521|101159911|FG002|NOT COMPLETED|Period Three||0||
48754271|NCT00591006|102187665|FG014|NOT COMPLETED|Overall Study||0||
48178320|NCT04057820|100757789|FG003|COMPLETED|Period 4||8||2
48178321|NCT04057820|100757790|FG004|COMPLETED|Period 4||0||0
48178322|NCT04057820|100757791|FG005|COMPLETED|Period 4||0||0
48178323|NCT04057820|100757792|FG006|COMPLETED|Period 4||16||3
48178324|NCT04057820|100757793|FG007|COMPLETED|Period 4||0||0
48178325|NCT04057820|100757794|FG008|COMPLETED|Period 4||33||4
48178326|NCT04057820|100757795|FG009|COMPLETED|Period 4||0||0
48178327|NCT04057820|100757796|FG010|COMPLETED|Period 4||19||4
48178328|NCT04057820|100757797|FG011|COMPLETED|Period 4||0||0
48178329|NCT04057820|100757798|FG012|COMPLETED|Period 4||19||3
48178330|NCT04057820|100757799|FG013|COMPLETED|Period 4||0||0
48178331|NCT04057820|100757800|FG014|COMPLETED|Period 4||22||3
48178332|NCT04057820|100757801|FG015|COMPLETED|Period 4||0||0
48338902|NCT02770521|101159912|FG003|NOT COMPLETED|Period Three||0||
48338903|NCT02770521|101159913|FG004|NOT COMPLETED|Period Three||0||
48754272|NCT00591006|102187666|FG015|NOT COMPLETED|Overall Study||1||
48754273|NCT00591006|102187667|FG016|NOT COMPLETED|Overall Study||0||
48178333|NCT04057820|100757786|FG000|NOT COMPLETED|Period 4||0||0
48178334|NCT04057820|100757787|FG001|NOT COMPLETED|Period 4||0||0
48178335|NCT04057820|100757788|FG002|NOT COMPLETED|Period 4||0||0
48178336|NCT04057820|100757789|FG003|NOT COMPLETED|Period 4||0||0
48178337|NCT04057820|100757790|FG004|NOT COMPLETED|Period 4||0||0
48178338|NCT04057820|100757791|FG005|NOT COMPLETED|Period 4||0||0
48178339|NCT04057820|100757792|FG006|NOT COMPLETED|Period 4||0||0
48178340|NCT04057820|100757793|FG007|NOT COMPLETED|Period 4||0||0
48178341|NCT04057820|100757794|FG008|NOT COMPLETED|Period 4||0||0
48178342|NCT04057820|100757795|FG009|NOT COMPLETED|Period 4||0||0
48178343|NCT04057820|100757796|FG010|NOT COMPLETED|Period 4||0||0
48178344|NCT04057820|100757797|FG011|NOT COMPLETED|Period 4||0||0
48178345|NCT04057820|100757798|FG012|NOT COMPLETED|Period 4||0||0
48178346|NCT04057820|100757799|FG013|NOT COMPLETED|Period 4||0||0
48178347|NCT04057820|100757800|FG014|NOT COMPLETED|Period 4||0||0
48178348|NCT04057820|100757801|FG015|NOT COMPLETED|Period 4||0||0
48178349|NCT04057820|100757786|FG000|STARTED|Period 5||0||0
48178350|NCT04057820|100757787|FG001|STARTED|Period 5||25||4
48178351|NCT04057820|100757788|FG002|STARTED|Period 5||0||0
48178352|NCT04057820|100757789|FG003|STARTED|Period 5||8||2
48178353|NCT04057820|100757790|FG004|STARTED|Period 5||0||0
48178354|NCT04057820|100757791|FG005|STARTED|Period 5||12||3
48178355|NCT04057820|100757792|FG006|STARTED|Period 5||0||0
48178356|NCT04057820|100757793|FG007|STARTED|Period 5||0||0
48178357|NCT04057820|100757794|FG008|STARTED|Period 5||16||4
48178358|NCT04057820|100757795|FG009|STARTED|Period 5||0||0
48178359|NCT04057820|100757796|FG010|STARTED|Period 5||19||4
48178360|NCT04057820|100757797|FG011|STARTED|Period 5||0||0
48178361|NCT04057820|100757798|FG012|STARTED|Period 5||16||3
48178362|NCT04057820|100757799|FG013|STARTED|Period 5||0||0
48178363|NCT04057820|100757800|FG014|STARTED|Period 5||17||3
48178364|NCT04057820|100757801|FG015|STARTED|Period 5||0||0
48178365|NCT04057820|100757786|FG000|COMPLETED|Period 5||0||0
48178366|NCT04057820|100757787|FG001|COMPLETED|Period 5||25||4
48178367|NCT04057820|100757788|FG002|COMPLETED|Period 5||0||0
48178368|NCT04057820|100757789|FG003|COMPLETED|Period 5||8||2
48178369|NCT04057820|100757790|FG004|COMPLETED|Period 5||0||0
48178370|NCT04057820|100757791|FG005|COMPLETED|Period 5||12||3
48178371|NCT04057820|100757792|FG006|COMPLETED|Period 5||0||0
48178372|NCT04057820|100757793|FG007|COMPLETED|Period 5||0||0
48178373|NCT04057820|100757794|FG008|COMPLETED|Period 5||16||4
48178374|NCT04057820|100757795|FG009|COMPLETED|Period 5||0||0
48178375|NCT04057820|100757796|FG010|COMPLETED|Period 5||19||4
48178376|NCT04057820|100757797|FG011|COMPLETED|Period 5||0||0
48338904|NCT02770521|101159914|FG005|NOT COMPLETED|Period Three||0||
48754274|NCT00591006|102187668|FG017|NOT COMPLETED|Overall Study||0||
48178377|NCT04057820|100757798|FG012|COMPLETED|Period 5||16||3
48178378|NCT04057820|100757799|FG013|COMPLETED|Period 5||0||0
48178379|NCT04057820|100757800|FG014|COMPLETED|Period 5||17||3
48178380|NCT04057820|100757801|FG015|COMPLETED|Period 5||0||0
48178381|NCT04057820|100757786|FG000|NOT COMPLETED|Period 5||0||0
48178382|NCT04057820|100757787|FG001|NOT COMPLETED|Period 5||0||0
48178383|NCT04057820|100757788|FG002|NOT COMPLETED|Period 5||0||0
48178384|NCT04057820|100757789|FG003|NOT COMPLETED|Period 5||0||0
48178385|NCT04057820|100757790|FG004|NOT COMPLETED|Period 5||0||0
48178386|NCT04057820|100757791|FG005|NOT COMPLETED|Period 5||0||0
48178387|NCT04057820|100757792|FG006|NOT COMPLETED|Period 5||0||0
48754275|NCT00591006|102187669|FG018|NOT COMPLETED|Overall Study||0||
48178388|NCT04057820|100757793|FG007|NOT COMPLETED|Period 5||0||0
48178389|NCT04057820|100757794|FG008|NOT COMPLETED|Period 5||0||0
48178390|NCT04057820|100757795|FG009|NOT COMPLETED|Period 5||0||0
48178391|NCT04057820|100757796|FG010|NOT COMPLETED|Period 5||0||0
48178392|NCT04057820|100757797|FG011|NOT COMPLETED|Period 5||0||0
48178393|NCT04057820|100757798|FG012|NOT COMPLETED|Period 5||0||0
48178394|NCT04057820|100757799|FG013|NOT COMPLETED|Period 5||0||0
48178395|NCT04057820|100757800|FG014|NOT COMPLETED|Period 5||0||0
48178396|NCT04057820|100757801|FG015|NOT COMPLETED|Period 5||0||0
48178397|NCT04057820|100757786|FG000|STARTED|Period 6||0||0
48338905|NCT02149810|101159915|FG000|STARTED|Overall Study||48||
48338906|NCT02149810|101159916|FG001|STARTED|Overall Study||47||
48338907|NCT02149810|101159915|FG000|Baseline|Overall Study||47||
48754276|NCT00591006|102187670|FG019|NOT COMPLETED|Overall Study||0||
48178398|NCT04057820|100757787|FG001|STARTED|Period 6||24||4
48178399|NCT04057820|100757788|FG002|STARTED|Period 6||0||0
48178400|NCT04057820|100757789|FG003|STARTED|Period 6||5||2
48178401|NCT04057820|100757790|FG004|STARTED|Period 6||0||0
48178402|NCT04057820|100757791|FG005|STARTED|Period 6||14||3
48178403|NCT04057820|100757792|FG006|STARTED|Period 6||0||0
48178404|NCT04057820|100757793|FG007|STARTED|Period 6||15||3
48178405|NCT04057820|100757794|FG008|STARTED|Period 6||0||0
48178406|NCT04057820|100757795|FG009|STARTED|Period 6||0||0
48178407|NCT04057820|100757796|FG010|STARTED|Period 6||13||4
48178408|NCT04057820|100757797|FG011|STARTED|Period 6||0||0
48178409|NCT04057820|100757798|FG012|STARTED|Period 6||17||3
48178410|NCT04057820|100757799|FG013|STARTED|Period 6||0||0
48338908|NCT02149810|101159916|FG001|Baseline|Overall Study||44||
48338909|NCT02149810|101159915|FG000|Week 4|Overall Study||43||
48338910|NCT02149810|101159916|FG001|Week 4|Overall Study||42||
48338911|NCT02149810|101159915|FG000|Week 8|Overall Study||40||
48338912|NCT02149810|101159916|FG001|Week 8|Overall Study||43||
48338913|NCT02149810|101159915|FG000|Week 12|Overall Study||40||
48413381|NCT01009333|101345816|FG004|STARTED|Week 2||2||
48413382|NCT01009333|101345817|FG005|STARTED|Week 2||2||
48413383|NCT01009333|101345812|FG000|COMPLETED|Week 2||2||
48413384|NCT01009333|101345813|FG001|COMPLETED|Week 2||2||
48631911|NCT00490035|101881655|FG003|NOT COMPLETED|Overall Study||6||
48631912|NCT02152007|101881656|FG000|STARTED|Overall Study||15||
48413385|NCT01009333|101345814|FG002|COMPLETED|Week 2||2||
48413386|NCT01009333|101345815|FG003|COMPLETED|Week 2||2||
48754277|NCT00591006|102187671|FG020|NOT COMPLETED|Overall Study||0||
48754278|NCT00591006|102187672|FG021|NOT COMPLETED|Overall Study||0||
48754279|NCT00591006|102187673|FG022|NOT COMPLETED|Overall Study||1||
48754280|NCT00591006|102187674|FG023|NOT COMPLETED|Overall Study||1||
48754281|NCT00141453|102187675|FG000|STARTED|Overall Study||288||
48754282|NCT00141453|102187676|FG001|STARTED|Overall Study||289||
48754283|NCT00141453|102187675|FG000|COMPLETED|Overall Study||282||
48754284|NCT00141453|102187676|FG001|COMPLETED|Overall Study||284||
48754285|NCT00141453|102187675|FG000|NOT COMPLETED|Overall Study||6||
48754286|NCT00141453|102187676|FG001|NOT COMPLETED|Overall Study||5||
48754287|NCT03359629|102187677|FG000|STARTED|Overall Study||200||
48631913|NCT02152007|101881656|FG000|COMPLETED|Overall Study||14||
48631914|NCT02152007|101881656|FG000|NOT COMPLETED|Overall Study||1||
48631915|NCT00329108|101881657|FG000|STARTED|Overall Study||15||
48631916|NCT00329108|101881658|FG001|STARTED|Overall Study||14||
48631917|NCT00329108|101881657|FG000|COMPLETED|Overall Study||5||
48631918|NCT00329108|101881658|FG001|COMPLETED|Overall Study||2||
48631919|NCT00329108|101881657|FG000|NOT COMPLETED|Overall Study||10||
48631920|NCT00329108|101881658|FG001|NOT COMPLETED|Overall Study||12||
48631921|NCT01308619|101881659|FG000|STARTED|Overall Study||84||
48631922|NCT01308619|101881660|FG001|STARTED|Overall Study||86||
48631923|NCT01308619|101881659|FG000|COMPLETED|Overall Study||77||
48631924|NCT01308619|101881660|FG001|COMPLETED|Overall Study||83||
48631925|NCT01308619|101881659|FG000|NOT COMPLETED|Overall Study||7||
48631926|NCT01308619|101881660|FG001|NOT COMPLETED|Overall Study||3||
48631927|NCT01712711|101881661|FG000|STARTED|Overall Study||20||
48754288|NCT03359629|102187678|FG001|STARTED|Overall Study||10||
48754289|NCT03359629|102187677|FG000|COMPLETED|Overall Study||200||
48754290|NCT03359629|102187678|FG001|COMPLETED|Overall Study||10||
48754291|NCT03359629|102187677|FG000|NOT COMPLETED|Overall Study||0||
48178411|NCT04057820|100757800|FG014|STARTED|Period 6||18||3
48178412|NCT04057820|100757801|FG015|STARTED|Period 6||0||0
48178413|NCT04057820|100757786|FG000|COMPLETED|Period 6||0||0
48178414|NCT04057820|100757787|FG001|COMPLETED|Period 6||24||4
48178415|NCT04057820|100757788|FG002|COMPLETED|Period 6||0||0
48178416|NCT04057820|100757789|FG003|COMPLETED|Period 6||5||2
48178417|NCT04057820|100757790|FG004|COMPLETED|Period 6||0||0
48178418|NCT04057820|100757791|FG005|COMPLETED|Period 6||14||3
48178419|NCT04057820|100757792|FG006|COMPLETED|Period 6||0||0
48178420|NCT04057820|100757793|FG007|COMPLETED|Period 6||15||3
48178421|NCT04057820|100757794|FG008|COMPLETED|Period 6||0||0
48178422|NCT04057820|100757795|FG009|COMPLETED|Period 6||0||0
48178423|NCT04057820|100757796|FG010|COMPLETED|Period 6||13||4
48178424|NCT04057820|100757797|FG011|COMPLETED|Period 6||0||0
48178425|NCT04057820|100757798|FG012|COMPLETED|Period 6||17||3
48178426|NCT04057820|100757799|FG013|COMPLETED|Period 6||0||0
48178427|NCT04057820|100757800|FG014|COMPLETED|Period 6||18||3
48338914|NCT02149810|101159916|FG001|Week 12|Overall Study||43||
48338915|NCT02149810|101159915|FG000|Week 24|Overall Study||31||
48338916|NCT02149810|101159916|FG001|Week 24|Overall Study||0||
48338917|NCT02149810|101159915|FG000|COMPLETED|Overall Study||40||
48338918|NCT02149810|101159916|FG001|COMPLETED|Overall Study||43||
48338919|NCT02149810|101159915|FG000|NOT COMPLETED|Overall Study||8||
48338920|NCT02149810|101159916|FG001|NOT COMPLETED|Overall Study||4||
48338921|NCT00074958|101159917|FG000|STARTED|Overall Study||16||
48338922|NCT00074958|101159917|FG000|COMPLETED|Overall Study||15||
48413387|NCT01009333|101345816|FG004|COMPLETED|Week 2||2||
48631928|NCT01712711|101881662|FG001|STARTED|Overall Study||20||
48631929|NCT01712711|101881661|FG000|COMPLETED|Overall Study||20||
48631930|NCT01712711|101881662|FG001|COMPLETED|Overall Study||20||
48338923|NCT00074958|101159917|FG000|NOT COMPLETED|Overall Study||1||
48338924|NCT02675075|101159918|FG000|STARTED|Overall Study||15||
48338925|NCT02675075|101159919|FG001|STARTED|Overall Study||19||
48338926|NCT02675075|101159918|FG000|COMPLETED|Overall Study||12||
48338927|NCT02675075|101159919|FG001|COMPLETED|Overall Study||19||
48338928|NCT02675075|101159918|FG000|NOT COMPLETED|Overall Study||3||
48338929|NCT02675075|101159919|FG001|NOT COMPLETED|Overall Study||0||
48338930|NCT00508391|101159920|FG000|STARTED|First Treatment||60||
48338931|NCT00508391|101159921|FG001|STARTED|First Treatment||62||
48338932|NCT00508391|101159920|FG000|COMPLETED|First Treatment||54||
48338933|NCT00508391|101159921|FG001|COMPLETED|First Treatment||59||
48338934|NCT00508391|101159920|FG000|NOT COMPLETED|First Treatment||6||
48338935|NCT00508391|101159921|FG001|NOT COMPLETED|First Treatment||3||
48338936|NCT00508391|101159920|FG000|STARTED|Second Treatment||54||
48338937|NCT00508391|101159921|FG001|STARTED|Second Treatment||59||
48338938|NCT00508391|101159920|FG000|COMPLETED|Second Treatment||52||
48338939|NCT00508391|101159921|FG001|COMPLETED|Second Treatment||59||
48338940|NCT00508391|101159920|FG000|NOT COMPLETED|Second Treatment||2||
48338941|NCT00508391|101159921|FG001|NOT COMPLETED|Second Treatment||0||
48338942|NCT00888511|101159922|FG000|STARTED|Overall Study||15||
48338943|NCT00888511|101159922|FG000|COMPLETED|Overall Study||15||
48338944|NCT00888511|101159922|FG000|NOT COMPLETED|Overall Study||0||
48338945|NCT00382031|101159923|FG000|STARTED|Overall Study||191||
48338946|NCT00382031|101159924|FG001|STARTED|Overall Study||95||
48338947|NCT00382031|101159923|FG000|COMPLETED|Overall Study||191||
48338948|NCT00382031|101159924|FG001|COMPLETED|Overall Study||95||
48338949|NCT00382031|101159923|FG000|NOT COMPLETED|Overall Study||0||
48338950|NCT00382031|101159924|FG001|NOT COMPLETED|Overall Study||0||
48338951|NCT02266108|101159925|FG000|STARTED|Overall Study||80||
48338952|NCT02266108|101159926|FG001|STARTED|Overall Study||71||
48338953|NCT02266108|101159925|FG000|COMPLETED|Overall Study||80||
48338954|NCT02266108|101159926|FG001|COMPLETED|Overall Study||71||
48338955|NCT02266108|101159925|FG000|NOT COMPLETED|Overall Study||0||
48338956|NCT02266108|101159926|FG001|NOT COMPLETED|Overall Study||0||
48338957|NCT00849667|101159927|FG000|STARTED|Overall Study||370||
48338958|NCT00849667|101159928|FG001|STARTED|Overall Study||366||
48338959|NCT00849667|101159929|FG002|STARTED|Overall Study||364||
48338960|NCT00849667|101159927|FG000|Safety Analysis Set|Overall Study||376||
48338961|NCT00849667|101159928|FG001|Safety Analysis Set|Overall Study||363||
48338962|NCT00849667|101159929|FG002|Safety Analysis Set|Overall Study||352||
48338963|NCT00849667|101159927|FG000|COMPLETED|Overall Study||0||
48338964|NCT00849667|101159928|FG001|COMPLETED|Overall Study||0||
48338965|NCT00849667|101159929|FG002|COMPLETED|Overall Study||0||
48338966|NCT00849667|101159927|FG000|NOT COMPLETED|Overall Study||370||
48338967|NCT00849667|101159928|FG001|NOT COMPLETED|Overall Study||366||
48338968|NCT00849667|101159929|FG002|NOT COMPLETED|Overall Study||364||
48338969|NCT00787787|101159930|FG000|STARTED|Overall Study||7||
48338970|NCT00787787|101159930|FG000|COMPLETED|Overall Study||0||
48338971|NCT00787787|101159930|FG000|NOT COMPLETED|Overall Study||7||
48338972|NCT00763009|101159931|FG000|STARTED|Overall Study||8||
48338973|NCT00763009|101159931|FG000|COMPLETED|Overall Study||7||
48338974|NCT00763009|101159931|FG000|NOT COMPLETED|Overall Study||1||
48338975|NCT03618056|101159932|FG000|STARTED|Overall Study||1||
48338976|NCT03618056|101159932|FG000|COMPLETED|Overall Study||1||
48338977|NCT03618056|101159932|FG000|NOT COMPLETED|Overall Study||0||
48338978|NCT04024501|101159933|FG000|STARTED|Overall Study||25||
48338979|NCT04024501|101159933|FG000|COMPLETED|Overall Study||25||
48338980|NCT04024501|101159933|FG000|NOT COMPLETED|Overall Study||0||
48338981|NCT01506882|101159934|FG000|STARTED|Overall Study||61||
48338982|NCT01506882|101159935|FG001|STARTED|Overall Study||10||
48338983|NCT01506882|101159934|FG000|COMPLETED|Overall Study||39||
48338984|NCT01506882|101159935|FG001|COMPLETED|Overall Study||3||
48338985|NCT01506882|101159934|FG000|NOT COMPLETED|Overall Study||22||
48338986|NCT01506882|101159935|FG001|NOT COMPLETED|Overall Study||7||
48338987|NCT03219073|101159936|FG000|STARTED|Overall Study||0||
48338988|NCT03219073|101159937|FG001|STARTED|Overall Study||1||
48338989|NCT03219073|101159936|FG000|COMPLETED|Overall Study||0||
48413388|NCT01009333|101345817|FG005|COMPLETED|Week 2||2||
48338990|NCT03219073|101159937|FG001|COMPLETED|Overall Study||1||
48338991|NCT03219073|101159936|FG000|NOT COMPLETED|Overall Study||0||
48338992|NCT03219073|101159937|FG001|NOT COMPLETED|Overall Study||0||
48338993|NCT00700804|101159938|FG000|STARTED|Overall Study||17||
48338994|NCT00700804|101159939|FG001|STARTED|Overall Study||17||
48338995|NCT00700804|101159938|FG000|COMPLETED|Overall Study||14||
48338996|NCT00700804|101159939|FG001|COMPLETED|Overall Study||13||
48338997|NCT00700804|101159938|FG000|NOT COMPLETED|Overall Study||3||
48338998|NCT00700804|101159939|FG001|NOT COMPLETED|Overall Study||4||
48338999|NCT01256177|101159940|FG000|STARTED|Overall Study||148||
48339000|NCT01256177|101159941|FG001|STARTED|Overall Study||148||
48339001|NCT01256177|101159940|FG000|COMPLETED|Overall Study||98||
48339002|NCT01256177|101159941|FG001|COMPLETED|Overall Study||111||
48339003|NCT01256177|101159940|FG000|NOT COMPLETED|Overall Study||50||
48339004|NCT01256177|101159941|FG001|NOT COMPLETED|Overall Study||37||
48413389|NCT01009333|101345812|FG000|NOT COMPLETED|Week 2||0||
48339005|NCT01959165|101159942|FG000|STARTED|Overall Study||13||
48413390|NCT01009333|101345813|FG001|NOT COMPLETED|Week 2||0||
48754292|NCT03359629|102187678|FG001|NOT COMPLETED|Overall Study||0||
48339006|NCT01959165|101159943|FG001|STARTED|Overall Study||11||
48339007|NCT01959165|101159944|FG002|STARTED|Overall Study||12||
48339008|NCT01959165|101159945|FG003|STARTED|Overall Study||9||
48339009|NCT01959165|101159942|FG000|COMPLETED|Overall Study||12|completed patients number in double blind period|
48339010|NCT01959165|101159943|FG001|COMPLETED|Overall Study||10|completed patients number in double blind period|
48339011|NCT01959165|101159944|FG002|COMPLETED|Overall Study||12|completed patients number in double blind period|
48339012|NCT01959165|101159945|FG003|COMPLETED|Overall Study||7|completed patients number in double blind period|
48339013|NCT01959165|101159942|FG000|NOT COMPLETED|Overall Study||1||
48339014|NCT01959165|101159943|FG001|NOT COMPLETED|Overall Study||1||
48339015|NCT01959165|101159944|FG002|NOT COMPLETED|Overall Study||0||
48339016|NCT01959165|101159945|FG003|NOT COMPLETED|Overall Study||2||
48339017|NCT02257580|101159946|FG000|STARTED|Overall Study||16||
48339018|NCT02257580|101159947|FG001|STARTED|Overall Study||12||
48339019|NCT02257580|101159946|FG000|COMPLETED|Overall Study||16||
48339020|NCT02257580|101159947|FG001|COMPLETED|Overall Study||12||
48339021|NCT02257580|101159946|FG000|NOT COMPLETED|Overall Study||0||
48339022|NCT02257580|101159947|FG001|NOT COMPLETED|Overall Study||0||
48339023|NCT02723201|101159948|FG000|STARTED|First Intervention Period||11||
48339024|NCT02723201|101159949|FG001|STARTED|First Intervention Period||7||
48339025|NCT02723201|101159950|FG002|STARTED|First Intervention Period||7||
48339026|NCT02723201|101159948|FG000|COMPLETED|First Intervention Period||11||
48754293|NCT03115359|102187679|FG000|STARTED|Overall Study||385||
48754294|NCT03115359|102187680|FG001|STARTED|Overall Study||385||
48754295|NCT03115359|102187679|FG000|COMPLETED|Overall Study||266||
48754296|NCT03115359|102187680|FG001|COMPLETED|Overall Study||263||
48754297|NCT03115359|102187679|FG000|NOT COMPLETED|Overall Study||119||
48754298|NCT03115359|102187680|FG001|NOT COMPLETED|Overall Study||122||
48754299|NCT02758210|102187681|FG000|STARTED|Overall Study||20||
48754300|NCT02758210|102187681|FG000|COMPLETED|Overall Study||20||
48754301|NCT02758210|102187681|FG000|NOT COMPLETED|Overall Study||0||
48754302|NCT00474123|102187682|FG000|STARTED|Overall Study||38||
48754303|NCT00474123|102187683|FG001|STARTED|Overall Study||40||
48754304|NCT00474123|102187682|FG000|COMPLETED|Overall Study||38||
48754305|NCT00474123|102187683|FG001|COMPLETED|Overall Study||40||
48754306|NCT00474123|102187682|FG000|NOT COMPLETED|Overall Study||0||
48754307|NCT00474123|102187683|FG001|NOT COMPLETED|Overall Study||0||
48754308|NCT01517750|102187684|FG000|STARTED|Overall Study||21||
48754309|NCT01517750|102187685|FG001|STARTED|Overall Study||19||
48754310|NCT01517750|102187686|FG002|STARTED|Overall Study||21||
48754311|NCT01517750|102187687|FG003|STARTED|Overall Study||19||
48754312|NCT01517750|102187684|FG000|COMPLETED|Overall Study||20||
48754313|NCT01517750|102187685|FG001|COMPLETED|Overall Study||17||
48754314|NCT01517750|102187686|FG002|COMPLETED|Overall Study||17||
48754315|NCT01517750|102187687|FG003|COMPLETED|Overall Study||18||
48754316|NCT01517750|102187684|FG000|NOT COMPLETED|Overall Study||1||
48754317|NCT01517750|102187685|FG001|NOT COMPLETED|Overall Study||2||
48754318|NCT01517750|102187686|FG002|NOT COMPLETED|Overall Study||4||
48754319|NCT01517750|102187687|FG003|NOT COMPLETED|Overall Study||1||
48754320|NCT00346216|102187688|FG000|STARTED|Overall Study||8072||
48754321|NCT00346216|102187689|FG001|STARTED|Overall Study||8040||
48754322|NCT00346216|102187690|FG002|STARTED|Overall Study||7969||
48754323|NCT00346216|102187688|FG000|COMPLETED|Overall Study||5664||
48754324|NCT00346216|102187689|FG001|COMPLETED|Overall Study||5580||
48754325|NCT00346216|102187690|FG002|COMPLETED|Overall Study||5621||
48754326|NCT00346216|102187688|FG000|NOT COMPLETED|Overall Study||2408||
48754327|NCT00346216|102187689|FG001|NOT COMPLETED|Overall Study||2460||
48754328|NCT00346216|102187690|FG002|NOT COMPLETED|Overall Study||2348||
48754329|NCT04233801|102187691|FG000|STARTED|Overall Study||73||
48339027|NCT02723201|101159949|FG001|COMPLETED|First Intervention Period||7||
48339028|NCT02723201|101159950|FG002|COMPLETED|First Intervention Period||7||
48339029|NCT02723201|101159948|FG000|NOT COMPLETED|First Intervention Period||0||
48339030|NCT02723201|101159949|FG001|NOT COMPLETED|First Intervention Period||0||
48754330|NCT04233801|102187692|FG001|STARTED|Overall Study||73||
48178428|NCT04057820|100757801|FG015|COMPLETED|Period 6||0||0
48754331|NCT04233801|102187693|FG002|STARTED|Overall Study||73||
48754332|NCT04233801|102187691|FG000|COMPLETED|Overall Study||73||
48754333|NCT04233801|102187692|FG001|COMPLETED|Overall Study||71||
48754334|NCT04233801|102187693|FG002|COMPLETED|Overall Study||69||
48754335|NCT04233801|102187691|FG000|NOT COMPLETED|Overall Study||0||
48754336|NCT04233801|102187692|FG001|NOT COMPLETED|Overall Study||2||
48754337|NCT04233801|102187693|FG002|NOT COMPLETED|Overall Study||4||
48754338|NCT00948753|102187694|FG000|STARTED|Phase 1||7||
48754339|NCT00948753|102187695|FG001|STARTED|Phase 1||6||
48754340|NCT00948753|102187696|FG002|STARTED|Phase 1||0||
48339031|NCT02723201|101159950|FG002|NOT COMPLETED|First Intervention Period||0||
48339032|NCT02723201|101159948|FG000|STARTED|Washout Period 1||11||
48339033|NCT02723201|101159949|FG001|STARTED|Washout Period 1||7||
48339034|NCT02723201|101159950|FG002|STARTED|Washout Period 1||7||
48754341|NCT00948753|102187694|FG000|COMPLETED|Phase 1||7||
48754342|NCT00948753|102187695|FG001|COMPLETED|Phase 1||6||
48754343|NCT00948753|102187696|FG002|COMPLETED|Phase 1||0||
48754344|NCT00948753|102187694|FG000|NOT COMPLETED|Phase 1||0||
48178429|NCT04057820|100757786|FG000|NOT COMPLETED|Period 6||0||0
48178430|NCT04057820|100757787|FG001|NOT COMPLETED|Period 6||0||0
48178431|NCT04057820|100757788|FG002|NOT COMPLETED|Period 6||0||0
48178432|NCT04057820|100757789|FG003|NOT COMPLETED|Period 6||0||0
48178433|NCT04057820|100757790|FG004|NOT COMPLETED|Period 6||0||0
48178434|NCT04057820|100757791|FG005|NOT COMPLETED|Period 6||0||0
48178435|NCT04057820|100757792|FG006|NOT COMPLETED|Period 6||0||0
48178436|NCT04057820|100757793|FG007|NOT COMPLETED|Period 6||0||0
48178437|NCT04057820|100757794|FG008|NOT COMPLETED|Period 6||0||0
48178438|NCT04057820|100757795|FG009|NOT COMPLETED|Period 6||0||0
48178439|NCT04057820|100757796|FG010|NOT COMPLETED|Period 6||0||0
48178440|NCT04057820|100757797|FG011|NOT COMPLETED|Period 6||0||0
48178441|NCT04057820|100757798|FG012|NOT COMPLETED|Period 6||0||0
48178442|NCT04057820|100757799|FG013|NOT COMPLETED|Period 6||0||0
48178443|NCT04057820|100757800|FG014|NOT COMPLETED|Period 6||0||0
48178444|NCT04057820|100757801|FG015|NOT COMPLETED|Period 6||0||0
48178445|NCT04057820|100757786|FG000|STARTED|Period 7||0||0
48178446|NCT04057820|100757787|FG001|STARTED|Period 7||24||4
48178447|NCT04057820|100757788|FG002|STARTED|Period 7||0||0
48178448|NCT04057820|100757789|FG003|STARTED|Period 7||9||2
48178449|NCT04057820|100757790|FG004|STARTED|Period 7||0||0
48339035|NCT02723201|101159948|FG000|COMPLETED|Washout Period 1||11||
48339036|NCT02723201|101159949|FG001|COMPLETED|Washout Period 1||7||
48339037|NCT02723201|101159950|FG002|COMPLETED|Washout Period 1||7||
48339038|NCT02723201|101159948|FG000|NOT COMPLETED|Washout Period 1||0||
48339039|NCT02723201|101159949|FG001|NOT COMPLETED|Washout Period 1||0||
48339040|NCT02723201|101159950|FG002|NOT COMPLETED|Washout Period 1||0||
48339041|NCT02723201|101159948|FG000|STARTED|Second Intervention Period||11||
48339042|NCT02723201|101159949|FG001|STARTED|Second Intervention Period||7||
48339043|NCT02723201|101159950|FG002|STARTED|Second Intervention Period||7||
48339044|NCT02723201|101159948|FG000|COMPLETED|Second Intervention Period||9||
48339045|NCT02723201|101159949|FG001|COMPLETED|Second Intervention Period||7||
48339046|NCT02723201|101159950|FG002|COMPLETED|Second Intervention Period||7||
48339047|NCT02723201|101159948|FG000|NOT COMPLETED|Second Intervention Period||2||
48339048|NCT02723201|101159949|FG001|NOT COMPLETED|Second Intervention Period||0||
48339049|NCT02723201|101159950|FG002|NOT COMPLETED|Second Intervention Period||0||
48339050|NCT02723201|101159948|FG000|STARTED|Washout Period 2||9||
48339051|NCT02723201|101159949|FG001|STARTED|Washout Period 2||0||
48339052|NCT02723201|101159950|FG002|STARTED|Washout Period 2||0||
48339053|NCT02723201|101159948|FG000|COMPLETED|Washout Period 2||9||
48339054|NCT02723201|101159949|FG001|COMPLETED|Washout Period 2||0||
48339055|NCT02723201|101159950|FG002|COMPLETED|Washout Period 2||0||
48339056|NCT02723201|101159948|FG000|NOT COMPLETED|Washout Period 2||0||
48339057|NCT02723201|101159949|FG001|NOT COMPLETED|Washout Period 2||0||
48339058|NCT02723201|101159950|FG002|NOT COMPLETED|Washout Period 2||0||
48178450|NCT04057820|100757791|FG005|STARTED|Period 7||14||3
48178451|NCT04057820|100757792|FG006|STARTED|Period 7||0||0
48178452|NCT04057820|100757793|FG007|STARTED|Period 7||15||3
48178453|NCT04057820|100757794|FG008|STARTED|Period 7||0||0
48178454|NCT04057820|100757795|FG009|STARTED|Period 7||34||4
48178455|NCT04057820|100757796|FG010|STARTED|Period 7||0||0
48178456|NCT04057820|100757797|FG011|STARTED|Period 7||0||0
48178457|NCT04057820|100757798|FG012|STARTED|Period 7||12||3
48339059|NCT02723201|101159948|FG000|STARTED|Third Intervention Period||9||
48339060|NCT02723201|101159949|FG001|STARTED|Third Intervention Period||0||
48178458|NCT04057820|100757799|FG013|STARTED|Period 7||0||0
48178459|NCT04057820|100757800|FG014|STARTED|Period 7||19||3
48178460|NCT04057820|100757801|FG015|STARTED|Period 7||0||0
48178461|NCT04057820|100757786|FG000|COMPLETED|Period 7||0||0
48178462|NCT04057820|100757787|FG001|COMPLETED|Period 7||24||4
48178463|NCT04057820|100757788|FG002|COMPLETED|Period 7||0||0
48339061|NCT02723201|101159950|FG002|STARTED|Third Intervention Period||0||
48339062|NCT02723201|101159948|FG000|COMPLETED|Third Intervention Period||9||
48339063|NCT02723201|101159949|FG001|COMPLETED|Third Intervention Period||0||
48339064|NCT02723201|101159950|FG002|COMPLETED|Third Intervention Period||0||
48339065|NCT02723201|101159948|FG000|NOT COMPLETED|Third Intervention Period||0||
48413391|NCT01009333|101345814|FG002|NOT COMPLETED|Week 2||0||
48413392|NCT01009333|101345815|FG003|NOT COMPLETED|Week 2||0||
48413393|NCT01009333|101345816|FG004|NOT COMPLETED|Week 2||0||
48413394|NCT01009333|101345817|FG005|NOT COMPLETED|Week 2||0||
48413395|NCT01009333|101345812|FG000|STARTED|Week 3||2||
48754345|NCT00948753|102187695|FG001|NOT COMPLETED|Phase 1||0||
48754346|NCT00948753|102187696|FG002|NOT COMPLETED|Phase 1||0||
48754347|NCT00948753|102187694|FG000|STARTED|Phase 2||0||
48754348|NCT00948753|102187695|FG001|STARTED|Phase 2||0||
48754349|NCT00948753|102187696|FG002|STARTED|Phase 2||25||
48754350|NCT00948753|102187694|FG000|COMPLETED|Phase 2||0||
48339066|NCT02723201|101159949|FG001|NOT COMPLETED|Third Intervention Period||0||
48339067|NCT02723201|101159950|FG002|NOT COMPLETED|Third Intervention Period||0||
48339068|NCT02723201|101159948|FG000|STARTED|Washout Period 3||9||
48339069|NCT02723201|101159949|FG001|STARTED|Washout Period 3||0||
48339070|NCT02723201|101159950|FG002|STARTED|Washout Period 3||0||
48339071|NCT02723201|101159948|FG000|COMPLETED|Washout Period 3||9||
48339072|NCT02723201|101159949|FG001|COMPLETED|Washout Period 3||0||
48339073|NCT02723201|101159950|FG002|COMPLETED|Washout Period 3||0||
48339074|NCT02723201|101159948|FG000|NOT COMPLETED|Washout Period 3||0||
48339075|NCT02723201|101159949|FG001|NOT COMPLETED|Washout Period 3||0||
48339076|NCT02723201|101159950|FG002|NOT COMPLETED|Washout Period 3||0||
48339077|NCT02723201|101159948|FG000|STARTED|Fourth Intervention Period||9||
48339078|NCT02723201|101159949|FG001|STARTED|Fourth Intervention Period||0||
48339079|NCT02723201|101159950|FG002|STARTED|Fourth Intervention Period||0||
48339080|NCT02723201|101159948|FG000|COMPLETED|Fourth Intervention Period||9||
48339081|NCT02723201|101159949|FG001|COMPLETED|Fourth Intervention Period||0||
48339082|NCT02723201|101159950|FG002|COMPLETED|Fourth Intervention Period||0||
48339083|NCT02723201|101159948|FG000|NOT COMPLETED|Fourth Intervention Period||0||
48339084|NCT02723201|101159949|FG001|NOT COMPLETED|Fourth Intervention Period||0||
48339085|NCT02723201|101159950|FG002|NOT COMPLETED|Fourth Intervention Period||0||
48339086|NCT05384041|101159951|FG000|STARTED|Overall Study||126||
48339087|NCT05384041|101159952|FG001|STARTED|Overall Study||129||
48339088|NCT05384041|101159951|FG000|COMPLETED|Overall Study||121||
48339089|NCT05384041|101159952|FG001|COMPLETED|Overall Study||125||
48339090|NCT05384041|101159951|FG000|NOT COMPLETED|Overall Study||5||
48339091|NCT05384041|101159952|FG001|NOT COMPLETED|Overall Study||4||
48339092|NCT01671280|101159953|FG000|STARTED|Overall Study||403||
48339093|NCT01671280|101159953|FG000|COMPLETED|Overall Study||401||
48339094|NCT01671280|101159953|FG000|NOT COMPLETED|Overall Study||2||
48339095|NCT01848145|101159954|FG000|STARTED|Infusion 1: Week 1, Day 1 - 226 Minutes||34||
48339096|NCT01848145|101159954|FG000|Completed Within 15min of Infusion Time|Infusion 1: Week 1, Day 1 - 226 Minutes||1||
48339097|NCT01848145|101159954|FG000|COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes||33||
48339098|NCT01848145|101159954|FG000|NOT COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes||1||
48339099|NCT01848145|101159954|FG000|STARTED|Infusion 2: Week 1, Day 3 - 167 Minutes||33||
48413396|NCT01009333|101345813|FG001|STARTED|Week 3||2||
48413397|NCT01009333|101345814|FG002|STARTED|Week 3||2||
48754351|NCT00948753|102187695|FG001|COMPLETED|Phase 2||0||
48754352|NCT00948753|102187696|FG002|COMPLETED|Phase 2||25||
48754353|NCT00948753|102187694|FG000|NOT COMPLETED|Phase 2||0||
48754354|NCT00948753|102187695|FG001|NOT COMPLETED|Phase 2||0||
48754355|NCT00948753|102187696|FG002|NOT COMPLETED|Phase 2||0||
48754356|NCT01381016|102187697|FG000|STARTED|Overall Study||13||
48754357|NCT01381016|102187698|FG001|STARTED|Overall Study||17||
48754358|NCT01381016|102187697|FG000|COMPLETED|Overall Study||10||
48754359|NCT01381016|102187698|FG001|COMPLETED|Overall Study||11||
48339100|NCT01848145|101159954|FG000|Completed Within 15min of Infusion Time|Infusion 2: Week 1, Day 3 - 167 Minutes||24||
48339101|NCT01848145|101159954|FG000|COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes||31||
48339102|NCT01848145|101159954|FG000|NOT COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes||2||
48339103|NCT01848145|101159954|FG000|STARTED|Infusion 3: Week 2, Day 1 - 120 Minutes||31||
48339104|NCT01848145|101159954|FG000|Completed Within 15min of Infusion Time|Infusion 3: Week 2, Day 1 - 120 Minutes||26||
48413398|NCT01009333|101345815|FG003|STARTED|Week 3||2||
48413399|NCT01009333|101345816|FG004|STARTED|Week 3||2||
48413400|NCT01009333|101345817|FG005|STARTED|Week 3||2||
48413401|NCT01009333|101345812|FG000|COMPLETED|Week 3||2||
48413402|NCT01009333|101345813|FG001|COMPLETED|Week 3||2||
48413403|NCT01009333|101345814|FG002|COMPLETED|Week 3||2||
48413404|NCT01009333|101345815|FG003|COMPLETED|Week 3||2||
48754360|NCT01381016|102187697|FG000|NOT COMPLETED|Overall Study||3||
48754361|NCT01381016|102187698|FG001|NOT COMPLETED|Overall Study||6||
48339105|NCT01848145|101159954|FG000|COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||30|Includes participants that completed Infusion 3 and proceeded to subsequent infusions.|
48339106|NCT01848145|101159954|FG000|NOT COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||1||
48339107|NCT01848145|101159954|FG000|STARTED|Subsequent Infusions: Weeks 3-8||30||
48339108|NCT01848145|101159954|FG000|COMPLETED|Subsequent Infusions: Weeks 3-8||20||
48754362|NCT02738801|102187699|FG000|STARTED|Overall Study||6||
48754363|NCT02738801|102187700|FG001|STARTED|Overall Study||17||
48413405|NCT01009333|101345816|FG004|COMPLETED|Week 3||2||
48413406|NCT01009333|101345817|FG005|COMPLETED|Week 3||2||
48413407|NCT01009333|101345812|FG000|NOT COMPLETED|Week 3||0||
48413408|NCT01009333|101345813|FG001|NOT COMPLETED|Week 3||0||
48413409|NCT01009333|101345814|FG002|NOT COMPLETED|Week 3||0||
48413410|NCT01009333|101345815|FG003|NOT COMPLETED|Week 3||0||
48754364|NCT02738801|102187699|FG000|COMPLETED|Overall Study||5||
48754365|NCT02738801|102187700|FG001|COMPLETED|Overall Study||15||
48754366|NCT02738801|102187699|FG000|NOT COMPLETED|Overall Study||1||
48413411|NCT01009333|101345816|FG004|NOT COMPLETED|Week 3||0||
48413412|NCT01009333|101345817|FG005|NOT COMPLETED|Week 3||0||
48754367|NCT02738801|102187700|FG001|NOT COMPLETED|Overall Study||2||
48754368|NCT00837902|102187701|FG000|STARTED|Overall Study||85||
48339109|NCT01848145|101159954|FG000|NOT COMPLETED|Subsequent Infusions: Weeks 3-8||10||
48413413|NCT01893879|101345818|FG000|STARTED|Overall Study||7||
48339110|NCT00463476|101159955|FG000|STARTED|Overall Study||151||
48339111|NCT00463476|101159956|FG001|STARTED|Overall Study||154||
48339112|NCT00463476|101159955|FG000|COMPLETED|Overall Study||149||
48339113|NCT00463476|101159956|FG001|COMPLETED|Overall Study||151||
48339114|NCT00463476|101159955|FG000|NOT COMPLETED|Overall Study||2||
48339115|NCT00463476|101159956|FG001|NOT COMPLETED|Overall Study||3||
48339116|NCT00378326|101159957|FG000|STARTED|Overall Study||26||
48754369|NCT00837902|102187702|FG001|STARTED|Overall Study||69||
48754370|NCT00837902|102187701|FG000|COMPLETED|Overall Study||85||
48754371|NCT00837902|102187702|FG001|COMPLETED|Overall Study||69||
48754372|NCT00837902|102187701|FG000|NOT COMPLETED|Overall Study||0||
48754373|NCT00837902|102187702|FG001|NOT COMPLETED|Overall Study||0||
48754374|NCT03287791|102187703|FG000|STARTED|Overall Study||312||
48754375|NCT03287791|102187704|FG001|STARTED|Overall Study||312||
48754376|NCT03287791|102187705|FG002|STARTED|Overall Study||300||
48754377|NCT03287791|102187703|FG000|Safety Population|Overall Study||306|Randomized participants with evidence in diary card of using ≥1 dose of study drug.|
48754378|NCT03287791|102187704|FG001|Safety Population|Overall Study||297|Randomized participants with evidence in diary card of using ≥1 dose of study drug.|
48339117|NCT00378326|101159957|FG000|COMPLETED|Overall Study||26||
48339118|NCT00378326|101159957|FG000|NOT COMPLETED|Overall Study||0||
48413414|NCT01893879|101345819|FG001|STARTED|Overall Study||7||
48413415|NCT01893879|101345818|FG000|COMPLETED|Overall Study||5||
48754379|NCT03287791|102187705|FG002|Safety Population|Overall Study||291|Randomized participants with evidence in diary card of using ≥1 dose of study drug.|
48339119|NCT00486447|101159958|FG000|STARTED|Overall Study||249||
48339120|NCT00486447|101159958|FG000|COMPLETED|Overall Study||249||
48339121|NCT00486447|101159958|FG000|NOT COMPLETED|Overall Study||0||
48339122|NCT01777763|101159959|FG000|STARTED|Overall Study||20||
48339123|NCT01777763|101159960|FG001|STARTED|Overall Study||210||
48339124|NCT01777763|101159959|FG000|COMPLETED|Overall Study||16||
48339125|NCT01777763|101159960|FG001|COMPLETED|Overall Study||163||
48339126|NCT01777763|101159959|FG000|NOT COMPLETED|Overall Study||4||
48339127|NCT01777763|101159960|FG001|NOT COMPLETED|Overall Study||47||
48339128|NCT03372941|101159961|FG000|STARTED|Overall Study||6||
48339129|NCT03372941|101159962|FG001|STARTED|Overall Study||5||
48339130|NCT03372941|101159961|FG000|COMPLETED|Overall Study||4||
48339131|NCT03372941|101159962|FG001|COMPLETED|Overall Study||1||
48754380|NCT03287791|102187703|FG000|mITT Population|Overall Study||291|Safety Population, met inclusion/exclusion criteria, have ≥1 post-baseline efficacy data|
48754381|NCT03287791|102187704|FG001|mITT Population|Overall Study||291|Safety Population, met inclusion/exclusion criteria, have ≥1 post-baseline efficacy data|
48754382|NCT03287791|102187705|FG002|mITT Population|Overall Study||283|Safety Population, met inclusion/exclusion criteria, have ≥1 post-baseline efficacy data|
48754383|NCT03287791|102187703|FG000|PP Population|Overall Study||262|mITT, \>75-125% doses and \>6 consecutive doses, or discontinued for lack of treatment-completed ≥8wks|
48754384|NCT03287791|102187704|FG001|PP Population|Overall Study||259|mITT, \>75-125% doses and \>6 consecutive doses, or discontinued for lack of treatment-completed ≥8wks|
48754385|NCT03287791|102187705|FG002|PP Population|Overall Study||245|mITT, \>75-125% doses and \>6 consecutive doses, or discontinued for lack of treatment-completed ≥8wks|
48754386|NCT03287791|102187703|FG000|COMPLETED|Overall Study||280||
48754387|NCT03287791|102187704|FG001|COMPLETED|Overall Study||276||
48754388|NCT03287791|102187705|FG002|COMPLETED|Overall Study||264||
48754389|NCT03287791|102187703|FG000|NOT COMPLETED|Overall Study||32||
48754390|NCT03287791|102187704|FG001|NOT COMPLETED|Overall Study||36||
48754391|NCT03287791|102187705|FG002|NOT COMPLETED|Overall Study||36||
48754392|NCT04423718|102187706|FG000|STARTED|Overall Study||337|Randomized|
48754393|NCT04423718|102187707|FG001|STARTED|Overall Study||336|Randomized|
48754394|NCT04423718|102187708|FG002|STARTED|Overall Study||338|Randomized|
48754395|NCT04423718|102187706|FG000|Treated|Overall Study||336||
48754396|NCT04423718|102187707|FG001|Treated|Overall Study||335||
48754397|NCT04423718|102187708|FG002|Treated|Overall Study||338||
48754398|NCT04423718|102187706|FG000|Completed Week 48|Overall Study||309||
48754399|NCT04423718|102187707|FG001|Completed Week 48|Overall Study||316||
48754400|NCT04423718|102187708|FG002|Completed Week 48|Overall Study||312||
48754401|NCT04423718|102187706|FG000|COMPLETED|Overall Study||305|Completed study treatment until Week 60|
48754402|NCT04423718|102187707|FG001|COMPLETED|Overall Study||310|Completed study treatment until Week 60|
48754403|NCT04423718|102187708|FG002|COMPLETED|Overall Study||308|Completed study treatment until Week 60|
48754404|NCT04423718|102187706|FG000|NOT COMPLETED|Overall Study||32||
48754405|NCT04423718|102187707|FG001|NOT COMPLETED|Overall Study||26||
48754406|NCT04423718|102187708|FG002|NOT COMPLETED|Overall Study||30||
48754407|NCT03253393|102187709|FG000|STARTED|First Intervention||12||
48754408|NCT03253393|102187710|FG001|STARTED|First Intervention||13||
48754409|NCT03253393|102187711|FG002|STARTED|First Intervention||0||
48754410|NCT03253393|102187709|FG000|COMPLETED|First Intervention||12||
48754411|NCT03253393|102187710|FG001|COMPLETED|First Intervention||13||
48754412|NCT03253393|102187711|FG002|COMPLETED|First Intervention||0||
48754413|NCT03253393|102187709|FG000|NOT COMPLETED|First Intervention||0||
48754414|NCT03253393|102187710|FG001|NOT COMPLETED|First Intervention||0||
48754415|NCT03253393|102187711|FG002|NOT COMPLETED|First Intervention||0||
48754416|NCT03253393|102187709|FG000|STARTED|Washout (Minimum 48 Hours)||12||
48754417|NCT03253393|102187710|FG001|STARTED|Washout (Minimum 48 Hours)||13||
48754418|NCT03253393|102187711|FG002|STARTED|Washout (Minimum 48 Hours)||0||
48754419|NCT03253393|102187709|FG000|COMPLETED|Washout (Minimum 48 Hours)||12||
48754420|NCT03253393|102187710|FG001|COMPLETED|Washout (Minimum 48 Hours)||13||
48754421|NCT03253393|102187711|FG002|COMPLETED|Washout (Minimum 48 Hours)||0||
48754422|NCT03253393|102187709|FG000|NOT COMPLETED|Washout (Minimum 48 Hours)||0||
48754423|NCT03253393|102187710|FG001|NOT COMPLETED|Washout (Minimum 48 Hours)||0||
48339132|NCT03372941|101159961|FG000|NOT COMPLETED|Overall Study||2||
48754424|NCT03253393|102187711|FG002|NOT COMPLETED|Washout (Minimum 48 Hours)||0||
48754425|NCT03253393|102187709|FG000|STARTED|Second Intervention||12||
48754426|NCT03253393|102187710|FG001|STARTED|Second Intervention||13||
48754427|NCT03253393|102187711|FG002|STARTED|Second Intervention||0||
48754428|NCT03253393|102187709|FG000|COMPLETED|Second Intervention||12||
48754429|NCT03253393|102187710|FG001|COMPLETED|Second Intervention||13||
48754430|NCT03253393|102187711|FG002|COMPLETED|Second Intervention||0||
48339133|NCT03372941|101159962|FG001|NOT COMPLETED|Overall Study||4||
48339134|NCT02899156|101159963|FG000|STARTED|Overall Study||11||
48339135|NCT02899156|101159964|FG001|STARTED|Overall Study||11||
48339136|NCT02899156|101159963|FG000|COMPLETED|Overall Study||10||
48754431|NCT03253393|102187709|FG000|NOT COMPLETED|Second Intervention||0||
48754432|NCT03253393|102187710|FG001|NOT COMPLETED|Second Intervention||0||
48754433|NCT03253393|102187711|FG002|NOT COMPLETED|Second Intervention||0||
48754434|NCT03253393|102187709|FG000|STARTED|Washout (Minimum 48 Hours)||12||
48754435|NCT03253393|102187710|FG001|STARTED|Washout (Minimum 48 Hours)||13||
48754436|NCT03253393|102187711|FG002|STARTED|Washout (Minimum 48 Hours)||0||
48178464|NCT04057820|100757789|FG003|COMPLETED|Period 7||9||2
48178465|NCT04057820|100757790|FG004|COMPLETED|Period 7||0||0
48178466|NCT04057820|100757791|FG005|COMPLETED|Period 7||14||3
48178467|NCT04057820|100757792|FG006|COMPLETED|Period 7||0||0
48178468|NCT04057820|100757793|FG007|COMPLETED|Period 7||15||3
48178469|NCT04057820|100757794|FG008|COMPLETED|Period 7||0||0
48178470|NCT04057820|100757795|FG009|COMPLETED|Period 7||34||4
48178471|NCT04057820|100757796|FG010|COMPLETED|Period 7||0||0
48178472|NCT04057820|100757797|FG011|COMPLETED|Period 7||0||0
48339137|NCT02899156|101159964|FG001|COMPLETED|Overall Study||10||
48339138|NCT02899156|101159963|FG000|NOT COMPLETED|Overall Study||1||
48339139|NCT02899156|101159964|FG001|NOT COMPLETED|Overall Study||1||
48339140|NCT02911688|101159965|FG000|STARTED|First Intervention||9||
48178473|NCT04057820|100757798|FG012|COMPLETED|Period 7||12||3
48178474|NCT04057820|100757799|FG013|COMPLETED|Period 7||0||0
48178475|NCT04057820|100757800|FG014|COMPLETED|Period 7||19||3
48178476|NCT04057820|100757801|FG015|COMPLETED|Period 7||0||0
48178477|NCT04057820|100757786|FG000|NOT COMPLETED|Period 7||0||0
48178478|NCT04057820|100757787|FG001|NOT COMPLETED|Period 7||0||0
48178479|NCT04057820|100757788|FG002|NOT COMPLETED|Period 7||0||0
48178480|NCT04057820|100757789|FG003|NOT COMPLETED|Period 7||0||0
48178481|NCT04057820|100757790|FG004|NOT COMPLETED|Period 7||0||0
48178482|NCT04057820|100757791|FG005|NOT COMPLETED|Period 7||0||0
48178483|NCT04057820|100757792|FG006|NOT COMPLETED|Period 7||0||0
48178484|NCT04057820|100757793|FG007|NOT COMPLETED|Period 7||0||0
48178485|NCT04057820|100757794|FG008|NOT COMPLETED|Period 7||0||0
48178486|NCT04057820|100757795|FG009|NOT COMPLETED|Period 7||0||0
48178487|NCT04057820|100757796|FG010|NOT COMPLETED|Period 7||0||0
48178488|NCT04057820|100757797|FG011|NOT COMPLETED|Period 7||0||0
48178489|NCT04057820|100757798|FG012|NOT COMPLETED|Period 7||0||0
48178490|NCT04057820|100757799|FG013|NOT COMPLETED|Period 7||0||0
48178491|NCT04057820|100757800|FG014|NOT COMPLETED|Period 7||0||0
48178492|NCT04057820|100757801|FG015|NOT COMPLETED|Period 7||0||0
48178493|NCT04057820|100757786|FG000|STARTED|Period 8||0||0
48178494|NCT04057820|100757787|FG001|STARTED|Period 8||21||4
48178495|NCT04057820|100757788|FG002|STARTED|Period 8||0||0
48178496|NCT04057820|100757789|FG003|STARTED|Period 8||10||2
48178497|NCT04057820|100757790|FG004|STARTED|Period 8||0||0
48178498|NCT04057820|100757791|FG005|STARTED|Period 8||14||3
48178499|NCT04057820|100757792|FG006|STARTED|Period 8||0||0
48178500|NCT04057820|100757793|FG007|STARTED|Period 8||18||3
48178501|NCT04057820|100757794|FG008|STARTED|Period 8||0||0
48178502|NCT04057820|100757795|FG009|STARTED|Period 8||32||4
48178503|NCT04057820|100757796|FG010|STARTED|Period 8||0||0
48178504|NCT04057820|100757797|FG011|STARTED|Period 8||9||4
48178505|NCT04057820|100757798|FG012|STARTED|Period 8||0||0
48178506|NCT04057820|100757799|FG013|STARTED|Period 8||0||0
48178507|NCT04057820|100757800|FG014|STARTED|Period 8||22||3
48178508|NCT04057820|100757801|FG015|STARTED|Period 8||0||0
48178509|NCT04057820|100757786|FG000|COMPLETED|Period 8||0||0
48178510|NCT04057820|100757787|FG001|COMPLETED|Period 8||21||4
48178511|NCT04057820|100757788|FG002|COMPLETED|Period 8||0||0
48178512|NCT04057820|100757789|FG003|COMPLETED|Period 8||10||2
48178513|NCT04057820|100757790|FG004|COMPLETED|Period 8||0||0
48178514|NCT04057820|100757791|FG005|COMPLETED|Period 8||14||3
48631931|NCT01712711|101881661|FG000|NOT COMPLETED|Overall Study||0||
48631932|NCT01712711|101881662|FG001|NOT COMPLETED|Overall Study||0||
48631933|NCT00963508|101881663|FG000|STARTED|Overall Study||206||
48631934|NCT00963508|101881664|FG001|STARTED|Overall Study||197||
48178515|NCT04057820|100757792|FG006|COMPLETED|Period 8||0||0
48631935|NCT00963508|101881663|FG000|COMPLETED|Overall Study||196||
48178516|NCT04057820|100757793|FG007|COMPLETED|Period 8||18||3
48178517|NCT04057820|100757794|FG008|COMPLETED|Period 8||0||0
48178518|NCT04057820|100757795|FG009|COMPLETED|Period 8||32||4
48178519|NCT04057820|100757796|FG010|COMPLETED|Period 8||0||0
48178520|NCT04057820|100757797|FG011|COMPLETED|Period 8||9||4
48178521|NCT04057820|100757798|FG012|COMPLETED|Period 8||0||0
48178522|NCT04057820|100757799|FG013|COMPLETED|Period 8||0||0
48178523|NCT04057820|100757800|FG014|COMPLETED|Period 8||22||3
48178524|NCT04057820|100757801|FG015|COMPLETED|Period 8||0||0
48631936|NCT00963508|101881664|FG001|COMPLETED|Overall Study||169||
48631937|NCT00963508|101881663|FG000|NOT COMPLETED|Overall Study||10||
48339141|NCT02911688|101159966|FG001|STARTED|First Intervention||9||
48178525|NCT04057820|100757786|FG000|NOT COMPLETED|Period 8||0||0
48178526|NCT04057820|100757787|FG001|NOT COMPLETED|Period 8||0||0
48178527|NCT04057820|100757788|FG002|NOT COMPLETED|Period 8||0||0
48178528|NCT04057820|100757789|FG003|NOT COMPLETED|Period 8||0||0
48178529|NCT04057820|100757790|FG004|NOT COMPLETED|Period 8||0||0
48178530|NCT04057820|100757791|FG005|NOT COMPLETED|Period 8||0||0
48178531|NCT04057820|100757792|FG006|NOT COMPLETED|Period 8||0||0
48178532|NCT04057820|100757793|FG007|NOT COMPLETED|Period 8||0||0
48339142|NCT02911688|101159965|FG000|Received Intervention|First Intervention||9||
48178533|NCT04057820|100757794|FG008|NOT COMPLETED|Period 8||0||0
48339143|NCT02911688|101159966|FG001|Received Intervention|First Intervention||9||
48178534|NCT04057820|100757795|FG009|NOT COMPLETED|Period 8||0||0
48178535|NCT04057820|100757796|FG010|NOT COMPLETED|Period 8||0||0
48178536|NCT04057820|100757797|FG011|NOT COMPLETED|Period 8||0||0
48178537|NCT04057820|100757798|FG012|NOT COMPLETED|Period 8||0||0
48178538|NCT04057820|100757799|FG013|NOT COMPLETED|Period 8||0||0
48178539|NCT04057820|100757800|FG014|NOT COMPLETED|Period 8||0||0
48178540|NCT04057820|100757801|FG015|NOT COMPLETED|Period 8||0||0
48178541|NCT04057820|100757786|FG000|STARTED|Period 9||0||0
48178542|NCT04057820|100757787|FG001|STARTED|Period 9||18||4
48178543|NCT04057820|100757788|FG002|STARTED|Period 9||0||0
48178544|NCT04057820|100757789|FG003|STARTED|Period 9||3||2
48178545|NCT04057820|100757790|FG004|STARTED|Period 9||0||0
48178546|NCT04057820|100757791|FG005|STARTED|Period 9||5||3
48178547|NCT04057820|100757792|FG006|STARTED|Period 9||0||0
48178548|NCT04057820|100757793|FG007|STARTED|Period 9||17||3
48178549|NCT04057820|100757794|FG008|STARTED|Period 9||0||0
48178550|NCT04057820|100757795|FG009|STARTED|Period 9||28||4
48178551|NCT04057820|100757796|FG010|STARTED|Period 9||0||0
48178552|NCT04057820|100757797|FG011|STARTED|Period 9||15||4
48178553|NCT04057820|100757798|FG012|STARTED|Period 9||0||0
48178554|NCT04057820|100757799|FG013|STARTED|Period 9||14||3
48178555|NCT04057820|100757800|FG014|STARTED|Period 9||0||0
48178556|NCT04057820|100757801|FG015|STARTED|Period 9||0||0
48178557|NCT04057820|100757786|FG000|COMPLETED|Period 9||0||0
48178558|NCT04057820|100757787|FG001|COMPLETED|Period 9||18||4
48178559|NCT04057820|100757788|FG002|COMPLETED|Period 9||0||0
48178560|NCT04057820|100757789|FG003|COMPLETED|Period 9||3||2
48178561|NCT04057820|100757790|FG004|COMPLETED|Period 9||0||0
48178562|NCT04057820|100757791|FG005|COMPLETED|Period 9||5||3
48178563|NCT04057820|100757792|FG006|COMPLETED|Period 9||0||0
48178564|NCT04057820|100757793|FG007|COMPLETED|Period 9||17||3
48178565|NCT04057820|100757794|FG008|COMPLETED|Period 9||0||0
48178566|NCT04057820|100757795|FG009|COMPLETED|Period 9||28||4
48178567|NCT04057820|100757796|FG010|COMPLETED|Period 9||0||0
48178568|NCT04057820|100757797|FG011|COMPLETED|Period 9||15||4
48178569|NCT04057820|100757798|FG012|COMPLETED|Period 9||0||0
48178570|NCT04057820|100757799|FG013|COMPLETED|Period 9||14||3
48178571|NCT04057820|100757800|FG014|COMPLETED|Period 9||0||0
48178572|NCT04057820|100757801|FG015|COMPLETED|Period 9||0||0
48178573|NCT04057820|100757786|FG000|NOT COMPLETED|Period 9||0||0
48178574|NCT04057820|100757787|FG001|NOT COMPLETED|Period 9||0||0
48178575|NCT04057820|100757788|FG002|NOT COMPLETED|Period 9||0||0
48178576|NCT04057820|100757789|FG003|NOT COMPLETED|Period 9||0||0
48178577|NCT04057820|100757790|FG004|NOT COMPLETED|Period 9||0||0
48178578|NCT04057820|100757791|FG005|NOT COMPLETED|Period 9||0||0
48178579|NCT04057820|100757792|FG006|NOT COMPLETED|Period 9||0||0
48178580|NCT04057820|100757793|FG007|NOT COMPLETED|Period 9||0||0
48178581|NCT04057820|100757794|FG008|NOT COMPLETED|Period 9||0||0
48178582|NCT04057820|100757795|FG009|NOT COMPLETED|Period 9||0||0
48178583|NCT04057820|100757796|FG010|NOT COMPLETED|Period 9||0||0
48178584|NCT04057820|100757797|FG011|NOT COMPLETED|Period 9||0||0
48178585|NCT04057820|100757798|FG012|NOT COMPLETED|Period 9||0||0
48178586|NCT04057820|100757799|FG013|NOT COMPLETED|Period 9||0||0
48178587|NCT04057820|100757800|FG014|NOT COMPLETED|Period 9||0||0
48754437|NCT03253393|102187709|FG000|COMPLETED|Washout (Minimum 48 Hours)||6||
48754438|NCT03253393|102187710|FG001|COMPLETED|Washout (Minimum 48 Hours)||6||
48754439|NCT03253393|102187711|FG002|COMPLETED|Washout (Minimum 48 Hours)||0||
48178588|NCT04057820|100757801|FG015|NOT COMPLETED|Period 9||0||0
48178589|NCT04057820|100757786|FG000|STARTED|Period 10||0||0
48178590|NCT04057820|100757787|FG001|STARTED|Period 10||26||4
48178591|NCT04057820|100757788|FG002|STARTED|Period 10||0||0
48178592|NCT04057820|100757789|FG003|STARTED|Period 10||8||2
48178593|NCT04057820|100757790|FG004|STARTED|Period 10||0||0
48754440|NCT03253393|102187709|FG000|NOT COMPLETED|Washout (Minimum 48 Hours)||6||
48754441|NCT03253393|102187710|FG001|NOT COMPLETED|Washout (Minimum 48 Hours)||7||
48754442|NCT03253393|102187711|FG002|NOT COMPLETED|Washout (Minimum 48 Hours)||0||
48754443|NCT03253393|102187709|FG000|STARTED|Third Intervention||6||
48178594|NCT04057820|100757791|FG005|STARTED|Period 10||17||3
48178595|NCT04057820|100757792|FG006|STARTED|Period 10||0||0
48178596|NCT04057820|100757793|FG007|STARTED|Period 10||7||3
48178597|NCT04057820|100757794|FG008|STARTED|Period 10||0||0
48178598|NCT04057820|100757795|FG009|STARTED|Period 10||32||4
48178599|NCT04057820|100757796|FG010|STARTED|Period 10||0||0
48178600|NCT04057820|100757797|FG011|STARTED|Period 10||17||4
48178601|NCT04057820|100757798|FG012|STARTED|Period 10||0||0
48178602|NCT04057820|100757799|FG013|STARTED|Period 10||23||3
48178603|NCT04057820|100757800|FG014|STARTED|Period 10||0||0
48178604|NCT04057820|100757801|FG015|STARTED|Period 10||15||3
48178605|NCT04057820|100757786|FG000|COMPLETED|Period 10||0||0
48754444|NCT03253393|102187710|FG001|STARTED|Third Intervention||6||
48754445|NCT03253393|102187711|FG002|STARTED|Third Intervention||13||
48754446|NCT03253393|102187709|FG000|COMPLETED|Third Intervention||6||
48178606|NCT04057820|100757787|FG001|COMPLETED|Period 10||26||4
48178607|NCT04057820|100757788|FG002|COMPLETED|Period 10||0||0
48178608|NCT04057820|100757789|FG003|COMPLETED|Period 10||8||2
48178609|NCT04057820|100757790|FG004|COMPLETED|Period 10||0||0
48178610|NCT04057820|100757791|FG005|COMPLETED|Period 10||17||3
48178611|NCT04057820|100757792|FG006|COMPLETED|Period 10||0||0
48178612|NCT04057820|100757793|FG007|COMPLETED|Period 10||7||3
48178613|NCT04057820|100757794|FG008|COMPLETED|Period 10||0||0
48178614|NCT04057820|100757795|FG009|COMPLETED|Period 10||32||4
48178615|NCT04057820|100757796|FG010|COMPLETED|Period 10||0||0
48178616|NCT04057820|100757797|FG011|COMPLETED|Period 10||17||4
48178617|NCT04057820|100757798|FG012|COMPLETED|Period 10||0||0
48178618|NCT04057820|100757799|FG013|COMPLETED|Period 10||23||3
48178619|NCT04057820|100757800|FG014|COMPLETED|Period 10||0||0
48178620|NCT04057820|100757801|FG015|COMPLETED|Period 10||15||3
48178621|NCT04057820|100757786|FG000|NOT COMPLETED|Period 10||0||0
48178622|NCT04057820|100757787|FG001|NOT COMPLETED|Period 10||0||0
48178623|NCT04057820|100757788|FG002|NOT COMPLETED|Period 10||0||0
48178624|NCT04057820|100757789|FG003|NOT COMPLETED|Period 10||0||0
48178625|NCT04057820|100757790|FG004|NOT COMPLETED|Period 10||0||0
48178626|NCT04057820|100757791|FG005|NOT COMPLETED|Period 10||0||0
48178627|NCT04057820|100757792|FG006|NOT COMPLETED|Period 10||0||0
48754447|NCT03253393|102187710|FG001|COMPLETED|Third Intervention||6||
48754448|NCT03253393|102187711|FG002|COMPLETED|Third Intervention||13||
48178628|NCT04057820|100757793|FG007|NOT COMPLETED|Period 10||0||0
48178629|NCT04057820|100757794|FG008|NOT COMPLETED|Period 10||0||0
48178630|NCT04057820|100757795|FG009|NOT COMPLETED|Period 10||0||0
48178631|NCT04057820|100757796|FG010|NOT COMPLETED|Period 10||0||0
48178632|NCT04057820|100757797|FG011|NOT COMPLETED|Period 10||0||0
48178633|NCT04057820|100757798|FG012|NOT COMPLETED|Period 10||0||0
48178634|NCT04057820|100757799|FG013|NOT COMPLETED|Period 10||0||0
48178635|NCT04057820|100757800|FG014|NOT COMPLETED|Period 10||0||0
48178636|NCT04057820|100757801|FG015|NOT COMPLETED|Period 10||0||0
48178637|NCT00656916|100757802|FG000|STARTED|Overall Study||1||
48178638|NCT00656916|100757803|FG001|STARTED|Overall Study||0||
48178639|NCT00656916|100757802|FG000|COMPLETED|Overall Study||1||
48178640|NCT00656916|100757803|FG001|COMPLETED|Overall Study||0||
48178641|NCT00656916|100757802|FG000|NOT COMPLETED|Overall Study||0||
48178642|NCT00656916|100757803|FG001|NOT COMPLETED|Overall Study||0||
48178643|NCT01282476|100757804|FG000|STARTED|Overall Study||18||
48178644|NCT01282476|100757804|FG000|COMPLETED|Overall Study||7||
48178645|NCT01282476|100757804|FG000|NOT COMPLETED|Overall Study||11||
48178646|NCT00658736|100759915|FG000|STARTED|Overall Study||19||
48178647|NCT00658736|100759916|FG001|STARTED|Overall Study||21||
48178648|NCT00658736|100759915|FG000|COMPLETED|Overall Study||13||
48178649|NCT00658736|100759916|FG001|COMPLETED|Overall Study||19||
48178650|NCT00658736|100759915|FG000|NOT COMPLETED|Overall Study||6||
48178651|NCT00658736|100759916|FG001|NOT COMPLETED|Overall Study||2||
48178652|NCT02698436|100759917|FG000|STARTED|Overall Study||59||
48178653|NCT02698436|100759918|FG001|STARTED|Overall Study||58||
48178654|NCT02698436|100759917|FG000|COMPLETED|Overall Study||52||
48178655|NCT02698436|100759918|FG001|COMPLETED|Overall Study||51||
48178656|NCT02698436|100759917|FG000|NOT COMPLETED|Overall Study||7||
48178657|NCT02698436|100759918|FG001|NOT COMPLETED|Overall Study||7||
48339144|NCT02911688|101159965|FG000|COMPLETED|First Intervention||9||
48178658|NCT03844321|100759919|FG000|STARTED|Overall Study||2220||
48178659|NCT03844321|100759920|FG001|STARTED|Overall Study||2192||
48178660|NCT03844321|100759919|FG000|COMPLETED|Overall Study||579||
48178661|NCT03844321|100759920|FG001|COMPLETED|Overall Study||533||
48178662|NCT03844321|100759919|FG000|NOT COMPLETED|Overall Study||1641||
48178663|NCT03844321|100759920|FG001|NOT COMPLETED|Overall Study||1659||
48178664|NCT02339389|100759921|FG000|STARTED|Overall Study||57||
48178665|NCT02339389|100759921|FG000|COMPLETED|Overall Study||41||
48178666|NCT02339389|100759921|FG000|NOT COMPLETED|Overall Study||16||
48178667|NCT00589550|100759922|FG000|STARTED|Overall Study||1||
48178668|NCT00589550|100759922|FG000|Withdrew From Study|Overall Study||1||
48178669|NCT00589550|100759922|FG000|COMPLETED|Overall Study||0||
48178670|NCT00589550|100759922|FG000|NOT COMPLETED|Overall Study||1||
48178671|NCT02501135|100759923|FG000|STARTED|Overall Study||281||
48178672|NCT02501135|100759923|FG000|COMPLETED|Overall Study||281||
48178673|NCT02501135|100759923|FG000|NOT COMPLETED|Overall Study||0||
48178674|NCT02694640|100759924|FG000|STARTED|Overall Study||55||
48178675|NCT02694640|100759925|FG001|STARTED|Overall Study||53||
48631938|NCT00963508|101881664|FG001|NOT COMPLETED|Overall Study||28||
48631939|NCT00630916|101881665|FG000|STARTED|Overall Study||756||
48631940|NCT00630916|101881665|FG000|Study Cohort|Overall Study||699||
48631941|NCT00630916|101881665|FG000|COMPLETED|Overall Study||546||
48631942|NCT00630916|101881665|FG000|NOT COMPLETED|Overall Study||210||
48631943|NCT01145482|101881666|FG000|STARTED|First Intervention (1 Day)||6||
48754449|NCT03253393|102187709|FG000|NOT COMPLETED|Third Intervention||0||
48178676|NCT02694640|100759926|FG002|STARTED|Overall Study||53||
48178677|NCT02694640|100759924|FG000|COMPLETED|Overall Study||48||
48178678|NCT02694640|100759925|FG001|COMPLETED|Overall Study||43||
48178679|NCT02694640|100759926|FG002|COMPLETED|Overall Study||35||
48178680|NCT02694640|100759924|FG000|NOT COMPLETED|Overall Study||7||
48178681|NCT02694640|100759925|FG001|NOT COMPLETED|Overall Study||10||
48178682|NCT02694640|100759926|FG002|NOT COMPLETED|Overall Study||18||
48631944|NCT01145482|101881667|FG001|STARTED|First Intervention (1 Day)||6||
48178683|NCT00873093|100759927|FG000|STARTED|Overall Study||4||
48178684|NCT00873093|100759928|FG001|STARTED|Overall Study||62||
48178685|NCT00873093|100759929|FG002|STARTED|Overall Study||49||
48178686|NCT00873093|100759930|FG003|STARTED|Overall Study||23||
48178687|NCT00873093|100759931|FG004|STARTED|Overall Study||10||
48178688|NCT00873093|100759927|FG000|COMPLETED|Overall Study||3||
48339145|NCT02911688|101159966|FG001|COMPLETED|First Intervention||9||
48339146|NCT02911688|101159965|FG000|NOT COMPLETED|First Intervention||0||
48339147|NCT02911688|101159966|FG001|NOT COMPLETED|First Intervention||0||
48339148|NCT02911688|101159965|FG000|STARTED|Washout||9||
48178689|NCT00873093|100759928|FG001|COMPLETED|Overall Study||35||
48178690|NCT00873093|100759929|FG002|COMPLETED|Overall Study||33||
48178691|NCT00873093|100759930|FG003|COMPLETED|Overall Study||12||
48178692|NCT00873093|100759931|FG004|COMPLETED|Overall Study||8||
48178693|NCT00873093|100759927|FG000|NOT COMPLETED|Overall Study||1||
48178694|NCT00873093|100759928|FG001|NOT COMPLETED|Overall Study||27||
48178695|NCT00873093|100759929|FG002|NOT COMPLETED|Overall Study||16||
48178696|NCT00873093|100759930|FG003|NOT COMPLETED|Overall Study||11||
48178697|NCT00873093|100759931|FG004|NOT COMPLETED|Overall Study||2||
48178698|NCT05462652|100759932|FG000|STARTED|Overall Study||111||
48178699|NCT05462652|100759933|FG001|STARTED|Overall Study||112||
48178700|NCT05462652|100759932|FG000|COMPLETED|Overall Study||96||
48178701|NCT05462652|100759933|FG001|COMPLETED|Overall Study||98||
48178702|NCT05462652|100759932|FG000|NOT COMPLETED|Overall Study||15||
48178703|NCT05462652|100759933|FG001|NOT COMPLETED|Overall Study||14||
48178704|NCT02708238|100759934|FG000|STARTED|Overall Study||60||
48178705|NCT02708238|100759935|FG001|STARTED|Overall Study||60||
48178706|NCT02708238|100759936|FG002|STARTED|Overall Study||60||
48339149|NCT02911688|101159966|FG001|STARTED|Washout||9||
48339150|NCT02911688|101159965|FG000|COMPLETED|Washout||8||
48339151|NCT02911688|101159966|FG001|COMPLETED|Washout||7||
48339152|NCT02911688|101159965|FG000|NOT COMPLETED|Washout||1||
48339153|NCT02911688|101159966|FG001|NOT COMPLETED|Washout||2||
48339154|NCT02911688|101159965|FG000|STARTED|Second Intervention||8||
48339155|NCT02911688|101159966|FG001|STARTED|Second Intervention||7||
48339156|NCT02911688|101159965|FG000|COMPLETED|Second Intervention||8||
48339157|NCT02911688|101159966|FG001|COMPLETED|Second Intervention||7||
48339158|NCT02911688|101159965|FG000|NOT COMPLETED|Second Intervention||0||
48339159|NCT02911688|101159966|FG001|NOT COMPLETED|Second Intervention||0||
48339160|NCT00559273|101159967|FG000|STARTED|Correction Period (20 Weeks)||153||
48339161|NCT00559273|101159968|FG001|STARTED|Correction Period (20 Weeks)||154||
48339162|NCT00559273|101159967|FG000|Treated|Correction Period (20 Weeks)||151||
48339163|NCT00559273|101159968|FG001|Treated|Correction Period (20 Weeks)||154||
48339164|NCT00559273|101159967|FG000|COMPLETED|Correction Period (20 Weeks)||144||
48339165|NCT00559273|101159968|FG001|COMPLETED|Correction Period (20 Weeks)||142||
48339166|NCT00559273|101159967|FG000|NOT COMPLETED|Correction Period (20 Weeks)||9||
48339167|NCT00559273|101159968|FG001|NOT COMPLETED|Correction Period (20 Weeks)||12||
48339168|NCT00559273|101159967|FG000|STARTED|Evaluation Period (8 Weeks)||144||
48339169|NCT00559273|101159968|FG001|STARTED|Evaluation Period (8 Weeks)||142||
48631945|NCT01145482|101881666|FG000|COMPLETED|First Intervention (1 Day)||6||
48631946|NCT01145482|101881667|FG001|COMPLETED|First Intervention (1 Day)||5||
48631947|NCT01145482|101881666|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48339170|NCT00559273|101159967|FG000|COMPLETED|Evaluation Period (8 Weeks)||141||
48339171|NCT00559273|101159968|FG001|COMPLETED|Evaluation Period (8 Weeks)||137||
48339172|NCT00559273|101159967|FG000|NOT COMPLETED|Evaluation Period (8 Weeks)||3||
48339173|NCT00559273|101159968|FG001|NOT COMPLETED|Evaluation Period (8 Weeks)||5||
48631948|NCT01145482|101881667|FG001|NOT COMPLETED|First Intervention (1 Day)||1||
48631949|NCT01145482|101881666|FG000|STARTED|Second Intervention (1 Day)||5||
48754450|NCT03253393|102187710|FG001|NOT COMPLETED|Third Intervention||0||
48754451|NCT03253393|102187711|FG002|NOT COMPLETED|Third Intervention||0||
48754452|NCT00445549|102187712|FG000|STARTED|Overall Study||12||
48178707|NCT02708238|100759934|FG000|COMPLETED|Overall Study||60||
48339174|NCT01449708|101159969|FG000|STARTED|Overall Study||61||
48631950|NCT01145482|101881667|FG001|STARTED|Second Intervention (1 Day)||6||
48631951|NCT01145482|101881666|FG000|COMPLETED|Second Intervention (1 Day)||5||
48631952|NCT01145482|101881667|FG001|COMPLETED|Second Intervention (1 Day)||6||
48631953|NCT01145482|101881666|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48631954|NCT01145482|101881667|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48631955|NCT00458237|101881668|FG000|STARTED|Overall Study||3||
48754453|NCT00445549|102187712|FG000|COMPLETED|Overall Study||0||
48178708|NCT02708238|100759935|FG001|COMPLETED|Overall Study||59||
48339175|NCT01449708|101159970|FG001|STARTED|Overall Study||63||
48339176|NCT01449708|101159969|FG000|COMPLETED|Overall Study||59||
48339177|NCT01449708|101159970|FG001|COMPLETED|Overall Study||60||
48339178|NCT01449708|101159969|FG000|NOT COMPLETED|Overall Study||2||
48339179|NCT01449708|101159970|FG001|NOT COMPLETED|Overall Study||3||
48754454|NCT00445549|102187712|FG000|NOT COMPLETED|Overall Study||12||
48178709|NCT02708238|100759936|FG002|COMPLETED|Overall Study||57||
48178710|NCT02708238|100759934|FG000|NOT COMPLETED|Overall Study||0||
48339180|NCT02117687|101159971|FG000|STARTED|Overall Study||40||
48339181|NCT02117687|101159972|FG001|STARTED|Overall Study||40||
48339182|NCT02117687|101159971|FG000|COMPLETED|Overall Study||39||
48631956|NCT00458237|101881669|FG001|STARTED|Overall Study||3||
48631957|NCT00458237|101881670|FG002|STARTED|Overall Study||5||
48631958|NCT00458237|101881668|FG000|COMPLETED|Overall Study||3||
48339183|NCT02117687|101159972|FG001|COMPLETED|Overall Study||36||
48339184|NCT02117687|101159971|FG000|NOT COMPLETED|Overall Study||1||
48339185|NCT02117687|101159972|FG001|NOT COMPLETED|Overall Study||4||
48339186|NCT03653390|101159973|FG000|STARTED|Overall Study||183||
48339187|NCT03653390|101159974|FG001|STARTED|Overall Study||159||
48339188|NCT03653390|101159975|FG002|STARTED|Overall Study||163||
48339189|NCT03653390|101159973|FG000|3 Month Survey|Overall Study||165||
48339190|NCT03653390|101159974|FG001|3 Month Survey|Overall Study||152||
48339191|NCT03653390|101159975|FG002|3 Month Survey|Overall Study||159||
48339192|NCT03653390|101159973|FG000|7 Month Survey|Overall Study||165||
48339193|NCT03653390|101159974|FG001|7 Month Survey|Overall Study||150||
48339194|NCT03653390|101159975|FG002|7 Month Survey|Overall Study||156||
48339195|NCT03653390|101159973|FG000|COMPLETED|Overall Study||163||
48339196|NCT03653390|101159974|FG001|COMPLETED|Overall Study||150||
48339197|NCT03653390|101159975|FG002|COMPLETED|Overall Study||155||
48339198|NCT03653390|101159973|FG000|NOT COMPLETED|Overall Study||20||
48339199|NCT03653390|101159974|FG001|NOT COMPLETED|Overall Study||9||
48413416|NCT01893879|101345819|FG001|COMPLETED|Overall Study||4||
48413417|NCT01893879|101345818|FG000|NOT COMPLETED|Overall Study||2||
48413418|NCT01893879|101345819|FG001|NOT COMPLETED|Overall Study||3||
48754455|NCT02560038|102187713|FG000|STARTED|Overall Study||3||
48754456|NCT02560038|102187713|FG000|COMPLETED|Overall Study||1||
48178711|NCT02708238|100759935|FG001|NOT COMPLETED|Overall Study||1||
48413419|NCT01077310|101345820|FG000|STARTED|Overall Study||67||
48413420|NCT01077310|101345821|FG001|STARTED|Overall Study||33||
48413421|NCT01077310|101345820|FG000|COMPLETED|Overall Study||67||
48413422|NCT01077310|101345821|FG001|COMPLETED|Overall Study||33||
48413423|NCT01077310|101345820|FG000|NOT COMPLETED|Overall Study||0||
48413424|NCT01077310|101345821|FG001|NOT COMPLETED|Overall Study||0||
48413425|NCT00772889|101345822|FG000|STARTED|Overall Study||375||
48413426|NCT00772889|101345823|FG001|STARTED|Overall Study||393||
48413427|NCT00772889|101345824|FG002|STARTED|Overall Study||203||
48631959|NCT00458237|101881669|FG001|COMPLETED|Overall Study||3||
48631960|NCT00458237|101881670|FG002|COMPLETED|Overall Study||5||
48178712|NCT02708238|100759936|FG002|NOT COMPLETED|Overall Study||3||
48178713|NCT00915902|100759937|FG000|STARTED|1st Treatment Period||20||
48178714|NCT00915902|100759938|FG001|STARTED|1st Treatment Period||22||
48178715|NCT00915902|100759937|FG000|COMPLETED|1st Treatment Period||19||
48413428|NCT00772889|101345822|FG000|Completed at Day 21|Overall Study||374||
48413429|NCT00772889|101345823|FG001|Completed at Day 21|Overall Study||390||
48339200|NCT03653390|101159975|FG002|NOT COMPLETED|Overall Study||8||
48339201|NCT00236080|101159976|FG000|STARTED|Overall Study||29||
48339202|NCT00236080|101159977|FG001|STARTED|Overall Study||28||
48339203|NCT00236080|101159978|FG002|STARTED|Overall Study||27||
48339204|NCT00236080|101159979|FG003|STARTED|Overall Study||25||
48339205|NCT00236080|101159980|FG004|STARTED|Overall Study||27||
48339206|NCT00236080|101159976|FG000|COMPLETED|Overall Study||27||
48339207|NCT00236080|101159977|FG001|COMPLETED|Overall Study||27||
48339208|NCT00236080|101159978|FG002|COMPLETED|Overall Study||22||
48339209|NCT00236080|101159979|FG003|COMPLETED|Overall Study||23||
48339210|NCT00236080|101159980|FG004|COMPLETED|Overall Study||26||
48339211|NCT00236080|101159976|FG000|NOT COMPLETED|Overall Study||2||
48339212|NCT00236080|101159977|FG001|NOT COMPLETED|Overall Study||1||
48413430|NCT00772889|101345824|FG002|Completed at Day 21|Overall Study||203||
48631961|NCT00458237|101881668|FG000|NOT COMPLETED|Overall Study||0||
48631962|NCT00458237|101881669|FG001|NOT COMPLETED|Overall Study||0||
48631963|NCT00458237|101881670|FG002|NOT COMPLETED|Overall Study||0||
48631964|NCT03248297|101881671|FG000|STARTED|Overall Study||253||
48631965|NCT03248297|101881672|FG001|STARTED|Overall Study||253||
48631966|NCT03248297|101881673|FG002|STARTED|Overall Study||250||
48631967|NCT03248297|101881671|FG000|COMPLETED|Overall Study||253||
48631968|NCT03248297|101881672|FG001|COMPLETED|Overall Study||253||
48631969|NCT03248297|101881673|FG002|COMPLETED|Overall Study||250||
48631970|NCT03248297|101881671|FG000|NOT COMPLETED|Overall Study||0||
48631971|NCT03248297|101881672|FG001|NOT COMPLETED|Overall Study||0||
48631972|NCT03248297|101881673|FG002|NOT COMPLETED|Overall Study||0||
48178716|NCT00915902|100759938|FG001|COMPLETED|1st Treatment Period||22||
48178717|NCT00915902|100759937|FG000|NOT COMPLETED|1st Treatment Period||1||
48178718|NCT00915902|100759938|FG001|NOT COMPLETED|1st Treatment Period||0||
48178719|NCT00915902|100759937|FG000|STARTED|Washout (4 Weeks)||19||
48178720|NCT00915902|100759938|FG001|STARTED|Washout (4 Weeks)||22||
48339213|NCT00236080|101159978|FG002|NOT COMPLETED|Overall Study||5||
48339214|NCT00236080|101159979|FG003|NOT COMPLETED|Overall Study||2||
48339215|NCT00236080|101159980|FG004|NOT COMPLETED|Overall Study||1||
48339216|NCT01773421|101159981|FG000|STARTED|Treatment Phase||7||
48339217|NCT01773421|101159982|FG001|STARTED|Treatment Phase||8||
48339218|NCT01773421|101159983|FG002|STARTED|Treatment Phase||19||
48413431|NCT00772889|101345822|FG000|COMPLETED|Overall Study||353||
48413432|NCT00772889|101345823|FG001|COMPLETED|Overall Study||375||
48413433|NCT00772889|101345824|FG002|COMPLETED|Overall Study||187||
48631973|NCT00747214|101881674|FG000|STARTED|Overall Study||27||
48631974|NCT00747214|101881675|FG001|STARTED|Overall Study||32||
48339219|NCT01773421|101159984|FG003|STARTED|Treatment Phase||7||
48339220|NCT01773421|101159985|FG004|STARTED|Treatment Phase||0||
48339221|NCT01773421|101159986|FG005|STARTED|Treatment Phase||0||
48339222|NCT01773421|101159987|FG006|STARTED|Treatment Phase||0||
48339223|NCT01773421|101159981|FG000|COMPLETED|Treatment Phase||7||
48339224|NCT01773421|101159982|FG001|COMPLETED|Treatment Phase||8||
48339225|NCT01773421|101159983|FG002|COMPLETED|Treatment Phase||13||
48339226|NCT01773421|101159984|FG003|COMPLETED|Treatment Phase||5||
48339227|NCT01773421|101159985|FG004|COMPLETED|Treatment Phase||0||
48339228|NCT01773421|101159986|FG005|COMPLETED|Treatment Phase||0||
48339229|NCT01773421|101159987|FG006|COMPLETED|Treatment Phase||0||
48339230|NCT01773421|101159981|FG000|NOT COMPLETED|Treatment Phase||0||
48339231|NCT01773421|101159982|FG001|NOT COMPLETED|Treatment Phase||0||
48339232|NCT01773421|101159983|FG002|NOT COMPLETED|Treatment Phase||6||
48339233|NCT01773421|101159984|FG003|NOT COMPLETED|Treatment Phase||2||
48339234|NCT01773421|101159985|FG004|NOT COMPLETED|Treatment Phase||0||
48339235|NCT01773421|101159986|FG005|NOT COMPLETED|Treatment Phase||0||
48339236|NCT01773421|101159987|FG006|NOT COMPLETED|Treatment Phase||0||
48339237|NCT01773421|101159981|FG000|STARTED|Extension Phase||0||
48339238|NCT01773421|101159982|FG001|STARTED|Extension Phase||0||
48339239|NCT01773421|101159983|FG002|STARTED|Extension Phase||0||
48339240|NCT01773421|101159984|FG003|STARTED|Extension Phase||0||
48339241|NCT01773421|101159985|FG004|STARTED|Extension Phase||15||
48339242|NCT01773421|101159986|FG005|STARTED|Extension Phase||3||
48339243|NCT01773421|101159987|FG006|STARTED|Extension Phase||0||
48339244|NCT01773421|101159981|FG000|COMPLETED|Extension Phase||0||
48339245|NCT01773421|101159982|FG001|COMPLETED|Extension Phase||0||
48339246|NCT01773421|101159983|FG002|COMPLETED|Extension Phase||0||
48339247|NCT01773421|101159984|FG003|COMPLETED|Extension Phase||0||
48339248|NCT01773421|101159985|FG004|COMPLETED|Extension Phase||12||
48339249|NCT01773421|101159986|FG005|COMPLETED|Extension Phase||1||
48339250|NCT01773421|101159987|FG006|COMPLETED|Extension Phase||0||
48339251|NCT01773421|101159981|FG000|NOT COMPLETED|Extension Phase||0||
48339252|NCT01773421|101159982|FG001|NOT COMPLETED|Extension Phase||0||
48339253|NCT01773421|101159983|FG002|NOT COMPLETED|Extension Phase||0||
48339254|NCT01773421|101159984|FG003|NOT COMPLETED|Extension Phase||0||
48339255|NCT01773421|101159985|FG004|NOT COMPLETED|Extension Phase||3||
48339256|NCT01773421|101159986|FG005|NOT COMPLETED|Extension Phase||2||
48339257|NCT01773421|101159987|FG006|NOT COMPLETED|Extension Phase||0||
48339258|NCT02971202|101159988|FG000|STARTED|Overall Study||12||
48339259|NCT02971202|101159989|FG001|STARTED|Overall Study||10||
48339260|NCT02971202|101159990|FG002|STARTED|Overall Study||11||
48339261|NCT02971202|101159988|FG000|Started Study|Overall Study||11||
48339262|NCT02971202|101159989|FG001|Started Study|Overall Study||10||
48339263|NCT02971202|101159990|FG002|Started Study|Overall Study||10||
48339264|NCT02971202|101159988|FG000|COMPLETED|Overall Study||10||
48339265|NCT02971202|101159989|FG001|COMPLETED|Overall Study||10||
48339266|NCT02971202|101159990|FG002|COMPLETED|Overall Study||10||
48339267|NCT02971202|101159988|FG000|NOT COMPLETED|Overall Study||2||
48339268|NCT02971202|101159989|FG001|NOT COMPLETED|Overall Study||0||
48339269|NCT02971202|101159990|FG002|NOT COMPLETED|Overall Study||1||
48339270|NCT00638937|101159991|FG000|STARTED|Overall Study||37||
48339271|NCT00638937|101159991|FG000|COMPLETED|Overall Study||37||
48339272|NCT00638937|101159991|FG000|NOT COMPLETED|Overall Study||0||
48339273|NCT01084551|101159992|FG000|STARTED|Overall Study||95||
48339274|NCT01084551|101159993|FG001|STARTED|Overall Study||95||
48339275|NCT01084551|101159994|FG002|STARTED|Overall Study||94||
48339276|NCT01084551|101159992|FG000|COMPLETED|Overall Study||86||
48339277|NCT01084551|101159993|FG001|COMPLETED|Overall Study||81||
48339278|NCT01084551|101159994|FG002|COMPLETED|Overall Study||86||
48339279|NCT01084551|101159992|FG000|NOT COMPLETED|Overall Study||9||
48339280|NCT01084551|101159993|FG001|NOT COMPLETED|Overall Study||14||
48339281|NCT01084551|101159994|FG002|NOT COMPLETED|Overall Study||8||
48339282|NCT02495948|101159995|FG000|STARTED|Period 1, First 30 Days of Wear||83||
48339283|NCT02495948|101159996|FG001|STARTED|Period 1, First 30 Days of Wear||84||
48339284|NCT02495948|101159995|FG000|COMPLETED|Period 1, First 30 Days of Wear||83||
48339285|NCT02495948|101159996|FG001|COMPLETED|Period 1, First 30 Days of Wear||83||
48339286|NCT02495948|101159995|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||0||
48339287|NCT02495948|101159996|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||1||
48339288|NCT02495948|101159995|FG000|STARTED|Period 2, Second 30 Days of Wear||83||
48339289|NCT02495948|101159996|FG001|STARTED|Period 2, Second 30 Days of Wear||83||
48339290|NCT02495948|101159995|FG000|COMPLETED|Period 2, Second 30 Days of Wear||82||
48339291|NCT02495948|101159996|FG001|COMPLETED|Period 2, Second 30 Days of Wear||82||
48631975|NCT00747214|101881674|FG000|COMPLETED|Overall Study||19||
48631976|NCT00747214|101881675|FG001|COMPLETED|Overall Study||29||
48339292|NCT02495948|101159995|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||1||
48631977|NCT00747214|101881674|FG000|NOT COMPLETED|Overall Study||8||
48631978|NCT00747214|101881675|FG001|NOT COMPLETED|Overall Study||3||
48631979|NCT02696798|101881676|FG000|STARTED|Blinded Treatment Dosing Period||104||
48339293|NCT02495948|101159996|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||1||
48339294|NCT00618748|101159997|FG000|STARTED|Overall Study||56||
48339295|NCT00618748|101159998|FG001|STARTED|Overall Study||25||
48339296|NCT00618748|101159999|FG002|STARTED|Overall Study||20||
48339297|NCT00618748|101159997|FG000|COMPLETED|Overall Study||45||
48339298|NCT00618748|101159998|FG001|COMPLETED|Overall Study||20||
48339299|NCT00618748|101159999|FG002|COMPLETED|Overall Study||6||
48339300|NCT00618748|101159997|FG000|NOT COMPLETED|Overall Study||11||
48339301|NCT00618748|101159998|FG001|NOT COMPLETED|Overall Study||5||
48339302|NCT00618748|101159999|FG002|NOT COMPLETED|Overall Study||14||
48339303|NCT01817790|101160000|FG000|STARTED|Overall Study||314||
48339304|NCT01817790|101160001|FG001|STARTED|Overall Study||312||
48413434|NCT00772889|101345822|FG000|NOT COMPLETED|Overall Study||22||
48413435|NCT00772889|101345823|FG001|NOT COMPLETED|Overall Study||18||
48413436|NCT00772889|101345824|FG002|NOT COMPLETED|Overall Study||16||
48413437|NCT03137173|101345825|FG000|STARTED|Overall Study||335||
48413438|NCT03137173|101345826|FG001|STARTED|Overall Study||344||
48413439|NCT03137173|101345825|FG000|COMPLETED|Overall Study||309||
48413440|NCT03137173|101345826|FG001|COMPLETED|Overall Study||308||
48339305|NCT01817790|101160000|FG000|COMPLETED|Overall Study||310||
48339306|NCT01817790|101160001|FG001|COMPLETED|Overall Study||304||
48339307|NCT01817790|101160000|FG000|NOT COMPLETED|Overall Study||4||
48339308|NCT01817790|101160001|FG001|NOT COMPLETED|Overall Study||8||
48339309|NCT00094757|101160002|FG000|STARTED|Overall Study||205||
48339310|NCT00094757|101160003|FG001|STARTED|Overall Study||206||
48339311|NCT00094757|101160004|FG002|STARTED|Overall Study||110||
48339312|NCT00094757|101160002|FG000|COMPLETED|Overall Study||152||
48339313|NCT00094757|101160003|FG001|COMPLETED|Overall Study||144||
48413441|NCT03137173|101345825|FG000|NOT COMPLETED|Overall Study||26||
48413442|NCT03137173|101345826|FG001|NOT COMPLETED|Overall Study||36||
48339314|NCT00094757|101160004|FG002|COMPLETED|Overall Study||80||
48339315|NCT00094757|101160002|FG000|NOT COMPLETED|Overall Study||53||
48339316|NCT00094757|101160003|FG001|NOT COMPLETED|Overall Study||62||
48339317|NCT00094757|101160004|FG002|NOT COMPLETED|Overall Study||30||
48339318|NCT00445302|101160005|FG000|STARTED|Overall Study||6||
48339319|NCT00445302|101160006|FG001|STARTED|Overall Study||5||
48339320|NCT00445302|101160007|FG002|STARTED|Overall Study||6||
48339321|NCT00445302|101160008|FG003|STARTED|Overall Study||6||
48339322|NCT00445302|101160005|FG000|COMPLETED|Overall Study||6||
48339323|NCT00445302|101160006|FG001|COMPLETED|Overall Study||5||
48339324|NCT00445302|101160007|FG002|COMPLETED|Overall Study||6||
48339325|NCT00445302|101160008|FG003|COMPLETED|Overall Study||6||
48339326|NCT00445302|101160005|FG000|NOT COMPLETED|Overall Study||0||
48339327|NCT00445302|101160006|FG001|NOT COMPLETED|Overall Study||0||
48339328|NCT00445302|101160007|FG002|NOT COMPLETED|Overall Study||0||
48339329|NCT00445302|101160008|FG003|NOT COMPLETED|Overall Study||0||
48339330|NCT01926626|101160009|FG000|STARTED|Overall Study||38||
48339331|NCT01926626|101160009|FG000|Received Moclobemide|Overall Study||37||
48339332|NCT01926626|101160009|FG000|COMPLETED|Overall Study||16||
48339333|NCT01926626|101160009|FG000|NOT COMPLETED|Overall Study||22||
48339334|NCT00544869|101160010|FG000|STARTED|Overall Study||36||
48339335|NCT00544869|101160011|FG001|STARTED|Overall Study||14||
48339336|NCT00544869|101160012|FG002|STARTED|Overall Study||2||
48339337|NCT00544869|101160010|FG000|COMPLETED|Overall Study||24||
48339338|NCT00544869|101160011|FG001|COMPLETED|Overall Study||12||
48339339|NCT00544869|101160012|FG002|COMPLETED|Overall Study||2||
48339340|NCT00544869|101160010|FG000|NOT COMPLETED|Overall Study||12||
48339341|NCT00544869|101160011|FG001|NOT COMPLETED|Overall Study||2||
48339342|NCT00544869|101160012|FG002|NOT COMPLETED|Overall Study||0||
48339343|NCT02411747|101160013|FG000|STARTED|Overall Study||16||
48339344|NCT02411747|101160014|FG001|STARTED|Overall Study||16||
48339345|NCT02411747|101160013|FG000|Simulation Training Completed|Overall Study||16||
48339346|NCT02411747|101160014|FG001|Simulation Training Completed|Overall Study||16||
48339347|NCT02411747|101160013|FG000|COMPLETED|Overall Study||13||
48339348|NCT02411747|101160014|FG001|COMPLETED|Overall Study||12||
48339349|NCT02411747|101160013|FG000|NOT COMPLETED|Overall Study||3||
48339350|NCT02411747|101160014|FG001|NOT COMPLETED|Overall Study||4||
48339351|NCT01261559|101160015|FG000|STARTED|Overall Study||36||
48339352|NCT01261559|101160016|FG001|STARTED|Overall Study||36||
48339353|NCT01261559|101160015|FG000|COMPLETED|Overall Study||36||
48339354|NCT01261559|101160016|FG001|COMPLETED|Overall Study||36||
48339355|NCT01261559|101160015|FG000|NOT COMPLETED|Overall Study||0||
48339356|NCT01261559|101160016|FG001|NOT COMPLETED|Overall Study||0||
48339357|NCT01707030|101160017|FG000|STARTED|Overall Study||67||
48339358|NCT01707030|101160018|FG001|STARTED|Overall Study||71||
48339359|NCT01707030|101160017|FG000|COMPLETED|Overall Study||56||
48339360|NCT01707030|101160018|FG001|COMPLETED|Overall Study||54||
48339361|NCT01707030|101160017|FG000|NOT COMPLETED|Overall Study||11||
48339362|NCT01707030|101160018|FG001|NOT COMPLETED|Overall Study||17||
48339363|NCT00605267|101160019|FG000|STARTED|Overall Study||98||
48339364|NCT00605267|101160020|FG001|STARTED|Overall Study||99||
48339365|NCT00605267|101160019|FG000|COMPLETED|Overall Study||95||
48339366|NCT00605267|101160020|FG001|COMPLETED|Overall Study||90||
48339367|NCT00605267|101160019|FG000|NOT COMPLETED|Overall Study||3||
48339368|NCT00605267|101160020|FG001|NOT COMPLETED|Overall Study||9||
48339369|NCT01262625|101160021|FG000|STARTED|Overall Study||518||
48339370|NCT01262625|101160022|FG001|STARTED|Overall Study||532||
48339371|NCT01262625|101160021|FG000|Scan Available|Overall Study||475||
48339372|NCT01262625|101160022|FG001|Scan Available|Overall Study||465||
48339373|NCT01262625|101160021|FG000|Uninterpretable Scan|Overall Study||6||
48339374|NCT01262625|101160022|FG001|Uninterpretable Scan|Overall Study||4||
48339375|NCT01262625|101160021|FG000|COMPLETED|Overall Study||516||
48339376|NCT01262625|101160022|FG001|COMPLETED|Overall Study||531||
48339377|NCT01262625|101160021|FG000|NOT COMPLETED|Overall Study||2||
48339378|NCT01262625|101160022|FG001|NOT COMPLETED|Overall Study||1||
48339379|NCT00804687|101160023|FG000|STARTED|Period 1: Treatment Period||9||
48754457|NCT02560038|102187713|FG000|NOT COMPLETED|Overall Study||2||
48754458|NCT02782676|102187714|FG000|STARTED|Overall Study||211||211
48754459|NCT02782676|102187715|FG001|STARTED|Overall Study||210||210
48339380|NCT00804687|101160024|FG001|STARTED|Period 1: Treatment Period||9||
48339381|NCT00804687|101160025|FG002|STARTED|Period 1: Treatment Period||9||
48339382|NCT00804687|101160026|FG003|STARTED|Period 1: Treatment Period||9||
48339383|NCT00804687|101160027|FG004|STARTED|Period 1: Treatment Period||9||
48339384|NCT00804687|101160028|FG005|STARTED|Period 1: Treatment Period||8||
48339385|NCT00804687|101160023|FG000|COMPLETED|Period 1: Treatment Period||9||
48339386|NCT00804687|101160024|FG001|COMPLETED|Period 1: Treatment Period||9||
48339387|NCT00804687|101160025|FG002|COMPLETED|Period 1: Treatment Period||9||
48339388|NCT00804687|101160026|FG003|COMPLETED|Period 1: Treatment Period||9||
48339389|NCT00804687|101160027|FG004|COMPLETED|Period 1: Treatment Period||9||
48339390|NCT00804687|101160028|FG005|COMPLETED|Period 1: Treatment Period||8||
48339391|NCT00804687|101160023|FG000|NOT COMPLETED|Period 1: Treatment Period||0||
48339392|NCT00804687|101160024|FG001|NOT COMPLETED|Period 1: Treatment Period||0||
48339393|NCT00804687|101160025|FG002|NOT COMPLETED|Period 1: Treatment Period||0||
48339394|NCT00804687|101160026|FG003|NOT COMPLETED|Period 1: Treatment Period||0||
48339395|NCT00804687|101160027|FG004|NOT COMPLETED|Period 1: Treatment Period||0||
48339396|NCT00804687|101160028|FG005|NOT COMPLETED|Period 1: Treatment Period||0||
48339397|NCT00804687|101160023|FG000|STARTED|Period 2: Washout Period||9||
48339398|NCT00804687|101160024|FG001|STARTED|Period 2: Washout Period||9||
48339399|NCT00804687|101160025|FG002|STARTED|Period 2: Washout Period||9||
48339400|NCT00804687|101160026|FG003|STARTED|Period 2: Washout Period||9||
48339401|NCT00804687|101160027|FG004|STARTED|Period 2: Washout Period||9||
48339402|NCT00804687|101160028|FG005|STARTED|Period 2: Washout Period||8||
48339403|NCT00804687|101160023|FG000|COMPLETED|Period 2: Washout Period||9||
48339404|NCT00804687|101160024|FG001|COMPLETED|Period 2: Washout Period||9||
48339405|NCT00804687|101160025|FG002|COMPLETED|Period 2: Washout Period||9||
48339406|NCT00804687|101160026|FG003|COMPLETED|Period 2: Washout Period||9||
48339407|NCT00804687|101160027|FG004|COMPLETED|Period 2: Washout Period||9||
48339408|NCT00804687|101160028|FG005|COMPLETED|Period 2: Washout Period||8||
48339409|NCT00804687|101160023|FG000|NOT COMPLETED|Period 2: Washout Period||0||
48339410|NCT00804687|101160024|FG001|NOT COMPLETED|Period 2: Washout Period||0||
48339411|NCT00804687|101160025|FG002|NOT COMPLETED|Period 2: Washout Period||0||
48339412|NCT00804687|101160026|FG003|NOT COMPLETED|Period 2: Washout Period||0||
48339413|NCT00804687|101160027|FG004|NOT COMPLETED|Period 2: Washout Period||0||
48339414|NCT00804687|101160028|FG005|NOT COMPLETED|Period 2: Washout Period||0||
48339415|NCT00804687|101160023|FG000|STARTED|Period 3: Treatment Period||9||
48339416|NCT00804687|101160024|FG001|STARTED|Period 3: Treatment Period||9||
48339417|NCT00804687|101160025|FG002|STARTED|Period 3: Treatment Period||9||
48339418|NCT00804687|101160026|FG003|STARTED|Period 3: Treatment Period||9||
48339419|NCT00804687|101160027|FG004|STARTED|Period 3: Treatment Period||9||
48339420|NCT00804687|101160028|FG005|STARTED|Period 3: Treatment Period||8||
48339421|NCT00804687|101160023|FG000|COMPLETED|Period 3: Treatment Period||9||
48339422|NCT00804687|101160024|FG001|COMPLETED|Period 3: Treatment Period||9||
48339423|NCT00804687|101160025|FG002|COMPLETED|Period 3: Treatment Period||9||
48339424|NCT00804687|101160026|FG003|COMPLETED|Period 3: Treatment Period||8||
48339425|NCT00804687|101160027|FG004|COMPLETED|Period 3: Treatment Period||9||
48339426|NCT00804687|101160028|FG005|COMPLETED|Period 3: Treatment Period||8||
48339427|NCT00804687|101160023|FG000|NOT COMPLETED|Period 3: Treatment Period||0||
48339428|NCT00804687|101160024|FG001|NOT COMPLETED|Period 3: Treatment Period||0||
48339429|NCT00804687|101160025|FG002|NOT COMPLETED|Period 3: Treatment Period||0||
48339430|NCT00804687|101160026|FG003|NOT COMPLETED|Period 3: Treatment Period||1||
48339431|NCT00804687|101160027|FG004|NOT COMPLETED|Period 3: Treatment Period||0||
48339432|NCT00804687|101160028|FG005|NOT COMPLETED|Period 3: Treatment Period||0||
48339433|NCT00804687|101160023|FG000|STARTED|Period 4: Washout Period||9||
48339434|NCT00804687|101160024|FG001|STARTED|Period 4: Washout Period||9||
48339435|NCT00804687|101160025|FG002|STARTED|Period 4: Washout Period||9||
48339436|NCT00804687|101160026|FG003|STARTED|Period 4: Washout Period||8||
48754460|NCT02782676|102187714|FG000|COMPLETED|Overall Study||211||211
48754461|NCT02782676|102187715|FG001|COMPLETED|Overall Study||209||209
48754462|NCT02782676|102187714|FG000|NOT COMPLETED|Overall Study||0||0
48754463|NCT02782676|102187715|FG001|NOT COMPLETED|Overall Study||1||1
48754464|NCT01706458|102187716|FG000|STARTED|Overall Study||9||
48754465|NCT01706458|102187717|FG001|STARTED|Overall Study||9||
48754466|NCT01706458|102187716|FG000|COMPLETED|Overall Study||6||
48339437|NCT00804687|101160027|FG004|STARTED|Period 4: Washout Period||9||
48339438|NCT00804687|101160028|FG005|STARTED|Period 4: Washout Period||8||
48339439|NCT00804687|101160023|FG000|COMPLETED|Period 4: Washout Period||9||
48339440|NCT00804687|101160024|FG001|COMPLETED|Period 4: Washout Period||9||
48339441|NCT00804687|101160025|FG002|COMPLETED|Period 4: Washout Period||9||
48754467|NCT01706458|102187717|FG001|COMPLETED|Overall Study||5||
48754468|NCT01706458|102187716|FG000|NOT COMPLETED|Overall Study||3||
48754469|NCT01706458|102187717|FG001|NOT COMPLETED|Overall Study||4||
48754470|NCT01921205|102187718|FG000|STARTED|Overall Study||172||
48754471|NCT01921205|102187719|FG001|STARTED|Overall Study||171||
48754472|NCT01921205|102187718|FG000|COMPLETED|Overall Study||151||
48754473|NCT01921205|102187719|FG001|COMPLETED|Overall Study||151||
48754474|NCT01921205|102187718|FG000|NOT COMPLETED|Overall Study||21||
48754475|NCT01921205|102187719|FG001|NOT COMPLETED|Overall Study||20||
48754476|NCT00674479|102187720|FG000|STARTED|Overall Study||51||
48754477|NCT00674479|102187720|FG000|COMPLETED|Overall Study||51||
48754478|NCT00674479|102187720|FG000|NOT COMPLETED|Overall Study||0||
48754479|NCT04002960|102187721|FG000|STARTED|Overall Study||23||
48754480|NCT04002960|102187721|FG000|COMPLETED|Overall Study||21||
48754481|NCT04002960|102187721|FG000|NOT COMPLETED|Overall Study||2||
48754482|NCT00308139|102187722|FG000|STARTED|Overall Study||152||
48754483|NCT00308139|102187723|FG001|STARTED|Overall Study||151||
48754484|NCT00308139|102187722|FG000|Intent to Treat (ITT)|Overall Study||148||
48754485|NCT00308139|102187723|FG001|Intent to Treat (ITT)|Overall Study||147||
48754486|NCT00308139|102187722|FG000|ITT in the 30-Week Assessment|Overall Study||148||
48754487|NCT00308139|102187723|FG001|ITT in the 30-Week Assessment|Overall Study||145||
48754488|NCT00308139|102187722|FG000|Pharmacokinetics Population|Overall Study||129||
48754489|NCT00308139|102187723|FG001|Pharmacokinetics Population|Overall Study||0||
48754490|NCT00308139|102187722|FG000|Evaluable Meal Tolerance Cohort|Overall Study||27||
48754491|NCT00308139|102187723|FG001|Evaluable Meal Tolerance Cohort|Overall Study||24||
48754492|NCT00308139|102187722|FG000|30-Week Completed|Overall Study||128||
48754493|NCT00308139|102187723|FG001|30-Week Completed|Overall Study||130||
48178721|NCT00915902|100759937|FG000|COMPLETED|Washout (4 Weeks)||19||
48178722|NCT00915902|100759938|FG001|COMPLETED|Washout (4 Weeks)||21||
48178723|NCT00915902|100759937|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
48178724|NCT00915902|100759938|FG001|NOT COMPLETED|Washout (4 Weeks)||1||
48178725|NCT00915902|100759937|FG000|STARTED|2nd Treatment Period||19||
48178726|NCT00915902|100759938|FG001|STARTED|2nd Treatment Period||21||
48178727|NCT00915902|100759937|FG000|COMPLETED|2nd Treatment Period||19||
48178728|NCT00915902|100759938|FG001|COMPLETED|2nd Treatment Period||20||
48178729|NCT00915902|100759937|FG000|NOT COMPLETED|2nd Treatment Period||0||
48178730|NCT00915902|100759938|FG001|NOT COMPLETED|2nd Treatment Period||1||
48178731|NCT02118714|100759939|FG000|STARTED|Overall Study||20||
48178732|NCT02118714|100759939|FG000|COMPLETED|Overall Study||17||
48178733|NCT02118714|100759939|FG000|NOT COMPLETED|Overall Study||3||
48178734|NCT01580098|100759940|FG000|STARTED|Overall Study||76||
48178735|NCT01580098|100759941|FG001|STARTED|Overall Study||114||
48178736|NCT01580098|100759942|FG002|STARTED|Overall Study||3||
48178737|NCT01580098|100759940|FG000|COMPLETED|Overall Study||61||
48178738|NCT01580098|100759941|FG001|COMPLETED|Overall Study||101||
48178739|NCT01580098|100759942|FG002|COMPLETED|Overall Study||0||
48178740|NCT01580098|100759940|FG000|NOT COMPLETED|Overall Study||15||
48178741|NCT01580098|100759941|FG001|NOT COMPLETED|Overall Study||13||
48178742|NCT01580098|100759942|FG002|NOT COMPLETED|Overall Study||3||
48178743|NCT00802659|100759943|FG000|STARTED|Overall Study||0||
48178744|NCT00802659|100759944|FG001|STARTED|Overall Study||2||
48178745|NCT00802659|100759945|FG002|STARTED|Overall Study||0||
48178746|NCT00802659|100759946|FG003|STARTED|Overall Study||0||
48178747|NCT00802659|100759943|FG000|COMPLETED|Overall Study||0||
48178748|NCT00802659|100759944|FG001|COMPLETED|Overall Study||1||
48178749|NCT00802659|100759945|FG002|COMPLETED|Overall Study||0||
48178750|NCT00802659|100759946|FG003|COMPLETED|Overall Study||0||
48178751|NCT00802659|100759943|FG000|NOT COMPLETED|Overall Study||0||
48178752|NCT00802659|100759944|FG001|NOT COMPLETED|Overall Study||1||
48178753|NCT00802659|100759945|FG002|NOT COMPLETED|Overall Study||0||
48178754|NCT00802659|100759946|FG003|NOT COMPLETED|Overall Study||0||
48178755|NCT00088205|100759947|FG000|STARTED|Overall Study||60||
48178756|NCT00088205|100759947|FG000|Received at Least 1 Dose of Study Drug|Overall Study||60||
48413443|NCT02607865|101345827|FG000|STARTED|Overall Study||466||
48754494|NCT00308139|102187722|FG000|COMPLETED|Overall Study||58||
48754495|NCT00308139|102187723|FG001|COMPLETED|Overall Study||64||
48754496|NCT00308139|102187722|FG000|NOT COMPLETED|Overall Study||94||
48754497|NCT00308139|102187723|FG001|NOT COMPLETED|Overall Study||87||
48754498|NCT02570503|102187724|FG000|STARTED|Overall Study||34||
48754499|NCT02570503|102187725|FG001|STARTED|Overall Study||30||
48754500|NCT02570503|102187724|FG000|COMPLETED|Overall Study||34||
48754501|NCT02570503|102187725|FG001|COMPLETED|Overall Study||30||
48754502|NCT02570503|102187724|FG000|NOT COMPLETED|Overall Study||0||
48178757|NCT00088205|100759947|FG000|Efficacy Population|Overall Study||59||
48178758|NCT00088205|100759947|FG000|COMPLETED|Overall Study||0||
48178759|NCT00088205|100759947|FG000|NOT COMPLETED|Overall Study||60||
48178760|NCT02019563|100759948|FG000|STARTED|Overall Study||40||
48178761|NCT02019563|100759949|FG001|STARTED|Overall Study||30||
48178762|NCT02019563|100759948|FG000|COMPLETED|Overall Study||40||
48178763|NCT02019563|100759949|FG001|COMPLETED|Overall Study||30||
48178764|NCT02019563|100759948|FG000|NOT COMPLETED|Overall Study||0||
48178765|NCT02019563|100759949|FG001|NOT COMPLETED|Overall Study||0||
48178766|NCT03657264|100759950|FG000|STARTED|Overall Study||12||
48178767|NCT03657264|100759951|FG001|STARTED|Overall Study||12||
48178768|NCT03657264|100759952|FG002|STARTED|Overall Study||12||
48754503|NCT02570503|102187725|FG001|NOT COMPLETED|Overall Study||0||
48754504|NCT00772538|102187726|FG000|STARTED|Overall Study||222||
48754505|NCT00772538|102187727|FG001|STARTED|Overall Study||237||
48178769|NCT03657264|100759953|FG003|STARTED|Overall Study||12||
48631980|NCT02696798|101881677|FG001|STARTED|Blinded Treatment Dosing Period||114||
48631981|NCT02696798|101881678|FG002|STARTED|Blinded Treatment Dosing Period||98||
48631982|NCT02696798|101881676|FG000|COMPLETED|Blinded Treatment Dosing Period||93||
48178770|NCT03657264|100759950|FG000|COMPLETED|Overall Study||12||
48178771|NCT03657264|100759951|FG001|COMPLETED|Overall Study||12||
48178772|NCT03657264|100759952|FG002|COMPLETED|Overall Study||12||
48178773|NCT03657264|100759953|FG003|COMPLETED|Overall Study||12||
48178774|NCT03657264|100759950|FG000|NOT COMPLETED|Overall Study||0||
48178775|NCT03657264|100759951|FG001|NOT COMPLETED|Overall Study||0||
48178776|NCT03657264|100759952|FG002|NOT COMPLETED|Overall Study||0||
48178777|NCT03657264|100759953|FG003|NOT COMPLETED|Overall Study||0||
48178778|NCT00634322|100759954|FG000|STARTED|Overall Study||1||
48631983|NCT02696798|101881677|FG001|COMPLETED|Blinded Treatment Dosing Period||99||
48631984|NCT02696798|101881678|FG002|COMPLETED|Blinded Treatment Dosing Period||90||
48631985|NCT02696798|101881676|FG000|NOT COMPLETED|Blinded Treatment Dosing Period||11||
48631986|NCT02696798|101881677|FG001|NOT COMPLETED|Blinded Treatment Dosing Period||15||
48631987|NCT02696798|101881678|FG002|NOT COMPLETED|Blinded Treatment Dosing Period||8||
48178779|NCT00634322|100759955|FG001|STARTED|Overall Study||1||
48178780|NCT00634322|100759956|FG002|STARTED|Overall Study||5||
48178781|NCT00634322|100759954|FG000|COMPLETED|Overall Study||1||
48178782|NCT00634322|100759955|FG001|COMPLETED|Overall Study||1||
48178783|NCT00634322|100759956|FG002|COMPLETED|Overall Study||5||
48178784|NCT00634322|100759954|FG000|NOT COMPLETED|Overall Study||0||
48178785|NCT00634322|100759955|FG001|NOT COMPLETED|Overall Study||0||
48178786|NCT00634322|100759956|FG002|NOT COMPLETED|Overall Study||0||
48178787|NCT01091428|100759957|FG000|STARTED|Phase 1||38||
48178788|NCT01091428|100759958|FG001|STARTED|Phase 1||11||
48178789|NCT01091428|100759959|FG002|STARTED|Phase 1||0||
48178790|NCT01091428|100759960|FG003|STARTED|Phase 1||0||
48178791|NCT01091428|100759957|FG000|COMPLETED|Phase 1||0||
48178792|NCT01091428|100759958|FG001|COMPLETED|Phase 1||0||
48178793|NCT01091428|100759959|FG002|COMPLETED|Phase 1||0||
48178794|NCT01091428|100759960|FG003|COMPLETED|Phase 1||0||
48178795|NCT01091428|100759957|FG000|NOT COMPLETED|Phase 1||38||
48178796|NCT01091428|100759958|FG001|NOT COMPLETED|Phase 1||11||
48178797|NCT01091428|100759959|FG002|NOT COMPLETED|Phase 1||0||
48178798|NCT01091428|100759960|FG003|NOT COMPLETED|Phase 1||0||
48178799|NCT01091428|100759957|FG000|STARTED|Phase 2||0||
48178800|NCT01091428|100759958|FG001|STARTED|Phase 2||0||
48178801|NCT01091428|100759959|FG002|STARTED|Phase 2||73||
48339442|NCT00804687|101160026|FG003|COMPLETED|Period 4: Washout Period||8||
48339443|NCT00804687|101160027|FG004|COMPLETED|Period 4: Washout Period||9||
48339444|NCT00804687|101160028|FG005|COMPLETED|Period 4: Washout Period||8||
48339445|NCT00804687|101160023|FG000|NOT COMPLETED|Period 4: Washout Period||0||
48339446|NCT00804687|101160024|FG001|NOT COMPLETED|Period 4: Washout Period||0||
48339447|NCT00804687|101160025|FG002|NOT COMPLETED|Period 4: Washout Period||0||
48339448|NCT00804687|101160026|FG003|NOT COMPLETED|Period 4: Washout Period||0||
48631988|NCT02696798|101881676|FG000|STARTED|Extended Treatment Period||93||
48631989|NCT02696798|101881677|FG001|STARTED|Extended Treatment Period||98||
48631990|NCT02696798|101881678|FG002|STARTED|Extended Treatment Period||90||
48631991|NCT02696798|101881676|FG000|COMPLETED|Extended Treatment Period||81||
48631992|NCT02696798|101881677|FG001|COMPLETED|Extended Treatment Period||89||
48631993|NCT02696798|101881678|FG002|COMPLETED|Extended Treatment Period||80||
48631994|NCT02696798|101881676|FG000|NOT COMPLETED|Extended Treatment Period||12||
48631995|NCT02696798|101881677|FG001|NOT COMPLETED|Extended Treatment Period||9||
48631996|NCT02696798|101881678|FG002|NOT COMPLETED|Extended Treatment Period||10||
48178802|NCT01091428|100759960|FG003|STARTED|Phase 2||69||
48178803|NCT01091428|100759957|FG000|COMPLETED|Phase 2||0||
48178804|NCT01091428|100759958|FG001|COMPLETED|Phase 2||0||
48178805|NCT01091428|100759959|FG002|COMPLETED|Phase 2||0||
48178806|NCT01091428|100759960|FG003|COMPLETED|Phase 2||0||
48178807|NCT01091428|100759957|FG000|NOT COMPLETED|Phase 2||0||
48178808|NCT01091428|100759958|FG001|NOT COMPLETED|Phase 2||0||
48178809|NCT01091428|100759959|FG002|NOT COMPLETED|Phase 2||73||
48178810|NCT01091428|100759960|FG003|NOT COMPLETED|Phase 2||69||
48178811|NCT01558674|100759961|FG000|STARTED|Part 1||11||
48178812|NCT01558674|100759962|FG001|STARTED|Part 1||0||
48178813|NCT01558674|100759961|FG000|COMPLETED|Part 1||0||
48178814|NCT01558674|100759962|FG001|COMPLETED|Part 1||0||
48178815|NCT01558674|100759961|FG000|NOT COMPLETED|Part 1||11||
48178816|NCT01558674|100759962|FG001|NOT COMPLETED|Part 1||0||
48178817|NCT01558674|100759961|FG000|STARTED|Part 2||0||
48178818|NCT01558674|100759962|FG001|STARTED|Part 2||0||
48178819|NCT01558674|100759961|FG000|COMPLETED|Part 2||0||
48178820|NCT01558674|100759962|FG001|COMPLETED|Part 2||0||
48178821|NCT01558674|100759961|FG000|NOT COMPLETED|Part 2||0||
48178822|NCT01558674|100759962|FG001|NOT COMPLETED|Part 2||0||
48339449|NCT00804687|101160027|FG004|NOT COMPLETED|Period 4: Washout Period||0||
48178823|NCT01265030|100759963|FG000|STARTED|Overall Study||9|Goal enrollment of 15 subjects|
48178824|NCT01265030|100759963|FG000|COMPLETED|Overall Study||9||
48178825|NCT01265030|100759963|FG000|NOT COMPLETED|Overall Study||0||
48178826|NCT00972179|100759964|FG000|STARTED|Overall Study||6||
48178827|NCT00972179|100759965|FG001|STARTED|Overall Study||6||
48178828|NCT00972179|100759966|FG002|STARTED|Overall Study||6||
48178829|NCT00972179|100759967|FG003|STARTED|Overall Study||6||
48178830|NCT00972179|100759968|FG004|STARTED|Overall Study||7||
48178831|NCT00972179|100759969|FG005|STARTED|Overall Study||6||
48178832|NCT00972179|100759970|FG006|STARTED|Overall Study||12||
48178833|NCT00972179|100759964|FG000|COMPLETED|Overall Study||5||
48178834|NCT00972179|100759965|FG001|COMPLETED|Overall Study||3||
48178835|NCT00972179|100759966|FG002|COMPLETED|Overall Study||5||
48178836|NCT00972179|100759967|FG003|COMPLETED|Overall Study||5||
48178837|NCT00972179|100759968|FG004|COMPLETED|Overall Study||5||
48178838|NCT00972179|100759969|FG005|COMPLETED|Overall Study||3||
48178839|NCT00972179|100759970|FG006|COMPLETED|Overall Study||8||
48178840|NCT00972179|100759964|FG000|NOT COMPLETED|Overall Study||1||
48631997|NCT02696798|101881676|FG000|STARTED|Post-treatment Follow-up Period||5||
48631998|NCT02696798|101881677|FG001|STARTED|Post-treatment Follow-up Period||34||
48631999|NCT02696798|101881678|FG002|STARTED|Post-treatment Follow-up Period||22||
48632000|NCT02696798|101881676|FG000|COMPLETED|Post-treatment Follow-up Period||0||
48632001|NCT02696798|101881677|FG001|COMPLETED|Post-treatment Follow-up Period||8||
48178841|NCT00972179|100759965|FG001|NOT COMPLETED|Overall Study||3||
48178842|NCT00972179|100759966|FG002|NOT COMPLETED|Overall Study||1||
48178843|NCT00972179|100759967|FG003|NOT COMPLETED|Overall Study||1||
48178844|NCT00972179|100759968|FG004|NOT COMPLETED|Overall Study||2||
48178845|NCT00972179|100759969|FG005|NOT COMPLETED|Overall Study||3||
48178846|NCT00972179|100759970|FG006|NOT COMPLETED|Overall Study||4||
48178847|NCT03537261|100759971|FG000|STARTED|Overall Study||41||
48178848|NCT03537261|100759972|FG001|STARTED|Overall Study||39||
48178849|NCT03537261|100759971|FG000|Completed Baseline Assessment|Overall Study||35||
48178850|NCT03537261|100759972|FG001|Completed Baseline Assessment|Overall Study||28||
48178851|NCT03537261|100759971|FG000|COMPLETED|Overall Study||33||
48178852|NCT03537261|100759972|FG001|COMPLETED|Overall Study||27||
48178853|NCT03537261|100759971|FG000|NOT COMPLETED|Overall Study||8||
48178854|NCT03537261|100759972|FG001|NOT COMPLETED|Overall Study||12||
48178855|NCT02724787|100759973|FG000|STARTED|Overall Study||24||
48178856|NCT02724787|100759973|FG000|COMPLETED|Overall Study||22||
48178857|NCT02724787|100759973|FG000|NOT COMPLETED|Overall Study||2||
48178858|NCT03918239|100759974|FG000|STARTED|Overall Study||94||
48178859|NCT03918239|100759975|FG001|STARTED|Overall Study||96||
48178860|NCT03918239|100759974|FG000|COMPLETED|Overall Study||84||
48178861|NCT03918239|100759975|FG001|COMPLETED|Overall Study||89||
48178862|NCT03918239|100759974|FG000|NOT COMPLETED|Overall Study||10||
48178863|NCT03918239|100759975|FG001|NOT COMPLETED|Overall Study||7||
48178864|NCT05781490|100759976|FG000|STARTED|Overall Study||10||
48178865|NCT05781490|100759976|FG000|COMPLETED|Overall Study||10||
48178866|NCT05781490|100759976|FG000|NOT COMPLETED|Overall Study||0||
48178867|NCT04267575|100759977|FG000|STARTED|Overall Study||20||
48178868|NCT04267575|100759977|FG000|COMPLETED|Overall Study||20||
48178869|NCT04267575|100759977|FG000|NOT COMPLETED|Overall Study||0||
48178870|NCT00478608|100759978|FG000|STARTED|Overall Study||79||
48178871|NCT00478608|100759978|FG000|COMPLETED|Overall Study||59||
48178872|NCT00478608|100759978|FG000|NOT COMPLETED|Overall Study||20||
48632002|NCT02696798|101881678|FG002|COMPLETED|Post-treatment Follow-up Period||3||
48178873|NCT01495221|100759979|FG000|STARTED|Overall Study||9||
48178874|NCT01495221|100759979|FG000|COMPLETED|Overall Study||9||
48178875|NCT01495221|100759979|FG000|NOT COMPLETED|Overall Study||0||
48178876|NCT04267614|100759980|FG000|STARTED|Overall Study||1226|(Medical records retrieved)|
48178877|NCT04267614|100759980|FG000|Included in Analysis|Overall Study||979||
48178878|NCT04267614|100759980|FG000|COMPLETED|Overall Study||979||
48178879|NCT04267614|100759980|FG000|NOT COMPLETED|Overall Study||247||
48178880|NCT00437125|100759981|FG000|STARTED|Overall Study||151||
48178881|NCT00437125|100759981|FG000|COMPLETED|Overall Study||119||
48178882|NCT00437125|100759981|FG000|NOT COMPLETED|Overall Study||32||
48178883|NCT02291289|100759982|FG000|STARTED|Induction Treatment||93||
48178884|NCT02291289|100759983|FG001|STARTED|Induction Treatment||0||
48178885|NCT02291289|100759984|FG002|STARTED|Induction Treatment||0||
48178886|NCT02291289|100759985|FG003|STARTED|Induction Treatment||635||
48178887|NCT02291289|100759986|FG004|STARTED|Induction Treatment||0||
48178888|NCT02291289|100759987|FG005|STARTED|Induction Treatment||0||
48178889|NCT02291289|100759988|FG006|STARTED|Induction Treatment||6||
48178890|NCT02291289|100759989|FG007|STARTED|Induction Treatment||0||
48178891|NCT02291289|100759990|FG008|STARTED|Induction Treatment||0||
48178892|NCT02291289|100759991|FG009|STARTED|Induction Treatment||310||
48632003|NCT02696798|101881676|FG000|NOT COMPLETED|Post-treatment Follow-up Period||5||
48632004|NCT02696798|101881677|FG001|NOT COMPLETED|Post-treatment Follow-up Period||26||
48178893|NCT02291289|100759992|FG010|STARTED|Induction Treatment||0||
48178894|NCT02291289|100759993|FG011|STARTED|Induction Treatment||0||
48178895|NCT02291289|100759994|FG012|STARTED|Induction Treatment||0||
48178896|NCT02291289|100759982|FG000|Treated During Induction Phase|Induction Treatment||93||
48178897|NCT02291289|100759983|FG001|Treated During Induction Phase|Induction Treatment||0||
48178898|NCT02291289|100759984|FG002|Treated During Induction Phase|Induction Treatment||0||
48178899|NCT02291289|100759985|FG003|Treated During Induction Phase|Induction Treatment||632||
48178900|NCT02291289|100759986|FG004|Treated During Induction Phase|Induction Treatment||0||
48178901|NCT02291289|100759987|FG005|Treated During Induction Phase|Induction Treatment||0||
48188645|NCT05257837|100783297|FG003|NOT COMPLETED|Overall Study||0||
48339450|NCT00804687|101160028|FG005|NOT COMPLETED|Period 4: Washout Period||0||
48339451|NCT00804687|101160023|FG000|STARTED|Period 5: Treatment Period||9||
48339452|NCT00804687|101160024|FG001|STARTED|Period 5: Treatment Period||9||
48339453|NCT00804687|101160025|FG002|STARTED|Period 5: Treatment Period||9||
48339454|NCT00804687|101160026|FG003|STARTED|Period 5: Treatment Period||8||
48339455|NCT00804687|101160027|FG004|STARTED|Period 5: Treatment Period||9||
48339456|NCT00804687|101160028|FG005|STARTED|Period 5: Treatment Period||8||
48339457|NCT00804687|101160023|FG000|COMPLETED|Period 5: Treatment Period||8||
48339458|NCT00804687|101160024|FG001|COMPLETED|Period 5: Treatment Period||9||
48339459|NCT00804687|101160025|FG002|COMPLETED|Period 5: Treatment Period||8||
48339460|NCT00804687|101160026|FG003|COMPLETED|Period 5: Treatment Period||8||
48339461|NCT00804687|101160027|FG004|COMPLETED|Period 5: Treatment Period||8||
48339462|NCT00804687|101160028|FG005|COMPLETED|Period 5: Treatment Period||8||
48339463|NCT00804687|101160023|FG000|NOT COMPLETED|Period 5: Treatment Period||1||
48339464|NCT00804687|101160024|FG001|NOT COMPLETED|Period 5: Treatment Period||0||
48339465|NCT00804687|101160025|FG002|NOT COMPLETED|Period 5: Treatment Period||1||
48339466|NCT00804687|101160026|FG003|NOT COMPLETED|Period 5: Treatment Period||0||
48339467|NCT00804687|101160027|FG004|NOT COMPLETED|Period 5: Treatment Period||1||
48339468|NCT00804687|101160028|FG005|NOT COMPLETED|Period 5: Treatment Period||0||
48339469|NCT02804763|101160029|FG000|STARTED|Double-Blind Period (Week 1 to Week 24)||45||
48339470|NCT02804763|101160030|FG001|STARTED|Double-Blind Period (Week 1 to Week 24)||45||
48339471|NCT02804763|101160031|FG002|STARTED|Double-Blind Period (Week 1 to Week 24)||45||
48339472|NCT02804763|101160032|FG003|STARTED|Double-Blind Period (Week 1 to Week 24)||47||
48339473|NCT02804763|101160029|FG000|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||44||
48339474|NCT02804763|101160030|FG001|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||45||
48339475|NCT02804763|101160031|FG002|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||44||
48339476|NCT02804763|101160032|FG003|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||45||
48339477|NCT02804763|101160029|FG000|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||44||
48339478|NCT02804763|101160030|FG001|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||44||
48339479|NCT02804763|101160031|FG002|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||44||
48339480|NCT02804763|101160032|FG003|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||45||
48339481|NCT02804763|101160029|FG000|COMPLETED|Double-Blind Period (Week 1 to Week 24)||44||
48339482|NCT02804763|101160030|FG001|COMPLETED|Double-Blind Period (Week 1 to Week 24)||44||
48339483|NCT02804763|101160031|FG002|COMPLETED|Double-Blind Period (Week 1 to Week 24)||44||
48339484|NCT02804763|101160032|FG003|COMPLETED|Double-Blind Period (Week 1 to Week 24)||45||
48339485|NCT02804763|101160029|FG000|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||1||
48339486|NCT02804763|101160030|FG001|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||1||
48339487|NCT02804763|101160031|FG002|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||1||
48339488|NCT02804763|101160032|FG003|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||2||
48339489|NCT02804763|101160029|FG000|STARTED|Observational Period (Wk 24 to Wk 48)||44||
48339490|NCT02804763|101160030|FG001|STARTED|Observational Period (Wk 24 to Wk 48)||44||
48339491|NCT02804763|101160031|FG002|STARTED|Observational Period (Wk 24 to Wk 48)||44||
48339492|NCT02804763|101160032|FG003|STARTED|Observational Period (Wk 24 to Wk 48)||45||
48339493|NCT02804763|101160029|FG000|COMPLETED|Observational Period (Wk 24 to Wk 48)||38||
48339494|NCT02804763|101160030|FG001|COMPLETED|Observational Period (Wk 24 to Wk 48)||43||
48339495|NCT02804763|101160031|FG002|COMPLETED|Observational Period (Wk 24 to Wk 48)||41||
48339496|NCT02804763|101160032|FG003|COMPLETED|Observational Period (Wk 24 to Wk 48)||42||
48339497|NCT02804763|101160029|FG000|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||6||
48339498|NCT02804763|101160030|FG001|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||1||
48339499|NCT02804763|101160031|FG002|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||3||
48339500|NCT02804763|101160032|FG003|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||3||
48339501|NCT02002702|101160033|FG000|STARTED|Overall Study||16||
48339502|NCT02002702|101160034|FG001|STARTED|Overall Study||15||
48339503|NCT02002702|101160035|FG002|STARTED|Overall Study||15||
48339504|NCT02002702|101160033|FG000|COMPLETED|Overall Study||16||
48339505|NCT02002702|101160034|FG001|COMPLETED|Overall Study||15||
48339506|NCT02002702|101160035|FG002|COMPLETED|Overall Study||15||
48339507|NCT02002702|101160033|FG000|NOT COMPLETED|Overall Study||0||
48339508|NCT02002702|101160034|FG001|NOT COMPLETED|Overall Study||0||
48339509|NCT02002702|101160035|FG002|NOT COMPLETED|Overall Study||0||
48339510|NCT02553135|101160036|FG000|STARTED|Overall Study||6||
48339511|NCT02553135|101160036|FG000|COMPLETED|Overall Study||6||
48339512|NCT02553135|101160036|FG000|NOT COMPLETED|Overall Study||0||
48339513|NCT00483327|101160037|FG000|STARTED|Overall Study||30||
48339514|NCT00483327|101160037|FG000|COMPLETED|Overall Study||20||
48339515|NCT00483327|101160037|FG000|NOT COMPLETED|Overall Study||10||
48339516|NCT03158220|101160038|FG000|STARTED|Overall Study||570||
48339517|NCT03158220|101160039|FG001|STARTED|Overall Study||642||
48339518|NCT03158220|101160038|FG000|Vaccination 1|Overall Study||570||
48339519|NCT03158220|101160039|FG001|Vaccination 1|Overall Study||640||
48339520|NCT03158220|101160038|FG000|Vaccination 2|Overall Study||563||
48339521|NCT03158220|101160039|FG001|Vaccination 2|Overall Study||635||
48339522|NCT03158220|101160038|FG000|Vaccination 3|Overall Study||556||
48178902|NCT02291289|100759988|FG006|Treated During Induction Phase|Induction Treatment||6||
48178903|NCT02291289|100759989|FG007|Treated During Induction Phase|Induction Treatment||0||
48178904|NCT02291289|100759990|FG008|Treated During Induction Phase|Induction Treatment||0||
48178905|NCT02291289|100759991|FG009|Treated During Induction Phase|Induction Treatment||309||
48178906|NCT02291289|100759992|FG010|Treated During Induction Phase|Induction Treatment||0||
48178907|NCT02291289|100759993|FG011|Treated During Induction Phase|Induction Treatment||0||
48339523|NCT03158220|101160039|FG001|Vaccination 3|Overall Study||629||
48339524|NCT03158220|101160038|FG000|COMPLETED|Overall Study||553||
48339525|NCT03158220|101160039|FG001|COMPLETED|Overall Study||626||
48339526|NCT03158220|101160038|FG000|NOT COMPLETED|Overall Study||17||
48339527|NCT03158220|101160039|FG001|NOT COMPLETED|Overall Study||16||
48339528|NCT03529409|101160040|FG000|STARTED|Randomized||30||
48339529|NCT03529409|101160041|FG001|STARTED|Randomized||31||
48339530|NCT03529409|101160042|FG002|STARTED|Randomized||5||
48339531|NCT03529409|101160040|FG000|COMPLETED|Randomized||30||
48339532|NCT03529409|101160041|FG001|COMPLETED|Randomized||31||
48339533|NCT03529409|101160042|FG002|COMPLETED|Randomized||0||
48339534|NCT03529409|101160040|FG000|NOT COMPLETED|Randomized||0||
48339535|NCT03529409|101160041|FG001|NOT COMPLETED|Randomized||0||
48339536|NCT03529409|101160042|FG002|NOT COMPLETED|Randomized||5||
48339537|NCT03529409|101160040|FG000|STARTED|Post-treatment Assessment||30||
48339538|NCT03529409|101160041|FG001|STARTED|Post-treatment Assessment||31||
48339539|NCT03529409|101160042|FG002|STARTED|Post-treatment Assessment||0||
48339540|NCT03529409|101160040|FG000|COMPLETED|Post-treatment Assessment||26||
48339541|NCT03529409|101160041|FG001|COMPLETED|Post-treatment Assessment||26||
48339542|NCT03529409|101160042|FG002|COMPLETED|Post-treatment Assessment||0||
48339543|NCT03529409|101160040|FG000|NOT COMPLETED|Post-treatment Assessment||4||
48339544|NCT03529409|101160041|FG001|NOT COMPLETED|Post-treatment Assessment||5||
48339545|NCT03529409|101160042|FG002|NOT COMPLETED|Post-treatment Assessment||0||
48339546|NCT03529409|101160040|FG000|STARTED|Follow-up Assessment||28||
48339547|NCT03529409|101160041|FG001|STARTED|Follow-up Assessment||30||
48339548|NCT03529409|101160042|FG002|STARTED|Follow-up Assessment||0||
48339549|NCT03529409|101160040|FG000|COMPLETED|Follow-up Assessment||27||
48339550|NCT03529409|101160041|FG001|COMPLETED|Follow-up Assessment||29||
48339551|NCT03529409|101160042|FG002|COMPLETED|Follow-up Assessment||0||
48339552|NCT03529409|101160040|FG000|NOT COMPLETED|Follow-up Assessment||1||
48339553|NCT03529409|101160041|FG001|NOT COMPLETED|Follow-up Assessment||1||
48339554|NCT03529409|101160042|FG002|NOT COMPLETED|Follow-up Assessment||0||
48339555|NCT01551693|101160043|FG000|STARTED|Overall Study||1||
48339556|NCT01551693|101160044|FG001|STARTED|Overall Study||2||
48339557|NCT01551693|101160043|FG000|COMPLETED|Overall Study||0||
48339558|NCT01551693|101160044|FG001|COMPLETED|Overall Study||0||
48339559|NCT01551693|101160043|FG000|NOT COMPLETED|Overall Study||1||
48339560|NCT01551693|101160044|FG001|NOT COMPLETED|Overall Study||2||
48339561|NCT00818259|101160045|FG000|STARTED|Randomization||12||
48339562|NCT00818259|101160046|FG001|STARTED|Randomization||11||
48339563|NCT00818259|101160047|FG002|STARTED|Randomization||19||
48339564|NCT00818259|101160048|FG003|STARTED|Randomization||20||
48339565|NCT00818259|101160049|FG004|STARTED|Randomization||19||
48339566|NCT00818259|101160050|FG005|STARTED|Randomization||0||
48339567|NCT00818259|101160051|FG006|STARTED|Randomization||5||
48339568|NCT00818259|101160052|FG007|STARTED|Randomization||0||
48339569|NCT00818259|101160053|FG008|STARTED|Randomization||6||
48339570|NCT00818259|101160045|FG000|COMPLETED|Randomization||12||
48339571|NCT00818259|101160046|FG001|COMPLETED|Randomization||11||
48339572|NCT00818259|101160047|FG002|COMPLETED|Randomization||19||
48339573|NCT00818259|101160048|FG003|COMPLETED|Randomization||20||
48339574|NCT00818259|101160049|FG004|COMPLETED|Randomization||19||
48339575|NCT00818259|101160050|FG005|COMPLETED|Randomization||0||
48339576|NCT00818259|101160051|FG006|COMPLETED|Randomization||5||
48339577|NCT00818259|101160052|FG007|COMPLETED|Randomization||0||
48178908|NCT02291289|100759994|FG012|Treated During Induction Phase|Induction Treatment||0||
48178909|NCT02291289|100759982|FG000|COMPLETED|Induction Treatment||63||
48178910|NCT02291289|100759983|FG001|COMPLETED|Induction Treatment||0||
48178911|NCT02291289|100759984|FG002|COMPLETED|Induction Treatment||0||
48178912|NCT02291289|100759985|FG003|COMPLETED|Induction Treatment||460||
48178913|NCT02291289|100759986|FG004|COMPLETED|Induction Treatment||0||
48178914|NCT02291289|100759987|FG005|COMPLETED|Induction Treatment||0||
48339578|NCT00818259|101160053|FG008|COMPLETED|Randomization||6||
48339579|NCT00818259|101160045|FG000|NOT COMPLETED|Randomization||0||
48339580|NCT00818259|101160046|FG001|NOT COMPLETED|Randomization||0||
48339581|NCT00818259|101160047|FG002|NOT COMPLETED|Randomization||0||
48178915|NCT02291289|100759988|FG006|COMPLETED|Induction Treatment||5||
48339582|NCT00818259|101160048|FG003|NOT COMPLETED|Randomization||0||
48339583|NCT00818259|101160049|FG004|NOT COMPLETED|Randomization||0||
48339584|NCT00818259|101160050|FG005|NOT COMPLETED|Randomization||0||
48339585|NCT00818259|101160051|FG006|NOT COMPLETED|Randomization||0||
48339586|NCT00818259|101160052|FG007|NOT COMPLETED|Randomization||0||
48339587|NCT00818259|101160053|FG008|NOT COMPLETED|Randomization||0||
48339588|NCT00818259|101160045|FG000|STARTED|Part I||12||
48339589|NCT00818259|101160046|FG001|STARTED|Part I||11||
48339590|NCT00818259|101160047|FG002|STARTED|Part I||0||
48632005|NCT02696798|101881678|FG002|NOT COMPLETED|Post-treatment Follow-up Period||19||
48632006|NCT03573297|101881679|FG000|STARTED|Open Label Treatment Period||896|Treated|
48632007|NCT03573297|101881680|FG001|STARTED|Open Label Treatment Period||0|Treated|
48632008|NCT03573297|101881681|FG002|STARTED|Open Label Treatment Period||0|Treated|
48632009|NCT03573297|101881682|FG003|STARTED|Open Label Treatment Period||0|Treated|
48632010|NCT03573297|101881679|FG000|COMPLETED|Open Label Treatment Period||440||
48632011|NCT03573297|101881680|FG001|COMPLETED|Open Label Treatment Period||0||
48632012|NCT03573297|101881681|FG002|COMPLETED|Open Label Treatment Period||0||
48632013|NCT03573297|101881682|FG003|COMPLETED|Open Label Treatment Period||0||
48178916|NCT02291289|100759989|FG007|COMPLETED|Induction Treatment||0||
48178917|NCT02291289|100759990|FG008|COMPLETED|Induction Treatment||0||
48178918|NCT02291289|100759991|FG009|COMPLETED|Induction Treatment||135||
48178919|NCT02291289|100759992|FG010|COMPLETED|Induction Treatment||0||
48178920|NCT02291289|100759993|FG011|COMPLETED|Induction Treatment||0||
48178921|NCT02291289|100759994|FG012|COMPLETED|Induction Treatment||0||
48178922|NCT02291289|100759982|FG000|NOT COMPLETED|Induction Treatment||30||
48178923|NCT02291289|100759983|FG001|NOT COMPLETED|Induction Treatment||0||
48178924|NCT02291289|100759984|FG002|NOT COMPLETED|Induction Treatment||0||
48178925|NCT02291289|100759985|FG003|NOT COMPLETED|Induction Treatment||175||
48178926|NCT02291289|100759986|FG004|NOT COMPLETED|Induction Treatment||0||
48178927|NCT02291289|100759987|FG005|NOT COMPLETED|Induction Treatment||0||
48178928|NCT02291289|100759988|FG006|NOT COMPLETED|Induction Treatment||1||
48178929|NCT02291289|100759989|FG007|NOT COMPLETED|Induction Treatment||0||
48178930|NCT02291289|100759990|FG008|NOT COMPLETED|Induction Treatment||0||
48339591|NCT00818259|101160048|FG003|STARTED|Part I||0||
48339592|NCT00818259|101160049|FG004|STARTED|Part I||0||
48339593|NCT00818259|101160050|FG005|STARTED|Part I||0||
48339594|NCT00818259|101160051|FG006|STARTED|Part I||0||
48339595|NCT00818259|101160052|FG007|STARTED|Part I||0||
48339596|NCT00818259|101160053|FG008|STARTED|Part I||0||
48339597|NCT00818259|101160045|FG000|COMPLETED|Part I||11||
48339598|NCT00818259|101160046|FG001|COMPLETED|Part I||11||
48339599|NCT00818259|101160047|FG002|COMPLETED|Part I||0||
48339600|NCT00818259|101160048|FG003|COMPLETED|Part I||0||
48339601|NCT00818259|101160049|FG004|COMPLETED|Part I||0||
48339602|NCT00818259|101160050|FG005|COMPLETED|Part I||0||
48339603|NCT00818259|101160051|FG006|COMPLETED|Part I||0||
48339604|NCT00818259|101160052|FG007|COMPLETED|Part I||0||
48339605|NCT00818259|101160053|FG008|COMPLETED|Part I||0||
48339606|NCT00818259|101160045|FG000|NOT COMPLETED|Part I||1||
48339607|NCT00818259|101160046|FG001|NOT COMPLETED|Part I||0||
48339608|NCT00818259|101160047|FG002|NOT COMPLETED|Part I||0||
48339609|NCT00818259|101160048|FG003|NOT COMPLETED|Part I||0||
48339610|NCT00818259|101160049|FG004|NOT COMPLETED|Part I||0||
48339611|NCT00818259|101160050|FG005|NOT COMPLETED|Part I||0||
48339612|NCT00818259|101160051|FG006|NOT COMPLETED|Part I||0||
48339613|NCT00818259|101160052|FG007|NOT COMPLETED|Part I||0||
48339614|NCT00818259|101160053|FG008|NOT COMPLETED|Part I||0||
48632014|NCT03573297|101881679|FG000|NOT COMPLETED|Open Label Treatment Period||456||
48632015|NCT03573297|101881680|FG001|NOT COMPLETED|Open Label Treatment Period||0||
48632016|NCT03573297|101881681|FG002|NOT COMPLETED|Open Label Treatment Period||0||
48632017|NCT03573297|101881682|FG003|NOT COMPLETED|Open Label Treatment Period||0||
48632018|NCT03573297|101881679|FG000|STARTED|Double-Blind Treatment Period||0|Randomized into Double-Blind Period|
48632019|NCT03573297|101881680|FG001|STARTED|Double-Blind Treatment Period||145|Randomized into Double-Blind Period|
48632020|NCT03573297|101881681|FG002|STARTED|Double-Blind Treatment Period||147|Randomized into Double-Blind Period|
48178931|NCT02291289|100759991|FG009|NOT COMPLETED|Induction Treatment||175||
48178932|NCT02291289|100759992|FG010|NOT COMPLETED|Induction Treatment||0||
48178933|NCT02291289|100759993|FG011|NOT COMPLETED|Induction Treatment||0||
48178934|NCT02291289|100759994|FG012|NOT COMPLETED|Induction Treatment||0||
48178935|NCT02291289|100759982|FG000|STARTED|Maintenance Treatment Phase||0||
48178936|NCT02291289|100759983|FG001|STARTED|Maintenance Treatment Phase||40||
48178937|NCT02291289|100759984|FG002|STARTED|Maintenance Treatment Phase||20||
48178938|NCT02291289|100759985|FG003|STARTED|Maintenance Treatment Phase||0||
48178939|NCT02291289|100759986|FG004|STARTED|Maintenance Treatment Phase||297||
48178940|NCT02291289|100759987|FG005|STARTED|Maintenance Treatment Phase||148||
48339615|NCT00818259|101160045|FG000|STARTED|Part II||0||
48339616|NCT00818259|101160046|FG001|STARTED|Part II||0||
48339617|NCT00818259|101160047|FG002|STARTED|Part II||19||
48339618|NCT00818259|101160048|FG003|STARTED|Part II||20||
48339619|NCT00818259|101160049|FG004|STARTED|Part II||0||
48339620|NCT00818259|101160050|FG005|STARTED|Part II||0||
48339621|NCT00818259|101160051|FG006|STARTED|Part II||0||
48339622|NCT00818259|101160052|FG007|STARTED|Part II||0||
48178941|NCT02291289|100759988|FG006|STARTED|Maintenance Treatment Phase||0||
48178942|NCT02291289|100759989|FG007|STARTED|Maintenance Treatment Phase||3||
48178943|NCT02291289|100759990|FG008|STARTED|Maintenance Treatment Phase||2||
48178944|NCT02291289|100759991|FG009|STARTED|Maintenance Treatment Phase||0||
48339623|NCT00818259|101160053|FG008|STARTED|Part II||0||
48339624|NCT00818259|101160045|FG000|Treated|Part II||0||
48339625|NCT00818259|101160046|FG001|Treated|Part II||0||
48339626|NCT00818259|101160047|FG002|Treated|Part II||19||
48339627|NCT00818259|101160048|FG003|Treated|Part II||19||
48339628|NCT00818259|101160049|FG004|Treated|Part II||0||
48178945|NCT02291289|100759992|FG010|STARTED|Maintenance Treatment Phase||65||
48178946|NCT02291289|100759993|FG011|STARTED|Maintenance Treatment Phase||34||
48632021|NCT03573297|101881682|FG003|STARTED|Double-Blind Treatment Period||148|Randomized into Double-Blind Period|
48632022|NCT03573297|101881679|FG000|Randomized and Treated in Double-Blind Treatment Period|Double-Blind Treatment Period||0||
48632023|NCT03573297|101881680|FG001|Randomized and Treated in Double-Blind Treatment Period|Double-Blind Treatment Period||145||
48632024|NCT03573297|101881681|FG002|Randomized and Treated in Double-Blind Treatment Period|Double-Blind Treatment Period||144||
48632025|NCT03573297|101881682|FG003|Randomized and Treated in Double-Blind Treatment Period|Double-Blind Treatment Period||147||
48632026|NCT03573297|101881679|FG000|COMPLETED|Double-Blind Treatment Period||0||
48632027|NCT03573297|101881680|FG001|COMPLETED|Double-Blind Treatment Period||79||
48632028|NCT03573297|101881681|FG002|COMPLETED|Double-Blind Treatment Period||82||
48632029|NCT03573297|101881682|FG003|COMPLETED|Double-Blind Treatment Period||84||
48632030|NCT03573297|101881679|FG000|NOT COMPLETED|Double-Blind Treatment Period||0||
48632031|NCT03573297|101881680|FG001|NOT COMPLETED|Double-Blind Treatment Period||66||
48632032|NCT03573297|101881681|FG002|NOT COMPLETED|Double-Blind Treatment Period||65||
48632033|NCT03573297|101881682|FG003|NOT COMPLETED|Double-Blind Treatment Period||64||
48632034|NCT01997125|101881683|FG000|STARTED|Overall Study||1||
48632035|NCT01997125|101881683|FG000|COMPLETED|Overall Study||1||
48178947|NCT02291289|100759994|FG012|STARTED|Maintenance Treatment Phase||0||
48178948|NCT02291289|100759982|FG000|Treated During Maintenance Phase|Maintenance Treatment Phase||0||
48178949|NCT02291289|100759983|FG001|Treated During Maintenance Phase|Maintenance Treatment Phase||40||
48178950|NCT02291289|100759984|FG002|Treated During Maintenance Phase|Maintenance Treatment Phase||18||
48178951|NCT02291289|100759985|FG003|Treated During Maintenance Phase|Maintenance Treatment Phase||0||
48178952|NCT02291289|100759986|FG004|Treated During Maintenance Phase|Maintenance Treatment Phase||293||
48339629|NCT00818259|101160050|FG005|Treated|Part II||0||
48339630|NCT00818259|101160051|FG006|Treated|Part II||0||
48339631|NCT00818259|101160052|FG007|Treated|Part II||0||
48339632|NCT00818259|101160053|FG008|Treated|Part II||0||
48339633|NCT00818259|101160045|FG000|COMPLETED|Part II||0||
48339634|NCT00818259|101160046|FG001|COMPLETED|Part II||0||
48339635|NCT00818259|101160047|FG002|COMPLETED|Part II||18||
48339636|NCT00818259|101160048|FG003|COMPLETED|Part II||18||
48339637|NCT00818259|101160049|FG004|COMPLETED|Part II||0||
48339638|NCT00818259|101160050|FG005|COMPLETED|Part II||0||
48339639|NCT00818259|101160051|FG006|COMPLETED|Part II||0||
48632036|NCT01997125|101881683|FG000|NOT COMPLETED|Overall Study||0||
48632037|NCT01026493|101881684|FG000|STARTED|Overall Study||8||
48632038|NCT01026493|101881685|FG001|STARTED|Overall Study||7||
48632039|NCT01026493|101881686|FG002|STARTED|Overall Study||9||
48632040|NCT01026493|101881687|FG003|STARTED|Overall Study||8||
48632041|NCT01026493|101881688|FG004|STARTED|Overall Study||75||
48632042|NCT01026493|101881689|FG005|STARTED|Overall Study||76||
48632043|NCT01026493|101881690|FG006|STARTED|Overall Study||36||
48178953|NCT02291289|100759987|FG005|Treated During Maintenance Phase|Maintenance Treatment Phase||143||
48178954|NCT02291289|100759988|FG006|Treated During Maintenance Phase|Maintenance Treatment Phase||0||
48632044|NCT01026493|101881691|FG007|STARTED|Overall Study||38||
48632045|NCT01026493|101881684|FG000|COMPLETED|Overall Study||8||
48632046|NCT01026493|101881685|FG001|COMPLETED|Overall Study||6||
48632047|NCT01026493|101881686|FG002|COMPLETED|Overall Study||9||
48632048|NCT01026493|101881687|FG003|COMPLETED|Overall Study||8||
48632049|NCT01026493|101881688|FG004|COMPLETED|Overall Study||73||
48632050|NCT01026493|101881689|FG005|COMPLETED|Overall Study||73||
48632051|NCT01026493|101881690|FG006|COMPLETED|Overall Study||32||
48632052|NCT01026493|101881691|FG007|COMPLETED|Overall Study||37||
48632053|NCT01026493|101881684|FG000|NOT COMPLETED|Overall Study||0||
48632054|NCT01026493|101881685|FG001|NOT COMPLETED|Overall Study||1||
48632055|NCT01026493|101881686|FG002|NOT COMPLETED|Overall Study||0||
48632056|NCT01026493|101881687|FG003|NOT COMPLETED|Overall Study||0||
48632057|NCT01026493|101881688|FG004|NOT COMPLETED|Overall Study||2||
48632058|NCT01026493|101881689|FG005|NOT COMPLETED|Overall Study||3||
48632059|NCT01026493|101881690|FG006|NOT COMPLETED|Overall Study||4||
48632060|NCT01026493|101881691|FG007|NOT COMPLETED|Overall Study||1||
48632061|NCT02577029|101881692|FG000|STARTED|Overall Study||10||
48178955|NCT02291289|100759989|FG007|Treated During Maintenance Phase|Maintenance Treatment Phase||3||
48178956|NCT02291289|100759990|FG008|Treated During Maintenance Phase|Maintenance Treatment Phase||2||
48178957|NCT02291289|100759991|FG009|Treated During Maintenance Phase|Maintenance Treatment Phase||0||
48178958|NCT02291289|100759992|FG010|Treated During Maintenance Phase|Maintenance Treatment Phase||64||
48178959|NCT02291289|100759993|FG011|Treated During Maintenance Phase|Maintenance Treatment Phase||34||
48178960|NCT02291289|100759994|FG012|Treated During Maintenance Phase|Maintenance Treatment Phase||0||
48178961|NCT02291289|100759982|FG000|COMPLETED|Maintenance Treatment Phase||0||
48178962|NCT02291289|100759983|FG001|COMPLETED|Maintenance Treatment Phase||6||
48178963|NCT02291289|100759984|FG002|COMPLETED|Maintenance Treatment Phase||2||
48188646|NCT01118962|100783298|FG000|STARTED|Overall Study||39||
48339640|NCT00818259|101160052|FG007|COMPLETED|Part II||0||
48339641|NCT00818259|101160053|FG008|COMPLETED|Part II||0||
48339642|NCT00818259|101160045|FG000|NOT COMPLETED|Part II||0||
48339643|NCT00818259|101160046|FG001|NOT COMPLETED|Part II||0||
48339644|NCT00818259|101160047|FG002|NOT COMPLETED|Part II||1||
48178964|NCT02291289|100759985|FG003|COMPLETED|Maintenance Treatment Phase||0||
48178965|NCT02291289|100759986|FG004|COMPLETED|Maintenance Treatment Phase||66||
48178966|NCT02291289|100759987|FG005|COMPLETED|Maintenance Treatment Phase||21||
48178967|NCT02291289|100759988|FG006|COMPLETED|Maintenance Treatment Phase||0||
48413444|NCT02607865|101345828|FG001|STARTED|Overall Study||466||
48413445|NCT02607865|101345829|FG002|STARTED|Overall Study||465||
48178968|NCT02291289|100759989|FG007|COMPLETED|Maintenance Treatment Phase||0||
48178969|NCT02291289|100759990|FG008|COMPLETED|Maintenance Treatment Phase||1||
48339645|NCT00818259|101160048|FG003|NOT COMPLETED|Part II||2||
48339646|NCT00818259|101160049|FG004|NOT COMPLETED|Part II||0||
48339647|NCT00818259|101160050|FG005|NOT COMPLETED|Part II||0||
48339648|NCT00818259|101160051|FG006|NOT COMPLETED|Part II||0||
48339649|NCT00818259|101160052|FG007|NOT COMPLETED|Part II||0||
48339650|NCT00818259|101160053|FG008|NOT COMPLETED|Part II||0||
48339651|NCT00818259|101160045|FG000|STARTED|Part III||0||
48339652|NCT00818259|101160046|FG001|STARTED|Part III||0||
48339653|NCT00818259|101160047|FG002|STARTED|Part III||0||
48339654|NCT00818259|101160048|FG003|STARTED|Part III||0||
48339655|NCT00818259|101160049|FG004|STARTED|Part III||19||
48339656|NCT00818259|101160050|FG005|STARTED|Part III||0||
48339657|NCT00818259|101160051|FG006|STARTED|Part III||0||
48339658|NCT00818259|101160052|FG007|STARTED|Part III||0||
48339659|NCT00818259|101160053|FG008|STARTED|Part III||0||
48339660|NCT00818259|101160045|FG000|COMPLETED|Part III||0||
48339661|NCT00818259|101160046|FG001|COMPLETED|Part III||0||
48339662|NCT00818259|101160047|FG002|COMPLETED|Part III||0||
48339663|NCT00818259|101160048|FG003|COMPLETED|Part III||0||
48339664|NCT00818259|101160049|FG004|COMPLETED|Part III||19||
48339665|NCT00818259|101160050|FG005|COMPLETED|Part III||0||
48339666|NCT00818259|101160051|FG006|COMPLETED|Part III||0||
48339667|NCT00818259|101160052|FG007|COMPLETED|Part III||0||
48339668|NCT00818259|101160053|FG008|COMPLETED|Part III||0||
48339669|NCT00818259|101160045|FG000|NOT COMPLETED|Part III||0||
48339670|NCT00818259|101160046|FG001|NOT COMPLETED|Part III||0||
48339671|NCT00818259|101160047|FG002|NOT COMPLETED|Part III||0||
48339672|NCT00818259|101160048|FG003|NOT COMPLETED|Part III||0||
48339673|NCT00818259|101160049|FG004|NOT COMPLETED|Part III||0||
48339674|NCT00818259|101160050|FG005|NOT COMPLETED|Part III||0||
48339675|NCT00818259|101160051|FG006|NOT COMPLETED|Part III||0||
48339676|NCT00818259|101160052|FG007|NOT COMPLETED|Part III||0||
48339677|NCT00818259|101160053|FG008|NOT COMPLETED|Part III||0||
48339678|NCT00818259|101160045|FG000|STARTED|Part IV||0||
48339679|NCT00818259|101160046|FG001|STARTED|Part IV||0||
48339680|NCT00818259|101160047|FG002|STARTED|Part IV||0||
48339681|NCT00818259|101160048|FG003|STARTED|Part IV||0||
48339682|NCT00818259|101160049|FG004|STARTED|Part IV||0||
48339683|NCT00818259|101160050|FG005|STARTED|Part IV||15||
48339684|NCT00818259|101160051|FG006|STARTED|Part IV||5||
48339685|NCT00818259|101160052|FG007|STARTED|Part IV||0||
48339686|NCT00818259|101160053|FG008|STARTED|Part IV||0||
48339687|NCT00818259|101160045|FG000|COMPLETED|Part IV||0||
48339688|NCT00818259|101160046|FG001|COMPLETED|Part IV||0||
48339689|NCT00818259|101160047|FG002|COMPLETED|Part IV||0||
48413446|NCT02607865|101345830|FG003|STARTED|Overall Study||467||
48413447|NCT02607865|101345827|FG000|Full Analysis Set (FAS)|Overall Study||466|One participant was excluded from the FAS as the participant was a confirmed screening failure.|
48178970|NCT02291289|100759991|FG009|COMPLETED|Maintenance Treatment Phase||0||
48178971|NCT02291289|100759992|FG010|COMPLETED|Maintenance Treatment Phase||12||
48178972|NCT02291289|100759993|FG011|COMPLETED|Maintenance Treatment Phase||6||
48178973|NCT02291289|100759994|FG012|COMPLETED|Maintenance Treatment Phase||0||
48178974|NCT02291289|100759982|FG000|NOT COMPLETED|Maintenance Treatment Phase||0||
48178975|NCT02291289|100759983|FG001|NOT COMPLETED|Maintenance Treatment Phase||34||
48178976|NCT02291289|100759984|FG002|NOT COMPLETED|Maintenance Treatment Phase||18||
48178977|NCT02291289|100759985|FG003|NOT COMPLETED|Maintenance Treatment Phase||0||
48339690|NCT00818259|101160048|FG003|COMPLETED|Part IV||0||
48339691|NCT00818259|101160049|FG004|COMPLETED|Part IV||0||
48339692|NCT00818259|101160050|FG005|COMPLETED|Part IV||14||
48339693|NCT00818259|101160051|FG006|COMPLETED|Part IV||5||
48339694|NCT00818259|101160052|FG007|COMPLETED|Part IV||0||
48178978|NCT02291289|100759986|FG004|NOT COMPLETED|Maintenance Treatment Phase||231||
48339695|NCT00818259|101160053|FG008|COMPLETED|Part IV||0||
48339696|NCT00818259|101160045|FG000|NOT COMPLETED|Part IV||0||
48339697|NCT00818259|101160046|FG001|NOT COMPLETED|Part IV||0||
48339698|NCT00818259|101160047|FG002|NOT COMPLETED|Part IV||0||
48339699|NCT00818259|101160048|FG003|NOT COMPLETED|Part IV||0||
48339700|NCT00818259|101160049|FG004|NOT COMPLETED|Part IV||0||
48339701|NCT00818259|101160050|FG005|NOT COMPLETED|Part IV||1||
48339702|NCT00818259|101160051|FG006|NOT COMPLETED|Part IV||0||
48339703|NCT00818259|101160052|FG007|NOT COMPLETED|Part IV||0||
48339704|NCT00818259|101160053|FG008|NOT COMPLETED|Part IV||0||
48339705|NCT00818259|101160045|FG000|STARTED|Part V||0||
48339706|NCT00818259|101160046|FG001|STARTED|Part V||0||
48339707|NCT00818259|101160047|FG002|STARTED|Part V||0||
48339708|NCT00818259|101160048|FG003|STARTED|Part V||0||
48339709|NCT00818259|101160049|FG004|STARTED|Part V||0||
48413448|NCT02607865|101345828|FG001|Full Analysis Set (FAS)|Overall Study||465|One participant was excluded from the FAS as the participant was a confirmed screening failure.|
48439947|NCT03099265|101409991|FG000|STARTED|Overall Study||9||
48339710|NCT00818259|101160050|FG005|STARTED|Part V||0||
48339711|NCT00818259|101160051|FG006|STARTED|Part V||0||
48339712|NCT00818259|101160052|FG007|STARTED|Part V||17||
48339713|NCT00818259|101160053|FG008|STARTED|Part V||6||
48339714|NCT00818259|101160045|FG000|COMPLETED|Part V||0||
48339715|NCT00818259|101160046|FG001|COMPLETED|Part V||0||
48339716|NCT00818259|101160047|FG002|COMPLETED|Part V||0||
48339717|NCT00818259|101160048|FG003|COMPLETED|Part V||0||
48339718|NCT00818259|101160049|FG004|COMPLETED|Part V||0||
48339719|NCT00818259|101160050|FG005|COMPLETED|Part V||0||
48339720|NCT00818259|101160051|FG006|COMPLETED|Part V||0||
48339721|NCT00818259|101160052|FG007|COMPLETED|Part V||16||
48339722|NCT00818259|101160053|FG008|COMPLETED|Part V||6||
48339723|NCT00818259|101160045|FG000|NOT COMPLETED|Part V||0||
48339724|NCT00818259|101160046|FG001|NOT COMPLETED|Part V||0||
48339725|NCT00818259|101160047|FG002|NOT COMPLETED|Part V||0||
48339726|NCT00818259|101160048|FG003|NOT COMPLETED|Part V||0||
48339727|NCT00818259|101160049|FG004|NOT COMPLETED|Part V||0||
48339728|NCT00818259|101160050|FG005|NOT COMPLETED|Part V||0||
48339729|NCT00818259|101160051|FG006|NOT COMPLETED|Part V||0||
48339730|NCT00818259|101160052|FG007|NOT COMPLETED|Part V||1||
48339731|NCT00818259|101160053|FG008|NOT COMPLETED|Part V||0||
48339732|NCT01290887|101160054|FG000|STARTED|Overall Study||481||
48339733|NCT01290887|101160055|FG001|STARTED|Overall Study||571||
48339734|NCT01290887|101160054|FG000|Safety Analysis Set|Overall Study||480||
48339735|NCT01290887|101160055|FG001|Safety Analysis Set|Overall Study||571||
48339736|NCT01290887|101160054|FG000|COMPLETED|Overall Study||15||
48339737|NCT01290887|101160055|FG001|COMPLETED|Overall Study||35||
48339738|NCT01290887|101160054|FG000|NOT COMPLETED|Overall Study||466||
48339739|NCT01290887|101160055|FG001|NOT COMPLETED|Overall Study||536||
48339740|NCT03329378|101160056|FG000|STARTED|Overall Study||2||
48339741|NCT03329378|101160057|FG001|STARTED|Overall Study||5||
48339742|NCT03329378|101160056|FG000|COMPLETED|Overall Study||2||
48339743|NCT03329378|101160057|FG001|COMPLETED|Overall Study||5||
48339744|NCT03329378|101160056|FG000|NOT COMPLETED|Overall Study||0||
48632062|NCT02577029|101881693|FG001|STARTED|Overall Study||2||
48632063|NCT02577029|101881694|FG002|STARTED|Overall Study||7||
48632064|NCT02577029|101881695|FG003|STARTED|Overall Study||12||
48339745|NCT03329378|101160057|FG001|NOT COMPLETED|Overall Study||0||
48339746|NCT00045032|101160058|FG000|STARTED|Overall Study||1697||
48339747|NCT00045032|101160059|FG001|STARTED|Overall Study||1702||
48339748|NCT00045032|101160060|FG002|STARTED|Overall Study||1700||
48339749|NCT00045032|101160058|FG000|Crossover to Adjuvant Herceptin|Overall Study||888||
48339750|NCT00045032|101160059|FG001|Crossover to Adjuvant Herceptin|Overall Study||0||
48339751|NCT00045032|101160060|FG002|Crossover to Adjuvant Herceptin|Overall Study||0||
48339752|NCT00045032|101160058|FG000|COMPLETED|Overall Study||834||
48339753|NCT00045032|101160059|FG001|COMPLETED|Overall Study||994||
48339754|NCT00045032|101160060|FG002|COMPLETED|Overall Study||974||
48339755|NCT00045032|101160058|FG000|NOT COMPLETED|Overall Study||863||
48339756|NCT00045032|101160059|FG001|NOT COMPLETED|Overall Study||708||
48339757|NCT00045032|101160060|FG002|NOT COMPLETED|Overall Study||726||
48339758|NCT00927563|101160061|FG000|STARTED|Overall Study||24||
48339759|NCT00927563|101160061|FG000|COMPLETED|Overall Study||22||
48339760|NCT00927563|101160061|FG000|NOT COMPLETED|Overall Study||2||
48339761|NCT02009878|101160062|FG000|STARTED|Overall Study||10||
48339762|NCT02009878|101160063|FG001|STARTED|Overall Study||11||
48339763|NCT02009878|101160064|FG002|STARTED|Overall Study||9||
48339764|NCT02009878|101160062|FG000|COMPLETED|Overall Study||10||
48339765|NCT02009878|101160063|FG001|COMPLETED|Overall Study||10||
48339766|NCT02009878|101160064|FG002|COMPLETED|Overall Study||9||
48339767|NCT02009878|101160062|FG000|NOT COMPLETED|Overall Study||0||
48339768|NCT02009878|101160063|FG001|NOT COMPLETED|Overall Study||1||
48339769|NCT02009878|101160064|FG002|NOT COMPLETED|Overall Study||0||
48339770|NCT01703000|101160065|FG000|STARTED|Overall Study||100||
48632065|NCT02577029|101881696|FG004|STARTED|Overall Study||11||
48339771|NCT01703000|101160065|FG000|COMPLETED|Overall Study||99||
48339772|NCT01703000|101160065|FG000|NOT COMPLETED|Overall Study||1||
48339773|NCT00947284|101160066|FG000|STARTED|Overall Study||0||
48339774|NCT00947284|101160067|FG001|STARTED|Overall Study||3||
48339775|NCT00947284|101160066|FG000|COMPLETED|Overall Study||0||
48339776|NCT00947284|101160067|FG001|COMPLETED|Overall Study||0||
48339777|NCT00947284|101160066|FG000|NOT COMPLETED|Overall Study||0||
48339778|NCT00947284|101160067|FG001|NOT COMPLETED|Overall Study||3||
48339779|NCT00046228|101160068|FG000|STARTED|90 Days||806||
48339780|NCT00046228|101160069|FG001|STARTED|90 Days||818||
48339781|NCT00046228|101160070|FG002|STARTED|90 Days||828||
48339782|NCT00046228|101160068|FG000|COMPLETED|90 Days||793||
48339783|NCT00046228|101160069|FG001|COMPLETED|90 Days||810||
48339784|NCT00046228|101160070|FG002|COMPLETED|90 Days||813||
48339785|NCT00046228|101160068|FG000|NOT COMPLETED|90 Days||13||
48632066|NCT02577029|101881697|FG005|STARTED|Overall Study||13||
48632067|NCT02577029|101881698|FG006|STARTED|Overall Study||12||
48632068|NCT02577029|101881699|FG007|STARTED|Overall Study||12||
48632069|NCT02577029|101881692|FG000|COMPLETED|Overall Study||0||
48339786|NCT00046228|101160069|FG001|NOT COMPLETED|90 Days||8||
48339787|NCT00046228|101160070|FG002|NOT COMPLETED|90 Days||15||
48339788|NCT00046228|101160068|FG000|STARTED|1 Year||806||
48632070|NCT02577029|101881693|FG001|COMPLETED|Overall Study||0||
48339789|NCT00046228|101160069|FG001|STARTED|1 Year||818||
48339790|NCT00046228|101160070|FG002|STARTED|1 Year||828||
48339791|NCT00046228|101160068|FG000|COMPLETED|1 Year||787||
48339792|NCT00046228|101160069|FG001|COMPLETED|1 Year||804||
48339793|NCT00046228|101160070|FG002|COMPLETED|1 Year||816||
48339794|NCT00046228|101160068|FG000|NOT COMPLETED|1 Year||19||
48339795|NCT00046228|101160069|FG001|NOT COMPLETED|1 Year||14||
48339796|NCT00046228|101160070|FG002|NOT COMPLETED|1 Year||12||
48339797|NCT01647737|101160071|FG000|STARTED|Overall Study||30||
48339798|NCT01647737|101160072|FG001|STARTED|Overall Study||30||
48339799|NCT01647737|101160071|FG000|COMPLETED|Overall Study||26||
48339800|NCT01647737|101160072|FG001|COMPLETED|Overall Study||25||
48339801|NCT01647737|101160071|FG000|NOT COMPLETED|Overall Study||4||
48339802|NCT01647737|101160072|FG001|NOT COMPLETED|Overall Study||5||
48339803|NCT01054079|101160073|FG000|STARTED|Overall Study||20||
48339804|NCT01054079|101160073|FG000|# Recieved Proper PSA Testing|Overall Study||10||
48339805|NCT01054079|101160073|FG000|COMPLETED|Overall Study||20||
48339806|NCT01054079|101160073|FG000|NOT COMPLETED|Overall Study||0||
48339807|NCT01176916|101160074|FG000|STARTED|Overall Study||564||
48339808|NCT01176916|101160074|FG000|Treated|Overall Study||558||
48339809|NCT01176916|101160074|FG000|Assigne But Not Treated|Overall Study||6||
48339810|NCT01176916|101160074|FG000|COMPLETED|Overall Study||397||
48339811|NCT01176916|101160074|FG000|NOT COMPLETED|Overall Study||167||
48339812|NCT01307033|101160075|FG000|STARTED|8-week Double-blind Period||144||
48339813|NCT01307033|101160076|FG001|STARTED|8-week Double-blind Period||134||
48339814|NCT01307033|101160077|FG002|STARTED|8-week Double-blind Period||0||
48339815|NCT01307033|101160078|FG003|STARTED|8-week Double-blind Period||0||
48339816|NCT01307033|101160075|FG000|COMPLETED|8-week Double-blind Period||131||
48339817|NCT01307033|101160076|FG001|COMPLETED|8-week Double-blind Period||127||
48339818|NCT01307033|101160077|FG002|COMPLETED|8-week Double-blind Period||0||
48339819|NCT01307033|101160078|FG003|COMPLETED|8-week Double-blind Period||0||
48339820|NCT01307033|101160075|FG000|NOT COMPLETED|8-week Double-blind Period||13||
48339821|NCT01307033|101160076|FG001|NOT COMPLETED|8-week Double-blind Period||7||
48339822|NCT01307033|101160077|FG002|NOT COMPLETED|8-week Double-blind Period||0||
48339823|NCT01307033|101160078|FG003|NOT COMPLETED|8-week Double-blind Period||0||
48339824|NCT01307033|101160075|FG000|STARTED|44-week Open-label Extension||0||
48339825|NCT01307033|101160076|FG001|STARTED|44-week Open-label Extension||0||
48339826|NCT01307033|101160077|FG002|STARTED|44-week Open-label Extension||131||
48339827|NCT01307033|101160078|FG003|STARTED|44-week Open-label Extension||127||
48339828|NCT01307033|101160075|FG000|COMPLETED|44-week Open-label Extension||0||
48339829|NCT01307033|101160076|FG001|COMPLETED|44-week Open-label Extension||0||
48339830|NCT01307033|101160077|FG002|COMPLETED|44-week Open-label Extension||120||
48632071|NCT02577029|101881694|FG002|COMPLETED|Overall Study||0||
48632072|NCT02577029|101881695|FG003|COMPLETED|Overall Study||0||
48632073|NCT02577029|101881696|FG004|COMPLETED|Overall Study||0||
48632074|NCT02577029|101881697|FG005|COMPLETED|Overall Study||0||
48632075|NCT02577029|101881698|FG006|COMPLETED|Overall Study||0||
48632076|NCT02577029|101881699|FG007|COMPLETED|Overall Study||0||
48632077|NCT02577029|101881692|FG000|NOT COMPLETED|Overall Study||10||
48632078|NCT02577029|101881693|FG001|NOT COMPLETED|Overall Study||2||
48632079|NCT02577029|101881694|FG002|NOT COMPLETED|Overall Study||7||
48632080|NCT02577029|101881695|FG003|NOT COMPLETED|Overall Study||12||
48632081|NCT02577029|101881696|FG004|NOT COMPLETED|Overall Study||11||
48632082|NCT02577029|101881697|FG005|NOT COMPLETED|Overall Study||13||
48632083|NCT02577029|101881698|FG006|NOT COMPLETED|Overall Study||12||
48339831|NCT01307033|101160078|FG003|COMPLETED|44-week Open-label Extension||115||
48339832|NCT01307033|101160075|FG000|NOT COMPLETED|44-week Open-label Extension||0||
48339833|NCT01307033|101160076|FG001|NOT COMPLETED|44-week Open-label Extension||0||
48339834|NCT01307033|101160077|FG002|NOT COMPLETED|44-week Open-label Extension||11||
48339835|NCT01307033|101160078|FG003|NOT COMPLETED|44-week Open-label Extension||12||
48339836|NCT00491179|101160079|FG000|STARTED|Overall Study||25||
48632084|NCT02577029|101881699|FG007|NOT COMPLETED|Overall Study||12||
48632085|NCT00423046|101881700|FG000|STARTED|Overall Study||553||
48632086|NCT00423046|101881701|FG001|STARTED|Overall Study||553||
48632087|NCT00423046|101881700|FG000|COMPLETED|Overall Study||213||
48339837|NCT00491179|101160080|FG001|STARTED|Overall Study||10||
48339838|NCT00491179|101160079|FG000|COMPLETED|Overall Study||18||
48339839|NCT00491179|101160080|FG001|COMPLETED|Overall Study||8||
48339840|NCT00491179|101160079|FG000|NOT COMPLETED|Overall Study||7||
48339841|NCT00491179|101160080|FG001|NOT COMPLETED|Overall Study||2||
48339842|NCT02761967|101160081|FG000|STARTED|Overall Study||70||
48339843|NCT02761967|101160082|FG001|STARTED|Overall Study||70||
48339844|NCT02761967|101160081|FG000|COMPLETED|Overall Study||65||
48339845|NCT02761967|101160082|FG001|COMPLETED|Overall Study||64||
48339846|NCT02761967|101160081|FG000|NOT COMPLETED|Overall Study||5||
48339847|NCT02761967|101160082|FG001|NOT COMPLETED|Overall Study||6||
48339848|NCT01072344|101160083|FG000|STARTED|Overall Study||46||
48339849|NCT01072344|101160084|FG001|STARTED|Overall Study||47||
48339850|NCT01072344|101160083|FG000|COMPLETED|Overall Study||35||
48339851|NCT01072344|101160084|FG001|COMPLETED|Overall Study||29||
48339852|NCT01072344|101160083|FG000|NOT COMPLETED|Overall Study||11||
48339853|NCT01072344|101160084|FG001|NOT COMPLETED|Overall Study||18||
48339854|NCT01728779|101160085|FG000|STARTED|Overall Study||38||
48339855|NCT01728779|101160085|FG000|COMPLETED|Overall Study||37||
48339856|NCT01728779|101160085|FG000|NOT COMPLETED|Overall Study||1||
48339857|NCT00930059|101160086|FG000|STARTED|Overall Study||100||
48339858|NCT00930059|101160087|FG001|STARTED|Overall Study||91||
48339859|NCT00930059|101160086|FG000|COMPLETED|Overall Study||92||
48339860|NCT00930059|101160087|FG001|COMPLETED|Overall Study||79||
48339861|NCT00930059|101160086|FG000|NOT COMPLETED|Overall Study||8||
48339862|NCT00930059|101160087|FG001|NOT COMPLETED|Overall Study||12||
48339863|NCT03480802|101160088|FG000|STARTED|Overall Study||152|Vaccinated on Day 1|
48632088|NCT00423046|101881701|FG001|COMPLETED|Overall Study||208||
48632089|NCT00423046|101881700|FG000|NOT COMPLETED|Overall Study||340||
48632090|NCT00423046|101881701|FG001|NOT COMPLETED|Overall Study||345||
48632091|NCT04079790|101881702|FG000|STARTED|Part 1, Period 1(Day 1 to Day 4)||14||
48632092|NCT04079790|101881703|FG001|STARTED|Part 1, Period 1(Day 1 to Day 4)||2||
48632093|NCT04079790|101881704|FG002|STARTED|Part 1, Period 1(Day 1 to Day 4)||0||
48632094|NCT04079790|101881705|FG003|STARTED|Part 1, Period 1(Day 1 to Day 4)||0||
48632095|NCT04079790|101881702|FG000|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||13||
48339864|NCT03480802|101160089|FG001|STARTED|Overall Study||150|Vaccinated on Day 1|
48339865|NCT03480802|101160088|FG000|Week 8|Overall Study||150|Vaccinated with PNEUMOVAX™23|
48339866|NCT03480802|101160089|FG001|Week 8|Overall Study||148|Vaccinated with PNEUMOVAX™23|
48339867|NCT03480802|101160088|FG000|COMPLETED|Overall Study||145||
48339868|NCT03480802|101160089|FG001|COMPLETED|Overall Study||147||
48339869|NCT03480802|101160088|FG000|NOT COMPLETED|Overall Study||7||
48339870|NCT03480802|101160089|FG001|NOT COMPLETED|Overall Study||3||
48339871|NCT02848079|101160090|FG000|STARTED|Overall Study||41||
48339872|NCT02848079|101160090|FG000|Receieved Study Treatment|Overall Study||41||
48339873|NCT02848079|101160090|FG000|Discontinued|Overall Study||41||
48339874|NCT02848079|101160090|FG000|COMPLETED|Overall Study||41||
48339875|NCT02848079|101160090|FG000|NOT COMPLETED|Overall Study||0||
48339876|NCT02522767|101160091|FG000|STARTED|Double-blind||114||
48339877|NCT02522767|101160092|FG001|STARTED|Double-blind||114||
48339878|NCT02522767|101160091|FG000|COMPLETED|Double-blind||103||
48339879|NCT02522767|101160092|FG001|COMPLETED|Double-blind||90||
48339880|NCT02522767|101160091|FG000|NOT COMPLETED|Double-blind||11||
48339881|NCT02522767|101160092|FG001|NOT COMPLETED|Double-blind||24||
48339882|NCT02522767|101160091|FG000|STARTED|Open-label||88||
48339883|NCT02522767|101160092|FG001|STARTED|Open-label||82||
48339884|NCT02522767|101160091|FG000|COMPLETED|Open-label||83||
48339885|NCT02522767|101160092|FG001|COMPLETED|Open-label||75||
48339886|NCT02522767|101160091|FG000|NOT COMPLETED|Open-label||5||
48339887|NCT02522767|101160092|FG001|NOT COMPLETED|Open-label||7||
48339888|NCT03773302|101160093|FG000|STARTED|Overall Study||29||
48339889|NCT03773302|101160094|FG001|STARTED|Overall Study||19||
48632096|NCT04079790|101881703|FG001|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||2||
48632097|NCT04079790|101881704|FG002|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0||
48339890|NCT03773302|101160093|FG000|COMPLETED|Overall Study||29||
48339891|NCT03773302|101160094|FG001|COMPLETED|Overall Study||17||
48339892|NCT03773302|101160093|FG000|NOT COMPLETED|Overall Study||0||
48339893|NCT03773302|101160094|FG001|NOT COMPLETED|Overall Study||2||
48339894|NCT01578031|101160095|FG000|STARTED|Overall Study||129||
48339895|NCT01578031|101160096|FG001|STARTED|Overall Study||69||
48339896|NCT01578031|101160097|FG002|STARTED|Overall Study||12||
48339897|NCT01578031|101160098|FG003|STARTED|Overall Study||30||
48339898|NCT01578031|101160095|FG000|COMPLETED|Overall Study||67||
48339899|NCT01578031|101160096|FG001|COMPLETED|Overall Study||35||
48339900|NCT01578031|101160097|FG002|COMPLETED|Overall Study||12||
48339901|NCT01578031|101160098|FG003|COMPLETED|Overall Study||30||
48339902|NCT01578031|101160095|FG000|NOT COMPLETED|Overall Study||62||
48339903|NCT01578031|101160096|FG001|NOT COMPLETED|Overall Study||34||
48632098|NCT04079790|101881705|FG003|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0||
48339904|NCT01578031|101160097|FG002|NOT COMPLETED|Overall Study||0||
48339905|NCT01578031|101160098|FG003|NOT COMPLETED|Overall Study||0||
48339906|NCT03419078|101160099|FG000|STARTED|Overall Study||245||
48339907|NCT03419078|101160100|FG001|STARTED|Overall Study||148||
48339908|NCT03419078|101160101|FG002|STARTED|Overall Study||91||
48339909|NCT03419078|101160099|FG000|COMPLETED|Overall Study||245||
48339910|NCT03419078|101160100|FG001|COMPLETED|Overall Study||148||
48339911|NCT03419078|101160101|FG002|COMPLETED|Overall Study||91||
48339912|NCT03419078|101160099|FG000|NOT COMPLETED|Overall Study||0||
48339913|NCT03419078|101160100|FG001|NOT COMPLETED|Overall Study||0||
48339914|NCT03419078|101160101|FG002|NOT COMPLETED|Overall Study||0||
48339915|NCT02542267|101160102|FG000|STARTED|Overall Study||108||
48339916|NCT02542267|101160102|FG000|COMPLETED|Overall Study||53||
48339917|NCT02542267|101160102|FG000|NOT COMPLETED|Overall Study||55||
48339918|NCT01111305|101160103|FG000|STARTED|Overall Study||4||
48339919|NCT01111305|101160104|FG001|STARTED|Overall Study||4||
48339920|NCT01111305|101160103|FG000|COMPLETED|Overall Study||4||
48339921|NCT01111305|101160104|FG001|COMPLETED|Overall Study||4||
48339922|NCT01111305|101160103|FG000|NOT COMPLETED|Overall Study||0||
48339923|NCT01111305|101160104|FG001|NOT COMPLETED|Overall Study||0||
48339924|NCT01583179|101160105|FG000|STARTED|Overall Study||14||
48339925|NCT01583179|101160106|FG001|STARTED|Overall Study||12||
48339926|NCT01583179|101160105|FG000|COMPLETED|Overall Study||13||
48339927|NCT01583179|101160106|FG001|COMPLETED|Overall Study||10||
48339928|NCT01583179|101160105|FG000|NOT COMPLETED|Overall Study||1||
48339929|NCT01583179|101160106|FG001|NOT COMPLETED|Overall Study||2||
48339930|NCT02921386|101160107|FG000|STARTED|Sequence A: Fasting||18||
48339931|NCT02921386|101160107|FG000|COMPLETED|Sequence A: Fasting||18||
48339932|NCT02921386|101160107|FG000|NOT COMPLETED|Sequence A: Fasting||0||
48339933|NCT02921386|101160107|FG000|STARTED|Sequence B: 15 g Fat Breakfast||18||
48339934|NCT02921386|101160107|FG000|COMPLETED|Sequence B: 15 g Fat Breakfast||18||
48339935|NCT02921386|101160107|FG000|NOT COMPLETED|Sequence B: 15 g Fat Breakfast||0||
48339936|NCT02921386|101160107|FG000|STARTED|Sequence C: 30 g Fat Breakfast||18||
48339937|NCT02921386|101160107|FG000|COMPLETED|Sequence C: 30 g Fat Breakfast||18||
48339938|NCT02921386|101160107|FG000|NOT COMPLETED|Sequence C: 30 g Fat Breakfast||0||
48339939|NCT02921386|101160107|FG000|STARTED|Sequence D: 45 g Fat Breakfast||18||
48339940|NCT02921386|101160107|FG000|COMPLETED|Sequence D: 45 g Fat Breakfast||18||
48339941|NCT02921386|101160107|FG000|NOT COMPLETED|Sequence D: 45 g Fat Breakfast||0||
48339942|NCT02921386|101160107|FG000|STARTED|Sequence E: FDA High Fat Breakfast||18||
48632099|NCT04079790|101881702|FG000|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||1||
48339943|NCT02921386|101160107|FG000|COMPLETED|Sequence E: FDA High Fat Breakfast||18||
48339944|NCT02921386|101160107|FG000|NOT COMPLETED|Sequence E: FDA High Fat Breakfast||0||
48339945|NCT01929057|101160108|FG000|STARTED|Overall Study||31||
48339946|NCT01929057|101160109|FG001|STARTED|Overall Study||3||
48339947|NCT01929057|101160108|FG000|COMPLETED|Overall Study||31||
48339948|NCT01929057|101160109|FG001|COMPLETED|Overall Study||3||
48339949|NCT01929057|101160108|FG000|NOT COMPLETED|Overall Study||0||
48339950|NCT01929057|101160109|FG001|NOT COMPLETED|Overall Study||0||
48339951|NCT00988247|101160110|FG000|STARTED|Overall Study||418||
48339952|NCT00988247|101160111|FG001|STARTED|Overall Study||111||
48339953|NCT00988247|101160110|FG000|Safety Population|Overall Study||415||
48339954|NCT00988247|101160111|FG001|Safety Population|Overall Study||111||
48339955|NCT00988247|101160110|FG000|Intent to Treat Population|Overall Study||414||
48339956|NCT00988247|101160111|FG001|Intent to Treat Population|Overall Study||110||
48339957|NCT00988247|101160110|FG000|COMPLETED|Overall Study||335||
48339958|NCT00988247|101160111|FG001|COMPLETED|Overall Study||85||
48339959|NCT00988247|101160110|FG000|NOT COMPLETED|Overall Study||83||
48339960|NCT00988247|101160111|FG001|NOT COMPLETED|Overall Study||26||
48339961|NCT00299988|101160112|FG000|STARTED|Overall Study||16||
48339962|NCT00299988|101160113|FG001|STARTED|Overall Study||8||
48339963|NCT00299988|101160112|FG000|COMPLETED|Overall Study||16||
48339964|NCT00299988|101160113|FG001|COMPLETED|Overall Study||8||
48339965|NCT00299988|101160112|FG000|NOT COMPLETED|Overall Study||0||
48339966|NCT00299988|101160113|FG001|NOT COMPLETED|Overall Study||0||
48339967|NCT04793399|101160114|FG000|STARTED|Overall Study||9||
48339968|NCT04793399|101160114|FG000|COMPLETED|Overall Study||4||
48339969|NCT04793399|101160114|FG000|NOT COMPLETED|Overall Study||5||
48339970|NCT00552110|101160115|FG000|STARTED|Overall Study||146||
48339971|NCT00552110|101160116|FG001|STARTED|Overall Study||139||
48339972|NCT00552110|101160117|FG002|STARTED|Overall Study||139||
48339973|NCT00552110|101160118|FG003|STARTED|Overall Study||141||
48632100|NCT04079790|101881703|FG001|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0||
48632101|NCT04079790|101881704|FG002|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0||
48339974|NCT00552110|101160119|FG004|STARTED|Overall Study||142||
48339975|NCT00552110|101160115|FG000|COMPLETED|Overall Study||142||
48339976|NCT00552110|101160116|FG001|COMPLETED|Overall Study||134||
48339977|NCT00552110|101160117|FG002|COMPLETED|Overall Study||137||
48339978|NCT00552110|101160118|FG003|COMPLETED|Overall Study||133||
48632102|NCT04079790|101881705|FG003|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0||
48339979|NCT00552110|101160119|FG004|COMPLETED|Overall Study||133||
48339980|NCT00552110|101160115|FG000|NOT COMPLETED|Overall Study||4||
48339981|NCT00552110|101160116|FG001|NOT COMPLETED|Overall Study||5||
48339982|NCT00552110|101160117|FG002|NOT COMPLETED|Overall Study||2||
48754506|NCT00772538|102187726|FG000|COMPLETED|Overall Study||202||
48754507|NCT00772538|102187727|FG001|COMPLETED|Overall Study||211||
48754508|NCT00772538|102187726|FG000|NOT COMPLETED|Overall Study||20||
48754509|NCT00772538|102187727|FG001|NOT COMPLETED|Overall Study||26||
48754510|NCT00524485|102187728|FG000|STARTED|Overall Study||12||
48754511|NCT00524485|102187728|FG000|COMPLETED|Overall Study||7||
48178979|NCT02291289|100759987|FG005|NOT COMPLETED|Maintenance Treatment Phase||127||
48178980|NCT02291289|100759988|FG006|NOT COMPLETED|Maintenance Treatment Phase||0||
48178981|NCT02291289|100759989|FG007|NOT COMPLETED|Maintenance Treatment Phase||3||
48178982|NCT02291289|100759990|FG008|NOT COMPLETED|Maintenance Treatment Phase||1||
48178983|NCT02291289|100759991|FG009|NOT COMPLETED|Maintenance Treatment Phase||0||
48178984|NCT02291289|100759992|FG010|NOT COMPLETED|Maintenance Treatment Phase||53||
48178985|NCT02291289|100759993|FG011|NOT COMPLETED|Maintenance Treatment Phase||28||
48178986|NCT02291289|100759994|FG012|NOT COMPLETED|Maintenance Treatment Phase||0||
48178987|NCT02291289|100759982|FG000|STARTED|Early Disease Progression||0||
48178988|NCT02291289|100759983|FG001|STARTED|Early Disease Progression||0||
48178989|NCT02291289|100759984|FG002|STARTED|Early Disease Progression||0||
48178990|NCT02291289|100759985|FG003|STARTED|Early Disease Progression||0||
48178991|NCT02291289|100759986|FG004|STARTED|Early Disease Progression||0||
48178992|NCT02291289|100759987|FG005|STARTED|Early Disease Progression||0||
48178993|NCT02291289|100759988|FG006|STARTED|Early Disease Progression||0||
48178994|NCT02291289|100759989|FG007|STARTED|Early Disease Progression||0||
48178995|NCT02291289|100759990|FG008|STARTED|Early Disease Progression||0||
48178996|NCT02291289|100759991|FG009|STARTED|Early Disease Progression||0||
48178997|NCT02291289|100759992|FG010|STARTED|Early Disease Progression||0||
48178998|NCT02291289|100759993|FG011|STARTED|Early Disease Progression||0||
48178999|NCT02291289|100759994|FG012|STARTED|Early Disease Progression||11||
48179000|NCT02291289|100759982|FG000|COMPLETED|Early Disease Progression||0||
48179001|NCT02291289|100759983|FG001|COMPLETED|Early Disease Progression||0||
48179002|NCT02291289|100759984|FG002|COMPLETED|Early Disease Progression||0||
48179003|NCT02291289|100759985|FG003|COMPLETED|Early Disease Progression||0||
48179004|NCT02291289|100759986|FG004|COMPLETED|Early Disease Progression||0||
48179005|NCT02291289|100759987|FG005|COMPLETED|Early Disease Progression||0||
48179006|NCT02291289|100759988|FG006|COMPLETED|Early Disease Progression||0||
48179007|NCT02291289|100759989|FG007|COMPLETED|Early Disease Progression||0||
48179008|NCT02291289|100759990|FG008|COMPLETED|Early Disease Progression||0||
48179009|NCT02291289|100759991|FG009|COMPLETED|Early Disease Progression||0||
48179010|NCT02291289|100759992|FG010|COMPLETED|Early Disease Progression||0||
48179011|NCT02291289|100759993|FG011|COMPLETED|Early Disease Progression||0||
48179012|NCT02291289|100759994|FG012|COMPLETED|Early Disease Progression||0||
48179013|NCT02291289|100759982|FG000|NOT COMPLETED|Early Disease Progression||0||
48179014|NCT02291289|100759983|FG001|NOT COMPLETED|Early Disease Progression||0||
48179015|NCT02291289|100759984|FG002|NOT COMPLETED|Early Disease Progression||0||
48179016|NCT02291289|100759985|FG003|NOT COMPLETED|Early Disease Progression||0||
48179017|NCT02291289|100759986|FG004|NOT COMPLETED|Early Disease Progression||0||
48179018|NCT02291289|100759987|FG005|NOT COMPLETED|Early Disease Progression||0||
48179019|NCT02291289|100759988|FG006|NOT COMPLETED|Early Disease Progression||0||
48179020|NCT02291289|100759989|FG007|NOT COMPLETED|Early Disease Progression||0||
48179021|NCT02291289|100759990|FG008|NOT COMPLETED|Early Disease Progression||0||
48179022|NCT02291289|100759991|FG009|NOT COMPLETED|Early Disease Progression||0||
48179023|NCT02291289|100759992|FG010|NOT COMPLETED|Early Disease Progression||0||
48179024|NCT02291289|100759993|FG011|NOT COMPLETED|Early Disease Progression||0||
48179025|NCT02291289|100759994|FG012|NOT COMPLETED|Early Disease Progression||11||
48179026|NCT00440180|100759995|FG000|STARTED|Overall Study||10||
48179027|NCT00440180|100759996|FG001|STARTED|Overall Study||10||
48179028|NCT00440180|100759995|FG000|COMPLETED|Overall Study||10||
48179029|NCT00440180|100759996|FG001|COMPLETED|Overall Study||10||
48179030|NCT00440180|100759995|FG000|NOT COMPLETED|Overall Study||0||
48179031|NCT00440180|100759996|FG001|NOT COMPLETED|Overall Study||0||
48179032|NCT01836458|100759997|FG000|STARTED|Overall Study||7||
48179033|NCT01836458|100759998|FG001|STARTED|Overall Study||4||
48179034|NCT01836458|100759999|FG002|STARTED|Overall Study||7||
48754512|NCT00524485|102187728|FG000|NOT COMPLETED|Overall Study||5||
48754513|NCT00310765|102187729|FG000|STARTED|Placebo Controlled Double Blind||11||
48179035|NCT01836458|100760000|FG003|STARTED|Overall Study||7||
48179036|NCT01836458|100759997|FG000|COMPLETED|Overall Study||4||
48179037|NCT01836458|100759998|FG001|COMPLETED|Overall Study||2||
48179038|NCT01836458|100759999|FG002|COMPLETED|Overall Study||2||
48179039|NCT01836458|100760000|FG003|COMPLETED|Overall Study||1||
48179040|NCT01836458|100759997|FG000|NOT COMPLETED|Overall Study||3||
48179041|NCT01836458|100759998|FG001|NOT COMPLETED|Overall Study||2||
48179042|NCT01836458|100759999|FG002|NOT COMPLETED|Overall Study||5||
48754514|NCT00310765|102187730|FG001|STARTED|Placebo Controlled Double Blind||7||
48754515|NCT00310765|102187729|FG000|COMPLETED|Placebo Controlled Double Blind||8||
48754516|NCT00310765|102187730|FG001|COMPLETED|Placebo Controlled Double Blind||5||
48179043|NCT01836458|100760000|FG003|NOT COMPLETED|Overall Study||6||
48179044|NCT04701593|100760001|FG000|STARTED|Overall Study||5||
48179045|NCT04701593|100760002|FG001|STARTED|Overall Study||9||
48754517|NCT00310765|102187729|FG000|NOT COMPLETED|Placebo Controlled Double Blind||3||
48339983|NCT00552110|101160118|FG003|NOT COMPLETED|Overall Study||8||
48339984|NCT00552110|101160119|FG004|NOT COMPLETED|Overall Study||9||
48339985|NCT03695913|101160120|FG000|STARTED|Overall Study||15||
48339986|NCT03695913|101160120|FG000|COMPLETED|Overall Study||15||
48339987|NCT03695913|101160120|FG000|NOT COMPLETED|Overall Study||0||
48339988|NCT01029730|101160121|FG000|STARTED|Combination Therapy||55||
48339989|NCT01029730|101160121|FG000|COMPLETED|Combination Therapy||39||
48339990|NCT01029730|101160121|FG000|NOT COMPLETED|Combination Therapy||16||
48339991|NCT01029730|101160121|FG000|STARTED|Maintenance Therapy||37||
48339992|NCT01029730|101160121|FG000|COMPLETED|Maintenance Therapy||14||
48339993|NCT01029730|101160121|FG000|NOT COMPLETED|Maintenance Therapy||23||
48339994|NCT01573910|101160122|FG000|STARTED|Overall Study||489||
48339995|NCT01573910|101160123|FG001|STARTED|Overall Study||493||
48339996|NCT01573910|101160122|FG000|COMPLETED|Overall Study||469||
48339997|NCT01573910|101160123|FG001|COMPLETED|Overall Study||476||
48339998|NCT01573910|101160122|FG000|NOT COMPLETED|Overall Study||20||
48339999|NCT01573910|101160123|FG001|NOT COMPLETED|Overall Study||17||
48340000|NCT03655444|101160124|FG000|STARTED|Overall Study||3||
48340001|NCT03655444|101160125|FG001|STARTED|Overall Study||3||
48340002|NCT03655444|101160124|FG000|COMPLETED|Overall Study||3||
48340003|NCT03655444|101160125|FG001|COMPLETED|Overall Study||3||
48340004|NCT03655444|101160124|FG000|NOT COMPLETED|Overall Study||0||
48340005|NCT03655444|101160125|FG001|NOT COMPLETED|Overall Study||0||
48340006|NCT00130286|101160126|FG000|STARTED|Overall Study||22||
48340007|NCT00130286|101160127|FG001|STARTED|Overall Study||19||
48340008|NCT00130286|101160128|FG002|STARTED|Overall Study||17||
48340009|NCT00130286|101160129|FG003|STARTED|Overall Study||19||
48340010|NCT00130286|101160126|FG000|COMPLETED|Overall Study||22||
48340011|NCT00130286|101160127|FG001|COMPLETED|Overall Study||16||
48340012|NCT00130286|101160128|FG002|COMPLETED|Overall Study||13||
48340013|NCT00130286|101160129|FG003|COMPLETED|Overall Study||17||
48340014|NCT00130286|101160126|FG000|NOT COMPLETED|Overall Study||0||
48340015|NCT00130286|101160127|FG001|NOT COMPLETED|Overall Study||3||
48340016|NCT00130286|101160128|FG002|NOT COMPLETED|Overall Study||4||
48340017|NCT00130286|101160129|FG003|NOT COMPLETED|Overall Study||2||
48340018|NCT00650858|101160130|FG000|STARTED|Overall Study||8||
48340019|NCT00650858|101160131|FG001|STARTED|Overall Study||8||
48340020|NCT00650858|101160132|FG002|STARTED|Overall Study||36||
48340021|NCT00650858|101160130|FG000|COMPLETED|Overall Study||8||
48340022|NCT00650858|101160131|FG001|COMPLETED|Overall Study||8||
48340023|NCT00650858|101160132|FG002|COMPLETED|Overall Study||36||
48340024|NCT00650858|101160130|FG000|NOT COMPLETED|Overall Study||0||
48340025|NCT00650858|101160131|FG001|NOT COMPLETED|Overall Study||0||
48340026|NCT00650858|101160132|FG002|NOT COMPLETED|Overall Study||0||
48340027|NCT00495157|101160133|FG000|STARTED|Overall Study||113||
48340028|NCT00495157|101160134|FG001|STARTED|Overall Study||115||
48340029|NCT00495157|101160135|FG002|STARTED|Overall Study||114||
48340030|NCT00495157|101160133|FG000|COMPLETED|Overall Study||97||
48340031|NCT00495157|101160134|FG001|COMPLETED|Overall Study||92||
48340032|NCT00495157|101160135|FG002|COMPLETED|Overall Study||101||
48340033|NCT00495157|101160133|FG000|NOT COMPLETED|Overall Study||16||
48340034|NCT00495157|101160134|FG001|NOT COMPLETED|Overall Study||23||
48340035|NCT00495157|101160135|FG002|NOT COMPLETED|Overall Study||13||
48340036|NCT00927368|101160136|FG000|STARTED|Overall Study||153||
48340037|NCT00927368|101160137|FG001|STARTED|Overall Study||157||
48340038|NCT00927368|101160138|FG002|STARTED|Overall Study||143||
48340039|NCT00927368|101160136|FG000|COMPLETED|Overall Study||147||
48340040|NCT00927368|101160137|FG001|COMPLETED|Overall Study||152||
48340041|NCT00927368|101160138|FG002|COMPLETED|Overall Study||138||
48340042|NCT00927368|101160136|FG000|NOT COMPLETED|Overall Study||6||
48340043|NCT00927368|101160137|FG001|NOT COMPLETED|Overall Study||5||
48340044|NCT00927368|101160138|FG002|NOT COMPLETED|Overall Study||5||
48340045|NCT01958645|101160139|FG000|STARTED|Overall Study||4||
48340046|NCT01958645|101160140|FG001|STARTED|Overall Study||4||
48340047|NCT01958645|101160141|FG002|STARTED|Overall Study||4||
48340048|NCT01958645|101160139|FG000|COMPLETED|Overall Study||4||
48340049|NCT01958645|101160140|FG001|COMPLETED|Overall Study||4||
48340050|NCT01958645|101160141|FG002|COMPLETED|Overall Study||4||
48340051|NCT01958645|101160139|FG000|NOT COMPLETED|Overall Study||0||
48340052|NCT01958645|101160140|FG001|NOT COMPLETED|Overall Study||0||
48340053|NCT01958645|101160141|FG002|NOT COMPLETED|Overall Study||0||
48413449|NCT02607865|101345829|FG002|Full Analysis Set (FAS)|Overall Study||465|One participant was excluded from the FAS as the participant was a confirmed screening failure.|
48439948|NCT03099265|101409991|FG000|Per Protocol Week 12|Overall Study||8||
48340054|NCT00325078|101160142|FG000|STARTED|Overall Study||8||
48340055|NCT00325078|101160143|FG001|STARTED|Overall Study||7||
48340056|NCT00325078|101160144|FG002|STARTED|Overall Study||25||
48340057|NCT00325078|101160142|FG000|COMPLETED|Overall Study||3||
48340058|NCT00325078|101160143|FG001|COMPLETED|Overall Study||2||
48340059|NCT00325078|101160144|FG002|COMPLETED|Overall Study||23||
48340060|NCT00325078|101160142|FG000|NOT COMPLETED|Overall Study||5||
48340061|NCT00325078|101160143|FG001|NOT COMPLETED|Overall Study||5||
48340062|NCT00325078|101160144|FG002|NOT COMPLETED|Overall Study||2||
48340063|NCT02497001|101160145|FG000|STARTED|Overall Study||640||
48340064|NCT02497001|101160146|FG001|STARTED|Overall Study||627||
48340065|NCT02497001|101160147|FG002|STARTED|Overall Study||316||
48179046|NCT04701593|100760001|FG000|COMPLETED|Overall Study||5||
48179047|NCT04701593|100760002|FG001|COMPLETED|Overall Study||9||
48179048|NCT04701593|100760001|FG000|NOT COMPLETED|Overall Study||0||
48179049|NCT04701593|100760002|FG001|NOT COMPLETED|Overall Study||0||
48179050|NCT02178436|100760003|FG000|STARTED|Overall Study||9||
48179051|NCT02178436|100760004|FG001|STARTED|Overall Study||0||
48179052|NCT02178436|100760005|FG002|STARTED|Overall Study||4||
48179053|NCT02178436|100760003|FG000|COMPLETED|Overall Study||9||
48179054|NCT02178436|100760004|FG001|COMPLETED|Overall Study||0||
48179055|NCT02178436|100760005|FG002|COMPLETED|Overall Study||4||
48179056|NCT02178436|100760003|FG000|NOT COMPLETED|Overall Study||0||
48179057|NCT02178436|100760004|FG001|NOT COMPLETED|Overall Study||0||
48179058|NCT02178436|100760005|FG002|NOT COMPLETED|Overall Study||0||
48179059|NCT03294213|100760006|FG000|STARTED|Overall Study||176||
48179060|NCT03294213|100760006|FG000|COMPLETED|Overall Study||176||
48179061|NCT03294213|100760006|FG000|NOT COMPLETED|Overall Study||0||
48179062|NCT00776100|100760007|FG000|STARTED|Overall Study||1||
48179063|NCT00776100|100760008|FG001|STARTED|Overall Study||1||
48179064|NCT00776100|100760007|FG000|COMPLETED|Overall Study||0||
48179065|NCT00776100|100760008|FG001|COMPLETED|Overall Study||1||
48179066|NCT00776100|100760007|FG000|NOT COMPLETED|Overall Study||1||
48179067|NCT00776100|100760008|FG001|NOT COMPLETED|Overall Study||0||
48179068|NCT01310868|100760009|FG000|STARTED|Overall Study||72||
48179069|NCT01310868|100760009|FG000|COMPLETED|Overall Study||59||
48179070|NCT01310868|100760009|FG000|NOT COMPLETED|Overall Study||13||
48179071|NCT05048394|100760010|FG000|STARTED|Overall Study||7||
48179072|NCT05048394|100760011|FG001|STARTED|Overall Study||4||
48179073|NCT05048394|100760010|FG000|COMPLETED|Overall Study||7||
48179074|NCT05048394|100760011|FG001|COMPLETED|Overall Study||4||
48179075|NCT05048394|100760010|FG000|NOT COMPLETED|Overall Study||0||
48179076|NCT05048394|100760011|FG001|NOT COMPLETED|Overall Study||0||
48179077|NCT00344370|100760012|FG000|STARTED|Overall Study||143||
48179078|NCT00344370|100760013|FG001|STARTED|Overall Study||71||
48179079|NCT00344370|100760012|FG000|COMPLETED|Overall Study||128||
48179080|NCT00344370|100760013|FG001|COMPLETED|Overall Study||68||
48179081|NCT00344370|100760012|FG000|NOT COMPLETED|Overall Study||15||
48179082|NCT00344370|100760013|FG001|NOT COMPLETED|Overall Study||3||
48179083|NCT00432679|100760014|FG000|STARTED|Overall Study||74||
48179084|NCT00432679|100760015|FG001|STARTED|Overall Study||75||
48179085|NCT00432679|100760014|FG000|COMPLETED|Overall Study||69||
48179086|NCT00432679|100760015|FG001|COMPLETED|Overall Study||72||
48179087|NCT00432679|100760014|FG000|NOT COMPLETED|Overall Study||5||
48340066|NCT02497001|101160148|FG003|STARTED|Overall Study||319||
48340067|NCT02497001|101160145|FG000|COMPLETED|Overall Study||566||
48179088|NCT00432679|100760015|FG001|NOT COMPLETED|Overall Study||3||
48179089|NCT00670462|100760016|FG000|STARTED|Overall Study||106||
48179090|NCT00670462|100760017|FG001|STARTED|Overall Study||107||
48179091|NCT00670462|100760016|FG000|COMPLETED|Overall Study||76||
48179092|NCT00670462|100760017|FG001|COMPLETED|Overall Study||76||
48179093|NCT00670462|100760016|FG000|NOT COMPLETED|Overall Study||30||
48179094|NCT00670462|100760017|FG001|NOT COMPLETED|Overall Study||31||
48179095|NCT02918890|100760018|FG000|STARTED|Overall Study||41||
48179096|NCT02918890|100760019|FG001|STARTED|Overall Study||42||
48179097|NCT02918890|100760018|FG000|Contralateral|Overall Study||7||
48179098|NCT02918890|100760019|FG001|Contralateral|Overall Study||3||
48179099|NCT02918890|100760018|FG000|Ipsilateral|Overall Study||26||
48340068|NCT02497001|101160146|FG001|COMPLETED|Overall Study||524||
48179100|NCT02918890|100760019|FG001|Ipsilateral|Overall Study||30||
48179101|NCT02918890|100760018|FG000|Bilateral|Overall Study||7||
48179102|NCT02918890|100760019|FG001|Bilateral|Overall Study||6||
48179103|NCT02918890|100760018|FG000|COMPLETED|Overall Study||41||
48179104|NCT02918890|100760019|FG001|COMPLETED|Overall Study||41||
48179105|NCT02918890|100760018|FG000|NOT COMPLETED|Overall Study||0||
48179106|NCT02918890|100760019|FG001|NOT COMPLETED|Overall Study||1||
48179107|NCT00806624|100760020|FG000|STARTED|Overall Study||79||
48179108|NCT00806624|100760021|FG001|STARTED|Overall Study||80||
48179109|NCT00806624|100760022|FG002|STARTED|Overall Study||75||
48179110|NCT00806624|100760020|FG000|COMPLETED|Overall Study||70||
48179111|NCT00806624|100760021|FG001|COMPLETED|Overall Study||68||
48179112|NCT00806624|100760022|FG002|COMPLETED|Overall Study||69||
48179113|NCT00806624|100760020|FG000|NOT COMPLETED|Overall Study||9||
48179114|NCT00806624|100760021|FG001|NOT COMPLETED|Overall Study||12||
48179115|NCT00806624|100760022|FG002|NOT COMPLETED|Overall Study||6||
48179116|NCT03223272|100760023|FG000|STARTED|Overall Study||7||
48179117|NCT03223272|100760023|FG000|COMPLETED|Overall Study||6||
48179118|NCT03223272|100760023|FG000|NOT COMPLETED|Overall Study||1||
48179119|NCT01388530|100760024|FG000|STARTED|Overall Study||25||
48340069|NCT02497001|101160147|FG002|COMPLETED|Overall Study||266||
48179120|NCT01388530|100760024|FG000|COMPLETED|Overall Study||20||
48179121|NCT01388530|100760024|FG000|NOT COMPLETED|Overall Study||5||
48179122|NCT01335308|100760025|FG000|STARTED|Overall Study||198||
48340070|NCT02497001|101160148|FG003|COMPLETED|Overall Study||278||
48340071|NCT02497001|101160145|FG000|NOT COMPLETED|Overall Study||74||
48340072|NCT02497001|101160146|FG001|NOT COMPLETED|Overall Study||103||
48340073|NCT02497001|101160147|FG002|NOT COMPLETED|Overall Study||50||
48340074|NCT02497001|101160148|FG003|NOT COMPLETED|Overall Study||41||
48340075|NCT01468311|101160149|FG000|STARTED|Overall Study||6||
48340076|NCT01468311|101160149|FG000|COMPLETED|Overall Study||4||
48340077|NCT01468311|101160149|FG000|NOT COMPLETED|Overall Study||2||
48340078|NCT00542997|101160150|FG000|STARTED|Wash in / Wash Out Period||51||
48340079|NCT00542997|101160150|FG000|COMPLETED|Wash in / Wash Out Period||46||
48340080|NCT00542997|101160150|FG000|NOT COMPLETED|Wash in / Wash Out Period||5||
48340081|NCT00542997|101160150|FG000|STARTED|Efficacy Period||46||
48340082|NCT00542997|101160150|FG000|COMPLETED|Efficacy Period||43||
48340083|NCT00542997|101160150|FG000|NOT COMPLETED|Efficacy Period||3||
48340084|NCT00773279|101160151|FG000|STARTED|Period 1||121||
48340085|NCT00773279|101160152|FG001|STARTED|Period 1||121||
48340086|NCT00773279|101160151|FG000|COMPLETED|Period 1||114||
48340087|NCT00773279|101160152|FG001|COMPLETED|Period 1||117||
48340088|NCT00773279|101160151|FG000|NOT COMPLETED|Period 1||7||
48632103|NCT04079790|101881702|FG000|STARTED|Part 1, Period 2 (Day 5 to Day 8)||13||
48179123|NCT01335308|100760026|FG001|STARTED|Overall Study||212||
48340089|NCT00773279|101160152|FG001|NOT COMPLETED|Period 1||4||
48340090|NCT00773279|101160151|FG000|STARTED|Period 2||114||
48340091|NCT00773279|101160152|FG001|STARTED|Period 2||117||
48340092|NCT00773279|101160151|FG000|COMPLETED|Period 2||111||
48632104|NCT04079790|101881703|FG001|STARTED|Part 1, Period 2 (Day 5 to Day 8)||2||
48632105|NCT04079790|101881704|FG002|STARTED|Part 1, Period 2 (Day 5 to Day 8)||0||
48632106|NCT04079790|101881705|FG003|STARTED|Part 1, Period 2 (Day 5 to Day 8)||0||
48632107|NCT04079790|101881702|FG000|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||13||
48632108|NCT04079790|101881703|FG001|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||2||
48632109|NCT04079790|101881704|FG002|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0||
48632110|NCT04079790|101881705|FG003|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0||
48340093|NCT00773279|101160152|FG001|COMPLETED|Period 2||111||
48340094|NCT00773279|101160151|FG000|NOT COMPLETED|Period 2||3||
48340095|NCT00773279|101160152|FG001|NOT COMPLETED|Period 2||6||
48340096|NCT05617521|101160153|FG000|STARTED|Overall Study||105||
48340097|NCT05617521|101160154|FG001|STARTED|Overall Study||106||
48340098|NCT05617521|101160153|FG000|COMPLETED|Overall Study||105||
48340099|NCT05617521|101160154|FG001|COMPLETED|Overall Study||106||
48340100|NCT05617521|101160153|FG000|NOT COMPLETED|Overall Study||0||
48179124|NCT01335308|100760027|FG002|STARTED|Overall Study||235||
48340101|NCT05617521|101160154|FG001|NOT COMPLETED|Overall Study||0||
48632111|NCT04079790|101881702|FG000|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0||
48632112|NCT04079790|101881703|FG001|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0||
48179125|NCT01335308|100760025|FG000|COMPLETED|Overall Study||158||
48340102|NCT01664793|101160155|FG000|STARTED|Overall Study||49039||
48340103|NCT01664793|101160156|FG001|STARTED|Overall Study||38626||
48413450|NCT02607865|101345830|FG003|Full Analysis Set (FAS)|Overall Study||467|One participant was excluded from the FAS as the participant was a confirmed screening failure.|
48413451|NCT02607865|101345827|FG000|Safety Analysis Set (SAS)|Overall Study||466||
48413452|NCT02607865|101345828|FG001|Safety Analysis Set (SAS)|Overall Study||464||
48413453|NCT02607865|101345829|FG002|Safety Analysis Set (SAS)|Overall Study||465||
48413454|NCT02607865|101345830|FG003|Safety Analysis Set (SAS)|Overall Study||466||
48413455|NCT02607865|101345827|FG000|COMPLETED|Overall Study||433||
48632113|NCT04079790|101881704|FG002|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0||
48632114|NCT04079790|101881705|FG003|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0||
48632115|NCT04079790|101881702|FG000|STARTED|Part 1, Period 3 (Day 9 to Day 11)||13||
48632116|NCT04079790|101881703|FG001|STARTED|Part 1, Period 3 (Day 9 to Day 11)||2||
48632117|NCT04079790|101881704|FG002|STARTED|Part 1, Period 3 (Day 9 to Day 11)||0||
48632118|NCT04079790|101881705|FG003|STARTED|Part 1, Period 3 (Day 9 to Day 11)||0||
48632119|NCT04079790|101881702|FG000|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||13||
48340104|NCT01664793|101160155|FG000|COMPLETED|Overall Study||49039||
48340105|NCT01664793|101160156|FG001|COMPLETED|Overall Study||38626||
48340106|NCT01664793|101160155|FG000|NOT COMPLETED|Overall Study||0||
48340107|NCT01664793|101160156|FG001|NOT COMPLETED|Overall Study||0||
48632120|NCT04079790|101881703|FG001|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||2||
48632121|NCT04079790|101881704|FG002|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0||
48340108|NCT05032950|101160157|FG000|STARTED|Overall Study||2|Assigned to Treatment|
48632122|NCT04079790|101881705|FG003|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0||
48340109|NCT05032950|101160158|FG001|STARTED|Overall Study||2|Assigned to Treatment|
48340110|NCT05032950|101160159|FG002|STARTED|Overall Study||2|Assigned to Treatment|
48413456|NCT02607865|101345828|FG001|COMPLETED|Overall Study||436||
48179126|NCT01335308|100760026|FG001|COMPLETED|Overall Study||145||
48179127|NCT01335308|100760027|FG002|COMPLETED|Overall Study||154||
48179128|NCT01335308|100760025|FG000|NOT COMPLETED|Overall Study||40||
48179129|NCT01335308|100760026|FG001|NOT COMPLETED|Overall Study||67||
48179130|NCT01335308|100760027|FG002|NOT COMPLETED|Overall Study||81||
48179131|NCT04266795|100760028|FG000|STARTED|Overall Study||81||
48179132|NCT04266795|100760029|FG001|STARTED|Overall Study||83||
48179133|NCT04266795|100760028|FG000|Safety Population|Overall Study||80|Safety population was defined as all participants who received at least 1 dose of any of the study medications (pevonedistat, venetoclax, or azacitidine).|
48179134|NCT04266795|100760029|FG001|Safety Population|Overall Study||81|Safety population was defined as all participants who received at least 1 dose of any of the study medications (pevonedistat, venetoclax, or azacitidine).|
48179135|NCT04266795|100760028|FG000|COMPLETED|Overall Study||0||
48179136|NCT04266795|100760029|FG001|COMPLETED|Overall Study||0||
48179137|NCT04266795|100760028|FG000|NOT COMPLETED|Overall Study||81||
48179138|NCT04266795|100760029|FG001|NOT COMPLETED|Overall Study||83||
48179139|NCT02954575|100760030|FG000|STARTED|Overall Study||57||
48179140|NCT02954575|100760030|FG000|Received Treatment|Overall Study||55||
48179141|NCT02954575|100760030|FG000|SAF Population|Overall Study||55|SAF population = study population of patients in safety analysis|
48179142|NCT02954575|100760030|FG000|FAS Population|Overall Study||55|FAS population = full analysis population|
48179143|NCT02954575|100760030|FG000|PP Population|Overall Study||52|PP population = per-protocol population|
48179144|NCT02954575|100760030|FG000|PK Population|Overall Study||21|PK population = study population of patients who underwent pharmacokinetic analysis|
48179145|NCT02954575|100760030|FG000|SURG Population|Overall Study||1|SURG population = study population of patients undergoing surgery treated with Wilate|
48179146|NCT02954575|100760030|FG000|COMPLETED|Overall Study||54||
48179147|NCT02954575|100760030|FG000|NOT COMPLETED|Overall Study||3||
48179148|NCT01824472|100760031|FG000|STARTED|Overall Study||17||
48179149|NCT01824472|100760032|FG001|STARTED|Overall Study||13||
48179150|NCT01824472|100760033|FG002|STARTED|Overall Study||15||
48179151|NCT01824472|100760031|FG000|COMPLETED|Overall Study||16||
48179152|NCT01824472|100760032|FG001|COMPLETED|Overall Study||6||
48179153|NCT01824472|100760033|FG002|COMPLETED|Overall Study||11||
48632123|NCT04079790|101881702|FG000|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0||
48632124|NCT04079790|101881703|FG001|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0||
48632125|NCT04079790|101881704|FG002|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0||
48632126|NCT04079790|101881705|FG003|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0||
48632127|NCT04079790|101881702|FG000|STARTED|Part 2, Period 1 (Day 1 to Day 3)||0||
48179154|NCT01824472|100760031|FG000|NOT COMPLETED|Overall Study||1||
48179155|NCT01824472|100760032|FG001|NOT COMPLETED|Overall Study||7||
48179156|NCT01824472|100760033|FG002|NOT COMPLETED|Overall Study||4||
48179157|NCT04667468|100760034|FG000|STARTED|Overall Study||102||
48632128|NCT04079790|101881703|FG001|STARTED|Part 2, Period 1 (Day 1 to Day 3)||0||
48179158|NCT04667468|100760035|FG001|STARTED|Overall Study||98||
48179159|NCT04667468|100760034|FG000|COMPLETED|Overall Study||102||
48632129|NCT04079790|101881704|FG002|STARTED|Part 2, Period 1 (Day 1 to Day 3)||15||
48632130|NCT04079790|101881705|FG003|STARTED|Part 2, Period 1 (Day 1 to Day 3)||3||
48632131|NCT04079790|101881702|FG000|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0||
48657132|NCT00063362|101943786|FG001|STARTED|Overall Study||26||
48179160|NCT04667468|100760035|FG001|COMPLETED|Overall Study||98||
48179161|NCT04667468|100760034|FG000|NOT COMPLETED|Overall Study||0||
48179162|NCT04667468|100760035|FG001|NOT COMPLETED|Overall Study||0||
48632132|NCT04079790|101881703|FG001|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0||
48632133|NCT04079790|101881704|FG002|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||12||
48632134|NCT04079790|101881705|FG003|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||3||
48632135|NCT04079790|101881702|FG000|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0||
48179163|NCT04426006|100760036|FG000|STARTED|Inclusion||526||
48179164|NCT04426006|100760036|FG000|COMPLETED|Inclusion||517|Participants who completed the self-administered questionnaire and had blood sample at inclusion|
48179165|NCT04426006|100760036|FG000|NOT COMPLETED|Inclusion||9||
48179166|NCT04426006|100760036|FG000|STARTED|3 Months||517||
48179167|NCT04426006|100760036|FG000|COMPLETED|3 Months||500||
48179168|NCT04426006|100760036|FG000|NOT COMPLETED|3 Months||17||
48179169|NCT04426006|100760036|FG000|STARTED|12 Months||500||
48179170|NCT04426006|100760036|FG000|COMPLETED|12 Months||462||
48179171|NCT04426006|100760036|FG000|NOT COMPLETED|12 Months||38||
48179172|NCT03226457|100760037|FG000|STARTED|Treatment 1: 6 Weeks||12||
48179173|NCT03226457|100760038|FG001|STARTED|Treatment 1: 6 Weeks||11||
48179174|NCT03226457|100760037|FG000|COMPLETED|Treatment 1: 6 Weeks||12||
48179175|NCT03226457|100760038|FG001|COMPLETED|Treatment 1: 6 Weeks||11||
48179176|NCT03226457|100760037|FG000|NOT COMPLETED|Treatment 1: 6 Weeks||0||
48179177|NCT03226457|100760038|FG001|NOT COMPLETED|Treatment 1: 6 Weeks||0||
48179178|NCT03226457|100760037|FG000|STARTED|Washout Period: Minimum 2 Weeks||12||
48179179|NCT03226457|100760038|FG001|STARTED|Washout Period: Minimum 2 Weeks||11||
48179180|NCT03226457|100760037|FG000|COMPLETED|Washout Period: Minimum 2 Weeks||12||
48179181|NCT03226457|100760038|FG001|COMPLETED|Washout Period: Minimum 2 Weeks||11||
48179182|NCT03226457|100760037|FG000|NOT COMPLETED|Washout Period: Minimum 2 Weeks||0||
48179183|NCT03226457|100760038|FG001|NOT COMPLETED|Washout Period: Minimum 2 Weeks||0||
48632136|NCT04079790|101881703|FG001|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0||
48632137|NCT04079790|101881704|FG002|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||3||
48632138|NCT04079790|101881705|FG003|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0||
48632139|NCT04079790|101881702|FG000|STARTED|Part 2, Period 2 (Day 1 to Day 3)||0||
48632140|NCT04079790|101881703|FG001|STARTED|Part 2, Period 2 (Day 1 to Day 3)||0||
48632141|NCT04079790|101881704|FG002|STARTED|Part 2, Period 2 (Day 1 to Day 3)||12||
48632142|NCT04079790|101881705|FG003|STARTED|Part 2, Period 2 (Day 1 to Day 3)||3||
48632143|NCT04079790|101881702|FG000|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0||
48632144|NCT04079790|101881703|FG001|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0||
48632145|NCT04079790|101881704|FG002|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||12||
48179184|NCT03226457|100760037|FG000|STARTED|Treatment 2: 6 Weeks||12||
48179185|NCT03226457|100760038|FG001|STARTED|Treatment 2: 6 Weeks||11||
48179186|NCT03226457|100760037|FG000|COMPLETED|Treatment 2: 6 Weeks||12||
48179187|NCT03226457|100760038|FG001|COMPLETED|Treatment 2: 6 Weeks||11||
48632146|NCT04079790|101881705|FG003|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||3||
48179188|NCT03226457|100760037|FG000|NOT COMPLETED|Treatment 2: 6 Weeks||0||
48179189|NCT03226457|100760038|FG001|NOT COMPLETED|Treatment 2: 6 Weeks||0||
48179190|NCT00445601|100760039|FG000|STARTED|Overall Study||201|Randomized to Treatment Arm|
48179191|NCT00445601|100760040|FG001|STARTED|Overall Study||205|Randomized to Treatment Arm|
48179192|NCT00445601|100760039|FG000|Received TURBT|Overall Study||190||
48179193|NCT00445601|100760040|FG001|Received TURBT|Overall Study||193||
48179194|NCT00445601|100760039|FG000|COMPLETED|Overall Study||168|Received Drug Instillation|
48179195|NCT00445601|100760040|FG001|COMPLETED|Overall Study||177|Received Drug Instillation|
48340111|NCT05032950|101160160|FG003|STARTED|Overall Study||2|Assigned to Treatment|
48340112|NCT05032950|101160161|FG004|STARTED|Overall Study||2|Assigned to Treatment|
48340113|NCT05032950|101160162|FG005|STARTED|Overall Study||2|Assigned to Treatment|
48340114|NCT05032950|101160157|FG000|COMPLETED|Overall Study||2|Completed|
48632147|NCT04079790|101881702|FG000|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0||
48632148|NCT04079790|101881703|FG001|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0||
48179196|NCT00445601|100760039|FG000|NOT COMPLETED|Overall Study||33||
48179197|NCT00445601|100760040|FG001|NOT COMPLETED|Overall Study||28||
48179198|NCT04069221|100760041|FG000|STARTED|Overall Study||8||
48179199|NCT04069221|100760042|FG001|STARTED|Overall Study||6||
48179200|NCT04069221|100760043|FG002|STARTED|Overall Study||6||
48179201|NCT04069221|100760044|FG003|STARTED|Overall Study||6||
48179202|NCT04069221|100760041|FG000|COMPLETED|Overall Study||8||
48340115|NCT05032950|101160158|FG001|COMPLETED|Overall Study||2|Completed|
48340116|NCT05032950|101160159|FG002|COMPLETED|Overall Study||1|Completed|
48340117|NCT05032950|101160160|FG003|COMPLETED|Overall Study||1|Completed|
48340118|NCT05032950|101160161|FG004|COMPLETED|Overall Study||2|Completed|
48632149|NCT04079790|101881704|FG002|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0||
48632150|NCT04079790|101881705|FG003|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0||
48632151|NCT02164916|101881706|FG000|STARTED|Overall Study||52||
48632152|NCT02164916|101881707|FG001|STARTED|Overall Study||54||
48632153|NCT02164916|101881706|FG000|Eligible|Overall Study||50||
48632154|NCT02164916|101881707|FG001|Eligible|Overall Study||49||
48340119|NCT05032950|101160162|FG005|COMPLETED|Overall Study||2|Completed|
48340120|NCT05032950|101160157|FG000|NOT COMPLETED|Overall Study||0||
48340121|NCT05032950|101160158|FG001|NOT COMPLETED|Overall Study||0||
48340122|NCT05032950|101160159|FG002|NOT COMPLETED|Overall Study||1||
48632155|NCT02164916|101881706|FG000|Cross-over to Arm II|Overall Study||24||
48179203|NCT04069221|100760042|FG001|COMPLETED|Overall Study||6||
48179204|NCT04069221|100760043|FG002|COMPLETED|Overall Study||6||
48179205|NCT04069221|100760044|FG003|COMPLETED|Overall Study||6||
48179206|NCT04069221|100760041|FG000|NOT COMPLETED|Overall Study||0||
48179207|NCT04069221|100760042|FG001|NOT COMPLETED|Overall Study||0||
48179208|NCT04069221|100760043|FG002|NOT COMPLETED|Overall Study||0||
48179209|NCT04069221|100760044|FG003|NOT COMPLETED|Overall Study||0||
48179210|NCT03285113|100760045|FG000|STARTED|Overall Study||10||
48179211|NCT03285113|100760045|FG000|COMPLETED|Overall Study||8||
48179212|NCT03285113|100760045|FG000|NOT COMPLETED|Overall Study||2||
48179213|NCT01000376|100760046|FG000|STARTED|Cycle 1 Day 1||6||
48179214|NCT01000376|100760047|FG001|STARTED|Cycle 1 Day 1||6||
48179215|NCT01000376|100760046|FG000|COMPLETED|Cycle 1 Day 1||4||
48179216|NCT01000376|100760047|FG001|COMPLETED|Cycle 1 Day 1||6||
48179217|NCT01000376|100760046|FG000|NOT COMPLETED|Cycle 1 Day 1||2||
48179218|NCT01000376|100760047|FG001|NOT COMPLETED|Cycle 1 Day 1||0||
48179219|NCT01000376|100760046|FG000|STARTED|Cycle 1 Day 15||4||
48179220|NCT01000376|100760047|FG001|STARTED|Cycle 1 Day 15||6||
48340123|NCT05032950|101160160|FG003|NOT COMPLETED|Overall Study||1||
48340124|NCT05032950|101160161|FG004|NOT COMPLETED|Overall Study||0||
48340125|NCT05032950|101160162|FG005|NOT COMPLETED|Overall Study||0||
48340126|NCT00441792|101160163|FG000|STARTED|Overall Study||59||
48340127|NCT00441792|101160164|FG001|STARTED|Overall Study||63||
48340128|NCT00441792|101160163|FG000|COMPLETED|Overall Study||59||
48340129|NCT00441792|101160164|FG001|COMPLETED|Overall Study||61||
48340130|NCT00441792|101160163|FG000|NOT COMPLETED|Overall Study||0||
48632156|NCT02164916|101881707|FG001|Cross-over to Arm II|Overall Study||0||
48632157|NCT02164916|101881706|FG000|COMPLETED|Overall Study||0||
48632158|NCT02164916|101881707|FG001|COMPLETED|Overall Study||0||
48632159|NCT02164916|101881706|FG000|NOT COMPLETED|Overall Study||52||
48754518|NCT00310765|102187730|FG001|NOT COMPLETED|Placebo Controlled Double Blind||2||
48754519|NCT00310765|102187729|FG000|STARTED|Open Label||8||
48754520|NCT00310765|102187730|FG001|STARTED|Open Label||5||
48179221|NCT01000376|100760046|FG000|COMPLETED|Cycle 1 Day 15||4||
48179222|NCT01000376|100760047|FG001|COMPLETED|Cycle 1 Day 15||6||
48632160|NCT02164916|101881707|FG001|NOT COMPLETED|Overall Study||54||
48632161|NCT00934375|101881708|FG000|STARTED|Overall Study||68||
48632162|NCT00934375|101881709|FG001|STARTED|Overall Study||77||
48632163|NCT00934375|101881708|FG000|COMPLETED|Overall Study||55||
48632164|NCT00934375|101881709|FG001|COMPLETED|Overall Study||55||
48754521|NCT00310765|102187729|FG000|COMPLETED|Open Label||7||
48754522|NCT00310765|102187730|FG001|COMPLETED|Open Label||3||
48754523|NCT00310765|102187729|FG000|NOT COMPLETED|Open Label||1||
48754524|NCT00310765|102187730|FG001|NOT COMPLETED|Open Label||2||
48754525|NCT03532542|102187731|FG000|STARTED|Overall Study||74||
48754526|NCT03532542|102187732|FG001|STARTED|Overall Study||97||
48179223|NCT01000376|100760046|FG000|NOT COMPLETED|Cycle 1 Day 15||0||
48179224|NCT01000376|100760047|FG001|NOT COMPLETED|Cycle 1 Day 15||0||
48179225|NCT00601718|100760048|FG000|STARTED|Overall Study||29||
48179226|NCT00601718|100760048|FG000|COMPLETED|Overall Study||29||
48179227|NCT00601718|100760048|FG000|NOT COMPLETED|Overall Study||0||
48179228|NCT03873246|100760049|FG000|STARTED|Overall Study||41||
48340131|NCT00441792|101160164|FG001|NOT COMPLETED|Overall Study||2||
48340132|NCT02731742|101160165|FG000|STARTED|Overall Study||3||
48340133|NCT02731742|101160166|FG001|STARTED|Overall Study||3||
48340134|NCT02731742|101160167|FG002|STARTED|Overall Study||6||
48340135|NCT02731742|101160168|FG003|STARTED|Overall Study||2||
48340136|NCT02731742|101160165|FG000|COMPLETED|Overall Study||0||
48340137|NCT02731742|101160166|FG001|COMPLETED|Overall Study||0||
48340138|NCT02731742|101160167|FG002|COMPLETED|Overall Study||0||
48340139|NCT02731742|101160168|FG003|COMPLETED|Overall Study||0||
48340140|NCT02731742|101160165|FG000|NOT COMPLETED|Overall Study||3||
48340141|NCT02731742|101160166|FG001|NOT COMPLETED|Overall Study||3||
48340142|NCT02731742|101160167|FG002|NOT COMPLETED|Overall Study||6||
48340143|NCT02731742|101160168|FG003|NOT COMPLETED|Overall Study||2||
48340144|NCT02949830|101160169|FG000|STARTED|Overall Study||16||
48340145|NCT02949830|101160169|FG000|COMPLETED|Overall Study||14||
48340146|NCT02949830|101160169|FG000|NOT COMPLETED|Overall Study||2||
48340147|NCT00006227|101160170|FG000|STARTED|Overall Study||31||
48754527|NCT03532542|102187731|FG000|Received at Least 1 Dose of Study Drug|Overall Study||74|Safety Analysis Set|
48179229|NCT03873246|100760050|FG001|STARTED|Overall Study||41||
48179230|NCT03873246|100760051|FG002|STARTED|Overall Study||41||
48179231|NCT03873246|100760049|FG000|COMPLETED|Overall Study||36||
48179232|NCT03873246|100760050|FG001|COMPLETED|Overall Study||29||
48179233|NCT03873246|100760051|FG002|COMPLETED|Overall Study||32||
48179234|NCT03873246|100760049|FG000|NOT COMPLETED|Overall Study||5||
48179235|NCT03873246|100760050|FG001|NOT COMPLETED|Overall Study||12||
48179236|NCT03873246|100760051|FG002|NOT COMPLETED|Overall Study||9||
48179237|NCT02262260|100760052|FG000|STARTED|Overall Study||45||
48179238|NCT02262260|100760053|FG001|STARTED|Overall Study||42||
48179239|NCT02262260|100760052|FG000|COMPLETED|Overall Study||34||
48632165|NCT00934375|101881708|FG000|NOT COMPLETED|Overall Study||13||
48632166|NCT00934375|101881709|FG001|NOT COMPLETED|Overall Study||22||
48632167|NCT03470922|101881710|FG000|STARTED|Overall Study||355||
48632168|NCT03470922|101881711|FG001|STARTED|Overall Study||359||
48632169|NCT03470922|101881710|FG000|COMPLETED|Overall Study||237|Continuing in the study|
48632170|NCT03470922|101881711|FG001|COMPLETED|Overall Study||227|Continuing in the study|
48632171|NCT03470922|101881710|FG000|NOT COMPLETED|Overall Study||118||
48632172|NCT03470922|101881711|FG001|NOT COMPLETED|Overall Study||132||
48179240|NCT02262260|100760053|FG001|COMPLETED|Overall Study||32||
48179241|NCT02262260|100760052|FG000|NOT COMPLETED|Overall Study||11||
48179242|NCT02262260|100760053|FG001|NOT COMPLETED|Overall Study||10||
48179243|NCT00615433|100760054|FG000|STARTED|Overall Study||120||
48179244|NCT00615433|100760055|FG001|STARTED|Overall Study||119||
48179245|NCT00615433|100760056|FG002|STARTED|Overall Study||123||
48179246|NCT00615433|100760057|FG003|STARTED|Overall Study||116||
48179247|NCT00615433|100760054|FG000|COMPLETED|Overall Study||77||
48179248|NCT00615433|100760055|FG001|COMPLETED|Overall Study||66||
48179249|NCT00615433|100760056|FG002|COMPLETED|Overall Study||84||
48179250|NCT00615433|100760057|FG003|COMPLETED|Overall Study||71||
48179251|NCT00615433|100760054|FG000|NOT COMPLETED|Overall Study||43||
48179252|NCT00615433|100760055|FG001|NOT COMPLETED|Overall Study||53||
48179253|NCT00615433|100760056|FG002|NOT COMPLETED|Overall Study||39||
48179254|NCT00615433|100760057|FG003|NOT COMPLETED|Overall Study||45||
48179255|NCT01689740|100760058|FG000|STARTED|Overall Study||2||
48179256|NCT01689740|100760059|FG001|STARTED|Overall Study||3||
48179257|NCT01689740|100760060|FG002|STARTED|Overall Study||5||
48179258|NCT01689740|100760058|FG000|COMPLETED|Overall Study||2||
48179259|NCT01689740|100760059|FG001|COMPLETED|Overall Study||3||
48179260|NCT01689740|100760060|FG002|COMPLETED|Overall Study||5||
48179261|NCT01689740|100760058|FG000|NOT COMPLETED|Overall Study||0||
48179262|NCT01689740|100760059|FG001|NOT COMPLETED|Overall Study||0||
48179263|NCT01689740|100760060|FG002|NOT COMPLETED|Overall Study||0||
48179264|NCT00439179|100760061|FG000|STARTED|Overall Study||3||
48179265|NCT00439179|100760062|FG001|STARTED|Overall Study||13||
48179266|NCT00439179|100760063|FG002|STARTED|Overall Study||6||
48179267|NCT00439179|100760064|FG003|STARTED|Overall Study||5||
48179268|NCT00439179|100760061|FG000|COMPLETED|Overall Study||3||
48179269|NCT00439179|100760062|FG001|COMPLETED|Overall Study||11||
48179270|NCT00439179|100760063|FG002|COMPLETED|Overall Study||6||
48179271|NCT00439179|100760064|FG003|COMPLETED|Overall Study||5||
48179272|NCT00439179|100760061|FG000|NOT COMPLETED|Overall Study||0||
48179273|NCT00439179|100760062|FG001|NOT COMPLETED|Overall Study||2||
48179274|NCT00439179|100760063|FG002|NOT COMPLETED|Overall Study||0||
48179275|NCT00439179|100760064|FG003|NOT COMPLETED|Overall Study||0||
48179276|NCT03528928|100760065|FG000|STARTED|Overall Study||8||
48179277|NCT03528928|100760065|FG000|COMPLETED|Overall Study||8||
48179278|NCT03528928|100760065|FG000|NOT COMPLETED|Overall Study||0||
48179279|NCT03875911|100760066|FG000|STARTED|Overall Study||6||7
48179280|NCT03875911|100760067|FG001|STARTED|Overall Study||7||7
48179281|NCT03875911|100760068|FG002|STARTED|Overall Study||6||6
48179282|NCT03875911|100760066|FG000|COMPLETED|Overall Study||2||3
48179283|NCT03875911|100760067|FG001|COMPLETED|Overall Study||1||1
48179284|NCT03875911|100760068|FG002|COMPLETED|Overall Study||2||2
48179285|NCT03875911|100760066|FG000|NOT COMPLETED|Overall Study||4||4
48179286|NCT03875911|100760067|FG001|NOT COMPLETED|Overall Study||6||6
48179287|NCT03875911|100760068|FG002|NOT COMPLETED|Overall Study||4||4
48179288|NCT01969162|100760069|FG000|STARTED|Overall Study||35||
48179289|NCT01969162|100760069|FG000|COMPLETED|Overall Study||35||
48179290|NCT01969162|100760069|FG000|NOT COMPLETED|Overall Study||0||
48179291|NCT01544114|100760070|FG000|STARTED|Overall Study||4||
48179292|NCT01544114|100760071|FG001|STARTED|Overall Study||20||
48179293|NCT01544114|100760072|FG002|STARTED|Overall Study||22||
48179294|NCT01544114|100760070|FG000|COMPLETED|Overall Study||3|completed study and received 6 months of study drug|
48179295|NCT01544114|100760071|FG001|COMPLETED|Overall Study||16|completed study and received 6 months of study drug|
48179296|NCT01544114|100760072|FG002|COMPLETED|Overall Study||17|completed study and received 6 months of study drug|
48179297|NCT01544114|100760070|FG000|NOT COMPLETED|Overall Study||1||
48179298|NCT01544114|100760071|FG001|NOT COMPLETED|Overall Study||4||
48179299|NCT01544114|100760072|FG002|NOT COMPLETED|Overall Study||5||
48179300|NCT00604786|100760073|FG000|STARTED|Overall Study||14||
48340148|NCT00006227|101160170|FG000|COMPLETED|Overall Study||31||
48632173|NCT03261193|101881712|FG000|STARTED|Overall Study||10||
48632174|NCT03261193|101881713|FG001|STARTED|Overall Study||11||
48632175|NCT03261193|101881712|FG000|COMPLETED|Overall Study||10||
48632176|NCT03261193|101881713|FG001|COMPLETED|Overall Study||11||
48632177|NCT03261193|101881712|FG000|NOT COMPLETED|Overall Study||0||
48632178|NCT03261193|101881713|FG001|NOT COMPLETED|Overall Study||0||
48179301|NCT00604786|100760074|FG001|STARTED|Overall Study||4||
48179302|NCT00604786|100760073|FG000|COMPLETED|Overall Study||12||
48179303|NCT00604786|100760074|FG001|COMPLETED|Overall Study||4||
48179304|NCT00604786|100760073|FG000|NOT COMPLETED|Overall Study||2||
48179305|NCT00604786|100760074|FG001|NOT COMPLETED|Overall Study||0||
48179306|NCT01727518|100760075|FG000|STARTED|Overall Study||14966||
48179307|NCT01727518|100760075|FG000|COMPLETED|Overall Study||14966|Ongoing longitudinal study|
48179308|NCT01727518|100760075|FG000|NOT COMPLETED|Overall Study||0||
48179309|NCT03679013|100760076|FG000|STARTED|Overall Study||8||
48179310|NCT03679013|100760077|FG001|STARTED|Overall Study||11||
48632179|NCT02410629|101881714|FG000|STARTED|Overall Study||8||
48179311|NCT03679013|100760076|FG000|COMPLETED|Overall Study||8||
48179312|NCT03679013|100760077|FG001|COMPLETED|Overall Study||7||
48179313|NCT03679013|100760076|FG000|NOT COMPLETED|Overall Study||0||
48179314|NCT03679013|100760077|FG001|NOT COMPLETED|Overall Study||4||
48179315|NCT02499328|100760078|FG000|STARTED|Overall Study||4||
48179316|NCT02499328|100760079|FG001|STARTED|Overall Study||7||
48179317|NCT02499328|100760080|FG002|STARTED|Overall Study||10||
48179318|NCT02499328|100760081|FG003|STARTED|Overall Study||11||
48179319|NCT02499328|100760082|FG004|STARTED|Overall Study||15||
48179320|NCT02499328|100760083|FG005|STARTED|Overall Study||9||
48179321|NCT02499328|100760084|FG006|STARTED|Overall Study||7||
48179322|NCT02499328|100760085|FG007|STARTED|Overall Study||6||
48179323|NCT02499328|100760086|FG008|STARTED|Overall Study||14||
48179324|NCT02499328|100760087|FG009|STARTED|Overall Study||24||
48179325|NCT02499328|100760088|FG010|STARTED|Overall Study||20||
48179326|NCT02499328|100760089|FG011|STARTED|Overall Study||54||
48179327|NCT02499328|100760090|FG012|STARTED|Overall Study||25||
48179328|NCT02499328|100760091|FG013|STARTED|Overall Study||17||
48179329|NCT02499328|100760092|FG014|STARTED|Overall Study||10||
48179330|NCT02499328|100760093|FG015|STARTED|Overall Study||1||
48179331|NCT02499328|100760094|FG016|STARTED|Overall Study||1||
48179332|NCT02499328|100760095|FG017|STARTED|Overall Study||55||
48179333|NCT02499328|100760096|FG018|STARTED|Overall Study||50||
48179334|NCT02499328|100760078|FG000|COMPLETED|Overall Study||0||
48179335|NCT02499328|100760079|FG001|COMPLETED|Overall Study||0||
48179336|NCT02499328|100760080|FG002|COMPLETED|Overall Study||0||
48413457|NCT02607865|101345829|FG002|COMPLETED|Overall Study||438||
48413458|NCT02607865|101345830|FG003|COMPLETED|Overall Study||451||
48413459|NCT02607865|101345827|FG000|NOT COMPLETED|Overall Study||33||
48413460|NCT02607865|101345828|FG001|NOT COMPLETED|Overall Study||30||
48413461|NCT02607865|101345829|FG002|NOT COMPLETED|Overall Study||27||
48413462|NCT02607865|101345830|FG003|NOT COMPLETED|Overall Study||16||
48413463|NCT02499172|101345831|FG000|STARTED|Overall Study||900||
48413464|NCT02499172|101345832|FG001|STARTED|Overall Study||899||
48413465|NCT02499172|101345833|FG002|STARTED|Overall Study||523||
48413466|NCT02499172|101345834|FG003|STARTED|Overall Study||436||
48413467|NCT02499172|101345831|FG000|COMPLETED|Overall Study||835||
48413468|NCT02499172|101345832|FG001|COMPLETED|Overall Study||835||
48413469|NCT02499172|101345833|FG002|COMPLETED|Overall Study||0||
48413470|NCT02499172|101345834|FG003|COMPLETED|Overall Study||0||
48413471|NCT02499172|101345831|FG000|NOT COMPLETED|Overall Study||65||
48632180|NCT02410629|101881715|FG001|STARTED|Overall Study||9||
48632181|NCT02410629|101881714|FG000|COMPLETED|Overall Study||5||
48632182|NCT02410629|101881715|FG001|COMPLETED|Overall Study||6||
48632183|NCT02410629|101881714|FG000|NOT COMPLETED|Overall Study||3||
48632184|NCT02410629|101881715|FG001|NOT COMPLETED|Overall Study||3||
48632185|NCT00944554|101881716|FG000|STARTED|Overall Study||50||
48632186|NCT00944554|101881717|FG001|STARTED|Overall Study||54||
48632187|NCT00944554|101881716|FG000|COMPLETED|Overall Study||22||
48632188|NCT00944554|101881717|FG001|COMPLETED|Overall Study||25||
48632189|NCT00944554|101881716|FG000|NOT COMPLETED|Overall Study||28||
48632190|NCT00944554|101881717|FG001|NOT COMPLETED|Overall Study||29||
48632191|NCT01299584|101881718|FG000|STARTED|Overall Study||775||
48632192|NCT01299584|101881718|FG000|COMPLETED|Overall Study||766||
48632193|NCT01299584|101881718|FG000|NOT COMPLETED|Overall Study||9||
48754528|NCT03532542|102187732|FG001|Received at Least 1 Dose of Study Drug|Overall Study||97|Safety Analysis Set|
48632194|NCT02308046|101881719|FG000|STARTED|Overall Study||107||
48632195|NCT02308046|101881720|FG001|STARTED|Overall Study||105||
48632196|NCT02308046|101881719|FG000|COMPLETED|Overall Study||73||
48632197|NCT02308046|101881720|FG001|COMPLETED|Overall Study||67||
48179337|NCT02499328|100760081|FG003|COMPLETED|Overall Study||0||
48179338|NCT02499328|100760082|FG004|COMPLETED|Overall Study||0||
48179339|NCT02499328|100760083|FG005|COMPLETED|Overall Study||0||
48179340|NCT02499328|100760084|FG006|COMPLETED|Overall Study||0||
48179341|NCT02499328|100760085|FG007|COMPLETED|Overall Study||0||
48179342|NCT02499328|100760086|FG008|COMPLETED|Overall Study||0||
48179343|NCT02499328|100760087|FG009|COMPLETED|Overall Study||0||
48179344|NCT02499328|100760088|FG010|COMPLETED|Overall Study||0||
48179345|NCT02499328|100760089|FG011|COMPLETED|Overall Study||0||
48179346|NCT02499328|100760090|FG012|COMPLETED|Overall Study||0||
48179347|NCT02499328|100760091|FG013|COMPLETED|Overall Study||0||
48413472|NCT02499172|101345832|FG001|NOT COMPLETED|Overall Study||64||
48413473|NCT02499172|101345833|FG002|NOT COMPLETED|Overall Study||523||
48413474|NCT02499172|101345834|FG003|NOT COMPLETED|Overall Study||436||
48413475|NCT04607291|101345835|FG000|STARTED|Overall Study||183||
48413476|NCT04607291|101345835|FG000|COMPLETED|Overall Study||183||
48413477|NCT04607291|101345835|FG000|NOT COMPLETED|Overall Study||0||
48632198|NCT02308046|101881719|FG000|NOT COMPLETED|Overall Study||34||
48632199|NCT02308046|101881720|FG001|NOT COMPLETED|Overall Study||38||
48632200|NCT03451071|101881721|FG000|STARTED|First Vaccine||56||
48632201|NCT03451071|101881721|FG000|COMPLETED|First Vaccine||55||
48632202|NCT03451071|101881721|FG000|NOT COMPLETED|First Vaccine||1||
48632203|NCT03451071|101881721|FG000|STARTED|Second Vaccine||55||
48632204|NCT03451071|101881721|FG000|COMPLETED|Second Vaccine||36||
48632205|NCT03451071|101881721|FG000|NOT COMPLETED|Second Vaccine||19||
48632206|NCT03451071|101881721|FG000|STARTED|Third Vaccine||36||
48632207|NCT03451071|101881721|FG000|COMPLETED|Third Vaccine||14||
48632208|NCT03451071|101881721|FG000|NOT COMPLETED|Third Vaccine||22||
48632209|NCT03451071|101881721|FG000|STARTED|Final Questionnaire and Blood Draw||14||
48632210|NCT03451071|101881721|FG000|COMPLETED|Final Questionnaire and Blood Draw||10||
48179348|NCT02499328|100760092|FG014|COMPLETED|Overall Study||0||
48179349|NCT02499328|100760093|FG015|COMPLETED|Overall Study||0||
48179350|NCT02499328|100760094|FG016|COMPLETED|Overall Study||0||
48179351|NCT02499328|100760095|FG017|COMPLETED|Overall Study||0||
48179352|NCT02499328|100760096|FG018|COMPLETED|Overall Study||1||
48179353|NCT02499328|100760078|FG000|NOT COMPLETED|Overall Study||4||
48179354|NCT02499328|100760079|FG001|NOT COMPLETED|Overall Study||7||
48179355|NCT02499328|100760080|FG002|NOT COMPLETED|Overall Study||10||
48179356|NCT02499328|100760081|FG003|NOT COMPLETED|Overall Study||11||
48179357|NCT02499328|100760082|FG004|NOT COMPLETED|Overall Study||15||
48179358|NCT02499328|100760083|FG005|NOT COMPLETED|Overall Study||9||
48179359|NCT02499328|100760084|FG006|NOT COMPLETED|Overall Study||7||
48179360|NCT02499328|100760085|FG007|NOT COMPLETED|Overall Study||6||
48179361|NCT02499328|100760086|FG008|NOT COMPLETED|Overall Study||14||
48340149|NCT00006227|101160170|FG000|NOT COMPLETED|Overall Study||0||
48340150|NCT02088385|101160171|FG000|STARTED|Overall Study||10||
48340151|NCT02088385|101160172|FG001|STARTED|Overall Study||10||
48340152|NCT02088385|101160171|FG000|COMPLETED|Overall Study||10||
48340153|NCT02088385|101160172|FG001|COMPLETED|Overall Study||10||
48340154|NCT02088385|101160171|FG000|NOT COMPLETED|Overall Study||0||
48340155|NCT02088385|101160172|FG001|NOT COMPLETED|Overall Study||0||
48632211|NCT03451071|101881721|FG000|NOT COMPLETED|Final Questionnaire and Blood Draw||4||
48632212|NCT03979066|101881722|FG000|STARTED|Overall Study||0||
48632213|NCT03979066|101881723|FG001|STARTED|Overall Study||0||
48632214|NCT03979066|101881722|FG000|COMPLETED|Overall Study||0||
48632215|NCT03979066|101881723|FG001|COMPLETED|Overall Study||0||
48340156|NCT02367521|101160173|FG000|STARTED|Overall Study||17||
48340157|NCT02367521|101160174|FG001|STARTED|Overall Study||17||
48340158|NCT02367521|101160173|FG000|COMPLETED|Overall Study||13||
48340159|NCT02367521|101160174|FG001|COMPLETED|Overall Study||17||
48340160|NCT02367521|101160173|FG000|NOT COMPLETED|Overall Study||4||
48340161|NCT02367521|101160174|FG001|NOT COMPLETED|Overall Study||0||
48340162|NCT01445535|101160175|FG000|STARTED|Overall Study||3||
48340163|NCT01445535|101160176|FG001|STARTED|Overall Study||3||
48340164|NCT01445535|101160177|FG002|STARTED|Overall Study||3||
48340165|NCT01445535|101160178|FG003|STARTED|Overall Study||6||
48340166|NCT01445535|101160175|FG000|COMPLETED|Overall Study||2||
48340167|NCT01445535|101160176|FG001|COMPLETED|Overall Study||3||
48340168|NCT01445535|101160177|FG002|COMPLETED|Overall Study||2||
48340169|NCT01445535|101160178|FG003|COMPLETED|Overall Study||4||
48340170|NCT01445535|101160175|FG000|NOT COMPLETED|Overall Study||1||
48340171|NCT01445535|101160176|FG001|NOT COMPLETED|Overall Study||0||
48340172|NCT01445535|101160177|FG002|NOT COMPLETED|Overall Study||1||
48340173|NCT01445535|101160178|FG003|NOT COMPLETED|Overall Study||2||
48340174|NCT02292212|101160179|FG000|STARTED|Pre-ViE Phase||17||
48340175|NCT02292212|101160179|FG000|COMPLETED|Pre-ViE Phase||17||
48340176|NCT02292212|101160179|FG000|NOT COMPLETED|Pre-ViE Phase||0||
48340177|NCT02292212|101160179|FG000|STARTED|ViE Phase||17||
48632216|NCT03979066|101881722|FG000|NOT COMPLETED|Overall Study||0||
48632217|NCT03979066|101881723|FG001|NOT COMPLETED|Overall Study||0||
48340178|NCT02292212|101160179|FG000|COMPLETED|ViE Phase||14||
48340179|NCT02292212|101160179|FG000|NOT COMPLETED|ViE Phase||3||
48340180|NCT02292212|101160179|FG000|STARTED|Post-ViE Phase||14||
48632218|NCT00667511|101881724|FG000|STARTED|Intervention 1: Home DHD||58||
48632219|NCT00667511|101881724|FG000|COMPLETED|Intervention 1: Home DHD||51||
48632220|NCT00667511|101881724|FG000|NOT COMPLETED|Intervention 1: Home DHD||7||
48179362|NCT02499328|100760087|FG009|NOT COMPLETED|Overall Study||24||
48179363|NCT02499328|100760088|FG010|NOT COMPLETED|Overall Study||20||
48179364|NCT02499328|100760089|FG011|NOT COMPLETED|Overall Study||54||
48179365|NCT02499328|100760090|FG012|NOT COMPLETED|Overall Study||25||
48179366|NCT02499328|100760091|FG013|NOT COMPLETED|Overall Study||17||
48179367|NCT02499328|100760092|FG014|NOT COMPLETED|Overall Study||10||
48179368|NCT02499328|100760093|FG015|NOT COMPLETED|Overall Study||1||
48179369|NCT02499328|100760094|FG016|NOT COMPLETED|Overall Study||1||
48179370|NCT02499328|100760095|FG017|NOT COMPLETED|Overall Study||55||
48340181|NCT02292212|101160179|FG000|COMPLETED|Post-ViE Phase||14||
48632221|NCT00667511|101881724|FG000|STARTED|Training/Transition Period||51||
48179371|NCT02499328|100760096|FG018|NOT COMPLETED|Overall Study||49||
48179372|NCT03685708|100760097|FG000|STARTED|Overall Study||14||
48179373|NCT03685708|100760098|FG001|STARTED|Overall Study||18||
48340182|NCT02292212|101160179|FG000|NOT COMPLETED|Post-ViE Phase||0||
48340183|NCT02152345|101160180|FG000|STARTED|Overall Study||28||
48340184|NCT02152345|101160181|FG001|STARTED|Overall Study||29||
48340185|NCT02152345|101160180|FG000|COMPLETED|Overall Study||24||
48340186|NCT02152345|101160181|FG001|COMPLETED|Overall Study||24||
48340187|NCT02152345|101160180|FG000|NOT COMPLETED|Overall Study||4||
48632222|NCT00667511|101881724|FG000|COMPLETED|Training/Transition Period||43||
48179374|NCT03685708|100760099|FG002|STARTED|Overall Study||46||
48179375|NCT03685708|100760097|FG000|COMPLETED|Overall Study||13||
48179376|NCT03685708|100760098|FG001|COMPLETED|Overall Study||16||
48179377|NCT03685708|100760099|FG002|COMPLETED|Overall Study||37||
48340188|NCT02152345|101160181|FG001|NOT COMPLETED|Overall Study||5||
48340189|NCT03665038|101160182|FG000|STARTED|Overall Study||8||
48340190|NCT03665038|101160183|FG001|STARTED|Overall Study||8||
48340191|NCT03665038|101160184|FG002|STARTED|Overall Study||12||
48340192|NCT03665038|101160182|FG000|COMPLETED|Overall Study||8||
48340193|NCT03665038|101160183|FG001|COMPLETED|Overall Study||8||
48340194|NCT03665038|101160184|FG002|COMPLETED|Overall Study||11||
48340195|NCT03665038|101160182|FG000|NOT COMPLETED|Overall Study||0||
48340196|NCT03665038|101160183|FG001|NOT COMPLETED|Overall Study||0||
48340197|NCT03665038|101160184|FG002|NOT COMPLETED|Overall Study||1||
48340198|NCT01231555|101160185|FG000|STARTED|Overall Study||8||
48340199|NCT01231555|101160186|FG001|STARTED|Overall Study||7||
48413478|NCT02169466|101345836|FG000|STARTED|Overall Study||6||
48657133|NCT00063362|101943785|FG000|COMPLETED|Overall Study||19||
48340200|NCT01231555|101160187|FG002|STARTED|Overall Study||8||
48340201|NCT01231555|101160185|FG000|COMPLETED|Overall Study||0||
48340202|NCT01231555|101160186|FG001|COMPLETED|Overall Study||0||
48340203|NCT01231555|101160187|FG002|COMPLETED|Overall Study||0||
48340204|NCT01231555|101160185|FG000|NOT COMPLETED|Overall Study||8||
48340205|NCT01231555|101160186|FG001|NOT COMPLETED|Overall Study||7||
48340206|NCT01231555|101160187|FG002|NOT COMPLETED|Overall Study||8||
48340207|NCT00354601|101160188|FG000|STARTED|Overall Study||2||
48340208|NCT00354601|101160188|FG000|COMPLETED|Overall Study||0||
48340209|NCT00354601|101160188|FG000|NOT COMPLETED|Overall Study||2||
48340210|NCT02908100|101160189|FG000|STARTED|Overall Study||86||
48340211|NCT02908100|101160190|FG001|STARTED|Overall Study||87||
48340212|NCT02908100|101160191|FG002|STARTED|Overall Study||87||
48340213|NCT02908100|101160189|FG000|COMPLETED|Overall Study||63||
48340214|NCT02908100|101160190|FG001|COMPLETED|Overall Study||66||
48340215|NCT02908100|101160191|FG002|COMPLETED|Overall Study||66||
48340216|NCT02908100|101160189|FG000|NOT COMPLETED|Overall Study||23||
48340217|NCT02908100|101160190|FG001|NOT COMPLETED|Overall Study||21||
48340218|NCT02908100|101160191|FG002|NOT COMPLETED|Overall Study||21||
48340219|NCT03118947|101160192|FG000|STARTED|Overall Study||78||
48340220|NCT03118947|101160192|FG000|COMPLETED|Overall Study||49||
48340221|NCT03118947|101160192|FG000|NOT COMPLETED|Overall Study||29||
48340222|NCT00956943|101160193|FG000|STARTED|Overall Study||43||
48340223|NCT00956943|101160194|FG001|STARTED|Overall Study||44||
48340224|NCT00956943|101160193|FG000|Baseline|Overall Study||43||
48340225|NCT00956943|101160194|FG001|Baseline|Overall Study||44||
48340226|NCT00956943|101160193|FG000|COMPLETED|Overall Study||34||
48340227|NCT00956943|101160194|FG001|COMPLETED|Overall Study||34||
48340228|NCT00956943|101160193|FG000|NOT COMPLETED|Overall Study||9||
48340229|NCT00956943|101160194|FG001|NOT COMPLETED|Overall Study||10||
48340230|NCT02222714|101160195|FG000|STARTED|Overall Study||15||
48340231|NCT02222714|101160196|FG001|STARTED|Overall Study||24||
48340232|NCT02222714|101160197|FG002|STARTED|Overall Study||12||
48340233|NCT02222714|101160198|FG003|STARTED|Overall Study||15||
48340234|NCT02222714|101160199|FG004|STARTED|Overall Study||44||
48340235|NCT02222714|101160195|FG000|COMPLETED|Overall Study||15||
48340236|NCT02222714|101160196|FG001|COMPLETED|Overall Study||22||
48340237|NCT02222714|101160197|FG002|COMPLETED|Overall Study||8||
48340238|NCT02222714|101160198|FG003|COMPLETED|Overall Study||11||
48340239|NCT02222714|101160199|FG004|COMPLETED|Overall Study||37||
48340240|NCT02222714|101160195|FG000|NOT COMPLETED|Overall Study||0||
48340241|NCT02222714|101160196|FG001|NOT COMPLETED|Overall Study||2||
48340242|NCT02222714|101160197|FG002|NOT COMPLETED|Overall Study||4||
48340243|NCT02222714|101160198|FG003|NOT COMPLETED|Overall Study||4||
48179378|NCT03685708|100760097|FG000|NOT COMPLETED|Overall Study||1||
48179379|NCT03685708|100760098|FG001|NOT COMPLETED|Overall Study||2||
48340244|NCT02222714|101160199|FG004|NOT COMPLETED|Overall Study||7||
48340245|NCT02104414|101160200|FG000|STARTED|Overall Study||5||
48340246|NCT02104414|101160201|FG001|STARTED|Overall Study||4||
48340247|NCT02104414|101160202|FG002|STARTED|Overall Study||2||
48340248|NCT02104414|101160200|FG000|COMPLETED|Overall Study||5||
48340249|NCT02104414|101160201|FG001|COMPLETED|Overall Study||4||
48340250|NCT02104414|101160202|FG002|COMPLETED|Overall Study||2||
48340251|NCT02104414|101160200|FG000|NOT COMPLETED|Overall Study||0||
48340252|NCT02104414|101160201|FG001|NOT COMPLETED|Overall Study||0||
48340253|NCT02104414|101160202|FG002|NOT COMPLETED|Overall Study||0||
48340254|NCT01285427|101160203|FG000|STARTED|Overall Study||300||
48340255|NCT01285427|101160203|FG000|COMPLETED|Overall Study||299||
48340256|NCT01285427|101160203|FG000|NOT COMPLETED|Overall Study||1||
48340257|NCT01629797|101160204|FG000|STARTED|Overall Study||100||
48340258|NCT01629797|101160204|FG000|COMPLETED|Overall Study||82||
48340259|NCT01629797|101160204|FG000|NOT COMPLETED|Overall Study||18||
48340260|NCT04134494|101160205|FG000|STARTED|Overall Study||15||
48179380|NCT03685708|100760099|FG002|NOT COMPLETED|Overall Study||9||
48340261|NCT04134494|101160205|FG000|COMPLETED|Overall Study||13||
48340262|NCT04134494|101160205|FG000|NOT COMPLETED|Overall Study||2||
48340263|NCT01299766|101160206|FG000|STARTED|Overall Study||111||
48340264|NCT01299766|101160207|FG001|STARTED|Overall Study||110||
48340265|NCT01299766|101160206|FG000|COMPLETED|Overall Study||77|Provided data at 24 months|
48340266|NCT01299766|101160207|FG001|COMPLETED|Overall Study||87|Provided data at 24 months|
48340267|NCT01299766|101160206|FG000|NOT COMPLETED|Overall Study||34||
48340268|NCT01299766|101160207|FG001|NOT COMPLETED|Overall Study||23||
48340269|NCT03308188|101160208|FG000|STARTED|Overall Study||202||
48340270|NCT03308188|101160209|FG001|STARTED|Overall Study||200||
48340271|NCT03308188|101160208|FG000|COMPLETED|Overall Study||202||
48340272|NCT03308188|101160209|FG001|COMPLETED|Overall Study||196||
48340273|NCT03308188|101160208|FG000|NOT COMPLETED|Overall Study||0||
48340274|NCT03308188|101160209|FG001|NOT COMPLETED|Overall Study||4||
48340275|NCT02421887|101160210|FG000|STARTED|Overall Study||85||
48340276|NCT02421887|101160211|FG001|STARTED|Overall Study||86||
48340277|NCT02421887|101160210|FG000|COMPLETED|Overall Study||68||
48340278|NCT02421887|101160211|FG001|COMPLETED|Overall Study||77||
48340279|NCT02421887|101160210|FG000|NOT COMPLETED|Overall Study||17||
48340280|NCT02421887|101160211|FG001|NOT COMPLETED|Overall Study||9||
48340281|NCT04591054|101160212|FG000|STARTED|Overall Study||28||
48340282|NCT04591054|101160213|FG001|STARTED|Overall Study||28||
48340283|NCT04591054|101160212|FG000|COMPLETED|Overall Study||24||
48340284|NCT04591054|101160213|FG001|COMPLETED|Overall Study||27||
48340285|NCT04591054|101160212|FG000|NOT COMPLETED|Overall Study||4||
48340286|NCT04591054|101160213|FG001|NOT COMPLETED|Overall Study||1||
48340287|NCT05198713|101160214|FG000|STARTED|Overall Study||15||
48340288|NCT05198713|101160214|FG000|COMPLETED|Overall Study||15||
48340289|NCT05198713|101160214|FG000|NOT COMPLETED|Overall Study||0||
48340290|NCT02440581|101160215|FG000|STARTED|Overall Study||37||
48340291|NCT02440581|101160216|FG001|STARTED|Overall Study||24||
48340292|NCT02440581|101160217|FG002|STARTED|Overall Study||50||
48340293|NCT02440581|101160218|FG003|STARTED|Overall Study||30||
48413479|NCT02169466|101345837|FG001|STARTED|Overall Study||6||
48413480|NCT02169466|101345838|FG002|STARTED|Overall Study||5||
48413481|NCT02169466|101345839|FG003|STARTED|Overall Study||5||
48413482|NCT02169466|101345836|FG000|25 mg BIA 9-1067|Overall Study||6||
48632223|NCT00667511|101881724|FG000|NOT COMPLETED|Training/Transition Period||8||
48632224|NCT00667511|101881724|FG000|STARTED|Intervention 2: Home NHD||43||
48340294|NCT02440581|101160215|FG000|COMPLETED|Overall Study||32||
48340295|NCT02440581|101160216|FG001|COMPLETED|Overall Study||13||
48340296|NCT02440581|101160217|FG002|COMPLETED|Overall Study||37||
48340297|NCT02440581|101160218|FG003|COMPLETED|Overall Study||16||
48340298|NCT02440581|101160215|FG000|NOT COMPLETED|Overall Study||5||
48340299|NCT02440581|101160216|FG001|NOT COMPLETED|Overall Study||11||
48413483|NCT02169466|101345837|FG001|25 mg BIA 9-1067|Overall Study||5||
48632225|NCT00667511|101881724|FG000|COMPLETED|Intervention 2: Home NHD||39||
48340300|NCT02440581|101160217|FG002|NOT COMPLETED|Overall Study||13||
48340301|NCT02440581|101160218|FG003|NOT COMPLETED|Overall Study||14||
48340302|NCT03222427|101160219|FG000|STARTED|Overall Study||8||
48340303|NCT03222427|101160219|FG000|Received One Dose of Study Drug|Overall Study||8||
48340304|NCT03222427|101160219|FG000|COMPLETED|Overall Study||8||
48340305|NCT03222427|101160219|FG000|NOT COMPLETED|Overall Study||0||
48340306|NCT01976806|101160220|FG000|STARTED|Overall Study||27||
48340307|NCT01976806|101160221|FG001|STARTED|Overall Study||28||
48340308|NCT01976806|101160220|FG000|COMPLETED|Overall Study||24||
48340309|NCT01976806|101160221|FG001|COMPLETED|Overall Study||22||
48340310|NCT01976806|101160220|FG000|NOT COMPLETED|Overall Study||3||
48340311|NCT01976806|101160221|FG001|NOT COMPLETED|Overall Study||6||
48340312|NCT00895830|101160222|FG000|STARTED|Overall Study||51||
48340313|NCT00895830|101160223|FG001|STARTED|Overall Study||50||
48340314|NCT00895830|101160224|FG002|STARTED|Overall Study||49||
48340315|NCT00895830|101160225|FG003|STARTED|Overall Study||52||
48340316|NCT00895830|101160226|FG004|STARTED|Overall Study||55||
48340317|NCT00895830|101160222|FG000|COMPLETED|Overall Study||51||
48340318|NCT00895830|101160223|FG001|COMPLETED|Overall Study||50||
48340319|NCT00895830|101160224|FG002|COMPLETED|Overall Study||49||
48340320|NCT00895830|101160225|FG003|COMPLETED|Overall Study||52||
48340321|NCT00895830|101160226|FG004|COMPLETED|Overall Study||55||
48340322|NCT00895830|101160222|FG000|NOT COMPLETED|Overall Study||0||
48340323|NCT00895830|101160223|FG001|NOT COMPLETED|Overall Study||0||
48340324|NCT00895830|101160224|FG002|NOT COMPLETED|Overall Study||0||
48340325|NCT00895830|101160225|FG003|NOT COMPLETED|Overall Study||0||
48340326|NCT00895830|101160226|FG004|NOT COMPLETED|Overall Study||0||
48340327|NCT01756274|101160227|FG000|STARTED|Overall Study||162||
48340328|NCT01756274|101160227|FG000|COMPLETED|Overall Study||159||
48340329|NCT01756274|101160227|FG000|NOT COMPLETED|Overall Study||3||
48340330|NCT04698629|101160228|FG000|STARTED|Overall Study||40||
48340331|NCT04698629|101160228|FG000|COMPLETED|Overall Study||39||
48340332|NCT04698629|101160228|FG000|NOT COMPLETED|Overall Study||1||
48340333|NCT01076348|101160229|FG000|STARTED|Overall Study||73||
48413484|NCT02169466|101345838|FG002|25 mg BIA 9-1067|Overall Study||5||
48632226|NCT00667511|101881724|FG000|NOT COMPLETED|Intervention 2: Home NHD||4||
48632227|NCT01799889|101885180|FG000|STARTED|Overall Study||41||
48632228|NCT01799889|101885181|FG001|STARTED|Overall Study||41||
48632229|NCT01799889|101885182|FG002|STARTED|Overall Study||44||
48632230|NCT01799889|101885183|FG003|STARTED|Overall Study||39||
48632231|NCT01799889|101885184|FG004|STARTED|Overall Study||49||
48632232|NCT01799889|101885185|FG005|STARTED|Overall Study||20||
48632233|NCT01799889|101885186|FG006|STARTED|Overall Study||21||
48632234|NCT01799889|101885187|FG007|STARTED|Overall Study||20||
48632235|NCT01799889|101885188|FG008|STARTED|Overall Study||33||
48632236|NCT01799889|101885189|FG009|STARTED|Overall Study||8||
48632237|NCT01799889|101885190|FG010|STARTED|Overall Study||7||
48632238|NCT01799889|101885191|FG011|STARTED|Overall Study||3||
48632239|NCT01799889|101885180|FG000|COMPLETED|Overall Study||0||
48632240|NCT01799889|101885181|FG001|COMPLETED|Overall Study||0||
48632241|NCT01799889|101885182|FG002|COMPLETED|Overall Study||0||
48632242|NCT01799889|101885183|FG003|COMPLETED|Overall Study||0||
48632243|NCT01799889|101885184|FG004|COMPLETED|Overall Study||0||
48632244|NCT01799889|101885185|FG005|COMPLETED|Overall Study||0||
48632245|NCT01799889|101885186|FG006|COMPLETED|Overall Study||0||
48632246|NCT01799889|101885187|FG007|COMPLETED|Overall Study||0||
48632247|NCT01799889|101885188|FG008|COMPLETED|Overall Study||0||
48632248|NCT01799889|101885189|FG009|COMPLETED|Overall Study||0||
48632249|NCT01799889|101885190|FG010|COMPLETED|Overall Study||0||
48340334|NCT01076348|101160229|FG000|COMPLETED|Overall Study||51||
48340335|NCT01076348|101160229|FG000|NOT COMPLETED|Overall Study||22||
48340336|NCT01225562|101160230|FG000|STARTED|Overall Study||7050||
48340337|NCT01225562|101160231|FG001|STARTED|Overall Study||7045||
48413485|NCT02169466|101345839|FG003|25 mg BIA 9-1067|Overall Study||5||
48632250|NCT01799889|101885191|FG011|COMPLETED|Overall Study||0||
48632251|NCT01799889|101885180|FG000|NOT COMPLETED|Overall Study||41||
48632252|NCT01799889|101885181|FG001|NOT COMPLETED|Overall Study||41||
48632253|NCT01799889|101885182|FG002|NOT COMPLETED|Overall Study||44||
48340338|NCT01225562|101160232|FG002|STARTED|Overall Study||7067||
48340339|NCT01225562|101160230|FG000|COMPLETED|Overall Study||6995||
48340340|NCT01225562|101160231|FG001|COMPLETED|Overall Study||6989||
48340341|NCT01225562|101160232|FG002|COMPLETED|Overall Study||7014||
48340342|NCT01225562|101160230|FG000|NOT COMPLETED|Overall Study||55||
48340343|NCT01225562|101160231|FG001|NOT COMPLETED|Overall Study||56||
48632254|NCT01799889|101885183|FG003|NOT COMPLETED|Overall Study||39||
48632255|NCT01799889|101885184|FG004|NOT COMPLETED|Overall Study||49||
48340344|NCT01225562|101160232|FG002|NOT COMPLETED|Overall Study||53||
48340345|NCT00964431|101160233|FG000|STARTED|Overall Study||50||
48340346|NCT00964431|101160234|FG001|STARTED|Overall Study||51||
48340347|NCT00964431|101160235|FG002|STARTED|Overall Study||51||
48340348|NCT00964431|101160236|FG003|STARTED|Overall Study||51||
48340349|NCT00964431|101160233|FG000|COMPLETED|Overall Study||50||
48340350|NCT00964431|101160234|FG001|COMPLETED|Overall Study||51||
48340351|NCT00964431|101160235|FG002|COMPLETED|Overall Study||51||
48340352|NCT00964431|101160236|FG003|COMPLETED|Overall Study||51||
48340353|NCT00964431|101160233|FG000|NOT COMPLETED|Overall Study||0||
48340354|NCT00964431|101160234|FG001|NOT COMPLETED|Overall Study||0||
48340355|NCT00964431|101160235|FG002|NOT COMPLETED|Overall Study||0||
48340356|NCT00964431|101160236|FG003|NOT COMPLETED|Overall Study||0||
48340357|NCT01709331|101163806|FG000|STARTED|Overall Study||18||
48340358|NCT01709331|101163806|FG000|COMPLETED|Overall Study||17||
48340359|NCT01709331|101163806|FG000|NOT COMPLETED|Overall Study||1||
48340360|NCT02109159|101163807|FG000|STARTED|Overall Study||4178||
48340361|NCT02109159|101163808|FG001|STARTED|Overall Study||4175||
48340362|NCT02109159|101163807|FG000|COMPLETED|Overall Study||4178||
48340363|NCT02109159|101163808|FG001|COMPLETED|Overall Study||4175||
48340364|NCT02109159|101163807|FG000|NOT COMPLETED|Overall Study||0||
48340365|NCT02109159|101163808|FG001|NOT COMPLETED|Overall Study||0||
48340366|NCT02107755|101163809|FG000|STARTED|Overall Study||8||
48340367|NCT02107755|101163809|FG000|COMPLETED|Overall Study||8||
48340368|NCT02107755|101163809|FG000|NOT COMPLETED|Overall Study||0||
48340369|NCT01109940|101163810|FG000|STARTED|Overall Study||21||
48340370|NCT01109940|101163811|FG001|STARTED|Overall Study||8||
48340371|NCT01109940|101163812|FG002|STARTED|Overall Study||7||
48340372|NCT01109940|101163813|FG003|STARTED|Overall Study||3||
48340373|NCT01109940|101163810|FG000|COMPLETED|Overall Study||13||
48340374|NCT01109940|101163811|FG001|COMPLETED|Overall Study||6||
48340375|NCT01109940|101163812|FG002|COMPLETED|Overall Study||6||
48340376|NCT01109940|101163813|FG003|COMPLETED|Overall Study||3||
48340377|NCT01109940|101163810|FG000|NOT COMPLETED|Overall Study||8||
48340378|NCT01109940|101163811|FG001|NOT COMPLETED|Overall Study||2||
48340379|NCT01109940|101163812|FG002|NOT COMPLETED|Overall Study||1||
48340380|NCT01109940|101163813|FG003|NOT COMPLETED|Overall Study||0||
48340381|NCT00234039|101163814|FG000|STARTED|Overall Study||58||
48340382|NCT00234039|101163814|FG000|Eligible|Overall Study||49||
48340383|NCT00234039|101163814|FG000|Eligible and Began Protocol Therapy|Overall Study||47||
48340384|NCT00234039|101163814|FG000|COMPLETED|Overall Study||8||
48340385|NCT00234039|101163814|FG000|NOT COMPLETED|Overall Study||50||
48340386|NCT03072160|101163815|FG000|STARTED|Overall Study||13||
48340387|NCT03072160|101163816|FG001|STARTED|Overall Study||4||
48340388|NCT03072160|101163815|FG000|COMPLETED|Overall Study||2||
48340389|NCT03072160|101163816|FG001|COMPLETED|Overall Study||0||
48340390|NCT03072160|101163815|FG000|NOT COMPLETED|Overall Study||11||
48340391|NCT03072160|101163816|FG001|NOT COMPLETED|Overall Study||4||
48340392|NCT03002974|101163817|FG000|STARTED|Overall Study||55||
48340393|NCT03002974|101163818|FG001|STARTED|Overall Study||56||
48340394|NCT03002974|101163819|FG002|STARTED|Overall Study||54||
48340395|NCT03002974|101163817|FG000|Intention To Treat Populatio|Overall Study||55||
48340396|NCT03002974|101163818|FG001|Intention To Treat Populatio|Overall Study||56||
48340397|NCT03002974|101163819|FG002|Intention To Treat Populatio|Overall Study||54||
48340398|NCT03002974|101163817|FG000|Safety Population|Overall Study||54||
48340399|NCT03002974|101163818|FG001|Safety Population|Overall Study||55||
48340400|NCT03002974|101163819|FG002|Safety Population|Overall Study||52||
48340401|NCT03002974|101163817|FG000|COMPLETED|Overall Study||35||
48340402|NCT03002974|101163818|FG001|COMPLETED|Overall Study||40||
48340403|NCT03002974|101163819|FG002|COMPLETED|Overall Study||36||
48340404|NCT03002974|101163817|FG000|NOT COMPLETED|Overall Study||20||
48340405|NCT03002974|101163818|FG001|NOT COMPLETED|Overall Study||16||
48340406|NCT03002974|101163819|FG002|NOT COMPLETED|Overall Study||18||
48340407|NCT01814787|101163820|FG000|STARTED|Overall Study||685||
48340408|NCT01814787|101163821|FG001|STARTED|Overall Study||684||
48340409|NCT01814787|101163820|FG000|COMPLETED|Overall Study||685||
48340410|NCT01814787|101163821|FG001|COMPLETED|Overall Study||684||
48340411|NCT01814787|101163820|FG000|NOT COMPLETED|Overall Study||0||
48340412|NCT01814787|101163821|FG001|NOT COMPLETED|Overall Study||0||
48340413|NCT00802360|101163822|FG000|STARTED|Overall Study||42||
48340414|NCT00802360|101163823|FG001|STARTED|Overall Study||42||
48340415|NCT00802360|101163824|FG002|STARTED|Overall Study||42||
48340416|NCT00802360|101163825|FG003|STARTED|Overall Study||39||
48340417|NCT00802360|101163822|FG000|COMPLETED|Overall Study||18||
48340418|NCT00802360|101163823|FG001|COMPLETED|Overall Study||16||
48340419|NCT00802360|101163824|FG002|COMPLETED|Overall Study||17||
48340420|NCT00802360|101163825|FG003|COMPLETED|Overall Study||17||
48340421|NCT00802360|101163822|FG000|NOT COMPLETED|Overall Study||24||
48340422|NCT00802360|101163823|FG001|NOT COMPLETED|Overall Study||26||
48340423|NCT00802360|101163824|FG002|NOT COMPLETED|Overall Study||25||
48340424|NCT00802360|101163825|FG003|NOT COMPLETED|Overall Study||22||
48340425|NCT00891995|101163826|FG000|STARTED|Overall Study||50||
48340426|NCT00891995|101163827|FG001|STARTED|Overall Study||21||
48340427|NCT00891995|101163826|FG000|COMPLETED|Overall Study||50||
48340428|NCT00891995|101163827|FG001|COMPLETED|Overall Study||21||
48340429|NCT00891995|101163826|FG000|NOT COMPLETED|Overall Study||0||
48340430|NCT00891995|101163827|FG001|NOT COMPLETED|Overall Study||0||
48340431|NCT01442181|101163828|FG000|STARTED|Overall Study||14||
48340432|NCT01442181|101163829|FG001|STARTED|Overall Study||11||
48340433|NCT01442181|101163828|FG000|COMPLETED|Overall Study||10||
48340434|NCT01442181|101163829|FG001|COMPLETED|Overall Study||8||
48340435|NCT01442181|101163828|FG000|NOT COMPLETED|Overall Study||4||
48340436|NCT01442181|101163829|FG001|NOT COMPLETED|Overall Study||3||
48340437|NCT02429856|101163830|FG000|STARTED|Overall Study||49||
48340438|NCT02429856|101163831|FG001|STARTED|Overall Study||51||
48340439|NCT02429856|101163830|FG000|COMPLETED|Overall Study||30||
48340440|NCT02429856|101163831|FG001|COMPLETED|Overall Study||32||
48340441|NCT02429856|101163830|FG000|NOT COMPLETED|Overall Study||19||
48340442|NCT02429856|101163831|FG001|NOT COMPLETED|Overall Study||19||
48340443|NCT03433781|101163832|FG000|STARTED|Overall Study||1||
48340444|NCT03433781|101163833|FG001|STARTED|Overall Study||3||
48340445|NCT03433781|101163834|FG002|STARTED|Overall Study||0||
48340446|NCT03433781|101163832|FG000|COMPLETED|Overall Study||0||
48340447|NCT03433781|101163833|FG001|COMPLETED|Overall Study||2||
48340448|NCT03433781|101163834|FG002|COMPLETED|Overall Study||0||
48340449|NCT03433781|101163832|FG000|NOT COMPLETED|Overall Study||1||
48340450|NCT03433781|101163833|FG001|NOT COMPLETED|Overall Study||1||
48340451|NCT03433781|101163834|FG002|NOT COMPLETED|Overall Study||0||
48340452|NCT00655928|101163835|FG000|STARTED|Overall Study||26||
48340453|NCT00655928|101163836|FG001|STARTED|Overall Study||26||
48340454|NCT00655928|101163835|FG000|COMPLETED|Overall Study||23||
48340455|NCT00655928|101163836|FG001|COMPLETED|Overall Study||24||
48340456|NCT00655928|101163835|FG000|NOT COMPLETED|Overall Study||3||
48340457|NCT00655928|101163836|FG001|NOT COMPLETED|Overall Study||2||
48340458|NCT00684177|101163837|FG000|STARTED|Overall Study||343||
48340459|NCT00684177|101163838|FG001|STARTED|Overall Study||164||
48340460|NCT00684177|101163837|FG000|COMPLETED|Overall Study||322||
48340461|NCT00684177|101163838|FG001|COMPLETED|Overall Study||141||
48340462|NCT00684177|101163837|FG000|NOT COMPLETED|Overall Study||21||
48340463|NCT00684177|101163838|FG001|NOT COMPLETED|Overall Study||23||
48340464|NCT02700984|101163839|FG000|STARTED|Overall Study||215|All enrolled subjects|
48340465|NCT02700984|101163840|FG001|STARTED|Overall Study||67|All enrolled subjects|
48340466|NCT02700984|101163839|FG000|COMPLETED|Overall Study||200|All subjects who completed the 60-month assessment|
48340467|NCT02700984|101163840|FG001|COMPLETED|Overall Study||53|All subjects who completed the 60-month assessment|
48340468|NCT02700984|101163839|FG000|NOT COMPLETED|Overall Study||15||
48340469|NCT02700984|101163840|FG001|NOT COMPLETED|Overall Study||14||
48340470|NCT01468987|101163841|FG000|STARTED|Overall Study||691||
48340471|NCT01468987|101163842|FG001|STARTED|Overall Study||678||
48340472|NCT01468987|101163841|FG000|Received at Least 1 Dose of Study Drug|Overall Study||691||
48340473|NCT01468987|101163842|FG001|Received at Least 1 Dose of Study Drug|Overall Study||677||
48340474|NCT01468987|101163841|FG000|COMPLETED|Overall Study||620||
48340475|NCT01468987|101163842|FG001|COMPLETED|Overall Study||618||
48340476|NCT01468987|101163841|FG000|NOT COMPLETED|Overall Study||71||
48340477|NCT01468987|101163842|FG001|NOT COMPLETED|Overall Study||60||
48340478|NCT01322022|101163843|FG000|STARTED|Overall Study||20||
48340479|NCT01322022|101163844|FG001|STARTED|Overall Study||20||
48340480|NCT01322022|101163843|FG000|Week 4|Overall Study||15||
48340481|NCT01322022|101163844|FG001|Week 4|Overall Study||18||
48340482|NCT01322022|101163843|FG000|COMPLETED|Overall Study||15||
48340483|NCT01322022|101163844|FG001|COMPLETED|Overall Study||18||
48340484|NCT01322022|101163843|FG000|NOT COMPLETED|Overall Study||5||
48340485|NCT01322022|101163844|FG001|NOT COMPLETED|Overall Study||2||
48632256|NCT01799889|101885185|FG005|NOT COMPLETED|Overall Study||20||
48632257|NCT01799889|101885186|FG006|NOT COMPLETED|Overall Study||21||
48632258|NCT01799889|101885187|FG007|NOT COMPLETED|Overall Study||20||
48340486|NCT01451645|101163845|FG000|STARTED|Overall Study||41||
48340487|NCT01451645|101163846|FG001|STARTED|Overall Study||41||
48340488|NCT01451645|101163845|FG000|COMPLETED|Overall Study||32||
48340489|NCT01451645|101163846|FG001|COMPLETED|Overall Study||33||
48340490|NCT01451645|101163845|FG000|NOT COMPLETED|Overall Study||9||
48340491|NCT01451645|101163846|FG001|NOT COMPLETED|Overall Study||8||
48340492|NCT00768898|101163847|FG000|STARTED|Overall Study||30||
48340493|NCT00768898|101163847|FG000|COMPLETED|Overall Study||28||
48340494|NCT00768898|101163847|FG000|NOT COMPLETED|Overall Study||2||
48340495|NCT03497845|101163848|FG000|STARTED|Overall Study||60||
48340496|NCT03497845|101163849|FG001|STARTED|Overall Study||58||
48340497|NCT03497845|101163850|FG002|STARTED|Overall Study||61||
48340498|NCT03497845|101163851|FG003|STARTED|Overall Study||60||
48340499|NCT03497845|101163852|FG004|STARTED|Overall Study||59||
48340500|NCT03497845|101163853|FG005|STARTED|Overall Study||62||
48340501|NCT03497845|101163854|FG006|STARTED|Overall Study||59||
48340502|NCT03497845|101163855|FG007|STARTED|Overall Study||60||
48340503|NCT03497845|101163856|FG008|STARTED|Overall Study||61||
48340504|NCT03497845|101163857|FG009|STARTED|Overall Study||59||
48340505|NCT03497845|101163858|FG010|STARTED|Overall Study||61||
48340506|NCT03497845|101163859|FG011|STARTED|Overall Study||60||
48413486|NCT02169466|101345836|FG000|50 mg BIA 9-1067|Overall Study||6||
48754529|NCT03532542|102187731|FG000|COMPLETED|Overall Study||26||
48754530|NCT03532542|102187732|FG001|COMPLETED|Overall Study||27||
48754531|NCT03532542|102187731|FG000|NOT COMPLETED|Overall Study||48||
48754532|NCT03532542|102187732|FG001|NOT COMPLETED|Overall Study||70||
48754533|NCT01938079|102187733|FG000|STARTED|Overall Study||10||
48754534|NCT01938079|102187734|FG001|STARTED|Overall Study||10||
48754535|NCT01938079|102187733|FG000|COMPLETED|Overall Study||10||
48754536|NCT01938079|102187734|FG001|COMPLETED|Overall Study||10||
48754537|NCT01938079|102187733|FG000|NOT COMPLETED|Overall Study||0||
48754538|NCT01938079|102187734|FG001|NOT COMPLETED|Overall Study||0||
48754539|NCT03165617|102187735|FG000|STARTED|Overall Study||2258||
48754540|NCT03165617|102187736|FG001|STARTED|Overall Study||2256||
48754541|NCT03165617|102187735|FG000|COMPLETED|Overall Study||2249||
48754542|NCT03165617|102187736|FG001|COMPLETED|Overall Study||2247||
48179381|NCT03351998|100760100|FG000|STARTED|Overall Study||23||
48179382|NCT03351998|100760101|FG001|STARTED|Overall Study||24||
48179383|NCT03351998|100760102|FG002|STARTED|Overall Study||21||
48754543|NCT03165617|102187735|FG000|NOT COMPLETED|Overall Study||9||
48754544|NCT03165617|102187736|FG001|NOT COMPLETED|Overall Study||9||
48754545|NCT00083889|102187737|FG000|STARTED|Overall Study||375||
48754546|NCT00083889|102187738|FG001|STARTED|Overall Study||375||
48754547|NCT00083889|102187737|FG000|Received Treatment|Overall Study||375||
48754548|NCT00083889|102187738|FG001|Received Treatment|Overall Study||360||
48179384|NCT03351998|100760100|FG000|COMPLETED|Overall Study||16||
48179385|NCT03351998|100760101|FG001|COMPLETED|Overall Study||19||
48179386|NCT03351998|100760102|FG002|COMPLETED|Overall Study||17||
48179387|NCT03351998|100760100|FG000|NOT COMPLETED|Overall Study||7||
48179388|NCT03351998|100760101|FG001|NOT COMPLETED|Overall Study||5||
48179389|NCT03351998|100760102|FG002|NOT COMPLETED|Overall Study||4||
48179390|NCT03257995|100760103|FG000|STARTED|Overall Study||9||
48179391|NCT03257995|100760104|FG001|STARTED|Overall Study||9||
48179392|NCT03257995|100760105|FG002|STARTED|Overall Study||9||
48340507|NCT03497845|101163848|FG000|COMPLETED|Overall Study||55|Groups A-D and G-J completed Day 142, Groups E, F, K, L completed Day 262.|
48340508|NCT03497845|101163849|FG001|COMPLETED|Overall Study||45|Groups A-D and G-J completed Day 142, Groups E, F, K, L completed Day 262.|
48340509|NCT03497845|101163850|FG002|COMPLETED|Overall Study||50|Groups A-D and G-J completed Day 142, Groups E, F, K, L completed Day 262.|
48340510|NCT03497845|101163851|FG003|COMPLETED|Overall Study||50|Groups A-D and G-J completed Day 142, Groups E, F, K, L completed Day 262.|
48340511|NCT03497845|101163852|FG004|COMPLETED|Overall Study||38|Groups A-D and G-J completed Day 142, Groups E, F, K, L completed Day 262.|
48413487|NCT02169466|101345837|FG001|50 mg BIA 9-1067|Overall Study||6||
48754549|NCT00083889|102187737|FG000|COMPLETED|Overall Study||0||
48754550|NCT00083889|102187738|FG001|COMPLETED|Overall Study||0||
48754551|NCT00083889|102187737|FG000|NOT COMPLETED|Overall Study||375||
48754552|NCT00083889|102187738|FG001|NOT COMPLETED|Overall Study||375||
48179393|NCT03257995|100760106|FG003|STARTED|Overall Study||9||
48179394|NCT03257995|100760107|FG004|STARTED|Overall Study||9||
48413488|NCT02169466|101345838|FG002|50 mg BIA 9-1067|Overall Study||5||
48754553|NCT00740220|102187739|FG000|STARTED|Overall Study||97||
48754554|NCT00740220|102187739|FG000|COMPLETED|Overall Study||88||
48754555|NCT00740220|102187739|FG000|NOT COMPLETED|Overall Study||9||
48179395|NCT03257995|100760108|FG005|STARTED|Overall Study||9||
48179396|NCT03257995|100760103|FG000|COMPLETED|Overall Study||9||
48632259|NCT01799889|101885188|FG008|NOT COMPLETED|Overall Study||33||
48632260|NCT01799889|101885189|FG009|NOT COMPLETED|Overall Study||8||
48632261|NCT01799889|101885190|FG010|NOT COMPLETED|Overall Study||7||
48632262|NCT01799889|101885191|FG011|NOT COMPLETED|Overall Study||3||
48340512|NCT03497845|101163853|FG005|COMPLETED|Overall Study||44|Groups A-D and G-J completed Day 142, Groups E, F, K, L completed Day 262.|
48340513|NCT03497845|101163854|FG006|COMPLETED|Overall Study||51|Groups A-D and G-J completed Day 142, Groups E, F, K, L completed Day 262.|
48340514|NCT03497845|101163855|FG007|COMPLETED|Overall Study||50|Groups A-D and G-J completed Day 142, Groups E, F, K, L completed Day 262.|
48632263|NCT00644059|101885192|FG000|STARTED|Overall Study||2019||
48632264|NCT00644059|101885193|FG001|STARTED|Overall Study||1849||
48632265|NCT00644059|101885194|FG002|STARTED|Overall Study||1034||
48632266|NCT00644059|101885192|FG000|COMPLETED|Overall Study||1895||
48340515|NCT03497845|101163856|FG008|COMPLETED|Overall Study||47|Groups A-D and G-J completed Day 142, Groups E, F, K, L completed Day 262.|
48340516|NCT03497845|101163857|FG009|COMPLETED|Overall Study||53|Groups A-D and G-J completed Day 142, Groups E, F, K, L completed Day 262.|
48340517|NCT03497845|101163858|FG010|COMPLETED|Overall Study||46|Groups A-D and G-J completed Day 142, Groups E, F, K, L completed Day 262.|
48340518|NCT03497845|101163859|FG011|COMPLETED|Overall Study||38|Groups A-D and G-J completed Day 142, Groups E, F, K, L completed Day 262.|
48632267|NCT00644059|101885193|FG001|COMPLETED|Overall Study||1726||
48632268|NCT00644059|101885194|FG002|COMPLETED|Overall Study||969||
48632269|NCT00644059|101885192|FG000|NOT COMPLETED|Overall Study||124||
48632270|NCT00644059|101885193|FG001|NOT COMPLETED|Overall Study||123||
48632271|NCT00644059|101885194|FG002|NOT COMPLETED|Overall Study||65||
48632272|NCT01553851|101885195|FG000|STARTED|Overall Study||20||
48632273|NCT01553851|101885195|FG000|COMPLETED|Overall Study||17||
48340519|NCT03497845|101163848|FG000|NOT COMPLETED|Overall Study||5||
48632274|NCT01553851|101885195|FG000|NOT COMPLETED|Overall Study||3||
48632275|NCT03044418|101885196|FG000|STARTED|Overall Study||30||
48632276|NCT03044418|101885196|FG000|COMPLETED|Overall Study||30||
48632277|NCT03044418|101885196|FG000|NOT COMPLETED|Overall Study||0||
48632278|NCT02997163|101885197|FG000|STARTED|Overall Study||9||
48632279|NCT02997163|101885198|FG001|STARTED|Overall Study||9||
48632280|NCT02997163|101885199|FG002|STARTED|Overall Study||8||
48340520|NCT03497845|101163849|FG001|NOT COMPLETED|Overall Study||13||
48340521|NCT03497845|101163850|FG002|NOT COMPLETED|Overall Study||11||
48340522|NCT03497845|101163851|FG003|NOT COMPLETED|Overall Study||10||
48632281|NCT02997163|101885200|FG003|STARTED|Overall Study||8||
48632282|NCT02997163|101885197|FG000|COMPLETED|Overall Study||8||
48632283|NCT02997163|101885198|FG001|COMPLETED|Overall Study||9||
48632284|NCT02997163|101885199|FG002|COMPLETED|Overall Study||8||
48632285|NCT02997163|101885200|FG003|COMPLETED|Overall Study||7||
48632286|NCT02997163|101885197|FG000|NOT COMPLETED|Overall Study||1||
48632287|NCT02997163|101885198|FG001|NOT COMPLETED|Overall Study||0||
48632288|NCT02997163|101885199|FG002|NOT COMPLETED|Overall Study||0||
48632289|NCT02997163|101885200|FG003|NOT COMPLETED|Overall Study||1||
48754556|NCT01539759|102187740|FG000|STARTED|Overall Study||56||
48754557|NCT01539759|102187741|FG001|STARTED|Overall Study||56||
48754558|NCT01539759|102187740|FG000|Had Successful IUD Placement|Overall Study||34||
48754559|NCT01539759|102187741|FG001|Had Successful IUD Placement|Overall Study||53||
48754560|NCT01539759|102187740|FG000|IUD Expulsion|Overall Study||1||
48179397|NCT03257995|100760104|FG001|COMPLETED|Overall Study||8||
48179398|NCT03257995|100760105|FG002|COMPLETED|Overall Study||9||
48179399|NCT03257995|100760106|FG003|COMPLETED|Overall Study||9||
48179400|NCT03257995|100760107|FG004|COMPLETED|Overall Study||9||
48179401|NCT03257995|100760108|FG005|COMPLETED|Overall Study||7||
48179402|NCT03257995|100760103|FG000|NOT COMPLETED|Overall Study||0||
48179403|NCT03257995|100760104|FG001|NOT COMPLETED|Overall Study||1||
48179404|NCT03257995|100760105|FG002|NOT COMPLETED|Overall Study||0||
48179405|NCT03257995|100760106|FG003|NOT COMPLETED|Overall Study||0||
48179406|NCT03257995|100760107|FG004|NOT COMPLETED|Overall Study||0||
48340523|NCT03497845|101163852|FG004|NOT COMPLETED|Overall Study||21||
48340524|NCT03497845|101163853|FG005|NOT COMPLETED|Overall Study||18||
48179407|NCT03257995|100760108|FG005|NOT COMPLETED|Overall Study||2||
48179408|NCT01990300|100760109|FG000|STARTED|Overall Study||3281||
48179409|NCT01990300|100760109|FG000|COMPLETED|Overall Study||3139||
48179410|NCT01990300|100760109|FG000|NOT COMPLETED|Overall Study||142||
48179411|NCT01991197|100760110|FG000|STARTED|Overall Study||9||
48179412|NCT01991197|100760111|FG001|STARTED|Overall Study||11||
48179413|NCT01991197|100760110|FG000|COMPLETED|Overall Study||6||
48179414|NCT01991197|100760111|FG001|COMPLETED|Overall Study||8||
48179415|NCT01991197|100760110|FG000|NOT COMPLETED|Overall Study||3||
48179416|NCT01991197|100760111|FG001|NOT COMPLETED|Overall Study||3||
48179417|NCT02701582|100760112|FG000|STARTED|Overall Study||35||
48179418|NCT02701582|100760113|FG001|STARTED|Overall Study||33||
48179419|NCT02701582|100760112|FG000|COMPLETED|Overall Study||33||
48179420|NCT02701582|100760113|FG001|COMPLETED|Overall Study||33||
48179421|NCT02701582|100760112|FG000|NOT COMPLETED|Overall Study||2||
48179422|NCT02701582|100760113|FG001|NOT COMPLETED|Overall Study||0||
48179423|NCT01592695|100760114|FG000|STARTED|Overall Study||31||
48179424|NCT01592695|100760115|FG001|STARTED|Overall Study||32||
48179425|NCT01592695|100760114|FG000|COMPLETED|Overall Study||23||
48179426|NCT01592695|100760115|FG001|COMPLETED|Overall Study||28||
48179427|NCT01592695|100760114|FG000|NOT COMPLETED|Overall Study||8||
48179428|NCT01592695|100760115|FG001|NOT COMPLETED|Overall Study||4||
48179429|NCT05886777|100760116|FG000|STARTED|Overall Study||155||
48179430|NCT05886777|100760117|FG001|STARTED|Overall Study||154||
48340525|NCT03497845|101163854|FG006|NOT COMPLETED|Overall Study||8||
48340526|NCT03497845|101163855|FG007|NOT COMPLETED|Overall Study||10||
48340527|NCT03497845|101163856|FG008|NOT COMPLETED|Overall Study||14||
48340528|NCT03497845|101163857|FG009|NOT COMPLETED|Overall Study||6||
48340529|NCT03497845|101163858|FG010|NOT COMPLETED|Overall Study||15||
48340530|NCT03497845|101163859|FG011|NOT COMPLETED|Overall Study||22||
48413489|NCT02169466|101345839|FG003|50 mg BIA 9-1067|Overall Study||5||
48632290|NCT02870868|101885201|FG000|STARTED|Overall Study||49||
48632291|NCT02870868|101885202|FG001|STARTED|Overall Study||50||
48632292|NCT02870868|101885201|FG000|COMPLETED|Overall Study||47||
48632293|NCT02870868|101885202|FG001|COMPLETED|Overall Study||49||
48632294|NCT02870868|101885201|FG000|NOT COMPLETED|Overall Study||2||
48632295|NCT02870868|101885202|FG001|NOT COMPLETED|Overall Study||1||
48632296|NCT00109343|101885203|FG000|STARTED|Overall Study||510||
48340531|NCT01960855|101163860|FG000|STARTED|Overall Study||56||
48340532|NCT01960855|101163861|FG001|STARTED|Overall Study||55||
48340533|NCT01960855|101163862|FG002|STARTED|Overall Study||55||
48340534|NCT01960855|101163863|FG003|STARTED|Overall Study||55||
48340535|NCT01960855|101163864|FG004|STARTED|Overall Study||55||
48340536|NCT01960855|101163860|FG000|COMPLETED|Overall Study||45||
48632297|NCT00109343|101885204|FG001|STARTED|Overall Study||258||
48632298|NCT00109343|101885205|FG002|STARTED|Overall Study||259||
48340537|NCT01960855|101163861|FG001|COMPLETED|Overall Study||51||
48340538|NCT01960855|101163862|FG002|COMPLETED|Overall Study||46||
48340539|NCT01960855|101163863|FG003|COMPLETED|Overall Study||51||
48340540|NCT01960855|101163864|FG004|COMPLETED|Overall Study||50||
48340541|NCT01960855|101163860|FG000|NOT COMPLETED|Overall Study||11||
48632299|NCT00109343|101885203|FG000|Vaccinated at Visit 1|Overall Study||510||
48754561|NCT01539759|102187741|FG001|IUD Expulsion|Overall Study||4||
48754562|NCT01539759|102187740|FG000|IUD Removal|Overall Study||2||
48179431|NCT05886777|100760118|FG002|STARTED|Overall Study||152||
48179432|NCT05886777|100760119|FG003|STARTED|Overall Study||155||
48179433|NCT05886777|100760120|FG004|STARTED|Overall Study||151||
48179434|NCT05886777|100760121|FG005|STARTED|Overall Study||158||
48179435|NCT05886777|100760122|FG006|STARTED|Overall Study||158||
48179436|NCT05886777|100760116|FG000|COMPLETED|Overall Study||153||
48179437|NCT05886777|100760117|FG001|COMPLETED|Overall Study||151||
48179438|NCT05886777|100760118|FG002|COMPLETED|Overall Study||147||
48179439|NCT05886777|100760119|FG003|COMPLETED|Overall Study||150||
48179440|NCT05886777|100760120|FG004|COMPLETED|Overall Study||148||
48179441|NCT05886777|100760121|FG005|COMPLETED|Overall Study||155||
48179442|NCT05886777|100760122|FG006|COMPLETED|Overall Study||157||
48179443|NCT05886777|100760116|FG000|NOT COMPLETED|Overall Study||2||
48179444|NCT05886777|100760117|FG001|NOT COMPLETED|Overall Study||3||
48179445|NCT05886777|100760118|FG002|NOT COMPLETED|Overall Study||5||
48179446|NCT05886777|100760119|FG003|NOT COMPLETED|Overall Study||5||
48179447|NCT05886777|100760120|FG004|NOT COMPLETED|Overall Study||3||
48179448|NCT05886777|100760121|FG005|NOT COMPLETED|Overall Study||3||
48179449|NCT05886777|100760122|FG006|NOT COMPLETED|Overall Study||1||
48632300|NCT00109343|101885204|FG001|Vaccinated at Visit 1|Overall Study||258||
48632301|NCT00109343|101885205|FG002|Vaccinated at Visit 1|Overall Study||259||
48179450|NCT01823614|100760123|FG000|STARTED|Overall Study||179||
48179451|NCT01823614|100760124|FG001|STARTED|Overall Study||140||
48179452|NCT01823614|100760125|FG002|STARTED|Overall Study||176||
48179453|NCT01823614|100760126|FG003|STARTED|Overall Study||122||
48179454|NCT01823614|100760127|FG004|STARTED|Overall Study||172||
48179455|NCT01823614|100760128|FG005|STARTED|Overall Study||154||
48179456|NCT01823614|100760123|FG000|COMPLETED|Overall Study||179||
48179457|NCT01823614|100760124|FG001|COMPLETED|Overall Study||140||
48179458|NCT01823614|100760125|FG002|COMPLETED|Overall Study||176||
48179459|NCT01823614|100760126|FG003|COMPLETED|Overall Study||122||
48179460|NCT01823614|100760127|FG004|COMPLETED|Overall Study||172||
48179461|NCT01823614|100760128|FG005|COMPLETED|Overall Study||154||
48179462|NCT01823614|100760123|FG000|NOT COMPLETED|Overall Study||0||
48179463|NCT01823614|100760124|FG001|NOT COMPLETED|Overall Study||0||
48179464|NCT01823614|100760125|FG002|NOT COMPLETED|Overall Study||0||
48179465|NCT01823614|100760126|FG003|NOT COMPLETED|Overall Study||0||
48179466|NCT01823614|100760127|FG004|NOT COMPLETED|Overall Study||0||
48179467|NCT01823614|100760128|FG005|NOT COMPLETED|Overall Study||0||
48179468|NCT02243631|100760129|FG000|STARTED|Overall Study||3||
48179469|NCT02243631|100760130|FG001|STARTED|Overall Study||5||
48179470|NCT02243631|100760129|FG000|COMPLETED|Overall Study||3||
48179471|NCT02243631|100760130|FG001|COMPLETED|Overall Study||4||
48179472|NCT02243631|100760129|FG000|NOT COMPLETED|Overall Study||0||
48179473|NCT02243631|100760130|FG001|NOT COMPLETED|Overall Study||1||
48179474|NCT01208415|100760131|FG000|STARTED|Overall Study||40||
48179475|NCT01208415|100760131|FG000|6 Months|Overall Study||37||
48179476|NCT01208415|100760131|FG000|COMPLETED|Overall Study||0||
48179477|NCT01208415|100760131|FG000|NOT COMPLETED|Overall Study||40||
48179478|NCT01010217|100760132|FG000|STARTED|Overall Study||89||
48179479|NCT01010217|100760133|FG001|STARTED|Overall Study||56||
48179480|NCT01010217|100760134|FG002|STARTED|Overall Study||22||
48179481|NCT01010217|100760135|FG003|STARTED|Overall Study||6||
48179482|NCT01010217|100760136|FG004|STARTED|Overall Study||3||
48179483|NCT01010217|100760132|FG000|COMPLETED|Overall Study||84||
48179484|NCT01010217|100760133|FG001|COMPLETED|Overall Study||51||
48179485|NCT01010217|100760134|FG002|COMPLETED|Overall Study||21||
48179486|NCT01010217|100760135|FG003|COMPLETED|Overall Study||0||
48179487|NCT01010217|100760136|FG004|COMPLETED|Overall Study||0||
48179488|NCT01010217|100760132|FG000|NOT COMPLETED|Overall Study||5||
48179489|NCT01010217|100760133|FG001|NOT COMPLETED|Overall Study||5||
48179490|NCT01010217|100760134|FG002|NOT COMPLETED|Overall Study||1||
48179491|NCT01010217|100760135|FG003|NOT COMPLETED|Overall Study||6||
48179492|NCT01010217|100760136|FG004|NOT COMPLETED|Overall Study||3||
48179493|NCT01083160|100760137|FG000|STARTED|Overall Study||82||
48179494|NCT01083160|100760137|FG000|Evaluable Population|Overall Study||71||
48179495|NCT01083160|100760137|FG000|COMPLETED|Overall Study||81||
48179496|NCT01083160|100760137|FG000|NOT COMPLETED|Overall Study||1||
48340542|NCT01960855|101163861|FG001|NOT COMPLETED|Overall Study||4||
48340543|NCT01960855|101163862|FG002|NOT COMPLETED|Overall Study||9||
48340544|NCT01960855|101163863|FG003|NOT COMPLETED|Overall Study||4||
48340545|NCT01960855|101163864|FG004|NOT COMPLETED|Overall Study||5||
48632302|NCT00109343|101885203|FG000|Vaccinated at Visit 2|Overall Study||0||
48179497|NCT00709592|100760138|FG000|STARTED|Overall Study||19||
48632303|NCT00109343|101885204|FG001|Vaccinated at Visit 2|Overall Study||246||
48179498|NCT00709592|100760139|FG001|STARTED|Overall Study||23||
48632304|NCT00109343|101885205|FG002|Vaccinated at Visit 2|Overall Study||246||
48179499|NCT00709592|100760138|FG000|COMPLETED|Overall Study||19||
48179500|NCT00709592|100760139|FG001|COMPLETED|Overall Study||22||
48179501|NCT00709592|100760138|FG000|NOT COMPLETED|Overall Study||0||
48179502|NCT00709592|100760139|FG001|NOT COMPLETED|Overall Study||1||
48179503|NCT02874066|100760140|FG000|STARTED|Overall Study||46||
48179504|NCT02874066|100760140|FG000|COMPLETED|Overall Study||46||
48179505|NCT02874066|100760140|FG000|NOT COMPLETED|Overall Study||0||
48179506|NCT01681368|100760141|FG000|STARTED|Overall Study||11||
48340546|NCT00620061|101163865|FG000|STARTED|Overall Study||439||
48340547|NCT00620061|101163865|FG000|COMPLETED|Overall Study||286||
48340548|NCT00620061|101163865|FG000|NOT COMPLETED|Overall Study||153||
48340549|NCT03403192|101163866|FG000|STARTED|Overall Study||41||
48179507|NCT01681368|100760141|FG000|COMPLETED|Overall Study||9||
48179508|NCT01681368|100760141|FG000|NOT COMPLETED|Overall Study||2||
48179509|NCT01186328|100760142|FG000|STARTED|Overall Study||6||
48340550|NCT03403192|101163867|FG001|STARTED|Overall Study||40||
48340551|NCT03403192|101163868|FG002|STARTED|Overall Study||40||
48179510|NCT01186328|100760143|FG001|STARTED|Overall Study||0||
48179511|NCT01186328|100760144|FG002|STARTED|Overall Study||0||
48179512|NCT01186328|100760142|FG000|COMPLETED|Overall Study||5||
48179513|NCT01186328|100760143|FG001|COMPLETED|Overall Study||0||
48179514|NCT01186328|100760144|FG002|COMPLETED|Overall Study||0||
48179515|NCT01186328|100760142|FG000|NOT COMPLETED|Overall Study||1||
48179516|NCT01186328|100760143|FG001|NOT COMPLETED|Overall Study||0||
48179517|NCT01186328|100760144|FG002|NOT COMPLETED|Overall Study||0||
48179518|NCT02326844|100761770|FG000|STARTED|Overall Study||3||
48179519|NCT02326844|100761770|FG000|COMPLETED|Overall Study||3||
48179520|NCT02326844|100761770|FG000|NOT COMPLETED|Overall Study||0||
48179521|NCT02771210|100761771|FG000|STARTED|Period 1||102||
48179522|NCT02771210|100761772|FG001|STARTED|Period 1||102||
48179523|NCT02771210|100761771|FG000|COMPLETED|Period 1||91||
48179524|NCT02771210|100761772|FG001|COMPLETED|Period 1||84||
48179525|NCT02771210|100761771|FG000|NOT COMPLETED|Period 1||11||
48179526|NCT02771210|100761772|FG001|NOT COMPLETED|Period 1||18||
48179527|NCT02771210|100761771|FG000|STARTED|Period 2||91|Completed treatment period 1 and continued to treatment period 2|
48179528|NCT02771210|100761772|FG001|STARTED|Period 2||84|Completed treatment period 1 and continued to treatment period 2|
48179529|NCT02771210|100761771|FG000|COMPLETED|Period 2||89||
48179530|NCT02771210|100761772|FG001|COMPLETED|Period 2||81||
48179531|NCT02771210|100761771|FG000|NOT COMPLETED|Period 2||2||
48179532|NCT02771210|100761772|FG001|NOT COMPLETED|Period 2||3||
48179533|NCT04814186|100761773|FG000|STARTED|Treatment Phase||53||
48179534|NCT04814186|100761773|FG000|COMPLETED|Treatment Phase||43||
48179535|NCT04814186|100761773|FG000|NOT COMPLETED|Treatment Phase||10||
48179536|NCT04814186|100761773|FG000|STARTED|Follow-Up Phase||53||
48179537|NCT04814186|100761773|FG000|COMPLETED|Follow-Up Phase||44||
48179538|NCT04814186|100761773|FG000|NOT COMPLETED|Follow-Up Phase||9||
48179539|NCT01544491|100761774|FG000|STARTED|Overall Study||52||
48179540|NCT01544491|100761775|FG001|STARTED|Overall Study||54||
48179541|NCT01544491|100761774|FG000|COMPLETED|Overall Study||47||
48179542|NCT01544491|100761775|FG001|COMPLETED|Overall Study||51||
48179543|NCT01544491|100761774|FG000|NOT COMPLETED|Overall Study||5||
48179544|NCT01544491|100761775|FG001|NOT COMPLETED|Overall Study||3||
48179545|NCT02942004|100761776|FG000|STARTED|Overall Study||46||
48179546|NCT02942004|100761777|FG001|STARTED|Overall Study||47||
48179547|NCT02942004|100761778|FG002|STARTED|Overall Study||45||
48179548|NCT02942004|100761776|FG000|Participants Who Received Study Drug|Overall Study||43||
48179549|NCT02942004|100761777|FG001|Participants Who Received Study Drug|Overall Study||38||
48179550|NCT02942004|100761778|FG002|Participants Who Received Study Drug|Overall Study||41||
48179551|NCT02942004|100761776|FG000|COMPLETED|Overall Study||42||
48179552|NCT02942004|100761777|FG001|COMPLETED|Overall Study||35||
48179553|NCT02942004|100761778|FG002|COMPLETED|Overall Study||36||
48179554|NCT02942004|100761776|FG000|NOT COMPLETED|Overall Study||4||
48179555|NCT02942004|100761777|FG001|NOT COMPLETED|Overall Study||12||
48179556|NCT02942004|100761778|FG002|NOT COMPLETED|Overall Study||9||
48179557|NCT04838626|100761779|FG000|STARTED|Overall Study||195||
48179558|NCT04838626|100761779|FG000|Participants Who Received Vidoflufolastat (18F) and Underwent PET/CT|Overall Study||184||
48179559|NCT04838626|100761779|FG000|COMPLETED|Overall Study||173||
48179560|NCT04838626|100761779|FG000|NOT COMPLETED|Overall Study||22||
48179561|NCT03930186|100761780|FG000|STARTED|Weeks 0 to 16||152||
48179562|NCT03930186|100761780|FG000|Received Study Drug|Weeks 0 to 16||152||
48179563|NCT03930186|100761780|FG000|COMPLETED|Weeks 0 to 16||140||
48179564|NCT03930186|100761780|FG000|NOT COMPLETED|Weeks 0 to 16||12||
48179565|NCT03930186|100761780|FG000|STARTED|Weeks 16 to 32||140||
48179566|NCT03930186|100761780|FG000|COMPLETED|Weeks 16 to 32||136||
48179567|NCT03930186|100761780|FG000|NOT COMPLETED|Weeks 16 to 32||4||
48179568|NCT01163149|100761781|FG000|STARTED|Primary Treatment Period||7||
48179569|NCT01163149|100761782|FG001|STARTED|Primary Treatment Period||6||
48179570|NCT01163149|100761783|FG002|STARTED|Primary Treatment Period||6||
48179571|NCT01163149|100761781|FG000|COMPLETED|Primary Treatment Period||7||
48340552|NCT03403192|101163869|FG003|STARTED|Overall Study||42||
48340553|NCT03403192|101163866|FG000|COMPLETED|Overall Study||37||
48179572|NCT01163149|100761782|FG001|COMPLETED|Primary Treatment Period||6||
48179573|NCT01163149|100761783|FG002|COMPLETED|Primary Treatment Period||6||
48179574|NCT01163149|100761781|FG000|NOT COMPLETED|Primary Treatment Period||0||
48340554|NCT03403192|101163867|FG001|COMPLETED|Overall Study||36||
48340555|NCT03403192|101163868|FG002|COMPLETED|Overall Study||37||
48340556|NCT03403192|101163869|FG003|COMPLETED|Overall Study||36||
48179575|NCT01163149|100761782|FG001|NOT COMPLETED|Primary Treatment Period||0||
48179576|NCT01163149|100761783|FG002|NOT COMPLETED|Primary Treatment Period||0||
48179577|NCT01163149|100761781|FG000|STARTED|Extension Treatment Period||7||
48179578|NCT01163149|100761782|FG001|STARTED|Extension Treatment Period||6||
48179579|NCT01163149|100761783|FG002|STARTED|Extension Treatment Period||6||
48179580|NCT01163149|100761781|FG000|COMPLETED|Extension Treatment Period||5||
48179581|NCT01163149|100761782|FG001|COMPLETED|Extension Treatment Period||5||
48179582|NCT01163149|100761783|FG002|COMPLETED|Extension Treatment Period||4||
48179583|NCT01163149|100761781|FG000|NOT COMPLETED|Extension Treatment Period||2||
48179584|NCT01163149|100761782|FG001|NOT COMPLETED|Extension Treatment Period||1||
48179585|NCT01163149|100761783|FG002|NOT COMPLETED|Extension Treatment Period||2||
48179586|NCT03122886|100761784|FG000|STARTED|Overall Study||10||
48179587|NCT03122886|100761785|FG001|STARTED|Overall Study||9||
48179588|NCT03122886|100761784|FG000|COMPLETED|Overall Study||9||
48179589|NCT03122886|100761785|FG001|COMPLETED|Overall Study||7||
48179590|NCT03122886|100761784|FG000|NOT COMPLETED|Overall Study||1||
48179591|NCT03122886|100761785|FG001|NOT COMPLETED|Overall Study||2||
48179592|NCT04163991|100761786|FG000|STARTED|Overall Study||16||
48179593|NCT04163991|100761787|FG001|STARTED|Overall Study||16||
48179594|NCT04163991|100761788|FG002|STARTED|Overall Study||16||
48179595|NCT04163991|100761789|FG003|STARTED|Overall Study||15||
48179596|NCT04163991|100761790|FG004|STARTED|Overall Study||15||
48179597|NCT04163991|100761786|FG000|COMPLETED|Overall Study||15||
48179598|NCT04163991|100761787|FG001|COMPLETED|Overall Study||13||
48179599|NCT04163991|100761788|FG002|COMPLETED|Overall Study||11||
48179600|NCT04163991|100761789|FG003|COMPLETED|Overall Study||12||
48179601|NCT04163991|100761790|FG004|COMPLETED|Overall Study||14||
48179602|NCT04163991|100761786|FG000|NOT COMPLETED|Overall Study||1||
48179603|NCT04163991|100761787|FG001|NOT COMPLETED|Overall Study||3||
48179604|NCT04163991|100761788|FG002|NOT COMPLETED|Overall Study||5||
48179605|NCT04163991|100761789|FG003|NOT COMPLETED|Overall Study||3||
48179606|NCT04163991|100761790|FG004|NOT COMPLETED|Overall Study||1||
48179607|NCT03232138|100761791|FG000|STARTED|Overall Study||21||
48179608|NCT03232138|100761792|FG001|STARTED|Overall Study||22||
48179609|NCT03232138|100761791|FG000|COMPLETED|Overall Study||17||
48179610|NCT03232138|100761792|FG001|COMPLETED|Overall Study||20||
48179611|NCT03232138|100761791|FG000|NOT COMPLETED|Overall Study||4||
48179612|NCT03232138|100761792|FG001|NOT COMPLETED|Overall Study||2||
48179613|NCT04612049|100761793|FG000|STARTED|Overall Study||12||
48179614|NCT04612049|100761794|FG001|STARTED|Overall Study||0||
48179615|NCT04612049|100761793|FG000|COMPLETED|Overall Study||12||
48179616|NCT04612049|100761794|FG001|COMPLETED|Overall Study||0||
48179617|NCT04612049|100761793|FG000|NOT COMPLETED|Overall Study||0||
48179618|NCT04612049|100761794|FG001|NOT COMPLETED|Overall Study||0||
48179619|NCT04997148|100761795|FG000|STARTED|Overall Study||116||
48179620|NCT04997148|100761795|FG000|COMPLETED|Overall Study||116||
48179621|NCT04997148|100761795|FG000|NOT COMPLETED|Overall Study||0||
48179622|NCT04581824|100761796|FG000|STARTED|Overall Study||121||
48179623|NCT04581824|100761797|FG001|STARTED|Overall Study||122||
48179624|NCT04581824|100761796|FG000|COMPLETED|Overall Study||42|Participants who completed follow-up or died due to any reason were considered as completed.|
48179625|NCT04581824|100761797|FG001|COMPLETED|Overall Study||48|Participants who completed follow-up or died due to any reason were considered as completed.|
48179626|NCT04581824|100761796|FG000|NOT COMPLETED|Overall Study||79||
48179627|NCT04581824|100761797|FG001|NOT COMPLETED|Overall Study||74||
48179628|NCT02021461|100761798|FG000|STARTED|Overall Study||38||
48179629|NCT02021461|100761798|FG000|COMPLETED|Overall Study||38||
48179630|NCT02021461|100761798|FG000|NOT COMPLETED|Overall Study||0||
48179631|NCT02723591|100761799|FG000|STARTED|Overall Study||300||
48179632|NCT02723591|100761800|FG001|STARTED|Overall Study||299||
48179633|NCT02723591|100761799|FG000|COMPLETED|Overall Study||204||
48179634|NCT02723591|100761800|FG001|COMPLETED|Overall Study||198||
48179635|NCT02723591|100761799|FG000|NOT COMPLETED|Overall Study||96||
48179636|NCT02723591|100761800|FG001|NOT COMPLETED|Overall Study||101||
48179637|NCT00170573|100761801|FG000|STARTED|Overall Study||77||
48179638|NCT00170573|100761801|FG000|COMPLETED|Overall Study||64||
48179639|NCT00170573|100761801|FG000|NOT COMPLETED|Overall Study||13||
48179640|NCT03677128|100761802|FG000|STARTED|Overall Study||46||
48179641|NCT03677128|100761803|FG001|STARTED|Overall Study||29||
48179642|NCT03677128|100761804|FG002|STARTED|Overall Study||63||
48179643|NCT03677128|100761805|FG003|STARTED|Overall Study||25||
48179644|NCT03677128|100761806|FG004|STARTED|Overall Study||4||
48179645|NCT03677128|100761802|FG000|COMPLETED|Overall Study||36||
48179646|NCT03677128|100761803|FG001|COMPLETED|Overall Study||16||
48179647|NCT03677128|100761804|FG002|COMPLETED|Overall Study||63||
48179648|NCT03677128|100761805|FG003|COMPLETED|Overall Study||25||
48179649|NCT03677128|100761806|FG004|COMPLETED|Overall Study||4||
48179650|NCT03677128|100761802|FG000|NOT COMPLETED|Overall Study||10||
48179651|NCT03677128|100761803|FG001|NOT COMPLETED|Overall Study||13||
48179652|NCT03677128|100761804|FG002|NOT COMPLETED|Overall Study||0||
48179653|NCT03677128|100761805|FG003|NOT COMPLETED|Overall Study||0||
48179654|NCT03677128|100761806|FG004|NOT COMPLETED|Overall Study||0||
48179655|NCT03138512|100761807|FG000|STARTED|Randomization||405||
48179656|NCT03138512|100761808|FG001|STARTED|Randomization||411||
48179657|NCT03138512|100761809|FG002|STARTED|Randomization||206||
48179658|NCT03138512|100761810|FG003|STARTED|Randomization||208||
48179659|NCT03138512|100761811|FG004|STARTED|Randomization||411||
48179660|NCT03138512|100761807|FG000|COMPLETED|Randomization||404|Continuing to Treatment|
48179661|NCT03138512|100761808|FG001|COMPLETED|Randomization||407|Continuing to Treatment|
48179662|NCT03138512|100761809|FG002|COMPLETED|Randomization||204|Continuing to Treatment|
48179663|NCT03138512|100761810|FG003|COMPLETED|Randomization||207|Continuing to Treatment|
48179664|NCT03138512|100761811|FG004|COMPLETED|Randomization||408|Continuing to Treatment|
48179665|NCT03138512|100761807|FG000|NOT COMPLETED|Randomization||1||
48179666|NCT03138512|100761808|FG001|NOT COMPLETED|Randomization||4||
48179667|NCT03138512|100761809|FG002|NOT COMPLETED|Randomization||2||
48179668|NCT03138512|100761810|FG003|NOT COMPLETED|Randomization||1||
48179669|NCT03138512|100761811|FG004|NOT COMPLETED|Randomization||3||
48179670|NCT03138512|100761807|FG000|STARTED|Treatment Part A||404||
48179671|NCT03138512|100761808|FG001|STARTED|Treatment Part A||407||
48179672|NCT03138512|100761809|FG002|STARTED|Treatment Part A||0||
48179673|NCT03138512|100761810|FG003|STARTED|Treatment Part A||0||
48179674|NCT03138512|100761811|FG004|STARTED|Treatment Part A||0||
48179675|NCT03138512|100761807|FG000|COMPLETED|Treatment Part A||229||
48179676|NCT03138512|100761808|FG001|COMPLETED|Treatment Part A||360||
48179677|NCT03138512|100761809|FG002|COMPLETED|Treatment Part A||0||
48179678|NCT03138512|100761810|FG003|COMPLETED|Treatment Part A||0||
48179679|NCT03138512|100761811|FG004|COMPLETED|Treatment Part A||0||
48179680|NCT03138512|100761807|FG000|NOT COMPLETED|Treatment Part A||175||
48179681|NCT03138512|100761808|FG001|NOT COMPLETED|Treatment Part A||47||
48179682|NCT03138512|100761809|FG002|NOT COMPLETED|Treatment Part A||0||
48179683|NCT03138512|100761810|FG003|NOT COMPLETED|Treatment Part A||0||
48179684|NCT03138512|100761811|FG004|NOT COMPLETED|Treatment Part A||0||
48179685|NCT03138512|100761807|FG000|STARTED|Treatment Part B||0||
48179686|NCT03138512|100761808|FG001|STARTED|Treatment Part B||0||
48179687|NCT03138512|100761809|FG002|STARTED|Treatment Part B||204||
48179688|NCT03138512|100761810|FG003|STARTED|Treatment Part B||207||
48179689|NCT03138512|100761811|FG004|STARTED|Treatment Part B||408||
48179690|NCT03138512|100761807|FG000|COMPLETED|Treatment Part B||0||
48179691|NCT03138512|100761808|FG001|COMPLETED|Treatment Part B||0||
48179692|NCT03138512|100761809|FG002|COMPLETED|Treatment Part B||118||
48179693|NCT03138512|100761810|FG003|COMPLETED|Treatment Part B||182||
48179694|NCT03138512|100761811|FG004|COMPLETED|Treatment Part B||327||
48179695|NCT03138512|100761807|FG000|NOT COMPLETED|Treatment Part B||0||
48179696|NCT03138512|100761808|FG001|NOT COMPLETED|Treatment Part B||0||
48179697|NCT03138512|100761809|FG002|NOT COMPLETED|Treatment Part B||86||
48179698|NCT03138512|100761810|FG003|NOT COMPLETED|Treatment Part B||25||
48179699|NCT03138512|100761811|FG004|NOT COMPLETED|Treatment Part B||81||
48179700|NCT04716881|100761812|FG000|STARTED|Overall Study||9||
48179701|NCT04716881|100761812|FG000|COMPLETED|Overall Study||7||
48179702|NCT04716881|100761812|FG000|NOT COMPLETED|Overall Study||2||
48179703|NCT02287610|100761813|FG000|STARTED|Overall Study||64||
48179704|NCT02287610|100761813|FG000|Per Protocol Follow-Up|Overall Study||56||
48179705|NCT02287610|100761813|FG000|COMPLETED|Overall Study||48||
48179706|NCT02287610|100761813|FG000|NOT COMPLETED|Overall Study||16||
48179707|NCT04158648|100761814|FG000|STARTED|Overall Study||73|All Participants Population|
48179708|NCT04158648|100761814|FG000|Received at Least One Dose of Study Drug|Overall Study||72|Treated Population|
48179709|NCT04158648|100761814|FG000|Completed 24 Weeks in the Study|Overall Study||71||
48179710|NCT04158648|100761814|FG000|Completed 52 Weeks in the Study|Overall Study||57||
48179711|NCT04158648|100761814|FG000|COMPLETED|Overall Study||0||
48179712|NCT04158648|100761814|FG000|NOT COMPLETED|Overall Study||73||
48179713|NCT03770273|100761815|FG000|STARTED|Overall Study||8||
48179714|NCT03770273|100761816|FG001|STARTED|Overall Study||8||
48179715|NCT03770273|100761815|FG000|COMPLETED|Overall Study||5||
48179716|NCT03770273|100761816|FG001|COMPLETED|Overall Study||7||
48179717|NCT03770273|100761815|FG000|NOT COMPLETED|Overall Study||3||
48179718|NCT03770273|100761816|FG001|NOT COMPLETED|Overall Study||1||
48179719|NCT00434837|100761817|FG000|STARTED|Overall Study||46||
48179720|NCT00434837|100761818|FG001|STARTED|Overall Study||44||
48179721|NCT00434837|100761819|FG002|STARTED|Overall Study||60||
48179722|NCT00434837|100761817|FG000|6 Months|Overall Study||39||
48179723|NCT00434837|100761818|FG001|6 Months|Overall Study||37||
48632305|NCT00109343|101885203|FG000|Vaccinated at Visit 4|Overall Study||466||
48632306|NCT00109343|101885204|FG001|Vaccinated at Visit 4|Overall Study||235||
48632307|NCT00109343|101885205|FG002|Vaccinated at Visit 4|Overall Study||240||
48632308|NCT00109343|101885203|FG000|COMPLETED|Overall Study||446||
48632309|NCT00109343|101885204|FG001|COMPLETED|Overall Study||221||
48632310|NCT00109343|101885205|FG002|COMPLETED|Overall Study||229||
48632311|NCT00109343|101885203|FG000|NOT COMPLETED|Overall Study||64||
48632312|NCT00109343|101885204|FG001|NOT COMPLETED|Overall Study||37||
48632313|NCT00109343|101885205|FG002|NOT COMPLETED|Overall Study||30||
48632314|NCT00945243|101885206|FG000|STARTED|Overall Study||11||
48632315|NCT00945243|101885206|FG000|COMPLETED|Overall Study||8||
48179724|NCT00434837|100761819|FG002|6 Months|Overall Study||0||
48179725|NCT00434837|100761817|FG000|1 Year|Overall Study||35||
48179726|NCT00434837|100761818|FG001|1 Year|Overall Study||34||
48179727|NCT00434837|100761819|FG002|1 Year|Overall Study||48||
48632316|NCT00945243|101885206|FG000|NOT COMPLETED|Overall Study||3||
48179728|NCT00434837|100761817|FG000|3 Years|Overall Study||44||
48179729|NCT00434837|100761818|FG001|3 Years|Overall Study||41||
48179730|NCT00434837|100761819|FG002|3 Years|Overall Study||48||
48179731|NCT00434837|100761817|FG000|7 Years|Overall Study||36||
48179732|NCT00434837|100761818|FG001|7 Years|Overall Study||36||
48179733|NCT00434837|100761819|FG002|7 Years|Overall Study||34||
48179734|NCT00434837|100761817|FG000|10-12 Years|Overall Study||32||
48632317|NCT02371616|101885207|FG000|STARTED|Overall Study||150||
48179735|NCT00434837|100761818|FG001|10-12 Years|Overall Study||28||
48340557|NCT03403192|101163866|FG000|NOT COMPLETED|Overall Study||4||
48340558|NCT03403192|101163867|FG001|NOT COMPLETED|Overall Study||4||
48179736|NCT00434837|100761819|FG002|10-12 Years|Overall Study||35||
48179737|NCT00434837|100761817|FG000|COMPLETED|Overall Study||26||
48179738|NCT00434837|100761818|FG001|COMPLETED|Overall Study||21||
48179739|NCT00434837|100761819|FG002|COMPLETED|Overall Study||30||
48179740|NCT00434837|100761817|FG000|NOT COMPLETED|Overall Study||20||
48179741|NCT00434837|100761818|FG001|NOT COMPLETED|Overall Study||23||
48179742|NCT00434837|100761819|FG002|NOT COMPLETED|Overall Study||30||
48179743|NCT04214418|100761820|FG000|STARTED|Overall Study||10||
48179744|NCT04214418|100761821|FG001|STARTED|Overall Study||4||
48179745|NCT04214418|100761822|FG002|STARTED|Overall Study||0||
48179746|NCT04214418|100761823|FG003|STARTED|Overall Study||0||
48179747|NCT04214418|100761824|FG004|STARTED|Overall Study||0||
48179748|NCT04214418|100761825|FG005|STARTED|Overall Study||0||
48179749|NCT04214418|100761820|FG000|COMPLETED|Overall Study||8||
48179750|NCT04214418|100761821|FG001|COMPLETED|Overall Study||2||
48179751|NCT04214418|100761822|FG002|COMPLETED|Overall Study||0||
48179752|NCT04214418|100761823|FG003|COMPLETED|Overall Study||0||
48179753|NCT04214418|100761824|FG004|COMPLETED|Overall Study||0||
48179754|NCT04214418|100761825|FG005|COMPLETED|Overall Study||0||
48179755|NCT04214418|100761820|FG000|NOT COMPLETED|Overall Study||2||
48179756|NCT04214418|100761821|FG001|NOT COMPLETED|Overall Study||2||
48179757|NCT04214418|100761822|FG002|NOT COMPLETED|Overall Study||0||
48179758|NCT04214418|100761823|FG003|NOT COMPLETED|Overall Study||0||
48179759|NCT04214418|100761824|FG004|NOT COMPLETED|Overall Study||0||
48179760|NCT04214418|100761825|FG005|NOT COMPLETED|Overall Study||0||
48179761|NCT04585815|100761826|FG000|STARTED|Sub-study A- Treatment Phase||4||
48340559|NCT03403192|101163868|FG002|NOT COMPLETED|Overall Study||3||
48340560|NCT03403192|101163869|FG003|NOT COMPLETED|Overall Study||6||
48340561|NCT01929135|101163870|FG000|STARTED|Overall Study||19||
48340562|NCT01929135|101163871|FG001|STARTED|Overall Study||19||
48340563|NCT01929135|101163870|FG000|COMPLETED|Overall Study||18||
48179762|NCT04585815|100761827|FG001|STARTED|Sub-study A- Treatment Phase||9||
48179763|NCT04585815|100761828|FG002|STARTED|Sub-study A- Treatment Phase||0||
48179764|NCT04585815|100761829|FG003|STARTED|Sub-study A- Treatment Phase||0||
48179765|NCT04585815|100761830|FG004|STARTED|Sub-study A- Treatment Phase||0||
48179766|NCT04585815|100761831|FG005|STARTED|Sub-study A- Treatment Phase||0||
48179767|NCT04585815|100761832|FG006|STARTED|Sub-study A- Treatment Phase||0||
48179768|NCT04585815|100761826|FG000|COMPLETED|Sub-study A- Treatment Phase||0||
48179769|NCT04585815|100761827|FG001|COMPLETED|Sub-study A- Treatment Phase||0||
48179770|NCT04585815|100761828|FG002|COMPLETED|Sub-study A- Treatment Phase||0||
48179771|NCT04585815|100761829|FG003|COMPLETED|Sub-study A- Treatment Phase||0||
48179772|NCT04585815|100761830|FG004|COMPLETED|Sub-study A- Treatment Phase||0||
48179773|NCT04585815|100761831|FG005|COMPLETED|Sub-study A- Treatment Phase||0||
48179774|NCT04585815|100761832|FG006|COMPLETED|Sub-study A- Treatment Phase||0||
48179775|NCT04585815|100761826|FG000|NOT COMPLETED|Sub-study A- Treatment Phase||4||
48179776|NCT04585815|100761827|FG001|NOT COMPLETED|Sub-study A- Treatment Phase||9||
48179777|NCT04585815|100761828|FG002|NOT COMPLETED|Sub-study A- Treatment Phase||0||
48179778|NCT04585815|100761829|FG003|NOT COMPLETED|Sub-study A- Treatment Phase||0||
48179779|NCT04585815|100761830|FG004|NOT COMPLETED|Sub-study A- Treatment Phase||0||
48179780|NCT04585815|100761831|FG005|NOT COMPLETED|Sub-study A- Treatment Phase||0||
48179781|NCT04585815|100761832|FG006|NOT COMPLETED|Sub-study A- Treatment Phase||0||
48179782|NCT04585815|100761826|FG000|STARTED|Sub-study A- Follow-up Phase||0||
48179783|NCT04585815|100761827|FG001|STARTED|Sub-study A- Follow-up Phase||1||
48340564|NCT01929135|101163871|FG001|COMPLETED|Overall Study||18||
48754563|NCT01539759|102187741|FG001|IUD Removal|Overall Study||7||
48179784|NCT04585815|100761828|FG002|STARTED|Sub-study A- Follow-up Phase||0||
48179785|NCT04585815|100761829|FG003|STARTED|Sub-study A- Follow-up Phase||0||
48179786|NCT04585815|100761830|FG004|STARTED|Sub-study A- Follow-up Phase||0||
48179787|NCT04585815|100761831|FG005|STARTED|Sub-study A- Follow-up Phase||0||
48179788|NCT04585815|100761832|FG006|STARTED|Sub-study A- Follow-up Phase||0||
48179789|NCT04585815|100761826|FG000|COMPLETED|Sub-study A- Follow-up Phase||0||
48179790|NCT04585815|100761827|FG001|COMPLETED|Sub-study A- Follow-up Phase||0||
48179791|NCT04585815|100761828|FG002|COMPLETED|Sub-study A- Follow-up Phase||0||
48179792|NCT04585815|100761829|FG003|COMPLETED|Sub-study A- Follow-up Phase||0||
48179793|NCT04585815|100761830|FG004|COMPLETED|Sub-study A- Follow-up Phase||0||
48179794|NCT04585815|100761831|FG005|COMPLETED|Sub-study A- Follow-up Phase||0||
48179795|NCT04585815|100761832|FG006|COMPLETED|Sub-study A- Follow-up Phase||0||
48179796|NCT04585815|100761826|FG000|NOT COMPLETED|Sub-study A- Follow-up Phase||0||
48179797|NCT04585815|100761827|FG001|NOT COMPLETED|Sub-study A- Follow-up Phase||1||
48340565|NCT01929135|101163870|FG000|NOT COMPLETED|Overall Study||1||
48340566|NCT01929135|101163871|FG001|NOT COMPLETED|Overall Study||1||
48340567|NCT03038308|101163872|FG000|STARTED|Overall Study||15||
48179798|NCT04585815|100761828|FG002|NOT COMPLETED|Sub-study A- Follow-up Phase||0||
48179799|NCT04585815|100761829|FG003|NOT COMPLETED|Sub-study A- Follow-up Phase||0||
48179800|NCT04585815|100761830|FG004|NOT COMPLETED|Sub-study A- Follow-up Phase||0||
48179801|NCT04585815|100761831|FG005|NOT COMPLETED|Sub-study A- Follow-up Phase||0||
48179802|NCT04585815|100761832|FG006|NOT COMPLETED|Sub-study A- Follow-up Phase||0||
48179803|NCT04585815|100761826|FG000|STARTED|Sub-study B- Treatment Phase||0||
48179804|NCT04585815|100761827|FG001|STARTED|Sub-study B- Treatment Phase||0||
48179805|NCT04585815|100761828|FG002|STARTED|Sub-study B- Treatment Phase||3||
48179806|NCT04585815|100761829|FG003|STARTED|Sub-study B- Treatment Phase||6||
48179807|NCT04585815|100761830|FG004|STARTED|Sub-study B- Treatment Phase||3||
48179808|NCT04585815|100761831|FG005|STARTED|Sub-study B- Treatment Phase||2||
48179809|NCT04585815|100761832|FG006|STARTED|Sub-study B- Treatment Phase||7||
48179810|NCT04585815|100761826|FG000|COMPLETED|Sub-study B- Treatment Phase||0||
48179811|NCT04585815|100761827|FG001|COMPLETED|Sub-study B- Treatment Phase||0||
48179812|NCT04585815|100761828|FG002|COMPLETED|Sub-study B- Treatment Phase||0||
48179813|NCT04585815|100761829|FG003|COMPLETED|Sub-study B- Treatment Phase||0||
48179814|NCT04585815|100761830|FG004|COMPLETED|Sub-study B- Treatment Phase||0||
48179815|NCT04585815|100761831|FG005|COMPLETED|Sub-study B- Treatment Phase||0||
48179816|NCT04585815|100761832|FG006|COMPLETED|Sub-study B- Treatment Phase||0||
48179817|NCT04585815|100761826|FG000|NOT COMPLETED|Sub-study B- Treatment Phase||0||
48179818|NCT04585815|100761827|FG001|NOT COMPLETED|Sub-study B- Treatment Phase||0||
48179819|NCT04585815|100761828|FG002|NOT COMPLETED|Sub-study B- Treatment Phase||3||
48179820|NCT04585815|100761829|FG003|NOT COMPLETED|Sub-study B- Treatment Phase||6||
48179821|NCT04585815|100761830|FG004|NOT COMPLETED|Sub-study B- Treatment Phase||3||
48179822|NCT04585815|100761831|FG005|NOT COMPLETED|Sub-study B- Treatment Phase||2||
48179823|NCT04585815|100761832|FG006|NOT COMPLETED|Sub-study B- Treatment Phase||7||
48632318|NCT02371616|101885208|FG001|STARTED|Overall Study||154||
48632319|NCT02371616|101885207|FG000|COMPLETED|Overall Study||146||
48632320|NCT02371616|101885208|FG001|COMPLETED|Overall Study||147||
48632321|NCT02371616|101885207|FG000|NOT COMPLETED|Overall Study||4||
48632322|NCT02371616|101885208|FG001|NOT COMPLETED|Overall Study||7||
48179824|NCT04585815|100761826|FG000|STARTED|Sub-study B- Follow-up Phase||0||
48179825|NCT04585815|100761827|FG001|STARTED|Sub-study B- Follow-up Phase||0||
48179826|NCT04585815|100761828|FG002|STARTED|Sub-study B- Follow-up Phase||2||
48179827|NCT04585815|100761829|FG003|STARTED|Sub-study B- Follow-up Phase||3||
48179828|NCT04585815|100761830|FG004|STARTED|Sub-study B- Follow-up Phase||1||
48179829|NCT04585815|100761831|FG005|STARTED|Sub-study B- Follow-up Phase||1||
48340568|NCT03038308|101163872|FG000|COMPLETED|Overall Study||11||
48340569|NCT03038308|101163872|FG000|NOT COMPLETED|Overall Study||4||
48340570|NCT00110994|101163873|FG000|STARTED|Double-blind (DB) Treatment||51||
48340571|NCT00110994|101163874|FG001|STARTED|Double-blind (DB) Treatment||50||
48340572|NCT00110994|101163873|FG000|Received Treatment|Double-blind (DB) Treatment||51||
48340573|NCT00110994|101163874|FG001|Received Treatment|Double-blind (DB) Treatment||50||
48340574|NCT00110994|101163873|FG000|COMPLETED|Double-blind (DB) Treatment||9||
48340575|NCT00110994|101163874|FG001|COMPLETED|Double-blind (DB) Treatment||3||
48340576|NCT00110994|101163873|FG000|NOT COMPLETED|Double-blind (DB) Treatment||42||
48340577|NCT00110994|101163874|FG001|NOT COMPLETED|Double-blind (DB) Treatment||47||
48340578|NCT00110994|101163873|FG000|STARTED|Active Follow-up||1||
48340579|NCT00110994|101163874|FG001|STARTED|Active Follow-up||2||
48340580|NCT00110994|101163873|FG000|COMPLETED|Active Follow-up||0||
48340581|NCT00110994|101163874|FG001|COMPLETED|Active Follow-up||0||
48632323|NCT01094288|101885209|FG000|STARTED|Overall Study||6||
48632324|NCT01094288|101885210|FG001|STARTED|Overall Study||15||
48632325|NCT01094288|101885211|FG002|STARTED|Overall Study||5||
48632326|NCT01094288|101885212|FG003|STARTED|Overall Study||3||
48632327|NCT01094288|101885213|FG004|STARTED|Overall Study||2||
48632328|NCT01094288|101885214|FG005|STARTED|Overall Study||4||
48632329|NCT01094288|101885215|FG006|STARTED|Overall Study||2||
48632330|NCT01094288|101885216|FG007|STARTED|Overall Study||4||
48632331|NCT01094288|101885209|FG000|COMPLETED|Overall Study||4||
48632332|NCT01094288|101885210|FG001|COMPLETED|Overall Study||5||
48632333|NCT01094288|101885211|FG002|COMPLETED|Overall Study||1||
48632334|NCT01094288|101885212|FG003|COMPLETED|Overall Study||1||
48632335|NCT01094288|101885213|FG004|COMPLETED|Overall Study||2||
48179830|NCT04585815|100761832|FG006|STARTED|Sub-study B- Follow-up Phase||4||
48179831|NCT04585815|100761826|FG000|COMPLETED|Sub-study B- Follow-up Phase||0||
48179832|NCT04585815|100761827|FG001|COMPLETED|Sub-study B- Follow-up Phase||0||
48179833|NCT04585815|100761828|FG002|COMPLETED|Sub-study B- Follow-up Phase||1||
48179834|NCT04585815|100761829|FG003|COMPLETED|Sub-study B- Follow-up Phase||0||
48179835|NCT04585815|100761830|FG004|COMPLETED|Sub-study B- Follow-up Phase||0||
48179836|NCT04585815|100761831|FG005|COMPLETED|Sub-study B- Follow-up Phase||0||
48179837|NCT04585815|100761832|FG006|COMPLETED|Sub-study B- Follow-up Phase||0||
48179838|NCT04585815|100761826|FG000|NOT COMPLETED|Sub-study B- Follow-up Phase||0||
48179839|NCT04585815|100761827|FG001|NOT COMPLETED|Sub-study B- Follow-up Phase||0||
48179840|NCT04585815|100761828|FG002|NOT COMPLETED|Sub-study B- Follow-up Phase||1||
48188647|NCT01118962|100783298|FG000|COMPLETED|Overall Study||29||
48340582|NCT00110994|101163873|FG000|NOT COMPLETED|Active Follow-up||1||
48340583|NCT00110994|101163874|FG001|NOT COMPLETED|Active Follow-up||2||
48632336|NCT01094288|101885214|FG005|COMPLETED|Overall Study||4||
48632337|NCT01094288|101885215|FG006|COMPLETED|Overall Study||2||
48632338|NCT01094288|101885216|FG007|COMPLETED|Overall Study||2||
48632339|NCT01094288|101885209|FG000|NOT COMPLETED|Overall Study||2||
48179841|NCT04585815|100761829|FG003|NOT COMPLETED|Sub-study B- Follow-up Phase||3||
48179842|NCT04585815|100761830|FG004|NOT COMPLETED|Sub-study B- Follow-up Phase||1||
48179843|NCT04585815|100761831|FG005|NOT COMPLETED|Sub-study B- Follow-up Phase||1||
48179844|NCT04585815|100761832|FG006|NOT COMPLETED|Sub-study B- Follow-up Phase||4||
48179845|NCT03443323|100761833|FG000|STARTED|Overall Study||98||12
48179846|NCT03443323|100761834|FG001|STARTED|Overall Study||88||10
48179847|NCT03443323|100761833|FG000|Baseline Data|Overall Study||96|Data pertaining to participating students were collected at all time points from parents, teachers, and students.|12
48179848|NCT03443323|100761834|FG001|Baseline Data|Overall Study||88|Data pertaining to participating students were collected at all time points from parents, teachers, and students.|10
48179849|NCT03443323|100761833|FG000|COMPLETED|Overall Study||95|Post-treatment (14 weeks)|12
48179850|NCT03443323|100761834|FG001|COMPLETED|Overall Study||86|Post-treatment (14 weeks)|10
48179851|NCT03443323|100761833|FG000|NOT COMPLETED|Overall Study||3||0
48179852|NCT03443323|100761834|FG001|NOT COMPLETED|Overall Study||2||0
48179853|NCT05446870|100761835|FG000|STARTED|Overall Study||80||
48179854|NCT05446870|100761836|FG001|STARTED|Overall Study||80||
48179855|NCT05446870|100761835|FG000|Treated|Overall Study||79||
48179856|NCT05446870|100761836|FG001|Treated|Overall Study||80||
48179857|NCT05446870|100761835|FG000|COMPLETED|Overall Study||7||
48179858|NCT05446870|100761836|FG001|COMPLETED|Overall Study||7||
48179859|NCT05446870|100761835|FG000|NOT COMPLETED|Overall Study||73||
48179860|NCT05446870|100761836|FG001|NOT COMPLETED|Overall Study||73||
48179861|NCT00686335|100761837|FG000|STARTED|Run-in Period||12||
48179862|NCT00686335|100761837|FG000|COMPLETED|Run-in Period||7||
48179863|NCT00686335|100761837|FG000|NOT COMPLETED|Run-in Period||5||
48179864|NCT00686335|100761837|FG000|STARTED|Treatment Period||7||
48179865|NCT00686335|100761837|FG000|COMPLETED|Treatment Period||7||
48179866|NCT00686335|100761837|FG000|NOT COMPLETED|Treatment Period||0||
48179867|NCT03625323|100761838|FG000|STARTED|Overall Study||114||
48179868|NCT03625323|100761839|FG001|STARTED|Overall Study||36||
48179869|NCT03625323|100761840|FG002|STARTED|Overall Study||37||
48179870|NCT03625323|100761838|FG000|COMPLETED|Overall Study||0||
48179871|NCT03625323|100761839|FG001|COMPLETED|Overall Study||0||
48179872|NCT03625323|100761840|FG002|COMPLETED|Overall Study||0||
48179873|NCT03625323|100761838|FG000|NOT COMPLETED|Overall Study||114||
48179874|NCT03625323|100761839|FG001|NOT COMPLETED|Overall Study||36||
48179875|NCT03625323|100761840|FG002|NOT COMPLETED|Overall Study||37||
48179876|NCT03702270|100761841|FG000|STARTED|Control||17||1
48179877|NCT03702270|100761842|FG001|STARTED|Control||31||1
48179878|NCT03702270|100761843|FG002|STARTED|Control||51||1
48413490|NCT02169466|101345836|FG000|100 mg BIA 9-1067|Overall Study||6||
48413491|NCT02169466|101345837|FG001|100 mg BIA 9-1067|Overall Study||6||
48179879|NCT03702270|100761844|FG003|STARTED|Control||27||1
48179880|NCT03702270|100761845|FG004|STARTED|Control||53||1
48179881|NCT03702270|100761846|FG005|STARTED|Control||65||1
48179882|NCT03702270|100761847|FG006|STARTED|Control||97||1
48179883|NCT03702270|100761848|FG007|STARTED|Control||87||1
48179884|NCT03702270|100761849|FG008|STARTED|Control||125||1
48179885|NCT03702270|100761850|FG009|STARTED|Control||179||1
48179886|NCT03702270|100761851|FG010|STARTED|Control||191||1
48179887|NCT03702270|100761852|FG011|STARTED|Control||111||1
48179888|NCT03702270|100761841|FG000|COMPLETED|Control||17||1
48179889|NCT03702270|100761842|FG001|COMPLETED|Control||31||1
48179890|NCT03702270|100761843|FG002|COMPLETED|Control||51||1
48179891|NCT03702270|100761844|FG003|COMPLETED|Control||27||1
48179892|NCT03702270|100761845|FG004|COMPLETED|Control||53||1
48179893|NCT03702270|100761846|FG005|COMPLETED|Control||65||1
48340584|NCT00110994|101163873|FG000|STARTED|Long Term Follow-up||41||
48340585|NCT00110994|101163874|FG001|STARTED|Long Term Follow-up||47||
48340586|NCT00110994|101163873|FG000|COMPLETED|Long Term Follow-up||22||
48340587|NCT00110994|101163874|FG001|COMPLETED|Long Term Follow-up||30||
48340588|NCT00110994|101163873|FG000|NOT COMPLETED|Long Term Follow-up||19||
48340589|NCT00110994|101163874|FG001|NOT COMPLETED|Long Term Follow-up||17||
48340590|NCT02090855|101163875|FG000|STARTED|Overall Study||108||
48340591|NCT02090855|101163875|FG000|COMPLETED|Overall Study||106||
48340592|NCT02090855|101163875|FG000|NOT COMPLETED|Overall Study||2||
48179894|NCT03702270|100761847|FG006|COMPLETED|Control||97||1
48179895|NCT03702270|100761848|FG007|COMPLETED|Control||87||1
48179896|NCT03702270|100761849|FG008|COMPLETED|Control||125||1
48179897|NCT03702270|100761850|FG009|COMPLETED|Control||179||1
48179898|NCT03702270|100761851|FG010|COMPLETED|Control||191||1
48340593|NCT03064763|101163876|FG000|STARTED|Overall Study||18||
48413492|NCT02169466|101345838|FG002|100 mg BIA 9-1067|Overall Study||5||
48179899|NCT03702270|100761852|FG011|COMPLETED|Control||111||1
48179900|NCT03702270|100761841|FG000|NOT COMPLETED|Control||0||0
48179901|NCT03702270|100761842|FG001|NOT COMPLETED|Control||0||0
48179902|NCT03702270|100761843|FG002|NOT COMPLETED|Control||0||0
48179903|NCT03702270|100761844|FG003|NOT COMPLETED|Control||0||0
48179904|NCT03702270|100761845|FG004|NOT COMPLETED|Control||0||0
48179905|NCT03702270|100761846|FG005|NOT COMPLETED|Control||0||0
48179906|NCT03702270|100761847|FG006|NOT COMPLETED|Control||0||0
48179907|NCT03702270|100761848|FG007|NOT COMPLETED|Control||0||0
48413493|NCT02169466|101345839|FG003|100 mg BIA 9-1067|Overall Study||5||
48413494|NCT02169466|101345836|FG000|Placebo|Overall Study||5||
48413495|NCT02169466|101345837|FG001|Placebo|Overall Study||6||
48632340|NCT01094288|101885210|FG001|NOT COMPLETED|Overall Study||10||
48632341|NCT01094288|101885211|FG002|NOT COMPLETED|Overall Study||4||
48632342|NCT01094288|101885212|FG003|NOT COMPLETED|Overall Study||2||
48632343|NCT01094288|101885213|FG004|NOT COMPLETED|Overall Study||0||
48632344|NCT01094288|101885214|FG005|NOT COMPLETED|Overall Study||0||
48632345|NCT01094288|101885215|FG006|NOT COMPLETED|Overall Study||0||
48340594|NCT03064763|101163876|FG000|Received Treatment|Overall Study||18||
48340595|NCT03064763|101163876|FG000|COMPLETED|Overall Study||9||
48340596|NCT03064763|101163876|FG000|NOT COMPLETED|Overall Study||9||
48340597|NCT00891202|101163877|FG000|STARTED|PAP (Up To Week 39)||20||
48340598|NCT00891202|101163878|FG001|STARTED|PAP (Up To Week 39)||20||
48340599|NCT00891202|101163879|FG002|STARTED|PAP (Up To Week 39)||0||
48340600|NCT00891202|101163880|FG003|STARTED|PAP (Up To Week 39)||0||
48340601|NCT00891202|101163877|FG000|COMPLETED|PAP (Up To Week 39)||19||
48632346|NCT01094288|101885216|FG007|NOT COMPLETED|Overall Study||2||
48632347|NCT01673386|101885217|FG000|STARTED|Overall Study||27||
48340602|NCT00891202|101163878|FG001|COMPLETED|PAP (Up To Week 39)||20||
48340603|NCT00891202|101163879|FG002|COMPLETED|PAP (Up To Week 39)||0||
48340604|NCT00891202|101163880|FG003|COMPLETED|PAP (Up To Week 39)||0||
48340605|NCT00891202|101163877|FG000|NOT COMPLETED|PAP (Up To Week 39)||1||
48340606|NCT00891202|101163878|FG001|NOT COMPLETED|PAP (Up To Week 39)||0||
48340607|NCT00891202|101163879|FG002|NOT COMPLETED|PAP (Up To Week 39)||0||
48340608|NCT00891202|101163880|FG003|NOT COMPLETED|PAP (Up To Week 39)||0||
48340609|NCT00891202|101163877|FG000|STARTED|LTTP (Post-Week 39 up to Week 312)||0||
48340610|NCT00891202|101163878|FG001|STARTED|LTTP (Post-Week 39 up to Week 312)||0||
48340611|NCT00891202|101163879|FG002|STARTED|LTTP (Post-Week 39 up to Week 312)||19||
48632348|NCT01673386|101885218|FG001|STARTED|Overall Study||31||
48632349|NCT01673386|101885217|FG000|COMPLETED|Overall Study||2||
48632350|NCT01673386|101885218|FG001|COMPLETED|Overall Study||4||
48632351|NCT01673386|101885217|FG000|NOT COMPLETED|Overall Study||25||
48632352|NCT01673386|101885218|FG001|NOT COMPLETED|Overall Study||27||
48632353|NCT05001620|101885219|FG000|STARTED|Overall Study||2||
48632354|NCT05001620|101885220|FG001|STARTED|Overall Study||14||
48754564|NCT01539759|102187740|FG000|IUD in Place at 6 Months Posptartum|Overall Study||32||
48754565|NCT01539759|102187741|FG001|IUD in Place at 6 Months Posptartum|Overall Study||40||
48754566|NCT01539759|102187740|FG000|COMPLETED|Overall Study||50||
48754567|NCT01539759|102187741|FG001|COMPLETED|Overall Study||48||
48754568|NCT01539759|102187740|FG000|NOT COMPLETED|Overall Study||6||
48754569|NCT01539759|102187741|FG001|NOT COMPLETED|Overall Study||8||
48754570|NCT00790803|102187742|FG000|STARTED|Overall Study||5||
48754571|NCT00790803|102187742|FG000|COMPLETED|Overall Study||5||
48754572|NCT00790803|102187742|FG000|NOT COMPLETED|Overall Study||0||
48754573|NCT03309020|102187743|FG000|STARTED|Overall Study||12||
48754574|NCT03309020|102187744|FG001|STARTED|Overall Study||25||
48754575|NCT03309020|102187743|FG000|Underwent Cataract Surgery|Overall Study||10||
48754576|NCT03309020|102187744|FG001|Underwent Cataract Surgery|Overall Study||24||
48754577|NCT03309020|102187743|FG000|COMPLETED|Overall Study||9||
48754578|NCT03309020|102187744|FG001|COMPLETED|Overall Study||24||
48754579|NCT03309020|102187743|FG000|NOT COMPLETED|Overall Study||3||
48754580|NCT03309020|102187744|FG001|NOT COMPLETED|Overall Study||1||
48754581|NCT04050553|102187745|FG000|STARTED|Period 1||21||
48340612|NCT00891202|101163880|FG003|STARTED|LTTP (Post-Week 39 up to Week 312)||20||
48340613|NCT00891202|101163877|FG000|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0||
48413496|NCT02169466|101345838|FG002|Placebo|Overall Study||5||
48413497|NCT02169466|101345839|FG003|Placebo|Overall Study||5||
48632355|NCT05001620|101885219|FG000|COMPLETED|Overall Study||1||
48632356|NCT05001620|101885220|FG001|COMPLETED|Overall Study||14||
48632357|NCT05001620|101885219|FG000|NOT COMPLETED|Overall Study||1||
48632358|NCT05001620|101885220|FG001|NOT COMPLETED|Overall Study||0||
48632359|NCT03034967|101885221|FG000|STARTED|Overall Study||102||
48632360|NCT03034967|101885222|FG001|STARTED|Overall Study||102||
48632361|NCT03034967|101885223|FG002|STARTED|Overall Study||103||
48754582|NCT04050553|102187746|FG001|STARTED|Period 1||21||
48754583|NCT04050553|102187745|FG000|Received At Least One Dose of Study Drug|Period 1||21||
48754584|NCT04050553|102187746|FG001|Received At Least One Dose of Study Drug|Period 1||21||
48754585|NCT04050553|102187745|FG000|COMPLETED|Period 1||18||
48754586|NCT04050553|102187746|FG001|COMPLETED|Period 1||17||
48340614|NCT00891202|101163878|FG001|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0||
48632362|NCT03034967|101885224|FG003|STARTED|Overall Study||103||
48340615|NCT00891202|101163879|FG002|COMPLETED|LTTP (Post-Week 39 up to Week 312)||12||
48413498|NCT02169466|101345836|FG000|COMPLETED|Overall Study||5||
48413499|NCT02169466|101345837|FG001|COMPLETED|Overall Study||5||
48632363|NCT03034967|101885225|FG004|STARTED|Overall Study||102||
48632364|NCT03034967|101885226|FG005|STARTED|Overall Study||102||
48754587|NCT04050553|102187745|FG000|NOT COMPLETED|Period 1||3||
48754588|NCT04050553|102187746|FG001|NOT COMPLETED|Period 1||4||
48754589|NCT04050553|102187745|FG000|STARTED|Wash-out||18||
48413500|NCT02169466|101345838|FG002|COMPLETED|Overall Study||5||
48632365|NCT03034967|101885221|FG000|COMPLETED|Overall Study||88||
48632366|NCT03034967|101885222|FG001|COMPLETED|Overall Study||97||
48754590|NCT04050553|102187746|FG001|STARTED|Wash-out||17||
48754591|NCT04050553|102187745|FG000|COMPLETED|Wash-out||18||
48413501|NCT02169466|101345839|FG003|COMPLETED|Overall Study||5||
48413502|NCT02169466|101345836|FG000|NOT COMPLETED|Overall Study||1||
48413503|NCT02169466|101345837|FG001|NOT COMPLETED|Overall Study||1||
48754592|NCT04050553|102187746|FG001|COMPLETED|Wash-out||15||
48754593|NCT04050553|102187745|FG000|NOT COMPLETED|Wash-out||0||
48754594|NCT04050553|102187746|FG001|NOT COMPLETED|Wash-out||2||
48754595|NCT04050553|102187745|FG000|STARTED|Period 2||18||
48754596|NCT04050553|102187746|FG001|STARTED|Period 2||15||
48754597|NCT04050553|102187745|FG000|Received At Least One Dose of Study Drug|Period 2||18||
48413504|NCT02169466|101345838|FG002|NOT COMPLETED|Overall Study||0||
48413505|NCT02169466|101345839|FG003|NOT COMPLETED|Overall Study||0||
48413506|NCT05375838|101345840|FG000|STARTED|Overall Study||50||
48413507|NCT05375838|101345841|FG001|STARTED|Overall Study||99||
48413508|NCT05375838|101345842|FG002|STARTED|Overall Study||101||
48413509|NCT05375838|101345843|FG003|STARTED|Overall Study||100||
48413510|NCT05375838|101345844|FG004|STARTED|Overall Study||100||
48413511|NCT05375838|101345845|FG005|STARTED|Overall Study||100||
48413512|NCT05375838|101345840|FG000|Received at Least 1 Dose of Study Drug|Overall Study||49||
48413513|NCT05375838|101345841|FG001|Received at Least 1 Dose of Study Drug|Overall Study||99||
48632367|NCT03034967|101885223|FG002|COMPLETED|Overall Study||90||
48632368|NCT03034967|101885224|FG003|COMPLETED|Overall Study||92||
48632369|NCT03034967|101885225|FG004|COMPLETED|Overall Study||88||
48632370|NCT03034967|101885226|FG005|COMPLETED|Overall Study||87||
48632371|NCT03034967|101885221|FG000|NOT COMPLETED|Overall Study||14||
48632372|NCT03034967|101885222|FG001|NOT COMPLETED|Overall Study||5||
48632373|NCT03034967|101885223|FG002|NOT COMPLETED|Overall Study||13||
48754598|NCT04050553|102187746|FG001|Received At Least One Dose of Study Drug|Period 2||15||
48754599|NCT04050553|102187745|FG000|COMPLETED|Period 2||18||
48754600|NCT04050553|102187746|FG001|COMPLETED|Period 2||15||
48754601|NCT04050553|102187745|FG000|NOT COMPLETED|Period 2||0||
48754602|NCT04050553|102187746|FG001|NOT COMPLETED|Period 2||0||
48754603|NCT03353675|102187747|FG000|STARTED|Overall Study||44||
48754604|NCT03353675|102187747|FG000|COMPLETED|Overall Study||40||
48754605|NCT03353675|102187747|FG000|NOT COMPLETED|Overall Study||4||
48754606|NCT03337308|102187748|FG000|STARTED|Overall Study||108||
48754607|NCT03337308|102187749|FG001|STARTED|Overall Study||110||
48754608|NCT03337308|102187750|FG002|STARTED|Overall Study||109||
48754609|NCT03337308|102187751|FG003|STARTED|Overall Study||55||
48340616|NCT00891202|101163880|FG003|COMPLETED|LTTP (Post-Week 39 up to Week 312)||15||
48340617|NCT00891202|101163877|FG000|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0||
48340618|NCT00891202|101163878|FG001|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0||
48340619|NCT00891202|101163879|FG002|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||7||
48340620|NCT00891202|101163880|FG003|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||5||
48340621|NCT01737931|101163881|FG000|STARTED|Overall Study||38||
48754610|NCT03337308|102187748|FG000|COMPLETED|Overall Study||103||
48754611|NCT03337308|102187749|FG001|COMPLETED|Overall Study||103||
48754612|NCT03337308|102187750|FG002|COMPLETED|Overall Study||104||
48754613|NCT03337308|102187751|FG003|COMPLETED|Overall Study||53||
48754614|NCT03337308|102187748|FG000|NOT COMPLETED|Overall Study||5||
48754615|NCT03337308|102187749|FG001|NOT COMPLETED|Overall Study||7||
48754616|NCT03337308|102187750|FG002|NOT COMPLETED|Overall Study||5||
48754617|NCT03337308|102187751|FG003|NOT COMPLETED|Overall Study||2||
48340622|NCT01737931|101163882|FG001|STARTED|Overall Study||40||
48632374|NCT03034967|101885224|FG003|NOT COMPLETED|Overall Study||11||
48632375|NCT03034967|101885225|FG004|NOT COMPLETED|Overall Study||14||
48632376|NCT03034967|101885226|FG005|NOT COMPLETED|Overall Study||15||
48632377|NCT01118299|101885227|FG000|STARTED|Overall Study||68||
48632378|NCT01118299|101885228|FG001|STARTED|Overall Study||29||
48632379|NCT01118299|101885227|FG000|COMPLETED|Overall Study||45||
48632380|NCT01118299|101885228|FG001|COMPLETED|Overall Study||0||
48754618|NCT03597347|102187752|FG000|STARTED|Overall Study||7||
48754619|NCT03597347|102187753|FG001|STARTED|Overall Study||3||
48754620|NCT03597347|102187754|FG002|STARTED|Overall Study||4||
48754621|NCT03597347|102187752|FG000|COMPLETED|Overall Study||0||
48340623|NCT01737931|101163883|FG002|STARTED|Overall Study||39||
48413514|NCT05375838|101345842|FG002|Received at Least 1 Dose of Study Drug|Overall Study||101||
48413515|NCT05375838|101345843|FG003|Received at Least 1 Dose of Study Drug|Overall Study||100||
48413516|NCT05375838|101345844|FG004|Received at Least 1 Dose of Study Drug|Overall Study||98||
48413517|NCT05375838|101345845|FG005|Received at Least 1 Dose of Study Drug|Overall Study||100||
48413518|NCT05375838|101345840|FG000|COMPLETED|Overall Study||46||
48632381|NCT01118299|101885227|FG000|NOT COMPLETED|Overall Study||23||
48754622|NCT03597347|102187753|FG001|COMPLETED|Overall Study||0||
48413519|NCT05375838|101345841|FG001|COMPLETED|Overall Study||90||
48413520|NCT05375838|101345842|FG002|COMPLETED|Overall Study||98||
48413521|NCT05375838|101345843|FG003|COMPLETED|Overall Study||93||
48632382|NCT01118299|101885228|FG001|NOT COMPLETED|Overall Study||29||
48754623|NCT03597347|102187754|FG002|COMPLETED|Overall Study||0||
48754624|NCT03597347|102187752|FG000|NOT COMPLETED|Overall Study||7||
48754625|NCT03597347|102187753|FG001|NOT COMPLETED|Overall Study||3||
48754626|NCT03597347|102187754|FG002|NOT COMPLETED|Overall Study||4||
48754627|NCT01943344|102187755|FG000|STARTED|Overall Study||12||
48340624|NCT01737931|101163881|FG000|COMPLETED|Overall Study||38||
48340625|NCT01737931|101163882|FG001|COMPLETED|Overall Study||38||
48340626|NCT01737931|101163883|FG002|COMPLETED|Overall Study||38||
48340627|NCT01737931|101163881|FG000|NOT COMPLETED|Overall Study||0||
48340628|NCT01737931|101163882|FG001|NOT COMPLETED|Overall Study||2||
48340629|NCT01737931|101163883|FG002|NOT COMPLETED|Overall Study||1||
48340630|NCT02597062|101163884|FG000|STARTED|Overall Study||76||
48340631|NCT02597062|101163884|FG000|COMPLETED|Overall Study||75||
48340632|NCT02597062|101163884|FG000|NOT COMPLETED|Overall Study||1||
48340633|NCT02527707|101163885|FG000|STARTED|Overall Study||15||
48340634|NCT02527707|101163885|FG000|COMPLETED|Overall Study||13||
48340635|NCT02527707|101163885|FG000|NOT COMPLETED|Overall Study||2||
48340636|NCT00777179|101163886|FG000|STARTED|Overall Study||75||
48340637|NCT00777179|101163887|FG001|STARTED|Overall Study||42||
48340638|NCT00777179|101163886|FG000|COMPLETED|Overall Study||75||
48340639|NCT00777179|101163887|FG001|COMPLETED|Overall Study||42||
48340640|NCT00777179|101163886|FG000|NOT COMPLETED|Overall Study||0||
48340641|NCT00777179|101163887|FG001|NOT COMPLETED|Overall Study||0||
48340642|NCT01987908|101163888|FG000|STARTED|Placebo Lead-in Period||23||
48340643|NCT01987908|101163889|FG001|STARTED|Placebo Lead-in Period||0||
48754628|NCT01943344|102187755|FG000|COMPLETED|Overall Study||9||
48754629|NCT01943344|102187755|FG000|NOT COMPLETED|Overall Study||3||
48754630|NCT04084171|102187756|FG000|STARTED|Overall Study||12||
48754631|NCT04084171|102187756|FG000|Baseline|Overall Study||12||
48754632|NCT04084171|102187756|FG000|COMPLETED|Overall Study||12||
48754633|NCT04084171|102187756|FG000|NOT COMPLETED|Overall Study||0||
48754634|NCT03192176|102187757|FG000|STARTED|Overall Study||44||
48754635|NCT03192176|102187758|FG001|STARTED|Overall Study||45||
48754636|NCT03192176|102187759|FG002|STARTED|Overall Study||44||
48340644|NCT01987908|101163890|FG002|STARTED|Placebo Lead-in Period||0||
48340645|NCT01987908|101163888|FG000|COMPLETED|Placebo Lead-in Period||14||
48340646|NCT01987908|101163889|FG001|COMPLETED|Placebo Lead-in Period||0||
48340647|NCT01987908|101163890|FG002|COMPLETED|Placebo Lead-in Period||0||
48340648|NCT01987908|101163888|FG000|NOT COMPLETED|Placebo Lead-in Period||9||
48340649|NCT01987908|101163889|FG001|NOT COMPLETED|Placebo Lead-in Period||0||
48340650|NCT01987908|101163890|FG002|NOT COMPLETED|Placebo Lead-in Period||0||
48340651|NCT01987908|101163888|FG000|STARTED|Treatment Period||0||
48340652|NCT01987908|101163889|FG001|STARTED|Treatment Period||11||
48340653|NCT01987908|101163890|FG002|STARTED|Treatment Period||3||
48340654|NCT01987908|101163888|FG000|COMPLETED|Treatment Period||0||
48340655|NCT01987908|101163889|FG001|COMPLETED|Treatment Period||10||
48340656|NCT01987908|101163890|FG002|COMPLETED|Treatment Period||2||
48340657|NCT01987908|101163888|FG000|NOT COMPLETED|Treatment Period||0||
48340658|NCT01987908|101163889|FG001|NOT COMPLETED|Treatment Period||1||
48340659|NCT01987908|101163890|FG002|NOT COMPLETED|Treatment Period||1||
48340660|NCT01987908|101163888|FG000|STARTED|Post-Treatment Observation Period||0||
48340661|NCT01987908|101163889|FG001|STARTED|Post-Treatment Observation Period||10||
48340662|NCT01987908|101163890|FG002|STARTED|Post-Treatment Observation Period||2||
48754637|NCT03192176|102187760|FG003|STARTED|Overall Study||45||
48754638|NCT03192176|102187761|FG004|STARTED|Overall Study||44||
48754639|NCT03192176|102187762|FG005|STARTED|Overall Study||45||
48754640|NCT03192176|102187763|FG006|STARTED|Overall Study||45||
48754641|NCT03192176|102187764|FG007|STARTED|Overall Study||44||
48754642|NCT03192176|102187757|FG000|Treated|Overall Study||43||
48754643|NCT03192176|102187758|FG001|Treated|Overall Study||45||
48754644|NCT03192176|102187759|FG002|Treated|Overall Study||43||
48754645|NCT03192176|102187760|FG003|Treated|Overall Study||45||
48754646|NCT03192176|102187761|FG004|Treated|Overall Study||44||
48754647|NCT03192176|102187762|FG005|Treated|Overall Study||43||
48754648|NCT03192176|102187763|FG006|Treated|Overall Study||45||
48754649|NCT03192176|102187764|FG007|Treated|Overall Study||44||
48754650|NCT03192176|102187757|FG000|COMPLETED|Overall Study||37||
48754651|NCT03192176|102187758|FG001|COMPLETED|Overall Study||40||
48340663|NCT01987908|101163888|FG000|COMPLETED|Post-Treatment Observation Period||0||
48340664|NCT01987908|101163889|FG001|COMPLETED|Post-Treatment Observation Period||7||
48340665|NCT01987908|101163890|FG002|COMPLETED|Post-Treatment Observation Period||2||
48340666|NCT01987908|101163888|FG000|NOT COMPLETED|Post-Treatment Observation Period||0||
48340667|NCT01987908|101163889|FG001|NOT COMPLETED|Post-Treatment Observation Period||3||
48340668|NCT01987908|101163890|FG002|NOT COMPLETED|Post-Treatment Observation Period||0||
48340669|NCT00454779|101163891|FG000|STARTED|First-line Treatment Phase||56||
48340670|NCT00454779|101163892|FG001|STARTED|First-line Treatment Phase||57||
48340671|NCT00454779|101163891|FG000|Received Study Medication|First-line Treatment Phase||56||
48340672|NCT00454779|101163892|FG001|Received Study Medication|First-line Treatment Phase||55||
48340673|NCT00454779|101163891|FG000|COMPLETED|First-line Treatment Phase||51||
48340674|NCT00454779|101163892|FG001|COMPLETED|First-line Treatment Phase||49||
48413522|NCT05375838|101345844|FG004|COMPLETED|Overall Study||94||
48754652|NCT03192176|102187759|FG002|COMPLETED|Overall Study||38||
48754653|NCT03192176|102187760|FG003|COMPLETED|Overall Study||33||
48754654|NCT03192176|102187761|FG004|COMPLETED|Overall Study||32||
48754655|NCT03192176|102187762|FG005|COMPLETED|Overall Study||34||
48754656|NCT03192176|102187763|FG006|COMPLETED|Overall Study||36||
48754657|NCT03192176|102187764|FG007|COMPLETED|Overall Study||37||
48754658|NCT03192176|102187757|FG000|NOT COMPLETED|Overall Study||7||
48632383|NCT02915835|101885229|FG000|STARTED|Overall Study||9||
48340675|NCT00454779|101163891|FG000|NOT COMPLETED|First-line Treatment Phase||5||
48340676|NCT00454779|101163892|FG001|NOT COMPLETED|First-line Treatment Phase||8||
48340677|NCT00454779|101163891|FG000|STARTED|Second-line Treatment Phase||0||
48340678|NCT00454779|101163892|FG001|STARTED|Second-line Treatment Phase||30||
48340679|NCT00454779|101163891|FG000|COMPLETED|Second-line Treatment Phase||0||
48340680|NCT00454779|101163892|FG001|COMPLETED|Second-line Treatment Phase||27||
48340681|NCT00454779|101163891|FG000|NOT COMPLETED|Second-line Treatment Phase||0||
48340682|NCT00454779|101163892|FG001|NOT COMPLETED|Second-line Treatment Phase||3||
48340683|NCT03689192|101163893|FG000|STARTED|Overall Study||13||
48340684|NCT03689192|101163893|FG000|COMPLETED|Overall Study||10||
48340685|NCT03689192|101163893|FG000|NOT COMPLETED|Overall Study||3||
48340686|NCT00880360|101163894|FG000|STARTED|Overall Study||19||
48340687|NCT00880360|101163894|FG000|COMPLETED|Overall Study||19||
48413523|NCT05375838|101345845|FG005|COMPLETED|Overall Study||96||
48413524|NCT05375838|101345840|FG000|NOT COMPLETED|Overall Study||4||
48413525|NCT05375838|101345841|FG001|NOT COMPLETED|Overall Study||9||
48632384|NCT02915835|101885230|FG001|STARTED|Overall Study||8||
48632385|NCT02915835|101885229|FG000|COMPLETED|Overall Study||8||
48632386|NCT02915835|101885230|FG001|COMPLETED|Overall Study||7||
48632387|NCT02915835|101885229|FG000|NOT COMPLETED|Overall Study||1||
48632388|NCT02915835|101885230|FG001|NOT COMPLETED|Overall Study||1||
48632389|NCT01685437|101885231|FG000|STARTED|Overall Study||189||
48754659|NCT03192176|102187758|FG001|NOT COMPLETED|Overall Study||5||
48754660|NCT03192176|102187759|FG002|NOT COMPLETED|Overall Study||6||
48754661|NCT03192176|102187760|FG003|NOT COMPLETED|Overall Study||12||
48754662|NCT03192176|102187761|FG004|NOT COMPLETED|Overall Study||12||
48632390|NCT01685437|101885231|FG000|COMPLETED|Overall Study||158||
48632391|NCT01685437|101885231|FG000|NOT COMPLETED|Overall Study||31||
48632392|NCT02759458|101885232|FG000|STARTED|Overall Study||20||
48632393|NCT02759458|101885233|FG001|STARTED|Overall Study||20||
48632394|NCT02759458|101885232|FG000|COMPLETED|Overall Study||20||
48754663|NCT03192176|102187762|FG005|NOT COMPLETED|Overall Study||11||
48632395|NCT02759458|101885233|FG001|COMPLETED|Overall Study||20||
48754664|NCT03192176|102187763|FG006|NOT COMPLETED|Overall Study||9||
48754665|NCT03192176|102187764|FG007|NOT COMPLETED|Overall Study||7||
48754666|NCT05280717|102187765|FG000|STARTED|Part A (Up to Week 35)||72|Enrolled|
48754667|NCT05280717|102187766|FG001|STARTED|Part A (Up to Week 35)||72|Enrolled|
48340688|NCT00880360|101163894|FG000|NOT COMPLETED|Overall Study||0||
48340689|NCT01818726|101163895|FG000|STARTED|Overall Study||10||
48340690|NCT01818726|101163896|FG001|STARTED|Overall Study||5||
48340691|NCT01818726|101163895|FG000|COMPLETED|Overall Study||4||
48340692|NCT01818726|101163896|FG001|COMPLETED|Overall Study||3||
48340693|NCT01818726|101163895|FG000|NOT COMPLETED|Overall Study||6||
48632396|NCT02759458|101885232|FG000|NOT COMPLETED|Overall Study||0||
48632397|NCT02759458|101885233|FG001|NOT COMPLETED|Overall Study||0||
48632398|NCT02530541|101885234|FG000|STARTED|Overall Study||21||21
48632399|NCT02530541|101885235|FG001|STARTED|Overall Study||23||23
48632400|NCT02530541|101885236|FG002|STARTED|Overall Study||22||22
48632401|NCT02530541|101885237|FG003|STARTED|Overall Study||21||21
48632402|NCT02530541|101885238|FG004|STARTED|Overall Study||20||20
48632403|NCT02530541|101885239|FG005|STARTED|Overall Study||19||19
48632404|NCT02530541|101885234|FG000|COMPLETED|Overall Study||14|33 were treated with both interventions, though interventions differ with application time. 24 subjects completed with passing treatment baseline values|14
48632405|NCT02530541|101885235|FG001|COMPLETED|Overall Study||15|33 were treated with both interventions, though interventions differ with application time. 24 subjects completed with passing treatment baseline values|15
48632406|NCT02530541|101885236|FG002|COMPLETED|Overall Study||14|33 were treated with both interventions, though interventions differ with application time. 24 subjects completed with passing treatment baseline values|14
48340694|NCT01818726|101163896|FG001|NOT COMPLETED|Overall Study||2||
48632407|NCT02530541|101885237|FG003|COMPLETED|Overall Study||15|33 were treated with both interventions, though interventions differ with application time. 24 subjects completed with passing treatment baseline values|15
48632408|NCT02530541|101885238|FG004|COMPLETED|Overall Study||15|33 were treated with both interventions, though interventions differ with application time. 24 subjects completed with passing treatment baseline values|15
48632409|NCT02530541|101885239|FG005|COMPLETED|Overall Study||14|33 were treated with both interventions, though interventions differ with application time. 24 subjects completed with passing treatment baseline values|14
48754668|NCT05280717|102187767|FG002|STARTED|Part A (Up to Week 35)||36|Enrolled|
48754669|NCT05280717|102187768|FG003|STARTED|Part A (Up to Week 35)||36|Enrolled|
48754670|NCT05280717|102187769|FG004|STARTED|Part A (Up to Week 35)||0|Enrolled|
48754671|NCT05280717|102187770|FG005|STARTED|Part A (Up to Week 35)||0|Enrolled|
48754672|NCT05280717|102187771|FG006|STARTED|Part A (Up to Week 35)||0|Enrolled|
48754673|NCT05280717|102187765|FG000|Safety Population|Part A (Up to Week 35)||71||
48340695|NCT02494596|101163897|FG000|STARTED|Overall Study||5||
48340696|NCT02494596|101163898|FG001|STARTED|Overall Study||7||
48340697|NCT02494596|101163899|FG002|STARTED|Overall Study||7||
48340698|NCT02494596|101163897|FG000|COMPLETED|Overall Study||2||
48413526|NCT05375838|101345842|FG002|NOT COMPLETED|Overall Study||3||
48179908|NCT03702270|100761849|FG008|NOT COMPLETED|Control||0||0
48179909|NCT03702270|100761850|FG009|NOT COMPLETED|Control||0||0
48179910|NCT03702270|100761851|FG010|NOT COMPLETED|Control||0||0
48179911|NCT03702270|100761852|FG011|NOT COMPLETED|Control||0||0
48179912|NCT03702270|100761841|FG000|STARTED|Intervention||237||1
48179913|NCT03702270|100761842|FG001|STARTED|Intervention||138||1
48179914|NCT03702270|100761843|FG002|STARTED|Intervention||113||1
48179915|NCT03702270|100761844|FG003|STARTED|Intervention||65||1
48179916|NCT03702270|100761845|FG004|STARTED|Intervention||76||1
48179917|NCT03702270|100761846|FG005|STARTED|Intervention||70||1
48179918|NCT03702270|100761847|FG006|STARTED|Intervention||77||1
48179919|NCT03702270|100761848|FG007|STARTED|Intervention||62||1
48179920|NCT03702270|100761849|FG008|STARTED|Intervention||61||1
48179921|NCT03702270|100761850|FG009|STARTED|Intervention||59||1
48179922|NCT03702270|100761851|FG010|STARTED|Intervention||41||1
48179923|NCT03702270|100761852|FG011|STARTED|Intervention||19||1
48179924|NCT03702270|100761841|FG000|COMPLETED|Intervention||237||1
48179925|NCT03702270|100761842|FG001|COMPLETED|Intervention||138||1
48179926|NCT03702270|100761843|FG002|COMPLETED|Intervention||113||1
48179927|NCT03702270|100761844|FG003|COMPLETED|Intervention||65||1
48179928|NCT03702270|100761845|FG004|COMPLETED|Intervention||76||1
48179929|NCT03702270|100761846|FG005|COMPLETED|Intervention||70||1
48179930|NCT03702270|100761847|FG006|COMPLETED|Intervention||77||1
48179931|NCT03702270|100761848|FG007|COMPLETED|Intervention||62||1
48179932|NCT03702270|100761849|FG008|COMPLETED|Intervention||61||1
48179933|NCT03702270|100761850|FG009|COMPLETED|Intervention||59||1
48179934|NCT03702270|100761851|FG010|COMPLETED|Intervention||41||1
48179935|NCT03702270|100761852|FG011|COMPLETED|Intervention||19||1
48179936|NCT03702270|100761841|FG000|NOT COMPLETED|Intervention||0||0
48179937|NCT03702270|100761842|FG001|NOT COMPLETED|Intervention||0||0
48179938|NCT03702270|100761843|FG002|NOT COMPLETED|Intervention||0||0
48179939|NCT03702270|100761844|FG003|NOT COMPLETED|Intervention||0||0
48179940|NCT03702270|100761845|FG004|NOT COMPLETED|Intervention||0||0
48179941|NCT03702270|100761846|FG005|NOT COMPLETED|Intervention||0||0
48179942|NCT03702270|100761847|FG006|NOT COMPLETED|Intervention||0||0
48179943|NCT03702270|100761848|FG007|NOT COMPLETED|Intervention||0||0
48179944|NCT03702270|100761849|FG008|NOT COMPLETED|Intervention||0||0
48179945|NCT03702270|100761850|FG009|NOT COMPLETED|Intervention||0||0
48179946|NCT03702270|100761851|FG010|NOT COMPLETED|Intervention||0||0
48179947|NCT03702270|100761852|FG011|NOT COMPLETED|Intervention||0||0
48179948|NCT05459688|100761853|FG000|STARTED|Overall Study||175||
48179949|NCT05459688|100761853|FG000|COMPLETED|Overall Study||146||
48179950|NCT05459688|100761853|FG000|NOT COMPLETED|Overall Study||29||
48179951|NCT04306367|100761854|FG000|STARTED|Overall Study||14||
48179952|NCT04306367|100761854|FG000|COMPLETED|Overall Study||1||
48179953|NCT04306367|100761854|FG000|NOT COMPLETED|Overall Study||13||
48179954|NCT01375114|100761855|FG000|STARTED|Overall Study||30||
48179955|NCT01375114|100761856|FG001|STARTED|Overall Study||63||
48340699|NCT02494596|101163898|FG001|COMPLETED|Overall Study||2||
48340700|NCT02494596|101163899|FG002|COMPLETED|Overall Study||6||
48340701|NCT02494596|101163897|FG000|NOT COMPLETED|Overall Study||3||
48340702|NCT02494596|101163898|FG001|NOT COMPLETED|Overall Study||5||
48179956|NCT01375114|100761857|FG002|STARTED|Overall Study||64||
48179957|NCT01375114|100761855|FG000|COMPLETED|Overall Study||24||
48179958|NCT01375114|100761856|FG001|COMPLETED|Overall Study||56||
48179959|NCT01375114|100761857|FG002|COMPLETED|Overall Study||56||
48179960|NCT01375114|100761855|FG000|NOT COMPLETED|Overall Study||6||
48179961|NCT01375114|100761856|FG001|NOT COMPLETED|Overall Study||7||
48179962|NCT01375114|100761857|FG002|NOT COMPLETED|Overall Study||8||
48179963|NCT04193293|100761858|FG000|STARTED|Overall Study||0||
48179964|NCT04193293|100761858|FG000|COMPLETED|Overall Study||0||
48179965|NCT04193293|100761858|FG000|NOT COMPLETED|Overall Study||0||
48179966|NCT03141528|100761859|FG000|STARTED|Overall Study||122||
48179967|NCT03141528|100761860|FG001|STARTED|Overall Study||118||
48179968|NCT03141528|100761859|FG000|COMPLETED|Overall Study||75||
48179969|NCT03141528|100761860|FG001|COMPLETED|Overall Study||77||
48179970|NCT03141528|100761859|FG000|NOT COMPLETED|Overall Study||47||
48179971|NCT03141528|100761860|FG001|NOT COMPLETED|Overall Study||41||
48179972|NCT00614198|100761861|FG000|STARTED|Stage 1||38||
48179973|NCT00614198|100761862|FG001|STARTED|Stage 1||34||
48179974|NCT00614198|100761861|FG000|COMPLETED|Stage 1||26||
48179975|NCT00614198|100761862|FG001|COMPLETED|Stage 1||29||
48179976|NCT00614198|100761861|FG000|NOT COMPLETED|Stage 1||12||
48179977|NCT00614198|100761862|FG001|NOT COMPLETED|Stage 1||5||
48179978|NCT00614198|100761861|FG000|STARTED|Stage 2||26||
48179979|NCT00614198|100761862|FG001|STARTED|Stage 2||29||
48179980|NCT00614198|100761861|FG000|COMPLETED|Stage 2||18||
48179981|NCT00614198|100761862|FG001|COMPLETED|Stage 2||17||
48179982|NCT00614198|100761861|FG000|NOT COMPLETED|Stage 2||8||
48179983|NCT00614198|100761862|FG001|NOT COMPLETED|Stage 2||12||
48179984|NCT05107401|100761863|FG000|STARTED|Overall Study||111||
48179985|NCT05107401|100761864|FG001|STARTED|Overall Study||105||
48179986|NCT05107401|100761863|FG000|COMPLETED|Overall Study||98||
48179987|NCT05107401|100761864|FG001|COMPLETED|Overall Study||93||
48179988|NCT05107401|100761863|FG000|NOT COMPLETED|Overall Study||13||
48340703|NCT02494596|101163899|FG002|NOT COMPLETED|Overall Study||1||
48179989|NCT05107401|100761864|FG001|NOT COMPLETED|Overall Study||12||
48179990|NCT05419830|100761865|FG000|STARTED|Overall Study||10||
48179991|NCT05419830|100761866|FG001|STARTED|Overall Study||10||
48179992|NCT05419830|100761867|FG002|STARTED|Overall Study||10||
48179993|NCT05419830|100761865|FG000|COMPLETED|Overall Study||10||
48179994|NCT05419830|100761866|FG001|COMPLETED|Overall Study||10||
48179995|NCT05419830|100761867|FG002|COMPLETED|Overall Study||10||
48179996|NCT05419830|100761865|FG000|NOT COMPLETED|Overall Study||0||
48179997|NCT05419830|100761866|FG001|NOT COMPLETED|Overall Study||0||
48179998|NCT05419830|100761867|FG002|NOT COMPLETED|Overall Study||0||
48179999|NCT05166811|100761868|FG000|STARTED|Overall Study||18|Participants enrolled in study|
48180000|NCT05166811|100761869|FG001|STARTED|Overall Study||17|Participants enrolled in study|
48180001|NCT05166811|100761870|FG002|STARTED|Overall Study||17|Participants enrolled in study|
48180002|NCT05166811|100761868|FG000|COMPLETED|Overall Study||18|Participants randomized to study arm|
48180003|NCT05166811|100761869|FG001|COMPLETED|Overall Study||17|Participants randomized to study arm|
48180004|NCT05166811|100761870|FG002|COMPLETED|Overall Study||17|Participants randomized to study arm|
48180005|NCT05166811|100761868|FG000|NOT COMPLETED|Overall Study||0||
48180006|NCT05166811|100761869|FG001|NOT COMPLETED|Overall Study||0||
48180007|NCT05166811|100761870|FG002|NOT COMPLETED|Overall Study||0||
48180008|NCT05716763|100761871|FG000|STARTED|Period I||12||
48180009|NCT05716763|100761872|FG001|STARTED|Period I||12||
48180010|NCT05716763|100761871|FG000|COMPLETED|Period I||12||
48180011|NCT05716763|100761872|FG001|COMPLETED|Period I||12||
48180012|NCT05716763|100761871|FG000|NOT COMPLETED|Period I||0||
48180013|NCT05716763|100761872|FG001|NOT COMPLETED|Period I||0||
48180014|NCT05716763|100761871|FG000|STARTED|Period II||12||
48180015|NCT05716763|100761872|FG001|STARTED|Period II||12||
48180016|NCT05716763|100761871|FG000|COMPLETED|Period II||12||
48180017|NCT05716763|100761872|FG001|COMPLETED|Period II||12||
48180018|NCT05716763|100761871|FG000|NOT COMPLETED|Period II||0||
48180019|NCT05716763|100761872|FG001|NOT COMPLETED|Period II||0||
48413527|NCT05375838|101345843|FG003|NOT COMPLETED|Overall Study||7||
48413528|NCT05375838|101345844|FG004|NOT COMPLETED|Overall Study||6||
48413529|NCT05375838|101345845|FG005|NOT COMPLETED|Overall Study||4||
48413530|NCT02710422|101345846|FG000|STARTED|Overall Study||12||
48413531|NCT02710422|101345847|FG001|STARTED|Overall Study||12||
48413532|NCT02710422|101345846|FG000|3 Month Visit|Overall Study||9||
48413533|NCT02710422|101345847|FG001|3 Month Visit|Overall Study||11||
48632410|NCT02530541|101885234|FG000|NOT COMPLETED|Overall Study||7||7
48632411|NCT02530541|101885235|FG001|NOT COMPLETED|Overall Study||8||8
48632412|NCT02530541|101885236|FG002|NOT COMPLETED|Overall Study||8||8
48632413|NCT02530541|101885237|FG003|NOT COMPLETED|Overall Study||6||6
48632414|NCT02530541|101885238|FG004|NOT COMPLETED|Overall Study||5||5
48632415|NCT02530541|101885239|FG005|NOT COMPLETED|Overall Study||5||5
48632416|NCT03426345|101885240|FG000|STARTED|Overall Study||155||
48632417|NCT03426345|101885241|FG001|STARTED|Overall Study||156||
48632418|NCT03426345|101885240|FG000|Safety Population|Overall Study||152|The Safety Population included all participants who received ≥1 administration of double-blind study treatment.|
48632419|NCT03426345|101885241|FG001|Safety Population|Overall Study||155|The Safety Population included all participants who received ≥1 administration of double-blind study treatment.|
48632420|NCT03426345|101885240|FG000|COMPLETED|Overall Study||137||
48632421|NCT03426345|101885241|FG001|COMPLETED|Overall Study||139||
48632422|NCT03426345|101885240|FG000|NOT COMPLETED|Overall Study||18||
48632423|NCT03426345|101885241|FG001|NOT COMPLETED|Overall Study||17||
48657118|NCT03745313|101943783|FG000|NOT COMPLETED|At 30 Days Follow-up||2||
48180020|NCT02724878|100761873|FG000|STARTED|Overall Study||65||
48180021|NCT02724878|100761873|FG000|Treated|Overall Study||60||
48180022|NCT02724878|100761873|FG000|Responders|Overall Study||20||
48180023|NCT02724878|100761873|FG000|COMPLETED|Overall Study||0||
48180024|NCT02724878|100761873|FG000|NOT COMPLETED|Overall Study||65||
48180025|NCT00650078|100761874|FG000|STARTED|Overall Study||231||
48180026|NCT00650078|100761875|FG001|STARTED|Overall Study||119||
48180027|NCT00650078|100761874|FG000|COMPLETED|Overall Study||217||
48180028|NCT00650078|100761875|FG001|COMPLETED|Overall Study||106||
48413534|NCT02710422|101345846|FG000|6 Month Visit|Overall Study||7||
48413535|NCT02710422|101345847|FG001|6 Month Visit|Overall Study||8||
48413536|NCT02710422|101345846|FG000|9 Month Visit|Overall Study||5||
48413537|NCT02710422|101345847|FG001|9 Month Visit|Overall Study||5||
48413538|NCT02710422|101345846|FG000|12 Month Visit|Overall Study||3||
48413539|NCT02710422|101345847|FG001|12 Month Visit|Overall Study||3||
48413540|NCT02710422|101345846|FG000|COMPLETED|Overall Study||3||
48413541|NCT02710422|101345847|FG001|COMPLETED|Overall Study||3||
48413542|NCT02710422|101345846|FG000|NOT COMPLETED|Overall Study||9||
48413543|NCT02710422|101345847|FG001|NOT COMPLETED|Overall Study||9||
48180029|NCT00650078|100761874|FG000|NOT COMPLETED|Overall Study||14||
48180030|NCT00650078|100761875|FG001|NOT COMPLETED|Overall Study||13||
48413544|NCT03228836|101345848|FG000|STARTED|Overall Study||28||
48413545|NCT03228836|101345848|FG000|Treated|Overall Study||28||
48413546|NCT03228836|101345848|FG000|COMPLETED|Overall Study||11||
48413547|NCT03228836|101345848|FG000|NOT COMPLETED|Overall Study||17||
48180031|NCT05990335|100761876|FG000|STARTED|Overall Study||64||
48180032|NCT05990335|100761877|FG001|STARTED|Overall Study||60||
48632424|NCT03043053|101885242|FG000|STARTED|Overall Study||31|Safety cohort includes all randomly assigned participants who received at least one dose of study drug|
48632425|NCT03043053|101885243|FG001|STARTED|Overall Study||30|Safety cohort includes all randomly assigned participants who received at least one dose of study drug|
48632426|NCT03043053|101885242|FG000|Started (mITT)|Overall Study||31|Modified Intention-To-Treat (mITT) cohort is defined as all subjects who completed at least 1 visit while on study drug|
48632427|NCT03043053|101885243|FG001|Started (mITT)|Overall Study||29|Modified Intention-To-Treat (mITT) cohort is defined as all subjects who completed at least 1 visit while on study drug|
48632428|NCT03043053|101885242|FG000|COMPLETED|Overall Study||28|Completed cohort (safety and mITT) includes all randomly assigned participants who received at least one dose of study drug and completed the study to Week 14|
48632429|NCT03043053|101885243|FG001|COMPLETED|Overall Study||22|Completed cohort (safety and mITT) includes all randomly assigned participants who received at least one dose of study drug and completed the study to Week 14|
48632430|NCT03043053|101885242|FG000|NOT COMPLETED|Overall Study||3||
48632431|NCT03043053|101885243|FG001|NOT COMPLETED|Overall Study||8||
48632432|NCT01183923|101885244|FG000|STARTED|Intervention 1 (7 Days)||1||
48632433|NCT01183923|101885245|FG001|STARTED|Intervention 1 (7 Days)||0||
48632434|NCT01183923|101885244|FG000|COMPLETED|Intervention 1 (7 Days)||1||
48632435|NCT01183923|101885245|FG001|COMPLETED|Intervention 1 (7 Days)||0||
48632436|NCT01183923|101885244|FG000|NOT COMPLETED|Intervention 1 (7 Days)||0||
48632437|NCT01183923|101885245|FG001|NOT COMPLETED|Intervention 1 (7 Days)||0||
48632438|NCT01183923|101885244|FG000|STARTED|Washout (14 Days)||1||
48632439|NCT01183923|101885245|FG001|STARTED|Washout (14 Days)||0||
48632440|NCT01183923|101885244|FG000|COMPLETED|Washout (14 Days)||1||
48632441|NCT01183923|101885245|FG001|COMPLETED|Washout (14 Days)||0||
48632442|NCT01183923|101885244|FG000|NOT COMPLETED|Washout (14 Days)||0||
48632443|NCT01183923|101885245|FG001|NOT COMPLETED|Washout (14 Days)||0||
48632444|NCT01183923|101885244|FG000|STARTED|Intervention 2 (7 Days)||1||
48632445|NCT01183923|101885245|FG001|STARTED|Intervention 2 (7 Days)||0||
48632446|NCT01183923|101885244|FG000|COMPLETED|Intervention 2 (7 Days)||1||
48632447|NCT01183923|101885245|FG001|COMPLETED|Intervention 2 (7 Days)||0||
48632448|NCT01183923|101885244|FG000|NOT COMPLETED|Intervention 2 (7 Days)||0||
48632449|NCT01183923|101885245|FG001|NOT COMPLETED|Intervention 2 (7 Days)||0||
48632450|NCT03444584|101885246|FG000|STARTED|Overall Study||24||
48632451|NCT03444584|101885247|FG001|STARTED|Overall Study||25||
48632452|NCT03444584|101885246|FG000|COMPLETED|Overall Study||24||
48632453|NCT03444584|101885247|FG001|COMPLETED|Overall Study||23||
48632454|NCT03444584|101885246|FG000|NOT COMPLETED|Overall Study||0||
48632455|NCT03444584|101885247|FG001|NOT COMPLETED|Overall Study||2||
48632456|NCT00909870|101885248|FG000|STARTED|Overall Study||274||
48632457|NCT00909870|101885249|FG001|STARTED|Overall Study||263||
48632458|NCT00909870|101885248|FG000|COMPLETED|Overall Study||251||
48632459|NCT00909870|101885249|FG001|COMPLETED|Overall Study||236||
48632460|NCT00909870|101885248|FG000|NOT COMPLETED|Overall Study||23||
48632461|NCT00909870|101885249|FG001|NOT COMPLETED|Overall Study||27||
48632462|NCT02337764|101885250|FG000|STARTED|Overall Study||222||
48632463|NCT02337764|101885250|FG000|COMPLETED|Overall Study||162||
48632464|NCT02337764|101885250|FG000|NOT COMPLETED|Overall Study||60||
48632465|NCT01130844|101885251|FG000|STARTED|Overall Study||21||
48632466|NCT01130844|101885252|FG001|STARTED|Overall Study||22||
48754674|NCT05280717|102187766|FG001|Safety Population|Part A (Up to Week 35)||71||
48754675|NCT05280717|102187767|FG002|Safety Population|Part A (Up to Week 35)||35||
48632467|NCT01130844|101885253|FG002|STARTED|Overall Study||9||
48632468|NCT01130844|101885251|FG000|COMPLETED|Overall Study||21||
48754676|NCT05280717|102187768|FG003|Safety Population|Part A (Up to Week 35)||38||
48754677|NCT05280717|102187769|FG004|Safety Population|Part A (Up to Week 35)||0||
48754678|NCT05280717|102187770|FG005|Safety Population|Part A (Up to Week 35)||0||
48754679|NCT05280717|102187771|FG006|Safety Population|Part A (Up to Week 35)||0||
48754680|NCT05280717|102187765|FG000|COMPLETED|Part A (Up to Week 35)||70||
48754681|NCT05280717|102187766|FG001|COMPLETED|Part A (Up to Week 35)||68||
48754682|NCT05280717|102187767|FG002|COMPLETED|Part A (Up to Week 35)||33||
48754683|NCT05280717|102187768|FG003|COMPLETED|Part A (Up to Week 35)||36||
48754684|NCT05280717|102187769|FG004|COMPLETED|Part A (Up to Week 35)||0||
48180033|NCT05990335|100761876|FG000|COMPLETED|Overall Study||64||
48180034|NCT05990335|100761877|FG001|COMPLETED|Overall Study||60||
48180035|NCT05990335|100761876|FG000|NOT COMPLETED|Overall Study||0||
48632469|NCT01130844|101885252|FG001|COMPLETED|Overall Study||22||
48632470|NCT01130844|101885253|FG002|COMPLETED|Overall Study||9||
48632471|NCT01130844|101885251|FG000|NOT COMPLETED|Overall Study||0||
48632472|NCT01130844|101885252|FG001|NOT COMPLETED|Overall Study||0||
48632473|NCT01130844|101885253|FG002|NOT COMPLETED|Overall Study||0||
48632474|NCT01032928|101885254|FG000|STARTED|Overall Study||30||
48632475|NCT01032928|101885254|FG000|COMPLETED|Overall Study||30||
48632476|NCT01032928|101885254|FG000|NOT COMPLETED|Overall Study||0||
48632477|NCT03257267|101885255|FG000|STARTED|Overall Study||304||
48632478|NCT03257267|101885256|FG001|STARTED|Overall Study||304||
48657119|NCT03745313|101943783|FG000|STARTED|At 6 Months Follow-up||57||
48754685|NCT05280717|102187770|FG005|COMPLETED|Part A (Up to Week 35)||0||
48754686|NCT05280717|102187771|FG006|COMPLETED|Part A (Up to Week 35)||0||
48180036|NCT05990335|100761877|FG001|NOT COMPLETED|Overall Study||0||
48180037|NCT04002830|100761878|FG000|STARTED|Overall Study||14||
48340704|NCT01679002|101163900|FG000|STARTED|Overall Study||4||
48632479|NCT03257267|101885255|FG000|Full Analysis Set (FAS)|Overall Study||304|The FAS included all randomized participants.|
48632480|NCT03257267|101885256|FG001|Full Analysis Set (FAS)|Overall Study||304|The FAS included all randomized participants.|
48632481|NCT03257267|101885255|FG000|Safety Analysis Set (SAF)|Overall Study||300|The SAF included all randomized participants who received any study drug.|
48632482|NCT03257267|101885256|FG001|Safety Analysis Set (SAF)|Overall Study||290|The SAF included all randomized participants who received any study drug.|
48632483|NCT03257267|101885255|FG000|Completed Treatment|Overall Study||38||
48632484|NCT03257267|101885256|FG001|Completed Treatment|Overall Study||0||
48632485|NCT03257267|101885255|FG000|COMPLETED|Overall Study||35|Completed Study|
48632486|NCT03257267|101885256|FG001|COMPLETED|Overall Study||0|Completed Study|
48632487|NCT03257267|101885255|FG000|NOT COMPLETED|Overall Study||269||
48632488|NCT03257267|101885256|FG001|NOT COMPLETED|Overall Study||304||
48632489|NCT04166214|101885257|FG000|STARTED|Overall Study||12||
48632490|NCT04166214|101885258|FG001|STARTED|Overall Study||39||
48632491|NCT04166214|101885257|FG000|COMPLETED|Overall Study||12||
48632492|NCT04166214|101885258|FG001|COMPLETED|Overall Study||39||
48632493|NCT04166214|101885257|FG000|NOT COMPLETED|Overall Study||0||
48340705|NCT01679002|101163901|FG001|STARTED|Overall Study||4||
48340706|NCT01679002|101163902|FG002|STARTED|Overall Study||4||
48340707|NCT01679002|101163900|FG000|BIA 2-093 900 mg Once-daily Period|Overall Study||4||
48632494|NCT04166214|101885258|FG001|NOT COMPLETED|Overall Study||0||
48632495|NCT02730962|101885259|FG000|STARTED|Overall Study||7||
48632496|NCT02730962|101885260|FG001|STARTED|Overall Study||5||
48632497|NCT02730962|101885259|FG000|COMPLETED|Overall Study||7||
48632498|NCT02730962|101885260|FG001|COMPLETED|Overall Study||5||
48632499|NCT02730962|101885259|FG000|NOT COMPLETED|Overall Study||0||
48632500|NCT02730962|101885260|FG001|NOT COMPLETED|Overall Study||0||
48632501|NCT02160626|101885261|FG000|STARTED|Overall Study||58||
48632502|NCT02160626|101885262|FG001|STARTED|Overall Study||57||
48632503|NCT02160626|101885263|FG002|STARTED|Overall Study||57||
48632504|NCT02160626|101885261|FG000|COMPLETED|Overall Study||57||
48632505|NCT02160626|101885262|FG001|COMPLETED|Overall Study||56||
48632506|NCT02160626|101885263|FG002|COMPLETED|Overall Study||56||
48632507|NCT02160626|101885261|FG000|NOT COMPLETED|Overall Study||1||
48632508|NCT02160626|101885262|FG001|NOT COMPLETED|Overall Study||1||
48632509|NCT02160626|101885263|FG002|NOT COMPLETED|Overall Study||1||
48632510|NCT02765165|101885264|FG000|STARTED|Treatment Period||3||
48632511|NCT02765165|101885265|FG001|STARTED|Treatment Period||4||
48632512|NCT02765165|101885266|FG002|STARTED|Treatment Period||3||
48632513|NCT02765165|101885267|FG003|STARTED|Treatment Period||3||
48632514|NCT02765165|101885268|FG004|STARTED|Treatment Period||6||
48632515|NCT02765165|101885269|FG005|STARTED|Treatment Period||3||
48632516|NCT02765165|101885270|FG006|STARTED|Treatment Period||4||
48632517|NCT02765165|101885264|FG000|COMPLETED|Treatment Period||0||
48632518|NCT02765165|101885265|FG001|COMPLETED|Treatment Period||0||
48632519|NCT02765165|101885266|FG002|COMPLETED|Treatment Period||0||
48632520|NCT02765165|101885267|FG003|COMPLETED|Treatment Period||0||
48632521|NCT02765165|101885268|FG004|COMPLETED|Treatment Period||0||
48632522|NCT02765165|101885269|FG005|COMPLETED|Treatment Period||0||
48632523|NCT02765165|101885270|FG006|COMPLETED|Treatment Period||0||
48340708|NCT01679002|101163901|FG001|BIA 2-093 900 mg Once-daily Period|Overall Study||3||
48340709|NCT01679002|101163902|FG002|BIA 2-093 900 mg Once-daily Period|Overall Study||4||
48340710|NCT01679002|101163900|FG000|BIA 2-093 450 mg Twice-daily Period|Overall Study||4||
48340711|NCT01679002|101163901|FG001|BIA 2-093 450 mg Twice-daily Period|Overall Study||4||
48340712|NCT01679002|101163902|FG002|BIA 2-093 450 mg Twice-daily Period|Overall Study||4||
48340713|NCT01679002|101163900|FG000|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||3||
48340714|NCT01679002|101163901|FG001|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4||
48340715|NCT01679002|101163902|FG002|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4||
48340716|NCT01679002|101163900|FG000|COMPLETED|Overall Study||3||
48340717|NCT01679002|101163901|FG001|COMPLETED|Overall Study||3||
48340718|NCT01679002|101163902|FG002|COMPLETED|Overall Study||4||
48340719|NCT01679002|101163900|FG000|NOT COMPLETED|Overall Study||1||
48340720|NCT01679002|101163901|FG001|NOT COMPLETED|Overall Study||1||
48340721|NCT01679002|101163902|FG002|NOT COMPLETED|Overall Study||0||
48340722|NCT01446809|101163903|FG000|STARTED|Overall Study||14||
48340723|NCT01446809|101163904|FG001|STARTED|Overall Study||7||
48340724|NCT01446809|101163905|FG002|STARTED|Overall Study||2||
48340725|NCT01446809|101163903|FG000|COMPLETED|Overall Study||14||
48632524|NCT02765165|101885264|FG000|NOT COMPLETED|Treatment Period||3||
48632525|NCT02765165|101885265|FG001|NOT COMPLETED|Treatment Period||4||
48632526|NCT02765165|101885266|FG002|NOT COMPLETED|Treatment Period||3||
48632527|NCT02765165|101885267|FG003|NOT COMPLETED|Treatment Period||3||
48632528|NCT02765165|101885268|FG004|NOT COMPLETED|Treatment Period||6||
48632529|NCT02765165|101885269|FG005|NOT COMPLETED|Treatment Period||3||
48632530|NCT02765165|101885270|FG006|NOT COMPLETED|Treatment Period||4||
48632531|NCT02765165|101885264|FG000|STARTED|Post-treatment Follow-up||1||
48632532|NCT02765165|101885265|FG001|STARTED|Post-treatment Follow-up||3||
48340726|NCT01446809|101163904|FG001|COMPLETED|Overall Study||7||
48340727|NCT01446809|101163905|FG002|COMPLETED|Overall Study||0||
48340728|NCT01446809|101163903|FG000|NOT COMPLETED|Overall Study||0||
48413548|NCT03721549|101345849|FG000|STARTED|Overall Study||8||
48413549|NCT03721549|101345850|FG001|STARTED|Overall Study||8||
48413550|NCT03721549|101345849|FG000|COMPLETED|Overall Study||7||
48413551|NCT03721549|101345850|FG001|COMPLETED|Overall Study||8||
48413552|NCT03721549|101345849|FG000|NOT COMPLETED|Overall Study||1||
48754687|NCT05280717|102187765|FG000|NOT COMPLETED|Part A (Up to Week 35)||2||
48754688|NCT05280717|102187766|FG001|NOT COMPLETED|Part A (Up to Week 35)||4||
48754689|NCT05280717|102187767|FG002|NOT COMPLETED|Part A (Up to Week 35)||3||
48754690|NCT05280717|102187768|FG003|NOT COMPLETED|Part A (Up to Week 35)||0||
48754691|NCT05280717|102187769|FG004|NOT COMPLETED|Part A (Up to Week 35)||0||
48754692|NCT05280717|102187770|FG005|NOT COMPLETED|Part A (Up to Week 35)||0||
48754693|NCT05280717|102187771|FG006|NOT COMPLETED|Part A (Up to Week 35)||0||
48180038|NCT04002830|100761878|FG000|COMPLETED|Overall Study||14|All patients received 60U/kg every two weeks|
48180039|NCT04002830|100761878|FG000|NOT COMPLETED|Overall Study||0||
48180040|NCT00984815|100761879|FG000|STARTED|Overall Study||86||
48180041|NCT00984815|100761879|FG000|COMPLETED|Overall Study||56||
48180042|NCT00984815|100761879|FG000|NOT COMPLETED|Overall Study||30||
48180043|NCT00597909|100761880|FG000|STARTED|Overall Study||0||
48180044|NCT00597909|100761881|FG001|STARTED|Overall Study||0||
48180045|NCT00597909|100761882|FG002|STARTED|Overall Study||0||
48180046|NCT00597909|100761880|FG000|COMPLETED|Overall Study||0||
48413553|NCT03721549|101345850|FG001|NOT COMPLETED|Overall Study||0||
48413554|NCT02565576|101345851|FG000|STARTED|Overall Study||22||
48632533|NCT02765165|101885266|FG002|STARTED|Post-treatment Follow-up||3||
48632534|NCT02765165|101885267|FG003|STARTED|Post-treatment Follow-up||3||
48632535|NCT02765165|101885268|FG004|STARTED|Post-treatment Follow-up||3||
48632536|NCT02765165|101885269|FG005|STARTED|Post-treatment Follow-up||3||
48632537|NCT02765165|101885270|FG006|STARTED|Post-treatment Follow-up||1||
48632538|NCT02765165|101885264|FG000|COMPLETED|Post-treatment Follow-up||0||
48632539|NCT02765165|101885265|FG001|COMPLETED|Post-treatment Follow-up||0||
48632540|NCT02765165|101885266|FG002|COMPLETED|Post-treatment Follow-up||0||
48632541|NCT02765165|101885267|FG003|COMPLETED|Post-treatment Follow-up||0||
48632542|NCT02765165|101885268|FG004|COMPLETED|Post-treatment Follow-up||0||
48632543|NCT02765165|101885269|FG005|COMPLETED|Post-treatment Follow-up||0||
48632544|NCT02765165|101885270|FG006|COMPLETED|Post-treatment Follow-up||0||
48632545|NCT02765165|101885264|FG000|NOT COMPLETED|Post-treatment Follow-up||1||
48632546|NCT02765165|101885265|FG001|NOT COMPLETED|Post-treatment Follow-up||3||
48632547|NCT02765165|101885266|FG002|NOT COMPLETED|Post-treatment Follow-up||3||
48632548|NCT02765165|101885267|FG003|NOT COMPLETED|Post-treatment Follow-up||3||
48632549|NCT02765165|101885268|FG004|NOT COMPLETED|Post-treatment Follow-up||3||
48754694|NCT05280717|102187765|FG000|STARTED|Part B (Up to Week 35)||0||
48754695|NCT05280717|102187766|FG001|STARTED|Part B (Up to Week 35)||0||
48754696|NCT05280717|102187767|FG002|STARTED|Part B (Up to Week 35)||0||
48754697|NCT05280717|102187768|FG003|STARTED|Part B (Up to Week 35)||0||
48754698|NCT05280717|102187769|FG004|STARTED|Part B (Up to Week 35)||0||
48754699|NCT05280717|102187770|FG005|STARTED|Part B (Up to Week 35)||0||
48754700|NCT05280717|102187771|FG006|STARTED|Part B (Up to Week 35)||0||
48180047|NCT00597909|100761881|FG001|COMPLETED|Overall Study||0||
48180048|NCT00597909|100761882|FG002|COMPLETED|Overall Study||0||
48180049|NCT00597909|100761880|FG000|NOT COMPLETED|Overall Study||0||
48180050|NCT00597909|100761881|FG001|NOT COMPLETED|Overall Study||0||
48180051|NCT00597909|100761882|FG002|NOT COMPLETED|Overall Study||0||
48180052|NCT03519581|100761883|FG000|STARTED|Overall Study||16||16
48180053|NCT03519581|100761884|FG001|STARTED|Overall Study||11||11
48180054|NCT03519581|100761883|FG000|COMPLETED|Overall Study||2||2
48180055|NCT03519581|100761884|FG001|COMPLETED|Overall Study||2||2
48180056|NCT03519581|100761883|FG000|NOT COMPLETED|Overall Study||14||14
48180057|NCT03519581|100761884|FG001|NOT COMPLETED|Overall Study||9||9
48413555|NCT02565576|101345852|FG001|STARTED|Overall Study||22||
48413556|NCT02565576|101345851|FG000|COMPLETED|Overall Study||17||
48413557|NCT02565576|101345852|FG001|COMPLETED|Overall Study||17||
48413558|NCT02565576|101345851|FG000|NOT COMPLETED|Overall Study||5||
48413559|NCT02565576|101345852|FG001|NOT COMPLETED|Overall Study||5||
48413560|NCT01158885|101345853|FG000|STARTED|Treatment Course 1||2||
48413561|NCT01158885|101345853|FG000|COMPLETED|Treatment Course 1||2||
48413562|NCT01158885|101345853|FG000|NOT COMPLETED|Treatment Course 1||0||
48413563|NCT01158885|101345853|FG000|STARTED|Treatment Course 2||0|Neither of the patients that were treated on Treatment Course 1 were eligible to proceed to Course 2|
48413564|NCT01158885|101345853|FG000|COMPLETED|Treatment Course 2||0||
48413565|NCT01158885|101345853|FG000|NOT COMPLETED|Treatment Course 2||0||
48413566|NCT02380703|101345854|FG000|STARTED|Overall Study||114|This is the number of PWD assigned to each arm.|
48413567|NCT02380703|101345855|FG001|STARTED|Overall Study||114|This is the number of PWD assigned to each arm.|
48413568|NCT02380703|101345854|FG000|Month 3|Overall Study||104|This is the number of PWD who reached the Month 3 assessment window.|
48413569|NCT02380703|101345855|FG001|Month 3|Overall Study||109|This is the number of PWD who reached the Month 3 assessment window.|
48413570|NCT02380703|101345854|FG000|Month 6|Overall Study||102|This is the number of PWD who reached the Month 6 assessment window.|
48657120|NCT03745313|101943783|FG000|COMPLETED|At 6 Months Follow-up||54||
48413571|NCT02380703|101345855|FG001|Month 6|Overall Study||107|This is the number of PWD who reached the Month 6 assessment window.|
48180058|NCT01658930|100761885|FG000|STARTED|Overall Study||350||
48180059|NCT01658930|100761886|FG001|STARTED|Overall Study||350||
48180060|NCT01658930|100761885|FG000|COMPLETED|Overall Study||350||
48180061|NCT01658930|100761886|FG001|COMPLETED|Overall Study||350||
48180062|NCT01658930|100761885|FG000|NOT COMPLETED|Overall Study||0||
48180063|NCT01658930|100761886|FG001|NOT COMPLETED|Overall Study||0||
48180064|NCT03030261|100761887|FG000|STARTED|Overall Study||25||
48180065|NCT03030261|100761887|FG000|COMPLETED|Overall Study||20||
48180066|NCT03030261|100761887|FG000|NOT COMPLETED|Overall Study||5||
48180067|NCT04867278|100761888|FG000|STARTED|Overall Study||59||
48180068|NCT04867278|100761889|FG001|STARTED|Overall Study||58||
48180069|NCT04867278|100761888|FG000|COMPLETED|Overall Study||54||
48180070|NCT04867278|100761889|FG001|COMPLETED|Overall Study||50||
48180071|NCT04867278|100761888|FG000|NOT COMPLETED|Overall Study||5||
48180072|NCT04867278|100761889|FG001|NOT COMPLETED|Overall Study||8||
48180073|NCT05907707|100761890|FG000|STARTED|First Intervention||5||
48180074|NCT05907707|100761891|FG001|STARTED|First Intervention||6||
48180075|NCT05907707|100761890|FG000|COMPLETED|First Intervention||5||
48180076|NCT05907707|100761891|FG001|COMPLETED|First Intervention||6||
48180077|NCT05907707|100761890|FG000|NOT COMPLETED|First Intervention||0||
48180078|NCT05907707|100761891|FG001|NOT COMPLETED|First Intervention||0||
48180079|NCT05907707|100761890|FG000|STARTED|Washout (9 Days)||5||
48180080|NCT05907707|100761891|FG001|STARTED|Washout (9 Days)||6||
48180081|NCT05907707|100761890|FG000|COMPLETED|Washout (9 Days)||5||
48180082|NCT05907707|100761891|FG001|COMPLETED|Washout (9 Days)||6||
48180083|NCT05907707|100761890|FG000|NOT COMPLETED|Washout (9 Days)||0||
48180084|NCT05907707|100761891|FG001|NOT COMPLETED|Washout (9 Days)||0||
48180085|NCT05907707|100761890|FG000|STARTED|Second Intervention||5||
48180086|NCT05907707|100761891|FG001|STARTED|Second Intervention||5||
48180087|NCT05907707|100761890|FG000|COMPLETED|Second Intervention||5||
48180088|NCT05907707|100761891|FG001|COMPLETED|Second Intervention||5||
48180089|NCT05907707|100761890|FG000|NOT COMPLETED|Second Intervention||0||
48180090|NCT05907707|100761891|FG001|NOT COMPLETED|Second Intervention||0||
48180091|NCT04574024|100761892|FG000|STARTED|Baseline||7||
48180092|NCT04574024|100761892|FG000|COMPLETED|Baseline||7||
48180093|NCT04574024|100761892|FG000|NOT COMPLETED|Baseline||0||
48180094|NCT04574024|100761892|FG000|STARTED|NBT-NM108 Treatment for 8 Weeks||3||
48180095|NCT04574024|100761892|FG000|COMPLETED|NBT-NM108 Treatment for 8 Weeks||3||
48180096|NCT04574024|100761892|FG000|NOT COMPLETED|NBT-NM108 Treatment for 8 Weeks||0||
48180097|NCT04574024|100761892|FG000|STARTED|NBT-NM108 Treatment for 12 Weeks||2||
48180098|NCT04574024|100761892|FG000|COMPLETED|NBT-NM108 Treatment for 12 Weeks||2||
48180099|NCT04574024|100761892|FG000|NOT COMPLETED|NBT-NM108 Treatment for 12 Weeks||0||
48180100|NCT00570258|100761893|FG000|STARTED|Overall Study||12||
48180101|NCT00570258|100761894|FG001|STARTED|Overall Study||15||
48180102|NCT00570258|100761893|FG000|COMPLETED|Overall Study||0||
48413572|NCT02380703|101345854|FG000|Month 12|Overall Study||99|This is the number of PWD who reached the Month 12 assessment window.|
48632550|NCT02765165|101885269|FG005|NOT COMPLETED|Post-treatment Follow-up||3||
48632551|NCT02765165|101885270|FG006|NOT COMPLETED|Post-treatment Follow-up||1||
48632552|NCT02667639|101885271|FG000|STARTED|Overall Study||25||
48632553|NCT02667639|101885272|FG001|STARTED|Overall Study||10||
48632554|NCT02667639|101885271|FG000|COMPLETED|Overall Study||25||
48632555|NCT02667639|101885272|FG001|COMPLETED|Overall Study||10||
48632556|NCT02667639|101885271|FG000|NOT COMPLETED|Overall Study||0||
48632557|NCT02667639|101885272|FG001|NOT COMPLETED|Overall Study||0||
48180103|NCT00570258|100761894|FG001|COMPLETED|Overall Study||0||
48632558|NCT00486044|101885273|FG000|STARTED|Overall Study||51||
48632559|NCT00486044|101885274|FG001|STARTED|Overall Study||49||
48180104|NCT00570258|100761893|FG000|NOT COMPLETED|Overall Study||12||
48180105|NCT00570258|100761894|FG001|NOT COMPLETED|Overall Study||15||
48180106|NCT05546411|100761895|FG000|STARTED|Overall Study||6||
48180107|NCT05546411|100761896|FG001|STARTED|Overall Study||2||
48180108|NCT05546411|100761895|FG000|COMPLETED|Overall Study||4||
48180109|NCT05546411|100761896|FG001|COMPLETED|Overall Study||1||
48180110|NCT05546411|100761895|FG000|NOT COMPLETED|Overall Study||2||
48180111|NCT05546411|100761896|FG001|NOT COMPLETED|Overall Study||1||
48180112|NCT02631603|100761897|FG000|STARTED|Overall Study||1||
48180113|NCT02631603|100761898|FG001|STARTED|Overall Study||3||
48180114|NCT02631603|100761897|FG000|COMPLETED|Overall Study||1||
48180115|NCT02631603|100761898|FG001|COMPLETED|Overall Study||3||
48180116|NCT02631603|100761897|FG000|NOT COMPLETED|Overall Study||0||
48340729|NCT01446809|101163904|FG001|NOT COMPLETED|Overall Study||0||
48340730|NCT01446809|101163905|FG002|NOT COMPLETED|Overall Study||2||
48340731|NCT04067518|101163906|FG000|STARTED|Overall Study||3||
48340732|NCT04067518|101163907|FG001|STARTED|Overall Study||25||
48340733|NCT04067518|101163906|FG000|Safety Analysis Set|Overall Study||3|Safety Analysis Set (SAF) included all participants who had received at least one dose of SHP674 in Part 1 or Part 2 of the study.|
48340734|NCT04067518|101163907|FG001|Safety Analysis Set|Overall Study||23|Safety Analysis Set (SAF) included all participants who had received at least one dose of SHP674 in Part 1 or Part 2 of the study.|
48439949|NCT03099265|101409991|FG000|Per Protocol Week 24|Overall Study||4||
48632560|NCT00486044|101885273|FG000|COMPLETED|Overall Study||49||
48632561|NCT00486044|101885274|FG001|COMPLETED|Overall Study||46||
48180117|NCT02631603|100761898|FG001|NOT COMPLETED|Overall Study||0||
48754701|NCT05280717|102187765|FG000|COMPLETED|Part B (Up to Week 35)||0||
48754702|NCT05280717|102187766|FG001|COMPLETED|Part B (Up to Week 35)||0||
48180118|NCT04281498|100761899|FG000|STARTED|Overall Study||6||
48180119|NCT04281498|100761899|FG000|COMPLETED|Overall Study||3||
48180120|NCT04281498|100761899|FG000|NOT COMPLETED|Overall Study||3||
48180121|NCT03092674|100761900|FG000|STARTED|Overall Study||26||
48180122|NCT03092674|100761901|FG001|STARTED|Overall Study||25||
48180123|NCT03092674|100761902|FG002|STARTED|Overall Study||25||
48180124|NCT03092674|100761900|FG000|COMPLETED|Overall Study||0||
48180125|NCT03092674|100761901|FG001|COMPLETED|Overall Study||0||
48180126|NCT03092674|100761902|FG002|COMPLETED|Overall Study||0||
48180127|NCT03092674|100761900|FG000|NOT COMPLETED|Overall Study||26||
48180128|NCT03092674|100761901|FG001|NOT COMPLETED|Overall Study||25||
48180129|NCT03092674|100761902|FG002|NOT COMPLETED|Overall Study||25||
48180130|NCT02343575|100761903|FG000|STARTED|Overall Study||1||
48180131|NCT02343575|100761904|FG001|STARTED|Overall Study||2||
48180132|NCT02343575|100761903|FG000|COMPLETED|Overall Study||1||
48180133|NCT02343575|100761904|FG001|COMPLETED|Overall Study||2||
48180134|NCT02343575|100761903|FG000|NOT COMPLETED|Overall Study||0||
48180135|NCT02343575|100761904|FG001|NOT COMPLETED|Overall Study||0||
48180136|NCT04963764|100761905|FG000|STARTED|Stage 1||5||
48180137|NCT04963764|100761906|FG001|STARTED|Stage 1||0||
48180138|NCT04963764|100761907|FG002|STARTED|Stage 1||0||
48180139|NCT04963764|100761905|FG000|COMPLETED|Stage 1||5||
48180140|NCT04963764|100761906|FG001|COMPLETED|Stage 1||0||
48180141|NCT04963764|100761907|FG002|COMPLETED|Stage 1||0||
48180142|NCT04963764|100761905|FG000|NOT COMPLETED|Stage 1||0||
48180143|NCT04963764|100761906|FG001|NOT COMPLETED|Stage 1||0||
48180144|NCT04963764|100761907|FG002|NOT COMPLETED|Stage 1||0||
48180145|NCT04963764|100761905|FG000|STARTED|Stage 2||0||
48180146|NCT04963764|100761906|FG001|STARTED|Stage 2||0||
48180147|NCT04963764|100761907|FG002|STARTED|Stage 2||1||
48180148|NCT04963764|100761905|FG000|COMPLETED|Stage 2||0||
48180149|NCT04963764|100761906|FG001|COMPLETED|Stage 2||0||
48180150|NCT04963764|100761907|FG002|COMPLETED|Stage 2||0||
48180151|NCT04963764|100761905|FG000|NOT COMPLETED|Stage 2||0||
48180152|NCT04963764|100761906|FG001|NOT COMPLETED|Stage 2||0||
48180153|NCT04963764|100761907|FG002|NOT COMPLETED|Stage 2||1||
48180154|NCT02035787|100761908|FG000|STARTED|Overall Study- 12 Months||12||
48180155|NCT02035787|100761909|FG001|STARTED|Overall Study- 12 Months||8||
48180156|NCT02035787|100761908|FG000|COMPLETED|Overall Study- 12 Months||4||
48340735|NCT04067518|101163906|FG000|- Standard Risk(SR)/Intermediate Risk (IR)|Overall Study||3||
48340736|NCT04067518|101163907|FG001|- Standard Risk(SR)/Intermediate Risk (IR)|Overall Study||21||
48754703|NCT05280717|102187767|FG002|COMPLETED|Part B (Up to Week 35)||0||
48754704|NCT05280717|102187768|FG003|COMPLETED|Part B (Up to Week 35)||0||
48754705|NCT05280717|102187769|FG004|COMPLETED|Part B (Up to Week 35)||0||
48754706|NCT05280717|102187770|FG005|COMPLETED|Part B (Up to Week 35)||0||
48180157|NCT02035787|100761909|FG001|COMPLETED|Overall Study- 12 Months||6||
48180158|NCT02035787|100761908|FG000|NOT COMPLETED|Overall Study- 12 Months||8||
48180159|NCT02035787|100761909|FG001|NOT COMPLETED|Overall Study- 12 Months||2||
48180160|NCT02035787|100761908|FG000|STARTED|Overall Study -6 Months||12||
48180161|NCT02035787|100761909|FG001|STARTED|Overall Study -6 Months||8||
48180162|NCT02035787|100761908|FG000|COMPLETED|Overall Study -6 Months||7||
48180163|NCT02035787|100761909|FG001|COMPLETED|Overall Study -6 Months||7||
48180164|NCT02035787|100761908|FG000|NOT COMPLETED|Overall Study -6 Months||5||
48180165|NCT02035787|100761909|FG001|NOT COMPLETED|Overall Study -6 Months||1||
48180166|NCT05035654|100761910|FG000|STARTED|Overall Study||3||
48180167|NCT05035654|100761911|FG001|STARTED|Overall Study||24||
48180168|NCT05035654|100761912|FG002|STARTED|Overall Study||21||
48180169|NCT05035654|100761910|FG000|COMPLETED|Overall Study||2||
48180170|NCT05035654|100761911|FG001|COMPLETED|Overall Study||22||
48180171|NCT05035654|100761912|FG002|COMPLETED|Overall Study||17||
48180172|NCT05035654|100761910|FG000|NOT COMPLETED|Overall Study||1||
48180173|NCT05035654|100761911|FG001|NOT COMPLETED|Overall Study||2||
48180174|NCT05035654|100761912|FG002|NOT COMPLETED|Overall Study||4||
48180175|NCT03237013|100764799|FG000|STARTED|Baseline to Immediate Post-treatment||73||
48180176|NCT03237013|100764800|FG001|STARTED|Baseline to Immediate Post-treatment||73||
48180177|NCT03237013|100764801|FG002|STARTED|Baseline to Immediate Post-treatment||73||
48180178|NCT03237013|100764799|FG000|COMPLETED|Baseline to Immediate Post-treatment||73||
48180179|NCT03237013|100764800|FG001|COMPLETED|Baseline to Immediate Post-treatment||73||
48754707|NCT05280717|102187771|FG006|COMPLETED|Part B (Up to Week 35)||0||
48754708|NCT05280717|102187765|FG000|NOT COMPLETED|Part B (Up to Week 35)||0||
48754709|NCT05280717|102187766|FG001|NOT COMPLETED|Part B (Up to Week 35)||0||
48180180|NCT03237013|100764801|FG002|COMPLETED|Baseline to Immediate Post-treatment||73||
48180181|NCT03237013|100764799|FG000|NOT COMPLETED|Baseline to Immediate Post-treatment||0||
48754710|NCT05280717|102187767|FG002|NOT COMPLETED|Part B (Up to Week 35)||0||
48180182|NCT03237013|100764800|FG001|NOT COMPLETED|Baseline to Immediate Post-treatment||0||
48180183|NCT03237013|100764801|FG002|NOT COMPLETED|Baseline to Immediate Post-treatment||0||
48180184|NCT03237013|100764799|FG000|STARTED|Immediate Post-treatment to 1-mo F/u||73||
48180185|NCT03237013|100764800|FG001|STARTED|Immediate Post-treatment to 1-mo F/u||73||
48180186|NCT03237013|100764801|FG002|STARTED|Immediate Post-treatment to 1-mo F/u||73||
48188648|NCT01118962|100783298|FG000|NOT COMPLETED|Overall Study||10||
48180187|NCT03237013|100764799|FG000|COMPLETED|Immediate Post-treatment to 1-mo F/u||30|The number of participants who responded to the follow-up survey 1 month after intervention|
48180188|NCT03237013|100764800|FG001|COMPLETED|Immediate Post-treatment to 1-mo F/u||43|The number of participants who responded to the follow-up survey 1 month after intervention|
48180189|NCT03237013|100764801|FG002|COMPLETED|Immediate Post-treatment to 1-mo F/u||36|The number of participants who responded to the follow-up survey 1 month after intervention|
48180190|NCT03237013|100764799|FG000|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||43||
48180191|NCT03237013|100764800|FG001|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||30||
48180192|NCT03237013|100764801|FG002|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||37||
48180193|NCT03744559|100764802|FG000|STARTED|Overall Study||81||
48180194|NCT03744559|100764803|FG001|STARTED|Overall Study||82||
48180195|NCT03744559|100764802|FG000|COMPLETED|Overall Study||48||
48632562|NCT00486044|101885273|FG000|NOT COMPLETED|Overall Study||2||
48632563|NCT00486044|101885274|FG001|NOT COMPLETED|Overall Study||3||
48180196|NCT03744559|100764803|FG001|COMPLETED|Overall Study||51||
48180197|NCT03744559|100764802|FG000|NOT COMPLETED|Overall Study||33||
48180198|NCT03744559|100764803|FG001|NOT COMPLETED|Overall Study||31||
48180199|NCT01190176|100764804|FG000|STARTED|Overall Study||32||
48180200|NCT01190176|100764804|FG000|COMPLETED|Overall Study||30||
48180201|NCT01190176|100764804|FG000|NOT COMPLETED|Overall Study||2||
48180202|NCT04927364|100764805|FG000|STARTED|Overall Study||8||
48180203|NCT04927364|100764805|FG000|Received TMS Treatment|Overall Study||6||
48180204|NCT04927364|100764805|FG000|COMPLETED|Overall Study||4||
48180205|NCT04927364|100764805|FG000|NOT COMPLETED|Overall Study||4||
48180206|NCT00075803|100764806|FG000|STARTED|Overall Study||295||
48180207|NCT00075803|100764807|FG001|STARTED|Overall Study||305||
48180208|NCT00075803|100764806|FG000|COMPLETED|Overall Study||295||
48180209|NCT00075803|100764807|FG001|COMPLETED|Overall Study||305||
48180210|NCT00075803|100764806|FG000|NOT COMPLETED|Overall Study||0||
48180211|NCT00075803|100764807|FG001|NOT COMPLETED|Overall Study||0||
48180212|NCT05723575|100764808|FG000|STARTED|Overall Study||15||
48180213|NCT05723575|100764808|FG000|COMPLETED|Overall Study||15||
48180214|NCT05723575|100764808|FG000|NOT COMPLETED|Overall Study||0||
48180215|NCT02367014|100764809|FG000|STARTED|Overall Study||9||
48180216|NCT02367014|100764810|FG001|STARTED|Overall Study||9||
48180217|NCT02367014|100764811|FG002|STARTED|Overall Study||9||
48180218|NCT02367014|100764812|FG003|STARTED|Overall Study||9||
48180219|NCT02367014|100764809|FG000|COMPLETED|Overall Study||9||
48180220|NCT02367014|100764810|FG001|COMPLETED|Overall Study||9||
48180221|NCT02367014|100764811|FG002|COMPLETED|Overall Study||9||
48180222|NCT02367014|100764812|FG003|COMPLETED|Overall Study||9||
48180223|NCT02367014|100764809|FG000|NOT COMPLETED|Overall Study||0||
48180224|NCT02367014|100764810|FG001|NOT COMPLETED|Overall Study||0||
48180225|NCT02367014|100764811|FG002|NOT COMPLETED|Overall Study||0||
48180226|NCT02367014|100764812|FG003|NOT COMPLETED|Overall Study||0||
48180227|NCT01155726|100764813|FG000|STARTED|Period 1, 3 Days (Masked)||24||
48180228|NCT01155726|100764814|FG001|STARTED|Period 1, 3 Days (Masked)||20||
48180229|NCT01155726|100764815|FG002|STARTED|Period 1, 3 Days (Masked)||30||
48180230|NCT01155726|100764816|FG003|STARTED|Period 1, 3 Days (Masked)||25||
48180231|NCT01155726|100764813|FG000|COMPLETED|Period 1, 3 Days (Masked)||23||
48413573|NCT02380703|101345855|FG001|Month 12|Overall Study||100|This is the number of PWD who reached the Month 12 assessment window.|
48413574|NCT02380703|101345854|FG000|COMPLETED|Overall Study||78|This is the number of PWD who completed the Month 12 assessment.|
48413575|NCT02380703|101345855|FG001|COMPLETED|Overall Study||78|This is the number of PWD who completed the Month 12 assessment.|
48413576|NCT02380703|101345854|FG000|NOT COMPLETED|Overall Study||36||
48413577|NCT02380703|101345855|FG001|NOT COMPLETED|Overall Study||36||
48632564|NCT02382939|101885275|FG000|STARTED|Overall Study||31||
48632565|NCT02382939|101885276|FG001|STARTED|Overall Study||61||
48632566|NCT02382939|101885275|FG000|Exposed|Overall Study||31||
48632567|NCT02382939|101885276|FG001|Exposed|Overall Study||61||
48180232|NCT01155726|100764814|FG001|COMPLETED|Period 1, 3 Days (Masked)||20||
48180233|NCT01155726|100764815|FG002|COMPLETED|Period 1, 3 Days (Masked)||28||
48413578|NCT01081951|101345856|FG000|STARTED|Overall Study||81||
48413579|NCT01081951|101345857|FG001|STARTED|Overall Study||81||
48632568|NCT02382939|101885275|FG000|COMPLETED|Overall Study||28||
48632569|NCT02382939|101885276|FG001|COMPLETED|Overall Study||58||
48632570|NCT02382939|101885275|FG000|NOT COMPLETED|Overall Study||3||
48632571|NCT02382939|101885276|FG001|NOT COMPLETED|Overall Study||3||
48180234|NCT01155726|100764816|FG003|COMPLETED|Period 1, 3 Days (Masked)||25||
48413580|NCT01081951|101345856|FG000|Received Study Treatment|Overall Study||81||
48413581|NCT01081951|101345857|FG001|Received Study Treatment|Overall Study||75||
48413582|NCT01081951|101345856|FG000|Entered Maintenance Phase|Overall Study||66||
48413583|NCT01081951|101345857|FG001|Entered Maintenance Phase|Overall Study||55||
48180235|NCT01155726|100764813|FG000|NOT COMPLETED|Period 1, 3 Days (Masked)||1||
48180236|NCT01155726|100764814|FG001|NOT COMPLETED|Period 1, 3 Days (Masked)||0||
48180237|NCT01155726|100764815|FG002|NOT COMPLETED|Period 1, 3 Days (Masked)||2||
48180238|NCT01155726|100764816|FG003|NOT COMPLETED|Period 1, 3 Days (Masked)||0||
48180239|NCT01155726|100764813|FG000|STARTED|Period 2, 3 Days (Unmask) or (Partial)||23||
48180240|NCT01155726|100764814|FG001|STARTED|Period 2, 3 Days (Unmask) or (Partial)||20||
48180241|NCT01155726|100764815|FG002|STARTED|Period 2, 3 Days (Unmask) or (Partial)||28||
48180242|NCT01155726|100764816|FG003|STARTED|Period 2, 3 Days (Unmask) or (Partial)||25||
48180243|NCT01155726|100764813|FG000|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||23||
48180244|NCT01155726|100764814|FG001|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||20||
48180245|NCT01155726|100764815|FG002|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||28||
48180246|NCT01155726|100764816|FG003|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||25||
48180247|NCT01155726|100764813|FG000|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0||
48180248|NCT01155726|100764814|FG001|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0||
48180249|NCT01155726|100764815|FG002|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0||
48180250|NCT01155726|100764816|FG003|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0||
48180251|NCT01925781|100764817|FG000|STARTED|Overall Study||5||
48180252|NCT01925781|100764818|FG001|STARTED|Overall Study||5||
48180253|NCT01925781|100764817|FG000|COMPLETED|Overall Study||3||
48180254|NCT01925781|100764818|FG001|COMPLETED|Overall Study||1||
48180255|NCT01925781|100764817|FG000|NOT COMPLETED|Overall Study||2||
48180256|NCT01925781|100764818|FG001|NOT COMPLETED|Overall Study||4||
48180257|NCT00737061|100764819|FG000|STARTED|Waiting Period||645||
48180258|NCT00737061|100764819|FG000|COMPLETED|Waiting Period||570||
48180259|NCT00737061|100764819|FG000|NOT COMPLETED|Waiting Period||75||
48180260|NCT00737061|100764819|FG000|STARTED|1 Year Wearing Period||570||
48180261|NCT00737061|100764819|FG000|COMPLETED|1 Year Wearing Period||553||
48180262|NCT00737061|100764819|FG000|NOT COMPLETED|1 Year Wearing Period||17||
48180263|NCT00810641|100764820|FG000|STARTED|Overall Study||52||
48180264|NCT00810641|100764821|FG001|STARTED|Overall Study||54||
48180265|NCT00810641|100764822|FG002|STARTED|Overall Study||51||
48180266|NCT00810641|100764820|FG000|COMPLETED|Overall Study||52||
48180267|NCT00810641|100764821|FG001|COMPLETED|Overall Study||53||
48180268|NCT00810641|100764822|FG002|COMPLETED|Overall Study||49||
48180269|NCT00810641|100764820|FG000|NOT COMPLETED|Overall Study||0||
48180270|NCT00810641|100764821|FG001|NOT COMPLETED|Overall Study||1||
48180271|NCT00810641|100764822|FG002|NOT COMPLETED|Overall Study||2||
48180272|NCT01619787|100764823|FG000|STARTED|Overall Study||217||
48180273|NCT01619787|100764823|FG000|COMPLETED|Overall Study||212||
48180274|NCT01619787|100764823|FG000|NOT COMPLETED|Overall Study||5||
48180275|NCT00610675|100764824|FG000|STARTED|Overall Study||346||
48180276|NCT00610675|100764824|FG000|Treated|Overall Study||342||
48180277|NCT00610675|100764824|FG000|COMPLETED|Overall Study||126||
48180278|NCT00610675|100764824|FG000|NOT COMPLETED|Overall Study||220||
48180279|NCT00802841|100764825|FG000|STARTED|Overall Study||96||
48180280|NCT00802841|100764826|FG001|STARTED|Overall Study||95||
48180281|NCT00802841|100764825|FG000|Full Analysis Set|Overall Study||96||
48180282|NCT00802841|100764826|FG001|Full Analysis Set|Overall Study||95||
48180283|NCT00802841|100764825|FG000|Safety Set|Overall Study||96||
48180284|NCT00802841|100764826|FG001|Safety Set|Overall Study||93||
48180285|NCT00802841|100764825|FG000|Cross-over Set|Overall Study||13||
48180286|NCT00802841|100764826|FG001|Cross-over Set|Overall Study||56||
48180287|NCT00802841|100764825|FG000|COMPLETED|Overall Study||0||
48180288|NCT00802841|100764826|FG001|COMPLETED|Overall Study||0||
48180289|NCT00802841|100764825|FG000|NOT COMPLETED|Overall Study||96||
48340737|NCT04067518|101163906|FG000|- Hihg Risk (HR)|Overall Study||0||
48340738|NCT04067518|101163907|FG001|- Hihg Risk (HR)|Overall Study||1||
48340739|NCT04067518|101163906|FG000|- Missing|Overall Study||0||
48632572|NCT01147822|101885277|FG000|STARTED|Overall Study||188||
48632573|NCT01147822|101885278|FG001|STARTED|Overall Study||179||
48632574|NCT01147822|101885277|FG000|Not Completed/Ongoing|Overall Study||111||
48632575|NCT01147822|101885278|FG001|Not Completed/Ongoing|Overall Study||102||
48632576|NCT01147822|101885277|FG000|COMPLETED|Overall Study||0||
48632577|NCT01147822|101885278|FG001|COMPLETED|Overall Study||0||
48632578|NCT01147822|101885277|FG000|NOT COMPLETED|Overall Study||188||
48632579|NCT01147822|101885278|FG001|NOT COMPLETED|Overall Study||179||
48632580|NCT00717886|101885279|FG000|STARTED|Overall Study||13||
48632581|NCT00717886|101885279|FG000|COMPLETED|Overall Study||9||
48632582|NCT00717886|101885279|FG000|NOT COMPLETED|Overall Study||4||
48180290|NCT00802841|100764826|FG001|NOT COMPLETED|Overall Study||95||
48180291|NCT01994720|100764827|FG000|STARTED|Overall Study||6589||
48180292|NCT01994720|100764828|FG001|STARTED|Overall Study||6610||
48632583|NCT03334175|101885280|FG000|STARTED|Overall Study||8||
48340740|NCT04067518|101163907|FG001|- Missing|Overall Study||1||
48340741|NCT04067518|101163906|FG000|Full Analysis Set|Overall Study||0|Full analysis set (FAS) included all participants who were enrolled and received SHP674 in Part 2 of the study.|
48632584|NCT03334175|101885281|FG001|STARTED|Overall Study||10||
48632585|NCT03334175|101885280|FG000|COMPLETED|Overall Study||8||
48632586|NCT03334175|101885281|FG001|COMPLETED|Overall Study||9||
48632587|NCT03334175|101885280|FG000|NOT COMPLETED|Overall Study||0||
48180293|NCT01994720|100764827|FG000|COMPLETED|Overall Study||6543||
48180294|NCT01994720|100764828|FG001|COMPLETED|Overall Study||6554||
48180295|NCT01994720|100764827|FG000|NOT COMPLETED|Overall Study||46||
48180296|NCT01994720|100764828|FG001|NOT COMPLETED|Overall Study||56||
48180297|NCT02148718|100764829|FG000|STARTED|Overall Study||86|Intent to Treat (ITT) population: all enrolled participants who received ≥ 1 dose of study drug|
48180298|NCT02148718|100764829|FG000|COMPLETED|Overall Study||55||
48340742|NCT04067518|101163907|FG001|Full Analysis Set|Overall Study||23|Full analysis set (FAS) included all participants who were enrolled and received SHP674 in Part 2 of the study.|
48340743|NCT04067518|101163906|FG000|Immunogenicity Analysis Set|Overall Study||3|Immunogenicity analysis set (IMAS) included all participants who had received at least one dose of SHP674 in Part 1 or Part 2 of the study and had at least one evaluable post-dose sample. If the pre-dose sample was missing it was considered negative.|
48340744|NCT04067518|101163907|FG001|Immunogenicity Analysis Set|Overall Study||22|Immunogenicity analysis set (IMAS) included all participants who had received at least one dose of SHP674 in Part 1 or Part 2 of the study and had at least one evaluable post-dose sample. If the pre-dose sample was missing it was considered negative.|
48340745|NCT04067518|101163906|FG000|Pharmacokinetic Analysis Set|Overall Study||3|Pharmacokinetic (PK) analysis included all participants enrolled in Part 1 or Part 2 who had received first dose of SHP674 at remission induction therapy, who were evaluable for non-compartmental analysis and included only the participants who had sufficient samples collected to provide interpretable PK results with no deviations that might had affected the PK interpretation.|
48340746|NCT04067518|101163907|FG001|Pharmacokinetic Analysis Set|Overall Study||23|Pharmacokinetic (PK) analysis included all participants enrolled in Part 1 or Part 2 who had received first dose of SHP674 at remission induction therapy, who were evaluable for non-compartmental analysis and included only the participants who had sufficient samples collected to provide interpretable PK results with no deviations that might had affected the PK interpretation.|
48340747|NCT04067518|101163906|FG000|COMPLETED|Overall Study||2||
48340748|NCT04067518|101163907|FG001|COMPLETED|Overall Study||20||
48340749|NCT04067518|101163906|FG000|NOT COMPLETED|Overall Study||1||
48340750|NCT04067518|101163907|FG001|NOT COMPLETED|Overall Study||5||
48340751|NCT03897751|101163908|FG000|STARTED|Overall Study||127||
48340752|NCT03897751|101163909|FG001|STARTED|Overall Study||125||
48340753|NCT03897751|101163908|FG000|COMPLETED|Overall Study||121||
48340754|NCT03897751|101163909|FG001|COMPLETED|Overall Study||119||
48340755|NCT03897751|101163908|FG000|NOT COMPLETED|Overall Study||6||
48340756|NCT03897751|101163909|FG001|NOT COMPLETED|Overall Study||6||
48340757|NCT00553462|101163910|FG000|STARTED|Overall Study||75||
48340758|NCT00553462|101163910|FG000|COMPLETED|Overall Study||61||
48340759|NCT00553462|101163910|FG000|NOT COMPLETED|Overall Study||14||
48340760|NCT00947531|101163911|FG000|STARTED|Overall Study||121||
48340761|NCT00947531|101163912|FG001|STARTED|Overall Study||121||
48340762|NCT00947531|101163911|FG000|COMPLETED|Overall Study||107||
48340763|NCT00947531|101163912|FG001|COMPLETED|Overall Study||110||
48340764|NCT00947531|101163911|FG000|NOT COMPLETED|Overall Study||14||
48340765|NCT00947531|101163912|FG001|NOT COMPLETED|Overall Study||11||
48754711|NCT05280717|102187768|FG003|NOT COMPLETED|Part B (Up to Week 35)||0||
48754712|NCT05280717|102187769|FG004|NOT COMPLETED|Part B (Up to Week 35)||0||
48754713|NCT05280717|102187770|FG005|NOT COMPLETED|Part B (Up to Week 35)||0||
48754714|NCT05280717|102187771|FG006|NOT COMPLETED|Part B (Up to Week 35)||0||
48754715|NCT05280717|102187765|FG000|STARTED|Part C (Up to Week 35)||0|Enrolled|
48754716|NCT05280717|102187766|FG001|STARTED|Part C (Up to Week 35)||0|Enrolled|
48754717|NCT05280717|102187767|FG002|STARTED|Part C (Up to Week 35)||0|Enrolled|
48754718|NCT05280717|102187768|FG003|STARTED|Part C (Up to Week 35)||0|Enrolled|
48754719|NCT05280717|102187769|FG004|STARTED|Part C (Up to Week 35)||0|Enrolled|
48754720|NCT05280717|102187770|FG005|STARTED|Part C (Up to Week 35)||100|Enrolled|
48754721|NCT05280717|102187771|FG006|STARTED|Part C (Up to Week 35)||0|Enrolled|
48754722|NCT05280717|102187765|FG000|Safety Population|Part C (Up to Week 35)||0||
48754723|NCT05280717|102187766|FG001|Safety Population|Part C (Up to Week 35)||0||
48754724|NCT05280717|102187767|FG002|Safety Population|Part C (Up to Week 35)||0||
48754725|NCT05280717|102187768|FG003|Safety Population|Part C (Up to Week 35)||0||
48754726|NCT05280717|102187769|FG004|Safety Population|Part C (Up to Week 35)||0||
48754727|NCT05280717|102187770|FG005|Safety Population|Part C (Up to Week 35)||98||
48754728|NCT05280717|102187771|FG006|Safety Population|Part C (Up to Week 35)||0||
48754729|NCT05280717|102187765|FG000|COMPLETED|Part C (Up to Week 35)||0||
48754730|NCT05280717|102187766|FG001|COMPLETED|Part C (Up to Week 35)||0||
48754731|NCT05280717|102187767|FG002|COMPLETED|Part C (Up to Week 35)||0||
48754732|NCT05280717|102187768|FG003|COMPLETED|Part C (Up to Week 35)||0||
48754733|NCT05280717|102187769|FG004|COMPLETED|Part C (Up to Week 35)||0||
48754734|NCT05280717|102187770|FG005|COMPLETED|Part C (Up to Week 35)||96||
48754735|NCT05280717|102187771|FG006|COMPLETED|Part C (Up to Week 35)||0||
48754736|NCT05280717|102187765|FG000|NOT COMPLETED|Part C (Up to Week 35)||0||
48754737|NCT05280717|102187766|FG001|NOT COMPLETED|Part C (Up to Week 35)||0||
48754738|NCT05280717|102187767|FG002|NOT COMPLETED|Part C (Up to Week 35)||0||
48754739|NCT05280717|102187768|FG003|NOT COMPLETED|Part C (Up to Week 35)||0||
48754740|NCT05280717|102187769|FG004|NOT COMPLETED|Part C (Up to Week 35)||0||
48754741|NCT05280717|102187770|FG005|NOT COMPLETED|Part C (Up to Week 35)||4||
48754742|NCT05280717|102187771|FG006|NOT COMPLETED|Part C (Up to Week 35)||0||
48754743|NCT00534365|102187772|FG000|STARTED|Overall Study||127||
48754744|NCT00534365|102187773|FG001|STARTED|Overall Study||136||
48754745|NCT00534365|102187772|FG000|Received Procedure|Overall Study||127||
48754746|NCT00534365|102187773|FG001|Received Procedure|Overall Study||129||
48754747|NCT00534365|102187772|FG000|Any Follow up|Overall Study||126||
48754748|NCT00534365|102187773|FG001|Any Follow up|Overall Study||135||
48754749|NCT00534365|102187772|FG000|Follow up at 12 Months or More|Overall Study||119||
48754750|NCT00534365|102187773|FG001|Follow up at 12 Months or More|Overall Study||128||
48754751|NCT00534365|102187772|FG000|Included in Intent to Treat Analysis|Overall Study||127||
48754752|NCT00534365|102187773|FG001|Included in Intent to Treat Analysis|Overall Study||136||
48754753|NCT00534365|102187772|FG000|COMPLETED|Overall Study||127|Included in per protocol|
48754754|NCT00534365|102187773|FG001|COMPLETED|Overall Study||129|Included in per protocol|
48754755|NCT00534365|102187772|FG000|NOT COMPLETED|Overall Study||0||
48754756|NCT00534365|102187773|FG001|NOT COMPLETED|Overall Study||7||
48340766|NCT01474590|101163913|FG000|STARTED|Overall Study||133||
48340767|NCT01474590|101163914|FG001|STARTED|Overall Study||133||
48340768|NCT01474590|101163913|FG000|COMPLETED|Overall Study||105||
48340769|NCT01474590|101163914|FG001|COMPLETED|Overall Study||116||
48340770|NCT01474590|101163913|FG000|NOT COMPLETED|Overall Study||28||
48340771|NCT01474590|101163914|FG001|NOT COMPLETED|Overall Study||17||
48340772|NCT02198833|101163915|FG000|STARTED|Overall Study||1||
48340773|NCT02198833|101163916|FG001|STARTED|Overall Study||1||
48340774|NCT02198833|101163915|FG000|COMPLETED|Overall Study||1||
48340775|NCT02198833|101163916|FG001|COMPLETED|Overall Study||1||
48340776|NCT02198833|101163915|FG000|NOT COMPLETED|Overall Study||0||
48340777|NCT02198833|101163916|FG001|NOT COMPLETED|Overall Study||0||
48340778|NCT01261819|101163917|FG000|STARTED|Overall Study||33||
48340779|NCT01261819|101163918|FG001|STARTED|Overall Study||33||
48340780|NCT01261819|101163917|FG000|COMPLETED|Overall Study||33||
48340781|NCT01261819|101163918|FG001|COMPLETED|Overall Study||33||
48340782|NCT01261819|101163917|FG000|NOT COMPLETED|Overall Study||0||
48340783|NCT01261819|101163918|FG001|NOT COMPLETED|Overall Study||0||
48340784|NCT00059202|101163919|FG000|STARTED|Overall Study||76||
48340785|NCT00059202|101163920|FG001|STARTED|Overall Study||74||
48340786|NCT00059202|101163919|FG000|COMPLETED|Overall Study||70||
48340787|NCT00059202|101163920|FG001|COMPLETED|Overall Study||59||
48340788|NCT00059202|101163919|FG000|NOT COMPLETED|Overall Study||6||
48340789|NCT00059202|101163920|FG001|NOT COMPLETED|Overall Study||15||
48340790|NCT05210504|101163921|FG000|STARTED|Overall Study||17||
48340791|NCT05210504|101163921|FG000|COMPLETED|Overall Study||17||
48340792|NCT05210504|101163921|FG000|NOT COMPLETED|Overall Study||0||
48340793|NCT01246206|101163922|FG000|STARTED|Overall Study||21||
48340794|NCT01246206|101163922|FG000|COMPLETED|Overall Study||20||
48340795|NCT01246206|101163922|FG000|NOT COMPLETED|Overall Study||1||
48340796|NCT02168686|101163923|FG000|STARTED|Overall Study||2||
48340797|NCT02168686|101163924|FG001|STARTED|Overall Study||2||
48340798|NCT02168686|101163925|FG002|STARTED|Overall Study||2||
48340799|NCT02168686|101163923|FG000|COMPLETED|Overall Study||2||
48340800|NCT02168686|101163924|FG001|COMPLETED|Overall Study||2||
48340801|NCT02168686|101163925|FG002|COMPLETED|Overall Study||2||
48340802|NCT02168686|101163923|FG000|NOT COMPLETED|Overall Study||0||
48340803|NCT02168686|101163924|FG001|NOT COMPLETED|Overall Study||0||
48340804|NCT02168686|101163925|FG002|NOT COMPLETED|Overall Study||0||
48340805|NCT02914509|101163926|FG000|STARTED|Overall Study||348||
48340806|NCT02914509|101163927|FG001|STARTED|Overall Study||217||
48340807|NCT02914509|101163926|FG000|COMPLETED|Overall Study||343||
48340808|NCT02914509|101163927|FG001|COMPLETED|Overall Study||211||
48340809|NCT02914509|101163926|FG000|NOT COMPLETED|Overall Study||5||
48340810|NCT02914509|101163927|FG001|NOT COMPLETED|Overall Study||6||
48340811|NCT00893516|101163928|FG000|STARTED|Overall Study||0||
48340812|NCT00893516|101163929|FG001|STARTED|Overall Study||0||
48340813|NCT00893516|101163928|FG000|COMPLETED|Overall Study||0||
48340814|NCT00893516|101163929|FG001|COMPLETED|Overall Study||0||
48340815|NCT00893516|101163928|FG000|NOT COMPLETED|Overall Study||0||
48340816|NCT00893516|101163929|FG001|NOT COMPLETED|Overall Study||0||
48340817|NCT02487108|101163930|FG000|STARTED|Overall Study||142||
48340818|NCT02487108|101163931|FG001|STARTED|Overall Study||142||
48340819|NCT02487108|101163932|FG002|STARTED|Overall Study||143||
48340820|NCT02487108|101163933|FG003|STARTED|Overall Study||142||
48340821|NCT02487108|101163930|FG000|Received at Least 1 Dose of Study Drug|Overall Study||142||
48340822|NCT02487108|101163931|FG001|Received at Least 1 Dose of Study Drug|Overall Study||142||
48340823|NCT02487108|101163932|FG002|Received at Least 1 Dose of Study Drug|Overall Study||141||
48340824|NCT02487108|101163933|FG003|Received at Least 1 Dose of Study Drug|Overall Study||142||
48340825|NCT02487108|101163930|FG000|COMPLETED|Overall Study||126||
48340826|NCT02487108|101163931|FG001|COMPLETED|Overall Study||126||
48340827|NCT02487108|101163932|FG002|COMPLETED|Overall Study||117||
48340828|NCT02487108|101163933|FG003|COMPLETED|Overall Study||131||
48754757|NCT03273426|102187774|FG000|STARTED|Overall Study||20||
48754758|NCT03273426|102187775|FG001|STARTED|Overall Study||20||
48754759|NCT03273426|102187774|FG000|COMPLETED|Overall Study||20||
48754760|NCT03273426|102187775|FG001|COMPLETED|Overall Study||20||
48754761|NCT03273426|102187774|FG000|NOT COMPLETED|Overall Study||0||
48340829|NCT02487108|101163930|FG000|NOT COMPLETED|Overall Study||16||
48340830|NCT02487108|101163931|FG001|NOT COMPLETED|Overall Study||16||
48340831|NCT02487108|101163932|FG002|NOT COMPLETED|Overall Study||26||
48754762|NCT03273426|102187775|FG001|NOT COMPLETED|Overall Study||0||
48340832|NCT02487108|101163933|FG003|NOT COMPLETED|Overall Study||11||
48340833|NCT01869348|101163934|FG000|STARTED|Overall Study||20||
48340834|NCT01869348|101163935|FG001|STARTED|Overall Study||20||
48340835|NCT01869348|101163934|FG000|COMPLETED|Overall Study||19||
48340836|NCT01869348|101163935|FG001|COMPLETED|Overall Study||19||
48754763|NCT04755816|102187776|FG000|STARTED|Overall Study||12||
48754764|NCT04755816|102187777|FG001|STARTED|Overall Study||20||
48754765|NCT04755816|102187778|FG002|STARTED|Overall Study||12||
48754766|NCT04755816|102187779|FG003|STARTED|Overall Study||18||
48754767|NCT04755816|102187776|FG000|COMPLETED|Overall Study||12||
48754768|NCT04755816|102187777|FG001|COMPLETED|Overall Study||20||
48754769|NCT04755816|102187778|FG002|COMPLETED|Overall Study||12||
48754770|NCT04755816|102187779|FG003|COMPLETED|Overall Study||18||
48754771|NCT04755816|102187776|FG000|NOT COMPLETED|Overall Study||0||
48754772|NCT04755816|102187777|FG001|NOT COMPLETED|Overall Study||0||
48754773|NCT04755816|102187778|FG002|NOT COMPLETED|Overall Study||0||
48754774|NCT04755816|102187779|FG003|NOT COMPLETED|Overall Study||0||
48754775|NCT00584948|102187780|FG000|STARTED|Overall Study||47||
48754776|NCT00584948|102187781|FG001|STARTED|Overall Study||47||
48754777|NCT00584948|102187780|FG000|COMPLETED|Overall Study||34||
48754778|NCT00584948|102187781|FG001|COMPLETED|Overall Study||36||
48754779|NCT00584948|102187780|FG000|NOT COMPLETED|Overall Study||13||
48754780|NCT00584948|102187781|FG001|NOT COMPLETED|Overall Study||11||
48754781|NCT02972931|102187782|FG000|STARTED|Overall Study||30||
48754782|NCT02972931|102187783|FG001|STARTED|Overall Study||32||
48754783|NCT02972931|102187782|FG000|COMPLETED|Overall Study||22||
48754784|NCT02972931|102187783|FG001|COMPLETED|Overall Study||22||
48754785|NCT02972931|102187782|FG000|NOT COMPLETED|Overall Study||8||
48754786|NCT02972931|102187783|FG001|NOT COMPLETED|Overall Study||10||
48754787|NCT02970799|102187784|FG000|STARTED|Overall Study||0||
48754788|NCT02970799|102187785|FG001|STARTED|Overall Study||0||
48754789|NCT02970799|102187784|FG000|COMPLETED|Overall Study||0||
48754790|NCT02970799|102187785|FG001|COMPLETED|Overall Study||0||
48754791|NCT02970799|102187784|FG000|NOT COMPLETED|Overall Study||0||
48754792|NCT02970799|102187785|FG001|NOT COMPLETED|Overall Study||0||
48754793|NCT00449696|102187786|FG000|STARTED|Overall Study||251||
48754794|NCT00449696|102187787|FG001|STARTED|Overall Study||128||
48754795|NCT00449696|102187786|FG000|Received Injection|Overall Study||249||
48754796|NCT00449696|102187787|FG001|Received Injection|Overall Study||128||
48340837|NCT01869348|101163934|FG000|NOT COMPLETED|Overall Study||1||
48340838|NCT01869348|101163935|FG001|NOT COMPLETED|Overall Study||1||
48340839|NCT00997516|101163936|FG000|STARTED|Short-term Follow-up (Post Operative)||37||
48340840|NCT00997516|101163937|FG001|STARTED|Short-term Follow-up (Post Operative)||38||
48340841|NCT00997516|101163936|FG000|COMPLETED|Short-term Follow-up (Post Operative)||37||
48340842|NCT00997516|101163937|FG001|COMPLETED|Short-term Follow-up (Post Operative)||38||
48340843|NCT00997516|101163936|FG000|NOT COMPLETED|Short-term Follow-up (Post Operative)||0||
48754797|NCT00449696|102187786|FG000|Analyzed Participants|Overall Study||247||
48754798|NCT00449696|102187787|FG001|Analyzed Participants|Overall Study||128||
48754799|NCT00449696|102187786|FG000|COMPLETED|Overall Study||231||
48754800|NCT00449696|102187787|FG001|COMPLETED|Overall Study||119||
48754801|NCT00449696|102187786|FG000|NOT COMPLETED|Overall Study||20||
48754802|NCT00449696|102187787|FG001|NOT COMPLETED|Overall Study||9||
48754803|NCT02384551|102187788|FG000|STARTED|Overall Study||35||
48340844|NCT00997516|101163937|FG001|NOT COMPLETED|Short-term Follow-up (Post Operative)||0||
48340845|NCT00997516|101163936|FG000|STARTED|Long-term Follow-up (After 6 Months)||37||
48340846|NCT00997516|101163937|FG001|STARTED|Long-term Follow-up (After 6 Months)||38||
48340847|NCT00997516|101163936|FG000|COMPLETED|Long-term Follow-up (After 6 Months)||31||
48340848|NCT00997516|101163937|FG001|COMPLETED|Long-term Follow-up (After 6 Months)||36||
48439950|NCT03099265|101409991|FG000|COMPLETED|Overall Study||8||
48754804|NCT02384551|102187789|FG001|STARTED|Overall Study||40||
48340849|NCT00997516|101163936|FG000|NOT COMPLETED|Long-term Follow-up (After 6 Months)||6||
48340850|NCT00997516|101163937|FG001|NOT COMPLETED|Long-term Follow-up (After 6 Months)||2||
48340851|NCT03882424|101163938|FG000|STARTED|Overall Study||38||
48340852|NCT03882424|101163939|FG001|STARTED|Overall Study||38||
48340853|NCT03882424|101163940|FG002|STARTED|Overall Study||38||
48754805|NCT02384551|102187790|FG002|STARTED|Overall Study||36||
48754806|NCT02384551|102187791|FG003|STARTED|Overall Study||39||
48754807|NCT02384551|102187788|FG000|COMPLETED|Overall Study||22||
48754808|NCT02384551|102187789|FG001|COMPLETED|Overall Study||26||
48754809|NCT02384551|102187790|FG002|COMPLETED|Overall Study||22||
48754810|NCT02384551|102187791|FG003|COMPLETED|Overall Study||25||
48180299|NCT02148718|100764829|FG000|NOT COMPLETED|Overall Study||31||
48340854|NCT03882424|101163938|FG000|COMPLETED|Overall Study||34||
48340855|NCT03882424|101163939|FG001|COMPLETED|Overall Study||38||
48754811|NCT02384551|102187788|FG000|NOT COMPLETED|Overall Study||13||
48754812|NCT02384551|102187789|FG001|NOT COMPLETED|Overall Study||14||
48754813|NCT02384551|102187790|FG002|NOT COMPLETED|Overall Study||14||
48754814|NCT02384551|102187791|FG003|NOT COMPLETED|Overall Study||14||
48754815|NCT06308822|102187792|FG000|STARTED|Overall Study||35||
48754816|NCT06308822|102187792|FG000|Eligible|Overall Study||34||
48754817|NCT06308822|102187792|FG000|Started Protocol Therapy|Overall Study||34||
48754818|NCT06308822|102187792|FG000|Eligible and Treated|Overall Study||33||
48754819|NCT06308822|102187792|FG000|Mutation Status Confirmed|Overall Study||18||
48754820|NCT06308822|102187792|FG000|Eligible, Treated and Mutation Status Confirmed|Overall Study||18|Primary efficacy analysis population|
48754821|NCT06308822|102187792|FG000|COMPLETED|Overall Study||0|Treatment continued until disease progression or intolerability|
48754822|NCT06308822|102187792|FG000|NOT COMPLETED|Overall Study||35||
48754823|NCT03960541|102187793|FG000|STARTED|Overall Study||4||
48754824|NCT03960541|102187794|FG001|STARTED|Overall Study||4||
48754825|NCT03960541|102187793|FG000|COMPLETED|Overall Study||4||
48754826|NCT03960541|102187794|FG001|COMPLETED|Overall Study||4||
48754827|NCT03960541|102187793|FG000|NOT COMPLETED|Overall Study||0||
48754828|NCT03960541|102187794|FG001|NOT COMPLETED|Overall Study||0||
48754829|NCT04349891|102187795|FG000|STARTED|First Intervention - 4 Weeks||15||
48754830|NCT04349891|102187796|FG001|STARTED|First Intervention - 4 Weeks||12||
48754831|NCT04349891|102187795|FG000|COMPLETED|First Intervention - 4 Weeks||11||
48754832|NCT04349891|102187796|FG001|COMPLETED|First Intervention - 4 Weeks||7||
48754833|NCT04349891|102187795|FG000|NOT COMPLETED|First Intervention - 4 Weeks||4||
48754834|NCT04349891|102187796|FG001|NOT COMPLETED|First Intervention - 4 Weeks||5||
48754835|NCT04349891|102187795|FG000|STARTED|Washout - 2 Weeks||11||
48754836|NCT04349891|102187796|FG001|STARTED|Washout - 2 Weeks||7||
48754837|NCT04349891|102187795|FG000|COMPLETED|Washout - 2 Weeks||10||
48754838|NCT04349891|102187796|FG001|COMPLETED|Washout - 2 Weeks||7||
48754839|NCT04349891|102187795|FG000|NOT COMPLETED|Washout - 2 Weeks||1||
48754840|NCT04349891|102187796|FG001|NOT COMPLETED|Washout - 2 Weeks||0||
48754841|NCT04349891|102187795|FG000|STARTED|Second Intervention - 4 Weeks||10||
48754842|NCT04349891|102187796|FG001|STARTED|Second Intervention - 4 Weeks||7||
48754843|NCT04349891|102187795|FG000|COMPLETED|Second Intervention - 4 Weeks||8||
48754844|NCT04349891|102187796|FG001|COMPLETED|Second Intervention - 4 Weeks||7||
48754845|NCT04349891|102187795|FG000|NOT COMPLETED|Second Intervention - 4 Weeks||2||
48754846|NCT04349891|102187796|FG001|NOT COMPLETED|Second Intervention - 4 Weeks||0||
48754847|NCT05875532|102187797|FG000|STARTED|Overall Study||34960||
48754848|NCT05875532|102187797|FG000|COMPLETED|Overall Study||34960||
48754849|NCT05875532|102187797|FG000|NOT COMPLETED|Overall Study||0||
48754850|NCT02595983|102187798|FG000|STARTED|Overall Study||12||
48754851|NCT02595983|102187798|FG000|COMPLETED|Overall Study||8||
48754852|NCT02595983|102187798|FG000|NOT COMPLETED|Overall Study||4||
48754853|NCT01147042|102187799|FG000|STARTED|Overall Study||2||
48754854|NCT01147042|102187800|FG001|STARTED|Overall Study||0||
48754855|NCT01147042|102187799|FG000|COMPLETED|Overall Study||2||
48754856|NCT01147042|102187800|FG001|COMPLETED|Overall Study||0||
48754857|NCT01147042|102187799|FG000|NOT COMPLETED|Overall Study||0||
48754858|NCT01147042|102187800|FG001|NOT COMPLETED|Overall Study||0||
48754859|NCT02994108|102187801|FG000|STARTED|Intervention Messages||74||
48754860|NCT02994108|102187802|FG001|STARTED|Intervention Messages||76||
48754861|NCT02994108|102187801|FG000|COMPLETED|Intervention Messages||72||
48754862|NCT02994108|102187802|FG001|COMPLETED|Intervention Messages||76||
48754863|NCT02994108|102187801|FG000|NOT COMPLETED|Intervention Messages||2||
48754864|NCT02994108|102187802|FG001|NOT COMPLETED|Intervention Messages||0||
48754865|NCT02994108|102187801|FG000|STARTED|Phase 1 Assessment||72|Enrolled participants were allowed to complete follow-up even if they did not receive all messages.|
48754866|NCT02994108|102187802|FG001|STARTED|Phase 1 Assessment||76|Enrolled participants were allowed to complete follow-up even if they did not receive all messages.|
48754867|NCT02994108|102187801|FG000|COMPLETED|Phase 1 Assessment||67||
48754868|NCT02994108|102187802|FG001|COMPLETED|Phase 1 Assessment||73||
48754869|NCT02994108|102187801|FG000|NOT COMPLETED|Phase 1 Assessment||5||
48754870|NCT02994108|102187802|FG001|NOT COMPLETED|Phase 1 Assessment||3||
48754871|NCT02994108|102187801|FG000|STARTED|Phase 2 Assessment||72|Enrolled participants were allowed to complete follow-up even if they did not receive all messages.|
48754872|NCT02994108|102187802|FG001|STARTED|Phase 2 Assessment||76|Enrolled participants were allowed to complete follow-up even if they did not receive all messages.|
48754873|NCT02994108|102187801|FG000|COMPLETED|Phase 2 Assessment||63||
48754874|NCT02994108|102187802|FG001|COMPLETED|Phase 2 Assessment||69||
48754875|NCT02994108|102187801|FG000|NOT COMPLETED|Phase 2 Assessment||9||
48754876|NCT02994108|102187802|FG001|NOT COMPLETED|Phase 2 Assessment||7||
48754877|NCT01453049|102187803|FG000|STARTED|Overall Study||42||
48754878|NCT01453049|102187804|FG001|STARTED|Overall Study||44||
48754879|NCT01453049|102187803|FG000|COMPLETED|Overall Study||1||
48754880|NCT01453049|102187804|FG001|COMPLETED|Overall Study||2||
48754881|NCT01453049|102187803|FG000|NOT COMPLETED|Overall Study||41||
48754882|NCT01453049|102187804|FG001|NOT COMPLETED|Overall Study||42||
48754883|NCT01690052|102187805|FG000|STARTED|FIRST INTERVENTION: 4 WEEKS||7||
48754884|NCT01690052|102187806|FG001|STARTED|FIRST INTERVENTION: 4 WEEKS||8||
48754885|NCT01690052|102187805|FG000|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6||
48754886|NCT01690052|102187806|FG001|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6||
48754887|NCT01690052|102187805|FG000|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||1||
48754888|NCT01690052|102187806|FG001|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||2||
48754889|NCT01690052|102187805|FG000|STARTED|Washout Period of 1 Week||6||
48754890|NCT01690052|102187806|FG001|STARTED|Washout Period of 1 Week||6||
48754891|NCT01690052|102187805|FG000|COMPLETED|Washout Period of 1 Week||6||
48754892|NCT01690052|102187806|FG001|COMPLETED|Washout Period of 1 Week||6||
48754893|NCT01690052|102187805|FG000|NOT COMPLETED|Washout Period of 1 Week||0||
48754894|NCT01690052|102187806|FG001|NOT COMPLETED|Washout Period of 1 Week||0||
48754895|NCT01690052|102187805|FG000|STARTED|SECOND INTERVENTION: 4 WEEKS||6||
48754896|NCT01690052|102187806|FG001|STARTED|SECOND INTERVENTION: 4 WEEKS||6||
48754897|NCT01690052|102187805|FG000|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6||
48754898|NCT01690052|102187806|FG001|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6||
48754899|NCT01690052|102187805|FG000|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0||
48754900|NCT01690052|102187806|FG001|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0||
48754901|NCT00434226|102187807|FG000|STARTED|Overall Study||30||
48754902|NCT00434226|102187808|FG001|STARTED|Overall Study||26||
48754903|NCT00434226|102187807|FG000|COMPLETED|Overall Study||0||
48754904|NCT00434226|102187808|FG001|COMPLETED|Overall Study||0||
48754905|NCT00434226|102187807|FG000|NOT COMPLETED|Overall Study||30||
48754906|NCT00434226|102187808|FG001|NOT COMPLETED|Overall Study||26||
48754907|NCT02588599|102187809|FG000|STARTED|Overall Study||54||
48754908|NCT02588599|102187809|FG000|COMPLETED|Overall Study||54||
48754909|NCT02588599|102187809|FG000|NOT COMPLETED|Overall Study||0||
48754910|NCT02343263|102187810|FG000|STARTED|Overall Study||5||
48754911|NCT02343263|102187811|FG001|STARTED|Overall Study||3||
48754912|NCT02343263|102187812|FG002|STARTED|Overall Study||1||
48754913|NCT02343263|102187810|FG000|COMPLETED|Overall Study||0|Study closed due for administrative reasons|
48754914|NCT02343263|102187811|FG001|COMPLETED|Overall Study||0|Study closed due for administrative reasons|
48754915|NCT02343263|102187812|FG002|COMPLETED|Overall Study||0|Study closed due for administrative reasons|
48754916|NCT02343263|102187810|FG000|NOT COMPLETED|Overall Study||5||
48754917|NCT02343263|102187811|FG001|NOT COMPLETED|Overall Study||3||
48754918|NCT02343263|102187812|FG002|NOT COMPLETED|Overall Study||1||
48754919|NCT02285855|102187813|FG000|STARTED|Overall Study||16||
48754920|NCT02285855|102187814|FG001|STARTED|Overall Study||2||
48754921|NCT02285855|102187813|FG000|Randomized|Overall Study||16||
48754922|NCT02285855|102187814|FG001|Randomized|Overall Study||2||
48754923|NCT02285855|102187813|FG000|COMPLETED|Overall Study||14||
48754924|NCT02285855|102187814|FG001|COMPLETED|Overall Study||1||
48754925|NCT02285855|102187813|FG000|NOT COMPLETED|Overall Study||2||
48754926|NCT02285855|102187814|FG001|NOT COMPLETED|Overall Study||1||
48754927|NCT02636699|102187815|FG000|STARTED|Overall Study||238||
48754928|NCT02636699|102187816|FG001|STARTED|Overall Study||118||
48754929|NCT02636699|102187815|FG000|COMPLETED|Overall Study||213||
48340856|NCT03882424|101163940|FG002|COMPLETED|Overall Study||38||
48340857|NCT03882424|101163938|FG000|NOT COMPLETED|Overall Study||4||
48340858|NCT03882424|101163939|FG001|NOT COMPLETED|Overall Study||0||
48340859|NCT03882424|101163940|FG002|NOT COMPLETED|Overall Study||0||
48340860|NCT00004054|101163941|FG000|STARTED|Overall Study||197||
48340861|NCT00004054|101163942|FG001|STARTED|Overall Study||200||
48340862|NCT00004054|101163941|FG000|COMPLETED|Overall Study||197||
48340863|NCT00004054|101163942|FG001|COMPLETED|Overall Study||200||
48340864|NCT00004054|101163941|FG000|NOT COMPLETED|Overall Study||0||
48340865|NCT00004054|101163942|FG001|NOT COMPLETED|Overall Study||0||
48340866|NCT03062657|101163943|FG000|STARTED|Overall Study||25||
48632588|NCT03334175|101885281|FG001|NOT COMPLETED|Overall Study||1||
48632589|NCT04239924|101885282|FG000|STARTED|Overall Study||20||
48632590|NCT04239924|101885282|FG000|Caregivers|Overall Study||10||
48632591|NCT04239924|101885282|FG000|Patient With Dementia|Overall Study||10||
48632592|NCT04239924|101885282|FG000|COMPLETED|Overall Study||18||
48632593|NCT04239924|101885282|FG000|NOT COMPLETED|Overall Study||2||
48632594|NCT02456896|101885283|FG000|STARTED|Overall Study||25||
48632595|NCT02456896|101885284|FG001|STARTED|Overall Study||25||
48632596|NCT02456896|101885283|FG000|COMPLETED|Overall Study||19||
48632597|NCT02456896|101885284|FG001|COMPLETED|Overall Study||21||
48632598|NCT02456896|101885283|FG000|NOT COMPLETED|Overall Study||6||
48632599|NCT02456896|101885284|FG001|NOT COMPLETED|Overall Study||4||
48632600|NCT02251275|101885285|FG000|STARTED|Overall Study||506||
48632601|NCT02251275|101885286|FG001|STARTED|Overall Study||570||
48632602|NCT02251275|101885287|FG002|STARTED|Overall Study||718||
48632603|NCT02251275|101885288|FG003|STARTED|Overall Study||6||
48632604|NCT02251275|101885289|FG004|STARTED|Overall Study||3||
48632605|NCT02251275|101885285|FG000|Received at Least 1 Dose of Study Drug|Overall Study||505||
48632606|NCT02251275|101885286|FG001|Received at Least 1 Dose of Study Drug|Overall Study||569||
48632607|NCT02251275|101885287|FG002|Received at Least 1 Dose of Study Drug|Overall Study||717||
48632608|NCT02251275|101885288|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6||
48632609|NCT02251275|101885289|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3||
48632610|NCT02251275|101885285|FG000|COMPLETED|Overall Study||434||
48632611|NCT02251275|101885286|FG001|COMPLETED|Overall Study||423||
48632612|NCT02251275|101885287|FG002|COMPLETED|Overall Study||624||
48632613|NCT02251275|101885288|FG003|COMPLETED|Overall Study||5||
48632614|NCT02251275|101885289|FG004|COMPLETED|Overall Study||2||
48754930|NCT02636699|102187816|FG001|COMPLETED|Overall Study||107||
48754931|NCT02636699|102187815|FG000|NOT COMPLETED|Overall Study||25||
48754932|NCT02636699|102187816|FG001|NOT COMPLETED|Overall Study||11||
48754933|NCT04124939|102187817|FG000|STARTED|Overall Study||21||
48340867|NCT03062657|101163943|FG000|6 Week Follow-Up|Overall Study||25||
48340868|NCT03062657|101163943|FG000|3 Month Follow-Up|Overall Study||18||
48340869|NCT03062657|101163943|FG000|6 Month Follow-Up|Overall Study||17||
48754934|NCT04124939|102187818|FG001|STARTED|Overall Study||20||
48754935|NCT04124939|102187817|FG000|COMPLETED|Overall Study||20||
48754936|NCT04124939|102187818|FG001|COMPLETED|Overall Study||17||
48754937|NCT04124939|102187817|FG000|NOT COMPLETED|Overall Study||1||
48754938|NCT04124939|102187818|FG001|NOT COMPLETED|Overall Study||3||
48754939|NCT00974142|102187819|FG000|STARTED|Overall Study||8||
48754940|NCT00974142|102187820|FG001|STARTED|Overall Study||9||
48754941|NCT00974142|102187819|FG000|COMPLETED|Overall Study||8||
48754942|NCT00974142|102187820|FG001|COMPLETED|Overall Study||9||
48754943|NCT00974142|102187819|FG000|NOT COMPLETED|Overall Study||0||
48754944|NCT00974142|102187820|FG001|NOT COMPLETED|Overall Study||0||
48754945|NCT00303823|102187821|FG000|STARTED|Overall Study||50||
48754946|NCT00303823|102187822|FG001|STARTED|Overall Study||48||
48754947|NCT00303823|102187821|FG000|COMPLETED|Overall Study||35||
48754948|NCT00303823|102187822|FG001|COMPLETED|Overall Study||38||
48754949|NCT00303823|102187821|FG000|NOT COMPLETED|Overall Study||15||
48754950|NCT00303823|102187822|FG001|NOT COMPLETED|Overall Study||10||
48754951|NCT00001832|102187823|FG000|STARTED|Apheresis Period||170||
48754952|NCT00001832|102187824|FG001|STARTED|Apheresis Period||0||
48754953|NCT00001832|102187825|FG002|STARTED|Apheresis Period||0||
48754954|NCT00001832|102187826|FG003|STARTED|Apheresis Period||0||
48754955|NCT00001832|102187827|FG004|STARTED|Apheresis Period||0||
48754956|NCT00001832|102187828|FG005|STARTED|Apheresis Period||0||
48754957|NCT00001832|102187829|FG006|STARTED|Apheresis Period||0||
48754958|NCT00001832|102187830|FG007|STARTED|Apheresis Period||0||
48754959|NCT00001832|102187831|FG008|STARTED|Apheresis Period||0||
48754960|NCT00001832|102187832|FG009|STARTED|Apheresis Period||0||
48754961|NCT00001832|102187833|FG010|STARTED|Apheresis Period||0||
48754962|NCT00001832|102187834|FG011|STARTED|Apheresis Period||0||
48754963|NCT00001832|102187835|FG012|STARTED|Apheresis Period||0||
48754964|NCT00001832|102187836|FG013|STARTED|Apheresis Period||0||
48754965|NCT00001832|102187837|FG014|STARTED|Apheresis Period||0||
48754966|NCT00001832|102187823|FG000|COMPLETED|Apheresis Period||110||
48754967|NCT00001832|102187824|FG001|COMPLETED|Apheresis Period||0||
48754968|NCT00001832|102187825|FG002|COMPLETED|Apheresis Period||0||
48754969|NCT00001832|102187826|FG003|COMPLETED|Apheresis Period||0||
48754970|NCT00001832|102187827|FG004|COMPLETED|Apheresis Period||0||
48754971|NCT00001832|102187828|FG005|COMPLETED|Apheresis Period||0||
48754972|NCT00001832|102187829|FG006|COMPLETED|Apheresis Period||0||
48754973|NCT00001832|102187830|FG007|COMPLETED|Apheresis Period||0||
48754974|NCT00001832|102187831|FG008|COMPLETED|Apheresis Period||0||
48754975|NCT00001832|102187832|FG009|COMPLETED|Apheresis Period||0||
48754976|NCT00001832|102187833|FG010|COMPLETED|Apheresis Period||0||
48754977|NCT00001832|102187834|FG011|COMPLETED|Apheresis Period||0||
48754978|NCT00001832|102187835|FG012|COMPLETED|Apheresis Period||0||
48754979|NCT00001832|102187836|FG013|COMPLETED|Apheresis Period||0||
48754980|NCT00001832|102187837|FG014|COMPLETED|Apheresis Period||0||
48754981|NCT00001832|102187823|FG000|NOT COMPLETED|Apheresis Period||60||
48754982|NCT00001832|102187824|FG001|NOT COMPLETED|Apheresis Period||0||
48754983|NCT00001832|102187825|FG002|NOT COMPLETED|Apheresis Period||0||
48754984|NCT00001832|102187826|FG003|NOT COMPLETED|Apheresis Period||0||
48754985|NCT00001832|102187827|FG004|NOT COMPLETED|Apheresis Period||0||
48754986|NCT00001832|102187828|FG005|NOT COMPLETED|Apheresis Period||0||
48754987|NCT00001832|102187829|FG006|NOT COMPLETED|Apheresis Period||0||
48754988|NCT00001832|102187830|FG007|NOT COMPLETED|Apheresis Period||0||
48754989|NCT00001832|102187831|FG008|NOT COMPLETED|Apheresis Period||0||
48340870|NCT03062657|101163943|FG000|COMPLETED|Overall Study||19||
48754990|NCT00001832|102187832|FG009|NOT COMPLETED|Apheresis Period||0||
48413584|NCT01081951|101345856|FG000|Ongoing Study Treatment at Data Cut-off|Overall Study||11||
48754991|NCT00001832|102187833|FG010|NOT COMPLETED|Apheresis Period||0||
48754992|NCT00001832|102187834|FG011|NOT COMPLETED|Apheresis Period||0||
48754993|NCT00001832|102187835|FG012|NOT COMPLETED|Apheresis Period||0||
48754994|NCT00001832|102187836|FG013|NOT COMPLETED|Apheresis Period||0||
48754995|NCT00001832|102187837|FG014|NOT COMPLETED|Apheresis Period||0||
48754996|NCT00001832|102187823|FG000|STARTED|Treatment Period||0||
48754997|NCT00001832|102187824|FG001|STARTED|Treatment Period||3||
48754998|NCT00001832|102187825|FG002|STARTED|Treatment Period||3||
48754999|NCT00001832|102187826|FG003|STARTED|Treatment Period||3||
48755000|NCT00001832|102187827|FG004|STARTED|Treatment Period||6||
48755001|NCT00001832|102187828|FG005|STARTED|Treatment Period||51||
48755002|NCT00001832|102187829|FG006|STARTED|Treatment Period||4||
48755003|NCT00001832|102187830|FG007|STARTED|Treatment Period||7||
48755004|NCT00001832|102187831|FG008|STARTED|Treatment Period||8||
48755005|NCT00001832|102187832|FG009|STARTED|Treatment Period||6||
48755006|NCT00001832|102187833|FG010|STARTED|Treatment Period||1||
48755007|NCT00001832|102187834|FG011|STARTED|Treatment Period||7||
48755008|NCT00001832|102187835|FG012|STARTED|Treatment Period||6||
48755009|NCT00001832|102187836|FG013|STARTED|Treatment Period||3||
48755010|NCT00001832|102187837|FG014|STARTED|Treatment Period||2||
48755011|NCT00001832|102187823|FG000|COMPLETED|Treatment Period||0||
48755012|NCT00001832|102187824|FG001|COMPLETED|Treatment Period||3||
48755013|NCT00001832|102187825|FG002|COMPLETED|Treatment Period||3||
48755014|NCT00001832|102187826|FG003|COMPLETED|Treatment Period||3||
48755015|NCT00001832|102187827|FG004|COMPLETED|Treatment Period||6||
48755016|NCT00001832|102187828|FG005|COMPLETED|Treatment Period||50||
48755017|NCT00001832|102187829|FG006|COMPLETED|Treatment Period||4||
48755018|NCT00001832|102187830|FG007|COMPLETED|Treatment Period||6||
48755019|NCT00001832|102187831|FG008|COMPLETED|Treatment Period||8||
48755020|NCT00001832|102187832|FG009|COMPLETED|Treatment Period||6||
48755021|NCT00001832|102187833|FG010|COMPLETED|Treatment Period||1||
48755022|NCT00001832|102187834|FG011|COMPLETED|Treatment Period||7||
48755023|NCT00001832|102187835|FG012|COMPLETED|Treatment Period||6||
48180300|NCT01500226|100764830|FG000|STARTED|Overall Study||684||
48180301|NCT01500226|100764831|FG001|STARTED|Overall Study||685||
48180302|NCT01500226|100764830|FG000|COMPLETED|Overall Study||185||
48180303|NCT01500226|100764831|FG001|COMPLETED|Overall Study||191||
48755024|NCT00001832|102187836|FG013|COMPLETED|Treatment Period||3||
48755025|NCT00001832|102187837|FG014|COMPLETED|Treatment Period||2||
48755026|NCT00001832|102187823|FG000|NOT COMPLETED|Treatment Period||0||
48755027|NCT00001832|102187824|FG001|NOT COMPLETED|Treatment Period||0||
48755028|NCT00001832|102187825|FG002|NOT COMPLETED|Treatment Period||0||
48755029|NCT00001832|102187826|FG003|NOT COMPLETED|Treatment Period||0||
48755030|NCT00001832|102187827|FG004|NOT COMPLETED|Treatment Period||0||
48755031|NCT00001832|102187828|FG005|NOT COMPLETED|Treatment Period||1||
48755032|NCT00001832|102187829|FG006|NOT COMPLETED|Treatment Period||0||
48755033|NCT00001832|102187830|FG007|NOT COMPLETED|Treatment Period||1||
48755034|NCT00001832|102187831|FG008|NOT COMPLETED|Treatment Period||0||
48755035|NCT00001832|102187832|FG009|NOT COMPLETED|Treatment Period||0||
48755036|NCT00001832|102187833|FG010|NOT COMPLETED|Treatment Period||0||
48755037|NCT00001832|102187834|FG011|NOT COMPLETED|Treatment Period||0||
48755038|NCT00001832|102187835|FG012|NOT COMPLETED|Treatment Period||0||
48755039|NCT00001832|102187836|FG013|NOT COMPLETED|Treatment Period||0||
48755040|NCT00001832|102187837|FG014|NOT COMPLETED|Treatment Period||0||
48755041|NCT04481243|102187838|FG000|STARTED|Overall Study||29||
48755042|NCT04481243|102187838|FG000|COMPLETED|Overall Study||25||
48755043|NCT04481243|102187838|FG000|NOT COMPLETED|Overall Study||4||
48180304|NCT01500226|100764830|FG000|NOT COMPLETED|Overall Study||499||
48340871|NCT03062657|101163943|FG000|NOT COMPLETED|Overall Study||6||
48340872|NCT04214652|101163944|FG000|STARTED|Overall Study||120||
48340873|NCT04214652|101163945|FG001|STARTED|Overall Study||60||
48340874|NCT04214652|101163944|FG000|COMPLETED|Overall Study||107||
48340875|NCT04214652|101163945|FG001|COMPLETED|Overall Study||56||
48340876|NCT04214652|101163944|FG000|NOT COMPLETED|Overall Study||13||
48755044|NCT03253679|102187839|FG000|STARTED|Overall Study||31||
48755045|NCT03253679|102187839|FG000|COMPLETED|Overall Study||30||
48755046|NCT03253679|102187839|FG000|NOT COMPLETED|Overall Study||1||
48755047|NCT01172535|102187840|FG000|STARTED|Overall Study||97||
48755048|NCT01172535|102187840|FG000|COMPLETED|Overall Study||89||
48755049|NCT01172535|102187840|FG000|NOT COMPLETED|Overall Study||8||
48755050|NCT03808090|102187841|FG000|STARTED|Overall Study||58||
48755051|NCT03808090|102187841|FG000|COMPLETED|Overall Study||58||
48755052|NCT03808090|102187841|FG000|NOT COMPLETED|Overall Study||0||
48755053|NCT01323582|102187842|FG000|STARTED|Weeks 1-4 (First Period)||12||
48755054|NCT01323582|102187843|FG001|STARTED|Weeks 1-4 (First Period)||14||
48755055|NCT01323582|102187842|FG000|COMPLETED|Weeks 1-4 (First Period)||10||
48755056|NCT01323582|102187843|FG001|COMPLETED|Weeks 1-4 (First Period)||12||
48755057|NCT01323582|102187842|FG000|NOT COMPLETED|Weeks 1-4 (First Period)||2||
48755058|NCT01323582|102187843|FG001|NOT COMPLETED|Weeks 1-4 (First Period)||2||
48755059|NCT01323582|102187842|FG000|STARTED|Weeks 5-7 (Washout)||10||
48755060|NCT01323582|102187843|FG001|STARTED|Weeks 5-7 (Washout)||12||
48755061|NCT01323582|102187842|FG000|COMPLETED|Weeks 5-7 (Washout)||10||
48755062|NCT01323582|102187843|FG001|COMPLETED|Weeks 5-7 (Washout)||11||
48755063|NCT01323582|102187842|FG000|NOT COMPLETED|Weeks 5-7 (Washout)||0||
48755064|NCT01323582|102187843|FG001|NOT COMPLETED|Weeks 5-7 (Washout)||1||
48755065|NCT01323582|102187842|FG000|STARTED|Weeks 8-11 (Period 2)||10||
48755066|NCT01323582|102187843|FG001|STARTED|Weeks 8-11 (Period 2)||11||
48755067|NCT01323582|102187842|FG000|COMPLETED|Weeks 8-11 (Period 2)||10||
48755068|NCT01323582|102187843|FG001|COMPLETED|Weeks 8-11 (Period 2)||10||
48755069|NCT01323582|102187842|FG000|NOT COMPLETED|Weeks 8-11 (Period 2)||0||
48755070|NCT01323582|102187843|FG001|NOT COMPLETED|Weeks 8-11 (Period 2)||1||
48755071|NCT04869982|102187844|FG000|STARTED|Overall Study||3064||
48632615|NCT02251275|101885285|FG000|NOT COMPLETED|Overall Study||72||
48755072|NCT04869982|102187845|FG001|STARTED|Overall Study||3064||
48755073|NCT04869982|102187844|FG000|COMPLETED|Overall Study||3040||
48755074|NCT04869982|102187845|FG001|COMPLETED|Overall Study||3048||
48755075|NCT04869982|102187844|FG000|NOT COMPLETED|Overall Study||24||
48755076|NCT04869982|102187845|FG001|NOT COMPLETED|Overall Study||16||
48755077|NCT01393158|102187846|FG000|STARTED|Overall Study||6||
48755078|NCT01393158|102187847|FG001|STARTED|Overall Study||10||
48755079|NCT01393158|102187846|FG000|COMPLETED|Overall Study||5||
48755080|NCT01393158|102187847|FG001|COMPLETED|Overall Study||10||
48755081|NCT01393158|102187846|FG000|NOT COMPLETED|Overall Study||1||
48755082|NCT01393158|102187847|FG001|NOT COMPLETED|Overall Study||0||
48755083|NCT03261336|102187848|FG000|STARTED|Overall Study||1||
48755084|NCT03261336|102187848|FG000|COMPLETED|Overall Study||0||
48755085|NCT03261336|102187848|FG000|NOT COMPLETED|Overall Study||1||
48632616|NCT02251275|101885286|FG001|NOT COMPLETED|Overall Study||147||
48632617|NCT02251275|101885287|FG002|NOT COMPLETED|Overall Study||94||
48632618|NCT02251275|101885288|FG003|NOT COMPLETED|Overall Study||1||
48632619|NCT02251275|101885289|FG004|NOT COMPLETED|Overall Study||1||
48632620|NCT03699748|101885290|FG000|STARTED|Overall Study||80||
48632621|NCT03699748|101885291|FG001|STARTED|Overall Study||80||
48632622|NCT03699748|101885290|FG000|Completed Baseline Survey|Overall Study||80||
48632623|NCT03699748|101885291|FG001|Completed Baseline Survey|Overall Study||80||
48632624|NCT03699748|101885290|FG000|Completed 4 Month Survey|Overall Study||74||
48632625|NCT03699748|101885291|FG001|Completed 4 Month Survey|Overall Study||71||
48632626|NCT03699748|101885290|FG000|Completed 12 Month Survey|Overall Study||59||
48632627|NCT03699748|101885291|FG001|Completed 12 Month Survey|Overall Study||57||
48632628|NCT03699748|101885290|FG000|COMPLETED|Overall Study||58||
48632629|NCT03699748|101885291|FG001|COMPLETED|Overall Study||57||
48755086|NCT03318549|102187849|FG000|STARTED|Overall Study||14||28
48755087|NCT03318549|102187850|FG001|STARTED|Overall Study||89||178
48755088|NCT03318549|102187851|FG002|STARTED|Overall Study||12||24
48755089|NCT03318549|102187852|FG003|STARTED|Overall Study||0||0
48755090|NCT03318549|102187853|FG004|STARTED|Overall Study||0||0
48755091|NCT03318549|102187854|FG005|STARTED|Overall Study||0||0
48755092|NCT03318549|102187855|FG006|STARTED|Overall Study||0||0
48755093|NCT03318549|102187849|FG000|COMPLETED|Overall Study||9||18
48755094|NCT03318549|102187850|FG001|COMPLETED|Overall Study||63||126
48755095|NCT03318549|102187851|FG002|COMPLETED|Overall Study||6||12
48755096|NCT03318549|102187852|FG003|COMPLETED|Overall Study||0||0
48755097|NCT03318549|102187853|FG004|COMPLETED|Overall Study||0||0
48755098|NCT03318549|102187854|FG005|COMPLETED|Overall Study||0||0
48632630|NCT03699748|101885290|FG000|NOT COMPLETED|Overall Study||22||
48632631|NCT03699748|101885291|FG001|NOT COMPLETED|Overall Study||23||
48632632|NCT03722576|101885292|FG000|STARTED|Overall Study||18||
48632633|NCT03722576|101885292|FG000|COMPLETED|Overall Study||11||
48632634|NCT03722576|101885292|FG000|NOT COMPLETED|Overall Study||7||
48632635|NCT02026297|101885293|FG000|STARTED|Overall Study||7||
48632636|NCT02026297|101885294|FG001|STARTED|Overall Study||13||
48632637|NCT02026297|101885293|FG000|COMPLETED|Overall Study||7||
48632638|NCT02026297|101885294|FG001|COMPLETED|Overall Study||13||
48632639|NCT02026297|101885293|FG000|NOT COMPLETED|Overall Study||0||
48755099|NCT03318549|102187855|FG006|COMPLETED|Overall Study||0||0
48755100|NCT03318549|102187849|FG000|NOT COMPLETED|Overall Study||5||10
48755101|NCT03318549|102187850|FG001|NOT COMPLETED|Overall Study||26||52
48755102|NCT03318549|102187851|FG002|NOT COMPLETED|Overall Study||6||12
48755103|NCT03318549|102187852|FG003|NOT COMPLETED|Overall Study||0||0
48755104|NCT03318549|102187853|FG004|NOT COMPLETED|Overall Study||0||0
48755105|NCT03318549|102187854|FG005|NOT COMPLETED|Overall Study||0||0
48632640|NCT02026297|101885294|FG001|NOT COMPLETED|Overall Study||0||
48632641|NCT01657617|101885295|FG000|STARTED|Overall Study||35||
48632642|NCT01657617|101885295|FG000|COMPLETED|Overall Study||35||
48632643|NCT01657617|101885295|FG000|NOT COMPLETED|Overall Study||0||
48632644|NCT00223821|101885296|FG000|STARTED|Overall Study||32||
48632645|NCT00223821|101885297|FG001|STARTED|Overall Study||32||
48755106|NCT03318549|102187855|FG006|NOT COMPLETED|Overall Study||0||0
48755107|NCT03289208|102187856|FG000|STARTED|Overall Study||11||
48755108|NCT03289208|102187857|FG001|STARTED|Overall Study||8||
48632646|NCT00223821|101885296|FG000|Completed Therapy|Overall Study||31||
48632647|NCT00223821|101885297|FG001|Completed Therapy|Overall Study||28||
48632648|NCT00223821|101885296|FG000|Completed Post-treatment Assessment|Overall Study||31||
48632649|NCT00223821|101885297|FG001|Completed Post-treatment Assessment|Overall Study||27||
48632650|NCT00223821|101885296|FG000|Completed 6-month Follow-up|Overall Study||28||
48632651|NCT00223821|101885297|FG001|Completed 6-month Follow-up|Overall Study||25||
48180305|NCT01500226|100764831|FG001|NOT COMPLETED|Overall Study||494||
48439951|NCT03099265|101409991|FG000|NOT COMPLETED|Overall Study||1||
48180306|NCT01054911|100764832|FG000|STARTED|Overall Study||5||
48180307|NCT01054911|100764832|FG000|COMPLETED|Overall Study||5||
48180308|NCT01054911|100764832|FG000|NOT COMPLETED|Overall Study||0||
48180309|NCT02338713|100764833|FG000|STARTED|Overall Study||27||
48180310|NCT02338713|100764833|FG000|COMPLETED|Overall Study||27||
48180311|NCT02338713|100764833|FG000|NOT COMPLETED|Overall Study||0||
48180312|NCT05719285|100764834|FG000|STARTED|Overall Study||50||
48180313|NCT05719285|100764835|FG001|STARTED|Overall Study||50||
48180314|NCT05719285|100764834|FG000|COMPLETED|Overall Study||50||
48180315|NCT05719285|100764835|FG001|COMPLETED|Overall Study||50||
48180316|NCT05719285|100764834|FG000|NOT COMPLETED|Overall Study||0||
48632652|NCT00223821|101885296|FG000|COMPLETED|Overall Study||28||
48632653|NCT00223821|101885297|FG001|COMPLETED|Overall Study||22||
48632654|NCT00223821|101885296|FG000|NOT COMPLETED|Overall Study||4||
48632655|NCT00223821|101885297|FG001|NOT COMPLETED|Overall Study||10||
48632656|NCT02696616|101885298|FG000|STARTED|Overall Study||12||
48632657|NCT02696616|101885299|FG001|STARTED|Overall Study||5||
48180317|NCT05719285|100764835|FG001|NOT COMPLETED|Overall Study||0||
48180318|NCT01589302|100764836|FG000|STARTED|Overall Study||154|2 patients were not eligible for study and did not being treatment|
48340877|NCT04214652|101163945|FG001|NOT COMPLETED|Overall Study||4||
48340878|NCT03705481|101163946|FG000|STARTED|Overall Study||5||
48340879|NCT03705481|101163946|FG000|COMPLETED|Overall Study||5||
48340880|NCT03705481|101163946|FG000|NOT COMPLETED|Overall Study||0||
48340881|NCT02970929|101163947|FG000|STARTED|Overall Study||157||
48340882|NCT02970929|101163947|FG000|Subjects Who Received Study Medication|Overall Study||156||
48340883|NCT02970929|101163947|FG000|COMPLETED|Overall Study||105||
48340884|NCT02970929|101163947|FG000|NOT COMPLETED|Overall Study||52||
48340885|NCT00403260|101163948|FG000|STARTED|Overall Study||848||
48340886|NCT00403260|101163949|FG001|STARTED|Overall Study||423||
48340887|NCT00403260|101163948|FG000|COMPLETED|Overall Study||723||
48340888|NCT00403260|101163949|FG001|COMPLETED|Overall Study||357||
48340889|NCT00403260|101163948|FG000|NOT COMPLETED|Overall Study||125||
48340890|NCT00403260|101163949|FG001|NOT COMPLETED|Overall Study||66||
48340891|NCT01834404|101163950|FG000|STARTED|Overall Study||12||
48340892|NCT01834404|101163951|FG001|STARTED|Overall Study||12||
48340893|NCT01834404|101163950|FG000|COMPLETED|Overall Study||12||
48340894|NCT01834404|101163951|FG001|COMPLETED|Overall Study||12||
48340895|NCT01834404|101163950|FG000|NOT COMPLETED|Overall Study||0||
48340896|NCT01834404|101163951|FG001|NOT COMPLETED|Overall Study||0||
48340897|NCT02932267|101163952|FG000|STARTED|Overall Study||50||
48340898|NCT02932267|101163952|FG000|COMPLETED|Overall Study||42||
48340899|NCT02932267|101163952|FG000|NOT COMPLETED|Overall Study||8||
48340900|NCT01276184|101163953|FG000|STARTED|Overall Study||13||
48340901|NCT01276184|101163954|FG001|STARTED|Overall Study||9||
48340902|NCT01276184|101163953|FG000|COMPLETED|Overall Study||13||
48340903|NCT01276184|101163954|FG001|COMPLETED|Overall Study||9||
48340904|NCT01276184|101163953|FG000|NOT COMPLETED|Overall Study||0||
48340905|NCT01276184|101163954|FG001|NOT COMPLETED|Overall Study||0||
48340906|NCT01552681|101163955|FG000|STARTED|Overall Study||33||
48340907|NCT01552681|101163956|FG001|STARTED|Overall Study||19||
48632658|NCT02696616|101885300|FG002|STARTED|Overall Study||6||
48632659|NCT02696616|101885301|FG003|STARTED|Overall Study||6||
48632660|NCT02696616|101885302|FG004|STARTED|Overall Study||6||
48180319|NCT01589302|100764836|FG000|Del17p Patients|Overall Study||76||
48180320|NCT01589302|100764836|FG000|Non-Del17p Patients|Overall Study||76||
48180321|NCT01589302|100764836|FG000|COMPLETED|Overall Study||152||
48340908|NCT01552681|101163955|FG000|COMPLETED|Overall Study||28||
48340909|NCT01552681|101163956|FG001|COMPLETED|Overall Study||18||
48180322|NCT01589302|100764836|FG000|NOT COMPLETED|Overall Study||2||
48180323|NCT01702428|100764837|FG000|STARTED|Overall Study||1239||
48180324|NCT01702428|100764838|FG001|STARTED|Overall Study||1232||
48180325|NCT01702428|100764839|FG002|STARTED|Overall Study||1243||
48180326|NCT01702428|100764840|FG003|STARTED|Overall Study||1289||
48180327|NCT01702428|100764837|FG000|COMPLETED|Overall Study||1175||
48180328|NCT01702428|100764838|FG001|COMPLETED|Overall Study||1162||
48180329|NCT01702428|100764839|FG002|COMPLETED|Overall Study||1190||
48180330|NCT01702428|100764840|FG003|COMPLETED|Overall Study||1232||
48180331|NCT01702428|100764837|FG000|NOT COMPLETED|Overall Study||64||
48180332|NCT01702428|100764838|FG001|NOT COMPLETED|Overall Study||70||
48180333|NCT01702428|100764839|FG002|NOT COMPLETED|Overall Study||53||
48180334|NCT01702428|100764840|FG003|NOT COMPLETED|Overall Study||57||
48180335|NCT00600743|100764841|FG000|STARTED|Overall Study||4||
48180336|NCT00600743|100764842|FG001|STARTED|Overall Study||4||
48180337|NCT00600743|100764843|FG002|STARTED|Overall Study||8||
48180338|NCT00600743|100764844|FG003|STARTED|Overall Study||7||
48180339|NCT00600743|100764841|FG000|COMPLETED|Overall Study||4||
48180340|NCT00600743|100764842|FG001|COMPLETED|Overall Study||4||
48180341|NCT00600743|100764843|FG002|COMPLETED|Overall Study||8||
48180342|NCT00600743|100764844|FG003|COMPLETED|Overall Study||7||
48180343|NCT00600743|100764841|FG000|NOT COMPLETED|Overall Study||0||
48180344|NCT00600743|100764842|FG001|NOT COMPLETED|Overall Study||0||
48180345|NCT00600743|100764843|FG002|NOT COMPLETED|Overall Study||0||
48180346|NCT00600743|100764844|FG003|NOT COMPLETED|Overall Study||0||
48180347|NCT00951561|100764845|FG000|STARTED|Overall Study||25||
48180348|NCT00951561|100764846|FG001|STARTED|Overall Study||29||
48180349|NCT00951561|100764847|FG002|STARTED|Overall Study||21||
48180350|NCT00951561|100764848|FG003|STARTED|Overall Study||27||
48180351|NCT00951561|100764845|FG000|COMPLETED|Overall Study||25||
48180352|NCT00951561|100764846|FG001|COMPLETED|Overall Study||29||
48180353|NCT00951561|100764847|FG002|COMPLETED|Overall Study||18||
48180354|NCT00951561|100764848|FG003|COMPLETED|Overall Study||26||
48180355|NCT00951561|100764845|FG000|NOT COMPLETED|Overall Study||0||
48180356|NCT00951561|100764846|FG001|NOT COMPLETED|Overall Study||0||
48180357|NCT00951561|100764847|FG002|NOT COMPLETED|Overall Study||3||
48180358|NCT00951561|100764848|FG003|NOT COMPLETED|Overall Study||1||
48180359|NCT01080196|100764849|FG000|STARTED|Overall Study||68||
48180360|NCT01080196|100764850|FG001|STARTED|Overall Study||66||
48180361|NCT01080196|100764849|FG000|COMPLETED|Overall Study||68||
48180362|NCT01080196|100764850|FG001|COMPLETED|Overall Study||66||
48180363|NCT01080196|100764849|FG000|NOT COMPLETED|Overall Study||0||
48180364|NCT01080196|100764850|FG001|NOT COMPLETED|Overall Study||0||
48180365|NCT02909101|100764851|FG000|STARTED|Overall Study||29||
48180366|NCT02909101|100764852|FG001|STARTED|Overall Study||29||
48632661|NCT02696616|101885303|FG005|STARTED|Overall Study||6||
48632662|NCT02696616|101885304|FG006|STARTED|Overall Study||6||
48632663|NCT02696616|101885298|FG000|COMPLETED|Overall Study||12||
48632664|NCT02696616|101885299|FG001|COMPLETED|Overall Study||4||
48632665|NCT02696616|101885300|FG002|COMPLETED|Overall Study||6||
48632666|NCT02696616|101885301|FG003|COMPLETED|Overall Study||6||
48180367|NCT02909101|100764851|FG000|COMPLETED|Overall Study||28||
48180368|NCT02909101|100764852|FG001|COMPLETED|Overall Study||28||
48180369|NCT02909101|100764851|FG000|NOT COMPLETED|Overall Study||1||
48180370|NCT02909101|100764852|FG001|NOT COMPLETED|Overall Study||1||
48180371|NCT01811563|100764853|FG000|STARTED|Overall Study||25||
48180372|NCT01811563|100764854|FG001|STARTED|Overall Study||23||
48632667|NCT02696616|101885302|FG004|COMPLETED|Overall Study||6||
48632668|NCT02696616|101885303|FG005|COMPLETED|Overall Study||6||
48632669|NCT02696616|101885304|FG006|COMPLETED|Overall Study||6||
48755109|NCT03289208|102187858|FG002|STARTED|Overall Study||11||
48180373|NCT01811563|100764853|FG000|COMPLETED|Overall Study||20||
48180374|NCT01811563|100764854|FG001|COMPLETED|Overall Study||20||
48632670|NCT02696616|101885298|FG000|NOT COMPLETED|Overall Study||0||
48755110|NCT03289208|102187856|FG000|COMPLETED|Overall Study||10||
48180375|NCT01811563|100764853|FG000|NOT COMPLETED|Overall Study||5||
48180376|NCT01811563|100764854|FG001|NOT COMPLETED|Overall Study||3||
48180377|NCT02234310|100764855|FG000|STARTED|Overall Study||33||
48180378|NCT02234310|100764855|FG000|Episodic Treatment Regimen|Overall Study||22||
48340910|NCT01552681|101163955|FG000|NOT COMPLETED|Overall Study||5||
48632671|NCT02696616|101885299|FG001|NOT COMPLETED|Overall Study||1||
48755111|NCT03289208|102187857|FG001|COMPLETED|Overall Study||8||
48180379|NCT02234310|100764855|FG000|Prophylactic Treatment Regimen|Overall Study||28||
48180380|NCT02234310|100764855|FG000|COMPLETED|Overall Study||27||
48180381|NCT02234310|100764855|FG000|NOT COMPLETED|Overall Study||6||
48180382|NCT02726178|100764856|FG000|STARTED|Overall Study||28||
48180383|NCT02726178|100764857|FG001|STARTED|Overall Study||28||
48180384|NCT02726178|100764856|FG000|COMPLETED|Overall Study||28||
48180385|NCT02726178|100764857|FG001|COMPLETED|Overall Study||28||
48180386|NCT02726178|100764856|FG000|NOT COMPLETED|Overall Study||0||
48180387|NCT02726178|100764857|FG001|NOT COMPLETED|Overall Study||0||
48180388|NCT02391038|100764858|FG000|STARTED|Overall Study||3||
48180389|NCT02391038|100764859|FG001|STARTED|Overall Study||3||
48180390|NCT02391038|100764860|FG002|STARTED|Overall Study||6||
48180391|NCT02391038|100764858|FG000|COMPLETED|Overall Study||0||
48180392|NCT02391038|100764859|FG001|COMPLETED|Overall Study||0||
48755112|NCT03289208|102187858|FG002|COMPLETED|Overall Study||11||
48755113|NCT03289208|102187856|FG000|NOT COMPLETED|Overall Study||1||
48180393|NCT02391038|100764860|FG002|COMPLETED|Overall Study||0||
48180394|NCT02391038|100764858|FG000|NOT COMPLETED|Overall Study||3||
48180395|NCT02391038|100764859|FG001|NOT COMPLETED|Overall Study||3||
48180396|NCT02391038|100764860|FG002|NOT COMPLETED|Overall Study||6||
48180397|NCT02163447|100764861|FG000|STARTED|Overall Study||106||
48180398|NCT02163447|100764862|FG001|STARTED|Overall Study||94||
48180399|NCT02163447|100764863|FG002|STARTED|Overall Study||100||
48180400|NCT02163447|100764861|FG000|Infants Born|Overall Study||101||
48180401|NCT02163447|100764862|FG001|Infants Born|Overall Study||93||
48180402|NCT02163447|100764863|FG002|Infants Born|Overall Study||100||
48180403|NCT02163447|100764861|FG000|COMPLETED|Overall Study||100||
48180404|NCT02163447|100764862|FG001|COMPLETED|Overall Study||88||
48180405|NCT02163447|100764863|FG002|COMPLETED|Overall Study||97||
48180406|NCT02163447|100764861|FG000|NOT COMPLETED|Overall Study||6||
48180407|NCT02163447|100764862|FG001|NOT COMPLETED|Overall Study||6||
48180408|NCT02163447|100764863|FG002|NOT COMPLETED|Overall Study||3||
48180409|NCT02189863|100764864|FG000|STARTED|First 2 Weeks||12||
48180410|NCT02189863|100764865|FG001|STARTED|First 2 Weeks||15||
48180411|NCT02189863|100764864|FG000|COMPLETED|First 2 Weeks||8||
48180412|NCT02189863|100764865|FG001|COMPLETED|First 2 Weeks||13||
48180413|NCT02189863|100764864|FG000|NOT COMPLETED|First 2 Weeks||4||
48180414|NCT02189863|100764865|FG001|NOT COMPLETED|First 2 Weeks||2||
48180415|NCT02189863|100764864|FG000|STARTED|Second 2 Weeks||8||
48180416|NCT02189863|100764865|FG001|STARTED|Second 2 Weeks||13||
48180417|NCT02189863|100764864|FG000|COMPLETED|Second 2 Weeks||8||
48180418|NCT02189863|100764865|FG001|COMPLETED|Second 2 Weeks||13||
48180419|NCT02189863|100764864|FG000|NOT COMPLETED|Second 2 Weeks||0||
48180420|NCT02189863|100764865|FG001|NOT COMPLETED|Second 2 Weeks||0||
48180421|NCT01169259|100764866|FG000|STARTED|Overall Study||6463||
48180422|NCT01169259|100764867|FG001|STARTED|Overall Study||6464||
48180423|NCT01169259|100764868|FG002|STARTED|Overall Study||6470||
48180424|NCT01169259|100764869|FG003|STARTED|Overall Study||6474||
48180425|NCT01169259|100764866|FG000|COMPLETED|Overall Study||6463||
48180426|NCT01169259|100764867|FG001|COMPLETED|Overall Study||6464||
48180427|NCT01169259|100764868|FG002|COMPLETED|Overall Study||6470||
48180428|NCT01169259|100764869|FG003|COMPLETED|Overall Study||6474||
48180429|NCT01169259|100764866|FG000|NOT COMPLETED|Overall Study||0||
48180430|NCT01169259|100764867|FG001|NOT COMPLETED|Overall Study||0||
48180431|NCT01169259|100764868|FG002|NOT COMPLETED|Overall Study||0||
48180432|NCT01169259|100764869|FG003|NOT COMPLETED|Overall Study||0||
48180433|NCT02563834|100764870|FG000|STARTED|Control (Saline) Infusion (*Day 1)||10||
48180434|NCT02563834|100764871|FG001|STARTED|Control (Saline) Infusion (*Day 1)||8||
48180435|NCT02563834|100764870|FG000|COMPLETED|Control (Saline) Infusion (*Day 1)||10||
48180436|NCT02563834|100764871|FG001|COMPLETED|Control (Saline) Infusion (*Day 1)||8||
48180437|NCT02563834|100764870|FG000|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0||
48180438|NCT02563834|100764871|FG001|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0||
48180439|NCT02563834|100764870|FG000|STARTED|Insulin Infusion (*Day 2)||10||
48180440|NCT02563834|100764871|FG001|STARTED|Insulin Infusion (*Day 2)||8||
48180441|NCT02563834|100764870|FG000|COMPLETED|Insulin Infusion (*Day 2)||10||
48180442|NCT02563834|100764871|FG001|COMPLETED|Insulin Infusion (*Day 2)||8||
48413585|NCT01081951|101345857|FG001|Ongoing Study Treatment at Data Cut-off|Overall Study||0||
48413586|NCT01081951|101345856|FG000|COMPLETED|Overall Study||25||
48755114|NCT03289208|102187857|FG001|NOT COMPLETED|Overall Study||0||
48755115|NCT03289208|102187858|FG002|NOT COMPLETED|Overall Study||0||
48180443|NCT02563834|100764870|FG000|NOT COMPLETED|Insulin Infusion (*Day 2)||0||
48180444|NCT02563834|100764871|FG001|NOT COMPLETED|Insulin Infusion (*Day 2)||0||
48180445|NCT03988374|100764872|FG000|STARTED|Overall Study||104||
48180446|NCT03988374|100764873|FG001|STARTED|Overall Study||107||
48180447|NCT03988374|100764874|FG002|STARTED|Overall Study||108||
48180448|NCT03988374|100764872|FG000|COMPLETED|Overall Study||103||
48180449|NCT03988374|100764873|FG001|COMPLETED|Overall Study||105||
48180450|NCT03988374|100764874|FG002|COMPLETED|Overall Study||107||
48180451|NCT03988374|100764872|FG000|NOT COMPLETED|Overall Study||1||
48180452|NCT03988374|100764873|FG001|NOT COMPLETED|Overall Study||2||
48180453|NCT03988374|100764874|FG002|NOT COMPLETED|Overall Study||1||
48180454|NCT01221181|100764875|FG000|STARTED|Overall Study||6||
48180455|NCT01221181|100764875|FG000|COMPLETED|Overall Study||5||
48180456|NCT01221181|100764875|FG000|NOT COMPLETED|Overall Study||1||
48180457|NCT03293485|100764876|FG000|STARTED|Overall Study||83||
48413587|NCT01081951|101345857|FG001|COMPLETED|Overall Study||26||
48755116|NCT00686777|102187859|FG000|STARTED|Overall Study||75||
48755117|NCT00686777|102187859|FG000|Completed 24 Weeks of Treatment|Overall Study||69||
48755118|NCT00686777|102187859|FG000|Completed 48 Weeks of Treatment|Overall Study||65||
48180458|NCT03293485|100764876|FG000|Treated|Overall Study||81||
48180459|NCT03293485|100764876|FG000|COMPLETED|Overall Study||78||
48180460|NCT03293485|100764876|FG000|NOT COMPLETED|Overall Study||5||
48180461|NCT01125774|100764877|FG000|STARTED|Overall Study||3018||
48632672|NCT02696616|101885300|FG002|NOT COMPLETED|Overall Study||0||
48180462|NCT01125774|100764878|FG001|STARTED|Overall Study||1502||
48180463|NCT01125774|100764879|FG002|STARTED|Overall Study||22||
48180464|NCT01125774|100764880|FG003|STARTED|Overall Study||6||
48755119|NCT00686777|102187859|FG000|Included in Follow-up (All Treated)|Overall Study||75||
48755120|NCT00686777|102187859|FG000|Completed 24 Weeks of Follow-up|Overall Study||70||
48755121|NCT00686777|102187859|FG000|COMPLETED|Overall Study||65||
48755122|NCT00686777|102187859|FG000|NOT COMPLETED|Overall Study||10||
48755123|NCT00739401|102187860|FG000|STARTED|Overall Study||44||
48755124|NCT00739401|102187860|FG000|COMPLETED|Overall Study||3||
48755125|NCT00739401|102187860|FG000|NOT COMPLETED|Overall Study||41||
48755126|NCT00983346|102187861|FG000|STARTED|Overall Study||17||
48755127|NCT00983346|102187861|FG000|COMPLETED|Overall Study||17||
48755128|NCT00983346|102187861|FG000|NOT COMPLETED|Overall Study||0||
48755129|NCT02140047|102187862|FG000|STARTED|Overall Study||52||
48755130|NCT02140047|102187863|FG001|STARTED|Overall Study||52||
48755131|NCT02140047|102187864|FG002|STARTED|Overall Study||50||
48755132|NCT02140047|102187862|FG000|COMPLETED|Overall Study||51||
48755133|NCT02140047|102187863|FG001|COMPLETED|Overall Study||51||
48755134|NCT02140047|102187864|FG002|COMPLETED|Overall Study||50||
48755135|NCT02140047|102187862|FG000|NOT COMPLETED|Overall Study||1||
48755136|NCT02140047|102187863|FG001|NOT COMPLETED|Overall Study||1||
48755137|NCT02140047|102187864|FG002|NOT COMPLETED|Overall Study||0||
48755138|NCT01908426|102187865|FG000|STARTED|Overall Study||470||
48755139|NCT01908426|102187866|FG001|STARTED|Overall Study||237||
48180465|NCT01125774|100764877|FG000|Treated|Overall Study||2638||
48180466|NCT01125774|100764878|FG001|Treated|Overall Study||1322||
48180467|NCT01125774|100764879|FG002|Treated|Overall Study||21||
48180468|NCT01125774|100764880|FG003|Treated|Overall Study||5||
48180469|NCT01125774|100764877|FG000|COMPLETED|Overall Study||1893||
48755140|NCT01908426|102187865|FG000|COMPLETED|Overall Study||73||
48755141|NCT01908426|102187866|FG001|COMPLETED|Overall Study||26||
48755142|NCT01908426|102187865|FG000|NOT COMPLETED|Overall Study||397||
48755143|NCT01908426|102187866|FG001|NOT COMPLETED|Overall Study||211||
48755144|NCT00774046|102187867|FG000|STARTED|Screening||116||
48755145|NCT00774046|102187867|FG000|COMPLETED|Screening||60||
48180470|NCT01125774|100764878|FG001|COMPLETED|Overall Study||948||
48180471|NCT01125774|100764879|FG002|COMPLETED|Overall Study||13||
48180472|NCT01125774|100764880|FG003|COMPLETED|Overall Study||3||
48180473|NCT01125774|100764877|FG000|NOT COMPLETED|Overall Study||1125||
48180474|NCT01125774|100764878|FG001|NOT COMPLETED|Overall Study||554||
48180475|NCT01125774|100764879|FG002|NOT COMPLETED|Overall Study||9||
48180476|NCT01125774|100764880|FG003|NOT COMPLETED|Overall Study||3||
48180477|NCT00003509|100764881|FG000|STARTED|Overall Study||13||
48180478|NCT00003509|100764881|FG000|COMPLETED|Overall Study||8||
48180479|NCT00003509|100764881|FG000|NOT COMPLETED|Overall Study||5||
48180480|NCT00507026|100764882|FG000|STARTED|Overall Study||145||
48180481|NCT00507026|100764883|FG001|STARTED|Overall Study||60||
48180482|NCT00507026|100764884|FG002|STARTED|Overall Study||72||
48340911|NCT01552681|101163956|FG001|NOT COMPLETED|Overall Study||1||
48340912|NCT04426695|101163957|FG000|STARTED|Overall Study||21||
48340913|NCT04426695|101163958|FG001|STARTED|Overall Study||19||
48340914|NCT04426695|101163959|FG002|STARTED|Overall Study||20||
48340915|NCT04426695|101163960|FG003|STARTED|Overall Study||208||
48340916|NCT04426695|101163961|FG004|STARTED|Overall Study||211||
48340917|NCT04426695|101163962|FG005|STARTED|Overall Study||210||
48340918|NCT04426695|101163963|FG006|STARTED|Overall Study||251||
48340919|NCT04426695|101163964|FG007|STARTED|Overall Study||252||
48340920|NCT04426695|101163965|FG008|STARTED|Overall Study||252||
48755146|NCT00774046|102187867|FG000|NOT COMPLETED|Screening||56||
48755147|NCT00774046|102187867|FG000|STARTED|Enrollment||60||
48755148|NCT00774046|102187867|FG000|COMPLETED|Enrollment||32||
48180483|NCT00507026|100764882|FG000|COMPLETED|Overall Study||132||
48340921|NCT04426695|101163966|FG009|STARTED|Overall Study||201||
48180484|NCT00507026|100764883|FG001|COMPLETED|Overall Study||56||
48180485|NCT00507026|100764884|FG002|COMPLETED|Overall Study||51||
48180486|NCT00507026|100764882|FG000|NOT COMPLETED|Overall Study||13||
48180487|NCT00507026|100764883|FG001|NOT COMPLETED|Overall Study||4||
48180488|NCT00507026|100764884|FG002|NOT COMPLETED|Overall Study||21||
48180489|NCT01107730|100764885|FG000|STARTED|Overall Study||11||
48180490|NCT01107730|100764886|FG001|STARTED|Overall Study||11||
48180491|NCT01107730|100764887|FG002|STARTED|Overall Study||11||
48180492|NCT01107730|100764885|FG000|COMPLETED|Overall Study||11||
48180493|NCT01107730|100764886|FG001|COMPLETED|Overall Study||11||
48340922|NCT04426695|101163967|FG010|STARTED|Overall Study||205||
48340923|NCT04426695|101163968|FG011|STARTED|Overall Study||203||
48340924|NCT04426695|101163969|FG012|STARTED|Overall Study||52||
48340925|NCT04426695|101163970|FG013|STARTED|Overall Study||58||
48340926|NCT04426695|101163971|FG014|STARTED|Overall Study||54||
48755149|NCT00774046|102187867|FG000|NOT COMPLETED|Enrollment||28||
48755150|NCT00774046|102187867|FG000|STARTED|Induction Therapy||32||
48755151|NCT00774046|102187867|FG000|COMPLETED|Induction Therapy||32||
48755152|NCT00774046|102187867|FG000|NOT COMPLETED|Induction Therapy||0||
48755153|NCT00774046|102187867|FG000|STARTED|Stem Cell Mobilization||10||
48755154|NCT00774046|102187867|FG000|COMPLETED|Stem Cell Mobilization||7||
48180494|NCT01107730|100764887|FG002|COMPLETED|Overall Study||11||
48180495|NCT01107730|100764885|FG000|NOT COMPLETED|Overall Study||0||
48180496|NCT01107730|100764886|FG001|NOT COMPLETED|Overall Study||0||
48180497|NCT01107730|100764887|FG002|NOT COMPLETED|Overall Study||0||
48180498|NCT03095599|100764888|FG000|STARTED|Overall Study||741||
48413588|NCT01081951|101345856|FG000|NOT COMPLETED|Overall Study||56||
48413589|NCT01081951|101345857|FG001|NOT COMPLETED|Overall Study||55||
48413590|NCT04652102|101345858|FG000|STARTED|Overall Study||19787||
48755155|NCT00774046|102187867|FG000|NOT COMPLETED|Stem Cell Mobilization||3||
48755156|NCT00774046|102187867|FG000|STARTED|Autologous Transplant||4||
48755157|NCT00774046|102187867|FG000|COMPLETED|Autologous Transplant||4||
48755158|NCT00774046|102187867|FG000|NOT COMPLETED|Autologous Transplant||0||
48755159|NCT00988832|102187868|FG000|STARTED|Overall Study||380||
48755160|NCT00988832|102187868|FG000|COMPLETED|Overall Study||380||
48755161|NCT00988832|102187868|FG000|NOT COMPLETED|Overall Study||0||
48755162|NCT03253796|102187869|FG000|STARTED|Period 1: Run-In||323||
48755163|NCT03253796|102187870|FG001|STARTED|Period 1: Run-In||0||
48755164|NCT03253796|102187871|FG002|STARTED|Period 1: Run-In||0||
48180499|NCT03095599|100764889|FG001|STARTED|Overall Study||148||
48180500|NCT03095599|100764888|FG000|Withdrawal Before Vaccination|Overall Study||1|Voluntary withdrawal.|
48632673|NCT02696616|101885301|FG003|NOT COMPLETED|Overall Study||0||
48632674|NCT02696616|101885302|FG004|NOT COMPLETED|Overall Study||0||
48632675|NCT02696616|101885303|FG005|NOT COMPLETED|Overall Study||0||
48632676|NCT02696616|101885304|FG006|NOT COMPLETED|Overall Study||0||
48632677|NCT02767531|101885305|FG000|STARTED|Period 1||1||
48632678|NCT02767531|101885306|FG001|STARTED|Period 1||1||
48632679|NCT02767531|101885305|FG000|COMPLETED|Period 1||1||
48632680|NCT02767531|101885306|FG001|COMPLETED|Period 1||1||
48632681|NCT02767531|101885305|FG000|NOT COMPLETED|Period 1||0||
48632682|NCT02767531|101885306|FG001|NOT COMPLETED|Period 1||0||
48632683|NCT02767531|101885305|FG000|STARTED|Period 2||1||
48632684|NCT02767531|101885306|FG001|STARTED|Period 2||1||
48632685|NCT02767531|101885305|FG000|COMPLETED|Period 2||1||
48632686|NCT02767531|101885306|FG001|COMPLETED|Period 2||1||
48632687|NCT02767531|101885305|FG000|NOT COMPLETED|Period 2||0||
48632688|NCT02767531|101885306|FG001|NOT COMPLETED|Period 2||0||
48632689|NCT02767531|101885305|FG000|STARTED|Period 3||1||
48632690|NCT02767531|101885306|FG001|STARTED|Period 3||1||
48632691|NCT02767531|101885305|FG000|COMPLETED|Period 3||1||
48632692|NCT02767531|101885306|FG001|COMPLETED|Period 3||1||
48413591|NCT04652102|101345859|FG001|STARTED|Overall Study||19753||
48632693|NCT02767531|101885305|FG000|NOT COMPLETED|Period 3||0||
48632694|NCT02767531|101885306|FG001|NOT COMPLETED|Period 3||0||
48632695|NCT02767531|101885305|FG000|STARTED|Period 4||1||
48632696|NCT02767531|101885306|FG001|STARTED|Period 4||1||
48632697|NCT02767531|101885305|FG000|COMPLETED|Period 4||1||
48632698|NCT02767531|101885306|FG001|COMPLETED|Period 4||1||
48632699|NCT02767531|101885305|FG000|NOT COMPLETED|Period 4||0||
48632700|NCT02767531|101885306|FG001|NOT COMPLETED|Period 4||0||
48632701|NCT00407511|101885307|FG000|STARTED|Overall Study||121||
48632702|NCT00407511|101885307|FG000|COMPLETED|Overall Study||99||
48755165|NCT03253796|102187872|FG003|STARTED|Period 1: Run-In||0||
48755166|NCT03253796|102187873|FG004|STARTED|Period 1: Run-In||0||
48340927|NCT04426695|101163972|FG015|STARTED|Overall Study||12||
48632703|NCT00407511|101885307|FG000|NOT COMPLETED|Overall Study||22||
48755167|NCT03253796|102187869|FG000|COMPLETED|Period 1: Run-In||207||
48755168|NCT03253796|102187870|FG001|COMPLETED|Period 1: Run-In||0||
48340928|NCT04426695|101163973|FG016|STARTED|Overall Study||12||
48340929|NCT04426695|101163974|FG017|STARTED|Overall Study||11||
48755169|NCT03253796|102187871|FG002|COMPLETED|Period 1: Run-In||0||
48755170|NCT03253796|102187872|FG003|COMPLETED|Period 1: Run-In||0||
48755171|NCT03253796|102187873|FG004|COMPLETED|Period 1: Run-In||0||
48755172|NCT03253796|102187869|FG000|NOT COMPLETED|Period 1: Run-In||116||
48755173|NCT03253796|102187870|FG001|NOT COMPLETED|Period 1: Run-In||0||
48755174|NCT03253796|102187871|FG002|NOT COMPLETED|Period 1: Run-In||0||
48180501|NCT03095599|100764889|FG001|Withdrawal Before Vaccination|Overall Study||0|Voluntary withdrawal.|
48180502|NCT03095599|100764888|FG000|Vaccinated|Overall Study||740||
48180503|NCT03095599|100764889|FG001|Vaccinated|Overall Study||148||
48340930|NCT04426695|101163957|FG000|Treated|Overall Study||18||
48340931|NCT04426695|101163958|FG001|Treated|Overall Study||18||
48340932|NCT04426695|101163959|FG002|Treated|Overall Study||20||
48340933|NCT04426695|101163960|FG003|Treated|Overall Study||204||
48340934|NCT04426695|101163961|FG004|Treated|Overall Study||206||
48340935|NCT04426695|101163962|FG005|Treated|Overall Study||205||
48340936|NCT04426695|101163963|FG006|Treated|Overall Study||247||
48340937|NCT04426695|101163964|FG007|Treated|Overall Study||246||
48413592|NCT04652102|101345858|FG000|Phase 2b Participants|Overall Study||2007||
48413593|NCT04652102|101345859|FG001|Phase 2b Participants|Overall Study||1987||
48632704|NCT01414244|101885308|FG000|STARTED|Overall Study||54||
48632705|NCT01414244|101885309|FG001|STARTED|Overall Study||52||
48632706|NCT01414244|101885308|FG000|COMPLETED|Overall Study||54||
48340938|NCT04426695|101163965|FG008|Treated|Overall Study||246||
48340939|NCT04426695|101163966|FG009|Treated|Overall Study||198||
48340940|NCT04426695|101163967|FG010|Treated|Overall Study||202||
48413594|NCT04652102|101345858|FG000|Phase 3 Participants|Overall Study||17780||
48632707|NCT01414244|101885309|FG001|COMPLETED|Overall Study||52||
48632708|NCT01414244|101885308|FG000|NOT COMPLETED|Overall Study||0||
48632709|NCT01414244|101885309|FG001|NOT COMPLETED|Overall Study||0||
48632710|NCT02866643|101885310|FG000|STARTED|Overall Study||48||
48755175|NCT03253796|102187872|FG003|NOT COMPLETED|Period 1: Run-In||0||
48180504|NCT03095599|100764888|FG000|COMPLETED|Overall Study||738||
48180505|NCT03095599|100764889|FG001|COMPLETED|Overall Study||148||
48413595|NCT04652102|101345859|FG001|Phase 3 Participants|Overall Study||17766||
48413596|NCT04652102|101345858|FG000|Rolled Over to Open-Label Phase|Overall Study||8513||
48413597|NCT04652102|101345859|FG001|Rolled Over to Open-Label Phase|Overall Study||0||
48413598|NCT04652102|101345858|FG000|COMPLETED|Overall Study||11451||
48413599|NCT04652102|101345859|FG001|COMPLETED|Overall Study||4161||
48413600|NCT04652102|101345858|FG000|NOT COMPLETED|Overall Study||8336||
48413601|NCT04652102|101345859|FG001|NOT COMPLETED|Overall Study||15592||
48413602|NCT01004874|101345860|FG000|STARTED|Overall Study||80||
48413603|NCT01004874|101345860|FG000|COMPLETED|Overall Study||80||
48413604|NCT01004874|101345860|FG000|NOT COMPLETED|Overall Study||0||
48413605|NCT02313506|101345861|FG000|STARTED|Overall Study||17||
48413606|NCT02313506|101345862|FG001|STARTED|Overall Study||17||
48413607|NCT02313506|101345861|FG000|COMPLETED|Overall Study||17||
48413608|NCT02313506|101345862|FG001|COMPLETED|Overall Study||17||
48413609|NCT02313506|101345861|FG000|NOT COMPLETED|Overall Study||0||
48413610|NCT02313506|101345862|FG001|NOT COMPLETED|Overall Study||0||
48413611|NCT01984294|101345863|FG000|STARTED|Overall Study||35||
48413612|NCT01984294|101345864|FG001|STARTED|Overall Study||32||
48413613|NCT01984294|101345865|FG002|STARTED|Overall Study||34||
48180506|NCT03095599|100764888|FG000|NOT COMPLETED|Overall Study||3||
48180507|NCT03095599|100764889|FG001|NOT COMPLETED|Overall Study||0||
48180508|NCT01567163|100764890|FG000|STARTED|Overall Study||22||
48180509|NCT01567163|100764890|FG000|Received at Least 1 Dose of Study Drug|Overall Study||22||
48180510|NCT01567163|100764890|FG000|Drug-Drug Interaction Population|Overall Study||18||
48180511|NCT01567163|100764890|FG000|COMPLETED|Overall Study||18||
48180512|NCT01567163|100764890|FG000|NOT COMPLETED|Overall Study||4||
48180513|NCT00131911|100764891|FG000|STARTED|Overall Study||51||
48180514|NCT00131911|100764892|FG001|STARTED|Overall Study||42||
48180515|NCT00131911|100764891|FG000|COMPLETED|Overall Study||50||
48340941|NCT04426695|101163968|FG011|Treated|Overall Study||197||
48340942|NCT04426695|101163969|FG012|Treated|Overall Study||51||
48180516|NCT00131911|100764892|FG001|COMPLETED|Overall Study||42||
48180517|NCT00131911|100764891|FG000|NOT COMPLETED|Overall Study||1||
48180518|NCT00131911|100764892|FG001|NOT COMPLETED|Overall Study||0||
48180519|NCT03092960|100764893|FG000|STARTED|Overall Study||212||
48180520|NCT03092960|100764894|FG001|STARTED|Overall Study||212||
48180521|NCT03092960|100764893|FG000|COMPLETED|Overall Study||180||
48180522|NCT03092960|100764894|FG001|COMPLETED|Overall Study||186||
48632711|NCT02866643|101885311|FG001|STARTED|Overall Study||47||
48632712|NCT02866643|101885310|FG000|Intent-to-Treat (ITT) Population|Overall Study||38|ITT population includes participants who were randomized and received the Nexplanon implant|
48632713|NCT02866643|101885311|FG001|Intent-to-Treat (ITT) Population|Overall Study||39|ITT population includes participants who were randomized and received the Nexplanon implant|
48632714|NCT02866643|101885310|FG000|Per Protocol Population|Overall Study||35|Received implant at protocol-specified time point|
48632715|NCT02866643|101885311|FG001|Per Protocol Population|Overall Study||35|Received implant at protocol-specified time point|
48632716|NCT02866643|101885310|FG000|COMPLETED|Overall Study||35||
48632717|NCT02866643|101885311|FG001|COMPLETED|Overall Study||35||
48632718|NCT02866643|101885310|FG000|NOT COMPLETED|Overall Study||13||
48632719|NCT02866643|101885311|FG001|NOT COMPLETED|Overall Study||12||
48632720|NCT03093181|101885312|FG000|STARTED|Overall Study||44||
48632721|NCT03093181|101885313|FG001|STARTED|Overall Study||44||
48180523|NCT03092960|100764893|FG000|NOT COMPLETED|Overall Study||32||
48180524|NCT03092960|100764894|FG001|NOT COMPLETED|Overall Study||26||
48180525|NCT00663117|100764895|FG000|STARTED|Overall Study||20||
48180526|NCT00663117|100764896|FG001|STARTED|Overall Study||20||
48180527|NCT00663117|100764895|FG000|COMPLETED|Overall Study||19||
48180528|NCT00663117|100764896|FG001|COMPLETED|Overall Study||20||
48180529|NCT00663117|100764895|FG000|NOT COMPLETED|Overall Study||1||
48180530|NCT00663117|100764896|FG001|NOT COMPLETED|Overall Study||0||
48180531|NCT02577835|100764897|FG000|STARTED|Overall Study||1342||
48413614|NCT01984294|101345863|FG000|COMPLETED|Overall Study||31||
48413615|NCT01984294|101345864|FG001|COMPLETED|Overall Study||29||
48413616|NCT01984294|101345865|FG002|COMPLETED|Overall Study||27||
48413617|NCT01984294|101345863|FG000|NOT COMPLETED|Overall Study||4||
48413618|NCT01984294|101345864|FG001|NOT COMPLETED|Overall Study||3||
48413619|NCT01984294|101345865|FG002|NOT COMPLETED|Overall Study||7||
48180532|NCT02577835|100764897|FG000|COMPLETED|Overall Study||1200||
48180533|NCT02577835|100764897|FG000|NOT COMPLETED|Overall Study||142||
48180534|NCT04102540|100764898|FG000|STARTED|Overall Study||32||
48413620|NCT01738594|101345866|FG000|STARTED|Registration and Treatment Start||0||
48413621|NCT01738594|101345867|FG001|STARTED|Registration and Treatment Start||3||
48413622|NCT01738594|101345868|FG002|STARTED|Registration and Treatment Start||0||
48413623|NCT01738594|101345869|FG003|STARTED|Registration and Treatment Start||0||
48413624|NCT01738594|101345870|FG004|STARTED|Registration and Treatment Start||1||
48413625|NCT01738594|101345871|FG005|STARTED|Registration and Treatment Start||3||
48413626|NCT01738594|101345872|FG006|STARTED|Registration and Treatment Start||0||
48413627|NCT01738594|101345873|FG007|STARTED|Registration and Treatment Start||0||
48413628|NCT01738594|101345866|FG000|Registered to Study|Registration and Treatment Start||0||
48413629|NCT01738594|101345867|FG001|Registered to Study|Registration and Treatment Start||3||
48755176|NCT03253796|102187873|FG004|NOT COMPLETED|Period 1: Run-In||0||
48755177|NCT03253796|102187869|FG000|STARTED|Period 2: Withdrawal vs Continued Tx||0|18 participants did not continue into Period 2|
48755178|NCT03253796|102187870|FG001|STARTED|Period 2: Withdrawal vs Continued Tx||63|18 participants did not continue into Period 2|
48755179|NCT03253796|102187871|FG002|STARTED|Period 2: Withdrawal vs Continued Tx||64|18 participants did not continue into Period 2|
48755180|NCT03253796|102187872|FG003|STARTED|Period 2: Withdrawal vs Continued Tx||62|18 participants did not continue into Period 2|
48180535|NCT04102540|100764898|FG000|COMPLETED|Overall Study||24||
48180536|NCT04102540|100764898|FG000|NOT COMPLETED|Overall Study||8||
48180537|NCT01708187|100764899|FG000|STARTED|Overall Study||1||
48180538|NCT01708187|100764900|FG001|STARTED|Overall Study||1||
48180539|NCT01708187|100764899|FG000|COMPLETED|Overall Study||1||
48180540|NCT01708187|100764900|FG001|COMPLETED|Overall Study||0||
48755181|NCT03253796|102187873|FG004|STARTED|Period 2: Withdrawal vs Continued Tx||0|18 participants did not continue into Period 2|
48755182|NCT03253796|102187869|FG000|COMPLETED|Period 2: Withdrawal vs Continued Tx||0||
48755183|NCT03253796|102187870|FG001|COMPLETED|Period 2: Withdrawal vs Continued Tx||53||
48755184|NCT03253796|102187871|FG002|COMPLETED|Period 2: Withdrawal vs Continued Tx||43||
48180541|NCT01708187|100764899|FG000|NOT COMPLETED|Overall Study||0||
48180542|NCT01708187|100764900|FG001|NOT COMPLETED|Overall Study||1||
48180543|NCT02266329|100764901|FG000|STARTED|Overall Study||59|Subjects Randomized|
48180544|NCT02266329|100764902|FG001|STARTED|Overall Study||30|Subjects Randomized|
48180545|NCT02266329|100764901|FG000|COMPLETED|Overall Study||52||
48340943|NCT04426695|101163970|FG013|Treated|Overall Study||56||
48340944|NCT04426695|101163971|FG014|Treated|Overall Study||54||
48340945|NCT04426695|101163972|FG015|Treated|Overall Study||12||
48340946|NCT04426695|101163973|FG016|Treated|Overall Study||12||
48340947|NCT04426695|101163974|FG017|Treated|Overall Study||11||
48340948|NCT04426695|101163957|FG000|COMPLETED|Overall Study||13||
48340949|NCT04426695|101163958|FG001|COMPLETED|Overall Study||12||
48340950|NCT04426695|101163959|FG002|COMPLETED|Overall Study||16||
48413630|NCT01738594|101345868|FG002|Registered to Study|Registration and Treatment Start||0||
48413631|NCT01738594|101345869|FG003|Registered to Study|Registration and Treatment Start||0||
48413632|NCT01738594|101345870|FG004|Registered to Study|Registration and Treatment Start||1||
48632722|NCT03093181|101885314|FG002|STARTED|Overall Study||44||
48632723|NCT03093181|101885312|FG000|COMPLETED|Overall Study||41||
48632724|NCT03093181|101885313|FG001|COMPLETED|Overall Study||42||
48632725|NCT03093181|101885314|FG002|COMPLETED|Overall Study||41||
48632726|NCT03093181|101885312|FG000|NOT COMPLETED|Overall Study||3||
48632727|NCT03093181|101885313|FG001|NOT COMPLETED|Overall Study||2||
48632728|NCT03093181|101885314|FG002|NOT COMPLETED|Overall Study||3||
48632729|NCT00924898|101885315|FG000|STARTED|Overall Study||92||
48632730|NCT00924898|101885315|FG000|COMPLETED|Overall Study||90||
48632731|NCT00924898|101885315|FG000|NOT COMPLETED|Overall Study||2||
48632732|NCT01047319|101885316|FG000|STARTED|Overall Study||345||
48632733|NCT01047319|101885317|FG001|STARTED|Overall Study||350||
48632734|NCT01047319|101885318|FG002|STARTED|Overall Study||352||
48755185|NCT03253796|102187872|FG003|COMPLETED|Period 2: Withdrawal vs Continued Tx||21||
48755186|NCT03253796|102187873|FG004|COMPLETED|Period 2: Withdrawal vs Continued Tx||0||
48755187|NCT03253796|102187869|FG000|NOT COMPLETED|Period 2: Withdrawal vs Continued Tx||0||
48755188|NCT03253796|102187870|FG001|NOT COMPLETED|Period 2: Withdrawal vs Continued Tx||10||
48755189|NCT03253796|102187871|FG002|NOT COMPLETED|Period 2: Withdrawal vs Continued Tx||21||
48755190|NCT03253796|102187872|FG003|NOT COMPLETED|Period 2: Withdrawal vs Continued Tx||41||
48755191|NCT03253796|102187873|FG004|NOT COMPLETED|Period 2: Withdrawal vs Continued Tx||0||
48755192|NCT03253796|102187869|FG000|STARTED|Period 2: Open-Label Retreatment||0||
48755193|NCT03253796|102187870|FG001|STARTED|Period 2: Open-Label Retreatment||0||
48180546|NCT02266329|100764902|FG001|COMPLETED|Overall Study||26||
48755194|NCT03253796|102187871|FG002|STARTED|Period 2: Open-Label Retreatment||0||
48755195|NCT03253796|102187872|FG003|STARTED|Period 2: Open-Label Retreatment||0||
48755196|NCT03253796|102187873|FG004|STARTED|Period 2: Open-Label Retreatment||63||
48755197|NCT03253796|102187869|FG000|COMPLETED|Period 2: Open-Label Retreatment||0||
48755198|NCT03253796|102187870|FG001|COMPLETED|Period 2: Open-Label Retreatment||0||
48767745|NCT02141295|102222817|FG002|COMPLETED|Overall Study||0||
48180547|NCT02266329|100764901|FG000|NOT COMPLETED|Overall Study||7||
48180548|NCT02266329|100764902|FG001|NOT COMPLETED|Overall Study||4||
48180549|NCT01734382|100764903|FG000|STARTED|Part 1||19||
48180550|NCT01734382|100764904|FG001|STARTED|Part 1||0||
48180551|NCT01734382|100764905|FG002|STARTED|Part 1||0||
48180552|NCT01734382|100764903|FG000|COMPLETED|Part 1||17||
48340951|NCT04426695|101163960|FG003|COMPLETED|Overall Study||146||
48340952|NCT04426695|101163961|FG004|COMPLETED|Overall Study||153||
48340953|NCT04426695|101163962|FG005|COMPLETED|Overall Study||148||
48340954|NCT04426695|101163963|FG006|COMPLETED|Overall Study||186||
48439952|NCT00054275|101409992|FG000|STARTED|Overall Study||39||
48632735|NCT01047319|101885316|FG000|COMPLETED|Overall Study||0||
48632736|NCT01047319|101885317|FG001|COMPLETED|Overall Study||0||
48632737|NCT01047319|101885318|FG002|COMPLETED|Overall Study||0||
48180553|NCT01734382|100764904|FG001|COMPLETED|Part 1||0||
48632738|NCT01047319|101885316|FG000|NOT COMPLETED|Overall Study||345||
48180554|NCT01734382|100764905|FG002|COMPLETED|Part 1||0||
48180555|NCT01734382|100764903|FG000|NOT COMPLETED|Part 1||2||
48755199|NCT03253796|102187871|FG002|COMPLETED|Period 2: Open-Label Retreatment||0||
48755200|NCT03253796|102187872|FG003|COMPLETED|Period 2: Open-Label Retreatment||0||
48755201|NCT03253796|102187873|FG004|COMPLETED|Period 2: Open-Label Retreatment||58||
48755202|NCT03253796|102187869|FG000|NOT COMPLETED|Period 2: Open-Label Retreatment||0||
48755203|NCT03253796|102187870|FG001|NOT COMPLETED|Period 2: Open-Label Retreatment||0||
48755204|NCT03253796|102187871|FG002|NOT COMPLETED|Period 2: Open-Label Retreatment||0||
48755205|NCT03253796|102187872|FG003|NOT COMPLETED|Period 2: Open-Label Retreatment||0||
48755206|NCT03253796|102187873|FG004|NOT COMPLETED|Period 2: Open-Label Retreatment||5||
48755207|NCT02163902|102187874|FG000|STARTED|Overall Study||113||
48755208|NCT02163902|102187875|FG001|STARTED|Overall Study||111||
48340955|NCT04426695|101163964|FG007|COMPLETED|Overall Study||195||
48340956|NCT04426695|101163965|FG008|COMPLETED|Overall Study||189||
48340957|NCT04426695|101163966|FG009|COMPLETED|Overall Study||157||
48340958|NCT04426695|101163967|FG010|COMPLETED|Overall Study||165||
48340959|NCT04426695|101163968|FG011|COMPLETED|Overall Study||166||
48340960|NCT04426695|101163969|FG012|COMPLETED|Overall Study||33||
48340961|NCT04426695|101163970|FG013|COMPLETED|Overall Study||28||
48340962|NCT04426695|101163971|FG014|COMPLETED|Overall Study||31||
48340963|NCT04426695|101163972|FG015|COMPLETED|Overall Study||5||
48340964|NCT04426695|101163973|FG016|COMPLETED|Overall Study||4||
48340965|NCT04426695|101163974|FG017|COMPLETED|Overall Study||7||
48340966|NCT04426695|101163957|FG000|NOT COMPLETED|Overall Study||8||
48340967|NCT04426695|101163958|FG001|NOT COMPLETED|Overall Study||7||
48340968|NCT04426695|101163959|FG002|NOT COMPLETED|Overall Study||4||
48340969|NCT04426695|101163960|FG003|NOT COMPLETED|Overall Study||62||
48340970|NCT04426695|101163961|FG004|NOT COMPLETED|Overall Study||58||
48340971|NCT04426695|101163962|FG005|NOT COMPLETED|Overall Study||62||
48340972|NCT04426695|101163963|FG006|NOT COMPLETED|Overall Study||65||
48755209|NCT02163902|102187874|FG000|COMPLETED|Overall Study||102||
48755210|NCT02163902|102187875|FG001|COMPLETED|Overall Study||98||
48755211|NCT02163902|102187874|FG000|NOT COMPLETED|Overall Study||11||
48755212|NCT02163902|102187875|FG001|NOT COMPLETED|Overall Study||13||
48755213|NCT00453895|102187876|FG000|STARTED|Overall Study||39||
48755214|NCT00453895|102187876|FG000|COMPLETED|Overall Study||39||
48755215|NCT00453895|102187876|FG000|NOT COMPLETED|Overall Study||0||
48755216|NCT01889667|102187877|FG000|STARTED|Overall Study||10||
48755217|NCT01889667|102187878|FG001|STARTED|Overall Study||10||
48755218|NCT01889667|102187879|FG002|STARTED|Overall Study||10||
48755219|NCT01889667|102187877|FG000|COMPLETED|Overall Study||10||
48755220|NCT01889667|102187878|FG001|COMPLETED|Overall Study||10||
48755221|NCT01889667|102187879|FG002|COMPLETED|Overall Study||10||
48755222|NCT01889667|102187877|FG000|NOT COMPLETED|Overall Study||0||
48755223|NCT01889667|102187878|FG001|NOT COMPLETED|Overall Study||0||
48755224|NCT01889667|102187879|FG002|NOT COMPLETED|Overall Study||0||
48755225|NCT03452540|102187880|FG000|STARTED|Overall Study||9||
48755226|NCT03452540|102187880|FG000|COMPLETED|Overall Study||5||
48340973|NCT04426695|101163964|FG007|NOT COMPLETED|Overall Study||57||
48755227|NCT03452540|102187880|FG000|NOT COMPLETED|Overall Study||4||
48755228|NCT03259230|102187881|FG000|STARTED|Overall Study||20||
48755229|NCT03259230|102187882|FG001|STARTED|Overall Study||20||
48755230|NCT03259230|102187881|FG000|Malignancy Analysis Set|Overall Study||19||
48755231|NCT03259230|102187882|FG001|Malignancy Analysis Set|Overall Study||20||
48755232|NCT03259230|102187881|FG000|COMPLETED|Overall Study||19||
48755233|NCT03259230|102187882|FG001|COMPLETED|Overall Study||20||
48755234|NCT03259230|102187881|FG000|NOT COMPLETED|Overall Study||1||
48340974|NCT04426695|101163965|FG008|NOT COMPLETED|Overall Study||63||
48340975|NCT04426695|101163966|FG009|NOT COMPLETED|Overall Study||44||
48340976|NCT04426695|101163967|FG010|NOT COMPLETED|Overall Study||40||
48340977|NCT04426695|101163968|FG011|NOT COMPLETED|Overall Study||37||
48340978|NCT04426695|101163969|FG012|NOT COMPLETED|Overall Study||19||
48340979|NCT04426695|101163970|FG013|NOT COMPLETED|Overall Study||30||
48340980|NCT04426695|101163971|FG014|NOT COMPLETED|Overall Study||23||
48340981|NCT04426695|101163972|FG015|NOT COMPLETED|Overall Study||7||
48340982|NCT04426695|101163973|FG016|NOT COMPLETED|Overall Study||8||
48340983|NCT04426695|101163974|FG017|NOT COMPLETED|Overall Study||4||
48340984|NCT01196442|101163975|FG000|STARTED|Overall Study||39||
48340985|NCT01196442|101163975|FG000|COMPLETED|Overall Study||39||
48340986|NCT01196442|101163975|FG000|NOT COMPLETED|Overall Study||0||
48340987|NCT04244370|101163976|FG000|STARTED|Overall Study||50||
48340988|NCT04244370|101163976|FG000|COMPLETED|Overall Study||49||
48755235|NCT03259230|102187882|FG001|NOT COMPLETED|Overall Study||0||
48755236|NCT02313766|102187883|FG000|STARTED|Overall Study||50||
48755237|NCT02313766|102187884|FG001|STARTED|Overall Study||50||
48755238|NCT02313766|102187885|FG002|STARTED|Overall Study||50||
48755239|NCT02313766|102187883|FG000|COMPLETED|Overall Study||49||
48755240|NCT02313766|102187884|FG001|COMPLETED|Overall Study||47||
48340989|NCT04244370|101163976|FG000|NOT COMPLETED|Overall Study||1||
48340990|NCT00887458|101163977|FG000|STARTED|Overall Study||17||
48340991|NCT00887458|101163978|FG001|STARTED|Overall Study||29||
48340992|NCT00887458|101163977|FG000|COMPLETED|Overall Study||17||
48340993|NCT00887458|101163978|FG001|COMPLETED|Overall Study||25||
48340994|NCT00887458|101163977|FG000|NOT COMPLETED|Overall Study||0||
48340995|NCT00887458|101163978|FG001|NOT COMPLETED|Overall Study||4||
48340996|NCT01107444|101163979|FG000|STARTED|Overall Study||120||
48340997|NCT01107444|101163980|FG001|STARTED|Overall Study||60||
48340998|NCT01107444|101163979|FG000|Received At Least 1 Dose of Study Drug|Overall Study||114||
48340999|NCT01107444|101163980|FG001|Received At Least 1 Dose of Study Drug|Overall Study||48||
48341000|NCT01107444|101163979|FG000|COMPLETED|Overall Study||112||
48413633|NCT01738594|101345871|FG005|Registered to Study|Registration and Treatment Start||3||
48755241|NCT02313766|102187885|FG002|COMPLETED|Overall Study||50||
48755242|NCT02313766|102187883|FG000|NOT COMPLETED|Overall Study||1||
48341001|NCT01107444|101163980|FG001|COMPLETED|Overall Study||47||
48341002|NCT01107444|101163979|FG000|NOT COMPLETED|Overall Study||8||
48341003|NCT01107444|101163980|FG001|NOT COMPLETED|Overall Study||13||
48341004|NCT01524991|101163981|FG000|STARTED|Overall Study||36||
48341005|NCT01524991|101163981|FG000|COMPLETED|Overall Study||2||
48341006|NCT01524991|101163981|FG000|NOT COMPLETED|Overall Study||34||
48341007|NCT00931164|101163982|FG000|STARTED|Overall Study||6||
48413634|NCT01738594|101345872|FG006|Registered to Study|Registration and Treatment Start||0||
48413635|NCT01738594|101345873|FG007|Registered to Study|Registration and Treatment Start||0||
48413636|NCT01738594|101345866|FG000|Treatment Started|Registration and Treatment Start||0||
48755243|NCT02313766|102187884|FG001|NOT COMPLETED|Overall Study||3||
48755244|NCT02313766|102187885|FG002|NOT COMPLETED|Overall Study||0||
48755245|NCT02856412|102187886|FG000|STARTED|Overall Study||41||
48755246|NCT02856412|102187887|FG001|STARTED|Overall Study||43||
48755247|NCT02856412|102187886|FG000|COMPLETED|Overall Study||30||
48755248|NCT02856412|102187887|FG001|COMPLETED|Overall Study||34||
48755249|NCT02856412|102187886|FG000|NOT COMPLETED|Overall Study||11||
48755250|NCT02856412|102187887|FG001|NOT COMPLETED|Overall Study||9||
48755251|NCT03593902|102187888|FG000|STARTED|Overall Study||9||
48755252|NCT03593902|102187888|FG000|COMPLETED|Overall Study||9||
48755253|NCT03593902|102187888|FG000|NOT COMPLETED|Overall Study||0||
48755254|NCT04006288|102187889|FG000|STARTED|Overall Study||15||
48755255|NCT04006288|102187890|FG001|STARTED|Overall Study||15||
48755256|NCT04006288|102187891|FG002|STARTED|Overall Study||15||
48755257|NCT04006288|102187892|FG003|STARTED|Overall Study||15||
48755258|NCT04006288|102187893|FG004|STARTED|Overall Study||15||
48755259|NCT04006288|102187894|FG005|STARTED|Overall Study||15||
48755260|NCT04006288|102187889|FG000|COMPLETED|Overall Study||14||
48755261|NCT04006288|102187890|FG001|COMPLETED|Overall Study||14||
48755262|NCT04006288|102187891|FG002|COMPLETED|Overall Study||15||
48755263|NCT04006288|102187892|FG003|COMPLETED|Overall Study||15||
48755264|NCT04006288|102187893|FG004|COMPLETED|Overall Study||15||
48755265|NCT04006288|102187894|FG005|COMPLETED|Overall Study||15||
48755266|NCT04006288|102187889|FG000|NOT COMPLETED|Overall Study||1||
48755267|NCT04006288|102187890|FG001|NOT COMPLETED|Overall Study||1||
48755268|NCT04006288|102187891|FG002|NOT COMPLETED|Overall Study||0||
48755269|NCT04006288|102187892|FG003|NOT COMPLETED|Overall Study||0||
48755270|NCT04006288|102187893|FG004|NOT COMPLETED|Overall Study||0||
48341008|NCT00931164|101163982|FG000|COMPLETED|Overall Study||6||
48755271|NCT04006288|102187894|FG005|NOT COMPLETED|Overall Study||0||
48755272|NCT01841281|102187895|FG000|STARTED|First Intervention (12 Weeks)||11||
48755273|NCT01841281|102187896|FG001|STARTED|First Intervention (12 Weeks)||12||
48341009|NCT00931164|101163982|FG000|NOT COMPLETED|Overall Study||0||
48341010|NCT02908516|101163983|FG000|STARTED|Overall Study||3||
48341011|NCT02908516|101163984|FG001|STARTED|Overall Study||3||
48755274|NCT01841281|102187897|FG002|STARTED|First Intervention (12 Weeks)||13||
48755275|NCT01841281|102187898|FG003|STARTED|First Intervention (12 Weeks)||14||
48341012|NCT02908516|101163983|FG000|COMPLETED|Overall Study||0||
48341013|NCT02908516|101163984|FG001|COMPLETED|Overall Study||0||
48341014|NCT02908516|101163983|FG000|NOT COMPLETED|Overall Study||3||
48341015|NCT02908516|101163984|FG001|NOT COMPLETED|Overall Study||3||
48341016|NCT03969875|101163985|FG000|STARTED|Overall Study||31||
48341017|NCT03969875|101163986|FG001|STARTED|Overall Study||29||
48341018|NCT03969875|101163987|FG002|STARTED|Overall Study||30||
48341019|NCT03969875|101163985|FG000|COMPLETED|Overall Study||24||
48341020|NCT03969875|101163986|FG001|COMPLETED|Overall Study||24||
48341021|NCT03969875|101163987|FG002|COMPLETED|Overall Study||24||
48341022|NCT03969875|101163985|FG000|NOT COMPLETED|Overall Study||7||
48341023|NCT03969875|101163986|FG001|NOT COMPLETED|Overall Study||5||
48341024|NCT03969875|101163987|FG002|NOT COMPLETED|Overall Study||6||
48341025|NCT00424398|101163988|FG000|STARTED|Overall Study||35||
48341026|NCT00424398|101163989|FG001|STARTED|Overall Study||36||
48341027|NCT00424398|101163990|FG002|STARTED|Overall Study||36||
48341028|NCT00424398|101163988|FG000|COMPLETED|Overall Study||32||
48341029|NCT00424398|101163989|FG001|COMPLETED|Overall Study||35||
48341030|NCT00424398|101163990|FG002|COMPLETED|Overall Study||36||
48341031|NCT00424398|101163988|FG000|NOT COMPLETED|Overall Study||3||
48341032|NCT00424398|101163989|FG001|NOT COMPLETED|Overall Study||1||
48341033|NCT00424398|101163990|FG002|NOT COMPLETED|Overall Study||0||
48341034|NCT01708057|101163991|FG000|STARTED|Overall Study||1||
48755276|NCT01841281|102187895|FG000|COMPLETED|First Intervention (12 Weeks)||11||
48755277|NCT01841281|102187896|FG001|COMPLETED|First Intervention (12 Weeks)||12||
48755278|NCT01841281|102187897|FG002|COMPLETED|First Intervention (12 Weeks)||13||
48755279|NCT01841281|102187898|FG003|COMPLETED|First Intervention (12 Weeks)||14||
48755280|NCT01841281|102187895|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0||
48755281|NCT01841281|102187896|FG001|NOT COMPLETED|First Intervention (12 Weeks)||0||
48180556|NCT01734382|100764904|FG001|NOT COMPLETED|Part 1||0||
48180557|NCT01734382|100764905|FG002|NOT COMPLETED|Part 1||0||
48180558|NCT01734382|100764903|FG000|STARTED|Part 2||0||
48180559|NCT01734382|100764904|FG001|STARTED|Part 2||7||
48180560|NCT01734382|100764905|FG002|STARTED|Part 2||15||
48180561|NCT01734382|100764903|FG000|COMPLETED|Part 2||0||
48180562|NCT01734382|100764904|FG001|COMPLETED|Part 2||5||
48180563|NCT01734382|100764905|FG002|COMPLETED|Part 2||8||
48180564|NCT01734382|100764903|FG000|NOT COMPLETED|Part 2||0||
48180565|NCT01734382|100764904|FG001|NOT COMPLETED|Part 2||2||
48180566|NCT01734382|100764905|FG002|NOT COMPLETED|Part 2||7||
48180567|NCT00684983|100764906|FG000|STARTED|Overall Study||19||
48180568|NCT00684983|100764907|FG001|STARTED|Overall Study||45||
48180569|NCT00684983|100764906|FG000|COMPLETED|Overall Study||19||
48180570|NCT00684983|100764907|FG001|COMPLETED|Overall Study||45||
48180571|NCT00684983|100764906|FG000|NOT COMPLETED|Overall Study||0||
48180572|NCT00684983|100764907|FG001|NOT COMPLETED|Overall Study||0||
48180573|NCT01959945|100764908|FG000|STARTED|Overall Study||80||
48180574|NCT01959945|100764909|FG001|STARTED|Overall Study||78||
48180575|NCT01959945|100764910|FG002|STARTED|Overall Study||28||
48180576|NCT01959945|100764911|FG003|STARTED|Overall Study||31||
48180577|NCT01959945|100764908|FG000|COMPLETED|Overall Study||76||
48180578|NCT01959945|100764909|FG001|COMPLETED|Overall Study||75||
48180579|NCT01959945|100764910|FG002|COMPLETED|Overall Study||9||
48180580|NCT01959945|100764911|FG003|COMPLETED|Overall Study||15||
48180581|NCT01959945|100764908|FG000|NOT COMPLETED|Overall Study||4||
48180582|NCT01959945|100764909|FG001|NOT COMPLETED|Overall Study||3||
48413637|NCT01738594|101345867|FG001|Treatment Started|Registration and Treatment Start||2||
48755282|NCT01841281|102187897|FG002|NOT COMPLETED|First Intervention (12 Weeks)||0||
48755283|NCT01841281|102187898|FG003|NOT COMPLETED|First Intervention (12 Weeks)||0||
48755284|NCT01841281|102187895|FG000|STARTED|Washout (6 Weeks)||11||
48755285|NCT01841281|102187896|FG001|STARTED|Washout (6 Weeks)||12||
48755286|NCT01841281|102187897|FG002|STARTED|Washout (6 Weeks)||13||
48755287|NCT01841281|102187898|FG003|STARTED|Washout (6 Weeks)||14||
48755288|NCT01841281|102187895|FG000|COMPLETED|Washout (6 Weeks)||9||
48755289|NCT01841281|102187896|FG001|COMPLETED|Washout (6 Weeks)||9||
48755290|NCT01841281|102187897|FG002|COMPLETED|Washout (6 Weeks)||10||
48755291|NCT01841281|102187898|FG003|COMPLETED|Washout (6 Weeks)||13||
48180583|NCT01959945|100764910|FG002|NOT COMPLETED|Overall Study||19||
48180584|NCT01959945|100764911|FG003|NOT COMPLETED|Overall Study||16||
48180585|NCT02201446|100764912|FG000|STARTED|Overall Study||81||
48180586|NCT02201446|100764913|FG001|STARTED|Overall Study||58||
48180587|NCT02201446|100764912|FG000|COMPLETED|Overall Study||81||
48180588|NCT02201446|100764913|FG001|COMPLETED|Overall Study||58||
48180589|NCT02201446|100764912|FG000|NOT COMPLETED|Overall Study||0||
48180590|NCT02201446|100764913|FG001|NOT COMPLETED|Overall Study||0||
48341035|NCT01708057|101163992|FG001|STARTED|Overall Study||1||
48755292|NCT01841281|102187895|FG000|NOT COMPLETED|Washout (6 Weeks)||2||
48755293|NCT01841281|102187896|FG001|NOT COMPLETED|Washout (6 Weeks)||3||
48180591|NCT04421378|100764914|FG000|STARTED|Overall Study||23||
48341036|NCT01708057|101163993|FG002|STARTED|Overall Study||1||
48341037|NCT01708057|101163991|FG000|COMPLETED|Overall Study||0||
48341038|NCT01708057|101163992|FG001|COMPLETED|Overall Study||0||
48180592|NCT04421378|100764915|FG001|STARTED|Overall Study||15||
48180593|NCT04421378|100764916|FG002|STARTED|Overall Study||19||
48180594|NCT04421378|100764917|FG003|STARTED|Overall Study||14||
48180595|NCT04421378|100764918|FG004|STARTED|Overall Study||3||
48341039|NCT01708057|101163993|FG002|COMPLETED|Overall Study||0||
48341040|NCT01708057|101163991|FG000|NOT COMPLETED|Overall Study||1||
48341041|NCT01708057|101163992|FG001|NOT COMPLETED|Overall Study||1||
48341042|NCT01708057|101163993|FG002|NOT COMPLETED|Overall Study||1||
48341043|NCT03455673|101163994|FG000|STARTED|Overall Study||3160|Potentially eligible patients|
48341044|NCT03455673|101163994|FG000|Patients With an ATE Score|Overall Study||3099||
48341045|NCT03455673|101163994|FG000|COMPLETED|Overall Study||3072||
48341046|NCT03455673|101163994|FG000|NOT COMPLETED|Overall Study||88||
48341047|NCT02700451|101163995|FG000|STARTED|Overall Study||60||
48341048|NCT02700451|101163996|FG001|STARTED|Overall Study||60||
48341049|NCT02700451|101163997|FG002|STARTED|Overall Study||58||
48341050|NCT02700451|101163995|FG000|COMPLETED|Overall Study||44||
48341051|NCT02700451|101163996|FG001|COMPLETED|Overall Study||43||
48341052|NCT02700451|101163997|FG002|COMPLETED|Overall Study||41||
48341053|NCT02700451|101163995|FG000|NOT COMPLETED|Overall Study||16||
48341054|NCT02700451|101163996|FG001|NOT COMPLETED|Overall Study||17||
48341055|NCT02700451|101163997|FG002|NOT COMPLETED|Overall Study||17||
48341056|NCT01589484|101163998|FG000|STARTED|Overall Study||104||
48341057|NCT01589484|101163998|FG000|COMPLETED|Overall Study||100||
48341058|NCT01589484|101163998|FG000|NOT COMPLETED|Overall Study||4||
48341059|NCT02116621|101163999|FG000|STARTED|Baseline||108||
48341060|NCT02116621|101164000|FG001|STARTED|Baseline||107||
48341061|NCT02116621|101163999|FG000|Completed Baseline Visit|Baseline||108||
48341062|NCT02116621|101164000|FG001|Completed Baseline Visit|Baseline||103||
48341063|NCT02116621|101163999|FG000|Completed Intervention Period|Baseline||95||
48341064|NCT02116621|101164000|FG001|Completed Intervention Period|Baseline||103||
48341065|NCT02116621|101163999|FG000|COMPLETED|Baseline||108||
48341066|NCT02116621|101164000|FG001|COMPLETED|Baseline||103||
48341067|NCT02116621|101163999|FG000|NOT COMPLETED|Baseline||0||
48341068|NCT02116621|101164000|FG001|NOT COMPLETED|Baseline||4||
48341069|NCT02116621|101163999|FG000|STARTED|Three Month Follow-up||108||
48341070|NCT02116621|101164000|FG001|STARTED|Three Month Follow-up||103||
48341071|NCT02116621|101163999|FG000|COMPLETED|Three Month Follow-up||89||
48341072|NCT02116621|101164000|FG001|COMPLETED|Three Month Follow-up||96||
48341073|NCT02116621|101163999|FG000|NOT COMPLETED|Three Month Follow-up||19||
48341074|NCT02116621|101164000|FG001|NOT COMPLETED|Three Month Follow-up||7||
48341075|NCT02116621|101163999|FG000|STARTED|Six Month Follow-up||103||
48341076|NCT02116621|101164000|FG001|STARTED|Six Month Follow-up||100||
48341077|NCT02116621|101163999|FG000|COMPLETED|Six Month Follow-up||99||
48341078|NCT02116621|101164000|FG001|COMPLETED|Six Month Follow-up||97||
48341079|NCT02116621|101163999|FG000|NOT COMPLETED|Six Month Follow-up||4||
48341080|NCT02116621|101164000|FG001|NOT COMPLETED|Six Month Follow-up||3||
48341081|NCT02116621|101163999|FG000|STARTED|Twelve Month Follow-up||100||
48341082|NCT02116621|101164000|FG001|STARTED|Twelve Month Follow-up||98||
48341083|NCT02116621|101163999|FG000|COMPLETED|Twelve Month Follow-up||84||
48341084|NCT02116621|101164000|FG001|COMPLETED|Twelve Month Follow-up||86||
48341085|NCT02116621|101163999|FG000|NOT COMPLETED|Twelve Month Follow-up||16||
48341086|NCT02116621|101164000|FG001|NOT COMPLETED|Twelve Month Follow-up||12||
48341087|NCT02772757|101164001|FG000|STARTED|Overall Study||22||
48341088|NCT02772757|101164002|FG001|STARTED|Overall Study||24||
48341089|NCT02772757|101164003|FG002|STARTED|Overall Study||26||
48341090|NCT02772757|101164001|FG000|COMPLETED|Overall Study||21||
48341091|NCT02772757|101164002|FG001|COMPLETED|Overall Study||21||
48341092|NCT02772757|101164003|FG002|COMPLETED|Overall Study||21||
48341093|NCT02772757|101164001|FG000|NOT COMPLETED|Overall Study||1||
48341094|NCT02772757|101164002|FG001|NOT COMPLETED|Overall Study||3||
48341095|NCT02772757|101164003|FG002|NOT COMPLETED|Overall Study||5||
48341096|NCT00445887|101164004|FG000|STARTED|Overall Study||33||
48341097|NCT00445887|101164005|FG001|STARTED|Overall Study||31||
48341098|NCT00445887|101164004|FG000|COMPLETED|Overall Study||33||
48341099|NCT00445887|101164005|FG001|COMPLETED|Overall Study||31||
48341100|NCT00445887|101164004|FG000|NOT COMPLETED|Overall Study||0||
48413638|NCT01738594|101345868|FG002|Treatment Started|Registration and Treatment Start||0||
48341101|NCT00445887|101164005|FG001|NOT COMPLETED|Overall Study||0||
48341102|NCT01894672|101164006|FG000|STARTED|Overall Study||7||
48341103|NCT01894672|101164006|FG000|COMPLETED|Overall Study||7||
48341104|NCT01894672|101164006|FG000|NOT COMPLETED|Overall Study||0||
48341105|NCT01505894|101164007|FG000|STARTED|Overall Study||12||
48341106|NCT01505894|101164008|FG001|STARTED|Overall Study||9||
48341107|NCT01505894|101164009|FG002|STARTED|Overall Study||9||
48413639|NCT01738594|101345869|FG003|Treatment Started|Registration and Treatment Start||0||
48413640|NCT01738594|101345870|FG004|Treatment Started|Registration and Treatment Start||1||
48413641|NCT01738594|101345871|FG005|Treatment Started|Registration and Treatment Start||3||
48341108|NCT01505894|101164010|FG003|STARTED|Overall Study||9||
48341109|NCT01505894|101164011|FG004|STARTED|Overall Study||9||
48341110|NCT01505894|101164012|FG005|STARTED|Overall Study||9||
48341111|NCT01505894|101164013|FG006|STARTED|Overall Study||8||
48341112|NCT01505894|101164014|FG007|STARTED|Overall Study||9||
48341113|NCT01505894|101164015|FG008|STARTED|Overall Study||9||
48341114|NCT01505894|101164007|FG000|COMPLETED|Overall Study||11||
48341115|NCT01505894|101164008|FG001|COMPLETED|Overall Study||9||
48413642|NCT01738594|101345872|FG006|Treatment Started|Registration and Treatment Start||0||
48755294|NCT01841281|102187897|FG002|NOT COMPLETED|Washout (6 Weeks)||3||
48755295|NCT01841281|102187898|FG003|NOT COMPLETED|Washout (6 Weeks)||1||
48180596|NCT04421378|100764914|FG000|COMPLETED|Overall Study||0||
48180597|NCT04421378|100764915|FG001|COMPLETED|Overall Study||0||
48180598|NCT04421378|100764916|FG002|COMPLETED|Overall Study||0||
48180599|NCT04421378|100764917|FG003|COMPLETED|Overall Study||0||
48180600|NCT04421378|100764918|FG004|COMPLETED|Overall Study||0||
48180601|NCT04421378|100764914|FG000|NOT COMPLETED|Overall Study||23||
48180602|NCT04421378|100764915|FG001|NOT COMPLETED|Overall Study||15||
48180603|NCT04421378|100764916|FG002|NOT COMPLETED|Overall Study||19||
48180604|NCT04421378|100764917|FG003|NOT COMPLETED|Overall Study||14||
48180605|NCT04421378|100764918|FG004|NOT COMPLETED|Overall Study||3||
48180606|NCT00219141|100764919|FG000|STARTED|Overall Study||154||
48180607|NCT00219141|100764920|FG001|STARTED|Overall Study||152||
48180608|NCT00219141|100764921|FG002|STARTED|Overall Study||154||
48180609|NCT00219141|100764919|FG000|COMPLETED|Overall Study||140||
48180610|NCT00219141|100764920|FG001|COMPLETED|Overall Study||131||
48180611|NCT00219141|100764921|FG002|COMPLETED|Overall Study||142||
48180612|NCT00219141|100764919|FG000|NOT COMPLETED|Overall Study||14||
48180613|NCT00219141|100764920|FG001|NOT COMPLETED|Overall Study||21||
48180614|NCT00219141|100764921|FG002|NOT COMPLETED|Overall Study||12||
48180615|NCT01007552|100764922|FG000|STARTED|Overall Study||50||
48180616|NCT01007552|100764922|FG000|COMPLETED|Overall Study||49||
48180617|NCT01007552|100764922|FG000|NOT COMPLETED|Overall Study||1||
48180618|NCT02487446|100764923|FG000|STARTED|Period 1||178||
48180619|NCT02487446|100764924|FG001|STARTED|Period 1||179||
48180620|NCT02487446|100764923|FG000|COMPLETED|Period 1||165||
48180621|NCT02487446|100764924|FG001|COMPLETED|Period 1||171||
48180622|NCT02487446|100764923|FG000|NOT COMPLETED|Period 1||13||
48180623|NCT02487446|100764924|FG001|NOT COMPLETED|Period 1||8||
48180624|NCT02487446|100764923|FG000|STARTED|Washout||165||
48180625|NCT02487446|100764924|FG001|STARTED|Washout||171||
48180626|NCT02487446|100764923|FG000|COMPLETED|Washout||162||
48180627|NCT02487446|100764924|FG001|COMPLETED|Washout||163||
48180628|NCT02487446|100764923|FG000|NOT COMPLETED|Washout||3||
48180629|NCT02487446|100764924|FG001|NOT COMPLETED|Washout||8||
48180630|NCT02487446|100764923|FG000|STARTED|Period 2||162||
48180631|NCT02487446|100764924|FG001|STARTED|Period 2||163||
48180632|NCT02487446|100764923|FG000|COMPLETED|Period 2||154||
48180633|NCT02487446|100764924|FG001|COMPLETED|Period 2||158||
48180634|NCT02487446|100764923|FG000|NOT COMPLETED|Period 2||8||
48180635|NCT02487446|100764924|FG001|NOT COMPLETED|Period 2||5||
48180636|NCT03472287|100764925|FG000|STARTED|Overall Study||8||
48755296|NCT01841281|102187895|FG000|STARTED|Second Intervention (12 Weeks)||9||
48755297|NCT01841281|102187896|FG001|STARTED|Second Intervention (12 Weeks)||9||
48755298|NCT01841281|102187897|FG002|STARTED|Second Intervention (12 Weeks)||10||
48180637|NCT03472287|100764926|FG001|STARTED|Overall Study||3||
48180638|NCT03472287|100764925|FG000|COMPLETED|Overall Study||8||
48180639|NCT03472287|100764926|FG001|COMPLETED|Overall Study||3||
48180640|NCT03472287|100764925|FG000|NOT COMPLETED|Overall Study||0||
48180641|NCT03472287|100764926|FG001|NOT COMPLETED|Overall Study||0||
48180642|NCT00725010|100764927|FG000|STARTED|Overall Study||50||
48180643|NCT00725010|100764927|FG000|COMPLETED|Overall Study||25||
48180644|NCT00725010|100764927|FG000|NOT COMPLETED|Overall Study||25||
48180645|NCT04996069|100764928|FG000|STARTED|Overall Study||25||
48180646|NCT04996069|100764928|FG000|Completion of the Study|Overall Study||25||
48180647|NCT04996069|100764928|FG000|COMPLETED|Overall Study||24||
48180648|NCT04996069|100764928|FG000|NOT COMPLETED|Overall Study||1||
48180649|NCT00918749|100764929|FG000|STARTED|Overall Study||70||
48180650|NCT00918749|100764930|FG001|STARTED|Overall Study||66||
48180651|NCT00918749|100764931|FG002|STARTED|Overall Study||69||
48180652|NCT00918749|100764929|FG000|ITT (Intent to Treat) Population|Overall Study||69||
48180653|NCT00918749|100764930|FG001|ITT (Intent to Treat) Population|Overall Study||66||
48180654|NCT00918749|100764931|FG002|ITT (Intent to Treat) Population|Overall Study||69||
48180655|NCT00918749|100764929|FG000|COMPLETED|Overall Study||63||
48180656|NCT00918749|100764930|FG001|COMPLETED|Overall Study||63||
48180657|NCT00918749|100764931|FG002|COMPLETED|Overall Study||62||
48180658|NCT00918749|100764929|FG000|NOT COMPLETED|Overall Study||7||
48180659|NCT00918749|100764930|FG001|NOT COMPLETED|Overall Study||3||
48180660|NCT00918749|100764931|FG002|NOT COMPLETED|Overall Study||7||
48180661|NCT03029780|100764932|FG000|STARTED|Overall Study||52||
48180662|NCT03029780|100764933|FG001|STARTED|Overall Study||52||
48180663|NCT03029780|100764932|FG000|COMPLETED|Overall Study||1||
48180664|NCT03029780|100764933|FG001|COMPLETED|Overall Study||1||
48180665|NCT03029780|100764932|FG000|NOT COMPLETED|Overall Study||51||
48180666|NCT03029780|100764933|FG001|NOT COMPLETED|Overall Study||51||
48180667|NCT03020095|100764934|FG000|STARTED|Overall Study||38||
48767746|NCT02141295|102222815|FG000|NOT COMPLETED|Overall Study||6||
48180668|NCT03020095|100764934|FG000|COMPLETED|Overall Study||37||
48180669|NCT03020095|100764934|FG000|NOT COMPLETED|Overall Study||1||
48180670|NCT00955903|100764935|FG000|STARTED|Overall Study||55||
48180671|NCT00955903|100764936|FG001|STARTED|Overall Study||54||
48180672|NCT00955903|100764937|FG002|STARTED|Overall Study||55||
48180673|NCT00955903|100764935|FG000|COMPLETED|Overall Study||49||
48180674|NCT00955903|100764936|FG001|COMPLETED|Overall Study||51||
48180675|NCT00955903|100764937|FG002|COMPLETED|Overall Study||48||
48341116|NCT01505894|101164009|FG002|COMPLETED|Overall Study||9||
48341117|NCT01505894|101164010|FG003|COMPLETED|Overall Study||9||
48341118|NCT01505894|101164011|FG004|COMPLETED|Overall Study||8||
48341119|NCT01505894|101164012|FG005|COMPLETED|Overall Study||9||
48341120|NCT01505894|101164013|FG006|COMPLETED|Overall Study||8||
48341121|NCT01505894|101164014|FG007|COMPLETED|Overall Study||9||
48341122|NCT01505894|101164015|FG008|COMPLETED|Overall Study||9||
48341123|NCT01505894|101164007|FG000|NOT COMPLETED|Overall Study||1||
48341124|NCT01505894|101164008|FG001|NOT COMPLETED|Overall Study||0||
48341125|NCT01505894|101164009|FG002|NOT COMPLETED|Overall Study||0||
48341126|NCT01505894|101164010|FG003|NOT COMPLETED|Overall Study||0||
48341127|NCT01505894|101164011|FG004|NOT COMPLETED|Overall Study||1||
48341128|NCT01505894|101164012|FG005|NOT COMPLETED|Overall Study||0||
48341129|NCT01505894|101164013|FG006|NOT COMPLETED|Overall Study||0||
48341130|NCT01505894|101164014|FG007|NOT COMPLETED|Overall Study||0||
48341131|NCT01505894|101164015|FG008|NOT COMPLETED|Overall Study||0||
48341132|NCT00727402|101164016|FG000|STARTED|Overall Study||205||
48341133|NCT00727402|101164016|FG000|COMPLETED|Overall Study||89||
48341134|NCT00727402|101164016|FG000|NOT COMPLETED|Overall Study||116||
48341135|NCT00501228|101164017|FG000|STARTED|Overall Study||2||
48341136|NCT00501228|101164017|FG000|COMPLETED|Overall Study||1||
48341137|NCT00501228|101164017|FG000|NOT COMPLETED|Overall Study||1||
48341138|NCT00967447|101164018|FG000|STARTED|Overall Study||2||
48341139|NCT00967447|101164018|FG000|COMPLETED|Overall Study||2||
48632739|NCT01047319|101885317|FG001|NOT COMPLETED|Overall Study||350||
48632740|NCT01047319|101885318|FG002|NOT COMPLETED|Overall Study||352||
48632741|NCT03845894|101885319|FG000|STARTED|Overall Study||12||
48632742|NCT03845894|101885320|FG001|STARTED|Overall Study||13||
48632743|NCT03845894|101885319|FG000|COMPLETED|Overall Study||12||
48632744|NCT03845894|101885320|FG001|COMPLETED|Overall Study||13||
48632745|NCT03845894|101885319|FG000|NOT COMPLETED|Overall Study||0||
48632746|NCT03845894|101885320|FG001|NOT COMPLETED|Overall Study||0||
48632747|NCT02783066|101885321|FG000|STARTED|Overall Study||16||
48632748|NCT02783066|101885321|FG000|COMPLETED|Overall Study||3||
48632749|NCT02783066|101885321|FG000|NOT COMPLETED|Overall Study||13||
48632750|NCT00433836|101885322|FG000|STARTED|Overall Study||151||
48632751|NCT00433836|101885323|FG001|STARTED|Overall Study||149||
48632752|NCT00433836|101885322|FG000|COMPLETED|Overall Study||138||
48632753|NCT00433836|101885323|FG001|COMPLETED|Overall Study||143||
48632754|NCT00433836|101885322|FG000|NOT COMPLETED|Overall Study||13||
48632755|NCT00433836|101885323|FG001|NOT COMPLETED|Overall Study||6||
48632756|NCT03350919|101885324|FG000|STARTED|Overall Study||25||
48632757|NCT03350919|101885325|FG001|STARTED|Overall Study||23||
48632758|NCT03350919|101885324|FG000|COMPLETED|Overall Study||23||
48632759|NCT03350919|101885325|FG001|COMPLETED|Overall Study||23||
48341140|NCT00967447|101164018|FG000|NOT COMPLETED|Overall Study||0||
48341141|NCT04188730|101164019|FG000|STARTED|Overall Study||4||
48632760|NCT03350919|101885324|FG000|NOT COMPLETED|Overall Study||2||
48341142|NCT04188730|101164020|FG001|STARTED|Overall Study||4||
48632761|NCT03350919|101885325|FG001|NOT COMPLETED|Overall Study||0||
48632762|NCT00982345|101885326|FG000|STARTED|Overall Study||20||
48632763|NCT00982345|101885326|FG000|COMPLETED|Overall Study||18||
48632764|NCT00982345|101885326|FG000|NOT COMPLETED|Overall Study||2||
48632765|NCT03620162|101885327|FG000|STARTED|Overall Study||179||
48632766|NCT03620162|101885328|FG001|STARTED|Overall Study||181||
48341143|NCT04188730|101164021|FG002|STARTED|Overall Study||4||
48341144|NCT04188730|101164022|FG003|STARTED|Overall Study||4||
48341145|NCT04188730|101164019|FG000|Period 1|Overall Study||4||
48341146|NCT04188730|101164020|FG001|Period 1|Overall Study||4||
48341147|NCT04188730|101164021|FG002|Period 1|Overall Study||4||
48341148|NCT04188730|101164022|FG003|Period 1|Overall Study||4||
48632767|NCT03620162|101885329|FG002|STARTED|Overall Study||180||
48632768|NCT03620162|101885330|FG003|STARTED|Overall Study||180||
48632769|NCT03620162|101885331|FG004|STARTED|Overall Study||180||
48632770|NCT03620162|101885327|FG000|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||179||
48632771|NCT03620162|101885328|FG001|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||181||
48632772|NCT03620162|101885329|FG002|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||178||
48632773|NCT03620162|101885330|FG003|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||179||
48632774|NCT03620162|101885331|FG004|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||179||
48632775|NCT03620162|101885327|FG000|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||176||
48632776|NCT03620162|101885328|FG001|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||175||
48632777|NCT03620162|101885329|FG002|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||166||
48632778|NCT03620162|101885330|FG003|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||169||
48632779|NCT03620162|101885331|FG004|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||173||
48657134|NCT00063362|101943786|FG001|COMPLETED|Overall Study||22||
48341149|NCT04188730|101164019|FG000|Period 2|Overall Study||3||
48341150|NCT04188730|101164020|FG001|Period 2|Overall Study||4||
48341151|NCT04188730|101164021|FG002|Period 2|Overall Study||4||
48632780|NCT03620162|101885327|FG000|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||175||
48632781|NCT03620162|101885328|FG001|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||174||
48632782|NCT03620162|101885329|FG002|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||161||
48632783|NCT03620162|101885330|FG003|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||167||
48632784|NCT03620162|101885331|FG004|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||173||
48632785|NCT03620162|101885327|FG000|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||165||
48632786|NCT03620162|101885328|FG001|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||168||
48632787|NCT03620162|101885329|FG002|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||150||
48341152|NCT04188730|101164022|FG003|Period 2|Overall Study||4||
48341153|NCT04188730|101164019|FG000|Period 3|Overall Study||3||
48341154|NCT04188730|101164020|FG001|Period 3|Overall Study||4||
48341155|NCT04188730|101164021|FG002|Period 3|Overall Study||4||
48341156|NCT04188730|101164022|FG003|Period 3|Overall Study||4||
48341157|NCT04188730|101164019|FG000|COMPLETED|Overall Study||3||
48341158|NCT04188730|101164020|FG001|COMPLETED|Overall Study||4||
48341159|NCT04188730|101164021|FG002|COMPLETED|Overall Study||4||
48341160|NCT04188730|101164022|FG003|COMPLETED|Overall Study||4||
48180676|NCT00955903|100764935|FG000|NOT COMPLETED|Overall Study||6||
48180677|NCT00955903|100764936|FG001|NOT COMPLETED|Overall Study||3||
48180678|NCT00955903|100764937|FG002|NOT COMPLETED|Overall Study||7||
48180679|NCT04602494|100764938|FG000|STARTED|Overall Study||1||
48180680|NCT04602494|100764939|FG001|STARTED|Overall Study||1||
48180681|NCT04602494|100764940|FG002|STARTED|Overall Study||2||
48180682|NCT04602494|100764938|FG000|COMPLETED|Overall Study||1||
48341161|NCT04188730|101164019|FG000|NOT COMPLETED|Overall Study||1||
48341162|NCT04188730|101164020|FG001|NOT COMPLETED|Overall Study||0||
48341163|NCT04188730|101164021|FG002|NOT COMPLETED|Overall Study||0||
48341164|NCT04188730|101164022|FG003|NOT COMPLETED|Overall Study||0||
48341165|NCT00582556|101164023|FG000|STARTED|Overall Study||14||
48341166|NCT00582556|101164024|FG001|STARTED|Overall Study||15||
48341167|NCT00582556|101164025|FG002|STARTED|Overall Study||14||
48341168|NCT00582556|101164023|FG000|COMPLETED|Overall Study||14||
48341169|NCT00582556|101164024|FG001|COMPLETED|Overall Study||14||
48341170|NCT00582556|101164025|FG002|COMPLETED|Overall Study||12||
48341171|NCT00582556|101164023|FG000|NOT COMPLETED|Overall Study||0||
48341172|NCT00582556|101164024|FG001|NOT COMPLETED|Overall Study||1||
48341173|NCT00582556|101164025|FG002|NOT COMPLETED|Overall Study||2||
48341174|NCT00454207|101164026|FG000|STARTED|Overall Study||21||
48341175|NCT00454207|101164027|FG001|STARTED|Overall Study||23||
48341176|NCT00454207|101164026|FG000|COMPLETED|Overall Study||17||
48341177|NCT00454207|101164027|FG001|COMPLETED|Overall Study||21||
48341178|NCT00454207|101164026|FG000|NOT COMPLETED|Overall Study||4||
48341179|NCT00454207|101164027|FG001|NOT COMPLETED|Overall Study||2||
48341180|NCT00275561|101164028|FG000|STARTED|Overall Study||21||
48341181|NCT00275561|101164029|FG001|STARTED|Overall Study||21||
48341182|NCT00275561|101164028|FG000|COMPLETED|Overall Study||19||
48341183|NCT00275561|101164029|FG001|COMPLETED|Overall Study||15||
48341184|NCT00275561|101164028|FG000|NOT COMPLETED|Overall Study||2||
48341185|NCT00275561|101164029|FG001|NOT COMPLETED|Overall Study||6||
48341186|NCT01384292|101164030|FG000|STARTED|Part A||5||
48341187|NCT01384292|101164031|FG001|STARTED|Part A||5||
48341188|NCT01384292|101164032|FG002|STARTED|Part A||4||
48341189|NCT01384292|101164030|FG000|COMPLETED|Part A||5||
48341190|NCT01384292|101164031|FG001|COMPLETED|Part A||5||
48341191|NCT01384292|101164032|FG002|COMPLETED|Part A||4||
48341192|NCT01384292|101164030|FG000|NOT COMPLETED|Part A||0||
48341193|NCT01384292|101164031|FG001|NOT COMPLETED|Part A||0||
48341194|NCT01384292|101164032|FG002|NOT COMPLETED|Part A||0||
48341195|NCT01384292|101164030|FG000|STARTED|Part B||3||
48341196|NCT01384292|101164031|FG001|STARTED|Part B||6||
48341197|NCT01384292|101164032|FG002|STARTED|Part B||0||
48341198|NCT01384292|101164030|FG000|COMPLETED|Part B||2||
48341199|NCT01384292|101164031|FG001|COMPLETED|Part B||6||
48341200|NCT01384292|101164032|FG002|COMPLETED|Part B||0||
48341201|NCT01384292|101164030|FG000|NOT COMPLETED|Part B||1||
48341202|NCT01384292|101164031|FG001|NOT COMPLETED|Part B||0||
48341203|NCT01384292|101164032|FG002|NOT COMPLETED|Part B||0||
48341204|NCT02930174|101164033|FG000|STARTED|Overall Study||12||
48341205|NCT02930174|101164034|FG001|STARTED|Overall Study||8||
48341206|NCT02930174|101164033|FG000|COMPLETED|Overall Study||12||
48755299|NCT01841281|102187898|FG003|STARTED|Second Intervention (12 Weeks)||13||
48755300|NCT01841281|102187895|FG000|COMPLETED|Second Intervention (12 Weeks)||9||
48755301|NCT01841281|102187896|FG001|COMPLETED|Second Intervention (12 Weeks)||6||
48341207|NCT02930174|101164034|FG001|COMPLETED|Overall Study||8||
48341208|NCT02930174|101164033|FG000|NOT COMPLETED|Overall Study||0||
48341209|NCT02930174|101164034|FG001|NOT COMPLETED|Overall Study||0||
48341210|NCT04303000|101164035|FG000|STARTED|Opioid Use Questionnaire||319||
48341211|NCT04303000|101164036|FG001|STARTED|Opioid Use Questionnaire||0||
48341212|NCT04303000|101164037|FG002|STARTED|Opioid Use Questionnaire||0||
48341213|NCT04303000|101164035|FG000|COMPLETED|Opioid Use Questionnaire||304||
48341214|NCT04303000|101164036|FG001|COMPLETED|Opioid Use Questionnaire||0||
48341215|NCT04303000|101164037|FG002|COMPLETED|Opioid Use Questionnaire||0||
48341216|NCT04303000|101164035|FG000|NOT COMPLETED|Opioid Use Questionnaire||15||
48341217|NCT04303000|101164036|FG001|NOT COMPLETED|Opioid Use Questionnaire||0||
48341218|NCT04303000|101164037|FG002|NOT COMPLETED|Opioid Use Questionnaire||0||
48341219|NCT04303000|101164035|FG000|STARTED|Training Portion||0||
48341220|NCT04303000|101164036|FG001|STARTED|Training Portion||55||
48341221|NCT04303000|101164037|FG002|STARTED|Training Portion||56||
48341222|NCT04303000|101164035|FG000|Month 1 Follow-Up|Training Portion||0||
48341223|NCT04303000|101164036|FG001|Month 1 Follow-Up|Training Portion||48||
48341224|NCT04303000|101164037|FG002|Month 1 Follow-Up|Training Portion||50||
48341225|NCT04303000|101164035|FG000|Month 2 Follow-Up|Training Portion||0||
48341226|NCT04303000|101164036|FG001|Month 2 Follow-Up|Training Portion||48||
48413643|NCT01738594|101345873|FG007|Treatment Started|Registration and Treatment Start||0||
48632788|NCT03620162|101885330|FG003|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||162||
48632789|NCT03620162|101885331|FG004|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||168||
48632790|NCT03620162|101885327|FG000|COMPLETED|Overall Study||164||
48632791|NCT03620162|101885328|FG001|COMPLETED|Overall Study||167||
48632792|NCT03620162|101885329|FG002|COMPLETED|Overall Study||147||
48632793|NCT03620162|101885330|FG003|COMPLETED|Overall Study||160||
48632794|NCT03620162|101885331|FG004|COMPLETED|Overall Study||167||
48632795|NCT03620162|101885327|FG000|NOT COMPLETED|Overall Study||15||
48341227|NCT04303000|101164037|FG002|Month 2 Follow-Up|Training Portion||50||
48341228|NCT04303000|101164035|FG000|Month 3 Follow-Up|Training Portion||0||
48341229|NCT04303000|101164036|FG001|Month 3 Follow-Up|Training Portion||47||
48341230|NCT04303000|101164037|FG002|Month 3 Follow-Up|Training Portion||48||
48341231|NCT04303000|101164035|FG000|COMPLETED|Training Portion||0||
48341232|NCT04303000|101164036|FG001|COMPLETED|Training Portion||45||
48632796|NCT03620162|101885328|FG001|NOT COMPLETED|Overall Study||14||
48632797|NCT03620162|101885329|FG002|NOT COMPLETED|Overall Study||33||
48632798|NCT03620162|101885330|FG003|NOT COMPLETED|Overall Study||20||
48632799|NCT03620162|101885331|FG004|NOT COMPLETED|Overall Study||13||
48632800|NCT03136198|101885332|FG000|STARTED|Overall Study||66||
48755302|NCT01841281|102187897|FG002|COMPLETED|Second Intervention (12 Weeks)||10||
48755303|NCT01841281|102187898|FG003|COMPLETED|Second Intervention (12 Weeks)||13||
48755304|NCT01841281|102187895|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0||
48755305|NCT01841281|102187896|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||3||
48755306|NCT01841281|102187897|FG002|NOT COMPLETED|Second Intervention (12 Weeks)||0||
48755307|NCT01841281|102187898|FG003|NOT COMPLETED|Second Intervention (12 Weeks)||0||
48755308|NCT02151487|102187899|FG000|STARTED|Overall Study||27||
48755309|NCT02151487|102187900|FG001|STARTED|Overall Study||27||
48755310|NCT02151487|102187901|FG002|STARTED|Overall Study||20||
48755311|NCT02151487|102187902|FG003|STARTED|Overall Study||23||
48755312|NCT02151487|102187899|FG000|COMPLETED|Overall Study||25||
48755313|NCT02151487|102187900|FG001|COMPLETED|Overall Study||22||
48755314|NCT02151487|102187901|FG002|COMPLETED|Overall Study||16||
48755315|NCT02151487|102187902|FG003|COMPLETED|Overall Study||20||
48341233|NCT04303000|101164037|FG002|COMPLETED|Training Portion||47||
48632801|NCT03136198|101885333|FG001|STARTED|Overall Study||64||
48632802|NCT03136198|101885332|FG000|COMPLETED|Overall Study||66||
48755316|NCT02151487|102187899|FG000|NOT COMPLETED|Overall Study||2||
48341234|NCT04303000|101164035|FG000|NOT COMPLETED|Training Portion||0||
48341235|NCT04303000|101164036|FG001|NOT COMPLETED|Training Portion||10||
48341236|NCT04303000|101164037|FG002|NOT COMPLETED|Training Portion||9||
48341237|NCT00667576|101164038|FG000|STARTED|Overall Study||30||
48341238|NCT00667576|101164039|FG001|STARTED|Overall Study||31||
48341239|NCT00667576|101164040|FG002|STARTED|Overall Study||31||
48341240|NCT00667576|101164041|FG003|STARTED|Overall Study||31||
48341241|NCT00667576|101164042|FG004|STARTED|Overall Study||30||
48341242|NCT00667576|101164038|FG000|COMPLETED|Overall Study||28||
48341243|NCT00667576|101164039|FG001|COMPLETED|Overall Study||30||
48341244|NCT00667576|101164040|FG002|COMPLETED|Overall Study||29||
48341245|NCT00667576|101164041|FG003|COMPLETED|Overall Study||27||
48341246|NCT00667576|101164042|FG004|COMPLETED|Overall Study||29||
48632803|NCT03136198|101885333|FG001|COMPLETED|Overall Study||64||
48755317|NCT02151487|102187900|FG001|NOT COMPLETED|Overall Study||5||
48341247|NCT00667576|101164038|FG000|NOT COMPLETED|Overall Study||2||
48341248|NCT00667576|101164039|FG001|NOT COMPLETED|Overall Study||1||
48341249|NCT00667576|101164040|FG002|NOT COMPLETED|Overall Study||2||
48341250|NCT00667576|101164041|FG003|NOT COMPLETED|Overall Study||4||
48341251|NCT00667576|101164042|FG004|NOT COMPLETED|Overall Study||1||
48341252|NCT03856944|101164043|FG000|STARTED|Overall Study||29||
48180683|NCT04602494|100764939|FG001|COMPLETED|Overall Study||1||
48180684|NCT04602494|100764940|FG002|COMPLETED|Overall Study||0||
48180685|NCT04602494|100764938|FG000|NOT COMPLETED|Overall Study||0||
48180686|NCT04602494|100764939|FG001|NOT COMPLETED|Overall Study||0||
48180687|NCT04602494|100764940|FG002|NOT COMPLETED|Overall Study||2||
48180688|NCT01844193|100764941|FG000|STARTED|Overall Study||19||
48180689|NCT01844193|100764942|FG001|STARTED|Overall Study||21||
48180690|NCT01844193|100764941|FG000|COMPLETED|Overall Study||13||
48180691|NCT01844193|100764942|FG001|COMPLETED|Overall Study||15||
48180692|NCT01844193|100764941|FG000|NOT COMPLETED|Overall Study||6||
48180693|NCT01844193|100764942|FG001|NOT COMPLETED|Overall Study||6||
48180694|NCT00900627|100764943|FG000|STARTED|Overall Study||6||
48180695|NCT00900627|100764944|FG001|STARTED|Overall Study||2||
48180696|NCT00900627|100764945|FG002|STARTED|Overall Study||6||
48180697|NCT00900627|100764946|FG003|STARTED|Overall Study||6||
48180698|NCT00900627|100764947|FG004|STARTED|Overall Study||94||
48180699|NCT00900627|100764948|FG005|STARTED|Overall Study||96||
48180700|NCT00900627|100764943|FG000|COMPLETED|Overall Study||0||
48180701|NCT00900627|100764944|FG001|COMPLETED|Overall Study||0||
48180702|NCT00900627|100764945|FG002|COMPLETED|Overall Study||0||
48180703|NCT00900627|100764946|FG003|COMPLETED|Overall Study||0||
48180704|NCT00900627|100764947|FG004|COMPLETED|Overall Study||65||
48180705|NCT00900627|100764948|FG005|COMPLETED|Overall Study||70||
48180706|NCT00900627|100764943|FG000|NOT COMPLETED|Overall Study||6||
48180707|NCT00900627|100764944|FG001|NOT COMPLETED|Overall Study||2||
48180708|NCT00900627|100764945|FG002|NOT COMPLETED|Overall Study||6||
48180709|NCT00900627|100764946|FG003|NOT COMPLETED|Overall Study||6||
48180710|NCT00900627|100764947|FG004|NOT COMPLETED|Overall Study||29||
48180711|NCT00900627|100764948|FG005|NOT COMPLETED|Overall Study||26||
48180712|NCT04707391|100764949|FG000|STARTED|Overall Study||626||
48180713|NCT04707391|100764950|FG001|STARTED|Overall Study||621||
48180714|NCT04707391|100764949|FG000|COMPLETED|Overall Study||541||
48180715|NCT04707391|100764950|FG001|COMPLETED|Overall Study||542||
48180716|NCT04707391|100764949|FG000|NOT COMPLETED|Overall Study||85||
48180717|NCT04707391|100764950|FG001|NOT COMPLETED|Overall Study||79||
48180718|NCT01591161|100764951|FG000|STARTED|Overall Study||245||
48180719|NCT01591161|100764952|FG001|STARTED|Overall Study||124||
48180720|NCT01591161|100764951|FG000|COMPLETED|Overall Study||174||
48180721|NCT01591161|100764952|FG001|COMPLETED|Overall Study||68||
48180722|NCT01591161|100764951|FG000|NOT COMPLETED|Overall Study||71||
48180723|NCT01591161|100764952|FG001|NOT COMPLETED|Overall Study||56||
48180724|NCT00598481|100764953|FG000|STARTED|Baseline||12||
48180725|NCT00598481|100764953|FG000|COMPLETED|Baseline||12||
48180726|NCT00598481|100764953|FG000|NOT COMPLETED|Baseline||0||
48180727|NCT00598481|100764953|FG000|STARTED|Treatment||12||
48341253|NCT03856944|101164043|FG000|COMPLETED|Overall Study||29||
48341254|NCT03856944|101164043|FG000|NOT COMPLETED|Overall Study||0||
48413644|NCT01738594|101345866|FG000|COMPLETED|Registration and Treatment Start||0||
48413645|NCT01738594|101345867|FG001|COMPLETED|Registration and Treatment Start||2||
48413646|NCT01738594|101345868|FG002|COMPLETED|Registration and Treatment Start||0||
48413647|NCT01738594|101345869|FG003|COMPLETED|Registration and Treatment Start||0||
48413648|NCT01738594|101345870|FG004|COMPLETED|Registration and Treatment Start||1||
48413649|NCT01738594|101345871|FG005|COMPLETED|Registration and Treatment Start||3||
48180728|NCT00598481|100764953|FG000|COMPLETED|Treatment||11||
48180729|NCT00598481|100764953|FG000|NOT COMPLETED|Treatment||1||
48180730|NCT03123263|100764954|FG000|STARTED|Overall Study||60||
48180731|NCT03123263|100764954|FG000|COMPLETED|Overall Study||60||
48180732|NCT03123263|100764954|FG000|NOT COMPLETED|Overall Study||0||
48180733|NCT02206152|100764955|FG000|STARTED|Pre-Randomization||22||
48341255|NCT02789657|101164044|FG000|STARTED|Overall Study||27||
48180734|NCT02206152|100764955|FG000|COMPLETED|Pre-Randomization||20||
48180735|NCT02206152|100764955|FG000|NOT COMPLETED|Pre-Randomization||2||
48180736|NCT02206152|100764955|FG000|STARTED|Placebo, Then NAC||10||
48180737|NCT02206152|100764955|FG000|COMPLETED|Placebo, Then NAC||10||
48180738|NCT02206152|100764955|FG000|NOT COMPLETED|Placebo, Then NAC||0||
48180739|NCT02206152|100764955|FG000|STARTED|NAC, Then Placebo||10||
48341256|NCT02789657|101164045|FG001|STARTED|Overall Study||3||
48341257|NCT02789657|101164046|FG002|STARTED|Overall Study||0||
48341258|NCT02789657|101164047|FG003|STARTED|Overall Study||2||
48341259|NCT02789657|101164044|FG000|COMPLETED|Overall Study||25||
48341260|NCT02789657|101164045|FG001|COMPLETED|Overall Study||3||
48341261|NCT02789657|101164046|FG002|COMPLETED|Overall Study||0||
48180740|NCT02206152|100764955|FG000|COMPLETED|NAC, Then Placebo||10||
48180741|NCT02206152|100764955|FG000|NOT COMPLETED|NAC, Then Placebo||0||
48413650|NCT01738594|101345872|FG006|COMPLETED|Registration and Treatment Start||0||
48180742|NCT00322374|100764956|FG000|STARTED|Enrollment||0||
48180743|NCT00322374|100764957|FG001|STARTED|Enrollment||0||
48341262|NCT02789657|101164047|FG003|COMPLETED|Overall Study||2||
48180744|NCT00322374|100764958|FG002|STARTED|Enrollment||0||
48180745|NCT00322374|100764959|FG003|STARTED|Enrollment||42||
48180746|NCT00322374|100764956|FG000|COMPLETED|Enrollment||0||
48180747|NCT00322374|100764957|FG001|COMPLETED|Enrollment||0||
48180748|NCT00322374|100764958|FG002|COMPLETED|Enrollment||0||
48180749|NCT00322374|100764959|FG003|COMPLETED|Enrollment||42||
48180750|NCT00322374|100764956|FG000|NOT COMPLETED|Enrollment||0||
48180751|NCT00322374|100764957|FG001|NOT COMPLETED|Enrollment||0||
48180752|NCT00322374|100764958|FG002|NOT COMPLETED|Enrollment||0||
48180753|NCT00322374|100764959|FG003|NOT COMPLETED|Enrollment||0||
48413651|NCT01738594|101345873|FG007|COMPLETED|Registration and Treatment Start||0||
48413652|NCT01738594|101345866|FG000|NOT COMPLETED|Registration and Treatment Start||0||
48413653|NCT01738594|101345867|FG001|NOT COMPLETED|Registration and Treatment Start||1||
48632804|NCT03136198|101885332|FG000|NOT COMPLETED|Overall Study||0||
48632805|NCT03136198|101885333|FG001|NOT COMPLETED|Overall Study||0||
48180754|NCT00322374|100764956|FG000|STARTED|Starting Dose||6||
48180755|NCT00322374|100764957|FG001|STARTED|Starting Dose||0||
48180756|NCT00322374|100764958|FG002|STARTED|Starting Dose||0||
48755318|NCT02151487|102187901|FG002|NOT COMPLETED|Overall Study||4||
48755319|NCT02151487|102187902|FG003|NOT COMPLETED|Overall Study||3||
48755320|NCT00525512|102187903|FG000|STARTED|Double-Blind Phase||259||
48755321|NCT00525512|102187904|FG001|STARTED|Double-Blind Phase||260||
48755322|NCT00525512|102187905|FG002|STARTED|Double-Blind Phase||0||
48755323|NCT00525512|102187906|FG003|STARTED|Double-Blind Phase||0||
48632806|NCT00434434|101885334|FG000|STARTED|Overall Study||23||
48632807|NCT00434434|101885335|FG001|STARTED|Overall Study||24||
48632808|NCT00434434|101885336|FG002|STARTED|Overall Study||14||
48632809|NCT00434434|101885334|FG000|COMPLETED|Overall Study||21||
48632810|NCT00434434|101885335|FG001|COMPLETED|Overall Study||24||
48632811|NCT00434434|101885336|FG002|COMPLETED|Overall Study||13||
48632812|NCT00434434|101885334|FG000|NOT COMPLETED|Overall Study||2||
48632813|NCT00434434|101885335|FG001|NOT COMPLETED|Overall Study||0||
48632814|NCT00434434|101885336|FG002|NOT COMPLETED|Overall Study||1||
48632815|NCT02690727|101885337|FG000|STARTED|Overall Study||9||
48632816|NCT02690727|101885338|FG001|STARTED|Overall Study||9||
48632817|NCT02690727|101885337|FG000|COMPLETED|Overall Study||7||
48632818|NCT02690727|101885338|FG001|COMPLETED|Overall Study||7||
48632819|NCT02690727|101885337|FG000|NOT COMPLETED|Overall Study||2||
48632820|NCT02690727|101885338|FG001|NOT COMPLETED|Overall Study||2||
48632821|NCT02576899|101885339|FG000|STARTED|Overall Study||16||
48632822|NCT02576899|101885340|FG001|STARTED|Overall Study||20||
48632823|NCT02576899|101885339|FG000|COMPLETED|Overall Study||5||
48632824|NCT02576899|101885340|FG001|COMPLETED|Overall Study||7||
48632825|NCT02576899|101885339|FG000|NOT COMPLETED|Overall Study||11||
48632826|NCT02576899|101885340|FG001|NOT COMPLETED|Overall Study||13||
48632827|NCT03587636|101885341|FG000|STARTED|Overall Study||39||
48632828|NCT03587636|101885342|FG001|STARTED|Overall Study||38||
48632829|NCT03587636|101885341|FG000|COMPLETED|Overall Study||37||
48632830|NCT03587636|101885342|FG001|COMPLETED|Overall Study||33||
48632831|NCT03587636|101885341|FG000|NOT COMPLETED|Overall Study||2||
48632832|NCT03587636|101885342|FG001|NOT COMPLETED|Overall Study||5||
48632833|NCT02394756|101885343|FG000|STARTED|Period 1||7||
48632834|NCT02394756|101885344|FG001|STARTED|Period 1||7||
48632835|NCT02394756|101885345|FG002|STARTED|Period 1||7||
48632836|NCT02394756|101885346|FG003|STARTED|Period 1||7||
48632837|NCT02394756|101885347|FG004|STARTED|Period 1||7||
48632838|NCT02394756|101885348|FG005|STARTED|Period 1||7||
48632839|NCT02394756|101885343|FG000|COMPLETED|Period 1||7||
48632840|NCT02394756|101885344|FG001|COMPLETED|Period 1||6||
48632841|NCT02394756|101885345|FG002|COMPLETED|Period 1||6||
48632842|NCT02394756|101885346|FG003|COMPLETED|Period 1||6||
48755324|NCT00525512|102187903|FG000|COMPLETED|Double-Blind Phase||163||
48755325|NCT00525512|102187904|FG001|COMPLETED|Double-Blind Phase||194||
48180757|NCT00322374|100764959|FG003|STARTED|Starting Dose||0||
48180758|NCT00322374|100764956|FG000|COMPLETED|Starting Dose||0||
48180759|NCT00322374|100764957|FG001|COMPLETED|Starting Dose||0||
48180760|NCT00322374|100764958|FG002|COMPLETED|Starting Dose||0||
48180761|NCT00322374|100764959|FG003|COMPLETED|Starting Dose||0||
48180762|NCT00322374|100764956|FG000|NOT COMPLETED|Starting Dose||6||
48180763|NCT00322374|100764957|FG001|NOT COMPLETED|Starting Dose||0||
48180764|NCT00322374|100764958|FG002|NOT COMPLETED|Starting Dose||0||
48755326|NCT00525512|102187905|FG002|COMPLETED|Double-Blind Phase||0||
48341263|NCT02789657|101164044|FG000|NOT COMPLETED|Overall Study||2||
48341264|NCT02789657|101164045|FG001|NOT COMPLETED|Overall Study||0||
48341265|NCT02789657|101164046|FG002|NOT COMPLETED|Overall Study||0||
48341266|NCT02789657|101164047|FG003|NOT COMPLETED|Overall Study||0||
48341267|NCT01727258|101164048|FG000|STARTED|Overall Study||51||
48413654|NCT01738594|101345868|FG002|NOT COMPLETED|Registration and Treatment Start||0||
48413655|NCT01738594|101345869|FG003|NOT COMPLETED|Registration and Treatment Start||0||
48632843|NCT02394756|101885347|FG004|COMPLETED|Period 1||7||
48632844|NCT02394756|101885348|FG005|COMPLETED|Period 1||6||
48180765|NCT00322374|100764959|FG003|NOT COMPLETED|Starting Dose||0||
48180766|NCT00322374|100764956|FG000|STARTED|First Escalation||0||
48180767|NCT00322374|100764957|FG001|STARTED|First Escalation||30||
48632845|NCT02394756|101885343|FG000|NOT COMPLETED|Period 1||0||
48632846|NCT02394756|101885344|FG001|NOT COMPLETED|Period 1||1||
48632847|NCT02394756|101885345|FG002|NOT COMPLETED|Period 1||1||
48632848|NCT02394756|101885346|FG003|NOT COMPLETED|Period 1||1||
48632849|NCT02394756|101885347|FG004|NOT COMPLETED|Period 1||0||
48632850|NCT02394756|101885348|FG005|NOT COMPLETED|Period 1||1||
48632851|NCT02394756|101885343|FG000|STARTED|Period 2||7||
48632852|NCT02394756|101885344|FG001|STARTED|Period 2||6||
48632853|NCT02394756|101885345|FG002|STARTED|Period 2||6||
48632854|NCT02394756|101885346|FG003|STARTED|Period 2||6||
48632855|NCT02394756|101885347|FG004|STARTED|Period 2||7||
48632856|NCT02394756|101885348|FG005|STARTED|Period 2||6||
48632857|NCT02394756|101885343|FG000|COMPLETED|Period 2||7||
48632858|NCT02394756|101885344|FG001|COMPLETED|Period 2||6||
48632859|NCT02394756|101885345|FG002|COMPLETED|Period 2||6||
48632860|NCT02394756|101885346|FG003|COMPLETED|Period 2||6||
48632861|NCT02394756|101885347|FG004|COMPLETED|Period 2||6||
48632862|NCT02394756|101885348|FG005|COMPLETED|Period 2||6||
48341268|NCT01727258|101164049|FG001|STARTED|Overall Study||51||
48341269|NCT01727258|101164050|FG002|STARTED|Overall Study||51||
48341270|NCT01727258|101164048|FG000|COMPLETED|Overall Study||49||
48341271|NCT01727258|101164049|FG001|COMPLETED|Overall Study||48||
48341272|NCT01727258|101164050|FG002|COMPLETED|Overall Study||50||
48341273|NCT01727258|101164048|FG000|NOT COMPLETED|Overall Study||2||
48341274|NCT01727258|101164049|FG001|NOT COMPLETED|Overall Study||3||
48341275|NCT01727258|101164050|FG002|NOT COMPLETED|Overall Study||1||
48341276|NCT01279057|101164051|FG000|STARTED|Overall Study||288||
48341277|NCT01279057|101164052|FG001|STARTED|Overall Study||292||
48341278|NCT01279057|101164053|FG002|STARTED|Overall Study||147||
48341279|NCT01279057|101164051|FG000|Per-Protocol (PPP) Population|Overall Study||257|All participants who satisfied the criteria set forth in the protocol in terms of dosing compliance, number of available post-randomization evaluations and absence of significant protocol violations.|
48341280|NCT01279057|101164052|FG001|Per-Protocol (PPP) Population|Overall Study||245|All participants who satisfied the criteria set forth in the protocol in terms of dosing compliance, number of available post-randomization evaluations and absence of significant protocol violations.|
48341281|NCT01279057|101164053|FG002|Per-Protocol (PPP) Population|Overall Study||126|All participants who satisfied the criteria set forth in the protocol in terms of dosing compliance, number of available post-randomization evaluations and absence of significant protocol violations.|
48341282|NCT01279057|101164051|FG000|Intent-to-Treat (ITT) Population|Overall Study||284|All participants in the PPP as well as all participants who administered at least one dose of randomized study drug and had at least one post-randomization evaluation.|
48341283|NCT01279057|101164052|FG001|Intent-to-Treat (ITT) Population|Overall Study||285|All participants in the PPP as well as all participants who administered at least one dose of randomized study drug and had at least one post-randomization evaluation.|
48341284|NCT01279057|101164053|FG002|Intent-to-Treat (ITT) Population|Overall Study||144|All participants in the PPP as well as all participants who administered at least one dose of randomized study drug and had at least one post-randomization evaluation.|
48341285|NCT01279057|101164051|FG000|COMPLETED|Overall Study||282||
48341286|NCT01279057|101164052|FG001|COMPLETED|Overall Study||287||
48341287|NCT01279057|101164053|FG002|COMPLETED|Overall Study||144||
48341288|NCT01279057|101164051|FG000|NOT COMPLETED|Overall Study||6||
48341289|NCT01279057|101164052|FG001|NOT COMPLETED|Overall Study||5||
48413656|NCT01738594|101345870|FG004|NOT COMPLETED|Registration and Treatment Start||0||
48413657|NCT01738594|101345871|FG005|NOT COMPLETED|Registration and Treatment Start||0||
48413658|NCT01738594|101345872|FG006|NOT COMPLETED|Registration and Treatment Start||0||
48413659|NCT01738594|101345873|FG007|NOT COMPLETED|Registration and Treatment Start||0||
48413660|NCT01738594|101345866|FG000|STARTED|Completed 2 Cycles/Reached 1st Response||0||
48632863|NCT02394756|101885343|FG000|NOT COMPLETED|Period 2||0||
48632864|NCT02394756|101885344|FG001|NOT COMPLETED|Period 2||0||
48632865|NCT02394756|101885345|FG002|NOT COMPLETED|Period 2||0||
48632866|NCT02394756|101885346|FG003|NOT COMPLETED|Period 2||0||
48632867|NCT02394756|101885347|FG004|NOT COMPLETED|Period 2||1||
48632868|NCT02394756|101885348|FG005|NOT COMPLETED|Period 2||0||
48632869|NCT02394756|101885343|FG000|STARTED|Period 3||7||
48632870|NCT02394756|101885344|FG001|STARTED|Period 3||6||
48632871|NCT02394756|101885345|FG002|STARTED|Period 3||6||
48632872|NCT02394756|101885346|FG003|STARTED|Period 3||6||
48632873|NCT02394756|101885347|FG004|STARTED|Period 3||6||
48341290|NCT01279057|101164053|FG002|NOT COMPLETED|Overall Study||3||
48341291|NCT01961544|101164054|FG000|STARTED|Overall Study||101||
48341292|NCT01961544|101164054|FG000|COMPLETED|Overall Study||88||
48341293|NCT01961544|101164054|FG000|NOT COMPLETED|Overall Study||13||
48413661|NCT01738594|101345867|FG001|STARTED|Completed 2 Cycles/Reached 1st Response||2||
48632874|NCT02394756|101885348|FG005|STARTED|Period 3||6||
48632875|NCT02394756|101885343|FG000|COMPLETED|Period 3||7||
48632876|NCT02394756|101885344|FG001|COMPLETED|Period 3||6||
48632877|NCT02394756|101885345|FG002|COMPLETED|Period 3||6||
48632878|NCT02394756|101885346|FG003|COMPLETED|Period 3||6||
48632879|NCT02394756|101885347|FG004|COMPLETED|Period 3||6||
48632880|NCT02394756|101885348|FG005|COMPLETED|Period 3||6||
48632881|NCT02394756|101885343|FG000|NOT COMPLETED|Period 3||0||
48632882|NCT02394756|101885344|FG001|NOT COMPLETED|Period 3||0||
48632883|NCT02394756|101885345|FG002|NOT COMPLETED|Period 3||0||
48632884|NCT02394756|101885346|FG003|NOT COMPLETED|Period 3||0||
48632885|NCT02394756|101885347|FG004|NOT COMPLETED|Period 3||0||
48632886|NCT02394756|101885348|FG005|NOT COMPLETED|Period 3||0||
48341294|NCT00579813|101164055|FG000|STARTED|Overall Study||60||
48341295|NCT00579813|101164056|FG001|STARTED|Overall Study||10||
48341296|NCT00579813|101164055|FG000|COMPLETED|Overall Study||60||
48341297|NCT00579813|101164056|FG001|COMPLETED|Overall Study||10||
48341298|NCT00579813|101164055|FG000|NOT COMPLETED|Overall Study||0||
48341299|NCT00579813|101164056|FG001|NOT COMPLETED|Overall Study||0||
48341300|NCT01984515|101164057|FG000|STARTED|Overall Study||59||
48341301|NCT01984515|101164057|FG000|Received CBT Session|Overall Study||40||
48341302|NCT01984515|101164057|FG000|COMPLETED|Overall Study||40||
48341303|NCT01984515|101164057|FG000|NOT COMPLETED|Overall Study||19||
48341304|NCT00546364|101164058|FG000|STARTED|Overall Study||20||
48341305|NCT00546364|101164059|FG001|STARTED|Overall Study||22||
48341306|NCT00546364|101164060|FG002|STARTED|Overall Study||20||
48341307|NCT00546364|101164058|FG000|Never Treated|Overall Study||0||
48341308|NCT00546364|101164059|FG001|Never Treated|Overall Study||0||
48341309|NCT00546364|101164060|FG002|Never Treated|Overall Study||0||
48341310|NCT00546364|101164058|FG000|COMPLETED|Overall Study||3||
48341311|NCT00546364|101164059|FG001|COMPLETED|Overall Study||4||
48341312|NCT00546364|101164060|FG002|COMPLETED|Overall Study||3||
48341313|NCT00546364|101164058|FG000|NOT COMPLETED|Overall Study||17||
48341314|NCT00546364|101164059|FG001|NOT COMPLETED|Overall Study||18||
48341315|NCT00546364|101164060|FG002|NOT COMPLETED|Overall Study||17||
48341316|NCT03257189|101164061|FG000|STARTED|Overall Study||30||
48341317|NCT03257189|101164061|FG000|COMPLETED|Overall Study||30||
48341318|NCT03257189|101164061|FG000|NOT COMPLETED|Overall Study||0||
48341319|NCT04051957|101164062|FG000|STARTED|Overall Study||7||
48341320|NCT04051957|101164063|FG001|STARTED|Overall Study||2||
48341321|NCT04051957|101164062|FG000|COMPLETED|Overall Study||5||
48341322|NCT04051957|101164063|FG001|COMPLETED|Overall Study||2||
48341323|NCT04051957|101164062|FG000|NOT COMPLETED|Overall Study||2||
48341324|NCT04051957|101164063|FG001|NOT COMPLETED|Overall Study||0||
48341325|NCT00675597|101164064|FG000|STARTED|Overall Study||26||
48341326|NCT00675597|101164064|FG000|COMPLETED|Overall Study||23||
48341327|NCT00675597|101164064|FG000|NOT COMPLETED|Overall Study||3||
48341328|NCT01701622|101164065|FG000|STARTED|Overall Study||1||
48341329|NCT01701622|101164065|FG000|COMPLETED|Overall Study||1||
48341330|NCT01701622|101164065|FG000|NOT COMPLETED|Overall Study||0||
48341331|NCT00669617|101164066|FG000|STARTED|Period 1||18||
48341332|NCT00669617|101164067|FG001|STARTED|Period 1||17||
48341333|NCT00669617|101164068|FG002|STARTED|Period 1||18||
48341334|NCT00669617|101164069|FG003|STARTED|Period 1||18||
48341335|NCT00669617|101164070|FG004|STARTED|Period 1||18||
48341336|NCT00669617|101164066|FG000|COMPLETED|Period 1||18||
48341337|NCT00669617|101164067|FG001|COMPLETED|Period 1||17||
48341338|NCT00669617|101164068|FG002|COMPLETED|Period 1||17||
48341339|NCT00669617|101164069|FG003|COMPLETED|Period 1||18||
48341340|NCT00669617|101164070|FG004|COMPLETED|Period 1||17||
48341341|NCT00669617|101164066|FG000|NOT COMPLETED|Period 1||0||
48341342|NCT00669617|101164067|FG001|NOT COMPLETED|Period 1||0||
48341343|NCT00669617|101164068|FG002|NOT COMPLETED|Period 1||1||
48341344|NCT00669617|101164069|FG003|NOT COMPLETED|Period 1||0||
48341345|NCT00669617|101164070|FG004|NOT COMPLETED|Period 1||1||
48341346|NCT00669617|101164066|FG000|STARTED|Period 2||18||
48341347|NCT00669617|101164067|FG001|STARTED|Period 2||17||
48341348|NCT00669617|101164068|FG002|STARTED|Period 2||17||
48341349|NCT00669617|101164069|FG003|STARTED|Period 2||18||
48341350|NCT00669617|101164070|FG004|STARTED|Period 2||17||
48341351|NCT00669617|101164066|FG000|COMPLETED|Period 2||18||
48341352|NCT00669617|101164067|FG001|COMPLETED|Period 2||17||
48341353|NCT00669617|101164068|FG002|COMPLETED|Period 2||17||
48341354|NCT00669617|101164069|FG003|COMPLETED|Period 2||18||
48341355|NCT00669617|101164070|FG004|COMPLETED|Period 2||17||
48341356|NCT00669617|101164066|FG000|NOT COMPLETED|Period 2||0||
48341357|NCT00669617|101164067|FG001|NOT COMPLETED|Period 2||0||
48341358|NCT00669617|101164068|FG002|NOT COMPLETED|Period 2||0||
48341359|NCT00669617|101164069|FG003|NOT COMPLETED|Period 2||0||
48341360|NCT00669617|101164070|FG004|NOT COMPLETED|Period 2||0||
48341361|NCT00669617|101164066|FG000|STARTED|Period 3||18||
48341362|NCT00669617|101164067|FG001|STARTED|Period 3||17||
48341363|NCT00669617|101164068|FG002|STARTED|Period 3||17||
48341364|NCT00669617|101164069|FG003|STARTED|Period 3||18||
48341365|NCT00669617|101164070|FG004|STARTED|Period 3||17||
48341366|NCT00669617|101164066|FG000|COMPLETED|Period 3||17||
48341367|NCT00669617|101164067|FG001|COMPLETED|Period 3||17||
48341368|NCT00669617|101164068|FG002|COMPLETED|Period 3||17||
48341369|NCT00669617|101164069|FG003|COMPLETED|Period 3||18||
48341370|NCT00669617|101164070|FG004|COMPLETED|Period 3||17||
48341371|NCT00669617|101164066|FG000|NOT COMPLETED|Period 3||1||
48341372|NCT00669617|101164067|FG001|NOT COMPLETED|Period 3||0||
48341373|NCT00669617|101164068|FG002|NOT COMPLETED|Period 3||0||
48341374|NCT00669617|101164069|FG003|NOT COMPLETED|Period 3||0||
48341375|NCT00669617|101164070|FG004|NOT COMPLETED|Period 3||0||
48341376|NCT00669617|101164066|FG000|STARTED|Period 4||17||
48341377|NCT00669617|101164067|FG001|STARTED|Period 4||17||
48341378|NCT00669617|101164068|FG002|STARTED|Period 4||17||
48341379|NCT00669617|101164069|FG003|STARTED|Period 4||18||
48341380|NCT00669617|101164070|FG004|STARTED|Period 4||17||
48341381|NCT00669617|101164066|FG000|COMPLETED|Period 4||17||
48341382|NCT00669617|101164067|FG001|COMPLETED|Period 4||17||
48341383|NCT00669617|101164068|FG002|COMPLETED|Period 4||17||
48341384|NCT00669617|101164069|FG003|COMPLETED|Period 4||18||
48341385|NCT00669617|101164070|FG004|COMPLETED|Period 4||17||
48341386|NCT00669617|101164066|FG000|NOT COMPLETED|Period 4||0||
48341387|NCT00669617|101164067|FG001|NOT COMPLETED|Period 4||0||
48341388|NCT00669617|101164068|FG002|NOT COMPLETED|Period 4||0||
48341389|NCT00669617|101164069|FG003|NOT COMPLETED|Period 4||0||
48341390|NCT00669617|101164070|FG004|NOT COMPLETED|Period 4||0||
48341391|NCT00669617|101164066|FG000|STARTED|Period 5||17||
48341392|NCT00669617|101164067|FG001|STARTED|Period 5||17||
48341393|NCT00669617|101164068|FG002|STARTED|Period 5||17||
48341394|NCT00669617|101164069|FG003|STARTED|Period 5||18||
48341395|NCT00669617|101164070|FG004|STARTED|Period 5||17||
48341396|NCT00669617|101164066|FG000|COMPLETED|Period 5||17||
48341397|NCT00669617|101164067|FG001|COMPLETED|Period 5||17||
48341398|NCT00669617|101164068|FG002|COMPLETED|Period 5||17||
48341399|NCT00669617|101164069|FG003|COMPLETED|Period 5||18||
48341400|NCT00669617|101164070|FG004|COMPLETED|Period 5||17||
48341401|NCT00669617|101164066|FG000|NOT COMPLETED|Period 5||0||
48341402|NCT00669617|101164067|FG001|NOT COMPLETED|Period 5||0||
48341403|NCT00669617|101164068|FG002|NOT COMPLETED|Period 5||0||
48341404|NCT00669617|101164069|FG003|NOT COMPLETED|Period 5||0||
48341405|NCT00669617|101164070|FG004|NOT COMPLETED|Period 5||0||
48341406|NCT00151892|101164071|FG000|STARTED|Overall Study||416||
48341407|NCT00151892|101164072|FG001|STARTED|Overall Study||413||
48341408|NCT00151892|101164071|FG000|COMPLETED|Overall Study||340||
48341409|NCT00151892|101164072|FG001|COMPLETED|Overall Study||330||
48341410|NCT00151892|101164071|FG000|NOT COMPLETED|Overall Study||76||
48341411|NCT00151892|101164072|FG001|NOT COMPLETED|Overall Study||83||
48341412|NCT01454076|101164073|FG000|STARTED|Overall Study||29||
48341413|NCT01454076|101164074|FG001|STARTED|Overall Study||20||
48341414|NCT01454076|101164075|FG002|STARTED|Overall Study||24||
48341415|NCT01454076|101164076|FG003|STARTED|Overall Study||18||
48341416|NCT01454076|101164077|FG004|STARTED|Overall Study||21||
48341417|NCT01454076|101164073|FG000|COMPLETED|Overall Study||16||
48341418|NCT01454076|101164074|FG001|COMPLETED|Overall Study||14||
48341419|NCT01454076|101164075|FG002|COMPLETED|Overall Study||15||
48341420|NCT01454076|101164076|FG003|COMPLETED|Overall Study||16||
48341421|NCT01454076|101164077|FG004|COMPLETED|Overall Study||15||
48341422|NCT01454076|101164073|FG000|NOT COMPLETED|Overall Study||13||
48341423|NCT01454076|101164074|FG001|NOT COMPLETED|Overall Study||6||
48341424|NCT01454076|101164075|FG002|NOT COMPLETED|Overall Study||9||
48341425|NCT01454076|101164076|FG003|NOT COMPLETED|Overall Study||2||
48341426|NCT01454076|101164077|FG004|NOT COMPLETED|Overall Study||6||
48341427|NCT03494647|101164078|FG000|STARTED|Overall Study||21||
48341428|NCT03494647|101164079|FG001|STARTED|Overall Study||22||
48341429|NCT03494647|101164078|FG000|COMPLETED|Overall Study||16||
48341430|NCT03494647|101164079|FG001|COMPLETED|Overall Study||16||
48341431|NCT03494647|101164078|FG000|NOT COMPLETED|Overall Study||5||
48341432|NCT03494647|101164079|FG001|NOT COMPLETED|Overall Study||6||
48341433|NCT01286493|101164080|FG000|STARTED|Overall Study||33||
48341434|NCT01286493|101164080|FG000|COMPLETED|Overall Study||30||
48341435|NCT01286493|101164080|FG000|NOT COMPLETED|Overall Study||3||
48341436|NCT01254669|101164081|FG000|STARTED|Overall Study||100||
48341437|NCT01254669|101164082|FG001|STARTED|Overall Study||100||
48341438|NCT01254669|101164081|FG000|COMPLETED|Overall Study||97||
48341439|NCT01254669|101164082|FG001|COMPLETED|Overall Study||96||
48341440|NCT01254669|101164081|FG000|NOT COMPLETED|Overall Study||3||
48413662|NCT01738594|101345868|FG002|STARTED|Completed 2 Cycles/Reached 1st Response||0||
48413663|NCT01738594|101345869|FG003|STARTED|Completed 2 Cycles/Reached 1st Response||0||
48413664|NCT01738594|101345870|FG004|STARTED|Completed 2 Cycles/Reached 1st Response||1||
48413665|NCT01738594|101345871|FG005|STARTED|Completed 2 Cycles/Reached 1st Response||3||
48341441|NCT01254669|101164082|FG001|NOT COMPLETED|Overall Study||4||
48341442|NCT00951821|101164083|FG000|STARTED|Overall Study||16||
48341443|NCT00951821|101164084|FG001|STARTED|Overall Study||8||
48341444|NCT00951821|101164083|FG000|COMPLETED|Overall Study||16||
48341445|NCT00951821|101164084|FG001|COMPLETED|Overall Study||8||
48341446|NCT00951821|101164083|FG000|NOT COMPLETED|Overall Study||0||
48341447|NCT00951821|101164084|FG001|NOT COMPLETED|Overall Study||0||
48341448|NCT01075347|101164085|FG000|STARTED|Overall Study||82||
48341449|NCT01075347|101164086|FG001|STARTED|Overall Study||83||
48341450|NCT01075347|101164085|FG000|COMPLETED|Overall Study||82||
48341451|NCT01075347|101164086|FG001|COMPLETED|Overall Study||83||
48341452|NCT01075347|101164085|FG000|NOT COMPLETED|Overall Study||0||
48341453|NCT01075347|101164086|FG001|NOT COMPLETED|Overall Study||0||
48341454|NCT01016873|101164087|FG000|STARTED|12 Months||75||
48341455|NCT01016873|101164088|FG001|STARTED|12 Months||75||
48341456|NCT01016873|101164089|FG002|STARTED|12 Months||80||
48341457|NCT01016873|101164087|FG000|COMPLETED|12 Months||74||
48341458|NCT01016873|101164088|FG001|COMPLETED|12 Months||72||
48341459|NCT01016873|101164089|FG002|COMPLETED|12 Months||79||
48341460|NCT01016873|101164087|FG000|NOT COMPLETED|12 Months||1||
48341461|NCT01016873|101164088|FG001|NOT COMPLETED|12 Months||3||
48341462|NCT01016873|101164089|FG002|NOT COMPLETED|12 Months||1||
48341463|NCT01016873|101164087|FG000|STARTED|24 Months||74||
48341464|NCT01016873|101164088|FG001|STARTED|24 Months||72||
48341465|NCT01016873|101164089|FG002|STARTED|24 Months||79||
48341466|NCT01016873|101164087|FG000|COMPLETED|24 Months||69||
48341467|NCT01016873|101164088|FG001|COMPLETED|24 Months||68||
48341468|NCT01016873|101164089|FG002|COMPLETED|24 Months||73||
48341469|NCT01016873|101164087|FG000|NOT COMPLETED|24 Months||5||
48341470|NCT01016873|101164088|FG001|NOT COMPLETED|24 Months||4||
48341471|NCT01016873|101164089|FG002|NOT COMPLETED|24 Months||6||
48341472|NCT01016873|101164087|FG000|STARTED|36 Months||69||
48341473|NCT01016873|101164088|FG001|STARTED|36 Months||68||
48341474|NCT01016873|101164089|FG002|STARTED|36 Months||73||
48341475|NCT01016873|101164087|FG000|COMPLETED|36 Months||58||
48341476|NCT01016873|101164088|FG001|COMPLETED|36 Months||64||
48341477|NCT01016873|101164089|FG002|COMPLETED|36 Months||67||
48341478|NCT01016873|101164087|FG000|NOT COMPLETED|36 Months||11||
48413666|NCT01738594|101345872|FG006|STARTED|Completed 2 Cycles/Reached 1st Response||0||
48413667|NCT01738594|101345873|FG007|STARTED|Completed 2 Cycles/Reached 1st Response||0||
48413668|NCT01738594|101345866|FG000|COMPLETED|Completed 2 Cycles/Reached 1st Response||0||
48413669|NCT01738594|101345867|FG001|COMPLETED|Completed 2 Cycles/Reached 1st Response||2||
48413670|NCT01738594|101345868|FG002|COMPLETED|Completed 2 Cycles/Reached 1st Response||0||
48413671|NCT01738594|101345869|FG003|COMPLETED|Completed 2 Cycles/Reached 1st Response||0||
48413672|NCT01738594|101345870|FG004|COMPLETED|Completed 2 Cycles/Reached 1st Response||1||
48413673|NCT01738594|101345871|FG005|COMPLETED|Completed 2 Cycles/Reached 1st Response||2||
48413674|NCT01738594|101345872|FG006|COMPLETED|Completed 2 Cycles/Reached 1st Response||0||
48413675|NCT01738594|101345873|FG007|COMPLETED|Completed 2 Cycles/Reached 1st Response||0||
48413676|NCT01738594|101345866|FG000|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0||
48413677|NCT01738594|101345867|FG001|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0||
48413678|NCT01738594|101345868|FG002|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0||
48413679|NCT01738594|101345869|FG003|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0||
48413680|NCT01738594|101345870|FG004|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0||
48413681|NCT01738594|101345871|FG005|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||1||
48413682|NCT01738594|101345872|FG006|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0||
48413683|NCT01738594|101345873|FG007|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0||
48413684|NCT01738594|101345866|FG000|STARTED|Completed 4 Cycles of Treatment||0||
48413685|NCT01738594|101345867|FG001|STARTED|Completed 4 Cycles of Treatment||2||
48413686|NCT01738594|101345868|FG002|STARTED|Completed 4 Cycles of Treatment||0||
48413687|NCT01738594|101345869|FG003|STARTED|Completed 4 Cycles of Treatment||0||
48413688|NCT01738594|101345870|FG004|STARTED|Completed 4 Cycles of Treatment||1||
48632887|NCT04219189|101885349|FG000|STARTED|Overall Study||19||
48632888|NCT04219189|101885350|FG001|STARTED|Overall Study||21||
48632889|NCT04219189|101885349|FG000|COMPLETED|Overall Study||18||
48632890|NCT04219189|101885350|FG001|COMPLETED|Overall Study||16||
48632891|NCT04219189|101885349|FG000|NOT COMPLETED|Overall Study||1||
48341479|NCT01016873|101164088|FG001|NOT COMPLETED|36 Months||4||
48341480|NCT01016873|101164089|FG002|NOT COMPLETED|36 Months||6||
48341481|NCT01444300|101164090|FG000|STARTED|Overall Study||12||
48341482|NCT01444300|101164091|FG001|STARTED|Overall Study||12||
48632892|NCT04219189|101885350|FG001|NOT COMPLETED|Overall Study||5||
48632893|NCT01706328|101885351|FG000|STARTED|2-week Run-in Period||993||
48341483|NCT01444300|101164090|FG000|COMPLETED|Overall Study||8||
48341484|NCT01444300|101164091|FG001|COMPLETED|Overall Study||12||
48341485|NCT01444300|101164090|FG000|NOT COMPLETED|Overall Study||4||
48341486|NCT01444300|101164091|FG001|NOT COMPLETED|Overall Study||0||
48632894|NCT01706328|101885352|FG001|STARTED|2-week Run-in Period||0||
48632895|NCT01706328|101885353|FG002|STARTED|2-week Run-in Period||0||
48632896|NCT01706328|101885351|FG000|COMPLETED|2-week Run-in Period||828||
48632897|NCT01706328|101885352|FG001|COMPLETED|2-week Run-in Period||0||
48632898|NCT01706328|101885353|FG002|COMPLETED|2-week Run-in Period||0||
48632899|NCT01706328|101885351|FG000|NOT COMPLETED|2-week Run-in Period||165||
48632900|NCT01706328|101885352|FG001|NOT COMPLETED|2-week Run-in Period||0||
48632901|NCT01706328|101885353|FG002|NOT COMPLETED|2-week Run-in Period||0||
48632902|NCT01706328|101885351|FG000|STARTED|12-week Double-blind Treatment Period||0||
48632903|NCT01706328|101885352|FG001|STARTED|12-week Double-blind Treatment Period||412||
48632904|NCT01706328|101885353|FG002|STARTED|12-week Double-blind Treatment Period||416||
48632905|NCT01706328|101885351|FG000|COMPLETED|12-week Double-blind Treatment Period||0||
48632906|NCT01706328|101885352|FG001|COMPLETED|12-week Double-blind Treatment Period||366||
48632907|NCT01706328|101885353|FG002|COMPLETED|12-week Double-blind Treatment Period||371||
48632908|NCT01706328|101885351|FG000|NOT COMPLETED|12-week Double-blind Treatment Period||0||
48632909|NCT01706328|101885352|FG001|NOT COMPLETED|12-week Double-blind Treatment Period||46||
48341487|NCT00289913|101164092|FG000|STARTED|Visit 1 (Stage I and Stage II)||155||
48341488|NCT00289913|101164093|FG001|STARTED|Visit 1 (Stage I and Stage II)||151||
48341489|NCT00289913|101164094|FG002|STARTED|Visit 1 (Stage I and Stage II)||159||
48341490|NCT00289913|101164095|FG003|STARTED|Visit 1 (Stage I and Stage II)||152||
48341491|NCT00289913|101164096|FG004|STARTED|Visit 1 (Stage I and Stage II)||654||
48341492|NCT00289913|101164092|FG000|COMPLETED|Visit 1 (Stage I and Stage II)||146||
48341493|NCT00289913|101164093|FG001|COMPLETED|Visit 1 (Stage I and Stage II)||135||
48341494|NCT00289913|101164094|FG002|COMPLETED|Visit 1 (Stage I and Stage II)||150||
48341495|NCT00289913|101164095|FG003|COMPLETED|Visit 1 (Stage I and Stage II)||141||
48341496|NCT00289913|101164096|FG004|COMPLETED|Visit 1 (Stage I and Stage II)||645||
48341497|NCT00289913|101164092|FG000|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9||
48341498|NCT00289913|101164093|FG001|NOT COMPLETED|Visit 1 (Stage I and Stage II)||16||
48341499|NCT00289913|101164094|FG002|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9||
48632910|NCT01706328|101885353|FG002|NOT COMPLETED|12-week Double-blind Treatment Period||45||
48632911|NCT01455519|101885354|FG000|STARTED|Overall Study||12||
48632912|NCT01455519|101885355|FG001|STARTED|Overall Study||23||
48632913|NCT01455519|101885354|FG000|COMPLETED|Overall Study||8||
48632914|NCT01455519|101885355|FG001|COMPLETED|Overall Study||18||
48632915|NCT01455519|101885354|FG000|NOT COMPLETED|Overall Study||4||
48632916|NCT01455519|101885355|FG001|NOT COMPLETED|Overall Study||5||
48632917|NCT03312738|101885356|FG000|STARTED|Overall Study||80||
48632918|NCT03312738|101885357|FG001|STARTED|Overall Study||79||
48632919|NCT03312738|101885356|FG000|COMPLETED|Overall Study||0||
48632920|NCT03312738|101885357|FG001|COMPLETED|Overall Study||0||
48341500|NCT00289913|101164095|FG003|NOT COMPLETED|Visit 1 (Stage I and Stage II)||11||
48341501|NCT00289913|101164096|FG004|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9||
48341502|NCT00289913|101164092|FG000|STARTED|Visit 2 (Stage I and Stage II)||146||
48341503|NCT00289913|101164093|FG001|STARTED|Visit 2 (Stage I and Stage II)||135||
48341504|NCT00289913|101164094|FG002|STARTED|Visit 2 (Stage I and Stage II)||150||
48632921|NCT03312738|101885356|FG000|NOT COMPLETED|Overall Study||80||
48341505|NCT00289913|101164095|FG003|STARTED|Visit 2 (Stage I and Stage II)||141||
48341506|NCT00289913|101164096|FG004|STARTED|Visit 2 (Stage I and Stage II)||645||
48341507|NCT00289913|101164092|FG000|COMPLETED|Visit 2 (Stage I and Stage II)||131||
48341508|NCT00289913|101164093|FG001|COMPLETED|Visit 2 (Stage I and Stage II)||114||
48341509|NCT00289913|101164094|FG002|COMPLETED|Visit 2 (Stage I and Stage II)||140||
48341510|NCT00289913|101164095|FG003|COMPLETED|Visit 2 (Stage I and Stage II)||135||
48341511|NCT00289913|101164096|FG004|COMPLETED|Visit 2 (Stage I and Stage II)||605||
48341512|NCT00289913|101164092|FG000|NOT COMPLETED|Visit 2 (Stage I and Stage II)||15||
48632922|NCT03312738|101885357|FG001|NOT COMPLETED|Overall Study||79||
48632923|NCT02471339|101885358|FG000|STARTED|Overall Study||32||
48632924|NCT02471339|101885359|FG001|STARTED|Overall Study||34||
48632925|NCT02471339|101885358|FG000|COMPLETED|Overall Study||30||
48632926|NCT02471339|101885359|FG001|COMPLETED|Overall Study||34||
48632927|NCT02471339|101885358|FG000|NOT COMPLETED|Overall Study||2||
48632928|NCT02471339|101885359|FG001|NOT COMPLETED|Overall Study||0||
48632929|NCT00183430|101885360|FG000|STARTED|Overall Study||9||
48632930|NCT00183430|101885361|FG001|STARTED|Overall Study||11||
48632931|NCT00183430|101885360|FG000|COMPLETED|Overall Study||3||
48632932|NCT00183430|101885361|FG001|COMPLETED|Overall Study||11||
48632933|NCT00183430|101885360|FG000|NOT COMPLETED|Overall Study||6||
48632934|NCT00183430|101885361|FG001|NOT COMPLETED|Overall Study||0||
48755327|NCT00525512|102187906|FG003|COMPLETED|Double-Blind Phase||0||
48755328|NCT00525512|102187903|FG000|NOT COMPLETED|Double-Blind Phase||96||
48755329|NCT00525512|102187904|FG001|NOT COMPLETED|Double-Blind Phase||66||
48755330|NCT00525512|102187905|FG002|NOT COMPLETED|Double-Blind Phase||0||
48755331|NCT00525512|102187906|FG003|NOT COMPLETED|Double-Blind Phase||0||
48755332|NCT00525512|102187903|FG000|STARTED|Open-Label Phase||0||
48755333|NCT00525512|102187904|FG001|STARTED|Open-Label Phase||0||
48755334|NCT00525512|102187905|FG002|STARTED|Open-Label Phase||164||
48413689|NCT01738594|101345871|FG005|STARTED|Completed 4 Cycles of Treatment||2||
48413690|NCT01738594|101345872|FG006|STARTED|Completed 4 Cycles of Treatment||0||
48413691|NCT01738594|101345873|FG007|STARTED|Completed 4 Cycles of Treatment||0||
48413692|NCT01738594|101345866|FG000|COMPLETED|Completed 4 Cycles of Treatment||0||
48413693|NCT01738594|101345867|FG001|COMPLETED|Completed 4 Cycles of Treatment||0||
48413694|NCT01738594|101345868|FG002|COMPLETED|Completed 4 Cycles of Treatment||0||
48413695|NCT01738594|101345869|FG003|COMPLETED|Completed 4 Cycles of Treatment||0||
48413696|NCT01738594|101345870|FG004|COMPLETED|Completed 4 Cycles of Treatment||1||
48413697|NCT01738594|101345871|FG005|COMPLETED|Completed 4 Cycles of Treatment||1||
48413698|NCT01738594|101345872|FG006|COMPLETED|Completed 4 Cycles of Treatment||0||
48413699|NCT01738594|101345873|FG007|COMPLETED|Completed 4 Cycles of Treatment||0||
48413700|NCT01738594|101345866|FG000|NOT COMPLETED|Completed 4 Cycles of Treatment||0||
48413701|NCT01738594|101345867|FG001|NOT COMPLETED|Completed 4 Cycles of Treatment||2||
48413702|NCT01738594|101345868|FG002|NOT COMPLETED|Completed 4 Cycles of Treatment||0||
48413703|NCT01738594|101345869|FG003|NOT COMPLETED|Completed 4 Cycles of Treatment||0||
48413704|NCT01738594|101345870|FG004|NOT COMPLETED|Completed 4 Cycles of Treatment||0||
48413705|NCT01738594|101345871|FG005|NOT COMPLETED|Completed 4 Cycles of Treatment||1||
48413706|NCT01738594|101345872|FG006|NOT COMPLETED|Completed 4 Cycles of Treatment||0||
48413707|NCT01738594|101345873|FG007|NOT COMPLETED|Completed 4 Cycles of Treatment||0||
48413708|NCT01738594|101345866|FG000|STARTED|Went on to Continue Treatment Cycle 5||0||
48632935|NCT02783911|101885362|FG000|STARTED|Overall Study||11||12
48632936|NCT02783911|101885363|FG001|STARTED|Overall Study||46||53
48632937|NCT02783911|101885362|FG000|COMPLETED|Overall Study||8||9
48632938|NCT02783911|101885363|FG001|COMPLETED|Overall Study||14||15
48632939|NCT02783911|101885362|FG000|NOT COMPLETED|Overall Study||3||3
48632940|NCT02783911|101885363|FG001|NOT COMPLETED|Overall Study||32||38
48632941|NCT01080261|101885364|FG000|STARTED|Overall Study||60||
48632942|NCT01080261|101885364|FG000|COMPLETED|Overall Study||60||
48632943|NCT01080261|101885364|FG000|NOT COMPLETED|Overall Study||0||
48632944|NCT01470170|101885365|FG000|STARTED|Overall Study||34||
48632945|NCT01470170|101885366|FG001|STARTED|Overall Study||35||
48632946|NCT01470170|101885367|FG002|STARTED|Overall Study||34||
48632947|NCT01470170|101885368|FG003|STARTED|Overall Study||36||
48632948|NCT01470170|101885369|FG004|STARTED|Overall Study||34||
48632949|NCT01470170|101885365|FG000|COMPLETED|Overall Study||34||
48632950|NCT01470170|101885366|FG001|COMPLETED|Overall Study||35||
48632951|NCT01470170|101885367|FG002|COMPLETED|Overall Study||34||
48632952|NCT01470170|101885368|FG003|COMPLETED|Overall Study||36||
48632953|NCT01470170|101885369|FG004|COMPLETED|Overall Study||34||
48632954|NCT01470170|101885365|FG000|NOT COMPLETED|Overall Study||0||
48632955|NCT01470170|101885366|FG001|NOT COMPLETED|Overall Study||0||
48632956|NCT01470170|101885367|FG002|NOT COMPLETED|Overall Study||0||
48632957|NCT01470170|101885368|FG003|NOT COMPLETED|Overall Study||0||
48632958|NCT01470170|101885369|FG004|NOT COMPLETED|Overall Study||0||
48632959|NCT01654276|101885370|FG000|STARTED|Overall Study||24||
48632960|NCT01654276|101885370|FG000|Visit 2 (2 Months)|Overall Study||19||
48632961|NCT01654276|101885370|FG000|Visit 3 (4 Months)|Overall Study||18||
48632962|NCT01654276|101885370|FG000|Visit 4 (6months)|Overall Study||18||
48632963|NCT01654276|101885370|FG000|COMPLETED|Overall Study||18||
48632964|NCT01654276|101885370|FG000|NOT COMPLETED|Overall Study||6||
48632965|NCT00997893|101885371|FG000|STARTED|Overall Study||14||
48755335|NCT00525512|102187906|FG003|STARTED|Open-Label Phase||194||
48632966|NCT00997893|101885372|FG001|STARTED|Overall Study||13||
48632967|NCT00997893|101885373|FG002|STARTED|Overall Study||13||
48632968|NCT00997893|101885371|FG000|COMPLETED|Overall Study||12||
48632969|NCT00997893|101885372|FG001|COMPLETED|Overall Study||12||
48632970|NCT00997893|101885373|FG002|COMPLETED|Overall Study||13||
48632971|NCT00997893|101885371|FG000|NOT COMPLETED|Overall Study||2||
48632972|NCT00997893|101885372|FG001|NOT COMPLETED|Overall Study||1||
48632973|NCT00997893|101885373|FG002|NOT COMPLETED|Overall Study||0||
48413709|NCT01738594|101345867|FG001|STARTED|Went on to Continue Treatment Cycle 5||0||
48413710|NCT01738594|101345868|FG002|STARTED|Went on to Continue Treatment Cycle 5||0||
48632974|NCT02265510|101885374|FG000|STARTED|Overall Study||3||
48632975|NCT02265510|101885375|FG001|STARTED|Overall Study||3||
48632976|NCT02265510|101885376|FG002|STARTED|Overall Study||6||
48632977|NCT02265510|101885377|FG003|STARTED|Overall Study||4||
48341513|NCT00289913|101164093|FG001|NOT COMPLETED|Visit 2 (Stage I and Stage II)||21||
48341514|NCT00289913|101164094|FG002|NOT COMPLETED|Visit 2 (Stage I and Stage II)||10||
48341515|NCT00289913|101164095|FG003|NOT COMPLETED|Visit 2 (Stage I and Stage II)||6||
48341516|NCT00289913|101164096|FG004|NOT COMPLETED|Visit 2 (Stage I and Stage II)||40||
48341517|NCT00289913|101164092|FG000|STARTED|Visit 3 (Stage I and Stage II)||131||
48341518|NCT00289913|101164093|FG001|STARTED|Visit 3 (Stage I and Stage II)||114||
48341519|NCT00289913|101164094|FG002|STARTED|Visit 3 (Stage I and Stage II)||140||
48341520|NCT00289913|101164095|FG003|STARTED|Visit 3 (Stage I and Stage II)||135||
48341521|NCT00289913|101164096|FG004|STARTED|Visit 3 (Stage I and Stage II)||605||
48341522|NCT00289913|101164092|FG000|COMPLETED|Visit 3 (Stage I and Stage II)||122||
48632978|NCT02265510|101885378|FG004|STARTED|Overall Study||3||
48632979|NCT02265510|101885379|FG005|STARTED|Overall Study||6||
48180768|NCT00322374|100764958|FG002|STARTED|First Escalation||0||
48180769|NCT00322374|100764959|FG003|STARTED|First Escalation||0||
48180770|NCT00322374|100764956|FG000|COMPLETED|First Escalation||0||
48180771|NCT00322374|100764957|FG001|COMPLETED|First Escalation||0||
48180772|NCT00322374|100764958|FG002|COMPLETED|First Escalation||0||
48180773|NCT00322374|100764959|FG003|COMPLETED|First Escalation||0||
48180774|NCT00322374|100764956|FG000|NOT COMPLETED|First Escalation||0||
48180775|NCT00322374|100764957|FG001|NOT COMPLETED|First Escalation||30||
48180776|NCT00322374|100764958|FG002|NOT COMPLETED|First Escalation||0||
48180777|NCT00322374|100764959|FG003|NOT COMPLETED|First Escalation||0||
48180778|NCT00322374|100764956|FG000|STARTED|Second Escalation||0||
48180779|NCT00322374|100764957|FG001|STARTED|Second Escalation||0||
48180780|NCT00322374|100764958|FG002|STARTED|Second Escalation||6||
48180781|NCT00322374|100764959|FG003|STARTED|Second Escalation||0||
48180782|NCT00322374|100764956|FG000|COMPLETED|Second Escalation||0||
48180783|NCT00322374|100764957|FG001|COMPLETED|Second Escalation||0||
48632980|NCT02265510|101885380|FG006|STARTED|Overall Study||3||
48180784|NCT00322374|100764958|FG002|COMPLETED|Second Escalation||0||
48180785|NCT00322374|100764959|FG003|COMPLETED|Second Escalation||0||
48632981|NCT02265510|101885381|FG007|STARTED|Overall Study||4||
48632982|NCT02265510|101885382|FG008|STARTED|Overall Study||4||
48180786|NCT00322374|100764956|FG000|NOT COMPLETED|Second Escalation||0||
48755336|NCT00525512|102187903|FG000|COMPLETED|Open-Label Phase||0||
48755337|NCT00525512|102187904|FG001|COMPLETED|Open-Label Phase||0||
48180787|NCT00322374|100764957|FG001|NOT COMPLETED|Second Escalation||0||
48180788|NCT00322374|100764958|FG002|NOT COMPLETED|Second Escalation||6||
48180789|NCT00322374|100764959|FG003|NOT COMPLETED|Second Escalation||0||
48180790|NCT04537949|100764960|FG000|STARTED|Treatment Phase||12||
48180791|NCT04537949|100764961|FG001|STARTED|Treatment Phase||12||
48180792|NCT04537949|100764962|FG002|STARTED|Treatment Phase||12||
48180793|NCT04537949|100764963|FG003|STARTED|Treatment Phase||12||
48180794|NCT04537949|100764964|FG004|STARTED|Treatment Phase||12||
48180795|NCT04537949|100764965|FG005|STARTED|Treatment Phase||12||
48180796|NCT04537949|100764966|FG006|STARTED|Treatment Phase||12||
48180797|NCT04537949|100764967|FG007|STARTED|Treatment Phase||12||
48180798|NCT04537949|100764960|FG000|COMPLETED|Treatment Phase||11||
48180799|NCT04537949|100764961|FG001|COMPLETED|Treatment Phase||12||
48180800|NCT04537949|100764962|FG002|COMPLETED|Treatment Phase||12||
48180801|NCT04537949|100764963|FG003|COMPLETED|Treatment Phase||12||
48180802|NCT04537949|100764964|FG004|COMPLETED|Treatment Phase||12||
48180803|NCT04537949|100764965|FG005|COMPLETED|Treatment Phase||12||
48180804|NCT04537949|100764966|FG006|COMPLETED|Treatment Phase||12||
48180805|NCT04537949|100764967|FG007|COMPLETED|Treatment Phase||12||
48180806|NCT04537949|100764960|FG000|NOT COMPLETED|Treatment Phase||1||
48180807|NCT04537949|100764961|FG001|NOT COMPLETED|Treatment Phase||0||
48180808|NCT04537949|100764962|FG002|NOT COMPLETED|Treatment Phase||0||
48180809|NCT04537949|100764963|FG003|NOT COMPLETED|Treatment Phase||0||
48180810|NCT04537949|100764964|FG004|NOT COMPLETED|Treatment Phase||0||
48180811|NCT04537949|100764965|FG005|NOT COMPLETED|Treatment Phase||0||
48180812|NCT04537949|100764966|FG006|NOT COMPLETED|Treatment Phase||0||
48180813|NCT04537949|100764967|FG007|NOT COMPLETED|Treatment Phase||0||
48180814|NCT04537949|100764960|FG000|STARTED|Follow-up Phase||11||
48180815|NCT04537949|100764961|FG001|STARTED|Follow-up Phase||12||
48180816|NCT04537949|100764962|FG002|STARTED|Follow-up Phase||12||
48180817|NCT04537949|100764963|FG003|STARTED|Follow-up Phase||12||
48180818|NCT04537949|100764964|FG004|STARTED|Follow-up Phase||12||
48180819|NCT04537949|100764965|FG005|STARTED|Follow-up Phase||12||
48180820|NCT04537949|100764966|FG006|STARTED|Follow-up Phase||12||
48180821|NCT04537949|100764967|FG007|STARTED|Follow-up Phase||12||
48180822|NCT04537949|100764960|FG000|COMPLETED|Follow-up Phase||8||
48755338|NCT00525512|102187905|FG002|COMPLETED|Open-Label Phase||158||
48755339|NCT00525512|102187906|FG003|COMPLETED|Open-Label Phase||189||
48755340|NCT00525512|102187903|FG000|NOT COMPLETED|Open-Label Phase||0||
48755341|NCT00525512|102187904|FG001|NOT COMPLETED|Open-Label Phase||0||
48755342|NCT00525512|102187905|FG002|NOT COMPLETED|Open-Label Phase||6||
48755343|NCT00525512|102187906|FG003|NOT COMPLETED|Open-Label Phase||5||
48755344|NCT02681809|102187907|FG000|STARTED|Overall Study||20||
48755345|NCT02681809|102187908|FG001|STARTED|Overall Study||19||
48755346|NCT02681809|102187909|FG002|STARTED|Overall Study||9||
48755347|NCT02681809|102187907|FG000|COMPLETED|Overall Study||15||
48755348|NCT02681809|102187908|FG001|COMPLETED|Overall Study||15||
48755349|NCT02681809|102187909|FG002|COMPLETED|Overall Study||8||
48755350|NCT02681809|102187907|FG000|NOT COMPLETED|Overall Study||5||
48755351|NCT02681809|102187908|FG001|NOT COMPLETED|Overall Study||4||
48755352|NCT02681809|102187909|FG002|NOT COMPLETED|Overall Study||1||
48180823|NCT04537949|100764961|FG001|COMPLETED|Follow-up Phase||8||
48180824|NCT04537949|100764962|FG002|COMPLETED|Follow-up Phase||12||
48180825|NCT04537949|100764963|FG003|COMPLETED|Follow-up Phase||9||
48180826|NCT04537949|100764964|FG004|COMPLETED|Follow-up Phase||9||
48180827|NCT04537949|100764965|FG005|COMPLETED|Follow-up Phase||11||
48180828|NCT04537949|100764966|FG006|COMPLETED|Follow-up Phase||7||
48180829|NCT04537949|100764967|FG007|COMPLETED|Follow-up Phase||6||
48180830|NCT04537949|100764960|FG000|NOT COMPLETED|Follow-up Phase||3||
48180831|NCT04537949|100764961|FG001|NOT COMPLETED|Follow-up Phase||4||
48180832|NCT04537949|100764962|FG002|NOT COMPLETED|Follow-up Phase||0||
48180833|NCT04537949|100764963|FG003|NOT COMPLETED|Follow-up Phase||3||
48180834|NCT04537949|100764964|FG004|NOT COMPLETED|Follow-up Phase||3||
48180835|NCT04537949|100764965|FG005|NOT COMPLETED|Follow-up Phase||1||
48180836|NCT04537949|100764966|FG006|NOT COMPLETED|Follow-up Phase||5||
48180837|NCT04537949|100764967|FG007|NOT COMPLETED|Follow-up Phase||6||
48180838|NCT00792428|100764968|FG000|STARTED|Overall Study||10||
48180839|NCT00792428|100764969|FG001|STARTED|Overall Study||10||
48180840|NCT00792428|100764968|FG000|COMPLETED|Overall Study||10||
48180841|NCT00792428|100764969|FG001|COMPLETED|Overall Study||10||
48180842|NCT00792428|100764968|FG000|NOT COMPLETED|Overall Study||0||
48180843|NCT00792428|100764969|FG001|NOT COMPLETED|Overall Study||0||
48755353|NCT03577275|102187910|FG000|STARTED|Overall Study||32||
48755354|NCT03577275|102187910|FG000|Placebo|Overall Study||32||
48755355|NCT03577275|102187910|FG000|Moxifloxacin 400mg|Overall Study||32||
48755356|NCT03577275|102187910|FG000|NST-4016 600mg|Overall Study||32||
48755357|NCT03577275|102187910|FG000|NST-4016 2000mg|Overall Study||32||
48632983|NCT02265510|101885383|FG009|STARTED|Overall Study||7||
48632984|NCT02265510|101885384|FG010|STARTED|Overall Study||5||
48632985|NCT02265510|101885385|FG011|STARTED|Overall Study||16||
48180844|NCT03268590|100764970|FG000|STARTED|Overall Study||33||
48180845|NCT03268590|100764970|FG000|COMPLETED|Overall Study||32||
48180846|NCT03268590|100764970|FG000|NOT COMPLETED|Overall Study||1||
48180847|NCT04071470|100764971|FG000|STARTED|Overall Study||62||
48180848|NCT04071470|100764972|FG001|STARTED|Overall Study||66||
48180849|NCT04071470|100764971|FG000|COMPLETED|Overall Study||62||
48180850|NCT04071470|100764972|FG001|COMPLETED|Overall Study||66||
48180851|NCT04071470|100764971|FG000|NOT COMPLETED|Overall Study||0||
48180852|NCT04071470|100764972|FG001|NOT COMPLETED|Overall Study||0||
48180853|NCT01950260|100764973|FG000|STARTED|Overall Study||30||
48180854|NCT01950260|100764974|FG001|STARTED|Overall Study||31||
48180855|NCT01950260|100764973|FG000|COMPLETED|Overall Study||30||
48180856|NCT01950260|100764974|FG001|COMPLETED|Overall Study||31||
48180857|NCT01950260|100764973|FG000|NOT COMPLETED|Overall Study||0||
48180858|NCT01950260|100764974|FG001|NOT COMPLETED|Overall Study||0||
48180859|NCT01560377|100764975|FG000|STARTED|Overall Study||147||
48180860|NCT01560377|100764975|FG000|Eligible for Analysis|Overall Study||139||
48180861|NCT01560377|100764975|FG000|COMPLETED|Overall Study||147||
48180862|NCT01560377|100764975|FG000|NOT COMPLETED|Overall Study||0||
48180863|NCT02696226|100764976|FG000|STARTED|Overall Study||1||
48755358|NCT03577275|102187910|FG000|COMPLETED|Overall Study||32||
48755359|NCT03577275|102187910|FG000|NOT COMPLETED|Overall Study||0||
48755360|NCT00582361|102191063|FG000|STARTED|Overall Study||25||
48755361|NCT00582361|102191064|FG001|STARTED|Overall Study||38||
48755362|NCT00582361|102191063|FG000|COMPLETED|Overall Study||25||
48755363|NCT00582361|102191064|FG001|COMPLETED|Overall Study||38||
48755364|NCT00582361|102191063|FG000|NOT COMPLETED|Overall Study||0||
48755365|NCT00582361|102191064|FG001|NOT COMPLETED|Overall Study||0||
48755366|NCT03804528|102191065|FG000|STARTED|Overall Study||75||
48755367|NCT03804528|102191065|FG000|COMPLETED|Overall Study||52||
48180864|NCT02696226|100764977|FG001|STARTED|Overall Study||0||
48180865|NCT02696226|100764978|FG002|STARTED|Overall Study||2||
48180866|NCT02696226|100764979|FG003|STARTED|Overall Study||0||
48180867|NCT02696226|100764976|FG000|COMPLETED|Overall Study||0||
48180868|NCT02696226|100764977|FG001|COMPLETED|Overall Study||0||
48180869|NCT02696226|100764978|FG002|COMPLETED|Overall Study||0||
48180870|NCT02696226|100764979|FG003|COMPLETED|Overall Study||0||
48180871|NCT02696226|100764976|FG000|NOT COMPLETED|Overall Study||1||
48180872|NCT02696226|100764977|FG001|NOT COMPLETED|Overall Study||0||
48341523|NCT00289913|101164093|FG001|COMPLETED|Visit 3 (Stage I and Stage II)||106||
48341524|NCT00289913|101164094|FG002|COMPLETED|Visit 3 (Stage I and Stage II)||138||
48341525|NCT00289913|101164095|FG003|COMPLETED|Visit 3 (Stage I and Stage II)||131||
48632986|NCT02265510|101885386|FG012|STARTED|Overall Study||9||
48632987|NCT02265510|101885387|FG013|STARTED|Overall Study||10||
48632988|NCT02265510|101885374|FG000|COMPLETED|Overall Study||0||
48632989|NCT02265510|101885375|FG001|COMPLETED|Overall Study||0||
48632990|NCT02265510|101885376|FG002|COMPLETED|Overall Study||0||
48632991|NCT02265510|101885377|FG003|COMPLETED|Overall Study||0||
48632992|NCT02265510|101885378|FG004|COMPLETED|Overall Study||0||
48632993|NCT02265510|101885379|FG005|COMPLETED|Overall Study||0||
48632994|NCT02265510|101885380|FG006|COMPLETED|Overall Study||0||
48632995|NCT02265510|101885381|FG007|COMPLETED|Overall Study||0||
48632996|NCT02265510|101885382|FG008|COMPLETED|Overall Study||0||
48755368|NCT03804528|102191065|FG000|NOT COMPLETED|Overall Study||23||
48180873|NCT02696226|100764978|FG002|NOT COMPLETED|Overall Study||2||
48180874|NCT02696226|100764979|FG003|NOT COMPLETED|Overall Study||0||
48341526|NCT00289913|101164096|FG004|COMPLETED|Visit 3 (Stage I and Stage II)||597||
48632997|NCT02265510|101885383|FG009|COMPLETED|Overall Study||0||
48632998|NCT02265510|101885384|FG010|COMPLETED|Overall Study||0||
48632999|NCT02265510|101885385|FG011|COMPLETED|Overall Study||0||
48633000|NCT02265510|101885386|FG012|COMPLETED|Overall Study||0||
48633001|NCT02265510|101885387|FG013|COMPLETED|Overall Study||0||
48633002|NCT02265510|101885374|FG000|NOT COMPLETED|Overall Study||3||
48633003|NCT02265510|101885375|FG001|NOT COMPLETED|Overall Study||3||
48633004|NCT02265510|101885376|FG002|NOT COMPLETED|Overall Study||6||
48633005|NCT02265510|101885377|FG003|NOT COMPLETED|Overall Study||4||
48633006|NCT02265510|101885378|FG004|NOT COMPLETED|Overall Study||3||
48633007|NCT02265510|101885379|FG005|NOT COMPLETED|Overall Study||6||
48633008|NCT02265510|101885380|FG006|NOT COMPLETED|Overall Study||3||
48633009|NCT02265510|101885381|FG007|NOT COMPLETED|Overall Study||4||
48633010|NCT02265510|101885382|FG008|NOT COMPLETED|Overall Study||4||
48633011|NCT02265510|101885383|FG009|NOT COMPLETED|Overall Study||7||
48633012|NCT02265510|101885384|FG010|NOT COMPLETED|Overall Study||5||
48755369|NCT02005549|102191066|FG000|STARTED|Overall Study||18||
48755370|NCT02005549|102191066|FG000|COMPLETED|Overall Study||18||
48755371|NCT02005549|102191066|FG000|NOT COMPLETED|Overall Study||0||
48180875|NCT01555021|100764980|FG000|STARTED|Overall Study||2||
48180876|NCT01555021|100764981|FG001|STARTED|Overall Study||2||
48180877|NCT01555021|100764980|FG000|COMPLETED|Overall Study||1||
48180878|NCT01555021|100764981|FG001|COMPLETED|Overall Study||0||
48413711|NCT01738594|101345869|FG003|STARTED|Went on to Continue Treatment Cycle 5||0||
48413712|NCT01738594|101345870|FG004|STARTED|Went on to Continue Treatment Cycle 5||1||
48413713|NCT01738594|101345871|FG005|STARTED|Went on to Continue Treatment Cycle 5||1||
48413714|NCT01738594|101345872|FG006|STARTED|Went on to Continue Treatment Cycle 5||0||
48633013|NCT02265510|101885385|FG011|NOT COMPLETED|Overall Study||16||
48633014|NCT02265510|101885386|FG012|NOT COMPLETED|Overall Study||9||
48180879|NCT01555021|100764980|FG000|NOT COMPLETED|Overall Study||1||
48180880|NCT01555021|100764981|FG001|NOT COMPLETED|Overall Study||2||
48180881|NCT02107443|100764982|FG000|STARTED|Overall Study||296||
48180882|NCT02107443|100764983|FG001|STARTED|Overall Study||250||
48180883|NCT02107443|100764982|FG000|COMPLETED|Overall Study||198||
48180884|NCT02107443|100764983|FG001|COMPLETED|Overall Study||167||
48633015|NCT02265510|101885387|FG013|NOT COMPLETED|Overall Study||10||
48180885|NCT02107443|100764982|FG000|NOT COMPLETED|Overall Study||98||
48180886|NCT02107443|100764983|FG001|NOT COMPLETED|Overall Study||83||
48180887|NCT02543723|100764984|FG000|STARTED|Overall Study||65||
48180888|NCT02543723|100764985|FG001|STARTED|Overall Study||63||
48180889|NCT02543723|100764984|FG000|COMPLETED|Overall Study||65||
48180890|NCT02543723|100764985|FG001|COMPLETED|Overall Study||63||
48180891|NCT02543723|100764984|FG000|NOT COMPLETED|Overall Study||0||
48180892|NCT02543723|100764985|FG001|NOT COMPLETED|Overall Study||0||
48180893|NCT03619174|100764986|FG000|STARTED|Overall Study||66||
48180894|NCT03619174|100764987|FG001|STARTED|Overall Study||33||
48180895|NCT03619174|100764986|FG000|COMPLETED|Overall Study||57||
48180896|NCT03619174|100764987|FG001|COMPLETED|Overall Study||29||
48180897|NCT03619174|100764986|FG000|NOT COMPLETED|Overall Study||9||
48180898|NCT03619174|100764987|FG001|NOT COMPLETED|Overall Study||4||
48180899|NCT04424290|100764988|FG000|STARTED|Overall Study||3||
48180900|NCT04424290|100764989|FG001|STARTED|Overall Study||3||
48180901|NCT04424290|100764990|FG002|STARTED|Overall Study||7||
48180902|NCT04424290|100764991|FG003|STARTED|Overall Study||10||
48180903|NCT04424290|100764992|FG004|STARTED|Overall Study||22||
48180904|NCT04424290|100764988|FG000|Treated|Overall Study||3||
48180905|NCT04424290|100764989|FG001|Treated|Overall Study||3||
48180906|NCT04424290|100764990|FG002|Treated|Overall Study||6||
48180907|NCT04424290|100764991|FG003|Treated|Overall Study||10||
48180908|NCT04424290|100764992|FG004|Treated|Overall Study||21||
48180909|NCT04424290|100764988|FG000|COMPLETED|Overall Study||3||
48180910|NCT04424290|100764989|FG001|COMPLETED|Overall Study||3||
48180911|NCT04424290|100764990|FG002|COMPLETED|Overall Study||6||
48180912|NCT04424290|100764991|FG003|COMPLETED|Overall Study||7||
48180913|NCT04424290|100764992|FG004|COMPLETED|Overall Study||20||
48180914|NCT04424290|100764988|FG000|NOT COMPLETED|Overall Study||0||
48180915|NCT04424290|100764989|FG001|NOT COMPLETED|Overall Study||0||
48413715|NCT01738594|101345873|FG007|STARTED|Went on to Continue Treatment Cycle 5||0||
48413716|NCT01738594|101345866|FG000|COMPLETED|Went on to Continue Treatment Cycle 5||0||
48413717|NCT01738594|101345867|FG001|COMPLETED|Went on to Continue Treatment Cycle 5||0||
48413718|NCT01738594|101345868|FG002|COMPLETED|Went on to Continue Treatment Cycle 5||0||
48413719|NCT01738594|101345869|FG003|COMPLETED|Went on to Continue Treatment Cycle 5||0||
48413720|NCT01738594|101345870|FG004|COMPLETED|Went on to Continue Treatment Cycle 5||0||
48413721|NCT01738594|101345871|FG005|COMPLETED|Went on to Continue Treatment Cycle 5||0||
48413722|NCT01738594|101345872|FG006|COMPLETED|Went on to Continue Treatment Cycle 5||0||
48413723|NCT01738594|101345873|FG007|COMPLETED|Went on to Continue Treatment Cycle 5||0||
48413724|NCT01738594|101345866|FG000|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0||
48413725|NCT01738594|101345867|FG001|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0||
48413726|NCT01738594|101345868|FG002|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0||
48413727|NCT01738594|101345869|FG003|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0||
48413728|NCT01738594|101345870|FG004|NOT COMPLETED|Went on to Continue Treatment Cycle 5||1||
48413729|NCT01738594|101345871|FG005|NOT COMPLETED|Went on to Continue Treatment Cycle 5||1||
48413730|NCT01738594|101345872|FG006|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0||
48413731|NCT01738594|101345873|FG007|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0||
48413732|NCT01738594|101345866|FG000|STARTED|Follow up for 1 Year||0|All patients that receive treatment on study go into the follow up period|
48413733|NCT01738594|101345867|FG001|STARTED|Follow up for 1 Year||2|All patients that receive treatment on study go into the follow up period|
48633016|NCT03150043|101885388|FG000|STARTED|Overall Study||65||
48633017|NCT03150043|101885388|FG000|COMPLETED|Overall Study||65||
48633018|NCT03150043|101885388|FG000|NOT COMPLETED|Overall Study||0||
48633019|NCT03427411|101885389|FG000|STARTED|Overall Study||30||
48180916|NCT04424290|100764990|FG002|NOT COMPLETED|Overall Study||1||
48180917|NCT04424290|100764991|FG003|NOT COMPLETED|Overall Study||3||
48180918|NCT04424290|100764992|FG004|NOT COMPLETED|Overall Study||2||
48180919|NCT01024751|100764993|FG000|STARTED|Enrolled Participants||156||
48180920|NCT01024751|100764994|FG001|STARTED|Enrolled Participants||156||
48633020|NCT03427411|101885390|FG001|STARTED|Overall Study||27||
48633021|NCT03427411|101885389|FG000|COMPLETED|Overall Study||30||
48633022|NCT03427411|101885390|FG001|COMPLETED|Overall Study||26||
48180921|NCT01024751|100764993|FG000|COMPLETED|Enrolled Participants||153||
48180922|NCT01024751|100764994|FG001|COMPLETED|Enrolled Participants||152||
48180923|NCT01024751|100764993|FG000|NOT COMPLETED|Enrolled Participants||3||
48180924|NCT01024751|100764994|FG001|NOT COMPLETED|Enrolled Participants||4||
48180925|NCT01024751|100764993|FG000|STARTED|Eligible Participants||153||
48180926|NCT01024751|100764994|FG001|STARTED|Eligible Participants||152||
48180927|NCT01024751|100764993|FG000|COMPLETED|Eligible Participants||153||
48180928|NCT01024751|100764994|FG001|COMPLETED|Eligible Participants||149||
48180929|NCT01024751|100764993|FG000|NOT COMPLETED|Eligible Participants||0||
48180930|NCT01024751|100764994|FG001|NOT COMPLETED|Eligible Participants||3||
48180931|NCT01012973|100764995|FG000|STARTED|Overall Study||106||
48180932|NCT01012973|100764996|FG001|STARTED|Overall Study||71||
48180933|NCT01012973|100764995|FG000|Participants Received Treatment|Overall Study||104||
48180934|NCT01012973|100764996|FG001|Participants Received Treatment|Overall Study||68||
48180935|NCT01012973|100764995|FG000|Fulfilled Requirements of FAS Population|Overall Study||103||
48180936|NCT01012973|100764996|FG001|Fulfilled Requirements of FAS Population|Overall Study||68||
48180937|NCT01012973|100764995|FG000|Completed Week 24, From FAS|Overall Study||97||
48180938|NCT01012973|100764996|FG001|Completed Week 24, From FAS|Overall Study||57||
48180939|NCT01012973|100764995|FG000|Completed Week 52, From FAS|Overall Study||91||
48180940|NCT01012973|100764996|FG001|Completed Week 52, From FAS|Overall Study||52||
48180941|NCT01012973|100764995|FG000|COMPLETED|Overall Study||90||
48180942|NCT01012973|100764996|FG001|COMPLETED|Overall Study||52||
48180943|NCT01012973|100764995|FG000|NOT COMPLETED|Overall Study||16||
48180944|NCT01012973|100764996|FG001|NOT COMPLETED|Overall Study||19||
48180945|NCT00231894|100764997|FG000|STARTED|Overall Study||31||
48180946|NCT00231894|100764998|FG001|STARTED|Overall Study||25||
48180947|NCT00231894|100764997|FG000|COMPLETED|Overall Study||30||
48180948|NCT00231894|100764998|FG001|COMPLETED|Overall Study||24||
48180949|NCT00231894|100764997|FG000|NOT COMPLETED|Overall Study||1||
48180950|NCT00231894|100764998|FG001|NOT COMPLETED|Overall Study||1||
48180951|NCT01340482|100764999|FG000|STARTED|Overall Study||27||
48180952|NCT01340482|100765000|FG001|STARTED|Overall Study||1||
48180953|NCT01340482|100765001|FG002|STARTED|Overall Study||1||
48180954|NCT01340482|100764999|FG000|COMPLETED|Overall Study||25||
48180955|NCT01340482|100765000|FG001|COMPLETED|Overall Study||1||
48180956|NCT01340482|100765001|FG002|COMPLETED|Overall Study||1||
48180957|NCT01340482|100764999|FG000|NOT COMPLETED|Overall Study||2||
48439953|NCT00054275|101409992|FG000|COMPLETED|Overall Study||28||
48633023|NCT03427411|101885389|FG000|NOT COMPLETED|Overall Study||0||
48633024|NCT03427411|101885390|FG001|NOT COMPLETED|Overall Study||1||
48633025|NCT03834350|101885391|FG000|STARTED|Overall Study||71||
48633026|NCT03834350|101885391|FG000|COMPLETED|Overall Study||70||
48633027|NCT03834350|101885391|FG000|NOT COMPLETED|Overall Study||1||
48633028|NCT00964782|101885392|FG000|STARTED|Overall Study||8||
48633029|NCT00964782|101885393|FG001|STARTED|Overall Study||8||
48633030|NCT00964782|101885392|FG000|COMPLETED|Overall Study||7||
48633031|NCT00964782|101885393|FG001|COMPLETED|Overall Study||8||
48633032|NCT00964782|101885392|FG000|NOT COMPLETED|Overall Study||1||
48633033|NCT00964782|101885393|FG001|NOT COMPLETED|Overall Study||0||
48633034|NCT00374868|101885394|FG000|STARTED|Overall Study||38||
48633035|NCT00374868|101885394|FG000|COMPLETED|Overall Study||2||
48633036|NCT00374868|101885394|FG000|NOT COMPLETED|Overall Study||36||
48180958|NCT01340482|100765000|FG001|NOT COMPLETED|Overall Study||0||
48180959|NCT01340482|100765001|FG002|NOT COMPLETED|Overall Study||0||
48180960|NCT00136812|100765002|FG000|STARTED|Overall Study||111||
48180961|NCT00136812|100765003|FG001|STARTED|Overall Study||113||
48180962|NCT00136812|100765002|FG000|COMPLETED|Overall Study||111||
48180963|NCT00136812|100765003|FG001|COMPLETED|Overall Study||113||
48180964|NCT00136812|100765002|FG000|NOT COMPLETED|Overall Study||0||
48180965|NCT00136812|100765003|FG001|NOT COMPLETED|Overall Study||0||
48180966|NCT02971891|100765004|FG000|STARTED|Overall Study||246||
48180967|NCT02971891|100765005|FG001|STARTED|Overall Study||238||
48180968|NCT02971891|100765004|FG000|Subjects Who Had 1 Wart|Overall Study||118||
48633037|NCT00473083|101885395|FG000|STARTED|Overall Study||50||
48633038|NCT00473083|101885396|FG001|STARTED|Overall Study||50||
48633039|NCT00473083|101885397|FG002|STARTED|Overall Study||50||
48633040|NCT00473083|101885395|FG000|COMPLETED|Overall Study||49||
48633041|NCT00473083|101885396|FG001|COMPLETED|Overall Study||50||
48633042|NCT00473083|101885397|FG002|COMPLETED|Overall Study||50||
48633043|NCT00473083|101885395|FG000|NOT COMPLETED|Overall Study||1||
48633044|NCT00473083|101885396|FG001|NOT COMPLETED|Overall Study||0||
48633045|NCT00473083|101885397|FG002|NOT COMPLETED|Overall Study||0||
48633046|NCT02081807|101885398|FG000|STARTED|Overall Study||7668||
48633047|NCT02081807|101885399|FG001|STARTED|Overall Study||26149||
48633048|NCT02081807|101885400|FG002|STARTED|Overall Study||14852||
48633049|NCT02081807|101885401|FG003|STARTED|Overall Study||9112||
48633050|NCT02081807|101885402|FG004|STARTED|Overall Study||27456||
48633051|NCT02081807|101885403|FG005|STARTED|Overall Study||76055||
48180969|NCT02971891|100765005|FG001|Subjects Who Had 1 Wart|Overall Study||117||
48633052|NCT02081807|101885404|FG006|STARTED|Overall Study||40207||
48633053|NCT02081807|101885405|FG007|STARTED|Overall Study||19729||
48633054|NCT02081807|101885398|FG000|COMPLETED|Overall Study||7668||
48633055|NCT02081807|101885399|FG001|COMPLETED|Overall Study||26149||
48439954|NCT00054275|101409992|FG000|NOT COMPLETED|Overall Study||11||
48633056|NCT02081807|101885400|FG002|COMPLETED|Overall Study||14852||
48633057|NCT02081807|101885401|FG003|COMPLETED|Overall Study||9112||
48633058|NCT02081807|101885402|FG004|COMPLETED|Overall Study||27456||
48633059|NCT02081807|101885403|FG005|COMPLETED|Overall Study||76055||
48633060|NCT02081807|101885404|FG006|COMPLETED|Overall Study||40207||
48633061|NCT02081807|101885405|FG007|COMPLETED|Overall Study||19729||
48755372|NCT04551989|102191067|FG000|STARTED|Overall Study||118||
48755373|NCT04551989|102191067|FG000|COMPLETED|Overall Study||107||
48180970|NCT02971891|100765004|FG000|Subjects Who Had 2 Warts|Overall Study||56||
48180971|NCT02971891|100765005|FG001|Subjects Who Had 2 Warts|Overall Study||53||
48180972|NCT02971891|100765004|FG000|Subjects Who Had 3 Warts|Overall Study||24||
48180973|NCT02971891|100765005|FG001|Subjects Who Had 3 Warts|Overall Study||24||
48180974|NCT02971891|100765004|FG000|Subjects Who Had 4 Warts|Overall Study||21||
48180975|NCT02971891|100765005|FG001|Subjects Who Had 4 Warts|Overall Study||12||
48180976|NCT02971891|100765004|FG000|Subjects Who Had 5 Warts|Overall Study||12||
48180977|NCT02971891|100765005|FG001|Subjects Who Had 5 Warts|Overall Study||11||
48180978|NCT02971891|100765004|FG000|Subjects Who Had 6 Warts|Overall Study||15||
48180979|NCT02971891|100765005|FG001|Subjects Who Had 6 Warts|Overall Study||21||
48180980|NCT02971891|100765004|FG000|COMPLETED|Overall Study||229||
48180981|NCT02971891|100765005|FG001|COMPLETED|Overall Study||214||
48180982|NCT02971891|100765004|FG000|NOT COMPLETED|Overall Study||17||
48180983|NCT02971891|100765005|FG001|NOT COMPLETED|Overall Study||24||
48180984|NCT01383993|100765006|FG000|STARTED|Overall Study||15||
48180985|NCT01383993|100765007|FG001|STARTED|Overall Study||4||
48180986|NCT01383993|100765008|FG002|STARTED|Overall Study||2||
48180987|NCT01383993|100765006|FG000|COMPLETED|Overall Study||12||
48180988|NCT01383993|100765007|FG001|COMPLETED|Overall Study||3||
48180989|NCT01383993|100765008|FG002|COMPLETED|Overall Study||1||
48180990|NCT01383993|100765006|FG000|NOT COMPLETED|Overall Study||3||
48180991|NCT01383993|100765007|FG001|NOT COMPLETED|Overall Study||1||
48180992|NCT01383993|100765008|FG002|NOT COMPLETED|Overall Study||1||
48180993|NCT02643979|100765009|FG000|STARTED|Overall Study||11||
48180994|NCT02643979|100765010|FG001|STARTED|Overall Study||11||
48180995|NCT02643979|100765009|FG000|COMPLETED|Overall Study||11||
48180996|NCT02643979|100765010|FG001|COMPLETED|Overall Study||11||
48180997|NCT02643979|100765009|FG000|NOT COMPLETED|Overall Study||0||
48180998|NCT02643979|100765010|FG001|NOT COMPLETED|Overall Study||0||
48180999|NCT01683994|100765011|FG000|STARTED|Overall Study||4||
48181000|NCT01683994|100765012|FG001|STARTED|Overall Study||8||
48181001|NCT01683994|100765013|FG002|STARTED|Overall Study||7||
48181002|NCT01683994|100765014|FG003|STARTED|Overall Study||13||
48181003|NCT01683994|100765015|FG004|STARTED|Overall Study||13||
48181004|NCT01683994|100765011|FG000|# of Patients Who Received Treatment|Overall Study||4||
48181005|NCT01683994|100765012|FG001|# of Patients Who Received Treatment|Overall Study||8||
48181006|NCT01683994|100765013|FG002|# of Patients Who Received Treatment|Overall Study||7||
48181007|NCT01683994|100765014|FG003|# of Patients Who Received Treatment|Overall Study||12||
48181008|NCT01683994|100765015|FG004|# of Patients Who Received Treatment|Overall Study||13||
48755374|NCT04551989|102191067|FG000|NOT COMPLETED|Overall Study||11||
48755375|NCT00383552|102191068|FG000|STARTED|Overall Study||182||
48181009|NCT01683994|100765011|FG000|COMPLETED|Overall Study||3||
48181010|NCT01683994|100765012|FG001|COMPLETED|Overall Study||8||
48181011|NCT01683994|100765013|FG002|COMPLETED|Overall Study||7||
48181012|NCT01683994|100765014|FG003|COMPLETED|Overall Study||10||
48181013|NCT01683994|100765015|FG004|COMPLETED|Overall Study||12||
48181014|NCT01683994|100765011|FG000|NOT COMPLETED|Overall Study||1||
48181015|NCT01683994|100765012|FG001|NOT COMPLETED|Overall Study||0||
48181016|NCT01683994|100765013|FG002|NOT COMPLETED|Overall Study||0||
48181017|NCT01683994|100765014|FG003|NOT COMPLETED|Overall Study||3||
48181018|NCT01683994|100765015|FG004|NOT COMPLETED|Overall Study||1||
48181019|NCT00771875|100765016|FG000|STARTED|Overall Study||10||
48181020|NCT00771875|100765017|FG001|STARTED|Overall Study||10||
48181021|NCT00771875|100765018|FG002|STARTED|Overall Study||10||
48181022|NCT00771875|100765016|FG000|COMPLETED|Overall Study||10||
48181023|NCT00771875|100765017|FG001|COMPLETED|Overall Study||9||
48181024|NCT00771875|100765018|FG002|COMPLETED|Overall Study||10||
48181025|NCT00771875|100765016|FG000|NOT COMPLETED|Overall Study||0||
48181026|NCT00771875|100765017|FG001|NOT COMPLETED|Overall Study||1||
48181027|NCT00771875|100765018|FG002|NOT COMPLETED|Overall Study||0||
48181028|NCT02320721|100765019|FG000|STARTED|Overall Study||508||
48181029|NCT02320721|100765020|FG001|STARTED|Overall Study||506||
48181030|NCT02320721|100765019|FG000|Treated (Safety Population)|Overall Study||508||
48181031|NCT02320721|100765020|FG001|Treated (Safety Population)|Overall Study||505||
48181032|NCT02320721|100765019|FG000|COMPLETED|Overall Study||481||
48181033|NCT02320721|100765020|FG001|COMPLETED|Overall Study||472||
48181034|NCT02320721|100765019|FG000|NOT COMPLETED|Overall Study||27||
48181035|NCT02320721|100765020|FG001|NOT COMPLETED|Overall Study||34||
48633062|NCT02081807|101885398|FG000|NOT COMPLETED|Overall Study||0||
48633063|NCT02081807|101885399|FG001|NOT COMPLETED|Overall Study||0||
48633064|NCT02081807|101885400|FG002|NOT COMPLETED|Overall Study||0||
48633065|NCT02081807|101885401|FG003|NOT COMPLETED|Overall Study||0||
48755376|NCT00383552|102191069|FG001|STARTED|Overall Study||188||
48181036|NCT03055832|100765021|FG000|STARTED|Baseline||71||
48633066|NCT02081807|101885402|FG004|NOT COMPLETED|Overall Study||0||
48755377|NCT00383552|102191070|FG002|STARTED|Overall Study||188||
48181037|NCT03055832|100765022|FG001|STARTED|Baseline||71||
48181038|NCT03055832|100765021|FG000|COMPLETED|Baseline||71||
48181039|NCT03055832|100765022|FG001|COMPLETED|Baseline||71||
48181040|NCT03055832|100765021|FG000|NOT COMPLETED|Baseline||0||
48181041|NCT03055832|100765022|FG001|NOT COMPLETED|Baseline||0||
48181042|NCT03055832|100765021|FG000|STARTED|Immediately Post-Procedure (Hour 1)||71||
48755378|NCT00383552|102191071|FG003|STARTED|Overall Study||188||
48755379|NCT00383552|102191068|FG000|COMPLETED|Overall Study||146||
48755380|NCT00383552|102191069|FG001|COMPLETED|Overall Study||147||
48755381|NCT00383552|102191070|FG002|COMPLETED|Overall Study||127||
48755382|NCT00383552|102191071|FG003|COMPLETED|Overall Study||116||
48755383|NCT00383552|102191068|FG000|NOT COMPLETED|Overall Study||36||
48755384|NCT00383552|102191069|FG001|NOT COMPLETED|Overall Study||41||
48755385|NCT00383552|102191070|FG002|NOT COMPLETED|Overall Study||61||
48755386|NCT00383552|102191071|FG003|NOT COMPLETED|Overall Study||72||
48755387|NCT04201431|102191072|FG000|STARTED|Vaccinations and Primary CHMI||12||
48755388|NCT04201431|102191073|FG001|STARTED|Vaccinations and Primary CHMI||4||
48181043|NCT03055832|100765022|FG001|STARTED|Immediately Post-Procedure (Hour 1)||71||
48181044|NCT03055832|100765021|FG000|COMPLETED|Immediately Post-Procedure (Hour 1)||71||
48181045|NCT03055832|100765022|FG001|COMPLETED|Immediately Post-Procedure (Hour 1)||71||
48181046|NCT03055832|100765021|FG000|NOT COMPLETED|Immediately Post-Procedure (Hour 1)||0||
48181047|NCT03055832|100765022|FG001|NOT COMPLETED|Immediately Post-Procedure (Hour 1)||0||
48181048|NCT03055832|100765021|FG000|STARTED|Day 1||71||
48181049|NCT03055832|100765022|FG001|STARTED|Day 1||71||
48181050|NCT03055832|100765021|FG000|COMPLETED|Day 1||71||
48181051|NCT03055832|100765022|FG001|COMPLETED|Day 1||71||
48181052|NCT03055832|100765021|FG000|NOT COMPLETED|Day 1||0||
48181053|NCT03055832|100765022|FG001|NOT COMPLETED|Day 1||0||
48181054|NCT03055832|100765021|FG000|STARTED|Week 2||71||
48181055|NCT03055832|100765022|FG001|STARTED|Week 2||71||
48181056|NCT03055832|100765021|FG000|COMPLETED|Week 2||70||
48181057|NCT03055832|100765022|FG001|COMPLETED|Week 2||71||
48181058|NCT03055832|100765021|FG000|NOT COMPLETED|Week 2||1||
48181059|NCT03055832|100765022|FG001|NOT COMPLETED|Week 2||0||
48181060|NCT03055832|100765021|FG000|STARTED|Week 4||70||
48181061|NCT03055832|100765022|FG001|STARTED|Week 4||71||
48181062|NCT03055832|100765021|FG000|COMPLETED|Week 4||70||
48181063|NCT03055832|100765022|FG001|COMPLETED|Week 4||71||
48181064|NCT03055832|100765021|FG000|NOT COMPLETED|Week 4||0||
48181065|NCT03055832|100765022|FG001|NOT COMPLETED|Week 4||0||
48181066|NCT02564055|100765023|FG000|STARTED|Overall Study||40||
48181067|NCT02564055|100765024|FG001|STARTED|Overall Study||41||
48181068|NCT02564055|100765025|FG002|STARTED|Overall Study||43||
48633067|NCT02081807|101885403|FG005|NOT COMPLETED|Overall Study||0||
48633068|NCT02081807|101885404|FG006|NOT COMPLETED|Overall Study||0||
48633069|NCT02081807|101885405|FG007|NOT COMPLETED|Overall Study||0||
48633070|NCT02943213|101885406|FG000|STARTED|Treatment Period 1||20||
48633071|NCT02943213|101885406|FG000|COMPLETED|Treatment Period 1||20||
48633072|NCT02943213|101885406|FG000|NOT COMPLETED|Treatment Period 1||0||
48633073|NCT02943213|101885406|FG000|STARTED|Treatment Period 2||20||
48633074|NCT02943213|101885406|FG000|COMPLETED|Treatment Period 2||20||
48633075|NCT02943213|101885406|FG000|NOT COMPLETED|Treatment Period 2||0||
48633076|NCT01569022|101885407|FG000|STARTED|First Intervention||21||
48633077|NCT01569022|101885408|FG001|STARTED|First Intervention||21||
48633078|NCT01569022|101885407|FG000|COMPLETED|First Intervention||19||
48633079|NCT01569022|101885408|FG001|COMPLETED|First Intervention||20||
48181069|NCT02564055|100765026|FG003|STARTED|Overall Study||41||
48181070|NCT02564055|100765027|FG004|STARTED|Overall Study||42||
48633080|NCT01569022|101885407|FG000|NOT COMPLETED|First Intervention||2||
48633081|NCT01569022|101885408|FG001|NOT COMPLETED|First Intervention||1||
48633082|NCT01569022|101885407|FG000|STARTED|Second Intervention||19||
48633083|NCT01569022|101885408|FG001|STARTED|Second Intervention||20||
48633084|NCT01569022|101885407|FG000|COMPLETED|Second Intervention||17||
48633085|NCT01569022|101885408|FG001|COMPLETED|Second Intervention||18||
48633086|NCT01569022|101885407|FG000|NOT COMPLETED|Second Intervention||2||
48633087|NCT01569022|101885408|FG001|NOT COMPLETED|Second Intervention||2||
48755389|NCT04201431|102191074|FG002|STARTED|Vaccinations and Primary CHMI||0||
48755390|NCT04201431|102191072|FG000|COMPLETED|Vaccinations and Primary CHMI||6||
48755391|NCT04201431|102191073|FG001|COMPLETED|Vaccinations and Primary CHMI||4||
48755392|NCT04201431|102191074|FG002|COMPLETED|Vaccinations and Primary CHMI||0||
48767747|NCT02141295|102222816|FG001|NOT COMPLETED|Overall Study||94||
48181071|NCT02564055|100765028|FG005|STARTED|Overall Study||40||
48181072|NCT02564055|100765023|FG000|COMPLETED|Overall Study||34||
48181073|NCT02564055|100765024|FG001|COMPLETED|Overall Study||36||
48181074|NCT02564055|100765025|FG002|COMPLETED|Overall Study||31||
48181075|NCT02564055|100765026|FG003|COMPLETED|Overall Study||35||
48633088|NCT04664205|101885409|FG000|STARTED|First Exercise Session||6||
48633089|NCT04664205|101885410|FG001|STARTED|First Exercise Session||5||
48633090|NCT04664205|101885411|FG002|STARTED|First Exercise Session||3||
48633091|NCT04664205|101885409|FG000|COMPLETED|First Exercise Session||6||
48633092|NCT04664205|101885410|FG001|COMPLETED|First Exercise Session||5||
48633093|NCT04664205|101885411|FG002|COMPLETED|First Exercise Session||3||
48633094|NCT04664205|101885409|FG000|NOT COMPLETED|First Exercise Session||0||
48633095|NCT04664205|101885410|FG001|NOT COMPLETED|First Exercise Session||0||
48633096|NCT04664205|101885411|FG002|NOT COMPLETED|First Exercise Session||0||
48633097|NCT04664205|101885409|FG000|STARTED|Second Exercise Session||6||
48633098|NCT04664205|101885410|FG001|STARTED|Second Exercise Session||5||
48633099|NCT04664205|101885411|FG002|STARTED|Second Exercise Session||3||
48633100|NCT04664205|101885409|FG000|COMPLETED|Second Exercise Session||6||
48633101|NCT04664205|101885410|FG001|COMPLETED|Second Exercise Session||5||
48633102|NCT04664205|101885411|FG002|COMPLETED|Second Exercise Session||3||
48633103|NCT04664205|101885409|FG000|NOT COMPLETED|Second Exercise Session||0||
48633104|NCT04664205|101885410|FG001|NOT COMPLETED|Second Exercise Session||0||
48633105|NCT04664205|101885411|FG002|NOT COMPLETED|Second Exercise Session||0||
48633106|NCT04664205|101885409|FG000|STARTED|Third Exercise Session||6||
48633107|NCT04664205|101885410|FG001|STARTED|Third Exercise Session||5||
48633108|NCT04664205|101885411|FG002|STARTED|Third Exercise Session||3||
48633109|NCT04664205|101885409|FG000|COMPLETED|Third Exercise Session||6||
48633110|NCT04664205|101885410|FG001|COMPLETED|Third Exercise Session||5||
48633111|NCT04664205|101885411|FG002|COMPLETED|Third Exercise Session||3||
48633112|NCT04664205|101885409|FG000|NOT COMPLETED|Third Exercise Session||0||
48633113|NCT04664205|101885410|FG001|NOT COMPLETED|Third Exercise Session||0||
48633114|NCT04664205|101885411|FG002|NOT COMPLETED|Third Exercise Session||0||
48633115|NCT03415178|101885412|FG000|STARTED|Parallel-Arm Period (up to Week 4)||34|Randomized|
48633116|NCT03415178|101885413|FG001|STARTED|Parallel-Arm Period (up to Week 4)||35|Randomized|
48633117|NCT03415178|101885412|FG000|Treated|Parallel-Arm Period (up to Week 4)||34||
48633118|NCT03415178|101885413|FG001|Treated|Parallel-Arm Period (up to Week 4)||33||
48633119|NCT03415178|101885412|FG000|COMPLETED|Parallel-Arm Period (up to Week 4)||34||
48633120|NCT03415178|101885413|FG001|COMPLETED|Parallel-Arm Period (up to Week 4)||33||
48633121|NCT03415178|101885412|FG000|NOT COMPLETED|Parallel-Arm Period (up to Week 4)||0||
48633122|NCT03415178|101885413|FG001|NOT COMPLETED|Parallel-Arm Period (up to Week 4)||2||
48633123|NCT03415178|101885412|FG000|STARTED|Single Arm Period (up to Week 16)||0||
48633124|NCT03415178|101885413|FG001|STARTED|Single Arm Period (up to Week 16)||66||
48633125|NCT03415178|101885412|FG000|COMPLETED|Single Arm Period (up to Week 16)||0||
48181076|NCT02564055|100765027|FG004|COMPLETED|Overall Study||27||
48181077|NCT02564055|100765028|FG005|COMPLETED|Overall Study||28||
48181078|NCT02564055|100765023|FG000|NOT COMPLETED|Overall Study||6||
48181079|NCT02564055|100765024|FG001|NOT COMPLETED|Overall Study||5||
48181080|NCT02564055|100765025|FG002|NOT COMPLETED|Overall Study||12||
48181081|NCT02564055|100765026|FG003|NOT COMPLETED|Overall Study||6||
48181082|NCT02564055|100765027|FG004|NOT COMPLETED|Overall Study||15||
48181083|NCT02564055|100765028|FG005|NOT COMPLETED|Overall Study||12||
48181084|NCT01300559|100765029|FG000|STARTED|Overall Study||30||
48181085|NCT01300559|100765030|FG001|STARTED|Overall Study||30||
48181086|NCT01300559|100765029|FG000|COMPLETED|Overall Study||30||
48181087|NCT01300559|100765030|FG001|COMPLETED|Overall Study||30||
48181088|NCT01300559|100765029|FG000|NOT COMPLETED|Overall Study||0||
48181089|NCT01300559|100765030|FG001|NOT COMPLETED|Overall Study||0||
48181090|NCT02774343|100765031|FG000|STARTED|Overall Study||15||
48181091|NCT02774343|100765032|FG001|STARTED|Overall Study||15||
48181092|NCT02774343|100765031|FG000|Received at Least One Capsule|Overall Study||12||
48181093|NCT02774343|100765032|FG001|Received at Least One Capsule|Overall Study||14||
48341527|NCT00289913|101164092|FG000|NOT COMPLETED|Visit 3 (Stage I and Stage II)||9||
48341528|NCT00289913|101164093|FG001|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8||
48633126|NCT03415178|101885413|FG001|COMPLETED|Single Arm Period (up to Week 16)||65||
48633127|NCT03415178|101885412|FG000|NOT COMPLETED|Single Arm Period (up to Week 16)||0||
48181094|NCT02774343|100765031|FG000|COMPLETED|Overall Study||9||
48181095|NCT02774343|100765032|FG001|COMPLETED|Overall Study||12||
48181096|NCT02774343|100765031|FG000|NOT COMPLETED|Overall Study||6||
48181097|NCT02774343|100765032|FG001|NOT COMPLETED|Overall Study||3||
48181098|NCT02209636|100765033|FG000|STARTED|Main/Parent Study||32||
48181099|NCT02209636|100765034|FG001|STARTED|Main/Parent Study||29||
48181100|NCT02209636|100765033|FG000|COMPLETED|Main/Parent Study||27||
48181101|NCT02209636|100765034|FG001|COMPLETED|Main/Parent Study||27||
48181102|NCT02209636|100765033|FG000|NOT COMPLETED|Main/Parent Study||5||
48181103|NCT02209636|100765034|FG001|NOT COMPLETED|Main/Parent Study||2||
48181104|NCT02209636|100765033|FG000|STARTED|Balance Sub-study||7||
48181105|NCT02209636|100765034|FG001|STARTED|Balance Sub-study||8||
48181106|NCT02209636|100765033|FG000|COMPLETED|Balance Sub-study||6||
48181107|NCT02209636|100765034|FG001|COMPLETED|Balance Sub-study||8||
48181108|NCT02209636|100765033|FG000|NOT COMPLETED|Balance Sub-study||1||
48181109|NCT02209636|100765034|FG001|NOT COMPLETED|Balance Sub-study||0||
48181110|NCT03785340|100765035|FG000|STARTED|Overall Study||126||
48181111|NCT03785340|100765036|FG001|STARTED|Overall Study||126||
48181112|NCT03785340|100765035|FG000|Received at Least 1 Study Treatment|Overall Study||126||
48181113|NCT03785340|100765036|FG001|Received at Least 1 Study Treatment|Overall Study||126||
48181114|NCT03785340|100765035|FG000|COMPLETED|Overall Study||123||
48633128|NCT03415178|101885413|FG001|NOT COMPLETED|Single Arm Period (up to Week 16)||1||
48633129|NCT02218463|101885414|FG000|STARTED|Overall Study||21||
48633130|NCT02218463|101885415|FG001|STARTED|Overall Study||22||
48341529|NCT00289913|101164094|FG002|NOT COMPLETED|Visit 3 (Stage I and Stage II)||2||
48181115|NCT03785340|100765036|FG001|COMPLETED|Overall Study||126||
48181116|NCT03785340|100765035|FG000|NOT COMPLETED|Overall Study||3||
48341530|NCT00289913|101164095|FG003|NOT COMPLETED|Visit 3 (Stage I and Stage II)||4||
48341531|NCT00289913|101164096|FG004|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8||
48341532|NCT00289913|101164092|FG000|STARTED|Visit 4 (Stage I and Stage II)||122||
48341533|NCT00289913|101164093|FG001|STARTED|Visit 4 (Stage I and Stage II)||106||
48341534|NCT00289913|101164094|FG002|STARTED|Visit 4 (Stage I and Stage II)||138||
48341535|NCT00289913|101164095|FG003|STARTED|Visit 4 (Stage I and Stage II)||131||
48341536|NCT00289913|101164096|FG004|STARTED|Visit 4 (Stage I and Stage II)||597||
48341537|NCT00289913|101164092|FG000|COMPLETED|Visit 4 (Stage I and Stage II)||122||
48341538|NCT00289913|101164093|FG001|COMPLETED|Visit 4 (Stage I and Stage II)||106||
48341539|NCT00289913|101164094|FG002|COMPLETED|Visit 4 (Stage I and Stage II)||138||
48341540|NCT00289913|101164095|FG003|COMPLETED|Visit 4 (Stage I and Stage II)||131||
48341541|NCT00289913|101164096|FG004|COMPLETED|Visit 4 (Stage I and Stage II)||597||
48341542|NCT00289913|101164092|FG000|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0||
48341543|NCT00289913|101164093|FG001|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0||
48341544|NCT00289913|101164094|FG002|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0||
48341545|NCT00289913|101164095|FG003|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0||
48341546|NCT00289913|101164096|FG004|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0||
48341547|NCT03160560|101164097|FG000|STARTED|First Intervention (3 Weeks)||25||
48341548|NCT03160560|101164098|FG001|STARTED|First Intervention (3 Weeks)||25||
48341549|NCT03160560|101164099|FG002|STARTED|First Intervention (3 Weeks)||25||
48341550|NCT03160560|101164100|FG003|STARTED|First Intervention (3 Weeks)||25||
48341551|NCT03160560|101164097|FG000|COMPLETED|First Intervention (3 Weeks)||23||
48341552|NCT03160560|101164098|FG001|COMPLETED|First Intervention (3 Weeks)||24||
48341553|NCT03160560|101164099|FG002|COMPLETED|First Intervention (3 Weeks)||24||
48341554|NCT03160560|101164100|FG003|COMPLETED|First Intervention (3 Weeks)||25||
48341555|NCT03160560|101164097|FG000|NOT COMPLETED|First Intervention (3 Weeks)||2||
48341556|NCT03160560|101164098|FG001|NOT COMPLETED|First Intervention (3 Weeks)||1||
48341557|NCT03160560|101164099|FG002|NOT COMPLETED|First Intervention (3 Weeks)||1||
48341558|NCT03160560|101164100|FG003|NOT COMPLETED|First Intervention (3 Weeks)||0||
48341559|NCT03160560|101164097|FG000|STARTED|Washout (2 Weeks)||23||
48341560|NCT03160560|101164098|FG001|STARTED|Washout (2 Weeks)||24||
48341561|NCT03160560|101164099|FG002|STARTED|Washout (2 Weeks)||24||
48341562|NCT03160560|101164100|FG003|STARTED|Washout (2 Weeks)||25||
48341563|NCT03160560|101164097|FG000|COMPLETED|Washout (2 Weeks)||23||
48341564|NCT03160560|101164098|FG001|COMPLETED|Washout (2 Weeks)||24||
48341565|NCT03160560|101164099|FG002|COMPLETED|Washout (2 Weeks)||24||
48341566|NCT03160560|101164100|FG003|COMPLETED|Washout (2 Weeks)||25||
48341567|NCT03160560|101164097|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
48341568|NCT03160560|101164098|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
48341569|NCT03160560|101164099|FG002|NOT COMPLETED|Washout (2 Weeks)||0||
48341570|NCT03160560|101164100|FG003|NOT COMPLETED|Washout (2 Weeks)||0||
48341571|NCT03160560|101164097|FG000|STARTED|Second Intervention (3 Weeks)||23||
48341572|NCT03160560|101164098|FG001|STARTED|Second Intervention (3 Weeks)||24||
48341573|NCT03160560|101164099|FG002|STARTED|Second Intervention (3 Weeks)||24||
48341574|NCT03160560|101164100|FG003|STARTED|Second Intervention (3 Weeks)||25||
48341575|NCT03160560|101164097|FG000|COMPLETED|Second Intervention (3 Weeks)||22||
48341576|NCT03160560|101164098|FG001|COMPLETED|Second Intervention (3 Weeks)||24||
48341577|NCT03160560|101164099|FG002|COMPLETED|Second Intervention (3 Weeks)||24||
48341578|NCT03160560|101164100|FG003|COMPLETED|Second Intervention (3 Weeks)||25||
48341579|NCT03160560|101164097|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||1||
48341580|NCT03160560|101164098|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0||
48341581|NCT03160560|101164099|FG002|NOT COMPLETED|Second Intervention (3 Weeks)||0||
48341582|NCT03160560|101164100|FG003|NOT COMPLETED|Second Intervention (3 Weeks)||0||
48341583|NCT00254566|101164101|FG000|STARTED|Overall Study||198||
48341584|NCT00254566|101164102|FG001|STARTED|Overall Study||198||
48341585|NCT00254566|101164101|FG000|COMPLETED|Overall Study||167||
48341586|NCT00254566|101164102|FG001|COMPLETED|Overall Study||172||
48341587|NCT00254566|101164101|FG000|NOT COMPLETED|Overall Study||31||
48341588|NCT00254566|101164102|FG001|NOT COMPLETED|Overall Study||26||
48341589|NCT00542620|101164103|FG000|STARTED|Overall Study||13||
48341590|NCT00542620|101164104|FG001|STARTED|Overall Study||12||
48341591|NCT00542620|101164103|FG000|Exposed to Drug|Overall Study||12||
48341592|NCT00542620|101164104|FG001|Exposed to Drug|Overall Study||13||
48341593|NCT00542620|101164103|FG000|COMPLETED|Overall Study||13||
48341594|NCT00542620|101164104|FG001|COMPLETED|Overall Study||12||
48341595|NCT00542620|101164103|FG000|NOT COMPLETED|Overall Study||0||
48341596|NCT00542620|101164104|FG001|NOT COMPLETED|Overall Study||0||
48341597|NCT01900002|101164105|FG000|STARTED|Overall Study||40||
48341598|NCT01900002|101164105|FG000|COMPLETED|Overall Study||34||
48341599|NCT01900002|101164105|FG000|NOT COMPLETED|Overall Study||6||
48341600|NCT01970176|101164106|FG000|STARTED|Overall Study||14||
48341601|NCT01970176|101164107|FG001|STARTED|Overall Study||6||
48341602|NCT01970176|101164106|FG000|COMPLETED|Overall Study||14||
48341603|NCT01970176|101164107|FG001|COMPLETED|Overall Study||6||
48341604|NCT01970176|101164106|FG000|NOT COMPLETED|Overall Study||0||
48341605|NCT01970176|101164107|FG001|NOT COMPLETED|Overall Study||0||
48341606|NCT02393209|101164108|FG000|STARTED|Overall Study||6||
48341607|NCT02393209|101164109|FG001|STARTED|Overall Study||8||
48755393|NCT04201431|102191072|FG000|NOT COMPLETED|Vaccinations and Primary CHMI||6||
48755394|NCT04201431|102191073|FG001|NOT COMPLETED|Vaccinations and Primary CHMI||0||
48755395|NCT04201431|102191074|FG002|NOT COMPLETED|Vaccinations and Primary CHMI||0||
48755396|NCT04201431|102191072|FG000|STARTED|4th Vaccination and Secondary CHMI||0||
48341608|NCT02393209|101164110|FG002|STARTED|Overall Study||0||
48341609|NCT02393209|101164111|FG003|STARTED|Overall Study||0||
48181117|NCT03785340|100765036|FG001|NOT COMPLETED|Overall Study||0||
48181118|NCT01716208|100765037|FG000|STARTED|Overall Study||12||
48181119|NCT01716208|100765037|FG000|COMPLETED|Overall Study||12||
48181120|NCT01716208|100765037|FG000|NOT COMPLETED|Overall Study||0||
48181121|NCT02682498|100765038|FG000|STARTED|Overall Study||18||
48181122|NCT02682498|100765039|FG001|STARTED|Overall Study||20||
48181123|NCT02682498|100765038|FG000|COMPLETED|Overall Study||18||
48181124|NCT02682498|100765039|FG001|COMPLETED|Overall Study||20||
48341610|NCT02393209|101164108|FG000|COMPLETED|Overall Study||0||
48341611|NCT02393209|101164109|FG001|COMPLETED|Overall Study||0||
48341612|NCT02393209|101164110|FG002|COMPLETED|Overall Study||0||
48341613|NCT02393209|101164111|FG003|COMPLETED|Overall Study||0||
48341614|NCT02393209|101164108|FG000|NOT COMPLETED|Overall Study||6||
48633131|NCT02218463|101885414|FG000|COMPLETED|Overall Study||18||
48633132|NCT02218463|101885415|FG001|COMPLETED|Overall Study||19||
48633133|NCT02218463|101885414|FG000|NOT COMPLETED|Overall Study||3||
48341615|NCT02393209|101164109|FG001|NOT COMPLETED|Overall Study||8||
48341616|NCT02393209|101164110|FG002|NOT COMPLETED|Overall Study||0||
48341617|NCT02393209|101164111|FG003|NOT COMPLETED|Overall Study||0||
48341618|NCT03804671|101164112|FG000|STARTED|Overall Study||6||
48341619|NCT03804671|101164112|FG000|COMPLETED|Overall Study||6||
48341620|NCT03804671|101164112|FG000|NOT COMPLETED|Overall Study||0||
48633134|NCT02218463|101885415|FG001|NOT COMPLETED|Overall Study||3||
48633135|NCT01130272|101885416|FG000|STARTED|Overall Study||107||
48633136|NCT01130272|101885417|FG001|STARTED|Overall Study||173||
48633137|NCT01130272|101885418|FG002|STARTED|Overall Study||169||
48633138|NCT01130272|101885419|FG003|STARTED|Overall Study||171||
48633139|NCT01130272|101885420|FG004|STARTED|Overall Study||169||
48633140|NCT01130272|101885416|FG000|Safety Analysis Set: as Randomized|Overall Study||105|All participants who received study drug as per randomized dose assignment.|
48633141|NCT01130272|101885417|FG001|Safety Analysis Set: as Randomized|Overall Study||171|All participants who received study drug as per randomized dose assignment.|
48633142|NCT01130272|101885418|FG002|Safety Analysis Set: as Randomized|Overall Study||166|All participants who received study drug as per randomized dose assignment.|
48341621|NCT00680836|101164113|FG000|STARTED|Overall Study||27||
48341622|NCT00680836|101164114|FG001|STARTED|Overall Study||27||
48341623|NCT00680836|101164113|FG000|COMPLETED|Overall Study||19||
48341624|NCT00680836|101164114|FG001|COMPLETED|Overall Study||25||
48341625|NCT00680836|101164113|FG000|NOT COMPLETED|Overall Study||8||
48341626|NCT00680836|101164114|FG001|NOT COMPLETED|Overall Study||2||
48341627|NCT01670994|101164115|FG000|STARTED|Overall Study||3||
48341628|NCT01670994|101164116|FG001|STARTED|Overall Study||3||
48633143|NCT01130272|101885419|FG003|Safety Analysis Set: as Randomized|Overall Study||167|All participants who received study drug as per randomized dose assignment.|
48341629|NCT01670994|101164115|FG000|COMPLETED|Overall Study||3||
48341630|NCT01670994|101164116|FG001|COMPLETED|Overall Study||0||
48341631|NCT01670994|101164115|FG000|NOT COMPLETED|Overall Study||0||
48755397|NCT04201431|102191073|FG001|STARTED|4th Vaccination and Secondary CHMI||0||
48755398|NCT04201431|102191074|FG002|STARTED|4th Vaccination and Secondary CHMI||5||
48755399|NCT04201431|102191072|FG000|COMPLETED|4th Vaccination and Secondary CHMI||0||
48755400|NCT04201431|102191073|FG001|COMPLETED|4th Vaccination and Secondary CHMI||0||
48755401|NCT04201431|102191074|FG002|COMPLETED|4th Vaccination and Secondary CHMI||5||
48755402|NCT04201431|102191072|FG000|NOT COMPLETED|4th Vaccination and Secondary CHMI||0||
48755403|NCT04201431|102191073|FG001|NOT COMPLETED|4th Vaccination and Secondary CHMI||0||
48755404|NCT04201431|102191074|FG002|NOT COMPLETED|4th Vaccination and Secondary CHMI||0||
48755405|NCT05379179|102191075|FG000|STARTED|Overall Study||2||
48181125|NCT02682498|100765038|FG000|NOT COMPLETED|Overall Study||0||
48181126|NCT02682498|100765039|FG001|NOT COMPLETED|Overall Study||0||
48181127|NCT00580229|100765040|FG000|STARTED|Overall Study||50||
48181128|NCT00580229|100765040|FG000|COMPLETED|Overall Study||50||
48181129|NCT00580229|100765040|FG000|NOT COMPLETED|Overall Study||0||
48181130|NCT04227340|100765041|FG000|STARTED|Overall Study||43||
48181131|NCT04227340|100765041|FG000|COMPLETED|Overall Study||40||
48341632|NCT01670994|101164116|FG001|NOT COMPLETED|Overall Study||3||
48341633|NCT04485455|101164117|FG000|STARTED|Overall Study||5||
48341634|NCT04485455|101164117|FG000|COMPLETED|Overall Study||5||
48341635|NCT04485455|101164117|FG000|NOT COMPLETED|Overall Study||0||
48755406|NCT05379179|102191076|FG001|STARTED|Overall Study||1||
48755407|NCT05379179|102191075|FG000|COMPLETED|Overall Study||2||
48181132|NCT04227340|100765041|FG000|NOT COMPLETED|Overall Study||3||
48188649|NCT03248570|100783299|FG000|STARTED|Overall Study||14||
48341636|NCT03242954|101164118|FG000|STARTED|Overall Study||43||
48341637|NCT03242954|101164119|FG001|STARTED|Overall Study||45||
48341638|NCT03242954|101164120|FG002|STARTED|Overall Study||41||
48341639|NCT03242954|101164121|FG003|STARTED|Overall Study||125||
48341640|NCT03242954|101164118|FG000|COMPLETED|Overall Study||43||
48439955|NCT04190056|101409993|FG000|STARTED|Overall Study||0||
48341641|NCT03242954|101164119|FG001|COMPLETED|Overall Study||45||
48341642|NCT03242954|101164120|FG002|COMPLETED|Overall Study||41||
48341643|NCT03242954|101164121|FG003|COMPLETED|Overall Study||125||
48341644|NCT03242954|101164118|FG000|NOT COMPLETED|Overall Study||0||
48341645|NCT03242954|101164119|FG001|NOT COMPLETED|Overall Study||0||
48341646|NCT03242954|101164120|FG002|NOT COMPLETED|Overall Study||0||
48341647|NCT03242954|101164121|FG003|NOT COMPLETED|Overall Study||0||
48341648|NCT03569202|101164122|FG000|STARTED|Part 1||3||3
48341649|NCT03569202|101164123|FG001|STARTED|Part 1||0||0
48341650|NCT03569202|101164122|FG000|COMPLETED|Part 1||3||3
48341651|NCT03569202|101164123|FG001|COMPLETED|Part 1||0||0
48341652|NCT03569202|101164122|FG000|NOT COMPLETED|Part 1||0||0
48341653|NCT03569202|101164123|FG001|NOT COMPLETED|Part 1||0||0
48341654|NCT03569202|101164122|FG000|STARTED|Part 2||9||9
48341655|NCT03569202|101164123|FG001|STARTED|Part 2||9||9
48341656|NCT03569202|101164122|FG000|COMPLETED|Part 2||9||9
48341657|NCT03569202|101164123|FG001|COMPLETED|Part 2||9||9
48341658|NCT03569202|101164122|FG000|NOT COMPLETED|Part 2||0||0
48341659|NCT03569202|101164123|FG001|NOT COMPLETED|Part 2||0||0
48341660|NCT03569202|101164122|FG000|STARTED|Part 3||26||0
48341661|NCT03569202|101164123|FG001|STARTED|Part 3||26||0
48341662|NCT03569202|101164122|FG000|COMPLETED|Part 3||24||0
48341663|NCT03569202|101164123|FG001|COMPLETED|Part 3||25||0
48341664|NCT03569202|101164122|FG000|NOT COMPLETED|Part 3||2||0
48341665|NCT03569202|101164123|FG001|NOT COMPLETED|Part 3||1||0
48341666|NCT00896532|101164124|FG000|STARTED|Months 1-24: Romosozumab Treatment Phase||52||
48341667|NCT00896532|101164125|FG001|STARTED|Months 1-24: Romosozumab Treatment Phase||51||
48341668|NCT00896532|101164126|FG002|STARTED|Months 1-24: Romosozumab Treatment Phase||55||
48341669|NCT00896532|101164127|FG003|STARTED|Months 1-24: Romosozumab Treatment Phase||51||
48341670|NCT00896532|101164128|FG004|STARTED|Months 1-24: Romosozumab Treatment Phase||54||
48341671|NCT00896532|101164129|FG005|STARTED|Months 1-24: Romosozumab Treatment Phase||51||
48341672|NCT00896532|101164130|FG006|STARTED|Months 1-24: Romosozumab Treatment Phase||53||
48341673|NCT00896532|101164131|FG007|STARTED|Months 1-24: Romosozumab Treatment Phase||52||
48341674|NCT00896532|101164132|FG008|STARTED|Months 1-24: Romosozumab Treatment Phase||0||
48341675|NCT00896532|101164133|FG009|STARTED|Months 1-24: Romosozumab Treatment Phase||0||
48341676|NCT00896532|101164134|FG010|STARTED|Months 1-24: Romosozumab Treatment Phase||0||
48341677|NCT00896532|101164135|FG011|STARTED|Months 1-24: Romosozumab Treatment Phase||0||
48341678|NCT00896532|101164136|FG012|STARTED|Months 1-24: Romosozumab Treatment Phase||0||
48341679|NCT00896532|101164137|FG013|STARTED|Months 1-24: Romosozumab Treatment Phase||0||
48341680|NCT00896532|101164138|FG014|STARTED|Months 1-24: Romosozumab Treatment Phase||0||
48341681|NCT00896532|101164139|FG015|STARTED|Months 1-24: Romosozumab Treatment Phase||0||
48341682|NCT00896532|101164140|FG016|STARTED|Months 1-24: Romosozumab Treatment Phase||0||
48341683|NCT00896532|101164141|FG017|STARTED|Months 1-24: Romosozumab Treatment Phase||0||
48341684|NCT00896532|101164142|FG018|STARTED|Months 1-24: Romosozumab Treatment Phase||0||
48341685|NCT00896532|101164143|FG019|STARTED|Months 1-24: Romosozumab Treatment Phase||0||
48341686|NCT00896532|101164144|FG020|STARTED|Months 1-24: Romosozumab Treatment Phase||0||
48341687|NCT00896532|101164145|FG021|STARTED|Months 1-24: Romosozumab Treatment Phase||0||
48341688|NCT00896532|101164146|FG022|STARTED|Months 1-24: Romosozumab Treatment Phase||0||
48341689|NCT00896532|101164124|FG000|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51||
48341690|NCT00896532|101164125|FG001|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51||
48341691|NCT00896532|101164126|FG002|Received Treatment|Months 1-24: Romosozumab Treatment Phase||54||
48341692|NCT00896532|101164127|FG003|Received Treatment|Months 1-24: Romosozumab Treatment Phase||49||
48341693|NCT00896532|101164128|FG004|Received Treatment|Months 1-24: Romosozumab Treatment Phase||53||
48341694|NCT00896532|101164129|FG005|Received Treatment|Months 1-24: Romosozumab Treatment Phase||48||
48755408|NCT05379179|102191076|FG001|COMPLETED|Overall Study||1||
48755409|NCT05379179|102191075|FG000|NOT COMPLETED|Overall Study||0||
48755410|NCT05379179|102191076|FG001|NOT COMPLETED|Overall Study||0||
48755411|NCT03904017|102191077|FG000|STARTED|Overall Study||3||
48755412|NCT03904017|102191078|FG001|STARTED|Overall Study||10||
48755413|NCT03904017|102191077|FG000|COMPLETED|Overall Study||3||
48755414|NCT03904017|102191078|FG001|COMPLETED|Overall Study||10||
48341695|NCT00896532|101164130|FG006|Received Treatment|Months 1-24: Romosozumab Treatment Phase||53||
48341696|NCT00896532|101164131|FG007|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51||
48341697|NCT00896532|101164132|FG008|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0||
48341698|NCT00896532|101164133|FG009|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0||
48413734|NCT01738594|101345868|FG002|STARTED|Follow up for 1 Year||0|All patients that receive treatment on study go into the follow up period|
48413735|NCT01738594|101345869|FG003|STARTED|Follow up for 1 Year||0|All patients that receive treatment on study go into the follow up period|
48413736|NCT01738594|101345870|FG004|STARTED|Follow up for 1 Year||1|All patients that receive treatment on study go into the follow up period|
48755415|NCT03904017|102191077|FG000|NOT COMPLETED|Overall Study||0||
48755416|NCT03904017|102191078|FG001|NOT COMPLETED|Overall Study||0||
48755417|NCT00280917|102191079|FG000|STARTED|Overall Study||65||
48341699|NCT00896532|101164134|FG010|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0||
48341700|NCT00896532|101164135|FG011|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0||
48755418|NCT00280917|102191080|FG001|STARTED|Overall Study||63||
48341701|NCT00896532|101164136|FG012|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0||
48341702|NCT00896532|101164137|FG013|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0||
48341703|NCT00896532|101164138|FG014|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0||
48755419|NCT00280917|102191081|FG002|STARTED|Overall Study||63||
48755420|NCT00280917|102191082|FG003|STARTED|Overall Study||63||
48755421|NCT00280917|102191079|FG000|COMPLETED|Overall Study||63||
48755422|NCT00280917|102191080|FG001|COMPLETED|Overall Study||57||
48755423|NCT00280917|102191081|FG002|COMPLETED|Overall Study||57||
48755424|NCT00280917|102191082|FG003|COMPLETED|Overall Study||61||
48755425|NCT00280917|102191079|FG000|NOT COMPLETED|Overall Study||2||
48755426|NCT00280917|102191080|FG001|NOT COMPLETED|Overall Study||6||
48755427|NCT00280917|102191081|FG002|NOT COMPLETED|Overall Study||6||
48755428|NCT00280917|102191082|FG003|NOT COMPLETED|Overall Study||2||
48755429|NCT03816696|102191083|FG000|STARTED|Period 1 (Up to Day 5)||16||
48755430|NCT03816696|102191083|FG000|COMPLETED|Period 1 (Up to Day 5)||16||
48755431|NCT03816696|102191083|FG000|NOT COMPLETED|Period 1 (Up to Day 5)||0||
48755432|NCT03816696|102191083|FG000|STARTED|Wash Out Period (Days 6 to 9)||16||
48755433|NCT03816696|102191083|FG000|COMPLETED|Wash Out Period (Days 6 to 9)||16||
48755434|NCT03816696|102191083|FG000|NOT COMPLETED|Wash Out Period (Days 6 to 9)||0||
48755435|NCT03816696|102191083|FG000|STARTED|Period 2 (Up to Day 7)||16||
48755436|NCT03816696|102191083|FG000|COMPLETED|Period 2 (Up to Day 7)||16||
48755437|NCT03816696|102191083|FG000|NOT COMPLETED|Period 2 (Up to Day 7)||0||
48755438|NCT03816696|102191083|FG000|STARTED|Period 3 (Up to Day 11)||16||
48755439|NCT03816696|102191083|FG000|COMPLETED|Period 3 (Up to Day 11)||16||
48755440|NCT03816696|102191083|FG000|NOT COMPLETED|Period 3 (Up to Day 11)||0||
48755441|NCT00770653|102191084|FG000|STARTED|Overall Study||155||
48755442|NCT00770653|102191085|FG001|STARTED|Overall Study||150||
48755443|NCT00770653|102191084|FG000|COMPLETED|Overall Study||123||
48755444|NCT00770653|102191085|FG001|COMPLETED|Overall Study||121||
48755445|NCT00770653|102191084|FG000|NOT COMPLETED|Overall Study||32||
48755446|NCT00770653|102191085|FG001|NOT COMPLETED|Overall Study||29||
48755447|NCT01260649|102191086|FG000|STARTED|Overall Study||8||
48755448|NCT01260649|102191087|FG001|STARTED|Overall Study||9||
48755449|NCT01260649|102191086|FG000|COMPLETED|Overall Study||6||
48755450|NCT01260649|102191087|FG001|COMPLETED|Overall Study||8||
48755451|NCT01260649|102191086|FG000|NOT COMPLETED|Overall Study||2||
48755452|NCT01260649|102191087|FG001|NOT COMPLETED|Overall Study||1||
48755453|NCT00387881|102191088|FG000|STARTED|Overall Study||334||
48755454|NCT00387881|102191089|FG001|STARTED|Overall Study||345||
48755455|NCT00387881|102191088|FG000|COMPLETED|Overall Study||245||
48755456|NCT00387881|102191089|FG001|COMPLETED|Overall Study||243||
48755457|NCT00387881|102191088|FG000|NOT COMPLETED|Overall Study||89||
48755458|NCT00387881|102191089|FG001|NOT COMPLETED|Overall Study||102||
48755459|NCT00079326|102191090|FG000|STARTED|Overall Study||15||
48755460|NCT00079326|102191091|FG001|STARTED|Overall Study||24||
48341704|NCT00896532|101164139|FG015|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0||
48341705|NCT00896532|101164140|FG016|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0||
48341706|NCT00896532|101164141|FG017|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0||
48341707|NCT00896532|101164142|FG018|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0||
48341708|NCT00896532|101164143|FG019|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0||
48341709|NCT00896532|101164144|FG020|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0||
48341710|NCT00896532|101164145|FG021|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0||
48341711|NCT00896532|101164146|FG022|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0||
48341712|NCT00896532|101164124|FG000|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||47||
48341713|NCT00896532|101164125|FG001|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||49||
48341714|NCT00896532|101164126|FG002|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||46||
48439956|NCT04190056|101409994|FG001|STARTED|Overall Study||1||
48755461|NCT00079326|102191090|FG000|COMPLETED|Overall Study||15||
48755462|NCT00079326|102191091|FG001|COMPLETED|Overall Study||24||
48755463|NCT00079326|102191090|FG000|NOT COMPLETED|Overall Study||0||
48755464|NCT00079326|102191091|FG001|NOT COMPLETED|Overall Study||0||
48755465|NCT02544321|102191092|FG000|STARTED|Overall Study||43||
48755466|NCT02544321|102191093|FG001|STARTED|Overall Study||43||
48755467|NCT02544321|102191092|FG000|Completed First Treatment|Overall Study||43||
48755468|NCT02544321|102191093|FG001|Completed First Treatment|Overall Study||41||
48755469|NCT02544321|102191092|FG000|Completed Washout|Overall Study||43||
48755470|NCT02544321|102191093|FG001|Completed Washout|Overall Study||41||
48755471|NCT02544321|102191092|FG000|Started Second Treatment|Overall Study||42||
48767748|NCT02141295|102222817|FG002|NOT COMPLETED|Overall Study||95||
48341715|NCT00896532|101164127|FG003|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||45||
48341716|NCT00896532|101164128|FG004|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||50||
48341717|NCT00896532|101164129|FG005|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||46||
48341718|NCT00896532|101164130|FG006|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||51||
48341719|NCT00896532|101164131|FG007|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||49||
48341720|NCT00896532|101164132|FG008|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0||
48341721|NCT00896532|101164133|FG009|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0||
48341722|NCT00896532|101164134|FG010|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0||
48341723|NCT00896532|101164135|FG011|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0||
48341724|NCT00896532|101164136|FG012|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0||
48341725|NCT00896532|101164137|FG013|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0||
48341726|NCT00896532|101164138|FG014|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0||
48341727|NCT00896532|101164139|FG015|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0||
48341728|NCT00896532|101164140|FG016|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0||
48341729|NCT00896532|101164141|FG017|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0||
48341730|NCT00896532|101164142|FG018|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0||
48341731|NCT00896532|101164143|FG019|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0||
48341732|NCT00896532|101164144|FG020|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0||
48341733|NCT00896532|101164145|FG021|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0||
48341734|NCT00896532|101164146|FG022|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0||
48341735|NCT00896532|101164124|FG000|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46||
48341736|NCT00896532|101164125|FG001|COMPLETED|Months 1-24: Romosozumab Treatment Phase||45||
48341737|NCT00896532|101164126|FG002|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46||
48341738|NCT00896532|101164127|FG003|COMPLETED|Months 1-24: Romosozumab Treatment Phase||39||
48341739|NCT00896532|101164128|FG004|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46||
48341740|NCT00896532|101164129|FG005|COMPLETED|Months 1-24: Romosozumab Treatment Phase||43||
48341741|NCT00896532|101164130|FG006|COMPLETED|Months 1-24: Romosozumab Treatment Phase||48||
48341742|NCT00896532|101164131|FG007|COMPLETED|Months 1-24: Romosozumab Treatment Phase||48||
48341743|NCT00896532|101164132|FG008|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
48341744|NCT00896532|101164133|FG009|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
48341745|NCT00896532|101164134|FG010|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
48341746|NCT00896532|101164135|FG011|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
48341747|NCT00896532|101164136|FG012|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
48341748|NCT00896532|101164137|FG013|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
48341749|NCT00896532|101164138|FG014|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
48341750|NCT00896532|101164139|FG015|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
48341751|NCT00896532|101164140|FG016|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
48341752|NCT00896532|101164141|FG017|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
48341753|NCT00896532|101164142|FG018|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
48341754|NCT00896532|101164143|FG019|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
48341755|NCT00896532|101164144|FG020|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
48341756|NCT00896532|101164145|FG021|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
48341757|NCT00896532|101164146|FG022|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
48341758|NCT00896532|101164124|FG000|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||6||
48341759|NCT00896532|101164125|FG001|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||6||
48341760|NCT00896532|101164126|FG002|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||9||
48341761|NCT00896532|101164127|FG003|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||12||
48341762|NCT00896532|101164128|FG004|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||8||
48341763|NCT00896532|101164129|FG005|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||8||
48341764|NCT00896532|101164130|FG006|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||5||
48341765|NCT00896532|101164131|FG007|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||4||
48341766|NCT00896532|101164132|FG008|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
48341767|NCT00896532|101164133|FG009|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
48341768|NCT00896532|101164134|FG010|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
48341769|NCT00896532|101164135|FG011|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
48341770|NCT00896532|101164136|FG012|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
48341771|NCT00896532|101164137|FG013|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
48341772|NCT00896532|101164138|FG014|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
48341773|NCT00896532|101164139|FG015|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
48341774|NCT00896532|101164140|FG016|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
48341775|NCT00896532|101164141|FG017|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
48341776|NCT00896532|101164142|FG018|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
48341777|NCT00896532|101164143|FG019|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
48341778|NCT00896532|101164144|FG020|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
48341779|NCT00896532|101164145|FG021|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
48755472|NCT02544321|102191093|FG001|Started Second Treatment|Overall Study||40||
48755473|NCT02544321|102191092|FG000|COMPLETED|Overall Study||41||
48755474|NCT02544321|102191093|FG001|COMPLETED|Overall Study||39||
48755475|NCT02544321|102191092|FG000|NOT COMPLETED|Overall Study||2||
48755476|NCT02544321|102191093|FG001|NOT COMPLETED|Overall Study||4||
48755477|NCT00474812|102191094|FG000|STARTED|Overall Study||51||
48755478|NCT00474812|102191094|FG000|COMPLETED|Overall Study||44||
48755479|NCT00474812|102191094|FG000|NOT COMPLETED|Overall Study||7||
48341780|NCT00896532|101164146|FG022|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
48341781|NCT00896532|101164124|FG000|STARTED|Months 24-36: Denosumab Extension Phase||0||
48341782|NCT00896532|101164125|FG001|STARTED|Months 24-36: Denosumab Extension Phase||0||
48341783|NCT00896532|101164126|FG002|STARTED|Months 24-36: Denosumab Extension Phase||0||
48341784|NCT00896532|101164127|FG003|STARTED|Months 24-36: Denosumab Extension Phase||0||
48341785|NCT00896532|101164128|FG004|STARTED|Months 24-36: Denosumab Extension Phase||0||
48341786|NCT00896532|101164129|FG005|STARTED|Months 24-36: Denosumab Extension Phase||0||
48341787|NCT00896532|101164130|FG006|STARTED|Months 24-36: Denosumab Extension Phase||0||
48341788|NCT00896532|101164131|FG007|STARTED|Months 24-36: Denosumab Extension Phase||0||
48341789|NCT00896532|101164132|FG008|STARTED|Months 24-36: Denosumab Extension Phase||18||
48341790|NCT00896532|101164133|FG009|STARTED|Months 24-36: Denosumab Extension Phase||18||
48341791|NCT00896532|101164134|FG010|STARTED|Months 24-36: Denosumab Extension Phase||20||
48341792|NCT00896532|101164135|FG011|STARTED|Months 24-36: Denosumab Extension Phase||21||
48341793|NCT00896532|101164136|FG012|STARTED|Months 24-36: Denosumab Extension Phase||93||
48341794|NCT00896532|101164137|FG013|STARTED|Months 24-36: Denosumab Extension Phase||90||
48341795|NCT00896532|101164138|FG014|STARTED|Months 24-36: Denosumab Extension Phase||0||
48341796|NCT00896532|101164139|FG015|STARTED|Months 24-36: Denosumab Extension Phase||0||
48341797|NCT00896532|101164140|FG016|STARTED|Months 24-36: Denosumab Extension Phase||0||
48341798|NCT00896532|101164141|FG017|STARTED|Months 24-36: Denosumab Extension Phase||0||
48341799|NCT00896532|101164142|FG018|STARTED|Months 24-36: Denosumab Extension Phase||0||
48341800|NCT00896532|101164143|FG019|STARTED|Months 24-36: Denosumab Extension Phase||0||
48755480|NCT00107653|102191095|FG000|STARTED|Overall Study||269||
48755481|NCT00107653|102191096|FG001|STARTED|Overall Study||300||
48755482|NCT00107653|102191095|FG000|COMPLETED|Overall Study||190||
48755483|NCT00107653|102191096|FG001|COMPLETED|Overall Study||224||
48755484|NCT00107653|102191095|FG000|NOT COMPLETED|Overall Study||79||
48755485|NCT00107653|102191096|FG001|NOT COMPLETED|Overall Study||76||
48755486|NCT03724942|102191097|FG000|STARTED|Overall Study||102||
48755487|NCT03724942|102191098|FG001|STARTED|Overall Study||62||
48755488|NCT03724942|102191097|FG000|COMPLETED|Overall Study||73||
48755489|NCT03724942|102191098|FG001|COMPLETED|Overall Study||44||
48755490|NCT03724942|102191097|FG000|NOT COMPLETED|Overall Study||29||
48755491|NCT03724942|102191098|FG001|NOT COMPLETED|Overall Study||18||
48755492|NCT03562195|102191099|FG000|STARTED|Overall Study||149||
48755493|NCT03562195|102191100|FG001|STARTED|Overall Study||151||
48755494|NCT03562195|102191099|FG000|COMPLETED|Overall Study||145||
48755495|NCT03562195|102191100|FG001|COMPLETED|Overall Study||138||
48755496|NCT03562195|102191099|FG000|NOT COMPLETED|Overall Study||4||
48755497|NCT03562195|102191100|FG001|NOT COMPLETED|Overall Study||13||
48755498|NCT00442169|102191101|FG000|STARTED|Part 1||17||
48755499|NCT00442169|102191102|FG001|STARTED|Part 1||24||
48755500|NCT00442169|102191103|FG002|STARTED|Part 1||40||
48755501|NCT00442169|102191104|FG003|STARTED|Part 1||31||
48755502|NCT00442169|102191105|FG004|STARTED|Part 1||0||
48755503|NCT00442169|102191106|FG005|STARTED|Part 1||0||
48755504|NCT00442169|102191101|FG000|COMPLETED|Part 1||17||
48755505|NCT00442169|102191102|FG001|COMPLETED|Part 1||24||
48755506|NCT00442169|102191103|FG002|COMPLETED|Part 1||40||
48755507|NCT00442169|102191104|FG003|COMPLETED|Part 1||31||
48755508|NCT00442169|102191105|FG004|COMPLETED|Part 1||0||
48755509|NCT00442169|102191106|FG005|COMPLETED|Part 1||0||
48755510|NCT00442169|102191101|FG000|NOT COMPLETED|Part 1||0||
48755511|NCT00442169|102191102|FG001|NOT COMPLETED|Part 1||0||
48755512|NCT00442169|102191103|FG002|NOT COMPLETED|Part 1||0||
48755513|NCT00442169|102191104|FG003|NOT COMPLETED|Part 1||0||
48755514|NCT00442169|102191105|FG004|NOT COMPLETED|Part 1||0||
48341801|NCT00896532|101164144|FG020|STARTED|Months 24-36: Denosumab Extension Phase||0||
48341802|NCT00896532|101164145|FG021|STARTED|Months 24-36: Denosumab Extension Phase||0||
48341803|NCT00896532|101164146|FG022|STARTED|Months 24-36: Denosumab Extension Phase||0||
48755515|NCT00442169|102191106|FG005|NOT COMPLETED|Part 1||0||
48755516|NCT00442169|102191101|FG000|STARTED|Part 2||0||
48755517|NCT00442169|102191102|FG001|STARTED|Part 2||0||
48755518|NCT00442169|102191103|FG002|STARTED|Part 2||0||
48755519|NCT00442169|102191104|FG003|STARTED|Part 2||0||
48755520|NCT00442169|102191105|FG004|STARTED|Part 2||25||
48755521|NCT00442169|102191106|FG005|STARTED|Part 2||57||
48755522|NCT00442169|102191101|FG000|COMPLETED|Part 2||0||
48755523|NCT00442169|102191102|FG001|COMPLETED|Part 2||0||
48755524|NCT00442169|102191103|FG002|COMPLETED|Part 2||0||
48755525|NCT00442169|102191104|FG003|COMPLETED|Part 2||0||
48755526|NCT00442169|102191105|FG004|COMPLETED|Part 2||25||
48755527|NCT00442169|102191106|FG005|COMPLETED|Part 2||57||
48755528|NCT00442169|102191101|FG000|NOT COMPLETED|Part 2||0||
48755529|NCT00442169|102191102|FG001|NOT COMPLETED|Part 2||0||
48755530|NCT00442169|102191103|FG002|NOT COMPLETED|Part 2||0||
48755531|NCT00442169|102191104|FG003|NOT COMPLETED|Part 2||0||
48755532|NCT00442169|102191105|FG004|NOT COMPLETED|Part 2||0||
48755533|NCT00442169|102191106|FG005|NOT COMPLETED|Part 2||0||
48755534|NCT00758771|102191107|FG000|STARTED|Overall Study||18||
48755535|NCT00758771|102191108|FG001|STARTED|Overall Study||20||
48755536|NCT00758771|102191107|FG000|COMPLETED|Overall Study||15||
48755537|NCT00758771|102191108|FG001|COMPLETED|Overall Study||15||
48755538|NCT00758771|102191107|FG000|NOT COMPLETED|Overall Study||3||
48755539|NCT00758771|102191108|FG001|NOT COMPLETED|Overall Study||5||
48755540|NCT00231816|102191109|FG000|STARTED|Overall Study||382||
48755541|NCT00231816|102191110|FG001|STARTED|Overall Study||381||
48755542|NCT00231816|102191109|FG000|Vaccinated at Visit 1|Overall Study||382||
48755543|NCT00231816|102191110|FG001|Vaccinated at Visit 1|Overall Study||380||
48755544|NCT00231816|102191109|FG000|Vaccinated at Visit 2|Overall Study||369||
48755545|NCT00231816|102191110|FG001|Vaccinated at Visit 2|Overall Study||371||
48755546|NCT00231816|102191109|FG000|COMPLETED|Overall Study||366||
48755547|NCT00231816|102191110|FG001|COMPLETED|Overall Study||369||
48755548|NCT00231816|102191109|FG000|NOT COMPLETED|Overall Study||16||
48755549|NCT00231816|102191110|FG001|NOT COMPLETED|Overall Study||12||
48755550|NCT01064440|102191111|FG000|STARTED|Overall Study||21||
48755551|NCT01064440|102191112|FG001|STARTED|Overall Study||20||
48755552|NCT01064440|102191113|FG002|STARTED|Overall Study||11||
48755553|NCT01064440|102191111|FG000|COMPLETED|Overall Study||18||
48755554|NCT01064440|102191112|FG001|COMPLETED|Overall Study||17||
48755555|NCT01064440|102191113|FG002|COMPLETED|Overall Study||8||
48755556|NCT01064440|102191111|FG000|NOT COMPLETED|Overall Study||3||
48755557|NCT01064440|102191112|FG001|NOT COMPLETED|Overall Study||3||
48755558|NCT01064440|102191113|FG002|NOT COMPLETED|Overall Study||3||
48755559|NCT03001557|102191114|FG000|STARTED|Core Phase||12||
48755560|NCT03001557|102191115|FG001|STARTED|Core Phase||12||
48755561|NCT03001557|102191116|FG002|STARTED|Core Phase||14||
48755562|NCT03001557|102191117|FG003|STARTED|Core Phase||13||
48755563|NCT03001557|102191118|FG004|STARTED|Core Phase||12||
48755564|NCT03001557|102191119|FG005|STARTED|Core Phase||0||
48755565|NCT03001557|102191120|FG006|STARTED|Core Phase||0||
48755566|NCT03001557|102191121|FG007|STARTED|Core Phase||0||
48755567|NCT03001557|102191114|FG000|Treated|Core Phase||12||
48755568|NCT03001557|102191115|FG001|Treated|Core Phase||12||
48755569|NCT03001557|102191116|FG002|Treated|Core Phase||13||
48755570|NCT03001557|102191117|FG003|Treated|Core Phase||13||
48755571|NCT03001557|102191118|FG004|Treated|Core Phase||12||
48755572|NCT03001557|102191119|FG005|Treated|Core Phase||0||
48755573|NCT03001557|102191120|FG006|Treated|Core Phase||0||
48755574|NCT03001557|102191121|FG007|Treated|Core Phase||0||
48755575|NCT03001557|102191114|FG000|COMPLETED|Core Phase||12||
48755576|NCT03001557|102191115|FG001|COMPLETED|Core Phase||12||
48755577|NCT03001557|102191116|FG002|COMPLETED|Core Phase||13||
48755578|NCT03001557|102191117|FG003|COMPLETED|Core Phase||13||
48755579|NCT03001557|102191118|FG004|COMPLETED|Core Phase||12||
48755580|NCT03001557|102191119|FG005|COMPLETED|Core Phase||0||
48755581|NCT03001557|102191120|FG006|COMPLETED|Core Phase||0||
48755582|NCT03001557|102191121|FG007|COMPLETED|Core Phase||0||
48755583|NCT03001557|102191114|FG000|NOT COMPLETED|Core Phase||0||
48755584|NCT03001557|102191115|FG001|NOT COMPLETED|Core Phase||0||
48755585|NCT03001557|102191116|FG002|NOT COMPLETED|Core Phase||1||
48755586|NCT03001557|102191117|FG003|NOT COMPLETED|Core Phase||0||
48755587|NCT03001557|102191118|FG004|NOT COMPLETED|Core Phase||0||
48755588|NCT03001557|102191119|FG005|NOT COMPLETED|Core Phase||0||
48755589|NCT03001557|102191120|FG006|NOT COMPLETED|Core Phase||0||
48755590|NCT03001557|102191121|FG007|NOT COMPLETED|Core Phase||0||
48755591|NCT03001557|102191114|FG000|STARTED|Extension Phase||0||
48755592|NCT03001557|102191115|FG001|STARTED|Extension Phase||0||
48755593|NCT03001557|102191116|FG002|STARTED|Extension Phase||0||
48755594|NCT03001557|102191117|FG003|STARTED|Extension Phase||0||
48755595|NCT03001557|102191118|FG004|STARTED|Extension Phase||0||
48755596|NCT03001557|102191119|FG005|STARTED|Extension Phase||5||
48755597|NCT03001557|102191120|FG006|STARTED|Extension Phase||14||
48755598|NCT03001557|102191121|FG007|STARTED|Extension Phase||6||
48755599|NCT03001557|102191114|FG000|COMPLETED|Extension Phase||0||
48755600|NCT03001557|102191115|FG001|COMPLETED|Extension Phase||0||
48755601|NCT03001557|102191116|FG002|COMPLETED|Extension Phase||0||
48755602|NCT03001557|102191117|FG003|COMPLETED|Extension Phase||0||
48755603|NCT03001557|102191118|FG004|COMPLETED|Extension Phase||0||
48755604|NCT03001557|102191119|FG005|COMPLETED|Extension Phase||0||
48755605|NCT03001557|102191120|FG006|COMPLETED|Extension Phase||0||
48755606|NCT03001557|102191121|FG007|COMPLETED|Extension Phase||0||
48755607|NCT03001557|102191114|FG000|NOT COMPLETED|Extension Phase||0||
48755608|NCT03001557|102191115|FG001|NOT COMPLETED|Extension Phase||0||
48755609|NCT03001557|102191116|FG002|NOT COMPLETED|Extension Phase||0||
48755610|NCT03001557|102191117|FG003|NOT COMPLETED|Extension Phase||0||
48755611|NCT03001557|102191118|FG004|NOT COMPLETED|Extension Phase||0||
48755612|NCT03001557|102191119|FG005|NOT COMPLETED|Extension Phase||5||
48755613|NCT03001557|102191120|FG006|NOT COMPLETED|Extension Phase||14||
48755614|NCT03001557|102191121|FG007|NOT COMPLETED|Extension Phase||6||
48755615|NCT00910104|102191122|FG000|STARTED|Overall Study||42||
48755616|NCT00910104|102191123|FG001|STARTED|Overall Study||49||
48755617|NCT00910104|102191122|FG000|COMPLETED|Overall Study||42||
48755618|NCT00910104|102191123|FG001|COMPLETED|Overall Study||49||
48755619|NCT00910104|102191122|FG000|NOT COMPLETED|Overall Study||0||
48755620|NCT00910104|102191123|FG001|NOT COMPLETED|Overall Study||0||
48755621|NCT03820544|102191124|FG000|STARTED|Overall Study||2||
48755622|NCT03820544|102191125|FG001|STARTED|Overall Study||2||
48755623|NCT03820544|102191124|FG000|COMPLETED|Overall Study||2||
48755624|NCT03820544|102191125|FG001|COMPLETED|Overall Study||2||
48755625|NCT03820544|102191124|FG000|NOT COMPLETED|Overall Study||0||
48755626|NCT03820544|102191125|FG001|NOT COMPLETED|Overall Study||0||
48755627|NCT03392935|102191126|FG000|STARTED|Overall Study||37||46
48755628|NCT03392935|102191126|FG000|COMPLETED|Overall Study||35||44
48755629|NCT03392935|102191126|FG000|NOT COMPLETED|Overall Study||2||2
48755630|NCT00625131|102191127|FG000|STARTED|Overall Study||38||
48755631|NCT00625131|102191128|FG001|STARTED|Overall Study||44||
48755632|NCT00625131|102191129|FG002|STARTED|Overall Study||5||
48755633|NCT00625131|102191127|FG000|COMPLETED|Overall Study||34||
48755634|NCT00625131|102191128|FG001|COMPLETED|Overall Study||42||
48755635|NCT00625131|102191129|FG002|COMPLETED|Overall Study||0||
48755636|NCT00625131|102191127|FG000|NOT COMPLETED|Overall Study||4||
48755637|NCT00625131|102191128|FG001|NOT COMPLETED|Overall Study||2||
48755638|NCT00625131|102191129|FG002|NOT COMPLETED|Overall Study||5||
48755639|NCT01048879|102191130|FG000|STARTED|Overall Study||1||
48755640|NCT01048879|102191131|FG001|STARTED|Overall Study||9||
48755641|NCT01048879|102191132|FG002|STARTED|Overall Study||5||
48755642|NCT01048879|102191130|FG000|COMPLETED|Overall Study||1||
48755643|NCT01048879|102191131|FG001|COMPLETED|Overall Study||9||
48755644|NCT01048879|102191132|FG002|COMPLETED|Overall Study||5||
48755645|NCT01048879|102191130|FG000|NOT COMPLETED|Overall Study||0||
48755646|NCT01048879|102191131|FG001|NOT COMPLETED|Overall Study||0||
48755647|NCT01048879|102191132|FG002|NOT COMPLETED|Overall Study||0||
48755648|NCT04890652|102191133|FG000|STARTED|Overall Study||27||
48755649|NCT04890652|102191133|FG000|COMPLETED|Overall Study||25||
48755650|NCT04890652|102191133|FG000|NOT COMPLETED|Overall Study||2||
48755651|NCT02927301|102191134|FG000|STARTED|Overall Study||181||
48755652|NCT02927301|102191134|FG000|Participants Who Had Surgery|Overall Study||159||
48755653|NCT02927301|102191134|FG000|COMPLETED|Overall Study||115||
48755654|NCT02927301|102191134|FG000|NOT COMPLETED|Overall Study||66||
48755655|NCT04392739|102191135|FG000|STARTED|Overall Study||34||
48755656|NCT04392739|102191135|FG000|COMPLETED|Overall Study||34||
48755657|NCT04392739|102191135|FG000|NOT COMPLETED|Overall Study||0||
48755658|NCT01075243|102191136|FG000|STARTED|Overall Study||163||
48755659|NCT01075243|102191137|FG001|STARTED|Overall Study||158||
48755660|NCT01075243|102191138|FG002|STARTED|Overall Study||80||
48755661|NCT01075243|102191136|FG000|COMPLETED|Overall Study||157||
48755662|NCT01075243|102191137|FG001|COMPLETED|Overall Study||155||
48755663|NCT01075243|102191138|FG002|COMPLETED|Overall Study||80||
48755664|NCT01075243|102191136|FG000|NOT COMPLETED|Overall Study||6||
48755665|NCT01075243|102191137|FG001|NOT COMPLETED|Overall Study||3||
48755666|NCT01075243|102191138|FG002|NOT COMPLETED|Overall Study||0||
48755667|NCT01537666|102191139|FG000|STARTED|Overall Study||6||
48755668|NCT01537666|102191140|FG001|STARTED|Overall Study||6||
48755669|NCT01537666|102191141|FG002|STARTED|Overall Study||6||
48755670|NCT01537666|102191142|FG003|STARTED|Overall Study||7||
48755671|NCT01537666|102191139|FG000|COMPLETED|Overall Study||6||
48755672|NCT01537666|102191140|FG001|COMPLETED|Overall Study||6||
48755673|NCT01537666|102191141|FG002|COMPLETED|Overall Study||6||
48755674|NCT01537666|102191142|FG003|COMPLETED|Overall Study||7||
48755675|NCT01537666|102191139|FG000|NOT COMPLETED|Overall Study||0||
48755676|NCT01537666|102191140|FG001|NOT COMPLETED|Overall Study||0||
48755677|NCT01537666|102191141|FG002|NOT COMPLETED|Overall Study||0||
48755678|NCT01537666|102191142|FG003|NOT COMPLETED|Overall Study||0||
48755679|NCT03655132|102191143|FG000|STARTED|Overall Study||22||
48755680|NCT03655132|102191144|FG001|STARTED|Overall Study||20||
48755681|NCT03655132|102191143|FG000|COMPLETED|Overall Study||20||
48755682|NCT03655132|102191144|FG001|COMPLETED|Overall Study||17||
48755683|NCT03655132|102191143|FG000|NOT COMPLETED|Overall Study||2||
48755684|NCT03655132|102191144|FG001|NOT COMPLETED|Overall Study||3||
48755685|NCT04196686|102191145|FG000|STARTED|First Treatment (4 Minutes)||78||
48755686|NCT04196686|102191146|FG001|STARTED|First Treatment (4 Minutes)||78||
48755687|NCT04196686|102191145|FG000|COMPLETED|First Treatment (4 Minutes)||78||
48755688|NCT04196686|102191146|FG001|COMPLETED|First Treatment (4 Minutes)||75||
48755689|NCT04196686|102191145|FG000|NOT COMPLETED|First Treatment (4 Minutes)||0||
48755690|NCT04196686|102191146|FG001|NOT COMPLETED|First Treatment (4 Minutes)||3||
48755691|NCT04196686|102191145|FG000|STARTED|Second Treatment (4 Minutes)||78||
48755692|NCT04196686|102191146|FG001|STARTED|Second Treatment (4 Minutes)||75||
48755693|NCT04196686|102191145|FG000|COMPLETED|Second Treatment (4 Minutes)||78||
48755694|NCT04196686|102191146|FG001|COMPLETED|Second Treatment (4 Minutes)||75||
48755695|NCT04196686|102191145|FG000|NOT COMPLETED|Second Treatment (4 Minutes)||0||
48755696|NCT04196686|102191146|FG001|NOT COMPLETED|Second Treatment (4 Minutes)||0||
48755697|NCT01358877|102191147|FG000|STARTED|Overall Study||2400||
48755698|NCT01358877|102191148|FG001|STARTED|Overall Study||2404||
48755699|NCT01358877|102191147|FG000|Did Not Receive Study Drug|Overall Study||22||
48181133|NCT03390036|100765042|FG000|STARTED|Overall Study||233|Safety Population and ITT Population|
48181134|NCT03390036|100765043|FG001|STARTED|Overall Study||230|Safety Population and ITT Population|
48181135|NCT03390036|100765044|FG002|STARTED|Overall Study||63|Safety Population and ITT Population|
48181136|NCT03390036|100765042|FG000|COMPLETED|Overall Study||231||
48181137|NCT03390036|100765043|FG001|COMPLETED|Overall Study||230||
48181138|NCT03390036|100765044|FG002|COMPLETED|Overall Study||63||
48181139|NCT03390036|100765042|FG000|NOT COMPLETED|Overall Study||2||
48181140|NCT03390036|100765043|FG001|NOT COMPLETED|Overall Study||0||
48181141|NCT03390036|100765044|FG002|NOT COMPLETED|Overall Study||0||
48341804|NCT00896532|101164124|FG000|Received Treatment|Months 24-36: Denosumab Extension Phase||0||
48341805|NCT00896532|101164125|FG001|Received Treatment|Months 24-36: Denosumab Extension Phase||0||
48633144|NCT01130272|101885420|FG004|Safety Analysis Set: as Randomized|Overall Study||162|All participants who received study drug as per randomized dose assignment.|
48633145|NCT01130272|101885416|FG000|Safety Analysis Set: Highest Dose Level|Overall Study||105|Reflects the reassignment of patients randomized more than once to the highest dose level arm.|
48633146|NCT01130272|101885417|FG001|Safety Analysis Set: Highest Dose Level|Overall Study||170|Reflects the reassignment of patients randomized more than once to the highest dose level arm.|
48633147|NCT01130272|101885418|FG002|Safety Analysis Set: Highest Dose Level|Overall Study||165|Reflects the reassignment of patients randomized more than once to the highest dose level arm.|
48633148|NCT01130272|101885419|FG003|Safety Analysis Set: Highest Dose Level|Overall Study||172|Reflects the reassignment of patients randomized more than once to the highest dose level arm.|
48633149|NCT01130272|101885420|FG004|Safety Analysis Set: Highest Dose Level|Overall Study||159|Reflects the reassignment of patients randomized more than once to the highest dose level arm.|
48633150|NCT01130272|101885416|FG000|COMPLETED|Overall Study||48||
48633151|NCT01130272|101885417|FG001|COMPLETED|Overall Study||131||
48633152|NCT01130272|101885418|FG002|COMPLETED|Overall Study||121||
48633153|NCT01130272|101885419|FG003|COMPLETED|Overall Study||103||
48633154|NCT01130272|101885420|FG004|COMPLETED|Overall Study||117||
48633155|NCT01130272|101885416|FG000|NOT COMPLETED|Overall Study||59||
48633156|NCT01130272|101885417|FG001|NOT COMPLETED|Overall Study||42||
48633157|NCT01130272|101885418|FG002|NOT COMPLETED|Overall Study||48||
48633158|NCT01130272|101885419|FG003|NOT COMPLETED|Overall Study||68||
48633159|NCT01130272|101885420|FG004|NOT COMPLETED|Overall Study||52||
48633160|NCT01391611|101885421|FG000|STARTED|Overall Study||25||
48341806|NCT00896532|101164126|FG002|Received Treatment|Months 24-36: Denosumab Extension Phase||0||
48341807|NCT00896532|101164127|FG003|Received Treatment|Months 24-36: Denosumab Extension Phase||0||
48341808|NCT00896532|101164128|FG004|Received Treatment|Months 24-36: Denosumab Extension Phase||0||
48341809|NCT00896532|101164129|FG005|Received Treatment|Months 24-36: Denosumab Extension Phase||0||
48341810|NCT00896532|101164130|FG006|Received Treatment|Months 24-36: Denosumab Extension Phase||0||
48341811|NCT00896532|101164131|FG007|Received Treatment|Months 24-36: Denosumab Extension Phase||0||
48341812|NCT00896532|101164132|FG008|Received Treatment|Months 24-36: Denosumab Extension Phase||18||
48341813|NCT00896532|101164133|FG009|Received Treatment|Months 24-36: Denosumab Extension Phase||18||
48341814|NCT00896532|101164134|FG010|Received Treatment|Months 24-36: Denosumab Extension Phase||19||
48341815|NCT00896532|101164135|FG011|Received Treatment|Months 24-36: Denosumab Extension Phase||19||
48341816|NCT00896532|101164136|FG012|Received Treatment|Months 24-36: Denosumab Extension Phase||90||
48341817|NCT00896532|101164137|FG013|Received Treatment|Months 24-36: Denosumab Extension Phase||88||
48341818|NCT00896532|101164138|FG014|Received Treatment|Months 24-36: Denosumab Extension Phase||0||
48341819|NCT00896532|101164139|FG015|Received Treatment|Months 24-36: Denosumab Extension Phase||0||
48181142|NCT01857323|100765045|FG000|STARTED|Overall Study||317||
48181143|NCT01857323|100765045|FG000|Safety Population|Overall Study||316||
48181144|NCT01857323|100765045|FG000|COMPLETED|Overall Study||253||
48181145|NCT01857323|100765045|FG000|NOT COMPLETED|Overall Study||64||
48181146|NCT01628510|100765046|FG000|STARTED|Overall Study||51||
48181147|NCT01628510|100765047|FG001|STARTED|Overall Study||49||
48181148|NCT01628510|100765046|FG000|COMPLETED|Overall Study||48||
48181149|NCT01628510|100765047|FG001|COMPLETED|Overall Study||44||
48181150|NCT01628510|100765046|FG000|NOT COMPLETED|Overall Study||3||
48633161|NCT01391611|101885421|FG000|COMPLETED|Overall Study||3||
48633162|NCT01391611|101885421|FG000|NOT COMPLETED|Overall Study||22||
48633163|NCT03329885|101885422|FG000|STARTED|Overall Study||9||
48181151|NCT01628510|100765047|FG001|NOT COMPLETED|Overall Study||5||
48181152|NCT01041508|100765048|FG000|STARTED|Overall Study||3||
48181153|NCT01041508|100765049|FG001|STARTED|Overall Study||6||
48181154|NCT01041508|100765050|FG002|STARTED|Overall Study||3||
48341820|NCT00896532|101164140|FG016|Received Treatment|Months 24-36: Denosumab Extension Phase||0||
48341821|NCT00896532|101164141|FG017|Received Treatment|Months 24-36: Denosumab Extension Phase||0||
48341822|NCT00896532|101164142|FG018|Received Treatment|Months 24-36: Denosumab Extension Phase||0||
48341823|NCT00896532|101164143|FG019|Received Treatment|Months 24-36: Denosumab Extension Phase||0||
48341824|NCT00896532|101164144|FG020|Received Treatment|Months 24-36: Denosumab Extension Phase||0||
48341825|NCT00896532|101164145|FG021|Received Treatment|Months 24-36: Denosumab Extension Phase||0||
48633164|NCT03329885|101885423|FG001|STARTED|Overall Study||6||
48633165|NCT03329885|101885424|FG002|STARTED|Overall Study||6||
48633166|NCT03329885|101885425|FG003|STARTED|Overall Study||6||
48633167|NCT03329885|101885426|FG004|STARTED|Overall Study||6||
48633168|NCT03329885|101885427|FG005|STARTED|Overall Study||3||
48633169|NCT03329885|101885428|FG006|STARTED|Overall Study||1||
48633170|NCT03329885|101885429|FG007|STARTED|Overall Study||1||
48633171|NCT03329885|101885430|FG008|STARTED|Overall Study||0||
48633172|NCT03329885|101885422|FG000|COMPLETED|Overall Study||9||
48341826|NCT00896532|101164146|FG022|Received Treatment|Months 24-36: Denosumab Extension Phase||0||
48181155|NCT01041508|100765051|FG003|STARTED|Overall Study||6||
48181156|NCT01041508|100765048|FG000|COMPLETED|Overall Study||3||
48181157|NCT01041508|100765049|FG001|COMPLETED|Overall Study||6||
48181158|NCT01041508|100765050|FG002|COMPLETED|Overall Study||3||
48181159|NCT01041508|100765051|FG003|COMPLETED|Overall Study||6||
48181160|NCT01041508|100765048|FG000|NOT COMPLETED|Overall Study||0||
48181161|NCT01041508|100765049|FG001|NOT COMPLETED|Overall Study||0||
48181162|NCT01041508|100765050|FG002|NOT COMPLETED|Overall Study||0||
48181163|NCT01041508|100765051|FG003|NOT COMPLETED|Overall Study||0||
48181164|NCT02444143|100765052|FG000|STARTED|Overall Study||10||
48181165|NCT02444143|100765053|FG001|STARTED|Overall Study||10||
48181166|NCT02444143|100765052|FG000|COMPLETED|Overall Study||10||
48181167|NCT02444143|100765053|FG001|COMPLETED|Overall Study||9||
48181168|NCT02444143|100765052|FG000|NOT COMPLETED|Overall Study||0||
48181169|NCT02444143|100765053|FG001|NOT COMPLETED|Overall Study||1||
48341827|NCT00896532|101164124|FG000|COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48341828|NCT00896532|101164125|FG001|COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48341829|NCT00896532|101164126|FG002|COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48341830|NCT00896532|101164127|FG003|COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48341831|NCT00896532|101164128|FG004|COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48341832|NCT00896532|101164129|FG005|COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48341833|NCT00896532|101164130|FG006|COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48341834|NCT00896532|101164131|FG007|COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48341835|NCT00896532|101164132|FG008|COMPLETED|Months 24-36: Denosumab Extension Phase||17||
48341836|NCT00896532|101164133|FG009|COMPLETED|Months 24-36: Denosumab Extension Phase||18||
48341837|NCT00896532|101164134|FG010|COMPLETED|Months 24-36: Denosumab Extension Phase||18||
48341838|NCT00896532|101164135|FG011|COMPLETED|Months 24-36: Denosumab Extension Phase||19||
48341839|NCT00896532|101164136|FG012|COMPLETED|Months 24-36: Denosumab Extension Phase||88||
48341840|NCT00896532|101164137|FG013|COMPLETED|Months 24-36: Denosumab Extension Phase||88||
48341841|NCT00896532|101164138|FG014|COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48341842|NCT00896532|101164139|FG015|COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48341843|NCT00896532|101164140|FG016|COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48341844|NCT00896532|101164141|FG017|COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48341845|NCT00896532|101164142|FG018|COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48341846|NCT00896532|101164143|FG019|COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48341847|NCT00896532|101164144|FG020|COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48341848|NCT00896532|101164145|FG021|COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48341849|NCT00896532|101164146|FG022|COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48341850|NCT00896532|101164124|FG000|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48341851|NCT00896532|101164125|FG001|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48341852|NCT00896532|101164126|FG002|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48341853|NCT00896532|101164127|FG003|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48633173|NCT03329885|101885423|FG001|COMPLETED|Overall Study||6||
48633174|NCT03329885|101885424|FG002|COMPLETED|Overall Study||6||
48633175|NCT03329885|101885425|FG003|COMPLETED|Overall Study||6||
48181170|NCT04019561|100765054|FG000|STARTED|Overall Study||25||
48181171|NCT04019561|100765055|FG001|STARTED|Overall Study||25||
48181172|NCT04019561|100765056|FG002|STARTED|Overall Study||24||
48341854|NCT00896532|101164128|FG004|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48633176|NCT03329885|101885426|FG004|COMPLETED|Overall Study||6||
48633177|NCT03329885|101885427|FG005|COMPLETED|Overall Study||3||
48633178|NCT03329885|101885428|FG006|COMPLETED|Overall Study||0||
48181173|NCT04019561|100765054|FG000|COMPLETED|Overall Study||21||
48181174|NCT04019561|100765055|FG001|COMPLETED|Overall Study||23||
48413737|NCT01738594|101345871|FG005|STARTED|Follow up for 1 Year||3|All patients that receive treatment on study go into the follow up period|
48413738|NCT01738594|101345872|FG006|STARTED|Follow up for 1 Year||0|All patients that receive treatment on study go into the follow up period|
48413739|NCT01738594|101345873|FG007|STARTED|Follow up for 1 Year||0|All patients that receive treatment on study go into the follow up period|
48413740|NCT01738594|101345866|FG000|COMPLETED|Follow up for 1 Year||0||
48413741|NCT01738594|101345867|FG001|COMPLETED|Follow up for 1 Year||2||
48755700|NCT01358877|102191148|FG001|Did Not Receive Study Drug|Overall Study||13||
48755701|NCT01358877|102191147|FG000|Received Study Drug (Safety Population)|Overall Study||2364||
48755702|NCT01358877|102191148|FG001|Received Study Drug (Safety Population)|Overall Study||2405||
48755703|NCT01358877|102191147|FG000|COMPLETED|Overall Study||0||
48755704|NCT01358877|102191148|FG001|COMPLETED|Overall Study||0||
48755705|NCT01358877|102191147|FG000|NOT COMPLETED|Overall Study||2400||
48755706|NCT01358877|102191148|FG001|NOT COMPLETED|Overall Study||2404||
48755707|NCT04516746|102191149|FG000|STARTED|Overall Study||21634||
48341855|NCT00896532|101164129|FG005|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48341856|NCT00896532|101164130|FG006|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48341857|NCT00896532|101164131|FG007|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48341858|NCT00896532|101164132|FG008|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||1||
48341859|NCT00896532|101164133|FG009|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48341860|NCT00896532|101164134|FG010|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2||
48341861|NCT00896532|101164135|FG011|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2||
48341862|NCT00896532|101164136|FG012|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||5||
48341863|NCT00896532|101164137|FG013|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2||
48341864|NCT00896532|101164138|FG014|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48755708|NCT04516746|102191150|FG001|STARTED|Overall Study||10816||
48755709|NCT04516746|102191149|FG000|Participants Who Received First Dose|Overall Study||21583||
48755710|NCT04516746|102191150|FG001|Participants Who Received First Dose|Overall Study||10797||
48755711|NCT04516746|102191149|FG000|Participants Who Received Second Dose|Overall Study||20770||
48755712|NCT04516746|102191150|FG001|Participants Who Received Second Dose|Overall Study||9954||
48755713|NCT04516746|102191149|FG000|COMPLETED|Overall Study||16099||
48755714|NCT04516746|102191150|FG001|COMPLETED|Overall Study||7213||
48755715|NCT04516746|102191149|FG000|NOT COMPLETED|Overall Study||5535||
48341865|NCT00896532|101164139|FG015|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48341866|NCT00896532|101164140|FG016|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48341867|NCT00896532|101164141|FG017|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48755716|NCT04516746|102191150|FG001|NOT COMPLETED|Overall Study||3603||
48755717|NCT00517296|102191151|FG000|STARTED|Overall Study||10||
48755718|NCT00517296|102191152|FG001|STARTED|Overall Study||11||
48755719|NCT00517296|102191151|FG000|COMPLETED|Overall Study||9||
48755720|NCT00517296|102191152|FG001|COMPLETED|Overall Study||11||
48341868|NCT00896532|101164142|FG018|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48341869|NCT00896532|101164143|FG019|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48341870|NCT00896532|101164144|FG020|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48341871|NCT00896532|101164145|FG021|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48341872|NCT00896532|101164146|FG022|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
48341873|NCT00896532|101164124|FG000|STARTED|Months 36-48: Romosozumab Retreatment||0||
48341874|NCT00896532|101164125|FG001|STARTED|Months 36-48: Romosozumab Retreatment||0||
48341875|NCT00896532|101164126|FG002|STARTED|Months 36-48: Romosozumab Retreatment||0||
48341876|NCT00896532|101164127|FG003|STARTED|Months 36-48: Romosozumab Retreatment||0||
48341877|NCT00896532|101164128|FG004|STARTED|Months 36-48: Romosozumab Retreatment||0||
48341878|NCT00896532|101164129|FG005|STARTED|Months 36-48: Romosozumab Retreatment||0||
48341879|NCT00896532|101164130|FG006|STARTED|Months 36-48: Romosozumab Retreatment||0||
48341880|NCT00896532|101164131|FG007|STARTED|Months 36-48: Romosozumab Retreatment||0||
48341881|NCT00896532|101164132|FG008|STARTED|Months 36-48: Romosozumab Retreatment||0||
48341882|NCT00896532|101164133|FG009|STARTED|Months 36-48: Romosozumab Retreatment||0||
48341883|NCT00896532|101164134|FG010|STARTED|Months 36-48: Romosozumab Retreatment||0||
48341884|NCT00896532|101164135|FG011|STARTED|Months 36-48: Romosozumab Retreatment||0||
48341885|NCT00896532|101164136|FG012|STARTED|Months 36-48: Romosozumab Retreatment||0||
48341886|NCT00896532|101164137|FG013|STARTED|Months 36-48: Romosozumab Retreatment||0||
48341887|NCT00896532|101164138|FG014|STARTED|Months 36-48: Romosozumab Retreatment||12||
48413742|NCT01738594|101345868|FG002|COMPLETED|Follow up for 1 Year||0||
48755721|NCT00517296|102191151|FG000|NOT COMPLETED|Overall Study||1||
48755722|NCT00517296|102191152|FG001|NOT COMPLETED|Overall Study||0||
48755723|NCT02714400|102191153|FG000|STARTED|First Intervention (1 Day)||12||
48755724|NCT02714400|102191154|FG001|STARTED|First Intervention (1 Day)||8||
48755725|NCT02714400|102191153|FG000|COMPLETED|First Intervention (1 Day)||12||
48755726|NCT02714400|102191154|FG001|COMPLETED|First Intervention (1 Day)||8||
48755727|NCT02714400|102191153|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48755728|NCT02714400|102191154|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48755729|NCT02714400|102191153|FG000|STARTED|Washout (>4 Days)||12||
48755730|NCT02714400|102191154|FG001|STARTED|Washout (>4 Days)||8||
48181175|NCT04019561|100765056|FG002|COMPLETED|Overall Study||19||
48181176|NCT04019561|100765054|FG000|NOT COMPLETED|Overall Study||4||
48181177|NCT04019561|100765055|FG001|NOT COMPLETED|Overall Study||2||
48181178|NCT04019561|100765056|FG002|NOT COMPLETED|Overall Study||5||
48181179|NCT03864133|100765057|FG000|STARTED|Overall Study||94||
48181180|NCT03864133|100765057|FG000|COMPLETED|Overall Study||94||
48181181|NCT03864133|100765057|FG000|NOT COMPLETED|Overall Study||0||
48181182|NCT04351750|100765058|FG000|STARTED|Overall Study||14||
48181183|NCT04351750|100765059|FG001|STARTED|Overall Study||15||
48181184|NCT04351750|100765060|FG002|STARTED|Overall Study||18||
48181185|NCT04351750|100765058|FG000|COMPLETED|Overall Study||12||
48181186|NCT04351750|100765059|FG001|COMPLETED|Overall Study||13||
48181187|NCT04351750|100765060|FG002|COMPLETED|Overall Study||13||
48181188|NCT04351750|100765058|FG000|NOT COMPLETED|Overall Study||2||
48181189|NCT04351750|100765059|FG001|NOT COMPLETED|Overall Study||2||
48181190|NCT04351750|100765060|FG002|NOT COMPLETED|Overall Study||5||
48181191|NCT03728153|100765061|FG000|STARTED|Overall Study||34||
48181192|NCT03728153|100765061|FG000|COMPLETED|Overall Study||32||
48181193|NCT03728153|100765061|FG000|NOT COMPLETED|Overall Study||2||
48181194|NCT00333788|100765062|FG000|STARTED|Overall Study||233||
48181195|NCT00333788|100765062|FG000|COMPLETED|Overall Study||71||
48181196|NCT00333788|100765062|FG000|NOT COMPLETED|Overall Study||162||
48181197|NCT04006366|100765063|FG000|STARTED|Overall Study||6||
48181198|NCT04006366|100765063|FG000|COMPLETED|Overall Study||5||
48181199|NCT04006366|100765063|FG000|NOT COMPLETED|Overall Study||1||
48181200|NCT03658811|100765064|FG000|STARTED|Overall Study||19||
48181201|NCT03658811|100765064|FG000|COMPLETED|Overall Study||16||
48181202|NCT03658811|100765064|FG000|NOT COMPLETED|Overall Study||3||
48181203|NCT01114620|100765065|FG000|STARTED|Overall Study||50||
48181204|NCT01114620|100765065|FG000|COMPLETED|Overall Study||50||
48181205|NCT01114620|100765065|FG000|NOT COMPLETED|Overall Study||0||
48181206|NCT04496414|100765066|FG000|STARTED|Overall Study||50||
48181207|NCT04496414|100765066|FG000|COMPLETED|Overall Study||50||
48181208|NCT04496414|100765066|FG000|NOT COMPLETED|Overall Study||0||
48181209|NCT01439711|100765067|FG000|STARTED|Overall Study||108||
48181210|NCT01439711|100765067|FG000|COMPLETED|Overall Study||68||
48181211|NCT01439711|100765067|FG000|NOT COMPLETED|Overall Study||40||
48181212|NCT01818700|100765068|FG000|STARTED|Overall Study||245||
48181213|NCT01818700|100765068|FG000|Safety Set|Overall Study||241||
48181214|NCT01818700|100765068|FG000|FAS Set|Overall Study||210||
48181215|NCT01818700|100765068|FG000|PP Set|Overall Study||105||
48181216|NCT01818700|100765068|FG000|COMPLETED|Overall Study||141||
48181217|NCT01818700|100765068|FG000|NOT COMPLETED|Overall Study||104||
48181218|NCT00109928|100765069|FG000|STARTED|Overall Study||34||
48181219|NCT00109928|100765069|FG000|Eligible|Overall Study||33||
48181220|NCT00109928|100765069|FG000|Eligible and Began Protocol Therapy|Overall Study||33||
48181221|NCT00109928|100765069|FG000|COMPLETED|Overall Study||21||
48181222|NCT00109928|100765069|FG000|NOT COMPLETED|Overall Study||13||
48181223|NCT00386308|100765070|FG000|STARTED|Overall Study||123||
48181224|NCT00386308|100765071|FG001|STARTED|Overall Study||73||
48181225|NCT00386308|100765070|FG000|Intent to Treat Population|Overall Study||117||
48181226|NCT00386308|100765071|FG001|Intent to Treat Population|Overall Study||72||
48181227|NCT00386308|100765070|FG000|Modified Intent to Treat Population|Overall Study||115||
48181228|NCT00386308|100765071|FG001|Modified Intent to Treat Population|Overall Study||72||
48181229|NCT00386308|100765070|FG000|COMPLETED|Overall Study||94||
48341888|NCT00896532|101164139|FG015|STARTED|Months 36-48: Romosozumab Retreatment||16||
48341889|NCT00896532|101164140|FG016|STARTED|Months 36-48: Romosozumab Retreatment||72||
48341890|NCT00896532|101164141|FG017|STARTED|Months 36-48: Romosozumab Retreatment||67||
48341891|NCT00896532|101164142|FG018|STARTED|Months 36-48: Romosozumab Retreatment||0||
48181230|NCT00386308|100765071|FG001|COMPLETED|Overall Study||54||
48181231|NCT00386308|100765070|FG000|NOT COMPLETED|Overall Study||29||
48181232|NCT00386308|100765071|FG001|NOT COMPLETED|Overall Study||19||
48181233|NCT02593032|100768018|FG000|STARTED|Overall Study||17||
48181234|NCT02593032|100768019|FG001|STARTED|Overall Study||33||
48181235|NCT02593032|100768018|FG000|COMPLETED|Overall Study||17||
48181236|NCT02593032|100768019|FG001|COMPLETED|Overall Study||33||
48181237|NCT02593032|100768018|FG000|NOT COMPLETED|Overall Study||0||
48181238|NCT02593032|100768019|FG001|NOT COMPLETED|Overall Study||0||
48341892|NCT00896532|101164143|FG019|STARTED|Months 36-48: Romosozumab Retreatment||0||
48181239|NCT00577720|100768020|FG000|STARTED|Overall Study||37||
48181240|NCT00577720|100768021|FG001|STARTED|Overall Study||36||
48181241|NCT00577720|100768022|FG002|STARTED|Overall Study||36||
48181242|NCT00577720|100768023|FG003|STARTED|Overall Study||72||
48181243|NCT00577720|100768020|FG000|ITT (Intent to Treat) Population|Overall Study||34||
48181244|NCT00577720|100768021|FG001|ITT (Intent to Treat) Population|Overall Study||35||
48181245|NCT00577720|100768022|FG002|ITT (Intent to Treat) Population|Overall Study||35||
48181246|NCT00577720|100768023|FG003|ITT (Intent to Treat) Population|Overall Study||65||
48181247|NCT00577720|100768020|FG000|COMPLETED|Overall Study||33||
48181248|NCT00577720|100768021|FG001|COMPLETED|Overall Study||35||
48181249|NCT00577720|100768022|FG002|COMPLETED|Overall Study||35||
48181250|NCT00577720|100768023|FG003|COMPLETED|Overall Study||65||
48341893|NCT00896532|101164144|FG020|STARTED|Months 36-48: Romosozumab Retreatment||0||
48181251|NCT00577720|100768020|FG000|NOT COMPLETED|Overall Study||4||
48341894|NCT00896532|101164145|FG021|STARTED|Months 36-48: Romosozumab Retreatment||0||
48341895|NCT00896532|101164146|FG022|STARTED|Months 36-48: Romosozumab Retreatment||0||
48341896|NCT00896532|101164124|FG000|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
48341897|NCT00896532|101164125|FG001|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
48341898|NCT00896532|101164126|FG002|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
48341899|NCT00896532|101164127|FG003|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
48341900|NCT00896532|101164128|FG004|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
48341901|NCT00896532|101164129|FG005|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
48341902|NCT00896532|101164130|FG006|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
48341903|NCT00896532|101164131|FG007|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
48341904|NCT00896532|101164132|FG008|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
48341905|NCT00896532|101164133|FG009|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
48341906|NCT00896532|101164134|FG010|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
48181252|NCT00577720|100768021|FG001|NOT COMPLETED|Overall Study||1||
48181253|NCT00577720|100768022|FG002|NOT COMPLETED|Overall Study||1||
48181254|NCT00577720|100768023|FG003|NOT COMPLETED|Overall Study||7||
48181255|NCT03658629|100768024|FG000|STARTED|Overall Study||158||
48181256|NCT03658629|100768025|FG001|STARTED|Overall Study||309||
48181257|NCT03658629|100768026|FG002|STARTED|Overall Study||155||
48181258|NCT03658629|100768027|FG003|STARTED|Overall Study||133||
48181259|NCT03658629|100768028|FG004|STARTED|Overall Study||313||
48181260|NCT03658629|100768029|FG005|STARTED|Overall Study||154||
48181261|NCT03658629|100768030|FG006|STARTED|Overall Study||153||
48181262|NCT03658629|100768024|FG000|Participants in Safety Population|Overall Study||157||
48181263|NCT03658629|100768025|FG001|Participants in Safety Population|Overall Study||305||
48181264|NCT03658629|100768026|FG002|Participants in Safety Population|Overall Study||156||
48341907|NCT00896532|101164135|FG011|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
48341908|NCT00896532|101164136|FG012|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
48341909|NCT00896532|101164137|FG013|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
48341910|NCT00896532|101164138|FG014|Received Romosozumab|Months 36-48: Romosozumab Retreatment||12||
48341911|NCT00896532|101164139|FG015|Received Romosozumab|Months 36-48: Romosozumab Retreatment||16||
48341912|NCT00896532|101164140|FG016|Received Romosozumab|Months 36-48: Romosozumab Retreatment||72||
48341913|NCT00896532|101164141|FG017|Received Romosozumab|Months 36-48: Romosozumab Retreatment||67||
48341914|NCT00896532|101164142|FG018|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
48341915|NCT00896532|101164143|FG019|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
48341916|NCT00896532|101164144|FG020|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
48341917|NCT00896532|101164145|FG021|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
48341918|NCT00896532|101164146|FG022|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
48341919|NCT00896532|101164124|FG000|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48341920|NCT00896532|101164125|FG001|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48341921|NCT00896532|101164126|FG002|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48341922|NCT00896532|101164127|FG003|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48341923|NCT00896532|101164128|FG004|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48341924|NCT00896532|101164129|FG005|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48341925|NCT00896532|101164130|FG006|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48341926|NCT00896532|101164131|FG007|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48341927|NCT00896532|101164132|FG008|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48181265|NCT03658629|100768027|FG003|Participants in Safety Population|Overall Study||132||
48181266|NCT03658629|100768028|FG004|Participants in Safety Population|Overall Study||311||
48181267|NCT03658629|100768029|FG005|Participants in Safety Population|Overall Study||153||
48181268|NCT03658629|100768030|FG006|Participants in Safety Population|Overall Study||151||
48181269|NCT03658629|100768024|FG000|COMPLETED|Overall Study||151||
48181270|NCT03658629|100768025|FG001|COMPLETED|Overall Study||296||
48181271|NCT03658629|100768026|FG002|COMPLETED|Overall Study||149||
48181272|NCT03658629|100768027|FG003|COMPLETED|Overall Study||125||
48181273|NCT03658629|100768028|FG004|COMPLETED|Overall Study||303||
48181274|NCT03658629|100768029|FG005|COMPLETED|Overall Study||151||
48181275|NCT03658629|100768030|FG006|COMPLETED|Overall Study||148||
48181276|NCT03658629|100768024|FG000|NOT COMPLETED|Overall Study||7||
48181277|NCT03658629|100768025|FG001|NOT COMPLETED|Overall Study||13||
48181278|NCT03658629|100768026|FG002|NOT COMPLETED|Overall Study||6||
48181279|NCT03658629|100768027|FG003|NOT COMPLETED|Overall Study||8||
48181280|NCT03658629|100768028|FG004|NOT COMPLETED|Overall Study||10||
48181281|NCT03658629|100768029|FG005|NOT COMPLETED|Overall Study||3||
48181282|NCT03658629|100768030|FG006|NOT COMPLETED|Overall Study||5||
48181283|NCT01804673|100768031|FG000|STARTED|Overall Study||174||
48181284|NCT01804673|100768031|FG000|Completed Hour 24|Overall Study||170||
48181285|NCT01804673|100768031|FG000|Completed Hour 48|Overall Study||79||
48181286|NCT01804673|100768031|FG000|Completed Hour 72|Overall Study||36||
48181287|NCT01804673|100768031|FG000|COMPLETED|Overall Study||34||
48341928|NCT00896532|101164133|FG009|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48341929|NCT00896532|101164134|FG010|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48181288|NCT01804673|100768031|FG000|NOT COMPLETED|Overall Study||140||
48181289|NCT03413605|100768032|FG000|STARTED|Overall Study Baseline||392||
48181290|NCT03413605|100768033|FG001|STARTED|Overall Study Baseline||409||
48181291|NCT03413605|100768032|FG000|COMPLETED|Overall Study Baseline||392||
48181292|NCT03413605|100768033|FG001|COMPLETED|Overall Study Baseline||409||
48181293|NCT03413605|100768032|FG000|NOT COMPLETED|Overall Study Baseline||0||
48181294|NCT03413605|100768033|FG001|NOT COMPLETED|Overall Study Baseline||0||
48181295|NCT03413605|100768032|FG000|STARTED|Post Intervention Assessment||392||
48181296|NCT03413605|100768033|FG001|STARTED|Post Intervention Assessment||409||
48181297|NCT03413605|100768032|FG000|COMPLETED|Post Intervention Assessment||392||
48181298|NCT03413605|100768033|FG001|COMPLETED|Post Intervention Assessment||409||
48181299|NCT03413605|100768032|FG000|NOT COMPLETED|Post Intervention Assessment||0||
48181300|NCT03413605|100768033|FG001|NOT COMPLETED|Post Intervention Assessment||0||
48181301|NCT03413605|100768032|FG000|STARTED|12-m Follow up||392||
48181302|NCT03413605|100768033|FG001|STARTED|12-m Follow up||409||
48181303|NCT03413605|100768032|FG000|COMPLETED|12-m Follow up||364||
48181304|NCT03413605|100768033|FG001|COMPLETED|12-m Follow up||382||
48181305|NCT03413605|100768032|FG000|NOT COMPLETED|12-m Follow up||28||
48181306|NCT03413605|100768033|FG001|NOT COMPLETED|12-m Follow up||27||
48181307|NCT04223154|100768034|FG000|STARTED|Overall Study||8||
48181308|NCT04223154|100768035|FG001|STARTED|Overall Study||3||
48181309|NCT04223154|100768034|FG000|COMPLETED|Overall Study||8||
48181310|NCT04223154|100768035|FG001|COMPLETED|Overall Study||3||
48413743|NCT01738594|101345869|FG003|COMPLETED|Follow up for 1 Year||0||
48633179|NCT03329885|101885429|FG007|COMPLETED|Overall Study||0||
48633180|NCT03329885|101885430|FG008|COMPLETED|Overall Study||0||
48633181|NCT03329885|101885422|FG000|NOT COMPLETED|Overall Study||0||
48633182|NCT03329885|101885423|FG001|NOT COMPLETED|Overall Study||0||
48633183|NCT03329885|101885424|FG002|NOT COMPLETED|Overall Study||0||
48633184|NCT03329885|101885425|FG003|NOT COMPLETED|Overall Study||0||
48633185|NCT03329885|101885426|FG004|NOT COMPLETED|Overall Study||0||
48633186|NCT03329885|101885427|FG005|NOT COMPLETED|Overall Study||0||
48633187|NCT03329885|101885428|FG006|NOT COMPLETED|Overall Study||1||
48633188|NCT03329885|101885429|FG007|NOT COMPLETED|Overall Study||1||
48633189|NCT03329885|101885430|FG008|NOT COMPLETED|Overall Study||0||
48633190|NCT02497469|101885431|FG000|STARTED|Overall Study||386||
48633191|NCT02497469|101885432|FG001|STARTED|Overall Study||385||
48633192|NCT02497469|101885431|FG000|Safety Analysis Set|Overall Study||386|Participants who received at least one dose of study drug.|
48633193|NCT02497469|101885432|FG001|Safety Analysis Set|Overall Study||383|Participants who received at least one dose of study drug.|
48633194|NCT02497469|101885431|FG000|COMPLETED|Overall Study||217||
48633195|NCT02497469|101885432|FG001|COMPLETED|Overall Study||270||
48633196|NCT02497469|101885431|FG000|NOT COMPLETED|Overall Study||169||
48633197|NCT02497469|101885432|FG001|NOT COMPLETED|Overall Study||115||
48633198|NCT01516216|101885433|FG000|STARTED|Overall Study||70||
48633199|NCT01516216|101885434|FG001|STARTED|Overall Study||69||
48633200|NCT01516216|101885433|FG000|AE Evaluable|Overall Study||67|Participants who started treatment were evaluable for AEs however all participants were followed for death (all-cause mortality).|
48633201|NCT01516216|101885434|FG001|AE Evaluable|Overall Study||68|Participants who started treatment were evaluable for AEs however all participants were followed for death (all-cause mortality).|
48633202|NCT01516216|101885433|FG000|Response Evaluable|Overall Study||62|Participants who started treatment were evaluable for response if underwent \>/=1 restaging scan.|
48633203|NCT01516216|101885434|FG001|Response Evaluable|Overall Study||66|Participants who started treatment were evaluable for response if underwent \>/=1 restaging scan.|
48633204|NCT01516216|101885433|FG000|COMPLETED|Overall Study||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason discontinued treatment provided.|
48633205|NCT01516216|101885434|FG001|COMPLETED|Overall Study||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason discontinued treatment provided.|
48633206|NCT01516216|101885433|FG000|NOT COMPLETED|Overall Study||70||
48633207|NCT01516216|101885434|FG001|NOT COMPLETED|Overall Study||69||
48633208|NCT01477567|101885435|FG000|STARTED|Overall Study||5||
48633209|NCT01477567|101885436|FG001|STARTED|Overall Study||6||
48413744|NCT01738594|101345870|FG004|COMPLETED|Follow up for 1 Year||1||
48413745|NCT01738594|101345871|FG005|COMPLETED|Follow up for 1 Year||0||
48413746|NCT01738594|101345872|FG006|COMPLETED|Follow up for 1 Year||0||
48413747|NCT01738594|101345873|FG007|COMPLETED|Follow up for 1 Year||0||
48181311|NCT04223154|100768034|FG000|NOT COMPLETED|Overall Study||0||
48181312|NCT04223154|100768035|FG001|NOT COMPLETED|Overall Study||0||
48181313|NCT02308501|100768036|FG000|STARTED|Overall Study||25||25
48181314|NCT02308501|100768037|FG001|STARTED|Overall Study||25||25
48181315|NCT02308501|100768036|FG000|Randomized Participant Eyes|Overall Study||25||25
48181316|NCT02308501|100768037|FG001|Randomized Participant Eyes|Overall Study||25||25
48181317|NCT02308501|100768036|FG000|COMPLETED|Overall Study||25||25
48181318|NCT02308501|100768037|FG001|COMPLETED|Overall Study||25||25
48181319|NCT02308501|100768036|FG000|NOT COMPLETED|Overall Study||0||0
48181320|NCT02308501|100768037|FG001|NOT COMPLETED|Overall Study||0||0
48181321|NCT01167179|100768038|FG000|STARTED|Overall Study||80||
48181322|NCT01167179|100768039|FG001|STARTED|Overall Study||80||
48181323|NCT01167179|100768038|FG000|COMPLETED|Overall Study||65||
48413748|NCT01738594|101345866|FG000|NOT COMPLETED|Follow up for 1 Year||0||
48413749|NCT01738594|101345867|FG001|NOT COMPLETED|Follow up for 1 Year||0||
48413750|NCT01738594|101345868|FG002|NOT COMPLETED|Follow up for 1 Year||0||
48413751|NCT01738594|101345869|FG003|NOT COMPLETED|Follow up for 1 Year||0||
48413752|NCT01738594|101345870|FG004|NOT COMPLETED|Follow up for 1 Year||0||
48755731|NCT02714400|102191153|FG000|COMPLETED|Washout (>4 Days)||12||
48181324|NCT01167179|100768039|FG001|COMPLETED|Overall Study||59||
48181325|NCT01167179|100768038|FG000|NOT COMPLETED|Overall Study||15||
48181326|NCT01167179|100768039|FG001|NOT COMPLETED|Overall Study||21||
48413753|NCT01738594|101345871|FG005|NOT COMPLETED|Follow up for 1 Year||3||
48413754|NCT01738594|101345872|FG006|NOT COMPLETED|Follow up for 1 Year||0||
48413755|NCT01738594|101345873|FG007|NOT COMPLETED|Follow up for 1 Year||0||
48755732|NCT02714400|102191154|FG001|COMPLETED|Washout (>4 Days)||8||
48755733|NCT02714400|102191153|FG000|NOT COMPLETED|Washout (>4 Days)||0||
48755734|NCT02714400|102191154|FG001|NOT COMPLETED|Washout (>4 Days)||0||
48341930|NCT00896532|101164135|FG011|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48341931|NCT00896532|101164136|FG012|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48341932|NCT00896532|101164137|FG013|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48341933|NCT00896532|101164138|FG014|COMPLETED|Months 36-48: Romosozumab Retreatment||12||
48341934|NCT00896532|101164139|FG015|COMPLETED|Months 36-48: Romosozumab Retreatment||14||
48341935|NCT00896532|101164140|FG016|COMPLETED|Months 36-48: Romosozumab Retreatment||65||
48341936|NCT00896532|101164141|FG017|COMPLETED|Months 36-48: Romosozumab Retreatment||64||
48341937|NCT00896532|101164142|FG018|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48341938|NCT00896532|101164143|FG019|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48341939|NCT00896532|101164144|FG020|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48341940|NCT00896532|101164145|FG021|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48341941|NCT00896532|101164146|FG022|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48755735|NCT02714400|102191153|FG000|STARTED|Second Intervention (1 Day)||12||
48755736|NCT02714400|102191154|FG001|STARTED|Second Intervention (1 Day)||8||
48755737|NCT02714400|102191153|FG000|COMPLETED|Second Intervention (1 Day)||12||
48755738|NCT02714400|102191154|FG001|COMPLETED|Second Intervention (1 Day)||8||
48755739|NCT02714400|102191153|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48755740|NCT02714400|102191154|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48755741|NCT01045967|102191155|FG000|STARTED|First Intervention||28||
48181327|NCT04230980|100768040|FG000|STARTED|Overall Study||36||
48181328|NCT04230980|100768041|FG001|STARTED|Overall Study||38||
48181329|NCT04230980|100768040|FG000|COMPLETED|Overall Study||35||
48181330|NCT04230980|100768041|FG001|COMPLETED|Overall Study||35||
48181331|NCT04230980|100768040|FG000|NOT COMPLETED|Overall Study||1||
48181332|NCT04230980|100768041|FG001|NOT COMPLETED|Overall Study||3||
48181333|NCT01330043|100768042|FG000|STARTED|Overall Study||111||
48341942|NCT00896532|101164124|FG000|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48413756|NCT03245840|101345874|FG000|STARTED|Overall Study||122||
48413757|NCT03245840|101345875|FG001|STARTED|Overall Study||11||
48413758|NCT03245840|101345874|FG000|Treated|Overall Study||121||
48413759|NCT03245840|101345875|FG001|Treated|Overall Study||10||
48413760|NCT03245840|101345874|FG000|COMPLETED|Overall Study||0||
48413761|NCT03245840|101345875|FG001|COMPLETED|Overall Study||0||
48413762|NCT03245840|101345874|FG000|NOT COMPLETED|Overall Study||122||
48413763|NCT03245840|101345875|FG001|NOT COMPLETED|Overall Study||11||
48413764|NCT00338806|101345876|FG000|STARTED|Acute Phase||2||
48413765|NCT00338806|101345877|FG001|STARTED|Acute Phase||5||
48413766|NCT00338806|101345876|FG000|COMPLETED|Acute Phase||2||
48413767|NCT00338806|101345877|FG001|COMPLETED|Acute Phase||4||
48755742|NCT01045967|102191156|FG001|STARTED|First Intervention||28||
48755743|NCT01045967|102191155|FG000|COMPLETED|First Intervention||28||
48755744|NCT01045967|102191156|FG001|COMPLETED|First Intervention||28||
48755745|NCT01045967|102191155|FG000|NOT COMPLETED|First Intervention||0||
48755746|NCT01045967|102191156|FG001|NOT COMPLETED|First Intervention||0||
48755747|NCT01045967|102191155|FG000|STARTED|Washout of 7 Days||28||
48755748|NCT01045967|102191156|FG001|STARTED|Washout of 7 Days||28||
48755749|NCT01045967|102191155|FG000|COMPLETED|Washout of 7 Days||28||
48755750|NCT01045967|102191156|FG001|COMPLETED|Washout of 7 Days||28||
48755751|NCT01045967|102191155|FG000|NOT COMPLETED|Washout of 7 Days||0||
48755752|NCT01045967|102191156|FG001|NOT COMPLETED|Washout of 7 Days||0||
48755753|NCT01045967|102191155|FG000|STARTED|Second Intervention||28||
48755754|NCT01045967|102191156|FG001|STARTED|Second Intervention||28||
48181334|NCT01330043|100768043|FG001|STARTED|Overall Study||112||
48181335|NCT01330043|100768042|FG000|COMPLETED|Overall Study||111||
48181336|NCT01330043|100768043|FG001|COMPLETED|Overall Study||108||
48181337|NCT01330043|100768042|FG000|NOT COMPLETED|Overall Study||0||
48181338|NCT01330043|100768043|FG001|NOT COMPLETED|Overall Study||4||
48181339|NCT00299689|100768044|FG000|STARTED|Overall Study||69||
48181340|NCT00299689|100768044|FG000|COMPLETED|Overall Study||69||
48181341|NCT00299689|100768044|FG000|NOT COMPLETED|Overall Study||0||
48181342|NCT02524054|100768045|FG000|STARTED|Overall Study||7||
48181343|NCT02524054|100768046|FG001|STARTED|Overall Study||9||
48181344|NCT02524054|100768047|FG002|STARTED|Overall Study||8||
48413768|NCT00338806|101345876|FG000|NOT COMPLETED|Acute Phase||0||
48413769|NCT00338806|101345877|FG001|NOT COMPLETED|Acute Phase||1||
48413770|NCT00338806|101345876|FG000|STARTED|Follow-up||2||
48633210|NCT01477567|101885437|FG002|STARTED|Overall Study||6||
48633211|NCT01477567|101885438|FG003|STARTED|Overall Study||6||
48633212|NCT01477567|101885439|FG004|STARTED|Overall Study||6||
48633213|NCT01477567|101885440|FG005|STARTED|Overall Study||5||
48633214|NCT01477567|101885441|FG006|STARTED|Overall Study||6||
48633215|NCT01477567|101885435|FG000|Received at Least 1 Dose of Study Drug|Overall Study||5||
48633216|NCT01477567|101885436|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
48633217|NCT01477567|101885437|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
48633218|NCT01477567|101885438|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6||
48633219|NCT01477567|101885439|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6||
48633220|NCT01477567|101885440|FG005|Received at Least 1 Dose of Study Drug|Overall Study||5||
48633221|NCT01477567|101885441|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6||
48633222|NCT01477567|101885435|FG000|COMPLETED|Overall Study||5||
48633223|NCT01477567|101885436|FG001|COMPLETED|Overall Study||6||
48633224|NCT01477567|101885437|FG002|COMPLETED|Overall Study||6||
48633225|NCT01477567|101885438|FG003|COMPLETED|Overall Study||6||
48755755|NCT01045967|102191155|FG000|COMPLETED|Second Intervention||28||
48755756|NCT01045967|102191156|FG001|COMPLETED|Second Intervention||27||
48755757|NCT01045967|102191155|FG000|NOT COMPLETED|Second Intervention||0||
48755758|NCT01045967|102191156|FG001|NOT COMPLETED|Second Intervention||1||
48181345|NCT02524054|100768045|FG000|COMPLETED|Overall Study||7||
48181346|NCT02524054|100768046|FG001|COMPLETED|Overall Study||9||
48181347|NCT02524054|100768047|FG002|COMPLETED|Overall Study||8||
48181348|NCT02524054|100768045|FG000|NOT COMPLETED|Overall Study||0||
48181349|NCT02524054|100768046|FG001|NOT COMPLETED|Overall Study||0||
48181350|NCT02524054|100768047|FG002|NOT COMPLETED|Overall Study||0||
48181351|NCT04004208|100768048|FG000|STARTED|Overall Study||75|All randomized participants who received any study treatment and had a baseline and at least one post-baseline assessment of efficacy (FAS)|
48181352|NCT04004208|100768049|FG001|STARTED|Overall Study||38|All randomized participants who received any study treatment and had a baseline and at least one post-baseline assessment of efficacy (FAS)|
48181353|NCT04004208|100768048|FG000|SAF|Overall Study||75|The safety analysis set (SAF) included all participants who received any type of study treatment.|
48181354|NCT04004208|100768049|FG001|SAF|Overall Study||38|The safety analysis set (SAF) included all participants who received any type of study treatment.|
48181355|NCT04004208|100768048|FG000|PKS|Overall Study||75|The pharmacokinetic analysis set (PKS) included all participants who received aflibercept treatment at the baseline visit and who had at least one nonmissing PK assessment following the first dose of study drug.|
48181356|NCT04004208|100768049|FG001|PKS|Overall Study||0|The pharmacokinetic analysis set (PKS) included all participants who received aflibercept treatment at the baseline visit and who had at least one nonmissing PK assessment following the first dose of study drug.|
48181357|NCT04004208|100768048|FG000|AAS|Overall Study||75|The anti-drug antibody (ADA) analysis set (AAS) included all participants who received aflibercept at baseline and had at least 1 nonmissing result in the ADA assay following the first study dose.|
48181358|NCT04004208|100768049|FG001|AAS|Overall Study||0|The anti-drug antibody (ADA) analysis set (AAS) included all participants who received aflibercept at baseline and had at least 1 nonmissing result in the ADA assay following the first study dose.|
48181359|NCT04004208|100768048|FG000|COMPLETED|Overall Study||68||
48633226|NCT01477567|101885439|FG004|COMPLETED|Overall Study||6||
48633227|NCT01477567|101885440|FG005|COMPLETED|Overall Study||5||
48633228|NCT01477567|101885441|FG006|COMPLETED|Overall Study||6||
48633229|NCT01477567|101885435|FG000|NOT COMPLETED|Overall Study||0||
48633230|NCT01477567|101885436|FG001|NOT COMPLETED|Overall Study||0||
48633231|NCT01477567|101885437|FG002|NOT COMPLETED|Overall Study||0||
48633232|NCT01477567|101885438|FG003|NOT COMPLETED|Overall Study||0||
48633233|NCT01477567|101885439|FG004|NOT COMPLETED|Overall Study||0||
48633234|NCT01477567|101885440|FG005|NOT COMPLETED|Overall Study||0||
48633235|NCT01477567|101885441|FG006|NOT COMPLETED|Overall Study||0||
48755759|NCT01089504|102191157|FG000|STARTED|Overall Study||8||
48755760|NCT01089504|102191158|FG001|STARTED|Overall Study||5||
48755761|NCT01089504|102191157|FG000|COMPLETED|Overall Study||5||
48755762|NCT01089504|102191158|FG001|COMPLETED|Overall Study||4||
48755763|NCT01089504|102191157|FG000|NOT COMPLETED|Overall Study||3||
48755764|NCT01089504|102191158|FG001|NOT COMPLETED|Overall Study||1||
48755765|NCT00979901|102191159|FG000|STARTED|Overall Study||352||
48181360|NCT04004208|100768049|FG001|COMPLETED|Overall Study||36||
48181361|NCT04004208|100768048|FG000|NOT COMPLETED|Overall Study||7||
48181362|NCT04004208|100768049|FG001|NOT COMPLETED|Overall Study||2||
48181363|NCT04668989|100768050|FG000|STARTED|First Intervention||36||
48181364|NCT04668989|100768051|FG001|STARTED|First Intervention||30||
48181365|NCT04668989|100768050|FG000|COMPLETED|First Intervention||36||
48181366|NCT04668989|100768051|FG001|COMPLETED|First Intervention||29||
48181367|NCT04668989|100768050|FG000|NOT COMPLETED|First Intervention||0||
48181368|NCT04668989|100768051|FG001|NOT COMPLETED|First Intervention||1||
48181369|NCT04668989|100768050|FG000|STARTED|Second Intervention||36||
48181370|NCT04668989|100768051|FG001|STARTED|Second Intervention||29||
48181371|NCT04668989|100768050|FG000|COMPLETED|Second Intervention||36||
48181372|NCT04668989|100768051|FG001|COMPLETED|Second Intervention||28||
48181373|NCT04668989|100768050|FG000|NOT COMPLETED|Second Intervention||0||
48181374|NCT04668989|100768051|FG001|NOT COMPLETED|Second Intervention||1||
48181375|NCT01868789|100768052|FG000|STARTED|Overall Study||9||
48755766|NCT00979901|102191160|FG001|STARTED|Overall Study||348||
48181376|NCT01868789|100768053|FG001|STARTED|Overall Study||14||
48181377|NCT01868789|100768052|FG000|COMPLETED|Overall Study||7||
48181378|NCT01868789|100768053|FG001|COMPLETED|Overall Study||12||
48181379|NCT01868789|100768052|FG000|NOT COMPLETED|Overall Study||2||
48181380|NCT01868789|100768053|FG001|NOT COMPLETED|Overall Study||2||
48181381|NCT02080520|100768054|FG000|STARTED|Overall Study||132||
48181382|NCT02080520|100768055|FG001|STARTED|Overall Study||133||
48181383|NCT02080520|100768054|FG000|COMPLETED|Overall Study||118||
48181384|NCT02080520|100768055|FG001|COMPLETED|Overall Study||116||
48755767|NCT00979901|102191161|FG002|STARTED|Overall Study||602||
48755768|NCT00979901|102191162|FG003|STARTED|Overall Study||275||
48755769|NCT00979901|102191159|FG000|COMPLETED|Overall Study||334||
48755770|NCT00979901|102191160|FG001|COMPLETED|Overall Study||336||
48755771|NCT00979901|102191161|FG002|COMPLETED|Overall Study||573||
48181385|NCT02080520|100768054|FG000|NOT COMPLETED|Overall Study||14||
48181386|NCT02080520|100768055|FG001|NOT COMPLETED|Overall Study||17||
48181387|NCT04640571|100768056|FG000|STARTED|Overall Study||2||
48181388|NCT04640571|100768057|FG001|STARTED|Overall Study||2||
48181389|NCT04640571|100768058|FG002|STARTED|Overall Study||2||
48181390|NCT04640571|100768059|FG003|STARTED|Overall Study||2||
48181391|NCT04640571|100768060|FG004|STARTED|Overall Study||2||
48181392|NCT04640571|100768061|FG005|STARTED|Overall Study||4||
48181393|NCT04640571|100768056|FG000|COMPLETED|Overall Study||2||
48181394|NCT04640571|100768057|FG001|COMPLETED|Overall Study||2||
48181395|NCT04640571|100768058|FG002|COMPLETED|Overall Study||2||
48181396|NCT04640571|100768059|FG003|COMPLETED|Overall Study||2||
48181397|NCT04640571|100768060|FG004|COMPLETED|Overall Study||2||
48181398|NCT04640571|100768061|FG005|COMPLETED|Overall Study||2||
48181399|NCT04640571|100768056|FG000|NOT COMPLETED|Overall Study||0||
48181400|NCT04640571|100768057|FG001|NOT COMPLETED|Overall Study||0||
48181401|NCT04640571|100768058|FG002|NOT COMPLETED|Overall Study||0||
48181402|NCT04640571|100768059|FG003|NOT COMPLETED|Overall Study||0||
48181403|NCT04640571|100768060|FG004|NOT COMPLETED|Overall Study||0||
48181404|NCT04640571|100768061|FG005|NOT COMPLETED|Overall Study||2||
48633236|NCT00723827|101885442|FG000|STARTED|Overall Study||682||
48633237|NCT00723827|101885442|FG000|COMPLETED|Overall Study||682||
48633238|NCT00723827|101885442|FG000|NOT COMPLETED|Overall Study||0||
48633239|NCT01038765|101885443|FG000|STARTED|Overall Study||111||
48633240|NCT01038765|101885444|FG001|STARTED|Overall Study||108||
48633241|NCT01038765|101885443|FG000|COMPLETED|Overall Study||102||
48755772|NCT00979901|102191162|FG003|COMPLETED|Overall Study||159||
48755773|NCT00979901|102191159|FG000|NOT COMPLETED|Overall Study||18||
48755774|NCT00979901|102191160|FG001|NOT COMPLETED|Overall Study||12||
48755775|NCT00979901|102191161|FG002|NOT COMPLETED|Overall Study||29||
48755776|NCT00979901|102191162|FG003|NOT COMPLETED|Overall Study||116||
48755777|NCT00322777|102191163|FG000|STARTED|Overall Study||39||
48755778|NCT00322777|102191164|FG001|STARTED|Overall Study||45||
48755779|NCT00322777|102191163|FG000|"Data Collection at BASELINE|"|Overall Study||39||
48755780|NCT00322777|102191164|FG001|"Data Collection at BASELINE|"|Overall Study||45||
48755781|NCT00322777|102191163|FG000|Data Collection at Week 8|Overall Study||39||
48755782|NCT00322777|102191164|FG001|Data Collection at Week 8|Overall Study||45||
48181405|NCT03824938|100768062|FG000|STARTED|Overall Study||7||
48181406|NCT03824938|100768063|FG001|STARTED|Overall Study||8||
48181407|NCT03824938|100768064|FG002|STARTED|Overall Study||7||
48181408|NCT03824938|100768065|FG003|STARTED|Overall Study||5||
48181409|NCT03824938|100768066|FG004|STARTED|Overall Study||7||
48181410|NCT03824938|100768067|FG005|STARTED|Overall Study||3||
48181411|NCT03824938|100768062|FG000|COMPLETED|Overall Study||5||
48181412|NCT03824938|100768063|FG001|COMPLETED|Overall Study||6||
48181413|NCT03824938|100768064|FG002|COMPLETED|Overall Study||7||
48181414|NCT03824938|100768065|FG003|COMPLETED|Overall Study||3||
48181415|NCT03824938|100768066|FG004|COMPLETED|Overall Study||6||
48181416|NCT03824938|100768067|FG005|COMPLETED|Overall Study||2||
48181417|NCT03824938|100768062|FG000|NOT COMPLETED|Overall Study||2||
48181418|NCT03824938|100768063|FG001|NOT COMPLETED|Overall Study||2||
48181419|NCT03824938|100768064|FG002|NOT COMPLETED|Overall Study||0||
48181420|NCT03824938|100768065|FG003|NOT COMPLETED|Overall Study||2||
48181421|NCT03824938|100768066|FG004|NOT COMPLETED|Overall Study||1||
48181422|NCT03824938|100768067|FG005|NOT COMPLETED|Overall Study||1||
48181423|NCT05244187|100768068|FG000|STARTED|Overall Study||59||
48181424|NCT05244187|100768069|FG001|STARTED|Overall Study||61||
48181425|NCT05244187|100768068|FG000|COMPLETED|Overall Study||48||
48181426|NCT05244187|100768069|FG001|COMPLETED|Overall Study||43||
48181427|NCT05244187|100768068|FG000|NOT COMPLETED|Overall Study||11||
48181428|NCT05244187|100768069|FG001|NOT COMPLETED|Overall Study||18||
48181429|NCT00972543|100768070|FG000|STARTED|Overall Study||5||
48181430|NCT00972543|100768071|FG001|STARTED|Overall Study||1||
48181431|NCT00972543|100768070|FG000|COMPLETED|Overall Study||0||
48181432|NCT00972543|100768071|FG001|COMPLETED|Overall Study||0||
48633242|NCT01038765|101885444|FG001|COMPLETED|Overall Study||103||
48633243|NCT01038765|101885443|FG000|NOT COMPLETED|Overall Study||9||
48181433|NCT00972543|100768070|FG000|NOT COMPLETED|Overall Study||5||
48181434|NCT00972543|100768071|FG001|NOT COMPLETED|Overall Study||1||
48755783|NCT00322777|102191163|FG000|Data Collection at Week 16|Overall Study||39||
48181435|NCT03323151|100768072|FG000|STARTED|Overall Study||3||
48181436|NCT03323151|100768073|FG001|STARTED|Overall Study||9||
48181437|NCT03323151|100768074|FG002|STARTED|Overall Study||4||
48181438|NCT03323151|100768075|FG003|STARTED|Overall Study||27||
48181439|NCT03323151|100768072|FG000|COMPLETED|Overall Study||3||
48181440|NCT03323151|100768073|FG001|COMPLETED|Overall Study||9||
48181441|NCT03323151|100768074|FG002|COMPLETED|Overall Study||4||
48181442|NCT03323151|100768075|FG003|COMPLETED|Overall Study||27||
48181443|NCT03323151|100768072|FG000|NOT COMPLETED|Overall Study||0||
48181444|NCT03323151|100768073|FG001|NOT COMPLETED|Overall Study||0||
48181445|NCT03323151|100768074|FG002|NOT COMPLETED|Overall Study||0||
48181446|NCT03323151|100768075|FG003|NOT COMPLETED|Overall Study||0||
48181447|NCT00896454|100768076|FG000|STARTED|Overall Study||33||
48755784|NCT00322777|102191164|FG001|Data Collection at Week 16|Overall Study||45||
48755785|NCT00322777|102191163|FG000|Data Collection at Week 24|Overall Study||39||
48755786|NCT00322777|102191164|FG001|Data Collection at Week 24|Overall Study||45||
48755787|NCT00322777|102191163|FG000|COMPLETED|Overall Study||39||
48755788|NCT00322777|102191164|FG001|COMPLETED|Overall Study||45||
48755789|NCT00322777|102191163|FG000|NOT COMPLETED|Overall Study||0||
48181448|NCT00896454|100768076|FG000|COMPLETED|Overall Study||0||
48181449|NCT00896454|100768076|FG000|NOT COMPLETED|Overall Study||33||
48181450|NCT01196104|100768077|FG000|STARTED|Overall Study||19||
48181451|NCT01196104|100768078|FG001|STARTED|Overall Study||20||
48181452|NCT01196104|100768077|FG000|COMPLETED|Overall Study||15||
48181453|NCT01196104|100768078|FG001|COMPLETED|Overall Study||15||
48181454|NCT01196104|100768077|FG000|NOT COMPLETED|Overall Study||4||
48181455|NCT01196104|100768078|FG001|NOT COMPLETED|Overall Study||5||
48181456|NCT01521949|100768079|FG000|STARTED|Overall Study||21||
48181457|NCT01521949|100768079|FG000|COMPLETED|Overall Study||21||
48181458|NCT01521949|100768079|FG000|NOT COMPLETED|Overall Study||0||
48181459|NCT01513967|100768080|FG000|STARTED|Overall Study||4||
48181460|NCT01513967|100768081|FG001|STARTED|Overall Study||4||
48181461|NCT01513967|100768082|FG002|STARTED|Overall Study||4||
48181462|NCT01513967|100768083|FG003|STARTED|Overall Study||6||
48181463|NCT01513967|100768084|FG004|STARTED|Overall Study||4||
48181464|NCT01513967|100768085|FG005|STARTED|Overall Study||4||
48181465|NCT01513967|100768086|FG006|STARTED|Overall Study||5||
48755790|NCT00322777|102191164|FG001|NOT COMPLETED|Overall Study||0||
48181466|NCT01513967|100768087|FG007|STARTED|Overall Study||8||
48181467|NCT01513967|100768080|FG000|COMPLETED|Overall Study||4||
48181468|NCT01513967|100768081|FG001|COMPLETED|Overall Study||4||
48181469|NCT01513967|100768082|FG002|COMPLETED|Overall Study||4||
48181470|NCT01513967|100768083|FG003|COMPLETED|Overall Study||6||
48181471|NCT01513967|100768084|FG004|COMPLETED|Overall Study||4||
48181472|NCT01513967|100768085|FG005|COMPLETED|Overall Study||3||
48181473|NCT01513967|100768086|FG006|COMPLETED|Overall Study||3||
48181474|NCT01513967|100768087|FG007|COMPLETED|Overall Study||6||
48181475|NCT01513967|100768080|FG000|NOT COMPLETED|Overall Study||0||
48181476|NCT01513967|100768081|FG001|NOT COMPLETED|Overall Study||0||
48181477|NCT01513967|100768082|FG002|NOT COMPLETED|Overall Study||0||
48181478|NCT01513967|100768083|FG003|NOT COMPLETED|Overall Study||0||
48181479|NCT01513967|100768084|FG004|NOT COMPLETED|Overall Study||0||
48181480|NCT01513967|100768085|FG005|NOT COMPLETED|Overall Study||1||
48181481|NCT01513967|100768086|FG006|NOT COMPLETED|Overall Study||2||
48181482|NCT01513967|100768087|FG007|NOT COMPLETED|Overall Study||2||
48181483|NCT04033991|100768088|FG000|STARTED|Overall Study||684||
48755791|NCT03585660|102191165|FG000|STARTED|Overall Study||106||
48755792|NCT03585660|102191165|FG000|COMPLETED|Overall Study||91||
48755793|NCT03585660|102191165|FG000|NOT COMPLETED|Overall Study||15||
48181484|NCT04033991|100768088|FG000|Participants Who Took First-line Sunitinib Therapy|Overall Study||622||
48181485|NCT04033991|100768088|FG000|Participants Who Took Second-line Axitinib Therapy|Overall Study||121||
48181486|NCT04033991|100768088|FG000|Participants Who Took First-line Sunitinib Therapy and Then Second-line Axitinib Therapy|Overall Study||59||
48181487|NCT04033991|100768088|FG000|Participants Who Took Drugs Other Than Sunitinib as First-line and Then Second-line Axitinib Therapy|Overall Study||62||
48755794|NCT00360230|102191166|FG000|STARTED|Overall Study||90||
48755795|NCT00360230|102191167|FG001|STARTED|Overall Study||90||
48181488|NCT04033991|100768088|FG000|COMPLETED|Overall Study||684||
48181489|NCT04033991|100768088|FG000|NOT COMPLETED|Overall Study||0||
48181490|NCT02400307|100768089|FG000|STARTED|Overall Study||11||
48181491|NCT02400307|100768090|FG001|STARTED|Overall Study||8||
48181492|NCT02400307|100768089|FG000|COMPLETED|Overall Study||10||
48181493|NCT02400307|100768090|FG001|COMPLETED|Overall Study||8||
48181494|NCT02400307|100768089|FG000|NOT COMPLETED|Overall Study||1||
48181495|NCT02400307|100768090|FG001|NOT COMPLETED|Overall Study||0||
48181496|NCT04012814|100768091|FG000|STARTED|Overall Study||39||
48181497|NCT04012814|100768091|FG000|COMPLETED|Overall Study||31||
48181498|NCT04012814|100768091|FG000|NOT COMPLETED|Overall Study||8||
48755796|NCT00360230|102191168|FG002|STARTED|Overall Study||45||
48181499|NCT02478359|100768092|FG000|STARTED|Overall Study||1349||
48755797|NCT00360230|102191169|FG003|STARTED|Overall Study||90||
48755798|NCT00360230|102191170|FG004|STARTED|Overall Study||90||
48181500|NCT02478359|100768093|FG001|STARTED|Overall Study||1358||
48181501|NCT02478359|100768092|FG000|Intention-to-treat Population Month 12|Overall Study||1243||
48755799|NCT00360230|102191171|FG005|STARTED|Overall Study||90||
48181502|NCT02478359|100768093|FG001|Intention-to-treat Population Month 12|Overall Study||1293||
48181503|NCT02478359|100768092|FG000|COMPLETED|Overall Study||1243||
48181504|NCT02478359|100768093|FG001|COMPLETED|Overall Study||1293||
48181505|NCT02478359|100768092|FG000|NOT COMPLETED|Overall Study||106||
48181506|NCT02478359|100768093|FG001|NOT COMPLETED|Overall Study||65||
48181507|NCT01058863|100768094|FG000|STARTED|Overall Study||72||
48181508|NCT01058863|100768094|FG000|Safety and ITT Populations|Overall Study||71||
48181509|NCT01058863|100768094|FG000|Treated With Albuterol Spiromax® 90 mcg|Overall Study||68||
48181510|NCT01058863|100768094|FG000|Treated With Albuterol Spiromax® 180 mcg|Overall Study||68||
48181511|NCT01058863|100768094|FG000|Treated With ProAir® HFA 90 mcg|Overall Study||70||
48181512|NCT01058863|100768094|FG000|Treated With ProAir® HFA 180 mcg|Overall Study||68||
48181513|NCT01058863|100768094|FG000|Treated With Placebo Inhaler|Overall Study||69||
48181514|NCT01058863|100768094|FG000|COMPLETED|Overall Study||68||
48181515|NCT01058863|100768094|FG000|NOT COMPLETED|Overall Study||4||
48181516|NCT02839681|100768095|FG000|STARTED|Overall Study||2||
48181517|NCT02839681|100768095|FG000|COMPLETED|Overall Study||0||
48181518|NCT02839681|100768095|FG000|NOT COMPLETED|Overall Study||2||
48181519|NCT01833117|100768096|FG000|STARTED|Overall Study||43||
48181520|NCT01833117|100768097|FG001|STARTED|Overall Study||19||
48181521|NCT01833117|100768096|FG000|COMPLETED|Overall Study||43||
48181522|NCT01833117|100768097|FG001|COMPLETED|Overall Study||19||
48181523|NCT01833117|100768096|FG000|NOT COMPLETED|Overall Study||0||
48181524|NCT01833117|100768097|FG001|NOT COMPLETED|Overall Study||0||
48181525|NCT00388362|100768098|FG000|STARTED|Enrolled||36||
48181526|NCT00388362|100768098|FG000|COMPLETED|Enrolled||23||
48181527|NCT00388362|100768098|FG000|NOT COMPLETED|Enrolled||13||
48181528|NCT00388362|100768098|FG000|STARTED|Remained on Study Median of 514 Days||23||
48181529|NCT00388362|100768098|FG000|COMPLETED|Remained on Study Median of 514 Days||21||
48181530|NCT00388362|100768098|FG000|NOT COMPLETED|Remained on Study Median of 514 Days||2||
48181531|NCT03389893|100768099|FG000|STARTED|Randomized Double Blind Period||46|The primary outcome was measured through Day 28, during the Randomized Double Blind Placebo Controlled (RDBPC) portion of the study.|
48181532|NCT03389893|100768100|FG001|STARTED|Randomized Double Blind Period||26|The primary outcome was measured through Day 28, during the Randomized Double Blind Placebo Controlled (RDBPC) portion of the study.|
48181533|NCT03389893|100768101|FG002|STARTED|Randomized Double Blind Period||0|The primary outcome was measured through Day 28, during the Randomized Double Blind Placebo Controlled (RDBPC) portion of the study.|
48181534|NCT03389893|100768102|FG003|STARTED|Randomized Double Blind Period||0|The primary outcome was measured through Day 28, during the Randomized Double Blind Placebo Controlled (RDBPC) portion of the study.|
48181535|NCT03389893|100768099|FG000|COMPLETED|Randomized Double Blind Period||45||
48755800|NCT00360230|102191172|FG006|STARTED|Overall Study||45||
48755801|NCT00360230|102191166|FG000|COMPLETED|Overall Study||84||
48755802|NCT00360230|102191167|FG001|COMPLETED|Overall Study||87||
48755803|NCT00360230|102191168|FG002|COMPLETED|Overall Study||42||
48755804|NCT00360230|102191169|FG003|COMPLETED|Overall Study||88||
48755805|NCT00360230|102191170|FG004|COMPLETED|Overall Study||85||
48755806|NCT00360230|102191171|FG005|COMPLETED|Overall Study||86||
48181536|NCT03389893|100768100|FG001|COMPLETED|Randomized Double Blind Period||26||
48181537|NCT03389893|100768101|FG002|COMPLETED|Randomized Double Blind Period||0||
48181538|NCT03389893|100768102|FG003|COMPLETED|Randomized Double Blind Period||0||
48181539|NCT03389893|100768099|FG000|NOT COMPLETED|Randomized Double Blind Period||1||
48181540|NCT03389893|100768100|FG001|NOT COMPLETED|Randomized Double Blind Period||0||
48181541|NCT03389893|100768101|FG002|NOT COMPLETED|Randomized Double Blind Period||0||
48181542|NCT03389893|100768102|FG003|NOT COMPLETED|Randomized Double Blind Period||0||
48181543|NCT03389893|100768099|FG000|STARTED|Open Label Extension and Follow-Up||0||
48181544|NCT03389893|100768100|FG001|STARTED|Open Label Extension and Follow-Up||0||
48181545|NCT03389893|100768101|FG002|STARTED|Open Label Extension and Follow-Up||45||
48181546|NCT03389893|100768102|FG003|STARTED|Open Label Extension and Follow-Up||26||
48755807|NCT00360230|102191172|FG006|COMPLETED|Overall Study||43||
48755808|NCT00360230|102191166|FG000|NOT COMPLETED|Overall Study||6||
48755809|NCT00360230|102191167|FG001|NOT COMPLETED|Overall Study||3||
48755810|NCT00360230|102191168|FG002|NOT COMPLETED|Overall Study||3||
48755811|NCT00360230|102191169|FG003|NOT COMPLETED|Overall Study||2||
48755812|NCT00360230|102191170|FG004|NOT COMPLETED|Overall Study||5||
48755813|NCT00360230|102191171|FG005|NOT COMPLETED|Overall Study||4||
48755814|NCT00360230|102191172|FG006|NOT COMPLETED|Overall Study||2||
48755815|NCT00894803|102191173|FG000|STARTED|Overall Study||101||
48755816|NCT00894803|102191174|FG001|STARTED|Overall Study||25||
48755817|NCT00894803|102191173|FG000|COMPLETED|Overall Study||81||
48755818|NCT00894803|102191174|FG001|COMPLETED|Overall Study||20||
48181547|NCT03389893|100768099|FG000|COMPLETED|Open Label Extension and Follow-Up||0|3 participants were lost to follow-up after Day 112|
48181548|NCT03389893|100768100|FG001|COMPLETED|Open Label Extension and Follow-Up||0|3 participants were lost to follow-up after Day 112|
48181549|NCT03389893|100768101|FG002|COMPLETED|Open Label Extension and Follow-Up||41|3 participants were lost to follow-up after Day 112|
48755819|NCT00894803|102191173|FG000|NOT COMPLETED|Overall Study||20||
48755820|NCT00894803|102191174|FG001|NOT COMPLETED|Overall Study||5||
48755821|NCT05498649|102191175|FG000|STARTED|Overall Study||86||
48755822|NCT05498649|102191175|FG000|COMPLETED|Overall Study||85||
48755823|NCT05498649|102191175|FG000|NOT COMPLETED|Overall Study||1||
48181550|NCT03389893|100768102|FG003|COMPLETED|Open Label Extension and Follow-Up||25|3 participants were lost to follow-up after Day 112|
48181551|NCT03389893|100768099|FG000|NOT COMPLETED|Open Label Extension and Follow-Up||0||
48181552|NCT03389893|100768100|FG001|NOT COMPLETED|Open Label Extension and Follow-Up||0||
48181553|NCT03389893|100768101|FG002|NOT COMPLETED|Open Label Extension and Follow-Up||4||
48181554|NCT03389893|100768102|FG003|NOT COMPLETED|Open Label Extension and Follow-Up||1||
48181555|NCT01959880|100768103|FG000|STARTED|Overall Study||1132||
48181556|NCT01959880|100768104|FG001|STARTED|Overall Study||369||
48181557|NCT01959880|100768105|FG002|STARTED|Overall Study||209||
48181558|NCT01959880|100768106|FG003|STARTED|Overall Study||181||
48181559|NCT01959880|100768103|FG000|COMPLETED|Overall Study||0||
48633244|NCT01038765|101885444|FG001|NOT COMPLETED|Overall Study||5||
48633245|NCT02130999|101885445|FG000|STARTED|Overall Study||6||
48633246|NCT02130999|101885446|FG001|STARTED|Overall Study||8||
48181560|NCT01959880|100768104|FG001|COMPLETED|Overall Study||0||
48181561|NCT01959880|100768105|FG002|COMPLETED|Overall Study||1||
48181562|NCT01959880|100768106|FG003|COMPLETED|Overall Study||0||
48181563|NCT01959880|100768103|FG000|NOT COMPLETED|Overall Study||1132||
48181564|NCT01959880|100768104|FG001|NOT COMPLETED|Overall Study||369||
48181565|NCT01959880|100768105|FG002|NOT COMPLETED|Overall Study||208||
48181566|NCT01959880|100768106|FG003|NOT COMPLETED|Overall Study||181||
48633247|NCT02130999|101885445|FG000|COMPLETED|Overall Study||6||
48181567|NCT03405662|100768107|FG000|STARTED|Overall Study||7||
48181568|NCT03405662|100768108|FG001|STARTED|Overall Study||7||
48181569|NCT03405662|100768107|FG000|COMPLETED|Overall Study||6||
48181570|NCT03405662|100768108|FG001|COMPLETED|Overall Study||4||
48181571|NCT03405662|100768107|FG000|NOT COMPLETED|Overall Study||1||
48181572|NCT03405662|100768108|FG001|NOT COMPLETED|Overall Study||3||
48181573|NCT04675242|100768109|FG000|STARTED|Overall Study||111||111
48181574|NCT04675242|100768110|FG001|STARTED|Overall Study||113||113
48181575|NCT04675242|100768109|FG000|COMPLETED|Overall Study||109||109
48181576|NCT04675242|100768110|FG001|COMPLETED|Overall Study||112||112
48181577|NCT04675242|100768109|FG000|NOT COMPLETED|Overall Study||2||2
48181578|NCT04675242|100768110|FG001|NOT COMPLETED|Overall Study||1||1
48181579|NCT03890120|100768111|FG000|STARTED|Blinded Treatment Phase (100.3 Weeks)||278||
48181580|NCT03890120|100768112|FG001|STARTED|Blinded Treatment Phase (100.3 Weeks)||141||
48181581|NCT03890120|100768113|FG002|STARTED|Blinded Treatment Phase (100.3 Weeks)||0||
48181582|NCT03890120|100768114|FG003|STARTED|Blinded Treatment Phase (100.3 Weeks)||0||
48181583|NCT03890120|100768111|FG000|COMPLETED|Blinded Treatment Phase (100.3 Weeks)||123||
48181584|NCT03890120|100768112|FG001|COMPLETED|Blinded Treatment Phase (100.3 Weeks)||66||
48341943|NCT00896532|101164125|FG001|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48341944|NCT00896532|101164126|FG002|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48341945|NCT00896532|101164127|FG003|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48633248|NCT02130999|101885446|FG001|COMPLETED|Overall Study||8||
48633249|NCT02130999|101885445|FG000|NOT COMPLETED|Overall Study||0||
48633250|NCT02130999|101885446|FG001|NOT COMPLETED|Overall Study||0||
48633251|NCT01248455|101885447|FG000|STARTED|Overall Study||9||
48633252|NCT01248455|101885447|FG000|COMPLETED|Overall Study||8||
48633253|NCT01248455|101885447|FG000|NOT COMPLETED|Overall Study||1||
48633254|NCT03621956|101885448|FG000|STARTED|Overall Study||15||
48633255|NCT03621956|101885449|FG001|STARTED|Overall Study||19||
48755824|NCT02421172|102191176|FG000|STARTED|Period 1||33||
48755825|NCT02421172|102191177|FG001|STARTED|Period 1||33||
48755826|NCT02421172|102191178|FG002|STARTED|Period 1||0||
48755827|NCT02421172|102191179|FG003|STARTED|Period 1||0||
48755828|NCT02421172|102191180|FG004|STARTED|Period 1||0||
48755829|NCT02421172|102191176|FG000|PD Analysis Set Period 1|Period 1||31||
48755830|NCT02421172|102191177|FG001|PD Analysis Set Period 1|Period 1||33||
48755831|NCT02421172|102191178|FG002|PD Analysis Set Period 1|Period 1||0||
48755832|NCT02421172|102191179|FG003|PD Analysis Set Period 1|Period 1||0||
48181585|NCT03890120|100768113|FG002|COMPLETED|Blinded Treatment Phase (100.3 Weeks)||0||
48181586|NCT03890120|100768114|FG003|COMPLETED|Blinded Treatment Phase (100.3 Weeks)||0||
48181587|NCT03890120|100768111|FG000|NOT COMPLETED|Blinded Treatment Phase (100.3 Weeks)||155||
48181588|NCT03890120|100768112|FG001|NOT COMPLETED|Blinded Treatment Phase (100.3 Weeks)||75||
48633256|NCT03621956|101885448|FG000|COMPLETED|Overall Study||15||
48633257|NCT03621956|101885449|FG001|COMPLETED|Overall Study||19||
48755833|NCT02421172|102191180|FG004|PD Analysis Set Period 1|Period 1||0||
48181589|NCT03890120|100768113|FG002|NOT COMPLETED|Blinded Treatment Phase (100.3 Weeks)||0||
48181590|NCT03890120|100768114|FG003|NOT COMPLETED|Blinded Treatment Phase (100.3 Weeks)||0||
48181591|NCT03890120|100768111|FG000|STARTED|Open-Label Extension Phase (45 Weeks)||0||
48181592|NCT03890120|100768112|FG001|STARTED|Open-Label Extension Phase (45 Weeks)||0||
48181593|NCT03890120|100768113|FG002|STARTED|Open-Label Extension Phase (45 Weeks)||80||
48181594|NCT03890120|100768114|FG003|STARTED|Open-Label Extension Phase (45 Weeks)||45||
48181595|NCT03890120|100768111|FG000|COMPLETED|Open-Label Extension Phase (45 Weeks)||0||
48181596|NCT03890120|100768112|FG001|COMPLETED|Open-Label Extension Phase (45 Weeks)||0||
48181597|NCT03890120|100768113|FG002|COMPLETED|Open-Label Extension Phase (45 Weeks)||0||
48181598|NCT03890120|100768114|FG003|COMPLETED|Open-Label Extension Phase (45 Weeks)||0||
48755834|NCT02421172|102191176|FG000|PK Analysis Set Period 1|Period 1||33||
48755835|NCT02421172|102191177|FG001|PK Analysis Set Period 1|Period 1||0||
48755836|NCT02421172|102191178|FG002|PK Analysis Set Period 1|Period 1||0||
48755837|NCT02421172|102191179|FG003|PK Analysis Set Period 1|Period 1||0||
48755838|NCT02421172|102191180|FG004|PK Analysis Set Period 1|Period 1||0||
48755839|NCT02421172|102191176|FG000|COMPLETED|Period 1||29||
48755840|NCT02421172|102191177|FG001|COMPLETED|Period 1||31||
48755841|NCT02421172|102191178|FG002|COMPLETED|Period 1||0||
48755842|NCT02421172|102191179|FG003|COMPLETED|Period 1||0||
48755843|NCT02421172|102191180|FG004|COMPLETED|Period 1||0||
48755844|NCT02421172|102191176|FG000|NOT COMPLETED|Period 1||4||
48755845|NCT02421172|102191177|FG001|NOT COMPLETED|Period 1||2||
48755846|NCT02421172|102191178|FG002|NOT COMPLETED|Period 1||0||
48755847|NCT02421172|102191179|FG003|NOT COMPLETED|Period 1||0||
48755848|NCT02421172|102191180|FG004|NOT COMPLETED|Period 1||0||
48755849|NCT02421172|102191176|FG000|STARTED|Period 2||0||
48755850|NCT02421172|102191177|FG001|STARTED|Period 2||0||
48755851|NCT02421172|102191178|FG002|STARTED|Period 2||29||
48755852|NCT02421172|102191179|FG003|STARTED|Period 2||16||
48755853|NCT02421172|102191180|FG004|STARTED|Period 2||15||
48755854|NCT02421172|102191176|FG000|COMPLETED|Period 2||0||
48755855|NCT02421172|102191177|FG001|COMPLETED|Period 2||0||
48755856|NCT02421172|102191178|FG002|COMPLETED|Period 2||22||
48755857|NCT02421172|102191179|FG003|COMPLETED|Period 2||13||
48755858|NCT02421172|102191180|FG004|COMPLETED|Period 2||14||
48341946|NCT00896532|101164128|FG004|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48341947|NCT00896532|101164129|FG005|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48755859|NCT02421172|102191176|FG000|NOT COMPLETED|Period 2||0||
48755860|NCT02421172|102191177|FG001|NOT COMPLETED|Period 2||0||
48755861|NCT02421172|102191178|FG002|NOT COMPLETED|Period 2||7||
48755862|NCT02421172|102191179|FG003|NOT COMPLETED|Period 2||3||
48755863|NCT02421172|102191180|FG004|NOT COMPLETED|Period 2||1||
48755864|NCT04842747|102191181|FG000|STARTED|Overall Study||134||
48755865|NCT04842747|102191182|FG001|STARTED|Overall Study||70||
48755866|NCT04842747|102191181|FG000|COMPLETED|Overall Study||125||
48755867|NCT04842747|102191182|FG001|COMPLETED|Overall Study||66||
48755868|NCT04842747|102191181|FG000|NOT COMPLETED|Overall Study||9||
48755869|NCT04842747|102191182|FG001|NOT COMPLETED|Overall Study||4||
48755870|NCT03441477|102191183|FG000|STARTED|Overall Study||225||
48755871|NCT03441477|102191183|FG000|COMPLETED|Overall Study||224||
48755872|NCT03441477|102191183|FG000|NOT COMPLETED|Overall Study||1||
48755873|NCT00436332|102191184|FG000|STARTED|Overall Study||84||
48341948|NCT00896532|101164130|FG006|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48341949|NCT00896532|101164131|FG007|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48341950|NCT00896532|101164132|FG008|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48341951|NCT00896532|101164133|FG009|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48341952|NCT00896532|101164134|FG010|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48341953|NCT00896532|101164135|FG011|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48341954|NCT00896532|101164136|FG012|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48341955|NCT00896532|101164137|FG013|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48341956|NCT00896532|101164138|FG014|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48341957|NCT00896532|101164139|FG015|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||2||
48341958|NCT00896532|101164140|FG016|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||7||
48341959|NCT00896532|101164141|FG017|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||3||
48341960|NCT00896532|101164142|FG018|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48341961|NCT00896532|101164143|FG019|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48341962|NCT00896532|101164144|FG020|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48755874|NCT00436332|102191184|FG000|Eligible|Overall Study||82||
48755875|NCT00436332|102191184|FG000|Eligible and Began Protocol Therapy|Overall Study||79||
48755876|NCT00436332|102191184|FG000|COMPLETED|Overall Study||1||
48755877|NCT00436332|102191184|FG000|NOT COMPLETED|Overall Study||83||
48755878|NCT01349959|102191185|FG000|STARTED|Overall Study||40||
48755879|NCT01349959|102191185|FG000|COMPLETED|Overall Study||33||
48755880|NCT01349959|102191185|FG000|NOT COMPLETED|Overall Study||7||
48341963|NCT00896532|101164145|FG021|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48413771|NCT00338806|101345877|FG001|STARTED|Follow-up||4||
48755881|NCT01391364|102191186|FG000|STARTED|Overall Study||222||
48755882|NCT01391364|102191187|FG001|STARTED|Overall Study||216||
48755883|NCT01391364|102191186|FG000|COMPLETED|Overall Study||217||
48755884|NCT01391364|102191187|FG001|COMPLETED|Overall Study||214||
48755885|NCT01391364|102191186|FG000|NOT COMPLETED|Overall Study||5||
48755886|NCT01391364|102191187|FG001|NOT COMPLETED|Overall Study||2||
48755887|NCT01187017|102191188|FG000|STARTED|Overall Study||1||
48755888|NCT01187017|102191188|FG000|COMPLETED|Overall Study||1||
48755889|NCT01187017|102191188|FG000|NOT COMPLETED|Overall Study||0||
48755890|NCT02777021|102191189|FG000|STARTED|Overall Study||60|366 patients were screened for eligibility for Aim 3. 154 patients consented for Aim 3.|
48755891|NCT02777021|102191190|FG001|STARTED|Overall Study||94|366 patients were screened for eligibility for Aim 3. 154 patients consented for Aim 3.|
48755892|NCT02777021|102191189|FG000|COMPLETED|Overall Study||43||
48755893|NCT02777021|102191190|FG001|COMPLETED|Overall Study||77||
48755894|NCT02777021|102191189|FG000|NOT COMPLETED|Overall Study||17||
48755895|NCT02777021|102191190|FG001|NOT COMPLETED|Overall Study||17||
48341964|NCT00896532|101164146|FG022|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
48341965|NCT00896532|101164124|FG000|STARTED|Months 48-72: Follow-on Phase||0||
48341966|NCT00896532|101164125|FG001|STARTED|Months 48-72: Follow-on Phase||0||
48341967|NCT00896532|101164126|FG002|STARTED|Months 48-72: Follow-on Phase||0||
48341968|NCT00896532|101164127|FG003|STARTED|Months 48-72: Follow-on Phase||0||
48181599|NCT03890120|100768111|FG000|NOT COMPLETED|Open-Label Extension Phase (45 Weeks)||0||
48341969|NCT00896532|101164128|FG004|STARTED|Months 48-72: Follow-on Phase||0||
48341970|NCT00896532|101164129|FG005|STARTED|Months 48-72: Follow-on Phase||0||
48341971|NCT00896532|101164130|FG006|STARTED|Months 48-72: Follow-on Phase||0||
48633258|NCT03621956|101885448|FG000|NOT COMPLETED|Overall Study||0||
48633259|NCT03621956|101885449|FG001|NOT COMPLETED|Overall Study||0||
48633260|NCT02240329|101885450|FG000|STARTED|Overall Study||4||
48633261|NCT02240329|101885450|FG000|Determination of Urge to Cough|Overall Study||4||
48633262|NCT02240329|101885450|FG000|COMPLETED|Overall Study||4||
48633263|NCT02240329|101885450|FG000|NOT COMPLETED|Overall Study||0||
48633264|NCT00833755|101885451|FG000|STARTED|Overall Study||16||
48633265|NCT00833755|101885452|FG001|STARTED|Overall Study||18||
48633266|NCT00833755|101885453|FG002|STARTED|Overall Study||22||
48633267|NCT00833755|101885454|FG003|STARTED|Overall Study||23||
48633268|NCT00833755|101885451|FG000|COMPLETED|Overall Study||12||
48633269|NCT00833755|101885452|FG001|COMPLETED|Overall Study||13||
48633270|NCT00833755|101885453|FG002|COMPLETED|Overall Study||20||
48755896|NCT03740048|102191191|FG000|STARTED|Overall Study||23||
48755897|NCT03740048|102191192|FG001|STARTED|Overall Study||25||
48755898|NCT03740048|102191191|FG000|COMPLETED|Overall Study||17||
48755899|NCT03740048|102191192|FG001|COMPLETED|Overall Study||16||
48755900|NCT03740048|102191191|FG000|NOT COMPLETED|Overall Study||6||
48755901|NCT03740048|102191192|FG001|NOT COMPLETED|Overall Study||9||
48755902|NCT02234843|102191193|FG000|STARTED|Overall Study||184||
48755903|NCT02234843|102191194|FG001|STARTED|Overall Study||67||
48755904|NCT02234843|102191195|FG002|STARTED|Overall Study||47||
48755905|NCT02234843|102191196|FG003|STARTED|Overall Study||21||
48755906|NCT02234843|102191197|FG004|STARTED|Overall Study||16||
48755907|NCT02234843|102191198|FG005|STARTED|Overall Study||92||
48755908|NCT02234843|102191199|FG006|STARTED|Overall Study||34||
48755909|NCT02234843|102191200|FG007|STARTED|Overall Study||22||
48755910|NCT02234843|102191201|FG008|STARTED|Overall Study||9||
48755911|NCT02234843|102191202|FG009|STARTED|Overall Study||8||
48755912|NCT02234843|102191193|FG000|COMPLETED|Overall Study||162||
48755913|NCT02234843|102191194|FG001|COMPLETED|Overall Study||61||
48755914|NCT02234843|102191195|FG002|COMPLETED|Overall Study||44||
48755915|NCT02234843|102191196|FG003|COMPLETED|Overall Study||16||
48755916|NCT02234843|102191197|FG004|COMPLETED|Overall Study||14||
48755917|NCT02234843|102191198|FG005|COMPLETED|Overall Study||79||
48755918|NCT02234843|102191199|FG006|COMPLETED|Overall Study||32||
48755919|NCT02234843|102191200|FG007|COMPLETED|Overall Study||20||
48755920|NCT02234843|102191201|FG008|COMPLETED|Overall Study||8||
48755921|NCT02234843|102191202|FG009|COMPLETED|Overall Study||8||
48755922|NCT02234843|102191193|FG000|NOT COMPLETED|Overall Study||22||
48755923|NCT02234843|102191194|FG001|NOT COMPLETED|Overall Study||6||
48755924|NCT02234843|102191195|FG002|NOT COMPLETED|Overall Study||3||
48755925|NCT02234843|102191196|FG003|NOT COMPLETED|Overall Study||5||
48755926|NCT02234843|102191197|FG004|NOT COMPLETED|Overall Study||2||
48755927|NCT02234843|102191198|FG005|NOT COMPLETED|Overall Study||13||
48755928|NCT02234843|102191199|FG006|NOT COMPLETED|Overall Study||2||
48755929|NCT02234843|102191200|FG007|NOT COMPLETED|Overall Study||2||
48755930|NCT02234843|102191201|FG008|NOT COMPLETED|Overall Study||1||
48755931|NCT02234843|102191202|FG009|NOT COMPLETED|Overall Study||0||
48755932|NCT04731636|102191203|FG000|STARTED|Overall Study||15||
48755933|NCT04731636|102191203|FG000|COMPLETED|Overall Study||15||
48755934|NCT04731636|102191203|FG000|NOT COMPLETED|Overall Study||0||
48755935|NCT00286728|102191204|FG000|STARTED|Overall Study||142||
48181600|NCT03890120|100768112|FG001|NOT COMPLETED|Open-Label Extension Phase (45 Weeks)||0||
48181601|NCT03890120|100768113|FG002|NOT COMPLETED|Open-Label Extension Phase (45 Weeks)||80||
48181602|NCT03890120|100768114|FG003|NOT COMPLETED|Open-Label Extension Phase (45 Weeks)||45||
48188650|NCT03248570|100783300|FG001|STARTED|Overall Study||12||
48633271|NCT00833755|101885454|FG003|COMPLETED|Overall Study||17||
48633272|NCT00833755|101885451|FG000|NOT COMPLETED|Overall Study||4||
48633273|NCT00833755|101885452|FG001|NOT COMPLETED|Overall Study||5||
48633274|NCT00833755|101885453|FG002|NOT COMPLETED|Overall Study||2||
48633275|NCT00833755|101885454|FG003|NOT COMPLETED|Overall Study||6||
48755936|NCT00286728|102191205|FG001|STARTED|Overall Study||145||
48755937|NCT00286728|102191204|FG000|COMPLETED|Overall Study||106||
48633276|NCT01721798|101885455|FG000|STARTED|Overall Study||36||
48633277|NCT01721798|101885456|FG001|STARTED|Overall Study||31||
48755938|NCT00286728|102191205|FG001|COMPLETED|Overall Study||116||
48755939|NCT00286728|102191204|FG000|NOT COMPLETED|Overall Study||36||
48755940|NCT00286728|102191205|FG001|NOT COMPLETED|Overall Study||29||
48755941|NCT02426580|102191206|FG000|STARTED|Overall Study||70||
48755942|NCT02426580|102191207|FG001|STARTED|Overall Study||70||
48341972|NCT00896532|101164131|FG007|STARTED|Months 48-72: Follow-on Phase||0||
48341973|NCT00896532|101164132|FG008|STARTED|Months 48-72: Follow-on Phase||0||
48341974|NCT00896532|101164133|FG009|STARTED|Months 48-72: Follow-on Phase||0||
48341975|NCT00896532|101164134|FG010|STARTED|Months 48-72: Follow-on Phase||0||
48341976|NCT00896532|101164135|FG011|STARTED|Months 48-72: Follow-on Phase||0||
48755943|NCT02426580|102191206|FG000|COMPLETED|Overall Study||59||
48755944|NCT02426580|102191207|FG001|COMPLETED|Overall Study||54||
48755945|NCT02426580|102191206|FG000|NOT COMPLETED|Overall Study||11||
48755946|NCT02426580|102191207|FG001|NOT COMPLETED|Overall Study||16||
48755947|NCT03341299|102191208|FG000|STARTED|Period 1||9||
48755948|NCT03341299|102191209|FG001|STARTED|Period 1||9||
48755949|NCT03341299|102191210|FG002|STARTED|Period 1||9||
48341977|NCT00896532|101164136|FG012|STARTED|Months 48-72: Follow-on Phase||0||
48341978|NCT00896532|101164137|FG013|STARTED|Months 48-72: Follow-on Phase||0||
48341979|NCT00896532|101164138|FG014|STARTED|Months 48-72: Follow-on Phase||0||
48341980|NCT00896532|101164139|FG015|STARTED|Months 48-72: Follow-on Phase||0||
48341981|NCT00896532|101164140|FG016|STARTED|Months 48-72: Follow-on Phase||0||
48341982|NCT00896532|101164141|FG017|STARTED|Months 48-72: Follow-on Phase||0||
48341983|NCT00896532|101164142|FG018|STARTED|Months 48-72: Follow-on Phase||51||
48341984|NCT00896532|101164143|FG019|STARTED|Months 48-72: Follow-on Phase||11||
48341985|NCT00896532|101164144|FG020|STARTED|Months 48-72: Follow-on Phase||12||
48341986|NCT00896532|101164145|FG021|STARTED|Months 48-72: Follow-on Phase||59||
48341987|NCT00896532|101164146|FG022|STARTED|Months 48-72: Follow-on Phase||8||
48341988|NCT00896532|101164124|FG000|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
48341989|NCT00896532|101164125|FG001|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
48341990|NCT00896532|101164126|FG002|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
48341991|NCT00896532|101164127|FG003|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
48341992|NCT00896532|101164128|FG004|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
48341993|NCT00896532|101164129|FG005|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
48341994|NCT00896532|101164130|FG006|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
48341995|NCT00896532|101164131|FG007|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
48341996|NCT00896532|101164132|FG008|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
48341997|NCT00896532|101164133|FG009|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
48341998|NCT00896532|101164134|FG010|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
48341999|NCT00896532|101164135|FG011|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
48342000|NCT00896532|101164136|FG012|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
48342001|NCT00896532|101164137|FG013|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
48342002|NCT00896532|101164138|FG014|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
48342003|NCT00896532|101164139|FG015|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
48342004|NCT00896532|101164140|FG016|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
48342005|NCT00896532|101164141|FG017|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
48342006|NCT00896532|101164142|FG018|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
48342007|NCT00896532|101164143|FG019|Received Zoledronic Acid|Months 48-72: Follow-on Phase||11||
48413772|NCT00338806|101345876|FG000|COMPLETED|Follow-up||1||
48413773|NCT00338806|101345877|FG001|COMPLETED|Follow-up||1||
48413774|NCT00338806|101345876|FG000|NOT COMPLETED|Follow-up||1||
48755950|NCT03341299|102191211|FG003|STARTED|Period 1||9||
48755951|NCT03341299|102191208|FG000|COMPLETED|Period 1||9||
48755952|NCT03341299|102191209|FG001|COMPLETED|Period 1||9||
48755953|NCT03341299|102191210|FG002|COMPLETED|Period 1||9||
48755954|NCT03341299|102191211|FG003|COMPLETED|Period 1||9||
48755955|NCT03341299|102191208|FG000|NOT COMPLETED|Period 1||0||
48755956|NCT03341299|102191209|FG001|NOT COMPLETED|Period 1||0||
48755957|NCT03341299|102191210|FG002|NOT COMPLETED|Period 1||0||
48755958|NCT03341299|102191211|FG003|NOT COMPLETED|Period 1||0||
48755959|NCT03341299|102191208|FG000|STARTED|Washout (A Minimum of 21 Hours)||9||
48755960|NCT03341299|102191209|FG001|STARTED|Washout (A Minimum of 21 Hours)||9||
48755961|NCT03341299|102191210|FG002|STARTED|Washout (A Minimum of 21 Hours)||9||
48755962|NCT03341299|102191211|FG003|STARTED|Washout (A Minimum of 21 Hours)||9||
48342008|NCT00896532|101164144|FG020|Received Zoledronic Acid|Months 48-72: Follow-on Phase||12||
48342009|NCT00896532|101164145|FG021|Received Zoledronic Acid|Months 48-72: Follow-on Phase||56||
48342010|NCT00896532|101164146|FG022|Received Zoledronic Acid|Months 48-72: Follow-on Phase||8||
48755963|NCT03341299|102191208|FG000|COMPLETED|Washout (A Minimum of 21 Hours)||9||
48755964|NCT03341299|102191209|FG001|COMPLETED|Washout (A Minimum of 21 Hours)||9||
48755965|NCT03341299|102191210|FG002|COMPLETED|Washout (A Minimum of 21 Hours)||8||
48755966|NCT03341299|102191211|FG003|COMPLETED|Washout (A Minimum of 21 Hours)||9||
48755967|NCT03341299|102191208|FG000|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0||
48755968|NCT03341299|102191209|FG001|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0||
48755969|NCT03341299|102191210|FG002|NOT COMPLETED|Washout (A Minimum of 21 Hours)||1||
48755970|NCT03341299|102191211|FG003|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0||
48755971|NCT03341299|102191208|FG000|STARTED|Period 2||9||
48181603|NCT04793464|100768115|FG000|STARTED|Overall Study||1125|Enrolled at Baseline|
48181604|NCT04793464|100768116|FG001|STARTED|Overall Study||483|Enrolled at Baseline|
48181605|NCT04793464|100768117|FG002|STARTED|Overall Study||15|Enrolled at Baseline|
48181606|NCT04793464|100768115|FG000|COMPLETED|Overall Study||624|Completed Follow-up|
48181607|NCT04793464|100768116|FG001|COMPLETED|Overall Study||300|Completed Follow-up|
48181608|NCT04793464|100768117|FG002|COMPLETED|Overall Study||10|Completed Follow-up|
48181609|NCT04793464|100768115|FG000|NOT COMPLETED|Overall Study||501||
48181610|NCT04793464|100768116|FG001|NOT COMPLETED|Overall Study||183||
48181611|NCT04793464|100768117|FG002|NOT COMPLETED|Overall Study||5||
48181612|NCT02435511|100768118|FG000|STARTED|Overall Study||202||
48181613|NCT02435511|100768119|FG001|STARTED|Overall Study||209||
48181614|NCT02435511|100768118|FG000|COMPLETED|Overall Study||158||
48181615|NCT02435511|100768119|FG001|COMPLETED|Overall Study||174||
48181616|NCT02435511|100768118|FG000|NOT COMPLETED|Overall Study||44||
48181617|NCT02435511|100768119|FG001|NOT COMPLETED|Overall Study||35||
48181618|NCT02959138|100768120|FG000|STARTED|Overall Study||10||
48181619|NCT02959138|100768121|FG001|STARTED|Overall Study||10||
48181620|NCT02959138|100768122|FG002|STARTED|Overall Study||16||
48181621|NCT02959138|100768120|FG000|COMPLETED|Overall Study||10||
48181622|NCT02959138|100768121|FG001|COMPLETED|Overall Study||9||
48181623|NCT02959138|100768122|FG002|COMPLETED|Overall Study||16||
48181624|NCT02959138|100768120|FG000|NOT COMPLETED|Overall Study||0||
48181625|NCT02959138|100768121|FG001|NOT COMPLETED|Overall Study||1||
48181626|NCT02959138|100768122|FG002|NOT COMPLETED|Overall Study||0||
48181627|NCT03088137|100768123|FG000|STARTED|Overall Study||55||
48181628|NCT03088137|100768124|FG001|STARTED|Overall Study||55||
48181629|NCT03088137|100768123|FG000|COMPLETED|Overall Study||55||
48181630|NCT03088137|100768124|FG001|COMPLETED|Overall Study||55||
48181631|NCT03088137|100768123|FG000|NOT COMPLETED|Overall Study||0||
48181632|NCT03088137|100768124|FG001|NOT COMPLETED|Overall Study||0||
48181633|NCT00884286|100768125|FG000|STARTED|Overall Study||34||
48181634|NCT00884286|100768126|FG001|STARTED|Overall Study||33||
48342011|NCT00896532|101164124|FG000|COMPLETED|Months 48-72: Follow-on Phase||0||
48755972|NCT03341299|102191209|FG001|STARTED|Period 2||9||
48755973|NCT03341299|102191210|FG002|STARTED|Period 2||8||
48755974|NCT03341299|102191211|FG003|STARTED|Period 2||9||
48755975|NCT03341299|102191208|FG000|COMPLETED|Period 2||9||
48755976|NCT03341299|102191209|FG001|COMPLETED|Period 2||9||
48755977|NCT03341299|102191210|FG002|COMPLETED|Period 2||8||
48755978|NCT03341299|102191211|FG003|COMPLETED|Period 2||9||
48755979|NCT03341299|102191208|FG000|NOT COMPLETED|Period 2||0||
48755980|NCT03341299|102191209|FG001|NOT COMPLETED|Period 2||0||
48755981|NCT03341299|102191210|FG002|NOT COMPLETED|Period 2||0||
48755982|NCT03341299|102191211|FG003|NOT COMPLETED|Period 2||0||
48755983|NCT03341299|102191208|FG000|STARTED|Washout (A Minimum of 21 Hours)||9||
48755984|NCT03341299|102191209|FG001|STARTED|Washout (A Minimum of 21 Hours)||9||
48755985|NCT03341299|102191210|FG002|STARTED|Washout (A Minimum of 21 Hours)||8||
48755986|NCT03341299|102191211|FG003|STARTED|Washout (A Minimum of 21 Hours)||9||
48755987|NCT03341299|102191208|FG000|COMPLETED|Washout (A Minimum of 21 Hours)||9||
48755988|NCT03341299|102191209|FG001|COMPLETED|Washout (A Minimum of 21 Hours)||9||
48755989|NCT03341299|102191210|FG002|COMPLETED|Washout (A Minimum of 21 Hours)||8||
48755990|NCT03341299|102191211|FG003|COMPLETED|Washout (A Minimum of 21 Hours)||9||
48755991|NCT03341299|102191208|FG000|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0||
48755992|NCT03341299|102191209|FG001|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0||
48755993|NCT03341299|102191210|FG002|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0||
48755994|NCT03341299|102191211|FG003|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0||
48755995|NCT03341299|102191208|FG000|STARTED|Period 3||9||
48755996|NCT03341299|102191209|FG001|STARTED|Period 3||9||
48755997|NCT03341299|102191210|FG002|STARTED|Period 3||8||
48755998|NCT03341299|102191211|FG003|STARTED|Period 3||9||
48755999|NCT03341299|102191208|FG000|COMPLETED|Period 3||9||
48756000|NCT03341299|102191209|FG001|COMPLETED|Period 3||9||
48756001|NCT03341299|102191210|FG002|COMPLETED|Period 3||8||
48756002|NCT03341299|102191211|FG003|COMPLETED|Period 3||9||
48756003|NCT03341299|102191208|FG000|NOT COMPLETED|Period 3||0||
48756004|NCT03341299|102191209|FG001|NOT COMPLETED|Period 3||0||
48756005|NCT03341299|102191210|FG002|NOT COMPLETED|Period 3||0||
48756006|NCT03341299|102191211|FG003|NOT COMPLETED|Period 3||0||
48756007|NCT03341299|102191208|FG000|STARTED|Washout (A Minimum of 21 Hours)||9||
48756008|NCT03341299|102191209|FG001|STARTED|Washout (A Minimum of 21 Hours)||9||
48756009|NCT03341299|102191210|FG002|STARTED|Washout (A Minimum of 21 Hours)||8||
48756010|NCT03341299|102191211|FG003|STARTED|Washout (A Minimum of 21 Hours)||9||
48756011|NCT03341299|102191208|FG000|COMPLETED|Washout (A Minimum of 21 Hours)||9||
48756012|NCT03341299|102191209|FG001|COMPLETED|Washout (A Minimum of 21 Hours)||9||
48756013|NCT03341299|102191210|FG002|COMPLETED|Washout (A Minimum of 21 Hours)||8||
48756014|NCT03341299|102191211|FG003|COMPLETED|Washout (A Minimum of 21 Hours)||9||
48756015|NCT03341299|102191208|FG000|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0||
48756016|NCT03341299|102191209|FG001|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0||
48756017|NCT03341299|102191210|FG002|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0||
48756018|NCT03341299|102191211|FG003|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0||
48756019|NCT03341299|102191208|FG000|STARTED|Period 4||9||
48756020|NCT03341299|102191209|FG001|STARTED|Period 4||9||
48756021|NCT03341299|102191210|FG002|STARTED|Period 4||8||
48756022|NCT03341299|102191211|FG003|STARTED|Period 4||9||
48756023|NCT03341299|102191208|FG000|COMPLETED|Period 4||9||
48756024|NCT03341299|102191209|FG001|COMPLETED|Period 4||9||
48756025|NCT03341299|102191210|FG002|COMPLETED|Period 4||8||
48756026|NCT03341299|102191211|FG003|COMPLETED|Period 4||9||
48756027|NCT03341299|102191208|FG000|NOT COMPLETED|Period 4||0||
48756028|NCT03341299|102191209|FG001|NOT COMPLETED|Period 4||0||
48756029|NCT03341299|102191210|FG002|NOT COMPLETED|Period 4||0||
48756030|NCT03341299|102191211|FG003|NOT COMPLETED|Period 4||0||
48756031|NCT00928486|102191212|FG000|STARTED|Overall Study||25||
48756032|NCT00928486|102191212|FG000|Efficacy Evaluable (EE)|Overall Study||24||
48756033|NCT00928486|102191212|FG000|COMPLETED|Overall Study||15||
48756034|NCT00928486|102191212|FG000|NOT COMPLETED|Overall Study||10||
48756035|NCT01446159|102191213|FG000|STARTED|Overall Study||3||
48756036|NCT01446159|102191214|FG001|STARTED|Overall Study||3||
48756037|NCT01446159|102191215|FG002|STARTED|Overall Study||92||
48756038|NCT01446159|102191216|FG003|STARTED|Overall Study||85||
48756039|NCT01446159|102191213|FG000|COMPLETED|Overall Study||0||
48756040|NCT01446159|102191214|FG001|COMPLETED|Overall Study||0||
48756041|NCT01446159|102191215|FG002|COMPLETED|Overall Study||21||
48756042|NCT01446159|102191216|FG003|COMPLETED|Overall Study||23||
48756043|NCT01446159|102191213|FG000|NOT COMPLETED|Overall Study||3||
48756044|NCT01446159|102191214|FG001|NOT COMPLETED|Overall Study||3||
48756045|NCT01446159|102191215|FG002|NOT COMPLETED|Overall Study||71||
48756046|NCT01446159|102191216|FG003|NOT COMPLETED|Overall Study||62||
48756047|NCT00981656|102191217|FG000|STARTED|Overall Study||37||
48756048|NCT00981656|102191217|FG000|Eligible and Started Study Treatment|Overall Study||34||
48756049|NCT00981656|102191217|FG000|COMPLETED|Overall Study||34|Participants contributing data to results are considered to have completed the study.|
48756050|NCT00981656|102191217|FG000|NOT COMPLETED|Overall Study||3||
48756051|NCT04011540|102191218|FG000|STARTED|Overall Study||57||
48756052|NCT04011540|102191219|FG001|STARTED|Overall Study||58||
48756053|NCT04011540|102191218|FG000|COMPLETED|Overall Study||48||
48756054|NCT04011540|102191219|FG001|COMPLETED|Overall Study||52||
48756055|NCT04011540|102191218|FG000|NOT COMPLETED|Overall Study||9||
48342012|NCT00896532|101164125|FG001|COMPLETED|Months 48-72: Follow-on Phase||0||
48342013|NCT00896532|101164126|FG002|COMPLETED|Months 48-72: Follow-on Phase||0||
48342014|NCT00896532|101164127|FG003|COMPLETED|Months 48-72: Follow-on Phase||0||
48342015|NCT00896532|101164128|FG004|COMPLETED|Months 48-72: Follow-on Phase||0||
48342016|NCT00896532|101164129|FG005|COMPLETED|Months 48-72: Follow-on Phase||0||
48342017|NCT00896532|101164130|FG006|COMPLETED|Months 48-72: Follow-on Phase||0||
48342018|NCT00896532|101164131|FG007|COMPLETED|Months 48-72: Follow-on Phase||0||
48342019|NCT00896532|101164132|FG008|COMPLETED|Months 48-72: Follow-on Phase||0||
48413775|NCT00338806|101345877|FG001|NOT COMPLETED|Follow-up||3||
48756056|NCT04011540|102191219|FG001|NOT COMPLETED|Overall Study||6||
48756057|NCT03768414|102191220|FG000|STARTED|Overall Study||294||
48756058|NCT03768414|102191221|FG001|STARTED|Overall Study||147||
48756059|NCT03768414|102191220|FG000|COMPLETED|Overall Study||0||
48756060|NCT03768414|102191221|FG001|COMPLETED|Overall Study||0||
48756061|NCT03768414|102191220|FG000|NOT COMPLETED|Overall Study||294||
48756062|NCT03768414|102191221|FG001|NOT COMPLETED|Overall Study||147||
48756063|NCT00617734|102191222|FG000|STARTED|Overall Study||49||
48756064|NCT00617734|102191223|FG001|STARTED|Overall Study||48||
48756065|NCT00617734|102191222|FG000|Received at Least 1 Dose of Study Drug|Overall Study||47||
48756066|NCT00617734|102191223|FG001|Received at Least 1 Dose of Study Drug|Overall Study||44||
48756067|NCT00617734|102191222|FG000|COMPLETED|Overall Study||41||
48756068|NCT00617734|102191223|FG001|COMPLETED|Overall Study||42||
48756069|NCT00617734|102191222|FG000|NOT COMPLETED|Overall Study||8||
48756070|NCT00617734|102191223|FG001|NOT COMPLETED|Overall Study||6||
48756071|NCT02903914|102191224|FG000|STARTED|Overall Study||8||
48756072|NCT02903914|102191225|FG001|STARTED|Overall Study||7||
48756073|NCT02903914|102191226|FG002|STARTED|Overall Study||85||
48756074|NCT02903914|102191227|FG003|STARTED|Overall Study||7||
48756075|NCT02903914|102191228|FG004|STARTED|Overall Study||10||
48756076|NCT02903914|102191229|FG005|STARTED|Overall Study||14||
48756077|NCT02903914|102191230|FG006|STARTED|Overall Study||123||
48756078|NCT02903914|102191231|FG007|STARTED|Overall Study||6||
48756079|NCT02903914|102191224|FG000|COMPLETED|Overall Study||0||
48756080|NCT02903914|102191225|FG001|COMPLETED|Overall Study||0||
48756081|NCT02903914|102191226|FG002|COMPLETED|Overall Study||0||
48756082|NCT02903914|102191227|FG003|COMPLETED|Overall Study||0||
48756083|NCT02903914|102191228|FG004|COMPLETED|Overall Study||0||
48756084|NCT02903914|102191229|FG005|COMPLETED|Overall Study||0||
48756085|NCT02903914|102191230|FG006|COMPLETED|Overall Study||0||
48756086|NCT02903914|102191231|FG007|COMPLETED|Overall Study||0||
48756087|NCT02903914|102191224|FG000|NOT COMPLETED|Overall Study||8||
48756088|NCT02903914|102191225|FG001|NOT COMPLETED|Overall Study||7||
48756089|NCT02903914|102191226|FG002|NOT COMPLETED|Overall Study||85||
48756090|NCT02903914|102191227|FG003|NOT COMPLETED|Overall Study||7||
48342020|NCT00896532|101164133|FG009|COMPLETED|Months 48-72: Follow-on Phase||0||
48342021|NCT00896532|101164134|FG010|COMPLETED|Months 48-72: Follow-on Phase||0||
48342022|NCT00896532|101164135|FG011|COMPLETED|Months 48-72: Follow-on Phase||0||
48342023|NCT00896532|101164136|FG012|COMPLETED|Months 48-72: Follow-on Phase||0||
48342024|NCT00896532|101164137|FG013|COMPLETED|Months 48-72: Follow-on Phase||0||
48342025|NCT00896532|101164138|FG014|COMPLETED|Months 48-72: Follow-on Phase||0||
48342026|NCT00896532|101164139|FG015|COMPLETED|Months 48-72: Follow-on Phase||0||
48342027|NCT00896532|101164140|FG016|COMPLETED|Months 48-72: Follow-on Phase||0||
48413776|NCT01234337|101345878|FG000|STARTED|Overall Study||266||
48633278|NCT01721798|101885457|FG002|STARTED|Overall Study||65||
48633279|NCT01721798|101885458|FG003|STARTED|Overall Study||67||
48633280|NCT01721798|101885455|FG000|6 Mos|Overall Study||35||
48633281|NCT01721798|101885456|FG001|6 Mos|Overall Study||30||
48342028|NCT00896532|101164141|FG017|COMPLETED|Months 48-72: Follow-on Phase||0||
48342029|NCT00896532|101164142|FG018|COMPLETED|Months 48-72: Follow-on Phase||50||
48342030|NCT00896532|101164143|FG019|COMPLETED|Months 48-72: Follow-on Phase||11||
48342031|NCT00896532|101164144|FG020|COMPLETED|Months 48-72: Follow-on Phase||12||
48342032|NCT00896532|101164145|FG021|COMPLETED|Months 48-72: Follow-on Phase||57||
48342033|NCT00896532|101164146|FG022|COMPLETED|Months 48-72: Follow-on Phase||8||
48342034|NCT00896532|101164124|FG000|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
48342035|NCT00896532|101164125|FG001|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
48633282|NCT01721798|101885457|FG002|6 Mos|Overall Study||60||
48633283|NCT01721798|101885458|FG003|6 Mos|Overall Study||62||
48633284|NCT01721798|101885455|FG000|12 Mos|Overall Study||34||
48633285|NCT01721798|101885456|FG001|12 Mos|Overall Study||29||
48633286|NCT01721798|101885457|FG002|12 Mos|Overall Study||58||
48342036|NCT00896532|101164126|FG002|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
48342037|NCT00896532|101164127|FG003|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
48342038|NCT00896532|101164128|FG004|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
48342039|NCT00896532|101164129|FG005|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
48342040|NCT00896532|101164130|FG006|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
48342041|NCT00896532|101164131|FG007|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
48342042|NCT00896532|101164132|FG008|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
48342043|NCT00896532|101164133|FG009|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
48633287|NCT01721798|101885458|FG003|12 Mos|Overall Study||62||
48633288|NCT01721798|101885455|FG000|18 Mos|Overall Study||32||
48633289|NCT01721798|101885456|FG001|18 Mos|Overall Study||29||
48633290|NCT01721798|101885457|FG002|18 Mos|Overall Study||55||
48633291|NCT01721798|101885458|FG003|18 Mos|Overall Study||60||
48633292|NCT01721798|101885455|FG000|COMPLETED|Overall Study||32||
48633293|NCT01721798|101885456|FG001|COMPLETED|Overall Study||29||
48633294|NCT01721798|101885457|FG002|COMPLETED|Overall Study||44||
48633295|NCT01721798|101885458|FG003|COMPLETED|Overall Study||48||
48633296|NCT01721798|101885455|FG000|NOT COMPLETED|Overall Study||4||
48633297|NCT01721798|101885456|FG001|NOT COMPLETED|Overall Study||2||
48633298|NCT01721798|101885457|FG002|NOT COMPLETED|Overall Study||21||
48633299|NCT01721798|101885458|FG003|NOT COMPLETED|Overall Study||19||
48633300|NCT03229499|101885459|FG000|STARTED|Overall Study||43||
48633301|NCT03229499|101885460|FG001|STARTED|Overall Study||41||
48633302|NCT03229499|101885459|FG000|COMPLETED|Overall Study||43||
48633303|NCT03229499|101885460|FG001|COMPLETED|Overall Study||38||
48633304|NCT03229499|101885459|FG000|NOT COMPLETED|Overall Study||0||
48633305|NCT03229499|101885460|FG001|NOT COMPLETED|Overall Study||3||
48633306|NCT02072200|101885461|FG000|STARTED|Overall Study||147||
48633307|NCT02072200|101885461|FG000|COMPLETED|Overall Study||145||
48633308|NCT02072200|101885461|FG000|NOT COMPLETED|Overall Study||2||
48633309|NCT00314145|101885462|FG000|STARTED|Overall Study||410||
48633310|NCT00314145|101885463|FG001|STARTED|Overall Study||410||
48633311|NCT00314145|101885462|FG000|COMPLETED|Overall Study||389||
48633312|NCT00314145|101885463|FG001|COMPLETED|Overall Study||381||
48633313|NCT00314145|101885462|FG000|NOT COMPLETED|Overall Study||21||
48633314|NCT00314145|101885463|FG001|NOT COMPLETED|Overall Study||29||
48633315|NCT01631214|101885464|FG000|STARTED|Overall Study||2047||
48633316|NCT01631214|101885465|FG001|STARTED|Overall Study||2046||
48633317|NCT01631214|101885464|FG000|Received Double-blind Treatment|Overall Study||2040||
48633318|NCT01631214|101885465|FG001|Received Double-blind Treatment|Overall Study||2038||
48633319|NCT01631214|101885464|FG000|Completed Double-blind Period|Overall Study||1823|Completion of the double-blind period is defined as having attended the month 12 study visit.|
48633320|NCT01631214|101885465|FG001|Completed Double-blind Period|Overall Study||1831|Completion of the double-blind period is defined as having attended the month 12 study visit.|
48633321|NCT01631214|101885464|FG000|Completed Primary Analysis Period|Overall Study||1576|Completion of the primary analysis period is defined as ongoing at the primary analysis cutoff date.|
48633322|NCT01631214|101885465|FG001|Completed Primary Analysis Period|Overall Study||1574|Completion of the primary analysis period is defined as ongoing at the primary analysis cutoff date.|
48633323|NCT01631214|101885464|FG000|COMPLETED|Overall Study||1503||
48633324|NCT01631214|101885465|FG001|COMPLETED|Overall Study||1523||
48633325|NCT01631214|101885464|FG000|NOT COMPLETED|Overall Study||544||
48633326|NCT01631214|101885465|FG001|NOT COMPLETED|Overall Study||523||
48633327|NCT02030600|101885466|FG000|STARTED|Treatment Period 1||361||
48633328|NCT02030600|101885467|FG001|STARTED|Treatment Period 1||360||
48633329|NCT02030600|101885466|FG000|Exposed|Treatment Period 1||356||
48633330|NCT02030600|101885467|FG001|Exposed|Treatment Period 1||357||
48633331|NCT02030600|101885466|FG000|COMPLETED|Treatment Period 1||308||
48633332|NCT02030600|101885467|FG001|COMPLETED|Treatment Period 1||315||
48633333|NCT02030600|101885466|FG000|NOT COMPLETED|Treatment Period 1||53||
48181635|NCT00884286|100768125|FG000|COMPLETED|Overall Study||2||
48181636|NCT00884286|100768126|FG001|COMPLETED|Overall Study||0||
48181637|NCT00884286|100768125|FG000|NOT COMPLETED|Overall Study||32||
48633334|NCT02030600|101885467|FG001|NOT COMPLETED|Treatment Period 1||45||
48633335|NCT02030600|101885466|FG000|STARTED|Treatment Period 2||308||
48633336|NCT02030600|101885467|FG001|STARTED|Treatment Period 2||315||
48633337|NCT02030600|101885466|FG000|COMPLETED|Treatment Period 2||283||
48181638|NCT00884286|100768126|FG001|NOT COMPLETED|Overall Study||33||
48181639|NCT02420327|100768127|FG000|STARTED|Overall Study||43||
48181640|NCT02420327|100768127|FG000|COMPLETED|Overall Study||27||
48181641|NCT02420327|100768127|FG000|NOT COMPLETED|Overall Study||16||
48181642|NCT04179461|100768128|FG000|STARTED|Overall Study||21||
48181643|NCT04179461|100768128|FG000|COMPLETED|Overall Study||17||
48633338|NCT02030600|101885467|FG001|COMPLETED|Treatment Period 2||297||
48633339|NCT02030600|101885466|FG000|NOT COMPLETED|Treatment Period 2||25||
48633340|NCT02030600|101885467|FG001|NOT COMPLETED|Treatment Period 2||18||
48633341|NCT01299909|101885468|FG000|STARTED|Overall Study||68||
48633342|NCT01299909|101885469|FG001|STARTED|Overall Study||67||
48756091|NCT02903914|102191228|FG004|NOT COMPLETED|Overall Study||10||
48756092|NCT02903914|102191229|FG005|NOT COMPLETED|Overall Study||14||
48756093|NCT02903914|102191230|FG006|NOT COMPLETED|Overall Study||123||
48756094|NCT02903914|102191231|FG007|NOT COMPLETED|Overall Study||6||
48756095|NCT04663321|102191232|FG000|STARTED|Overall Study||40||
48756096|NCT04663321|102191233|FG001|STARTED|Overall Study||19||
48756097|NCT04663321|102191234|FG002|STARTED|Overall Study||40||
48181644|NCT04179461|100768128|FG000|NOT COMPLETED|Overall Study||4||
48181645|NCT00531011|100768129|FG000|STARTED|Overall Study||103||
48181646|NCT00531011|100768130|FG001|STARTED|Overall Study||97||
48181647|NCT00531011|100768129|FG000|COMPLETED|Overall Study||99||
48181648|NCT00531011|100768130|FG001|COMPLETED|Overall Study||90||
48181649|NCT00531011|100768129|FG000|NOT COMPLETED|Overall Study||4||
48181650|NCT00531011|100768130|FG001|NOT COMPLETED|Overall Study||7||
48181651|NCT02781506|100768131|FG000|STARTED|Overall Study||7||
48181652|NCT02781506|100768131|FG000|COMPLETED|Overall Study||2||
48181653|NCT02781506|100768131|FG000|NOT COMPLETED|Overall Study||5||
48181654|NCT01207934|100768132|FG000|STARTED|Overall Study||6||
48181655|NCT01207934|100768133|FG001|STARTED|Overall Study||6||
48181656|NCT01207934|100768134|FG002|STARTED|Overall Study||6||
48756098|NCT04663321|102191232|FG000|COMPLETED|Overall Study||28||
48181657|NCT01207934|100768132|FG000|COMPLETED|Overall Study||6||
48181658|NCT01207934|100768133|FG001|COMPLETED|Overall Study||6||
48181659|NCT01207934|100768134|FG002|COMPLETED|Overall Study||6||
48181660|NCT01207934|100768132|FG000|NOT COMPLETED|Overall Study||0||
48181661|NCT01207934|100768133|FG001|NOT COMPLETED|Overall Study||0||
48181662|NCT01207934|100768134|FG002|NOT COMPLETED|Overall Study||0||
48181663|NCT02774213|100768135|FG000|STARTED|Overall Study||74||
48181664|NCT02774213|100768135|FG000|COMPLETED|Overall Study||55||
48181665|NCT02774213|100768135|FG000|NOT COMPLETED|Overall Study||19||
48181666|NCT01767129|100768136|FG000|STARTED|Treatment Period 1 (14 Days)||7||
48181667|NCT01767129|100768137|FG001|STARTED|Treatment Period 1 (14 Days)||7||
48181668|NCT01767129|100768136|FG000|COMPLETED|Treatment Period 1 (14 Days)||6||
48181669|NCT01767129|100768137|FG001|COMPLETED|Treatment Period 1 (14 Days)||7||
48181670|NCT01767129|100768136|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||1||
48181671|NCT01767129|100768137|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||0||
48181672|NCT01767129|100768136|FG000|STARTED|Treatment Period 2 (14 Days)||6||
48181673|NCT01767129|100768137|FG001|STARTED|Treatment Period 2 (14 Days)||7||
48181674|NCT01767129|100768136|FG000|COMPLETED|Treatment Period 2 (14 Days)||6||
48181675|NCT01767129|100768137|FG001|COMPLETED|Treatment Period 2 (14 Days)||7||
48181676|NCT01767129|100768136|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
48181677|NCT01767129|100768137|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
48181678|NCT02408549|100768138|FG000|STARTED|Overall Study||239||
48181679|NCT02408549|100768138|FG000|COMPLETED|Overall Study||157||
48181680|NCT02408549|100768138|FG000|NOT COMPLETED|Overall Study||82||
48756099|NCT04663321|102191233|FG001|COMPLETED|Overall Study||15||
48181681|NCT01077024|100768139|FG000|STARTED|Overall Study||267||
48181682|NCT01077024|100768140|FG001|STARTED|Overall Study||271||
48633343|NCT01299909|101885470|FG002|STARTED|Overall Study||40||
48633344|NCT01299909|101885468|FG000|COMPLETED|Overall Study||46||
48633345|NCT01299909|101885469|FG001|COMPLETED|Overall Study||49||
48633346|NCT01299909|101885470|FG002|COMPLETED|Overall Study||23||
48181683|NCT01077024|100768139|FG000|COMPLETED|Overall Study||236||
48181684|NCT01077024|100768140|FG001|COMPLETED|Overall Study||243||
48181685|NCT01077024|100768139|FG000|NOT COMPLETED|Overall Study||31||
48181686|NCT01077024|100768140|FG001|NOT COMPLETED|Overall Study||28||
48181687|NCT00442286|100768141|FG000|STARTED|Overall Study||181||
48181688|NCT00442286|100768142|FG001|STARTED|Overall Study||84||
48181689|NCT00442286|100768141|FG000|6 Months|Overall Study||177||
48181690|NCT00442286|100768142|FG001|6 Months|Overall Study||83||
48633347|NCT01299909|101885468|FG000|NOT COMPLETED|Overall Study||22||
48633348|NCT01299909|101885469|FG001|NOT COMPLETED|Overall Study||18||
48633349|NCT01299909|101885470|FG002|NOT COMPLETED|Overall Study||17||
48756100|NCT04663321|102191234|FG002|COMPLETED|Overall Study||35||
48756101|NCT04663321|102191232|FG000|NOT COMPLETED|Overall Study||12||
48181691|NCT00442286|100768141|FG000|12 Months|Overall Study||174||
48633350|NCT03340883|101885471|FG000|STARTED|Overall Study||4||
48633351|NCT03340883|101885472|FG001|STARTED|Overall Study||3||
48633352|NCT03340883|101885473|FG002|STARTED|Overall Study||4||
48181692|NCT00442286|100768142|FG001|12 Months|Overall Study||82||
48181693|NCT00442286|100768141|FG000|COMPLETED|Overall Study||174||
48181694|NCT00442286|100768142|FG001|COMPLETED|Overall Study||82||
48181695|NCT00442286|100768141|FG000|NOT COMPLETED|Overall Study||7||
48181696|NCT00442286|100768142|FG001|NOT COMPLETED|Overall Study||2||
48181697|NCT00780442|100768143|FG000|STARTED|Overall Study||12||
48181698|NCT00780442|100768144|FG001|STARTED|Overall Study||15||
48181699|NCT00780442|100768143|FG000|COMPLETED|Overall Study||12||
48181700|NCT00780442|100768144|FG001|COMPLETED|Overall Study||15||
48181701|NCT00780442|100768143|FG000|NOT COMPLETED|Overall Study||0||
48181702|NCT00780442|100768144|FG001|NOT COMPLETED|Overall Study||0||
48181703|NCT02873286|100768145|FG000|STARTED|Main Study||78|Received first vaccination|
48181704|NCT02873286|100768146|FG001|STARTED|Main Study||89|Received first vaccination|
48181705|NCT02873286|100768147|FG002|STARTED|Main Study||80|Received first vaccination|
48181706|NCT02873286|100768148|FG003|STARTED|Main Study||90|Received first vaccination|
48181707|NCT02873286|100768149|FG004|STARTED|Main Study||83|Received first vaccination|
48181708|NCT02873286|100768145|FG000|COMPLETED|Main Study||76|Completed active trial phase|
48181709|NCT02873286|100768146|FG001|COMPLETED|Main Study||84|Completed active trial phase|
48181710|NCT02873286|100768147|FG002|COMPLETED|Main Study||78|Completed active trial phase|
48181711|NCT02873286|100768148|FG003|COMPLETED|Main Study||89|Completed active trial phase|
48181712|NCT02873286|100768149|FG004|COMPLETED|Main Study||81|Completed active trial phase|
48181713|NCT02873286|100768145|FG000|NOT COMPLETED|Main Study||2||
48181714|NCT02873286|100768146|FG001|NOT COMPLETED|Main Study||5||
48181715|NCT02873286|100768147|FG002|NOT COMPLETED|Main Study||2||
48181716|NCT02873286|100768148|FG003|NOT COMPLETED|Main Study||1||
48181717|NCT02873286|100768149|FG004|NOT COMPLETED|Main Study||2||
48181718|NCT02873286|100768145|FG000|STARTED|Booster Substudy||43|Entered substudy and received booster vaccination|
48181719|NCT02873286|100768146|FG001|STARTED|Booster Substudy||0|Entered substudy and received booster vaccination|
48181720|NCT02873286|100768147|FG002|STARTED|Booster Substudy||45|Entered substudy and received booster vaccination|
48756102|NCT04663321|102191233|FG001|NOT COMPLETED|Overall Study||4||
48756103|NCT04663321|102191234|FG002|NOT COMPLETED|Overall Study||5||
48756104|NCT05789745|102191235|FG000|STARTED|Overall Study||6||
48756105|NCT05789745|102191236|FG001|STARTED|Overall Study||6||
48181721|NCT02873286|100768148|FG003|STARTED|Booster Substudy||0|Entered substudy and received booster vaccination|
48181722|NCT02873286|100768149|FG004|STARTED|Booster Substudy||0|Entered substudy and received booster vaccination|
48181723|NCT02873286|100768145|FG000|COMPLETED|Booster Substudy||43|Completed substudy active trial phase|
48181724|NCT02873286|100768146|FG001|COMPLETED|Booster Substudy||0|Completed substudy active trial phase|
48181725|NCT02873286|100768147|FG002|COMPLETED|Booster Substudy||45|Completed substudy active trial phase|
48181726|NCT02873286|100768148|FG003|COMPLETED|Booster Substudy||0|Completed substudy active trial phase|
48181727|NCT02873286|100768149|FG004|COMPLETED|Booster Substudy||0|Completed substudy active trial phase|
48181728|NCT02873286|100768145|FG000|NOT COMPLETED|Booster Substudy||0||
48181729|NCT02873286|100768146|FG001|NOT COMPLETED|Booster Substudy||0||
48181730|NCT02873286|100768147|FG002|NOT COMPLETED|Booster Substudy||0||
48181731|NCT02873286|100768148|FG003|NOT COMPLETED|Booster Substudy||0||
48181732|NCT02873286|100768149|FG004|NOT COMPLETED|Booster Substudy||0||
48181733|NCT04796935|100768150|FG000|STARTED|Overall Study||42||
48181734|NCT04796935|100768151|FG001|STARTED|Overall Study||48||
48181735|NCT04796935|100768150|FG000|Received Randomized Location Method|Overall Study||30||
48181736|NCT04796935|100768151|FG001|Received Randomized Location Method|Overall Study||46||
48181737|NCT04796935|100768150|FG000|Achieved Procedure Success|Overall Study||30|Procedure success was defined as confirmation of entry into the spinal canal using standard methods (e.g. return of cerebrospinal fluid from the needle).|
48181738|NCT04796935|100768151|FG001|Achieved Procedure Success|Overall Study||41|Procedure success was defined as confirmation of entry into the spinal canal using standard methods (e.g. return of cerebrospinal fluid from the needle).|
48181739|NCT04796935|100768150|FG000|COMPLETED|Overall Study||40||
48181740|NCT04796935|100768151|FG001|COMPLETED|Overall Study||46||
48181741|NCT04796935|100768150|FG000|NOT COMPLETED|Overall Study||2||
48181742|NCT04796935|100768151|FG001|NOT COMPLETED|Overall Study||2||
48181743|NCT03100838|100768152|FG000|STARTED|Overall Study||16||
48181744|NCT03100838|100768153|FG001|STARTED|Overall Study||16||
48181745|NCT03100838|100768154|FG002|STARTED|Overall Study||16||
48181746|NCT03100838|100768155|FG003|STARTED|Overall Study||16||
48181747|NCT03100838|100768152|FG000|COMPLETED|Overall Study||14||
48181748|NCT03100838|100768153|FG001|COMPLETED|Overall Study||14||
48181749|NCT03100838|100768154|FG002|COMPLETED|Overall Study||14||
48181750|NCT03100838|100768155|FG003|COMPLETED|Overall Study||15||
48181751|NCT03100838|100768152|FG000|NOT COMPLETED|Overall Study||2||
48181752|NCT03100838|100768153|FG001|NOT COMPLETED|Overall Study||2||
48181753|NCT03100838|100768154|FG002|NOT COMPLETED|Overall Study||2||
48181754|NCT03100838|100768155|FG003|NOT COMPLETED|Overall Study||1||
48181755|NCT00467142|100768156|FG000|STARTED|Overall Study||62||
48181756|NCT00467142|100768156|FG000|COMPLETED|Overall Study||59||
48181757|NCT00467142|100768156|FG000|NOT COMPLETED|Overall Study||3||
48181758|NCT00107380|100768157|FG000|STARTED|Overall Study||86||
48181759|NCT00107380|100768157|FG000|Eligible|Overall Study||84||
48181760|NCT00107380|100768157|FG000|COMPLETED|Overall Study||56||
48181761|NCT00107380|100768157|FG000|NOT COMPLETED|Overall Study||30||
48756106|NCT05789745|102191237|FG002|STARTED|Overall Study||6||
48756107|NCT05789745|102191238|FG003|STARTED|Overall Study||6||
48756108|NCT05789745|102191239|FG004|STARTED|Overall Study||8||
48756109|NCT05789745|102191235|FG000|COMPLETED|Overall Study||6||
48181762|NCT02764775|100768158|FG000|STARTED|Overall Study||14||
48181763|NCT02764775|100768158|FG000|COMPLETED|Overall Study||8||
48181764|NCT02764775|100768158|FG000|NOT COMPLETED|Overall Study||6||
48181765|NCT01290094|100768159|FG000|STARTED|Overall Study||41||
48181766|NCT01290094|100768159|FG000|COMPLETED|Overall Study||35||
48181767|NCT01290094|100768159|FG000|NOT COMPLETED|Overall Study||6||
48181768|NCT01782326|100768160|FG000|STARTED|Planned Treatment Epoch||1680||
48181769|NCT01782326|100768161|FG001|STARTED|Planned Treatment Epoch||1682||
48181770|NCT01782326|100768160|FG000|Full Analysis Set (FAS)|Planned Treatment Epoch||1675||
48181771|NCT01782326|100768161|FG001|Full Analysis Set (FAS)|Planned Treatment Epoch||1679||
48181772|NCT01782326|100768160|FG000|Per-protocol Set (PPS)|Planned Treatment Epoch||1528||
48181773|NCT01782326|100768161|FG001|Per-protocol Set (PPS)|Planned Treatment Epoch||1556||
48181774|NCT01782326|100768160|FG000|Serial Spirometry Set|Planned Treatment Epoch||280||
48181775|NCT01782326|100768161|FG001|Serial Spirometry Set|Planned Treatment Epoch||279||
48181776|NCT01782326|100768160|FG000|Safety Set (SAF)|Planned Treatment Epoch||1678||
48181777|NCT01782326|100768161|FG001|Safety Set (SAF)|Planned Treatment Epoch||1680||
48181778|NCT01782326|100768160|FG000|Urine Cortisol Set|Planned Treatment Epoch||266||
48181779|NCT01782326|100768161|FG001|Urine Cortisol Set|Planned Treatment Epoch||269||
48181780|NCT01782326|100768160|FG000|COMPLETED|Planned Treatment Epoch||1478||
48181781|NCT01782326|100768161|FG001|COMPLETED|Planned Treatment Epoch||1474||
48181782|NCT01782326|100768160|FG000|NOT COMPLETED|Planned Treatment Epoch||202||
48181783|NCT01782326|100768161|FG001|NOT COMPLETED|Planned Treatment Epoch||208||
48181784|NCT01782326|100768160|FG000|STARTED|Double-blind Treatment||1678||
48181785|NCT01782326|100768161|FG001|STARTED|Double-blind Treatment||1680||
48181786|NCT01782326|100768160|FG000|COMPLETED|Double-blind Treatment||1400||
48181787|NCT01782326|100768161|FG001|COMPLETED|Double-blind Treatment||1360||
48181788|NCT01782326|100768160|FG000|NOT COMPLETED|Double-blind Treatment||278||
48181789|NCT01782326|100768161|FG001|NOT COMPLETED|Double-blind Treatment||320||
48181790|NCT02139982|100768162|FG000|STARTED|Overall Study||8||
48181791|NCT02139982|100768163|FG001|STARTED|Overall Study||8||
48181792|NCT02139982|100768164|FG002|STARTED|Overall Study||8||
48181793|NCT02139982|100768165|FG003|STARTED|Overall Study||8||
48181794|NCT02139982|100768166|FG004|STARTED|Overall Study||13||
48181795|NCT02139982|100768167|FG005|STARTED|Overall Study||13||
48181796|NCT02139982|100768168|FG006|STARTED|Overall Study||13||
48181797|NCT02139982|100768169|FG007|STARTED|Overall Study||13||
48181798|NCT02139982|100768170|FG008|STARTED|Overall Study||13||
48181799|NCT02139982|100768171|FG009|STARTED|Overall Study||13||
48181800|NCT02139982|100768162|FG000|COMPLETED|Overall Study||8||
48181801|NCT02139982|100768163|FG001|COMPLETED|Overall Study||7||
48181802|NCT02139982|100768164|FG002|COMPLETED|Overall Study||8||
48181803|NCT02139982|100768165|FG003|COMPLETED|Overall Study||7||
48181804|NCT02139982|100768166|FG004|COMPLETED|Overall Study||13||
48181805|NCT02139982|100768167|FG005|COMPLETED|Overall Study||13||
48181806|NCT02139982|100768168|FG006|COMPLETED|Overall Study||13||
48181807|NCT02139982|100768169|FG007|COMPLETED|Overall Study||13||
48181808|NCT02139982|100768170|FG008|COMPLETED|Overall Study||13||
48181809|NCT02139982|100768171|FG009|COMPLETED|Overall Study||13||
48181810|NCT02139982|100768162|FG000|NOT COMPLETED|Overall Study||0||
48181811|NCT02139982|100768163|FG001|NOT COMPLETED|Overall Study||1||
48181812|NCT02139982|100768164|FG002|NOT COMPLETED|Overall Study||0||
48181813|NCT02139982|100768165|FG003|NOT COMPLETED|Overall Study||1||
48181814|NCT02139982|100768166|FG004|NOT COMPLETED|Overall Study||0||
48181815|NCT02139982|100768167|FG005|NOT COMPLETED|Overall Study||0||
48181816|NCT02139982|100768168|FG006|NOT COMPLETED|Overall Study||0||
48181817|NCT02139982|100768169|FG007|NOT COMPLETED|Overall Study||0||
48181818|NCT02139982|100768170|FG008|NOT COMPLETED|Overall Study||0||
48181819|NCT02139982|100768171|FG009|NOT COMPLETED|Overall Study||0||
48181820|NCT02025205|100768172|FG000|STARTED|Overall Study||43||
48181821|NCT02025205|100768173|FG001|STARTED|Overall Study||50||
48181822|NCT02025205|100768172|FG000|COMPLETED|Overall Study||40||
48181823|NCT02025205|100768173|FG001|COMPLETED|Overall Study||47||
48413777|NCT01234337|101345879|FG001|STARTED|Overall Study||271||
48756110|NCT05789745|102191236|FG001|COMPLETED|Overall Study||6||
48756111|NCT05789745|102191237|FG002|COMPLETED|Overall Study||6||
48756112|NCT05789745|102191238|FG003|COMPLETED|Overall Study||6||
48181824|NCT02025205|100768172|FG000|NOT COMPLETED|Overall Study||3||
48181825|NCT02025205|100768173|FG001|NOT COMPLETED|Overall Study||3||
48181826|NCT00506285|100768174|FG000|STARTED|3 Week Screening Phase||46||
48181827|NCT00506285|100768175|FG001|STARTED|3 Week Screening Phase||46||
48756113|NCT05789745|102191239|FG004|COMPLETED|Overall Study||7||
48181828|NCT00506285|100768174|FG000|COMPLETED|3 Week Screening Phase||29||
48181829|NCT00506285|100768175|FG001|COMPLETED|3 Week Screening Phase||36||
48181830|NCT00506285|100768174|FG000|NOT COMPLETED|3 Week Screening Phase||17||
48181831|NCT00506285|100768175|FG001|NOT COMPLETED|3 Week Screening Phase||10||
48181832|NCT00506285|100768174|FG000|STARTED|Double Blind Cross-Over Phase||29||
48181833|NCT00506285|100768175|FG001|STARTED|Double Blind Cross-Over Phase||36||
48188651|NCT03248570|100783299|FG000|COMPLETED|Overall Study||14||
48181834|NCT00506285|100768174|FG000|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||29||
48181835|NCT00506285|100768175|FG001|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||31||
48181836|NCT00506285|100768174|FG000|COMPLETED|Double Blind Cross-Over Phase||20||
48181837|NCT00506285|100768175|FG001|COMPLETED|Double Blind Cross-Over Phase||31||
48181838|NCT00506285|100768174|FG000|NOT COMPLETED|Double Blind Cross-Over Phase||9||
48181839|NCT00506285|100768175|FG001|NOT COMPLETED|Double Blind Cross-Over Phase||5||
48181840|NCT00506285|100768174|FG000|STARTED|6-month Open Label Phase||20||
48181841|NCT00506285|100768175|FG001|STARTED|6-month Open Label Phase||31||
48181842|NCT00506285|100768174|FG000|COMPLETED|6-month Open Label Phase||10||
48181843|NCT00506285|100768175|FG001|COMPLETED|6-month Open Label Phase||19||
48181844|NCT00506285|100768174|FG000|NOT COMPLETED|6-month Open Label Phase||10||
48181845|NCT00506285|100768175|FG001|NOT COMPLETED|6-month Open Label Phase||12||
48181846|NCT00946647|100768176|FG000|STARTED|Phase 1 Part||6||
48181847|NCT00946647|100768177|FG001|STARTED|Phase 1 Part||18||
48181848|NCT00946647|100768178|FG002|STARTED|Phase 1 Part||7||
48181849|NCT00946647|100768179|FG003|STARTED|Phase 1 Part||0||
48181850|NCT00946647|100768180|FG004|STARTED|Phase 1 Part||0||
48633353|NCT03340883|101885474|FG003|STARTED|Overall Study||4||
48633354|NCT03340883|101885475|FG004|STARTED|Overall Study||3||
48633355|NCT03340883|101885476|FG005|STARTED|Overall Study||3||
48181851|NCT00946647|100768176|FG000|COMPLETED|Phase 1 Part||0||
48181852|NCT00946647|100768177|FG001|COMPLETED|Phase 1 Part||0||
48181853|NCT00946647|100768178|FG002|COMPLETED|Phase 1 Part||0||
48181854|NCT00946647|100768179|FG003|COMPLETED|Phase 1 Part||0||
48181855|NCT00946647|100768180|FG004|COMPLETED|Phase 1 Part||0||
48181856|NCT00946647|100768176|FG000|NOT COMPLETED|Phase 1 Part||6||
48181857|NCT00946647|100768177|FG001|NOT COMPLETED|Phase 1 Part||18||
48181858|NCT00946647|100768178|FG002|NOT COMPLETED|Phase 1 Part||7||
48181859|NCT00946647|100768179|FG003|NOT COMPLETED|Phase 1 Part||0||
48181860|NCT00946647|100768180|FG004|NOT COMPLETED|Phase 1 Part||0||
48181861|NCT00946647|100768176|FG000|STARTED|Phase ll Part||0||
48181862|NCT00946647|100768177|FG001|STARTED|Phase ll Part||0||
48181863|NCT00946647|100768178|FG002|STARTED|Phase ll Part||0||
48181864|NCT00946647|100768179|FG003|STARTED|Phase ll Part||40||
48181865|NCT00946647|100768180|FG004|STARTED|Phase ll Part||42||
48181866|NCT00946647|100768176|FG000|Safety Set|Phase ll Part||0||
48181867|NCT00946647|100768177|FG001|Safety Set|Phase ll Part||0||
48633356|NCT03340883|101885471|FG000|COMPLETED|Overall Study||4||
48633357|NCT03340883|101885472|FG001|COMPLETED|Overall Study||3||
48633358|NCT03340883|101885473|FG002|COMPLETED|Overall Study||4||
48633359|NCT03340883|101885474|FG003|COMPLETED|Overall Study||4||
48181868|NCT00946647|100768178|FG002|Safety Set|Phase ll Part||0||
48181869|NCT00946647|100768179|FG003|Safety Set|Phase ll Part||38||
48181870|NCT00946647|100768180|FG004|Safety Set|Phase ll Part||42||
48181871|NCT00946647|100768176|FG000|COMPLETED|Phase ll Part||0||
48181872|NCT00946647|100768177|FG001|COMPLETED|Phase ll Part||0||
48181873|NCT00946647|100768178|FG002|COMPLETED|Phase ll Part||0||
48181874|NCT00946647|100768179|FG003|COMPLETED|Phase ll Part||0||
48181875|NCT00946647|100768180|FG004|COMPLETED|Phase ll Part||0||
48181876|NCT00946647|100768176|FG000|NOT COMPLETED|Phase ll Part||0||
48181877|NCT00946647|100768177|FG001|NOT COMPLETED|Phase ll Part||0||
48181878|NCT00946647|100768178|FG002|NOT COMPLETED|Phase ll Part||0||
48181879|NCT00946647|100768179|FG003|NOT COMPLETED|Phase ll Part||40||
48181880|NCT00946647|100768180|FG004|NOT COMPLETED|Phase ll Part||42||
48181881|NCT02410161|100768181|FG000|STARTED|Overall Study||10||
48181882|NCT02410161|100768182|FG001|STARTED|Overall Study||10||
48181883|NCT02410161|100768181|FG000|COMPLETED|Overall Study||10||
48181884|NCT02410161|100768182|FG001|COMPLETED|Overall Study||10||
48181885|NCT02410161|100768181|FG000|NOT COMPLETED|Overall Study||0||
48181886|NCT02410161|100768182|FG001|NOT COMPLETED|Overall Study||0||
48181887|NCT00097370|100768183|FG000|STARTED|Stage 1||37||
48342044|NCT00896532|101164134|FG010|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
48633360|NCT03340883|101885475|FG004|COMPLETED|Overall Study||3||
48181888|NCT00097370|100768183|FG000|COMPLETED|Stage 1||31||
48181889|NCT00097370|100768183|FG000|NOT COMPLETED|Stage 1||6||
48181890|NCT00097370|100768183|FG000|STARTED|Stage 2||72||
48181891|NCT00097370|100768183|FG000|COMPLETED|Stage 2||59||
48181892|NCT00097370|100768183|FG000|NOT COMPLETED|Stage 2||13||
48181893|NCT00097370|100768183|FG000|STARTED|Stage 3||59||
48181894|NCT00097370|100768183|FG000|COMPLETED|Stage 3||0||
48181895|NCT00097370|100768183|FG000|NOT COMPLETED|Stage 3||59||
48181896|NCT00939796|100768184|FG000|STARTED|Overall Study||16||
48181897|NCT00939796|100768184|FG000|COMPLETED|Overall Study||16||
48633361|NCT03340883|101885476|FG005|COMPLETED|Overall Study||3||
48181898|NCT00939796|100768184|FG000|NOT COMPLETED|Overall Study||0||
48181899|NCT02150044|100768185|FG000|STARTED|Overall Study||29||
48181900|NCT02150044|100768185|FG000|Lead-In Subjects|Overall Study||16||
48181901|NCT02150044|100768185|FG000|Study Cohort|Overall Study||13||
48633362|NCT03340883|101885471|FG000|NOT COMPLETED|Overall Study||0||
48181902|NCT02150044|100768185|FG000|COMPLETED|Overall Study||29||
48181903|NCT02150044|100768185|FG000|NOT COMPLETED|Overall Study||0||
48181904|NCT04463615|100768186|FG000|STARTED|Overall Study||1||
48181905|NCT04463615|100768186|FG000|COMPLETED|Overall Study||1||
48181906|NCT04463615|100768186|FG000|NOT COMPLETED|Overall Study||0||
48342045|NCT00896532|101164135|FG011|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
48342046|NCT00896532|101164136|FG012|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
48342047|NCT00896532|101164137|FG013|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
48342048|NCT00896532|101164138|FG014|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
48342049|NCT00896532|101164139|FG015|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
48342050|NCT00896532|101164140|FG016|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
48342051|NCT00896532|101164141|FG017|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
48342052|NCT00896532|101164142|FG018|NOT COMPLETED|Months 48-72: Follow-on Phase||1||
48342053|NCT00896532|101164143|FG019|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
48342054|NCT00896532|101164144|FG020|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
48342055|NCT00896532|101164145|FG021|NOT COMPLETED|Months 48-72: Follow-on Phase||2||
48342056|NCT00896532|101164146|FG022|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
48342057|NCT01948830|101164147|FG000|STARTED|Overall Study||323||
48342058|NCT01948830|101164148|FG001|STARTED|Overall Study||327||
48342059|NCT01948830|101164147|FG000|Safety Set|Overall Study||323||
48342060|NCT01948830|101164148|FG001|Safety Set|Overall Study||326||
48342061|NCT01948830|101164147|FG000|COMPLETED|Overall Study||290||
48342062|NCT01948830|101164148|FG001|COMPLETED|Overall Study||295||
48342063|NCT01948830|101164147|FG000|NOT COMPLETED|Overall Study||33||
48342064|NCT01948830|101164148|FG001|NOT COMPLETED|Overall Study||32||
48342065|NCT01220414|101164149|FG000|STARTED|Overall Study||15||
48342066|NCT01220414|101164150|FG001|STARTED|Overall Study||14||
48756114|NCT05789745|102191235|FG000|NOT COMPLETED|Overall Study||0||
48181907|NCT05677867|100768187|FG000|STARTED|Period 1||10||
48181908|NCT05677867|100768188|FG001|STARTED|Period 1||10||
48181909|NCT05677867|100768187|FG000|COMPLETED|Period 1||10||
48181910|NCT05677867|100768188|FG001|COMPLETED|Period 1||10||
48181911|NCT05677867|100768187|FG000|NOT COMPLETED|Period 1||0||
48181912|NCT05677867|100768188|FG001|NOT COMPLETED|Period 1||0||
48181913|NCT05677867|100768187|FG000|STARTED|Period 2||10||
48181914|NCT05677867|100768188|FG001|STARTED|Period 2||10||
48181915|NCT05677867|100768187|FG000|COMPLETED|Period 2||10||
48342067|NCT01220414|101164151|FG002|STARTED|Overall Study||14||
48342068|NCT01220414|101164152|FG003|STARTED|Overall Study||15||
48342069|NCT01220414|101164149|FG000|COMPLETED|Overall Study||14||
48342070|NCT01220414|101164150|FG001|COMPLETED|Overall Study||14||
48342071|NCT01220414|101164151|FG002|COMPLETED|Overall Study||14||
48756115|NCT05789745|102191236|FG001|NOT COMPLETED|Overall Study||0||
48756116|NCT05789745|102191237|FG002|NOT COMPLETED|Overall Study||0||
48756117|NCT05789745|102191238|FG003|NOT COMPLETED|Overall Study||0||
48756118|NCT05789745|102191239|FG004|NOT COMPLETED|Overall Study||1||
48756119|NCT04819945|102191240|FG000|STARTED|Overall Study||47||
48756120|NCT04819945|102191240|FG000|COMPLETED|Overall Study||46||
48756121|NCT04819945|102191240|FG000|NOT COMPLETED|Overall Study||1||
48756122|NCT04685798|102191241|FG000|STARTED|Overall Study||8||
48756123|NCT04685798|102191241|FG000|COMPLETED|Overall Study||6||
48756124|NCT04685798|102191241|FG000|NOT COMPLETED|Overall Study||2||
48756125|NCT00771914|102191242|FG000|STARTED|Overall Study||7||
48756126|NCT00771914|102191243|FG001|STARTED|Overall Study||6||
48756127|NCT00771914|102191244|FG002|STARTED|Overall Study||6||
48756128|NCT00771914|102191245|FG003|STARTED|Overall Study||8||
48756129|NCT00771914|102191242|FG000|COMPLETED|Overall Study||7||
48756130|NCT00771914|102191243|FG001|COMPLETED|Overall Study||6||
48756131|NCT00771914|102191244|FG002|COMPLETED|Overall Study||6||
48181916|NCT05677867|100768188|FG001|COMPLETED|Period 2||10||
48181917|NCT05677867|100768187|FG000|NOT COMPLETED|Period 2||0||
48181918|NCT05677867|100768188|FG001|NOT COMPLETED|Period 2||0||
48181919|NCT00429793|100768189|FG000|STARTED|Overall Study||60||
48181920|NCT00429793|100768189|FG000|COMPLETED|Overall Study||54||
48181921|NCT00429793|100768189|FG000|NOT COMPLETED|Overall Study||6||
48756132|NCT00771914|102191245|FG003|COMPLETED|Overall Study||6||
48181922|NCT00179010|100768190|FG000|STARTED|Overall Study||6||
48756133|NCT00771914|102191242|FG000|NOT COMPLETED|Overall Study||0||
48756134|NCT00771914|102191243|FG001|NOT COMPLETED|Overall Study||0||
48181923|NCT00179010|100768191|FG001|STARTED|Overall Study||7||
48181924|NCT00179010|100768190|FG000|COMPLETED|Overall Study||5||
48181925|NCT00179010|100768191|FG001|COMPLETED|Overall Study||5||
48342072|NCT01220414|101164152|FG003|COMPLETED|Overall Study||14||
48342073|NCT01220414|101164149|FG000|NOT COMPLETED|Overall Study||1||
48342074|NCT01220414|101164150|FG001|NOT COMPLETED|Overall Study||0||
48756135|NCT00771914|102191244|FG002|NOT COMPLETED|Overall Study||0||
48756136|NCT00771914|102191245|FG003|NOT COMPLETED|Overall Study||2||
48756137|NCT01346358|102191246|FG000|STARTED|Overall Study||6||
48756138|NCT01346358|102191247|FG001|STARTED|Overall Study||4||
48756139|NCT01346358|102191248|FG002|STARTED|Overall Study||3||
48181926|NCT00179010|100768190|FG000|NOT COMPLETED|Overall Study||1||
48342075|NCT01220414|101164151|FG002|NOT COMPLETED|Overall Study||0||
48342076|NCT01220414|101164152|FG003|NOT COMPLETED|Overall Study||1||
48342077|NCT01552902|101164153|FG000|STARTED|Overall Study||110||
48342078|NCT01552902|101164154|FG001|STARTED|Overall Study||218||
48342079|NCT01552902|101164155|FG002|STARTED|Overall Study||219||
48342080|NCT01552902|101164153|FG000|COMPLETED|Overall Study||97||
48342081|NCT01552902|101164154|FG001|COMPLETED|Overall Study||181||
48342082|NCT01552902|101164155|FG002|COMPLETED|Overall Study||186||
48342083|NCT01552902|101164153|FG000|NOT COMPLETED|Overall Study||13||
48342084|NCT01552902|101164154|FG001|NOT COMPLETED|Overall Study||37||
48756140|NCT01346358|102191249|FG003|STARTED|Overall Study||6||
48756141|NCT01346358|102191250|FG004|STARTED|Overall Study||5||
48756142|NCT01346358|102191251|FG005|STARTED|Overall Study||5||
48756143|NCT01346358|102191252|FG006|STARTED|Overall Study||3||
48756144|NCT01346358|102191253|FG007|STARTED|Overall Study||11||
48756145|NCT01346358|102191254|FG008|STARTED|Overall Study||9||
48342085|NCT01552902|101164155|FG002|NOT COMPLETED|Overall Study||33||
48342086|NCT00434967|101164156|FG000|STARTED|Overall Study||97||
48342087|NCT00434967|101164157|FG001|STARTED|Overall Study||465||
48342088|NCT00434967|101164158|FG002|STARTED|Overall Study||470||
48342089|NCT00434967|101164159|FG003|STARTED|Overall Study||492||
48342090|NCT00434967|101164156|FG000|COMPLETED|Overall Study||90||
48342091|NCT00434967|101164157|FG001|COMPLETED|Overall Study||457||
48342092|NCT00434967|101164158|FG002|COMPLETED|Overall Study||461||
48342093|NCT00434967|101164159|FG003|COMPLETED|Overall Study||478||
48342094|NCT00434967|101164156|FG000|NOT COMPLETED|Overall Study||7||
48342095|NCT00434967|101164157|FG001|NOT COMPLETED|Overall Study||8||
48342096|NCT00434967|101164158|FG002|NOT COMPLETED|Overall Study||9||
48342097|NCT00434967|101164159|FG003|NOT COMPLETED|Overall Study||14||
48342098|NCT02327260|101164160|FG000|STARTED|Overall Study||20||
48342099|NCT02327260|101164161|FG001|STARTED|Overall Study||24||
48342100|NCT02327260|101164162|FG002|STARTED|Overall Study||17||
48342101|NCT02327260|101164160|FG000|COMPLETED|Overall Study||14||
48342102|NCT02327260|101164161|FG001|COMPLETED|Overall Study||20||
48342103|NCT02327260|101164162|FG002|COMPLETED|Overall Study||15||
48342104|NCT02327260|101164160|FG000|NOT COMPLETED|Overall Study||6||
48342105|NCT02327260|101164161|FG001|NOT COMPLETED|Overall Study||4||
48342106|NCT02327260|101164162|FG002|NOT COMPLETED|Overall Study||2||
48342107|NCT04336163|101164163|FG000|STARTED|Overall Study||55||
48342108|NCT04336163|101164164|FG001|STARTED|Overall Study||0||
48342109|NCT04336163|101164163|FG000|COMPLETED|Overall Study||0||
48342110|NCT04336163|101164164|FG001|COMPLETED|Overall Study||0||
48342111|NCT04336163|101164163|FG000|NOT COMPLETED|Overall Study||55||
48342112|NCT04336163|101164164|FG001|NOT COMPLETED|Overall Study||0||
48342113|NCT00000479|101164165|FG000|STARTED|Overall Study||9968||
48342114|NCT00000479|101164166|FG001|STARTED|Overall Study||9971||
48756146|NCT01346358|102191246|FG000|COMPLETED|Overall Study||4||
48342115|NCT00000479|101164167|FG002|STARTED|Overall Study||9966||
48756147|NCT01346358|102191247|FG001|COMPLETED|Overall Study||3||
48413778|NCT01234337|101345878|FG000|Participants Received Treatment|Overall Study||260||
48413779|NCT01234337|101345879|FG001|Participants Received Treatment|Overall Study||267||
48413780|NCT01234337|101345878|FG000|COMPLETED|Overall Study||0||
48413781|NCT01234337|101345879|FG001|COMPLETED|Overall Study||0||
48413782|NCT01234337|101345878|FG000|NOT COMPLETED|Overall Study||266||
48342116|NCT00000479|101164168|FG003|STARTED|Overall Study||9971||
48342117|NCT00000479|101164165|FG000|COMPLETED|Overall Study||9968||
48342118|NCT00000479|101164166|FG001|COMPLETED|Overall Study||9971||
48342119|NCT00000479|101164167|FG002|COMPLETED|Overall Study||9966||
48342120|NCT00000479|101164168|FG003|COMPLETED|Overall Study||9971||
48413783|NCT01234337|101345879|FG001|NOT COMPLETED|Overall Study||271||
48413784|NCT03950440|101345880|FG000|STARTED|Overall Study||84||
48413785|NCT03950440|101345881|FG001|STARTED|Overall Study||82||
48756148|NCT01346358|102191248|FG002|COMPLETED|Overall Study||2||
48756149|NCT01346358|102191249|FG003|COMPLETED|Overall Study||5||
48756150|NCT01346358|102191250|FG004|COMPLETED|Overall Study||4||
48756151|NCT01346358|102191251|FG005|COMPLETED|Overall Study||3||
48756152|NCT01346358|102191252|FG006|COMPLETED|Overall Study||2||
48756153|NCT01346358|102191253|FG007|COMPLETED|Overall Study||7||
48342121|NCT00000479|101164165|FG000|NOT COMPLETED|Overall Study||0||
48342122|NCT00000479|101164166|FG001|NOT COMPLETED|Overall Study||0||
48342123|NCT00000479|101164167|FG002|NOT COMPLETED|Overall Study||0||
48342124|NCT00000479|101164168|FG003|NOT COMPLETED|Overall Study||0||
48342125|NCT00934102|101164169|FG000|STARTED|Period 1, One Night of Wear||16||
48342126|NCT00934102|101164170|FG001|STARTED|Period 1, One Night of Wear||15||
48342127|NCT00934102|101164171|FG002|STARTED|Period 1, One Night of Wear||15||
48342128|NCT00934102|101164169|FG000|COMPLETED|Period 1, One Night of Wear||15||
48413786|NCT03950440|101345882|FG002|STARTED|Overall Study||84||
48413787|NCT03950440|101345880|FG000|Primary Analysis|Overall Study||84||
48756154|NCT01346358|102191254|FG008|COMPLETED|Overall Study||6||
48756155|NCT01346358|102191246|FG000|NOT COMPLETED|Overall Study||2||
48756156|NCT01346358|102191247|FG001|NOT COMPLETED|Overall Study||1||
48756157|NCT01346358|102191248|FG002|NOT COMPLETED|Overall Study||1||
48756158|NCT01346358|102191249|FG003|NOT COMPLETED|Overall Study||1||
48342129|NCT00934102|101164170|FG001|COMPLETED|Period 1, One Night of Wear||15||
48342130|NCT00934102|101164171|FG002|COMPLETED|Period 1, One Night of Wear||15||
48342131|NCT00934102|101164169|FG000|NOT COMPLETED|Period 1, One Night of Wear||1||
48342132|NCT00934102|101164170|FG001|NOT COMPLETED|Period 1, One Night of Wear||0||
48342133|NCT00934102|101164171|FG002|NOT COMPLETED|Period 1, One Night of Wear||0||
48342134|NCT00934102|101164169|FG000|STARTED|Period 2, 7 Days/6 Nights of Wear||15||
48342135|NCT00934102|101164170|FG001|STARTED|Period 2, 7 Days/6 Nights of Wear||15||
48342136|NCT00934102|101164171|FG002|STARTED|Period 2, 7 Days/6 Nights of Wear||15||
48342137|NCT00934102|101164169|FG000|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15||
48342138|NCT00934102|101164170|FG001|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15||
48342139|NCT00934102|101164171|FG002|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15||
48342140|NCT00934102|101164169|FG000|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0||
48342141|NCT00934102|101164170|FG001|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0||
48342142|NCT00934102|101164171|FG002|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0||
48342143|NCT01294384|101164172|FG000|STARTED|Overall Study||101||
48756159|NCT01346358|102191250|FG004|NOT COMPLETED|Overall Study||1||
48756160|NCT01346358|102191251|FG005|NOT COMPLETED|Overall Study||2||
48756161|NCT01346358|102191252|FG006|NOT COMPLETED|Overall Study||1||
48342144|NCT01294384|101164173|FG001|STARTED|Overall Study||100||
48756162|NCT01346358|102191253|FG007|NOT COMPLETED|Overall Study||4||
48756163|NCT01346358|102191254|FG008|NOT COMPLETED|Overall Study||3||
48756164|NCT05043363|102191255|FG000|STARTED|Overall Study||114||
48756165|NCT05043363|102191255|FG000|COMPLETED|Overall Study||110||
48756166|NCT05043363|102191255|FG000|NOT COMPLETED|Overall Study||4||
48756167|NCT00784563|102191256|FG000|STARTED|Years 1 & 2||21||
48756168|NCT00784563|102191257|FG001|STARTED|Years 1 & 2||22||
48756169|NCT00784563|102191258|FG002|STARTED|Years 1 & 2||0||
48181927|NCT00179010|100768191|FG001|NOT COMPLETED|Overall Study||2||
48181928|NCT03135548|100768192|FG000|STARTED|Overall Study||19|Started are randomised/treated|
48181929|NCT03135548|100768193|FG001|STARTED|Overall Study||19|Started are randomised/treated|
48181930|NCT03135548|100768194|FG002|STARTED|Overall Study||21|Started are randomised/treated|
48181931|NCT03135548|100768192|FG000|COMPLETED|Overall Study||14||
48181932|NCT03135548|100768193|FG001|COMPLETED|Overall Study||15||
48181933|NCT03135548|100768194|FG002|COMPLETED|Overall Study||18||
48181934|NCT03135548|100768192|FG000|NOT COMPLETED|Overall Study||5||
48181935|NCT03135548|100768193|FG001|NOT COMPLETED|Overall Study||4||
48181936|NCT03135548|100768194|FG002|NOT COMPLETED|Overall Study||3||
48181937|NCT02268396|100768195|FG000|STARTED|Overall Study||138||
48181938|NCT02268396|100768195|FG000|COMPLETED|Overall Study||126||
48181939|NCT02268396|100768195|FG000|NOT COMPLETED|Overall Study||12||
48181940|NCT02748564|100768196|FG000|STARTED|Overall Study||3||
48181941|NCT02748564|100768197|FG001|STARTED|Overall Study||3||
48181942|NCT02748564|100768198|FG002|STARTED|Overall Study||4||
48181943|NCT02748564|100768196|FG000|COMPLETED|Overall Study||3||
48181944|NCT02748564|100768197|FG001|COMPLETED|Overall Study||3||
48181945|NCT02748564|100768198|FG002|COMPLETED|Overall Study||4||
48181946|NCT02748564|100768196|FG000|NOT COMPLETED|Overall Study||0||
48181947|NCT02748564|100768197|FG001|NOT COMPLETED|Overall Study||0||
48181948|NCT02748564|100768198|FG002|NOT COMPLETED|Overall Study||0||
48181949|NCT01406860|100768199|FG000|STARTED|Overall Study||11||
48181950|NCT01406860|100768200|FG001|STARTED|Overall Study||8||
48181951|NCT01406860|100768199|FG000|COMPLETED|Overall Study||11||
48181952|NCT01406860|100768200|FG001|COMPLETED|Overall Study||8||
48181953|NCT01406860|100768199|FG000|NOT COMPLETED|Overall Study||0||
48181954|NCT01406860|100768200|FG001|NOT COMPLETED|Overall Study||0||
48342145|NCT01294384|101164174|FG002|STARTED|Overall Study||104||
48342146|NCT01294384|101164172|FG000|COMPLETED|Overall Study||97||
48342147|NCT01294384|101164173|FG001|COMPLETED|Overall Study||94||
48342148|NCT01294384|101164174|FG002|COMPLETED|Overall Study||95||
48756170|NCT00784563|102191256|FG000|COMPLETED|Years 1 & 2||18||
48756171|NCT00784563|102191257|FG001|COMPLETED|Years 1 & 2||17||
48756172|NCT00784563|102191258|FG002|COMPLETED|Years 1 & 2||0||
48181955|NCT05121675|100768201|FG000|STARTED|Overall Study||53||
48181956|NCT05121675|100768202|FG001|STARTED|Overall Study||54||
48181957|NCT05121675|100768201|FG000|COMPLETED|Overall Study||48||
48181958|NCT05121675|100768202|FG001|COMPLETED|Overall Study||39||
48181959|NCT05121675|100768201|FG000|NOT COMPLETED|Overall Study||5||
48181960|NCT05121675|100768202|FG001|NOT COMPLETED|Overall Study||15||
48181961|NCT01720797|100768203|FG000|STARTED|Overall Study||12||
48181962|NCT01720797|100768204|FG001|STARTED|Overall Study||9||
48181963|NCT01720797|100768203|FG000|COMPLETED|Overall Study||9||
48181964|NCT01720797|100768204|FG001|COMPLETED|Overall Study||9||
48181965|NCT01720797|100768203|FG000|NOT COMPLETED|Overall Study||3||
48342149|NCT01294384|101164172|FG000|NOT COMPLETED|Overall Study||4||
48756173|NCT00784563|102191256|FG000|NOT COMPLETED|Years 1 & 2||3||
48756174|NCT00784563|102191257|FG001|NOT COMPLETED|Years 1 & 2||5||
48181966|NCT01720797|100768204|FG001|NOT COMPLETED|Overall Study||0||
48181967|NCT02451423|100768205|FG000|STARTED|Overall Study||6||
48756175|NCT00784563|102191258|FG002|NOT COMPLETED|Years 1 & 2||0||
48756176|NCT00784563|102191256|FG000|STARTED|Year 3||0||
48181968|NCT02451423|100768206|FG001|STARTED|Overall Study||6||
48756177|NCT00784563|102191257|FG001|STARTED|Year 3||0||
48756178|NCT00784563|102191258|FG002|STARTED|Year 3||17||
48756179|NCT00784563|102191256|FG000|COMPLETED|Year 3||0||
48756180|NCT00784563|102191257|FG001|COMPLETED|Year 3||0||
48342150|NCT01294384|101164173|FG001|NOT COMPLETED|Overall Study||6||
48342151|NCT01294384|101164174|FG002|NOT COMPLETED|Overall Study||9||
48342152|NCT00771472|101164175|FG000|STARTED|Overall Study||6||
48342153|NCT00771472|101164176|FG001|STARTED|Overall Study||4||
48342154|NCT00771472|101164175|FG000|COMPLETED|Overall Study||0||
48342155|NCT00771472|101164176|FG001|COMPLETED|Overall Study||0||
48342156|NCT00771472|101164175|FG000|NOT COMPLETED|Overall Study||6||
48342157|NCT00771472|101164176|FG001|NOT COMPLETED|Overall Study||4||
48342158|NCT05175170|101164177|FG000|STARTED|Overall Study||10||
48342159|NCT05175170|101164178|FG001|STARTED|Overall Study||10||
48342160|NCT05175170|101164177|FG000|COMPLETED|Overall Study||10||
48342161|NCT05175170|101164178|FG001|COMPLETED|Overall Study||10||
48342162|NCT05175170|101164177|FG000|NOT COMPLETED|Overall Study||0||
48342163|NCT05175170|101164178|FG001|NOT COMPLETED|Overall Study||0||
48342164|NCT00974220|101164179|FG000|STARTED|Treatment Period 1||9||
48342165|NCT00974220|101164180|FG001|STARTED|Treatment Period 1||7||
48342166|NCT00974220|101164179|FG000|COMPLETED|Treatment Period 1||7||
48342167|NCT00974220|101164180|FG001|COMPLETED|Treatment Period 1||5||
48342168|NCT00974220|101164179|FG000|NOT COMPLETED|Treatment Period 1||2||
48342169|NCT00974220|101164180|FG001|NOT COMPLETED|Treatment Period 1||2||
48342170|NCT00974220|101164179|FG000|STARTED|Treatment Period 2||7||
48342171|NCT00974220|101164180|FG001|STARTED|Treatment Period 2||5||
48342172|NCT00974220|101164179|FG000|COMPLETED|Treatment Period 2||7||
48342173|NCT00974220|101164180|FG001|COMPLETED|Treatment Period 2||5||
48342174|NCT00974220|101164179|FG000|NOT COMPLETED|Treatment Period 2||0||
48756181|NCT00784563|102191258|FG002|COMPLETED|Year 3||14||
48756182|NCT00784563|102191256|FG000|NOT COMPLETED|Year 3||0||
48756183|NCT00784563|102191257|FG001|NOT COMPLETED|Year 3||0||
48756184|NCT00784563|102191258|FG002|NOT COMPLETED|Year 3||3||
48756185|NCT03043313|102191259|FG000|STARTED|Overall Study||45||
48756186|NCT03043313|102191260|FG001|STARTED|Overall Study||41||
48413788|NCT03950440|101345881|FG001|Primary Analysis|Overall Study||82||
48413789|NCT03950440|101345882|FG002|Primary Analysis|Overall Study||84||
48756187|NCT03043313|102191261|FG002|STARTED|Overall Study||31||
48342175|NCT00974220|101164180|FG001|NOT COMPLETED|Treatment Period 2||0||
48342176|NCT01552057|101164181|FG000|STARTED|Overall Study||196||
48342177|NCT01552057|101164182|FG001|STARTED|Overall Study||197||
48342178|NCT01552057|101164181|FG000|Received at Least 1 Dose of Study Drug|Overall Study||194||
48342179|NCT01552057|101164182|FG001|Received at Least 1 Dose of Study Drug|Overall Study||196||
48342180|NCT01552057|101164181|FG000|COMPLETED|Overall Study||166||
48342181|NCT01552057|101164182|FG001|COMPLETED|Overall Study||149||
48342182|NCT01552057|101164181|FG000|NOT COMPLETED|Overall Study||30||
48342183|NCT01552057|101164182|FG001|NOT COMPLETED|Overall Study||48||
48342184|NCT00531960|101164183|FG000|STARTED|Overall Study||61||
48756188|NCT03043313|102191259|FG000|COMPLETED|Overall Study||0||
48756189|NCT03043313|102191260|FG001|COMPLETED|Overall Study||0||
48756190|NCT03043313|102191261|FG002|COMPLETED|Overall Study||0||
48756191|NCT03043313|102191259|FG000|NOT COMPLETED|Overall Study||45||
48756192|NCT03043313|102191260|FG001|NOT COMPLETED|Overall Study||41||
48756193|NCT03043313|102191261|FG002|NOT COMPLETED|Overall Study||31||
48756194|NCT00168844|102191262|FG000|STARTED|Overall Study||332||
48756195|NCT00168844|102191263|FG001|STARTED|Overall Study||332||
48756196|NCT00168844|102191264|FG002|STARTED|Overall Study||319||
48756197|NCT00168844|102191262|FG000|COMPLETED|Overall Study||277||
48756198|NCT00168844|102191263|FG001|COMPLETED|Overall Study||277||
48413790|NCT03950440|101345880|FG000|1 Month Follow-up|Overall Study||80||
48633363|NCT03340883|101885472|FG001|NOT COMPLETED|Overall Study||0||
48633364|NCT03340883|101885473|FG002|NOT COMPLETED|Overall Study||0||
48633365|NCT03340883|101885474|FG003|NOT COMPLETED|Overall Study||0||
48633366|NCT03340883|101885475|FG004|NOT COMPLETED|Overall Study||0||
48633367|NCT03340883|101885476|FG005|NOT COMPLETED|Overall Study||0||
48633368|NCT01277861|101885477|FG000|STARTED|Overall Study||51||
48633369|NCT01277861|101885478|FG001|STARTED|Overall Study||49||
48633370|NCT01277861|101885477|FG000|COMPLETED|Overall Study||49||
48633371|NCT01277861|101885478|FG001|COMPLETED|Overall Study||47||
48633372|NCT01277861|101885477|FG000|NOT COMPLETED|Overall Study||2||
48756199|NCT00168844|102191264|FG002|COMPLETED|Overall Study||228||
48756200|NCT00168844|102191262|FG000|NOT COMPLETED|Overall Study||55||
48756201|NCT00168844|102191263|FG001|NOT COMPLETED|Overall Study||55||
48756202|NCT00168844|102191264|FG002|NOT COMPLETED|Overall Study||91||
48756203|NCT02722564|102191265|FG000|STARTED|Overall Study||55||
48756204|NCT02722564|102191265|FG000|COMPLETED|Overall Study||55||
48756205|NCT02722564|102191265|FG000|NOT COMPLETED|Overall Study||0||
48342185|NCT00531960|101164184|FG001|STARTED|Overall Study||63||
48342186|NCT00531960|101164183|FG000|COMPLETED|Overall Study||0||
48342187|NCT00531960|101164184|FG001|COMPLETED|Overall Study||0||
48342188|NCT00531960|101164183|FG000|NOT COMPLETED|Overall Study||61||
48342189|NCT00531960|101164184|FG001|NOT COMPLETED|Overall Study||63||
48342190|NCT02337387|101167477|FG000|STARTED|Overall Study||14||
48342191|NCT02337387|101167478|FG001|STARTED|Overall Study||8||
48342192|NCT02337387|101167479|FG002|STARTED|Overall Study||3||
48342193|NCT02337387|101167480|FG003|STARTED|Overall Study||3||
48756206|NCT05108246|102191266|FG000|STARTED|Overall Study||9||
48756207|NCT05108246|102191267|FG001|STARTED|Overall Study||7||
48633373|NCT01277861|101885478|FG001|NOT COMPLETED|Overall Study||2||
48633374|NCT01125930|101885479|FG000|STARTED|Overall Study||22||
48633375|NCT01125930|101885480|FG001|STARTED|Overall Study||46||
48342194|NCT02337387|101167477|FG000|Received at Least 1 Dose of Study Drug|Overall Study||14||
48342195|NCT02337387|101167478|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8||
48342196|NCT02337387|101167479|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
48342197|NCT02337387|101167480|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3||
48342198|NCT02337387|101167477|FG000|COMPLETED|Overall Study||0||
48342199|NCT02337387|101167478|FG001|COMPLETED|Overall Study||0||
48342200|NCT02337387|101167479|FG002|COMPLETED|Overall Study||0||
48342201|NCT02337387|101167480|FG003|COMPLETED|Overall Study||0||
48342202|NCT02337387|101167477|FG000|NOT COMPLETED|Overall Study||14||
48342203|NCT02337387|101167478|FG001|NOT COMPLETED|Overall Study||8||
48342204|NCT02337387|101167479|FG002|NOT COMPLETED|Overall Study||3||
48633376|NCT01125930|101885479|FG000|COMPLETED|Overall Study||21||
48633377|NCT01125930|101885480|FG001|COMPLETED|Overall Study||36||
48633378|NCT01125930|101885479|FG000|NOT COMPLETED|Overall Study||1||
48633379|NCT01125930|101885480|FG001|NOT COMPLETED|Overall Study||10||
48633380|NCT02679976|101885481|FG000|STARTED|Overall Study||30||
48633381|NCT02679976|101885481|FG000|Hyperopes|Overall Study||16||
48633382|NCT02679976|101885481|FG000|Myopes|Overall Study||14||
48633383|NCT02679976|101885481|FG000|COMPLETED|Overall Study||30||
48633384|NCT02679976|101885481|FG000|NOT COMPLETED|Overall Study||0||
48633385|NCT01253161|101885482|FG000|STARTED|Overall Study||29||
48756208|NCT05108246|102191266|FG000|COMPLETED|Overall Study||9||
48756209|NCT05108246|102191267|FG001|COMPLETED|Overall Study||7||
48756210|NCT05108246|102191266|FG000|NOT COMPLETED|Overall Study||0||
48342205|NCT02337387|101167480|FG003|NOT COMPLETED|Overall Study||3||
48342206|NCT03049449|101167481|FG000|STARTED|Overall Study||0||
48342207|NCT03049449|101167482|FG001|STARTED|Overall Study||3||
48342208|NCT03049449|101167483|FG002|STARTED|Overall Study||4||
48342209|NCT03049449|101167484|FG003|STARTED|Overall Study||8||
48342210|NCT03049449|101167485|FG004|STARTED|Overall Study||5||
48342211|NCT03049449|101167486|FG005|STARTED|Overall Study||0||
48342212|NCT03049449|101167487|FG006|STARTED|Overall Study||3||
48342213|NCT03049449|101167488|FG007|STARTED|Overall Study||1||
48342214|NCT03049449|101167489|FG008|STARTED|Overall Study||1||
48342215|NCT03049449|101167490|FG009|STARTED|Overall Study||1||
48342216|NCT03049449|101167481|FG000|COMPLETED|Overall Study||0||
48342217|NCT03049449|101167482|FG001|COMPLETED|Overall Study||3||
48342218|NCT03049449|101167483|FG002|COMPLETED|Overall Study||3||
48342219|NCT03049449|101167484|FG003|COMPLETED|Overall Study||7||
48342220|NCT03049449|101167485|FG004|COMPLETED|Overall Study||5||
48342221|NCT03049449|101167486|FG005|COMPLETED|Overall Study||0||
48342222|NCT03049449|101167487|FG006|COMPLETED|Overall Study||3||
48342223|NCT03049449|101167488|FG007|COMPLETED|Overall Study||0||
48342224|NCT03049449|101167489|FG008|COMPLETED|Overall Study||0||
48342225|NCT03049449|101167490|FG009|COMPLETED|Overall Study||0||
48342226|NCT03049449|101167481|FG000|NOT COMPLETED|Overall Study||0||
48342227|NCT03049449|101167482|FG001|NOT COMPLETED|Overall Study||0||
48342228|NCT03049449|101167483|FG002|NOT COMPLETED|Overall Study||1||
48342229|NCT03049449|101167484|FG003|NOT COMPLETED|Overall Study||1||
48342230|NCT03049449|101167485|FG004|NOT COMPLETED|Overall Study||0||
48342231|NCT03049449|101167486|FG005|NOT COMPLETED|Overall Study||0||
48342232|NCT03049449|101167487|FG006|NOT COMPLETED|Overall Study||0||
48342233|NCT03049449|101167488|FG007|NOT COMPLETED|Overall Study||1||
48342234|NCT03049449|101167489|FG008|NOT COMPLETED|Overall Study||1||
48342235|NCT03049449|101167490|FG009|NOT COMPLETED|Overall Study||1||
48342236|NCT03896295|101167491|FG000|STARTED|Overall Study||7||
48342237|NCT03896295|101167492|FG001|STARTED|Overall Study||30||
48342238|NCT03896295|101167491|FG000|COMPLETED|Overall Study||0||
48342239|NCT03896295|101167492|FG001|COMPLETED|Overall Study||0||
48342240|NCT03896295|101167491|FG000|NOT COMPLETED|Overall Study||7||
48342241|NCT03896295|101167492|FG001|NOT COMPLETED|Overall Study||30||
48633386|NCT01253161|101885482|FG000|COMPLETED|Overall Study||28||
48633387|NCT01253161|101885482|FG000|NOT COMPLETED|Overall Study||1||
48633388|NCT03630393|101885483|FG000|STARTED|Overall Study||68||
48633389|NCT03630393|101885484|FG001|STARTED|Overall Study||71||
48633390|NCT03630393|101885483|FG000|COMPLETED|Overall Study||67||
48756211|NCT05108246|102191267|FG001|NOT COMPLETED|Overall Study||0||
48342242|NCT03486392|101167493|FG000|STARTED|Overall Study||60||
48342243|NCT03486392|101167494|FG001|STARTED|Overall Study||59||
48342244|NCT03486392|101167495|FG002|STARTED|Overall Study||118||
48342245|NCT03486392|101167496|FG003|STARTED|Overall Study||118||
48342246|NCT03486392|101167497|FG004|STARTED|Overall Study||119||
48342247|NCT03486392|101167493|FG000|COMPLETED|Overall Study||57||
48342248|NCT03486392|101167494|FG001|COMPLETED|Overall Study||59||
48342249|NCT03486392|101167495|FG002|COMPLETED|Overall Study||104||
48342250|NCT03486392|101167496|FG003|COMPLETED|Overall Study||109||
48342251|NCT03486392|101167497|FG004|COMPLETED|Overall Study||115||
48342252|NCT03486392|101167493|FG000|NOT COMPLETED|Overall Study||3||
48342253|NCT03486392|101167494|FG001|NOT COMPLETED|Overall Study||0||
48342254|NCT03486392|101167495|FG002|NOT COMPLETED|Overall Study||14||
48342255|NCT03486392|101167496|FG003|NOT COMPLETED|Overall Study||9||
48342256|NCT03486392|101167497|FG004|NOT COMPLETED|Overall Study||4||
48342257|NCT02525549|101167498|FG000|STARTED|Overall Study||365||
48342258|NCT02525549|101167499|FG001|STARTED|Overall Study||360||
48342259|NCT02525549|101167500|FG002|STARTED|Overall Study||178||
48342260|NCT02525549|101167498|FG000|COMPLETED|Overall Study||330||
48342261|NCT02525549|101167499|FG001|COMPLETED|Overall Study||307||
48342262|NCT02525549|101167500|FG002|COMPLETED|Overall Study||159||
48342263|NCT02525549|101167498|FG000|NOT COMPLETED|Overall Study||35||
48342264|NCT02525549|101167499|FG001|NOT COMPLETED|Overall Study||53||
48342265|NCT02525549|101167500|FG002|NOT COMPLETED|Overall Study||19||
48342266|NCT00388947|101167501|FG000|STARTED|Overall Study||1590||
48342267|NCT00388947|101167501|FG000|COMPLETED|Overall Study||1543||
48342268|NCT00388947|101167501|FG000|NOT COMPLETED|Overall Study||47||
48342269|NCT00473876|101167502|FG000|STARTED|Overall Study||39||
48342270|NCT00473876|101167503|FG001|STARTED|Overall Study||23||
48342271|NCT00473876|101167502|FG000|COMPLETED|Overall Study||36||
48342272|NCT00473876|101167503|FG001|COMPLETED|Overall Study||22||
48342273|NCT00473876|101167502|FG000|NOT COMPLETED|Overall Study||3||
48342274|NCT00473876|101167503|FG001|NOT COMPLETED|Overall Study||1||
48342275|NCT02197377|101167504|FG000|STARTED|Overall Study||30||
48342276|NCT02197377|101167505|FG001|STARTED|Overall Study||30||
48342277|NCT02197377|101167504|FG000|COMPLETED|Overall Study||30||
48342278|NCT02197377|101167505|FG001|COMPLETED|Overall Study||27||
48342279|NCT02197377|101167504|FG000|NOT COMPLETED|Overall Study||0||
48342280|NCT02197377|101167505|FG001|NOT COMPLETED|Overall Study||3||
48342281|NCT01955707|101167506|FG000|STARTED|Overall Study||82||
48342282|NCT01955707|101167507|FG001|STARTED|Overall Study||79||
48342283|NCT01955707|101167506|FG000|Withdrew Prior to Dosing|Overall Study||0||
48342284|NCT01955707|101167507|FG001|Withdrew Prior to Dosing|Overall Study||1||
48342285|NCT01955707|101167506|FG000|Dosed|Overall Study||82||
48342286|NCT01955707|101167507|FG001|Dosed|Overall Study||78||
48342287|NCT01955707|101167506|FG000|Received Total Volume of Study Drug|Overall Study||82||
48342288|NCT01955707|101167507|FG001|Received Total Volume of Study Drug|Overall Study||77||
48756212|NCT01231984|102191268|FG000|STARTED|Study Period 1||69||
48342289|NCT01955707|101167506|FG000|COMPLETED|Overall Study||62||
48756213|NCT01231984|102191269|FG001|STARTED|Study Period 1||70||
48756214|NCT01231984|102191270|FG002|STARTED|Study Period 1||66||
48756215|NCT01231984|102191271|FG003|STARTED|Study Period 1||69||
48756216|NCT01231984|102191268|FG000|COMPLETED|Study Period 1||57||
48756217|NCT01231984|102191269|FG001|COMPLETED|Study Period 1||63||
48756218|NCT01231984|102191270|FG002|COMPLETED|Study Period 1||59||
48756219|NCT01231984|102191271|FG003|COMPLETED|Study Period 1||60||
48756220|NCT01231984|102191268|FG000|NOT COMPLETED|Study Period 1||12||
48756221|NCT01231984|102191269|FG001|NOT COMPLETED|Study Period 1||7||
48756222|NCT01231984|102191270|FG002|NOT COMPLETED|Study Period 1||7||
48756223|NCT01231984|102191271|FG003|NOT COMPLETED|Study Period 1||9||
48756224|NCT01231984|102191268|FG000|STARTED|Study Period 2||57||
48756225|NCT01231984|102191269|FG001|STARTED|Study Period 2||63||
48756226|NCT01231984|102191270|FG002|STARTED|Study Period 2||59||
48756227|NCT01231984|102191271|FG003|STARTED|Study Period 2||60||
48756228|NCT01231984|102191268|FG000|COMPLETED|Study Period 2||54||
48756229|NCT01231984|102191269|FG001|COMPLETED|Study Period 2||61||
48342290|NCT01955707|101167507|FG001|COMPLETED|Overall Study||57||
48756230|NCT01231984|102191270|FG002|COMPLETED|Study Period 2||59||
48342291|NCT01955707|101167506|FG000|NOT COMPLETED|Overall Study||20||
48342292|NCT01955707|101167507|FG001|NOT COMPLETED|Overall Study||22||
48342293|NCT02949128|101167508|FG000|STARTED|Initial Evaluation Period (26 Weeks)||58||
48342294|NCT02949128|101167508|FG000|Received At Least 1 Dose of Study Drug|Initial Evaluation Period (26 Weeks)||58||
48342295|NCT02949128|101167508|FG000|COMPLETED|Initial Evaluation Period (26 Weeks)||49|Completed the Initial Evaluation Period|
48342296|NCT02949128|101167508|FG000|NOT COMPLETED|Initial Evaluation Period (26 Weeks)||9||
48342297|NCT02949128|101167508|FG000|STARTED|Extension Period (Up to 4.5 Years)||49||
48413791|NCT03950440|101345881|FG001|1 Month Follow-up|Overall Study||82||
48756231|NCT01231984|102191271|FG003|COMPLETED|Study Period 2||56||
48756232|NCT01231984|102191268|FG000|NOT COMPLETED|Study Period 2||3||
48756233|NCT01231984|102191269|FG001|NOT COMPLETED|Study Period 2||2||
48756234|NCT01231984|102191270|FG002|NOT COMPLETED|Study Period 2||0||
48756235|NCT01231984|102191271|FG003|NOT COMPLETED|Study Period 2||4||
48756236|NCT01667900|102191272|FG000|STARTED|Part A, Period 1||1||
48756237|NCT01667900|102191273|FG001|STARTED|Part A, Period 1||1||
48756238|NCT01667900|102191274|FG002|STARTED|Part A, Period 1||1||
48756239|NCT01667900|102191275|FG003|STARTED|Part A, Period 1||1||
48756240|NCT01667900|102191276|FG004|STARTED|Part A, Period 1||1||
48756241|NCT01667900|102191277|FG005|STARTED|Part A, Period 1||1||
48756242|NCT01667900|102191278|FG006|STARTED|Part A, Period 1||1||
48756243|NCT01667900|102191279|FG007|STARTED|Part A, Period 1||1||
48756244|NCT01667900|102191280|FG008|STARTED|Part A, Period 1||1||
48756245|NCT01667900|102191281|FG009|STARTED|Part A, Period 1||1||
48756246|NCT01667900|102191282|FG010|STARTED|Part A, Period 1||1||
48756247|NCT01667900|102191283|FG011|STARTED|Part A, Period 1||1||
48756248|NCT01667900|102191284|FG012|STARTED|Part A, Period 1||1||
48756249|NCT01667900|102191285|FG013|STARTED|Part A, Period 1||1||
48756250|NCT01667900|102191286|FG014|STARTED|Part A, Period 1||1||
48756251|NCT01667900|102191287|FG015|STARTED|Part A, Period 1||1||
48756252|NCT01667900|102191288|FG016|STARTED|Part A, Period 1||0||
48756253|NCT01667900|102191289|FG017|STARTED|Part A, Period 1||0||
48756254|NCT01667900|102191290|FG018|STARTED|Part A, Period 1||0||
48756255|NCT01667900|102191291|FG019|STARTED|Part A, Period 1||0||
48756256|NCT01667900|102191272|FG000|COMPLETED|Part A, Period 1||1||
48756257|NCT01667900|102191273|FG001|COMPLETED|Part A, Period 1||1||
48342298|NCT02949128|101167508|FG000|Received At Least 1 Dose of Study Drug|Extension Period (Up to 4.5 Years)||47||
48342299|NCT02949128|101167508|FG000|COMPLETED|Extension Period (Up to 4.5 Years)||28||
48756258|NCT01667900|102191274|FG002|COMPLETED|Part A, Period 1||1||
48756259|NCT01667900|102191275|FG003|COMPLETED|Part A, Period 1||1||
48756260|NCT01667900|102191276|FG004|COMPLETED|Part A, Period 1||1||
48756261|NCT01667900|102191277|FG005|COMPLETED|Part A, Period 1||1||
48342300|NCT02949128|101167508|FG000|NOT COMPLETED|Extension Period (Up to 4.5 Years)||21||
48342301|NCT04698525|101167509|FG000|STARTED|Overall Study||17||
48342302|NCT04698525|101167510|FG001|STARTED|Overall Study||16||
48342303|NCT04698525|101167509|FG000|COMPLETED|Overall Study||14||
48342304|NCT04698525|101167510|FG001|COMPLETED|Overall Study||13||
48342305|NCT04698525|101167509|FG000|NOT COMPLETED|Overall Study||3||
48342306|NCT04698525|101167510|FG001|NOT COMPLETED|Overall Study||3||
48342307|NCT01577238|101167511|FG000|STARTED|Overall Study||127||
48342308|NCT01577238|101167512|FG001|STARTED|Overall Study||123||
48342309|NCT01577238|101167511|FG000|COMPLETED|Overall Study||117||
48342310|NCT01577238|101167512|FG001|COMPLETED|Overall Study||111||
48342311|NCT01577238|101167511|FG000|NOT COMPLETED|Overall Study||10||
48342312|NCT01577238|101167512|FG001|NOT COMPLETED|Overall Study||12||
48413792|NCT03950440|101345882|FG002|1 Month Follow-up|Overall Study||84||
48756262|NCT01667900|102191278|FG006|COMPLETED|Part A, Period 1||1||
48756263|NCT01667900|102191279|FG007|COMPLETED|Part A, Period 1||1||
48181969|NCT02451423|100768207|FG002|STARTED|Overall Study||11||
48181970|NCT02451423|100768205|FG000|COMPLETED|Overall Study||6||
48181971|NCT02451423|100768206|FG001|COMPLETED|Overall Study||6||
48181972|NCT02451423|100768207|FG002|COMPLETED|Overall Study||11||
48181973|NCT02451423|100768205|FG000|NOT COMPLETED|Overall Study||0||
48181974|NCT02451423|100768206|FG001|NOT COMPLETED|Overall Study||0||
48181975|NCT02451423|100768207|FG002|NOT COMPLETED|Overall Study||0||
48181976|NCT02013687|100768208|FG000|STARTED|Overall Study||6||
48181977|NCT02013687|100768209|FG001|STARTED|Overall Study||6||
48181978|NCT02013687|100768210|FG002|STARTED|Overall Study||16||
48181979|NCT02013687|100768211|FG003|STARTED|Overall Study||16||
48181980|NCT02013687|100768208|FG000|COMPLETED|Overall Study||6||
48181981|NCT02013687|100768209|FG001|COMPLETED|Overall Study||6||
48181982|NCT02013687|100768210|FG002|COMPLETED|Overall Study||14||
48181983|NCT02013687|100768211|FG003|COMPLETED|Overall Study||14||
48181984|NCT02013687|100768208|FG000|NOT COMPLETED|Overall Study||0||
48342313|NCT01940484|101167513|FG000|STARTED|Overall Study||98||
48342314|NCT01940484|101167513|FG000|COMPLETED|Overall Study||88||
48342315|NCT01940484|101167513|FG000|NOT COMPLETED|Overall Study||10||
48342316|NCT03283085|101167514|FG000|STARTED|Overall Study||89||
48756264|NCT01667900|102191280|FG008|COMPLETED|Part A, Period 1||1||
48756265|NCT01667900|102191281|FG009|COMPLETED|Part A, Period 1||1||
48756266|NCT01667900|102191282|FG010|COMPLETED|Part A, Period 1||1||
48181985|NCT02013687|100768209|FG001|NOT COMPLETED|Overall Study||0||
48181986|NCT02013687|100768210|FG002|NOT COMPLETED|Overall Study||2||
48181987|NCT02013687|100768211|FG003|NOT COMPLETED|Overall Study||2||
48181988|NCT01946243|100768212|FG000|STARTED|Overall Study||96||
48181989|NCT01946243|100768212|FG000|COMPLETED|Overall Study||96||
48756267|NCT01667900|102191283|FG011|COMPLETED|Part A, Period 1||1||
48181990|NCT01946243|100768212|FG000|NOT COMPLETED|Overall Study||0||
48342317|NCT03283085|101167515|FG001|STARTED|Overall Study||159||
48342318|NCT03283085|101167516|FG002|STARTED|Overall Study||268||
48756268|NCT01667900|102191284|FG012|COMPLETED|Part A, Period 1||1||
48756269|NCT01667900|102191285|FG013|COMPLETED|Part A, Period 1||1||
48756270|NCT01667900|102191286|FG014|COMPLETED|Part A, Period 1||1||
48756271|NCT01667900|102191287|FG015|COMPLETED|Part A, Period 1||1||
48756272|NCT01667900|102191288|FG016|COMPLETED|Part A, Period 1||0||
48756273|NCT01667900|102191289|FG017|COMPLETED|Part A, Period 1||0||
48756274|NCT01667900|102191290|FG018|COMPLETED|Part A, Period 1||0||
48756275|NCT01667900|102191291|FG019|COMPLETED|Part A, Period 1||0||
48342319|NCT03283085|101167517|FG003|STARTED|Overall Study||5||
48342320|NCT03283085|101167518|FG004|STARTED|Overall Study||10||
48756276|NCT01667900|102191272|FG000|NOT COMPLETED|Part A, Period 1||0||
48756277|NCT01667900|102191273|FG001|NOT COMPLETED|Part A, Period 1||0||
48756278|NCT01667900|102191274|FG002|NOT COMPLETED|Part A, Period 1||0||
48756279|NCT01667900|102191275|FG003|NOT COMPLETED|Part A, Period 1||0||
48756280|NCT01667900|102191276|FG004|NOT COMPLETED|Part A, Period 1||0||
48756281|NCT01667900|102191277|FG005|NOT COMPLETED|Part A, Period 1||0||
48756282|NCT01667900|102191278|FG006|NOT COMPLETED|Part A, Period 1||0||
48756283|NCT01667900|102191279|FG007|NOT COMPLETED|Part A, Period 1||0||
48756284|NCT01667900|102191280|FG008|NOT COMPLETED|Part A, Period 1||0||
48756285|NCT01667900|102191281|FG009|NOT COMPLETED|Part A, Period 1||0||
48756286|NCT01667900|102191282|FG010|NOT COMPLETED|Part A, Period 1||0||
48756287|NCT01667900|102191283|FG011|NOT COMPLETED|Part A, Period 1||0||
48756288|NCT01667900|102191284|FG012|NOT COMPLETED|Part A, Period 1||0||
48756289|NCT01667900|102191285|FG013|NOT COMPLETED|Part A, Period 1||0||
48756290|NCT01667900|102191286|FG014|NOT COMPLETED|Part A, Period 1||0||
48756291|NCT01667900|102191287|FG015|NOT COMPLETED|Part A, Period 1||0||
48756292|NCT01667900|102191288|FG016|NOT COMPLETED|Part A, Period 1||0||
48756293|NCT01667900|102191289|FG017|NOT COMPLETED|Part A, Period 1||0||
48756294|NCT01667900|102191290|FG018|NOT COMPLETED|Part A, Period 1||0||
48756295|NCT01667900|102191291|FG019|NOT COMPLETED|Part A, Period 1||0||
48342321|NCT03283085|101167519|FG005|STARTED|Overall Study||26||
48342322|NCT03283085|101167514|FG000|COMPLETED|Overall Study||0||
48342323|NCT03283085|101167515|FG001|COMPLETED|Overall Study||117||
48342324|NCT03283085|101167516|FG002|COMPLETED|Overall Study||129||
48342325|NCT03283085|101167517|FG003|COMPLETED|Overall Study||0||
48342326|NCT03283085|101167518|FG004|COMPLETED|Overall Study||6||
48342327|NCT03283085|101167519|FG005|COMPLETED|Overall Study||12||
48342328|NCT03283085|101167514|FG000|NOT COMPLETED|Overall Study||89||
48342329|NCT03283085|101167515|FG001|NOT COMPLETED|Overall Study||42||
48342330|NCT03283085|101167516|FG002|NOT COMPLETED|Overall Study||139||
48756296|NCT01667900|102191272|FG000|STARTED|Part A, Washout 1||1||
48756297|NCT01667900|102191273|FG001|STARTED|Part A, Washout 1||1||
48756298|NCT01667900|102191274|FG002|STARTED|Part A, Washout 1||1||
48756299|NCT01667900|102191275|FG003|STARTED|Part A, Washout 1||1||
48756300|NCT01667900|102191276|FG004|STARTED|Part A, Washout 1||1||
48756301|NCT01667900|102191277|FG005|STARTED|Part A, Washout 1||1||
48756302|NCT01667900|102191278|FG006|STARTED|Part A, Washout 1||1||
48756303|NCT01667900|102191279|FG007|STARTED|Part A, Washout 1||1||
48756304|NCT01667900|102191280|FG008|STARTED|Part A, Washout 1||1||
48756305|NCT01667900|102191281|FG009|STARTED|Part A, Washout 1||1||
48756306|NCT01667900|102191282|FG010|STARTED|Part A, Washout 1||1||
48756307|NCT01667900|102191283|FG011|STARTED|Part A, Washout 1||1||
48756308|NCT01667900|102191284|FG012|STARTED|Part A, Washout 1||1||
48342331|NCT03283085|101167517|FG003|NOT COMPLETED|Overall Study||5||
48342332|NCT03283085|101167518|FG004|NOT COMPLETED|Overall Study||4||
48756309|NCT01667900|102191285|FG013|STARTED|Part A, Washout 1||1||
48756310|NCT01667900|102191286|FG014|STARTED|Part A, Washout 1||1||
48756311|NCT01667900|102191287|FG015|STARTED|Part A, Washout 1||1||
48756312|NCT01667900|102191288|FG016|STARTED|Part A, Washout 1||0||
48756313|NCT01667900|102191289|FG017|STARTED|Part A, Washout 1||0||
48756314|NCT01667900|102191290|FG018|STARTED|Part A, Washout 1||0||
48756315|NCT01667900|102191291|FG019|STARTED|Part A, Washout 1||0||
48756316|NCT01667900|102191272|FG000|COMPLETED|Part A, Washout 1||1||
48756317|NCT01667900|102191273|FG001|COMPLETED|Part A, Washout 1||1||
48756318|NCT01667900|102191274|FG002|COMPLETED|Part A, Washout 1||1||
48342333|NCT03283085|101167519|FG005|NOT COMPLETED|Overall Study||14||
48756319|NCT01667900|102191275|FG003|COMPLETED|Part A, Washout 1||1||
48756320|NCT01667900|102191276|FG004|COMPLETED|Part A, Washout 1||1||
48756321|NCT01667900|102191277|FG005|COMPLETED|Part A, Washout 1||1||
48342334|NCT01756456|101167520|FG000|STARTED|Treatment Period: Phase I/II||7||
48342335|NCT01756456|101167521|FG001|STARTED|Treatment Period: Phase I/II||7||
48342336|NCT01756456|101167522|FG002|STARTED|Treatment Period: Phase I/II||4||
48756322|NCT01667900|102191278|FG006|COMPLETED|Part A, Washout 1||1||
48756323|NCT01667900|102191279|FG007|COMPLETED|Part A, Washout 1||1||
48756324|NCT01667900|102191280|FG008|COMPLETED|Part A, Washout 1||1||
48756325|NCT01667900|102191281|FG009|COMPLETED|Part A, Washout 1||1||
48756326|NCT01667900|102191282|FG010|COMPLETED|Part A, Washout 1||1||
48756327|NCT01667900|102191283|FG011|COMPLETED|Part A, Washout 1||1||
48756328|NCT01667900|102191284|FG012|COMPLETED|Part A, Washout 1||1||
48756329|NCT01667900|102191285|FG013|COMPLETED|Part A, Washout 1||1||
48756330|NCT01667900|102191286|FG014|COMPLETED|Part A, Washout 1||1||
48756331|NCT01667900|102191287|FG015|COMPLETED|Part A, Washout 1||1||
48756332|NCT01667900|102191288|FG016|COMPLETED|Part A, Washout 1||0||
48756333|NCT01667900|102191289|FG017|COMPLETED|Part A, Washout 1||0||
48756334|NCT01667900|102191290|FG018|COMPLETED|Part A, Washout 1||0||
48756335|NCT01667900|102191291|FG019|COMPLETED|Part A, Washout 1||0||
48756336|NCT01667900|102191272|FG000|NOT COMPLETED|Part A, Washout 1||0||
48756337|NCT01667900|102191273|FG001|NOT COMPLETED|Part A, Washout 1||0||
48342337|NCT01756456|101167523|FG003|STARTED|Treatment Period: Phase I/II||52||
48342338|NCT01756456|101167524|FG004|STARTED|Treatment Period: Phase I/II||52||
48342339|NCT01756456|101167525|FG005|STARTED|Treatment Period: Phase I/II||52||
48342340|NCT01756456|101167520|FG000|COMPLETED|Treatment Period: Phase I/II||6||
48342341|NCT01756456|101167521|FG001|COMPLETED|Treatment Period: Phase I/II||6||
48342342|NCT01756456|101167522|FG002|COMPLETED|Treatment Period: Phase I/II||2||
48342343|NCT01756456|101167523|FG003|COMPLETED|Treatment Period: Phase I/II||45||
48342344|NCT01756456|101167524|FG004|COMPLETED|Treatment Period: Phase I/II||39||
48342345|NCT01756456|101167525|FG005|COMPLETED|Treatment Period: Phase I/II||48||
48342346|NCT01756456|101167520|FG000|NOT COMPLETED|Treatment Period: Phase I/II||1||
48342347|NCT01756456|101167521|FG001|NOT COMPLETED|Treatment Period: Phase I/II||1||
48342348|NCT01756456|101167522|FG002|NOT COMPLETED|Treatment Period: Phase I/II||2||
48342349|NCT01756456|101167523|FG003|NOT COMPLETED|Treatment Period: Phase I/II||7||
48342350|NCT01756456|101167524|FG004|NOT COMPLETED|Treatment Period: Phase I/II||13||
48342351|NCT01756456|101167525|FG005|NOT COMPLETED|Treatment Period: Phase I/II||4||
48342352|NCT01756456|101167520|FG000|STARTED|Follow Up Period Phase I/II||6||
48342353|NCT01756456|101167521|FG001|STARTED|Follow Up Period Phase I/II||6||
48342354|NCT01756456|101167522|FG002|STARTED|Follow Up Period Phase I/II||2||
48342355|NCT01756456|101167523|FG003|STARTED|Follow Up Period Phase I/II||45||
48342356|NCT01756456|101167524|FG004|STARTED|Follow Up Period Phase I/II||39||
48342357|NCT01756456|101167525|FG005|STARTED|Follow Up Period Phase I/II||48||
48342358|NCT01756456|101167520|FG000|COMPLETED|Follow Up Period Phase I/II||5||
48342359|NCT01756456|101167521|FG001|COMPLETED|Follow Up Period Phase I/II||5||
48342360|NCT01756456|101167522|FG002|COMPLETED|Follow Up Period Phase I/II||1||
48342361|NCT01756456|101167523|FG003|COMPLETED|Follow Up Period Phase I/II||12||
48342362|NCT01756456|101167524|FG004|COMPLETED|Follow Up Period Phase I/II||13||
48342363|NCT01756456|101167525|FG005|COMPLETED|Follow Up Period Phase I/II||15||
48342364|NCT01756456|101167520|FG000|NOT COMPLETED|Follow Up Period Phase I/II||1||
48342365|NCT01756456|101167521|FG001|NOT COMPLETED|Follow Up Period Phase I/II||1||
48756338|NCT01667900|102191274|FG002|NOT COMPLETED|Part A, Washout 1||0||
48756339|NCT01667900|102191275|FG003|NOT COMPLETED|Part A, Washout 1||0||
48756340|NCT01667900|102191276|FG004|NOT COMPLETED|Part A, Washout 1||0||
48756341|NCT01667900|102191277|FG005|NOT COMPLETED|Part A, Washout 1||0||
48756342|NCT01667900|102191278|FG006|NOT COMPLETED|Part A, Washout 1||0||
48756343|NCT01667900|102191279|FG007|NOT COMPLETED|Part A, Washout 1||0||
48756344|NCT01667900|102191280|FG008|NOT COMPLETED|Part A, Washout 1||0||
48756345|NCT01667900|102191281|FG009|NOT COMPLETED|Part A, Washout 1||0||
48756346|NCT01667900|102191282|FG010|NOT COMPLETED|Part A, Washout 1||0||
48756347|NCT01667900|102191283|FG011|NOT COMPLETED|Part A, Washout 1||0||
48342366|NCT01756456|101167522|FG002|NOT COMPLETED|Follow Up Period Phase I/II||1||
48342367|NCT01756456|101167523|FG003|NOT COMPLETED|Follow Up Period Phase I/II||33||
48342368|NCT01756456|101167524|FG004|NOT COMPLETED|Follow Up Period Phase I/II||26||
48342369|NCT01756456|101167525|FG005|NOT COMPLETED|Follow Up Period Phase I/II||33||
48342370|NCT03168867|101167526|FG000|STARTED|Overall Study||74||
48342371|NCT03168867|101167527|FG001|STARTED|Overall Study||75||
48342372|NCT03168867|101167526|FG000|COMPLETED|Overall Study||73||
48342373|NCT03168867|101167527|FG001|COMPLETED|Overall Study||70||
48342374|NCT03168867|101167526|FG000|NOT COMPLETED|Overall Study||1||
48342375|NCT03168867|101167527|FG001|NOT COMPLETED|Overall Study||5||
48342376|NCT03370770|101167528|FG000|STARTED|Overall Study||204||
48342377|NCT03370770|101167528|FG000|COMPLETED|Overall Study||98||
48342378|NCT03370770|101167528|FG000|NOT COMPLETED|Overall Study||106||
48342379|NCT02472847|101167529|FG000|STARTED|Overall Study||24||
48342380|NCT02472847|101167530|FG001|STARTED|Overall Study||26||
48342381|NCT02472847|101167529|FG000|COMPLETED|Overall Study||23||
48342382|NCT02472847|101167530|FG001|COMPLETED|Overall Study||21||
48756348|NCT01667900|102191284|FG012|NOT COMPLETED|Part A, Washout 1||0||
48756349|NCT01667900|102191285|FG013|NOT COMPLETED|Part A, Washout 1||0||
48756350|NCT01667900|102191286|FG014|NOT COMPLETED|Part A, Washout 1||0||
48756351|NCT01667900|102191287|FG015|NOT COMPLETED|Part A, Washout 1||0||
48756352|NCT01667900|102191288|FG016|NOT COMPLETED|Part A, Washout 1||0||
48756353|NCT01667900|102191289|FG017|NOT COMPLETED|Part A, Washout 1||0||
48756354|NCT01667900|102191290|FG018|NOT COMPLETED|Part A, Washout 1||0||
48756355|NCT01667900|102191291|FG019|NOT COMPLETED|Part A, Washout 1||0||
48756356|NCT01667900|102191272|FG000|STARTED|Part A, Period 2||1||
48756357|NCT01667900|102191273|FG001|STARTED|Part A, Period 2||1||
48342383|NCT02472847|101167529|FG000|NOT COMPLETED|Overall Study||1||
48342384|NCT02472847|101167530|FG001|NOT COMPLETED|Overall Study||5||
48342385|NCT01290627|101167531|FG000|STARTED|Overall Study||10||
48342386|NCT01290627|101167532|FG001|STARTED|Overall Study||10||
48342387|NCT01290627|101167533|FG002|STARTED|Overall Study||10||
48342388|NCT01290627|101167531|FG000|COMPLETED|Overall Study||10||
48413793|NCT03950440|101345880|FG000|COMPLETED|Overall Study||76|6 month follow-up|
48413794|NCT03950440|101345881|FG001|COMPLETED|Overall Study||80|6 month follow-up|
48413795|NCT03950440|101345882|FG002|COMPLETED|Overall Study||83|6 month follow-up|
48756358|NCT01667900|102191274|FG002|STARTED|Part A, Period 2||1||
48756359|NCT01667900|102191275|FG003|STARTED|Part A, Period 2||1||
48342389|NCT01290627|101167532|FG001|COMPLETED|Overall Study||10||
48342390|NCT01290627|101167533|FG002|COMPLETED|Overall Study||10||
48342391|NCT01290627|101167531|FG000|NOT COMPLETED|Overall Study||0||
48756360|NCT01667900|102191276|FG004|STARTED|Part A, Period 2||1||
48756361|NCT01667900|102191277|FG005|STARTED|Part A, Period 2||1||
48342392|NCT01290627|101167532|FG001|NOT COMPLETED|Overall Study||0||
48342393|NCT01290627|101167533|FG002|NOT COMPLETED|Overall Study||0||
48342394|NCT03135249|101167534|FG000|STARTED|Overall Study||9||
48342395|NCT03135249|101167534|FG000|COMPLETED|Overall Study||7||
48342396|NCT03135249|101167534|FG000|NOT COMPLETED|Overall Study||2||
48342397|NCT02153099|101167535|FG000|STARTED|Overall Study||6||
48342398|NCT02153099|101167536|FG001|STARTED|Overall Study||6||
48342399|NCT02153099|101167537|FG002|STARTED|Overall Study||6||
48342400|NCT02153099|101167538|FG003|STARTED|Overall Study||6||
48342401|NCT02153099|101167539|FG004|STARTED|Overall Study||6||
48342402|NCT02153099|101167540|FG005|STARTED|Overall Study||6||
48342403|NCT02153099|101167541|FG006|STARTED|Overall Study||12||
48342404|NCT02153099|101167535|FG000|COMPLETED|Overall Study||6||
48342405|NCT02153099|101167536|FG001|COMPLETED|Overall Study||6||
48342406|NCT02153099|101167537|FG002|COMPLETED|Overall Study||6||
48342407|NCT02153099|101167538|FG003|COMPLETED|Overall Study||6||
48756362|NCT01667900|102191278|FG006|STARTED|Part A, Period 2||1||
48756363|NCT01667900|102191279|FG007|STARTED|Part A, Period 2||1||
48756364|NCT01667900|102191280|FG008|STARTED|Part A, Period 2||1||
48756365|NCT01667900|102191281|FG009|STARTED|Part A, Period 2||1||
48756366|NCT01667900|102191282|FG010|STARTED|Part A, Period 2||1||
48756367|NCT01667900|102191283|FG011|STARTED|Part A, Period 2||1||
48756368|NCT01667900|102191284|FG012|STARTED|Part A, Period 2||1||
48756369|NCT01667900|102191285|FG013|STARTED|Part A, Period 2||1||
48756370|NCT01667900|102191286|FG014|STARTED|Part A, Period 2||1||
48756371|NCT01667900|102191287|FG015|STARTED|Part A, Period 2||1||
48342408|NCT02153099|101167539|FG004|COMPLETED|Overall Study||6||
48342409|NCT02153099|101167540|FG005|COMPLETED|Overall Study||6||
48342410|NCT02153099|101167541|FG006|COMPLETED|Overall Study||12||
48342411|NCT02153099|101167535|FG000|NOT COMPLETED|Overall Study||0||
48342412|NCT02153099|101167536|FG001|NOT COMPLETED|Overall Study||0||
48413796|NCT03950440|101345880|FG000|NOT COMPLETED|Overall Study||8||
48413797|NCT03950440|101345881|FG001|NOT COMPLETED|Overall Study||2||
48413798|NCT03950440|101345882|FG002|NOT COMPLETED|Overall Study||1||
48342413|NCT02153099|101167537|FG002|NOT COMPLETED|Overall Study||0||
48342414|NCT02153099|101167538|FG003|NOT COMPLETED|Overall Study||0||
48756372|NCT01667900|102191288|FG016|STARTED|Part A, Period 2||0||
48756373|NCT01667900|102191289|FG017|STARTED|Part A, Period 2||0||
48756374|NCT01667900|102191290|FG018|STARTED|Part A, Period 2||0||
48342415|NCT02153099|101167539|FG004|NOT COMPLETED|Overall Study||0||
48342416|NCT02153099|101167540|FG005|NOT COMPLETED|Overall Study||0||
48342417|NCT02153099|101167541|FG006|NOT COMPLETED|Overall Study||0||
48342418|NCT05172544|101167542|FG000|STARTED|Overall Study||10||
48342419|NCT05172544|101167543|FG001|STARTED|Overall Study||10||
48342420|NCT05172544|101167544|FG002|STARTED|Overall Study||6||
48342421|NCT05172544|101167542|FG000|COMPLETED|Overall Study||9||
48342422|NCT05172544|101167543|FG001|COMPLETED|Overall Study||10||
48342423|NCT05172544|101167544|FG002|COMPLETED|Overall Study||5||
48342424|NCT05172544|101167542|FG000|NOT COMPLETED|Overall Study||1||
48342425|NCT05172544|101167543|FG001|NOT COMPLETED|Overall Study||0||
48756375|NCT01667900|102191291|FG019|STARTED|Part A, Period 2||0||
48756376|NCT01667900|102191272|FG000|COMPLETED|Part A, Period 2||1||
48756377|NCT01667900|102191273|FG001|COMPLETED|Part A, Period 2||1||
48756378|NCT01667900|102191274|FG002|COMPLETED|Part A, Period 2||1||
48756379|NCT01667900|102191275|FG003|COMPLETED|Part A, Period 2||1||
48756380|NCT01667900|102191276|FG004|COMPLETED|Part A, Period 2||1||
48633391|NCT03630393|101885484|FG001|COMPLETED|Overall Study||71||
48633392|NCT03630393|101885483|FG000|NOT COMPLETED|Overall Study||1||
48756381|NCT01667900|102191277|FG005|COMPLETED|Part A, Period 2||1||
48756382|NCT01667900|102191278|FG006|COMPLETED|Part A, Period 2||1||
48756383|NCT01667900|102191279|FG007|COMPLETED|Part A, Period 2||1||
48633393|NCT03630393|101885484|FG001|NOT COMPLETED|Overall Study||0||
48633394|NCT01704261|101885485|FG000|STARTED|Overall Study||154||
48633395|NCT01704261|101885486|FG001|STARTED|Overall Study||153||
48633396|NCT01704261|101885485|FG000|COMPLETED|Overall Study||141||
48756384|NCT01667900|102191280|FG008|COMPLETED|Part A, Period 2||1||
48756385|NCT01667900|102191281|FG009|COMPLETED|Part A, Period 2||1||
48756386|NCT01667900|102191282|FG010|COMPLETED|Part A, Period 2||1||
48756387|NCT01667900|102191283|FG011|COMPLETED|Part A, Period 2||1||
48756388|NCT01667900|102191284|FG012|COMPLETED|Part A, Period 2||1||
48756389|NCT01667900|102191285|FG013|COMPLETED|Part A, Period 2||1||
48756390|NCT01667900|102191286|FG014|COMPLETED|Part A, Period 2||1||
48756391|NCT01667900|102191287|FG015|COMPLETED|Part A, Period 2||1||
48633397|NCT01704261|101885486|FG001|COMPLETED|Overall Study||138||
48633398|NCT01704261|101885485|FG000|NOT COMPLETED|Overall Study||13||
48756392|NCT01667900|102191288|FG016|COMPLETED|Part A, Period 2||0||
48756393|NCT01667900|102191289|FG017|COMPLETED|Part A, Period 2||0||
48756394|NCT01667900|102191290|FG018|COMPLETED|Part A, Period 2||0||
48756395|NCT01667900|102191291|FG019|COMPLETED|Part A, Period 2||0||
48756396|NCT01667900|102191272|FG000|NOT COMPLETED|Part A, Period 2||0||
48756397|NCT01667900|102191273|FG001|NOT COMPLETED|Part A, Period 2||0||
48756398|NCT01667900|102191274|FG002|NOT COMPLETED|Part A, Period 2||0||
48756399|NCT01667900|102191275|FG003|NOT COMPLETED|Part A, Period 2||0||
48756400|NCT01667900|102191276|FG004|NOT COMPLETED|Part A, Period 2||0||
48756401|NCT01667900|102191277|FG005|NOT COMPLETED|Part A, Period 2||0||
48756402|NCT01667900|102191278|FG006|NOT COMPLETED|Part A, Period 2||0||
48756403|NCT01667900|102191279|FG007|NOT COMPLETED|Part A, Period 2||0||
48756404|NCT01667900|102191280|FG008|NOT COMPLETED|Part A, Period 2||0||
48756405|NCT01667900|102191281|FG009|NOT COMPLETED|Part A, Period 2||0||
48756406|NCT01667900|102191282|FG010|NOT COMPLETED|Part A, Period 2||0||
48756407|NCT01667900|102191283|FG011|NOT COMPLETED|Part A, Period 2||0||
48756408|NCT01667900|102191284|FG012|NOT COMPLETED|Part A, Period 2||0||
48756409|NCT01667900|102191285|FG013|NOT COMPLETED|Part A, Period 2||0||
48756410|NCT01667900|102191286|FG014|NOT COMPLETED|Part A, Period 2||0||
48756411|NCT01667900|102191287|FG015|NOT COMPLETED|Part A, Period 2||0||
48342426|NCT05172544|101167544|FG002|NOT COMPLETED|Overall Study||1||
48342427|NCT00885079|101167545|FG000|STARTED|Overall Study||93||
48342428|NCT00885079|101167546|FG001|STARTED|Overall Study||95||
48633399|NCT01704261|101885486|FG001|NOT COMPLETED|Overall Study||15||
48633400|NCT01259245|101885487|FG000|STARTED|Overall Study||98||
48342429|NCT00885079|101167545|FG000|COMPLETED|Overall Study||91||
48342430|NCT00885079|101167546|FG001|COMPLETED|Overall Study||91||
48342431|NCT00885079|101167545|FG000|NOT COMPLETED|Overall Study||2||
48342432|NCT00885079|101167546|FG001|NOT COMPLETED|Overall Study||4||
48342433|NCT00977470|101167547|FG000|STARTED|Overall Study||38||
48342434|NCT00977470|101167548|FG001|STARTED|Overall Study||38||
48342435|NCT00977470|101167547|FG000|COMPLETED|Overall Study||0||
48342436|NCT00977470|101167548|FG001|COMPLETED|Overall Study||0||
48633401|NCT01259245|101885488|FG001|STARTED|Overall Study||94||
48633402|NCT01259245|101885487|FG000|COMPLETED|Overall Study||70||
48756412|NCT01667900|102191288|FG016|NOT COMPLETED|Part A, Period 2||0||
48756413|NCT01667900|102191289|FG017|NOT COMPLETED|Part A, Period 2||0||
48756414|NCT01667900|102191290|FG018|NOT COMPLETED|Part A, Period 2||0||
48756415|NCT01667900|102191291|FG019|NOT COMPLETED|Part A, Period 2||0||
48756416|NCT01667900|102191272|FG000|STARTED|Part A, Washout 2||1||
48756417|NCT01667900|102191273|FG001|STARTED|Part A, Washout 2||1||
48756418|NCT01667900|102191274|FG002|STARTED|Part A, Washout 2||1||
48633403|NCT01259245|101885488|FG001|COMPLETED|Overall Study||68||
48633404|NCT01259245|101885487|FG000|NOT COMPLETED|Overall Study||28||
48633405|NCT01259245|101885488|FG001|NOT COMPLETED|Overall Study||26||
48633406|NCT02472353|101885489|FG000|STARTED|Overall Study||14||
48633407|NCT02472353|101885490|FG001|STARTED|Overall Study||16||
48181991|NCT00178256|100768213|FG000|STARTED|Overall Study||10||
48181992|NCT00178256|100768214|FG001|STARTED|Overall Study||7||
48181993|NCT00178256|100768215|FG002|STARTED|Overall Study||6||
48181994|NCT00178256|100768216|FG003|STARTED|Overall Study||18||
48181995|NCT00178256|100768213|FG000|COMPLETED|Overall Study||6||
48181996|NCT00178256|100768214|FG001|COMPLETED|Overall Study||6||
48181997|NCT00178256|100768215|FG002|COMPLETED|Overall Study||6||
48181998|NCT00178256|100768216|FG003|COMPLETED|Overall Study||16||
48181999|NCT00178256|100768213|FG000|NOT COMPLETED|Overall Study||4||
48182000|NCT00178256|100768214|FG001|NOT COMPLETED|Overall Study||1||
48182001|NCT00178256|100768215|FG002|NOT COMPLETED|Overall Study||0||
48182002|NCT00178256|100768216|FG003|NOT COMPLETED|Overall Study||2||
48182003|NCT00147043|100768217|FG000|STARTED|Overall Study||5||
48182004|NCT00147043|100768217|FG000|COMPLETED|Overall Study||5||
48182005|NCT00147043|100768217|FG000|NOT COMPLETED|Overall Study||0||
48182006|NCT02419755|100768218|FG000|STARTED|Overall Study||6||
48182007|NCT02419755|100768219|FG001|STARTED|Overall Study||6||
48182008|NCT02419755|100768218|FG000|COMPLETED|Overall Study||3||
48182009|NCT02419755|100768219|FG001|COMPLETED|Overall Study||2||
48182010|NCT02419755|100768218|FG000|NOT COMPLETED|Overall Study||3||
48182011|NCT02419755|100768219|FG001|NOT COMPLETED|Overall Study||4||
48182012|NCT00885495|100768220|FG000|STARTED|Overall Study||8||
48182013|NCT00885495|100768221|FG001|STARTED|Overall Study||9||
48182014|NCT00885495|100768220|FG000|COMPLETED|Overall Study||6||
48182015|NCT00885495|100768221|FG001|COMPLETED|Overall Study||6||
48182016|NCT00885495|100768220|FG000|NOT COMPLETED|Overall Study||2||
48182017|NCT00885495|100768221|FG001|NOT COMPLETED|Overall Study||3||
48182018|NCT01625338|100768222|FG000|STARTED|Overall Study||114||
48182019|NCT01625338|100768223|FG001|STARTED|Overall Study||200||
48182020|NCT01625338|100768224|FG002|STARTED|Overall Study||220||
48182021|NCT01625338|100768222|FG000|COMPLETED|Overall Study||82||
48182022|NCT01625338|100768223|FG001|COMPLETED|Overall Study||156||
48182023|NCT01625338|100768224|FG002|COMPLETED|Overall Study||181||
48182024|NCT01625338|100768222|FG000|NOT COMPLETED|Overall Study||32||
48182025|NCT01625338|100768223|FG001|NOT COMPLETED|Overall Study||44||
48182026|NCT01625338|100768224|FG002|NOT COMPLETED|Overall Study||39||
48182027|NCT00581256|100768225|FG000|STARTED|Overall Study||28||
48182028|NCT00581256|100768226|FG001|STARTED|Overall Study||26||
48182029|NCT00581256|100768225|FG000|COMPLETED|Overall Study||28||
48182030|NCT00581256|100768226|FG001|COMPLETED|Overall Study||26||
48182031|NCT00581256|100768225|FG000|NOT COMPLETED|Overall Study||0||
48182032|NCT00581256|100768226|FG001|NOT COMPLETED|Overall Study||0||
48182033|NCT03615482|100768227|FG000|STARTED|Overall Study||600||
48633408|NCT02472353|101885489|FG000|COMPLETED|Overall Study||10||
48633409|NCT02472353|101885490|FG001|COMPLETED|Overall Study||10||
48633410|NCT02472353|101885489|FG000|NOT COMPLETED|Overall Study||4||
48633411|NCT02472353|101885490|FG001|NOT COMPLETED|Overall Study||6||
48633412|NCT01141608|101885491|FG000|STARTED|Overall Study||152||
48182034|NCT03615482|100768228|FG001|STARTED|Overall Study||600||
48182035|NCT03615482|100768227|FG000|Vaccinated|Overall Study||599||
48182036|NCT03615482|100768228|FG001|Vaccinated|Overall Study||598||
48182037|NCT03615482|100768227|FG000|COMPLETED|Overall Study||583||
48182038|NCT03615482|100768228|FG001|COMPLETED|Overall Study||583||
48182039|NCT03615482|100768227|FG000|NOT COMPLETED|Overall Study||17||
48182040|NCT03615482|100768228|FG001|NOT COMPLETED|Overall Study||17||
48182041|NCT03073005|100768229|FG000|STARTED|Overall Study||33||
48182042|NCT03073005|100768230|FG001|STARTED|Overall Study||37||
48182043|NCT03073005|100768231|FG002|STARTED|Overall Study||36||
48182044|NCT03073005|100768232|FG003|STARTED|Overall Study||37||
48633413|NCT01141608|101885492|FG001|STARTED|Overall Study||150||
48633414|NCT01141608|101885491|FG000|COMPLETED|Overall Study||152||
48182045|NCT03073005|100768229|FG000|Received Initial Training|Overall Study||29||
48182046|NCT03073005|100768230|FG001|Received Initial Training|Overall Study||29||
48182047|NCT03073005|100768231|FG002|Received Initial Training|Overall Study||33||
48182048|NCT03073005|100768232|FG003|Received Initial Training|Overall Study||33||
48188652|NCT03248570|100783300|FG001|COMPLETED|Overall Study||12||
48633415|NCT01141608|101885492|FG001|COMPLETED|Overall Study||150||
48633416|NCT01141608|101885491|FG000|NOT COMPLETED|Overall Study||0||
48756419|NCT01667900|102191275|FG003|STARTED|Part A, Washout 2||1||
48756420|NCT01667900|102191276|FG004|STARTED|Part A, Washout 2||1||
48633417|NCT01141608|101885492|FG001|NOT COMPLETED|Overall Study||0||
48633418|NCT00487188|101885493|FG000|STARTED|Induction Phase||31||
48633419|NCT00487188|101885494|FG001|STARTED|Induction Phase||16||
48633420|NCT00487188|101885495|FG002|STARTED|Induction Phase||0||
48633421|NCT00487188|101885493|FG000|Safety Population|Induction Phase||29||
48756421|NCT01667900|102191277|FG005|STARTED|Part A, Washout 2||1||
48756422|NCT01667900|102191278|FG006|STARTED|Part A, Washout 2||1||
48756423|NCT01667900|102191279|FG007|STARTED|Part A, Washout 2||1||
48756424|NCT01667900|102191280|FG008|STARTED|Part A, Washout 2||1||
48756425|NCT01667900|102191281|FG009|STARTED|Part A, Washout 2||1||
48756426|NCT01667900|102191282|FG010|STARTED|Part A, Washout 2||1||
48756427|NCT01667900|102191283|FG011|STARTED|Part A, Washout 2||1||
48756428|NCT01667900|102191284|FG012|STARTED|Part A, Washout 2||1||
48756429|NCT01667900|102191285|FG013|STARTED|Part A, Washout 2||1||
48756430|NCT01667900|102191286|FG014|STARTED|Part A, Washout 2||1||
48756431|NCT01667900|102191287|FG015|STARTED|Part A, Washout 2||1||
48756432|NCT01667900|102191288|FG016|STARTED|Part A, Washout 2||0||
48756433|NCT01667900|102191289|FG017|STARTED|Part A, Washout 2||0||
48756434|NCT01667900|102191290|FG018|STARTED|Part A, Washout 2||0||
48756435|NCT01667900|102191291|FG019|STARTED|Part A, Washout 2||0||
48756436|NCT01667900|102191272|FG000|COMPLETED|Part A, Washout 2||1||
48756437|NCT01667900|102191273|FG001|COMPLETED|Part A, Washout 2||1||
48756438|NCT01667900|102191274|FG002|COMPLETED|Part A, Washout 2||1||
48756439|NCT01667900|102191275|FG003|COMPLETED|Part A, Washout 2||1||
48756440|NCT01667900|102191276|FG004|COMPLETED|Part A, Washout 2||1||
48756441|NCT01667900|102191277|FG005|COMPLETED|Part A, Washout 2||1||
48756442|NCT01667900|102191278|FG006|COMPLETED|Part A, Washout 2||1||
48756443|NCT01667900|102191279|FG007|COMPLETED|Part A, Washout 2||1||
48756444|NCT01667900|102191280|FG008|COMPLETED|Part A, Washout 2||1||
48756445|NCT01667900|102191281|FG009|COMPLETED|Part A, Washout 2||1||
48756446|NCT01667900|102191282|FG010|COMPLETED|Part A, Washout 2||1||
48756447|NCT01667900|102191283|FG011|COMPLETED|Part A, Washout 2||1||
48756448|NCT01667900|102191284|FG012|COMPLETED|Part A, Washout 2||1||
48756449|NCT01667900|102191285|FG013|COMPLETED|Part A, Washout 2||1||
48756450|NCT01667900|102191286|FG014|COMPLETED|Part A, Washout 2||1||
48756451|NCT01667900|102191287|FG015|COMPLETED|Part A, Washout 2||1||
48756452|NCT01667900|102191288|FG016|COMPLETED|Part A, Washout 2||0||
48756453|NCT01667900|102191289|FG017|COMPLETED|Part A, Washout 2||0||
48756454|NCT01667900|102191290|FG018|COMPLETED|Part A, Washout 2||0||
48756455|NCT01667900|102191291|FG019|COMPLETED|Part A, Washout 2||0||
48756456|NCT01667900|102191272|FG000|NOT COMPLETED|Part A, Washout 2||0||
48756457|NCT01667900|102191273|FG001|NOT COMPLETED|Part A, Washout 2||0||
48756458|NCT01667900|102191274|FG002|NOT COMPLETED|Part A, Washout 2||0||
48756459|NCT01667900|102191275|FG003|NOT COMPLETED|Part A, Washout 2||0||
48756460|NCT01667900|102191276|FG004|NOT COMPLETED|Part A, Washout 2||0||
48756461|NCT01667900|102191277|FG005|NOT COMPLETED|Part A, Washout 2||0||
48756462|NCT01667900|102191278|FG006|NOT COMPLETED|Part A, Washout 2||0||
48756463|NCT01667900|102191279|FG007|NOT COMPLETED|Part A, Washout 2||0||
48756464|NCT01667900|102191280|FG008|NOT COMPLETED|Part A, Washout 2||0||
48756465|NCT01667900|102191281|FG009|NOT COMPLETED|Part A, Washout 2||0||
48756466|NCT01667900|102191282|FG010|NOT COMPLETED|Part A, Washout 2||0||
48756467|NCT01667900|102191283|FG011|NOT COMPLETED|Part A, Washout 2||0||
48756468|NCT01667900|102191284|FG012|NOT COMPLETED|Part A, Washout 2||0||
48756469|NCT01667900|102191285|FG013|NOT COMPLETED|Part A, Washout 2||0||
48756470|NCT01667900|102191286|FG014|NOT COMPLETED|Part A, Washout 2||0||
48756471|NCT01667900|102191287|FG015|NOT COMPLETED|Part A, Washout 2||0||
48756472|NCT01667900|102191288|FG016|NOT COMPLETED|Part A, Washout 2||0||
48756473|NCT01667900|102191289|FG017|NOT COMPLETED|Part A, Washout 2||0||
48756474|NCT01667900|102191290|FG018|NOT COMPLETED|Part A, Washout 2||0||
48633422|NCT00487188|101885494|FG001|Safety Population|Induction Phase||18||
48633423|NCT00487188|101885495|FG002|Safety Population|Induction Phase||0||
48756475|NCT01667900|102191291|FG019|NOT COMPLETED|Part A, Washout 2||0||
48633424|NCT00487188|101885493|FG000|COMPLETED|Induction Phase||22||
48633425|NCT00487188|101885494|FG001|COMPLETED|Induction Phase||9||
48633426|NCT00487188|101885495|FG002|COMPLETED|Induction Phase||0||
48756476|NCT01667900|102191272|FG000|STARTED|Part A, Period 3||1||
48756477|NCT01667900|102191273|FG001|STARTED|Part A, Period 3||1||
48756478|NCT01667900|102191274|FG002|STARTED|Part A, Period 3||1||
48756479|NCT01667900|102191275|FG003|STARTED|Part A, Period 3||1||
48756480|NCT01667900|102191276|FG004|STARTED|Part A, Period 3||1||
48756481|NCT01667900|102191277|FG005|STARTED|Part A, Period 3||1||
48756482|NCT01667900|102191278|FG006|STARTED|Part A, Period 3||1||
48756483|NCT01667900|102191279|FG007|STARTED|Part A, Period 3||1||
48756484|NCT01667900|102191280|FG008|STARTED|Part A, Period 3||1||
48756485|NCT01667900|102191281|FG009|STARTED|Part A, Period 3||1||
48756486|NCT01667900|102191282|FG010|STARTED|Part A, Period 3||1||
48756487|NCT01667900|102191283|FG011|STARTED|Part A, Period 3||1||
48756488|NCT01667900|102191284|FG012|STARTED|Part A, Period 3||1||
48756489|NCT01667900|102191285|FG013|STARTED|Part A, Period 3||1||
48756490|NCT01667900|102191286|FG014|STARTED|Part A, Period 3||1||
48182049|NCT03073005|100768229|FG000|COMPLETED|Overall Study||25|Completed entire protocol thru discharge testing|
48182050|NCT03073005|100768230|FG001|COMPLETED|Overall Study||25|Completed entire protocol thru discharge testing|
48182051|NCT03073005|100768231|FG002|COMPLETED|Overall Study||24|Completed entire protocol thru discharge testing|
48182052|NCT03073005|100768232|FG003|COMPLETED|Overall Study||24|Completed entire protocol thru discharge testing|
48182053|NCT03073005|100768229|FG000|NOT COMPLETED|Overall Study||8||
48182054|NCT03073005|100768230|FG001|NOT COMPLETED|Overall Study||12||
48182055|NCT03073005|100768231|FG002|NOT COMPLETED|Overall Study||12||
48182056|NCT03073005|100768232|FG003|NOT COMPLETED|Overall Study||13||
48182057|NCT01375959|100768233|FG000|STARTED|First Intervention (6 Weeks)||17||
48182058|NCT01375959|100768234|FG001|STARTED|First Intervention (6 Weeks)||21||
48182059|NCT01375959|100768233|FG000|Received Invertention|First Intervention (6 Weeks)||17||
48182060|NCT01375959|100768234|FG001|Received Invertention|First Intervention (6 Weeks)||21||
48182061|NCT01375959|100768233|FG000|COMPLETED|First Intervention (6 Weeks)||15||
48182062|NCT01375959|100768234|FG001|COMPLETED|First Intervention (6 Weeks)||18||
48182063|NCT01375959|100768233|FG000|NOT COMPLETED|First Intervention (6 Weeks)||2||
48182064|NCT01375959|100768234|FG001|NOT COMPLETED|First Intervention (6 Weeks)||3||
48182065|NCT01375959|100768233|FG000|STARTED|Wash-Out (3 Weeks)||15||
48182066|NCT01375959|100768234|FG001|STARTED|Wash-Out (3 Weeks)||18||
48182067|NCT01375959|100768233|FG000|COMPLETED|Wash-Out (3 Weeks)||15||
48182068|NCT01375959|100768234|FG001|COMPLETED|Wash-Out (3 Weeks)||18||
48182069|NCT01375959|100768233|FG000|NOT COMPLETED|Wash-Out (3 Weeks)||0||
48182070|NCT01375959|100768234|FG001|NOT COMPLETED|Wash-Out (3 Weeks)||0||
48182071|NCT01375959|100768233|FG000|STARTED|Second Intervention (6 Weeks)||15||
48182072|NCT01375959|100768234|FG001|STARTED|Second Intervention (6 Weeks)||18||
48182073|NCT01375959|100768233|FG000|COMPLETED|Second Intervention (6 Weeks)||15||
48182074|NCT01375959|100768234|FG001|COMPLETED|Second Intervention (6 Weeks)||15||
48633427|NCT00487188|101885493|FG000|NOT COMPLETED|Induction Phase||9||
48633428|NCT00487188|101885494|FG001|NOT COMPLETED|Induction Phase||7||
48633429|NCT00487188|101885495|FG002|NOT COMPLETED|Induction Phase||0||
48633430|NCT00487188|101885493|FG000|STARTED|Maintenance Phase||10||
48633431|NCT00487188|101885494|FG001|STARTED|Maintenance Phase||8||
48633432|NCT00487188|101885495|FG002|STARTED|Maintenance Phase||9||
48633433|NCT00487188|101885493|FG000|COMPLETED|Maintenance Phase||7||
48633434|NCT00487188|101885494|FG001|COMPLETED|Maintenance Phase||8||
48633435|NCT00487188|101885495|FG002|COMPLETED|Maintenance Phase||8||
48182075|NCT01375959|100768233|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0||
48182076|NCT01375959|100768234|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||3||
48182077|NCT01781611|100768235|FG000|STARTED|Overall Study||13||
48182078|NCT01781611|100768236|FG001|STARTED|Overall Study||5||
48182079|NCT01781611|100768235|FG000|COMPLETED|Overall Study||9||
48182080|NCT01781611|100768236|FG001|COMPLETED|Overall Study||5||
48182081|NCT01781611|100768235|FG000|NOT COMPLETED|Overall Study||4||
48182082|NCT01781611|100768236|FG001|NOT COMPLETED|Overall Study||0||
48182083|NCT01076088|100768237|FG000|STARTED|Overall Study||122||
48182084|NCT01076088|100768238|FG001|STARTED|Overall Study||125||
48182085|NCT01076088|100768239|FG002|STARTED|Overall Study||126||
48182086|NCT01076088|100768240|FG003|STARTED|Overall Study||124||
48182087|NCT01076088|100768241|FG004|STARTED|Overall Study||120||
48182088|NCT01076088|100768242|FG005|STARTED|Overall Study||127||
48342437|NCT00977470|101167547|FG000|NOT COMPLETED|Overall Study||38||
48342438|NCT00977470|101167548|FG001|NOT COMPLETED|Overall Study||38||
48182089|NCT01076088|100768237|FG000|COMPLETED|Overall Study||111||
48182090|NCT01076088|100768238|FG001|COMPLETED|Overall Study||107||
48182091|NCT01076088|100768239|FG002|COMPLETED|Overall Study||109||
48182092|NCT01076088|100768240|FG003|COMPLETED|Overall Study||109||
48182093|NCT01076088|100768241|FG004|COMPLETED|Overall Study||104||
48182094|NCT01076088|100768242|FG005|COMPLETED|Overall Study||104||
48182095|NCT01076088|100768237|FG000|NOT COMPLETED|Overall Study||11||
48182096|NCT01076088|100768238|FG001|NOT COMPLETED|Overall Study||18||
48182097|NCT01076088|100768239|FG002|NOT COMPLETED|Overall Study||17||
48182098|NCT01076088|100768240|FG003|NOT COMPLETED|Overall Study||15||
48182099|NCT01076088|100768241|FG004|NOT COMPLETED|Overall Study||16||
48633436|NCT00487188|101885493|FG000|NOT COMPLETED|Maintenance Phase||3||
48633437|NCT00487188|101885494|FG001|NOT COMPLETED|Maintenance Phase||0||
48633438|NCT00487188|101885495|FG002|NOT COMPLETED|Maintenance Phase||1||
48633439|NCT00350545|101885496|FG000|STARTED|Overall Study||37||
48633440|NCT00350545|101885496|FG000|COMPLETED|Overall Study||35||
48633441|NCT00350545|101885496|FG000|NOT COMPLETED|Overall Study||2||
48633442|NCT01092767|101885497|FG000|STARTED|Overall Study||50||
48633443|NCT01092767|101885497|FG000|COMPLETED|Overall Study||45||
48182100|NCT01076088|100768242|FG005|NOT COMPLETED|Overall Study||23||
48182101|NCT01628874|100768243|FG000|STARTED|Overall Study||34||
48182102|NCT01628874|100768244|FG001|STARTED|Overall Study||32||
48182103|NCT01628874|100768243|FG000|COMPLETED|Overall Study||29||
48182104|NCT01628874|100768244|FG001|COMPLETED|Overall Study||29||
48633444|NCT01092767|101885497|FG000|NOT COMPLETED|Overall Study||5||
48182105|NCT01628874|100768243|FG000|NOT COMPLETED|Overall Study||5||
48342439|NCT00506857|101167549|FG000|STARTED|Overall Study||80||
48633445|NCT03427892|101885498|FG000|STARTED|Overall Study||21|Open Label (baseline to week 8)|
48633446|NCT03427892|101885498|FG000|COMPLETED|Overall Study||19||
48342440|NCT00506857|101167549|FG000|COMPLETED|Overall Study||80||
48342441|NCT00506857|101167549|FG000|NOT COMPLETED|Overall Study||0||
48342442|NCT01097629|101167550|FG000|STARTED|Double-Blind (DB) Treatment (TRT) Phase||240||
48342443|NCT01097629|101167551|FG001|STARTED|Double-Blind (DB) Treatment (TRT) Phase||392||
48342444|NCT01097629|101167552|FG002|STARTED|Double-Blind (DB) Treatment (TRT) Phase||387||
48633447|NCT03427892|101885498|FG000|NOT COMPLETED|Overall Study||2||
48633448|NCT00726453|101885499|FG000|STARTED|Primary Enrollment Group||1402||
48633449|NCT00726453|101885500|FG001|STARTED|Primary Enrollment Group||0||
48756491|NCT01667900|102191287|FG015|STARTED|Part A, Period 3||1||
48756492|NCT01667900|102191288|FG016|STARTED|Part A, Period 3||0||
48756493|NCT01667900|102191289|FG017|STARTED|Part A, Period 3||0||
48756494|NCT01667900|102191290|FG018|STARTED|Part A, Period 3||0||
48756495|NCT01667900|102191291|FG019|STARTED|Part A, Period 3||0||
48756496|NCT01667900|102191272|FG000|COMPLETED|Part A, Period 3||1||
48756497|NCT01667900|102191273|FG001|COMPLETED|Part A, Period 3||1||
48756498|NCT01667900|102191274|FG002|COMPLETED|Part A, Period 3||1||
48756499|NCT01667900|102191275|FG003|COMPLETED|Part A, Period 3||1||
48756500|NCT01667900|102191276|FG004|COMPLETED|Part A, Period 3||1||
48756501|NCT01667900|102191277|FG005|COMPLETED|Part A, Period 3||1||
48756502|NCT01667900|102191278|FG006|COMPLETED|Part A, Period 3||1||
48413799|NCT01402375|101345883|FG000|STARTED|Overall Study||120||
48413800|NCT01402375|101345884|FG001|STARTED|Overall Study||120||
48413801|NCT01402375|101345885|FG002|STARTED|Overall Study||120||
48413802|NCT01402375|101345886|FG003|STARTED|Overall Study||120||
48413803|NCT01402375|101345887|FG004|STARTED|Overall Study||120||
48413804|NCT01402375|101345888|FG005|STARTED|Overall Study||120||
48413805|NCT01402375|101345883|FG000|COMPLETED|Overall Study||120||
48413806|NCT01402375|101345884|FG001|COMPLETED|Overall Study||120||
48342445|NCT01097629|101167553|FG003|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0||
48342446|NCT01097629|101167554|FG004|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0||
48342447|NCT01097629|101167555|FG005|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0||
48342448|NCT01097629|101167556|FG006|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0||
48342449|NCT01097629|101167557|FG007|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0||
48342450|NCT01097629|101167550|FG000|Treated|Double-Blind (DB) Treatment (TRT) Phase||239||
48342451|NCT01097629|101167551|FG001|Treated|Double-Blind (DB) Treatment (TRT) Phase||387||
48342452|NCT01097629|101167552|FG002|Treated|Double-Blind (DB) Treatment (TRT) Phase||383||
48342453|NCT01097629|101167553|FG003|Treated|Double-Blind (DB) Treatment (TRT) Phase||0||
48342454|NCT01097629|101167554|FG004|Treated|Double-Blind (DB) Treatment (TRT) Phase||0||
48413807|NCT01402375|101345885|FG002|COMPLETED|Overall Study||120||
48413808|NCT01402375|101345886|FG003|COMPLETED|Overall Study||120||
48413809|NCT01402375|101345887|FG004|COMPLETED|Overall Study||120||
48413810|NCT01402375|101345888|FG005|COMPLETED|Overall Study||120||
48413811|NCT01402375|101345883|FG000|NOT COMPLETED|Overall Study||0||
48633450|NCT00726453|101885499|FG000|COMPLETED|Primary Enrollment Group||1371||
48633451|NCT00726453|101885500|FG001|COMPLETED|Primary Enrollment Group||0||
48756503|NCT01667900|102191279|FG007|COMPLETED|Part A, Period 3||1||
48756504|NCT01667900|102191280|FG008|COMPLETED|Part A, Period 3||1||
48756505|NCT01667900|102191281|FG009|COMPLETED|Part A, Period 3||1||
48182106|NCT01628874|100768244|FG001|NOT COMPLETED|Overall Study||3||
48633452|NCT00726453|101885499|FG000|NOT COMPLETED|Primary Enrollment Group||31||
48633453|NCT00726453|101885500|FG001|NOT COMPLETED|Primary Enrollment Group||0||
48633454|NCT00726453|101885499|FG000|STARTED|38 mm Length Group||0||
48633455|NCT00726453|101885500|FG001|STARTED|38 mm Length Group||114||
48633456|NCT00726453|101885499|FG000|COMPLETED|38 mm Length Group||0||
48756506|NCT01667900|102191282|FG010|COMPLETED|Part A, Period 3||1||
48756507|NCT01667900|102191283|FG011|COMPLETED|Part A, Period 3||1||
48756508|NCT01667900|102191284|FG012|COMPLETED|Part A, Period 3||1||
48342455|NCT01097629|101167555|FG005|Treated|Double-Blind (DB) Treatment (TRT) Phase||0||
48342456|NCT01097629|101167556|FG006|Treated|Double-Blind (DB) Treatment (TRT) Phase||0||
48413812|NCT01402375|101345884|FG001|NOT COMPLETED|Overall Study||0||
48633457|NCT00726453|101885500|FG001|COMPLETED|38 mm Length Group||111||
48633458|NCT00726453|101885499|FG000|NOT COMPLETED|38 mm Length Group||0||
48633459|NCT00726453|101885500|FG001|NOT COMPLETED|38 mm Length Group||3||
48756509|NCT01667900|102191285|FG013|COMPLETED|Part A, Period 3||1||
48413813|NCT01402375|101345885|FG002|NOT COMPLETED|Overall Study||0||
48756510|NCT01667900|102191286|FG014|COMPLETED|Part A, Period 3||1||
48756511|NCT01667900|102191287|FG015|COMPLETED|Part A, Period 3||1||
48756512|NCT01667900|102191288|FG016|COMPLETED|Part A, Period 3||0||
48413814|NCT01402375|101345886|FG003|NOT COMPLETED|Overall Study||0||
48413815|NCT01402375|101345887|FG004|NOT COMPLETED|Overall Study||0||
48342457|NCT01097629|101167557|FG007|Treated|Double-Blind (DB) Treatment (TRT) Phase||0||
48342458|NCT01097629|101167550|FG000|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||205||
48633460|NCT02349386|101885501|FG000|STARTED|24-Week Double-Blind Main Study||9||
48633461|NCT02349386|101885502|FG001|STARTED|24-Week Double-Blind Main Study||8||
48633462|NCT02349386|101885503|FG002|STARTED|24-Week Double-Blind Main Study||9||
48633463|NCT02349386|101885504|FG003|STARTED|24-Week Double-Blind Main Study||8||
48633464|NCT02349386|101885501|FG000|COMPLETED|24-Week Double-Blind Main Study||3||
48633465|NCT02349386|101885502|FG001|COMPLETED|24-Week Double-Blind Main Study||2||
48633466|NCT02349386|101885503|FG002|COMPLETED|24-Week Double-Blind Main Study||4||
48633467|NCT02349386|101885504|FG003|COMPLETED|24-Week Double-Blind Main Study||0||
48633468|NCT02349386|101885501|FG000|NOT COMPLETED|24-Week Double-Blind Main Study||6||
48633469|NCT02349386|101885502|FG001|NOT COMPLETED|24-Week Double-Blind Main Study||6||
48633470|NCT02349386|101885503|FG002|NOT COMPLETED|24-Week Double-Blind Main Study||5||
48756513|NCT01667900|102191289|FG017|COMPLETED|Part A, Period 3||0||
48756514|NCT01667900|102191290|FG018|COMPLETED|Part A, Period 3||0||
48756515|NCT01667900|102191291|FG019|COMPLETED|Part A, Period 3||0||
48756516|NCT01667900|102191272|FG000|NOT COMPLETED|Part A, Period 3||0||
48756517|NCT01667900|102191273|FG001|NOT COMPLETED|Part A, Period 3||0||
48756518|NCT01667900|102191274|FG002|NOT COMPLETED|Part A, Period 3||0||
48756519|NCT01667900|102191275|FG003|NOT COMPLETED|Part A, Period 3||0||
48756520|NCT01667900|102191276|FG004|NOT COMPLETED|Part A, Period 3||0||
48756521|NCT01667900|102191277|FG005|NOT COMPLETED|Part A, Period 3||0||
48756522|NCT01667900|102191278|FG006|NOT COMPLETED|Part A, Period 3||0||
48756523|NCT01667900|102191279|FG007|NOT COMPLETED|Part A, Period 3||0||
48756524|NCT01667900|102191280|FG008|NOT COMPLETED|Part A, Period 3||0||
48756525|NCT01667900|102191281|FG009|NOT COMPLETED|Part A, Period 3||0||
48756526|NCT01667900|102191282|FG010|NOT COMPLETED|Part A, Period 3||0||
48756527|NCT01667900|102191283|FG011|NOT COMPLETED|Part A, Period 3||0||
48756528|NCT01667900|102191284|FG012|NOT COMPLETED|Part A, Period 3||0||
48756529|NCT01667900|102191285|FG013|NOT COMPLETED|Part A, Period 3||0||
48756530|NCT01667900|102191286|FG014|NOT COMPLETED|Part A, Period 3||0||
48756531|NCT01667900|102191287|FG015|NOT COMPLETED|Part A, Period 3||0||
48756532|NCT01667900|102191288|FG016|NOT COMPLETED|Part A, Period 3||0||
48756533|NCT01667900|102191289|FG017|NOT COMPLETED|Part A, Period 3||0||
48756534|NCT01667900|102191290|FG018|NOT COMPLETED|Part A, Period 3||0||
48756535|NCT01667900|102191291|FG019|NOT COMPLETED|Part A, Period 3||0||
48756536|NCT01667900|102191272|FG000|STARTED|Part B||0||
48756537|NCT01667900|102191273|FG001|STARTED|Part B||0||
48756538|NCT01667900|102191274|FG002|STARTED|Part B||0||
48756539|NCT01667900|102191275|FG003|STARTED|Part B||0||
48756540|NCT01667900|102191276|FG004|STARTED|Part B||0||
48756541|NCT01667900|102191277|FG005|STARTED|Part B||0||
48756542|NCT01667900|102191278|FG006|STARTED|Part B||0||
48756543|NCT01667900|102191279|FG007|STARTED|Part B||0||
48756544|NCT01667900|102191280|FG008|STARTED|Part B||0||
48756545|NCT01667900|102191281|FG009|STARTED|Part B||0||
48756546|NCT01667900|102191282|FG010|STARTED|Part B||0||
48756547|NCT01667900|102191283|FG011|STARTED|Part B||0||
48756548|NCT01667900|102191284|FG012|STARTED|Part B||0||
48756549|NCT01667900|102191285|FG013|STARTED|Part B||0||
48756550|NCT01667900|102191286|FG014|STARTED|Part B||0||
48756551|NCT01667900|102191287|FG015|STARTED|Part B||0||
48756552|NCT01667900|102191288|FG016|STARTED|Part B||11||
48756553|NCT01667900|102191289|FG017|STARTED|Part B||11||
48756554|NCT01667900|102191290|FG018|STARTED|Part B||10||
48756555|NCT01667900|102191291|FG019|STARTED|Part B||10||
48756556|NCT01667900|102191272|FG000|COMPLETED|Part B||0||
48756557|NCT01667900|102191273|FG001|COMPLETED|Part B||0||
48756558|NCT01667900|102191274|FG002|COMPLETED|Part B||0||
48756559|NCT01667900|102191275|FG003|COMPLETED|Part B||0||
48756560|NCT01667900|102191276|FG004|COMPLETED|Part B||0||
48756561|NCT01667900|102191277|FG005|COMPLETED|Part B||0||
48756562|NCT01667900|102191278|FG006|COMPLETED|Part B||0||
48756563|NCT01667900|102191279|FG007|COMPLETED|Part B||0||
48756564|NCT01667900|102191280|FG008|COMPLETED|Part B||0||
48756565|NCT01667900|102191281|FG009|COMPLETED|Part B||0||
48756566|NCT01667900|102191282|FG010|COMPLETED|Part B||0||
48756567|NCT01667900|102191283|FG011|COMPLETED|Part B||0||
48756568|NCT01667900|102191284|FG012|COMPLETED|Part B||0||
48756569|NCT01667900|102191285|FG013|COMPLETED|Part B||0||
48756570|NCT01667900|102191286|FG014|COMPLETED|Part B||0||
48756571|NCT01667900|102191287|FG015|COMPLETED|Part B||0||
48756572|NCT01667900|102191288|FG016|COMPLETED|Part B||10||
48756573|NCT01667900|102191289|FG017|COMPLETED|Part B||11||
48756574|NCT01667900|102191290|FG018|COMPLETED|Part B||10||
48756575|NCT01667900|102191291|FG019|COMPLETED|Part B||10||
48756576|NCT01667900|102191272|FG000|NOT COMPLETED|Part B||0||
48756577|NCT01667900|102191273|FG001|NOT COMPLETED|Part B||0||
48756578|NCT01667900|102191274|FG002|NOT COMPLETED|Part B||0||
48756579|NCT01667900|102191275|FG003|NOT COMPLETED|Part B||0||
48756580|NCT01667900|102191276|FG004|NOT COMPLETED|Part B||0||
48756581|NCT01667900|102191277|FG005|NOT COMPLETED|Part B||0||
48756582|NCT01667900|102191278|FG006|NOT COMPLETED|Part B||0||
48756583|NCT01667900|102191279|FG007|NOT COMPLETED|Part B||0||
48756584|NCT01667900|102191280|FG008|NOT COMPLETED|Part B||0||
48756585|NCT01667900|102191281|FG009|NOT COMPLETED|Part B||0||
48756586|NCT01667900|102191282|FG010|NOT COMPLETED|Part B||0||
48342459|NCT01097629|101167551|FG001|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||346||
48342460|NCT01097629|101167552|FG002|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||330||
48342461|NCT01097629|101167553|FG003|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
48342462|NCT01097629|101167554|FG004|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
48342463|NCT01097629|101167555|FG005|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
48342464|NCT01097629|101167556|FG006|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
48342465|NCT01097629|101167557|FG007|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
48342466|NCT01097629|101167550|FG000|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||35||
48342467|NCT01097629|101167551|FG001|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||46||
48342468|NCT01097629|101167552|FG002|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||57||
48342469|NCT01097629|101167553|FG003|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
48756587|NCT01667900|102191283|FG011|NOT COMPLETED|Part B||0||
48756588|NCT01667900|102191284|FG012|NOT COMPLETED|Part B||0||
48342470|NCT01097629|101167554|FG004|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
48342471|NCT01097629|101167555|FG005|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
48342472|NCT01097629|101167556|FG006|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
48342473|NCT01097629|101167557|FG007|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
48342474|NCT01097629|101167550|FG000|STARTED|DB RO Phase||0||
48342475|NCT01097629|101167551|FG001|STARTED|DB RO Phase||0||
48342476|NCT01097629|101167552|FG002|STARTED|DB RO Phase||0||
48342477|NCT01097629|101167553|FG003|STARTED|DB RO Phase||97||
48342478|NCT01097629|101167554|FG004|STARTED|DB RO Phase||108||
48413816|NCT01402375|101345888|FG005|NOT COMPLETED|Overall Study||0||
48413817|NCT02132169|101345889|FG000|STARTED|Overall Study||341||
48413818|NCT02132169|101345890|FG001|STARTED|Overall Study||171||
48413819|NCT02132169|101345889|FG000|COMPLETED|Overall Study||326||
48413820|NCT02132169|101345890|FG001|COMPLETED|Overall Study||162||
48633471|NCT02349386|101885504|FG003|NOT COMPLETED|24-Week Double-Blind Main Study||8||
48633472|NCT02349386|101885501|FG000|STARTED|28-Week Double-Blind Optional Extension||3||
48633473|NCT02349386|101885502|FG001|STARTED|28-Week Double-Blind Optional Extension||2||
48633474|NCT02349386|101885503|FG002|STARTED|28-Week Double-Blind Optional Extension||4||
48633475|NCT02349386|101885504|FG003|STARTED|28-Week Double-Blind Optional Extension||0||
48633476|NCT02349386|101885501|FG000|COMPLETED|28-Week Double-Blind Optional Extension||1||
48633477|NCT02349386|101885502|FG001|COMPLETED|28-Week Double-Blind Optional Extension||2||
48633478|NCT02349386|101885503|FG002|COMPLETED|28-Week Double-Blind Optional Extension||1||
48633479|NCT02349386|101885504|FG003|COMPLETED|28-Week Double-Blind Optional Extension||0||
48633480|NCT02349386|101885501|FG000|NOT COMPLETED|28-Week Double-Blind Optional Extension||2||
48633481|NCT02349386|101885502|FG001|NOT COMPLETED|28-Week Double-Blind Optional Extension||0||
48633482|NCT02349386|101885503|FG002|NOT COMPLETED|28-Week Double-Blind Optional Extension||3||
48633483|NCT02349386|101885504|FG003|NOT COMPLETED|28-Week Double-Blind Optional Extension||0||
48633484|NCT03101020|101885505|FG000|STARTED|Overall Study||10||
48633485|NCT03101020|101885506|FG001|STARTED|Overall Study||10||
48633486|NCT03101020|101885505|FG000|COMPLETED|Overall Study||9||
48633487|NCT03101020|101885506|FG001|COMPLETED|Overall Study||7||
48633488|NCT03101020|101885505|FG000|NOT COMPLETED|Overall Study||1||
48633489|NCT03101020|101885506|FG001|NOT COMPLETED|Overall Study||3||
48633490|NCT03055936|101885507|FG000|STARTED|Overall Study||14||
48633491|NCT03055936|101885508|FG001|STARTED|Overall Study||14||
48633492|NCT03055936|101885509|FG002|STARTED|Overall Study||14||
48633493|NCT03055936|101885510|FG003|STARTED|Overall Study||14||
48633494|NCT03055936|101885507|FG000|COMPLETED|Overall Study||12||
48633495|NCT03055936|101885508|FG001|COMPLETED|Overall Study||13||
48633496|NCT03055936|101885509|FG002|COMPLETED|Overall Study||12||
48633497|NCT03055936|101885510|FG003|COMPLETED|Overall Study||13||
48633498|NCT03055936|101885507|FG000|NOT COMPLETED|Overall Study||2||
48633499|NCT03055936|101885508|FG001|NOT COMPLETED|Overall Study||1||
48633500|NCT03055936|101885509|FG002|NOT COMPLETED|Overall Study||2||
48633501|NCT03055936|101885510|FG003|NOT COMPLETED|Overall Study||1||
48633502|NCT01533259|101885511|FG000|STARTED|Overall Study||48||
48633503|NCT01533259|101885511|FG000|COMPLETED|Overall Study||48||
48633504|NCT01533259|101885511|FG000|NOT COMPLETED|Overall Study||0||
48633505|NCT03658980|101885512|FG000|STARTED|Overall Study||143||
48633506|NCT03658980|101885513|FG001|STARTED|Overall Study||156||
48633507|NCT03658980|101885512|FG000|COMPLETED|Overall Study||139||
48633508|NCT03658980|101885513|FG001|COMPLETED|Overall Study||151||
48633509|NCT03658980|101885512|FG000|NOT COMPLETED|Overall Study||4||
48633510|NCT03658980|101885513|FG001|NOT COMPLETED|Overall Study||5||
48633511|NCT03408899|101885514|FG000|STARTED|PC-1005 Gel: 4 mL Dose||13||
48633512|NCT03408899|101885514|FG000|COMPLETED|PC-1005 Gel: 4 mL Dose||12||
48633513|NCT03408899|101885514|FG000|NOT COMPLETED|PC-1005 Gel: 4 mL Dose||1||
48756589|NCT01667900|102191285|FG013|NOT COMPLETED|Part B||0||
48413821|NCT02132169|101345889|FG000|NOT COMPLETED|Overall Study||15||
48633514|NCT03408899|101885514|FG000|STARTED|PC-1005 Gel: 16 mL Dose||12||
48633515|NCT03408899|101885514|FG000|COMPLETED|PC-1005 Gel: 16 mL Dose||12||
48633516|NCT03408899|101885514|FG000|NOT COMPLETED|PC-1005 Gel: 16 mL Dose||0||
48633517|NCT03408899|101885514|FG000|STARTED|PC-1005 Gel: 32 mL Dose||12||
48633518|NCT03408899|101885514|FG000|COMPLETED|PC-1005 Gel: 32 mL Dose||12||
48756590|NCT01667900|102191286|FG014|NOT COMPLETED|Part B||0||
48413822|NCT02132169|101345890|FG001|NOT COMPLETED|Overall Study||9||
48413823|NCT00474539|101345891|FG000|STARTED|Infant Series||223||
48413824|NCT00474539|101345892|FG001|STARTED|Infant Series||226||
48413825|NCT00474539|101345891|FG000|Vaccinated Dose 1|Infant Series||218||
48413826|NCT00474539|101345892|FG001|Vaccinated Dose 1|Infant Series||226||
48413827|NCT00474539|101345891|FG000|Vaccinated Dose 2|Infant Series||217||
48413828|NCT00474539|101345892|FG001|Vaccinated Dose 2|Infant Series||222||
48413829|NCT00474539|101345891|FG000|Vaccinated Dose 3|Infant Series||214||
48182107|NCT00209027|100768245|FG000|STARTED|Overall Study||10||
48413830|NCT00474539|101345892|FG001|Vaccinated Dose 3|Infant Series||221||
48413831|NCT00474539|101345891|FG000|COMPLETED|Infant Series||213||
48413832|NCT00474539|101345892|FG001|COMPLETED|Infant Series||220||
48413833|NCT00474539|101345891|FG000|NOT COMPLETED|Infant Series||10||
48413834|NCT00474539|101345892|FG001|NOT COMPLETED|Infant Series||6||
48756591|NCT01667900|102191287|FG015|NOT COMPLETED|Part B||0||
48756592|NCT01667900|102191288|FG016|NOT COMPLETED|Part B||1||
48756593|NCT01667900|102191289|FG017|NOT COMPLETED|Part B||0||
48413835|NCT00474539|101345891|FG000|STARTED|After Infant Series||213||
48413836|NCT00474539|101345892|FG001|STARTED|After Infant Series||220||
48413837|NCT00474539|101345891|FG000|COMPLETED|After Infant Series||209||
48413838|NCT00474539|101345892|FG001|COMPLETED|After Infant Series||220||
48756594|NCT01667900|102191290|FG018|NOT COMPLETED|Part B||0||
48756595|NCT01667900|102191291|FG019|NOT COMPLETED|Part B||0||
48756596|NCT00703014|102191292|FG000|STARTED|Mothers Base Trial P05787 (NCT00696800)||757||
48756597|NCT00703014|102191293|FG001|STARTED|Mothers Base Trial P05787 (NCT00696800)||752||
48756598|NCT00703014|102191294|FG002|STARTED|Mothers Base Trial P05787 (NCT00696800)||0||
48756599|NCT00703014|102191295|FG003|STARTED|Mothers Base Trial P05787 (NCT00696800)||0||
48756600|NCT00703014|102191292|FG000|Treated|Mothers Base Trial P05787 (NCT00696800)||756||
48182108|NCT00209027|100768246|FG001|STARTED|Overall Study||10||
48182109|NCT00209027|100768245|FG000|COMPLETED|Overall Study||0||
48182110|NCT00209027|100768246|FG001|COMPLETED|Overall Study||10||
48182111|NCT00209027|100768245|FG000|NOT COMPLETED|Overall Study||10||
48182112|NCT00209027|100768246|FG001|NOT COMPLETED|Overall Study||0||
48182113|NCT05114590|100768247|FG000|STARTED|Overall Study||124||
48182114|NCT05114590|100768247|FG000|Completed the 16-week Study Treatment Period|Overall Study||111||
48182115|NCT05114590|100768247|FG000|COMPLETED|Overall Study||110|Completed study per protocol.|
48182116|NCT05114590|100768247|FG000|NOT COMPLETED|Overall Study||14||
48182117|NCT03896230|100768248|FG000|STARTED|Overall Study||5||
48182118|NCT03896230|100768249|FG001|STARTED|Overall Study||4||
48182119|NCT03896230|100768250|FG002|STARTED|Overall Study||2||
48182120|NCT03896230|100768248|FG000|COMPLETED|Overall Study||5||
48182121|NCT03896230|100768249|FG001|COMPLETED|Overall Study||4||
48413839|NCT00474539|101345891|FG000|NOT COMPLETED|After Infant Series||4||
48413840|NCT00474539|101345892|FG001|NOT COMPLETED|After Infant Series||0||
48413841|NCT00474539|101345891|FG000|STARTED|Toddler Dose||209||
48413842|NCT00474539|101345892|FG001|STARTED|Toddler Dose||220||
48413843|NCT00474539|101345891|FG000|COMPLETED|Toddler Dose||208||
48413844|NCT00474539|101345892|FG001|COMPLETED|Toddler Dose||220||
48182122|NCT03896230|100768250|FG002|COMPLETED|Overall Study||2||
48413845|NCT00474539|101345891|FG000|NOT COMPLETED|Toddler Dose||1||
48413846|NCT00474539|101345892|FG001|NOT COMPLETED|Toddler Dose||0||
48413847|NCT02417129|101345893|FG000|STARTED|Overall Study||2||
48413848|NCT02417129|101345894|FG001|STARTED|Overall Study||0||
48413849|NCT02417129|101345893|FG000|COMPLETED|Overall Study||2||
48756601|NCT00703014|102191293|FG001|Treated|Mothers Base Trial P05787 (NCT00696800)||750||
48756602|NCT00703014|102191294|FG002|Treated|Mothers Base Trial P05787 (NCT00696800)||0||
48756603|NCT00703014|102191295|FG003|Treated|Mothers Base Trial P05787 (NCT00696800)||0||
48756604|NCT00703014|102191292|FG000|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||672||
48756605|NCT00703014|102191293|FG001|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||704||
48633519|NCT03408899|101885514|FG000|NOT COMPLETED|PC-1005 Gel: 32 mL Dose||0||
48633520|NCT03036267|101885515|FG000|STARTED|Overall Study||46||
48633521|NCT03036267|101885515|FG000|COMPLETED|Overall Study||46||
48633522|NCT03036267|101885515|FG000|NOT COMPLETED|Overall Study||0||
48633523|NCT04040439|101885516|FG000|STARTED|Overall Study||111||
48633524|NCT04040439|101885516|FG000|COMPLETED|Overall Study||98||
48633525|NCT04040439|101885516|FG000|NOT COMPLETED|Overall Study||13||
48633526|NCT00701363|101888722|FG000|STARTED|Screening (Pre-assignment) Phase||128||
48342479|NCT01097629|101167555|FG005|STARTED|DB RO Phase||173||
48342480|NCT01097629|101167556|FG006|STARTED|DB RO Phase||171||
48342481|NCT01097629|101167557|FG007|STARTED|DB RO Phase||327||
48342482|NCT01097629|101167550|FG000|COMPLETED|DB RO Phase||0||
48342483|NCT01097629|101167551|FG001|COMPLETED|DB RO Phase||0||
48342484|NCT01097629|101167552|FG002|COMPLETED|DB RO Phase||0||
48342485|NCT01097629|101167553|FG003|COMPLETED|DB RO Phase||96||
48413850|NCT02417129|101345894|FG001|COMPLETED|Overall Study||0||
48413851|NCT02417129|101345893|FG000|NOT COMPLETED|Overall Study||0||
48413852|NCT02417129|101345894|FG001|NOT COMPLETED|Overall Study||0||
48413853|NCT03377452|101345895|FG000|STARTED|Overall Study||44||
48633527|NCT00701363|101888723|FG001|STARTED|Screening (Pre-assignment) Phase||0||
48633528|NCT00701363|101888724|FG002|STARTED|Screening (Pre-assignment) Phase||0||
48633529|NCT00701363|101888725|FG003|STARTED|Screening (Pre-assignment) Phase||0||
48756606|NCT00703014|102191294|FG002|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0||
48633530|NCT00701363|101888722|FG000|COMPLETED|Screening (Pre-assignment) Phase||124||
48633531|NCT00701363|101888723|FG001|COMPLETED|Screening (Pre-assignment) Phase||0||
48633532|NCT00701363|101888724|FG002|COMPLETED|Screening (Pre-assignment) Phase||0||
48182123|NCT03896230|100768248|FG000|NOT COMPLETED|Overall Study||0||
48182124|NCT03896230|100768249|FG001|NOT COMPLETED|Overall Study||0||
48182125|NCT03896230|100768250|FG002|NOT COMPLETED|Overall Study||0||
48182126|NCT00401817|100768251|FG000|STARTED|Overall Study||11||
48182127|NCT00401817|100768251|FG000|COMPLETED|Overall Study||11||
48182128|NCT00401817|100768251|FG000|NOT COMPLETED|Overall Study||0||
48182129|NCT03590743|100768252|FG000|STARTED|Overall Study||2||
48633533|NCT00701363|101888725|FG003|COMPLETED|Screening (Pre-assignment) Phase||0||
48756607|NCT00703014|102191295|FG003|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0||
48756608|NCT00703014|102191292|FG000|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||295||
48756609|NCT00703014|102191293|FG001|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||286||
48756610|NCT00703014|102191294|FG002|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0||
48182130|NCT03590743|100768253|FG001|STARTED|Overall Study||3||
48182131|NCT03590743|100768252|FG000|COMPLETED|Overall Study||2||
48182132|NCT03590743|100768253|FG001|COMPLETED|Overall Study||2||
48182133|NCT03590743|100768252|FG000|NOT COMPLETED|Overall Study||0||
48342486|NCT01097629|101167554|FG004|COMPLETED|DB RO Phase||108||
48342487|NCT01097629|101167555|FG005|COMPLETED|DB RO Phase||172||
48657135|NCT00063362|101943785|FG000|NOT COMPLETED|Overall Study||4||
48182134|NCT03590743|100768253|FG001|NOT COMPLETED|Overall Study||1||
48182135|NCT01653847|100768254|FG000|STARTED|Overall Study||20||
48182136|NCT01653847|100768255|FG001|STARTED|Overall Study||20||
48633534|NCT00701363|101888722|FG000|NOT COMPLETED|Screening (Pre-assignment) Phase||4||
48342488|NCT01097629|101167556|FG006|COMPLETED|DB RO Phase||168||
48342489|NCT01097629|101167557|FG007|COMPLETED|DB RO Phase||326||
48342490|NCT01097629|101167550|FG000|NOT COMPLETED|DB RO Phase||0||
48342491|NCT01097629|101167551|FG001|NOT COMPLETED|DB RO Phase||0||
48342492|NCT01097629|101167552|FG002|NOT COMPLETED|DB RO Phase||0||
48342493|NCT01097629|101167553|FG003|NOT COMPLETED|DB RO Phase||1||
48633535|NCT00701363|101888723|FG001|NOT COMPLETED|Screening (Pre-assignment) Phase||0||
48633536|NCT00701363|101888724|FG002|NOT COMPLETED|Screening (Pre-assignment) Phase||0||
48633537|NCT00701363|101888725|FG003|NOT COMPLETED|Screening (Pre-assignment) Phase||0||
48633538|NCT00701363|101888722|FG000|STARTED|Treatment Phase 1||124||
48633539|NCT00701363|101888723|FG001|STARTED|Treatment Phase 1||0||
48633540|NCT00701363|101888724|FG002|STARTED|Treatment Phase 1||0||
48633541|NCT00701363|101888725|FG003|STARTED|Treatment Phase 1||0||
48633542|NCT00701363|101888722|FG000|COMPLETED|Treatment Phase 1||109||
48633543|NCT00701363|101888723|FG001|COMPLETED|Treatment Phase 1||0||
48756611|NCT00703014|102191295|FG003|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0||
48756612|NCT00703014|102191292|FG000|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||462||
48756613|NCT00703014|102191293|FG001|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||466||
48756614|NCT00703014|102191294|FG002|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0||
48342494|NCT01097629|101167554|FG004|NOT COMPLETED|DB RO Phase||0||
48342495|NCT01097629|101167555|FG005|NOT COMPLETED|DB RO Phase||1||
48342496|NCT01097629|101167556|FG006|NOT COMPLETED|DB RO Phase||3||
48342497|NCT01097629|101167557|FG007|NOT COMPLETED|DB RO Phase||1||
48342498|NCT03862027|101167558|FG000|STARTED|Overall Study||1||
48342499|NCT03862027|101167558|FG000|COMPLETED|Overall Study||1||
48342500|NCT03862027|101167558|FG000|NOT COMPLETED|Overall Study||0||
48342501|NCT02673229|101167559|FG000|STARTED|Overall Study||8||
48342502|NCT02673229|101167560|FG001|STARTED|Overall Study||12||
48342503|NCT02673229|101167559|FG000|COMPLETED|Overall Study||7||
48342504|NCT02673229|101167560|FG001|COMPLETED|Overall Study||9||
48342505|NCT02673229|101167559|FG000|NOT COMPLETED|Overall Study||1||
48342506|NCT02673229|101167560|FG001|NOT COMPLETED|Overall Study||3||
48342507|NCT00318292|101167561|FG000|STARTED|Overall Study||45||
48342508|NCT00318292|101167562|FG001|STARTED|Overall Study||45||
48342509|NCT00318292|101167561|FG000|COMPLETED|Overall Study||45||
48342510|NCT00318292|101167562|FG001|COMPLETED|Overall Study||45||
48342511|NCT00318292|101167561|FG000|NOT COMPLETED|Overall Study||0||
48342512|NCT00318292|101167562|FG001|NOT COMPLETED|Overall Study||0||
48342513|NCT01227967|101167563|FG000|STARTED|Overall Study||314||
48633544|NCT00701363|101888724|FG002|COMPLETED|Treatment Phase 1||0||
48633545|NCT00701363|101888725|FG003|COMPLETED|Treatment Phase 1||0||
48633546|NCT00701363|101888722|FG000|NOT COMPLETED|Treatment Phase 1||15||
48633547|NCT00701363|101888723|FG001|NOT COMPLETED|Treatment Phase 1||0||
48633548|NCT00701363|101888724|FG002|NOT COMPLETED|Treatment Phase 1||0||
48633549|NCT00701363|101888725|FG003|NOT COMPLETED|Treatment Phase 1||0||
48756615|NCT00703014|102191295|FG003|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0||
48756616|NCT00703014|102191292|FG000|STARTED|Mothers Follow Up Trial P05712||274||
48756617|NCT00703014|102191293|FG001|STARTED|Mothers Follow Up Trial P05712||267||
48756618|NCT00703014|102191294|FG002|STARTED|Mothers Follow Up Trial P05712||0||
48756619|NCT00703014|102191295|FG003|STARTED|Mothers Follow Up Trial P05712||0||
48342514|NCT01227967|101167564|FG001|STARTED|Overall Study||316||
48342515|NCT01227967|101167563|FG000|COMPLETED|Overall Study||298|Results were through database cutoff (10 November 2016) for efficacy analysis (through Day 28 visit)|
48342516|NCT01227967|101167564|FG001|COMPLETED|Overall Study||303|Results were through database cutoff (10 November 2016) for efficacy analysis (through Day 28 visit)|
48342517|NCT01227967|101167563|FG000|NOT COMPLETED|Overall Study||16||
48342518|NCT01227967|101167564|FG001|NOT COMPLETED|Overall Study||13||
48633550|NCT00701363|101888722|FG000|STARTED|Treatment Phase 2||0||
48756620|NCT00703014|102191292|FG000|COMPLETED|Mothers Follow Up Trial P05712||241||
48756621|NCT00703014|102191293|FG001|COMPLETED|Mothers Follow Up Trial P05712||235||
48756622|NCT00703014|102191294|FG002|COMPLETED|Mothers Follow Up Trial P05712||0||
48756623|NCT00703014|102191295|FG003|COMPLETED|Mothers Follow Up Trial P05712||0||
48756624|NCT00703014|102191292|FG000|NOT COMPLETED|Mothers Follow Up Trial P05712||33||
48756625|NCT00703014|102191293|FG001|NOT COMPLETED|Mothers Follow Up Trial P05712||32||
48633551|NCT00701363|101888723|FG001|STARTED|Treatment Phase 2||13||
48633552|NCT00701363|101888724|FG002|STARTED|Treatment Phase 2||70||
48633553|NCT00701363|101888725|FG003|STARTED|Treatment Phase 2||26||
48633554|NCT00701363|101888722|FG000|COMPLETED|Treatment Phase 2||0||
48633555|NCT00701363|101888723|FG001|COMPLETED|Treatment Phase 2||13||
48633556|NCT00701363|101888724|FG002|COMPLETED|Treatment Phase 2||68||
48413854|NCT03377452|101345896|FG001|STARTED|Overall Study||46||
48413855|NCT03377452|101345895|FG000|Post Treatment|Overall Study||40||
48413856|NCT03377452|101345896|FG001|Post Treatment|Overall Study||44||
48633557|NCT00701363|101888725|FG003|COMPLETED|Treatment Phase 2||26||
48633558|NCT00701363|101888722|FG000|NOT COMPLETED|Treatment Phase 2||0||
48633559|NCT00701363|101888723|FG001|NOT COMPLETED|Treatment Phase 2||0||
48413857|NCT03377452|101345895|FG000|3 Month Follow-up|Overall Study||39||
48633560|NCT00701363|101888724|FG002|NOT COMPLETED|Treatment Phase 2||2||
48633561|NCT00701363|101888725|FG003|NOT COMPLETED|Treatment Phase 2||0||
48633562|NCT02550795|101888726|FG000|STARTED|Overall Study||50||
48756626|NCT00703014|102191294|FG002|NOT COMPLETED|Mothers Follow Up Trial P05712||0||
48756627|NCT00703014|102191295|FG003|NOT COMPLETED|Mothers Follow Up Trial P05712||0||
48756628|NCT00703014|102191292|FG000|STARTED|Fetuses/Infants Follow Up Trial P05712||0||
48756629|NCT00703014|102191293|FG001|STARTED|Fetuses/Infants Follow Up Trial P05712||0||
48756630|NCT00703014|102191294|FG002|STARTED|Fetuses/Infants Follow Up Trial P05712||352||
48756631|NCT00703014|102191295|FG003|STARTED|Fetuses/Infants Follow Up Trial P05712||326||
48756632|NCT00703014|102191292|FG000|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0||
48756633|NCT00703014|102191293|FG001|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0||
48756634|NCT00703014|102191294|FG002|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||344||
48756635|NCT00703014|102191295|FG003|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||315||
48756636|NCT00703014|102191292|FG000|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0||
48756637|NCT00703014|102191293|FG001|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0||
48756638|NCT00703014|102191294|FG002|COMPLETED|Fetuses/Infants Follow Up Trial P05712||305||
48756639|NCT00703014|102191295|FG003|COMPLETED|Fetuses/Infants Follow Up Trial P05712||284||
48413858|NCT03377452|101345896|FG001|3 Month Follow-up|Overall Study||40||
48413859|NCT03377452|101345895|FG000|COMPLETED|Overall Study||39||
48413860|NCT03377452|101345896|FG001|COMPLETED|Overall Study||40||
48633563|NCT02550795|101888727|FG001|STARTED|Overall Study||50||
48633564|NCT02550795|101888728|FG002|STARTED|Overall Study||50||
48633565|NCT02550795|101888726|FG000|COMPLETED|Overall Study||50||
48633566|NCT02550795|101888727|FG001|COMPLETED|Overall Study||49||
48633567|NCT02550795|101888728|FG002|COMPLETED|Overall Study||50||
48633568|NCT02550795|101888726|FG000|NOT COMPLETED|Overall Study||0||
48633569|NCT02550795|101888727|FG001|NOT COMPLETED|Overall Study||1||
48633570|NCT02550795|101888728|FG002|NOT COMPLETED|Overall Study||0||
48633571|NCT05259917|101888729|FG000|STARTED|Overall Study||18||
48633572|NCT05259917|101888730|FG001|STARTED|Overall Study||18||
48633573|NCT05259917|101888731|FG002|STARTED|Overall Study||15||
48633574|NCT05259917|101888732|FG003|STARTED|Overall Study||17||
48633575|NCT05259917|101888733|FG004|STARTED|Overall Study||20||
48633576|NCT05259917|101888734|FG005|STARTED|Overall Study||22||
48413861|NCT03377452|101345895|FG000|NOT COMPLETED|Overall Study||5||
48633577|NCT05259917|101888729|FG000|COMPLETED|Overall Study||10|Completed - defined as treating 3 attacks with IMP. Trial Termination by Sponsor, defined as ongoing patients terminated once the trial objectives were met.|
48633578|NCT05259917|101888730|FG001|COMPLETED|Overall Study||14|Completed - defined as treating 3 attacks with IMP. Trial Termination by Sponsor, defined as ongoing patients terminated once the trial objectives were met.|
48633579|NCT05259917|101888731|FG002|COMPLETED|Overall Study||8|Completed - defined as treating 3 attacks with IMP. Trial Termination by Sponsor, defined as ongoing patients terminated once the trial objectives were met.|
48633580|NCT05259917|101888732|FG003|COMPLETED|Overall Study||12|Completed - defined as treating 3 attacks with IMP. Trial Termination by Sponsor, defined as ongoing patients terminated once the trial objectives were met.|
48633581|NCT05259917|101888733|FG004|COMPLETED|Overall Study||8|Completed - defined as treating 3 attacks with IMP. Trial Termination by Sponsor, defined as ongoing patients terminated once the trial objectives were met.|
48413862|NCT03377452|101345896|FG001|NOT COMPLETED|Overall Study||6||
48413863|NCT00850135|101345897|FG000|STARTED|Overall Study||57||
48633582|NCT05259917|101888734|FG005|COMPLETED|Overall Study||16|Completed - defined as treating 3 attacks with IMP. Trial Termination by Sponsor, defined as ongoing patients terminated once the trial objectives were met.|
48633583|NCT05259917|101888729|FG000|NOT COMPLETED|Overall Study||8||
48633584|NCT05259917|101888730|FG001|NOT COMPLETED|Overall Study||4||
48756640|NCT00703014|102191292|FG000|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0||
48756641|NCT00703014|102191293|FG001|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0||
48413864|NCT00850135|101345897|FG000|COMPLETED|Overall Study||56||
48413865|NCT00850135|101345897|FG000|NOT COMPLETED|Overall Study||1||
48413866|NCT00806494|101345898|FG000|STARTED|Overall Study||331||
48413867|NCT00806494|101345898|FG000|COMPLETED|Overall Study||251||
48413868|NCT00806494|101345898|FG000|NOT COMPLETED|Overall Study||80||
48413869|NCT02712008|101345899|FG000|STARTED|Baseline (Day 1) up to Week 12||50||
48413870|NCT02712008|101345900|FG001|STARTED|Baseline (Day 1) up to Week 12||100||
48413871|NCT02712008|101345901|FG002|STARTED|Baseline (Day 1) up to Week 12||152||
48756642|NCT00703014|102191294|FG002|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||47||
48756643|NCT00703014|102191295|FG003|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||42||
48756644|NCT05236270|102191296|FG000|STARTED|Overall Study||42||
48756645|NCT05236270|102191297|FG001|STARTED|Overall Study||42||
48756646|NCT05236270|102191298|FG002|STARTED|Overall Study||35||
48182137|NCT01653847|100768254|FG000|COMPLETED|Overall Study||19||
48182138|NCT01653847|100768255|FG001|COMPLETED|Overall Study||20||
48182139|NCT01653847|100768254|FG000|NOT COMPLETED|Overall Study||1||
48182140|NCT01653847|100768255|FG001|NOT COMPLETED|Overall Study||0||
48413872|NCT02712008|101345902|FG003|STARTED|Baseline (Day 1) up to Week 12||0||
48413873|NCT02712008|101345903|FG004|STARTED|Baseline (Day 1) up to Week 12||0||
48413874|NCT02712008|101345904|FG005|STARTED|Baseline (Day 1) up to Week 12||0||
48413875|NCT02712008|101345905|FG006|STARTED|Baseline (Day 1) up to Week 12||0||
48413876|NCT02712008|101345906|FG007|STARTED|Baseline (Day 1) up to Week 12||0||
48413877|NCT02712008|101345899|FG000|COMPLETED|Baseline (Day 1) up to Week 12||46||
48413878|NCT02712008|101345900|FG001|COMPLETED|Baseline (Day 1) up to Week 12||97||
48413879|NCT02712008|101345901|FG002|COMPLETED|Baseline (Day 1) up to Week 12||148||
48413880|NCT02712008|101345902|FG003|COMPLETED|Baseline (Day 1) up to Week 12||0||
48413881|NCT02712008|101345903|FG004|COMPLETED|Baseline (Day 1) up to Week 12||0||
48413882|NCT02712008|101345904|FG005|COMPLETED|Baseline (Day 1) up to Week 12||0||
48413883|NCT02712008|101345905|FG006|COMPLETED|Baseline (Day 1) up to Week 12||0||
48413884|NCT02712008|101345906|FG007|COMPLETED|Baseline (Day 1) up to Week 12||0||
48413885|NCT02712008|101345899|FG000|NOT COMPLETED|Baseline (Day 1) up to Week 12||4||
48413886|NCT02712008|101345900|FG001|NOT COMPLETED|Baseline (Day 1) up to Week 12||3||
48413887|NCT02712008|101345901|FG002|NOT COMPLETED|Baseline (Day 1) up to Week 12||4||
48413888|NCT02712008|101345902|FG003|NOT COMPLETED|Baseline (Day 1) up to Week 12||0||
48413889|NCT02712008|101345903|FG004|NOT COMPLETED|Baseline (Day 1) up to Week 12||0||
48413890|NCT02712008|101345904|FG005|NOT COMPLETED|Baseline (Day 1) up to Week 12||0||
48413891|NCT02712008|101345905|FG006|NOT COMPLETED|Baseline (Day 1) up to Week 12||0||
48413892|NCT02712008|101345906|FG007|NOT COMPLETED|Baseline (Day 1) up to Week 12||0||
48413893|NCT02712008|101345899|FG000|STARTED|From Week 12 up to Week 36||45||
48413894|NCT02712008|101345900|FG001|STARTED|From Week 12 up to Week 36||0||
48413895|NCT02712008|101345901|FG002|STARTED|From Week 12 up to Week 36||0||
48413896|NCT02712008|101345902|FG003|STARTED|From Week 12 up to Week 36||44||
48413897|NCT02712008|101345903|FG004|STARTED|From Week 12 up to Week 36||52||
48413898|NCT02712008|101345904|FG005|STARTED|From Week 12 up to Week 36||46||
48413899|NCT02712008|101345905|FG006|STARTED|From Week 12 up to Week 36||48||
48413900|NCT02712008|101345906|FG007|STARTED|From Week 12 up to Week 36||49||
48413901|NCT02712008|101345899|FG000|COMPLETED|From Week 12 up to Week 36||44||
48413902|NCT02712008|101345900|FG001|COMPLETED|From Week 12 up to Week 36||0||
48413903|NCT02712008|101345901|FG002|COMPLETED|From Week 12 up to Week 36||0||
48413904|NCT02712008|101345902|FG003|COMPLETED|From Week 12 up to Week 36||42||
48413905|NCT02712008|101345903|FG004|COMPLETED|From Week 12 up to Week 36||50||
48413906|NCT02712008|101345904|FG005|COMPLETED|From Week 12 up to Week 36||46||
48413907|NCT02712008|101345905|FG006|COMPLETED|From Week 12 up to Week 36||43||
48413908|NCT02712008|101345906|FG007|COMPLETED|From Week 12 up to Week 36||45||
48756647|NCT05236270|102191299|FG003|STARTED|Overall Study||35||
48756648|NCT05236270|102191300|FG004|STARTED|Overall Study||42||
48756649|NCT05236270|102191301|FG005|STARTED|Overall Study||31||
48756650|NCT05236270|102191302|FG006|STARTED|Overall Study||41||
48182141|NCT00605319|100768256|FG000|STARTED|Overall Study||17||
48182142|NCT00605319|100768256|FG000|COMPLETED|Overall Study||11||
48182143|NCT00605319|100768256|FG000|NOT COMPLETED|Overall Study||6||
48182144|NCT02173535|100768257|FG000|STARTED|Period 1||12||
48182145|NCT02173535|100768258|FG001|STARTED|Period 1||12||
48182146|NCT02173535|100768259|FG002|STARTED|Period 1||12||
48413909|NCT02712008|101345899|FG000|NOT COMPLETED|From Week 12 up to Week 36||1||
48413910|NCT02712008|101345900|FG001|NOT COMPLETED|From Week 12 up to Week 36||0||
48413911|NCT02712008|101345901|FG002|NOT COMPLETED|From Week 12 up to Week 36||0||
48413912|NCT02712008|101345902|FG003|NOT COMPLETED|From Week 12 up to Week 36||2||
48413913|NCT02712008|101345903|FG004|NOT COMPLETED|From Week 12 up to Week 36||2||
48413914|NCT02712008|101345904|FG005|NOT COMPLETED|From Week 12 up to Week 36||0||
48756651|NCT05236270|102191303|FG007|STARTED|Overall Study||44||
48756652|NCT05236270|102191296|FG000|COMPLETED|Overall Study||39||
48756653|NCT05236270|102191297|FG001|COMPLETED|Overall Study||40||
48756654|NCT05236270|102191298|FG002|COMPLETED|Overall Study||35||
48756655|NCT05236270|102191299|FG003|COMPLETED|Overall Study||35||
48756656|NCT05236270|102191300|FG004|COMPLETED|Overall Study||40||
48182147|NCT02173535|100768260|FG003|STARTED|Period 1||12||
48182148|NCT02173535|100768261|FG004|STARTED|Period 1||12||
48182149|NCT02173535|100768262|FG005|STARTED|Period 1||12||
48413915|NCT02712008|101345905|FG006|NOT COMPLETED|From Week 12 up to Week 36||5||
48413916|NCT02712008|101345906|FG007|NOT COMPLETED|From Week 12 up to Week 36||4||
48413917|NCT00423267|101345907|FG000|STARTED|Period A||9||
48413918|NCT00423267|101345908|FG001|STARTED|Period A||7||
48413919|NCT00423267|101345907|FG000|COMPLETED|Period A||7||
48413920|NCT00423267|101345908|FG001|COMPLETED|Period A||6||
48413921|NCT00423267|101345907|FG000|NOT COMPLETED|Period A||2||
48413922|NCT00423267|101345908|FG001|NOT COMPLETED|Period A||1||
48413923|NCT00423267|101345907|FG000|STARTED|Period B||12||
48413924|NCT00423267|101345908|FG001|STARTED|Period B||0||
48413925|NCT00423267|101345907|FG000|COMPLETED|Period B||12||
48413926|NCT00423267|101345908|FG001|COMPLETED|Period B||0||
48413927|NCT00423267|101345907|FG000|NOT COMPLETED|Period B||0||
48413928|NCT00423267|101345908|FG001|NOT COMPLETED|Period B||0||
48413929|NCT00684073|101345909|FG000|STARTED|Selection||60||
48413930|NCT00684073|101345909|FG000|COMPLETED|Selection||53||
48413931|NCT00684073|101345909|FG000|NOT COMPLETED|Selection||7||
48413932|NCT00684073|101345909|FG000|STARTED|Treatment (Days 1 Through 5)||53||
48413933|NCT00684073|101345909|FG000|COMPLETED|Treatment (Days 1 Through 5)||52||
48413934|NCT00684073|101345909|FG000|NOT COMPLETED|Treatment (Days 1 Through 5)||1||
48413935|NCT00703781|101345910|FG000|STARTED|Overall Study||63||
48413936|NCT00703781|101345911|FG001|STARTED|Overall Study||63||
48413937|NCT00703781|101345910|FG000|COMPLETED|Overall Study||61||
48413938|NCT00703781|101345911|FG001|COMPLETED|Overall Study||61||
48413939|NCT00703781|101345910|FG000|NOT COMPLETED|Overall Study||2||
48413940|NCT00703781|101345911|FG001|NOT COMPLETED|Overall Study||2||
48413941|NCT02591511|101345912|FG000|STARTED|Overall Study||30||
48413942|NCT02591511|101345913|FG001|STARTED|Overall Study||33||
48413943|NCT02591511|101345912|FG000|COMPLETED|Overall Study||30||
48413944|NCT02591511|101345913|FG001|COMPLETED|Overall Study||33||
48413945|NCT02591511|101345912|FG000|NOT COMPLETED|Overall Study||0||
48413946|NCT02591511|101345913|FG001|NOT COMPLETED|Overall Study||0||
48413947|NCT01066637|101345914|FG000|STARTED|Overall Study||16||
48413948|NCT01066637|101345915|FG001|STARTED|Overall Study||10||
48413949|NCT01066637|101345914|FG000|COMPLETED|Overall Study||16||
48413950|NCT01066637|101345915|FG001|COMPLETED|Overall Study||10||
48413951|NCT01066637|101345914|FG000|NOT COMPLETED|Overall Study||0||
48413952|NCT01066637|101345915|FG001|NOT COMPLETED|Overall Study||0||
48413953|NCT01566981|101345916|FG000|STARTED|Overall Study||58||
48413954|NCT01566981|101345917|FG001|STARTED|Overall Study||62||
48413955|NCT01566981|101345916|FG000|COMPLETED|Overall Study||53||
48413956|NCT01566981|101345917|FG001|COMPLETED|Overall Study||54||
48413957|NCT01566981|101345916|FG000|NOT COMPLETED|Overall Study||5||
48413958|NCT01566981|101345917|FG001|NOT COMPLETED|Overall Study||8||
48413959|NCT00866606|101345918|FG000|STARTED|Overall Study||35||
48413960|NCT00866606|101345918|FG000|COMPLETED|Overall Study||31||
48413961|NCT00866606|101345918|FG000|NOT COMPLETED|Overall Study||4||
48633585|NCT05259917|101888731|FG002|NOT COMPLETED|Overall Study||7||
48633586|NCT05259917|101888732|FG003|NOT COMPLETED|Overall Study||5||
48633587|NCT05259917|101888733|FG004|NOT COMPLETED|Overall Study||12||
48633588|NCT05259917|101888734|FG005|NOT COMPLETED|Overall Study||6||
48633589|NCT03937778|101888735|FG000|STARTED|Overall Study||7||
48633590|NCT03937778|101888735|FG000|COMPLETED|Overall Study||5||
48633591|NCT03937778|101888735|FG000|NOT COMPLETED|Overall Study||2||
48413962|NCT01021293|101345919|FG000|STARTED|Overall Study||550||
48413963|NCT01021293|101345920|FG001|STARTED|Overall Study||550||
48413964|NCT01021293|101345919|FG000|COMPLETED|Overall Study||538||
48413965|NCT01021293|101345920|FG001|COMPLETED|Overall Study||526||
48413966|NCT01021293|101345919|FG000|NOT COMPLETED|Overall Study||12||
48413967|NCT01021293|101345920|FG001|NOT COMPLETED|Overall Study||24||
48413968|NCT00462488|101345921|FG000|STARTED|Overall Study||23||
48413969|NCT00462488|101345922|FG001|STARTED|Overall Study||23||
48413970|NCT00462488|101345921|FG000|Completed Induction Phase|Overall Study||22||
48633592|NCT03256578|101888736|FG000|STARTED|Overall Study||204||
48633593|NCT03256578|101888737|FG001|STARTED|Overall Study||206||
48633594|NCT03256578|101888736|FG000|COMPLETED|Overall Study||138||
48633595|NCT03256578|101888737|FG001|COMPLETED|Overall Study||150||
48633596|NCT03256578|101888736|FG000|NOT COMPLETED|Overall Study||66||
48633597|NCT03256578|101888737|FG001|NOT COMPLETED|Overall Study||56||
48633598|NCT00193453|101888738|FG000|STARTED|Overall Study||69||
48413971|NCT00462488|101345922|FG001|Completed Induction Phase|Overall Study||23||
48413972|NCT00462488|101345921|FG000|Completed Induction 2/Maintenance 1|Overall Study||18||
48413973|NCT00462488|101345922|FG001|Completed Induction 2/Maintenance 1|Overall Study||9||
48413974|NCT00462488|101345921|FG000|Completed Maintenance 2|Overall Study||7||
48413975|NCT00462488|101345922|FG001|Completed Maintenance 2|Overall Study||6||
48413976|NCT00462488|101345921|FG000|COMPLETED|Overall Study||3|Completed the full 51/57 weeks of study|
48413977|NCT00462488|101345922|FG001|COMPLETED|Overall Study||6|Completed the full 51/57 weeks of study|
48413978|NCT00462488|101345921|FG000|NOT COMPLETED|Overall Study||20||
48413979|NCT00462488|101345922|FG001|NOT COMPLETED|Overall Study||17||
48413980|NCT01357720|101345923|FG000|STARTED|Overall Study||200||
48413981|NCT01357720|101345924|FG001|STARTED|Overall Study||200||
48413982|NCT01357720|101345923|FG000|COMPLETED|Overall Study||198||
48413983|NCT01357720|101345924|FG001|COMPLETED|Overall Study||195||
48413984|NCT01357720|101345923|FG000|NOT COMPLETED|Overall Study||2||
48413985|NCT01357720|101345924|FG001|NOT COMPLETED|Overall Study||5||
48413986|NCT01057394|101345925|FG000|STARTED|Overall Study||0||
48413987|NCT01057394|101345926|FG001|STARTED|Overall Study||21||
48413988|NCT01057394|101345925|FG000|COMPLETED|Overall Study||0||
48413989|NCT01057394|101345926|FG001|COMPLETED|Overall Study||19||
48413990|NCT01057394|101345925|FG000|NOT COMPLETED|Overall Study||0||
48413991|NCT01057394|101345926|FG001|NOT COMPLETED|Overall Study||2||
48413992|NCT01572844|101345927|FG000|STARTED|Overall Study||3||3
48413993|NCT01572844|101345928|FG001|STARTED|Overall Study||3||3
48413994|NCT01572844|101345927|FG000|COMPLETED|Overall Study||2||2
48413995|NCT01572844|101345928|FG001|COMPLETED|Overall Study||2||2
48413996|NCT01572844|101345927|FG000|NOT COMPLETED|Overall Study||1||1
48413997|NCT01572844|101345928|FG001|NOT COMPLETED|Overall Study||1||1
48413998|NCT01951326|101345929|FG000|STARTED|Overall Study||166||
48413999|NCT01951326|101345930|FG001|STARTED|Overall Study||165||
48414000|NCT01951326|101345929|FG000|COMPLETED|Overall Study||87||
48414001|NCT01951326|101345930|FG001|COMPLETED|Overall Study||87||
48414002|NCT01951326|101345929|FG000|NOT COMPLETED|Overall Study||79||
48414003|NCT01951326|101345930|FG001|NOT COMPLETED|Overall Study||78||
48414004|NCT01562379|101345931|FG000|STARTED|Overall Study||1438||
48182150|NCT02173535|100768263|FG006|STARTED|Period 1||12||
48182151|NCT02173535|100768264|FG007|STARTED|Period 1||12||
48182152|NCT02173535|100768265|FG008|STARTED|Period 1||12||
48182153|NCT02173535|100768266|FG009|STARTED|Period 1||12||
48414005|NCT01562379|101345932|FG001|STARTED|Overall Study||1492||
48414006|NCT01562379|101345933|FG002|STARTED|Overall Study||851||
48414007|NCT01562379|101345934|FG003|STARTED|Overall Study||843||
48414008|NCT01562379|101345935|FG004|STARTED|Overall Study||825||
48414009|NCT01562379|101345931|FG000|COMPLETED|Overall Study||1312||
48633599|NCT00193453|101888738|FG000|COMPLETED|Overall Study||21||
48633600|NCT00193453|101888738|FG000|NOT COMPLETED|Overall Study||48||
48633601|NCT01739335|101888739|FG000|STARTED|Overall Study||41||
48633602|NCT01739335|101888740|FG001|STARTED|Overall Study||40||
48633603|NCT01739335|101888739|FG000|COMPLETED|Overall Study||34||
48633604|NCT01739335|101888740|FG001|COMPLETED|Overall Study||35||
48633605|NCT01739335|101888739|FG000|NOT COMPLETED|Overall Study||7||
48633606|NCT01739335|101888740|FG001|NOT COMPLETED|Overall Study||5||
48633607|NCT04357795|101888741|FG000|STARTED|Overall Study||134||
48633608|NCT04357795|101888741|FG000|COMPLETED|Overall Study||115||
48633609|NCT04357795|101888741|FG000|NOT COMPLETED|Overall Study||19||
48633610|NCT02349412|101888742|FG000|STARTED|Overall Study||202||
48633611|NCT02349412|101888743|FG001|STARTED|Overall Study||203||
48633612|NCT02349412|101888742|FG000|Completed Week-12 QOL Assessment Measure|Overall Study||92||
48756657|NCT05236270|102191301|FG005|COMPLETED|Overall Study||31||
48756658|NCT05236270|102191302|FG006|COMPLETED|Overall Study||40||
48756659|NCT05236270|102191303|FG007|COMPLETED|Overall Study||41||
48756660|NCT05236270|102191296|FG000|NOT COMPLETED|Overall Study||3||
48182154|NCT02173535|100768267|FG010|STARTED|Period 1||12||
48182155|NCT02173535|100768268|FG011|STARTED|Period 1||12||
48182156|NCT02173535|100768269|FG012|STARTED|Period 1||12||
48182157|NCT02173535|100768270|FG013|STARTED|Period 1||12||
48182158|NCT02173535|100768271|FG014|STARTED|Period 1||12||
48182159|NCT02173535|100768272|FG015|STARTED|Period 1||12||
48182160|NCT02173535|100768273|FG016|STARTED|Period 1||12||
48414010|NCT01562379|101345932|FG001|COMPLETED|Overall Study||1395||
48414011|NCT01562379|101345933|FG002|COMPLETED|Overall Study||789||
48414012|NCT01562379|101345934|FG003|COMPLETED|Overall Study||786||
48414013|NCT01562379|101345935|FG004|COMPLETED|Overall Study||785||
48414014|NCT01562379|101345931|FG000|NOT COMPLETED|Overall Study||126||
48414015|NCT01562379|101345932|FG001|NOT COMPLETED|Overall Study||97||
48414016|NCT01562379|101345933|FG002|NOT COMPLETED|Overall Study||62||
48633613|NCT02349412|101888743|FG001|Completed Week-12 QOL Assessment Measure|Overall Study||101||
48633614|NCT02349412|101888742|FG000|Completed Week-24 QOL Assessment Measure|Overall Study||68||
48633615|NCT02349412|101888743|FG001|Completed Week-24 QOL Assessment Measure|Overall Study||80||
48756661|NCT05236270|102191297|FG001|NOT COMPLETED|Overall Study||2||
48182161|NCT02173535|100768274|FG017|STARTED|Period 1||12||
48182162|NCT02173535|100768275|FG018|STARTED|Period 1||12||
48182163|NCT02173535|100768276|FG019|STARTED|Period 1||12||
48182164|NCT02173535|100768257|FG000|COMPLETED|Period 1||12||
48414017|NCT01562379|101345934|FG003|NOT COMPLETED|Overall Study||57||
48414018|NCT01562379|101345935|FG004|NOT COMPLETED|Overall Study||40||
48414019|NCT00742391|101345936|FG000|STARTED|Overall Study||126||
48414020|NCT00742391|101345937|FG001|STARTED|Overall Study||129||
48414021|NCT00742391|101345936|FG000|COMPLETED|Overall Study||122||
48414022|NCT00742391|101345937|FG001|COMPLETED|Overall Study||128||
48414023|NCT00742391|101345936|FG000|NOT COMPLETED|Overall Study||4||
48414024|NCT00742391|101345937|FG001|NOT COMPLETED|Overall Study||1||
48414025|NCT03479203|101345938|FG000|STARTED|Overall Study||31||
48414026|NCT03479203|101345938|FG000|COMPLETED|Overall Study||31||
48414027|NCT03479203|101345938|FG000|NOT COMPLETED|Overall Study||0||
48182165|NCT02173535|100768258|FG001|COMPLETED|Period 1||12||
48182166|NCT02173535|100768259|FG002|COMPLETED|Period 1||12||
48414028|NCT02543801|101345939|FG000|STARTED|Overall Study||61||
48414029|NCT02543801|101345940|FG001|STARTED|Overall Study||60||
48633616|NCT02349412|101888742|FG000|COMPLETED|Overall Study||195||
48633617|NCT02349412|101888743|FG001|COMPLETED|Overall Study||196||
48633618|NCT02349412|101888742|FG000|NOT COMPLETED|Overall Study||7||
48633619|NCT02349412|101888743|FG001|NOT COMPLETED|Overall Study||7||
48633620|NCT02530385|101888744|FG000|STARTED|Overall Study||12||
48633621|NCT02530385|101888745|FG001|STARTED|Overall Study||12||
48633622|NCT02530385|101888744|FG000|COMPLETED|Overall Study||12||
48633623|NCT02530385|101888745|FG001|COMPLETED|Overall Study||11||
48633624|NCT02530385|101888744|FG000|NOT COMPLETED|Overall Study||0||
48633625|NCT02530385|101888745|FG001|NOT COMPLETED|Overall Study||1||
48633626|NCT04596293|101888746|FG000|STARTED|Induction Phase Week 0-8||11||
48633627|NCT04596293|101888747|FG001|STARTED|Induction Phase Week 0-8||11||
48633628|NCT04596293|101888748|FG002|STARTED|Induction Phase Week 0-8||11||
48633629|NCT04596293|101888746|FG000|Safety Population|Induction Phase Week 0-8||13||
48633630|NCT04596293|101888747|FG001|Safety Population|Induction Phase Week 0-8||12||
48633631|NCT04596293|101888748|FG002|Safety Population|Induction Phase Week 0-8||13||
48633632|NCT04596293|101888746|FG000|COMPLETED|Induction Phase Week 0-8||11||
48633633|NCT04596293|101888747|FG001|COMPLETED|Induction Phase Week 0-8||11||
48633634|NCT04596293|101888748|FG002|COMPLETED|Induction Phase Week 0-8||10||
48633635|NCT04596293|101888746|FG000|NOT COMPLETED|Induction Phase Week 0-8||0||
48633636|NCT04596293|101888747|FG001|NOT COMPLETED|Induction Phase Week 0-8||0||
48633637|NCT04596293|101888748|FG002|NOT COMPLETED|Induction Phase Week 0-8||1||
48633638|NCT04596293|101888746|FG000|STARTED|Extension Phase Week 8-16||11|One subject completed induction phase of BBT-401-1S 1600mg did not participated in extension phase.|
48633639|NCT04596293|101888747|FG001|STARTED|Extension Phase Week 8-16||11|One subject completed induction phase of BBT-401-1S 1600mg did not participated in extension phase.|
48633640|NCT04596293|101888748|FG002|STARTED|Extension Phase Week 8-16||9|One subject completed induction phase of BBT-401-1S 1600mg did not participated in extension phase.|
48633641|NCT04596293|101888746|FG000|Safety Population|Extension Phase Week 8-16||6||
48633642|NCT04596293|101888747|FG001|Safety Population|Extension Phase Week 8-16||8||
48633643|NCT04596293|101888748|FG002|Safety Population|Extension Phase Week 8-16||17||
48633644|NCT04596293|101888746|FG000|COMPLETED|Extension Phase Week 8-16||11||
48633645|NCT04596293|101888747|FG001|COMPLETED|Extension Phase Week 8-16||10||
48633646|NCT04596293|101888748|FG002|COMPLETED|Extension Phase Week 8-16||8||
48633647|NCT04596293|101888746|FG000|NOT COMPLETED|Extension Phase Week 8-16||0||
48633648|NCT04596293|101888747|FG001|NOT COMPLETED|Extension Phase Week 8-16||1||
48633649|NCT04596293|101888748|FG002|NOT COMPLETED|Extension Phase Week 8-16||1||
48633650|NCT02239289|101888749|FG000|STARTED|Overall Study||21||
48633651|NCT02239289|101888749|FG000|COMPLETED|Overall Study||21||
48633652|NCT02239289|101888749|FG000|NOT COMPLETED|Overall Study||0||
48633653|NCT00623181|101888750|FG000|STARTED|Overall Study||56||
48633654|NCT00623181|101888751|FG001|STARTED|Overall Study||54||
48633655|NCT00623181|101888750|FG000|COMPLETED|Overall Study||56||
48633656|NCT00623181|101888751|FG001|COMPLETED|Overall Study||54||
48633657|NCT00623181|101888750|FG000|NOT COMPLETED|Overall Study||0||
48633658|NCT00623181|101888751|FG001|NOT COMPLETED|Overall Study||0||
48633659|NCT04635839|101888752|FG000|STARTED|Overall Study||22||
48633660|NCT04635839|101888753|FG001|STARTED|Overall Study||24||
48633661|NCT04635839|101888752|FG000|COMPLETED|Overall Study||21||
48633662|NCT04635839|101888753|FG001|COMPLETED|Overall Study||24||
48633663|NCT04635839|101888752|FG000|NOT COMPLETED|Overall Study||1||
48633664|NCT04635839|101888753|FG001|NOT COMPLETED|Overall Study||0||
48633665|NCT01294046|101888754|FG000|STARTED|Overall Study||3||
48633666|NCT01294046|101888754|FG000|COMPLETED|Overall Study||0||
48633667|NCT01294046|101888754|FG000|NOT COMPLETED|Overall Study||3||
48633668|NCT02774889|101888755|FG000|STARTED|Overall Study||23||
48633669|NCT02774889|101888756|FG001|STARTED|Overall Study||22||
48633670|NCT02774889|101888755|FG000|COMPLETED|Overall Study||21||
48633671|NCT02774889|101888756|FG001|COMPLETED|Overall Study||21||
48633672|NCT02774889|101888755|FG000|NOT COMPLETED|Overall Study||2||
48633673|NCT02774889|101888756|FG001|NOT COMPLETED|Overall Study||1||
48633674|NCT01142336|101888757|FG000|STARTED|Overall Study||26||
48633675|NCT01142336|101888758|FG001|STARTED|Overall Study||23||
48633676|NCT01142336|101888757|FG000|COMPLETED|Overall Study||25||
48633677|NCT01142336|101888758|FG001|COMPLETED|Overall Study||21||
48633678|NCT01142336|101888757|FG000|NOT COMPLETED|Overall Study||1||
48633679|NCT01142336|101888758|FG001|NOT COMPLETED|Overall Study||2||
48633680|NCT02832037|101888759|FG000|STARTED|Overall Study||85|= Randomized and Treated|
48633681|NCT02832037|101888760|FG001|STARTED|Overall Study||84|= Randomized and Treated|
48657136|NCT00063362|101943786|FG001|NOT COMPLETED|Overall Study||4||
48633682|NCT02832037|101888761|FG002|STARTED|Overall Study||85|= Randomized and Treated|
48633683|NCT02832037|101888762|FG003|STARTED|Overall Study||85|= Randomized and Treated|
48633684|NCT02832037|101888763|FG004|STARTED|Overall Study||170|= Randomized and Treated|
48633685|NCT02832037|101888759|FG000|COMPLETED|Overall Study||66||
48182167|NCT02173535|100768260|FG003|COMPLETED|Period 1||12||
48182168|NCT02173535|100768261|FG004|COMPLETED|Period 1||12||
48414030|NCT02543801|101345941|FG002|STARTED|Overall Study||59||
48414031|NCT02543801|101345942|FG003|STARTED|Overall Study||59||
48414032|NCT02543801|101345939|FG000|COMPLETED|Overall Study||60||
48414033|NCT02543801|101345940|FG001|COMPLETED|Overall Study||58||
48414034|NCT02543801|101345941|FG002|COMPLETED|Overall Study||59||
48414035|NCT02543801|101345942|FG003|COMPLETED|Overall Study||59||
48414036|NCT02543801|101345939|FG000|NOT COMPLETED|Overall Study||1||
48414037|NCT02543801|101345940|FG001|NOT COMPLETED|Overall Study||2||
48414038|NCT02543801|101345941|FG002|NOT COMPLETED|Overall Study||0||
48414039|NCT02543801|101345942|FG003|NOT COMPLETED|Overall Study||0||
48414040|NCT00440232|101345943|FG000|STARTED|Overall Study||36||
48414041|NCT00440232|101345944|FG001|STARTED|Overall Study||38||
48414042|NCT00440232|101345943|FG000|COMPLETED|Overall Study||33||
48414043|NCT00440232|101345944|FG001|COMPLETED|Overall Study||34||
48414044|NCT00440232|101345943|FG000|NOT COMPLETED|Overall Study||3||
48414045|NCT00440232|101345944|FG001|NOT COMPLETED|Overall Study||4||
48414046|NCT01156012|101345945|FG000|STARTED|Overall Study||213||
48414047|NCT01156012|101345946|FG001|STARTED|Overall Study||189||
48414048|NCT01156012|101345945|FG000|COMPLETED|Overall Study||206||
48756662|NCT05236270|102191298|FG002|NOT COMPLETED|Overall Study||0||
48756663|NCT05236270|102191299|FG003|NOT COMPLETED|Overall Study||0||
48756664|NCT05236270|102191300|FG004|NOT COMPLETED|Overall Study||2||
48182169|NCT02173535|100768262|FG005|COMPLETED|Period 1||12||
48414049|NCT01156012|101345946|FG001|COMPLETED|Overall Study||186||
48414050|NCT01156012|101345945|FG000|NOT COMPLETED|Overall Study||7||
48414051|NCT01156012|101345946|FG001|NOT COMPLETED|Overall Study||3||
48414052|NCT00550615|101345947|FG000|STARTED|Overall Study||3||
48414053|NCT00550615|101345948|FG001|STARTED|Overall Study||3||
48633686|NCT02832037|101888760|FG001|COMPLETED|Overall Study||72||
48633687|NCT02832037|101888761|FG002|COMPLETED|Overall Study||77||
48633688|NCT02832037|101888762|FG003|COMPLETED|Overall Study||78||
48633689|NCT02832037|101888763|FG004|COMPLETED|Overall Study||151||
48633690|NCT02832037|101888759|FG000|NOT COMPLETED|Overall Study||19||
48633691|NCT02832037|101888760|FG001|NOT COMPLETED|Overall Study||12||
48633692|NCT02832037|101888761|FG002|NOT COMPLETED|Overall Study||8||
48633693|NCT02832037|101888762|FG003|NOT COMPLETED|Overall Study||7||
48633694|NCT02832037|101888763|FG004|NOT COMPLETED|Overall Study||19||
48633695|NCT00477685|101888764|FG000|STARTED|Overall Study||10||
48633696|NCT00477685|101888764|FG000|COMPLETED|Overall Study||10||
48633697|NCT00477685|101888764|FG000|NOT COMPLETED|Overall Study||0||
48633698|NCT01838876|101888765|FG000|STARTED|Overall Study||442||
48633699|NCT01838876|101888765|FG000|Safety Population; Received Study Drug|Overall Study||345||
48633700|NCT01838876|101888765|FG000|Entered Safety Follow-up Period|Overall Study||287||
48633701|NCT01838876|101888765|FG000|COMPLETED|Overall Study||209||
48633702|NCT01838876|101888765|FG000|NOT COMPLETED|Overall Study||233||
48633703|NCT01138735|101888766|FG000|STARTED|Overall Study||142||
48633704|NCT01138735|101888767|FG001|STARTED|Overall Study||143||
48633705|NCT01138735|101888766|FG000|COMPLETED|Overall Study||134||
48633706|NCT01138735|101888767|FG001|COMPLETED|Overall Study||126||
48633707|NCT01138735|101888766|FG000|NOT COMPLETED|Overall Study||8||
48633708|NCT01138735|101888767|FG001|NOT COMPLETED|Overall Study||17||
48633709|NCT01963611|101888768|FG000|STARTED|Overall Study||51||
48633710|NCT01963611|101888769|FG001|STARTED|Overall Study||49||
48633711|NCT01963611|101888770|FG002|STARTED|Overall Study||52||
48633712|NCT01963611|101888771|FG003|STARTED|Overall Study||52||
48414054|NCT00550615|101345949|FG002|STARTED|Overall Study||10||
48414055|NCT00550615|101345950|FG003|STARTED|Overall Study||22||
48414056|NCT00550615|101345947|FG000|COMPLETED|Overall Study||3||
48414057|NCT00550615|101345948|FG001|COMPLETED|Overall Study||3||
48414058|NCT00550615|101345949|FG002|COMPLETED|Overall Study||6||
48414059|NCT00550615|101345950|FG003|COMPLETED|Overall Study||12||
48414060|NCT00550615|101345947|FG000|NOT COMPLETED|Overall Study||0||
48414061|NCT00550615|101345948|FG001|NOT COMPLETED|Overall Study||0||
48414062|NCT00550615|101345949|FG002|NOT COMPLETED|Overall Study||4||
48414063|NCT00550615|101345950|FG003|NOT COMPLETED|Overall Study||10||
48414064|NCT01744340|101345951|FG000|STARTED|Overall Study||8||
48414065|NCT01744340|101345952|FG001|STARTED|Overall Study||15||
48414066|NCT01744340|101345951|FG000|COMPLETED|Overall Study||8||
48414067|NCT01744340|101345952|FG001|COMPLETED|Overall Study||15||
48414068|NCT01744340|101345951|FG000|NOT COMPLETED|Overall Study||0||
48414069|NCT01744340|101345952|FG001|NOT COMPLETED|Overall Study||0||
48414070|NCT02442765|101345953|FG000|STARTED|Stage 1- (Days 1 to 42)||194||
48414071|NCT02442765|101345954|FG001|STARTED|Stage 1- (Days 1 to 42)||96||
48414072|NCT02442765|101345955|FG002|STARTED|Stage 1- (Days 1 to 42)||97||
48414073|NCT02442765|101345956|FG003|STARTED|Stage 1- (Days 1 to 42)||0||
48414074|NCT02442765|101345957|FG004|STARTED|Stage 1- (Days 1 to 42)||0||
48414075|NCT02442765|101345958|FG005|STARTED|Stage 1- (Days 1 to 42)||0||
48633713|NCT01963611|101888772|FG004|STARTED|Overall Study||51||
48633714|NCT01963611|101888768|FG000|Safety Analysis Set|Overall Study||51||
48633715|NCT01963611|101888769|FG001|Safety Analysis Set|Overall Study||49||
48633716|NCT01963611|101888770|FG002|Safety Analysis Set|Overall Study||52||
48633717|NCT01963611|101888771|FG003|Safety Analysis Set|Overall Study||52||
48182170|NCT02173535|100768263|FG006|COMPLETED|Period 1||12||
48182171|NCT02173535|100768264|FG007|COMPLETED|Period 1||12||
48182172|NCT02173535|100768265|FG008|COMPLETED|Period 1||12||
48182173|NCT02173535|100768266|FG009|COMPLETED|Period 1||12||
48182174|NCT02173535|100768267|FG010|COMPLETED|Period 1||12||
48182175|NCT02173535|100768268|FG011|COMPLETED|Period 1||12||
48182176|NCT02173535|100768269|FG012|COMPLETED|Period 1||12||
48182177|NCT02173535|100768270|FG013|COMPLETED|Period 1||12||
48182178|NCT02173535|100768271|FG014|COMPLETED|Period 1||12||
48342519|NCT02689492|101167565|FG000|STARTED|Overall Study||401||
48342520|NCT02689492|101167565|FG000|COMPLETED|Overall Study||315||
48342521|NCT02689492|101167565|FG000|NOT COMPLETED|Overall Study||86||
48342522|NCT01099969|101167566|FG000|STARTED|Overall Study||15||
48342523|NCT01099969|101167567|FG001|STARTED|Overall Study||15||
48342524|NCT01099969|101167568|FG002|STARTED|Overall Study||15||
48182179|NCT02173535|100768272|FG015|COMPLETED|Period 1||12||
48182180|NCT02173535|100768273|FG016|COMPLETED|Period 1||12||
48342525|NCT01099969|101167569|FG003|STARTED|Overall Study||15||
48342526|NCT01099969|101167566|FG000|COMPLETED|Overall Study||15||
48633718|NCT01963611|101888772|FG004|Safety Analysis Set|Overall Study||50||
48633719|NCT01963611|101888768|FG000|COMPLETED|Overall Study||0||
48756665|NCT05236270|102191301|FG005|NOT COMPLETED|Overall Study||0||
48756666|NCT05236270|102191302|FG006|NOT COMPLETED|Overall Study||1||
48756667|NCT05236270|102191303|FG007|NOT COMPLETED|Overall Study||3||
48756668|NCT03270943|102191304|FG000|STARTED|Intervention Refinement||6||
48756669|NCT03270943|102191305|FG001|STARTED|Intervention Refinement||9||
48182181|NCT02173535|100768274|FG017|COMPLETED|Period 1||12||
48182182|NCT02173535|100768275|FG018|COMPLETED|Period 1||12||
48182183|NCT02173535|100768276|FG019|COMPLETED|Period 1||12||
48182184|NCT02173535|100768257|FG000|NOT COMPLETED|Period 1||0||
48182185|NCT02173535|100768258|FG001|NOT COMPLETED|Period 1||0||
48342527|NCT01099969|101167567|FG001|COMPLETED|Overall Study||15||
48342528|NCT01099969|101167568|FG002|COMPLETED|Overall Study||15||
48414076|NCT02442765|101345959|FG006|STARTED|Stage 1- (Days 1 to 42)||0||
48414077|NCT02442765|101345960|FG007|STARTED|Stage 1- (Days 1 to 42)||0||
48414078|NCT02442765|101345953|FG000|COMPLETED|Stage 1- (Days 1 to 42)||194||
48414079|NCT02442765|101345954|FG001|COMPLETED|Stage 1- (Days 1 to 42)||96||
48414080|NCT02442765|101345955|FG002|COMPLETED|Stage 1- (Days 1 to 42)||97||
48414081|NCT02442765|101345956|FG003|COMPLETED|Stage 1- (Days 1 to 42)||0||
48414082|NCT02442765|101345957|FG004|COMPLETED|Stage 1- (Days 1 to 42)||0||
48182186|NCT02173535|100768259|FG002|NOT COMPLETED|Period 1||0||
48182187|NCT02173535|100768260|FG003|NOT COMPLETED|Period 1||0||
48182188|NCT02173535|100768261|FG004|NOT COMPLETED|Period 1||0||
48182189|NCT02173535|100768262|FG005|NOT COMPLETED|Period 1||0||
48182190|NCT02173535|100768263|FG006|NOT COMPLETED|Period 1||0||
48182191|NCT02173535|100768264|FG007|NOT COMPLETED|Period 1||0||
48182192|NCT02173535|100768265|FG008|NOT COMPLETED|Period 1||0||
48182193|NCT02173535|100768266|FG009|NOT COMPLETED|Period 1||0||
48182194|NCT02173535|100768267|FG010|NOT COMPLETED|Period 1||0||
48182195|NCT02173535|100768268|FG011|NOT COMPLETED|Period 1||0||
48182196|NCT02173535|100768269|FG012|NOT COMPLETED|Period 1||0||
48182197|NCT02173535|100768270|FG013|NOT COMPLETED|Period 1||0||
48182198|NCT02173535|100768271|FG014|NOT COMPLETED|Period 1||0||
48414083|NCT02442765|101345958|FG005|COMPLETED|Stage 1- (Days 1 to 42)||0||
48414084|NCT02442765|101345959|FG006|COMPLETED|Stage 1- (Days 1 to 42)||0||
48182199|NCT02173535|100768272|FG015|NOT COMPLETED|Period 1||0||
48182200|NCT02173535|100768273|FG016|NOT COMPLETED|Period 1||0||
48182201|NCT02173535|100768274|FG017|NOT COMPLETED|Period 1||0||
48182202|NCT02173535|100768275|FG018|NOT COMPLETED|Period 1||0||
48342529|NCT01099969|101167569|FG003|COMPLETED|Overall Study||15||
48342530|NCT01099969|101167566|FG000|NOT COMPLETED|Overall Study||0||
48342531|NCT01099969|101167567|FG001|NOT COMPLETED|Overall Study||0||
48342532|NCT01099969|101167568|FG002|NOT COMPLETED|Overall Study||0||
48342533|NCT01099969|101167569|FG003|NOT COMPLETED|Overall Study||0||
48342534|NCT02620904|101167570|FG000|STARTED|Overall Study||4||
48633720|NCT01963611|101888769|FG001|COMPLETED|Overall Study||0||
48633721|NCT01963611|101888770|FG002|COMPLETED|Overall Study||0||
48633722|NCT01963611|101888771|FG003|COMPLETED|Overall Study||0||
48633723|NCT01963611|101888772|FG004|COMPLETED|Overall Study||0||
48633724|NCT01963611|101888768|FG000|NOT COMPLETED|Overall Study||51||
48633725|NCT01963611|101888769|FG001|NOT COMPLETED|Overall Study||49||
48633726|NCT01963611|101888770|FG002|NOT COMPLETED|Overall Study||52||
48756670|NCT03270943|102191304|FG000|COMPLETED|Intervention Refinement||6||
48756671|NCT03270943|102191305|FG001|COMPLETED|Intervention Refinement||6||
48182203|NCT02173535|100768276|FG019|NOT COMPLETED|Period 1||0||
48414085|NCT02442765|101345960|FG007|COMPLETED|Stage 1- (Days 1 to 42)||0||
48414086|NCT02442765|101345953|FG000|NOT COMPLETED|Stage 1- (Days 1 to 42)||0||
48182204|NCT02173535|100768257|FG000|STARTED|Period 2||12||
48182205|NCT02173535|100768258|FG001|STARTED|Period 2||12||
48182206|NCT02173535|100768259|FG002|STARTED|Period 2||12||
48182207|NCT02173535|100768260|FG003|STARTED|Period 2||12||
48182208|NCT02173535|100768261|FG004|STARTED|Period 2||12||
48182209|NCT02173535|100768262|FG005|STARTED|Period 2||12||
48633727|NCT01963611|101888771|FG003|NOT COMPLETED|Overall Study||52||
48633728|NCT01963611|101888772|FG004|NOT COMPLETED|Overall Study||51||
48633729|NCT01258374|101888773|FG000|STARTED|Overall Study||15||
48414087|NCT02442765|101345954|FG001|NOT COMPLETED|Stage 1- (Days 1 to 42)||0||
48414088|NCT02442765|101345955|FG002|NOT COMPLETED|Stage 1- (Days 1 to 42)||0||
48414089|NCT02442765|101345956|FG003|NOT COMPLETED|Stage 1- (Days 1 to 42)||0||
48633730|NCT01258374|101888773|FG000|COMPLETED|Overall Study||15||
48633731|NCT01258374|101888773|FG000|NOT COMPLETED|Overall Study||0||
48633732|NCT01117870|101888774|FG000|STARTED|Overall Study||15||
48633733|NCT01117870|101888775|FG001|STARTED|Overall Study||16||
48633734|NCT01117870|101888774|FG000|COMPLETED|Overall Study||14||
48633735|NCT01117870|101888775|FG001|COMPLETED|Overall Study||16||
48633736|NCT01117870|101888774|FG000|NOT COMPLETED|Overall Study||1||
48633737|NCT01117870|101888775|FG001|NOT COMPLETED|Overall Study||0||
48633738|NCT05471505|101888776|FG000|STARTED|Overall Study||72095||
48633739|NCT05471505|101888777|FG001|STARTED|Overall Study||48627||
48633740|NCT05471505|101888776|FG000|COMPLETED|Overall Study||72095||
48633741|NCT05471505|101888777|FG001|COMPLETED|Overall Study||48627||
48633742|NCT05471505|101888776|FG000|NOT COMPLETED|Overall Study||0||
48633743|NCT05471505|101888777|FG001|NOT COMPLETED|Overall Study||0||
48633744|NCT00808340|101888778|FG000|STARTED|First Intervention||4||
48633745|NCT00808340|101888779|FG001|STARTED|First Intervention||9||
48633746|NCT00808340|101888780|FG002|STARTED|First Intervention||7||
48633747|NCT00808340|101888781|FG003|STARTED|First Intervention||3||
48414090|NCT02442765|101345957|FG004|NOT COMPLETED|Stage 1- (Days 1 to 42)||0||
48414091|NCT02442765|101345958|FG005|NOT COMPLETED|Stage 1- (Days 1 to 42)||0||
48414092|NCT02442765|101345959|FG006|NOT COMPLETED|Stage 1- (Days 1 to 42)||0||
48414093|NCT02442765|101345960|FG007|NOT COMPLETED|Stage 1- (Days 1 to 42)||0||
48414094|NCT02442765|101345953|FG000|STARTED|Stage 2- (Days 43 to 85)||0||
48414095|NCT02442765|101345954|FG001|STARTED|Stage 2- (Days 43 to 85)||0||
48414096|NCT02442765|101345955|FG002|STARTED|Stage 2- (Days 43 to 85)||0||
48414097|NCT02442765|101345956|FG003|STARTED|Stage 2- (Days 43 to 85)||63||
48414098|NCT02442765|101345957|FG004|STARTED|Stage 2- (Days 43 to 85)||96||
48182210|NCT02173535|100768263|FG006|STARTED|Period 2||12||
48414099|NCT02442765|101345958|FG005|STARTED|Stage 2- (Days 43 to 85)||97||
48414100|NCT02442765|101345959|FG006|STARTED|Stage 2- (Days 43 to 85)||65||
48633748|NCT00808340|101888782|FG004|STARTED|First Intervention||5||
48633749|NCT00808340|101888783|FG005|STARTED|First Intervention||6||
48633750|NCT00808340|101888778|FG000|COMPLETED|First Intervention||4||
48633751|NCT00808340|101888779|FG001|COMPLETED|First Intervention||9||
48633752|NCT00808340|101888780|FG002|COMPLETED|First Intervention||7||
48633753|NCT00808340|101888781|FG003|COMPLETED|First Intervention||3||
48414101|NCT02442765|101345960|FG007|STARTED|Stage 2- (Days 43 to 85)||66||
48414102|NCT02442765|101345953|FG000|COMPLETED|Stage 2- (Days 43 to 85)||0||
48633754|NCT00808340|101888782|FG004|COMPLETED|First Intervention||5||
48182211|NCT02173535|100768264|FG007|STARTED|Period 2||12||
48182212|NCT02173535|100768265|FG008|STARTED|Period 2||12||
48342535|NCT02620904|101167571|FG001|STARTED|Overall Study||5||
48342536|NCT02620904|101167570|FG000|COMPLETED|Overall Study||4||
48342537|NCT02620904|101167571|FG001|COMPLETED|Overall Study||5||
48342538|NCT02620904|101167570|FG000|NOT COMPLETED|Overall Study||0||
48342539|NCT02620904|101167571|FG001|NOT COMPLETED|Overall Study||0||
48342540|NCT03954626|101167572|FG000|STARTED|Overall Study||14||
48342541|NCT03954626|101167572|FG000|COMPLETED|Overall Study||14||
48342542|NCT03954626|101167572|FG000|NOT COMPLETED|Overall Study||0||
48342543|NCT03195517|101167573|FG000|STARTED|Overall Study||33||
48342544|NCT03195517|101167573|FG000|COMPLETED|Overall Study||33||
48342545|NCT03195517|101167573|FG000|NOT COMPLETED|Overall Study||0||
48342546|NCT01750255|101167574|FG000|STARTED|Overall Study||49||
48342547|NCT01750255|101167575|FG001|STARTED|Overall Study||43||
48342548|NCT01750255|101167574|FG000|COMPLETED|Overall Study||43||
48342549|NCT01750255|101167575|FG001|COMPLETED|Overall Study||38||
48342550|NCT01750255|101167574|FG000|NOT COMPLETED|Overall Study||6||
48342551|NCT01750255|101167575|FG001|NOT COMPLETED|Overall Study||5||
48342552|NCT03636906|101167576|FG000|STARTED|Overall Study||65||
48414103|NCT02442765|101345954|FG001|COMPLETED|Stage 2- (Days 43 to 85)||0||
48633755|NCT00808340|101888783|FG005|COMPLETED|First Intervention||6||
48633756|NCT00808340|101888778|FG000|NOT COMPLETED|First Intervention||0||
48633757|NCT00808340|101888779|FG001|NOT COMPLETED|First Intervention||0||
48182213|NCT02173535|100768266|FG009|STARTED|Period 2||12||
48182214|NCT02173535|100768267|FG010|STARTED|Period 2||12||
48342553|NCT03636906|101167577|FG001|STARTED|Overall Study||71||
48633758|NCT00808340|101888780|FG002|NOT COMPLETED|First Intervention||0||
48633759|NCT00808340|101888781|FG003|NOT COMPLETED|First Intervention||0||
48633760|NCT00808340|101888782|FG004|NOT COMPLETED|First Intervention||0||
48633761|NCT00808340|101888783|FG005|NOT COMPLETED|First Intervention||0||
48633762|NCT00808340|101888778|FG000|STARTED|Second Intervention||4||
48342554|NCT03636906|101167578|FG002|STARTED|Overall Study||65||
48342555|NCT03636906|101167576|FG000|COMPLETED|Overall Study||61||
48342556|NCT03636906|101167577|FG001|COMPLETED|Overall Study||71||
48182215|NCT02173535|100768268|FG011|STARTED|Period 2||12||
48182216|NCT02173535|100768269|FG012|STARTED|Period 2||12||
48633763|NCT00808340|101888779|FG001|STARTED|Second Intervention||9||
48182217|NCT02173535|100768270|FG013|STARTED|Period 2||12||
48182218|NCT02173535|100768271|FG014|STARTED|Period 2||12||
48182219|NCT02173535|100768272|FG015|STARTED|Period 2||12||
48182220|NCT02173535|100768273|FG016|STARTED|Period 2||12||
48182221|NCT02173535|100768274|FG017|STARTED|Period 2||12||
48182222|NCT02173535|100768275|FG018|STARTED|Period 2||12||
48182223|NCT02173535|100768276|FG019|STARTED|Period 2||12||
48182224|NCT02173535|100768257|FG000|COMPLETED|Period 2||12||
48182225|NCT02173535|100768258|FG001|COMPLETED|Period 2||12||
48182226|NCT02173535|100768259|FG002|COMPLETED|Period 2||12||
48182227|NCT02173535|100768260|FG003|COMPLETED|Period 2||12||
48182228|NCT02173535|100768261|FG004|COMPLETED|Period 2||12||
48182229|NCT02173535|100768262|FG005|COMPLETED|Period 2||12||
48182230|NCT02173535|100768263|FG006|COMPLETED|Period 2||12||
48182231|NCT02173535|100768264|FG007|COMPLETED|Period 2||12||
48182232|NCT02173535|100768265|FG008|COMPLETED|Period 2||12||
48182233|NCT02173535|100768266|FG009|COMPLETED|Period 2||12||
48182234|NCT02173535|100768267|FG010|COMPLETED|Period 2||12||
48182235|NCT02173535|100768268|FG011|COMPLETED|Period 2||12||
48182236|NCT02173535|100768269|FG012|COMPLETED|Period 2||12||
48182237|NCT02173535|100768270|FG013|COMPLETED|Period 2||12||
48182238|NCT02173535|100768271|FG014|COMPLETED|Period 2||12||
48182239|NCT02173535|100768272|FG015|COMPLETED|Period 2||12||
48182240|NCT02173535|100768273|FG016|COMPLETED|Period 2||12||
48342557|NCT03636906|101167578|FG002|COMPLETED|Overall Study||60||
48342558|NCT03636906|101167576|FG000|NOT COMPLETED|Overall Study||4||
48342559|NCT03636906|101167577|FG001|NOT COMPLETED|Overall Study||0||
48342560|NCT03636906|101167578|FG002|NOT COMPLETED|Overall Study||5||
48342561|NCT01989221|101167579|FG000|STARTED|Overall Study||14||
48342562|NCT01989221|101167579|FG000|COMPLETED|Overall Study||14||
48342563|NCT01989221|101167579|FG000|NOT COMPLETED|Overall Study||0||
48342564|NCT00984204|101167580|FG000|STARTED|Overall Study||188||
48342565|NCT00984204|101167580|FG000|COMPLETED|Overall Study||173||
48342566|NCT00984204|101167580|FG000|NOT COMPLETED|Overall Study||15||
48342567|NCT04551014|101167581|FG000|STARTED|Overall Study||105||142
48342568|NCT04551014|101167582|FG001|STARTED|Overall Study||109||149
48342569|NCT04551014|101167581|FG000|COMPLETED|Overall Study||105||142
48342570|NCT04551014|101167582|FG001|COMPLETED|Overall Study||109||149
48342571|NCT04551014|101167581|FG000|NOT COMPLETED|Overall Study||0||0
48342572|NCT04551014|101167582|FG001|NOT COMPLETED|Overall Study||0||0
48342573|NCT00103012|101167583|FG000|STARTED|Overall Study||17||
48342574|NCT00103012|101167584|FG001|STARTED|Overall Study||14||
48342575|NCT00103012|101167585|FG002|STARTED|Overall Study||16||
48342576|NCT00103012|101167583|FG000|COMPLETED|Overall Study||14||
48342577|NCT00103012|101167584|FG001|COMPLETED|Overall Study||13||
48342578|NCT00103012|101167585|FG002|COMPLETED|Overall Study||12||
48342579|NCT00103012|101167583|FG000|NOT COMPLETED|Overall Study||3||
48342580|NCT00103012|101167584|FG001|NOT COMPLETED|Overall Study||1||
48342581|NCT00103012|101167585|FG002|NOT COMPLETED|Overall Study||4||
48342582|NCT03663166|101167586|FG000|STARTED|Overall Study||19||
48342583|NCT03663166|101167586|FG000|COMPLETED|Overall Study||18||
48342584|NCT03663166|101167586|FG000|NOT COMPLETED|Overall Study||1||
48342585|NCT00989989|101167587|FG000|STARTED|Overall Study||132||
48342586|NCT00989989|101167588|FG001|STARTED|Overall Study||133||
48342587|NCT00989989|101167589|FG002|STARTED|Overall Study||131||
48342588|NCT00989989|101167587|FG000|COMPLETED|Overall Study||114||
48342589|NCT00989989|101167588|FG001|COMPLETED|Overall Study||123||
48342590|NCT00989989|101167589|FG002|COMPLETED|Overall Study||108||
48342591|NCT00989989|101167587|FG000|NOT COMPLETED|Overall Study||18||
48342592|NCT00989989|101167588|FG001|NOT COMPLETED|Overall Study||10||
48342593|NCT00989989|101167589|FG002|NOT COMPLETED|Overall Study||23||
48342594|NCT01557790|101167590|FG000|STARTED|Overall Study||5||
48342595|NCT01557790|101167590|FG000|COMPLETED|Overall Study||4||
48342596|NCT01557790|101167590|FG000|NOT COMPLETED|Overall Study||1||
48342597|NCT01354132|101167591|FG000|STARTED|Randomization||32||
48342598|NCT01354132|101167592|FG001|STARTED|Randomization||31||
48342599|NCT01354132|101167591|FG000|COMPLETED|Randomization||31||
48342600|NCT01354132|101167592|FG001|COMPLETED|Randomization||30||
48342601|NCT01354132|101167591|FG000|NOT COMPLETED|Randomization||1||
48342602|NCT01354132|101167592|FG001|NOT COMPLETED|Randomization||1||
48342603|NCT01354132|101167591|FG000|STARTED|Double Blind (Visits 1-7)||31||
48342604|NCT01354132|101167592|FG001|STARTED|Double Blind (Visits 1-7)||30||
48342605|NCT01354132|101167591|FG000|Completed More Than 1 Visit|Double Blind (Visits 1-7)||4||
48633764|NCT00808340|101888780|FG002|STARTED|Second Intervention||7||
48342606|NCT01354132|101167592|FG001|Completed More Than 1 Visit|Double Blind (Visits 1-7)||5||
48182241|NCT02173535|100768274|FG017|COMPLETED|Period 2||12||
48182242|NCT02173535|100768275|FG018|COMPLETED|Period 2||12||
48182243|NCT02173535|100768276|FG019|COMPLETED|Period 2||12||
48182244|NCT02173535|100768257|FG000|NOT COMPLETED|Period 2||0||
48182245|NCT02173535|100768258|FG001|NOT COMPLETED|Period 2||0||
48182246|NCT02173535|100768259|FG002|NOT COMPLETED|Period 2||0||
48182247|NCT02173535|100768260|FG003|NOT COMPLETED|Period 2||0||
48182248|NCT02173535|100768261|FG004|NOT COMPLETED|Period 2||0||
48182249|NCT02173535|100768262|FG005|NOT COMPLETED|Period 2||0||
48182250|NCT02173535|100768263|FG006|NOT COMPLETED|Period 2||0||
48182251|NCT02173535|100768264|FG007|NOT COMPLETED|Period 2||0||
48182252|NCT02173535|100768265|FG008|NOT COMPLETED|Period 2||0||
48182253|NCT02173535|100768266|FG009|NOT COMPLETED|Period 2||0||
48182254|NCT02173535|100768267|FG010|NOT COMPLETED|Period 2||0||
48182255|NCT02173535|100768268|FG011|NOT COMPLETED|Period 2||0||
48182256|NCT02173535|100768269|FG012|NOT COMPLETED|Period 2||0||
48182257|NCT02173535|100768270|FG013|NOT COMPLETED|Period 2||0||
48182258|NCT02173535|100768271|FG014|NOT COMPLETED|Period 2||0||
48182259|NCT02173535|100768272|FG015|NOT COMPLETED|Period 2||0||
48182260|NCT02173535|100768273|FG016|NOT COMPLETED|Period 2||0||
48182261|NCT02173535|100768274|FG017|NOT COMPLETED|Period 2||0||
48182262|NCT02173535|100768275|FG018|NOT COMPLETED|Period 2||0||
48182263|NCT02173535|100768276|FG019|NOT COMPLETED|Period 2||0||
48182264|NCT02173535|100768257|FG000|STARTED|Period 3||12||
48182265|NCT02173535|100768258|FG001|STARTED|Period 3||12||
48182266|NCT02173535|100768259|FG002|STARTED|Period 3||12||
48182267|NCT02173535|100768260|FG003|STARTED|Period 3||12||
48182268|NCT02173535|100768261|FG004|STARTED|Period 3||12||
48182269|NCT02173535|100768262|FG005|STARTED|Period 3||12||
48182270|NCT02173535|100768263|FG006|STARTED|Period 3||12||
48182271|NCT02173535|100768264|FG007|STARTED|Period 3||12||
48182272|NCT02173535|100768265|FG008|STARTED|Period 3||12||
48182273|NCT02173535|100768266|FG009|STARTED|Period 3||12||
48182274|NCT02173535|100768267|FG010|STARTED|Period 3||12||
48182275|NCT02173535|100768268|FG011|STARTED|Period 3||12||
48182276|NCT02173535|100768269|FG012|STARTED|Period 3||12||
48182277|NCT02173535|100768270|FG013|STARTED|Period 3||12||
48182278|NCT02173535|100768271|FG014|STARTED|Period 3||12||
48182279|NCT02173535|100768272|FG015|STARTED|Period 3||12||
48414104|NCT02442765|101345955|FG002|COMPLETED|Stage 2- (Days 43 to 85)||0||
48414105|NCT02442765|101345956|FG003|COMPLETED|Stage 2- (Days 43 to 85)||56||
48414106|NCT02442765|101345957|FG004|COMPLETED|Stage 2- (Days 43 to 85)||86||
48414107|NCT02442765|101345958|FG005|COMPLETED|Stage 2- (Days 43 to 85)||92||
48414108|NCT02442765|101345959|FG006|COMPLETED|Stage 2- (Days 43 to 85)||59||
48414109|NCT02442765|101345960|FG007|COMPLETED|Stage 2- (Days 43 to 85)||55||
48414110|NCT02442765|101345953|FG000|NOT COMPLETED|Stage 2- (Days 43 to 85)||0||
48414111|NCT02442765|101345954|FG001|NOT COMPLETED|Stage 2- (Days 43 to 85)||0||
48414112|NCT02442765|101345955|FG002|NOT COMPLETED|Stage 2- (Days 43 to 85)||0||
48756672|NCT03270943|102191304|FG000|NOT COMPLETED|Intervention Refinement||0||
48756673|NCT03270943|102191305|FG001|NOT COMPLETED|Intervention Refinement||3||
48756674|NCT03270943|102191304|FG000|STARTED|Randomized (Willingness to be)||30||
48756675|NCT03270943|102191305|FG001|STARTED|Randomized (Willingness to be)||32||
48756676|NCT03270943|102191304|FG000|COMPLETED|Randomized (Willingness to be)||30||
48756677|NCT03270943|102191305|FG001|COMPLETED|Randomized (Willingness to be)||31||
48756678|NCT03270943|102191304|FG000|NOT COMPLETED|Randomized (Willingness to be)||0||
48756679|NCT03270943|102191305|FG001|NOT COMPLETED|Randomized (Willingness to be)||1||
48756680|NCT00865345|102191306|FG000|STARTED|Overall Study||63||
48756681|NCT00865345|102191306|FG000|COMPLETED|Overall Study||61||
48756682|NCT00865345|102191306|FG000|NOT COMPLETED|Overall Study||2||
48756683|NCT03291067|102191307|FG000|STARTED|Overall Study||94||
48756684|NCT03291067|102191308|FG001|STARTED|Overall Study||92||
48756685|NCT03291067|102191309|FG002|STARTED|Overall Study||94||
48756686|NCT03291067|102191310|FG003|STARTED|Overall Study||94||
48182280|NCT02173535|100768273|FG016|STARTED|Period 3||12||
48182281|NCT02173535|100768274|FG017|STARTED|Period 3||12||
48182282|NCT02173535|100768275|FG018|STARTED|Period 3||12||
48182283|NCT02173535|100768276|FG019|STARTED|Period 3||12||
48182284|NCT02173535|100768257|FG000|COMPLETED|Period 3||12||
48182285|NCT02173535|100768258|FG001|COMPLETED|Period 3||12||
48182286|NCT02173535|100768259|FG002|COMPLETED|Period 3||12||
48182287|NCT02173535|100768260|FG003|COMPLETED|Period 3||12||
48182288|NCT02173535|100768261|FG004|COMPLETED|Period 3||12||
48182289|NCT02173535|100768262|FG005|COMPLETED|Period 3||12||
48182290|NCT02173535|100768263|FG006|COMPLETED|Period 3||12||
48182291|NCT02173535|100768264|FG007|COMPLETED|Period 3||12||
48182292|NCT02173535|100768265|FG008|COMPLETED|Period 3||12||
48182293|NCT02173535|100768266|FG009|COMPLETED|Period 3||12||
48182294|NCT02173535|100768267|FG010|COMPLETED|Period 3||12||
48182295|NCT02173535|100768268|FG011|COMPLETED|Period 3||12||
48414113|NCT02442765|101345956|FG003|NOT COMPLETED|Stage 2- (Days 43 to 85)||7||
48414114|NCT02442765|101345957|FG004|NOT COMPLETED|Stage 2- (Days 43 to 85)||10||
48414115|NCT02442765|101345958|FG005|NOT COMPLETED|Stage 2- (Days 43 to 85)||5||
48414116|NCT02442765|101345959|FG006|NOT COMPLETED|Stage 2- (Days 43 to 85)||6||
48439957|NCT04190056|101409993|FG000|COMPLETED|Overall Study||0||
48756687|NCT03291067|102191307|FG000|Treated|Overall Study||95||
48182296|NCT02173535|100768269|FG012|COMPLETED|Period 3||12||
48182297|NCT02173535|100768270|FG013|COMPLETED|Period 3||12||
48182298|NCT02173535|100768271|FG014|COMPLETED|Period 3||12||
48182299|NCT02173535|100768272|FG015|COMPLETED|Period 3||12||
48182300|NCT02173535|100768273|FG016|COMPLETED|Period 3||12||
48182301|NCT02173535|100768274|FG017|COMPLETED|Period 3||12||
48182302|NCT02173535|100768275|FG018|COMPLETED|Period 3||12||
48182303|NCT02173535|100768276|FG019|COMPLETED|Period 3||12||
48182304|NCT02173535|100768257|FG000|NOT COMPLETED|Period 3||0||
48182305|NCT02173535|100768258|FG001|NOT COMPLETED|Period 3||0||
48182306|NCT02173535|100768259|FG002|NOT COMPLETED|Period 3||0||
48182307|NCT02173535|100768260|FG003|NOT COMPLETED|Period 3||0||
48182308|NCT02173535|100768261|FG004|NOT COMPLETED|Period 3||0||
48182309|NCT02173535|100768262|FG005|NOT COMPLETED|Period 3||0||
48182310|NCT02173535|100768263|FG006|NOT COMPLETED|Period 3||0||
48182311|NCT02173535|100768264|FG007|NOT COMPLETED|Period 3||0||
48182312|NCT02173535|100768265|FG008|NOT COMPLETED|Period 3||0||
48633765|NCT00808340|101888781|FG003|STARTED|Second Intervention||3||
48633766|NCT00808340|101888782|FG004|STARTED|Second Intervention||5||
48633767|NCT00808340|101888783|FG005|STARTED|Second Intervention||6||
48633768|NCT00808340|101888778|FG000|COMPLETED|Second Intervention||4||
48633769|NCT00808340|101888779|FG001|COMPLETED|Second Intervention||9||
48633770|NCT00808340|101888780|FG002|COMPLETED|Second Intervention||7||
48633771|NCT00808340|101888781|FG003|COMPLETED|Second Intervention||3||
48633772|NCT00808340|101888782|FG004|COMPLETED|Second Intervention||5||
48633773|NCT00808340|101888783|FG005|COMPLETED|Second Intervention||6||
48633774|NCT00808340|101888778|FG000|NOT COMPLETED|Second Intervention||0||
48633775|NCT00808340|101888779|FG001|NOT COMPLETED|Second Intervention||0||
48633776|NCT00808340|101888780|FG002|NOT COMPLETED|Second Intervention||0||
48633777|NCT00808340|101888781|FG003|NOT COMPLETED|Second Intervention||0||
48633778|NCT00808340|101888782|FG004|NOT COMPLETED|Second Intervention||0||
48633779|NCT00808340|101888783|FG005|NOT COMPLETED|Second Intervention||0||
48756688|NCT03291067|102191308|FG001|Treated|Overall Study||90||
48756689|NCT03291067|102191309|FG002|Treated|Overall Study||93||
48756690|NCT03291067|102191310|FG003|Treated|Overall Study||90||
48756691|NCT03291067|102191307|FG000|COMPLETED|Overall Study||84||
48756692|NCT03291067|102191308|FG001|COMPLETED|Overall Study||78||
48756693|NCT03291067|102191309|FG002|COMPLETED|Overall Study||61||
48633780|NCT00808340|101888778|FG000|STARTED|Third Intervention||4||
48633781|NCT00808340|101888779|FG001|STARTED|Third Intervention||9||
48633782|NCT00808340|101888780|FG002|STARTED|Third Intervention||7||
48633783|NCT00808340|101888781|FG003|STARTED|Third Intervention||3||
48633784|NCT00808340|101888782|FG004|STARTED|Third Intervention||5||
48633785|NCT00808340|101888783|FG005|STARTED|Third Intervention||6||
48633786|NCT00808340|101888778|FG000|COMPLETED|Third Intervention||4||
48633787|NCT00808340|101888779|FG001|COMPLETED|Third Intervention||9||
48633788|NCT00808340|101888780|FG002|COMPLETED|Third Intervention||7||
48633789|NCT00808340|101888781|FG003|COMPLETED|Third Intervention||3||
48633790|NCT00808340|101888782|FG004|COMPLETED|Third Intervention||5||
48633791|NCT00808340|101888783|FG005|COMPLETED|Third Intervention||6||
48756694|NCT03291067|102191310|FG003|COMPLETED|Overall Study||77||
48756695|NCT03291067|102191307|FG000|NOT COMPLETED|Overall Study||10||
48756696|NCT03291067|102191308|FG001|NOT COMPLETED|Overall Study||14||
48756697|NCT03291067|102191309|FG002|NOT COMPLETED|Overall Study||33||
48756698|NCT03291067|102191310|FG003|NOT COMPLETED|Overall Study||17||
48756699|NCT03285724|102191311|FG000|STARTED|Overall Study||1||
48756700|NCT03285724|102191311|FG000|COMPLETED|Overall Study||1||
48756701|NCT03285724|102191311|FG000|NOT COMPLETED|Overall Study||0||
48182313|NCT02173535|100768266|FG009|NOT COMPLETED|Period 3||0||
48182314|NCT02173535|100768267|FG010|NOT COMPLETED|Period 3||0||
48182315|NCT02173535|100768268|FG011|NOT COMPLETED|Period 3||0||
48182316|NCT02173535|100768269|FG012|NOT COMPLETED|Period 3||0||
48182317|NCT02173535|100768270|FG013|NOT COMPLETED|Period 3||0||
48182318|NCT02173535|100768271|FG014|NOT COMPLETED|Period 3||0||
48633792|NCT00808340|101888778|FG000|NOT COMPLETED|Third Intervention||0||
48633793|NCT00808340|101888779|FG001|NOT COMPLETED|Third Intervention||0||
48633794|NCT00808340|101888780|FG002|NOT COMPLETED|Third Intervention||0||
48633795|NCT00808340|101888781|FG003|NOT COMPLETED|Third Intervention||0||
48633796|NCT00808340|101888782|FG004|NOT COMPLETED|Third Intervention||0||
48633797|NCT00808340|101888783|FG005|NOT COMPLETED|Third Intervention||0||
48633798|NCT04009837|101888784|FG000|STARTED|Overall Study||91||
48633799|NCT04009837|101888785|FG001|STARTED|Overall Study||93||
48633800|NCT04009837|101888784|FG000|8-Weeks (Post-intervention)|Overall Study||83||
48633801|NCT04009837|101888785|FG001|8-Weeks (Post-intervention)|Overall Study||82||
48633802|NCT04009837|101888784|FG000|COMPLETED|Overall Study||83||
48182319|NCT02173535|100768272|FG015|NOT COMPLETED|Period 3||0||
48182320|NCT02173535|100768273|FG016|NOT COMPLETED|Period 3||0||
48182321|NCT02173535|100768274|FG017|NOT COMPLETED|Period 3||0||
48633803|NCT04009837|101888785|FG001|COMPLETED|Overall Study||82||
48633804|NCT04009837|101888784|FG000|NOT COMPLETED|Overall Study||8||
48633805|NCT04009837|101888785|FG001|NOT COMPLETED|Overall Study||11||
48633806|NCT02156258|101888786|FG000|STARTED|Overall Study||674||
48633807|NCT02156258|101888787|FG001|STARTED|Overall Study||203||
48633808|NCT02156258|101888788|FG002|STARTED|Overall Study||355||
48756702|NCT00781768|102191312|FG000|STARTED|Overall Study||89||
48756703|NCT00781768|102191313|FG001|STARTED|Overall Study||92||
48182322|NCT02173535|100768275|FG018|NOT COMPLETED|Period 3||0||
48182323|NCT02173535|100768276|FG019|NOT COMPLETED|Period 3||0||
48182324|NCT02173535|100768257|FG000|STARTED|Period 4||12||
48182325|NCT02173535|100768258|FG001|STARTED|Period 4||12||
48182326|NCT02173535|100768259|FG002|STARTED|Period 4||12||
48756704|NCT00781768|102191312|FG000|COMPLETED|Overall Study||89||
48756705|NCT00781768|102191313|FG001|COMPLETED|Overall Study||90||
48756706|NCT00781768|102191312|FG000|NOT COMPLETED|Overall Study||0||
48756707|NCT00781768|102191313|FG001|NOT COMPLETED|Overall Study||2||
48342607|NCT01354132|101167591|FG000|Stopped After First Visit|Double Blind (Visits 1-7)||3||
48342608|NCT01354132|101167592|FG001|Stopped After First Visit|Double Blind (Visits 1-7)||2||
48342609|NCT01354132|101167591|FG000|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||2||
48182327|NCT02173535|100768260|FG003|STARTED|Period 4||12||
48342610|NCT01354132|101167592|FG001|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||4||
48342611|NCT01354132|101167591|FG000|COMPLETED|Double Blind (Visits 1-7)||22||
48342612|NCT01354132|101167592|FG001|COMPLETED|Double Blind (Visits 1-7)||19||
48342613|NCT01354132|101167591|FG000|NOT COMPLETED|Double Blind (Visits 1-7)||9||
48342614|NCT01354132|101167592|FG001|NOT COMPLETED|Double Blind (Visits 1-7)||11||
48342615|NCT01354132|101167591|FG000|STARTED|1 Month Post Study Medication||22||
48342616|NCT01354132|101167592|FG001|STARTED|1 Month Post Study Medication||19||
48342617|NCT01354132|101167591|FG000|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||21||
48342618|NCT01354132|101167592|FG001|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||16||
48342619|NCT01354132|101167591|FG000|COMPLETED|1 Month Post Study Medication||21||
48342620|NCT01354132|101167592|FG001|COMPLETED|1 Month Post Study Medication||16||
48342621|NCT01354132|101167591|FG000|NOT COMPLETED|1 Month Post Study Medication||1||
48342622|NCT01354132|101167592|FG001|NOT COMPLETED|1 Month Post Study Medication||3||
48342623|NCT01499173|101167593|FG000|STARTED|Overall Study||101||
48342624|NCT01499173|101167593|FG000|COMPLETED|Overall Study||64||
48342625|NCT01499173|101167593|FG000|NOT COMPLETED|Overall Study||37||
48342626|NCT01763164|101167594|FG000|STARTED|Treatment Phase||269||
48342627|NCT01763164|101167595|FG001|STARTED|Treatment Phase||133||
48342628|NCT01763164|101167594|FG000|Treated/Safety Set|Treatment Phase||269||
48342629|NCT01763164|101167595|FG001|Treated/Safety Set|Treatment Phase||114||
48342630|NCT01763164|101167594|FG000|Full Analysis Set|Treatment Phase||269||
48342631|NCT01763164|101167595|FG001|Full Analysis Set|Treatment Phase||133||
48342632|NCT01763164|101167594|FG000|COMPLETED|Treatment Phase||0||
48342633|NCT01763164|101167595|FG001|COMPLETED|Treatment Phase||0||
48342634|NCT01763164|101167594|FG000|NOT COMPLETED|Treatment Phase||269||
48342635|NCT01763164|101167595|FG001|NOT COMPLETED|Treatment Phase||133||
48342636|NCT01763164|101167594|FG000|STARTED|Follow up Phase||200||
48342637|NCT01763164|101167595|FG001|STARTED|Follow up Phase||78||
48342638|NCT01763164|101167594|FG000|COMPLETED|Follow up Phase||3||
48342639|NCT01763164|101167595|FG001|COMPLETED|Follow up Phase||3||
48342640|NCT01763164|101167594|FG000|NOT COMPLETED|Follow up Phase||197||
48342641|NCT01763164|101167595|FG001|NOT COMPLETED|Follow up Phase||75||
48342642|NCT03367871|101167596|FG000|STARTED|Overall Study||17||
48182328|NCT02173535|100768261|FG004|STARTED|Period 4||12||
48342643|NCT03367871|101167596|FG000|COMPLETED|Overall Study||16||
48342644|NCT03367871|101167596|FG000|NOT COMPLETED|Overall Study||1||
48342645|NCT01838044|101167597|FG000|STARTED|Overall Study||89||
48342646|NCT01838044|101167598|FG001|STARTED|Overall Study||91||
48342647|NCT01838044|101167597|FG000|COMPLETED|Overall Study||81||
48342648|NCT01838044|101167598|FG001|COMPLETED|Overall Study||75||
48342649|NCT01838044|101167597|FG000|NOT COMPLETED|Overall Study||8||
48439958|NCT04190056|101409994|FG001|COMPLETED|Overall Study||1||
48342650|NCT01838044|101167598|FG001|NOT COMPLETED|Overall Study||16||
48342651|NCT01007526|101167599|FG000|STARTED|Overall Study||31||
48342652|NCT01007526|101167599|FG000|COMPLETED|Overall Study||31||
48342653|NCT01007526|101167599|FG000|NOT COMPLETED|Overall Study||0||
48342654|NCT02397473|101167600|FG000|STARTED|Treatment Phase||57||
48342655|NCT02397473|101167601|FG001|STARTED|Treatment Phase||52||
48342656|NCT02397473|101167600|FG000|Received at Least One Dose of Study Drug|Treatment Phase||57||
48182329|NCT02173535|100768262|FG005|STARTED|Period 4||12||
48182330|NCT02173535|100768263|FG006|STARTED|Period 4||12||
48182331|NCT02173535|100768264|FG007|STARTED|Period 4||12||
48182332|NCT02173535|100768265|FG008|STARTED|Period 4||12||
48182333|NCT02173535|100768266|FG009|STARTED|Period 4||12||
48182334|NCT02173535|100768267|FG010|STARTED|Period 4||12||
48182335|NCT02173535|100768268|FG011|STARTED|Period 4||12||
48182336|NCT02173535|100768269|FG012|STARTED|Period 4||12||
48342657|NCT02397473|101167601|FG001|Received at Least One Dose of Study Drug|Treatment Phase||49||
48342658|NCT02397473|101167600|FG000|COMPLETED|Treatment Phase||45||
48342659|NCT02397473|101167601|FG001|COMPLETED|Treatment Phase||45||
48342660|NCT02397473|101167600|FG000|NOT COMPLETED|Treatment Phase||12||
48342661|NCT02397473|101167601|FG001|NOT COMPLETED|Treatment Phase||7||
48342662|NCT02397473|101167600|FG000|STARTED|Post Treatment Follow-up Phase||50||
48342663|NCT02397473|101167601|FG001|STARTED|Post Treatment Follow-up Phase||47||
48342664|NCT02397473|101167600|FG000|COMPLETED|Post Treatment Follow-up Phase||47||
48342665|NCT02397473|101167601|FG001|COMPLETED|Post Treatment Follow-up Phase||45||
48342666|NCT02397473|101167600|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||3||
48342667|NCT02397473|101167601|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||2||
48342668|NCT02413203|101167602|FG000|STARTED|Overall Study||10||
48342669|NCT02413203|101167603|FG001|STARTED|Overall Study||10||
48342670|NCT02413203|101167602|FG000|COMPLETED|Overall Study||10||
48342671|NCT02413203|101167603|FG001|COMPLETED|Overall Study||10||
48342672|NCT02413203|101167602|FG000|NOT COMPLETED|Overall Study||0||
48342673|NCT02413203|101167603|FG001|NOT COMPLETED|Overall Study||0||
48342674|NCT04354428|101167604|FG000|STARTED|Overall Study||83||
48342675|NCT04354428|101167605|FG001|STARTED|Overall Study||71||
48342676|NCT04354428|101167606|FG002|STARTED|Overall Study||77||
48342677|NCT04354428|101167607|FG003|STARTED|Overall Study||29||
48342678|NCT04354428|101167608|FG004|STARTED|Overall Study||29||
48342679|NCT04354428|101167604|FG000|Completed Enrollment|Overall Study||80||
48342680|NCT04354428|101167605|FG001|Completed Enrollment|Overall Study||65||
48342681|NCT04354428|101167606|FG002|Completed Enrollment|Overall Study||74||
48342682|NCT04354428|101167607|FG003|Completed Enrollment|Overall Study||27||
48342683|NCT04354428|101167608|FG004|Completed Enrollment|Overall Study||28||
48342684|NCT04354428|101167604|FG000|COMPLETED|Overall Study||75||
48342685|NCT04354428|101167605|FG001|COMPLETED|Overall Study||62||
48342686|NCT04354428|101167606|FG002|COMPLETED|Overall Study||71||
48342687|NCT04354428|101167607|FG003|COMPLETED|Overall Study||19||
48342688|NCT04354428|101167608|FG004|COMPLETED|Overall Study||25||
48342689|NCT04354428|101167604|FG000|NOT COMPLETED|Overall Study||8||
48342690|NCT04354428|101167605|FG001|NOT COMPLETED|Overall Study||9||
48342691|NCT04354428|101167606|FG002|NOT COMPLETED|Overall Study||6||
48342692|NCT04354428|101167607|FG003|NOT COMPLETED|Overall Study||10||
48342693|NCT04354428|101167608|FG004|NOT COMPLETED|Overall Study||4||
48342694|NCT00848744|101167609|FG000|STARTED|Overall Study||10||
48439959|NCT04190056|101409993|FG000|NOT COMPLETED|Overall Study||0||
48342695|NCT00848744|101167609|FG000|COMPLETED|Overall Study||10||
48342696|NCT00848744|101167609|FG000|NOT COMPLETED|Overall Study||0||
48342697|NCT00474240|101167610|FG000|STARTED|Overall Study||27||
48342698|NCT00474240|101167611|FG001|STARTED|Overall Study||26||
48342699|NCT00474240|101167612|FG002|STARTED|Overall Study||26||
48342700|NCT00474240|101167613|FG003|STARTED|Overall Study||26||
48342701|NCT00474240|101167614|FG004|STARTED|Overall Study||26||
48342702|NCT00474240|101167615|FG005|STARTED|Overall Study||26||
48342703|NCT00474240|101167610|FG000|COMPLETED|Overall Study||26||
48342704|NCT00474240|101167611|FG001|COMPLETED|Overall Study||25||
48342705|NCT00474240|101167612|FG002|COMPLETED|Overall Study||17||
48342706|NCT00474240|101167613|FG003|COMPLETED|Overall Study||10||
48342707|NCT00474240|101167614|FG004|COMPLETED|Overall Study||18||
48342708|NCT00474240|101167615|FG005|COMPLETED|Overall Study||8||
48342709|NCT00474240|101167610|FG000|NOT COMPLETED|Overall Study||1||
48342710|NCT00474240|101167611|FG001|NOT COMPLETED|Overall Study||1||
48342711|NCT00474240|101167612|FG002|NOT COMPLETED|Overall Study||9||
48342712|NCT00474240|101167613|FG003|NOT COMPLETED|Overall Study||16||
48342713|NCT00474240|101167614|FG004|NOT COMPLETED|Overall Study||8||
48342714|NCT00474240|101167615|FG005|NOT COMPLETED|Overall Study||18||
48342715|NCT02344576|101167616|FG000|STARTED|Enrollment||142||
48342716|NCT02344576|101167617|FG001|STARTED|Enrollment||121||
48342717|NCT02344576|101167618|FG002|STARTED|Enrollment||111||
48342718|NCT02344576|101167619|FG003|STARTED|Enrollment||71||
48182337|NCT02173535|100768270|FG013|STARTED|Period 4||12||
48342719|NCT02344576|101167616|FG000|Agreed to Survey Data Collection|Enrollment||135||
48342720|NCT02344576|101167617|FG001|Agreed to Survey Data Collection|Enrollment||113||
48342721|NCT02344576|101167618|FG002|Agreed to Survey Data Collection|Enrollment||111||
48342722|NCT02344576|101167619|FG003|Agreed to Survey Data Collection|Enrollment||71||
48342723|NCT02344576|101167616|FG000|COMPLETED|Enrollment||135||
48342724|NCT02344576|101167617|FG001|COMPLETED|Enrollment||113||
48342725|NCT02344576|101167618|FG002|COMPLETED|Enrollment||111||
48342726|NCT02344576|101167619|FG003|COMPLETED|Enrollment||71||
48342727|NCT02344576|101167616|FG000|NOT COMPLETED|Enrollment||7||
48342728|NCT02344576|101167617|FG001|NOT COMPLETED|Enrollment||8||
48342729|NCT02344576|101167618|FG002|NOT COMPLETED|Enrollment||0||
48342730|NCT02344576|101167619|FG003|NOT COMPLETED|Enrollment||0||
48342731|NCT02344576|101167616|FG000|STARTED|1-Month Follow-Up||135||
48342732|NCT02344576|101167617|FG001|STARTED|1-Month Follow-Up||113||
48342733|NCT02344576|101167618|FG002|STARTED|1-Month Follow-Up||111||
48342734|NCT02344576|101167619|FG003|STARTED|1-Month Follow-Up||71||
48342735|NCT02344576|101167616|FG000|Completed 1-Month Survey|1-Month Follow-Up||104||
48342736|NCT02344576|101167617|FG001|Completed 1-Month Survey|1-Month Follow-Up||79||
48342737|NCT02344576|101167618|FG002|Completed 1-Month Survey|1-Month Follow-Up||89||
48342738|NCT02344576|101167619|FG003|Completed 1-Month Survey|1-Month Follow-Up||53||
48342739|NCT02344576|101167616|FG000|COMPLETED|1-Month Follow-Up||117||
48342740|NCT02344576|101167617|FG001|COMPLETED|1-Month Follow-Up||86||
48342741|NCT02344576|101167618|FG002|COMPLETED|1-Month Follow-Up||92||
48342742|NCT02344576|101167619|FG003|COMPLETED|1-Month Follow-Up||58||
48342743|NCT02344576|101167616|FG000|NOT COMPLETED|1-Month Follow-Up||18||
48342744|NCT02344576|101167617|FG001|NOT COMPLETED|1-Month Follow-Up||27||
48342745|NCT02344576|101167618|FG002|NOT COMPLETED|1-Month Follow-Up||19||
48342746|NCT02344576|101167619|FG003|NOT COMPLETED|1-Month Follow-Up||13||
48342747|NCT02344576|101167616|FG000|STARTED|6-Month Follow-Up||117||
48342748|NCT02344576|101167617|FG001|STARTED|6-Month Follow-Up||86||
48342749|NCT02344576|101167618|FG002|STARTED|6-Month Follow-Up||92||
48342750|NCT02344576|101167619|FG003|STARTED|6-Month Follow-Up||58||
48342751|NCT02344576|101167616|FG000|Completed 6-Month Survey|6-Month Follow-Up||98||
48342752|NCT02344576|101167617|FG001|Completed 6-Month Survey|6-Month Follow-Up||67||
48342753|NCT02344576|101167618|FG002|Completed 6-Month Survey|6-Month Follow-Up||78||
48342754|NCT02344576|101167619|FG003|Completed 6-Month Survey|6-Month Follow-Up||50||
48342755|NCT02344576|101167616|FG000|COMPLETED|6-Month Follow-Up||98||
48342756|NCT02344576|101167617|FG001|COMPLETED|6-Month Follow-Up||67||
48342757|NCT02344576|101167618|FG002|COMPLETED|6-Month Follow-Up||78||
48342758|NCT02344576|101167619|FG003|COMPLETED|6-Month Follow-Up||50||
48342759|NCT02344576|101167616|FG000|NOT COMPLETED|6-Month Follow-Up||19||
48342760|NCT02344576|101167617|FG001|NOT COMPLETED|6-Month Follow-Up||19||
48342761|NCT02344576|101167618|FG002|NOT COMPLETED|6-Month Follow-Up||14||
48342762|NCT02344576|101167619|FG003|NOT COMPLETED|6-Month Follow-Up||8||
48342763|NCT02344576|101167616|FG000|STARTED|12-Month Medical Record Follow-Up||98|12-month period applicable to patient participants only.|
48342764|NCT02344576|101167617|FG001|STARTED|12-Month Medical Record Follow-Up||67|12-month period applicable to patient participants only.|
48342765|NCT02344576|101167618|FG002|STARTED|12-Month Medical Record Follow-Up||78|12-month period applicable to patient participants only.|
48342766|NCT02344576|101167619|FG003|STARTED|12-Month Medical Record Follow-Up||50|12-month period applicable to patient participants only.|
48342767|NCT02344576|101167616|FG000|COMPLETED|12-Month Medical Record Follow-Up||98|12-month period applicable to patient participants only.|
48342768|NCT02344576|101167617|FG001|COMPLETED|12-Month Medical Record Follow-Up||67|12-month period applicable to patient participants only.|
48342769|NCT02344576|101167618|FG002|COMPLETED|12-Month Medical Record Follow-Up||78|12-month period applicable to patient participants only.|
48342770|NCT02344576|101167619|FG003|COMPLETED|12-Month Medical Record Follow-Up||50|12-month period applicable to patient participants only.|
48342771|NCT02344576|101167616|FG000|NOT COMPLETED|12-Month Medical Record Follow-Up||0||
48342772|NCT02344576|101167617|FG001|NOT COMPLETED|12-Month Medical Record Follow-Up||0||
48342773|NCT02344576|101167618|FG002|NOT COMPLETED|12-Month Medical Record Follow-Up||0||
48342774|NCT02344576|101167619|FG003|NOT COMPLETED|12-Month Medical Record Follow-Up||0||
48342775|NCT00395967|101167620|FG000|STARTED|Treatment Period||5||
48342776|NCT00395967|101167620|FG000|COMPLETED|Treatment Period||4||
48342777|NCT00395967|101167620|FG000|NOT COMPLETED|Treatment Period||1||
48342778|NCT00395967|101167620|FG000|STARTED|Follow-up Period||5||
48342779|NCT00395967|101167620|FG000|COMPLETED|Follow-up Period||3||
48342780|NCT00395967|101167620|FG000|NOT COMPLETED|Follow-up Period||2||
48342781|NCT01299727|101167621|FG000|STARTED|Overall Study||4||
48342782|NCT01299727|101167622|FG001|STARTED|Overall Study||4||
48342783|NCT01299727|101167623|FG002|STARTED|Overall Study||4||
48342784|NCT01299727|101167621|FG000|COMPLETED|Overall Study||0||
48342785|NCT01299727|101167622|FG001|COMPLETED|Overall Study||0||
48342786|NCT01299727|101167623|FG002|COMPLETED|Overall Study||0||
48342787|NCT01299727|101167621|FG000|NOT COMPLETED|Overall Study||4||
48342788|NCT01299727|101167622|FG001|NOT COMPLETED|Overall Study||4||
48342789|NCT01299727|101167623|FG002|NOT COMPLETED|Overall Study||4||
48342790|NCT00256295|101167624|FG000|STARTED|Overall Study||7||
48342791|NCT00256295|101167624|FG000|COMPLETED|Overall Study||3||
48342792|NCT00256295|101167624|FG000|NOT COMPLETED|Overall Study||4||
48342793|NCT00699192|101167625|FG000|STARTED|Overall Study||275||
48342794|NCT00699192|101167626|FG001|STARTED|Overall Study||272||
48342795|NCT00699192|101167627|FG002|STARTED|Overall Study||272||
48342796|NCT00699192|101167625|FG000|COMPLETED|Overall Study||259||
48342797|NCT00699192|101167626|FG001|COMPLETED|Overall Study||260||
48342798|NCT00699192|101167627|FG002|COMPLETED|Overall Study||261||
48342799|NCT00699192|101167625|FG000|NOT COMPLETED|Overall Study||16||
48342800|NCT00699192|101167626|FG001|NOT COMPLETED|Overall Study||12||
48342801|NCT00699192|101167627|FG002|NOT COMPLETED|Overall Study||11||
48342802|NCT02678429|101167628|FG000|STARTED|Overall Study||3||
48342803|NCT02678429|101167629|FG001|STARTED|Overall Study||1||
48342804|NCT02678429|101167628|FG000|COMPLETED|Overall Study||0||
48342805|NCT02678429|101167629|FG001|COMPLETED|Overall Study||0||
48342806|NCT02678429|101167628|FG000|NOT COMPLETED|Overall Study||3||
48342807|NCT02678429|101167629|FG001|NOT COMPLETED|Overall Study||1||
48342808|NCT02086331|101167630|FG000|STARTED|Overall Study||5||
48342809|NCT02086331|101167630|FG000|COMPLETED|Overall Study||5||
48342810|NCT02086331|101167630|FG000|NOT COMPLETED|Overall Study||0||
48342811|NCT01496157|101167631|FG000|STARTED|Overall Study||13||
48342812|NCT01496157|101167631|FG000|COMPLETED|Overall Study||13||
48342813|NCT01496157|101167631|FG000|NOT COMPLETED|Overall Study||0||
48414117|NCT02442765|101345960|FG007|NOT COMPLETED|Stage 2- (Days 43 to 85)||11||
48414118|NCT04048876|101345961|FG000|STARTED|Placebo Controlled Phase||13||
48414119|NCT04048876|101345962|FG001|STARTED|Placebo Controlled Phase||15||
48414120|NCT04048876|101345963|FG002|STARTED|Placebo Controlled Phase||13||
48342814|NCT02440334|101167632|FG000|STARTED|Overall Study||53||
48342815|NCT02440334|101167632|FG000|COMPLETED|Overall Study||53||
48342816|NCT02440334|101167632|FG000|NOT COMPLETED|Overall Study||0||
48342817|NCT01628926|101167633|FG000|STARTED|Overall Study||168||
48342818|NCT01628926|101167634|FG001|STARTED|Overall Study||167||
48342819|NCT01628926|101167635|FG002|STARTED|Overall Study||85||
48342820|NCT01628926|101167633|FG000|COMPLETED|Overall Study||142||
48633809|NCT02156258|101888786|FG000|COMPLETED|Overall Study||642||
48633810|NCT02156258|101888787|FG001|COMPLETED|Overall Study||124||
48342821|NCT01628926|101167634|FG001|COMPLETED|Overall Study||144||
48342822|NCT01628926|101167635|FG002|COMPLETED|Overall Study||68||
48342823|NCT01628926|101167633|FG000|NOT COMPLETED|Overall Study||26||
48342824|NCT01628926|101167634|FG001|NOT COMPLETED|Overall Study||23||
48342825|NCT01628926|101167635|FG002|NOT COMPLETED|Overall Study||17||
48414121|NCT04048876|101345964|FG003|STARTED|Placebo Controlled Phase||15||
48633811|NCT02156258|101888788|FG002|COMPLETED|Overall Study||244||
48342826|NCT01587989|101167636|FG000|STARTED|12-Week Open-Label Run-In Period||77||
48342827|NCT01587989|101167637|FG001|STARTED|12-Week Open-Label Run-In Period||0||
48342828|NCT01587989|101167638|FG002|STARTED|12-Week Open-Label Run-In Period||0||
48414122|NCT04048876|101345961|FG000|Continuing to Follow Up|Placebo Controlled Phase||7||
48342829|NCT01587989|101167636|FG000|COMPLETED|12-Week Open-Label Run-In Period||65||
48439960|NCT04190056|101409994|FG001|NOT COMPLETED|Overall Study||0||
48414123|NCT04048876|101345962|FG001|Continuing to Follow Up|Placebo Controlled Phase||12||
48342830|NCT01587989|101167637|FG001|COMPLETED|12-Week Open-Label Run-In Period||0||
48342831|NCT01587989|101167638|FG002|COMPLETED|12-Week Open-Label Run-In Period||0||
48342832|NCT01587989|101167636|FG000|NOT COMPLETED|12-Week Open-Label Run-In Period||12||
48342833|NCT01587989|101167637|FG001|NOT COMPLETED|12-Week Open-Label Run-In Period||0||
48342834|NCT01587989|101167638|FG002|NOT COMPLETED|12-Week Open-Label Run-In Period||0||
48342835|NCT01587989|101167636|FG000|STARTED|Randomized Study Treatment||0||
48342836|NCT01587989|101167637|FG001|STARTED|Randomized Study Treatment||32||
48342837|NCT01587989|101167638|FG002|STARTED|Randomized Study Treatment||33||
48342838|NCT01587989|101167636|FG000|COMPLETED|Randomized Study Treatment||0||
48342839|NCT01587989|101167637|FG001|COMPLETED|Randomized Study Treatment||30||
48342840|NCT01587989|101167638|FG002|COMPLETED|Randomized Study Treatment||32||
48342841|NCT01587989|101167636|FG000|NOT COMPLETED|Randomized Study Treatment||0||
48342842|NCT01587989|101167637|FG001|NOT COMPLETED|Randomized Study Treatment||2||
48342843|NCT01587989|101167638|FG002|NOT COMPLETED|Randomized Study Treatment||1||
48342844|NCT02472457|101167639|FG000|STARTED|Overall Study||8||
48342845|NCT02472457|101167640|FG001|STARTED|Overall Study||11||
48756708|NCT00481832|102191314|FG000|STARTED|Enrollment||50||
48756709|NCT00481832|102191314|FG000|COMPLETED|Enrollment||40||
48756710|NCT00481832|102191314|FG000|NOT COMPLETED|Enrollment||10||
48756711|NCT00481832|102191314|FG000|STARTED|Autologous Hematopoietic Cell Transplant||40||
48756712|NCT00481832|102191314|FG000|COMPLETED|Autologous Hematopoietic Cell Transplant||40||
48756713|NCT00481832|102191314|FG000|NOT COMPLETED|Autologous Hematopoietic Cell Transplant||0||
48342846|NCT02472457|101167639|FG000|COMPLETED|Overall Study||8||
48342847|NCT02472457|101167640|FG001|COMPLETED|Overall Study||10||
48342848|NCT02472457|101167639|FG000|NOT COMPLETED|Overall Study||0||
48414124|NCT04048876|101345963|FG002|Continuing to Follow Up|Placebo Controlled Phase||8||
48414125|NCT04048876|101345964|FG003|Continuing to Follow Up|Placebo Controlled Phase||11||
48414126|NCT04048876|101345961|FG000|COMPLETED|Placebo Controlled Phase||2|= continuing to active treatment phase|
48414127|NCT04048876|101345962|FG001|COMPLETED|Placebo Controlled Phase||0|= continuing to active treatment phase|
48414128|NCT04048876|101345963|FG002|COMPLETED|Placebo Controlled Phase||3|= continuing to active treatment phase|
48414129|NCT04048876|101345964|FG003|COMPLETED|Placebo Controlled Phase||2|= continuing to active treatment phase|
48414130|NCT04048876|101345961|FG000|NOT COMPLETED|Placebo Controlled Phase||11||
48414131|NCT04048876|101345962|FG001|NOT COMPLETED|Placebo Controlled Phase||15||
48414132|NCT04048876|101345963|FG002|NOT COMPLETED|Placebo Controlled Phase||10||
48414133|NCT04048876|101345964|FG003|NOT COMPLETED|Placebo Controlled Phase||13||
48414134|NCT04048876|101345961|FG000|STARTED|Active Treatment Phase||2||
48414135|NCT04048876|101345962|FG001|STARTED|Active Treatment Phase||0||
48414136|NCT04048876|101345963|FG002|STARTED|Active Treatment Phase||3||
48414137|NCT04048876|101345964|FG003|STARTED|Active Treatment Phase||2||
48414138|NCT04048876|101345961|FG000|Placebo to CC-90001 200mg|Active Treatment Phase||0|Participants who received placebo in the placebo-controlled phase and then received CC-90001 200mg in active treatment phase|
48414139|NCT04048876|101345962|FG001|Placebo to CC-90001 200mg|Active Treatment Phase||0|Participants who received placebo in the placebo-controlled phase and then received CC-90001 200mg in active treatment phase|
48414140|NCT04048876|101345963|FG002|Placebo to CC-90001 200mg|Active Treatment Phase||0|Participants who received placebo in the placebo-controlled phase and then received CC-90001 200mg in active treatment phase|
48414141|NCT04048876|101345964|FG003|Placebo to CC-90001 200mg|Active Treatment Phase||1|Participants who received placebo in the placebo-controlled phase and then received CC-90001 200mg in active treatment phase|
48756714|NCT00481832|102191314|FG000|STARTED|Inter-transplant Period||40||
48342849|NCT02472457|101167640|FG001|NOT COMPLETED|Overall Study||1||
48342850|NCT02764541|101167641|FG000|STARTED|Overall Study||36||
48439961|NCT01728376|101409995|FG000|STARTED|Overall Study||22||
48439962|NCT01728376|101409996|FG001|STARTED|Overall Study||11||
48756715|NCT00481832|102191314|FG000|COMPLETED|Inter-transplant Period||13||
48342851|NCT02764541|101167642|FG001|STARTED|Overall Study||21||
48342852|NCT02764541|101167643|FG002|STARTED|Overall Study||37||
48342853|NCT02764541|101167644|FG003|STARTED|Overall Study||19||
48342854|NCT02764541|101167645|FG004|STARTED|Overall Study||1||
48342855|NCT02764541|101167646|FG005|STARTED|Overall Study||2||
48342856|NCT02764541|101167647|FG006|STARTED|Overall Study||55||
48342857|NCT02764541|101167648|FG007|STARTED|Overall Study||21||
48342858|NCT02764541|101167641|FG000|COMPLETED|Overall Study||33||
48342859|NCT02764541|101167642|FG001|COMPLETED|Overall Study||20||
48342860|NCT02764541|101167643|FG002|COMPLETED|Overall Study||36||
48342861|NCT02764541|101167644|FG003|COMPLETED|Overall Study||16||
48342862|NCT02764541|101167645|FG004|COMPLETED|Overall Study||0||
48342863|NCT02764541|101167646|FG005|COMPLETED|Overall Study||0||
48342864|NCT02764541|101167647|FG006|COMPLETED|Overall Study||52||
48342865|NCT02764541|101167648|FG007|COMPLETED|Overall Study||18||
48342866|NCT02764541|101167641|FG000|NOT COMPLETED|Overall Study||3||
48342867|NCT02764541|101167642|FG001|NOT COMPLETED|Overall Study||1||
48342868|NCT02764541|101167643|FG002|NOT COMPLETED|Overall Study||1||
48342869|NCT02764541|101167644|FG003|NOT COMPLETED|Overall Study||3||
48342870|NCT02764541|101167645|FG004|NOT COMPLETED|Overall Study||1||
48342871|NCT02764541|101167646|FG005|NOT COMPLETED|Overall Study||2||
48342872|NCT02764541|101167647|FG006|NOT COMPLETED|Overall Study||3||
48342873|NCT02764541|101167648|FG007|NOT COMPLETED|Overall Study||3||
48342874|NCT03936387|101167649|FG000|STARTED|Overall Study||10||
48342875|NCT03936387|101167649|FG000|COMPLETED|Overall Study||10||
48342876|NCT03936387|101167649|FG000|NOT COMPLETED|Overall Study||0||
48342877|NCT01748799|101167650|FG000|STARTED|Overall Study||6||
48342878|NCT01748799|101167651|FG001|STARTED|Overall Study||1||
48342879|NCT01748799|101167652|FG002|STARTED|Overall Study||1||
48342880|NCT01748799|101167653|FG003|STARTED|Overall Study||2||
48342881|NCT01748799|101167654|FG004|STARTED|Overall Study||1||
48342882|NCT01748799|101167655|FG005|STARTED|Overall Study||2||
48342883|NCT01748799|101167656|FG006|STARTED|Overall Study||2||
48342884|NCT01748799|101167657|FG007|STARTED|Overall Study||1||
48342885|NCT01748799|101167650|FG000|Completed SAU of Fixed Dose Placebo|Overall Study||2||
48342886|NCT01748799|101167651|FG001|Completed SAU of Fixed Dose Placebo|Overall Study||1||
48342887|NCT01748799|101167652|FG002|Completed SAU of Fixed Dose Placebo|Overall Study||1||
48342888|NCT01748799|101167653|FG003|Completed SAU of Fixed Dose Placebo|Overall Study||2||
48342889|NCT01748799|101167654|FG004|Completed SAU of Fixed Dose Placebo|Overall Study||1||
48342890|NCT01748799|101167655|FG005|Completed SAU of Fixed Dose Placebo|Overall Study||1||
48342891|NCT01748799|101167656|FG006|Completed SAU of Fixed Dose Placebo|Overall Study||1||
48342892|NCT01748799|101167657|FG007|Completed SAU of Fixed Dose Placebo|Overall Study||1||
48342893|NCT01748799|101167650|FG000|Completed Fixed Dose Placebo|Overall Study||2||
48342894|NCT01748799|101167651|FG001|Completed Fixed Dose Placebo|Overall Study||1||
48342895|NCT01748799|101167652|FG002|Completed Fixed Dose Placebo|Overall Study||1||
48342896|NCT01748799|101167653|FG003|Completed Fixed Dose Placebo|Overall Study||2||
48342897|NCT01748799|101167654|FG004|Completed Fixed Dose Placebo|Overall Study||1||
48342898|NCT01748799|101167655|FG005|Completed Fixed Dose Placebo|Overall Study||1||
48342899|NCT01748799|101167656|FG006|Completed Fixed Dose Placebo|Overall Study||1||
48342900|NCT01748799|101167657|FG007|Completed Fixed Dose Placebo|Overall Study||1||
48342901|NCT01748799|101167650|FG000|Completed SAU of Fixed Dose Sativex|Overall Study||1||
48342902|NCT01748799|101167651|FG001|Completed SAU of Fixed Dose Sativex|Overall Study||1||
48342903|NCT01748799|101167652|FG002|Completed SAU of Fixed Dose Sativex|Overall Study||1||
48342904|NCT01748799|101167653|FG003|Completed SAU of Fixed Dose Sativex|Overall Study||2||
48414142|NCT04048876|101345961|FG000|Placebo to CC-90001 400mg|Active Treatment Phase||0|Participants who received placebo in the placebo-controlled phase and then received CC-90001 400mg in active treatment phase.|
48342905|NCT01748799|101167654|FG004|Completed SAU of Fixed Dose Sativex|Overall Study||1||
48342906|NCT01748799|101167655|FG005|Completed SAU of Fixed Dose Sativex|Overall Study||1||
48342907|NCT01748799|101167656|FG006|Completed SAU of Fixed Dose Sativex|Overall Study||1||
48342908|NCT01748799|101167657|FG007|Completed SAU of Fixed Dose Sativex|Overall Study||1||
48342909|NCT01748799|101167650|FG000|Completed Fixed Dose Sativex|Overall Study||1||
48342910|NCT01748799|101167651|FG001|Completed Fixed Dose Sativex|Overall Study||1||
48342911|NCT01748799|101167652|FG002|Completed Fixed Dose Sativex|Overall Study||1||
48342912|NCT01748799|101167653|FG003|Completed Fixed Dose Sativex|Overall Study||2||
48342913|NCT01748799|101167654|FG004|Completed Fixed Dose Sativex|Overall Study||1||
48342914|NCT01748799|101167655|FG005|Completed Fixed Dose Sativex|Overall Study||1||
48342915|NCT01748799|101167656|FG006|Completed Fixed Dose Sativex|Overall Study||1||
48342916|NCT01748799|101167657|FG007|Completed Fixed Dose Sativex|Overall Study||1||
48342917|NCT01748799|101167650|FG000|Completed SAU of Self-titrated Placebo|Overall Study||5||
48342918|NCT01748799|101167651|FG001|Completed SAU of Self-titrated Placebo|Overall Study||1||
48414143|NCT04048876|101345962|FG001|Placebo to CC-90001 400mg|Active Treatment Phase||0|Participants who received placebo in the placebo-controlled phase and then received CC-90001 400mg in active treatment phase.|
48439963|NCT01728376|101409997|FG002|STARTED|Overall Study||19||
48342919|NCT01748799|101167652|FG002|Completed SAU of Self-titrated Placebo|Overall Study||1||
48342920|NCT01748799|101167653|FG003|Completed SAU of Self-titrated Placebo|Overall Study||2||
48342921|NCT01748799|101167654|FG004|Completed SAU of Self-titrated Placebo|Overall Study||1||
48342922|NCT01748799|101167655|FG005|Completed SAU of Self-titrated Placebo|Overall Study||2||
48342923|NCT01748799|101167656|FG006|Completed SAU of Self-titrated Placebo|Overall Study||1||
48342924|NCT01748799|101167657|FG007|Completed SAU of Self-titrated Placebo|Overall Study||1||
48342925|NCT01748799|101167650|FG000|Completed Self-titrated Placebo|Overall Study||4||
48342926|NCT01748799|101167651|FG001|Completed Self-titrated Placebo|Overall Study||1||
48342927|NCT01748799|101167652|FG002|Completed Self-titrated Placebo|Overall Study||1||
48342928|NCT01748799|101167653|FG003|Completed Self-titrated Placebo|Overall Study||2||
48342929|NCT01748799|101167654|FG004|Completed Self-titrated Placebo|Overall Study||1||
48342930|NCT01748799|101167655|FG005|Completed Self-titrated Placebo|Overall Study||2||
48342931|NCT01748799|101167656|FG006|Completed Self-titrated Placebo|Overall Study||1||
48342932|NCT01748799|101167657|FG007|Completed Self-titrated Placebo|Overall Study||1||
48342933|NCT01748799|101167650|FG000|Completed SAU of Self-titrated Sativex|Overall Study||2||
48342934|NCT01748799|101167651|FG001|Completed SAU of Self-titrated Sativex|Overall Study||1||
48342935|NCT01748799|101167652|FG002|Completed SAU of Self-titrated Sativex|Overall Study||1||
48342936|NCT01748799|101167653|FG003|Completed SAU of Self-titrated Sativex|Overall Study||2||
48342937|NCT01748799|101167654|FG004|Completed SAU of Self-titrated Sativex|Overall Study||1||
48342938|NCT01748799|101167655|FG005|Completed SAU of Self-titrated Sativex|Overall Study||2||
48342939|NCT01748799|101167656|FG006|Completed SAU of Self-titrated Sativex|Overall Study||1||
48342940|NCT01748799|101167657|FG007|Completed SAU of Self-titrated Sativex|Overall Study||1||
48342941|NCT01748799|101167650|FG000|Completed Self-titrated Sativex|Overall Study||1||
48342942|NCT01748799|101167651|FG001|Completed Self-titrated Sativex|Overall Study||1||
48342943|NCT01748799|101167652|FG002|Completed Self-titrated Sativex|Overall Study||1||
48342944|NCT01748799|101167653|FG003|Completed Self-titrated Sativex|Overall Study||2||
48342945|NCT01748799|101167654|FG004|Completed Self-titrated Sativex|Overall Study||1||
48342946|NCT01748799|101167655|FG005|Completed Self-titrated Sativex|Overall Study||1||
48342947|NCT01748799|101167656|FG006|Completed Self-titrated Sativex|Overall Study||1||
48342948|NCT01748799|101167657|FG007|Completed Self-titrated Sativex|Overall Study||1||
48342949|NCT01748799|101167650|FG000|COMPLETED|Overall Study||1||
48342950|NCT01748799|101167651|FG001|COMPLETED|Overall Study||1||
48342951|NCT01748799|101167652|FG002|COMPLETED|Overall Study||1||
48342952|NCT01748799|101167653|FG003|COMPLETED|Overall Study||2||
48342953|NCT01748799|101167654|FG004|COMPLETED|Overall Study||1||
48342954|NCT01748799|101167655|FG005|COMPLETED|Overall Study||1||
48342955|NCT01748799|101167656|FG006|COMPLETED|Overall Study||1||
48342956|NCT01748799|101167657|FG007|COMPLETED|Overall Study||1||
48342957|NCT01748799|101167650|FG000|NOT COMPLETED|Overall Study||5||
48342958|NCT01748799|101167651|FG001|NOT COMPLETED|Overall Study||0||
48342959|NCT01748799|101167652|FG002|NOT COMPLETED|Overall Study||0||
48342960|NCT01748799|101167653|FG003|NOT COMPLETED|Overall Study||0||
48342961|NCT01748799|101167654|FG004|NOT COMPLETED|Overall Study||0||
48342962|NCT01748799|101167655|FG005|NOT COMPLETED|Overall Study||1||
48342963|NCT01748799|101167656|FG006|NOT COMPLETED|Overall Study||1||
48342964|NCT01748799|101167657|FG007|NOT COMPLETED|Overall Study||0||
48342965|NCT02502864|101167658|FG000|STARTED|Overall Study||9||
48342966|NCT02502864|101167658|FG000|COMPLETED|Overall Study||8||
48342967|NCT02502864|101167658|FG000|NOT COMPLETED|Overall Study||1||
48342968|NCT02159807|101167659|FG000|STARTED|Overall Study||67||
48342969|NCT02159807|101167660|FG001|STARTED|Overall Study||52||
48342970|NCT02159807|101167661|FG002|STARTED|Overall Study||51||
48342971|NCT02159807|101167659|FG000|COMPLETED|Overall Study||66||
48342972|NCT02159807|101167660|FG001|COMPLETED|Overall Study||51||
48342973|NCT02159807|101167661|FG002|COMPLETED|Overall Study||48||
48342974|NCT02159807|101167659|FG000|NOT COMPLETED|Overall Study||1||
48342975|NCT02159807|101167660|FG001|NOT COMPLETED|Overall Study||1||
48342976|NCT02159807|101167661|FG002|NOT COMPLETED|Overall Study||3||
48342977|NCT03216382|101167662|FG000|STARTED|Overall Study||41||
48342978|NCT03216382|101167663|FG001|STARTED|Overall Study||54||
48342979|NCT03216382|101167662|FG000|COMPLETED|Overall Study||34||
48342980|NCT03216382|101167663|FG001|COMPLETED|Overall Study||44||
48342981|NCT03216382|101167662|FG000|NOT COMPLETED|Overall Study||7||
48342982|NCT03216382|101167663|FG001|NOT COMPLETED|Overall Study||10||
48342983|NCT02073487|101167664|FG000|STARTED|Overall Study||16||
48342984|NCT02073487|101167665|FG001|STARTED|Overall Study||16||
48342985|NCT02073487|101167664|FG000|COMPLETED|Overall Study||14||
48342986|NCT02073487|101167665|FG001|COMPLETED|Overall Study||16||
48342987|NCT02073487|101167664|FG000|NOT COMPLETED|Overall Study||2||
48342988|NCT02073487|101167665|FG001|NOT COMPLETED|Overall Study||0||
48342989|NCT01268293|101167666|FG000|STARTED|Overall Study||9||
48342990|NCT01268293|101167666|FG000|Completed Cycle 1|Overall Study||9||
48342991|NCT01268293|101167666|FG000|COMPLETED|Overall Study||0||
48342992|NCT01268293|101167666|FG000|NOT COMPLETED|Overall Study||9||
48342993|NCT00758784|101167667|FG000|STARTED|Overall Study||38||
48342994|NCT00758784|101167667|FG000|COMPLETED|Overall Study||36||
48342995|NCT00758784|101167667|FG000|NOT COMPLETED|Overall Study||2||
48342996|NCT02066792|101167668|FG000|STARTED|Overall Study||40||
48342997|NCT02066792|101167669|FG001|STARTED|Overall Study||38||
48342998|NCT02066792|101167670|FG002|STARTED|Overall Study||38||
48342999|NCT02066792|101167671|FG003|STARTED|Overall Study||36||
48343000|NCT02066792|101167668|FG000|COMPLETED|Overall Study||33||
48343001|NCT02066792|101167669|FG001|COMPLETED|Overall Study||33||
48343002|NCT02066792|101167670|FG002|COMPLETED|Overall Study||30||
48343003|NCT02066792|101167671|FG003|COMPLETED|Overall Study||27||
48343004|NCT02066792|101167668|FG000|NOT COMPLETED|Overall Study||7||
48343005|NCT02066792|101167669|FG001|NOT COMPLETED|Overall Study||5||
48343006|NCT02066792|101167670|FG002|NOT COMPLETED|Overall Study||8||
48343007|NCT02066792|101167671|FG003|NOT COMPLETED|Overall Study||9||
48343008|NCT02959814|101167672|FG000|STARTED|Overall Study||329||
48343009|NCT02959814|101167672|FG000|COMPLETED|Overall Study||272||
48343010|NCT02959814|101167672|FG000|NOT COMPLETED|Overall Study||57||
48343011|NCT00189462|101167673|FG000|STARTED|Overall Study||50||
48343012|NCT00189462|101167674|FG001|STARTED|Overall Study||49||
48343013|NCT00189462|101167673|FG000|COMPLETED|Overall Study||27||
48343014|NCT00189462|101167674|FG001|COMPLETED|Overall Study||28||
48343015|NCT00189462|101167673|FG000|NOT COMPLETED|Overall Study||23||
48343016|NCT00189462|101167674|FG001|NOT COMPLETED|Overall Study||21||
48343017|NCT02251912|101167675|FG000|STARTED|Overall Study||12||
48343018|NCT02251912|101167676|FG001|STARTED|Overall Study||10||
48343019|NCT02251912|101167675|FG000|COMPLETED|Overall Study||10||
48343020|NCT02251912|101167676|FG001|COMPLETED|Overall Study||5||
48343021|NCT02251912|101167675|FG000|NOT COMPLETED|Overall Study||2||
48343022|NCT02251912|101167676|FG001|NOT COMPLETED|Overall Study||5||
48343023|NCT00420511|101167677|FG000|STARTED|Overall Study||10||
48343024|NCT00420511|101167678|FG001|STARTED|Overall Study||11||
48343025|NCT00420511|101167677|FG000|COMPLETED|Overall Study||8||
48343026|NCT00420511|101167678|FG001|COMPLETED|Overall Study||10||
48343027|NCT00420511|101167677|FG000|NOT COMPLETED|Overall Study||2||
48343028|NCT00420511|101167678|FG001|NOT COMPLETED|Overall Study||1||
48343029|NCT00393718|101167679|FG000|STARTED|Overall Study||268||
48343030|NCT00393718|101167680|FG001|STARTED|Overall Study||132||
48343031|NCT00393718|101167679|FG000|COMPLETED|Overall Study||225||
48343032|NCT00393718|101167680|FG001|COMPLETED|Overall Study||110||
48343033|NCT00393718|101167679|FG000|NOT COMPLETED|Overall Study||43||
48343034|NCT00393718|101167680|FG001|NOT COMPLETED|Overall Study||22||
48343035|NCT00755079|101167681|FG000|STARTED|Overall Study||18||
48343036|NCT00755079|101167682|FG001|STARTED|Overall Study||22||
48343037|NCT00755079|101167681|FG000|COMPLETED|Overall Study||17||
48343038|NCT00755079|101167682|FG001|COMPLETED|Overall Study||16||
48343039|NCT00755079|101167681|FG000|NOT COMPLETED|Overall Study||1||
48343040|NCT00755079|101167682|FG001|NOT COMPLETED|Overall Study||6||
48343041|NCT01989130|101167683|FG000|STARTED|Overall Study||43||
48343042|NCT01989130|101167684|FG001|STARTED|Overall Study||27||
48343043|NCT01989130|101167683|FG000|COMPLETED|Overall Study||43||
48343044|NCT01989130|101167684|FG001|COMPLETED|Overall Study||27||
48343045|NCT01989130|101167683|FG000|NOT COMPLETED|Overall Study||0||
48343046|NCT01989130|101167684|FG001|NOT COMPLETED|Overall Study||0||
48343047|NCT02965378|101167685|FG000|STARTED|Overall Study||25||
48343048|NCT02965378|101167686|FG001|STARTED|Overall Study||9||
48343049|NCT02965378|101167685|FG000|Participants on Docetaxel Re-registered to AZD4547 After Progression.|Overall Study||0||
48343050|NCT02965378|101167686|FG001|Participants on Docetaxel Re-registered to AZD4547 After Progression.|Overall Study||2||
48343051|NCT02965378|101167685|FG000|COMPLETED|Overall Study||0|1 re-registered participant did not complete AZD4547 due to progression, and the other re-registered participant, due to adverse event|
48343052|NCT02965378|101167686|FG001|COMPLETED|Overall Study||0|1 re-registered participant did not complete AZD4547 due to progression, and the other re-registered participant, due to adverse event|
48343053|NCT02965378|101167685|FG000|NOT COMPLETED|Overall Study||25||
48343054|NCT02965378|101167686|FG001|NOT COMPLETED|Overall Study||9||
48343055|NCT01111604|101167687|FG000|STARTED|Overall Study||54||
48343056|NCT01111604|101167688|FG001|STARTED|Overall Study||52||
48343057|NCT01111604|101167689|FG002|STARTED|Overall Study||52||
48343058|NCT01111604|101167687|FG000|Received at Least One Dose of Study Drug|Overall Study||49||
48343059|NCT01111604|101167688|FG001|Received at Least One Dose of Study Drug|Overall Study||52||
48343060|NCT01111604|101167689|FG002|Received at Least One Dose of Study Drug|Overall Study||52||
48343061|NCT01111604|101167687|FG000|COMPLETED|Overall Study||46||
48343062|NCT01111604|101167688|FG001|COMPLETED|Overall Study||52||
48343063|NCT01111604|101167689|FG002|COMPLETED|Overall Study||49||
48343064|NCT01111604|101167687|FG000|NOT COMPLETED|Overall Study||8||
48182338|NCT02173535|100768271|FG014|STARTED|Period 4||12||
48182339|NCT02173535|100768272|FG015|STARTED|Period 4||12||
48343065|NCT01111604|101167688|FG001|NOT COMPLETED|Overall Study||0||
48343066|NCT01111604|101167689|FG002|NOT COMPLETED|Overall Study||3||
48343067|NCT01169779|101167690|FG000|STARTED|Overall Study||195||
48343068|NCT01169779|101167691|FG001|STARTED|Overall Study||196||
48343069|NCT01169779|101167690|FG000|Treated/Safety Population|Overall Study||194||
48343070|NCT01169779|101167691|FG001|Treated/Safety Population|Overall Study||196||
48343071|NCT01169779|101167690|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study||193||
48343072|NCT01169779|101167691|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||195||
48343073|NCT01169779|101167690|FG000|Subgroup for Standardized Meal Test|Overall Study||130||
48343074|NCT01169779|101167691|FG001|Subgroup for Standardized Meal Test|Overall Study||121||
48182340|NCT02173535|100768273|FG016|STARTED|Period 4||12||
48343075|NCT01169779|101167690|FG000|COMPLETED|Overall Study||184||
48182341|NCT02173535|100768274|FG017|STARTED|Period 4||12||
48343076|NCT01169779|101167691|FG001|COMPLETED|Overall Study||179||
48439964|NCT01728376|101409998|FG003|STARTED|Overall Study||9||
48182342|NCT02173535|100768275|FG018|STARTED|Period 4||12||
48633812|NCT02156258|101888786|FG000|NOT COMPLETED|Overall Study||32||
48633813|NCT02156258|101888787|FG001|NOT COMPLETED|Overall Study||79||
48633814|NCT02156258|101888788|FG002|NOT COMPLETED|Overall Study||111||
48633815|NCT00325416|101888789|FG000|STARTED|Phase I: Dose Escalation||70||
48633816|NCT00325416|101888790|FG001|STARTED|Phase I: Dose Escalation||60||
48756716|NCT00481832|102191314|FG000|NOT COMPLETED|Inter-transplant Period||27||
48756717|NCT00481832|102191314|FG000|STARTED|Allogenic Hematopoietic Cell Transplant||13||
48343077|NCT01169779|101167690|FG000|NOT COMPLETED|Overall Study||11||
48343078|NCT01169779|101167691|FG001|NOT COMPLETED|Overall Study||17||
48343079|NCT01243268|101167692|FG000|STARTED|Overall Study||674||
48343080|NCT01243268|101167692|FG000|COMPLETED|Overall Study||610||
48343081|NCT01243268|101167692|FG000|NOT COMPLETED|Overall Study||64||
48343082|NCT03990870|101167693|FG000|STARTED|Overall Study||16||
48343083|NCT03990870|101167694|FG001|STARTED|Overall Study||8||
48343084|NCT03990870|101167693|FG000|COMPLETED|Overall Study||13||
48343085|NCT03990870|101167694|FG001|COMPLETED|Overall Study||7||
48343086|NCT03990870|101167693|FG000|NOT COMPLETED|Overall Study||3||
48343087|NCT03990870|101167694|FG001|NOT COMPLETED|Overall Study||1||
48343088|NCT00661583|101167695|FG000|STARTED|Overall Study||10||
48343089|NCT00661583|101167696|FG001|STARTED|Overall Study||10||
48343090|NCT00661583|101167697|FG002|STARTED|Overall Study||10||
48343091|NCT00661583|101167695|FG000|COMPLETED|Overall Study||10||
48343092|NCT00661583|101167696|FG001|COMPLETED|Overall Study||10||
48343093|NCT00661583|101167697|FG002|COMPLETED|Overall Study||10||
48756718|NCT00481832|102191314|FG000|COMPLETED|Allogenic Hematopoietic Cell Transplant||13||
48756719|NCT00481832|102191314|FG000|NOT COMPLETED|Allogenic Hematopoietic Cell Transplant||0||
48756720|NCT00301808|102191315|FG000|STARTED|Overall Study||29||
48756721|NCT00301808|102191315|FG000|COMPLETED|Overall Study||17||
48756722|NCT00301808|102191315|FG000|NOT COMPLETED|Overall Study||12||
48756723|NCT05473026|102191316|FG000|STARTED|Overall Study||13||
48756724|NCT05473026|102191317|FG001|STARTED|Overall Study||13||
48756725|NCT05473026|102191316|FG000|COMPLETED|Overall Study||8||
48343094|NCT00661583|101167695|FG000|NOT COMPLETED|Overall Study||0||
48343095|NCT00661583|101167696|FG001|NOT COMPLETED|Overall Study||0||
48343096|NCT00661583|101167697|FG002|NOT COMPLETED|Overall Study||0||
48343097|NCT00548548|101167698|FG000|STARTED|Overall Study||387||
48343098|NCT00548548|101167699|FG001|STARTED|Overall Study||387||
48343099|NCT00548548|101167698|FG000|Treated|Overall Study||383||
48343100|NCT00548548|101167699|FG001|Treated|Overall Study||384||
48343101|NCT00548548|101167698|FG000|Safety Population|Overall Study||386||
48343102|NCT00548548|101167699|FG001|Safety Population|Overall Study||381||
48343103|NCT00548548|101167698|FG000|COMPLETED|Overall Study||25||
48439965|NCT01728376|101409999|FG004|STARTED|Overall Study||14||
48439966|NCT01728376|101410000|FG005|STARTED|Overall Study||7||
48756726|NCT05473026|102191317|FG001|COMPLETED|Overall Study||11||
48756727|NCT05473026|102191316|FG000|NOT COMPLETED|Overall Study||5||
48756728|NCT05473026|102191317|FG001|NOT COMPLETED|Overall Study||2||
48756729|NCT03863795|102191318|FG000|STARTED|Overall Study||306||
48343104|NCT00548548|101167699|FG001|COMPLETED|Overall Study||21||
48343105|NCT00548548|101167698|FG000|NOT COMPLETED|Overall Study||362||
48343106|NCT00548548|101167699|FG001|NOT COMPLETED|Overall Study||366||
48343107|NCT03618641|101167700|FG000|STARTED|Overall Study||34||
48343108|NCT03618641|101167700|FG000|COMPLETED|Overall Study||34||
48343109|NCT03618641|101167700|FG000|NOT COMPLETED|Overall Study||0||
48343110|NCT02730260|101167701|FG000|STARTED|Overall Study||258||
48343111|NCT02730260|101167702|FG001|STARTED|Overall Study||260||
48343112|NCT02730260|101167701|FG000|COMPLETED|Overall Study||176||
48343113|NCT02730260|101167702|FG001|COMPLETED|Overall Study||185||
48343114|NCT02730260|101167701|FG000|NOT COMPLETED|Overall Study||82||
48343115|NCT02730260|101167702|FG001|NOT COMPLETED|Overall Study||75||
48343116|NCT02594644|101167703|FG000|STARTED|Overall Study||16||
48343117|NCT02594644|101167704|FG001|STARTED|Overall Study||16||
48343118|NCT02594644|101167703|FG000|COMPLETED|Overall Study||16||
48343119|NCT02594644|101167704|FG001|COMPLETED|Overall Study||15||
48343120|NCT02594644|101167703|FG000|NOT COMPLETED|Overall Study||0||
48756730|NCT03863795|102191319|FG001|STARTED|Overall Study||269||
48756731|NCT03863795|102191320|FG002|STARTED|Overall Study||244||
48756732|NCT03863795|102191321|FG003|STARTED|Overall Study||281||
48756733|NCT03863795|102191318|FG000|COMPLETED|Overall Study||306||
48756734|NCT03863795|102191319|FG001|COMPLETED|Overall Study||269||
48756735|NCT03863795|102191320|FG002|COMPLETED|Overall Study||244||
48756736|NCT03863795|102191321|FG003|COMPLETED|Overall Study||281||
48756737|NCT03863795|102191318|FG000|NOT COMPLETED|Overall Study||0||
48756738|NCT03863795|102191319|FG001|NOT COMPLETED|Overall Study||0||
48756739|NCT03863795|102191320|FG002|NOT COMPLETED|Overall Study||0||
48756740|NCT03863795|102191321|FG003|NOT COMPLETED|Overall Study||0||
48756741|NCT03316196|102191322|FG000|STARTED|Overall Study||42||
48756742|NCT03316196|102191323|FG001|STARTED|Overall Study||39||
48756743|NCT03316196|102191322|FG000|COMPLETED|Overall Study||35||
48756744|NCT03316196|102191323|FG001|COMPLETED|Overall Study||28||
48756745|NCT03316196|102191322|FG000|NOT COMPLETED|Overall Study||7||
48343121|NCT02594644|101167704|FG001|NOT COMPLETED|Overall Study||1||
48343122|NCT03709602|101167705|FG000|STARTED|Overall Study||16||
48343123|NCT03709602|101167706|FG001|STARTED|Overall Study||16||
48343124|NCT03709602|101167707|FG002|STARTED|Overall Study||3044||
48343125|NCT03709602|101167705|FG000|COMPLETED|Overall Study||16||
48343126|NCT03709602|101167706|FG001|COMPLETED|Overall Study||16||
48343127|NCT03709602|101167707|FG002|COMPLETED|Overall Study||3044||
48343128|NCT03709602|101167705|FG000|NOT COMPLETED|Overall Study||0||
48343129|NCT03709602|101167706|FG001|NOT COMPLETED|Overall Study||0||
48343130|NCT03709602|101167707|FG002|NOT COMPLETED|Overall Study||0||
48343131|NCT02586805|101167708|FG000|STARTED|Overall Study||41||
48343132|NCT02586805|101167709|FG001|STARTED|Overall Study||28||
48343133|NCT02586805|101167710|FG002|STARTED|Overall Study||29||
48343134|NCT02586805|101167711|FG003|STARTED|Overall Study||27||
48343135|NCT02586805|101167708|FG000|COMPLETED|Overall Study||35||
48343136|NCT02586805|101167709|FG001|COMPLETED|Overall Study||27||
48343137|NCT02586805|101167710|FG002|COMPLETED|Overall Study||26||
48343138|NCT02586805|101167711|FG003|COMPLETED|Overall Study||25||
48343139|NCT02586805|101167708|FG000|NOT COMPLETED|Overall Study||6||
48343140|NCT02586805|101167709|FG001|NOT COMPLETED|Overall Study||1||
48343141|NCT02586805|101167710|FG002|NOT COMPLETED|Overall Study||3||
48343142|NCT02586805|101167711|FG003|NOT COMPLETED|Overall Study||2||
48343143|NCT00808444|101167712|FG000|STARTED|Overall Study||233||
48343144|NCT00808444|101167713|FG001|STARTED|Overall Study||233||
48343145|NCT00808444|101167712|FG000|COMPLETED|Overall Study||232||
48343146|NCT00808444|101167713|FG001|COMPLETED|Overall Study||232||
48343147|NCT00808444|101167712|FG000|NOT COMPLETED|Overall Study||1||
48756746|NCT03316196|102191323|FG001|NOT COMPLETED|Overall Study||11||
48756747|NCT03919773|102191324|FG000|STARTED|First Intervention- (12 Weeks)||16||
48756748|NCT03919773|102191325|FG001|STARTED|First Intervention- (12 Weeks)||14||
48756749|NCT03919773|102191324|FG000|COMPLETED|First Intervention- (12 Weeks)||15||
48756750|NCT03919773|102191325|FG001|COMPLETED|First Intervention- (12 Weeks)||12||
48756751|NCT03919773|102191324|FG000|NOT COMPLETED|First Intervention- (12 Weeks)||1||
48756752|NCT03919773|102191325|FG001|NOT COMPLETED|First Intervention- (12 Weeks)||2||
48756753|NCT03919773|102191324|FG000|STARTED|Washout (6 Weeks)||15||
48756754|NCT03919773|102191325|FG001|STARTED|Washout (6 Weeks)||12||
48343148|NCT00808444|101167713|FG001|NOT COMPLETED|Overall Study||1||
48343149|NCT00382967|101167714|FG000|STARTED|Overall Study||122||
48343150|NCT00382967|101167715|FG001|STARTED|Overall Study||138||
48343151|NCT00382967|101167714|FG000|COMPLETED|Overall Study||121||
48343152|NCT00382967|101167715|FG001|COMPLETED|Overall Study||137||
48414144|NCT04048876|101345963|FG002|Placebo to CC-90001 400mg|Active Treatment Phase||0|Participants who received placebo in the placebo-controlled phase and then received CC-90001 400mg in active treatment phase.|
48414145|NCT04048876|101345964|FG003|Placebo to CC-90001 400mg|Active Treatment Phase||1|Participants who received placebo in the placebo-controlled phase and then received CC-90001 400mg in active treatment phase.|
48414146|NCT04048876|101345961|FG000|COMPLETED|Active Treatment Phase||0||
48414147|NCT04048876|101345962|FG001|COMPLETED|Active Treatment Phase||0||
48414148|NCT04048876|101345963|FG002|COMPLETED|Active Treatment Phase||0||
48414149|NCT04048876|101345964|FG003|COMPLETED|Active Treatment Phase||0||
48414150|NCT04048876|101345961|FG000|NOT COMPLETED|Active Treatment Phase||2||
48414151|NCT04048876|101345962|FG001|NOT COMPLETED|Active Treatment Phase||0||
48414152|NCT04048876|101345963|FG002|NOT COMPLETED|Active Treatment Phase||3||
48414153|NCT04048876|101345964|FG003|NOT COMPLETED|Active Treatment Phase||2||
48414154|NCT00819052|101345965|FG000|STARTED|Overall Study||148||
48414155|NCT00819052|101345966|FG001|STARTED|Overall Study||295||
48414156|NCT00819052|101345965|FG000|COMPLETED|Overall Study||142||
48414157|NCT00819052|101345966|FG001|COMPLETED|Overall Study||281||
48414158|NCT00819052|101345965|FG000|NOT COMPLETED|Overall Study||6||
48414159|NCT00819052|101345966|FG001|NOT COMPLETED|Overall Study||14||
48414160|NCT00869375|101345967|FG000|STARTED|Overall Study||3||
48414161|NCT00869375|101345968|FG001|STARTED|Overall Study||3||
48414162|NCT00869375|101345967|FG000|COMPLETED|Overall Study||3||
48414163|NCT00869375|101345968|FG001|COMPLETED|Overall Study||3||
48414164|NCT00869375|101345967|FG000|NOT COMPLETED|Overall Study||0||
48414165|NCT00869375|101345968|FG001|NOT COMPLETED|Overall Study||0||
48414166|NCT01594749|101345969|FG000|STARTED|Overall Study||507||
48414167|NCT01594749|101345970|FG001|STARTED|Overall Study||508||
48414168|NCT01594749|101345969|FG000|Treated|Overall Study||503||
48414169|NCT01594749|101345970|FG001|Treated|Overall Study||498||
48414170|NCT01594749|101345969|FG000|COMPLETED|Overall Study||485||
48414171|NCT01594749|101345970|FG001|COMPLETED|Overall Study||490||
48414172|NCT01594749|101345969|FG000|NOT COMPLETED|Overall Study||22||
48414173|NCT01594749|101345970|FG001|NOT COMPLETED|Overall Study||18||
48414174|NCT05466240|101345971|FG000|STARTED|Overall Study||14||
48414175|NCT05466240|101345972|FG001|STARTED|Overall Study||7||
48414176|NCT05466240|101345971|FG000|COMPLETED|Overall Study||12||
48414177|NCT05466240|101345972|FG001|COMPLETED|Overall Study||7||
48414178|NCT05466240|101345971|FG000|NOT COMPLETED|Overall Study||2||
48414179|NCT05466240|101345972|FG001|NOT COMPLETED|Overall Study||0||
48414180|NCT02608892|101345973|FG000|STARTED|Overall Study||51||
48414181|NCT02608892|101345974|FG001|STARTED|Overall Study||49||
48414182|NCT02608892|101345973|FG000|COMPLETED|Overall Study||50||
48414183|NCT02608892|101345974|FG001|COMPLETED|Overall Study||49||
48414184|NCT02608892|101345973|FG000|NOT COMPLETED|Overall Study||1||
48414185|NCT02608892|101345974|FG001|NOT COMPLETED|Overall Study||0||
48414186|NCT00731666|101345975|FG000|STARTED|Overall Study||40||
48414187|NCT00731666|101345975|FG000|COMPLETED|Overall Study||28||
48414188|NCT00731666|101345975|FG000|NOT COMPLETED|Overall Study||12||
48633817|NCT00325416|101888789|FG000|COMPLETED|Phase I: Dose Escalation||48||
48633818|NCT00325416|101888790|FG001|COMPLETED|Phase I: Dose Escalation||44||
48633819|NCT00325416|101888789|FG000|NOT COMPLETED|Phase I: Dose Escalation||22||
48343153|NCT00382967|101167714|FG000|NOT COMPLETED|Overall Study||1||
48343154|NCT00382967|101167715|FG001|NOT COMPLETED|Overall Study||1||
48343155|NCT03424161|101167716|FG000|STARTED|Overall Study||27||
48343156|NCT03424161|101167716|FG000|COMPLETED|Overall Study||10||
48343157|NCT03424161|101167716|FG000|NOT COMPLETED|Overall Study||17||
48633820|NCT00325416|101888790|FG001|NOT COMPLETED|Phase I: Dose Escalation||16||
48343158|NCT04002167|101167717|FG000|STARTED|Overall Study||33||
48343159|NCT04002167|101167718|FG001|STARTED|Overall Study||32||
48343160|NCT04002167|101167719|FG002|STARTED|Overall Study||0||
48343161|NCT04002167|101167717|FG000|COMPLETED|Overall Study||21||
48343162|NCT04002167|101167718|FG001|COMPLETED|Overall Study||15||
48414189|NCT01425528|101345976|FG000|STARTED|Overall Study||6||
48414190|NCT01425528|101345977|FG001|STARTED|Overall Study||6||
48414191|NCT01425528|101345976|FG000|COMPLETED|Overall Study||5||
48414192|NCT01425528|101345977|FG001|COMPLETED|Overall Study||5||
48414193|NCT01425528|101345976|FG000|NOT COMPLETED|Overall Study||1||
48414194|NCT01425528|101345977|FG001|NOT COMPLETED|Overall Study||1||
48414195|NCT00542425|101345978|FG000|STARTED|Initial 24 Weeks||46||
48414196|NCT00542425|101345979|FG001|STARTED|Initial 24 Weeks||43||
48414197|NCT00542425|101345980|FG002|STARTED|Initial 24 Weeks||43||
48414198|NCT00542425|101345981|FG003|STARTED|Initial 24 Weeks||45||
48414199|NCT00542425|101345982|FG004|STARTED|Initial 24 Weeks||45||
48414200|NCT00542425|101345978|FG000|COMPLETED|Initial 24 Weeks||42||
48414201|NCT00542425|101345979|FG001|COMPLETED|Initial 24 Weeks||33||
48414202|NCT00542425|101345980|FG002|COMPLETED|Initial 24 Weeks||36||
48414203|NCT00542425|101345981|FG003|COMPLETED|Initial 24 Weeks||34||
48414204|NCT00542425|101345982|FG004|COMPLETED|Initial 24 Weeks||39||
48414205|NCT00542425|101345978|FG000|NOT COMPLETED|Initial 24 Weeks||4||
48414206|NCT00542425|101345979|FG001|NOT COMPLETED|Initial 24 Weeks||10||
48414207|NCT00542425|101345980|FG002|NOT COMPLETED|Initial 24 Weeks||7||
48414208|NCT00542425|101345981|FG003|NOT COMPLETED|Initial 24 Weeks||11||
48414209|NCT00542425|101345982|FG004|NOT COMPLETED|Initial 24 Weeks||6||
48414210|NCT00542425|101345978|FG000|STARTED|Extended 24 Weeks of Treatment||11||
48414211|NCT00542425|101345979|FG001|STARTED|Extended 24 Weeks of Treatment||13||
48414212|NCT00542425|101345980|FG002|STARTED|Extended 24 Weeks of Treatment||10||
48414213|NCT00542425|101345981|FG003|STARTED|Extended 24 Weeks of Treatment||7||
48414214|NCT00542425|101345982|FG004|STARTED|Extended 24 Weeks of Treatment||14||
48414215|NCT00542425|101345978|FG000|COMPLETED|Extended 24 Weeks of Treatment||10||
48414216|NCT00542425|101345979|FG001|COMPLETED|Extended 24 Weeks of Treatment||11||
48414217|NCT00542425|101345980|FG002|COMPLETED|Extended 24 Weeks of Treatment||8||
48414218|NCT00542425|101345981|FG003|COMPLETED|Extended 24 Weeks of Treatment||6||
48414219|NCT00542425|101345982|FG004|COMPLETED|Extended 24 Weeks of Treatment||13||
48414220|NCT00542425|101345978|FG000|NOT COMPLETED|Extended 24 Weeks of Treatment||1||
48414221|NCT00542425|101345979|FG001|NOT COMPLETED|Extended 24 Weeks of Treatment||2||
48414222|NCT00542425|101345980|FG002|NOT COMPLETED|Extended 24 Weeks of Treatment||2||
48414223|NCT00542425|101345981|FG003|NOT COMPLETED|Extended 24 Weeks of Treatment||1||
48414224|NCT00542425|101345982|FG004|NOT COMPLETED|Extended 24 Weeks of Treatment||1||
48414225|NCT03267576|101345983|FG000|STARTED|Period 1: Day 0 to 27||31||
48414226|NCT03267576|101345984|FG001|STARTED|Period 1: Day 0 to 27||32||
48414227|NCT03267576|101345983|FG000|COMPLETED|Period 1: Day 0 to 27||31||
48414228|NCT03267576|101345984|FG001|COMPLETED|Period 1: Day 0 to 27||32||
48414229|NCT03267576|101345983|FG000|NOT COMPLETED|Period 1: Day 0 to 27||0||
48414230|NCT03267576|101345984|FG001|NOT COMPLETED|Period 1: Day 0 to 27||0||
48414231|NCT03267576|101345983|FG000|STARTED|Washout Period: 16 Days||31||
48414232|NCT03267576|101345984|FG001|STARTED|Washout Period: 16 Days||32||
48414233|NCT03267576|101345983|FG000|COMPLETED|Washout Period: 16 Days||31||
48414234|NCT03267576|101345984|FG001|COMPLETED|Washout Period: 16 Days||32||
48414235|NCT03267576|101345983|FG000|NOT COMPLETED|Washout Period: 16 Days||0||
48414236|NCT03267576|101345984|FG001|NOT COMPLETED|Washout Period: 16 Days||0||
48414237|NCT03267576|101345983|FG000|STARTED|Period 2: Day 44 to 71||31||
48414238|NCT03267576|101345984|FG001|STARTED|Period 2: Day 44 to 71||32||
48414239|NCT03267576|101345983|FG000|COMPLETED|Period 2: Day 44 to 71||30||
48414240|NCT03267576|101345984|FG001|COMPLETED|Period 2: Day 44 to 71||30||
48633821|NCT00325416|101888789|FG000|STARTED|Phase II: Treatment at MTD||78||
48633822|NCT00325416|101888790|FG001|STARTED|Phase II: Treatment at MTD||42||
48633823|NCT00325416|101888789|FG000|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||38||
48633824|NCT00325416|101888790|FG001|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||34||
48633825|NCT00325416|101888789|FG000|Enrolled During Phase II|Phase II: Treatment at MTD||40||
48633826|NCT00325416|101888790|FG001|Enrolled During Phase II|Phase II: Treatment at MTD||8||
48633827|NCT00325416|101888789|FG000|COMPLETED|Phase II: Treatment at MTD||78||
48633828|NCT00325416|101888790|FG001|COMPLETED|Phase II: Treatment at MTD||40||
48633829|NCT00325416|101888789|FG000|NOT COMPLETED|Phase II: Treatment at MTD||0||
48633830|NCT00325416|101888790|FG001|NOT COMPLETED|Phase II: Treatment at MTD||2||
48633831|NCT01962675|101888791|FG000|STARTED|Overall Study||7||
48633832|NCT01962675|101888792|FG001|STARTED|Overall Study||7||
48414241|NCT03267576|101345983|FG000|NOT COMPLETED|Period 2: Day 44 to 71||1||
48414242|NCT03267576|101345984|FG001|NOT COMPLETED|Period 2: Day 44 to 71||2||
48414243|NCT04430036|101345985|FG000|STARTED|Safety Run in Phase||4||
48414244|NCT04430036|101345985|FG000|COMPLETED|Safety Run in Phase||2||
48414245|NCT04430036|101345985|FG000|NOT COMPLETED|Safety Run in Phase||2||
48414246|NCT04430036|101345985|FG000|STARTED|Phase II, Stage 1||0|No participants were enrolled in the Phase II, Stage I of the study due to early termination of the study|
48414247|NCT04430036|101345985|FG000|COMPLETED|Phase II, Stage 1||0||
48414248|NCT04430036|101345985|FG000|NOT COMPLETED|Phase II, Stage 1||0||
48414249|NCT04430036|101345985|FG000|STARTED|Phase ll, Stage 2||0||
48414250|NCT04430036|101345985|FG000|COMPLETED|Phase ll, Stage 2||0||
48633833|NCT01962675|101888791|FG000|COMPLETED|Overall Study||7||
48633834|NCT01962675|101888792|FG001|COMPLETED|Overall Study||7||
48633835|NCT01962675|101888791|FG000|NOT COMPLETED|Overall Study||0||
48633836|NCT01962675|101888792|FG001|NOT COMPLETED|Overall Study||0||
48414251|NCT04430036|101345985|FG000|NOT COMPLETED|Phase ll, Stage 2||0||
48414252|NCT01809327|101345986|FG000|STARTED|Overall Study||237||
48414253|NCT01809327|101345987|FG001|STARTED|Overall Study||237||
48414254|NCT01809327|101345988|FG002|STARTED|Overall Study||238||
48414255|NCT01809327|101345989|FG003|STARTED|Overall Study||237||
48414256|NCT01809327|101345990|FG004|STARTED|Overall Study||237||
48414257|NCT01809327|101345986|FG000|COMPLETED|Overall Study||205||
48414258|NCT01809327|101345987|FG001|COMPLETED|Overall Study||211||
48414259|NCT01809327|101345988|FG002|COMPLETED|Overall Study||216||
48414260|NCT01809327|101345989|FG003|COMPLETED|Overall Study||225||
48414261|NCT01809327|101345990|FG004|COMPLETED|Overall Study||212||
48414262|NCT01809327|101345986|FG000|NOT COMPLETED|Overall Study||32||
48414263|NCT01809327|101345987|FG001|NOT COMPLETED|Overall Study||26||
48414264|NCT01809327|101345988|FG002|NOT COMPLETED|Overall Study||22||
48414265|NCT01809327|101345989|FG003|NOT COMPLETED|Overall Study||12||
48414266|NCT01809327|101345990|FG004|NOT COMPLETED|Overall Study||25||
48414267|NCT03756285|101345991|FG000|STARTED|Overall Study||27||
48633837|NCT03069989|101888793|FG000|STARTED|Dosing Period 1 (Up to 2 Days)||3||
48633838|NCT03069989|101888794|FG001|STARTED|Dosing Period 1 (Up to 2 Days)||5||
48633839|NCT03069989|101888793|FG000|COMPLETED|Dosing Period 1 (Up to 2 Days)||3||
48633840|NCT03069989|101888794|FG001|COMPLETED|Dosing Period 1 (Up to 2 Days)||5||
48633841|NCT03069989|101888793|FG000|NOT COMPLETED|Dosing Period 1 (Up to 2 Days)||0||
48633842|NCT03069989|101888794|FG001|NOT COMPLETED|Dosing Period 1 (Up to 2 Days)||0||
48633843|NCT03069989|101888793|FG000|STARTED|Wash Out Period (Up to 28 Days))||3||
48756755|NCT03919773|102191324|FG000|COMPLETED|Washout (6 Weeks)||12||
48756756|NCT03919773|102191325|FG001|COMPLETED|Washout (6 Weeks)||12||
48756757|NCT03919773|102191324|FG000|NOT COMPLETED|Washout (6 Weeks)||3||
48756758|NCT03919773|102191325|FG001|NOT COMPLETED|Washout (6 Weeks)||0||
48756759|NCT03919773|102191324|FG000|STARTED|Second Intervention-(12 Weeks)||12||
48756760|NCT03919773|102191325|FG001|STARTED|Second Intervention-(12 Weeks)||12||
48756761|NCT03919773|102191324|FG000|COMPLETED|Second Intervention-(12 Weeks)||10||
48756762|NCT03919773|102191325|FG001|COMPLETED|Second Intervention-(12 Weeks)||11||
48756763|NCT03919773|102191324|FG000|NOT COMPLETED|Second Intervention-(12 Weeks)||2||
48756764|NCT03919773|102191325|FG001|NOT COMPLETED|Second Intervention-(12 Weeks)||1||
48756765|NCT01844765|102191326|FG000|STARTED|Overall Study||34||
48756766|NCT01844765|102191327|FG001|STARTED|Overall Study||25||
48756767|NCT01844765|102191326|FG000|Treated|Overall Study||33||
48756768|NCT01844765|102191327|FG001|Treated|Overall Study||25||
48756769|NCT01844765|102191326|FG000|Untreated|Overall Study||1||
48756770|NCT01844765|102191327|FG001|Untreated|Overall Study||0||
48756771|NCT01844765|102191326|FG000|COMPLETED|Overall Study||19|Completed = Treatment duration is completed per protocol|
48756772|NCT01844765|102191327|FG001|COMPLETED|Overall Study||10|Completed = Treatment duration is completed per protocol|
48756773|NCT01844765|102191326|FG000|NOT COMPLETED|Overall Study||15||
48756774|NCT01844765|102191327|FG001|NOT COMPLETED|Overall Study||15||
48756775|NCT00468169|102191328|FG000|STARTED|Overall Study||57||
48756776|NCT00468169|102191329|FG001|STARTED|Overall Study||53||
48756777|NCT00468169|102191328|FG000|COMPLETED|Overall Study||56||
48756778|NCT00468169|102191329|FG001|COMPLETED|Overall Study||53||
48756779|NCT00468169|102191328|FG000|NOT COMPLETED|Overall Study||1||
48756780|NCT00468169|102191329|FG001|NOT COMPLETED|Overall Study||0||
48756781|NCT05178173|102191330|FG000|STARTED|Overall Study||72||
48756782|NCT05178173|102191331|FG001|STARTED|Overall Study||77||
48756783|NCT05178173|102191332|FG002|STARTED|Overall Study||81||
48756784|NCT05178173|102191330|FG000|qPCR Performed|Overall Study||62||
48756785|NCT05178173|102191331|FG001|qPCR Performed|Overall Study||67||
48756786|NCT05178173|102191332|FG002|qPCR Performed|Overall Study||68||
48756787|NCT05178173|102191330|FG000|qPCR Analysis Population|Overall Study||48||
48756788|NCT05178173|102191331|FG001|qPCR Analysis Population|Overall Study||46||
48756789|NCT05178173|102191332|FG002|qPCR Analysis Population|Overall Study||52||
48756790|NCT05178173|102191330|FG000|COMPLETED|Overall Study||72||
48756791|NCT05178173|102191331|FG001|COMPLETED|Overall Study||77||
48756792|NCT05178173|102191332|FG002|COMPLETED|Overall Study||79||
48756793|NCT05178173|102191330|FG000|NOT COMPLETED|Overall Study||0||
48756794|NCT05178173|102191331|FG001|NOT COMPLETED|Overall Study||0||
48756795|NCT05178173|102191332|FG002|NOT COMPLETED|Overall Study||2||
48756796|NCT04617782|102191333|FG000|STARTED|Treatment A - 5 mg TDS||60|The disposition summary reported in the CSR does not list disposition by sequence of treatment, and instead lists disposition by the treatment received. The statistical group that analyzed the data was an external vendor that is no longer contracted and not available to re-analyze the participant flow by sequence. Since the Sponsor does not have internal statistical capabilities, the participant flow summary is presented by treatment received, and not by sequence of treatment.|
48756797|NCT04617782|102191333|FG000|COMPLETED|Treatment A - 5 mg TDS||57||
48756798|NCT04617782|102191333|FG000|NOT COMPLETED|Treatment A - 5 mg TDS||3||
48756799|NCT04617782|102191333|FG000|STARTED|Treatment B - 10 mg TDS||55|The disposition summary reported in the CSR does not list disposition by sequence of treatment, and instead lists disposition by the treatment received. The statistical group that analyzed the data was an external vendor that is no longer contracted and not available to re-analyze the participant flow by sequence. Since the Sponsor does not have internal statistical capabilities, the participant flow summary is presented by treatment received, and not by sequence of treatment.|
48756800|NCT04617782|102191333|FG000|COMPLETED|Treatment B - 10 mg TDS||53||
48756801|NCT04617782|102191333|FG000|NOT COMPLETED|Treatment B - 10 mg TDS||2||
48633844|NCT03069989|101888794|FG001|STARTED|Wash Out Period (Up to 28 Days))||5||
48633845|NCT03069989|101888793|FG000|COMPLETED|Wash Out Period (Up to 28 Days))||3||
48633846|NCT03069989|101888794|FG001|COMPLETED|Wash Out Period (Up to 28 Days))||5||
48767749|NCT04004988|102222818|FG000|STARTED|Period 1||24||
48767750|NCT04004988|102222819|FG001|STARTED|Period 1||23||
48767751|NCT04004988|102222818|FG000|Received at Least One Dose of Study Drug|Period 1||22||
48767752|NCT04004988|102222819|FG001|Received at Least One Dose of Study Drug|Period 1||23||
48182343|NCT02173535|100768276|FG019|STARTED|Period 4||12||
48182344|NCT02173535|100768257|FG000|COMPLETED|Period 4||12||
48182345|NCT02173535|100768258|FG001|COMPLETED|Period 4||12||
48182346|NCT02173535|100768259|FG002|COMPLETED|Period 4||12||
48182347|NCT02173535|100768260|FG003|COMPLETED|Period 4||12||
48182348|NCT02173535|100768261|FG004|COMPLETED|Period 4||12||
48182349|NCT02173535|100768262|FG005|COMPLETED|Period 4||12||
48182350|NCT02173535|100768263|FG006|COMPLETED|Period 4||12||
48182351|NCT02173535|100768264|FG007|COMPLETED|Period 4||12||
48182352|NCT02173535|100768265|FG008|COMPLETED|Period 4||12||
48182353|NCT02173535|100768266|FG009|COMPLETED|Period 4||12||
48182354|NCT02173535|100768267|FG010|COMPLETED|Period 4||12||
48182355|NCT02173535|100768268|FG011|COMPLETED|Period 4||12||
48343163|NCT04002167|101167719|FG002|COMPLETED|Overall Study||0||
48343164|NCT04002167|101167717|FG000|NOT COMPLETED|Overall Study||12||
48343165|NCT04002167|101167718|FG001|NOT COMPLETED|Overall Study||17||
48343166|NCT04002167|101167719|FG002|NOT COMPLETED|Overall Study||0||
48343167|NCT00970606|101167720|FG000|STARTED|Overall Study||4||
48343168|NCT00970606|101167721|FG001|STARTED|Overall Study||3||
48343169|NCT00970606|101167720|FG000|COMPLETED|Overall Study||4||
48343170|NCT00970606|101167721|FG001|COMPLETED|Overall Study||3||
48343171|NCT00970606|101167720|FG000|NOT COMPLETED|Overall Study||0||
48343172|NCT00970606|101167721|FG001|NOT COMPLETED|Overall Study||0||
48343173|NCT01889602|101167722|FG000|STARTED|First Intervention||20||
48343174|NCT01889602|101167723|FG001|STARTED|First Intervention||20||
48343175|NCT01889602|101167724|FG002|STARTED|First Intervention||20||
48343176|NCT01889602|101167722|FG000|COMPLETED|First Intervention||19||
48343177|NCT01889602|101167723|FG001|COMPLETED|First Intervention||17||
48182356|NCT02173535|100768269|FG012|COMPLETED|Period 4||12||
48182357|NCT02173535|100768270|FG013|COMPLETED|Period 4||12||
48182358|NCT02173535|100768271|FG014|COMPLETED|Period 4||12||
48343178|NCT01889602|101167724|FG002|COMPLETED|First Intervention||18||
48343179|NCT01889602|101167722|FG000|NOT COMPLETED|First Intervention||1||
48343180|NCT01889602|101167723|FG001|NOT COMPLETED|First Intervention||3||
48343181|NCT01889602|101167724|FG002|NOT COMPLETED|First Intervention||2||
48343182|NCT01889602|101167722|FG000|STARTED|First Washout Period of at Least 2 Weeks||19||
48182359|NCT02173535|100768272|FG015|COMPLETED|Period 4||12||
48182360|NCT02173535|100768273|FG016|COMPLETED|Period 4||12||
48182361|NCT02173535|100768274|FG017|COMPLETED|Period 4||12||
48343183|NCT01889602|101167723|FG001|STARTED|First Washout Period of at Least 2 Weeks||17||
48343184|NCT01889602|101167724|FG002|STARTED|First Washout Period of at Least 2 Weeks||18||
48182362|NCT02173535|100768275|FG018|COMPLETED|Period 4||12||
48182363|NCT02173535|100768276|FG019|COMPLETED|Period 4||12||
48343185|NCT01889602|101167722|FG000|COMPLETED|First Washout Period of at Least 2 Weeks||19||
48414268|NCT03756285|101345992|FG001|STARTED|Overall Study||14||
48633847|NCT03069989|101888793|FG000|NOT COMPLETED|Wash Out Period (Up to 28 Days))||0||
48633848|NCT03069989|101888794|FG001|NOT COMPLETED|Wash Out Period (Up to 28 Days))||0||
48633849|NCT03069989|101888793|FG000|STARTED|Dosing Period 2 (Up to 16 Days)||3||
48633850|NCT03069989|101888794|FG001|STARTED|Dosing Period 2 (Up to 16 Days)||5||
48633851|NCT03069989|101888793|FG000|COMPLETED|Dosing Period 2 (Up to 16 Days)||2||
48633852|NCT03069989|101888794|FG001|COMPLETED|Dosing Period 2 (Up to 16 Days)||5||
48633853|NCT03069989|101888793|FG000|NOT COMPLETED|Dosing Period 2 (Up to 16 Days)||1||
48633854|NCT03069989|101888794|FG001|NOT COMPLETED|Dosing Period 2 (Up to 16 Days)||0||
48633855|NCT01434511|101888795|FG000|STARTED|Overall Study||1||
48182364|NCT02173535|100768257|FG000|NOT COMPLETED|Period 4||0||
48182365|NCT02173535|100768258|FG001|NOT COMPLETED|Period 4||0||
48182366|NCT02173535|100768259|FG002|NOT COMPLETED|Period 4||0||
48182367|NCT02173535|100768260|FG003|NOT COMPLETED|Period 4||0||
48182368|NCT02173535|100768261|FG004|NOT COMPLETED|Period 4||0||
48182369|NCT02173535|100768262|FG005|NOT COMPLETED|Period 4||0||
48182370|NCT02173535|100768263|FG006|NOT COMPLETED|Period 4||0||
48182371|NCT02173535|100768264|FG007|NOT COMPLETED|Period 4||0||
48182372|NCT02173535|100768265|FG008|NOT COMPLETED|Period 4||0||
48182373|NCT02173535|100768266|FG009|NOT COMPLETED|Period 4||0||
48182374|NCT02173535|100768267|FG010|NOT COMPLETED|Period 4||0||
48182375|NCT02173535|100768268|FG011|NOT COMPLETED|Period 4||0||
48182376|NCT02173535|100768269|FG012|NOT COMPLETED|Period 4||0||
48182377|NCT02173535|100768270|FG013|NOT COMPLETED|Period 4||0||
48182378|NCT02173535|100768271|FG014|NOT COMPLETED|Period 4||0||
48182379|NCT02173535|100768272|FG015|NOT COMPLETED|Period 4||0||
48182380|NCT02173535|100768273|FG016|NOT COMPLETED|Period 4||0||
48182381|NCT02173535|100768274|FG017|NOT COMPLETED|Period 4||0||
48182382|NCT02173535|100768275|FG018|NOT COMPLETED|Period 4||0||
48182383|NCT02173535|100768276|FG019|NOT COMPLETED|Period 4||0||
48182384|NCT02173535|100768257|FG000|STARTED|Period 5||12||
48633856|NCT01434511|101888795|FG000|COMPLETED|Overall Study||1||
48633857|NCT01434511|101888795|FG000|NOT COMPLETED|Overall Study||0||
48633858|NCT01258049|101888796|FG000|STARTED|Overall Study||77||
48633859|NCT01258049|101888797|FG001|STARTED|Overall Study||74||
48633860|NCT01258049|101888796|FG000|COMPLETED|Overall Study||75||
48633861|NCT01258049|101888797|FG001|COMPLETED|Overall Study||72||
48633862|NCT01258049|101888796|FG000|NOT COMPLETED|Overall Study||2||
48633863|NCT01258049|101888797|FG001|NOT COMPLETED|Overall Study||2||
48633864|NCT03255187|101888798|FG000|STARTED|Periodfrom Enrollment to First Follow-up||35||
48633865|NCT03255187|101888799|FG001|STARTED|Periodfrom Enrollment to First Follow-up||35||
48756802|NCT04617782|102191333|FG000|STARTED|Treatment C - 10 mg Oral||56|The disposition summary reported in the CSR does not list disposition by sequence of treatment, and instead lists disposition by the treatment received. The statistical group that analyzed the data was an external vendor that is no longer contracted and not available to re-analyze the participant flow by sequence. Since the Sponsor does not have internal statistical capabilities, the participant flow summary is presented by treatment received, and not by sequence of treatment.|
48756803|NCT04617782|102191333|FG000|COMPLETED|Treatment C - 10 mg Oral||53||
48756804|NCT04617782|102191333|FG000|NOT COMPLETED|Treatment C - 10 mg Oral||3||
48756805|NCT03182374|102191334|FG000|STARTED|Overall Study||125||
48756806|NCT03182374|102191335|FG001|STARTED|Overall Study||127||
48756807|NCT03182374|102191334|FG000|Treated|Overall Study||124|Patients who received the first injection|
48756808|NCT03182374|102191335|FG001|Treated|Overall Study||127|Patients who received the first injection|
48756809|NCT03182374|102191334|FG000|12-month Follow-up|Overall Study||111||
48756810|NCT03182374|102191335|FG001|12-month Follow-up|Overall Study||106||
48756811|NCT03182374|102191334|FG000|COMPLETED|Overall Study||111|Subjects will complete after 5 years follow up|
48756812|NCT03182374|102191335|FG001|COMPLETED|Overall Study||106|Subjects will complete after 5 years follow up|
48182385|NCT02173535|100768258|FG001|STARTED|Period 5||12||
48633866|NCT03255187|101888798|FG000|COMPLETED|Periodfrom Enrollment to First Follow-up||34||
48633867|NCT03255187|101888799|FG001|COMPLETED|Periodfrom Enrollment to First Follow-up||32||
48633868|NCT03255187|101888798|FG000|NOT COMPLETED|Periodfrom Enrollment to First Follow-up||1||
48633869|NCT03255187|101888799|FG001|NOT COMPLETED|Periodfrom Enrollment to First Follow-up||3||
48633870|NCT03255187|101888798|FG000|STARTED|Period From First to Second Follow-up||34||
48633871|NCT03255187|101888799|FG001|STARTED|Period From First to Second Follow-up||32||
48633872|NCT03255187|101888798|FG000|COMPLETED|Period From First to Second Follow-up||34||
48633873|NCT03255187|101888799|FG001|COMPLETED|Period From First to Second Follow-up||31||
48182386|NCT02173535|100768259|FG002|STARTED|Period 5||12||
48182387|NCT02173535|100768260|FG003|STARTED|Period 5||12||
48633874|NCT03255187|101888798|FG000|NOT COMPLETED|Period From First to Second Follow-up||0||
48182388|NCT02173535|100768261|FG004|STARTED|Period 5||12||
48633875|NCT03255187|101888799|FG001|NOT COMPLETED|Period From First to Second Follow-up||1||
48633876|NCT03255187|101888798|FG000|STARTED|Period From Second to Third Follow-up||34||
48182389|NCT02173535|100768262|FG005|STARTED|Period 5||12||
48182390|NCT02173535|100768263|FG006|STARTED|Period 5||12||
48182391|NCT02173535|100768264|FG007|STARTED|Period 5||12||
48182392|NCT02173535|100768265|FG008|STARTED|Period 5||12||
48182393|NCT02173535|100768266|FG009|STARTED|Period 5||12||
48182394|NCT02173535|100768267|FG010|STARTED|Period 5||12||
48182395|NCT02173535|100768268|FG011|STARTED|Period 5||12||
48182396|NCT02173535|100768269|FG012|STARTED|Period 5||12||
48182397|NCT02173535|100768270|FG013|STARTED|Period 5||12||
48182398|NCT02173535|100768271|FG014|STARTED|Period 5||12||
48756813|NCT03182374|102191334|FG000|NOT COMPLETED|Overall Study||14||
48756814|NCT03182374|102191335|FG001|NOT COMPLETED|Overall Study||21||
48756815|NCT01572207|102191336|FG000|STARTED|Overall Study||14||
48756816|NCT01572207|102191337|FG001|STARTED|Overall Study||16||
48343186|NCT01889602|101167723|FG001|COMPLETED|First Washout Period of at Least 2 Weeks||17||
48343187|NCT01889602|101167724|FG002|COMPLETED|First Washout Period of at Least 2 Weeks||18||
48343188|NCT01889602|101167722|FG000|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0||
48343189|NCT01889602|101167723|FG001|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0||
48756817|NCT01572207|102191336|FG000|COMPLETED|Overall Study||12||
48756818|NCT01572207|102191337|FG001|COMPLETED|Overall Study||13||
48756819|NCT01572207|102191336|FG000|NOT COMPLETED|Overall Study||2||
48756820|NCT01572207|102191337|FG001|NOT COMPLETED|Overall Study||3||
48182399|NCT02173535|100768272|FG015|STARTED|Period 5||12||
48182400|NCT02173535|100768273|FG016|STARTED|Period 5||12||
48182401|NCT02173535|100768274|FG017|STARTED|Period 5||12||
48182402|NCT02173535|100768275|FG018|STARTED|Period 5||12||
48182403|NCT02173535|100768276|FG019|STARTED|Period 5||12||
48182404|NCT02173535|100768257|FG000|COMPLETED|Period 5||12||
48182405|NCT02173535|100768258|FG001|COMPLETED|Period 5||12||
48182406|NCT02173535|100768259|FG002|COMPLETED|Period 5||12||
48182407|NCT02173535|100768260|FG003|COMPLETED|Period 5||12||
48182408|NCT02173535|100768261|FG004|COMPLETED|Period 5||12||
48182409|NCT02173535|100768262|FG005|COMPLETED|Period 5||12||
48182410|NCT02173535|100768263|FG006|COMPLETED|Period 5||12||
48182411|NCT02173535|100768264|FG007|COMPLETED|Period 5||12||
48182412|NCT02173535|100768265|FG008|COMPLETED|Period 5||12||
48182413|NCT02173535|100768266|FG009|COMPLETED|Period 5||12||
48182414|NCT02173535|100768267|FG010|COMPLETED|Period 5||12||
48182415|NCT02173535|100768268|FG011|COMPLETED|Period 5||12||
48182416|NCT02173535|100768269|FG012|COMPLETED|Period 5||12||
48182417|NCT02173535|100768270|FG013|COMPLETED|Period 5||12||
48633877|NCT03255187|101888799|FG001|STARTED|Period From Second to Third Follow-up||31||
48633878|NCT03255187|101888798|FG000|COMPLETED|Period From Second to Third Follow-up||34||
48633879|NCT03255187|101888799|FG001|COMPLETED|Period From Second to Third Follow-up||31||
48633880|NCT03255187|101888798|FG000|NOT COMPLETED|Period From Second to Third Follow-up||0||
48633881|NCT03255187|101888799|FG001|NOT COMPLETED|Period From Second to Third Follow-up||0||
48633882|NCT03255187|101888798|FG000|STARTED|Period From Third to Fourth Follow-up||34||
48633883|NCT03255187|101888799|FG001|STARTED|Period From Third to Fourth Follow-up||31||
48633884|NCT03255187|101888798|FG000|COMPLETED|Period From Third to Fourth Follow-up||34||
48633885|NCT03255187|101888799|FG001|COMPLETED|Period From Third to Fourth Follow-up||31||
48633886|NCT03255187|101888798|FG000|NOT COMPLETED|Period From Third to Fourth Follow-up||0||
48633887|NCT03255187|101888799|FG001|NOT COMPLETED|Period From Third to Fourth Follow-up||0||
48633888|NCT03255187|101888798|FG000|STARTED|Period at Fourth Follow-up||34||
48633889|NCT03255187|101888799|FG001|STARTED|Period at Fourth Follow-up||31||
48756821|NCT02219464|102191338|FG000|STARTED|Overall Study||30||
48756822|NCT02219464|102191339|FG001|STARTED|Overall Study||30||
48182418|NCT02173535|100768271|FG014|COMPLETED|Period 5||12||
48182419|NCT02173535|100768272|FG015|COMPLETED|Period 5||12||
48182420|NCT02173535|100768273|FG016|COMPLETED|Period 5||12||
48182421|NCT02173535|100768274|FG017|COMPLETED|Period 5||12||
48182422|NCT02173535|100768275|FG018|COMPLETED|Period 5||12||
48182423|NCT02173535|100768276|FG019|COMPLETED|Period 5||12||
48182424|NCT02173535|100768257|FG000|NOT COMPLETED|Period 5||0||
48182425|NCT02173535|100768258|FG001|NOT COMPLETED|Period 5||0||
48633890|NCT03255187|101888798|FG000|COMPLETED|Period at Fourth Follow-up||34||
48633891|NCT03255187|101888799|FG001|COMPLETED|Period at Fourth Follow-up||31||
48633892|NCT03255187|101888798|FG000|NOT COMPLETED|Period at Fourth Follow-up||0||
48633893|NCT03255187|101888799|FG001|NOT COMPLETED|Period at Fourth Follow-up||0||
48633894|NCT01114724|101888800|FG000|STARTED|Overall Study||50||
48633895|NCT01114724|101888800|FG000|COMPLETED|Overall Study||40||
48633896|NCT01114724|101888800|FG000|NOT COMPLETED|Overall Study||10||
48633897|NCT00300053|101888801|FG000|STARTED|Overall Study||55||
48182426|NCT02173535|100768259|FG002|NOT COMPLETED|Period 5||0||
48633898|NCT00300053|101888802|FG001|STARTED|Overall Study||56||
48633899|NCT00300053|101888803|FG002|STARTED|Overall Study||56||
48633900|NCT00300053|101888801|FG000|3-Month Evaluation|Overall Study||55||
48756823|NCT02219464|102191338|FG000|COMPLETED|Overall Study||27||
48756824|NCT02219464|102191339|FG001|COMPLETED|Overall Study||30||
48756825|NCT02219464|102191338|FG000|NOT COMPLETED|Overall Study||3||
48756826|NCT02219464|102191339|FG001|NOT COMPLETED|Overall Study||0||
48756827|NCT05482308|102191340|FG000|STARTED|Overall Study||6||
48756828|NCT05482308|102191341|FG001|STARTED|Overall Study||6||
48756829|NCT05482308|102191340|FG000|COMPLETED|Overall Study||5||
48182427|NCT02173535|100768260|FG003|NOT COMPLETED|Period 5||0||
48182428|NCT02173535|100768261|FG004|NOT COMPLETED|Period 5||0||
48182429|NCT02173535|100768262|FG005|NOT COMPLETED|Period 5||0||
48182430|NCT02173535|100768263|FG006|NOT COMPLETED|Period 5||0||
48182431|NCT02173535|100768264|FG007|NOT COMPLETED|Period 5||0||
48182432|NCT02173535|100768265|FG008|NOT COMPLETED|Period 5||0||
48182433|NCT02173535|100768266|FG009|NOT COMPLETED|Period 5||0||
48182434|NCT02173535|100768267|FG010|NOT COMPLETED|Period 5||0||
48182435|NCT02173535|100768268|FG011|NOT COMPLETED|Period 5||0||
48633901|NCT00300053|101888802|FG001|3-Month Evaluation|Overall Study||56||
48633902|NCT00300053|101888803|FG002|3-Month Evaluation|Overall Study||54||
48633903|NCT00300053|101888801|FG000|6-Month Evaluation|Overall Study||54||
48633904|NCT00300053|101888802|FG001|6-Month Evaluation|Overall Study||55||
48633905|NCT00300053|101888803|FG002|6-Month Evaluation|Overall Study||53||
48633906|NCT00300053|101888801|FG000|COMPLETED|Overall Study||53||
48633907|NCT00300053|101888802|FG001|COMPLETED|Overall Study||53||
48633908|NCT00300053|101888803|FG002|COMPLETED|Overall Study||50||
48633909|NCT00300053|101888801|FG000|NOT COMPLETED|Overall Study||2||
48633910|NCT00300053|101888802|FG001|NOT COMPLETED|Overall Study||3||
48182436|NCT02173535|100768269|FG012|NOT COMPLETED|Period 5||0||
48182437|NCT02173535|100768270|FG013|NOT COMPLETED|Period 5||0||
48182438|NCT02173535|100768271|FG014|NOT COMPLETED|Period 5||0||
48182439|NCT02173535|100768272|FG015|NOT COMPLETED|Period 5||0||
48182440|NCT02173535|100768273|FG016|NOT COMPLETED|Period 5||0||
48182441|NCT02173535|100768274|FG017|NOT COMPLETED|Period 5||0||
48182442|NCT02173535|100768275|FG018|NOT COMPLETED|Period 5||0||
48182443|NCT02173535|100768276|FG019|NOT COMPLETED|Period 5||0||
48182444|NCT00372060|100768277|FG000|STARTED|Period I - Double-blind (Weeks 0-12)||66||
48182445|NCT00372060|100768278|FG001|STARTED|Period I - Double-blind (Weeks 0-12)||68||
48182446|NCT00372060|100768277|FG000|COMPLETED|Period I - Double-blind (Weeks 0-12)||63||
48182447|NCT00372060|100768278|FG001|COMPLETED|Period I - Double-blind (Weeks 0-12)||67||
48182448|NCT00372060|100768277|FG000|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||3||
48182449|NCT00372060|100768278|FG001|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||1||
48182450|NCT00372060|100768277|FG000|STARTED|Period II - Open-label (Weeks 12-52)||63||
48182451|NCT00372060|100768278|FG001|STARTED|Period II - Open-label (Weeks 12-52)||67||
48182452|NCT00372060|100768277|FG000|COMPLETED|Period II - Open-label (Weeks 12-52)||49||
48182453|NCT00372060|100768278|FG001|COMPLETED|Period II - Open-label (Weeks 12-52)||59||
48182454|NCT00372060|100768277|FG000|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||14||
48182455|NCT00372060|100768278|FG001|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||8||
48182456|NCT01458275|100768279|FG000|STARTED|Overall Study||283||
48182457|NCT01458275|100768280|FG001|STARTED|Overall Study||282||
48182458|NCT01458275|100768281|FG002|STARTED|Overall Study||282||
48182459|NCT01458275|100768279|FG000|COMPLETED|Overall Study||269||
48182460|NCT01458275|100768280|FG001|COMPLETED|Overall Study||269||
48182461|NCT01458275|100768281|FG002|COMPLETED|Overall Study||273||
48182462|NCT01458275|100768279|FG000|NOT COMPLETED|Overall Study||14||
48182463|NCT01458275|100768280|FG001|NOT COMPLETED|Overall Study||13||
48182464|NCT01458275|100768281|FG002|NOT COMPLETED|Overall Study||9||
48182465|NCT01923389|100768282|FG000|STARTED|Overall Study||2||
48182466|NCT01923389|100768283|FG001|STARTED|Overall Study||2||
48182467|NCT01923389|100768282|FG000|COMPLETED|Overall Study||1||
48182468|NCT01923389|100768283|FG001|COMPLETED|Overall Study||2||
48182469|NCT01923389|100768282|FG000|NOT COMPLETED|Overall Study||1||
48182470|NCT01923389|100768283|FG001|NOT COMPLETED|Overall Study||0||
48182471|NCT01930643|100768284|FG000|STARTED|Overall Study||7||
48182472|NCT01930643|100768285|FG001|STARTED|Overall Study||6||
48182473|NCT01930643|100768284|FG000|COMPLETED|Overall Study||7||
48182474|NCT01930643|100768285|FG001|COMPLETED|Overall Study||6||
48182475|NCT01930643|100768284|FG000|NOT COMPLETED|Overall Study||0||
48182476|NCT01930643|100768285|FG001|NOT COMPLETED|Overall Study||0||
48182477|NCT02682563|100768286|FG000|STARTED|Overall Study||24||
48182478|NCT02682563|100768287|FG001|STARTED|Overall Study||20||
48182479|NCT02682563|100768286|FG000|COMPLETED|Overall Study||24||
48182480|NCT02682563|100768287|FG001|COMPLETED|Overall Study||20||
48182481|NCT02682563|100768286|FG000|NOT COMPLETED|Overall Study||0||
48182482|NCT02682563|100768287|FG001|NOT COMPLETED|Overall Study||0||
48182483|NCT00678444|100768288|FG000|STARTED|Overall Study||100||
48182484|NCT00678444|100768289|FG001|STARTED|Overall Study||99||
48633911|NCT00300053|101888803|FG002|NOT COMPLETED|Overall Study||6||
48633912|NCT01654887|101888804|FG000|STARTED|Overall Study||103||
48633913|NCT01654887|101888805|FG001|STARTED|Overall Study||88||
48633914|NCT01654887|101888804|FG000|COMPLETED|Overall Study||103||
48633915|NCT01654887|101888805|FG001|COMPLETED|Overall Study||88||
48633916|NCT01654887|101888804|FG000|NOT COMPLETED|Overall Study||0||
48182485|NCT00678444|100768288|FG000|COMPLETED|Overall Study||100||
48633917|NCT01654887|101888805|FG001|NOT COMPLETED|Overall Study||0||
48633918|NCT04056468|101888806|FG000|STARTED|Overall Study||8||
48182486|NCT00678444|100768289|FG001|COMPLETED|Overall Study||99||
48182487|NCT00678444|100768288|FG000|NOT COMPLETED|Overall Study||0||
48633919|NCT04056468|101888807|FG001|STARTED|Overall Study||8||
48633920|NCT04056468|101888808|FG002|STARTED|Overall Study||8||
48633921|NCT04056468|101888806|FG000|COMPLETED|Overall Study||8||
48182488|NCT00678444|100768289|FG001|NOT COMPLETED|Overall Study||0||
48182489|NCT00513019|100768290|FG000|STARTED|Overall Study||17||
48182490|NCT00513019|100768291|FG001|STARTED|Overall Study||18||
48182491|NCT00513019|100768290|FG000|COMPLETED|Overall Study||12||
48182492|NCT00513019|100768291|FG001|COMPLETED|Overall Study||13||
48182493|NCT00513019|100768290|FG000|NOT COMPLETED|Overall Study||5||
48182494|NCT00513019|100768291|FG001|NOT COMPLETED|Overall Study||5||
48182495|NCT02337361|100768292|FG000|STARTED|Baseline Assessment||99||
48182496|NCT02337361|100768293|FG001|STARTED|Baseline Assessment||86||
48633922|NCT04056468|101888807|FG001|COMPLETED|Overall Study||8||
48182497|NCT02337361|100768292|FG000|COMPLETED|Baseline Assessment||99||
48182498|NCT02337361|100768293|FG001|COMPLETED|Baseline Assessment||86||
48182499|NCT02337361|100768292|FG000|NOT COMPLETED|Baseline Assessment||0||
48182500|NCT02337361|100768293|FG001|NOT COMPLETED|Baseline Assessment||0||
48182501|NCT02337361|100768292|FG000|STARTED|3-month Follow-up||99||
48182502|NCT02337361|100768293|FG001|STARTED|3-month Follow-up||86||
48182503|NCT02337361|100768292|FG000|COMPLETED|3-month Follow-up||80||
48182504|NCT02337361|100768293|FG001|COMPLETED|3-month Follow-up||72||
48182505|NCT02337361|100768292|FG000|NOT COMPLETED|3-month Follow-up||19||
48182506|NCT02337361|100768293|FG001|NOT COMPLETED|3-month Follow-up||14||
48182507|NCT02337361|100768292|FG000|STARTED|6-month Follow-up||80||
48182508|NCT02337361|100768293|FG001|STARTED|6-month Follow-up||72||
48182509|NCT02337361|100768292|FG000|COMPLETED|6-month Follow-up||78||
48182510|NCT02337361|100768293|FG001|COMPLETED|6-month Follow-up||68||
48182511|NCT02337361|100768292|FG000|NOT COMPLETED|6-month Follow-up||2||
48182512|NCT02337361|100768293|FG001|NOT COMPLETED|6-month Follow-up||4||
48182513|NCT02930122|100768294|FG000|STARTED|Overall Study||3||
48182514|NCT02930122|100768295|FG001|STARTED|Overall Study||3||
48182515|NCT02930122|100768294|FG000|COMPLETED|Overall Study||0||
48182516|NCT02930122|100768295|FG001|COMPLETED|Overall Study||0||
48182517|NCT02930122|100768294|FG000|NOT COMPLETED|Overall Study||3||
48182518|NCT02930122|100768295|FG001|NOT COMPLETED|Overall Study||3||
48182519|NCT02216422|100768296|FG000|STARTED|Overall Study||36||
48182520|NCT02216422|100768296|FG000|COMPLETED|Overall Study||36||
48182521|NCT02216422|100768296|FG000|NOT COMPLETED|Overall Study||0||
48182522|NCT02766673|100768297|FG000|STARTED|Overall Study||4||
48182523|NCT02766673|100768298|FG001|STARTED|Overall Study||4||
48182524|NCT02766673|100768299|FG002|STARTED|Overall Study||4||
48182525|NCT02766673|100768300|FG003|STARTED|Overall Study||4||
48182526|NCT02766673|100768301|FG004|STARTED|Overall Study||4||
48182527|NCT02766673|100768302|FG005|STARTED|Overall Study||4||
48343190|NCT01889602|101167724|FG002|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0||
48343191|NCT01889602|101167722|FG000|STARTED|Second Intervention||19||
48343192|NCT01889602|101167723|FG001|STARTED|Second Intervention||17||
48343193|NCT01889602|101167724|FG002|STARTED|Second Intervention||18||
48343194|NCT01889602|101167722|FG000|COMPLETED|Second Intervention||18||
48343195|NCT01889602|101167723|FG001|COMPLETED|Second Intervention||17||
48343196|NCT01889602|101167724|FG002|COMPLETED|Second Intervention||16||
48343197|NCT01889602|101167722|FG000|NOT COMPLETED|Second Intervention||1||
48343198|NCT01889602|101167723|FG001|NOT COMPLETED|Second Intervention||0||
48343199|NCT01889602|101167724|FG002|NOT COMPLETED|Second Intervention||2||
48343200|NCT01889602|101167722|FG000|STARTED|Second Washout Period of at Least 2 Week||18||
48343201|NCT01889602|101167723|FG001|STARTED|Second Washout Period of at Least 2 Week||17||
48343202|NCT01889602|101167724|FG002|STARTED|Second Washout Period of at Least 2 Week||16||
48343203|NCT01889602|101167722|FG000|COMPLETED|Second Washout Period of at Least 2 Week||18||
48343204|NCT01889602|101167723|FG001|COMPLETED|Second Washout Period of at Least 2 Week||17||
48343205|NCT01889602|101167724|FG002|COMPLETED|Second Washout Period of at Least 2 Week||16||
48343206|NCT01889602|101167722|FG000|NOT COMPLETED|Second Washout Period of at Least 2 Week||0||
48343207|NCT01889602|101167723|FG001|NOT COMPLETED|Second Washout Period of at Least 2 Week||0||
48343208|NCT01889602|101167724|FG002|NOT COMPLETED|Second Washout Period of at Least 2 Week||0||
48343209|NCT01889602|101167722|FG000|STARTED|Third Intervention||18||
48343210|NCT01889602|101167723|FG001|STARTED|Third Intervention||17||
48343211|NCT01889602|101167724|FG002|STARTED|Third Intervention||16||
48343212|NCT01889602|101167722|FG000|COMPLETED|Third Intervention||15||
48343213|NCT01889602|101167723|FG001|COMPLETED|Third Intervention||15||
48343214|NCT01889602|101167724|FG002|COMPLETED|Third Intervention||16||
48343215|NCT01889602|101167722|FG000|NOT COMPLETED|Third Intervention||3||
48343216|NCT01889602|101167723|FG001|NOT COMPLETED|Third Intervention||2||
48343217|NCT01889602|101167724|FG002|NOT COMPLETED|Third Intervention||0||
48343218|NCT01889602|101167722|FG000|STARTED|Third Washout Period of at Least 2 Weeks||15||
48343219|NCT01889602|101167723|FG001|STARTED|Third Washout Period of at Least 2 Weeks||15||
48343220|NCT01889602|101167724|FG002|STARTED|Third Washout Period of at Least 2 Weeks||16||
48343221|NCT01889602|101167722|FG000|COMPLETED|Third Washout Period of at Least 2 Weeks||15||
48343222|NCT01889602|101167723|FG001|COMPLETED|Third Washout Period of at Least 2 Weeks||15||
48343223|NCT01889602|101167724|FG002|COMPLETED|Third Washout Period of at Least 2 Weeks||16||
48343224|NCT01889602|101167722|FG000|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0||
48182528|NCT02766673|100768297|FG000|COMPLETED|Overall Study||3||
48182529|NCT02766673|100768298|FG001|COMPLETED|Overall Study||4||
48182530|NCT02766673|100768299|FG002|COMPLETED|Overall Study||4||
48182531|NCT02766673|100768300|FG003|COMPLETED|Overall Study||4||
48182532|NCT02766673|100768301|FG004|COMPLETED|Overall Study||4||
48182533|NCT02766673|100768302|FG005|COMPLETED|Overall Study||3||
48182534|NCT02766673|100768297|FG000|NOT COMPLETED|Overall Study||1||
48182535|NCT02766673|100768298|FG001|NOT COMPLETED|Overall Study||0||
48182536|NCT02766673|100768299|FG002|NOT COMPLETED|Overall Study||0||
48182537|NCT02766673|100768300|FG003|NOT COMPLETED|Overall Study||0||
48182538|NCT02766673|100768301|FG004|NOT COMPLETED|Overall Study||0||
48182539|NCT02766673|100768302|FG005|NOT COMPLETED|Overall Study||1||
48343225|NCT01889602|101167723|FG001|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0||
48343226|NCT01889602|101167724|FG002|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0||
48343227|NCT00709202|101167725|FG000|STARTED|Overall Study||19||
48343228|NCT00709202|101167726|FG001|STARTED|Overall Study||21||
48343229|NCT00709202|101167725|FG000|COMPLETED|Overall Study||13||
48343230|NCT00709202|101167726|FG001|COMPLETED|Overall Study||15||
48343231|NCT00709202|101167725|FG000|NOT COMPLETED|Overall Study||6||
48343232|NCT00709202|101167726|FG001|NOT COMPLETED|Overall Study||6||
48343233|NCT00607048|101167727|FG000|STARTED|Overall Study||3||
48343234|NCT00607048|101167728|FG001|STARTED|Overall Study||6||
48182540|NCT02949518|100768303|FG000|STARTED|Overall Study||28||
48182541|NCT02949518|100768304|FG001|STARTED|Overall Study||28||
48182542|NCT02949518|100768303|FG000|COMPLETED|Overall Study||25||
48182543|NCT02949518|100768304|FG001|COMPLETED|Overall Study||26||
48182544|NCT02949518|100768303|FG000|NOT COMPLETED|Overall Study||3||
48182545|NCT02949518|100768304|FG001|NOT COMPLETED|Overall Study||2||
48182546|NCT00479674|100768305|FG000|STARTED|Overall Study||41||
48182547|NCT00479674|100768305|FG000|COMPLETED|Overall Study||0||
48182548|NCT00479674|100768305|FG000|NOT COMPLETED|Overall Study||41||
48182549|NCT03053492|100768306|FG000|STARTED|Overall Study||33||
48182550|NCT03053492|100768307|FG001|STARTED|Overall Study||33||
48182551|NCT03053492|100768306|FG000|COMPLETED|Overall Study||25||
48182552|NCT03053492|100768307|FG001|COMPLETED|Overall Study||27||
48182553|NCT03053492|100768306|FG000|NOT COMPLETED|Overall Study||8||
48182554|NCT03053492|100768307|FG001|NOT COMPLETED|Overall Study||6||
48182555|NCT00956540|100768308|FG000|STARTED|Overall Study||54||
48182556|NCT00956540|100768309|FG001|STARTED|Overall Study||50||
48182557|NCT00956540|100768310|FG002|STARTED|Overall Study||46||
48182558|NCT00956540|100768311|FG003|STARTED|Overall Study||45||
48182559|NCT00956540|100768308|FG000|COMPLETED|Overall Study||51||
48182560|NCT00956540|100768309|FG001|COMPLETED|Overall Study||46||
48414269|NCT03756285|101345991|FG000|COMPLETED|Overall Study||24||
48414270|NCT03756285|101345992|FG001|COMPLETED|Overall Study||9||
48414271|NCT03756285|101345991|FG000|NOT COMPLETED|Overall Study||3||
48414272|NCT03756285|101345992|FG001|NOT COMPLETED|Overall Study||5||
48414273|NCT00942422|101345993|FG000|STARTED|Overall Study||8||
48414274|NCT00942422|101345993|FG000|COMPLETED|Overall Study||5||
48414275|NCT00942422|101345993|FG000|NOT COMPLETED|Overall Study||3||
48414276|NCT00939341|101345994|FG000|STARTED|Overall Study||862||
48414277|NCT00939341|101345994|FG000|COMPLETED|Overall Study||796||
48633923|NCT04056468|101888808|FG002|COMPLETED|Overall Study||8||
48182561|NCT00956540|100768310|FG002|COMPLETED|Overall Study||43||
48182562|NCT00956540|100768311|FG003|COMPLETED|Overall Study||41||
48182563|NCT00956540|100768308|FG000|NOT COMPLETED|Overall Study||3||
48182564|NCT00956540|100768309|FG001|NOT COMPLETED|Overall Study||4||
48182565|NCT00956540|100768310|FG002|NOT COMPLETED|Overall Study||3||
48182566|NCT00956540|100768311|FG003|NOT COMPLETED|Overall Study||4||
48182567|NCT02360774|100768312|FG000|STARTED|Overall Study||15||
48182568|NCT02360774|100768313|FG001|STARTED|Overall Study||15||
48182569|NCT02360774|100768312|FG000|COMPLETED|Overall Study||12||
48182570|NCT02360774|100768313|FG001|COMPLETED|Overall Study||13||
48182571|NCT02360774|100768312|FG000|NOT COMPLETED|Overall Study||3||
48182572|NCT02360774|100768313|FG001|NOT COMPLETED|Overall Study||2||
48182573|NCT02176928|100768314|FG000|STARTED|Overall Study||21||
48182574|NCT02176928|100768315|FG001|STARTED|Overall Study||21||
48182575|NCT02176928|100768314|FG000|COMPLETED|Overall Study||19||
48343235|NCT00607048|101167729|FG002|STARTED|Overall Study||7||
48343236|NCT00607048|101167730|FG003|STARTED|Overall Study||3||
48343237|NCT00607048|101167731|FG004|STARTED|Overall Study||6||
48343238|NCT00607048|101167732|FG005|STARTED|Overall Study||7||
48414278|NCT00939341|101345994|FG000|NOT COMPLETED|Overall Study||66||
48414279|NCT02354690|101345995|FG000|STARTED|Overall Study||13||
48414280|NCT02354690|101345995|FG000|COMPLETED|Overall Study||12||
48182576|NCT02176928|100768315|FG001|COMPLETED|Overall Study||17||
48182577|NCT02176928|100768314|FG000|NOT COMPLETED|Overall Study||2||
48182578|NCT02176928|100768315|FG001|NOT COMPLETED|Overall Study||4||
48182579|NCT03712098|100768316|FG000|STARTED|Overall Study||19||
48182580|NCT03712098|100768317|FG001|STARTED|Overall Study||21||
48182581|NCT03712098|100768316|FG000|COMPLETED|Overall Study||5||
48182582|NCT03712098|100768317|FG001|COMPLETED|Overall Study||9||
48182583|NCT03712098|100768316|FG000|NOT COMPLETED|Overall Study||14||
48182584|NCT03712098|100768317|FG001|NOT COMPLETED|Overall Study||12||
48182585|NCT03523871|100768318|FG000|STARTED|Overall Study||20||
48182586|NCT03523871|100768318|FG000|COMPLETED|Overall Study||19||
48182587|NCT03523871|100768318|FG000|NOT COMPLETED|Overall Study||1||
48343239|NCT00607048|101167727|FG000|COMPLETED|Overall Study||0||
48343240|NCT00607048|101167728|FG001|COMPLETED|Overall Study||2||
48343241|NCT00607048|101167729|FG002|COMPLETED|Overall Study||3||
48343242|NCT00607048|101167730|FG003|COMPLETED|Overall Study||0||
48343243|NCT00607048|101167731|FG004|COMPLETED|Overall Study||0||
48343244|NCT00607048|101167732|FG005|COMPLETED|Overall Study||2||
48343245|NCT00607048|101167727|FG000|NOT COMPLETED|Overall Study||3||
48343246|NCT00607048|101167728|FG001|NOT COMPLETED|Overall Study||4||
48343247|NCT00607048|101167729|FG002|NOT COMPLETED|Overall Study||4||
48343248|NCT00607048|101167730|FG003|NOT COMPLETED|Overall Study||3||
48343249|NCT00607048|101167731|FG004|NOT COMPLETED|Overall Study||6||
48343250|NCT00607048|101167732|FG005|NOT COMPLETED|Overall Study||5||
48343251|NCT00480857|101167733|FG000|STARTED|Overall Study||19||
48343252|NCT00480857|101167733|FG000|COMPLETED|Overall Study||17||
48343253|NCT00480857|101167733|FG000|NOT COMPLETED|Overall Study||2||
48343254|NCT00600171|101167734|FG000|STARTED|Overall Study||102||
48343255|NCT00600171|101167735|FG001|STARTED|Overall Study||101||
48343256|NCT00600171|101167736|FG002|STARTED|Overall Study||101||
48343257|NCT00600171|101167737|FG003|STARTED|Overall Study||100||
48343258|NCT00600171|101167738|FG004|STARTED|Overall Study||101||
48343259|NCT00600171|101167739|FG005|STARTED|Overall Study||102||
48343260|NCT00600171|101167734|FG000|COMPLETED|Overall Study||86||
48343261|NCT00600171|101167735|FG001|COMPLETED|Overall Study||84||
48756830|NCT05482308|102191341|FG001|COMPLETED|Overall Study||5||
48756831|NCT05482308|102191340|FG000|NOT COMPLETED|Overall Study||1||
48756832|NCT05482308|102191341|FG001|NOT COMPLETED|Overall Study||1||
48756833|NCT05288816|102191342|FG000|STARTED|Overall Study||4||
48756834|NCT05288816|102191343|FG001|STARTED|Overall Study||4||
48756835|NCT05288816|102191344|FG002|STARTED|Overall Study||8||
48756836|NCT05288816|102191342|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4||
48756837|NCT05288816|102191343|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4||
48756838|NCT05288816|102191344|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8||
48756839|NCT05288816|102191342|FG000|COMPLETED|Overall Study||4||
48756840|NCT05288816|102191343|FG001|COMPLETED|Overall Study||4||
48756841|NCT05288816|102191344|FG002|COMPLETED|Overall Study||8||
48756842|NCT05288816|102191342|FG000|NOT COMPLETED|Overall Study||0||
48756843|NCT05288816|102191343|FG001|NOT COMPLETED|Overall Study||0||
48756844|NCT05288816|102191344|FG002|NOT COMPLETED|Overall Study||0||
48756845|NCT00005906|102191345|FG000|STARTED|Overall Study||4||
48756846|NCT00005906|102191345|FG000|COMPLETED|Overall Study||1||
48756847|NCT00005906|102191345|FG000|NOT COMPLETED|Overall Study||3||
48756848|NCT00178477|102191346|FG000|STARTED|Overall Study||10||
48756849|NCT00178477|102191346|FG000|COMPLETED|Overall Study||5||
48756850|NCT00178477|102191346|FG000|NOT COMPLETED|Overall Study||5||
48756851|NCT03726489|102191347|FG000|STARTED|Overall Study||390||
48756852|NCT03726489|102191348|FG001|STARTED|Overall Study||393||
48756853|NCT03726489|102191347|FG000|Received Phototherapy|Overall Study||232|Subjects who initiated phototherapy|
48756854|NCT03726489|102191348|FG001|Received Phototherapy|Overall Study||309|Subjects who initiated phototherapy|
48756855|NCT03726489|102191347|FG000|DLQI Assessed|Overall Study||252|Includes subjects who completed DLQI before or within assessment window.|
48756856|NCT03726489|102191348|FG001|DLQI Assessed|Overall Study||308|Includes subjects who completed DLQI before or within assessment window.|
48756857|NCT03726489|102191347|FG000|PGA Assessed|Overall Study||217||
48756858|NCT03726489|102191348|FG001|PGA Assessed|Overall Study||255||
48756859|NCT03726489|102191347|FG000|COMPLETED|Overall Study||390|Includes subjects who withdrew prior to Week 12, who are included in the analysis as non-responders|
48756860|NCT03726489|102191348|FG001|COMPLETED|Overall Study||393|Includes subjects who withdrew prior to Week 12, who are included in the analysis as non-responders|
48756861|NCT03726489|102191347|FG000|NOT COMPLETED|Overall Study||0||
48756862|NCT03726489|102191348|FG001|NOT COMPLETED|Overall Study||0||
48756863|NCT00671658|102191349|FG000|STARTED|Overall Study||220||
48756864|NCT00671658|102191349|FG000|COMPLETED|Overall Study||215||
48756865|NCT00671658|102191349|FG000|NOT COMPLETED|Overall Study||5||
48756866|NCT02780401|102191350|FG000|STARTED|Overall Study||10||
48756867|NCT02780401|102191351|FG001|STARTED|Overall Study||12||
48756868|NCT02780401|102191352|FG002|STARTED|Overall Study||10||
48756869|NCT02780401|102191350|FG000|COMPLETED|Overall Study||10||
48756870|NCT02780401|102191351|FG001|COMPLETED|Overall Study||10||
48756871|NCT02780401|102191352|FG002|COMPLETED|Overall Study||10||
48756872|NCT02780401|102191350|FG000|NOT COMPLETED|Overall Study||0||
48756873|NCT02780401|102191351|FG001|NOT COMPLETED|Overall Study||2||
48756874|NCT02780401|102191352|FG002|NOT COMPLETED|Overall Study||0||
48756875|NCT00837252|102191353|FG000|STARTED|Overall Study||5||
48756876|NCT00837252|102191353|FG000|COMPLETED|Overall Study||5||
48756877|NCT00837252|102191353|FG000|NOT COMPLETED|Overall Study||0||
48343262|NCT00600171|101167736|FG002|COMPLETED|Overall Study||91||
48343263|NCT00600171|101167737|FG003|COMPLETED|Overall Study||88||
48343264|NCT00600171|101167738|FG004|COMPLETED|Overall Study||93||
48343265|NCT00600171|101167739|FG005|COMPLETED|Overall Study||97||
48343266|NCT00600171|101167734|FG000|NOT COMPLETED|Overall Study||16||
48343267|NCT00600171|101167735|FG001|NOT COMPLETED|Overall Study||17||
48343268|NCT00600171|101167736|FG002|NOT COMPLETED|Overall Study||10||
48343269|NCT00600171|101167737|FG003|NOT COMPLETED|Overall Study||12||
48343270|NCT00600171|101167738|FG004|NOT COMPLETED|Overall Study||8||
48343271|NCT00600171|101167739|FG005|NOT COMPLETED|Overall Study||5||
48343272|NCT00961961|101167740|FG000|STARTED|Phase I||177||
48343273|NCT00961961|101167741|FG001|STARTED|Phase I||0||
48343274|NCT00961961|101167742|FG002|STARTED|Phase I||0||
48343275|NCT00961961|101167743|FG003|STARTED|Phase I||0||
48343276|NCT00961961|101167740|FG000|COMPLETED|Phase I||51||
48343277|NCT00961961|101167741|FG001|COMPLETED|Phase I||0||
48343278|NCT00961961|101167742|FG002|COMPLETED|Phase I||0||
48343279|NCT00961961|101167743|FG003|COMPLETED|Phase I||0||
48343280|NCT00961961|101167740|FG000|NOT COMPLETED|Phase I||126||
48343281|NCT00961961|101167741|FG001|NOT COMPLETED|Phase I||0||
48343282|NCT00961961|101167742|FG002|NOT COMPLETED|Phase I||0||
48343283|NCT00961961|101167743|FG003|NOT COMPLETED|Phase I||0||
48343284|NCT00961961|101167740|FG000|STARTED|Phase II||0||
48343285|NCT00961961|101167741|FG001|STARTED|Phase II||0||
48343286|NCT00961961|101167742|FG002|STARTED|Phase II||29||
48343287|NCT00961961|101167743|FG003|STARTED|Phase II||22||
48343288|NCT00961961|101167740|FG000|COMPLETED|Phase II||0||
48343289|NCT00961961|101167741|FG001|COMPLETED|Phase II||0||
48343290|NCT00961961|101167742|FG002|COMPLETED|Phase II||17||
48343291|NCT00961961|101167743|FG003|COMPLETED|Phase II||14||
48343292|NCT00961961|101167740|FG000|NOT COMPLETED|Phase II||0||
48343293|NCT00961961|101167741|FG001|NOT COMPLETED|Phase II||0||
48343294|NCT00961961|101167742|FG002|NOT COMPLETED|Phase II||12||
48343295|NCT00961961|101167743|FG003|NOT COMPLETED|Phase II||8||
48343296|NCT01365156|101167744|FG000|STARTED|Overall Study||14||
48343297|NCT01365156|101167745|FG001|STARTED|Overall Study||14||
48343298|NCT01365156|101167744|FG000|COMPLETED|Overall Study||14||
48343299|NCT01365156|101167745|FG001|COMPLETED|Overall Study||14||
48343300|NCT01365156|101167744|FG000|NOT COMPLETED|Overall Study||0||
48343301|NCT01365156|101167745|FG001|NOT COMPLETED|Overall Study||0||
48343302|NCT01661790|101167746|FG000|STARTED|Overall Study||36||
48343303|NCT01661790|101167747|FG001|STARTED|Overall Study||36||
48343304|NCT01661790|101167746|FG000|COMPLETED|Overall Study||36||
48343305|NCT01661790|101167747|FG001|COMPLETED|Overall Study||34||
48756878|NCT04951115|102191354|FG000|STARTED|Overall Study||6||
48756879|NCT04951115|102191354|FG000|COMPLETED|Overall Study||5||
48756880|NCT04951115|102191354|FG000|NOT COMPLETED|Overall Study||1||
48756881|NCT01924845|102191355|FG000|STARTED|Overall Study||24||
48756882|NCT01924845|102191355|FG000|COMPLETED|Overall Study||18||
48756883|NCT01924845|102191355|FG000|NOT COMPLETED|Overall Study||6||
48756884|NCT01364896|102191356|FG000|STARTED|Overall Study||46||
48756885|NCT01364896|102191356|FG000|COMPLETED|Overall Study||46||
48756886|NCT01364896|102191356|FG000|NOT COMPLETED|Overall Study||0||
48756887|NCT04416204|102191357|FG000|STARTED|First Visit||6||
48756888|NCT04416204|102191358|FG001|STARTED|First Visit||8||
48756889|NCT04416204|102191359|FG002|STARTED|First Visit||7||
48756890|NCT04416204|102191360|FG003|STARTED|First Visit||8||
48756891|NCT04416204|102191357|FG000|COMPLETED|First Visit||6||
48756892|NCT04416204|102191358|FG001|COMPLETED|First Visit||8||
48756893|NCT04416204|102191359|FG002|COMPLETED|First Visit||7||
48756894|NCT04416204|102191360|FG003|COMPLETED|First Visit||8||
48756895|NCT04416204|102191357|FG000|NOT COMPLETED|First Visit||0||
48756896|NCT04416204|102191358|FG001|NOT COMPLETED|First Visit||0||
48756897|NCT04416204|102191359|FG002|NOT COMPLETED|First Visit||0||
48343306|NCT01661790|101167746|FG000|NOT COMPLETED|Overall Study||0||
48343307|NCT01661790|101167747|FG001|NOT COMPLETED|Overall Study||2||
48756898|NCT04416204|102191360|FG003|NOT COMPLETED|First Visit||0||
48756899|NCT04416204|102191357|FG000|STARTED|Washout (3-6 Weeks)||6||
48756900|NCT04416204|102191358|FG001|STARTED|Washout (3-6 Weeks)||8||
48756901|NCT04416204|102191359|FG002|STARTED|Washout (3-6 Weeks)||7||
48756902|NCT04416204|102191360|FG003|STARTED|Washout (3-6 Weeks)||8||
48756903|NCT04416204|102191357|FG000|COMPLETED|Washout (3-6 Weeks)||5||
48756904|NCT04416204|102191358|FG001|COMPLETED|Washout (3-6 Weeks)||8||
48343308|NCT01856114|101167748|FG000|STARTED|Overall Study||11||
48343309|NCT01856114|101167749|FG001|STARTED|Overall Study||11||
48343310|NCT01856114|101167748|FG000|COMPLETED|Overall Study||9||
48343311|NCT01856114|101167749|FG001|COMPLETED|Overall Study||11||
48343312|NCT01856114|101167748|FG000|NOT COMPLETED|Overall Study||2||
48756905|NCT04416204|102191359|FG002|COMPLETED|Washout (3-6 Weeks)||6||
48756906|NCT04416204|102191360|FG003|COMPLETED|Washout (3-6 Weeks)||7||
48756907|NCT04416204|102191357|FG000|NOT COMPLETED|Washout (3-6 Weeks)||1||
48756908|NCT04416204|102191358|FG001|NOT COMPLETED|Washout (3-6 Weeks)||0||
48756909|NCT04416204|102191359|FG002|NOT COMPLETED|Washout (3-6 Weeks)||1||
48756910|NCT04416204|102191360|FG003|NOT COMPLETED|Washout (3-6 Weeks)||1||
48756911|NCT04416204|102191357|FG000|STARTED|Second Visit||5||
48343313|NCT01856114|101167749|FG001|NOT COMPLETED|Overall Study||0||
48343314|NCT00611247|101167750|FG000|STARTED|Overall Study||5||
48343315|NCT00611247|101167751|FG001|STARTED|Overall Study||31||
48343316|NCT00611247|101167750|FG000|COMPLETED|Overall Study||3||
48414281|NCT02354690|101345995|FG000|NOT COMPLETED|Overall Study||1||
48414282|NCT01104922|101345996|FG000|STARTED|Overall Study||48||
48414283|NCT01104922|101345996|FG000|COMPLETED|Overall Study||48||
48414284|NCT01104922|101345996|FG000|NOT COMPLETED|Overall Study||0||
48414285|NCT03198728|101345997|FG000|STARTED|Overall Study||214||
48414286|NCT03198728|101345998|FG001|STARTED|Overall Study||100||
48756912|NCT04416204|102191358|FG001|STARTED|Second Visit||8||
48756913|NCT04416204|102191359|FG002|STARTED|Second Visit||6||
48756914|NCT04416204|102191360|FG003|STARTED|Second Visit||7||
48756915|NCT04416204|102191357|FG000|COMPLETED|Second Visit||5||
48756916|NCT04416204|102191358|FG001|COMPLETED|Second Visit||8||
48756917|NCT04416204|102191359|FG002|COMPLETED|Second Visit||6||
48756918|NCT04416204|102191360|FG003|COMPLETED|Second Visit||7||
48756919|NCT04416204|102191357|FG000|NOT COMPLETED|Second Visit||0||
48756920|NCT04416204|102191358|FG001|NOT COMPLETED|Second Visit||0||
48756921|NCT04416204|102191359|FG002|NOT COMPLETED|Second Visit||0||
48756922|NCT04416204|102191360|FG003|NOT COMPLETED|Second Visit||0||
48756923|NCT03402217|102191361|FG000|STARTED|Overall Study||20||
48756924|NCT03402217|102191361|FG000|COMPLETED|Overall Study||19||
48756925|NCT03402217|102191361|FG000|NOT COMPLETED|Overall Study||1||
48756926|NCT05460754|102191362|FG000|STARTED|Overall Study||5||
48756927|NCT05460754|102191363|FG001|STARTED|Overall Study||5||
48756928|NCT05460754|102191362|FG000|COMPLETED|Overall Study||5||
48756929|NCT05460754|102191363|FG001|COMPLETED|Overall Study||5||
48756930|NCT05460754|102191362|FG000|NOT COMPLETED|Overall Study||0||
48756931|NCT05460754|102191363|FG001|NOT COMPLETED|Overall Study||0||
48756932|NCT02498925|102191364|FG000|STARTED|Overall Study||39||
48756933|NCT02498925|102191365|FG001|STARTED|Overall Study||41||
48756934|NCT02498925|102191364|FG000|COMPLETED|Overall Study||34||
48756935|NCT02498925|102191365|FG001|COMPLETED|Overall Study||35||
48756936|NCT02498925|102191364|FG000|NOT COMPLETED|Overall Study||5||
48414287|NCT03198728|101345997|FG000|COMPLETED|Overall Study||162|Day 365. Five subjects withdrew from treatment or were lost to follow up after Day 365|
48414288|NCT03198728|101345998|FG001|COMPLETED|Overall Study||76|Day 365. Five subjects withdrew from treatment or were lost to follow up after Day 365|
48414289|NCT03198728|101345997|FG000|NOT COMPLETED|Overall Study||52||
48756937|NCT02498925|102191365|FG001|NOT COMPLETED|Overall Study||6||
48756938|NCT01710345|102191366|FG000|STARTED|Overall Study||40||
48756939|NCT01710345|102191367|FG001|STARTED|Overall Study||40||
48756940|NCT01710345|102191368|FG002|STARTED|Overall Study||20||
48756941|NCT01710345|102191366|FG000|COMPLETED|Overall Study||37||
48756942|NCT01710345|102191367|FG001|COMPLETED|Overall Study||35||
48756943|NCT01710345|102191368|FG002|COMPLETED|Overall Study||19||
48756944|NCT01710345|102191366|FG000|NOT COMPLETED|Overall Study||3||
48756945|NCT01710345|102191367|FG001|NOT COMPLETED|Overall Study||5||
48756946|NCT01710345|102191368|FG002|NOT COMPLETED|Overall Study||1||
48756947|NCT01766050|102191369|FG000|STARTED|Overall Study||22||
48756948|NCT01766050|102191369|FG000|COMPLETED|Overall Study||18||
48756949|NCT01766050|102191369|FG000|NOT COMPLETED|Overall Study||4||
48756950|NCT02654782|102191370|FG000|STARTED|Overall Study||5||
48756951|NCT02654782|102191371|FG001|STARTED|Overall Study||5||
48756952|NCT02654782|102191370|FG000|COMPLETED|Overall Study||5||
48756953|NCT02654782|102191371|FG001|COMPLETED|Overall Study||5||
48756954|NCT02654782|102191370|FG000|NOT COMPLETED|Overall Study||0||
48756955|NCT02654782|102191371|FG001|NOT COMPLETED|Overall Study||0||
48756956|NCT02228681|102191372|FG000|STARTED|Overall Study||37||
48756957|NCT02228681|102191373|FG001|STARTED|Overall Study||37||
48756958|NCT02228681|102191372|FG000|COMPLETED|Overall Study||37||
48756959|NCT02228681|102191373|FG001|COMPLETED|Overall Study||37||
48756960|NCT02228681|102191372|FG000|NOT COMPLETED|Overall Study||0||
48756961|NCT02228681|102191373|FG001|NOT COMPLETED|Overall Study||0||
48756962|NCT01003301|102191374|FG000|STARTED|Overall Study||10||
48756963|NCT01003301|102191375|FG001|STARTED|Overall Study||9||
48756964|NCT01003301|102191374|FG000|COMPLETED|Overall Study||10||
48756965|NCT01003301|102191375|FG001|COMPLETED|Overall Study||9||
48756966|NCT01003301|102191374|FG000|NOT COMPLETED|Overall Study||0||
48756967|NCT01003301|102191375|FG001|NOT COMPLETED|Overall Study||0||
48414290|NCT03198728|101345998|FG001|NOT COMPLETED|Overall Study||24||
48414291|NCT02994927|101345999|FG000|STARTED|Overall Study||165||
48414292|NCT02994927|101346000|FG001|STARTED|Overall Study||166||
48414293|NCT02994927|101345999|FG000|COMPLETED|Overall Study||150||
48756968|NCT03737123|102194204|FG000|STARTED|Study Treatment||6||
48414294|NCT02994927|101346000|FG001|COMPLETED|Overall Study||151||
48414295|NCT02994927|101345999|FG000|NOT COMPLETED|Overall Study||15||
48414296|NCT02994927|101346000|FG001|NOT COMPLETED|Overall Study||15||
48756969|NCT03737123|102194205|FG001|STARTED|Study Treatment||0||
48756970|NCT03737123|102194204|FG000|COMPLETED|Study Treatment||0||
48756971|NCT03737123|102194205|FG001|COMPLETED|Study Treatment||0||
48756972|NCT03737123|102194204|FG000|NOT COMPLETED|Study Treatment||6||
48756973|NCT03737123|102194205|FG001|NOT COMPLETED|Study Treatment||0||
48756974|NCT03737123|102194204|FG000|STARTED|Follow up||6|Treatment and Follow up both are at different time period. Therefore, the number of subjects to start follow up is not equal to the number of subjects who have completed treatment.|
48756975|NCT03737123|102194205|FG001|STARTED|Follow up||0|Treatment and Follow up both are at different time period. Therefore, the number of subjects to start follow up is not equal to the number of subjects who have completed treatment.|
48633924|NCT04056468|101888806|FG000|NOT COMPLETED|Overall Study||0||
48182588|NCT00479037|100768319|FG000|STARTED|Overall Study||41||
48182589|NCT00479037|100768320|FG001|STARTED|Overall Study||40||
48182590|NCT00479037|100768319|FG000|COMPLETED|Overall Study||38||
48182591|NCT00479037|100768320|FG001|COMPLETED|Overall Study||34||
48182592|NCT00479037|100768319|FG000|NOT COMPLETED|Overall Study||3||
48182593|NCT00479037|100768320|FG001|NOT COMPLETED|Overall Study||6||
48182594|NCT03119571|100768321|FG000|STARTED|Overall Study||31||
48182595|NCT03119571|100768322|FG001|STARTED|Overall Study||34||
48182596|NCT03119571|100768321|FG000|COMPLETED|Overall Study||31||
48182597|NCT03119571|100768322|FG001|COMPLETED|Overall Study||34||
48182598|NCT03119571|100768321|FG000|NOT COMPLETED|Overall Study||0||
48182599|NCT03119571|100768322|FG001|NOT COMPLETED|Overall Study||0||
48182600|NCT00262743|100768323|FG000|STARTED|Overall Study||27||
48182601|NCT00262743|100768324|FG001|STARTED|Overall Study||42||
48182602|NCT00262743|100768323|FG000|COMPLETED|Overall Study||27||
48182603|NCT00262743|100768324|FG001|COMPLETED|Overall Study||30||
48182604|NCT00262743|100768323|FG000|NOT COMPLETED|Overall Study||0||
48182605|NCT00262743|100768324|FG001|NOT COMPLETED|Overall Study||12||
48182606|NCT00280293|100768325|FG000|STARTED|Overall Study||55||
48182607|NCT00280293|100768326|FG001|STARTED|Overall Study||57||
48182608|NCT00280293|100768325|FG000|COMPLETED|Overall Study||29||
48182609|NCT00280293|100768326|FG001|COMPLETED|Overall Study||34||
48182610|NCT00280293|100768325|FG000|NOT COMPLETED|Overall Study||26||
48182611|NCT00280293|100768326|FG001|NOT COMPLETED|Overall Study||23||
48182612|NCT00802737|100768327|FG000|STARTED|Overall Study||17||
48182613|NCT00802737|100768328|FG001|STARTED|Overall Study||11||
48182614|NCT00802737|100768329|FG002|STARTED|Overall Study||1||
48182615|NCT00802737|100768327|FG000|COMPLETED|Overall Study||0||
48182616|NCT00802737|100768328|FG001|COMPLETED|Overall Study||0||
48182617|NCT00802737|100768329|FG002|COMPLETED|Overall Study||0||
48182618|NCT00802737|100768327|FG000|NOT COMPLETED|Overall Study||17||
48182619|NCT00802737|100768328|FG001|NOT COMPLETED|Overall Study||11||
48182620|NCT00802737|100768329|FG002|NOT COMPLETED|Overall Study||1||
48182621|NCT04467840|100768330|FG000|STARTED|Overall Study||237|ITT populaion|
48182622|NCT04467840|100768331|FG001|STARTED|Overall Study||238|ITT populaion|
48182623|NCT04467840|100768330|FG000|mITT Population|Overall Study||230||
48182624|NCT04467840|100768331|FG001|mITT Population|Overall Study||233||
48182625|NCT04467840|100768330|FG000|COMPLETED|Overall Study||186||
48182626|NCT04467840|100768331|FG001|COMPLETED|Overall Study||186||
48182627|NCT04467840|100768330|FG000|NOT COMPLETED|Overall Study||51||
48182628|NCT04467840|100768331|FG001|NOT COMPLETED|Overall Study||52||
48182629|NCT00750893|100768332|FG000|STARTED|Overall Study||3111||
48182630|NCT00750893|100768332|FG000|COMPLETED|Overall Study||2569||
48182631|NCT00750893|100768332|FG000|NOT COMPLETED|Overall Study||542||
48182632|NCT00777803|100768333|FG000|STARTED|Overall Study||284||
48182633|NCT00777803|100768334|FG001|STARTED|Overall Study||97||
48182634|NCT00777803|100768333|FG000|COMPLETED|Overall Study||269||
48182635|NCT00777803|100768334|FG001|COMPLETED|Overall Study||90||
48182636|NCT00777803|100768333|FG000|NOT COMPLETED|Overall Study||15||
48182637|NCT00777803|100768334|FG001|NOT COMPLETED|Overall Study||7||
48182638|NCT02117544|100768335|FG000|STARTED|Period 1||54||
48182639|NCT02117544|100768336|FG001|STARTED|Period 1||55||
48756976|NCT03737123|102194204|FG000|COMPLETED|Follow up||0||
48756977|NCT03737123|102194205|FG001|COMPLETED|Follow up||0||
48756978|NCT03737123|102194204|FG000|NOT COMPLETED|Follow up||6||
48756979|NCT03737123|102194205|FG001|NOT COMPLETED|Follow up||0||
48756980|NCT04366349|102194206|FG000|STARTED|Overall Study||13||
48756981|NCT04366349|102194207|FG001|STARTED|Overall Study||18||
48756982|NCT04366349|102194208|FG002|STARTED|Overall Study||18||
48182640|NCT02117544|100768335|FG000|Treated|Period 1||52||
48182641|NCT02117544|100768336|FG001|Treated|Period 1||55||
48182642|NCT02117544|100768335|FG000|COMPLETED|Period 1||52||
48182643|NCT02117544|100768336|FG001|COMPLETED|Period 1||55||
48182644|NCT02117544|100768335|FG000|NOT COMPLETED|Period 1||2||
48182645|NCT02117544|100768336|FG001|NOT COMPLETED|Period 1||0||
48182646|NCT02117544|100768335|FG000|STARTED|Period 2||52||
48182647|NCT02117544|100768336|FG001|STARTED|Period 2||55||
48182648|NCT02117544|100768335|FG000|COMPLETED|Period 2||52||
48182649|NCT02117544|100768336|FG001|COMPLETED|Period 2||55||
48182650|NCT02117544|100768335|FG000|NOT COMPLETED|Period 2||0||
48182651|NCT02117544|100768336|FG001|NOT COMPLETED|Period 2||0||
48182652|NCT02385721|100768337|FG000|STARTED|Overall Study||601||
48182653|NCT02385721|100768337|FG000|COMPLETED|Overall Study||371||
48182654|NCT02385721|100768337|FG000|NOT COMPLETED|Overall Study||230||
48182655|NCT00658697|100768338|FG000|STARTED|Overall Study||41||
48182656|NCT00658697|100768338|FG000|COMPLETED|Overall Study||41||
48182657|NCT00658697|100768338|FG000|NOT COMPLETED|Overall Study||0||
48182658|NCT01305356|100768339|FG000|STARTED|Overall Study||132||
48182659|NCT01305356|100768340|FG001|STARTED|Overall Study||167||
48182660|NCT01305356|100768339|FG000|COMPLETED|Overall Study||132||
48182661|NCT01305356|100768340|FG001|COMPLETED|Overall Study||167||
48182662|NCT01305356|100768339|FG000|NOT COMPLETED|Overall Study||0||
48756983|NCT04366349|102194209|FG003|STARTED|Overall Study||4||
48756984|NCT04366349|102194210|FG004|STARTED|Overall Study||6||
48756985|NCT04366349|102194211|FG005|STARTED|Overall Study||6||
48756986|NCT04366349|102194206|FG000|COMPLETED|Overall Study||12||
48756987|NCT04366349|102194207|FG001|COMPLETED|Overall Study||18||
48182663|NCT01305356|100768340|FG001|NOT COMPLETED|Overall Study||0||
48182664|NCT00305760|100768341|FG000|STARTED|Overall Study||60||
48182665|NCT00305760|100768341|FG000|COMPLETED|Overall Study||13||
48182666|NCT00305760|100768341|FG000|NOT COMPLETED|Overall Study||47||
48182667|NCT01651403|100768342|FG000|STARTED|Double-Blind Period (Through Week 48/72)||60||
48182668|NCT01651403|100768343|FG001|STARTED|Double-Blind Period (Through Week 48/72)||30||
48182669|NCT01651403|100768342|FG000|COMPLETED|Double-Blind Period (Through Week 48/72)||56||
48182670|NCT01651403|100768343|FG001|COMPLETED|Double-Blind Period (Through Week 48/72)||25||
48182671|NCT01651403|100768342|FG000|NOT COMPLETED|Double-Blind Period (Through Week 48/72)||4||
48182672|NCT01651403|100768343|FG001|NOT COMPLETED|Double-Blind Period (Through Week 48/72)||5||
48182673|NCT01651403|100768342|FG000|STARTED|Open-Label Phase (Weeks 49/73-192)||56||
48182674|NCT01651403|100768343|FG001|STARTED|Open-Label Phase (Weeks 49/73-192)||25||
48182675|NCT01651403|100768342|FG000|COMPLETED|Open-Label Phase (Weeks 49/73-192)||35||
48182676|NCT01651403|100768343|FG001|COMPLETED|Open-Label Phase (Weeks 49/73-192)||11||
48182677|NCT01651403|100768342|FG000|NOT COMPLETED|Open-Label Phase (Weeks 49/73-192)||21||
48182678|NCT01651403|100768343|FG001|NOT COMPLETED|Open-Label Phase (Weeks 49/73-192)||14||
48182679|NCT04814342|100768344|FG000|STARTED|Overall Study||5||
48182680|NCT04814342|100768344|FG000|COMPLETED|Overall Study||5||
48182681|NCT04814342|100768344|FG000|NOT COMPLETED|Overall Study||0||
48182682|NCT02230579|100768345|FG000|STARTED|Overall Study||6||
48182683|NCT02230579|100768346|FG001|STARTED|Overall Study||6||
48182684|NCT02230579|100768347|FG002|STARTED|Overall Study||6||
48182685|NCT02230579|100768348|FG003|STARTED|Overall Study||6||
48182686|NCT02230579|100768349|FG004|STARTED|Overall Study||6||
48182687|NCT02230579|100768350|FG005|STARTED|Overall Study||6||
48182688|NCT02230579|100768351|FG006|STARTED|Overall Study||12||
48182689|NCT02230579|100768345|FG000|COMPLETED|Overall Study||6||
48182690|NCT02230579|100768346|FG001|COMPLETED|Overall Study||6||
48182691|NCT02230579|100768347|FG002|COMPLETED|Overall Study||6||
48182692|NCT02230579|100768348|FG003|COMPLETED|Overall Study||6||
48756988|NCT04366349|102194208|FG002|COMPLETED|Overall Study||18||
48756989|NCT04366349|102194209|FG003|COMPLETED|Overall Study||4||
48756990|NCT04366349|102194210|FG004|COMPLETED|Overall Study||6||
48756991|NCT04366349|102194211|FG005|COMPLETED|Overall Study||6||
48756992|NCT04366349|102194206|FG000|NOT COMPLETED|Overall Study||1||
48756993|NCT04366349|102194207|FG001|NOT COMPLETED|Overall Study||0||
48182693|NCT02230579|100768349|FG004|COMPLETED|Overall Study||6||
48182694|NCT02230579|100768350|FG005|COMPLETED|Overall Study||6||
48182695|NCT02230579|100768351|FG006|COMPLETED|Overall Study||12||
48182696|NCT02230579|100768345|FG000|NOT COMPLETED|Overall Study||0||
48182697|NCT02230579|100768346|FG001|NOT COMPLETED|Overall Study||0||
48182698|NCT02230579|100768347|FG002|NOT COMPLETED|Overall Study||0||
48182699|NCT02230579|100768348|FG003|NOT COMPLETED|Overall Study||0||
48182700|NCT02230579|100768349|FG004|NOT COMPLETED|Overall Study||0||
48182701|NCT02230579|100768350|FG005|NOT COMPLETED|Overall Study||0||
48182702|NCT02230579|100768351|FG006|NOT COMPLETED|Overall Study||0||
48182703|NCT00311155|100768352|FG000|STARTED|Overall Study||694||
48343317|NCT00611247|101167751|FG001|COMPLETED|Overall Study||10||
48343318|NCT00611247|101167750|FG000|NOT COMPLETED|Overall Study||2||
48343319|NCT00611247|101167751|FG001|NOT COMPLETED|Overall Study||21||
48343320|NCT04897867|101167752|FG000|STARTED|Overall Study||110||
48343321|NCT04897867|101167752|FG000|Safety Population|Overall Study||110|Safety Population consisted of all enrolled participants who received at least one cryolipolysis treatment cycle (started or completed).|
48756994|NCT04366349|102194208|FG002|NOT COMPLETED|Overall Study||0||
48756995|NCT04366349|102194209|FG003|NOT COMPLETED|Overall Study||0||
48756996|NCT04366349|102194210|FG004|NOT COMPLETED|Overall Study||0||
48182704|NCT00311155|100768352|FG000|COMPLETED|Overall Study||601||
48182705|NCT00311155|100768352|FG000|NOT COMPLETED|Overall Study||93||
48182706|NCT02718417|100768353|FG000|STARTED|Chemotherapy Phase (CP)||332||
48182707|NCT02718417|100768354|FG001|STARTED|Chemotherapy Phase (CP)||331||
48182708|NCT02718417|100768355|FG002|STARTED|Chemotherapy Phase (CP)||335||
48182709|NCT02718417|100768353|FG000|Safety Population|Chemotherapy Phase (CP)||328|Participants who had received at least one dose of study drug|
48182710|NCT02718417|100768354|FG001|Safety Population|Chemotherapy Phase (CP)||329|Participants who had received at least one dose of study drug|
48182711|NCT02718417|100768355|FG002|Safety Population|Chemotherapy Phase (CP)||334|Participants who had received at least one dose of study drug|
48182712|NCT02718417|100768353|FG000|COMPLETED|Chemotherapy Phase (CP)||280||
48182713|NCT02718417|100768354|FG001|COMPLETED|Chemotherapy Phase (CP)||294||
48182714|NCT02718417|100768355|FG002|COMPLETED|Chemotherapy Phase (CP)||289||
48182715|NCT02718417|100768353|FG000|NOT COMPLETED|Chemotherapy Phase (CP)||52||
48343322|NCT04897867|101167752|FG000|Received Treatment in Session 2|Overall Study||100||
48368089|NCT03032068|101230103|FG000|4 Weeks Postoperative Visit|Overall Study||9||
48368090|NCT03032068|101230103|FG000|8 Weeks Postoperative Visit|Overall Study||9||
48756997|NCT04366349|102194211|FG005|NOT COMPLETED|Overall Study||0||
48756998|NCT00062439|102194212|FG000|STARTED|Induction Chemotherapy + Radiotherapy||46||
48182716|NCT02718417|100768354|FG001|NOT COMPLETED|Chemotherapy Phase (CP)||37||
48756999|NCT00062439|102194212|FG000|COMPLETED|Induction Chemotherapy + Radiotherapy||38||
48182717|NCT02718417|100768355|FG002|NOT COMPLETED|Chemotherapy Phase (CP)||46||
48182718|NCT02718417|100768353|FG000|STARTED|Maintenance Phase (MP)||267||
48182719|NCT02718417|100768354|FG001|STARTED|Maintenance Phase (MP)||288||
48182720|NCT02718417|100768355|FG002|STARTED|Maintenance Phase (MP)||0||
48182721|NCT02718417|100768353|FG000|COMPLETED|Maintenance Phase (MP)||1||
48182722|NCT02718417|100768354|FG001|COMPLETED|Maintenance Phase (MP)||1||
48182723|NCT02718417|100768355|FG002|COMPLETED|Maintenance Phase (MP)||0||
48182724|NCT02718417|100768353|FG000|NOT COMPLETED|Maintenance Phase (MP)||266||
48182725|NCT02718417|100768354|FG001|NOT COMPLETED|Maintenance Phase (MP)||287||
48182726|NCT02718417|100768355|FG002|NOT COMPLETED|Maintenance Phase (MP)||0||
48182727|NCT02718417|100768353|FG000|STARTED|Observation Phase (OP)||0||
48182728|NCT02718417|100768354|FG001|STARTED|Observation Phase (OP)||0||
48182729|NCT02718417|100768355|FG002|STARTED|Observation Phase (OP)||284||
48182730|NCT02718417|100768353|FG000|COMPLETED|Observation Phase (OP)||0||
48182731|NCT02718417|100768354|FG001|COMPLETED|Observation Phase (OP)||0||
48182732|NCT02718417|100768355|FG002|COMPLETED|Observation Phase (OP)||2||
48182733|NCT02718417|100768353|FG000|NOT COMPLETED|Observation Phase (OP)||0||
48182734|NCT02718417|100768354|FG001|NOT COMPLETED|Observation Phase (OP)||0||
48182735|NCT02718417|100768355|FG002|NOT COMPLETED|Observation Phase (OP)||282||
48182736|NCT02718417|100768353|FG000|STARTED|Follow-up Phase||238||
48182737|NCT02718417|100768354|FG001|STARTED|Follow-up Phase||263||
48182738|NCT02718417|100768355|FG002|STARTED|Follow-up Phase||39||
48182739|NCT02718417|100768353|FG000|COMPLETED|Follow-up Phase||103||
48182740|NCT02718417|100768354|FG001|COMPLETED|Follow-up Phase||91||
48182741|NCT02718417|100768355|FG002|COMPLETED|Follow-up Phase||20||
48182742|NCT02718417|100768353|FG000|NOT COMPLETED|Follow-up Phase||135||
48182743|NCT02718417|100768354|FG001|NOT COMPLETED|Follow-up Phase||172||
48182744|NCT02718417|100768355|FG002|NOT COMPLETED|Follow-up Phase||19||
48182745|NCT02718417|100768353|FG000|STARTED|Long-term Follow-up Phase||139||
48182746|NCT02718417|100768354|FG001|STARTED|Long-term Follow-up Phase||112||
48182747|NCT02718417|100768355|FG002|STARTED|Long-term Follow-up Phase||135||
48182748|NCT02718417|100768353|FG000|COMPLETED|Long-term Follow-up Phase||0||
48182749|NCT02718417|100768354|FG001|COMPLETED|Long-term Follow-up Phase||0||
48182750|NCT02718417|100768355|FG002|COMPLETED|Long-term Follow-up Phase||0||
48182751|NCT02718417|100768353|FG000|NOT COMPLETED|Long-term Follow-up Phase||139||
48182752|NCT02718417|100768354|FG001|NOT COMPLETED|Long-term Follow-up Phase||112||
48633925|NCT04056468|101888807|FG001|NOT COMPLETED|Overall Study||0||
48633926|NCT04056468|101888808|FG002|NOT COMPLETED|Overall Study||0||
48633927|NCT00301834|101888809|FG000|STARTED|Overall Study||35||
48633928|NCT00301834|101888809|FG000|COMPLETED|Overall Study||34||
48633929|NCT00301834|101888809|FG000|NOT COMPLETED|Overall Study||1||
48633930|NCT03116230|101888810|FG000|STARTED|Overall Study||19||
48182753|NCT02718417|100768355|FG002|NOT COMPLETED|Long-term Follow-up Phase||135||
48182754|NCT01458249|100768356|FG000|STARTED|Overall Study||52||
48182755|NCT01458249|100768356|FG000|Participants Treated|Overall Study||51||
48182756|NCT01458249|100768356|FG000|COMPLETED|Overall Study||44||
48182757|NCT01458249|100768356|FG000|NOT COMPLETED|Overall Study||8||
48182758|NCT00389974|100768357|FG000|STARTED|Overall Study||19||
48182759|NCT00389974|100768357|FG000|COMPLETED|Overall Study||19||
48182760|NCT00389974|100768357|FG000|NOT COMPLETED|Overall Study||0||
48188653|NCT03248570|100783299|FG000|NOT COMPLETED|Overall Study||0||
48188654|NCT03248570|100783300|FG001|NOT COMPLETED|Overall Study||0||
48188655|NCT02328014|100783301|FG000|STARTED|Overall Study||6||
48188656|NCT02328014|100783302|FG001|STARTED|Overall Study||6||
48188657|NCT02328014|100783303|FG002|STARTED|Overall Study||6||
48188658|NCT02328014|100783304|FG003|STARTED|Overall Study||22||
48633931|NCT03116230|101888811|FG001|STARTED|Overall Study||19||
48188659|NCT02328014|100783301|FG000|COMPLETED|Overall Study||0||
48188660|NCT02328014|100783302|FG001|COMPLETED|Overall Study||0||
48188661|NCT02328014|100783303|FG002|COMPLETED|Overall Study||0||
48188662|NCT02328014|100783304|FG003|COMPLETED|Overall Study||0||
48188663|NCT02328014|100783301|FG000|NOT COMPLETED|Overall Study||6||
48188664|NCT02328014|100783302|FG001|NOT COMPLETED|Overall Study||6||
48188665|NCT02328014|100783303|FG002|NOT COMPLETED|Overall Study||6||
48188666|NCT02328014|100783304|FG003|NOT COMPLETED|Overall Study||22||
48188667|NCT02107274|100783305|FG000|STARTED|Treatment vs. Placebo||39||
48188668|NCT02107274|100783306|FG001|STARTED|Treatment vs. Placebo||39||
48188669|NCT02107274|100783305|FG000|COMPLETED|Treatment vs. Placebo||36||
48414297|NCT00129376|101346001|FG000|STARTED|Overall Study||63||
48188670|NCT02107274|100783306|FG001|COMPLETED|Treatment vs. Placebo||37||
48188671|NCT02107274|100783305|FG000|NOT COMPLETED|Treatment vs. Placebo||3||
48188672|NCT02107274|100783306|FG001|NOT COMPLETED|Treatment vs. Placebo||2||
48188673|NCT02107274|100783305|FG000|STARTED|Control Phase||36||
48188674|NCT02107274|100783306|FG001|STARTED|Control Phase||37||
48188675|NCT02107274|100783305|FG000|COMPLETED|Control Phase||33||
48188676|NCT02107274|100783306|FG001|COMPLETED|Control Phase||35||
48188677|NCT02107274|100783305|FG000|NOT COMPLETED|Control Phase||3||
48188678|NCT02107274|100783306|FG001|NOT COMPLETED|Control Phase||2||
48188679|NCT00329303|100783307|FG000|STARTED|Overall Study||34||
48414298|NCT00129376|101346001|FG000|COMPLETED|Overall Study||61||
48633932|NCT03116230|101888810|FG000|COMPLETED|Overall Study||15||
48633933|NCT03116230|101888811|FG001|COMPLETED|Overall Study||17||
48182761|NCT01489020|100772076|FG000|STARTED|Overall Study||12||
48182762|NCT01489020|100772077|FG001|STARTED|Overall Study||4||
48633934|NCT03116230|101888810|FG000|NOT COMPLETED|Overall Study||4||
48633935|NCT03116230|101888811|FG001|NOT COMPLETED|Overall Study||2||
48633936|NCT01697579|101888812|FG000|STARTED|Base Study-Cycle 1||74||
48633937|NCT01697579|101888813|FG001|STARTED|Base Study-Cycle 1||43||
48633938|NCT01697579|101888814|FG002|STARTED|Base Study-Cycle 1||44||
48633939|NCT01697579|101888815|FG003|STARTED|Base Study-Cycle 1||41||
48182763|NCT01489020|100772078|FG002|STARTED|Overall Study||12||
48182764|NCT01489020|100772079|FG003|STARTED|Overall Study||4||
48182765|NCT01489020|100772080|FG004|STARTED|Overall Study||12||
48182766|NCT01489020|100772081|FG005|STARTED|Overall Study||4||
48182767|NCT01489020|100772076|FG000|COMPLETED|Overall Study||11||
48182768|NCT01489020|100772077|FG001|COMPLETED|Overall Study||4||
48182769|NCT01489020|100772078|FG002|COMPLETED|Overall Study||9||
48182770|NCT01489020|100772079|FG003|COMPLETED|Overall Study||4||
48182771|NCT01489020|100772080|FG004|COMPLETED|Overall Study||6||
48182772|NCT01489020|100772081|FG005|COMPLETED|Overall Study||4||
48182773|NCT01489020|100772076|FG000|NOT COMPLETED|Overall Study||1||
48182774|NCT01489020|100772077|FG001|NOT COMPLETED|Overall Study||0||
48182775|NCT01489020|100772078|FG002|NOT COMPLETED|Overall Study||3||
48182776|NCT01489020|100772079|FG003|NOT COMPLETED|Overall Study||0||
48182777|NCT01489020|100772080|FG004|NOT COMPLETED|Overall Study||6||
48182778|NCT01489020|100772081|FG005|NOT COMPLETED|Overall Study||0||
48182779|NCT01754779|100772082|FG000|STARTED|First Intervention (1 Week)||2||
48182780|NCT01754779|100772083|FG001|STARTED|First Intervention (1 Week)||1||
48182781|NCT01754779|100772084|FG002|STARTED|First Intervention (1 Week)||2||
48182782|NCT01754779|100772085|FG003|STARTED|First Intervention (1 Week)||3||
48182783|NCT01754779|100772086|FG004|STARTED|First Intervention (1 Week)||3||
48182784|NCT01754779|100772087|FG005|STARTED|First Intervention (1 Week)||2||
48182785|NCT01754779|100772082|FG000|COMPLETED|First Intervention (1 Week)||2||
48182786|NCT01754779|100772083|FG001|COMPLETED|First Intervention (1 Week)||1||
48182787|NCT01754779|100772084|FG002|COMPLETED|First Intervention (1 Week)||2||
48633940|NCT01697579|101888816|FG004|STARTED|Base Study-Cycle 1||38||
48633941|NCT01697579|101888817|FG005|STARTED|Base Study-Cycle 1||0||
48633942|NCT01697579|101888818|FG006|STARTED|Base Study-Cycle 1||0||
48633943|NCT01697579|101888812|FG000|COMPLETED|Base Study-Cycle 1||72||
48633944|NCT01697579|101888813|FG001|COMPLETED|Base Study-Cycle 1||42||
48633945|NCT01697579|101888814|FG002|COMPLETED|Base Study-Cycle 1||43||
48633946|NCT01697579|101888815|FG003|COMPLETED|Base Study-Cycle 1||40||
48633947|NCT01697579|101888816|FG004|COMPLETED|Base Study-Cycle 1||35||
48633948|NCT01697579|101888817|FG005|COMPLETED|Base Study-Cycle 1||0||
48633949|NCT01697579|101888818|FG006|COMPLETED|Base Study-Cycle 1||0||
48633950|NCT01697579|101888812|FG000|NOT COMPLETED|Base Study-Cycle 1||2||
48633951|NCT01697579|101888813|FG001|NOT COMPLETED|Base Study-Cycle 1||1||
48757000|NCT00062439|102194212|FG000|NOT COMPLETED|Induction Chemotherapy + Radiotherapy||8||
48757001|NCT00062439|102194212|FG000|STARTED|Post Chemoradiation Assessment||38||
48757002|NCT00062439|102194212|FG000|COMPLETED|Post Chemoradiation Assessment||29||
48757003|NCT00062439|102194212|FG000|NOT COMPLETED|Post Chemoradiation Assessment||9||
48182788|NCT01754779|100772085|FG003|COMPLETED|First Intervention (1 Week)||3||
48182789|NCT01754779|100772086|FG004|COMPLETED|First Intervention (1 Week)||3||
48182790|NCT01754779|100772087|FG005|COMPLETED|First Intervention (1 Week)||2||
48182791|NCT01754779|100772082|FG000|NOT COMPLETED|First Intervention (1 Week)||0||
48182792|NCT01754779|100772083|FG001|NOT COMPLETED|First Intervention (1 Week)||0||
48182793|NCT01754779|100772084|FG002|NOT COMPLETED|First Intervention (1 Week)||0||
48182794|NCT01754779|100772085|FG003|NOT COMPLETED|First Intervention (1 Week)||0||
48368091|NCT03032068|101230103|FG000|12 Weeks Postoperative Visit|Overall Study||9||
48633952|NCT01697579|101888814|FG002|NOT COMPLETED|Base Study-Cycle 1||1||
48757004|NCT00062439|102194212|FG000|STARTED|Surgery||29||
48182795|NCT01754779|100772086|FG004|NOT COMPLETED|First Intervention (1 Week)||0||
48182796|NCT01754779|100772087|FG005|NOT COMPLETED|First Intervention (1 Week)||0||
48182797|NCT01754779|100772082|FG000|STARTED|Washout (1 Week)||2||
48182798|NCT01754779|100772083|FG001|STARTED|Washout (1 Week)||1||
48633953|NCT01697579|101888815|FG003|NOT COMPLETED|Base Study-Cycle 1||1||
48182799|NCT01754779|100772084|FG002|STARTED|Washout (1 Week)||2||
48182800|NCT01754779|100772085|FG003|STARTED|Washout (1 Week)||3||
48182801|NCT01754779|100772086|FG004|STARTED|Washout (1 Week)||3||
48182802|NCT01754779|100772087|FG005|STARTED|Washout (1 Week)||2||
48182803|NCT01754779|100772082|FG000|COMPLETED|Washout (1 Week)||2||
48182804|NCT01754779|100772083|FG001|COMPLETED|Washout (1 Week)||1||
48182805|NCT01754779|100772084|FG002|COMPLETED|Washout (1 Week)||2||
48182806|NCT01754779|100772085|FG003|COMPLETED|Washout (1 Week)||3||
48182807|NCT01754779|100772086|FG004|COMPLETED|Washout (1 Week)||3||
48182808|NCT01754779|100772087|FG005|COMPLETED|Washout (1 Week)||2||
48182809|NCT01754779|100772082|FG000|NOT COMPLETED|Washout (1 Week)||0||
48182810|NCT01754779|100772083|FG001|NOT COMPLETED|Washout (1 Week)||0||
48182811|NCT01754779|100772084|FG002|NOT COMPLETED|Washout (1 Week)||0||
48368092|NCT03032068|101230103|FG000|COMPLETED|Overall Study||9||
48633954|NCT01697579|101888816|FG004|NOT COMPLETED|Base Study-Cycle 1||3||
48633955|NCT01697579|101888817|FG005|NOT COMPLETED|Base Study-Cycle 1||0||
48633956|NCT01697579|101888818|FG006|NOT COMPLETED|Base Study-Cycle 1||0||
48633957|NCT01697579|101888812|FG000|STARTED|Optional Extension-Cycles 2-6||0||
48633958|NCT01697579|101888813|FG001|STARTED|Optional Extension-Cycles 2-6||0||
48633959|NCT01697579|101888814|FG002|STARTED|Optional Extension-Cycles 2-6||0||
48633960|NCT01697579|101888815|FG003|STARTED|Optional Extension-Cycles 2-6||0||
48633961|NCT01697579|101888816|FG004|STARTED|Optional Extension-Cycles 2-6||0||
48633962|NCT01697579|101888817|FG005|STARTED|Optional Extension-Cycles 2-6||47||
48633963|NCT01697579|101888818|FG006|STARTED|Optional Extension-Cycles 2-6||106||
48633964|NCT01697579|101888812|FG000|COMPLETED|Optional Extension-Cycles 2-6||0||
48633965|NCT01697579|101888813|FG001|COMPLETED|Optional Extension-Cycles 2-6||0||
48633966|NCT01697579|101888814|FG002|COMPLETED|Optional Extension-Cycles 2-6||0||
48633967|NCT01697579|101888815|FG003|COMPLETED|Optional Extension-Cycles 2-6||0||
48633968|NCT01697579|101888816|FG004|COMPLETED|Optional Extension-Cycles 2-6||0||
48633969|NCT01697579|101888817|FG005|COMPLETED|Optional Extension-Cycles 2-6||12||
48633970|NCT01697579|101888818|FG006|COMPLETED|Optional Extension-Cycles 2-6||37||
48633971|NCT01697579|101888812|FG000|NOT COMPLETED|Optional Extension-Cycles 2-6||0||
48633972|NCT01697579|101888813|FG001|NOT COMPLETED|Optional Extension-Cycles 2-6||0||
48633973|NCT01697579|101888814|FG002|NOT COMPLETED|Optional Extension-Cycles 2-6||0||
48633974|NCT01697579|101888815|FG003|NOT COMPLETED|Optional Extension-Cycles 2-6||0||
48633975|NCT01697579|101888816|FG004|NOT COMPLETED|Optional Extension-Cycles 2-6||0||
48633976|NCT01697579|101888817|FG005|NOT COMPLETED|Optional Extension-Cycles 2-6||35||
48633977|NCT01697579|101888818|FG006|NOT COMPLETED|Optional Extension-Cycles 2-6||69||
48633978|NCT03527264|101888819|FG000|STARTED|Overall Study||3||
48633979|NCT03527264|101888820|FG001|STARTED|Overall Study||1||
48633980|NCT03527264|101888821|FG002|STARTED|Overall Study||0||
48633981|NCT03527264|101888822|FG003|STARTED|Overall Study||0||
48633982|NCT03527264|101888819|FG000|COMPLETED|Overall Study||3||
48633983|NCT03527264|101888820|FG001|COMPLETED|Overall Study||1||
48633984|NCT03527264|101888821|FG002|COMPLETED|Overall Study||0||
48633985|NCT03527264|101888822|FG003|COMPLETED|Overall Study||0||
48633986|NCT03527264|101888819|FG000|NOT COMPLETED|Overall Study||0||
48182812|NCT01754779|100772085|FG003|NOT COMPLETED|Washout (1 Week)||0||
48182813|NCT01754779|100772086|FG004|NOT COMPLETED|Washout (1 Week)||0||
48182814|NCT01754779|100772087|FG005|NOT COMPLETED|Washout (1 Week)||0||
48182815|NCT01754779|100772082|FG000|STARTED|Second Intervention (1 Week)||2||
48182816|NCT01754779|100772083|FG001|STARTED|Second Intervention (1 Week)||1||
48182817|NCT01754779|100772084|FG002|STARTED|Second Intervention (1 Week)||2||
48182818|NCT01754779|100772085|FG003|STARTED|Second Intervention (1 Week)||3||
48182819|NCT01754779|100772086|FG004|STARTED|Second Intervention (1 Week)||3||
48182820|NCT01754779|100772087|FG005|STARTED|Second Intervention (1 Week)||2||
48182821|NCT01754779|100772082|FG000|COMPLETED|Second Intervention (1 Week)||2||
48182822|NCT01754779|100772083|FG001|COMPLETED|Second Intervention (1 Week)||1||
48182823|NCT01754779|100772084|FG002|COMPLETED|Second Intervention (1 Week)||2||
48182824|NCT01754779|100772085|FG003|COMPLETED|Second Intervention (1 Week)||3||
48182825|NCT01754779|100772086|FG004|COMPLETED|Second Intervention (1 Week)||3||
48182826|NCT01754779|100772087|FG005|COMPLETED|Second Intervention (1 Week)||2||
48182827|NCT01754779|100772082|FG000|NOT COMPLETED|Second Intervention (1 Week)||0||
48182828|NCT01754779|100772083|FG001|NOT COMPLETED|Second Intervention (1 Week)||0||
48182829|NCT01754779|100772084|FG002|NOT COMPLETED|Second Intervention (1 Week)||0||
48182830|NCT01754779|100772085|FG003|NOT COMPLETED|Second Intervention (1 Week)||0||
48182831|NCT01754779|100772086|FG004|NOT COMPLETED|Second Intervention (1 Week)||0||
48182832|NCT01754779|100772087|FG005|NOT COMPLETED|Second Intervention (1 Week)||0||
48182833|NCT01754779|100772082|FG000|STARTED|Washout (1 Week)||2||
48182834|NCT01754779|100772083|FG001|STARTED|Washout (1 Week)||1||
48182835|NCT01754779|100772084|FG002|STARTED|Washout (1 Week)||2||
48182836|NCT01754779|100772085|FG003|STARTED|Washout (1 Week)||3||
48182837|NCT01754779|100772086|FG004|STARTED|Washout (1 Week)||3||
48182838|NCT01754779|100772087|FG005|STARTED|Washout (1 Week)||2||
48182839|NCT01754779|100772082|FG000|COMPLETED|Washout (1 Week)||2||
48182840|NCT01754779|100772083|FG001|COMPLETED|Washout (1 Week)||1||
48182841|NCT01754779|100772084|FG002|COMPLETED|Washout (1 Week)||2||
48182842|NCT01754779|100772085|FG003|COMPLETED|Washout (1 Week)||3||
48182843|NCT01754779|100772086|FG004|COMPLETED|Washout (1 Week)||3||
48182844|NCT01754779|100772087|FG005|COMPLETED|Washout (1 Week)||2||
48182845|NCT01754779|100772082|FG000|NOT COMPLETED|Washout (1 Week)||0||
48633987|NCT03527264|101888820|FG001|NOT COMPLETED|Overall Study||0||
48633988|NCT03527264|101888821|FG002|NOT COMPLETED|Overall Study||0||
48633989|NCT03527264|101888822|FG003|NOT COMPLETED|Overall Study||0||
48633990|NCT04084015|101888823|FG000|STARTED|Overall Study||2||
48182846|NCT01754779|100772083|FG001|NOT COMPLETED|Washout (1 Week)||0||
48182847|NCT01754779|100772084|FG002|NOT COMPLETED|Washout (1 Week)||0||
48182848|NCT01754779|100772085|FG003|NOT COMPLETED|Washout (1 Week)||0||
48182849|NCT01754779|100772086|FG004|NOT COMPLETED|Washout (1 Week)||0||
48633991|NCT04084015|101888823|FG000|COMPLETED|Overall Study||2||
48633992|NCT04084015|101888823|FG000|NOT COMPLETED|Overall Study||0||
48182850|NCT01754779|100772087|FG005|NOT COMPLETED|Washout (1 Week)||0||
48182851|NCT01754779|100772082|FG000|STARTED|Third Intervention (1 Week)||2||
48368093|NCT03032068|101230103|FG000|NOT COMPLETED|Overall Study||1||
48368094|NCT01798706|101230104|FG000|STARTED|Overall Study||176||
48182852|NCT01754779|100772083|FG001|STARTED|Third Intervention (1 Week)||1||
48182853|NCT01754779|100772084|FG002|STARTED|Third Intervention (1 Week)||2||
48182854|NCT01754779|100772085|FG003|STARTED|Third Intervention (1 Week)||3||
48182855|NCT01754779|100772086|FG004|STARTED|Third Intervention (1 Week)||3||
48182856|NCT01754779|100772087|FG005|STARTED|Third Intervention (1 Week)||2||
48633993|NCT01369433|101888824|FG000|STARTED|Overall Study||209||
48633994|NCT01369433|101888825|FG001|STARTED|Overall Study||16||
48633995|NCT01369433|101888824|FG000|COMPLETED|Overall Study||0||
48633996|NCT01369433|101888825|FG001|COMPLETED|Overall Study||0||
48633997|NCT01369433|101888824|FG000|NOT COMPLETED|Overall Study||209||
48633998|NCT01369433|101888825|FG001|NOT COMPLETED|Overall Study||16||
48633999|NCT02990000|101888826|FG000|STARTED|Overall Study||155||
48634000|NCT02990000|101888827|FG001|STARTED|Overall Study||133||
48634001|NCT02990000|101888826|FG000|Begin Treatment|Overall Study||119||
48182857|NCT01754779|100772082|FG000|COMPLETED|Third Intervention (1 Week)||2||
48182858|NCT01754779|100772083|FG001|COMPLETED|Third Intervention (1 Week)||1||
48182859|NCT01754779|100772084|FG002|COMPLETED|Third Intervention (1 Week)||2||
48182860|NCT01754779|100772085|FG003|COMPLETED|Third Intervention (1 Week)||3||
48182861|NCT01754779|100772086|FG004|COMPLETED|Third Intervention (1 Week)||3||
48182862|NCT01754779|100772087|FG005|COMPLETED|Third Intervention (1 Week)||2||
48182863|NCT01754779|100772082|FG000|NOT COMPLETED|Third Intervention (1 Week)||0||
48182864|NCT01754779|100772083|FG001|NOT COMPLETED|Third Intervention (1 Week)||0||
48182865|NCT01754779|100772084|FG002|NOT COMPLETED|Third Intervention (1 Week)||0||
48182866|NCT01754779|100772085|FG003|NOT COMPLETED|Third Intervention (1 Week)||0||
48182867|NCT01754779|100772086|FG004|NOT COMPLETED|Third Intervention (1 Week)||0||
48182868|NCT01754779|100772087|FG005|NOT COMPLETED|Third Intervention (1 Week)||0||
48182869|NCT01177813|100772088|FG000|STARTED|Overall Study||228||
48182870|NCT01177813|100772089|FG001|STARTED|Overall Study||224||
48182871|NCT01177813|100772090|FG002|STARTED|Overall Study||224||
48182872|NCT01177813|100772091|FG003|STARTED|Overall Study||223||
48182873|NCT01177813|100772092|FG004|STARTED|Overall Study||87||
48634002|NCT02990000|101888827|FG001|Begin Treatment|Overall Study||99||
48634003|NCT02990000|101888826|FG000|COMPLETED|Overall Study||119||
48634004|NCT02990000|101888827|FG001|COMPLETED|Overall Study||99||
48634005|NCT02990000|101888826|FG000|NOT COMPLETED|Overall Study||36||
48634006|NCT02990000|101888827|FG001|NOT COMPLETED|Overall Study||34||
48634007|NCT04113694|101888828|FG000|STARTED|Overall Study||259||
48634008|NCT04113694|101888828|FG000|COMPLETED|Overall Study||248||
48634009|NCT04113694|101888828|FG000|NOT COMPLETED|Overall Study||11||
48634010|NCT04456686|101888829|FG000|STARTED|Overall Study||78||
48634011|NCT04456686|101888830|FG001|STARTED|Overall Study||39||
48634012|NCT04456686|101888829|FG000|Received at Least 1 Dose of Study Drug|Overall Study||77||
48634013|NCT04456686|101888830|FG001|Received at Least 1 Dose of Study Drug|Overall Study||36||
48634014|NCT04456686|101888829|FG000|COMPLETED|Overall Study||63||
48757005|NCT00062439|102194212|FG000|COMPLETED|Surgery||22||
48757006|NCT00062439|102194212|FG000|NOT COMPLETED|Surgery||7||
48757007|NCT00062439|102194212|FG000|STARTED|Consolidation Chemotherapy||22||
48757008|NCT00062439|102194212|FG000|COMPLETED|Consolidation Chemotherapy||20||
48757009|NCT00062439|102194212|FG000|NOT COMPLETED|Consolidation Chemotherapy||2||
48757010|NCT04949191|102194213|FG000|STARTED|Overall Study||2||
48757011|NCT04949191|102194214|FG001|STARTED|Overall Study||5||
48757012|NCT04949191|102194215|FG002|STARTED|Overall Study||2||
48757013|NCT04949191|102194216|FG003|STARTED|Overall Study||1||
48757014|NCT04949191|102194213|FG000|COMPLETED|Overall Study||1||
48182874|NCT01177813|100772088|FG000|COMPLETED|Overall Study||187||
48182875|NCT01177813|100772089|FG001|COMPLETED|Overall Study||206||
48182876|NCT01177813|100772090|FG002|COMPLETED|Overall Study||204||
48182877|NCT01177813|100772091|FG003|COMPLETED|Overall Study||206||
48182878|NCT01177813|100772092|FG004|COMPLETED|Overall Study||78||
48182879|NCT01177813|100772088|FG000|NOT COMPLETED|Overall Study||41||
48182880|NCT01177813|100772089|FG001|NOT COMPLETED|Overall Study||18||
48182881|NCT01177813|100772090|FG002|NOT COMPLETED|Overall Study||20||
48182882|NCT01177813|100772091|FG003|NOT COMPLETED|Overall Study||17||
48182883|NCT01177813|100772092|FG004|NOT COMPLETED|Overall Study||9||
48182884|NCT00402883|100772093|FG000|STARTED|Induction Therapy||5||
48182885|NCT00402883|100772093|FG000|COMPLETED|Induction Therapy||5||
48182886|NCT00402883|100772093|FG000|NOT COMPLETED|Induction Therapy||0||
48182887|NCT00402883|100772093|FG000|STARTED|Consolidation Therapy||5||
48182888|NCT00402883|100772093|FG000|COMPLETED|Consolidation Therapy||5||
48182889|NCT00402883|100772093|FG000|NOT COMPLETED|Consolidation Therapy||0||
48182890|NCT00402883|100772093|FG000|STARTED|Maintenance Therapy||5||
48182891|NCT00402883|100772093|FG000|COMPLETED|Maintenance Therapy||5||
48182892|NCT00402883|100772093|FG000|NOT COMPLETED|Maintenance Therapy||0||
48182893|NCT01349829|100772094|FG000|STARTED|Overall Study||126||
48182894|NCT01349829|100772095|FG001|STARTED|Overall Study||125||
48634015|NCT04456686|101888830|FG001|COMPLETED|Overall Study||32||
48634016|NCT04456686|101888829|FG000|NOT COMPLETED|Overall Study||15||
48634017|NCT04456686|101888830|FG001|NOT COMPLETED|Overall Study||7||
48634018|NCT00719901|101888831|FG000|STARTED|Overall Study||11||
48634019|NCT00719901|101888831|FG000|COMPLETED|Overall Study||0||
48757015|NCT04949191|102194214|FG001|COMPLETED|Overall Study||3||
48182895|NCT01349829|100772094|FG000|COMPLETED|Overall Study||117||
48182896|NCT01349829|100772095|FG001|COMPLETED|Overall Study||102||
48182897|NCT01349829|100772094|FG000|NOT COMPLETED|Overall Study||9||
48182898|NCT01349829|100772095|FG001|NOT COMPLETED|Overall Study||23||
48343323|NCT04897867|101167752|FG000|Evaluable Population 1|Overall Study||96|Evaluable Population 1 consisted of all participants who completed the cryolipolysis treatment plan to the midsection and completed the Cryolipolysis Satisfaction Questionnaire (CSQ)-Midsection Item #1 at 12 weeks after the final treatment session and who do not have any significant protocol deviation or violation.|
48414299|NCT00129376|101346001|FG000|NOT COMPLETED|Overall Study||2||
48414300|NCT01468844|101346002|FG000|STARTED|Overall Study||4||
48414301|NCT01468844|101346003|FG001|STARTED|Overall Study||2||
48414302|NCT01468844|101346002|FG000|COMPLETED|Overall Study||2||
48414303|NCT01468844|101346003|FG001|COMPLETED|Overall Study||2||
48414304|NCT01468844|101346002|FG000|NOT COMPLETED|Overall Study||2||
48414305|NCT01468844|101346003|FG001|NOT COMPLETED|Overall Study||0||
48414306|NCT02353806|101346004|FG000|STARTED|Overall Study||16||
48414307|NCT02353806|101346004|FG000|COMPLETED|Overall Study||6||
48414308|NCT02353806|101346004|FG000|NOT COMPLETED|Overall Study||10||
48414309|NCT01970540|101346005|FG000|STARTED|Overall Study||73||
48414310|NCT01970540|101346006|FG001|STARTED|Overall Study||28||
48414311|NCT01970540|101346007|FG002|STARTED|Overall Study||19||
48634020|NCT00719901|101888831|FG000|NOT COMPLETED|Overall Study||11||
48634021|NCT01963234|101888832|FG000|STARTED|Overall Study||268||
48634022|NCT01963234|101888833|FG001|STARTED|Overall Study||171||
48634023|NCT01963234|101888832|FG000|COMPLETED|Overall Study||207||
48634024|NCT01963234|101888833|FG001|COMPLETED|Overall Study||171||
48634025|NCT01963234|101888832|FG000|NOT COMPLETED|Overall Study||61||
48634026|NCT01963234|101888833|FG001|NOT COMPLETED|Overall Study||0||
48634027|NCT05203185|101888834|FG000|STARTED|Overall Study||49||
48634028|NCT05203185|101888835|FG001|STARTED|Overall Study||35||
48634029|NCT05203185|101888836|FG002|STARTED|Overall Study||793||
48634030|NCT05203185|101888837|FG003|STARTED|Overall Study||735||
48634031|NCT05203185|101888834|FG000|COMPLETED|Overall Study||49||
48634032|NCT05203185|101888835|FG001|COMPLETED|Overall Study||35||
48634033|NCT05203185|101888836|FG002|COMPLETED|Overall Study||793||
48634034|NCT05203185|101888837|FG003|COMPLETED|Overall Study||735||
48182899|NCT00447330|100772096|FG000|STARTED|Overall Study||60||
48343324|NCT04897867|101167752|FG000|Evaluable Population 3|Overall Study||107|Evaluable Population 3 consisted of all participants who completed the cryolipolysis treatment plan for any body areas (Midsection, Upper Arms, Inner Thighs, Outer Thighs and Submental Area) and do not have any significant protocol deviation or violation.|
48343325|NCT04897867|101167752|FG000|COMPLETED|Overall Study||99||
48343326|NCT04897867|101167752|FG000|NOT COMPLETED|Overall Study||11||
48343327|NCT01083667|101167753|FG000|STARTED|Overall Study||32||
48343328|NCT01083667|101167753|FG000|COMPLETED|Overall Study||22||
48343329|NCT01083667|101167753|FG000|NOT COMPLETED|Overall Study||10||
48343330|NCT00909155|101167754|FG000|STARTED|Overall Study||15||
48343331|NCT00909155|101167755|FG001|STARTED|Overall Study||14||
48343332|NCT00909155|101167756|FG002|STARTED|Overall Study||21||
48343333|NCT00909155|101167754|FG000|COMPLETED|Overall Study||12||
48343334|NCT00909155|101167755|FG001|COMPLETED|Overall Study||9||
48343335|NCT00909155|101167756|FG002|COMPLETED|Overall Study||14||
48343336|NCT00909155|101167754|FG000|NOT COMPLETED|Overall Study||3||
48343337|NCT00909155|101167755|FG001|NOT COMPLETED|Overall Study||5||
48343338|NCT00909155|101167756|FG002|NOT COMPLETED|Overall Study||7||
48343339|NCT00490542|101167757|FG000|STARTED|Overall Study||38||
48414312|NCT01970540|101346005|FG000|COMPLETED|Overall Study||0||
48414313|NCT01970540|101346006|FG001|COMPLETED|Overall Study||0||
48414314|NCT01970540|101346007|FG002|COMPLETED|Overall Study||0||
48414315|NCT01970540|101346005|FG000|NOT COMPLETED|Overall Study||73||
48634035|NCT05203185|101888834|FG000|NOT COMPLETED|Overall Study||0||
48634036|NCT05203185|101888835|FG001|NOT COMPLETED|Overall Study||0||
48182900|NCT00447330|100772096|FG000|COMPLETED|Overall Study||58||
48182901|NCT00447330|100772096|FG000|NOT COMPLETED|Overall Study||2||
48414316|NCT01970540|101346006|FG001|NOT COMPLETED|Overall Study||28||
48414317|NCT01970540|101346007|FG002|NOT COMPLETED|Overall Study||19||
48414318|NCT01925014|101346008|FG000|STARTED|Overall Study||1535||
48414319|NCT01925014|101346009|FG001|STARTED|Overall Study||1539||
48414320|NCT01925014|101346008|FG000|COMPLETED|Overall Study||1526||
48414321|NCT01925014|101346009|FG001|COMPLETED|Overall Study||1520||
48414322|NCT01925014|101346008|FG000|NOT COMPLETED|Overall Study||9||
48414323|NCT01925014|101346009|FG001|NOT COMPLETED|Overall Study||19||
48182902|NCT00929305|100772097|FG000|STARTED|Overall Study||43||
48182903|NCT00929305|100772098|FG001|STARTED|Overall Study||43||
48182904|NCT00929305|100772097|FG000|COMPLETED|Overall Study||43||
48414324|NCT04673630|101346010|FG000|STARTED|Overall Study||18||
48414325|NCT04673630|101346010|FG000|COMPLETED|Overall Study||18||
48414326|NCT04673630|101346010|FG000|NOT COMPLETED|Overall Study||0||
48414327|NCT02650193|101346011|FG000|STARTED|Overall Study||6||
48414328|NCT02650193|101346012|FG001|STARTED|Overall Study||6||
48414329|NCT02650193|101346013|FG002|STARTED|Overall Study||13||
48414330|NCT02650193|101346011|FG000|COMPLETED|Overall Study||6||
48182905|NCT00929305|100772098|FG001|COMPLETED|Overall Study||43||
48634037|NCT05203185|101888836|FG002|NOT COMPLETED|Overall Study||0||
48634038|NCT05203185|101888837|FG003|NOT COMPLETED|Overall Study||0||
48634039|NCT03636256|101888838|FG000|STARTED|Overall Study||4||
48414331|NCT02650193|101346012|FG001|COMPLETED|Overall Study||6||
48414332|NCT02650193|101346013|FG002|COMPLETED|Overall Study||13||
48414333|NCT02650193|101346011|FG000|NOT COMPLETED|Overall Study||0||
48414334|NCT02650193|101346012|FG001|NOT COMPLETED|Overall Study||0||
48414335|NCT02650193|101346013|FG002|NOT COMPLETED|Overall Study||0||
48634040|NCT03636256|101888839|FG001|STARTED|Overall Study||3||
48634041|NCT03636256|101888840|FG002|STARTED|Overall Study||3||
48634042|NCT03636256|101888841|FG003|STARTED|Overall Study||9||
48634043|NCT03636256|101888842|FG004|STARTED|Overall Study||1||
48634044|NCT03636256|101888843|FG005|STARTED|Overall Study||5||
48634045|NCT03636256|101888844|FG006|STARTED|Overall Study||2||
48634046|NCT03636256|101888845|FG007|STARTED|Overall Study||2||
48634047|NCT03636256|101888846|FG008|STARTED|Overall Study||7||
48634048|NCT03636256|101888838|FG000|COMPLETED|Overall Study||1||
48634049|NCT03636256|101888839|FG001|COMPLETED|Overall Study||3||
48634050|NCT03636256|101888840|FG002|COMPLETED|Overall Study||1||
48182906|NCT00929305|100772097|FG000|NOT COMPLETED|Overall Study||0||
48343340|NCT00490542|101167758|FG001|STARTED|Overall Study||35||
48343341|NCT00490542|101167757|FG000|COMPLETED|Overall Study||31||
48757016|NCT04949191|102194215|FG002|COMPLETED|Overall Study||1||
48757017|NCT04949191|102194216|FG003|COMPLETED|Overall Study||0||
48757018|NCT04949191|102194213|FG000|NOT COMPLETED|Overall Study||1||
48634051|NCT03636256|101888841|FG003|COMPLETED|Overall Study||8||
48634052|NCT03636256|101888842|FG004|COMPLETED|Overall Study||1||
48634053|NCT03636256|101888843|FG005|COMPLETED|Overall Study||1||
48634054|NCT03636256|101888844|FG006|COMPLETED|Overall Study||0||
48634055|NCT03636256|101888845|FG007|COMPLETED|Overall Study||2||
48634056|NCT03636256|101888846|FG008|COMPLETED|Overall Study||2||
48634057|NCT03636256|101888838|FG000|NOT COMPLETED|Overall Study||3||
48757019|NCT04949191|102194214|FG001|NOT COMPLETED|Overall Study||2||
48757020|NCT04949191|102194215|FG002|NOT COMPLETED|Overall Study||1||
48757021|NCT04949191|102194216|FG003|NOT COMPLETED|Overall Study||1||
48757022|NCT00837434|102194217|FG000|STARTED|Overall Study||43||
48757023|NCT00837434|102194218|FG001|STARTED|Overall Study||20||
48757024|NCT00837434|102194217|FG000|COMPLETED|Overall Study||34||
48757025|NCT00837434|102194218|FG001|COMPLETED|Overall Study||19||
48757026|NCT00837434|102194217|FG000|NOT COMPLETED|Overall Study||9||
48757027|NCT00837434|102194218|FG001|NOT COMPLETED|Overall Study||1||
48757028|NCT02958995|102194219|FG000|STARTED|Overall Study||2630666||
48757029|NCT02958995|102194220|FG001|STARTED|Overall Study||107495||
48757030|NCT02958995|102194219|FG000|COMPLETED|Overall Study||2630666||
48757031|NCT02958995|102194220|FG001|COMPLETED|Overall Study||107495||
48757032|NCT02958995|102194219|FG000|NOT COMPLETED|Overall Study||0||
48757033|NCT02958995|102194220|FG001|NOT COMPLETED|Overall Study||0||
48757034|NCT02008396|102194221|FG000|STARTED|Stage 1||4||
48182907|NCT00929305|100772098|FG001|NOT COMPLETED|Overall Study||0||
48182908|NCT02322775|100772099|FG000|STARTED|Overall Study||106||
48182909|NCT02322775|100772100|FG001|STARTED|Overall Study||105||
48343342|NCT00490542|101167758|FG001|COMPLETED|Overall Study||31||
48343343|NCT00490542|101167757|FG000|NOT COMPLETED|Overall Study||7||
48343344|NCT00490542|101167758|FG001|NOT COMPLETED|Overall Study||4||
48343345|NCT03588741|101167759|FG000|STARTED|Overall Study||1||
48343346|NCT03588741|101167759|FG000|COMPLETED|Overall Study||0||
48343347|NCT03588741|101167759|FG000|NOT COMPLETED|Overall Study||1||
48343348|NCT00688909|101167760|FG000|STARTED|Overall Study||261||
48343349|NCT00688909|101167760|FG000|COMPLETED|Overall Study||228||
48343350|NCT00688909|101167760|FG000|NOT COMPLETED|Overall Study||33||
48343351|NCT03124069|101167761|FG000|STARTED|Overall Study||37||
48343352|NCT03124069|101167761|FG000|COMPLETED|Overall Study||37||
48343353|NCT03124069|101167761|FG000|NOT COMPLETED|Overall Study||0||
48343354|NCT00754156|101167762|FG000|STARTED|Overall Study||8||
48343355|NCT00754156|101167763|FG001|STARTED|Overall Study||6||
48414336|NCT01899729|101350038|FG000|STARTED|Overall Study||9||
48634058|NCT03636256|101888839|FG001|NOT COMPLETED|Overall Study||0||
48634059|NCT03636256|101888840|FG002|NOT COMPLETED|Overall Study||2||
48414337|NCT01899729|101350039|FG001|STARTED|Overall Study||9||
48414338|NCT01899729|101350040|FG002|STARTED|Overall Study||8||
48414339|NCT01899729|101350041|FG003|STARTED|Overall Study||9||
48634060|NCT03636256|101888841|FG003|NOT COMPLETED|Overall Study||1||
48634061|NCT03636256|101888842|FG004|NOT COMPLETED|Overall Study||0||
48634062|NCT03636256|101888843|FG005|NOT COMPLETED|Overall Study||4||
48634063|NCT03636256|101888844|FG006|NOT COMPLETED|Overall Study||2||
48343356|NCT00754156|101167762|FG000|COMPLETED|Overall Study||8||
48343357|NCT00754156|101167763|FG001|COMPLETED|Overall Study||6||
48343358|NCT00754156|101167762|FG000|NOT COMPLETED|Overall Study||0||
48414340|NCT01899729|101350042|FG004|STARTED|Overall Study||11||
48634064|NCT03636256|101888845|FG007|NOT COMPLETED|Overall Study||0||
48343359|NCT00754156|101167763|FG001|NOT COMPLETED|Overall Study||0||
48343360|NCT01961115|101167764|FG000|STARTED|Overall Study||2||
48757035|NCT02008396|102194222|FG001|STARTED|Stage 1||4||
48757036|NCT02008396|102194223|FG002|STARTED|Stage 1||4||
48757037|NCT02008396|102194221|FG000|COMPLETED|Stage 1||3|Primary Endpoint|
48182910|NCT02322775|100772099|FG000|COMPLETED|Overall Study||101||
48414341|NCT01899729|101350038|FG000|COMPLETED|Overall Study||7||
48414342|NCT01899729|101350039|FG001|COMPLETED|Overall Study||7||
48414343|NCT01899729|101350040|FG002|COMPLETED|Overall Study||6||
48182911|NCT02322775|100772100|FG001|COMPLETED|Overall Study||99||
48182912|NCT02322775|100772099|FG000|NOT COMPLETED|Overall Study||5||
48414344|NCT01899729|101350041|FG003|COMPLETED|Overall Study||9||
48414345|NCT01899729|101350042|FG004|COMPLETED|Overall Study||9||
48414346|NCT01899729|101350038|FG000|NOT COMPLETED|Overall Study||2||
48343361|NCT01961115|101167765|FG001|STARTED|Overall Study||0||
48343362|NCT01961115|101167766|FG002|STARTED|Overall Study||9||
48343363|NCT01961115|101167764|FG000|COMPLETED|Overall Study||0|The protocol called for 12 patients to be enrolled. After 3 years and 4 months only 11 pts enrolled.|
48634065|NCT03636256|101888846|FG008|NOT COMPLETED|Overall Study||5||
48757038|NCT02008396|102194222|FG001|COMPLETED|Stage 1||4|Primary Endpoint|
48182913|NCT02322775|100772100|FG001|NOT COMPLETED|Overall Study||6||
48182914|NCT02460900|100772101|FG000|STARTED|Overall Study||46||
48182915|NCT02460900|100772102|FG001|STARTED|Overall Study||47||
48182916|NCT02460900|100772103|FG002|STARTED|Overall Study||42||
48182917|NCT02460900|100772104|FG003|STARTED|Overall Study||49||
48343364|NCT01961115|101167765|FG001|COMPLETED|Overall Study||0|The protocol called for 12 patients to be enrolled. After 3 years and 4 months only 11 pts enrolled.|
48343365|NCT01961115|101167766|FG002|COMPLETED|Overall Study||5|The protocol called for 12 patients to be enrolled. After 3 years and 4 months only 11 pts enrolled.|
48343366|NCT01961115|101167764|FG000|NOT COMPLETED|Overall Study||2||
48343367|NCT01961115|101167765|FG001|NOT COMPLETED|Overall Study||0||
48343368|NCT01961115|101167766|FG002|NOT COMPLETED|Overall Study||4||
48343369|NCT01231412|101167767|FG000|STARTED|Overall Study||77||
48343370|NCT01231412|101167768|FG001|STARTED|Overall Study||91||
48343371|NCT01231412|101167769|FG002|STARTED|Overall Study||6||
48343372|NCT01231412|101167767|FG000|COMPLETED|Overall Study||77||
48343373|NCT01231412|101167768|FG001|COMPLETED|Overall Study||90||
48343374|NCT01231412|101167769|FG002|COMPLETED|Overall Study||6||
48343375|NCT01231412|101167767|FG000|NOT COMPLETED|Overall Study||0||
48343376|NCT01231412|101167768|FG001|NOT COMPLETED|Overall Study||1||
48343377|NCT01231412|101167769|FG002|NOT COMPLETED|Overall Study||0||
48343378|NCT03670030|101167770|FG000|STARTED|Overall Study||5||
48343379|NCT03670030|101167770|FG000|COMPLETED|Overall Study||5||
48343380|NCT03670030|101167770|FG000|NOT COMPLETED|Overall Study||0||
48343381|NCT03157531|101167771|FG000|STARTED|Overall Study||97||
48343382|NCT03157531|101167771|FG000|Analyzed at 30 Days For MAEs|Overall Study||93||
48343383|NCT03157531|101167771|FG000|COMPLETED|Overall Study||91||
48414347|NCT01899729|101350039|FG001|NOT COMPLETED|Overall Study||2||
48634066|NCT02941640|101888847|FG000|STARTED|Overall Study||30||
48634067|NCT02941640|101888848|FG001|STARTED|Overall Study||30||
48634068|NCT02941640|101888849|FG002|STARTED|Overall Study||30||
48634069|NCT02941640|101888850|FG003|STARTED|Overall Study||30||
48634070|NCT02941640|101888847|FG000|COMPLETED|Overall Study||30||
48634071|NCT02941640|101888848|FG001|COMPLETED|Overall Study||30||
48634072|NCT02941640|101888849|FG002|COMPLETED|Overall Study||30||
48757039|NCT02008396|102194223|FG002|COMPLETED|Stage 1||4|Primary Endpoint|
48182918|NCT02460900|100772101|FG000|COMPLETED|Overall Study||36||
48182919|NCT02460900|100772102|FG001|COMPLETED|Overall Study||37||
48182920|NCT02460900|100772103|FG002|COMPLETED|Overall Study||28||
48182921|NCT02460900|100772104|FG003|COMPLETED|Overall Study||30||
48182922|NCT02460900|100772101|FG000|NOT COMPLETED|Overall Study||10||
48182923|NCT02460900|100772102|FG001|NOT COMPLETED|Overall Study||10||
48182924|NCT02460900|100772103|FG002|NOT COMPLETED|Overall Study||14||
48182925|NCT02460900|100772104|FG003|NOT COMPLETED|Overall Study||19||
48182926|NCT03379233|100772105|FG000|STARTED|Overall Study||1||
48182927|NCT03379233|100772106|FG001|STARTED|Overall Study||6||
48182928|NCT03379233|100772105|FG000|COMPLETED|Overall Study||0||
48182929|NCT03379233|100772106|FG001|COMPLETED|Overall Study||0||
48182930|NCT03379233|100772105|FG000|NOT COMPLETED|Overall Study||1||
48414348|NCT01899729|101350040|FG002|NOT COMPLETED|Overall Study||2||
48634073|NCT02941640|101888850|FG003|COMPLETED|Overall Study||30||
48634074|NCT02941640|101888847|FG000|NOT COMPLETED|Overall Study||0||
48414349|NCT01899729|101350041|FG003|NOT COMPLETED|Overall Study||0||
48634075|NCT02941640|101888848|FG001|NOT COMPLETED|Overall Study||0||
48634076|NCT02941640|101888849|FG002|NOT COMPLETED|Overall Study||0||
48634077|NCT02941640|101888850|FG003|NOT COMPLETED|Overall Study||0||
48634078|NCT01870596|101888851|FG000|STARTED|Overall Study||14||
48634079|NCT01870596|101888852|FG001|STARTED|Overall Study||18||
48634080|NCT01870596|101888851|FG000|COMPLETED|Overall Study||14||
48634081|NCT01870596|101888852|FG001|COMPLETED|Overall Study||18||
48634082|NCT01870596|101888851|FG000|NOT COMPLETED|Overall Study||0||
48634083|NCT01870596|101888852|FG001|NOT COMPLETED|Overall Study||0||
48634084|NCT02641834|101888853|FG000|STARTED|Overall Study||60||
48634085|NCT02641834|101888854|FG001|STARTED|Overall Study||58||
48634086|NCT02641834|101888853|FG000|COMPLETED|Overall Study||50||
48634087|NCT02641834|101888854|FG001|COMPLETED|Overall Study||50||
48634088|NCT02641834|101888853|FG000|NOT COMPLETED|Overall Study||10||
48634089|NCT02641834|101888854|FG001|NOT COMPLETED|Overall Study||8||
48634090|NCT01715298|101888855|FG000|STARTED|Overall Study||216||
48757040|NCT02008396|102194221|FG000|NOT COMPLETED|Stage 1||1||
48182931|NCT03379233|100772106|FG001|NOT COMPLETED|Overall Study||6||
48182932|NCT01052662|100772107|FG000|STARTED|Overall Study||28||
48182933|NCT01052662|100772108|FG001|STARTED|Overall Study||27||
48182934|NCT01052662|100772109|FG002|STARTED|Overall Study||32||
48182935|NCT01052662|100772107|FG000|Stabilization Phase|Overall Study||21||
48182936|NCT01052662|100772108|FG001|Stabilization Phase|Overall Study||21||
48182937|NCT01052662|100772109|FG002|Stabilization Phase|Overall Study||26||
48182938|NCT01052662|100772107|FG000|Discontinuation Phase|Overall Study||6||
48182939|NCT01052662|100772108|FG001|Discontinuation Phase|Overall Study||5||
48182940|NCT01052662|100772109|FG002|Discontinuation Phase|Overall Study||10||
48182941|NCT01052662|100772107|FG000|COMPLETED|Overall Study||6||
48182942|NCT01052662|100772108|FG001|COMPLETED|Overall Study||5||
48182943|NCT01052662|100772109|FG002|COMPLETED|Overall Study||10||
48343384|NCT03157531|101167771|FG000|NOT COMPLETED|Overall Study||6||
48343385|NCT00950170|101167772|FG000|STARTED|Overall Study||23||
48343386|NCT00950170|101167772|FG000|COMPLETED|Overall Study||19||
48343387|NCT00950170|101167772|FG000|NOT COMPLETED|Overall Study||4||
48343388|NCT01707992|101167773|FG000|STARTED|Placebo-Controlled Phase (24 Months)||740||
48634091|NCT01715298|101888856|FG001|STARTED|Overall Study||216||
48182944|NCT01052662|100772107|FG000|NOT COMPLETED|Overall Study||22||
48182945|NCT01052662|100772108|FG001|NOT COMPLETED|Overall Study||22||
48343389|NCT01707992|101167774|FG001|STARTED|Placebo-Controlled Phase (24 Months)||727||
48343390|NCT01707992|101167775|FG002|STARTED|Placebo-Controlled Phase (24 Months)||732||
48343391|NCT01707992|101167776|FG003|STARTED|Placebo-Controlled Phase (24 Months)||0||
48343392|NCT01707992|101167777|FG004|STARTED|Placebo-Controlled Phase (24 Months)||0||
48182946|NCT01052662|100772109|FG002|NOT COMPLETED|Overall Study||22||
48368095|NCT01798706|101230105|FG001|STARTED|Overall Study||174||
48182947|NCT02297503|100772110|FG000|STARTED|Overall Study||30||
48182948|NCT02297503|100772111|FG001|STARTED|Overall Study||31||
48343393|NCT01707992|101167778|FG005|STARTED|Placebo-Controlled Phase (24 Months)||0||
48343394|NCT01707992|101167773|FG000|COMPLETED|Placebo-Controlled Phase (24 Months)||596||
48343395|NCT01707992|101167774|FG001|COMPLETED|Placebo-Controlled Phase (24 Months)||623||
48343396|NCT01707992|101167775|FG002|COMPLETED|Placebo-Controlled Phase (24 Months)||532||
48343397|NCT01707992|101167776|FG003|COMPLETED|Placebo-Controlled Phase (24 Months)||0||
48343398|NCT01707992|101167777|FG004|COMPLETED|Placebo-Controlled Phase (24 Months)||0||
48343399|NCT01707992|101167778|FG005|COMPLETED|Placebo-Controlled Phase (24 Months)||0||
48343400|NCT01707992|101167773|FG000|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||144||
48343401|NCT01707992|101167774|FG001|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||104||
48343402|NCT01707992|101167775|FG002|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||200||
48343403|NCT01707992|101167776|FG003|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0||
48343404|NCT01707992|101167777|FG004|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0||
48343405|NCT01707992|101167778|FG005|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0||
48343406|NCT01707992|101167773|FG000|STARTED|Active Treatment Phase (24 Months)||0||
48343407|NCT01707992|101167774|FG001|STARTED|Active Treatment Phase (24 Months)||0||
48343408|NCT01707992|101167775|FG002|STARTED|Active Treatment Phase (24 Months)||0||
48343409|NCT01707992|101167776|FG003|STARTED|Active Treatment Phase (24 Months)||891||
48343410|NCT01707992|101167777|FG004|STARTED|Active Treatment Phase (24 Months)||504||
48343411|NCT01707992|101167778|FG005|STARTED|Active Treatment Phase (24 Months)||215||
48343412|NCT01707992|101167773|FG000|COMPLETED|Active Treatment Phase (24 Months)||0||
48343413|NCT01707992|101167774|FG001|COMPLETED|Active Treatment Phase (24 Months)||0||
48343414|NCT01707992|101167775|FG002|COMPLETED|Active Treatment Phase (24 Months)||0||
48343415|NCT01707992|101167776|FG003|COMPLETED|Active Treatment Phase (24 Months)||7||
48343416|NCT01707992|101167777|FG004|COMPLETED|Active Treatment Phase (24 Months)||10||
48343417|NCT01707992|101167778|FG005|COMPLETED|Active Treatment Phase (24 Months)||0||
48343418|NCT01707992|101167773|FG000|NOT COMPLETED|Active Treatment Phase (24 Months)||0||
48343419|NCT01707992|101167774|FG001|NOT COMPLETED|Active Treatment Phase (24 Months)||0||
48343420|NCT01707992|101167775|FG002|NOT COMPLETED|Active Treatment Phase (24 Months)||0||
48343421|NCT01707992|101167776|FG003|NOT COMPLETED|Active Treatment Phase (24 Months)||884||
48343422|NCT01707992|101167777|FG004|NOT COMPLETED|Active Treatment Phase (24 Months)||494||
48343423|NCT01707992|101167778|FG005|NOT COMPLETED|Active Treatment Phase (24 Months)||215||
48343424|NCT01285349|101167779|FG000|STARTED|Overall Study||190||
48343425|NCT01285349|101167780|FG001|STARTED|Overall Study||190||
48343426|NCT01285349|101167781|FG002|STARTED|Overall Study||184||
48343427|NCT01285349|101167779|FG000|COMPLETED|Overall Study||163||
48343428|NCT01285349|101167780|FG001|COMPLETED|Overall Study||170||
48343429|NCT01285349|101167781|FG002|COMPLETED|Overall Study||157||
48343430|NCT01285349|101167779|FG000|NOT COMPLETED|Overall Study||27||
48343431|NCT01285349|101167780|FG001|NOT COMPLETED|Overall Study||20||
48343432|NCT01285349|101167781|FG002|NOT COMPLETED|Overall Study||27||
48343433|NCT03068715|101167782|FG000|STARTED|Overall Study||15||
48343434|NCT03068715|101167783|FG001|STARTED|Overall Study||15||
48343435|NCT03068715|101167782|FG000|COMPLETED|Overall Study||14||
48343436|NCT03068715|101167783|FG001|COMPLETED|Overall Study||15||
48343437|NCT03068715|101167782|FG000|NOT COMPLETED|Overall Study||1||
48343438|NCT03068715|101167783|FG001|NOT COMPLETED|Overall Study||0||
48343439|NCT00404092|101167784|FG000|STARTED|Overall Study||9||
48343440|NCT00404092|101167785|FG001|STARTED|Overall Study||8||
48343441|NCT00404092|101167786|FG002|STARTED|Overall Study||9||
48343442|NCT00404092|101167787|FG003|STARTED|Overall Study||20||
48343443|NCT00404092|101167784|FG000|COMPLETED|Overall Study||8||
48343444|NCT00404092|101167785|FG001|COMPLETED|Overall Study||8||
48343445|NCT00404092|101167786|FG002|COMPLETED|Overall Study||8||
48343446|NCT00404092|101167787|FG003|COMPLETED|Overall Study||20||
48343447|NCT00404092|101167784|FG000|NOT COMPLETED|Overall Study||1||
48343448|NCT00404092|101167785|FG001|NOT COMPLETED|Overall Study||0||
48343449|NCT00404092|101167786|FG002|NOT COMPLETED|Overall Study||1||
48343450|NCT00404092|101167787|FG003|NOT COMPLETED|Overall Study||0||
48343451|NCT02928952|101167788|FG000|STARTED|Overall Study||65||
48343452|NCT02928952|101167789|FG001|STARTED|Overall Study||67||
48343453|NCT02928952|101167788|FG000|COMPLETED|Overall Study||55||
48343454|NCT02928952|101167789|FG001|COMPLETED|Overall Study||60||
48343455|NCT02928952|101167788|FG000|NOT COMPLETED|Overall Study||10||
48343456|NCT02928952|101167789|FG001|NOT COMPLETED|Overall Study||7||
48343457|NCT01946178|101167790|FG000|STARTED|Overall Study||73||
48343458|NCT01946178|101167790|FG000|COMPLETED|Overall Study||71||
48343459|NCT01946178|101167790|FG000|NOT COMPLETED|Overall Study||2||
48343460|NCT05340504|101167791|FG000|STARTED|Overall Study||6||
48343461|NCT05340504|101167792|FG001|STARTED|Overall Study||6||
48343462|NCT05340504|101167791|FG000|COMPLETED|Overall Study||5||
48343463|NCT05340504|101167792|FG001|COMPLETED|Overall Study||6||
48343464|NCT05340504|101167791|FG000|NOT COMPLETED|Overall Study||1||
48343465|NCT05340504|101167792|FG001|NOT COMPLETED|Overall Study||0||
48343466|NCT03624816|101167793|FG000|STARTED|Overall Study||107||
48343467|NCT03624816|101167794|FG001|STARTED|Overall Study||33||
48343468|NCT03624816|101167793|FG000|COMPLETED|Overall Study||97||
48343469|NCT03624816|101167794|FG001|COMPLETED|Overall Study||26||
48343470|NCT03624816|101167793|FG000|NOT COMPLETED|Overall Study||10||
48757041|NCT02008396|102194222|FG001|NOT COMPLETED|Stage 1||0||
48757042|NCT02008396|102194223|FG002|NOT COMPLETED|Stage 1||0||
48757043|NCT02008396|102194221|FG000|STARTED|Stage 2||3||
48757044|NCT02008396|102194222|FG001|STARTED|Stage 2||0||
48757045|NCT02008396|102194223|FG002|STARTED|Stage 2||0||
48343471|NCT03624816|101167794|FG001|NOT COMPLETED|Overall Study||7||
48343472|NCT00723957|101167795|FG000|STARTED|Overall Study||98||
48343473|NCT00723957|101167796|FG001|STARTED|Overall Study||99||
48757046|NCT02008396|102194221|FG000|COMPLETED|Stage 2||3||
48757047|NCT02008396|102194222|FG001|COMPLETED|Stage 2||0||
48757048|NCT02008396|102194223|FG002|COMPLETED|Stage 2||0||
48343474|NCT00723957|101167795|FG000|COMPLETED|Overall Study||47||
48343475|NCT00723957|101167796|FG001|COMPLETED|Overall Study||46||
48343476|NCT00723957|101167795|FG000|NOT COMPLETED|Overall Study||51||
48343477|NCT00723957|101167796|FG001|NOT COMPLETED|Overall Study||53||
48343478|NCT03838484|101167797|FG000|STARTED|Overall Study||5||
48343479|NCT03838484|101167798|FG001|STARTED|Overall Study||5||
48343480|NCT03838484|101167799|FG002|STARTED|Overall Study||4||
48343481|NCT03838484|101167800|FG003|STARTED|Overall Study||4||
48343482|NCT03838484|101167797|FG000|COMPLETED|Overall Study||5||
48343483|NCT03838484|101167798|FG001|COMPLETED|Overall Study||4||
48343484|NCT03838484|101167799|FG002|COMPLETED|Overall Study||4||
48343485|NCT03838484|101167800|FG003|COMPLETED|Overall Study||4||
48343486|NCT03838484|101167797|FG000|NOT COMPLETED|Overall Study||0||
48343487|NCT03838484|101167798|FG001|NOT COMPLETED|Overall Study||1||
48343488|NCT03838484|101167799|FG002|NOT COMPLETED|Overall Study||0||
48343489|NCT03838484|101167800|FG003|NOT COMPLETED|Overall Study||0||
48343490|NCT00883493|101167801|FG000|STARTED|Overall Study||212||
48343491|NCT00883493|101167802|FG001|STARTED|Overall Study||209||
48343492|NCT00883493|101167801|FG000|Intention To Treat Analysis Population|Overall Study||204||
48343493|NCT00883493|101167802|FG001|Intention To Treat Analysis Population|Overall Study||195||
48343494|NCT00883493|101167801|FG000|Per Protocol Analysis Population|Overall Study||162||
48343495|NCT00883493|101167802|FG001|Per Protocol Analysis Population|Overall Study||155||
48343496|NCT00883493|101167801|FG000|COMPLETED|Overall Study||166||
48343497|NCT00883493|101167802|FG001|COMPLETED|Overall Study||159||
48343498|NCT00883493|101167801|FG000|NOT COMPLETED|Overall Study||46||
48343499|NCT00883493|101167802|FG001|NOT COMPLETED|Overall Study||50||
48343500|NCT01499290|101167803|FG000|STARTED|Overall Study||529||
48343501|NCT01499290|101167804|FG001|STARTED|Overall Study||529||
48343502|NCT01499290|101167803|FG000|COMPLETED|Overall Study||474||
48343503|NCT01499290|101167804|FG001|COMPLETED|Overall Study||494||
48343504|NCT01499290|101167803|FG000|NOT COMPLETED|Overall Study||55||
48343505|NCT01499290|101167804|FG001|NOT COMPLETED|Overall Study||35||
48343506|NCT00888355|101167805|FG000|STARTED|Overall Study||108||
48343507|NCT00888355|101167806|FG001|STARTED|Overall Study||108||
48343508|NCT00888355|101167807|FG002|STARTED|Overall Study||106||
48343509|NCT00888355|101167808|FG003|STARTED|Overall Study||106||
48343510|NCT00888355|101167805|FG000|COMPLETED|Overall Study||86||
48343511|NCT00888355|101167806|FG001|COMPLETED|Overall Study||99||
48343512|NCT00888355|101167807|FG002|COMPLETED|Overall Study||94||
48414350|NCT01899729|101350042|FG004|NOT COMPLETED|Overall Study||2||
48414351|NCT01137006|101350043|FG000|STARTED|Overall Study||3||
48414352|NCT01137006|101350044|FG001|STARTED|Overall Study||3||
48414353|NCT01137006|101350045|FG002|STARTED|Overall Study||8||
48414354|NCT01137006|101350046|FG003|STARTED|Overall Study||3||
48757049|NCT02008396|102194221|FG000|NOT COMPLETED|Stage 2||0||
48757050|NCT02008396|102194222|FG001|NOT COMPLETED|Stage 2||0||
48757051|NCT02008396|102194223|FG002|NOT COMPLETED|Stage 2||0||
48757052|NCT04235140|102194224|FG000|STARTED|Overall Study||52||
48757053|NCT04235140|102194224|FG000|Rollover Participants|Overall Study||39||
48757054|NCT04235140|102194224|FG000|Lumacaftor (LUM)/ Ivacaftor (IVA)-Naïve Participants|Overall Study||13||
48343513|NCT00888355|101167808|FG003|COMPLETED|Overall Study||96||
48343514|NCT00888355|101167805|FG000|NOT COMPLETED|Overall Study||22||
48343515|NCT00888355|101167806|FG001|NOT COMPLETED|Overall Study||9||
48414355|NCT01137006|101350047|FG004|STARTED|Overall Study||3||
48414356|NCT01137006|101350048|FG005|STARTED|Overall Study||4||
48414357|NCT01137006|101350049|FG006|STARTED|Overall Study||3||
48414358|NCT01137006|101350043|FG000|Completed at Least 1 Treatment Cycle|Overall Study||3||
48757055|NCT04235140|102194224|FG000|COMPLETED|Overall Study||38||
48757056|NCT04235140|102194224|FG000|NOT COMPLETED|Overall Study||14||
48757057|NCT02787564|102194225|FG000|STARTED|Overall Study||32||
48757058|NCT02787564|102194226|FG001|STARTED|Overall Study||29||
48757059|NCT02787564|102194225|FG000|COMPLETED|Overall Study||25||
48757060|NCT02787564|102194226|FG001|COMPLETED|Overall Study||27||
48757061|NCT02787564|102194225|FG000|NOT COMPLETED|Overall Study||7||
48757062|NCT02787564|102194226|FG001|NOT COMPLETED|Overall Study||2||
48343516|NCT00888355|101167807|FG002|NOT COMPLETED|Overall Study||12||
48343517|NCT00888355|101167808|FG003|NOT COMPLETED|Overall Study||10||
48343518|NCT02076165|101167809|FG000|STARTED|Overall Study||74||
48343519|NCT02076165|101167810|FG001|STARTED|Overall Study||75||
48343520|NCT02076165|101167809|FG000|COMPLETED|Overall Study||66||
48343521|NCT02076165|101167810|FG001|COMPLETED|Overall Study||69||
48343522|NCT02076165|101167809|FG000|NOT COMPLETED|Overall Study||8||
48414359|NCT01137006|101350044|FG001|Completed at Least 1 Treatment Cycle|Overall Study||3||
48343523|NCT02076165|101167810|FG001|NOT COMPLETED|Overall Study||6||
48343524|NCT00191854|101167811|FG000|STARTED|Overall Study||49||
48343525|NCT00191854|101167812|FG001|STARTED|Overall Study||47||
48343526|NCT00191854|101167813|FG002|STARTED|Overall Study||51||
48343527|NCT00191854|101167811|FG000|Received at Least One Dose of Study Drug|Overall Study||49||
48343528|NCT00191854|101167812|FG001|Received at Least One Dose of Study Drug|Overall Study||47||
48343529|NCT00191854|101167813|FG002|Received at Least One Dose of Study Drug|Overall Study||50||
48343530|NCT00191854|101167811|FG000|COMPLETED|Overall Study||12||
48343531|NCT00191854|101167812|FG001|COMPLETED|Overall Study||17||
48343532|NCT00191854|101167813|FG002|COMPLETED|Overall Study||12||
48343533|NCT00191854|101167811|FG000|NOT COMPLETED|Overall Study||37||
48343534|NCT00191854|101167812|FG001|NOT COMPLETED|Overall Study||30||
48343535|NCT00191854|101167813|FG002|NOT COMPLETED|Overall Study||39||
48343536|NCT01920802|101167814|FG000|STARTED|Overall Study||11||
48343537|NCT01920802|101167815|FG001|STARTED|Overall Study||9||
48634092|NCT01715298|101888855|FG000|Full Analysis Set (FAS)|Overall Study||215||
48634093|NCT01715298|101888856|FG001|Full Analysis Set (FAS)|Overall Study||214||
48634094|NCT01715298|101888855|FG000|COMPLETED|Overall Study||209||
48634095|NCT01715298|101888856|FG001|COMPLETED|Overall Study||205||
48634096|NCT01715298|101888855|FG000|NOT COMPLETED|Overall Study||7||
48634097|NCT01715298|101888856|FG001|NOT COMPLETED|Overall Study||11||
48634098|NCT03502798|101888857|FG000|STARTED|Overall Study||5||
48634099|NCT03502798|101888858|FG001|STARTED|Overall Study||40||
48634100|NCT03502798|101888857|FG000|COMPLETED|Overall Study||5||
48634101|NCT03502798|101888858|FG001|COMPLETED|Overall Study||33||
48634102|NCT03502798|101888857|FG000|NOT COMPLETED|Overall Study||0||
48634103|NCT03502798|101888858|FG001|NOT COMPLETED|Overall Study||7||
48634104|NCT03479905|101888859|FG000|STARTED|Overall Study||47||
48634105|NCT03479905|101888860|FG001|STARTED|Overall Study||48||
48634106|NCT03479905|101888861|FG002|STARTED|Overall Study||48||
48634107|NCT03479905|101888859|FG000|COMPLETED|Overall Study||43||
48634108|NCT03479905|101888860|FG001|COMPLETED|Overall Study||43||
48634109|NCT03479905|101888861|FG002|COMPLETED|Overall Study||43||
48634110|NCT03479905|101888859|FG000|NOT COMPLETED|Overall Study||4||
48757063|NCT00918281|102194227|FG000|STARTED|Overall Study||70||
48757064|NCT00918281|102194227|FG000|COMPLETED|Overall Study||41||
48634111|NCT03479905|101888860|FG001|NOT COMPLETED|Overall Study||5||
48634112|NCT03479905|101888861|FG002|NOT COMPLETED|Overall Study||5||
48634113|NCT00769561|101888862|FG000|STARTED|Overall Study||29||
48634114|NCT00769561|101888863|FG001|STARTED|Overall Study||29||
48634115|NCT00769561|101888862|FG000|COMPLETED|Overall Study||26||
48634116|NCT00769561|101888863|FG001|COMPLETED|Overall Study||24||
48634117|NCT00769561|101888862|FG000|NOT COMPLETED|Overall Study||3||
48757065|NCT00918281|102194227|FG000|NOT COMPLETED|Overall Study||29||
48757066|NCT03466658|102194228|FG000|STARTED|Overall Study||17||34
48757067|NCT03466658|102194228|FG000|COMPLETED|Overall Study||14||28
48343538|NCT01920802|101167816|FG002|STARTED|Overall Study||11||
48343539|NCT01920802|101167814|FG000|COMPLETED|Overall Study||7||
48343540|NCT01920802|101167815|FG001|COMPLETED|Overall Study||7||
48343541|NCT01920802|101167816|FG002|COMPLETED|Overall Study||10||
48343542|NCT01920802|101167814|FG000|NOT COMPLETED|Overall Study||4||
48343543|NCT01920802|101167815|FG001|NOT COMPLETED|Overall Study||2||
48343544|NCT01920802|101167816|FG002|NOT COMPLETED|Overall Study||1||
48343545|NCT01284504|101167817|FG000|STARTED|Overall Study||0||
48343546|NCT01284504|101167818|FG001|STARTED|Overall Study||0||
48343547|NCT01284504|101167817|FG000|COMPLETED|Overall Study||0||
48343548|NCT01284504|101167818|FG001|COMPLETED|Overall Study||0||
48634118|NCT00769561|101888863|FG001|NOT COMPLETED|Overall Study||5||
48634119|NCT00819039|101888864|FG000|STARTED|Overall Study||46||
48634120|NCT00819039|101888865|FG001|STARTED|Overall Study||27||
48634121|NCT00819039|101888866|FG002|STARTED|Overall Study||25||
48634122|NCT00819039|101888864|FG000|COMPLETED|Overall Study||44||
48634123|NCT00819039|101888865|FG001|COMPLETED|Overall Study||27||
48634124|NCT00819039|101888866|FG002|COMPLETED|Overall Study||24||
48634125|NCT00819039|101888864|FG000|NOT COMPLETED|Overall Study||2||
48634126|NCT00819039|101888865|FG001|NOT COMPLETED|Overall Study||0||
48634127|NCT00819039|101888866|FG002|NOT COMPLETED|Overall Study||1||
48634128|NCT02873689|101888867|FG000|STARTED|Overall Study||109||
48634129|NCT02873689|101888868|FG001|STARTED|Overall Study||108||
48634130|NCT02873689|101888867|FG000|Treated|Overall Study||108||
48634131|NCT02873689|101888868|FG001|Treated|Overall Study||107||
48634132|NCT02873689|101888867|FG000|COMPLETED|Overall Study||102||
48634133|NCT02873689|101888868|FG001|COMPLETED|Overall Study||103||
48634134|NCT02873689|101888867|FG000|NOT COMPLETED|Overall Study||7||
48634135|NCT02873689|101888868|FG001|NOT COMPLETED|Overall Study||5||
48634136|NCT03462680|101888869|FG000|STARTED|Overall Study||21||
48757068|NCT03466658|102194228|FG000|NOT COMPLETED|Overall Study||3||6
48757069|NCT02735863|102194229|FG000|STARTED|Overall Study||6||
48343549|NCT01284504|101167817|FG000|NOT COMPLETED|Overall Study||0||
48343550|NCT01284504|101167818|FG001|NOT COMPLETED|Overall Study||0||
48343551|NCT00670007|101167819|FG000|STARTED|Overall Study||140||
48634137|NCT03462680|101888870|FG001|STARTED|Overall Study||26||
48634138|NCT03462680|101888869|FG000|COMPLETED|Overall Study||18||
48634139|NCT03462680|101888870|FG001|COMPLETED|Overall Study||21||
48634140|NCT03462680|101888869|FG000|NOT COMPLETED|Overall Study||3||
48343552|NCT00670007|101167819|FG000|COMPLETED|Overall Study||131||
48343553|NCT00670007|101167819|FG000|NOT COMPLETED|Overall Study||9||
48343554|NCT00323284|101167820|FG000|STARTED|12 Months Follow-up||116||
48343555|NCT00323284|101167821|FG001|STARTED|12 Months Follow-up||123||
48343556|NCT00323284|101167820|FG000|COMPLETED|12 Months Follow-up||111||
48343557|NCT00323284|101167821|FG001|COMPLETED|12 Months Follow-up||114||
48343558|NCT00323284|101167820|FG000|NOT COMPLETED|12 Months Follow-up||5||
48343559|NCT00323284|101167821|FG001|NOT COMPLETED|12 Months Follow-up||9||
48343560|NCT00323284|101167820|FG000|STARTED|24 Months Follow-up||116||
48343561|NCT00323284|101167821|FG001|STARTED|24 Months Follow-up||123||
48343562|NCT00323284|101167820|FG000|COMPLETED|24 Months Follow-up||98||
48343563|NCT00323284|101167821|FG001|COMPLETED|24 Months Follow-up||101||
48343564|NCT00323284|101167820|FG000|NOT COMPLETED|24 Months Follow-up||18||
48343565|NCT00323284|101167821|FG001|NOT COMPLETED|24 Months Follow-up||22||
48343566|NCT04348851|101167822|FG000|STARTED|Post-Test 1||13||
48343567|NCT04348851|101167823|FG001|STARTED|Post-Test 1||13||
48343568|NCT04348851|101167824|FG002|STARTED|Post-Test 1||13||
48343569|NCT04348851|101167825|FG003|STARTED|Post-Test 1||14||
48343570|NCT04348851|101167822|FG000|COMPLETED|Post-Test 1||13||
48343571|NCT04348851|101167823|FG001|COMPLETED|Post-Test 1||11||
48343572|NCT04348851|101167824|FG002|COMPLETED|Post-Test 1||13||
48343573|NCT04348851|101167825|FG003|COMPLETED|Post-Test 1||14||
48343574|NCT04348851|101167822|FG000|NOT COMPLETED|Post-Test 1||0||
48343575|NCT04348851|101167823|FG001|NOT COMPLETED|Post-Test 1||2||
48343576|NCT04348851|101167824|FG002|NOT COMPLETED|Post-Test 1||0||
48343577|NCT04348851|101167825|FG003|NOT COMPLETED|Post-Test 1||0||
48343578|NCT04348851|101167822|FG000|STARTED|Post-Test 2||13||
48343579|NCT04348851|101167823|FG001|STARTED|Post-Test 2||11||
48182949|NCT02297503|100772110|FG000|Initial Single Treatment|Overall Study||29||
48182950|NCT02297503|100772111|FG001|Initial Single Treatment|Overall Study||31||
48182951|NCT02297503|100772110|FG000|First Combined Treatment|Overall Study||28||
48182952|NCT02297503|100772111|FG001|First Combined Treatment|Overall Study||28||
48182953|NCT02297503|100772110|FG000|Second Combined Treatment|Overall Study||28||
48182954|NCT02297503|100772111|FG001|Second Combined Treatment|Overall Study||28||
48182955|NCT02297503|100772110|FG000|COMPLETED|Overall Study||28||
48182956|NCT02297503|100772111|FG001|COMPLETED|Overall Study||27||
48182957|NCT02297503|100772110|FG000|NOT COMPLETED|Overall Study||2||
48182958|NCT02297503|100772111|FG001|NOT COMPLETED|Overall Study||4||
48182959|NCT04719013|100772112|FG000|STARTED|Overall Study||85||
48182960|NCT04719013|100772112|FG000|COMPLETED|Overall Study||75||
48182961|NCT04719013|100772112|FG000|NOT COMPLETED|Overall Study||10||
48414360|NCT01137006|101350045|FG002|Completed at Least 1 Treatment Cycle|Overall Study||8||
48634141|NCT03462680|101888870|FG001|NOT COMPLETED|Overall Study||5||
48182962|NCT04305236|100772113|FG000|STARTED|Overall Study||1||
48182963|NCT04305236|100772113|FG000|COMPLETED|Overall Study||1||
48182964|NCT04305236|100772113|FG000|NOT COMPLETED|Overall Study||0||
48182965|NCT02412761|100772114|FG000|STARTED|First Intervention (2 Weeks)||5||
48182966|NCT02412761|100772115|FG001|STARTED|First Intervention (2 Weeks)||6||
48182967|NCT02412761|100772116|FG002|STARTED|First Intervention (2 Weeks)||5||
48182968|NCT02412761|100772117|FG003|STARTED|First Intervention (2 Weeks)||8||
48182969|NCT02412761|100772118|FG004|STARTED|First Intervention (2 Weeks)||4||
48182970|NCT02412761|100772119|FG005|STARTED|First Intervention (2 Weeks)||7||
48182971|NCT02412761|100772114|FG000|COMPLETED|First Intervention (2 Weeks)||5||
48182972|NCT02412761|100772115|FG001|COMPLETED|First Intervention (2 Weeks)||5||
48182973|NCT02412761|100772116|FG002|COMPLETED|First Intervention (2 Weeks)||4||
48182974|NCT02412761|100772117|FG003|COMPLETED|First Intervention (2 Weeks)||8||
48182975|NCT02412761|100772118|FG004|COMPLETED|First Intervention (2 Weeks)||4||
48182976|NCT02412761|100772119|FG005|COMPLETED|First Intervention (2 Weeks)||6||
48182977|NCT02412761|100772114|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0||
48182978|NCT02412761|100772115|FG001|NOT COMPLETED|First Intervention (2 Weeks)||1||
48182979|NCT02412761|100772116|FG002|NOT COMPLETED|First Intervention (2 Weeks)||1||
48343580|NCT04348851|101167824|FG002|STARTED|Post-Test 2||13||
48343581|NCT04348851|101167825|FG003|STARTED|Post-Test 2||14||
48343582|NCT04348851|101167822|FG000|COMPLETED|Post-Test 2||13||
48343583|NCT04348851|101167823|FG001|COMPLETED|Post-Test 2||10||
48343584|NCT04348851|101167824|FG002|COMPLETED|Post-Test 2||13||
48343585|NCT04348851|101167825|FG003|COMPLETED|Post-Test 2||13||
48343586|NCT04348851|101167822|FG000|NOT COMPLETED|Post-Test 2||0||
48343587|NCT04348851|101167823|FG001|NOT COMPLETED|Post-Test 2||1||
48343588|NCT04348851|101167824|FG002|NOT COMPLETED|Post-Test 2||0||
48343589|NCT04348851|101167825|FG003|NOT COMPLETED|Post-Test 2||1||
48343590|NCT00619957|101167826|FG000|STARTED|Month 24 Double-Blind||93||
48343591|NCT00619957|101167827|FG001|STARTED|Month 24 Double-Blind||192||
48343592|NCT00619957|101167826|FG000|Intent to Treat (ITT Population)|Month 24 Double-Blind||93||
48343593|NCT00619957|101167827|FG001|Intent to Treat (ITT Population)|Month 24 Double-Blind||191||
48343594|NCT00619957|101167826|FG000|COMPLETED|Month 24 Double-Blind||75||
48343595|NCT00619957|101167827|FG001|COMPLETED|Month 24 Double-Blind||175||
48343596|NCT00619957|101167826|FG000|NOT COMPLETED|Month 24 Double-Blind||18||
48343597|NCT00619957|101167827|FG001|NOT COMPLETED|Month 24 Double-Blind||17||
48343598|NCT00619957|101167826|FG000|STARTED|Month 48 Open-Label||67||
48343599|NCT00619957|101167827|FG001|STARTED|Month 48 Open-Label||151||
48343600|NCT00619957|101167826|FG000|COMPLETED|Month 48 Open-Label||55||
48343601|NCT00619957|101167827|FG001|COMPLETED|Month 48 Open-Label||134||
48343602|NCT00619957|101167826|FG000|NOT COMPLETED|Month 48 Open-Label||12||
48343603|NCT00619957|101167827|FG001|NOT COMPLETED|Month 48 Open-Label||17||
48343604|NCT02863198|101167828|FG000|STARTED|Overall Study||60||
48343605|NCT02863198|101167829|FG001|STARTED|Overall Study||60||
48343606|NCT02863198|101167828|FG000|COMPLETED|Overall Study||60||
48343607|NCT02863198|101167829|FG001|COMPLETED|Overall Study||60||
48343608|NCT02863198|101167828|FG000|NOT COMPLETED|Overall Study||0||
48343609|NCT02863198|101167829|FG001|NOT COMPLETED|Overall Study||0||
48343610|NCT04187092|101167830|FG000|STARTED|Overall Study||17||
48343611|NCT04187092|101167831|FG001|STARTED|Overall Study||17||
48343612|NCT04187092|101167830|FG000|COMPLETED|Overall Study||15||
48343613|NCT04187092|101167831|FG001|COMPLETED|Overall Study||14||
48343614|NCT04187092|101167830|FG000|NOT COMPLETED|Overall Study||2||
48343615|NCT04187092|101167831|FG001|NOT COMPLETED|Overall Study||3||
48343616|NCT03072602|101167832|FG000|STARTED|Overall Study||39|81 participants started the study; 39 Blacks and 42 Whites|
48343617|NCT03072602|101167833|FG001|STARTED|Overall Study||42|81 participants started the study; 39 Blacks and 42 Whites|
48343618|NCT03072602|101167832|FG000|Total Participant Screened for the Purpose of Eligibilty|Overall Study||47|94 participants were screened for eligibility|
48343619|NCT03072602|101167833|FG001|Total Participant Screened for the Purpose of Eligibilty|Overall Study||47|94 participants were screened for eligibility|
48343620|NCT03072602|101167832|FG000|Ineligible Participants|Overall Study||8|13 determined ineligible by screening labs|
48343621|NCT03072602|101167833|FG001|Ineligible Participants|Overall Study||5|13 determined ineligible by screening labs|
48343622|NCT03072602|101167832|FG000|Participant Received Standardized Meals|Overall Study||39|81 Participants received 3 days of standardized meals to control for salt intake|
48343623|NCT03072602|101167833|FG001|Participant Received Standardized Meals|Overall Study||42|81 Participants received 3 days of standardized meals to control for salt intake|
48343624|NCT03072602|101167832|FG000|Study Dropouts|Overall Study||4|7 study dropouts|
48343625|NCT03072602|101167833|FG001|Study Dropouts|Overall Study||3|7 study dropouts|
48343626|NCT03072602|101167832|FG000|Participants Returned for Glucose Challenge Protocol|Overall Study||35|74 participants returned for the glucose challenge protocol|
48343627|NCT03072602|101167833|FG001|Participants Returned for Glucose Challenge Protocol|Overall Study||39|74 participants returned for the glucose challenge protocol|
48343628|NCT03072602|101167832|FG000|Unable to Complete the Protocol|Overall Study||1||
48343629|NCT03072602|101167833|FG001|Unable to Complete the Protocol|Overall Study||1||
48343630|NCT03072602|101167832|FG000|COMPLETED|Overall Study||34|72 participants completed the study; 34 Blacks and 38 Whites|
48343631|NCT03072602|101167833|FG001|COMPLETED|Overall Study||38|72 participants completed the study; 34 Blacks and 38 Whites|
48343632|NCT03072602|101167832|FG000|NOT COMPLETED|Overall Study||5||
48343633|NCT03072602|101167833|FG001|NOT COMPLETED|Overall Study||4||
48343634|NCT01731002|101167834|FG000|STARTED|Overall Study||75||
48343635|NCT01731002|101167835|FG001|STARTED|Overall Study||72||
48343636|NCT01731002|101167836|FG002|STARTED|Overall Study||77||
48343637|NCT01731002|101167834|FG000|COMPLETED|Overall Study||71||
48343638|NCT01731002|101167835|FG001|COMPLETED|Overall Study||68||
48343639|NCT01731002|101167836|FG002|COMPLETED|Overall Study||74||
48343640|NCT01731002|101167834|FG000|NOT COMPLETED|Overall Study||4||
48343641|NCT01731002|101167835|FG001|NOT COMPLETED|Overall Study||4||
48343642|NCT01731002|101167836|FG002|NOT COMPLETED|Overall Study||3||
48343643|NCT02305563|101167837|FG000|STARTED|Treatment Period||3|Started = Randomized|
48343644|NCT02305563|101167838|FG001|STARTED|Treatment Period||3|Started = Randomized|
48343645|NCT02305563|101167839|FG002|STARTED|Treatment Period||26|Started = Randomized|
48343646|NCT02305563|101167840|FG003|STARTED|Treatment Period||14|Started = Randomized|
48343647|NCT02305563|101167841|FG004|STARTED|Treatment Period||24|Started = Randomized|
48343648|NCT02305563|101167837|FG000|COMPLETED|Treatment Period||1|Completed = Continuing in the treatment period|
48343649|NCT02305563|101167838|FG001|COMPLETED|Treatment Period||1|Completed = Continuing in the treatment period|
48343650|NCT02305563|101167839|FG002|COMPLETED|Treatment Period||0|Completed = Continuing in the treatment period|
48343651|NCT02305563|101167840|FG003|COMPLETED|Treatment Period||0|Completed = Continuing in the treatment period|
48343652|NCT02305563|101167841|FG004|COMPLETED|Treatment Period||0|Completed = Continuing in the treatment period|
48343653|NCT02305563|101167837|FG000|NOT COMPLETED|Treatment Period||2||
48343654|NCT02305563|101167838|FG001|NOT COMPLETED|Treatment Period||2||
48343655|NCT02305563|101167839|FG002|NOT COMPLETED|Treatment Period||26||
48343656|NCT02305563|101167840|FG003|NOT COMPLETED|Treatment Period||14||
48343657|NCT02305563|101167841|FG004|NOT COMPLETED|Treatment Period||24||
48343658|NCT02305563|101167837|FG000|STARTED|Follow-up Period||3|Started = Entered follow-up|
48343659|NCT02305563|101167838|FG001|STARTED|Follow-up Period||3|Started = Entered follow-up|
48343660|NCT02305563|101167839|FG002|STARTED|Follow-up Period||11|Started = Entered follow-up|
48343661|NCT02305563|101167840|FG003|STARTED|Follow-up Period||6|Started = Entered follow-up|
48343662|NCT02305563|101167841|FG004|STARTED|Follow-up Period||12|Started = Entered follow-up|
48343663|NCT02305563|101167837|FG000|COMPLETED|Follow-up Period||0|Completed = Continuing in the follow-up period|
48343664|NCT02305563|101167838|FG001|COMPLETED|Follow-up Period||0|Completed = Continuing in the follow-up period|
48343665|NCT02305563|101167839|FG002|COMPLETED|Follow-up Period||0|Completed = Continuing in the follow-up period|
48343666|NCT02305563|101167840|FG003|COMPLETED|Follow-up Period||0|Completed = Continuing in the follow-up period|
48343667|NCT02305563|101167841|FG004|COMPLETED|Follow-up Period||0|Completed = Continuing in the follow-up period|
48343668|NCT02305563|101167837|FG000|NOT COMPLETED|Follow-up Period||3||
48343669|NCT02305563|101167838|FG001|NOT COMPLETED|Follow-up Period||3||
48343670|NCT02305563|101167839|FG002|NOT COMPLETED|Follow-up Period||11||
48343671|NCT02305563|101167840|FG003|NOT COMPLETED|Follow-up Period||6||
48343672|NCT02305563|101167841|FG004|NOT COMPLETED|Follow-up Period||12||
48343673|NCT00929240|101172176|FG000|STARTED|Initial Treatment Phase||284||
48343674|NCT00929240|101172177|FG001|STARTED|Initial Treatment Phase||0||
48343675|NCT00929240|101172178|FG002|STARTED|Initial Treatment Phase||0||
48343676|NCT00929240|101172176|FG000|COMPLETED|Initial Treatment Phase||185||
48343677|NCT00929240|101172177|FG001|COMPLETED|Initial Treatment Phase||0||
48343678|NCT00929240|101172178|FG002|COMPLETED|Initial Treatment Phase||0||
48343679|NCT00929240|101172176|FG000|NOT COMPLETED|Initial Treatment Phase||99||
48343680|NCT00929240|101172177|FG001|NOT COMPLETED|Initial Treatment Phase||0||
48343681|NCT00929240|101172178|FG002|NOT COMPLETED|Initial Treatment Phase||0||
48343682|NCT00929240|101172176|FG000|STARTED|Maintenance Phase||0||
48343683|NCT00929240|101172177|FG001|STARTED|Maintenance Phase||94||
48343684|NCT00929240|101172178|FG002|STARTED|Maintenance Phase||91||
48343685|NCT00929240|101172176|FG000|COMPLETED|Maintenance Phase||0||
48343686|NCT00929240|101172177|FG001|COMPLETED|Maintenance Phase||0||
48343687|NCT00929240|101172178|FG002|COMPLETED|Maintenance Phase||0||
48182980|NCT02412761|100772117|FG003|NOT COMPLETED|First Intervention (2 Weeks)||0||
48414361|NCT01137006|101350046|FG003|Completed at Least 1 Treatment Cycle|Overall Study||3||
48343688|NCT00929240|101172176|FG000|NOT COMPLETED|Maintenance Phase||0||
48343689|NCT00929240|101172177|FG001|NOT COMPLETED|Maintenance Phase||94||
48414362|NCT01137006|101350047|FG004|Completed at Least 1 Treatment Cycle|Overall Study||3||
48757070|NCT02735863|102194230|FG001|STARTED|Overall Study||16||
48757071|NCT02735863|102194231|FG002|STARTED|Overall Study||8||
48757072|NCT02735863|102194229|FG000|COMPLETED|Overall Study||5||
48757073|NCT02735863|102194230|FG001|COMPLETED|Overall Study||14||
48757074|NCT02735863|102194231|FG002|COMPLETED|Overall Study||7||
48757075|NCT02735863|102194229|FG000|NOT COMPLETED|Overall Study||1||
48757076|NCT02735863|102194230|FG001|NOT COMPLETED|Overall Study||2||
48757077|NCT02735863|102194231|FG002|NOT COMPLETED|Overall Study||1||
48757078|NCT02529852|102194232|FG000|STARTED|Overall Study||53||
48757079|NCT02529852|102194232|FG000|Phase 1b|Overall Study||6||
48757080|NCT02529852|102194232|FG000|Phase 2|Overall Study||47||
48757081|NCT02529852|102194232|FG000|COMPLETED|Overall Study||51||
48757082|NCT02529852|102194232|FG000|NOT COMPLETED|Overall Study||2||
48757083|NCT05305443|102194233|FG000|STARTED|Stage 1: First Intervention||278||
48757084|NCT05305443|102194234|FG001|STARTED|Stage 1: First Intervention||0||
48757085|NCT05305443|102194235|FG002|STARTED|Stage 1: First Intervention||0||
48757086|NCT05305443|102194236|FG003|STARTED|Stage 1: First Intervention||0||
48757087|NCT05305443|102194237|FG004|STARTED|Stage 1: First Intervention||276||
48757088|NCT05305443|102194238|FG005|STARTED|Stage 1: First Intervention||0||
48757089|NCT05305443|102194239|FG006|STARTED|Stage 1: First Intervention||0||
48757090|NCT05305443|102194240|FG007|STARTED|Stage 1: First Intervention||0||
48757091|NCT05305443|102194233|FG000|COMPLETED|Stage 1: First Intervention||132||
48757092|NCT05305443|102194234|FG001|COMPLETED|Stage 1: First Intervention||0||
48757093|NCT05305443|102194235|FG002|COMPLETED|Stage 1: First Intervention||0||
48757094|NCT05305443|102194236|FG003|COMPLETED|Stage 1: First Intervention||0||
48757095|NCT05305443|102194237|FG004|COMPLETED|Stage 1: First Intervention||276||
48757096|NCT05305443|102194238|FG005|COMPLETED|Stage 1: First Intervention||0||
48757097|NCT05305443|102194239|FG006|COMPLETED|Stage 1: First Intervention||0||
48757098|NCT05305443|102194240|FG007|COMPLETED|Stage 1: First Intervention||0||
48757099|NCT05305443|102194233|FG000|NOT COMPLETED|Stage 1: First Intervention||146||
48757100|NCT05305443|102194234|FG001|NOT COMPLETED|Stage 1: First Intervention||0||
48757101|NCT05305443|102194235|FG002|NOT COMPLETED|Stage 1: First Intervention||0||
48182981|NCT02412761|100772118|FG004|NOT COMPLETED|First Intervention (2 Weeks)||0||
48182982|NCT02412761|100772119|FG005|NOT COMPLETED|First Intervention (2 Weeks)||1||
48182983|NCT02412761|100772114|FG000|STARTED|Second Intervention (2 Weeks)||5||
48182984|NCT02412761|100772115|FG001|STARTED|Second Intervention (2 Weeks)||5||
48182985|NCT02412761|100772116|FG002|STARTED|Second Intervention (2 Weeks)||4||
48757102|NCT05305443|102194236|FG003|NOT COMPLETED|Stage 1: First Intervention||0||
48634142|NCT01030900|101888871|FG000|STARTED|Overall Study||50||
48757103|NCT05305443|102194237|FG004|NOT COMPLETED|Stage 1: First Intervention||0||
48757104|NCT05305443|102194238|FG005|NOT COMPLETED|Stage 1: First Intervention||0||
48757105|NCT05305443|102194239|FG006|NOT COMPLETED|Stage 1: First Intervention||0||
48757106|NCT05305443|102194240|FG007|NOT COMPLETED|Stage 1: First Intervention||0||
48414363|NCT01137006|101350048|FG005|Completed at Least 1 Treatment Cycle|Overall Study||4||
48414364|NCT01137006|101350049|FG006|Completed at Least 1 Treatment Cycle|Overall Study||3||
48343690|NCT00929240|101172178|FG002|NOT COMPLETED|Maintenance Phase||91||
48343691|NCT00675025|101172179|FG000|STARTED|Overall Study||54||
48343692|NCT00675025|101172180|FG001|STARTED|Overall Study||63||
48343693|NCT00675025|101172179|FG000|COMPLETED|Overall Study||0||
48343694|NCT00675025|101172180|FG001|COMPLETED|Overall Study||0||
48343695|NCT00675025|101172179|FG000|NOT COMPLETED|Overall Study||54||
48343696|NCT00675025|101172180|FG001|NOT COMPLETED|Overall Study||63||
48343697|NCT01658514|101172181|FG000|STARTED|Overall Study||14||
48343698|NCT01658514|101172182|FG001|STARTED|Overall Study||11||
48343699|NCT01658514|101172183|FG002|STARTED|Overall Study||14||
48343700|NCT01658514|101172181|FG000|Completed Treatment A|Overall Study||14||
48343701|NCT01658514|101172182|FG001|Completed Treatment A|Overall Study||11||
48343702|NCT01658514|101172183|FG002|Completed Treatment A|Overall Study||12||
48343703|NCT01658514|101172181|FG000|Completed Treatment B|Overall Study||13||
48343704|NCT01658514|101172182|FG001|Completed Treatment B|Overall Study||11||
48343705|NCT01658514|101172183|FG002|Completed Treatment B|Overall Study||14||
48343706|NCT01658514|101172181|FG000|Completed Treatment C|Overall Study||13||
48343707|NCT01658514|101172182|FG001|Completed Treatment C|Overall Study||11||
48343708|NCT01658514|101172183|FG002|Completed Treatment C|Overall Study||12||
48343709|NCT01658514|101172181|FG000|Started - Normal RF Cohort Only|Overall Study||3||
48343710|NCT01658514|101172182|FG001|Started - Normal RF Cohort Only|Overall Study||2||
48343711|NCT01658514|101172183|FG002|Started - Normal RF Cohort Only|Overall Study||3||
48343712|NCT01658514|101172181|FG000|Completed - Normal RF Cohort Only|Overall Study||3||
48343713|NCT01658514|101172182|FG001|Completed - Normal RF Cohort Only|Overall Study||2||
48343714|NCT01658514|101172183|FG002|Completed - Normal RF Cohort Only|Overall Study||3||
48343715|NCT01658514|101172181|FG000|Started - Mild RI Cohort Only|Overall Study||4||
48343716|NCT01658514|101172182|FG001|Started - Mild RI Cohort Only|Overall Study||3||
48343717|NCT01658514|101172183|FG002|Started - Mild RI Cohort Only|Overall Study||4||
48343718|NCT01658514|101172181|FG000|Completed - Mild RI Cohort Only|Overall Study||4||
48414365|NCT01137006|101350043|FG000|COMPLETED|Overall Study||3||
48343719|NCT01658514|101172182|FG001|Completed - Mild RI Cohort Only|Overall Study||3||
48414366|NCT01137006|101350044|FG001|COMPLETED|Overall Study||3||
48414367|NCT01137006|101350045|FG002|COMPLETED|Overall Study||8||
48414368|NCT01137006|101350046|FG003|COMPLETED|Overall Study||3||
48414369|NCT01137006|101350047|FG004|COMPLETED|Overall Study||3||
48414370|NCT01137006|101350048|FG005|COMPLETED|Overall Study||4||
48414371|NCT01137006|101350049|FG006|COMPLETED|Overall Study||3||
48414372|NCT01137006|101350043|FG000|NOT COMPLETED|Overall Study||0||
48414373|NCT01137006|101350044|FG001|NOT COMPLETED|Overall Study||0||
48414374|NCT01137006|101350045|FG002|NOT COMPLETED|Overall Study||0||
48757107|NCT05305443|102194233|FG000|STARTED|Stage 2: Second Intervention||0|5 participants were not randomized following Stage 1|
48757108|NCT05305443|102194234|FG001|STARTED|Stage 2: Second Intervention||141|5 participants were not randomized following Stage 1|
48757109|NCT05305443|102194235|FG002|STARTED|Stage 2: Second Intervention||10|5 participants were not randomized following Stage 1|
48757110|NCT05305443|102194236|FG003|STARTED|Stage 2: Second Intervention||126|5 participants were not randomized following Stage 1|
48757111|NCT05305443|102194237|FG004|STARTED|Stage 2: Second Intervention||0|5 participants were not randomized following Stage 1|
48757112|NCT05305443|102194238|FG005|STARTED|Stage 2: Second Intervention||140|5 participants were not randomized following Stage 1|
48757113|NCT05305443|102194239|FG006|STARTED|Stage 2: Second Intervention||6|5 participants were not randomized following Stage 1|
48757114|NCT05305443|102194240|FG007|STARTED|Stage 2: Second Intervention||126|5 participants were not randomized following Stage 1|
48757115|NCT05305443|102194233|FG000|COMPLETED|Stage 2: Second Intervention||0||
48757116|NCT05305443|102194234|FG001|COMPLETED|Stage 2: Second Intervention||24||
48757117|NCT05305443|102194235|FG002|COMPLETED|Stage 2: Second Intervention||10||
48757118|NCT05305443|102194236|FG003|COMPLETED|Stage 2: Second Intervention||15||
48757119|NCT05305443|102194237|FG004|COMPLETED|Stage 2: Second Intervention||0||
48757120|NCT05305443|102194238|FG005|COMPLETED|Stage 2: Second Intervention||5||
48757121|NCT05305443|102194239|FG006|COMPLETED|Stage 2: Second Intervention||6||
48757122|NCT05305443|102194240|FG007|COMPLETED|Stage 2: Second Intervention||23||
48757123|NCT05305443|102194233|FG000|NOT COMPLETED|Stage 2: Second Intervention||0||
48757124|NCT05305443|102194234|FG001|NOT COMPLETED|Stage 2: Second Intervention||117||
48757125|NCT05305443|102194235|FG002|NOT COMPLETED|Stage 2: Second Intervention||0||
48757126|NCT05305443|102194236|FG003|NOT COMPLETED|Stage 2: Second Intervention||111||
48757127|NCT05305443|102194237|FG004|NOT COMPLETED|Stage 2: Second Intervention||0||
48757128|NCT05305443|102194238|FG005|NOT COMPLETED|Stage 2: Second Intervention||135||
48757129|NCT05305443|102194239|FG006|NOT COMPLETED|Stage 2: Second Intervention||0||
48757130|NCT05305443|102194240|FG007|NOT COMPLETED|Stage 2: Second Intervention||103||
48757131|NCT03346434|102194241|FG000|STARTED|Overall Study||10||
48757132|NCT03346434|102194242|FG001|STARTED|Overall Study||10||
48757133|NCT03346434|102194243|FG002|STARTED|Overall Study||10||
48757134|NCT03346434|102194244|FG003|STARTED|Overall Study||10||
48757135|NCT03346434|102194245|FG004|STARTED|Overall Study||79||
48757136|NCT03346434|102194246|FG005|STARTED|Overall Study||83||
48757137|NCT03346434|102194241|FG000|Completed Part A|Overall Study||10||
48757138|NCT03346434|102194242|FG001|Completed Part A|Overall Study||10||
48757139|NCT03346434|102194243|FG002|Completed Part A|Overall Study||9||
48757140|NCT03346434|102194244|FG003|Completed Part A|Overall Study||10||
48757141|NCT03346434|102194245|FG004|Completed Part A|Overall Study||0||
48757142|NCT03346434|102194246|FG005|Completed Part A|Overall Study||0||
48757143|NCT03346434|102194241|FG000|Completed Part B (Week 16)|Overall Study||0||
48757144|NCT03346434|102194242|FG001|Completed Part B (Week 16)|Overall Study||0||
48757145|NCT03346434|102194243|FG002|Completed Part B (Week 16)|Overall Study||0||
48757146|NCT03346434|102194244|FG003|Completed Part B (Week 16)|Overall Study||0||
48757147|NCT03346434|102194245|FG004|Completed Part B (Week 16)|Overall Study||76||
48757148|NCT03346434|102194246|FG005|Completed Part B (Week 16)|Overall Study||83||
48757149|NCT03346434|102194241|FG000|Completed Part B (Week 28)|Overall Study||0|End of Study|
48182986|NCT02412761|100772117|FG003|STARTED|Second Intervention (2 Weeks)||8||
48414375|NCT01137006|101350046|FG003|NOT COMPLETED|Overall Study||0||
48414376|NCT01137006|101350047|FG004|NOT COMPLETED|Overall Study||0||
48414377|NCT01137006|101350048|FG005|NOT COMPLETED|Overall Study||0||
48414378|NCT01137006|101350049|FG006|NOT COMPLETED|Overall Study||0||
48414379|NCT03595176|101350050|FG000|STARTED|Overall Study||47||
48414380|NCT03595176|101350051|FG001|STARTED|Overall Study||384||
48414381|NCT03595176|101350050|FG000|COMPLETED|Overall Study||47||
48414382|NCT03595176|101350051|FG001|COMPLETED|Overall Study||381||
48414383|NCT03595176|101350050|FG000|NOT COMPLETED|Overall Study||0||
48414384|NCT03595176|101350051|FG001|NOT COMPLETED|Overall Study||3||
48414385|NCT00413777|101350052|FG000|STARTED|Fixed-dose Period||22|Screened N=47; Titration period N=46; Subjects were randomized only at Fixed dose period, as above|
48414386|NCT00413777|101350053|FG001|STARTED|Fixed-dose Period||24|Screened N=47; Titration period N=46; Subjects were randomized only at Fixed dose period, as above|
48414387|NCT00413777|101350052|FG000|COMPLETED|Fixed-dose Period||18||
48414388|NCT00413777|101350053|FG001|COMPLETED|Fixed-dose Period||21||
48414389|NCT00413777|101350052|FG000|NOT COMPLETED|Fixed-dose Period||4||
48414390|NCT00413777|101350053|FG001|NOT COMPLETED|Fixed-dose Period||3||
48414391|NCT00413777|101350052|FG000|STARTED|Extension Period||17||
48414392|NCT00413777|101350053|FG001|STARTED|Extension Period||18||
48414393|NCT00413777|101350052|FG000|COMPLETED|Extension Period||17||
48414394|NCT00413777|101350053|FG001|COMPLETED|Extension Period||18||
48182987|NCT02412761|100772118|FG004|STARTED|Second Intervention (2 Weeks)||4||
48182988|NCT02412761|100772119|FG005|STARTED|Second Intervention (2 Weeks)||6||
48182989|NCT02412761|100772114|FG000|COMPLETED|Second Intervention (2 Weeks)||5||
48182990|NCT02412761|100772115|FG001|COMPLETED|Second Intervention (2 Weeks)||5||
48182991|NCT02412761|100772116|FG002|COMPLETED|Second Intervention (2 Weeks)||4||
48182992|NCT02412761|100772117|FG003|COMPLETED|Second Intervention (2 Weeks)||8||
48182993|NCT02412761|100772118|FG004|COMPLETED|Second Intervention (2 Weeks)||4||
48182994|NCT02412761|100772119|FG005|COMPLETED|Second Intervention (2 Weeks)||6||
48182995|NCT02412761|100772114|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48182996|NCT02412761|100772115|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48182997|NCT02412761|100772116|FG002|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48182998|NCT02412761|100772117|FG003|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48182999|NCT02412761|100772118|FG004|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48183000|NCT02412761|100772119|FG005|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48183001|NCT02412761|100772114|FG000|STARTED|Third Intervention (2 Weeks)||5||
48183002|NCT02412761|100772115|FG001|STARTED|Third Intervention (2 Weeks)||5||
48183003|NCT02412761|100772116|FG002|STARTED|Third Intervention (2 Weeks)||4||
48183004|NCT02412761|100772117|FG003|STARTED|Third Intervention (2 Weeks)||8||
48183005|NCT02412761|100772118|FG004|STARTED|Third Intervention (2 Weeks)||4||
48183006|NCT02412761|100772119|FG005|STARTED|Third Intervention (2 Weeks)||6||
48183007|NCT02412761|100772114|FG000|COMPLETED|Third Intervention (2 Weeks)||5||
48183008|NCT02412761|100772115|FG001|COMPLETED|Third Intervention (2 Weeks)||5||
48183009|NCT02412761|100772116|FG002|COMPLETED|Third Intervention (2 Weeks)||4||
48183010|NCT02412761|100772117|FG003|COMPLETED|Third Intervention (2 Weeks)||8||
48183011|NCT02412761|100772118|FG004|COMPLETED|Third Intervention (2 Weeks)||4||
48183012|NCT02412761|100772119|FG005|COMPLETED|Third Intervention (2 Weeks)||6||
48343720|NCT01658514|101172183|FG002|Completed - Mild RI Cohort Only|Overall Study||4||
48343721|NCT01658514|101172181|FG000|Started - Moderate RI Cohort Only|Overall Study||4||
48343722|NCT01658514|101172182|FG001|Started - Moderate RI Cohort Only|Overall Study||4||
48343723|NCT01658514|101172183|FG002|Started - Moderate RI Cohort Only|Overall Study||4||
48343724|NCT01658514|101172181|FG000|Completed - Moderate RI Cohort Only|Overall Study||3||
48343725|NCT01658514|101172182|FG001|Completed - Moderate RI Cohort Only|Overall Study||4||
48343726|NCT01658514|101172183|FG002|Completed - Moderate RI Cohort Only|Overall Study||2||
48634143|NCT01030900|101888871|FG000|COMPLETED|Overall Study||48||
48634144|NCT01030900|101888871|FG000|NOT COMPLETED|Overall Study||2||
48634145|NCT02340949|101888872|FG000|STARTED|Overall Study||115||
48634146|NCT02340949|101888873|FG001|STARTED|Overall Study||65||
48634147|NCT02340949|101888872|FG000|COMPLETED|Overall Study||99|Completed the treatment as per protocol|
48634148|NCT02340949|101888873|FG001|COMPLETED|Overall Study||61|Completed the treatment as per protocol|
48634149|NCT02340949|101888872|FG000|NOT COMPLETED|Overall Study||16||
48634150|NCT02340949|101888873|FG001|NOT COMPLETED|Overall Study||4||
48634151|NCT02225587|101888874|FG000|STARTED|Overall Study||200|Received Vaccination 1|
48634152|NCT02225587|101888875|FG001|STARTED|Overall Study||200|Received Vaccination 1|
48634153|NCT02225587|101888874|FG000|Vaccination 2|Overall Study||188|Received Vaccination 2|
48634154|NCT02225587|101888875|FG001|Vaccination 2|Overall Study||185|Received Vaccination 2|
48634155|NCT02225587|101888874|FG000|Vaccination 3|Overall Study||172|Received Vaccination 3|
48634156|NCT02225587|101888875|FG001|Vaccination 3|Overall Study||164|Received Vaccination 3|
48634157|NCT02225587|101888874|FG000|COMPLETED|Overall Study||172||
48634158|NCT02225587|101888875|FG001|COMPLETED|Overall Study||162||
48634159|NCT02225587|101888874|FG000|NOT COMPLETED|Overall Study||28||
48634160|NCT02225587|101888875|FG001|NOT COMPLETED|Overall Study||38||
48634161|NCT01380366|101888876|FG000|STARTED|Overall Study||15||
48634162|NCT01380366|101888876|FG000|COMPLETED|Overall Study||15||
48634163|NCT01380366|101888876|FG000|NOT COMPLETED|Overall Study||0||
48634164|NCT00984867|101888877|FG000|STARTED|Overall Study||226||
48634165|NCT00984867|101888878|FG001|STARTED|Overall Study||225||
48634166|NCT00984867|101888877|FG000|COMPLETED|Overall Study||203||
48634167|NCT00984867|101888878|FG001|COMPLETED|Overall Study||208||
48634168|NCT00984867|101888877|FG000|NOT COMPLETED|Overall Study||23||
48634169|NCT00984867|101888878|FG001|NOT COMPLETED|Overall Study||17||
48634170|NCT00754741|101888879|FG000|STARTED|Overall Study||567||
48183013|NCT02412761|100772114|FG000|NOT COMPLETED|Third Intervention (2 Weeks)||0||
48183014|NCT02412761|100772115|FG001|NOT COMPLETED|Third Intervention (2 Weeks)||0||
48183015|NCT02412761|100772116|FG002|NOT COMPLETED|Third Intervention (2 Weeks)||0||
48183016|NCT02412761|100772117|FG003|NOT COMPLETED|Third Intervention (2 Weeks)||0||
48183017|NCT02412761|100772118|FG004|NOT COMPLETED|Third Intervention (2 Weeks)||0||
48183018|NCT02412761|100772119|FG005|NOT COMPLETED|Third Intervention (2 Weeks)||0||
48183019|NCT01676220|100772120|FG000|STARTED|Overall Study||439||
48183020|NCT01676220|100772121|FG001|STARTED|Overall Study||439||
48183021|NCT01676220|100772120|FG000|Treated|Overall Study||435||
48183022|NCT01676220|100772121|FG001|Treated|Overall Study||438||
48343727|NCT01658514|101172181|FG000|Started - Severe RI Cohort Only|Overall Study||3||
48343728|NCT01658514|101172182|FG001|Started - Severe RI Cohort Only|Overall Study||2||
48343729|NCT01658514|101172183|FG002|Started - Severe RI Cohort Only|Overall Study||3||
48343730|NCT01658514|101172181|FG000|Completed - Severe RI Cohort Only|Overall Study||3||
48183023|NCT01676220|100772120|FG000|Modified Intent-To-Treat Population|Overall Study||432||
48183024|NCT01676220|100772121|FG001|Modified Intent-To-Treat Population|Overall Study||430||
48183025|NCT01676220|100772120|FG000|COMPLETED|Overall Study||337||
48343731|NCT01658514|101172182|FG001|Completed - Severe RI Cohort Only|Overall Study||2||
48414395|NCT00413777|101350052|FG000|NOT COMPLETED|Extension Period||0||
48414396|NCT00413777|101350053|FG001|NOT COMPLETED|Extension Period||0||
48414397|NCT04051944|101350054|FG000|STARTED|Overall Study||11||
48414398|NCT04051944|101350055|FG001|STARTED|Overall Study||10||
48414399|NCT04051944|101350054|FG000|COMPLETED|Overall Study||3||
48414400|NCT04051944|101350055|FG001|COMPLETED|Overall Study||6||
48414401|NCT04051944|101350054|FG000|NOT COMPLETED|Overall Study||8||
48414402|NCT04051944|101350055|FG001|NOT COMPLETED|Overall Study||4||
48414403|NCT04815291|101350056|FG000|STARTED|Overall Study||93||
48414404|NCT04815291|101350056|FG000|COMPLETED|Overall Study||85||
48757150|NCT03346434|102194242|FG001|Completed Part B (Week 28)|Overall Study||0|End of Study|
48757151|NCT03346434|102194243|FG002|Completed Part B (Week 28)|Overall Study||0|End of Study|
48757152|NCT03346434|102194244|FG003|Completed Part B (Week 28)|Overall Study||0|End of Study|
48757153|NCT03346434|102194245|FG004|Completed Part B (Week 28)|Overall Study||1|End of Study|
48757154|NCT03346434|102194246|FG005|Completed Part B (Week 28)|Overall Study||1|End of Study|
48757155|NCT03346434|102194241|FG000|COMPLETED|Overall Study||10||
48183026|NCT01676220|100772121|FG001|COMPLETED|Overall Study||314||
48183027|NCT01676220|100772120|FG000|NOT COMPLETED|Overall Study||102||
48183028|NCT01676220|100772121|FG001|NOT COMPLETED|Overall Study||125||
48183029|NCT03018106|100772122|FG000|STARTED|Overall Study||0||
48343732|NCT01658514|101172183|FG002|Completed - Severe RI Cohort Only|Overall Study||3||
48343733|NCT01658514|101172181|FG000|COMPLETED|Overall Study||13||
48343734|NCT01658514|101172182|FG001|COMPLETED|Overall Study||11||
48343735|NCT01658514|101172183|FG002|COMPLETED|Overall Study||12||
48414405|NCT04815291|101350056|FG000|NOT COMPLETED|Overall Study||8||
48414406|NCT00245635|101350057|FG000|STARTED|Overall Study||25||
48414407|NCT00245635|101350058|FG001|STARTED|Overall Study||18||
48414408|NCT00245635|101350057|FG000|COMPLETED|Overall Study||25||
48414409|NCT00245635|101350058|FG001|COMPLETED|Overall Study||18||
48414410|NCT00245635|101350057|FG000|NOT COMPLETED|Overall Study||0||
48414411|NCT00245635|101350058|FG001|NOT COMPLETED|Overall Study||0||
48634171|NCT00754741|101888880|FG001|STARTED|Overall Study||569||
48634172|NCT00754741|101888881|FG002|STARTED|Overall Study||556||
48634173|NCT00754741|101888879|FG000|COMPLETED|Overall Study||510||
48634174|NCT00754741|101888880|FG001|COMPLETED|Overall Study||500||
48634175|NCT00754741|101888881|FG002|COMPLETED|Overall Study||502||
48634176|NCT00754741|101888879|FG000|NOT COMPLETED|Overall Study||57||
48634177|NCT00754741|101888880|FG001|NOT COMPLETED|Overall Study||69||
48634178|NCT00754741|101888881|FG002|NOT COMPLETED|Overall Study||54||
48634179|NCT03188822|101888882|FG000|STARTED|Overall Study||9||
48634180|NCT03188822|101888882|FG000|COMPLETED|Overall Study||2||
48634181|NCT03188822|101888882|FG000|NOT COMPLETED|Overall Study||7||
48634182|NCT03316105|101888883|FG000|STARTED|Overall Study||9||
48634183|NCT03316105|101888884|FG001|STARTED|Overall Study||7||
48757156|NCT03346434|102194242|FG001|COMPLETED|Overall Study||10||
48757157|NCT03346434|102194243|FG002|COMPLETED|Overall Study||9||
48757158|NCT03346434|102194244|FG003|COMPLETED|Overall Study||10||
48757159|NCT03346434|102194245|FG004|COMPLETED|Overall Study||1||
48757160|NCT03346434|102194246|FG005|COMPLETED|Overall Study||1||
48183030|NCT03018106|100772123|FG001|STARTED|Overall Study||1||
48183031|NCT03018106|100772122|FG000|COMPLETED|Overall Study||0||
48757161|NCT03346434|102194241|FG000|NOT COMPLETED|Overall Study||0||
48757162|NCT03346434|102194242|FG001|NOT COMPLETED|Overall Study||0||
48757163|NCT03346434|102194243|FG002|NOT COMPLETED|Overall Study||1||
48757164|NCT03346434|102194244|FG003|NOT COMPLETED|Overall Study||0||
48757165|NCT03346434|102194245|FG004|NOT COMPLETED|Overall Study||78||
48183032|NCT03018106|100772123|FG001|COMPLETED|Overall Study||0||
48183033|NCT03018106|100772122|FG000|NOT COMPLETED|Overall Study||0||
48183034|NCT03018106|100772123|FG001|NOT COMPLETED|Overall Study||1||
48183035|NCT01607411|100772124|FG000|STARTED|Period I||14||
48183036|NCT01607411|100772125|FG001|STARTED|Period I||13||
48183037|NCT01607411|100772126|FG002|STARTED|Period I||14||
48183038|NCT01607411|100772127|FG003|STARTED|Period I||14||
48183039|NCT01607411|100772124|FG000|COMPLETED|Period I||14||
48183040|NCT01607411|100772125|FG001|COMPLETED|Period I||13||
48183041|NCT01607411|100772126|FG002|COMPLETED|Period I||14||
48183042|NCT01607411|100772127|FG003|COMPLETED|Period I||14||
48183043|NCT01607411|100772124|FG000|NOT COMPLETED|Period I||0||
48343736|NCT01658514|101172181|FG000|NOT COMPLETED|Overall Study||1||
48414412|NCT01796106|101350059|FG000|STARTED|Overall Study||5||5
48414413|NCT01796106|101350060|FG001|STARTED|Overall Study||7||7
48414414|NCT01796106|101350059|FG000|12 Months Follow up|Overall Study||0||0
48183044|NCT01607411|100772125|FG001|NOT COMPLETED|Period I||0||
48183045|NCT01607411|100772126|FG002|NOT COMPLETED|Period I||0||
48183046|NCT01607411|100772127|FG003|NOT COMPLETED|Period I||0||
48414415|NCT01796106|101350060|FG001|12 Months Follow up|Overall Study||0||0
48414416|NCT01796106|101350059|FG000|COMPLETED|Overall Study||0|24 month follow up was expected for completion.|0
48414417|NCT01796106|101350060|FG001|COMPLETED|Overall Study||0|24 month follow up was expected for completion.|0
48634184|NCT03316105|101888883|FG000|COMPLETED|Overall Study||9||
48634185|NCT03316105|101888884|FG001|COMPLETED|Overall Study||7||
48634186|NCT03316105|101888883|FG000|NOT COMPLETED|Overall Study||0||
48634187|NCT03316105|101888884|FG001|NOT COMPLETED|Overall Study||0||
48634188|NCT01206764|101888885|FG000|STARTED|Overall Study||142||
48634189|NCT01206764|101888885|FG000|COMPLETED|Overall Study||4||
48634190|NCT01206764|101888885|FG000|NOT COMPLETED|Overall Study||138||
48634191|NCT00410163|101888886|FG000|STARTED|Treatment and Follow-up Phase (2 Years)||31||
48634192|NCT00410163|101888887|FG001|STARTED|Treatment and Follow-up Phase (2 Years)||30||
48634193|NCT00410163|101888886|FG000|COMPLETED|Treatment and Follow-up Phase (2 Years)||19||
48634194|NCT00410163|101888887|FG001|COMPLETED|Treatment and Follow-up Phase (2 Years)||19||
48634195|NCT00410163|101888886|FG000|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||12||
48634196|NCT00410163|101888887|FG001|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||11||
48634197|NCT00410163|101888886|FG000|STARTED|Extended Follow-up (FU) Phase (2-5 Years||20||
48634198|NCT00410163|101888887|FG001|STARTED|Extended Follow-up (FU) Phase (2-5 Years||21||
48634199|NCT00410163|101888886|FG000|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10||
48183047|NCT01607411|100772124|FG000|STARTED|Period II||14||
48183048|NCT01607411|100772125|FG001|STARTED|Period II||14||
48183049|NCT01607411|100772126|FG002|STARTED|Period II||13||
48183050|NCT01607411|100772127|FG003|STARTED|Period II||14||
48183051|NCT01607411|100772124|FG000|COMPLETED|Period II||14||
48183052|NCT01607411|100772125|FG001|COMPLETED|Period II||14||
48634200|NCT00410163|101888887|FG001|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||11||
48634201|NCT00410163|101888886|FG000|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10||
48634202|NCT00410163|101888887|FG001|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10||
48634203|NCT00426270|101888888|FG000|STARTED|Overall Study||116||
48634204|NCT00426270|101888888|FG000|COMPLETED|Overall Study||110||
48634205|NCT00426270|101888888|FG000|NOT COMPLETED|Overall Study||6||
48343737|NCT01658514|101172182|FG001|NOT COMPLETED|Overall Study||0||
48343738|NCT01658514|101172183|FG002|NOT COMPLETED|Overall Study||2||
48343739|NCT00516919|101172184|FG000|STARTED|Overall Study||40||
48343740|NCT00516919|101172185|FG001|STARTED|Overall Study||39||
48343741|NCT00516919|101172184|FG000|COMPLETED|Overall Study||30||
48634206|NCT00879190|101888889|FG000|STARTED|Overall Study||43||
48183053|NCT01607411|100772126|FG002|COMPLETED|Period II||13||
48183054|NCT01607411|100772127|FG003|COMPLETED|Period II||14||
48183055|NCT01607411|100772124|FG000|NOT COMPLETED|Period II||0||
48183056|NCT01607411|100772125|FG001|NOT COMPLETED|Period II||0||
48183057|NCT01607411|100772126|FG002|NOT COMPLETED|Period II||0||
48183058|NCT01607411|100772127|FG003|NOT COMPLETED|Period II||0||
48183059|NCT01607411|100772124|FG000|STARTED|Period III||14||
48183060|NCT01607411|100772125|FG001|STARTED|Period III||14||
48183061|NCT01607411|100772126|FG002|STARTED|Period III||14||
48183062|NCT01607411|100772127|FG003|STARTED|Period III||13||
48183063|NCT01607411|100772124|FG000|COMPLETED|Period III||14||
48183064|NCT01607411|100772125|FG001|COMPLETED|Period III||14||
48343742|NCT00516919|101172185|FG001|COMPLETED|Overall Study||32||
48343743|NCT00516919|101172184|FG000|NOT COMPLETED|Overall Study||10||
48343744|NCT00516919|101172185|FG001|NOT COMPLETED|Overall Study||7||
48343745|NCT01562028|101172186|FG000|STARTED|Overall Study||37||
48183065|NCT01607411|100772126|FG002|COMPLETED|Period III||14||
48183066|NCT01607411|100772127|FG003|COMPLETED|Period III||13||
48183067|NCT01607411|100772124|FG000|NOT COMPLETED|Period III||0||
48343746|NCT01562028|101172187|FG001|STARTED|Overall Study||72||
48343747|NCT01562028|101172186|FG000|COMPLETED|Overall Study||34||
48343748|NCT01562028|101172187|FG001|COMPLETED|Overall Study||70||
48343749|NCT01562028|101172186|FG000|NOT COMPLETED|Overall Study||3||
48343750|NCT01562028|101172187|FG001|NOT COMPLETED|Overall Study||2||
48343751|NCT01752023|101172188|FG000|STARTED|Overall Study||2||
48343752|NCT01752023|101172189|FG001|STARTED|Overall Study||1||
48343753|NCT01752023|101172188|FG000|COMPLETED|Overall Study||0||
48343754|NCT01752023|101172189|FG001|COMPLETED|Overall Study||0||
48343755|NCT01752023|101172188|FG000|NOT COMPLETED|Overall Study||2||
48343756|NCT01752023|101172189|FG001|NOT COMPLETED|Overall Study||1||
48343757|NCT01509625|101172190|FG000|STARTED|Overall Study||272||
48343758|NCT01509625|101172190|FG000|COMPLETED|Overall Study||263||
48343759|NCT01509625|101172190|FG000|NOT COMPLETED|Overall Study||9||
48343760|NCT02853760|101172191|FG000|STARTED|First Intervention (3 Hours)||7||
48343761|NCT02853760|101172192|FG001|STARTED|First Intervention (3 Hours)||10||
48343762|NCT02853760|101172193|FG002|STARTED|First Intervention (3 Hours)||7||
48343763|NCT02853760|101172194|FG003|STARTED|First Intervention (3 Hours)||8||
48343764|NCT02853760|101172195|FG004|STARTED|First Intervention (3 Hours)||8||
48343765|NCT02853760|101172196|FG005|STARTED|First Intervention (3 Hours)||7||
48343766|NCT02853760|101172191|FG000|COMPLETED|First Intervention (3 Hours)||7||
48343767|NCT02853760|101172192|FG001|COMPLETED|First Intervention (3 Hours)||10||
48343768|NCT02853760|101172193|FG002|COMPLETED|First Intervention (3 Hours)||7||
48343769|NCT02853760|101172194|FG003|COMPLETED|First Intervention (3 Hours)||8||
48343770|NCT02853760|101172195|FG004|COMPLETED|First Intervention (3 Hours)||8||
48343771|NCT02853760|101172196|FG005|COMPLETED|First Intervention (3 Hours)||7||
48343772|NCT02853760|101172191|FG000|NOT COMPLETED|First Intervention (3 Hours)||0||
48343773|NCT02853760|101172192|FG001|NOT COMPLETED|First Intervention (3 Hours)||0||
48343774|NCT02853760|101172193|FG002|NOT COMPLETED|First Intervention (3 Hours)||0||
48343775|NCT02853760|101172194|FG003|NOT COMPLETED|First Intervention (3 Hours)||0||
48343776|NCT02853760|101172195|FG004|NOT COMPLETED|First Intervention (3 Hours)||0||
48757166|NCT03346434|102194246|FG005|NOT COMPLETED|Overall Study||82||
48757167|NCT03489863|102194247|FG000|STARTED|Overall Study||7||
48757168|NCT03489863|102194248|FG001|STARTED|Overall Study||7||
48757169|NCT03489863|102194247|FG000|COMPLETED|Overall Study||7||
48757170|NCT03489863|102194248|FG001|COMPLETED|Overall Study||6||
48757171|NCT03489863|102194247|FG000|NOT COMPLETED|Overall Study||0||
48757172|NCT03489863|102194248|FG001|NOT COMPLETED|Overall Study||1||
48757173|NCT05196828|102194249|FG000|STARTED|Overall Study||44||
48757174|NCT05196828|102194250|FG001|STARTED|Overall Study||59||
48757175|NCT05196828|102194249|FG000|COMPLETED|Overall Study||41||
48757176|NCT05196828|102194250|FG001|COMPLETED|Overall Study||55||
48757177|NCT05196828|102194249|FG000|NOT COMPLETED|Overall Study||3||
48757178|NCT05196828|102194250|FG001|NOT COMPLETED|Overall Study||4||
48757179|NCT01991808|102194251|FG000|STARTED|Overall Study||16||
48757180|NCT01991808|102194251|FG000|COMPLETED|Overall Study||16||
48757181|NCT01991808|102194251|FG000|NOT COMPLETED|Overall Study||0||
48757182|NCT00246519|102194252|FG000|STARTED|Overall Study||442||
48757183|NCT00246519|102194253|FG001|STARTED|Overall Study||446||
48757184|NCT00246519|102194252|FG000|COMPLETED|Overall Study||386||
48757185|NCT00246519|102194253|FG001|COMPLETED|Overall Study||382||
48757186|NCT00246519|102194252|FG000|NOT COMPLETED|Overall Study||56||
48757187|NCT00246519|102194253|FG001|NOT COMPLETED|Overall Study||64||
48757188|NCT03164668|102194254|FG000|STARTED|Overall Study||11||
48757189|NCT03164668|102194255|FG001|STARTED|Overall Study||7||
48757190|NCT03164668|102194256|FG002|STARTED|Overall Study||10||
48757191|NCT03164668|102194257|FG003|STARTED|Overall Study||9||
48757192|NCT03164668|102194254|FG000|Completed Week 4|Overall Study||11||
48757193|NCT03164668|102194255|FG001|Completed Week 4|Overall Study||5||
48757194|NCT03164668|102194256|FG002|Completed Week 4|Overall Study||6||
48757195|NCT03164668|102194257|FG003|Completed Week 4|Overall Study||6||
48757196|NCT03164668|102194254|FG000|COMPLETED|Overall Study||10||
48757197|NCT03164668|102194255|FG001|COMPLETED|Overall Study||5||
48757198|NCT03164668|102194256|FG002|COMPLETED|Overall Study||6||
48757199|NCT03164668|102194257|FG003|COMPLETED|Overall Study||6||
48343777|NCT02853760|101172196|FG005|NOT COMPLETED|First Intervention (3 Hours)||0||
48343778|NCT02853760|101172191|FG000|STARTED|Washout (1 Week)||7||
48343779|NCT02853760|101172192|FG001|STARTED|Washout (1 Week)||10||
48757200|NCT03164668|102194254|FG000|NOT COMPLETED|Overall Study||1||
48757201|NCT03164668|102194255|FG001|NOT COMPLETED|Overall Study||2||
48757202|NCT03164668|102194256|FG002|NOT COMPLETED|Overall Study||4||
48757203|NCT03164668|102194257|FG003|NOT COMPLETED|Overall Study||3||
48757204|NCT05121766|102194258|FG000|STARTED|Overall Study||16||
48757205|NCT05121766|102194259|FG001|STARTED|Overall Study||16||
48757206|NCT05121766|102194258|FG000|COMPLETED|Overall Study||8||
48757207|NCT05121766|102194259|FG001|COMPLETED|Overall Study||10||
48757208|NCT05121766|102194258|FG000|NOT COMPLETED|Overall Study||8||
48757209|NCT05121766|102194259|FG001|NOT COMPLETED|Overall Study||6||
48757210|NCT00074711|102194260|FG000|STARTED|Overall Study||120||
48757211|NCT00074711|102194261|FG001|STARTED|Overall Study||121||
48757212|NCT00074711|102194260|FG000|COMPLETED|Overall Study||105||
48757213|NCT00074711|102194261|FG001|COMPLETED|Overall Study||106||
48757214|NCT00074711|102194260|FG000|NOT COMPLETED|Overall Study||15||
48757215|NCT00074711|102194261|FG001|NOT COMPLETED|Overall Study||15||
48757216|NCT05362487|102194262|FG000|STARTED|Overall Study||4|Performed Visit 1 (baseline)|
48757217|NCT05362487|102194262|FG000|Perform Visit 2 (8 Weeks)|Overall Study||3||
48757218|NCT05362487|102194262|FG000|COMPLETED|Overall Study||0||
48757219|NCT05362487|102194262|FG000|NOT COMPLETED|Overall Study||4||
48757220|NCT02845297|102194263|FG000|STARTED|Phase 1 (2 Years)||40||
48757221|NCT02845297|102194264|FG001|STARTED|Phase 1 (2 Years)||0||
48757222|NCT02845297|102194263|FG000|COMPLETED|Phase 1 (2 Years)||40||
48757223|NCT02845297|102194264|FG001|COMPLETED|Phase 1 (2 Years)||0||
48757224|NCT02845297|102194263|FG000|NOT COMPLETED|Phase 1 (2 Years)||0||
48757225|NCT02845297|102194264|FG001|NOT COMPLETED|Phase 1 (2 Years)||0||
48757226|NCT02845297|102194263|FG000|STARTED|Phase (2 Years)||0||
48757227|NCT02845297|102194264|FG001|STARTED|Phase (2 Years)||27||
48757228|NCT02845297|102194263|FG000|COMPLETED|Phase (2 Years)||0||
48757229|NCT02845297|102194264|FG001|COMPLETED|Phase (2 Years)||27||
48757230|NCT02845297|102194263|FG000|NOT COMPLETED|Phase (2 Years)||0||
48757231|NCT02845297|102194264|FG001|NOT COMPLETED|Phase (2 Years)||0||
48757232|NCT01352117|102194265|FG000|STARTED|Overall Study||96||
48757233|NCT01352117|102194266|FG001|STARTED|Overall Study||96||
48757234|NCT01352117|102194265|FG000|Entered Step 2 to Initiate Delayed ET|Overall Study||32||
48757235|NCT01352117|102194266|FG001|Entered Step 2 to Initiate Delayed ET|Overall Study||0||
48757236|NCT01352117|102194265|FG000|Study Week 48 Data Potential|Overall Study||80|Enrolled \>=45 weeks prior to the date when DSMB's recommendation to close the study became public.|
48757237|NCT01352117|102194266|FG001|Study Week 48 Data Potential|Overall Study||83|Enrolled \>=45 weeks prior to the date when DSMB's recommendation to close the study became public.|
48757238|NCT01352117|102194265|FG000|Study Week 96 Data Potential|Overall Study||58|Enrolled \>=93 weeks prior to the date when DSMB's recommendation to close the study became public.|
48757239|NCT01352117|102194266|FG001|Study Week 96 Data Potential|Overall Study||61|Enrolled \>=93 weeks prior to the date when DSMB's recommendation to close the study became public.|
48757240|NCT01352117|102194265|FG000|COMPLETED|Overall Study||75|Completed study, including the long-term safety follow-up in Step 3.|
48757241|NCT01352117|102194266|FG001|COMPLETED|Overall Study||72|Completed study, including the long-term safety follow-up in Step 3.|
48757242|NCT01352117|102194265|FG000|NOT COMPLETED|Overall Study||21||
48757243|NCT01352117|102194266|FG001|NOT COMPLETED|Overall Study||24||
48757244|NCT02412306|102194267|FG000|STARTED|Overall Study||5||
48757245|NCT02412306|102194268|FG001|STARTED|Overall Study||9||
48757246|NCT02412306|102194269|FG002|STARTED|Overall Study||21||
48757247|NCT02412306|102194270|FG003|STARTED|Overall Study||14||
48757248|NCT02412306|102194271|FG004|STARTED|Overall Study||17||
48757249|NCT02412306|102194267|FG000|COMPLETED|Overall Study||0||
48757250|NCT02412306|102194268|FG001|COMPLETED|Overall Study||1||
48757251|NCT02412306|102194269|FG002|COMPLETED|Overall Study||5||
48757252|NCT02412306|102194270|FG003|COMPLETED|Overall Study||14||
48757253|NCT02412306|102194271|FG004|COMPLETED|Overall Study||15||
48757254|NCT02412306|102194267|FG000|NOT COMPLETED|Overall Study||5||
48757255|NCT02412306|102194268|FG001|NOT COMPLETED|Overall Study||8||
48757256|NCT02412306|102194269|FG002|NOT COMPLETED|Overall Study||16||
48757257|NCT02412306|102194270|FG003|NOT COMPLETED|Overall Study||0||
48757258|NCT02412306|102194271|FG004|NOT COMPLETED|Overall Study||2||
48757259|NCT04906499|102194272|FG000|STARTED|Overall Study||7||
48757260|NCT04906499|102194272|FG000|COMPLETED|Overall Study||6||
48757261|NCT04906499|102194272|FG000|NOT COMPLETED|Overall Study||1||
48757262|NCT05120713|102194273|FG000|STARTED|Overall Study||70||
48757263|NCT05120713|102194274|FG001|STARTED|Overall Study||70||
48757264|NCT05120713|102194273|FG000|COMPLETED|Overall Study||70||
48757265|NCT05120713|102194274|FG001|COMPLETED|Overall Study||70||
48757266|NCT05120713|102194273|FG000|NOT COMPLETED|Overall Study||0||
48757267|NCT05120713|102194274|FG001|NOT COMPLETED|Overall Study||0||
48757268|NCT03839940|102194275|FG000|STARTED|Overall Study||20||
48757269|NCT03839940|102194276|FG001|STARTED|Overall Study||19||
48757270|NCT03839940|102194275|FG000|COMPLETED|Overall Study||16||
48757271|NCT03839940|102194276|FG001|COMPLETED|Overall Study||17||
48757272|NCT03839940|102194275|FG000|NOT COMPLETED|Overall Study||4||
48757273|NCT03839940|102194276|FG001|NOT COMPLETED|Overall Study||2||
48757274|NCT05626738|102194277|FG000|STARTED|Overall Study||38||
48757275|NCT05626738|102194277|FG000|COMPLETED|Overall Study||38||
48757276|NCT05626738|102194277|FG000|NOT COMPLETED|Overall Study||0||
48757277|NCT04205240|102194278|FG000|STARTED|Overall Study||1||
48757278|NCT04205240|102194278|FG000|COMPLETED|Overall Study||1||
48757279|NCT04205240|102194278|FG000|NOT COMPLETED|Overall Study||0||
48757280|NCT01941485|102194279|FG000|STARTED|Overall Study||59||
48757281|NCT01941485|102194279|FG000|COMPLETED|Overall Study||59||
48757282|NCT01941485|102194279|FG000|NOT COMPLETED|Overall Study||0||
48757283|NCT00762359|102194280|FG000|STARTED|Overall Study||226||
48757284|NCT00762359|102194281|FG001|STARTED|Overall Study||235||
48757285|NCT00762359|102194280|FG000|COMPLETED|Overall Study||167||
48757286|NCT00762359|102194281|FG001|COMPLETED|Overall Study||178||
48757287|NCT00762359|102194280|FG000|NOT COMPLETED|Overall Study||59||
48757288|NCT00762359|102194281|FG001|NOT COMPLETED|Overall Study||57||
48757289|NCT05560425|102194282|FG000|STARTED|Overall Study||7||
48757290|NCT05560425|102194283|FG001|STARTED|Overall Study||9||
48757291|NCT05560425|102194282|FG000|COMPLETED|Overall Study||7||
48757292|NCT05560425|102194283|FG001|COMPLETED|Overall Study||7||
48757293|NCT05560425|102194282|FG000|NOT COMPLETED|Overall Study||0||
48757294|NCT05560425|102194283|FG001|NOT COMPLETED|Overall Study||2||
48757295|NCT04051996|102194284|FG000|STARTED|Overall Study||1||
48757296|NCT04051996|102194285|FG001|STARTED|Overall Study||0||
48757297|NCT04051996|102194284|FG000|COMPLETED|Overall Study||1||
48757298|NCT04051996|102194285|FG001|COMPLETED|Overall Study||0||
48757299|NCT04051996|102194284|FG000|NOT COMPLETED|Overall Study||0||
48757300|NCT04051996|102194285|FG001|NOT COMPLETED|Overall Study||0||
48757301|NCT00537134|102194286|FG000|STARTED|Overall Study||42||
48757302|NCT00537134|102194287|FG001|STARTED|Overall Study||38||
48757303|NCT00537134|102194286|FG000|COMPLETED|Overall Study||42||
48757304|NCT00537134|102194287|FG001|COMPLETED|Overall Study||38||
48757305|NCT00537134|102194286|FG000|NOT COMPLETED|Overall Study||0||
48757306|NCT00537134|102194287|FG001|NOT COMPLETED|Overall Study||0||
48757307|NCT01691534|102194288|FG000|STARTED|Overall Study||15||
48757308|NCT01691534|102194289|FG001|STARTED|Overall Study||15||
48757309|NCT01691534|102194290|FG002|STARTED|Overall Study||15||
48757310|NCT01691534|102194291|FG003|STARTED|Overall Study||15||
48757311|NCT01691534|102194292|FG004|STARTED|Overall Study||15||
48757312|NCT01691534|102194293|FG005|STARTED|Overall Study||15||
48757313|NCT01691534|102194294|FG006|STARTED|Overall Study||15||
48757314|NCT01691534|102194288|FG000|COMPLETED|Overall Study||15||
48757315|NCT01691534|102194289|FG001|COMPLETED|Overall Study||14||
48757316|NCT01691534|102194290|FG002|COMPLETED|Overall Study||14||
48757317|NCT01691534|102194291|FG003|COMPLETED|Overall Study||14||
48757318|NCT01691534|102194292|FG004|COMPLETED|Overall Study||15||
48757319|NCT01691534|102194293|FG005|COMPLETED|Overall Study||14||
48757320|NCT01691534|102194294|FG006|COMPLETED|Overall Study||14||
48757321|NCT01691534|102194288|FG000|NOT COMPLETED|Overall Study||0||
48757322|NCT01691534|102194289|FG001|NOT COMPLETED|Overall Study||1||
48757323|NCT01691534|102194290|FG002|NOT COMPLETED|Overall Study||1||
48757324|NCT01691534|102194291|FG003|NOT COMPLETED|Overall Study||1||
48757325|NCT01691534|102194292|FG004|NOT COMPLETED|Overall Study||0||
48757326|NCT01691534|102194293|FG005|NOT COMPLETED|Overall Study||1||
48757327|NCT01691534|102194294|FG006|NOT COMPLETED|Overall Study||1||
48757328|NCT02226367|102194295|FG000|STARTED|Overall Study||46||
48757329|NCT02226367|102194296|FG001|STARTED|Overall Study||56||
48757330|NCT02226367|102194295|FG000|COMPLETED|Overall Study||37||
48757331|NCT02226367|102194296|FG001|COMPLETED|Overall Study||49||
48757332|NCT02226367|102194295|FG000|NOT COMPLETED|Overall Study||9||
48757333|NCT02226367|102194296|FG001|NOT COMPLETED|Overall Study||7||
48757334|NCT05098028|102194297|FG000|STARTED|Overall Study||7||
48757335|NCT05098028|102194298|FG001|STARTED|Overall Study||8||
48757336|NCT05098028|102194299|FG002|STARTED|Overall Study||11||
48343780|NCT02853760|101172193|FG002|STARTED|Washout (1 Week)||7||
48343781|NCT02853760|101172194|FG003|STARTED|Washout (1 Week)||8||
48343782|NCT02853760|101172195|FG004|STARTED|Washout (1 Week)||8||
48343783|NCT02853760|101172196|FG005|STARTED|Washout (1 Week)||7||
48343784|NCT02853760|101172191|FG000|COMPLETED|Washout (1 Week)||7||
48757337|NCT05098028|102194300|FG003|STARTED|Overall Study||9||
48757338|NCT05098028|102194301|FG004|STARTED|Overall Study||9||
48757339|NCT05098028|102194297|FG000|COMPLETED|Overall Study||7||
48757340|NCT05098028|102194298|FG001|COMPLETED|Overall Study||8||
48757341|NCT05098028|102194299|FG002|COMPLETED|Overall Study||11||
48757342|NCT05098028|102194300|FG003|COMPLETED|Overall Study||9||
48757343|NCT05098028|102194301|FG004|COMPLETED|Overall Study||8||
48757344|NCT05098028|102194297|FG000|NOT COMPLETED|Overall Study||0||
48757345|NCT05098028|102194298|FG001|NOT COMPLETED|Overall Study||0||
48757346|NCT05098028|102194299|FG002|NOT COMPLETED|Overall Study||0||
48757347|NCT05098028|102194300|FG003|NOT COMPLETED|Overall Study||0||
48757348|NCT05098028|102194301|FG004|NOT COMPLETED|Overall Study||1||
48757349|NCT01897025|102194302|FG000|STARTED|Overall Study||10||
48757350|NCT01897025|102194303|FG001|STARTED|Overall Study||9||
48343785|NCT02853760|101172192|FG001|COMPLETED|Washout (1 Week)||10||
48343786|NCT02853760|101172193|FG002|COMPLETED|Washout (1 Week)||6||
48634207|NCT00879190|101888890|FG001|STARTED|Overall Study||49||
48343787|NCT02853760|101172194|FG003|COMPLETED|Washout (1 Week)||6||
48757351|NCT01897025|102194302|FG000|COMPLETED|Overall Study||10||
48757352|NCT01897025|102194303|FG001|COMPLETED|Overall Study||9||
48757353|NCT01897025|102194302|FG000|NOT COMPLETED|Overall Study||0||
48757354|NCT01897025|102194303|FG001|NOT COMPLETED|Overall Study||0||
48414418|NCT01796106|101350059|FG000|NOT COMPLETED|Overall Study||5||5
48414419|NCT01796106|101350060|FG001|NOT COMPLETED|Overall Study||7||7
48414420|NCT04995666|101350061|FG000|STARTED|Overall Study||19||
48414421|NCT04995666|101350061|FG000|COMPLETED|Overall Study||19||
48414422|NCT04995666|101350061|FG000|NOT COMPLETED|Overall Study||0||
48414423|NCT02139176|101350062|FG000|STARTED|Overall Study||100||
48414424|NCT02139176|101350063|FG001|STARTED|Overall Study||100||
48414425|NCT02139176|101350062|FG000|COMPLETED|Overall Study||100||
48414426|NCT02139176|101350063|FG001|COMPLETED|Overall Study||100||
48757355|NCT01259063|102194304|FG000|STARTED|Overall Study||33||
48757356|NCT01259063|102194304|FG000|COMPLETED|Overall Study||33||
48757357|NCT01259063|102194304|FG000|NOT COMPLETED|Overall Study||0||
48757358|NCT00377520|102194305|FG000|STARTED|Overall Study||27||
48343788|NCT02853760|101172195|FG004|COMPLETED|Washout (1 Week)||8||
48343789|NCT02853760|101172196|FG005|COMPLETED|Washout (1 Week)||5||
48343790|NCT02853760|101172191|FG000|NOT COMPLETED|Washout (1 Week)||0||
48343791|NCT02853760|101172192|FG001|NOT COMPLETED|Washout (1 Week)||0||
48343792|NCT02853760|101172193|FG002|NOT COMPLETED|Washout (1 Week)||1||
48343793|NCT02853760|101172194|FG003|NOT COMPLETED|Washout (1 Week)||2||
48343794|NCT02853760|101172195|FG004|NOT COMPLETED|Washout (1 Week)||0||
48343795|NCT02853760|101172196|FG005|NOT COMPLETED|Washout (1 Week)||2||
48343796|NCT02853760|101172191|FG000|STARTED|Second Intervention (3 Hours)||7||
48343797|NCT02853760|101172192|FG001|STARTED|Second Intervention (3 Hours)||10||
48343798|NCT02853760|101172193|FG002|STARTED|Second Intervention (3 Hours)||6||
48343799|NCT02853760|101172194|FG003|STARTED|Second Intervention (3 Hours)||6||
48343800|NCT02853760|101172195|FG004|STARTED|Second Intervention (3 Hours)||8||
48343801|NCT02853760|101172196|FG005|STARTED|Second Intervention (3 Hours)||5||
48343802|NCT02853760|101172191|FG000|COMPLETED|Second Intervention (3 Hours)||7||
48343803|NCT02853760|101172192|FG001|COMPLETED|Second Intervention (3 Hours)||10||
48343804|NCT02853760|101172193|FG002|COMPLETED|Second Intervention (3 Hours)||6||
48343805|NCT02853760|101172194|FG003|COMPLETED|Second Intervention (3 Hours)||6||
48343806|NCT02853760|101172195|FG004|COMPLETED|Second Intervention (3 Hours)||8||
48343807|NCT02853760|101172196|FG005|COMPLETED|Second Intervention (3 Hours)||5||
48414427|NCT02139176|101350062|FG000|NOT COMPLETED|Overall Study||0||
48634208|NCT00879190|101888889|FG000|COMPLETED|Overall Study||43||
48634209|NCT00879190|101888890|FG001|COMPLETED|Overall Study||49||
48757359|NCT00377520|102194305|FG000|COMPLETED|Overall Study||26||
48757360|NCT00377520|102194305|FG000|NOT COMPLETED|Overall Study||1||
48757361|NCT01126749|102194306|FG000|STARTED|Phase 1b||3||
48757362|NCT01126749|102194307|FG001|STARTED|Phase 1b||6||
48757363|NCT01126749|102194308|FG002|STARTED|Phase 1b||0||
48757364|NCT01126749|102194309|FG003|STARTED|Phase 1b||0||
48757365|NCT01126749|102194306|FG000|COMPLETED|Phase 1b||0||
48757366|NCT01126749|102194307|FG001|COMPLETED|Phase 1b||0||
48757367|NCT01126749|102194308|FG002|COMPLETED|Phase 1b||0||
48757368|NCT01126749|102194309|FG003|COMPLETED|Phase 1b||0||
48757369|NCT01126749|102194306|FG000|NOT COMPLETED|Phase 1b||3||
48757370|NCT01126749|102194307|FG001|NOT COMPLETED|Phase 1b||6||
48757371|NCT01126749|102194308|FG002|NOT COMPLETED|Phase 1b||0||
48757372|NCT01126749|102194309|FG003|NOT COMPLETED|Phase 1b||0||
48757373|NCT01126749|102194306|FG000|STARTED|Phase 2||0||
48757374|NCT01126749|102194307|FG001|STARTED|Phase 2||0||
48343808|NCT02853760|101172191|FG000|NOT COMPLETED|Second Intervention (3 Hours)||0||
48343809|NCT02853760|101172192|FG001|NOT COMPLETED|Second Intervention (3 Hours)||0||
48343810|NCT02853760|101172193|FG002|NOT COMPLETED|Second Intervention (3 Hours)||0||
48343811|NCT02853760|101172194|FG003|NOT COMPLETED|Second Intervention (3 Hours)||0||
48343812|NCT02853760|101172195|FG004|NOT COMPLETED|Second Intervention (3 Hours)||0||
48343813|NCT02853760|101172196|FG005|NOT COMPLETED|Second Intervention (3 Hours)||0||
48343814|NCT02853760|101172191|FG000|STARTED|Washout (1 Week)||7||
48343815|NCT02853760|101172192|FG001|STARTED|Washout (1 Week)||10||
48634210|NCT00879190|101888889|FG000|NOT COMPLETED|Overall Study||0||
48634211|NCT00879190|101888890|FG001|NOT COMPLETED|Overall Study||0||
48634212|NCT00835926|101888891|FG000|STARTED|Overall Study||61||
48634213|NCT00835926|101888892|FG001|STARTED|Overall Study||60||
48634214|NCT00835926|101888891|FG000|COMPLETED|Overall Study||61||
48634215|NCT00835926|101888892|FG001|COMPLETED|Overall Study||60||
48634216|NCT00835926|101888891|FG000|NOT COMPLETED|Overall Study||0||
48634217|NCT00835926|101888892|FG001|NOT COMPLETED|Overall Study||0||
48634218|NCT02354118|101888893|FG000|STARTED|Overall Study||222||
48634219|NCT02354118|101888894|FG001|STARTED|Overall Study||214||
48634220|NCT02354118|101888893|FG000|COMPLETED|Overall Study||222||
48634221|NCT02354118|101888894|FG001|COMPLETED|Overall Study||214||
48757375|NCT01126749|102194308|FG002|STARTED|Phase 2||42||
48757376|NCT01126749|102194309|FG003|STARTED|Phase 2||41||
48757377|NCT01126749|102194306|FG000|Safety Analysis Set (SAS)/Treated|Phase 2||0||
48757378|NCT01126749|102194307|FG001|Safety Analysis Set (SAS)/Treated|Phase 2||0||
48757379|NCT01126749|102194308|FG002|Safety Analysis Set (SAS)/Treated|Phase 2||41||
48757380|NCT01126749|102194309|FG003|Safety Analysis Set (SAS)/Treated|Phase 2||39||
48757381|NCT01126749|102194306|FG000|Modified-intent-to-treat (MITT)|Phase 2||0||
48343816|NCT02853760|101172193|FG002|STARTED|Washout (1 Week)||6||
48414428|NCT02139176|101350063|FG001|NOT COMPLETED|Overall Study||0||
48414429|NCT00886587|101350064|FG000|STARTED|Overall Study||41||
48757382|NCT01126749|102194307|FG001|Modified-intent-to-treat (MITT)|Phase 2||0||
48414430|NCT00886587|101350065|FG001|STARTED|Overall Study||41||
48414431|NCT00886587|101350064|FG000|COMPLETED|Overall Study||37||
48414432|NCT00886587|101350065|FG001|COMPLETED|Overall Study||39||
48414433|NCT00886587|101350064|FG000|NOT COMPLETED|Overall Study||4||
48414434|NCT00886587|101350065|FG001|NOT COMPLETED|Overall Study||2||
48414435|NCT04035473|101350066|FG000|STARTED|Screening/Baseline||20||
48414436|NCT04035473|101350067|FG001|STARTED|Screening/Baseline||22||
48414437|NCT04035473|101350066|FG000|COMPLETED|Screening/Baseline||20||
48414438|NCT04035473|101350067|FG001|COMPLETED|Screening/Baseline||20||
48414439|NCT04035473|101350066|FG000|NOT COMPLETED|Screening/Baseline||0||
48414440|NCT04035473|101350067|FG001|NOT COMPLETED|Screening/Baseline||2||
48414441|NCT04035473|101350066|FG000|STARTED|Treatment Period 1||20||
48343817|NCT02853760|101172194|FG003|STARTED|Washout (1 Week)||6||
48343818|NCT02853760|101172195|FG004|STARTED|Washout (1 Week)||8||
48343819|NCT02853760|101172196|FG005|STARTED|Washout (1 Week)||5||
48343820|NCT02853760|101172191|FG000|COMPLETED|Washout (1 Week)||7||
48343821|NCT02853760|101172192|FG001|COMPLETED|Washout (1 Week)||10||
48343822|NCT02853760|101172193|FG002|COMPLETED|Washout (1 Week)||6||
48343823|NCT02853760|101172194|FG003|COMPLETED|Washout (1 Week)||6||
48343824|NCT02853760|101172195|FG004|COMPLETED|Washout (1 Week)||8||
48343825|NCT02853760|101172196|FG005|COMPLETED|Washout (1 Week)||5||
48343826|NCT02853760|101172191|FG000|NOT COMPLETED|Washout (1 Week)||0||
48343827|NCT02853760|101172192|FG001|NOT COMPLETED|Washout (1 Week)||0||
48343828|NCT02853760|101172193|FG002|NOT COMPLETED|Washout (1 Week)||0||
48343829|NCT02853760|101172194|FG003|NOT COMPLETED|Washout (1 Week)||0||
48343830|NCT02853760|101172195|FG004|NOT COMPLETED|Washout (1 Week)||0||
48343831|NCT02853760|101172196|FG005|NOT COMPLETED|Washout (1 Week)||0||
48343832|NCT02853760|101172191|FG000|STARTED|Third Intervention (3 Hours)||7||
48343833|NCT02853760|101172192|FG001|STARTED|Third Intervention (3 Hours)||10||
48343834|NCT02853760|101172193|FG002|STARTED|Third Intervention (3 Hours)||6||
48414442|NCT04035473|101350067|FG001|STARTED|Treatment Period 1||20||
48414443|NCT04035473|101350066|FG000|COMPLETED|Treatment Period 1||20||
48414444|NCT04035473|101350067|FG001|COMPLETED|Treatment Period 1||20||
48343835|NCT02853760|101172194|FG003|STARTED|Third Intervention (3 Hours)||6||
48414445|NCT04035473|101350066|FG000|NOT COMPLETED|Treatment Period 1||0||
48343836|NCT02853760|101172195|FG004|STARTED|Third Intervention (3 Hours)||8||
48414446|NCT04035473|101350067|FG001|NOT COMPLETED|Treatment Period 1||0||
48343837|NCT02853760|101172196|FG005|STARTED|Third Intervention (3 Hours)||5||
48343838|NCT02853760|101172191|FG000|COMPLETED|Third Intervention (3 Hours)||7||
48343839|NCT02853760|101172192|FG001|COMPLETED|Third Intervention (3 Hours)||10||
48343840|NCT02853760|101172193|FG002|COMPLETED|Third Intervention (3 Hours)||6||
48414447|NCT04035473|101350066|FG000|STARTED|Treatment Period 2||18||
48414448|NCT04035473|101350067|FG001|STARTED|Treatment Period 2||19||
48414449|NCT04035473|101350066|FG000|COMPLETED|Treatment Period 2||18||
48414450|NCT04035473|101350067|FG001|COMPLETED|Treatment Period 2||19||
48414451|NCT04035473|101350066|FG000|NOT COMPLETED|Treatment Period 2||0||
48414452|NCT04035473|101350067|FG001|NOT COMPLETED|Treatment Period 2||0||
48414453|NCT04035473|101350066|FG000|STARTED|Follow-up Period||18||
48414454|NCT04035473|101350067|FG001|STARTED|Follow-up Period||19||
48414455|NCT04035473|101350066|FG000|COMPLETED|Follow-up Period||16||
48414456|NCT04035473|101350067|FG001|COMPLETED|Follow-up Period||19||
48414457|NCT04035473|101350066|FG000|NOT COMPLETED|Follow-up Period||2||
48414458|NCT04035473|101350067|FG001|NOT COMPLETED|Follow-up Period||0||
48414459|NCT00827112|101350068|FG000|STARTED|Overall Study||65||
48414460|NCT00827112|101350069|FG001|STARTED|Overall Study||64||
48343841|NCT02853760|101172194|FG003|COMPLETED|Third Intervention (3 Hours)||6||
48343842|NCT02853760|101172195|FG004|COMPLETED|Third Intervention (3 Hours)||8||
48343843|NCT02853760|101172196|FG005|COMPLETED|Third Intervention (3 Hours)||5||
48414461|NCT00827112|101350068|FG000|Treated|Overall Study||60||
48414462|NCT00827112|101350069|FG001|Treated|Overall Study||61||
48414463|NCT00827112|101350068|FG000|COMPLETED|Overall Study||50||
48414464|NCT00827112|101350069|FG001|COMPLETED|Overall Study||52||
48414465|NCT00827112|101350068|FG000|NOT COMPLETED|Overall Study||15||
48414466|NCT00827112|101350069|FG001|NOT COMPLETED|Overall Study||12||
48414467|NCT00811395|101350070|FG000|STARTED|Initial Treatment (PDY6045 or PDY6046)||41||
48634222|NCT02354118|101888893|FG000|NOT COMPLETED|Overall Study||0||
48414468|NCT00811395|101350071|FG001|STARTED|Initial Treatment (PDY6045 or PDY6046)||37||
48414469|NCT00811395|101350072|FG002|STARTED|Initial Treatment (PDY6045 or PDY6046)||38||
48414470|NCT00811395|101350073|FG003|STARTED|Initial Treatment (PDY6045 or PDY6046)||40||
48343844|NCT02853760|101172191|FG000|NOT COMPLETED|Third Intervention (3 Hours)||0||
48343845|NCT02853760|101172192|FG001|NOT COMPLETED|Third Intervention (3 Hours)||0||
48343846|NCT02853760|101172193|FG002|NOT COMPLETED|Third Intervention (3 Hours)||0||
48343847|NCT02853760|101172194|FG003|NOT COMPLETED|Third Intervention (3 Hours)||0||
48343848|NCT02853760|101172195|FG004|NOT COMPLETED|Third Intervention (3 Hours)||0||
48343849|NCT02853760|101172196|FG005|NOT COMPLETED|Third Intervention (3 Hours)||0||
48343850|NCT01903265|101172197|FG000|STARTED|Overall Study||103||
48343851|NCT01903265|101172198|FG001|STARTED|Overall Study||102||
48343852|NCT01903265|101172197|FG000|COMPLETED|Overall Study||89||
48343853|NCT01903265|101172198|FG001|COMPLETED|Overall Study||85||
48343854|NCT01903265|101172197|FG000|NOT COMPLETED|Overall Study||14||
48343855|NCT01903265|101172198|FG001|NOT COMPLETED|Overall Study||17||
48343856|NCT00355121|101172199|FG000|STARTED|Overall Study||353||
48343857|NCT00355121|101172200|FG001|STARTED|Overall Study||353||
48343858|NCT00355121|101172201|FG002|STARTED|Overall Study||175||
48343859|NCT00355121|101172199|FG000|COMPLETED|Overall Study||332||
48343860|NCT00355121|101172200|FG001|COMPLETED|Overall Study||324||
48343861|NCT00355121|101172201|FG002|COMPLETED|Overall Study||170||
48343862|NCT00355121|101172199|FG000|NOT COMPLETED|Overall Study||21||
48343863|NCT00355121|101172200|FG001|NOT COMPLETED|Overall Study||29||
48343864|NCT00355121|101172201|FG002|NOT COMPLETED|Overall Study||5||
48343865|NCT01523873|101172202|FG000|STARTED|Overall Study||35921||
48343866|NCT01523873|101172202|FG000|Administered With Dotarem|Overall Study||35474||
48343867|NCT01523873|101172202|FG000|COMPLETED|Overall Study||35499||
48634223|NCT02354118|101888894|FG001|NOT COMPLETED|Overall Study||0||
48634224|NCT00547339|101888895|FG000|STARTED|Overall Study||15||
48634225|NCT00547339|101888896|FG001|STARTED|Overall Study||15||
48343868|NCT01523873|101172202|FG000|NOT COMPLETED|Overall Study||422||
48343869|NCT02318784|101172203|FG000|STARTED|Overall Study||62||
48343870|NCT02318784|101172203|FG000|COMPLETED|Overall Study||0||
48343871|NCT02318784|101172203|FG000|NOT COMPLETED|Overall Study||62||
48634226|NCT00547339|101888897|FG002|STARTED|Overall Study||15||
48634227|NCT00547339|101888898|FG003|STARTED|Overall Study||47||
48757383|NCT01126749|102194308|FG002|Modified-intent-to-treat (MITT)|Phase 2||40||
48343872|NCT00348140|101172204|FG000|STARTED|Overall Study||487||
48757384|NCT01126749|102194309|FG003|Modified-intent-to-treat (MITT)|Phase 2||39||
48757385|NCT01126749|102194306|FG000|COMPLETED|Phase 2||0||
48757386|NCT01126749|102194307|FG001|COMPLETED|Phase 2||0||
48757387|NCT01126749|102194308|FG002|COMPLETED|Phase 2||0||
48757388|NCT01126749|102194309|FG003|COMPLETED|Phase 2||0||
48757389|NCT01126749|102194306|FG000|NOT COMPLETED|Phase 2||0||
48757390|NCT01126749|102194307|FG001|NOT COMPLETED|Phase 2||0||
48757391|NCT01126749|102194308|FG002|NOT COMPLETED|Phase 2||42||
48343873|NCT00348140|101172205|FG001|STARTED|Overall Study||490||
48343874|NCT00348140|101172206|FG002|STARTED|Overall Study||491||
48414471|NCT00811395|101350074|FG004|STARTED|Initial Treatment (PDY6045 or PDY6046)||42||
48757392|NCT01126749|102194309|FG003|NOT COMPLETED|Phase 2||41||
48757393|NCT01914003|102194310|FG000|STARTED|Overall Study||27||
48757394|NCT01914003|102194311|FG001|STARTED|Overall Study||26||
48757395|NCT01914003|102194310|FG000|COMPLETED|Overall Study||19||
48757396|NCT01914003|102194311|FG001|COMPLETED|Overall Study||14||
48757397|NCT01914003|102194310|FG000|NOT COMPLETED|Overall Study||8||
48757398|NCT01914003|102194311|FG001|NOT COMPLETED|Overall Study||12||
48757399|NCT02989493|102194312|FG000|STARTED|Overall Study||29||
48757400|NCT02989493|102194313|FG001|STARTED|Overall Study||32||
48757401|NCT02989493|102194312|FG000|COMPLETED|Overall Study||29||
48757402|NCT02989493|102194313|FG001|COMPLETED|Overall Study||32||
48757403|NCT02989493|102194312|FG000|NOT COMPLETED|Overall Study||0||
48757404|NCT02989493|102194313|FG001|NOT COMPLETED|Overall Study||0||
48757405|NCT04564846|102194314|FG000|STARTED|Overall Study||25||
48757406|NCT04564846|102194315|FG001|STARTED|Overall Study||24||
48757407|NCT04564846|102194314|FG000|COMPLETED|Overall Study||21||
48757408|NCT04564846|102194315|FG001|COMPLETED|Overall Study||20||
48757409|NCT04564846|102194314|FG000|NOT COMPLETED|Overall Study||4||
48343875|NCT00348140|101172204|FG000|COMPLETED|Overall Study||361||
48634228|NCT00547339|101888895|FG000|COMPLETED|Overall Study||15||
48634229|NCT00547339|101888896|FG001|COMPLETED|Overall Study||15||
48634230|NCT00547339|101888897|FG002|COMPLETED|Overall Study||14||
48634231|NCT00547339|101888898|FG003|COMPLETED|Overall Study||47||
48634232|NCT00547339|101888895|FG000|NOT COMPLETED|Overall Study||0||
48757410|NCT04564846|102194315|FG001|NOT COMPLETED|Overall Study||4||
48757411|NCT03744312|102194316|FG000|STARTED|Overall Study||6||
48757412|NCT03744312|102194317|FG001|STARTED|Overall Study||3||
48757413|NCT03744312|102194316|FG000|COMPLETED|Overall Study||6||
48757414|NCT03744312|102194317|FG001|COMPLETED|Overall Study||1||
48757415|NCT03744312|102194316|FG000|NOT COMPLETED|Overall Study||0||
48757416|NCT03744312|102194317|FG001|NOT COMPLETED|Overall Study||2||
48757417|NCT03040999|102194318|FG000|STARTED|Overall Study||402|Randomized|
48757418|NCT03040999|102194319|FG001|STARTED|Overall Study||402|Randomized|
48757419|NCT03040999|102194318|FG000|Treated|Overall Study||398||
48757420|NCT03040999|102194319|FG001|Treated|Overall Study||398||
48343876|NCT00348140|101172205|FG001|COMPLETED|Overall Study||351||
48343877|NCT00348140|101172206|FG002|COMPLETED|Overall Study||328||
48343878|NCT00348140|101172204|FG000|NOT COMPLETED|Overall Study||126||
48757421|NCT03040999|102194318|FG000|COMPLETED|Overall Study||0||
48343879|NCT00348140|101172205|FG001|NOT COMPLETED|Overall Study||139||
48343880|NCT00348140|101172206|FG002|NOT COMPLETED|Overall Study||163||
48343881|NCT00863551|101172207|FG000|STARTED|Overall Study||12||
48343882|NCT00863551|101172207|FG000|COMPLETED|Overall Study||12||
48343883|NCT00863551|101172207|FG000|NOT COMPLETED|Overall Study||0||
48343884|NCT02582658|101172208|FG000|STARTED|Overall Study||171||
48343885|NCT02582658|101172208|FG000|COMPLETED|Overall Study||146||
48343886|NCT02582658|101172208|FG000|NOT COMPLETED|Overall Study||25||
48343887|NCT01511445|101172209|FG000|STARTED|Overall Study||53|Enrollment|
48343888|NCT01511445|101172210|FG001|STARTED|Overall Study||51|Enrollment|
48343889|NCT01511445|101172209|FG000|Surgeries Completed|Overall Study||53||
48343890|NCT01511445|101172210|FG001|Surgeries Completed|Overall Study||51||
48414472|NCT00811395|101350075|FG005|STARTED|Initial Treatment (PDY6045 or PDY6046)||41||
48414473|NCT00811395|101350070|FG000|COMPLETED|Initial Treatment (PDY6045 or PDY6046)||38||
48634233|NCT00547339|101888896|FG001|NOT COMPLETED|Overall Study||0||
48757422|NCT03040999|102194319|FG001|COMPLETED|Overall Study||0||
48757423|NCT03040999|102194318|FG000|NOT COMPLETED|Overall Study||402||
48757424|NCT03040999|102194319|FG001|NOT COMPLETED|Overall Study||402||
48757425|NCT03439280|102194320|FG000|STARTED|Overall Study||4||
48343891|NCT01511445|101172209|FG000|Primary Completion October, 2014|Overall Study||48||
48343892|NCT01511445|101172210|FG001|Primary Completion October, 2014|Overall Study||47||
48343893|NCT01511445|101172209|FG000|Follow-up Completion|Overall Study||48||
48343894|NCT01511445|101172210|FG001|Follow-up Completion|Overall Study||47||
48343895|NCT01511445|101172209|FG000|COMPLETED|Overall Study||48||
48343896|NCT01511445|101172210|FG001|COMPLETED|Overall Study||47||
48343897|NCT01511445|101172209|FG000|NOT COMPLETED|Overall Study||5||
48757426|NCT03439280|102194321|FG001|STARTED|Overall Study||3||
48757427|NCT03439280|102194322|FG002|STARTED|Overall Study||12||
48757428|NCT03439280|102194323|FG003|STARTED|Overall Study||22||
48757429|NCT03439280|102194324|FG004|STARTED|Overall Study||3||
48757430|NCT03439280|102194325|FG005|STARTED|Overall Study||6||
48757431|NCT03439280|102194326|FG006|STARTED|Overall Study||0||
48757432|NCT03439280|102194320|FG000|COMPLETED|Overall Study||4||
48757433|NCT03439280|102194321|FG001|COMPLETED|Overall Study||3||
48757434|NCT03439280|102194322|FG002|COMPLETED|Overall Study||12||
48757435|NCT03439280|102194323|FG003|COMPLETED|Overall Study||22||
48757436|NCT03439280|102194324|FG004|COMPLETED|Overall Study||3||
48757437|NCT03439280|102194325|FG005|COMPLETED|Overall Study||6||
48757438|NCT03439280|102194326|FG006|COMPLETED|Overall Study||0||
48757439|NCT03439280|102194320|FG000|NOT COMPLETED|Overall Study||0||
48757440|NCT03439280|102194321|FG001|NOT COMPLETED|Overall Study||0||
48757441|NCT03439280|102194322|FG002|NOT COMPLETED|Overall Study||0||
48757442|NCT03439280|102194323|FG003|NOT COMPLETED|Overall Study||0||
48757443|NCT03439280|102194324|FG004|NOT COMPLETED|Overall Study||0||
48757444|NCT03439280|102194325|FG005|NOT COMPLETED|Overall Study||0||
48757445|NCT03439280|102194326|FG006|NOT COMPLETED|Overall Study||0||
48757446|NCT00966186|102194327|FG000|STARTED|Overall Study||60||
48757447|NCT00966186|102194328|FG001|STARTED|Overall Study||60||
48757448|NCT00966186|102194327|FG000|COMPLETED|Overall Study||60||
48757449|NCT00966186|102194328|FG001|COMPLETED|Overall Study||60||
48757450|NCT00966186|102194327|FG000|NOT COMPLETED|Overall Study||0||
48757451|NCT00966186|102194328|FG001|NOT COMPLETED|Overall Study||0||
48757452|NCT00005780|102194329|FG000|STARTED|EPOCH-R Administration||26||
48757453|NCT00005780|102194329|FG000|COMPLETED|EPOCH-R Administration||26||
48757454|NCT00005780|102194329|FG000|NOT COMPLETED|EPOCH-R Administration||0||
48757455|NCT00005780|102194329|FG000|STARTED|Vaccine Administration Following EPOCH-R||24||
48757456|NCT00005780|102194329|FG000|COMPLETED|Vaccine Administration Following EPOCH-R||23||
48757457|NCT00005780|102194329|FG000|NOT COMPLETED|Vaccine Administration Following EPOCH-R||1||
48414474|NCT00811395|101350071|FG001|COMPLETED|Initial Treatment (PDY6045 or PDY6046)||33||
48634234|NCT00547339|101888897|FG002|NOT COMPLETED|Overall Study||1||
48634235|NCT00547339|101888898|FG003|NOT COMPLETED|Overall Study||0||
48634236|NCT00703534|101888899|FG000|STARTED|Overall Study||235||
48634237|NCT00703534|101888900|FG001|STARTED|Overall Study||243||
48634238|NCT00703534|101888899|FG000|COMPLETED|Overall Study||205||
48634239|NCT00703534|101888900|FG001|COMPLETED|Overall Study||218||
48634240|NCT00703534|101888899|FG000|NOT COMPLETED|Overall Study||30||
48634241|NCT00703534|101888900|FG001|NOT COMPLETED|Overall Study||25||
48634242|NCT00408499|101888901|FG000|STARTED|Phase 1: Dose Levels 1-4||4||
48634243|NCT00408499|101888902|FG001|STARTED|Phase 1: Dose Levels 1-4||7||
48634244|NCT00408499|101888903|FG002|STARTED|Phase 1: Dose Levels 1-4||3||
48634245|NCT00408499|101888904|FG003|STARTED|Phase 1: Dose Levels 1-4||6||
48634246|NCT00408499|101888905|FG004|STARTED|Phase 1: Dose Levels 1-4||0||
48634247|NCT00408499|101888901|FG000|COMPLETED|Phase 1: Dose Levels 1-4||2||
48634248|NCT00408499|101888902|FG001|COMPLETED|Phase 1: Dose Levels 1-4||5||
48634249|NCT00408499|101888903|FG002|COMPLETED|Phase 1: Dose Levels 1-4||2||
48634250|NCT00408499|101888904|FG003|COMPLETED|Phase 1: Dose Levels 1-4||6||
48634251|NCT00408499|101888905|FG004|COMPLETED|Phase 1: Dose Levels 1-4||0||
48634252|NCT00408499|101888901|FG000|NOT COMPLETED|Phase 1: Dose Levels 1-4||2||
48634253|NCT00408499|101888902|FG001|NOT COMPLETED|Phase 1: Dose Levels 1-4||2||
48634254|NCT00408499|101888903|FG002|NOT COMPLETED|Phase 1: Dose Levels 1-4||1||
48183068|NCT01607411|100772125|FG001|NOT COMPLETED|Period III||0||
48183069|NCT01607411|100772126|FG002|NOT COMPLETED|Period III||0||
48183070|NCT01607411|100772127|FG003|NOT COMPLETED|Period III||0||
48183071|NCT01607411|100772124|FG000|STARTED|Period IV||13||
48183072|NCT01607411|100772125|FG001|STARTED|Period IV||14||
48183073|NCT01607411|100772126|FG002|STARTED|Period IV||14||
48183074|NCT01607411|100772127|FG003|STARTED|Period IV||14||
48183075|NCT01607411|100772124|FG000|COMPLETED|Period IV||13||
48183076|NCT01607411|100772125|FG001|COMPLETED|Period IV||14||
48183077|NCT01607411|100772126|FG002|COMPLETED|Period IV||14||
48183078|NCT01607411|100772127|FG003|COMPLETED|Period IV||14||
48183079|NCT01607411|100772124|FG000|NOT COMPLETED|Period IV||0||
48183080|NCT01607411|100772125|FG001|NOT COMPLETED|Period IV||0||
48183081|NCT01607411|100772126|FG002|NOT COMPLETED|Period IV||0||
48183082|NCT01607411|100772127|FG003|NOT COMPLETED|Period IV||0||
48183083|NCT03023332|100772128|FG000|STARTED|Overall Study||86||
48183084|NCT03023332|100772129|FG001|STARTED|Overall Study||86||
48183085|NCT03023332|100772130|FG002|STARTED|Overall Study||70||
48183086|NCT03023332|100772131|FG003|STARTED|Overall Study||68||
48183087|NCT03023332|100772128|FG000|COMPLETED|Overall Study||62||
48183088|NCT03023332|100772129|FG001|COMPLETED|Overall Study||65||
48183089|NCT03023332|100772130|FG002|COMPLETED|Overall Study||58||
48183090|NCT03023332|100772131|FG003|COMPLETED|Overall Study||48||
48183091|NCT03023332|100772128|FG000|NOT COMPLETED|Overall Study||24||
48183092|NCT03023332|100772129|FG001|NOT COMPLETED|Overall Study||21||
48183093|NCT03023332|100772130|FG002|NOT COMPLETED|Overall Study||12||
48183094|NCT03023332|100772131|FG003|NOT COMPLETED|Overall Study||20||
48183095|NCT01327547|100772132|FG000|STARTED|Overall Study||70||
48183096|NCT01327547|100772133|FG001|STARTED|Overall Study||67||
48757458|NCT03853473|102194330|FG000|STARTED|Overall Study||6|Study participants were assigned to either group after they completed baseline testing. Five individuals were consented following their surgical consultation and their baseline testing session was scheduled for a later date due to the timing of their planned surgery. Those participants reconsidered study participation and withdrew. These five individuals account for the discrepancy between total patients enrolled (17) and total patients who started and were assigned to a group (12).|
48757459|NCT03853473|102194331|FG001|STARTED|Overall Study||6|Study participants were assigned to either group after they completed baseline testing. Five individuals were consented following their surgical consultation and their baseline testing session was scheduled for a later date due to the timing of their planned surgery. Those participants reconsidered study participation and withdrew. These five individuals account for the discrepancy between total patients enrolled (17) and total patients who started and were assigned to a group (12).|
48183097|NCT01327547|100772132|FG000|Randomized and Not Treated|Overall Study||0||
48183098|NCT01327547|100772133|FG001|Randomized and Not Treated|Overall Study||1||
48183099|NCT01327547|100772132|FG000|COMPLETED|Overall Study||50||
48183100|NCT01327547|100772133|FG001|COMPLETED|Overall Study||45||
48183101|NCT01327547|100772132|FG000|NOT COMPLETED|Overall Study||20||
48183102|NCT01327547|100772133|FG001|NOT COMPLETED|Overall Study||22||
48183103|NCT01034111|100772134|FG000|STARTED|Overall Study||30||
48634255|NCT00408499|101888904|FG003|NOT COMPLETED|Phase 1: Dose Levels 1-4||0||
48183104|NCT01034111|100772134|FG000|COMPLETED|Overall Study||30||
48183105|NCT01034111|100772134|FG000|NOT COMPLETED|Overall Study||0||
48183106|NCT00373295|100772135|FG000|STARTED|Intervention 1 (8 Days)||2||
48183107|NCT00373295|100772136|FG001|STARTED|Intervention 1 (8 Days)||3||
48183108|NCT00373295|100772137|FG002|STARTED|Intervention 1 (8 Days)||1||
48183109|NCT00373295|100772138|FG003|STARTED|Intervention 1 (8 Days)||2||
48183110|NCT00373295|100772139|FG004|STARTED|Intervention 1 (8 Days)||3||
48183111|NCT00373295|100772140|FG005|STARTED|Intervention 1 (8 Days)||2||
48183112|NCT00373295|100772135|FG000|COMPLETED|Intervention 1 (8 Days)||2||
48183113|NCT00373295|100772136|FG001|COMPLETED|Intervention 1 (8 Days)||1||
48183114|NCT00373295|100772137|FG002|COMPLETED|Intervention 1 (8 Days)||1||
48183115|NCT00373295|100772138|FG003|COMPLETED|Intervention 1 (8 Days)||2||
48183116|NCT00373295|100772139|FG004|COMPLETED|Intervention 1 (8 Days)||2||
48183117|NCT00373295|100772140|FG005|COMPLETED|Intervention 1 (8 Days)||2||
48183118|NCT00373295|100772135|FG000|NOT COMPLETED|Intervention 1 (8 Days)||0||
48183119|NCT00373295|100772136|FG001|NOT COMPLETED|Intervention 1 (8 Days)||2||
48183120|NCT00373295|100772137|FG002|NOT COMPLETED|Intervention 1 (8 Days)||0||
48183121|NCT00373295|100772138|FG003|NOT COMPLETED|Intervention 1 (8 Days)||0||
48634256|NCT00408499|101888905|FG004|NOT COMPLETED|Phase 1: Dose Levels 1-4||0||
48634257|NCT00408499|101888901|FG000|STARTED|Phase II- MTD Expansion||0||
48634258|NCT00408499|101888902|FG001|STARTED|Phase II- MTD Expansion||0||
48634259|NCT00408499|101888903|FG002|STARTED|Phase II- MTD Expansion||0||
48634260|NCT00408499|101888904|FG003|STARTED|Phase II- MTD Expansion||0||
48634261|NCT00408499|101888905|FG004|STARTED|Phase II- MTD Expansion||44||
48634262|NCT00408499|101888901|FG000|COMPLETED|Phase II- MTD Expansion||0||
48634263|NCT00408499|101888902|FG001|COMPLETED|Phase II- MTD Expansion||0||
48634264|NCT00408499|101888903|FG002|COMPLETED|Phase II- MTD Expansion||0||
48634265|NCT00408499|101888904|FG003|COMPLETED|Phase II- MTD Expansion||0||
48634266|NCT00408499|101888905|FG004|COMPLETED|Phase II- MTD Expansion||24||
48634267|NCT00408499|101888901|FG000|NOT COMPLETED|Phase II- MTD Expansion||0||
48634268|NCT00408499|101888902|FG001|NOT COMPLETED|Phase II- MTD Expansion||0||
48634269|NCT00408499|101888903|FG002|NOT COMPLETED|Phase II- MTD Expansion||0||
48634270|NCT00408499|101888904|FG003|NOT COMPLETED|Phase II- MTD Expansion||0||
48634271|NCT00408499|101888905|FG004|NOT COMPLETED|Phase II- MTD Expansion||20||
48634272|NCT03883386|101888906|FG000|STARTED|First Assignment||2||
48634273|NCT03883386|101888907|FG001|STARTED|First Assignment||1||
48634274|NCT03883386|101888906|FG000|Surveys Begun|First Assignment||1||
48634275|NCT03883386|101888907|FG001|Surveys Begun|First Assignment||1||
48634276|NCT03883386|101888906|FG000|COMPLETED|First Assignment||0||
48634277|NCT03883386|101888907|FG001|COMPLETED|First Assignment||0||
48634278|NCT03883386|101888906|FG000|NOT COMPLETED|First Assignment||2||
48757460|NCT03853473|102194330|FG000|COMPLETED|Overall Study||5||
48757461|NCT03853473|102194331|FG001|COMPLETED|Overall Study||4||
48183122|NCT00373295|100772139|FG004|NOT COMPLETED|Intervention 1 (8 Days)||1||
48183123|NCT00373295|100772140|FG005|NOT COMPLETED|Intervention 1 (8 Days)||0||
48183124|NCT00373295|100772135|FG000|STARTED|Intervention 2 (8 Days)||2||
48634279|NCT03883386|101888907|FG001|NOT COMPLETED|First Assignment||1||
48343898|NCT01511445|101172210|FG001|NOT COMPLETED|Overall Study||4||
48343899|NCT03619213|101172211|FG000|STARTED|Overall Study||3131||
48343900|NCT03619213|101172212|FG001|STARTED|Overall Study||3132||
48343901|NCT03619213|101172211|FG000|COMPLETED|Overall Study||3121||
48343902|NCT03619213|101172212|FG001|COMPLETED|Overall Study||3121||
48343903|NCT03619213|101172211|FG000|NOT COMPLETED|Overall Study||10||
48343904|NCT03619213|101172212|FG001|NOT COMPLETED|Overall Study||11||
48414475|NCT00811395|101350072|FG002|COMPLETED|Initial Treatment (PDY6045 or PDY6046)||36||
48414476|NCT00811395|101350073|FG003|COMPLETED|Initial Treatment (PDY6045 or PDY6046)||38||
48414477|NCT00811395|101350074|FG004|COMPLETED|Initial Treatment (PDY6045 or PDY6046)||37||
48414478|NCT00811395|101350075|FG005|COMPLETED|Initial Treatment (PDY6045 or PDY6046)||35||
48414479|NCT00811395|101350070|FG000|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||3||
48343905|NCT01316042|101172213|FG000|STARTED|Overall Study||2||
48343906|NCT01316042|101172214|FG001|STARTED|Overall Study||2||
48343907|NCT01316042|101172213|FG000|COMPLETED|Overall Study||2||
48343908|NCT01316042|101172214|FG001|COMPLETED|Overall Study||1||
48343909|NCT01316042|101172213|FG000|NOT COMPLETED|Overall Study||0||
48343910|NCT01316042|101172214|FG001|NOT COMPLETED|Overall Study||1||
48343911|NCT02274688|101172215|FG000|STARTED|Overall Study||86||
48343912|NCT02274688|101172216|FG001|STARTED|Overall Study||85||
48343913|NCT02274688|101172215|FG000|COMPLETED|Overall Study||72||
48343914|NCT02274688|101172216|FG001|COMPLETED|Overall Study||72||
48343915|NCT02274688|101172215|FG000|NOT COMPLETED|Overall Study||14||
48757462|NCT03853473|102194330|FG000|NOT COMPLETED|Overall Study||1||
48757463|NCT03853473|102194331|FG001|NOT COMPLETED|Overall Study||2||
48757464|NCT02719535|102194332|FG000|STARTED|Overall Study||59||
48757465|NCT02719535|102194332|FG000|COMPLETED|Overall Study||37||
48757466|NCT02719535|102194332|FG000|NOT COMPLETED|Overall Study||22||
48757467|NCT02182895|102194333|FG000|STARTED|Overall Study||35||
48757468|NCT02182895|102194334|FG001|STARTED|Overall Study||37||
48757469|NCT02182895|102194333|FG000|COMPLETED|Overall Study||33||
48757470|NCT02182895|102194334|FG001|COMPLETED|Overall Study||33||
48757471|NCT02182895|102194333|FG000|NOT COMPLETED|Overall Study||2||
48757472|NCT02182895|102194334|FG001|NOT COMPLETED|Overall Study||4||
48757473|NCT02060721|102194335|FG000|STARTED|Overall Study||76||
48757474|NCT02060721|102194335|FG000|COMPLETED|Overall Study||38||
48757475|NCT02060721|102194335|FG000|NOT COMPLETED|Overall Study||38||
48757476|NCT01097668|102194336|FG000|STARTED|Overall Study||21||
48757477|NCT01097668|102194337|FG001|STARTED|Overall Study||22||
48757478|NCT01097668|102194336|FG000|Week 20|Overall Study||21||
48757479|NCT01097668|102194337|FG001|Week 20|Overall Study||22||
48757480|NCT01097668|102194336|FG000|Week 48|Overall Study||19||
48757481|NCT01097668|102194337|FG001|Week 48|Overall Study||20||
48757482|NCT01097668|102194336|FG000|COMPLETED|Overall Study||19||
48757483|NCT01097668|102194337|FG001|COMPLETED|Overall Study||20||
48757484|NCT01097668|102194336|FG000|NOT COMPLETED|Overall Study||2||
48757485|NCT01097668|102194337|FG001|NOT COMPLETED|Overall Study||2||
48757486|NCT01809938|102194338|FG000|STARTED|First Intervention (170 Minutes)||5||
48757487|NCT01809938|102194339|FG001|STARTED|First Intervention (170 Minutes)||5||
48757488|NCT01809938|102194338|FG000|COMPLETED|First Intervention (170 Minutes)||5||
48757489|NCT01809938|102194339|FG001|COMPLETED|First Intervention (170 Minutes)||5||
48757490|NCT01809938|102194338|FG000|NOT COMPLETED|First Intervention (170 Minutes)||0||
48757491|NCT01809938|102194339|FG001|NOT COMPLETED|First Intervention (170 Minutes)||0||
48757492|NCT01809938|102194338|FG000|STARTED|Washout (Not Less Than 24 Hours)||5||
48757493|NCT01809938|102194339|FG001|STARTED|Washout (Not Less Than 24 Hours)||5||
48757494|NCT01809938|102194338|FG000|COMPLETED|Washout (Not Less Than 24 Hours)||5||
48343916|NCT02274688|101172216|FG001|NOT COMPLETED|Overall Study||13||
48343917|NCT02203149|101172217|FG000|STARTED|Part 1||31||
48343918|NCT02203149|101172218|FG001|STARTED|Part 1||32||
48343919|NCT02203149|101172219|FG002|STARTED|Part 1||0||
48343920|NCT02203149|101172220|FG003|STARTED|Part 1||0||
48343921|NCT02203149|101172221|FG004|STARTED|Part 1||0||
48343922|NCT02203149|101172217|FG000|COMPLETED|Part 1||31||
48343923|NCT02203149|101172218|FG001|COMPLETED|Part 1||31||
48343924|NCT02203149|101172219|FG002|COMPLETED|Part 1||0||
48343925|NCT02203149|101172220|FG003|COMPLETED|Part 1||0||
48343926|NCT02203149|101172221|FG004|COMPLETED|Part 1||0||
48343927|NCT02203149|101172217|FG000|NOT COMPLETED|Part 1||0||
48343928|NCT02203149|101172218|FG001|NOT COMPLETED|Part 1||1||
48343929|NCT02203149|101172219|FG002|NOT COMPLETED|Part 1||0||
48343930|NCT02203149|101172220|FG003|NOT COMPLETED|Part 1||0||
48343931|NCT02203149|101172221|FG004|NOT COMPLETED|Part 1||0||
48343932|NCT02203149|101172217|FG000|STARTED|Part 2||0||
48343933|NCT02203149|101172218|FG001|STARTED|Part 2||0||
48343934|NCT02203149|101172219|FG002|STARTED|Part 2||227||
48414480|NCT00811395|101350071|FG001|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||4||
48414481|NCT00811395|101350072|FG002|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2||
48414482|NCT00811395|101350073|FG003|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2||
48343935|NCT02203149|101172220|FG003|STARTED|Part 2||74||
48343936|NCT02203149|101172221|FG004|STARTED|Part 2||35||
48343937|NCT02203149|101172217|FG000|Started Deferred Active Treatment|Part 2||0||
48343938|NCT02203149|101172218|FG001|Started Deferred Active Treatment|Part 2||0||
48343939|NCT02203149|101172219|FG002|Started Deferred Active Treatment|Part 2||0||
48183125|NCT00373295|100772136|FG001|STARTED|Intervention 2 (8 Days)||1||
48183126|NCT00373295|100772137|FG002|STARTED|Intervention 2 (8 Days)||1||
48183127|NCT00373295|100772138|FG003|STARTED|Intervention 2 (8 Days)||2||
48183128|NCT00373295|100772139|FG004|STARTED|Intervention 2 (8 Days)||2||
48183129|NCT00373295|100772140|FG005|STARTED|Intervention 2 (8 Days)||2||
48183130|NCT00373295|100772135|FG000|COMPLETED|Intervention 2 (8 Days)||2||
48183131|NCT00373295|100772136|FG001|COMPLETED|Intervention 2 (8 Days)||1||
48183132|NCT00373295|100772137|FG002|COMPLETED|Intervention 2 (8 Days)||1||
48414483|NCT00811395|101350074|FG004|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||5||
48414484|NCT00811395|101350075|FG005|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||6||
48414485|NCT00811395|101350070|FG000|STARTED|Extension Treatment||31||
48414486|NCT00811395|101350071|FG001|STARTED|Extension Treatment||28||
48414487|NCT00811395|101350072|FG002|STARTED|Extension Treatment||27||
48414488|NCT00811395|101350073|FG003|STARTED|Extension Treatment||37||
48414489|NCT00811395|101350074|FG004|STARTED|Extension Treatment||30||
48414490|NCT00811395|101350075|FG005|STARTED|Extension Treatment||29||
48414491|NCT00811395|101350070|FG000|COMPLETED|Extension Treatment||29||
48414492|NCT00811395|101350071|FG001|COMPLETED|Extension Treatment||22||
48414493|NCT00811395|101350072|FG002|COMPLETED|Extension Treatment||24||
48414494|NCT00811395|101350073|FG003|COMPLETED|Extension Treatment||34||
48414495|NCT00811395|101350074|FG004|COMPLETED|Extension Treatment||30||
48414496|NCT00811395|101350075|FG005|COMPLETED|Extension Treatment||27||
48414497|NCT00811395|101350070|FG000|NOT COMPLETED|Extension Treatment||2||
48414498|NCT00811395|101350071|FG001|NOT COMPLETED|Extension Treatment||6||
48414499|NCT00811395|101350072|FG002|NOT COMPLETED|Extension Treatment||3||
48414500|NCT00811395|101350073|FG003|NOT COMPLETED|Extension Treatment||3||
48414501|NCT00811395|101350074|FG004|NOT COMPLETED|Extension Treatment||0||
48414502|NCT00811395|101350075|FG005|NOT COMPLETED|Extension Treatment||2||
48414503|NCT03681808|101350076|FG000|STARTED|Overall Study||123||
48757495|NCT01809938|102194339|FG001|COMPLETED|Washout (Not Less Than 24 Hours)||5||
48757496|NCT01809938|102194338|FG000|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0||
48757497|NCT01809938|102194339|FG001|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0||
48183133|NCT00373295|100772138|FG003|COMPLETED|Intervention 2 (8 Days)||2||
48414504|NCT03681808|101350077|FG001|STARTED|Overall Study||119||
48414505|NCT03681808|101350076|FG000|COMPLETED|Overall Study||109||
48414506|NCT03681808|101350077|FG001|COMPLETED|Overall Study||102||
48414507|NCT03681808|101350076|FG000|NOT COMPLETED|Overall Study||14||
48414508|NCT03681808|101350077|FG001|NOT COMPLETED|Overall Study||17||
48414509|NCT01628718|101350078|FG000|STARTED|Overall Study||60||
48414510|NCT01628718|101350079|FG001|STARTED|Overall Study||62||
48414511|NCT01628718|101350078|FG000|COMPLETED|Overall Study||33||
48183134|NCT00373295|100772139|FG004|COMPLETED|Intervention 2 (8 Days)||2||
48634280|NCT03883386|101888906|FG000|STARTED|Washout and Second Assignment||0||
48634281|NCT03883386|101888907|FG001|STARTED|Washout and Second Assignment||0||
48634282|NCT03883386|101888906|FG000|COMPLETED|Washout and Second Assignment||0||
48634283|NCT03883386|101888907|FG001|COMPLETED|Washout and Second Assignment||0||
48634284|NCT03883386|101888906|FG000|NOT COMPLETED|Washout and Second Assignment||0||
48634285|NCT03883386|101888907|FG001|NOT COMPLETED|Washout and Second Assignment||0||
48634286|NCT05264116|101888908|FG000|STARTED|Overall Study||12||
48183135|NCT00373295|100772140|FG005|COMPLETED|Intervention 2 (8 Days)||2||
48183136|NCT00373295|100772135|FG000|NOT COMPLETED|Intervention 2 (8 Days)||0||
48183137|NCT00373295|100772136|FG001|NOT COMPLETED|Intervention 2 (8 Days)||0||
48183138|NCT00373295|100772137|FG002|NOT COMPLETED|Intervention 2 (8 Days)||0||
48414512|NCT01628718|101350079|FG001|COMPLETED|Overall Study||37||
48634287|NCT05264116|101888908|FG000|COMPLETED|Overall Study||12||
48634288|NCT05264116|101888908|FG000|NOT COMPLETED|Overall Study||0||
48634289|NCT01381120|101888909|FG000|STARTED|Overall Study||50||
48634290|NCT01381120|101888910|FG001|STARTED|Overall Study||27||
48634291|NCT01381120|101888909|FG000|COMPLETED|Overall Study||39||
48634292|NCT01381120|101888910|FG001|COMPLETED|Overall Study||18||
48634293|NCT01381120|101888909|FG000|NOT COMPLETED|Overall Study||11||
48634294|NCT01381120|101888910|FG001|NOT COMPLETED|Overall Study||9||
48183139|NCT00373295|100772138|FG003|NOT COMPLETED|Intervention 2 (8 Days)||0||
48183140|NCT00373295|100772139|FG004|NOT COMPLETED|Intervention 2 (8 Days)||0||
48183141|NCT00373295|100772140|FG005|NOT COMPLETED|Intervention 2 (8 Days)||0||
48183142|NCT00373295|100772135|FG000|STARTED|Intervention 3 (8 Days)||2||
48183143|NCT00373295|100772136|FG001|STARTED|Intervention 3 (8 Days)||1||
48183144|NCT00373295|100772137|FG002|STARTED|Intervention 3 (8 Days)||1||
48414513|NCT01628718|101350078|FG000|NOT COMPLETED|Overall Study||27||
48414514|NCT01628718|101350079|FG001|NOT COMPLETED|Overall Study||25||
48414515|NCT02646891|101350080|FG000|STARTED|Overall Study||6||
48414516|NCT02646891|101350081|FG001|STARTED|Overall Study||12||
48414517|NCT02646891|101350082|FG002|STARTED|Overall Study||12||
48414518|NCT02646891|101350083|FG003|STARTED|Overall Study||6||
48414519|NCT02646891|101350084|FG004|STARTED|Overall Study||12||
48414520|NCT02646891|101350085|FG005|STARTED|Overall Study||12||
48414521|NCT02646891|101350086|FG006|STARTED|Overall Study||139||
48414522|NCT02646891|101350087|FG007|STARTED|Overall Study||140||
48414523|NCT02646891|101350088|FG008|STARTED|Overall Study||140||
48757498|NCT01809938|102194338|FG000|STARTED|Second Intervention (170 Minutes)||5||
48183145|NCT00373295|100772138|FG003|STARTED|Intervention 3 (8 Days)||2||
48183146|NCT00373295|100772139|FG004|STARTED|Intervention 3 (8 Days)||2||
48183147|NCT00373295|100772140|FG005|STARTED|Intervention 3 (8 Days)||2||
48183148|NCT00373295|100772135|FG000|COMPLETED|Intervention 3 (8 Days)||2||
48183149|NCT00373295|100772136|FG001|COMPLETED|Intervention 3 (8 Days)||1||
48183150|NCT00373295|100772137|FG002|COMPLETED|Intervention 3 (8 Days)||1||
48183151|NCT00373295|100772138|FG003|COMPLETED|Intervention 3 (8 Days)||2||
48183152|NCT00373295|100772139|FG004|COMPLETED|Intervention 3 (8 Days)||2||
48343940|NCT02203149|101172220|FG003|Started Deferred Active Treatment|Part 2||73||
48343941|NCT02203149|101172221|FG004|Started Deferred Active Treatment|Part 2||0||
48343942|NCT02203149|101172217|FG000|COMPLETED|Part 2||0||
48183153|NCT00373295|100772140|FG005|COMPLETED|Intervention 3 (8 Days)||2||
48183154|NCT00373295|100772135|FG000|NOT COMPLETED|Intervention 3 (8 Days)||0||
48183155|NCT00373295|100772136|FG001|NOT COMPLETED|Intervention 3 (8 Days)||0||
48183156|NCT00373295|100772137|FG002|NOT COMPLETED|Intervention 3 (8 Days)||0||
48183157|NCT00373295|100772138|FG003|NOT COMPLETED|Intervention 3 (8 Days)||0||
48183158|NCT00373295|100772139|FG004|NOT COMPLETED|Intervention 3 (8 Days)||0||
48183159|NCT00373295|100772140|FG005|NOT COMPLETED|Intervention 3 (8 Days)||0||
48183160|NCT04147260|100772141|FG000|STARTED|Overall Study||9||
48183161|NCT04147260|100772142|FG001|STARTED|Overall Study||27||
48183162|NCT04147260|100772143|FG002|STARTED|Overall Study||9||
48183163|NCT04147260|100772144|FG003|STARTED|Overall Study||28||
48183164|NCT04147260|100772145|FG004|STARTED|Overall Study||12||
48183165|NCT04147260|100772141|FG000|COMPLETED|Overall Study||8||
48183166|NCT04147260|100772142|FG001|COMPLETED|Overall Study||27||
48183167|NCT04147260|100772143|FG002|COMPLETED|Overall Study||7||
48183168|NCT04147260|100772144|FG003|COMPLETED|Overall Study||25||
48183169|NCT04147260|100772145|FG004|COMPLETED|Overall Study||12||
48183170|NCT04147260|100772141|FG000|NOT COMPLETED|Overall Study||1||
48183171|NCT04147260|100772142|FG001|NOT COMPLETED|Overall Study||0||
48183172|NCT04147260|100772143|FG002|NOT COMPLETED|Overall Study||2||
48183173|NCT04147260|100772144|FG003|NOT COMPLETED|Overall Study||3||
48183174|NCT04147260|100772145|FG004|NOT COMPLETED|Overall Study||0||
48183175|NCT00905060|100772146|FG000|STARTED|Surgical Resection||70|All patients underwent aggressive resection with intra-operative collection of tissue to generate autologous vaccine. Forty-six patients met all pre- and postoperative criteria for enrollment and constitute the intention-to-treat population|
48183176|NCT00905060|100772146|FG000|COMPLETED|Surgical Resection||46||
48183177|NCT00905060|100772146|FG000|NOT COMPLETED|Surgical Resection||24||
48183178|NCT00905060|100772146|FG000|STARTED|Vaccination Treatment Period||46||
48183179|NCT00905060|100772146|FG000|COMPLETED|Vaccination Treatment Period||46||
48183180|NCT00905060|100772146|FG000|NOT COMPLETED|Vaccination Treatment Period||0||
48183181|NCT04963062|100772147|FG000|STARTED|Overall Study||56||
48183182|NCT04963062|100772148|FG001|STARTED|Overall Study||58||
48183183|NCT04963062|100772147|FG000|COMPLETED|Overall Study||52||
48183184|NCT04963062|100772148|FG001|COMPLETED|Overall Study||56||
48183185|NCT04963062|100772147|FG000|NOT COMPLETED|Overall Study||4||
48343943|NCT02203149|101172218|FG001|COMPLETED|Part 2||0||
48343944|NCT02203149|101172219|FG002|COMPLETED|Part 2||226||
48634295|NCT00142415|101888911|FG000|STARTED|Overall Study||3||
48634296|NCT00142415|101888912|FG001|STARTED|Overall Study||3||
48634297|NCT00142415|101888913|FG002|STARTED|Overall Study||6||
48634298|NCT00142415|101888914|FG003|STARTED|Overall Study||3||
48634299|NCT00142415|101888915|FG004|STARTED|Overall Study||3||
48634300|NCT00142415|101888916|FG005|STARTED|Overall Study||8||
48634301|NCT00142415|101888911|FG000|COMPLETED|Overall Study||3|Defined as completion of Cycle 1 (ie, received 111-In-DOTA-cG250 and 177-Lu-DOTA-cG250)|
48634302|NCT00142415|101888912|FG001|COMPLETED|Overall Study||3|Defined as completion of Cycle 1 (ie, received 111-In-DOTA-cG250 and 177-Lu-DOTA-cG250)|
48634303|NCT00142415|101888913|FG002|COMPLETED|Overall Study||6|Defined as completion of Cycle 1 (ie, received 111-In-DOTA-cG250 and 177-Lu-DOTA-cG250)|
48634304|NCT00142415|101888914|FG003|COMPLETED|Overall Study||3|Defined as completion of Cycle 1 (ie, received 111-In-DOTA-cG250 and 177-Lu-DOTA-cG250)|
48634305|NCT00142415|101888915|FG004|COMPLETED|Overall Study||2|Defined as completion of Cycle 1 (ie, received 111-In-DOTA-cG250 and 177-Lu-DOTA-cG250)|
48634306|NCT00142415|101888916|FG005|COMPLETED|Overall Study||6|Defined as completion of Cycle 1 (ie, received 111-In-DOTA-cG250 and 177-Lu-DOTA-cG250)|
48634307|NCT00142415|101888911|FG000|NOT COMPLETED|Overall Study||0||
48634308|NCT00142415|101888912|FG001|NOT COMPLETED|Overall Study||0||
48634309|NCT00142415|101888913|FG002|NOT COMPLETED|Overall Study||0||
48634310|NCT00142415|101888914|FG003|NOT COMPLETED|Overall Study||0||
48634311|NCT00142415|101888915|FG004|NOT COMPLETED|Overall Study||1||
48183186|NCT04963062|100772148|FG001|NOT COMPLETED|Overall Study||2||
48183187|NCT01473420|100772149|FG000|STARTED|Titration Period (18 Weeks)||160||
48183188|NCT01473420|100772150|FG001|STARTED|Titration Period (18 Weeks)||160||
48183189|NCT01473420|100772149|FG000|Treated|Titration Period (18 Weeks)||80||
48183190|NCT01473420|100772150|FG001|Treated|Titration Period (18 Weeks)||86||
48183191|NCT01473420|100772149|FG000|COMPLETED|Titration Period (18 Weeks)||124||
48183192|NCT01473420|100772150|FG001|COMPLETED|Titration Period (18 Weeks)||122||
48183193|NCT01473420|100772149|FG000|NOT COMPLETED|Titration Period (18 Weeks)||36||
48183194|NCT01473420|100772150|FG001|NOT COMPLETED|Titration Period (18 Weeks)||38||
48183195|NCT01473420|100772149|FG000|STARTED|Maintenance Period (16 Weeks)||124||
48183196|NCT01473420|100772150|FG001|STARTED|Maintenance Period (16 Weeks)||122||
48183197|NCT01473420|100772149|FG000|COMPLETED|Maintenance Period (16 Weeks)||106||
48183198|NCT01473420|100772150|FG001|COMPLETED|Maintenance Period (16 Weeks)||105||
48757499|NCT01809938|102194339|FG001|STARTED|Second Intervention (170 Minutes)||5||
48757500|NCT01809938|102194338|FG000|COMPLETED|Second Intervention (170 Minutes)||5||
48757501|NCT01809938|102194339|FG001|COMPLETED|Second Intervention (170 Minutes)||5||
48757502|NCT01809938|102194338|FG000|NOT COMPLETED|Second Intervention (170 Minutes)||0||
48757503|NCT01809938|102194339|FG001|NOT COMPLETED|Second Intervention (170 Minutes)||0||
48757504|NCT05200143|102194340|FG000|STARTED|Overall Study||4||
48757505|NCT05200143|102194340|FG000|COMPLETED|Overall Study||4||
48757506|NCT05200143|102194340|FG000|NOT COMPLETED|Overall Study||0||
48757507|NCT03859024|102194341|FG000|STARTED|Overall Study||23||
48757508|NCT03859024|102194342|FG001|STARTED|Overall Study||25||
48757509|NCT03859024|102194341|FG000|COMPLETED|Overall Study||23||
48757510|NCT03859024|102194342|FG001|COMPLETED|Overall Study||24||
48757511|NCT03859024|102194341|FG000|NOT COMPLETED|Overall Study||0||
48757512|NCT03859024|102194342|FG001|NOT COMPLETED|Overall Study||1||
48757513|NCT04924062|102194343|FG000|STARTED|Overall Study||75||
48757514|NCT04924062|102194344|FG001|STARTED|Overall Study||83||
48183199|NCT01473420|100772149|FG000|NOT COMPLETED|Maintenance Period (16 Weeks)||18||
48183200|NCT01473420|100772150|FG001|NOT COMPLETED|Maintenance Period (16 Weeks)||17||
48183201|NCT01222832|100772151|FG000|STARTED|Overall Study||113||
48183202|NCT01222832|100772152|FG001|STARTED|Overall Study||113||
48183203|NCT01222832|100772151|FG000|COMPLETED|Overall Study||113||
48183204|NCT01222832|100772152|FG001|COMPLETED|Overall Study||112||
48183205|NCT01222832|100772151|FG000|NOT COMPLETED|Overall Study||0||
48183206|NCT01222832|100772152|FG001|NOT COMPLETED|Overall Study||1||
48183207|NCT05515679|100772153|FG000|STARTED|Baseline||22||
48183208|NCT05515679|100772154|FG001|STARTED|Baseline||13||
48183209|NCT05515679|100772155|FG002|STARTED|Baseline||10||
48183210|NCT05515679|100772153|FG000|COMPLETED|Baseline||22||
48183211|NCT05515679|100772154|FG001|COMPLETED|Baseline||13||
48634312|NCT00142415|101888916|FG005|NOT COMPLETED|Overall Study||2||
48634313|NCT02188160|101888917|FG000|STARTED|Overall Study||73||
48634314|NCT02188160|101888918|FG001|STARTED|Overall Study||77||
48634315|NCT02188160|101888917|FG000|COMPLETED|Overall Study||72||
48634316|NCT02188160|101888918|FG001|COMPLETED|Overall Study||76||
48634317|NCT02188160|101888917|FG000|NOT COMPLETED|Overall Study||1||
48634318|NCT02188160|101888918|FG001|NOT COMPLETED|Overall Study||1||
48634319|NCT02209064|101888919|FG000|STARTED|Overall Study||25||
48634320|NCT02209064|101888919|FG000|COMPLETED|Overall Study||25||
48634321|NCT02209064|101888919|FG000|NOT COMPLETED|Overall Study||0||
48634322|NCT01799941|101888920|FG000|STARTED|Overall Study||367||
48183212|NCT05515679|100772155|FG002|COMPLETED|Baseline||10||
48634323|NCT01799941|101888920|FG000|COMPLETED|Overall Study||271||
48634324|NCT01799941|101888920|FG000|NOT COMPLETED|Overall Study||96||
48634325|NCT05998967|101888921|FG000|STARTED|Overall Study||17||
48634326|NCT05998967|101888922|FG001|STARTED|Overall Study||19||
48634327|NCT05998967|101888921|FG000|COMPLETED|Overall Study||14||
48634328|NCT05998967|101888922|FG001|COMPLETED|Overall Study||14||
48634329|NCT05998967|101888921|FG000|NOT COMPLETED|Overall Study||3||
48634330|NCT05998967|101888922|FG001|NOT COMPLETED|Overall Study||5||
48634331|NCT04969289|101888923|FG000|STARTED|Overall Study||60||
48634332|NCT04969289|101888924|FG001|STARTED|Overall Study||59||
48183213|NCT05515679|100772153|FG000|NOT COMPLETED|Baseline||0||
48183214|NCT05515679|100772154|FG001|NOT COMPLETED|Baseline||0||
48183215|NCT05515679|100772155|FG002|NOT COMPLETED|Baseline||0||
48183216|NCT05515679|100772153|FG000|STARTED|Treatment||22||
48183217|NCT05515679|100772154|FG001|STARTED|Treatment||13||
48634333|NCT04969289|101888923|FG000|COMPLETED|Overall Study||47||
48634334|NCT04969289|101888924|FG001|COMPLETED|Overall Study||50||
48634335|NCT04969289|101888923|FG000|NOT COMPLETED|Overall Study||13||
48634336|NCT04969289|101888924|FG001|NOT COMPLETED|Overall Study||9||
48634337|NCT00900562|101888925|FG000|STARTED|Overall Study||12||
48634338|NCT00900562|101888926|FG001|STARTED|Overall Study||7||
48634339|NCT00900562|101888925|FG000|COMPLETED|Overall Study||0||
48634340|NCT00900562|101888926|FG001|COMPLETED|Overall Study||0||
48634341|NCT00900562|101888925|FG000|NOT COMPLETED|Overall Study||12||
48634342|NCT00900562|101888926|FG001|NOT COMPLETED|Overall Study||7||
48634343|NCT00695019|101888927|FG000|STARTED|Overall Study||59||
48183218|NCT05515679|100772155|FG002|STARTED|Treatment||0||
48183219|NCT05515679|100772153|FG000|COMPLETED|Treatment||22||
48343945|NCT02203149|101172220|FG003|COMPLETED|Part 2||71||
48634344|NCT00695019|101888928|FG001|STARTED|Overall Study||53||
48634345|NCT00695019|101888929|FG002|STARTED|Overall Study||57||
48634346|NCT00695019|101888927|FG000|COMPLETED|Overall Study||46||
48757515|NCT04924062|102194343|FG000|COMPLETED|Overall Study||0||
48757516|NCT04924062|102194344|FG001|COMPLETED|Overall Study||0||
48757517|NCT04924062|102194343|FG000|NOT COMPLETED|Overall Study||75||
48757518|NCT04924062|102194344|FG001|NOT COMPLETED|Overall Study||83||
48757519|NCT02246530|102194345|FG000|STARTED|Overall Study||9||
48183220|NCT05515679|100772154|FG001|COMPLETED|Treatment||13||
48183221|NCT05515679|100772155|FG002|COMPLETED|Treatment||0||
48183222|NCT05515679|100772153|FG000|NOT COMPLETED|Treatment||0||
48634347|NCT00695019|101888928|FG001|COMPLETED|Overall Study||39||
48634348|NCT00695019|101888929|FG002|COMPLETED|Overall Study||47||
48634349|NCT00695019|101888927|FG000|NOT COMPLETED|Overall Study||13||
48634350|NCT00695019|101888928|FG001|NOT COMPLETED|Overall Study||14||
48634351|NCT00695019|101888929|FG002|NOT COMPLETED|Overall Study||10||
48634352|NCT03451045|101888930|FG000|STARTED|Overall Study||175||
48634353|NCT03451045|101888931|FG001|STARTED|Overall Study||91||
48634354|NCT03451045|101888932|FG002|STARTED|Overall Study||181||
48634355|NCT03451045|101888930|FG000|COMPLETED|Overall Study||148||
48634356|NCT03451045|101888931|FG001|COMPLETED|Overall Study||85||
48634357|NCT03451045|101888932|FG002|COMPLETED|Overall Study||154||
48634358|NCT03451045|101888930|FG000|NOT COMPLETED|Overall Study||27||
48634359|NCT03451045|101888931|FG001|NOT COMPLETED|Overall Study||6||
48634360|NCT03451045|101888932|FG002|NOT COMPLETED|Overall Study||27||
48634361|NCT00706563|101888933|FG000|STARTED|Overall Study||61||
48634362|NCT00706563|101888934|FG001|STARTED|Overall Study||59||
48634363|NCT00706563|101888933|FG000|COMPLETED|Overall Study||61||
48634364|NCT00706563|101888934|FG001|COMPLETED|Overall Study||59||
48757520|NCT02246530|102194346|FG001|STARTED|Overall Study||2||
48757521|NCT02246530|102194345|FG000|COMPLETED|Overall Study||5||
48757522|NCT02246530|102194346|FG001|COMPLETED|Overall Study||2||
48757523|NCT02246530|102194345|FG000|NOT COMPLETED|Overall Study||4||
48757524|NCT02246530|102194346|FG001|NOT COMPLETED|Overall Study||0||
48757525|NCT01782898|102194347|FG000|STARTED|Overall Study||35||
48757526|NCT01782898|102194348|FG001|STARTED|Overall Study||35||
48757527|NCT01782898|102194347|FG000|COMPLETED|Overall Study||29||
48757528|NCT01782898|102194348|FG001|COMPLETED|Overall Study||29||
48757529|NCT01782898|102194347|FG000|NOT COMPLETED|Overall Study||6||
48757530|NCT01782898|102194348|FG001|NOT COMPLETED|Overall Study||6||
48757531|NCT00764699|102194349|FG000|STARTED|Overall Study||3||
48757532|NCT00764699|102194349|FG000|COMPLETED|Overall Study||0||
48757533|NCT00764699|102194349|FG000|NOT COMPLETED|Overall Study||3||
48757534|NCT05064735|102194350|FG000|STARTED|Overall Study||271||
48757535|NCT05064735|102194351|FG001|STARTED|Overall Study||136||
48634365|NCT00706563|101888933|FG000|NOT COMPLETED|Overall Study||0||
48634366|NCT00706563|101888934|FG001|NOT COMPLETED|Overall Study||0||
48634367|NCT04400318|101888935|FG000|STARTED|Overall Study||72||
48634368|NCT04400318|101888936|FG001|STARTED|Overall Study||37||
48634369|NCT04400318|101888935|FG000|COMPLETED|Overall Study||70||
48634370|NCT04400318|101888936|FG001|COMPLETED|Overall Study||33||
48634371|NCT04400318|101888935|FG000|NOT COMPLETED|Overall Study||2||
48634372|NCT04400318|101888936|FG001|NOT COMPLETED|Overall Study||4||
48634373|NCT01668797|101888937|FG000|STARTED|Phase A (Conversion Phase)||406||
48634374|NCT01668797|101888938|FG001|STARTED|Phase A (Conversion Phase)||0||
48634375|NCT01668797|101888939|FG002|STARTED|Phase A (Conversion Phase)||0||
48634376|NCT01668797|101888940|FG003|STARTED|Phase A (Conversion Phase)||0||
48634377|NCT01668797|101888937|FG000|COMPLETED|Phase A (Conversion Phase)||346||
48634378|NCT01668797|101888938|FG001|COMPLETED|Phase A (Conversion Phase)||0||
48634379|NCT01668797|101888939|FG002|COMPLETED|Phase A (Conversion Phase)||0||
48634380|NCT01668797|101888940|FG003|COMPLETED|Phase A (Conversion Phase)||0||
48634381|NCT01668797|101888937|FG000|NOT COMPLETED|Phase A (Conversion Phase)||60||
48634382|NCT01668797|101888938|FG001|NOT COMPLETED|Phase A (Conversion Phase)||0||
48634383|NCT01668797|101888939|FG002|NOT COMPLETED|Phase A (Conversion Phase)||0||
48634384|NCT01668797|101888940|FG003|NOT COMPLETED|Phase A (Conversion Phase)||0||
48634385|NCT01668797|101888937|FG000|STARTED|Phase B (Stabilization Phase)||0||
48634386|NCT01668797|101888938|FG001|STARTED|Phase B (Stabilization Phase)||464||
48634387|NCT01668797|101888939|FG002|STARTED|Phase B (Stabilization Phase)||0||
48634388|NCT01668797|101888940|FG003|STARTED|Phase B (Stabilization Phase)||0||
48634389|NCT01668797|101888937|FG000|COMPLETED|Phase B (Stabilization Phase)||0||
48634390|NCT01668797|101888938|FG001|COMPLETED|Phase B (Stabilization Phase)||202||
48634391|NCT01668797|101888939|FG002|COMPLETED|Phase B (Stabilization Phase)||0||
48634392|NCT01668797|101888940|FG003|COMPLETED|Phase B (Stabilization Phase)||0||
48757536|NCT05064735|102194350|FG000|Full Analysis Set (FAS)|Overall Study||271||
48757537|NCT05064735|102194351|FG001|Full Analysis Set (FAS)|Overall Study||136||
48757538|NCT05064735|102194350|FG000|Safety Analysis Set (SAS)|Overall Study||269||
48757539|NCT05064735|102194351|FG001|Safety Analysis Set (SAS)|Overall Study||135||
48757540|NCT05064735|102194350|FG000|COMPLETED|Overall Study||246||
48757541|NCT05064735|102194351|FG001|COMPLETED|Overall Study||122||
48757542|NCT05064735|102194350|FG000|NOT COMPLETED|Overall Study||25||
48757543|NCT05064735|102194351|FG001|NOT COMPLETED|Overall Study||14||
48757544|NCT04079296|102194352|FG000|STARTED|Dose Escalation Phase (56 Days)||6||
48757545|NCT04079296|102194353|FG001|STARTED|Dose Escalation Phase (56 Days)||5||
48757546|NCT04079296|102194354|FG002|STARTED|Dose Escalation Phase (56 Days)||8||
48634393|NCT01668797|101888937|FG000|NOT COMPLETED|Phase B (Stabilization Phase)||0||
48634394|NCT01668797|101888938|FG001|NOT COMPLETED|Phase B (Stabilization Phase)||262||
48634395|NCT01668797|101888939|FG002|NOT COMPLETED|Phase B (Stabilization Phase)||0||
48634396|NCT01668797|101888940|FG003|NOT COMPLETED|Phase B (Stabilization Phase)||0||
48634397|NCT01668797|101888937|FG000|STARTED|Phase C (Double-Blind Maintenance Phase)||0||
48634398|NCT01668797|101888938|FG001|STARTED|Phase C (Double-Blind Maintenance Phase)||0||
48634399|NCT01668797|101888939|FG002|STARTED|Phase C (Double-Blind Maintenance Phase)||97||
48634400|NCT01668797|101888940|FG003|STARTED|Phase C (Double-Blind Maintenance Phase)||105||
48757547|NCT04079296|102194355|FG003|STARTED|Dose Escalation Phase (56 Days)||0||
48757548|NCT04079296|102194356|FG004|STARTED|Dose Escalation Phase (56 Days)||0||
48757549|NCT04079296|102194352|FG000|COMPLETED|Dose Escalation Phase (56 Days)||2||
48757550|NCT04079296|102194353|FG001|COMPLETED|Dose Escalation Phase (56 Days)||1||
48757551|NCT04079296|102194354|FG002|COMPLETED|Dose Escalation Phase (56 Days)||4||
48757552|NCT04079296|102194355|FG003|COMPLETED|Dose Escalation Phase (56 Days)||0||
48757553|NCT04079296|102194356|FG004|COMPLETED|Dose Escalation Phase (56 Days)||0||
48757554|NCT04079296|102194352|FG000|NOT COMPLETED|Dose Escalation Phase (56 Days)||4||
48757555|NCT04079296|102194353|FG001|NOT COMPLETED|Dose Escalation Phase (56 Days)||4||
48757556|NCT04079296|102194354|FG002|NOT COMPLETED|Dose Escalation Phase (56 Days)||4||
48757557|NCT04079296|102194355|FG003|NOT COMPLETED|Dose Escalation Phase (56 Days)||0||
48757558|NCT04079296|102194356|FG004|NOT COMPLETED|Dose Escalation Phase (56 Days)||0||
48757559|NCT04079296|102194352|FG000|STARTED|Dose Expansion Phase (168 Days)||0||
48757560|NCT04079296|102194353|FG001|STARTED|Dose Expansion Phase (168 Days)||0||
48757561|NCT04079296|102194354|FG002|STARTED|Dose Expansion Phase (168 Days)||0||
48757562|NCT04079296|102194355|FG003|STARTED|Dose Expansion Phase (168 Days)||12||
48757563|NCT04079296|102194356|FG004|STARTED|Dose Expansion Phase (168 Days)||12||
48757564|NCT04079296|102194352|FG000|COMPLETED|Dose Expansion Phase (168 Days)||0||
48757565|NCT04079296|102194353|FG001|COMPLETED|Dose Expansion Phase (168 Days)||0||
48757566|NCT04079296|102194354|FG002|COMPLETED|Dose Expansion Phase (168 Days)||0||
48343946|NCT02203149|101172221|FG004|COMPLETED|Part 2||34||
48343947|NCT02203149|101172217|FG000|NOT COMPLETED|Part 2||0||
48343948|NCT02203149|101172218|FG001|NOT COMPLETED|Part 2||0||
48343949|NCT02203149|101172219|FG002|NOT COMPLETED|Part 2||1||
48343950|NCT02203149|101172220|FG003|NOT COMPLETED|Part 2||3||
48343951|NCT02203149|101172221|FG004|NOT COMPLETED|Part 2||1||
48414524|NCT02646891|101350089|FG009|STARTED|Overall Study||139||
48634401|NCT01668797|101888937|FG000|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0||
48634402|NCT01668797|101888938|FG001|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0||
48634403|NCT01668797|101888939|FG002|COMPLETED|Phase C (Double-Blind Maintenance Phase)||14||
48634404|NCT01668797|101888940|FG003|COMPLETED|Phase C (Double-Blind Maintenance Phase)||9||
48634405|NCT01668797|101888937|FG000|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0||
48634406|NCT01668797|101888938|FG001|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0||
48634407|NCT01668797|101888939|FG002|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||83||
48634408|NCT01668797|101888940|FG003|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||96||
48634409|NCT01458587|101888941|FG000|STARTED|Overall Study||35||
48634410|NCT01458587|101888942|FG001|STARTED|Overall Study||35||
48634411|NCT01458587|101888941|FG000|COMPLETED|Overall Study||34||
48634412|NCT01458587|101888942|FG001|COMPLETED|Overall Study||35||
48634413|NCT01458587|101888941|FG000|NOT COMPLETED|Overall Study||1||
48634414|NCT01458587|101888942|FG001|NOT COMPLETED|Overall Study||0||
48634415|NCT00737048|101888943|FG000|STARTED|Overall Study||132||
48634416|NCT00737048|101888944|FG001|STARTED|Overall Study||66||
48634417|NCT00737048|101888945|FG002|STARTED|Overall Study||130||
48634418|NCT00737048|101888943|FG000|COMPLETED|Overall Study||129||
48634419|NCT00737048|101888944|FG001|COMPLETED|Overall Study||60||
48634420|NCT00737048|101888945|FG002|COMPLETED|Overall Study||126||
48634421|NCT00737048|101888943|FG000|NOT COMPLETED|Overall Study||3||
48634422|NCT00737048|101888944|FG001|NOT COMPLETED|Overall Study||6||
48634423|NCT00737048|101888945|FG002|NOT COMPLETED|Overall Study||4||
48634424|NCT01122173|101888946|FG000|STARTED|Overall Study||150||
48634425|NCT01122173|101888946|FG000|COMPLETED|Overall Study||141||
48634426|NCT01122173|101888946|FG000|NOT COMPLETED|Overall Study||9||
48634427|NCT00207740|101888947|FG000|STARTED|Overall Study||78||
48634428|NCT00207740|101888948|FG001|STARTED|Overall Study||77||
48634429|NCT00207740|101888949|FG002|STARTED|Overall Study||76||
48634430|NCT00207740|101888950|FG003|STARTED|Overall Study||78||
48634431|NCT00207740|101888947|FG000|COMPLETED|Overall Study||49||
48634432|NCT00207740|101888948|FG001|COMPLETED|Overall Study||36||
48634433|NCT00207740|101888949|FG002|COMPLETED|Overall Study||36||
48634434|NCT00207740|101888950|FG003|COMPLETED|Overall Study||35||
48634435|NCT00207740|101888947|FG000|NOT COMPLETED|Overall Study||29||
48634436|NCT00207740|101888948|FG001|NOT COMPLETED|Overall Study||41||
48634437|NCT00207740|101888949|FG002|NOT COMPLETED|Overall Study||40||
48634438|NCT00207740|101888950|FG003|NOT COMPLETED|Overall Study||43||
48634439|NCT03857256|101888951|FG000|STARTED|Overall Study||65||
48634440|NCT03857256|101888952|FG001|STARTED|Overall Study||66||
48634441|NCT03857256|101888953|FG002|STARTED|Overall Study||66||
48634442|NCT03857256|101888954|FG003|STARTED|Overall Study||66||
48757567|NCT04079296|102194355|FG003|COMPLETED|Dose Expansion Phase (168 Days)||1||
48343952|NCT03437447|101172222|FG000|STARTED|Treatment Period 1||20||
48343953|NCT03437447|101172223|FG001|STARTED|Treatment Period 1||20||
48343954|NCT03437447|101172224|FG002|STARTED|Treatment Period 1||20||
48343955|NCT03437447|101172222|FG000|COMPLETED|Treatment Period 1||20||
48343956|NCT03437447|101172223|FG001|COMPLETED|Treatment Period 1||20||
48343957|NCT03437447|101172224|FG002|COMPLETED|Treatment Period 1||19||
48343958|NCT03437447|101172222|FG000|NOT COMPLETED|Treatment Period 1||0||
48343959|NCT03437447|101172223|FG001|NOT COMPLETED|Treatment Period 1||0||
48343960|NCT03437447|101172224|FG002|NOT COMPLETED|Treatment Period 1||1||
48634443|NCT03857256|101888951|FG000|COMPLETED|Overall Study||64||
48757568|NCT04079296|102194356|FG004|COMPLETED|Dose Expansion Phase (168 Days)||3||
48343961|NCT03437447|101172222|FG000|STARTED|Treatment Period 2||20||
48343962|NCT03437447|101172223|FG001|STARTED|Treatment Period 2||20||
48343963|NCT03437447|101172224|FG002|STARTED|Treatment Period 2||19||
48343964|NCT03437447|101172222|FG000|COMPLETED|Treatment Period 2||20||
48343965|NCT03437447|101172223|FG001|COMPLETED|Treatment Period 2||20||
48343966|NCT03437447|101172224|FG002|COMPLETED|Treatment Period 2||19||
48343967|NCT03437447|101172222|FG000|NOT COMPLETED|Treatment Period 2||0||
48343968|NCT03437447|101172223|FG001|NOT COMPLETED|Treatment Period 2||0||
48343969|NCT03437447|101172224|FG002|NOT COMPLETED|Treatment Period 2||0||
48343970|NCT03437447|101172222|FG000|STARTED|Treatment Period 3||20||
48343971|NCT03437447|101172223|FG001|STARTED|Treatment Period 3||20||
48343972|NCT03437447|101172224|FG002|STARTED|Treatment Period 3||19||
48343973|NCT03437447|101172222|FG000|COMPLETED|Treatment Period 3||20||
48343974|NCT03437447|101172223|FG001|COMPLETED|Treatment Period 3||20||
48343975|NCT03437447|101172224|FG002|COMPLETED|Treatment Period 3||19||
48343976|NCT03437447|101172222|FG000|NOT COMPLETED|Treatment Period 3||0||
48343977|NCT03437447|101172223|FG001|NOT COMPLETED|Treatment Period 3||0||
48343978|NCT03437447|101172224|FG002|NOT COMPLETED|Treatment Period 3||0||
48343979|NCT01245647|101172225|FG000|STARTED|Overall Study||7||
48343980|NCT01245647|101172226|FG001|STARTED|Overall Study||12||
48343981|NCT01245647|101172225|FG000|COMPLETED|Overall Study||7||
48343982|NCT01245647|101172226|FG001|COMPLETED|Overall Study||8||
48343983|NCT01245647|101172225|FG000|NOT COMPLETED|Overall Study||0||
48343984|NCT01245647|101172226|FG001|NOT COMPLETED|Overall Study||4||
48343985|NCT01070329|101172227|FG000|STARTED|Overall Study||261||
48343986|NCT01070329|101172228|FG001|STARTED|Overall Study||266||
48343987|NCT01070329|101172227|FG000|COMPLETED|Overall Study||209||
48343988|NCT01070329|101172228|FG001|COMPLETED|Overall Study||217||
48343989|NCT01070329|101172227|FG000|NOT COMPLETED|Overall Study||52||
48343990|NCT01070329|101172228|FG001|NOT COMPLETED|Overall Study||49||
48343991|NCT00542191|101172229|FG000|STARTED|Overall Study||21||
48343992|NCT00542191|101172229|FG000|COMPLETED|Overall Study||18||
48343993|NCT00542191|101172229|FG000|NOT COMPLETED|Overall Study||3||
48343994|NCT02633540|101172230|FG000|STARTED|Overall Study||2||
48343995|NCT02633540|101172230|FG000|COMPLETED|Overall Study||2||
48343996|NCT02633540|101172230|FG000|NOT COMPLETED|Overall Study||0||
48343997|NCT03878485|101172231|FG000|STARTED|Overall Study||10||
48343998|NCT03878485|101172231|FG000|COMPLETED|Overall Study||10||
48757569|NCT04079296|102194352|FG000|NOT COMPLETED|Dose Expansion Phase (168 Days)||0||
48757570|NCT04079296|102194353|FG001|NOT COMPLETED|Dose Expansion Phase (168 Days)||0||
48757571|NCT04079296|102194354|FG002|NOT COMPLETED|Dose Expansion Phase (168 Days)||0||
48757572|NCT04079296|102194355|FG003|NOT COMPLETED|Dose Expansion Phase (168 Days)||11||
48757573|NCT04079296|102194356|FG004|NOT COMPLETED|Dose Expansion Phase (168 Days)||9||
48757574|NCT04053036|102194357|FG000|STARTED|Overall Study||11||
48757575|NCT04053036|102194358|FG001|STARTED|Overall Study||11||
48757576|NCT04053036|102194357|FG000|COMPLETED|Overall Study||11||
48757577|NCT04053036|102194358|FG001|COMPLETED|Overall Study||11||
48343999|NCT03878485|101172231|FG000|NOT COMPLETED|Overall Study||0||
48344000|NCT01126580|101172232|FG000|STARTED|Overall Study||269||
48344001|NCT01126580|101172233|FG001|STARTED|Overall Study||270||
48344002|NCT01126580|101172234|FG002|STARTED|Overall Study||268||
48344003|NCT01126580|101172232|FG000|Received at Least 1 Dose of Study Drug|Overall Study||269||
48344004|NCT01126580|101172233|FG001|Received at Least 1 Dose of Study Drug|Overall Study||270||
48344005|NCT01126580|101172234|FG002|Received at Least 1 Dose of Study Drug|Overall Study||268||
48344006|NCT01126580|101172232|FG000|Completed 26 Weeks|Overall Study||233||
48344007|NCT01126580|101172233|FG001|Completed 26 Weeks|Overall Study||242||
48344008|NCT01126580|101172234|FG002|Completed 26 Weeks|Overall Study||226||
48344009|NCT01126580|101172232|FG000|COMPLETED|Overall Study||220||
48344010|NCT01126580|101172233|FG001|COMPLETED|Overall Study||218||
48344011|NCT01126580|101172234|FG002|COMPLETED|Overall Study||213||
48344012|NCT01126580|101172232|FG000|NOT COMPLETED|Overall Study||49||
48344013|NCT01126580|101172233|FG001|NOT COMPLETED|Overall Study||52||
48344014|NCT01126580|101172234|FG002|NOT COMPLETED|Overall Study||55||
48344015|NCT02347631|101172235|FG000|STARTED|Washout 1 (1 Month)||61||
48344016|NCT02347631|101172236|FG001|STARTED|Washout 1 (1 Month)||57||
48344017|NCT02347631|101172235|FG000|COMPLETED|Washout 1 (1 Month)||61||
48344018|NCT02347631|101172236|FG001|COMPLETED|Washout 1 (1 Month)||57||
48344019|NCT02347631|101172235|FG000|NOT COMPLETED|Washout 1 (1 Month)||0||
48344020|NCT02347631|101172236|FG001|NOT COMPLETED|Washout 1 (1 Month)||0||
48344021|NCT02347631|101172235|FG000|STARTED|First Intervention (2 Months)||61||
48757578|NCT04053036|102194357|FG000|NOT COMPLETED|Overall Study||0||
48757579|NCT04053036|102194358|FG001|NOT COMPLETED|Overall Study||0||
48344022|NCT02347631|101172236|FG001|STARTED|First Intervention (2 Months)||57||
48344023|NCT02347631|101172235|FG000|COMPLETED|First Intervention (2 Months)||54||
48344024|NCT02347631|101172236|FG001|COMPLETED|First Intervention (2 Months)||51||
48344025|NCT02347631|101172235|FG000|NOT COMPLETED|First Intervention (2 Months)||7||
48344026|NCT02347631|101172236|FG001|NOT COMPLETED|First Intervention (2 Months)||6||
48344027|NCT02347631|101172235|FG000|STARTED|Washout 2 (1 Month)||54||
48344028|NCT02347631|101172236|FG001|STARTED|Washout 2 (1 Month)||51||
48344029|NCT02347631|101172235|FG000|COMPLETED|Washout 2 (1 Month)||52||
48757580|NCT02893293|102194359|FG000|STARTED|Overall Study||9||
48757581|NCT02893293|102194360|FG001|STARTED|Overall Study||5||
48344030|NCT02347631|101172236|FG001|COMPLETED|Washout 2 (1 Month)||48||
48344031|NCT02347631|101172235|FG000|NOT COMPLETED|Washout 2 (1 Month)||2||
48344032|NCT02347631|101172236|FG001|NOT COMPLETED|Washout 2 (1 Month)||3||
48344033|NCT02347631|101172235|FG000|STARTED|Second Intervention (2 Months)||52||
48344034|NCT02347631|101172236|FG001|STARTED|Second Intervention (2 Months)||48||
48344035|NCT02347631|101172235|FG000|COMPLETED|Second Intervention (2 Months)||39||
48344036|NCT02347631|101172236|FG001|COMPLETED|Second Intervention (2 Months)||44||
48344037|NCT02347631|101172235|FG000|NOT COMPLETED|Second Intervention (2 Months)||13||
48344038|NCT02347631|101172236|FG001|NOT COMPLETED|Second Intervention (2 Months)||4||
48344039|NCT02939131|101172237|FG000|STARTED|Overall Study||81||6
48344040|NCT02939131|101172238|FG001|STARTED|Overall Study||75||7
48344041|NCT02939131|101172237|FG000|Week 24 Visit|Overall Study||74||6
48344042|NCT02939131|101172238|FG001|Week 24 Visit|Overall Study||72||7
48344043|NCT02939131|101172237|FG000|COMPLETED|Overall Study||70|This is the completion information for the week 48 visit|6
48344044|NCT02939131|101172238|FG001|COMPLETED|Overall Study||66|This is the completion information for the week 48 visit|7
48344045|NCT02939131|101172237|FG000|NOT COMPLETED|Overall Study||11||0
48344046|NCT02939131|101172238|FG001|NOT COMPLETED|Overall Study||9||0
48344047|NCT00054132|101172239|FG000|STARTED|Overall Study||38||
48344048|NCT00054132|101172239|FG000|COMPLETED|Overall Study||37||
48344049|NCT00054132|101172239|FG000|NOT COMPLETED|Overall Study||1||
48344050|NCT03521791|101172240|FG000|STARTED|Overall Study||76||
48344051|NCT03521791|101172241|FG001|STARTED|Overall Study||90||
48344052|NCT03521791|101172240|FG000|COMPLETED|Overall Study||69||
48344053|NCT03521791|101172241|FG001|COMPLETED|Overall Study||73||
48344054|NCT03521791|101172240|FG000|NOT COMPLETED|Overall Study||7||
48344055|NCT03521791|101172241|FG001|NOT COMPLETED|Overall Study||17||
48344056|NCT00862251|101172242|FG000|STARTED|Overall Study||322||
48344057|NCT00862251|101172243|FG001|STARTED|Overall Study||162||
48344058|NCT00862251|101172244|FG002|STARTED|Overall Study||324||
48344059|NCT00862251|101172242|FG000|COMPLETED|Overall Study||303||
48344060|NCT00862251|101172243|FG001|COMPLETED|Overall Study||157||
48344061|NCT00862251|101172244|FG002|COMPLETED|Overall Study||315||
48344062|NCT00862251|101172242|FG000|NOT COMPLETED|Overall Study||19||
48344063|NCT00862251|101172243|FG001|NOT COMPLETED|Overall Study||5||
48344064|NCT00862251|101172244|FG002|NOT COMPLETED|Overall Study||9||
48344065|NCT01993888|101172245|FG000|STARTED|Overall Study||50||
48344066|NCT01993888|101172246|FG001|STARTED|Overall Study||52||
48344067|NCT01993888|101172245|FG000|COMPLETED|Overall Study||48||
48344068|NCT01993888|101172246|FG001|COMPLETED|Overall Study||49||
48344069|NCT01993888|101172245|FG000|NOT COMPLETED|Overall Study||2||
48344070|NCT01993888|101172246|FG001|NOT COMPLETED|Overall Study||3||
48344071|NCT01535235|101172247|FG000|STARTED|Overall Study||16||
48344072|NCT01535235|101172248|FG001|STARTED|Overall Study||15||
48344073|NCT01535235|101172247|FG000|COMPLETED|Overall Study||15||
48344074|NCT01535235|101172248|FG001|COMPLETED|Overall Study||15||
48344075|NCT01535235|101172247|FG000|NOT COMPLETED|Overall Study||1||
48344076|NCT01535235|101172248|FG001|NOT COMPLETED|Overall Study||0||
48344077|NCT02613208|101172249|FG000|STARTED|Overall Study||111||
48344078|NCT02613208|101172249|FG000|COMPLETED|Overall Study||64||
48344079|NCT02613208|101172249|FG000|NOT COMPLETED|Overall Study||47||
48344080|NCT00999830|101172250|FG000|STARTED|Overall Study||14||
48344081|NCT00999830|101172251|FG001|STARTED|Overall Study||13||
48344082|NCT00999830|101172250|FG000|COMPLETED|Overall Study||14||
48344083|NCT00999830|101172251|FG001|COMPLETED|Overall Study||13||
48344084|NCT00999830|101172250|FG000|NOT COMPLETED|Overall Study||0||
48344085|NCT00999830|101172251|FG001|NOT COMPLETED|Overall Study||0||
48344086|NCT01727089|101172252|FG000|STARTED|Overall Study||29||
48344087|NCT01727089|101172253|FG001|STARTED|Overall Study||30||
48344088|NCT01727089|101172252|FG000|COMPLETED|Overall Study||29||
48344089|NCT01727089|101172253|FG001|COMPLETED|Overall Study||30||
48344090|NCT01727089|101172252|FG000|NOT COMPLETED|Overall Study||0||
48344091|NCT01727089|101172253|FG001|NOT COMPLETED|Overall Study||0||
48344092|NCT04492566|101172254|FG000|STARTED|Overall Study||10||
48344093|NCT04492566|101172254|FG000|COMPLETED|Overall Study||10||
48344094|NCT04492566|101172254|FG000|NOT COMPLETED|Overall Study||0||
48344095|NCT00430755|101172255|FG000|STARTED|Overall Study||98||
48344096|NCT00430755|101172255|FG000|COMPLETED|Overall Study||45||
48344097|NCT00430755|101172255|FG000|NOT COMPLETED|Overall Study||53||
48344098|NCT01929083|101172256|FG000|STARTED|Intervention 1||10||
48344099|NCT01929083|101172257|FG001|STARTED|Intervention 1||9||
48344100|NCT01929083|101172256|FG000|Returned for 1st Ibutilide Administratio|Intervention 1||7||
48344101|NCT01929083|101172257|FG001|Returned for 1st Ibutilide Administratio|Intervention 1||9||
48344102|NCT01929083|101172256|FG000|COMPLETED|Intervention 1||7||
48414525|NCT02646891|101350080|FG000|Received at Least 1 Dose|Overall Study||6||
48634444|NCT03857256|101888952|FG001|COMPLETED|Overall Study||63||
48344103|NCT01929083|101172257|FG001|COMPLETED|Intervention 1||9||
48344104|NCT01929083|101172256|FG000|NOT COMPLETED|Intervention 1||3||
48344105|NCT01929083|101172257|FG001|NOT COMPLETED|Intervention 1||0||
48344106|NCT01929083|101172256|FG000|STARTED|Intervention 2||7||
48344107|NCT01929083|101172257|FG001|STARTED|Intervention 2||9||
48344108|NCT01929083|101172256|FG000|Returned for 2nd Ibutilide Administratio|Intervention 2||7||
48344109|NCT01929083|101172257|FG001|Returned for 2nd Ibutilide Administratio|Intervention 2||8||
48344110|NCT01929083|101172256|FG000|COMPLETED|Intervention 2||7||
48344111|NCT01929083|101172257|FG001|COMPLETED|Intervention 2||8||
48344112|NCT01929083|101172256|FG000|NOT COMPLETED|Intervention 2||0||
48344113|NCT01929083|101172257|FG001|NOT COMPLETED|Intervention 2||1||
48344114|NCT00582894|101172258|FG000|STARTED|Overall Study||17||
48344115|NCT00582894|101172258|FG000|Day 100 Post Transplant|Overall Study||17||
48344116|NCT00582894|101172258|FG000|COMPLETED|Overall Study||17||
48344117|NCT00582894|101172258|FG000|NOT COMPLETED|Overall Study||0||
48344118|NCT00358657|101172259|FG000|STARTED|Overall Study||14||
48344119|NCT00358657|101172259|FG000|COMPLETED|Overall Study||14||
48344120|NCT00358657|101172259|FG000|NOT COMPLETED|Overall Study||0||
48344121|NCT02663895|101172260|FG000|STARTED|Overall Study||12||
48344122|NCT02663895|101172260|FG000|COMPLETED|Overall Study||5||
48344123|NCT02663895|101172260|FG000|NOT COMPLETED|Overall Study||7||
48344124|NCT03065179|101172261|FG000|STARTED|Overall Study||25||
48344125|NCT03065179|101172261|FG000|COMPLETED|Overall Study||25||
48344126|NCT03065179|101172261|FG000|NOT COMPLETED|Overall Study||0||
48344127|NCT00619502|101172262|FG000|STARTED|Overall Study||130||
48344128|NCT00619502|101172263|FG001|STARTED|Overall Study||124||
48344129|NCT00619502|101172262|FG000|COMPLETED|Overall Study||122||
48344130|NCT00619502|101172263|FG001|COMPLETED|Overall Study||114||
48344131|NCT00619502|101172262|FG000|NOT COMPLETED|Overall Study||8||
48344132|NCT00619502|101172263|FG001|NOT COMPLETED|Overall Study||10||
48344133|NCT03631927|101172264|FG000|STARTED|Overall Study||5094||
48344134|NCT03631927|101172264|FG000|COMPLETED|Overall Study||4669||
48344135|NCT03631927|101172264|FG000|NOT COMPLETED|Overall Study||425||
48344136|NCT00712348|101172265|FG000|STARTED|Overall Study||31||
48344137|NCT00712348|101172265|FG000|COMPLETED|Overall Study||30||
48344138|NCT00712348|101172265|FG000|NOT COMPLETED|Overall Study||1||
48757582|NCT02893293|102194359|FG000|COMPLETED|Overall Study||8||
48757583|NCT02893293|102194360|FG001|COMPLETED|Overall Study||5||
48757584|NCT02893293|102194359|FG000|NOT COMPLETED|Overall Study||1||
48757585|NCT02893293|102194360|FG001|NOT COMPLETED|Overall Study||0||
48757586|NCT02358473|102194361|FG000|STARTED|Overall Study||13||
48757587|NCT02358473|102194361|FG000|COMPLETED|Overall Study||0||
48757588|NCT02358473|102194361|FG000|NOT COMPLETED|Overall Study||13||
48757589|NCT00262860|102194362|FG000|STARTED|Overall Study||18||
48757590|NCT00262860|102194362|FG000|COMPLETED|Overall Study||16||
48757591|NCT00262860|102194362|FG000|NOT COMPLETED|Overall Study||2||
48757592|NCT01026844|102194363|FG000|STARTED|Overall Study||19||
48344139|NCT01157117|101172266|FG000|STARTED|Overall Study||28||
48344140|NCT01157117|101172267|FG001|STARTED|Overall Study||29||
48344141|NCT01157117|101172268|FG002|STARTED|Overall Study||20||
48344142|NCT01157117|101172266|FG000|Began Omalizumab or Placebo Dosing|Overall Study||27||
48344143|NCT01157117|101172267|FG001|Began Omalizumab or Placebo Dosing|Overall Study||28||
48344144|NCT01157117|101172268|FG002|Began Omalizumab or Placebo Dosing|Overall Study||0||
48344145|NCT01157117|101172266|FG000|Began Milk OIT Dosing at Month 4|Overall Study||27||
48344146|NCT01157117|101172267|FG001|Began Milk OIT Dosing at Month 4|Overall Study||28||
48757593|NCT01026844|102194364|FG001|STARTED|Overall Study||8||
48757594|NCT01026844|102194363|FG000|COMPLETED|Overall Study||19||
48757595|NCT01026844|102194364|FG001|COMPLETED|Overall Study||8||
48757596|NCT01026844|102194363|FG000|NOT COMPLETED|Overall Study||0||
48757597|NCT01026844|102194364|FG001|NOT COMPLETED|Overall Study||0||
48757598|NCT01169103|102194365|FG000|STARTED|Overall Study||11||
48757599|NCT01169103|102194366|FG001|STARTED|Overall Study||11||
48757600|NCT01169103|102194365|FG000|COMPLETED|Overall Study||5||
48757601|NCT01169103|102194366|FG001|COMPLETED|Overall Study||7||
48757602|NCT01169103|102194365|FG000|NOT COMPLETED|Overall Study||6||
48344147|NCT01157117|101172268|FG002|Began Milk OIT Dosing at Month 4|Overall Study||0||
48344148|NCT01157117|101172266|FG000|Reached Milk OIT Maintenance Dosing|Overall Study||26||
48344149|NCT01157117|101172267|FG001|Reached Milk OIT Maintenance Dosing|Overall Study||26||
48344150|NCT01157117|101172268|FG002|Reached Milk OIT Maintenance Dosing|Overall Study||0||
48344151|NCT01157117|101172266|FG000|Unblinded at Month 16|Overall Study||26||
48344152|NCT01157117|101172267|FG001|Unblinded at Month 16|Overall Study||26||
48344153|NCT01157117|101172268|FG002|Unblinded at Month 16|Overall Study||0||
48344154|NCT01157117|101172266|FG000|Completed Month 28 Desensitization OFC|Overall Study||26||
48344155|NCT01157117|101172267|FG001|Completed Month 28 Desensitization OFC|Overall Study||24||
48344156|NCT01157117|101172268|FG002|Completed Month 28 Desensitization OFC|Overall Study||0||
48344157|NCT01157117|101172266|FG000|Discontinued Milk OIT at Month 30|Overall Study||24||
48344158|NCT01157117|101172267|FG001|Discontinued Milk OIT at Month 30|Overall Study||20||
48344159|NCT01157117|101172268|FG002|Discontinued Milk OIT at Month 30|Overall Study||0||
48344160|NCT01157117|101172266|FG000|Completed Month 32 Tolerance OFC|Overall Study||24||
48368096|NCT01798706|101230104|FG000|COMPLETED|Overall Study||155||
48757603|NCT01169103|102194366|FG001|NOT COMPLETED|Overall Study||4||
48757604|NCT04854135|102194367|FG000|STARTED|Overall Study||20||
48757605|NCT04854135|102194367|FG000|COMPLETED|Overall Study||20||
48757606|NCT04854135|102194367|FG000|NOT COMPLETED|Overall Study||0||
48757607|NCT04739982|102194368|FG000|STARTED|Overall Study||322||
48757608|NCT04739982|102194369|FG001|STARTED|Overall Study||219||
48757609|NCT04739982|102194368|FG000|Completed Week 4 Survey|Overall Study||127||
48757610|NCT04739982|102194369|FG001|Completed Week 4 Survey|Overall Study||149||
48757611|NCT04739982|102194368|FG000|COMPLETED|Overall Study||127||
48757612|NCT04739982|102194369|FG001|COMPLETED|Overall Study||149||
48757613|NCT04739982|102194368|FG000|NOT COMPLETED|Overall Study||195||
48757614|NCT04739982|102194369|FG001|NOT COMPLETED|Overall Study||70||
48757615|NCT03796728|102194370|FG000|STARTED|Overall Study||60||
48757616|NCT03796728|102194370|FG000|COMPLETED|Overall Study||36||
48757617|NCT03796728|102194370|FG000|NOT COMPLETED|Overall Study||24||
48757618|NCT02731638|102194371|FG000|STARTED|Overall Study||35||
48757619|NCT02731638|102194372|FG001|STARTED|Overall Study||35||
48757620|NCT02731638|102194371|FG000|COMPLETED|Overall Study||29||
48757621|NCT02731638|102194372|FG001|COMPLETED|Overall Study||26||
48757622|NCT02731638|102194371|FG000|NOT COMPLETED|Overall Study||6||
48757623|NCT02731638|102194372|FG001|NOT COMPLETED|Overall Study||9||
48757624|NCT00980954|102194373|FG000|STARTED|Overall Study||118||
48757625|NCT00980954|102194374|FG001|STARTED|Overall Study||118||
48757626|NCT00980954|102194373|FG000|Eligible|Overall Study||109||
48757627|NCT00980954|102194374|FG001|Eligible|Overall Study||103||
48757628|NCT00980954|102194373|FG000|COMPLETED|Overall Study||109|Participants contributing data to results are considered to have completed the study.|
48757629|NCT00980954|102194374|FG001|COMPLETED|Overall Study||103|Participants contributing data to results are considered to have completed the study.|
48757630|NCT00980954|102194373|FG000|NOT COMPLETED|Overall Study||9||
48757631|NCT00980954|102194374|FG001|NOT COMPLETED|Overall Study||15||
48757632|NCT04097678|102194375|FG000|STARTED|Overall Study||73||
48757633|NCT04097678|102194376|FG001|STARTED|Overall Study||73||
48757634|NCT04097678|102194375|FG000|COMPLETED|Overall Study||56||
48757635|NCT04097678|102194376|FG001|COMPLETED|Overall Study||55||
48634445|NCT03857256|101888953|FG002|COMPLETED|Overall Study||65||
48634446|NCT03857256|101888954|FG003|COMPLETED|Overall Study||63||
48634447|NCT03857256|101888951|FG000|NOT COMPLETED|Overall Study||1||
48634448|NCT03857256|101888952|FG001|NOT COMPLETED|Overall Study||3||
48634449|NCT03857256|101888953|FG002|NOT COMPLETED|Overall Study||1||
48634450|NCT03857256|101888954|FG003|NOT COMPLETED|Overall Study||3||
48757636|NCT04097678|102194375|FG000|NOT COMPLETED|Overall Study||17||
48757637|NCT04097678|102194376|FG001|NOT COMPLETED|Overall Study||18||
48757638|NCT00435409|102194377|FG000|STARTED|Overall Study||221||
48757639|NCT00435409|102194378|FG001|STARTED|Overall Study||143||
48757640|NCT00435409|102194379|FG002|STARTED|Overall Study||78||
48757641|NCT00435409|102194377|FG000|Treated|Overall Study||217||
48634451|NCT04262219|101888955|FG000|STARTED|Overall Study||32||
48634452|NCT04262219|101888955|FG000|COMPLETED|Overall Study||30||
48634453|NCT04262219|101888955|FG000|NOT COMPLETED|Overall Study||2||
48634454|NCT04748718|101888956|FG000|STARTED|Overall Study||62||
48634455|NCT04748718|101888956|FG000|COMPLETED|Overall Study||12||
48634456|NCT04748718|101888956|FG000|NOT COMPLETED|Overall Study||50||
48634457|NCT01675778|101888957|FG000|STARTED|Overall Study||174||
48634458|NCT01675778|101888957|FG000|COMPLETED|Overall Study||174||
48634459|NCT01675778|101888957|FG000|NOT COMPLETED|Overall Study||0||
48634460|NCT01740206|101888958|FG000|STARTED|Overall Study||14||
48634461|NCT01740206|101888959|FG001|STARTED|Overall Study||34||
48634462|NCT01740206|101888958|FG000|COMPLETED|Overall Study||14||
48634463|NCT01740206|101888959|FG001|COMPLETED|Overall Study||34||
48634464|NCT01740206|101888958|FG000|NOT COMPLETED|Overall Study||0||
48634465|NCT01740206|101888959|FG001|NOT COMPLETED|Overall Study||0||
48634466|NCT00795340|101888960|FG000|STARTED|Overall Study||153||
48634467|NCT00795340|101888961|FG001|STARTED|Overall Study||153||
48634468|NCT00795340|101888960|FG000|COMPLETED|Overall Study||146||
48634469|NCT00795340|101888961|FG001|COMPLETED|Overall Study||153||
48634470|NCT00795340|101888960|FG000|NOT COMPLETED|Overall Study||7||
48634471|NCT00795340|101888961|FG001|NOT COMPLETED|Overall Study||0||
48634472|NCT00720759|101888962|FG000|STARTED|Overall Study||6||
48634473|NCT00720759|101888963|FG001|STARTED|Overall Study||6||
48634474|NCT00720759|101888964|FG002|STARTED|Overall Study||6||
48634475|NCT00720759|101888965|FG003|STARTED|Overall Study||6||
48634476|NCT00720759|101888962|FG000|COMPLETED|Overall Study||6||
48634477|NCT00720759|101888963|FG001|COMPLETED|Overall Study||5||
48634478|NCT00720759|101888964|FG002|COMPLETED|Overall Study||5||
48634479|NCT00720759|101888965|FG003|COMPLETED|Overall Study||6||
48634480|NCT00720759|101888962|FG000|NOT COMPLETED|Overall Study||0||
48634481|NCT00720759|101888963|FG001|NOT COMPLETED|Overall Study||1||
48634482|NCT00720759|101888964|FG002|NOT COMPLETED|Overall Study||1||
48634483|NCT00720759|101888965|FG003|NOT COMPLETED|Overall Study||0||
48634484|NCT03530293|101888966|FG000|STARTED|Pre-randomization||81||
48634485|NCT03530293|101888967|FG001|STARTED|Pre-randomization||0||
48757642|NCT00435409|102194378|FG001|Treated|Overall Study||139||
48757643|NCT00435409|102194379|FG002|Treated|Overall Study||78||
48757644|NCT00435409|102194377|FG000|COMPLETED|Overall Study||0||
48757645|NCT00435409|102194378|FG001|COMPLETED|Overall Study||0||
48757646|NCT00435409|102194379|FG002|COMPLETED|Overall Study||0||
48757647|NCT00435409|102194377|FG000|NOT COMPLETED|Overall Study||221||
48757648|NCT00435409|102194378|FG001|NOT COMPLETED|Overall Study||143||
48757649|NCT00435409|102194379|FG002|NOT COMPLETED|Overall Study||78||
48757650|NCT03207126|102194380|FG000|STARTED|Overall Study||10||10
48757651|NCT03207126|102194380|FG000|COMPLETED|Overall Study||10||10
48757652|NCT03207126|102194380|FG000|NOT COMPLETED|Overall Study||0||0
48757653|NCT03633396|102194381|FG000|STARTED|Overall Study||29||
48757654|NCT03633396|102194382|FG001|STARTED|Overall Study||30||
48757655|NCT03633396|102194381|FG000|COMPLETED|Overall Study||23||
48757656|NCT03633396|102194382|FG001|COMPLETED|Overall Study||24||
48757657|NCT03633396|102194381|FG000|NOT COMPLETED|Overall Study||6||
48757658|NCT03633396|102194382|FG001|NOT COMPLETED|Overall Study||6||
48757659|NCT00976274|102194383|FG000|STARTED|Overall Study||31||
48757660|NCT00976274|102194384|FG001|STARTED|Overall Study||29||
48757661|NCT00976274|102194383|FG000|COMPLETED|Overall Study||24||
48757662|NCT00976274|102194384|FG001|COMPLETED|Overall Study||21||
48757663|NCT00976274|102194383|FG000|NOT COMPLETED|Overall Study||7||
48757664|NCT00976274|102194384|FG001|NOT COMPLETED|Overall Study||8||
48757665|NCT01395797|102194385|FG000|STARTED|Overall Study||19||
48757666|NCT01395797|102194386|FG001|STARTED|Overall Study||4||
48757667|NCT01395797|102194387|FG002|STARTED|Overall Study||18||
48344161|NCT01157117|101172267|FG001|Completed Month 32 Tolerance OFC|Overall Study||20||
48344162|NCT01157117|101172268|FG002|Completed Month 32 Tolerance OFC|Overall Study||0||
48344163|NCT01157117|101172266|FG000|Completed Final Month 38 Study Visit|Overall Study||19||
48344164|NCT01157117|101172267|FG001|Completed Final Month 38 Study Visit|Overall Study||18||
48344165|NCT01157117|101172268|FG002|Completed Final Month 38 Study Visit|Overall Study||3||
48344166|NCT01157117|101172266|FG000|COMPLETED|Overall Study||19||
48344167|NCT01157117|101172267|FG001|COMPLETED|Overall Study||18||
48344168|NCT01157117|101172268|FG002|COMPLETED|Overall Study||5||
48344169|NCT01157117|101172266|FG000|NOT COMPLETED|Overall Study||9||
48414526|NCT02646891|101350081|FG001|Received at Least 1 Dose|Overall Study||12||
48757668|NCT01395797|102194388|FG003|STARTED|Overall Study||15||
48757669|NCT01395797|102194389|FG004|STARTED|Overall Study||9||
48757670|NCT01395797|102194390|FG005|STARTED|Overall Study||17||
48757671|NCT01395797|102194385|FG000|COMPLETED|Overall Study||16||
48757672|NCT01395797|102194386|FG001|COMPLETED|Overall Study||3||
48757673|NCT01395797|102194387|FG002|COMPLETED|Overall Study||14||
48757674|NCT01395797|102194388|FG003|COMPLETED|Overall Study||13||
48757675|NCT01395797|102194389|FG004|COMPLETED|Overall Study||7||
48757676|NCT01395797|102194390|FG005|COMPLETED|Overall Study||14||
48757677|NCT01395797|102194385|FG000|NOT COMPLETED|Overall Study||3||
48757678|NCT01395797|102194386|FG001|NOT COMPLETED|Overall Study||1||
48757679|NCT01395797|102194387|FG002|NOT COMPLETED|Overall Study||4||
48757680|NCT01395797|102194388|FG003|NOT COMPLETED|Overall Study||2||
48757681|NCT01395797|102194389|FG004|NOT COMPLETED|Overall Study||2||
48757682|NCT01395797|102194390|FG005|NOT COMPLETED|Overall Study||3||
48757683|NCT03985761|102194391|FG000|STARTED|Overall Study||17||
48757684|NCT03985761|102194392|FG001|STARTED|Overall Study||16||
48757685|NCT03985761|102194391|FG000|COMPLETED|Overall Study||15||
48757686|NCT03985761|102194392|FG001|COMPLETED|Overall Study||13||
48757687|NCT03985761|102194391|FG000|NOT COMPLETED|Overall Study||2||
48757688|NCT03985761|102194392|FG001|NOT COMPLETED|Overall Study||3||
48757689|NCT02135861|102194393|FG000|STARTED|Overall Study||21||
48757690|NCT02135861|102194394|FG001|STARTED|Overall Study||12||
48757691|NCT02135861|102194395|FG002|STARTED|Overall Study||3||
48757692|NCT02135861|102194393|FG000|COMPLETED|Overall Study||21||
48757693|NCT02135861|102194394|FG001|COMPLETED|Overall Study||12||
48757694|NCT02135861|102194395|FG002|COMPLETED|Overall Study||3||
48757695|NCT02135861|102194393|FG000|NOT COMPLETED|Overall Study||0||
48757696|NCT02135861|102194394|FG001|NOT COMPLETED|Overall Study||0||
48757697|NCT02135861|102194395|FG002|NOT COMPLETED|Overall Study||0||
48757698|NCT00627393|102194396|FG000|STARTED|Intention-To-Treat Analysis||58||
48757699|NCT00627393|102194397|FG001|STARTED|Intention-To-Treat Analysis||56||
48344170|NCT01157117|101172267|FG001|NOT COMPLETED|Overall Study||11||
48344171|NCT01157117|101172268|FG002|NOT COMPLETED|Overall Study||15||
48344172|NCT01392183|101172269|FG000|STARTED|First Drug Administration||35||
48344173|NCT01392183|101172270|FG001|STARTED|First Drug Administration||34||
48344174|NCT01392183|101172269|FG000|Eligible to Cross Over to 2nd Drug|First Drug Administration||29|29 participants were eligible to cross over, 8 out of those 29 eligible participants withdrew consent.|
48344175|NCT01392183|101172270|FG001|Eligible to Cross Over to 2nd Drug|First Drug Administration||31|29 participants were eligible to cross over, 8 out of those 29 eligible participants withdrew consent.|
48344176|NCT01392183|101172269|FG000|COMPLETED|First Drug Administration||21||
48344177|NCT01392183|101172270|FG001|COMPLETED|First Drug Administration||15||
48344178|NCT01392183|101172269|FG000|NOT COMPLETED|First Drug Administration||14||
48414527|NCT02646891|101350082|FG002|Received at Least 1 Dose|Overall Study||12||
48414528|NCT02646891|101350083|FG003|Received at Least 1 Dose|Overall Study||6||
48757700|NCT00627393|102194396|FG000|COMPLETED|Intention-To-Treat Analysis||49||
48757701|NCT00627393|102194397|FG001|COMPLETED|Intention-To-Treat Analysis||48||
48757702|NCT00627393|102194396|FG000|NOT COMPLETED|Intention-To-Treat Analysis||9||
48757703|NCT00627393|102194397|FG001|NOT COMPLETED|Intention-To-Treat Analysis||8||
48757704|NCT00627393|102194396|FG000|STARTED|Per-Protocol Analysis||49||
48757705|NCT00627393|102194397|FG001|STARTED|Per-Protocol Analysis||48||
48757706|NCT00627393|102194396|FG000|COMPLETED|Per-Protocol Analysis||39||
48757707|NCT00627393|102194397|FG001|COMPLETED|Per-Protocol Analysis||35||
48757708|NCT00627393|102194396|FG000|NOT COMPLETED|Per-Protocol Analysis||10||
48757709|NCT00627393|102194397|FG001|NOT COMPLETED|Per-Protocol Analysis||13||
48757710|NCT03858049|102194398|FG000|STARTED|Overall Study||86||
48757711|NCT03858049|102194399|FG001|STARTED|Overall Study||86||
48634486|NCT03530293|101888968|FG002|STARTED|Pre-randomization||0||
48634487|NCT03530293|101888966|FG000|Safety Analysis Set|Pre-randomization||80|The safety analysis set includes all enrolled subjects who received at least one dose of study drug and had any safety data collected after the first dose of study drug.|
48634488|NCT03530293|101888967|FG001|Safety Analysis Set|Pre-randomization||0|The safety analysis set includes all enrolled subjects who received at least one dose of study drug and had any safety data collected after the first dose of study drug.|
48634489|NCT03530293|101888968|FG002|Safety Analysis Set|Pre-randomization||0|The safety analysis set includes all enrolled subjects who received at least one dose of study drug and had any safety data collected after the first dose of study drug.|
48634490|NCT03530293|101888966|FG000|COMPLETED|Pre-randomization||57||
48757712|NCT03858049|102194398|FG000|COMPLETED|Overall Study||69||
48757713|NCT03858049|102194399|FG001|COMPLETED|Overall Study||76||
48757714|NCT03858049|102194398|FG000|NOT COMPLETED|Overall Study||17||
48757715|NCT03858049|102194399|FG001|NOT COMPLETED|Overall Study||10||
48757716|NCT03157830|102194400|FG000|STARTED|Overall Study||43||
48344179|NCT01392183|101172270|FG001|NOT COMPLETED|First Drug Administration||19||
48344180|NCT01392183|101172269|FG000|STARTED|Second Drug Administration||21||
48344181|NCT01392183|101172270|FG001|STARTED|Second Drug Administration||15||
48344182|NCT01392183|101172269|FG000|Treatment Ended: Progression|Second Drug Administration||18||
48634491|NCT03530293|101888967|FG001|COMPLETED|Pre-randomization||0||
48634492|NCT03530293|101888968|FG002|COMPLETED|Pre-randomization||0||
48634493|NCT03530293|101888966|FG000|NOT COMPLETED|Pre-randomization||24||
48634494|NCT03530293|101888967|FG001|NOT COMPLETED|Pre-randomization||0||
48634495|NCT03530293|101888968|FG002|NOT COMPLETED|Pre-randomization||0||
48634496|NCT03530293|101888966|FG000|STARTED|Randomized Withdrawal Period / Follow-up||0|5 subjects completed the pre-randomization period but were ineligible for randomization due to lack of response.|
48634497|NCT03530293|101888967|FG001|STARTED|Randomized Withdrawal Period / Follow-up||26|5 subjects completed the pre-randomization period but were ineligible for randomization due to lack of response.|
48634498|NCT03530293|101888968|FG002|STARTED|Randomized Withdrawal Period / Follow-up||26|5 subjects completed the pre-randomization period but were ineligible for randomization due to lack of response.|
48634499|NCT03530293|101888966|FG000|COMPLETED|Randomized Withdrawal Period / Follow-up||0||
48634500|NCT03530293|101888967|FG001|COMPLETED|Randomized Withdrawal Period / Follow-up||9||
48634501|NCT03530293|101888968|FG002|COMPLETED|Randomized Withdrawal Period / Follow-up||9||
48634502|NCT03530293|101888966|FG000|NOT COMPLETED|Randomized Withdrawal Period / Follow-up||0||
48634503|NCT03530293|101888967|FG001|NOT COMPLETED|Randomized Withdrawal Period / Follow-up||17||
48634504|NCT03530293|101888968|FG002|NOT COMPLETED|Randomized Withdrawal Period / Follow-up||17||
48634505|NCT00544414|101888969|FG000|STARTED|Overall Study||31||
48634506|NCT00544414|101888969|FG000|COMPLETED|Overall Study||31||
48634507|NCT00544414|101888969|FG000|NOT COMPLETED|Overall Study||0||
48634508|NCT01484340|101888970|FG000|STARTED|Overall Study||281||
48634509|NCT01484340|101888971|FG001|STARTED|Overall Study||279||
48634510|NCT01484340|101888970|FG000|COMPLETED|Overall Study||281||
48634511|NCT01484340|101888971|FG001|COMPLETED|Overall Study||279||
48634512|NCT01484340|101888970|FG000|NOT COMPLETED|Overall Study||0||
48634513|NCT01484340|101888971|FG001|NOT COMPLETED|Overall Study||0||
48634514|NCT03133676|101888972|FG000|STARTED|Overall Study||6||
48757717|NCT03157830|102194400|FG000|COMPLETED|Overall Study||41||
48757718|NCT03157830|102194400|FG000|NOT COMPLETED|Overall Study||2||
48757719|NCT02558894|102194401|FG000|STARTED|Overall Study||32||
48757720|NCT02558894|102194402|FG001|STARTED|Overall Study||33||
48757721|NCT02558894|102194401|FG000|Patients Who Received IP|Overall Study||32||
48344183|NCT01392183|101172270|FG001|Treatment Ended: Progression|Second Drug Administration||11||
48344184|NCT01392183|101172269|FG000|Treatment Ended: Adverse Events|Second Drug Administration||1||
48344185|NCT01392183|101172270|FG001|Treatment Ended: Adverse Events|Second Drug Administration||2||
48344186|NCT01392183|101172269|FG000|Treatment Ended: Participant Withdrew|Second Drug Administration||2||
48634515|NCT03133676|101888973|FG001|STARTED|Overall Study||3||
48634516|NCT03133676|101888974|FG002|STARTED|Overall Study||3||
48634517|NCT03133676|101888975|FG003|STARTED|Overall Study||6||
48634518|NCT03133676|101888976|FG004|STARTED|Overall Study||6||
48634519|NCT03133676|101888977|FG005|STARTED|Overall Study||9||
48634520|NCT03133676|101888978|FG006|STARTED|Overall Study||9||
48634521|NCT03133676|101888979|FG007|STARTED|Overall Study||9||
48634522|NCT03133676|101888980|FG008|STARTED|Overall Study||9||
48634523|NCT03133676|101888972|FG000|COMPLETED|Overall Study||6||
48634524|NCT03133676|101888973|FG001|COMPLETED|Overall Study||3||
48634525|NCT03133676|101888974|FG002|COMPLETED|Overall Study||3||
48634526|NCT03133676|101888975|FG003|COMPLETED|Overall Study||6||
48634527|NCT03133676|101888976|FG004|COMPLETED|Overall Study||6||
48634528|NCT03133676|101888977|FG005|COMPLETED|Overall Study||9||
48634529|NCT03133676|101888978|FG006|COMPLETED|Overall Study||9||
48634530|NCT03133676|101888979|FG007|COMPLETED|Overall Study||9||
48634531|NCT03133676|101888980|FG008|COMPLETED|Overall Study||9||
48634532|NCT03133676|101888972|FG000|NOT COMPLETED|Overall Study||0||
48634533|NCT03133676|101888973|FG001|NOT COMPLETED|Overall Study||0||
48634534|NCT03133676|101888974|FG002|NOT COMPLETED|Overall Study||0||
48634535|NCT03133676|101888975|FG003|NOT COMPLETED|Overall Study||0||
48634536|NCT03133676|101888976|FG004|NOT COMPLETED|Overall Study||0||
48634537|NCT03133676|101888977|FG005|NOT COMPLETED|Overall Study||0||
48634538|NCT03133676|101888978|FG006|NOT COMPLETED|Overall Study||0||
48634539|NCT03133676|101888979|FG007|NOT COMPLETED|Overall Study||0||
48634540|NCT03133676|101888980|FG008|NOT COMPLETED|Overall Study||0||
48634541|NCT03095287|101888981|FG000|STARTED|Overall Study||2||
48634542|NCT03095287|101888981|FG000|COMPLETED|Overall Study||0||
48634543|NCT03095287|101888981|FG000|NOT COMPLETED|Overall Study||2||
48634544|NCT01655901|101888982|FG000|STARTED|First Intervention (Hour 1)||5||
48634545|NCT01655901|101888983|FG001|STARTED|First Intervention (Hour 1)||5||
48634546|NCT01655901|101888984|FG002|STARTED|First Intervention (Hour 1)||5||
48634547|NCT01655901|101888985|FG003|STARTED|First Intervention (Hour 1)||5||
48634548|NCT01655901|101888986|FG004|STARTED|First Intervention (Hour 1)||5||
48634549|NCT01655901|101888987|FG005|STARTED|First Intervention (Hour 1)||5||
48634550|NCT01655901|101888982|FG000|COMPLETED|First Intervention (Hour 1)||5||
48634551|NCT01655901|101888983|FG001|COMPLETED|First Intervention (Hour 1)||5||
48634552|NCT01655901|101888984|FG002|COMPLETED|First Intervention (Hour 1)||5||
48634553|NCT01655901|101888985|FG003|COMPLETED|First Intervention (Hour 1)||5||
48634554|NCT01655901|101888986|FG004|COMPLETED|First Intervention (Hour 1)||5||
48634555|NCT01655901|101888987|FG005|COMPLETED|First Intervention (Hour 1)||5||
48634556|NCT01655901|101888982|FG000|NOT COMPLETED|First Intervention (Hour 1)||0||
48634557|NCT01655901|101888983|FG001|NOT COMPLETED|First Intervention (Hour 1)||0||
48634558|NCT01655901|101888984|FG002|NOT COMPLETED|First Intervention (Hour 1)||0||
48634559|NCT01655901|101888985|FG003|NOT COMPLETED|First Intervention (Hour 1)||0||
48634560|NCT01655901|101888986|FG004|NOT COMPLETED|First Intervention (Hour 1)||0||
48634561|NCT01655901|101888987|FG005|NOT COMPLETED|First Intervention (Hour 1)||0||
48634562|NCT01655901|101888982|FG000|STARTED|Washout (1 Week)||5||
48634563|NCT01655901|101888983|FG001|STARTED|Washout (1 Week)||5||
48634564|NCT01655901|101888984|FG002|STARTED|Washout (1 Week)||5||
48634565|NCT01655901|101888985|FG003|STARTED|Washout (1 Week)||5||
48634566|NCT01655901|101888986|FG004|STARTED|Washout (1 Week)||5||
48634567|NCT01655901|101888987|FG005|STARTED|Washout (1 Week)||5||
48634568|NCT01655901|101888982|FG000|COMPLETED|Washout (1 Week)||5||
48634569|NCT01655901|101888983|FG001|COMPLETED|Washout (1 Week)||5||
48634570|NCT01655901|101888984|FG002|COMPLETED|Washout (1 Week)||5||
48634571|NCT01655901|101888985|FG003|COMPLETED|Washout (1 Week)||5||
48634572|NCT01655901|101888986|FG004|COMPLETED|Washout (1 Week)||5||
48634573|NCT01655901|101888987|FG005|COMPLETED|Washout (1 Week)||5||
48634574|NCT01655901|101888982|FG000|NOT COMPLETED|Washout (1 Week)||0||
48634575|NCT01655901|101888983|FG001|NOT COMPLETED|Washout (1 Week)||0||
48634576|NCT01655901|101888984|FG002|NOT COMPLETED|Washout (1 Week)||0||
48634577|NCT01655901|101888985|FG003|NOT COMPLETED|Washout (1 Week)||0||
48634578|NCT01655901|101888986|FG004|NOT COMPLETED|Washout (1 Week)||0||
48634579|NCT01655901|101888987|FG005|NOT COMPLETED|Washout (1 Week)||0||
48634580|NCT01655901|101888982|FG000|STARTED|Second Intervention (Hour 2)||5||
48634581|NCT01655901|101888983|FG001|STARTED|Second Intervention (Hour 2)||5||
48634582|NCT01655901|101888984|FG002|STARTED|Second Intervention (Hour 2)||5||
48634583|NCT01655901|101888985|FG003|STARTED|Second Intervention (Hour 2)||5||
48634584|NCT01655901|101888986|FG004|STARTED|Second Intervention (Hour 2)||5||
48634585|NCT01655901|101888987|FG005|STARTED|Second Intervention (Hour 2)||5||
48634586|NCT01655901|101888982|FG000|COMPLETED|Second Intervention (Hour 2)||5||
48634587|NCT01655901|101888983|FG001|COMPLETED|Second Intervention (Hour 2)||5||
48634588|NCT01655901|101888984|FG002|COMPLETED|Second Intervention (Hour 2)||5||
48634589|NCT01655901|101888985|FG003|COMPLETED|Second Intervention (Hour 2)||5||
48634590|NCT01655901|101888986|FG004|COMPLETED|Second Intervention (Hour 2)||5||
48634591|NCT01655901|101888987|FG005|COMPLETED|Second Intervention (Hour 2)||5||
48634592|NCT01655901|101888982|FG000|NOT COMPLETED|Second Intervention (Hour 2)||0||
48634593|NCT01655901|101888983|FG001|NOT COMPLETED|Second Intervention (Hour 2)||0||
48634594|NCT01655901|101888984|FG002|NOT COMPLETED|Second Intervention (Hour 2)||0||
48634595|NCT01655901|101888985|FG003|NOT COMPLETED|Second Intervention (Hour 2)||0||
48634596|NCT01655901|101888986|FG004|NOT COMPLETED|Second Intervention (Hour 2)||0||
48634597|NCT01655901|101888987|FG005|NOT COMPLETED|Second Intervention (Hour 2)||0||
48634598|NCT01655901|101888982|FG000|STARTED|Washout (1 Week)||5||
48634599|NCT01655901|101888983|FG001|STARTED|Washout (1 Week)||5||
48634600|NCT01655901|101888984|FG002|STARTED|Washout (1 Week)||5||
48634601|NCT01655901|101888985|FG003|STARTED|Washout (1 Week)||5||
48634602|NCT01655901|101888986|FG004|STARTED|Washout (1 Week)||5||
48634603|NCT01655901|101888987|FG005|STARTED|Washout (1 Week)||5||
48634604|NCT01655901|101888982|FG000|COMPLETED|Washout (1 Week)||5||
48634605|NCT01655901|101888983|FG001|COMPLETED|Washout (1 Week)||5||
48634606|NCT01655901|101888984|FG002|COMPLETED|Washout (1 Week)||5||
48634607|NCT01655901|101888985|FG003|COMPLETED|Washout (1 Week)||5||
48634608|NCT01655901|101888986|FG004|COMPLETED|Washout (1 Week)||5||
48634609|NCT01655901|101888987|FG005|COMPLETED|Washout (1 Week)||5||
48634610|NCT01655901|101888982|FG000|NOT COMPLETED|Washout (1 Week)||0||
48634611|NCT01655901|101888983|FG001|NOT COMPLETED|Washout (1 Week)||0||
48634612|NCT01655901|101888984|FG002|NOT COMPLETED|Washout (1 Week)||0||
48634613|NCT01655901|101888985|FG003|NOT COMPLETED|Washout (1 Week)||0||
48634614|NCT01655901|101888986|FG004|NOT COMPLETED|Washout (1 Week)||0||
48634615|NCT01655901|101888987|FG005|NOT COMPLETED|Washout (1 Week)||0||
48634616|NCT01655901|101888982|FG000|STARTED|Third Intervention (Hour 3)||5||
48634617|NCT01655901|101888983|FG001|STARTED|Third Intervention (Hour 3)||5||
48634618|NCT01655901|101888984|FG002|STARTED|Third Intervention (Hour 3)||5||
48634619|NCT01655901|101888985|FG003|STARTED|Third Intervention (Hour 3)||5||
48634620|NCT01655901|101888986|FG004|STARTED|Third Intervention (Hour 3)||5||
48634621|NCT01655901|101888987|FG005|STARTED|Third Intervention (Hour 3)||5||
48634622|NCT01655901|101888982|FG000|COMPLETED|Third Intervention (Hour 3)||4||
48634623|NCT01655901|101888983|FG001|COMPLETED|Third Intervention (Hour 3)||4||
48634624|NCT01655901|101888984|FG002|COMPLETED|Third Intervention (Hour 3)||4||
48634625|NCT01655901|101888985|FG003|COMPLETED|Third Intervention (Hour 3)||5||
48634626|NCT01655901|101888986|FG004|COMPLETED|Third Intervention (Hour 3)||4||
48634627|NCT01655901|101888987|FG005|COMPLETED|Third Intervention (Hour 3)||5||
48634628|NCT01655901|101888982|FG000|NOT COMPLETED|Third Intervention (Hour 3)||1||
48634629|NCT01655901|101888983|FG001|NOT COMPLETED|Third Intervention (Hour 3)||1||
48634630|NCT01655901|101888984|FG002|NOT COMPLETED|Third Intervention (Hour 3)||1||
48634631|NCT01655901|101888985|FG003|NOT COMPLETED|Third Intervention (Hour 3)||0||
48634632|NCT01655901|101888986|FG004|NOT COMPLETED|Third Intervention (Hour 3)||1||
48634633|NCT01655901|101888987|FG005|NOT COMPLETED|Third Intervention (Hour 3)||0||
48634634|NCT00843349|101888988|FG000|STARTED|Overall Study||11||
48634635|NCT00843349|101888989|FG001|STARTED|Overall Study||11||
48634636|NCT00843349|101888990|FG002|STARTED|Overall Study||10||
48634637|NCT00843349|101888991|FG003|STARTED|Overall Study||11||
48634638|NCT00843349|101888988|FG000|COMPLETED|Overall Study||8||
48634639|NCT00843349|101888989|FG001|COMPLETED|Overall Study||11||
48634640|NCT00843349|101888990|FG002|COMPLETED|Overall Study||10||
48634641|NCT00843349|101888991|FG003|COMPLETED|Overall Study||10||
48634642|NCT00843349|101888988|FG000|NOT COMPLETED|Overall Study||3||
48634643|NCT00843349|101888989|FG001|NOT COMPLETED|Overall Study||0||
48634644|NCT00843349|101888990|FG002|NOT COMPLETED|Overall Study||0||
48634645|NCT00843349|101888991|FG003|NOT COMPLETED|Overall Study||1||
48634646|NCT04711005|101888992|FG000|STARTED|Overall Study||6||
48634647|NCT04711005|101888993|FG001|STARTED|Overall Study||6||
48634648|NCT04711005|101888994|FG002|STARTED|Overall Study||6||
48634649|NCT04711005|101888995|FG003|STARTED|Overall Study||6||
48634650|NCT04711005|101888996|FG004|STARTED|Overall Study||6||
48634651|NCT04711005|101888997|FG005|STARTED|Overall Study||6||
48634652|NCT04711005|101888998|FG006|STARTED|Overall Study||6||
48634653|NCT04711005|101888999|FG007|STARTED|Overall Study||9||
48634654|NCT04711005|101889000|FG008|STARTED|Overall Study||19||
48634655|NCT04711005|101889001|FG009|STARTED|Overall Study||4||
48634656|NCT04711005|101888992|FG000|COMPLETED|Overall Study||6||
48634657|NCT04711005|101888993|FG001|COMPLETED|Overall Study||6||
48634658|NCT04711005|101888994|FG002|COMPLETED|Overall Study||6||
48634659|NCT04711005|101888995|FG003|COMPLETED|Overall Study||6||
48634660|NCT04711005|101888996|FG004|COMPLETED|Overall Study||6||
48634661|NCT04711005|101888997|FG005|COMPLETED|Overall Study||6||
48634662|NCT04711005|101888998|FG006|COMPLETED|Overall Study||6||
48634663|NCT04711005|101888999|FG007|COMPLETED|Overall Study||6||
48634664|NCT04711005|101889000|FG008|COMPLETED|Overall Study||18||
48634665|NCT04711005|101889001|FG009|COMPLETED|Overall Study||4||
48634666|NCT04711005|101888992|FG000|NOT COMPLETED|Overall Study||0||
48634667|NCT04711005|101888993|FG001|NOT COMPLETED|Overall Study||0||
48634668|NCT04711005|101888994|FG002|NOT COMPLETED|Overall Study||0||
48634669|NCT04711005|101888995|FG003|NOT COMPLETED|Overall Study||0||
48634670|NCT04711005|101888996|FG004|NOT COMPLETED|Overall Study||0||
48634671|NCT04711005|101888997|FG005|NOT COMPLETED|Overall Study||0||
48634672|NCT04711005|101888998|FG006|NOT COMPLETED|Overall Study||0||
48634673|NCT04711005|101888999|FG007|NOT COMPLETED|Overall Study||3||
48634674|NCT04711005|101889000|FG008|NOT COMPLETED|Overall Study||1||
48634675|NCT04711005|101889001|FG009|NOT COMPLETED|Overall Study||0||
48634676|NCT02314546|101889002|FG000|STARTED|Overall Study||5||
48344187|NCT01392183|101172270|FG001|Treatment Ended: Participant Withdrew|Second Drug Administration||1||
48344188|NCT01392183|101172269|FG000|Treatment Ended: Death|Second Drug Administration||0||
48344189|NCT01392183|101172270|FG001|Treatment Ended: Death|Second Drug Administration||1||
48344190|NCT01392183|101172269|FG000|COMPLETED|Second Drug Administration||21||
48344191|NCT01392183|101172270|FG001|COMPLETED|Second Drug Administration||15||
48344192|NCT01392183|101172269|FG000|NOT COMPLETED|Second Drug Administration||0||
48634677|NCT02314546|101889003|FG001|STARTED|Overall Study||5||
48634678|NCT02314546|101889004|FG002|STARTED|Overall Study||5||
48634679|NCT02314546|101889002|FG000|COMPLETED|Overall Study||5||
48634680|NCT02314546|101889003|FG001|COMPLETED|Overall Study||5||
48757722|NCT02558894|102194402|FG001|Patients Who Received IP|Overall Study||32||
48757723|NCT02558894|102194401|FG000|COMPLETED|Overall Study||0||
48344193|NCT01392183|101172270|FG001|NOT COMPLETED|Second Drug Administration||0||
48414529|NCT02646891|101350084|FG004|Received at Least 1 Dose|Overall Study||12||
48344194|NCT01596257|101172271|FG000|STARTED|Overall Study||61||
48344195|NCT01596257|101172272|FG001|STARTED|Overall Study||55||
48344196|NCT01596257|101172271|FG000|COMPLETED|Overall Study||38||
48344197|NCT01596257|101172272|FG001|COMPLETED|Overall Study||36||
48344198|NCT01596257|101172271|FG000|NOT COMPLETED|Overall Study||23||
48344199|NCT01596257|101172272|FG001|NOT COMPLETED|Overall Study||19||
48344200|NCT00355264|101172273|FG000|STARTED|Part 1 (2 Weeks)||12||
48344201|NCT00355264|101172273|FG000|COMPLETED|Part 1 (2 Weeks)||12||
48344202|NCT00355264|101172273|FG000|NOT COMPLETED|Part 1 (2 Weeks)||0||
48344203|NCT00355264|101172273|FG000|STARTED|Part 2 (8 Weeks)||12||
48344204|NCT00355264|101172273|FG000|COMPLETED|Part 2 (8 Weeks)||12||
48344205|NCT00355264|101172273|FG000|NOT COMPLETED|Part 2 (8 Weeks)||0||
48344206|NCT00355264|101172273|FG000|STARTED|Part 3 (7 Weeks of Extension)||2||
48344207|NCT00355264|101172273|FG000|COMPLETED|Part 3 (7 Weeks of Extension)||2||
48344208|NCT00355264|101172273|FG000|NOT COMPLETED|Part 3 (7 Weeks of Extension)||0||
48344209|NCT00355264|101172273|FG000|STARTED|Extension (Variable Duration)||12||
48344210|NCT00355264|101172273|FG000|COMPLETED|Extension (Variable Duration)||10||
48344211|NCT00355264|101172273|FG000|NOT COMPLETED|Extension (Variable Duration)||2||
48344212|NCT02408692|101172274|FG000|STARTED|Overall Study||5||
48344213|NCT02408692|101172275|FG001|STARTED|Overall Study||5||
48344214|NCT02408692|101172276|FG002|STARTED|Overall Study||5||
48344215|NCT02408692|101172274|FG000|COMPLETED|Overall Study||5||
48344216|NCT02408692|101172275|FG001|COMPLETED|Overall Study||5||
48344217|NCT02408692|101172276|FG002|COMPLETED|Overall Study||5||
48344218|NCT02408692|101172274|FG000|NOT COMPLETED|Overall Study||0||
48344219|NCT02408692|101172275|FG001|NOT COMPLETED|Overall Study||0||
48344220|NCT02408692|101172276|FG002|NOT COMPLETED|Overall Study||0||
48344221|NCT01075178|101172277|FG000|STARTED|Subject Matching||1148||
48344222|NCT01075178|101172278|FG001|STARTED|Subject Matching||1421||
48344223|NCT01075178|101172277|FG000|COMPLETED|Subject Matching||1018||
48344224|NCT01075178|101172278|FG001|COMPLETED|Subject Matching||1018||
48344225|NCT01075178|101172277|FG000|NOT COMPLETED|Subject Matching||130||
48344226|NCT01075178|101172278|FG001|NOT COMPLETED|Subject Matching||403||
48344227|NCT01075178|101172277|FG000|STARTED|Subject Chart Review||1018||
48344228|NCT01075178|101172278|FG001|STARTED|Subject Chart Review||1018||
48344229|NCT01075178|101172277|FG000|COMPLETED|Subject Chart Review||1009||
48344230|NCT01075178|101172278|FG001|COMPLETED|Subject Chart Review||1009||
48344231|NCT01075178|101172277|FG000|NOT COMPLETED|Subject Chart Review||9||
48344232|NCT01075178|101172278|FG001|NOT COMPLETED|Subject Chart Review||9||
48344233|NCT00840827|101172279|FG000|STARTED|Overall Study||6||
48344234|NCT00840827|101172279|FG000|COMPLETED|Overall Study||0||
48344235|NCT00840827|101172279|FG000|NOT COMPLETED|Overall Study||6||
48344236|NCT00096161|101172280|FG000|STARTED|Overall Study||20||
48344237|NCT00096161|101172281|FG001|STARTED|Overall Study||10||
48344238|NCT00096161|101172282|FG002|STARTED|Overall Study||6||
48344239|NCT00096161|101172283|FG003|STARTED|Overall Study||0||
48414530|NCT02646891|101350085|FG005|Received at Least 1 Dose|Overall Study||12||
48344240|NCT00096161|101172280|FG000|COMPLETED|Overall Study||20||
48344241|NCT00096161|101172281|FG001|COMPLETED|Overall Study||10||
48344242|NCT00096161|101172282|FG002|COMPLETED|Overall Study||6||
48414531|NCT02646891|101350086|FG006|Received at Least 1 Dose|Overall Study||139||
48439967|NCT01728376|101409995|FG000|Treated|Overall Study||22||
48634681|NCT02314546|101889004|FG002|COMPLETED|Overall Study||5||
48757724|NCT02558894|102194402|FG001|COMPLETED|Overall Study||0||
48344243|NCT00096161|101172283|FG003|COMPLETED|Overall Study||0||
48344244|NCT00096161|101172280|FG000|NOT COMPLETED|Overall Study||0||
48344245|NCT00096161|101172281|FG001|NOT COMPLETED|Overall Study||0||
48344246|NCT00096161|101172282|FG002|NOT COMPLETED|Overall Study||0||
48344247|NCT00096161|101172283|FG003|NOT COMPLETED|Overall Study||0||
48344248|NCT00849017|101172284|FG000|STARTED|Treatment Period (156 Weeks)||101||
48344249|NCT00849017|101172285|FG001|STARTED|Treatment Period (156 Weeks)||101||
48344250|NCT00849017|101172286|FG002|STARTED|Treatment Period (156 Weeks)||99||
48344251|NCT00849017|101172284|FG000|COMPLETED|Treatment Period (156 Weeks)||58||
48634682|NCT02314546|101889002|FG000|NOT COMPLETED|Overall Study||0||
48634683|NCT02314546|101889003|FG001|NOT COMPLETED|Overall Study||0||
48634684|NCT02314546|101889004|FG002|NOT COMPLETED|Overall Study||0||
48757725|NCT02558894|102194401|FG000|NOT COMPLETED|Overall Study||32||
48344252|NCT00849017|101172285|FG001|COMPLETED|Treatment Period (156 Weeks)||68||
48344253|NCT00849017|101172286|FG002|COMPLETED|Treatment Period (156 Weeks)||57||
48344254|NCT00849017|101172284|FG000|NOT COMPLETED|Treatment Period (156 Weeks)||43||
48344255|NCT00849017|101172285|FG001|NOT COMPLETED|Treatment Period (156 Weeks)||33||
48344256|NCT00849017|101172286|FG002|NOT COMPLETED|Treatment Period (156 Weeks)||42||
48344257|NCT00849017|101172284|FG000|STARTED|Follow-up Period (8 Weeks)||101||
48183223|NCT05515679|100772154|FG001|NOT COMPLETED|Treatment||0||
48634685|NCT01949545|101889005|FG000|STARTED|Overall Study||11||
48634686|NCT01949545|101889006|FG001|STARTED|Overall Study||17||
48634687|NCT01949545|101889007|FG002|STARTED|Overall Study||14||
48634688|NCT01949545|101889008|FG003|STARTED|Overall Study||4||
48634689|NCT01949545|101889005|FG000|COMPLETED|Overall Study||11||
48634690|NCT01949545|101889006|FG001|COMPLETED|Overall Study||17||
48634691|NCT01949545|101889007|FG002|COMPLETED|Overall Study||14||
48634692|NCT01949545|101889008|FG003|COMPLETED|Overall Study||4||
48634693|NCT01949545|101889005|FG000|NOT COMPLETED|Overall Study||0||
48634694|NCT01949545|101889006|FG001|NOT COMPLETED|Overall Study||0||
48183224|NCT05515679|100772155|FG002|NOT COMPLETED|Treatment||0||
48344258|NCT00849017|101172285|FG001|STARTED|Follow-up Period (8 Weeks)||101||
48344259|NCT00849017|101172286|FG002|STARTED|Follow-up Period (8 Weeks)||99||
48344260|NCT00849017|101172284|FG000|COMPLETED|Follow-up Period (8 Weeks)||76||
48344261|NCT00849017|101172285|FG001|COMPLETED|Follow-up Period (8 Weeks)||83||
48344262|NCT00849017|101172286|FG002|COMPLETED|Follow-up Period (8 Weeks)||74||
48344263|NCT00849017|101172284|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||25||
48344264|NCT00849017|101172285|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||18||
48344265|NCT00849017|101172286|FG002|NOT COMPLETED|Follow-up Period (8 Weeks)||25||
48183225|NCT05515679|100772153|FG000|STARTED|Post-Treatment||22||
48183226|NCT05515679|100772154|FG001|STARTED|Post-Treatment||13||
48183227|NCT05515679|100772155|FG002|STARTED|Post-Treatment||0||
48183228|NCT05515679|100772153|FG000|COMPLETED|Post-Treatment||22||
48183229|NCT05515679|100772154|FG001|COMPLETED|Post-Treatment||13||
48183230|NCT05515679|100772155|FG002|COMPLETED|Post-Treatment||0||
48183231|NCT05515679|100772153|FG000|NOT COMPLETED|Post-Treatment||0||
48183232|NCT05515679|100772154|FG001|NOT COMPLETED|Post-Treatment||0||
48183233|NCT05515679|100772155|FG002|NOT COMPLETED|Post-Treatment||0||
48183234|NCT02998528|100772156|FG000|STARTED|Randomization Period||113||
48183235|NCT02998528|100772157|FG001|STARTED|Randomization Period||213||
48183236|NCT02998528|100772158|FG002|STARTED|Randomization Period||179||
48183237|NCT02998528|100772156|FG000|All Concurrently Randomized Participants in Arms B and C|Randomization Period||0|The primary population for efficacy analyses|
48183238|NCT02998528|100772157|FG001|All Concurrently Randomized Participants in Arms B and C|Randomization Period||179|The primary population for efficacy analyses|
48183239|NCT02998528|100772158|FG002|All Concurrently Randomized Participants in Arms B and C|Randomization Period||179|The primary population for efficacy analyses|
48183240|NCT02998528|100772156|FG000|COMPLETED|Randomization Period||112||
48183241|NCT02998528|100772157|FG001|COMPLETED|Randomization Period||207||
48183242|NCT02998528|100772158|FG002|COMPLETED|Randomization Period||176||
48183243|NCT02998528|100772156|FG000|NOT COMPLETED|Randomization Period||1||
48183244|NCT02998528|100772157|FG001|NOT COMPLETED|Randomization Period||6||
48344266|NCT03576144|101172287|FG000|STARTED|Overall Study||10|Started are treated|
48344267|NCT03576144|101172288|FG001|STARTED|Overall Study||8|Started are treated|
48344268|NCT03576144|101172289|FG002|STARTED|Overall Study||8|Started are treated|
48344269|NCT03576144|101172290|FG003|STARTED|Overall Study||8|Started are treated|
48344270|NCT03576144|101172291|FG004|STARTED|Overall Study||8|Started are treated|
48344271|NCT03576144|101172292|FG005|STARTED|Overall Study||8|Started are treated|
48344272|NCT03576144|101172287|FG000|COMPLETED|Overall Study||10||
48344273|NCT03576144|101172288|FG001|COMPLETED|Overall Study||8||
48344274|NCT03576144|101172289|FG002|COMPLETED|Overall Study||8||
48344275|NCT03576144|101172290|FG003|COMPLETED|Overall Study||8||
48344276|NCT03576144|101172291|FG004|COMPLETED|Overall Study||8||
48344277|NCT03576144|101172292|FG005|COMPLETED|Overall Study||8||
48344278|NCT03576144|101172287|FG000|NOT COMPLETED|Overall Study||0||
48344279|NCT03576144|101172288|FG001|NOT COMPLETED|Overall Study||0||
48344280|NCT03576144|101172289|FG002|NOT COMPLETED|Overall Study||0||
48344281|NCT03576144|101172290|FG003|NOT COMPLETED|Overall Study||0||
48344282|NCT03576144|101172291|FG004|NOT COMPLETED|Overall Study||0||
48344283|NCT03576144|101172292|FG005|NOT COMPLETED|Overall Study||0||
48344284|NCT02639351|101172293|FG000|STARTED|Overall Study||16||
48344285|NCT02639351|101172294|FG001|STARTED|Overall Study||16||
48344286|NCT02639351|101172295|FG002|STARTED|Overall Study||16||
48344287|NCT02639351|101172296|FG003|STARTED|Overall Study||16||
48344288|NCT02639351|101172297|FG004|STARTED|Overall Study||16||
48414532|NCT02646891|101350087|FG007|Received at Least 1 Dose|Overall Study||139||
48414533|NCT02646891|101350088|FG008|Received at Least 1 Dose|Overall Study||140||
48634695|NCT01949545|101889007|FG002|NOT COMPLETED|Overall Study||0||
48634696|NCT01949545|101889008|FG003|NOT COMPLETED|Overall Study||0||
48634697|NCT03482024|101889009|FG000|STARTED|Overall Study||14||
48634698|NCT03482024|101889010|FG001|STARTED|Overall Study||8||
48183245|NCT02998528|100772158|FG002|NOT COMPLETED|Randomization Period||3||
48183246|NCT02998528|100772156|FG000|STARTED|Neoadjuvant Treatment Period||111||
48183247|NCT02998528|100772157|FG001|STARTED|Neoadjuvant Treatment Period||208||
48634699|NCT03482024|101889011|FG002|STARTED|Overall Study||8||
48634700|NCT03482024|101889012|FG003|STARTED|Overall Study||7||
48634701|NCT03482024|101889013|FG004|STARTED|Overall Study||8||
48634702|NCT03482024|101889009|FG000|Received At Least One Dose of Study Drug|Overall Study||14||
48634703|NCT03482024|101889010|FG001|Received At Least One Dose of Study Drug|Overall Study||8||
48634704|NCT03482024|101889011|FG002|Received At Least One Dose of Study Drug|Overall Study||8||
48634705|NCT03482024|101889012|FG003|Received At Least One Dose of Study Drug|Overall Study||7||
48634706|NCT03482024|101889013|FG004|Received At Least One Dose of Study Drug|Overall Study||8||
48634707|NCT03482024|101889009|FG000|COMPLETED|Overall Study||13||
48634708|NCT03482024|101889010|FG001|COMPLETED|Overall Study||8||
48634709|NCT03482024|101889011|FG002|COMPLETED|Overall Study||8||
48634710|NCT03482024|101889012|FG003|COMPLETED|Overall Study||7||
48634711|NCT03482024|101889013|FG004|COMPLETED|Overall Study||8||
48634712|NCT03482024|101889009|FG000|NOT COMPLETED|Overall Study||1||
48634713|NCT03482024|101889010|FG001|NOT COMPLETED|Overall Study||0||
48634714|NCT03482024|101889011|FG002|NOT COMPLETED|Overall Study||0||
48634715|NCT03482024|101889012|FG003|NOT COMPLETED|Overall Study||0||
48634716|NCT03482024|101889013|FG004|NOT COMPLETED|Overall Study||0||
48634717|NCT00863122|101889014|FG000|STARTED|Overall Study||19||
48634718|NCT00863122|101889015|FG001|STARTED|Overall Study||7||
48634719|NCT00863122|101889014|FG000|COMPLETED|Overall Study||19||
48634720|NCT00863122|101889015|FG001|COMPLETED|Overall Study||7||
48634721|NCT00863122|101889014|FG000|NOT COMPLETED|Overall Study||0||
48634722|NCT00863122|101889015|FG001|NOT COMPLETED|Overall Study||0||
48634723|NCT01114555|101889016|FG000|STARTED|Overall Study||34||
48634724|NCT01114555|101889016|FG000|COMPLETED|Overall Study||34||
48634725|NCT01114555|101889016|FG000|NOT COMPLETED|Overall Study||0||
48634726|NCT00656617|101889017|FG000|STARTED|Overall Study||106||
48634727|NCT00656617|101889017|FG000|Run-in Induction Phase|Overall Study||3||
48634728|NCT00656617|101889017|FG000|Induction Phase|Overall Study||103||
48634729|NCT00656617|101889017|FG000|COMPLETED|Overall Study||99||
48634730|NCT00656617|101889017|FG000|NOT COMPLETED|Overall Study||7||
48634731|NCT00658528|101889018|FG000|STARTED|Overall Study||531||
48634732|NCT00658528|101889019|FG001|STARTED|Overall Study||524||
48634733|NCT00658528|101889018|FG000|COMPLETED|Overall Study||491||
48634734|NCT00658528|101889019|FG001|COMPLETED|Overall Study||479||
48634735|NCT00658528|101889018|FG000|NOT COMPLETED|Overall Study||40||
48634736|NCT00658528|101889019|FG001|NOT COMPLETED|Overall Study||45||
48634737|NCT04023578|101889020|FG000|STARTED|Overall Study||15||
48634738|NCT04023578|101889020|FG000|COMPLETED|Overall Study||13||
48634739|NCT04023578|101889020|FG000|NOT COMPLETED|Overall Study||2||
48634740|NCT04213261|101889021|FG000|STARTED|Overall Study||6||13
48634741|NCT04213261|101889022|FG001|STARTED|Overall Study||6||13
48634742|NCT04213261|101889021|FG000|COMPLETED|Overall Study||6||13
48634743|NCT04213261|101889022|FG001|COMPLETED|Overall Study||6||13
48634744|NCT04213261|101889021|FG000|NOT COMPLETED|Overall Study||0||0
48634745|NCT04213261|101889022|FG001|NOT COMPLETED|Overall Study||0||0
48634746|NCT03329989|101889023|FG000|STARTED|Overall Study||158||
48634747|NCT03329989|101889023|FG000|COMPLETED|Overall Study||135||
48634748|NCT03329989|101889023|FG000|NOT COMPLETED|Overall Study||23||
48634749|NCT01101178|101889024|FG000|STARTED|Period 1||40||
48634750|NCT01101178|101889025|FG001|STARTED|Period 1||39||
48634751|NCT01101178|101889024|FG000|COMPLETED|Period 1||36||
48634752|NCT01101178|101889025|FG001|COMPLETED|Period 1||35||
48634753|NCT01101178|101889024|FG000|NOT COMPLETED|Period 1||4||
48634754|NCT01101178|101889025|FG001|NOT COMPLETED|Period 1||4||
48634755|NCT01101178|101889024|FG000|STARTED|Period 2||36||
48634756|NCT01101178|101889025|FG001|STARTED|Period 2||35||
48634757|NCT01101178|101889024|FG000|COMPLETED|Period 2||36||
48634758|NCT01101178|101889025|FG001|COMPLETED|Period 2||34||
48634759|NCT01101178|101889024|FG000|NOT COMPLETED|Period 2||0||
48634760|NCT01101178|101889025|FG001|NOT COMPLETED|Period 2||1||
48414534|NCT02646891|101350089|FG009|Received at Least 1 Dose|Overall Study||139||
48414535|NCT02646891|101350080|FG000|COMPLETED|Overall Study||4||
48414536|NCT02646891|101350081|FG001|COMPLETED|Overall Study||11||
48634761|NCT00362232|101889026|FG000|STARTED|Treatment (12 +/- 2 Days)||1584||
48634762|NCT00362232|101889027|FG001|STARTED|Treatment (12 +/- 2 Days)||1564||
48634763|NCT00362232|101889026|FG000|Received Treatment|Treatment (12 +/- 2 Days)||1526||
48634764|NCT00362232|101889027|FG001|Received Treatment|Treatment (12 +/- 2 Days)||1508||
48634765|NCT00362232|101889026|FG000|COMPLETED|Treatment (12 +/- 2 Days)||1425||
48634766|NCT00362232|101889027|FG001|COMPLETED|Treatment (12 +/- 2 Days)||1413||
48634767|NCT00362232|101889026|FG000|NOT COMPLETED|Treatment (12 +/- 2 Days)||159||
48634768|NCT00362232|101889027|FG001|NOT COMPLETED|Treatment (12 +/- 2 Days)||151||
48634769|NCT00362232|101889026|FG000|STARTED|Follow-up (30 (+ 5) Days)||1471||
48634770|NCT00362232|101889027|FG001|STARTED|Follow-up (30 (+ 5) Days)||1455||
48634771|NCT00362232|101889026|FG000|COMPLETED|Follow-up (30 (+ 5) Days)||1433||
48634772|NCT00362232|101889027|FG001|COMPLETED|Follow-up (30 (+ 5) Days)||1416||
48634773|NCT00362232|101889026|FG000|NOT COMPLETED|Follow-up (30 (+ 5) Days)||38||
48634774|NCT00362232|101889027|FG001|NOT COMPLETED|Follow-up (30 (+ 5) Days)||39||
48634775|NCT02470741|101889028|FG000|STARTED|Overall Study||6||
48634776|NCT02470741|101889029|FG001|STARTED|Overall Study||6||
48634777|NCT02470741|101889028|FG000|COMPLETED|Overall Study||3||
48634778|NCT02470741|101889029|FG001|COMPLETED|Overall Study||4||
48634779|NCT02470741|101889028|FG000|NOT COMPLETED|Overall Study||3||
48634780|NCT02470741|101889029|FG001|NOT COMPLETED|Overall Study||2||
48634781|NCT02145390|101889030|FG000|STARTED|Overall Study||1||
48634782|NCT02145390|101889030|FG000|COMPLETED|Overall Study||0||
48634783|NCT02145390|101889030|FG000|NOT COMPLETED|Overall Study||1||
48634784|NCT03631641|101889031|FG000|STARTED|Overall Study||3||
48634785|NCT03631641|101889031|FG000|COMPLETED|Overall Study||3||
48634786|NCT03631641|101889031|FG000|NOT COMPLETED|Overall Study||0||
48634787|NCT01192815|101889032|FG000|STARTED|Overall Study||2||
48634788|NCT01192815|101889032|FG000|COMPLETED|Overall Study||0||
48634789|NCT01192815|101889032|FG000|NOT COMPLETED|Overall Study||2||
48634790|NCT02423408|101889033|FG000|STARTED|Overall Study||83||
48634791|NCT02423408|101889034|FG001|STARTED|Overall Study||82||
48634792|NCT02423408|101889033|FG000|COMPLETED|Overall Study||82||
48634793|NCT02423408|101889034|FG001|COMPLETED|Overall Study||80||
48634794|NCT02423408|101889033|FG000|NOT COMPLETED|Overall Study||1||
48634795|NCT02423408|101889034|FG001|NOT COMPLETED|Overall Study||2||
48634796|NCT00537277|101889035|FG000|STARTED|Overall Study||161||
48634797|NCT00537277|101889035|FG000|Exposed to Trial Drug|Overall Study||160||
48634798|NCT00537277|101889035|FG000|COMPLETED|Overall Study||112||
48634799|NCT00537277|101889035|FG000|NOT COMPLETED|Overall Study||49||
48634800|NCT02668003|101889036|FG000|STARTED|Overall Study||501||
48634801|NCT02668003|101889037|FG001|STARTED|Overall Study||501||
48634802|NCT02668003|101889036|FG000|COMPLETED|Overall Study||500||
48634803|NCT02668003|101889037|FG001|COMPLETED|Overall Study||496||
48634804|NCT02668003|101889036|FG000|NOT COMPLETED|Overall Study||1||
48634805|NCT02668003|101889037|FG001|NOT COMPLETED|Overall Study||5||
48634806|NCT02475369|101889038|FG000|STARTED|Run-in Washout Period #1 (7 Days)||10||
48634807|NCT02475369|101889039|FG001|STARTED|Run-in Washout Period #1 (7 Days)||11||
48634808|NCT02475369|101889038|FG000|COMPLETED|Run-in Washout Period #1 (7 Days)||3||
48634809|NCT02475369|101889039|FG001|COMPLETED|Run-in Washout Period #1 (7 Days)||9||
48634810|NCT02475369|101889038|FG000|NOT COMPLETED|Run-in Washout Period #1 (7 Days)||7||
48634811|NCT02475369|101889039|FG001|NOT COMPLETED|Run-in Washout Period #1 (7 Days)||2||
48634812|NCT02475369|101889038|FG000|STARTED|Treatment Period #1 (10 Days)||3||
48634813|NCT02475369|101889039|FG001|STARTED|Treatment Period #1 (10 Days)||9||
48634814|NCT02475369|101889038|FG000|COMPLETED|Treatment Period #1 (10 Days)||3||
48634815|NCT02475369|101889039|FG001|COMPLETED|Treatment Period #1 (10 Days)||9||
48634816|NCT02475369|101889038|FG000|NOT COMPLETED|Treatment Period #1 (10 Days)||0||
48634817|NCT02475369|101889039|FG001|NOT COMPLETED|Treatment Period #1 (10 Days)||0||
48634818|NCT02475369|101889038|FG000|STARTED|Run-in Washout Period #2 (7 Days)||3||
48634819|NCT02475369|101889039|FG001|STARTED|Run-in Washout Period #2 (7 Days)||9||
48634820|NCT02475369|101889038|FG000|COMPLETED|Run-in Washout Period #2 (7 Days)||3||
48634821|NCT02475369|101889039|FG001|COMPLETED|Run-in Washout Period #2 (7 Days)||9||
48634822|NCT02475369|101889038|FG000|NOT COMPLETED|Run-in Washout Period #2 (7 Days)||0||
48634823|NCT02475369|101889039|FG001|NOT COMPLETED|Run-in Washout Period #2 (7 Days)||0||
48634824|NCT02475369|101889038|FG000|STARTED|Treatment Period #2 (10 Days)||3||
48634825|NCT02475369|101889039|FG001|STARTED|Treatment Period #2 (10 Days)||9||
48634826|NCT02475369|101889038|FG000|COMPLETED|Treatment Period #2 (10 Days)||3||
48634827|NCT02475369|101889039|FG001|COMPLETED|Treatment Period #2 (10 Days)||9||
48634828|NCT02475369|101889038|FG000|NOT COMPLETED|Treatment Period #2 (10 Days)||0||
48634829|NCT02475369|101889039|FG001|NOT COMPLETED|Treatment Period #2 (10 Days)||0||
48634830|NCT02631057|101889040|FG000|STARTED|Overall Study||899||
48634831|NCT02631057|101889041|FG001|STARTED|Overall Study||3414||
48634832|NCT02631057|101889040|FG000|COMPLETED|Overall Study||899||
48634833|NCT02631057|101889041|FG001|COMPLETED|Overall Study||3414||
48634834|NCT02631057|101889040|FG000|NOT COMPLETED|Overall Study||0||
48414537|NCT02646891|101350082|FG002|COMPLETED|Overall Study||11||
48414538|NCT02646891|101350083|FG003|COMPLETED|Overall Study||6||
48414539|NCT02646891|101350084|FG004|COMPLETED|Overall Study||12||
48414540|NCT02646891|101350085|FG005|COMPLETED|Overall Study||12||
48414541|NCT02646891|101350086|FG006|COMPLETED|Overall Study||130||
48414542|NCT02646891|101350087|FG007|COMPLETED|Overall Study||127||
48414543|NCT02646891|101350088|FG008|COMPLETED|Overall Study||130||
48414544|NCT02646891|101350089|FG009|COMPLETED|Overall Study||134||
48414545|NCT02646891|101350080|FG000|NOT COMPLETED|Overall Study||2||
48414546|NCT02646891|101350081|FG001|NOT COMPLETED|Overall Study||1||
48414547|NCT02646891|101350082|FG002|NOT COMPLETED|Overall Study||1||
48414548|NCT02646891|101350083|FG003|NOT COMPLETED|Overall Study||0||
48414549|NCT02646891|101350084|FG004|NOT COMPLETED|Overall Study||0||
48414550|NCT02646891|101350085|FG005|NOT COMPLETED|Overall Study||0||
48414551|NCT02646891|101350086|FG006|NOT COMPLETED|Overall Study||9||
48634835|NCT02631057|101889041|FG001|NOT COMPLETED|Overall Study||0||
48634836|NCT02324153|101889042|FG000|STARTED|Overall Study||41||
48634837|NCT02324153|101889043|FG001|STARTED|Overall Study||39||
48634838|NCT02324153|101889042|FG000|COMPLETED|Overall Study||33||
48634839|NCT02324153|101889043|FG001|COMPLETED|Overall Study||38||
48634840|NCT02324153|101889042|FG000|NOT COMPLETED|Overall Study||8||
48634841|NCT02324153|101889043|FG001|NOT COMPLETED|Overall Study||1||
48634842|NCT01240382|101889044|FG000|STARTED|Overall Study||144||
48634843|NCT01240382|101889045|FG001|STARTED|Overall Study||143||
48634844|NCT01240382|101889044|FG000|COMPLETED|Overall Study||142||
48634845|NCT01240382|101889045|FG001|COMPLETED|Overall Study||139||
48634846|NCT01240382|101889044|FG000|NOT COMPLETED|Overall Study||2||
48634847|NCT01240382|101889045|FG001|NOT COMPLETED|Overall Study||4||
48634848|NCT00671060|101889046|FG000|STARTED|Overall Study||77||
48634849|NCT00671060|101889047|FG001|STARTED|Overall Study||76||
48634850|NCT00671060|101889046|FG000|COMPLETED|Overall Study||76||
48634851|NCT00671060|101889047|FG001|COMPLETED|Overall Study||75||
48634852|NCT00671060|101889046|FG000|NOT COMPLETED|Overall Study||1||
48634853|NCT00671060|101889047|FG001|NOT COMPLETED|Overall Study||1||
48634854|NCT00375752|101891701|FG000|STARTED|Overall Study||79||
48634855|NCT00375752|101891702|FG001|STARTED|Overall Study||89||
48634856|NCT00375752|101891701|FG000|COMPLETED|Overall Study||67||
48634857|NCT00375752|101891702|FG001|COMPLETED|Overall Study||74||
48634858|NCT00375752|101891701|FG000|NOT COMPLETED|Overall Study||12||
48634859|NCT00375752|101891702|FG001|NOT COMPLETED|Overall Study||15||
48634860|NCT00914069|101891703|FG000|STARTED|Overall Study||84||
48634861|NCT00914069|101891704|FG001|STARTED|Overall Study||88||
48634862|NCT00914069|101891703|FG000|COMPLETED|Overall Study||84||
48634863|NCT00914069|101891704|FG001|COMPLETED|Overall Study||88||
48634864|NCT00914069|101891703|FG000|NOT COMPLETED|Overall Study||0||
48634865|NCT00914069|101891704|FG001|NOT COMPLETED|Overall Study||0||
48634866|NCT01010763|101891705|FG000|STARTED|Overall Study||96||
48634867|NCT01010763|101891706|FG001|STARTED|Overall Study||84||
48634868|NCT01010763|101891705|FG000|COMPLETED|Overall Study||61||
48634869|NCT01010763|101891706|FG001|COMPLETED|Overall Study||54||
48634870|NCT01010763|101891705|FG000|NOT COMPLETED|Overall Study||35||
48634871|NCT01010763|101891706|FG001|NOT COMPLETED|Overall Study||30||
48634872|NCT03871556|101891707|FG000|STARTED|Overall Study||40||
48634873|NCT03871556|101891707|FG000|COMPLETED|Overall Study||40||
48634874|NCT03871556|101891707|FG000|NOT COMPLETED|Overall Study||0||
48634875|NCT03979313|101891708|FG000|STARTED|Primary Cohort (Data Cut Off 11/3/2021)||496||
48634876|NCT03979313|101891709|FG001|STARTED|Primary Cohort (Data Cut Off 11/3/2021)||994||
48634877|NCT03979313|101891708|FG000|Completed Day 151 Follow up|Primary Cohort (Data Cut Off 11/3/2021)||488||
48634878|NCT03979313|101891709|FG001|Completed Day 151 Follow up|Primary Cohort (Data Cut Off 11/3/2021)||977||
48634879|NCT03979313|101891708|FG000|Completed Day 361 Follow up|Primary Cohort (Data Cut Off 11/3/2021)||453||
48634880|NCT03979313|101891709|FG001|Completed Day 361 Follow up|Primary Cohort (Data Cut Off 11/3/2021)||914||
48634881|NCT03979313|101891708|FG000|Treated Participants|Primary Cohort (Data Cut Off 11/3/2021)||491||
48634882|NCT03979313|101891709|FG001|Treated Participants|Primary Cohort (Data Cut Off 11/3/2021)||994||
48634883|NCT03979313|101891708|FG000|COMPLETED|Primary Cohort (Data Cut Off 11/3/2021)||43|Study completion at Day 511. At this DCO several subjects did not complete the study and were still ongoing.|
48634884|NCT03979313|101891709|FG001|COMPLETED|Primary Cohort (Data Cut Off 11/3/2021)||89|Study completion at Day 511. At this DCO several subjects did not complete the study and were still ongoing.|
48634885|NCT03979313|101891708|FG000|NOT COMPLETED|Primary Cohort (Data Cut Off 11/3/2021)||453||
48634886|NCT03979313|101891709|FG001|NOT COMPLETED|Primary Cohort (Data Cut Off 11/3/2021)||905||
48634887|NCT03979313|101891708|FG000|STARTED|All Subjects||1003||
48634888|NCT03979313|101891709|FG001|STARTED|All Subjects||2009||
48634889|NCT03979313|101891708|FG000|Completed Day 151 Follow up|All Subjects||985||
48634890|NCT03979313|101891709|FG001|Completed Day 151 Follow up|All Subjects||1977||
48344289|NCT02639351|101172293|FG000|COMPLETED|Overall Study||16||
48344290|NCT02639351|101172294|FG001|COMPLETED|Overall Study||16||
48634891|NCT03979313|101891708|FG000|Completed Day 361 Follow up|All Subjects||967||
48634892|NCT03979313|101891709|FG001|Completed Day 361 Follow up|All Subjects||1944||
48634893|NCT03979313|101891708|FG000|Treated Participants|All Subjects||997||
48757726|NCT02558894|102194402|FG001|NOT COMPLETED|Overall Study||33||
48757727|NCT00882440|102194403|FG000|STARTED|Overall Study||78||
48757728|NCT00882440|102194404|FG001|STARTED|Overall Study||80||
48757729|NCT00882440|102194405|FG002|STARTED|Overall Study||82||
48757730|NCT00882440|102194406|FG003|STARTED|Overall Study||79||
48757731|NCT00882440|102194407|FG004|STARTED|Overall Study||90||
48757732|NCT00882440|102194408|FG005|STARTED|Overall Study||84||
48757733|NCT00882440|102194409|FG006|STARTED|Overall Study||83||
48757734|NCT00882440|102194403|FG000|COMPLETED|Overall Study||67||
48757735|NCT00882440|102194404|FG001|COMPLETED|Overall Study||72||
48757736|NCT00882440|102194405|FG002|COMPLETED|Overall Study||75||
48344291|NCT02639351|101172295|FG002|COMPLETED|Overall Study||16||
48344292|NCT02639351|101172296|FG003|COMPLETED|Overall Study||16||
48757737|NCT00882440|102194406|FG003|COMPLETED|Overall Study||76||
48757738|NCT00882440|102194407|FG004|COMPLETED|Overall Study||80||
48757739|NCT00882440|102194408|FG005|COMPLETED|Overall Study||77||
48757740|NCT00882440|102194409|FG006|COMPLETED|Overall Study||79||
48757741|NCT00882440|102194403|FG000|NOT COMPLETED|Overall Study||11||
48757742|NCT00882440|102194404|FG001|NOT COMPLETED|Overall Study||8||
48757743|NCT00882440|102194405|FG002|NOT COMPLETED|Overall Study||7||
48634894|NCT03979313|101891709|FG001|Treated Participants|All Subjects||1997||
48634895|NCT03979313|101891708|FG000|COMPLETED|All Subjects||923|Study completion at day 511|
48634896|NCT03979313|101891709|FG001|COMPLETED|All Subjects||1873|Study completion at day 511|
48634897|NCT03979313|101891708|FG000|NOT COMPLETED|All Subjects||80||
48634898|NCT03979313|101891709|FG001|NOT COMPLETED|All Subjects||136||
48634899|NCT00392223|101891710|FG000|STARTED|Overall Study||58||
48757744|NCT00882440|102194406|FG003|NOT COMPLETED|Overall Study||3||
48634900|NCT00392223|101891711|FG001|STARTED|Overall Study||60||
48634901|NCT00392223|101891710|FG000|COMPLETED|Overall Study||49||
48634902|NCT00392223|101891711|FG001|COMPLETED|Overall Study||47||
48634903|NCT00392223|101891710|FG000|NOT COMPLETED|Overall Study||9||
48634904|NCT00392223|101891711|FG001|NOT COMPLETED|Overall Study||13||
48634905|NCT01471626|101891712|FG000|STARTED|Overall Study||21||
48634906|NCT01471626|101891712|FG000|COMPLETED|Overall Study||21||
48634907|NCT01471626|101891712|FG000|NOT COMPLETED|Overall Study||0||
48634908|NCT00761319|101891713|FG000|STARTED|Overall Study||353||
48634909|NCT00761319|101891714|FG001|STARTED|Overall Study||352||
48634910|NCT00761319|101891713|FG000|COMPLETED|Overall Study||305||
48634911|NCT00761319|101891714|FG001|COMPLETED|Overall Study||318||
48634912|NCT00761319|101891713|FG000|NOT COMPLETED|Overall Study||48||
48634913|NCT00761319|101891714|FG001|NOT COMPLETED|Overall Study||34||
48634914|NCT01027949|101891715|FG000|STARTED|Overall Study||894||
48634915|NCT01027949|101891715|FG000|COMPLETED|Overall Study||208||
48634916|NCT01027949|101891715|FG000|NOT COMPLETED|Overall Study||686||
48634917|NCT03980223|101891716|FG000|STARTED|Overall Study||292||
48634918|NCT03980223|101891717|FG001|STARTED|Overall Study||140||
48634919|NCT03980223|101891718|FG002|STARTED|Overall Study||141||
48183248|NCT02998528|100772158|FG002|STARTED|Neoadjuvant Treatment Period||176||
48183249|NCT02998528|100772156|FG000|All Treated Participants From Concurrently Randomized Arms B and C|Neoadjuvant Treatment Period||0|The primary population for safety analyses|
48183250|NCT02998528|100772157|FG001|All Treated Participants From Concurrently Randomized Arms B and C|Neoadjuvant Treatment Period||176|The primary population for safety analyses|
48183251|NCT02998528|100772158|FG002|All Treated Participants From Concurrently Randomized Arms B and C|Neoadjuvant Treatment Period||176|The primary population for safety analyses|
48183252|NCT02998528|100772156|FG000|COMPLETED|Neoadjuvant Treatment Period||101||
48183253|NCT02998528|100772157|FG001|COMPLETED|Neoadjuvant Treatment Period||177||
48183254|NCT02998528|100772158|FG002|COMPLETED|Neoadjuvant Treatment Period||165||
48183255|NCT02998528|100772156|FG000|NOT COMPLETED|Neoadjuvant Treatment Period||10||
48183256|NCT02998528|100772157|FG001|NOT COMPLETED|Neoadjuvant Treatment Period||31||
48183257|NCT02998528|100772158|FG002|NOT COMPLETED|Neoadjuvant Treatment Period||11||
48183258|NCT02998528|100772156|FG000|STARTED|Systemic Adjuvant Treatment Period||37||
48183259|NCT02998528|100772157|FG001|STARTED|Systemic Adjuvant Treatment Period||47||
48183260|NCT02998528|100772158|FG002|STARTED|Systemic Adjuvant Treatment Period||26||
48183261|NCT02998528|100772156|FG000|COMPLETED|Systemic Adjuvant Treatment Period||28||
48183262|NCT02998528|100772157|FG001|COMPLETED|Systemic Adjuvant Treatment Period||41||
48183263|NCT02998528|100772158|FG002|COMPLETED|Systemic Adjuvant Treatment Period||22||
48183264|NCT02998528|100772156|FG000|NOT COMPLETED|Systemic Adjuvant Treatment Period||9||
48183265|NCT02998528|100772157|FG001|NOT COMPLETED|Systemic Adjuvant Treatment Period||6||
48183266|NCT02998528|100772158|FG002|NOT COMPLETED|Systemic Adjuvant Treatment Period||4||
48183267|NCT01113463|100772159|FG000|STARTED|Overall Study||17||
48183268|NCT01113463|100772159|FG000|COMPLETED|Overall Study||12||
48183269|NCT01113463|100772159|FG000|NOT COMPLETED|Overall Study||5||
48183270|NCT01477749|100772160|FG000|STARTED|Overall Study||47||
48183271|NCT01477749|100772160|FG000|COMPLETED|Overall Study||43||
48183272|NCT01477749|100772160|FG000|NOT COMPLETED|Overall Study||4||
48183273|NCT01579578|100772161|FG000|STARTED|Overall Study||13||
48183274|NCT01579578|100772162|FG001|STARTED|Overall Study||12||
48183275|NCT01579578|100772161|FG000|Ongoing|Overall Study||3||
48183276|NCT01579578|100772162|FG001|Ongoing|Overall Study||0||
48183277|NCT01579578|100772161|FG000|COMPLETED|Overall Study||0||
48183278|NCT01579578|100772162|FG001|COMPLETED|Overall Study||0||
48183279|NCT01579578|100772161|FG000|NOT COMPLETED|Overall Study||13||
48183280|NCT01579578|100772162|FG001|NOT COMPLETED|Overall Study||12||
48183281|NCT03101592|100772163|FG000|STARTED|Overall Study||3123||10
48183282|NCT03101592|100772164|FG001|STARTED|Overall Study||2896||10
48183283|NCT03101592|100772165|FG002|STARTED|Overall Study||3099||10
48183284|NCT03101592|100772163|FG000|COMPLETED|Overall Study||3012||10
48183285|NCT03101592|100772164|FG001|COMPLETED|Overall Study||2726||10
48183286|NCT03101592|100772165|FG002|COMPLETED|Overall Study||2981||10
48183287|NCT03101592|100772163|FG000|NOT COMPLETED|Overall Study||111||0
48183288|NCT03101592|100772164|FG001|NOT COMPLETED|Overall Study||170||0
48183289|NCT03101592|100772165|FG002|NOT COMPLETED|Overall Study||118||0
48183290|NCT02886728|100772166|FG000|STARTED|Overall Study||417||
48183291|NCT02886728|100772167|FG001|STARTED|Overall Study||207||
48183292|NCT02886728|100772168|FG002|STARTED|Overall Study||210||
48634920|NCT03980223|101891719|FG003|STARTED|Overall Study||68||
48634921|NCT03980223|101891716|FG000|COMPLETED|Overall Study||217||
48183293|NCT02886728|100772169|FG003|STARTED|Overall Study||418||
48183294|NCT02886728|100772166|FG000|COMPLETED|Overall Study||345||
48183295|NCT02886728|100772167|FG001|COMPLETED|Overall Study||175||
48183296|NCT02886728|100772168|FG002|COMPLETED|Overall Study||174||
48183297|NCT02886728|100772169|FG003|COMPLETED|Overall Study||331||
48183298|NCT02886728|100772166|FG000|NOT COMPLETED|Overall Study||72||
48634922|NCT03980223|101891717|FG001|COMPLETED|Overall Study||100||
48634923|NCT03980223|101891718|FG002|COMPLETED|Overall Study||109||
48634924|NCT03980223|101891719|FG003|COMPLETED|Overall Study||47||
48634925|NCT03980223|101891716|FG000|NOT COMPLETED|Overall Study||75||
48634926|NCT03980223|101891717|FG001|NOT COMPLETED|Overall Study||40||
48634927|NCT03980223|101891718|FG002|NOT COMPLETED|Overall Study||32||
48344293|NCT02639351|101172297|FG004|COMPLETED|Overall Study||16||
48344294|NCT02639351|101172293|FG000|NOT COMPLETED|Overall Study||0||
48344295|NCT02639351|101172294|FG001|NOT COMPLETED|Overall Study||0||
48344296|NCT02639351|101172295|FG002|NOT COMPLETED|Overall Study||0||
48344297|NCT02639351|101172296|FG003|NOT COMPLETED|Overall Study||0||
48344298|NCT02639351|101172297|FG004|NOT COMPLETED|Overall Study||0||
48344299|NCT01990261|101172298|FG000|STARTED|Overall Study||33||
48344300|NCT01990261|101172298|FG000|Treated|Overall Study||29||
48634928|NCT03980223|101891719|FG003|NOT COMPLETED|Overall Study||21||
48634929|NCT04745351|101891720|FG000|STARTED|Overall Study||166||
48634930|NCT04745351|101891721|FG001|STARTED|Overall Study||83||
48634931|NCT04745351|101891720|FG000|COMPLETED|Overall Study||95||
48634932|NCT04745351|101891721|FG001|COMPLETED|Overall Study||50||
48634933|NCT04745351|101891720|FG000|NOT COMPLETED|Overall Study||71||
48414552|NCT02646891|101350087|FG007|NOT COMPLETED|Overall Study||13||
48414553|NCT02646891|101350088|FG008|NOT COMPLETED|Overall Study||10||
48183299|NCT02886728|100772167|FG001|NOT COMPLETED|Overall Study||32||
48183300|NCT02886728|100772168|FG002|NOT COMPLETED|Overall Study||36||
48183301|NCT02886728|100772169|FG003|NOT COMPLETED|Overall Study||87||
48414554|NCT02646891|101350089|FG009|NOT COMPLETED|Overall Study||5||
48414555|NCT03661983|101350090|FG000|STARTED|Open Label Stabilization Phase||36||
48757745|NCT00882440|102194407|FG004|NOT COMPLETED|Overall Study||10||
48757746|NCT00882440|102194408|FG005|NOT COMPLETED|Overall Study||7||
48757747|NCT00882440|102194409|FG006|NOT COMPLETED|Overall Study||4||
48344301|NCT01990261|101172298|FG000|COMPLETED|Overall Study||8||
48344302|NCT01990261|101172298|FG000|NOT COMPLETED|Overall Study||25||
48344303|NCT03219164|101172299|FG000|STARTED|Overall Study||74||
48344304|NCT03219164|101172300|FG001|STARTED|Overall Study||75||
48414556|NCT03661983|101350091|FG001|STARTED|Open Label Stabilization Phase||0||
48414557|NCT03661983|101350092|FG002|STARTED|Open Label Stabilization Phase||0||
48414558|NCT03661983|101350093|FG003|STARTED|Open Label Stabilization Phase||0||
48344305|NCT03219164|101172299|FG000|COMPLETED|Overall Study||49||
48344306|NCT03219164|101172300|FG001|COMPLETED|Overall Study||57||
48414559|NCT03661983|101350090|FG000|COMPLETED|Open Label Stabilization Phase||25||
48414560|NCT03661983|101350091|FG001|COMPLETED|Open Label Stabilization Phase||0||
48634934|NCT04745351|101891721|FG001|NOT COMPLETED|Overall Study||33||
48634935|NCT00712920|101891722|FG000|STARTED|Overall Study||192||
48634936|NCT00712920|101891723|FG001|STARTED|Overall Study||197||
48634937|NCT00712920|101891724|FG002|STARTED|Overall Study||192||
48757748|NCT04698343|102194410|FG000|STARTED|Overall Study||20||
48183302|NCT04404257|100772170|FG000|STARTED|Overall Study||85||
48344307|NCT03219164|101172299|FG000|NOT COMPLETED|Overall Study||25||
48183303|NCT04404257|100772171|FG001|STARTED|Overall Study||85||
48183304|NCT04404257|100772170|FG000|COMPLETED|Overall Study||85||
48183305|NCT04404257|100772171|FG001|COMPLETED|Overall Study||85||
48183306|NCT04404257|100772170|FG000|NOT COMPLETED|Overall Study||0||
48183307|NCT04404257|100772171|FG001|NOT COMPLETED|Overall Study||0||
48183308|NCT01880515|100772172|FG000|STARTED|Overall Study||53||
48183309|NCT01880515|100772173|FG001|STARTED|Overall Study||54||
48183310|NCT01880515|100772172|FG000|COMPLETED|Overall Study||45||
48183311|NCT01880515|100772173|FG001|COMPLETED|Overall Study||45||
48183312|NCT01880515|100772172|FG000|NOT COMPLETED|Overall Study||8||
48183313|NCT01880515|100772173|FG001|NOT COMPLETED|Overall Study||9||
48183314|NCT00681187|100772174|FG000|STARTED|Overall Study||11||
48183315|NCT00681187|100772175|FG001|STARTED|Overall Study||15||
48183316|NCT00681187|100772174|FG000|COMPLETED|Overall Study||10||
48183317|NCT00681187|100772175|FG001|COMPLETED|Overall Study||13||
48344308|NCT03219164|101172300|FG001|NOT COMPLETED|Overall Study||18||
48344309|NCT04898166|101172301|FG000|STARTED|Overall Study||220||
48344310|NCT04898166|101172302|FG001|STARTED|Overall Study||80||
48344311|NCT04898166|101172301|FG000|COMPLETED|Overall Study||220||
48344312|NCT04898166|101172302|FG001|COMPLETED|Overall Study||80||
48183318|NCT00681187|100772174|FG000|NOT COMPLETED|Overall Study||1||
48183319|NCT00681187|100772175|FG001|NOT COMPLETED|Overall Study||2||
48183320|NCT00463151|100772176|FG000|STARTED|Overall Study||35||
48183321|NCT00463151|100772177|FG001|STARTED|Overall Study||29||
48183322|NCT00463151|100772178|FG002|STARTED|Overall Study||29||
48183323|NCT00463151|100772179|FG003|STARTED|Overall Study||31||
48183324|NCT00463151|100772176|FG000|COMPLETED|Overall Study||33||
48183325|NCT00463151|100772177|FG001|COMPLETED|Overall Study||24||
48183326|NCT00463151|100772178|FG002|COMPLETED|Overall Study||26||
48183327|NCT00463151|100772179|FG003|COMPLETED|Overall Study||24||
48183328|NCT00463151|100772176|FG000|NOT COMPLETED|Overall Study||2||
48344313|NCT04898166|101172301|FG000|NOT COMPLETED|Overall Study||0||
48414561|NCT03661983|101350092|FG002|COMPLETED|Open Label Stabilization Phase||0||
48414562|NCT03661983|101350093|FG003|COMPLETED|Open Label Stabilization Phase||0||
48414563|NCT03661983|101350090|FG000|NOT COMPLETED|Open Label Stabilization Phase||11||
48634938|NCT00712920|101891722|FG000|COMPLETED|Overall Study||175||
48757749|NCT04698343|102194410|FG000|Completed Phase 1|Overall Study||14||
48183329|NCT00463151|100772177|FG001|NOT COMPLETED|Overall Study||5||
48344314|NCT04898166|101172302|FG001|NOT COMPLETED|Overall Study||0||
48344315|NCT00215930|101172303|FG000|STARTED|Overall Study||53||
48634939|NCT00712920|101891723|FG001|COMPLETED|Overall Study||180||
48634940|NCT00712920|101891724|FG002|COMPLETED|Overall Study||180||
48414564|NCT03661983|101350091|FG001|NOT COMPLETED|Open Label Stabilization Phase||0||
48414565|NCT03661983|101350092|FG002|NOT COMPLETED|Open Label Stabilization Phase||0||
48414566|NCT03661983|101350093|FG003|NOT COMPLETED|Open Label Stabilization Phase||0||
48414567|NCT03661983|101350090|FG000|STARTED|Double-blind Randomized Phase||0||
48414568|NCT03661983|101350091|FG001|STARTED|Double-blind Randomized Phase||9||
48414569|NCT03661983|101350092|FG002|STARTED|Double-blind Randomized Phase||8||
48414570|NCT03661983|101350093|FG003|STARTED|Double-blind Randomized Phase||8||
48414571|NCT03661983|101350090|FG000|COMPLETED|Double-blind Randomized Phase||0||
48414572|NCT03661983|101350091|FG001|COMPLETED|Double-blind Randomized Phase||7||
48344316|NCT00215930|101172303|FG000|COMPLETED|Overall Study||53||
48344317|NCT00215930|101172303|FG000|NOT COMPLETED|Overall Study||0||
48344318|NCT01267955|101172304|FG000|STARTED|Stage 1 (6 Months)||20||
48344319|NCT01267955|101172304|FG000|COMPLETED|Stage 1 (6 Months)||17|Subjects contributing data to the primary analysis are considered to have completed the study.|
48344320|NCT01267955|101172304|FG000|NOT COMPLETED|Stage 1 (6 Months)||3||
48344321|NCT01267955|101172304|FG000|STARTED|Stage 2 (6 Months)||45||
48344322|NCT01267955|101172304|FG000|COMPLETED|Stage 2 (6 Months)||39||
48344323|NCT01267955|101172304|FG000|NOT COMPLETED|Stage 2 (6 Months)||6||
48344324|NCT01272583|101172305|FG000|STARTED|Overall Study||8||
48414573|NCT03661983|101350092|FG002|COMPLETED|Double-blind Randomized Phase||7||
48414574|NCT03661983|101350093|FG003|COMPLETED|Double-blind Randomized Phase||0||
48414575|NCT03661983|101350090|FG000|NOT COMPLETED|Double-blind Randomized Phase||0||
48414576|NCT03661983|101350091|FG001|NOT COMPLETED|Double-blind Randomized Phase||2||
48414577|NCT03661983|101350092|FG002|NOT COMPLETED|Double-blind Randomized Phase||1||
48414578|NCT03661983|101350093|FG003|NOT COMPLETED|Double-blind Randomized Phase||8||
48414579|NCT00439309|101350094|FG000|STARTED|Treatment||54||
48634941|NCT00712920|101891722|FG000|NOT COMPLETED|Overall Study||17||
48634942|NCT00712920|101891723|FG001|NOT COMPLETED|Overall Study||17||
48634943|NCT00712920|101891724|FG002|NOT COMPLETED|Overall Study||12||
48634944|NCT01140906|101891725|FG000|STARTED|Overall Study||158||
48634945|NCT01140906|101891726|FG001|STARTED|Overall Study||151||
48634946|NCT01140906|101891727|FG002|STARTED|Overall Study||151||
48634947|NCT01140906|101891728|FG003|STARTED|Overall Study||147||
48634948|NCT01140906|101891725|FG000|COMPLETED|Overall Study||133||
48634949|NCT01140906|101891726|FG001|COMPLETED|Overall Study||117||
48634950|NCT01140906|101891727|FG002|COMPLETED|Overall Study||125||
48634951|NCT01140906|101891728|FG003|COMPLETED|Overall Study||131||
48634952|NCT01140906|101891725|FG000|NOT COMPLETED|Overall Study||25||
48634953|NCT01140906|101891726|FG001|NOT COMPLETED|Overall Study||34||
48634954|NCT01140906|101891727|FG002|NOT COMPLETED|Overall Study||26||
48634955|NCT01140906|101891728|FG003|NOT COMPLETED|Overall Study||16||
48634956|NCT02948400|101891729|FG000|STARTED|Overall Study||254||
48634957|NCT02948400|101891730|FG001|STARTED|Overall Study||225||
48634958|NCT02948400|101891729|FG000|COMPLETED|Overall Study||181||
48634959|NCT02948400|101891730|FG001|COMPLETED|Overall Study||179||
48634960|NCT02948400|101891729|FG000|NOT COMPLETED|Overall Study||73||
48634961|NCT02948400|101891730|FG001|NOT COMPLETED|Overall Study||46||
48634962|NCT04800627|101891731|FG000|STARTED|Overall Study||2||
48634963|NCT04800627|101891731|FG000|COMPLETED|Overall Study||0||
48634964|NCT04800627|101891731|FG000|NOT COMPLETED|Overall Study||2||
48634965|NCT02321527|101891732|FG000|STARTED|Overall Study||21||
48634966|NCT02321527|101891732|FG000|COMPLETED|Overall Study||20||
48414580|NCT00439309|101350095|FG001|STARTED|Treatment||15||
48414581|NCT00439309|101350094|FG000|COMPLETED|Treatment||54||
48634967|NCT02321527|101891732|FG000|NOT COMPLETED|Overall Study||1||
48634968|NCT00916578|101891733|FG000|STARTED|Overall Study||33||
48634969|NCT00916578|101891733|FG000|COMPLETED|Overall Study||26||
48634970|NCT00916578|101891733|FG000|NOT COMPLETED|Overall Study||7||
48634971|NCT00961064|101891734|FG000|STARTED|Initial Treatment (Weeks 1 - 20)||30||
48634972|NCT00961064|101891734|FG000|COMPLETED|Initial Treatment (Weeks 1 - 20)||14||
48634973|NCT00961064|101891734|FG000|NOT COMPLETED|Initial Treatment (Weeks 1 - 20)||16||
48757750|NCT04698343|102194410|FG000|Completed Phase 2|Overall Study||4||
48757751|NCT04698343|102194410|FG000|Completed Phase 3|Overall Study||3||
48757752|NCT04698343|102194410|FG000|COMPLETED|Overall Study||3||
48757753|NCT04698343|102194410|FG000|NOT COMPLETED|Overall Study||17||
48183330|NCT00463151|100772178|FG002|NOT COMPLETED|Overall Study||3||
48183331|NCT00463151|100772179|FG003|NOT COMPLETED|Overall Study||7||
48183332|NCT02761629|100772180|FG000|STARTED|Overall Study||90||
48183333|NCT02761629|100772181|FG001|STARTED|Overall Study||90||
48183334|NCT02761629|100772180|FG000|Treated|Overall Study||82||
48183335|NCT02761629|100772181|FG001|Treated|Overall Study||86||
48183336|NCT02761629|100772180|FG000|COMPLETED|Overall Study||63||
48757754|NCT03924622|102194411|FG000|STARTED|Overall Study||12||
48757755|NCT03924622|102194412|FG001|STARTED|Overall Study||12||
48757756|NCT03924622|102194413|FG002|STARTED|Overall Study||12||
48183337|NCT02761629|100772181|FG001|COMPLETED|Overall Study||58||
48183338|NCT02761629|100772180|FG000|NOT COMPLETED|Overall Study||27||
48183339|NCT02761629|100772181|FG001|NOT COMPLETED|Overall Study||32||
48183340|NCT03677375|100772182|FG000|STARTED|Overall Study||93||
48757757|NCT03924622|102194414|FG003|STARTED|Overall Study||12||
48757758|NCT03924622|102194415|FG004|STARTED|Overall Study||12||
48183341|NCT03677375|100772182|FG000|COMPLETED|Overall Study||81||
48183342|NCT03677375|100772182|FG000|NOT COMPLETED|Overall Study||12||
48183343|NCT01461993|100772183|FG000|STARTED|Overall Study||999||
48183344|NCT01461993|100772184|FG001|STARTED|Overall Study||998||
48183345|NCT01461993|100772185|FG002|STARTED|Overall Study||502||
48183346|NCT01461993|100772183|FG000|COMPLETED|Overall Study||848||
48183347|NCT01461993|100772184|FG001|COMPLETED|Overall Study||841||
48183348|NCT01461993|100772185|FG002|COMPLETED|Overall Study||438||
48183349|NCT01461993|100772183|FG000|NOT COMPLETED|Overall Study||151||
48183350|NCT01461993|100772184|FG001|NOT COMPLETED|Overall Study||157||
48183351|NCT01461993|100772185|FG002|NOT COMPLETED|Overall Study||64||
48183352|NCT02165124|100772186|FG000|STARTED|Overall Study||20||
48183353|NCT02165124|100772186|FG000|COMPLETED|Overall Study||15||
48183354|NCT02165124|100772186|FG000|NOT COMPLETED|Overall Study||5||
48183355|NCT00619151|100772187|FG000|STARTED|Overall Study||2||
48183356|NCT00619151|100772188|FG001|STARTED|Overall Study||0||
48183357|NCT00619151|100772187|FG000|COMPLETED|Overall Study||1||
48183358|NCT00619151|100772188|FG001|COMPLETED|Overall Study||0||
48183359|NCT00619151|100772187|FG000|NOT COMPLETED|Overall Study||1||
48183360|NCT00619151|100772188|FG001|NOT COMPLETED|Overall Study||0||
48183361|NCT00680056|100772189|FG000|STARTED|First Intervention||16||
48183362|NCT00680056|100772190|FG001|STARTED|First Intervention||17||
48183363|NCT00680056|100772189|FG000|COMPLETED|First Intervention||15||
48183364|NCT00680056|100772190|FG001|COMPLETED|First Intervention||15||
48183365|NCT00680056|100772189|FG000|NOT COMPLETED|First Intervention||1||
48183366|NCT00680056|100772190|FG001|NOT COMPLETED|First Intervention||2||
48183367|NCT00680056|100772189|FG000|STARTED|Washout Period of One Week||15||
48183368|NCT00680056|100772190|FG001|STARTED|Washout Period of One Week||15||
48183369|NCT00680056|100772189|FG000|COMPLETED|Washout Period of One Week||15||
48183370|NCT00680056|100772190|FG001|COMPLETED|Washout Period of One Week||15||
48183371|NCT00680056|100772189|FG000|NOT COMPLETED|Washout Period of One Week||0||
48183372|NCT00680056|100772190|FG001|NOT COMPLETED|Washout Period of One Week||0||
48757759|NCT03924622|102194416|FG005|STARTED|Overall Study||12||
48757760|NCT03924622|102194411|FG000|COMPLETED|Overall Study||10||
48757761|NCT03924622|102194412|FG001|COMPLETED|Overall Study||9||
48757762|NCT03924622|102194413|FG002|COMPLETED|Overall Study||9||
48757763|NCT03924622|102194414|FG003|COMPLETED|Overall Study||8||
48183373|NCT00680056|100772189|FG000|STARTED|Second Intervention||15||
48183374|NCT00680056|100772190|FG001|STARTED|Second Intervention||15||
48183375|NCT00680056|100772189|FG000|COMPLETED|Second Intervention||12||
48183376|NCT00680056|100772190|FG001|COMPLETED|Second Intervention||14||
48183377|NCT00680056|100772189|FG000|NOT COMPLETED|Second Intervention||3||
48183378|NCT00680056|100772190|FG001|NOT COMPLETED|Second Intervention||1||
48183379|NCT03220737|100772191|FG000|STARTED|Main Study (Day 1 - 181)||163||
48183380|NCT03220737|100772192|FG001|STARTED|Main Study (Day 1 - 181)||26||
48183381|NCT03220737|100772193|FG002|STARTED|Main Study (Day 1 - 181)||158||
48183382|NCT03220737|100772194|FG003|STARTED|Main Study (Day 1 - 181)||27||
48183383|NCT03220737|100772195|FG004|STARTED|Main Study (Day 1 - 181)||150||
48183384|NCT03220737|100772196|FG005|STARTED|Main Study (Day 1 - 181)||26||
48757764|NCT03924622|102194415|FG004|COMPLETED|Overall Study||9||
48757765|NCT03924622|102194416|FG005|COMPLETED|Overall Study||9||
48757766|NCT03924622|102194411|FG000|NOT COMPLETED|Overall Study||2||
48757767|NCT03924622|102194412|FG001|NOT COMPLETED|Overall Study||3||
48183385|NCT03220737|100772197|FG006|STARTED|Main Study (Day 1 - 181)||2688||
48183386|NCT03220737|100772191|FG000|COMPLETED|Main Study (Day 1 - 181)||157||
48183387|NCT03220737|100772192|FG001|COMPLETED|Main Study (Day 1 - 181)||24||
48183388|NCT03220737|100772193|FG002|COMPLETED|Main Study (Day 1 - 181)||146||
48183389|NCT03220737|100772194|FG003|COMPLETED|Main Study (Day 1 - 181)||24||
48183390|NCT03220737|100772195|FG004|COMPLETED|Main Study (Day 1 - 181)||130||
48183391|NCT03220737|100772196|FG005|COMPLETED|Main Study (Day 1 - 181)||25||
48183392|NCT03220737|100772197|FG006|COMPLETED|Main Study (Day 1 - 181)||2687||
48183393|NCT03220737|100772191|FG000|NOT COMPLETED|Main Study (Day 1 - 181)||6||
48183394|NCT03220737|100772192|FG001|NOT COMPLETED|Main Study (Day 1 - 181)||2||
48183395|NCT03220737|100772193|FG002|NOT COMPLETED|Main Study (Day 1 - 181)||12||
48183396|NCT03220737|100772194|FG003|NOT COMPLETED|Main Study (Day 1 - 181)||3||
48183397|NCT03220737|100772195|FG004|NOT COMPLETED|Main Study (Day 1 - 181)||20||
48183398|NCT03220737|100772196|FG005|NOT COMPLETED|Main Study (Day 1 - 181)||1||
48183399|NCT03220737|100772197|FG006|NOT COMPLETED|Main Study (Day 1 - 181)||1||
48183400|NCT03220737|100772191|FG000|STARTED|Placebo Crossover (Day 181-365)||13||
48183401|NCT03220737|100772192|FG001|STARTED|Placebo Crossover (Day 181-365)||0||
48183402|NCT03220737|100772193|FG002|STARTED|Placebo Crossover (Day 181-365)||11||
48183403|NCT03220737|100772194|FG003|STARTED|Placebo Crossover (Day 181-365)||0||
48183404|NCT03220737|100772195|FG004|STARTED|Placebo Crossover (Day 181-365)||7||
48183405|NCT03220737|100772196|FG005|STARTED|Placebo Crossover (Day 181-365)||0||
48414582|NCT00439309|101350095|FG001|COMPLETED|Treatment||15||
48414583|NCT00439309|101350094|FG000|NOT COMPLETED|Treatment||0||
48414584|NCT00439309|101350095|FG001|NOT COMPLETED|Treatment||0||
48414585|NCT00439309|101350094|FG000|STARTED|Follow-Up||54||
48414586|NCT00439309|101350095|FG001|STARTED|Follow-Up||15||
48634974|NCT00961064|101891734|FG000|STARTED|Extended Access: Week 20 to Up to Year 5||14||
48634975|NCT00961064|101891734|FG000|COMPLETED|Extended Access: Week 20 to Up to Year 5||7||
48634976|NCT00961064|101891734|FG000|NOT COMPLETED|Extended Access: Week 20 to Up to Year 5||7||
48634977|NCT02320175|101891735|FG000|STARTED|Overall Study||3538||
48634978|NCT02320175|101891736|FG001|STARTED|Overall Study||2940||
48634979|NCT02320175|101891735|FG000|COMPLETED|Overall Study||3538||
48634980|NCT02320175|101891736|FG001|COMPLETED|Overall Study||2940||
48634981|NCT02320175|101891735|FG000|NOT COMPLETED|Overall Study||0||
48634982|NCT02320175|101891736|FG001|NOT COMPLETED|Overall Study||0||
48634983|NCT02141555|101891737|FG000|STARTED|Overall Study||2||
48634984|NCT02141555|101891738|FG001|STARTED|Overall Study||2||
48634985|NCT02141555|101891737|FG000|COMPLETED|Overall Study||2||
48634986|NCT02141555|101891738|FG001|COMPLETED|Overall Study||2||
48634987|NCT02141555|101891737|FG000|NOT COMPLETED|Overall Study||0||
48634988|NCT02141555|101891738|FG001|NOT COMPLETED|Overall Study||0||
48634989|NCT00966433|101891739|FG000|STARTED|Overall Study||11||
48634990|NCT00966433|101891740|FG001|STARTED|Overall Study||11||
48634991|NCT00966433|101891741|FG002|STARTED|Overall Study||11||
48634992|NCT00966433|101891739|FG000|COMPLETED|Overall Study||10||
48634993|NCT00966433|101891740|FG001|COMPLETED|Overall Study||10||
48634994|NCT00966433|101891741|FG002|COMPLETED|Overall Study||11||
48634995|NCT00966433|101891739|FG000|NOT COMPLETED|Overall Study||1||
48634996|NCT00966433|101891740|FG001|NOT COMPLETED|Overall Study||1||
48634997|NCT00966433|101891741|FG002|NOT COMPLETED|Overall Study||0||
48634998|NCT01384877|101891742|FG000|STARTED|Treatment 1||17||
48634999|NCT01384877|101891743|FG001|STARTED|Treatment 1||15||
48635000|NCT01384877|101891742|FG000|COMPLETED|Treatment 1||17||
48635001|NCT01384877|101891743|FG001|COMPLETED|Treatment 1||15||
48635002|NCT01384877|101891742|FG000|NOT COMPLETED|Treatment 1||0||
48635003|NCT01384877|101891743|FG001|NOT COMPLETED|Treatment 1||0||
48635004|NCT01384877|101891742|FG000|STARTED|Treatment 2||16||
48635005|NCT01384877|101891743|FG001|STARTED|Treatment 2||13||
48183406|NCT03220737|100772197|FG006|STARTED|Placebo Crossover (Day 181-365)||0||
48183407|NCT03220737|100772191|FG000|COMPLETED|Placebo Crossover (Day 181-365)||13||
48183408|NCT03220737|100772192|FG001|COMPLETED|Placebo Crossover (Day 181-365)||0||
48183409|NCT03220737|100772193|FG002|COMPLETED|Placebo Crossover (Day 181-365)||11||
48183410|NCT03220737|100772194|FG003|COMPLETED|Placebo Crossover (Day 181-365)||0||
48183411|NCT03220737|100772195|FG004|COMPLETED|Placebo Crossover (Day 181-365)||5||
48183412|NCT03220737|100772196|FG005|COMPLETED|Placebo Crossover (Day 181-365)||0||
48635006|NCT01384877|101891742|FG000|COMPLETED|Treatment 2||14||
48183413|NCT03220737|100772197|FG006|COMPLETED|Placebo Crossover (Day 181-365)||0||
48183414|NCT03220737|100772191|FG000|NOT COMPLETED|Placebo Crossover (Day 181-365)||0||
48183415|NCT03220737|100772192|FG001|NOT COMPLETED|Placebo Crossover (Day 181-365)||0||
48183416|NCT03220737|100772193|FG002|NOT COMPLETED|Placebo Crossover (Day 181-365)||0||
48188680|NCT00329303|100783308|FG001|STARTED|Overall Study||37||
48414587|NCT00439309|101350094|FG000|COMPLETED|Follow-Up||51||
48414588|NCT00439309|101350095|FG001|COMPLETED|Follow-Up||13||
48635007|NCT01384877|101891743|FG001|COMPLETED|Treatment 2||11||
48414589|NCT00439309|101350094|FG000|NOT COMPLETED|Follow-Up||3||
48635008|NCT01384877|101891742|FG000|NOT COMPLETED|Treatment 2||2||
48635009|NCT01384877|101891743|FG001|NOT COMPLETED|Treatment 2||2||
48635010|NCT03738696|101891744|FG000|STARTED|Overall Study||28||
48635011|NCT03738696|101891745|FG001|STARTED|Overall Study||36||
48635012|NCT03738696|101891744|FG000|COMPLETED|Overall Study||20||
48635013|NCT03738696|101891745|FG001|COMPLETED|Overall Study||21||
48757768|NCT03924622|102194413|FG002|NOT COMPLETED|Overall Study||3||
48757769|NCT03924622|102194414|FG003|NOT COMPLETED|Overall Study||4||
48757770|NCT03924622|102194415|FG004|NOT COMPLETED|Overall Study||3||
48757771|NCT03924622|102194416|FG005|NOT COMPLETED|Overall Study||3||
48757772|NCT04657679|102194417|FG000|STARTED|Overall Study||17||
48757773|NCT04657679|102194418|FG001|STARTED|Overall Study||4||
48757774|NCT04657679|102194417|FG000|COMPLETED|Overall Study||14||
48757775|NCT04657679|102194418|FG001|COMPLETED|Overall Study||3||
48757776|NCT04657679|102194417|FG000|NOT COMPLETED|Overall Study||3||
48757777|NCT04657679|102194418|FG001|NOT COMPLETED|Overall Study||1||
48757778|NCT04861597|102194419|FG000|STARTED|Overall Study||18||
48757779|NCT04861597|102194420|FG001|STARTED|Overall Study||12||
48757780|NCT04861597|102194419|FG000|COMPLETED|Overall Study||12||
48757781|NCT04861597|102194420|FG001|COMPLETED|Overall Study||9||
48757782|NCT04861597|102194419|FG000|NOT COMPLETED|Overall Study||6||
48757783|NCT04861597|102194420|FG001|NOT COMPLETED|Overall Study||3||
48757784|NCT03770260|102194421|FG000|STARTED|Overall Study||3||
48757785|NCT03770260|102194422|FG001|STARTED|Overall Study||4||
48757786|NCT03770260|102194423|FG002|STARTED|Overall Study||1||
48757787|NCT03770260|102194424|FG003|STARTED|Overall Study||0||
48757788|NCT03770260|102194421|FG000|COMPLETED|Overall Study||3||
48757789|NCT03770260|102194422|FG001|COMPLETED|Overall Study||3||
48757790|NCT03770260|102194423|FG002|COMPLETED|Overall Study||1||
48757791|NCT03770260|102194424|FG003|COMPLETED|Overall Study||0||
48757792|NCT03770260|102194421|FG000|NOT COMPLETED|Overall Study||0||
48757793|NCT03770260|102194422|FG001|NOT COMPLETED|Overall Study||1||
48757794|NCT03770260|102194423|FG002|NOT COMPLETED|Overall Study||0||
48757795|NCT03770260|102194424|FG003|NOT COMPLETED|Overall Study||0||
48757796|NCT04648033|102194425|FG000|STARTED|Overall Study||3||
48757797|NCT04648033|102194426|FG001|STARTED|Overall Study||2||
48757798|NCT04648033|102194427|FG002|STARTED|Overall Study||1||
48757799|NCT04648033|102194428|FG003|STARTED|Overall Study||15||
48757800|NCT04648033|102194425|FG000|COMPLETED|Overall Study||3||
48757801|NCT04648033|102194426|FG001|COMPLETED|Overall Study||2||
48757802|NCT04648033|102194427|FG002|COMPLETED|Overall Study||1||
48757803|NCT04648033|102194428|FG003|COMPLETED|Overall Study||15||
48757804|NCT04648033|102194425|FG000|NOT COMPLETED|Overall Study||0||
48757805|NCT04648033|102194426|FG001|NOT COMPLETED|Overall Study||0||
48757806|NCT04648033|102194427|FG002|NOT COMPLETED|Overall Study||0||
48757807|NCT04648033|102194428|FG003|NOT COMPLETED|Overall Study||0||
48757808|NCT02647281|102194429|FG000|STARTED|Single-Ascending Dose(Part 1-62 Days)||8||
48757809|NCT02647281|102194430|FG001|STARTED|Single-Ascending Dose(Part 1-62 Days)||6||
48757810|NCT02647281|102194431|FG002|STARTED|Single-Ascending Dose(Part 1-62 Days)||6||
48757811|NCT02647281|102194432|FG003|STARTED|Single-Ascending Dose(Part 1-62 Days)||6||
48757812|NCT02647281|102194433|FG004|STARTED|Single-Ascending Dose(Part 1-62 Days)||6||
48757813|NCT02647281|102194434|FG005|STARTED|Single-Ascending Dose(Part 1-62 Days)||0||
48757814|NCT02647281|102194435|FG006|STARTED|Single-Ascending Dose(Part 1-62 Days)||0||
48757815|NCT02647281|102194436|FG007|STARTED|Single-Ascending Dose(Part 1-62 Days)||0||
48757816|NCT02647281|102194437|FG008|STARTED|Single-Ascending Dose(Part 1-62 Days)||0||
48757817|NCT02647281|102194429|FG000|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||8||
48757818|NCT02647281|102194430|FG001|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6||
48757819|NCT02647281|102194431|FG002|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6||
48757820|NCT02647281|102194432|FG003|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6||
48757821|NCT02647281|102194433|FG004|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6||
48757822|NCT02647281|102194434|FG005|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0||
48757823|NCT02647281|102194435|FG006|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0||
48757824|NCT02647281|102194436|FG007|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0||
48757825|NCT02647281|102194437|FG008|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0||
48757826|NCT02647281|102194429|FG000|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0||
48757827|NCT02647281|102194430|FG001|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0||
48757828|NCT02647281|102194431|FG002|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0||
48757829|NCT02647281|102194432|FG003|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0||
48757830|NCT02647281|102194433|FG004|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0||
48757831|NCT02647281|102194434|FG005|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0||
48757832|NCT02647281|102194435|FG006|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0||
48757833|NCT02647281|102194436|FG007|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0||
48757834|NCT02647281|102194437|FG008|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0||
48757835|NCT02647281|102194429|FG000|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0||
48757836|NCT02647281|102194430|FG001|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0||
48757837|NCT02647281|102194431|FG002|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0||
48757838|NCT02647281|102194432|FG003|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0||
48757839|NCT02647281|102194433|FG004|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0||
48757840|NCT02647281|102194434|FG005|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6||
48757841|NCT02647281|102194435|FG006|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6||
48757842|NCT02647281|102194436|FG007|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6||
48767753|NCT04004988|102222818|FG000|COMPLETED|Period 1||21||
48183417|NCT03220737|100772194|FG003|NOT COMPLETED|Placebo Crossover (Day 181-365)||0||
48183418|NCT03220737|100772195|FG004|NOT COMPLETED|Placebo Crossover (Day 181-365)||2||
48344325|NCT01272583|101172306|FG001|STARTED|Overall Study||8||
48344326|NCT01272583|101172305|FG000|COMPLETED|Overall Study||8||
48344327|NCT01272583|101172306|FG001|COMPLETED|Overall Study||8||
48344328|NCT01272583|101172305|FG000|NOT COMPLETED|Overall Study||0||
48344329|NCT01272583|101172306|FG001|NOT COMPLETED|Overall Study||0||
48344330|NCT01341457|101172307|FG000|STARTED|Overall Study||7||
48344331|NCT01341457|101172308|FG001|STARTED|Overall Study||10||
48344332|NCT01341457|101172307|FG000|Received at Least One Dose of Study Drug|Overall Study||7||
48344333|NCT01341457|101172308|FG001|Received at Least One Dose of Study Drug|Overall Study||10||
48344334|NCT01341457|101172307|FG000|COMPLETED|Overall Study||5||
48344335|NCT01341457|101172308|FG001|COMPLETED|Overall Study||10||
48344336|NCT01341457|101172307|FG000|NOT COMPLETED|Overall Study||2||
48344337|NCT01341457|101172308|FG001|NOT COMPLETED|Overall Study||0||
48344338|NCT01700829|101172309|FG000|STARTED|Overall Study||41||
48344339|NCT01700829|101172310|FG001|STARTED|Overall Study||41||
48344340|NCT01700829|101172309|FG000|COMPLETED|Overall Study||40||
48344341|NCT01700829|101172310|FG001|COMPLETED|Overall Study||40||
48344342|NCT01700829|101172309|FG000|NOT COMPLETED|Overall Study||1||
48344343|NCT01700829|101172310|FG001|NOT COMPLETED|Overall Study||1||
48344344|NCT03514914|101172311|FG000|STARTED|Overall Study||1200||10
48344345|NCT03514914|101172312|FG001|STARTED|Overall Study||1202||10
48344346|NCT03514914|101172311|FG000|9 Month Follow-up|Overall Study||1091||10
48344347|NCT03514914|101172312|FG001|9 Month Follow-up|Overall Study||1114||10
48344348|NCT03514914|101172311|FG000|COMPLETED|Overall Study||1080||10
48344349|NCT03514914|101172312|FG001|COMPLETED|Overall Study||1110||10
48344350|NCT03514914|101172311|FG000|NOT COMPLETED|Overall Study||120||0
48344351|NCT03514914|101172312|FG001|NOT COMPLETED|Overall Study||92||0
48344352|NCT00806221|101172313|FG000|STARTED|Overall Study||22||
48344353|NCT00806221|101172313|FG000|COMPLETED|Overall Study||20||
48344354|NCT00806221|101172313|FG000|NOT COMPLETED|Overall Study||2||
48344355|NCT00832819|101172314|FG000|STARTED|Overall Study||6||
48344356|NCT00832819|101172315|FG001|STARTED|Overall Study||6||
48344357|NCT00832819|101172316|FG002|STARTED|Overall Study||16||
48344358|NCT00832819|101172314|FG000|COMPLETED|Overall Study||6||
48344359|NCT00832819|101172315|FG001|COMPLETED|Overall Study||5||
48344360|NCT00832819|101172316|FG002|COMPLETED|Overall Study||15||
48183419|NCT03220737|100772196|FG005|NOT COMPLETED|Placebo Crossover (Day 181-365)||0||
48183420|NCT03220737|100772197|FG006|NOT COMPLETED|Placebo Crossover (Day 181-365)||0||
48183421|NCT03220737|100772191|FG000|STARTED|Long-term Follow-up (Day 365-730)||73||
48183422|NCT03220737|100772192|FG001|STARTED|Long-term Follow-up (Day 365-730)||0||
48183423|NCT03220737|100772193|FG002|STARTED|Long-term Follow-up (Day 365-730)||0||
48183424|NCT03220737|100772194|FG003|STARTED|Long-term Follow-up (Day 365-730)||0||
48183425|NCT03220737|100772195|FG004|STARTED|Long-term Follow-up (Day 365-730)||0||
48183426|NCT03220737|100772196|FG005|STARTED|Long-term Follow-up (Day 365-730)||0||
48183427|NCT03220737|100772197|FG006|STARTED|Long-term Follow-up (Day 365-730)||0||
48183428|NCT03220737|100772191|FG000|COMPLETED|Long-term Follow-up (Day 365-730)||62||
48183429|NCT03220737|100772192|FG001|COMPLETED|Long-term Follow-up (Day 365-730)||0||
48183430|NCT03220737|100772193|FG002|COMPLETED|Long-term Follow-up (Day 365-730)||0||
48344361|NCT00832819|101172314|FG000|NOT COMPLETED|Overall Study||0||
48183431|NCT03220737|100772194|FG003|COMPLETED|Long-term Follow-up (Day 365-730)||0||
48183432|NCT03220737|100772195|FG004|COMPLETED|Long-term Follow-up (Day 365-730)||0||
48183433|NCT03220737|100772196|FG005|COMPLETED|Long-term Follow-up (Day 365-730)||0||
48183434|NCT03220737|100772197|FG006|COMPLETED|Long-term Follow-up (Day 365-730)||0||
48183435|NCT03220737|100772191|FG000|NOT COMPLETED|Long-term Follow-up (Day 365-730)||11||
48183436|NCT03220737|100772192|FG001|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0||
48183437|NCT03220737|100772193|FG002|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0||
48183438|NCT03220737|100772194|FG003|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0||
48183439|NCT03220737|100772195|FG004|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0||
48344362|NCT00832819|101172315|FG001|NOT COMPLETED|Overall Study||1||
48344363|NCT00832819|101172316|FG002|NOT COMPLETED|Overall Study||1||
48344364|NCT02871479|101172317|FG000|STARTED|Overall Study||36||
48344365|NCT02871479|101172318|FG001|STARTED|Overall Study||24||
48344366|NCT02871479|101172319|FG002|STARTED|Overall Study||11||
48344367|NCT02871479|101172317|FG000|COMPLETED|Overall Study||33||
48344368|NCT02871479|101172318|FG001|COMPLETED|Overall Study||21||
48344369|NCT02871479|101172319|FG002|COMPLETED|Overall Study||11||
48344370|NCT02871479|101172317|FG000|NOT COMPLETED|Overall Study||3||
48183440|NCT03220737|100772196|FG005|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0||
48183441|NCT03220737|100772197|FG006|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0||
48344371|NCT02871479|101172318|FG001|NOT COMPLETED|Overall Study||3||
48344372|NCT02871479|101172319|FG002|NOT COMPLETED|Overall Study||0||
48757843|NCT02647281|102194437|FG008|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6||
48757844|NCT02647281|102194429|FG000|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0||
48757845|NCT02647281|102194430|FG001|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0||
48757846|NCT02647281|102194431|FG002|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0||
48757847|NCT02647281|102194432|FG003|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0||
48757848|NCT02647281|102194433|FG004|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0||
48757849|NCT02647281|102194434|FG005|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6||
48757850|NCT02647281|102194435|FG006|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6||
48757851|NCT02647281|102194436|FG007|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6||
48414590|NCT00439309|101350095|FG001|NOT COMPLETED|Follow-Up||2||
48414591|NCT00782756|101350096|FG000|STARTED|Overall Study||40||
48414592|NCT00782756|101350096|FG000|COMPLETED|Overall Study||40||
48414593|NCT00782756|101350096|FG000|NOT COMPLETED|Overall Study||0||
48414594|NCT02967172|101350097|FG000|STARTED|Overall Study||49||
48414595|NCT02967172|101350098|FG001|STARTED|Overall Study||51||
48414596|NCT02967172|101350097|FG000|COMPLETED|Overall Study||49||
48414597|NCT02967172|101350098|FG001|COMPLETED|Overall Study||51||
48414598|NCT02967172|101350097|FG000|NOT COMPLETED|Overall Study||0||
48414599|NCT02967172|101350098|FG001|NOT COMPLETED|Overall Study||0||
48414600|NCT00656799|101350099|FG000|STARTED|Overall Study||6||
48414601|NCT00656799|101350099|FG000|COMPLETED|Overall Study||4||
48414602|NCT00656799|101350099|FG000|NOT COMPLETED|Overall Study||2||
48414603|NCT00983242|101350100|FG000|STARTED|Colchicine Alone||24||
48414604|NCT00983242|101350100|FG000|COMPLETED|Colchicine Alone||24||
48414605|NCT00983242|101350100|FG000|NOT COMPLETED|Colchicine Alone||0||
48414606|NCT00983242|101350100|FG000|STARTED|14 Day Washout Period||24||
48344373|NCT02581995|101172320|FG000|STARTED|Overall Study||560||
48344374|NCT02581995|101172320|FG000|Treated|Overall Study||560||
48344375|NCT02581995|101172320|FG000|COMPLETED|Overall Study||529||
48344376|NCT02581995|101172320|FG000|NOT COMPLETED|Overall Study||31||
48344377|NCT03371355|101172321|FG000|STARTED|Overall Study||27||
48344378|NCT03371355|101172322|FG001|STARTED|Overall Study||26||
48344379|NCT03371355|101172323|FG002|STARTED|Overall Study||26||
48344380|NCT03371355|101172324|FG003|STARTED|Overall Study||26||
48344381|NCT03371355|101172321|FG000|COMPLETED|Overall Study||26|Completed here refers to participants who completed study treatment.|
48344382|NCT03371355|101172322|FG001|COMPLETED|Overall Study||24|Completed here refers to participants who completed study treatment.|
48344383|NCT03371355|101172323|FG002|COMPLETED|Overall Study||22|Completed here refers to participants who completed study treatment.|
48344384|NCT03371355|101172324|FG003|COMPLETED|Overall Study||19|Completed here refers to participants who completed study treatment.|
48344385|NCT03371355|101172321|FG000|NOT COMPLETED|Overall Study||1||
48344386|NCT03371355|101172322|FG001|NOT COMPLETED|Overall Study||2||
48344387|NCT03371355|101172323|FG002|NOT COMPLETED|Overall Study||4||
48344388|NCT03371355|101172324|FG003|NOT COMPLETED|Overall Study||7||
48344389|NCT02921425|101172325|FG000|STARTED|Overall Study||47||
48344390|NCT02921425|101172325|FG000|Second Visit|Overall Study||47||
48344391|NCT02921425|101172325|FG000|COMPLETED|Overall Study||38||
48344392|NCT02921425|101172325|FG000|NOT COMPLETED|Overall Study||9||
48344393|NCT00432809|101172326|FG000|STARTED|1 Year Follow-up||50||
48344394|NCT00432809|101172327|FG001|STARTED|1 Year Follow-up||50||
48344395|NCT00432809|101172328|FG002|STARTED|1 Year Follow-up||50||
48344396|NCT00432809|101172326|FG000|COMPLETED|1 Year Follow-up||41||
48344397|NCT00432809|101172327|FG001|COMPLETED|1 Year Follow-up||50||
48344398|NCT00432809|101172328|FG002|COMPLETED|1 Year Follow-up||49||
48344399|NCT00432809|101172326|FG000|NOT COMPLETED|1 Year Follow-up||9||
48635014|NCT03738696|101891744|FG000|NOT COMPLETED|Overall Study||8||
48635015|NCT03738696|101891745|FG001|NOT COMPLETED|Overall Study||15||
48635016|NCT00700635|101891746|FG000|STARTED|Overall Study||111||
48635017|NCT00700635|101891747|FG001|STARTED|Overall Study||111||
48635018|NCT00700635|101891748|FG002|STARTED|Overall Study||111||
48635019|NCT00700635|101891746|FG000|COMPLETED|Overall Study||100||
48635020|NCT00700635|101891747|FG001|COMPLETED|Overall Study||103||
48635021|NCT00700635|101891748|FG002|COMPLETED|Overall Study||110||
48635022|NCT00700635|101891746|FG000|NOT COMPLETED|Overall Study||11||
48635023|NCT00700635|101891747|FG001|NOT COMPLETED|Overall Study||8||
48635024|NCT00700635|101891748|FG002|NOT COMPLETED|Overall Study||1||
48635025|NCT03290768|101891749|FG000|STARTED|Overall Study||358||
48635026|NCT03290768|101891749|FG000|COMPLETED|Overall Study||193||
48757852|NCT02647281|102194437|FG008|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||5||
48757853|NCT02647281|102194429|FG000|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0||
48344400|NCT00432809|101172327|FG001|NOT COMPLETED|1 Year Follow-up||0||
48344401|NCT00432809|101172328|FG002|NOT COMPLETED|1 Year Follow-up||1||
48344402|NCT00432809|101172326|FG000|STARTED|2 Year Sub-study||20||
48414607|NCT00983242|101350100|FG000|COMPLETED|14 Day Washout Period||24||
48414608|NCT00983242|101350100|FG000|NOT COMPLETED|14 Day Washout Period||0||
48414609|NCT00983242|101350100|FG000|STARTED|Verapamil HCl ER Alone||24||
48414610|NCT00983242|101350100|FG000|COMPLETED|Verapamil HCl ER Alone||24||
48635027|NCT03290768|101891749|FG000|NOT COMPLETED|Overall Study||165||
48635028|NCT02634177|101891750|FG000|STARTED|Overall Study||151||
48635029|NCT02634177|101891751|FG001|STARTED|Overall Study||153||
48757854|NCT02647281|102194430|FG001|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0||
48757855|NCT02647281|102194431|FG002|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0||
48757856|NCT02647281|102194432|FG003|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0||
48757857|NCT02647281|102194433|FG004|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0||
48757858|NCT02647281|102194434|FG005|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0||
48757859|NCT02647281|102194435|FG006|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0||
48757860|NCT02647281|102194436|FG007|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0||
48757861|NCT02647281|102194437|FG008|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||1||
48757862|NCT03965130|102194438|FG000|STARTED|Overall Study||10||
48757863|NCT03965130|102194438|FG000|COMPLETED|Overall Study||10||
48757864|NCT03965130|102194438|FG000|NOT COMPLETED|Overall Study||0||
48757865|NCT01612351|102194439|FG000|STARTED|Chemotherapy||40||
48757866|NCT01612351|102194439|FG000|COMPLETED|Chemotherapy||40||
48757867|NCT01612351|102194439|FG000|NOT COMPLETED|Chemotherapy||0||
48757868|NCT01612351|102194439|FG000|STARTED|Transoral Surgery||39||
48757869|NCT01612351|102194439|FG000|COMPLETED|Transoral Surgery||39||
48757870|NCT01612351|102194439|FG000|NOT COMPLETED|Transoral Surgery||0||
48757871|NCT01612351|102194439|FG000|STARTED|Post-Operative Treatment||39||
48757872|NCT01612351|102194439|FG000|COMPLETED|Post-Operative Treatment||39||
48757873|NCT01612351|102194439|FG000|NOT COMPLETED|Post-Operative Treatment||0||
48757874|NCT03679247|102194440|FG000|STARTED|Overall Study||1029|Data is reported at the patient level (n=2026). Groups of patients sharing the same PCP panel (PCP or PCP plus a nurse practitioner or physician assistant) were grouped as units. The units were stratified based on two factors (size of unit and mean SBP).|87
48757875|NCT03679247|102194441|FG001|STARTED|Overall Study||997|Data is reported at the patient level (n=2026). Groups of patients sharing the same PCP panel (PCP or PCP plus a nurse practitioner or physician assistant) were grouped as units. The units were stratified based on two factors (size of unit and mean SBP).|87
48757876|NCT03679247|102194440|FG000|COMPLETED|Overall Study||1029|Data is reported at the patient level (n=2026). Groups of patients sharing the same PCP panel (PCP or PCP plus a nurse practitioner or physician assistant) were grouped as units. The units were stratified based on two factors (size of unit and mean SBP).|87
48757877|NCT03679247|102194441|FG001|COMPLETED|Overall Study||997|Data is reported at the patient level (n=2026). Groups of patients sharing the same PCP panel (PCP or PCP plus a nurse practitioner or physician assistant) were grouped as units. The units were stratified based on two factors (size of unit and mean SBP).|87
48757878|NCT03679247|102194440|FG000|NOT COMPLETED|Overall Study||0||0
48757879|NCT03679247|102194441|FG001|NOT COMPLETED|Overall Study||0||0
48757880|NCT05083351|102194442|FG000|STARTED|Overall Study||88||
48757881|NCT05083351|102194442|FG000|COMPLETED|Overall Study||39||
48757882|NCT05083351|102194442|FG000|NOT COMPLETED|Overall Study||49||
48757883|NCT03661723|102194443|FG000|STARTED|Overall Study||6||
48757884|NCT03661723|102194444|FG001|STARTED|Overall Study||24||
48757885|NCT03661723|102194445|FG002|STARTED|Overall Study||6||
48757886|NCT03661723|102194446|FG003|STARTED|Overall Study||24||
48757887|NCT03661723|102194443|FG000|COMPLETED|Overall Study||0||
48757888|NCT03661723|102194444|FG001|COMPLETED|Overall Study||0||
48757889|NCT03661723|102194445|FG002|COMPLETED|Overall Study||0||
48757890|NCT03661723|102194446|FG003|COMPLETED|Overall Study||0||
48757891|NCT03661723|102194443|FG000|NOT COMPLETED|Overall Study||6||
48757892|NCT03661723|102194444|FG001|NOT COMPLETED|Overall Study||24||
48757893|NCT03661723|102194445|FG002|NOT COMPLETED|Overall Study||6||
48757894|NCT03661723|102194446|FG003|NOT COMPLETED|Overall Study||24||
48757895|NCT03096834|102194447|FG000|STARTED|Double-Blind Treatment Epoch||121||
48757896|NCT03096834|102194448|FG001|STARTED|Double-Blind Treatment Epoch||125||
48757897|NCT03096834|102194449|FG002|STARTED|Double-Blind Treatment Epoch||0||
48757898|NCT03096834|102194450|FG003|STARTED|Double-Blind Treatment Epoch||0||
48757899|NCT03096834|102194447|FG000|COMPLETED|Double-Blind Treatment Epoch||118||
48757900|NCT03096834|102194448|FG001|COMPLETED|Double-Blind Treatment Epoch||122||
48757901|NCT03096834|102194449|FG002|COMPLETED|Double-Blind Treatment Epoch||0||
48344403|NCT00432809|101172327|FG001|STARTED|2 Year Sub-study||20||
48344404|NCT00432809|101172328|FG002|STARTED|2 Year Sub-study||20||
48344405|NCT00432809|101172326|FG000|COMPLETED|2 Year Sub-study||17||
48344406|NCT00432809|101172327|FG001|COMPLETED|2 Year Sub-study||18||
48344407|NCT00432809|101172328|FG002|COMPLETED|2 Year Sub-study||19||
48757902|NCT03096834|102194450|FG003|COMPLETED|Double-Blind Treatment Epoch||0||
48757903|NCT03096834|102194447|FG000|NOT COMPLETED|Double-Blind Treatment Epoch||3||
48757904|NCT03096834|102194448|FG001|NOT COMPLETED|Double-Blind Treatment Epoch||3||
48757905|NCT03096834|102194449|FG002|NOT COMPLETED|Double-Blind Treatment Epoch||0||
48757906|NCT03096834|102194450|FG003|NOT COMPLETED|Double-Blind Treatment Epoch||0||
48757907|NCT03096834|102194447|FG000|STARTED|Open-Label Treatment Epoch||0||
48757908|NCT03096834|102194448|FG001|STARTED|Open-Label Treatment Epoch||0||
48757909|NCT03096834|102194449|FG002|STARTED|Open-Label Treatment Epoch||118||
48757910|NCT03096834|102194450|FG003|STARTED|Open-Label Treatment Epoch||122||
48757911|NCT03096834|102194447|FG000|COMPLETED|Open-Label Treatment Epoch||0||
48757912|NCT03096834|102194448|FG001|COMPLETED|Open-Label Treatment Epoch||0||
48183442|NCT02472314|100772198|FG000|STARTED|Overall Study||34||
48344408|NCT00432809|101172326|FG000|NOT COMPLETED|2 Year Sub-study||3||
48344409|NCT00432809|101172327|FG001|NOT COMPLETED|2 Year Sub-study||2||
48757913|NCT03096834|102194449|FG002|COMPLETED|Open-Label Treatment Epoch||86||
48757914|NCT03096834|102194450|FG003|COMPLETED|Open-Label Treatment Epoch||83||
48757915|NCT03096834|102194447|FG000|NOT COMPLETED|Open-Label Treatment Epoch||0||
48757916|NCT03096834|102194448|FG001|NOT COMPLETED|Open-Label Treatment Epoch||0||
48757917|NCT03096834|102194449|FG002|NOT COMPLETED|Open-Label Treatment Epoch||32||
48757918|NCT03096834|102194450|FG003|NOT COMPLETED|Open-Label Treatment Epoch||39||
48757919|NCT03096834|102194447|FG000|STARTED|Safety Follow-Up Epoch||0|After completing the Double-Blind and/or Open -Label Epoch, a Follow-Up Visit (16 weeks after the last dose of AMG334) was required as part of routine safety monitoring unless participants continued onto commercial AMG334 (contingent upon marketing authorization and commercial availability in the participating country).|
48757920|NCT03096834|102194448|FG001|STARTED|Safety Follow-Up Epoch||0|After completing the Double-Blind and/or Open -Label Epoch, a Follow-Up Visit (16 weeks after the last dose of AMG334) was required as part of routine safety monitoring unless participants continued onto commercial AMG334 (contingent upon marketing authorization and commercial availability in the participating country).|
48757921|NCT03096834|102194449|FG002|STARTED|Safety Follow-Up Epoch||66|After completing the Double-Blind and/or Open -Label Epoch, a Follow-Up Visit (16 weeks after the last dose of AMG334) was required as part of routine safety monitoring unless participants continued onto commercial AMG334 (contingent upon marketing authorization and commercial availability in the participating country).|
48757922|NCT03096834|102194450|FG003|STARTED|Safety Follow-Up Epoch||61|After completing the Double-Blind and/or Open -Label Epoch, a Follow-Up Visit (16 weeks after the last dose of AMG334) was required as part of routine safety monitoring unless participants continued onto commercial AMG334 (contingent upon marketing authorization and commercial availability in the participating country).|
48757923|NCT03096834|102194447|FG000|COMPLETED|Safety Follow-Up Epoch||0||
48757924|NCT03096834|102194448|FG001|COMPLETED|Safety Follow-Up Epoch||0||
48757925|NCT03096834|102194449|FG002|COMPLETED|Safety Follow-Up Epoch||65||
48757926|NCT03096834|102194450|FG003|COMPLETED|Safety Follow-Up Epoch||59||
48757927|NCT03096834|102194447|FG000|NOT COMPLETED|Safety Follow-Up Epoch||0||
48757928|NCT03096834|102194448|FG001|NOT COMPLETED|Safety Follow-Up Epoch||0||
48757929|NCT03096834|102194449|FG002|NOT COMPLETED|Safety Follow-Up Epoch||1||
48757930|NCT03096834|102194450|FG003|NOT COMPLETED|Safety Follow-Up Epoch||2||
48757931|NCT03096834|102194447|FG000|STARTED|Post-Trial Access Epoch||0|Only participants who had demonstrated continued clinical benefit and who did not have access to commercially available drug were eligible to enter to Post-Trial Access Epoch.|
48757932|NCT03096834|102194448|FG001|STARTED|Post-Trial Access Epoch||0|Only participants who had demonstrated continued clinical benefit and who did not have access to commercially available drug were eligible to enter to Post-Trial Access Epoch.|
48757933|NCT03096834|102194449|FG002|STARTED|Post-Trial Access Epoch||21|Only participants who had demonstrated continued clinical benefit and who did not have access to commercially available drug were eligible to enter to Post-Trial Access Epoch.|
48757934|NCT03096834|102194450|FG003|STARTED|Post-Trial Access Epoch||15|Only participants who had demonstrated continued clinical benefit and who did not have access to commercially available drug were eligible to enter to Post-Trial Access Epoch.|
48757935|NCT03096834|102194447|FG000|COMPLETED|Post-Trial Access Epoch||0||
48757936|NCT03096834|102194448|FG001|COMPLETED|Post-Trial Access Epoch||0||
48757937|NCT03096834|102194449|FG002|COMPLETED|Post-Trial Access Epoch||21||
48757938|NCT03096834|102194450|FG003|COMPLETED|Post-Trial Access Epoch||15||
48757939|NCT03096834|102194447|FG000|NOT COMPLETED|Post-Trial Access Epoch||0||
48757940|NCT03096834|102194448|FG001|NOT COMPLETED|Post-Trial Access Epoch||0||
48757941|NCT03096834|102194449|FG002|NOT COMPLETED|Post-Trial Access Epoch||0||
48757942|NCT03096834|102194450|FG003|NOT COMPLETED|Post-Trial Access Epoch||0||
48757943|NCT03525444|102194451|FG000|STARTED|Overall Study||203||
48757944|NCT03525444|102194452|FG001|STARTED|Overall Study||200||
48757945|NCT03525444|102194451|FG000|Safety Set|Overall Study||201|Based on actual treatment received.|
48757946|NCT03525444|102194452|FG001|Safety Set|Overall Study||202|Based on actual treatment received.|
48757947|NCT03525444|102194451|FG000|COMPLETED|Overall Study||203||
48757948|NCT03525444|102194452|FG001|COMPLETED|Overall Study||197||
48757949|NCT03525444|102194451|FG000|NOT COMPLETED|Overall Study||0||
48757950|NCT03525444|102194452|FG001|NOT COMPLETED|Overall Study||3||
48757951|NCT02340026|102194453|FG000|STARTED|Treatment Phase||21||
48757952|NCT02340026|102194454|FG001|STARTED|Treatment Phase||20||
48757953|NCT02340026|102194453|FG000|COMPLETED|Treatment Phase||19||
48757954|NCT02340026|102194454|FG001|COMPLETED|Treatment Phase||18||
48757955|NCT02340026|102194453|FG000|NOT COMPLETED|Treatment Phase||2||
48757956|NCT02340026|102194454|FG001|NOT COMPLETED|Treatment Phase||2||
48757957|NCT02340026|102194453|FG000|STARTED|Follow-up Phase||19||
48757958|NCT02340026|102194454|FG001|STARTED|Follow-up Phase||18||
48757959|NCT02340026|102194453|FG000|COMPLETED|Follow-up Phase||18||
48757960|NCT02340026|102194454|FG001|COMPLETED|Follow-up Phase||18||
48757961|NCT02340026|102194453|FG000|NOT COMPLETED|Follow-up Phase||1||
48757962|NCT02340026|102194454|FG001|NOT COMPLETED|Follow-up Phase||0||
48757963|NCT01680341|102194455|FG000|STARTED|Overall Study||136||
48757964|NCT01680341|102194456|FG001|STARTED|Overall Study||136||
48757965|NCT01680341|102194455|FG000|Exposed|Overall Study||135||
48757966|NCT01680341|102194456|FG001|Exposed|Overall Study||134||
48757967|NCT01680341|102194455|FG000|COMPLETED|Overall Study||115||
48757968|NCT01680341|102194456|FG001|COMPLETED|Overall Study||119||
48757969|NCT01680341|102194455|FG000|NOT COMPLETED|Overall Study||21||
48757970|NCT01680341|102194456|FG001|NOT COMPLETED|Overall Study||17||
48757971|NCT03589859|102194457|FG000|STARTED|Overall Study||18||
48757972|NCT03589859|102194458|FG001|STARTED|Overall Study||6||
48757973|NCT03589859|102194457|FG000|COMPLETED|Overall Study||18||
48757974|NCT03589859|102194458|FG001|COMPLETED|Overall Study||0||
48757975|NCT03589859|102194457|FG000|NOT COMPLETED|Overall Study||0||
48757976|NCT03589859|102194458|FG001|NOT COMPLETED|Overall Study||6||
48757977|NCT03267277|102194459|FG000|STARTED|Overall Study||14||
48757978|NCT03267277|102194459|FG000|COMPLETED|Overall Study||13||
48757979|NCT03267277|102194459|FG000|NOT COMPLETED|Overall Study||1||
48757980|NCT02535312|102194460|FG000|STARTED|Overall Study||3||
48757981|NCT02535312|102194461|FG001|STARTED|Overall Study||4||
48757982|NCT02535312|102194462|FG002|STARTED|Overall Study||3||
48757983|NCT02535312|102194463|FG003|STARTED|Overall Study||6||
48757984|NCT02535312|102194464|FG004|STARTED|Overall Study||14||
48757985|NCT02535312|102194460|FG000|COMPLETED|Overall Study||3||
48757986|NCT02535312|102194461|FG001|COMPLETED|Overall Study||4||
48757987|NCT02535312|102194462|FG002|COMPLETED|Overall Study||3||
48757988|NCT02535312|102194463|FG003|COMPLETED|Overall Study||6||
48757989|NCT02535312|102194464|FG004|COMPLETED|Overall Study||14||
48757990|NCT02535312|102194460|FG000|NOT COMPLETED|Overall Study||0||
48757991|NCT02535312|102194461|FG001|NOT COMPLETED|Overall Study||0||
48757992|NCT02535312|102194462|FG002|NOT COMPLETED|Overall Study||0||
48757993|NCT02535312|102194463|FG003|NOT COMPLETED|Overall Study||0||
48757994|NCT02535312|102194464|FG004|NOT COMPLETED|Overall Study||0||
48757995|NCT01935934|102194465|FG000|STARTED|Overall Study||70||
48757996|NCT01935934|102194466|FG001|STARTED|Overall Study||32||
48757997|NCT01935934|102194465|FG000|COMPLETED|Overall Study||70||
48757998|NCT01935934|102194466|FG001|COMPLETED|Overall Study||32||
48757999|NCT01935934|102194465|FG000|NOT COMPLETED|Overall Study||0||
48758000|NCT01935934|102194466|FG001|NOT COMPLETED|Overall Study||0||
48758001|NCT05137041|102194467|FG000|STARTED|Overall Study||113||
48758002|NCT05137041|102194468|FG001|STARTED|Overall Study||108||
48758003|NCT05137041|102194467|FG000|Intent-to-Treat Population|Overall Study||113|Intent-to-Treat population was defined as all participants randomized.|
48758004|NCT05137041|102194468|FG001|Intent-to-Treat Population|Overall Study||108|Intent-to-Treat population was defined as all participants randomized.|
48758005|NCT05137041|102194467|FG000|Safety Population|Overall Study||114|"Safety population was defined as all participants randomized into the study and, if randomized to the patch arm, had the device installed."|
48758006|NCT05137041|102194468|FG001|Safety Population|Overall Study||107|"Safety population was defined as all participants randomized into the study and, if randomized to the patch arm, had the device installed."|
48758007|NCT05137041|102194467|FG000|Modified Intent-to-Treat Population|Overall Study||91|"Modified Intent-to-Treat population was defined as all participants randomized that had the Numerical Rating Scale (NRS) evaluation done at baseline and Day 5 with the exclusion of participants without any pain at baseline (i.e. baseline instantaneous pain NRS score equal to 0)."|
48758008|NCT05137041|102194468|FG001|Modified Intent-to-Treat Population|Overall Study||89|"Modified Intent-to-Treat population was defined as all participants randomized that had the Numerical Rating Scale (NRS) evaluation done at baseline and Day 5 with the exclusion of participants without any pain at baseline (i.e. baseline instantaneous pain NRS score equal to 0)."|
48758009|NCT05137041|102194467|FG000|Full Analysis Set|Overall Study||97|"Full Analysis Set population was defined as all participants randomized that had the NRS evaluation done at baseline and that were not using any rescue medication starting from randomization to Day 5 Visit 2 or starting before the study and still ongoing at randomization with the exclusion of participants without any pain at baseline (i.e. baseline instantaneous pain NRS score equal to 0)."|
48758010|NCT05137041|102194468|FG001|Full Analysis Set|Overall Study||84|"Full Analysis Set population was defined as all participants randomized that had the NRS evaluation done at baseline and that were not using any rescue medication starting from randomization to Day 5 Visit 2 or starting before the study and still ongoing at randomization with the exclusion of participants without any pain at baseline (i.e. baseline instantaneous pain NRS score equal to 0)."|
48758011|NCT05137041|102194467|FG000|COMPLETED|Overall Study||112||
48758012|NCT05137041|102194468|FG001|COMPLETED|Overall Study||104||
48758013|NCT05137041|102194467|FG000|NOT COMPLETED|Overall Study||1||
48758014|NCT05137041|102194468|FG001|NOT COMPLETED|Overall Study||4||
48758015|NCT05622734|102194469|FG000|STARTED|Overall Study||39||
48758016|NCT05622734|102194469|FG000|COMPLETED|Overall Study||29||
48758017|NCT05622734|102194469|FG000|NOT COMPLETED|Overall Study||10||
48758018|NCT01052493|102194470|FG000|STARTED|Intervention 1 (Up to 10 Days)||4||
48758019|NCT01052493|102194471|FG001|STARTED|Intervention 1 (Up to 10 Days)||4||
48758020|NCT01052493|102194472|FG002|STARTED|Intervention 1 (Up to 10 Days)||4||
48758021|NCT01052493|102194470|FG000|COMPLETED|Intervention 1 (Up to 10 Days)||3||
48758022|NCT01052493|102194471|FG001|COMPLETED|Intervention 1 (Up to 10 Days)||4||
48758023|NCT01052493|102194472|FG002|COMPLETED|Intervention 1 (Up to 10 Days)||4||
48758024|NCT01052493|102194470|FG000|NOT COMPLETED|Intervention 1 (Up to 10 Days)||1||
48758025|NCT01052493|102194471|FG001|NOT COMPLETED|Intervention 1 (Up to 10 Days)||0||
48414611|NCT00983242|101350100|FG000|NOT COMPLETED|Verapamil HCl ER Alone||0||
48414612|NCT00983242|101350100|FG000|STARTED|Colchicine With Verapamil HCl ER||24||
48414613|NCT00983242|101350100|FG000|COMPLETED|Colchicine With Verapamil HCl ER||24||
48414614|NCT00983242|101350100|FG000|NOT COMPLETED|Colchicine With Verapamil HCl ER||0||
48414615|NCT04062240|101350101|FG000|STARTED|Overall Study||15||
48414616|NCT04062240|101350101|FG000|COMPLETED|Overall Study||14||
48635030|NCT02634177|101891750|FG000|COMPLETED|Overall Study||140||
48758026|NCT01052493|102194472|FG002|NOT COMPLETED|Intervention 1 (Up to 10 Days)||0||
48758027|NCT01052493|102194470|FG000|STARTED|Washout Period 1 (up to 5 Days)||3||
48758028|NCT01052493|102194471|FG001|STARTED|Washout Period 1 (up to 5 Days)||4||
48758029|NCT01052493|102194472|FG002|STARTED|Washout Period 1 (up to 5 Days)||4||
48758030|NCT01052493|102194470|FG000|COMPLETED|Washout Period 1 (up to 5 Days)||3||
48758031|NCT01052493|102194471|FG001|COMPLETED|Washout Period 1 (up to 5 Days)||4||
48758032|NCT01052493|102194472|FG002|COMPLETED|Washout Period 1 (up to 5 Days)||4||
48758033|NCT01052493|102194470|FG000|NOT COMPLETED|Washout Period 1 (up to 5 Days)||0||
48183443|NCT02472314|100772199|FG001|STARTED|Overall Study||36||
48414617|NCT04062240|101350101|FG000|NOT COMPLETED|Overall Study||1||
48414618|NCT01320033|101350102|FG000|STARTED|Overall Study||216||
48414619|NCT01320033|101350103|FG001|STARTED|Overall Study||224||
48635031|NCT02634177|101891751|FG001|COMPLETED|Overall Study||141||
48635032|NCT02634177|101891750|FG000|NOT COMPLETED|Overall Study||11||
48635033|NCT02634177|101891751|FG001|NOT COMPLETED|Overall Study||12||
48635034|NCT02199574|101891752|FG000|STARTED|Overall Study||12||
48635035|NCT02199574|101891752|FG000|COMPLETED|Overall Study||12||
48635036|NCT02199574|101891752|FG000|NOT COMPLETED|Overall Study||0||
48635037|NCT00464685|101891753|FG000|STARTED|Overall Study||126||
48635038|NCT00464685|101891754|FG001|STARTED|Overall Study||127||
48758034|NCT01052493|102194471|FG001|NOT COMPLETED|Washout Period 1 (up to 5 Days)||0||
48758035|NCT01052493|102194472|FG002|NOT COMPLETED|Washout Period 1 (up to 5 Days)||0||
48758036|NCT01052493|102194470|FG000|STARTED|Intervention 2 (up to 10 Days)||4||
48758037|NCT01052493|102194471|FG001|STARTED|Intervention 2 (up to 10 Days)||4||
48758038|NCT01052493|102194472|FG002|STARTED|Intervention 2 (up to 10 Days)||4||
48758039|NCT01052493|102194470|FG000|COMPLETED|Intervention 2 (up to 10 Days)||4||
48758040|NCT01052493|102194471|FG001|COMPLETED|Intervention 2 (up to 10 Days)||4||
48758041|NCT01052493|102194472|FG002|COMPLETED|Intervention 2 (up to 10 Days)||4||
48758042|NCT01052493|102194470|FG000|NOT COMPLETED|Intervention 2 (up to 10 Days)||0||
48758043|NCT01052493|102194471|FG001|NOT COMPLETED|Intervention 2 (up to 10 Days)||0||
48344410|NCT00432809|101172328|FG002|NOT COMPLETED|2 Year Sub-study||1||
48758044|NCT01052493|102194472|FG002|NOT COMPLETED|Intervention 2 (up to 10 Days)||0||
48758045|NCT01052493|102194470|FG000|STARTED|Washout Period 2 (up to 5 Days)||4||
48758046|NCT01052493|102194471|FG001|STARTED|Washout Period 2 (up to 5 Days)||4||
48758047|NCT01052493|102194472|FG002|STARTED|Washout Period 2 (up to 5 Days)||4||
48758048|NCT01052493|102194470|FG000|COMPLETED|Washout Period 2 (up to 5 Days)||4||
48758049|NCT01052493|102194471|FG001|COMPLETED|Washout Period 2 (up to 5 Days)||4||
48758050|NCT01052493|102194472|FG002|COMPLETED|Washout Period 2 (up to 5 Days)||4||
48758051|NCT01052493|102194470|FG000|NOT COMPLETED|Washout Period 2 (up to 5 Days)||0||
48758052|NCT01052493|102194471|FG001|NOT COMPLETED|Washout Period 2 (up to 5 Days)||0||
48758053|NCT01052493|102194472|FG002|NOT COMPLETED|Washout Period 2 (up to 5 Days)||0||
48758054|NCT01052493|102194470|FG000|STARTED|Intervention 3 (up to 10 Days)||4||
48758055|NCT01052493|102194471|FG001|STARTED|Intervention 3 (up to 10 Days)||4||
48758056|NCT01052493|102194472|FG002|STARTED|Intervention 3 (up to 10 Days)||4||
48183444|NCT02472314|100772198|FG000|COMPLETED|Overall Study||34||
48183445|NCT02472314|100772199|FG001|COMPLETED|Overall Study||36||
48183446|NCT02472314|100772198|FG000|NOT COMPLETED|Overall Study||0||
48183447|NCT02472314|100772199|FG001|NOT COMPLETED|Overall Study||0||
48183448|NCT00848211|100772200|FG000|STARTED|Overall Study||6||
48183449|NCT00848211|100772201|FG001|STARTED|Overall Study||7||
48183450|NCT00848211|100772202|FG002|STARTED|Overall Study||6||
48183451|NCT00848211|100772203|FG003|STARTED|Overall Study||5||
48183452|NCT00848211|100772200|FG000|COMPLETED|Overall Study||6||
48183453|NCT00848211|100772201|FG001|COMPLETED|Overall Study||6||
48183454|NCT00848211|100772202|FG002|COMPLETED|Overall Study||5||
48758057|NCT01052493|102194470|FG000|COMPLETED|Intervention 3 (up to 10 Days)||4||
48758058|NCT01052493|102194471|FG001|COMPLETED|Intervention 3 (up to 10 Days)||4||
48758059|NCT01052493|102194472|FG002|COMPLETED|Intervention 3 (up to 10 Days)||4||
48758060|NCT01052493|102194470|FG000|NOT COMPLETED|Intervention 3 (up to 10 Days)||0||
48758061|NCT01052493|102194471|FG001|NOT COMPLETED|Intervention 3 (up to 10 Days)||0||
48758062|NCT01052493|102194472|FG002|NOT COMPLETED|Intervention 3 (up to 10 Days)||0||
48758063|NCT00179621|102194473|FG000|STARTED|Double-Blind Period||67||
48758064|NCT00179621|102194474|FG001|STARTED|Double-Blind Period||69||
48758065|NCT00179621|102194475|FG002|STARTED|Double-Blind Period||69||
48758066|NCT00179621|102194476|FG003|STARTED|Double-Blind Period||0||
48758067|NCT00179621|102194473|FG000|COMPLETED|Double-Blind Period||3||
48183455|NCT00848211|100772203|FG003|COMPLETED|Overall Study||5||
48183456|NCT00848211|100772200|FG000|NOT COMPLETED|Overall Study||0||
48183457|NCT00848211|100772201|FG001|NOT COMPLETED|Overall Study||1||
48183458|NCT00848211|100772202|FG002|NOT COMPLETED|Overall Study||1||
48183459|NCT00848211|100772203|FG003|NOT COMPLETED|Overall Study||0||
48183460|NCT04529538|100772204|FG000|STARTED|Overall Study||21||
48183461|NCT04529538|100772205|FG001|STARTED|Overall Study||23||
48183462|NCT04529538|100772206|FG002|STARTED|Overall Study||53||
48183463|NCT04529538|100772207|FG003|STARTED|Overall Study||27||
48183464|NCT04529538|100772208|FG004|STARTED|Overall Study||20||
48183465|NCT04529538|100772209|FG005|STARTED|Overall Study||21||
48183466|NCT04529538|100772210|FG006|STARTED|Overall Study||40||
48183467|NCT04529538|100772211|FG007|STARTED|Overall Study||21||
48758068|NCT00179621|102194474|FG001|COMPLETED|Double-Blind Period||23||
48758069|NCT00179621|102194475|FG002|COMPLETED|Double-Blind Period||39||
48758070|NCT00179621|102194476|FG003|COMPLETED|Double-Blind Period||0||
48758071|NCT00179621|102194473|FG000|NOT COMPLETED|Double-Blind Period||64||
48758072|NCT00179621|102194474|FG001|NOT COMPLETED|Double-Blind Period||46||
48758073|NCT00179621|102194475|FG002|NOT COMPLETED|Double-Blind Period||30||
48758074|NCT00179621|102194476|FG003|NOT COMPLETED|Double-Blind Period||0||
48758075|NCT00179621|102194473|FG000|STARTED|Open-Label Period||0||
48758076|NCT00179621|102194474|FG001|STARTED|Open-Label Period||42||
48758077|NCT00179621|102194475|FG002|STARTED|Open-Label Period||47||
48758078|NCT00179621|102194476|FG003|STARTED|Open-Label Period||56||
48758079|NCT00179621|102194473|FG000|COMPLETED|Open-Label Period||0||
48758080|NCT00179621|102194474|FG001|COMPLETED|Open-Label Period||14||
48758081|NCT00179621|102194475|FG002|COMPLETED|Open-Label Period||19||
48183468|NCT04529538|100772204|FG000|Received 1st Vaccination|Overall Study||20||
48183469|NCT04529538|100772205|FG001|Received 1st Vaccination|Overall Study||20||
48183470|NCT04529538|100772206|FG002|Received 1st Vaccination|Overall Study||50||
48183471|NCT04529538|100772207|FG003|Received 1st Vaccination|Overall Study||25||
48183472|NCT04529538|100772208|FG004|Received 1st Vaccination|Overall Study||19||
48183473|NCT04529538|100772209|FG005|Received 1st Vaccination|Overall Study||17||
48758082|NCT00179621|102194476|FG003|COMPLETED|Open-Label Period||13||
48758083|NCT00179621|102194473|FG000|NOT COMPLETED|Open-Label Period||0||
48758084|NCT00179621|102194474|FG001|NOT COMPLETED|Open-Label Period||28||
48758085|NCT00179621|102194475|FG002|NOT COMPLETED|Open-Label Period||28||
48758086|NCT00179621|102194476|FG003|NOT COMPLETED|Open-Label Period||43||
48758087|NCT01414634|102194477|FG000|STARTED|Overall Study||1||
48758088|NCT01414634|102194478|FG001|STARTED|Overall Study||1||
48758089|NCT01414634|102194479|FG002|STARTED|Overall Study||1||
48758090|NCT01414634|102194480|FG003|STARTED|Overall Study||1||
48758091|NCT01414634|102194481|FG004|STARTED|Overall Study||1||
48758092|NCT01414634|102194482|FG005|STARTED|Overall Study||2||
48758093|NCT01414634|102194483|FG006|STARTED|Overall Study||1||
48758094|NCT01414634|102194484|FG007|STARTED|Overall Study||1||
48758095|NCT01414634|102194477|FG000|COMPLETED|Overall Study||1||
48758096|NCT01414634|102194478|FG001|COMPLETED|Overall Study||1||
48758097|NCT01414634|102194479|FG002|COMPLETED|Overall Study||1||
48758098|NCT01414634|102194480|FG003|COMPLETED|Overall Study||1||
48183474|NCT04529538|100772210|FG006|Received 1st Vaccination|Overall Study||35||
48758099|NCT01414634|102194481|FG004|COMPLETED|Overall Study||1||
48758100|NCT01414634|102194482|FG005|COMPLETED|Overall Study||2||
48758101|NCT01414634|102194483|FG006|COMPLETED|Overall Study||1||
48758102|NCT01414634|102194484|FG007|COMPLETED|Overall Study||1||
48183475|NCT04529538|100772211|FG007|Received 1st Vaccination|Overall Study||19||
48183476|NCT04529538|100772204|FG000|Received 2nd Vaccination|Overall Study||0||
48183477|NCT04529538|100772205|FG001|Received 2nd Vaccination|Overall Study||0||
48758103|NCT01414634|102194477|FG000|NOT COMPLETED|Overall Study||0||
48183478|NCT04529538|100772206|FG002|Received 2nd Vaccination|Overall Study||49||
48183479|NCT04529538|100772207|FG003|Received 2nd Vaccination|Overall Study||22||
48183480|NCT04529538|100772208|FG004|Received 2nd Vaccination|Overall Study||0||
48183481|NCT04529538|100772209|FG005|Received 2nd Vaccination|Overall Study||0||
48183482|NCT04529538|100772210|FG006|Received 2nd Vaccination|Overall Study||35||
48183483|NCT04529538|100772211|FG007|Received 2nd Vaccination|Overall Study||18||
48183484|NCT04529538|100772204|FG000|COMPLETED|Overall Study||18||
48183485|NCT04529538|100772205|FG001|COMPLETED|Overall Study||18||
48183486|NCT04529538|100772206|FG002|COMPLETED|Overall Study||49||
48183487|NCT04529538|100772207|FG003|COMPLETED|Overall Study||22||
48183488|NCT04529538|100772208|FG004|COMPLETED|Overall Study||19||
48183489|NCT04529538|100772209|FG005|COMPLETED|Overall Study||17||
48183490|NCT04529538|100772210|FG006|COMPLETED|Overall Study||35||
48183491|NCT04529538|100772211|FG007|COMPLETED|Overall Study||19||
48183492|NCT04529538|100772204|FG000|NOT COMPLETED|Overall Study||3||
48183493|NCT04529538|100772205|FG001|NOT COMPLETED|Overall Study||5||
48183494|NCT04529538|100772206|FG002|NOT COMPLETED|Overall Study||4||
48183495|NCT04529538|100772207|FG003|NOT COMPLETED|Overall Study||5||
48183496|NCT04529538|100772208|FG004|NOT COMPLETED|Overall Study||1||
48183497|NCT04529538|100772209|FG005|NOT COMPLETED|Overall Study||4||
48183498|NCT04529538|100772210|FG006|NOT COMPLETED|Overall Study||5||
48183499|NCT04529538|100772211|FG007|NOT COMPLETED|Overall Study||2||
48183500|NCT02059161|100772212|FG000|STARTED|Overall Study||245||
48183501|NCT02059161|100772213|FG001|STARTED|Overall Study||263||
48635039|NCT00464685|101891753|FG000|COMPLETED|Overall Study||103||
48635040|NCT00464685|101891754|FG001|COMPLETED|Overall Study||94||
48635041|NCT00464685|101891753|FG000|NOT COMPLETED|Overall Study||23||
48635042|NCT00464685|101891754|FG001|NOT COMPLETED|Overall Study||33||
48635043|NCT02402062|101891755|FG000|STARTED|Overall Study||17||
48635044|NCT02402062|101891755|FG000|COMPLETED|Overall Study||17||
48183502|NCT02059161|100772212|FG000|Treated|Overall Study||241||
48183503|NCT02059161|100772213|FG001|Treated|Overall Study||258||
48183504|NCT02059161|100772212|FG000|COMPLETED|Overall Study||196||
48635045|NCT02402062|101891755|FG000|NOT COMPLETED|Overall Study||0||
48635046|NCT00898937|101891756|FG000|STARTED|Overall Study||25||
48635047|NCT00898937|101891757|FG001|STARTED|Overall Study||21||
48635048|NCT00898937|101891758|FG002|STARTED|Overall Study||9||
48635049|NCT00898937|101891756|FG000|COMPLETED|Overall Study||25||
48635050|NCT00898937|101891757|FG001|COMPLETED|Overall Study||21||
48635051|NCT00898937|101891758|FG002|COMPLETED|Overall Study||9||
48635052|NCT00898937|101891756|FG000|NOT COMPLETED|Overall Study||0||
48635053|NCT00898937|101891757|FG001|NOT COMPLETED|Overall Study||0||
48635054|NCT00898937|101891758|FG002|NOT COMPLETED|Overall Study||0||
48635055|NCT01683526|101891759|FG000|STARTED|Overall Study||60||
48635056|NCT01683526|101891760|FG001|STARTED|Overall Study||57||
48635057|NCT01683526|101891759|FG000|COMPLETED|Overall Study||60||
48635058|NCT01683526|101891760|FG001|COMPLETED|Overall Study||57||
48635059|NCT01683526|101891759|FG000|NOT COMPLETED|Overall Study||0||
48635060|NCT01683526|101891760|FG001|NOT COMPLETED|Overall Study||0||
48635061|NCT00390689|101891761|FG000|STARTED|Overall Study||48||
48635062|NCT00390689|101891762|FG001|STARTED|Overall Study||53||
48635063|NCT00390689|101891763|FG002|STARTED|Overall Study||53||
48635064|NCT00390689|101891761|FG000|COMPLETED|Overall Study||43||
48635065|NCT00390689|101891762|FG001|COMPLETED|Overall Study||48||
48183505|NCT02059161|100772213|FG001|COMPLETED|Overall Study||222||
48183506|NCT02059161|100772212|FG000|NOT COMPLETED|Overall Study||49||
48183507|NCT02059161|100772213|FG001|NOT COMPLETED|Overall Study||41||
48183508|NCT02501811|100772214|FG000|STARTED|Overall Study||33||
48183509|NCT02501811|100772215|FG001|STARTED|Overall Study||29||
48183510|NCT02501811|100772216|FG002|STARTED|Overall Study||31||
48183511|NCT02501811|100772217|FG003|STARTED|Overall Study||32||
48183512|NCT02501811|100772214|FG000|COMPLETED|Overall Study||29||
48183513|NCT02501811|100772215|FG001|COMPLETED|Overall Study||23||
48183514|NCT02501811|100772216|FG002|COMPLETED|Overall Study||25||
48183515|NCT02501811|100772217|FG003|COMPLETED|Overall Study||25||
48183516|NCT02501811|100772214|FG000|NOT COMPLETED|Overall Study||4||
48183517|NCT02501811|100772215|FG001|NOT COMPLETED|Overall Study||6||
48183518|NCT02501811|100772216|FG002|NOT COMPLETED|Overall Study||6||
48635066|NCT00390689|101891763|FG002|COMPLETED|Overall Study||50||
48635067|NCT00390689|101891761|FG000|NOT COMPLETED|Overall Study||5||
48635068|NCT00390689|101891762|FG001|NOT COMPLETED|Overall Study||5||
48635069|NCT00390689|101891763|FG002|NOT COMPLETED|Overall Study||3||
48183519|NCT02501811|100772217|FG003|NOT COMPLETED|Overall Study||7||
48183520|NCT00235495|100772218|FG000|STARTED|Overall Study||422||
48183521|NCT00235495|100772219|FG001|STARTED|Overall Study||419||
48183522|NCT00235495|100772218|FG000|COMPLETED|Overall Study||354||
48183523|NCT00235495|100772219|FG001|COMPLETED|Overall Study||351||
48183524|NCT00235495|100772218|FG000|NOT COMPLETED|Overall Study||68||
48183525|NCT00235495|100772219|FG001|NOT COMPLETED|Overall Study||68||
48635070|NCT00420745|101891764|FG000|STARTED|Overall Study||670||
48635071|NCT00420745|101891765|FG001|STARTED|Overall Study||339||
48635072|NCT00420745|101891764|FG000|COMPLETED|Overall Study||655||
48635073|NCT00420745|101891765|FG001|COMPLETED|Overall Study||333||
48635074|NCT00420745|101891764|FG000|NOT COMPLETED|Overall Study||15||
48635075|NCT00420745|101891765|FG001|NOT COMPLETED|Overall Study||6||
48758104|NCT01414634|102194478|FG001|NOT COMPLETED|Overall Study||0||
48183526|NCT00701311|100772220|FG000|STARTED|Overall Study||17||
48183527|NCT00701311|100772220|FG000|COMPLETED|Overall Study||9||
48183528|NCT00701311|100772220|FG000|NOT COMPLETED|Overall Study||8||
48183529|NCT01871285|100772221|FG000|STARTED|First Intervention (1 Day)||18||
48344411|NCT03971721|101172329|FG000|STARTED|Overall Study||3||
48344412|NCT03971721|101172329|FG000|COMPLETED|Overall Study||3||
48344413|NCT03971721|101172329|FG000|NOT COMPLETED|Overall Study||0||
48344414|NCT00095563|101172330|FG000|STARTED|Overall Study||39||
48344415|NCT00095563|101172330|FG000|COMPLETED|Overall Study||39||
48344416|NCT00095563|101172330|FG000|NOT COMPLETED|Overall Study||0||
48344417|NCT04108429|101172331|FG000|STARTED|Overall Study||117||
48344418|NCT04108429|101172331|FG000|COMPLETED|Overall Study||117||
48344419|NCT04108429|101172331|FG000|NOT COMPLETED|Overall Study||0||
48344420|NCT03037281|101172332|FG000|STARTED|Overall Study||6||
48344421|NCT03037281|101172333|FG001|STARTED|Overall Study||8||
48344422|NCT03037281|101172332|FG000|COMPLETED|Overall Study||6||
48344423|NCT03037281|101172333|FG001|COMPLETED|Overall Study||8||
48344424|NCT03037281|101172332|FG000|NOT COMPLETED|Overall Study||0||
48344425|NCT03037281|101172333|FG001|NOT COMPLETED|Overall Study||0||
48344426|NCT01510327|101172334|FG000|STARTED|Overall Study||22||
48344427|NCT01510327|101172334|FG000|COMPLETED|Overall Study||22||
48344428|NCT01510327|101172334|FG000|NOT COMPLETED|Overall Study||0||
48344429|NCT01553149|101172335|FG000|STARTED|Overall Study||37||
48344430|NCT01553149|101172336|FG001|STARTED|Overall Study||38||
48344431|NCT01553149|101172335|FG000|COMPLETED|Overall Study||32||
48344432|NCT01553149|101172336|FG001|COMPLETED|Overall Study||18||
48344433|NCT01553149|101172335|FG000|NOT COMPLETED|Overall Study||5||
48344434|NCT01553149|101172336|FG001|NOT COMPLETED|Overall Study||20||
48344435|NCT01815957|101172337|FG000|STARTED|Overall Study||7||
48344436|NCT01815957|101172337|FG000|COMPLETED|Overall Study||0||
48344437|NCT01815957|101172337|FG000|NOT COMPLETED|Overall Study||7||
48344438|NCT00702143|101172338|FG000|STARTED|Overall Study||45||
48344439|NCT00702143|101172339|FG001|STARTED|Overall Study||60||
48344440|NCT00702143|101172340|FG002|STARTED|Overall Study||79||
48344441|NCT00702143|101172338|FG000|COMPLETED|Overall Study||45||
48344442|NCT00702143|101172339|FG001|COMPLETED|Overall Study||60||
48344443|NCT00702143|101172340|FG002|COMPLETED|Overall Study||78||
48344444|NCT00702143|101172338|FG000|NOT COMPLETED|Overall Study||0||
48344445|NCT00702143|101172339|FG001|NOT COMPLETED|Overall Study||0||
48344446|NCT00702143|101172340|FG002|NOT COMPLETED|Overall Study||1||
48344447|NCT03056443|101172341|FG000|STARTED|Overall Study||13||
48344448|NCT03056443|101172341|FG000|COMPLETED|Overall Study||13||
48344449|NCT03056443|101172341|FG000|NOT COMPLETED|Overall Study||0||
48344450|NCT02991599|101172342|FG000|STARTED|Overall Study||98||
48344451|NCT02991599|101172343|FG001|STARTED|Overall Study||98||
48344452|NCT02991599|101172342|FG000|COMPLETED|Overall Study||60||
48344453|NCT02991599|101172343|FG001|COMPLETED|Overall Study||61||
48344454|NCT02991599|101172342|FG000|NOT COMPLETED|Overall Study||38||
48344455|NCT02991599|101172343|FG001|NOT COMPLETED|Overall Study||37||
48344456|NCT01676831|101172344|FG000|STARTED|Overall Study||8||
48344457|NCT01676831|101172345|FG001|STARTED|Overall Study||5||
48344458|NCT01676831|101172344|FG000|COMPLETED|Overall Study||8||
48344459|NCT01676831|101172345|FG001|COMPLETED|Overall Study||4||
48344460|NCT01676831|101172344|FG000|NOT COMPLETED|Overall Study||0||
48344461|NCT01676831|101172345|FG001|NOT COMPLETED|Overall Study||1||
48344462|NCT02737163|101172346|FG000|STARTED|Overall Study||95||
48344463|NCT02737163|101172346|FG000|COMPLETED|Overall Study||95||
48758105|NCT01414634|102194479|FG002|NOT COMPLETED|Overall Study||0||
48758106|NCT01414634|102194480|FG003|NOT COMPLETED|Overall Study||0||
48758107|NCT01414634|102194481|FG004|NOT COMPLETED|Overall Study||0||
48758108|NCT01414634|102194482|FG005|NOT COMPLETED|Overall Study||0||
48758109|NCT01414634|102194483|FG006|NOT COMPLETED|Overall Study||0||
48183530|NCT01871285|100772222|FG001|STARTED|First Intervention (1 Day)||15||
48183531|NCT01871285|100772223|FG002|STARTED|First Intervention (1 Day)||4||
48183532|NCT01871285|100772224|FG003|STARTED|First Intervention (1 Day)||2||
48183533|NCT01871285|100772221|FG000|COMPLETED|First Intervention (1 Day)||17||
48183534|NCT01871285|100772222|FG001|COMPLETED|First Intervention (1 Day)||14||
48183535|NCT01871285|100772223|FG002|COMPLETED|First Intervention (1 Day)||3||
48183536|NCT01871285|100772224|FG003|COMPLETED|First Intervention (1 Day)||2||
48183537|NCT01871285|100772221|FG000|NOT COMPLETED|First Intervention (1 Day)||1||
48344464|NCT02737163|101172346|FG000|NOT COMPLETED|Overall Study||0||
48344465|NCT02304926|101172347|FG000|STARTED|Overall Study||22||
48344466|NCT02304926|101172348|FG001|STARTED|Overall Study||20||
48344467|NCT02304926|101172347|FG000|COMPLETED|Overall Study||20||
48414620|NCT01320033|101350104|FG002|STARTED|Overall Study||222||
48344468|NCT02304926|101172348|FG001|COMPLETED|Overall Study||19||
48344469|NCT02304926|101172347|FG000|NOT COMPLETED|Overall Study||2||
48344470|NCT02304926|101172348|FG001|NOT COMPLETED|Overall Study||1||
48344471|NCT04343651|101172349|FG000|STARTED|Overall Study||29||
48344472|NCT04343651|101172350|FG001|STARTED|Overall Study||57||
48344473|NCT04343651|101172349|FG000|COMPLETED|Overall Study||17||
48344474|NCT04343651|101172350|FG001|COMPLETED|Overall Study||33||
48344475|NCT04343651|101172349|FG000|NOT COMPLETED|Overall Study||12||
48344476|NCT04343651|101172350|FG001|NOT COMPLETED|Overall Study||24||
48344477|NCT03054363|101172351|FG000|STARTED|Overall Study||20||
48344478|NCT03054363|101172352|FG001|STARTED|Overall Study||22||
48183538|NCT01871285|100772222|FG001|NOT COMPLETED|First Intervention (1 Day)||1||
48183539|NCT01871285|100772223|FG002|NOT COMPLETED|First Intervention (1 Day)||1||
48183540|NCT01871285|100772224|FG003|NOT COMPLETED|First Intervention (1 Day)||0||
48344479|NCT03054363|101172351|FG000|COMPLETED|Overall Study||20||
48344480|NCT03054363|101172352|FG001|COMPLETED|Overall Study||22||
48344481|NCT03054363|101172351|FG000|NOT COMPLETED|Overall Study||0||
48183541|NCT01871285|100772221|FG000|STARTED|Second Intervention (1 Day)||17||
48183542|NCT01871285|100772222|FG001|STARTED|Second Intervention (1 Day)||14||
48183543|NCT01871285|100772223|FG002|STARTED|Second Intervention (1 Day)||3||
48758110|NCT01414634|102194484|FG007|NOT COMPLETED|Overall Study||0||
48758111|NCT05126563|102194485|FG000|STARTED|Overall Study||39||
48758112|NCT05126563|102194486|FG001|STARTED|Overall Study||40||
48758113|NCT05126563|102194485|FG000|COMPLETED|Overall Study||34||
48758114|NCT05126563|102194486|FG001|COMPLETED|Overall Study||30||
48758115|NCT05126563|102194485|FG000|NOT COMPLETED|Overall Study||5||
48758116|NCT05126563|102194486|FG001|NOT COMPLETED|Overall Study||10||
48758117|NCT00667628|102194487|FG000|STARTED|Overall Study||25||
48758118|NCT00667628|102194488|FG001|STARTED|Overall Study||27||
48183544|NCT01871285|100772224|FG003|STARTED|Second Intervention (1 Day)||2||
48183545|NCT01871285|100772221|FG000|COMPLETED|Second Intervention (1 Day)||17||
48183546|NCT01871285|100772222|FG001|COMPLETED|Second Intervention (1 Day)||14||
48183547|NCT01871285|100772223|FG002|COMPLETED|Second Intervention (1 Day)||3||
48183548|NCT01871285|100772224|FG003|COMPLETED|Second Intervention (1 Day)||2||
48183549|NCT01871285|100772221|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48183550|NCT01871285|100772222|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48183551|NCT01871285|100772223|FG002|NOT COMPLETED|Second Intervention (1 Day)||0||
48183552|NCT01871285|100772224|FG003|NOT COMPLETED|Second Intervention (1 Day)||0||
48183553|NCT00647348|100772225|FG000|STARTED|Overall Study||70||
48183554|NCT00647348|100772226|FG001|STARTED|Overall Study||70||
48183555|NCT00647348|100772225|FG000|COMPLETED|Overall Study||67||
48183556|NCT00647348|100772226|FG001|COMPLETED|Overall Study||64||
48183557|NCT00647348|100772225|FG000|NOT COMPLETED|Overall Study||3||
48183558|NCT00647348|100772226|FG001|NOT COMPLETED|Overall Study||6||
48183559|NCT00329719|100772227|FG000|STARTED|Overall Study||12||
48758119|NCT00667628|102194487|FG000|COMPLETED|Overall Study||0||
48758120|NCT00667628|102194488|FG001|COMPLETED|Overall Study||0||
48758121|NCT00667628|102194487|FG000|NOT COMPLETED|Overall Study||25||
48758122|NCT00667628|102194488|FG001|NOT COMPLETED|Overall Study||27||
48183560|NCT00329719|100772228|FG001|STARTED|Overall Study||49||
48183561|NCT00329719|100772229|FG002|STARTED|Overall Study||9||
48183562|NCT00329719|100772230|FG003|STARTED|Overall Study||45||
48183563|NCT00329719|100772227|FG000|COMPLETED|Overall Study||12||
48183564|NCT00329719|100772228|FG001|COMPLETED|Overall Study||49||
48183565|NCT00329719|100772229|FG002|COMPLETED|Overall Study||9||
48758123|NCT00060528|102194489|FG000|STARTED|Overall Study||8||
48758124|NCT00060528|102194490|FG001|STARTED|Overall Study||9||
48758125|NCT00060528|102194491|FG002|STARTED|Overall Study||7||
48758126|NCT00060528|102194492|FG003|STARTED|Overall Study||8||
48758127|NCT00060528|102194489|FG000|COMPLETED|Overall Study||8||
48183566|NCT00329719|100772230|FG003|COMPLETED|Overall Study||44||
48344482|NCT03054363|101172352|FG001|NOT COMPLETED|Overall Study||0||
48344483|NCT05499520|101172353|FG000|STARTED|Overall Study||210||
48183567|NCT00329719|100772227|FG000|NOT COMPLETED|Overall Study||0||
48344484|NCT05499520|101172354|FG001|STARTED|Overall Study||103||
48758128|NCT00060528|102194490|FG001|COMPLETED|Overall Study||9||
48758129|NCT00060528|102194491|FG002|COMPLETED|Overall Study||7||
48758130|NCT00060528|102194492|FG003|COMPLETED|Overall Study||8||
48183568|NCT00329719|100772228|FG001|NOT COMPLETED|Overall Study||0||
48183569|NCT00329719|100772229|FG002|NOT COMPLETED|Overall Study||0||
48183570|NCT00329719|100772230|FG003|NOT COMPLETED|Overall Study||1||
48183571|NCT01852955|100772231|FG000|STARTED|Overall Study||35||
48758131|NCT00060528|102194489|FG000|NOT COMPLETED|Overall Study||0||
48758132|NCT00060528|102194490|FG001|NOT COMPLETED|Overall Study||0||
48758133|NCT00060528|102194491|FG002|NOT COMPLETED|Overall Study||0||
48758134|NCT00060528|102194492|FG003|NOT COMPLETED|Overall Study||0||
48758135|NCT00119847|102194493|FG000|STARTED|Overall Study||149||
48758136|NCT00119847|102194494|FG001|STARTED|Overall Study||151||
48758137|NCT00119847|102194493|FG000|COMPLETED|Overall Study||118||
48758138|NCT00119847|102194494|FG001|COMPLETED|Overall Study||119||
48183572|NCT01852955|100772232|FG001|STARTED|Overall Study||35||
48183573|NCT01852955|100772231|FG000|COMPLETED|Overall Study||33||
48758139|NCT00119847|102194493|FG000|NOT COMPLETED|Overall Study||31||
48758140|NCT00119847|102194494|FG001|NOT COMPLETED|Overall Study||32||
48758141|NCT00644423|102194495|FG000|STARTED|Overall Study||6||
48758142|NCT00644423|102194496|FG001|STARTED|Overall Study||5||
48758143|NCT00644423|102194495|FG000|COMPLETED|Overall Study||5||
48758144|NCT00644423|102194496|FG001|COMPLETED|Overall Study||4||
48183574|NCT01852955|100772232|FG001|COMPLETED|Overall Study||32||
48758145|NCT00644423|102194495|FG000|NOT COMPLETED|Overall Study||1||
48758146|NCT00644423|102194496|FG001|NOT COMPLETED|Overall Study||1||
48758147|NCT01383928|102194497|FG000|STARTED|Overall Study||7||
48758148|NCT01383928|102194498|FG001|STARTED|Overall Study||7||
48758149|NCT01383928|102194499|FG002|STARTED|Overall Study||50||
48758150|NCT01383928|102194497|FG000|COMPLETED|Overall Study||2|Completed=participants who completed 16 cycles per protocol and entered Maintenance phase.|
48758151|NCT01383928|102194498|FG001|COMPLETED|Overall Study||0|Completed=participants who completed 16 cycles per protocol and entered Maintenance phase.|
48758152|NCT01383928|102194499|FG002|COMPLETED|Overall Study||10|Completed=participants who completed 16 cycles per protocol and entered Maintenance phase.|
48758153|NCT01383928|102194497|FG000|NOT COMPLETED|Overall Study||5||
48758154|NCT01383928|102194498|FG001|NOT COMPLETED|Overall Study||7||
48758155|NCT01383928|102194499|FG002|NOT COMPLETED|Overall Study||40||
48758156|NCT05552027|102194500|FG000|STARTED|Overall Study||46||
48758157|NCT05552027|102194501|FG001|STARTED|Overall Study||46||
48758158|NCT05552027|102194500|FG000|COMPLETED|Overall Study||46||
48758159|NCT05552027|102194501|FG001|COMPLETED|Overall Study||46||
48758160|NCT05552027|102194500|FG000|NOT COMPLETED|Overall Study||0||
48758161|NCT05552027|102194501|FG001|NOT COMPLETED|Overall Study||0||
48758162|NCT04484961|102194502|FG000|STARTED|Overall Study||24||
48758163|NCT04484961|102194503|FG001|STARTED|Overall Study||26||
48758164|NCT04484961|102194502|FG000|COMPLETED|Overall Study||15||
48758165|NCT04484961|102194503|FG001|COMPLETED|Overall Study||17||
48758166|NCT04484961|102194502|FG000|NOT COMPLETED|Overall Study||9||
48758167|NCT04484961|102194503|FG001|NOT COMPLETED|Overall Study||9||
48758168|NCT03379818|102197585|FG000|STARTED|Overall Study||12||
48758169|NCT03379818|102197586|FG001|STARTED|Overall Study||14||
48183575|NCT01852955|100772231|FG000|NOT COMPLETED|Overall Study||2||
48183576|NCT01852955|100772232|FG001|NOT COMPLETED|Overall Study||3||
48183577|NCT01625910|100772233|FG000|STARTED|Overall Study||35||
48183578|NCT01625910|100772234|FG001|STARTED|Overall Study||37||
48183579|NCT01625910|100772233|FG000|COMPLETED|Overall Study||32||
48183580|NCT01625910|100772234|FG001|COMPLETED|Overall Study||33||
48183581|NCT01625910|100772233|FG000|NOT COMPLETED|Overall Study||3||
48183582|NCT01625910|100772234|FG001|NOT COMPLETED|Overall Study||4||
48183583|NCT01813422|100772235|FG000|STARTED|Overall Study||486||
48183584|NCT01813422|100772236|FG001|STARTED|Overall Study||484||
48183585|NCT01813422|100772235|FG000|Received Treatment|Overall Study||484||
48183586|NCT01813422|100772236|FG001|Received Treatment|Overall Study||484||
48344485|NCT05499520|101172355|FG002|STARTED|Overall Study||113||
48344486|NCT05499520|101172356|FG003|STARTED|Overall Study||107||
48344487|NCT05499520|101172357|FG004|STARTED|Overall Study||110||
48183587|NCT01813422|100772235|FG000|COMPLETED|Overall Study||466||
48758170|NCT03379818|102197585|FG000|COMPLETED|Overall Study||7||
48758171|NCT03379818|102197586|FG001|COMPLETED|Overall Study||7||
48758172|NCT03379818|102197585|FG000|NOT COMPLETED|Overall Study||5||
48758173|NCT03379818|102197586|FG001|NOT COMPLETED|Overall Study||7||
48758174|NCT04757766|102197587|FG000|STARTED|Overall Study||349||
48758175|NCT04757766|102197587|FG000|COMPLETED|Overall Study||349||
48758176|NCT04757766|102197587|FG000|NOT COMPLETED|Overall Study||0||
48758177|NCT01751061|102197588|FG000|STARTED|Overall Study||210||
48183588|NCT01813422|100772236|FG001|COMPLETED|Overall Study||468||
48183589|NCT01813422|100772235|FG000|NOT COMPLETED|Overall Study||20||
48183590|NCT01813422|100772236|FG001|NOT COMPLETED|Overall Study||16||
48183591|NCT03342911|100772237|FG000|STARTED|Overall Study||34||
48758178|NCT01751061|102197589|FG001|STARTED|Overall Study||206||
48758179|NCT01751061|102197588|FG000|COMPLETED|Overall Study||154||
48758180|NCT01751061|102197589|FG001|COMPLETED|Overall Study||172||
48758181|NCT01751061|102197588|FG000|NOT COMPLETED|Overall Study||56||
48758182|NCT01751061|102197589|FG001|NOT COMPLETED|Overall Study||34||
48758183|NCT03379675|102197590|FG000|STARTED|Overall Study||24||
48183592|NCT03342911|100772237|FG000|COMPLETED|Overall Study||30||
48758184|NCT03379675|102197591|FG001|STARTED|Overall Study||24||
48758185|NCT03379675|102197592|FG002|STARTED|Overall Study||24||
48344488|NCT05499520|101172358|FG005|STARTED|Overall Study||107||
48344489|NCT05499520|101172359|FG006|STARTED|Overall Study||112||
48344490|NCT05499520|101172360|FG007|STARTED|Overall Study||106||
48344491|NCT05499520|101172361|FG008|STARTED|Overall Study||107||
48344492|NCT05499520|101172362|FG009|STARTED|Overall Study||305||
48344493|NCT05499520|101172363|FG010|STARTED|Overall Study||155||
48344494|NCT05499520|101172364|FG011|STARTED|Overall Study||146||
48414621|NCT01320033|101350102|FG000|COMPLETED|Overall Study||158||
48414622|NCT01320033|101350103|FG001|COMPLETED|Overall Study||160||
48414623|NCT01320033|101350104|FG002|COMPLETED|Overall Study||169||
48414624|NCT01320033|101350102|FG000|NOT COMPLETED|Overall Study||58||
48414625|NCT01320033|101350103|FG001|NOT COMPLETED|Overall Study||64||
48635076|NCT02587936|101891766|FG000|STARTED|Overall Study||9730||71
48635077|NCT02587936|101891767|FG001|STARTED|Overall Study||8538||70
48635078|NCT02587936|101891766|FG000|COMPLETED|Overall Study||5508||71
48635079|NCT02587936|101891767|FG001|COMPLETED|Overall Study||5492||70
48635080|NCT02587936|101891766|FG000|NOT COMPLETED|Overall Study||4222||0
48635081|NCT02587936|101891767|FG001|NOT COMPLETED|Overall Study||3046||0
48635082|NCT02357459|101891768|FG000|STARTED|Overall Study||161||
48635083|NCT02357459|101891769|FG001|STARTED|Overall Study||163||
48635084|NCT02357459|101891770|FG002|STARTED|Overall Study||162||
48635085|NCT02357459|101891768|FG000|COMPLETED|Overall Study||144||
48635086|NCT02357459|101891769|FG001|COMPLETED|Overall Study||149||
48635087|NCT02357459|101891770|FG002|COMPLETED|Overall Study||150||
48635088|NCT02357459|101891768|FG000|NOT COMPLETED|Overall Study||17||
48635089|NCT02357459|101891769|FG001|NOT COMPLETED|Overall Study||14||
48635090|NCT02357459|101891770|FG002|NOT COMPLETED|Overall Study||12||
48635091|NCT00753519|101891771|FG000|STARTED|Overall Study||13||
48635092|NCT00753519|101891772|FG001|STARTED|Overall Study||15||
48635093|NCT00753519|101891771|FG000|COMPLETED|Overall Study||13||
48635094|NCT00753519|101891772|FG001|COMPLETED|Overall Study||13||
48635095|NCT00753519|101891771|FG000|NOT COMPLETED|Overall Study||0||
48635096|NCT00753519|101891772|FG001|NOT COMPLETED|Overall Study||2||
48635097|NCT02369653|101891773|FG000|STARTED|Overall Study||256||
48758186|NCT03379675|102197590|FG000|COMPLETED|Overall Study||20||
48758187|NCT03379675|102197591|FG001|COMPLETED|Overall Study||22||
48758188|NCT03379675|102197592|FG002|COMPLETED|Overall Study||22||
48758189|NCT03379675|102197590|FG000|NOT COMPLETED|Overall Study||4||
48758190|NCT03379675|102197591|FG001|NOT COMPLETED|Overall Study||2||
48758191|NCT03379675|102197592|FG002|NOT COMPLETED|Overall Study||2||
48758192|NCT03485924|102197593|FG000|STARTED|Overall Study||23||
48758193|NCT03485924|102197594|FG001|STARTED|Overall Study||17||
48758194|NCT03485924|102197593|FG000|COMPLETED|Overall Study||23||
48758195|NCT03485924|102197594|FG001|COMPLETED|Overall Study||17||
48758196|NCT03485924|102197593|FG000|NOT COMPLETED|Overall Study||0||
48758197|NCT03485924|102197594|FG001|NOT COMPLETED|Overall Study||0||
48758198|NCT04026113|102197595|FG000|STARTED|Double-Blind Treatment Period (12 Weeks)||164|Randomized|
48758199|NCT04026113|102197596|FG001|STARTED|Double-Blind Treatment Period (12 Weeks)||166|Randomized|
48758200|NCT04026113|102197597|FG002|STARTED|Double-Blind Treatment Period (12 Weeks)||55|Randomized|
48758201|NCT04026113|102197598|FG003|STARTED|Double-Blind Treatment Period (12 Weeks)||53|Randomized|
48758202|NCT04026113|102197595|FG000|Randomized and Treated|Double-Blind Treatment Period (12 Weeks)||164||
48758203|NCT04026113|102197596|FG001|Randomized and Treated|Double-Blind Treatment Period (12 Weeks)||164||
48758204|NCT04026113|102197597|FG002|Randomized and Treated|Double-Blind Treatment Period (12 Weeks)||55||
48758205|NCT04026113|102197598|FG003|Randomized and Treated|Double-Blind Treatment Period (12 Weeks)||53||
48758206|NCT04026113|102197595|FG000|COMPLETED|Double-Blind Treatment Period (12 Weeks)||145||
48758207|NCT04026113|102197596|FG001|COMPLETED|Double-Blind Treatment Period (12 Weeks)||148||
48758208|NCT04026113|102197597|FG002|COMPLETED|Double-Blind Treatment Period (12 Weeks)||52||
48758209|NCT04026113|102197598|FG003|COMPLETED|Double-Blind Treatment Period (12 Weeks)||46||
48758210|NCT04026113|102197595|FG000|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||19||
48758211|NCT04026113|102197596|FG001|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||18||
48758212|NCT04026113|102197597|FG002|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||3||
48758213|NCT04026113|102197598|FG003|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||7||
48758214|NCT04026113|102197595|FG000|STARTED|Post-Intervention Period (1 Week)||66||
48758215|NCT04026113|102197596|FG001|STARTED|Post-Intervention Period (1 Week)||75||
48758216|NCT04026113|102197597|FG002|STARTED|Post-Intervention Period (1 Week)||20||
48758217|NCT04026113|102197598|FG003|STARTED|Post-Intervention Period (1 Week)||20||
48758218|NCT04026113|102197595|FG000|COMPLETED|Post-Intervention Period (1 Week)||65||
48758219|NCT04026113|102197596|FG001|COMPLETED|Post-Intervention Period (1 Week)||75||
48758220|NCT04026113|102197597|FG002|COMPLETED|Post-Intervention Period (1 Week)||19||
48758221|NCT04026113|102197598|FG003|COMPLETED|Post-Intervention Period (1 Week)||20||
48344495|NCT05499520|101172365|FG012|STARTED|Overall Study||150||
48344496|NCT05499520|101172366|FG013|STARTED|Overall Study||156||
48344497|NCT05499520|101172367|FG014|STARTED|Overall Study||146||
48344498|NCT05499520|101172368|FG015|STARTED|Overall Study||154||
48414626|NCT01320033|101350104|FG002|NOT COMPLETED|Overall Study||53||
48344499|NCT05499520|101172369|FG016|STARTED|Overall Study||150||
48635098|NCT02369653|101891774|FG001|STARTED|Overall Study||256||
48635099|NCT02369653|101891773|FG000|Adverse Event Analysis Population|Overall Study||250||
48635100|NCT02369653|101891774|FG001|Adverse Event Analysis Population|Overall Study||262||
48635101|NCT02369653|101891773|FG000|COMPLETED|Overall Study||242||
48635102|NCT02369653|101891774|FG001|COMPLETED|Overall Study||249||
48635103|NCT02369653|101891773|FG000|NOT COMPLETED|Overall Study||14||
48635104|NCT02369653|101891774|FG001|NOT COMPLETED|Overall Study||7||
48635105|NCT01566370|101891775|FG000|STARTED|Overall Study||2||
48635106|NCT01566370|101891776|FG001|STARTED|Overall Study||1||
48635107|NCT01566370|101891775|FG000|COMPLETED|Overall Study||0||
48635108|NCT01566370|101891776|FG001|COMPLETED|Overall Study||0||
48635109|NCT01566370|101891775|FG000|NOT COMPLETED|Overall Study||2||
48635110|NCT01566370|101891776|FG001|NOT COMPLETED|Overall Study||1||
48635111|NCT01787838|101891777|FG000|STARTED|Overall Study||2509||
48758222|NCT04026113|102197595|FG000|NOT COMPLETED|Post-Intervention Period (1 Week)||1||
48758223|NCT04026113|102197596|FG001|NOT COMPLETED|Post-Intervention Period (1 Week)||0||
48344500|NCT05499520|101172370|FG017|STARTED|Overall Study||154||
48344501|NCT05499520|101172353|FG000|COMPLETED|Overall Study||210||
48344502|NCT05499520|101172354|FG001|COMPLETED|Overall Study||103||
48344503|NCT05499520|101172355|FG002|COMPLETED|Overall Study||75||
48344504|NCT05499520|101172356|FG003|COMPLETED|Overall Study||66||
48758224|NCT04026113|102197597|FG002|NOT COMPLETED|Post-Intervention Period (1 Week)||1||
48758225|NCT04026113|102197598|FG003|NOT COMPLETED|Post-Intervention Period (1 Week)||0||
48758226|NCT01451606|102197599|FG000|STARTED|Overall Study||16||
48758227|NCT01451606|102197600|FG001|STARTED|Overall Study||18||
48758228|NCT01451606|102197599|FG000|COMPLETED|Overall Study||12||
48758229|NCT01451606|102197600|FG001|COMPLETED|Overall Study||15||
48758230|NCT01451606|102197599|FG000|NOT COMPLETED|Overall Study||4||
48758231|NCT01451606|102197600|FG001|NOT COMPLETED|Overall Study||3||
48758232|NCT00322855|102197601|FG000|STARTED|Overall Study||1||
48758233|NCT00322855|102197601|FG000|COMPLETED|Overall Study||1||
48758234|NCT00322855|102197601|FG000|NOT COMPLETED|Overall Study||0||
48758235|NCT03041038|102197602|FG000|STARTED|Overall Study||11||
48758236|NCT03041038|102197603|FG001|STARTED|Overall Study||9||
48758237|NCT03041038|102197602|FG000|Week 16|Overall Study||10||
48758238|NCT03041038|102197603|FG001|Week 16|Overall Study||8||
48758239|NCT03041038|102197602|FG000|Week 32|Overall Study||9||
48758240|NCT03041038|102197603|FG001|Week 32|Overall Study||8||
48758241|NCT03041038|102197602|FG000|COMPLETED|Overall Study||5||
48758242|NCT03041038|102197603|FG001|COMPLETED|Overall Study||7||
48758243|NCT03041038|102197602|FG000|NOT COMPLETED|Overall Study||6||
48758244|NCT03041038|102197603|FG001|NOT COMPLETED|Overall Study||2||
48758245|NCT04529083|102197604|FG000|STARTED|Overall Study||11||
48758246|NCT04529083|102197604|FG000|COMPLETED|Overall Study||8||
48758247|NCT04529083|102197604|FG000|NOT COMPLETED|Overall Study||3||
48758248|NCT03497676|102197605|FG000|STARTED|Cohort 1 Treatment Initiation to Week 16||30||
48758249|NCT03497676|102197606|FG001|STARTED|Cohort 1 Treatment Initiation to Week 16||25||
48758250|NCT03497676|102197607|FG002|STARTED|Cohort 1 Treatment Initiation to Week 16||0||
48758251|NCT03497676|102197608|FG003|STARTED|Cohort 1 Treatment Initiation to Week 16||0||
48758252|NCT03497676|102197605|FG000|COMPLETED|Cohort 1 Treatment Initiation to Week 16||29||
48758253|NCT03497676|102197606|FG001|COMPLETED|Cohort 1 Treatment Initiation to Week 16||23||
48758254|NCT03497676|102197607|FG002|COMPLETED|Cohort 1 Treatment Initiation to Week 16||0||
48758255|NCT03497676|102197608|FG003|COMPLETED|Cohort 1 Treatment Initiation to Week 16||0||
48758256|NCT03497676|102197605|FG000|NOT COMPLETED|Cohort 1 Treatment Initiation to Week 16||1||
48758257|NCT03497676|102197606|FG001|NOT COMPLETED|Cohort 1 Treatment Initiation to Week 16||2||
48758258|NCT03497676|102197607|FG002|NOT COMPLETED|Cohort 1 Treatment Initiation to Week 16||0||
48758259|NCT03497676|102197608|FG003|NOT COMPLETED|Cohort 1 Treatment Initiation to Week 16||0||
48758260|NCT03497676|102197605|FG000|STARTED|Cohort 1 Week 16 Through End of Cohort 1||29||
48758261|NCT03497676|102197606|FG001|STARTED|Cohort 1 Week 16 Through End of Cohort 1||23||
48758262|NCT03497676|102197607|FG002|STARTED|Cohort 1 Week 16 Through End of Cohort 1||0||
48758263|NCT03497676|102197608|FG003|STARTED|Cohort 1 Week 16 Through End of Cohort 1||0||
48758264|NCT03497676|102197605|FG000|COMPLETED|Cohort 1 Week 16 Through End of Cohort 1||28||
48758265|NCT03497676|102197606|FG001|COMPLETED|Cohort 1 Week 16 Through End of Cohort 1||21||
48758266|NCT03497676|102197607|FG002|COMPLETED|Cohort 1 Week 16 Through End of Cohort 1||0||
48758267|NCT03497676|102197608|FG003|COMPLETED|Cohort 1 Week 16 Through End of Cohort 1||0||
48758268|NCT03497676|102197605|FG000|NOT COMPLETED|Cohort 1 Week 16 Through End of Cohort 1||1||
48758269|NCT03497676|102197606|FG001|NOT COMPLETED|Cohort 1 Week 16 Through End of Cohort 1||2||
48758270|NCT03497676|102197607|FG002|NOT COMPLETED|Cohort 1 Week 16 Through End of Cohort 1||0||
48758271|NCT03497676|102197608|FG003|NOT COMPLETED|Cohort 1 Week 16 Through End of Cohort 1||0||
48758272|NCT03497676|102197605|FG000|STARTED|Cohort 2 Treatment Initiation to Week 24||0||
48758273|NCT03497676|102197606|FG001|STARTED|Cohort 2 Treatment Initiation to Week 24||0||
48758274|NCT03497676|102197607|FG002|STARTED|Cohort 2 Treatment Initiation to Week 24||144||
48758275|NCT03497676|102197608|FG003|STARTED|Cohort 2 Treatment Initiation to Week 24||0||
48758276|NCT03497676|102197605|FG000|COMPLETED|Cohort 2 Treatment Initiation to Week 24||0||
48758277|NCT03497676|102197606|FG001|COMPLETED|Cohort 2 Treatment Initiation to Week 24||0||
48767754|NCT04004988|102222819|FG001|COMPLETED|Period 1||20||
48344505|NCT05499520|101172357|FG004|COMPLETED|Overall Study||64||
48758278|NCT03497676|102197607|FG002|COMPLETED|Cohort 2 Treatment Initiation to Week 24||141||
48758279|NCT03497676|102197608|FG003|COMPLETED|Cohort 2 Treatment Initiation to Week 24||0||
48758280|NCT03497676|102197605|FG000|NOT COMPLETED|Cohort 2 Treatment Initiation to Week 24||0||
48758281|NCT03497676|102197606|FG001|NOT COMPLETED|Cohort 2 Treatment Initiation to Week 24||0||
48635112|NCT01787838|101891777|FG000|COMPLETED|Overall Study||1096||
48635113|NCT01787838|101891777|FG000|NOT COMPLETED|Overall Study||1413||
48635114|NCT01189266|101891778|FG000|STARTED|Overall Study||6||
48758282|NCT03497676|102197607|FG002|NOT COMPLETED|Cohort 2 Treatment Initiation to Week 24||3||
48758283|NCT03497676|102197608|FG003|NOT COMPLETED|Cohort 2 Treatment Initiation to Week 24||0||
48183593|NCT03342911|100772237|FG000|NOT COMPLETED|Overall Study||4||
48183594|NCT01925170|100772238|FG000|STARTED|Overall Study||1638||
48183595|NCT01925170|100772238|FG000|COMPLETED|Overall Study||1585||
48183596|NCT01925170|100772238|FG000|NOT COMPLETED|Overall Study||53||
48183597|NCT01646320|100772239|FG000|STARTED|Short-term Period (Day 1 to Week 24)||160||
48183598|NCT01646320|100772240|FG001|STARTED|Short-term Period (Day 1 to Week 24)||160||
48183599|NCT01646320|100772239|FG000|COMPLETED|Short-term Period (Day 1 to Week 24)||148||
48183600|NCT01646320|100772240|FG001|COMPLETED|Short-term Period (Day 1 to Week 24)||153||
48183601|NCT01646320|100772239|FG000|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||12||
48183602|NCT01646320|100772240|FG001|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||7||
48183603|NCT01646320|100772239|FG000|STARTED|Long-term Period (Weeks 24 to 52)||147||
48183604|NCT01646320|100772240|FG001|STARTED|Long-term Period (Weeks 24 to 52)||147||
48183605|NCT01646320|100772239|FG000|COMPLETED|Long-term Period (Weeks 24 to 52)||141||
48183606|NCT01646320|100772240|FG001|COMPLETED|Long-term Period (Weeks 24 to 52)||140||
48183607|NCT01646320|100772239|FG000|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||6||
48183608|NCT01646320|100772240|FG001|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||7||
48183609|NCT01656759|100772241|FG000|STARTED|Overall Study||27||
48183610|NCT01656759|100772242|FG001|STARTED|Overall Study||25||
48183611|NCT01656759|100772241|FG000|COMPLETED|Overall Study||25||
48183612|NCT01656759|100772242|FG001|COMPLETED|Overall Study||22||
48183613|NCT01656759|100772241|FG000|NOT COMPLETED|Overall Study||2||
48183614|NCT01656759|100772242|FG001|NOT COMPLETED|Overall Study||3||
48183615|NCT02018315|100772243|FG000|STARTED|Overall Study||14||
48183616|NCT02018315|100772243|FG000|COMPLETED|Overall Study||14||
48183617|NCT02018315|100772243|FG000|NOT COMPLETED|Overall Study||0||
48183618|NCT03248440|100772244|FG000|STARTED|Overall Study||131||
48183619|NCT03248440|100772245|FG001|STARTED|Overall Study||132||
48183620|NCT03248440|100772244|FG000|COMPLETED|Overall Study||116||
48183621|NCT03248440|100772245|FG001|COMPLETED|Overall Study||120||
48758284|NCT03497676|102197605|FG000|STARTED|Cohort 2 Week 24 to Week 48||0||
48183622|NCT03248440|100772244|FG000|NOT COMPLETED|Overall Study||15||
48183623|NCT03248440|100772245|FG001|NOT COMPLETED|Overall Study||12||
48183624|NCT00372528|100772246|FG000|STARTED|Overall Study||21||
48183625|NCT00372528|100772246|FG000|COMPLETED|Overall Study||0||
48183626|NCT00372528|100772246|FG000|NOT COMPLETED|Overall Study||21||
48183627|NCT00965484|100772247|FG000|STARTED|Overall Study||136||
48183628|NCT00965484|100772247|FG000|COMPLETED|Overall Study||134||
48344506|NCT05499520|101172358|FG005|COMPLETED|Overall Study||107||
48635115|NCT01189266|101891779|FG001|STARTED|Overall Study||6||
48635116|NCT01189266|101891780|FG002|STARTED|Overall Study||67||
48183629|NCT00965484|100772247|FG000|NOT COMPLETED|Overall Study||2||
48183630|NCT02819479|100772248|FG000|STARTED|Overall Study||10||
48183631|NCT02819479|100772248|FG000|COMPLETED|Overall Study||8||
48183632|NCT02819479|100772248|FG000|NOT COMPLETED|Overall Study||2||
48183633|NCT02342314|100772249|FG000|STARTED|Part A||6||
48183634|NCT02342314|100772250|FG001|STARTED|Part A||3||
48183635|NCT02342314|100772251|FG002|STARTED|Part A||3||
48183636|NCT02342314|100772252|FG003|STARTED|Part A||3||
48183637|NCT02342314|100772253|FG004|STARTED|Part A||6||
48183638|NCT02342314|100772254|FG005|STARTED|Part A||3||
48183639|NCT02342314|100772255|FG006|STARTED|Part A||0||
48183640|NCT02342314|100772256|FG007|STARTED|Part A||0||
48183641|NCT02342314|100772257|FG008|STARTED|Part A||0||
48183642|NCT02342314|100772258|FG009|STARTED|Part A||0||
48183643|NCT02342314|100772259|FG010|STARTED|Part A||0||
48183644|NCT02342314|100772260|FG011|STARTED|Part A||0||
48183645|NCT02342314|100772261|FG012|STARTED|Part A||0||
48414627|NCT00783263|101350105|FG000|STARTED|Overall Study||99||
48635117|NCT01189266|101891778|FG000|COMPLETED|Overall Study||0||
48635118|NCT01189266|101891779|FG001|COMPLETED|Overall Study||0||
48635119|NCT01189266|101891780|FG002|COMPLETED|Overall Study||2||
48635120|NCT01189266|101891778|FG000|NOT COMPLETED|Overall Study||6||
48635121|NCT01189266|101891779|FG001|NOT COMPLETED|Overall Study||6||
48635122|NCT01189266|101891780|FG002|NOT COMPLETED|Overall Study||65||
48183646|NCT02342314|100772262|FG013|STARTED|Part A||0||
48183647|NCT02342314|100772263|FG014|STARTED|Part A||0||
48183648|NCT02342314|100772264|FG015|STARTED|Part A||0||
48183649|NCT02342314|100772265|FG016|STARTED|Part A||0||
48183650|NCT02342314|100772249|FG000|COMPLETED|Part A||6||
48183651|NCT02342314|100772250|FG001|COMPLETED|Part A||3||
48183652|NCT02342314|100772251|FG002|COMPLETED|Part A||3||
48183653|NCT02342314|100772252|FG003|COMPLETED|Part A||3||
48414628|NCT00783263|101350106|FG001|STARTED|Overall Study||98||
48635123|NCT03839641|101891781|FG000|STARTED|Overall Study||5||
48414629|NCT00783263|101350107|FG002|STARTED|Overall Study||122||
48414630|NCT00783263|101350108|FG003|STARTED|Overall Study||121||
48414631|NCT00783263|101350105|FG000|COMPLETED|Overall Study||95||
48414632|NCT00783263|101350106|FG001|COMPLETED|Overall Study||96||
48414633|NCT00783263|101350107|FG002|COMPLETED|Overall Study||119||
48414634|NCT00783263|101350108|FG003|COMPLETED|Overall Study||118||
48414635|NCT00783263|101350105|FG000|NOT COMPLETED|Overall Study||4||
48414636|NCT00783263|101350106|FG001|NOT COMPLETED|Overall Study||2||
48414637|NCT00783263|101350107|FG002|NOT COMPLETED|Overall Study||3||
48635124|NCT03839641|101891782|FG001|STARTED|Overall Study||5||
48635125|NCT03839641|101891781|FG000|COMPLETED|Overall Study||4||
48635126|NCT03839641|101891782|FG001|COMPLETED|Overall Study||4||
48635127|NCT03839641|101891781|FG000|NOT COMPLETED|Overall Study||1||
48635128|NCT03839641|101891782|FG001|NOT COMPLETED|Overall Study||1||
48635129|NCT01937299|101891783|FG000|STARTED|Overall Study||117||
48635130|NCT01937299|101891784|FG001|STARTED|Overall Study||116||
48635131|NCT01937299|101891783|FG000|COMPLETED|Overall Study||103||
48635132|NCT01937299|101891784|FG001|COMPLETED|Overall Study||112||
48758285|NCT03497676|102197606|FG001|STARTED|Cohort 2 Week 24 to Week 48||0||
48758286|NCT03497676|102197607|FG002|STARTED|Cohort 2 Week 24 to Week 48||141||
48758287|NCT03497676|102197608|FG003|STARTED|Cohort 2 Week 24 to Week 48||0||
48758288|NCT03497676|102197605|FG000|COMPLETED|Cohort 2 Week 24 to Week 48||0||
48758289|NCT03497676|102197606|FG001|COMPLETED|Cohort 2 Week 24 to Week 48||0||
48758290|NCT03497676|102197607|FG002|COMPLETED|Cohort 2 Week 24 to Week 48||140||
48414638|NCT00783263|101350108|FG003|NOT COMPLETED|Overall Study||3||
48414639|NCT03887286|101350109|FG000|STARTED|Overall Study||47||
48414640|NCT03887286|101350109|FG000|COMPLETED|Overall Study||47||
48414641|NCT03887286|101350109|FG000|NOT COMPLETED|Overall Study||0||
48758291|NCT03497676|102197608|FG003|COMPLETED|Cohort 2 Week 24 to Week 48||0||
48758292|NCT03497676|102197605|FG000|NOT COMPLETED|Cohort 2 Week 24 to Week 48||0||
48758293|NCT03497676|102197606|FG001|NOT COMPLETED|Cohort 2 Week 24 to Week 48||0||
48344507|NCT05499520|101172359|FG006|COMPLETED|Overall Study||81||
48344508|NCT05499520|101172360|FG007|COMPLETED|Overall Study||61||
48344509|NCT05499520|101172361|FG008|COMPLETED|Overall Study||65||
48344510|NCT05499520|101172362|FG009|COMPLETED|Overall Study||305||
48344511|NCT05499520|101172363|FG010|COMPLETED|Overall Study||155||
48344512|NCT05499520|101172364|FG011|COMPLETED|Overall Study||109||
48344513|NCT05499520|101172365|FG012|COMPLETED|Overall Study||97||
48344514|NCT05499520|101172366|FG013|COMPLETED|Overall Study||107||
48344515|NCT05499520|101172367|FG014|COMPLETED|Overall Study||146||
48344516|NCT05499520|101172368|FG015|COMPLETED|Overall Study||118||
48344517|NCT05499520|101172369|FG016|COMPLETED|Overall Study||92||
48344518|NCT05499520|101172370|FG017|COMPLETED|Overall Study||101||
48344519|NCT05499520|101172353|FG000|NOT COMPLETED|Overall Study||0||
48344520|NCT05499520|101172354|FG001|NOT COMPLETED|Overall Study||0||
48344521|NCT05499520|101172355|FG002|NOT COMPLETED|Overall Study||38||
48344522|NCT05499520|101172356|FG003|NOT COMPLETED|Overall Study||41||
48344523|NCT05499520|101172357|FG004|NOT COMPLETED|Overall Study||46||
48344524|NCT05499520|101172358|FG005|NOT COMPLETED|Overall Study||0||
48344525|NCT05499520|101172359|FG006|NOT COMPLETED|Overall Study||31||
48344526|NCT05499520|101172360|FG007|NOT COMPLETED|Overall Study||45||
48344527|NCT05499520|101172361|FG008|NOT COMPLETED|Overall Study||42||
48344528|NCT05499520|101172362|FG009|NOT COMPLETED|Overall Study||0||
48344529|NCT05499520|101172363|FG010|NOT COMPLETED|Overall Study||0||
48344530|NCT05499520|101172364|FG011|NOT COMPLETED|Overall Study||37||
48344531|NCT05499520|101172365|FG012|NOT COMPLETED|Overall Study||53||
48344532|NCT05499520|101172366|FG013|NOT COMPLETED|Overall Study||49||
48414642|NCT00514592|101350110|FG000|STARTED|Overall Study||230||
48414643|NCT00514592|101350110|FG000|COMPLETED|Overall Study||230||
48635133|NCT01937299|101891783|FG000|NOT COMPLETED|Overall Study||14||
48635134|NCT01937299|101891784|FG001|NOT COMPLETED|Overall Study||4||
48635135|NCT01163617|101891785|FG000|STARTED|Phase A (User Experience), Weeks 0 and 2||19||
48635136|NCT01163617|101891786|FG001|STARTED|Phase A (User Experience), Weeks 0 and 2||23||
48635137|NCT01163617|101891787|FG002|STARTED|Phase A (User Experience), Weeks 0 and 2||21||
48758294|NCT03497676|102197607|FG002|NOT COMPLETED|Cohort 2 Week 24 to Week 48||1||
48758295|NCT03497676|102197608|FG003|NOT COMPLETED|Cohort 2 Week 24 to Week 48||0||
48758296|NCT04672239|102197609|FG000|STARTED|Week 2 Survey||80||
48758297|NCT04672239|102197610|FG001|STARTED|Week 2 Survey||75||
48758298|NCT04672239|102197611|FG002|STARTED|Week 2 Survey||71||
48758299|NCT04672239|102197609|FG000|COMPLETED|Week 2 Survey||69||
48758300|NCT04672239|102197610|FG001|COMPLETED|Week 2 Survey||69||
48758301|NCT04672239|102197611|FG002|COMPLETED|Week 2 Survey||59||
48758302|NCT04672239|102197609|FG000|NOT COMPLETED|Week 2 Survey||11||
48758303|NCT04672239|102197610|FG001|NOT COMPLETED|Week 2 Survey||6||
48344533|NCT05499520|101172367|FG014|NOT COMPLETED|Overall Study||0||
48344534|NCT05499520|101172368|FG015|NOT COMPLETED|Overall Study||36||
48344535|NCT05499520|101172369|FG016|NOT COMPLETED|Overall Study||58||
48344536|NCT05499520|101172370|FG017|NOT COMPLETED|Overall Study||53||
48414644|NCT00514592|101350110|FG000|NOT COMPLETED|Overall Study||0||
48414645|NCT00957723|101350111|FG000|STARTED|Overall Study||411||
48414646|NCT00957723|101350111|FG000|COMPLETED|Overall Study||298||
48414647|NCT00957723|101350111|FG000|NOT COMPLETED|Overall Study||113||
48758304|NCT04672239|102197611|FG002|NOT COMPLETED|Week 2 Survey||12||
48414648|NCT00779116|101350112|FG000|STARTED|First Intervention||109||
48414649|NCT00779116|101350113|FG001|STARTED|First Intervention||108||
48414650|NCT00779116|101350112|FG000|COMPLETED|First Intervention||109||
48414651|NCT00779116|101350113|FG001|COMPLETED|First Intervention||108||
48414652|NCT00779116|101350112|FG000|NOT COMPLETED|First Intervention||0||
48414653|NCT00779116|101350113|FG001|NOT COMPLETED|First Intervention||0||
48183654|NCT02342314|100772253|FG004|COMPLETED|Part A||6||
48183655|NCT02342314|100772254|FG005|COMPLETED|Part A||3||
48183656|NCT02342314|100772255|FG006|COMPLETED|Part A||0||
48183657|NCT02342314|100772256|FG007|COMPLETED|Part A||0||
48183658|NCT02342314|100772257|FG008|COMPLETED|Part A||0||
48183659|NCT02342314|100772258|FG009|COMPLETED|Part A||0||
48183660|NCT02342314|100772259|FG010|COMPLETED|Part A||0||
48183661|NCT02342314|100772260|FG011|COMPLETED|Part A||0||
48183662|NCT02342314|100772261|FG012|COMPLETED|Part A||0||
48183663|NCT02342314|100772262|FG013|COMPLETED|Part A||0||
48183664|NCT02342314|100772263|FG014|COMPLETED|Part A||0||
48183665|NCT02342314|100772264|FG015|COMPLETED|Part A||0||
48183666|NCT02342314|100772265|FG016|COMPLETED|Part A||0||
48183667|NCT02342314|100772249|FG000|NOT COMPLETED|Part A||0||
48183668|NCT02342314|100772250|FG001|NOT COMPLETED|Part A||0||
48183669|NCT02342314|100772251|FG002|NOT COMPLETED|Part A||0||
48183670|NCT02342314|100772252|FG003|NOT COMPLETED|Part A||0||
48183671|NCT02342314|100772253|FG004|NOT COMPLETED|Part A||0||
48183672|NCT02342314|100772254|FG005|NOT COMPLETED|Part A||0||
48183673|NCT02342314|100772255|FG006|NOT COMPLETED|Part A||0||
48183674|NCT02342314|100772256|FG007|NOT COMPLETED|Part A||0||
48183675|NCT02342314|100772257|FG008|NOT COMPLETED|Part A||0||
48183676|NCT02342314|100772258|FG009|NOT COMPLETED|Part A||0||
48183677|NCT02342314|100772259|FG010|NOT COMPLETED|Part A||0||
48183678|NCT02342314|100772260|FG011|NOT COMPLETED|Part A||0||
48183679|NCT02342314|100772261|FG012|NOT COMPLETED|Part A||0||
48183680|NCT02342314|100772262|FG013|NOT COMPLETED|Part A||0||
48183681|NCT02342314|100772263|FG014|NOT COMPLETED|Part A||0||
48183682|NCT02342314|100772264|FG015|NOT COMPLETED|Part A||0||
48183683|NCT02342314|100772265|FG016|NOT COMPLETED|Part A||0||
48183684|NCT02342314|100772249|FG000|STARTED|Part B||0||
48183685|NCT02342314|100772250|FG001|STARTED|Part B||0||
48183686|NCT02342314|100772251|FG002|STARTED|Part B||0||
48183687|NCT02342314|100772252|FG003|STARTED|Part B||0||
48183688|NCT02342314|100772253|FG004|STARTED|Part B||0||
48183689|NCT02342314|100772254|FG005|STARTED|Part B||0||
48183690|NCT02342314|100772255|FG006|STARTED|Part B||11||
48183691|NCT02342314|100772256|FG007|STARTED|Part B||3||
48414654|NCT00779116|101350112|FG000|STARTED|Interval Between Doses (8-10 Minutes)||109||
48414655|NCT00779116|101350113|FG001|STARTED|Interval Between Doses (8-10 Minutes)||108||
48635138|NCT01163617|101891788|FG003|STARTED|Phase A (User Experience), Weeks 0 and 2||21||
48635139|NCT01163617|101891789|FG004|STARTED|Phase A (User Experience), Weeks 0 and 2||0||
48635140|NCT01163617|101891790|FG005|STARTED|Phase A (User Experience), Weeks 0 and 2||0||
48635141|NCT01163617|101891791|FG006|STARTED|Phase A (User Experience), Weeks 0 and 2||0||
48635142|NCT01163617|101891792|FG007|STARTED|Phase A (User Experience), Weeks 0 and 2||0||
48183692|NCT02342314|100772257|FG008|STARTED|Part B||3||
48183693|NCT02342314|100772258|FG009|STARTED|Part B||3||
48183694|NCT02342314|100772259|FG010|STARTED|Part B||3||
48183695|NCT02342314|100772260|FG011|STARTED|Part B||3||
48183696|NCT02342314|100772261|FG012|STARTED|Part B||3||
48183697|NCT02342314|100772262|FG013|STARTED|Part B||3||
48183698|NCT02342314|100772263|FG014|STARTED|Part B||3||
48183699|NCT02342314|100772264|FG015|STARTED|Part B||3||
48183700|NCT02342314|100772265|FG016|STARTED|Part B||6||
48183701|NCT02342314|100772249|FG000|COMPLETED|Part B||0||
48183702|NCT02342314|100772250|FG001|COMPLETED|Part B||0||
48183703|NCT02342314|100772251|FG002|COMPLETED|Part B||0||
48183704|NCT02342314|100772252|FG003|COMPLETED|Part B||0||
48183705|NCT02342314|100772253|FG004|COMPLETED|Part B||0||
48183706|NCT02342314|100772254|FG005|COMPLETED|Part B||0||
48183707|NCT02342314|100772255|FG006|COMPLETED|Part B||11||
48183708|NCT02342314|100772256|FG007|COMPLETED|Part B||3||
48183709|NCT02342314|100772257|FG008|COMPLETED|Part B||3||
48183710|NCT02342314|100772258|FG009|COMPLETED|Part B||3||
48183711|NCT02342314|100772259|FG010|COMPLETED|Part B||3||
48635143|NCT01163617|101891785|FG000|COMPLETED|Phase A (User Experience), Weeks 0 and 2||19||
48767755|NCT04004988|102222818|FG000|NOT COMPLETED|Period 1||3||
48183712|NCT02342314|100772260|FG011|COMPLETED|Part B||3||
48183713|NCT02342314|100772261|FG012|COMPLETED|Part B||3||
48183714|NCT02342314|100772262|FG013|COMPLETED|Part B||3||
48183715|NCT02342314|100772263|FG014|COMPLETED|Part B||3||
48183716|NCT02342314|100772264|FG015|COMPLETED|Part B||3||
48183717|NCT02342314|100772265|FG016|COMPLETED|Part B||6||
48183718|NCT02342314|100772249|FG000|NOT COMPLETED|Part B||0||
48183719|NCT02342314|100772250|FG001|NOT COMPLETED|Part B||0||
48183720|NCT02342314|100772251|FG002|NOT COMPLETED|Part B||0||
48183721|NCT02342314|100772252|FG003|NOT COMPLETED|Part B||0||
48183722|NCT02342314|100772253|FG004|NOT COMPLETED|Part B||0||
48183723|NCT02342314|100772254|FG005|NOT COMPLETED|Part B||0||
48183724|NCT02342314|100772255|FG006|NOT COMPLETED|Part B||0||
48183725|NCT02342314|100772256|FG007|NOT COMPLETED|Part B||0||
48183726|NCT02342314|100772257|FG008|NOT COMPLETED|Part B||0||
48183727|NCT02342314|100772258|FG009|NOT COMPLETED|Part B||0||
48183728|NCT02342314|100772259|FG010|NOT COMPLETED|Part B||0||
48635144|NCT01163617|101891786|FG001|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21||
48183729|NCT02342314|100772260|FG011|NOT COMPLETED|Part B||0||
48183730|NCT02342314|100772261|FG012|NOT COMPLETED|Part B||0||
48183731|NCT02342314|100772262|FG013|NOT COMPLETED|Part B||0||
48183732|NCT02342314|100772263|FG014|NOT COMPLETED|Part B||0||
48183733|NCT02342314|100772264|FG015|NOT COMPLETED|Part B||0||
48183734|NCT02342314|100772265|FG016|NOT COMPLETED|Part B||0||
48183735|NCT03285711|100772266|FG000|STARTED|Blinded Phase (Up to Week 16)||4||
48183736|NCT03285711|100772267|FG001|STARTED|Blinded Phase (Up to Week 16)||5||
48183737|NCT03285711|100772268|FG002|STARTED|Blinded Phase (Up to Week 16)||0||
48183738|NCT03285711|100772269|FG003|STARTED|Blinded Phase (Up to Week 16)||0||
48183739|NCT03285711|100772266|FG000|COMPLETED|Blinded Phase (Up to Week 16)||1||
48183740|NCT03285711|100772267|FG001|COMPLETED|Blinded Phase (Up to Week 16)||4||
48183741|NCT03285711|100772268|FG002|COMPLETED|Blinded Phase (Up to Week 16)||0||
48183742|NCT03285711|100772269|FG003|COMPLETED|Blinded Phase (Up to Week 16)||0||
48183743|NCT03285711|100772266|FG000|NOT COMPLETED|Blinded Phase (Up to Week 16)||3||
48183744|NCT03285711|100772267|FG001|NOT COMPLETED|Blinded Phase (Up to Week 16)||1||
48183745|NCT03285711|100772268|FG002|NOT COMPLETED|Blinded Phase (Up to Week 16)||0||
48183746|NCT03285711|100772269|FG003|NOT COMPLETED|Blinded Phase (Up to Week 16)||0||
48183747|NCT03285711|100772266|FG000|STARTED|Blinded Phase (Week 16 to 32)||0||
48183748|NCT03285711|100772267|FG001|STARTED|Blinded Phase (Week 16 to 32)||3||
48183749|NCT03285711|100772268|FG002|STARTED|Blinded Phase (Week 16 to 32)||1||
48183750|NCT03285711|100772269|FG003|STARTED|Blinded Phase (Week 16 to 32)||1||
48183751|NCT03285711|100772266|FG000|COMPLETED|Blinded Phase (Week 16 to 32)||0||
48183752|NCT03285711|100772267|FG001|COMPLETED|Blinded Phase (Week 16 to 32)||3||
48183753|NCT03285711|100772268|FG002|COMPLETED|Blinded Phase (Week 16 to 32)||0||
48183754|NCT03285711|100772269|FG003|COMPLETED|Blinded Phase (Week 16 to 32)||1||
48183755|NCT03285711|100772266|FG000|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0||
48183756|NCT03285711|100772267|FG001|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0||
48183757|NCT03285711|100772268|FG002|NOT COMPLETED|Blinded Phase (Week 16 to 32)||1||
48183758|NCT03285711|100772269|FG003|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0||
48183759|NCT03285711|100772266|FG000|STARTED|Extended Blinded Phase (Week 32 to 52)||0||
48183760|NCT03285711|100772267|FG001|STARTED|Extended Blinded Phase (Week 32 to 52)||3||
48183761|NCT03285711|100772268|FG002|STARTED|Extended Blinded Phase (Week 32 to 52)||0||
48183762|NCT03285711|100772269|FG003|STARTED|Extended Blinded Phase (Week 32 to 52)||1||
48183763|NCT03285711|100772266|FG000|COMPLETED|Extended Blinded Phase (Week 32 to 52)||0||
48183764|NCT03285711|100772267|FG001|COMPLETED|Extended Blinded Phase (Week 32 to 52)||2||
48183765|NCT03285711|100772268|FG002|COMPLETED|Extended Blinded Phase (Week 32 to 52)||0||
48183766|NCT03285711|100772269|FG003|COMPLETED|Extended Blinded Phase (Week 32 to 52)||1||
48183767|NCT03285711|100772266|FG000|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0||
48183768|NCT03285711|100772267|FG001|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||1||
48183769|NCT03285711|100772268|FG002|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0||
48183770|NCT03285711|100772269|FG003|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0||
48183771|NCT01158378|100772270|FG000|STARTED|Overall Study||124||
48635145|NCT01163617|101891787|FG002|COMPLETED|Phase A (User Experience), Weeks 0 and 2||20||
48635146|NCT01163617|101891788|FG003|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21||
48635147|NCT01163617|101891789|FG004|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0||
48635148|NCT01163617|101891790|FG005|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0||
48635149|NCT01163617|101891791|FG006|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0||
48635150|NCT01163617|101891792|FG007|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0||
48635151|NCT01163617|101891785|FG000|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0||
48635152|NCT01163617|101891786|FG001|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||2||
48635153|NCT01163617|101891787|FG002|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||1||
48635154|NCT01163617|101891788|FG003|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0||
48635155|NCT01163617|101891789|FG004|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0||
48635156|NCT01163617|101891790|FG005|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0||
48635157|NCT01163617|101891791|FG006|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0||
48635158|NCT01163617|101891792|FG007|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0||
48635159|NCT01163617|101891785|FG000|STARTED|Phase B (Injection Time), Week 4||0||
48635160|NCT01163617|101891786|FG001|STARTED|Phase B (Injection Time), Week 4||0||
48635161|NCT01163617|101891787|FG002|STARTED|Phase B (Injection Time), Week 4||0||
48635162|NCT01163617|101891788|FG003|STARTED|Phase B (Injection Time), Week 4||0||
48635163|NCT01163617|101891789|FG004|STARTED|Phase B (Injection Time), Week 4||18||
48635164|NCT01163617|101891790|FG005|STARTED|Phase B (Injection Time), Week 4||27||
48183772|NCT01158378|100772271|FG001|STARTED|Overall Study||126||
48183773|NCT01158378|100772270|FG000|COMPLETED|Overall Study||114||
48183774|NCT01158378|100772271|FG001|COMPLETED|Overall Study||117||
48183775|NCT01158378|100772270|FG000|NOT COMPLETED|Overall Study||10||
48183776|NCT01158378|100772271|FG001|NOT COMPLETED|Overall Study||9||
48183777|NCT04496167|100772272|FG000|STARTED|Overall Study||102||
48183778|NCT04496167|100772273|FG001|STARTED|Overall Study||96||
48183779|NCT04496167|100772272|FG000|Received at Least 1 Dose of Study Drug|Overall Study||101||
48183780|NCT04496167|100772273|FG001|Received at Least 1 Dose of Study Drug|Overall Study||94||
48183781|NCT04496167|100772272|FG000|COMPLETED|Overall Study||84||
48183782|NCT04496167|100772273|FG001|COMPLETED|Overall Study||80||
48183783|NCT04496167|100772272|FG000|NOT COMPLETED|Overall Study||18||
48183784|NCT04496167|100772273|FG001|NOT COMPLETED|Overall Study||16||
48183785|NCT01152554|100772274|FG000|STARTED|Overall Study||610||
48183786|NCT01152554|100772275|FG001|STARTED|Overall Study||203||
48183787|NCT01152554|100772274|FG000|Received Treatment|Overall Study||607||
48183788|NCT01152554|100772275|FG001|Received Treatment|Overall Study||201||
48183789|NCT01152554|100772274|FG000|COMPLETED|Overall Study||276||
48183790|NCT01152554|100772275|FG001|COMPLETED|Overall Study||92||
48183791|NCT01152554|100772274|FG000|NOT COMPLETED|Overall Study||334||
48183792|NCT01152554|100772275|FG001|NOT COMPLETED|Overall Study||111||
48183793|NCT01244763|100772276|FG000|STARTED|Overall Study||24||
48183794|NCT01244763|100772277|FG001|STARTED|Overall Study||24||
48183795|NCT01244763|100772278|FG002|STARTED|Overall Study||24||
48183796|NCT01244763|100772279|FG003|STARTED|Overall Study||24||
48183797|NCT01244763|100772280|FG004|STARTED|Overall Study||24||
48183798|NCT01244763|100772281|FG005|STARTED|Overall Study||25||
48183799|NCT01244763|100772276|FG000|Safety Population|Overall Study||24|All participants who received any dose of study drug.|
48183800|NCT01244763|100772277|FG001|Safety Population|Overall Study||24|All participants who received any dose of study drug.|
48183801|NCT01244763|100772278|FG002|Safety Population|Overall Study||24|All participants who received any dose of study drug.|
48183802|NCT01244763|100772279|FG003|Safety Population|Overall Study||24|All participants who received any dose of study drug.|
48183803|NCT01244763|100772280|FG004|Safety Population|Overall Study||24|All participants who received any dose of study drug.|
48183804|NCT01244763|100772281|FG005|Safety Population|Overall Study||25|All participants who received any dose of study drug.|
48183805|NCT01244763|100772276|FG000|Efficacy Evaluable (EE) Population|Overall Study||23|All participants who received at least 2 weeks of study drug with a hemoglobin (Hb) Baseline (BL) and a valid post-BL value at 2 weeks into study.|
48183806|NCT01244763|100772277|FG001|Efficacy Evaluable (EE) Population|Overall Study||24|All participants who received at least 2 weeks of study drug with a hemoglobin (Hb) Baseline (BL) and a valid post-BL value at 2 weeks into study.|
48344537|NCT03430310|101172371|FG000|STARTED|Overall Study||32||
48635165|NCT01163617|101891791|FG006|STARTED|Phase B (Injection Time), Week 4||16||
48635166|NCT01163617|101891792|FG007|STARTED|Phase B (Injection Time), Week 4||20||
48635167|NCT01163617|101891785|FG000|COMPLETED|Phase B (Injection Time), Week 4||0||
48635168|NCT01163617|101891786|FG001|COMPLETED|Phase B (Injection Time), Week 4||0||
48635169|NCT01163617|101891787|FG002|COMPLETED|Phase B (Injection Time), Week 4||0||
48635170|NCT01163617|101891788|FG003|COMPLETED|Phase B (Injection Time), Week 4||0||
48635171|NCT01163617|101891789|FG004|COMPLETED|Phase B (Injection Time), Week 4||18||
48635172|NCT01163617|101891790|FG005|COMPLETED|Phase B (Injection Time), Week 4||27||
48635173|NCT01163617|101891791|FG006|COMPLETED|Phase B (Injection Time), Week 4||16||
48758305|NCT04672239|102197609|FG000|STARTED|Week 6 Survey||80|All participants who did not withdraw themselves or were not withdrawn by the PI were automatically invited to complete any follow-up survey, even if they missed, failed a check-item on, or only partially completed a previous survey.|
48767756|NCT04004988|102222819|FG001|NOT COMPLETED|Period 1||3||
48183807|NCT01244763|100772278|FG002|Efficacy Evaluable (EE) Population|Overall Study||23|All participants who received at least 2 weeks of study drug with a hemoglobin (Hb) Baseline (BL) and a valid post-BL value at 2 weeks into study.|
48183808|NCT01244763|100772279|FG003|Efficacy Evaluable (EE) Population|Overall Study||24|All participants who received at least 2 weeks of study drug with a hemoglobin (Hb) Baseline (BL) and a valid post-BL value at 2 weeks into study.|
48635174|NCT01163617|101891792|FG007|COMPLETED|Phase B (Injection Time), Week 4||20||
48635175|NCT01163617|101891785|FG000|NOT COMPLETED|Phase B (Injection Time), Week 4||0||
48635176|NCT01163617|101891786|FG001|NOT COMPLETED|Phase B (Injection Time), Week 4||0||
48635177|NCT01163617|101891787|FG002|NOT COMPLETED|Phase B (Injection Time), Week 4||0||
48635178|NCT01163617|101891788|FG003|NOT COMPLETED|Phase B (Injection Time), Week 4||0||
48635179|NCT01163617|101891789|FG004|NOT COMPLETED|Phase B (Injection Time), Week 4||0||
48635180|NCT01163617|101891790|FG005|NOT COMPLETED|Phase B (Injection Time), Week 4||0||
48183809|NCT01244763|100772280|FG004|Efficacy Evaluable (EE) Population|Overall Study||24|All participants who received at least 2 weeks of study drug with a hemoglobin (Hb) Baseline (BL) and a valid post-BL value at 2 weeks into study.|
48183810|NCT01244763|100772281|FG005|Efficacy Evaluable (EE) Population|Overall Study||25|All participants who received at least 2 weeks of study drug with a hemoglobin (Hb) Baseline (BL) and a valid post-BL value at 2 weeks into study.|
48183811|NCT01244763|100772276|FG000|COMPLETED|Overall Study||21||
48183812|NCT01244763|100772277|FG001|COMPLETED|Overall Study||21||
48183813|NCT01244763|100772278|FG002|COMPLETED|Overall Study||22||
48183814|NCT01244763|100772279|FG003|COMPLETED|Overall Study||23||
48183815|NCT01244763|100772280|FG004|COMPLETED|Overall Study||21||
48183816|NCT01244763|100772281|FG005|COMPLETED|Overall Study||21||
48183817|NCT01244763|100772276|FG000|NOT COMPLETED|Overall Study||3||
48183818|NCT01244763|100772277|FG001|NOT COMPLETED|Overall Study||3||
48344538|NCT03430310|101172372|FG001|STARTED|Overall Study||33||
48344539|NCT03430310|101172371|FG000|COMPLETED|Overall Study||27||
48344540|NCT03430310|101172372|FG001|COMPLETED|Overall Study||30||
48344541|NCT03430310|101172371|FG000|NOT COMPLETED|Overall Study||5||
48344542|NCT03430310|101172372|FG001|NOT COMPLETED|Overall Study||3||
48344543|NCT00331760|101172373|FG000|STARTED|Overall Study||58||
48344544|NCT00331760|101172374|FG001|STARTED|Overall Study||48||
48635181|NCT01163617|101891791|FG006|NOT COMPLETED|Phase B (Injection Time), Week 4||0||
48758306|NCT04672239|102197610|FG001|STARTED|Week 6 Survey||74|All participants who did not withdraw themselves or were not withdrawn by the PI were automatically invited to complete any follow-up survey, even if they missed, failed a check-item on, or only partially completed a previous survey.|
48758307|NCT04672239|102197611|FG002|STARTED|Week 6 Survey||71|All participants who did not withdraw themselves or were not withdrawn by the PI were automatically invited to complete any follow-up survey, even if they missed, failed a check-item on, or only partially completed a previous survey.|
48758308|NCT04672239|102197609|FG000|COMPLETED|Week 6 Survey||62||
48758309|NCT04672239|102197610|FG001|COMPLETED|Week 6 Survey||65||
48758310|NCT04672239|102197611|FG002|COMPLETED|Week 6 Survey||61||
48758311|NCT04672239|102197609|FG000|NOT COMPLETED|Week 6 Survey||18||
48758312|NCT04672239|102197610|FG001|NOT COMPLETED|Week 6 Survey||9||
48758313|NCT04672239|102197611|FG002|NOT COMPLETED|Week 6 Survey||10||
48758314|NCT04672239|102197609|FG000|STARTED|3-Month Follow-up Survey||79|All participants who did not withdraw themselves or were not withdrawn by the PI were automatically invited to complete any follow-up survey, even if they missed, failed a check-item on, or only partially completed a previous survey.|
48758315|NCT04672239|102197610|FG001|STARTED|3-Month Follow-up Survey||72|All participants who did not withdraw themselves or were not withdrawn by the PI were automatically invited to complete any follow-up survey, even if they missed, failed a check-item on, or only partially completed a previous survey.|
48758316|NCT04672239|102197611|FG002|STARTED|3-Month Follow-up Survey||70|All participants who did not withdraw themselves or were not withdrawn by the PI were automatically invited to complete any follow-up survey, even if they missed, failed a check-item on, or only partially completed a previous survey.|
48758317|NCT04672239|102197609|FG000|COMPLETED|3-Month Follow-up Survey||57||
48758318|NCT04672239|102197610|FG001|COMPLETED|3-Month Follow-up Survey||62||
48758319|NCT04672239|102197611|FG002|COMPLETED|3-Month Follow-up Survey||53||
48758320|NCT04672239|102197609|FG000|NOT COMPLETED|3-Month Follow-up Survey||22||
48758321|NCT04672239|102197610|FG001|NOT COMPLETED|3-Month Follow-up Survey||10||
48758322|NCT04672239|102197611|FG002|NOT COMPLETED|3-Month Follow-up Survey||17||
48767757|NCT04004988|102222818|FG000|STARTED|Period 2||21||
48767758|NCT04004988|102222819|FG001|STARTED|Period 2||20||
48183819|NCT01244763|100772278|FG002|NOT COMPLETED|Overall Study||2||
48183820|NCT01244763|100772279|FG003|NOT COMPLETED|Overall Study||1||
48414656|NCT00779116|101350112|FG000|COMPLETED|Interval Between Doses (8-10 Minutes)||109||
48183821|NCT01244763|100772280|FG004|NOT COMPLETED|Overall Study||3||
48414657|NCT00779116|101350113|FG001|COMPLETED|Interval Between Doses (8-10 Minutes)||108||
48183822|NCT01244763|100772281|FG005|NOT COMPLETED|Overall Study||4||
48183823|NCT03862482|100772282|FG000|STARTED|Overall Study||8||40
48183824|NCT03862482|100772283|FG001|STARTED|Overall Study||8||40
48183825|NCT03862482|100772284|FG002|STARTED|Overall Study||6||30
48183826|NCT03862482|100772282|FG000|COMPLETED|Overall Study||8||39
48183827|NCT03862482|100772283|FG001|COMPLETED|Overall Study||8||38
48183828|NCT03862482|100772284|FG002|COMPLETED|Overall Study||6||30
48344545|NCT00331760|101172373|FG000|COMPLETED|Overall Study||43||
48183829|NCT03862482|100772282|FG000|NOT COMPLETED|Overall Study||0||1
48183830|NCT03862482|100772283|FG001|NOT COMPLETED|Overall Study||0||2
48183831|NCT03862482|100772284|FG002|NOT COMPLETED|Overall Study||0||0
48183832|NCT00163215|100772285|FG000|STARTED|Overall Study||46||
48183833|NCT00163215|100772285|FG000|COMPLETED|Overall Study||31||
48183834|NCT00163215|100772285|FG000|NOT COMPLETED|Overall Study||15||
48183835|NCT01040780|100772286|FG000|STARTED|Overall Study||200||
48183836|NCT01040780|100772287|FG001|STARTED|Overall Study||199||
48183837|NCT01040780|100772286|FG000|COMPLETED|Overall Study||199||
48183838|NCT01040780|100772287|FG001|COMPLETED|Overall Study||196||
48183839|NCT01040780|100772286|FG000|NOT COMPLETED|Overall Study||1||
48183840|NCT01040780|100772287|FG001|NOT COMPLETED|Overall Study||3||
48183841|NCT00504348|100772288|FG000|STARTED|Overall Study||25||
48183842|NCT00504348|100772288|FG000|COMPLETED|Overall Study||17||
48183843|NCT00504348|100772288|FG000|NOT COMPLETED|Overall Study||8||
48183844|NCT00180674|100772289|FG000|STARTED|Phase 1, Observation Period||14||
48183845|NCT00180674|100772289|FG000|COMPLETED|Phase 1, Observation Period||10||
48344546|NCT00331760|101172374|FG001|COMPLETED|Overall Study||40||
48183846|NCT00180674|100772289|FG000|NOT COMPLETED|Phase 1, Observation Period||4||
48344547|NCT00331760|101172373|FG000|NOT COMPLETED|Overall Study||15||
48344548|NCT00331760|101172374|FG001|NOT COMPLETED|Overall Study||8||
48183847|NCT00180674|100772289|FG000|STARTED|Phase 2, Warfarin Treatment Period||10||
48183848|NCT00180674|100772289|FG000|COMPLETED|Phase 2, Warfarin Treatment Period||9||
48344549|NCT01032629|101172375|FG000|STARTED|Overall Study||1442||
48344550|NCT01032629|101172376|FG001|STARTED|Overall Study||1445||
48344551|NCT01032629|101172377|FG002|STARTED|Overall Study||1443||
48344552|NCT01032629|101172375|FG000|Treated|Overall Study||1441||
48344553|NCT01032629|101172376|FG001|Treated|Overall Study||1445||
48344554|NCT01032629|101172377|FG002|Treated|Overall Study||1441||
48344555|NCT01032629|101172375|FG000|COMPLETED|Overall Study||1297||
48344556|NCT01032629|101172376|FG001|COMPLETED|Overall Study||1344||
48344557|NCT01032629|101172377|FG002|COMPLETED|Overall Study||1355||
48344558|NCT01032629|101172375|FG000|NOT COMPLETED|Overall Study||145||
48344559|NCT01032629|101172376|FG001|NOT COMPLETED|Overall Study||101||
48414658|NCT00779116|101350112|FG000|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0||
48414659|NCT00779116|101350113|FG001|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0||
48414660|NCT00779116|101350112|FG000|STARTED|Second Intervention||109||
48414661|NCT00779116|101350113|FG001|STARTED|Second Intervention||108||
48414662|NCT00779116|101350112|FG000|COMPLETED|Second Intervention||109||
48414663|NCT00779116|101350113|FG001|COMPLETED|Second Intervention||108||
48414664|NCT00779116|101350112|FG000|NOT COMPLETED|Second Intervention||0||
48414665|NCT00779116|101350113|FG001|NOT COMPLETED|Second Intervention||0||
48414666|NCT00807989|101350114|FG000|STARTED|Overall Study||107||
48344560|NCT01032629|101172377|FG002|NOT COMPLETED|Overall Study||88||
48344561|NCT01485614|101172378|FG000|STARTED|Randomization||96||
48344562|NCT01485614|101172379|FG001|STARTED|Randomization||90||
48344563|NCT01485614|101172380|FG002|STARTED|Randomization||9||
48344564|NCT01485614|101172381|FG003|STARTED|Randomization||5||
48344565|NCT01485614|101172378|FG000|COMPLETED|Randomization||95||
48344566|NCT01485614|101172379|FG001|COMPLETED|Randomization||90||
48344567|NCT01485614|101172380|FG002|COMPLETED|Randomization||9||
48414667|NCT00807989|101350115|FG001|STARTED|Overall Study||100||
48414668|NCT00807989|101350114|FG000|COMPLETED|Overall Study||104||
48344568|NCT01485614|101172381|FG003|COMPLETED|Randomization||5||
48414669|NCT00807989|101350115|FG001|COMPLETED|Overall Study||98||
48414670|NCT00807989|101350114|FG000|NOT COMPLETED|Overall Study||3||
48414671|NCT00807989|101350115|FG001|NOT COMPLETED|Overall Study||2||
48414672|NCT01196091|101350116|FG000|STARTED|Overall Study||387||
48414673|NCT01196091|101350117|FG001|STARTED|Overall Study||389||
48414674|NCT01196091|101350118|FG002|STARTED|Overall Study||388||
48414675|NCT01196091|101350116|FG000|Received at Least 1 Dose of Study Drug|Overall Study||386||
48414676|NCT01196091|101350117|FG001|Received at Least 1 Dose of Study Drug|Overall Study||389||
48414677|NCT01196091|101350118|FG002|Received at Least 1 Dose of Study Drug|Overall Study||387||
48414678|NCT01196091|101350116|FG000|ITT-Received Drug and Excluded Sites|Overall Study||381||
48414679|NCT01196091|101350117|FG001|ITT-Received Drug and Excluded Sites|Overall Study||378||
48414680|NCT01196091|101350118|FG002|ITT-Received Drug and Excluded Sites|Overall Study||379||
48414681|NCT01196091|101350116|FG000|Follow-Up|Overall Study||103||
48414682|NCT01196091|101350117|FG001|Follow-Up|Overall Study||105||
48414683|NCT01196091|101350118|FG002|Follow-Up|Overall Study||128||
48414684|NCT01196091|101350116|FG000|COMPLETED|Overall Study||299||
48414685|NCT01196091|101350117|FG001|COMPLETED|Overall Study||291||
48414686|NCT01196091|101350118|FG002|COMPLETED|Overall Study||284||
48414687|NCT01196091|101350116|FG000|NOT COMPLETED|Overall Study||88||
48414688|NCT01196091|101350117|FG001|NOT COMPLETED|Overall Study||98||
48414689|NCT01196091|101350118|FG002|NOT COMPLETED|Overall Study||104||
48414690|NCT03702166|101350119|FG000|STARTED|Overall Study||10||
48414691|NCT03702166|101350119|FG000|COMPLETED|Overall Study||8|10 participants were started and included in baseline measures, only 8 remained at post-treatment.|
48414692|NCT03702166|101350119|FG000|NOT COMPLETED|Overall Study||2||
48414693|NCT00508820|101350120|FG000|STARTED|Overall Study||168||
48414694|NCT00508820|101350121|FG001|STARTED|Overall Study||239||
48414695|NCT00508820|101350120|FG000|COMPLETED|Overall Study||113||
48414696|NCT00508820|101350121|FG001|COMPLETED|Overall Study||175||
48414697|NCT00508820|101350120|FG000|NOT COMPLETED|Overall Study||55||
48414698|NCT00508820|101350121|FG001|NOT COMPLETED|Overall Study||64||
48414699|NCT02309372|101350122|FG000|STARTED|Overall Study||27||
48414700|NCT02309372|101350123|FG001|STARTED|Overall Study||27||
48635182|NCT01163617|101891792|FG007|NOT COMPLETED|Phase B (Injection Time), Week 4||0||
48635183|NCT01925417|101891793|FG000|STARTED|Overall Study||34||
48635184|NCT01925417|101891793|FG000|COMPLETED|Overall Study||31||
48635185|NCT01925417|101891793|FG000|NOT COMPLETED|Overall Study||3||
48635186|NCT00634504|101891794|FG000|STARTED|Overall Study||11||
48635187|NCT00634504|101891795|FG001|STARTED|Overall Study||9||
48635188|NCT00634504|101891794|FG000|COMPLETED|Overall Study||10||
48183849|NCT00180674|100772289|FG000|NOT COMPLETED|Phase 2, Warfarin Treatment Period||1||
48414701|NCT02309372|101350122|FG000|COMPLETED|Overall Study||24||
48183850|NCT03560141|100772290|FG000|STARTED|Overall Study||6||12
48414702|NCT02309372|101350123|FG001|COMPLETED|Overall Study||25||
48635189|NCT00634504|101891795|FG001|COMPLETED|Overall Study||9||
48183851|NCT03560141|100772291|FG001|STARTED|Overall Study||5||10
48635190|NCT00634504|101891794|FG000|NOT COMPLETED|Overall Study||1||
48635191|NCT00634504|101891795|FG001|NOT COMPLETED|Overall Study||0||
48635192|NCT00317369|101891796|FG000|STARTED|Overall Study||10||
48344569|NCT01485614|101172378|FG000|NOT COMPLETED|Randomization||1||
48344570|NCT01485614|101172379|FG001|NOT COMPLETED|Randomization||0||
48344571|NCT01485614|101172380|FG002|NOT COMPLETED|Randomization||0||
48344572|NCT01485614|101172381|FG003|NOT COMPLETED|Randomization||0||
48344573|NCT01485614|101172378|FG000|STARTED|Weeks 0-20||95||
48344574|NCT01485614|101172379|FG001|STARTED|Weeks 0-20||90||
48344575|NCT01485614|101172380|FG002|STARTED|Weeks 0-20||9||
48344576|NCT01485614|101172381|FG003|STARTED|Weeks 0-20||5||
48344577|NCT01485614|101172378|FG000|Treated|Weeks 0-20||95||
48344578|NCT01485614|101172379|FG001|Treated|Weeks 0-20||90||
48758323|NCT04672239|102197609|FG000|STARTED|6-Month Follow-up Survey||79|All participants who did not withdraw themselves or were not withdrawn by the PI were automatically invited to complete any follow-up survey, even if they missed, failed a check-item on, or only partially completed a previous survey.|
48758324|NCT04672239|102197610|FG001|STARTED|6-Month Follow-up Survey||71|All participants who did not withdraw themselves or were not withdrawn by the PI were automatically invited to complete any follow-up survey, even if they missed, failed a check-item on, or only partially completed a previous survey.|
48758325|NCT04672239|102197611|FG002|STARTED|6-Month Follow-up Survey||69|All participants who did not withdraw themselves or were not withdrawn by the PI were automatically invited to complete any follow-up survey, even if they missed, failed a check-item on, or only partially completed a previous survey.|
48758326|NCT04672239|102197609|FG000|COMPLETED|6-Month Follow-up Survey||57||
48758327|NCT04672239|102197610|FG001|COMPLETED|6-Month Follow-up Survey||59||
48758328|NCT04672239|102197611|FG002|COMPLETED|6-Month Follow-up Survey||58||
48758329|NCT04672239|102197609|FG000|NOT COMPLETED|6-Month Follow-up Survey||22||
48758330|NCT04672239|102197610|FG001|NOT COMPLETED|6-Month Follow-up Survey||12||
48758331|NCT04672239|102197611|FG002|NOT COMPLETED|6-Month Follow-up Survey||11||
48758332|NCT03020667|102197612|FG000|STARTED|At Month 3||525||
48758333|NCT03020667|102197613|FG001|STARTED|At Month 3||70||
48758334|NCT03020667|102197614|FG002|STARTED|At Month 3||0||
48758335|NCT03020667|102197615|FG003|STARTED|At Month 3||0||
48758336|NCT03020667|102197616|FG004|STARTED|At Month 3||0||
48758337|NCT03020667|102197617|FG005|STARTED|At Month 3||0||
48758338|NCT03020667|102197612|FG000|COMPLETED|At Month 3||215||
48758339|NCT03020667|102197613|FG001|COMPLETED|At Month 3||70||
48758340|NCT03020667|102197614|FG002|COMPLETED|At Month 3||0||
48758341|NCT03020667|102197615|FG003|COMPLETED|At Month 3||0||
48758342|NCT03020667|102197616|FG004|COMPLETED|At Month 3||0||
48183852|NCT03560141|100772290|FG000|COMPLETED|Overall Study||6||12
48183853|NCT03560141|100772291|FG001|COMPLETED|Overall Study||5||10
48183854|NCT03560141|100772290|FG000|NOT COMPLETED|Overall Study||0||0
48183855|NCT03560141|100772291|FG001|NOT COMPLETED|Overall Study||0||0
48183856|NCT01603940|100772292|FG000|STARTED|Overall Study||16||
48183857|NCT01603940|100772293|FG001|STARTED|Overall Study||14||
48183858|NCT01603940|100772292|FG000|COMPLETED|Overall Study||16||
48183859|NCT01603940|100772293|FG001|COMPLETED|Overall Study||14||
48183860|NCT01603940|100772292|FG000|NOT COMPLETED|Overall Study||0||
48183861|NCT01603940|100772293|FG001|NOT COMPLETED|Overall Study||0||
48635193|NCT00317369|101891797|FG001|STARTED|Overall Study||9||
48635194|NCT00317369|101891798|FG002|STARTED|Overall Study||10||
48635195|NCT00317369|101891796|FG000|COMPLETED|Overall Study||8||
48635196|NCT00317369|101891797|FG001|COMPLETED|Overall Study||7||
48635197|NCT00317369|101891798|FG002|COMPLETED|Overall Study||8||
48635198|NCT00317369|101891796|FG000|NOT COMPLETED|Overall Study||2||
48635199|NCT00317369|101891797|FG001|NOT COMPLETED|Overall Study||2||
48635200|NCT00317369|101891798|FG002|NOT COMPLETED|Overall Study||2||
48635201|NCT00797563|101891799|FG000|STARTED|Overall Study||102||
48635202|NCT00797563|101891799|FG000|COMPLETED|Overall Study||101||
48635203|NCT00797563|101891799|FG000|NOT COMPLETED|Overall Study||1||
48635204|NCT04465422|101891800|FG000|STARTED|Overall Study||17||
48635205|NCT04465422|101891801|FG001|STARTED|Overall Study||16||
48635206|NCT04465422|101891800|FG000|COMPLETED|Overall Study||17||
48635207|NCT04465422|101891801|FG001|COMPLETED|Overall Study||14||
48635208|NCT04465422|101891800|FG000|NOT COMPLETED|Overall Study||0||
48635209|NCT04465422|101891801|FG001|NOT COMPLETED|Overall Study||2||
48635210|NCT01582451|101891802|FG000|STARTED|Overall Study||307||
48635211|NCT01582451|101891803|FG001|STARTED|Overall Study||159||
48635212|NCT01582451|101891802|FG000|Received at Least 1 Dose of Study Drug|Overall Study||305||
48758343|NCT03020667|102197617|FG005|COMPLETED|At Month 3||0||
48758344|NCT03020667|102197612|FG000|NOT COMPLETED|At Month 3||310||
48758345|NCT03020667|102197613|FG001|NOT COMPLETED|At Month 3||0||
48758346|NCT03020667|102197614|FG002|NOT COMPLETED|At Month 3||0||
48758347|NCT03020667|102197615|FG003|NOT COMPLETED|At Month 3||0||
48758348|NCT03020667|102197616|FG004|NOT COMPLETED|At Month 3||0||
48758349|NCT03020667|102197617|FG005|NOT COMPLETED|At Month 3||0||
48758350|NCT03020667|102197612|FG000|STARTED|At Month 6||215||
48758351|NCT03020667|102197613|FG001|STARTED|At Month 6||70||
48758352|NCT03020667|102197614|FG002|STARTED|At Month 6||191||
48758353|NCT03020667|102197615|FG003|STARTED|At Month 6||0||
48758354|NCT03020667|102197616|FG004|STARTED|At Month 6||0||
48183862|NCT04242875|100772294|FG000|STARTED|Overall Study||30||60
48183863|NCT04242875|100772294|FG000|COMPLETED|Overall Study||28||56
48183864|NCT04242875|100772294|FG000|NOT COMPLETED|Overall Study||2||4
48183865|NCT02874846|100772295|FG000|STARTED|Overall Study||8||
48183866|NCT02874846|100772296|FG001|STARTED|Overall Study||4||
48183867|NCT02874846|100772295|FG000|COMPLETED|Overall Study||8||
48758355|NCT03020667|102197617|FG005|STARTED|At Month 6||0||
48758356|NCT03020667|102197612|FG000|COMPLETED|At Month 6||107||
48758357|NCT03020667|102197613|FG001|COMPLETED|At Month 6||50||
48758358|NCT03020667|102197614|FG002|COMPLETED|At Month 6||191||
48758359|NCT03020667|102197615|FG003|COMPLETED|At Month 6||0||
48758360|NCT03020667|102197616|FG004|COMPLETED|At Month 6||0||
48758361|NCT03020667|102197617|FG005|COMPLETED|At Month 6||0||
48758362|NCT03020667|102197612|FG000|NOT COMPLETED|At Month 6||108||
48758363|NCT03020667|102197613|FG001|NOT COMPLETED|At Month 6||20||
48758364|NCT03020667|102197614|FG002|NOT COMPLETED|At Month 6||0||
48758365|NCT03020667|102197615|FG003|NOT COMPLETED|At Month 6||0||
48758366|NCT03020667|102197616|FG004|NOT COMPLETED|At Month 6||0||
48758367|NCT03020667|102197617|FG005|NOT COMPLETED|At Month 6||0||
48758368|NCT03020667|102197612|FG000|STARTED|At Month 9||107||
48758369|NCT03020667|102197613|FG001|STARTED|At Month 9||50||
48758370|NCT03020667|102197614|FG002|STARTED|At Month 9||191||
48758371|NCT03020667|102197615|FG003|STARTED|At Month 9||264||
48758372|NCT03020667|102197616|FG004|STARTED|At Month 9||0||
48183868|NCT02874846|100772296|FG001|COMPLETED|Overall Study||4||
48758373|NCT03020667|102197617|FG005|STARTED|At Month 9||0||
48183869|NCT02874846|100772295|FG000|NOT COMPLETED|Overall Study||0||
48183870|NCT02874846|100772296|FG001|NOT COMPLETED|Overall Study||0||
48183871|NCT01515956|100772297|FG000|STARTED|Overall Study||15||
48183872|NCT01515956|100772297|FG000|COMPLETED|Overall Study||15||
48183873|NCT01515956|100772297|FG000|NOT COMPLETED|Overall Study||0||
48635213|NCT01582451|101891803|FG001|Received at Least 1 Dose of Study Drug|Overall Study||159||
48635214|NCT01582451|101891802|FG000|COMPLETED|Overall Study||275||
48635215|NCT01582451|101891803|FG001|COMPLETED|Overall Study||139||
48635216|NCT01582451|101891802|FG000|NOT COMPLETED|Overall Study||32||
48758374|NCT03020667|102197612|FG000|COMPLETED|At Month 9||12||
48758375|NCT03020667|102197613|FG001|COMPLETED|At Month 9||42||
48758376|NCT03020667|102197614|FG002|COMPLETED|At Month 9||113||
48758377|NCT03020667|102197615|FG003|COMPLETED|At Month 9||264||
48758378|NCT03020667|102197616|FG004|COMPLETED|At Month 9||0||
48758379|NCT03020667|102197617|FG005|COMPLETED|At Month 9||0||
48758380|NCT03020667|102197612|FG000|NOT COMPLETED|At Month 9||95||
48758381|NCT03020667|102197613|FG001|NOT COMPLETED|At Month 9||8||
48758382|NCT03020667|102197614|FG002|NOT COMPLETED|At Month 9||78||
48183874|NCT01882062|100772298|FG000|STARTED|Overall Study||10||
48183875|NCT01882062|100772298|FG000|COMPLETED|Overall Study||10||
48183876|NCT01882062|100772298|FG000|NOT COMPLETED|Overall Study||0||
48183877|NCT03553940|100772299|FG000|STARTED|Overall Study||22||
48183878|NCT03553940|100772300|FG001|STARTED|Overall Study||21||
48183879|NCT03553940|100772299|FG000|COMPLETED|Overall Study||22||
48183880|NCT03553940|100772300|FG001|COMPLETED|Overall Study||21||
48183881|NCT03553940|100772299|FG000|NOT COMPLETED|Overall Study||0||
48183882|NCT03553940|100772300|FG001|NOT COMPLETED|Overall Study||0||
48183883|NCT02900781|100772301|FG000|STARTED|Overall Study||4|Study terminated due to device not working at our facility .|
48183884|NCT02900781|100772302|FG001|STARTED|Overall Study||5|Study terminated due to device not working at our facility .|
48183885|NCT02900781|100772301|FG000|COMPLETED|Overall Study||0|Participants were unable to use the device as required in the protocol. No data collected|
48183886|NCT02900781|100772302|FG001|COMPLETED|Overall Study||0|Participants were unable to use the device as required in the protocol. No data collected|
48183887|NCT02900781|100772301|FG000|NOT COMPLETED|Overall Study||4||
48183888|NCT02900781|100772302|FG001|NOT COMPLETED|Overall Study||5||
48183889|NCT01603121|100772303|FG000|STARTED|First Intervention, 10 Hours||1||
48183890|NCT01603121|100772304|FG001|STARTED|First Intervention, 10 Hours||0||
48183891|NCT01603121|100772303|FG000|COMPLETED|First Intervention, 10 Hours||1||
48183892|NCT01603121|100772304|FG001|COMPLETED|First Intervention, 10 Hours||0||
48183893|NCT01603121|100772303|FG000|NOT COMPLETED|First Intervention, 10 Hours||0||
48183894|NCT01603121|100772304|FG001|NOT COMPLETED|First Intervention, 10 Hours||0||
48183895|NCT01603121|100772303|FG000|STARTED|Second Intervention, 10 Hours||1||
48183896|NCT01603121|100772304|FG001|STARTED|Second Intervention, 10 Hours||0||
48183897|NCT01603121|100772303|FG000|COMPLETED|Second Intervention, 10 Hours||0||
48183898|NCT01603121|100772304|FG001|COMPLETED|Second Intervention, 10 Hours||0||
48414703|NCT02309372|101350122|FG000|NOT COMPLETED|Overall Study||3||
48414704|NCT02309372|101350123|FG001|NOT COMPLETED|Overall Study||2||
48414705|NCT02371980|101350124|FG000|STARTED|Open-label Period||1106||
48414706|NCT02371980|101350125|FG001|STARTED|Open-label Period||0||
48414707|NCT02371980|101350126|FG002|STARTED|Open-label Period||0||
48414708|NCT02371980|101350127|FG003|STARTED|Open-label Period||0||
48414709|NCT02371980|101350128|FG004|STARTED|Open-label Period||0||
48414710|NCT02371980|101350124|FG000|COMPLETED|Open-label Period||580||
48414711|NCT02371980|101350125|FG001|COMPLETED|Open-label Period||0||
48414712|NCT02371980|101350126|FG002|COMPLETED|Open-label Period||0||
48414713|NCT02371980|101350127|FG003|COMPLETED|Open-label Period||0||
48414714|NCT02371980|101350128|FG004|COMPLETED|Open-label Period||0||
48414715|NCT02371980|101350124|FG000|NOT COMPLETED|Open-label Period||526||
48414716|NCT02371980|101350125|FG001|NOT COMPLETED|Open-label Period||0||
48414717|NCT02371980|101350126|FG002|NOT COMPLETED|Open-label Period||0||
48414718|NCT02371980|101350127|FG003|NOT COMPLETED|Open-label Period||0||
48414719|NCT02371980|101350128|FG004|NOT COMPLETED|Open-label Period||0||
48414720|NCT02371980|101350124|FG000|STARTED|Double-blind Period||0||
48758383|NCT03020667|102197615|FG003|NOT COMPLETED|At Month 9||0||
48758384|NCT03020667|102197616|FG004|NOT COMPLETED|At Month 9||0||
48758385|NCT03020667|102197617|FG005|NOT COMPLETED|At Month 9||0||
48758386|NCT03020667|102197612|FG000|STARTED|At Month 12||12||
48758387|NCT03020667|102197613|FG001|STARTED|At Month 12||42||
48758388|NCT03020667|102197614|FG002|STARTED|At Month 12||113||
48758389|NCT03020667|102197615|FG003|STARTED|At Month 12||264||
48758390|NCT03020667|102197616|FG004|STARTED|At Month 12||73||
48758391|NCT03020667|102197617|FG005|STARTED|At Month 12||0||
48758392|NCT03020667|102197612|FG000|COMPLETED|At Month 12||4||
48758393|NCT03020667|102197613|FG001|COMPLETED|At Month 12||28||
48183899|NCT01603121|100772303|FG000|NOT COMPLETED|Second Intervention, 10 Hours||1||
48183900|NCT01603121|100772304|FG001|NOT COMPLETED|Second Intervention, 10 Hours||0||
48183901|NCT01481935|100772305|FG000|STARTED|Overall Study||97||
48183902|NCT01481935|100772306|FG001|STARTED|Overall Study||93||
48183903|NCT01481935|100772305|FG000|COMPLETED|Overall Study||97||
48183904|NCT01481935|100772306|FG001|COMPLETED|Overall Study||93||
48183905|NCT01481935|100772305|FG000|NOT COMPLETED|Overall Study||0||
48183906|NCT01481935|100772306|FG001|NOT COMPLETED|Overall Study||0||
48183907|NCT03499600|100772307|FG000|STARTED|Overall Study||39||
48183908|NCT03499600|100772308|FG001|STARTED|Overall Study||50||
48183909|NCT03499600|100772307|FG000|COMPLETED|Overall Study||18||
48183910|NCT03499600|100772308|FG001|COMPLETED|Overall Study||20||
48183911|NCT03499600|100772307|FG000|NOT COMPLETED|Overall Study||21||
48183912|NCT03499600|100772308|FG001|NOT COMPLETED|Overall Study||30||
48183913|NCT03311854|100772309|FG000|STARTED|Overall Study||14||
48414721|NCT02371980|101350125|FG001|STARTED|Double-blind Period||151||
48414722|NCT02371980|101350126|FG002|STARTED|Double-blind Period||140||
48414723|NCT02371980|101350127|FG003|STARTED|Double-blind Period||145||
48758394|NCT03020667|102197614|FG002|COMPLETED|At Month 12||75||
48758395|NCT03020667|102197615|FG003|COMPLETED|At Month 12||134||
48758396|NCT03020667|102197616|FG004|COMPLETED|At Month 12||73||
48758397|NCT03020667|102197617|FG005|COMPLETED|At Month 12||0||
48758398|NCT03020667|102197612|FG000|NOT COMPLETED|At Month 12||8||
48758399|NCT03020667|102197613|FG001|NOT COMPLETED|At Month 12||14||
48758400|NCT03020667|102197614|FG002|NOT COMPLETED|At Month 12||38||
48414724|NCT02371980|101350128|FG004|STARTED|Double-blind Period||144||
48183914|NCT03311854|100772309|FG000|COMPLETED|Overall Study||14||
48183915|NCT03311854|100772309|FG000|NOT COMPLETED|Overall Study||0||
48183916|NCT02448719|100772310|FG000|STARTED|Overall Study||12||
48414725|NCT02371980|101350124|FG000|COMPLETED|Double-blind Period||0||
48414726|NCT02371980|101350125|FG001|COMPLETED|Double-blind Period||70||
48635217|NCT01582451|101891803|FG001|NOT COMPLETED|Overall Study||20||
48635218|NCT02787304|101891804|FG000|STARTED|Overall Study||49||
48635219|NCT02787304|101891805|FG001|STARTED|Overall Study||50||
48635220|NCT02787304|101891806|FG002|STARTED|Overall Study||49||
48635221|NCT02787304|101891807|FG003|STARTED|Overall Study||49||
48758401|NCT03020667|102197615|FG003|NOT COMPLETED|At Month 12||130||
48758402|NCT03020667|102197616|FG004|NOT COMPLETED|At Month 12||0||
48758403|NCT03020667|102197617|FG005|NOT COMPLETED|At Month 12||0||
48758404|NCT03020667|102197612|FG000|STARTED|At Month 15||4||
48758405|NCT03020667|102197613|FG001|STARTED|At Month 15||28||
48183917|NCT02448719|100772311|FG001|STARTED|Overall Study||6||
48344579|NCT01485614|101172380|FG002|Treated|Weeks 0-20||9||
48344580|NCT01485614|101172381|FG003|Treated|Weeks 0-20||5||
48344581|NCT01485614|101172378|FG000|COMPLETED|Weeks 0-20||85||
48344582|NCT01485614|101172379|FG001|COMPLETED|Weeks 0-20||86||
48344583|NCT01485614|101172380|FG002|COMPLETED|Weeks 0-20||8||
48635222|NCT02787304|101891804|FG000|COMPLETED|Overall Study||13||
48635223|NCT02787304|101891805|FG001|COMPLETED|Overall Study||12||
48635224|NCT02787304|101891806|FG002|COMPLETED|Overall Study||8||
48635225|NCT02787304|101891807|FG003|COMPLETED|Overall Study||15||
48635226|NCT02787304|101891804|FG000|NOT COMPLETED|Overall Study||36||
48635227|NCT02787304|101891805|FG001|NOT COMPLETED|Overall Study||38||
48635228|NCT02787304|101891806|FG002|NOT COMPLETED|Overall Study||41||
48635229|NCT02787304|101891807|FG003|NOT COMPLETED|Overall Study||34||
48635230|NCT04342169|101891808|FG000|STARTED|Overall Study||185||
48635231|NCT04342169|101891809|FG001|STARTED|Overall Study||183||
48635232|NCT04342169|101891808|FG000|COMPLETED|Overall Study||89||
48635233|NCT04342169|101891809|FG001|COMPLETED|Overall Study||89||
48635234|NCT04342169|101891808|FG000|NOT COMPLETED|Overall Study||96||
48635235|NCT04342169|101891809|FG001|NOT COMPLETED|Overall Study||94||
48635236|NCT02747927|101891810|FG000|STARTED|Overall Study||6698||
48635237|NCT02747927|101891811|FG001|STARTED|Overall Study||13401||
48635238|NCT02747927|101891810|FG000|Treated: Safety Set|Overall Study||6687|Safety Set included all randomized participants who received at least 1 dose of the trial vaccines (TDV or placebo).|
48635239|NCT02747927|101891811|FG001|Treated: Safety Set|Overall Study||13380|Safety Set included all randomized participants who received at least 1 dose of the trial vaccines (TDV or placebo).|
48635240|NCT02747927|101891810|FG000|COMPLETED|Overall Study||6477|Completed = Number of participants who had not discontinued from the trial at the time of the Part 1 analysis.|
48635241|NCT02747927|101891811|FG001|COMPLETED|Overall Study||12943|Completed = Number of participants who had not discontinued from the trial at the time of the Part 1 analysis.|
48635242|NCT02747927|101891810|FG000|NOT COMPLETED|Overall Study||221||
48635243|NCT02747927|101891811|FG001|NOT COMPLETED|Overall Study||458||
48635244|NCT02090881|101891812|FG000|STARTED|Overall Study||25||
48758406|NCT03020667|102197614|FG002|STARTED|At Month 15||75||
48758407|NCT03020667|102197615|FG003|STARTED|At Month 15||134||
48758408|NCT03020667|102197616|FG004|STARTED|At Month 15||73||
48183918|NCT02448719|100772312|FG002|STARTED|Overall Study||6||
48183919|NCT02448719|100772313|FG003|STARTED|Overall Study||6||
48183920|NCT02448719|100772314|FG004|STARTED|Overall Study||6||
48183921|NCT02448719|100772315|FG005|STARTED|Overall Study||6||
48344584|NCT01485614|101172381|FG003|COMPLETED|Weeks 0-20||5||
48344585|NCT01485614|101172378|FG000|NOT COMPLETED|Weeks 0-20||10||
48344586|NCT01485614|101172379|FG001|NOT COMPLETED|Weeks 0-20||4||
48344587|NCT01485614|101172380|FG002|NOT COMPLETED|Weeks 0-20||1||
48344588|NCT01485614|101172381|FG003|NOT COMPLETED|Weeks 0-20||0||
48344589|NCT01485614|101172378|FG000|STARTED|Weeks 20-54||85||
48344590|NCT01485614|101172379|FG001|STARTED|Weeks 20-54||86||
48344591|NCT01485614|101172380|FG002|STARTED|Weeks 20-54||8||
48344592|NCT01485614|101172381|FG003|STARTED|Weeks 20-54||5||
48344593|NCT01485614|101172378|FG000|COMPLETED|Weeks 20-54||74||
48344594|NCT01485614|101172379|FG001|COMPLETED|Weeks 20-54||78||
48344595|NCT01485614|101172380|FG002|COMPLETED|Weeks 20-54||6||
48344596|NCT01485614|101172381|FG003|COMPLETED|Weeks 20-54||5||
48344597|NCT01485614|101172378|FG000|NOT COMPLETED|Weeks 20-54||11||
48344598|NCT01485614|101172379|FG001|NOT COMPLETED|Weeks 20-54||8||
48344599|NCT01485614|101172380|FG002|NOT COMPLETED|Weeks 20-54||2||
48414727|NCT02371980|101350126|FG002|COMPLETED|Double-blind Period||84||
48414728|NCT02371980|101350127|FG003|COMPLETED|Double-blind Period||96||
48414729|NCT02371980|101350128|FG004|COMPLETED|Double-blind Period||86||
48344600|NCT01485614|101172381|FG003|NOT COMPLETED|Weeks 20-54||0||
48635245|NCT02090881|101891812|FG000|COMPLETED|Overall Study||25||
48635246|NCT02090881|101891812|FG000|NOT COMPLETED|Overall Study||0||
48758409|NCT03020667|102197617|FG005|STARTED|At Month 15||1||
48758410|NCT03020667|102197612|FG000|COMPLETED|At Month 15||1||
48183922|NCT02448719|100772316|FG006|STARTED|Overall Study||6||
48183923|NCT02448719|100772317|FG007|STARTED|Overall Study||6||
48183924|NCT02448719|100772318|FG008|STARTED|Overall Study||6||
48183925|NCT02448719|100772319|FG009|STARTED|Overall Study||6||
48183926|NCT02448719|100772320|FG010|STARTED|Overall Study||6||
48183927|NCT02448719|100772310|FG000|COMPLETED|Overall Study||12||
48183928|NCT02448719|100772311|FG001|COMPLETED|Overall Study||6||
48183929|NCT02448719|100772312|FG002|COMPLETED|Overall Study||6||
48183930|NCT02448719|100772313|FG003|COMPLETED|Overall Study||6||
48183931|NCT02448719|100772314|FG004|COMPLETED|Overall Study||5||
48183932|NCT02448719|100772315|FG005|COMPLETED|Overall Study||6||
48183933|NCT02448719|100772316|FG006|COMPLETED|Overall Study||6||
48344601|NCT00924703|101172382|FG000|STARTED|Overall Study||68||
48344602|NCT00924703|101172382|FG000|COMPLETED|Overall Study||46||
48344603|NCT00924703|101172382|FG000|NOT COMPLETED|Overall Study||22||
48344604|NCT01805180|101172383|FG000|STARTED|Lead-in Donor Phase||7||
48344605|NCT01805180|101172384|FG001|STARTED|Lead-in Donor Phase||0||
48635247|NCT02511717|101891813|FG000|STARTED|Overall Study||10||
48635248|NCT02511717|101891814|FG001|STARTED|Overall Study||10||
48635249|NCT02511717|101891813|FG000|COMPLETED|Overall Study||8||
48635250|NCT02511717|101891814|FG001|COMPLETED|Overall Study||10||
48635251|NCT02511717|101891813|FG000|NOT COMPLETED|Overall Study||2||
48635252|NCT02511717|101891814|FG001|NOT COMPLETED|Overall Study||0||
48635253|NCT02721069|101891815|FG000|STARTED|Overall Study||175||
48758411|NCT03020667|102197613|FG001|COMPLETED|At Month 15||18||
48758412|NCT03020667|102197614|FG002|COMPLETED|At Month 15||31||
48758413|NCT03020667|102197615|FG003|COMPLETED|At Month 15||98||
48758414|NCT03020667|102197616|FG004|COMPLETED|At Month 15||10||
48758415|NCT03020667|102197617|FG005|COMPLETED|At Month 15||1||
48758416|NCT03020667|102197612|FG000|NOT COMPLETED|At Month 15||3||
48758417|NCT03020667|102197613|FG001|NOT COMPLETED|At Month 15||10||
48758418|NCT03020667|102197614|FG002|NOT COMPLETED|At Month 15||44||
48758419|NCT03020667|102197615|FG003|NOT COMPLETED|At Month 15||36||
48758420|NCT03020667|102197616|FG004|NOT COMPLETED|At Month 15||63||
48758421|NCT03020667|102197617|FG005|NOT COMPLETED|At Month 15||0||
48758422|NCT03020667|102197612|FG000|STARTED|At Month 18||1||
48758423|NCT03020667|102197613|FG001|STARTED|At Month 18||18||
48758424|NCT03020667|102197614|FG002|STARTED|At Month 18||31||
48758425|NCT03020667|102197615|FG003|STARTED|At Month 18||98||
48758426|NCT03020667|102197616|FG004|STARTED|At Month 18||10||
48758427|NCT03020667|102197617|FG005|STARTED|At Month 18||1||
48758428|NCT03020667|102197612|FG000|COMPLETED|At Month 18||0||
48758429|NCT03020667|102197613|FG001|COMPLETED|At Month 18||6||
48758430|NCT03020667|102197614|FG002|COMPLETED|At Month 18||22||
48758431|NCT03020667|102197615|FG003|COMPLETED|At Month 18||48||
48758432|NCT03020667|102197616|FG004|COMPLETED|At Month 18||7||
48758433|NCT03020667|102197617|FG005|COMPLETED|At Month 18||0||
48758434|NCT03020667|102197612|FG000|NOT COMPLETED|At Month 18||1||
48183934|NCT02448719|100772317|FG007|COMPLETED|Overall Study||6||
48344606|NCT01805180|101172385|FG002|STARTED|Lead-in Donor Phase||0||
48344607|NCT01805180|101172383|FG000|COMPLETED|Lead-in Donor Phase||6||
48758435|NCT03020667|102197613|FG001|NOT COMPLETED|At Month 18||12||
48183935|NCT02448719|100772318|FG008|COMPLETED|Overall Study||6||
48183936|NCT02448719|100772319|FG009|COMPLETED|Overall Study||6||
48183937|NCT02448719|100772320|FG010|COMPLETED|Overall Study||6||
48183938|NCT02448719|100772310|FG000|NOT COMPLETED|Overall Study||0||
48344608|NCT01805180|101172384|FG001|COMPLETED|Lead-in Donor Phase||0||
48344609|NCT01805180|101172385|FG002|COMPLETED|Lead-in Donor Phase||0||
48758436|NCT03020667|102197614|FG002|NOT COMPLETED|At Month 18||9||
48758437|NCT03020667|102197615|FG003|NOT COMPLETED|At Month 18||50||
48758438|NCT03020667|102197616|FG004|NOT COMPLETED|At Month 18||3||
48758439|NCT03020667|102197617|FG005|NOT COMPLETED|At Month 18||1||
48758440|NCT02538510|102197618|FG000|STARTED|Overall Study||25||
48758441|NCT02538510|102197619|FG001|STARTED|Overall Study||25||
48183939|NCT02448719|100772311|FG001|NOT COMPLETED|Overall Study||0||
48635254|NCT02721069|101891815|FG000|COMPLETED|Overall Study||117||
48635255|NCT02721069|101891815|FG000|NOT COMPLETED|Overall Study||58||
48183940|NCT02448719|100772312|FG002|NOT COMPLETED|Overall Study||0||
48758442|NCT02538510|102197618|FG000|COMPLETED|Overall Study||25||
48758443|NCT02538510|102197619|FG001|COMPLETED|Overall Study||25||
48758444|NCT02538510|102197618|FG000|NOT COMPLETED|Overall Study||0||
48758445|NCT02538510|102197619|FG001|NOT COMPLETED|Overall Study||0||
48758446|NCT00771758|102197620|FG000|STARTED|Overall Study||44||
48758447|NCT00771758|102197621|FG001|STARTED|Overall Study||43||
48758448|NCT00771758|102197622|FG002|STARTED|Overall Study||21||
48758449|NCT00771758|102197620|FG000|COMPLETED|Overall Study||36||
48758450|NCT00771758|102197621|FG001|COMPLETED|Overall Study||31||
48758451|NCT00771758|102197622|FG002|COMPLETED|Overall Study||19||
48758452|NCT00771758|102197620|FG000|NOT COMPLETED|Overall Study||8||
48758453|NCT00771758|102197621|FG001|NOT COMPLETED|Overall Study||12||
48758454|NCT00771758|102197622|FG002|NOT COMPLETED|Overall Study||2||
48758455|NCT00383786|102197623|FG000|STARTED|Overall Study||22||
48635256|NCT00962598|101891816|FG000|STARTED|Overall Study||7||
48183941|NCT02448719|100772313|FG003|NOT COMPLETED|Overall Study||0||
48183942|NCT02448719|100772314|FG004|NOT COMPLETED|Overall Study||1||
48635257|NCT00962598|101891817|FG001|STARTED|Overall Study||9||
48635258|NCT00962598|101891816|FG000|COMPLETED|Overall Study||7||
48635259|NCT00962598|101891817|FG001|COMPLETED|Overall Study||9||
48635260|NCT00962598|101891816|FG000|NOT COMPLETED|Overall Study||0||
48635261|NCT00962598|101891817|FG001|NOT COMPLETED|Overall Study||0||
48635262|NCT01202591|101891818|FG000|STARTED|Overall Study||5||
48635263|NCT01202591|101891819|FG001|STARTED|Overall Study||5||
48635264|NCT01202591|101891820|FG002|STARTED|Overall Study||12||
48635265|NCT01202591|101891821|FG003|STARTED|Overall Study||9||
48183943|NCT02448719|100772315|FG005|NOT COMPLETED|Overall Study||0||
48183944|NCT02448719|100772316|FG006|NOT COMPLETED|Overall Study||0||
48183945|NCT02448719|100772317|FG007|NOT COMPLETED|Overall Study||0||
48183946|NCT02448719|100772318|FG008|NOT COMPLETED|Overall Study||0||
48183947|NCT02448719|100772319|FG009|NOT COMPLETED|Overall Study||0||
48183948|NCT02448719|100772320|FG010|NOT COMPLETED|Overall Study||0||
48183949|NCT05641077|100772321|FG000|STARTED|Overall Study||50||
48635266|NCT01202591|101891822|FG004|STARTED|Overall Study||5||
48635267|NCT01202591|101891823|FG005|STARTED|Overall Study||4||
48635268|NCT01202591|101891818|FG000|COMPLETED|Overall Study||0||
48635269|NCT01202591|101891819|FG001|COMPLETED|Overall Study||0||
48635270|NCT01202591|101891820|FG002|COMPLETED|Overall Study||1||
48758456|NCT00383786|102197624|FG001|STARTED|Overall Study||25||
48758457|NCT00383786|102197623|FG000|COMPLETED|Overall Study||18||
48758458|NCT00383786|102197624|FG001|COMPLETED|Overall Study||13||
48344610|NCT01805180|101172383|FG000|NOT COMPLETED|Lead-in Donor Phase||1||
48344611|NCT01805180|101172384|FG001|NOT COMPLETED|Lead-in Donor Phase||0||
48344612|NCT01805180|101172385|FG002|NOT COMPLETED|Lead-in Donor Phase||0||
48635271|NCT01202591|101891821|FG003|COMPLETED|Overall Study||2||
48635272|NCT01202591|101891822|FG004|COMPLETED|Overall Study||0||
48635273|NCT01202591|101891823|FG005|COMPLETED|Overall Study||0||
48635274|NCT01202591|101891818|FG000|NOT COMPLETED|Overall Study||5||
48183950|NCT05641077|100772322|FG001|STARTED|Overall Study||50||
48183951|NCT05641077|100772321|FG000|COMPLETED|Overall Study||50||
48183952|NCT05641077|100772322|FG001|COMPLETED|Overall Study||50||
48183953|NCT05641077|100772321|FG000|NOT COMPLETED|Overall Study||0||
48183954|NCT05641077|100772322|FG001|NOT COMPLETED|Overall Study||0||
48183955|NCT02427646|100772323|FG000|STARTED|Overall Study||24||
48344613|NCT01805180|101172383|FG000|STARTED|Pivotal Randomization Through Study Exit||0||
48635275|NCT01202591|101891819|FG001|NOT COMPLETED|Overall Study||5||
48635276|NCT01202591|101891820|FG002|NOT COMPLETED|Overall Study||11||
48635277|NCT01202591|101891821|FG003|NOT COMPLETED|Overall Study||7||
48635278|NCT01202591|101891822|FG004|NOT COMPLETED|Overall Study||5||
48183956|NCT02427646|100772324|FG001|STARTED|Overall Study||28||
48183957|NCT02427646|100772323|FG000|COMPLETED|Overall Study||16||
48635279|NCT01202591|101891823|FG005|NOT COMPLETED|Overall Study||4||
48758459|NCT00383786|102197623|FG000|NOT COMPLETED|Overall Study||4||
48183958|NCT02427646|100772324|FG001|COMPLETED|Overall Study||14||
48183959|NCT02427646|100772323|FG000|NOT COMPLETED|Overall Study||8||
48414730|NCT02371980|101350124|FG000|NOT COMPLETED|Double-blind Period||0||
48414731|NCT02371980|101350125|FG001|NOT COMPLETED|Double-blind Period||81||
48344614|NCT01805180|101172384|FG001|STARTED|Pivotal Randomization Through Study Exit||22||
48183960|NCT02427646|100772324|FG001|NOT COMPLETED|Overall Study||14||
48183961|NCT01880554|100772325|FG000|STARTED|Overall Study||68||
48183962|NCT01880554|100772325|FG000|Population Eligible|Overall Study||58||
48183963|NCT01880554|100772325|FG000|Population Eligible and Assessable|Overall Study||54||
48183964|NCT01880554|100772325|FG000|COMPLETED|Overall Study||52||
48183965|NCT01880554|100772325|FG000|NOT COMPLETED|Overall Study||16||
48183966|NCT03929302|100772326|FG000|STARTED|Neurocognitive and MRS Testing||15|Part A enrollment|
48183967|NCT03929302|100772327|FG001|STARTED|Neurocognitive and MRS Testing||15|Part A enrollment|
48344615|NCT01805180|101172385|FG002|STARTED|Pivotal Randomization Through Study Exit||20||
48758460|NCT00383786|102197624|FG001|NOT COMPLETED|Overall Study||12||
48758461|NCT04798183|102197625|FG000|STARTED|Overall Study||14||
48758462|NCT04798183|102197626|FG001|STARTED|Overall Study||14||
48758463|NCT04798183|102197625|FG000|COMPLETED|Overall Study||14||
48758464|NCT04798183|102197626|FG001|COMPLETED|Overall Study||14||
48183968|NCT03929302|100772328|FG002|STARTED|Neurocognitive and MRS Testing||11|Part A enrollment|
48183969|NCT03929302|100772326|FG000|COMPLETED|Neurocognitive and MRS Testing||15||
48344616|NCT01805180|101172383|FG000|COMPLETED|Pivotal Randomization Through Study Exit||0||
48344617|NCT01805180|101172384|FG001|COMPLETED|Pivotal Randomization Through Study Exit||17||
48344618|NCT01805180|101172385|FG002|COMPLETED|Pivotal Randomization Through Study Exit||15||
48344619|NCT01805180|101172383|FG000|NOT COMPLETED|Pivotal Randomization Through Study Exit||0||
48344620|NCT01805180|101172384|FG001|NOT COMPLETED|Pivotal Randomization Through Study Exit||5||
48344621|NCT01805180|101172385|FG002|NOT COMPLETED|Pivotal Randomization Through Study Exit||5||
48344622|NCT00670709|101172386|FG000|STARTED|Overall Study||27||
48344623|NCT00670709|101172387|FG001|STARTED|Overall Study||15||
48344624|NCT00670709|101172386|FG000|COMPLETED|Overall Study||27||
48344625|NCT00670709|101172387|FG001|COMPLETED|Overall Study||15||
48344626|NCT00670709|101172386|FG000|NOT COMPLETED|Overall Study||0||
48344627|NCT00670709|101172387|FG001|NOT COMPLETED|Overall Study||0||
48344628|NCT04711837|101172388|FG000|STARTED|Overall Study||170||
48344629|NCT04711837|101172389|FG001|STARTED|Overall Study||85||
48344630|NCT04711837|101172388|FG000|COMPLETED|Overall Study||168||
48344631|NCT04711837|101172389|FG001|COMPLETED|Overall Study||83||
48344632|NCT04711837|101172388|FG000|NOT COMPLETED|Overall Study||2||
48344633|NCT04711837|101172389|FG001|NOT COMPLETED|Overall Study||2||
48344634|NCT01832961|101172390|FG000|STARTED|First Intervention||8||
48344635|NCT01832961|101172391|FG001|STARTED|First Intervention||7||
48344636|NCT01832961|101172390|FG000|COMPLETED|First Intervention||8||
48344637|NCT01832961|101172391|FG001|COMPLETED|First Intervention||7||
48344638|NCT01832961|101172390|FG000|NOT COMPLETED|First Intervention||0||
48344639|NCT01832961|101172391|FG001|NOT COMPLETED|First Intervention||0||
48344640|NCT01832961|101172390|FG000|STARTED|Washout||8||
48344641|NCT01832961|101172391|FG001|STARTED|Washout||7||
48344642|NCT01832961|101172390|FG000|COMPLETED|Washout||8||
48344643|NCT01832961|101172391|FG001|COMPLETED|Washout||7||
48344644|NCT01832961|101172390|FG000|NOT COMPLETED|Washout||0||
48344645|NCT01832961|101172391|FG001|NOT COMPLETED|Washout||0||
48344646|NCT01832961|101172390|FG000|STARTED|Second Intervention||8||
48344647|NCT01832961|101172391|FG001|STARTED|Second Intervention||7||
48344648|NCT01832961|101172390|FG000|COMPLETED|Second Intervention||8||
48414732|NCT02371980|101350126|FG002|NOT COMPLETED|Double-blind Period||56||
48414733|NCT02371980|101350127|FG003|NOT COMPLETED|Double-blind Period||49||
48344649|NCT01832961|101172391|FG001|COMPLETED|Second Intervention||7||
48414734|NCT02371980|101350128|FG004|NOT COMPLETED|Double-blind Period||58||
48414735|NCT00498706|101350129|FG000|STARTED|Overall Study||163||
48414736|NCT00498706|101350130|FG001|STARTED|Overall Study||162||
48183970|NCT03929302|100772327|FG001|COMPLETED|Neurocognitive and MRS Testing||15||
48183971|NCT03929302|100772328|FG002|COMPLETED|Neurocognitive and MRS Testing||11||
48183972|NCT03929302|100772326|FG000|NOT COMPLETED|Neurocognitive and MRS Testing||0||
48183973|NCT03929302|100772327|FG001|NOT COMPLETED|Neurocognitive and MRS Testing||0||
48183974|NCT03929302|100772328|FG002|NOT COMPLETED|Neurocognitive and MRS Testing||0||
48183975|NCT03929302|100772326|FG000|STARTED|Intervention - myTAP Mouth Shield||15||
48183976|NCT03929302|100772327|FG001|STARTED|Intervention - myTAP Mouth Shield||15||
48183977|NCT03929302|100772328|FG002|STARTED|Intervention - myTAP Mouth Shield||11||
48344650|NCT01832961|101172390|FG000|NOT COMPLETED|Second Intervention||0||
48344651|NCT01832961|101172391|FG001|NOT COMPLETED|Second Intervention||0||
48344652|NCT01832961|101172390|FG000|STARTED|Third Intervention||8||
48344653|NCT01832961|101172391|FG001|STARTED|Third Intervention||7||
48414737|NCT00498706|101350129|FG000|Post Treatment Week 18|Overall Study||163||
48758465|NCT04798183|102197625|FG000|NOT COMPLETED|Overall Study||0||
48183978|NCT03929302|100772326|FG000|COMPLETED|Intervention - myTAP Mouth Shield||7||
48344654|NCT01832961|101172390|FG000|COMPLETED|Third Intervention||8||
48344655|NCT01832961|101172391|FG001|COMPLETED|Third Intervention||7||
48344656|NCT01832961|101172390|FG000|NOT COMPLETED|Third Intervention||0||
48344657|NCT01832961|101172391|FG001|NOT COMPLETED|Third Intervention||0||
48758466|NCT04798183|102197626|FG001|NOT COMPLETED|Overall Study||0||
48183979|NCT03929302|100772327|FG001|COMPLETED|Intervention - myTAP Mouth Shield||7||
48183980|NCT03929302|100772328|FG002|COMPLETED|Intervention - myTAP Mouth Shield||6||
48183981|NCT03929302|100772326|FG000|NOT COMPLETED|Intervention - myTAP Mouth Shield||8||
48344658|NCT04378426|101172392|FG000|STARTED|Overall Study||1||
48344659|NCT04378426|101172393|FG001|STARTED|Overall Study||0||
48344660|NCT04378426|101172392|FG000|COMPLETED|Overall Study||1||
48344661|NCT04378426|101172393|FG001|COMPLETED|Overall Study||0||
48344662|NCT04378426|101172392|FG000|NOT COMPLETED|Overall Study||0||
48344663|NCT04378426|101172393|FG001|NOT COMPLETED|Overall Study||0||
48344664|NCT01846455|101172394|FG000|STARTED|Overall Study||9||
48344665|NCT01846455|101172395|FG001|STARTED|Overall Study||8||
48344666|NCT01846455|101172396|FG002|STARTED|Overall Study||8||
48635280|NCT00765076|101891824|FG000|STARTED|Overall Study||69||
48635281|NCT00765076|101891825|FG001|STARTED|Overall Study||73||
48635282|NCT00765076|101891826|FG002|STARTED|Overall Study||50||
48635283|NCT00765076|101891824|FG000|COMPLETED|Overall Study||68||
48183982|NCT03929302|100772327|FG001|NOT COMPLETED|Intervention - myTAP Mouth Shield||8||
48183983|NCT03929302|100772328|FG002|NOT COMPLETED|Intervention - myTAP Mouth Shield||5||
48183984|NCT01845636|100772329|FG000|STARTED|Overall Study||41||
48344667|NCT01846455|101172397|FG003|STARTED|Overall Study||10||
48344668|NCT01846455|101172398|FG004|STARTED|Overall Study||8||
48344669|NCT01846455|101172394|FG000|PK Population|Overall Study||6||
48344670|NCT01846455|101172395|FG001|PK Population|Overall Study||7||
48344671|NCT01846455|101172396|FG002|PK Population|Overall Study||6||
48344672|NCT01846455|101172397|FG003|PK Population|Overall Study||6||
48344673|NCT01846455|101172398|FG004|PK Population|Overall Study||8||
48344674|NCT01846455|101172394|FG000|COMPLETED|Overall Study||9||
48344675|NCT01846455|101172395|FG001|COMPLETED|Overall Study||8||
48344676|NCT01846455|101172396|FG002|COMPLETED|Overall Study||8||
48344677|NCT01846455|101172397|FG003|COMPLETED|Overall Study||10||
48344678|NCT01846455|101172398|FG004|COMPLETED|Overall Study||8||
48344679|NCT01846455|101172394|FG000|NOT COMPLETED|Overall Study||0||
48344680|NCT01846455|101172395|FG001|NOT COMPLETED|Overall Study||0||
48344681|NCT01846455|101172396|FG002|NOT COMPLETED|Overall Study||0||
48344682|NCT01846455|101172397|FG003|NOT COMPLETED|Overall Study||0||
48344683|NCT01846455|101172398|FG004|NOT COMPLETED|Overall Study||0||
48344684|NCT01147926|101172399|FG000|STARTED|Overall Study||187||
48344685|NCT01147926|101172400|FG001|STARTED|Overall Study||187||
48344686|NCT01147926|101172399|FG000|COMPLETED|Overall Study||160||
48344687|NCT01147926|101172400|FG001|COMPLETED|Overall Study||158||
48344688|NCT01147926|101172399|FG000|NOT COMPLETED|Overall Study||27||
48344689|NCT01147926|101172400|FG001|NOT COMPLETED|Overall Study||29||
48344690|NCT01662648|101172401|FG000|STARTED|Overall Study||520||
48344691|NCT01662648|101172402|FG001|STARTED|Overall Study||597||
48344692|NCT01662648|101172401|FG000|COMPLETED|Overall Study||373||
48344693|NCT01662648|101172402|FG001|COMPLETED|Overall Study||419||
48635284|NCT00765076|101891825|FG001|COMPLETED|Overall Study||73||
48635285|NCT00765076|101891826|FG002|COMPLETED|Overall Study||49||
48635286|NCT00765076|101891824|FG000|NOT COMPLETED|Overall Study||1||
48635287|NCT00765076|101891825|FG001|NOT COMPLETED|Overall Study||0||
48635288|NCT00765076|101891826|FG002|NOT COMPLETED|Overall Study||1||
48183985|NCT01845636|100772329|FG000|COMPLETED|Overall Study||37||
48183986|NCT01845636|100772329|FG000|NOT COMPLETED|Overall Study||4||
48183987|NCT01712789|100772330|FG000|STARTED|Overall Study||682||
48183988|NCT01712789|100772330|FG000|Received Study Treatment|Overall Study||676||
48183989|NCT01712789|100772330|FG000|COMPLETED|Overall Study||0|"Completed = did not discontinue treatment~Note: Reason for Not Completed below equates to Reason for Treatment Discontinuation"|
48183990|NCT01712789|100772330|FG000|NOT COMPLETED|Overall Study||682||
48344694|NCT01662648|101172401|FG000|NOT COMPLETED|Overall Study||147||
48344695|NCT01662648|101172402|FG001|NOT COMPLETED|Overall Study||178||
48344696|NCT01790490|101172403|FG000|STARTED|Overall Study||3||
48344697|NCT01790490|101172404|FG001|STARTED|Overall Study||3||
48344698|NCT01790490|101172405|FG002|STARTED|Overall Study||2||
48344699|NCT01790490|101172403|FG000|COMPLETED|Overall Study||3||
48344700|NCT01790490|101172404|FG001|COMPLETED|Overall Study||3||
48344701|NCT01790490|101172405|FG002|COMPLETED|Overall Study||2||
48344702|NCT01790490|101172403|FG000|NOT COMPLETED|Overall Study||0||
48344703|NCT01790490|101172404|FG001|NOT COMPLETED|Overall Study||0||
48344704|NCT01790490|101172405|FG002|NOT COMPLETED|Overall Study||0||
48344705|NCT03968419|101172406|FG000|STARTED|Treatment Period||35||
48344706|NCT03968419|101172407|FG001|STARTED|Treatment Period||35||
48344707|NCT03968419|101172408|FG002|STARTED|Treatment Period||18||
48344708|NCT03968419|101172406|FG000|COMPLETED|Treatment Period||35||
48635289|NCT03550209|101891827|FG000|STARTED|Overall Study||12||
48635290|NCT03550209|101891828|FG001|STARTED|Overall Study||12||
48758467|NCT01436149|102197627|FG000|STARTED|Antidepressant Lead-in Phase||1262||
48344709|NCT03968419|101172407|FG001|COMPLETED|Treatment Period||35||
48344710|NCT03968419|101172408|FG002|COMPLETED|Treatment Period||17||
48344711|NCT03968419|101172406|FG000|NOT COMPLETED|Treatment Period||0||
48344712|NCT03968419|101172407|FG001|NOT COMPLETED|Treatment Period||0||
48344713|NCT03968419|101172408|FG002|NOT COMPLETED|Treatment Period||1||
48635291|NCT03550209|101891829|FG002|STARTED|Overall Study||13||
48183991|NCT01561079|100772331|FG000|STARTED|Overall Study||127||
48183992|NCT01561079|100772331|FG000|COMPLETED|Overall Study||49||
48183993|NCT01561079|100772331|FG000|NOT COMPLETED|Overall Study||78||
48183994|NCT02071095|100772332|FG000|STARTED|Overall Study||12||
48183995|NCT02071095|100772333|FG001|STARTED|Overall Study||3||
48183996|NCT02071095|100772332|FG000|COMPLETED|Overall Study||12||
48183997|NCT02071095|100772333|FG001|COMPLETED|Overall Study||3||
48183998|NCT02071095|100772332|FG000|NOT COMPLETED|Overall Study||0||
48183999|NCT02071095|100772333|FG001|NOT COMPLETED|Overall Study||0||
48184000|NCT01318811|100772334|FG000|STARTED|Overall Study||4||
48184001|NCT01318811|100772335|FG001|STARTED|Overall Study||8||
48184002|NCT01318811|100772334|FG000|COMPLETED|Overall Study||3||
48184003|NCT01318811|100772335|FG001|COMPLETED|Overall Study||4||
48184004|NCT01318811|100772334|FG000|NOT COMPLETED|Overall Study||1||
48184005|NCT01318811|100772335|FG001|NOT COMPLETED|Overall Study||4||
48184006|NCT00739583|100772336|FG000|STARTED|Overall Study||10||
48184007|NCT00739583|100772337|FG001|STARTED|Overall Study||10||
48184008|NCT00739583|100772336|FG000|COMPLETED|Overall Study||10||
48184009|NCT00739583|100772337|FG001|COMPLETED|Overall Study||10||
48344714|NCT03968419|101172406|FG000|STARTED|Safety Follow-up Period||35||
48344715|NCT03968419|101172407|FG001|STARTED|Safety Follow-up Period||35||
48344716|NCT03968419|101172408|FG002|STARTED|Safety Follow-up Period||18||
48758468|NCT01436149|102197628|FG001|STARTED|Antidepressant Lead-in Phase||0||
48758469|NCT01436149|102197629|FG002|STARTED|Antidepressant Lead-in Phase||0||
48758470|NCT01436149|102197627|FG000|COMPLETED|Antidepressant Lead-in Phase||896||
48758471|NCT01436149|102197628|FG001|COMPLETED|Antidepressant Lead-in Phase||0||
48184010|NCT00739583|100772336|FG000|NOT COMPLETED|Overall Study||0||
48184011|NCT00739583|100772337|FG001|NOT COMPLETED|Overall Study||0||
48184012|NCT01349907|100772338|FG000|STARTED|Overall Study||241||
48184013|NCT01349907|100772339|FG001|STARTED|Overall Study||81||
48184014|NCT01349907|100772338|FG000|COMPLETED|Overall Study||102||
48184015|NCT01349907|100772339|FG001|COMPLETED|Overall Study||38||
48184016|NCT01349907|100772338|FG000|NOT COMPLETED|Overall Study||139||
48184017|NCT01349907|100772339|FG001|NOT COMPLETED|Overall Study||43||
48184018|NCT02169830|100772340|FG000|STARTED|Diet Intervention (4 Weeks)||0||
48184019|NCT02169830|100772341|FG001|STARTED|Diet Intervention (4 Weeks)||0||
48184020|NCT02169830|100772342|FG002|STARTED|Diet Intervention (4 Weeks)||33||
48184021|NCT02169830|100772340|FG000|COMPLETED|Diet Intervention (4 Weeks)||0||
48184022|NCT02169830|100772341|FG001|COMPLETED|Diet Intervention (4 Weeks)||0||
48184023|NCT02169830|100772342|FG002|COMPLETED|Diet Intervention (4 Weeks)||32||
48184024|NCT02169830|100772340|FG000|NOT COMPLETED|Diet Intervention (4 Weeks)||0||
48184025|NCT02169830|100772341|FG001|NOT COMPLETED|Diet Intervention (4 Weeks)||0||
48184026|NCT02169830|100772342|FG002|NOT COMPLETED|Diet Intervention (4 Weeks)||1||
48184027|NCT02169830|100772340|FG000|STARTED|Second Intervention (8 Weeks)||12||
48184028|NCT02169830|100772341|FG001|STARTED|Second Intervention (8 Weeks)||5||
48184029|NCT02169830|100772342|FG002|STARTED|Second Intervention (8 Weeks)||0||
48758472|NCT01436149|102197629|FG002|COMPLETED|Antidepressant Lead-in Phase||0||
48758473|NCT01436149|102197627|FG000|NOT COMPLETED|Antidepressant Lead-in Phase||366||
48184030|NCT02169830|100772340|FG000|COMPLETED|Second Intervention (8 Weeks)||9||
48184031|NCT02169830|100772341|FG001|COMPLETED|Second Intervention (8 Weeks)||0||
48184032|NCT02169830|100772342|FG002|COMPLETED|Second Intervention (8 Weeks)||0||
48184033|NCT02169830|100772340|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||3||
48184034|NCT02169830|100772341|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||5||
48184035|NCT02169830|100772342|FG002|NOT COMPLETED|Second Intervention (8 Weeks)||0||
48184036|NCT02169830|100772340|FG000|STARTED|Third Intervention (8 Weeks)||0||
48184037|NCT02169830|100772341|FG001|STARTED|Third Intervention (8 Weeks)||4||
48184038|NCT02169830|100772342|FG002|STARTED|Third Intervention (8 Weeks)||0||
48184039|NCT02169830|100772340|FG000|COMPLETED|Third Intervention (8 Weeks)||0||
48184040|NCT02169830|100772341|FG001|COMPLETED|Third Intervention (8 Weeks)||2||
48184041|NCT02169830|100772342|FG002|COMPLETED|Third Intervention (8 Weeks)||0||
48184042|NCT02169830|100772340|FG000|NOT COMPLETED|Third Intervention (8 Weeks)||0||
48184043|NCT02169830|100772341|FG001|NOT COMPLETED|Third Intervention (8 Weeks)||2||
48184044|NCT02169830|100772342|FG002|NOT COMPLETED|Third Intervention (8 Weeks)||0||
48184045|NCT00832260|100772343|FG000|STARTED|Overall Study||70||
48184046|NCT00832260|100772343|FG000|COMPLETED|Overall Study||70||
48184047|NCT00832260|100772343|FG000|NOT COMPLETED|Overall Study||0||
48184048|NCT02521259|100772344|FG000|STARTED|Overall Study||35||
48184049|NCT02521259|100772345|FG001|STARTED|Overall Study||33||
48184050|NCT02521259|100772344|FG000|COMPLETED|Overall Study||34||
48184051|NCT02521259|100772345|FG001|COMPLETED|Overall Study||28||
48344717|NCT03968419|101172406|FG000|COMPLETED|Safety Follow-up Period||30||
48344718|NCT03968419|101172407|FG001|COMPLETED|Safety Follow-up Period||32||
48758474|NCT01436149|102197628|FG001|NOT COMPLETED|Antidepressant Lead-in Phase||0||
48758475|NCT01436149|102197629|FG002|NOT COMPLETED|Antidepressant Lead-in Phase||0||
48184052|NCT02521259|100772344|FG000|NOT COMPLETED|Overall Study||1||
48184053|NCT02521259|100772345|FG001|NOT COMPLETED|Overall Study||5||
48184054|NCT00610883|100772346|FG000|STARTED|Overall Study||17||
48184055|NCT00610883|100772346|FG000|COMPLETED|Overall Study||17||
48184056|NCT00610883|100772346|FG000|NOT COMPLETED|Overall Study||0||
48184057|NCT00738530|100772347|FG000|STARTED|Overall Study||327||
48184058|NCT00738530|100772348|FG001|STARTED|Overall Study||322||
48184059|NCT00738530|100772347|FG000|Treated|Overall Study||325||
48184060|NCT00738530|100772348|FG001|Treated|Overall Study||316||
48184061|NCT00738530|100772347|FG000|COMPLETED|Overall Study||93||
48184062|NCT00738530|100772348|FG001|COMPLETED|Overall Study||84||
48184063|NCT00738530|100772347|FG000|NOT COMPLETED|Overall Study||234||
48184064|NCT00738530|100772348|FG001|NOT COMPLETED|Overall Study||238||
48344719|NCT03968419|101172408|FG002|COMPLETED|Safety Follow-up Period||17||
48344720|NCT03968419|101172406|FG000|NOT COMPLETED|Safety Follow-up Period||5||
48344721|NCT03968419|101172407|FG001|NOT COMPLETED|Safety Follow-up Period||3||
48344722|NCT03968419|101172408|FG002|NOT COMPLETED|Safety Follow-up Period||1||
48635292|NCT03550209|101891830|FG003|STARTED|Overall Study||35||
48635293|NCT03550209|101891827|FG000|COMPLETED|Overall Study||11||
48344723|NCT00582517|101172409|FG000|STARTED|Overall Study||45||
48758476|NCT01436149|102197627|FG000|STARTED|Randomized Phase||492||
48344724|NCT00582517|101172410|FG001|STARTED|Overall Study||55||
48344725|NCT00582517|101172409|FG000|COMPLETED|Overall Study||45||
48344726|NCT00582517|101172410|FG001|COMPLETED|Overall Study||55||
48344727|NCT00582517|101172409|FG000|NOT COMPLETED|Overall Study||0||
48344728|NCT00582517|101172410|FG001|NOT COMPLETED|Overall Study||0||
48344729|NCT01808560|101172411|FG000|STARTED|Randomization and Treatment Allocation||18||
48344730|NCT01808560|101172412|FG001|STARTED|Randomization and Treatment Allocation||16||
48344731|NCT01808560|101172413|FG002|STARTED|Randomization and Treatment Allocation||0||
48344732|NCT01808560|101172411|FG000|COMPLETED|Randomization and Treatment Allocation||18||
48344733|NCT01808560|101172412|FG001|COMPLETED|Randomization and Treatment Allocation||16||
48344734|NCT01808560|101172413|FG002|COMPLETED|Randomization and Treatment Allocation||0||
48344735|NCT01808560|101172411|FG000|NOT COMPLETED|Randomization and Treatment Allocation||0||
48344736|NCT01808560|101172412|FG001|NOT COMPLETED|Randomization and Treatment Allocation||0||
48344737|NCT01808560|101172413|FG002|NOT COMPLETED|Randomization and Treatment Allocation||0||
48344738|NCT01808560|101172411|FG000|STARTED|1-Month After Cataract Surgery||16||
48344739|NCT01808560|101172412|FG001|STARTED|1-Month After Cataract Surgery||13||
48344740|NCT01808560|101172413|FG002|STARTED|1-Month After Cataract Surgery||0||
48344741|NCT01808560|101172411|FG000|COMPLETED|1-Month After Cataract Surgery||16||
48344742|NCT01808560|101172412|FG001|COMPLETED|1-Month After Cataract Surgery||13||
48344743|NCT01808560|101172413|FG002|COMPLETED|1-Month After Cataract Surgery||0||
48344744|NCT01808560|101172411|FG000|NOT COMPLETED|1-Month After Cataract Surgery||0||
48344745|NCT01808560|101172412|FG001|NOT COMPLETED|1-Month After Cataract Surgery||0||
48344746|NCT01808560|101172413|FG002|NOT COMPLETED|1-Month After Cataract Surgery||0||
48344747|NCT01808560|101172411|FG000|STARTED|3-Month After Cataract Surgery||17||
48344748|NCT01808560|101172412|FG001|STARTED|3-Month After Cataract Surgery||13||
48344749|NCT01808560|101172413|FG002|STARTED|3-Month After Cataract Surgery||0||
48344750|NCT01808560|101172411|FG000|COMPLETED|3-Month After Cataract Surgery||17||
48344751|NCT01808560|101172412|FG001|COMPLETED|3-Month After Cataract Surgery||13||
48344752|NCT01808560|101172413|FG002|COMPLETED|3-Month After Cataract Surgery||0||
48344753|NCT01808560|101172411|FG000|NOT COMPLETED|3-Month After Cataract Surgery||0||
48344754|NCT01808560|101172412|FG001|NOT COMPLETED|3-Month After Cataract Surgery||0||
48344755|NCT01808560|101172413|FG002|NOT COMPLETED|3-Month After Cataract Surgery||0||
48344756|NCT01808560|101172411|FG000|STARTED|Crossover Treatment||0||
48344757|NCT01808560|101172412|FG001|STARTED|Crossover Treatment||0||
48344758|NCT01808560|101172413|FG002|STARTED|Crossover Treatment||13||
48344759|NCT01808560|101172411|FG000|COMPLETED|Crossover Treatment||0||
48344760|NCT01808560|101172412|FG001|COMPLETED|Crossover Treatment||0||
48344761|NCT01808560|101172413|FG002|COMPLETED|Crossover Treatment||13||
48344762|NCT01808560|101172411|FG000|NOT COMPLETED|Crossover Treatment||0||
48344763|NCT01808560|101172412|FG001|NOT COMPLETED|Crossover Treatment||0||
48344764|NCT01808560|101172413|FG002|NOT COMPLETED|Crossover Treatment||0||
48635294|NCT03550209|101891828|FG001|COMPLETED|Overall Study||9||
48635295|NCT03550209|101891829|FG002|COMPLETED|Overall Study||11||
48635296|NCT03550209|101891830|FG003|COMPLETED|Overall Study||31||
48635297|NCT03550209|101891827|FG000|NOT COMPLETED|Overall Study||1||
48635298|NCT03550209|101891828|FG001|NOT COMPLETED|Overall Study||3||
48635299|NCT03550209|101891829|FG002|NOT COMPLETED|Overall Study||2||
48635300|NCT03550209|101891830|FG003|NOT COMPLETED|Overall Study||4||
48344765|NCT01808560|101172411|FG000|STARTED|4-Month After Cataract Surgery||0||
48344766|NCT01808560|101172412|FG001|STARTED|4-Month After Cataract Surgery||0||
48344767|NCT01808560|101172413|FG002|STARTED|4-Month After Cataract Surgery||13||
48414738|NCT00498706|101350130|FG001|Post Treatment Week 18|Overall Study||162||
48635301|NCT00903201|101891831|FG000|STARTED|Overall Study||61||
48635302|NCT00903201|101891832|FG001|STARTED|Overall Study||44||
48184065|NCT02341534|100772349|FG000|STARTED|Overall Study||398||
48184066|NCT02341534|100772350|FG001|STARTED|Overall Study||392||
48184067|NCT02341534|100772349|FG000|COMPLETED|Overall Study||322||
48184068|NCT02341534|100772350|FG001|COMPLETED|Overall Study||325||
48184069|NCT02341534|100772349|FG000|NOT COMPLETED|Overall Study||76||
48635303|NCT00903201|101891833|FG002|STARTED|Overall Study||41||
48184070|NCT02341534|100772350|FG001|NOT COMPLETED|Overall Study||67||
48184071|NCT03688542|100772351|FG000|STARTED|Overall Study||0||27
48344768|NCT01808560|101172411|FG000|COMPLETED|4-Month After Cataract Surgery||0||
48635304|NCT00903201|101891831|FG000|COMPLETED|Overall Study||56||
48635305|NCT00903201|101891832|FG001|COMPLETED|Overall Study||38||
48635306|NCT00903201|101891833|FG002|COMPLETED|Overall Study||39||
48635307|NCT00903201|101891831|FG000|NOT COMPLETED|Overall Study||5||
48635308|NCT00903201|101891832|FG001|NOT COMPLETED|Overall Study||6||
48635309|NCT00903201|101891833|FG002|NOT COMPLETED|Overall Study||2||
48344769|NCT01808560|101172412|FG001|COMPLETED|4-Month After Cataract Surgery||0||
48344770|NCT01808560|101172413|FG002|COMPLETED|4-Month After Cataract Surgery||13||
48344771|NCT01808560|101172411|FG000|NOT COMPLETED|4-Month After Cataract Surgery||0||
48344772|NCT01808560|101172412|FG001|NOT COMPLETED|4-Month After Cataract Surgery||0||
48344773|NCT01808560|101172413|FG002|NOT COMPLETED|4-Month After Cataract Surgery||0||
48184072|NCT03688542|100772352|FG001|STARTED|Overall Study||0||29
48635310|NCT01416571|101891834|FG000|STARTED|Overall Study||78||
48184073|NCT03688542|100772351|FG000|COMPLETED|Overall Study||0||27
48184074|NCT03688542|100772352|FG001|COMPLETED|Overall Study||0||28
48184075|NCT03688542|100772351|FG000|NOT COMPLETED|Overall Study||0||0
48184076|NCT03688542|100772352|FG001|NOT COMPLETED|Overall Study||0||1
48184077|NCT01017120|100772353|FG000|STARTED|Overall Study||373||
48184078|NCT01017120|100772354|FG001|STARTED|Overall Study||369||
48184079|NCT01017120|100772353|FG000|COMPLETED|Overall Study||307||
48184080|NCT01017120|100772354|FG001|COMPLETED|Overall Study||334||
48184081|NCT01017120|100772353|FG000|NOT COMPLETED|Overall Study||66||
48184082|NCT01017120|100772354|FG001|NOT COMPLETED|Overall Study||35||
48184083|NCT03330119|100772355|FG000|STARTED|Overall Study||641|"Reason Not Completed was reported in aggregate - this data was not recorded as separate rows per reason."|
48184084|NCT03330119|100772356|FG001|STARTED|Overall Study||853|"Reason Not Completed was reported in aggregate - this data was not recorded as separate rows per reason."|
48184085|NCT03330119|100772355|FG000|COMPLETED|Overall Study||475||
48184086|NCT03330119|100772356|FG001|COMPLETED|Overall Study||571||
48184087|NCT03330119|100772355|FG000|NOT COMPLETED|Overall Study||166||
48184088|NCT03330119|100772356|FG001|NOT COMPLETED|Overall Study||282||
48184089|NCT01154036|100772357|FG000|STARTED|Phase I||120||
48184090|NCT01154036|100772358|FG001|STARTED|Phase I||483||
48184091|NCT01154036|100772359|FG002|STARTED|Phase I||944||
48184092|NCT01154036|100772360|FG003|STARTED|Phase I||0||
48184093|NCT01154036|100772361|FG004|STARTED|Phase I||0||
48184094|NCT01154036|100772362|FG005|STARTED|Phase I||0||
48184095|NCT01154036|100772363|FG006|STARTED|Phase I||0||
48184096|NCT01154036|100772364|FG007|STARTED|Phase I||0||
48184097|NCT01154036|100772357|FG000|COMPLETED|Phase I||117||
48184098|NCT01154036|100772358|FG001|COMPLETED|Phase I||455||
48184099|NCT01154036|100772359|FG002|COMPLETED|Phase I||888||
48344774|NCT02371850|101172414|FG000|STARTED|Overall Study||10||
48344775|NCT02371850|101172414|FG000|COMPLETED|Overall Study||10||
48414739|NCT00498706|101350129|FG000|COMPLETED|Overall Study||163||
48635311|NCT01416571|101891834|FG000|COMPLETED|Overall Study||76||
48635312|NCT01416571|101891834|FG000|NOT COMPLETED|Overall Study||2||
48635313|NCT00255177|101891835|FG000|STARTED|Overall Study||11||
48635314|NCT00255177|101891836|FG001|STARTED|Overall Study||14||
48635315|NCT00255177|101891837|FG002|STARTED|Overall Study||13||
48635316|NCT00255177|101891838|FG003|STARTED|Overall Study||6||
48635317|NCT00255177|101891835|FG000|COMPLETED|Overall Study||9||
48635318|NCT00255177|101891836|FG001|COMPLETED|Overall Study||13||
48635319|NCT00255177|101891837|FG002|COMPLETED|Overall Study||12||
48635320|NCT00255177|101891838|FG003|COMPLETED|Overall Study||4||
48635321|NCT00255177|101891835|FG000|NOT COMPLETED|Overall Study||2||
48635322|NCT00255177|101891836|FG001|NOT COMPLETED|Overall Study||1||
48635323|NCT00255177|101891837|FG002|NOT COMPLETED|Overall Study||1||
48635324|NCT00255177|101891838|FG003|NOT COMPLETED|Overall Study||2||
48635325|NCT03813108|101891839|FG000|STARTED|Overall Study||10||
48635326|NCT03813108|101891840|FG001|STARTED|Overall Study||10||
48344776|NCT02371850|101172414|FG000|NOT COMPLETED|Overall Study||0||
48344777|NCT00100048|101172415|FG000|STARTED|Cohort I-Monotherapy Phase 10 Days||7||
48344778|NCT00100048|101172416|FG001|STARTED|Cohort I-Monotherapy Phase 10 Days||7||
48344779|NCT00100048|101172417|FG002|STARTED|Cohort I-Monotherapy Phase 10 Days||6||
48344780|NCT00100048|101172418|FG003|STARTED|Cohort I-Monotherapy Phase 10 Days||8||
48368097|NCT01798706|101230105|FG001|COMPLETED|Overall Study||153||
48414740|NCT00498706|101350130|FG001|COMPLETED|Overall Study||162||
48184100|NCT01154036|100772360|FG003|COMPLETED|Phase I||0||
48184101|NCT01154036|100772361|FG004|COMPLETED|Phase I||0||
48184102|NCT01154036|100772362|FG005|COMPLETED|Phase I||0||
48184103|NCT01154036|100772363|FG006|COMPLETED|Phase I||0||
48184104|NCT01154036|100772364|FG007|COMPLETED|Phase I||0||
48184105|NCT01154036|100772357|FG000|NOT COMPLETED|Phase I||3||
48184106|NCT01154036|100772358|FG001|NOT COMPLETED|Phase I||28||
48184107|NCT01154036|100772359|FG002|NOT COMPLETED|Phase I||56||
48184108|NCT01154036|100772360|FG003|NOT COMPLETED|Phase I||0||
48184109|NCT01154036|100772361|FG004|NOT COMPLETED|Phase I||0||
48184110|NCT01154036|100772362|FG005|NOT COMPLETED|Phase I||0||
48184111|NCT01154036|100772363|FG006|NOT COMPLETED|Phase I||0||
48635327|NCT03813108|101891841|FG002|STARTED|Overall Study||20||
48635328|NCT03813108|101891842|FG003|STARTED|Overall Study||3||
48635329|NCT03813108|101891843|FG004|STARTED|Overall Study||0||
48635330|NCT03813108|101891844|FG005|STARTED|Overall Study||0||
48635331|NCT03813108|101891839|FG000|COMPLETED|Overall Study||8||
48635332|NCT03813108|101891840|FG001|COMPLETED|Overall Study||9||
48184112|NCT01154036|100772364|FG007|NOT COMPLETED|Phase I||0||
48758477|NCT01436149|102197628|FG001|STARTED|Randomized Phase||202||
48758478|NCT01436149|102197629|FG002|STARTED|Randomized Phase||202||
48758479|NCT01436149|102197627|FG000|COMPLETED|Randomized Phase||415||
48758480|NCT01436149|102197628|FG001|COMPLETED|Randomized Phase||164||
48184113|NCT01154036|100772357|FG000|STARTED|Phase II||0||
48184114|NCT01154036|100772358|FG001|STARTED|Phase II||0||
48184115|NCT01154036|100772359|FG002|STARTED|Phase II||0||
48184116|NCT01154036|100772360|FG003|STARTED|Phase II||28||
48184117|NCT01154036|100772361|FG004|STARTED|Phase II||124||
48414741|NCT00498706|101350129|FG000|NOT COMPLETED|Overall Study||0||
48414742|NCT00498706|101350130|FG001|NOT COMPLETED|Overall Study||0||
48414743|NCT00369564|101350131|FG000|STARTED|Overall Study||127||
48414744|NCT00369564|101350132|FG001|STARTED|Overall Study||123||
48635333|NCT03813108|101891841|FG002|COMPLETED|Overall Study||0||
48635334|NCT03813108|101891842|FG003|COMPLETED|Overall Study||3||
48635335|NCT03813108|101891843|FG004|COMPLETED|Overall Study||0||
48635336|NCT03813108|101891844|FG005|COMPLETED|Overall Study||0||
48635337|NCT03813108|101891839|FG000|NOT COMPLETED|Overall Study||2||
48635338|NCT03813108|101891840|FG001|NOT COMPLETED|Overall Study||1||
48635339|NCT03813108|101891841|FG002|NOT COMPLETED|Overall Study||20||
48635340|NCT03813108|101891842|FG003|NOT COMPLETED|Overall Study||0||
48184118|NCT01154036|100772362|FG005|STARTED|Phase II||126||
48184119|NCT01154036|100772363|FG006|STARTED|Phase II||234||
48184120|NCT01154036|100772364|FG007|STARTED|Phase II||206||
48184121|NCT01154036|100772357|FG000|COMPLETED|Phase II||0||
48184122|NCT01154036|100772358|FG001|COMPLETED|Phase II||0||
48184123|NCT01154036|100772359|FG002|COMPLETED|Phase II||0||
48184124|NCT01154036|100772360|FG003|COMPLETED|Phase II||27||
48184125|NCT01154036|100772361|FG004|COMPLETED|Phase II||116||
48184126|NCT01154036|100772362|FG005|COMPLETED|Phase II||121||
48184127|NCT01154036|100772363|FG006|COMPLETED|Phase II||225||
48184128|NCT01154036|100772364|FG007|COMPLETED|Phase II||200||
48184129|NCT01154036|100772357|FG000|NOT COMPLETED|Phase II||0||
48184130|NCT01154036|100772358|FG001|NOT COMPLETED|Phase II||0||
48184131|NCT01154036|100772359|FG002|NOT COMPLETED|Phase II||0||
48184132|NCT01154036|100772360|FG003|NOT COMPLETED|Phase II||1||
48184133|NCT01154036|100772361|FG004|NOT COMPLETED|Phase II||8||
48184134|NCT01154036|100772362|FG005|NOT COMPLETED|Phase II||5||
48184135|NCT01154036|100772363|FG006|NOT COMPLETED|Phase II||9||
48184136|NCT01154036|100772364|FG007|NOT COMPLETED|Phase II||6||
48184137|NCT00377741|100772365|FG000|STARTED|Overall Study||16||
48184138|NCT00377741|100772366|FG001|STARTED|Overall Study||15||
48184139|NCT00377741|100772365|FG000|COMPLETED|Overall Study||16||
48184140|NCT00377741|100772366|FG001|COMPLETED|Overall Study||15||
48184141|NCT00377741|100772365|FG000|NOT COMPLETED|Overall Study||0||
48184142|NCT00377741|100772366|FG001|NOT COMPLETED|Overall Study||0||
48184143|NCT00360555|100772367|FG000|STARTED|Overall Study||396||
48184144|NCT00360555|100772368|FG001|STARTED|Overall Study||393||
48184145|NCT00360555|100772369|FG002|STARTED|Overall Study||396||
48184146|NCT00360555|100772370|FG003|STARTED|Overall Study||399||
48184147|NCT00360555|100772367|FG000|COMPLETED|Overall Study||274||
48184148|NCT00360555|100772368|FG001|COMPLETED|Overall Study||259||
48184149|NCT00360555|100772369|FG002|COMPLETED|Overall Study||251||
48184150|NCT00360555|100772370|FG003|COMPLETED|Overall Study||287||
48184151|NCT00360555|100772367|FG000|NOT COMPLETED|Overall Study||122||
48184152|NCT00360555|100772368|FG001|NOT COMPLETED|Overall Study||134||
48184153|NCT00360555|100772369|FG002|NOT COMPLETED|Overall Study||145||
48184154|NCT00360555|100772370|FG003|NOT COMPLETED|Overall Study||112||
48184155|NCT02507219|100772371|FG000|STARTED|Overall Study||5||
48184156|NCT02507219|100772372|FG001|STARTED|Overall Study||4||
48635341|NCT03813108|101891843|FG004|NOT COMPLETED|Overall Study||0||
48635342|NCT03813108|101891844|FG005|NOT COMPLETED|Overall Study||0||
48758481|NCT01436149|102197629|FG002|COMPLETED|Randomized Phase||160||
48184157|NCT02507219|100772373|FG002|STARTED|Overall Study||3||
48184158|NCT02507219|100772374|FG003|STARTED|Overall Study||3||
48184159|NCT02507219|100772375|FG004|STARTED|Overall Study||4||
48184160|NCT02507219|100772376|FG005|STARTED|Overall Study||3||
48184161|NCT02507219|100772371|FG000|COMPLETED|Overall Study||4||
48184162|NCT02507219|100772372|FG001|COMPLETED|Overall Study||4||
48184163|NCT02507219|100772373|FG002|COMPLETED|Overall Study||3||
48635343|NCT02908347|101891845|FG000|STARTED|Overall Study||23||
48758482|NCT01436149|102197627|FG000|NOT COMPLETED|Randomized Phase||77||
48184164|NCT02507219|100772374|FG003|COMPLETED|Overall Study||3||
48184165|NCT02507219|100772375|FG004|COMPLETED|Overall Study||3||
48184166|NCT02507219|100772376|FG005|COMPLETED|Overall Study||3||
48184167|NCT02507219|100772371|FG000|NOT COMPLETED|Overall Study||1||
48184168|NCT02507219|100772372|FG001|NOT COMPLETED|Overall Study||0||
48184169|NCT02507219|100772373|FG002|NOT COMPLETED|Overall Study||0||
48758483|NCT01436149|102197628|FG001|NOT COMPLETED|Randomized Phase||38||
48635344|NCT02908347|101891846|FG001|STARTED|Overall Study||23||
48184170|NCT02507219|100772374|FG003|NOT COMPLETED|Overall Study||0||
48184171|NCT02507219|100772375|FG004|NOT COMPLETED|Overall Study||1||
48184172|NCT02507219|100772376|FG005|NOT COMPLETED|Overall Study||0||
48184173|NCT00136916|100772377|FG000|STARTED|Overall Study||319||
48184174|NCT00136916|100772378|FG001|STARTED|Overall Study||316||
48414745|NCT00369564|101350131|FG000|COMPLETED|Overall Study||84||
48635345|NCT02908347|101891845|FG000|COMPLETED|Overall Study||22||
48344781|NCT00100048|101172419|FG004|STARTED|Cohort I-Monotherapy Phase 10 Days||7||
48344782|NCT00100048|101172420|FG005|STARTED|Cohort I-Monotherapy Phase 10 Days||0||
48344783|NCT00100048|101172415|FG000|Treated|Cohort I-Monotherapy Phase 10 Days||7||
48344784|NCT00100048|101172416|FG001|Treated|Cohort I-Monotherapy Phase 10 Days||7||
48344785|NCT00100048|101172417|FG002|Treated|Cohort I-Monotherapy Phase 10 Days||6||
48184175|NCT00136916|100772377|FG000|Received Treatment|Overall Study||316||
48184176|NCT00136916|100772378|FG001|Received Treatment|Overall Study||311||
48184177|NCT00136916|100772377|FG000|COMPLETED|Overall Study||194||
48184178|NCT00136916|100772378|FG001|COMPLETED|Overall Study||212||
48184179|NCT00136916|100772377|FG000|NOT COMPLETED|Overall Study||125||
48184180|NCT00136916|100772378|FG001|NOT COMPLETED|Overall Study||104||
48184181|NCT01853254|100772379|FG000|STARTED|Overall Study||272||
48184182|NCT01853254|100772379|FG000|COMPLETED|Overall Study||168||
48184183|NCT01853254|100772379|FG000|NOT COMPLETED|Overall Study||104||
48184184|NCT02722941|100772380|FG000|STARTED|Overall Study||15||
48184185|NCT02722941|100772381|FG001|STARTED|Overall Study||15||
48184186|NCT02722941|100772380|FG000|COMPLETED|Overall Study||15||
48184187|NCT02722941|100772381|FG001|COMPLETED|Overall Study||15||
48184188|NCT02722941|100772380|FG000|NOT COMPLETED|Overall Study||0||
48184189|NCT02722941|100772381|FG001|NOT COMPLETED|Overall Study||0||
48184190|NCT01222247|100772382|FG000|STARTED|Overall Study||1429||
48184191|NCT01222247|100772383|FG001|STARTED|Overall Study||1402||
48184192|NCT01222247|100772382|FG000|Received 2 Doses|Overall Study||860||
48184193|NCT01222247|100772383|FG001|Received 2 Doses|Overall Study||826||
48184194|NCT01222247|100772382|FG000|Received 1 Dose|Overall Study||568||
48184195|NCT01222247|100772383|FG001|Received 1 Dose|Overall Study||571||
48184196|NCT01222247|100772382|FG000|Did Not Receive Assigned Medication|Overall Study||1||
48184197|NCT01222247|100772383|FG001|Did Not Receive Assigned Medication|Overall Study||5||
48184198|NCT01222247|100772382|FG000|COMPLETED|Overall Study||1427||
48184199|NCT01222247|100772383|FG001|COMPLETED|Overall Study||1400||
48184200|NCT01222247|100772382|FG000|NOT COMPLETED|Overall Study||2||
48184201|NCT01222247|100772383|FG001|NOT COMPLETED|Overall Study||2||
48184202|NCT02668432|100772384|FG000|STARTED|Overall Study||5||
48184203|NCT02668432|100772385|FG001|STARTED|Overall Study||4||
48184204|NCT02668432|100772384|FG000|COMPLETED|Overall Study||5||
48184205|NCT02668432|100772385|FG001|COMPLETED|Overall Study||4||
48184206|NCT02668432|100772384|FG000|NOT COMPLETED|Overall Study||0||
48184207|NCT02668432|100772385|FG001|NOT COMPLETED|Overall Study||0||
48184208|NCT02061761|100772386|FG000|STARTED|Overall Study||3|Started treatment|
48184209|NCT02061761|100772387|FG001|STARTED|Overall Study||9|Started treatment|
48184210|NCT02061761|100772388|FG002|STARTED|Overall Study||6|Started treatment|
48184211|NCT02061761|100772389|FG003|STARTED|Overall Study||9|Started treatment|
48344786|NCT00100048|101172418|FG003|Treated|Cohort I-Monotherapy Phase 10 Days||8||
48344787|NCT00100048|101172419|FG004|Treated|Cohort I-Monotherapy Phase 10 Days||7||
48344788|NCT00100048|101172420|FG005|Treated|Cohort I-Monotherapy Phase 10 Days||0||
48344789|NCT00100048|101172415|FG000|COMPLETED|Cohort I-Monotherapy Phase 10 Days||7||
48344790|NCT00100048|101172416|FG001|COMPLETED|Cohort I-Monotherapy Phase 10 Days||7||
48344791|NCT00100048|101172417|FG002|COMPLETED|Cohort I-Monotherapy Phase 10 Days||6||
48344792|NCT00100048|101172418|FG003|COMPLETED|Cohort I-Monotherapy Phase 10 Days||8||
48344793|NCT00100048|101172419|FG004|COMPLETED|Cohort I-Monotherapy Phase 10 Days||7||
48344794|NCT00100048|101172420|FG005|COMPLETED|Cohort I-Monotherapy Phase 10 Days||0||
48344795|NCT00100048|101172415|FG000|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0||
48344796|NCT00100048|101172416|FG001|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0||
48344797|NCT00100048|101172417|FG002|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0||
48344798|NCT00100048|101172418|FG003|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0||
48344799|NCT00100048|101172419|FG004|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0||
48344800|NCT00100048|101172420|FG005|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0||
48344801|NCT00100048|101172415|FG000|STARTED|Cohort I & II-Combination Therapy Phase||41||
48344802|NCT00100048|101172416|FG001|STARTED|Cohort I & II-Combination Therapy Phase||40||
48344803|NCT00100048|101172417|FG002|STARTED|Cohort I & II-Combination Therapy Phase||41||
48344804|NCT00100048|101172418|FG003|STARTED|Cohort I & II-Combination Therapy Phase||40||
48344805|NCT00100048|101172419|FG004|STARTED|Cohort I & II-Combination Therapy Phase||0||
48344806|NCT00100048|101172420|FG005|STARTED|Cohort I & II-Combination Therapy Phase||39||
48184212|NCT02061761|100772390|FG004|STARTED|Overall Study||11|Started treatment|
48184213|NCT02061761|100772391|FG005|STARTED|Overall Study||7|Started treatment|
48184214|NCT02061761|100772392|FG006|STARTED|Overall Study||1|Started treatment|
48184215|NCT02061761|100772393|FG007|STARTED|Overall Study||4|Started treatment|
48184216|NCT02061761|100772394|FG008|STARTED|Overall Study||56|Started treatment|
48184217|NCT02061761|100772386|FG000|Chronic Lymphocytic Leukemia (CLL)|Overall Study||0|Tumor type eligible for expansion|
48184218|NCT02061761|100772387|FG001|Chronic Lymphocytic Leukemia (CLL)|Overall Study||0|Tumor type eligible for expansion|
48184219|NCT02061761|100772388|FG002|Chronic Lymphocytic Leukemia (CLL)|Overall Study||0|Tumor type eligible for expansion|
48184220|NCT02061761|100772389|FG003|Chronic Lymphocytic Leukemia (CLL)|Overall Study||0|Tumor type eligible for expansion|
48344807|NCT00100048|101172415|FG000|Treated|Cohort I & II-Combination Therapy Phase||39||
48344808|NCT00100048|101172416|FG001|Treated|Cohort I & II-Combination Therapy Phase||40||
48344809|NCT00100048|101172417|FG002|Treated|Cohort I & II-Combination Therapy Phase||41||
48414746|NCT00369564|101350132|FG001|COMPLETED|Overall Study||100||
48414747|NCT00369564|101350131|FG000|NOT COMPLETED|Overall Study||43||
48414748|NCT00369564|101350132|FG001|NOT COMPLETED|Overall Study||23||
48414749|NCT02177942|101350133|FG000|STARTED|Overall Study||262||
48635346|NCT02908347|101891846|FG001|COMPLETED|Overall Study||22||
48635347|NCT02908347|101891845|FG000|NOT COMPLETED|Overall Study||1||
48635348|NCT02908347|101891846|FG001|NOT COMPLETED|Overall Study||1||
48635349|NCT02802228|101891847|FG000|STARTED|Overall Study||20||
48184221|NCT02061761|100772390|FG004|Chronic Lymphocytic Leukemia (CLL)|Overall Study||2|Tumor type eligible for expansion|
48184222|NCT02061761|100772391|FG005|Chronic Lymphocytic Leukemia (CLL)|Overall Study||0|Tumor type eligible for expansion|
48184223|NCT02061761|100772392|FG006|Chronic Lymphocytic Leukemia (CLL)|Overall Study||0|Tumor type eligible for expansion|
48184224|NCT02061761|100772393|FG007|Chronic Lymphocytic Leukemia (CLL)|Overall Study||0|Tumor type eligible for expansion|
48184225|NCT02061761|100772394|FG008|Chronic Lymphocytic Leukemia (CLL)|Overall Study||0|Tumor type eligible for expansion|
48184226|NCT02061761|100772386|FG000|Diffuse Large B-Cell Lymphoma (DLBCL)|Overall Study||0|Tumor type eligible for expansion|
48184227|NCT02061761|100772387|FG001|Diffuse Large B-Cell Lymphoma (DLBCL)|Overall Study||0|Tumor type eligible for expansion|
48184228|NCT02061761|100772388|FG002|Diffuse Large B-Cell Lymphoma (DLBCL)|Overall Study||0|Tumor type eligible for expansion|
48184229|NCT02061761|100772389|FG003|Diffuse Large B-Cell Lymphoma (DLBCL)|Overall Study||0|Tumor type eligible for expansion|
48184230|NCT02061761|100772390|FG004|Diffuse Large B-Cell Lymphoma (DLBCL)|Overall Study||2|Tumor type eligible for expansion|
48184231|NCT02061761|100772391|FG005|Diffuse Large B-Cell Lymphoma (DLBCL)|Overall Study||0|Tumor type eligible for expansion|
48184232|NCT02061761|100772392|FG006|Diffuse Large B-Cell Lymphoma (DLBCL)|Overall Study||0|Tumor type eligible for expansion|
48184233|NCT02061761|100772393|FG007|Diffuse Large B-Cell Lymphoma (DLBCL)|Overall Study||0|Tumor type eligible for expansion|
48184234|NCT02061761|100772394|FG008|Diffuse Large B-Cell Lymphoma (DLBCL)|Overall Study||15|Tumor type eligible for expansion|
48184235|NCT02061761|100772386|FG000|Indolent Non-Hodgkin Lymphoma (iNHL)|Overall Study||0|Tumor type eligible for expansion|
48184236|NCT02061761|100772387|FG001|Indolent Non-Hodgkin Lymphoma (iNHL)|Overall Study||0|Tumor type eligible for expansion|
48184237|NCT02061761|100772388|FG002|Indolent Non-Hodgkin Lymphoma (iNHL)|Overall Study||0|Tumor type eligible for expansion|
48184238|NCT02061761|100772389|FG003|Indolent Non-Hodgkin Lymphoma (iNHL)|Overall Study||0|Tumor type eligible for expansion|
48184239|NCT02061761|100772390|FG004|Indolent Non-Hodgkin Lymphoma (iNHL)|Overall Study||4|Tumor type eligible for expansion|
48184240|NCT02061761|100772391|FG005|Indolent Non-Hodgkin Lymphoma (iNHL)|Overall Study||0|Tumor type eligible for expansion|
48184241|NCT02061761|100772392|FG006|Indolent Non-Hodgkin Lymphoma (iNHL)|Overall Study||0|Tumor type eligible for expansion|
48184242|NCT02061761|100772393|FG007|Indolent Non-Hodgkin Lymphoma (iNHL)|Overall Study||0|Tumor type eligible for expansion|
48184243|NCT02061761|100772394|FG008|Indolent Non-Hodgkin Lymphoma (iNHL)|Overall Study||0|Tumor type eligible for expansion|
48184244|NCT02061761|100772386|FG000|Hodgkin Lymphoma (HL)|Overall Study||0|Tumor type eligible for expansion|
48184245|NCT02061761|100772387|FG001|Hodgkin Lymphoma (HL)|Overall Study||0|Tumor type eligible for expansion|
48184246|NCT02061761|100772388|FG002|Hodgkin Lymphoma (HL)|Overall Study||0|Tumor type eligible for expansion|
48184247|NCT02061761|100772389|FG003|Hodgkin Lymphoma (HL)|Overall Study||0|Tumor type eligible for expansion|
48635350|NCT02802228|101891848|FG001|STARTED|Overall Study||10||
48635351|NCT02802228|101891847|FG000|COMPLETED|Overall Study||15||
48635352|NCT02802228|101891848|FG001|COMPLETED|Overall Study||10||
48635353|NCT02802228|101891847|FG000|NOT COMPLETED|Overall Study||5||
48635354|NCT02802228|101891848|FG001|NOT COMPLETED|Overall Study||0||
48635355|NCT00294658|101891849|FG000|STARTED|Overall Study||66||
48635356|NCT00294658|101891850|FG001|STARTED|Overall Study||60||
48635357|NCT00294658|101891849|FG000|COMPLETED|Overall Study||60||
48635358|NCT00294658|101891850|FG001|COMPLETED|Overall Study||51||
48635359|NCT00294658|101891849|FG000|NOT COMPLETED|Overall Study||6||
48635360|NCT00294658|101891850|FG001|NOT COMPLETED|Overall Study||9||
48635361|NCT04459338|101891851|FG000|STARTED|Overall Study||5||
48635362|NCT04459338|101891852|FG001|STARTED|Overall Study||6||
48635363|NCT04459338|101891851|FG000|COMPLETED|Overall Study||4||
48635364|NCT04459338|101891852|FG001|COMPLETED|Overall Study||6||
48635365|NCT04459338|101891851|FG000|NOT COMPLETED|Overall Study||1||
48635366|NCT04459338|101891852|FG001|NOT COMPLETED|Overall Study||0||
48414750|NCT02177942|101350134|FG001|STARTED|Overall Study||266||
48414751|NCT02177942|101350133|FG000|COMPLETED|Overall Study||185||
48414752|NCT02177942|101350134|FG001|COMPLETED|Overall Study||178||
48414753|NCT02177942|101350133|FG000|NOT COMPLETED|Overall Study||77||
48414754|NCT02177942|101350134|FG001|NOT COMPLETED|Overall Study||88||
48414755|NCT02773849|101350135|FG000|STARTED|Overall Study||157||
48414756|NCT02773849|101350135|FG000|COMPLETED|Overall Study||95||
48635367|NCT00352118|101891853|FG000|STARTED|Overall Study||4||
48635368|NCT00352118|101891853|FG000|COMPLETED|Overall Study||0||
48635369|NCT00352118|101891853|FG000|NOT COMPLETED|Overall Study||4||
48635370|NCT00630292|101891854|FG000|STARTED|Overall Study||6||
48635371|NCT00630292|101891854|FG000|COMPLETED|Overall Study||5||
48635372|NCT00630292|101891854|FG000|NOT COMPLETED|Overall Study||1||
48635373|NCT02318264|101891855|FG000|STARTED|Overall Study||8||
48635374|NCT02318264|101891856|FG001|STARTED|Overall Study||7||
48635375|NCT02318264|101891855|FG000|COMPLETED|Overall Study||8||
48635376|NCT02318264|101891856|FG001|COMPLETED|Overall Study||7||
48184248|NCT02061761|100772390|FG004|Hodgkin Lymphoma (HL)|Overall Study||3|Tumor type eligible for expansion|
48184249|NCT02061761|100772391|FG005|Hodgkin Lymphoma (HL)|Overall Study||0|Tumor type eligible for expansion|
48188681|NCT00329303|100783307|FG000|COMPLETED|Overall Study||32||
48758484|NCT01436149|102197629|FG002|NOT COMPLETED|Randomized Phase||42||
48758485|NCT02365649|102197630|FG000|STARTED|Double-Blind Induction (Weeks 1-16)||37||
48758486|NCT02365649|102197631|FG001|STARTED|Double-Blind Induction (Weeks 1-16)||39||
48758487|NCT02365649|102197632|FG002|STARTED|Double-Blind Induction (Weeks 1-16)||37||
48758488|NCT02365649|102197633|FG003|STARTED|Double-Blind Induction (Weeks 1-16)||36||
48758489|NCT02365649|102197634|FG004|STARTED|Double-Blind Induction (Weeks 1-16)||36||
48184250|NCT02061761|100772392|FG006|Hodgkin Lymphoma (HL)|Overall Study||0|Tumor type eligible for expansion|
48184251|NCT02061761|100772393|FG007|Hodgkin Lymphoma (HL)|Overall Study||0|Tumor type eligible for expansion|
48184252|NCT02061761|100772394|FG008|Hodgkin Lymphoma (HL)|Overall Study||0|Tumor type eligible for expansion|
48184253|NCT02061761|100772386|FG000|HL-anti-PD-1 Naive|Overall Study||0|Tumor type eligible for expansion|
48758490|NCT02365649|102197635|FG005|STARTED|Double-Blind Induction (Weeks 1-16)||35||
48758491|NCT02365649|102197636|FG006|STARTED|Double-Blind Induction (Weeks 1-16)||0||
48758492|NCT02365649|102197637|FG007|STARTED|Double-Blind Induction (Weeks 1-16)||0||
48758493|NCT02365649|102197638|FG008|STARTED|Double-Blind Induction (Weeks 1-16)||0||
48758494|NCT02365649|102197639|FG009|STARTED|Double-Blind Induction (Weeks 1-16)||0||
48758495|NCT02365649|102197630|FG000|COMPLETED|Double-Blind Induction (Weeks 1-16)||27||
48758496|NCT02365649|102197631|FG001|COMPLETED|Double-Blind Induction (Weeks 1-16)||34||
48758497|NCT02365649|102197632|FG002|COMPLETED|Double-Blind Induction (Weeks 1-16)||33||
48184254|NCT02061761|100772387|FG001|HL-anti-PD-1 Naive|Overall Study||0|Tumor type eligible for expansion|
48184255|NCT02061761|100772388|FG002|HL-anti-PD-1 Naive|Overall Study||0|Tumor type eligible for expansion|
48184256|NCT02061761|100772389|FG003|HL-anti-PD-1 Naive|Overall Study||0|Tumor type eligible for expansion|
48184257|NCT02061761|100772390|FG004|HL-anti-PD-1 Naive|Overall Study||0|Tumor type eligible for expansion|
48758498|NCT02365649|102197633|FG003|COMPLETED|Double-Blind Induction (Weeks 1-16)||27||
48758499|NCT02365649|102197634|FG004|COMPLETED|Double-Blind Induction (Weeks 1-16)||29||
48758500|NCT02365649|102197635|FG005|COMPLETED|Double-Blind Induction (Weeks 1-16)||30||
48758501|NCT02365649|102197636|FG006|COMPLETED|Double-Blind Induction (Weeks 1-16)||0||
48758502|NCT02365649|102197637|FG007|COMPLETED|Double-Blind Induction (Weeks 1-16)||0||
48758503|NCT02365649|102197638|FG008|COMPLETED|Double-Blind Induction (Weeks 1-16)||0||
48758504|NCT02365649|102197639|FG009|COMPLETED|Double-Blind Induction (Weeks 1-16)||0||
48758505|NCT02365649|102197630|FG000|NOT COMPLETED|Double-Blind Induction (Weeks 1-16)||10||
48184258|NCT02061761|100772391|FG005|HL-anti-PD-1 Naive|Overall Study||0|Tumor type eligible for expansion|
48184259|NCT02061761|100772392|FG006|HL-anti-PD-1 Naive|Overall Study||0|Tumor type eligible for expansion|
48184260|NCT02061761|100772393|FG007|HL-anti-PD-1 Naive|Overall Study||0|Tumor type eligible for expansion|
48758506|NCT02365649|102197631|FG001|NOT COMPLETED|Double-Blind Induction (Weeks 1-16)||5||
48758507|NCT02365649|102197632|FG002|NOT COMPLETED|Double-Blind Induction (Weeks 1-16)||4||
48758508|NCT02365649|102197633|FG003|NOT COMPLETED|Double-Blind Induction (Weeks 1-16)||9||
48758509|NCT02365649|102197634|FG004|NOT COMPLETED|Double-Blind Induction (Weeks 1-16)||7||
48758510|NCT02365649|102197635|FG005|NOT COMPLETED|Double-Blind Induction (Weeks 1-16)||5||
48758511|NCT02365649|102197636|FG006|NOT COMPLETED|Double-Blind Induction (Weeks 1-16)||0||
48758512|NCT02365649|102197637|FG007|NOT COMPLETED|Double-Blind Induction (Weeks 1-16)||0||
48758513|NCT02365649|102197638|FG008|NOT COMPLETED|Double-Blind Induction (Weeks 1-16)||0||
48758514|NCT02365649|102197639|FG009|NOT COMPLETED|Double-Blind Induction (Weeks 1-16)||0||
48758515|NCT02365649|102197630|FG000|STARTED|Double-Blind Extension (Weeks 16-52)||0||
48758516|NCT02365649|102197631|FG001|STARTED|Double-Blind Extension (Weeks 16-52)||0||
48758517|NCT02365649|102197632|FG002|STARTED|Double-Blind Extension (Weeks 16-52)||0||
48758518|NCT02365649|102197633|FG003|STARTED|Double-Blind Extension (Weeks 16-52)||0||
48758519|NCT02365649|102197634|FG004|STARTED|Double-Blind Extension (Weeks 16-52)||0||
48758520|NCT02365649|102197635|FG005|STARTED|Double-Blind Extension (Weeks 16-52)||0||
48758521|NCT02365649|102197636|FG006|STARTED|Double-Blind Extension (Weeks 16-52)||61||
48758522|NCT02365649|102197637|FG007|STARTED|Double-Blind Extension (Weeks 16-52)||23||
48758523|NCT02365649|102197638|FG008|STARTED|Double-Blind Extension (Weeks 16-52)||59||
48758524|NCT02365649|102197639|FG009|STARTED|Double-Blind Extension (Weeks 16-52)||37||
48758525|NCT02365649|102197630|FG000|Switched to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who met inadequate response criteria at or after Week 20 and switched to OL 12 mg BID.|
48758526|NCT02365649|102197631|FG001|Switched to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who met inadequate response criteria at or after Week 20 and switched to OL 12 mg BID.|
48758527|NCT02365649|102197632|FG002|Switched to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who met inadequate response criteria at or after Week 20 and switched to OL 12 mg BID.|
48758528|NCT02365649|102197633|FG003|Switched to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who met inadequate response criteria at or after Week 20 and switched to OL 12 mg BID.|
48758529|NCT02365649|102197634|FG004|Switched to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who met inadequate response criteria at or after Week 20 and switched to OL 12 mg BID.|
48758530|NCT02365649|102197635|FG005|Switched to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who met inadequate response criteria at or after Week 20 and switched to OL 12 mg BID.|
48758531|NCT02365649|102197636|FG006|Switched to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||21|Participants who met inadequate response criteria at or after Week 20 and switched to OL 12 mg BID.|
48758532|NCT02365649|102197637|FG007|Switched to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||5|Participants who met inadequate response criteria at or after Week 20 and switched to OL 12 mg BID.|
48758533|NCT02365649|102197638|FG008|Switched to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||17|Participants who met inadequate response criteria at or after Week 20 and switched to OL 12 mg BID.|
48758534|NCT02365649|102197639|FG009|Switched to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||17|Participants who met inadequate response criteria at or after Week 20 and switched to OL 12 mg BID.|
48758535|NCT02365649|102197630|FG000|Further Dose Escalated to OL 24 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who were switched to OL 12 mg BID and then further dose escalated to OL 24 mg BID.|
48758536|NCT02365649|102197631|FG001|Further Dose Escalated to OL 24 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who were switched to OL 12 mg BID and then further dose escalated to OL 24 mg BID.|
48758537|NCT02365649|102197632|FG002|Further Dose Escalated to OL 24 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who were switched to OL 12 mg BID and then further dose escalated to OL 24 mg BID.|
48758538|NCT02365649|102197633|FG003|Further Dose Escalated to OL 24 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who were switched to OL 12 mg BID and then further dose escalated to OL 24 mg BID.|
48758539|NCT02365649|102197634|FG004|Further Dose Escalated to OL 24 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who were switched to OL 12 mg BID and then further dose escalated to OL 24 mg BID.|
48758540|NCT02365649|102197635|FG005|Further Dose Escalated to OL 24 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who were switched to OL 12 mg BID and then further dose escalated to OL 24 mg BID.|
48758541|NCT02365649|102197636|FG006|Further Dose Escalated to OL 24 mg BID|Double-Blind Extension (Weeks 16-52)||5|Participants who were switched to OL 12 mg BID and then further dose escalated to OL 24 mg BID.|
48758542|NCT02365649|102197637|FG007|Further Dose Escalated to OL 24 mg BID|Double-Blind Extension (Weeks 16-52)||2|Participants who were switched to OL 12 mg BID and then further dose escalated to OL 24 mg BID.|
48758543|NCT02365649|102197638|FG008|Further Dose Escalated to OL 24 mg BID|Double-Blind Extension (Weeks 16-52)||10|Participants who were switched to OL 12 mg BID and then further dose escalated to OL 24 mg BID.|
48758544|NCT02365649|102197639|FG009|Further Dose Escalated to OL 24 mg BID|Double-Blind Extension (Weeks 16-52)||10|Participants who were switched to OL 12 mg BID and then further dose escalated to OL 24 mg BID.|
48368098|NCT01798706|101230104|FG000|NOT COMPLETED|Overall Study||21||
48635377|NCT02318264|101891855|FG000|NOT COMPLETED|Overall Study||0||
48758545|NCT02365649|102197630|FG000|Dose De-escalated to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who were dose escalated to OL 24 mg BID and then dose de-escalated to OL 12 mg BID.|
48758546|NCT02365649|102197631|FG001|Dose De-escalated to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who were dose escalated to OL 24 mg BID and then dose de-escalated to OL 12 mg BID.|
48758547|NCT02365649|102197632|FG002|Dose De-escalated to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who were dose escalated to OL 24 mg BID and then dose de-escalated to OL 12 mg BID.|
48758548|NCT02365649|102197633|FG003|Dose De-escalated to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who were dose escalated to OL 24 mg BID and then dose de-escalated to OL 12 mg BID.|
48758549|NCT02365649|102197634|FG004|Dose De-escalated to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who were dose escalated to OL 24 mg BID and then dose de-escalated to OL 12 mg BID.|
48758550|NCT02365649|102197635|FG005|Dose De-escalated to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who were dose escalated to OL 24 mg BID and then dose de-escalated to OL 12 mg BID.|
48758551|NCT02365649|102197636|FG006|Dose De-escalated to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who were dose escalated to OL 24 mg BID and then dose de-escalated to OL 12 mg BID.|
48758552|NCT02365649|102197637|FG007|Dose De-escalated to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who were dose escalated to OL 24 mg BID and then dose de-escalated to OL 12 mg BID.|
48767759|NCT04004988|102222818|FG000|Received at Least One Dose of Study Drug|Period 2||21||
48635378|NCT02318264|101891856|FG001|NOT COMPLETED|Overall Study||0||
48635379|NCT00409825|101891857|FG000|STARTED|Overall Study||61||
48635380|NCT00409825|101891857|FG000|COMPLETED|Overall Study||61||
48635381|NCT00409825|101891857|FG000|NOT COMPLETED|Overall Study||0||
48635382|NCT03091439|101891858|FG000|STARTED|Overall Study||1||
48635383|NCT03091439|101891859|FG001|STARTED|Overall Study||0||
48635384|NCT03091439|101891858|FG000|COMPLETED|Overall Study||0||
48635385|NCT03091439|101891859|FG001|COMPLETED|Overall Study||0||
48635386|NCT03091439|101891858|FG000|NOT COMPLETED|Overall Study||1||
48635387|NCT03091439|101891859|FG001|NOT COMPLETED|Overall Study||0||
48635388|NCT02059239|101891860|FG000|STARTED|Overall Study||18||
48635389|NCT02059239|101891861|FG001|STARTED|Overall Study||16||
48635390|NCT02059239|101891860|FG000|COMPLETED|Overall Study||16||
48635391|NCT02059239|101891861|FG001|COMPLETED|Overall Study||13||
48635392|NCT02059239|101891860|FG000|NOT COMPLETED|Overall Study||2||
48635393|NCT02059239|101891861|FG001|NOT COMPLETED|Overall Study||3||
48758553|NCT02365649|102197638|FG008|Dose De-escalated to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who were dose escalated to OL 24 mg BID and then dose de-escalated to OL 12 mg BID.|
48758554|NCT02365649|102197639|FG009|Dose De-escalated to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who were dose escalated to OL 24 mg BID and then dose de-escalated to OL 12 mg BID.|
48758555|NCT02365649|102197630|FG000|COMPLETED|Double-Blind Extension (Weeks 16-52)||0||
48758556|NCT02365649|102197631|FG001|COMPLETED|Double-Blind Extension (Weeks 16-52)||0||
48758557|NCT02365649|102197632|FG002|COMPLETED|Double-Blind Extension (Weeks 16-52)||0||
48758558|NCT02365649|102197633|FG003|COMPLETED|Double-Blind Extension (Weeks 16-52)||0||
48635394|NCT01294514|101891862|FG000|STARTED|Overall Study||27||
48635395|NCT01294514|101891862|FG000|COMPLETED|Overall Study||26||
48635396|NCT01294514|101891862|FG000|NOT COMPLETED|Overall Study||1||
48635397|NCT03098979|101891863|FG000|STARTED|Overall Study||76||
48635398|NCT03098979|101891864|FG001|STARTED|Overall Study||27||
48635399|NCT03098979|101891865|FG002|STARTED|Overall Study||50||
48635400|NCT03098979|101891866|FG003|STARTED|Overall Study||51||
48635401|NCT03098979|101891867|FG004|STARTED|Overall Study||50||
48635402|NCT03098979|101891868|FG005|STARTED|Overall Study||51||
48635403|NCT03098979|101891863|FG000|COMPLETED|Overall Study||70||
48635404|NCT03098979|101891864|FG001|COMPLETED|Overall Study||25||
48635405|NCT03098979|101891865|FG002|COMPLETED|Overall Study||46||
48635406|NCT03098979|101891866|FG003|COMPLETED|Overall Study||46||
48635407|NCT03098979|101891867|FG004|COMPLETED|Overall Study||41||
48635408|NCT03098979|101891868|FG005|COMPLETED|Overall Study||47||
48635409|NCT03098979|101891863|FG000|NOT COMPLETED|Overall Study||6||
48635410|NCT03098979|101891864|FG001|NOT COMPLETED|Overall Study||2||
48635411|NCT03098979|101891865|FG002|NOT COMPLETED|Overall Study||4||
48635412|NCT03098979|101891866|FG003|NOT COMPLETED|Overall Study||5||
48635413|NCT03098979|101891867|FG004|NOT COMPLETED|Overall Study||9||
48635414|NCT03098979|101891868|FG005|NOT COMPLETED|Overall Study||4||
48635415|NCT00896064|101891869|FG000|STARTED|Overall Study||22||
48635416|NCT00896064|101891870|FG001|STARTED|Overall Study||21||
48635417|NCT00896064|101891869|FG000|COMPLETED|Overall Study||22||
48635418|NCT00896064|101891870|FG001|COMPLETED|Overall Study||21||
48635419|NCT00896064|101891869|FG000|NOT COMPLETED|Overall Study||0||
48635420|NCT00896064|101891870|FG001|NOT COMPLETED|Overall Study||0||
48635421|NCT01385644|101891871|FG000|STARTED|Overall Study||4||
48635422|NCT01385644|101891872|FG001|STARTED|Overall Study||4||
48635423|NCT01385644|101891871|FG000|COMPLETED|Overall Study||4||
48635424|NCT01385644|101891872|FG001|COMPLETED|Overall Study||4||
48635425|NCT01385644|101891871|FG000|NOT COMPLETED|Overall Study||0||
48635426|NCT01385644|101891872|FG001|NOT COMPLETED|Overall Study||0||
48635427|NCT00091819|101891873|FG000|STARTED|Overall Study||429||
48635428|NCT00091819|101891874|FG001|STARTED|Overall Study||433||
48635429|NCT00091819|101891873|FG000|COMPLETED|Overall Study||387||
48635430|NCT00091819|101891874|FG001|COMPLETED|Overall Study||387||
48635431|NCT00091819|101891873|FG000|NOT COMPLETED|Overall Study||42||
48635432|NCT00091819|101891874|FG001|NOT COMPLETED|Overall Study||46||
48635433|NCT02290184|101891875|FG000|STARTED|Overall Study||22||
48635434|NCT02290184|101891876|FG001|STARTED|Overall Study||23||
48635435|NCT02290184|101891875|FG000|3-month Follow-up|Overall Study||22||
48635436|NCT02290184|101891876|FG001|3-month Follow-up|Overall Study||23||
48635437|NCT02290184|101891875|FG000|COMPLETED|Overall Study||22||
48635438|NCT02290184|101891876|FG001|COMPLETED|Overall Study||23||
48635439|NCT02290184|101891875|FG000|NOT COMPLETED|Overall Study||0||
48758559|NCT02365649|102197634|FG004|COMPLETED|Double-Blind Extension (Weeks 16-52)||0||
48758560|NCT02365649|102197635|FG005|COMPLETED|Double-Blind Extension (Weeks 16-52)||0||
48344810|NCT00100048|101172418|FG003|Treated|Cohort I & II-Combination Therapy Phase||40||
48344811|NCT00100048|101172419|FG004|Treated|Cohort I & II-Combination Therapy Phase||0||
48344812|NCT00100048|101172420|FG005|Treated|Cohort I & II-Combination Therapy Phase||38||
48344813|NCT00100048|101172415|FG000|Never Treated|Cohort I & II-Combination Therapy Phase||2||
48344814|NCT00100048|101172416|FG001|Never Treated|Cohort I & II-Combination Therapy Phase||0||
48344815|NCT00100048|101172417|FG002|Never Treated|Cohort I & II-Combination Therapy Phase||0||
48635440|NCT02290184|101891876|FG001|NOT COMPLETED|Overall Study||0||
48635441|NCT02722967|101891877|FG000|STARTED|Overall Study||22||
48758561|NCT02365649|102197636|FG006|COMPLETED|Double-Blind Extension (Weeks 16-52)||43||
48758562|NCT02365649|102197637|FG007|COMPLETED|Double-Blind Extension (Weeks 16-52)||21||
48758563|NCT02365649|102197638|FG008|COMPLETED|Double-Blind Extension (Weeks 16-52)||43||
48758564|NCT02365649|102197639|FG009|COMPLETED|Double-Blind Extension (Weeks 16-52)||22||
48344816|NCT00100048|101172418|FG003|Never Treated|Cohort I & II-Combination Therapy Phase||0||
48368099|NCT01798706|101230105|FG001|NOT COMPLETED|Overall Study||21||
48635442|NCT02722967|101891878|FG001|STARTED|Overall Study||12||
48635443|NCT02722967|101891879|FG002|STARTED|Overall Study||15||
48635444|NCT02722967|101891877|FG000|COMPLETED|Overall Study||17||
48635445|NCT02722967|101891878|FG001|COMPLETED|Overall Study||10||
48635446|NCT02722967|101891879|FG002|COMPLETED|Overall Study||11||
48635447|NCT02722967|101891877|FG000|NOT COMPLETED|Overall Study||5||
48635448|NCT02722967|101891878|FG001|NOT COMPLETED|Overall Study||2||
48635449|NCT02722967|101891879|FG002|NOT COMPLETED|Overall Study||4||
48635450|NCT02753881|101891880|FG000|STARTED|Overall Study||10||
48635451|NCT02753881|101891881|FG001|STARTED|Overall Study||10||
48635452|NCT02753881|101891882|FG002|STARTED|Overall Study||10||
48635453|NCT02753881|101891880|FG000|COMPLETED|Overall Study||10||
48635454|NCT02753881|101891881|FG001|COMPLETED|Overall Study||10||
48414757|NCT02773849|101350135|FG000|NOT COMPLETED|Overall Study||62||
48414758|NCT02364999|101350136|FG000|STARTED|Overall Study||358||
48414759|NCT02364999|101350137|FG001|STARTED|Overall Study||361||
48414760|NCT02364999|101350136|FG000|Received Treatment|Overall Study||356||
48414761|NCT02364999|101350137|FG001|Received Treatment|Overall Study||358||
48414762|NCT02364999|101350136|FG000|COMPLETED|Overall Study||193||
48635455|NCT02753881|101891882|FG002|COMPLETED|Overall Study||10||
48635456|NCT02753881|101891880|FG000|NOT COMPLETED|Overall Study||0||
48635457|NCT02753881|101891881|FG001|NOT COMPLETED|Overall Study||0||
48635458|NCT02753881|101891882|FG002|NOT COMPLETED|Overall Study||0||
48635459|NCT02335944|101891883|FG000|STARTED|Treatment Phase||4||
48635460|NCT02335944|101891884|FG001|STARTED|Treatment Phase||5||
48635461|NCT02335944|101891885|FG002|STARTED|Treatment Phase||3||
48635462|NCT02335944|101891886|FG003|STARTED|Treatment Phase||16||
48635463|NCT02335944|101891887|FG004|STARTED|Treatment Phase||5||
48758565|NCT02365649|102197630|FG000|NOT COMPLETED|Double-Blind Extension (Weeks 16-52)||0||
48758566|NCT02365649|102197631|FG001|NOT COMPLETED|Double-Blind Extension (Weeks 16-52)||0||
48758567|NCT02365649|102197632|FG002|NOT COMPLETED|Double-Blind Extension (Weeks 16-52)||0||
48758568|NCT02365649|102197633|FG003|NOT COMPLETED|Double-Blind Extension (Weeks 16-52)||0||
48414763|NCT02364999|101350137|FG001|COMPLETED|Overall Study||188||
48414764|NCT02364999|101350136|FG000|NOT COMPLETED|Overall Study||165||
48414765|NCT02364999|101350137|FG001|NOT COMPLETED|Overall Study||173||
48635464|NCT02335944|101891888|FG005|STARTED|Treatment Phase||52||
48635465|NCT02335944|101891889|FG006|STARTED|Treatment Phase||3||
48635466|NCT02335944|101891890|FG007|STARTED|Treatment Phase||47||
48635467|NCT02335944|101891891|FG008|STARTED|Treatment Phase||42||
48635468|NCT02335944|101891892|FG009|STARTED|Treatment Phase||0||
48635469|NCT02335944|101891883|FG000|COMPLETED|Treatment Phase||0||
48635470|NCT02335944|101891884|FG001|COMPLETED|Treatment Phase||0||
48635471|NCT02335944|101891885|FG002|COMPLETED|Treatment Phase||0||
48635472|NCT02335944|101891886|FG003|COMPLETED|Treatment Phase||1||
48635473|NCT02335944|101891887|FG004|COMPLETED|Treatment Phase||0||
48635474|NCT02335944|101891888|FG005|COMPLETED|Treatment Phase||2||
48635475|NCT02335944|101891889|FG006|COMPLETED|Treatment Phase||0||
48635476|NCT02335944|101891890|FG007|COMPLETED|Treatment Phase||5||
48635477|NCT02335944|101891891|FG008|COMPLETED|Treatment Phase||6||
48414766|NCT01843933|101350138|FG000|STARTED|Overall Study||104||
48758569|NCT02365649|102197634|FG004|NOT COMPLETED|Double-Blind Extension (Weeks 16-52)||0||
48758570|NCT02365649|102197635|FG005|NOT COMPLETED|Double-Blind Extension (Weeks 16-52)||0||
48758571|NCT02365649|102197636|FG006|NOT COMPLETED|Double-Blind Extension (Weeks 16-52)||18||
48414767|NCT01843933|101350139|FG001|STARTED|Overall Study||107||
48414768|NCT01843933|101350138|FG000|COMPLETED|Overall Study||98||
48414769|NCT01843933|101350139|FG001|COMPLETED|Overall Study||103||
48414770|NCT01843933|101350138|FG000|NOT COMPLETED|Overall Study||6||
48635478|NCT02335944|101891892|FG009|COMPLETED|Treatment Phase||0||
48635479|NCT02335944|101891883|FG000|NOT COMPLETED|Treatment Phase||4||
48635480|NCT02335944|101891884|FG001|NOT COMPLETED|Treatment Phase||5||
48635481|NCT02335944|101891885|FG002|NOT COMPLETED|Treatment Phase||3||
48635482|NCT02335944|101891886|FG003|NOT COMPLETED|Treatment Phase||15||
48635483|NCT02335944|101891887|FG004|NOT COMPLETED|Treatment Phase||5||
48635484|NCT02335944|101891888|FG005|NOT COMPLETED|Treatment Phase||50||
48635485|NCT02335944|101891889|FG006|NOT COMPLETED|Treatment Phase||3||
48635486|NCT02335944|101891890|FG007|NOT COMPLETED|Treatment Phase||42||
48635487|NCT02335944|101891891|FG008|NOT COMPLETED|Treatment Phase||36||
48635488|NCT02335944|101891892|FG009|NOT COMPLETED|Treatment Phase||0||
48635489|NCT02335944|101891883|FG000|STARTED|Post-treatment Follow-up||1||
48635490|NCT02335944|101891884|FG001|STARTED|Post-treatment Follow-up||0||
48635491|NCT02335944|101891885|FG002|STARTED|Post-treatment Follow-up||0||
48635492|NCT02335944|101891886|FG003|STARTED|Post-treatment Follow-up||2||
48344817|NCT00100048|101172419|FG004|Never Treated|Cohort I & II-Combination Therapy Phase||0||
48344818|NCT00100048|101172420|FG005|Never Treated|Cohort I & II-Combination Therapy Phase||1||
48344819|NCT00100048|101172415|FG000|COMPLETED|Cohort I & II-Combination Therapy Phase||27||
48344820|NCT00100048|101172416|FG001|COMPLETED|Cohort I & II-Combination Therapy Phase||31||
48344821|NCT00100048|101172417|FG002|COMPLETED|Cohort I & II-Combination Therapy Phase||28||
48414771|NCT01843933|101350139|FG001|NOT COMPLETED|Overall Study||4||
48414772|NCT00735072|101350140|FG000|STARTED|Overall Study||23||
48414773|NCT00735072|101350141|FG001|STARTED|Overall Study||22||
48635493|NCT02335944|101891887|FG004|STARTED|Post-treatment Follow-up||0||
48635494|NCT02335944|101891888|FG005|STARTED|Post-treatment Follow-up||13||
48635495|NCT02335944|101891889|FG006|STARTED|Post-treatment Follow-up||0||
48635496|NCT02335944|101891890|FG007|STARTED|Post-treatment Follow-up||5||
48635497|NCT02335944|101891891|FG008|STARTED|Post-treatment Follow-up||3||
48635498|NCT02335944|101891892|FG009|STARTED|Post-treatment Follow-up||0||
48344822|NCT00100048|101172418|FG003|COMPLETED|Cohort I & II-Combination Therapy Phase||30||
48414774|NCT00735072|101350140|FG000|COMPLETED|Overall Study||22||
48414775|NCT00735072|101350141|FG001|COMPLETED|Overall Study||21||
48414776|NCT00735072|101350140|FG000|NOT COMPLETED|Overall Study||1||
48635499|NCT02335944|101891883|FG000|COMPLETED|Post-treatment Follow-up||0||
48635500|NCT02335944|101891884|FG001|COMPLETED|Post-treatment Follow-up||0||
48635501|NCT02335944|101891885|FG002|COMPLETED|Post-treatment Follow-up||0||
48635502|NCT02335944|101891886|FG003|COMPLETED|Post-treatment Follow-up||0||
48635503|NCT02335944|101891887|FG004|COMPLETED|Post-treatment Follow-up||0||
48635504|NCT02335944|101891888|FG005|COMPLETED|Post-treatment Follow-up||0||
48414777|NCT00735072|101350141|FG001|NOT COMPLETED|Overall Study||1||
48414778|NCT00676806|101350142|FG000|STARTED|Overall Study||3||
48414779|NCT00676806|101350143|FG001|STARTED|Overall Study||3||
48635505|NCT02335944|101891889|FG006|COMPLETED|Post-treatment Follow-up||0||
48635506|NCT02335944|101891890|FG007|COMPLETED|Post-treatment Follow-up||0||
48635507|NCT02335944|101891891|FG008|COMPLETED|Post-treatment Follow-up||0||
48635508|NCT02335944|101891892|FG009|COMPLETED|Post-treatment Follow-up||0||
48635509|NCT02335944|101891883|FG000|NOT COMPLETED|Post-treatment Follow-up||1||
48635510|NCT02335944|101891884|FG001|NOT COMPLETED|Post-treatment Follow-up||0||
48414780|NCT00676806|101350142|FG000|COMPLETED|Overall Study||3||
48635511|NCT02335944|101891885|FG002|NOT COMPLETED|Post-treatment Follow-up||0||
48635512|NCT02335944|101891886|FG003|NOT COMPLETED|Post-treatment Follow-up||2||
48635513|NCT02335944|101891887|FG004|NOT COMPLETED|Post-treatment Follow-up||0||
48635514|NCT02335944|101891888|FG005|NOT COMPLETED|Post-treatment Follow-up||13||
48635515|NCT02335944|101891889|FG006|NOT COMPLETED|Post-treatment Follow-up||0||
48635516|NCT02335944|101891890|FG007|NOT COMPLETED|Post-treatment Follow-up||5||
48635517|NCT02335944|101891891|FG008|NOT COMPLETED|Post-treatment Follow-up||3||
48635518|NCT02335944|101891892|FG009|NOT COMPLETED|Post-treatment Follow-up||0||
48635519|NCT01513590|101891893|FG000|STARTED|Overall Study||197||
48344823|NCT00100048|101172419|FG004|COMPLETED|Cohort I & II-Combination Therapy Phase||0||
48344824|NCT00100048|101172420|FG005|COMPLETED|Cohort I & II-Combination Therapy Phase||26||
48344825|NCT00100048|101172415|FG000|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||14||
48344826|NCT00100048|101172416|FG001|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||9||
48344827|NCT00100048|101172417|FG002|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13||
48344828|NCT00100048|101172418|FG003|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||10||
48344829|NCT00100048|101172419|FG004|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||0||
48344830|NCT00100048|101172420|FG005|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13||
48344831|NCT04223609|101172421|FG000|STARTED|Overall Study||6||
48344832|NCT04223609|101172422|FG001|STARTED|Overall Study||8||
48344833|NCT04223609|101172421|FG000|COMPLETED|Overall Study||6||
48344834|NCT04223609|101172422|FG001|COMPLETED|Overall Study||6||
48344835|NCT04223609|101172421|FG000|NOT COMPLETED|Overall Study||0||
48344836|NCT04223609|101172422|FG001|NOT COMPLETED|Overall Study||2||
48635520|NCT01513590|101891894|FG001|STARTED|Overall Study||197||
48635521|NCT01513590|101891893|FG000|Exposed|Overall Study||196||
48635522|NCT01513590|101891894|FG001|Exposed|Overall Study||195||
48635523|NCT01513590|101891893|FG000|COMPLETED|Overall Study||187||
48635524|NCT01513590|101891894|FG001|COMPLETED|Overall Study||184||
48635525|NCT01513590|101891893|FG000|NOT COMPLETED|Overall Study||10||
48635526|NCT01513590|101891894|FG001|NOT COMPLETED|Overall Study||13||
48635527|NCT00862992|101891895|FG000|STARTED|Overall Study||12||
48635528|NCT00862992|101891896|FG001|STARTED|Overall Study||10||
48635529|NCT00862992|101891897|FG002|STARTED|Overall Study||12||
48635530|NCT00862992|101891895|FG000|COMPLETED|Overall Study||9||
48635531|NCT00862992|101891896|FG001|COMPLETED|Overall Study||9||
48635532|NCT00862992|101891897|FG002|COMPLETED|Overall Study||9||
48635533|NCT00862992|101891895|FG000|NOT COMPLETED|Overall Study||3||
48635534|NCT00862992|101891896|FG001|NOT COMPLETED|Overall Study||1||
48635535|NCT00862992|101891897|FG002|NOT COMPLETED|Overall Study||3||
48635536|NCT02026141|101891898|FG000|STARTED|Overall Study||20||
48635537|NCT02026141|101891899|FG001|STARTED|Overall Study||20||
48635538|NCT02026141|101891898|FG000|COMPLETED|Overall Study||20||
48635539|NCT02026141|101891899|FG001|COMPLETED|Overall Study||19||
48635540|NCT02026141|101891898|FG000|NOT COMPLETED|Overall Study||0||
48635541|NCT02026141|101891899|FG001|NOT COMPLETED|Overall Study||1||
48635542|NCT02453048|101891900|FG000|STARTED|Overall Study||12||
48635543|NCT02453048|101891901|FG001|STARTED|Overall Study||12||
48635544|NCT02453048|101891902|FG002|STARTED|Overall Study||12||
48635545|NCT02453048|101891903|FG003|STARTED|Overall Study||12||
48635546|NCT02453048|101891904|FG004|STARTED|Overall Study||6||
48635547|NCT02453048|101891900|FG000|6-month Follow-up|Overall Study||12||
48344837|NCT01784796|101172423|FG000|STARTED|Overall Study||87||
48635548|NCT02453048|101891901|FG001|6-month Follow-up|Overall Study||12||
48635549|NCT02453048|101891902|FG002|6-month Follow-up|Overall Study||12||
48635550|NCT02453048|101891903|FG003|6-month Follow-up|Overall Study||12||
48635551|NCT02453048|101891904|FG004|6-month Follow-up|Overall Study||6||
48635552|NCT02453048|101891900|FG000|COMPLETED|Overall Study||12||
48635553|NCT02453048|101891901|FG001|COMPLETED|Overall Study||11||
48635554|NCT02453048|101891902|FG002|COMPLETED|Overall Study||10||
48635555|NCT02453048|101891903|FG003|COMPLETED|Overall Study||12||
48635556|NCT02453048|101891904|FG004|COMPLETED|Overall Study||0||
48635557|NCT02453048|101891900|FG000|NOT COMPLETED|Overall Study||0||
48344838|NCT01784796|101172424|FG001|STARTED|Overall Study||77||
48344839|NCT01784796|101172423|FG000|Baseline Data Collected|Overall Study||75||
48344840|NCT01784796|101172424|FG001|Baseline Data Collected|Overall Study||61||
48344841|NCT01784796|101172423|FG000|4 Week Data Collection|Overall Study||48||
48344842|NCT01784796|101172424|FG001|4 Week Data Collection|Overall Study||41||
48344843|NCT01784796|101172423|FG000|8 wk Data Collection|Overall Study||50||
48344844|NCT01784796|101172424|FG001|8 wk Data Collection|Overall Study||46||
48635558|NCT02453048|101891901|FG001|NOT COMPLETED|Overall Study||1||
48635559|NCT02453048|101891902|FG002|NOT COMPLETED|Overall Study||2||
48635560|NCT02453048|101891903|FG003|NOT COMPLETED|Overall Study||0||
48635561|NCT02453048|101891904|FG004|NOT COMPLETED|Overall Study||6||
48344845|NCT01784796|101172423|FG000|COMPLETED|Overall Study||39|This is data collected 6 months after end of intervention|
48344846|NCT01784796|101172424|FG001|COMPLETED|Overall Study||34|This is data collected 6 months after end of intervention|
48344847|NCT01784796|101172423|FG000|NOT COMPLETED|Overall Study||48||
48414781|NCT00676806|101350143|FG001|COMPLETED|Overall Study||3||
48635562|NCT01563081|101891905|FG000|STARTED|Overall Study||30||
48635563|NCT01563081|101891906|FG001|STARTED|Overall Study||30||
48635564|NCT01563081|101891905|FG000|COMPLETED|Overall Study||30||
48635565|NCT01563081|101891906|FG001|COMPLETED|Overall Study||30||
48635566|NCT01563081|101891905|FG000|NOT COMPLETED|Overall Study||0||
48344848|NCT01784796|101172424|FG001|NOT COMPLETED|Overall Study||43||
48635567|NCT01563081|101891906|FG001|NOT COMPLETED|Overall Study||0||
48635568|NCT02543840|101891907|FG000|STARTED|Overall Study||1050||
48635569|NCT02543840|101891908|FG001|STARTED|Overall Study||62||
48635570|NCT02543840|101891907|FG000|0 Month Timepoint (t0)|Overall Study||593||
48635571|NCT02543840|101891908|FG001|0 Month Timepoint (t0)|Overall Study||40||
48344849|NCT03440944|101172425|FG000|STARTED|Overall Study||9||
48344850|NCT03440944|101172426|FG001|STARTED|Overall Study||9||
48344851|NCT03440944|101172425|FG000|COMPLETED|Overall Study||8||
48635572|NCT02543840|101891907|FG000|6 Month Timepoint (t6)|Overall Study||66||
48635573|NCT02543840|101891908|FG001|6 Month Timepoint (t6)|Overall Study||0||
48635574|NCT02543840|101891907|FG000|12 Month Timepoint (t12)|Overall Study||391||
48635575|NCT02543840|101891908|FG001|12 Month Timepoint (t12)|Overall Study||22||
48635576|NCT02543840|101891907|FG000|COMPLETED|Overall Study||1050||
48635577|NCT02543840|101891908|FG001|COMPLETED|Overall Study||62||
48635578|NCT02543840|101891907|FG000|NOT COMPLETED|Overall Study||0||
48635579|NCT02543840|101891908|FG001|NOT COMPLETED|Overall Study||0||
48635580|NCT01222299|101891909|FG000|STARTED|Overall Study||21||
48635581|NCT01222299|101891910|FG001|STARTED|Overall Study||23||
48635582|NCT01222299|101891911|FG002|STARTED|Overall Study||22||
48635583|NCT01222299|101891912|FG003|STARTED|Overall Study||23||
48635584|NCT01222299|101891909|FG000|COMPLETED|Overall Study||21||
48635585|NCT01222299|101891910|FG001|COMPLETED|Overall Study||21||
48635586|NCT01222299|101891911|FG002|COMPLETED|Overall Study||20||
48635587|NCT01222299|101891912|FG003|COMPLETED|Overall Study||18||
48635588|NCT01222299|101891909|FG000|NOT COMPLETED|Overall Study||0||
48635589|NCT01222299|101891910|FG001|NOT COMPLETED|Overall Study||2||
48635590|NCT01222299|101891911|FG002|NOT COMPLETED|Overall Study||2||
48635591|NCT01222299|101891912|FG003|NOT COMPLETED|Overall Study||5||
48635592|NCT03769493|101891913|FG000|STARTED|Overall Study||10||
48635593|NCT03769493|101891913|FG000|COMPLETED|Overall Study||7||
48635594|NCT03769493|101891913|FG000|NOT COMPLETED|Overall Study||3||
48635595|NCT04319224|101891914|FG000|STARTED|Overall Study||1||
48635596|NCT04319224|101891915|FG001|STARTED|Overall Study||3||
48635597|NCT04319224|101891914|FG000|COMPLETED|Overall Study||1||
48635598|NCT04319224|101891915|FG001|COMPLETED|Overall Study||3||
48635599|NCT04319224|101891914|FG000|NOT COMPLETED|Overall Study||0||
48635600|NCT04319224|101891915|FG001|NOT COMPLETED|Overall Study||0||
48635601|NCT02182804|101891916|FG000|STARTED|Overall Study||44||
48344852|NCT03440944|101172426|FG001|COMPLETED|Overall Study||8||
48344853|NCT03440944|101172425|FG000|NOT COMPLETED|Overall Study||1||
48635602|NCT02182804|101891916|FG000|COMPLETED|Overall Study||44||
48635603|NCT02182804|101891916|FG000|NOT COMPLETED|Overall Study||0||
48635604|NCT00506675|101891917|FG000|STARTED|Overall Study||27||
48635605|NCT00506675|101891918|FG001|STARTED|Overall Study||28||
48635606|NCT00506675|101891917|FG000|COMPLETED|Overall Study||27||
48635607|NCT00506675|101891918|FG001|COMPLETED|Overall Study||28||
48635608|NCT00506675|101891917|FG000|NOT COMPLETED|Overall Study||0||
48635609|NCT00506675|101891918|FG001|NOT COMPLETED|Overall Study||0||
48635610|NCT02991521|101891919|FG000|STARTED|Overall Study||182||
48635611|NCT02991521|101891919|FG000|COMPLETED|Overall Study||182||
48635612|NCT02991521|101891919|FG000|NOT COMPLETED|Overall Study||0||
48635613|NCT01184872|101891920|FG000|STARTED|Overall Study||81||
48635614|NCT01184872|101891921|FG001|STARTED|Overall Study||39||
48635615|NCT01184872|101891920|FG000|Safety Set|Overall Study||80||
48635616|NCT01184872|101891921|FG001|Safety Set|Overall Study||40||
48635617|NCT01184872|101891920|FG000|Clinical Evaluable Set (CES)|Overall Study||73||
48635618|NCT01184872|101891921|FG001|Clinical Evaluable Set (CES)|Overall Study||30||
48635619|NCT01184872|101891920|FG000|Microbiologically Evaluable Set (MES)|Overall Study||65||
48344854|NCT03440944|101172426|FG001|NOT COMPLETED|Overall Study||1||
48344855|NCT01413958|101172427|FG000|STARTED|Overall Study||288||
48344856|NCT01413958|101172428|FG001|STARTED|Overall Study||287||
48635620|NCT01184872|101891921|FG001|Microbiologically Evaluable Set (MES)|Overall Study||27||
48635621|NCT01184872|101891920|FG000|COMPLETED|Overall Study||71||
48635622|NCT01184872|101891921|FG001|COMPLETED|Overall Study||31||
48635623|NCT01184872|101891920|FG000|NOT COMPLETED|Overall Study||10||
48635624|NCT01184872|101891921|FG001|NOT COMPLETED|Overall Study||8||
48635625|NCT00942851|101891922|FG000|STARTED|Overall Study||12||
48414782|NCT00676806|101350142|FG000|NOT COMPLETED|Overall Study||0||
48414783|NCT00676806|101350143|FG001|NOT COMPLETED|Overall Study||0||
48758572|NCT02365649|102197637|FG007|NOT COMPLETED|Double-Blind Extension (Weeks 16-52)||2||
48758573|NCT02365649|102197638|FG008|NOT COMPLETED|Double-Blind Extension (Weeks 16-52)||16||
48758574|NCT02365649|102197639|FG009|NOT COMPLETED|Double-Blind Extension (Weeks 16-52)||15||
48758575|NCT03710187|102197640|FG000|STARTED|Overall Study||41||
48758576|NCT03710187|102197641|FG001|STARTED|Overall Study||43||
48758577|NCT03710187|102197640|FG000|COMPLETED|Overall Study||41||
48758578|NCT03710187|102197641|FG001|COMPLETED|Overall Study||43||
48758579|NCT03710187|102197640|FG000|NOT COMPLETED|Overall Study||0||
48758580|NCT03710187|102197641|FG001|NOT COMPLETED|Overall Study||0||
48758581|NCT01968447|102197642|FG000|STARTED|Overall Study||20||
48758582|NCT01968447|102197643|FG001|STARTED|Overall Study||20||
48758583|NCT01968447|102197642|FG000|COMPLETED|Overall Study||20||
48184261|NCT02061761|100772394|FG008|HL-anti-PD-1 Naive|Overall Study||21|Tumor type eligible for expansion|
48414784|NCT03345849|101350144|FG000|STARTED|Part 1: Induction Period (Weeks 1-12)||176||
48758584|NCT01968447|102197643|FG001|COMPLETED|Overall Study||20||
48758585|NCT01968447|102197642|FG000|NOT COMPLETED|Overall Study||0||
48758586|NCT01968447|102197643|FG001|NOT COMPLETED|Overall Study||0||
48758587|NCT02101775|102197644|FG000|STARTED|Overall Study||65||
48758588|NCT02101775|102197645|FG001|STARTED|Overall Study||34||
48758589|NCT02101775|102197646|FG002|STARTED|Overall Study||25||
48758590|NCT02101775|102197644|FG000|COMPLETED|Overall Study||61||
48758591|NCT02101775|102197645|FG001|COMPLETED|Overall Study||33||
48758592|NCT02101775|102197646|FG002|COMPLETED|Overall Study||25||
48758593|NCT02101775|102197644|FG000|NOT COMPLETED|Overall Study||4||
48758594|NCT02101775|102197645|FG001|NOT COMPLETED|Overall Study||1||
48758595|NCT02101775|102197646|FG002|NOT COMPLETED|Overall Study||0||
48758596|NCT05856422|102197647|FG000|STARTED|Overall Study||21||
48758597|NCT05856422|102197647|FG000|COMPLETED|Overall Study||13||
48758598|NCT05856422|102197647|FG000|NOT COMPLETED|Overall Study||8||
48758599|NCT00915954|102197648|FG000|STARTED|Overall Study||10||
48758600|NCT00915954|102197649|FG001|STARTED|Overall Study||8||
48758601|NCT00915954|102197650|FG002|STARTED|Overall Study||10||
48758602|NCT00915954|102197648|FG000|COMPLETED|Overall Study||10||
48758603|NCT00915954|102197649|FG001|COMPLETED|Overall Study||8||
48758604|NCT00915954|102197650|FG002|COMPLETED|Overall Study||10||
48758605|NCT00915954|102197648|FG000|NOT COMPLETED|Overall Study||0||
48758606|NCT00915954|102197649|FG001|NOT COMPLETED|Overall Study||0||
48758607|NCT00915954|102197650|FG002|NOT COMPLETED|Overall Study||0||
48758608|NCT02918370|102197651|FG000|STARTED|Overall Study||36||
48758609|NCT02918370|102197652|FG001|STARTED|Overall Study||39||
48758610|NCT02918370|102197651|FG000|COMPLETED|Overall Study||34||
48758611|NCT02918370|102197652|FG001|COMPLETED|Overall Study||30||
48758612|NCT02918370|102197651|FG000|NOT COMPLETED|Overall Study||2||
48758613|NCT02918370|102197652|FG001|NOT COMPLETED|Overall Study||9||
48758614|NCT02539823|102197653|FG000|STARTED|Overall Study||15||
48758615|NCT02539823|102197654|FG001|STARTED|Overall Study||14||
48758616|NCT02539823|102197655|FG002|STARTED|Overall Study||13||
48758617|NCT02539823|102197653|FG000|COMPLETED|Overall Study||15||
48758618|NCT02539823|102197654|FG001|COMPLETED|Overall Study||14||
48758619|NCT02539823|102197655|FG002|COMPLETED|Overall Study||13||
48758620|NCT02539823|102197653|FG000|NOT COMPLETED|Overall Study||0||
48758621|NCT02539823|102197654|FG001|NOT COMPLETED|Overall Study||0||
48758622|NCT02539823|102197655|FG002|NOT COMPLETED|Overall Study||0||
48758623|NCT02673372|102197656|FG000|STARTED|Overall Study||30||
48758624|NCT02673372|102197657|FG001|STARTED|Overall Study||30||
48758625|NCT02673372|102197656|FG000|COMPLETED|Overall Study||30||
48758626|NCT02673372|102197657|FG001|COMPLETED|Overall Study||30||
48758627|NCT02673372|102197656|FG000|NOT COMPLETED|Overall Study||0||
48184262|NCT02061761|100772386|FG000|HL-anti-PD-1 Progressed|Overall Study||0|Tumor type eligible for expansion|
48414785|NCT03345849|101350145|FG001|STARTED|Part 1: Induction Period (Weeks 1-12)||350||
48414786|NCT03345849|101350146|FG002|STARTED|Part 1: Induction Period (Weeks 1-12)||0||
48414787|NCT03345849|101350147|FG003|STARTED|Part 1: Induction Period (Weeks 1-12)||0||
48414788|NCT03345849|101350144|FG000|Received Study Drug|Part 1: Induction Period (Weeks 1-12)||176||
48414789|NCT03345849|101350145|FG001|Received Study Drug|Part 1: Induction Period (Weeks 1-12)||350||
48414790|NCT03345849|101350146|FG002|Received Study Drug|Part 1: Induction Period (Weeks 1-12)||0||
48414791|NCT03345849|101350147|FG003|Received Study Drug|Part 1: Induction Period (Weeks 1-12)||0||
48414792|NCT03345849|101350144|FG000|COMPLETED|Part 1: Induction Period (Weeks 1-12)||154||
48414793|NCT03345849|101350145|FG001|COMPLETED|Part 1: Induction Period (Weeks 1-12)||330||
48414794|NCT03345849|101350146|FG002|COMPLETED|Part 1: Induction Period (Weeks 1-12)||0||
48414795|NCT03345849|101350147|FG003|COMPLETED|Part 1: Induction Period (Weeks 1-12)||0||
48758628|NCT02673372|102197657|FG001|NOT COMPLETED|Overall Study||0||
48758629|NCT03534804|102197658|FG000|STARTED|Overall Study||36||
48758630|NCT03534804|102197658|FG000|COMPLETED|Overall Study||35||
48758631|NCT03534804|102197658|FG000|NOT COMPLETED|Overall Study||1||
48758632|NCT05005260|102197659|FG000|STARTED|Overall Study||42||
48758633|NCT05005260|102197660|FG001|STARTED|Overall Study||46||
48188682|NCT00329303|100783308|FG001|COMPLETED|Overall Study||35||
48758634|NCT05005260|102197659|FG000|COMPLETED|Overall Study||39||
48758635|NCT05005260|102197660|FG001|COMPLETED|Overall Study||44||
48184263|NCT02061761|100772387|FG001|HL-anti-PD-1 Progressed|Overall Study||0|Tumor type eligible for expansion|
48635626|NCT00942851|101891923|FG001|STARTED|Overall Study||12||
48635627|NCT00942851|101891922|FG000|COMPLETED|Overall Study||12||
48635628|NCT00942851|101891923|FG001|COMPLETED|Overall Study||11||
48184264|NCT02061761|100772388|FG002|HL-anti-PD-1 Progressed|Overall Study||0|Tumor type eligible for expansion|
48184265|NCT02061761|100772389|FG003|HL-anti-PD-1 Progressed|Overall Study||0|Tumor type eligible for expansion|
48184266|NCT02061761|100772390|FG004|HL-anti-PD-1 Progressed|Overall Study||0|Tumor type eligible for expansion|
48184267|NCT02061761|100772391|FG005|HL-anti-PD-1 Progressed|Overall Study||0|Tumor type eligible for expansion|
48184268|NCT02061761|100772392|FG006|HL-anti-PD-1 Progressed|Overall Study||0|Tumor type eligible for expansion|
48184269|NCT02061761|100772393|FG007|HL-anti-PD-1 Progressed|Overall Study||0|Tumor type eligible for expansion|
48184270|NCT02061761|100772394|FG008|HL-anti-PD-1 Progressed|Overall Study||20|Tumor type eligible for expansion|
48184271|NCT02061761|100772386|FG000|COMPLETED|Overall Study||0|Completed treatment|
48184272|NCT02061761|100772387|FG001|COMPLETED|Overall Study||1|Completed treatment|
48184273|NCT02061761|100772388|FG002|COMPLETED|Overall Study||0|Completed treatment|
48184274|NCT02061761|100772389|FG003|COMPLETED|Overall Study||0|Completed treatment|
48184275|NCT02061761|100772390|FG004|COMPLETED|Overall Study||0|Completed treatment|
48184276|NCT02061761|100772391|FG005|COMPLETED|Overall Study||2|Completed treatment|
48184277|NCT02061761|100772392|FG006|COMPLETED|Overall Study||0|Completed treatment|
48184278|NCT02061761|100772393|FG007|COMPLETED|Overall Study||0|Completed treatment|
48184279|NCT02061761|100772394|FG008|COMPLETED|Overall Study||5|Completed treatment|
48184280|NCT02061761|100772386|FG000|NOT COMPLETED|Overall Study||3||
48184281|NCT02061761|100772387|FG001|NOT COMPLETED|Overall Study||8||
48184282|NCT02061761|100772388|FG002|NOT COMPLETED|Overall Study||6||
48184283|NCT02061761|100772389|FG003|NOT COMPLETED|Overall Study||9||
48184284|NCT02061761|100772390|FG004|NOT COMPLETED|Overall Study||11||
48635629|NCT00942851|101891922|FG000|NOT COMPLETED|Overall Study||0||
48635630|NCT00942851|101891923|FG001|NOT COMPLETED|Overall Study||1||
48635631|NCT03736720|101891924|FG000|STARTED|Overall Study||11||
48635632|NCT03736720|101891924|FG000|COMPLETED|Overall Study||11||
48635633|NCT03736720|101891924|FG000|NOT COMPLETED|Overall Study||0||
48635634|NCT03530696|101891925|FG000|STARTED|Overall Study||39||
48635635|NCT03530696|101891926|FG001|STARTED|Overall Study||16||
48635636|NCT03530696|101891925|FG000|COMPLETED|Overall Study||38||
48635637|NCT03530696|101891926|FG001|COMPLETED|Overall Study||14||
48635638|NCT03530696|101891925|FG000|NOT COMPLETED|Overall Study||1||
48635639|NCT03530696|101891926|FG001|NOT COMPLETED|Overall Study||2||
48635640|NCT03861039|101891927|FG000|STARTED|Overall Study||148||
48635641|NCT03861039|101891928|FG001|STARTED|Overall Study||147||
48635642|NCT03861039|101891929|FG002|STARTED|Overall Study||148||
48635643|NCT03861039|101891927|FG000|Received at Least One Dose of Study Drug|Overall Study||148||
48635644|NCT03861039|101891928|FG001|Received at Least One Dose of Study Drug|Overall Study||147||
48635645|NCT03861039|101891929|FG002|Received at Least One Dose of Study Drug|Overall Study||148||
48635646|NCT03861039|101891927|FG000|COMPLETED|Overall Study||145||
48635647|NCT03861039|101891928|FG001|COMPLETED|Overall Study||139||
48635648|NCT03861039|101891929|FG002|COMPLETED|Overall Study||133||
48635649|NCT03861039|101891927|FG000|NOT COMPLETED|Overall Study||3||
48635650|NCT03861039|101891928|FG001|NOT COMPLETED|Overall Study||8||
48635651|NCT03861039|101891929|FG002|NOT COMPLETED|Overall Study||15||
48635652|NCT00832975|101891930|FG000|STARTED|Overall Study||157||
48635653|NCT00832975|101891930|FG000|COMPLETED|Overall Study||118||
48635654|NCT00832975|101891930|FG000|NOT COMPLETED|Overall Study||39||
48635655|NCT00959751|101891931|FG000|STARTED|Overall Study||97||
48184285|NCT02061761|100772391|FG005|NOT COMPLETED|Overall Study||5||
48184286|NCT02061761|100772392|FG006|NOT COMPLETED|Overall Study||1||
48184287|NCT02061761|100772393|FG007|NOT COMPLETED|Overall Study||4||
48184288|NCT02061761|100772394|FG008|NOT COMPLETED|Overall Study||51||
48184289|NCT00419003|100772395|FG000|STARTED|Phase I, Ketamine Infusion||13||
48635656|NCT00959751|101891932|FG001|STARTED|Overall Study||98||
48635657|NCT00959751|101891931|FG000|COMPLETED|Overall Study||88||
48184290|NCT00419003|100772396|FG001|STARTED|Phase I, Ketamine Infusion||13||
48184291|NCT00419003|100772395|FG000|COMPLETED|Phase I, Ketamine Infusion||7||
48184292|NCT00419003|100772396|FG001|COMPLETED|Phase I, Ketamine Infusion||7||
48184293|NCT00419003|100772395|FG000|NOT COMPLETED|Phase I, Ketamine Infusion||6||
48184294|NCT00419003|100772396|FG001|NOT COMPLETED|Phase I, Ketamine Infusion||6||
48184295|NCT00419003|100772395|FG000|STARTED|Phase 2, Riluzole/Placebo Follow-Up||6||
48184296|NCT00419003|100772396|FG001|STARTED|Phase 2, Riluzole/Placebo Follow-Up||8||
48184297|NCT00419003|100772395|FG000|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||5||
48184298|NCT00419003|100772396|FG001|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||8||
48184299|NCT00419003|100772395|FG000|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||1||
48184300|NCT00419003|100772396|FG001|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||0||
48635658|NCT00959751|101891932|FG001|COMPLETED|Overall Study||86||
48635659|NCT00959751|101891931|FG000|NOT COMPLETED|Overall Study||9||
48635660|NCT00959751|101891932|FG001|NOT COMPLETED|Overall Study||12||
48635661|NCT01998360|101891933|FG000|STARTED|Overall Study||50||
48635662|NCT01998360|101891934|FG001|STARTED|Overall Study||50||
48635663|NCT01998360|101891933|FG000|COMPLETED|Overall Study||50||
48184301|NCT02449044|100772397|FG000|STARTED|Overall Study||111||
48184302|NCT02449044|100772397|FG000|COMPLETED|Overall Study||47||
48344857|NCT01413958|101172427|FG000|COMPLETED|Overall Study||288||
48635664|NCT01998360|101891934|FG001|COMPLETED|Overall Study||50||
48635665|NCT01998360|101891933|FG000|NOT COMPLETED|Overall Study||0||
48635666|NCT01998360|101891934|FG001|NOT COMPLETED|Overall Study||0||
48635667|NCT02353780|101891935|FG000|STARTED|Overall Study||3||
48635668|NCT02353780|101891936|FG001|STARTED|Overall Study||3||
48635669|NCT02353780|101891937|FG002|STARTED|Overall Study||3||
48635670|NCT02353780|101891935|FG000|COMPLETED|Overall Study||3||
48635671|NCT02353780|101891936|FG001|COMPLETED|Overall Study||3||
48635672|NCT02353780|101891937|FG002|COMPLETED|Overall Study||3||
48635673|NCT02353780|101891935|FG000|NOT COMPLETED|Overall Study||0||
48635674|NCT02353780|101891936|FG001|NOT COMPLETED|Overall Study||0||
48635675|NCT02353780|101891937|FG002|NOT COMPLETED|Overall Study||0||
48635676|NCT00083915|101891938|FG000|STARTED|Overall Study||52||
48635677|NCT00083915|101891939|FG001|STARTED|Overall Study||45||
48635678|NCT00083915|101891938|FG000|COMPLETED|Overall Study||2||
48635679|NCT00083915|101891939|FG001|COMPLETED|Overall Study||8||
48635680|NCT00083915|101891938|FG000|NOT COMPLETED|Overall Study||50||
48635681|NCT00083915|101891939|FG001|NOT COMPLETED|Overall Study||37||
48635682|NCT01869374|101891940|FG000|STARTED|Overall Study||9||
48635683|NCT01869374|101891941|FG001|STARTED|Overall Study||9||
48635684|NCT01869374|101891940|FG000|COMPLETED|Overall Study||9||
48635685|NCT01869374|101891941|FG001|COMPLETED|Overall Study||8||
48635686|NCT01869374|101891940|FG000|NOT COMPLETED|Overall Study||0||
48635687|NCT01869374|101891941|FG001|NOT COMPLETED|Overall Study||1||
48635688|NCT00706797|101891942|FG000|STARTED|Overall Study||70||
48635689|NCT00706797|101891943|FG001|STARTED|Overall Study||71||
48635690|NCT00706797|101891942|FG000|Safety Population|Overall Study||63||
48635691|NCT00706797|101891943|FG001|Safety Population|Overall Study||71||
48635692|NCT00706797|101891942|FG000|COMPLETED|Overall Study||1||
48635693|NCT00706797|101891943|FG001|COMPLETED|Overall Study||0||
48635694|NCT00706797|101891942|FG000|NOT COMPLETED|Overall Study||69||
48635695|NCT00706797|101891943|FG001|NOT COMPLETED|Overall Study||71||
48635696|NCT01658839|101891944|FG000|STARTED|Overall Study||25||
48635697|NCT01658839|101891944|FG000|COMPLETED|Overall Study||25||
48635698|NCT01658839|101891944|FG000|NOT COMPLETED|Overall Study||0||
48635699|NCT00565461|101891945|FG000|STARTED|Overall Study||40||
48635700|NCT00565461|101891946|FG001|STARTED|Overall Study||40||
48635701|NCT00565461|101891947|FG002|STARTED|Overall Study||40||
48635702|NCT00565461|101891948|FG003|STARTED|Overall Study||40||
48635703|NCT00565461|101891945|FG000|COMPLETED|Overall Study||40||
48635704|NCT00565461|101891946|FG001|COMPLETED|Overall Study||39||
48635705|NCT00565461|101891947|FG002|COMPLETED|Overall Study||39||
48635706|NCT00565461|101891948|FG003|COMPLETED|Overall Study||37||
48635707|NCT00565461|101891945|FG000|NOT COMPLETED|Overall Study||0||
48635708|NCT00565461|101891946|FG001|NOT COMPLETED|Overall Study||1||
48635709|NCT00565461|101891947|FG002|NOT COMPLETED|Overall Study||1||
48635710|NCT00565461|101891948|FG003|NOT COMPLETED|Overall Study||3||
48635711|NCT03746509|101891949|FG000|STARTED|Overall Study||11||
48635712|NCT03746509|101891950|FG001|STARTED|Overall Study||10||
48635713|NCT03746509|101891951|FG002|STARTED|Overall Study||11||
48635714|NCT03746509|101891952|FG003|STARTED|Overall Study||10||
48635715|NCT03746509|101891949|FG000|COMPLETED|Overall Study||7||
48635716|NCT03746509|101891950|FG001|COMPLETED|Overall Study||8||
48635717|NCT03746509|101891951|FG002|COMPLETED|Overall Study||9||
48635718|NCT03746509|101891952|FG003|COMPLETED|Overall Study||9||
48635719|NCT03746509|101891949|FG000|NOT COMPLETED|Overall Study||4||
48184303|NCT02449044|100772397|FG000|NOT COMPLETED|Overall Study||64||
48184304|NCT01866917|100772398|FG000|STARTED|Overall Study||17||
48184305|NCT01866917|100772399|FG001|STARTED|Overall Study||18||
48184306|NCT01866917|100772398|FG000|COMPLETED|Overall Study||13||
48184307|NCT01866917|100772399|FG001|COMPLETED|Overall Study||12||
48184308|NCT01866917|100772398|FG000|NOT COMPLETED|Overall Study||4||
48184309|NCT01866917|100772399|FG001|NOT COMPLETED|Overall Study||6||
48184310|NCT01023308|100772400|FG000|STARTED|Overall Study||387||
48184311|NCT01023308|100772401|FG001|STARTED|Overall Study||381||
48184312|NCT01023308|100772400|FG000|COMPLETED|Overall Study||102||
48184313|NCT01023308|100772401|FG001|COMPLETED|Overall Study||102||
48344858|NCT01413958|101172428|FG001|COMPLETED|Overall Study||286||
48635720|NCT03746509|101891950|FG001|NOT COMPLETED|Overall Study||2||
48635721|NCT03746509|101891951|FG002|NOT COMPLETED|Overall Study||2||
48635722|NCT03746509|101891952|FG003|NOT COMPLETED|Overall Study||1||
48635723|NCT00851591|101891953|FG000|STARTED|Overall Study||2||
48635724|NCT00851591|101891954|FG001|STARTED|Overall Study||1||
48635725|NCT00851591|101891953|FG000|COMPLETED|Overall Study||0||
48635726|NCT00851591|101891954|FG001|COMPLETED|Overall Study||1||
48635727|NCT00851591|101891953|FG000|NOT COMPLETED|Overall Study||2||
48635728|NCT00851591|101891954|FG001|NOT COMPLETED|Overall Study||0||
48184314|NCT01023308|100772400|FG000|NOT COMPLETED|Overall Study||285||
48184315|NCT01023308|100772401|FG001|NOT COMPLETED|Overall Study||279||
48184316|NCT02965144|100772402|FG000|STARTED|Overall Study||13||
48184317|NCT02965144|100772402|FG000|COMPLETED|Overall Study||13||
48635729|NCT01446705|101891955|FG000|STARTED|Overall Study||50446||
48635730|NCT01446705|101891956|FG001|STARTED|Overall Study||6627||
48758636|NCT05005260|102197659|FG000|NOT COMPLETED|Overall Study||3||
48758637|NCT05005260|102197660|FG001|NOT COMPLETED|Overall Study||2||
48758638|NCT04372017|102197661|FG000|STARTED|Overall Study||1||
48758639|NCT04372017|102197662|FG001|STARTED|Overall Study||0||
48758640|NCT04372017|102197663|FG002|STARTED|Overall Study||0||
48758641|NCT04372017|102197664|FG003|STARTED|Overall Study||0||
48758642|NCT04372017|102197661|FG000|COMPLETED|Overall Study||1||
48758643|NCT04372017|102197662|FG001|COMPLETED|Overall Study||0||
48758644|NCT04372017|102197663|FG002|COMPLETED|Overall Study||0||
48344859|NCT01413958|101172427|FG000|NOT COMPLETED|Overall Study||0||
48344860|NCT01413958|101172428|FG001|NOT COMPLETED|Overall Study||1||
48344861|NCT03359902|101172429|FG000|STARTED|Overall Study||41||
48344862|NCT03359902|101172430|FG001|STARTED|Overall Study||18||
48344863|NCT03359902|101172429|FG000|COMPLETED|Overall Study||41||
48344864|NCT03359902|101172430|FG001|COMPLETED|Overall Study||18||
48344865|NCT03359902|101172429|FG000|NOT COMPLETED|Overall Study||0||
48344866|NCT03359902|101172430|FG001|NOT COMPLETED|Overall Study||0||
48344867|NCT01381094|101172431|FG000|STARTED|Overall Study||18||
48344868|NCT01381094|101172432|FG001|STARTED|Overall Study||18||
48344869|NCT01381094|101172433|FG002|STARTED|Overall Study||17||
48344870|NCT01381094|101172434|FG003|STARTED|Overall Study||19||
48344871|NCT01381094|101172435|FG004|STARTED|Overall Study||19||
48344872|NCT01381094|101172431|FG000|COMPLETED|Overall Study||16||
48344873|NCT01381094|101172432|FG001|COMPLETED|Overall Study||15||
48344874|NCT01381094|101172433|FG002|COMPLETED|Overall Study||17||
48344875|NCT01381094|101172434|FG003|COMPLETED|Overall Study||18||
48344876|NCT01381094|101172435|FG004|COMPLETED|Overall Study||18||
48344877|NCT01381094|101172431|FG000|NOT COMPLETED|Overall Study||2||
48344878|NCT01381094|101172432|FG001|NOT COMPLETED|Overall Study||3||
48344879|NCT01381094|101172433|FG002|NOT COMPLETED|Overall Study||0||
48344880|NCT01381094|101172434|FG003|NOT COMPLETED|Overall Study||1||
48344881|NCT01381094|101172435|FG004|NOT COMPLETED|Overall Study||1||
48344882|NCT00603239|101172436|FG000|STARTED|Overall Study||111||
48758645|NCT04372017|102197664|FG003|COMPLETED|Overall Study||0||
48758646|NCT04372017|102197661|FG000|NOT COMPLETED|Overall Study||0||
48414796|NCT03345849|101350144|FG000|NOT COMPLETED|Part 1: Induction Period (Weeks 1-12)||22||
48414797|NCT03345849|101350145|FG001|NOT COMPLETED|Part 1: Induction Period (Weeks 1-12)||20||
48414798|NCT03345849|101350146|FG002|NOT COMPLETED|Part 1: Induction Period (Weeks 1-12)||0||
48414799|NCT03345849|101350147|FG003|NOT COMPLETED|Part 1: Induction Period (Weeks 1-12)||0||
48414800|NCT03345849|101350144|FG000|STARTED|Part 2: Extended Treatment (Weeks 12-24)||0|Participants who were clinical non-responders at the end of the induction period (Week 12) could enter Part 2.|
48414801|NCT03345849|101350145|FG001|STARTED|Part 2: Extended Treatment (Weeks 12-24)||0|Participants who were clinical non-responders at the end of the induction period (Week 12) could enter Part 2.|
48758647|NCT04372017|102197662|FG001|NOT COMPLETED|Overall Study||0||
48344883|NCT00603239|101172437|FG001|STARTED|Overall Study||54||
48635731|NCT01446705|101891955|FG000|COMPLETED|Overall Study||50446||
48344884|NCT00603239|101172436|FG000|COMPLETED|Overall Study||96||
48344885|NCT00603239|101172437|FG001|COMPLETED|Overall Study||50||
48344886|NCT00603239|101172436|FG000|NOT COMPLETED|Overall Study||15||
48344887|NCT00603239|101172437|FG001|NOT COMPLETED|Overall Study||4||
48344888|NCT03837184|101172438|FG000|STARTED|Overall Study||2||
48344889|NCT03837184|101172438|FG000|COMPLETED|Overall Study||2||
48414802|NCT03345849|101350146|FG002|STARTED|Part 2: Extended Treatment (Weeks 12-24)||57|Participants who were clinical non-responders at the end of the induction period (Week 12) could enter Part 2.|
48414803|NCT03345849|101350147|FG003|STARTED|Part 2: Extended Treatment (Weeks 12-24)||59|Participants who were clinical non-responders at the end of the induction period (Week 12) could enter Part 2.|
48439968|NCT01728376|101409996|FG001|Treated|Overall Study||10||
48635732|NCT01446705|101891956|FG001|COMPLETED|Overall Study||6627||
48344890|NCT03837184|101172438|FG000|NOT COMPLETED|Overall Study||0||
48344891|NCT01200433|101172439|FG000|STARTED|Overall Study||21||
48344892|NCT01200433|101172440|FG001|STARTED|Overall Study||23||
48344893|NCT01200433|101172439|FG000|COMPLETED|Overall Study||21||
48344894|NCT01200433|101172440|FG001|COMPLETED|Overall Study||23||
48344895|NCT01200433|101172439|FG000|NOT COMPLETED|Overall Study||0||
48344896|NCT01200433|101172440|FG001|NOT COMPLETED|Overall Study||0||
48635733|NCT01446705|101891955|FG000|NOT COMPLETED|Overall Study||0||
48635734|NCT01446705|101891956|FG001|NOT COMPLETED|Overall Study||0||
48635735|NCT00639509|101891957|FG000|STARTED|Overall Study||24||
48635736|NCT00639509|101891957|FG000|COMPLETED|Overall Study||23||
48635737|NCT00639509|101891957|FG000|NOT COMPLETED|Overall Study||1||
48635738|NCT01018979|101891958|FG000|STARTED|Overall Study||7||
48635739|NCT01018979|101891959|FG001|STARTED|Overall Study||13||
48635740|NCT01018979|101891958|FG000|Received at Least One Dose|Overall Study||7||
48635741|NCT01018979|101891959|FG001|Received at Least One Dose|Overall Study||12||
48635742|NCT01018979|101891958|FG000|COMPLETED|Overall Study||4||
48635743|NCT01018979|101891959|FG001|COMPLETED|Overall Study||3||
48635744|NCT01018979|101891958|FG000|NOT COMPLETED|Overall Study||3||
48635745|NCT01018979|101891959|FG001|NOT COMPLETED|Overall Study||10||
48758648|NCT04372017|102197663|FG002|NOT COMPLETED|Overall Study||0||
48344897|NCT01294228|101172441|FG000|STARTED|Overall Study||1001||
48344898|NCT01294228|101172441|FG000|COMPLETED|Overall Study||1001||
48344899|NCT01294228|101172441|FG000|NOT COMPLETED|Overall Study||0||
48344900|NCT01879410|101172442|FG000|STARTED|Overall Study||350||
48635746|NCT02246777|101891960|FG000|STARTED|Overall Study||32||
48635747|NCT02246777|101891960|FG000|COMPLETED|Overall Study||29||
48635748|NCT02246777|101891960|FG000|NOT COMPLETED|Overall Study||3||
48635749|NCT04062227|101891961|FG000|STARTED|Overall Study||26||
48635750|NCT04062227|101891961|FG000|COMPLETED|Overall Study||16||
48635751|NCT04062227|101891961|FG000|NOT COMPLETED|Overall Study||10||
48635752|NCT02054156|101891962|FG000|STARTED|Overall Study||110||
48635753|NCT02054156|101891963|FG001|STARTED|Overall Study||111||
48635754|NCT02054156|101891962|FG000|COMPLETED|Overall Study||35||
48635755|NCT02054156|101891963|FG001|COMPLETED|Overall Study||30||
48635756|NCT02054156|101891962|FG000|NOT COMPLETED|Overall Study||75||
48635757|NCT02054156|101891963|FG001|NOT COMPLETED|Overall Study||81||
48635758|NCT02025075|101891964|FG000|STARTED|Overall Study||16||
48635759|NCT02025075|101891965|FG001|STARTED|Overall Study||21||
48635760|NCT02025075|101891964|FG000|COMPLETED|Overall Study||16||
48635761|NCT02025075|101891965|FG001|COMPLETED|Overall Study||19||
48635762|NCT02025075|101891964|FG000|NOT COMPLETED|Overall Study||0||
48758649|NCT04372017|102197664|FG003|NOT COMPLETED|Overall Study||0||
48758650|NCT02018562|102197665|FG000|STARTED|Overall Study||25||
48635763|NCT02025075|101891965|FG001|NOT COMPLETED|Overall Study||2||
48635764|NCT00557466|101891966|FG000|STARTED|Overall Study||98||
48635765|NCT00557466|101891967|FG001|STARTED|Overall Study||92||
48635766|NCT00557466|101891968|FG002|STARTED|Overall Study||101||
48635767|NCT00557466|101891969|FG003|STARTED|Overall Study||96||
48635768|NCT00557466|101891970|FG004|STARTED|Overall Study||90||
48635769|NCT00557466|101891971|FG005|STARTED|Overall Study||91||
48635770|NCT00557466|101891966|FG000|Safety Population|Overall Study||98||
48635771|NCT00557466|101891967|FG001|Safety Population|Overall Study||92||
48184318|NCT02965144|100772402|FG000|NOT COMPLETED|Overall Study||0||
48184319|NCT02015663|100772403|FG000|STARTED|Overall Study||16||
48184320|NCT02015663|100772404|FG001|STARTED|Overall Study||16||
48184321|NCT02015663|100772403|FG000|COMPLETED|Overall Study||1||
48635772|NCT00557466|101891968|FG002|Safety Population|Overall Study||101||
48635773|NCT00557466|101891969|FG003|Safety Population|Overall Study||96||
48635774|NCT00557466|101891970|FG004|Safety Population|Overall Study||90||
48635775|NCT00557466|101891971|FG005|Safety Population|Overall Study||91||
48635776|NCT00557466|101891966|FG000|Intent to Treat Population|Overall Study||98||
48635777|NCT00557466|101891967|FG001|Intent to Treat Population|Overall Study||91||
48184322|NCT02015663|100772404|FG001|COMPLETED|Overall Study||4||
48184323|NCT02015663|100772403|FG000|NOT COMPLETED|Overall Study||15||
48184324|NCT02015663|100772404|FG001|NOT COMPLETED|Overall Study||12||
48184325|NCT00674492|100772405|FG000|STARTED|Overall Study||21||
48184326|NCT00674492|100772405|FG000|COMPLETED|Overall Study||21||
48184327|NCT00674492|100772405|FG000|NOT COMPLETED|Overall Study||0||
48184328|NCT02015195|100772406|FG000|STARTED|Overall Study||16||
48184329|NCT02015195|100772407|FG001|STARTED|Overall Study||16||
48184330|NCT02015195|100772408|FG002|STARTED|Overall Study||16||
48184331|NCT02015195|100772409|FG003|STARTED|Overall Study||1||
48344901|NCT01879410|101172443|FG001|STARTED|Overall Study||350||
48344902|NCT01879410|101172442|FG000|Intent-to-Treat Population|Overall Study||349||
48344903|NCT01879410|101172443|FG001|Intent-to-Treat Population|Overall Study||348||
48344904|NCT01879410|101172442|FG000|COMPLETED|Overall Study||326||
48344905|NCT01879410|101172443|FG001|COMPLETED|Overall Study||312||
48344906|NCT01879410|101172442|FG000|NOT COMPLETED|Overall Study||24||
48344907|NCT01879410|101172443|FG001|NOT COMPLETED|Overall Study||38||
48344908|NCT00484315|101172444|FG000|STARTED|12-Month Clinical Follow-up||942||
48635778|NCT00557466|101891968|FG002|Intent to Treat Population|Overall Study||98||
48635779|NCT00557466|101891969|FG003|Intent to Treat Population|Overall Study||93||
48635780|NCT00557466|101891970|FG004|Intent to Treat Population|Overall Study||87||
48635781|NCT00557466|101891971|FG005|Intent to Treat Population|Overall Study||89||
48635782|NCT00557466|101891966|FG000|COMPLETED|Overall Study||94||
48635783|NCT00557466|101891967|FG001|COMPLETED|Overall Study||87||
48758651|NCT02018562|102197666|FG001|STARTED|Overall Study||25||
48758652|NCT02018562|102197665|FG000|COMPLETED|Overall Study||22||
48758653|NCT02018562|102197666|FG001|COMPLETED|Overall Study||25||
48758654|NCT02018562|102197665|FG000|NOT COMPLETED|Overall Study||3||
48344909|NCT00484315|101172445|FG001|STARTED|12-Month Clinical Follow-up||320||
48344910|NCT00484315|101172444|FG000|COMPLETED|12-Month Clinical Follow-up||914||
48635784|NCT00557466|101891968|FG002|COMPLETED|Overall Study||95||
48635785|NCT00557466|101891969|FG003|COMPLETED|Overall Study||92||
48758655|NCT02018562|102197666|FG001|NOT COMPLETED|Overall Study||0||
48758656|NCT03074409|102197667|FG000|STARTED|Overall Study||41||
48184332|NCT02015195|100772410|FG004|STARTED|Overall Study||16||
48184333|NCT02015195|100772411|FG005|STARTED|Overall Study||16||
48184334|NCT02015195|100772412|FG006|STARTED|Overall Study||16||
48184335|NCT02015195|100772406|FG000|COMPLETED|Overall Study||16||
48184336|NCT02015195|100772407|FG001|COMPLETED|Overall Study||16||
48184337|NCT02015195|100772408|FG002|COMPLETED|Overall Study||16||
48635786|NCT00557466|101891970|FG004|COMPLETED|Overall Study||87||
48184338|NCT02015195|100772409|FG003|COMPLETED|Overall Study||0||
48635787|NCT00557466|101891971|FG005|COMPLETED|Overall Study||85||
48635788|NCT00557466|101891966|FG000|NOT COMPLETED|Overall Study||4||
48635789|NCT00557466|101891967|FG001|NOT COMPLETED|Overall Study||5||
48184339|NCT02015195|100772410|FG004|COMPLETED|Overall Study||16||
48184340|NCT02015195|100772411|FG005|COMPLETED|Overall Study||16||
48184341|NCT02015195|100772412|FG006|COMPLETED|Overall Study||16||
48184342|NCT02015195|100772406|FG000|NOT COMPLETED|Overall Study||0||
48184343|NCT02015195|100772407|FG001|NOT COMPLETED|Overall Study||0||
48184344|NCT02015195|100772408|FG002|NOT COMPLETED|Overall Study||0||
48184345|NCT02015195|100772409|FG003|NOT COMPLETED|Overall Study||1||
48184346|NCT02015195|100772410|FG004|NOT COMPLETED|Overall Study||0||
48184347|NCT02015195|100772411|FG005|NOT COMPLETED|Overall Study||0||
48184348|NCT02015195|100772412|FG006|NOT COMPLETED|Overall Study||0||
48758657|NCT03074409|102197668|FG001|STARTED|Overall Study||42||
48758658|NCT03074409|102197667|FG000|COMPLETED|Overall Study||37||
48758659|NCT03074409|102197668|FG001|COMPLETED|Overall Study||38||
48758660|NCT03074409|102197667|FG000|NOT COMPLETED|Overall Study||4||
48758661|NCT03074409|102197668|FG001|NOT COMPLETED|Overall Study||4||
48758662|NCT04583280|102197669|FG000|STARTED|Overall Study||8||
48758663|NCT04583280|102197670|FG001|STARTED|Overall Study||20||
48184349|NCT00146640|100772413|FG000|STARTED|Overall Study||144||
48184350|NCT00146640|100772414|FG001|STARTED|Overall Study||144||
48184351|NCT00146640|100772413|FG000|COMPLETED|Overall Study||121||
48184352|NCT00146640|100772414|FG001|COMPLETED|Overall Study||130||
48184353|NCT00146640|100772413|FG000|NOT COMPLETED|Overall Study||23||
48635790|NCT00557466|101891968|FG002|NOT COMPLETED|Overall Study||6||
48635791|NCT00557466|101891969|FG003|NOT COMPLETED|Overall Study||4||
48344911|NCT00484315|101172445|FG001|COMPLETED|12-Month Clinical Follow-up||311||
48344912|NCT00484315|101172444|FG000|NOT COMPLETED|12-Month Clinical Follow-up||28||
48344913|NCT00484315|101172445|FG001|NOT COMPLETED|12-Month Clinical Follow-up||9||
48344914|NCT00484315|101172444|FG000|STARTED|9-Month Angiographic Follow-up||256||
48635792|NCT00557466|101891970|FG004|NOT COMPLETED|Overall Study||3||
48635793|NCT00557466|101891971|FG005|NOT COMPLETED|Overall Study||6||
48635794|NCT00891813|101891972|FG000|STARTED|Overall Study||100||
48635795|NCT00891813|101891972|FG000|COMPLETED|Overall Study||88||
48635796|NCT00891813|101891972|FG000|NOT COMPLETED|Overall Study||12||
48635797|NCT00640289|101891973|FG000|STARTED|Overall Study||72||
48635798|NCT00640289|101891973|FG000|COMPLETED|Overall Study||59||
48635799|NCT00640289|101891973|FG000|NOT COMPLETED|Overall Study||13||
48635800|NCT00750269|101891974|FG000|STARTED|Overall Study||8||
48635801|NCT00750269|101891975|FG001|STARTED|Overall Study||8||
48635802|NCT00750269|101891976|FG002|STARTED|Overall Study||18||
48635803|NCT00750269|101891977|FG003|STARTED|Overall Study||43||
48635804|NCT00750269|101891978|FG004|STARTED|Overall Study||43||
48635805|NCT00750269|101891974|FG000|COMPLETED|Overall Study||8||
48184354|NCT00146640|100772414|FG001|NOT COMPLETED|Overall Study||14||
48184355|NCT00415493|100772415|FG000|STARTED|Overall Study||12||
48184356|NCT00415493|100772416|FG001|STARTED|Overall Study||12||
48184357|NCT00415493|100772415|FG000|COMPLETED|Overall Study||12||
48184358|NCT00415493|100772416|FG001|COMPLETED|Overall Study||12||
48635806|NCT00750269|101891975|FG001|COMPLETED|Overall Study||7||
48635807|NCT00750269|101891976|FG002|COMPLETED|Overall Study||14||
48635808|NCT00750269|101891977|FG003|COMPLETED|Overall Study||38||
48635809|NCT00750269|101891978|FG004|COMPLETED|Overall Study||33||
48635810|NCT00750269|101891974|FG000|NOT COMPLETED|Overall Study||0||
48635811|NCT00750269|101891975|FG001|NOT COMPLETED|Overall Study||1||
48635812|NCT00750269|101891976|FG002|NOT COMPLETED|Overall Study||4||
48635813|NCT00750269|101891977|FG003|NOT COMPLETED|Overall Study||5||
48635814|NCT00750269|101891978|FG004|NOT COMPLETED|Overall Study||10||
48635815|NCT00607893|101891979|FG000|STARTED|Overall Study||77|Underwent Randomization|
48635816|NCT00607893|101891980|FG001|STARTED|Overall Study||76|Underwent Randomization|
48635817|NCT00607893|101891979|FG000|Completed Baseline Visit|Overall Study||74|Completed Baseline Visit|
48635818|NCT00607893|101891980|FG001|Completed Baseline Visit|Overall Study||75|Completed Baseline Visit|
48635819|NCT00607893|101891979|FG000|Completed 8 Week Visit|Overall Study||71|Completed 8 Week Visit|
48635820|NCT00607893|101891980|FG001|Completed 8 Week Visit|Overall Study||72|Completed 8 Week Visit|
48635821|NCT00607893|101891979|FG000|Completed 12 Week Visit|Overall Study||0||
48758664|NCT04583280|102197669|FG000|COMPLETED|Overall Study||8||
48758665|NCT04583280|102197670|FG001|COMPLETED|Overall Study||19||
48184359|NCT00415493|100772415|FG000|NOT COMPLETED|Overall Study||0||
48184360|NCT00415493|100772416|FG001|NOT COMPLETED|Overall Study||0||
48184361|NCT00112112|100772417|FG000|STARTED|Overall Study||10||
48184362|NCT00112112|100772418|FG001|STARTED|Overall Study||10||
48184363|NCT00112112|100772417|FG000|COMPLETED|Overall Study||10||
48184364|NCT00112112|100772418|FG001|COMPLETED|Overall Study||10||
48184365|NCT00112112|100772417|FG000|NOT COMPLETED|Overall Study||0||
48184366|NCT00112112|100772418|FG001|NOT COMPLETED|Overall Study||0||
48344915|NCT00484315|101172445|FG001|STARTED|9-Month Angiographic Follow-up||74||
48344916|NCT00484315|101172444|FG000|COMPLETED|9-Month Angiographic Follow-up||228||
48344917|NCT00484315|101172445|FG001|COMPLETED|9-Month Angiographic Follow-up||61||
48344918|NCT00484315|101172444|FG000|NOT COMPLETED|9-Month Angiographic Follow-up||28||
48344919|NCT00484315|101172445|FG001|NOT COMPLETED|9-Month Angiographic Follow-up||13||
48635822|NCT00607893|101891980|FG001|Completed 12 Week Visit|Overall Study||29||
48635823|NCT00607893|101891979|FG000|COMPLETED|Overall Study||71||
48635824|NCT00607893|101891980|FG001|COMPLETED|Overall Study||72||
48184367|NCT01440049|100772419|FG000|STARTED|Overall Study||160||
48184368|NCT01440049|100772419|FG000|COMPLETED|Overall Study||155||
48184369|NCT01440049|100772419|FG000|NOT COMPLETED|Overall Study||5||
48184370|NCT00691028|100775734|FG000|STARTED|Open-label Period||0||
48758666|NCT04583280|102197669|FG000|NOT COMPLETED|Overall Study||0||
48758667|NCT04583280|102197670|FG001|NOT COMPLETED|Overall Study||1||
48758668|NCT05194124|102197671|FG000|STARTED|Run-in Period (1 Week)||2||
48758669|NCT05194124|102197672|FG001|STARTED|Run-in Period (1 Week)||1||
48758670|NCT05194124|102197673|FG002|STARTED|Run-in Period (1 Week)||16||
48758671|NCT05194124|102197674|FG003|STARTED|Run-in Period (1 Week)||0||
48758672|NCT05194124|102197675|FG004|STARTED|Run-in Period (1 Week)||0||
48758673|NCT05194124|102197676|FG005|STARTED|Run-in Period (1 Week)||0||
48414804|NCT03345849|101350144|FG000|COMPLETED|Part 2: Extended Treatment (Weeks 12-24)||0||
48635825|NCT00607893|101891979|FG000|NOT COMPLETED|Overall Study||6||
48635826|NCT00607893|101891980|FG001|NOT COMPLETED|Overall Study||4||
48184371|NCT00691028|100775735|FG001|STARTED|Open-label Period||0||
48184372|NCT00691028|100775736|FG002|STARTED|Open-label Period||0||
48184373|NCT00691028|100775737|FG003|STARTED|Open-label Period||327||
48184374|NCT00691028|100775734|FG000|COMPLETED|Open-label Period||0||
48184375|NCT00691028|100775735|FG001|COMPLETED|Open-label Period||0||
48635827|NCT03157089|101891981|FG000|STARTED|Overall Study||12||
48635828|NCT03157089|101891982|FG001|STARTED|Overall Study||12||
48635829|NCT03157089|101891981|FG000|Treated|Overall Study||12|Treated with afatinib+pembrolizumab|
48635830|NCT03157089|101891982|FG001|Treated|Overall Study||12|Treated with afatinib+pembrolizumab|
48758674|NCT05194124|102197677|FG006|STARTED|Run-in Period (1 Week)||0||
48758675|NCT05194124|102197678|FG007|STARTED|Run-in Period (1 Week)||0||
48758676|NCT05194124|102197679|FG008|STARTED|Run-in Period (1 Week)||0||
48758677|NCT05194124|102197680|FG009|STARTED|Run-in Period (1 Week)||0||
48758678|NCT05194124|102197671|FG000|COMPLETED|Run-in Period (1 Week)||2||
48758679|NCT05194124|102197672|FG001|COMPLETED|Run-in Period (1 Week)||1||
48635831|NCT03157089|101891981|FG000|COMPLETED|Overall Study||0||
48635832|NCT03157089|101891982|FG001|COMPLETED|Overall Study||0||
48635833|NCT03157089|101891981|FG000|NOT COMPLETED|Overall Study||12||
48635834|NCT03157089|101891982|FG001|NOT COMPLETED|Overall Study||12||
48635835|NCT00963235|101891983|FG000|STARTED|Overall Study||331||
48635836|NCT00963235|101891983|FG000|Vaccinated Dose 1|Overall Study||329||
48758680|NCT05194124|102197673|FG002|COMPLETED|Run-in Period (1 Week)||16||
48758681|NCT05194124|102197674|FG003|COMPLETED|Run-in Period (1 Week)||0||
48758682|NCT05194124|102197675|FG004|COMPLETED|Run-in Period (1 Week)||0||
48758683|NCT05194124|102197676|FG005|COMPLETED|Run-in Period (1 Week)||0||
48758684|NCT05194124|102197677|FG006|COMPLETED|Run-in Period (1 Week)||0||
48758685|NCT05194124|102197678|FG007|COMPLETED|Run-in Period (1 Week)||0||
48758686|NCT05194124|102197679|FG008|COMPLETED|Run-in Period (1 Week)||0||
48758687|NCT05194124|102197680|FG009|COMPLETED|Run-in Period (1 Week)||0||
48758688|NCT05194124|102197671|FG000|NOT COMPLETED|Run-in Period (1 Week)||0||
48758689|NCT05194124|102197672|FG001|NOT COMPLETED|Run-in Period (1 Week)||0||
48758690|NCT05194124|102197673|FG002|NOT COMPLETED|Run-in Period (1 Week)||0||
48758691|NCT05194124|102197674|FG003|NOT COMPLETED|Run-in Period (1 Week)||0||
48758692|NCT05194124|102197675|FG004|NOT COMPLETED|Run-in Period (1 Week)||0||
48758693|NCT05194124|102197676|FG005|NOT COMPLETED|Run-in Period (1 Week)||0||
48635837|NCT00963235|101891983|FG000|Vaccinated Dose 2|Overall Study||300||
48635838|NCT00963235|101891983|FG000|Vaccinated Dose 3|Overall Study||279||
48635839|NCT00963235|101891983|FG000|Completed Dose 3 1-month Blood Draw|Overall Study||277||
48635840|NCT00963235|101891983|FG000|COMPLETED|Overall Study||271||
48635841|NCT00963235|101891983|FG000|NOT COMPLETED|Overall Study||60||
48758694|NCT05194124|102197677|FG006|NOT COMPLETED|Run-in Period (1 Week)||0||
48635842|NCT02034006|101891984|FG000|STARTED|Overall Study||200||
48635843|NCT02034006|101891984|FG000|Once Treated Patients|Overall Study||70||
48635844|NCT02034006|101891984|FG000|Re-treated Patients|Overall Study||130||
48635845|NCT02034006|101891984|FG000|COMPLETED|Overall Study||186||
48635846|NCT02034006|101891984|FG000|NOT COMPLETED|Overall Study||14||
48635847|NCT02472405|101891985|FG000|STARTED|Overall Study||18||
48635848|NCT02472405|101891985|FG000|COMPLETED|Overall Study||8||
48635849|NCT02472405|101891985|FG000|NOT COMPLETED|Overall Study||10||
48635850|NCT00485836|101891986|FG000|STARTED|Overall Study||130||
48635851|NCT00485836|101891987|FG001|STARTED|Overall Study||132||
48758695|NCT05194124|102197678|FG007|NOT COMPLETED|Run-in Period (1 Week)||0||
48758696|NCT05194124|102197679|FG008|NOT COMPLETED|Run-in Period (1 Week)||0||
48758697|NCT05194124|102197680|FG009|NOT COMPLETED|Run-in Period (1 Week)||0||
48758698|NCT05194124|102197671|FG000|STARTED|Double Blind (DB) Period (13 Weeks)||0||
48758699|NCT05194124|102197672|FG001|STARTED|Double Blind (DB) Period (13 Weeks)||0||
48184376|NCT00691028|100775736|FG002|COMPLETED|Open-label Period||0||
48184377|NCT00691028|100775737|FG003|COMPLETED|Open-label Period||307||
48184378|NCT00691028|100775734|FG000|NOT COMPLETED|Open-label Period||0||
48184379|NCT00691028|100775735|FG001|NOT COMPLETED|Open-label Period||0||
48184380|NCT00691028|100775736|FG002|NOT COMPLETED|Open-label Period||0||
48184381|NCT00691028|100775737|FG003|NOT COMPLETED|Open-label Period||20||
48184382|NCT00691028|100775734|FG000|STARTED|Double-blind Period||99||
48635852|NCT00485836|101891988|FG002|STARTED|Overall Study||130||
48758700|NCT05194124|102197673|FG002|STARTED|Double Blind (DB) Period (13 Weeks)||0||
48635853|NCT00485836|101891986|FG000|Received Study Drug (Safety Population)|Overall Study||129||
48635854|NCT00485836|101891987|FG001|Received Study Drug (Safety Population)|Overall Study||132||
48635855|NCT00485836|101891988|FG002|Received Study Drug (Safety Population)|Overall Study||129||
48635856|NCT00485836|101891986|FG000|COMPLETED|Overall Study||115||
48635857|NCT00485836|101891987|FG001|COMPLETED|Overall Study||129||
48635858|NCT00485836|101891988|FG002|COMPLETED|Overall Study||119||
48635859|NCT00485836|101891986|FG000|NOT COMPLETED|Overall Study||15||
48635860|NCT00485836|101891987|FG001|NOT COMPLETED|Overall Study||3||
48635861|NCT00485836|101891988|FG002|NOT COMPLETED|Overall Study||11||
48635862|NCT02202252|101891989|FG000|STARTED|Overall Study||30||
48635863|NCT02202252|101891990|FG001|STARTED|Overall Study||30||
48635864|NCT02202252|101891989|FG000|COMPLETED|Overall Study||30||
48635865|NCT02202252|101891990|FG001|COMPLETED|Overall Study||30||
48635866|NCT02202252|101891989|FG000|NOT COMPLETED|Overall Study||0||
48635867|NCT02202252|101891990|FG001|NOT COMPLETED|Overall Study||0||
48635868|NCT02349438|101891991|FG000|STARTED|Period 1||11||
48635869|NCT02349438|101891992|FG001|STARTED|Period 1||10||
48635870|NCT02349438|101891991|FG000|COMPLETED|Period 1||11||
48635871|NCT02349438|101891992|FG001|COMPLETED|Period 1||10||
48635872|NCT02349438|101891991|FG000|NOT COMPLETED|Period 1||0||
48635873|NCT02349438|101891992|FG001|NOT COMPLETED|Period 1||0||
48635874|NCT02349438|101891991|FG000|STARTED|Period 2||11||
48635875|NCT02349438|101891992|FG001|STARTED|Period 2||10||
48184383|NCT00691028|100775735|FG001|STARTED|Double-blind Period||104||
48184384|NCT00691028|100775736|FG002|STARTED|Double-blind Period||104||
48184385|NCT00691028|100775737|FG003|STARTED|Double-blind Period||0||
48184386|NCT00691028|100775734|FG000|COMPLETED|Double-blind Period||86||
48184387|NCT00691028|100775735|FG001|COMPLETED|Double-blind Period||91||
48184388|NCT00691028|100775736|FG002|COMPLETED|Double-blind Period||95||
48184389|NCT00691028|100775737|FG003|COMPLETED|Double-blind Period||0||
48184390|NCT00691028|100775734|FG000|NOT COMPLETED|Double-blind Period||13||
48184391|NCT00691028|100775735|FG001|NOT COMPLETED|Double-blind Period||13||
48184392|NCT00691028|100775736|FG002|NOT COMPLETED|Double-blind Period||9||
48184393|NCT00691028|100775737|FG003|NOT COMPLETED|Double-blind Period||0||
48184394|NCT04038099|100775738|FG000|STARTED|Overall Study||30||
48184395|NCT04038099|100775739|FG001|STARTED|Overall Study||33||
48344920|NCT05047523|101172446|FG000|STARTED|Primary Evaluation Period (48 Weeks)||15||
48344921|NCT05047523|101172447|FG001|STARTED|Primary Evaluation Period (48 Weeks)||16||
48344922|NCT05047523|101172448|FG002|STARTED|Primary Evaluation Period (48 Weeks)||4||
48344923|NCT05047523|101172449|FG003|STARTED|Primary Evaluation Period (48 Weeks)||5||
48344924|NCT05047523|101172450|FG004|STARTED|Primary Evaluation Period (48 Weeks)||0||
48344925|NCT05047523|101172451|FG005|STARTED|Primary Evaluation Period (48 Weeks)||0||
48344926|NCT05047523|101172446|FG000|Received at Least 1 Dose of Study Drug|Primary Evaluation Period (48 Weeks)||15||
48344927|NCT05047523|101172447|FG001|Received at Least 1 Dose of Study Drug|Primary Evaluation Period (48 Weeks)||16||
48344928|NCT05047523|101172448|FG002|Received at Least 1 Dose of Study Drug|Primary Evaluation Period (48 Weeks)||4||
48344929|NCT05047523|101172449|FG003|Received at Least 1 Dose of Study Drug|Primary Evaluation Period (48 Weeks)||5||
48344930|NCT05047523|101172450|FG004|Received at Least 1 Dose of Study Drug|Primary Evaluation Period (48 Weeks)||0||
48344931|NCT05047523|101172451|FG005|Received at Least 1 Dose of Study Drug|Primary Evaluation Period (48 Weeks)||0||
48344932|NCT05047523|101172446|FG000|COMPLETED|Primary Evaluation Period (48 Weeks)||12||
48344933|NCT05047523|101172447|FG001|COMPLETED|Primary Evaluation Period (48 Weeks)||11||
48344934|NCT05047523|101172448|FG002|COMPLETED|Primary Evaluation Period (48 Weeks)||0||
48344935|NCT05047523|101172449|FG003|COMPLETED|Primary Evaluation Period (48 Weeks)||1||
48344936|NCT05047523|101172450|FG004|COMPLETED|Primary Evaluation Period (48 Weeks)||0||
48635876|NCT02349438|101891991|FG000|COMPLETED|Period 2||11||
48635877|NCT02349438|101891992|FG001|COMPLETED|Period 2||10||
48635878|NCT02349438|101891991|FG000|NOT COMPLETED|Period 2||0||
48635879|NCT02349438|101891992|FG001|NOT COMPLETED|Period 2||0||
48635880|NCT01160614|101891993|FG000|STARTED|Overall Study||5||
48184396|NCT04038099|100775738|FG000|COMPLETED|Overall Study||30||
48184397|NCT04038099|100775739|FG001|COMPLETED|Overall Study||33||
48184398|NCT04038099|100775738|FG000|NOT COMPLETED|Overall Study||0||
48184399|NCT04038099|100775739|FG001|NOT COMPLETED|Overall Study||0||
48635881|NCT01160614|101891994|FG001|STARTED|Overall Study||25||
48635882|NCT01160614|101891993|FG000|COMPLETED|Overall Study||5||
48635883|NCT01160614|101891994|FG001|COMPLETED|Overall Study||23||
48635884|NCT01160614|101891993|FG000|NOT COMPLETED|Overall Study||0||
48635885|NCT01160614|101891994|FG001|NOT COMPLETED|Overall Study||2||
48635886|NCT03837847|101891995|FG000|STARTED|Overall Study||33||
48635887|NCT03837847|101891996|FG001|STARTED|Overall Study||30||
48635888|NCT03837847|101891995|FG000|COMPLETED|Overall Study||33||
48635889|NCT03837847|101891996|FG001|COMPLETED|Overall Study||30||
48635890|NCT03837847|101891995|FG000|NOT COMPLETED|Overall Study||0||
48635891|NCT03837847|101891996|FG001|NOT COMPLETED|Overall Study||0||
48635892|NCT01860989|101891997|FG000|STARTED|Overall Study||11||
48635893|NCT01860989|101891997|FG000|COMPLETED|Overall Study||6||
48635894|NCT01860989|101891997|FG000|NOT COMPLETED|Overall Study||5||
48635895|NCT00720278|101891998|FG000|STARTED|Overall Study||178||
48635896|NCT00720278|101891999|FG001|STARTED|Overall Study||170||
48184400|NCT00654238|100775740|FG000|STARTED|Overall Study||59||
48635897|NCT00720278|101892000|FG002|STARTED|Overall Study||178||
48635898|NCT00720278|101891998|FG000|COMPLETED|Overall Study||171||
48635899|NCT00720278|101891999|FG001|COMPLETED|Overall Study||166||
48635900|NCT00720278|101892000|FG002|COMPLETED|Overall Study||172||
48635901|NCT00720278|101891998|FG000|NOT COMPLETED|Overall Study||7||
48635902|NCT00720278|101891999|FG001|NOT COMPLETED|Overall Study||4||
48635903|NCT00720278|101892000|FG002|NOT COMPLETED|Overall Study||6||
48635904|NCT02875080|101894488|FG000|STARTED|Overall Study||6||
48635905|NCT02875080|101894489|FG001|STARTED|Overall Study||6||
48635906|NCT02875080|101894490|FG002|STARTED|Overall Study||6||
48635907|NCT02875080|101894488|FG000|COMPLETED|Overall Study||4||
48635908|NCT02875080|101894489|FG001|COMPLETED|Overall Study||6||
48184401|NCT00654238|100775740|FG000|COMPLETED|Overall Study||55||
48184402|NCT00654238|100775740|FG000|NOT COMPLETED|Overall Study||4||
48635909|NCT02875080|101894490|FG002|COMPLETED|Overall Study||6||
48635910|NCT02875080|101894488|FG000|NOT COMPLETED|Overall Study||2||
48635911|NCT02875080|101894489|FG001|NOT COMPLETED|Overall Study||0||
48635912|NCT02875080|101894490|FG002|NOT COMPLETED|Overall Study||0||
48635913|NCT02196831|101894491|FG000|STARTED|Overall Study||30||
48635914|NCT02196831|101894492|FG001|STARTED|Overall Study||30||
48184403|NCT03713645|100775741|FG000|STARTED|Overall Study||36||
48344937|NCT05047523|101172451|FG005|COMPLETED|Primary Evaluation Period (48 Weeks)||0||
48344938|NCT05047523|101172446|FG000|NOT COMPLETED|Primary Evaluation Period (48 Weeks)||3||
48344939|NCT05047523|101172447|FG001|NOT COMPLETED|Primary Evaluation Period (48 Weeks)||5||
48344940|NCT05047523|101172448|FG002|NOT COMPLETED|Primary Evaluation Period (48 Weeks)||4||
48184404|NCT03713645|100775741|FG000|COMPLETED|Overall Study||36||
48184405|NCT03713645|100775741|FG000|NOT COMPLETED|Overall Study||0||
48184406|NCT03076359|100775742|FG000|STARTED|Overall Study||170||
48184407|NCT03076359|100775743|FG001|STARTED|Overall Study||150||
48184408|NCT03076359|100775742|FG000|COMPLETED|Overall Study||170||
48184409|NCT03076359|100775743|FG001|COMPLETED|Overall Study||150||
48184410|NCT03076359|100775742|FG000|NOT COMPLETED|Overall Study||0||
48184411|NCT03076359|100775743|FG001|NOT COMPLETED|Overall Study||0||
48184412|NCT01316692|100775744|FG000|STARTED|Overall Study||12||
48184413|NCT01316692|100775744|FG000|COMPLETED|Overall Study||0||
48184414|NCT01316692|100775744|FG000|NOT COMPLETED|Overall Study||12||
48184415|NCT00590980|100775745|FG000|STARTED|Overall Study||82||
48635915|NCT02196831|101894491|FG000|Received Follow-up Imaging|Overall Study||26||
48635916|NCT02196831|101894492|FG001|Received Follow-up Imaging|Overall Study||28||
48635917|NCT02196831|101894491|FG000|COMPLETED|Overall Study||21||
48184416|NCT00590980|100775745|FG000|COMPLETED|Overall Study||72||
48184417|NCT00590980|100775745|FG000|NOT COMPLETED|Overall Study||10||
48184418|NCT04365413|100775746|FG000|STARTED|Overall Study||45||
48184419|NCT04365413|100775746|FG000|COMPLETED|Overall Study||45||
48184420|NCT04365413|100775746|FG000|NOT COMPLETED|Overall Study||0||
48184421|NCT02419547|100775747|FG000|STARTED|Overall Study||11||
48184422|NCT02419547|100775747|FG000|COMPLETED|Overall Study||11||
48184423|NCT02419547|100775747|FG000|NOT COMPLETED|Overall Study||0||
48184424|NCT01755689|100775748|FG000|STARTED|Overall Study||259||
48184425|NCT01755689|100775749|FG001|STARTED|Overall Study||259||
48184426|NCT01755689|100775750|FG002|STARTED|Overall Study||261||
48184427|NCT01755689|100775751|FG003|STARTED|Overall Study||260||
48184428|NCT01755689|100775752|FG004|STARTED|Overall Study||261||
48344941|NCT05047523|101172449|FG003|NOT COMPLETED|Primary Evaluation Period (48 Weeks)||4||
48344942|NCT05047523|101172450|FG004|NOT COMPLETED|Primary Evaluation Period (48 Weeks)||0||
48344943|NCT05047523|101172451|FG005|NOT COMPLETED|Primary Evaluation Period (48 Weeks)||0||
48635918|NCT02196831|101894492|FG001|COMPLETED|Overall Study||26||
48635919|NCT02196831|101894491|FG000|NOT COMPLETED|Overall Study||9||
48635920|NCT02196831|101894492|FG001|NOT COMPLETED|Overall Study||4||
48635921|NCT01303419|101894493|FG000|STARTED|Overall Study||224||
48635922|NCT01303419|101894493|FG000|COMPLETED|Overall Study||128||
48184429|NCT01755689|100775748|FG000|COMPLETED|Overall Study||256||
48184430|NCT01755689|100775749|FG001|COMPLETED|Overall Study||254||
48184431|NCT01755689|100775750|FG002|COMPLETED|Overall Study||255||
48184432|NCT01755689|100775751|FG003|COMPLETED|Overall Study||254||
48184433|NCT01755689|100775752|FG004|COMPLETED|Overall Study||255||
48184434|NCT01755689|100775748|FG000|NOT COMPLETED|Overall Study||3||
48184435|NCT01755689|100775749|FG001|NOT COMPLETED|Overall Study||5||
48184436|NCT01755689|100775750|FG002|NOT COMPLETED|Overall Study||6||
48344944|NCT05047523|101172446|FG000|STARTED|Extension Period (24 Weeks)||0||
48344945|NCT05047523|101172447|FG001|STARTED|Extension Period (24 Weeks)||0||
48344946|NCT05047523|101172448|FG002|STARTED|Extension Period (24 Weeks)||0||
48344947|NCT05047523|101172449|FG003|STARTED|Extension Period (24 Weeks)||0||
48344948|NCT05047523|101172450|FG004|STARTED|Extension Period (24 Weeks)||12||
48344949|NCT05047523|101172451|FG005|STARTED|Extension Period (24 Weeks)||12||
48344950|NCT05047523|101172446|FG000|Received at Least 1 Dose of Study Drug|Extension Period (24 Weeks)||0||
48344951|NCT05047523|101172447|FG001|Received at Least 1 Dose of Study Drug|Extension Period (24 Weeks)||0||
48344952|NCT05047523|101172448|FG002|Received at Least 1 Dose of Study Drug|Extension Period (24 Weeks)||0||
48368100|NCT01264965|101230106|FG000|STARTED|Overall Study||25||
48635923|NCT01303419|101894493|FG000|NOT COMPLETED|Overall Study||96||
48184437|NCT01755689|100775751|FG003|NOT COMPLETED|Overall Study||6||
48184438|NCT01755689|100775752|FG004|NOT COMPLETED|Overall Study||6||
48184439|NCT00997243|100775753|FG000|STARTED|Overall Study||7||
48184440|NCT00997243|100775753|FG000|COMPLETED|Overall Study||0||
48184441|NCT00997243|100775753|FG000|NOT COMPLETED|Overall Study||7||
48184442|NCT00906503|100775754|FG000|STARTED|Overall Study||9||
48184443|NCT00906503|100775754|FG000|COMPLETED|Overall Study||9||
48184444|NCT00906503|100775754|FG000|NOT COMPLETED|Overall Study||0||
48184445|NCT03255941|100775755|FG000|STARTED|Overall Study||177|The 460 randomized participants were equally randomized between lay health workers and clinical providers. These 460 were then assessed by the gold standard nurse and 92 participants were deemed to be not eligible or refused injection.|
48184446|NCT03255941|100775756|FG001|STARTED|Overall Study||178|The 460 randomized participants were equally randomized between lay health workers and clinical providers. These 460 were then assessed by the gold standard nurse and 92 participants were deemed to be not eligible or refused injection.|
48184447|NCT03255941|100775757|FG002|STARTED|Overall Study||53|The 460 randomized participants were equally randomized between lay health workers and clinical providers. These 460 were then assessed by the gold standard nurse and 92 participants were deemed to be not eligible or refused injection.|
48758701|NCT05194124|102197674|FG003|STARTED|Double Blind (DB) Period (13 Weeks)||2||
48758702|NCT05194124|102197675|FG004|STARTED|Double Blind (DB) Period (13 Weeks)||1||
48184448|NCT03255941|100775758|FG003|STARTED|Overall Study||52|The 460 randomized participants were equally randomized between lay health workers and clinical providers. These 460 were then assessed by the gold standard nurse and 92 participants were deemed to be not eligible or refused injection.|
48184449|NCT03255941|100775755|FG000|Deemed Eligible to Receive DMPA|Overall Study||140||
48184450|NCT03255941|100775756|FG001|Deemed Eligible to Receive DMPA|Overall Study||134||
48635924|NCT02674659|101894494|FG000|STARTED|Overall Study||43||
48635925|NCT02674659|101894495|FG001|STARTED|Overall Study||44||
48635926|NCT02674659|101894494|FG000|COMPLETED|Overall Study||39||
48635927|NCT02674659|101894495|FG001|COMPLETED|Overall Study||40||
48635928|NCT02674659|101894494|FG000|NOT COMPLETED|Overall Study||4||
48635929|NCT02674659|101894495|FG001|NOT COMPLETED|Overall Study||4||
48635930|NCT04383132|101894496|FG000|STARTED|Overall Study||173||
48635931|NCT04383132|101894497|FG001|STARTED|Overall Study||173||
48635932|NCT04383132|101894496|FG000|COMPLETED|Overall Study||173||
48635933|NCT04383132|101894497|FG001|COMPLETED|Overall Study||173||
48635934|NCT04383132|101894496|FG000|NOT COMPLETED|Overall Study||0||
48635935|NCT04383132|101894497|FG001|NOT COMPLETED|Overall Study||0||
48635936|NCT01452347|101894498|FG000|STARTED|Overall Study||168||
48635937|NCT01452347|101894499|FG001|STARTED|Overall Study||84||
48635938|NCT01452347|101894498|FG000|COMPLETED|Overall Study||151||
48635939|NCT01452347|101894499|FG001|COMPLETED|Overall Study||77||
48635940|NCT01452347|101894498|FG000|NOT COMPLETED|Overall Study||17||
48635941|NCT01452347|101894499|FG001|NOT COMPLETED|Overall Study||7||
48635942|NCT00116142|101894500|FG000|STARTED|Overall Study||175||
48635943|NCT00116142|101894501|FG001|STARTED|Overall Study||175||
48635944|NCT00116142|101894500|FG000|Treated|Overall Study||174||
48635945|NCT00116142|101894501|FG001|Treated|Overall Study||171||
48635946|NCT00116142|101894500|FG000|COMPLETED|Overall Study||156||
48635947|NCT00116142|101894501|FG001|COMPLETED|Overall Study||155||
48635948|NCT00116142|101894500|FG000|NOT COMPLETED|Overall Study||19||
48635949|NCT00116142|101894501|FG001|NOT COMPLETED|Overall Study||20||
48635950|NCT01572792|101894502|FG000|STARTED|Lead-in Study||337||
48635951|NCT01572792|101894503|FG001|STARTED|Lead-in Study||338||
48635952|NCT01572792|101894504|FG002|STARTED|Lead-in Study||338||
48635953|NCT01572792|101894505|FG003|STARTED|Lead-in Study||340||
48635954|NCT01572792|101894506|FG004|STARTED|Lead-in Study||339||
48635955|NCT01572792|101894502|FG000|COMPLETED|Lead-in Study||236||
48635956|NCT01572792|101894503|FG001|COMPLETED|Lead-in Study||272||
48635957|NCT01572792|101894504|FG002|COMPLETED|Lead-in Study||276||
48635958|NCT01572792|101894505|FG003|COMPLETED|Lead-in Study||268||
48758703|NCT05194124|102197676|FG005|STARTED|Double Blind (DB) Period (13 Weeks)||9||
48635959|NCT01572792|101894506|FG004|COMPLETED|Lead-in Study||270||
48635960|NCT01572792|101894502|FG000|NOT COMPLETED|Lead-in Study||101||
48635961|NCT01572792|101894503|FG001|NOT COMPLETED|Lead-in Study||66||
48635962|NCT01572792|101894504|FG002|NOT COMPLETED|Lead-in Study||62||
48635963|NCT01572792|101894505|FG003|NOT COMPLETED|Lead-in Study||72||
48635964|NCT01572792|101894506|FG004|NOT COMPLETED|Lead-in Study||69||
48635965|NCT01572792|101894502|FG000|STARTED|Extension Study||146||
48635966|NCT01572792|101894503|FG001|STARTED|Extension Study||184||
48635967|NCT01572792|101894504|FG002|STARTED|Extension Study||205||
48635968|NCT01572792|101894505|FG003|STARTED|Extension Study||194||
48635969|NCT01572792|101894506|FG004|STARTED|Extension Study||192||
48635970|NCT01572792|101894502|FG000|COMPLETED|Extension Study||121||
48635971|NCT01572792|101894503|FG001|COMPLETED|Extension Study||155||
48635972|NCT01572792|101894504|FG002|COMPLETED|Extension Study||179||
48635973|NCT01572792|101894505|FG003|COMPLETED|Extension Study||165||
48635974|NCT01572792|101894506|FG004|COMPLETED|Extension Study||160||
48635975|NCT01572792|101894502|FG000|NOT COMPLETED|Extension Study||25||
48635976|NCT01572792|101894503|FG001|NOT COMPLETED|Extension Study||29||
48635977|NCT01572792|101894504|FG002|NOT COMPLETED|Extension Study||26||
48758704|NCT05194124|102197677|FG006|STARTED|Double Blind (DB) Period (13 Weeks)||7||
48758705|NCT05194124|102197678|FG007|STARTED|Double Blind (DB) Period (13 Weeks)||0||
48758706|NCT05194124|102197679|FG008|STARTED|Double Blind (DB) Period (13 Weeks)||0||
48758707|NCT05194124|102197680|FG009|STARTED|Double Blind (DB) Period (13 Weeks)||0||
48635978|NCT01572792|101894505|FG003|NOT COMPLETED|Extension Study||29||
48635979|NCT01572792|101894506|FG004|NOT COMPLETED|Extension Study||32||
48635980|NCT03160170|101894507|FG000|STARTED|Overall Study||10||
48635981|NCT03160170|101894508|FG001|STARTED|Overall Study||10||
48635982|NCT03160170|101894507|FG000|COMPLETED|Overall Study||10||
48635983|NCT03160170|101894508|FG001|COMPLETED|Overall Study||10||
48635984|NCT03160170|101894507|FG000|NOT COMPLETED|Overall Study||0||
48635985|NCT03160170|101894508|FG001|NOT COMPLETED|Overall Study||0||
48635986|NCT02469857|101894509|FG000|STARTED|Overall Study||143|As Treated (Safety) Analysis Set|
48635987|NCT02469857|101894510|FG001|STARTED|Overall Study||147|As Treated (Safety) Analysis Set|
48635988|NCT02469857|101894509|FG000|COMPLETED|Overall Study||118|As Treated (Safety) Analysis Set|
48758708|NCT05194124|102197671|FG000|COMPLETED|Double Blind (DB) Period (13 Weeks)||0||
48758709|NCT05194124|102197672|FG001|COMPLETED|Double Blind (DB) Period (13 Weeks)||0||
48758710|NCT05194124|102197673|FG002|COMPLETED|Double Blind (DB) Period (13 Weeks)||0||
48758711|NCT05194124|102197674|FG003|COMPLETED|Double Blind (DB) Period (13 Weeks)||1||
48184451|NCT03255941|100775757|FG002|Deemed Eligible to Receive DMPA|Overall Study||48||
48635989|NCT02469857|101894510|FG001|COMPLETED|Overall Study||115|As Treated (Safety) Analysis Set|
48344953|NCT05047523|101172449|FG003|Received at Least 1 Dose of Study Drug|Extension Period (24 Weeks)||0||
48344954|NCT05047523|101172450|FG004|Received at Least 1 Dose of Study Drug|Extension Period (24 Weeks)||12||
48344955|NCT05047523|101172451|FG005|Received at Least 1 Dose of Study Drug|Extension Period (24 Weeks)||12||
48414805|NCT03345849|101350145|FG001|COMPLETED|Part 2: Extended Treatment (Weeks 12-24)||0||
48414806|NCT03345849|101350146|FG002|COMPLETED|Part 2: Extended Treatment (Weeks 12-24)||49||
48414807|NCT03345849|101350147|FG003|COMPLETED|Part 2: Extended Treatment (Weeks 12-24)||49||
48414808|NCT03345849|101350144|FG000|NOT COMPLETED|Part 2: Extended Treatment (Weeks 12-24)||0||
48414809|NCT03345849|101350145|FG001|NOT COMPLETED|Part 2: Extended Treatment (Weeks 12-24)||0||
48414810|NCT03345849|101350146|FG002|NOT COMPLETED|Part 2: Extended Treatment (Weeks 12-24)||8||
48344956|NCT05047523|101172446|FG000|COMPLETED|Extension Period (24 Weeks)||0||
48344957|NCT05047523|101172447|FG001|COMPLETED|Extension Period (24 Weeks)||0||
48344958|NCT05047523|101172448|FG002|COMPLETED|Extension Period (24 Weeks)||0||
48344959|NCT05047523|101172449|FG003|COMPLETED|Extension Period (24 Weeks)||0||
48344960|NCT05047523|101172450|FG004|COMPLETED|Extension Period (24 Weeks)||3||
48344961|NCT05047523|101172451|FG005|COMPLETED|Extension Period (24 Weeks)||3||
48344962|NCT05047523|101172446|FG000|NOT COMPLETED|Extension Period (24 Weeks)||0||
48344963|NCT05047523|101172447|FG001|NOT COMPLETED|Extension Period (24 Weeks)||0||
48344964|NCT05047523|101172448|FG002|NOT COMPLETED|Extension Period (24 Weeks)||0||
48344965|NCT05047523|101172449|FG003|NOT COMPLETED|Extension Period (24 Weeks)||0||
48344966|NCT05047523|101172450|FG004|NOT COMPLETED|Extension Period (24 Weeks)||9||
48344967|NCT05047523|101172451|FG005|NOT COMPLETED|Extension Period (24 Weeks)||9||
48344968|NCT02658448|101172452|FG000|STARTED|Overall Study||19||
48344969|NCT02658448|101172452|FG000|COMPLETED|Overall Study||18||
48344970|NCT02658448|101172452|FG000|NOT COMPLETED|Overall Study||1||
48344971|NCT00008385|101172453|FG000|STARTED|Overall Study||521||
48344972|NCT00008385|101172454|FG001|STARTED|Overall Study||1040||
48344973|NCT00008385|101172453|FG000|Treated|Overall Study||477||
48344974|NCT00008385|101172454|FG001|Treated|Overall Study||865||
48344975|NCT00008385|101172453|FG000|Off Treatment Reasons Reported|Overall Study||398||
48344976|NCT00008385|101172454|FG001|Off Treatment Reasons Reported|Overall Study||795||
48344977|NCT00008385|101172453|FG000|COMPLETED|Overall Study||134||
48344978|NCT00008385|101172454|FG001|COMPLETED|Overall Study||238||
48344979|NCT00008385|101172453|FG000|NOT COMPLETED|Overall Study||387||
48344980|NCT00008385|101172454|FG001|NOT COMPLETED|Overall Study||802||
48344981|NCT03502330|101172455|FG000|STARTED|Overall Study||3||
48344982|NCT03502330|101172456|FG001|STARTED|Overall Study||6||
48344983|NCT03502330|101172457|FG002|STARTED|Overall Study||3||
48344984|NCT03502330|101172458|FG003|STARTED|Overall Study||5||
48344985|NCT03502330|101172459|FG004|STARTED|Overall Study||3||
48344986|NCT03502330|101172460|FG005|STARTED|Overall Study||6||
48344987|NCT03502330|101172461|FG006|STARTED|Overall Study||8||
48414811|NCT03345849|101350147|FG003|NOT COMPLETED|Part 2: Extended Treatment (Weeks 12-24)||10||
48414812|NCT01810289|101350148|FG000|STARTED|Overall Study||7277||
48635990|NCT02469857|101894509|FG000|NOT COMPLETED|Overall Study||25||
48635991|NCT02469857|101894510|FG001|NOT COMPLETED|Overall Study||32||
48635992|NCT01603602|101894511|FG000|STARTED|Overall Study||77||
48635993|NCT01603602|101894512|FG001|STARTED|Overall Study||78||
48635994|NCT01603602|101894513|FG002|STARTED|Overall Study||80||
48635995|NCT01603602|101894511|FG000|COMPLETED|Overall Study||75||
48635996|NCT01603602|101894512|FG001|COMPLETED|Overall Study||78||
48635997|NCT01603602|101894513|FG002|COMPLETED|Overall Study||79||
48344988|NCT03502330|101172462|FG007|STARTED|Overall Study||8||
48414813|NCT01810289|101350149|FG001|STARTED|Overall Study||4747||
48414814|NCT01810289|101350148|FG000|COMPLETED|Overall Study||7277||
48635998|NCT01603602|101894511|FG000|NOT COMPLETED|Overall Study||2||
48635999|NCT01603602|101894512|FG001|NOT COMPLETED|Overall Study||0||
48636000|NCT01603602|101894513|FG002|NOT COMPLETED|Overall Study||1||
48636001|NCT01034553|101894514|FG000|STARTED|Overall Study||3||
48344989|NCT03502330|101172463|FG008|STARTED|Overall Study||0||
48344990|NCT03502330|101172455|FG000|COMPLETED|Overall Study||0||
48344991|NCT03502330|101172456|FG001|COMPLETED|Overall Study||0||
48344992|NCT03502330|101172457|FG002|COMPLETED|Overall Study||0||
48344993|NCT03502330|101172458|FG003|COMPLETED|Overall Study||0||
48344994|NCT03502330|101172459|FG004|COMPLETED|Overall Study||0||
48344995|NCT03502330|101172460|FG005|COMPLETED|Overall Study||0||
48344996|NCT03502330|101172461|FG006|COMPLETED|Overall Study||0||
48344997|NCT03502330|101172462|FG007|COMPLETED|Overall Study||0||
48758712|NCT05194124|102197675|FG004|COMPLETED|Double Blind (DB) Period (13 Weeks)||1||
48758713|NCT05194124|102197676|FG005|COMPLETED|Double Blind (DB) Period (13 Weeks)||7||
48758714|NCT05194124|102197677|FG006|COMPLETED|Double Blind (DB) Period (13 Weeks)||7||
48758715|NCT05194124|102197678|FG007|COMPLETED|Double Blind (DB) Period (13 Weeks)||0||
48636002|NCT01034553|101894515|FG001|STARTED|Overall Study||4||
48636003|NCT01034553|101894516|FG002|STARTED|Overall Study||3||
48636004|NCT01034553|101894517|FG003|STARTED|Overall Study||3||
48636005|NCT01034553|101894518|FG004|STARTED|Overall Study||6||
48636006|NCT01034553|101894519|FG005|STARTED|Overall Study||7||
48636007|NCT01034553|101894514|FG000|COMPLETED|Overall Study||3||
48636008|NCT01034553|101894515|FG001|COMPLETED|Overall Study||4||
48636009|NCT01034553|101894516|FG002|COMPLETED|Overall Study||3||
48636010|NCT01034553|101894517|FG003|COMPLETED|Overall Study||3||
48636011|NCT01034553|101894518|FG004|COMPLETED|Overall Study||6||
48636012|NCT01034553|101894519|FG005|COMPLETED|Overall Study||7||
48636013|NCT01034553|101894514|FG000|NOT COMPLETED|Overall Study||0||
48636014|NCT01034553|101894515|FG001|NOT COMPLETED|Overall Study||0||
48758716|NCT05194124|102197679|FG008|COMPLETED|Double Blind (DB) Period (13 Weeks)||0||
48758717|NCT05194124|102197680|FG009|COMPLETED|Double Blind (DB) Period (13 Weeks)||0||
48344998|NCT03502330|101172463|FG008|COMPLETED|Overall Study||0||
48758718|NCT05194124|102197671|FG000|NOT COMPLETED|Double Blind (DB) Period (13 Weeks)||0||
48758719|NCT05194124|102197672|FG001|NOT COMPLETED|Double Blind (DB) Period (13 Weeks)||0||
48758720|NCT05194124|102197673|FG002|NOT COMPLETED|Double Blind (DB) Period (13 Weeks)||0||
48758721|NCT05194124|102197674|FG003|NOT COMPLETED|Double Blind (DB) Period (13 Weeks)||1||
48758722|NCT05194124|102197675|FG004|NOT COMPLETED|Double Blind (DB) Period (13 Weeks)||0||
48758723|NCT05194124|102197676|FG005|NOT COMPLETED|Double Blind (DB) Period (13 Weeks)||2||
48758724|NCT05194124|102197677|FG006|NOT COMPLETED|Double Blind (DB) Period (13 Weeks)||0||
48758725|NCT05194124|102197678|FG007|NOT COMPLETED|Double Blind (DB) Period (13 Weeks)||0||
48758726|NCT05194124|102197679|FG008|NOT COMPLETED|Double Blind (DB) Period (13 Weeks)||0||
48758727|NCT05194124|102197680|FG009|NOT COMPLETED|Double Blind (DB) Period (13 Weeks)||0||
48344999|NCT03502330|101172455|FG000|NOT COMPLETED|Overall Study||3||
48345000|NCT03502330|101172456|FG001|NOT COMPLETED|Overall Study||6||
48345001|NCT03502330|101172457|FG002|NOT COMPLETED|Overall Study||3||
48758728|NCT05194124|102197671|FG000|STARTED|Open Label (OL) Period (13 Weeks)||0||
48758729|NCT05194124|102197672|FG001|STARTED|Open Label (OL) Period (13 Weeks)||0||
48758730|NCT05194124|102197673|FG002|STARTED|Open Label (OL) Period (13 Weeks)||0||
48636015|NCT01034553|101894516|FG002|NOT COMPLETED|Overall Study||0||
48758731|NCT05194124|102197674|FG003|STARTED|Open Label (OL) Period (13 Weeks)||0||
48345002|NCT03502330|101172458|FG003|NOT COMPLETED|Overall Study||5||
48636016|NCT01034553|101894517|FG003|NOT COMPLETED|Overall Study||0||
48636017|NCT01034553|101894518|FG004|NOT COMPLETED|Overall Study||0||
48636018|NCT01034553|101894519|FG005|NOT COMPLETED|Overall Study||0||
48636019|NCT01991314|101894520|FG000|STARTED|Overall Study||45||
48636020|NCT01991314|101894521|FG001|STARTED|Overall Study||43||
48636021|NCT01991314|101894520|FG000|COMPLETED|Overall Study||34||
48636022|NCT01991314|101894521|FG001|COMPLETED|Overall Study||32||
48758732|NCT05194124|102197675|FG004|STARTED|Open Label (OL) Period (13 Weeks)||0||
48758733|NCT05194124|102197676|FG005|STARTED|Open Label (OL) Period (13 Weeks)||0||
48758734|NCT05194124|102197677|FG006|STARTED|Open Label (OL) Period (13 Weeks)||0||
48758735|NCT05194124|102197678|FG007|STARTED|Open Label (OL) Period (13 Weeks)||1||
48758736|NCT05194124|102197679|FG008|STARTED|Open Label (OL) Period (13 Weeks)||1||
48758737|NCT05194124|102197680|FG009|STARTED|Open Label (OL) Period (13 Weeks)||14||
48758738|NCT05194124|102197671|FG000|COMPLETED|Open Label (OL) Period (13 Weeks)||0||
48758739|NCT05194124|102197672|FG001|COMPLETED|Open Label (OL) Period (13 Weeks)||0||
48758740|NCT05194124|102197673|FG002|COMPLETED|Open Label (OL) Period (13 Weeks)||0||
48758741|NCT05194124|102197674|FG003|COMPLETED|Open Label (OL) Period (13 Weeks)||0||
48758742|NCT05194124|102197675|FG004|COMPLETED|Open Label (OL) Period (13 Weeks)||0||
48758743|NCT05194124|102197676|FG005|COMPLETED|Open Label (OL) Period (13 Weeks)||0||
48758744|NCT05194124|102197677|FG006|COMPLETED|Open Label (OL) Period (13 Weeks)||0||
48758745|NCT05194124|102197678|FG007|COMPLETED|Open Label (OL) Period (13 Weeks)||1||
48758746|NCT05194124|102197679|FG008|COMPLETED|Open Label (OL) Period (13 Weeks)||1||
48758747|NCT05194124|102197680|FG009|COMPLETED|Open Label (OL) Period (13 Weeks)||13||
48758748|NCT05194124|102197671|FG000|NOT COMPLETED|Open Label (OL) Period (13 Weeks)||0||
48758749|NCT05194124|102197672|FG001|NOT COMPLETED|Open Label (OL) Period (13 Weeks)||0||
48758750|NCT05194124|102197673|FG002|NOT COMPLETED|Open Label (OL) Period (13 Weeks)||0||
48758751|NCT05194124|102197674|FG003|NOT COMPLETED|Open Label (OL) Period (13 Weeks)||0||
48758752|NCT05194124|102197675|FG004|NOT COMPLETED|Open Label (OL) Period (13 Weeks)||0||
48758753|NCT05194124|102197676|FG005|NOT COMPLETED|Open Label (OL) Period (13 Weeks)||0||
48758754|NCT05194124|102197677|FG006|NOT COMPLETED|Open Label (OL) Period (13 Weeks)||0||
48758755|NCT05194124|102197678|FG007|NOT COMPLETED|Open Label (OL) Period (13 Weeks)||0||
48758756|NCT05194124|102197679|FG008|NOT COMPLETED|Open Label (OL) Period (13 Weeks)||0||
48758757|NCT05194124|102197680|FG009|NOT COMPLETED|Open Label (OL) Period (13 Weeks)||1||
48758758|NCT03773978|102197681|FG000|STARTED|PK/Safety and OLLI Period||220||
48758759|NCT03773978|102197682|FG001|STARTED|PK/Safety and OLLI Period||0||
48758760|NCT03773978|102197681|FG000|PK/Safety Period|PK/Safety and OLLI Period||29||
48758761|NCT03773978|102197682|FG001|PK/Safety Period|PK/Safety and OLLI Period||0||
48758762|NCT03773978|102197681|FG000|OLLI Period|PK/Safety and OLLI Period||219||
48758763|NCT03773978|102197682|FG001|OLLI Period|PK/Safety and OLLI Period||0||
48758764|NCT03773978|102197681|FG000|Received at Least One Dose of Study Drug|PK/Safety and OLLI Period||220||
48758765|NCT03773978|102197682|FG001|Received at Least One Dose of Study Drug|PK/Safety and OLLI Period||0||
48636023|NCT01991314|101894520|FG000|NOT COMPLETED|Overall Study||11||
48636024|NCT01991314|101894521|FG001|NOT COMPLETED|Overall Study||11||
48636025|NCT00845182|101894522|FG000|STARTED|Overall Study||13||
48636026|NCT00845182|101894523|FG001|STARTED|Overall Study||15||
48636027|NCT00845182|101894524|FG002|STARTED|Overall Study||15||
48636028|NCT00845182|101894522|FG000|COMPLETED|Overall Study||10||
48636029|NCT00845182|101894523|FG001|COMPLETED|Overall Study||11||
48636030|NCT00845182|101894524|FG002|COMPLETED|Overall Study||9||
48636031|NCT00845182|101894522|FG000|NOT COMPLETED|Overall Study||3||
48636032|NCT00845182|101894523|FG001|NOT COMPLETED|Overall Study||4||
48636033|NCT00845182|101894524|FG002|NOT COMPLETED|Overall Study||6||
48636034|NCT00148798|101894525|FG000|STARTED|Overall Study||557||
48636035|NCT00148798|101894526|FG001|STARTED|Overall Study||568||
48636036|NCT00148798|101894525|FG000|COMPLETED|Overall Study||557||
48636037|NCT00148798|101894526|FG001|COMPLETED|Overall Study||568||
48636038|NCT00148798|101894525|FG000|NOT COMPLETED|Overall Study||0||
48636039|NCT00148798|101894526|FG001|NOT COMPLETED|Overall Study||0||
48636040|NCT02879032|101894527|FG000|STARTED|Overall Study||130|Patients were selected by purposive sampling as samples were taken according to selection criteria|
48636041|NCT02879032|101894527|FG000|COMPLETED|Overall Study||130||
48636042|NCT02879032|101894527|FG000|NOT COMPLETED|Overall Study||0||
48636043|NCT03438266|101894528|FG000|STARTED|Overall Study||60||
48636044|NCT03438266|101894528|FG000|COMPLETED|Overall Study||60||
48636045|NCT03438266|101894528|FG000|NOT COMPLETED|Overall Study||0||
48636046|NCT00903968|101894529|FG000|STARTED|Overall Study||3||
48636047|NCT00903968|101894530|FG001|STARTED|Overall Study||3||
48636048|NCT00903968|101894531|FG002|STARTED|Overall Study||3||
48636049|NCT00903968|101894532|FG003|STARTED|Overall Study||3||
48636050|NCT00903968|101894533|FG004|STARTED|Overall Study||4||
48636051|NCT00903968|101894534|FG005|STARTED|Overall Study||6||
48636052|NCT00903968|101894535|FG006|STARTED|Overall Study||3||
48636053|NCT00903968|101894536|FG007|STARTED|Overall Study||33||
48636054|NCT00903968|101894529|FG000|COMPLETED|Overall Study||0||
48636055|NCT00903968|101894530|FG001|COMPLETED|Overall Study||0||
48636056|NCT00903968|101894531|FG002|COMPLETED|Overall Study||0||
48636057|NCT00903968|101894532|FG003|COMPLETED|Overall Study||0||
48636058|NCT00903968|101894533|FG004|COMPLETED|Overall Study||0||
48636059|NCT00903968|101894534|FG005|COMPLETED|Overall Study||0||
48636060|NCT00903968|101894535|FG006|COMPLETED|Overall Study||0||
48636061|NCT00903968|101894536|FG007|COMPLETED|Overall Study||0||
48636062|NCT00903968|101894529|FG000|NOT COMPLETED|Overall Study||3||
48636063|NCT00903968|101894530|FG001|NOT COMPLETED|Overall Study||3||
48636064|NCT00903968|101894531|FG002|NOT COMPLETED|Overall Study||3||
48636065|NCT00903968|101894532|FG003|NOT COMPLETED|Overall Study||3||
48636066|NCT00903968|101894533|FG004|NOT COMPLETED|Overall Study||4||
48636067|NCT00903968|101894534|FG005|NOT COMPLETED|Overall Study||6||
48636068|NCT00903968|101894535|FG006|NOT COMPLETED|Overall Study||3||
48636069|NCT00903968|101894536|FG007|NOT COMPLETED|Overall Study||33||
48636070|NCT01537367|101894537|FG000|STARTED|Overall Study||615||
48636071|NCT01537367|101894538|FG001|STARTED|Overall Study||610||
48636072|NCT01537367|101894539|FG002|STARTED|Overall Study||613||
48636073|NCT01537367|101894537|FG000|COMPLETED|Overall Study||615||
48636074|NCT01537367|101894538|FG001|COMPLETED|Overall Study||610||
48636075|NCT01537367|101894539|FG002|COMPLETED|Overall Study||613||
48636076|NCT01537367|101894537|FG000|NOT COMPLETED|Overall Study||0||
48636077|NCT01537367|101894538|FG001|NOT COMPLETED|Overall Study||0||
48636078|NCT01537367|101894539|FG002|NOT COMPLETED|Overall Study||0||
48636079|NCT03318341|101894540|FG000|STARTED|Month 1||13||
48636080|NCT03318341|101894541|FG001|STARTED|Month 1||13||
48636081|NCT03318341|101894540|FG000|COMPLETED|Month 1||13||
48636082|NCT03318341|101894541|FG001|COMPLETED|Month 1||12||
48636083|NCT03318341|101894540|FG000|NOT COMPLETED|Month 1||0||
48636084|NCT03318341|101894541|FG001|NOT COMPLETED|Month 1||1||
48636085|NCT03318341|101894540|FG000|STARTED|Month 2||13||
48636086|NCT03318341|101894541|FG001|STARTED|Month 2||12||
48636087|NCT03318341|101894540|FG000|COMPLETED|Month 2||13||
48636088|NCT03318341|101894541|FG001|COMPLETED|Month 2||12||
48636089|NCT03318341|101894540|FG000|NOT COMPLETED|Month 2||0||
48636090|NCT03318341|101894541|FG001|NOT COMPLETED|Month 2||0||
48636091|NCT03197129|101894542|FG000|STARTED|Overall Study||60||
48636092|NCT03197129|101894543|FG001|STARTED|Overall Study||62||
48636093|NCT03197129|101894542|FG000|COMPLETED|Overall Study||56||
48636094|NCT03197129|101894543|FG001|COMPLETED|Overall Study||57||
48636095|NCT03197129|101894542|FG000|NOT COMPLETED|Overall Study||4||
48636096|NCT03197129|101894543|FG001|NOT COMPLETED|Overall Study||5||
48636097|NCT00657605|101894544|FG000|STARTED|Overall Study||3||
48636098|NCT00657605|101894544|FG000|COMPLETED|Overall Study||3||
48636099|NCT00657605|101894544|FG000|NOT COMPLETED|Overall Study||0||
48636100|NCT00127803|101894545|FG000|STARTED|Overall Study||13||
48636101|NCT00127803|101894546|FG001|STARTED|Overall Study||13||
48636102|NCT00127803|101894547|FG002|STARTED|Overall Study||12||
48636103|NCT00127803|101894548|FG003|STARTED|Overall Study||12||
48636104|NCT00127803|101894545|FG000|COMPLETED|Overall Study||10||
48414815|NCT01810289|101350149|FG001|COMPLETED|Overall Study||4747||
48414816|NCT01810289|101350148|FG000|NOT COMPLETED|Overall Study||0||
48414817|NCT01810289|101350149|FG001|NOT COMPLETED|Overall Study||0||
48414818|NCT01228435|101350150|FG000|STARTED|Overall Study||1||
48414819|NCT01228435|101350151|FG001|STARTED|Overall Study||2||
48414820|NCT01228435|101350150|FG000|COMPLETED|Overall Study||1||
48636105|NCT00127803|101894546|FG001|COMPLETED|Overall Study||13||
48636106|NCT00127803|101894547|FG002|COMPLETED|Overall Study||12||
48636107|NCT00127803|101894548|FG003|COMPLETED|Overall Study||11||
48636108|NCT00127803|101894545|FG000|NOT COMPLETED|Overall Study||3||
48636109|NCT00127803|101894546|FG001|NOT COMPLETED|Overall Study||0||
48636110|NCT00127803|101894547|FG002|NOT COMPLETED|Overall Study||0||
48636111|NCT00127803|101894548|FG003|NOT COMPLETED|Overall Study||1||
48636112|NCT01604772|101894549|FG000|STARTED|Overall Study||16||
48636113|NCT01604772|101894549|FG000|COMPLETED|Overall Study||16||
48636114|NCT01604772|101894549|FG000|NOT COMPLETED|Overall Study||0||
48636115|NCT04323592|101894550|FG000|STARTED|Overall Study||83||
48636116|NCT04323592|101894551|FG001|STARTED|Overall Study||90||
48636117|NCT04323592|101894550|FG000|COMPLETED|Overall Study||83||
48636118|NCT04323592|101894551|FG001|COMPLETED|Overall Study||90||
48636119|NCT04323592|101894550|FG000|NOT COMPLETED|Overall Study||0||
48414821|NCT01228435|101350151|FG001|COMPLETED|Overall Study||2||
48414822|NCT01228435|101350150|FG000|NOT COMPLETED|Overall Study||0||
48758766|NCT03773978|102197681|FG000|COMPLETED|PK/Safety and OLLI Period||163||
48758767|NCT03773978|102197682|FG001|COMPLETED|PK/Safety and OLLI Period||0||
48758768|NCT03773978|102197681|FG000|NOT COMPLETED|PK/Safety and OLLI Period||57||
48758769|NCT03773978|102197682|FG001|NOT COMPLETED|PK/Safety and OLLI Period||0||
48758770|NCT03773978|102197681|FG000|STARTED|DBW Period||82||
48758771|NCT03773978|102197682|FG001|STARTED|DBW Period||81||
48758772|NCT03773978|102197681|FG000|COMPLETED|DBW Period||56||
48636120|NCT04323592|101894551|FG001|NOT COMPLETED|Overall Study||0||
48636121|NCT01254877|101894552|FG000|STARTED|Overall Study||67||
48636122|NCT01254877|101894553|FG001|STARTED|Overall Study||69||
48636123|NCT01254877|101894554|FG002|STARTED|Overall Study||69||
48636124|NCT01254877|101894552|FG000|COMPLETED|Overall Study||57||
48636125|NCT01254877|101894553|FG001|COMPLETED|Overall Study||58||
48636126|NCT01254877|101894554|FG002|COMPLETED|Overall Study||64||
48636127|NCT01254877|101894552|FG000|NOT COMPLETED|Overall Study||10||
48636128|NCT01254877|101894553|FG001|NOT COMPLETED|Overall Study||11||
48636129|NCT01254877|101894554|FG002|NOT COMPLETED|Overall Study||5||
48636130|NCT02305316|101894555|FG000|STARTED|Overall Study||14||
48636131|NCT02305316|101894556|FG001|STARTED|Overall Study||14||
48758773|NCT03773978|102197682|FG001|COMPLETED|DBW Period||32||
48758774|NCT03773978|102197681|FG000|NOT COMPLETED|DBW Period||26||
48758775|NCT03773978|102197682|FG001|NOT COMPLETED|DBW Period||49||
48758776|NCT03542487|102197683|FG000|STARTED|Primary Care Practices Randomization||3641||10
48758777|NCT03542487|102197684|FG001|STARTED|Primary Care Practices Randomization||3411||10
48758778|NCT03542487|102197685|FG002|STARTED|Primary Care Practices Randomization||0||0
48414823|NCT01228435|101350151|FG001|NOT COMPLETED|Overall Study||0||
48414824|NCT00545740|101350152|FG000|STARTED|Overall Study||145||
48414825|NCT00545740|101350153|FG001|STARTED|Overall Study||145||
48758779|NCT03542487|102197686|FG003|STARTED|Primary Care Practices Randomization||0||0
48414826|NCT00545740|101350154|FG002|STARTED|Overall Study||151||
48414827|NCT00545740|101350155|FG003|STARTED|Overall Study||149||
48414828|NCT00545740|101350152|FG000|COMPLETED|Overall Study||70||
48636132|NCT02305316|101894555|FG000|COMPLETED|Overall Study||14||
48636133|NCT02305316|101894556|FG001|COMPLETED|Overall Study||14||
48636134|NCT02305316|101894555|FG000|NOT COMPLETED|Overall Study||0||
48636135|NCT02305316|101894556|FG001|NOT COMPLETED|Overall Study||0||
48636136|NCT02058095|101894557|FG000|STARTED|Overall Study||15||
48636137|NCT02058095|101894558|FG001|STARTED|Overall Study||7||
48636138|NCT02058095|101894557|FG000|COMPLETED|Overall Study||14||
48636139|NCT02058095|101894558|FG001|COMPLETED|Overall Study||7||
48636140|NCT02058095|101894557|FG000|NOT COMPLETED|Overall Study||1||
48636141|NCT02058095|101894558|FG001|NOT COMPLETED|Overall Study||0||
48636142|NCT03104413|101894559|FG000|STARTED|Induction Period 1||207||
48636143|NCT03104413|101894560|FG001|STARTED|Induction Period 1||206||
48345003|NCT03502330|101172459|FG004|NOT COMPLETED|Overall Study||3||
48345004|NCT03502330|101172460|FG005|NOT COMPLETED|Overall Study||6||
48345005|NCT03502330|101172461|FG006|NOT COMPLETED|Overall Study||8||
48345006|NCT03502330|101172462|FG007|NOT COMPLETED|Overall Study||8||
48345007|NCT03502330|101172463|FG008|NOT COMPLETED|Overall Study||0||
48345008|NCT01349140|101172464|FG000|STARTED|Overall Study||14||28
48345009|NCT01349140|101172464|FG000|COMPLETED|Overall Study||14||28
48345010|NCT01349140|101172464|FG000|NOT COMPLETED|Overall Study||0||0
48345011|NCT00054847|101172465|FG000|STARTED|Overall Study||367||
48345012|NCT00054847|101172466|FG001|STARTED|Overall Study||366||
48345013|NCT00054847|101172465|FG000|COMPLETED|Overall Study||269||
48345014|NCT00054847|101172466|FG001|COMPLETED|Overall Study||266||
48345015|NCT00054847|101172465|FG000|NOT COMPLETED|Overall Study||98||
48345016|NCT00054847|101172466|FG001|NOT COMPLETED|Overall Study||100||
48345017|NCT03403400|101172467|FG000|STARTED|Overall Study||5||
48345018|NCT03403400|101172468|FG001|STARTED|Overall Study||6||
48345019|NCT03403400|101172469|FG002|STARTED|Overall Study||6||
48345020|NCT03403400|101172467|FG000|COMPLETED|Overall Study||3||
48345021|NCT03403400|101172468|FG001|COMPLETED|Overall Study||6||
48345022|NCT03403400|101172469|FG002|COMPLETED|Overall Study||4||
48345023|NCT03403400|101172467|FG000|NOT COMPLETED|Overall Study||2||
48414829|NCT00545740|101350153|FG001|COMPLETED|Overall Study||62||
48345024|NCT03403400|101172468|FG001|NOT COMPLETED|Overall Study||0||
48345025|NCT03403400|101172469|FG002|NOT COMPLETED|Overall Study||2||
48345026|NCT01023789|101172470|FG000|STARTED|30-day Follow-up Visit||812||
48345027|NCT01023789|101172470|FG000|COMPLETED|30-day Follow-up Visit||812||
48345028|NCT01023789|101172470|FG000|NOT COMPLETED|30-day Follow-up Visit||0||
48345029|NCT01023789|101172470|FG000|STARTED|180-day Clinical Follow-up||812||
48345030|NCT01023789|101172470|FG000|COMPLETED|180-day Clinical Follow-up||812||
48345031|NCT01023789|101172470|FG000|NOT COMPLETED|180-day Clinical Follow-up||0||
48345032|NCT01023789|101172470|FG000|STARTED|1 - Year Visit||812||
48345033|NCT01023789|101172470|FG000|COMPLETED|1 - Year Visit||812||
48345034|NCT01023789|101172470|FG000|NOT COMPLETED|1 - Year Visit||0||
48345035|NCT01023789|101172470|FG000|STARTED|2 - Year Visit||812||
48345036|NCT01023789|101172470|FG000|COMPLETED|2 - Year Visit||812||
48345037|NCT01023789|101172470|FG000|NOT COMPLETED|2 - Year Visit||0||
48345038|NCT01023789|101172470|FG000|STARTED|3 - Year Visit||812||
48345039|NCT01023789|101172470|FG000|COMPLETED|3 - Year Visit||769||
48345040|NCT01023789|101172470|FG000|NOT COMPLETED|3 - Year Visit||43||
48345041|NCT01324830|101172471|FG000|STARTED|Overall Study||3||
48345042|NCT01324830|101172472|FG001|STARTED|Overall Study||3||
48414830|NCT00545740|101350154|FG002|COMPLETED|Overall Study||55||
48345043|NCT01324830|101172473|FG002|STARTED|Overall Study||3||
48345044|NCT01324830|101172474|FG003|STARTED|Overall Study||3||
48414831|NCT00545740|101350155|FG003|COMPLETED|Overall Study||78||
48414832|NCT00545740|101350152|FG000|NOT COMPLETED|Overall Study||75||
48414833|NCT00545740|101350153|FG001|NOT COMPLETED|Overall Study||83||
48414834|NCT00545740|101350154|FG002|NOT COMPLETED|Overall Study||96||
48414835|NCT00545740|101350155|FG003|NOT COMPLETED|Overall Study||71||
48414836|NCT00590031|101350156|FG000|STARTED|Overall Study||61||
48414837|NCT00590031|101350156|FG000|COMPLETED|Overall Study||55||
48414838|NCT00590031|101350156|FG000|NOT COMPLETED|Overall Study||6||
48414839|NCT02541994|101350157|FG000|STARTED|Overall Study||5||
48414840|NCT02541994|101350157|FG000|COMPLETED|Overall Study||5||
48414841|NCT02541994|101350157|FG000|NOT COMPLETED|Overall Study||0||
48414842|NCT01888965|101350158|FG000|STARTED|Overall Study||9||
48414843|NCT01888965|101350158|FG000|COMPLETED|Overall Study||0||
48414844|NCT01888965|101350158|FG000|NOT COMPLETED|Overall Study||9||
48414845|NCT03194256|101350159|FG000|STARTED|Overall Study||41||
48414846|NCT03194256|101350160|FG001|STARTED|Overall Study||39||
48414847|NCT03194256|101350159|FG000|Laboratory Session 2|Overall Study||41||
48414848|NCT03194256|101350160|FG001|Laboratory Session 2|Overall Study||36||
48414849|NCT03194256|101350159|FG000|Laboratory Session 3|Overall Study||40||
48414850|NCT03194256|101350160|FG001|Laboratory Session 3|Overall Study||33||
48414851|NCT03194256|101350159|FG000|Laboratory Session 4|Overall Study||39||
48414852|NCT03194256|101350160|FG001|Laboratory Session 4|Overall Study||33||
48414853|NCT03194256|101350159|FG000|COMPLETED|Overall Study||38||
48414854|NCT03194256|101350160|FG001|COMPLETED|Overall Study||32||
48414855|NCT03194256|101350159|FG000|NOT COMPLETED|Overall Study||3||
48414856|NCT03194256|101350160|FG001|NOT COMPLETED|Overall Study||7||
48414857|NCT00142818|101350161|FG000|STARTED|Overall Study||45||
48414858|NCT00142818|101350162|FG001|STARTED|Overall Study||40||
48414859|NCT00142818|101350163|FG002|STARTED|Overall Study||37||
48414860|NCT00142818|101350164|FG003|STARTED|Overall Study||42||
48414861|NCT00142818|101350161|FG000|COMPLETED|Overall Study||28||
48414862|NCT00142818|101350162|FG001|COMPLETED|Overall Study||19||
48414863|NCT00142818|101350163|FG002|COMPLETED|Overall Study||24||
48414864|NCT00142818|101350164|FG003|COMPLETED|Overall Study||20||
48414865|NCT00142818|101350161|FG000|NOT COMPLETED|Overall Study||17||
48414866|NCT00142818|101350162|FG001|NOT COMPLETED|Overall Study||21||
48414867|NCT00142818|101350163|FG002|NOT COMPLETED|Overall Study||13||
48414868|NCT00142818|101350164|FG003|NOT COMPLETED|Overall Study||22||
48414869|NCT01521260|101350165|FG000|STARTED|Overall Study||15||
48414870|NCT01521260|101350166|FG001|STARTED|Overall Study||15||
48414871|NCT01521260|101350165|FG000|COMPLETED|Overall Study||15||
48414872|NCT01521260|101350166|FG001|COMPLETED|Overall Study||15||
48414873|NCT01521260|101350165|FG000|NOT COMPLETED|Overall Study||0||
48414874|NCT01521260|101350166|FG001|NOT COMPLETED|Overall Study||0||
48414875|NCT00438191|101350167|FG000|STARTED|Overall Study||43||
48414876|NCT00438191|101350168|FG001|STARTED|Overall Study||40||
48414877|NCT00438191|101350167|FG000|COMPLETED|Overall Study||32||
48414878|NCT00438191|101350168|FG001|COMPLETED|Overall Study||26||
48414879|NCT00438191|101350167|FG000|NOT COMPLETED|Overall Study||11||
48414880|NCT00438191|101350168|FG001|NOT COMPLETED|Overall Study||14||
48414881|NCT02140762|101350169|FG000|STARTED|Overall Study||154||
48414882|NCT02140762|101350170|FG001|STARTED|Overall Study||151||
48414883|NCT02140762|101350169|FG000|COMPLETED|Overall Study||137||
48758780|NCT03542487|102197687|FG004|STARTED|Primary Care Practices Randomization||0||0
48758781|NCT03542487|102197688|FG005|STARTED|Primary Care Practices Randomization||0||0
48758782|NCT03542487|102197683|FG000|COMPLETED|Primary Care Practices Randomization||3641||10
48758783|NCT03542487|102197684|FG001|COMPLETED|Primary Care Practices Randomization||2182||10
48758784|NCT03542487|102197685|FG002|COMPLETED|Primary Care Practices Randomization||0||0
48758785|NCT03542487|102197686|FG003|COMPLETED|Primary Care Practices Randomization||0||0
48758786|NCT03542487|102197687|FG004|COMPLETED|Primary Care Practices Randomization||0||0
48758787|NCT03542487|102197688|FG005|COMPLETED|Primary Care Practices Randomization||0||0
48758788|NCT03542487|102197683|FG000|NOT COMPLETED|Primary Care Practices Randomization||0||0
48758789|NCT03542487|102197684|FG001|NOT COMPLETED|Primary Care Practices Randomization||1229||0
48758790|NCT03542487|102197685|FG002|NOT COMPLETED|Primary Care Practices Randomization||0||0
48758791|NCT03542487|102197686|FG003|NOT COMPLETED|Primary Care Practices Randomization||0||0
48758792|NCT03542487|102197687|FG004|NOT COMPLETED|Primary Care Practices Randomization||0||0
48758793|NCT03542487|102197688|FG005|NOT COMPLETED|Primary Care Practices Randomization||0||0
48758794|NCT03542487|102197683|FG000|STARTED|Participant Randomization||0|Participants assigned to the ten (10) primary care practices in the experimental group, whose providers placed flow sheet orders (totaling 2182 participants), were allocated to one of four reminder message groups. Allocation to these reminder groups was determined alphabetically by the first letter of the participants' last names.|0
48758795|NCT03542487|102197684|FG001|STARTED|Participant Randomization||0|Participants assigned to the ten (10) primary care practices in the experimental group, whose providers placed flow sheet orders (totaling 2182 participants), were allocated to one of four reminder message groups. Allocation to these reminder groups was determined alphabetically by the first letter of the participants' last names.|0
48758796|NCT03542487|102197685|FG002|STARTED|Participant Randomization||466|Participants assigned to the ten (10) primary care practices in the experimental group, whose providers placed flow sheet orders (totaling 2182 participants), were allocated to one of four reminder message groups. Allocation to these reminder groups was determined alphabetically by the first letter of the participants' last names.|10
48414884|NCT02140762|101350170|FG001|COMPLETED|Overall Study||139||
48414885|NCT02140762|101350169|FG000|NOT COMPLETED|Overall Study||17||
48414886|NCT02140762|101350170|FG001|NOT COMPLETED|Overall Study||12||
48414887|NCT02417935|101350171|FG000|STARTED|Treatment Period||151||
48414888|NCT02417935|101350172|FG001|STARTED|Treatment Period||153||
48414889|NCT02417935|101350171|FG000|Received at Least One Dose of Study Drug|Treatment Period||151||
48414890|NCT02417935|101350172|FG001|Received at Least One Dose of Study Drug|Treatment Period||152||
48414891|NCT02417935|101350171|FG000|COMPLETED|Treatment Period||130||
48414892|NCT02417935|101350172|FG001|COMPLETED|Treatment Period||137||
48758797|NCT03542487|102197686|FG003|STARTED|Participant Randomization||589|Participants assigned to the ten (10) primary care practices in the experimental group, whose providers placed flow sheet orders (totaling 2182 participants), were allocated to one of four reminder message groups. Allocation to these reminder groups was determined alphabetically by the first letter of the participants' last names.|10
48414893|NCT02417935|101350171|FG000|NOT COMPLETED|Treatment Period||21||
48414894|NCT02417935|101350172|FG001|NOT COMPLETED|Treatment Period||16||
48414895|NCT02417935|101350171|FG000|STARTED|Tapering Period||134||
48414896|NCT02417935|101350172|FG001|STARTED|Tapering Period||142||
48414897|NCT02417935|101350171|FG000|COMPLETED|Tapering Period||134||
48414898|NCT02417935|101350172|FG001|COMPLETED|Tapering Period||142||
48414899|NCT02417935|101350171|FG000|NOT COMPLETED|Tapering Period||0||
48414900|NCT02417935|101350172|FG001|NOT COMPLETED|Tapering Period||0||
48414901|NCT00911144|101350173|FG000|STARTED|Overall Study||335||
48414902|NCT00911144|101350174|FG001|STARTED|Overall Study||113||
48414903|NCT00911144|101350173|FG000|COMPLETED|Overall Study||319||
48414904|NCT00911144|101350174|FG001|COMPLETED|Overall Study||108||
48184452|NCT03255941|100775758|FG003|Deemed Eligible to Receive DMPA|Overall Study||46||
48345045|NCT01324830|101172475|FG004|STARTED|Overall Study||7||
48414905|NCT00911144|101350173|FG000|NOT COMPLETED|Overall Study||16||
48414906|NCT00911144|101350174|FG001|NOT COMPLETED|Overall Study||5||
48414907|NCT02394028|101350175|FG000|STARTED|Induction Phase||59||
48414908|NCT02394028|101350176|FG001|STARTED|Induction Phase||120||
48345046|NCT01324830|101172476|FG005|STARTED|Overall Study||7||
48345047|NCT01324830|101172477|FG006|STARTED|Overall Study||3||
48345048|NCT01324830|101172478|FG007|STARTED|Overall Study||3||
48345049|NCT01324830|101172479|FG008|STARTED|Overall Study||5||
48345050|NCT01324830|101172480|FG009|STARTED|Overall Study||6||
48345051|NCT01324830|101172481|FG010|STARTED|Overall Study||4||
48345052|NCT01324830|101172482|FG011|STARTED|Overall Study||1||
48414909|NCT02394028|101350177|FG002|STARTED|Induction Phase||121||
48414910|NCT02394028|101350178|FG003|STARTED|Induction Phase||176||
48414911|NCT02394028|101350179|FG004|STARTED|Induction Phase||174||
48758798|NCT03542487|102197687|FG004|STARTED|Participant Randomization||554|Participants assigned to the ten (10) primary care practices in the experimental group, whose providers placed flow sheet orders (totaling 2182 participants), were allocated to one of four reminder message groups. Allocation to these reminder groups was determined alphabetically by the first letter of the participants' last names.|10
48758799|NCT03542487|102197688|FG005|STARTED|Participant Randomization||573|Participants assigned to the ten (10) primary care practices in the experimental group, whose providers placed flow sheet orders (totaling 2182 participants), were allocated to one of four reminder message groups. Allocation to these reminder groups was determined alphabetically by the first letter of the participants' last names.|10
48758800|NCT03542487|102197683|FG000|COMPLETED|Participant Randomization||0|Primary care practices in the experimental group were excluded as they did not have any participants with the corresponding first letter of the last names used for participant assignment.|0
48758801|NCT03542487|102197684|FG001|COMPLETED|Participant Randomization||0|Primary care practices in the experimental group were excluded as they did not have any participants with the corresponding first letter of the last names used for participant assignment.|0
48758802|NCT03542487|102197685|FG002|COMPLETED|Participant Randomization||466|Primary care practices in the experimental group were excluded as they did not have any participants with the corresponding first letter of the last names used for participant assignment.|8
48758803|NCT03542487|102197686|FG003|COMPLETED|Participant Randomization||589|Primary care practices in the experimental group were excluded as they did not have any participants with the corresponding first letter of the last names used for participant assignment.|7
48758804|NCT03542487|102197687|FG004|COMPLETED|Participant Randomization||554|Primary care practices in the experimental group were excluded as they did not have any participants with the corresponding first letter of the last names used for participant assignment.|7
48758805|NCT03542487|102197688|FG005|COMPLETED|Participant Randomization||573|Primary care practices in the experimental group were excluded as they did not have any participants with the corresponding first letter of the last names used for participant assignment.|7
48758806|NCT03542487|102197683|FG000|NOT COMPLETED|Participant Randomization||0||0
48758807|NCT03542487|102197684|FG001|NOT COMPLETED|Participant Randomization||0||0
48758808|NCT03542487|102197685|FG002|NOT COMPLETED|Participant Randomization||0||2
48758809|NCT03542487|102197686|FG003|NOT COMPLETED|Participant Randomization||0||3
48758810|NCT03542487|102197687|FG004|NOT COMPLETED|Participant Randomization||0||3
48758811|NCT03542487|102197688|FG005|NOT COMPLETED|Participant Randomization||0||3
48345053|NCT01324830|101172483|FG012|STARTED|Overall Study||1||
48345054|NCT01324830|101172484|FG013|STARTED|Overall Study||1||
48345055|NCT01324830|101172485|FG014|STARTED|Overall Study||1||
48345056|NCT01324830|101172486|FG015|STARTED|Overall Study||3||
48345057|NCT01324830|101172487|FG016|STARTED|Overall Study||3||
48345058|NCT01324830|101172488|FG017|STARTED|Overall Study||6||
48345059|NCT01324830|101172489|FG018|STARTED|Overall Study||6||
48345060|NCT01324830|101172471|FG000|COMPLETED|Overall Study||0||
48345061|NCT01324830|101172472|FG001|COMPLETED|Overall Study||0||
48345062|NCT01324830|101172473|FG002|COMPLETED|Overall Study||0||
48414912|NCT02394028|101350180|FG005|STARTED|Induction Phase||97||
48345063|NCT01324830|101172474|FG003|COMPLETED|Overall Study||0||
48345064|NCT01324830|101172475|FG004|COMPLETED|Overall Study||0||
48345065|NCT01324830|101172476|FG005|COMPLETED|Overall Study||0||
48345066|NCT01324830|101172477|FG006|COMPLETED|Overall Study||0||
48345067|NCT01324830|101172478|FG007|COMPLETED|Overall Study||0||
48345068|NCT01324830|101172479|FG008|COMPLETED|Overall Study||0||
48345069|NCT01324830|101172480|FG009|COMPLETED|Overall Study||0||
48345070|NCT01324830|101172481|FG010|COMPLETED|Overall Study||0||
48414913|NCT02394028|101350181|FG006|STARTED|Induction Phase||143||
48414914|NCT02394028|101350182|FG007|STARTED|Induction Phase||145||
48414915|NCT02394028|101350183|FG008|STARTED|Induction Phase||0||
48758812|NCT00756106|102197689|FG000|STARTED|Overall Study||15||
48758813|NCT00756106|102197689|FG000|COMPLETED|Overall Study||3||
48758814|NCT00756106|102197689|FG000|NOT COMPLETED|Overall Study||12||
48758815|NCT00537394|102197690|FG000|STARTED|First Year of Follow-up||181||
48758816|NCT00537394|102197691|FG001|STARTED|First Year of Follow-up||179||
48758817|NCT00537394|102197692|FG002|STARTED|First Year of Follow-up||53||
48758818|NCT00537394|102197690|FG000|COMPLETED|First Year of Follow-up||169||
48758819|NCT00537394|102197691|FG001|COMPLETED|First Year of Follow-up||168||
48758820|NCT00537394|102197692|FG002|COMPLETED|First Year of Follow-up||50||
48414916|NCT02394028|101350184|FG009|STARTED|Induction Phase||0||
48414917|NCT02394028|101350185|FG010|STARTED|Induction Phase||0||
48414918|NCT02394028|101350175|FG000|COMPLETED|Induction Phase||52||
48414919|NCT02394028|101350176|FG001|COMPLETED|Induction Phase||104||
48414920|NCT02394028|101350177|FG002|COMPLETED|Induction Phase||108||
48758821|NCT00537394|102197690|FG000|NOT COMPLETED|First Year of Follow-up||12||
48758822|NCT00537394|102197691|FG001|NOT COMPLETED|First Year of Follow-up||11||
48758823|NCT00537394|102197692|FG002|NOT COMPLETED|First Year of Follow-up||3||
48758824|NCT00537394|102197690|FG000|STARTED|2nd Year of Follow-up||169||
48758825|NCT00537394|102197691|FG001|STARTED|2nd Year of Follow-up||168||
48758826|NCT00537394|102197692|FG002|STARTED|2nd Year of Follow-up||50||
48758827|NCT00537394|102197690|FG000|COMPLETED|2nd Year of Follow-up||158||
48758828|NCT00537394|102197691|FG001|COMPLETED|2nd Year of Follow-up||159||
48758829|NCT00537394|102197692|FG002|COMPLETED|2nd Year of Follow-up||44||
48758830|NCT00537394|102197690|FG000|NOT COMPLETED|2nd Year of Follow-up||11||
48758831|NCT00537394|102197691|FG001|NOT COMPLETED|2nd Year of Follow-up||9||
48758832|NCT00537394|102197692|FG002|NOT COMPLETED|2nd Year of Follow-up||6||
48414921|NCT02394028|101350178|FG003|COMPLETED|Induction Phase||141||
48414922|NCT02394028|101350179|FG004|COMPLETED|Induction Phase||145||
48414923|NCT02394028|101350180|FG005|COMPLETED|Induction Phase||80||
48758833|NCT03409796|102197693|FG000|STARTED|Overall Study||9||
48414924|NCT02394028|101350181|FG006|COMPLETED|Induction Phase||118||
48414925|NCT02394028|101350182|FG007|COMPLETED|Induction Phase||114||
48758834|NCT03409796|102197694|FG001|STARTED|Overall Study||7||
48758835|NCT03409796|102197693|FG000|COMPLETED|Overall Study||7||
48414926|NCT02394028|101350183|FG008|COMPLETED|Induction Phase||0||
48414927|NCT02394028|101350184|FG009|COMPLETED|Induction Phase||0||
48414928|NCT02394028|101350185|FG010|COMPLETED|Induction Phase||0||
48414929|NCT02394028|101350175|FG000|NOT COMPLETED|Induction Phase||7||
48414930|NCT02394028|101350176|FG001|NOT COMPLETED|Induction Phase||16||
48414931|NCT02394028|101350177|FG002|NOT COMPLETED|Induction Phase||13||
48414932|NCT02394028|101350178|FG003|NOT COMPLETED|Induction Phase||35||
48414933|NCT02394028|101350179|FG004|NOT COMPLETED|Induction Phase||29||
48414934|NCT02394028|101350180|FG005|NOT COMPLETED|Induction Phase||17||
48414935|NCT02394028|101350181|FG006|NOT COMPLETED|Induction Phase||25||
48758836|NCT03409796|102197694|FG001|COMPLETED|Overall Study||6||
48758837|NCT03409796|102197693|FG000|NOT COMPLETED|Overall Study||2||
48414936|NCT02394028|101350182|FG007|NOT COMPLETED|Induction Phase||31||
48414937|NCT02394028|101350183|FG008|NOT COMPLETED|Induction Phase||0||
48414938|NCT02394028|101350184|FG009|NOT COMPLETED|Induction Phase||0||
48414939|NCT02394028|101350185|FG010|NOT COMPLETED|Induction Phase||0||
48414940|NCT02394028|101350175|FG000|STARTED|Maintenance Phase||0||
48414941|NCT02394028|101350176|FG001|STARTED|Maintenance Phase||0||
48414942|NCT02394028|101350177|FG002|STARTED|Maintenance Phase||0||
48636144|NCT03104413|101894561|FG002|STARTED|Induction Period 1||205||
48636145|NCT03104413|101894562|FG003|STARTED|Induction Period 1||0||
48636146|NCT03104413|101894563|FG004|STARTED|Induction Period 1||0||
48636147|NCT03104413|101894564|FG005|STARTED|Induction Period 1||0||
48636148|NCT03104413|101894565|FG006|STARTED|Induction Period 1||0||
48636149|NCT03104413|101894559|FG000|COMPLETED|Induction Period 1||186||
48636150|NCT03104413|101894560|FG001|COMPLETED|Induction Period 1||202||
48636151|NCT03104413|101894561|FG002|COMPLETED|Induction Period 1||199||
48636152|NCT03104413|101894562|FG003|COMPLETED|Induction Period 1||0||
48636153|NCT03104413|101894563|FG004|COMPLETED|Induction Period 1||0||
48636154|NCT03104413|101894564|FG005|COMPLETED|Induction Period 1||0||
48636155|NCT03104413|101894565|FG006|COMPLETED|Induction Period 1||0||
48636156|NCT03104413|101894559|FG000|NOT COMPLETED|Induction Period 1||21||
48636157|NCT03104413|101894560|FG001|NOT COMPLETED|Induction Period 1||4||
48636158|NCT03104413|101894561|FG002|NOT COMPLETED|Induction Period 1||6||
48636159|NCT03104413|101894562|FG003|NOT COMPLETED|Induction Period 1||0||
48758838|NCT03409796|102197694|FG001|NOT COMPLETED|Overall Study||1||
48758839|NCT00374140|102197695|FG000|STARTED|Overall Study||40||
48758840|NCT00374140|102197695|FG000|COMPLETED|Overall Study||38||
48758841|NCT00374140|102197695|FG000|NOT COMPLETED|Overall Study||2||
48758842|NCT04475081|102197696|FG000|STARTED|Overall Study||25||
48758843|NCT04475081|102197697|FG001|STARTED|Overall Study||25||
48758844|NCT04475081|102197696|FG000|COMPLETED|Overall Study||19||
48758845|NCT04475081|102197697|FG001|COMPLETED|Overall Study||15||
48758846|NCT04475081|102197696|FG000|NOT COMPLETED|Overall Study||6||
48758847|NCT04475081|102197697|FG001|NOT COMPLETED|Overall Study||10||
48758848|NCT04682197|102197698|FG000|STARTED|Overall Study||72||
48758849|NCT04682197|102197699|FG001|STARTED|Overall Study||72||
48758850|NCT04682197|102197698|FG000|COMPLETED|Overall Study||67||
48758851|NCT04682197|102197699|FG001|COMPLETED|Overall Study||67||
48758852|NCT04682197|102197698|FG000|NOT COMPLETED|Overall Study||5||
48758853|NCT04682197|102197699|FG001|NOT COMPLETED|Overall Study||5||
48758854|NCT02814916|102197700|FG000|STARTED|Overall Study||91||
48758855|NCT02814916|102197701|FG001|STARTED|Overall Study||78||
48758856|NCT02814916|102197702|FG002|STARTED|Overall Study||30||
48758857|NCT02814916|102197700|FG000|COMPLETED|Overall Study||91||
48758858|NCT02814916|102197701|FG001|COMPLETED|Overall Study||74||
48758859|NCT02814916|102197702|FG002|COMPLETED|Overall Study||30||
48758860|NCT02814916|102197700|FG000|NOT COMPLETED|Overall Study||0||
48758861|NCT02814916|102197701|FG001|NOT COMPLETED|Overall Study||4||
48758862|NCT02814916|102197702|FG002|NOT COMPLETED|Overall Study||0||
48414943|NCT02394028|101350178|FG003|STARTED|Maintenance Phase||0||
48414944|NCT02394028|101350179|FG004|STARTED|Maintenance Phase||0||
48414945|NCT02394028|101350180|FG005|STARTED|Maintenance Phase||0||
48414946|NCT02394028|101350181|FG006|STARTED|Maintenance Phase||0||
48414947|NCT02394028|101350182|FG007|STARTED|Maintenance Phase||0||
48414948|NCT02394028|101350183|FG008|STARTED|Maintenance Phase||53||
48414949|NCT02394028|101350184|FG009|STARTED|Maintenance Phase||217||
48414950|NCT02394028|101350185|FG010|STARTED|Maintenance Phase||217||
48414951|NCT02394028|101350175|FG000|COMPLETED|Maintenance Phase||0||
48414952|NCT02394028|101350176|FG001|COMPLETED|Maintenance Phase||0||
48636160|NCT03104413|101894563|FG004|NOT COMPLETED|Induction Period 1||0||
48636161|NCT03104413|101894564|FG005|NOT COMPLETED|Induction Period 1||0||
48636162|NCT03104413|101894565|FG006|NOT COMPLETED|Induction Period 1||0||
48636163|NCT03104413|101894559|FG000|STARTED|Induction Period 2||0||
48636164|NCT03104413|101894560|FG001|STARTED|Induction Period 2||0||
48636165|NCT03104413|101894561|FG002|STARTED|Induction Period 2||0||
48636166|NCT03104413|101894562|FG003|STARTED|Induction Period 2||41||
48636167|NCT03104413|101894563|FG004|STARTED|Induction Period 2||42||
48636168|NCT03104413|101894564|FG005|STARTED|Induction Period 2||42||
48636169|NCT03104413|101894565|FG006|STARTED|Induction Period 2||86||
48636170|NCT03104413|101894559|FG000|COMPLETED|Induction Period 2||0||
48636171|NCT03104413|101894560|FG001|COMPLETED|Induction Period 2||0||
48636172|NCT03104413|101894561|FG002|COMPLETED|Induction Period 2||0||
48636173|NCT03104413|101894562|FG003|COMPLETED|Induction Period 2||39||
48636174|NCT03104413|101894563|FG004|COMPLETED|Induction Period 2||39||
48636175|NCT03104413|101894564|FG005|COMPLETED|Induction Period 2||38||
48636176|NCT03104413|101894565|FG006|COMPLETED|Induction Period 2||76||
48636177|NCT03104413|101894559|FG000|NOT COMPLETED|Induction Period 2||0||
48636178|NCT03104413|101894560|FG001|NOT COMPLETED|Induction Period 2||0||
48636179|NCT03104413|101894561|FG002|NOT COMPLETED|Induction Period 2||0||
48636180|NCT03104413|101894562|FG003|NOT COMPLETED|Induction Period 2||2||
48636181|NCT03104413|101894563|FG004|NOT COMPLETED|Induction Period 2||3||
48636182|NCT03104413|101894564|FG005|NOT COMPLETED|Induction Period 2||4||
48636183|NCT03104413|101894565|FG006|NOT COMPLETED|Induction Period 2||10||
48636184|NCT02612857|101894566|FG000|STARTED|Overall Study||11||
48636185|NCT02612857|101894567|FG001|STARTED|Overall Study||9||
48636186|NCT02612857|101894568|FG002|STARTED|Overall Study||10||
48636187|NCT02612857|101894566|FG000|COMPLETED|Overall Study||8||
48636188|NCT02612857|101894567|FG001|COMPLETED|Overall Study||5||
48636189|NCT02612857|101894568|FG002|COMPLETED|Overall Study||6||
48636190|NCT02612857|101894566|FG000|NOT COMPLETED|Overall Study||3||
48636191|NCT02612857|101894567|FG001|NOT COMPLETED|Overall Study||4||
48636192|NCT02612857|101894568|FG002|NOT COMPLETED|Overall Study||4||
48636193|NCT01532089|101894569|FG000|STARTED|Overall Study||45|Randomized|
48636194|NCT01532089|101894570|FG001|STARTED|Overall Study||43|Randomized|
48636195|NCT01532089|101894569|FG000|COMPLETED|Overall Study||45||
48636196|NCT01532089|101894570|FG001|COMPLETED|Overall Study||43||
48636197|NCT01532089|101894569|FG000|NOT COMPLETED|Overall Study||0||
48636198|NCT01532089|101894570|FG001|NOT COMPLETED|Overall Study||0||
48636199|NCT02101294|101894571|FG000|STARTED|Overall Study||31||
48636200|NCT02101294|101894571|FG000|COMPLETED|Overall Study||20||
48636201|NCT02101294|101894571|FG000|NOT COMPLETED|Overall Study||11||
48636202|NCT00612235|101894572|FG000|STARTED|Overall Study||20||
48636203|NCT00612235|101894573|FG001|STARTED|Overall Study||20||
48636204|NCT00612235|101894574|FG002|STARTED|Overall Study||20||
48636205|NCT00612235|101894575|FG003|STARTED|Overall Study||20||
48636206|NCT00612235|101894572|FG000|COMPLETED|Overall Study||20||
48636207|NCT00612235|101894573|FG001|COMPLETED|Overall Study||20||
48636208|NCT00612235|101894574|FG002|COMPLETED|Overall Study||20||
48636209|NCT00612235|101894575|FG003|COMPLETED|Overall Study||20||
48636210|NCT00612235|101894572|FG000|NOT COMPLETED|Overall Study||0||
48636211|NCT00612235|101894573|FG001|NOT COMPLETED|Overall Study||0||
48636212|NCT00612235|101894574|FG002|NOT COMPLETED|Overall Study||0||
48636213|NCT00612235|101894575|FG003|NOT COMPLETED|Overall Study||0||
48636214|NCT05172570|101894576|FG000|STARTED|Overall Study||6||
48636215|NCT05172570|101894577|FG001|STARTED|Overall Study||7||
48636216|NCT05172570|101894578|FG002|STARTED|Overall Study||7||
48636217|NCT05172570|101894576|FG000|COMPLETED|Overall Study||6||
48636218|NCT05172570|101894577|FG001|COMPLETED|Overall Study||6||
48636219|NCT05172570|101894578|FG002|COMPLETED|Overall Study||6||
48636220|NCT05172570|101894576|FG000|NOT COMPLETED|Overall Study||0||
48636221|NCT05172570|101894577|FG001|NOT COMPLETED|Overall Study||1||
48636222|NCT05172570|101894578|FG002|NOT COMPLETED|Overall Study||1||
48636223|NCT01179516|101894579|FG000|STARTED|Overall Study||160||
48636224|NCT01179516|101894580|FG001|STARTED|Overall Study||157||
48636225|NCT01179516|101894581|FG002|STARTED|Overall Study||152||
48636226|NCT01179516|101894579|FG000|Treated|Overall Study||160||
48636227|NCT01179516|101894580|FG001|Treated|Overall Study||154||
48636228|NCT01179516|101894581|FG002|Treated|Overall Study||151||
48636229|NCT01179516|101894579|FG000|COMPLETED|Overall Study||133||
48636230|NCT01179516|101894580|FG001|COMPLETED|Overall Study||131||
48636231|NCT01179516|101894581|FG002|COMPLETED|Overall Study||121||
48636232|NCT01179516|101894579|FG000|NOT COMPLETED|Overall Study||27||
48636233|NCT01179516|101894580|FG001|NOT COMPLETED|Overall Study||26||
48636234|NCT01179516|101894581|FG002|NOT COMPLETED|Overall Study||31||
48636235|NCT00655889|101894582|FG000|STARTED|Overall Study||13||
48636236|NCT00655889|101894582|FG000|COMPLETED|Overall Study||11||
48636237|NCT00655889|101894582|FG000|NOT COMPLETED|Overall Study||2||
48636238|NCT04377659|101894583|FG000|STARTED|Overall Study||3||
48636239|NCT04377659|101894584|FG001|STARTED|Overall Study||6||
48636240|NCT04377659|101894583|FG000|COMPLETED|Overall Study||3||
48636241|NCT04377659|101894584|FG001|COMPLETED|Overall Study||6||
48636242|NCT04377659|101894583|FG000|NOT COMPLETED|Overall Study||0||
48636243|NCT04377659|101894584|FG001|NOT COMPLETED|Overall Study||0||
48636244|NCT04285411|101894585|FG000|STARTED|Overall Study||10||
48636245|NCT04285411|101894585|FG000|COMPLETED|Overall Study||10||
48636246|NCT04285411|101894585|FG000|NOT COMPLETED|Overall Study||0||
48636247|NCT00715208|101894586|FG000|STARTED|Overall Study||7||
48636248|NCT00715208|101894587|FG001|STARTED|Overall Study||48||
48636249|NCT00715208|101894586|FG000|COMPLETED|Overall Study||6||
48636250|NCT00715208|101894587|FG001|COMPLETED|Overall Study||39||
48636251|NCT00715208|101894586|FG000|NOT COMPLETED|Overall Study||1||
48636252|NCT00715208|101894587|FG001|NOT COMPLETED|Overall Study||9||
48636253|NCT00529035|101894588|FG000|STARTED|Overall Study||29||
48636254|NCT00529035|101894588|FG000|COMPLETED|Overall Study||28||
48636255|NCT00529035|101894588|FG000|NOT COMPLETED|Overall Study||1||
48636256|NCT01408641|101894589|FG000|STARTED|Overall Study||1||
48636257|NCT01408641|101894590|FG001|STARTED|Overall Study||0||
48636258|NCT01408641|101894589|FG000|COMPLETED|Overall Study||0||
48636259|NCT01408641|101894590|FG001|COMPLETED|Overall Study||0||
48636260|NCT01408641|101894589|FG000|NOT COMPLETED|Overall Study||1||
48636261|NCT01408641|101894590|FG001|NOT COMPLETED|Overall Study||0||
48636262|NCT00470548|101894591|FG000|STARTED|Overall Study||3||
48636263|NCT00470548|101894592|FG001|STARTED|Overall Study||3||
48636264|NCT00470548|101894593|FG002|STARTED|Overall Study||6||
48636265|NCT00470548|101894594|FG003|STARTED|Overall Study||37||
48636266|NCT00470548|101894591|FG000|COMPLETED|Overall Study||3||
48636267|NCT00470548|101894592|FG001|COMPLETED|Overall Study||3||
48636268|NCT00470548|101894593|FG002|COMPLETED|Overall Study||6||
48636269|NCT00470548|101894594|FG003|COMPLETED|Overall Study||37||
48636270|NCT00470548|101894591|FG000|NOT COMPLETED|Overall Study||0||
48636271|NCT00470548|101894592|FG001|NOT COMPLETED|Overall Study||0||
48636272|NCT00470548|101894593|FG002|NOT COMPLETED|Overall Study||0||
48636273|NCT00470548|101894594|FG003|NOT COMPLETED|Overall Study||0||
48636274|NCT01806129|101894595|FG000|STARTED|Overall Study||278||
48636275|NCT01806129|101894596|FG001|STARTED|Overall Study||156||
48636276|NCT01806129|101894595|FG000|Eligible and Analyzable Patients|Overall Study||269||
48636277|NCT01806129|101894596|FG001|Eligible and Analyzable Patients|Overall Study||151||
48636278|NCT01806129|101894595|FG000|COMPLETED|Overall Study||278||
48636279|NCT01806129|101894596|FG001|COMPLETED|Overall Study||156||
48636280|NCT01806129|101894595|FG000|NOT COMPLETED|Overall Study||0||
48636281|NCT01806129|101894596|FG001|NOT COMPLETED|Overall Study||0||
48636282|NCT02385318|101894597|FG000|STARTED|Overall Study||204||
48636283|NCT02385318|101894598|FG001|STARTED|Overall Study||210||
48636284|NCT02385318|101894599|FG002|STARTED|Overall Study||105||
48636285|NCT02385318|101894597|FG000|COMPLETED|Overall Study||200||
48636286|NCT02385318|101894598|FG001|COMPLETED|Overall Study||203||
48636287|NCT02385318|101894599|FG002|COMPLETED|Overall Study||99||
48636288|NCT02385318|101894597|FG000|NOT COMPLETED|Overall Study||4||
48636289|NCT02385318|101894598|FG001|NOT COMPLETED|Overall Study||7||
48636290|NCT02385318|101894599|FG002|NOT COMPLETED|Overall Study||6||
48636291|NCT01260948|101894600|FG000|STARTED|First Intervention||13||
48636292|NCT01260948|101894601|FG001|STARTED|First Intervention||13||
48636293|NCT01260948|101894600|FG000|COMPLETED|First Intervention||13||
48636294|NCT01260948|101894601|FG001|COMPLETED|First Intervention||13||
48636295|NCT01260948|101894600|FG000|NOT COMPLETED|First Intervention||0||
48636296|NCT01260948|101894601|FG001|NOT COMPLETED|First Intervention||0||
48636297|NCT01260948|101894600|FG000|STARTED|Washout of 28 Days||13||
48636298|NCT01260948|101894601|FG001|STARTED|Washout of 28 Days||13||
48636299|NCT01260948|101894600|FG000|COMPLETED|Washout of 28 Days||12||
48636300|NCT01260948|101894601|FG001|COMPLETED|Washout of 28 Days||10||
48636301|NCT01260948|101894600|FG000|NOT COMPLETED|Washout of 28 Days||1||
48636302|NCT01260948|101894601|FG001|NOT COMPLETED|Washout of 28 Days||3||
48636303|NCT01260948|101894600|FG000|STARTED|Second Intervention||12||
48636304|NCT01260948|101894601|FG001|STARTED|Second Intervention||10||
48636305|NCT01260948|101894600|FG000|COMPLETED|Second Intervention||12||
48636306|NCT01260948|101894601|FG001|COMPLETED|Second Intervention||9||
48636307|NCT01260948|101894600|FG000|NOT COMPLETED|Second Intervention||0||
48636308|NCT01260948|101894601|FG001|NOT COMPLETED|Second Intervention||1||
48636309|NCT00208975|101894602|FG000|STARTED|Overall Study||15||
48636310|NCT00208975|101894602|FG000|COMPLETED|Overall Study||15||
48636311|NCT00208975|101894602|FG000|NOT COMPLETED|Overall Study||0||
48636312|NCT00817063|101894603|FG000|STARTED|Overall Study||298||
48636313|NCT00817063|101894604|FG001|STARTED|Overall Study||298||
48636314|NCT00817063|101894603|FG000|COMPLETED|Overall Study||161||
48636315|NCT00817063|101894604|FG001|COMPLETED|Overall Study||128||
48636316|NCT00817063|101894603|FG000|NOT COMPLETED|Overall Study||137||
48636317|NCT00817063|101894604|FG001|NOT COMPLETED|Overall Study||170||
48636318|NCT01682031|101894605|FG000|STARTED|Overall Study||8||
48636319|NCT01682031|101894606|FG001|STARTED|Overall Study||10||
48636320|NCT01682031|101894605|FG000|COMPLETED|Overall Study||7||
48636321|NCT01682031|101894606|FG001|COMPLETED|Overall Study||5||
48636322|NCT01682031|101894605|FG000|NOT COMPLETED|Overall Study||1||
48636323|NCT01682031|101894606|FG001|NOT COMPLETED|Overall Study||5||
48636324|NCT00929669|101894607|FG000|STARTED|Overall Study||2||
48636325|NCT00929669|101894607|FG000|COMPLETED|Overall Study||1||
48636326|NCT00929669|101894607|FG000|NOT COMPLETED|Overall Study||1||
48636327|NCT00831844|101894608|FG000|STARTED|Overall Study||10||
48636328|NCT00831844|101894609|FG001|STARTED|Overall Study||12||
48636329|NCT00831844|101894610|FG002|STARTED|Overall Study||21||
48636330|NCT00831844|101894611|FG003|STARTED|Overall Study||10||
48636331|NCT00831844|101894612|FG004|STARTED|Overall Study||14||
48636332|NCT00831844|101894613|FG005|STARTED|Overall Study||20||
48636333|NCT00831844|101894614|FG006|STARTED|Overall Study||10||
48636334|NCT00831844|101894615|FG007|STARTED|Overall Study||10||
48636335|NCT00831844|101894616|FG008|STARTED|Overall Study||9||
48758863|NCT05131308|102197703|FG000|STARTED|Overall Study||64||
48758864|NCT05131308|102197704|FG001|STARTED|Overall Study||36||
48758865|NCT05131308|102197705|FG002|STARTED|Overall Study||60||
48758866|NCT05131308|102197703|FG000|COMPLETED|Overall Study||64||
48345071|NCT01324830|101172482|FG011|COMPLETED|Overall Study||0||
48345072|NCT01324830|101172483|FG012|COMPLETED|Overall Study||0||
48345073|NCT01324830|101172484|FG013|COMPLETED|Overall Study||0||
48345074|NCT01324830|101172485|FG014|COMPLETED|Overall Study||0||
48345075|NCT01324830|101172486|FG015|COMPLETED|Overall Study||0||
48345076|NCT01324830|101172487|FG016|COMPLETED|Overall Study||0||
48345077|NCT01324830|101172488|FG017|COMPLETED|Overall Study||0||
48636336|NCT00831844|101894617|FG009|STARTED|Overall Study||0||
48636337|NCT00831844|101894608|FG000|COMPLETED|Overall Study||0||
48636338|NCT00831844|101894609|FG001|COMPLETED|Overall Study||0||
48636339|NCT00831844|101894610|FG002|COMPLETED|Overall Study||1||
48636340|NCT00831844|101894611|FG003|COMPLETED|Overall Study||0||
48636341|NCT00831844|101894612|FG004|COMPLETED|Overall Study||0||
48636342|NCT00831844|101894613|FG005|COMPLETED|Overall Study||1||
48636343|NCT00831844|101894614|FG006|COMPLETED|Overall Study||0||
48636344|NCT00831844|101894615|FG007|COMPLETED|Overall Study||0||
48636345|NCT00831844|101894616|FG008|COMPLETED|Overall Study||0||
48636346|NCT00831844|101894617|FG009|COMPLETED|Overall Study||0||
48636347|NCT00831844|101894608|FG000|NOT COMPLETED|Overall Study||10||
48636348|NCT00831844|101894609|FG001|NOT COMPLETED|Overall Study||12||
48636349|NCT00831844|101894610|FG002|NOT COMPLETED|Overall Study||20||
48636350|NCT00831844|101894611|FG003|NOT COMPLETED|Overall Study||10||
48636351|NCT00831844|101894612|FG004|NOT COMPLETED|Overall Study||14||
48636352|NCT00831844|101894613|FG005|NOT COMPLETED|Overall Study||19||
48636353|NCT00831844|101894614|FG006|NOT COMPLETED|Overall Study||10||
48636354|NCT00831844|101894615|FG007|NOT COMPLETED|Overall Study||10||
48636355|NCT00831844|101894616|FG008|NOT COMPLETED|Overall Study||9||
48636356|NCT00831844|101894617|FG009|NOT COMPLETED|Overall Study||0||
48636357|NCT01289522|101894618|FG000|STARTED|Overall Study||54||
48636358|NCT01289522|101894618|FG000|COMPLETED|Overall Study||43||
48636359|NCT01289522|101894618|FG000|NOT COMPLETED|Overall Study||11||
48636360|NCT01649765|101894619|FG000|STARTED|Overall Study||40||
48636361|NCT01649765|101894620|FG001|STARTED|Overall Study||53||
48636362|NCT01649765|101894619|FG000|COMPLETED|Overall Study||31||
48636363|NCT01649765|101894620|FG001|COMPLETED|Overall Study||45||
48636364|NCT01649765|101894619|FG000|NOT COMPLETED|Overall Study||9||
48636365|NCT01649765|101894620|FG001|NOT COMPLETED|Overall Study||8||
48636366|NCT01056276|101894621|FG000|STARTED|Treatment Period-Cycles 1-8||18||
48636367|NCT01056276|101894622|FG001|STARTED|Treatment Period-Cycles 1-8||41||
48636368|NCT01056276|101894621|FG000|COMPLETED|Treatment Period-Cycles 1-8||5||
48636369|NCT01056276|101894622|FG001|COMPLETED|Treatment Period-Cycles 1-8||33||
48636370|NCT01056276|101894621|FG000|NOT COMPLETED|Treatment Period-Cycles 1-8||13||
48636371|NCT01056276|101894622|FG001|NOT COMPLETED|Treatment Period-Cycles 1-8||8||
48636372|NCT01056276|101894621|FG000|STARTED|Maintenance Therapy||0||
48636373|NCT01056276|101894622|FG001|STARTED|Maintenance Therapy||28||
48636374|NCT01056276|101894621|FG000|COMPLETED|Maintenance Therapy||0||
48636375|NCT01056276|101894622|FG001|COMPLETED|Maintenance Therapy||0||
48636376|NCT01056276|101894621|FG000|NOT COMPLETED|Maintenance Therapy||0||
48636377|NCT01056276|101894622|FG001|NOT COMPLETED|Maintenance Therapy||28||
48636378|NCT01944423|101894623|FG000|STARTED|Overall Study||27||
48636379|NCT01944423|101894624|FG001|STARTED|Overall Study||26||
48636380|NCT01944423|101894623|FG000|End of Treatment|Overall Study||21||
48636381|NCT01944423|101894624|FG001|End of Treatment|Overall Study||20||
48636382|NCT01944423|101894623|FG000|1-month Follow-up|Overall Study||22||
48636383|NCT01944423|101894624|FG001|1-month Follow-up|Overall Study||19||
48758867|NCT05131308|102197704|FG001|COMPLETED|Overall Study||36||
48758868|NCT05131308|102197705|FG002|COMPLETED|Overall Study||60||
48345078|NCT01324830|101172489|FG018|COMPLETED|Overall Study||0||
48345079|NCT01324830|101172471|FG000|NOT COMPLETED|Overall Study||3||
48345080|NCT01324830|101172472|FG001|NOT COMPLETED|Overall Study||3||
48345081|NCT01324830|101172473|FG002|NOT COMPLETED|Overall Study||3||
48345082|NCT01324830|101172474|FG003|NOT COMPLETED|Overall Study||3||
48345083|NCT01324830|101172475|FG004|NOT COMPLETED|Overall Study||7||
48345084|NCT01324830|101172476|FG005|NOT COMPLETED|Overall Study||7||
48345085|NCT01324830|101172477|FG006|NOT COMPLETED|Overall Study||3||
48345086|NCT01324830|101172478|FG007|NOT COMPLETED|Overall Study||3||
48636384|NCT01944423|101894623|FG000|4-month Follow-up|Overall Study||19||
48636385|NCT01944423|101894624|FG001|4-month Follow-up|Overall Study||16||
48636386|NCT01944423|101894623|FG000|COMPLETED|Overall Study||19||
48758869|NCT05131308|102197703|FG000|NOT COMPLETED|Overall Study||0||
48758870|NCT05131308|102197704|FG001|NOT COMPLETED|Overall Study||0||
48345087|NCT01324830|101172479|FG008|NOT COMPLETED|Overall Study||5||
48636387|NCT01944423|101894624|FG001|COMPLETED|Overall Study||17||
48636388|NCT01944423|101894623|FG000|NOT COMPLETED|Overall Study||8||
48636389|NCT01944423|101894624|FG001|NOT COMPLETED|Overall Study||9||
48636390|NCT01092923|101894625|FG000|STARTED|Overall Study||10||
48636391|NCT01092923|101894626|FG001|STARTED|Overall Study||10||
48636392|NCT01092923|101894625|FG000|COMPLETED|Overall Study||10||
48758871|NCT05131308|102197705|FG002|NOT COMPLETED|Overall Study||0||
48758872|NCT05370495|102197706|FG000|STARTED|Overall Study||50|Randomized|50
48758873|NCT05370495|102197707|FG001|STARTED|Overall Study||51|Randomized|51
48758874|NCT05370495|102197708|FG002|STARTED|Overall Study||51|Randomized|51
48758875|NCT05370495|102197709|FG003|STARTED|Overall Study||49|Randomized|49
48758876|NCT05370495|102197706|FG000|Withdraw Before Treatment|Overall Study||1||1
48758877|NCT05370495|102197707|FG001|Withdraw Before Treatment|Overall Study||0||0
48758878|NCT05370495|102197708|FG002|Withdraw Before Treatment|Overall Study||1||1
48758879|NCT05370495|102197709|FG003|Withdraw Before Treatment|Overall Study||1||1
48758880|NCT05370495|102197706|FG000|Received Investigational Product Treatment|Overall Study||49||49
48758881|NCT05370495|102197707|FG001|Received Investigational Product Treatment|Overall Study||51||51
48758882|NCT05370495|102197708|FG002|Received Investigational Product Treatment|Overall Study||50||50
48758883|NCT05370495|102197709|FG003|Received Investigational Product Treatment|Overall Study||48||48
48758884|NCT05370495|102197706|FG000|Discontinued|Overall Study||1||1
48184453|NCT03255941|100775755|FG000|COMPLETED|Overall Study||139||
48636393|NCT01092923|101894626|FG001|COMPLETED|Overall Study||10||
48636394|NCT01092923|101894625|FG000|NOT COMPLETED|Overall Study||0||
48636395|NCT01092923|101894626|FG001|NOT COMPLETED|Overall Study||0||
48636396|NCT04682301|101894627|FG000|STARTED|Overall Study||102|Includes participants in focus groups only (Aim I), the shared decision making only (Aim II), and those enrolled in both Aim I and Aim II.|
48636397|NCT04682301|101894627|FG000|COMPLETED|Overall Study||40|Includes only individuals who participated in Aim II (100% completion of individuals enrolled in Aim II).|
48636398|NCT04682301|101894627|FG000|NOT COMPLETED|Overall Study||62||
48636399|NCT00593814|101894628|FG000|STARTED|Overall Study||139||
48636400|NCT00593814|101894629|FG001|STARTED|Overall Study||120||
48636401|NCT00593814|101894628|FG000|COMPLETED|Overall Study||115||
48636402|NCT00593814|101894629|FG001|COMPLETED|Overall Study||120||
48636403|NCT00593814|101894628|FG000|NOT COMPLETED|Overall Study||24||
48636404|NCT00593814|101894629|FG001|NOT COMPLETED|Overall Study||0||
48636405|NCT03261401|101894630|FG000|STARTED|Overall Study||17||
48636406|NCT03261401|101894631|FG001|STARTED|Overall Study||6||
48636407|NCT03261401|101894632|FG002|STARTED|Overall Study||6||
48636408|NCT03261401|101894633|FG003|STARTED|Overall Study||6||
48636409|NCT03261401|101894634|FG004|STARTED|Overall Study||6||
48636410|NCT03261401|101894635|FG005|STARTED|Overall Study||6||
48636411|NCT03261401|101894636|FG006|STARTED|Overall Study||6||
48636412|NCT03261401|101894637|FG007|STARTED|Overall Study||6||
48636413|NCT03261401|101894638|FG008|STARTED|Overall Study||6||
48636414|NCT03261401|101894639|FG009|STARTED|Overall Study||1||
48636415|NCT03261401|101894640|FG010|STARTED|Overall Study||6||
48636416|NCT03261401|101894641|FG011|STARTED|Overall Study||8||
48636417|NCT03261401|101894642|FG012|STARTED|Overall Study||8||
48636418|NCT03261401|101894630|FG000|COMPLETED|Overall Study||17||
48636419|NCT03261401|101894631|FG001|COMPLETED|Overall Study||6||
48636420|NCT03261401|101894632|FG002|COMPLETED|Overall Study||6||
48636421|NCT03261401|101894633|FG003|COMPLETED|Overall Study||6||
48636422|NCT03261401|101894634|FG004|COMPLETED|Overall Study||6||
48636423|NCT03261401|101894635|FG005|COMPLETED|Overall Study||5||
48636424|NCT03261401|101894636|FG006|COMPLETED|Overall Study||6||
48636425|NCT03261401|101894637|FG007|COMPLETED|Overall Study||6||
48636426|NCT03261401|101894638|FG008|COMPLETED|Overall Study||6||
48636427|NCT03261401|101894639|FG009|COMPLETED|Overall Study||1||
48636428|NCT03261401|101894640|FG010|COMPLETED|Overall Study||6||
48636429|NCT03261401|101894641|FG011|COMPLETED|Overall Study||8||
48636430|NCT03261401|101894642|FG012|COMPLETED|Overall Study||7||
48636431|NCT03261401|101894630|FG000|NOT COMPLETED|Overall Study||0||
48636432|NCT03261401|101894631|FG001|NOT COMPLETED|Overall Study||0||
48636433|NCT03261401|101894632|FG002|NOT COMPLETED|Overall Study||0||
48636434|NCT03261401|101894633|FG003|NOT COMPLETED|Overall Study||0||
48636435|NCT03261401|101894634|FG004|NOT COMPLETED|Overall Study||0||
48636436|NCT03261401|101894635|FG005|NOT COMPLETED|Overall Study||1||
48636437|NCT03261401|101894636|FG006|NOT COMPLETED|Overall Study||0||
48636438|NCT03261401|101894637|FG007|NOT COMPLETED|Overall Study||0||
48636439|NCT03261401|101894638|FG008|NOT COMPLETED|Overall Study||0||
48758885|NCT05370495|102197707|FG001|Discontinued|Overall Study||0||0
48758886|NCT05370495|102197708|FG002|Discontinued|Overall Study||0||0
48758887|NCT05370495|102197709|FG003|Discontinued|Overall Study||2||2
48758888|NCT05370495|102197706|FG000|COMPLETED|Overall Study||48||48
48758889|NCT05370495|102197707|FG001|COMPLETED|Overall Study||51||51
48758890|NCT05370495|102197708|FG002|COMPLETED|Overall Study||50||50
48758891|NCT05370495|102197709|FG003|COMPLETED|Overall Study||46||46
48758892|NCT05370495|102197706|FG000|NOT COMPLETED|Overall Study||2||2
48758893|NCT05370495|102197707|FG001|NOT COMPLETED|Overall Study||0||0
48758894|NCT05370495|102197708|FG002|NOT COMPLETED|Overall Study||1||1
48636440|NCT03261401|101894639|FG009|NOT COMPLETED|Overall Study||0||
48414953|NCT02394028|101350177|FG002|COMPLETED|Maintenance Phase||0||
48414954|NCT02394028|101350178|FG003|COMPLETED|Maintenance Phase||0||
48414955|NCT02394028|101350179|FG004|COMPLETED|Maintenance Phase||0||
48414956|NCT02394028|101350180|FG005|COMPLETED|Maintenance Phase||0||
48414957|NCT02394028|101350181|FG006|COMPLETED|Maintenance Phase||0||
48414958|NCT02394028|101350182|FG007|COMPLETED|Maintenance Phase||0||
48414959|NCT02394028|101350183|FG008|COMPLETED|Maintenance Phase||41||
48414960|NCT02394028|101350184|FG009|COMPLETED|Maintenance Phase||175||
48414961|NCT02394028|101350185|FG010|COMPLETED|Maintenance Phase||165||
48414962|NCT02394028|101350175|FG000|NOT COMPLETED|Maintenance Phase||0||
48414963|NCT02394028|101350176|FG001|NOT COMPLETED|Maintenance Phase||0||
48414964|NCT02394028|101350177|FG002|NOT COMPLETED|Maintenance Phase||0||
48414965|NCT02394028|101350178|FG003|NOT COMPLETED|Maintenance Phase||0||
48414966|NCT02394028|101350179|FG004|NOT COMPLETED|Maintenance Phase||0||
48414967|NCT02394028|101350180|FG005|NOT COMPLETED|Maintenance Phase||0||
48414968|NCT02394028|101350181|FG006|NOT COMPLETED|Maintenance Phase||0||
48414969|NCT02394028|101350182|FG007|NOT COMPLETED|Maintenance Phase||0||
48414970|NCT02394028|101350183|FG008|NOT COMPLETED|Maintenance Phase||12||
48414971|NCT02394028|101350184|FG009|NOT COMPLETED|Maintenance Phase||42||
48414972|NCT02394028|101350185|FG010|NOT COMPLETED|Maintenance Phase||52||
48414973|NCT00517634|101350186|FG000|STARTED|First Treatment Period||4||
48414974|NCT00517634|101350187|FG001|STARTED|First Treatment Period||4||
48414975|NCT00517634|101350188|FG002|STARTED|First Treatment Period||4||
48414976|NCT00517634|101350189|FG003|STARTED|First Treatment Period||3||
48414977|NCT00517634|101350190|FG004|STARTED|First Treatment Period||4||
48414978|NCT00517634|101350191|FG005|STARTED|First Treatment Period||4||
48414979|NCT00517634|101350186|FG000|COMPLETED|First Treatment Period||4||
48414980|NCT00517634|101350187|FG001|COMPLETED|First Treatment Period||4||
48414981|NCT00517634|101350188|FG002|COMPLETED|First Treatment Period||4||
48414982|NCT00517634|101350189|FG003|COMPLETED|First Treatment Period||3||
48414983|NCT00517634|101350190|FG004|COMPLETED|First Treatment Period||4||
48414984|NCT00517634|101350191|FG005|COMPLETED|First Treatment Period||4||
48414985|NCT00517634|101350186|FG000|NOT COMPLETED|First Treatment Period||0||
48414986|NCT00517634|101350187|FG001|NOT COMPLETED|First Treatment Period||0||
48414987|NCT00517634|101350188|FG002|NOT COMPLETED|First Treatment Period||0||
48414988|NCT00517634|101350189|FG003|NOT COMPLETED|First Treatment Period||0||
48414989|NCT00517634|101350190|FG004|NOT COMPLETED|First Treatment Period||0||
48414990|NCT00517634|101350191|FG005|NOT COMPLETED|First Treatment Period||0||
48414991|NCT00517634|101350186|FG000|STARTED|Second Treatment Period||4||
48414992|NCT00517634|101350187|FG001|STARTED|Second Treatment Period||4||
48414993|NCT00517634|101350188|FG002|STARTED|Second Treatment Period||4||
48414994|NCT00517634|101350189|FG003|STARTED|Second Treatment Period||3||
48414995|NCT00517634|101350190|FG004|STARTED|Second Treatment Period||4||
48414996|NCT00517634|101350191|FG005|STARTED|Second Treatment Period||4||
48414997|NCT00517634|101350186|FG000|COMPLETED|Second Treatment Period||4||
48414998|NCT00517634|101350187|FG001|COMPLETED|Second Treatment Period||4||
48414999|NCT00517634|101350188|FG002|COMPLETED|Second Treatment Period||4||
48415000|NCT00517634|101350189|FG003|COMPLETED|Second Treatment Period||3||
48415001|NCT00517634|101350190|FG004|COMPLETED|Second Treatment Period||3||
48415002|NCT00517634|101350191|FG005|COMPLETED|Second Treatment Period||4||
48415003|NCT00517634|101350186|FG000|NOT COMPLETED|Second Treatment Period||0||
48415004|NCT00517634|101350187|FG001|NOT COMPLETED|Second Treatment Period||0||
48415005|NCT00517634|101350188|FG002|NOT COMPLETED|Second Treatment Period||0||
48415006|NCT00517634|101350189|FG003|NOT COMPLETED|Second Treatment Period||0||
48415007|NCT00517634|101350190|FG004|NOT COMPLETED|Second Treatment Period||1||
48415008|NCT00517634|101350191|FG005|NOT COMPLETED|Second Treatment Period||0||
48415009|NCT00517634|101350186|FG000|STARTED|Third Treatment Period||4||
48415010|NCT00517634|101350187|FG001|STARTED|Third Treatment Period||4||
48415011|NCT00517634|101350188|FG002|STARTED|Third Treatment Period||4||
48415012|NCT00517634|101350189|FG003|STARTED|Third Treatment Period||3||
48415013|NCT00517634|101350190|FG004|STARTED|Third Treatment Period||3||
48415014|NCT00517634|101350191|FG005|STARTED|Third Treatment Period||4||
48415015|NCT00517634|101350186|FG000|COMPLETED|Third Treatment Period||4||
48415016|NCT00517634|101350187|FG001|COMPLETED|Third Treatment Period||4||
48415017|NCT00517634|101350188|FG002|COMPLETED|Third Treatment Period||4||
48415018|NCT00517634|101350189|FG003|COMPLETED|Third Treatment Period||3||
48415019|NCT00517634|101350190|FG004|COMPLETED|Third Treatment Period||3||
48415020|NCT00517634|101350191|FG005|COMPLETED|Third Treatment Period||4||
48415021|NCT00517634|101350186|FG000|NOT COMPLETED|Third Treatment Period||0||
48415022|NCT00517634|101350187|FG001|NOT COMPLETED|Third Treatment Period||0||
48415023|NCT00517634|101350188|FG002|NOT COMPLETED|Third Treatment Period||0||
48415024|NCT00517634|101350189|FG003|NOT COMPLETED|Third Treatment Period||0||
48636441|NCT03261401|101894640|FG010|NOT COMPLETED|Overall Study||0||
48415025|NCT00517634|101350190|FG004|NOT COMPLETED|Third Treatment Period||0||
48415026|NCT00517634|101350191|FG005|NOT COMPLETED|Third Treatment Period||0||
48415027|NCT02407236|101350192|FG000|STARTED|Induction Study (8 Weeks)||319||
48415028|NCT02407236|101350193|FG001|STARTED|Induction Study (8 Weeks)||320||
48415029|NCT02407236|101350194|FG002|STARTED|Induction Study (8 Weeks)||322||
48415030|NCT02407236|101350195|FG003|STARTED|Induction Study (8 Weeks)||0||
48415031|NCT02407236|101350196|FG004|STARTED|Induction Study (8 Weeks)||0||
48636442|NCT03261401|101894641|FG011|NOT COMPLETED|Overall Study||0||
48636443|NCT03261401|101894642|FG012|NOT COMPLETED|Overall Study||1||
48636444|NCT01950663|101894643|FG000|STARTED|Overall Study||468||
48636445|NCT01950663|101894643|FG000|COMPLETED|Overall Study||467||
48636446|NCT01950663|101894643|FG000|NOT COMPLETED|Overall Study||1||
48636447|NCT01240694|101894644|FG000|STARTED|Overall Study||136||
48636448|NCT01240694|101894644|FG000|Received at Least 1 Dose of Study Drug|Overall Study||136||
48636449|NCT01240694|101894644|FG000|COMPLETED|Overall Study||1||
48636450|NCT01240694|101894644|FG000|NOT COMPLETED|Overall Study||135||
48636451|NCT01126424|101894645|FG000|STARTED|Overall Study||3||
48636452|NCT01126424|101894646|FG001|STARTED|Overall Study||4||
48636453|NCT01126424|101894647|FG002|STARTED|Overall Study||5||
48636454|NCT01126424|101894648|FG003|STARTED|Overall Study||6||
48636455|NCT01126424|101894649|FG004|STARTED|Overall Study||4||
48636456|NCT01126424|101894650|FG005|STARTED|Overall Study||4||
48636457|NCT01126424|101894645|FG000|Safety Analysis Subset 1 (SAF 1)|Overall Study||3||
48345088|NCT01324830|101172480|FG009|NOT COMPLETED|Overall Study||6||
48345089|NCT01324830|101172481|FG010|NOT COMPLETED|Overall Study||4||
48345090|NCT01324830|101172482|FG011|NOT COMPLETED|Overall Study||1||
48345091|NCT01324830|101172483|FG012|NOT COMPLETED|Overall Study||1||
48345092|NCT01324830|101172484|FG013|NOT COMPLETED|Overall Study||1||
48345093|NCT01324830|101172485|FG014|NOT COMPLETED|Overall Study||1||
48345094|NCT01324830|101172486|FG015|NOT COMPLETED|Overall Study||3||
48345095|NCT01324830|101172487|FG016|NOT COMPLETED|Overall Study||3||
48345096|NCT01324830|101172488|FG017|NOT COMPLETED|Overall Study||6||
48345097|NCT01324830|101172489|FG018|NOT COMPLETED|Overall Study||6||
48345098|NCT00716976|101172490|FG000|STARTED|Overall Study||65||
48345099|NCT00716976|101172491|FG001|STARTED|Overall Study||66||
48345100|NCT00716976|101172490|FG000|COMPLETED|Overall Study||45||
48345101|NCT00716976|101172491|FG001|COMPLETED|Overall Study||57||
48345102|NCT00716976|101172490|FG000|NOT COMPLETED|Overall Study||20||
48345103|NCT00716976|101172491|FG001|NOT COMPLETED|Overall Study||9||
48345104|NCT00868790|101172492|FG000|STARTED|Period 1||11||
48345105|NCT00868790|101172493|FG001|STARTED|Period 1||8||
48345106|NCT00868790|101172494|FG002|STARTED|Period 1||4||
48345107|NCT00868790|101172495|FG003|STARTED|Period 1||4||
48345108|NCT00868790|101172496|FG004|STARTED|Period 1||19||
48345109|NCT00868790|101172497|FG005|STARTED|Period 1||3||
48345110|NCT00868790|101172498|FG006|STARTED|Period 1||4||
48345111|NCT00868790|101172499|FG007|STARTED|Period 1||20||
48345112|NCT00868790|101172500|FG008|STARTED|Period 1||11||
48345113|NCT00868790|101172501|FG009|STARTED|Period 1||3||
48345114|NCT00868790|101172502|FG010|STARTED|Period 1||9||
48345115|NCT00868790|101172503|FG011|STARTED|Period 1||4||
48345116|NCT00868790|101172504|FG012|STARTED|Period 1||7||
48345117|NCT00868790|101172505|FG013|STARTED|Period 1||11||
48345118|NCT00868790|101172492|FG000|COMPLETED|Period 1||9||
48345119|NCT00868790|101172493|FG001|COMPLETED|Period 1||7||
48345120|NCT00868790|101172494|FG002|COMPLETED|Period 1||4||
48636458|NCT01126424|101894646|FG001|Safety Analysis Subset 1 (SAF 1)|Overall Study||4||
48636459|NCT01126424|101894647|FG002|Safety Analysis Subset 1 (SAF 1)|Overall Study||4||
48636460|NCT01126424|101894648|FG003|Safety Analysis Subset 1 (SAF 1)|Overall Study||4||
48636461|NCT01126424|101894649|FG004|Safety Analysis Subset 1 (SAF 1)|Overall Study||4||
48636462|NCT01126424|101894650|FG005|Safety Analysis Subset 1 (SAF 1)|Overall Study||4||
48636463|NCT01126424|101894645|FG000|COMPLETED|Overall Study||3||
48636464|NCT01126424|101894646|FG001|COMPLETED|Overall Study||4||
48636465|NCT01126424|101894647|FG002|COMPLETED|Overall Study||4||
48636466|NCT01126424|101894648|FG003|COMPLETED|Overall Study||3||
48636467|NCT01126424|101894649|FG004|COMPLETED|Overall Study||2||
48636468|NCT01126424|101894650|FG005|COMPLETED|Overall Study||4||
48636469|NCT01126424|101894645|FG000|NOT COMPLETED|Overall Study||0||
48636470|NCT01126424|101894646|FG001|NOT COMPLETED|Overall Study||0||
48636471|NCT01126424|101894647|FG002|NOT COMPLETED|Overall Study||1||
48636472|NCT01126424|101894648|FG003|NOT COMPLETED|Overall Study||3||
48636473|NCT01126424|101894649|FG004|NOT COMPLETED|Overall Study||2||
48636474|NCT01126424|101894650|FG005|NOT COMPLETED|Overall Study||0||
48636475|NCT02741284|101894651|FG000|STARTED|Overall Study||57||
48345121|NCT00868790|101172495|FG003|COMPLETED|Period 1||4||
48345122|NCT00868790|101172496|FG004|COMPLETED|Period 1||18||
48345123|NCT00868790|101172497|FG005|COMPLETED|Period 1||2||
48345124|NCT00868790|101172498|FG006|COMPLETED|Period 1||4||
48345125|NCT00868790|101172499|FG007|COMPLETED|Period 1||17||
48345126|NCT00868790|101172500|FG008|COMPLETED|Period 1||10||
48636476|NCT02741284|101894652|FG001|STARTED|Overall Study||57||
48636477|NCT02741284|101894651|FG000|COMPLETED|Overall Study||51||
48636478|NCT02741284|101894652|FG001|COMPLETED|Overall Study||48||
48636479|NCT02741284|101894651|FG000|NOT COMPLETED|Overall Study||6||
48345127|NCT00868790|101172501|FG009|COMPLETED|Period 1||3||
48345128|NCT00868790|101172502|FG010|COMPLETED|Period 1||9||
48345129|NCT00868790|101172503|FG011|COMPLETED|Period 1||4||
48345130|NCT00868790|101172504|FG012|COMPLETED|Period 1||7||
48345131|NCT00868790|101172505|FG013|COMPLETED|Period 1||9||
48345132|NCT00868790|101172492|FG000|NOT COMPLETED|Period 1||2||
48345133|NCT00868790|101172493|FG001|NOT COMPLETED|Period 1||1||
48636480|NCT02741284|101894652|FG001|NOT COMPLETED|Overall Study||9||
48636481|NCT03901300|101894653|FG000|STARTED|Overall Study||35||
48415032|NCT02407236|101350197|FG005|STARTED|Induction Study (8 Weeks)||0||
48415033|NCT02407236|101350198|FG006|STARTED|Induction Study (8 Weeks)||0||
48415034|NCT02407236|101350199|FG007|STARTED|Induction Study (8 Weeks)||0||
48415035|NCT02407236|101350200|FG008|STARTED|Induction Study (8 Weeks)||0||
48415036|NCT02407236|101350201|FG009|STARTED|Induction Study (8 Weeks)||0||
48415037|NCT02407236|101350202|FG010|STARTED|Induction Study (8 Weeks)||0||
48415038|NCT02407236|101350203|FG011|STARTED|Induction Study (8 Weeks)||0||
48415039|NCT02407236|101350204|FG012|STARTED|Induction Study (8 Weeks)||0||
48415040|NCT02407236|101350192|FG000|COMPLETED|Induction Study (8 Weeks)||296||
48415041|NCT02407236|101350193|FG001|COMPLETED|Induction Study (8 Weeks)||309||
48415042|NCT02407236|101350194|FG002|COMPLETED|Induction Study (8 Weeks)||307||
48415043|NCT02407236|101350195|FG003|COMPLETED|Induction Study (8 Weeks)||0||
48415044|NCT02407236|101350196|FG004|COMPLETED|Induction Study (8 Weeks)||0||
48415045|NCT02407236|101350197|FG005|COMPLETED|Induction Study (8 Weeks)||0||
48415046|NCT02407236|101350198|FG006|COMPLETED|Induction Study (8 Weeks)||0||
48415047|NCT02407236|101350199|FG007|COMPLETED|Induction Study (8 Weeks)||0||
48415048|NCT02407236|101350200|FG008|COMPLETED|Induction Study (8 Weeks)||0||
48415049|NCT02407236|101350201|FG009|COMPLETED|Induction Study (8 Weeks)||0||
48415050|NCT02407236|101350202|FG010|COMPLETED|Induction Study (8 Weeks)||0||
48415051|NCT02407236|101350203|FG011|COMPLETED|Induction Study (8 Weeks)||0||
48415052|NCT02407236|101350204|FG012|COMPLETED|Induction Study (8 Weeks)||0||
48415053|NCT02407236|101350192|FG000|NOT COMPLETED|Induction Study (8 Weeks)||23||
48415054|NCT02407236|101350193|FG001|NOT COMPLETED|Induction Study (8 Weeks)||11||
48415055|NCT02407236|101350194|FG002|NOT COMPLETED|Induction Study (8 Weeks)||15||
48415056|NCT02407236|101350195|FG003|NOT COMPLETED|Induction Study (8 Weeks)||0||
48415057|NCT02407236|101350196|FG004|NOT COMPLETED|Induction Study (8 Weeks)||0||
48415058|NCT02407236|101350197|FG005|NOT COMPLETED|Induction Study (8 Weeks)||0||
48415059|NCT02407236|101350198|FG006|NOT COMPLETED|Induction Study (8 Weeks)||0||
48415060|NCT02407236|101350199|FG007|NOT COMPLETED|Induction Study (8 Weeks)||0||
48415061|NCT02407236|101350200|FG008|NOT COMPLETED|Induction Study (8 Weeks)||0||
48415062|NCT02407236|101350201|FG009|NOT COMPLETED|Induction Study (8 Weeks)||0||
48415063|NCT02407236|101350202|FG010|NOT COMPLETED|Induction Study (8 Weeks)||0||
48415064|NCT02407236|101350203|FG011|NOT COMPLETED|Induction Study (8 Weeks)||0||
48415065|NCT02407236|101350204|FG012|NOT COMPLETED|Induction Study (8 Weeks)||0||
48415066|NCT02407236|101350192|FG000|STARTED|Maintenance Study (44 Weeks)||0||
48415067|NCT02407236|101350193|FG001|STARTED|Maintenance Study (44 Weeks)||0||
48415068|NCT02407236|101350194|FG002|STARTED|Maintenance Study (44 Weeks)||0||
48415069|NCT02407236|101350195|FG003|STARTED|Maintenance Study (44 Weeks)||175||
48415070|NCT02407236|101350196|FG004|STARTED|Maintenance Study (44 Weeks)||172||
48415071|NCT02407236|101350197|FG005|STARTED|Maintenance Study (44 Weeks)||176||
48415072|NCT02407236|101350198|FG006|STARTED|Maintenance Study (44 Weeks)||103||
48415073|NCT02407236|101350199|FG007|STARTED|Maintenance Study (44 Weeks)||157||
48415074|NCT02407236|101350200|FG008|STARTED|Maintenance Study (44 Weeks)||0||
48415075|NCT02407236|101350201|FG009|STARTED|Maintenance Study (44 Weeks)||0||
48415076|NCT02407236|101350202|FG010|STARTED|Maintenance Study (44 Weeks)||0||
48415077|NCT02407236|101350203|FG011|STARTED|Maintenance Study (44 Weeks)||0||
48415078|NCT02407236|101350204|FG012|STARTED|Maintenance Study (44 Weeks)||0||
48415079|NCT02407236|101350192|FG000|COMPLETED|Maintenance Study (44 Weeks)||0||
48415080|NCT02407236|101350193|FG001|COMPLETED|Maintenance Study (44 Weeks)||0||
48415081|NCT02407236|101350194|FG002|COMPLETED|Maintenance Study (44 Weeks)||0||
48415082|NCT02407236|101350195|FG003|COMPLETED|Maintenance Study (44 Weeks)||132||
48415083|NCT02407236|101350196|FG004|COMPLETED|Maintenance Study (44 Weeks)||148||
48415084|NCT02407236|101350197|FG005|COMPLETED|Maintenance Study (44 Weeks)||158||
48415085|NCT02407236|101350198|FG006|COMPLETED|Maintenance Study (44 Weeks)||76||
48415086|NCT02407236|101350199|FG007|COMPLETED|Maintenance Study (44 Weeks)||128||
48415087|NCT02407236|101350200|FG008|COMPLETED|Maintenance Study (44 Weeks)||0||
48415088|NCT02407236|101350201|FG009|COMPLETED|Maintenance Study (44 Weeks)||0||
48415089|NCT02407236|101350202|FG010|COMPLETED|Maintenance Study (44 Weeks)||0||
48415090|NCT02407236|101350203|FG011|COMPLETED|Maintenance Study (44 Weeks)||0||
48415091|NCT02407236|101350204|FG012|COMPLETED|Maintenance Study (44 Weeks)||0||
48415092|NCT02407236|101350192|FG000|NOT COMPLETED|Maintenance Study (44 Weeks)||0||
48415093|NCT02407236|101350193|FG001|NOT COMPLETED|Maintenance Study (44 Weeks)||0||
48415094|NCT02407236|101350194|FG002|NOT COMPLETED|Maintenance Study (44 Weeks)||0||
48415095|NCT02407236|101350195|FG003|NOT COMPLETED|Maintenance Study (44 Weeks)||43||
48415096|NCT02407236|101350196|FG004|NOT COMPLETED|Maintenance Study (44 Weeks)||24||
48415097|NCT02407236|101350197|FG005|NOT COMPLETED|Maintenance Study (44 Weeks)||18||
48415098|NCT02407236|101350198|FG006|NOT COMPLETED|Maintenance Study (44 Weeks)||27||
48415099|NCT02407236|101350199|FG007|NOT COMPLETED|Maintenance Study (44 Weeks)||29||
48415100|NCT02407236|101350200|FG008|NOT COMPLETED|Maintenance Study (44 Weeks)||0||
48415101|NCT02407236|101350201|FG009|NOT COMPLETED|Maintenance Study (44 Weeks)||0||
48415102|NCT02407236|101350202|FG010|NOT COMPLETED|Maintenance Study (44 Weeks)||0||
48415103|NCT02407236|101350203|FG011|NOT COMPLETED|Maintenance Study (44 Weeks)||0||
48415104|NCT02407236|101350204|FG012|NOT COMPLETED|Maintenance Study (44 Weeks)||0||
48415105|NCT02407236|101350192|FG000|STARTED|Long-term Extension Period (176 Weeks)||0||
48415106|NCT02407236|101350193|FG001|STARTED|Long-term Extension Period (176 Weeks)||0||
48345134|NCT00868790|101172494|FG002|NOT COMPLETED|Period 1||0||
48345135|NCT00868790|101172495|FG003|NOT COMPLETED|Period 1||0||
48345136|NCT00868790|101172496|FG004|NOT COMPLETED|Period 1||1||
48345137|NCT00868790|101172497|FG005|NOT COMPLETED|Period 1||1||
48345138|NCT00868790|101172498|FG006|NOT COMPLETED|Period 1||0||
48345139|NCT00868790|101172499|FG007|NOT COMPLETED|Period 1||3||
48345140|NCT00868790|101172500|FG008|NOT COMPLETED|Period 1||1||
48345141|NCT00868790|101172501|FG009|NOT COMPLETED|Period 1||0||
48345142|NCT00868790|101172502|FG010|NOT COMPLETED|Period 1||0||
48345143|NCT00868790|101172503|FG011|NOT COMPLETED|Period 1||0||
48345144|NCT00868790|101172504|FG012|NOT COMPLETED|Period 1||0||
48345145|NCT00868790|101172505|FG013|NOT COMPLETED|Period 1||2||
48345146|NCT00868790|101172492|FG000|STARTED|Period 2||9||
48345147|NCT00868790|101172493|FG001|STARTED|Period 2||7||
48345148|NCT00868790|101172494|FG002|STARTED|Period 2||4||
48345149|NCT00868790|101172495|FG003|STARTED|Period 2||4||
48345150|NCT00868790|101172496|FG004|STARTED|Period 2||18||
48345151|NCT00868790|101172497|FG005|STARTED|Period 2||2||
48345152|NCT00868790|101172498|FG006|STARTED|Period 2||4||
48345153|NCT00868790|101172499|FG007|STARTED|Period 2||17||
48345154|NCT00868790|101172500|FG008|STARTED|Period 2||10||
48345155|NCT00868790|101172501|FG009|STARTED|Period 2||3||
48345156|NCT00868790|101172502|FG010|STARTED|Period 2||9||
48345157|NCT00868790|101172503|FG011|STARTED|Period 2||4||
48345158|NCT00868790|101172504|FG012|STARTED|Period 2||7||
48345159|NCT00868790|101172505|FG013|STARTED|Period 2||9||
48345160|NCT00868790|101172492|FG000|COMPLETED|Period 2||9||
48345161|NCT00868790|101172493|FG001|COMPLETED|Period 2||6||
48345162|NCT00868790|101172494|FG002|COMPLETED|Period 2||4||
48345163|NCT00868790|101172495|FG003|COMPLETED|Period 2||4||
48345164|NCT00868790|101172496|FG004|COMPLETED|Period 2||18||
48345165|NCT00868790|101172497|FG005|COMPLETED|Period 2||1||
48345166|NCT00868790|101172498|FG006|COMPLETED|Period 2||4||
48345167|NCT00868790|101172499|FG007|COMPLETED|Period 2||17||
48345168|NCT00868790|101172500|FG008|COMPLETED|Period 2||8||
48345169|NCT00868790|101172501|FG009|COMPLETED|Period 2||3||
48345170|NCT00868790|101172502|FG010|COMPLETED|Period 2||9||
48345171|NCT00868790|101172503|FG011|COMPLETED|Period 2||4||
48758895|NCT05370495|102197709|FG003|NOT COMPLETED|Overall Study||3||3
48758896|NCT05291520|102197710|FG000|STARTED|Overall Study||8||
48758897|NCT05291520|102197711|FG001|STARTED|Overall Study||8||
48758898|NCT05291520|102197712|FG002|STARTED|Overall Study||8||
48758899|NCT05291520|102197710|FG000|COMPLETED|Overall Study||8||
48758900|NCT05291520|102197711|FG001|COMPLETED|Overall Study||8||
48758901|NCT05291520|102197712|FG002|COMPLETED|Overall Study||7||
48758902|NCT05291520|102197710|FG000|NOT COMPLETED|Overall Study||0||
48758903|NCT05291520|102197711|FG001|NOT COMPLETED|Overall Study||0||
48758904|NCT05291520|102197712|FG002|NOT COMPLETED|Overall Study||1||
48758905|NCT01827137|102197713|FG000|STARTED|Overall Study||20||
48758906|NCT01827137|102197713|FG000|COMPLETED|Overall Study||19||
48758907|NCT01827137|102197713|FG000|NOT COMPLETED|Overall Study||1||
48758908|NCT03284710|102197714|FG000|STARTED|Overall Study||36||
48758909|NCT03284710|102197715|FG001|STARTED|Overall Study||36||
48758910|NCT03284710|102197716|FG002|STARTED|Overall Study||36||
48758911|NCT03284710|102197717|FG003|STARTED|Overall Study||24||
48758912|NCT03284710|102197714|FG000|Month 6.5 Immunogenicity Timepoint|Overall Study||31||
48758913|NCT03284710|102197715|FG001|Month 6.5 Immunogenicity Timepoint|Overall Study||31||
48758914|NCT03284710|102197716|FG002|Month 6.5 Immunogenicity Timepoint|Overall Study||31||
48758915|NCT03284710|102197717|FG003|Month 6.5 Immunogenicity Timepoint|Overall Study||18||
48758916|NCT03284710|102197714|FG000|Month 12 Immunogenicity Timepoint|Overall Study||30||
48758917|NCT03284710|102197715|FG001|Month 12 Immunogenicity Timepoint|Overall Study||31||
48758918|NCT03284710|102197716|FG002|Month 12 Immunogenicity Timepoint|Overall Study||31||
48758919|NCT03284710|102197717|FG003|Month 12 Immunogenicity Timepoint|Overall Study||17||
48758920|NCT03284710|102197714|FG000|Month 12.5 Immunogenicity Timepoint|Overall Study||0||
48758921|NCT03284710|102197715|FG001|Month 12.5 Immunogenicity Timepoint|Overall Study||0||
48758922|NCT03284710|102197716|FG002|Month 12.5 Immunogenicity Timepoint|Overall Study||0||
48758923|NCT03284710|102197717|FG003|Month 12.5 Immunogenicity Timepoint|Overall Study||0||
48758924|NCT03284710|102197714|FG000|Month 18 Immunogenicity Timepoint|Overall Study||0||
48758925|NCT03284710|102197715|FG001|Month 18 Immunogenicity Timepoint|Overall Study||0||
48758926|NCT03284710|102197716|FG002|Month 18 Immunogenicity Timepoint|Overall Study||0||
48758927|NCT03284710|102197717|FG003|Month 18 Immunogenicity Timepoint|Overall Study||0||
48758928|NCT03284710|102197714|FG000|COMPLETED|Overall Study||30||
48758929|NCT03284710|102197715|FG001|COMPLETED|Overall Study||31||
48758930|NCT03284710|102197716|FG002|COMPLETED|Overall Study||32||
48345172|NCT00868790|101172504|FG012|COMPLETED|Period 2||7||
48345173|NCT00868790|101172505|FG013|COMPLETED|Period 2||8||
48345174|NCT00868790|101172492|FG000|NOT COMPLETED|Period 2||0||
48345175|NCT00868790|101172493|FG001|NOT COMPLETED|Period 2||1||
48345176|NCT00868790|101172494|FG002|NOT COMPLETED|Period 2||0||
48758931|NCT03284710|102197717|FG003|COMPLETED|Overall Study||16||
48758932|NCT03284710|102197714|FG000|NOT COMPLETED|Overall Study||6||
48345177|NCT00868790|101172495|FG003|NOT COMPLETED|Period 2||0||
48345178|NCT00868790|101172496|FG004|NOT COMPLETED|Period 2||0||
48345179|NCT00868790|101172497|FG005|NOT COMPLETED|Period 2||1||
48345180|NCT00868790|101172498|FG006|NOT COMPLETED|Period 2||0||
48758933|NCT03284710|102197715|FG001|NOT COMPLETED|Overall Study||5||
48758934|NCT03284710|102197716|FG002|NOT COMPLETED|Overall Study||4||
48758935|NCT03284710|102197717|FG003|NOT COMPLETED|Overall Study||8||
48758936|NCT04607668|102197718|FG000|STARTED|Overall Study||164|All patients in the ITT population.|
48758937|NCT04607668|102197719|FG001|STARTED|Overall Study||162|All patients in the ITT population.|
48758938|NCT04607668|102197718|FG000|Patients With ≥ 1 Dose of Study Drug, n (%)|Overall Study||159||
48758939|NCT04607668|102197719|FG001|Patients With ≥ 1 Dose of Study Drug, n (%)|Overall Study||160||
48345181|NCT00868790|101172499|FG007|NOT COMPLETED|Period 2||0||
48345182|NCT00868790|101172500|FG008|NOT COMPLETED|Period 2||2||
48345183|NCT00868790|101172501|FG009|NOT COMPLETED|Period 2||0||
48345184|NCT00868790|101172502|FG010|NOT COMPLETED|Period 2||0||
48345185|NCT00868790|101172503|FG011|NOT COMPLETED|Period 2||0||
48758940|NCT04607668|102197718|FG000|COMPLETED|Overall Study||0||
48758941|NCT04607668|102197719|FG001|COMPLETED|Overall Study||0||
48758942|NCT04607668|102197718|FG000|NOT COMPLETED|Overall Study||164||
48758943|NCT04607668|102197719|FG001|NOT COMPLETED|Overall Study||162||
48758944|NCT02953652|102197720|FG000|STARTED|Overall Study||55||
48758945|NCT02953652|102197720|FG000|COMPLETED|Overall Study||3||
48758946|NCT02953652|102197720|FG000|NOT COMPLETED|Overall Study||52||
48758947|NCT03547518|102197721|FG000|STARTED|Overall Study||13||
48758948|NCT03547518|102197722|FG001|STARTED|Overall Study||12||
48758949|NCT03547518|102197721|FG000|COMPLETED|Overall Study||11||
48758950|NCT03547518|102197722|FG001|COMPLETED|Overall Study||12||
48758951|NCT03547518|102197721|FG000|NOT COMPLETED|Overall Study||2||
48758952|NCT03547518|102197722|FG001|NOT COMPLETED|Overall Study||0||
48758953|NCT04204447|102197723|FG000|STARTED|Overall Study||90||
48758954|NCT04204447|102197724|FG001|STARTED|Overall Study||86||
48758955|NCT04204447|102197723|FG000|COMPLETED|Overall Study||83||
48758956|NCT04204447|102197724|FG001|COMPLETED|Overall Study||81||
48758957|NCT04204447|102197723|FG000|NOT COMPLETED|Overall Study||7||
48758958|NCT04204447|102197724|FG001|NOT COMPLETED|Overall Study||5||
48758959|NCT03019406|102197725|FG000|STARTED|PAP: up to 25 Weeks||6||
48758960|NCT03019406|102197726|FG001|STARTED|PAP: up to 25 Weeks||5||
48758961|NCT03019406|102197727|FG002|STARTED|PAP: up to 25 Weeks||5||
48758962|NCT03019406|102197728|FG003|STARTED|PAP: up to 25 Weeks||6||
48758963|NCT03019406|102197725|FG000|Treated|PAP: up to 25 Weeks||6||
48758964|NCT03019406|102197726|FG001|Treated|PAP: up to 25 Weeks||5||
48758965|NCT03019406|102197727|FG002|Treated|PAP: up to 25 Weeks||5||
48758966|NCT03019406|102197728|FG003|Treated|PAP: up to 25 Weeks||6||
48758967|NCT03019406|102197725|FG000|COMPLETED|PAP: up to 25 Weeks||6||
48758968|NCT03019406|102197726|FG001|COMPLETED|PAP: up to 25 Weeks||5||
48758969|NCT03019406|102197727|FG002|COMPLETED|PAP: up to 25 Weeks||5||
48758970|NCT03019406|102197728|FG003|COMPLETED|PAP: up to 25 Weeks||6||
48758971|NCT03019406|102197725|FG000|NOT COMPLETED|PAP: up to 25 Weeks||0||
48758972|NCT03019406|102197726|FG001|NOT COMPLETED|PAP: up to 25 Weeks||0||
48345186|NCT00868790|101172504|FG012|NOT COMPLETED|Period 2||0||
48345187|NCT00868790|101172505|FG013|NOT COMPLETED|Period 2||1||
48345188|NCT00868790|101172492|FG000|STARTED|Period 3||9||
48758973|NCT03019406|102197727|FG002|NOT COMPLETED|PAP: up to 25 Weeks||0||
48758974|NCT03019406|102197728|FG003|NOT COMPLETED|PAP: up to 25 Weeks||0||
48758975|NCT03019406|102197725|FG000|STARTED|ETP: Ongoing From Week 26||6||
48758976|NCT03019406|102197726|FG001|STARTED|ETP: Ongoing From Week 26||5||
48758977|NCT03019406|102197727|FG002|STARTED|ETP: Ongoing From Week 26||5||
48758978|NCT03019406|102197728|FG003|STARTED|ETP: Ongoing From Week 26||3||
48758979|NCT03019406|102197725|FG000|COMPLETED|ETP: Ongoing From Week 26||0||
48758980|NCT03019406|102197726|FG001|COMPLETED|ETP: Ongoing From Week 26||0||
48758981|NCT03019406|102197727|FG002|COMPLETED|ETP: Ongoing From Week 26||0||
48758982|NCT03019406|102197728|FG003|COMPLETED|ETP: Ongoing From Week 26||0||
48758983|NCT03019406|102197725|FG000|NOT COMPLETED|ETP: Ongoing From Week 26||6||
48758984|NCT03019406|102197726|FG001|NOT COMPLETED|ETP: Ongoing From Week 26||5||
48758985|NCT03019406|102197727|FG002|NOT COMPLETED|ETP: Ongoing From Week 26||5||
48758986|NCT03019406|102197728|FG003|NOT COMPLETED|ETP: Ongoing From Week 26||3||
48758987|NCT03035032|102197729|FG000|STARTED|Overall Study||107||
48758988|NCT03035032|102197729|FG000|COMPLETED|Overall Study||64||
48758989|NCT03035032|102197729|FG000|NOT COMPLETED|Overall Study||43||
48758990|NCT04607005|102197730|FG000|STARTED|Overall Study||84||
48345189|NCT00868790|101172493|FG001|STARTED|Period 3||6||
48758991|NCT04607005|102197731|FG001|STARTED|Overall Study||85||
48758992|NCT04607005|102197730|FG000|Intent-to-Treat Population|Overall Study||84||
48758993|NCT04607005|102197731|FG001|Intent-to-Treat Population|Overall Study||85||
48758994|NCT04607005|102197730|FG000|Intent-to-Treat Population Excluding Non GCP Sites|Overall Study||80||
48758995|NCT04607005|102197731|FG001|Intent-to-Treat Population Excluding Non GCP Sites|Overall Study||83||
48758996|NCT04607005|102197730|FG000|COMPLETED|Overall Study||78||
48758997|NCT04607005|102197731|FG001|COMPLETED|Overall Study||69||
48758998|NCT04607005|102197730|FG000|NOT COMPLETED|Overall Study||6||
48758999|NCT04607005|102197731|FG001|NOT COMPLETED|Overall Study||16||
48345190|NCT00868790|101172494|FG002|STARTED|Period 3||4||
48759000|NCT03474588|102197732|FG000|STARTED|Overall Study||28||
48759001|NCT03474588|102197733|FG001|STARTED|Overall Study||23||
48759002|NCT03474588|102197732|FG000|Follow up 1|Overall Study||27||
48759003|NCT03474588|102197733|FG001|Follow up 1|Overall Study||21||
48759004|NCT03474588|102197732|FG000|Follow up 2|Overall Study||27||
48345191|NCT00868790|101172495|FG003|STARTED|Period 3||4||
48345192|NCT00868790|101172496|FG004|STARTED|Period 3||18||
48345193|NCT00868790|101172497|FG005|STARTED|Period 3||1||
48345194|NCT00868790|101172498|FG006|STARTED|Period 3||4||
48345195|NCT00868790|101172499|FG007|STARTED|Period 3||17||
48345196|NCT00868790|101172500|FG008|STARTED|Period 3||8||
48345197|NCT00868790|101172501|FG009|STARTED|Period 3||3||
48345198|NCT00868790|101172502|FG010|STARTED|Period 3||9||
48345199|NCT00868790|101172503|FG011|STARTED|Period 3||4||
48345200|NCT00868790|101172504|FG012|STARTED|Period 3||7||
48345201|NCT00868790|101172505|FG013|STARTED|Period 3||8||
48345202|NCT00868790|101172492|FG000|COMPLETED|Period 3||9||
48345203|NCT00868790|101172493|FG001|COMPLETED|Period 3||6||
48345204|NCT00868790|101172494|FG002|COMPLETED|Period 3||4||
48345205|NCT00868790|101172495|FG003|COMPLETED|Period 3||3||
48345206|NCT00868790|101172496|FG004|COMPLETED|Period 3||18||
48345207|NCT00868790|101172497|FG005|COMPLETED|Period 3||1||
48345208|NCT00868790|101172498|FG006|COMPLETED|Period 3||4||
48345209|NCT00868790|101172499|FG007|COMPLETED|Period 3||17||
48345210|NCT00868790|101172500|FG008|COMPLETED|Period 3||8||
48345211|NCT00868790|101172501|FG009|COMPLETED|Period 3||2||
48345212|NCT00868790|101172502|FG010|COMPLETED|Period 3||8||
48345213|NCT00868790|101172503|FG011|COMPLETED|Period 3||4||
48345214|NCT00868790|101172504|FG012|COMPLETED|Period 3||7||
48345215|NCT00868790|101172505|FG013|COMPLETED|Period 3||8||
48345216|NCT00868790|101172492|FG000|NOT COMPLETED|Period 3||0||
48345217|NCT00868790|101172493|FG001|NOT COMPLETED|Period 3||0||
48345218|NCT00868790|101172494|FG002|NOT COMPLETED|Period 3||0||
48345219|NCT00868790|101172495|FG003|NOT COMPLETED|Period 3||1||
48345220|NCT00868790|101172496|FG004|NOT COMPLETED|Period 3||0||
48345221|NCT00868790|101172497|FG005|NOT COMPLETED|Period 3||0||
48345222|NCT00868790|101172498|FG006|NOT COMPLETED|Period 3||0||
48345223|NCT00868790|101172499|FG007|NOT COMPLETED|Period 3||0||
48345224|NCT00868790|101172500|FG008|NOT COMPLETED|Period 3||0||
48345225|NCT00868790|101172501|FG009|NOT COMPLETED|Period 3||1||
48345226|NCT00868790|101172502|FG010|NOT COMPLETED|Period 3||1||
48345227|NCT00868790|101172503|FG011|NOT COMPLETED|Period 3||0||
48345228|NCT00868790|101172504|FG012|NOT COMPLETED|Period 3||0||
48345229|NCT00868790|101172505|FG013|NOT COMPLETED|Period 3||0||
48345230|NCT00868790|101172492|FG000|STARTED|Period 4||9||
48345231|NCT00868790|101172493|FG001|STARTED|Period 4||6||
48345232|NCT00868790|101172494|FG002|STARTED|Period 4||4||
48345233|NCT00868790|101172495|FG003|STARTED|Period 4||3||
48345234|NCT00868790|101172496|FG004|STARTED|Period 4||18||
48415107|NCT02407236|101350194|FG002|STARTED|Long-term Extension Period (176 Weeks)||0||
48345235|NCT00868790|101172497|FG005|STARTED|Period 4||1||
48345236|NCT00868790|101172498|FG006|STARTED|Period 4||4||
48345237|NCT00868790|101172499|FG007|STARTED|Period 4||17||
48345238|NCT00868790|101172500|FG008|STARTED|Period 4||8||
48345239|NCT00868790|101172501|FG009|STARTED|Period 4||2||
48345240|NCT00868790|101172502|FG010|STARTED|Period 4||8||
48345241|NCT00868790|101172503|FG011|STARTED|Period 4||4||
48345242|NCT00868790|101172504|FG012|STARTED|Period 4||7||
48345243|NCT00868790|101172505|FG013|STARTED|Period 4||8||
48345244|NCT00868790|101172492|FG000|COMPLETED|Period 4||7||
48345245|NCT00868790|101172493|FG001|COMPLETED|Period 4||6||
48345246|NCT00868790|101172494|FG002|COMPLETED|Period 4||3||
48345247|NCT00868790|101172495|FG003|COMPLETED|Period 4||3||
48636482|NCT03901300|101894654|FG001|STARTED|Overall Study||37||
48636483|NCT03901300|101894653|FG000|COMPLETED|Overall Study||32||
48636484|NCT03901300|101894654|FG001|COMPLETED|Overall Study||37||
48636485|NCT03901300|101894653|FG000|NOT COMPLETED|Overall Study||3||
48636486|NCT03901300|101894654|FG001|NOT COMPLETED|Overall Study||0||
48345248|NCT00868790|101172496|FG004|COMPLETED|Period 4||18||
48345249|NCT00868790|101172497|FG005|COMPLETED|Period 4||1||
48345250|NCT00868790|101172498|FG006|COMPLETED|Period 4||4||
48345251|NCT00868790|101172499|FG007|COMPLETED|Period 4||14||
48345252|NCT00868790|101172500|FG008|COMPLETED|Period 4||6||
48345253|NCT00868790|101172501|FG009|COMPLETED|Period 4||2||
48345254|NCT00868790|101172502|FG010|COMPLETED|Period 4||5||
48345255|NCT00868790|101172503|FG011|COMPLETED|Period 4||3||
48345256|NCT00868790|101172504|FG012|COMPLETED|Period 4||6||
48345257|NCT00868790|101172505|FG013|COMPLETED|Period 4||7||
48345258|NCT00868790|101172492|FG000|NOT COMPLETED|Period 4||2||
48415108|NCT02407236|101350195|FG003|STARTED|Long-term Extension Period (176 Weeks)||0||
48415109|NCT02407236|101350196|FG004|STARTED|Long-term Extension Period (176 Weeks)||0||
48415110|NCT02407236|101350197|FG005|STARTED|Long-term Extension Period (176 Weeks)||0||
48415111|NCT02407236|101350198|FG006|STARTED|Long-term Extension Period (176 Weeks)||0||
48415112|NCT02407236|101350199|FG007|STARTED|Long-term Extension Period (176 Weeks)||0||
48415113|NCT02407236|101350200|FG008|STARTED|Long-term Extension Period (176 Weeks)||115||
48415114|NCT02407236|101350201|FG009|STARTED|Long-term Extension Period (176 Weeks)||141||
48636487|NCT01401166|101894655|FG000|STARTED|Crossover Treatment 1 (Cycles 1 to 4)||122||
48636488|NCT01401166|101894656|FG001|STARTED|Crossover Treatment 1 (Cycles 1 to 4)||122||
48345259|NCT00868790|101172493|FG001|NOT COMPLETED|Period 4||0||
48345260|NCT00868790|101172494|FG002|NOT COMPLETED|Period 4||1||
48345261|NCT00868790|101172495|FG003|NOT COMPLETED|Period 4||0||
48345262|NCT00868790|101172496|FG004|NOT COMPLETED|Period 4||0||
48345263|NCT00868790|101172497|FG005|NOT COMPLETED|Period 4||0||
48345264|NCT00868790|101172498|FG006|NOT COMPLETED|Period 4||0||
48345265|NCT00868790|101172499|FG007|NOT COMPLETED|Period 4||3||
48345266|NCT00868790|101172500|FG008|NOT COMPLETED|Period 4||2||
48345267|NCT00868790|101172501|FG009|NOT COMPLETED|Period 4||0||
48345268|NCT00868790|101172502|FG010|NOT COMPLETED|Period 4||3||
48345269|NCT00868790|101172503|FG011|NOT COMPLETED|Period 4||1||
48345270|NCT00868790|101172504|FG012|NOT COMPLETED|Period 4||1||
48415115|NCT02407236|101350202|FG010|STARTED|Long-term Extension Period (176 Weeks)||143||
48415116|NCT02407236|101350203|FG011|STARTED|Long-term Extension Period (176 Weeks)||73||
48415117|NCT02407236|101350204|FG012|STARTED|Long-term Extension Period (176 Weeks)||116||
48636489|NCT01401166|101894657|FG002|STARTED|Crossover Treatment 1 (Cycles 1 to 4)||121||
48636490|NCT01401166|101894658|FG003|STARTED|Crossover Treatment 1 (Cycles 1 to 4)||118||
48636491|NCT01401166|101894655|FG000|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119||
48636492|NCT01401166|101894656|FG001|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||120||
48636493|NCT01401166|101894657|FG002|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119||
48636494|NCT01401166|101894658|FG003|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||116||
48636495|NCT01401166|101894655|FG000|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||3||
48636496|NCT01401166|101894656|FG001|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2||
48345271|NCT00868790|101172505|FG013|NOT COMPLETED|Period 4||1||
48439969|NCT01728376|101409997|FG002|Treated|Overall Study||19||
48636497|NCT01401166|101894657|FG002|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2||
48759005|NCT03474588|102197733|FG001|Follow up 2|Overall Study||20||
48345272|NCT00868790|101172492|FG000|STARTED|Post-study||7||
48345273|NCT00868790|101172493|FG001|STARTED|Post-study||6||
48345274|NCT00868790|101172494|FG002|STARTED|Post-study||3||
48345275|NCT00868790|101172495|FG003|STARTED|Post-study||3||
48345276|NCT00868790|101172496|FG004|STARTED|Post-study||18||
48759006|NCT03474588|102197732|FG000|Follow up 3|Overall Study||25||
48759007|NCT03474588|102197733|FG001|Follow up 3|Overall Study||18||
48759008|NCT03474588|102197732|FG000|COMPLETED|Overall Study||24||
48759009|NCT03474588|102197733|FG001|COMPLETED|Overall Study||19||
48759010|NCT03474588|102197732|FG000|NOT COMPLETED|Overall Study||4||
48759011|NCT03474588|102197733|FG001|NOT COMPLETED|Overall Study||4||
48184454|NCT03255941|100775756|FG001|COMPLETED|Overall Study||132||
48184455|NCT03255941|100775757|FG002|COMPLETED|Overall Study||48||
48345277|NCT00868790|101172497|FG005|STARTED|Post-study||1||
48759012|NCT05472090|102197734|FG000|STARTED|Overall Study||32||
48759013|NCT05472090|102197735|FG001|STARTED|Overall Study||31||
48759014|NCT05472090|102197734|FG000|COMPLETED|Overall Study||26||
48759015|NCT05472090|102197735|FG001|COMPLETED|Overall Study||25||
48759016|NCT05472090|102197734|FG000|NOT COMPLETED|Overall Study||6||
48759017|NCT05472090|102197735|FG001|NOT COMPLETED|Overall Study||6||
48759018|NCT03982355|102197736|FG000|STARTED|Overall Study||10||10
48759019|NCT03982355|102197737|FG001|STARTED|Overall Study||10||10
48759020|NCT03982355|102197736|FG000|COMPLETED|Overall Study||10||10
48759021|NCT03982355|102197737|FG001|COMPLETED|Overall Study||10||10
48759022|NCT03982355|102197736|FG000|NOT COMPLETED|Overall Study||0||0
48759023|NCT03982355|102197737|FG001|NOT COMPLETED|Overall Study||0||0
48759024|NCT02296164|102197738|FG000|STARTED|Overall Study||298|Registered: 301; Only registered/not enrolled:1; Enrolled: 300|
48759025|NCT02296164|102197738|FG000|COMPLETED|Overall Study||188||
48759026|NCT02296164|102197738|FG000|NOT COMPLETED|Overall Study||110||
48759027|NCT05526716|102197739|FG000|STARTED|Overall Study||540||
48759028|NCT05526716|102197740|FG001|STARTED|Overall Study||540||
48759029|NCT05526716|102197739|FG000|Vaccinated at Visit 1|Overall Study||536|QIV|
48759030|NCT05526716|102197740|FG001|Vaccinated at Visit 1|Overall Study||536|QIV|
48759031|NCT05526716|102197739|FG000|Vaccinated at Visit 1|Overall Study||534|V116|
48759032|NCT05526716|102197740|FG001|Vaccinated at Visit 1|Overall Study||0|V116|
48759033|NCT05526716|102197739|FG000|Vaccinated at Visit 1|Overall Study||0|Placebo|
48759034|NCT05526716|102197740|FG001|Vaccinated at Visit 1|Overall Study||535|Placebo|
48345278|NCT00868790|101172498|FG006|STARTED|Post-study||4||
48759035|NCT05526716|102197739|FG000|Vaccinated at Visit 3|Overall Study||522|Placebo|
48759036|NCT05526716|102197740|FG001|Vaccinated at Visit 3|Overall Study||0|Placebo|
48759037|NCT05526716|102197739|FG000|Vaccinated at Visit 3|Overall Study||0|V116|
48759038|NCT05526716|102197740|FG001|Vaccinated at Visit 3|Overall Study||518|V116|
48759039|NCT05526716|102197739|FG000|COMPLETED|Overall Study||510||
48759040|NCT05526716|102197740|FG001|COMPLETED|Overall Study||507||
48759041|NCT05526716|102197739|FG000|NOT COMPLETED|Overall Study||30||
48759042|NCT05526716|102197740|FG001|NOT COMPLETED|Overall Study||33||
48759043|NCT03602612|102197741|FG000|STARTED|Dose Escalation Phase||0||
48759044|NCT03602612|102197742|FG001|STARTED|Dose Escalation Phase||6||
48759045|NCT03602612|102197743|FG002|STARTED|Dose Escalation Phase||3||
48759046|NCT03602612|102197744|FG003|STARTED|Dose Escalation Phase||2||
48759047|NCT03602612|102197745|FG004|STARTED|Dose Escalation Phase||3||
48345279|NCT00868790|101172499|FG007|STARTED|Post-study||14||
48345280|NCT00868790|101172500|FG008|STARTED|Post-study||6||
48345281|NCT00868790|101172501|FG009|STARTED|Post-study||2||
48345282|NCT00868790|101172502|FG010|STARTED|Post-study||5||
48345283|NCT00868790|101172503|FG011|STARTED|Post-study||3||
48345284|NCT00868790|101172504|FG012|STARTED|Post-study||6||
48345285|NCT00868790|101172505|FG013|STARTED|Post-study||7||
48345286|NCT00868790|101172492|FG000|COMPLETED|Post-study||7||
48345287|NCT00868790|101172493|FG001|COMPLETED|Post-study||6||
48345288|NCT00868790|101172494|FG002|COMPLETED|Post-study||3||
48345289|NCT00868790|101172495|FG003|COMPLETED|Post-study||3||
48415118|NCT02407236|101350192|FG000|COMPLETED|Long-term Extension Period (176 Weeks)||0||
48415119|NCT02407236|101350193|FG001|COMPLETED|Long-term Extension Period (176 Weeks)||0||
48415120|NCT02407236|101350194|FG002|COMPLETED|Long-term Extension Period (176 Weeks)||0||
48415121|NCT02407236|101350195|FG003|COMPLETED|Long-term Extension Period (176 Weeks)||0||
48415122|NCT02407236|101350196|FG004|COMPLETED|Long-term Extension Period (176 Weeks)||0||
48415123|NCT02407236|101350197|FG005|COMPLETED|Long-term Extension Period (176 Weeks)||0||
48415124|NCT02407236|101350198|FG006|COMPLETED|Long-term Extension Period (176 Weeks)||0||
48415125|NCT02407236|101350199|FG007|COMPLETED|Long-term Extension Period (176 Weeks)||0||
48415126|NCT02407236|101350200|FG008|COMPLETED|Long-term Extension Period (176 Weeks)||34||
48415127|NCT02407236|101350201|FG009|COMPLETED|Long-term Extension Period (176 Weeks)||99||
48415128|NCT02407236|101350202|FG010|COMPLETED|Long-term Extension Period (176 Weeks)||101||
48415129|NCT02407236|101350203|FG011|COMPLETED|Long-term Extension Period (176 Weeks)||0||
48415130|NCT02407236|101350204|FG012|COMPLETED|Long-term Extension Period (176 Weeks)||95||
48759048|NCT03602612|102197746|FG005|STARTED|Dose Escalation Phase||3||
48759049|NCT03602612|102197747|FG006|STARTED|Dose Escalation Phase||0||
48759050|NCT03602612|102197748|FG007|STARTED|Dose Escalation Phase||1||
48759051|NCT03602612|102197749|FG008|STARTED|Dose Escalation Phase||8||
48759052|NCT03602612|102197750|FG009|STARTED|Dose Escalation Phase||1||
48759053|NCT03602612|102197741|FG000|COMPLETED|Dose Escalation Phase||0||
48759054|NCT03602612|102197742|FG001|COMPLETED|Dose Escalation Phase||6||
48759055|NCT03602612|102197743|FG002|COMPLETED|Dose Escalation Phase||3||
48759056|NCT03602612|102197744|FG003|COMPLETED|Dose Escalation Phase||2||
48759057|NCT03602612|102197745|FG004|COMPLETED|Dose Escalation Phase||3||
48759058|NCT03602612|102197746|FG005|COMPLETED|Dose Escalation Phase||3||
48759059|NCT03602612|102197747|FG006|COMPLETED|Dose Escalation Phase||0||
48759060|NCT03602612|102197748|FG007|COMPLETED|Dose Escalation Phase||1||
48759061|NCT03602612|102197749|FG008|COMPLETED|Dose Escalation Phase||0||
48759062|NCT03602612|102197750|FG009|COMPLETED|Dose Escalation Phase||0||
48759063|NCT03602612|102197741|FG000|NOT COMPLETED|Dose Escalation Phase||0||
48759064|NCT03602612|102197742|FG001|NOT COMPLETED|Dose Escalation Phase||0||
48759065|NCT03602612|102197743|FG002|NOT COMPLETED|Dose Escalation Phase||0||
48759066|NCT03602612|102197744|FG003|NOT COMPLETED|Dose Escalation Phase||0||
48759067|NCT03602612|102197745|FG004|NOT COMPLETED|Dose Escalation Phase||0||
48759068|NCT03602612|102197746|FG005|NOT COMPLETED|Dose Escalation Phase||0||
48345290|NCT00868790|101172496|FG004|COMPLETED|Post-study||17||
48345291|NCT00868790|101172497|FG005|COMPLETED|Post-study||1||
48759069|NCT03602612|102197747|FG006|NOT COMPLETED|Dose Escalation Phase||0||
48759070|NCT03602612|102197748|FG007|NOT COMPLETED|Dose Escalation Phase||0||
48759071|NCT03602612|102197749|FG008|NOT COMPLETED|Dose Escalation Phase||8||
48759072|NCT03602612|102197750|FG009|NOT COMPLETED|Dose Escalation Phase||1||
48759073|NCT03602612|102197741|FG000|STARTED|Dose Expansion Phase||0||
48759074|NCT03602612|102197742|FG001|STARTED|Dose Expansion Phase||0||
48759075|NCT03602612|102197743|FG002|STARTED|Dose Expansion Phase||0||
48759076|NCT03602612|102197744|FG003|STARTED|Dose Expansion Phase||0||
48759077|NCT03602612|102197745|FG004|STARTED|Dose Expansion Phase||0||
48759078|NCT03602612|102197746|FG005|STARTED|Dose Expansion Phase||0||
48759079|NCT03602612|102197747|FG006|STARTED|Dose Expansion Phase||8||
48345292|NCT00868790|101172498|FG006|COMPLETED|Post-study||4||
48759080|NCT03602612|102197748|FG007|STARTED|Dose Expansion Phase||1||
48759081|NCT03602612|102197749|FG008|STARTED|Dose Expansion Phase||0||
48345293|NCT00868790|101172499|FG007|COMPLETED|Post-study||12||
48345294|NCT00868790|101172500|FG008|COMPLETED|Post-study||6||
48345295|NCT00868790|101172501|FG009|COMPLETED|Post-study||1||
48345296|NCT00868790|101172502|FG010|COMPLETED|Post-study||5||
48345297|NCT00868790|101172503|FG011|COMPLETED|Post-study||3||
48345298|NCT00868790|101172504|FG012|COMPLETED|Post-study||6||
48345299|NCT00868790|101172505|FG013|COMPLETED|Post-study||7||
48345300|NCT00868790|101172492|FG000|NOT COMPLETED|Post-study||0||
48345301|NCT00868790|101172493|FG001|NOT COMPLETED|Post-study||0||
48345302|NCT00868790|101172494|FG002|NOT COMPLETED|Post-study||0||
48345303|NCT00868790|101172495|FG003|NOT COMPLETED|Post-study||0||
48345304|NCT00868790|101172496|FG004|NOT COMPLETED|Post-study||1||
48345305|NCT00868790|101172497|FG005|NOT COMPLETED|Post-study||0||
48345306|NCT00868790|101172498|FG006|NOT COMPLETED|Post-study||0||
48345307|NCT00868790|101172499|FG007|NOT COMPLETED|Post-study||2||
48345308|NCT00868790|101172500|FG008|NOT COMPLETED|Post-study||0||
48345309|NCT00868790|101172501|FG009|NOT COMPLETED|Post-study||1||
48345310|NCT00868790|101172502|FG010|NOT COMPLETED|Post-study||0||
48345311|NCT00868790|101172503|FG011|NOT COMPLETED|Post-study||0||
48345312|NCT00868790|101172504|FG012|NOT COMPLETED|Post-study||0||
48345313|NCT00868790|101172505|FG013|NOT COMPLETED|Post-study||0||
48345314|NCT02604264|101172506|FG000|STARTED|Run-In||618|The 1-mo run-in period data was used to determine pre-study demographics and PBC rate.|
48184456|NCT03255941|100775758|FG003|COMPLETED|Overall Study||46||
48415131|NCT02407236|101350192|FG000|NOT COMPLETED|Long-term Extension Period (176 Weeks)||0||
48415132|NCT02407236|101350193|FG001|NOT COMPLETED|Long-term Extension Period (176 Weeks)||0||
48415133|NCT02407236|101350194|FG002|NOT COMPLETED|Long-term Extension Period (176 Weeks)||0||
48415134|NCT02407236|101350195|FG003|NOT COMPLETED|Long-term Extension Period (176 Weeks)||0||
48415135|NCT02407236|101350196|FG004|NOT COMPLETED|Long-term Extension Period (176 Weeks)||0||
48415136|NCT02407236|101350197|FG005|NOT COMPLETED|Long-term Extension Period (176 Weeks)||0||
48636498|NCT01401166|101894658|FG003|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2||
48636499|NCT01401166|101894655|FG000|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119||
48636500|NCT01401166|101894656|FG001|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||120||
48636501|NCT01401166|101894657|FG002|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119||
48636502|NCT01401166|101894658|FG003|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||116||
48415137|NCT02407236|101350198|FG006|NOT COMPLETED|Long-term Extension Period (176 Weeks)||0||
48415138|NCT02407236|101350199|FG007|NOT COMPLETED|Long-term Extension Period (176 Weeks)||0||
48415139|NCT02407236|101350200|FG008|NOT COMPLETED|Long-term Extension Period (176 Weeks)||81||
48636503|NCT01401166|101894655|FG000|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||113||
48636504|NCT01401166|101894656|FG001|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||116||
48636505|NCT01401166|101894657|FG002|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||107||
48636506|NCT01401166|101894658|FG003|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||105||
48759082|NCT03602612|102197750|FG009|STARTED|Dose Expansion Phase||0||
48759083|NCT03602612|102197741|FG000|COMPLETED|Dose Expansion Phase||0||
48636507|NCT01401166|101894655|FG000|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||6||
48184457|NCT03255941|100775755|FG000|NOT COMPLETED|Overall Study||38||
48184458|NCT03255941|100775756|FG001|NOT COMPLETED|Overall Study||46||
48184459|NCT03255941|100775757|FG002|NOT COMPLETED|Overall Study||5||
48184460|NCT03255941|100775758|FG003|NOT COMPLETED|Overall Study||6||
48184461|NCT01672983|100775759|FG000|STARTED|Overall Study||18||
48184462|NCT01672983|100775760|FG001|STARTED|Overall Study||18||
48184463|NCT01672983|100775761|FG002|STARTED|Overall Study||19||
48184464|NCT01672983|100775762|FG003|STARTED|Overall Study||18||
48184465|NCT01672983|100775763|FG004|STARTED|Overall Study||19||
48184466|NCT01672983|100775764|FG005|STARTED|Overall Study||18||
48184467|NCT01672983|100775759|FG000|Completed Study Drug|Overall Study||18||
48184468|NCT01672983|100775760|FG001|Completed Study Drug|Overall Study||17||
48184469|NCT01672983|100775761|FG002|Completed Study Drug|Overall Study||18||
48184470|NCT01672983|100775762|FG003|Completed Study Drug|Overall Study||18||
48184471|NCT01672983|100775763|FG004|Completed Study Drug|Overall Study||12||
48184472|NCT01672983|100775764|FG005|Completed Study Drug|Overall Study||17||
48184473|NCT01672983|100775759|FG000|COMPLETED|Overall Study||18||
48184474|NCT01672983|100775760|FG001|COMPLETED|Overall Study||18||
48184475|NCT01672983|100775761|FG002|COMPLETED|Overall Study||19||
48184476|NCT01672983|100775762|FG003|COMPLETED|Overall Study||18||
48636508|NCT01401166|101894656|FG001|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||4||
48636509|NCT01401166|101894657|FG002|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||12||
48636510|NCT01401166|101894658|FG003|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||11||
48636511|NCT01401166|101894655|FG000|STARTED|Continuation Treatment (Cycles 9 to 18)||113||
48636512|NCT01401166|101894656|FG001|STARTED|Continuation Treatment (Cycles 9 to 18)||116||
48636513|NCT01401166|101894657|FG002|STARTED|Continuation Treatment (Cycles 9 to 18)||107||
48636514|NCT01401166|101894658|FG003|STARTED|Continuation Treatment (Cycles 9 to 18)||105||
48636515|NCT01401166|101894655|FG000|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109||
48636516|NCT01401166|101894656|FG001|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109||
48636517|NCT01401166|101894657|FG002|COMPLETED|Continuation Treatment (Cycles 9 to 18)||105||
48636518|NCT01401166|101894658|FG003|COMPLETED|Continuation Treatment (Cycles 9 to 18)||102||
48636519|NCT01401166|101894655|FG000|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||4||
48636520|NCT01401166|101894656|FG001|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||7||
48636521|NCT01401166|101894657|FG002|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||2||
48636522|NCT01401166|101894658|FG003|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||3||
48636523|NCT01401166|101894655|FG000|STARTED|Safety Follow-Up Period||124||
48636524|NCT01401166|101894656|FG001|STARTED|Safety Follow-Up Period||124||
48636525|NCT01401166|101894657|FG002|STARTED|Safety Follow-Up Period||121||
48636526|NCT01401166|101894658|FG003|STARTED|Safety Follow-Up Period||119||
48636527|NCT01401166|101894655|FG000|COMPLETED|Safety Follow-Up Period||99||
48636528|NCT01401166|101894656|FG001|COMPLETED|Safety Follow-Up Period||106||
48636529|NCT01401166|101894657|FG002|COMPLETED|Safety Follow-Up Period||104||
48636530|NCT01401166|101894658|FG003|COMPLETED|Safety Follow-Up Period||100||
48636531|NCT01401166|101894655|FG000|NOT COMPLETED|Safety Follow-Up Period||25||
48636532|NCT01401166|101894656|FG001|NOT COMPLETED|Safety Follow-Up Period||18||
48636533|NCT01401166|101894657|FG002|NOT COMPLETED|Safety Follow-Up Period||17||
48636534|NCT01401166|101894658|FG003|NOT COMPLETED|Safety Follow-Up Period||19||
48636535|NCT00262925|101894659|FG000|STARTED|Overall Study||12||
48636536|NCT00262925|101894659|FG000|COMPLETED|Overall Study||1||
48759084|NCT03602612|102197742|FG001|COMPLETED|Dose Expansion Phase||0||
48184477|NCT01672983|100775763|FG004|COMPLETED|Overall Study||19||
48184478|NCT01672983|100775764|FG005|COMPLETED|Overall Study||18||
48184479|NCT01672983|100775759|FG000|NOT COMPLETED|Overall Study||0||
48759085|NCT03602612|102197743|FG002|COMPLETED|Dose Expansion Phase||0||
48759086|NCT03602612|102197744|FG003|COMPLETED|Dose Expansion Phase||0||
48759087|NCT03602612|102197745|FG004|COMPLETED|Dose Expansion Phase||0||
48759088|NCT03602612|102197746|FG005|COMPLETED|Dose Expansion Phase||0||
48759089|NCT03602612|102197747|FG006|COMPLETED|Dose Expansion Phase||8||
48184480|NCT01672983|100775760|FG001|NOT COMPLETED|Overall Study||0||
48759090|NCT03602612|102197748|FG007|COMPLETED|Dose Expansion Phase||1||
48759091|NCT03602612|102197749|FG008|COMPLETED|Dose Expansion Phase||0||
48759092|NCT03602612|102197750|FG009|COMPLETED|Dose Expansion Phase||0||
48759093|NCT03602612|102197741|FG000|NOT COMPLETED|Dose Expansion Phase||0||
48759094|NCT03602612|102197742|FG001|NOT COMPLETED|Dose Expansion Phase||0||
48759095|NCT03602612|102197743|FG002|NOT COMPLETED|Dose Expansion Phase||0||
48636537|NCT00262925|101894659|FG000|NOT COMPLETED|Overall Study||11||
48636538|NCT02515227|101894660|FG000|STARTED|Overall Study||6||
48636539|NCT02515227|101894661|FG001|STARTED|Overall Study||16||
48636540|NCT02515227|101894660|FG000|Received at Least 1 Vaccine|Overall Study||6||
48636541|NCT02515227|101894661|FG001|Received at Least 1 Vaccine|Overall Study||16||
48636542|NCT02515227|101894660|FG000|COMPLETED|Overall Study||4|This milestone reflects receipt of all 6 vaccines and remaining on study to week 13 at least.|
48636543|NCT02515227|101894661|FG001|COMPLETED|Overall Study||5|This milestone reflects receipt of all 6 vaccines and remaining on study to week 13 at least.|
48636544|NCT02515227|101894660|FG000|NOT COMPLETED|Overall Study||2||
48636545|NCT02515227|101894661|FG001|NOT COMPLETED|Overall Study||11||
48636546|NCT00587457|101894662|FG000|STARTED|Overall Study||3||
48759096|NCT03602612|102197744|FG003|NOT COMPLETED|Dose Expansion Phase||0||
48759097|NCT03602612|102197745|FG004|NOT COMPLETED|Dose Expansion Phase||0||
48759098|NCT03602612|102197746|FG005|NOT COMPLETED|Dose Expansion Phase||0||
48636547|NCT00587457|101894663|FG001|STARTED|Overall Study||3||
48636548|NCT00587457|101894664|FG002|STARTED|Overall Study||5||
48759099|NCT03602612|102197747|FG006|NOT COMPLETED|Dose Expansion Phase||0||
48759100|NCT03602612|102197748|FG007|NOT COMPLETED|Dose Expansion Phase||0||
48759101|NCT03602612|102197749|FG008|NOT COMPLETED|Dose Expansion Phase||0||
48759102|NCT03602612|102197750|FG009|NOT COMPLETED|Dose Expansion Phase||0||
48759103|NCT00878501|102197751|FG000|STARTED|Overall Study||104||
48345315|NCT02604264|101172507|FG001|STARTED|Run-In||611|The 1-mo run-in period data was used to determine pre-study demographics and PBC rate.|
48345316|NCT02604264|101172506|FG000|COMPLETED|Run-In||618||
48345317|NCT02604264|101172507|FG001|COMPLETED|Run-In||611||
48345318|NCT02604264|101172506|FG000|NOT COMPLETED|Run-In||0||
48345319|NCT02604264|101172507|FG001|NOT COMPLETED|Run-In||0||
48345320|NCT02604264|101172506|FG000|STARTED|Intervention||1445||
48345321|NCT02604264|101172507|FG001|STARTED|Intervention||1467||
48345322|NCT02604264|101172506|FG000|COMPLETED|Intervention||1245||
48345323|NCT02604264|101172507|FG001|COMPLETED|Intervention||1225||
48345324|NCT02604264|101172506|FG000|NOT COMPLETED|Intervention||200||
48345325|NCT02604264|101172507|FG001|NOT COMPLETED|Intervention||242||
48345326|NCT01526356|101172508|FG000|STARTED|Overall Study||59||
48345327|NCT01526356|101172509|FG001|STARTED|Overall Study||63||
48636549|NCT00587457|101894662|FG000|COMPLETED|Overall Study||0||
48636550|NCT00587457|101894663|FG001|COMPLETED|Overall Study||0||
48636551|NCT00587457|101894664|FG002|COMPLETED|Overall Study||0||
48636552|NCT00587457|101894662|FG000|NOT COMPLETED|Overall Study||3||
48636553|NCT00587457|101894663|FG001|NOT COMPLETED|Overall Study||3||
48636554|NCT00587457|101894664|FG002|NOT COMPLETED|Overall Study||5||
48636555|NCT00104234|101894665|FG000|STARTED|Overall Study||19||
48759104|NCT00878501|102197752|FG001|STARTED|Overall Study||44||
48759105|NCT00878501|102197753|FG002|STARTED|Overall Study||93||
48759106|NCT00878501|102197751|FG000|Interim Analysis|Overall Study||83||
48759107|NCT00878501|102197752|FG001|Interim Analysis|Overall Study||37||
48759108|NCT00878501|102197753|FG002|Interim Analysis|Overall Study||81||
48759109|NCT00878501|102197751|FG000|COMPLETED|Overall Study||87||
48759110|NCT00878501|102197752|FG001|COMPLETED|Overall Study||37||
48636556|NCT00104234|101894666|FG001|STARTED|Overall Study||20||
48636557|NCT00104234|101894665|FG000|COMPLETED|Overall Study||19||
48636558|NCT00104234|101894666|FG001|COMPLETED|Overall Study||19||
48636559|NCT00104234|101894665|FG000|NOT COMPLETED|Overall Study||0||
48636560|NCT00104234|101894666|FG001|NOT COMPLETED|Overall Study||1||
48415140|NCT02407236|101350201|FG009|NOT COMPLETED|Long-term Extension Period (176 Weeks)||42||
48415141|NCT02407236|101350202|FG010|NOT COMPLETED|Long-term Extension Period (176 Weeks)||42||
48415142|NCT02407236|101350203|FG011|NOT COMPLETED|Long-term Extension Period (176 Weeks)||73||
48415143|NCT02407236|101350204|FG012|NOT COMPLETED|Long-term Extension Period (176 Weeks)||21||
48415144|NCT01497665|101350205|FG000|STARTED|Overall Study||16||
48415145|NCT01497665|101350205|FG000|Completed Effifcacy Assessment|Overall Study||10||
48415146|NCT01497665|101350205|FG000|COMPLETED|Overall Study||16||
48415147|NCT01497665|101350205|FG000|NOT COMPLETED|Overall Study||0||
48415148|NCT00750867|101350206|FG000|STARTED|Overall Study||9||
48415149|NCT00750867|101350206|FG000|COMPLETED|Overall Study||7||
48415150|NCT00750867|101350206|FG000|NOT COMPLETED|Overall Study||2||
48415151|NCT00887913|101350207|FG000|STARTED|Overall Study||69||
48415152|NCT00887913|101350207|FG000|COMPLETED|Overall Study||63||
48415153|NCT00887913|101350207|FG000|NOT COMPLETED|Overall Study||6||
48415154|NCT04554394|101350208|FG000|STARTED|Overall Study||62||195
48415155|NCT04554394|101350209|FG001|STARTED|Overall Study||62||62
48415156|NCT04554394|101350208|FG000|COMPLETED|Overall Study||53||136
48415157|NCT04554394|101350209|FG001|COMPLETED|Overall Study||53||53
48415158|NCT04554394|101350208|FG000|NOT COMPLETED|Overall Study||9||59
48415159|NCT04554394|101350209|FG001|NOT COMPLETED|Overall Study||9||9
48415160|NCT03198884|101350210|FG000|STARTED|Overall Study||20||
48415161|NCT03198884|101350210|FG000|COMPLETED|Overall Study||20||
48415162|NCT03198884|101350210|FG000|NOT COMPLETED|Overall Study||0||
48415163|NCT04180475|101350211|FG000|STARTED|Overall Study||5||
48415164|NCT04180475|101350211|FG000|COMPLETED|Overall Study||5||
48415165|NCT04180475|101350211|FG000|NOT COMPLETED|Overall Study||0||
48415166|NCT03481634|101350212|FG000|STARTED|Overall Study||190||
48415167|NCT03481634|101350213|FG001|STARTED|Overall Study||189||
48415168|NCT03481634|101350214|FG002|STARTED|Overall Study||187||
48415169|NCT03481634|101350212|FG000|COMPLETED|Overall Study||157||
48415170|NCT03481634|101350213|FG001|COMPLETED|Overall Study||154||
48415171|NCT03481634|101350214|FG002|COMPLETED|Overall Study||153||
48636561|NCT00770367|101894667|FG000|STARTED|First Intervention||18||
48636562|NCT00770367|101894668|FG001|STARTED|First Intervention||18||
48636563|NCT00770367|101894667|FG000|COMPLETED|First Intervention||18||
48636564|NCT00770367|101894668|FG001|COMPLETED|First Intervention||16||
48636565|NCT00770367|101894667|FG000|NOT COMPLETED|First Intervention||0||
48636566|NCT00770367|101894668|FG001|NOT COMPLETED|First Intervention||2||
48636567|NCT00770367|101894667|FG000|STARTED|Washout Period of 4 Weeks||18||
48636568|NCT00770367|101894668|FG001|STARTED|Washout Period of 4 Weeks||16||
48415172|NCT03481634|101350212|FG000|NOT COMPLETED|Overall Study||33||
48415173|NCT03481634|101350213|FG001|NOT COMPLETED|Overall Study||35||
48415174|NCT03481634|101350214|FG002|NOT COMPLETED|Overall Study||34||
48415175|NCT02469597|101350215|FG000|STARTED|Overall Study||22||
48415176|NCT02469597|101350216|FG001|STARTED|Overall Study||24||
48415177|NCT02469597|101350215|FG000|COMPLETED|Overall Study||22||
48415178|NCT02469597|101350216|FG001|COMPLETED|Overall Study||24||
48415179|NCT02469597|101350215|FG000|NOT COMPLETED|Overall Study||0||
48415180|NCT02469597|101350216|FG001|NOT COMPLETED|Overall Study||0||
48415181|NCT00908895|101350217|FG000|STARTED|Overall Study||57||
48415182|NCT00908895|101350218|FG001|STARTED|Overall Study||63||
48415183|NCT00908895|101350217|FG000|COMPLETED|Overall Study||53||
48415184|NCT00908895|101350218|FG001|COMPLETED|Overall Study||57||
48415185|NCT00908895|101350217|FG000|NOT COMPLETED|Overall Study||4||
48415186|NCT00908895|101350218|FG001|NOT COMPLETED|Overall Study||6||
48415187|NCT01225211|101350219|FG000|STARTED|Overall Study||21||
48415188|NCT01225211|101350220|FG001|STARTED|Overall Study||20||
48415189|NCT01225211|101350221|FG002|STARTED|Overall Study||21||
48415190|NCT01225211|101350222|FG003|STARTED|Overall Study||27||
48415191|NCT01225211|101350223|FG004|STARTED|Overall Study||23||
48415192|NCT01225211|101350224|FG005|STARTED|Overall Study||21||
48415193|NCT01225211|101350225|FG006|STARTED|Overall Study||42||
48415194|NCT01225211|101350226|FG007|STARTED|Overall Study||11||
48415195|NCT01225211|101350227|FG008|STARTED|Overall Study||63||
48415196|NCT01225211|101350228|FG009|STARTED|Overall Study||62||
48415197|NCT01225211|101350219|FG000|COMPLETED|Overall Study||21||
48415198|NCT01225211|101350220|FG001|COMPLETED|Overall Study||20||
48415199|NCT01225211|101350221|FG002|COMPLETED|Overall Study||20||
48636569|NCT00770367|101894667|FG000|COMPLETED|Washout Period of 4 Weeks||18||
48636570|NCT00770367|101894668|FG001|COMPLETED|Washout Period of 4 Weeks||15||
48636571|NCT00770367|101894667|FG000|NOT COMPLETED|Washout Period of 4 Weeks||0||
48636572|NCT00770367|101894668|FG001|NOT COMPLETED|Washout Period of 4 Weeks||1||
48636573|NCT00770367|101894667|FG000|STARTED|Second Intervention||18||
48636574|NCT00770367|101894668|FG001|STARTED|Second Intervention||15||
48636575|NCT00770367|101894667|FG000|COMPLETED|Second Intervention||16||
48636576|NCT00770367|101894668|FG001|COMPLETED|Second Intervention||15||
48636577|NCT00770367|101894667|FG000|NOT COMPLETED|Second Intervention||2||
48759111|NCT00878501|102197753|FG002|COMPLETED|Overall Study||85||
48759112|NCT00878501|102197751|FG000|NOT COMPLETED|Overall Study||17||
48636578|NCT00770367|101894668|FG001|NOT COMPLETED|Second Intervention||0||
48636579|NCT00434252|101894669|FG000|STARTED|Overall Study||71||
48636580|NCT00434252|101894670|FG001|STARTED|Overall Study||143||
48636581|NCT00434252|101894669|FG000|Treated|Overall Study||69||
48636582|NCT00434252|101894670|FG001|Treated|Overall Study||143||
48636583|NCT00434252|101894669|FG000|COMPLETED|Overall Study||7||
48636584|NCT00434252|101894670|FG001|COMPLETED|Overall Study||12||
48636585|NCT00434252|101894669|FG000|NOT COMPLETED|Overall Study||64||
48636586|NCT00434252|101894670|FG001|NOT COMPLETED|Overall Study||131||
48636587|NCT00157755|101894671|FG000|STARTED|Overall Study||26||
48636588|NCT00157755|101894672|FG001|STARTED|Overall Study||19||
48636589|NCT00157755|101894673|FG002|STARTED|Overall Study||10||
48636590|NCT00157755|101894674|FG003|STARTED|Overall Study||15||
48636591|NCT00157755|101894675|FG004|STARTED|Overall Study||12||
48636592|NCT00157755|101894676|FG005|STARTED|Overall Study||5||
48636593|NCT00157755|101894671|FG000|COMPLETED|Overall Study||24||
48636594|NCT00157755|101894672|FG001|COMPLETED|Overall Study||15||
48636595|NCT00157755|101894673|FG002|COMPLETED|Overall Study||3||
48636596|NCT00157755|101894674|FG003|COMPLETED|Overall Study||11||
48636597|NCT00157755|101894675|FG004|COMPLETED|Overall Study||10||
48184481|NCT01672983|100775761|FG002|NOT COMPLETED|Overall Study||0||
48184482|NCT01672983|100775762|FG003|NOT COMPLETED|Overall Study||0||
48345328|NCT01526356|101172510|FG002|STARTED|Overall Study||57||
48345329|NCT01526356|101172508|FG000|COMPLETED|Overall Study||51||
48345330|NCT01526356|101172509|FG001|COMPLETED|Overall Study||53||
48345331|NCT01526356|101172510|FG002|COMPLETED|Overall Study||45||
48636598|NCT00157755|101894676|FG005|COMPLETED|Overall Study||0||
48636599|NCT00157755|101894671|FG000|NOT COMPLETED|Overall Study||2||
48636600|NCT00157755|101894672|FG001|NOT COMPLETED|Overall Study||4||
48636601|NCT00157755|101894673|FG002|NOT COMPLETED|Overall Study||7||
48636602|NCT00157755|101894674|FG003|NOT COMPLETED|Overall Study||4||
48345332|NCT01526356|101172508|FG000|NOT COMPLETED|Overall Study||8||
48345333|NCT01526356|101172509|FG001|NOT COMPLETED|Overall Study||10||
48345334|NCT01526356|101172510|FG002|NOT COMPLETED|Overall Study||12||
48345335|NCT01614964|101172511|FG000|STARTED|Overall Study||33||
48345336|NCT01614964|101172512|FG001|STARTED|Overall Study||33||
48345337|NCT01614964|101172511|FG000|COMPLETED|Overall Study||28||
48345338|NCT01614964|101172512|FG001|COMPLETED|Overall Study||33||
48345339|NCT01614964|101172511|FG000|NOT COMPLETED|Overall Study||5||
48345340|NCT01614964|101172512|FG001|NOT COMPLETED|Overall Study||0||
48345341|NCT03303989|101172513|FG000|STARTED|Overall Study||24||
48345342|NCT03303989|101172514|FG001|STARTED|Overall Study||11||
48345343|NCT03303989|101172513|FG000|COMPLETED|Overall Study||22||
48345344|NCT03303989|101172514|FG001|COMPLETED|Overall Study||10||
48345345|NCT03303989|101172513|FG000|NOT COMPLETED|Overall Study||2||
48345346|NCT03303989|101172514|FG001|NOT COMPLETED|Overall Study||1||
48345347|NCT01551745|101172515|FG000|STARTED|Overall Study||5||
48636603|NCT00157755|101894675|FG004|NOT COMPLETED|Overall Study||2||
48636604|NCT00157755|101894676|FG005|NOT COMPLETED|Overall Study||5||
48636605|NCT04181788|101894677|FG000|STARTED|TREATMENT||4||
48636606|NCT04181788|101894678|FG001|STARTED|TREATMENT||12||
48636607|NCT04181788|101894679|FG002|STARTED|TREATMENT||6||
48636608|NCT04181788|101894680|FG003|STARTED|TREATMENT||12||
48636609|NCT04181788|101894681|FG004|STARTED|TREATMENT||41||
48636610|NCT04181788|101894682|FG005|STARTED|TREATMENT||80||
48636611|NCT04181788|101894677|FG000|COMPLETED|TREATMENT||0||
48759113|NCT00878501|102197752|FG001|NOT COMPLETED|Overall Study||7||
48759114|NCT00878501|102197753|FG002|NOT COMPLETED|Overall Study||8||
48759115|NCT02218372|102197754|FG000|STARTED|Overall Study||100||
48759116|NCT02218372|102197755|FG001|STARTED|Overall Study||48||
48759117|NCT02218372|102197754|FG000|Treated|Overall Study||98||
48184483|NCT01672983|100775763|FG004|NOT COMPLETED|Overall Study||0||
48345348|NCT01551745|101172515|FG000|COMPLETED|Overall Study||2||
48345349|NCT01551745|101172515|FG000|NOT COMPLETED|Overall Study||3||
48636612|NCT04181788|101894678|FG001|COMPLETED|TREATMENT||0||
48636613|NCT04181788|101894679|FG002|COMPLETED|TREATMENT||0||
48636614|NCT04181788|101894680|FG003|COMPLETED|TREATMENT||0||
48636615|NCT04181788|101894681|FG004|COMPLETED|TREATMENT||0||
48636616|NCT04181788|101894682|FG005|COMPLETED|TREATMENT||0||
48636617|NCT04181788|101894677|FG000|NOT COMPLETED|TREATMENT||4||
48636618|NCT04181788|101894678|FG001|NOT COMPLETED|TREATMENT||12||
48636619|NCT04181788|101894679|FG002|NOT COMPLETED|TREATMENT||6||
48636620|NCT04181788|101894680|FG003|NOT COMPLETED|TREATMENT||12||
48636621|NCT04181788|101894681|FG004|NOT COMPLETED|TREATMENT||41||
48636622|NCT04181788|101894682|FG005|NOT COMPLETED|TREATMENT||80||
48759118|NCT02218372|102197755|FG001|Treated|Overall Study||44||
48636623|NCT04181788|101894677|FG000|STARTED|FOLLOW-UP||3|All participants who entered treatment phase were either on-going on treatment or discontinued treatment. Those who discontinued treatment either entered the follow-up period or discontinued the study at the end of treatment.|
48184484|NCT01672983|100775764|FG005|NOT COMPLETED|Overall Study||0||
48184485|NCT01719861|100775765|FG000|STARTED|Cycle 1||6||
48184486|NCT01719861|100775765|FG000|COMPLETED|Cycle 1||2||
48636624|NCT04181788|101894678|FG001|STARTED|FOLLOW-UP||9|All participants who entered treatment phase were either on-going on treatment or discontinued treatment. Those who discontinued treatment either entered the follow-up period or discontinued the study at the end of treatment.|
48636625|NCT04181788|101894679|FG002|STARTED|FOLLOW-UP||6|All participants who entered treatment phase were either on-going on treatment or discontinued treatment. Those who discontinued treatment either entered the follow-up period or discontinued the study at the end of treatment.|
48636626|NCT04181788|101894680|FG003|STARTED|FOLLOW-UP||7|All participants who entered treatment phase were either on-going on treatment or discontinued treatment. Those who discontinued treatment either entered the follow-up period or discontinued the study at the end of treatment.|
48636627|NCT04181788|101894681|FG004|STARTED|FOLLOW-UP||20|All participants who entered treatment phase were either on-going on treatment or discontinued treatment. Those who discontinued treatment either entered the follow-up period or discontinued the study at the end of treatment.|
48636628|NCT04181788|101894682|FG005|STARTED|FOLLOW-UP||49|All participants who entered treatment phase were either on-going on treatment or discontinued treatment. Those who discontinued treatment either entered the follow-up period or discontinued the study at the end of treatment.|
48636629|NCT04181788|101894677|FG000|COMPLETED|FOLLOW-UP||3||
48636630|NCT04181788|101894678|FG001|COMPLETED|FOLLOW-UP||8||
48636631|NCT04181788|101894679|FG002|COMPLETED|FOLLOW-UP||4||
48636632|NCT04181788|101894680|FG003|COMPLETED|FOLLOW-UP||2||
48636633|NCT04181788|101894681|FG004|COMPLETED|FOLLOW-UP||9||
48636634|NCT04181788|101894682|FG005|COMPLETED|FOLLOW-UP||22||
48636635|NCT04181788|101894677|FG000|NOT COMPLETED|FOLLOW-UP||0||
48636636|NCT04181788|101894678|FG001|NOT COMPLETED|FOLLOW-UP||1||
48636637|NCT04181788|101894679|FG002|NOT COMPLETED|FOLLOW-UP||2||
48636638|NCT04181788|101894680|FG003|NOT COMPLETED|FOLLOW-UP||5||
48636639|NCT04181788|101894681|FG004|NOT COMPLETED|FOLLOW-UP||11||
48636640|NCT04181788|101894682|FG005|NOT COMPLETED|FOLLOW-UP||27||
48415200|NCT01225211|101350222|FG003|COMPLETED|Overall Study||27||
48415201|NCT01225211|101350223|FG004|COMPLETED|Overall Study||23||
48415202|NCT01225211|101350224|FG005|COMPLETED|Overall Study||21||
48415203|NCT01225211|101350225|FG006|COMPLETED|Overall Study||41||
48415204|NCT01225211|101350226|FG007|COMPLETED|Overall Study||11||
48415205|NCT01225211|101350227|FG008|COMPLETED|Overall Study||62||
48636641|NCT01541748|101894683|FG000|STARTED|Overall Study||74||
48636642|NCT01541748|101894683|FG000|COMPLETED|Overall Study||43||
48636643|NCT01541748|101894683|FG000|NOT COMPLETED|Overall Study||31||
48636644|NCT00458835|101894684|FG000|STARTED|Overall Study||5||
48184487|NCT01719861|100775765|FG000|NOT COMPLETED|Cycle 1||4||
48184488|NCT01719861|100775765|FG000|STARTED|Cycle 2||2||
48415206|NCT01225211|101350228|FG009|COMPLETED|Overall Study||57||
48415207|NCT01225211|101350219|FG000|NOT COMPLETED|Overall Study||0||
48415208|NCT01225211|101350220|FG001|NOT COMPLETED|Overall Study||0||
48415209|NCT01225211|101350221|FG002|NOT COMPLETED|Overall Study||1||
48415210|NCT01225211|101350222|FG003|NOT COMPLETED|Overall Study||0||
48415211|NCT01225211|101350223|FG004|NOT COMPLETED|Overall Study||0||
48415212|NCT01225211|101350224|FG005|NOT COMPLETED|Overall Study||0||
48415213|NCT01225211|101350225|FG006|NOT COMPLETED|Overall Study||1||
48415214|NCT01225211|101350226|FG007|NOT COMPLETED|Overall Study||0||
48415215|NCT01225211|101350227|FG008|NOT COMPLETED|Overall Study||1||
48415216|NCT01225211|101350228|FG009|NOT COMPLETED|Overall Study||5||
48415217|NCT04745065|101350229|FG000|STARTED|Overall Study||119||
48415218|NCT04745065|101350230|FG001|STARTED|Overall Study||118||
48415219|NCT04745065|101350229|FG000|COMPLETED|Overall Study||85||
48415220|NCT04745065|101350230|FG001|COMPLETED|Overall Study||88||
48415221|NCT04745065|101350229|FG000|NOT COMPLETED|Overall Study||34||
48184489|NCT01719861|100775765|FG000|COMPLETED|Cycle 2||1||
48184490|NCT01719861|100775765|FG000|NOT COMPLETED|Cycle 2||1||
48184491|NCT01528709|100775766|FG000|STARTED|Overall Study||86||
48184492|NCT01528709|100775767|FG001|STARTED|Overall Study||87||
48415222|NCT04745065|101350230|FG001|NOT COMPLETED|Overall Study||30||
48415223|NCT01590810|101350231|FG000|STARTED|Overall Study||8||
48415224|NCT01590810|101350232|FG001|STARTED|Overall Study||8||
48415225|NCT01590810|101350233|FG002|STARTED|Overall Study||8||
48415226|NCT01590810|101350234|FG003|STARTED|Overall Study||8||
48415227|NCT01590810|101350235|FG004|STARTED|Overall Study||2||
48415228|NCT01590810|101350231|FG000|COMPLETED|Overall Study||8||
48415229|NCT01590810|101350232|FG001|COMPLETED|Overall Study||7||
48415230|NCT01590810|101350233|FG002|COMPLETED|Overall Study||7||
48415231|NCT01590810|101350234|FG003|COMPLETED|Overall Study||8||
48415232|NCT01590810|101350235|FG004|COMPLETED|Overall Study||2||
48415233|NCT01590810|101350231|FG000|NOT COMPLETED|Overall Study||0||
48184493|NCT01528709|100775766|FG000|COMPLETED|Overall Study||73||
48415234|NCT01590810|101350232|FG001|NOT COMPLETED|Overall Study||1||
48415235|NCT01590810|101350233|FG002|NOT COMPLETED|Overall Study||1||
48415236|NCT01590810|101350234|FG003|NOT COMPLETED|Overall Study||0||
48415237|NCT01590810|101350235|FG004|NOT COMPLETED|Overall Study||0||
48415238|NCT01815099|101350236|FG000|STARTED|Overall Study||4||
48415239|NCT01815099|101350236|FG000|Began rTMS Treatment|Overall Study||3||
48345350|NCT01110187|101172516|FG000|STARTED|Overall Study||7||
48345351|NCT01110187|101172517|FG001|STARTED|Overall Study||4||
48345352|NCT01110187|101172516|FG000|COMPLETED|Overall Study||7||
48345353|NCT01110187|101172517|FG001|COMPLETED|Overall Study||4||
48345354|NCT01110187|101172516|FG000|NOT COMPLETED|Overall Study||0||
48345355|NCT01110187|101172517|FG001|NOT COMPLETED|Overall Study||0||
48345356|NCT03093402|101172518|FG000|STARTED|Overall Study||27||
48345357|NCT03093402|101172519|FG001|STARTED|Overall Study||28||
48345358|NCT03093402|101172520|FG002|STARTED|Overall Study||26||
48345359|NCT03093402|101172521|FG003|STARTED|Overall Study||28||
48345360|NCT03093402|101172518|FG000|COMPLETED|Overall Study||20||
48345361|NCT03093402|101172519|FG001|COMPLETED|Overall Study||23||
48345362|NCT03093402|101172520|FG002|COMPLETED|Overall Study||24||
48345363|NCT03093402|101172521|FG003|COMPLETED|Overall Study||24||
48345364|NCT03093402|101172518|FG000|NOT COMPLETED|Overall Study||7||
48345365|NCT03093402|101172519|FG001|NOT COMPLETED|Overall Study||5||
48345366|NCT03093402|101172520|FG002|NOT COMPLETED|Overall Study||2||
48345367|NCT03093402|101172521|FG003|NOT COMPLETED|Overall Study||4||
48345368|NCT03772327|101172522|FG000|STARTED|Overall Study||30|Eligible participants were randomized at the end of a screening visit|
48345369|NCT03772327|101172523|FG001|STARTED|Overall Study||33|Eligible participants were randomized at the end of a screening visit|
48184494|NCT01528709|100775767|FG001|COMPLETED|Overall Study||72||
48345370|NCT03772327|101172522|FG000|Week 0 Visit|Overall Study||28||
48345371|NCT03772327|101172523|FG001|Week 0 Visit|Overall Study||33||
48345372|NCT03772327|101172522|FG000|COMPLETED|Overall Study||25||
48345373|NCT03772327|101172523|FG001|COMPLETED|Overall Study||26||
48345374|NCT03772327|101172522|FG000|NOT COMPLETED|Overall Study||5||
48345375|NCT03772327|101172523|FG001|NOT COMPLETED|Overall Study||7||
48345376|NCT00260208|101172524|FG000|STARTED|Overall Study||184||
48345377|NCT00260208|101172525|FG001|STARTED|Overall Study||172||
48184495|NCT01528709|100775766|FG000|NOT COMPLETED|Overall Study||13||
48184496|NCT01528709|100775767|FG001|NOT COMPLETED|Overall Study||15||
48184497|NCT00787943|100775768|FG000|STARTED|Overall Study||10||
48184498|NCT00787943|100775768|FG000|COMPLETED|Overall Study||10||
48184499|NCT00787943|100775768|FG000|NOT COMPLETED|Overall Study||0||
48184500|NCT02029703|100775769|FG000|STARTED|Overall Study||20||
48184501|NCT02029703|100775770|FG001|STARTED|Overall Study||22||
48184502|NCT02029703|100775769|FG000|COMPLETED|Overall Study||20||
48184503|NCT02029703|100775770|FG001|COMPLETED|Overall Study||22||
48184504|NCT02029703|100775769|FG000|NOT COMPLETED|Overall Study||0||
48184505|NCT02029703|100775770|FG001|NOT COMPLETED|Overall Study||0||
48184506|NCT02912195|100775771|FG000|STARTED|Overall Study||16||
48184507|NCT02912195|100775772|FG001|STARTED|Overall Study||16||
48184508|NCT02912195|100775771|FG000|COMPLETED|Overall Study||16||
48415240|NCT01815099|101350236|FG000|COMPLETED|Overall Study||2|For completers: one completed a protocol of 10 sessions and one completed a protocol of 15 sessions|
48636645|NCT00458835|101894685|FG001|STARTED|Overall Study||5||
48345378|NCT00260208|101172524|FG000|Intent to Treat (ITT) Population|Overall Study||182||
48345379|NCT00260208|101172525|FG001|Intent to Treat (ITT) Population|Overall Study||169||
48345380|NCT00260208|101172524|FG000|Modified ITT|Overall Study||101||
48345381|NCT00260208|101172525|FG001|Modified ITT|Overall Study||96||
48345382|NCT00260208|101172524|FG000|COMPLETED|Overall Study||137||
48345383|NCT00260208|101172525|FG001|COMPLETED|Overall Study||138||
48345384|NCT00260208|101172524|FG000|NOT COMPLETED|Overall Study||47||
48345385|NCT00260208|101172525|FG001|NOT COMPLETED|Overall Study||34||
48345386|NCT03182738|101172526|FG000|STARTED|Overall Study||50||
48345387|NCT03182738|101172527|FG001|STARTED|Overall Study||50||
48345388|NCT03182738|101172526|FG000|COMPLETED|Overall Study||41||
48345389|NCT03182738|101172527|FG001|COMPLETED|Overall Study||45||
48345390|NCT03182738|101172526|FG000|NOT COMPLETED|Overall Study||9||
48345391|NCT03182738|101172527|FG001|NOT COMPLETED|Overall Study||5||
48345392|NCT04646148|101172528|FG000|STARTED|Overall Study||0||
48345393|NCT04646148|101172529|FG001|STARTED|Overall Study||1||
48345394|NCT04646148|101172530|FG002|STARTED|Overall Study||0||
48345395|NCT04646148|101172531|FG003|STARTED|Overall Study||1||
48345396|NCT04646148|101172532|FG004|STARTED|Overall Study||1||
48345397|NCT04646148|101172533|FG005|STARTED|Overall Study||2||
48345398|NCT04646148|101172534|FG006|STARTED|Overall Study||1||
48345399|NCT04646148|101172535|FG007|STARTED|Overall Study||2||
48345400|NCT04646148|101172536|FG008|STARTED|Overall Study||1||
48636646|NCT00458835|101894686|FG002|STARTED|Overall Study||5||
48184509|NCT02912195|100775772|FG001|COMPLETED|Overall Study||16||
48345401|NCT04646148|101172537|FG009|STARTED|Overall Study||2||
48415241|NCT01815099|101350236|FG000|NOT COMPLETED|Overall Study||2||
48415242|NCT02141854|101350237|FG000|STARTED|Run-In Period (Pre-assignment)||882||
48415243|NCT02141854|101350238|FG001|STARTED|Run-In Period (Pre-assignment)||0||
48636647|NCT00458835|101894687|FG003|STARTED|Overall Study||5||
48184510|NCT02912195|100775771|FG000|NOT COMPLETED|Overall Study||0||
48184511|NCT02912195|100775772|FG001|NOT COMPLETED|Overall Study||0||
48345402|NCT04646148|101172538|FG010|STARTED|Overall Study||1||
48345403|NCT04646148|101172539|FG011|STARTED|Overall Study||2||
48345404|NCT04646148|101172540|FG012|STARTED|Overall Study||1||
48345405|NCT04646148|101172541|FG013|STARTED|Overall Study||1||
48345406|NCT04646148|101172542|FG014|STARTED|Overall Study||2||
48636648|NCT00458835|101894688|FG004|STARTED|Overall Study||5||
48759119|NCT02218372|102197754|FG000|COMPLETED|Overall Study||95||
48759120|NCT02218372|102197755|FG001|COMPLETED|Overall Study||42||
48759121|NCT02218372|102197754|FG000|NOT COMPLETED|Overall Study||5||
48759122|NCT02218372|102197755|FG001|NOT COMPLETED|Overall Study||6||
48759123|NCT00984256|102197756|FG000|STARTED|Overall Study||6||
48759124|NCT00984256|102197757|FG001|STARTED|Overall Study||30||
48759125|NCT00984256|102197756|FG000|COMPLETED|Overall Study||6||
48759126|NCT00984256|102197757|FG001|COMPLETED|Overall Study||29||
48759127|NCT00984256|102197756|FG000|NOT COMPLETED|Overall Study||0||
48759128|NCT00984256|102197757|FG001|NOT COMPLETED|Overall Study||1||
48759129|NCT05719311|102197758|FG000|STARTED|Overall Study||13||
48759130|NCT05719311|102197758|FG000|COMPLETED|Overall Study||13||
48759131|NCT05719311|102197758|FG000|NOT COMPLETED|Overall Study||0||
48759132|NCT02004236|102197759|FG000|STARTED|Overall Study||75||
48345407|NCT04646148|101172543|FG015|STARTED|Overall Study||2||
48345408|NCT04646148|101172528|FG000|COMPLETED|Overall Study||0||
48345409|NCT04646148|101172529|FG001|COMPLETED|Overall Study||0||
48345410|NCT04646148|101172530|FG002|COMPLETED|Overall Study||0||
48345411|NCT04646148|101172531|FG003|COMPLETED|Overall Study||1||
48345412|NCT04646148|101172532|FG004|COMPLETED|Overall Study||0||
48345413|NCT04646148|101172533|FG005|COMPLETED|Overall Study||1||
48345414|NCT04646148|101172534|FG006|COMPLETED|Overall Study||0||
48345415|NCT04646148|101172535|FG007|COMPLETED|Overall Study||1||
48345416|NCT04646148|101172536|FG008|COMPLETED|Overall Study||1||
48345417|NCT04646148|101172537|FG009|COMPLETED|Overall Study||2||
48345418|NCT04646148|101172538|FG010|COMPLETED|Overall Study||1||
48345419|NCT04646148|101172539|FG011|COMPLETED|Overall Study||2||
48345420|NCT04646148|101172540|FG012|COMPLETED|Overall Study||1||
48415244|NCT02141854|101350239|FG002|STARTED|Run-In Period (Pre-assignment)||0||
48415245|NCT02141854|101350240|FG003|STARTED|Run-In Period (Pre-assignment)||0||
48415246|NCT02141854|101350241|FG004|STARTED|Run-In Period (Pre-assignment)||0||
48415247|NCT02141854|101350242|FG005|STARTED|Run-In Period (Pre-assignment)||0||
48415248|NCT02141854|101350237|FG000|COMPLETED|Run-In Period (Pre-assignment)||728||
48415249|NCT02141854|101350238|FG001|COMPLETED|Run-In Period (Pre-assignment)||0||
48415250|NCT02141854|101350239|FG002|COMPLETED|Run-In Period (Pre-assignment)||0||
48415251|NCT02141854|101350240|FG003|COMPLETED|Run-In Period (Pre-assignment)||0||
48415252|NCT02141854|101350241|FG004|COMPLETED|Run-In Period (Pre-assignment)||0||
48415253|NCT02141854|101350242|FG005|COMPLETED|Run-In Period (Pre-assignment)||0||
48415254|NCT02141854|101350237|FG000|NOT COMPLETED|Run-In Period (Pre-assignment)||154||
48415255|NCT02141854|101350238|FG001|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
48415256|NCT02141854|101350239|FG002|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
48415257|NCT02141854|101350240|FG003|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
48415258|NCT02141854|101350241|FG004|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
48415259|NCT02141854|101350242|FG005|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
48415260|NCT02141854|101350237|FG000|STARTED|Treatment Period||0||
48415261|NCT02141854|101350238|FG001|STARTED|Treatment Period||146||
48415262|NCT02141854|101350239|FG002|STARTED|Treatment Period||145||
48415263|NCT02141854|101350240|FG003|STARTED|Treatment Period||146||
48636649|NCT00458835|101894689|FG005|STARTED|Overall Study||5||
48759133|NCT02004236|102197760|FG001|STARTED|Overall Study||75||
48759134|NCT02004236|102197761|FG002|STARTED|Overall Study||75||
48759135|NCT02004236|102197759|FG000|COMPLETED|Overall Study||75||
48759136|NCT02004236|102197760|FG001|COMPLETED|Overall Study||75||
48759137|NCT02004236|102197761|FG002|COMPLETED|Overall Study||59||
48759138|NCT02004236|102197759|FG000|NOT COMPLETED|Overall Study||0||
48759139|NCT02004236|102197760|FG001|NOT COMPLETED|Overall Study||0||
48759140|NCT02004236|102197761|FG002|NOT COMPLETED|Overall Study||16||
48345421|NCT04646148|101172541|FG013|COMPLETED|Overall Study||1||
48345422|NCT04646148|101172542|FG014|COMPLETED|Overall Study||2||
48345423|NCT04646148|101172543|FG015|COMPLETED|Overall Study||0||
48636650|NCT00458835|101894684|FG000|COMPLETED|Overall Study||5||
48636651|NCT00458835|101894685|FG001|COMPLETED|Overall Study||5||
48636652|NCT00458835|101894686|FG002|COMPLETED|Overall Study||5||
48636653|NCT00458835|101894687|FG003|COMPLETED|Overall Study||5||
48636654|NCT00458835|101894688|FG004|COMPLETED|Overall Study||5||
48636655|NCT00458835|101894689|FG005|COMPLETED|Overall Study||4||
48636656|NCT00458835|101894684|FG000|NOT COMPLETED|Overall Study||0||
48636657|NCT00458835|101894685|FG001|NOT COMPLETED|Overall Study||0||
48636658|NCT00458835|101894686|FG002|NOT COMPLETED|Overall Study||0||
48636659|NCT00458835|101894687|FG003|NOT COMPLETED|Overall Study||0||
48636660|NCT00458835|101894688|FG004|NOT COMPLETED|Overall Study||0||
48636661|NCT00458835|101894689|FG005|NOT COMPLETED|Overall Study||1||
48636662|NCT00055237|101894690|FG000|STARTED|Overall Study||17||
48636663|NCT00055237|101894691|FG001|STARTED|Overall Study||2||
48636664|NCT00055237|101894690|FG000|COMPLETED|Overall Study||17||
48636665|NCT00055237|101894691|FG001|COMPLETED|Overall Study||2||
48636666|NCT00055237|101894690|FG000|NOT COMPLETED|Overall Study||0||
48636667|NCT00055237|101894691|FG001|NOT COMPLETED|Overall Study||0||
48636668|NCT00248560|101894692|FG000|STARTED|Overall Study||36||
48636669|NCT00248560|101894692|FG000|COMPLETED|Overall Study||36||
48636670|NCT00248560|101894692|FG000|NOT COMPLETED|Overall Study||0||
48415264|NCT02141854|101350241|FG004|STARTED|Treatment Period||146||
48636671|NCT00484159|101894693|FG000|STARTED|Overall Study||50||
48184512|NCT04319094|100775773|FG000|STARTED|Baseline||75||
48184513|NCT04319094|100775774|FG001|STARTED|Baseline||74||
48184514|NCT04319094|100775773|FG000|COMPLETED|Baseline||69||
48184515|NCT04319094|100775774|FG001|COMPLETED|Baseline||65||
48184516|NCT04319094|100775773|FG000|NOT COMPLETED|Baseline||6||
48184517|NCT04319094|100775774|FG001|NOT COMPLETED|Baseline||9||
48184518|NCT04319094|100775773|FG000|STARTED|Post-Intervention||69||
48184519|NCT04319094|100775774|FG001|STARTED|Post-Intervention||65||
48184520|NCT04319094|100775773|FG000|COMPLETED|Post-Intervention||56||
48184521|NCT04319094|100775774|FG001|COMPLETED|Post-Intervention||52||
48184522|NCT04319094|100775773|FG000|NOT COMPLETED|Post-Intervention||13||
48184523|NCT04319094|100775774|FG001|NOT COMPLETED|Post-Intervention||13||
48184524|NCT04319094|100775773|FG000|STARTED|3-month||57||
48184525|NCT04319094|100775774|FG001|STARTED|3-month||55||
48184526|NCT04319094|100775773|FG000|COMPLETED|3-month||45||
48345424|NCT04646148|101172528|FG000|NOT COMPLETED|Overall Study||0||
48345425|NCT04646148|101172529|FG001|NOT COMPLETED|Overall Study||1||
48345426|NCT04646148|101172530|FG002|NOT COMPLETED|Overall Study||0||
48345427|NCT04646148|101172531|FG003|NOT COMPLETED|Overall Study||0||
48345428|NCT04646148|101172532|FG004|NOT COMPLETED|Overall Study||1||
48345429|NCT04646148|101172533|FG005|NOT COMPLETED|Overall Study||1||
48345430|NCT04646148|101172534|FG006|NOT COMPLETED|Overall Study||1||
48345431|NCT04646148|101172535|FG007|NOT COMPLETED|Overall Study||1||
48345432|NCT04646148|101172536|FG008|NOT COMPLETED|Overall Study||0||
48345433|NCT04646148|101172537|FG009|NOT COMPLETED|Overall Study||0||
48345434|NCT04646148|101172538|FG010|NOT COMPLETED|Overall Study||0||
48345435|NCT04646148|101172539|FG011|NOT COMPLETED|Overall Study||0||
48184527|NCT04319094|100775774|FG001|COMPLETED|3-month||43||
48184528|NCT04319094|100775773|FG000|NOT COMPLETED|3-month||12||
48184529|NCT04319094|100775774|FG001|NOT COMPLETED|3-month||12||
48184530|NCT04319094|100775773|FG000|STARTED|6-month||54||
48184531|NCT04319094|100775774|FG001|STARTED|6-month||50||
48184532|NCT04319094|100775773|FG000|COMPLETED|6-month||39||
48184533|NCT04319094|100775774|FG001|COMPLETED|6-month||37||
48184534|NCT04319094|100775773|FG000|NOT COMPLETED|6-month||15||
48184535|NCT04319094|100775774|FG001|NOT COMPLETED|6-month||13||
48184536|NCT04319094|100775773|FG000|STARTED|9-month||53||
48184537|NCT04319094|100775774|FG001|STARTED|9-month||46||
48184538|NCT04319094|100775773|FG000|COMPLETED|9-month||37||
48345436|NCT04646148|101172540|FG012|NOT COMPLETED|Overall Study||0||
48345437|NCT04646148|101172541|FG013|NOT COMPLETED|Overall Study||0||
48345438|NCT04646148|101172542|FG014|NOT COMPLETED|Overall Study||0||
48345439|NCT04646148|101172543|FG015|NOT COMPLETED|Overall Study||2||
48345440|NCT01145560|101172544|FG000|STARTED|Overall Study||100||
48345441|NCT01145560|101172545|FG001|STARTED|Overall Study||100||
48184539|NCT04319094|100775774|FG001|COMPLETED|9-month||36||
48184540|NCT04319094|100775773|FG000|NOT COMPLETED|9-month||16||
48184541|NCT04319094|100775774|FG001|NOT COMPLETED|9-month||10||
48184542|NCT04319094|100775773|FG000|STARTED|12-month||45||
48184543|NCT04319094|100775774|FG001|STARTED|12-month||41||
48184544|NCT04319094|100775773|FG000|COMPLETED|12-month||34||
48345442|NCT01145560|101172546|FG002|STARTED|Overall Study||100||
48345443|NCT01145560|101172544|FG000|Received Treatment|Overall Study||99||
48415265|NCT02141854|101350242|FG005|STARTED|Treatment Period||145||
48636672|NCT00484159|101894694|FG001|STARTED|Overall Study||50||
48184545|NCT04319094|100775774|FG001|COMPLETED|12-month||33||
48184546|NCT04319094|100775773|FG000|NOT COMPLETED|12-month||11||
48184547|NCT04319094|100775774|FG001|NOT COMPLETED|12-month||8||
48184548|NCT04545619|100775775|FG000|STARTED|Overall Study||40||
48184549|NCT04545619|100775775|FG000|QDOT nGEN Catheter Inserted|Overall Study||39||
48184550|NCT04545619|100775775|FG000|COMPLETED|Overall Study||39||
48184551|NCT04545619|100775775|FG000|NOT COMPLETED|Overall Study||1||
48345444|NCT01145560|101172545|FG001|Received Treatment|Overall Study||98||
48345445|NCT01145560|101172546|FG002|Received Treatment|Overall Study||99||
48345446|NCT01145560|101172544|FG000|Completed Treatment|Overall Study||69||
48345447|NCT01145560|101172545|FG001|Completed Treatment|Overall Study||85||
48345448|NCT01145560|101172546|FG002|Completed Treatment|Overall Study||78||
48345449|NCT01145560|101172544|FG000|COMPLETED|Overall Study||96||
48415266|NCT02141854|101350237|FG000|Intent to Treat Population|Treatment Period||0||
48759141|NCT05138653|102197762|FG000|STARTED|Single Ascending Dose (Up to 13 Weeks)||2||
48759142|NCT05138653|102197763|FG001|STARTED|Single Ascending Dose (Up to 13 Weeks)||4||
48759143|NCT05138653|102197764|FG002|STARTED|Single Ascending Dose (Up to 13 Weeks)||2||
48759144|NCT05138653|102197765|FG003|STARTED|Single Ascending Dose (Up to 13 Weeks)||2||
48759145|NCT05138653|102197766|FG004|STARTED|Single Ascending Dose (Up to 13 Weeks)||3||
48759146|NCT05138653|102197767|FG005|STARTED|Single Ascending Dose (Up to 13 Weeks)||2||
48759147|NCT05138653|102197768|FG006|STARTED|Single Ascending Dose (Up to 13 Weeks)||3||
48759148|NCT05138653|102197769|FG007|STARTED|Single Ascending Dose (Up to 13 Weeks)||2||
48759149|NCT05138653|102197770|FG008|STARTED|Single Ascending Dose (Up to 13 Weeks)||4||
48759150|NCT05138653|102197771|FG009|STARTED|Single Ascending Dose (Up to 13 Weeks)||3||
48759151|NCT05138653|102197772|FG010|STARTED|Single Ascending Dose (Up to 13 Weeks)||0||
48415267|NCT02141854|101350238|FG001|Intent to Treat Population|Treatment Period||146||
48415268|NCT02141854|101350239|FG002|Intent to Treat Population|Treatment Period||145||
48759152|NCT05138653|102197773|FG011|STARTED|Single Ascending Dose (Up to 13 Weeks)||0||
48759153|NCT05138653|102197774|FG012|STARTED|Single Ascending Dose (Up to 13 Weeks)||0||
48759154|NCT05138653|102197775|FG013|STARTED|Single Ascending Dose (Up to 13 Weeks)||0||
48759155|NCT05138653|102197776|FG014|STARTED|Single Ascending Dose (Up to 13 Weeks)||0||
48759156|NCT05138653|102197777|FG015|STARTED|Single Ascending Dose (Up to 13 Weeks)||0||
48759157|NCT05138653|102197762|FG000|COMPLETED|Single Ascending Dose (Up to 13 Weeks)||1||
48759158|NCT05138653|102197763|FG001|COMPLETED|Single Ascending Dose (Up to 13 Weeks)||2||
48759159|NCT05138653|102197764|FG002|COMPLETED|Single Ascending Dose (Up to 13 Weeks)||2||
48759160|NCT05138653|102197765|FG003|COMPLETED|Single Ascending Dose (Up to 13 Weeks)||2||
48345450|NCT01145560|101172545|FG001|COMPLETED|Overall Study||96||
48345451|NCT01145560|101172546|FG002|COMPLETED|Overall Study||98||
48345452|NCT01145560|101172544|FG000|NOT COMPLETED|Overall Study||4||
48345453|NCT01145560|101172545|FG001|NOT COMPLETED|Overall Study||4||
48345454|NCT01145560|101172546|FG002|NOT COMPLETED|Overall Study||2||
48345455|NCT02601573|101172547|FG000|STARTED|Overall Study||23||
48345456|NCT02601573|101172548|FG001|STARTED|Overall Study||24||
48345457|NCT02601573|101172549|FG002|STARTED|Overall Study||17||
48345458|NCT02601573|101172550|FG003|STARTED|Overall Study||18||
48345459|NCT02601573|101172551|FG004|STARTED|Overall Study||18||
48345460|NCT02601573|101172547|FG000|COMPLETED|Overall Study||23||
48345461|NCT02601573|101172548|FG001|COMPLETED|Overall Study||20||
48345462|NCT02601573|101172549|FG002|COMPLETED|Overall Study||16||
48345463|NCT02601573|101172550|FG003|COMPLETED|Overall Study||17||
48345464|NCT02601573|101172551|FG004|COMPLETED|Overall Study||16||
48345465|NCT02601573|101172547|FG000|NOT COMPLETED|Overall Study||0||
48345466|NCT02601573|101172548|FG001|NOT COMPLETED|Overall Study||4||
48345467|NCT02601573|101172549|FG002|NOT COMPLETED|Overall Study||1||
48345468|NCT02601573|101172550|FG003|NOT COMPLETED|Overall Study||1||
48345469|NCT02601573|101172551|FG004|NOT COMPLETED|Overall Study||2||
48345470|NCT01431287|101176429|FG000|STARTED|Overall Study||510||
48345471|NCT01431287|101176430|FG001|STARTED|Overall Study||507||
48345472|NCT01431287|101176431|FG002|STARTED|Overall Study||507||
48345473|NCT01431287|101176432|FG003|STARTED|Overall Study||508||
48345474|NCT01431287|101176433|FG004|STARTED|Overall Study||507||
48345475|NCT01431287|101176429|FG000|COMPLETED|Overall Study||412||
48184552|NCT00999661|100775776|FG000|STARTED|Overall Study||231||
48184553|NCT00999661|100775776|FG000|COMPLETED|Overall Study||161||
48184554|NCT00999661|100775776|FG000|NOT COMPLETED|Overall Study||70||
48184555|NCT02092987|100775777|FG000|STARTED|Overall Study||110||
48184556|NCT02092987|100775778|FG001|STARTED|Overall Study||111||
48184557|NCT02092987|100775777|FG000|COMPLETED|Overall Study||106||
48184558|NCT02092987|100775778|FG001|COMPLETED|Overall Study||103||
48184559|NCT02092987|100775777|FG000|NOT COMPLETED|Overall Study||4||
48184560|NCT02092987|100775778|FG001|NOT COMPLETED|Overall Study||8||
48184561|NCT02414828|100775779|FG000|STARTED|Overall Study||11||
48184562|NCT02414828|100775780|FG001|STARTED|Overall Study||10||
48184563|NCT02414828|100775781|FG002|STARTED|Overall Study||20||
48184564|NCT02414828|100775782|FG003|STARTED|Overall Study||31||
48184565|NCT02414828|100775779|FG000|COMPLETED|Overall Study||11||
48184566|NCT02414828|100775780|FG001|COMPLETED|Overall Study||9||
48184567|NCT02414828|100775781|FG002|COMPLETED|Overall Study||19||
48184568|NCT02414828|100775782|FG003|COMPLETED|Overall Study||29||
48184569|NCT02414828|100775779|FG000|NOT COMPLETED|Overall Study||0||
48184570|NCT02414828|100775780|FG001|NOT COMPLETED|Overall Study||1||
48184571|NCT02414828|100775781|FG002|NOT COMPLETED|Overall Study||1||
48184572|NCT02414828|100775782|FG003|NOT COMPLETED|Overall Study||2||
48345476|NCT01431287|101176430|FG001|COMPLETED|Overall Study||409||
48345477|NCT01431287|101176431|FG002|COMPLETED|Overall Study||410||
48345478|NCT01431287|101176432|FG003|COMPLETED|Overall Study||445||
48345479|NCT01431287|101176433|FG004|COMPLETED|Overall Study||430||
48345480|NCT01431287|101176429|FG000|NOT COMPLETED|Overall Study||98||
48345481|NCT01431287|101176430|FG001|NOT COMPLETED|Overall Study||98||
48345482|NCT01431287|101176431|FG002|NOT COMPLETED|Overall Study||97||
48345483|NCT01431287|101176432|FG003|NOT COMPLETED|Overall Study||63||
48184573|NCT00333138|100775783|FG000|STARTED|Core Study (6 Months)||93||
48184574|NCT00333138|100775784|FG001|STARTED|Core Study (6 Months)||94||
48184575|NCT00333138|100775785|FG002|STARTED|Core Study (6 Months)||94||
48184576|NCT00333138|100775783|FG000|COMPLETED|Core Study (6 Months)||86||
48184577|NCT00333138|100775784|FG001|COMPLETED|Core Study (6 Months)||88||
48184578|NCT00333138|100775785|FG002|COMPLETED|Core Study (6 Months)||82||
48184579|NCT00333138|100775783|FG000|NOT COMPLETED|Core Study (6 Months)||7||
48184580|NCT00333138|100775784|FG001|NOT COMPLETED|Core Study (6 Months)||6||
48184581|NCT00333138|100775785|FG002|NOT COMPLETED|Core Study (6 Months)||12||
48345484|NCT01431287|101176433|FG004|NOT COMPLETED|Overall Study||77||
48345485|NCT00793793|101176434|FG000|STARTED|Overall Study||8||
48345486|NCT00793793|101176435|FG001|STARTED|Overall Study||6||
48345487|NCT00793793|101176436|FG002|STARTED|Overall Study||7||
48345488|NCT00793793|101176437|FG003|STARTED|Overall Study||7||
48345489|NCT00793793|101176438|FG004|STARTED|Overall Study||6||
48345490|NCT00793793|101176439|FG005|STARTED|Overall Study||6||
48345491|NCT00793793|101176440|FG006|STARTED|Overall Study||7||
48345492|NCT00793793|101176441|FG007|STARTED|Overall Study||6||
48345493|NCT00793793|101176442|FG008|STARTED|Overall Study||15||
48345494|NCT00793793|101176443|FG009|STARTED|Overall Study||15||
48345495|NCT00793793|101176444|FG010|STARTED|Overall Study||6||
48345496|NCT00793793|101176445|FG011|STARTED|Overall Study||7||
48345497|NCT00793793|101176434|FG000|COMPLETED|Overall Study||8||
48345498|NCT00793793|101176435|FG001|COMPLETED|Overall Study||5||
48345499|NCT00793793|101176436|FG002|COMPLETED|Overall Study||5||
48345500|NCT00793793|101176437|FG003|COMPLETED|Overall Study||4||
48345501|NCT00793793|101176438|FG004|COMPLETED|Overall Study||4||
48184582|NCT00333138|100775783|FG000|STARTED|Extension Study (Month6 to End of Study)||83||
48345502|NCT00793793|101176439|FG005|COMPLETED|Overall Study||4||
48345503|NCT00793793|101176440|FG006|COMPLETED|Overall Study||3||
48345504|NCT00793793|101176441|FG007|COMPLETED|Overall Study||6||
48345505|NCT00793793|101176442|FG008|COMPLETED|Overall Study||6||
48345506|NCT00793793|101176443|FG009|COMPLETED|Overall Study||6||
48345507|NCT00793793|101176444|FG010|COMPLETED|Overall Study||3||
48184583|NCT00333138|100775784|FG001|STARTED|Extension Study (Month6 to End of Study)||87||
48345508|NCT00793793|101176445|FG011|COMPLETED|Overall Study||1||
48345509|NCT00793793|101176434|FG000|NOT COMPLETED|Overall Study||0||
48345510|NCT00793793|101176435|FG001|NOT COMPLETED|Overall Study||1||
48345511|NCT00793793|101176436|FG002|NOT COMPLETED|Overall Study||2||
48345512|NCT00793793|101176437|FG003|NOT COMPLETED|Overall Study||3||
48184584|NCT00333138|100775785|FG002|STARTED|Extension Study (Month6 to End of Study)||80||
48184585|NCT00333138|100775783|FG000|COMPLETED|Extension Study (Month6 to End of Study)||40||
48184586|NCT00333138|100775784|FG001|COMPLETED|Extension Study (Month6 to End of Study)||45||
48184587|NCT00333138|100775785|FG002|COMPLETED|Extension Study (Month6 to End of Study)||37||
48184588|NCT00333138|100775783|FG000|NOT COMPLETED|Extension Study (Month6 to End of Study)||43||
48184589|NCT00333138|100775784|FG001|NOT COMPLETED|Extension Study (Month6 to End of Study)||42||
48184590|NCT00333138|100775785|FG002|NOT COMPLETED|Extension Study (Month6 to End of Study)||43||
48184591|NCT04001114|100775786|FG000|STARTED|Overall Study||18||
48184592|NCT04001114|100775787|FG001|STARTED|Overall Study||13||
48184593|NCT04001114|100775786|FG000|COMPLETED|Overall Study||17||
48184594|NCT04001114|100775787|FG001|COMPLETED|Overall Study||9||
48184595|NCT04001114|100775786|FG000|NOT COMPLETED|Overall Study||1||
48184596|NCT04001114|100775787|FG001|NOT COMPLETED|Overall Study||4||
48184597|NCT00176865|100775788|FG000|STARTED|Overall Study||3||
48184598|NCT00176865|100775789|FG001|STARTED|Overall Study||10||
48184599|NCT00176865|100775790|FG002|STARTED|Overall Study||6||
48184600|NCT00176865|100775788|FG000|COMPLETED|Overall Study||3||
48184601|NCT00176865|100775789|FG001|COMPLETED|Overall Study||10||
48184602|NCT00176865|100775790|FG002|COMPLETED|Overall Study||6||
48184603|NCT00176865|100775788|FG000|NOT COMPLETED|Overall Study||0||
48184604|NCT00176865|100775789|FG001|NOT COMPLETED|Overall Study||0||
48184605|NCT00176865|100775790|FG002|NOT COMPLETED|Overall Study||0||
48184606|NCT02303574|100775791|FG000|STARTED|Part 1a (Fasted State)- SAD||6||
48184607|NCT02303574|100775792|FG001|STARTED|Part 1a (Fasted State)- SAD||6||
48345513|NCT00793793|101176438|FG004|NOT COMPLETED|Overall Study||2||
48345514|NCT00793793|101176439|FG005|NOT COMPLETED|Overall Study||2||
48345515|NCT00793793|101176440|FG006|NOT COMPLETED|Overall Study||4||
48345516|NCT00793793|101176441|FG007|NOT COMPLETED|Overall Study||0||
48345517|NCT00793793|101176442|FG008|NOT COMPLETED|Overall Study||9||
48345518|NCT00793793|101176443|FG009|NOT COMPLETED|Overall Study||9||
48345519|NCT00793793|101176444|FG010|NOT COMPLETED|Overall Study||3||
48345520|NCT00793793|101176445|FG011|NOT COMPLETED|Overall Study||6||
48345521|NCT01910792|101176446|FG000|STARTED|Overall Study||9||
48345522|NCT01910792|101176447|FG001|STARTED|Overall Study||10||
48345523|NCT01910792|101176446|FG000|COMPLETED|Overall Study||9||
48345524|NCT01910792|101176447|FG001|COMPLETED|Overall Study||10||
48345525|NCT01910792|101176446|FG000|NOT COMPLETED|Overall Study||0||
48345526|NCT01910792|101176447|FG001|NOT COMPLETED|Overall Study||0||
48345527|NCT00981526|101176448|FG000|STARTED|Overall Study||26||
48345528|NCT00981526|101176449|FG001|STARTED|Overall Study||28||
48345529|NCT00981526|101176448|FG000|COMPLETED|Overall Study||22||
48345530|NCT00981526|101176449|FG001|COMPLETED|Overall Study||22||
48345531|NCT00981526|101176448|FG000|NOT COMPLETED|Overall Study||4||
48345532|NCT00981526|101176449|FG001|NOT COMPLETED|Overall Study||6||
48345533|NCT01193686|101176450|FG000|STARTED|Overall Study||15||
48345534|NCT01193686|101176451|FG001|STARTED|Overall Study||9||
48345535|NCT01193686|101176450|FG000|Completed Baseline Assessment|Overall Study||15||
48345536|NCT01193686|101176451|FG001|Completed Baseline Assessment|Overall Study||9||
48345537|NCT01193686|101176450|FG000|Completed Mentor Training|Overall Study||9||
48345538|NCT01193686|101176451|FG001|Completed Mentor Training|Overall Study||0||
48415269|NCT02141854|101350240|FG003|Intent to Treat Population|Treatment Period||146||
48415270|NCT02141854|101350241|FG004|Intent to Treat Population|Treatment Period||146||
48415271|NCT02141854|101350242|FG005|Intent to Treat Population|Treatment Period||145||
48415272|NCT02141854|101350237|FG000|Safety Population|Treatment Period||0||
48415273|NCT02141854|101350238|FG001|Safety Population|Treatment Period||145||
48415274|NCT02141854|101350239|FG002|Safety Population|Treatment Period||143||
48345539|NCT01193686|101176450|FG000|Completed Visits and Final Assessment|Overall Study||8||
48345540|NCT01193686|101176451|FG001|Completed Visits and Final Assessment|Overall Study||8||
48345541|NCT01193686|101176450|FG000|COMPLETED|Overall Study||8||
48345542|NCT01193686|101176451|FG001|COMPLETED|Overall Study||8||
48345543|NCT01193686|101176450|FG000|NOT COMPLETED|Overall Study||7||
48415275|NCT02141854|101350240|FG003|Safety Population|Treatment Period||146||
48345544|NCT01193686|101176451|FG001|NOT COMPLETED|Overall Study||1||
48345545|NCT00127127|101176452|FG000|STARTED|Overall Study||3||
48345546|NCT00127127|101176453|FG001|STARTED|Overall Study||6||
48345547|NCT00127127|101176454|FG002|STARTED|Overall Study||3||
48345548|NCT00127127|101176455|FG003|STARTED|Overall Study||6||
48345549|NCT00127127|101176452|FG000|COMPLETED|Overall Study||2||
48345550|NCT00127127|101176453|FG001|COMPLETED|Overall Study||1||
48345551|NCT00127127|101176454|FG002|COMPLETED|Overall Study||3||
48345552|NCT00127127|101176455|FG003|COMPLETED|Overall Study||3||
48345553|NCT00127127|101176452|FG000|NOT COMPLETED|Overall Study||1||
48345554|NCT00127127|101176453|FG001|NOT COMPLETED|Overall Study||5||
48345555|NCT00127127|101176454|FG002|NOT COMPLETED|Overall Study||0||
48345556|NCT00127127|101176455|FG003|NOT COMPLETED|Overall Study||3||
48345557|NCT02162862|101176456|FG000|STARTED|Overall Study||31||
48345558|NCT02162862|101176457|FG001|STARTED|Overall Study||35||
48345559|NCT02162862|101176458|FG002|STARTED|Overall Study||33||
48345560|NCT02162862|101176456|FG000|COMPLETED|Overall Study||31||
48345561|NCT02162862|101176457|FG001|COMPLETED|Overall Study||24||
48345562|NCT02162862|101176458|FG002|COMPLETED|Overall Study||29||
48415276|NCT02141854|101350241|FG004|Safety Population|Treatment Period||145||
48415277|NCT02141854|101350242|FG005|Safety Population|Treatment Period||144||
48415278|NCT02141854|101350237|FG000|Full Analysis Set|Treatment Period||0||
48415279|NCT02141854|101350238|FG001|Full Analysis Set|Treatment Period||145||
48415280|NCT02141854|101350239|FG002|Full Analysis Set|Treatment Period||141||
48184608|NCT02303574|100775793|FG002|STARTED|Part 1a (Fasted State)- SAD||6||
48184609|NCT02303574|100775794|FG003|STARTED|Part 1a (Fasted State)- SAD||6||
48184610|NCT02303574|100775795|FG004|STARTED|Part 1a (Fasted State)- SAD||6||
48184611|NCT02303574|100775796|FG005|STARTED|Part 1a (Fasted State)- SAD||0||
48184612|NCT02303574|100775797|FG006|STARTED|Part 1a (Fasted State)- SAD||0||
48184613|NCT02303574|100775798|FG007|STARTED|Part 1a (Fasted State)- SAD||0||
48184614|NCT02303574|100775799|FG008|STARTED|Part 1a (Fasted State)- SAD||0||
48184615|NCT02303574|100775800|FG009|STARTED|Part 1a (Fasted State)- SAD||15||
48184616|NCT02303574|100775791|FG000|COMPLETED|Part 1a (Fasted State)- SAD||6||
48184617|NCT02303574|100775792|FG001|COMPLETED|Part 1a (Fasted State)- SAD||6||
48184618|NCT02303574|100775793|FG002|COMPLETED|Part 1a (Fasted State)- SAD||5||
48184619|NCT02303574|100775794|FG003|COMPLETED|Part 1a (Fasted State)- SAD||6||
48184620|NCT02303574|100775795|FG004|COMPLETED|Part 1a (Fasted State)- SAD||6||
48184621|NCT02303574|100775796|FG005|COMPLETED|Part 1a (Fasted State)- SAD||0||
48184622|NCT02303574|100775797|FG006|COMPLETED|Part 1a (Fasted State)- SAD||0||
48184623|NCT02303574|100775798|FG007|COMPLETED|Part 1a (Fasted State)- SAD||0||
48184624|NCT02303574|100775799|FG008|COMPLETED|Part 1a (Fasted State)- SAD||0||
48184625|NCT02303574|100775800|FG009|COMPLETED|Part 1a (Fasted State)- SAD||15||
48184626|NCT02303574|100775791|FG000|NOT COMPLETED|Part 1a (Fasted State)- SAD||0||
48184627|NCT02303574|100775792|FG001|NOT COMPLETED|Part 1a (Fasted State)- SAD||0||
48184628|NCT02303574|100775793|FG002|NOT COMPLETED|Part 1a (Fasted State)- SAD||1||
48184629|NCT02303574|100775794|FG003|NOT COMPLETED|Part 1a (Fasted State)- SAD||0||
48184630|NCT02303574|100775795|FG004|NOT COMPLETED|Part 1a (Fasted State)- SAD||0||
48345563|NCT02162862|101176456|FG000|NOT COMPLETED|Overall Study||0||
48345564|NCT02162862|101176457|FG001|NOT COMPLETED|Overall Study||11||
48415281|NCT02141854|101350240|FG003|Full Analysis Set|Treatment Period||146||
48415282|NCT02141854|101350241|FG004|Full Analysis Set|Treatment Period||145||
48415283|NCT02141854|101350242|FG005|Full Analysis Set|Treatment Period||143||
48415284|NCT02141854|101350237|FG000|COMPLETED|Treatment Period||0||
48184631|NCT02303574|100775796|FG005|NOT COMPLETED|Part 1a (Fasted State)- SAD||0||
48184632|NCT02303574|100775797|FG006|NOT COMPLETED|Part 1a (Fasted State)- SAD||0||
48184633|NCT02303574|100775798|FG007|NOT COMPLETED|Part 1a (Fasted State)- SAD||0||
48184634|NCT02303574|100775799|FG008|NOT COMPLETED|Part 1a (Fasted State)- SAD||0||
48184635|NCT02303574|100775800|FG009|NOT COMPLETED|Part 1a (Fasted State)- SAD||0||
48184636|NCT02303574|100775791|FG000|STARTED|Part 1b (Fed State) - SAD||0||
48184637|NCT02303574|100775792|FG001|STARTED|Part 1b (Fed State) - SAD||0||
48184638|NCT02303574|100775793|FG002|STARTED|Part 1b (Fed State) - SAD||0||
48345565|NCT02162862|101176458|FG002|NOT COMPLETED|Overall Study||4||
48345566|NCT02945657|101176459|FG000|STARTED|Overall Study||32||
48345567|NCT02945657|101176459|FG000|COMPLETED|Overall Study||28||
48415285|NCT02141854|101350238|FG001|COMPLETED|Treatment Period||136||
48415286|NCT02141854|101350239|FG002|COMPLETED|Treatment Period||136||
48415287|NCT02141854|101350240|FG003|COMPLETED|Treatment Period||135||
48184639|NCT02303574|100775794|FG003|STARTED|Part 1b (Fed State) - SAD||0||
48184640|NCT02303574|100775795|FG004|STARTED|Part 1b (Fed State) - SAD||0||
48184641|NCT02303574|100775796|FG005|STARTED|Part 1b (Fed State) - SAD||5||
48184642|NCT02303574|100775797|FG006|STARTED|Part 1b (Fed State) - SAD||0||
48184643|NCT02303574|100775798|FG007|STARTED|Part 1b (Fed State) - SAD||0||
48184644|NCT02303574|100775799|FG008|STARTED|Part 1b (Fed State) - SAD||0||
48415288|NCT02141854|101350241|FG004|COMPLETED|Treatment Period||136||
48415289|NCT02141854|101350242|FG005|COMPLETED|Treatment Period||107||
48415290|NCT02141854|101350237|FG000|NOT COMPLETED|Treatment Period||0||
48415291|NCT02141854|101350238|FG001|NOT COMPLETED|Treatment Period||10||
48415292|NCT02141854|101350239|FG002|NOT COMPLETED|Treatment Period||9||
48345568|NCT02945657|101176459|FG000|NOT COMPLETED|Overall Study||4||
48345569|NCT03244059|101176460|FG000|STARTED|Specific Aim 1||11||
48345570|NCT03244059|101176461|FG001|STARTED|Specific Aim 1||6||
48345571|NCT03244059|101176460|FG000|COMPLETED|Specific Aim 1||10||
48345572|NCT03244059|101176461|FG001|COMPLETED|Specific Aim 1||6||
48345573|NCT03244059|101176460|FG000|NOT COMPLETED|Specific Aim 1||1||
48345574|NCT03244059|101176461|FG001|NOT COMPLETED|Specific Aim 1||0||
48415293|NCT02141854|101350240|FG003|NOT COMPLETED|Treatment Period||11||
48184645|NCT02303574|100775800|FG009|STARTED|Part 1b (Fed State) - SAD||3||
48184646|NCT02303574|100775791|FG000|COMPLETED|Part 1b (Fed State) - SAD||0||
48184647|NCT02303574|100775792|FG001|COMPLETED|Part 1b (Fed State) - SAD||0||
48184648|NCT02303574|100775793|FG002|COMPLETED|Part 1b (Fed State) - SAD||0||
48184649|NCT02303574|100775794|FG003|COMPLETED|Part 1b (Fed State) - SAD||0||
48184650|NCT02303574|100775795|FG004|COMPLETED|Part 1b (Fed State) - SAD||0||
48184651|NCT02303574|100775796|FG005|COMPLETED|Part 1b (Fed State) - SAD||5||
48184652|NCT02303574|100775797|FG006|COMPLETED|Part 1b (Fed State) - SAD||0||
48184653|NCT02303574|100775798|FG007|COMPLETED|Part 1b (Fed State) - SAD||0||
48184654|NCT02303574|100775799|FG008|COMPLETED|Part 1b (Fed State) - SAD||0||
48345575|NCT03244059|101176460|FG000|STARTED|Specific Aim 2||11||
48345576|NCT03244059|101176461|FG001|STARTED|Specific Aim 2||6||
48345577|NCT03244059|101176460|FG000|COMPLETED|Specific Aim 2||10||
48415294|NCT02141854|101350241|FG004|NOT COMPLETED|Treatment Period||10||
48345578|NCT03244059|101176461|FG001|COMPLETED|Specific Aim 2||6||
48345579|NCT03244059|101176460|FG000|NOT COMPLETED|Specific Aim 2||1||
48184655|NCT02303574|100775800|FG009|COMPLETED|Part 1b (Fed State) - SAD||3||
48345580|NCT03244059|101176461|FG001|NOT COMPLETED|Specific Aim 2||0||
48345581|NCT02533089|101176462|FG000|STARTED|Overall Study||605||51
48415295|NCT02141854|101350242|FG005|NOT COMPLETED|Treatment Period||38||
48415296|NCT01228084|101350243|FG000|STARTED|Overall Study||20||
48184656|NCT02303574|100775791|FG000|NOT COMPLETED|Part 1b (Fed State) - SAD||0||
48345582|NCT02533089|101176463|FG001|STARTED|Overall Study||548||52
48636673|NCT00484159|101894695|FG002|STARTED|Overall Study||51||
48636674|NCT00484159|101894693|FG000|COMPLETED|Overall Study||49||
48636675|NCT00484159|101894694|FG001|COMPLETED|Overall Study||49||
48636676|NCT00484159|101894695|FG002|COMPLETED|Overall Study||51||
48636677|NCT00484159|101894693|FG000|NOT COMPLETED|Overall Study||1||
48636678|NCT00484159|101894694|FG001|NOT COMPLETED|Overall Study||1||
48636679|NCT00484159|101894695|FG002|NOT COMPLETED|Overall Study||0||
48636680|NCT02841046|101894696|FG000|STARTED|Overall Study||25||
48184657|NCT02303574|100775792|FG001|NOT COMPLETED|Part 1b (Fed State) - SAD||0||
48345583|NCT02533089|101176462|FG000|COMPLETED|Overall Study||364||36
48345584|NCT02533089|101176463|FG001|COMPLETED|Overall Study||434||38
48345585|NCT02533089|101176462|FG000|NOT COMPLETED|Overall Study||241||15
48345586|NCT02533089|101176463|FG001|NOT COMPLETED|Overall Study||114||14
48345587|NCT00213239|101176464|FG000|STARTED|Overall Study||32||
48345588|NCT00213239|101176465|FG001|STARTED|Overall Study||32||
48345589|NCT00213239|101176464|FG000|COMPLETED|Overall Study||32||
48345590|NCT00213239|101176465|FG001|COMPLETED|Overall Study||32||
48345591|NCT00213239|101176464|FG000|NOT COMPLETED|Overall Study||0||
48345592|NCT00213239|101176465|FG001|NOT COMPLETED|Overall Study||0||
48345593|NCT01624194|101176466|FG000|STARTED|Overall Study||16||
48345594|NCT01624194|101176467|FG001|STARTED|Overall Study||18||
48345595|NCT01624194|101176466|FG000|COMPLETED|Overall Study||14||
48636681|NCT02841046|101894697|FG001|STARTED|Overall Study||25||
48636682|NCT02841046|101894696|FG000|COMPLETED|Overall Study||25||
48636683|NCT02841046|101894697|FG001|COMPLETED|Overall Study||25||
48636684|NCT02841046|101894696|FG000|NOT COMPLETED|Overall Study||0||
48636685|NCT02841046|101894697|FG001|NOT COMPLETED|Overall Study||0||
48636686|NCT02300610|101894698|FG000|STARTED|Overall Study||3||
48759161|NCT05138653|102197766|FG004|COMPLETED|Single Ascending Dose (Up to 13 Weeks)||2||
48636687|NCT02300610|101894699|FG001|STARTED|Overall Study||3||
48636688|NCT02300610|101894700|FG002|STARTED|Overall Study||4||
48636689|NCT02300610|101894698|FG000|COMPLETED|Overall Study||2||
48636690|NCT02300610|101894699|FG001|COMPLETED|Overall Study||3||
48184658|NCT02303574|100775793|FG002|NOT COMPLETED|Part 1b (Fed State) - SAD||0||
48184659|NCT02303574|100775794|FG003|NOT COMPLETED|Part 1b (Fed State) - SAD||0||
48184660|NCT02303574|100775795|FG004|NOT COMPLETED|Part 1b (Fed State) - SAD||0||
48184661|NCT02303574|100775796|FG005|NOT COMPLETED|Part 1b (Fed State) - SAD||0||
48184662|NCT02303574|100775797|FG006|NOT COMPLETED|Part 1b (Fed State) - SAD||0||
48184663|NCT02303574|100775798|FG007|NOT COMPLETED|Part 1b (Fed State) - SAD||0||
48184664|NCT02303574|100775799|FG008|NOT COMPLETED|Part 1b (Fed State) - SAD||0||
48184665|NCT02303574|100775800|FG009|NOT COMPLETED|Part 1b (Fed State) - SAD||0||
48184666|NCT02303574|100775791|FG000|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0||
48184667|NCT02303574|100775792|FG001|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0||
48184668|NCT02303574|100775793|FG002|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0||
48184669|NCT02303574|100775794|FG003|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0||
48184670|NCT02303574|100775795|FG004|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0||
48184671|NCT02303574|100775796|FG005|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0||
48184672|NCT02303574|100775797|FG006|STARTED|Part 2 - Multiple Ascending Dose (MAD)||6||
48184673|NCT02303574|100775798|FG007|STARTED|Part 2 - Multiple Ascending Dose (MAD)||8||
48184674|NCT02303574|100775799|FG008|STARTED|Part 2 - Multiple Ascending Dose (MAD)||10||
48184675|NCT02303574|100775800|FG009|STARTED|Part 2 - Multiple Ascending Dose (MAD)||12||
48184676|NCT02303574|100775791|FG000|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0||
48184677|NCT02303574|100775792|FG001|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0||
48345596|NCT01624194|101176467|FG001|COMPLETED|Overall Study||18||
48636691|NCT02300610|101894700|FG002|COMPLETED|Overall Study||3||
48636692|NCT02300610|101894698|FG000|NOT COMPLETED|Overall Study||1||
48636693|NCT02300610|101894699|FG001|NOT COMPLETED|Overall Study||0||
48636694|NCT02300610|101894700|FG002|NOT COMPLETED|Overall Study||1||
48636695|NCT03315949|101894701|FG000|STARTED|Overall Study||176||
48636696|NCT03315949|101894702|FG001|STARTED|Overall Study||176||
48759162|NCT05138653|102197767|FG005|COMPLETED|Single Ascending Dose (Up to 13 Weeks)||2||
48759163|NCT05138653|102197768|FG006|COMPLETED|Single Ascending Dose (Up to 13 Weeks)||2||
48759164|NCT05138653|102197769|FG007|COMPLETED|Single Ascending Dose (Up to 13 Weeks)||2||
48759165|NCT05138653|102197770|FG008|COMPLETED|Single Ascending Dose (Up to 13 Weeks)||3||
48759166|NCT05138653|102197771|FG009|COMPLETED|Single Ascending Dose (Up to 13 Weeks)||3||
48759167|NCT05138653|102197772|FG010|COMPLETED|Single Ascending Dose (Up to 13 Weeks)||0||
48759168|NCT05138653|102197773|FG011|COMPLETED|Single Ascending Dose (Up to 13 Weeks)||0||
48759169|NCT05138653|102197774|FG012|COMPLETED|Single Ascending Dose (Up to 13 Weeks)||0||
48759170|NCT05138653|102197775|FG013|COMPLETED|Single Ascending Dose (Up to 13 Weeks)||0||
48759171|NCT05138653|102197776|FG014|COMPLETED|Single Ascending Dose (Up to 13 Weeks)||0||
48759172|NCT05138653|102197777|FG015|COMPLETED|Single Ascending Dose (Up to 13 Weeks)||0||
48759173|NCT05138653|102197762|FG000|NOT COMPLETED|Single Ascending Dose (Up to 13 Weeks)||1||
48759174|NCT05138653|102197763|FG001|NOT COMPLETED|Single Ascending Dose (Up to 13 Weeks)||2||
48759175|NCT05138653|102197764|FG002|NOT COMPLETED|Single Ascending Dose (Up to 13 Weeks)||0||
48759176|NCT05138653|102197765|FG003|NOT COMPLETED|Single Ascending Dose (Up to 13 Weeks)||0||
48759177|NCT05138653|102197766|FG004|NOT COMPLETED|Single Ascending Dose (Up to 13 Weeks)||1||
48759178|NCT05138653|102197767|FG005|NOT COMPLETED|Single Ascending Dose (Up to 13 Weeks)||0||
48759179|NCT05138653|102197768|FG006|NOT COMPLETED|Single Ascending Dose (Up to 13 Weeks)||1||
48759180|NCT05138653|102197769|FG007|NOT COMPLETED|Single Ascending Dose (Up to 13 Weeks)||0||
48759181|NCT05138653|102197770|FG008|NOT COMPLETED|Single Ascending Dose (Up to 13 Weeks)||1||
48636697|NCT03315949|101894701|FG000|COMPLETED|Overall Study||171||
48636698|NCT03315949|101894702|FG001|COMPLETED|Overall Study||166||
48759182|NCT05138653|102197771|FG009|NOT COMPLETED|Single Ascending Dose (Up to 13 Weeks)||0||
48759183|NCT05138653|102197772|FG010|NOT COMPLETED|Single Ascending Dose (Up to 13 Weeks)||0||
48759184|NCT05138653|102197773|FG011|NOT COMPLETED|Single Ascending Dose (Up to 13 Weeks)||0||
48184678|NCT02303574|100775793|FG002|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0||
48188683|NCT00329303|100783307|FG000|NOT COMPLETED|Overall Study||2||
48345597|NCT01624194|101176466|FG000|NOT COMPLETED|Overall Study||2||
48636699|NCT03315949|101894701|FG000|NOT COMPLETED|Overall Study||5||
48184679|NCT02303574|100775794|FG003|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0||
48184680|NCT02303574|100775795|FG004|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0||
48184681|NCT02303574|100775796|FG005|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0||
48636700|NCT03315949|101894702|FG001|NOT COMPLETED|Overall Study||10||
48636701|NCT04470427|101894703|FG000|STARTED|Part A: Blinded||15206|Randomization Set (Part A): All participants who were randomized, regardless of the participant's treatment status in the study. Participants were analyzed according to the treatment group to which they were randomized.|
48636702|NCT04470427|101894704|FG001|STARTED|Part A: Blinded||15209|Randomization Set (Part A): All participants who were randomized, regardless of the participant's treatment status in the study. Participants were analyzed according to the treatment group to which they were randomized.|
48636703|NCT04470427|101894705|FG002|STARTED|Part A: Blinded||0|Randomization Set (Part A): All participants who were randomized, regardless of the participant's treatment status in the study. Participants were analyzed according to the treatment group to which they were randomized.|
48636704|NCT04470427|101894706|FG003|STARTED|Part A: Blinded||0|Randomization Set (Part A): All participants who were randomized, regardless of the participant's treatment status in the study. Participants were analyzed according to the treatment group to which they were randomized.|
48636705|NCT04470427|101894707|FG004|STARTED|Part A: Blinded||0|Randomization Set (Part A): All participants who were randomized, regardless of the participant's treatment status in the study. Participants were analyzed according to the treatment group to which they were randomized.|
48759185|NCT05138653|102197774|FG012|NOT COMPLETED|Single Ascending Dose (Up to 13 Weeks)||0||
48184682|NCT02303574|100775797|FG006|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||6||
48184683|NCT02303574|100775798|FG007|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||7||
48184684|NCT02303574|100775799|FG008|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||10||
48184685|NCT02303574|100775800|FG009|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||12||
48184686|NCT02303574|100775791|FG000|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0||
48184687|NCT02303574|100775792|FG001|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0||
48184688|NCT02303574|100775793|FG002|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0||
48184689|NCT02303574|100775794|FG003|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0||
48184690|NCT02303574|100775795|FG004|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0||
48184691|NCT02303574|100775796|FG005|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0||
48184692|NCT02303574|100775797|FG006|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0||
48184693|NCT02303574|100775798|FG007|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||1||
48184694|NCT02303574|100775799|FG008|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0||
48184695|NCT02303574|100775800|FG009|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0||
48184696|NCT03194776|100775801|FG000|STARTED|Overall Study||23||
48184697|NCT03194776|100775802|FG001|STARTED|Overall Study||23||
48184698|NCT03194776|100775801|FG000|COMPLETED|Overall Study||23||
48184699|NCT03194776|100775802|FG001|COMPLETED|Overall Study||23||
48184700|NCT03194776|100775801|FG000|NOT COMPLETED|Overall Study||0||
48184701|NCT03194776|100775802|FG001|NOT COMPLETED|Overall Study||0||
48184702|NCT02379117|100775803|FG000|STARTED|Overall Study||30||
48184703|NCT02379117|100775804|FG001|STARTED|Overall Study||31||
48184704|NCT02379117|100775803|FG000|COMPLETED|Overall Study||30||
48184705|NCT02379117|100775804|FG001|COMPLETED|Overall Study||31||
48184706|NCT02379117|100775803|FG000|NOT COMPLETED|Overall Study||0||
48184707|NCT02379117|100775804|FG001|NOT COMPLETED|Overall Study||0||
48184708|NCT03985098|100775805|FG000|STARTED|Overall Study||247||
48184709|NCT03985098|100775806|FG001|STARTED|Overall Study||480||
48184710|NCT03985098|100775805|FG000|COMPLETED|Overall Study||240||
48184711|NCT03985098|100775806|FG001|COMPLETED|Overall Study||480||
48184712|NCT03985098|100775805|FG000|NOT COMPLETED|Overall Study||7||
48184713|NCT03985098|100775806|FG001|NOT COMPLETED|Overall Study||0||
48184714|NCT01861301|100775807|FG000|STARTED|Overall Study||18||
48184715|NCT01861301|100775807|FG000|COMPLETED|Overall Study||18||
48184716|NCT01861301|100775807|FG000|NOT COMPLETED|Overall Study||0||
48184717|NCT04990440|100775808|FG000|STARTED|Overall Study||1||
48184718|NCT04990440|100775809|FG001|STARTED|Overall Study||4||
48345598|NCT01624194|101176467|FG001|NOT COMPLETED|Overall Study||0||
48636706|NCT04470427|101894708|FG005|STARTED|Part A: Blinded||0|Randomization Set (Part A): All participants who were randomized, regardless of the participant's treatment status in the study. Participants were analyzed according to the treatment group to which they were randomized.|
48636707|NCT04470427|101894703|FG000|Received Any Study Injection|Part A: Blinded||15166||
48636708|NCT04470427|101894704|FG001|Received Any Study Injection|Part A: Blinded||15180||
48636709|NCT04470427|101894705|FG002|Received Any Study Injection|Part A: Blinded||0||
48636710|NCT04470427|101894706|FG003|Received Any Study Injection|Part A: Blinded||0||
48759186|NCT05138653|102197775|FG013|NOT COMPLETED|Single Ascending Dose (Up to 13 Weeks)||0||
48759187|NCT05138653|102197776|FG014|NOT COMPLETED|Single Ascending Dose (Up to 13 Weeks)||0||
48759188|NCT05138653|102197777|FG015|NOT COMPLETED|Single Ascending Dose (Up to 13 Weeks)||0||
48759189|NCT05138653|102197762|FG000|STARTED|Multiple Ascending Dose (Up to 12 Weeks)||0||
48759190|NCT05138653|102197763|FG001|STARTED|Multiple Ascending Dose (Up to 12 Weeks)||0||
48759191|NCT05138653|102197764|FG002|STARTED|Multiple Ascending Dose (Up to 12 Weeks)||0||
48759192|NCT05138653|102197765|FG003|STARTED|Multiple Ascending Dose (Up to 12 Weeks)||0||
48759193|NCT05138653|102197766|FG004|STARTED|Multiple Ascending Dose (Up to 12 Weeks)||0||
48184719|NCT04990440|100775810|FG002|STARTED|Overall Study||1||
48345599|NCT01335971|101176468|FG000|STARTED|Overall Study||31||
48184720|NCT04990440|100775808|FG000|COMPLETED|Overall Study||1||
48184721|NCT04990440|100775809|FG001|COMPLETED|Overall Study||4||
48184722|NCT04990440|100775810|FG002|COMPLETED|Overall Study||0||
48184723|NCT04990440|100775808|FG000|NOT COMPLETED|Overall Study||0||
48184724|NCT04990440|100775809|FG001|NOT COMPLETED|Overall Study||0||
48184725|NCT04990440|100775810|FG002|NOT COMPLETED|Overall Study||1||
48184726|NCT01333943|100775811|FG000|STARTED|Overall Study||47||
48184727|NCT01333943|100775812|FG001|STARTED|Overall Study||47||
48184728|NCT01333943|100775811|FG000|COMPLETED|Overall Study||46||
48184729|NCT01333943|100775812|FG001|COMPLETED|Overall Study||47||
48184730|NCT01333943|100775811|FG000|NOT COMPLETED|Overall Study||1||
48184731|NCT01333943|100775812|FG001|NOT COMPLETED|Overall Study||0||
48184732|NCT00830947|100775813|FG000|STARTED|Overall Study||23||
48184733|NCT00830947|100775814|FG001|STARTED|Overall Study||22||
48184734|NCT00830947|100775813|FG000|COMPLETED|Overall Study||19||
48184735|NCT00830947|100775814|FG001|COMPLETED|Overall Study||18||
48184736|NCT00830947|100775813|FG000|NOT COMPLETED|Overall Study||4||
48184737|NCT00830947|100775814|FG001|NOT COMPLETED|Overall Study||4||
48184738|NCT00813488|100775815|FG000|STARTED|Titration Period 1||107||
48184739|NCT00813488|100775816|FG001|STARTED|Titration Period 1||106||
48184740|NCT00813488|100775815|FG000|COMPLETED|Titration Period 1||80||
48184741|NCT00813488|100775816|FG001|COMPLETED|Titration Period 1||89||
48184742|NCT00813488|100775815|FG000|NOT COMPLETED|Titration Period 1||27||
48184743|NCT00813488|100775816|FG001|NOT COMPLETED|Titration Period 1||17||
48184744|NCT00813488|100775815|FG000|STARTED|Titration Period 2||80||
48184745|NCT00813488|100775816|FG001|STARTED|Titration Period 2||89||
48184746|NCT00813488|100775815|FG000|COMPLETED|Titration Period 2||64||
48184747|NCT00813488|100775816|FG001|COMPLETED|Titration Period 2||79||
48184748|NCT00813488|100775815|FG000|NOT COMPLETED|Titration Period 2||16||
48184749|NCT00813488|100775816|FG001|NOT COMPLETED|Titration Period 2||10||
48184750|NCT00813488|100775815|FG000|STARTED|Double-blind Treatment Period 1||72||
48184751|NCT00813488|100775816|FG001|STARTED|Double-blind Treatment Period 1||71||
48184752|NCT00813488|100775815|FG000|COMPLETED|Double-blind Treatment Period 1||71||
48184753|NCT00813488|100775816|FG001|COMPLETED|Double-blind Treatment Period 1||66||
48184754|NCT00813488|100775815|FG000|NOT COMPLETED|Double-blind Treatment Period 1||1||
48184755|NCT00813488|100775816|FG001|NOT COMPLETED|Double-blind Treatment Period 1||5||
48184756|NCT00813488|100775815|FG000|STARTED|Double-blind Treatment Period 2||71||
48184757|NCT00813488|100775816|FG001|STARTED|Double-blind Treatment Period 2||66||
48184758|NCT00813488|100775815|FG000|COMPLETED|Double-blind Treatment Period 2||66||
48184759|NCT00813488|100775816|FG001|COMPLETED|Double-blind Treatment Period 2||65||
48184760|NCT00813488|100775815|FG000|NOT COMPLETED|Double-blind Treatment Period 2||5||
48184761|NCT00813488|100775816|FG001|NOT COMPLETED|Double-blind Treatment Period 2||1||
48184762|NCT00813488|100775815|FG000|STARTED|Open-label Extension||65||
48184763|NCT00813488|100775816|FG001|STARTED|Open-label Extension||66||
48184764|NCT00813488|100775815|FG000|COMPLETED|Open-label Extension||53||
48184765|NCT00813488|100775816|FG001|COMPLETED|Open-label Extension||59||
48184766|NCT00813488|100775815|FG000|NOT COMPLETED|Open-label Extension||12||
48184767|NCT00813488|100775816|FG001|NOT COMPLETED|Open-label Extension||7||
48184768|NCT05584657|100775817|FG000|STARTED|Overall Study||1111||
48184769|NCT05584657|100775818|FG001|STARTED|Overall Study||1111||
48184770|NCT05584657|100775817|FG000|COMPLETED|Overall Study||1057||
48184771|NCT05584657|100775818|FG001|COMPLETED|Overall Study||1063||
48184772|NCT05584657|100775817|FG000|NOT COMPLETED|Overall Study||54||
48184773|NCT05584657|100775818|FG001|NOT COMPLETED|Overall Study||48||
48184774|NCT04883346|100775819|FG000|STARTED|Overall Study||34||
48184775|NCT04883346|100775819|FG000|COMPLETED|Overall Study||31||
48184776|NCT04883346|100775819|FG000|NOT COMPLETED|Overall Study||3||
48184777|NCT04081545|100775820|FG000|STARTED|Overall Study||86||
48184778|NCT04081545|100775821|FG001|STARTED|Overall Study||95||
48184779|NCT04081545|100775820|FG000|COMPLETED|Overall Study||86||
48184780|NCT04081545|100775821|FG001|COMPLETED|Overall Study||95||
48184781|NCT04081545|100775820|FG000|NOT COMPLETED|Overall Study||0||
48184782|NCT04081545|100775821|FG001|NOT COMPLETED|Overall Study||0||
48184783|NCT03673098|100775822|FG000|STARTED|Overall Study||23||
48184784|NCT03673098|100775823|FG001|STARTED|Overall Study||21||
48184785|NCT03673098|100775822|FG000|COMPLETED|Overall Study||13||
48184786|NCT03673098|100775823|FG001|COMPLETED|Overall Study||17||
48184787|NCT03673098|100775822|FG000|NOT COMPLETED|Overall Study||10||
48184788|NCT03673098|100775823|FG001|NOT COMPLETED|Overall Study||4||
48184789|NCT02613897|100775824|FG000|STARTED|Overall Study||22||
48184790|NCT02613897|100775825|FG001|STARTED|Overall Study||22||
48184791|NCT02613897|100775826|FG002|STARTED|Overall Study||12||
48184792|NCT02613897|100775824|FG000|COMPLETED|Overall Study||22||
48184793|NCT02613897|100775825|FG001|COMPLETED|Overall Study||22||
48184794|NCT02613897|100775826|FG002|COMPLETED|Overall Study||12||
48184795|NCT02613897|100775824|FG000|NOT COMPLETED|Overall Study||0||
48184796|NCT02613897|100775825|FG001|NOT COMPLETED|Overall Study||0||
48184797|NCT02613897|100775826|FG002|NOT COMPLETED|Overall Study||0||
48184798|NCT00445692|100775827|FG000|STARTED|Overall Study||31||
48184799|NCT00445692|100775827|FG000|COMPLETED|Overall Study||15||
48184800|NCT00445692|100775827|FG000|NOT COMPLETED|Overall Study||16||
48184801|NCT02240680|100775828|FG000|STARTED|Overall Study (Up to 24 Weeks)||151||
48184802|NCT02240680|100775829|FG001|STARTED|Overall Study (Up to 24 Weeks)||151||
48184803|NCT02240680|100775830|FG002|STARTED|Overall Study (Up to 24 Weeks)||0||
48184804|NCT02240680|100775831|FG003|STARTED|Overall Study (Up to 24 Weeks)||0||
48184805|NCT02240680|100775828|FG000|COMPLETED|Overall Study (Up to 24 Weeks)||136||
48184806|NCT02240680|100775829|FG001|COMPLETED|Overall Study (Up to 24 Weeks)||143||
48184807|NCT02240680|100775830|FG002|COMPLETED|Overall Study (Up to 24 Weeks)||0||
48184808|NCT02240680|100775831|FG003|COMPLETED|Overall Study (Up to 24 Weeks)||0||
48184809|NCT02240680|100775828|FG000|NOT COMPLETED|Overall Study (Up to 24 Weeks)||15||
48184810|NCT02240680|100775829|FG001|NOT COMPLETED|Overall Study (Up to 24 Weeks)||8||
48184811|NCT02240680|100775830|FG002|NOT COMPLETED|Overall Study (Up to 24 Weeks)||0||
48184812|NCT02240680|100775831|FG003|NOT COMPLETED|Overall Study (Up to 24 Weeks)||0||
48184813|NCT02240680|100775828|FG000|STARTED|Japanese Patients (Up to 52 Weeks)||0||
48184814|NCT02240680|100775829|FG001|STARTED|Japanese Patients (Up to 52 Weeks)||0||
48184815|NCT02240680|100775830|FG002|STARTED|Japanese Patients (Up to 52 Weeks)||50||
48636711|NCT04470427|101894707|FG004|Received Any Study Injection|Part A: Blinded||0||
48636712|NCT04470427|101894708|FG005|Received Any Study Injection|Part A: Blinded||0||
48636713|NCT04470427|101894703|FG000|Per-Protocol (PP) Set:|Part A: Blinded||14164|Participants who received any study injection, were severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) negative (defined as no immunologic or virologic evidence of prior COVID-19 at Day 1 before the first dose), and had no major protocol deviations, Participants were analyzed according to the treatment group to which they were randomized. Participants who did not receive the second dose within 21 or 42 days after the first injection date were excluded from the PP Set.|
48636714|NCT04470427|101894704|FG001|Per-Protocol (PP) Set:|Part A: Blinded||14287|Participants who received any study injection, were severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) negative (defined as no immunologic or virologic evidence of prior COVID-19 at Day 1 before the first dose), and had no major protocol deviations, Participants were analyzed according to the treatment group to which they were randomized. Participants who did not receive the second dose within 21 or 42 days after the first injection date were excluded from the PP Set.|
48656970|NCT03735979|101943737|FG000|COMPLETED|Overall Study||56|Includes those that died prior to the modified Rankin Scale assessment at 90 days after randomization.|
48656971|NCT03735979|101943738|FG001|COMPLETED|Overall Study||210|Includes those that died prior to the modified Rankin Scale assessment at 90 days after randomization.|
48657121|NCT03745313|101943783|FG000|NOT COMPLETED|At 6 Months Follow-up||3||
48184816|NCT02240680|100775831|FG003|STARTED|Japanese Patients (Up to 52 Weeks)||52||
48184817|NCT02240680|100775828|FG000|COMPLETED|Japanese Patients (Up to 52 Weeks)||0||
48184818|NCT02240680|100775829|FG001|COMPLETED|Japanese Patients (Up to 52 Weeks)||0||
48184819|NCT02240680|100775830|FG002|COMPLETED|Japanese Patients (Up to 52 Weeks)||42||
48184820|NCT02240680|100775831|FG003|COMPLETED|Japanese Patients (Up to 52 Weeks)||45||
48184821|NCT02240680|100775828|FG000|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||0||
48184822|NCT02240680|100775829|FG001|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||0||
48184823|NCT02240680|100775830|FG002|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||8||
48184824|NCT02240680|100775831|FG003|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||7||
48184825|NCT02081365|100775832|FG000|STARTED|Overall Study||74||
48184826|NCT02081365|100775833|FG001|STARTED|Overall Study||77||
48184827|NCT02081365|100775832|FG000|Received Allocated Intervention|Overall Study||46||
48184828|NCT02081365|100775833|FG001|Received Allocated Intervention|Overall Study||59||
48184829|NCT02081365|100775832|FG000|COMPLETED|Overall Study||44||
48184830|NCT02081365|100775833|FG001|COMPLETED|Overall Study||54||
48184831|NCT02081365|100775832|FG000|NOT COMPLETED|Overall Study||30||
48184832|NCT02081365|100775833|FG001|NOT COMPLETED|Overall Study||23||
48184833|NCT01066156|100775834|FG000|STARTED|Overall Study||34||
48184834|NCT01066156|100775834|FG000|COMPLETED|Overall Study||24||
48184835|NCT01066156|100775834|FG000|NOT COMPLETED|Overall Study||10||
48184836|NCT03019458|100775835|FG000|STARTED|Overall Study||24||
48184837|NCT03019458|100775836|FG001|STARTED|Overall Study||26||
48184838|NCT03019458|100775835|FG000|COMPLETED|Overall Study||24||
48184839|NCT03019458|100775836|FG001|COMPLETED|Overall Study||25||
48184840|NCT03019458|100775835|FG000|NOT COMPLETED|Overall Study||0||
48184841|NCT03019458|100775836|FG001|NOT COMPLETED|Overall Study||1||
48184842|NCT01661881|100775837|FG000|STARTED|Overall Study||23||
48184843|NCT01661881|100775837|FG000|COMPLETED|Overall Study||22||
48184844|NCT01661881|100775837|FG000|NOT COMPLETED|Overall Study||1||
48184845|NCT01932996|100775838|FG000|STARTED|Overall Study||172||
48184846|NCT01932996|100775839|FG001|STARTED|Overall Study||180||
48184847|NCT01932996|100775838|FG000|COMPLETED|Overall Study||170||
48184848|NCT01932996|100775839|FG001|COMPLETED|Overall Study||180||
48184849|NCT01932996|100775838|FG000|NOT COMPLETED|Overall Study||2||
48184850|NCT01932996|100775839|FG001|NOT COMPLETED|Overall Study||0||
48184851|NCT02800928|100775840|FG000|STARTED|Overall Study||9||
48184852|NCT02800928|100775841|FG001|STARTED|Overall Study||8||
48184853|NCT02800928|100775840|FG000|COMPLETED|Overall Study||7||
48184854|NCT02800928|100775841|FG001|COMPLETED|Overall Study||6||
48184855|NCT02800928|100775840|FG000|NOT COMPLETED|Overall Study||2||
48184856|NCT02800928|100775841|FG001|NOT COMPLETED|Overall Study||2||
48184857|NCT02713997|100775842|FG000|STARTED|Overall Study||16||
48184858|NCT02713997|100775843|FG001|STARTED|Overall Study||14||
48184859|NCT02713997|100775844|FG002|STARTED|Overall Study||13||
48184860|NCT02713997|100775842|FG000|COMPLETED|Overall Study||16||
48184861|NCT02713997|100775843|FG001|COMPLETED|Overall Study||14||
48184862|NCT02713997|100775844|FG002|COMPLETED|Overall Study||13||
48184863|NCT02713997|100775842|FG000|NOT COMPLETED|Overall Study||0||
48184864|NCT02713997|100775843|FG001|NOT COMPLETED|Overall Study||0||
48184865|NCT02713997|100775844|FG002|NOT COMPLETED|Overall Study||0||
48184866|NCT01577732|100775845|FG000|STARTED|Overall Study||300||
48184867|NCT01577732|100775845|FG000|COMPLETED|Overall Study||300||
48184868|NCT01577732|100775845|FG000|NOT COMPLETED|Overall Study||0||
48184869|NCT02949674|100775846|FG000|STARTED|Overall Study||31||
48184870|NCT02949674|100775847|FG001|STARTED|Overall Study||31||
48184871|NCT02949674|100775848|FG002|STARTED|Overall Study||31||
48184872|NCT02949674|100775846|FG000|COMPLETED|Overall Study||31||
48184873|NCT02949674|100775847|FG001|COMPLETED|Overall Study||31||
48184874|NCT02949674|100775848|FG002|COMPLETED|Overall Study||31||
48184875|NCT02949674|100775846|FG000|NOT COMPLETED|Overall Study||0||
48184876|NCT02949674|100775847|FG001|NOT COMPLETED|Overall Study||0||
48184877|NCT02949674|100775848|FG002|NOT COMPLETED|Overall Study||0||
48184878|NCT02555371|100775849|FG000|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||306|Variable \& fixed run-in periods have been combined since all par. received OL mepolizumab 100 mg SC|
48184879|NCT02555371|100775850|FG001|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0|Variable \& fixed run-in periods have been combined since all par. received OL mepolizumab 100 mg SC|
48184880|NCT02555371|100775851|FG002|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0|Variable \& fixed run-in periods have been combined since all par. received OL mepolizumab 100 mg SC|
48184881|NCT02555371|100775852|FG003|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0|Variable \& fixed run-in periods have been combined since all par. received OL mepolizumab 100 mg SC|
48184882|NCT02555371|100775853|FG004|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0|Variable \& fixed run-in periods have been combined since all par. received OL mepolizumab 100 mg SC|
48184883|NCT02555371|100775849|FG000|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||295||
48184884|NCT02555371|100775850|FG001|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0||
48184885|NCT02555371|100775851|FG002|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0||
48184886|NCT02555371|100775852|FG003|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0||
48184887|NCT02555371|100775853|FG004|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0||
48184888|NCT02555371|100775849|FG000|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||11||
48184889|NCT02555371|100775850|FG001|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0||
48184890|NCT02555371|100775851|FG002|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0||
48184891|NCT02555371|100775852|FG003|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0||
48184892|NCT02555371|100775853|FG004|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0||
48184893|NCT02555371|100775849|FG000|STARTED|Part C (DB Period: Up to 52W)||0|Double-blind Treatment Period|
48184894|NCT02555371|100775850|FG001|STARTED|Part C (DB Period: Up to 52W)||151|Double-blind Treatment Period|
48656972|NCT03735979|101943739|FG002|COMPLETED|Overall Study||212|Includes those that died prior to the modified Rankin Scale assessment at 90 days after randomization.|
48656973|NCT03735979|101943737|FG000|NOT COMPLETED|Overall Study||3||
48184895|NCT02555371|100775851|FG002|STARTED|Part C (DB Period: Up to 52W)||144|Double-blind Treatment Period|
48184896|NCT02555371|100775852|FG003|STARTED|Part C (DB Period: Up to 52W)||0|Double-blind Treatment Period|
48184897|NCT02555371|100775853|FG004|STARTED|Part C (DB Period: Up to 52W)||0|Double-blind Treatment Period|
48184898|NCT02555371|100775849|FG000|COMPLETED|Part C (DB Period: Up to 52W)||0||
48184899|NCT02555371|100775850|FG001|COMPLETED|Part C (DB Period: Up to 52W)||62||
48184900|NCT02555371|100775851|FG002|COMPLETED|Part C (DB Period: Up to 52W)||96||
48184901|NCT02555371|100775852|FG003|COMPLETED|Part C (DB Period: Up to 52W)||0||
48184902|NCT02555371|100775853|FG004|COMPLETED|Part C (DB Period: Up to 52W)||0||
48184903|NCT02555371|100775849|FG000|NOT COMPLETED|Part C (DB Period: Up to 52W)||0||
48184904|NCT02555371|100775850|FG001|NOT COMPLETED|Part C (DB Period: Up to 52W)||89||
48184905|NCT02555371|100775851|FG002|NOT COMPLETED|Part C (DB Period: Up to 52W)||48||
48184906|NCT02555371|100775852|FG003|NOT COMPLETED|Part C (DB Period: Up to 52W)||0||
48184907|NCT02555371|100775853|FG004|NOT COMPLETED|Part C (DB Period: Up to 52W)||0||
48184908|NCT02555371|100775849|FG000|STARTED|PartD(OL: 52W Post-randomization PartC)||0||
48184909|NCT02555371|100775850|FG001|STARTED|PartD(OL: 52W Post-randomization PartC)||0||
48184910|NCT02555371|100775851|FG002|STARTED|PartD(OL: 52W Post-randomization PartC)||0||
48184911|NCT02555371|100775852|FG003|STARTED|PartD(OL: 52W Post-randomization PartC)||84||
48184912|NCT02555371|100775853|FG004|STARTED|PartD(OL: 52W Post-randomization PartC)||45||
48184913|NCT02555371|100775849|FG000|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0||
48184914|NCT02555371|100775850|FG001|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0||
48184915|NCT02555371|100775851|FG002|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0||
48184916|NCT02555371|100775852|FG003|COMPLETED|PartD(OL: 52W Post-randomization PartC)||80||
48184917|NCT02555371|100775853|FG004|COMPLETED|PartD(OL: 52W Post-randomization PartC)||42||
48184918|NCT02555371|100775849|FG000|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0||
48184919|NCT02555371|100775850|FG001|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0||
48184920|NCT02555371|100775851|FG002|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0||
48184921|NCT02555371|100775852|FG003|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||4||
48184922|NCT02555371|100775853|FG004|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||3||
48184923|NCT00742885|100775854|FG000|STARTED|Overall Study||50||
48184924|NCT00742885|100775855|FG001|STARTED|Overall Study||50||
48184925|NCT00742885|100775854|FG000|COMPLETED|Overall Study||49||
48415297|NCT01228084|101350243|FG000|COMPLETED|Overall Study||16||
48415298|NCT01228084|101350243|FG000|NOT COMPLETED|Overall Study||4||
48184926|NCT00742885|100775855|FG001|COMPLETED|Overall Study||50||
48184927|NCT00742885|100775854|FG000|NOT COMPLETED|Overall Study||1||
48184928|NCT00742885|100775855|FG001|NOT COMPLETED|Overall Study||0||
48184929|NCT02953548|100775856|FG000|STARTED|Overall Study||5||
48184930|NCT02953548|100775857|FG001|STARTED|Overall Study||4||
48184931|NCT02953548|100775856|FG000|COMPLETED|Overall Study||5||
48184932|NCT02953548|100775857|FG001|COMPLETED|Overall Study||4||
48184933|NCT02953548|100775856|FG000|NOT COMPLETED|Overall Study||0||
48184934|NCT02953548|100775857|FG001|NOT COMPLETED|Overall Study||0||
48184935|NCT02037061|100775858|FG000|STARTED|Overall Study||22||
48184936|NCT02037061|100775859|FG001|STARTED|Overall Study||24||
48184937|NCT02037061|100775858|FG000|COMPLETED|Overall Study||22||
48184938|NCT02037061|100775859|FG001|COMPLETED|Overall Study||24||
48184939|NCT02037061|100775858|FG000|NOT COMPLETED|Overall Study||0||
48184940|NCT02037061|100775859|FG001|NOT COMPLETED|Overall Study||0||
48184941|NCT00604721|100775860|FG000|STARTED|Overall Study||19||
48345600|NCT01335971|101176469|FG001|STARTED|Overall Study||29||
48345601|NCT01335971|101176470|FG002|STARTED|Overall Study||29||
48345602|NCT01335971|101176468|FG000|COMPLETED|Overall Study||29||
48345603|NCT01335971|101176469|FG001|COMPLETED|Overall Study||28||
48345604|NCT01335971|101176470|FG002|COMPLETED|Overall Study||28||
48345605|NCT01335971|101176468|FG000|NOT COMPLETED|Overall Study||2||
48345606|NCT01335971|101176469|FG001|NOT COMPLETED|Overall Study||1||
48345607|NCT01335971|101176470|FG002|NOT COMPLETED|Overall Study||1||
48345608|NCT01236391|101176471|FG000|STARTED|Overall Study||111||
48345609|NCT01236391|101176471|FG000|COMPLETED|Overall Study||95||
48345610|NCT01236391|101176471|FG000|NOT COMPLETED|Overall Study||16||
48345611|NCT03352245|101176472|FG000|STARTED|Overall Study||20||
48345612|NCT03352245|101176473|FG001|STARTED|Overall Study||20||
48345613|NCT03352245|101176472|FG000|COMPLETED|Overall Study||20||
48345614|NCT03352245|101176473|FG001|COMPLETED|Overall Study||19||
48345615|NCT03352245|101176472|FG000|NOT COMPLETED|Overall Study||0||
48345616|NCT03352245|101176473|FG001|NOT COMPLETED|Overall Study||1||
48345617|NCT03192904|101176474|FG000|STARTED|Overall Study||35||
48184942|NCT00604721|100775860|FG000|COMPLETED|Overall Study||17||
48184943|NCT00604721|100775860|FG000|NOT COMPLETED|Overall Study||2||
48184944|NCT01258387|100775861|FG000|STARTED|Overall Study||6||
48184945|NCT01258387|100775862|FG001|STARTED|Overall Study||6||
48184946|NCT01258387|100775863|FG002|STARTED|Overall Study||6||
48184947|NCT01258387|100775864|FG003|STARTED|Overall Study||6||
48184948|NCT01258387|100775865|FG004|STARTED|Overall Study||6||
48184949|NCT01258387|100775866|FG005|STARTED|Overall Study||6||
48184950|NCT01258387|100775867|FG006|STARTED|Overall Study||4||
48184951|NCT01258387|100775861|FG000|Patients Randomized to GGF2|Overall Study||4||
48184952|NCT01258387|100775862|FG001|Patients Randomized to GGF2|Overall Study||4||
48184953|NCT01258387|100775863|FG002|Patients Randomized to GGF2|Overall Study||4||
48184954|NCT01258387|100775864|FG003|Patients Randomized to GGF2|Overall Study||4||
48184955|NCT01258387|100775865|FG004|Patients Randomized to GGF2|Overall Study||4||
48184956|NCT01258387|100775866|FG005|Patients Randomized to GGF2|Overall Study||4||
48184957|NCT01258387|100775867|FG006|Patients Randomized to GGF2|Overall Study||3||
48184958|NCT01258387|100775861|FG000|Patients Randomized to Placebo|Overall Study||2||
48184959|NCT01258387|100775862|FG001|Patients Randomized to Placebo|Overall Study||2||
48184960|NCT01258387|100775863|FG002|Patients Randomized to Placebo|Overall Study||2||
48184961|NCT01258387|100775864|FG003|Patients Randomized to Placebo|Overall Study||2||
48184962|NCT01258387|100775865|FG004|Patients Randomized to Placebo|Overall Study||2||
48184963|NCT01258387|100775866|FG005|Patients Randomized to Placebo|Overall Study||2||
48184964|NCT01258387|100775867|FG006|Patients Randomized to Placebo|Overall Study||1||
48184965|NCT01258387|100775861|FG000|COMPLETED|Overall Study||6||
48184966|NCT01258387|100775862|FG001|COMPLETED|Overall Study||6||
48184967|NCT01258387|100775863|FG002|COMPLETED|Overall Study||6||
48184968|NCT01258387|100775864|FG003|COMPLETED|Overall Study||6||
48184969|NCT01258387|100775865|FG004|COMPLETED|Overall Study||6||
48184970|NCT01258387|100775866|FG005|COMPLETED|Overall Study||6||
48184971|NCT01258387|100775867|FG006|COMPLETED|Overall Study||4||
48184972|NCT01258387|100775861|FG000|NOT COMPLETED|Overall Study||0||
48184973|NCT01258387|100775862|FG001|NOT COMPLETED|Overall Study||0||
48184974|NCT01258387|100775863|FG002|NOT COMPLETED|Overall Study||0||
48345618|NCT03192904|101176475|FG001|STARTED|Overall Study||35||
48184975|NCT01258387|100775864|FG003|NOT COMPLETED|Overall Study||0||
48345619|NCT03192904|101176474|FG000|COMPLETED|Overall Study||32||
48184976|NCT01258387|100775865|FG004|NOT COMPLETED|Overall Study||0||
48184977|NCT01258387|100775866|FG005|NOT COMPLETED|Overall Study||0||
48184978|NCT01258387|100775867|FG006|NOT COMPLETED|Overall Study||0||
48184979|NCT02096081|100775868|FG000|STARTED|Overall Study||122||
48184980|NCT02096081|100775869|FG001|STARTED|Overall Study||128||
48184981|NCT02096081|100775868|FG000|COMPLETED|Overall Study||119||
48184982|NCT02096081|100775869|FG001|COMPLETED|Overall Study||124||
48184983|NCT02096081|100775868|FG000|NOT COMPLETED|Overall Study||3||
48345620|NCT03192904|101176475|FG001|COMPLETED|Overall Study||33||
48345621|NCT03192904|101176474|FG000|NOT COMPLETED|Overall Study||3||
48345622|NCT03192904|101176475|FG001|NOT COMPLETED|Overall Study||2||
48345623|NCT00891735|101176476|FG000|STARTED|Overall Study||275||
48345624|NCT00891735|101176477|FG001|STARTED|Overall Study||274||
48345625|NCT00891735|101176478|FG002|STARTED|Overall Study||275||
48345626|NCT00891735|101176479|FG003|STARTED|Overall Study||273||
48345627|NCT00891735|101176476|FG000|COMPLETED|Overall Study||258||
48345628|NCT00891735|101176477|FG001|COMPLETED|Overall Study||258||
48345629|NCT00891735|101176478|FG002|COMPLETED|Overall Study||263||
48345630|NCT00891735|101176479|FG003|COMPLETED|Overall Study||258||
48345631|NCT00891735|101176476|FG000|NOT COMPLETED|Overall Study||17||
48345632|NCT00891735|101176477|FG001|NOT COMPLETED|Overall Study||16||
48345633|NCT00891735|101176478|FG002|NOT COMPLETED|Overall Study||12||
48345634|NCT00891735|101176479|FG003|NOT COMPLETED|Overall Study||15||
48345635|NCT03700047|101176480|FG000|STARTED|Overall Study||142||
48345636|NCT03700047|101176481|FG001|STARTED|Overall Study||60||
48345637|NCT03700047|101176482|FG002|STARTED|Overall Study||68||
48345638|NCT03700047|101176480|FG000|COMPLETED|Overall Study||126||
48345639|NCT03700047|101176481|FG001|COMPLETED|Overall Study||50||
48345640|NCT03700047|101176482|FG002|COMPLETED|Overall Study||58||
48345641|NCT03700047|101176480|FG000|NOT COMPLETED|Overall Study||16||
48345642|NCT03700047|101176481|FG001|NOT COMPLETED|Overall Study||10||
48345643|NCT03700047|101176482|FG002|NOT COMPLETED|Overall Study||10||
48345644|NCT03851510|101176483|FG000|STARTED|Overall Study||57||
48345645|NCT03851510|101176483|FG000|COMPLETED|Overall Study||54||
48345646|NCT03851510|101176483|FG000|NOT COMPLETED|Overall Study||3||
48345647|NCT02823457|101176484|FG000|STARTED|Overall Study||20||
48345648|NCT02823457|101176484|FG000|COMPLETED|Overall Study||15||
48345649|NCT02823457|101176484|FG000|NOT COMPLETED|Overall Study||5||
48345650|NCT01097044|101176485|FG000|STARTED|Overall Study||39||
48345651|NCT01097044|101176486|FG001|STARTED|Overall Study||38||
48345652|NCT01097044|101176485|FG000|COMPLETED|Overall Study||34||
48415299|NCT02130635|101350244|FG000|STARTED|Part A-Safety and Tolerability||7||
48415300|NCT02130635|101350245|FG001|STARTED|Part A-Safety and Tolerability||21||
48345653|NCT01097044|101176486|FG001|COMPLETED|Overall Study||33||
48345654|NCT01097044|101176485|FG000|NOT COMPLETED|Overall Study||5||
48345655|NCT01097044|101176486|FG001|NOT COMPLETED|Overall Study||5||
48345656|NCT00691665|101176487|FG000|STARTED|Overall Study||65||
48345657|NCT00691665|101176488|FG001|STARTED|Overall Study||65||
48345658|NCT00691665|101176487|FG000|COMPLETED|Overall Study||65||
48345659|NCT00691665|101176488|FG001|COMPLETED|Overall Study||65||
48345660|NCT00691665|101176487|FG000|NOT COMPLETED|Overall Study||0||
48345661|NCT00691665|101176488|FG001|NOT COMPLETED|Overall Study||0||
48345662|NCT03757039|101176489|FG000|STARTED|Overall Study||32||
48345663|NCT03757039|101176490|FG001|STARTED|Overall Study||9||
48345664|NCT03757039|101176489|FG000|AOHG MF|Overall Study||11|AOHG MF = AIR OPTIX plus HydraGlyde Multifocal contact lenses|
48345665|NCT03757039|101176490|FG001|AOHG MF|Overall Study||0|AOHG MF = AIR OPTIX plus HydraGlyde Multifocal contact lenses|
48345666|NCT03757039|101176489|FG000|DT1 MF|Overall Study||11|DT1 MF = DAILIES TOTAL1 Multifocal contact lenses|
48345667|NCT03757039|101176490|FG001|DT1 MF|Overall Study||0|DT1 MF = DAILIES TOTAL1 Multifocal contact lenses|
48345668|NCT03757039|101176489|FG000|DACP MF|Overall Study||10|DACP MF = DAILIES AquaComfort Plus Multifocal contact lenses|
48345669|NCT03757039|101176490|FG001|DACP MF|Overall Study||0|DACP MF = DAILIES AquaComfort Plus Multifocal contact lenses|
48345670|NCT03757039|101176489|FG000|COMPLETED|Overall Study||32||
48345671|NCT03757039|101176490|FG001|COMPLETED|Overall Study||9||
48345672|NCT03757039|101176489|FG000|NOT COMPLETED|Overall Study||0||
48345673|NCT03757039|101176490|FG001|NOT COMPLETED|Overall Study||0||
48345674|NCT00693706|101176491|FG000|STARTED|Overall Study||101||
48345675|NCT00693706|101176492|FG001|STARTED|Overall Study||99||
48345676|NCT00693706|101176491|FG000|COMPLETED|Overall Study||101||
48345677|NCT00693706|101176492|FG001|COMPLETED|Overall Study||98||
48345678|NCT00693706|101176491|FG000|NOT COMPLETED|Overall Study||0||
48345679|NCT00693706|101176492|FG001|NOT COMPLETED|Overall Study||1||
48345680|NCT04007159|101176493|FG000|STARTED|Induction Phase||280||
48345681|NCT04007159|101176493|FG000|COMPLETED|Induction Phase||258||
48345682|NCT04007159|101176493|FG000|NOT COMPLETED|Induction Phase||22||
48345683|NCT04007159|101176493|FG000|STARTED|Rest Phase||258||
48345684|NCT04007159|101176493|FG000|COMPLETED|Rest Phase||258||
48345685|NCT04007159|101176493|FG000|NOT COMPLETED|Rest Phase||0||
48345686|NCT04007159|101176493|FG000|STARTED|Challenge Phase||258||
48345687|NCT04007159|101176493|FG000|COMPLETED|Challenge Phase||255||
48345688|NCT04007159|101176493|FG000|NOT COMPLETED|Challenge Phase||3||
48345689|NCT00179959|101176494|FG000|STARTED|Overall Study||15||
48345690|NCT00179959|101176495|FG001|STARTED|Overall Study||16||
48345691|NCT00179959|101176494|FG000|COMPLETED|Overall Study||9||
48345692|NCT00179959|101176495|FG001|COMPLETED|Overall Study||13||
48345693|NCT00179959|101176494|FG000|NOT COMPLETED|Overall Study||6||
48345694|NCT00179959|101176495|FG001|NOT COMPLETED|Overall Study||3||
48345695|NCT02643095|101176496|FG000|STARTED|Overall Study||22||
48345696|NCT02643095|101176496|FG000|COMPLETED|Overall Study||21||
48345697|NCT02643095|101176496|FG000|NOT COMPLETED|Overall Study||1||
48345698|NCT00595231|101176497|FG000|STARTED|Overall Study||120||
48345699|NCT00595231|101176498|FG001|STARTED|Overall Study||119||
48345700|NCT00595231|101176497|FG000|COMPLETED|Overall Study||115||
48345701|NCT00595231|101176498|FG001|COMPLETED|Overall Study||114||
48345702|NCT00595231|101176497|FG000|NOT COMPLETED|Overall Study||5||
48345703|NCT00595231|101176498|FG001|NOT COMPLETED|Overall Study||5||
48345704|NCT05003115|101176499|FG000|STARTED|Overall Study||15||
48345705|NCT05003115|101176500|FG001|STARTED|Overall Study||14||
48345706|NCT05003115|101176499|FG000|COMPLETED|Overall Study||15||
48345707|NCT05003115|101176500|FG001|COMPLETED|Overall Study||11||
48345708|NCT05003115|101176499|FG000|NOT COMPLETED|Overall Study||0||
48345709|NCT05003115|101176500|FG001|NOT COMPLETED|Overall Study||3||
48345710|NCT00382148|101176501|FG000|STARTED|Overall Study||4||
48345711|NCT00382148|101176502|FG001|STARTED|Overall Study||7||
48345712|NCT00382148|101176501|FG000|COMPLETED|Overall Study||3||
48345713|NCT00382148|101176502|FG001|COMPLETED|Overall Study||7||
48345714|NCT00382148|101176501|FG000|NOT COMPLETED|Overall Study||1||
48345715|NCT00382148|101176502|FG001|NOT COMPLETED|Overall Study||0||
48345716|NCT03823391|101176503|FG000|STARTED|Period 1: Week 1 to Week 12||17||
48345717|NCT03823391|101176504|FG001|STARTED|Period 1: Week 1 to Week 12||31||
48345718|NCT03823391|101176503|FG000|COMPLETED|Period 1: Week 1 to Week 12||17||
48345719|NCT03823391|101176504|FG001|COMPLETED|Period 1: Week 1 to Week 12||31||
48345720|NCT03823391|101176503|FG000|NOT COMPLETED|Period 1: Week 1 to Week 12||0||
48345721|NCT03823391|101176504|FG001|NOT COMPLETED|Period 1: Week 1 to Week 12||0||
48345722|NCT03823391|101176503|FG000|STARTED|Period 2: Weeks 12 to Week 24||17||
48345723|NCT03823391|101176504|FG001|STARTED|Period 2: Weeks 12 to Week 24||31||
48345724|NCT03823391|101176503|FG000|COMPLETED|Period 2: Weeks 12 to Week 24||15||
48345725|NCT03823391|101176504|FG001|COMPLETED|Period 2: Weeks 12 to Week 24||30||
48345726|NCT03823391|101176503|FG000|NOT COMPLETED|Period 2: Weeks 12 to Week 24||2||
48345727|NCT03823391|101176504|FG001|NOT COMPLETED|Period 2: Weeks 12 to Week 24||1||
48345728|NCT02620020|101176505|FG000|STARTED|Overall Study||141|Full analysis set (FAS): All randomized participants per interactive voice response system (IVRS)|
48345729|NCT02620020|101176506|FG001|STARTED|Overall Study||141|Full analysis set (FAS): All randomized participants per interactive voice response system (IVRS)|
48345730|NCT02620020|101176507|FG002|STARTED|Overall Study||140|Full analysis set (FAS): All randomized participants per interactive voice response system (IVRS)|
48345731|NCT02620020|101176508|FG003|STARTED|Overall Study||141|Full analysis set (FAS): All randomized participants per interactive voice response system (IVRS)|
48368101|NCT01264965|101230106|FG000|COMPLETED|Overall Study||15||
48345732|NCT02620020|101176505|FG000|Modified Intent to Treat Set (mITT)|Overall Study||140|mITT: Participants who received at least 1 dose of study drug \& data up to 5 wks after last dose|
48345733|NCT02620020|101176506|FG001|Modified Intent to Treat Set (mITT)|Overall Study||139|mITT: Participants who received at least 1 dose of study drug \& data up to 5 wks after last dose|
48184984|NCT02096081|100775869|FG001|NOT COMPLETED|Overall Study||4||
48184985|NCT04254679|100775870|FG000|STARTED|Overall Study||42||
48184986|NCT04254679|100775871|FG001|STARTED|Overall Study||39||
48345734|NCT02620020|101176507|FG002|Modified Intent to Treat Set (mITT)|Overall Study||139|mITT: Participants who received at least 1 dose of study drug \& data up to 5 wks after last dose|
48345735|NCT02620020|101176508|FG003|Modified Intent to Treat Set (mITT)|Overall Study||140|mITT: Participants who received at least 1 dose of study drug \& data up to 5 wks after last dose|
48345736|NCT02620020|101176505|FG000|COMPLETED|Overall Study||97||
48345737|NCT02620020|101176506|FG001|COMPLETED|Overall Study||106||
48345738|NCT02620020|101176507|FG002|COMPLETED|Overall Study||115||
48345739|NCT02620020|101176508|FG003|COMPLETED|Overall Study||115||
48345740|NCT02620020|101176505|FG000|NOT COMPLETED|Overall Study||44||
48345741|NCT02620020|101176506|FG001|NOT COMPLETED|Overall Study||35||
48345742|NCT02620020|101176507|FG002|NOT COMPLETED|Overall Study||25||
48345743|NCT02620020|101176508|FG003|NOT COMPLETED|Overall Study||26||
48345744|NCT03322358|101176509|FG000|STARTED|Overall Study||77||
48345745|NCT03322358|101176510|FG001|STARTED|Overall Study||75||
48345746|NCT03322358|101176511|FG002|STARTED|Overall Study||75||
48345747|NCT03322358|101176512|FG003|STARTED|Overall Study||74||
48345748|NCT03322358|101176513|FG004|STARTED|Overall Study||75||
48345749|NCT03322358|101176514|FG005|STARTED|Overall Study||76||
48345750|NCT03322358|101176509|FG000|COMPLETED|Overall Study||77||
48345751|NCT03322358|101176510|FG001|COMPLETED|Overall Study||75||
48345752|NCT03322358|101176511|FG002|COMPLETED|Overall Study||75||
48345753|NCT03322358|101176512|FG003|COMPLETED|Overall Study||74||
48345754|NCT03322358|101176513|FG004|COMPLETED|Overall Study||75||
48345755|NCT03322358|101176514|FG005|COMPLETED|Overall Study||76||
48345756|NCT03322358|101176509|FG000|NOT COMPLETED|Overall Study||0||
48345757|NCT03322358|101176510|FG001|NOT COMPLETED|Overall Study||0||
48345758|NCT03322358|101176511|FG002|NOT COMPLETED|Overall Study||0||
48345759|NCT03322358|101176512|FG003|NOT COMPLETED|Overall Study||0||
48345760|NCT03322358|101176513|FG004|NOT COMPLETED|Overall Study||0||
48184987|NCT04254679|100775870|FG000|COMPLETED|Overall Study||39||
48184988|NCT04254679|100775871|FG001|COMPLETED|Overall Study||37||
48184989|NCT04254679|100775870|FG000|NOT COMPLETED|Overall Study||3||
48184990|NCT04254679|100775871|FG001|NOT COMPLETED|Overall Study||2||
48184991|NCT00813111|100775872|FG000|STARTED|Overall Study||66||
48184992|NCT00813111|100775873|FG001|STARTED|Overall Study||70||
48184993|NCT00813111|100775872|FG000|COMPLETED|Overall Study||64||
48184994|NCT00813111|100775873|FG001|COMPLETED|Overall Study||70||
48184995|NCT00813111|100775872|FG000|NOT COMPLETED|Overall Study||2||
48184996|NCT00813111|100775873|FG001|NOT COMPLETED|Overall Study||0||
48184997|NCT00184028|100775874|FG000|STARTED|Overall Study||12||
48184998|NCT00184028|100775874|FG000|COMPLETED|Overall Study||2||
48184999|NCT00184028|100775874|FG000|NOT COMPLETED|Overall Study||10||
48185000|NCT00742274|100775875|FG000|STARTED|Overall Study||30||
48185001|NCT00742274|100775876|FG001|STARTED|Overall Study||31||
48185002|NCT00742274|100775875|FG000|COMPLETED|Overall Study||27||
48185003|NCT00742274|100775876|FG001|COMPLETED|Overall Study||28||
48185004|NCT00742274|100775875|FG000|NOT COMPLETED|Overall Study||3||
48185005|NCT00742274|100775876|FG001|NOT COMPLETED|Overall Study||3||
48185006|NCT03398356|100775877|FG000|STARTED|Before Treatment||15||
48185007|NCT03398356|100775878|FG001|STARTED|Before Treatment||21||
48185008|NCT03398356|100775879|FG002|STARTED|Before Treatment||11||
48185009|NCT03398356|100775877|FG000|COMPLETED|Before Treatment||12||
48185010|NCT03398356|100775878|FG001|COMPLETED|Before Treatment||13||
48185011|NCT03398356|100775879|FG002|COMPLETED|Before Treatment||0||
48185012|NCT03398356|100775877|FG000|NOT COMPLETED|Before Treatment||3||
48185013|NCT03398356|100775878|FG001|NOT COMPLETED|Before Treatment||8||
48185014|NCT03398356|100775879|FG002|NOT COMPLETED|Before Treatment||11||
48185015|NCT03398356|100775877|FG000|STARTED|After 6 Weeks of Treatment||12||
48185016|NCT03398356|100775878|FG001|STARTED|After 6 Weeks of Treatment||13||
48185017|NCT03398356|100775879|FG002|STARTED|After 6 Weeks of Treatment||0||
48188684|NCT00329303|100783308|FG001|NOT COMPLETED|Overall Study||2||
48345761|NCT03322358|101176514|FG005|NOT COMPLETED|Overall Study||0||
48345762|NCT00500266|101176515|FG000|STARTED|Overall Study||1053||
48345763|NCT00500266|101176515|FG000|Treated|Overall Study||1049||
48345764|NCT00500266|101176515|FG000|COMPLETED|Overall Study||1040||
48345765|NCT00500266|101176515|FG000|NOT COMPLETED|Overall Study||13||
48345766|NCT04647110|101176516|FG000|STARTED|Overall Study||345||
48345767|NCT04647110|101176517|FG001|STARTED|Overall Study||204||
48345768|NCT04647110|101176516|FG000|COMPLETED|Overall Study||345||
48345769|NCT04647110|101176517|FG001|COMPLETED|Overall Study||204||
48345770|NCT04647110|101176516|FG000|NOT COMPLETED|Overall Study||0||
48345771|NCT04647110|101176517|FG001|NOT COMPLETED|Overall Study||0||
48345772|NCT01147497|101176518|FG000|STARTED|Overall Study||37||
48345773|NCT01147497|101176519|FG001|STARTED|Overall Study||36||
48345774|NCT01147497|101176518|FG000|COMPLETED|Overall Study||35||
48345775|NCT01147497|101176519|FG001|COMPLETED|Overall Study||36||
48345776|NCT01147497|101176518|FG000|NOT COMPLETED|Overall Study||2||
48345777|NCT01147497|101176519|FG001|NOT COMPLETED|Overall Study||0||
48345778|NCT01427309|101176520|FG000|STARTED|Overall Study||7253||
48345779|NCT01427309|101176521|FG001|STARTED|Overall Study||7244||
48345780|NCT01427309|101176522|FG002|STARTED|Overall Study||8737||
48345781|NCT01427309|101176523|FG003|STARTED|Overall Study||8749||
48345782|NCT01427309|101176520|FG000|COMPLETED|Overall Study||6881||
48345783|NCT01427309|101176521|FG001|COMPLETED|Overall Study||6837||
48345784|NCT01427309|101176522|FG002|COMPLETED|Overall Study||8376||
48345785|NCT01427309|101176523|FG003|COMPLETED|Overall Study||8373||
48345786|NCT01427309|101176520|FG000|NOT COMPLETED|Overall Study||372||
48345787|NCT01427309|101176521|FG001|NOT COMPLETED|Overall Study||407||
48345788|NCT01427309|101176522|FG002|NOT COMPLETED|Overall Study||361||
48345789|NCT01427309|101176523|FG003|NOT COMPLETED|Overall Study||376||
48345790|NCT00709826|101176524|FG000|STARTED|Overall Study||70||
48345791|NCT00709826|101176525|FG001|STARTED|Overall Study||39||
48345792|NCT00709826|101176524|FG000|COMPLETED|Overall Study||68||
48345793|NCT00709826|101176525|FG001|COMPLETED|Overall Study||38||
48345794|NCT00709826|101176524|FG000|NOT COMPLETED|Overall Study||2||
48345795|NCT00709826|101176525|FG001|NOT COMPLETED|Overall Study||1||
48345796|NCT03793439|101176526|FG000|STARTED|Overall Study||5||
48345797|NCT03793439|101176526|FG000|COMPLETED|Overall Study||3||
48345798|NCT03793439|101176526|FG000|NOT COMPLETED|Overall Study||2||
48345799|NCT02357420|101176527|FG000|STARTED|Overall Study||104||
48345800|NCT02357420|101176528|FG001|STARTED|Overall Study||98||
48345801|NCT02357420|101176529|FG002|STARTED|Overall Study||109||
48345802|NCT02357420|101176530|FG003|STARTED|Overall Study||82||
48345803|NCT02357420|101176527|FG000|Full Analysis Set (FAS)|Overall Study||104||
48345804|NCT02357420|101176528|FG001|Full Analysis Set (FAS)|Overall Study||98||
48345805|NCT02357420|101176529|FG002|Full Analysis Set (FAS)|Overall Study||109||
48345806|NCT02357420|101176530|FG003|Full Analysis Set (FAS)|Overall Study||81||
48345807|NCT02357420|101176527|FG000|COMPLETED|Overall Study||92||
48345808|NCT02357420|101176528|FG001|COMPLETED|Overall Study||86||
48345809|NCT02357420|101176529|FG002|COMPLETED|Overall Study||93||
48345810|NCT02357420|101176530|FG003|COMPLETED|Overall Study||63||
48345811|NCT02357420|101176527|FG000|NOT COMPLETED|Overall Study||12||
48345812|NCT02357420|101176528|FG001|NOT COMPLETED|Overall Study||12||
48345813|NCT02357420|101176529|FG002|NOT COMPLETED|Overall Study||16||
48345814|NCT02357420|101176530|FG003|NOT COMPLETED|Overall Study||19||
48345815|NCT03029832|101176531|FG000|STARTED|Overall Study||4||
48345816|NCT03029832|101176532|FG001|STARTED|Overall Study||1||
48345817|NCT03029832|101176531|FG000|COMPLETED|Overall Study||0||
48345818|NCT03029832|101176532|FG001|COMPLETED|Overall Study||0||
48345819|NCT03029832|101176531|FG000|NOT COMPLETED|Overall Study||4||
48345820|NCT03029832|101176532|FG001|NOT COMPLETED|Overall Study||1||
48345821|NCT00206726|101176533|FG000|STARTED|Overall Study||60||
48345822|NCT00206726|101176533|FG000|Treatment Started|Overall Study||57||
48345823|NCT00206726|101176533|FG000|4 Cycles Completed|Overall Study||41||
48345824|NCT00206726|101176533|FG000|COMPLETED|Overall Study||9||
48345825|NCT00206726|101176533|FG000|NOT COMPLETED|Overall Study||51||
48345826|NCT02690701|101176534|FG000|STARTED|Treatment Period 1||46|46|
48345827|NCT02690701|101176535|FG001|STARTED|Treatment Period 1||45|46|
48345828|NCT02690701|101176534|FG000|COMPLETED|Treatment Period 1||44|44|
48345829|NCT02690701|101176535|FG001|COMPLETED|Treatment Period 1||42|44|
48345830|NCT02690701|101176534|FG000|NOT COMPLETED|Treatment Period 1||2||
48345831|NCT02690701|101176535|FG001|NOT COMPLETED|Treatment Period 1||3||
48345832|NCT02690701|101176534|FG000|STARTED|Treatment Period 2||44|44|
48345833|NCT02690701|101176535|FG001|STARTED|Treatment Period 2||42|44|
48345834|NCT02690701|101176534|FG000|COMPLETED|Treatment Period 2||41|41|
48345835|NCT02690701|101176535|FG001|COMPLETED|Treatment Period 2||37|41|
48345836|NCT02690701|101176534|FG000|NOT COMPLETED|Treatment Period 2||3||
48345837|NCT02690701|101176535|FG001|NOT COMPLETED|Treatment Period 2||5||
48345838|NCT01508455|101176536|FG000|STARTED|Overall Study||6||
48345839|NCT01508455|101176536|FG000|COMPLETED|Overall Study||6||
48345840|NCT01508455|101176536|FG000|NOT COMPLETED|Overall Study||0||
48345841|NCT02612909|101176537|FG000|STARTED|Phase 2||100||
48345842|NCT02612909|101176538|FG001|STARTED|Phase 2||100||
48345843|NCT02612909|101176539|FG002|STARTED|Phase 2||100||
48345844|NCT02612909|101176540|FG003|STARTED|Phase 2||0||
48345845|NCT02612909|101176541|FG004|STARTED|Phase 2||0||
48345846|NCT02612909|101176537|FG000|Received Injection 1|Phase 2||100||
48345847|NCT02612909|101176538|FG001|Received Injection 1|Phase 2||100||
48345848|NCT02612909|101176539|FG002|Received Injection 1|Phase 2||100||
48345849|NCT02612909|101176540|FG003|Received Injection 1|Phase 2||0||
48345850|NCT02612909|101176541|FG004|Received Injection 1|Phase 2||0||
48345851|NCT02612909|101176537|FG000|Received Injection 2|Phase 2||98||
48345852|NCT02612909|101176538|FG001|Received Injection 2|Phase 2||95||
48345853|NCT02612909|101176539|FG002|Received Injection 2|Phase 2||99||
48345854|NCT02612909|101176540|FG003|Received Injection 2|Phase 2||0||
48345855|NCT02612909|101176541|FG004|Received Injection 2|Phase 2||0||
48345856|NCT02612909|101176537|FG000|Completed Day 29 Clinic Visit|Phase 2||98|8 days after injection 2|
48345857|NCT02612909|101176538|FG001|Completed Day 29 Clinic Visit|Phase 2||95|8 days after injection 2|
48345858|NCT02612909|101176539|FG002|Completed Day 29 Clinic Visit|Phase 2||99|8 days after injection 2|
48345859|NCT02612909|101176540|FG003|Completed Day 29 Clinic Visit|Phase 2||0|8 days after injection 2|
48345860|NCT02612909|101176541|FG004|Completed Day 29 Clinic Visit|Phase 2||0|8 days after injection 2|
48345861|NCT02612909|101176537|FG000|Completed Day 43 Clinic Visit|Phase 2||97|22 days after injection 2 (immunogenicity assessed)|
48345862|NCT02612909|101176538|FG001|Completed Day 43 Clinic Visit|Phase 2||94|22 days after injection 2 (immunogenicity assessed)|
48345863|NCT02612909|101176539|FG002|Completed Day 43 Clinic Visit|Phase 2||99|22 days after injection 2 (immunogenicity assessed)|
48345864|NCT02612909|101176540|FG003|Completed Day 43 Clinic Visit|Phase 2||0|22 days after injection 2 (immunogenicity assessed)|
48345865|NCT02612909|101176541|FG004|Completed Day 43 Clinic Visit|Phase 2||0|22 days after injection 2 (immunogenicity assessed)|
48345866|NCT02612909|101176537|FG000|COMPLETED|Phase 2||98||
48345867|NCT02612909|101176538|FG001|COMPLETED|Phase 2||95||
48345868|NCT02612909|101176539|FG002|COMPLETED|Phase 2||99||
48345869|NCT02612909|101176540|FG003|COMPLETED|Phase 2||0||
48345870|NCT02612909|101176541|FG004|COMPLETED|Phase 2||0||
48345871|NCT02612909|101176537|FG000|NOT COMPLETED|Phase 2||2||
48345872|NCT02612909|101176538|FG001|NOT COMPLETED|Phase 2||5||
48345873|NCT02612909|101176539|FG002|NOT COMPLETED|Phase 2||1||
48345874|NCT02612909|101176540|FG003|NOT COMPLETED|Phase 2||0||
48345875|NCT02612909|101176541|FG004|NOT COMPLETED|Phase 2||0||
48345876|NCT02612909|101176537|FG000|STARTED|Phase 3||0||
48345877|NCT02612909|101176538|FG001|STARTED|Phase 3||0||
48345878|NCT02612909|101176539|FG002|STARTED|Phase 3||0||
48345879|NCT02612909|101176540|FG003|STARTED|Phase 3||105||
48345880|NCT02612909|101176541|FG004|STARTED|Phase 3||525||
48345881|NCT02612909|101176537|FG000|Received Injection 1|Phase 3||0||
48345882|NCT02612909|101176538|FG001|Received Injection 1|Phase 3||0||
48345883|NCT02612909|101176539|FG002|Received Injection 1|Phase 3||0||
48345884|NCT02612909|101176540|FG003|Received Injection 1|Phase 3||105||
48345885|NCT02612909|101176541|FG004|Received Injection 1|Phase 3||525||
48345886|NCT02612909|101176537|FG000|Received Injection 2|Phase 3||0||
48345887|NCT02612909|101176538|FG001|Received Injection 2|Phase 3||0||
48345888|NCT02612909|101176539|FG002|Received Injection 2|Phase 3||0||
48345889|NCT02612909|101176540|FG003|Received Injection 2|Phase 3||103||
48345890|NCT02612909|101176541|FG004|Received Injection 2|Phase 3||520||
48345891|NCT02612909|101176537|FG000|Completed Day 29 Clinic Visit|Phase 3||0||
48345892|NCT02612909|101176538|FG001|Completed Day 29 Clinic Visit|Phase 3||0||
48345893|NCT02612909|101176539|FG002|Completed Day 29 Clinic Visit|Phase 3||0||
48345894|NCT02612909|101176540|FG003|Completed Day 29 Clinic Visit|Phase 3||104||
48345895|NCT02612909|101176541|FG004|Completed Day 29 Clinic Visit|Phase 3||525||
48345896|NCT02612909|101176537|FG000|Completed Day 43 Clinic Visit|Phase 3||0||
48345897|NCT02612909|101176538|FG001|Completed Day 43 Clinic Visit|Phase 3||0||
48345898|NCT02612909|101176539|FG002|Completed Day 43 Clinic Visit|Phase 3||0||
48345899|NCT02612909|101176540|FG003|Completed Day 43 Clinic Visit|Phase 3||104||
48345900|NCT02612909|101176541|FG004|Completed Day 43 Clinic Visit|Phase 3||524||
48345901|NCT02612909|101176537|FG000|COMPLETED|Phase 3||0||
48345902|NCT02612909|101176538|FG001|COMPLETED|Phase 3||0||
48345903|NCT02612909|101176539|FG002|COMPLETED|Phase 3||0||
48345904|NCT02612909|101176540|FG003|COMPLETED|Phase 3||104||
48345905|NCT02612909|101176541|FG004|COMPLETED|Phase 3||525||
48345906|NCT02612909|101176537|FG000|NOT COMPLETED|Phase 3||0||
48345907|NCT02612909|101176538|FG001|NOT COMPLETED|Phase 3||0||
48345908|NCT02612909|101176539|FG002|NOT COMPLETED|Phase 3||0||
48345909|NCT02612909|101176540|FG003|NOT COMPLETED|Phase 3||1||
48345910|NCT02612909|101176541|FG004|NOT COMPLETED|Phase 3||0||
48345911|NCT03195894|101176542|FG000|STARTED|Overall Study||59||
48345912|NCT03195894|101176543|FG001|STARTED|Overall Study||56||
48415301|NCT02130635|101350246|FG002|STARTED|Part A-Safety and Tolerability||0||
48415302|NCT02130635|101350247|FG003|STARTED|Part A-Safety and Tolerability||0||
48415303|NCT02130635|101350248|FG004|STARTED|Part A-Safety and Tolerability||0||
48345913|NCT03195894|101176542|FG000|COMPLETED|Overall Study||26||
48345914|NCT03195894|101176543|FG001|COMPLETED|Overall Study||28||
48345915|NCT03195894|101176542|FG000|NOT COMPLETED|Overall Study||33||
48345916|NCT03195894|101176543|FG001|NOT COMPLETED|Overall Study||28||
48345917|NCT00522392|101176544|FG000|STARTED|Overall Study||23||
48345918|NCT00522392|101176545|FG001|STARTED|Overall Study||25||
48345919|NCT00522392|101176544|FG000|Pts w/ Measurable Disease at Baseline|Overall Study||16||
48345920|NCT00522392|101176545|FG001|Pts w/ Measurable Disease at Baseline|Overall Study||16||
48415304|NCT02130635|101350249|FG005|STARTED|Part A-Safety and Tolerability||0||
48345921|NCT00522392|101176544|FG000|Pts w/ QOL Assessments Complete|Overall Study||12||
48345922|NCT00522392|101176545|FG001|Pts w/ QOL Assessments Complete|Overall Study||8||
48345923|NCT00522392|101176544|FG000|COMPLETED|Overall Study||15||
48345924|NCT00522392|101176545|FG001|COMPLETED|Overall Study||12||
48345925|NCT00522392|101176544|FG000|NOT COMPLETED|Overall Study||8||
48345926|NCT00522392|101176545|FG001|NOT COMPLETED|Overall Study||13||
48345927|NCT03185546|101176546|FG000|STARTED|Baseline Through Week 12||6||
48345928|NCT03185546|101176547|FG001|STARTED|Baseline Through Week 12||10||
48345929|NCT03185546|101176548|FG002|STARTED|Baseline Through Week 12||5||
48345930|NCT03185546|101176549|FG003|STARTED|Baseline Through Week 12||5||
48345931|NCT03185546|101176550|FG004|STARTED|Baseline Through Week 12||6||
48345932|NCT03185546|101176551|FG005|STARTED|Baseline Through Week 12||6||
48345933|NCT03185546|101176552|FG006|STARTED|Baseline Through Week 12||7||
48345934|NCT03185546|101176553|FG007|STARTED|Baseline Through Week 12||5||
48345935|NCT03185546|101176546|FG000|COMPLETED|Baseline Through Week 12||2||
48345936|NCT03185546|101176547|FG001|COMPLETED|Baseline Through Week 12||7||
48345937|NCT03185546|101176548|FG002|COMPLETED|Baseline Through Week 12||4||
48345938|NCT03185546|101176549|FG003|COMPLETED|Baseline Through Week 12||4||
48345939|NCT03185546|101176550|FG004|COMPLETED|Baseline Through Week 12||5||
48345940|NCT03185546|101176551|FG005|COMPLETED|Baseline Through Week 12||4||
48345941|NCT03185546|101176552|FG006|COMPLETED|Baseline Through Week 12||4||
48345942|NCT03185546|101176553|FG007|COMPLETED|Baseline Through Week 12||2||
48345943|NCT03185546|101176546|FG000|NOT COMPLETED|Baseline Through Week 12||4||
48345944|NCT03185546|101176547|FG001|NOT COMPLETED|Baseline Through Week 12||3||
48345945|NCT03185546|101176548|FG002|NOT COMPLETED|Baseline Through Week 12||1||
48345946|NCT03185546|101176549|FG003|NOT COMPLETED|Baseline Through Week 12||1||
48345947|NCT03185546|101176550|FG004|NOT COMPLETED|Baseline Through Week 12||1||
48345948|NCT03185546|101176551|FG005|NOT COMPLETED|Baseline Through Week 12||2||
48345949|NCT03185546|101176552|FG006|NOT COMPLETED|Baseline Through Week 12||3||
48345950|NCT03185546|101176553|FG007|NOT COMPLETED|Baseline Through Week 12||3||
48345951|NCT03185546|101176546|FG000|STARTED|Week 12 Through Day 30 Follow up||2||
48345952|NCT03185546|101176547|FG001|STARTED|Week 12 Through Day 30 Follow up||7||
48345953|NCT03185546|101176548|FG002|STARTED|Week 12 Through Day 30 Follow up||4||
48345954|NCT03185546|101176549|FG003|STARTED|Week 12 Through Day 30 Follow up||4||
48345955|NCT03185546|101176550|FG004|STARTED|Week 12 Through Day 30 Follow up||5||
48345956|NCT03185546|101176551|FG005|STARTED|Week 12 Through Day 30 Follow up||4||
48345957|NCT03185546|101176552|FG006|STARTED|Week 12 Through Day 30 Follow up||4||
48345958|NCT03185546|101176553|FG007|STARTED|Week 12 Through Day 30 Follow up||2||
48345959|NCT03185546|101176546|FG000|COMPLETED|Week 12 Through Day 30 Follow up||2||
48345960|NCT03185546|101176547|FG001|COMPLETED|Week 12 Through Day 30 Follow up||7||
48345961|NCT03185546|101176548|FG002|COMPLETED|Week 12 Through Day 30 Follow up||4||
48345962|NCT03185546|101176549|FG003|COMPLETED|Week 12 Through Day 30 Follow up||3||
48345963|NCT03185546|101176550|FG004|COMPLETED|Week 12 Through Day 30 Follow up||5||
48345964|NCT03185546|101176551|FG005|COMPLETED|Week 12 Through Day 30 Follow up||4||
48345965|NCT03185546|101176552|FG006|COMPLETED|Week 12 Through Day 30 Follow up||3||
48345966|NCT03185546|101176553|FG007|COMPLETED|Week 12 Through Day 30 Follow up||2||
48345967|NCT03185546|101176546|FG000|NOT COMPLETED|Week 12 Through Day 30 Follow up||0||
48345968|NCT03185546|101176547|FG001|NOT COMPLETED|Week 12 Through Day 30 Follow up||0||
48345969|NCT03185546|101176548|FG002|NOT COMPLETED|Week 12 Through Day 30 Follow up||0||
48345970|NCT03185546|101176549|FG003|NOT COMPLETED|Week 12 Through Day 30 Follow up||1||
48345971|NCT03185546|101176550|FG004|NOT COMPLETED|Week 12 Through Day 30 Follow up||0||
48345972|NCT03185546|101176551|FG005|NOT COMPLETED|Week 12 Through Day 30 Follow up||0||
48345973|NCT03185546|101176552|FG006|NOT COMPLETED|Week 12 Through Day 30 Follow up||1||
48345974|NCT03185546|101176553|FG007|NOT COMPLETED|Week 12 Through Day 30 Follow up||0||
48345975|NCT00140855|101176554|FG000|STARTED|Overall Study||6||
48345976|NCT00140855|101176554|FG000|COMPLETED|Overall Study||4||
48345977|NCT00140855|101176554|FG000|NOT COMPLETED|Overall Study||2||
48345978|NCT01053429|101176555|FG000|STARTED|Overall Study||3391||
48345979|NCT01053429|101176555|FG000|COMPLETED|Overall Study||3018||
48345980|NCT01053429|101176555|FG000|NOT COMPLETED|Overall Study||373||
48345981|NCT02494570|101176556|FG000|STARTED|Overall Study||34||
48345982|NCT02494570|101176556|FG000|COMPLETED|Overall Study||34||
48345983|NCT02494570|101176556|FG000|NOT COMPLETED|Overall Study||0||
48345984|NCT00925600|101176557|FG000|STARTED|Overall Study||386||
48345985|NCT00925600|101176558|FG001|STARTED|Overall Study||383||
48345986|NCT00925600|101176557|FG000|Received Treatment|Overall Study||383||
48345987|NCT00925600|101176558|FG001|Received Treatment|Overall Study||382||
48345988|NCT00925600|101176557|FG000|COMPLETED|Overall Study||354||
48345989|NCT00925600|101176558|FG001|COMPLETED|Overall Study||355||
48345990|NCT00925600|101176557|FG000|NOT COMPLETED|Overall Study||32||
48345991|NCT00925600|101176558|FG001|NOT COMPLETED|Overall Study||28||
48345992|NCT04139122|101176559|FG000|STARTED|Overall Study||6||
48345993|NCT04139122|101176560|FG001|STARTED|Overall Study||6||
48345994|NCT04139122|101176561|FG002|STARTED|Overall Study||5||
48345995|NCT04139122|101176562|FG003|STARTED|Overall Study||4||
48345996|NCT04139122|101176563|FG004|STARTED|Overall Study||8||
48345997|NCT04139122|101176564|FG005|STARTED|Overall Study||20||
48345998|NCT04139122|101176565|FG006|STARTED|Overall Study||20||
48345999|NCT04139122|101176566|FG007|STARTED|Overall Study||20||
48346000|NCT04139122|101176559|FG000|COMPLETED|Overall Study||5||
48346001|NCT04139122|101176560|FG001|COMPLETED|Overall Study||6||
48346002|NCT04139122|101176561|FG002|COMPLETED|Overall Study||5||
48346003|NCT04139122|101176562|FG003|COMPLETED|Overall Study||4||
48346004|NCT04139122|101176563|FG004|COMPLETED|Overall Study||8||
48346005|NCT04139122|101176564|FG005|COMPLETED|Overall Study||20||
48346006|NCT04139122|101176565|FG006|COMPLETED|Overall Study||20||
48346007|NCT04139122|101176566|FG007|COMPLETED|Overall Study||19||
48346008|NCT04139122|101176559|FG000|NOT COMPLETED|Overall Study||1||
48346009|NCT04139122|101176560|FG001|NOT COMPLETED|Overall Study||0||
48346010|NCT04139122|101176561|FG002|NOT COMPLETED|Overall Study||0||
48346011|NCT04139122|101176562|FG003|NOT COMPLETED|Overall Study||0||
48346012|NCT04139122|101176563|FG004|NOT COMPLETED|Overall Study||0||
48346013|NCT04139122|101176564|FG005|NOT COMPLETED|Overall Study||0||
48346014|NCT04139122|101176565|FG006|NOT COMPLETED|Overall Study||0||
48346015|NCT04139122|101176566|FG007|NOT COMPLETED|Overall Study||1||
48346016|NCT02507349|101176567|FG000|STARTED|Overall Study||1232||
48415305|NCT02130635|101350250|FG006|STARTED|Part A-Safety and Tolerability||0||
48415306|NCT02130635|101350251|FG007|STARTED|Part A-Safety and Tolerability||0||
48415307|NCT02130635|101350252|FG008|STARTED|Part A-Safety and Tolerability||0||
48415308|NCT02130635|101350244|FG000|COMPLETED|Part A-Safety and Tolerability||7||
48415309|NCT02130635|101350245|FG001|COMPLETED|Part A-Safety and Tolerability||21||
48415310|NCT02130635|101350246|FG002|COMPLETED|Part A-Safety and Tolerability||0||
48415311|NCT02130635|101350247|FG003|COMPLETED|Part A-Safety and Tolerability||0||
48415312|NCT02130635|101350248|FG004|COMPLETED|Part A-Safety and Tolerability||0||
48415313|NCT02130635|101350249|FG005|COMPLETED|Part A-Safety and Tolerability||0||
48415314|NCT02130635|101350250|FG006|COMPLETED|Part A-Safety and Tolerability||0||
48415315|NCT02130635|101350251|FG007|COMPLETED|Part A-Safety and Tolerability||0||
48415316|NCT02130635|101350252|FG008|COMPLETED|Part A-Safety and Tolerability||0||
48415317|NCT02130635|101350244|FG000|NOT COMPLETED|Part A-Safety and Tolerability||0||
48415318|NCT02130635|101350245|FG001|NOT COMPLETED|Part A-Safety and Tolerability||0||
48415319|NCT02130635|101350246|FG002|NOT COMPLETED|Part A-Safety and Tolerability||0||
48415320|NCT02130635|101350247|FG003|NOT COMPLETED|Part A-Safety and Tolerability||0||
48415321|NCT02130635|101350248|FG004|NOT COMPLETED|Part A-Safety and Tolerability||0||
48346017|NCT02507349|101176568|FG001|STARTED|Overall Study||1211||
48346018|NCT02507349|101176567|FG000|COMPLETED|Overall Study||1045||
48346019|NCT02507349|101176568|FG001|COMPLETED|Overall Study||1050||
48346020|NCT02507349|101176567|FG000|NOT COMPLETED|Overall Study||187||
48346021|NCT02507349|101176568|FG001|NOT COMPLETED|Overall Study||161||
48346022|NCT02786901|101176569|FG000|STARTED|Overall Study||199||
48346023|NCT02786901|101176570|FG001|STARTED|Overall Study||201||
48346024|NCT02786901|101176571|FG002|STARTED|Overall Study||200||
48346025|NCT02786901|101176569|FG000|COMPLETED|Overall Study||122||
48346026|NCT02786901|101176570|FG001|COMPLETED|Overall Study||145||
48346027|NCT02786901|101176571|FG002|COMPLETED|Overall Study||159||
48346028|NCT02786901|101176569|FG000|NOT COMPLETED|Overall Study||77||
48415322|NCT02130635|101350249|FG005|NOT COMPLETED|Part A-Safety and Tolerability||0||
48415323|NCT02130635|101350250|FG006|NOT COMPLETED|Part A-Safety and Tolerability||0||
48415324|NCT02130635|101350251|FG007|NOT COMPLETED|Part A-Safety and Tolerability||0||
48415325|NCT02130635|101350252|FG008|NOT COMPLETED|Part A-Safety and Tolerability||0||
48415326|NCT02130635|101350244|FG000|STARTED|Part B-Dose-Response Relationship||0||
48415327|NCT02130635|101350245|FG001|STARTED|Part B-Dose-Response Relationship||0||
48415328|NCT02130635|101350246|FG002|STARTED|Part B-Dose-Response Relationship||5||
48415329|NCT02130635|101350247|FG003|STARTED|Part B-Dose-Response Relationship||5||
48415330|NCT02130635|101350248|FG004|STARTED|Part B-Dose-Response Relationship||5||
48415331|NCT02130635|101350249|FG005|STARTED|Part B-Dose-Response Relationship||5||
48415332|NCT02130635|101350250|FG006|STARTED|Part B-Dose-Response Relationship||6||
48415333|NCT02130635|101350251|FG007|STARTED|Part B-Dose-Response Relationship||5||
48415334|NCT02130635|101350252|FG008|STARTED|Part B-Dose-Response Relationship||5||
48415335|NCT02130635|101350244|FG000|COMPLETED|Part B-Dose-Response Relationship||0||
48415336|NCT02130635|101350245|FG001|COMPLETED|Part B-Dose-Response Relationship||0||
48415337|NCT02130635|101350246|FG002|COMPLETED|Part B-Dose-Response Relationship||5||
48415338|NCT02130635|101350247|FG003|COMPLETED|Part B-Dose-Response Relationship||5||
48415339|NCT02130635|101350248|FG004|COMPLETED|Part B-Dose-Response Relationship||5||
48415340|NCT02130635|101350249|FG005|COMPLETED|Part B-Dose-Response Relationship||5||
48415341|NCT02130635|101350250|FG006|COMPLETED|Part B-Dose-Response Relationship||6||
48415342|NCT02130635|101350251|FG007|COMPLETED|Part B-Dose-Response Relationship||5||
48415343|NCT02130635|101350252|FG008|COMPLETED|Part B-Dose-Response Relationship||5||
48439970|NCT01728376|101409998|FG003|Treated|Overall Study||9||
48346029|NCT02786901|101176570|FG001|NOT COMPLETED|Overall Study||56||
48346030|NCT02786901|101176571|FG002|NOT COMPLETED|Overall Study||41||
48346031|NCT00828464|101176572|FG000|STARTED|Overall Study||30||
48346032|NCT00828464|101176572|FG000|COMPLETED|Overall Study||29||
48346033|NCT00828464|101176572|FG000|NOT COMPLETED|Overall Study||1||
48346034|NCT00706628|101176573|FG000|STARTED|Overall Study||47||
48346035|NCT00706628|101176574|FG001|STARTED|Overall Study||21||
48346036|NCT00706628|101176575|FG002|STARTED|Overall Study||16||
48346037|NCT00706628|101176576|FG003|STARTED|Overall Study||3||
48415344|NCT02130635|101350244|FG000|NOT COMPLETED|Part B-Dose-Response Relationship||0||
48346038|NCT00706628|101176573|FG000|COMPLETED|Overall Study||0||
48346039|NCT00706628|101176574|FG001|COMPLETED|Overall Study||0||
48346040|NCT00706628|101176575|FG002|COMPLETED|Overall Study||0||
48346041|NCT00706628|101176576|FG003|COMPLETED|Overall Study||0||
48346042|NCT00706628|101176573|FG000|NOT COMPLETED|Overall Study||47||
48346043|NCT00706628|101176574|FG001|NOT COMPLETED|Overall Study||21||
48346044|NCT00706628|101176575|FG002|NOT COMPLETED|Overall Study||16||
48346045|NCT00706628|101176576|FG003|NOT COMPLETED|Overall Study||3||
48346046|NCT01172067|101176577|FG000|STARTED|Overall Study||200||
48346047|NCT01172067|101176578|FG001|STARTED|Overall Study||200||
48346048|NCT01172067|101176577|FG000|COMPLETED|Overall Study||153||
48346049|NCT01172067|101176578|FG001|COMPLETED|Overall Study||163||
48346050|NCT01172067|101176577|FG000|NOT COMPLETED|Overall Study||47||
48346051|NCT01172067|101176578|FG001|NOT COMPLETED|Overall Study||37||
48346052|NCT04271761|101176579|FG000|STARTED|Overall Study||14||
48346053|NCT04271761|101176579|FG000|COMPLETED|Overall Study||14||
48346054|NCT04271761|101176579|FG000|NOT COMPLETED|Overall Study||0||
48346055|NCT00781365|101176580|FG000|STARTED|Overall Study||228||
48346056|NCT00781365|101176581|FG001|STARTED|Overall Study||222||
48346057|NCT00781365|101176580|FG000|COMPLETED|Overall Study||194||
48346058|NCT00781365|101176581|FG001|COMPLETED|Overall Study||186||
48346059|NCT00781365|101176580|FG000|NOT COMPLETED|Overall Study||34||
48346060|NCT00781365|101176581|FG001|NOT COMPLETED|Overall Study||36||
48346061|NCT01245673|101176582|FG000|STARTED|Enrollment||28||
48346062|NCT01245673|101176582|FG000|COMPLETED|Enrollment||27||
48346063|NCT01245673|101176582|FG000|NOT COMPLETED|Enrollment||1||
48346064|NCT01245673|101176582|FG000|STARTED|Pre Transplant Vaccinations||27||
48346065|NCT01245673|101176582|FG000|Pre Transplant Vaccinations 1-3|Pre Transplant Vaccinations||27|MAGE-A3, GM-CSF, Hiltonol®, PCV vaccine \~10 days before apheresis.|
48346066|NCT01245673|101176582|FG000|COMPLETED|Pre Transplant Vaccinations||27||
48346067|NCT01245673|101176582|FG000|NOT COMPLETED|Pre Transplant Vaccinations||0||
48346068|NCT01245673|101176582|FG000|STARTED|Activated/Costimulated Autologous T Cell||27||
48346069|NCT01245673|101176582|FG000|COMPLETED|Activated/Costimulated Autologous T Cell||27||
48346070|NCT01245673|101176582|FG000|NOT COMPLETED|Activated/Costimulated Autologous T Cell||0||
48346071|NCT01245673|101176582|FG000|STARTED|MAGE-A3, Hiltonol®, PVC After T Cells||27|On study Days 14, 42 and 90 study participants will receive MAGE-A3, Hiltonol® and PVC vaccine.|
48346072|NCT01245673|101176582|FG000|COMPLETED|MAGE-A3, Hiltonol®, PVC After T Cells||26||
48346073|NCT01245673|101176582|FG000|NOT COMPLETED|MAGE-A3, Hiltonol®, PVC After T Cells||1||
48346074|NCT01245673|101176582|FG000|STARTED|Start Lenalidomide||26||
48346075|NCT01245673|101176582|FG000|COMPLETED|Start Lenalidomide||26||
48346076|NCT01245673|101176582|FG000|NOT COMPLETED|Start Lenalidomide||0||
48346077|NCT01245673|101176582|FG000|STARTED|Maintenance: MAGE-A3, PVC After T Cells||26||
48346078|NCT01245673|101176582|FG000|COMPLETED|Maintenance: MAGE-A3, PVC After T Cells||26||
48346079|NCT01245673|101176582|FG000|NOT COMPLETED|Maintenance: MAGE-A3, PVC After T Cells||0||
48346080|NCT02673333|101176583|FG000|STARTED|Overall Study||39||
48346081|NCT02673333|101176583|FG000|COMPLETED|Overall Study||39||
48346082|NCT02673333|101176583|FG000|NOT COMPLETED|Overall Study||0||
48346083|NCT00376961|101176584|FG000|STARTED|Initial Registration||68||
48346084|NCT00376961|101176585|FG001|STARTED|Initial Registration||0||
48346085|NCT00376961|101176584|FG000|Eligible|Initial Registration||65||
48346086|NCT00376961|101176585|FG001|Eligible|Initial Registration||0||
48346087|NCT00376961|101176584|FG000|COMPLETED|Initial Registration||61||
48346088|NCT00376961|101176585|FG001|COMPLETED|Initial Registration||0||
48346089|NCT00376961|101176584|FG000|NOT COMPLETED|Initial Registration||7||
48346090|NCT00376961|101176585|FG001|NOT COMPLETED|Initial Registration||0||
48346091|NCT00376961|101176584|FG000|STARTED|Maintenance||0||
48759194|NCT05138653|102197767|FG005|STARTED|Multiple Ascending Dose (Up to 12 Weeks)||0||
48759195|NCT05138653|102197768|FG006|STARTED|Multiple Ascending Dose (Up to 12 Weeks)||0||
48759196|NCT05138653|102197769|FG007|STARTED|Multiple Ascending Dose (Up to 12 Weeks)||0||
48759197|NCT05138653|102197770|FG008|STARTED|Multiple Ascending Dose (Up to 12 Weeks)||0||
48346092|NCT00376961|101176585|FG001|STARTED|Maintenance||50||
48346093|NCT00376961|101176584|FG000|Eligible|Maintenance||0||
48346094|NCT00376961|101176585|FG001|Eligible|Maintenance||47||
48415345|NCT02130635|101350245|FG001|NOT COMPLETED|Part B-Dose-Response Relationship||0||
48415346|NCT02130635|101350246|FG002|NOT COMPLETED|Part B-Dose-Response Relationship||0||
48415347|NCT02130635|101350247|FG003|NOT COMPLETED|Part B-Dose-Response Relationship||0||
48415348|NCT02130635|101350248|FG004|NOT COMPLETED|Part B-Dose-Response Relationship||0||
48415349|NCT02130635|101350249|FG005|NOT COMPLETED|Part B-Dose-Response Relationship||0||
48759198|NCT05138653|102197771|FG009|STARTED|Multiple Ascending Dose (Up to 12 Weeks)||0||
48346095|NCT00376961|101176584|FG000|COMPLETED|Maintenance||0||
48346096|NCT00376961|101176585|FG001|COMPLETED|Maintenance||27||
48346097|NCT00376961|101176584|FG000|NOT COMPLETED|Maintenance||0||
48346098|NCT00376961|101176585|FG001|NOT COMPLETED|Maintenance||23||
48346099|NCT00855439|101176586|FG000|STARTED|Overall Study||22||
48346100|NCT00855439|101176587|FG001|STARTED|Overall Study||24||
48346101|NCT00855439|101176586|FG000|COMPLETED|Overall Study||19||
48346102|NCT00855439|101176587|FG001|COMPLETED|Overall Study||24||
48346103|NCT00855439|101176586|FG000|NOT COMPLETED|Overall Study||3||
48415350|NCT02130635|101350250|FG006|NOT COMPLETED|Part B-Dose-Response Relationship||0||
48415351|NCT02130635|101350251|FG007|NOT COMPLETED|Part B-Dose-Response Relationship||0||
48415352|NCT02130635|101350252|FG008|NOT COMPLETED|Part B-Dose-Response Relationship||0||
48415353|NCT03018340|101350253|FG000|STARTED|Overall Study||52||
48346104|NCT00855439|101176587|FG001|NOT COMPLETED|Overall Study||0||
48346105|NCT00666562|101176588|FG000|STARTED|Overall Study||11||
48346106|NCT00666562|101176589|FG001|STARTED|Overall Study||10||
48346107|NCT00666562|101176590|FG002|STARTED|Overall Study||10||
48346108|NCT00666562|101176588|FG000|COMPLETED|Overall Study||11||
48346109|NCT00666562|101176589|FG001|COMPLETED|Overall Study||8||
48415354|NCT03018340|101350254|FG001|STARTED|Overall Study||155||
48415355|NCT03018340|101350253|FG000|COMPLETED|Overall Study||44||
48415356|NCT03018340|101350254|FG001|COMPLETED|Overall Study||125||
48185018|NCT03398356|100775877|FG000|COMPLETED|After 6 Weeks of Treatment||12||
48185019|NCT03398356|100775878|FG001|COMPLETED|After 6 Weeks of Treatment||11||
48346110|NCT00666562|101176590|FG002|COMPLETED|Overall Study||10||
48346111|NCT00666562|101176588|FG000|NOT COMPLETED|Overall Study||0||
48415357|NCT03018340|101350253|FG000|NOT COMPLETED|Overall Study||8||
48185020|NCT03398356|100775879|FG002|COMPLETED|After 6 Weeks of Treatment||0||
48415358|NCT03018340|101350254|FG001|NOT COMPLETED|Overall Study||30||
48415359|NCT03128372|101350255|FG000|STARTED|Overall Study||32||
48415360|NCT03128372|101350255|FG000|COMPLETED|Overall Study||32||
48415361|NCT03128372|101350255|FG000|NOT COMPLETED|Overall Study||0||
48346112|NCT00666562|101176589|FG001|NOT COMPLETED|Overall Study||2||
48346113|NCT00666562|101176590|FG002|NOT COMPLETED|Overall Study||0||
48346114|NCT03770403|101176591|FG000|STARTED|Overall Study||145||
48346115|NCT03770403|101176591|FG000|COMPLETED|Overall Study||28||
48346116|NCT03770403|101176591|FG000|NOT COMPLETED|Overall Study||117||
48346117|NCT00461175|101176592|FG000|STARTED|Overall Study||43600||
48346118|NCT00461175|101176593|FG001|STARTED|Overall Study||18735||
48346119|NCT00461175|101176592|FG000|COMPLETED|Overall Study||43078||
48346120|NCT00461175|101176593|FG001|COMPLETED|Overall Study||18370||
48346121|NCT00461175|101176592|FG000|NOT COMPLETED|Overall Study||522||
48346122|NCT00461175|101176593|FG001|NOT COMPLETED|Overall Study||365||
48346123|NCT00880750|101176594|FG000|STARTED|First Intervention||39||
48346124|NCT00880750|101176595|FG001|STARTED|First Intervention||33||
48346125|NCT00880750|101176594|FG000|COMPLETED|First Intervention||30||
48346126|NCT00880750|101176595|FG001|COMPLETED|First Intervention||32||
48346127|NCT00880750|101176594|FG000|NOT COMPLETED|First Intervention||9||
48346128|NCT00880750|101176595|FG001|NOT COMPLETED|First Intervention||1||
48346129|NCT00880750|101176594|FG000|STARTED|Washout Period||30||
48346130|NCT00880750|101176595|FG001|STARTED|Washout Period||32||
48346131|NCT00880750|101176594|FG000|COMPLETED|Washout Period||30||
48346132|NCT00880750|101176595|FG001|COMPLETED|Washout Period||32||
48346133|NCT00880750|101176594|FG000|NOT COMPLETED|Washout Period||0||
48346134|NCT00880750|101176595|FG001|NOT COMPLETED|Washout Period||0||
48346135|NCT00880750|101176594|FG000|STARTED|Second Intervention||30||
48346136|NCT00880750|101176595|FG001|STARTED|Second Intervention||32||
48346137|NCT00880750|101176594|FG000|COMPLETED|Second Intervention||26||
48346138|NCT00880750|101176595|FG001|COMPLETED|Second Intervention||30||
48346139|NCT00880750|101176594|FG000|NOT COMPLETED|Second Intervention||4||
48346140|NCT00880750|101176595|FG001|NOT COMPLETED|Second Intervention||2||
48346141|NCT00737529|101176596|FG000|STARTED|Overall Study||134||
48346142|NCT00737529|101176596|FG000|COMPLETED|Overall Study||1||
48346143|NCT00737529|101176596|FG000|NOT COMPLETED|Overall Study||133||
48346144|NCT02041962|101176597|FG000|STARTED|Overall Study||123|Completed baseline and randomized|
48346145|NCT02041962|101176598|FG001|STARTED|Overall Study||115|Completed baseline and randomized|
48346146|NCT02041962|101176597|FG000|Participants Completing 6 mo. f/up|Overall Study||69||
48346147|NCT02041962|101176598|FG001|Participants Completing 6 mo. f/up|Overall Study||44||
48346148|NCT02041962|101176597|FG000|Participants Completing 12 mo. f/up|Overall Study||42||
48346149|NCT02041962|101176598|FG001|Participants Completing 12 mo. f/up|Overall Study||31||
48346150|NCT02041962|101176597|FG000|COMPLETED|Overall Study||42||
48346151|NCT02041962|101176598|FG001|COMPLETED|Overall Study||31||
48346152|NCT02041962|101176597|FG000|NOT COMPLETED|Overall Study||81||
48346153|NCT02041962|101176598|FG001|NOT COMPLETED|Overall Study||84||
48346154|NCT00928070|101176599|FG000|STARTED|Overall Study||283||
48346155|NCT00928070|101176600|FG001|STARTED|Overall Study||283||
48346156|NCT00928070|101176599|FG000|Treated|Overall Study||281||
48346157|NCT00928070|101176600|FG001|Treated|Overall Study||281||
48346158|NCT00928070|101176599|FG000|COMPLETED|Overall Study||220||
48346159|NCT00928070|101176600|FG001|COMPLETED|Overall Study||226||
48346160|NCT00928070|101176599|FG000|NOT COMPLETED|Overall Study||63||
48346161|NCT00928070|101176600|FG001|NOT COMPLETED|Overall Study||57||
48346162|NCT01841632|101176601|FG000|STARTED|Overall Study||3||
48346163|NCT01841632|101176601|FG000|COMPLETED|Overall Study||3||
48346164|NCT01841632|101176601|FG000|NOT COMPLETED|Overall Study||0||
48346165|NCT02537678|101176602|FG000|STARTED|Baseline to Post-treatment||91||
48346166|NCT02537678|101176603|FG001|STARTED|Baseline to Post-treatment||92||
48346167|NCT02537678|101176602|FG000|Completed Post-treatment|Baseline to Post-treatment||61||
48346168|NCT02537678|101176603|FG001|Completed Post-treatment|Baseline to Post-treatment||71||
48346169|NCT02537678|101176602|FG000|COMPLETED|Baseline to Post-treatment||61||
48346170|NCT02537678|101176603|FG001|COMPLETED|Baseline to Post-treatment||71||
48346171|NCT02537678|101176602|FG000|NOT COMPLETED|Baseline to Post-treatment||30||
48346172|NCT02537678|101176603|FG001|NOT COMPLETED|Baseline to Post-treatment||21||
48346173|NCT02537678|101176602|FG000|STARTED|Post-treatment to 6 Month Assessment||61||
48346174|NCT02537678|101176603|FG001|STARTED|Post-treatment to 6 Month Assessment||71||
48346175|NCT02537678|101176602|FG000|COMPLETED|Post-treatment to 6 Month Assessment||53||
48346176|NCT02537678|101176603|FG001|COMPLETED|Post-treatment to 6 Month Assessment||64||
48346177|NCT02537678|101176602|FG000|NOT COMPLETED|Post-treatment to 6 Month Assessment||8||
48346178|NCT02537678|101176603|FG001|NOT COMPLETED|Post-treatment to 6 Month Assessment||7||
48346179|NCT02537678|101176602|FG000|STARTED|6 Month to 12 Month Assessment||53||
48415362|NCT01685060|101350256|FG000|STARTED|Overall Study||140||
48415363|NCT01685060|101350256|FG000|Entered Post-treatment Efficacy f/u|Overall Study||7||
48415364|NCT01685060|101350256|FG000|Entered Survival Follow up|Overall Study||98||
48415365|NCT01685060|101350256|FG000|Discontinued From Study|Overall Study||35||
48346180|NCT02537678|101176603|FG001|STARTED|6 Month to 12 Month Assessment||64||
48346181|NCT02537678|101176602|FG000|COMPLETED|6 Month to 12 Month Assessment||53||
48346182|NCT02537678|101176603|FG001|COMPLETED|6 Month to 12 Month Assessment||63||
48346183|NCT02537678|101176602|FG000|NOT COMPLETED|6 Month to 12 Month Assessment||0||
48346184|NCT02537678|101176603|FG001|NOT COMPLETED|6 Month to 12 Month Assessment||1||
48346185|NCT03496701|101176604|FG000|STARTED|Overall Study||77||
48346186|NCT03496701|101176604|FG000|COMPLETED|Overall Study||77||
48346187|NCT03496701|101176604|FG000|NOT COMPLETED|Overall Study||0||
48346188|NCT00222105|101176605|FG000|STARTED|Overall Study||25||
48346189|NCT00222105|101176605|FG000|COMPLETED|Overall Study||11||
48346190|NCT00222105|101176605|FG000|NOT COMPLETED|Overall Study||14||
48346191|NCT01237951|101176606|FG000|STARTED|Overall Study||75||
48346192|NCT01237951|101176606|FG000|COMPLETED|Overall Study||74||
48346193|NCT01237951|101176606|FG000|NOT COMPLETED|Overall Study||1||
48346194|NCT03041311|101176607|FG000|STARTED|Overall Study||54||
48346195|NCT03041311|101176608|FG001|STARTED|Overall Study||53||
48346196|NCT03041311|101176607|FG000|COMPLETED|Overall Study||0||
48346197|NCT03041311|101176608|FG001|COMPLETED|Overall Study||0||
48346198|NCT03041311|101176607|FG000|NOT COMPLETED|Overall Study||54||
48346199|NCT03041311|101176608|FG001|NOT COMPLETED|Overall Study||53||
48346200|NCT05148884|101176609|FG000|STARTED|Overall Study||18||
48346201|NCT05148884|101176610|FG001|STARTED|Overall Study||9||
48346202|NCT05148884|101176609|FG000|COMPLETED|Overall Study||15||
48346203|NCT05148884|101176610|FG001|COMPLETED|Overall Study||8||
48346204|NCT05148884|101176609|FG000|NOT COMPLETED|Overall Study||3||
48346205|NCT05148884|101176610|FG001|NOT COMPLETED|Overall Study||1||
48346206|NCT04826900|101176611|FG000|STARTED|Overall Study||15||
48346207|NCT04826900|101176612|FG001|STARTED|Overall Study||16||
48346208|NCT04826900|101176611|FG000|COMPLETED|Overall Study||14||
48346209|NCT04826900|101176612|FG001|COMPLETED|Overall Study||15||
48346210|NCT04826900|101176611|FG000|NOT COMPLETED|Overall Study||1||
48415366|NCT01685060|101350256|FG000|COMPLETED|Overall Study||0||
48346211|NCT04826900|101176612|FG001|NOT COMPLETED|Overall Study||1||
48346212|NCT01238120|101176613|FG000|STARTED|Overall Study||25|Randomized|
48346213|NCT01238120|101176614|FG001|STARTED|Overall Study||23|Randomized|
48346214|NCT01238120|101176615|FG002|STARTED|Overall Study||25|Randomized|
48346215|NCT01238120|101176616|FG003|STARTED|Overall Study||24|Randomized|
48346216|NCT01238120|101176613|FG000|Received Intervention and Completed Baseline Assessments|Overall Study||21||
48346217|NCT01238120|101176614|FG001|Received Intervention and Completed Baseline Assessments|Overall Study||22||
48346218|NCT01238120|101176615|FG002|Received Intervention and Completed Baseline Assessments|Overall Study||22||
48656974|NCT03735979|101943738|FG001|NOT COMPLETED|Overall Study||17||
48656975|NCT03735979|101943739|FG002|NOT COMPLETED|Overall Study||16||
48346219|NCT01238120|101176616|FG003|Received Intervention and Completed Baseline Assessments|Overall Study||21||
48346220|NCT01238120|101176613|FG000|COMPLETED|Overall Study||17||
48346221|NCT01238120|101176614|FG001|COMPLETED|Overall Study||22||
48346222|NCT01238120|101176615|FG002|COMPLETED|Overall Study||21||
48346223|NCT01238120|101176616|FG003|COMPLETED|Overall Study||18||
48346224|NCT01238120|101176613|FG000|NOT COMPLETED|Overall Study||8||
48346225|NCT01238120|101176614|FG001|NOT COMPLETED|Overall Study||1||
48346226|NCT01238120|101176615|FG002|NOT COMPLETED|Overall Study||4||
48346227|NCT01238120|101176616|FG003|NOT COMPLETED|Overall Study||6||
48346228|NCT03124459|101176617|FG000|STARTED|Part 1-Open Label Dose Escalation||6|Participants in the Part 2 double-blind placebo controlled portion of the study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|
48346229|NCT03124459|101176618|FG001|STARTED|Part 1-Open Label Dose Escalation||6|Participants in the Part 2 double-blind placebo controlled portion of the study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|
48346230|NCT03124459|101176619|FG002|STARTED|Part 1-Open Label Dose Escalation||6|Participants in the Part 2 double-blind placebo controlled portion of the study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|
48346231|NCT03124459|101176620|FG003|STARTED|Part 1-Open Label Dose Escalation||0|Participants in the Part 2 double-blind placebo controlled portion of the study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|
48346232|NCT03124459|101176621|FG004|STARTED|Part 1-Open Label Dose Escalation||0|Participants in the Part 2 double-blind placebo controlled portion of the study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|
48368102|NCT01264965|101230106|FG000|NOT COMPLETED|Overall Study||10||
48368103|NCT01289392|101230107|FG000|STARTED|Overall Study||9||
48415367|NCT01685060|101350256|FG000|NOT COMPLETED|Overall Study||140||
48415368|NCT03727802|101350257|FG000|STARTED|Overall Study||3||
48415369|NCT03727802|101350258|FG001|STARTED|Overall Study||3||
48415370|NCT03727802|101350259|FG002|STARTED|Overall Study||3||
48415371|NCT03727802|101350260|FG003|STARTED|Overall Study||3||
48415372|NCT03727802|101350261|FG004|STARTED|Overall Study||4||
48415373|NCT03727802|101350262|FG005|STARTED|Overall Study||4||
48415374|NCT03727802|101350263|FG006|STARTED|Overall Study||4||
48415375|NCT03727802|101350264|FG007|STARTED|Overall Study||4||
48415376|NCT03727802|101350265|FG008|STARTED|Overall Study||6||
48415377|NCT03727802|101350257|FG000|COMPLETED|Overall Study||3||
48415378|NCT03727802|101350258|FG001|COMPLETED|Overall Study||3||
48415379|NCT03727802|101350259|FG002|COMPLETED|Overall Study||3||
48415380|NCT03727802|101350260|FG003|COMPLETED|Overall Study||3||
48415381|NCT03727802|101350261|FG004|COMPLETED|Overall Study||4||
48415382|NCT03727802|101350262|FG005|COMPLETED|Overall Study||4||
48759199|NCT05138653|102197772|FG010|STARTED|Multiple Ascending Dose (Up to 12 Weeks)||9||
48759200|NCT05138653|102197773|FG011|STARTED|Multiple Ascending Dose (Up to 12 Weeks)||8||
48759201|NCT05138653|102197774|FG012|STARTED|Multiple Ascending Dose (Up to 12 Weeks)||6||
48759202|NCT05138653|102197775|FG013|STARTED|Multiple Ascending Dose (Up to 12 Weeks)||7||
48415383|NCT03727802|101350263|FG006|COMPLETED|Overall Study||4||
48415384|NCT03727802|101350264|FG007|COMPLETED|Overall Study||3||
48415385|NCT03727802|101350265|FG008|COMPLETED|Overall Study||5||
48415386|NCT03727802|101350257|FG000|NOT COMPLETED|Overall Study||0||
48415387|NCT03727802|101350258|FG001|NOT COMPLETED|Overall Study||0||
48415388|NCT03727802|101350259|FG002|NOT COMPLETED|Overall Study||0||
48415389|NCT03727802|101350260|FG003|NOT COMPLETED|Overall Study||0||
48415390|NCT03727802|101350261|FG004|NOT COMPLETED|Overall Study||0||
48415391|NCT03727802|101350262|FG005|NOT COMPLETED|Overall Study||0||
48415392|NCT03727802|101350263|FG006|NOT COMPLETED|Overall Study||0||
48415393|NCT03727802|101350264|FG007|NOT COMPLETED|Overall Study||1||
48415394|NCT03727802|101350265|FG008|NOT COMPLETED|Overall Study||1||
48415395|NCT00216086|101350266|FG000|STARTED|Overall Study||22||
48415396|NCT00216086|101350266|FG000|COMPLETED|Overall Study||18||
48415397|NCT00216086|101350266|FG000|NOT COMPLETED|Overall Study||4||
48415398|NCT00256204|101350267|FG000|STARTED|Overall Study||298||
48415399|NCT00256204|101350268|FG001|STARTED|Overall Study||288||
48415400|NCT00256204|101350269|FG002|STARTED|Overall Study||295||
48415401|NCT00256204|101350270|FG003|STARTED|Overall Study||293||
48415402|NCT00256204|101350267|FG000|COMPLETED|Overall Study||231||
48415403|NCT00256204|101350268|FG001|COMPLETED|Overall Study||238||
48415404|NCT00256204|101350269|FG002|COMPLETED|Overall Study||241||
48759203|NCT05138653|102197776|FG014|STARTED|Multiple Ascending Dose (Up to 12 Weeks)||8||
48759204|NCT05138653|102197777|FG015|STARTED|Multiple Ascending Dose (Up to 12 Weeks)||8||
48759205|NCT05138653|102197762|FG000|COMPLETED|Multiple Ascending Dose (Up to 12 Weeks)||0||
48759206|NCT05138653|102197763|FG001|COMPLETED|Multiple Ascending Dose (Up to 12 Weeks)||0||
48415405|NCT00256204|101350270|FG003|COMPLETED|Overall Study||244||
48415406|NCT00256204|101350267|FG000|NOT COMPLETED|Overall Study||67||
48415407|NCT00256204|101350268|FG001|NOT COMPLETED|Overall Study||50||
48415408|NCT00256204|101350269|FG002|NOT COMPLETED|Overall Study||54||
48415409|NCT00256204|101350270|FG003|NOT COMPLETED|Overall Study||49||
48415410|NCT03323385|101350271|FG000|STARTED|Overall Study||27||
48415411|NCT03323385|101350272|FG001|STARTED|Overall Study||30||
48415412|NCT03323385|101350271|FG000|Dosed|Overall Study||27||
48415413|NCT03323385|101350272|FG001|Dosed|Overall Study||28||
48415414|NCT03323385|101350271|FG000|COMPLETED|Overall Study||26||
48185021|NCT03398356|100775877|FG000|NOT COMPLETED|After 6 Weeks of Treatment||0||
48185022|NCT03398356|100775878|FG001|NOT COMPLETED|After 6 Weeks of Treatment||2||
48185023|NCT03398356|100775879|FG002|NOT COMPLETED|After 6 Weeks of Treatment||0||
48185024|NCT03398356|100775877|FG000|STARTED|Post 6 Week Period Initial Evaluation||14||
48185025|NCT03398356|100775878|FG001|STARTED|Post 6 Week Period Initial Evaluation||11||
48185026|NCT03398356|100775879|FG002|STARTED|Post 6 Week Period Initial Evaluation||0||
48346233|NCT03124459|101176622|FG005|STARTED|Part 1-Open Label Dose Escalation||0|Participants in the Part 2 double-blind placebo controlled portion of the study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|
48346234|NCT03124459|101176617|FG000|COMPLETED|Part 1-Open Label Dose Escalation||6||
48346235|NCT03124459|101176618|FG001|COMPLETED|Part 1-Open Label Dose Escalation||6||
48346236|NCT03124459|101176619|FG002|COMPLETED|Part 1-Open Label Dose Escalation||6||
48346237|NCT03124459|101176620|FG003|COMPLETED|Part 1-Open Label Dose Escalation||0||
48346238|NCT03124459|101176621|FG004|COMPLETED|Part 1-Open Label Dose Escalation||0||
48346239|NCT03124459|101176622|FG005|COMPLETED|Part 1-Open Label Dose Escalation||0||
48346240|NCT03124459|101176617|FG000|NOT COMPLETED|Part 1-Open Label Dose Escalation||0||
48346241|NCT03124459|101176618|FG001|NOT COMPLETED|Part 1-Open Label Dose Escalation||0||
48346242|NCT03124459|101176619|FG002|NOT COMPLETED|Part 1-Open Label Dose Escalation||0||
48346243|NCT03124459|101176620|FG003|NOT COMPLETED|Part 1-Open Label Dose Escalation||0||
48346244|NCT03124459|101176621|FG004|NOT COMPLETED|Part 1-Open Label Dose Escalation||0||
48346245|NCT03124459|101176622|FG005|NOT COMPLETED|Part 1-Open Label Dose Escalation||0||
48346246|NCT03124459|101176617|FG000|STARTED|Phase 2- Randomized Doubled-blind||0|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|
48346247|NCT03124459|101176618|FG001|STARTED|Phase 2- Randomized Doubled-blind||0|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|
48368104|NCT01289392|101230108|FG001|STARTED|Overall Study||9||
48415415|NCT03323385|101350272|FG001|COMPLETED|Overall Study||27||
48415416|NCT03323385|101350271|FG000|NOT COMPLETED|Overall Study||1||
48415417|NCT03323385|101350272|FG001|NOT COMPLETED|Overall Study||3||
48415418|NCT01694667|101350273|FG000|STARTED|Overall Study||29||
48415419|NCT01694667|101350274|FG001|STARTED|Overall Study||28||
48415420|NCT01694667|101350273|FG000|COMPLETED|Overall Study||29||
48759207|NCT05138653|102197764|FG002|COMPLETED|Multiple Ascending Dose (Up to 12 Weeks)||0||
48759208|NCT05138653|102197765|FG003|COMPLETED|Multiple Ascending Dose (Up to 12 Weeks)||0||
48759209|NCT05138653|102197766|FG004|COMPLETED|Multiple Ascending Dose (Up to 12 Weeks)||0||
48415421|NCT01694667|101350274|FG001|COMPLETED|Overall Study||28||
48415422|NCT01694667|101350273|FG000|NOT COMPLETED|Overall Study||0||
48415423|NCT01694667|101350274|FG001|NOT COMPLETED|Overall Study||0||
48415424|NCT04397757|101350275|FG000|STARTED|Overall Study||41||
48415425|NCT04397757|101350276|FG001|STARTED|Overall Study||39||
48415426|NCT04397757|101350275|FG000|Treated|Overall Study||39||
48415427|NCT04397757|101350276|FG001|Treated|Overall Study||39||
48415428|NCT04397757|101350275|FG000|COMPLETED|Overall Study||32||
48415429|NCT04397757|101350276|FG001|COMPLETED|Overall Study||25||
48415430|NCT04397757|101350275|FG000|NOT COMPLETED|Overall Study||9||
48415431|NCT04397757|101350276|FG001|NOT COMPLETED|Overall Study||14||
48415432|NCT03512028|101350277|FG000|STARTED|Overall Study||19||
48415433|NCT03512028|101350278|FG001|STARTED|Overall Study||15||
48415434|NCT03512028|101350277|FG000|COMPLETED|Overall Study||15||
48759210|NCT05138653|102197767|FG005|COMPLETED|Multiple Ascending Dose (Up to 12 Weeks)||0||
48759211|NCT05138653|102197768|FG006|COMPLETED|Multiple Ascending Dose (Up to 12 Weeks)||0||
48759212|NCT05138653|102197769|FG007|COMPLETED|Multiple Ascending Dose (Up to 12 Weeks)||0||
48759213|NCT05138653|102197770|FG008|COMPLETED|Multiple Ascending Dose (Up to 12 Weeks)||0||
48759214|NCT05138653|102197771|FG009|COMPLETED|Multiple Ascending Dose (Up to 12 Weeks)||0||
48759215|NCT05138653|102197772|FG010|COMPLETED|Multiple Ascending Dose (Up to 12 Weeks)||8||
48759216|NCT05138653|102197773|FG011|COMPLETED|Multiple Ascending Dose (Up to 12 Weeks)||8||
48759217|NCT05138653|102197774|FG012|COMPLETED|Multiple Ascending Dose (Up to 12 Weeks)||5||
48759218|NCT05138653|102197775|FG013|COMPLETED|Multiple Ascending Dose (Up to 12 Weeks)||6||
48759219|NCT05138653|102197776|FG014|COMPLETED|Multiple Ascending Dose (Up to 12 Weeks)||7||
48759220|NCT05138653|102197777|FG015|COMPLETED|Multiple Ascending Dose (Up to 12 Weeks)||7||
48759221|NCT05138653|102197762|FG000|NOT COMPLETED|Multiple Ascending Dose (Up to 12 Weeks)||0||
48759222|NCT05138653|102197763|FG001|NOT COMPLETED|Multiple Ascending Dose (Up to 12 Weeks)||0||
48759223|NCT05138653|102197764|FG002|NOT COMPLETED|Multiple Ascending Dose (Up to 12 Weeks)||0||
48759224|NCT05138653|102197765|FG003|NOT COMPLETED|Multiple Ascending Dose (Up to 12 Weeks)||0||
48759225|NCT05138653|102197766|FG004|NOT COMPLETED|Multiple Ascending Dose (Up to 12 Weeks)||0||
48185027|NCT03398356|100775877|FG000|COMPLETED|Post 6 Week Period Initial Evaluation||14||
48185028|NCT03398356|100775878|FG001|COMPLETED|Post 6 Week Period Initial Evaluation||11||
48368105|NCT01289392|101230109|FG002|STARTED|Overall Study||7||
48415435|NCT03512028|101350278|FG001|COMPLETED|Overall Study||15||
48185029|NCT03398356|100775879|FG002|COMPLETED|Post 6 Week Period Initial Evaluation||0||
48415436|NCT03512028|101350277|FG000|NOT COMPLETED|Overall Study||4||
48415437|NCT03512028|101350278|FG001|NOT COMPLETED|Overall Study||0||
48185030|NCT03398356|100775877|FG000|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0||
48185031|NCT03398356|100775878|FG001|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0||
48185032|NCT03398356|100775879|FG002|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0||
48185033|NCT03398356|100775877|FG000|STARTED|After 12 Weeks of Treatment||14||
48185034|NCT03398356|100775878|FG001|STARTED|After 12 Weeks of Treatment||11||
48185035|NCT03398356|100775879|FG002|STARTED|After 12 Weeks of Treatment||0||
48185036|NCT03398356|100775877|FG000|COMPLETED|After 12 Weeks of Treatment||14|two of the patients were moved from group B, because of intolerance of the higher dose of the drug|
48185037|NCT03398356|100775878|FG001|COMPLETED|After 12 Weeks of Treatment||11|two of the patients were moved from group B, because of intolerance of the higher dose of the drug|
48185038|NCT03398356|100775879|FG002|COMPLETED|After 12 Weeks of Treatment||0|two of the patients were moved from group B, because of intolerance of the higher dose of the drug|
48185039|NCT03398356|100775877|FG000|NOT COMPLETED|After 12 Weeks of Treatment||0||
48185040|NCT03398356|100775878|FG001|NOT COMPLETED|After 12 Weeks of Treatment||0||
48346248|NCT03124459|101176619|FG002|STARTED|Phase 2- Randomized Doubled-blind||0|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|
48656976|NCT00677040|101943740|FG000|STARTED|Overall Study||20||
48656977|NCT00677040|101943740|FG000|COMPLETED|Overall Study||20||
48656978|NCT00677040|101943740|FG000|NOT COMPLETED|Overall Study||0||
48656979|NCT02656173|101943741|FG000|STARTED|Overall Study||285||
48185041|NCT03398356|100775879|FG002|NOT COMPLETED|After 12 Weeks of Treatment||0||
48185042|NCT03398356|100775877|FG000|STARTED|After 15 Weeks of Treatment||14||
48185043|NCT03398356|100775878|FG001|STARTED|After 15 Weeks of Treatment||11||
48188685|NCT03639675|100783309|FG000|STARTED|Overall Study||16||
48346249|NCT03124459|101176620|FG003|STARTED|Phase 2- Randomized Doubled-blind||21|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|
48346250|NCT03124459|101176621|FG004|STARTED|Phase 2- Randomized Doubled-blind||24|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|
48346251|NCT03124459|101176622|FG005|STARTED|Phase 2- Randomized Doubled-blind||0|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|
48346252|NCT03124459|101176617|FG000|COMPLETED|Phase 2- Randomized Doubled-blind||0||
48346253|NCT03124459|101176618|FG001|COMPLETED|Phase 2- Randomized Doubled-blind||0||
48346254|NCT03124459|101176619|FG002|COMPLETED|Phase 2- Randomized Doubled-blind||0||
48346255|NCT03124459|101176620|FG003|COMPLETED|Phase 2- Randomized Doubled-blind||9||
48346256|NCT03124459|101176621|FG004|COMPLETED|Phase 2- Randomized Doubled-blind||5||
48346257|NCT03124459|101176622|FG005|COMPLETED|Phase 2- Randomized Doubled-blind||0||
48346258|NCT03124459|101176617|FG000|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0||
48346259|NCT03124459|101176618|FG001|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0||
48346260|NCT03124459|101176619|FG002|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0||
48346261|NCT03124459|101176620|FG003|NOT COMPLETED|Phase 2- Randomized Doubled-blind||12||
48346262|NCT03124459|101176621|FG004|NOT COMPLETED|Phase 2- Randomized Doubled-blind||19||
48346263|NCT03124459|101176622|FG005|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0||
48346264|NCT03124459|101176617|FG000|STARTED|Part 2- Open Label ACE-083||0|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study. Participants that completed the Part 2 double-blind placebo controlled portion of the study were able to move into the open-label portion of the study.|
48346265|NCT03124459|101176618|FG001|STARTED|Part 2- Open Label ACE-083||0|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study. Participants that completed the Part 2 double-blind placebo controlled portion of the study were able to move into the open-label portion of the study.|
48346266|NCT03124459|101176619|FG002|STARTED|Part 2- Open Label ACE-083||0|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study. Participants that completed the Part 2 double-blind placebo controlled portion of the study were able to move into the open-label portion of the study.|
48368106|NCT01289392|101230107|FG000|COMPLETED|Overall Study||9||
48415438|NCT03062605|101350279|FG000|STARTED|Overall Study||25||
48656980|NCT02656173|101943742|FG001|STARTED|Overall Study||283||
48185044|NCT03398356|100775879|FG002|STARTED|After 15 Weeks of Treatment||0||
48185045|NCT03398356|100775877|FG000|COMPLETED|After 15 Weeks of Treatment||14||
48185046|NCT03398356|100775878|FG001|COMPLETED|After 15 Weeks of Treatment||11||
48415439|NCT03062605|101350280|FG001|STARTED|Overall Study||23||
48415440|NCT03062605|101350279|FG000|COMPLETED|Overall Study||14||
48636715|NCT04470427|101894705|FG002|Per-Protocol (PP) Set:|Part A: Blinded||0|Participants who received any study injection, were severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) negative (defined as no immunologic or virologic evidence of prior COVID-19 at Day 1 before the first dose), and had no major protocol deviations, Participants were analyzed according to the treatment group to which they were randomized. Participants who did not receive the second dose within 21 or 42 days after the first injection date were excluded from the PP Set.|
48656981|NCT02656173|101943741|FG000|Received Treatment|Overall Study||284||
48656982|NCT02656173|101943742|FG001|Received Treatment|Overall Study||282||
48185047|NCT03398356|100775879|FG002|COMPLETED|After 15 Weeks of Treatment||0||
48185048|NCT03398356|100775877|FG000|NOT COMPLETED|After 15 Weeks of Treatment||0||
48185049|NCT03398356|100775878|FG001|NOT COMPLETED|After 15 Weeks of Treatment||0||
48185050|NCT03398356|100775879|FG002|NOT COMPLETED|After 15 Weeks of Treatment||0||
48185051|NCT01106976|100775880|FG000|STARTED|Overall Study||67||
48346267|NCT03124459|101176620|FG003|STARTED|Part 2- Open Label ACE-083||0|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study. Participants that completed the Part 2 double-blind placebo controlled portion of the study were able to move into the open-label portion of the study.|
48346268|NCT03124459|101176621|FG004|STARTED|Part 2- Open Label ACE-083||0|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study. Participants that completed the Part 2 double-blind placebo controlled portion of the study were able to move into the open-label portion of the study.|
48346269|NCT03124459|101176622|FG005|STARTED|Part 2- Open Label ACE-083||40|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study. Participants that completed the Part 2 double-blind placebo controlled portion of the study were able to move into the open-label portion of the study.|
48346270|NCT03124459|101176617|FG000|COMPLETED|Part 2- Open Label ACE-083||0||
48346271|NCT03124459|101176618|FG001|COMPLETED|Part 2- Open Label ACE-083||0||
48346272|NCT03124459|101176619|FG002|COMPLETED|Part 2- Open Label ACE-083||0||
48346273|NCT03124459|101176620|FG003|COMPLETED|Part 2- Open Label ACE-083||0||
48346274|NCT03124459|101176621|FG004|COMPLETED|Part 2- Open Label ACE-083||0||
48346275|NCT03124459|101176622|FG005|COMPLETED|Part 2- Open Label ACE-083||17||
48346276|NCT03124459|101176617|FG000|NOT COMPLETED|Part 2- Open Label ACE-083||0||
48346277|NCT03124459|101176618|FG001|NOT COMPLETED|Part 2- Open Label ACE-083||0||
48346278|NCT03124459|101176619|FG002|NOT COMPLETED|Part 2- Open Label ACE-083||0||
48346279|NCT03124459|101176620|FG003|NOT COMPLETED|Part 2- Open Label ACE-083||0||
48346280|NCT03124459|101176621|FG004|NOT COMPLETED|Part 2- Open Label ACE-083||0||
48346281|NCT03124459|101176622|FG005|NOT COMPLETED|Part 2- Open Label ACE-083||23||
48346282|NCT02770807|101176623|FG000|STARTED|Overall Study||59|patients randomized|
48346283|NCT02770807|101176624|FG001|STARTED|Overall Study||58|patients randomized|
48346284|NCT02770807|101176625|FG002|STARTED|Overall Study||59|patients randomized|
48346285|NCT02770807|101176623|FG000|Participants Who Took the Study Drug|Overall Study||59||
48346286|NCT02770807|101176624|FG001|Participants Who Took the Study Drug|Overall Study||57||
48346287|NCT02770807|101176625|FG002|Participants Who Took the Study Drug|Overall Study||59||
48346288|NCT02770807|101176623|FG000|Modified Intention to Treat Population - mITT|Overall Study||56||
48346289|NCT02770807|101176624|FG001|Modified Intention to Treat Population - mITT|Overall Study||54||
48346290|NCT02770807|101176625|FG002|Modified Intention to Treat Population - mITT|Overall Study||54||
48346291|NCT02770807|101176623|FG000|Safety Population - SAF|Overall Study||59||
48346292|NCT02770807|101176624|FG001|Safety Population - SAF|Overall Study||57||
48346293|NCT02770807|101176625|FG002|Safety Population - SAF|Overall Study||59||
48346294|NCT02770807|101176623|FG000|Per Protocol Population - PP|Overall Study||36||
48346295|NCT02770807|101176624|FG001|Per Protocol Population - PP|Overall Study||38||
48346296|NCT02770807|101176625|FG002|Per Protocol Population - PP|Overall Study||33||
48346297|NCT02770807|101176623|FG000|Completed Visit 9|Overall Study||43||
48346298|NCT02770807|101176624|FG001|Completed Visit 9|Overall Study||46||
48346299|NCT02770807|101176625|FG002|Completed Visit 9|Overall Study||43||
48346300|NCT02770807|101176623|FG000|Discontinued Prior to Visit 9|Overall Study||16||
48346301|NCT02770807|101176624|FG001|Discontinued Prior to Visit 9|Overall Study||11||
48346302|NCT02770807|101176625|FG002|Discontinued Prior to Visit 9|Overall Study||16||
48346303|NCT02770807|101176623|FG000|Participants From Month 6 to Month 9|Overall Study||43||
48346304|NCT02770807|101176624|FG001|Participants From Month 6 to Month 9|Overall Study||46||
48346305|NCT02770807|101176625|FG002|Participants From Month 6 to Month 9|Overall Study||43||
48346306|NCT02770807|101176623|FG000|Participants From Month 9 to month12|Overall Study||34||
48346307|NCT02770807|101176624|FG001|Participants From Month 9 to month12|Overall Study||38||
48346308|NCT02770807|101176625|FG002|Participants From Month 9 to month12|Overall Study||36||
48346309|NCT02770807|101176623|FG000|COMPLETED|Overall Study||34||
48346310|NCT02770807|101176624|FG001|COMPLETED|Overall Study||38||
48346311|NCT02770807|101176625|FG002|COMPLETED|Overall Study||36||
48346312|NCT02770807|101176623|FG000|NOT COMPLETED|Overall Study||25||
48346313|NCT02770807|101176624|FG001|NOT COMPLETED|Overall Study||20||
48346314|NCT02770807|101176625|FG002|NOT COMPLETED|Overall Study||23||
48415441|NCT03062605|101350280|FG001|COMPLETED|Overall Study||13||
48415442|NCT03062605|101350279|FG000|NOT COMPLETED|Overall Study||11||
48415443|NCT03062605|101350280|FG001|NOT COMPLETED|Overall Study||10||
48185052|NCT01106976|100775880|FG000|COMPLETED|Overall Study||59||
48185053|NCT01106976|100775880|FG000|NOT COMPLETED|Overall Study||8||
48185054|NCT00958009|100775881|FG000|STARTED|Overall Study||109||
48185055|NCT00958009|100775881|FG000|COMPLETED|Overall Study||107||
48185056|NCT00958009|100775881|FG000|NOT COMPLETED|Overall Study||2||
48185057|NCT03888885|100775882|FG000|STARTED|Overall Study||208||
48185058|NCT03888885|100775883|FG001|STARTED|Overall Study||202||
48185059|NCT03888885|100775882|FG000|Post-intervention|Overall Study||191||
48185060|NCT03888885|100775883|FG001|Post-intervention|Overall Study||190||
48185061|NCT03888885|100775882|FG000|COMPLETED|Overall Study||188||
48185062|NCT03888885|100775883|FG001|COMPLETED|Overall Study||184||
48185063|NCT03888885|100775882|FG000|NOT COMPLETED|Overall Study||20||
48185064|NCT03888885|100775883|FG001|NOT COMPLETED|Overall Study||18||
48185065|NCT01008722|100775884|FG000|STARTED|Overall Study||36||
48185066|NCT01008722|100775885|FG001|STARTED|Overall Study||71||
48185067|NCT01008722|100775884|FG000|COMPLETED|Overall Study||36||
48185068|NCT01008722|100775885|FG001|COMPLETED|Overall Study||71||
48185069|NCT01008722|100775884|FG000|NOT COMPLETED|Overall Study||0||
48636716|NCT04470427|101894706|FG003|Per-Protocol (PP) Set:|Part A: Blinded||0|Participants who received any study injection, were severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) negative (defined as no immunologic or virologic evidence of prior COVID-19 at Day 1 before the first dose), and had no major protocol deviations, Participants were analyzed according to the treatment group to which they were randomized. Participants who did not receive the second dose within 21 or 42 days after the first injection date were excluded from the PP Set.|
48636717|NCT04470427|101894707|FG004|Per-Protocol (PP) Set:|Part A: Blinded||0|Participants who received any study injection, were severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) negative (defined as no immunologic or virologic evidence of prior COVID-19 at Day 1 before the first dose), and had no major protocol deviations, Participants were analyzed according to the treatment group to which they were randomized. Participants who did not receive the second dose within 21 or 42 days after the first injection date were excluded from the PP Set.|
48656983|NCT02656173|101943741|FG000|COMPLETED|Overall Study||272||
48656984|NCT02656173|101943742|FG001|COMPLETED|Overall Study||272||
48656985|NCT02656173|101943741|FG000|NOT COMPLETED|Overall Study||13||
48656986|NCT02656173|101943742|FG001|NOT COMPLETED|Overall Study||11||
48415444|NCT00864539|101350281|FG000|STARTED|Overall Study||104||
48415445|NCT00864539|101350282|FG001|STARTED|Overall Study||95||
48415446|NCT00864539|101350283|FG002|STARTED|Overall Study||102||
48415447|NCT00864539|101350284|FG003|STARTED|Overall Study||96||
48185070|NCT01008722|100775885|FG001|NOT COMPLETED|Overall Study||0||
48185071|NCT04562779|100775886|FG000|STARTED|Overall Study||14||
48185072|NCT04562779|100775887|FG001|STARTED|Overall Study||13||
48185073|NCT04562779|100775888|FG002|STARTED|Overall Study||17||
48185074|NCT04562779|100775886|FG000|COMPLETED|Overall Study||5||
48185075|NCT04562779|100775887|FG001|COMPLETED|Overall Study||6||
48185076|NCT04562779|100775888|FG002|COMPLETED|Overall Study||7||
48185077|NCT04562779|100775886|FG000|NOT COMPLETED|Overall Study||9||
48185078|NCT04562779|100775887|FG001|NOT COMPLETED|Overall Study||7||
48185079|NCT04562779|100775888|FG002|NOT COMPLETED|Overall Study||10||
48185080|NCT02223182|100775889|FG000|STARTED|Double-Blind Period||49||
48185081|NCT02223182|100775890|FG001|STARTED|Double-Blind Period||49||
48185082|NCT02223182|100775891|FG002|STARTED|Double-Blind Period||47||
48185083|NCT02223182|100775892|FG003|STARTED|Double-Blind Period||53||
48185084|NCT02223182|100775889|FG000|COMPLETED|Double-Blind Period||47||
48185085|NCT02223182|100775890|FG001|COMPLETED|Double-Blind Period||45||
48185086|NCT02223182|100775891|FG002|COMPLETED|Double-Blind Period||45||
48185087|NCT02223182|100775892|FG003|COMPLETED|Double-Blind Period||52||
48185088|NCT02223182|100775889|FG000|NOT COMPLETED|Double-Blind Period||2||
48185089|NCT02223182|100775890|FG001|NOT COMPLETED|Double-Blind Period||4||
48185090|NCT02223182|100775891|FG002|NOT COMPLETED|Double-Blind Period||2||
48185091|NCT02223182|100775892|FG003|NOT COMPLETED|Double-Blind Period||1||
48185092|NCT02223182|100775889|FG000|STARTED|Open-Label 500 Period||46||
48185093|NCT02223182|100775890|FG001|STARTED|Open-Label 500 Period||45||
48185094|NCT02223182|100775891|FG002|STARTED|Open-Label 500 Period||44||
48185095|NCT02223182|100775892|FG003|STARTED|Open-Label 500 Period||52||
48185096|NCT02223182|100775889|FG000|COMPLETED|Open-Label 500 Period||40||
48185097|NCT02223182|100775890|FG001|COMPLETED|Open-Label 500 Period||43||
48185098|NCT02223182|100775891|FG002|COMPLETED|Open-Label 500 Period||32||
48185099|NCT02223182|100775892|FG003|COMPLETED|Open-Label 500 Period||42||
48415448|NCT00864539|101350285|FG004|STARTED|Overall Study||103||
48415449|NCT00864539|101350286|FG005|STARTED|Overall Study||85||
48415450|NCT00864539|101350281|FG000|COMPLETED|Overall Study||95||
48415451|NCT00864539|101350282|FG001|COMPLETED|Overall Study||72||
48415452|NCT00864539|101350283|FG002|COMPLETED|Overall Study||92||
48185100|NCT02223182|100775889|FG000|NOT COMPLETED|Open-Label 500 Period||6||
48185101|NCT02223182|100775890|FG001|NOT COMPLETED|Open-Label 500 Period||2||
48185102|NCT02223182|100775891|FG002|NOT COMPLETED|Open-Label 500 Period||12||
48185103|NCT02223182|100775892|FG003|NOT COMPLETED|Open-Label 500 Period||10||
48415453|NCT00864539|101350284|FG003|COMPLETED|Overall Study||89||
48415454|NCT00864539|101350285|FG004|COMPLETED|Overall Study||81||
48415455|NCT00864539|101350286|FG005|COMPLETED|Overall Study||71||
48415456|NCT00864539|101350281|FG000|NOT COMPLETED|Overall Study||9||
48415457|NCT00864539|101350282|FG001|NOT COMPLETED|Overall Study||23||
48415458|NCT00864539|101350283|FG002|NOT COMPLETED|Overall Study||10||
48415459|NCT00864539|101350284|FG003|NOT COMPLETED|Overall Study||7||
48636718|NCT04470427|101894708|FG005|Per-Protocol (PP) Set:|Part A: Blinded||0|Participants who received any study injection, were severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) negative (defined as no immunologic or virologic evidence of prior COVID-19 at Day 1 before the first dose), and had no major protocol deviations, Participants were analyzed according to the treatment group to which they were randomized. Participants who did not receive the second dose within 21 or 42 days after the first injection date were excluded from the PP Set.|
48636719|NCT04470427|101894703|FG000|Per-Protocol Random Subcohort for Immunogenicity (PPRSI)|Part A: Blinded||272|All participants in the FAS who were sampled into the random subcohort and received both planned doses (received the treatment the participant was randomized to with Dose 2 received within 21 or 42 days after Dose 1, and no major protocol deviation that impacted critical or key data.|
48656987|NCT02284854|101943743|FG000|STARTED|Overall Study||23||
48656988|NCT02284854|101943744|FG001|STARTED|Overall Study||20||
48656989|NCT02284854|101943743|FG000|COMPLETED|Overall Study||18||
48185104|NCT02223182|100775889|FG000|STARTED|Open-Label 300 Period||34||
48185105|NCT02223182|100775890|FG001|STARTED|Open-Label 300 Period||38||
48185106|NCT02223182|100775891|FG002|STARTED|Open-Label 300 Period||29||
48185107|NCT02223182|100775892|FG003|STARTED|Open-Label 300 Period||39||
48185108|NCT02223182|100775889|FG000|COMPLETED|Open-Label 300 Period||23||
48185109|NCT02223182|100775890|FG001|COMPLETED|Open-Label 300 Period||23||
48185110|NCT02223182|100775891|FG002|COMPLETED|Open-Label 300 Period||14||
48185111|NCT02223182|100775892|FG003|COMPLETED|Open-Label 300 Period||24||
48185112|NCT02223182|100775889|FG000|NOT COMPLETED|Open-Label 300 Period||11||
48185113|NCT02223182|100775890|FG001|NOT COMPLETED|Open-Label 300 Period||15||
48185114|NCT02223182|100775891|FG002|NOT COMPLETED|Open-Label 300 Period||15||
48185115|NCT02223182|100775892|FG003|NOT COMPLETED|Open-Label 300 Period||15||
48185116|NCT01155999|100775893|FG000|STARTED|Overall Study||146||
48185117|NCT01155999|100775894|FG001|STARTED|Overall Study||140||
48185118|NCT01155999|100775893|FG000|COMPLETED|Overall Study||139||
48185119|NCT01155999|100775894|FG001|COMPLETED|Overall Study||136||
48185120|NCT01155999|100775893|FG000|NOT COMPLETED|Overall Study||7||
48185121|NCT01155999|100775894|FG001|NOT COMPLETED|Overall Study||4||
48185122|NCT02276547|100775895|FG000|STARTED|Overall Study||27||
48185123|NCT02276547|100775895|FG000|COMPLETED|Overall Study||23||
48346315|NCT00316264|101176626|FG000|STARTED|Overall Study||83||
48346316|NCT00316264|101176627|FG001|STARTED|Overall Study||84||
48346317|NCT00316264|101176628|FG002|STARTED|Overall Study||93||
48346318|NCT00316264|101176626|FG000|COMPLETED|Overall Study||77||
48346319|NCT00316264|101176627|FG001|COMPLETED|Overall Study||77||
48346320|NCT00316264|101176628|FG002|COMPLETED|Overall Study||87||
48346321|NCT00316264|101176626|FG000|NOT COMPLETED|Overall Study||6||
48346322|NCT00316264|101176627|FG001|NOT COMPLETED|Overall Study||7||
48346323|NCT00316264|101176628|FG002|NOT COMPLETED|Overall Study||6||
48346324|NCT05300087|101176629|FG000|STARTED|Overall Study||30||
48346325|NCT05300087|101176630|FG001|STARTED|Overall Study||30||
48346326|NCT05300087|101176629|FG000|COMPLETED|Overall Study||30||
48346327|NCT05300087|101176630|FG001|COMPLETED|Overall Study||29||
48415460|NCT00864539|101350285|FG004|NOT COMPLETED|Overall Study||22||
48415461|NCT00864539|101350286|FG005|NOT COMPLETED|Overall Study||14||
48415462|NCT01056601|101350287|FG000|STARTED|Overall Study||7||
48415463|NCT01056601|101350287|FG000|COMPLETED|Overall Study||7||
48415464|NCT01056601|101350287|FG000|NOT COMPLETED|Overall Study||0||
48415465|NCT01882439|101350288|FG000|STARTED|Overall Study||131||
48185124|NCT02276547|100775895|FG000|NOT COMPLETED|Overall Study||4||
48185125|NCT03190083|100775896|FG000|STARTED|Overall Study||16||
48185126|NCT03190083|100775896|FG000|COMPLETED|Overall Study||16||
48185127|NCT03190083|100775896|FG000|NOT COMPLETED|Overall Study||0||
48185128|NCT01744496|100775897|FG000|STARTED|Titration Period||33||
48185129|NCT01744496|100775898|FG001|STARTED|Titration Period||35||
48185130|NCT01744496|100775897|FG000|COMPLETED|Titration Period||31||
48185131|NCT01744496|100775898|FG001|COMPLETED|Titration Period||33||
48185132|NCT01744496|100775897|FG000|NOT COMPLETED|Titration Period||2||
48185133|NCT01744496|100775898|FG001|NOT COMPLETED|Titration Period||2||
48185134|NCT01744496|100775897|FG000|STARTED|Maintenance Period||31||
48185135|NCT01744496|100775898|FG001|STARTED|Maintenance Period||33||
48185136|NCT01744496|100775897|FG000|COMPLETED|Maintenance Period||27||
48185137|NCT01744496|100775898|FG001|COMPLETED|Maintenance Period||29||
48185138|NCT01744496|100775897|FG000|NOT COMPLETED|Maintenance Period||4||
48185139|NCT01744496|100775898|FG001|NOT COMPLETED|Maintenance Period||4||
48185140|NCT01004263|100775899|FG000|STARTED|Overall Study||606||
48185141|NCT01004263|100775899|FG000|COMPLETED|Overall Study||427||
48346328|NCT05300087|101176629|FG000|NOT COMPLETED|Overall Study||0||
48346329|NCT05300087|101176630|FG001|NOT COMPLETED|Overall Study||1||
48346330|NCT02006576|101176631|FG000|STARTED|Overall Study||35||
48415466|NCT01882439|101350289|FG001|STARTED|Overall Study||132||
48415467|NCT01882439|101350290|FG002|STARTED|Overall Study||66||
48185142|NCT01004263|100775899|FG000|NOT COMPLETED|Overall Study||179||
48346331|NCT02006576|101176632|FG001|STARTED|Overall Study||51||
48346332|NCT02006576|101176633|FG002|STARTED|Overall Study||32||
48346333|NCT02006576|101176631|FG000|COMPLETED|Overall Study||17||
48185143|NCT00983619|100775900|FG000|STARTED|Overall Study||3||
48185144|NCT00983619|100775901|FG001|STARTED|Overall Study||4||
48185145|NCT00983619|100775902|FG002|STARTED|Overall Study||3||
48185146|NCT00983619|100775903|FG003|STARTED|Overall Study||6||
48185147|NCT00983619|100775904|FG004|STARTED|Overall Study||3||
48185148|NCT00983619|100775905|FG005|STARTED|Overall Study||76||
48185149|NCT00983619|100775906|FG006|STARTED|Overall Study||3||
48185150|NCT00983619|100775907|FG007|STARTED|Overall Study||3||
48185151|NCT00983619|100775908|FG008|STARTED|Overall Study||1||
48185152|NCT00983619|100775909|FG009|STARTED|Overall Study||3||
48185153|NCT00983619|100775910|FG010|STARTED|Overall Study||17||
48185154|NCT00983619|100775911|FG011|STARTED|Overall Study||14||
48185155|NCT00983619|100775900|FG000|COMPLETED|Overall Study||0||
48185156|NCT00983619|100775901|FG001|COMPLETED|Overall Study||0||
48185157|NCT00983619|100775902|FG002|COMPLETED|Overall Study||0||
48185158|NCT00983619|100775903|FG003|COMPLETED|Overall Study||1||
48185159|NCT00983619|100775904|FG004|COMPLETED|Overall Study||0||
48185160|NCT00983619|100775905|FG005|COMPLETED|Overall Study||9||
48185161|NCT00983619|100775906|FG006|COMPLETED|Overall Study||0||
48185162|NCT00983619|100775907|FG007|COMPLETED|Overall Study||1||
48185163|NCT00983619|100775908|FG008|COMPLETED|Overall Study||0||
48185164|NCT00983619|100775909|FG009|COMPLETED|Overall Study||0||
48185165|NCT00983619|100775910|FG010|COMPLETED|Overall Study||6||
48185166|NCT00983619|100775911|FG011|COMPLETED|Overall Study||3||
48185167|NCT00983619|100775900|FG000|NOT COMPLETED|Overall Study||3||
48185168|NCT00983619|100775901|FG001|NOT COMPLETED|Overall Study||4||
48185169|NCT00983619|100775902|FG002|NOT COMPLETED|Overall Study||3||
48185170|NCT00983619|100775903|FG003|NOT COMPLETED|Overall Study||5||
48185171|NCT00983619|100775904|FG004|NOT COMPLETED|Overall Study||3||
48185172|NCT00983619|100775905|FG005|NOT COMPLETED|Overall Study||67||
48185173|NCT00983619|100775906|FG006|NOT COMPLETED|Overall Study||3||
48185174|NCT00983619|100775907|FG007|NOT COMPLETED|Overall Study||2||
48185175|NCT00983619|100775908|FG008|NOT COMPLETED|Overall Study||1||
48636720|NCT04470427|101894704|FG001|Per-Protocol Random Subcohort for Immunogenicity (PPRSI)|Part A: Blinded||1185|All participants in the FAS who were sampled into the random subcohort and received both planned doses (received the treatment the participant was randomized to with Dose 2 received within 21 or 42 days after Dose 1, and no major protocol deviation that impacted critical or key data.|
48636721|NCT04470427|101894705|FG002|Per-Protocol Random Subcohort for Immunogenicity (PPRSI)|Part A: Blinded||0|All participants in the FAS who were sampled into the random subcohort and received both planned doses (received the treatment the participant was randomized to with Dose 2 received within 21 or 42 days after Dose 1, and no major protocol deviation that impacted critical or key data.|
48636722|NCT04470427|101894706|FG003|Per-Protocol Random Subcohort for Immunogenicity (PPRSI)|Part A: Blinded||0|All participants in the FAS who were sampled into the random subcohort and received both planned doses (received the treatment the participant was randomized to with Dose 2 received within 21 or 42 days after Dose 1, and no major protocol deviation that impacted critical or key data.|
48636723|NCT04470427|101894707|FG004|Per-Protocol Random Subcohort for Immunogenicity (PPRSI)|Part A: Blinded||0|All participants in the FAS who were sampled into the random subcohort and received both planned doses (received the treatment the participant was randomized to with Dose 2 received within 21 or 42 days after Dose 1, and no major protocol deviation that impacted critical or key data.|
48636724|NCT04470427|101894708|FG005|Per-Protocol Random Subcohort for Immunogenicity (PPRSI)|Part A: Blinded||0|All participants in the FAS who were sampled into the random subcohort and received both planned doses (received the treatment the participant was randomized to with Dose 2 received within 21 or 42 days after Dose 1, and no major protocol deviation that impacted critical or key data.|
48636725|NCT04470427|101894703|FG000|Solicited Safety Set|Part A: Blinded||15159|All randomized participants who received at least 1 dose and contributed any solicited AR data; (had at least 1 post-baseline solicited safety assessment. Participants were included in the treatment group corresponding to the study vaccination they actually received.|
48185176|NCT00983619|100775909|FG009|NOT COMPLETED|Overall Study||3||
48185177|NCT00983619|100775910|FG010|NOT COMPLETED|Overall Study||11||
48185178|NCT00983619|100775911|FG011|NOT COMPLETED|Overall Study||11||
48185179|NCT04878172|100775912|FG000|STARTED|Overall Study||2||
48185180|NCT04878172|100775913|FG001|STARTED|Overall Study||2||
48185181|NCT04878172|100775914|FG002|STARTED|Overall Study||2||
48185182|NCT04878172|100775915|FG003|STARTED|Overall Study||3||
48656990|NCT02284854|101943744|FG001|COMPLETED|Overall Study||20||
48656991|NCT02284854|101943743|FG000|NOT COMPLETED|Overall Study||5||
48185183|NCT04878172|100775912|FG000|COMPLETED|Overall Study||2||
48185184|NCT04878172|100775913|FG001|COMPLETED|Overall Study||2||
48185185|NCT04878172|100775914|FG002|COMPLETED|Overall Study||2||
48185186|NCT04878172|100775915|FG003|COMPLETED|Overall Study||3||
48185187|NCT04878172|100775912|FG000|NOT COMPLETED|Overall Study||0||
48185188|NCT04878172|100775913|FG001|NOT COMPLETED|Overall Study||0||
48185189|NCT04878172|100775914|FG002|NOT COMPLETED|Overall Study||0||
48185190|NCT04878172|100775915|FG003|NOT COMPLETED|Overall Study||0||
48185191|NCT04212169|100775916|FG000|STARTED|Overall Study||56||
48185192|NCT04212169|100775917|FG001|STARTED|Overall Study||19||
48185193|NCT04212169|100775918|FG002|STARTED|Overall Study||18||
48185194|NCT04212169|100775919|FG003|STARTED|Overall Study||55||
48185195|NCT04212169|100775916|FG000|COMPLETED|Overall Study||42||
48185196|NCT04212169|100775917|FG001|COMPLETED|Overall Study||16||
48185197|NCT04212169|100775918|FG002|COMPLETED|Overall Study||13||
48185198|NCT04212169|100775919|FG003|COMPLETED|Overall Study||42||
48185199|NCT04212169|100775916|FG000|NOT COMPLETED|Overall Study||14||
48185200|NCT04212169|100775917|FG001|NOT COMPLETED|Overall Study||3||
48185201|NCT04212169|100775918|FG002|NOT COMPLETED|Overall Study||5||
48185202|NCT04212169|100775919|FG003|NOT COMPLETED|Overall Study||13||
48185203|NCT02284464|100775920|FG000|STARTED|Overall Study||52||
48185204|NCT02284464|100775921|FG001|STARTED|Overall Study||53||
48185205|NCT02284464|100775920|FG000|COMPLETED|Overall Study||39||
48185206|NCT02284464|100775921|FG001|COMPLETED|Overall Study||36||
48185207|NCT02284464|100775920|FG000|NOT COMPLETED|Overall Study||13||
48185208|NCT02284464|100775921|FG001|NOT COMPLETED|Overall Study||17||
48185209|NCT00322868|100775922|FG000|STARTED|Overall Study||21||
48185210|NCT00322868|100775922|FG000|COMPLETED|Overall Study||20||
48185211|NCT00322868|100775922|FG000|NOT COMPLETED|Overall Study||1||
48185212|NCT01861756|100775923|FG000|STARTED|Overall Study||101||
48185213|NCT01861756|100775924|FG001|STARTED|Overall Study||103||
48185214|NCT01861756|100775923|FG000|COMPLETED|Overall Study||88||
48185215|NCT01861756|100775924|FG001|COMPLETED|Overall Study||85||
48185216|NCT01861756|100775923|FG000|NOT COMPLETED|Overall Study||13||
48185217|NCT01861756|100775924|FG001|NOT COMPLETED|Overall Study||18||
48185218|NCT01723826|100775925|FG000|STARTED|Overall Study||47||
48185219|NCT01723826|100775926|FG001|STARTED|Overall Study||63||
48185220|NCT01723826|100775927|FG002|STARTED|Overall Study||101||
48185221|NCT01723826|100775928|FG003|STARTED|Overall Study||149||
48185222|NCT01723826|100775925|FG000|COMPLETED|Overall Study||20||
48185223|NCT01723826|100775926|FG001|COMPLETED|Overall Study||27||
48185224|NCT01723826|100775927|FG002|COMPLETED|Overall Study||44||
48185225|NCT01723826|100775928|FG003|COMPLETED|Overall Study||59||
48185226|NCT01723826|100775925|FG000|NOT COMPLETED|Overall Study||27||
48185227|NCT01723826|100775926|FG001|NOT COMPLETED|Overall Study||36||
48185228|NCT01723826|100775927|FG002|NOT COMPLETED|Overall Study||57||
48185229|NCT01723826|100775928|FG003|NOT COMPLETED|Overall Study||90||
48185230|NCT00935792|100775929|FG000|STARTED|Overall Study||7||
48636726|NCT04470427|101894704|FG001|Solicited Safety Set|Part A: Blinded||15179|All randomized participants who received at least 1 dose and contributed any solicited AR data; (had at least 1 post-baseline solicited safety assessment. Participants were included in the treatment group corresponding to the study vaccination they actually received.|
48636727|NCT04470427|101894705|FG002|Solicited Safety Set|Part A: Blinded||0|All randomized participants who received at least 1 dose and contributed any solicited AR data; (had at least 1 post-baseline solicited safety assessment. Participants were included in the treatment group corresponding to the study vaccination they actually received.|
48656992|NCT02284854|101943744|FG001|NOT COMPLETED|Overall Study||0||
48656993|NCT03769467|101943745|FG000|STARTED|Overall Study||6||
48656994|NCT03769467|101943746|FG001|STARTED|Overall Study||6||
48185231|NCT00935792|100775930|FG001|STARTED|Overall Study||9||
48185232|NCT00935792|100775931|FG002|STARTED|Overall Study||12||
48185233|NCT00935792|100775929|FG000|COMPLETED|Overall Study||6||
48185234|NCT00935792|100775930|FG001|COMPLETED|Overall Study||6||
48185235|NCT00935792|100775931|FG002|COMPLETED|Overall Study||12||
48185236|NCT00935792|100775929|FG000|NOT COMPLETED|Overall Study||1||
48185237|NCT00935792|100775930|FG001|NOT COMPLETED|Overall Study||3||
48346334|NCT02006576|101176632|FG001|COMPLETED|Overall Study||44||
48346335|NCT02006576|101176633|FG002|COMPLETED|Overall Study||15||
48346336|NCT02006576|101176631|FG000|NOT COMPLETED|Overall Study||18||
48346337|NCT02006576|101176632|FG001|NOT COMPLETED|Overall Study||7||
48346338|NCT02006576|101176633|FG002|NOT COMPLETED|Overall Study||17||
48346339|NCT03501979|101176634|FG000|STARTED|Overall Study||17||
48346340|NCT03501979|101176634|FG000|COMPLETED|Overall Study||17||
48346341|NCT03501979|101176634|FG000|NOT COMPLETED|Overall Study||0||
48346342|NCT01057277|101176635|FG000|STARTED|Overall Study||3||
48346343|NCT01057277|101176635|FG000|COMPLETED|Overall Study||3||
48346344|NCT01057277|101176635|FG000|NOT COMPLETED|Overall Study||0||
48346345|NCT02983604|101176636|FG000|STARTED|Overall Study||4||
48346346|NCT02983604|101176637|FG001|STARTED|Overall Study||3||
48346347|NCT02983604|101176638|FG002|STARTED|Overall Study||4||
48346348|NCT02983604|101176639|FG003|STARTED|Overall Study||3||
48346349|NCT02983604|101176636|FG000|COMPLETED|Overall Study||4||
48346350|NCT02983604|101176637|FG001|COMPLETED|Overall Study||3||
48346351|NCT02983604|101176638|FG002|COMPLETED|Overall Study||3||
48185238|NCT00935792|100775931|FG002|NOT COMPLETED|Overall Study||0||
48185239|NCT01403987|100775932|FG000|STARTED|Overall Study||34||
48185240|NCT01403987|100775933|FG001|STARTED|Overall Study||34||
48346352|NCT02983604|101176639|FG003|COMPLETED|Overall Study||3||
48346353|NCT02983604|101176636|FG000|NOT COMPLETED|Overall Study||0||
48346354|NCT02983604|101176637|FG001|NOT COMPLETED|Overall Study||0||
48346355|NCT02983604|101176638|FG002|NOT COMPLETED|Overall Study||1||
48185241|NCT01403987|100775934|FG002|STARTED|Overall Study||68||
48185242|NCT01403987|100775932|FG000|COMPLETED|Overall Study||16||
48185243|NCT01403987|100775933|FG001|COMPLETED|Overall Study||17||
48185244|NCT01403987|100775934|FG002|COMPLETED|Overall Study||50||
48185245|NCT01403987|100775932|FG000|NOT COMPLETED|Overall Study||18||
48185246|NCT01403987|100775933|FG001|NOT COMPLETED|Overall Study||17||
48185247|NCT01403987|100775934|FG002|NOT COMPLETED|Overall Study||18||
48346356|NCT02983604|101176639|FG003|NOT COMPLETED|Overall Study||0||
48346357|NCT00618722|101176640|FG000|STARTED|Overall Study||21||
48346358|NCT00618722|101176641|FG001|STARTED|Overall Study||20||
48185248|NCT02431533|100775935|FG000|STARTED|Overall Study||25||
48185249|NCT02431533|100775936|FG001|STARTED|Overall Study||25||
48185250|NCT02431533|100775935|FG000|COMPLETED|Overall Study||23||
48185251|NCT02431533|100775936|FG001|COMPLETED|Overall Study||22||
48185252|NCT02431533|100775935|FG000|NOT COMPLETED|Overall Study||2||
48185253|NCT02431533|100775936|FG001|NOT COMPLETED|Overall Study||3||
48185254|NCT01474512|100775937|FG000|STARTED|Induction Period||431||
48185255|NCT01474512|100775938|FG001|STARTED|Induction Period||432||
48185256|NCT01474512|100775939|FG002|STARTED|Induction Period||433||
48636728|NCT04470427|101894706|FG003|Solicited Safety Set|Part A: Blinded||0|All randomized participants who received at least 1 dose and contributed any solicited AR data; (had at least 1 post-baseline solicited safety assessment. Participants were included in the treatment group corresponding to the study vaccination they actually received.|
48636729|NCT04470427|101894707|FG004|Solicited Safety Set|Part A: Blinded||0|All randomized participants who received at least 1 dose and contributed any solicited AR data; (had at least 1 post-baseline solicited safety assessment. Participants were included in the treatment group corresponding to the study vaccination they actually received.|
48636730|NCT04470427|101894708|FG005|Solicited Safety Set|Part A: Blinded||0|All randomized participants who received at least 1 dose and contributed any solicited AR data; (had at least 1 post-baseline solicited safety assessment. Participants were included in the treatment group corresponding to the study vaccination they actually received.|
48636731|NCT04470427|101894703|FG000|Safety Set|Part A: Blinded||15162|All randomized participants who received at least 1 dose. Participants were included in the treatment group corresponding to dose they actually received. For a participant who was randomized to placebo but received any dose of mRNA-1273 at any injection, the participant was included in the mRNA-1273 group in the Safety Set.|
48636732|NCT04470427|101894704|FG001|Safety Set|Part A: Blinded||15184|All randomized participants who received at least 1 dose. Participants were included in the treatment group corresponding to dose they actually received. For a participant who was randomized to placebo but received any dose of mRNA-1273 at any injection, the participant was included in the mRNA-1273 group in the Safety Set.|
48636733|NCT04470427|101894705|FG002|Safety Set|Part A: Blinded||0|All randomized participants who received at least 1 dose. Participants were included in the treatment group corresponding to dose they actually received. For a participant who was randomized to placebo but received any dose of mRNA-1273 at any injection, the participant was included in the mRNA-1273 group in the Safety Set.|
48636734|NCT04470427|101894706|FG003|Safety Set|Part A: Blinded||0|All randomized participants who received at least 1 dose. Participants were included in the treatment group corresponding to dose they actually received. For a participant who was randomized to placebo but received any dose of mRNA-1273 at any injection, the participant was included in the mRNA-1273 group in the Safety Set.|
48636735|NCT04470427|101894707|FG004|Safety Set|Part A: Blinded||0|All randomized participants who received at least 1 dose. Participants were included in the treatment group corresponding to dose they actually received. For a participant who was randomized to placebo but received any dose of mRNA-1273 at any injection, the participant was included in the mRNA-1273 group in the Safety Set.|
48185257|NCT01474512|100775940|FG003|STARTED|Induction Period||0||
48185258|NCT01474512|100775941|FG004|STARTED|Induction Period||0||
48185259|NCT01474512|100775942|FG005|STARTED|Induction Period||0||
48185260|NCT01474512|100775943|FG006|STARTED|Induction Period||0||
48185261|NCT01474512|100775944|FG007|STARTED|Induction Period||0||
48185262|NCT01474512|100775945|FG008|STARTED|Induction Period||0||
48185263|NCT01474512|100775946|FG009|STARTED|Induction Period||0||
48185264|NCT01474512|100775947|FG010|STARTED|Induction Period||0||
48185265|NCT01474512|100775948|FG011|STARTED|Induction Period||0||
48185266|NCT01474512|100775949|FG012|STARTED|Induction Period||0||
48185267|NCT01474512|100775950|FG013|STARTED|Induction Period||0||
48185268|NCT01474512|100775951|FG014|STARTED|Induction Period||0||
48185269|NCT01474512|100775952|FG015|STARTED|Induction Period||0||
48185270|NCT01474512|100775953|FG016|STARTED|Induction Period||0||
48185271|NCT01474512|100775954|FG017|STARTED|Induction Period||0||
48185272|NCT01474512|100775937|FG000|Received Study Drug|Induction Period||431||
48185273|NCT01474512|100775938|FG001|Received Study Drug|Induction Period||432||
48185274|NCT01474512|100775939|FG002|Received Study Drug|Induction Period||433||
48185275|NCT01474512|100775940|FG003|Received Study Drug|Induction Period||0||
48185276|NCT01474512|100775941|FG004|Received Study Drug|Induction Period||0||
48185277|NCT01474512|100775942|FG005|Received Study Drug|Induction Period||0||
48185278|NCT01474512|100775943|FG006|Received Study Drug|Induction Period||0||
48185279|NCT01474512|100775944|FG007|Received Study Drug|Induction Period||0||
48185280|NCT01474512|100775945|FG008|Received Study Drug|Induction Period||0||
48185281|NCT01474512|100775946|FG009|Received Study Drug|Induction Period||0||
48185282|NCT01474512|100775947|FG010|Received Study Drug|Induction Period||0||
48346359|NCT00618722|101176642|FG002|STARTED|Overall Study||22||
48346360|NCT00618722|101176643|FG003|STARTED|Overall Study||22||
48346361|NCT00618722|101176640|FG000|Received Treatment|Overall Study||20||
48185283|NCT01474512|100775948|FG011|Received Study Drug|Induction Period||0||
48185284|NCT01474512|100775949|FG012|Received Study Drug|Induction Period||0||
48185285|NCT01474512|100775950|FG013|Received Study Drug|Induction Period||0||
48185286|NCT01474512|100775951|FG014|Received Study Drug|Induction Period||0||
48185287|NCT01474512|100775952|FG015|Received Study Drug|Induction Period||0||
48185288|NCT01474512|100775953|FG016|Received Study Drug|Induction Period||0||
48185289|NCT01474512|100775954|FG017|Received Study Drug|Induction Period||0||
48185290|NCT01474512|100775937|FG000|COMPLETED|Induction Period||407||
48185291|NCT01474512|100775938|FG001|COMPLETED|Induction Period||408||
48185292|NCT01474512|100775939|FG002|COMPLETED|Induction Period||415||
48185293|NCT01474512|100775940|FG003|COMPLETED|Induction Period||0||
48185294|NCT01474512|100775941|FG004|COMPLETED|Induction Period||0||
48185295|NCT01474512|100775942|FG005|COMPLETED|Induction Period||0||
48185296|NCT01474512|100775943|FG006|COMPLETED|Induction Period||0||
48185297|NCT01474512|100775944|FG007|COMPLETED|Induction Period||0||
48185298|NCT01474512|100775945|FG008|COMPLETED|Induction Period||0||
48185299|NCT01474512|100775946|FG009|COMPLETED|Induction Period||0||
48185300|NCT01474512|100775947|FG010|COMPLETED|Induction Period||0||
48185301|NCT01474512|100775948|FG011|COMPLETED|Induction Period||0||
48185302|NCT01474512|100775949|FG012|COMPLETED|Induction Period||0||
48185303|NCT01474512|100775950|FG013|COMPLETED|Induction Period||0||
48185304|NCT01474512|100775951|FG014|COMPLETED|Induction Period||0||
48185305|NCT01474512|100775952|FG015|COMPLETED|Induction Period||0||
48185306|NCT01474512|100775953|FG016|COMPLETED|Induction Period||0||
48185307|NCT01474512|100775954|FG017|COMPLETED|Induction Period||0||
48185308|NCT01474512|100775937|FG000|NOT COMPLETED|Induction Period||24||
48185309|NCT01474512|100775938|FG001|NOT COMPLETED|Induction Period||24||
48185310|NCT01474512|100775939|FG002|NOT COMPLETED|Induction Period||18||
48185311|NCT01474512|100775940|FG003|NOT COMPLETED|Induction Period||0||
48185312|NCT01474512|100775941|FG004|NOT COMPLETED|Induction Period||0||
48185313|NCT01474512|100775942|FG005|NOT COMPLETED|Induction Period||0||
48185314|NCT01474512|100775943|FG006|NOT COMPLETED|Induction Period||0||
48185315|NCT01474512|100775944|FG007|NOT COMPLETED|Induction Period||0||
48185316|NCT01474512|100775945|FG008|NOT COMPLETED|Induction Period||0||
48185317|NCT01474512|100775946|FG009|NOT COMPLETED|Induction Period||0||
48185318|NCT01474512|100775947|FG010|NOT COMPLETED|Induction Period||0||
48185319|NCT01474512|100775948|FG011|NOT COMPLETED|Induction Period||0||
48185320|NCT01474512|100775949|FG012|NOT COMPLETED|Induction Period||0||
48185321|NCT01474512|100775950|FG013|NOT COMPLETED|Induction Period||0||
48636736|NCT04470427|101894708|FG005|Safety Set|Part A: Blinded||0|All randomized participants who received at least 1 dose. Participants were included in the treatment group corresponding to dose they actually received. For a participant who was randomized to placebo but received any dose of mRNA-1273 at any injection, the participant was included in the mRNA-1273 group in the Safety Set.|
48656995|NCT03769467|101943747|FG002|STARTED|Overall Study||0||
48656996|NCT03769467|101943745|FG000|COMPLETED|Overall Study||0||
48759226|NCT05138653|102197767|FG005|NOT COMPLETED|Multiple Ascending Dose (Up to 12 Weeks)||0||
48185322|NCT01474512|100775951|FG014|NOT COMPLETED|Induction Period||0||
48185323|NCT01474512|100775952|FG015|NOT COMPLETED|Induction Period||0||
48185324|NCT01474512|100775953|FG016|NOT COMPLETED|Induction Period||0||
48185325|NCT01474512|100775954|FG017|NOT COMPLETED|Induction Period||0||
48185326|NCT01474512|100775937|FG000|STARTED|Maintenance Period||0||
48185327|NCT01474512|100775938|FG001|STARTED|Maintenance Period||0||
48185328|NCT01474512|100775939|FG002|STARTED|Maintenance Period||0||
48185329|NCT01474512|100775940|FG003|STARTED|Maintenance Period||226||
48185330|NCT01474512|100775941|FG004|STARTED|Maintenance Period||227||
48185331|NCT01474512|100775942|FG005|STARTED|Maintenance Period||229||
48185332|NCT01474512|100775943|FG006|STARTED|Maintenance Period||16||
48185333|NCT01474512|100775944|FG007|STARTED|Maintenance Period||391||
48185334|NCT01474512|100775945|FG008|STARTED|Maintenance Period||78||
48185335|NCT01474512|100775946|FG009|STARTED|Maintenance Period||62||
48185336|NCT01474512|100775947|FG010|STARTED|Maintenance Period||0||
48185337|NCT01474512|100775948|FG011|STARTED|Maintenance Period||0||
48185338|NCT01474512|100775949|FG012|STARTED|Maintenance Period||0||
48185339|NCT01474512|100775950|FG013|STARTED|Maintenance Period||0||
48185340|NCT01474512|100775951|FG014|STARTED|Maintenance Period||0||
48346362|NCT00618722|101176641|FG001|Received Treatment|Overall Study||20||
48346363|NCT00618722|101176642|FG002|Received Treatment|Overall Study||22||
48346364|NCT00618722|101176643|FG003|Received Treatment|Overall Study||22||
48346365|NCT00618722|101176640|FG000|COMPLETED|Overall Study||18||
48346366|NCT00618722|101176641|FG001|COMPLETED|Overall Study||18||
48346367|NCT00618722|101176642|FG002|COMPLETED|Overall Study||19||
48346368|NCT00618722|101176643|FG003|COMPLETED|Overall Study||18||
48346369|NCT00618722|101176640|FG000|NOT COMPLETED|Overall Study||3||
48346370|NCT00618722|101176641|FG001|NOT COMPLETED|Overall Study||2||
48346371|NCT00618722|101176642|FG002|NOT COMPLETED|Overall Study||3||
48346372|NCT00618722|101176643|FG003|NOT COMPLETED|Overall Study||4||
48346373|NCT02335502|101176644|FG000|STARTED|Overall Study||66||
48346374|NCT02335502|101176644|FG000|Received Trial System|Overall Study||65||
48415468|NCT01882439|101350291|FG003|STARTED|Overall Study||65||
48185341|NCT01474512|100775952|FG015|STARTED|Maintenance Period||0||
48185342|NCT01474512|100775953|FG016|STARTED|Maintenance Period||0||
48185343|NCT01474512|100775954|FG017|STARTED|Maintenance Period||0||
48185344|NCT01474512|100775937|FG000|Received Study Drug|Maintenance Period||0||
48185345|NCT01474512|100775938|FG001|Received Study Drug|Maintenance Period||0||
48185346|NCT01474512|100775939|FG002|Received Study Drug|Maintenance Period||0||
48185347|NCT01474512|100775940|FG003|Received Study Drug|Maintenance Period||226||
48185348|NCT01474512|100775941|FG004|Received Study Drug|Maintenance Period||227||
48185349|NCT01474512|100775942|FG005|Received Study Drug|Maintenance Period||229||
48346375|NCT02335502|101176644|FG000|Receiving Permanent System|Overall Study||56||
48346376|NCT02335502|101176644|FG000|COMPLETED|Overall Study||49||
48636737|NCT04470427|101894703|FG000|Full Analysis Set|Part A: Blinded||15166|All randomized participants who received at least 1 dose. Participants were analyzed according to the treatment group to which they were randomized.|
48415469|NCT01882439|101350288|FG000|COMPLETED|Overall Study||122||
48415470|NCT01882439|101350289|FG001|COMPLETED|Overall Study||111||
48415471|NCT01882439|101350290|FG002|COMPLETED|Overall Study||56||
48415472|NCT01882439|101350291|FG003|COMPLETED|Overall Study||56||
48415473|NCT01882439|101350288|FG000|NOT COMPLETED|Overall Study||9||
48415474|NCT01882439|101350289|FG001|NOT COMPLETED|Overall Study||21||
48185350|NCT01474512|100775943|FG006|Received Study Drug|Maintenance Period||16||
48185351|NCT01474512|100775944|FG007|Received Study Drug|Maintenance Period||391||
48185352|NCT01474512|100775945|FG008|Received Study Drug|Maintenance Period||78||
48185353|NCT01474512|100775946|FG009|Received Study Drug|Maintenance Period||62||
48185354|NCT01474512|100775947|FG010|Received Study Drug|Maintenance Period||0||
48636738|NCT04470427|101894704|FG001|Full Analysis Set|Part A: Blinded||15180|All randomized participants who received at least 1 dose. Participants were analyzed according to the treatment group to which they were randomized.|
48636739|NCT04470427|101894705|FG002|Full Analysis Set|Part A: Blinded||0|All randomized participants who received at least 1 dose. Participants were analyzed according to the treatment group to which they were randomized.|
48636740|NCT04470427|101894706|FG003|Full Analysis Set|Part A: Blinded||0|All randomized participants who received at least 1 dose. Participants were analyzed according to the treatment group to which they were randomized.|
48636741|NCT04470427|101894707|FG004|Full Analysis Set|Part A: Blinded||0|All randomized participants who received at least 1 dose. Participants were analyzed according to the treatment group to which they were randomized.|
48636742|NCT04470427|101894708|FG005|Full Analysis Set|Part A: Blinded||0|All randomized participants who received at least 1 dose. Participants were analyzed according to the treatment group to which they were randomized.|
48185355|NCT01474512|100775948|FG011|Received Study Drug|Maintenance Period||0||
48185356|NCT01474512|100775949|FG012|Received Study Drug|Maintenance Period||0||
48185357|NCT01474512|100775950|FG013|Received Study Drug|Maintenance Period||0||
48185358|NCT01474512|100775951|FG014|Received Study Drug|Maintenance Period||0||
48185359|NCT01474512|100775952|FG015|Received Study Drug|Maintenance Period||0||
48185360|NCT01474512|100775953|FG016|Received Study Drug|Maintenance Period||0||
48185361|NCT01474512|100775954|FG017|Received Study Drug|Maintenance Period||0||
48185362|NCT01474512|100775937|FG000|Relapsed Population Received Drug|Maintenance Period||0||
48185363|NCT01474512|100775938|FG001|Relapsed Population Received Drug|Maintenance Period||0||
48415475|NCT01882439|101350290|FG002|NOT COMPLETED|Overall Study||10||
48415476|NCT01882439|101350291|FG003|NOT COMPLETED|Overall Study||9||
48415477|NCT05643170|101350292|FG000|STARTED|Overall Study||4||
48415478|NCT05643170|101350292|FG000|COMPLETED|Overall Study||0||
48185364|NCT01474512|100775939|FG002|Relapsed Population Received Drug|Maintenance Period||0||
48185365|NCT01474512|100775940|FG003|Relapsed Population Received Drug|Maintenance Period||0||
48185366|NCT01474512|100775941|FG004|Relapsed Population Received Drug|Maintenance Period||0||
48185367|NCT01474512|100775942|FG005|Relapsed Population Received Drug|Maintenance Period||0||
48185368|NCT01474512|100775943|FG006|Relapsed Population Received Drug|Maintenance Period||0||
48185369|NCT01474512|100775944|FG007|Relapsed Population Received Drug|Maintenance Period||0||
48185370|NCT01474512|100775945|FG008|Relapsed Population Received Drug|Maintenance Period||0||
48185371|NCT01474512|100775946|FG009|Relapsed Population Received Drug|Maintenance Period||0||
48185372|NCT01474512|100775947|FG010|Relapsed Population Received Drug|Maintenance Period||348||
48185373|NCT01474512|100775948|FG011|Relapsed Population Received Drug|Maintenance Period||0||
48185374|NCT01474512|100775949|FG012|Relapsed Population Received Drug|Maintenance Period||0||
48185375|NCT01474512|100775950|FG013|Relapsed Population Received Drug|Maintenance Period||0||
48185376|NCT01474512|100775951|FG014|Relapsed Population Received Drug|Maintenance Period||0||
48185377|NCT01474512|100775952|FG015|Relapsed Population Received Drug|Maintenance Period||0||
48346377|NCT02335502|101176644|FG000|NOT COMPLETED|Overall Study||17||
48346378|NCT01642212|101176645|FG000|STARTED|Single-blind Baseline||119||
48346379|NCT01642212|101176646|FG001|STARTED|Single-blind Baseline||0||
48346380|NCT01642212|101176647|FG002|STARTED|Single-blind Baseline||0||
48346381|NCT01642212|101176648|FG003|STARTED|Single-blind Baseline||0||
48346382|NCT01642212|101176649|FG004|STARTED|Single-blind Baseline||0||
48346383|NCT01642212|101176645|FG000|COMPLETED|Single-blind Baseline||93||
48346384|NCT01642212|101176646|FG001|COMPLETED|Single-blind Baseline||0||
48346385|NCT01642212|101176647|FG002|COMPLETED|Single-blind Baseline||0||
48346386|NCT01642212|101176648|FG003|COMPLETED|Single-blind Baseline||0||
48346387|NCT01642212|101176649|FG004|COMPLETED|Single-blind Baseline||0||
48346388|NCT01642212|101176645|FG000|NOT COMPLETED|Single-blind Baseline||26||
48346389|NCT01642212|101176646|FG001|NOT COMPLETED|Single-blind Baseline||0||
48346390|NCT01642212|101176647|FG002|NOT COMPLETED|Single-blind Baseline||0||
48415479|NCT05643170|101350292|FG000|NOT COMPLETED|Overall Study||4||
48415480|NCT02089191|101350293|FG000|STARTED|Period 1, First 12 Hours||16||
48415481|NCT02089191|101350294|FG001|STARTED|Period 1, First 12 Hours||15||
48415482|NCT02089191|101350293|FG000|COMPLETED|Period 1, First 12 Hours||16||
48415483|NCT02089191|101350294|FG001|COMPLETED|Period 1, First 12 Hours||15||
48415484|NCT02089191|101350293|FG000|NOT COMPLETED|Period 1, First 12 Hours||0||
48415485|NCT02089191|101350294|FG001|NOT COMPLETED|Period 1, First 12 Hours||0||
48415486|NCT02089191|101350293|FG000|STARTED|Period 2, Second 12 Hours||15||
48346391|NCT01642212|101176648|FG003|NOT COMPLETED|Single-blind Baseline||0||
48346392|NCT01642212|101176649|FG004|NOT COMPLETED|Single-blind Baseline||0||
48346393|NCT01642212|101176645|FG000|STARTED|Double-blind Treatment||0||
48346394|NCT01642212|101176646|FG001|STARTED|Double-blind Treatment||42||
48636743|NCT04470427|101894703|FG000|COMPLETED|Part A: Blinded||14375|Completed Part A (from first dose up to participant decision visit (PDV)/unblinding) and continued to Part B Open-label.|
48636744|NCT04470427|101894704|FG001|COMPLETED|Part A: Blinded||14661|Completed Part A (from first dose up to participant decision visit (PDV)/unblinding) and continued to Part B Open-label.|
48636745|NCT04470427|101894705|FG002|COMPLETED|Part A: Blinded||0|Completed Part A (from first dose up to participant decision visit (PDV)/unblinding) and continued to Part B Open-label.|
48636746|NCT04470427|101894706|FG003|COMPLETED|Part A: Blinded||0|Completed Part A (from first dose up to participant decision visit (PDV)/unblinding) and continued to Part B Open-label.|
48636747|NCT04470427|101894707|FG004|COMPLETED|Part A: Blinded||0|Completed Part A (from first dose up to participant decision visit (PDV)/unblinding) and continued to Part B Open-label.|
48636748|NCT04470427|101894708|FG005|COMPLETED|Part A: Blinded||0|Completed Part A (from first dose up to participant decision visit (PDV)/unblinding) and continued to Part B Open-label.|
48346395|NCT01642212|101176647|FG002|STARTED|Double-blind Treatment||51||
48346396|NCT01642212|101176648|FG003|STARTED|Double-blind Treatment||0||
48346397|NCT01642212|101176649|FG004|STARTED|Double-blind Treatment||0||
48346398|NCT01642212|101176645|FG000|COMPLETED|Double-blind Treatment||0||
48346399|NCT01642212|101176646|FG001|COMPLETED|Double-blind Treatment||39||
48346400|NCT01642212|101176647|FG002|COMPLETED|Double-blind Treatment||49||
48346401|NCT01642212|101176648|FG003|COMPLETED|Double-blind Treatment||0||
48346402|NCT01642212|101176649|FG004|COMPLETED|Double-blind Treatment||0||
48346403|NCT01642212|101176645|FG000|NOT COMPLETED|Double-blind Treatment||0||
48346404|NCT01642212|101176646|FG001|NOT COMPLETED|Double-blind Treatment||3||
48346405|NCT01642212|101176647|FG002|NOT COMPLETED|Double-blind Treatment||2||
48346406|NCT01642212|101176648|FG003|NOT COMPLETED|Double-blind Treatment||0||
48346407|NCT01642212|101176649|FG004|NOT COMPLETED|Double-blind Treatment||0||
48346408|NCT01642212|101176645|FG000|STARTED|Open-label Extension||0||
48346409|NCT01642212|101176646|FG001|STARTED|Open-label Extension||0||
48346410|NCT01642212|101176647|FG002|STARTED|Open-label Extension||0||
48346411|NCT01642212|101176648|FG003|STARTED|Open-label Extension||37||
48346412|NCT01642212|101176649|FG004|STARTED|Open-label Extension||45||
48346413|NCT01642212|101176645|FG000|COMPLETED|Open-label Extension||0||
48346414|NCT01642212|101176646|FG001|COMPLETED|Open-label Extension||0||
48346415|NCT01642212|101176647|FG002|COMPLETED|Open-label Extension||0||
48346416|NCT01642212|101176648|FG003|COMPLETED|Open-label Extension||27||
48346417|NCT01642212|101176649|FG004|COMPLETED|Open-label Extension||37||
48346418|NCT01642212|101176645|FG000|NOT COMPLETED|Open-label Extension||0||
48346419|NCT01642212|101176646|FG001|NOT COMPLETED|Open-label Extension||0||
48346420|NCT01642212|101176647|FG002|NOT COMPLETED|Open-label Extension||0||
48346421|NCT01642212|101176648|FG003|NOT COMPLETED|Open-label Extension||10||
48346422|NCT01642212|101176649|FG004|NOT COMPLETED|Open-label Extension||8||
48346423|NCT02536248|101176650|FG000|STARTED|First Intervention (6 Weeks)||10||
48346424|NCT02536248|101176651|FG001|STARTED|First Intervention (6 Weeks)||10||
48346425|NCT02536248|101176650|FG000|COMPLETED|First Intervention (6 Weeks)||10||
48346426|NCT02536248|101176651|FG001|COMPLETED|First Intervention (6 Weeks)||10||
48346427|NCT02536248|101176650|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0||
48346428|NCT02536248|101176651|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0||
48346429|NCT02536248|101176650|FG000|STARTED|Wash-out (14 Days)||10||
48346430|NCT02536248|101176651|FG001|STARTED|Wash-out (14 Days)||10||
48346431|NCT02536248|101176650|FG000|COMPLETED|Wash-out (14 Days)||10||
48346432|NCT02536248|101176651|FG001|COMPLETED|Wash-out (14 Days)||10||
48346433|NCT02536248|101176650|FG000|NOT COMPLETED|Wash-out (14 Days)||0||
48346434|NCT02536248|101176651|FG001|NOT COMPLETED|Wash-out (14 Days)||0||
48346435|NCT02536248|101176650|FG000|STARTED|Second Intervention (6 Weeks)||10||
48346436|NCT02536248|101176651|FG001|STARTED|Second Intervention (6 Weeks)||10||
48346437|NCT02536248|101176650|FG000|COMPLETED|Second Intervention (6 Weeks)||10||
48346438|NCT02536248|101176651|FG001|COMPLETED|Second Intervention (6 Weeks)||10||
48346439|NCT02536248|101176650|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0||
48346440|NCT02536248|101176651|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0||
48346441|NCT03481270|101176652|FG000|STARTED|Overall Study||324||
48346442|NCT03481270|101176653|FG001|STARTED|Overall Study||313||
48346443|NCT03481270|101176652|FG000|COMPLETED|Overall Study||324||
48346444|NCT03481270|101176653|FG001|COMPLETED|Overall Study||313||
48346445|NCT03481270|101176652|FG000|NOT COMPLETED|Overall Study||0||
48346446|NCT03481270|101176653|FG001|NOT COMPLETED|Overall Study||0||
48346447|NCT04026568|101176654|FG000|STARTED|Overall Study||0||
48346448|NCT04026568|101176655|FG001|STARTED|Overall Study||1||
48346449|NCT04026568|101176654|FG000|COMPLETED|Overall Study||0||
48346450|NCT04026568|101176655|FG001|COMPLETED|Overall Study||0||
48346451|NCT04026568|101176654|FG000|NOT COMPLETED|Overall Study||0||
48346452|NCT04026568|101176655|FG001|NOT COMPLETED|Overall Study||1||
48346453|NCT00803114|101176656|FG000|STARTED|Overall Study||113||
48346454|NCT00803114|101176657|FG001|STARTED|Overall Study||115||
48346455|NCT00803114|101176656|FG000|COMPLETED|Overall Study||113||
48346456|NCT00803114|101176657|FG001|COMPLETED|Overall Study||115||
48346457|NCT00803114|101176656|FG000|NOT COMPLETED|Overall Study||0||
48346458|NCT00803114|101176657|FG001|NOT COMPLETED|Overall Study||0||
48346459|NCT00749190|101176658|FG000|STARTED|Overall Study||71||
48346460|NCT00749190|101176659|FG001|STARTED|Overall Study||71||
48346461|NCT00749190|101176660|FG002|STARTED|Overall Study||71||
48346462|NCT00749190|101176661|FG003|STARTED|Overall Study||71||
48346463|NCT00749190|101176662|FG004|STARTED|Overall Study||70||
48346464|NCT00749190|101176663|FG005|STARTED|Overall Study||70||
48346465|NCT00749190|101176664|FG006|STARTED|Overall Study||71||
48346466|NCT00749190|101176658|FG000|COMPLETED|Overall Study||66||
48346467|NCT00749190|101176659|FG001|COMPLETED|Overall Study||66||
48346468|NCT00749190|101176660|FG002|COMPLETED|Overall Study||70||
48346469|NCT00749190|101176661|FG003|COMPLETED|Overall Study||66||
48346470|NCT00749190|101176662|FG004|COMPLETED|Overall Study||70||
48346471|NCT00749190|101176663|FG005|COMPLETED|Overall Study||65||
48346472|NCT00749190|101176664|FG006|COMPLETED|Overall Study||70||
48346473|NCT00749190|101176658|FG000|NOT COMPLETED|Overall Study||5||
48346474|NCT00749190|101176659|FG001|NOT COMPLETED|Overall Study||5||
48346475|NCT00749190|101176660|FG002|NOT COMPLETED|Overall Study||1||
48346476|NCT00749190|101176661|FG003|NOT COMPLETED|Overall Study||5||
48346477|NCT00749190|101176662|FG004|NOT COMPLETED|Overall Study||0||
48346478|NCT00749190|101176663|FG005|NOT COMPLETED|Overall Study||5||
48346479|NCT00749190|101176664|FG006|NOT COMPLETED|Overall Study||1||
48346480|NCT04552470|101176665|FG000|STARTED|Overall Study||9||
48346481|NCT04552470|101176666|FG001|STARTED|Overall Study||10||
48346482|NCT04552470|101176667|FG002|STARTED|Overall Study||9||
48346483|NCT04552470|101176668|FG003|STARTED|Overall Study||9||
48346484|NCT04552470|101176665|FG000|COMPLETED|Overall Study||9||
48346485|NCT04552470|101176666|FG001|COMPLETED|Overall Study||10||
48346486|NCT04552470|101176667|FG002|COMPLETED|Overall Study||9||
48346487|NCT04552470|101176668|FG003|COMPLETED|Overall Study||9||
48346488|NCT04552470|101176665|FG000|NOT COMPLETED|Overall Study||0||
48346489|NCT04552470|101176666|FG001|NOT COMPLETED|Overall Study||0||
48346490|NCT04552470|101176667|FG002|NOT COMPLETED|Overall Study||0||
48346491|NCT04552470|101176668|FG003|NOT COMPLETED|Overall Study||0||
48346492|NCT01705691|101176669|FG000|STARTED|Overall Study||19||
48346493|NCT01705691|101176670|FG001|STARTED|Overall Study||30||
48346494|NCT01705691|101176669|FG000|COMPLETED|Overall Study||16||
48346495|NCT01705691|101176670|FG001|COMPLETED|Overall Study||24||
48346496|NCT01705691|101176669|FG000|NOT COMPLETED|Overall Study||3||
48346497|NCT01705691|101176670|FG001|NOT COMPLETED|Overall Study||6||
48346498|NCT02278783|101176671|FG000|STARTED|Overall Study||1||
48346499|NCT02278783|101176671|FG000|COMPLETED|Overall Study||1||
48346500|NCT02278783|101176671|FG000|NOT COMPLETED|Overall Study||0||
48346501|NCT00759603|101176672|FG000|STARTED|Overall Study||59||
48346502|NCT00759603|101176672|FG000|COMPLETED|Overall Study||59||
48346503|NCT00759603|101176672|FG000|NOT COMPLETED|Overall Study||0||
48346504|NCT02886702|101176673|FG000|STARTED|Overall Study||284|Randomized (Safety Population)|
48346505|NCT02886702|101176674|FG001|STARTED|Overall Study||286|Randomized (Safety Population)|
48346506|NCT02886702|101176675|FG002|STARTED|Overall Study||285|Randomized (Safety Population)|
48346507|NCT02886702|101176673|FG000|Modified Intent-to Treat (mITT)|Overall Study||263|met all inclusion/exclusion criteria, received study treatment, and had a post-Baseline evaluation|
48346508|NCT02886702|101176674|FG001|Modified Intent-to Treat (mITT)|Overall Study||266|met all inclusion/exclusion criteria, received study treatment, and had a post-Baseline evaluation|
48346509|NCT02886702|101176675|FG002|Modified Intent-to Treat (mITT)|Overall Study||275|met all inclusion/exclusion criteria, received study treatment, and had a post-Baseline evaluation|
48346510|NCT02886702|101176673|FG000|Per-Protocol Population (PP)|Overall Study||208|all randomized subjects who complied with the protocol|
48346511|NCT02886702|101176674|FG001|Per-Protocol Population (PP)|Overall Study||209|all randomized subjects who complied with the protocol|
48346512|NCT02886702|101176675|FG002|Per-Protocol Population (PP)|Overall Study||201|all randomized subjects who complied with the protocol|
48346513|NCT02886702|101176673|FG000|COMPLETED|Overall Study||236||
48346514|NCT02886702|101176674|FG001|COMPLETED|Overall Study||235||
48346515|NCT02886702|101176675|FG002|COMPLETED|Overall Study||232||
48346516|NCT02886702|101176673|FG000|NOT COMPLETED|Overall Study||48||
48346517|NCT02886702|101176674|FG001|NOT COMPLETED|Overall Study||51||
48346518|NCT02886702|101176675|FG002|NOT COMPLETED|Overall Study||53||
48346519|NCT02241486|101176676|FG000|STARTED|Overall Study||2||
48346520|NCT02241486|101176676|FG000|COMPLETED|Overall Study||2||
48346521|NCT02241486|101176676|FG000|NOT COMPLETED|Overall Study||0||
48346522|NCT00756548|101176677|FG000|STARTED|Overall Study||186||
48346523|NCT00756548|101176678|FG001|STARTED|Overall Study||185||
48346524|NCT00756548|101176677|FG000|COMPLETED|Overall Study||184||
48346525|NCT00756548|101176678|FG001|COMPLETED|Overall Study||185||
48636749|NCT04470427|101894703|FG000|NOT COMPLETED|Part A: Blinded||831||
48346526|NCT00756548|101176677|FG000|NOT COMPLETED|Overall Study||2||
48346527|NCT00756548|101176678|FG001|NOT COMPLETED|Overall Study||0||
48346528|NCT00623831|101176679|FG000|STARTED|Overall Study||13||
48346529|NCT00623831|101176680|FG001|STARTED|Overall Study||4||
48346530|NCT00623831|101176679|FG000|COMPLETED|Overall Study||12||
48346531|NCT00623831|101176680|FG001|COMPLETED|Overall Study||3||
48346532|NCT00623831|101176679|FG000|NOT COMPLETED|Overall Study||1||
48346533|NCT00623831|101176680|FG001|NOT COMPLETED|Overall Study||1||
48346534|NCT01841619|101176681|FG000|STARTED|Overall Study||16||
48346535|NCT01841619|101176681|FG000|COMPLETED|Overall Study||16||
48346536|NCT01841619|101176681|FG000|NOT COMPLETED|Overall Study||0||
48636750|NCT04470427|101894704|FG001|NOT COMPLETED|Part A: Blinded||548||
48636751|NCT04470427|101894705|FG002|NOT COMPLETED|Part A: Blinded||0||
48636752|NCT04470427|101894706|FG003|NOT COMPLETED|Part A: Blinded||0||
48636753|NCT04470427|101894707|FG004|NOT COMPLETED|Part A: Blinded||0||
48636754|NCT04470427|101894708|FG005|NOT COMPLETED|Part A: Blinded||0||
48636755|NCT04470427|101894703|FG000|STARTED|Part B :Open-label||0|Randomization Set from Part A and who received at least 1 dose. Participants were analyzed according to the treatment group to which they actually received.|
48636756|NCT04470427|101894704|FG001|STARTED|Part B :Open-label||0|Randomization Set from Part A and who received at least 1 dose. Participants were analyzed according to the treatment group to which they actually received.|
48636757|NCT04470427|101894705|FG002|STARTED|Part B :Open-label||2513|Randomization Set from Part A and who received at least 1 dose. Participants were analyzed according to the treatment group to which they actually received.|
48636758|NCT04470427|101894706|FG003|STARTED|Part B :Open-label||12649|Randomization Set from Part A and who received at least 1 dose. Participants were analyzed according to the treatment group to which they actually received.|
48636759|NCT04470427|101894707|FG004|STARTED|Part B :Open-label||15184|Randomization Set from Part A and who received at least 1 dose. Participants were analyzed according to the treatment group to which they actually received.|
48636760|NCT04470427|101894708|FG005|STARTED|Part B :Open-label||0|Randomization Set from Part A and who received at least 1 dose. Participants were analyzed according to the treatment group to which they actually received.|
48636761|NCT04470427|101894703|FG000|Safety Set|Part B :Open-label||0|"All randomized participants who received at least 1 dose in Part A and continued in Part B.~Participants were included in the treatment group corresponding to dose they actually received. For a participant who was randomized to placebo but received any dose of mRNA-1273 at any injection, the participant was included in the mRNA-1273 group in the Safety Set."|
48636762|NCT04470427|101894704|FG001|Safety Set|Part B :Open-label||0|"All randomized participants who received at least 1 dose in Part A and continued in Part B.~Participants were included in the treatment group corresponding to dose they actually received. For a participant who was randomized to placebo but received any dose of mRNA-1273 at any injection, the participant was included in the mRNA-1273 group in the Safety Set."|
48636763|NCT04470427|101894705|FG002|Safety Set|Part B :Open-label||2513|"All randomized participants who received at least 1 dose in Part A and continued in Part B.~Participants were included in the treatment group corresponding to dose they actually received. For a participant who was randomized to placebo but received any dose of mRNA-1273 at any injection, the participant was included in the mRNA-1273 group in the Safety Set."|
48636764|NCT04470427|101894706|FG003|Safety Set|Part B :Open-label||12649|"All randomized participants who received at least 1 dose in Part A and continued in Part B.~Participants were included in the treatment group corresponding to dose they actually received. For a participant who was randomized to placebo but received any dose of mRNA-1273 at any injection, the participant was included in the mRNA-1273 group in the Safety Set."|
48656997|NCT03769467|101943746|FG001|COMPLETED|Overall Study||0||
48656998|NCT03769467|101943747|FG002|COMPLETED|Overall Study||0||
48346537|NCT03251326|101176682|FG000|STARTED|Overall Study||1||
48346538|NCT03251326|101176683|FG001|STARTED|Overall Study||1||
48346539|NCT03251326|101176684|FG002|STARTED|Overall Study||1||
48346540|NCT03251326|101176685|FG003|STARTED|Overall Study||1||
48346541|NCT03251326|101176682|FG000|COMPLETED|Overall Study||1||
48346542|NCT03251326|101176683|FG001|COMPLETED|Overall Study||1||
48346543|NCT03251326|101176684|FG002|COMPLETED|Overall Study||0||
48346544|NCT03251326|101176685|FG003|COMPLETED|Overall Study||0||
48346545|NCT03251326|101176682|FG000|NOT COMPLETED|Overall Study||0||
48346546|NCT03251326|101176683|FG001|NOT COMPLETED|Overall Study||0||
48346547|NCT03251326|101176684|FG002|NOT COMPLETED|Overall Study||1||
48346548|NCT03251326|101176685|FG003|NOT COMPLETED|Overall Study||1||
48346549|NCT01475734|101176686|FG000|STARTED|Overall Study||22||
48346550|NCT01475734|101176687|FG001|STARTED|Overall Study||22||
48346551|NCT01475734|101176686|FG000|COMPLETED|Overall Study||20||
48346552|NCT01475734|101176687|FG001|COMPLETED|Overall Study||21||
48346553|NCT01475734|101176686|FG000|NOT COMPLETED|Overall Study||2||
48346554|NCT01475734|101176687|FG001|NOT COMPLETED|Overall Study||1||
48346555|NCT03502187|101176688|FG000|STARTED|Overall Study||43||
48346556|NCT03502187|101176689|FG001|STARTED|Overall Study||43||
48346557|NCT03502187|101176690|FG002|STARTED|Overall Study||42||
48346558|NCT03502187|101176688|FG000|COMPLETED|Overall Study||34||
48346559|NCT03502187|101176689|FG001|COMPLETED|Overall Study||36||
48346560|NCT03502187|101176690|FG002|COMPLETED|Overall Study||34||
48346561|NCT03502187|101176688|FG000|NOT COMPLETED|Overall Study||9||
48346562|NCT03502187|101176689|FG001|NOT COMPLETED|Overall Study||7||
48346563|NCT03502187|101176690|FG002|NOT COMPLETED|Overall Study||8||
48346564|NCT00624221|101176691|FG000|STARTED|Overall Study||20||
48346565|NCT00624221|101176692|FG001|STARTED|Overall Study||20||
48346566|NCT00624221|101176691|FG000|COMPLETED|Overall Study||20||
48346567|NCT00624221|101176692|FG001|COMPLETED|Overall Study||20||
48346568|NCT00624221|101176691|FG000|NOT COMPLETED|Overall Study||0||
48346569|NCT00624221|101176692|FG001|NOT COMPLETED|Overall Study||0||
48346570|NCT02395991|101176693|FG000|STARTED|Overall Study||60||
48636765|NCT04470427|101894707|FG004|Safety Set|Part B :Open-label||15184|"All randomized participants who received at least 1 dose in Part A and continued in Part B.~Participants were included in the treatment group corresponding to dose they actually received. For a participant who was randomized to placebo but received any dose of mRNA-1273 at any injection, the participant was included in the mRNA-1273 group in the Safety Set."|
48346571|NCT02395991|101176693|FG000|COMPLETED|Overall Study||59||
48346572|NCT02395991|101176693|FG000|NOT COMPLETED|Overall Study||1||
48346573|NCT02272790|101176694|FG000|STARTED|Overall Study||9||
48346574|NCT02272790|101176695|FG001|STARTED|Overall Study||39||
48346575|NCT02272790|101176696|FG002|STARTED|Overall Study||23||
48346576|NCT02272790|101176697|FG003|STARTED|Overall Study||12||
48346577|NCT02272790|101176698|FG004|STARTED|Overall Study||6||
48346578|NCT02272790|101176699|FG005|STARTED|Overall Study||6||
48346579|NCT02272790|101176694|FG000|COMPLETED|Overall Study||9||
48346580|NCT02272790|101176695|FG001|COMPLETED|Overall Study||38||
48346581|NCT02272790|101176696|FG002|COMPLETED|Overall Study||23||
48346582|NCT02272790|101176697|FG003|COMPLETED|Overall Study||12||
48346583|NCT02272790|101176698|FG004|COMPLETED|Overall Study||6||
48346584|NCT02272790|101176699|FG005|COMPLETED|Overall Study||6||
48346585|NCT02272790|101176694|FG000|NOT COMPLETED|Overall Study||0||
48346586|NCT02272790|101176695|FG001|NOT COMPLETED|Overall Study||1||
48346587|NCT02272790|101176696|FG002|NOT COMPLETED|Overall Study||0||
48346588|NCT02272790|101176697|FG003|NOT COMPLETED|Overall Study||0||
48636766|NCT04470427|101894708|FG005|Safety Set|Part B :Open-label||0|"All randomized participants who received at least 1 dose in Part A and continued in Part B.~Participants were included in the treatment group corresponding to dose they actually received. For a participant who was randomized to placebo but received any dose of mRNA-1273 at any injection, the participant was included in the mRNA-1273 group in the Safety Set."|
48636767|NCT04470427|101894703|FG000|PP Set|Part B :Open-label||0|Participants who were randomized in Part A, and were SARS-CoV-2 negative and had no major protocol deviations that impacted critical data.|
48636768|NCT04470427|101894704|FG001|PP Set|Part B :Open-label||0|Participants who were randomized in Part A, and were SARS-CoV-2 negative and had no major protocol deviations that impacted critical data.|
48636769|NCT04470427|101894705|FG002|PP Set|Part B :Open-label||2104|Participants who were randomized in Part A, and were SARS-CoV-2 negative and had no major protocol deviations that impacted critical data.|
48656999|NCT03769467|101943745|FG000|NOT COMPLETED|Overall Study||6||
48759227|NCT05138653|102197768|FG006|NOT COMPLETED|Multiple Ascending Dose (Up to 12 Weeks)||0||
48759228|NCT05138653|102197769|FG007|NOT COMPLETED|Multiple Ascending Dose (Up to 12 Weeks)||0||
48346589|NCT02272790|101176698|FG004|NOT COMPLETED|Overall Study||0||
48346590|NCT02272790|101176699|FG005|NOT COMPLETED|Overall Study||0||
48346591|NCT01815645|101176700|FG000|STARTED|Overall Study||32||
48346592|NCT01815645|101176701|FG001|STARTED|Overall Study||33||
48346593|NCT01815645|101176700|FG000|COMPLETED|Overall Study||32||
48346594|NCT01815645|101176701|FG001|COMPLETED|Overall Study||33||
48759229|NCT05138653|102197770|FG008|NOT COMPLETED|Multiple Ascending Dose (Up to 12 Weeks)||0||
48759230|NCT05138653|102197771|FG009|NOT COMPLETED|Multiple Ascending Dose (Up to 12 Weeks)||0||
48759231|NCT05138653|102197772|FG010|NOT COMPLETED|Multiple Ascending Dose (Up to 12 Weeks)||1||
48759232|NCT05138653|102197773|FG011|NOT COMPLETED|Multiple Ascending Dose (Up to 12 Weeks)||0||
48759233|NCT05138653|102197774|FG012|NOT COMPLETED|Multiple Ascending Dose (Up to 12 Weeks)||1||
48346595|NCT01815645|101176700|FG000|NOT COMPLETED|Overall Study||0||
48346596|NCT01815645|101176701|FG001|NOT COMPLETED|Overall Study||0||
48346597|NCT00450580|101176702|FG000|STARTED|Overall Study||106||
48346598|NCT00450580|101176703|FG001|STARTED|Overall Study||106||
48346599|NCT00450580|101176702|FG000|COMPLETED|Overall Study||90||
48346600|NCT00450580|101176703|FG001|COMPLETED|Overall Study||90||
48346601|NCT00450580|101176702|FG000|NOT COMPLETED|Overall Study||16||
48346602|NCT00450580|101176703|FG001|NOT COMPLETED|Overall Study||16||
48346603|NCT01400932|101176704|FG000|STARTED|Overall Study||178||
48346604|NCT01400932|101176705|FG001|STARTED|Overall Study||182||
48346605|NCT01400932|101176704|FG000|COMPLETED|Overall Study||164||
48346606|NCT01400932|101176705|FG001|COMPLETED|Overall Study||167||
48346607|NCT01400932|101176704|FG000|NOT COMPLETED|Overall Study||14||
48346608|NCT01400932|101176705|FG001|NOT COMPLETED|Overall Study||15||
48346609|NCT04672083|101176706|FG000|STARTED|Overall Study||6||
48346610|NCT04672083|101176707|FG001|STARTED|Overall Study||6||
48346611|NCT04672083|101176708|FG002|STARTED|Overall Study||6||
48759234|NCT05138653|102197775|FG013|NOT COMPLETED|Multiple Ascending Dose (Up to 12 Weeks)||1||
48346612|NCT04672083|101176709|FG003|STARTED|Overall Study||6||
48346613|NCT04672083|101176710|FG004|STARTED|Overall Study||8||
48346614|NCT04672083|101176706|FG000|COMPLETED|Overall Study||5||
48346615|NCT04672083|101176707|FG001|COMPLETED|Overall Study||6||
48346616|NCT04672083|101176708|FG002|COMPLETED|Overall Study||6||
48346617|NCT04672083|101176709|FG003|COMPLETED|Overall Study||6||
48346618|NCT04672083|101176710|FG004|COMPLETED|Overall Study||8||
48346619|NCT04672083|101176706|FG000|NOT COMPLETED|Overall Study||1||
48346620|NCT04672083|101176707|FG001|NOT COMPLETED|Overall Study||0||
48346621|NCT04672083|101176708|FG002|NOT COMPLETED|Overall Study||0||
48346622|NCT04672083|101176709|FG003|NOT COMPLETED|Overall Study||0||
48346623|NCT04672083|101176710|FG004|NOT COMPLETED|Overall Study||0||
48346624|NCT00499109|101176711|FG000|STARTED|Overall Study||183||
48346625|NCT00499109|101176712|FG001|STARTED|Overall Study||92||
48346626|NCT00499109|101176711|FG000|COMPLETED|Overall Study||165||
48657000|NCT03769467|101943746|FG001|NOT COMPLETED|Overall Study||6||
48346627|NCT00499109|101176712|FG001|COMPLETED|Overall Study||85||
48346628|NCT00499109|101176711|FG000|NOT COMPLETED|Overall Study||18||
48346629|NCT00499109|101176712|FG001|NOT COMPLETED|Overall Study||7||
48346630|NCT01085682|101176713|FG000|STARTED|Overall Study||31||
48346631|NCT01085682|101176714|FG001|STARTED|Overall Study||28||
48346632|NCT01085682|101176713|FG000|COMPLETED|Overall Study||6||
48346633|NCT01085682|101176714|FG001|COMPLETED|Overall Study||3||
48346634|NCT01085682|101176713|FG000|NOT COMPLETED|Overall Study||25||
48346635|NCT01085682|101176714|FG001|NOT COMPLETED|Overall Study||25||
48346636|NCT01950819|101176715|FG000|STARTED|Overall Study||1022||
48346637|NCT01950819|101176716|FG001|STARTED|Overall Study||1015||
48346638|NCT01950819|101176715|FG000|COMPLETED|Overall Study||893||
48346639|NCT01950819|101176716|FG001|COMPLETED|Overall Study||881||
48346640|NCT01950819|101176715|FG000|NOT COMPLETED|Overall Study||129||
48346641|NCT01950819|101176716|FG001|NOT COMPLETED|Overall Study||134||
48346642|NCT00332202|101176717|FG000|STARTED|Overall Study||504||
48346643|NCT00332202|101176718|FG001|STARTED|Overall Study||254||
48346644|NCT00332202|101176717|FG000|Received At Least One Dose of Study Drug|Overall Study||493||
48346645|NCT00332202|101176718|FG001|Received At Least One Dose of Study Drug|Overall Study||249||
48346646|NCT00332202|101176717|FG000|COMPLETED|Overall Study||263||
48346647|NCT00332202|101176718|FG001|COMPLETED|Overall Study||129||
48346648|NCT00332202|101176717|FG000|NOT COMPLETED|Overall Study||241||
48346649|NCT00332202|101176718|FG001|NOT COMPLETED|Overall Study||125||
48346650|NCT03926143|101176719|FG000|STARTED|Overall Study||9||
48346651|NCT03926143|101176719|FG000|COMPLETED|Overall Study||0||
48346652|NCT03926143|101176719|FG000|NOT COMPLETED|Overall Study||9||
48346653|NCT01228747|101176720|FG000|STARTED|Overall Study||125||
48346654|NCT01228747|101176721|FG001|STARTED|Overall Study||126||
48346655|NCT01228747|101176720|FG000|COMPLETED|Overall Study||60||
48346656|NCT01228747|101176721|FG001|COMPLETED|Overall Study||81||
48346657|NCT01228747|101176720|FG000|NOT COMPLETED|Overall Study||65||
48346658|NCT01228747|101176721|FG001|NOT COMPLETED|Overall Study||45||
48346659|NCT04249882|101176722|FG000|STARTED|Overall Study||19||
48346660|NCT04249882|101176723|FG001|STARTED|Overall Study||19||
48346661|NCT04249882|101176724|FG002|STARTED|Overall Study||15||
48346662|NCT04249882|101176722|FG000|COMPLETED|Overall Study||17||
48346663|NCT04249882|101176723|FG001|COMPLETED|Overall Study||17||
48346664|NCT04249882|101176724|FG002|COMPLETED|Overall Study||14||
48346665|NCT04249882|101176722|FG000|NOT COMPLETED|Overall Study||2||
48346666|NCT04249882|101176723|FG001|NOT COMPLETED|Overall Study||2||
48346667|NCT04249882|101176724|FG002|NOT COMPLETED|Overall Study||1||
48346668|NCT00733902|101176725|FG000|STARTED|Overall Study||174||
48346669|NCT00733902|101176726|FG001|STARTED|Overall Study||174||
48346670|NCT00733902|101176727|FG002|STARTED|Overall Study||174||
48346671|NCT00733902|101176728|FG003|STARTED|Overall Study||175||
48346672|NCT00733902|101176725|FG000|Treated|Overall Study||172||
48346673|NCT00733902|101176726|FG001|Treated|Overall Study||172||
48346674|NCT00733902|101176727|FG002|Treated|Overall Study||172||
48346675|NCT00733902|101176728|FG003|Treated|Overall Study||174||
48346676|NCT00733902|101176725|FG000|COMPLETED|Overall Study||10||
48346677|NCT00733902|101176726|FG001|COMPLETED|Overall Study||12||
48346678|NCT00733902|101176727|FG002|COMPLETED|Overall Study||13||
48346679|NCT00733902|101176728|FG003|COMPLETED|Overall Study||11||
48346680|NCT00733902|101176725|FG000|NOT COMPLETED|Overall Study||164||
48657001|NCT03769467|101943747|FG002|NOT COMPLETED|Overall Study||0||
48346681|NCT00733902|101176726|FG001|NOT COMPLETED|Overall Study||162||
48346682|NCT00733902|101176727|FG002|NOT COMPLETED|Overall Study||161||
48346683|NCT00733902|101176728|FG003|NOT COMPLETED|Overall Study||164||
48346684|NCT03358472|101176729|FG000|STARTED|Overall Study||35||
48346685|NCT03358472|101176730|FG001|STARTED|Overall Study||19||
48346686|NCT03358472|101176731|FG002|STARTED|Overall Study||35||
48346687|NCT03358472|101176729|FG000|Intention-to-Treat (ITT)|Overall Study||35||
48346688|NCT03358472|101176730|FG001|Intention-to-Treat (ITT)|Overall Study||19||
48346689|NCT03358472|101176731|FG002|Intention-to-Treat (ITT)|Overall Study||35||
48346690|NCT03358472|101176729|FG000|All Participants as Treated (APaT)|Overall Study||34||
48346691|NCT03358472|101176730|FG001|All Participants as Treated (APaT)|Overall Study||19||
48346692|NCT03358472|101176731|FG002|All Participants as Treated (APaT)|Overall Study||34||
48346693|NCT03358472|101176729|FG000|COMPLETED|Overall Study||20||
48346694|NCT03358472|101176730|FG001|COMPLETED|Overall Study||9||
48346695|NCT03358472|101176731|FG002|COMPLETED|Overall Study||19||
48346696|NCT03358472|101176729|FG000|NOT COMPLETED|Overall Study||15||
48346697|NCT03358472|101176730|FG001|NOT COMPLETED|Overall Study||10||
48346698|NCT03358472|101176731|FG002|NOT COMPLETED|Overall Study||16||
48346699|NCT01409928|101176732|FG000|STARTED|Overall Study||16||
48346700|NCT01409928|101176732|FG000|COMPLETED|Overall Study||4||
48346701|NCT01409928|101176732|FG000|NOT COMPLETED|Overall Study||12||
48346702|NCT01287754|101176733|FG000|STARTED|Overall Study||3||
48346703|NCT01287754|101176734|FG001|STARTED|Overall Study||21||
48346704|NCT01287754|101176733|FG000|COMPLETED|Overall Study||0||
48346705|NCT01287754|101176734|FG001|COMPLETED|Overall Study||0||
48346706|NCT01287754|101176733|FG000|NOT COMPLETED|Overall Study||3||
48346707|NCT01287754|101176734|FG001|NOT COMPLETED|Overall Study||21||
48346708|NCT02013544|101176735|FG000|STARTED|Overall Study||182||
48346709|NCT02013544|101176736|FG001|STARTED|Overall Study||376||
48346710|NCT02013544|101176735|FG000|Safety Population|Overall Study||180||
48346711|NCT02013544|101176736|FG001|Safety Population|Overall Study||374||
48346712|NCT02013544|101176735|FG000|ITT Population|Overall Study||157||
48346713|NCT02013544|101176736|FG001|ITT Population|Overall Study||325||
48346714|NCT02013544|101176735|FG000|COMPLETED|Overall Study||171||
48346715|NCT02013544|101176736|FG001|COMPLETED|Overall Study||356||
48346716|NCT02013544|101176735|FG000|NOT COMPLETED|Overall Study||11||
48346717|NCT02013544|101176736|FG001|NOT COMPLETED|Overall Study||20||
48346718|NCT02912364|101176737|FG000|STARTED|Treatment 1||23||
48346719|NCT02912364|101176738|FG001|STARTED|Treatment 1||23||
48346720|NCT02912364|101176737|FG000|Received Intervention|Treatment 1||18||
48346721|NCT02912364|101176738|FG001|Received Intervention|Treatment 1||18||
48346722|NCT02912364|101176737|FG000|COMPLETED|Treatment 1||13||
48346723|NCT02912364|101176738|FG001|COMPLETED|Treatment 1||11||
48346724|NCT02912364|101176737|FG000|NOT COMPLETED|Treatment 1||10||
48346725|NCT02912364|101176738|FG001|NOT COMPLETED|Treatment 1||12||
48346726|NCT02912364|101176737|FG000|STARTED|Washout Period||13||
48346727|NCT02912364|101176738|FG001|STARTED|Washout Period||11||
48346728|NCT02912364|101176737|FG000|COMPLETED|Washout Period||13||
48346729|NCT02912364|101176738|FG001|COMPLETED|Washout Period||11||
48346730|NCT02912364|101176737|FG000|NOT COMPLETED|Washout Period||0||
48346731|NCT02912364|101176738|FG001|NOT COMPLETED|Washout Period||0||
48346732|NCT02912364|101176737|FG000|STARTED|Treatment 2||13||
48346733|NCT02912364|101176738|FG001|STARTED|Treatment 2||11||
48346734|NCT02912364|101176737|FG000|Received Intervention|Treatment 2||12||
48346735|NCT02912364|101176738|FG001|Received Intervention|Treatment 2||11||
48346736|NCT02912364|101176737|FG000|COMPLETED|Treatment 2||12||
48346737|NCT02912364|101176738|FG001|COMPLETED|Treatment 2||11||
48346738|NCT02912364|101176737|FG000|NOT COMPLETED|Treatment 2||1||
48346739|NCT02912364|101176738|FG001|NOT COMPLETED|Treatment 2||0||
48346740|NCT02209766|101176739|FG000|STARTED|Overall Study||6||
48346741|NCT02209766|101176740|FG001|STARTED|Overall Study||3||
48346742|NCT02209766|101176741|FG002|STARTED|Overall Study||6||
48346743|NCT02209766|101176742|FG003|STARTED|Overall Study||3||
48346744|NCT02209766|101176743|FG004|STARTED|Overall Study||6||
48346745|NCT02209766|101176739|FG000|COMPLETED|Overall Study||6||
48346746|NCT02209766|101176740|FG001|COMPLETED|Overall Study||3||
48346747|NCT02209766|101176741|FG002|COMPLETED|Overall Study||6||
48346748|NCT02209766|101176742|FG003|COMPLETED|Overall Study||2||
48346749|NCT02209766|101176743|FG004|COMPLETED|Overall Study||6||
48346750|NCT02209766|101176739|FG000|NOT COMPLETED|Overall Study||0||
48346751|NCT02209766|101176740|FG001|NOT COMPLETED|Overall Study||0||
48346752|NCT02209766|101176741|FG002|NOT COMPLETED|Overall Study||0||
48346753|NCT02209766|101176742|FG003|NOT COMPLETED|Overall Study||1||
48346754|NCT02209766|101176743|FG004|NOT COMPLETED|Overall Study||0||
48346755|NCT00935883|101176744|FG000|STARTED|Treatment Period||20||
48346756|NCT00935883|101176745|FG001|STARTED|Treatment Period||40||
48346757|NCT00935883|101176744|FG000|COMPLETED|Treatment Period||19||
48346758|NCT00935883|101176745|FG001|COMPLETED|Treatment Period||38||
48346759|NCT00935883|101176744|FG000|NOT COMPLETED|Treatment Period||1||
48346760|NCT00935883|101176745|FG001|NOT COMPLETED|Treatment Period||2||
48346761|NCT00935883|101176744|FG000|STARTED|Follow-Up Period||19||
48346762|NCT00935883|101176745|FG001|STARTED|Follow-Up Period||38||
48346763|NCT00935883|101176744|FG000|COMPLETED|Follow-Up Period||19||
48346764|NCT00935883|101176745|FG001|COMPLETED|Follow-Up Period||38||
48636770|NCT04470427|101894706|FG003|PP Set|Part B :Open-label||12060|Participants who were randomized in Part A, and were SARS-CoV-2 negative and had no major protocol deviations that impacted critical data.|
48636771|NCT04470427|101894707|FG004|PP Set|Part B :Open-label||14287|Participants who were randomized in Part A, and were SARS-CoV-2 negative and had no major protocol deviations that impacted critical data.|
48636772|NCT04470427|101894708|FG005|PP Set|Part B :Open-label||0|Participants who were randomized in Part A, and were SARS-CoV-2 negative and had no major protocol deviations that impacted critical data.|
48636773|NCT04470427|101894703|FG000|Participants Who Had PDV/Unblinding) and Had the Option to Receive Booster Dose in Part C|Part B :Open-label||0||
48636774|NCT04470427|101894704|FG001|Participants Who Had PDV/Unblinding) and Had the Option to Receive Booster Dose in Part C|Part B :Open-label||0||
48636775|NCT04470427|101894705|FG002|Participants Who Had PDV/Unblinding) and Had the Option to Receive Booster Dose in Part C|Part B :Open-label||1725||
48636776|NCT04470427|101894706|FG003|Participants Who Had PDV/Unblinding) and Had the Option to Receive Booster Dose in Part C|Part B :Open-label||12649||
48759235|NCT05138653|102197776|FG014|NOT COMPLETED|Multiple Ascending Dose (Up to 12 Weeks)||1||
48759236|NCT05138653|102197777|FG015|NOT COMPLETED|Multiple Ascending Dose (Up to 12 Weeks)||1||
48759237|NCT02521285|102197778|FG000|STARTED|Overall Study||10||
48759238|NCT02521285|102197779|FG001|STARTED|Overall Study||11||
48759239|NCT02521285|102197778|FG000|COMPLETED|Overall Study||8||
48759240|NCT02521285|102197779|FG001|COMPLETED|Overall Study||8||
48759241|NCT02521285|102197778|FG000|NOT COMPLETED|Overall Study||2||
48759242|NCT02521285|102197779|FG001|NOT COMPLETED|Overall Study||3||
48759243|NCT04364386|102197780|FG000|STARTED|Overall Study||10||
48759244|NCT04364386|102197780|FG000|COMPLETED|Overall Study||10||
48759245|NCT04364386|102197780|FG000|NOT COMPLETED|Overall Study||0||
48759246|NCT03524612|102197781|FG000|STARTED|Overall Study||105|All patients were included in the Full Analysis Set (FAS) and Safety Set (SAF)|
48759247|NCT03524612|102197781|FG000|COMPLETED|Overall Study||63||
48759248|NCT03524612|102197781|FG000|NOT COMPLETED|Overall Study||42||
48759249|NCT00995761|102197782|FG000|STARTED|Overall Study||48||
48759250|NCT00995761|102197782|FG000|COMPLETED|Overall Study||48||
48759251|NCT00995761|102197782|FG000|NOT COMPLETED|Overall Study||0||
48759252|NCT04065048|102197783|FG000|STARTED|Overall Study||18||
48759253|NCT04065048|102197784|FG001|STARTED|Overall Study||17||
48759254|NCT04065048|102197785|FG002|STARTED|Overall Study||16||
48759255|NCT04065048|102197786|FG003|STARTED|Overall Study||16||
48759256|NCT04065048|102197783|FG000|COMPLETED|Overall Study||16||
48759257|NCT04065048|102197784|FG001|COMPLETED|Overall Study||15||
48759258|NCT04065048|102197785|FG002|COMPLETED|Overall Study||14||
48759259|NCT04065048|102197786|FG003|COMPLETED|Overall Study||15||
48759260|NCT04065048|102197783|FG000|NOT COMPLETED|Overall Study||2||
48759261|NCT04065048|102197784|FG001|NOT COMPLETED|Overall Study||2||
48759262|NCT04065048|102197785|FG002|NOT COMPLETED|Overall Study||2||
48759263|NCT04065048|102197786|FG003|NOT COMPLETED|Overall Study||1||
48759264|NCT02955589|102197787|FG000|STARTED|Overall Study||23||
48759265|NCT02955589|102197787|FG000|COMPLETED|Overall Study||23||
48759266|NCT02955589|102197787|FG000|NOT COMPLETED|Overall Study||0||
48759267|NCT01584232|102197788|FG000|STARTED|Overall Study||181||
48759268|NCT01584232|102197789|FG001|STARTED|Overall Study||180||
48759269|NCT01584232|102197788|FG000|Received at Least 1 Dose of Study Drug|Overall Study||181||
48759270|NCT01584232|102197789|FG001|Received at Least 1 Dose of Study Drug|Overall Study||180||
48759271|NCT01584232|102197788|FG000|COMPLETED|Overall Study||173||
48759272|NCT01584232|102197789|FG001|COMPLETED|Overall Study||177||
48759273|NCT01584232|102197788|FG000|NOT COMPLETED|Overall Study||8||
48759274|NCT01584232|102197789|FG001|NOT COMPLETED|Overall Study||3||
48759275|NCT03466918|102197790|FG000|STARTED|Overall Study||58||
48759276|NCT03466918|102197790|FG000|Analysis Population|Overall Study||50|8/58 patients were roll-in patients. Roll-in patients were not included in the analysis.|
48759277|NCT03466918|102197790|FG000|COMPLETED|Overall Study||58||
48759278|NCT03466918|102197790|FG000|NOT COMPLETED|Overall Study||0||
48759279|NCT05358366|102197791|FG000|STARTED|Overall Study||31||
48759280|NCT05358366|102197792|FG001|STARTED|Overall Study||27||
48759281|NCT05358366|102197791|FG000|Completed Follow-Up 1 (Month 1)|Overall Study||26||
48759282|NCT05358366|102197792|FG001|Completed Follow-Up 1 (Month 1)|Overall Study||26||
48346765|NCT00935883|101176744|FG000|NOT COMPLETED|Follow-Up Period||0||
48636777|NCT04470427|101894707|FG004|Participants Who Had PDV/Unblinding) and Had the Option to Receive Booster Dose in Part C|Part B :Open-label||14661||
48636778|NCT04470427|101894708|FG005|Participants Who Had PDV/Unblinding) and Had the Option to Receive Booster Dose in Part C|Part B :Open-label||0||
48346766|NCT00935883|101176745|FG001|NOT COMPLETED|Follow-Up Period||0||
48346767|NCT00518349|101176746|FG000|STARTED|Overall Study||60||
48346768|NCT00518349|101176747|FG001|STARTED|Overall Study||60||
48346769|NCT00518349|101176746|FG000|COMPLETED|Overall Study||60||
48346770|NCT00518349|101176747|FG001|COMPLETED|Overall Study||60||
48346771|NCT00518349|101176746|FG000|NOT COMPLETED|Overall Study||0||
48636779|NCT04470427|101894703|FG000|COMPLETED|Part B :Open-label||0|Completed Part B (from first dose up to PDV/unblinding) and had the option to receive booster dose in Part C.|
48636780|NCT04470427|101894704|FG001|COMPLETED|Part B :Open-label||0|Completed Part B (from first dose up to PDV/unblinding) and had the option to receive booster dose in Part C.|
48636781|NCT04470427|101894705|FG002|COMPLETED|Part B :Open-label||149|Completed Part B (from first dose up to PDV/unblinding) and had the option to receive booster dose in Part C.|
48636782|NCT04470427|101894706|FG003|COMPLETED|Part B :Open-label||10464|Completed Part B (from first dose up to PDV/unblinding) and had the option to receive booster dose in Part C.|
48636783|NCT04470427|101894707|FG004|COMPLETED|Part B :Open-label||10171|Completed Part B (from first dose up to PDV/unblinding) and had the option to receive booster dose in Part C.|
48636784|NCT04470427|101894708|FG005|COMPLETED|Part B :Open-label||0|Completed Part B (from first dose up to PDV/unblinding) and had the option to receive booster dose in Part C.|
48346772|NCT00518349|101176747|FG001|NOT COMPLETED|Overall Study||0||
48636785|NCT04470427|101894703|FG000|NOT COMPLETED|Part B :Open-label||0||
48636786|NCT04470427|101894704|FG001|NOT COMPLETED|Part B :Open-label||0||
48636787|NCT04470427|101894705|FG002|NOT COMPLETED|Part B :Open-label||2364||
48636788|NCT04470427|101894706|FG003|NOT COMPLETED|Part B :Open-label||2185||
48636789|NCT04470427|101894707|FG004|NOT COMPLETED|Part B :Open-label||5013||
48636790|NCT04470427|101894708|FG005|NOT COMPLETED|Part B :Open-label||0||
48636791|NCT04470427|101894703|FG000|STARTED|Part C: Booster||0|Safety Set: Participants who continued from Part B and opted to receive a booster dose.in Part C.|
48636792|NCT04470427|101894704|FG001|STARTED|Part C: Booster||0|Safety Set: Participants who continued from Part B and opted to receive a booster dose.in Part C.|
48636793|NCT04470427|101894705|FG002|STARTED|Part C: Booster||0|Safety Set: Participants who continued from Part B and opted to receive a booster dose.in Part C.|
48636794|NCT04470427|101894706|FG003|STARTED|Part C: Booster||0|Safety Set: Participants who continued from Part B and opted to receive a booster dose.in Part C.|
48636795|NCT04470427|101894707|FG004|STARTED|Part C: Booster||0|Safety Set: Participants who continued from Part B and opted to receive a booster dose.in Part C.|
48636796|NCT04470427|101894708|FG005|STARTED|Part C: Booster||19609|Safety Set: Participants who continued from Part B and opted to receive a booster dose.in Part C.|
48636797|NCT04470427|101894703|FG000|PP Set|Part C: Booster||0|Participants who were randomized in Part A, previously receiving 2 doses of mRNA-1273, then received mRNA-1273 booster in Part C, and were pre-booster SARS-CoV-2 negative and had no major protocol deviations that impacted critical data.|
48346773|NCT02022826|101176748|FG000|STARTED|Overall Study||167||
48346774|NCT02022826|101176748|FG000|COMPLETED|Overall Study||139||
48346775|NCT02022826|101176748|FG000|NOT COMPLETED|Overall Study||28||
48346776|NCT02500537|101176749|FG000|STARTED|Overall Study||60||
48346777|NCT02500537|101176750|FG001|STARTED|Overall Study||40||
48346778|NCT02500537|101176749|FG000|COMPLETED|Overall Study||57||
48346779|NCT02500537|101176750|FG001|COMPLETED|Overall Study||39||
48346780|NCT02500537|101176749|FG000|NOT COMPLETED|Overall Study||3||
48346781|NCT02500537|101176750|FG001|NOT COMPLETED|Overall Study||1||
48636798|NCT04470427|101894704|FG001|PP Set|Part C: Booster||0|Participants who were randomized in Part A, previously receiving 2 doses of mRNA-1273, then received mRNA-1273 booster in Part C, and were pre-booster SARS-CoV-2 negative and had no major protocol deviations that impacted critical data.|
48636799|NCT04470427|101894705|FG002|PP Set|Part C: Booster||0|Participants who were randomized in Part A, previously receiving 2 doses of mRNA-1273, then received mRNA-1273 booster in Part C, and were pre-booster SARS-CoV-2 negative and had no major protocol deviations that impacted critical data.|
48636800|NCT04470427|101894706|FG003|PP Set|Part C: Booster||0|Participants who were randomized in Part A, previously receiving 2 doses of mRNA-1273, then received mRNA-1273 booster in Part C, and were pre-booster SARS-CoV-2 negative and had no major protocol deviations that impacted critical data.|
48636801|NCT04470427|101894707|FG004|PP Set|Part C: Booster||0|Participants who were randomized in Part A, previously receiving 2 doses of mRNA-1273, then received mRNA-1273 booster in Part C, and were pre-booster SARS-CoV-2 negative and had no major protocol deviations that impacted critical data.|
48636802|NCT04470427|101894708|FG005|PP Set|Part C: Booster||16368|Participants who were randomized in Part A, previously receiving 2 doses of mRNA-1273, then received mRNA-1273 booster in Part C, and were pre-booster SARS-CoV-2 negative and had no major protocol deviations that impacted critical data.|
48636803|NCT04470427|101894703|FG000|PP Immunogenicity Subset (PPIS)|Part C: Booster||0|Participants who were in PPRSI in Part A, randomized and received 2 doses of mRNA-1273 in Part A, were SARS-CoV-2 negative at baseline, received booster in Part C, and had no major protocol deviations that impacted critical data.|
48636804|NCT04470427|101894704|FG001|PP Immunogenicity Subset (PPIS)|Part C: Booster||0|Participants who were in PPRSI in Part A, randomized and received 2 doses of mRNA-1273 in Part A, were SARS-CoV-2 negative at baseline, received booster in Part C, and had no major protocol deviations that impacted critical data.|
48636805|NCT04470427|101894705|FG002|PP Immunogenicity Subset (PPIS)|Part C: Booster||0|Participants who were in PPRSI in Part A, randomized and received 2 doses of mRNA-1273 in Part A, were SARS-CoV-2 negative at baseline, received booster in Part C, and had no major protocol deviations that impacted critical data.|
48657002|NCT04743206|101943748|FG000|STARTED|SOC Airway Clearance Device ( VEST)||1||
48657122|NCT03745313|101943783|FG000|STARTED|At 1 Year Follow-up||51||
48759283|NCT05358366|102197791|FG000|Completed Follow-Up 2 (Month 4)|Overall Study||25||
48759284|NCT05358366|102197792|FG001|Completed Follow-Up 2 (Month 4)|Overall Study||23||
48759285|NCT05358366|102197791|FG000|COMPLETED|Overall Study||25||
48759286|NCT05358366|102197792|FG001|COMPLETED|Overall Study||23||
48759287|NCT05358366|102197791|FG000|NOT COMPLETED|Overall Study||6||
48759288|NCT05358366|102197792|FG001|NOT COMPLETED|Overall Study||4||
48759289|NCT03629886|102197793|FG000|STARTED|Overall Study||1671||
48759290|NCT03629886|102197794|FG001|STARTED|Overall Study||1866||
48346782|NCT01755169|101180552|FG000|STARTED|Overall Study||2||
48346783|NCT01755169|101180553|FG001|STARTED|Overall Study||1||
48759291|NCT03629886|102197793|FG000|COMPLETED|Overall Study||1671||
48759292|NCT03629886|102197794|FG001|COMPLETED|Overall Study||1686||
48759293|NCT03629886|102197793|FG000|NOT COMPLETED|Overall Study||0||
48759294|NCT03629886|102197794|FG001|NOT COMPLETED|Overall Study||180||
48759295|NCT01339832|102197795|FG000|STARTED|Overall Study||51||
48759296|NCT01339832|102197795|FG000|COMPLETED|Overall Study||37||
48759297|NCT01339832|102197795|FG000|NOT COMPLETED|Overall Study||14||
48759298|NCT05164120|102197796|FG000|STARTED|Overall Study||20||
48759299|NCT05164120|102197797|FG001|STARTED|Overall Study||20||
48759300|NCT05164120|102197796|FG000|COMPLETED|Overall Study||18||
48759301|NCT05164120|102197797|FG001|COMPLETED|Overall Study||18||
48759302|NCT05164120|102197796|FG000|NOT COMPLETED|Overall Study||2||
48759303|NCT05164120|102197797|FG001|NOT COMPLETED|Overall Study||2||
48759304|NCT03638453|102197798|FG000|STARTED|Overall Study||20||
48759305|NCT03638453|102197799|FG001|STARTED|Overall Study||20||
48759306|NCT03638453|102197798|FG000|COMPLETED|Overall Study||20||
48759307|NCT03638453|102197799|FG001|COMPLETED|Overall Study||20||
48759308|NCT03638453|102197798|FG000|NOT COMPLETED|Overall Study||0||
48759309|NCT03638453|102197799|FG001|NOT COMPLETED|Overall Study||0||
48759310|NCT00558142|102197800|FG000|STARTED|Overall Study||10||
48759311|NCT00558142|102197801|FG001|STARTED|Overall Study||13||
48759312|NCT00558142|102197802|FG002|STARTED|Overall Study||8||
48759313|NCT00558142|102197803|FG003|STARTED|Overall Study||76||
48759314|NCT00558142|102197800|FG000|COMPLETED|Overall Study||8||
48759315|NCT00558142|102197801|FG001|COMPLETED|Overall Study||8||
48759316|NCT00558142|102197802|FG002|COMPLETED|Overall Study||8||
48759317|NCT00558142|102197803|FG003|COMPLETED|Overall Study||66||
48759318|NCT00558142|102197800|FG000|NOT COMPLETED|Overall Study||2||
48759319|NCT00558142|102197801|FG001|NOT COMPLETED|Overall Study||5||
48759320|NCT00558142|102197802|FG002|NOT COMPLETED|Overall Study||0||
48759321|NCT00558142|102197803|FG003|NOT COMPLETED|Overall Study||10||
48759322|NCT01614249|102197804|FG000|STARTED|Overall Study||107||
48759323|NCT01614249|102197805|FG001|STARTED|Overall Study||109||
48759324|NCT01614249|102197804|FG000|At Week-4|Overall Study||98||
48759325|NCT01614249|102197805|FG001|At Week-4|Overall Study||92||
48759326|NCT01614249|102197804|FG000|At Week-8 (End of Study Period)|Overall Study||96||
48759327|NCT01614249|102197805|FG001|At Week-8 (End of Study Period)|Overall Study||86||
48346784|NCT01755169|101180554|FG002|STARTED|Overall Study||0||
48346785|NCT01755169|101180555|FG003|STARTED|Overall Study||1||
48636806|NCT04470427|101894706|FG003|PP Immunogenicity Subset (PPIS)|Part C: Booster||0|Participants who were in PPRSI in Part A, randomized and received 2 doses of mRNA-1273 in Part A, were SARS-CoV-2 negative at baseline, received booster in Part C, and had no major protocol deviations that impacted critical data.|
48636807|NCT04470427|101894707|FG004|PP Immunogenicity Subset (PPIS)|Part C: Booster||0|Participants who were in PPRSI in Part A, randomized and received 2 doses of mRNA-1273 in Part A, were SARS-CoV-2 negative at baseline, received booster in Part C, and had no major protocol deviations that impacted critical data.|
48657003|NCT04743206|101943748|FG000|COMPLETED|SOC Airway Clearance Device ( VEST)||1||
48657004|NCT04743206|101943748|FG000|NOT COMPLETED|SOC Airway Clearance Device ( VEST)||0||
48759328|NCT01614249|102197804|FG000|COMPLETED|Overall Study||96||
48759329|NCT01614249|102197805|FG001|COMPLETED|Overall Study||86||
48759330|NCT01614249|102197804|FG000|NOT COMPLETED|Overall Study||11||
48759331|NCT01614249|102197805|FG001|NOT COMPLETED|Overall Study||23||
48759332|NCT02633059|102197806|FG000|STARTED|Overall Study||4||
48759333|NCT02633059|102197807|FG001|STARTED|Overall Study||7||
48759334|NCT02633059|102197808|FG002|STARTED|Overall Study||4||
48759335|NCT02633059|102197809|FG003|STARTED|Overall Study||18||
48759336|NCT02633059|102197806|FG000|COMPLETED|Overall Study||4||
48759337|NCT02633059|102197807|FG001|COMPLETED|Overall Study||6||
48759338|NCT02633059|102197808|FG002|COMPLETED|Overall Study||4||
48759339|NCT02633059|102197809|FG003|COMPLETED|Overall Study||16||
48759340|NCT02633059|102197806|FG000|NOT COMPLETED|Overall Study||0||
48759341|NCT02633059|102197807|FG001|NOT COMPLETED|Overall Study||1||
48759342|NCT02633059|102197808|FG002|NOT COMPLETED|Overall Study||0||
48759343|NCT02633059|102197809|FG003|NOT COMPLETED|Overall Study||2||
48759344|NCT02620774|102197810|FG000|STARTED|Overall Study||10||
48759345|NCT02620774|102197811|FG001|STARTED|Overall Study||6||
48759346|NCT02620774|102197810|FG000|COMPLETED|Overall Study||10||
48759347|NCT02620774|102197811|FG001|COMPLETED|Overall Study||6||
48759348|NCT02620774|102197810|FG000|NOT COMPLETED|Overall Study||0||
48759349|NCT02620774|102197811|FG001|NOT COMPLETED|Overall Study||0||
48759350|NCT02183675|102197812|FG000|STARTED|Treatment Period 1 (10 Days)||6||
48759351|NCT02183675|102197813|FG001|STARTED|Treatment Period 1 (10 Days)||6||
48759352|NCT02183675|102197814|FG002|STARTED|Treatment Period 1 (10 Days)||6||
48759353|NCT02183675|102197815|FG003|STARTED|Treatment Period 1 (10 Days)||6||
48759354|NCT02183675|102197816|FG004|STARTED|Treatment Period 1 (10 Days)||6||
48759355|NCT02183675|102197817|FG005|STARTED|Treatment Period 1 (10 Days)||6||
48759356|NCT02183675|102197812|FG000|COMPLETED|Treatment Period 1 (10 Days)||6||
48759357|NCT02183675|102197813|FG001|COMPLETED|Treatment Period 1 (10 Days)||6||
48759358|NCT02183675|102197814|FG002|COMPLETED|Treatment Period 1 (10 Days)||6||
48759359|NCT02183675|102197815|FG003|COMPLETED|Treatment Period 1 (10 Days)||6||
48759360|NCT02183675|102197816|FG004|COMPLETED|Treatment Period 1 (10 Days)||6||
48759361|NCT02183675|102197817|FG005|COMPLETED|Treatment Period 1 (10 Days)||6||
48759362|NCT02183675|102197812|FG000|NOT COMPLETED|Treatment Period 1 (10 Days)||0||
48759363|NCT02183675|102197813|FG001|NOT COMPLETED|Treatment Period 1 (10 Days)||0||
48759364|NCT02183675|102197814|FG002|NOT COMPLETED|Treatment Period 1 (10 Days)||0||
48759365|NCT02183675|102197815|FG003|NOT COMPLETED|Treatment Period 1 (10 Days)||0||
48759366|NCT02183675|102197816|FG004|NOT COMPLETED|Treatment Period 1 (10 Days)||0||
48759367|NCT02183675|102197817|FG005|NOT COMPLETED|Treatment Period 1 (10 Days)||0||
48759368|NCT02183675|102197812|FG000|STARTED|Treatment Period 2 (10 Days)||6||
48759369|NCT02183675|102197813|FG001|STARTED|Treatment Period 2 (10 Days)||6||
48759370|NCT02183675|102197814|FG002|STARTED|Treatment Period 2 (10 Days)||6||
48759371|NCT02183675|102197815|FG003|STARTED|Treatment Period 2 (10 Days)||6||
48185378|NCT01474512|100775953|FG016|Relapsed Population Received Drug|Maintenance Period||0||
48185379|NCT01474512|100775954|FG017|Relapsed Population Received Drug|Maintenance Period||0||
48185380|NCT01474512|100775937|FG000|Relapsed Population Completers|Maintenance Period||0||
48185381|NCT01474512|100775938|FG001|Relapsed Population Completers|Maintenance Period||0||
48185382|NCT01474512|100775939|FG002|Relapsed Population Completers|Maintenance Period||0||
48185383|NCT01474512|100775940|FG003|Relapsed Population Completers|Maintenance Period||0||
48185384|NCT01474512|100775941|FG004|Relapsed Population Completers|Maintenance Period||0||
48185385|NCT01474512|100775942|FG005|Relapsed Population Completers|Maintenance Period||0||
48185386|NCT01474512|100775943|FG006|Relapsed Population Completers|Maintenance Period||0||
48185387|NCT01474512|100775944|FG007|Relapsed Population Completers|Maintenance Period||0||
48185388|NCT01474512|100775945|FG008|Relapsed Population Completers|Maintenance Period||0||
48185389|NCT01474512|100775946|FG009|Relapsed Population Completers|Maintenance Period||0||
48185390|NCT01474512|100775947|FG010|Relapsed Population Completers|Maintenance Period||321||
48185391|NCT01474512|100775948|FG011|Relapsed Population Completers|Maintenance Period||0||
48185392|NCT01474512|100775949|FG012|Relapsed Population Completers|Maintenance Period||0||
48636808|NCT04470427|101894708|FG005|PP Immunogenicity Subset (PPIS)|Part C: Booster||731|Participants who were in PPRSI in Part A, randomized and received 2 doses of mRNA-1273 in Part A, were SARS-CoV-2 negative at baseline, received booster in Part C, and had no major protocol deviations that impacted critical data.|
48636809|NCT04470427|101894703|FG000|PPIS-Negative (Neg)|Part C: Booster||0|Participants who were in Part C PPIS and were pre-booster SARS-CoV-2 negative (as determined by non-positive RT-PCR test and negative serology anti-SARS-CoV-2 assay test on or before BD-Day 1).|
48636810|NCT04470427|101894704|FG001|PPIS-Negative (Neg)|Part C: Booster||0|Participants who were in Part C PPIS and were pre-booster SARS-CoV-2 negative (as determined by non-positive RT-PCR test and negative serology anti-SARS-CoV-2 assay test on or before BD-Day 1).|
48636811|NCT04470427|101894705|FG002|PPIS-Negative (Neg)|Part C: Booster||0|Participants who were in Part C PPIS and were pre-booster SARS-CoV-2 negative (as determined by non-positive RT-PCR test and negative serology anti-SARS-CoV-2 assay test on or before BD-Day 1).|
48657005|NCT04743206|101943748|FG000|STARTED|PIAPD||1||
48657006|NCT04743206|101943748|FG000|COMPLETED|PIAPD||1||
48657007|NCT04743206|101943748|FG000|NOT COMPLETED|PIAPD||0||
48185393|NCT01474512|100775950|FG013|Relapsed Population Completers|Maintenance Period||0||
48185394|NCT01474512|100775951|FG014|Relapsed Population Completers|Maintenance Period||0||
48185395|NCT01474512|100775952|FG015|Relapsed Population Completers|Maintenance Period||0||
48185396|NCT01474512|100775953|FG016|Relapsed Population Completers|Maintenance Period||0||
48185397|NCT01474512|100775954|FG017|Relapsed Population Completers|Maintenance Period||0||
48185398|NCT01474512|100775937|FG000|COMPLETED|Maintenance Period||0||
48185399|NCT01474512|100775938|FG001|COMPLETED|Maintenance Period||0||
48185400|NCT01474512|100775939|FG002|COMPLETED|Maintenance Period||0||
48185401|NCT01474512|100775940|FG003|COMPLETED|Maintenance Period||24||
48185402|NCT01474512|100775941|FG004|COMPLETED|Maintenance Period||108||
48185403|NCT01474512|100775942|FG005|COMPLETED|Maintenance Period||177||
48185404|NCT01474512|100775943|FG006|COMPLETED|Maintenance Period||6||
48185405|NCT01474512|100775944|FG007|COMPLETED|Maintenance Period||350||
48185406|NCT01474512|100775945|FG008|COMPLETED|Maintenance Period||62||
48185407|NCT01474512|100775946|FG009|COMPLETED|Maintenance Period||44||
48185408|NCT01474512|100775947|FG010|COMPLETED|Maintenance Period||0||
48185409|NCT01474512|100775948|FG011|COMPLETED|Maintenance Period||0||
48185410|NCT01474512|100775949|FG012|COMPLETED|Maintenance Period||0||
48185411|NCT01474512|100775950|FG013|COMPLETED|Maintenance Period||0||
48185412|NCT01474512|100775951|FG014|COMPLETED|Maintenance Period||0||
48185413|NCT01474512|100775952|FG015|COMPLETED|Maintenance Period||0||
48185414|NCT01474512|100775953|FG016|COMPLETED|Maintenance Period||0||
48185415|NCT01474512|100775954|FG017|COMPLETED|Maintenance Period||0||
48185416|NCT01474512|100775937|FG000|NOT COMPLETED|Maintenance Period||0||
48185417|NCT01474512|100775938|FG001|NOT COMPLETED|Maintenance Period||0||
48185418|NCT01474512|100775939|FG002|NOT COMPLETED|Maintenance Period||0||
48185419|NCT01474512|100775940|FG003|NOT COMPLETED|Maintenance Period||202||
48185420|NCT01474512|100775941|FG004|NOT COMPLETED|Maintenance Period||119||
48185421|NCT01474512|100775942|FG005|NOT COMPLETED|Maintenance Period||52||
48185422|NCT01474512|100775943|FG006|NOT COMPLETED|Maintenance Period||10||
48185423|NCT01474512|100775944|FG007|NOT COMPLETED|Maintenance Period||41||
48185424|NCT01474512|100775945|FG008|NOT COMPLETED|Maintenance Period||16||
48185425|NCT01474512|100775946|FG009|NOT COMPLETED|Maintenance Period||18||
48185426|NCT01474512|100775947|FG010|NOT COMPLETED|Maintenance Period||0||
48185427|NCT01474512|100775948|FG011|NOT COMPLETED|Maintenance Period||0||
48185428|NCT01474512|100775949|FG012|NOT COMPLETED|Maintenance Period||0||
48185429|NCT01474512|100775950|FG013|NOT COMPLETED|Maintenance Period||0||
48185430|NCT01474512|100775951|FG014|NOT COMPLETED|Maintenance Period||0||
48185431|NCT01474512|100775952|FG015|NOT COMPLETED|Maintenance Period||0||
48185432|NCT01474512|100775953|FG016|NOT COMPLETED|Maintenance Period||0||
48185433|NCT01474512|100775954|FG017|NOT COMPLETED|Maintenance Period||0||
48185434|NCT01474512|100775937|FG000|STARTED|Long-Term Extension Period||0||
48185435|NCT01474512|100775938|FG001|STARTED|Long-Term Extension Period||0||
48185436|NCT01474512|100775939|FG002|STARTED|Long-Term Extension Period||0||
48185437|NCT01474512|100775940|FG003|STARTED|Long-Term Extension Period||0||
48185438|NCT01474512|100775941|FG004|STARTED|Long-Term Extension Period||0||
48185439|NCT01474512|100775942|FG005|STARTED|Long-Term Extension Period||0||
48185440|NCT01474512|100775943|FG006|STARTED|Long-Term Extension Period||0||
48185441|NCT01474512|100775944|FG007|STARTED|Long-Term Extension Period||0||
48346786|NCT01755169|101180552|FG000|COMPLETED|Overall Study||2||
48346787|NCT01755169|101180553|FG001|COMPLETED|Overall Study||1||
48346788|NCT01755169|101180554|FG002|COMPLETED|Overall Study||0||
48346789|NCT01755169|101180555|FG003|COMPLETED|Overall Study||1||
48346790|NCT01755169|101180552|FG000|NOT COMPLETED|Overall Study||0||
48346791|NCT01755169|101180553|FG001|NOT COMPLETED|Overall Study||0||
48185442|NCT01474512|100775945|FG008|STARTED|Long-Term Extension Period||0||
48185443|NCT01474512|100775946|FG009|STARTED|Long-Term Extension Period||0||
48185444|NCT01474512|100775947|FG010|STARTED|Long-Term Extension Period||0||
48185445|NCT01474512|100775948|FG011|STARTED|Long-Term Extension Period||26||
48185446|NCT01474512|100775949|FG012|STARTED|Long-Term Extension Period||1054||
48185447|NCT01474512|100775950|FG013|STARTED|Long-Term Extension Period||1075||
48185448|NCT01474512|100775951|FG014|STARTED|Long-Term Extension Period||0||
48185449|NCT01474512|100775952|FG015|STARTED|Long-Term Extension Period||0||
48185450|NCT01474512|100775953|FG016|STARTED|Long-Term Extension Period||0||
48185451|NCT01474512|100775954|FG017|STARTED|Long-Term Extension Period||0||
48185452|NCT01474512|100775937|FG000|COMPLETED|Long-Term Extension Period||0||
48185453|NCT01474512|100775938|FG001|COMPLETED|Long-Term Extension Period||0||
48185454|NCT01474512|100775939|FG002|COMPLETED|Long-Term Extension Period||0||
48185455|NCT01474512|100775940|FG003|COMPLETED|Long-Term Extension Period||0||
48185456|NCT01474512|100775941|FG004|COMPLETED|Long-Term Extension Period||0||
48185457|NCT01474512|100775942|FG005|COMPLETED|Long-Term Extension Period||0||
48185458|NCT01474512|100775943|FG006|COMPLETED|Long-Term Extension Period||0||
48185459|NCT01474512|100775944|FG007|COMPLETED|Long-Term Extension Period||0||
48185460|NCT01474512|100775945|FG008|COMPLETED|Long-Term Extension Period||0||
48185461|NCT01474512|100775946|FG009|COMPLETED|Long-Term Extension Period||0||
48185462|NCT01474512|100775947|FG010|COMPLETED|Long-Term Extension Period||0||
48185463|NCT01474512|100775948|FG011|COMPLETED|Long-Term Extension Period||0||
48185464|NCT01474512|100775949|FG012|COMPLETED|Long-Term Extension Period||836||
48346792|NCT01755169|101180554|FG002|NOT COMPLETED|Overall Study||0||
48346793|NCT01755169|101180555|FG003|NOT COMPLETED|Overall Study||0||
48346794|NCT01193335|101180556|FG000|STARTED|Infant Series||100||
48346795|NCT01193335|101180557|FG001|STARTED|Infant Series||100||
48346796|NCT01193335|101180556|FG000|COMPLETED|Infant Series||100||
48346797|NCT01193335|101180557|FG001|COMPLETED|Infant Series||100||
48415487|NCT02089191|101350294|FG001|STARTED|Period 2, Second 12 Hours||15||
48415488|NCT02089191|101350293|FG000|COMPLETED|Period 2, Second 12 Hours||15||
48415489|NCT02089191|101350294|FG001|COMPLETED|Period 2, Second 12 Hours||15||
48415490|NCT02089191|101350293|FG000|NOT COMPLETED|Period 2, Second 12 Hours||0||
48415491|NCT02089191|101350294|FG001|NOT COMPLETED|Period 2, Second 12 Hours||0||
48415492|NCT02061540|101350295|FG000|STARTED|Overall Study||27||
48415493|NCT02061540|101350295|FG000|Down-Titrated on LUM001 During the Study|Overall Study||5||
48185465|NCT01474512|100775950|FG013|COMPLETED|Long-Term Extension Period||855||
48185466|NCT01474512|100775951|FG014|COMPLETED|Long-Term Extension Period||0||
48185467|NCT01474512|100775952|FG015|COMPLETED|Long-Term Extension Period||0||
48185468|NCT01474512|100775953|FG016|COMPLETED|Long-Term Extension Period||0||
48185469|NCT01474512|100775954|FG017|COMPLETED|Long-Term Extension Period||0||
48185470|NCT01474512|100775937|FG000|NOT COMPLETED|Long-Term Extension Period||0||
48346798|NCT01193335|101180556|FG000|NOT COMPLETED|Infant Series||0||
48346799|NCT01193335|101180557|FG001|NOT COMPLETED|Infant Series||0||
48346800|NCT01193335|101180556|FG000|STARTED|After Infant Series||100||
48346801|NCT01193335|101180557|FG001|STARTED|After Infant Series||100||
48346802|NCT01193335|101180556|FG000|COMPLETED|After Infant Series||99||
48346803|NCT01193335|101180557|FG001|COMPLETED|After Infant Series||97||
48346804|NCT01193335|101180556|FG000|NOT COMPLETED|After Infant Series||1||
48346805|NCT01193335|101180557|FG001|NOT COMPLETED|After Infant Series||3||
48346806|NCT01193335|101180556|FG000|STARTED|Toddler Dose||99||
48346807|NCT01193335|101180557|FG001|STARTED|Toddler Dose||97||
48346808|NCT01193335|101180556|FG000|COMPLETED|Toddler Dose||99||
48346809|NCT01193335|101180557|FG001|COMPLETED|Toddler Dose||97||
48346810|NCT01193335|101180556|FG000|NOT COMPLETED|Toddler Dose||0||
48346811|NCT01193335|101180557|FG001|NOT COMPLETED|Toddler Dose||0||
48346812|NCT01193335|101180556|FG000|STARTED|1-Year Follow-up||99||
48415494|NCT02061540|101350295|FG000|COMPLETED|Overall Study||23||
48415495|NCT02061540|101350295|FG000|NOT COMPLETED|Overall Study||4||
48185471|NCT01474512|100775938|FG001|NOT COMPLETED|Long-Term Extension Period||0||
48185472|NCT01474512|100775939|FG002|NOT COMPLETED|Long-Term Extension Period||0||
48185473|NCT01474512|100775940|FG003|NOT COMPLETED|Long-Term Extension Period||0||
48185474|NCT01474512|100775941|FG004|NOT COMPLETED|Long-Term Extension Period||0||
48185475|NCT01474512|100775942|FG005|NOT COMPLETED|Long-Term Extension Period||0||
48185476|NCT01474512|100775943|FG006|NOT COMPLETED|Long-Term Extension Period||0||
48185477|NCT01474512|100775944|FG007|NOT COMPLETED|Long-Term Extension Period||0||
48185478|NCT01474512|100775945|FG008|NOT COMPLETED|Long-Term Extension Period||0||
48185479|NCT01474512|100775946|FG009|NOT COMPLETED|Long-Term Extension Period||0||
48185480|NCT01474512|100775947|FG010|NOT COMPLETED|Long-Term Extension Period||0||
48185481|NCT01474512|100775948|FG011|NOT COMPLETED|Long-Term Extension Period||26||
48185482|NCT01474512|100775949|FG012|NOT COMPLETED|Long-Term Extension Period||218||
48185483|NCT01474512|100775950|FG013|NOT COMPLETED|Long-Term Extension Period||220||
48185484|NCT01474512|100775951|FG014|NOT COMPLETED|Long-Term Extension Period||0||
48185485|NCT01474512|100775952|FG015|NOT COMPLETED|Long-Term Extension Period||0||
48185486|NCT01474512|100775953|FG016|NOT COMPLETED|Long-Term Extension Period||0||
48185487|NCT01474512|100775954|FG017|NOT COMPLETED|Long-Term Extension Period||0||
48185488|NCT01474512|100775937|FG000|STARTED|Post-Treatment Follow-Up||0||
48185489|NCT01474512|100775938|FG001|STARTED|Post-Treatment Follow-Up||0||
48185490|NCT01474512|100775939|FG002|STARTED|Post-Treatment Follow-Up||0||
48185491|NCT01474512|100775940|FG003|STARTED|Post-Treatment Follow-Up||0||
48185492|NCT01474512|100775941|FG004|STARTED|Post-Treatment Follow-Up||0||
48185493|NCT01474512|100775942|FG005|STARTED|Post-Treatment Follow-Up||0||
48185494|NCT01474512|100775943|FG006|STARTED|Post-Treatment Follow-Up||0||
48185495|NCT01474512|100775944|FG007|STARTED|Post-Treatment Follow-Up||0||
48185496|NCT01474512|100775945|FG008|STARTED|Post-Treatment Follow-Up||0||
48185497|NCT01474512|100775946|FG009|STARTED|Post-Treatment Follow-Up||0||
48185498|NCT01474512|100775947|FG010|STARTED|Post-Treatment Follow-Up||0||
48185499|NCT01474512|100775948|FG011|STARTED|Post-Treatment Follow-Up||0||
48185500|NCT01474512|100775949|FG012|STARTED|Post-Treatment Follow-Up||0||
48185501|NCT01474512|100775950|FG013|STARTED|Post-Treatment Follow-Up||0||
48185502|NCT01474512|100775951|FG014|STARTED|Post-Treatment Follow-Up||18||
48185503|NCT01474512|100775952|FG015|STARTED|Post-Treatment Follow-Up||25||
48185504|NCT01474512|100775953|FG016|STARTED|Post-Treatment Follow-Up||700||
48185505|NCT01474512|100775954|FG017|STARTED|Post-Treatment Follow-Up||285||
48185506|NCT01474512|100775937|FG000|COMPLETED|Post-Treatment Follow-Up||0||
48185507|NCT01474512|100775938|FG001|COMPLETED|Post-Treatment Follow-Up||0||
48185508|NCT01474512|100775939|FG002|COMPLETED|Post-Treatment Follow-Up||0||
48185509|NCT01474512|100775940|FG003|COMPLETED|Post-Treatment Follow-Up||0||
48185510|NCT01474512|100775941|FG004|COMPLETED|Post-Treatment Follow-Up||0||
48185511|NCT01474512|100775942|FG005|COMPLETED|Post-Treatment Follow-Up||0||
48185512|NCT01474512|100775943|FG006|COMPLETED|Post-Treatment Follow-Up||0||
48185513|NCT01474512|100775944|FG007|COMPLETED|Post-Treatment Follow-Up||0||
48185514|NCT01474512|100775945|FG008|COMPLETED|Post-Treatment Follow-Up||0||
48185515|NCT01474512|100775946|FG009|COMPLETED|Post-Treatment Follow-Up||0||
48185516|NCT01474512|100775947|FG010|COMPLETED|Post-Treatment Follow-Up||0||
48185517|NCT01474512|100775948|FG011|COMPLETED|Post-Treatment Follow-Up||0||
48185518|NCT01474512|100775949|FG012|COMPLETED|Post-Treatment Follow-Up||0||
48185519|NCT01474512|100775950|FG013|COMPLETED|Post-Treatment Follow-Up||0||
48185520|NCT01474512|100775951|FG014|COMPLETED|Post-Treatment Follow-Up||0||
48185521|NCT01474512|100775952|FG015|COMPLETED|Post-Treatment Follow-Up||17||
48185522|NCT01474512|100775953|FG016|COMPLETED|Post-Treatment Follow-Up||544||
48185523|NCT01474512|100775954|FG017|COMPLETED|Post-Treatment Follow-Up||239||
48185524|NCT01474512|100775937|FG000|NOT COMPLETED|Post-Treatment Follow-Up||0||
48185525|NCT01474512|100775938|FG001|NOT COMPLETED|Post-Treatment Follow-Up||0||
48185526|NCT01474512|100775939|FG002|NOT COMPLETED|Post-Treatment Follow-Up||0||
48185527|NCT01474512|100775940|FG003|NOT COMPLETED|Post-Treatment Follow-Up||0||
48185528|NCT01474512|100775941|FG004|NOT COMPLETED|Post-Treatment Follow-Up||0||
48185529|NCT01474512|100775942|FG005|NOT COMPLETED|Post-Treatment Follow-Up||0||
48185530|NCT01474512|100775943|FG006|NOT COMPLETED|Post-Treatment Follow-Up||0||
48185531|NCT01474512|100775944|FG007|NOT COMPLETED|Post-Treatment Follow-Up||0||
48185532|NCT01474512|100775945|FG008|NOT COMPLETED|Post-Treatment Follow-Up||0||
48185533|NCT01474512|100775946|FG009|NOT COMPLETED|Post-Treatment Follow-Up||0||
48185534|NCT01474512|100775947|FG010|NOT COMPLETED|Post-Treatment Follow-Up||0||
48185535|NCT01474512|100775948|FG011|NOT COMPLETED|Post-Treatment Follow-Up||0||
48185536|NCT01474512|100775949|FG012|NOT COMPLETED|Post-Treatment Follow-Up||0||
48185537|NCT01474512|100775950|FG013|NOT COMPLETED|Post-Treatment Follow-Up||0||
48185538|NCT01474512|100775951|FG014|NOT COMPLETED|Post-Treatment Follow-Up||18||
48185539|NCT01474512|100775952|FG015|NOT COMPLETED|Post-Treatment Follow-Up||8||
48185540|NCT01474512|100775953|FG016|NOT COMPLETED|Post-Treatment Follow-Up||156||
48185541|NCT01474512|100775954|FG017|NOT COMPLETED|Post-Treatment Follow-Up||46||
48185542|NCT00664521|100775955|FG000|STARTED|Overall Study||18||
48185543|NCT00664521|100775956|FG001|STARTED|Overall Study||9||
48185544|NCT00664521|100775955|FG000|COMPLETED|Overall Study||12||
48185545|NCT00664521|100775956|FG001|COMPLETED|Overall Study||8||
48185546|NCT00664521|100775955|FG000|NOT COMPLETED|Overall Study||6||
48185547|NCT00664521|100775956|FG001|NOT COMPLETED|Overall Study||1||
48185548|NCT02402764|100775957|FG000|STARTED|Overall Study||10||
48185549|NCT02402764|100775957|FG000|COMPLETED|Overall Study||10||
48185550|NCT02402764|100775957|FG000|NOT COMPLETED|Overall Study||0||
48185551|NCT01256476|100775958|FG000|STARTED|Overall Study||164||
48185552|NCT01256476|100775959|FG001|STARTED|Overall Study||164||
48185553|NCT01256476|100775958|FG000|COMPLETED|Overall Study||158||
48185554|NCT01256476|100775959|FG001|COMPLETED|Overall Study||157||
48185555|NCT01256476|100775958|FG000|NOT COMPLETED|Overall Study||6||
48185556|NCT01256476|100775959|FG001|NOT COMPLETED|Overall Study||7||
48185557|NCT00654940|100775960|FG000|STARTED|Period 1||13||
48185558|NCT00654940|100775961|FG001|STARTED|Period 1||12||
48185559|NCT00654940|100775960|FG000|Received Study Treatment|Period 1||12||
48185560|NCT00654940|100775961|FG001|Received Study Treatment|Period 1||12||
48185561|NCT00654940|100775960|FG000|COMPLETED|Period 1||12||
48185562|NCT00654940|100775961|FG001|COMPLETED|Period 1||11||
48185563|NCT00654940|100775960|FG000|NOT COMPLETED|Period 1||1||
48185564|NCT00654940|100775961|FG001|NOT COMPLETED|Period 1||1||
48185565|NCT00654940|100775960|FG000|STARTED|Washout Period of 2 Weeks||12||
48185566|NCT00654940|100775961|FG001|STARTED|Washout Period of 2 Weeks||11||
48185567|NCT00654940|100775960|FG000|COMPLETED|Washout Period of 2 Weeks||12||
48185568|NCT00654940|100775961|FG001|COMPLETED|Washout Period of 2 Weeks||11||
48185569|NCT00654940|100775960|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0||
48185570|NCT00654940|100775961|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0||
48185571|NCT00654940|100775960|FG000|STARTED|Period 2||12||
48185572|NCT00654940|100775961|FG001|STARTED|Period 2||11||
48185573|NCT00654940|100775960|FG000|COMPLETED|Period 2||12||
48185574|NCT00654940|100775961|FG001|COMPLETED|Period 2||11||
48185575|NCT00654940|100775960|FG000|NOT COMPLETED|Period 2||0||
48185576|NCT00654940|100775961|FG001|NOT COMPLETED|Period 2||0||
48185577|NCT02696785|100775962|FG000|STARTED|Blinded Treatment Period||87||
48185578|NCT02696785|100775963|FG001|STARTED|Blinded Treatment Period||90||
48185579|NCT02696785|100775964|FG002|STARTED|Blinded Treatment Period||83||
48185580|NCT02696785|100775965|FG003|STARTED|Blinded Treatment Period||81||
48185581|NCT02696785|100775962|FG000|Received at Least One Dose of Study Drug|Blinded Treatment Period||86||
48185582|NCT02696785|100775963|FG001|Received at Least One Dose of Study Drug|Blinded Treatment Period||90||
48657008|NCT02657551|101943749|FG000|STARTED|Overall Study||8||
48185583|NCT02696785|100775964|FG002|Received at Least One Dose of Study Drug|Blinded Treatment Period||83||
48185584|NCT02696785|100775965|FG003|Received at Least One Dose of Study Drug|Blinded Treatment Period||81||
48185585|NCT02696785|100775962|FG000|COMPLETED|Blinded Treatment Period||86||
48185586|NCT02696785|100775963|FG001|COMPLETED|Blinded Treatment Period||88||
48185587|NCT02696785|100775964|FG002|COMPLETED|Blinded Treatment Period||79||
48185588|NCT02696785|100775965|FG003|COMPLETED|Blinded Treatment Period||78||
48185589|NCT02696785|100775962|FG000|NOT COMPLETED|Blinded Treatment Period||1||
48185590|NCT02696785|100775963|FG001|NOT COMPLETED|Blinded Treatment Period||2||
48185591|NCT02696785|100775964|FG002|NOT COMPLETED|Blinded Treatment Period||4||
48185592|NCT02696785|100775965|FG003|NOT COMPLETED|Blinded Treatment Period||3||
48185593|NCT02696785|100775962|FG000|STARTED|Washout Period||0||
48185594|NCT02696785|100775963|FG001|STARTED|Washout Period||88||
48185595|NCT02696785|100775964|FG002|STARTED|Washout Period||0||
48185596|NCT02696785|100775965|FG003|STARTED|Washout Period||0||
48185597|NCT02696785|100775962|FG000|COMPLETED|Washout Period||0||
48185598|NCT02696785|100775963|FG001|COMPLETED|Washout Period||86||
48185599|NCT02696785|100775964|FG002|COMPLETED|Washout Period||0||
48185600|NCT02696785|100775965|FG003|COMPLETED|Washout Period||0||
48185601|NCT02696785|100775962|FG000|NOT COMPLETED|Washout Period||0||
48185602|NCT02696785|100775963|FG001|NOT COMPLETED|Washout Period||2||
48185603|NCT02696785|100775964|FG002|NOT COMPLETED|Washout Period||0||
48185604|NCT02696785|100775965|FG003|NOT COMPLETED|Washout Period||0||
48185605|NCT02696785|100775962|FG000|STARTED|Extended Treatment Period||86||
48185606|NCT02696785|100775963|FG001|STARTED|Extended Treatment Period||86||
48185607|NCT02696785|100775964|FG002|STARTED|Extended Treatment Period||79||
48185608|NCT02696785|100775965|FG003|STARTED|Extended Treatment Period||78||
48185609|NCT02696785|100775962|FG000|COMPLETED|Extended Treatment Period||83||
48185610|NCT02696785|100775963|FG001|COMPLETED|Extended Treatment Period||80||
48185611|NCT02696785|100775964|FG002|COMPLETED|Extended Treatment Period||74||
48185612|NCT02696785|100775965|FG003|COMPLETED|Extended Treatment Period||72||
48657009|NCT02657551|101943749|FG000|COMPLETED|Overall Study||0||
48657010|NCT02657551|101943749|FG000|NOT COMPLETED|Overall Study||8||
48185613|NCT02696785|100775962|FG000|NOT COMPLETED|Extended Treatment Period||3||
48185614|NCT02696785|100775963|FG001|NOT COMPLETED|Extended Treatment Period||6||
48185615|NCT02696785|100775964|FG002|NOT COMPLETED|Extended Treatment Period||5||
48185616|NCT02696785|100775965|FG003|NOT COMPLETED|Extended Treatment Period||6||
48185617|NCT02696785|100775962|FG000|STARTED|Follow-up Period||1||
48185618|NCT02696785|100775963|FG001|STARTED|Follow-up Period||0||
48346813|NCT01193335|101180557|FG001|STARTED|1-Year Follow-up||97||
48185619|NCT02696785|100775964|FG002|STARTED|Follow-up Period||24||
48185620|NCT02696785|100775965|FG003|STARTED|Follow-up Period||16||
48185621|NCT02696785|100775962|FG000|COMPLETED|Follow-up Period||0||
48185622|NCT02696785|100775963|FG001|COMPLETED|Follow-up Period||0||
48185623|NCT02696785|100775964|FG002|COMPLETED|Follow-up Period||11||
48185624|NCT02696785|100775965|FG003|COMPLETED|Follow-up Period||8||
48185625|NCT02696785|100775962|FG000|NOT COMPLETED|Follow-up Period||1||
48185626|NCT02696785|100775963|FG001|NOT COMPLETED|Follow-up Period||0||
48185627|NCT02696785|100775964|FG002|NOT COMPLETED|Follow-up Period||13||
48185628|NCT02696785|100775965|FG003|NOT COMPLETED|Follow-up Period||8||
48185629|NCT00083174|100775966|FG000|STARTED|Randomization Period||2285||
48185630|NCT00083174|100775967|FG001|STARTED|Randomization Period||2275||
48185631|NCT00083174|100775968|FG002|STARTED|Randomization Period||0||
48185632|NCT00083174|100775966|FG000|COMPLETED|Randomization Period||2285||
48185633|NCT00083174|100775967|FG001|COMPLETED|Randomization Period||2275||
48185634|NCT00083174|100775968|FG002|COMPLETED|Randomization Period||0||
48346814|NCT01193335|101180556|FG000|COMPLETED|1-Year Follow-up||88||
48346815|NCT01193335|101180557|FG001|COMPLETED|1-Year Follow-up||88||
48346816|NCT01193335|101180556|FG000|NOT COMPLETED|1-Year Follow-up||11||
48346817|NCT01193335|101180557|FG001|NOT COMPLETED|1-Year Follow-up||9||
48346818|NCT01193335|101180556|FG000|STARTED|2-Year Follow-up||88||
48346819|NCT01193335|101180557|FG001|STARTED|2-Year Follow-up||88||
48415496|NCT02109939|101350296|FG000|STARTED|Overall Study||681||
48415497|NCT02109939|101350297|FG001|STARTED|Overall Study||717||
48185635|NCT00083174|100775966|FG000|NOT COMPLETED|Randomization Period||0||
48185636|NCT00083174|100775967|FG001|NOT COMPLETED|Randomization Period||0||
48185637|NCT00083174|100775968|FG002|NOT COMPLETED|Randomization Period||0||
48185638|NCT00083174|100775966|FG000|STARTED|Open-label Extension||0||
48185639|NCT00083174|100775967|FG001|STARTED|Open-label Extension||0||
48185640|NCT00083174|100775968|FG002|STARTED|Open-label Extension||2831||
48185641|NCT00083174|100775966|FG000|COMPLETED|Open-label Extension||0||
48185642|NCT00083174|100775967|FG001|COMPLETED|Open-label Extension||0||
48185643|NCT00083174|100775968|FG002|COMPLETED|Open-label Extension||2831||
48185644|NCT00083174|100775966|FG000|NOT COMPLETED|Open-label Extension||0||
48185645|NCT00083174|100775967|FG001|NOT COMPLETED|Open-label Extension||0||
48185646|NCT00083174|100775968|FG002|NOT COMPLETED|Open-label Extension||0||
48185647|NCT00765362|100775969|FG000|STARTED|Overall Study||419||
48185648|NCT00765362|100775969|FG000|COMPLETED|Overall Study||282||
48415498|NCT02109939|101350296|FG000|COMPLETED|Overall Study||560||
48636812|NCT04470427|101894706|FG003|PPIS-Negative (Neg)|Part C: Booster||0|Participants who were in Part C PPIS and were pre-booster SARS-CoV-2 negative (as determined by non-positive RT-PCR test and negative serology anti-SARS-CoV-2 assay test on or before BD-Day 1).|
48636813|NCT04470427|101894707|FG004|PPIS-Negative (Neg)|Part C: Booster||0|Participants who were in Part C PPIS and were pre-booster SARS-CoV-2 negative (as determined by non-positive RT-PCR test and negative serology anti-SARS-CoV-2 assay test on or before BD-Day 1).|
48636814|NCT04470427|101894708|FG005|PPIS-Negative (Neg)|Part C: Booster||682|Participants who were in Part C PPIS and were pre-booster SARS-CoV-2 negative (as determined by non-positive RT-PCR test and negative serology anti-SARS-CoV-2 assay test on or before BD-Day 1).|
48636815|NCT04470427|101894703|FG000|COMPLETED|Part C: Booster||0|Participants are considered to have completed the study if they complete the final visit at Day 759 (Month 25), 24 months following their receipt of the original second dose of investigational product (IP) (where original refers to the IP received following randomization).|
48636816|NCT04470427|101894704|FG001|COMPLETED|Part C: Booster||0|Participants are considered to have completed the study if they complete the final visit at Day 759 (Month 25), 24 months following their receipt of the original second dose of investigational product (IP) (where original refers to the IP received following randomization).|
48636817|NCT04470427|101894705|FG002|COMPLETED|Part C: Booster||0|Participants are considered to have completed the study if they complete the final visit at Day 759 (Month 25), 24 months following their receipt of the original second dose of investigational product (IP) (where original refers to the IP received following randomization).|
48185649|NCT00765362|100775969|FG000|NOT COMPLETED|Overall Study||137||
48185650|NCT04648891|100775970|FG000|STARTED|First Experimental Visit||5||
48185651|NCT04648891|100775971|FG001|STARTED|First Experimental Visit||8||
48185652|NCT04648891|100775972|FG002|STARTED|First Experimental Visit||6||
48185653|NCT04648891|100775973|FG003|STARTED|First Experimental Visit||5||
48185654|NCT04648891|100775974|FG004|STARTED|First Experimental Visit||2||
48185655|NCT04648891|100775975|FG005|STARTED|First Experimental Visit||6||
48185656|NCT04648891|100775970|FG000|COMPLETED|First Experimental Visit||5||
48185657|NCT04648891|100775971|FG001|COMPLETED|First Experimental Visit||8||
48346820|NCT01193335|101180556|FG000|COMPLETED|2-Year Follow-up||81||
48346821|NCT01193335|101180557|FG001|COMPLETED|2-Year Follow-up||80||
48346822|NCT01193335|101180556|FG000|NOT COMPLETED|2-Year Follow-up||7||
48346823|NCT01193335|101180557|FG001|NOT COMPLETED|2-Year Follow-up||8||
48346824|NCT00686543|101180558|FG000|STARTED|Overall Study||14||
48346825|NCT00686543|101180559|FG001|STARTED|Overall Study||21||
48346826|NCT00686543|101180560|FG002|STARTED|Overall Study||20||
48346827|NCT00686543|101180561|FG003|STARTED|Overall Study||20||
48346828|NCT00686543|101180558|FG000|COMPLETED|Overall Study||0||
48346829|NCT00686543|101180559|FG001|COMPLETED|Overall Study||20||
48346830|NCT00686543|101180560|FG002|COMPLETED|Overall Study||15||
48346831|NCT00686543|101180561|FG003|COMPLETED|Overall Study||17||
48346832|NCT00686543|101180558|FG000|NOT COMPLETED|Overall Study||14||
48346833|NCT00686543|101180559|FG001|NOT COMPLETED|Overall Study||1||
48346834|NCT00686543|101180560|FG002|NOT COMPLETED|Overall Study||5||
48346835|NCT00686543|101180561|FG003|NOT COMPLETED|Overall Study||3||
48346836|NCT01495988|101180562|FG000|STARTED|Vem +/- Bev (Protocol v2.0)||0||
48346837|NCT01495988|101180563|FG001|STARTED|Vem +/- Bev (Protocol v2.0)||0||
48346838|NCT01495988|101180564|FG002|STARTED|Vem +/- Bev (Protocol v2.0)||5||
48346839|NCT01495988|101180565|FG003|STARTED|Vem +/- Bev (Protocol v2.0)||3||
48346840|NCT01495988|101180562|FG000|COMPLETED|Vem +/- Bev (Protocol v2.0)||0||
48346841|NCT01495988|101180563|FG001|COMPLETED|Vem +/- Bev (Protocol v2.0)||0||
48346842|NCT01495988|101180564|FG002|COMPLETED|Vem +/- Bev (Protocol v2.0)||5||
48415499|NCT02109939|101350297|FG001|COMPLETED|Overall Study||607||
48346843|NCT01495988|101180565|FG003|COMPLETED|Vem +/- Bev (Protocol v2.0)||3||
48346844|NCT01495988|101180562|FG000|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0||
48346845|NCT01495988|101180563|FG001|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0||
48346846|NCT01495988|101180564|FG002|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0||
48346847|NCT01495988|101180565|FG003|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0||
48346848|NCT01495988|101180562|FG000|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0||
48346849|NCT01495988|101180563|FG001|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||2||
48346850|NCT01495988|101180564|FG002|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0||
48346851|NCT01495988|101180565|FG003|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0||
48346852|NCT01495988|101180562|FG000|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0||
48346853|NCT01495988|101180563|FG001|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||2||
48346854|NCT01495988|101180564|FG002|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0||
48346855|NCT01495988|101180565|FG003|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0||
48346856|NCT01495988|101180562|FG000|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0||
48415500|NCT02109939|101350296|FG000|NOT COMPLETED|Overall Study||121||
48415501|NCT02109939|101350297|FG001|NOT COMPLETED|Overall Study||110||
48415502|NCT02850276|101350298|FG000|STARTED|Overall Study||76||
48415503|NCT02850276|101350298|FG000|COMPLETED|Overall Study||15||
48415504|NCT02850276|101350298|FG000|NOT COMPLETED|Overall Study||61||
48415505|NCT03598140|101350299|FG000|STARTED|Overall Study||10||
48415506|NCT03598140|101350300|FG001|STARTED|Overall Study||11||
48415507|NCT03598140|101350299|FG000|COMPLETED|Overall Study||9||
48415508|NCT03598140|101350300|FG001|COMPLETED|Overall Study||11||
48415509|NCT03598140|101350299|FG000|NOT COMPLETED|Overall Study||1||
48415510|NCT03598140|101350300|FG001|NOT COMPLETED|Overall Study||0||
48415511|NCT00033293|101350301|FG000|STARTED|Overall Study||26||
48415512|NCT00033293|101350302|FG001|STARTED|Overall Study||27||
48415513|NCT00033293|101350301|FG000|COMPLETED|Overall Study||16||
48415514|NCT00033293|101350302|FG001|COMPLETED|Overall Study||9||
48415515|NCT00033293|101350301|FG000|NOT COMPLETED|Overall Study||10||
48415516|NCT00033293|101350302|FG001|NOT COMPLETED|Overall Study||18||
48415517|NCT02481986|101350303|FG000|STARTED|Overall Study||108||
48415518|NCT02481986|101350304|FG001|STARTED|Overall Study||115||
48415519|NCT02481986|101350303|FG000|COMPLETED|Overall Study||103||
48415520|NCT02481986|101350304|FG001|COMPLETED|Overall Study||106||
48346857|NCT01495988|101180563|FG001|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0||
48346858|NCT01495988|101180564|FG002|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0||
48346859|NCT01495988|101180565|FG003|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0||
48346860|NCT00609622|101180566|FG000|STARTED|Overall Study||96||
48346861|NCT00609622|101180567|FG001|STARTED|Overall Study||95||
48346862|NCT00609622|101180566|FG000|COMPLETED|Overall Study||0||
48346863|NCT00609622|101180567|FG001|COMPLETED|Overall Study||0||
48346864|NCT00609622|101180566|FG000|NOT COMPLETED|Overall Study||96||
48346865|NCT00609622|101180567|FG001|NOT COMPLETED|Overall Study||95||
48346866|NCT01530243|101180568|FG000|STARTED|Overall Study||26||
48346867|NCT01530243|101180569|FG001|STARTED|Overall Study||26||
48346868|NCT01530243|101180570|FG002|STARTED|Overall Study||26||
48346869|NCT01530243|101180571|FG003|STARTED|Overall Study||26||
48346870|NCT01530243|101180568|FG000|COMPLETED|Overall Study||24||
48346871|NCT01530243|101180569|FG001|COMPLETED|Overall Study||23||
48346872|NCT01530243|101180570|FG002|COMPLETED|Overall Study||23||
48346873|NCT01530243|101180571|FG003|COMPLETED|Overall Study||24||
48346874|NCT01530243|101180568|FG000|NOT COMPLETED|Overall Study||2||
48346875|NCT01530243|101180569|FG001|NOT COMPLETED|Overall Study||3||
48346876|NCT01530243|101180570|FG002|NOT COMPLETED|Overall Study||3||
48346877|NCT01530243|101180571|FG003|NOT COMPLETED|Overall Study||2||
48346878|NCT02547623|101180572|FG000|STARTED|Overall Study||126||
48346879|NCT02547623|101180573|FG001|STARTED|Overall Study||55||
48346880|NCT02547623|101180572|FG000|COMPLETED|Overall Study||122||
48346881|NCT02547623|101180573|FG001|COMPLETED|Overall Study||52||
48346882|NCT02547623|101180572|FG000|NOT COMPLETED|Overall Study||4||
48346883|NCT02547623|101180573|FG001|NOT COMPLETED|Overall Study||3||
48346884|NCT02698189|101180574|FG000|STARTED|Overall Study||3||
48346885|NCT02698189|101180575|FG001|STARTED|Overall Study||6||
48346886|NCT02698189|101180574|FG000|COMPLETED|Overall Study||0||
48346887|NCT02698189|101180575|FG001|COMPLETED|Overall Study||0||
48346888|NCT02698189|101180574|FG000|NOT COMPLETED|Overall Study||3||
48346889|NCT02698189|101180575|FG001|NOT COMPLETED|Overall Study||6||
48415521|NCT02481986|101350303|FG000|NOT COMPLETED|Overall Study||5||
48415522|NCT02481986|101350304|FG001|NOT COMPLETED|Overall Study||9||
48415523|NCT00826540|101350305|FG000|STARTED|Overall Study||83||
48415524|NCT00826540|101350305|FG000|COMPLETED|Overall Study||79||
48346890|NCT00469079|101180576|FG000|STARTED|Overall Study||27||
48346891|NCT00469079|101180577|FG001|STARTED|Overall Study||52||
48346892|NCT00469079|101180578|FG002|STARTED|Overall Study||51||
48346893|NCT00469079|101180576|FG000|COMPLETED|Overall Study||18||
48346894|NCT00469079|101180577|FG001|COMPLETED|Overall Study||30||
48346895|NCT00469079|101180578|FG002|COMPLETED|Overall Study||32||
48346896|NCT00469079|101180576|FG000|NOT COMPLETED|Overall Study||9||
48346897|NCT00469079|101180577|FG001|NOT COMPLETED|Overall Study||22||
48346898|NCT00469079|101180578|FG002|NOT COMPLETED|Overall Study||19||
48346899|NCT05292755|101180579|FG000|STARTED|Overall Study||40||
48415525|NCT00826540|101350305|FG000|NOT COMPLETED|Overall Study||4||
48346900|NCT05292755|101180580|FG001|STARTED|Overall Study||40||
48346901|NCT05292755|101180579|FG000|COMPLETED|Overall Study||35||
48346902|NCT05292755|101180580|FG001|COMPLETED|Overall Study||31||
48346903|NCT05292755|101180579|FG000|NOT COMPLETED|Overall Study||5||
48346904|NCT05292755|101180580|FG001|NOT COMPLETED|Overall Study||9||
48346905|NCT00502840|101180581|FG000|STARTED|Overall Study||193||
48346906|NCT00502840|101180581|FG000|COMPLETED|Overall Study||93||
48346907|NCT00502840|101180581|FG000|NOT COMPLETED|Overall Study||100||
48346908|NCT00624234|101180582|FG000|STARTED|Overall Study||8||
48346909|NCT00624234|101180583|FG001|STARTED|Overall Study||9||
48346910|NCT00624234|101180584|FG002|STARTED|Overall Study||26||
48346911|NCT00624234|101180585|FG003|STARTED|Overall Study||14||
48346912|NCT00624234|101180586|FG004|STARTED|Overall Study||18||
48346913|NCT00624234|101180587|FG005|STARTED|Overall Study||14||
48346914|NCT00624234|101180582|FG000|COMPLETED|Overall Study||8||
48346915|NCT00624234|101180583|FG001|COMPLETED|Overall Study||9||
48346916|NCT00624234|101180584|FG002|COMPLETED|Overall Study||26||
48346917|NCT00624234|101180585|FG003|COMPLETED|Overall Study||14||
48346918|NCT00624234|101180586|FG004|COMPLETED|Overall Study||18||
48346919|NCT00624234|101180587|FG005|COMPLETED|Overall Study||14||
48346920|NCT00624234|101180582|FG000|NOT COMPLETED|Overall Study||0||
48346921|NCT00624234|101180583|FG001|NOT COMPLETED|Overall Study||0||
48346922|NCT00624234|101180584|FG002|NOT COMPLETED|Overall Study||0||
48346923|NCT00624234|101180585|FG003|NOT COMPLETED|Overall Study||0||
48346924|NCT00624234|101180586|FG004|NOT COMPLETED|Overall Study||0||
48346925|NCT00624234|101180587|FG005|NOT COMPLETED|Overall Study||0||
48657011|NCT01840163|101943750|FG000|STARTED|First Follow up -Primary Outcome||267||
48759372|NCT02183675|102197816|FG004|STARTED|Treatment Period 2 (10 Days)||6||
48759373|NCT02183675|102197817|FG005|STARTED|Treatment Period 2 (10 Days)||6||
48759374|NCT02183675|102197812|FG000|COMPLETED|Treatment Period 2 (10 Days)||6||
48759375|NCT02183675|102197813|FG001|COMPLETED|Treatment Period 2 (10 Days)||6||
48759376|NCT02183675|102197814|FG002|COMPLETED|Treatment Period 2 (10 Days)||6||
48759377|NCT02183675|102197815|FG003|COMPLETED|Treatment Period 2 (10 Days)||6||
48759378|NCT02183675|102197816|FG004|COMPLETED|Treatment Period 2 (10 Days)||6||
48759379|NCT02183675|102197817|FG005|COMPLETED|Treatment Period 2 (10 Days)||4||
48759380|NCT02183675|102197812|FG000|NOT COMPLETED|Treatment Period 2 (10 Days)||0||
48759381|NCT02183675|102197813|FG001|NOT COMPLETED|Treatment Period 2 (10 Days)||0||
48759382|NCT02183675|102197814|FG002|NOT COMPLETED|Treatment Period 2 (10 Days)||0||
48759383|NCT02183675|102197815|FG003|NOT COMPLETED|Treatment Period 2 (10 Days)||0||
48759384|NCT02183675|102197816|FG004|NOT COMPLETED|Treatment Period 2 (10 Days)||0||
48759385|NCT02183675|102197817|FG005|NOT COMPLETED|Treatment Period 2 (10 Days)||2||
48759386|NCT02183675|102197812|FG000|STARTED|Treatment Period 3 (10 Days)||6||
48759387|NCT02183675|102197813|FG001|STARTED|Treatment Period 3 (10 Days)||6||
48759388|NCT02183675|102197814|FG002|STARTED|Treatment Period 3 (10 Days)||6||
48759389|NCT02183675|102197815|FG003|STARTED|Treatment Period 3 (10 Days)||6||
48346926|NCT02661594|101180588|FG000|STARTED|Overall Study||10||
48346927|NCT02661594|101180589|FG001|STARTED|Overall Study||11||
48346928|NCT02661594|101180590|FG002|STARTED|Overall Study||10||
48346929|NCT02661594|101180591|FG003|STARTED|Overall Study||9||
48346930|NCT02661594|101180588|FG000|COMPLETED|Overall Study||9||
48346931|NCT02661594|101180589|FG001|COMPLETED|Overall Study||11||
48346932|NCT02661594|101180590|FG002|COMPLETED|Overall Study||9||
48346933|NCT02661594|101180591|FG003|COMPLETED|Overall Study||9||
48346934|NCT02661594|101180588|FG000|NOT COMPLETED|Overall Study||1||
48346935|NCT02661594|101180589|FG001|NOT COMPLETED|Overall Study||0||
48346936|NCT02661594|101180590|FG002|NOT COMPLETED|Overall Study||1||
48346937|NCT02661594|101180591|FG003|NOT COMPLETED|Overall Study||0||
48346938|NCT01696357|101180592|FG000|STARTED|Overall Study||42||
48346939|NCT01696357|101180593|FG001|STARTED|Overall Study||42||
48346940|NCT01696357|101180592|FG000|COMPLETED|Overall Study||40||
48346941|NCT01696357|101180593|FG001|COMPLETED|Overall Study||41||
48346942|NCT01696357|101180592|FG000|NOT COMPLETED|Overall Study||2||
48346943|NCT01696357|101180593|FG001|NOT COMPLETED|Overall Study||1||
48346944|NCT01412229|101180594|FG000|STARTED|Overall Study||39||
48346945|NCT01412229|101180594|FG000|COMPLETED|Overall Study||38||
48346946|NCT01412229|101180594|FG000|NOT COMPLETED|Overall Study||1||
48346947|NCT01892722|101180595|FG000|STARTED|Overall Study||107||
48346948|NCT01892722|101180596|FG001|STARTED|Overall Study||108||
48346949|NCT01892722|101180595|FG000|Full Analysis Set|Overall Study||107||
48346950|NCT01892722|101180596|FG001|Full Analysis Set|Overall Study||107||
48346951|NCT01892722|101180595|FG000|COMPLETED|Overall Study||100||
48346952|NCT01892722|101180596|FG001|COMPLETED|Overall Study||88||
48346953|NCT01892722|101180595|FG000|NOT COMPLETED|Overall Study||7||
48346954|NCT01892722|101180596|FG001|NOT COMPLETED|Overall Study||20||
48346955|NCT00642642|101180597|FG000|STARTED|Biopsy & Product Manufacture||122||
48346956|NCT00642642|101180597|FG000|COMPLETED|Biopsy & Product Manufacture||109||
48346957|NCT00642642|101180597|FG000|NOT COMPLETED|Biopsy & Product Manufacture||13||
48346958|NCT00642642|101180597|FG000|STARTED|Treatment & Follow Up||109||
48346959|NCT00642642|101180597|FG000|COMPLETED|Treatment & Follow Up||92||
48346960|NCT00642642|101180597|FG000|NOT COMPLETED|Treatment & Follow Up||17||
48346961|NCT01678976|101180598|FG000|STARTED|First Period||6||
48759390|NCT02183675|102197816|FG004|STARTED|Treatment Period 3 (10 Days)||6||
48759391|NCT02183675|102197817|FG005|STARTED|Treatment Period 3 (10 Days)||4||
48759392|NCT02183675|102197812|FG000|COMPLETED|Treatment Period 3 (10 Days)||6||
48759393|NCT02183675|102197813|FG001|COMPLETED|Treatment Period 3 (10 Days)||6||
48759394|NCT02183675|102197814|FG002|COMPLETED|Treatment Period 3 (10 Days)||6||
48759395|NCT02183675|102197815|FG003|COMPLETED|Treatment Period 3 (10 Days)||6||
48759396|NCT02183675|102197816|FG004|COMPLETED|Treatment Period 3 (10 Days)||6||
48759397|NCT02183675|102197817|FG005|COMPLETED|Treatment Period 3 (10 Days)||4||
48759398|NCT02183675|102197812|FG000|NOT COMPLETED|Treatment Period 3 (10 Days)||0||
48759399|NCT02183675|102197813|FG001|NOT COMPLETED|Treatment Period 3 (10 Days)||0||
48759400|NCT02183675|102197814|FG002|NOT COMPLETED|Treatment Period 3 (10 Days)||0||
48759401|NCT02183675|102197815|FG003|NOT COMPLETED|Treatment Period 3 (10 Days)||0||
48759402|NCT02183675|102197816|FG004|NOT COMPLETED|Treatment Period 3 (10 Days)||0||
48759403|NCT02183675|102197817|FG005|NOT COMPLETED|Treatment Period 3 (10 Days)||0||
48759404|NCT02891174|102197818|FG000|STARTED|First Intervention (24 Hours)||20||
48759405|NCT02891174|102197819|FG001|STARTED|First Intervention (24 Hours)||23||
48759406|NCT02891174|102197818|FG000|Received First Intervention|First Intervention (24 Hours)||19||
48759407|NCT02891174|102197819|FG001|Received First Intervention|First Intervention (24 Hours)||18||
48759408|NCT02891174|102197818|FG000|COMPLETED|First Intervention (24 Hours)||17||
48759409|NCT02891174|102197819|FG001|COMPLETED|First Intervention (24 Hours)||10||
48759410|NCT02891174|102197818|FG000|NOT COMPLETED|First Intervention (24 Hours)||3||
48759411|NCT02891174|102197819|FG001|NOT COMPLETED|First Intervention (24 Hours)||13||
48759412|NCT02891174|102197818|FG000|STARTED|Second Intervention (24 Hours)||17||
48759413|NCT02891174|102197819|FG001|STARTED|Second Intervention (24 Hours)||10||
48759414|NCT02891174|102197818|FG000|COMPLETED|Second Intervention (24 Hours)||11||
48759415|NCT02891174|102197819|FG001|COMPLETED|Second Intervention (24 Hours)||3||
48759416|NCT02891174|102197818|FG000|NOT COMPLETED|Second Intervention (24 Hours)||6||
48759417|NCT02891174|102197819|FG001|NOT COMPLETED|Second Intervention (24 Hours)||7||
48759418|NCT01539824|102197820|FG000|STARTED|Overall Study||12||
48759419|NCT01539824|102197820|FG000|COMPLETED|Overall Study||12||
48759420|NCT01539824|102197820|FG000|NOT COMPLETED|Overall Study||0||
48759421|NCT02163538|102197821|FG000|STARTED|Overall Study||71||
48759422|NCT02163538|102197822|FG001|STARTED|Overall Study||71||
48759423|NCT02163538|102197821|FG000|COMPLETED|Overall Study||70||
48759424|NCT02163538|102197822|FG001|COMPLETED|Overall Study||70||
48759425|NCT02163538|102197821|FG000|NOT COMPLETED|Overall Study||1||
48759426|NCT02163538|102197822|FG001|NOT COMPLETED|Overall Study||1||
48759427|NCT00633477|102197823|FG000|STARTED|Overall Study||7||
48759428|NCT00633477|102197824|FG001|STARTED|Overall Study||11||
48759429|NCT00633477|102197823|FG000|Randomized But Not Treated|Overall Study||1||
48759430|NCT00633477|102197824|FG001|Randomized But Not Treated|Overall Study||0||
48759431|NCT00633477|102197823|FG000|Prematurely Discontinued Study Drug|Overall Study||1||
48759432|NCT00633477|102197824|FG001|Prematurely Discontinued Study Drug|Overall Study||0||
48759433|NCT00633477|102197823|FG000|Completed Study Through Day 28|Overall Study||4||
48759434|NCT00633477|102197824|FG001|Completed Study Through Day 28|Overall Study||8||
48759435|NCT00633477|102197823|FG000|COMPLETED|Overall Study||5||
48759436|NCT00633477|102197824|FG001|COMPLETED|Overall Study||11||
48759437|NCT00633477|102197823|FG000|NOT COMPLETED|Overall Study||2||
48759438|NCT00633477|102197824|FG001|NOT COMPLETED|Overall Study||0||
48759439|NCT03915717|102197825|FG000|STARTED|Overall Study||14||
48759440|NCT03915717|102197825|FG000|COMPLETED|Overall Study||8||
48759441|NCT03915717|102197825|FG000|NOT COMPLETED|Overall Study||6||
48759442|NCT02985827|102197826|FG000|STARTED|Overall Study||33||
48759443|NCT02985827|102197827|FG001|STARTED|Overall Study||15||
48759444|NCT02985827|102197826|FG000|COMPLETED|Overall Study||33||
48759445|NCT02985827|102197827|FG001|COMPLETED|Overall Study||15||
48759446|NCT02985827|102197826|FG000|NOT COMPLETED|Overall Study||0||
48759447|NCT02985827|102197827|FG001|NOT COMPLETED|Overall Study||0||
48759448|NCT04742556|102197828|FG000|STARTED|Overall Study||3||
48759449|NCT04742556|102197829|FG001|STARTED|Overall Study||4||
48759450|NCT04742556|102197830|FG002|STARTED|Overall Study||8||
48759451|NCT04742556|102197828|FG000|COMPLETED|Overall Study||0||
48759452|NCT04742556|102197829|FG001|COMPLETED|Overall Study||0||
48759453|NCT04742556|102197830|FG002|COMPLETED|Overall Study||0||
48759454|NCT04742556|102197828|FG000|NOT COMPLETED|Overall Study||3||
48759455|NCT04742556|102197829|FG001|NOT COMPLETED|Overall Study||4||
48759456|NCT04742556|102197830|FG002|NOT COMPLETED|Overall Study||8||
48759457|NCT05712460|102200360|FG000|STARTED|Part 1 Period 1 (4 Days)||1||
48759458|NCT05712460|102200361|FG001|STARTED|Part 1 Period 1 (4 Days)||1||
48759459|NCT05712460|102200362|FG002|STARTED|Part 1 Period 1 (4 Days)||1||
48759460|NCT05712460|102200363|FG003|STARTED|Part 1 Period 1 (4 Days)||1||
48759461|NCT05712460|102200364|FG004|STARTED|Part 1 Period 1 (4 Days)||1||
48759462|NCT05712460|102200365|FG005|STARTED|Part 1 Period 1 (4 Days)||1||
48759463|NCT05712460|102200366|FG006|STARTED|Part 1 Period 1 (4 Days)||1||
48759464|NCT05712460|102200367|FG007|STARTED|Part 1 Period 1 (4 Days)||1||
48759465|NCT05712460|102200368|FG008|STARTED|Part 1 Period 1 (4 Days)||1||
48759466|NCT05712460|102200369|FG009|STARTED|Part 1 Period 1 (4 Days)||1||
48759467|NCT05712460|102200370|FG010|STARTED|Part 1 Period 1 (4 Days)||1||
48759468|NCT05712460|102200371|FG011|STARTED|Part 1 Period 1 (4 Days)||1||
48759469|NCT05712460|102200360|FG000|COMPLETED|Part 1 Period 1 (4 Days)||1||
48759470|NCT05712460|102200361|FG001|COMPLETED|Part 1 Period 1 (4 Days)||1||
48759471|NCT05712460|102200362|FG002|COMPLETED|Part 1 Period 1 (4 Days)||1||
48759472|NCT05712460|102200363|FG003|COMPLETED|Part 1 Period 1 (4 Days)||1||
48759473|NCT05712460|102200364|FG004|COMPLETED|Part 1 Period 1 (4 Days)||1||
48346962|NCT01678976|101180599|FG001|STARTED|First Period||7||
48346963|NCT01678976|101180598|FG000|COMPLETED|First Period||6||
48346964|NCT01678976|101180599|FG001|COMPLETED|First Period||6||
48346965|NCT01678976|101180598|FG000|NOT COMPLETED|First Period||0||
48346966|NCT01678976|101180599|FG001|NOT COMPLETED|First Period||1||
48346967|NCT01678976|101180598|FG000|STARTED|Second Period||6||
48346968|NCT01678976|101180599|FG001|STARTED|Second Period||6||
48415526|NCT01279954|101350306|FG000|STARTED|Overall Study||5||
48415527|NCT01279954|101350307|FG001|STARTED|Overall Study||5||
48415528|NCT01279954|101350306|FG000|COMPLETED|Overall Study||2||
48415529|NCT01279954|101350307|FG001|COMPLETED|Overall Study||1||
48415530|NCT01279954|101350306|FG000|NOT COMPLETED|Overall Study||3||
48415531|NCT01279954|101350307|FG001|NOT COMPLETED|Overall Study||4||
48415532|NCT00808028|101350308|FG000|STARTED|Stage 1 (6 Months)||121||
48415533|NCT00808028|101350309|FG001|STARTED|Stage 1 (6 Months)||22||
48636818|NCT04470427|101894706|FG003|COMPLETED|Part C: Booster||0|Participants are considered to have completed the study if they complete the final visit at Day 759 (Month 25), 24 months following their receipt of the original second dose of investigational product (IP) (where original refers to the IP received following randomization).|
48185658|NCT04648891|100775972|FG002|COMPLETED|First Experimental Visit||6||
48636819|NCT04470427|101894707|FG004|COMPLETED|Part C: Booster||0|Participants are considered to have completed the study if they complete the final visit at Day 759 (Month 25), 24 months following their receipt of the original second dose of investigational product (IP) (where original refers to the IP received following randomization).|
48636820|NCT04470427|101894708|FG005|COMPLETED|Part C: Booster||16691|Participants are considered to have completed the study if they complete the final visit at Day 759 (Month 25), 24 months following their receipt of the original second dose of investigational product (IP) (where original refers to the IP received following randomization).|
48636821|NCT04470427|101894703|FG000|NOT COMPLETED|Part C: Booster||0||
48636822|NCT04470427|101894704|FG001|NOT COMPLETED|Part C: Booster||0||
48636823|NCT04470427|101894705|FG002|NOT COMPLETED|Part C: Booster||0||
48636824|NCT04470427|101894706|FG003|NOT COMPLETED|Part C: Booster||0||
48636825|NCT04470427|101894707|FG004|NOT COMPLETED|Part C: Booster||0||
48759474|NCT05712460|102200365|FG005|COMPLETED|Part 1 Period 1 (4 Days)||1||
48759475|NCT05712460|102200366|FG006|COMPLETED|Part 1 Period 1 (4 Days)||1||
48759476|NCT05712460|102200367|FG007|COMPLETED|Part 1 Period 1 (4 Days)||1||
48759477|NCT05712460|102200368|FG008|COMPLETED|Part 1 Period 1 (4 Days)||1||
48759478|NCT05712460|102200369|FG009|COMPLETED|Part 1 Period 1 (4 Days)||1||
48346969|NCT01678976|101180598|FG000|COMPLETED|Second Period||6||
48346970|NCT01678976|101180599|FG001|COMPLETED|Second Period||6||
48346971|NCT01678976|101180598|FG000|NOT COMPLETED|Second Period||0||
48346972|NCT01678976|101180599|FG001|NOT COMPLETED|Second Period||0||
48346973|NCT00317044|101180600|FG000|STARTED|Overall Study||320||
48346974|NCT00317044|101180601|FG001|STARTED|Overall Study||313||
48346975|NCT00317044|101180602|FG002|STARTED|Overall Study||328||
48346976|NCT00317044|101180600|FG000|COMPLETED|Overall Study||272||
48346977|NCT00317044|101180601|FG001|COMPLETED|Overall Study||273||
48346978|NCT00317044|101180602|FG002|COMPLETED|Overall Study||283||
48346979|NCT00317044|101180600|FG000|NOT COMPLETED|Overall Study||48||
48346980|NCT00317044|101180601|FG001|NOT COMPLETED|Overall Study||40||
48346981|NCT00317044|101180602|FG002|NOT COMPLETED|Overall Study||45||
48415534|NCT00808028|101350310|FG002|STARTED|Stage 1 (6 Months)||198||
48346982|NCT01672957|101180603|FG000|STARTED|Overall Study||128||
48759479|NCT05712460|102200370|FG010|COMPLETED|Part 1 Period 1 (4 Days)||1||
48759480|NCT05712460|102200371|FG011|COMPLETED|Part 1 Period 1 (4 Days)||1||
48346983|NCT01672957|101180603|FG000|Intent-to-treat (ITT) Population|Overall Study||123||
48346984|NCT01672957|101180603|FG000|COMPLETED|Overall Study||73||
48346985|NCT01672957|101180603|FG000|NOT COMPLETED|Overall Study||55||
48759481|NCT05712460|102200360|FG000|NOT COMPLETED|Part 1 Period 1 (4 Days)||0||
48759482|NCT05712460|102200361|FG001|NOT COMPLETED|Part 1 Period 1 (4 Days)||0||
48759483|NCT05712460|102200362|FG002|NOT COMPLETED|Part 1 Period 1 (4 Days)||0||
48759484|NCT05712460|102200363|FG003|NOT COMPLETED|Part 1 Period 1 (4 Days)||0||
48759485|NCT05712460|102200364|FG004|NOT COMPLETED|Part 1 Period 1 (4 Days)||0||
48759486|NCT05712460|102200365|FG005|NOT COMPLETED|Part 1 Period 1 (4 Days)||0||
48759487|NCT05712460|102200366|FG006|NOT COMPLETED|Part 1 Period 1 (4 Days)||0||
48759488|NCT05712460|102200367|FG007|NOT COMPLETED|Part 1 Period 1 (4 Days)||0||
48759489|NCT05712460|102200368|FG008|NOT COMPLETED|Part 1 Period 1 (4 Days)||0||
48759490|NCT05712460|102200369|FG009|NOT COMPLETED|Part 1 Period 1 (4 Days)||0||
48759491|NCT05712460|102200370|FG010|NOT COMPLETED|Part 1 Period 1 (4 Days)||0||
48759492|NCT05712460|102200371|FG011|NOT COMPLETED|Part 1 Period 1 (4 Days)||0||
48759493|NCT05712460|102200360|FG000|STARTED|Part 1 Period 2 (4 Days)||1||
48759494|NCT05712460|102200361|FG001|STARTED|Part 1 Period 2 (4 Days)||1||
48759495|NCT05712460|102200362|FG002|STARTED|Part 1 Period 2 (4 Days)||1||
48759496|NCT05712460|102200363|FG003|STARTED|Part 1 Period 2 (4 Days)||1||
48759497|NCT05712460|102200364|FG004|STARTED|Part 1 Period 2 (4 Days)||1||
48759498|NCT05712460|102200365|FG005|STARTED|Part 1 Period 2 (4 Days)||1||
48759499|NCT05712460|102200366|FG006|STARTED|Part 1 Period 2 (4 Days)||1||
48346986|NCT02370121|101180604|FG000|STARTED|Overall Study||12||
48346987|NCT02370121|101180605|FG001|STARTED|Overall Study||12||
48759500|NCT05712460|102200367|FG007|STARTED|Part 1 Period 2 (4 Days)||1||
48759501|NCT05712460|102200368|FG008|STARTED|Part 1 Period 2 (4 Days)||1||
48759502|NCT05712460|102200369|FG009|STARTED|Part 1 Period 2 (4 Days)||1||
48759503|NCT05712460|102200370|FG010|STARTED|Part 1 Period 2 (4 Days)||1||
48759504|NCT05712460|102200371|FG011|STARTED|Part 1 Period 2 (4 Days)||1||
48759505|NCT05712460|102200360|FG000|COMPLETED|Part 1 Period 2 (4 Days)||1||
48759506|NCT05712460|102200361|FG001|COMPLETED|Part 1 Period 2 (4 Days)||1||
48759507|NCT05712460|102200362|FG002|COMPLETED|Part 1 Period 2 (4 Days)||1||
48759508|NCT05712460|102200363|FG003|COMPLETED|Part 1 Period 2 (4 Days)||1||
48759509|NCT05712460|102200364|FG004|COMPLETED|Part 1 Period 2 (4 Days)||1||
48759510|NCT05712460|102200365|FG005|COMPLETED|Part 1 Period 2 (4 Days)||1||
48759511|NCT05712460|102200366|FG006|COMPLETED|Part 1 Period 2 (4 Days)||1||
48759512|NCT05712460|102200367|FG007|COMPLETED|Part 1 Period 2 (4 Days)||1||
48759513|NCT05712460|102200368|FG008|COMPLETED|Part 1 Period 2 (4 Days)||1||
48759514|NCT05712460|102200369|FG009|COMPLETED|Part 1 Period 2 (4 Days)||1||
48759515|NCT05712460|102200370|FG010|COMPLETED|Part 1 Period 2 (4 Days)||1||
48759516|NCT05712460|102200371|FG011|COMPLETED|Part 1 Period 2 (4 Days)||1||
48759517|NCT05712460|102200360|FG000|NOT COMPLETED|Part 1 Period 2 (4 Days)||0||
48759518|NCT05712460|102200361|FG001|NOT COMPLETED|Part 1 Period 2 (4 Days)||0||
48759519|NCT05712460|102200362|FG002|NOT COMPLETED|Part 1 Period 2 (4 Days)||0||
48759520|NCT05712460|102200363|FG003|NOT COMPLETED|Part 1 Period 2 (4 Days)||0||
48759521|NCT05712460|102200364|FG004|NOT COMPLETED|Part 1 Period 2 (4 Days)||0||
48759522|NCT05712460|102200365|FG005|NOT COMPLETED|Part 1 Period 2 (4 Days)||0||
48759523|NCT05712460|102200366|FG006|NOT COMPLETED|Part 1 Period 2 (4 Days)||0||
48759524|NCT05712460|102200367|FG007|NOT COMPLETED|Part 1 Period 2 (4 Days)||0||
48759525|NCT05712460|102200368|FG008|NOT COMPLETED|Part 1 Period 2 (4 Days)||0||
48759526|NCT05712460|102200369|FG009|NOT COMPLETED|Part 1 Period 2 (4 Days)||0||
48759527|NCT05712460|102200370|FG010|NOT COMPLETED|Part 1 Period 2 (4 Days)||0||
48759528|NCT05712460|102200371|FG011|NOT COMPLETED|Part 1 Period 2 (4 Days)||0||
48759529|NCT05712460|102200360|FG000|STARTED|Part 1 Period 3 (4 Days)||1||
48759530|NCT05712460|102200361|FG001|STARTED|Part 1 Period 3 (4 Days)||1||
48759531|NCT05712460|102200362|FG002|STARTED|Part 1 Period 3 (4 Days)||1||
48759532|NCT05712460|102200363|FG003|STARTED|Part 1 Period 3 (4 Days)||1||
48759533|NCT05712460|102200364|FG004|STARTED|Part 1 Period 3 (4 Days)||1||
48759534|NCT05712460|102200365|FG005|STARTED|Part 1 Period 3 (4 Days)||1||
48759535|NCT05712460|102200366|FG006|STARTED|Part 1 Period 3 (4 Days)||1||
48759536|NCT05712460|102200367|FG007|STARTED|Part 1 Period 3 (4 Days)||1||
48346988|NCT02370121|101180604|FG000|COMPLETED|Overall Study||11||
48346989|NCT02370121|101180605|FG001|COMPLETED|Overall Study||11||
48346990|NCT02370121|101180604|FG000|NOT COMPLETED|Overall Study||1||
48346991|NCT02370121|101180605|FG001|NOT COMPLETED|Overall Study||1||
48346992|NCT05195528|101180606|FG000|STARTED|Placebo-controlled Treatment Period||259||
48346993|NCT05195528|101180607|FG001|STARTED|Placebo-controlled Treatment Period||258||
48346994|NCT05195528|101180608|FG002|STARTED|Placebo-controlled Treatment Period||259||
48759537|NCT05712460|102200368|FG008|STARTED|Part 1 Period 3 (4 Days)||1||
48759538|NCT05712460|102200369|FG009|STARTED|Part 1 Period 3 (4 Days)||1||
48759539|NCT05712460|102200370|FG010|STARTED|Part 1 Period 3 (4 Days)||1||
48759540|NCT05712460|102200371|FG011|STARTED|Part 1 Period 3 (4 Days)||1||
48759541|NCT05712460|102200360|FG000|COMPLETED|Part 1 Period 3 (4 Days)||1||
48759542|NCT05712460|102200361|FG001|COMPLETED|Part 1 Period 3 (4 Days)||1||
48759543|NCT05712460|102200362|FG002|COMPLETED|Part 1 Period 3 (4 Days)||1||
48759544|NCT05712460|102200363|FG003|COMPLETED|Part 1 Period 3 (4 Days)||1||
48759545|NCT05712460|102200364|FG004|COMPLETED|Part 1 Period 3 (4 Days)||1||
48759546|NCT05712460|102200365|FG005|COMPLETED|Part 1 Period 3 (4 Days)||1||
48759547|NCT05712460|102200366|FG006|COMPLETED|Part 1 Period 3 (4 Days)||1||
48759548|NCT05712460|102200367|FG007|COMPLETED|Part 1 Period 3 (4 Days)||0||
48759549|NCT05712460|102200368|FG008|COMPLETED|Part 1 Period 3 (4 Days)||1||
48759550|NCT05712460|102200369|FG009|COMPLETED|Part 1 Period 3 (4 Days)||1||
48759551|NCT05712460|102200370|FG010|COMPLETED|Part 1 Period 3 (4 Days)||1||
48759552|NCT05712460|102200371|FG011|COMPLETED|Part 1 Period 3 (4 Days)||1||
48759553|NCT05712460|102200360|FG000|NOT COMPLETED|Part 1 Period 3 (4 Days)||0||
48759554|NCT05712460|102200361|FG001|NOT COMPLETED|Part 1 Period 3 (4 Days)||0||
48759555|NCT05712460|102200362|FG002|NOT COMPLETED|Part 1 Period 3 (4 Days)||0||
48759556|NCT05712460|102200363|FG003|NOT COMPLETED|Part 1 Period 3 (4 Days)||0||
48759557|NCT05712460|102200364|FG004|NOT COMPLETED|Part 1 Period 3 (4 Days)||0||
48759558|NCT05712460|102200365|FG005|NOT COMPLETED|Part 1 Period 3 (4 Days)||0||
48759559|NCT05712460|102200366|FG006|NOT COMPLETED|Part 1 Period 3 (4 Days)||0||
48759560|NCT05712460|102200367|FG007|NOT COMPLETED|Part 1 Period 3 (4 Days)||1||
48759561|NCT05712460|102200368|FG008|NOT COMPLETED|Part 1 Period 3 (4 Days)||0||
48346995|NCT05195528|101180609|FG003|STARTED|Placebo-controlled Treatment Period||0||
48346996|NCT05195528|101180610|FG004|STARTED|Placebo-controlled Treatment Period||0||
48415535|NCT00808028|101350311|FG003|STARTED|Stage 1 (6 Months)||198||
48636826|NCT04470427|101894708|FG005|NOT COMPLETED|Part C: Booster||2918||
48636827|NCT02318940|101894709|FG000|STARTED|Overall Study||50||
48636828|NCT02318940|101894710|FG001|STARTED|Overall Study||50||
48368107|NCT01289392|101230108|FG001|COMPLETED|Overall Study||9||
48368108|NCT01289392|101230109|FG002|COMPLETED|Overall Study||7||
48368109|NCT01289392|101230107|FG000|NOT COMPLETED|Overall Study||0||
48636829|NCT02318940|101894709|FG000|COMPLETED|Overall Study||49||
48636830|NCT02318940|101894710|FG001|COMPLETED|Overall Study||50||
48636831|NCT02318940|101894709|FG000|NOT COMPLETED|Overall Study||1||
48636832|NCT02318940|101894710|FG001|NOT COMPLETED|Overall Study||0||
48636833|NCT00849056|101894711|FG000|STARTED|Treatment Period (TP) (156 Weeks)||151||
48636834|NCT00849056|101894712|FG001|STARTED|Treatment Period (TP) (156 Weeks)||150||
48636835|NCT00849056|101894711|FG000|COMPLETED|Treatment Period (TP) (156 Weeks)||88||
48636836|NCT00849056|101894712|FG001|COMPLETED|Treatment Period (TP) (156 Weeks)||100||
48636837|NCT00849056|101894711|FG000|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||63||
48636838|NCT00849056|101894712|FG001|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||50||
48636839|NCT00849056|101894711|FG000|STARTED|Follow-up Period (FUP) (8 Weeks)||149||
48636840|NCT00849056|101894712|FG001|STARTED|Follow-up Period (FUP) (8 Weeks)||149||
48636841|NCT00849056|101894711|FG000|COMPLETED|Follow-up Period (FUP) (8 Weeks)||122||
48636842|NCT00849056|101894712|FG001|COMPLETED|Follow-up Period (FUP) (8 Weeks)||124||
48636843|NCT00849056|101894711|FG000|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||27||
48636844|NCT00849056|101894712|FG001|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||25||
48636845|NCT00596635|101894713|FG000|STARTED|Overall Study||17||
48636846|NCT00596635|101894714|FG001|STARTED|Overall Study||20||
48636847|NCT00596635|101894715|FG002|STARTED|Overall Study||19||
48636848|NCT00596635|101894713|FG000|COMPLETED|Overall Study||10||
48636849|NCT00596635|101894714|FG001|COMPLETED|Overall Study||7||
48636850|NCT00596635|101894715|FG002|COMPLETED|Overall Study||11||
48636851|NCT00596635|101894713|FG000|NOT COMPLETED|Overall Study||7||
48636852|NCT00596635|101894714|FG001|NOT COMPLETED|Overall Study||13||
48636853|NCT00596635|101894715|FG002|NOT COMPLETED|Overall Study||8||
48636854|NCT01093417|101894716|FG000|STARTED|Overall Study||15||
48636855|NCT01093417|101894717|FG001|STARTED|Overall Study||30||
48636856|NCT01093417|101894716|FG000|COMPLETED|Overall Study||15||
48636857|NCT01093417|101894717|FG001|COMPLETED|Overall Study||29||
48636858|NCT01093417|101894716|FG000|NOT COMPLETED|Overall Study||0||
48636859|NCT01093417|101894717|FG001|NOT COMPLETED|Overall Study||1||
48636860|NCT00941928|101894718|FG000|STARTED|Overall Study||2||
48636861|NCT00941928|101894718|FG000|COMPLETED|Overall Study||0||
48636862|NCT00941928|101894718|FG000|NOT COMPLETED|Overall Study||2||
48636863|NCT01643213|101894719|FG000|STARTED|Overall Study||13||
48636864|NCT01643213|101894720|FG001|STARTED|Overall Study||14||
48636865|NCT01643213|101894719|FG000|COMPLETED|Overall Study||12||
48636866|NCT01643213|101894720|FG001|COMPLETED|Overall Study||14||
48636867|NCT01643213|101894719|FG000|NOT COMPLETED|Overall Study||1||
48636868|NCT01643213|101894720|FG001|NOT COMPLETED|Overall Study||0||
48636869|NCT02085551|101894721|FG000|STARTED|Overall Study||85||
48636870|NCT02085551|101894721|FG000|COMPLETED|Overall Study||85||
48636871|NCT02085551|101894721|FG000|NOT COMPLETED|Overall Study||0||
48636872|NCT01631188|101894722|FG000|STARTED|Overall Study||100||
48636873|NCT01631188|101894722|FG000|COMPLETED|Overall Study||25||
48636874|NCT01631188|101894722|FG000|NOT COMPLETED|Overall Study||75||
48636875|NCT02199496|101894723|FG000|STARTED|Ustekinumab-Single Dose||3||
48346997|NCT05195528|101180606|FG000|Intent to Treat Analysis Set|Placebo-controlled Treatment Period||258|Intent-to-treat (ITT): all efficacy analyses were conducted on the ITT Set using the planned treatment even if the participant received a different incorrect treatment.|
48346998|NCT05195528|101180607|FG001|Intent to Treat Analysis Set|Placebo-controlled Treatment Period||257|Intent-to-treat (ITT): all efficacy analyses were conducted on the ITT Set using the planned treatment even if the participant received a different incorrect treatment.|
48346999|NCT05195528|101180608|FG002|Intent to Treat Analysis Set|Placebo-controlled Treatment Period||257|Intent-to-treat (ITT): all efficacy analyses were conducted on the ITT Set using the planned treatment even if the participant received a different incorrect treatment.|
48759562|NCT05712460|102200369|FG009|NOT COMPLETED|Part 1 Period 3 (4 Days)||0||
48759563|NCT05712460|102200370|FG010|NOT COMPLETED|Part 1 Period 3 (4 Days)||0||
48759564|NCT05712460|102200371|FG011|NOT COMPLETED|Part 1 Period 3 (4 Days)||0||
48759565|NCT05712460|102200360|FG000|STARTED|Part 2 Period 4 (1 Day)||1||
48759566|NCT05712460|102200361|FG001|STARTED|Part 2 Period 4 (1 Day)||1||
48759567|NCT05712460|102200362|FG002|STARTED|Part 2 Period 4 (1 Day)||1||
48759568|NCT05712460|102200363|FG003|STARTED|Part 2 Period 4 (1 Day)||1||
48759569|NCT05712460|102200364|FG004|STARTED|Part 2 Period 4 (1 Day)||1||
48759570|NCT05712460|102200365|FG005|STARTED|Part 2 Period 4 (1 Day)||1||
48759571|NCT05712460|102200366|FG006|STARTED|Part 2 Period 4 (1 Day)||1||
48759572|NCT05712460|102200367|FG007|STARTED|Part 2 Period 4 (1 Day)||0||
48759573|NCT05712460|102200368|FG008|STARTED|Part 2 Period 4 (1 Day)||1||
48759574|NCT05712460|102200369|FG009|STARTED|Part 2 Period 4 (1 Day)||1||
48759575|NCT05712460|102200370|FG010|STARTED|Part 2 Period 4 (1 Day)||1||
48759576|NCT05712460|102200371|FG011|STARTED|Part 2 Period 4 (1 Day)||1||
48759577|NCT05712460|102200360|FG000|COMPLETED|Part 2 Period 4 (1 Day)||1||
48759578|NCT05712460|102200361|FG001|COMPLETED|Part 2 Period 4 (1 Day)||1||
48759579|NCT05712460|102200362|FG002|COMPLETED|Part 2 Period 4 (1 Day)||1||
48759580|NCT05712460|102200363|FG003|COMPLETED|Part 2 Period 4 (1 Day)||1||
48759581|NCT05712460|102200364|FG004|COMPLETED|Part 2 Period 4 (1 Day)||1||
48759582|NCT05712460|102200365|FG005|COMPLETED|Part 2 Period 4 (1 Day)||1||
48759583|NCT05712460|102200366|FG006|COMPLETED|Part 2 Period 4 (1 Day)||1||
48759584|NCT05712460|102200367|FG007|COMPLETED|Part 2 Period 4 (1 Day)||0||
48759585|NCT05712460|102200368|FG008|COMPLETED|Part 2 Period 4 (1 Day)||1||
48759586|NCT05712460|102200369|FG009|COMPLETED|Part 2 Period 4 (1 Day)||1||
48759587|NCT05712460|102200370|FG010|COMPLETED|Part 2 Period 4 (1 Day)||1||
48759588|NCT05712460|102200371|FG011|COMPLETED|Part 2 Period 4 (1 Day)||1||
48759589|NCT05712460|102200360|FG000|NOT COMPLETED|Part 2 Period 4 (1 Day)||0||
48759590|NCT05712460|102200361|FG001|NOT COMPLETED|Part 2 Period 4 (1 Day)||0||
48759591|NCT05712460|102200362|FG002|NOT COMPLETED|Part 2 Period 4 (1 Day)||0||
48759592|NCT05712460|102200363|FG003|NOT COMPLETED|Part 2 Period 4 (1 Day)||0||
48347000|NCT05195528|101180609|FG003|Intent to Treat Analysis Set|Placebo-controlled Treatment Period||0|Intent-to-treat (ITT): all efficacy analyses were conducted on the ITT Set using the planned treatment even if the participant received a different incorrect treatment.|
48347001|NCT05195528|101180610|FG004|Intent to Treat Analysis Set|Placebo-controlled Treatment Period||0|Intent-to-treat (ITT): all efficacy analyses were conducted on the ITT Set using the planned treatment even if the participant received a different incorrect treatment.|
48347002|NCT05195528|101180606|FG000|Safety Analysis Set|Placebo-controlled Treatment Period||256|Safety Analysis Set (SAS): all safety analyses were conducted on the Safety Set using the actual treatment the participant received even if the participant was randomized to receive a different treatment.|
48347003|NCT05195528|101180607|FG001|Safety Analysis Set|Placebo-controlled Treatment Period||259|Safety Analysis Set (SAS): all safety analyses were conducted on the Safety Set using the actual treatment the participant received even if the participant was randomized to receive a different treatment.|
48347004|NCT05195528|101180608|FG002|Safety Analysis Set|Placebo-controlled Treatment Period||257|Safety Analysis Set (SAS): all safety analyses were conducted on the Safety Set using the actual treatment the participant received even if the participant was randomized to receive a different treatment.|
48759593|NCT05712460|102200364|FG004|NOT COMPLETED|Part 2 Period 4 (1 Day)||0||
48759594|NCT05712460|102200365|FG005|NOT COMPLETED|Part 2 Period 4 (1 Day)||0||
48759595|NCT05712460|102200366|FG006|NOT COMPLETED|Part 2 Period 4 (1 Day)||0||
48759596|NCT05712460|102200367|FG007|NOT COMPLETED|Part 2 Period 4 (1 Day)||0||
48759597|NCT05712460|102200368|FG008|NOT COMPLETED|Part 2 Period 4 (1 Day)||0||
48759598|NCT05712460|102200369|FG009|NOT COMPLETED|Part 2 Period 4 (1 Day)||0||
48759599|NCT05712460|102200370|FG010|NOT COMPLETED|Part 2 Period 4 (1 Day)||0||
48759600|NCT05712460|102200371|FG011|NOT COMPLETED|Part 2 Period 4 (1 Day)||0||
48759601|NCT05712460|102200360|FG000|STARTED|Part 2 Period 5 (1 Day)||1||
48759602|NCT05712460|102200361|FG001|STARTED|Part 2 Period 5 (1 Day)||1||
48759603|NCT05712460|102200362|FG002|STARTED|Part 2 Period 5 (1 Day)||1||
48759604|NCT05712460|102200363|FG003|STARTED|Part 2 Period 5 (1 Day)||1||
48759605|NCT05712460|102200364|FG004|STARTED|Part 2 Period 5 (1 Day)||1||
48759606|NCT05712460|102200365|FG005|STARTED|Part 2 Period 5 (1 Day)||1||
48759607|NCT05712460|102200366|FG006|STARTED|Part 2 Period 5 (1 Day)||1||
48759608|NCT05712460|102200367|FG007|STARTED|Part 2 Period 5 (1 Day)||0||
48415536|NCT00808028|101350308|FG000|COMPLETED|Stage 1 (6 Months)||116||
48415537|NCT00808028|101350309|FG001|COMPLETED|Stage 1 (6 Months)||21||
48415538|NCT00808028|101350310|FG002|COMPLETED|Stage 1 (6 Months)||191||
48415539|NCT00808028|101350311|FG003|COMPLETED|Stage 1 (6 Months)||183||
48415540|NCT00808028|101350308|FG000|NOT COMPLETED|Stage 1 (6 Months)||5||
48415541|NCT00808028|101350309|FG001|NOT COMPLETED|Stage 1 (6 Months)||1||
48415542|NCT00808028|101350310|FG002|NOT COMPLETED|Stage 1 (6 Months)||7||
48415543|NCT00808028|101350311|FG003|NOT COMPLETED|Stage 1 (6 Months)||15||
48415544|NCT00808028|101350308|FG000|STARTED|Stage 2 (Followed up to 48 Months )||80||
48415545|NCT00808028|101350309|FG001|STARTED|Stage 2 (Followed up to 48 Months )||0||
48636876|NCT02199496|101894724|FG001|STARTED|Ustekinumab-Single Dose||0||
48415546|NCT00808028|101350310|FG002|STARTED|Stage 2 (Followed up to 48 Months )||170||
48415547|NCT00808028|101350311|FG003|STARTED|Stage 2 (Followed up to 48 Months )||151||
48347005|NCT05195528|101180609|FG003|Safety Analysis Set|Placebo-controlled Treatment Period||0|Safety Analysis Set (SAS): all safety analyses were conducted on the Safety Set using the actual treatment the participant received even if the participant was randomized to receive a different treatment.|
48347006|NCT05195528|101180610|FG004|Safety Analysis Set|Placebo-controlled Treatment Period||0|Safety Analysis Set (SAS): all safety analyses were conducted on the Safety Set using the actual treatment the participant received even if the participant was randomized to receive a different treatment.|
48347007|NCT05195528|101180606|FG000|COMPLETED|Placebo-controlled Treatment Period||247||
48347008|NCT05195528|101180607|FG001|COMPLETED|Placebo-controlled Treatment Period||250||
48347009|NCT05195528|101180608|FG002|COMPLETED|Placebo-controlled Treatment Period||242||
48347010|NCT05195528|101180609|FG003|COMPLETED|Placebo-controlled Treatment Period||0||
48347011|NCT05195528|101180610|FG004|COMPLETED|Placebo-controlled Treatment Period||0||
48347012|NCT05195528|101180606|FG000|NOT COMPLETED|Placebo-controlled Treatment Period||12||
48347013|NCT05195528|101180607|FG001|NOT COMPLETED|Placebo-controlled Treatment Period||8||
48347014|NCT05195528|101180608|FG002|NOT COMPLETED|Placebo-controlled Treatment Period||17||
48347015|NCT05195528|101180609|FG003|NOT COMPLETED|Placebo-controlled Treatment Period||0||
48347016|NCT05195528|101180610|FG004|NOT COMPLETED|Placebo-controlled Treatment Period||0||
48347017|NCT05195528|101180606|FG000|STARTED|Extension Period||0||
48415548|NCT00808028|101350308|FG000|COMPLETED|Stage 2 (Followed up to 48 Months )||69||
48415549|NCT00808028|101350309|FG001|COMPLETED|Stage 2 (Followed up to 48 Months )||0||
48415550|NCT00808028|101350310|FG002|COMPLETED|Stage 2 (Followed up to 48 Months )||141||
48415551|NCT00808028|101350311|FG003|COMPLETED|Stage 2 (Followed up to 48 Months )||128||
48415552|NCT00808028|101350308|FG000|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||11||
48415553|NCT00808028|101350309|FG001|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||0||
48636877|NCT02199496|101894723|FG000|COMPLETED|Ustekinumab-Single Dose||3||
48636878|NCT02199496|101894724|FG001|COMPLETED|Ustekinumab-Single Dose||0||
48636879|NCT02199496|101894723|FG000|NOT COMPLETED|Ustekinumab-Single Dose||0||
48636880|NCT02199496|101894724|FG001|NOT COMPLETED|Ustekinumab-Single Dose||0||
48636881|NCT02199496|101894723|FG000|STARTED|Ustekinumab-Multi-dose||3||
48759609|NCT05712460|102200368|FG008|STARTED|Part 2 Period 5 (1 Day)||1||
48759610|NCT05712460|102200369|FG009|STARTED|Part 2 Period 5 (1 Day)||1||
48759611|NCT05712460|102200370|FG010|STARTED|Part 2 Period 5 (1 Day)||1||
48759612|NCT05712460|102200371|FG011|STARTED|Part 2 Period 5 (1 Day)||1||
48759613|NCT05712460|102200360|FG000|COMPLETED|Part 2 Period 5 (1 Day)||1||
48347018|NCT05195528|101180607|FG001|STARTED|Extension Period||247||
48347019|NCT05195528|101180608|FG002|STARTED|Extension Period||237||
48347020|NCT05195528|101180609|FG003|STARTED|Extension Period||122||
48347021|NCT05195528|101180610|FG004|STARTED|Extension Period||122||
48415554|NCT00808028|101350310|FG002|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||29||
48415555|NCT00808028|101350311|FG003|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||23||
48415556|NCT00303329|101350312|FG000|STARTED|Overall Study||85||
48636882|NCT02199496|101894724|FG001|STARTED|Ustekinumab-Multi-dose||2||
48759614|NCT05712460|102200361|FG001|COMPLETED|Part 2 Period 5 (1 Day)||1||
48759615|NCT05712460|102200362|FG002|COMPLETED|Part 2 Period 5 (1 Day)||1||
48759616|NCT05712460|102200363|FG003|COMPLETED|Part 2 Period 5 (1 Day)||1||
48759617|NCT05712460|102200364|FG004|COMPLETED|Part 2 Period 5 (1 Day)||1||
48347022|NCT05195528|101180606|FG000|Intent to Treat Analysis Set|Extension Period||0|ITT: all efficacy analyses were conducted on the ITT Set using the planned treatment even if the participant received a different incorrect treatment.|
48368110|NCT01289392|101230108|FG001|NOT COMPLETED|Overall Study||0||
48368111|NCT01289392|101230109|FG002|NOT COMPLETED|Overall Study||0||
48415557|NCT00303329|101350313|FG001|STARTED|Overall Study||99||
48415558|NCT00303329|101350312|FG000|COMPLETED|Overall Study||50||
48415559|NCT00303329|101350313|FG001|COMPLETED|Overall Study||37||
48759618|NCT05712460|102200365|FG005|COMPLETED|Part 2 Period 5 (1 Day)||1||
48759619|NCT05712460|102200366|FG006|COMPLETED|Part 2 Period 5 (1 Day)||1||
48759620|NCT05712460|102200367|FG007|COMPLETED|Part 2 Period 5 (1 Day)||0||
48759621|NCT05712460|102200368|FG008|COMPLETED|Part 2 Period 5 (1 Day)||1||
48759622|NCT05712460|102200369|FG009|COMPLETED|Part 2 Period 5 (1 Day)||1||
48415560|NCT00303329|101350312|FG000|NOT COMPLETED|Overall Study||35||
48415561|NCT00303329|101350313|FG001|NOT COMPLETED|Overall Study||62||
48415562|NCT00928499|101350314|FG000|STARTED|Overall Study||18||
48415563|NCT00928499|101350315|FG001|STARTED|Overall Study||14||
48415564|NCT00928499|101350314|FG000|COMPLETED|Overall Study||18||
48415565|NCT00928499|101350315|FG001|COMPLETED|Overall Study||14||
48415566|NCT00928499|101350314|FG000|NOT COMPLETED|Overall Study||0||
48415567|NCT00928499|101350315|FG001|NOT COMPLETED|Overall Study||0||
48415568|NCT01792024|101350316|FG000|STARTED|Overall Study||27||
48415569|NCT01792024|101350316|FG000|COMPLETED|Overall Study||27||
48636883|NCT02199496|101894723|FG000|COMPLETED|Ustekinumab-Multi-dose||3||
48636884|NCT02199496|101894724|FG001|COMPLETED|Ustekinumab-Multi-dose||2||
48636885|NCT02199496|101894723|FG000|NOT COMPLETED|Ustekinumab-Multi-dose||0||
48636886|NCT02199496|101894724|FG001|NOT COMPLETED|Ustekinumab-Multi-dose||0||
48636887|NCT00937950|101894725|FG000|STARTED|Overall Study||2003||
48636888|NCT00937950|101894725|FG000|COMPLETED|Overall Study||1787||
48636889|NCT00937950|101894725|FG000|NOT COMPLETED|Overall Study||216||
48415570|NCT01792024|101350316|FG000|NOT COMPLETED|Overall Study||0||
48415571|NCT00829010|101350317|FG000|STARTED|Overall Study||83||
48415572|NCT00829010|101350318|FG001|STARTED|Overall Study||101||
48636890|NCT01951950|101894726|FG000|STARTED|Overall Study||26||
48636891|NCT01951950|101894727|FG001|STARTED|Overall Study||26||
48636892|NCT01951950|101894726|FG000|COMPLETED|Overall Study||20||
48636893|NCT01951950|101894727|FG001|COMPLETED|Overall Study||20||
48636894|NCT01951950|101894726|FG000|NOT COMPLETED|Overall Study||6||
48636895|NCT01951950|101894727|FG001|NOT COMPLETED|Overall Study||6||
48636896|NCT02630030|101894728|FG000|STARTED|Overall Study||3||
48636897|NCT02630030|101894728|FG000|COMPLETED|Overall Study||3||
48415573|NCT00829010|101350319|FG002|STARTED|Overall Study||100||
48415574|NCT00829010|101350320|FG003|STARTED|Overall Study||100||
48415575|NCT00829010|101350321|FG004|STARTED|Overall Study||100||
48415576|NCT00829010|101350317|FG000|COMPLETED|Overall Study||73||
48759623|NCT05712460|102200370|FG010|COMPLETED|Part 2 Period 5 (1 Day)||1||
48759624|NCT05712460|102200371|FG011|COMPLETED|Part 2 Period 5 (1 Day)||1||
48759625|NCT05712460|102200360|FG000|NOT COMPLETED|Part 2 Period 5 (1 Day)||0||
48759626|NCT05712460|102200361|FG001|NOT COMPLETED|Part 2 Period 5 (1 Day)||0||
48185659|NCT04648891|100775973|FG003|COMPLETED|First Experimental Visit||5||
48185660|NCT04648891|100775974|FG004|COMPLETED|First Experimental Visit||2||
48759627|NCT05712460|102200362|FG002|NOT COMPLETED|Part 2 Period 5 (1 Day)||0||
48759628|NCT05712460|102200363|FG003|NOT COMPLETED|Part 2 Period 5 (1 Day)||0||
48759629|NCT05712460|102200364|FG004|NOT COMPLETED|Part 2 Period 5 (1 Day)||0||
48759630|NCT05712460|102200365|FG005|NOT COMPLETED|Part 2 Period 5 (1 Day)||0||
48759631|NCT05712460|102200366|FG006|NOT COMPLETED|Part 2 Period 5 (1 Day)||0||
48759632|NCT05712460|102200367|FG007|NOT COMPLETED|Part 2 Period 5 (1 Day)||0||
48347023|NCT05195528|101180607|FG001|Intent to Treat Analysis Set|Extension Period||247|ITT: all efficacy analyses were conducted on the ITT Set using the planned treatment even if the participant received a different incorrect treatment.|
48347024|NCT05195528|101180608|FG002|Intent to Treat Analysis Set|Extension Period||235|ITT: all efficacy analyses were conducted on the ITT Set using the planned treatment even if the participant received a different incorrect treatment.|
48347025|NCT05195528|101180609|FG003|Intent to Treat Analysis Set|Extension Period||119|ITT: all efficacy analyses were conducted on the ITT Set using the planned treatment even if the participant received a different incorrect treatment.|
48347026|NCT05195528|101180610|FG004|Intent to Treat Analysis Set|Extension Period||122|ITT: all efficacy analyses were conducted on the ITT Set using the planned treatment even if the participant received a different incorrect treatment.|
48415577|NCT00829010|101350318|FG001|COMPLETED|Overall Study||92||
48415578|NCT00829010|101350319|FG002|COMPLETED|Overall Study||97||
48415579|NCT00829010|101350320|FG003|COMPLETED|Overall Study||92||
48415580|NCT00829010|101350321|FG004|COMPLETED|Overall Study||98||
48415581|NCT00829010|101350317|FG000|NOT COMPLETED|Overall Study||10||
48415582|NCT00829010|101350318|FG001|NOT COMPLETED|Overall Study||9||
48415583|NCT00829010|101350319|FG002|NOT COMPLETED|Overall Study||3||
48415584|NCT00829010|101350320|FG003|NOT COMPLETED|Overall Study||8||
48415585|NCT00829010|101350321|FG004|NOT COMPLETED|Overall Study||2||
48415586|NCT00935701|101350322|FG000|STARTED|Overall Study||10||
48415587|NCT00935701|101350322|FG000|Transition Acupressure to Acupuncture|Overall Study||9||
48415588|NCT00935701|101350322|FG000|COMPLETED|Overall Study||9||
48415589|NCT00935701|101350322|FG000|NOT COMPLETED|Overall Study||1||
48415590|NCT03008889|101350323|FG000|STARTED|Overall Study||1||
48415591|NCT03008889|101350324|FG001|STARTED|Overall Study||1||
48415592|NCT03008889|101350323|FG000|COMPLETED|Overall Study||1||
48415593|NCT03008889|101350324|FG001|COMPLETED|Overall Study||1||
48415594|NCT03008889|101350323|FG000|NOT COMPLETED|Overall Study||0||
48415595|NCT03008889|101350324|FG001|NOT COMPLETED|Overall Study||0||
48415596|NCT02933489|101350325|FG000|STARTED|Overall Study||757||
48415597|NCT02933489|101350326|FG001|STARTED|Overall Study||759||
48415598|NCT02933489|101350325|FG000|DBTperformed|Overall Study||726||
48415599|NCT02933489|101350326|FG001|DBTperformed|Overall Study||737||
48347027|NCT05195528|101180606|FG000|Safety Analysis Set|Extension Period||0|SAS: all safety analyses were conducted on the Safety Set using the actual treatment the participant received even if the participant was randomized to receive a different treatment.|
48368112|NCT03196297|101230110|FG000|STARTED|Main Period||36|Concizumab- Main part|
48415600|NCT02933489|101350325|FG000|AB MR Performed|Overall Study||713||
48415601|NCT02933489|101350326|FG001|AB MR Performed|Overall Study||733||
48415602|NCT02933489|101350325|FG000|DCIS Detected|Overall Study||5||
48415603|NCT02933489|101350326|FG001|DCIS Detected|Overall Study||6||
48415604|NCT02933489|101350325|FG000|PAM50 NanoString|Overall Study||0||
48415605|NCT02933489|101350326|FG001|PAM50 NanoString|Overall Study||0||
48415606|NCT02933489|101350325|FG000|COMPLETED|Overall Study||713||
48415607|NCT02933489|101350326|FG001|COMPLETED|Overall Study||731||
48415608|NCT02933489|101350325|FG000|NOT COMPLETED|Overall Study||44||
48415609|NCT02933489|101350326|FG001|NOT COMPLETED|Overall Study||28||
48415610|NCT03147495|101350327|FG000|STARTED|Overall Study||40||
48415611|NCT03147495|101350328|FG001|STARTED|Overall Study||46||
48415612|NCT03147495|101350327|FG000|COMPLETED|Overall Study||40||
48415613|NCT03147495|101350328|FG001|COMPLETED|Overall Study||40||
48415614|NCT03147495|101350327|FG000|NOT COMPLETED|Overall Study||0||
48415615|NCT03147495|101350328|FG001|NOT COMPLETED|Overall Study||6||
48415616|NCT01947127|101350329|FG000|STARTED|Overall Study||166||
48415617|NCT01947127|101350330|FG001|STARTED|Overall Study||292||
48415618|NCT01947127|101350329|FG000|COMPLETED|Overall Study||143||
48415619|NCT01947127|101350330|FG001|COMPLETED|Overall Study||249||
48415620|NCT01947127|101350329|FG000|NOT COMPLETED|Overall Study||23||
48415621|NCT01947127|101350330|FG001|NOT COMPLETED|Overall Study||43||
48415622|NCT00989664|101350331|FG000|STARTED|Dosimetric and Therapeutic Treatment||61||
48415623|NCT00989664|101350331|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0||
48415624|NCT00989664|101350331|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||61||
48415625|NCT00989664|101350331|FG000|STARTED|Long-Term Follow-Up||14||
48415626|NCT00989664|101350331|FG000|COMPLETED|Long-Term Follow-Up||11||
48415627|NCT00989664|101350331|FG000|NOT COMPLETED|Long-Term Follow-Up||3||
48415628|NCT00547729|101350332|FG000|STARTED|Overall Study||71||
48415629|NCT00547729|101350332|FG000|COMPLETED|Overall Study||71||
48415630|NCT00547729|101350332|FG000|NOT COMPLETED|Overall Study||0||
48415631|NCT00890201|101350333|FG000|STARTED|Overall Study||38||
48415632|NCT00890201|101350334|FG001|STARTED|Overall Study||159||
48415633|NCT00890201|101350333|FG000|COMPLETED|Overall Study||33||
48415634|NCT00890201|101350334|FG001|COMPLETED|Overall Study||103||
48415635|NCT00890201|101350333|FG000|NOT COMPLETED|Overall Study||5||
48185661|NCT04648891|100775975|FG005|COMPLETED|First Experimental Visit||6||
48185662|NCT04648891|100775970|FG000|NOT COMPLETED|First Experimental Visit||0||
48636898|NCT02630030|101894728|FG000|NOT COMPLETED|Overall Study||0||
48636899|NCT01267279|101894729|FG000|STARTED|Overall Study||24||
48636900|NCT01267279|101894730|FG001|STARTED|Overall Study||27||
48636901|NCT01267279|101894729|FG000|COMPLETED|Overall Study||22||
48636902|NCT01267279|101894730|FG001|COMPLETED|Overall Study||21||
48636903|NCT01267279|101894729|FG000|NOT COMPLETED|Overall Study||2||
48636904|NCT01267279|101894730|FG001|NOT COMPLETED|Overall Study||6||
48636905|NCT00858988|101894731|FG000|STARTED|Randomized and Allocation||74||
48636906|NCT00858988|101894732|FG001|STARTED|Randomized and Allocation||73||
48636907|NCT00858988|101894731|FG000|COMPLETED|Randomized and Allocation||74||
48636908|NCT00858988|101894732|FG001|COMPLETED|Randomized and Allocation||73||
48636909|NCT00858988|101894731|FG000|NOT COMPLETED|Randomized and Allocation||0||
48636910|NCT00858988|101894732|FG001|NOT COMPLETED|Randomized and Allocation||0||
48636911|NCT00858988|101894731|FG000|STARTED|Analysis||74||
48636912|NCT00858988|101894732|FG001|STARTED|Analysis||73||
48636913|NCT00858988|101894731|FG000|COMPLETED|Analysis||72||
48636914|NCT00858988|101894732|FG001|COMPLETED|Analysis||72||
48636915|NCT00858988|101894731|FG000|NOT COMPLETED|Analysis||2||
48636916|NCT00858988|101894732|FG001|NOT COMPLETED|Analysis||1||
48636917|NCT00741611|101894733|FG000|STARTED|Overall Study||4||
48636918|NCT00741611|101894734|FG001|STARTED|Overall Study||3||
48636919|NCT00741611|101894735|FG002|STARTED|Overall Study||29||
48636920|NCT00741611|101894733|FG000|COMPLETED|Overall Study||4||
48636921|NCT00741611|101894734|FG001|COMPLETED|Overall Study||1||
48636922|NCT00741611|101894735|FG002|COMPLETED|Overall Study||26||
48636923|NCT00741611|101894733|FG000|NOT COMPLETED|Overall Study||0||
48636924|NCT00741611|101894734|FG001|NOT COMPLETED|Overall Study||2||
48636925|NCT00741611|101894735|FG002|NOT COMPLETED|Overall Study||3||
48636926|NCT03834168|101894736|FG000|STARTED|Overall Study||19|42 participants started the study; 19 Lean and 23 Obese|
48636927|NCT03834168|101894737|FG001|STARTED|Overall Study||23|42 participants started the study; 19 Lean and 23 Obese|
48636928|NCT03834168|101894736|FG000|Total Participant Screened for the Purpose of Eligibility|Overall Study||22|52 Participants were screened for the eligibilty|
48636929|NCT03834168|101894737|FG001|Total Participant Screened for the Purpose of Eligibility|Overall Study||30|52 Participants were screened for the eligibilty|
48636930|NCT03834168|101894736|FG000|Ineligible Participants|Overall Study||3|10 participants determined ineligible by screening labs|
48636931|NCT03834168|101894737|FG001|Ineligible Participants|Overall Study||7|10 participants determined ineligible by screening labs|
48636932|NCT03834168|101894736|FG000|Unable to Complete the Protocol|Overall Study||0||
48636933|NCT03834168|101894737|FG001|Unable to Complete the Protocol|Overall Study||1||
48636934|NCT03834168|101894736|FG000|Study Dropouts|Overall Study||1||
48636935|NCT03834168|101894737|FG001|Study Dropouts|Overall Study||0||
48636936|NCT03834168|101894736|FG000|Participants Received 5 Days of Standardized Meals|Overall Study||19|42 participants received 5 days of standardized meals to control the salt intake|
48636937|NCT03834168|101894737|FG001|Participants Received 5 Days of Standardized Meals|Overall Study||23|42 participants received 5 days of standardized meals to control the salt intake|
48636938|NCT03834168|101894736|FG000|Participants Returned for the 24-h Inpatient Protocol|Overall Study||18|41 participants returned for the 24-h inpatient protocol|
48636939|NCT03834168|101894737|FG001|Participants Returned for the 24-h Inpatient Protocol|Overall Study||23|41 participants returned for the 24-h inpatient protocol|
48636940|NCT03834168|101894736|FG000|COMPLETED|Overall Study||18|40 participants completed the study; 18 Lean and 22 Obese|
48636941|NCT03834168|101894737|FG001|COMPLETED|Overall Study||22|40 participants completed the study; 18 Lean and 22 Obese|
48636942|NCT03834168|101894736|FG000|NOT COMPLETED|Overall Study||1||
48636943|NCT03834168|101894737|FG001|NOT COMPLETED|Overall Study||1||
48636944|NCT02674503|101894738|FG000|STARTED|Overall Study||62||
48636945|NCT02674503|101894739|FG001|STARTED|Overall Study||70||
48636946|NCT02674503|101894738|FG000|COMPLETED|Overall Study||60||
48636947|NCT02674503|101894739|FG001|COMPLETED|Overall Study||68||
48636948|NCT02674503|101894738|FG000|NOT COMPLETED|Overall Study||2||
48636949|NCT02674503|101894739|FG001|NOT COMPLETED|Overall Study||2||
48636950|NCT02566005|101894740|FG000|STARTED|Overall Study||100||
48636951|NCT02566005|101894741|FG001|STARTED|Overall Study||100||
48636952|NCT02566005|101894740|FG000|COMPLETED|Overall Study||92||
48636953|NCT02566005|101894741|FG001|COMPLETED|Overall Study||94||
48636954|NCT02566005|101894740|FG000|NOT COMPLETED|Overall Study||8||
48636955|NCT02566005|101894741|FG001|NOT COMPLETED|Overall Study||6||
48636956|NCT00423605|101894742|FG000|STARTED|Overall Study||560||
48636957|NCT00423605|101894742|FG000|COMPLETED|Overall Study||319||
48636958|NCT00423605|101894742|FG000|NOT COMPLETED|Overall Study||241||
48636959|NCT00089648|101894743|FG000|STARTED|Overall Study||61||
48636960|NCT00089648|101894743|FG000|COMPLETED|Overall Study||20||
48636961|NCT00089648|101894743|FG000|NOT COMPLETED|Overall Study||41||
48636962|NCT01692756|101894744|FG000|STARTED|Overall Study||12||
48636963|NCT01692756|101894745|FG001|STARTED|Overall Study||12||
48185663|NCT04648891|100775971|FG001|NOT COMPLETED|First Experimental Visit||0||
48185664|NCT04648891|100775972|FG002|NOT COMPLETED|First Experimental Visit||0||
48185665|NCT04648891|100775973|FG003|NOT COMPLETED|First Experimental Visit||0||
48185666|NCT04648891|100775974|FG004|NOT COMPLETED|First Experimental Visit||0||
48185667|NCT04648891|100775975|FG005|NOT COMPLETED|First Experimental Visit||0||
48185668|NCT04648891|100775970|FG000|STARTED|Second Experimental Visit||5||
48185669|NCT04648891|100775971|FG001|STARTED|Second Experimental Visit||8||
48185670|NCT04648891|100775972|FG002|STARTED|Second Experimental Visit||6||
48185671|NCT04648891|100775973|FG003|STARTED|Second Experimental Visit||5||
48185672|NCT04648891|100775974|FG004|STARTED|Second Experimental Visit||2||
48185673|NCT04648891|100775975|FG005|STARTED|Second Experimental Visit||6||
48185674|NCT04648891|100775970|FG000|COMPLETED|Second Experimental Visit||5||
48185675|NCT04648891|100775971|FG001|COMPLETED|Second Experimental Visit||8||
48185676|NCT04648891|100775972|FG002|COMPLETED|Second Experimental Visit||6||
48185677|NCT04648891|100775973|FG003|COMPLETED|Second Experimental Visit||5||
48185678|NCT04648891|100775974|FG004|COMPLETED|Second Experimental Visit||2||
48185679|NCT04648891|100775975|FG005|COMPLETED|Second Experimental Visit||6||
48185680|NCT04648891|100775970|FG000|NOT COMPLETED|Second Experimental Visit||0||
48185681|NCT04648891|100775971|FG001|NOT COMPLETED|Second Experimental Visit||0||
48185682|NCT04648891|100775972|FG002|NOT COMPLETED|Second Experimental Visit||0||
48185683|NCT04648891|100775973|FG003|NOT COMPLETED|Second Experimental Visit||0||
48185684|NCT04648891|100775974|FG004|NOT COMPLETED|Second Experimental Visit||0||
48185685|NCT04648891|100775975|FG005|NOT COMPLETED|Second Experimental Visit||0||
48185686|NCT04648891|100775970|FG000|STARTED|Third Experimental Visit||5||
48185687|NCT04648891|100775971|FG001|STARTED|Third Experimental Visit||8||
48185688|NCT04648891|100775972|FG002|STARTED|Third Experimental Visit||6||
48185689|NCT04648891|100775973|FG003|STARTED|Third Experimental Visit||5||
48185690|NCT04648891|100775974|FG004|STARTED|Third Experimental Visit||2||
48185691|NCT04648891|100775975|FG005|STARTED|Third Experimental Visit||6||
48185692|NCT04648891|100775970|FG000|COMPLETED|Third Experimental Visit||5||
48185693|NCT04648891|100775971|FG001|COMPLETED|Third Experimental Visit||8||
48185694|NCT04648891|100775972|FG002|COMPLETED|Third Experimental Visit||6||
48185695|NCT04648891|100775973|FG003|COMPLETED|Third Experimental Visit||5||
48185696|NCT04648891|100775974|FG004|COMPLETED|Third Experimental Visit||2||
48185697|NCT04648891|100775975|FG005|COMPLETED|Third Experimental Visit||6||
48185698|NCT04648891|100775970|FG000|NOT COMPLETED|Third Experimental Visit||0||
48185699|NCT04648891|100775971|FG001|NOT COMPLETED|Third Experimental Visit||0||
48185700|NCT04648891|100775972|FG002|NOT COMPLETED|Third Experimental Visit||0||
48185701|NCT04648891|100775973|FG003|NOT COMPLETED|Third Experimental Visit||0||
48185702|NCT04648891|100775974|FG004|NOT COMPLETED|Third Experimental Visit||0||
48185703|NCT04648891|100775975|FG005|NOT COMPLETED|Third Experimental Visit||0||
48415636|NCT00890201|101350334|FG001|NOT COMPLETED|Overall Study||56||
48415637|NCT02881151|101350335|FG000|STARTED|Hospital Admission and Surgery (3 Days)||6||
48415638|NCT02881151|101350335|FG000|COMPLETED|Hospital Admission and Surgery (3 Days)||6||
48415639|NCT02881151|101350335|FG000|NOT COMPLETED|Hospital Admission and Surgery (3 Days)||0||
48415640|NCT02881151|101350335|FG000|STARTED|Post-surgical Washout (65 to 93 Days)||6||
48415641|NCT02881151|101350335|FG000|COMPLETED|Post-surgical Washout (65 to 93 Days)||5||
48759633|NCT05712460|102200368|FG008|NOT COMPLETED|Part 2 Period 5 (1 Day)||0||
48759634|NCT05712460|102200369|FG009|NOT COMPLETED|Part 2 Period 5 (1 Day)||0||
48759635|NCT05712460|102200370|FG010|NOT COMPLETED|Part 2 Period 5 (1 Day)||0||
48759636|NCT05712460|102200371|FG011|NOT COMPLETED|Part 2 Period 5 (1 Day)||0||
48759637|NCT05712460|102200360|FG000|STARTED|Part 2 Period 6 (1 Day)||1||
48759638|NCT05712460|102200361|FG001|STARTED|Part 2 Period 6 (1 Day)||1||
48759639|NCT05712460|102200362|FG002|STARTED|Part 2 Period 6 (1 Day)||1||
48759640|NCT05712460|102200363|FG003|STARTED|Part 2 Period 6 (1 Day)||1||
48759641|NCT05712460|102200364|FG004|STARTED|Part 2 Period 6 (1 Day)||1||
48759642|NCT05712460|102200365|FG005|STARTED|Part 2 Period 6 (1 Day)||1||
48185704|NCT01347645|100775976|FG000|STARTED|Overall Study||3||
48185705|NCT01347645|100775977|FG001|STARTED|Overall Study||8||
48759643|NCT05712460|102200366|FG006|STARTED|Part 2 Period 6 (1 Day)||1||
48759644|NCT05712460|102200367|FG007|STARTED|Part 2 Period 6 (1 Day)||0||
48759645|NCT05712460|102200368|FG008|STARTED|Part 2 Period 6 (1 Day)||1||
48759646|NCT05712460|102200369|FG009|STARTED|Part 2 Period 6 (1 Day)||1||
48759647|NCT05712460|102200370|FG010|STARTED|Part 2 Period 6 (1 Day)||1||
48759648|NCT05712460|102200371|FG011|STARTED|Part 2 Period 6 (1 Day)||1||
48759649|NCT05712460|102200360|FG000|COMPLETED|Part 2 Period 6 (1 Day)||1||
48759650|NCT05712460|102200361|FG001|COMPLETED|Part 2 Period 6 (1 Day)||1||
48759651|NCT05712460|102200362|FG002|COMPLETED|Part 2 Period 6 (1 Day)||1||
48759652|NCT05712460|102200363|FG003|COMPLETED|Part 2 Period 6 (1 Day)||1||
48759653|NCT05712460|102200364|FG004|COMPLETED|Part 2 Period 6 (1 Day)||1||
48759654|NCT05712460|102200365|FG005|COMPLETED|Part 2 Period 6 (1 Day)||1||
48759655|NCT05712460|102200366|FG006|COMPLETED|Part 2 Period 6 (1 Day)||1||
48185706|NCT01347645|100775978|FG002|STARTED|Overall Study||3||
48185707|NCT01347645|100775979|FG003|STARTED|Overall Study||34||
48185708|NCT01347645|100775980|FG004|STARTED|Overall Study||34||
48185709|NCT01347645|100775976|FG000|COMPLETED|Overall Study||0||
48185710|NCT01347645|100775977|FG001|COMPLETED|Overall Study||0||
48185711|NCT01347645|100775978|FG002|COMPLETED|Overall Study||0||
48185712|NCT01347645|100775979|FG003|COMPLETED|Overall Study||0||
48185713|NCT01347645|100775980|FG004|COMPLETED|Overall Study||0||
48185714|NCT01347645|100775976|FG000|NOT COMPLETED|Overall Study||3||
48185715|NCT01347645|100775977|FG001|NOT COMPLETED|Overall Study||8||
48185716|NCT01347645|100775978|FG002|NOT COMPLETED|Overall Study||3||
48185717|NCT01347645|100775979|FG003|NOT COMPLETED|Overall Study||34||
48185718|NCT01347645|100775980|FG004|NOT COMPLETED|Overall Study||34||
48185719|NCT02865434|100775981|FG000|STARTED|Overall Study||3||
48185720|NCT02865434|100775982|FG001|STARTED|Overall Study||3||
48185721|NCT02865434|100775983|FG002|STARTED|Overall Study||3||
48185722|NCT02865434|100775984|FG003|STARTED|Overall Study||3||
48185723|NCT02865434|100775985|FG004|STARTED|Overall Study||3||
48185724|NCT02865434|100775986|FG005|STARTED|Overall Study||3||
48185725|NCT02865434|100775987|FG006|STARTED|Overall Study||3||
48185726|NCT02865434|100775988|FG007|STARTED|Overall Study||3||
48185727|NCT02865434|100775989|FG008|STARTED|Overall Study||3||
48185728|NCT02865434|100775990|FG009|STARTED|Overall Study||6||
48636964|NCT01692756|101894746|FG002|STARTED|Overall Study||13||
48636965|NCT01692756|101894747|FG003|STARTED|Overall Study||12||
48636966|NCT01692756|101894744|FG000|COMPLETED|Overall Study||11||
48636967|NCT01692756|101894745|FG001|COMPLETED|Overall Study||11||
48185729|NCT02865434|100775991|FG010|STARTED|Overall Study||6||
48185730|NCT02865434|100775981|FG000|COMPLETED|Overall Study||3||
48185731|NCT02865434|100775982|FG001|COMPLETED|Overall Study||3||
48185732|NCT02865434|100775983|FG002|COMPLETED|Overall Study||3||
48185733|NCT02865434|100775984|FG003|COMPLETED|Overall Study||3||
48185734|NCT02865434|100775985|FG004|COMPLETED|Overall Study||3||
48185735|NCT02865434|100775986|FG005|COMPLETED|Overall Study||3||
48185736|NCT02865434|100775987|FG006|COMPLETED|Overall Study||3||
48185737|NCT02865434|100775988|FG007|COMPLETED|Overall Study||3||
48185738|NCT02865434|100775989|FG008|COMPLETED|Overall Study||3||
48185739|NCT02865434|100775990|FG009|COMPLETED|Overall Study||6||
48185740|NCT02865434|100775991|FG010|COMPLETED|Overall Study||6||
48185741|NCT02865434|100775981|FG000|NOT COMPLETED|Overall Study||0||
48185742|NCT02865434|100775982|FG001|NOT COMPLETED|Overall Study||0||
48185743|NCT02865434|100775983|FG002|NOT COMPLETED|Overall Study||0||
48185744|NCT02865434|100775984|FG003|NOT COMPLETED|Overall Study||0||
48185745|NCT02865434|100775985|FG004|NOT COMPLETED|Overall Study||0||
48185746|NCT02865434|100775986|FG005|NOT COMPLETED|Overall Study||0||
48185747|NCT02865434|100775987|FG006|NOT COMPLETED|Overall Study||0||
48185748|NCT02865434|100775988|FG007|NOT COMPLETED|Overall Study||0||
48185749|NCT02865434|100775989|FG008|NOT COMPLETED|Overall Study||0||
48185750|NCT02865434|100775990|FG009|NOT COMPLETED|Overall Study||0||
48185751|NCT02865434|100775991|FG010|NOT COMPLETED|Overall Study||0||
48185752|NCT02040792|100775992|FG000|STARTED|Overall Study||70||
48185753|NCT02040792|100775993|FG001|STARTED|Overall Study||68||
48347028|NCT05195528|101180607|FG001|Safety Analysis Set|Extension Period||248|SAS: all safety analyses were conducted on the Safety Set using the actual treatment the participant received even if the participant was randomized to receive a different treatment.|
48347029|NCT05195528|101180608|FG002|Safety Analysis Set|Extension Period||236|SAS: all safety analyses were conducted on the Safety Set using the actual treatment the participant received even if the participant was randomized to receive a different treatment.|
48347030|NCT05195528|101180609|FG003|Safety Analysis Set|Extension Period||118|SAS: all safety analyses were conducted on the Safety Set using the actual treatment the participant received even if the participant was randomized to receive a different treatment.|
48347031|NCT05195528|101180610|FG004|Safety Analysis Set|Extension Period||121|SAS: all safety analyses were conducted on the Safety Set using the actual treatment the participant received even if the participant was randomized to receive a different treatment.|
48347032|NCT05195528|101180606|FG000|COMPLETED|Extension Period||0||
48636968|NCT01692756|101894746|FG002|COMPLETED|Overall Study||11||
48636969|NCT01692756|101894747|FG003|COMPLETED|Overall Study||12||
48636970|NCT01692756|101894744|FG000|NOT COMPLETED|Overall Study||1||
48636971|NCT01692756|101894745|FG001|NOT COMPLETED|Overall Study||1||
48636972|NCT01692756|101894746|FG002|NOT COMPLETED|Overall Study||2||
48636973|NCT01692756|101894747|FG003|NOT COMPLETED|Overall Study||0||
48636974|NCT00634972|101894748|FG000|STARTED|Overall Study||40||
48636975|NCT00634972|101894749|FG001|STARTED|Overall Study||43||
48636976|NCT00634972|101894748|FG000|COMPLETED|Overall Study||40||
48636977|NCT00634972|101894749|FG001|COMPLETED|Overall Study||43||
48636978|NCT00634972|101894748|FG000|NOT COMPLETED|Overall Study||0||
48636979|NCT00634972|101894749|FG001|NOT COMPLETED|Overall Study||0||
48636980|NCT03440320|101894750|FG000|STARTED|Overall Study||18||
48636981|NCT03440320|101894751|FG001|STARTED|Overall Study||14||
48636982|NCT03440320|101894750|FG000|COMPLETED|Overall Study||18||
48636983|NCT03440320|101894751|FG001|COMPLETED|Overall Study||13||
48185754|NCT02040792|100775994|FG002|STARTED|Overall Study||71||
48185755|NCT02040792|100775995|FG003|STARTED|Overall Study||71||
48185756|NCT02040792|100775996|FG004|STARTED|Overall Study||74||
48185757|NCT02040792|100775992|FG000|COMPLETED|Overall Study||64||
48185758|NCT02040792|100775993|FG001|COMPLETED|Overall Study||65||
48185759|NCT02040792|100775994|FG002|COMPLETED|Overall Study||68||
48185760|NCT02040792|100775995|FG003|COMPLETED|Overall Study||64||
48185761|NCT02040792|100775996|FG004|COMPLETED|Overall Study||67||
48185762|NCT02040792|100775992|FG000|NOT COMPLETED|Overall Study||6||
48185763|NCT02040792|100775993|FG001|NOT COMPLETED|Overall Study||3||
48185764|NCT02040792|100775994|FG002|NOT COMPLETED|Overall Study||3||
48185765|NCT02040792|100775995|FG003|NOT COMPLETED|Overall Study||7||
48185766|NCT02040792|100775996|FG004|NOT COMPLETED|Overall Study||7||
48185767|NCT02033993|100775997|FG000|STARTED|Overall Study||99||
48185768|NCT02033993|100775998|FG001|STARTED|Overall Study||100||
48185769|NCT02033993|100775997|FG000|COMPLETED|Overall Study||96||
48185770|NCT02033993|100775998|FG001|COMPLETED|Overall Study||91||
48185771|NCT02033993|100775997|FG000|NOT COMPLETED|Overall Study||3||
48185772|NCT02033993|100775998|FG001|NOT COMPLETED|Overall Study||9||
48185773|NCT00683449|100775999|FG000|STARTED|Overall Study||5||
48185774|NCT00683449|100776000|FG001|STARTED|Overall Study||13||
48185775|NCT00683449|100776001|FG002|STARTED|Overall Study||3||
48185776|NCT00683449|100776002|FG003|STARTED|Overall Study||6||
48185777|NCT00683449|100776003|FG004|STARTED|Overall Study||2||
48185778|NCT00683449|100775999|FG000|COMPLETED|Overall Study||5||
48185779|NCT00683449|100776000|FG001|COMPLETED|Overall Study||12||
48185780|NCT00683449|100776001|FG002|COMPLETED|Overall Study||3||
48185781|NCT00683449|100776002|FG003|COMPLETED|Overall Study||6||
48185782|NCT00683449|100776003|FG004|COMPLETED|Overall Study||2||
48185783|NCT00683449|100775999|FG000|NOT COMPLETED|Overall Study||0||
48185784|NCT00683449|100776000|FG001|NOT COMPLETED|Overall Study||1||
48185785|NCT00683449|100776001|FG002|NOT COMPLETED|Overall Study||0||
48185786|NCT00683449|100776002|FG003|NOT COMPLETED|Overall Study||0||
48185787|NCT00683449|100776003|FG004|NOT COMPLETED|Overall Study||0||
48185788|NCT03909165|100776004|FG000|STARTED|Overall Study||16||
48185789|NCT03909165|100776005|FG001|STARTED|Overall Study||34||
48185790|NCT03909165|100776006|FG002|STARTED|Overall Study||31||
48185791|NCT03909165|100776007|FG003|STARTED|Overall Study||32||
48185792|NCT03909165|100776008|FG004|STARTED|Overall Study||32||
48185793|NCT03909165|100776004|FG000|Treated|Overall Study||15||
48185794|NCT03909165|100776005|FG001|Treated|Overall Study||32||
48185795|NCT03909165|100776006|FG002|Treated|Overall Study||29||
48185796|NCT03909165|100776007|FG003|Treated|Overall Study||31||
48185797|NCT03909165|100776008|FG004|Treated|Overall Study||31||
48185798|NCT03909165|100776004|FG000|COMPLETED|Overall Study||15||
48185799|NCT03909165|100776005|FG001|COMPLETED|Overall Study||31||
48185800|NCT03909165|100776006|FG002|COMPLETED|Overall Study||29||
48185801|NCT03909165|100776007|FG003|COMPLETED|Overall Study||31||
48185802|NCT03909165|100776008|FG004|COMPLETED|Overall Study||31||
48185803|NCT03909165|100776004|FG000|NOT COMPLETED|Overall Study||1||
48185804|NCT03909165|100776005|FG001|NOT COMPLETED|Overall Study||3||
48185805|NCT03909165|100776006|FG002|NOT COMPLETED|Overall Study||2||
48185806|NCT03909165|100776007|FG003|NOT COMPLETED|Overall Study||1||
48185807|NCT03909165|100776008|FG004|NOT COMPLETED|Overall Study||1||
48185808|NCT02225275|100776009|FG000|STARTED|Overall Study||9||
48185809|NCT02225275|100776009|FG000|COMPLETED|Overall Study||9||
48185810|NCT02225275|100776009|FG000|NOT COMPLETED|Overall Study||0||
48185811|NCT01521143|100776010|FG000|STARTED|Overall Study||40||
48185812|NCT01521143|100776011|FG001|STARTED|Overall Study||36||
48185813|NCT01521143|100776012|FG002|STARTED|Overall Study||8||
48185814|NCT01521143|100776013|FG003|STARTED|Overall Study||7||
48185815|NCT01521143|100776010|FG000|Received Treatment|Overall Study||20||
48185816|NCT01521143|100776011|FG001|Received Treatment|Overall Study||20||
48185817|NCT01521143|100776012|FG002|Received Treatment|Overall Study||3||
48185818|NCT01521143|100776013|FG003|Received Treatment|Overall Study||4||
48185819|NCT01521143|100776010|FG000|COMPLETED|Overall Study||11||
48185820|NCT01521143|100776011|FG001|COMPLETED|Overall Study||10||
48185821|NCT01521143|100776012|FG002|COMPLETED|Overall Study||0||
48185822|NCT01521143|100776013|FG003|COMPLETED|Overall Study||0||
48185823|NCT01521143|100776010|FG000|NOT COMPLETED|Overall Study||29||
48185824|NCT01521143|100776011|FG001|NOT COMPLETED|Overall Study||26||
48185825|NCT01521143|100776012|FG002|NOT COMPLETED|Overall Study||8||
48185826|NCT01521143|100776013|FG003|NOT COMPLETED|Overall Study||7||
48185827|NCT03703206|100776014|FG000|STARTED|Overall Study||60||
48185828|NCT03703206|100776015|FG001|STARTED|Overall Study||59||
48185829|NCT03703206|100776014|FG000|COMPLETED|Overall Study||60||
48185830|NCT03703206|100776015|FG001|COMPLETED|Overall Study||59||
48185831|NCT03703206|100776014|FG000|NOT COMPLETED|Overall Study||0||
48185832|NCT03703206|100776015|FG001|NOT COMPLETED|Overall Study||0||
48185833|NCT02554513|100776016|FG000|STARTED|First Treatment Phase (7 Weeks)||3||
48185834|NCT02554513|100776017|FG001|STARTED|First Treatment Phase (7 Weeks)||3||
48185835|NCT02554513|100776016|FG000|COMPLETED|First Treatment Phase (7 Weeks)||3||
48185836|NCT02554513|100776017|FG001|COMPLETED|First Treatment Phase (7 Weeks)||2||
48185837|NCT02554513|100776016|FG000|NOT COMPLETED|First Treatment Phase (7 Weeks)||0||
48185838|NCT02554513|100776017|FG001|NOT COMPLETED|First Treatment Phase (7 Weeks)||1||
48185839|NCT02554513|100776016|FG000|STARTED|Washout (2 Weeks)||3||
48185840|NCT02554513|100776017|FG001|STARTED|Washout (2 Weeks)||2||
48185841|NCT02554513|100776016|FG000|COMPLETED|Washout (2 Weeks)||3||
48185842|NCT02554513|100776017|FG001|COMPLETED|Washout (2 Weeks)||2||
48185843|NCT02554513|100776016|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
48185844|NCT02554513|100776017|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
48185845|NCT02554513|100776016|FG000|STARTED|Second Treatment Phase (7 Weeks)||3||
48185846|NCT02554513|100776017|FG001|STARTED|Second Treatment Phase (7 Weeks)||2||
48185847|NCT02554513|100776016|FG000|COMPLETED|Second Treatment Phase (7 Weeks)||3||
48185848|NCT02554513|100776017|FG001|COMPLETED|Second Treatment Phase (7 Weeks)||2||
48185849|NCT02554513|100776016|FG000|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0||
48185850|NCT02554513|100776017|FG001|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0||
48185851|NCT00877851|100776018|FG000|STARTED|Overall Study||41||
48185852|NCT00877851|100776019|FG001|STARTED|Overall Study||43||
48185853|NCT00877851|100776018|FG000|COMPLETED|Overall Study||32||
48185854|NCT00877851|100776019|FG001|COMPLETED|Overall Study||38||
48185855|NCT00877851|100776018|FG000|NOT COMPLETED|Overall Study||9||
48759656|NCT05712460|102200367|FG007|COMPLETED|Part 2 Period 6 (1 Day)||0||
48759657|NCT05712460|102200368|FG008|COMPLETED|Part 2 Period 6 (1 Day)||1||
48759658|NCT05712460|102200369|FG009|COMPLETED|Part 2 Period 6 (1 Day)||1||
48759659|NCT05712460|102200370|FG010|COMPLETED|Part 2 Period 6 (1 Day)||1||
48759660|NCT05712460|102200371|FG011|COMPLETED|Part 2 Period 6 (1 Day)||1||
48185856|NCT00877851|100776019|FG001|NOT COMPLETED|Overall Study||5||
48185857|NCT03005288|100776020|FG000|STARTED|Overall Study||39|All the participants who were assigned a randomization number.|
48185858|NCT03005288|100776021|FG001|STARTED|Overall Study||39|All the participants who were assigned a randomization number.|
48185859|NCT03005288|100776020|FG000|Safety Analysis Set|Overall Study||37|All subjects that received any study drug.|
48185860|NCT03005288|100776021|FG001|Safety Analysis Set|Overall Study||38|All subjects that received any study drug.|
48185861|NCT03005288|100776020|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||36|All subjects who received any study drug and experienced no protocol deviations.|
48185862|NCT03005288|100776021|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||0|All subjects who received any study drug and experienced no protocol deviations.|
48185863|NCT03005288|100776020|FG000|Pharmacodynamics (PD) Analysis Set|Overall Study||36|All subjects who received any study drug and experienced no protocol deviations.|
48185864|NCT03005288|100776021|FG001|Pharmacodynamics (PD) Analysis Set|Overall Study||36|All subjects who received any study drug and experienced no protocol deviations.|
48185865|NCT03005288|100776020|FG000|COMPLETED|Overall Study||27||
48347033|NCT05195528|101180607|FG001|COMPLETED|Extension Period||219||
48347034|NCT05195528|101180608|FG002|COMPLETED|Extension Period||206||
48347035|NCT05195528|101180609|FG003|COMPLETED|Extension Period||106||
48347036|NCT05195528|101180610|FG004|COMPLETED|Extension Period||103||
48347037|NCT05195528|101180606|FG000|NOT COMPLETED|Extension Period||0||
48415642|NCT02881151|101350335|FG000|NOT COMPLETED|Post-surgical Washout (65 to 93 Days)||1||
48415643|NCT02881151|101350335|FG000|STARTED|DBS Titration-Optimization (14 Days)||5||
48415644|NCT02881151|101350335|FG000|COMPLETED|DBS Titration-Optimization (14 Days)||5||
48415645|NCT02881151|101350335|FG000|NOT COMPLETED|DBS Titration-Optimization (14 Days)||0||
48415646|NCT02881151|101350335|FG000|STARTED|Unblinded Treatment Phase (90 Days)||5||
48759661|NCT05712460|102200360|FG000|NOT COMPLETED|Part 2 Period 6 (1 Day)||0||
48759662|NCT05712460|102200361|FG001|NOT COMPLETED|Part 2 Period 6 (1 Day)||0||
48759663|NCT05712460|102200362|FG002|NOT COMPLETED|Part 2 Period 6 (1 Day)||0||
48759664|NCT05712460|102200363|FG003|NOT COMPLETED|Part 2 Period 6 (1 Day)||0||
48759665|NCT05712460|102200364|FG004|NOT COMPLETED|Part 2 Period 6 (1 Day)||0||
48759666|NCT05712460|102200365|FG005|NOT COMPLETED|Part 2 Period 6 (1 Day)||0||
48759667|NCT05712460|102200366|FG006|NOT COMPLETED|Part 2 Period 6 (1 Day)||0||
48185866|NCT03005288|100776021|FG001|COMPLETED|Overall Study||31||
48185867|NCT03005288|100776020|FG000|NOT COMPLETED|Overall Study||12||
48185868|NCT03005288|100776021|FG001|NOT COMPLETED|Overall Study||8||
48185869|NCT00372567|100776022|FG000|STARTED|Phase 1 Sub-study||0||
48185870|NCT00372567|100776023|FG001|STARTED|Phase 1 Sub-study||0||
48185871|NCT00372567|100776024|FG002|STARTED|Phase 1 Sub-study||12||
48185872|NCT00372567|100776022|FG000|COMPLETED|Phase 1 Sub-study||0||
48185873|NCT00372567|100776023|FG001|COMPLETED|Phase 1 Sub-study||0||
48185874|NCT00372567|100776024|FG002|COMPLETED|Phase 1 Sub-study||12||
48185875|NCT00372567|100776022|FG000|NOT COMPLETED|Phase 1 Sub-study||0||
48185876|NCT00372567|100776023|FG001|NOT COMPLETED|Phase 1 Sub-study||0||
48185877|NCT00372567|100776024|FG002|NOT COMPLETED|Phase 1 Sub-study||0||
48185878|NCT00372567|100776022|FG000|STARTED|Phase 3 Study||31||
48185879|NCT00372567|100776023|FG001|STARTED|Phase 3 Study||26||
48185880|NCT00372567|100776024|FG002|STARTED|Phase 3 Study||12||
48185881|NCT00372567|100776022|FG000|Received Treatment|Phase 3 Study||31||
48185882|NCT00372567|100776023|FG001|Received Treatment|Phase 3 Study||25||
48185883|NCT00372567|100776024|FG002|Received Treatment|Phase 3 Study||12||
48185884|NCT00372567|100776022|FG000|COMPLETED|Phase 3 Study||0||
48185885|NCT00372567|100776023|FG001|COMPLETED|Phase 3 Study||0||
48347038|NCT05195528|101180607|FG001|NOT COMPLETED|Extension Period||28||
48347039|NCT05195528|101180608|FG002|NOT COMPLETED|Extension Period||31||
48347040|NCT05195528|101180609|FG003|NOT COMPLETED|Extension Period||16||
48347041|NCT05195528|101180610|FG004|NOT COMPLETED|Extension Period||19||
48347042|NCT01309737|101180611|FG000|STARTED|Week 0 to 16||383||
48347043|NCT01309737|101180612|FG001|STARTED|Week 0 to 16||381||
48347044|NCT01309737|101180613|FG002|STARTED|Week 0 to 16||196||
48347045|NCT01309737|101180614|FG003|STARTED|Week 0 to 16||0||
48347046|NCT01309737|101180615|FG004|STARTED|Week 0 to 16||0||
48347047|NCT01309737|101180611|FG000|Treated|Week 0 to 16||382||
48347048|NCT01309737|101180612|FG001|Treated|Week 0 to 16||381||
48347049|NCT01309737|101180613|FG002|Treated|Week 0 to 16||196||
48347050|NCT01309737|101180614|FG003|Treated|Week 0 to 16||0||
48759668|NCT05712460|102200367|FG007|NOT COMPLETED|Part 2 Period 6 (1 Day)||0||
48347051|NCT01309737|101180615|FG004|Treated|Week 0 to 16||0||
48347052|NCT01309737|101180611|FG000|COMPLETED|Week 0 to 16||331||
48347053|NCT01309737|101180612|FG001|COMPLETED|Week 0 to 16||341||
48347054|NCT01309737|101180613|FG002|COMPLETED|Week 0 to 16||152||
48347055|NCT01309737|101180614|FG003|COMPLETED|Week 0 to 16||0||
48415647|NCT02881151|101350335|FG000|COMPLETED|Unblinded Treatment Phase (90 Days)||5||
48415648|NCT02881151|101350335|FG000|NOT COMPLETED|Unblinded Treatment Phase (90 Days)||0||
48415649|NCT02881151|101350335|FG000|STARTED|Withdrawal Phase (21 Days)||3||
48415650|NCT02881151|101350335|FG000|COMPLETED|Withdrawal Phase (21 Days)||3||
48415651|NCT02881151|101350335|FG000|NOT COMPLETED|Withdrawal Phase (21 Days)||0||
48347056|NCT01309737|101180615|FG004|COMPLETED|Week 0 to 16||0||
48347057|NCT01309737|101180611|FG000|NOT COMPLETED|Week 0 to 16||52||
48347058|NCT01309737|101180612|FG001|NOT COMPLETED|Week 0 to 16||40||
48347059|NCT01309737|101180613|FG002|NOT COMPLETED|Week 0 to 16||44||
48347060|NCT01309737|101180614|FG003|NOT COMPLETED|Week 0 to 16||0||
48347061|NCT01309737|101180615|FG004|NOT COMPLETED|Week 0 to 16||0||
48347062|NCT01309737|101180611|FG000|STARTED|Week 16 to 52||331||
48347063|NCT01309737|101180612|FG001|STARTED|Week 16 to 52||341||
48347064|NCT01309737|101180613|FG002|STARTED|Week 16 to 52||0||
48347065|NCT01309737|101180614|FG003|STARTED|Week 16 to 52||75||
48347066|NCT01309737|101180615|FG004|STARTED|Week 16 to 52||77||
48347067|NCT01309737|101180611|FG000|COMPLETED|Week 16 to 52||198||
48347068|NCT01309737|101180612|FG001|COMPLETED|Week 16 to 52||238||
48347069|NCT01309737|101180613|FG002|COMPLETED|Week 16 to 52||0||
48347070|NCT01309737|101180614|FG003|COMPLETED|Week 16 to 52||41||
48347071|NCT01309737|101180615|FG004|COMPLETED|Week 16 to 52||44||
48347072|NCT01309737|101180611|FG000|NOT COMPLETED|Week 16 to 52||133||
48415652|NCT02881151|101350335|FG000|STARTED|Continuation Phase (6 Months)||5||
48415653|NCT02881151|101350335|FG000|COMPLETED|Continuation Phase (6 Months)||5||
48415654|NCT02881151|101350335|FG000|NOT COMPLETED|Continuation Phase (6 Months)||0||
48347073|NCT01309737|101180612|FG001|NOT COMPLETED|Week 16 to 52||103||
48347074|NCT01309737|101180613|FG002|NOT COMPLETED|Week 16 to 52||0||
48347075|NCT01309737|101180614|FG003|NOT COMPLETED|Week 16 to 52||34||
48347076|NCT01309737|101180615|FG004|NOT COMPLETED|Week 16 to 52||33||
48347077|NCT02029976|101180616|FG000|STARTED|YR-1 Post Intervention vs Baseline||132||
48347078|NCT02029976|101180617|FG001|STARTED|YR-1 Post Intervention vs Baseline||132||
48347079|NCT02029976|101180616|FG000|COMPLETED|YR-1 Post Intervention vs Baseline||120||
48347080|NCT02029976|101180617|FG001|COMPLETED|YR-1 Post Intervention vs Baseline||124||
48347081|NCT02029976|101180616|FG000|NOT COMPLETED|YR-1 Post Intervention vs Baseline||12||
48347082|NCT02029976|101180617|FG001|NOT COMPLETED|YR-1 Post Intervention vs Baseline||8||
48347083|NCT02029976|101180616|FG000|STARTED|YR-2 Follow Up vs Baseline||132||
48347084|NCT02029976|101180617|FG001|STARTED|YR-2 Follow Up vs Baseline||132||
48347085|NCT02029976|101180616|FG000|COMPLETED|YR-2 Follow Up vs Baseline||122||
48347086|NCT02029976|101180617|FG001|COMPLETED|YR-2 Follow Up vs Baseline||124||
48347087|NCT02029976|101180616|FG000|NOT COMPLETED|YR-2 Follow Up vs Baseline||10||
48347088|NCT02029976|101180617|FG001|NOT COMPLETED|YR-2 Follow Up vs Baseline||8||
48347089|NCT00342355|101180618|FG000|STARTED|Overall Study||444||
48347090|NCT00342355|101180619|FG001|STARTED|Overall Study||440||
48347091|NCT00342355|101180620|FG002|STARTED|Overall Study||444||
48347092|NCT00342355|101180621|FG003|STARTED|Overall Study||443||
48347093|NCT00342355|101180618|FG000|COMPLETED|Overall Study||444||
48347094|NCT00342355|101180619|FG001|COMPLETED|Overall Study||440||
48347095|NCT00342355|101180620|FG002|COMPLETED|Overall Study||444||
48347096|NCT00342355|101180621|FG003|COMPLETED|Overall Study||443||
48347097|NCT00342355|101180618|FG000|NOT COMPLETED|Overall Study||0||
48347098|NCT00342355|101180619|FG001|NOT COMPLETED|Overall Study||0||
48347099|NCT00342355|101180620|FG002|NOT COMPLETED|Overall Study||0||
48347100|NCT00342355|101180621|FG003|NOT COMPLETED|Overall Study||0||
48347101|NCT00956930|101180622|FG000|STARTED|Overall Study||24||
48347102|NCT00956930|101180623|FG001|STARTED|Overall Study||21||
48347103|NCT00956930|101180622|FG000|COMPLETED|Overall Study||24||
48347104|NCT00956930|101180623|FG001|COMPLETED|Overall Study||21||
48347105|NCT00956930|101180622|FG000|NOT COMPLETED|Overall Study||0||
48347106|NCT00956930|101180623|FG001|NOT COMPLETED|Overall Study||0||
48347107|NCT02706938|101180624|FG000|STARTED|First Period, 6 Weeks||32||
48347108|NCT02706938|101180625|FG001|STARTED|First Period, 6 Weeks||33||
48347109|NCT02706938|101180624|FG000|COMPLETED|First Period, 6 Weeks||21||
48759669|NCT05712460|102200368|FG008|NOT COMPLETED|Part 2 Period 6 (1 Day)||0||
48759670|NCT05712460|102200369|FG009|NOT COMPLETED|Part 2 Period 6 (1 Day)||0||
48759671|NCT05712460|102200370|FG010|NOT COMPLETED|Part 2 Period 6 (1 Day)||0||
48759672|NCT05712460|102200371|FG011|NOT COMPLETED|Part 2 Period 6 (1 Day)||0||
48759673|NCT05712460|102200360|FG000|STARTED|Part 2 Period 7 (1 Day)||1||
48347110|NCT02706938|101180625|FG001|COMPLETED|First Period, 6 Weeks||31||
48347111|NCT02706938|101180624|FG000|NOT COMPLETED|First Period, 6 Weeks||11||
48347112|NCT02706938|101180625|FG001|NOT COMPLETED|First Period, 6 Weeks||2||
48347113|NCT02706938|101180624|FG000|STARTED|Second Period, 6 Weeks||21||
48347114|NCT02706938|101180625|FG001|STARTED|Second Period, 6 Weeks||31||
48347115|NCT02706938|101180624|FG000|COMPLETED|Second Period, 6 Weeks||21|Because this is a crossover trial, only 39 patients who completed both interventions were analyzed.|
48347116|NCT02706938|101180625|FG001|COMPLETED|Second Period, 6 Weeks||21|Because this is a crossover trial, only 39 patients who completed both interventions were analyzed.|
48347117|NCT02706938|101180624|FG000|NOT COMPLETED|Second Period, 6 Weeks||0||
48347118|NCT02706938|101180625|FG001|NOT COMPLETED|Second Period, 6 Weeks||10||
48636984|NCT03440320|101894750|FG000|NOT COMPLETED|Overall Study||0||
48636985|NCT03440320|101894751|FG001|NOT COMPLETED|Overall Study||1||
48636986|NCT02572167|101894752|FG000|STARTED|Overall Study||6||
48636987|NCT02572167|101894753|FG001|STARTED|Overall Study||56||
48347119|NCT03404648|101180626|FG000|STARTED|Overall Study||19||
48347120|NCT03404648|101180626|FG000|COMPLETED|Overall Study||19||
48347121|NCT03404648|101180626|FG000|NOT COMPLETED|Overall Study||0||
48347122|NCT01578902|101180627|FG000|STARTED|Overall Study||84||
48347123|NCT01578902|101180627|FG000|COMPLETED|Overall Study||84||
48347124|NCT01578902|101180627|FG000|NOT COMPLETED|Overall Study||0||
48347125|NCT01769105|101180628|FG000|STARTED|First Intervention||16||
48347126|NCT01769105|101180629|FG001|STARTED|First Intervention||19||
48347127|NCT01769105|101180628|FG000|COMPLETED|First Intervention||14||
48347128|NCT01769105|101180629|FG001|COMPLETED|First Intervention||17||
48347129|NCT01769105|101180628|FG000|NOT COMPLETED|First Intervention||2||
48347130|NCT01769105|101180629|FG001|NOT COMPLETED|First Intervention||2||
48347131|NCT01769105|101180628|FG000|STARTED|Cross-over||14||
48347132|NCT01769105|101180629|FG001|STARTED|Cross-over||0||
48347133|NCT01769105|101180628|FG000|COMPLETED|Cross-over||9||
48347134|NCT01769105|101180629|FG001|COMPLETED|Cross-over||0||
48347135|NCT01769105|101180628|FG000|NOT COMPLETED|Cross-over||5||
48636988|NCT02572167|101894754|FG002|STARTED|Overall Study||31||
48636989|NCT02572167|101894752|FG000|COMPLETED|Overall Study||0||
48636990|NCT02572167|101894753|FG001|COMPLETED|Overall Study||0||
48636991|NCT02572167|101894754|FG002|COMPLETED|Overall Study||0||
48759674|NCT05712460|102200361|FG001|STARTED|Part 2 Period 7 (1 Day)||1||
48347136|NCT01769105|101180629|FG001|NOT COMPLETED|Cross-over||0||
48347137|NCT00398112|101180630|FG000|STARTED|Overall Study||18||
48347138|NCT00398112|101180630|FG000|COMPLETED|Overall Study||0||
48347139|NCT00398112|101180630|FG000|NOT COMPLETED|Overall Study||18||
48347140|NCT00486603|101180631|FG000|STARTED|Overall Study||3||
48347141|NCT00486603|101180632|FG001|STARTED|Overall Study||7||
48347142|NCT00486603|101180633|FG002|STARTED|Overall Study||3||
48636992|NCT02572167|101894752|FG000|NOT COMPLETED|Overall Study||6||
48636993|NCT02572167|101894753|FG001|NOT COMPLETED|Overall Study||56||
48759675|NCT05712460|102200362|FG002|STARTED|Part 2 Period 7 (1 Day)||1||
48759676|NCT05712460|102200363|FG003|STARTED|Part 2 Period 7 (1 Day)||1||
48759677|NCT05712460|102200364|FG004|STARTED|Part 2 Period 7 (1 Day)||1||
48347143|NCT00486603|101180634|FG003|STARTED|Overall Study||3||
48347144|NCT00486603|101180635|FG004|STARTED|Overall Study||76||
48347145|NCT00486603|101180631|FG000|COMPLETED|Overall Study||2||
48347146|NCT00486603|101180632|FG001|COMPLETED|Overall Study||6||
48347147|NCT00486603|101180633|FG002|COMPLETED|Overall Study||3||
48347148|NCT00486603|101180634|FG003|COMPLETED|Overall Study||3||
48636994|NCT02572167|101894754|FG002|NOT COMPLETED|Overall Study||31||
48759678|NCT05712460|102200365|FG005|STARTED|Part 2 Period 7 (1 Day)||1||
48347149|NCT00486603|101180635|FG004|COMPLETED|Overall Study||76||
48347150|NCT00486603|101180631|FG000|NOT COMPLETED|Overall Study||1||
48347151|NCT00486603|101180632|FG001|NOT COMPLETED|Overall Study||1||
48347152|NCT00486603|101180633|FG002|NOT COMPLETED|Overall Study||0||
48759679|NCT05712460|102200366|FG006|STARTED|Part 2 Period 7 (1 Day)||1||
48759680|NCT05712460|102200367|FG007|STARTED|Part 2 Period 7 (1 Day)||0||
48759681|NCT05712460|102200368|FG008|STARTED|Part 2 Period 7 (1 Day)||1||
48347153|NCT00486603|101180634|FG003|NOT COMPLETED|Overall Study||0||
48347154|NCT00486603|101180635|FG004|NOT COMPLETED|Overall Study||0||
48347155|NCT00365989|101180636|FG000|STARTED|Overall Study||50||
48347156|NCT00365989|101180636|FG000|COMPLETED|Overall Study||48||
48347157|NCT00365989|101180636|FG000|NOT COMPLETED|Overall Study||2||
48347158|NCT03912584|101180637|FG000|STARTED|Overall Study||10||
48347159|NCT03912584|101180637|FG000|COMPLETED|Overall Study||10||
48347160|NCT03912584|101180637|FG000|NOT COMPLETED|Overall Study||0||
48347161|NCT01128387|101180638|FG000|STARTED|Overall Study||5||
48347162|NCT01128387|101180639|FG001|STARTED|Overall Study||6||
48347163|NCT01128387|101180638|FG000|COMPLETED|Overall Study||5||
48347164|NCT01128387|101180639|FG001|COMPLETED|Overall Study||5||
48347165|NCT01128387|101180638|FG000|NOT COMPLETED|Overall Study||0||
48347166|NCT01128387|101180639|FG001|NOT COMPLETED|Overall Study||1||
48347167|NCT02216136|101180640|FG000|STARTED|Overall Study||72||
48347168|NCT02216136|101180641|FG001|STARTED|Overall Study||90||
48347169|NCT02216136|101180642|FG002|STARTED|Overall Study||0||
48347170|NCT02216136|101180640|FG000|COMPLETED|Overall Study||72||
48347171|NCT02216136|101180641|FG001|COMPLETED|Overall Study||90||
48347172|NCT02216136|101180642|FG002|COMPLETED|Overall Study||0||
48759682|NCT05712460|102200369|FG009|STARTED|Part 2 Period 7 (1 Day)||1||
48759683|NCT05712460|102200370|FG010|STARTED|Part 2 Period 7 (1 Day)||1||
48759684|NCT05712460|102200371|FG011|STARTED|Part 2 Period 7 (1 Day)||1||
48759685|NCT05712460|102200360|FG000|COMPLETED|Part 2 Period 7 (1 Day)||1||
48759686|NCT05712460|102200361|FG001|COMPLETED|Part 2 Period 7 (1 Day)||1||
48759687|NCT05712460|102200362|FG002|COMPLETED|Part 2 Period 7 (1 Day)||1||
48347173|NCT02216136|101180640|FG000|NOT COMPLETED|Overall Study||0||
48347174|NCT02216136|101180641|FG001|NOT COMPLETED|Overall Study||0||
48347175|NCT02216136|101180642|FG002|NOT COMPLETED|Overall Study||0||
48347176|NCT04525703|101180643|FG000|STARTED|Overall Study||12||
48347177|NCT04525703|101180644|FG001|STARTED|Overall Study||21||
48347178|NCT04525703|101180645|FG002|STARTED|Overall Study||15||
48347179|NCT04525703|101180643|FG000|Completed Baseline Interview|Overall Study||12||
48347180|NCT04525703|101180644|FG001|Completed Baseline Interview|Overall Study||21||
48347181|NCT04525703|101180645|FG002|Completed Baseline Interview|Overall Study||15||
48347182|NCT04525703|101180643|FG000|Attended Any of the P4P Program|Overall Study||9||
48347183|NCT04525703|101180644|FG001|Attended Any of the P4P Program|Overall Study||16||
48347184|NCT04525703|101180645|FG002|Attended Any of the P4P Program|Overall Study||11||
48347185|NCT04525703|101180643|FG000|Completed P4P Program|Overall Study||7||
48347186|NCT04525703|101180644|FG001|Completed P4P Program|Overall Study||12||
48347187|NCT04525703|101180645|FG002|Completed P4P Program|Overall Study||9||
48347188|NCT04525703|101180643|FG000|Completed Post Intervention Survey|Overall Study||7||
48347189|NCT04525703|101180644|FG001|Completed Post Intervention Survey|Overall Study||12||
48347190|NCT04525703|101180645|FG002|Completed Post Intervention Survey|Overall Study||9||
48347191|NCT04525703|101180643|FG000|Completed 3-month Follow up Survey|Overall Study||6||
48347192|NCT04525703|101180644|FG001|Completed 3-month Follow up Survey|Overall Study||6||
48347193|NCT04525703|101180645|FG002|Completed 3-month Follow up Survey|Overall Study||7||
48347194|NCT04525703|101180643|FG000|COMPLETED|Overall Study||6||
48347195|NCT04525703|101180644|FG001|COMPLETED|Overall Study||6||
48347196|NCT04525703|101180645|FG002|COMPLETED|Overall Study||7||
48347197|NCT04525703|101180643|FG000|NOT COMPLETED|Overall Study||6||
48636995|NCT00424008|101894755|FG000|STARTED|Overall Study||371||
48636996|NCT00424008|101894756|FG001|STARTED|Overall Study||351||
48636997|NCT00424008|101894755|FG000|COMPLETED|Overall Study||22||
48636998|NCT00424008|101894756|FG001|COMPLETED|Overall Study||16||
48636999|NCT00424008|101894755|FG000|NOT COMPLETED|Overall Study||349||
48637000|NCT00424008|101894756|FG001|NOT COMPLETED|Overall Study||335||
48637001|NCT02934178|101894757|FG000|STARTED|Received Vaccination 1||12||
48637002|NCT02934178|101894758|FG001|STARTED|Received Vaccination 1||4||
48637003|NCT02934178|101894757|FG000|COMPLETED|Received Vaccination 1||12||
48637004|NCT02934178|101894758|FG001|COMPLETED|Received Vaccination 1||4||
48637005|NCT02934178|101894757|FG000|NOT COMPLETED|Received Vaccination 1||0||
48637006|NCT02934178|101894758|FG001|NOT COMPLETED|Received Vaccination 1||0||
48637007|NCT02934178|101894757|FG000|STARTED|Received Vaccination 2||12||
48637008|NCT02934178|101894758|FG001|STARTED|Received Vaccination 2||4||
48637009|NCT02934178|101894757|FG000|COMPLETED|Received Vaccination 2||12||
48637010|NCT02934178|101894758|FG001|COMPLETED|Received Vaccination 2||3||
48637011|NCT02934178|101894757|FG000|NOT COMPLETED|Received Vaccination 2||0||
48637012|NCT02934178|101894758|FG001|NOT COMPLETED|Received Vaccination 2||1||
48637013|NCT02934178|101894757|FG000|STARTED|Received Vaccination 3||12||
48637014|NCT02934178|101894758|FG001|STARTED|Received Vaccination 3||3||
48759688|NCT05712460|102200363|FG003|COMPLETED|Part 2 Period 7 (1 Day)||1||
48759689|NCT05712460|102200364|FG004|COMPLETED|Part 2 Period 7 (1 Day)||1||
48759690|NCT05712460|102200365|FG005|COMPLETED|Part 2 Period 7 (1 Day)||1||
48759691|NCT05712460|102200366|FG006|COMPLETED|Part 2 Period 7 (1 Day)||1||
48759692|NCT05712460|102200367|FG007|COMPLETED|Part 2 Period 7 (1 Day)||0||
48759693|NCT05712460|102200368|FG008|COMPLETED|Part 2 Period 7 (1 Day)||1||
48759694|NCT05712460|102200369|FG009|COMPLETED|Part 2 Period 7 (1 Day)||1||
48759695|NCT05712460|102200370|FG010|COMPLETED|Part 2 Period 7 (1 Day)||1||
48759696|NCT05712460|102200371|FG011|COMPLETED|Part 2 Period 7 (1 Day)||1||
48759697|NCT05712460|102200360|FG000|NOT COMPLETED|Part 2 Period 7 (1 Day)||0||
48759698|NCT05712460|102200361|FG001|NOT COMPLETED|Part 2 Period 7 (1 Day)||0||
48759699|NCT05712460|102200362|FG002|NOT COMPLETED|Part 2 Period 7 (1 Day)||0||
48759700|NCT05712460|102200363|FG003|NOT COMPLETED|Part 2 Period 7 (1 Day)||0||
48759701|NCT05712460|102200364|FG004|NOT COMPLETED|Part 2 Period 7 (1 Day)||0||
48759702|NCT05712460|102200365|FG005|NOT COMPLETED|Part 2 Period 7 (1 Day)||0||
48759703|NCT05712460|102200366|FG006|NOT COMPLETED|Part 2 Period 7 (1 Day)||0||
48759704|NCT05712460|102200367|FG007|NOT COMPLETED|Part 2 Period 7 (1 Day)||0||
48759705|NCT05712460|102200368|FG008|NOT COMPLETED|Part 2 Period 7 (1 Day)||0||
48759706|NCT05712460|102200369|FG009|NOT COMPLETED|Part 2 Period 7 (1 Day)||0||
48759707|NCT05712460|102200370|FG010|NOT COMPLETED|Part 2 Period 7 (1 Day)||0||
48759708|NCT05712460|102200371|FG011|NOT COMPLETED|Part 2 Period 7 (1 Day)||0||
48759709|NCT02086175|102200372|FG000|STARTED|Overall Study||25||
48759710|NCT02086175|102200372|FG000|COMPLETED|Overall Study||25||
48759711|NCT02086175|102200372|FG000|NOT COMPLETED|Overall Study||0||
48759712|NCT03542812|102200373|FG000|STARTED|Overall Study||10||
48759713|NCT03542812|102200374|FG001|STARTED|Overall Study||6||
48759714|NCT03542812|102200373|FG000|COMPLETED|Overall Study||10||
48347198|NCT04525703|101180644|FG001|NOT COMPLETED|Overall Study||15||
48347199|NCT04525703|101180645|FG002|NOT COMPLETED|Overall Study||8||
48347200|NCT01361711|101180646|FG000|STARTED|Trial Entry (Registration)||53||
48347201|NCT01361711|101180646|FG000|Received Dose of Study Drug|Trial Entry (Registration)||52||
48347202|NCT01361711|101180646|FG000|COMPLETED|Trial Entry (Registration)||52||
48347203|NCT01361711|101180646|FG000|NOT COMPLETED|Trial Entry (Registration)||1||
48347204|NCT01361711|101180646|FG000|STARTED|Week 9 Bone Marrow Response Assessment||52||
48347205|NCT01361711|101180646|FG000|COMPLETED|Week 9 Bone Marrow Response Assessment||51|As soon as a patient is determined to have achieved Minimal Residual Disease negative Complete Remission or Complete remission with incomplete marrow recovery (per iwCLL2008 criteria), both alemtuzumab and ofatumumab will be stopped.|
48347206|NCT01361711|101180646|FG000|NOT COMPLETED|Week 9 Bone Marrow Response Assessment||1||
48347207|NCT01361711|101180646|FG000|STARTED|Continued Treatment After 9 Weeks||51||
48347208|NCT01361711|101180646|FG000|COMPLETED|Continued Treatment After 9 Weeks||44|As soon as a patient is determined to have achieved Minimal Residual Disease negative Complete Remission or Complete remission with incomplete marrow recovery (per iwCLL2008 criteria), both alemtuzumab and ofatumumab will be stopped.|
48347209|NCT01361711|101180646|FG000|NOT COMPLETED|Continued Treatment After 9 Weeks||7||
48347210|NCT01361711|101180646|FG000|STARTED|Continued Treatment After 12 Weeks||44|A bone marrow biopsy will be performed during week 9 to assess response. If biopsy results show residual CLL with minimal involvement (\< 10% involvement), an additional bone marrow biopsy is recommended after week 12 of treatment.|
48347211|NCT01361711|101180646|FG000|COMPLETED|Continued Treatment After 12 Weeks||41|As soon as a patient is determined to have achieved Minimal Residual Disease negative Complete Remission or Complete remission with incomplete marrow recovery (per iwCLL2008 criteria), both alemtuzumab and ofatumumab will be stopped.|
48347212|NCT01361711|101180646|FG000|NOT COMPLETED|Continued Treatment After 12 Weeks||3||
48347213|NCT01361711|101180646|FG000|STARTED|Completed Week 18 of Treatment||41||
48347214|NCT01361711|101180646|FG000|COMPLETED|Completed Week 18 of Treatment||30|As soon as a patient is determined to have achieved Minimal Residual Disease negative Complete Remission or Complete remission with incomplete marrow recovery (per iwCLL2008 criteria), both alemtuzumab and ofatumumab will be stopped.|
48347215|NCT01361711|101180646|FG000|NOT COMPLETED|Completed Week 18 of Treatment||11||
48347216|NCT01361711|101180646|FG000|STARTED|10 Year Follow-up||52||
48347217|NCT01361711|101180646|FG000|COMPLETED|10 Year Follow-up||2||
48347218|NCT01361711|101180646|FG000|NOT COMPLETED|10 Year Follow-up||50||
48347219|NCT03417440|101180647|FG000|STARTED|Overall Study||13||
48347220|NCT03417440|101180648|FG001|STARTED|Overall Study||13||
48347221|NCT03417440|101180649|FG002|STARTED|Overall Study||14||
48347222|NCT03417440|101180650|FG003|STARTED|Overall Study||14||
48347223|NCT03417440|101180651|FG004|STARTED|Overall Study||14||
48415655|NCT02477800|101350336|FG000|STARTED|Placebo-Controlled Period||545||
48637015|NCT02934178|101894757|FG000|COMPLETED|Received Vaccination 3||11||
48637016|NCT02934178|101894758|FG001|COMPLETED|Received Vaccination 3||3||
48637017|NCT02934178|101894757|FG000|NOT COMPLETED|Received Vaccination 3||1||
48637018|NCT02934178|101894758|FG001|NOT COMPLETED|Received Vaccination 3||0||
48637019|NCT01050153|101894759|FG000|STARTED|Overall Study||25||
48637020|NCT01050153|101894760|FG001|STARTED|Overall Study||25||
48637021|NCT01050153|101894759|FG000|COMPLETED|Overall Study||25||
48637022|NCT01050153|101894760|FG001|COMPLETED|Overall Study||25||
48637023|NCT01050153|101894759|FG000|NOT COMPLETED|Overall Study||0||
48637024|NCT01050153|101894760|FG001|NOT COMPLETED|Overall Study||0||
48759715|NCT03542812|102200374|FG001|COMPLETED|Overall Study||6||
48759716|NCT03542812|102200373|FG000|NOT COMPLETED|Overall Study||0||
48759717|NCT03542812|102200374|FG001|NOT COMPLETED|Overall Study||0||
48759718|NCT01838395|102200375|FG000|STARTED|Overall Study||3||
48759719|NCT01838395|102200376|FG001|STARTED|Overall Study||3||
48759720|NCT01838395|102200377|FG002|STARTED|Overall Study||6||
48759721|NCT01838395|102200378|FG003|STARTED|Overall Study||4||
48347224|NCT03417440|101180652|FG005|STARTED|Overall Study||12||
48347225|NCT03417440|101180653|FG006|STARTED|Overall Study||15||
48347226|NCT03417440|101180654|FG007|STARTED|Overall Study||12||
48347227|NCT03417440|101180647|FG000|Non-completer But Included in ITT|Overall Study||1||
48347228|NCT03417440|101180648|FG001|Non-completer But Included in ITT|Overall Study||1||
48347229|NCT03417440|101180649|FG002|Non-completer But Included in ITT|Overall Study||1||
48347230|NCT03417440|101180650|FG003|Non-completer But Included in ITT|Overall Study||1||
48347231|NCT03417440|101180651|FG004|Non-completer But Included in ITT|Overall Study||2||
48347232|NCT03417440|101180652|FG005|Non-completer But Included in ITT|Overall Study||0||
48347233|NCT03417440|101180653|FG006|Non-completer But Included in ITT|Overall Study||0||
48347234|NCT03417440|101180654|FG007|Non-completer But Included in ITT|Overall Study||1||
48347235|NCT03417440|101180647|FG000|Non-completer But NOT Included in ITT|Overall Study||1||
48347236|NCT03417440|101180648|FG001|Non-completer But NOT Included in ITT|Overall Study||0||
48347237|NCT03417440|101180649|FG002|Non-completer But NOT Included in ITT|Overall Study||1||
48347238|NCT03417440|101180650|FG003|Non-completer But NOT Included in ITT|Overall Study||0||
48347239|NCT03417440|101180651|FG004|Non-completer But NOT Included in ITT|Overall Study||0||
48347240|NCT03417440|101180652|FG005|Non-completer But NOT Included in ITT|Overall Study||0||
48347241|NCT03417440|101180653|FG006|Non-completer But NOT Included in ITT|Overall Study||0||
48347242|NCT03417440|101180654|FG007|Non-completer But NOT Included in ITT|Overall Study||0||
48347243|NCT03417440|101180647|FG000|COMPLETED|Overall Study||11||
48347244|NCT03417440|101180648|FG001|COMPLETED|Overall Study||12||
48347245|NCT03417440|101180649|FG002|COMPLETED|Overall Study||12||
48347246|NCT03417440|101180650|FG003|COMPLETED|Overall Study||13||
48347247|NCT03417440|101180651|FG004|COMPLETED|Overall Study||12||
48347248|NCT03417440|101180652|FG005|COMPLETED|Overall Study||12||
48347249|NCT03417440|101180653|FG006|COMPLETED|Overall Study||15||
48347250|NCT03417440|101180654|FG007|COMPLETED|Overall Study||11||
48347251|NCT03417440|101180647|FG000|NOT COMPLETED|Overall Study||2||
48347252|NCT03417440|101180648|FG001|NOT COMPLETED|Overall Study||1||
48347253|NCT03417440|101180649|FG002|NOT COMPLETED|Overall Study||2||
48347254|NCT03417440|101180650|FG003|NOT COMPLETED|Overall Study||1||
48347255|NCT03417440|101180651|FG004|NOT COMPLETED|Overall Study||2||
48347256|NCT03417440|101180652|FG005|NOT COMPLETED|Overall Study||0||
48347257|NCT03417440|101180653|FG006|NOT COMPLETED|Overall Study||0||
48347258|NCT03417440|101180654|FG007|NOT COMPLETED|Overall Study||1||
48347259|NCT03871491|101180655|FG000|STARTED|Overall Study||14590||
48759722|NCT01838395|102200379|FG004|STARTED|Overall Study||23||
48759723|NCT01838395|102200380|FG005|STARTED|Overall Study||3||
48759724|NCT01838395|102200375|FG000|COMPLETED|Overall Study||3||
48759725|NCT01838395|102200376|FG001|COMPLETED|Overall Study||2||
48759726|NCT01838395|102200377|FG002|COMPLETED|Overall Study||5||
48759727|NCT01838395|102200378|FG003|COMPLETED|Overall Study||4||
48759728|NCT01838395|102200379|FG004|COMPLETED|Overall Study||22||
48759729|NCT01838395|102200380|FG005|COMPLETED|Overall Study||3||
48759730|NCT01838395|102200375|FG000|NOT COMPLETED|Overall Study||0||
48759731|NCT01838395|102200376|FG001|NOT COMPLETED|Overall Study||1||
48759732|NCT01838395|102200377|FG002|NOT COMPLETED|Overall Study||1||
48759733|NCT01838395|102200378|FG003|NOT COMPLETED|Overall Study||0||
48759734|NCT01838395|102200379|FG004|NOT COMPLETED|Overall Study||1||
48759735|NCT01838395|102200380|FG005|NOT COMPLETED|Overall Study||0||
48347260|NCT03871491|101180656|FG001|STARTED|Overall Study||14687||
48347261|NCT03871491|101180657|FG002|STARTED|Overall Study||14688||
48347262|NCT03871491|101180658|FG003|STARTED|Overall Study||14782||
48347263|NCT03871491|101180655|FG000|Treated|Overall Study||14589||
48347264|NCT03871491|101180656|FG001|Treated|Overall Study||14686||
48347265|NCT03871491|101180657|FG002|Treated|Overall Study||14687||
48347266|NCT03871491|101180658|FG003|Treated|Overall Study||14781||
48347267|NCT03871491|101180655|FG000|Included in Intention to Treat (ITT) Analysis|Overall Study||14590||
48415656|NCT02477800|101350337|FG001|STARTED|Placebo-Controlled Period||547||
48347268|NCT03871491|101180656|FG001|Included in Intention to Treat (ITT) Analysis|Overall Study||14687||
48347269|NCT03871491|101180657|FG002|Included in Intention to Treat (ITT) Analysis|Overall Study||14688||
48415657|NCT02477800|101350338|FG002|STARTED|Placebo-Controlled Period||555||
48415658|NCT02477800|101350339|FG003|STARTED|Placebo-Controlled Period||0||
48415659|NCT02477800|101350340|FG004|STARTED|Placebo-Controlled Period||0||
48347270|NCT03871491|101180658|FG003|Included in Intention to Treat (ITT) Analysis|Overall Study||14782||
48347271|NCT03871491|101180655|FG000|COMPLETED|Overall Study||14526||
48347272|NCT03871491|101180656|FG001|COMPLETED|Overall Study||14658||
48347273|NCT03871491|101180657|FG002|COMPLETED|Overall Study||14637||
48347274|NCT03871491|101180658|FG003|COMPLETED|Overall Study||14756||
48759736|NCT01690143|102200381|FG000|STARTED|Overall Study||45||
48415660|NCT02477800|101350341|FG005|STARTED|Placebo-Controlled Period||0||
48759737|NCT01690143|102200381|FG000|COMPLETED|Overall Study||44||
48759738|NCT01690143|102200381|FG000|NOT COMPLETED|Overall Study||1||
48759739|NCT04750824|102200382|FG000|STARTED|Overall Study||72||
48759740|NCT04750824|102200383|FG001|STARTED|Overall Study||38||
48759741|NCT04750824|102200382|FG000|First Line Therapy Patients|Overall Study||16||
48759742|NCT04750824|102200383|FG001|First Line Therapy Patients|Overall Study||36||
48759743|NCT04750824|102200382|FG000|COMPLETED|Overall Study||10|Patients receiving index therapy at data collection (i.e.11-November-2020 to 20-January-2021)|
48347275|NCT03871491|101180655|FG000|NOT COMPLETED|Overall Study||64||
48347276|NCT03871491|101180656|FG001|NOT COMPLETED|Overall Study||29||
48347277|NCT03871491|101180657|FG002|NOT COMPLETED|Overall Study||51||
48347278|NCT03871491|101180658|FG003|NOT COMPLETED|Overall Study||26||
48347279|NCT03593915|101180659|FG000|STARTED|Overall Study||3|Any patient who received at least 1 dose of study drug.|
48347280|NCT03593915|101180660|FG001|STARTED|Overall Study||3|Any patient who received at least 1 dose of study drug.|
48347281|NCT03593915|101180661|FG002|STARTED|Overall Study||3|Any patient who received at least 1 dose of study drug.|
48347282|NCT03593915|101180662|FG003|STARTED|Overall Study||4|Any patient who received at least 1 dose of study drug.|
48347283|NCT03593915|101180663|FG004|STARTED|Overall Study||3|Any patient who received at least 1 dose of study drug.|
48347284|NCT03593915|101180664|FG005|STARTED|Overall Study||4|Any patient who received at least 1 dose of study drug.|
48347285|NCT03593915|101180659|FG000|COMPLETED|Overall Study||3|Completed Cycle 1|
48347286|NCT03593915|101180660|FG001|COMPLETED|Overall Study||3|Completed Cycle 1|
48347287|NCT03593915|101180661|FG002|COMPLETED|Overall Study||3|Completed Cycle 1|
48347288|NCT03593915|101180662|FG003|COMPLETED|Overall Study||3|Completed Cycle 1|
48347289|NCT03593915|101180663|FG004|COMPLETED|Overall Study||3|Completed Cycle 1|
48347290|NCT03593915|101180664|FG005|COMPLETED|Overall Study||3|Completed Cycle 1|
48347291|NCT03593915|101180659|FG000|NOT COMPLETED|Overall Study||0||
48347292|NCT03593915|101180660|FG001|NOT COMPLETED|Overall Study||0||
48347293|NCT03593915|101180661|FG002|NOT COMPLETED|Overall Study||0||
48347294|NCT03593915|101180662|FG003|NOT COMPLETED|Overall Study||1||
48347295|NCT03593915|101180663|FG004|NOT COMPLETED|Overall Study||0||
48347296|NCT03593915|101180664|FG005|NOT COMPLETED|Overall Study||1||
48347297|NCT00825370|101180665|FG000|STARTED|Overall Study||175||
48347298|NCT00825370|101180666|FG001|STARTED|Overall Study||175||
48347299|NCT00825370|101180665|FG000|COMPLETED|Overall Study||175||
48347300|NCT00825370|101180666|FG001|COMPLETED|Overall Study||175||
48347301|NCT00825370|101180665|FG000|NOT COMPLETED|Overall Study||0||
48347302|NCT00825370|101180666|FG001|NOT COMPLETED|Overall Study||0||
48347303|NCT00238264|101180667|FG000|STARTED|Overall Study||92||
48347304|NCT00238264|101180667|FG000|COMPLETED|Overall Study||56||
48347305|NCT00238264|101180667|FG000|NOT COMPLETED|Overall Study||36||
48347306|NCT03035760|101180668|FG000|STARTED|First Intervention - 10/7 Days Follow-up||8||
48347307|NCT03035760|101180669|FG001|STARTED|First Intervention - 10/7 Days Follow-up||8||
48347308|NCT03035760|101180670|FG002|STARTED|First Intervention - 10/7 Days Follow-up||8||
48347309|NCT03035760|101180671|FG003|STARTED|First Intervention - 10/7 Days Follow-up||6||
48347310|NCT03035760|101180672|FG004|STARTED|First Intervention - 10/7 Days Follow-up||6||
48347311|NCT03035760|101180668|FG000|COMPLETED|First Intervention - 10/7 Days Follow-up||8||
48347312|NCT03035760|101180669|FG001|COMPLETED|First Intervention - 10/7 Days Follow-up||8||
48347313|NCT03035760|101180670|FG002|COMPLETED|First Intervention - 10/7 Days Follow-up||8||
48347314|NCT03035760|101180671|FG003|COMPLETED|First Intervention - 10/7 Days Follow-up||6||
48347315|NCT03035760|101180672|FG004|COMPLETED|First Intervention - 10/7 Days Follow-up||6||
48347316|NCT03035760|101180668|FG000|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0||
48347317|NCT03035760|101180669|FG001|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0||
48347318|NCT03035760|101180670|FG002|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0||
48347319|NCT03035760|101180671|FG003|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0||
48759744|NCT04750824|102200383|FG001|COMPLETED|Overall Study||14|Patients receiving index therapy at data collection (i.e.11-November-2020 to 20-January-2021)|
48759745|NCT04750824|102200382|FG000|NOT COMPLETED|Overall Study||62||
48759746|NCT04750824|102200383|FG001|NOT COMPLETED|Overall Study||24||
48759747|NCT00717574|102200384|FG000|STARTED|Overall Study||16||
48759748|NCT00717574|102200385|FG001|STARTED|Overall Study||16||
48759749|NCT00717574|102200384|FG000|COMPLETED|Overall Study||14||
48759750|NCT00717574|102200385|FG001|COMPLETED|Overall Study||14||
48759751|NCT00717574|102200384|FG000|NOT COMPLETED|Overall Study||2||
48759752|NCT00717574|102200385|FG001|NOT COMPLETED|Overall Study||2||
48759753|NCT04913610|102200386|FG000|STARTED|Randomized Participants||31||
48759754|NCT04913610|102200387|FG001|STARTED|Randomized Participants||31||
48759755|NCT04913610|102200388|FG002|STARTED|Randomized Participants||30||
48759756|NCT04913610|102200389|FG003|STARTED|Randomized Participants||30||
48759757|NCT04913610|102200390|FG004|STARTED|Randomized Participants||31||
48759758|NCT04913610|102200386|FG000|COMPLETED|Randomized Participants||31||
48759759|NCT04913610|102200387|FG001|COMPLETED|Randomized Participants||31||
48759760|NCT04913610|102200388|FG002|COMPLETED|Randomized Participants||29||
48347320|NCT03035760|101180672|FG004|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0||
48347321|NCT03035760|101180668|FG000|STARTED|Second Intervention - 7 Days Follow-up||0||
48347322|NCT03035760|101180669|FG001|STARTED|Second Intervention - 7 Days Follow-up||0||
48347323|NCT03035760|101180670|FG002|STARTED|Second Intervention - 7 Days Follow-up||0||
48759761|NCT04913610|102200389|FG003|COMPLETED|Randomized Participants||29||
48759762|NCT04913610|102200390|FG004|COMPLETED|Randomized Participants||31||
48759763|NCT04913610|102200386|FG000|NOT COMPLETED|Randomized Participants||0||
48759764|NCT04913610|102200387|FG001|NOT COMPLETED|Randomized Participants||0||
48759765|NCT04913610|102200388|FG002|NOT COMPLETED|Randomized Participants||1||
48759766|NCT04913610|102200389|FG003|NOT COMPLETED|Randomized Participants||1||
48759767|NCT04913610|102200390|FG004|NOT COMPLETED|Randomized Participants||0||
48347324|NCT03035760|101180671|FG003|STARTED|Second Intervention - 7 Days Follow-up||6||
48347325|NCT03035760|101180672|FG004|STARTED|Second Intervention - 7 Days Follow-up||6||
48347326|NCT03035760|101180668|FG000|COMPLETED|Second Intervention - 7 Days Follow-up||0||
48347327|NCT03035760|101180669|FG001|COMPLETED|Second Intervention - 7 Days Follow-up||0||
48347328|NCT03035760|101180670|FG002|COMPLETED|Second Intervention - 7 Days Follow-up||0||
48415661|NCT02477800|101350342|FG006|STARTED|Placebo-Controlled Period||0||
48415662|NCT02477800|101350336|FG000|COMPLETED|Placebo-Controlled Period||325||
48415663|NCT02477800|101350337|FG001|COMPLETED|Placebo-Controlled Period||325||
48415664|NCT02477800|101350338|FG002|COMPLETED|Placebo-Controlled Period||288||
48415665|NCT02477800|101350339|FG003|COMPLETED|Placebo-Controlled Period||0||
48415666|NCT02477800|101350340|FG004|COMPLETED|Placebo-Controlled Period||0||
48415667|NCT02477800|101350341|FG005|COMPLETED|Placebo-Controlled Period||0||
48415668|NCT02477800|101350342|FG006|COMPLETED|Placebo-Controlled Period||0||
48415669|NCT02477800|101350336|FG000|NOT COMPLETED|Placebo-Controlled Period||220||
48415670|NCT02477800|101350337|FG001|NOT COMPLETED|Placebo-Controlled Period||222||
48415671|NCT02477800|101350338|FG002|NOT COMPLETED|Placebo-Controlled Period||267||
48415672|NCT02477800|101350339|FG003|NOT COMPLETED|Placebo-Controlled Period||0||
48415673|NCT02477800|101350340|FG004|NOT COMPLETED|Placebo-Controlled Period||0||
48415674|NCT02477800|101350341|FG005|NOT COMPLETED|Placebo-Controlled Period||0||
48415675|NCT02477800|101350342|FG006|NOT COMPLETED|Placebo-Controlled Period||0||
48415676|NCT02477800|101350336|FG000|STARTED|Long Term Extension Period||0||
48415677|NCT02477800|101350337|FG001|STARTED|Long Term Extension Period||0||
48415678|NCT02477800|101350338|FG002|STARTED|Long Term Extension Period||0||
48415679|NCT02477800|101350339|FG003|STARTED|Long Term Extension Period||150||
48415680|NCT02477800|101350340|FG004|STARTED|Long Term Extension Period||152||
48415681|NCT02477800|101350341|FG005|STARTED|Long Term Extension Period||299||
48415682|NCT02477800|101350342|FG006|STARTED|Long Term Extension Period||251||
48415683|NCT02477800|101350336|FG000|COMPLETED|Long Term Extension Period||0||
48415684|NCT02477800|101350337|FG001|COMPLETED|Long Term Extension Period||0||
48415685|NCT02477800|101350338|FG002|COMPLETED|Long Term Extension Period||0||
48415686|NCT02477800|101350339|FG003|COMPLETED|Long Term Extension Period||0||
48415687|NCT02477800|101350340|FG004|COMPLETED|Long Term Extension Period||0||
48415688|NCT02477800|101350341|FG005|COMPLETED|Long Term Extension Period||0||
48415689|NCT02477800|101350342|FG006|COMPLETED|Long Term Extension Period||0||
48415690|NCT02477800|101350336|FG000|NOT COMPLETED|Long Term Extension Period||0||
48415691|NCT02477800|101350337|FG001|NOT COMPLETED|Long Term Extension Period||0||
48415692|NCT02477800|101350338|FG002|NOT COMPLETED|Long Term Extension Period||0||
48415693|NCT02477800|101350339|FG003|NOT COMPLETED|Long Term Extension Period||150||
48415694|NCT02477800|101350340|FG004|NOT COMPLETED|Long Term Extension Period||152||
48415695|NCT02477800|101350341|FG005|NOT COMPLETED|Long Term Extension Period||299||
48759768|NCT04913610|102200386|FG000|STARTED|Treated (ITT & Safety Population)||31||
48759769|NCT04913610|102200387|FG001|STARTED|Treated (ITT & Safety Population)||31||
48759770|NCT04913610|102200388|FG002|STARTED|Treated (ITT & Safety Population)||29||
48759771|NCT04913610|102200389|FG003|STARTED|Treated (ITT & Safety Population)||29||
48347329|NCT03035760|101180671|FG003|COMPLETED|Second Intervention - 7 Days Follow-up||6||
48347330|NCT03035760|101180672|FG004|COMPLETED|Second Intervention - 7 Days Follow-up||6||
48347331|NCT03035760|101180668|FG000|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0||
48347332|NCT03035760|101180669|FG001|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0||
48347333|NCT03035760|101180670|FG002|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0||
48415696|NCT02477800|101350342|FG006|NOT COMPLETED|Long Term Extension Period||251||
48415697|NCT00877890|101350343|FG000|STARTED|Overall Study||129||
48415698|NCT00877890|101350344|FG001|STARTED|Overall Study||125||
48415699|NCT00877890|101350343|FG000|Intent to Treat (ITT)|Overall Study||129||
48415700|NCT00877890|101350344|FG001|Intent to Treat (ITT)|Overall Study||123||
48415701|NCT00877890|101350343|FG000|COMPLETED|Overall Study||109||
48415702|NCT00877890|101350344|FG001|COMPLETED|Overall Study||95||
48415703|NCT00877890|101350343|FG000|NOT COMPLETED|Overall Study||20||
48415704|NCT00877890|101350344|FG001|NOT COMPLETED|Overall Study||30||
48415705|NCT04050540|101350345|FG000|STARTED|Overall Study||224||
48415706|NCT04050540|101350346|FG001|STARTED|Overall Study||225||
48415707|NCT04050540|101350345|FG000|COMPLETED|Overall Study||220||
48759772|NCT04913610|102200390|FG004|STARTED|Treated (ITT & Safety Population)||31||
48759773|NCT04913610|102200386|FG000|COMPLETED|Treated (ITT & Safety Population)||30||
48759774|NCT04913610|102200387|FG001|COMPLETED|Treated (ITT & Safety Population)||31||
48759775|NCT04913610|102200388|FG002|COMPLETED|Treated (ITT & Safety Population)||29||
48759776|NCT04913610|102200389|FG003|COMPLETED|Treated (ITT & Safety Population)||29||
48759777|NCT04913610|102200390|FG004|COMPLETED|Treated (ITT & Safety Population)||30||
48415708|NCT04050540|101350346|FG001|COMPLETED|Overall Study||222||
48415709|NCT04050540|101350345|FG000|NOT COMPLETED|Overall Study||4||
48415710|NCT04050540|101350346|FG001|NOT COMPLETED|Overall Study||3||
48415711|NCT00967343|101350347|FG000|STARTED|Overall Study||40||
48415712|NCT00967343|101350347|FG000|COMPLETED|Overall Study||2||
48415713|NCT00967343|101350347|FG000|NOT COMPLETED|Overall Study||38||
48415714|NCT01933399|101350348|FG000|STARTED|Overall Study||29||
48415715|NCT01933399|101350349|FG001|STARTED|Overall Study||32||
48415716|NCT01933399|101350350|FG002|STARTED|Overall Study||37||
48347334|NCT03035760|101180671|FG003|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0||
48347335|NCT03035760|101180672|FG004|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0||
48347336|NCT00158184|101180673|FG000|STARTED|Overall Study||16||
48347337|NCT00158184|101180674|FG001|STARTED|Overall Study||11||
48347338|NCT00158184|101180673|FG000|COMPLETED|Overall Study||10||
48347339|NCT00158184|101180674|FG001|COMPLETED|Overall Study||9||
48347340|NCT00158184|101180673|FG000|NOT COMPLETED|Overall Study||6||
48347341|NCT00158184|101180674|FG001|NOT COMPLETED|Overall Study||2||
48347342|NCT01159262|101180675|FG000|STARTED|Overall Study||14||
48347343|NCT01159262|101180676|FG001|STARTED|Overall Study||14||
48347344|NCT01159262|101180677|FG002|STARTED|Overall Study||8||
48347345|NCT01159262|101180675|FG000|COMPLETED|Overall Study||14||
48347346|NCT01159262|101180676|FG001|COMPLETED|Overall Study||14||
48347347|NCT01159262|101180677|FG002|COMPLETED|Overall Study||8||
48347348|NCT01159262|101180675|FG000|NOT COMPLETED|Overall Study||0||
48347349|NCT01159262|101180676|FG001|NOT COMPLETED|Overall Study||0||
48347350|NCT01159262|101180677|FG002|NOT COMPLETED|Overall Study||0||
48347351|NCT03304522|101180678|FG000|STARTED|Overall Study||46||
48347352|NCT03304522|101180679|FG001|STARTED|Overall Study||43||
48347353|NCT03304522|101180678|FG000|COMPLETED|Overall Study||45||
48347354|NCT03304522|101180679|FG001|COMPLETED|Overall Study||35||
48347355|NCT03304522|101180678|FG000|NOT COMPLETED|Overall Study||1||
48347356|NCT03304522|101180679|FG001|NOT COMPLETED|Overall Study||8||
48347357|NCT00110305|101180680|FG000|STARTED|Overall Study||279||
48347358|NCT00110305|101180681|FG001|STARTED|Overall Study||89||
48347359|NCT00110305|101180680|FG000|COMPLETED|Overall Study||165||
48347360|NCT00110305|101180681|FG001|COMPLETED|Overall Study||57||
48347361|NCT00110305|101180680|FG000|NOT COMPLETED|Overall Study||114||
48347362|NCT00110305|101180681|FG001|NOT COMPLETED|Overall Study||32||
48347363|NCT04003610|101180682|FG000|STARTED|Overall Study||0||
48347364|NCT04003610|101180683|FG001|STARTED|Overall Study||1||
48347365|NCT04003610|101180684|FG002|STARTED|Overall Study||6||
48347366|NCT04003610|101180682|FG000|COMPLETED|Overall Study||0||
48347367|NCT04003610|101180683|FG001|COMPLETED|Overall Study||0||
48347368|NCT04003610|101180684|FG002|COMPLETED|Overall Study||0||
48347369|NCT04003610|101180682|FG000|NOT COMPLETED|Overall Study||0||
48347370|NCT04003610|101180683|FG001|NOT COMPLETED|Overall Study||1||
48347371|NCT04003610|101180684|FG002|NOT COMPLETED|Overall Study||6||
48347372|NCT00851903|101180685|FG000|STARTED|Overall Study||112||
48347373|NCT00851903|101180685|FG000|Safety Population|Overall Study||112||
48347374|NCT00851903|101180685|FG000|Treated by Combination|Overall Study||111||
48347375|NCT00851903|101180685|FG000|Modified Intent-To-Treat Population|Overall Study||111||
48347376|NCT00851903|101180685|FG000|COMPLETED|Overall Study||110||
48347377|NCT00851903|101180685|FG000|NOT COMPLETED|Overall Study||2||
48347378|NCT01891643|101180686|FG000|STARTED|Overall Study||13||
48347379|NCT01891643|101180687|FG001|STARTED|Overall Study||10||
48347380|NCT01891643|101180686|FG000|COMPLETED|Overall Study||3|Completed = continuing treatment in the main CA204-006 study (NCT01335399)|
48347381|NCT01891643|101180687|FG001|COMPLETED|Overall Study||0|Completed = continuing treatment in the main CA204-006 study (NCT01335399)|
48347382|NCT01891643|101180686|FG000|NOT COMPLETED|Overall Study||10||
48347383|NCT01891643|101180687|FG001|NOT COMPLETED|Overall Study||10||
48347384|NCT01883141|101180688|FG000|STARTED|Overall Study||31||
48347385|NCT01883141|101180688|FG000|Passing Eligibility|Overall Study||30|Passing inclusion and exlcusion criteria|
48347386|NCT01883141|101180688|FG000|EP Study Performed|Overall Study||30||
48347387|NCT01883141|101180688|FG000|Usable EP Data|Overall Study||26|Electrical instability (N=1), Technical failure (N=2), No veins available for lead placement (N=1)|
48347388|NCT01883141|101180688|FG000|BiV Pacing-Distal|Overall Study||24||
48347389|NCT01883141|101180688|FG000|BiV Pacing-Mid|Overall Study||25||
48347390|NCT01883141|101180688|FG000|BiV Pacing-Standard Therapy|Overall Study||26|Proximal pacing|
48347391|NCT01883141|101180688|FG000|Multispot-pacing|Overall Study||24||
48347392|NCT01883141|101180688|FG000|BiV Pacing-Anterior|Overall Study||23||
48347393|NCT01883141|101180688|FG000|Biv Pacing-Posterior|Overall Study||22||
48347394|NCT01883141|101180688|FG000|Multivein|Overall Study||23||
48347395|NCT01883141|101180688|FG000|COMPLETED|Overall Study||31||
48347396|NCT01883141|101180688|FG000|NOT COMPLETED|Overall Study||0||
48347397|NCT02034123|101180689|FG000|STARTED|Part1(Median of 7.286 Weeks of Exposure)||1||
48415717|NCT01933399|101350348|FG000|COMPLETED|Overall Study||29||
48759778|NCT04913610|102200386|FG000|NOT COMPLETED|Treated (ITT & Safety Population)||1||
48759779|NCT04913610|102200387|FG001|NOT COMPLETED|Treated (ITT & Safety Population)||0||
48759780|NCT04913610|102200388|FG002|NOT COMPLETED|Treated (ITT & Safety Population)||0||
48759781|NCT04913610|102200389|FG003|NOT COMPLETED|Treated (ITT & Safety Population)||0||
48759782|NCT04913610|102200390|FG004|NOT COMPLETED|Treated (ITT & Safety Population)||1||
48759783|NCT05131165|102200391|FG000|STARTED|Overall Study||50||
48347398|NCT02034123|101180690|FG001|STARTED|Part1(Median of 7.286 Weeks of Exposure)||1||
48347399|NCT02034123|101180691|FG002|STARTED|Part1(Median of 7.286 Weeks of Exposure)||5||
48347400|NCT02034123|101180692|FG003|STARTED|Part1(Median of 7.286 Weeks of Exposure)||3||
48347401|NCT02034123|101180693|FG004|STARTED|Part1(Median of 7.286 Weeks of Exposure)||7||
48347402|NCT02034123|101180694|FG005|STARTED|Part1(Median of 7.286 Weeks of Exposure)||3||
48347403|NCT02034123|101180695|FG006|STARTED|Part1(Median of 7.286 Weeks of Exposure)||2||
48347404|NCT02034123|101180696|FG007|STARTED|Part1(Median of 7.286 Weeks of Exposure)||5||
48347405|NCT02034123|101180697|FG008|STARTED|Part1(Median of 7.286 Weeks of Exposure)||2||
48347406|NCT02034123|101180698|FG009|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0||
48185886|NCT00372567|100776024|FG002|COMPLETED|Phase 3 Study||0||
48185887|NCT00372567|100776022|FG000|NOT COMPLETED|Phase 3 Study||31||
48185888|NCT00372567|100776023|FG001|NOT COMPLETED|Phase 3 Study||26||
48759784|NCT05131165|102200392|FG001|STARTED|Overall Study||51||
48759785|NCT05131165|102200393|FG002|STARTED|Overall Study||58||
48759786|NCT05131165|102200391|FG000|Completed Month-3 Visits|Overall Study||44|Completed the month-3 visits, which included a survey, and the final administration of conditional incentives for the Incentives group|
48759787|NCT05131165|102200392|FG001|Completed Month-3 Visits|Overall Study||46|Completed the month-3 visits, which included a survey, and the final administration of conditional incentives for the Incentives group|
48759788|NCT05131165|102200393|FG002|Completed Month-3 Visits|Overall Study||54|Completed the month-3 visits, which included a survey, and the final administration of conditional incentives for the Incentives group|
48759789|NCT05131165|102200391|FG000|COMPLETED|Overall Study||45|Completed the final study visit, scheduled at around 9 months after baseline.|
48759790|NCT05131165|102200392|FG001|COMPLETED|Overall Study||46|Completed the final study visit, scheduled at around 9 months after baseline.|
48759791|NCT05131165|102200393|FG002|COMPLETED|Overall Study||50|Completed the final study visit, scheduled at around 9 months after baseline.|
48759792|NCT05131165|102200391|FG000|NOT COMPLETED|Overall Study||5||
48759793|NCT05131165|102200392|FG001|NOT COMPLETED|Overall Study||5||
48759794|NCT05131165|102200393|FG002|NOT COMPLETED|Overall Study||8||
48759795|NCT05131204|102200394|FG000|STARTED|Overall Study||2||
48759796|NCT05131204|102200395|FG001|STARTED|Overall Study||1||
48759797|NCT05131204|102200394|FG000|COMPLETED|Overall Study||0||
48759798|NCT05131204|102200395|FG001|COMPLETED|Overall Study||0||
48759799|NCT05131204|102200394|FG000|NOT COMPLETED|Overall Study||2||
48759800|NCT05131204|102200395|FG001|NOT COMPLETED|Overall Study||1||
48759801|NCT04575155|102200396|FG000|STARTED|Baseline||61||
48759802|NCT04575155|102200397|FG001|STARTED|Baseline||58||
48759803|NCT04575155|102200396|FG000|COMPLETED|Baseline||61||
48759804|NCT04575155|102200397|FG001|COMPLETED|Baseline||58||
48759805|NCT04575155|102200396|FG000|NOT COMPLETED|Baseline||0||
48759806|NCT04575155|102200397|FG001|NOT COMPLETED|Baseline||0||
48759807|NCT04575155|102200396|FG000|STARTED|2 Month||61||
48759808|NCT04575155|102200397|FG001|STARTED|2 Month||58||
48759809|NCT04575155|102200396|FG000|COMPLETED|2 Month||54||
48759810|NCT04575155|102200397|FG001|COMPLETED|2 Month||54||
48759811|NCT04575155|102200396|FG000|NOT COMPLETED|2 Month||7||
48759812|NCT04575155|102200397|FG001|NOT COMPLETED|2 Month||4||
48759813|NCT04364867|102200398|FG000|STARTED|Overall Study||51||
48759814|NCT04364867|102200399|FG001|STARTED|Overall Study||51||
48759815|NCT04364867|102200398|FG000|COMPLETED|Overall Study||19||
48759816|NCT04364867|102200399|FG001|COMPLETED|Overall Study||35||
48759817|NCT04364867|102200398|FG000|NOT COMPLETED|Overall Study||32||
48759818|NCT04364867|102200399|FG001|NOT COMPLETED|Overall Study||16||
48759819|NCT03624881|102200400|FG000|STARTED|Overall Study||283||
48759820|NCT03624881|102200401|FG001|STARTED|Overall Study||50||
48759821|NCT03624881|102200400|FG000|Safety Set|Overall Study||261||
48759822|NCT03624881|102200401|FG001|Safety Set|Overall Study||49||
48759823|NCT03624881|102200400|FG000|COMPLETED|Overall Study||237||
48759824|NCT03624881|102200401|FG001|COMPLETED|Overall Study||44||
48759825|NCT03624881|102200400|FG000|NOT COMPLETED|Overall Study||46||
48759826|NCT03624881|102200401|FG001|NOT COMPLETED|Overall Study||6||
48759827|NCT03748823|102200402|FG000|STARTED|Randomized Treatment Period||46||
48759828|NCT03748823|102200403|FG001|STARTED|Randomized Treatment Period||90||
48759829|NCT03748823|102200402|FG000|Received at Least 1 Dose of Study Drug|Randomized Treatment Period||46||
48759830|NCT03748823|102200403|FG001|Received at Least 1 Dose of Study Drug|Randomized Treatment Period||90||
48759831|NCT03748823|102200402|FG000|Treated and Not Included in Analysis|Randomized Treatment Period||1|Participants from 1 site with source documentation deviations and findings related to deficiencies in Investigator oversight.|
48759832|NCT03748823|102200403|FG001|Treated and Not Included in Analysis|Randomized Treatment Period||6|Participants from 1 site with source documentation deviations and findings related to deficiencies in Investigator oversight.|
48759833|NCT03748823|102200402|FG000|Full Analysis Set|Randomized Treatment Period||45|Participants who had signed informed consent, randomized, received at least 1 dose of ravulizumab (participants from one noncompliant site were excluded from analysis).|
48759834|NCT03748823|102200403|FG001|Full Analysis Set|Randomized Treatment Period||84|Participants who had signed informed consent, randomized, received at least 1 dose of ravulizumab (participants from one noncompliant site were excluded from analysis).|
48185889|NCT00372567|100776024|FG002|NOT COMPLETED|Phase 3 Study||12||
48759835|NCT03748823|102200402|FG000|Safety Analysis Set|Randomized Treatment Period||45|All participants who received at least 1 dose of ravulizumab (participants from one noncompliant site were excluded from analysis).|
48759836|NCT03748823|102200403|FG001|Safety Analysis Set|Randomized Treatment Period||84|All participants who received at least 1 dose of ravulizumab (participants from one noncompliant site were excluded from analysis).|
48759837|NCT03748823|102200402|FG000|COMPLETED|Randomized Treatment Period||44||
48759838|NCT03748823|102200403|FG001|COMPLETED|Randomized Treatment Period||84||
48759839|NCT03748823|102200402|FG000|NOT COMPLETED|Randomized Treatment Period||2||
48759840|NCT03748823|102200403|FG001|NOT COMPLETED|Randomized Treatment Period||6||
48759841|NCT03748823|102200402|FG000|STARTED|Extension Period||44||
48759842|NCT03748823|102200403|FG001|STARTED|Extension Period||83||
48185890|NCT02687919|100776025|FG000|STARTED|Overall Study||16||
48185891|NCT02687919|100776026|FG001|STARTED|Overall Study||15||
48185892|NCT02687919|100776025|FG000|COMPLETED|Overall Study||8||
48759843|NCT03748823|102200402|FG000|Received at Least 1 Dose of Study Drug|Extension Period||44||
48759844|NCT03748823|102200403|FG001|Received at Least 1 Dose of Study Drug|Extension Period||83||
48759845|NCT03748823|102200402|FG000|Treated But Not Included in the Analysis|Extension Period||1|Participants from 1 site with source documentation deviations and findings related to deficiencies in Investigator oversight.|
48759846|NCT03748823|102200403|FG001|Treated But Not Included in the Analysis|Extension Period||6|Participants from 1 site with source documentation deviations and findings related to deficiencies in Investigator oversight.|
48759847|NCT03748823|102200402|FG000|COMPLETED|Extension Period||31||
48759848|NCT03748823|102200403|FG001|COMPLETED|Extension Period||64||
48759849|NCT03748823|102200402|FG000|NOT COMPLETED|Extension Period||13||
48347407|NCT02034123|101180699|FG010|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0||
48347408|NCT02034123|101180700|FG011|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0||
48759850|NCT03748823|102200403|FG001|NOT COMPLETED|Extension Period||19||
48759851|NCT03692208|102200404|FG000|STARTED|Overall Study||57||
48759852|NCT03692208|102200405|FG001|STARTED|Overall Study||53||
48759853|NCT03692208|102200404|FG000|Received Allocated Intervention|Overall Study||42|Received Allocated Intervention|
48759854|NCT03692208|102200405|FG001|Received Allocated Intervention|Overall Study||33|Received Allocated Intervention|
48759855|NCT03692208|102200404|FG000|Follow-Up Survey|Overall Study||41||
48759856|NCT03692208|102200405|FG001|Follow-Up Survey|Overall Study||25||
48759857|NCT03692208|102200404|FG000|COMPLETED|Overall Study||50|Excluded from final analysis: withdrawn participants|
48759858|NCT03692208|102200405|FG001|COMPLETED|Overall Study||50|Excluded from final analysis: withdrawn participants|
48759859|NCT03692208|102200404|FG000|NOT COMPLETED|Overall Study||7||
48759860|NCT03692208|102200405|FG001|NOT COMPLETED|Overall Study||3||
48759861|NCT02173769|102200406|FG000|STARTED|Overall Study||1858||
48347409|NCT02034123|101180701|FG012|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0||
48347410|NCT02034123|101180702|FG013|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0||
48347411|NCT02034123|101180703|FG014|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0||
48347412|NCT02034123|101180704|FG015|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0||
48347413|NCT02034123|101180705|FG016|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0||
48347414|NCT02034123|101180706|FG017|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0||
48347415|NCT02034123|101180689|FG000|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1||
48347416|NCT02034123|101180690|FG001|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1||
48347417|NCT02034123|101180691|FG002|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||5||
48759862|NCT02173769|102200406|FG000|COMPLETED|Overall Study||1854||
48759863|NCT02173769|102200406|FG000|NOT COMPLETED|Overall Study||4||
48759864|NCT03270436|102200407|FG000|STARTED|Baseline||213||
48759865|NCT03270436|102200408|FG001|STARTED|Baseline||167||
48347418|NCT02034123|101180692|FG003|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1||
48347419|NCT02034123|101180693|FG004|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||5||
48759866|NCT03270436|102200407|FG000|COMPLETED|Baseline||212||
48759867|NCT03270436|102200408|FG001|COMPLETED|Baseline||166||
48415718|NCT01933399|101350349|FG001|COMPLETED|Overall Study||32||
48347420|NCT02034123|101180694|FG005|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||3||
48347421|NCT02034123|101180695|FG006|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2||
48347422|NCT02034123|101180696|FG007|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||4||
48347423|NCT02034123|101180697|FG008|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
48347424|NCT02034123|101180698|FG009|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
48347425|NCT02034123|101180699|FG010|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
48347426|NCT02034123|101180700|FG011|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
48415719|NCT01933399|101350350|FG002|COMPLETED|Overall Study||37||
48415720|NCT01933399|101350348|FG000|NOT COMPLETED|Overall Study||0||
48415721|NCT01933399|101350349|FG001|NOT COMPLETED|Overall Study||0||
48415722|NCT01933399|101350350|FG002|NOT COMPLETED|Overall Study||0||
48347427|NCT02034123|101180701|FG012|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
48347428|NCT02034123|101180702|FG013|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
48347429|NCT02034123|101180703|FG014|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
48185893|NCT02687919|100776026|FG001|COMPLETED|Overall Study||9||
48415723|NCT05049122|101350351|FG000|STARTED|Overall Study||25|Enrolled|
48415724|NCT05049122|101350351|FG000|Participants Who Completed the Week 24 Study Treatment Period as Per Protocol|Overall Study||23||
48415725|NCT05049122|101350351|FG000|Participants Who Were Considered Stable Condition at Week 24|Overall Study||3||
48415726|NCT05049122|101350351|FG000|q4w Regimen Participants (Stable Condition)Who Completed Week 52 Study Treatment Period Per Protocol|Overall Study||3||
48759868|NCT03270436|102200407|FG000|NOT COMPLETED|Baseline||1||
48759869|NCT03270436|102200408|FG001|NOT COMPLETED|Baseline||1||
48759870|NCT03270436|102200407|FG000|STARTED|Immediate Post-Intervention||213|All enrolled participants were contacted to provide data at post-intervention whether or not they completed baseline data collection.|
48759871|NCT03270436|102200408|FG001|STARTED|Immediate Post-Intervention||167|All enrolled participants were contacted to provide data at post-intervention whether or not they completed baseline data collection.|
48759872|NCT03270436|102200407|FG000|COMPLETED|Immediate Post-Intervention||172||
48759873|NCT03270436|102200408|FG001|COMPLETED|Immediate Post-Intervention||111||
48759874|NCT03270436|102200407|FG000|NOT COMPLETED|Immediate Post-Intervention||41||
48759875|NCT03270436|102200408|FG001|NOT COMPLETED|Immediate Post-Intervention||56||
48759876|NCT03270436|102200407|FG000|STARTED|6 Months Post-Intervention||213|All enrolled participants were contacted to provide data at 6 months post-intervention whether or not they completed previous data collections.|
48759877|NCT03270436|102200408|FG001|STARTED|6 Months Post-Intervention||167|All enrolled participants were contacted to provide data at 6 months post-intervention whether or not they completed previous data collections.|
48759878|NCT03270436|102200407|FG000|COMPLETED|6 Months Post-Intervention||173||
48759879|NCT03270436|102200408|FG001|COMPLETED|6 Months Post-Intervention||116||
48759880|NCT03270436|102200407|FG000|NOT COMPLETED|6 Months Post-Intervention||40||
48759881|NCT03270436|102200408|FG001|NOT COMPLETED|6 Months Post-Intervention||51||
48759882|NCT00948246|102200409|FG000|STARTED|Overall Study||110||
48759883|NCT00948246|102200409|FG000|COMPLETED|Overall Study||86||
48759884|NCT00948246|102200409|FG000|NOT COMPLETED|Overall Study||24||
48759885|NCT05430854|102200410|FG000|STARTED|Overall Study||47||
48759886|NCT05430854|102200411|FG001|STARTED|Overall Study||57||
48759887|NCT05430854|102200412|FG002|STARTED|Overall Study||51||
48759888|NCT05430854|102200410|FG000|COMPLETED|Overall Study||8||
48759889|NCT05430854|102200411|FG001|COMPLETED|Overall Study||4||
48759890|NCT05430854|102200412|FG002|COMPLETED|Overall Study||5||
48759891|NCT05430854|102200410|FG000|NOT COMPLETED|Overall Study||39||
48759892|NCT05430854|102200411|FG001|NOT COMPLETED|Overall Study||53||
48759893|NCT05430854|102200412|FG002|NOT COMPLETED|Overall Study||46||
48759894|NCT04076696|102200413|FG000|STARTED|Overall Study||38||
48759895|NCT04076696|102200413|FG000|COMPLETED|Overall Study||38||
48759896|NCT04076696|102200413|FG000|NOT COMPLETED|Overall Study||0||
48759897|NCT04571944|102200414|FG000|STARTED|Overall Study||105||
48759898|NCT04571944|102200415|FG001|STARTED|Overall Study||102||
48759899|NCT04571944|102200414|FG000|COMPLETED|Overall Study||99||
48759900|NCT04571944|102200415|FG001|COMPLETED|Overall Study||102||
48759901|NCT04571944|102200414|FG000|NOT COMPLETED|Overall Study||6||
48759902|NCT04571944|102200415|FG001|NOT COMPLETED|Overall Study||0||
48759903|NCT04504253|102200416|FG000|STARTED|Overall Study||9||
48759904|NCT04504253|102200417|FG001|STARTED|Overall Study||9||
48185894|NCT02687919|100776025|FG000|NOT COMPLETED|Overall Study||8||
48185895|NCT02687919|100776026|FG001|NOT COMPLETED|Overall Study||6||
48185896|NCT02303743|100776027|FG000|STARTED|Overall Study||108||
48185897|NCT02303743|100776028|FG001|STARTED|Overall Study||152||
48185898|NCT02303743|100776027|FG000|COMPLETED|Overall Study||108||
48185899|NCT02303743|100776028|FG001|COMPLETED|Overall Study||152||
48185900|NCT02303743|100776027|FG000|NOT COMPLETED|Overall Study||0||
48185901|NCT02303743|100776028|FG001|NOT COMPLETED|Overall Study||0||
48185902|NCT00670982|100776029|FG000|STARTED|Overall Study||22||
48185903|NCT00670982|100776030|FG001|STARTED|Overall Study||7||
48415727|NCT05049122|101350351|FG000|Participants Who Continued the q2w Regimen|Overall Study||20||
48415728|NCT05049122|101350351|FG000|The q2w Regimen Participants Who Completed the Week 52 Treatment Period as Per Protocol|Overall Study||19||
48415729|NCT05049122|101350351|FG000|COMPLETED|Overall Study||22|Participants who completed the Week 52 treatment period as per protocol|
48415730|NCT05049122|101350351|FG000|NOT COMPLETED|Overall Study||3||
48415731|NCT02385292|101350352|FG000|STARTED|Overall Study||0||
48415732|NCT02385292|101350353|FG001|STARTED|Overall Study||0||
48415733|NCT02385292|101350352|FG000|COMPLETED|Overall Study||0||
48759905|NCT04504253|102200416|FG000|COMPLETED|Overall Study||6||
48759906|NCT04504253|102200417|FG001|COMPLETED|Overall Study||6||
48759907|NCT04504253|102200416|FG000|NOT COMPLETED|Overall Study||3||
48759908|NCT04504253|102200417|FG001|NOT COMPLETED|Overall Study||3||
48759909|NCT02595892|102200418|FG000|STARTED|Overall Study||36||
48759910|NCT02595892|102200419|FG001|STARTED|Overall Study||34||
48759911|NCT02595892|102200418|FG000|Number of Participants From Arm I Who Crossed-over to Arm II|Overall Study||15||
48185904|NCT00670982|100776029|FG000|COMPLETED|Overall Study||22||
48759912|NCT02595892|102200419|FG001|Number of Participants From Arm I Who Crossed-over to Arm II|Overall Study||0||
48759913|NCT02595892|102200418|FG000|COMPLETED|Overall Study||36||
48759914|NCT02595892|102200419|FG001|COMPLETED|Overall Study||34||
48759915|NCT02595892|102200418|FG000|NOT COMPLETED|Overall Study||0||
48759916|NCT02595892|102200419|FG001|NOT COMPLETED|Overall Study||0||
48185905|NCT00670982|100776030|FG001|COMPLETED|Overall Study||7||
48347430|NCT02034123|101180704|FG015|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
48347431|NCT02034123|101180705|FG016|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
48347432|NCT02034123|101180706|FG017|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
48347433|NCT02034123|101180689|FG000|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
48347434|NCT02034123|101180690|FG001|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
48347435|NCT02034123|101180691|FG002|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
48759917|NCT02702492|102200420|FG000|STARTED|Overall Study||3||
48759918|NCT02702492|102200421|FG001|STARTED|Overall Study||3||
48759919|NCT02702492|102200422|FG002|STARTED|Overall Study||5||
48759920|NCT02702492|102200423|FG003|STARTED|Overall Study||7||
48759921|NCT02702492|102200424|FG004|STARTED|Overall Study||5||
48759922|NCT02702492|102200425|FG005|STARTED|Overall Study||3||
48759923|NCT02702492|102200426|FG006|STARTED|Overall Study||4||
48759924|NCT02702492|102200427|FG007|STARTED|Overall Study||12||
48759925|NCT02702492|102200428|FG008|STARTED|Overall Study||7||
48759926|NCT02702492|102200429|FG009|STARTED|Overall Study||1||
48759927|NCT02702492|102200430|FG010|STARTED|Overall Study||1||
48759928|NCT02702492|102200431|FG011|STARTED|Overall Study||5||
48759929|NCT02702492|102200432|FG012|STARTED|Overall Study||4||
48185906|NCT00670982|100776029|FG000|NOT COMPLETED|Overall Study||0||
48185907|NCT00670982|100776030|FG001|NOT COMPLETED|Overall Study||0||
48185908|NCT02706626|100776031|FG000|STARTED|Overall Study||27||
48759930|NCT02702492|102200420|FG000|COMPLETED|Overall Study||0||
48759931|NCT02702492|102200421|FG001|COMPLETED|Overall Study||0||
48759932|NCT02702492|102200422|FG002|COMPLETED|Overall Study||0||
48415734|NCT02385292|101350353|FG001|COMPLETED|Overall Study||0||
48415735|NCT02385292|101350352|FG000|NOT COMPLETED|Overall Study||0||
48415736|NCT02385292|101350353|FG001|NOT COMPLETED|Overall Study||0||
48415737|NCT01351415|101350354|FG000|STARTED|Overall Study||245||
48415738|NCT01351415|101350355|FG001|STARTED|Overall Study||240||
48415739|NCT01351415|101350354|FG000|Treated Participants|Overall Study||243||
48415740|NCT01351415|101350355|FG001|Treated Participants|Overall Study||232||
48347436|NCT02034123|101180692|FG003|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2||
48347437|NCT02034123|101180693|FG004|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2||
48347438|NCT02034123|101180694|FG005|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
48347439|NCT02034123|101180695|FG006|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
48347440|NCT02034123|101180696|FG007|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1||
48347441|NCT02034123|101180697|FG008|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2||
48347442|NCT02034123|101180698|FG009|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
48347443|NCT02034123|101180699|FG010|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
48415741|NCT01351415|101350354|FG000|COMPLETED|Overall Study||0||
48415742|NCT01351415|101350355|FG001|COMPLETED|Overall Study||0||
48415743|NCT01351415|101350354|FG000|NOT COMPLETED|Overall Study||245||
48415744|NCT01351415|101350355|FG001|NOT COMPLETED|Overall Study||240||
48415745|NCT04383665|101350356|FG000|STARTED|Overall Study||2||
48415746|NCT04383665|101350357|FG001|STARTED|Overall Study||2||
48415747|NCT04383665|101350358|FG002|STARTED|Overall Study||2||
48415748|NCT04383665|101350359|FG003|STARTED|Overall Study||2||
48415749|NCT04383665|101350360|FG004|STARTED|Overall Study||2||
48415750|NCT04383665|101350361|FG005|STARTED|Overall Study||2||
48415751|NCT04383665|101350356|FG000|COMPLETED|Overall Study||2||
48415752|NCT04383665|101350357|FG001|COMPLETED|Overall Study||2||
48185909|NCT02706626|100776032|FG001|STARTED|Overall Study||4||
48347444|NCT02034123|101180700|FG011|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
48347445|NCT02034123|101180701|FG012|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
48347446|NCT02034123|101180702|FG013|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
48347447|NCT02034123|101180703|FG014|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
48347448|NCT02034123|101180704|FG015|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
48347449|NCT02034123|101180705|FG016|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
48347450|NCT02034123|101180706|FG017|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
48347451|NCT02034123|101180689|FG000|STARTED|Part2(Up to 2 Years)||0||
48347452|NCT02034123|101180690|FG001|STARTED|Part2(Up to 2 Years)||0||
48347453|NCT02034123|101180691|FG002|STARTED|Part2(Up to 2 Years)||0||
48347454|NCT02034123|101180692|FG003|STARTED|Part2(Up to 2 Years)||0||
48347455|NCT02034123|101180693|FG004|STARTED|Part2(Up to 2 Years)||0||
48347456|NCT02034123|101180694|FG005|STARTED|Part2(Up to 2 Years)||0||
48347457|NCT02034123|101180695|FG006|STARTED|Part2(Up to 2 Years)||0||
48347458|NCT02034123|101180696|FG007|STARTED|Part2(Up to 2 Years)||0||
48347459|NCT02034123|101180697|FG008|STARTED|Part2(Up to 2 Years)||0||
48347460|NCT02034123|101180698|FG009|STARTED|Part2(Up to 2 Years)||0||
48347461|NCT02034123|101180699|FG010|STARTED|Part2(Up to 2 Years)||0||
48347462|NCT02034123|101180700|FG011|STARTED|Part2(Up to 2 Years)||0||
48415753|NCT04383665|101350358|FG002|COMPLETED|Overall Study||2||
48347463|NCT02034123|101180701|FG012|STARTED|Part2(Up to 2 Years)||0||
48347464|NCT02034123|101180702|FG013|STARTED|Part2(Up to 2 Years)||0||
48347465|NCT02034123|101180703|FG014|STARTED|Part2(Up to 2 Years)||0||
48347466|NCT02034123|101180704|FG015|STARTED|Part2(Up to 2 Years)||0||
48347467|NCT02034123|101180705|FG016|STARTED|Part2(Up to 2 Years)||0||
48347468|NCT02034123|101180706|FG017|STARTED|Part2(Up to 2 Years)||0||
48347469|NCT02034123|101180689|FG000|COMPLETED|Part2(Up to 2 Years)||0||
48347470|NCT02034123|101180690|FG001|COMPLETED|Part2(Up to 2 Years)||0||
48347471|NCT02034123|101180691|FG002|COMPLETED|Part2(Up to 2 Years)||0||
48347472|NCT02034123|101180692|FG003|COMPLETED|Part2(Up to 2 Years)||0||
48347473|NCT02034123|101180693|FG004|COMPLETED|Part2(Up to 2 Years)||0||
48759933|NCT02702492|102200423|FG003|COMPLETED|Overall Study||0||
48759934|NCT02702492|102200424|FG004|COMPLETED|Overall Study||0||
48759935|NCT02702492|102200425|FG005|COMPLETED|Overall Study||0||
48759936|NCT02702492|102200426|FG006|COMPLETED|Overall Study||0||
48759937|NCT02702492|102200427|FG007|COMPLETED|Overall Study||0||
48759938|NCT02702492|102200428|FG008|COMPLETED|Overall Study||0||
48759939|NCT02702492|102200429|FG009|COMPLETED|Overall Study||0||
48759940|NCT02702492|102200430|FG010|COMPLETED|Overall Study||0||
48347474|NCT02034123|101180694|FG005|COMPLETED|Part2(Up to 2 Years)||0||
48347475|NCT02034123|101180695|FG006|COMPLETED|Part2(Up to 2 Years)||0||
48347476|NCT02034123|101180696|FG007|COMPLETED|Part2(Up to 2 Years)||0||
48347477|NCT02034123|101180697|FG008|COMPLETED|Part2(Up to 2 Years)||0||
48347478|NCT02034123|101180698|FG009|COMPLETED|Part2(Up to 2 Years)||0||
48347479|NCT02034123|101180699|FG010|COMPLETED|Part2(Up to 2 Years)||0||
48347480|NCT02034123|101180700|FG011|COMPLETED|Part2(Up to 2 Years)||0||
48347481|NCT02034123|101180701|FG012|COMPLETED|Part2(Up to 2 Years)||0||
48347482|NCT02034123|101180702|FG013|COMPLETED|Part2(Up to 2 Years)||0||
48347483|NCT02034123|101180703|FG014|COMPLETED|Part2(Up to 2 Years)||0||
48347484|NCT02034123|101180704|FG015|COMPLETED|Part2(Up to 2 Years)||0||
48347485|NCT02034123|101180705|FG016|COMPLETED|Part2(Up to 2 Years)||0||
48347486|NCT02034123|101180706|FG017|COMPLETED|Part2(Up to 2 Years)||0||
48347487|NCT02034123|101180689|FG000|NOT COMPLETED|Part2(Up to 2 Years)||0||
48347488|NCT02034123|101180690|FG001|NOT COMPLETED|Part2(Up to 2 Years)||0||
48759941|NCT02702492|102200431|FG011|COMPLETED|Overall Study||0||
48759942|NCT02702492|102200432|FG012|COMPLETED|Overall Study||0||
48759943|NCT02702492|102200420|FG000|NOT COMPLETED|Overall Study||3||
48759944|NCT02702492|102200421|FG001|NOT COMPLETED|Overall Study||3||
48759945|NCT02702492|102200422|FG002|NOT COMPLETED|Overall Study||5||
48759946|NCT02702492|102200423|FG003|NOT COMPLETED|Overall Study||7||
48759947|NCT02702492|102200424|FG004|NOT COMPLETED|Overall Study||5||
48759948|NCT02702492|102200425|FG005|NOT COMPLETED|Overall Study||3||
48759949|NCT02702492|102200426|FG006|NOT COMPLETED|Overall Study||4||
48759950|NCT02702492|102200427|FG007|NOT COMPLETED|Overall Study||12||
48759951|NCT02702492|102200428|FG008|NOT COMPLETED|Overall Study||7||
48759952|NCT02702492|102200429|FG009|NOT COMPLETED|Overall Study||1||
48759953|NCT02702492|102200430|FG010|NOT COMPLETED|Overall Study||1||
48759954|NCT02702492|102200431|FG011|NOT COMPLETED|Overall Study||5||
48759955|NCT02702492|102200432|FG012|NOT COMPLETED|Overall Study||4||
48185910|NCT02706626|100776033|FG002|STARTED|Overall Study||1||
48759956|NCT05010707|102200433|FG000|STARTED|Overall Study||12||
48759957|NCT05010707|102200434|FG001|STARTED|Overall Study||13||
48759958|NCT05010707|102200435|FG002|STARTED|Overall Study||14||
48759959|NCT05010707|102200433|FG000|COMPLETED|Overall Study||11||
48759960|NCT05010707|102200434|FG001|COMPLETED|Overall Study||12||
48185911|NCT02706626|100776031|FG000|COMPLETED|Overall Study||27||
48185912|NCT02706626|100776032|FG001|COMPLETED|Overall Study||4||
48185913|NCT02706626|100776033|FG002|COMPLETED|Overall Study||1||
48185914|NCT02706626|100776031|FG000|NOT COMPLETED|Overall Study||0||
48347489|NCT02034123|101180691|FG002|NOT COMPLETED|Part2(Up to 2 Years)||0||
48347490|NCT02034123|101180692|FG003|NOT COMPLETED|Part2(Up to 2 Years)||0||
48347491|NCT02034123|101180693|FG004|NOT COMPLETED|Part2(Up to 2 Years)||0||
48347492|NCT02034123|101180694|FG005|NOT COMPLETED|Part2(Up to 2 Years)||0||
48759961|NCT05010707|102200435|FG002|COMPLETED|Overall Study||14||
48759962|NCT05010707|102200433|FG000|NOT COMPLETED|Overall Study||1||
48759963|NCT05010707|102200434|FG001|NOT COMPLETED|Overall Study||1||
48185915|NCT02706626|100776032|FG001|NOT COMPLETED|Overall Study||0||
48347493|NCT02034123|101180695|FG006|NOT COMPLETED|Part2(Up to 2 Years)||0||
48347494|NCT02034123|101180696|FG007|NOT COMPLETED|Part2(Up to 2 Years)||0||
48185916|NCT02706626|100776033|FG002|NOT COMPLETED|Overall Study||0||
48185917|NCT00619476|100776034|FG000|STARTED|Overall Study||95||
48185918|NCT00619476|100776035|FG001|STARTED|Overall Study||107||
48347495|NCT02034123|101180697|FG008|NOT COMPLETED|Part2(Up to 2 Years)||0||
48347496|NCT02034123|101180698|FG009|NOT COMPLETED|Part2(Up to 2 Years)||0||
48347497|NCT02034123|101180699|FG010|NOT COMPLETED|Part2(Up to 2 Years)||0||
48759964|NCT05010707|102200435|FG002|NOT COMPLETED|Overall Study||0||
48759965|NCT05652010|102200436|FG000|STARTED|First Intervention||22||
48759966|NCT05652010|102200437|FG001|STARTED|First Intervention||25||
48759967|NCT05652010|102200436|FG000|COMPLETED|First Intervention||22||
48759968|NCT05652010|102200437|FG001|COMPLETED|First Intervention||24||
48759969|NCT05652010|102200436|FG000|NOT COMPLETED|First Intervention||0||
48759970|NCT05652010|102200437|FG001|NOT COMPLETED|First Intervention||1||
48637025|NCT00549055|101894761|FG000|STARTED|Overall Study||38||
48637026|NCT00549055|101894761|FG000|COMPLETED|Overall Study||3||
48637027|NCT00549055|101894761|FG000|NOT COMPLETED|Overall Study||35||
48637028|NCT02309359|101894762|FG000|STARTED|Overall Study||69||
48637029|NCT02309359|101894763|FG001|STARTED|Overall Study||70||
48637030|NCT02309359|101894764|FG002|STARTED|Overall Study||68||
48637031|NCT02309359|101894765|FG003|STARTED|Overall Study||69||
48637032|NCT02309359|101894766|FG004|STARTED|Overall Study||69||
48637033|NCT02309359|101894762|FG000|COMPLETED|Overall Study||57||
48637034|NCT02309359|101894763|FG001|COMPLETED|Overall Study||62||
48637035|NCT02309359|101894764|FG002|COMPLETED|Overall Study||57||
48637036|NCT02309359|101894765|FG003|COMPLETED|Overall Study||57||
48637037|NCT02309359|101894766|FG004|COMPLETED|Overall Study||60||
48637038|NCT02309359|101894762|FG000|NOT COMPLETED|Overall Study||12||
48637039|NCT02309359|101894763|FG001|NOT COMPLETED|Overall Study||8||
48637040|NCT02309359|101894764|FG002|NOT COMPLETED|Overall Study||11||
48637041|NCT02309359|101894765|FG003|NOT COMPLETED|Overall Study||12||
48637042|NCT02309359|101894766|FG004|NOT COMPLETED|Overall Study||9||
48637043|NCT02987868|101894767|FG000|STARTED|First Intervention||8||
48637044|NCT02987868|101894768|FG001|STARTED|First Intervention||8||
48637045|NCT02987868|101894767|FG000|COMPLETED|First Intervention||8||
48637046|NCT02987868|101894768|FG001|COMPLETED|First Intervention||8||
48637047|NCT02987868|101894767|FG000|NOT COMPLETED|First Intervention||0||
48637048|NCT02987868|101894768|FG001|NOT COMPLETED|First Intervention||0||
48347498|NCT02034123|101180700|FG011|NOT COMPLETED|Part2(Up to 2 Years)||0||
48347499|NCT02034123|101180701|FG012|NOT COMPLETED|Part2(Up to 2 Years)||0||
48415754|NCT04383665|101350359|FG003|COMPLETED|Overall Study||2||
48415755|NCT04383665|101350360|FG004|COMPLETED|Overall Study||2||
48415756|NCT04383665|101350361|FG005|COMPLETED|Overall Study||2||
48415757|NCT04383665|101350356|FG000|NOT COMPLETED|Overall Study||0||
48415758|NCT04383665|101350357|FG001|NOT COMPLETED|Overall Study||0||
48415759|NCT04383665|101350358|FG002|NOT COMPLETED|Overall Study||0||
48415760|NCT04383665|101350359|FG003|NOT COMPLETED|Overall Study||0||
48415761|NCT04383665|101350360|FG004|NOT COMPLETED|Overall Study||0||
48415762|NCT04383665|101350361|FG005|NOT COMPLETED|Overall Study||0||
48415763|NCT00498927|101350362|FG000|STARTED|Overall Study||47||
48637049|NCT02987868|101894767|FG000|STARTED|Wash Out Period 1 Week||8||
48637050|NCT02987868|101894768|FG001|STARTED|Wash Out Period 1 Week||8||
48637051|NCT02987868|101894767|FG000|COMPLETED|Wash Out Period 1 Week||8||
48637052|NCT02987868|101894768|FG001|COMPLETED|Wash Out Period 1 Week||8||
48637053|NCT02987868|101894767|FG000|NOT COMPLETED|Wash Out Period 1 Week||0||
48637054|NCT02987868|101894768|FG001|NOT COMPLETED|Wash Out Period 1 Week||0||
48637055|NCT02987868|101894767|FG000|STARTED|Second Intervention||8||
48637056|NCT02987868|101894768|FG001|STARTED|Second Intervention||8||
48637057|NCT02987868|101894767|FG000|COMPLETED|Second Intervention||8||
48637058|NCT02987868|101894768|FG001|COMPLETED|Second Intervention||8||
48637059|NCT02987868|101894767|FG000|NOT COMPLETED|Second Intervention||0||
48637060|NCT02987868|101894768|FG001|NOT COMPLETED|Second Intervention||0||
48637061|NCT00324155|101894769|FG000|STARTED|Enrolled and Randomized||250||
48637062|NCT00324155|101894770|FG001|STARTED|Enrolled and Randomized||252||
48637063|NCT00324155|101894769|FG000|COMPLETED|Enrolled and Randomized||247||
48637064|NCT00324155|101894770|FG001|COMPLETED|Enrolled and Randomized||251||
48637065|NCT00324155|101894769|FG000|NOT COMPLETED|Enrolled and Randomized||3||
48347500|NCT02034123|101180702|FG013|NOT COMPLETED|Part2(Up to 2 Years)||0||
48347501|NCT02034123|101180703|FG014|NOT COMPLETED|Part2(Up to 2 Years)||0||
48347502|NCT02034123|101180704|FG015|NOT COMPLETED|Part2(Up to 2 Years)||0||
48637066|NCT00324155|101894770|FG001|NOT COMPLETED|Enrolled and Randomized||1||
48637067|NCT00324155|101894769|FG000|STARTED|Received Treatment in Induction Phase||247||
48637068|NCT00324155|101894770|FG001|STARTED|Received Treatment in Induction Phase||251||
48637069|NCT00324155|101894769|FG000|COMPLETED|Received Treatment in Induction Phase||45||
48637070|NCT00324155|101894770|FG001|COMPLETED|Received Treatment in Induction Phase||54||
48637071|NCT00324155|101894769|FG000|NOT COMPLETED|Received Treatment in Induction Phase||202||
48347503|NCT02034123|101180705|FG016|NOT COMPLETED|Part2(Up to 2 Years)||0||
48347504|NCT02034123|101180706|FG017|NOT COMPLETED|Part2(Up to 2 Years)||0||
48415764|NCT00498927|101350362|FG000|COMPLETED|Overall Study||47||
48415765|NCT00498927|101350362|FG000|NOT COMPLETED|Overall Study||0||
48415766|NCT01495689|101350363|FG000|STARTED|Overall Study||26||
48637072|NCT00324155|101894770|FG001|NOT COMPLETED|Received Treatment in Induction Phase||197||
48637073|NCT00324155|101894769|FG000|STARTED|Received Treatment in Maintenance Phase||43||
48637074|NCT00324155|101894770|FG001|STARTED|Received Treatment in Maintenance Phase||53||
48347505|NCT00927485|101180707|FG000|STARTED|Overall Study||21||
48347506|NCT00927485|101180708|FG001|STARTED|Overall Study||23||
48347507|NCT00927485|101180707|FG000|COMPLETED|Overall Study||15||
48347508|NCT00927485|101180708|FG001|COMPLETED|Overall Study||19||
48347509|NCT00927485|101180707|FG000|NOT COMPLETED|Overall Study||6||
48347510|NCT00927485|101180708|FG001|NOT COMPLETED|Overall Study||4||
48347511|NCT00870688|101180709|FG000|STARTED|Overall Study||82||
48415767|NCT01495689|101350364|FG001|STARTED|Overall Study||23||
48637075|NCT00324155|101894769|FG000|COMPLETED|Received Treatment in Maintenance Phase||11||
48637076|NCT00324155|101894770|FG001|COMPLETED|Received Treatment in Maintenance Phase||6||
48637077|NCT00324155|101894769|FG000|NOT COMPLETED|Received Treatment in Maintenance Phase||32||
48637078|NCT00324155|101894770|FG001|NOT COMPLETED|Received Treatment in Maintenance Phase||47||
48347512|NCT00870688|101180709|FG000|COMPLETED|Overall Study||78||
48347513|NCT00870688|101180709|FG000|NOT COMPLETED|Overall Study||4||
48347514|NCT01276288|101180710|FG000|STARTED|Overall Study||7||
48415768|NCT01495689|101350363|FG000|COMPLETED|Overall Study||16||
48415769|NCT01495689|101350364|FG001|COMPLETED|Overall Study||16||
48415770|NCT01495689|101350363|FG000|NOT COMPLETED|Overall Study||10||
48415771|NCT01495689|101350364|FG001|NOT COMPLETED|Overall Study||7||
48415772|NCT01060150|101350365|FG000|STARTED|Overall Study||115||
48415773|NCT01060150|101350365|FG000|Treated|Overall Study||113||
48415774|NCT01060150|101350365|FG000|COMPLETED|Overall Study||92||
48415775|NCT01060150|101350365|FG000|NOT COMPLETED|Overall Study||23||
48415776|NCT01775995|101350366|FG000|STARTED|Overall Study||21||
48415777|NCT01775995|101350367|FG001|STARTED|Overall Study||14||
48415778|NCT01775995|101350366|FG000|COMPLETED|Overall Study||20||
48415779|NCT01775995|101350367|FG001|COMPLETED|Overall Study||13||
48415780|NCT01775995|101350366|FG000|NOT COMPLETED|Overall Study||1||
48415781|NCT01775995|101350367|FG001|NOT COMPLETED|Overall Study||1||
48415782|NCT03894501|101350368|FG000|STARTED|Overall Study||15||
48415783|NCT03894501|101350369|FG001|STARTED|Overall Study||15||
48415784|NCT03894501|101350368|FG000|COMPLETED|Overall Study||15||
48415785|NCT03894501|101350369|FG001|COMPLETED|Overall Study||15||
48415786|NCT03894501|101350368|FG000|NOT COMPLETED|Overall Study||0||
48415787|NCT03894501|101350369|FG001|NOT COMPLETED|Overall Study||0||
48415788|NCT01108263|101350370|FG000|STARTED|Overall Study||2||
48415789|NCT01108263|101350371|FG001|STARTED|Overall Study||3||
48415790|NCT01108263|101350370|FG000|COMPLETED|Overall Study||2||
48415791|NCT01108263|101350371|FG001|COMPLETED|Overall Study||2||
48415792|NCT01108263|101350370|FG000|NOT COMPLETED|Overall Study||0||
48415793|NCT01108263|101350371|FG001|NOT COMPLETED|Overall Study||1||
48415794|NCT04697888|101350372|FG000|STARTED|Overall Study||2||
48415795|NCT04697888|101350372|FG000|COMPLETED|Overall Study||2||
48415796|NCT04697888|101350372|FG000|NOT COMPLETED|Overall Study||0||
48415797|NCT00281528|101350373|FG000|STARTED|Overall Study||75||
48415798|NCT00281528|101350374|FG001|STARTED|Overall Study||54||
48415799|NCT00281528|101350375|FG002|STARTED|Overall Study||79||
48415800|NCT00281528|101350373|FG000|COMPLETED|Overall Study||0||
48415801|NCT00281528|101350374|FG001|COMPLETED|Overall Study||0||
48415802|NCT00281528|101350375|FG002|COMPLETED|Overall Study||0||
48415803|NCT00281528|101350373|FG000|NOT COMPLETED|Overall Study||75||
48415804|NCT00281528|101350374|FG001|NOT COMPLETED|Overall Study||54||
48415805|NCT00281528|101350375|FG002|NOT COMPLETED|Overall Study||79||
48415806|NCT01795716|101350376|FG000|STARTED|First Intervention (13 Days)||10||
48415807|NCT01795716|101350377|FG001|STARTED|First Intervention (13 Days)||11||
48415808|NCT01795716|101350376|FG000|COMPLETED|First Intervention (13 Days)||10||
48415809|NCT01795716|101350377|FG001|COMPLETED|First Intervention (13 Days)||11||
48415810|NCT01795716|101350376|FG000|NOT COMPLETED|First Intervention (13 Days)||0||
48415811|NCT01795716|101350377|FG001|NOT COMPLETED|First Intervention (13 Days)||0||
48415812|NCT01795716|101350376|FG000|STARTED|Washout (10 Days)||10||
48415813|NCT01795716|101350377|FG001|STARTED|Washout (10 Days)||11||
48415814|NCT01795716|101350376|FG000|COMPLETED|Washout (10 Days)||10||
48415815|NCT01795716|101350377|FG001|COMPLETED|Washout (10 Days)||11||
48415816|NCT01795716|101350376|FG000|NOT COMPLETED|Washout (10 Days)||0||
48637079|NCT00324155|101894769|FG000|STARTED|Follow-up Phase||247||
48415817|NCT01795716|101350377|FG001|NOT COMPLETED|Washout (10 Days)||0||
48439971|NCT01728376|101409999|FG004|Treated|Overall Study||14||
48185919|NCT00619476|100776036|FG002|STARTED|Overall Study||84||
48185920|NCT00619476|100776037|FG003|STARTED|Overall Study||90||
48185921|NCT00619476|100776034|FG000|Intent-to-Treat Population|Overall Study||95||
48185922|NCT00619476|100776035|FG001|Intent-to-Treat Population|Overall Study||107||
48185923|NCT00619476|100776036|FG002|Intent-to-Treat Population|Overall Study||82||
48185924|NCT00619476|100776037|FG003|Intent-to-Treat Population|Overall Study||87||
48185925|NCT00619476|100776034|FG000|Safety Population|Overall Study||95||
48185926|NCT00619476|100776035|FG001|Safety Population|Overall Study||107||
48185927|NCT00619476|100776036|FG002|Safety Population|Overall Study||82||
48185928|NCT00619476|100776037|FG003|Safety Population|Overall Study||87||
48185929|NCT00619476|100776034|FG000|COMPLETED|Overall Study||64||
48185930|NCT00619476|100776035|FG001|COMPLETED|Overall Study||85||
48185931|NCT00619476|100776036|FG002|COMPLETED|Overall Study||60||
48185932|NCT00619476|100776037|FG003|COMPLETED|Overall Study||56||
48759971|NCT05652010|102200436|FG000|STARTED|Second Intervention||22||
48759972|NCT05652010|102200437|FG001|STARTED|Second Intervention||24||
48759973|NCT05652010|102200436|FG000|COMPLETED|Second Intervention||21||
48759974|NCT05652010|102200437|FG001|COMPLETED|Second Intervention||24||
48759975|NCT05652010|102200436|FG000|NOT COMPLETED|Second Intervention||1||
48759976|NCT05652010|102200437|FG001|NOT COMPLETED|Second Intervention||0||
48759977|NCT01903356|102200438|FG000|STARTED|Overall Study||724||
48185933|NCT00619476|100776034|FG000|NOT COMPLETED|Overall Study||31||
48185934|NCT00619476|100776035|FG001|NOT COMPLETED|Overall Study||22||
48185935|NCT00619476|100776036|FG002|NOT COMPLETED|Overall Study||24||
48185936|NCT00619476|100776037|FG003|NOT COMPLETED|Overall Study||34||
48185937|NCT05124899|100776038|FG000|STARTED|Overall Study||15||60
48185938|NCT05124899|100776038|FG000|CAP UnScented|Overall Study||10||10
48185939|NCT05124899|100776038|FG000|CAP Herbal Mint|Overall Study||12||12
48185940|NCT05124899|100776038|FG000|CAP Mountain Berry|Overall Study||8||8
48185941|NCT05124899|100776038|FG000|SPF Standard|Overall Study||15||15
48185942|NCT05124899|100776038|FG000|Untreated Sites|Overall Study||15||15
48185943|NCT05124899|100776038|FG000|COMPLETED|Overall Study||12||32
48185944|NCT05124899|100776038|FG000|NOT COMPLETED|Overall Study||3||28
48185945|NCT00696293|100776039|FG000|STARTED|Overall Study||30||
48185946|NCT00696293|100776039|FG000|COMPLETED|Overall Study||28||
48185947|NCT00696293|100776039|FG000|NOT COMPLETED|Overall Study||2||
48185948|NCT04975789|100776040|FG000|STARTED|Overall Study||18||
48185949|NCT04975789|100776041|FG001|STARTED|Overall Study||18||
48185950|NCT04975789|100776042|FG002|STARTED|Overall Study||4||
48185951|NCT04975789|100776043|FG003|STARTED|Overall Study||21||
48347515|NCT01276288|101180711|FG001|STARTED|Overall Study||6||
48347516|NCT01276288|101180712|FG002|STARTED|Overall Study||5||
48347517|NCT01276288|101180713|FG003|STARTED|Overall Study||5||
48347518|NCT01276288|101180710|FG000|Received EMPA|Overall Study||6||
48347519|NCT01276288|101180711|FG001|Received EMPA|Overall Study||5||
48347520|NCT01276288|101180712|FG002|Received EMPA|Overall Study||5||
48347521|NCT01276288|101180713|FG003|Received EMPA|Overall Study||5||
48347522|NCT01276288|101180710|FG000|Received EMPA+HCT|Overall Study||5||
48347523|NCT01276288|101180711|FG001|Received EMPA+HCT|Overall Study||5||
48347524|NCT01276288|101180712|FG002|Received EMPA+HCT|Overall Study||0||
48347525|NCT01276288|101180713|FG003|Received EMPA+HCT|Overall Study||0||
48347526|NCT01276288|101180710|FG000|Received EMPA+TOR|Overall Study||0||
48759978|NCT01903356|102200438|FG000|COMPLETED|Overall Study||709||
48759979|NCT01903356|102200438|FG000|NOT COMPLETED|Overall Study||15||
48759980|NCT04090203|102200439|FG000|STARTED|Overall Study||8||
48759981|NCT04090203|102200439|FG000|COMPLETED|Overall Study||8||
48759982|NCT04090203|102200439|FG000|NOT COMPLETED|Overall Study||0||
48759983|NCT05635461|102200440|FG000|STARTED|Period 1: Dosing 1 (Day 1)||5||
48759984|NCT05635461|102200441|FG001|STARTED|Period 1: Dosing 1 (Day 1)||5||
48759985|NCT05635461|102200442|FG002|STARTED|Period 1: Dosing 1 (Day 1)||5||
48759986|NCT05635461|102200443|FG003|STARTED|Period 1: Dosing 1 (Day 1)||6||
48759987|NCT05635461|102200444|FG004|STARTED|Period 1: Dosing 1 (Day 1)||5||
48759988|NCT05635461|102200445|FG005|STARTED|Period 1: Dosing 1 (Day 1)||6||
48759989|NCT05635461|102200440|FG000|COMPLETED|Period 1: Dosing 1 (Day 1)||5||
48759990|NCT05635461|102200441|FG001|COMPLETED|Period 1: Dosing 1 (Day 1)||5||
48759991|NCT05635461|102200442|FG002|COMPLETED|Period 1: Dosing 1 (Day 1)||5||
48759992|NCT05635461|102200443|FG003|COMPLETED|Period 1: Dosing 1 (Day 1)||6||
48185952|NCT04975789|100776040|FG000|Completed Follow Up|Overall Study||15||
48185953|NCT04975789|100776041|FG001|Completed Follow Up|Overall Study||13||
48185954|NCT04975789|100776042|FG002|Completed Follow Up|Overall Study||4||
48185955|NCT04975789|100776043|FG003|Completed Follow Up|Overall Study||21||
48185956|NCT04975789|100776040|FG000|COMPLETED|Overall Study||18||
48185957|NCT04975789|100776041|FG001|COMPLETED|Overall Study||18||
48185958|NCT04975789|100776042|FG002|COMPLETED|Overall Study||4||
48185959|NCT04975789|100776043|FG003|COMPLETED|Overall Study||21||
48185960|NCT04975789|100776040|FG000|NOT COMPLETED|Overall Study||0||
48347527|NCT01276288|101180711|FG001|Received EMPA+TOR|Overall Study||0||
48347528|NCT01276288|101180712|FG002|Received EMPA+TOR|Overall Study||5||
48185961|NCT04975789|100776041|FG001|NOT COMPLETED|Overall Study||0||
48759993|NCT05635461|102200444|FG004|COMPLETED|Period 1: Dosing 1 (Day 1)||5||
48185962|NCT04975789|100776042|FG002|NOT COMPLETED|Overall Study||0||
48185963|NCT04975789|100776043|FG003|NOT COMPLETED|Overall Study||0||
48185964|NCT00968838|100776044|FG000|STARTED|Overall Study||50||
48185965|NCT00968838|100776045|FG001|STARTED|Overall Study||58||
48185966|NCT00968838|100776044|FG000|COMPLETED|Overall Study||50||
48185967|NCT00968838|100776045|FG001|COMPLETED|Overall Study||58||
48185968|NCT00968838|100776044|FG000|NOT COMPLETED|Overall Study||0||
48185969|NCT00968838|100776045|FG001|NOT COMPLETED|Overall Study||0||
48185970|NCT02708641|100776046|FG000|STARTED|Overall Study||12||
48185971|NCT02708641|100776046|FG000|COMPLETED|Overall Study||12||
48185972|NCT02708641|100776046|FG000|NOT COMPLETED|Overall Study||0||
48185973|NCT00709891|100776047|FG000|STARTED|Baseline, Cross-sectional Phase||47208||
48185974|NCT00709891|100776047|FG000|COMPLETED|Baseline, Cross-sectional Phase||45758||
48185975|NCT00709891|100776047|FG000|NOT COMPLETED|Baseline, Cross-sectional Phase||1450||
48185976|NCT00709891|100776047|FG000|STARTED|Longitudinal Follow-up Phase||10002||
48185977|NCT00709891|100776047|FG000|COMPLETED|Longitudinal Follow-up Phase||5020||
48185978|NCT00709891|100776047|FG000|NOT COMPLETED|Longitudinal Follow-up Phase||4982||
48185979|NCT01237678|100776048|FG000|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||33||
48185980|NCT01237678|100776049|FG001|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0||
48185981|NCT01237678|100776050|FG002|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0||
48185982|NCT01237678|100776048|FG000|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||33||
48185983|NCT01237678|100776049|FG001|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0||
48185984|NCT01237678|100776050|FG002|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0||
48185985|NCT01237678|100776048|FG000|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0||
48185986|NCT01237678|100776049|FG001|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0||
48185987|NCT01237678|100776050|FG002|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0||
48185988|NCT01237678|100776048|FG000|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||33||
48185989|NCT01237678|100776049|FG001|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0||
48185990|NCT01237678|100776050|FG002|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0||
48185991|NCT01237678|100776048|FG000|STARTED|Phase II||0||
48185992|NCT01237678|100776049|FG001|STARTED|Phase II||98||
48185993|NCT01237678|100776050|FG002|STARTED|Phase II||50||
48185994|NCT01237678|100776048|FG000|Received Intervention|Phase II||0||
48185995|NCT01237678|100776049|FG001|Received Intervention|Phase II||94||
48185996|NCT01237678|100776050|FG002|Received Intervention|Phase II||47||
48185997|NCT01237678|100776048|FG000|COMPLETED|Phase II||0||
48185998|NCT01237678|100776049|FG001|COMPLETED|Phase II||0||
48185999|NCT01237678|100776050|FG002|COMPLETED|Phase II||0||
48186000|NCT01237678|100776048|FG000|NOT COMPLETED|Phase II||0||
48186001|NCT01237678|100776049|FG001|NOT COMPLETED|Phase II||98||
48186002|NCT01237678|100776050|FG002|NOT COMPLETED|Phase II||50||
48186003|NCT01617083|100776051|FG000|STARTED|Overall Study||18||
48186004|NCT01617083|100776052|FG001|STARTED|Overall Study||14||
48186005|NCT01617083|100776053|FG002|STARTED|Overall Study||15||
48186006|NCT01617083|100776051|FG000|COMPLETED|Overall Study||18||
48186007|NCT01617083|100776052|FG001|COMPLETED|Overall Study||14||
48347529|NCT01276288|101180713|FG003|Received EMPA+TOR|Overall Study||5||
48347530|NCT01276288|101180710|FG000|COMPLETED|Overall Study||5||
48637080|NCT00324155|101894770|FG001|STARTED|Follow-up Phase||251||
48637081|NCT00324155|101894769|FG000|COMPLETED|Follow-up Phase||236||
48637082|NCT00324155|101894770|FG001|COMPLETED|Follow-up Phase||245||
48637083|NCT00324155|101894769|FG000|NOT COMPLETED|Follow-up Phase||11||
48637084|NCT00324155|101894770|FG001|NOT COMPLETED|Follow-up Phase||6||
48637085|NCT01829347|101894771|FG000|STARTED|VTI-210||9||
48637086|NCT01829347|101894772|FG001|STARTED|VTI-210||9||
48637087|NCT01829347|101894771|FG000|COMPLETED|VTI-210||3||
48637088|NCT01829347|101894772|FG001|COMPLETED|VTI-210||6||
48637089|NCT01829347|101894771|FG000|NOT COMPLETED|VTI-210||6||
48637090|NCT01829347|101894772|FG001|NOT COMPLETED|VTI-210||3||
48637091|NCT01829347|101894771|FG000|STARTED|VTI-210E||3||
48186008|NCT01617083|100776053|FG002|COMPLETED|Overall Study||15||
48186009|NCT01617083|100776051|FG000|NOT COMPLETED|Overall Study||0||
48186010|NCT01617083|100776052|FG001|NOT COMPLETED|Overall Study||0||
48186011|NCT01617083|100776053|FG002|NOT COMPLETED|Overall Study||0||
48186012|NCT04159896|100776054|FG000|STARTED|Overall Study||10||
48186013|NCT04159896|100776054|FG000|COMPLETED|Overall Study||0||
48186014|NCT04159896|100776054|FG000|NOT COMPLETED|Overall Study||10||
48186015|NCT04446975|100776055|FG000|STARTED|Randomization Period 1 (8 Weeks)||2435||
48186016|NCT04446975|100776056|FG001|STARTED|Randomization Period 1 (8 Weeks)||1295||
48186017|NCT04446975|100776057|FG002|STARTED|Randomization Period 1 (8 Weeks)||883||
48186018|NCT04446975|100776058|FG003|STARTED|Randomization Period 1 (8 Weeks)||833||
48186019|NCT04446975|100776055|FG000|COMPLETED|Randomization Period 1 (8 Weeks)||2435||
48186020|NCT04446975|100776056|FG001|COMPLETED|Randomization Period 1 (8 Weeks)||1295||
48186021|NCT04446975|100776057|FG002|COMPLETED|Randomization Period 1 (8 Weeks)||883||
48186022|NCT04446975|100776058|FG003|COMPLETED|Randomization Period 1 (8 Weeks)||833||
48186023|NCT04446975|100776055|FG000|NOT COMPLETED|Randomization Period 1 (8 Weeks)||0||
48347531|NCT01276288|101180711|FG001|COMPLETED|Overall Study||5||
48637092|NCT01829347|101894772|FG001|STARTED|VTI-210E||6||
48637093|NCT01829347|101894771|FG000|COMPLETED|VTI-210E||0||
48637094|NCT01829347|101894772|FG001|COMPLETED|VTI-210E||0||
48637095|NCT01829347|101894771|FG000|NOT COMPLETED|VTI-210E||3||
48637096|NCT01829347|101894772|FG001|NOT COMPLETED|VTI-210E||6||
48186024|NCT04446975|100776056|FG001|NOT COMPLETED|Randomization Period 1 (8 Weeks)||0||
48186025|NCT04446975|100776057|FG002|NOT COMPLETED|Randomization Period 1 (8 Weeks)||0||
48186026|NCT04446975|100776058|FG003|NOT COMPLETED|Randomization Period 1 (8 Weeks)||0||
48186027|NCT04446975|100776055|FG000|STARTED|Washout Period 1 (4 Weeks)||0||
48186028|NCT04446975|100776056|FG001|STARTED|Washout Period 1 (4 Weeks)||0||
48186029|NCT04446975|100776057|FG002|STARTED|Washout Period 1 (4 Weeks)||0||
48186030|NCT04446975|100776058|FG003|STARTED|Washout Period 1 (4 Weeks)||0||
48186031|NCT04446975|100776055|FG000|COMPLETED|Washout Period 1 (4 Weeks)||0||
48186032|NCT04446975|100776056|FG001|COMPLETED|Washout Period 1 (4 Weeks)||0||
48186033|NCT04446975|100776057|FG002|COMPLETED|Washout Period 1 (4 Weeks)||0||
48186034|NCT04446975|100776058|FG003|COMPLETED|Washout Period 1 (4 Weeks)||0||
48186035|NCT04446975|100776055|FG000|NOT COMPLETED|Washout Period 1 (4 Weeks)||0||
48186036|NCT04446975|100776056|FG001|NOT COMPLETED|Washout Period 1 (4 Weeks)||0||
48186037|NCT04446975|100776057|FG002|NOT COMPLETED|Washout Period 1 (4 Weeks)||0||
48186038|NCT04446975|100776058|FG003|NOT COMPLETED|Washout Period 1 (4 Weeks)||0||
48186039|NCT04446975|100776055|FG000|STARTED|Randomization Period 2 (8 Weeks)||2527||
48186040|NCT04446975|100776056|FG001|STARTED|Randomization Period 2 (8 Weeks)||1285||
48186041|NCT04446975|100776057|FG002|STARTED|Randomization Period 2 (8 Weeks)||927||
48186042|NCT04446975|100776058|FG003|STARTED|Randomization Period 2 (8 Weeks)||936||
48186043|NCT04446975|100776055|FG000|COMPLETED|Randomization Period 2 (8 Weeks)||2527||
48186044|NCT04446975|100776056|FG001|COMPLETED|Randomization Period 2 (8 Weeks)||1285||
48186045|NCT04446975|100776057|FG002|COMPLETED|Randomization Period 2 (8 Weeks)||927||
48186046|NCT04446975|100776058|FG003|COMPLETED|Randomization Period 2 (8 Weeks)||936||
48186047|NCT04446975|100776055|FG000|NOT COMPLETED|Randomization Period 2 (8 Weeks)||0||
48186048|NCT04446975|100776056|FG001|NOT COMPLETED|Randomization Period 2 (8 Weeks)||0||
48186049|NCT04446975|100776057|FG002|NOT COMPLETED|Randomization Period 2 (8 Weeks)||0||
48186050|NCT04446975|100776058|FG003|NOT COMPLETED|Randomization Period 2 (8 Weeks)||0||
48186051|NCT04446975|100776055|FG000|STARTED|Washout Period 2 (4 Weeks)||0||
48186052|NCT04446975|100776056|FG001|STARTED|Washout Period 2 (4 Weeks)||0||
48186053|NCT04446975|100776057|FG002|STARTED|Washout Period 2 (4 Weeks)||0||
48186054|NCT04446975|100776058|FG003|STARTED|Washout Period 2 (4 Weeks)||0||
48186055|NCT04446975|100776055|FG000|COMPLETED|Washout Period 2 (4 Weeks)||0||
48186056|NCT04446975|100776056|FG001|COMPLETED|Washout Period 2 (4 Weeks)||0||
48186057|NCT04446975|100776057|FG002|COMPLETED|Washout Period 2 (4 Weeks)||0||
48186058|NCT04446975|100776058|FG003|COMPLETED|Washout Period 2 (4 Weeks)||0||
48186059|NCT04446975|100776055|FG000|NOT COMPLETED|Washout Period 2 (4 Weeks)||0||
48186060|NCT04446975|100776056|FG001|NOT COMPLETED|Washout Period 2 (4 Weeks)||0||
48186061|NCT04446975|100776057|FG002|NOT COMPLETED|Washout Period 2 (4 Weeks)||0||
48186062|NCT04446975|100776058|FG003|NOT COMPLETED|Washout Period 2 (4 Weeks)||0||
48186063|NCT04446975|100776055|FG000|STARTED|Randomization Period 3 (8 Weeks)||2174||
48186064|NCT04446975|100776056|FG001|STARTED|Randomization Period 3 (8 Weeks)||1105||
48186065|NCT04446975|100776057|FG002|STARTED|Randomization Period 3 (8 Weeks)||818||
48186066|NCT04446975|100776058|FG003|STARTED|Randomization Period 3 (8 Weeks)||821||
48186067|NCT04446975|100776055|FG000|COMPLETED|Randomization Period 3 (8 Weeks)||2174||
48186068|NCT04446975|100776056|FG001|COMPLETED|Randomization Period 3 (8 Weeks)||1105||
48186069|NCT04446975|100776057|FG002|COMPLETED|Randomization Period 3 (8 Weeks)||818||
48186070|NCT04446975|100776058|FG003|COMPLETED|Randomization Period 3 (8 Weeks)||821||
48186071|NCT04446975|100776055|FG000|NOT COMPLETED|Randomization Period 3 (8 Weeks)||0||
48415818|NCT01795716|101350376|FG000|STARTED|Second Intervention (13 Days)||10||
48415819|NCT01795716|101350377|FG001|STARTED|Second Intervention (13 Days)||11||
48415820|NCT01795716|101350376|FG000|COMPLETED|Second Intervention (13 Days)||10||
48415821|NCT01795716|101350377|FG001|COMPLETED|Second Intervention (13 Days)||11||
48186072|NCT04446975|100776056|FG001|NOT COMPLETED|Randomization Period 3 (8 Weeks)||0||
48186073|NCT04446975|100776057|FG002|NOT COMPLETED|Randomization Period 3 (8 Weeks)||0||
48186074|NCT04446975|100776058|FG003|NOT COMPLETED|Randomization Period 3 (8 Weeks)||0||
48186075|NCT04446975|100776055|FG000|STARTED|Washout Period 3 (4 Weeks)||0||
48186076|NCT04446975|100776056|FG001|STARTED|Washout Period 3 (4 Weeks)||0||
48186077|NCT04446975|100776057|FG002|STARTED|Washout Period 3 (4 Weeks)||0||
48186078|NCT04446975|100776058|FG003|STARTED|Washout Period 3 (4 Weeks)||0||
48186079|NCT04446975|100776055|FG000|COMPLETED|Washout Period 3 (4 Weeks)||0||
48186080|NCT04446975|100776056|FG001|COMPLETED|Washout Period 3 (4 Weeks)||0||
48186081|NCT04446975|100776057|FG002|COMPLETED|Washout Period 3 (4 Weeks)||0||
48186082|NCT04446975|100776058|FG003|COMPLETED|Washout Period 3 (4 Weeks)||0||
48186083|NCT04446975|100776055|FG000|NOT COMPLETED|Washout Period 3 (4 Weeks)||0||
48186084|NCT04446975|100776056|FG001|NOT COMPLETED|Washout Period 3 (4 Weeks)||0||
48186085|NCT04446975|100776057|FG002|NOT COMPLETED|Washout Period 3 (4 Weeks)||0||
48186086|NCT04446975|100776058|FG003|NOT COMPLETED|Washout Period 3 (4 Weeks)||0||
48186087|NCT04446975|100776055|FG000|STARTED|Randomization Period 4 (8 Weeks)||2607||
48186088|NCT04446975|100776056|FG001|STARTED|Randomization Period 4 (8 Weeks)||1248||
48415822|NCT01795716|101350376|FG000|NOT COMPLETED|Second Intervention (13 Days)||0||
48415823|NCT01795716|101350377|FG001|NOT COMPLETED|Second Intervention (13 Days)||0||
48415824|NCT00523744|101350378|FG000|STARTED|Phase 1 - Amlodipine+Olmesartan||257||
48415825|NCT00523744|101350378|FG000|COMPLETED|Phase 1 - Amlodipine+Olmesartan||251||
48415826|NCT00523744|101350378|FG000|NOT COMPLETED|Phase 1 - Amlodipine+Olmesartan||6||
48347532|NCT01276288|101180712|FG002|COMPLETED|Overall Study||5||
48347533|NCT01276288|101180713|FG003|COMPLETED|Overall Study||5||
48347534|NCT01276288|101180710|FG000|NOT COMPLETED|Overall Study||2||
48347535|NCT01276288|101180711|FG001|NOT COMPLETED|Overall Study||1||
48347536|NCT01276288|101180712|FG002|NOT COMPLETED|Overall Study||0||
48347537|NCT01276288|101180713|FG003|NOT COMPLETED|Overall Study||0||
48347538|NCT01961531|101180714|FG000|STARTED|Overall Study||40||
48347539|NCT01961531|101180714|FG000|COMPLETED|Overall Study||40||
48347540|NCT01961531|101180714|FG000|NOT COMPLETED|Overall Study||0||
48347541|NCT01717638|101180715|FG000|STARTED|Overall Study||67||
48347542|NCT01717638|101180716|FG001|STARTED|Overall Study||61||
48347543|NCT01717638|101180717|FG002|STARTED|Overall Study||60||
48347544|NCT01717638|101180718|FG003|STARTED|Overall Study||66||
48347545|NCT01717638|101180719|FG004|STARTED|Overall Study||64||
48347546|NCT01717638|101180720|FG005|STARTED|Overall Study||55||
48347547|NCT01717638|101180721|FG006|STARTED|Overall Study||43||
48347548|NCT01717638|101180722|FG007|STARTED|Overall Study||29||
48347549|NCT01717638|101180723|FG008|STARTED|Overall Study||28||
48347550|NCT01717638|101180724|FG009|STARTED|Overall Study||100||
48347551|NCT01717638|101180725|FG010|STARTED|Overall Study||11||
48347552|NCT01717638|101180726|FG011|STARTED|Overall Study||12||
48347553|NCT01717638|101180727|FG012|STARTED|Overall Study||209||
48347554|NCT01717638|101180715|FG000|COMPLETED|Overall Study||67||
48347555|NCT01717638|101180716|FG001|COMPLETED|Overall Study||60||
48347556|NCT01717638|101180717|FG002|COMPLETED|Overall Study||59||
48347557|NCT01717638|101180718|FG003|COMPLETED|Overall Study||66||
48347558|NCT01717638|101180719|FG004|COMPLETED|Overall Study||63||
48347559|NCT01717638|101180720|FG005|COMPLETED|Overall Study||54||
48347560|NCT01717638|101180721|FG006|COMPLETED|Overall Study||41||
48347561|NCT01717638|101180722|FG007|COMPLETED|Overall Study||28||
48347562|NCT01717638|101180723|FG008|COMPLETED|Overall Study||26||
48347563|NCT01717638|101180724|FG009|COMPLETED|Overall Study||99||
48347564|NCT01717638|101180725|FG010|COMPLETED|Overall Study||11||
48347565|NCT01717638|101180726|FG011|COMPLETED|Overall Study||12||
48347566|NCT01717638|101180727|FG012|COMPLETED|Overall Study||190||
48347567|NCT01717638|101180715|FG000|NOT COMPLETED|Overall Study||0||
48347568|NCT01717638|101180716|FG001|NOT COMPLETED|Overall Study||1||
48347569|NCT01717638|101180717|FG002|NOT COMPLETED|Overall Study||1||
48347570|NCT01717638|101180718|FG003|NOT COMPLETED|Overall Study||0||
48347571|NCT01717638|101180719|FG004|NOT COMPLETED|Overall Study||1||
48347572|NCT01717638|101180720|FG005|NOT COMPLETED|Overall Study||1||
48347573|NCT01717638|101180721|FG006|NOT COMPLETED|Overall Study||2||
48347574|NCT01717638|101180722|FG007|NOT COMPLETED|Overall Study||1||
48347575|NCT01717638|101180723|FG008|NOT COMPLETED|Overall Study||2||
48347576|NCT01717638|101180724|FG009|NOT COMPLETED|Overall Study||1||
48347577|NCT01717638|101180725|FG010|NOT COMPLETED|Overall Study||0||
48347578|NCT01717638|101180726|FG011|NOT COMPLETED|Overall Study||0||
48347579|NCT01717638|101180727|FG012|NOT COMPLETED|Overall Study||19||
48347580|NCT02722044|101180728|FG000|STARTED|Overall Study||33||
48347581|NCT02722044|101180728|FG000|COMPLETED|Overall Study||28||
48347582|NCT02722044|101180728|FG000|NOT COMPLETED|Overall Study||5||
48347583|NCT00195650|101180729|FG000|STARTED|Overall Study||846||
48347584|NCT00195650|101180729|FG000|COMPLETED|Overall Study||321||
48347585|NCT00195650|101180729|FG000|NOT COMPLETED|Overall Study||525||
48347586|NCT00486902|101180730|FG000|STARTED|Overall Study||94||
48347587|NCT00486902|101180731|FG001|STARTED|Overall Study||94||
48347588|NCT00486902|101180730|FG000|COMPLETED|Overall Study||85||
48347589|NCT00486902|101180731|FG001|COMPLETED|Overall Study||89||
48347590|NCT00486902|101180730|FG000|NOT COMPLETED|Overall Study||9||
48347591|NCT00486902|101180731|FG001|NOT COMPLETED|Overall Study||5||
48347592|NCT01587950|101180732|FG000|STARTED|Period 1||12||
48347593|NCT01587950|101180732|FG000|Received 5% KNO3 Solution (5 Minutes)|Period 1||5||
48347594|NCT01587950|101180732|FG000|Received 5% KNO3 Solution (2 Minutes)|Period 1||3||
48347595|NCT01587950|101180732|FG000|Received Sterile Water (2 Minutes)|Period 1||2||
48347596|NCT01587950|101180732|FG000|Received 5% KNO3 Solution (10 Minutes)|Period 1||4||
48347597|NCT01587950|101180732|FG000|Received 2.5% KNO3 Solution (2 Minutes)|Period 1||4||
48347598|NCT01587950|101180732|FG000|Received 2.5% KNO3 Solution (10 Minutes)|Period 1||3||
48347599|NCT01587950|101180732|FG000|Received Sterile Water (10 Minutes)|Period 1||5||
48347600|NCT01587950|101180732|FG000|Received 2.5% KNO3 Solution (5 Minutes)|Period 1||5||
48347601|NCT01587950|101180732|FG000|Received Sterile Water (5 Minutes)|Period 1||5||
48347602|NCT01587950|101180732|FG000|COMPLETED|Period 1||12||
48347603|NCT01587950|101180732|FG000|NOT COMPLETED|Period 1||0||
48347604|NCT01587950|101180732|FG000|STARTED|Washout 1||12||
48347605|NCT01587950|101180732|FG000|COMPLETED|Washout 1||12||
48347606|NCT01587950|101180732|FG000|NOT COMPLETED|Washout 1||0||
48415827|NCT00523744|101350378|FG000|STARTED|Phase 2 - Amlodipine+Valsartan||176||
48347607|NCT01587950|101180732|FG000|STARTED|Period 2||12||
48347608|NCT01587950|101180732|FG000|Received Sterile Water (2 Minutes)|Period 2||8||
48347609|NCT01587950|101180732|FG000|Received 5% KNO3 Solution (10 Minutes)|Period 2||4||
48347610|NCT01587950|101180732|FG000|Received 2.5% KNO3 Solution (5 Minutes)|Period 2||2||
48347611|NCT01587950|101180732|FG000|Received 2.5% KNO3 Solution (10 Minutes)|Period 2||6||
48347612|NCT01587950|101180732|FG000|Received 5% KNO3 Solution (2 Minutes)|Period 2||6||
48415828|NCT00523744|101350378|FG000|COMPLETED|Phase 2 - Amlodipine+Valsartan||173||
48347613|NCT01587950|101180732|FG000|Received Sterile Water (5 Minutes)|Period 2||2||
48347614|NCT01587950|101180732|FG000|Received 2.5% KNO3 Solution (2 Minutes)|Period 2||4||
48759994|NCT05635461|102200445|FG005|COMPLETED|Period 1: Dosing 1 (Day 1)||6||
48759995|NCT05635461|102200440|FG000|NOT COMPLETED|Period 1: Dosing 1 (Day 1)||0||
48759996|NCT05635461|102200441|FG001|NOT COMPLETED|Period 1: Dosing 1 (Day 1)||0||
48186089|NCT04446975|100776057|FG002|STARTED|Randomization Period 4 (8 Weeks)||963||
48347615|NCT01587950|101180732|FG000|Received Sterile Water (10 Minutes)|Period 2||2||
48347616|NCT01587950|101180732|FG000|Received 5% KNO3 Solution (5 Minutes)|Period 2||2||
48347617|NCT01587950|101180732|FG000|COMPLETED|Period 2||12||
48347618|NCT01587950|101180732|FG000|NOT COMPLETED|Period 2||0||
48347619|NCT01587950|101180732|FG000|STARTED|Washout 2||12||
48347620|NCT01587950|101180732|FG000|COMPLETED|Washout 2||12||
48347621|NCT01587950|101180732|FG000|NOT COMPLETED|Washout 2||0||
48347622|NCT01587950|101180732|FG000|STARTED|Period 3||12||
48347623|NCT01587950|101180732|FG000|Received 2.5% KNO3 Solution (2 Minutes)|Period 3||4||
48347624|NCT01587950|101180732|FG000|Received Sterile Water (10 Minutes)|Period 3||5||
48347625|NCT01587950|101180732|FG000|Received Sterile Water (2 Minutes)|Period 3||2||
48347626|NCT01587950|101180732|FG000|Received 5% KNO3 Solution (10 Minutes)|Period 3||4||
48347627|NCT01587950|101180732|FG000|Received Sterile Water (5 Minutes)|Period 3||5||
48347628|NCT01587950|101180732|FG000|Received 5% KNO3 Solution (5 Minutes)|Period 3||5||
48347629|NCT01587950|101180732|FG000|Received 5% KNO3 Solution (2 Minutes)|Period 3||3||
48347630|NCT01587950|101180732|FG000|Received 2.5% KNO3 Solution (10 Minutes)|Period 3||3||
48347631|NCT01587950|101180732|FG000|Received 2.5% KNO3 Solution (5 Minutes)|Period 3||5||
48347632|NCT01587950|101180732|FG000|COMPLETED|Period 3||12||
48347633|NCT01587950|101180732|FG000|NOT COMPLETED|Period 3||0||
48347634|NCT02514044|101180733|FG000|STARTED|Dexedrine+tDCS+Speech Therapy (1 Day)||10||
48347635|NCT02514044|101180733|FG000|COMPLETED|Dexedrine+tDCS+Speech Therapy (1 Day)||10||
48347636|NCT02514044|101180733|FG000|NOT COMPLETED|Dexedrine+tDCS+Speech Therapy (1 Day)||0||
48347637|NCT02514044|101180733|FG000|STARTED|Washout (1 Week)||10||
48347638|NCT02514044|101180733|FG000|COMPLETED|Washout (1 Week)||10||
48347639|NCT02514044|101180733|FG000|NOT COMPLETED|Washout (1 Week)||0||
48347640|NCT02514044|101180733|FG000|STARTED|Placebo+tDCS+Speech Therapy (1 Day)||10||
48347641|NCT02514044|101180733|FG000|COMPLETED|Placebo+tDCS+Speech Therapy (1 Day)||10||
48347642|NCT02514044|101180733|FG000|NOT COMPLETED|Placebo+tDCS+Speech Therapy (1 Day)||0||
48347643|NCT00591734|101180734|FG000|STARTED|Overall Study||57||
48347644|NCT00591734|101180734|FG000|COMPLETED|Overall Study||4||
48347645|NCT00591734|101180734|FG000|NOT COMPLETED|Overall Study||53||
48347646|NCT01914679|101180735|FG000|STARTED|Overall Study||17||
48347647|NCT01914679|101180735|FG000|Began 12 Week Actual RINCE Treatment|Overall Study||17||
48347648|NCT01914679|101180735|FG000|COMPLETED|Overall Study||12||
48347649|NCT01914679|101180735|FG000|NOT COMPLETED|Overall Study||5||
48347650|NCT03812510|101180736|FG000|STARTED|Overall Study||426||
48347651|NCT03812510|101180736|FG000|COMPLETED|Overall Study||274||
48347652|NCT03812510|101180736|FG000|NOT COMPLETED|Overall Study||152||
48347653|NCT02354833|101180737|FG000|STARTED|Overall Study||38||
48347654|NCT02354833|101180738|FG001|STARTED|Overall Study||43||
48347655|NCT02354833|101180737|FG000|COMPLETED|Overall Study||38||
48347656|NCT02354833|101180738|FG001|COMPLETED|Overall Study||43||
48347657|NCT02354833|101180737|FG000|NOT COMPLETED|Overall Study||0||
48347658|NCT02354833|101180738|FG001|NOT COMPLETED|Overall Study||0||
48759997|NCT05635461|102200442|FG002|NOT COMPLETED|Period 1: Dosing 1 (Day 1)||0||
48759998|NCT05635461|102200443|FG003|NOT COMPLETED|Period 1: Dosing 1 (Day 1)||0||
48759999|NCT05635461|102200444|FG004|NOT COMPLETED|Period 1: Dosing 1 (Day 1)||0||
48760000|NCT05635461|102200445|FG005|NOT COMPLETED|Period 1: Dosing 1 (Day 1)||0||
48760001|NCT05635461|102200440|FG000|STARTED|Washout Period (7 Days)||5||
48760002|NCT05635461|102200441|FG001|STARTED|Washout Period (7 Days)||5||
48760003|NCT05635461|102200442|FG002|STARTED|Washout Period (7 Days)||5||
48186090|NCT04446975|100776058|FG003|STARTED|Randomization Period 4 (8 Weeks)||832||
48186091|NCT04446975|100776055|FG000|COMPLETED|Randomization Period 4 (8 Weeks)||2607||
48347659|NCT00371267|101180739|FG000|STARTED|Overall Study||48||
48347660|NCT00371267|101180740|FG001|STARTED|Overall Study||50||
48347661|NCT00371267|101180739|FG000|COMPLETED|Overall Study||39||
48347662|NCT00371267|101180740|FG001|COMPLETED|Overall Study||32||
48347663|NCT00371267|101180739|FG000|NOT COMPLETED|Overall Study||9||
48347664|NCT00371267|101180740|FG001|NOT COMPLETED|Overall Study||18||
48347665|NCT01859403|101180741|FG000|STARTED|Primary Endpoint Measure||21||
48347666|NCT01859403|101180742|FG001|STARTED|Primary Endpoint Measure||30||
48347667|NCT01859403|101180741|FG000|COMPLETED|Primary Endpoint Measure||20||
48347668|NCT01859403|101180742|FG001|COMPLETED|Primary Endpoint Measure||26||
48347669|NCT01859403|101180741|FG000|NOT COMPLETED|Primary Endpoint Measure||1||
48347670|NCT01859403|101180742|FG001|NOT COMPLETED|Primary Endpoint Measure||4||
48347671|NCT01859403|101180741|FG000|STARTED|Secondary Endpoint Measure||20||
48347672|NCT01859403|101180742|FG001|STARTED|Secondary Endpoint Measure||26||
48347673|NCT01859403|101180741|FG000|COMPLETED|Secondary Endpoint Measure||14||
48347674|NCT01859403|101180742|FG001|COMPLETED|Secondary Endpoint Measure||18||
48347675|NCT01859403|101180741|FG000|NOT COMPLETED|Secondary Endpoint Measure||6||
48347676|NCT01859403|101180742|FG001|NOT COMPLETED|Secondary Endpoint Measure||8||
48347677|NCT00422279|101180743|FG000|STARTED|Overall Study||2||
48347678|NCT00422279|101180744|FG001|STARTED|Overall Study||2||
48347679|NCT00422279|101180743|FG000|24 Month After Loading Period|Overall Study||2||
48347680|NCT00422279|101180744|FG001|24 Month After Loading Period|Overall Study||2||
48347681|NCT00422279|101180743|FG000|COMPLETED|Overall Study||2||
48347682|NCT00422279|101180744|FG001|COMPLETED|Overall Study||2||
48347683|NCT00422279|101180743|FG000|NOT COMPLETED|Overall Study||0||
48347684|NCT00422279|101180744|FG001|NOT COMPLETED|Overall Study||0||
48347685|NCT04725682|101180745|FG000|STARTED|Overall Study||33||
48347686|NCT04725682|101180746|FG001|STARTED|Overall Study||34||
48347687|NCT04725682|101180745|FG000|COMPLETED|Overall Study||23||
48347688|NCT04725682|101180746|FG001|COMPLETED|Overall Study||26||
48347689|NCT04725682|101180745|FG000|NOT COMPLETED|Overall Study||10||
48347690|NCT04725682|101180746|FG001|NOT COMPLETED|Overall Study||8||
48347691|NCT02292849|101180747|FG000|STARTED|Overall Study||11||
48347692|NCT02292849|101180748|FG001|STARTED|Overall Study||8||
48347693|NCT02292849|101180749|FG002|STARTED|Overall Study||10||
48347694|NCT02292849|101180747|FG000|COMPLETED|Overall Study||7||
48347695|NCT02292849|101180748|FG001|COMPLETED|Overall Study||6||
48347696|NCT02292849|101180749|FG002|COMPLETED|Overall Study||8||
48347697|NCT02292849|101180747|FG000|NOT COMPLETED|Overall Study||4||
48347698|NCT02292849|101180748|FG001|NOT COMPLETED|Overall Study||2||
48347699|NCT02292849|101180749|FG002|NOT COMPLETED|Overall Study||2||
48347700|NCT02909153|101180750|FG000|STARTED|Overall Study||6||
48347701|NCT02909153|101180751|FG001|STARTED|Overall Study||6||
48637097|NCT04685811|101894773|FG000|STARTED|Overall Study||16||
48637098|NCT04685811|101894773|FG000|COMPLETED|Overall Study||16||
48637099|NCT04685811|101894773|FG000|NOT COMPLETED|Overall Study||0||
48637100|NCT00397579|101894774|FG000|STARTED|Overall Study||11||
48347702|NCT02909153|101180752|FG002|STARTED|Overall Study||6||
48347703|NCT02909153|101180753|FG003|STARTED|Overall Study||6||
48347704|NCT02909153|101180754|FG004|STARTED|Overall Study||6||
48347705|NCT02909153|101180750|FG000|Triferic in Dianeal PD Solution|Overall Study||6|Cohort 1: 5 mg Fe/L Triferic, Cohort 2: 12.5 mg Fe/L Triferic, Cohort 3: 7.5 mg Fe/L Triferic|
48347706|NCT02909153|101180751|FG001|Triferic in Dianeal PD Solution|Overall Study||6|Cohort 1: 5 mg Fe/L Triferic, Cohort 2: 12.5 mg Fe/L Triferic, Cohort 3: 7.5 mg Fe/L Triferic|
48347707|NCT02909153|101180752|FG002|Triferic in Dianeal PD Solution|Overall Study||6|Cohort 1: 5 mg Fe/L Triferic, Cohort 2: 12.5 mg Fe/L Triferic, Cohort 3: 7.5 mg Fe/L Triferic|
48347708|NCT02909153|101180753|FG003|Triferic in Dianeal PD Solution|Overall Study||0|Cohort 1: 5 mg Fe/L Triferic, Cohort 2: 12.5 mg Fe/L Triferic, Cohort 3: 7.5 mg Fe/L Triferic|
48347709|NCT02909153|101180754|FG004|Triferic in Dianeal PD Solution|Overall Study||0|Cohort 1: 5 mg Fe/L Triferic, Cohort 2: 12.5 mg Fe/L Triferic, Cohort 3: 7.5 mg Fe/L Triferic|
48347710|NCT02909153|101180750|FG000|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6||
48347711|NCT02909153|101180751|FG001|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||5||
48347712|NCT02909153|101180752|FG002|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6||
48347713|NCT02909153|101180753|FG003|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6||
48347714|NCT02909153|101180754|FG004|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6||
48347715|NCT02909153|101180750|FG000|Triferic in Extraneal PD Solution|Overall Study||0|Cohort 4: dosed Triferic 5 mg Fe/L, Cohort 5: dosed Triferic 2.5 mg Fe/L|
48347716|NCT02909153|101180751|FG001|Triferic in Extraneal PD Solution|Overall Study||0|Cohort 4: dosed Triferic 5 mg Fe/L, Cohort 5: dosed Triferic 2.5 mg Fe/L|
48347717|NCT02909153|101180752|FG002|Triferic in Extraneal PD Solution|Overall Study||0|Cohort 4: dosed Triferic 5 mg Fe/L, Cohort 5: dosed Triferic 2.5 mg Fe/L|
48347718|NCT02909153|101180753|FG003|Triferic in Extraneal PD Solution|Overall Study||6|Cohort 4: dosed Triferic 5 mg Fe/L, Cohort 5: dosed Triferic 2.5 mg Fe/L|
48347719|NCT02909153|101180754|FG004|Triferic in Extraneal PD Solution|Overall Study||6|Cohort 4: dosed Triferic 5 mg Fe/L, Cohort 5: dosed Triferic 2.5 mg Fe/L|
48347720|NCT02909153|101180750|FG000|COMPLETED|Overall Study||6||
48347721|NCT02909153|101180751|FG001|COMPLETED|Overall Study||5||
48347722|NCT02909153|101180752|FG002|COMPLETED|Overall Study||6||
48347723|NCT02909153|101180753|FG003|COMPLETED|Overall Study||6||
48347724|NCT02909153|101180754|FG004|COMPLETED|Overall Study||6||
48347725|NCT02909153|101180750|FG000|NOT COMPLETED|Overall Study||0||
48347726|NCT02909153|101180751|FG001|NOT COMPLETED|Overall Study||1||
48347727|NCT02909153|101180752|FG002|NOT COMPLETED|Overall Study||0||
48347728|NCT02909153|101180753|FG003|NOT COMPLETED|Overall Study||0||
48347729|NCT02909153|101180754|FG004|NOT COMPLETED|Overall Study||0||
48347730|NCT02284165|101180755|FG000|STARTED|Overall Study||36448||
48347731|NCT02284165|101180756|FG001|STARTED|Overall Study||40272||
48347732|NCT02284165|101180757|FG002|STARTED|Overall Study||70996||
48347733|NCT02284165|101180755|FG000|COMPLETED|Overall Study||36448||
48347734|NCT02284165|101180756|FG001|COMPLETED|Overall Study||40272||
48347735|NCT02284165|101180757|FG002|COMPLETED|Overall Study||70996||
48347736|NCT02284165|101180755|FG000|NOT COMPLETED|Overall Study||0||
48347737|NCT02284165|101180756|FG001|NOT COMPLETED|Overall Study||0||
48347738|NCT02284165|101180757|FG002|NOT COMPLETED|Overall Study||0||
48347739|NCT01264939|101180758|FG000|STARTED|Overall Study||84||
48347740|NCT01264939|101180759|FG001|STARTED|Overall Study||252||
48347741|NCT01264939|101180758|FG000|COMPLETED|Overall Study||66||
48347742|NCT01264939|101180759|FG001|COMPLETED|Overall Study||224||
48637101|NCT00397579|101894774|FG000|COMPLETED|Overall Study||11||
48637102|NCT00397579|101894774|FG000|NOT COMPLETED|Overall Study||0||
48637103|NCT00481676|101894775|FG000|STARTED|Overall Study||27||
48347743|NCT01264939|101180758|FG000|NOT COMPLETED|Overall Study||18||
48347744|NCT01264939|101180759|FG001|NOT COMPLETED|Overall Study||28||
48347745|NCT01151137|101180760|FG000|STARTED|Overall Study||1617||
48347746|NCT01151137|101180761|FG001|STARTED|Overall Study||1619||
48347747|NCT01151137|101180760|FG000|Treated|Overall Study||1610||
48347748|NCT01151137|101180761|FG001|Treated|Overall Study||1613||
48347749|NCT01151137|101180760|FG000|Discontinued Treatment|Overall Study||171||
48347750|NCT01151137|101180761|FG001|Discontinued Treatment|Overall Study||342||
48347751|NCT01151137|101180760|FG000|COMPLETED|Overall Study||1601||
48347752|NCT01151137|101180761|FG001|COMPLETED|Overall Study||1591||
48347753|NCT01151137|101180760|FG000|NOT COMPLETED|Overall Study||16||
48347754|NCT01151137|101180761|FG001|NOT COMPLETED|Overall Study||28||
48347755|NCT01147809|101180762|FG000|STARTED|Phase I (168 Days)||3||
48347756|NCT01147809|101180763|FG001|STARTED|Phase I (168 Days)||9||
48347757|NCT01147809|101180764|FG002|STARTED|Phase I (168 Days)||4||
48347758|NCT01147809|101180765|FG003|STARTED|Phase I (168 Days)||10||
48347759|NCT01147809|101180766|FG004|STARTED|Phase I (168 Days)||0||
48347760|NCT01147809|101180767|FG005|STARTED|Phase I (168 Days)||0||
48347761|NCT01147809|101180762|FG000|COMPLETED|Phase I (168 Days)||2||
48347762|NCT01147809|101180763|FG001|COMPLETED|Phase I (168 Days)||8||
48347763|NCT01147809|101180764|FG002|COMPLETED|Phase I (168 Days)||2||
48347764|NCT01147809|101180765|FG003|COMPLETED|Phase I (168 Days)||5||
48347765|NCT01147809|101180766|FG004|COMPLETED|Phase I (168 Days)||0||
48347766|NCT01147809|101180767|FG005|COMPLETED|Phase I (168 Days)||0||
48347767|NCT01147809|101180762|FG000|NOT COMPLETED|Phase I (168 Days)||1||
48347768|NCT01147809|101180763|FG001|NOT COMPLETED|Phase I (168 Days)||1||
48347769|NCT01147809|101180764|FG002|NOT COMPLETED|Phase I (168 Days)||2||
48347770|NCT01147809|101180765|FG003|NOT COMPLETED|Phase I (168 Days)||5||
48347771|NCT01147809|101180766|FG004|NOT COMPLETED|Phase I (168 Days)||0||
48347772|NCT01147809|101180767|FG005|NOT COMPLETED|Phase I (168 Days)||0||
48347773|NCT01147809|101180762|FG000|STARTED|Phase II (168 Days)||0||
48347774|NCT01147809|101180763|FG001|STARTED|Phase II (168 Days)||0||
48347775|NCT01147809|101180764|FG002|STARTED|Phase II (168 Days)||0||
48347776|NCT01147809|101180765|FG003|STARTED|Phase II (168 Days)||0||
48347777|NCT01147809|101180766|FG004|STARTED|Phase II (168 Days)||23||
48347778|NCT01147809|101180767|FG005|STARTED|Phase II (168 Days)||52||
48347779|NCT01147809|101180762|FG000|Ongoing|Phase II (168 Days)||0||
48347780|NCT01147809|101180763|FG001|Ongoing|Phase II (168 Days)||0||
48347781|NCT01147809|101180764|FG002|Ongoing|Phase II (168 Days)||0||
48347782|NCT01147809|101180765|FG003|Ongoing|Phase II (168 Days)||0||
48347783|NCT01147809|101180766|FG004|Ongoing|Phase II (168 Days)||1||
48347784|NCT01147809|101180767|FG005|Ongoing|Phase II (168 Days)||0||
48347785|NCT01147809|101180762|FG000|COMPLETED|Phase II (168 Days)||0||
48347786|NCT01147809|101180763|FG001|COMPLETED|Phase II (168 Days)||0||
48347787|NCT01147809|101180764|FG002|COMPLETED|Phase II (168 Days)||0||
48347788|NCT01147809|101180765|FG003|COMPLETED|Phase II (168 Days)||0||
48347789|NCT01147809|101180766|FG004|COMPLETED|Phase II (168 Days)||7||
48347790|NCT01147809|101180767|FG005|COMPLETED|Phase II (168 Days)||19||
48347791|NCT01147809|101180762|FG000|NOT COMPLETED|Phase II (168 Days)||0||
48347792|NCT01147809|101180763|FG001|NOT COMPLETED|Phase II (168 Days)||0||
48347793|NCT01147809|101180764|FG002|NOT COMPLETED|Phase II (168 Days)||0||
48347794|NCT01147809|101180765|FG003|NOT COMPLETED|Phase II (168 Days)||0||
48347795|NCT01147809|101180766|FG004|NOT COMPLETED|Phase II (168 Days)||16||
48347796|NCT01147809|101180767|FG005|NOT COMPLETED|Phase II (168 Days)||33||
48347797|NCT01271686|101180768|FG000|STARTED|Overall Study||16||
48347798|NCT01271686|101180768|FG000|COMPLETED|Overall Study||16||
48347799|NCT01271686|101180768|FG000|NOT COMPLETED|Overall Study||0||
48347800|NCT03866200|101180769|FG000|STARTED|First Intervention (90 Days)||5||
48347801|NCT03866200|101180770|FG001|STARTED|First Intervention (90 Days)||1||
48347802|NCT03866200|101180769|FG000|COMPLETED|First Intervention (90 Days)||5||
48347803|NCT03866200|101180770|FG001|COMPLETED|First Intervention (90 Days)||1||
48347804|NCT03866200|101180769|FG000|NOT COMPLETED|First Intervention (90 Days)||0||
48347805|NCT03866200|101180770|FG001|NOT COMPLETED|First Intervention (90 Days)||0||
48347806|NCT03866200|101180769|FG000|STARTED|Washout (30 Days)||5||
48347807|NCT03866200|101180770|FG001|STARTED|Washout (30 Days)||1||
48347808|NCT03866200|101180769|FG000|COMPLETED|Washout (30 Days)||5||
48347809|NCT03866200|101180770|FG001|COMPLETED|Washout (30 Days)||1||
48347810|NCT03866200|101180769|FG000|NOT COMPLETED|Washout (30 Days)||0||
48347811|NCT03866200|101180770|FG001|NOT COMPLETED|Washout (30 Days)||0||
48347812|NCT03866200|101180769|FG000|STARTED|Second Intervention (90 Days)||5||
48637104|NCT00481676|101894776|FG001|STARTED|Overall Study||22||
48347813|NCT03866200|101180770|FG001|STARTED|Second Intervention (90 Days)||1||
48347814|NCT03866200|101180769|FG000|COMPLETED|Second Intervention (90 Days)||5||
48347815|NCT03866200|101180770|FG001|COMPLETED|Second Intervention (90 Days)||1||
48347816|NCT03866200|101180769|FG000|NOT COMPLETED|Second Intervention (90 Days)||0||
48347817|NCT03866200|101180770|FG001|NOT COMPLETED|Second Intervention (90 Days)||0||
48347818|NCT04429022|101180771|FG000|STARTED|Overall Study||28||
48347819|NCT04429022|101180772|FG001|STARTED|Overall Study||40||
48347820|NCT04429022|101180771|FG000|COMPLETED|Overall Study||10||
48347821|NCT04429022|101180772|FG001|COMPLETED|Overall Study||39||
48347822|NCT04429022|101180771|FG000|NOT COMPLETED|Overall Study||18||
48347823|NCT04429022|101180772|FG001|NOT COMPLETED|Overall Study||1||
48347824|NCT02658461|101180773|FG000|STARTED|Overall Study||12||
48347825|NCT02658461|101180774|FG001|STARTED|Overall Study||12||
48347826|NCT02658461|101180775|FG002|STARTED|Overall Study||12||
48347827|NCT02658461|101180773|FG000|COMPLETED|Overall Study||12||
48347828|NCT02658461|101180774|FG001|COMPLETED|Overall Study||12||
48347829|NCT02658461|101180775|FG002|COMPLETED|Overall Study||12||
48347830|NCT02658461|101180773|FG000|NOT COMPLETED|Overall Study||0||
48347831|NCT02658461|101180774|FG001|NOT COMPLETED|Overall Study||0||
48347832|NCT02658461|101180775|FG002|NOT COMPLETED|Overall Study||0||
48347833|NCT02443402|101180776|FG000|STARTED|Overall Study||36||
48347834|NCT02443402|101180777|FG001|STARTED|Overall Study||31||
48347835|NCT02443402|101180776|FG000|COMPLETED|Overall Study||32||
48347836|NCT02443402|101180777|FG001|COMPLETED|Overall Study||28||
48347837|NCT02443402|101180776|FG000|NOT COMPLETED|Overall Study||4||
48347838|NCT02443402|101180777|FG001|NOT COMPLETED|Overall Study||3||
48347839|NCT01221857|101180778|FG000|STARTED|Overall Study||12||
48347840|NCT01221857|101180778|FG000|COMPLETED|Overall Study||12|1 patient received unmanipulated cord only.|
48347841|NCT01221857|101180778|FG000|NOT COMPLETED|Overall Study||0||
48347842|NCT01564784|101180779|FG000|STARTED|Overall Study||164||
48347843|NCT01564784|101180780|FG001|STARTED|Overall Study||143||
48347844|NCT01564784|101180779|FG000|COMPLETED|Overall Study||30||
48347845|NCT01564784|101180780|FG001|COMPLETED|Overall Study||10||
48347846|NCT01564784|101180779|FG000|NOT COMPLETED|Overall Study||134||
48347847|NCT01564784|101180780|FG001|NOT COMPLETED|Overall Study||133||
48347848|NCT00628355|101180781|FG000|STARTED|Overall Study||15||
48347849|NCT00628355|101180782|FG001|STARTED|Overall Study||15||
48347850|NCT00628355|101180781|FG000|COMPLETED|Overall Study||14||
48347851|NCT00628355|101180782|FG001|COMPLETED|Overall Study||14||
48347852|NCT00628355|101180781|FG000|NOT COMPLETED|Overall Study||1||
48347853|NCT00628355|101180782|FG001|NOT COMPLETED|Overall Study||1||
48637105|NCT00481676|101894775|FG000|COMPLETED|Overall Study||25||
48637106|NCT00481676|101894776|FG001|COMPLETED|Overall Study||17||
48637107|NCT00481676|101894775|FG000|NOT COMPLETED|Overall Study||2||
48637108|NCT00481676|101894776|FG001|NOT COMPLETED|Overall Study||5||
48637109|NCT00513799|101894777|FG000|STARTED|One-Month Follow-Up||75||
48637110|NCT00513799|101894778|FG001|STARTED|One-Month Follow-Up||75||
48637111|NCT00513799|101894779|FG002|STARTED|One-Month Follow-Up||75||
48637112|NCT00513799|101894780|FG003|STARTED|One-Month Follow-Up||75||
48637113|NCT00513799|101894777|FG000|COMPLETED|One-Month Follow-Up||64||
48637114|NCT00513799|101894778|FG001|COMPLETED|One-Month Follow-Up||62||
48637115|NCT00513799|101894779|FG002|COMPLETED|One-Month Follow-Up||64||
48637116|NCT00513799|101894780|FG003|COMPLETED|One-Month Follow-Up||54||
48637117|NCT00513799|101894777|FG000|NOT COMPLETED|One-Month Follow-Up||11||
48637118|NCT00513799|101894778|FG001|NOT COMPLETED|One-Month Follow-Up||13||
48637119|NCT00513799|101894779|FG002|NOT COMPLETED|One-Month Follow-Up||11||
48637120|NCT00513799|101894780|FG003|NOT COMPLETED|One-Month Follow-Up||21||
48637121|NCT00513799|101894777|FG000|STARTED|Four-Month Follow-Up||64||
48637122|NCT00513799|101894778|FG001|STARTED|Four-Month Follow-Up||62||
48347854|NCT01212445|101180783|FG000|STARTED|Overall Study||52||
48347855|NCT01212445|101180784|FG001|STARTED|Overall Study||51||
48347856|NCT01212445|101180785|FG002|STARTED|Overall Study||51||
48347857|NCT01212445|101180783|FG000|COMPLETED|Overall Study||52||
48347858|NCT01212445|101180784|FG001|COMPLETED|Overall Study||51||
48347859|NCT01212445|101180785|FG002|COMPLETED|Overall Study||51||
48347860|NCT01212445|101180783|FG000|NOT COMPLETED|Overall Study||0||
48347861|NCT01212445|101180784|FG001|NOT COMPLETED|Overall Study||0||
48347862|NCT01212445|101180785|FG002|NOT COMPLETED|Overall Study||0||
48347863|NCT05900115|101180786|FG000|STARTED|Overall Study||304||
48347864|NCT05900115|101180787|FG001|STARTED|Overall Study||272||
48347865|NCT05900115|101180786|FG000|Completed Pretest|Overall Study||206||
48347866|NCT05900115|101180787|FG001|Completed Pretest|Overall Study||188||
48637123|NCT00513799|101894779|FG002|STARTED|Four-Month Follow-Up||64||
48637124|NCT00513799|101894780|FG003|STARTED|Four-Month Follow-Up||54||
48637125|NCT00513799|101894777|FG000|COMPLETED|Four-Month Follow-Up||64||
48637126|NCT00513799|101894778|FG001|COMPLETED|Four-Month Follow-Up||57||
48637127|NCT00513799|101894779|FG002|COMPLETED|Four-Month Follow-Up||57||
48347867|NCT05900115|101180786|FG000|COMPLETED|Overall Study||175||
48347868|NCT05900115|101180787|FG001|COMPLETED|Overall Study||174||
48347869|NCT05900115|101180786|FG000|NOT COMPLETED|Overall Study||129||
48347870|NCT05900115|101180787|FG001|NOT COMPLETED|Overall Study||98||
48347871|NCT01412879|101180788|FG000|STARTED|Initial Registration (Induction Therapy)||18||
48347872|NCT01412879|101180789|FG001|STARTED|Initial Registration (Induction Therapy)||35||
48347873|NCT01412879|101180790|FG002|STARTED|Initial Registration (Induction Therapy)||0||
48347874|NCT01412879|101180788|FG000|Treatment Started|Initial Registration (Induction Therapy)||17||
48347875|NCT01412879|101180789|FG001|Treatment Started|Initial Registration (Induction Therapy)||35||
48347876|NCT01412879|101180790|FG002|Treatment Started|Initial Registration (Induction Therapy)||0||
48347877|NCT01412879|101180788|FG000|COMPLETED|Initial Registration (Induction Therapy)||5||
48347878|NCT01412879|101180789|FG001|COMPLETED|Initial Registration (Induction Therapy)||27||
48637128|NCT00513799|101894780|FG003|COMPLETED|Four-Month Follow-Up||51||
48637129|NCT00513799|101894777|FG000|NOT COMPLETED|Four-Month Follow-Up||0||
48347879|NCT01412879|101180790|FG002|COMPLETED|Initial Registration (Induction Therapy)||0||
48347880|NCT01412879|101180788|FG000|NOT COMPLETED|Initial Registration (Induction Therapy)||13||
48760004|NCT05635461|102200443|FG003|STARTED|Washout Period (7 Days)||6||
48760005|NCT05635461|102200444|FG004|STARTED|Washout Period (7 Days)||5||
48760006|NCT05635461|102200445|FG005|STARTED|Washout Period (7 Days)||6||
48760007|NCT05635461|102200440|FG000|COMPLETED|Washout Period (7 Days)||5||
48760008|NCT05635461|102200441|FG001|COMPLETED|Washout Period (7 Days)||5||
48760009|NCT05635461|102200442|FG002|COMPLETED|Washout Period (7 Days)||5||
48760010|NCT05635461|102200443|FG003|COMPLETED|Washout Period (7 Days)||6||
48760011|NCT05635461|102200444|FG004|COMPLETED|Washout Period (7 Days)||5||
48760012|NCT05635461|102200445|FG005|COMPLETED|Washout Period (7 Days)||6||
48760013|NCT05635461|102200440|FG000|NOT COMPLETED|Washout Period (7 Days)||0||
48760014|NCT05635461|102200441|FG001|NOT COMPLETED|Washout Period (7 Days)||0||
48760015|NCT05635461|102200442|FG002|NOT COMPLETED|Washout Period (7 Days)||0||
48347881|NCT01412879|101180789|FG001|NOT COMPLETED|Initial Registration (Induction Therapy)||8||
48760016|NCT05635461|102200443|FG003|NOT COMPLETED|Washout Period (7 Days)||0||
48760017|NCT05635461|102200444|FG004|NOT COMPLETED|Washout Period (7 Days)||0||
48760018|NCT05635461|102200445|FG005|NOT COMPLETED|Washout Period (7 Days)||0||
48760019|NCT05635461|102200440|FG000|STARTED|Period 2: Dosing 2 (Day 1)||5||
48760020|NCT05635461|102200441|FG001|STARTED|Period 2: Dosing 2 (Day 1)||5||
48760021|NCT05635461|102200442|FG002|STARTED|Period 2: Dosing 2 (Day 1)||5||
48347882|NCT01412879|101180790|FG002|NOT COMPLETED|Initial Registration (Induction Therapy)||0||
48347883|NCT01412879|101180788|FG000|STARTED|Consolidation Therapy||0||
48347884|NCT01412879|101180789|FG001|STARTED|Consolidation Therapy||0||
48760022|NCT05635461|102200443|FG003|STARTED|Period 2: Dosing 2 (Day 1)||6||
48760023|NCT05635461|102200444|FG004|STARTED|Period 2: Dosing 2 (Day 1)||5||
48760024|NCT05635461|102200445|FG005|STARTED|Period 2: Dosing 2 (Day 1)||6||
48760025|NCT05635461|102200440|FG000|COMPLETED|Period 2: Dosing 2 (Day 1)||5||
48760026|NCT05635461|102200441|FG001|COMPLETED|Period 2: Dosing 2 (Day 1)||5||
48760027|NCT05635461|102200442|FG002|COMPLETED|Period 2: Dosing 2 (Day 1)||5||
48760028|NCT05635461|102200443|FG003|COMPLETED|Period 2: Dosing 2 (Day 1)||6||
48760029|NCT05635461|102200444|FG004|COMPLETED|Period 2: Dosing 2 (Day 1)||4||
48760030|NCT05635461|102200445|FG005|COMPLETED|Period 2: Dosing 2 (Day 1)||6||
48760031|NCT05635461|102200440|FG000|NOT COMPLETED|Period 2: Dosing 2 (Day 1)||0||
48760032|NCT05635461|102200441|FG001|NOT COMPLETED|Period 2: Dosing 2 (Day 1)||0||
48760033|NCT05635461|102200442|FG002|NOT COMPLETED|Period 2: Dosing 2 (Day 1)||0||
48760034|NCT05635461|102200443|FG003|NOT COMPLETED|Period 2: Dosing 2 (Day 1)||0||
48760035|NCT05635461|102200444|FG004|NOT COMPLETED|Period 2: Dosing 2 (Day 1)||1||
48760036|NCT05635461|102200445|FG005|NOT COMPLETED|Period 2: Dosing 2 (Day 1)||0||
48760037|NCT05635461|102200440|FG000|STARTED|Washout Period (7 Days)||5||
48760038|NCT05635461|102200441|FG001|STARTED|Washout Period (7 Days)||5||
48760039|NCT05635461|102200442|FG002|STARTED|Washout Period (7 Days)||5||
48760040|NCT05635461|102200443|FG003|STARTED|Washout Period (7 Days)||6||
48760041|NCT05635461|102200444|FG004|STARTED|Washout Period (7 Days)||4||
48760042|NCT05635461|102200445|FG005|STARTED|Washout Period (7 Days)||6||
48760043|NCT05635461|102200440|FG000|COMPLETED|Washout Period (7 Days)||5||
48760044|NCT05635461|102200441|FG001|COMPLETED|Washout Period (7 Days)||5||
48760045|NCT05635461|102200442|FG002|COMPLETED|Washout Period (7 Days)||5||
48760046|NCT05635461|102200443|FG003|COMPLETED|Washout Period (7 Days)||6||
48760047|NCT05635461|102200444|FG004|COMPLETED|Washout Period (7 Days)||4||
48347885|NCT01412879|101180790|FG002|STARTED|Consolidation Therapy||26||
48347886|NCT01412879|101180788|FG000|COMPLETED|Consolidation Therapy||0||
48347887|NCT01412879|101180789|FG001|COMPLETED|Consolidation Therapy||0||
48347888|NCT01412879|101180790|FG002|COMPLETED|Consolidation Therapy||26||
48347889|NCT01412879|101180788|FG000|NOT COMPLETED|Consolidation Therapy||0||
48347890|NCT01412879|101180789|FG001|NOT COMPLETED|Consolidation Therapy||0||
48760048|NCT05635461|102200445|FG005|COMPLETED|Washout Period (7 Days)||6||
48760049|NCT05635461|102200440|FG000|NOT COMPLETED|Washout Period (7 Days)||0||
48760050|NCT05635461|102200441|FG001|NOT COMPLETED|Washout Period (7 Days)||0||
48347891|NCT01412879|101180790|FG002|NOT COMPLETED|Consolidation Therapy||0||
48760051|NCT05635461|102200442|FG002|NOT COMPLETED|Washout Period (7 Days)||0||
48760052|NCT05635461|102200443|FG003|NOT COMPLETED|Washout Period (7 Days)||0||
48760053|NCT05635461|102200444|FG004|NOT COMPLETED|Washout Period (7 Days)||0||
48186092|NCT04446975|100776056|FG001|COMPLETED|Randomization Period 4 (8 Weeks)||1248||
48347892|NCT02811744|101180791|FG000|STARTED|Overall Study||6||
48347893|NCT02811744|101180792|FG001|STARTED|Overall Study||5||
48347894|NCT02811744|101180791|FG000|COMPLETED|Overall Study||6||
48760054|NCT05635461|102200445|FG005|NOT COMPLETED|Washout Period (7 Days)||0||
48760055|NCT05635461|102200440|FG000|STARTED|Period 3: Dosing 3 (Day 1)||5||
48760056|NCT05635461|102200441|FG001|STARTED|Period 3: Dosing 3 (Day 1)||5||
48760057|NCT05635461|102200442|FG002|STARTED|Period 3: Dosing 3 (Day 1)||5||
48760058|NCT05635461|102200443|FG003|STARTED|Period 3: Dosing 3 (Day 1)||6||
48760059|NCT05635461|102200444|FG004|STARTED|Period 3: Dosing 3 (Day 1)||4||
48760060|NCT05635461|102200445|FG005|STARTED|Period 3: Dosing 3 (Day 1)||6||
48760061|NCT05635461|102200440|FG000|COMPLETED|Period 3: Dosing 3 (Day 1)||5||
48760062|NCT05635461|102200441|FG001|COMPLETED|Period 3: Dosing 3 (Day 1)||4||
48760063|NCT05635461|102200442|FG002|COMPLETED|Period 3: Dosing 3 (Day 1)||5||
48760064|NCT05635461|102200443|FG003|COMPLETED|Period 3: Dosing 3 (Day 1)||5||
48760065|NCT05635461|102200444|FG004|COMPLETED|Period 3: Dosing 3 (Day 1)||4||
48760066|NCT05635461|102200445|FG005|COMPLETED|Period 3: Dosing 3 (Day 1)||6||
48760067|NCT05635461|102200440|FG000|NOT COMPLETED|Period 3: Dosing 3 (Day 1)||0||
48760068|NCT05635461|102200441|FG001|NOT COMPLETED|Period 3: Dosing 3 (Day 1)||1||
48760069|NCT05635461|102200442|FG002|NOT COMPLETED|Period 3: Dosing 3 (Day 1)||0||
48760070|NCT05635461|102200443|FG003|NOT COMPLETED|Period 3: Dosing 3 (Day 1)||1||
48760071|NCT05635461|102200444|FG004|NOT COMPLETED|Period 3: Dosing 3 (Day 1)||0||
48760072|NCT05635461|102200445|FG005|NOT COMPLETED|Period 3: Dosing 3 (Day 1)||0||
48760073|NCT03893396|102200446|FG000|STARTED|Overall Study||143||
48760074|NCT03893396|102200447|FG001|STARTED|Overall Study||294||
48760075|NCT03893396|102200448|FG002|STARTED|Overall Study||546||
48760076|NCT03893396|102200446|FG000|One-year Follow-up|Overall Study||138||
48760077|NCT03893396|102200447|FG001|One-year Follow-up|Overall Study||281||
48760078|NCT03893396|102200448|FG002|One-year Follow-up|Overall Study||530||
48760079|NCT03893396|102200446|FG000|COMPLETED|Overall Study||127||
48760080|NCT03893396|102200447|FG001|COMPLETED|Overall Study||268||
48760081|NCT03893396|102200448|FG002|COMPLETED|Overall Study||501||
48760082|NCT03893396|102200446|FG000|NOT COMPLETED|Overall Study||16||
48760083|NCT03893396|102200447|FG001|NOT COMPLETED|Overall Study||26||
48760084|NCT03893396|102200448|FG002|NOT COMPLETED|Overall Study||45||
48760085|NCT05172128|102200449|FG000|STARTED|Overall Study||12||
48760086|NCT05172128|102200449|FG000|COMPLETED|Overall Study||10||
48760087|NCT05172128|102200449|FG000|NOT COMPLETED|Overall Study||2||
48760088|NCT05295849|102200450|FG000|STARTED|Overall Study||20||
48760089|NCT05295849|102200450|FG000|COMPLETED|Overall Study||20||
48760090|NCT05295849|102200450|FG000|NOT COMPLETED|Overall Study||0||
48760091|NCT03959423|102200451|FG000|STARTED|Overall Study||160||
48760092|NCT03959423|102200452|FG001|STARTED|Overall Study||128||
48760093|NCT03959423|102200451|FG000|COMPLETED|Overall Study||151||
48760094|NCT03959423|102200452|FG001|COMPLETED|Overall Study||124||
48760095|NCT03959423|102200451|FG000|NOT COMPLETED|Overall Study||9||
48760096|NCT03959423|102200452|FG001|NOT COMPLETED|Overall Study||4||
48760097|NCT03164616|102200453|FG000|STARTED|Overall Study||338|Randomized and included in global cohort analysis|
48760098|NCT03164616|102200454|FG001|STARTED|Overall Study||338|Randomized and included in global cohort analysis|
48760099|NCT03164616|102200455|FG002|STARTED|Overall Study||337|Randomized and included in global cohort analysis|
48760100|NCT03164616|102200453|FG000|Received Treatment|Overall Study||331||
48760101|NCT03164616|102200454|FG001|Received Treatment|Overall Study||335||
48760102|NCT03164616|102200455|FG002|Received Treatment|Overall Study||331||
48760103|NCT03164616|102200453|FG000|COMPLETED|Overall Study||80|Completed study or ongoing in study at primary completion date (global cohort final analysis DCO of 12 March 2021)|
48760104|NCT03164616|102200454|FG001|COMPLETED|Overall Study||65|Completed study or ongoing in study at primary completion date (global cohort final analysis DCO of 12 March 2021)|
48760105|NCT03164616|102200455|FG002|COMPLETED|Overall Study||40|Completed study or ongoing in study at primary completion date (global cohort final analysis DCO of 12 March 2021)|
48760106|NCT03164616|102200453|FG000|NOT COMPLETED|Overall Study||258||
48760107|NCT03164616|102200454|FG001|NOT COMPLETED|Overall Study||273||
48760108|NCT03164616|102200455|FG002|NOT COMPLETED|Overall Study||297||
48760109|NCT05468814|102200456|FG000|STARTED|Overall Study||60||
48760110|NCT05468814|102200457|FG001|STARTED|Overall Study||60||
48760111|NCT05468814|102200456|FG000|COMPLETED|Overall Study||55||
48760112|NCT05468814|102200457|FG001|COMPLETED|Overall Study||54||
48760113|NCT05468814|102200456|FG000|NOT COMPLETED|Overall Study||5||
48760114|NCT05468814|102200457|FG001|NOT COMPLETED|Overall Study||6||
48760115|NCT00392327|102200458|FG000|STARTED|Overall Study||87||
48760116|NCT00392327|102200459|FG001|STARTED|Overall Study||93||
48760117|NCT00392327|102200460|FG002|STARTED|Overall Study||56||
48760118|NCT00392327|102200461|FG003|STARTED|Overall Study||58||
48760119|NCT00392327|102200462|FG004|STARTED|Overall Study||23||
48760120|NCT00392327|102200463|FG005|STARTED|Overall Study||19||
48760121|NCT00392327|102200464|FG006|STARTED|Overall Study||21||
48760122|NCT00392327|102200465|FG007|STARTED|Overall Study||22||
48760123|NCT00392327|102200458|FG000|COMPLETED|Overall Study||72||
48760124|NCT00392327|102200459|FG001|COMPLETED|Overall Study||74||
48760125|NCT00392327|102200460|FG002|COMPLETED|Overall Study||36||
48760126|NCT00392327|102200461|FG003|COMPLETED|Overall Study||42||
48760127|NCT00392327|102200462|FG004|COMPLETED|Overall Study||20||
48760128|NCT00392327|102200463|FG005|COMPLETED|Overall Study||14||
48760129|NCT00392327|102200464|FG006|COMPLETED|Overall Study||12||
48760130|NCT00392327|102200465|FG007|COMPLETED|Overall Study||11||
48760131|NCT00392327|102200458|FG000|NOT COMPLETED|Overall Study||15||
48760132|NCT00392327|102200459|FG001|NOT COMPLETED|Overall Study||19||
48760133|NCT00392327|102200460|FG002|NOT COMPLETED|Overall Study||20||
48760134|NCT00392327|102200461|FG003|NOT COMPLETED|Overall Study||16||
48760135|NCT00392327|102200462|FG004|NOT COMPLETED|Overall Study||3||
48760136|NCT00392327|102200463|FG005|NOT COMPLETED|Overall Study||5||
48760137|NCT00392327|102200464|FG006|NOT COMPLETED|Overall Study||9||
48760138|NCT00392327|102200465|FG007|NOT COMPLETED|Overall Study||11||
48760139|NCT03397966|102200466|FG000|STARTED|Study Visit 1||3||
48760140|NCT03397966|102200467|FG001|STARTED|Study Visit 1||2||
48760141|NCT03397966|102200466|FG000|COMPLETED|Study Visit 1||3||
48760142|NCT03397966|102200467|FG001|COMPLETED|Study Visit 1||2||
48760143|NCT03397966|102200466|FG000|NOT COMPLETED|Study Visit 1||0||
48760144|NCT03397966|102200467|FG001|NOT COMPLETED|Study Visit 1||0||
48760145|NCT03397966|102200466|FG000|STARTED|Washout Period (2+ Weeks)||3||
48760146|NCT03397966|102200467|FG001|STARTED|Washout Period (2+ Weeks)||2||
48760147|NCT03397966|102200466|FG000|COMPLETED|Washout Period (2+ Weeks)||3||
48760148|NCT03397966|102200467|FG001|COMPLETED|Washout Period (2+ Weeks)||2||
48760149|NCT03397966|102200466|FG000|NOT COMPLETED|Washout Period (2+ Weeks)||0||
48760150|NCT03397966|102200467|FG001|NOT COMPLETED|Washout Period (2+ Weeks)||0||
48760151|NCT03397966|102200466|FG000|STARTED|Study Visit 2||3||
48760152|NCT03397966|102200467|FG001|STARTED|Study Visit 2||2||
48760153|NCT03397966|102200466|FG000|COMPLETED|Study Visit 2||3||
48760154|NCT03397966|102200467|FG001|COMPLETED|Study Visit 2||2||
48760155|NCT03397966|102200466|FG000|NOT COMPLETED|Study Visit 2||0||
48760156|NCT03397966|102200467|FG001|NOT COMPLETED|Study Visit 2||0||
48760157|NCT03388346|102200468|FG000|STARTED|Overall Study||22||
48760158|NCT03388346|102200468|FG000|COMPLETED|Overall Study||22||
48760159|NCT03388346|102200468|FG000|NOT COMPLETED|Overall Study||0||
48760160|NCT02432703|102200469|FG000|STARTED|Overall Study||75||
48760161|NCT02432703|102200470|FG001|STARTED|Overall Study||74||
48760162|NCT02432703|102200469|FG000|COMPLETED|Overall Study||53||
48760163|NCT02432703|102200470|FG001|COMPLETED|Overall Study||56||
48760164|NCT02432703|102200469|FG000|NOT COMPLETED|Overall Study||22||
48760165|NCT02432703|102200470|FG001|NOT COMPLETED|Overall Study||18||
48760166|NCT05720897|102200471|FG000|STARTED|Overall Study||30||
48760167|NCT05720897|102200472|FG001|STARTED|Overall Study||30||
48760168|NCT05720897|102200471|FG000|COMPLETED|Overall Study||28||
48186093|NCT04446975|100776057|FG002|COMPLETED|Randomization Period 4 (8 Weeks)||963||
48186094|NCT04446975|100776058|FG003|COMPLETED|Randomization Period 4 (8 Weeks)||832||
48186095|NCT04446975|100776055|FG000|NOT COMPLETED|Randomization Period 4 (8 Weeks)||0||
48186096|NCT04446975|100776056|FG001|NOT COMPLETED|Randomization Period 4 (8 Weeks)||0||
48186097|NCT04446975|100776057|FG002|NOT COMPLETED|Randomization Period 4 (8 Weeks)||0||
48186098|NCT04446975|100776058|FG003|NOT COMPLETED|Randomization Period 4 (8 Weeks)||0||
48637130|NCT00513799|101894778|FG001|NOT COMPLETED|Four-Month Follow-Up||5||
48637131|NCT00513799|101894779|FG002|NOT COMPLETED|Four-Month Follow-Up||7||
48637132|NCT00513799|101894780|FG003|NOT COMPLETED|Four-Month Follow-Up||3||
48637133|NCT02811159|101894781|FG000|STARTED|Treatment Course 1||20||
48637134|NCT02811159|101894781|FG000|COMPLETED|Treatment Course 1||19||
48637135|NCT02811159|101894781|FG000|NOT COMPLETED|Treatment Course 1||1||
48637136|NCT02811159|101894781|FG000|STARTED|Treatment Course 2||4||
48637137|NCT02811159|101894781|FG000|COMPLETED|Treatment Course 2||4||
48637138|NCT02811159|101894781|FG000|NOT COMPLETED|Treatment Course 2||0||
48637139|NCT03407482|101894782|FG000|STARTED|Overall Study||160||
48637140|NCT03407482|101894782|FG000|COMPLETED|Overall Study||29||
48637141|NCT03407482|101894782|FG000|NOT COMPLETED|Overall Study||131||
48657012|NCT01840163|101943751|FG001|STARTED|First Follow up -Primary Outcome||270||
48657013|NCT01840163|101943750|FG000|COMPLETED|First Follow up -Primary Outcome||248|Participants that completed Locoregional first follow up (primary outcome)|
48657014|NCT01840163|101943751|FG001|COMPLETED|First Follow up -Primary Outcome||254|Participants that completed Locoregional first follow up (primary outcome)|
48657015|NCT01840163|101943750|FG000|NOT COMPLETED|First Follow up -Primary Outcome||19||
48657016|NCT01840163|101943751|FG001|NOT COMPLETED|First Follow up -Primary Outcome||16||
48657017|NCT01840163|101943750|FG000|STARTED|Systemic Follow Up-secondary Outcome||265||
48657018|NCT01840163|101943751|FG001|STARTED|Systemic Follow Up-secondary Outcome||266||
48657019|NCT01840163|101943750|FG000|COMPLETED|Systemic Follow Up-secondary Outcome||174||
48657020|NCT01840163|101943751|FG001|COMPLETED|Systemic Follow Up-secondary Outcome||191||
48657021|NCT01840163|101943750|FG000|NOT COMPLETED|Systemic Follow Up-secondary Outcome||91||
48657022|NCT01840163|101943751|FG001|NOT COMPLETED|Systemic Follow Up-secondary Outcome||75||
48657023|NCT02410200|101943752|FG000|STARTED|Overall Study||22||
48760169|NCT05720897|102200472|FG001|COMPLETED|Overall Study||30||
48760170|NCT05720897|102200471|FG000|NOT COMPLETED|Overall Study||2||
48760171|NCT05720897|102200472|FG001|NOT COMPLETED|Overall Study||0||
48760172|NCT02516696|102200473|FG000|STARTED|Overall Study||7||
48760173|NCT02516696|102200474|FG001|STARTED|Overall Study||5||
48760174|NCT02516696|102200473|FG000|COMPLETED|Overall Study||7||
48186099|NCT03704298|100776059|FG000|STARTED|Overall Study||5||
48186100|NCT03704298|100776060|FG001|STARTED|Overall Study||4||
48657024|NCT02410200|101943752|FG000|COMPLETED|Overall Study||20||
48657025|NCT02410200|101943752|FG000|NOT COMPLETED|Overall Study||2||
48657026|NCT02018809|101943753|FG000|STARTED|Overall Study||50||
48657027|NCT02018809|101943754|FG001|STARTED|Overall Study||50||
48657028|NCT02018809|101943755|FG002|STARTED|Overall Study||50||
48760175|NCT02516696|102200474|FG001|COMPLETED|Overall Study||5||
48347895|NCT02811744|101180792|FG001|COMPLETED|Overall Study||5||
48760176|NCT02516696|102200473|FG000|NOT COMPLETED|Overall Study||0||
48760177|NCT02516696|102200474|FG001|NOT COMPLETED|Overall Study||0||
48760178|NCT01808755|102200475|FG000|STARTED|Overall Study||30||
48760179|NCT01808755|102200476|FG001|STARTED|Overall Study||30||
48760180|NCT01808755|102200475|FG000|COMPLETED|Overall Study||30||
48760181|NCT01808755|102200476|FG001|COMPLETED|Overall Study||30||
48760182|NCT01808755|102200475|FG000|NOT COMPLETED|Overall Study||0||
48760183|NCT01808755|102200476|FG001|NOT COMPLETED|Overall Study||0||
48760184|NCT03009058|102200477|FG000|STARTED|Overall Study||2||
48760185|NCT03009058|102200477|FG000|COMPLETED|Overall Study||0||
48760186|NCT03009058|102200477|FG000|NOT COMPLETED|Overall Study||2||
48760187|NCT00521079|102200478|FG000|STARTED|Overall Study||192||
48760188|NCT00521079|102200479|FG001|STARTED|Overall Study||102||
48760189|NCT00521079|102200478|FG000|Surgical Roll-In|Overall Study||9||
48760190|NCT00521079|102200479|FG001|Surgical Roll-In|Overall Study||5||
48347896|NCT02811744|101180791|FG000|NOT COMPLETED|Overall Study||0||
48347897|NCT02811744|101180792|FG001|NOT COMPLETED|Overall Study||0||
48347898|NCT03664726|101180793|FG000|STARTED|Overall Study||21||
48347899|NCT03664726|101180794|FG001|STARTED|Overall Study||20||
48347900|NCT03664726|101180795|FG002|STARTED|Overall Study||18||
48347901|NCT03664726|101180796|FG003|STARTED|Overall Study||19||
48760191|NCT00521079|102200478|FG000|COMPLETED|Overall Study||178||
48760192|NCT00521079|102200479|FG001|COMPLETED|Overall Study||97||
48760193|NCT00521079|102200478|FG000|NOT COMPLETED|Overall Study||14||
48760194|NCT00521079|102200479|FG001|NOT COMPLETED|Overall Study||5||
48760195|NCT04500158|102200480|FG000|STARTED|Overall Study||32||
48760196|NCT04500158|102200481|FG001|STARTED|Overall Study||27||
48760197|NCT04500158|102200480|FG000|COMPLETED|Overall Study||15||
48760198|NCT04500158|102200481|FG001|COMPLETED|Overall Study||16||
48760199|NCT04500158|102200480|FG000|NOT COMPLETED|Overall Study||17||
48760200|NCT04500158|102200481|FG001|NOT COMPLETED|Overall Study||11||
48760201|NCT02177695|102200482|FG000|STARTED|ITT Analysis||120||
48760202|NCT02177695|102200483|FG001|STARTED|ITT Analysis||117||
48760203|NCT02177695|102200482|FG000|COMPLETED|ITT Analysis||115||
48760204|NCT02177695|102200483|FG001|COMPLETED|ITT Analysis||112||
48760205|NCT02177695|102200482|FG000|NOT COMPLETED|ITT Analysis||5||
48347902|NCT03664726|101180793|FG000|COMPLETED|Overall Study||21||
48347903|NCT03664726|101180794|FG001|COMPLETED|Overall Study||20||
48347904|NCT03664726|101180795|FG002|COMPLETED|Overall Study||18||
48347905|NCT03664726|101180796|FG003|COMPLETED|Overall Study||19||
48760206|NCT02177695|102200483|FG001|NOT COMPLETED|ITT Analysis||5||
48760207|NCT02177695|102200482|FG000|STARTED|Primary COXEN Analysis||115||
48760208|NCT02177695|102200483|FG001|STARTED|Primary COXEN Analysis||112||
48760209|NCT02177695|102200482|FG000|Participants Excluded From Primary COXEN Analysis|Primary COXEN Analysis||33||
48760210|NCT02177695|102200483|FG001|Participants Excluded From Primary COXEN Analysis|Primary COXEN Analysis||27||
48760211|NCT02177695|102200482|FG000|COMPLETED|Primary COXEN Analysis||82||
48760212|NCT02177695|102200483|FG001|COMPLETED|Primary COXEN Analysis||85||
48760213|NCT02177695|102200482|FG000|NOT COMPLETED|Primary COXEN Analysis||33||
48760214|NCT02177695|102200483|FG001|NOT COMPLETED|Primary COXEN Analysis||27||
48760215|NCT04218240|102200484|FG000|STARTED|Overall Study||58||
48760216|NCT04218240|102200485|FG001|STARTED|Overall Study||32||
48760217|NCT04218240|102200484|FG000|COMPLETED|Overall Study||24||
48347906|NCT03664726|101180793|FG000|NOT COMPLETED|Overall Study||0||
48760218|NCT04218240|102200485|FG001|COMPLETED|Overall Study||11||
48760219|NCT04218240|102200484|FG000|NOT COMPLETED|Overall Study||34||
48760220|NCT04218240|102200485|FG001|NOT COMPLETED|Overall Study||21||
48760221|NCT01235897|102200486|FG000|STARTED|Overall Study||16||
48760222|NCT01235897|102200486|FG000|COMPLETED|Overall Study||16||
48760223|NCT01235897|102200486|FG000|NOT COMPLETED|Overall Study||0||
48760224|NCT02476617|102200487|FG000|STARTED|Overall Study||25||
48760225|NCT02476617|102200487|FG000|COMPLETED|Overall Study||23||
48347907|NCT03664726|101180794|FG001|NOT COMPLETED|Overall Study||0||
48347908|NCT03664726|101180795|FG002|NOT COMPLETED|Overall Study||0||
48760226|NCT02476617|102200487|FG000|NOT COMPLETED|Overall Study||2||
48760227|NCT03926208|102200488|FG000|STARTED|Overall Study||119||
48760228|NCT03926208|102200489|FG001|STARTED|Overall Study||123||
48760229|NCT03926208|102200488|FG000|COMPLETED|Overall Study||119||
48760230|NCT03926208|102200489|FG001|COMPLETED|Overall Study||123||
48760231|NCT03926208|102200488|FG000|NOT COMPLETED|Overall Study||0||
48760232|NCT03926208|102200489|FG001|NOT COMPLETED|Overall Study||0||
48760233|NCT02718898|102200490|FG000|STARTED|Blinded Treatment Period||74||
48760234|NCT02718898|102200491|FG001|STARTED|Blinded Treatment Period||75||
48760235|NCT02718898|102200492|FG002|STARTED|Blinded Treatment Period||0||
48760236|NCT02718898|102200493|FG003|STARTED|Blinded Treatment Period||0||
48760237|NCT02718898|102200494|FG004|STARTED|Blinded Treatment Period||0||
48760238|NCT02718898|102200495|FG005|STARTED|Blinded Treatment Period||0||
48760239|NCT02718898|102200496|FG006|STARTED|Blinded Treatment Period||0||
48760240|NCT02718898|102200490|FG000|COMPLETED|Blinded Treatment Period||65||
48760241|NCT02718898|102200491|FG001|COMPLETED|Blinded Treatment Period||74||
48760242|NCT02718898|102200492|FG002|COMPLETED|Blinded Treatment Period||0||
48760243|NCT02718898|102200493|FG003|COMPLETED|Blinded Treatment Period||0||
48760244|NCT02718898|102200494|FG004|COMPLETED|Blinded Treatment Period||0||
48760245|NCT02718898|102200495|FG005|COMPLETED|Blinded Treatment Period||0||
48347909|NCT03664726|101180796|FG003|NOT COMPLETED|Overall Study||0||
48347910|NCT01390389|101180797|FG000|STARTED|Overall Study||10||
48347911|NCT01390389|101180798|FG001|STARTED|Overall Study||9||
48347912|NCT01390389|101180797|FG000|COMPLETED|Overall Study||6||
48347913|NCT01390389|101180798|FG001|COMPLETED|Overall Study||8||
48415829|NCT00523744|101350378|FG000|NOT COMPLETED|Phase 2 - Amlodipine+Valsartan||3||
48760246|NCT02718898|102200496|FG006|COMPLETED|Blinded Treatment Period||0||
48760247|NCT02718898|102200490|FG000|NOT COMPLETED|Blinded Treatment Period||9||
48760248|NCT02718898|102200491|FG001|NOT COMPLETED|Blinded Treatment Period||1||
48760249|NCT02718898|102200492|FG002|NOT COMPLETED|Blinded Treatment Period||0||
48760250|NCT02718898|102200493|FG003|NOT COMPLETED|Blinded Treatment Period||0||
48760251|NCT02718898|102200494|FG004|NOT COMPLETED|Blinded Treatment Period||0||
48347914|NCT01390389|101180797|FG000|NOT COMPLETED|Overall Study||4||
48347915|NCT01390389|101180798|FG001|NOT COMPLETED|Overall Study||1||
48347916|NCT01966731|101180799|FG000|STARTED|Overall Study||635||
48347917|NCT01966731|101180799|FG000|Initiated Hydroxyurea|Overall Study||606||
48347918|NCT01966731|101180799|FG000|Completed 3 Months of Treatment|Overall Study||600||
48347919|NCT01966731|101180799|FG000|Completed Study|Overall Study||0||
48347920|NCT01966731|101180799|FG000|COMPLETED|Overall Study||0||
48347921|NCT01966731|101180799|FG000|NOT COMPLETED|Overall Study||635||
48347922|NCT01225341|101180800|FG000|STARTED|Overall Study||0||
48347923|NCT01225341|101180801|FG001|STARTED|Overall Study||0||
48415830|NCT00523744|101350378|FG000|STARTED|Phase 3 - Amlodipine+Valsartan+HCTZ||91||
48760252|NCT02718898|102200495|FG005|NOT COMPLETED|Blinded Treatment Period||0||
48760253|NCT02718898|102200496|FG006|NOT COMPLETED|Blinded Treatment Period||0||
48760254|NCT02718898|102200490|FG000|STARTED|Open Label Treatment Period (OLTP)||0||
48760255|NCT02718898|102200491|FG001|STARTED|Open Label Treatment Period (OLTP)||0||
48347924|NCT01225341|101180800|FG000|COMPLETED|Overall Study||0||
48347925|NCT01225341|101180801|FG001|COMPLETED|Overall Study||0||
48347926|NCT01225341|101180800|FG000|NOT COMPLETED|Overall Study||0||
48347927|NCT01225341|101180801|FG001|NOT COMPLETED|Overall Study||0||
48347928|NCT04871815|101180802|FG000|STARTED|Baseline Day 1-7||22||
48347929|NCT04871815|101180802|FG000|COMPLETED|Baseline Day 1-7||22||
48347930|NCT04871815|101180802|FG000|NOT COMPLETED|Baseline Day 1-7||0||
48347931|NCT04871815|101180802|FG000|STARTED|N115 Treatment Day 8-14||22||
48347932|NCT04871815|101180802|FG000|COMPLETED|N115 Treatment Day 8-14||22||
48347933|NCT04871815|101180802|FG000|NOT COMPLETED|N115 Treatment Day 8-14||0||
48347934|NCT03584009|101180803|FG000|STARTED|Overall Study||51||
48347935|NCT03584009|101180804|FG001|STARTED|Overall Study||52||
48347936|NCT03584009|101180803|FG000|COMPLETED|Overall Study||0||
48347937|NCT03584009|101180804|FG001|COMPLETED|Overall Study||0||
48347938|NCT03584009|101180803|FG000|NOT COMPLETED|Overall Study||51||
48347939|NCT03584009|101180804|FG001|NOT COMPLETED|Overall Study||52||
48347940|NCT01207466|101180805|FG000|STARTED|Period 1, One Week of Wear||46||
48347941|NCT01207466|101180806|FG001|STARTED|Period 1, One Week of Wear||48||
48347942|NCT01207466|101180805|FG000|COMPLETED|Period 1, One Week of Wear||46||
48347943|NCT01207466|101180806|FG001|COMPLETED|Period 1, One Week of Wear||48||
48347944|NCT01207466|101180805|FG000|NOT COMPLETED|Period 1, One Week of Wear||0||
48347945|NCT01207466|101180806|FG001|NOT COMPLETED|Period 1, One Week of Wear||0||
48347946|NCT01207466|101180805|FG000|STARTED|Period 2, One Week of Wear||45||
48347947|NCT01207466|101180806|FG001|STARTED|Period 2, One Week of Wear||48||
48347948|NCT01207466|101180805|FG000|COMPLETED|Period 2, One Week of Wear||45||
48347949|NCT01207466|101180806|FG001|COMPLETED|Period 2, One Week of Wear||48||
48347950|NCT01207466|101180805|FG000|NOT COMPLETED|Period 2, One Week of Wear||0||
48347951|NCT01207466|101180806|FG001|NOT COMPLETED|Period 2, One Week of Wear||0||
48347952|NCT00432237|101180807|FG000|STARTED|Overall Study||244||
48347953|NCT00432237|101180808|FG001|STARTED|Overall Study||485||
48347954|NCT00432237|101180809|FG002|STARTED|Overall Study||484||
48347955|NCT00432237|101180810|FG003|STARTED|Overall Study||490||
48347956|NCT00432237|101180807|FG000|Completed--With Data|Overall Study||176||
48347957|NCT00432237|101180808|FG001|Completed--With Data|Overall Study||381||
48347958|NCT00432237|101180809|FG002|Completed--With Data|Overall Study||370||
48347959|NCT00432237|101180810|FG003|Completed--With Data|Overall Study||365||
48347960|NCT00432237|101180807|FG000|Completed--No Data|Overall Study||1||
48347961|NCT00432237|101180808|FG001|Completed--No Data|Overall Study||3||
48347962|NCT00432237|101180809|FG002|Completed--No Data|Overall Study||5||
48347963|NCT00432237|101180810|FG003|Completed--No Data|Overall Study||1||
48347964|NCT00432237|101180807|FG000|COMPLETED|Overall Study||177||
48347965|NCT00432237|101180808|FG001|COMPLETED|Overall Study||384||
48347966|NCT00432237|101180809|FG002|COMPLETED|Overall Study||375||
48347967|NCT00432237|101180810|FG003|COMPLETED|Overall Study||366||
48347968|NCT00432237|101180807|FG000|NOT COMPLETED|Overall Study||67||
48347969|NCT00432237|101180808|FG001|NOT COMPLETED|Overall Study||101||
48347970|NCT00432237|101180809|FG002|NOT COMPLETED|Overall Study||109||
48347971|NCT00432237|101180810|FG003|NOT COMPLETED|Overall Study||124||
48347972|NCT01552876|101180811|FG000|STARTED|Overall Study||20||
48347973|NCT01552876|101180812|FG001|STARTED|Overall Study||20||
48347974|NCT01552876|101180811|FG000|COMPLETED|Overall Study||20||
48347975|NCT01552876|101180812|FG001|COMPLETED|Overall Study||20||
48347976|NCT01552876|101180811|FG000|NOT COMPLETED|Overall Study||0||
48347977|NCT01552876|101180812|FG001|NOT COMPLETED|Overall Study||0||
48347978|NCT00785577|101180813|FG000|STARTED|Study Period 2: Therapy Phase||89||
48347979|NCT00785577|101180814|FG001|STARTED|Study Period 2: Therapy Phase||45||
48760256|NCT02718898|102200492|FG002|STARTED|Open Label Treatment Period (OLTP)||65||
48760257|NCT02718898|102200493|FG003|STARTED|Open Label Treatment Period (OLTP)||74||
48760258|NCT02718898|102200494|FG004|STARTED|Open Label Treatment Period (OLTP)||0||
48760259|NCT02718898|102200495|FG005|STARTED|Open Label Treatment Period (OLTP)||0||
48760260|NCT02718898|102200496|FG006|STARTED|Open Label Treatment Period (OLTP)||0||
48760261|NCT02718898|102200490|FG000|COMPLETED|Open Label Treatment Period (OLTP)||0||
48760262|NCT02718898|102200491|FG001|COMPLETED|Open Label Treatment Period (OLTP)||0||
48760263|NCT02718898|102200492|FG002|COMPLETED|Open Label Treatment Period (OLTP)||62||
48760264|NCT02718898|102200493|FG003|COMPLETED|Open Label Treatment Period (OLTP)||64||
48760265|NCT02718898|102200494|FG004|COMPLETED|Open Label Treatment Period (OLTP)||0||
48760266|NCT02718898|102200495|FG005|COMPLETED|Open Label Treatment Period (OLTP)||0||
48760267|NCT02718898|102200496|FG006|COMPLETED|Open Label Treatment Period (OLTP)||0||
48760268|NCT02718898|102200490|FG000|NOT COMPLETED|Open Label Treatment Period (OLTP)||0||
48760269|NCT02718898|102200491|FG001|NOT COMPLETED|Open Label Treatment Period (OLTP)||0||
48760270|NCT02718898|102200492|FG002|NOT COMPLETED|Open Label Treatment Period (OLTP)||3||
48760271|NCT02718898|102200493|FG003|NOT COMPLETED|Open Label Treatment Period (OLTP)||10||
48760272|NCT02718898|102200494|FG004|NOT COMPLETED|Open Label Treatment Period (OLTP)||0||
48760273|NCT02718898|102200495|FG005|NOT COMPLETED|Open Label Treatment Period (OLTP)||0||
48760274|NCT02718898|102200496|FG006|NOT COMPLETED|Open Label Treatment Period (OLTP)||0||
48760275|NCT02718898|102200490|FG000|STARTED|Post Treatment Follow-up Period||0||
48760276|NCT02718898|102200491|FG001|STARTED|Post Treatment Follow-up Period||0||
48760277|NCT02718898|102200492|FG002|STARTED|Post Treatment Follow-up Period||0||
48760278|NCT02718898|102200493|FG003|STARTED|Post Treatment Follow-up Period||0||
48760279|NCT02718898|102200494|FG004|STARTED|Post Treatment Follow-up Period||1||
48760280|NCT02718898|102200495|FG005|STARTED|Post Treatment Follow-up Period||78||
48760281|NCT02718898|102200496|FG006|STARTED|Post Treatment Follow-up Period||49||
48760282|NCT02718898|102200490|FG000|COMPLETED|Post Treatment Follow-up Period||0||
48760283|NCT02718898|102200491|FG001|COMPLETED|Post Treatment Follow-up Period||0||
48760284|NCT02718898|102200492|FG002|COMPLETED|Post Treatment Follow-up Period||0||
48760285|NCT02718898|102200493|FG003|COMPLETED|Post Treatment Follow-up Period||0||
48760286|NCT02718898|102200494|FG004|COMPLETED|Post Treatment Follow-up Period||0||
48760287|NCT02718898|102200495|FG005|COMPLETED|Post Treatment Follow-up Period||67||
48760288|NCT02718898|102200496|FG006|COMPLETED|Post Treatment Follow-up Period||44||
48760289|NCT02718898|102200490|FG000|NOT COMPLETED|Post Treatment Follow-up Period||0||
48760290|NCT02718898|102200491|FG001|NOT COMPLETED|Post Treatment Follow-up Period||0||
48760291|NCT02718898|102200492|FG002|NOT COMPLETED|Post Treatment Follow-up Period||0||
48760292|NCT02718898|102200493|FG003|NOT COMPLETED|Post Treatment Follow-up Period||0||
48760293|NCT02718898|102200494|FG004|NOT COMPLETED|Post Treatment Follow-up Period||1||
48760294|NCT02718898|102200495|FG005|NOT COMPLETED|Post Treatment Follow-up Period||11||
48760295|NCT02718898|102200496|FG006|NOT COMPLETED|Post Treatment Follow-up Period||5||
48760296|NCT04231669|102200497|FG000|STARTED|Overall Study||100||5
48760297|NCT04231669|102200498|FG001|STARTED|Overall Study||100||5
48760298|NCT04231669|102200497|FG000|COMPLETED|Overall Study||100||5
48760299|NCT04231669|102200498|FG001|COMPLETED|Overall Study||94||5
48760300|NCT04231669|102200497|FG000|NOT COMPLETED|Overall Study||0||0
48760301|NCT04231669|102200498|FG001|NOT COMPLETED|Overall Study||6||0
48760302|NCT01345240|102200499|FG000|STARTED|Overall Study||142||
48760303|NCT01345240|102200500|FG001|STARTED|Overall Study||142||
48760304|NCT01345240|102200501|FG002|STARTED|Overall Study||141||
48760305|NCT01345240|102200502|FG003|STARTED|Overall Study||141||
48760306|NCT01345240|102200503|FG004|STARTED|Overall Study||139||
48760307|NCT01345240|102200499|FG000|COMPLETED|Overall Study||131||
48760308|NCT01345240|102200500|FG001|COMPLETED|Overall Study||128||
48760309|NCT01345240|102200501|FG002|COMPLETED|Overall Study||123||
48347980|NCT00785577|101180815|FG002|STARTED|Study Period 2: Therapy Phase||43||
48347981|NCT00785577|101180816|FG003|STARTED|Study Period 2: Therapy Phase||49||
48347982|NCT00785577|101180817|FG004|STARTED|Study Period 2: Therapy Phase||47||
48439972|NCT01728376|101410000|FG005|Treated|Overall Study||7||
48760310|NCT01345240|102200502|FG003|COMPLETED|Overall Study||132||
48760311|NCT01345240|102200503|FG004|COMPLETED|Overall Study||129||
48760312|NCT01345240|102200499|FG000|NOT COMPLETED|Overall Study||11||
48760313|NCT01345240|102200500|FG001|NOT COMPLETED|Overall Study||14||
48760314|NCT01345240|102200501|FG002|NOT COMPLETED|Overall Study||18||
48760315|NCT01345240|102200502|FG003|NOT COMPLETED|Overall Study||9||
48760316|NCT01345240|102200503|FG004|NOT COMPLETED|Overall Study||10||
48760317|NCT03598036|102200504|FG000|STARTED|Overall Study||5||
48760318|NCT03598036|102200505|FG001|STARTED|Overall Study||0||
48760319|NCT03598036|102200504|FG000|Week 1: 7.9 mg Twice Daily|Overall Study||5||
48760320|NCT03598036|102200505|FG001|Week 1: 7.9 mg Twice Daily|Overall Study||0||
48760321|NCT03598036|102200504|FG000|Week 2: 15.9 mg Twice Daily|Overall Study||5||
48760322|NCT03598036|102200505|FG001|Week 2: 15.9 mg Twice Daily|Overall Study||0||
48186101|NCT03704298|100776061|FG002|STARTED|Overall Study||3||
48186102|NCT03704298|100776062|FG003|STARTED|Overall Study||3||
48186103|NCT03704298|100776059|FG000|COMPLETED|Overall Study||0||
48186104|NCT03704298|100776060|FG001|COMPLETED|Overall Study||0||
48186105|NCT03704298|100776061|FG002|COMPLETED|Overall Study||0||
48186106|NCT03704298|100776062|FG003|COMPLETED|Overall Study||0||
48186107|NCT03704298|100776059|FG000|NOT COMPLETED|Overall Study||5||
48186108|NCT03704298|100776060|FG001|NOT COMPLETED|Overall Study||4||
48186109|NCT03704298|100776061|FG002|NOT COMPLETED|Overall Study||3||
48186110|NCT03704298|100776062|FG003|NOT COMPLETED|Overall Study||3||
48186111|NCT02956967|100776063|FG000|STARTED|Overall Study||171||
48186112|NCT02956967|100776063|FG000|COMPLETED|Overall Study||123||
48760323|NCT03598036|102200504|FG000|Weeks 3 - 24: 23.7 mg Twice Daily|Overall Study||5||
48760324|NCT03598036|102200505|FG001|Weeks 3 - 24: 23.7 mg Twice Daily|Overall Study||0||
48760325|NCT03598036|102200504|FG000|COMPLETED|Overall Study||4||
48760326|NCT03598036|102200505|FG001|COMPLETED|Overall Study||0||
48760327|NCT03598036|102200504|FG000|NOT COMPLETED|Overall Study||1||
48760328|NCT03598036|102200505|FG001|NOT COMPLETED|Overall Study||0||
48760329|NCT00829426|102200506|FG000|STARTED|First Intervention||16||
48760330|NCT00829426|102200507|FG001|STARTED|First Intervention||16||
48760331|NCT00829426|102200506|FG000|COMPLETED|First Intervention||16||
48760332|NCT00829426|102200507|FG001|COMPLETED|First Intervention||16||
48760333|NCT00829426|102200506|FG000|NOT COMPLETED|First Intervention||0||
48760334|NCT00829426|102200507|FG001|NOT COMPLETED|First Intervention||0||
48760335|NCT00829426|102200506|FG000|STARTED|Washout: 7 Days||16||
48760336|NCT00829426|102200507|FG001|STARTED|Washout: 7 Days||16||
48760337|NCT00829426|102200506|FG000|COMPLETED|Washout: 7 Days||15||
48347983|NCT00785577|101180813|FG000|COMPLETED|Study Period 2: Therapy Phase||78||
48760338|NCT00829426|102200507|FG001|COMPLETED|Washout: 7 Days||16||
48760339|NCT00829426|102200506|FG000|NOT COMPLETED|Washout: 7 Days||1||
48760340|NCT00829426|102200507|FG001|NOT COMPLETED|Washout: 7 Days||0||
48186113|NCT02956967|100776063|FG000|NOT COMPLETED|Overall Study||48||
48186114|NCT01668147|100776064|FG000|STARTED|Overall Study||13||
48760341|NCT00829426|102200506|FG000|STARTED|Second Intervention||15||
48760342|NCT00829426|102200507|FG001|STARTED|Second Intervention||16||
48760343|NCT00829426|102200506|FG000|COMPLETED|Second Intervention||15||
48760344|NCT00829426|102200507|FG001|COMPLETED|Second Intervention||16||
48760345|NCT00829426|102200506|FG000|NOT COMPLETED|Second Intervention||0||
48186115|NCT01668147|100776064|FG000|COMPLETED|Overall Study||7||
48760346|NCT00829426|102200507|FG001|NOT COMPLETED|Second Intervention||0||
48760347|NCT03583099|102200508|FG000|STARTED|Overall Study||1118||51
48760348|NCT03583099|102200509|FG001|STARTED|Overall Study||886||48
48760349|NCT03583099|102200508|FG000|Primary Analysis Population|Overall Study||226||49
48760350|NCT03583099|102200509|FG001|Primary Analysis Population|Overall Study||161||44
48760351|NCT03583099|102200508|FG000|COMPLETED|Overall Study||802||51
48760352|NCT03583099|102200509|FG001|COMPLETED|Overall Study||613||46
48760353|NCT03583099|102200508|FG000|NOT COMPLETED|Overall Study||316||0
48760354|NCT03583099|102200509|FG001|NOT COMPLETED|Overall Study||273||2
48347984|NCT00785577|101180814|FG001|COMPLETED|Study Period 2: Therapy Phase||36||
48347985|NCT00785577|101180815|FG002|COMPLETED|Study Period 2: Therapy Phase||25||
48347986|NCT00785577|101180816|FG003|COMPLETED|Study Period 2: Therapy Phase||36||
48347987|NCT00785577|101180817|FG004|COMPLETED|Study Period 2: Therapy Phase||27||
48347988|NCT00785577|101180813|FG000|NOT COMPLETED|Study Period 2: Therapy Phase||11||
48347989|NCT00785577|101180814|FG001|NOT COMPLETED|Study Period 2: Therapy Phase||9||
48347990|NCT00785577|101180815|FG002|NOT COMPLETED|Study Period 2: Therapy Phase||18||
48347991|NCT00785577|101180816|FG003|NOT COMPLETED|Study Period 2: Therapy Phase||13||
48347992|NCT00785577|101180817|FG004|NOT COMPLETED|Study Period 2: Therapy Phase||20||
48347993|NCT00785577|101180813|FG000|STARTED|Study Period 3: 1-Week Washout Phase||78||
48347994|NCT00785577|101180814|FG001|STARTED|Study Period 3: 1-Week Washout Phase||36||
48347995|NCT00785577|101180815|FG002|STARTED|Study Period 3: 1-Week Washout Phase||25||
48347996|NCT00785577|101180816|FG003|STARTED|Study Period 3: 1-Week Washout Phase||36||
48347997|NCT00785577|101180817|FG004|STARTED|Study Period 3: 1-Week Washout Phase||27||
48347998|NCT00785577|101180813|FG000|COMPLETED|Study Period 3: 1-Week Washout Phase||78||
48347999|NCT00785577|101180814|FG001|COMPLETED|Study Period 3: 1-Week Washout Phase||36||
48348000|NCT00785577|101180815|FG002|COMPLETED|Study Period 3: 1-Week Washout Phase||25||
48348001|NCT00785577|101180816|FG003|COMPLETED|Study Period 3: 1-Week Washout Phase||35||
48348002|NCT00785577|101180817|FG004|COMPLETED|Study Period 3: 1-Week Washout Phase||26||
48348003|NCT00785577|101180813|FG000|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0||
48348004|NCT00785577|101180814|FG001|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0||
48348005|NCT00785577|101180815|FG002|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0||
48348006|NCT00785577|101180816|FG003|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1||
48348007|NCT00785577|101180817|FG004|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1||
48348008|NCT01934504|101180818|FG000|STARTED|Overall Study||6||
48348009|NCT01934504|101180819|FG001|STARTED|Overall Study||3||
48637142|NCT02402036|101898487|FG000|STARTED|Overall Study||10||
48637143|NCT02402036|101898487|FG000|COMPLETED|Overall Study||10||
48637144|NCT02402036|101898487|FG000|NOT COMPLETED|Overall Study||0||
48637145|NCT00548327|101898488|FG000|STARTED|Overall Study||6||
48637146|NCT00548327|101898489|FG001|STARTED|Overall Study||5||
48637147|NCT00548327|101898488|FG000|COMPLETED|Overall Study||6||
48637148|NCT00548327|101898489|FG001|COMPLETED|Overall Study||4||
48637149|NCT00548327|101898488|FG000|NOT COMPLETED|Overall Study||0||
48637150|NCT00548327|101898489|FG001|NOT COMPLETED|Overall Study||1||
48637151|NCT00998946|101898490|FG000|STARTED|Overall Study||29||
48637152|NCT00998946|101898490|FG000|Safety Population|Overall Study||27||
48637153|NCT00998946|101898490|FG000|COMPLETED|Overall Study||20||
48637154|NCT00998946|101898490|FG000|NOT COMPLETED|Overall Study||9||
48637155|NCT00254072|101898491|FG000|STARTED|Overall Study||180||
48637156|NCT00254072|101898492|FG001|STARTED|Overall Study||175||
48637157|NCT00254072|101898491|FG000|COMPLETED|Overall Study||180||
48637158|NCT00254072|101898492|FG001|COMPLETED|Overall Study||175||
48637159|NCT00254072|101898491|FG000|NOT COMPLETED|Overall Study||0||
48637160|NCT00254072|101898492|FG001|NOT COMPLETED|Overall Study||0||
48637161|NCT00303186|101898493|FG000|STARTED|Overall Study||107||
48637162|NCT00303186|101898493|FG000|COMPLETED|Overall Study||55||
48637163|NCT00303186|101898493|FG000|NOT COMPLETED|Overall Study||52||
48637164|NCT00283959|101898494|FG000|STARTED|Treatment Period||4||
48637165|NCT00283959|101898494|FG000|Safety Population|Treatment Period||4|All enrolled participants who received at least 1 dose of study drug|
48637166|NCT00283959|101898494|FG000|Pharmacodynamics (PD) Population|Treatment Period||4|Received study drug and had a non-missing baseline and postbaseline PD parameter recorded|
48637167|NCT00283959|101898494|FG000|COMPLETED|Treatment Period||4||
48637168|NCT00283959|101898494|FG000|NOT COMPLETED|Treatment Period||0||
48637169|NCT00283959|101898494|FG000|STARTED|Extension Period||4||
48637170|NCT00283959|101898494|FG000|COMPLETED|Extension Period||3||
48760355|NCT01419236|102200510|FG000|STARTED|Overall Study||36||
48760356|NCT01419236|102200511|FG001|STARTED|Overall Study||40||
48760357|NCT01419236|102200510|FG000|Received at Least 1 Dose of Study Drug|Overall Study||35||
48760358|NCT01419236|102200511|FG001|Received at Least 1 Dose of Study Drug|Overall Study||39||
48760359|NCT01419236|102200510|FG000|COMPLETED|Overall Study||31||
48760360|NCT01419236|102200511|FG001|COMPLETED|Overall Study||35||
48760361|NCT01419236|102200510|FG000|NOT COMPLETED|Overall Study||5||
48760362|NCT01419236|102200511|FG001|NOT COMPLETED|Overall Study||5||
48760363|NCT01864018|102200512|FG000|STARTED|Overall Study||51||
48760364|NCT01864018|102200513|FG001|STARTED|Overall Study||36||
48760365|NCT01864018|102200512|FG000|Accrued During Phase I|Overall Study||10||
48760366|NCT01864018|102200513|FG001|Accrued During Phase I|Overall Study||0||
48760367|NCT01864018|102200512|FG000|Accrued During Phase II|Overall Study||41||
48760368|NCT01864018|102200513|FG001|Accrued During Phase II|Overall Study||36||
48760369|NCT01864018|102200512|FG000|COMPLETED|Overall Study||48||
48760370|NCT01864018|102200513|FG001|COMPLETED|Overall Study||35||
48348010|NCT01934504|101180820|FG002|STARTED|Overall Study||16||
48348011|NCT01934504|101180821|FG003|STARTED|Overall Study||8||
48348012|NCT01934504|101180818|FG000|COMPLETED|Overall Study||5||
48348013|NCT01934504|101180819|FG001|COMPLETED|Overall Study||3||
48348014|NCT01934504|101180820|FG002|COMPLETED|Overall Study||11||
48348015|NCT01934504|101180821|FG003|COMPLETED|Overall Study||1||
48348016|NCT01934504|101180818|FG000|NOT COMPLETED|Overall Study||1||
48348017|NCT01934504|101180819|FG001|NOT COMPLETED|Overall Study||0||
48348018|NCT01934504|101180820|FG002|NOT COMPLETED|Overall Study||5||
48348019|NCT01934504|101180821|FG003|NOT COMPLETED|Overall Study||7||
48348020|NCT00943683|101180822|FG000|STARTED|Overall Study||81||
48348021|NCT00943683|101180823|FG001|STARTED|Overall Study||175||
48760371|NCT01864018|102200512|FG000|NOT COMPLETED|Overall Study||3||
48760372|NCT01864018|102200513|FG001|NOT COMPLETED|Overall Study||1||
48348022|NCT00943683|101180822|FG000|COMPLETED|Overall Study||74||
48348023|NCT00943683|101180823|FG001|COMPLETED|Overall Study||169||
48760373|NCT04038359|102200514|FG000|STARTED|Overall Study||52||
48760374|NCT04038359|102200515|FG001|STARTED|Overall Study||51||
48760375|NCT04038359|102200514|FG000|Received At Least 1 Dose of Study Drug|Overall Study||51|All-treated (AT) Analysis Set/Modified Intent-to-treat (mITT) Analysis Set|
48760376|NCT04038359|102200515|FG001|Received At Least 1 Dose of Study Drug|Overall Study||51|All-treated (AT) Analysis Set/Modified Intent-to-treat (mITT) Analysis Set|
48760377|NCT04038359|102200514|FG000|COMPLETED|Overall Study||32||
48760378|NCT04038359|102200515|FG001|COMPLETED|Overall Study||36||
48760379|NCT04038359|102200514|FG000|NOT COMPLETED|Overall Study||20||
48760380|NCT04038359|102200515|FG001|NOT COMPLETED|Overall Study||15||
48760381|NCT02250326|102200516|FG000|STARTED|Pre-treatment||81|Started = Randomized|
48760382|NCT02250326|102200517|FG001|STARTED|Pre-treatment||79|Started = Randomized|
48760383|NCT02250326|102200518|FG002|STARTED|Pre-treatment||80|Started = Randomized|
48760384|NCT02250326|102200516|FG000|COMPLETED|Pre-treatment||79|Completed = Treated|
48760385|NCT02250326|102200517|FG001|COMPLETED|Pre-treatment||78|Completed = Treated|
48760386|NCT02250326|102200518|FG002|COMPLETED|Pre-treatment||79|Completed = Treated|
48760387|NCT02250326|102200516|FG000|NOT COMPLETED|Pre-treatment||2||
48760388|NCT02250326|102200517|FG001|NOT COMPLETED|Pre-treatment||1||
48760389|NCT02250326|102200518|FG002|NOT COMPLETED|Pre-treatment||1||
48760390|NCT02250326|102200516|FG000|STARTED|Treatment||79||
48760391|NCT02250326|102200517|FG001|STARTED|Treatment||78||
48760392|NCT02250326|102200518|FG002|STARTED|Treatment||79||
48760393|NCT02250326|102200516|FG000|COMPLETED|Treatment||0||
48760394|NCT02250326|102200517|FG001|COMPLETED|Treatment||0||
48760395|NCT02250326|102200518|FG002|COMPLETED|Treatment||0||
48760396|NCT02250326|102200516|FG000|NOT COMPLETED|Treatment||79||
48760397|NCT02250326|102200517|FG001|NOT COMPLETED|Treatment||78||
48760398|NCT02250326|102200518|FG002|NOT COMPLETED|Treatment||79||
48760399|NCT02250326|102200516|FG000|STARTED|Extension Period||0|Started = met the criteria for treatment continuation in the extension period|
48760400|NCT02250326|102200517|FG001|STARTED|Extension Period||4|Started = met the criteria for treatment continuation in the extension period|
48760401|NCT02250326|102200518|FG002|STARTED|Extension Period||0|Started = met the criteria for treatment continuation in the extension period|
48760402|NCT02250326|102200516|FG000|COMPLETED|Extension Period||0||
48760403|NCT02250326|102200517|FG001|COMPLETED|Extension Period||0||
48760404|NCT02250326|102200518|FG002|COMPLETED|Extension Period||0||
48760405|NCT02250326|102200516|FG000|NOT COMPLETED|Extension Period||0||
48760406|NCT02250326|102200517|FG001|NOT COMPLETED|Extension Period||4||
48760407|NCT02250326|102200518|FG002|NOT COMPLETED|Extension Period||0||
48760408|NCT02546609|102200519|FG000|STARTED|Overall Study||24||
48760409|NCT02546609|102200520|FG001|STARTED|Overall Study||35||
48348024|NCT00943683|101180822|FG000|NOT COMPLETED|Overall Study||7||
48348025|NCT00943683|101180823|FG001|NOT COMPLETED|Overall Study||6||
48348026|NCT01922921|101180824|FG000|STARTED|Overall Study||16||
48348027|NCT01922921|101180825|FG001|STARTED|Overall Study||15||
48348028|NCT01922921|101180824|FG000|COMPLETED|Overall Study||15||
48348029|NCT01922921|101180825|FG001|COMPLETED|Overall Study||14||
48348030|NCT01922921|101180824|FG000|NOT COMPLETED|Overall Study||1||
48348031|NCT01922921|101180825|FG001|NOT COMPLETED|Overall Study||1||
48348032|NCT01542307|101180826|FG000|STARTED|Overall Study||22||33
48348033|NCT01542307|101180827|FG001|STARTED|Overall Study||22||31
48348034|NCT01542307|101180826|FG000|COMPLETED|Overall Study||22||33
48348035|NCT01542307|101180827|FG001|COMPLETED|Overall Study||22||30
48348036|NCT01542307|101180826|FG000|NOT COMPLETED|Overall Study||0||0
48348037|NCT01542307|101180827|FG001|NOT COMPLETED|Overall Study||0||1
48348038|NCT02599402|101180828|FG000|STARTED|Overall Study||533||
48348039|NCT02599402|101180828|FG000|COMPLETED|Overall Study||0||
48348040|NCT02599402|101180828|FG000|NOT COMPLETED|Overall Study||533||
48348041|NCT01974817|101180829|FG000|STARTED|Overall Study||25||
48348042|NCT01974817|101180829|FG000|COMPLETED|Overall Study||17||
48348043|NCT01974817|101180829|FG000|NOT COMPLETED|Overall Study||8||
48760410|NCT02546609|102200521|FG002|STARTED|Overall Study||32||
48760411|NCT02546609|102200519|FG000|COMPLETED|Overall Study||22||
48348044|NCT03213665|101180830|FG000|STARTED|Overall Study||20||
48348045|NCT03213665|101180830|FG000|COMPLETED|Overall Study||1||
48348046|NCT03213665|101180830|FG000|NOT COMPLETED|Overall Study||19||
48348047|NCT01175369|101180831|FG000|STARTED|Overall Study||265||
48348048|NCT01175369|101180832|FG001|STARTED|Overall Study||265||
48348049|NCT01175369|101180831|FG000|COMPLETED|Overall Study||263||
48348050|NCT01175369|101180832|FG001|COMPLETED|Overall Study||260||
48348051|NCT01175369|101180831|FG000|NOT COMPLETED|Overall Study||2||
48348052|NCT01175369|101180832|FG001|NOT COMPLETED|Overall Study||5||
48348053|NCT00496366|101180833|FG000|STARTED|Overall Study||11||
48348054|NCT00496366|101180833|FG000|COMPLETED|Overall Study||10||
48348055|NCT00496366|101180833|FG000|NOT COMPLETED|Overall Study||1||
48348056|NCT02318095|101180834|FG000|STARTED|Overall Study||40||
48348057|NCT02318095|101180834|FG000|COMPLETED|Overall Study||39||
48348058|NCT02318095|101180834|FG000|NOT COMPLETED|Overall Study||1||
48348059|NCT01122927|101180835|FG000|STARTED|Period 1 - Conversion Phase||297||
48348060|NCT01122927|101180836|FG001|STARTED|Period 1 - Conversion Phase||0||
48348061|NCT01122927|101180835|FG000|COMPLETED|Period 1 - Conversion Phase||283||
48348062|NCT01122927|101180836|FG001|COMPLETED|Period 1 - Conversion Phase||0||
48348063|NCT01122927|101180835|FG000|NOT COMPLETED|Period 1 - Conversion Phase||14||
48348064|NCT01122927|101180836|FG001|NOT COMPLETED|Period 1 - Conversion Phase||0||
48348065|NCT01122927|101180835|FG000|STARTED|Period 2- Open-label Treatment Phase||0||
48348066|NCT01122927|101180836|FG001|STARTED|Period 2- Open-label Treatment Phase||510||
48348067|NCT01122927|101180835|FG000|COMPLETED|Period 2- Open-label Treatment Phase||0||
48348068|NCT01122927|101180836|FG001|COMPLETED|Period 2- Open-label Treatment Phase||198||
48348069|NCT01122927|101180835|FG000|NOT COMPLETED|Period 2- Open-label Treatment Phase||0||
48348070|NCT01122927|101180836|FG001|NOT COMPLETED|Period 2- Open-label Treatment Phase||312||
48348071|NCT00833092|101180837|FG000|STARTED|Overall Study||54||
48348072|NCT00833092|101180838|FG001|STARTED|Overall Study||57||
48348073|NCT00833092|101180837|FG000|COMPLETED|Overall Study||50||
48348074|NCT00833092|101180838|FG001|COMPLETED|Overall Study||50||
48348075|NCT00833092|101180837|FG000|NOT COMPLETED|Overall Study||4||
48637171|NCT00283959|101898494|FG000|NOT COMPLETED|Extension Period||1||
48637172|NCT01179399|101898495|FG000|STARTED|Overall Study||32||
48637173|NCT01179399|101898495|FG000|COMPLETED|Overall Study||0||
48637174|NCT01179399|101898495|FG000|NOT COMPLETED|Overall Study||32||
48637175|NCT00250588|101898496|FG000|STARTED|Overall Study||81||
48637176|NCT00250588|101898497|FG001|STARTED|Overall Study||84||
48637177|NCT00250588|101898498|FG002|STARTED|Overall Study||87||
48415831|NCT00523744|101350378|FG000|COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||91||
48415832|NCT00523744|101350378|FG000|NOT COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||0||
48415833|NCT03516227|101350379|FG000|STARTED|Overall Study||20||
48415834|NCT03516227|101350380|FG001|STARTED|Overall Study||20||
48637178|NCT00250588|101898496|FG000|COMPLETED|Overall Study||72||
48637179|NCT00250588|101898497|FG001|COMPLETED|Overall Study||65||
48637180|NCT00250588|101898498|FG002|COMPLETED|Overall Study||74||
48637181|NCT00250588|101898496|FG000|NOT COMPLETED|Overall Study||9||
48637182|NCT00250588|101898497|FG001|NOT COMPLETED|Overall Study||19||
48637183|NCT00250588|101898498|FG002|NOT COMPLETED|Overall Study||13||
48637184|NCT01562444|101898499|FG000|STARTED|Overall Study||48||
48637185|NCT01562444|101898500|FG001|STARTED|Overall Study||51||
48186116|NCT01668147|100776064|FG000|NOT COMPLETED|Overall Study||6||
48348076|NCT00833092|101180838|FG001|NOT COMPLETED|Overall Study||7||
48348077|NCT00809133|101180839|FG000|STARTED|Overall Study||3||
48348078|NCT00809133|101180840|FG001|STARTED|Overall Study||7||
48348079|NCT00809133|101180841|FG002|STARTED|Overall Study||6||
48348080|NCT00809133|101180842|FG003|STARTED|Overall Study||3||
48415835|NCT03516227|101350379|FG000|COMPLETED|Overall Study||19||
48415836|NCT03516227|101350380|FG001|COMPLETED|Overall Study||16||
48415837|NCT03516227|101350379|FG000|NOT COMPLETED|Overall Study||1||
48415838|NCT03516227|101350380|FG001|NOT COMPLETED|Overall Study||4||
48637186|NCT01562444|101898501|FG002|STARTED|Overall Study||106||
48415839|NCT03698370|101350381|FG000|STARTED|First Scan||13||
48415840|NCT03698370|101350382|FG001|STARTED|First Scan||14||
48415841|NCT03698370|101350381|FG000|COMPLETED|First Scan||13||
48415842|NCT03698370|101350382|FG001|COMPLETED|First Scan||14||
48415843|NCT03698370|101350381|FG000|NOT COMPLETED|First Scan||0||
48415844|NCT03698370|101350382|FG001|NOT COMPLETED|First Scan||0||
48415845|NCT03698370|101350381|FG000|STARTED|Second Scan||13||
48415846|NCT03698370|101350382|FG001|STARTED|Second Scan||14||
48415847|NCT03698370|101350381|FG000|COMPLETED|Second Scan||13||
48415848|NCT03698370|101350382|FG001|COMPLETED|Second Scan||14||
48415849|NCT03698370|101350381|FG000|NOT COMPLETED|Second Scan||0||
48415850|NCT03698370|101350382|FG001|NOT COMPLETED|Second Scan||0||
48415851|NCT01277666|101350383|FG000|STARTED|Overall Study||203||
48415852|NCT01277666|101350384|FG001|STARTED|Overall Study||203||
48415853|NCT01277666|101350385|FG002|STARTED|Overall Study||202||
48415854|NCT01277666|101350383|FG000|COMPLETED|Overall Study||158||
48415855|NCT01277666|101350384|FG001|COMPLETED|Overall Study||144||
48415856|NCT01277666|101350385|FG002|COMPLETED|Overall Study||153||
48415857|NCT01277666|101350383|FG000|NOT COMPLETED|Overall Study||45||
48415858|NCT01277666|101350384|FG001|NOT COMPLETED|Overall Study||59||
48415859|NCT01277666|101350385|FG002|NOT COMPLETED|Overall Study||49||
48415860|NCT03123549|101350386|FG000|STARTED|Overall Study||182||
48415861|NCT03123549|101350387|FG001|STARTED|Overall Study||170||
48415862|NCT03123549|101350386|FG000|COMPLETED|Overall Study||168||
48415863|NCT03123549|101350387|FG001|COMPLETED|Overall Study||127||
48637187|NCT01562444|101898499|FG000|COMPLETED|Overall Study||43||
48637188|NCT01562444|101898500|FG001|COMPLETED|Overall Study||49||
48637189|NCT01562444|101898501|FG002|COMPLETED|Overall Study||99||
48415864|NCT03123549|101350386|FG000|NOT COMPLETED|Overall Study||14||
48415865|NCT03123549|101350387|FG001|NOT COMPLETED|Overall Study||43||
48415866|NCT01396486|101350388|FG000|STARTED|Overall Study||20||
48637190|NCT01562444|101898499|FG000|NOT COMPLETED|Overall Study||5||
48637191|NCT01562444|101898500|FG001|NOT COMPLETED|Overall Study||2||
48637192|NCT01562444|101898501|FG002|NOT COMPLETED|Overall Study||7||
48637193|NCT01605903|101898502|FG000|STARTED|Overall Study||345||
48637194|NCT01605903|101898503|FG001|STARTED|Overall Study||343||
48637195|NCT01605903|101898502|FG000|COMPLETED|Overall Study||345||
48760412|NCT02546609|102200520|FG001|COMPLETED|Overall Study||24||
48760413|NCT02546609|102200521|FG002|COMPLETED|Overall Study||25||
48760414|NCT02546609|102200519|FG000|NOT COMPLETED|Overall Study||2||
48760415|NCT02546609|102200520|FG001|NOT COMPLETED|Overall Study||11||
48760416|NCT02546609|102200521|FG002|NOT COMPLETED|Overall Study||7||
48760417|NCT00079417|102200522|FG000|STARTED|Overall Study||28||
48760418|NCT00079417|102200522|FG000|COMPLETED|Overall Study||19||
48760419|NCT00079417|102200522|FG000|NOT COMPLETED|Overall Study||9||
48760420|NCT05139680|102200523|FG000|STARTED|Overall Study||10||
48760421|NCT05139680|102200523|FG000|COMPLETED|Overall Study||10||
48760422|NCT05139680|102200523|FG000|NOT COMPLETED|Overall Study||0||
48760423|NCT03735875|102200524|FG000|STARTED|Overall Study||8||
48760424|NCT03735875|102200525|FG001|STARTED|Overall Study||0||
48760425|NCT03735875|102200524|FG000|COMPLETED|Overall Study||8||
48760426|NCT03735875|102200525|FG001|COMPLETED|Overall Study||0||
48760427|NCT03735875|102200524|FG000|NOT COMPLETED|Overall Study||0||
48760428|NCT03735875|102200525|FG001|NOT COMPLETED|Overall Study||0||
48760429|NCT04494841|102200526|FG000|STARTED|Overall Study||20||
48760430|NCT04494841|102200526|FG000|COMPLETED|Overall Study||20||
48760431|NCT04494841|102200526|FG000|NOT COMPLETED|Overall Study||0||
48760432|NCT04659044|102200527|FG000|STARTED|Induction||3||
48760433|NCT04659044|102200527|FG000|COMPLETED|Induction||0||
48760434|NCT04659044|102200527|FG000|NOT COMPLETED|Induction||3||
48760435|NCT04659044|102200527|FG000|STARTED|Maintenance Therapy||0||
48760436|NCT04659044|102200527|FG000|COMPLETED|Maintenance Therapy||0||
48760437|NCT04659044|102200527|FG000|NOT COMPLETED|Maintenance Therapy||0||
48760438|NCT03373240|102200528|FG000|STARTED|Overall Study||22||
48760439|NCT03373240|102200529|FG001|STARTED|Overall Study||24||
48760440|NCT03373240|102200528|FG000|4-week Post Treatment|Overall Study||14||
48760441|NCT03373240|102200529|FG001|4-week Post Treatment|Overall Study||23||
48760442|NCT03373240|102200528|FG000|COMPLETED|Overall Study||11||
48760443|NCT03373240|102200529|FG001|COMPLETED|Overall Study||20||
48760444|NCT03373240|102200528|FG000|NOT COMPLETED|Overall Study||11||
48760445|NCT03373240|102200529|FG001|NOT COMPLETED|Overall Study||4||
48415867|NCT01396486|101350389|FG001|STARTED|Overall Study||19||
48637196|NCT01605903|101898503|FG001|COMPLETED|Overall Study||343||
48637197|NCT01605903|101898502|FG000|NOT COMPLETED|Overall Study||0||
48186117|NCT00225420|100776065|FG000|STARTED|Overall Study||9||
48186118|NCT00225420|100776066|FG001|STARTED|Overall Study||6||
48186119|NCT00225420|100776067|FG002|STARTED|Overall Study||3||
48186120|NCT00225420|100776065|FG000|COMPLETED|Overall Study||9||
48186121|NCT00225420|100776066|FG001|COMPLETED|Overall Study||6||
48186122|NCT00225420|100776067|FG002|COMPLETED|Overall Study||3||
48186123|NCT00225420|100776065|FG000|NOT COMPLETED|Overall Study||0||
48186124|NCT00225420|100776066|FG001|NOT COMPLETED|Overall Study||0||
48186125|NCT00225420|100776067|FG002|NOT COMPLETED|Overall Study||0||
48637198|NCT01605903|101898503|FG001|NOT COMPLETED|Overall Study||0||
48637199|NCT02969018|101898504|FG000|STARTED|Overall Study||25||
48637200|NCT02969018|101898505|FG001|STARTED|Overall Study||29||
48637201|NCT02969018|101898506|FG002|STARTED|Overall Study||26||
48637202|NCT02969018|101898507|FG003|STARTED|Overall Study||25||
48186126|NCT02685293|100779728|FG000|STARTED|Treatment Period 1||1||
48186127|NCT02685293|100779729|FG001|STARTED|Treatment Period 1||3||
48186128|NCT02685293|100779728|FG000|COMPLETED|Treatment Period 1||1||
48186129|NCT02685293|100779729|FG001|COMPLETED|Treatment Period 1||3||
48186130|NCT02685293|100779728|FG000|NOT COMPLETED|Treatment Period 1||0||
48186131|NCT02685293|100779729|FG001|NOT COMPLETED|Treatment Period 1||0||
48348081|NCT00809133|101180843|FG004|STARTED|Overall Study||5||
48348082|NCT00809133|101180844|FG005|STARTED|Overall Study||7||
48348083|NCT00809133|101180845|FG006|STARTED|Overall Study||6||
48348084|NCT00809133|101180846|FG007|STARTED|Overall Study||8||
48415868|NCT01396486|101350390|FG002|STARTED|Overall Study||22||
48415869|NCT01396486|101350388|FG000|Exposed|Overall Study||19||
48415870|NCT01396486|101350389|FG001|Exposed|Overall Study||16||
48415871|NCT01396486|101350390|FG002|Exposed|Overall Study||17||
48415872|NCT01396486|101350388|FG000|COMPLETED|Overall Study||10||
48415873|NCT01396486|101350389|FG001|COMPLETED|Overall Study||7||
48415874|NCT01396486|101350390|FG002|COMPLETED|Overall Study||10||
48415875|NCT01396486|101350388|FG000|NOT COMPLETED|Overall Study||10||
48415876|NCT01396486|101350389|FG001|NOT COMPLETED|Overall Study||12||
48415877|NCT01396486|101350390|FG002|NOT COMPLETED|Overall Study||12||
48415878|NCT01315873|101350391|FG000|STARTED|Overall Study||24||
48415879|NCT01315873|101350391|FG000|COMPLETED|Overall Study||24||
48415880|NCT01315873|101350391|FG000|NOT COMPLETED|Overall Study||0||
48415881|NCT01542632|101350392|FG000|STARTED|Overall Study||25||
48760446|NCT02085460|102200530|FG000|STARTED|Overall Study||31||
48760447|NCT02085460|102200531|FG001|STARTED|Overall Study||32||
48760448|NCT02085460|102200532|FG002|STARTED|Overall Study||31||
48760449|NCT02085460|102200530|FG000|COMPLETED|Overall Study||17||
48760450|NCT02085460|102200531|FG001|COMPLETED|Overall Study||24||
48760451|NCT02085460|102200532|FG002|COMPLETED|Overall Study||21||
48760452|NCT02085460|102200530|FG000|NOT COMPLETED|Overall Study||14||
48348085|NCT00809133|101180847|FG008|STARTED|Overall Study||3||
48348086|NCT00809133|101180848|FG009|STARTED|Overall Study||9||
48348087|NCT00809133|101180849|FG010|STARTED|Overall Study||6||
48348088|NCT00809133|101180850|FG011|STARTED|Overall Study||8||
48348089|NCT00809133|101180851|FG012|STARTED|Overall Study||5||
48348090|NCT00809133|101180852|FG013|STARTED|Overall Study||7||
48415882|NCT01542632|101350393|FG001|STARTED|Overall Study||25||
48415883|NCT01542632|101350394|FG002|STARTED|Overall Study||24||
48637203|NCT02969018|101898508|FG004|STARTED|Overall Study||29||
48637204|NCT02969018|101898509|FG005|STARTED|Overall Study||25||
48760453|NCT02085460|102200531|FG001|NOT COMPLETED|Overall Study||8||
48760454|NCT02085460|102200532|FG002|NOT COMPLETED|Overall Study||10||
48760455|NCT02420717|102200533|FG000|STARTED|Overall Study||5||
48760456|NCT02420717|102200534|FG001|STARTED|Overall Study||3||
48760457|NCT02420717|102200535|FG002|STARTED|Overall Study||3||
48760458|NCT02420717|102200533|FG000|COMPLETED|Overall Study||3||
48760459|NCT02420717|102200534|FG001|COMPLETED|Overall Study||3||
48760460|NCT02420717|102200535|FG002|COMPLETED|Overall Study||3||
48760461|NCT02420717|102200533|FG000|NOT COMPLETED|Overall Study||2||
48760462|NCT02420717|102200534|FG001|NOT COMPLETED|Overall Study||0||
48760463|NCT02420717|102200535|FG002|NOT COMPLETED|Overall Study||0||
48186132|NCT02685293|100779728|FG000|STARTED|Washout Period||1||
48186133|NCT02685293|100779729|FG001|STARTED|Washout Period||3||
48348091|NCT00809133|101180839|FG000|COMPLETED|Overall Study||0||
48186134|NCT02685293|100779728|FG000|COMPLETED|Washout Period||1||
48348092|NCT00809133|101180840|FG001|COMPLETED|Overall Study||0||
48348093|NCT00809133|101180841|FG002|COMPLETED|Overall Study||0||
48348094|NCT00809133|101180842|FG003|COMPLETED|Overall Study||0||
48415884|NCT01542632|101350395|FG003|STARTED|Overall Study||21||
48415885|NCT01542632|101350396|FG004|STARTED|Overall Study||21||
48415886|NCT01542632|101350397|FG005|STARTED|Overall Study||24||
48415887|NCT01542632|101350392|FG000|COMPLETED|Overall Study||25||
48637205|NCT02969018|101898510|FG006|STARTED|Overall Study||30||
48637206|NCT02969018|101898511|FG007|STARTED|Overall Study||23||
48637207|NCT02969018|101898504|FG000|COMPLETED|Overall Study||21||
48186135|NCT02685293|100779729|FG001|COMPLETED|Washout Period||3||
48186136|NCT02685293|100779728|FG000|NOT COMPLETED|Washout Period||0||
48186137|NCT02685293|100779729|FG001|NOT COMPLETED|Washout Period||0||
48186138|NCT02685293|100779728|FG000|STARTED|Treatment Period 2||1||
48186139|NCT02685293|100779729|FG001|STARTED|Treatment Period 2||3||
48186140|NCT02685293|100779728|FG000|COMPLETED|Treatment Period 2||1||
48186141|NCT02685293|100779729|FG001|COMPLETED|Treatment Period 2||3||
48186142|NCT02685293|100779728|FG000|NOT COMPLETED|Treatment Period 2||0||
48186143|NCT02685293|100779729|FG001|NOT COMPLETED|Treatment Period 2||0||
48186144|NCT04374565|100779730|FG000|STARTED|Overall Study||29||
48186145|NCT04374565|100779730|FG000|COMPLETED|Overall Study||29||
48186146|NCT04374565|100779730|FG000|NOT COMPLETED|Overall Study||0||
48186147|NCT00768599|100779731|FG000|STARTED|Overall Study||45||
48186148|NCT00768599|100779732|FG001|STARTED|Overall Study||43||
48186149|NCT00768599|100779733|FG002|STARTED|Overall Study||47||
48186150|NCT00768599|100779731|FG000|COMPLETED|Overall Study||34||
48186151|NCT00768599|100779732|FG001|COMPLETED|Overall Study||27||
48186152|NCT00768599|100779733|FG002|COMPLETED|Overall Study||35||
48186153|NCT00768599|100779731|FG000|NOT COMPLETED|Overall Study||11||
48186154|NCT00768599|100779732|FG001|NOT COMPLETED|Overall Study||16||
48186155|NCT00768599|100779733|FG002|NOT COMPLETED|Overall Study||12||
48186156|NCT02174198|100779734|FG000|STARTED|Overall Study||16||
48186157|NCT02174198|100779735|FG001|STARTED|Overall Study||16||
48186158|NCT02174198|100779734|FG000|COMPLETED|Overall Study||16||
48186159|NCT02174198|100779735|FG001|COMPLETED|Overall Study||16||
48186160|NCT02174198|100779734|FG000|NOT COMPLETED|Overall Study||0||
48186161|NCT02174198|100779735|FG001|NOT COMPLETED|Overall Study||0||
48186162|NCT01853163|100779736|FG000|STARTED|Overall Study||45||
48186163|NCT01853163|100779737|FG001|STARTED|Overall Study||29||
48186164|NCT01853163|100779738|FG002|STARTED|Overall Study||7||
48186165|NCT01853163|100779739|FG003|STARTED|Overall Study||11||
48186166|NCT01853163|100779736|FG000|COMPLETED|Overall Study||45||
48186167|NCT01853163|100779737|FG001|COMPLETED|Overall Study||29||
48186168|NCT01853163|100779738|FG002|COMPLETED|Overall Study||7||
48186169|NCT01853163|100779739|FG003|COMPLETED|Overall Study||11||
48186170|NCT01853163|100779736|FG000|NOT COMPLETED|Overall Study||0||
48186171|NCT01853163|100779737|FG001|NOT COMPLETED|Overall Study||0||
48186172|NCT01853163|100779738|FG002|NOT COMPLETED|Overall Study||0||
48186173|NCT01853163|100779739|FG003|NOT COMPLETED|Overall Study||0||
48186174|NCT01115998|100779740|FG000|STARTED|Overall Study||17||
48186175|NCT01115998|100779741|FG001|STARTED|Overall Study||17||
48186176|NCT01115998|100779740|FG000|COMPLETED|Overall Study||11||
48186177|NCT01115998|100779741|FG001|COMPLETED|Overall Study||11||
48186178|NCT01115998|100779740|FG000|NOT COMPLETED|Overall Study||6||
48186179|NCT01115998|100779741|FG001|NOT COMPLETED|Overall Study||6||
48186180|NCT02462083|100779742|FG000|STARTED|Overall Study||555||
48186181|NCT02462083|100779742|FG000|Safety Population|Overall Study||550|All participants with \>=1 confirmed dose of study drug \& \>=1 post-Baseline safety assessment.|
48186182|NCT02462083|100779742|FG000|COMPLETED|Overall Study||136||
48186183|NCT02462083|100779742|FG000|NOT COMPLETED|Overall Study||419||
48186184|NCT00924664|100779743|FG000|STARTED|Overall Study||322||
48186185|NCT00924664|100779744|FG001|STARTED|Overall Study||527||
48186186|NCT00924664|100779743|FG000|Treated|Overall Study||321||
48186187|NCT00924664|100779744|FG001|Treated|Overall Study||527||
48186188|NCT00924664|100779743|FG000|COMPLETED|Overall Study||0||
48186189|NCT00924664|100779744|FG001|COMPLETED|Overall Study||0||
48186190|NCT00924664|100779743|FG000|NOT COMPLETED|Overall Study||322||
48186191|NCT00924664|100779744|FG001|NOT COMPLETED|Overall Study||527||
48186192|NCT05142228|100779745|FG000|STARTED|Overall Study||1||
48186193|NCT05142228|100779746|FG001|STARTED|Overall Study||0||
48186194|NCT05142228|100779745|FG000|COMPLETED|Overall Study||1||
48186195|NCT05142228|100779746|FG001|COMPLETED|Overall Study||0||
48186196|NCT05142228|100779745|FG000|NOT COMPLETED|Overall Study||0||
48186197|NCT05142228|100779746|FG001|NOT COMPLETED|Overall Study||0||
48186198|NCT00630539|100779747|FG000|STARTED|Overall Study||34||
48186199|NCT00630539|100779748|FG001|STARTED|Overall Study||33||
48186200|NCT00630539|100779749|FG002|STARTED|Overall Study||29||
48186201|NCT00630539|100779750|FG003|STARTED|Overall Study||30||
48186202|NCT00630539|100779747|FG000|COMPLETED|Overall Study||33||
48186203|NCT00630539|100779748|FG001|COMPLETED|Overall Study||29||
48186204|NCT00630539|100779749|FG002|COMPLETED|Overall Study||28||
48186205|NCT00630539|100779750|FG003|COMPLETED|Overall Study||27||
48186206|NCT00630539|100779747|FG000|NOT COMPLETED|Overall Study||1||
48186207|NCT00630539|100779748|FG001|NOT COMPLETED|Overall Study||4||
48186208|NCT00630539|100779749|FG002|NOT COMPLETED|Overall Study||1||
48186209|NCT00630539|100779750|FG003|NOT COMPLETED|Overall Study||3||
48186210|NCT01511536|100779751|FG000|STARTED|Phase 1||3||
48186211|NCT01511536|100779752|FG001|STARTED|Phase 1||7||
48186212|NCT01511536|100779753|FG002|STARTED|Phase 1||0||
48186213|NCT01511536|100779751|FG000|COMPLETED|Phase 1||3||
48186214|NCT01511536|100779752|FG001|COMPLETED|Phase 1||6||
48186215|NCT01511536|100779753|FG002|COMPLETED|Phase 1||0||
48186216|NCT01511536|100779751|FG000|NOT COMPLETED|Phase 1||0||
48186217|NCT01511536|100779752|FG001|NOT COMPLETED|Phase 1||1||
48186218|NCT01511536|100779753|FG002|NOT COMPLETED|Phase 1||0||
48186219|NCT01511536|100779751|FG000|STARTED|Phase 2||0||
48186220|NCT01511536|100779752|FG001|STARTED|Phase 2||0||
48186221|NCT01511536|100779753|FG002|STARTED|Phase 2||27||
48186222|NCT01511536|100779751|FG000|COMPLETED|Phase 2||0||
48186223|NCT01511536|100779752|FG001|COMPLETED|Phase 2||0||
48186224|NCT01511536|100779753|FG002|COMPLETED|Phase 2||18||
48186225|NCT01511536|100779751|FG000|NOT COMPLETED|Phase 2||0||
48186226|NCT01511536|100779752|FG001|NOT COMPLETED|Phase 2||0||
48186227|NCT01511536|100779753|FG002|NOT COMPLETED|Phase 2||9||
48186228|NCT03697460|100779754|FG000|STARTED|Overall Study||12||
48186229|NCT03697460|100779754|FG000|COMPLETED|Overall Study||9||
48186230|NCT03697460|100779754|FG000|NOT COMPLETED|Overall Study||3||
48186231|NCT02886936|100779755|FG000|STARTED|Overall Study||26||
48186232|NCT02886936|100779756|FG001|STARTED|Overall Study||27||
48186233|NCT02886936|100779757|FG002|STARTED|Overall Study||18||
48186234|NCT02886936|100779755|FG000|COMPLETED|Overall Study||22||
48186235|NCT02886936|100779756|FG001|COMPLETED|Overall Study||24||
48186236|NCT02886936|100779757|FG002|COMPLETED|Overall Study||18||
48186237|NCT02886936|100779755|FG000|NOT COMPLETED|Overall Study||4||
48186238|NCT02886936|100779756|FG001|NOT COMPLETED|Overall Study||3||
48186239|NCT02886936|100779757|FG002|NOT COMPLETED|Overall Study||0||
48186240|NCT00178620|100779758|FG000|STARTED|Overall Study||37||
48186241|NCT00178620|100779759|FG001|STARTED|Overall Study||253||
48186242|NCT00178620|100779760|FG002|STARTED|Overall Study||37||
48186243|NCT00178620|100779761|FG003|STARTED|Overall Study||63||
48186244|NCT00178620|100779758|FG000|COMPLETED|Overall Study||37||
48186245|NCT00178620|100779759|FG001|COMPLETED|Overall Study||253||
48637208|NCT02969018|101898505|FG001|COMPLETED|Overall Study||21||
48637209|NCT02969018|101898506|FG002|COMPLETED|Overall Study||20||
48637210|NCT02969018|101898507|FG003|COMPLETED|Overall Study||20||
48637211|NCT02969018|101898508|FG004|COMPLETED|Overall Study||27||
48637212|NCT02969018|101898509|FG005|COMPLETED|Overall Study||17||
48637213|NCT02969018|101898510|FG006|COMPLETED|Overall Study||22||
48637214|NCT02969018|101898511|FG007|COMPLETED|Overall Study||16||
48637215|NCT02969018|101898504|FG000|NOT COMPLETED|Overall Study||4||
48637216|NCT02969018|101898505|FG001|NOT COMPLETED|Overall Study||8||
48760464|NCT00129402|102200536|FG000|STARTED|Start Period1 to End Period1 (Week 1-6)||43||
48348095|NCT00809133|101180843|FG004|COMPLETED|Overall Study||0||
48760465|NCT00129402|102200537|FG001|STARTED|Start Period1 to End Period1 (Week 1-6)||40||
48760466|NCT00129402|102200538|FG002|STARTED|Start Period1 to End Period1 (Week 1-6)||43||
48760467|NCT00129402|102200539|FG003|STARTED|Start Period1 to End Period1 (Week 1-6)||40||
48760468|NCT00129402|102200540|FG004|STARTED|Start Period1 to End Period1 (Week 1-6)||40||
48760469|NCT00129402|102200541|FG005|STARTED|Start Period1 to End Period1 (Week 1-6)||42||
48760470|NCT00129402|102200542|FG006|STARTED|Start Period1 to End Period1 (Week 1-6)||0||
48186246|NCT00178620|100779760|FG002|COMPLETED|Overall Study||37||
48186247|NCT00178620|100779761|FG003|COMPLETED|Overall Study||63||
48186248|NCT00178620|100779758|FG000|NOT COMPLETED|Overall Study||0||
48186249|NCT00178620|100779759|FG001|NOT COMPLETED|Overall Study||0||
48186250|NCT00178620|100779760|FG002|NOT COMPLETED|Overall Study||0||
48186251|NCT00178620|100779761|FG003|NOT COMPLETED|Overall Study||0||
48186252|NCT01400893|100779762|FG000|STARTED|Overall Study||69||
48186253|NCT01400893|100779763|FG001|STARTED|Overall Study||65||
48186254|NCT01400893|100779762|FG000|COMPLETED|Overall Study||42||
48186255|NCT01400893|100779763|FG001|COMPLETED|Overall Study||38||
48186256|NCT01400893|100779762|FG000|NOT COMPLETED|Overall Study||27||
48637217|NCT02969018|101898506|FG002|NOT COMPLETED|Overall Study||6||
48760471|NCT00129402|102200536|FG000|COMPLETED|Start Period1 to End Period1 (Week 1-6)||43||
48760472|NCT00129402|102200537|FG001|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39||
48760473|NCT00129402|102200538|FG002|COMPLETED|Start Period1 to End Period1 (Week 1-6)||41||
48760474|NCT00129402|102200539|FG003|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39||
48760475|NCT00129402|102200540|FG004|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39||
48760476|NCT00129402|102200541|FG005|COMPLETED|Start Period1 to End Period1 (Week 1-6)||40||
48760477|NCT00129402|102200542|FG006|COMPLETED|Start Period1 to End Period1 (Week 1-6)||0||
48760478|NCT00129402|102200536|FG000|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0||
48760479|NCT00129402|102200537|FG001|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1||
48760480|NCT00129402|102200538|FG002|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2||
48760481|NCT00129402|102200539|FG003|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1||
48760482|NCT00129402|102200540|FG004|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1||
48186257|NCT01400893|100779763|FG001|NOT COMPLETED|Overall Study||27||
48186258|NCT03660943|100779764|FG000|STARTED|Overall Study||145||
48186259|NCT03660943|100779765|FG001|STARTED|Overall Study||187||
48186260|NCT03660943|100779764|FG000|Treated|Overall Study||140||
48186261|NCT03660943|100779765|FG001|Treated|Overall Study||184||
48186262|NCT03660943|100779764|FG000|COMPLETED|Overall Study||109||
48186263|NCT03660943|100779765|FG001|COMPLETED|Overall Study||134||
48186264|NCT03660943|100779764|FG000|NOT COMPLETED|Overall Study||36||
48186265|NCT03660943|100779765|FG001|NOT COMPLETED|Overall Study||53||
48186266|NCT00293462|100779766|FG000|STARTED|Overall Study||31||
48348096|NCT00809133|101180844|FG005|COMPLETED|Overall Study||0||
48637218|NCT02969018|101898507|FG003|NOT COMPLETED|Overall Study||5||
48637219|NCT02969018|101898508|FG004|NOT COMPLETED|Overall Study||2||
48186267|NCT00293462|100779767|FG001|STARTED|Overall Study||29||
48637220|NCT02969018|101898509|FG005|NOT COMPLETED|Overall Study||8||
48348097|NCT00809133|101180845|FG006|COMPLETED|Overall Study||0||
48348098|NCT00809133|101180846|FG007|COMPLETED|Overall Study||0||
48348099|NCT00809133|101180847|FG008|COMPLETED|Overall Study||0||
48348100|NCT00809133|101180848|FG009|COMPLETED|Overall Study||0||
48348101|NCT00809133|101180849|FG010|COMPLETED|Overall Study||0||
48348102|NCT00809133|101180850|FG011|COMPLETED|Overall Study||0||
48348103|NCT00809133|101180851|FG012|COMPLETED|Overall Study||0||
48348104|NCT00809133|101180852|FG013|COMPLETED|Overall Study||0||
48348105|NCT00809133|101180839|FG000|NOT COMPLETED|Overall Study||3||
48348106|NCT00809133|101180840|FG001|NOT COMPLETED|Overall Study||7||
48348107|NCT00809133|101180841|FG002|NOT COMPLETED|Overall Study||6||
48348108|NCT00809133|101180842|FG003|NOT COMPLETED|Overall Study||3||
48348109|NCT00809133|101180843|FG004|NOT COMPLETED|Overall Study||5||
48348110|NCT00809133|101180844|FG005|NOT COMPLETED|Overall Study||7||
48348111|NCT00809133|101180845|FG006|NOT COMPLETED|Overall Study||6||
48348112|NCT00809133|101180846|FG007|NOT COMPLETED|Overall Study||8||
48348113|NCT00809133|101180847|FG008|NOT COMPLETED|Overall Study||3||
48348114|NCT00809133|101180848|FG009|NOT COMPLETED|Overall Study||9||
48348115|NCT00809133|101180849|FG010|NOT COMPLETED|Overall Study||6||
48348116|NCT00809133|101180850|FG011|NOT COMPLETED|Overall Study||8||
48348117|NCT00809133|101180851|FG012|NOT COMPLETED|Overall Study||5||
48348118|NCT00809133|101180852|FG013|NOT COMPLETED|Overall Study||7||
48348119|NCT02036320|101180853|FG000|STARTED|Period 1||95||
48348120|NCT02036320|101180854|FG001|STARTED|Period 1||95||
48348121|NCT02036320|101180853|FG000|COMPLETED|Period 1||95||
48348122|NCT02036320|101180854|FG001|COMPLETED|Period 1||95||
48348123|NCT02036320|101180853|FG000|NOT COMPLETED|Period 1||0||
48348124|NCT02036320|101180854|FG001|NOT COMPLETED|Period 1||0||
48348125|NCT02036320|101180853|FG000|STARTED|Period 2||95||
48348126|NCT02036320|101180854|FG001|STARTED|Period 2||95||
48348127|NCT02036320|101180853|FG000|COMPLETED|Period 2||95||
48348128|NCT02036320|101180854|FG001|COMPLETED|Period 2||95||
48348129|NCT02036320|101180853|FG000|NOT COMPLETED|Period 2||0||
48348130|NCT02036320|101180854|FG001|NOT COMPLETED|Period 2||0||
48348131|NCT00828451|101180855|FG000|STARTED|Overall Study||29||
48348132|NCT00828451|101180855|FG000|COMPLETED|Overall Study||18||
48348133|NCT00828451|101180855|FG000|NOT COMPLETED|Overall Study||11||
48348134|NCT01850615|101180856|FG000|STARTED|Overall Study||116||
48348135|NCT01850615|101180857|FG001|STARTED|Overall Study||120||
48348136|NCT01850615|101180856|FG000|Exposed|Overall Study||115||
48348137|NCT01850615|101180857|FG001|Exposed|Overall Study||120||
48348138|NCT01850615|101180856|FG000|COMPLETED|Overall Study||107||
48348139|NCT01850615|101180857|FG001|COMPLETED|Overall Study||115||
48348140|NCT01850615|101180856|FG000|NOT COMPLETED|Overall Study||9||
48348141|NCT01850615|101180857|FG001|NOT COMPLETED|Overall Study||5||
48348142|NCT01262898|101180858|FG000|STARTED|Overall Study||21||
48348143|NCT01262898|101180859|FG001|STARTED|Overall Study||18||
48348144|NCT01262898|101180860|FG002|STARTED|Overall Study||18||
48348145|NCT01262898|101180861|FG003|STARTED|Overall Study||22||
48348146|NCT01262898|101180858|FG000|COMPLETED|Overall Study||18||
48348147|NCT01262898|101180859|FG001|COMPLETED|Overall Study||16||
48348148|NCT01262898|101180860|FG002|COMPLETED|Overall Study||18||
48348149|NCT01262898|101180861|FG003|COMPLETED|Overall Study||22||
48348150|NCT01262898|101180858|FG000|NOT COMPLETED|Overall Study||3||
48348151|NCT01262898|101180859|FG001|NOT COMPLETED|Overall Study||2||
48348152|NCT01262898|101180860|FG002|NOT COMPLETED|Overall Study||0||
48348153|NCT01262898|101180861|FG003|NOT COMPLETED|Overall Study||0||
48348154|NCT02498821|101180862|FG000|STARTED|Overall Study||63||
48348155|NCT02498821|101180863|FG001|STARTED|Overall Study||65||
48348156|NCT02498821|101180862|FG000|COMPLETED|Overall Study||60||
48348157|NCT02498821|101180863|FG001|COMPLETED|Overall Study||60||
48348158|NCT02498821|101180862|FG000|NOT COMPLETED|Overall Study||3||
48348159|NCT02498821|101180863|FG001|NOT COMPLETED|Overall Study||5||
48348160|NCT03258814|101180864|FG000|STARTED|Overall Study||4||
48415888|NCT01542632|101350393|FG001|COMPLETED|Overall Study||24||
48415889|NCT01542632|101350394|FG002|COMPLETED|Overall Study||23||
48415890|NCT01542632|101350395|FG003|COMPLETED|Overall Study||19||
48415891|NCT01542632|101350396|FG004|COMPLETED|Overall Study||17||
48415892|NCT01542632|101350397|FG005|COMPLETED|Overall Study||24||
48415893|NCT01542632|101350392|FG000|NOT COMPLETED|Overall Study||0||
48415894|NCT01542632|101350393|FG001|NOT COMPLETED|Overall Study||1||
48348161|NCT03258814|101180865|FG001|STARTED|Overall Study||3||
48348162|NCT03258814|101180866|FG002|STARTED|Overall Study||10||
48348163|NCT03258814|101180864|FG000|COMPLETED|Overall Study||0||
48348164|NCT03258814|101180865|FG001|COMPLETED|Overall Study||0||
48348165|NCT03258814|101180866|FG002|COMPLETED|Overall Study||0||
48348166|NCT03258814|101180864|FG000|NOT COMPLETED|Overall Study||4||
48348167|NCT03258814|101180865|FG001|NOT COMPLETED|Overall Study||3||
48348168|NCT03258814|101180866|FG002|NOT COMPLETED|Overall Study||10||
48348169|NCT01445171|101180867|FG000|STARTED|Overall Study||295||
48348170|NCT01445171|101180867|FG000|Implanted With Study Device|Overall Study||287||
48415895|NCT01542632|101350394|FG002|NOT COMPLETED|Overall Study||1||
48348171|NCT01445171|101180867|FG000|COMPLETED|Overall Study||200||
48348172|NCT01445171|101180867|FG000|NOT COMPLETED|Overall Study||95||
48348173|NCT04317690|101180868|FG000|STARTED|Overall Study||100||
48348174|NCT04317690|101180869|FG001|STARTED|Overall Study||100||
48348175|NCT04317690|101180870|FG002|STARTED|Overall Study||140||
48348176|NCT04317690|101180871|FG003|STARTED|Overall Study||100||
48348177|NCT04317690|101180872|FG004|STARTED|Overall Study||99||
48348178|NCT04317690|101180868|FG000|COMPLETED|Overall Study||100||
48348179|NCT04317690|101180869|FG001|COMPLETED|Overall Study||96||
48348180|NCT04317690|101180870|FG002|COMPLETED|Overall Study||140||
48348181|NCT04317690|101180871|FG003|COMPLETED|Overall Study||98||
48348182|NCT04317690|101180872|FG004|COMPLETED|Overall Study||99||
48348183|NCT04317690|101180868|FG000|NOT COMPLETED|Overall Study||0||
48348184|NCT04317690|101180869|FG001|NOT COMPLETED|Overall Study||4||
48348185|NCT04317690|101180870|FG002|NOT COMPLETED|Overall Study||0||
48348186|NCT04317690|101180871|FG003|NOT COMPLETED|Overall Study||2||
48348187|NCT04317690|101180872|FG004|NOT COMPLETED|Overall Study||0||
48348188|NCT03537664|101180873|FG000|STARTED|Overall Study||20||
48348189|NCT03537664|101180874|FG001|STARTED|Overall Study||25||
48348190|NCT03537664|101180873|FG000|Metabolic Activity of Bacteria|Overall Study||15||
48348191|NCT03537664|101180874|FG001|Metabolic Activity of Bacteria|Overall Study||25||
48348192|NCT03537664|101180873|FG000|Bacterial Levels|Overall Study||20||
48186268|NCT00293462|100779768|FG002|STARTED|Overall Study||31||
48186269|NCT00293462|100779766|FG000|COMPLETED|Overall Study||24||
48186270|NCT00293462|100779767|FG001|COMPLETED|Overall Study||21||
48186271|NCT00293462|100779768|FG002|COMPLETED|Overall Study||19||
48186272|NCT00293462|100779766|FG000|NOT COMPLETED|Overall Study||7||
48186273|NCT00293462|100779767|FG001|NOT COMPLETED|Overall Study||8||
48348193|NCT03537664|101180874|FG001|Bacterial Levels|Overall Study||25||
48348194|NCT03537664|101180873|FG000|Bacterial Community Diversity|Overall Study||10||
48415896|NCT01542632|101350395|FG003|NOT COMPLETED|Overall Study||2||
48637221|NCT02969018|101898510|FG006|NOT COMPLETED|Overall Study||8||
48637222|NCT02969018|101898511|FG007|NOT COMPLETED|Overall Study||7||
48637223|NCT00071981|101898512|FG000|STARTED|Overall Study||47||
48637224|NCT00071981|101898513|FG001|STARTED|Overall Study||43||
48637225|NCT00071981|101898514|FG002|STARTED|Overall Study||37||
48186274|NCT00293462|100779768|FG002|NOT COMPLETED|Overall Study||12||
48186275|NCT00714233|100779769|FG000|STARTED|Overall Study||10||
48186276|NCT00714233|100779770|FG001|STARTED|Overall Study||11||
48186277|NCT00714233|100779771|FG002|STARTED|Overall Study||11||
48186278|NCT00714233|100779772|FG003|STARTED|Overall Study||10||
48186279|NCT00714233|100779769|FG000|COMPLETED|Overall Study||6||
48186280|NCT00714233|100779770|FG001|COMPLETED|Overall Study||10||
48186281|NCT00714233|100779771|FG002|COMPLETED|Overall Study||10||
48186282|NCT00714233|100779772|FG003|COMPLETED|Overall Study||6||
48186283|NCT00714233|100779769|FG000|NOT COMPLETED|Overall Study||4||
48186284|NCT00714233|100779770|FG001|NOT COMPLETED|Overall Study||1||
48186285|NCT00714233|100779771|FG002|NOT COMPLETED|Overall Study||1||
48186286|NCT00714233|100779772|FG003|NOT COMPLETED|Overall Study||4||
48186287|NCT03772314|100779773|FG000|STARTED|Overall Study||22||
48186288|NCT03772314|100779774|FG001|STARTED|Overall Study||22||
48186289|NCT03772314|100779773|FG000|COMPLETED|Overall Study||15||
48186290|NCT03772314|100779774|FG001|COMPLETED|Overall Study||20||
48186291|NCT03772314|100779773|FG000|NOT COMPLETED|Overall Study||7||
48186292|NCT03772314|100779774|FG001|NOT COMPLETED|Overall Study||2||
48186293|NCT00801242|100779775|FG000|STARTED|Overall Study||220||
48186294|NCT00801242|100779775|FG000|Safety Analysis Set|Overall Study||216||
48186295|NCT00801242|100779775|FG000|Full Analysis Set (FAS), Cycle 1|Overall Study||213||
48186296|NCT00801242|100779775|FG000|FAS, Off-treatment Cycle 1|Overall Study||191||
48186297|NCT00801242|100779775|FG000|Started Cycle 2|Overall Study||35||
48186298|NCT00801242|100779775|FG000|Started Cycle 3|Overall Study||2||
48186299|NCT00801242|100779775|FG000|COMPLETED|Overall Study||168||
48186300|NCT00801242|100779775|FG000|NOT COMPLETED|Overall Study||52||
48760483|NCT00129402|102200541|FG005|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2||
48760484|NCT00129402|102200542|FG006|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0||
48186301|NCT00528190|100779776|FG000|STARTED|Overall Study||18||
48186302|NCT00528190|100779777|FG001|STARTED|Overall Study||17||
48186303|NCT00528190|100779776|FG000|COMPLETED|Overall Study||18||
48186304|NCT00528190|100779777|FG001|COMPLETED|Overall Study||16||
48186305|NCT00528190|100779776|FG000|NOT COMPLETED|Overall Study||0||
48186306|NCT00528190|100779777|FG001|NOT COMPLETED|Overall Study||1||
48186307|NCT01449929|100779778|FG000|STARTED|Randomization Phase 96 Week||242||
48186308|NCT01449929|100779779|FG001|STARTED|Randomization Phase 96 Week||242||
48186309|NCT01449929|100779780|FG002|STARTED|Randomization Phase 96 Week||0||
48186310|NCT01449929|100779778|FG000|COMPLETED|Randomization Phase 96 Week||209||
48415897|NCT01542632|101350396|FG004|NOT COMPLETED|Overall Study||4||
48637226|NCT00071981|101898515|FG003|STARTED|Overall Study||48||
48637227|NCT00071981|101898512|FG000|Eligible|Overall Study||43||
48637228|NCT00071981|101898513|FG001|Eligible|Overall Study||36||
48637229|NCT00071981|101898514|FG002|Eligible|Overall Study||33||
48637230|NCT00071981|101898515|FG003|Eligible|Overall Study||42||
48760485|NCT00129402|102200536|FG000|STARTED|Start Period2 to End Period2 (Week 7-33)||0||
48760486|NCT00129402|102200537|FG001|STARTED|Start Period2 to End Period2 (Week 7-33)||0||
48760487|NCT00129402|102200538|FG002|STARTED|Start Period2 to End Period2 (Week 7-33)||122||
48760488|NCT00129402|102200539|FG003|STARTED|Start Period2 to End Period2 (Week 7-33)||0||
48186311|NCT01449929|100779779|FG001|COMPLETED|Randomization Phase 96 Week||189||
48186312|NCT01449929|100779780|FG002|COMPLETED|Randomization Phase 96 Week||0||
48186313|NCT01449929|100779778|FG000|NOT COMPLETED|Randomization Phase 96 Week||33||
48186314|NCT01449929|100779779|FG001|NOT COMPLETED|Randomization Phase 96 Week||53||
48186315|NCT01449929|100779780|FG002|NOT COMPLETED|Randomization Phase 96 Week||0||
48186316|NCT01449929|100779778|FG000|STARTED|Extension Phase Approximately 3 Years||0||
48186317|NCT01449929|100779779|FG001|STARTED|Extension Phase Approximately 3 Years||0||
48415898|NCT01542632|101350397|FG005|NOT COMPLETED|Overall Study||0||
48186318|NCT01449929|100779780|FG002|STARTED|Extension Phase Approximately 3 Years||123||
48415899|NCT01431794|101350398|FG000|STARTED|Overall Study||13||
48415900|NCT01431794|101350399|FG001|STARTED|Overall Study||0||
48637231|NCT00071981|101898512|FG000|Treated|Overall Study||45||
48637232|NCT00071981|101898513|FG001|Treated|Overall Study||38||
48637233|NCT00071981|101898514|FG002|Treated|Overall Study||36||
48637234|NCT00071981|101898515|FG003|Treated|Overall Study||48||
48637235|NCT00071981|101898512|FG000|Eligible and Treated|Overall Study||41||
48637236|NCT00071981|101898513|FG001|Eligible and Treated|Overall Study||33||
48637237|NCT00071981|101898514|FG002|Eligible and Treated|Overall Study||32||
48637238|NCT00071981|101898515|FG003|Eligible and Treated|Overall Study||42||
48637239|NCT00071981|101898512|FG000|Have CTL Response Data|Overall Study||40||
48637240|NCT00071981|101898513|FG001|Have CTL Response Data|Overall Study||30||
48637241|NCT00071981|101898514|FG002|Have CTL Response Data|Overall Study||29||
48637242|NCT00071981|101898515|FG003|Have CTL Response Data|Overall Study||41||
48637243|NCT00071981|101898512|FG000|Have Helper T Cell Response Data|Overall Study||37||
48637244|NCT00071981|101898513|FG001|Have Helper T Cell Response Data|Overall Study||27||
48657029|NCT02018809|101943756|FG003|STARTED|Overall Study||50||
48348195|NCT03537664|101180874|FG001|Bacterial Community Diversity|Overall Study||0||
48348196|NCT03537664|101180873|FG000|Endodontic Success|Overall Study||20||
48348197|NCT03537664|101180874|FG001|Endodontic Success|Overall Study||10||
48348198|NCT03537664|101180873|FG000|COMPLETED|Overall Study||20||
48348199|NCT03537664|101180874|FG001|COMPLETED|Overall Study||25||
48348200|NCT03537664|101180873|FG000|NOT COMPLETED|Overall Study||0||
48348201|NCT03537664|101180874|FG001|NOT COMPLETED|Overall Study||0||
48348202|NCT01061008|101180875|FG000|STARTED|Overall Study||16||
48348203|NCT01061008|101180876|FG001|STARTED|Overall Study||15||
48348204|NCT01061008|101180875|FG000|COMPLETED|Overall Study||10||
48348205|NCT01061008|101180876|FG001|COMPLETED|Overall Study||9||
48348206|NCT01061008|101180875|FG000|NOT COMPLETED|Overall Study||6||
48348207|NCT01061008|101180876|FG001|NOT COMPLETED|Overall Study||6||
48348208|NCT00477087|101180877|FG000|STARTED|Overall Study||10||
48348209|NCT00477087|101180877|FG000|COMPLETED|Overall Study||10||
48348210|NCT00477087|101180877|FG000|NOT COMPLETED|Overall Study||0||
48348211|NCT02319369|101180878|FG000|STARTED|Overall Study||7||
48348212|NCT02319369|101180879|FG001|STARTED|Overall Study||6||
48348213|NCT02319369|101180880|FG002|STARTED|Overall Study||11||
48348214|NCT02319369|101180881|FG003|STARTED|Overall Study||8||
48348215|NCT02319369|101180882|FG004|STARTED|Overall Study||5||
48348216|NCT02319369|101180883|FG005|STARTED|Overall Study||7||
48348217|NCT02319369|101180884|FG006|STARTED|Overall Study||3||
48348218|NCT02319369|101180885|FG007|STARTED|Overall Study||6||
48348219|NCT02319369|101180886|FG008|STARTED|Overall Study||4||
48348220|NCT02319369|101180887|FG009|STARTED|Overall Study||9||
48348221|NCT02319369|101180888|FG010|STARTED|Overall Study||3||
48348222|NCT02319369|101180889|FG011|STARTED|Overall Study||4||
48348223|NCT02319369|101180890|FG012|STARTED|Overall Study||1||
48348224|NCT02319369|101180878|FG000|COMPLETED|Overall Study||7||
48348225|NCT02319369|101180879|FG001|COMPLETED|Overall Study||6||
48348226|NCT02319369|101180880|FG002|COMPLETED|Overall Study||11||
48348227|NCT02319369|101180881|FG003|COMPLETED|Overall Study||8||
48348228|NCT02319369|101180882|FG004|COMPLETED|Overall Study||5||
48348229|NCT02319369|101180883|FG005|COMPLETED|Overall Study||7||
48348230|NCT02319369|101180884|FG006|COMPLETED|Overall Study||3||
48348231|NCT02319369|101180885|FG007|COMPLETED|Overall Study||6||
48348232|NCT02319369|101180886|FG008|COMPLETED|Overall Study||4||
48348233|NCT02319369|101180887|FG009|COMPLETED|Overall Study||9||
48348234|NCT02319369|101180888|FG010|COMPLETED|Overall Study||3||
48348235|NCT02319369|101180889|FG011|COMPLETED|Overall Study||4||
48348236|NCT02319369|101180890|FG012|COMPLETED|Overall Study||1||
48348237|NCT02319369|101180878|FG000|NOT COMPLETED|Overall Study||0||
48348238|NCT02319369|101180879|FG001|NOT COMPLETED|Overall Study||0||
48348239|NCT02319369|101180880|FG002|NOT COMPLETED|Overall Study||0||
48348240|NCT02319369|101180881|FG003|NOT COMPLETED|Overall Study||0||
48348241|NCT02319369|101180882|FG004|NOT COMPLETED|Overall Study||0||
48348242|NCT02319369|101180883|FG005|NOT COMPLETED|Overall Study||0||
48348243|NCT02319369|101180884|FG006|NOT COMPLETED|Overall Study||0||
48348244|NCT02319369|101180885|FG007|NOT COMPLETED|Overall Study||0||
48348245|NCT02319369|101180886|FG008|NOT COMPLETED|Overall Study||0||
48348246|NCT02319369|101180887|FG009|NOT COMPLETED|Overall Study||0||
48348247|NCT02319369|101180888|FG010|NOT COMPLETED|Overall Study||0||
48348248|NCT02319369|101180889|FG011|NOT COMPLETED|Overall Study||0||
48348249|NCT02319369|101180890|FG012|NOT COMPLETED|Overall Study||0||
48348250|NCT00629083|101180891|FG000|STARTED|Overall Study||228||
48348251|NCT00629083|101180892|FG001|STARTED|Overall Study||117||
48348252|NCT00629083|101180891|FG000|COMPLETED|Overall Study||200||
48348253|NCT00629083|101180892|FG001|COMPLETED|Overall Study||103||
48348254|NCT00629083|101180891|FG000|NOT COMPLETED|Overall Study||28||
48348255|NCT00629083|101180892|FG001|NOT COMPLETED|Overall Study||14||
48348256|NCT01518530|101183959|FG000|STARTED|Active Treatment Period||10||
48348257|NCT01518530|101183959|FG000|COMPLETED|Active Treatment Period||9||
48348258|NCT01518530|101183959|FG000|NOT COMPLETED|Active Treatment Period||1||
48348259|NCT01518530|101183959|FG000|STARTED|Post-Treatment Follow-up||9||
48348260|NCT01518530|101183959|FG000|COMPLETED|Post-Treatment Follow-up||9||
48348261|NCT01518530|101183959|FG000|NOT COMPLETED|Post-Treatment Follow-up||0||
48348262|NCT01479348|101183960|FG000|STARTED|Overall Study||5||
48348263|NCT01479348|101183961|FG001|STARTED|Overall Study||0||
48348264|NCT01479348|101183960|FG000|COMPLETED|Overall Study||5||
48348265|NCT01479348|101183961|FG001|COMPLETED|Overall Study||0||
48348266|NCT01479348|101183960|FG000|NOT COMPLETED|Overall Study||0||
48348267|NCT01479348|101183961|FG001|NOT COMPLETED|Overall Study||0||
48348268|NCT02049502|101183962|FG000|STARTED|Overall Study||8||
48348269|NCT02049502|101183962|FG000|COMPLETED|Overall Study||8||
48348270|NCT02049502|101183962|FG000|NOT COMPLETED|Overall Study||0||
48348271|NCT02757547|101183963|FG000|STARTED|Overall Study||2||
48348272|NCT02757547|101183963|FG000|COMPLETED|Overall Study||2||
48348273|NCT02757547|101183963|FG000|NOT COMPLETED|Overall Study||0||
48348274|NCT02988856|101183964|FG000|STARTED|Overall Study||11||
48348275|NCT02988856|101183964|FG000|COMPLETED|Overall Study||8||
48348276|NCT02988856|101183964|FG000|NOT COMPLETED|Overall Study||3||
48348277|NCT04025632|101183965|FG000|STARTED|Overall Study||15||
48348278|NCT04025632|101183966|FG001|STARTED|Overall Study||12||
48348279|NCT04025632|101183965|FG000|Completed Main Portion|Overall Study||15||
48348280|NCT04025632|101183966|FG001|Completed Main Portion|Overall Study||12||
48348281|NCT04025632|101183965|FG000|Started Main Portion Safety Follow-up|Overall Study||2|Refers to study participants who completed the 8-week blinded treatment period in the Main Portion of the study and had not entered the Extension Portion.|
48348282|NCT04025632|101183966|FG001|Started Main Portion Safety Follow-up|Overall Study||0|Refers to study participants who completed the 8-week blinded treatment period in the Main Portion of the study and had not entered the Extension Portion.|
48368113|NCT03196297|101230110|FG000|Full Analysis Set (FAS)|Main Period||36||
48415901|NCT01431794|101350400|FG002|STARTED|Overall Study||0||
48415902|NCT01431794|101350401|FG003|STARTED|Overall Study||0||
48415903|NCT01431794|101350402|FG004|STARTED|Overall Study||0||
48760489|NCT00129402|102200540|FG004|STARTED|Start Period2 to End Period2 (Week 7-33)||0||
48760490|NCT00129402|102200541|FG005|STARTED|Start Period2 to End Period2 (Week 7-33)||118||
48760491|NCT00129402|102200542|FG006|STARTED|Start Period2 to End Period2 (Week 7-33)||0||
48760492|NCT00129402|102200536|FG000|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0||
48760493|NCT00129402|102200537|FG001|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0||
48760494|NCT00129402|102200538|FG002|COMPLETED|Start Period2 to End Period2 (Week 7-33)||114||
48760495|NCT00129402|102200539|FG003|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0||
48760496|NCT00129402|102200540|FG004|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0||
48760497|NCT00129402|102200541|FG005|COMPLETED|Start Period2 to End Period2 (Week 7-33)||113||
48760498|NCT00129402|102200542|FG006|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0||
48186319|NCT01449929|100779778|FG000|COMPLETED|Extension Phase Approximately 3 Years||0||
48186320|NCT01449929|100779779|FG001|COMPLETED|Extension Phase Approximately 3 Years||0||
48186321|NCT01449929|100779780|FG002|COMPLETED|Extension Phase Approximately 3 Years||115||
48415904|NCT01431794|101350398|FG000|COMPLETED|Overall Study||13||
48415905|NCT01431794|101350399|FG001|COMPLETED|Overall Study||0||
48186322|NCT01449929|100779778|FG000|NOT COMPLETED|Extension Phase Approximately 3 Years||0||
48186323|NCT01449929|100779779|FG001|NOT COMPLETED|Extension Phase Approximately 3 Years||0||
48415906|NCT01431794|101350400|FG002|COMPLETED|Overall Study||0||
48415907|NCT01431794|101350401|FG003|COMPLETED|Overall Study||0||
48415908|NCT01431794|101350402|FG004|COMPLETED|Overall Study||0||
48415909|NCT01431794|101350398|FG000|NOT COMPLETED|Overall Study||0||
48415910|NCT01431794|101350399|FG001|NOT COMPLETED|Overall Study||0||
48415911|NCT01431794|101350400|FG002|NOT COMPLETED|Overall Study||0||
48415912|NCT01431794|101350401|FG003|NOT COMPLETED|Overall Study||0||
48415913|NCT01431794|101350402|FG004|NOT COMPLETED|Overall Study||0||
48415914|NCT01526928|101350403|FG000|STARTED|Overall Study||38|Total|
48415915|NCT01526928|101350404|FG001|STARTED|Overall Study||19|Total|
48415916|NCT01526928|101350405|FG002|STARTED|Overall Study||209|Total|
48415917|NCT01526928|101350406|FG003|STARTED|Overall Study||245|Total|
48415918|NCT01526928|101350407|FG004|STARTED|Overall Study||95|Total|
48760499|NCT00129402|102200536|FG000|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0||
48186324|NCT01449929|100779780|FG002|NOT COMPLETED|Extension Phase Approximately 3 Years||8||
48186325|NCT01770860|100779781|FG000|STARTED|Overall Study||46||
48186326|NCT01770860|100779781|FG000|Randomization|Overall Study||45||
48186327|NCT01770860|100779781|FG000|COMPLETED|Overall Study||40||
48186328|NCT01770860|100779781|FG000|NOT COMPLETED|Overall Study||6||
48186329|NCT04668144|100779782|FG000|STARTED|Overall Study||25||
48186330|NCT04668144|100779783|FG001|STARTED|Overall Study||25||
48415919|NCT01526928|101350408|FG005|STARTED|Overall Study||6|Total|
48760500|NCT00129402|102200537|FG001|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0||
48760501|NCT00129402|102200538|FG002|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||8||
48760502|NCT00129402|102200539|FG003|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0||
48760503|NCT00129402|102200540|FG004|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0||
48760504|NCT00129402|102200541|FG005|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||5||
48760505|NCT00129402|102200542|FG006|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0||
48760506|NCT00129402|102200536|FG000|STARTED|Start Period3 to End Period3(Week 34-53)||0||
48760507|NCT00129402|102200537|FG001|STARTED|Start Period3 to End Period3(Week 34-53)||0||
48760508|NCT00129402|102200538|FG002|STARTED|Start Period3 to End Period3(Week 34-53)||0||
48760509|NCT00129402|102200539|FG003|STARTED|Start Period3 to End Period3(Week 34-53)||0||
48760510|NCT00129402|102200540|FG004|STARTED|Start Period3 to End Period3(Week 34-53)||0||
48760511|NCT00129402|102200541|FG005|STARTED|Start Period3 to End Period3(Week 34-53)||0||
48760512|NCT00129402|102200542|FG006|STARTED|Start Period3 to End Period3(Week 34-53)||228||
48760513|NCT00129402|102200536|FG000|COMPLETED|Start Period3 to End Period3(Week 34-53)||0||
48760514|NCT00129402|102200537|FG001|COMPLETED|Start Period3 to End Period3(Week 34-53)||0||
48415920|NCT01526928|101350403|FG000|Started Phase 1|Overall Study||38|Upon completion of Cycle 1, Phase 1 pts could participate in an optional Treatment-extension Period|
48415921|NCT01526928|101350404|FG001|Started Phase 1|Overall Study||19|Upon completion of Cycle 1, Phase 1 pts could participate in an optional Treatment-extension Period|
48415922|NCT01526928|101350405|FG002|Started Phase 1|Overall Study||18|Upon completion of Cycle 1, Phase 1 pts could participate in an optional Treatment-extension Period|
48415923|NCT01526928|101350406|FG003|Started Phase 1|Overall Study||17|Upon completion of Cycle 1, Phase 1 pts could participate in an optional Treatment-extension Period|
48415924|NCT01526928|101350407|FG004|Started Phase 1|Overall Study||13|Upon completion of Cycle 1, Phase 1 pts could participate in an optional Treatment-extension Period|
48415925|NCT01526928|101350408|FG005|Started Phase 1|Overall Study||6|Upon completion of Cycle 1, Phase 1 pts could participate in an optional Treatment-extension Period|
48415926|NCT01526928|101350403|FG000|Started Phase 2|Overall Study||0||
48415927|NCT01526928|101350404|FG001|Started Phase 2|Overall Study||0||
48415928|NCT01526928|101350405|FG002|Started Phase 2|Overall Study||191||
48415929|NCT01526928|101350406|FG003|Started Phase 2|Overall Study||228||
48415930|NCT01526928|101350407|FG004|Started Phase 2|Overall Study||82||
48415931|NCT01526928|101350408|FG005|Started Phase 2|Overall Study||0||
48415932|NCT01526928|101350403|FG000|COMPLETED|Overall Study||0||
48415933|NCT01526928|101350404|FG001|COMPLETED|Overall Study||0||
48415934|NCT01526928|101350405|FG002|COMPLETED|Overall Study||0||
48415935|NCT01526928|101350406|FG003|COMPLETED|Overall Study||0||
48415936|NCT01526928|101350407|FG004|COMPLETED|Overall Study||0||
48415937|NCT01526928|101350408|FG005|COMPLETED|Overall Study||0||
48415938|NCT01526928|101350403|FG000|NOT COMPLETED|Overall Study||38||
48415939|NCT01526928|101350404|FG001|NOT COMPLETED|Overall Study||19||
48415940|NCT01526928|101350405|FG002|NOT COMPLETED|Overall Study||209||
48415941|NCT01526928|101350406|FG003|NOT COMPLETED|Overall Study||245||
48415942|NCT01526928|101350407|FG004|NOT COMPLETED|Overall Study||95||
48415943|NCT01526928|101350408|FG005|NOT COMPLETED|Overall Study||6||
48415944|NCT02975206|101350409|FG000|STARTED|Overall Study||161||
48415945|NCT02975206|101350410|FG001|STARTED|Overall Study||161||
48415946|NCT02975206|101350411|FG002|STARTED|Overall Study||162||
48415947|NCT02975206|101350409|FG000|COMPLETED|Overall Study||134||
48415948|NCT02975206|101350410|FG001|COMPLETED|Overall Study||144||
48415949|NCT02975206|101350411|FG002|COMPLETED|Overall Study||145||
48415950|NCT02975206|101350409|FG000|NOT COMPLETED|Overall Study||27||
48415951|NCT02975206|101350410|FG001|NOT COMPLETED|Overall Study||17||
48415952|NCT02975206|101350411|FG002|NOT COMPLETED|Overall Study||17||
48415953|NCT04283773|101353284|FG000|STARTED|Overall Study||22||
48415954|NCT04283773|101353285|FG001|STARTED|Overall Study||20||
48415955|NCT04283773|101353286|FG002|STARTED|Overall Study||20||
48415956|NCT04283773|101353284|FG000|COMPLETED|Overall Study||22||
48415957|NCT04283773|101353285|FG001|COMPLETED|Overall Study||20||
48415958|NCT04283773|101353286|FG002|COMPLETED|Overall Study||20||
48415959|NCT04283773|101353284|FG000|NOT COMPLETED|Overall Study||0||
48415960|NCT04283773|101353285|FG001|NOT COMPLETED|Overall Study||0||
48415961|NCT04283773|101353286|FG002|NOT COMPLETED|Overall Study||0||
48415962|NCT01987609|101353287|FG000|STARTED|Overall Study||7||14
48415963|NCT01987609|101353287|FG000|Hylenex Injected in Arm|Overall Study||6||6
48415964|NCT01987609|101353287|FG000|Normal Saline Injected in Arm|Overall Study||6||6
48415965|NCT01987609|101353287|FG000|COMPLETED|Overall Study||6||12
48415966|NCT01987609|101353287|FG000|NOT COMPLETED|Overall Study||1||2
48415967|NCT03267511|101353288|FG000|STARTED|Overall Study||31||
48415968|NCT03267511|101353289|FG001|STARTED|Overall Study||31||
48415969|NCT03267511|101353290|FG002|STARTED|Overall Study||30||
48415970|NCT03267511|101353291|FG003|STARTED|Overall Study||31||
48415971|NCT03267511|101353288|FG000|COMPLETED|Overall Study||31||
48637245|NCT00071981|101898514|FG002|Have Helper T Cell Response Data|Overall Study||25||
48637246|NCT00071981|101898515|FG003|Have Helper T Cell Response Data|Overall Study||39||
48637247|NCT00071981|101898512|FG000|COMPLETED|Overall Study||1||
48637248|NCT00071981|101898513|FG001|COMPLETED|Overall Study||2||
48637249|NCT00071981|101898514|FG002|COMPLETED|Overall Study||0||
48637250|NCT00071981|101898515|FG003|COMPLETED|Overall Study||3||
48415972|NCT03267511|101353289|FG001|COMPLETED|Overall Study||31||
48415973|NCT03267511|101353290|FG002|COMPLETED|Overall Study||30||
48415974|NCT03267511|101353291|FG003|COMPLETED|Overall Study||30||
48415975|NCT03267511|101353288|FG000|NOT COMPLETED|Overall Study||0||
48415976|NCT03267511|101353289|FG001|NOT COMPLETED|Overall Study||0||
48415977|NCT03267511|101353290|FG002|NOT COMPLETED|Overall Study||0||
48415978|NCT03267511|101353291|FG003|NOT COMPLETED|Overall Study||1||
48415979|NCT01878786|101353292|FG000|STARTED|Overall Study||9||
48637251|NCT00071981|101898512|FG000|NOT COMPLETED|Overall Study||46||
48637252|NCT00071981|101898513|FG001|NOT COMPLETED|Overall Study||41||
48637253|NCT00071981|101898514|FG002|NOT COMPLETED|Overall Study||37||
48637254|NCT00071981|101898515|FG003|NOT COMPLETED|Overall Study||45||
48637255|NCT01551173|101898516|FG000|STARTED|Overall Study||218||
48415980|NCT01878786|101353293|FG001|STARTED|Overall Study||9||
48415981|NCT01878786|101353294|FG002|STARTED|Overall Study||7||
48415982|NCT01878786|101353292|FG000|COMPLETED|Overall Study||0||
48415983|NCT01878786|101353293|FG001|COMPLETED|Overall Study||0||
48637256|NCT01551173|101898517|FG001|STARTED|Overall Study||218||
48637257|NCT01551173|101898516|FG000|Full Analysis Set (FAS)|Overall Study||210||
48348283|NCT04025632|101183965|FG000|Completed Main Portion Safety Follow-up|Overall Study||0|Refers to study participants who completed the 8-week blinded treatment period in the Main Portion of the study and had not entered the Extension Portion.|
48348284|NCT04025632|101183966|FG001|Completed Main Portion Safety Follow-up|Overall Study||0|Refers to study participants who completed the 8-week blinded treatment period in the Main Portion of the study and had not entered the Extension Portion.|
48348285|NCT04025632|101183965|FG000|Started Extension Portion|Overall Study||13||
48348286|NCT04025632|101183966|FG001|Started Extension Portion|Overall Study||12||
48348287|NCT04025632|101183965|FG000|COMPLETED|Overall Study||0|Completed Main Portion, Main Portion Safety Follow-up or Extension Portion.|
48348288|NCT04025632|101183966|FG001|COMPLETED|Overall Study||0|Completed Main Portion, Main Portion Safety Follow-up or Extension Portion.|
48348289|NCT04025632|101183965|FG000|NOT COMPLETED|Overall Study||15||
48348290|NCT04025632|101183966|FG001|NOT COMPLETED|Overall Study||12||
48348291|NCT01491178|101183967|FG000|STARTED|Overall Study||6443||
48348292|NCT01491178|101183967|FG000|COMPLETED|Overall Study||3649||
48348293|NCT01491178|101183967|FG000|NOT COMPLETED|Overall Study||2794||
48348294|NCT00087438|101183968|FG000|STARTED|Overall Study||59||
48348295|NCT00087438|101183968|FG000|COMPLETED|Overall Study||55||
48348296|NCT00087438|101183968|FG000|NOT COMPLETED|Overall Study||4||
48348297|NCT01602731|101183969|FG000|STARTED|Overall Study||45||
48348298|NCT01602731|101183969|FG000|Cognitive Impairment|Overall Study||44||
48348299|NCT01602731|101183969|FG000|Poor Medication Adherence|Overall Study||24||
48348300|NCT01602731|101183969|FG000|COMPLETED|Overall Study||15||
48348301|NCT01602731|101183969|FG000|NOT COMPLETED|Overall Study||30||
48348302|NCT00673595|101183970|FG000|STARTED|Overall Study||8||
48348303|NCT00673595|101183971|FG001|STARTED|Overall Study||11||
48348304|NCT00673595|101183970|FG000|COMPLETED|Overall Study||8||
48348305|NCT00673595|101183971|FG001|COMPLETED|Overall Study||11||
48348306|NCT00673595|101183970|FG000|NOT COMPLETED|Overall Study||0||
48348307|NCT00673595|101183971|FG001|NOT COMPLETED|Overall Study||0||
48348308|NCT02115308|101183972|FG000|STARTED|Overall Study||15|03SEPT2014|
48348309|NCT02115308|101183973|FG001|STARTED|Overall Study||25|03SEPT2014|
48348310|NCT02115308|101183972|FG000|COMPLETED|Overall Study||13|16JAN2018|
48348311|NCT02115308|101183973|FG001|COMPLETED|Overall Study||23|16JAN2018|
48348312|NCT02115308|101183972|FG000|NOT COMPLETED|Overall Study||2||
48415984|NCT01878786|101353294|FG002|COMPLETED|Overall Study||0||
48415985|NCT01878786|101353292|FG000|NOT COMPLETED|Overall Study||9||
48348313|NCT02115308|101183973|FG001|NOT COMPLETED|Overall Study||2||
48348314|NCT00749203|101183974|FG000|STARTED|First Infusion Day 1||22||
48348315|NCT00749203|101183975|FG001|STARTED|First Infusion Day 1||19||
48348316|NCT00749203|101183974|FG000|COMPLETED|First Infusion Day 1||22||
48348317|NCT00749203|101183975|FG001|COMPLETED|First Infusion Day 1||19||
48348318|NCT00749203|101183974|FG000|NOT COMPLETED|First Infusion Day 1||0||
48348319|NCT00749203|101183975|FG001|NOT COMPLETED|First Infusion Day 1||0||
48348320|NCT00749203|101183974|FG000|STARTED|no Infusion at Week 1||22||
48348321|NCT00749203|101183975|FG001|STARTED|no Infusion at Week 1||19||
48348322|NCT00749203|101183974|FG000|COMPLETED|no Infusion at Week 1||22||
48348323|NCT00749203|101183975|FG001|COMPLETED|no Infusion at Week 1||15||
48348324|NCT00749203|101183974|FG000|NOT COMPLETED|no Infusion at Week 1||0||
48348325|NCT00749203|101183975|FG001|NOT COMPLETED|no Infusion at Week 1||4||
48348326|NCT00749203|101183974|FG000|STARTED|Second Infusion at 2 Weeks||16||
48348327|NCT00749203|101183975|FG001|STARTED|Second Infusion at 2 Weeks||15||
48348328|NCT00749203|101183974|FG000|COMPLETED|Second Infusion at 2 Weeks||16||
48348329|NCT00749203|101183975|FG001|COMPLETED|Second Infusion at 2 Weeks||13||
48348330|NCT00749203|101183974|FG000|NOT COMPLETED|Second Infusion at 2 Weeks||0||
48348331|NCT00749203|101183975|FG001|NOT COMPLETED|Second Infusion at 2 Weeks||2||
48348332|NCT02185521|101183976|FG000|STARTED|Overall Study||127||
48348333|NCT02185521|101183976|FG000|COMPLETED|Overall Study||125||
48348334|NCT02185521|101183976|FG000|NOT COMPLETED|Overall Study||2||
48348335|NCT01322815|101183977|FG000|STARTED|Overall Study||7||
48415986|NCT01878786|101353293|FG001|NOT COMPLETED|Overall Study||9||
48415987|NCT01878786|101353294|FG002|NOT COMPLETED|Overall Study||7||
48415988|NCT00626795|101353295|FG000|STARTED|Open-label TD1414 Cream TID Treatment||0||
48760515|NCT00129402|102200538|FG002|COMPLETED|Start Period3 to End Period3(Week 34-53)||0||
48760516|NCT00129402|102200539|FG003|COMPLETED|Start Period3 to End Period3(Week 34-53)||0||
48760517|NCT00129402|102200540|FG004|COMPLETED|Start Period3 to End Period3(Week 34-53)||0||
48760518|NCT00129402|102200541|FG005|COMPLETED|Start Period3 to End Period3(Week 34-53)||0||
48760519|NCT00129402|102200542|FG006|COMPLETED|Start Period3 to End Period3(Week 34-53)||222||
48760520|NCT00129402|102200536|FG000|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0||
48760521|NCT00129402|102200537|FG001|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0||
48760522|NCT00129402|102200538|FG002|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0||
48760523|NCT00129402|102200539|FG003|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0||
48760524|NCT00129402|102200540|FG004|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0||
48760525|NCT00129402|102200541|FG005|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0||
48760526|NCT00129402|102200542|FG006|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||6||
48760527|NCT01149096|102200543|FG000|STARTED|Overall Study||6||
48760528|NCT01149096|102200544|FG001|STARTED|Overall Study||7||
48760529|NCT01149096|102200543|FG000|COMPLETED|Overall Study||6||
48760530|NCT01149096|102200544|FG001|COMPLETED|Overall Study||6||
48760531|NCT01149096|102200543|FG000|NOT COMPLETED|Overall Study||0||
48760532|NCT01149096|102200544|FG001|NOT COMPLETED|Overall Study||1||
48760533|NCT00965354|102200545|FG000|STARTED|Overall Study||131||
48760534|NCT00965354|102200545|FG000|COMPLETED|Overall Study||131||
48760535|NCT00965354|102200545|FG000|NOT COMPLETED|Overall Study||0||
48760536|NCT03204188|102200546|FG000|STARTED|Conditioning Phase (12 Weeks)||15||
48760537|NCT03204188|102200546|FG000|COMPLETED|Conditioning Phase (12 Weeks)||15||
48760538|NCT03204188|102200546|FG000|NOT COMPLETED|Conditioning Phase (12 Weeks)||0||
48760539|NCT03204188|102200546|FG000|STARTED|Immunotherapy Phase (1 Year)||15||
48760540|NCT03204188|102200546|FG000|COMPLETED|Immunotherapy Phase (1 Year)||10||
48760541|NCT03204188|102200546|FG000|NOT COMPLETED|Immunotherapy Phase (1 Year)||5||
48760542|NCT03204188|102200546|FG000|STARTED|Follow-up Phase (Extension Study)||10||
48760543|NCT03204188|102200546|FG000|COMPLETED|Follow-up Phase (Extension Study)||4||
48760544|NCT03204188|102200546|FG000|NOT COMPLETED|Follow-up Phase (Extension Study)||6||
48760545|NCT02968134|102200547|FG000|STARTED|Overall Study||8||
48760546|NCT02968134|102200547|FG000|COMPLETED|Overall Study||8||
48760547|NCT02968134|102200547|FG000|NOT COMPLETED|Overall Study||0||
48760548|NCT04408989|102200548|FG000|STARTED|Overall Study||37||
48760549|NCT04408989|102200549|FG001|STARTED|Overall Study||39||
48760550|NCT04408989|102200550|FG002|STARTED|Overall Study||38||
48760551|NCT04408989|102200548|FG000|COMPLETED|Overall Study||37||
48760552|NCT04408989|102200549|FG001|COMPLETED|Overall Study||39||
48760553|NCT04408989|102200550|FG002|COMPLETED|Overall Study||35||
48760554|NCT04408989|102200548|FG000|NOT COMPLETED|Overall Study||0||
48760555|NCT04408989|102200549|FG001|NOT COMPLETED|Overall Study||0||
48760556|NCT04408989|102200550|FG002|NOT COMPLETED|Overall Study||3||
48760557|NCT03361137|102200551|FG000|STARTED|Overall Study||1||
48760558|NCT03361137|102200552|FG001|STARTED|Overall Study||9||
48760559|NCT03361137|102200553|FG002|STARTED|Overall Study||1||
48760560|NCT03361137|102200554|FG003|STARTED|Overall Study||2||
48348336|NCT01322815|101183978|FG001|STARTED|Overall Study||4||
48348337|NCT01322815|101183977|FG000|COMPLETED|Overall Study||7||
48760561|NCT03361137|102200555|FG004|STARTED|Overall Study||1||
48348338|NCT01322815|101183978|FG001|COMPLETED|Overall Study||4||
48348339|NCT01322815|101183977|FG000|NOT COMPLETED|Overall Study||0||
48348340|NCT01322815|101183978|FG001|NOT COMPLETED|Overall Study||0||
48348341|NCT00104871|101183979|FG000|STARTED|Overall Study||22||
48415989|NCT00626795|101353296|FG001|STARTED|Open-label TD1414 Cream TID Treatment||65||
48415990|NCT00626795|101353297|FG002|STARTED|Open-label TD1414 Cream TID Treatment||0||
48415991|NCT00626795|101353295|FG000|COMPLETED|Open-label TD1414 Cream TID Treatment||0||
48348342|NCT00104871|101183979|FG000|COMPLETED|Overall Study||21||
48348343|NCT00104871|101183979|FG000|NOT COMPLETED|Overall Study||1||
48348344|NCT02625402|101183980|FG000|STARTED|Overall Study||42||
48348345|NCT02625402|101183981|FG001|STARTED|Overall Study||37||
48348346|NCT02625402|101183980|FG000|COMPLETED|Overall Study||33||
48348347|NCT02625402|101183981|FG001|COMPLETED|Overall Study||25||
48348348|NCT02625402|101183980|FG000|NOT COMPLETED|Overall Study||9||
48348349|NCT02625402|101183981|FG001|NOT COMPLETED|Overall Study||12||
48348350|NCT03040154|101183982|FG000|STARTED|Overall Study||110||
48348351|NCT03040154|101183983|FG001|STARTED|Overall Study||105||
48348352|NCT03040154|101183982|FG000|COMPLETED|Overall Study||110||
48348353|NCT03040154|101183983|FG001|COMPLETED|Overall Study||105||
48348354|NCT03040154|101183982|FG000|NOT COMPLETED|Overall Study||0||
48348355|NCT03040154|101183983|FG001|NOT COMPLETED|Overall Study||0||
48348356|NCT00682630|101183984|FG000|STARTED|First Intervention (Day 0)||21||
48348357|NCT00682630|101183985|FG001|STARTED|First Intervention (Day 0)||21||
48348358|NCT00682630|101183984|FG000|COMPLETED|First Intervention (Day 0)||20||
48348359|NCT00682630|101183985|FG001|COMPLETED|First Intervention (Day 0)||21||
48348360|NCT00682630|101183984|FG000|NOT COMPLETED|First Intervention (Day 0)||1||
48348361|NCT00682630|101183985|FG001|NOT COMPLETED|First Intervention (Day 0)||0||
48348362|NCT00682630|101183984|FG000|STARTED|Washout (43 Days)||20||
48348363|NCT00682630|101183985|FG001|STARTED|Washout (43 Days)||21||
48348364|NCT00682630|101183984|FG000|COMPLETED|Washout (43 Days)||18||
48348365|NCT00682630|101183985|FG001|COMPLETED|Washout (43 Days)||19||
48348366|NCT00682630|101183984|FG000|NOT COMPLETED|Washout (43 Days)||2||
48348367|NCT00682630|101183985|FG001|NOT COMPLETED|Washout (43 Days)||2||
48348368|NCT00682630|101183984|FG000|STARTED|Second Intervention (Day 43)||18||
48348369|NCT00682630|101183985|FG001|STARTED|Second Intervention (Day 43)||19||
48348370|NCT00682630|101183984|FG000|COMPLETED|Second Intervention (Day 43)||18||
48348371|NCT00682630|101183985|FG001|COMPLETED|Second Intervention (Day 43)||19||
48348372|NCT00682630|101183984|FG000|NOT COMPLETED|Second Intervention (Day 43)||0||
48348373|NCT00682630|101183985|FG001|NOT COMPLETED|Second Intervention (Day 43)||0||
48348374|NCT00682630|101183984|FG000|STARTED|Follow-up (42 Days)||18||
48348375|NCT00682630|101183985|FG001|STARTED|Follow-up (42 Days)||19||
48348376|NCT00682630|101183984|FG000|COMPLETED|Follow-up (42 Days)||18||
48348377|NCT00682630|101183985|FG001|COMPLETED|Follow-up (42 Days)||19||
48348378|NCT00682630|101183984|FG000|NOT COMPLETED|Follow-up (42 Days)||0||
48348379|NCT00682630|101183985|FG001|NOT COMPLETED|Follow-up (42 Days)||0||
48348380|NCT00807664|101183986|FG000|STARTED|Overall Study||88||
48348381|NCT00807664|101183987|FG001|STARTED|Overall Study||94||
48348382|NCT00807664|101183986|FG000|COMPLETED|Overall Study||77||
48348383|NCT00807664|101183987|FG001|COMPLETED|Overall Study||75||
48348384|NCT00807664|101183986|FG000|NOT COMPLETED|Overall Study||11||
48348385|NCT00807664|101183987|FG001|NOT COMPLETED|Overall Study||19||
48348386|NCT04125680|101183988|FG000|STARTED|Overall Study||17||
48348387|NCT04125680|101183988|FG000|COMPLETED|Overall Study||2||
48348388|NCT04125680|101183988|FG000|NOT COMPLETED|Overall Study||15||
48348389|NCT02828267|101183989|FG000|STARTED|Overall Study||10||
48348390|NCT02828267|101183990|FG001|STARTED|Overall Study||21||
48348391|NCT02828267|101183991|FG002|STARTED|Overall Study||24||
48348392|NCT02828267|101183992|FG003|STARTED|Overall Study||20||
48348393|NCT02828267|101183989|FG000|COMPLETED|Overall Study||10||
48348394|NCT02828267|101183990|FG001|COMPLETED|Overall Study||21||
48348395|NCT02828267|101183991|FG002|COMPLETED|Overall Study||24||
48348396|NCT02828267|101183992|FG003|COMPLETED|Overall Study||20||
48348397|NCT02828267|101183989|FG000|NOT COMPLETED|Overall Study||0||
48348398|NCT02828267|101183990|FG001|NOT COMPLETED|Overall Study||0||
48415992|NCT00626795|101353296|FG001|COMPLETED|Open-label TD1414 Cream TID Treatment||64||
48415993|NCT00626795|101353297|FG002|COMPLETED|Open-label TD1414 Cream TID Treatment||0||
48415994|NCT00626795|101353295|FG000|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||0||
48415995|NCT00626795|101353296|FG001|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||1||
48348399|NCT02828267|101183991|FG002|NOT COMPLETED|Overall Study||0||
48348400|NCT02828267|101183992|FG003|NOT COMPLETED|Overall Study||0||
48348401|NCT01287104|101183993|FG000|STARTED|Overall Study||4||
48348402|NCT01287104|101183994|FG001|STARTED|Overall Study||7||
48348403|NCT01287104|101183995|FG002|STARTED|Overall Study||12||
48348404|NCT01287104|101183996|FG003|STARTED|Overall Study||11||
48348405|NCT01287104|101183993|FG000|COMPLETED|Overall Study||3||
48348406|NCT01287104|101183994|FG001|COMPLETED|Overall Study||2||
48348407|NCT01287104|101183995|FG002|COMPLETED|Overall Study||5||
48348408|NCT01287104|101183996|FG003|COMPLETED|Overall Study||8||
48348409|NCT01287104|101183993|FG000|NOT COMPLETED|Overall Study||1||
48348410|NCT01287104|101183994|FG001|NOT COMPLETED|Overall Study||5||
48348411|NCT01287104|101183995|FG002|NOT COMPLETED|Overall Study||7||
48348412|NCT01287104|101183996|FG003|NOT COMPLETED|Overall Study||3||
48348413|NCT01573442|101183997|FG000|STARTED|Overall Study||113||
48348414|NCT01573442|101183998|FG001|STARTED|Overall Study||114||
48348415|NCT01573442|101183997|FG000|COMPLETED|Overall Study||104||
48348416|NCT01573442|101183998|FG001|COMPLETED|Overall Study||104||
48415996|NCT00626795|101353297|FG002|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||0||
48415997|NCT00626795|101353295|FG000|STARTED|Blinded Treatment||204||
48415998|NCT00626795|101353296|FG001|STARTED|Blinded Treatment||205||
48415999|NCT00626795|101353297|FG002|STARTED|Blinded Treatment||205||
48416000|NCT00626795|101353295|FG000|COMPLETED|Blinded Treatment||194||
48637258|NCT01551173|101898517|FG001|Full Analysis Set (FAS)|Overall Study||214||
48637259|NCT01551173|101898516|FG000|COMPLETED|Overall Study||190||
48637260|NCT01551173|101898517|FG001|COMPLETED|Overall Study||186||
48637261|NCT01551173|101898516|FG000|NOT COMPLETED|Overall Study||28||
48637262|NCT01551173|101898517|FG001|NOT COMPLETED|Overall Study||32||
48637263|NCT00143507|101898518|FG000|STARTED|Overall Study||5479||
48637264|NCT00143507|101898519|FG001|STARTED|Overall Study||5438||
48637265|NCT00143507|101898518|FG000|COMPLETED|Overall Study||4792||
48637266|NCT00143507|101898519|FG001|COMPLETED|Overall Study||4786||
48416001|NCT00626795|101353296|FG001|COMPLETED|Blinded Treatment||200||
48416002|NCT00626795|101353297|FG002|COMPLETED|Blinded Treatment||196||
48637267|NCT00143507|101898518|FG000|NOT COMPLETED|Overall Study||687||
48637268|NCT00143507|101898519|FG001|NOT COMPLETED|Overall Study||652||
48637269|NCT02017717|101898520|FG000|STARTED|Before Treatment Period||10||
48637270|NCT02017717|101898521|FG001|STARTED|Before Treatment Period||10||
48637271|NCT02017717|101898522|FG002|STARTED|Before Treatment Period||20||
48637272|NCT02017717|101898523|FG003|STARTED|Before Treatment Period||184||
48637273|NCT02017717|101898524|FG004|STARTED|Before Treatment Period||185||
48637274|NCT02017717|101898525|FG005|STARTED|Before Treatment Period||31||
48637275|NCT02017717|101898526|FG006|STARTED|Before Treatment Period||30||
48637276|NCT02017717|101898527|FG007|STARTED|Before Treatment Period||29||
48637277|NCT02017717|101898528|FG008|STARTED|Before Treatment Period||30||
48637278|NCT02017717|101898520|FG000|Randomized|Before Treatment Period||10||
48637279|NCT02017717|101898521|FG001|Randomized|Before Treatment Period||10||
48637280|NCT02017717|101898522|FG002|Randomized|Before Treatment Period||0||
48637281|NCT02017717|101898523|FG003|Randomized|Before Treatment Period||184||
48416003|NCT00626795|101353295|FG000|NOT COMPLETED|Blinded Treatment||10||
48416004|NCT00626795|101353296|FG001|NOT COMPLETED|Blinded Treatment||5||
48416005|NCT00626795|101353297|FG002|NOT COMPLETED|Blinded Treatment||9||
48416006|NCT01599585|101353298|FG000|STARTED|Overall Study||62||
48416007|NCT01599585|101353299|FG001|STARTED|Overall Study||59||
48416008|NCT01599585|101353298|FG000|COMPLETED|Overall Study||40||
48416009|NCT01599585|101353299|FG001|COMPLETED|Overall Study||42||
48637282|NCT02017717|101898524|FG004|Randomized|Before Treatment Period||185||
48637283|NCT02017717|101898525|FG005|Randomized|Before Treatment Period||0||
48637284|NCT02017717|101898526|FG006|Randomized|Before Treatment Period||0||
48637285|NCT02017717|101898527|FG007|Randomized|Before Treatment Period||29||
48637286|NCT02017717|101898528|FG008|Randomized|Before Treatment Period||30||
48637287|NCT02017717|101898520|FG000|COMPLETED|Before Treatment Period||10|Completed = Moved to treatment period|
48637288|NCT02017717|101898521|FG001|COMPLETED|Before Treatment Period||10|Completed = Moved to treatment period|
48637289|NCT02017717|101898522|FG002|COMPLETED|Before Treatment Period||20|Completed = Moved to treatment period|
48637290|NCT02017717|101898523|FG003|COMPLETED|Before Treatment Period||182|Completed = Moved to treatment period|
48637291|NCT02017717|101898524|FG004|COMPLETED|Before Treatment Period||165|Completed = Moved to treatment period|
48657030|NCT02018809|101943753|FG000|COMPLETED|Overall Study||50||
48416010|NCT01599585|101353298|FG000|NOT COMPLETED|Overall Study||22||
48416011|NCT01599585|101353299|FG001|NOT COMPLETED|Overall Study||17||
48416012|NCT02802735|101353300|FG000|STARTED|Overall Study||4||
48416013|NCT02802735|101353301|FG001|STARTED|Overall Study||4||
48416014|NCT02802735|101353302|FG002|STARTED|Overall Study||4||
48416015|NCT02802735|101353303|FG003|STARTED|Overall Study||12||
48416016|NCT02802735|101353304|FG004|STARTED|Overall Study||4||
48637292|NCT02017717|101898525|FG005|COMPLETED|Before Treatment Period||31|Completed = Moved to treatment period|
48637293|NCT02017717|101898526|FG006|COMPLETED|Before Treatment Period||30|Completed = Moved to treatment period|
48637294|NCT02017717|101898527|FG007|COMPLETED|Before Treatment Period||28|Completed = Moved to treatment period|
48637295|NCT02017717|101898528|FG008|COMPLETED|Before Treatment Period||28|Completed = Moved to treatment period|
48637296|NCT02017717|101898520|FG000|NOT COMPLETED|Before Treatment Period||0||
48637297|NCT02017717|101898521|FG001|NOT COMPLETED|Before Treatment Period||0||
48637298|NCT02017717|101898522|FG002|NOT COMPLETED|Before Treatment Period||0||
48637299|NCT02017717|101898523|FG003|NOT COMPLETED|Before Treatment Period||2||
48637300|NCT02017717|101898524|FG004|NOT COMPLETED|Before Treatment Period||20||
48760562|NCT03361137|102200551|FG000|COMPLETED|Overall Study||0||
48760563|NCT03361137|102200552|FG001|COMPLETED|Overall Study||9||
48760564|NCT03361137|102200553|FG002|COMPLETED|Overall Study||1||
48760565|NCT03361137|102200554|FG003|COMPLETED|Overall Study||2||
48760566|NCT03361137|102200555|FG004|COMPLETED|Overall Study||1||
48760567|NCT03361137|102200551|FG000|NOT COMPLETED|Overall Study||1||
48760568|NCT03361137|102200552|FG001|NOT COMPLETED|Overall Study||0||
48760569|NCT03361137|102200553|FG002|NOT COMPLETED|Overall Study||0||
48760570|NCT03361137|102200554|FG003|NOT COMPLETED|Overall Study||0||
48760571|NCT03361137|102200555|FG004|NOT COMPLETED|Overall Study||0||
48760572|NCT03389477|102200556|FG000|STARTED|Step 1||19||
48760573|NCT03389477|102200557|FG001|STARTED|Step 1||7||
48760574|NCT03389477|102200556|FG000|COMPLETED|Step 1||18||
48760575|NCT03389477|102200557|FG001|COMPLETED|Step 1||7||
48760576|NCT03389477|102200556|FG000|NOT COMPLETED|Step 1||1||
48760577|NCT03389477|102200557|FG001|NOT COMPLETED|Step 1||0||
48760578|NCT03389477|102200556|FG000|STARTED|Step 2||18||
48760579|NCT03389477|102200557|FG001|STARTED|Step 2||7||
48760580|NCT03389477|102200556|FG000|COMPLETED|Step 2||16||
48760581|NCT03389477|102200557|FG001|COMPLETED|Step 2||3||
48760582|NCT03389477|102200556|FG000|NOT COMPLETED|Step 2||2||
48760583|NCT03389477|102200557|FG001|NOT COMPLETED|Step 2||4||
48760584|NCT03389477|102200556|FG000|STARTED|Step 3||16||
48760585|NCT03389477|102200557|FG001|STARTED|Step 3||3||
48760586|NCT03389477|102200556|FG000|COMPLETED|Step 3||11||
48760587|NCT03389477|102200557|FG001|COMPLETED|Step 3||2||
48760588|NCT03389477|102200556|FG000|NOT COMPLETED|Step 3||5||
48760589|NCT03389477|102200557|FG001|NOT COMPLETED|Step 3||1||
48348417|NCT01573442|101183997|FG000|NOT COMPLETED|Overall Study||9||
48348418|NCT01573442|101183998|FG001|NOT COMPLETED|Overall Study||10||
48348419|NCT04574999|101183999|FG000|STARTED|Overall Study||114||
48348420|NCT04574999|101184000|FG001|STARTED|Overall Study||53||
48348421|NCT04574999|101183999|FG000|COMPLETED|Overall Study||105||
48348422|NCT04574999|101184000|FG001|COMPLETED|Overall Study||48||
48348423|NCT04574999|101183999|FG000|NOT COMPLETED|Overall Study||9||
48348424|NCT04574999|101184000|FG001|NOT COMPLETED|Overall Study||5||
48348425|NCT03133767|101184001|FG000|STARTED|Overall Study||79||
48348426|NCT03133767|101184002|FG001|STARTED|Overall Study||78||
48348427|NCT03133767|101184001|FG000|COMPLETED|Overall Study||41||
48348428|NCT03133767|101184002|FG001|COMPLETED|Overall Study||53||
48348429|NCT03133767|101184001|FG000|NOT COMPLETED|Overall Study||38||
48348430|NCT03133767|101184002|FG001|NOT COMPLETED|Overall Study||25||
48348431|NCT00345605|101184003|FG000|STARTED|Initial Washout||6||
48348432|NCT00345605|101184004|FG001|STARTED|Initial Washout||6||
48348433|NCT00345605|101184003|FG000|COMPLETED|Initial Washout||6||
48348434|NCT00345605|101184004|FG001|COMPLETED|Initial Washout||6||
48348435|NCT00345605|101184003|FG000|NOT COMPLETED|Initial Washout||0||
48348436|NCT00345605|101184004|FG001|NOT COMPLETED|Initial Washout||0||
48348437|NCT00345605|101184003|FG000|STARTED|Arm 1||6||
48348438|NCT00345605|101184004|FG001|STARTED|Arm 1||6||
48348439|NCT00345605|101184003|FG000|COMPLETED|Arm 1||6||
48348440|NCT00345605|101184004|FG001|COMPLETED|Arm 1||5||
48348441|NCT00345605|101184003|FG000|NOT COMPLETED|Arm 1||0||
48348442|NCT00345605|101184004|FG001|NOT COMPLETED|Arm 1||1||
48348443|NCT00345605|101184003|FG000|STARTED|Interval||6||
48348444|NCT00345605|101184004|FG001|STARTED|Interval||6||
48348445|NCT00345605|101184003|FG000|COMPLETED|Interval||6||
48348446|NCT00345605|101184004|FG001|COMPLETED|Interval||6||
48348447|NCT00345605|101184003|FG000|NOT COMPLETED|Interval||0||
48348448|NCT00345605|101184004|FG001|NOT COMPLETED|Interval||0||
48348449|NCT00345605|101184003|FG000|STARTED|Crossover Wash-out||6||
48760590|NCT02741128|102200558|FG000|STARTED|Overall Study||89||
48760591|NCT02741128|102200559|FG001|STARTED|Overall Study||44||
48348450|NCT00345605|101184004|FG001|STARTED|Crossover Wash-out||6||
48348451|NCT00345605|101184003|FG000|COMPLETED|Crossover Wash-out||6||
48348452|NCT00345605|101184004|FG001|COMPLETED|Crossover Wash-out||6||
48348453|NCT00345605|101184003|FG000|NOT COMPLETED|Crossover Wash-out||0||
48348454|NCT00345605|101184004|FG001|NOT COMPLETED|Crossover Wash-out||0||
48348455|NCT00345605|101184003|FG000|STARTED|Arm 2, Opposite Treatment||6||
48348456|NCT00345605|101184004|FG001|STARTED|Arm 2, Opposite Treatment||6||
48760592|NCT02741128|102200558|FG000|Vaccinated|Overall Study||88||
48637301|NCT02017717|101898525|FG005|NOT COMPLETED|Before Treatment Period||0||
48637302|NCT02017717|101898526|FG006|NOT COMPLETED|Before Treatment Period||0||
48637303|NCT02017717|101898527|FG007|NOT COMPLETED|Before Treatment Period||1||
48637304|NCT02017717|101898528|FG008|NOT COMPLETED|Before Treatment Period||2||
48637305|NCT02017717|101898520|FG000|STARTED|Treatment Period||10|Started = Treated|
48637306|NCT02017717|101898521|FG001|STARTED|Treatment Period||10|Started = Treated|
48637307|NCT02017717|101898522|FG002|STARTED|Treatment Period||20|Started = Treated|
48637308|NCT02017717|101898523|FG003|STARTED|Treatment Period||182|Started = Treated|
48637309|NCT02017717|101898524|FG004|STARTED|Treatment Period||165|Started = Treated|
48637310|NCT02017717|101898525|FG005|STARTED|Treatment Period||31|Started = Treated|
48637311|NCT02017717|101898526|FG006|STARTED|Treatment Period||30|Started = Treated|
48637312|NCT02017717|101898527|FG007|STARTED|Treatment Period||28|Started = Treated|
48637313|NCT02017717|101898528|FG008|STARTED|Treatment Period||28|Started = Treated|
48637314|NCT02017717|101898520|FG000|COMPLETED|Treatment Period||0|Completed = Continuing in the treatment period|
48637315|NCT02017717|101898521|FG001|COMPLETED|Treatment Period||1|Completed = Continuing in the treatment period|
48637316|NCT02017717|101898522|FG002|COMPLETED|Treatment Period||0|Completed = Continuing in the treatment period|
48637317|NCT02017717|101898523|FG003|COMPLETED|Treatment Period||1|Completed = Continuing in the treatment period|
48637318|NCT02017717|101898524|FG004|COMPLETED|Treatment Period||1|Completed = Continuing in the treatment period|
48637319|NCT02017717|101898525|FG005|COMPLETED|Treatment Period||2|Completed = Continuing in the treatment period|
48637320|NCT02017717|101898526|FG006|COMPLETED|Treatment Period||0|Completed = Continuing in the treatment period|
48637321|NCT02017717|101898527|FG007|COMPLETED|Treatment Period||0|Completed = Continuing in the treatment period|
48637322|NCT02017717|101898528|FG008|COMPLETED|Treatment Period||0|Completed = Continuing in the treatment period|
48637323|NCT02017717|101898520|FG000|NOT COMPLETED|Treatment Period||10||
48637324|NCT02017717|101898521|FG001|NOT COMPLETED|Treatment Period||9||
48637325|NCT02017717|101898522|FG002|NOT COMPLETED|Treatment Period||20||
48637326|NCT02017717|101898523|FG003|NOT COMPLETED|Treatment Period||181||
48637327|NCT02017717|101898524|FG004|NOT COMPLETED|Treatment Period||164||
48637328|NCT02017717|101898525|FG005|NOT COMPLETED|Treatment Period||29||
48637329|NCT02017717|101898526|FG006|NOT COMPLETED|Treatment Period||30||
48637330|NCT02017717|101898527|FG007|NOT COMPLETED|Treatment Period||28||
48637331|NCT02017717|101898528|FG008|NOT COMPLETED|Treatment Period||28||
48637332|NCT03977818|101898529|FG000|STARTED|Overall Study||2165||
48637333|NCT03977818|101898529|FG000|COMPLETED|Overall Study||2165||
48637334|NCT03977818|101898529|FG000|NOT COMPLETED|Overall Study||0||
48637335|NCT01856933|101898530|FG000|STARTED|Overall Study||6||
48637336|NCT01856933|101898530|FG000|COMPLETED|Overall Study||6||
48637337|NCT01856933|101898530|FG000|NOT COMPLETED|Overall Study||0||
48637338|NCT03370302|101898531|FG000|STARTED|Dose Escalation Phase||3||
48637339|NCT03370302|101898532|FG001|STARTED|Dose Escalation Phase||6||
48637340|NCT03370302|101898533|FG002|STARTED|Dose Escalation Phase||7||
48637341|NCT03370302|101898534|FG003|STARTED|Dose Escalation Phase||0||
48637342|NCT03370302|101898535|FG004|STARTED|Dose Escalation Phase||3||
48637343|NCT03370302|101898536|FG005|STARTED|Dose Escalation Phase||3||
48637344|NCT03370302|101898531|FG000|COMPLETED|Dose Escalation Phase||0||
48637345|NCT03370302|101898532|FG001|COMPLETED|Dose Escalation Phase||0||
48637346|NCT03370302|101898533|FG002|COMPLETED|Dose Escalation Phase||0||
48637347|NCT03370302|101898534|FG003|COMPLETED|Dose Escalation Phase||0||
48637348|NCT03370302|101898535|FG004|COMPLETED|Dose Escalation Phase||0||
48637349|NCT03370302|101898536|FG005|COMPLETED|Dose Escalation Phase||0||
48637350|NCT03370302|101898531|FG000|NOT COMPLETED|Dose Escalation Phase||3||
48637351|NCT03370302|101898532|FG001|NOT COMPLETED|Dose Escalation Phase||6||
48637352|NCT03370302|101898533|FG002|NOT COMPLETED|Dose Escalation Phase||7||
48637353|NCT03370302|101898534|FG003|NOT COMPLETED|Dose Escalation Phase||0||
48637354|NCT03370302|101898535|FG004|NOT COMPLETED|Dose Escalation Phase||3||
48637355|NCT03370302|101898536|FG005|NOT COMPLETED|Dose Escalation Phase||3||
48637356|NCT03370302|101898531|FG000|STARTED|Dose Expansion Phase||0||
48637357|NCT03370302|101898532|FG001|STARTED|Dose Expansion Phase||0||
48637358|NCT03370302|101898533|FG002|STARTED|Dose Expansion Phase||0||
48637359|NCT03370302|101898534|FG003|STARTED|Dose Expansion Phase||6||
48637360|NCT03370302|101898535|FG004|STARTED|Dose Expansion Phase||0||
48637361|NCT03370302|101898536|FG005|STARTED|Dose Expansion Phase||0||
48637362|NCT03370302|101898531|FG000|COMPLETED|Dose Expansion Phase||0||
48637363|NCT03370302|101898532|FG001|COMPLETED|Dose Expansion Phase||0||
48637364|NCT03370302|101898533|FG002|COMPLETED|Dose Expansion Phase||0||
48637365|NCT03370302|101898534|FG003|COMPLETED|Dose Expansion Phase||0||
48637366|NCT03370302|101898535|FG004|COMPLETED|Dose Expansion Phase||0||
48637367|NCT03370302|101898536|FG005|COMPLETED|Dose Expansion Phase||0||
48637368|NCT03370302|101898531|FG000|NOT COMPLETED|Dose Expansion Phase||0||
48637369|NCT03370302|101898532|FG001|NOT COMPLETED|Dose Expansion Phase||0||
48637370|NCT03370302|101898533|FG002|NOT COMPLETED|Dose Expansion Phase||0||
48637371|NCT03370302|101898534|FG003|NOT COMPLETED|Dose Expansion Phase||6||
48637372|NCT03370302|101898535|FG004|NOT COMPLETED|Dose Expansion Phase||0||
48637373|NCT03370302|101898536|FG005|NOT COMPLETED|Dose Expansion Phase||0||
48637374|NCT04059250|101898537|FG000|STARTED|Overall Study||25||25
48637375|NCT04059250|101898538|FG001|STARTED|Overall Study||25||25
48637376|NCT04059250|101898537|FG000|COMPLETED|Overall Study||25||25
48637377|NCT04059250|101898538|FG001|COMPLETED|Overall Study||25||25
48637378|NCT04059250|101898537|FG000|NOT COMPLETED|Overall Study||0||0
48637379|NCT04059250|101898538|FG001|NOT COMPLETED|Overall Study||0||0
48637380|NCT02362451|101898539|FG000|STARTED|Overall Study||6||
48637381|NCT02362451|101898540|FG001|STARTED|Overall Study||1||
48637382|NCT02362451|101898539|FG000|COMPLETED|Overall Study||2||
48637383|NCT02362451|101898540|FG001|COMPLETED|Overall Study||0||
48637384|NCT02362451|101898539|FG000|NOT COMPLETED|Overall Study||4||
48637385|NCT02362451|101898540|FG001|NOT COMPLETED|Overall Study||1||
48637386|NCT03617588|101898541|FG000|STARTED|Overall Study||20||
48637387|NCT03617588|101898542|FG001|STARTED|Overall Study||29||
48637388|NCT03617588|101898541|FG000|COMPLETED|Overall Study||19||
48637389|NCT03617588|101898542|FG001|COMPLETED|Overall Study||29||
48637390|NCT03617588|101898541|FG000|NOT COMPLETED|Overall Study||1||
48637391|NCT03617588|101898542|FG001|NOT COMPLETED|Overall Study||0||
48637392|NCT00390013|101898543|FG000|STARTED|Phase 1||0||
48637393|NCT00390013|101898544|FG001|STARTED|Phase 1||0||
48637394|NCT00390013|101898545|FG002|STARTED|Phase 1||2||
48637395|NCT00390013|101898546|FG003|STARTED|Phase 1||2||
48637396|NCT00390013|101898543|FG000|COMPLETED|Phase 1||0||
48637397|NCT00390013|101898544|FG001|COMPLETED|Phase 1||0||
48637398|NCT00390013|101898545|FG002|COMPLETED|Phase 1||2||
48637399|NCT00390013|101898546|FG003|COMPLETED|Phase 1||1||
48637400|NCT00390013|101898543|FG000|NOT COMPLETED|Phase 1||0||
48637401|NCT00390013|101898544|FG001|NOT COMPLETED|Phase 1||0||
48637402|NCT00390013|101898545|FG002|NOT COMPLETED|Phase 1||0||
48637403|NCT00390013|101898546|FG003|NOT COMPLETED|Phase 1||1||
48637404|NCT00390013|101898543|FG000|STARTED|Phase 2 First Treatment||3||
48637405|NCT00390013|101898544|FG001|STARTED|Phase 2 First Treatment||2||
48186331|NCT04668144|100779784|FG002|STARTED|Overall Study||27||
48186332|NCT04668144|100779782|FG000|COMPLETED|Overall Study||25||
48637406|NCT00390013|101898545|FG002|STARTED|Phase 2 First Treatment||0||
48637407|NCT00390013|101898546|FG003|STARTED|Phase 2 First Treatment||0||
48637408|NCT00390013|101898543|FG000|COMPLETED|Phase 2 First Treatment||2||
48637409|NCT00390013|101898544|FG001|COMPLETED|Phase 2 First Treatment||1||
48637410|NCT00390013|101898545|FG002|COMPLETED|Phase 2 First Treatment||0||
48637411|NCT00390013|101898546|FG003|COMPLETED|Phase 2 First Treatment||0||
48637412|NCT00390013|101898543|FG000|NOT COMPLETED|Phase 2 First Treatment||1||
48637413|NCT00390013|101898544|FG001|NOT COMPLETED|Phase 2 First Treatment||1||
48637414|NCT00390013|101898545|FG002|NOT COMPLETED|Phase 2 First Treatment||0||
48637415|NCT00390013|101898546|FG003|NOT COMPLETED|Phase 2 First Treatment||0||
48637416|NCT00390013|101898543|FG000|STARTED|Phase 2 Second Treatment||2||
48637417|NCT00390013|101898544|FG001|STARTED|Phase 2 Second Treatment||1||
48637418|NCT00390013|101898545|FG002|STARTED|Phase 2 Second Treatment||0||
48637419|NCT00390013|101898546|FG003|STARTED|Phase 2 Second Treatment||0||
48637420|NCT00390013|101898543|FG000|COMPLETED|Phase 2 Second Treatment||2||
48637421|NCT00390013|101898544|FG001|COMPLETED|Phase 2 Second Treatment||1||
48637422|NCT00390013|101898545|FG002|COMPLETED|Phase 2 Second Treatment||0||
48637423|NCT00390013|101898546|FG003|COMPLETED|Phase 2 Second Treatment||0||
48637424|NCT00390013|101898543|FG000|NOT COMPLETED|Phase 2 Second Treatment||0||
48637425|NCT00390013|101898544|FG001|NOT COMPLETED|Phase 2 Second Treatment||0||
48637426|NCT00390013|101898545|FG002|NOT COMPLETED|Phase 2 Second Treatment||0||
48637427|NCT00390013|101898546|FG003|NOT COMPLETED|Phase 2 Second Treatment||0||
48637428|NCT01171534|101898547|FG000|STARTED|Overall Study||0||
48637429|NCT01171534|101898548|FG001|STARTED|Overall Study||7||
48637430|NCT01171534|101898547|FG000|COMPLETED|Overall Study||0||
48637431|NCT01171534|101898548|FG001|COMPLETED|Overall Study||4||
48637432|NCT01171534|101898547|FG000|NOT COMPLETED|Overall Study||0||
48186333|NCT04668144|100779783|FG001|COMPLETED|Overall Study||24||
48637433|NCT01171534|101898548|FG001|NOT COMPLETED|Overall Study||3||
48637434|NCT01389232|101898549|FG000|STARTED|Overall Study||100||
48637435|NCT01389232|101898549|FG000|COMPLETED|Overall Study||81||
48637436|NCT01389232|101898549|FG000|NOT COMPLETED|Overall Study||19||
48186334|NCT04668144|100779784|FG002|COMPLETED|Overall Study||25||
48637437|NCT02911116|101898550|FG000|STARTED|Overall Study||5||
48637438|NCT02911116|101898551|FG001|STARTED|Overall Study||3||
48637439|NCT02911116|101898550|FG000|COMPLETED|Overall Study||4||
48637440|NCT02911116|101898551|FG001|COMPLETED|Overall Study||2||
48637441|NCT02911116|101898550|FG000|NOT COMPLETED|Overall Study||1||
48186335|NCT04668144|100779782|FG000|NOT COMPLETED|Overall Study||0||
48637442|NCT02911116|101898551|FG001|NOT COMPLETED|Overall Study||1||
48186336|NCT04668144|100779783|FG001|NOT COMPLETED|Overall Study||1||
48186337|NCT04668144|100779784|FG002|NOT COMPLETED|Overall Study||2||
48637443|NCT02084797|101898552|FG000|STARTED|Overall Study||10||
48637444|NCT02084797|101898552|FG000|COMPLETED|Overall Study||10||
48637445|NCT02084797|101898552|FG000|NOT COMPLETED|Overall Study||0||
48637446|NCT00671749|101898553|FG000|STARTED|Overall Study||100||
48637447|NCT00671749|101898553|FG000|COMPLETED|Overall Study||92||
48637448|NCT00671749|101898553|FG000|NOT COMPLETED|Overall Study||8||
48637449|NCT00165698|101898554|FG000|STARTED|Overall Study||120||
48637450|NCT00165698|101898555|FG001|STARTED|Overall Study||120||
48637451|NCT00165698|101898554|FG000|COMPLETED|Overall Study||112||
48637452|NCT00165698|101898555|FG001|COMPLETED|Overall Study||105||
48637453|NCT00165698|101898554|FG000|NOT COMPLETED|Overall Study||8||
48637454|NCT00165698|101898555|FG001|NOT COMPLETED|Overall Study||15||
48637455|NCT01461551|101898556|FG000|STARTED|Overall Study||35||
48637456|NCT01461551|101898557|FG001|STARTED|Overall Study||35||
48637457|NCT01461551|101898558|FG002|STARTED|Overall Study||35||
48637458|NCT01461551|101898556|FG000|COMPLETED|Overall Study||33||
48637459|NCT01461551|101898557|FG001|COMPLETED|Overall Study||34||
48637460|NCT01461551|101898558|FG002|COMPLETED|Overall Study||33||
48637461|NCT01461551|101898556|FG000|NOT COMPLETED|Overall Study||2||
48637462|NCT01461551|101898557|FG001|NOT COMPLETED|Overall Study||1||
48637463|NCT01461551|101898558|FG002|NOT COMPLETED|Overall Study||2||
48637464|NCT00005047|101898559|FG000|STARTED|Overall Study||58||
48637465|NCT00005047|101898560|FG001|STARTED|Overall Study||56||
48637466|NCT00005047|101898561|FG002|STARTED|Overall Study||227||
48637467|NCT00005047|101898562|FG003|STARTED|Overall Study||158||
48637468|NCT00005047|101898559|FG000|COMPLETED|Overall Study||39||
48637469|NCT00005047|101898560|FG001|COMPLETED|Overall Study||56||
48637470|NCT00005047|101898561|FG002|COMPLETED|Overall Study||227||
48637471|NCT00005047|101898562|FG003|COMPLETED|Overall Study||158||
48637472|NCT00005047|101898559|FG000|NOT COMPLETED|Overall Study||19||
48637473|NCT00005047|101898560|FG001|NOT COMPLETED|Overall Study||0||
48637474|NCT00005047|101898561|FG002|NOT COMPLETED|Overall Study||0||
48637475|NCT00005047|101898562|FG003|NOT COMPLETED|Overall Study||0||
48637476|NCT02114684|101898563|FG000|STARTED|Overall Study||98||
48637477|NCT02114684|101898564|FG001|STARTED|Overall Study||98||
48637478|NCT02114684|101898563|FG000|COMPLETED|Overall Study||86||
48637479|NCT02114684|101898564|FG001|COMPLETED|Overall Study||88||
48637480|NCT02114684|101898563|FG000|NOT COMPLETED|Overall Study||12||
48637481|NCT02114684|101898564|FG001|NOT COMPLETED|Overall Study||10||
48637482|NCT00870727|101898565|FG000|STARTED|Overall Study||17||
48637483|NCT00870727|101898566|FG001|STARTED|Overall Study||16||
48637484|NCT00870727|101898565|FG000|COMPLETED|Overall Study||16||
48637485|NCT00870727|101898566|FG001|COMPLETED|Overall Study||11||
48637486|NCT00870727|101898565|FG000|NOT COMPLETED|Overall Study||1||
48637487|NCT00870727|101898566|FG001|NOT COMPLETED|Overall Study||5||
48637488|NCT01648764|101898567|FG000|STARTED|Overall Study||3||
48637489|NCT01648764|101898568|FG001|STARTED|Overall Study||3||
48637490|NCT01648764|101898569|FG002|STARTED|Overall Study||3||
48637491|NCT01648764|101898570|FG003|STARTED|Overall Study||3||
48637492|NCT01648764|101898571|FG004|STARTED|Overall Study||3||
48637493|NCT01648764|101898572|FG005|STARTED|Overall Study||5||
48637494|NCT01648764|101898573|FG006|STARTED|Overall Study||9||
48637495|NCT01648764|101898574|FG007|STARTED|Overall Study||3||
48637496|NCT01648764|101898575|FG008|STARTED|Overall Study||3||
48637497|NCT01648764|101898576|FG009|STARTED|Overall Study||7||
48637498|NCT01648764|101898577|FG010|STARTED|Overall Study||3||
48637499|NCT01648764|101898578|FG011|STARTED|Overall Study||9||
48637500|NCT01648764|101898579|FG012|STARTED|Overall Study||7||
48637501|NCT01648764|101898580|FG013|STARTED|Overall Study||12||
48637502|NCT01648764|101898567|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
48637503|NCT01648764|101898568|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3||
48637504|NCT01648764|101898569|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
48637505|NCT01648764|101898570|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3||
48637506|NCT01648764|101898571|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3||
48348457|NCT00345605|101184003|FG000|COMPLETED|Arm 2, Opposite Treatment||5||
48348458|NCT00345605|101184004|FG001|COMPLETED|Arm 2, Opposite Treatment||6||
48348459|NCT00345605|101184003|FG000|NOT COMPLETED|Arm 2, Opposite Treatment||1||
48348460|NCT00345605|101184004|FG001|NOT COMPLETED|Arm 2, Opposite Treatment||0||
48348461|NCT00778830|101184005|FG000|STARTED|Overall Study||101||
48348462|NCT00778830|101184006|FG001|STARTED|Overall Study||188||
48348463|NCT00778830|101184005|FG000|COMPLETED|Overall Study||101||
48348464|NCT00778830|101184006|FG001|COMPLETED|Overall Study||187||
48348465|NCT00778830|101184005|FG000|NOT COMPLETED|Overall Study||0||
48348466|NCT00778830|101184006|FG001|NOT COMPLETED|Overall Study||1||
48348467|NCT02210780|101184007|FG000|STARTED|Overall Study||97||
48637507|NCT01648764|101898572|FG005|Received at Least 1 Dose of Study Drug|Overall Study||5||
48637508|NCT01648764|101898573|FG006|Received at Least 1 Dose of Study Drug|Overall Study||9||
48637509|NCT01648764|101898574|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3||
48637510|NCT01648764|101898575|FG008|Received at Least 1 Dose of Study Drug|Overall Study||3||
48348468|NCT02210780|101184008|FG001|STARTED|Overall Study||97||
48348469|NCT02210780|101184007|FG000|COMPLETED|Overall Study||92||
48637511|NCT01648764|101898576|FG009|Received at Least 1 Dose of Study Drug|Overall Study||7||
48637512|NCT01648764|101898577|FG010|Received at Least 1 Dose of Study Drug|Overall Study||3||
48348470|NCT02210780|101184008|FG001|COMPLETED|Overall Study||89||
48348471|NCT02210780|101184007|FG000|NOT COMPLETED|Overall Study||5||
48637513|NCT01648764|101898578|FG011|Received at Least 1 Dose of Study Drug|Overall Study||9||
48637514|NCT01648764|101898579|FG012|Received at Least 1 Dose of Study Drug|Overall Study||7||
48637515|NCT01648764|101898580|FG013|Received at Least 1 Dose of Study Drug|Overall Study||12||
48186338|NCT01321073|100779785|FG000|STARTED|Overall Study||64||
48186339|NCT01321073|100779785|FG000|COMPLETED|Overall Study||57||
48186340|NCT01321073|100779785|FG000|NOT COMPLETED|Overall Study||7||
48186341|NCT03059992|100779786|FG000|STARTED|Overall Study||233||
48186342|NCT03059992|100779786|FG000|COMPLETED|Overall Study||124||
48186343|NCT03059992|100779786|FG000|NOT COMPLETED|Overall Study||109||
48637516|NCT01648764|101898567|FG000|COMPLETED|Overall Study||3||
48637517|NCT01648764|101898568|FG001|COMPLETED|Overall Study||2||
48637518|NCT01648764|101898569|FG002|COMPLETED|Overall Study||3||
48637519|NCT01648764|101898570|FG003|COMPLETED|Overall Study||3||
48637520|NCT01648764|101898571|FG004|COMPLETED|Overall Study||3||
48637521|NCT01648764|101898572|FG005|COMPLETED|Overall Study||3||
48760593|NCT02741128|102200559|FG001|Vaccinated|Overall Study||44||
48760594|NCT02741128|102200558|FG000|COMPLETED|Overall Study||82||
48760595|NCT02741128|102200559|FG001|COMPLETED|Overall Study||43||
48760596|NCT02741128|102200558|FG000|NOT COMPLETED|Overall Study||7||
48760597|NCT02741128|102200559|FG001|NOT COMPLETED|Overall Study||1||
48760598|NCT01506596|102200560|FG000|STARTED|Overall Study||42||
48760599|NCT01506596|102200560|FG000|COMPLETED|Overall Study||41||
48760600|NCT01506596|102200560|FG000|NOT COMPLETED|Overall Study||1||
48760601|NCT01251965|102200561|FG000|STARTED|Overall Study||4||
48760602|NCT01251965|102200562|FG001|STARTED|Overall Study||5||
48760603|NCT01251965|102200563|FG002|STARTED|Overall Study||18||
48760604|NCT01251965|102200561|FG000|COMPLETED|Overall Study||3||
48760605|NCT01251965|102200562|FG001|COMPLETED|Overall Study||3||
48760606|NCT01251965|102200563|FG002|COMPLETED|Overall Study||7||
48186344|NCT02357758|100779787|FG000|STARTED|Overall Study||25||
48186345|NCT02357758|100779788|FG001|STARTED|Overall Study||20||
48186346|NCT02357758|100779789|FG002|STARTED|Overall Study||12||
48186347|NCT02357758|100779787|FG000|COMPLETED|Overall Study||9||
48186348|NCT02357758|100779788|FG001|COMPLETED|Overall Study||20||
48186349|NCT02357758|100779789|FG002|COMPLETED|Overall Study||5||
48186350|NCT02357758|100779787|FG000|NOT COMPLETED|Overall Study||16||
48637522|NCT01648764|101898573|FG006|COMPLETED|Overall Study||4||
48637523|NCT01648764|101898574|FG007|COMPLETED|Overall Study||3||
48637524|NCT01648764|101898575|FG008|COMPLETED|Overall Study||3||
48186351|NCT02357758|100779788|FG001|NOT COMPLETED|Overall Study||0||
48186352|NCT02357758|100779789|FG002|NOT COMPLETED|Overall Study||7||
48186353|NCT02859597|100779790|FG000|STARTED|Overall Study||22||
48186354|NCT02859597|100779791|FG001|STARTED|Overall Study||19||
48186355|NCT02859597|100779790|FG000|COMPLETED|Overall Study||22||
48186356|NCT02859597|100779791|FG001|COMPLETED|Overall Study||19||
48186357|NCT02859597|100779790|FG000|NOT COMPLETED|Overall Study||0||
48348472|NCT02210780|101184008|FG001|NOT COMPLETED|Overall Study||8||
48348473|NCT02333227|101184009|FG000|STARTED|Overall Study||5520|Enrolled and consented to the PPaX trial|4
48348474|NCT02333227|101184010|FG001|STARTED|Overall Study||4549|Enrolled and consented to the PPaX trial|4
48348475|NCT02333227|101184009|FG000|COMPLETED|Overall Study||5321|Analyzed for primary outcomes|4
48348476|NCT02333227|101184010|FG001|COMPLETED|Overall Study||4349|Analyzed for primary outcomes|4
48348477|NCT02333227|101184009|FG000|NOT COMPLETED|Overall Study||199||0
48348478|NCT02333227|101184010|FG001|NOT COMPLETED|Overall Study||200||0
48348479|NCT01120639|101184011|FG000|STARTED|Overall Study||6||
48348480|NCT01120639|101184012|FG001|STARTED|Overall Study||6||
48416017|NCT02802735|101353300|FG000|COMPLETED|Overall Study||4||
48416018|NCT02802735|101353301|FG001|COMPLETED|Overall Study||3||
48416019|NCT02802735|101353302|FG002|COMPLETED|Overall Study||4||
48416020|NCT02802735|101353303|FG003|COMPLETED|Overall Study||12||
48416021|NCT02802735|101353304|FG004|COMPLETED|Overall Study||4||
48760607|NCT01251965|102200561|FG000|NOT COMPLETED|Overall Study||1||
48760608|NCT01251965|102200562|FG001|NOT COMPLETED|Overall Study||2||
48760609|NCT01251965|102200563|FG002|NOT COMPLETED|Overall Study||11||
48760610|NCT03299556|102200564|FG000|STARTED|Overall Study||113||
48186358|NCT02859597|100779791|FG001|NOT COMPLETED|Overall Study||0||
48348481|NCT01120639|101184013|FG002|STARTED|Overall Study||6||
48760611|NCT03299556|102200565|FG001|STARTED|Overall Study||146||
48760612|NCT03299556|102200566|FG002|STARTED|Overall Study||161||
48186359|NCT03628924|100779792|FG000|STARTED|Placebo Controlled Period (Week 0 - 16)||62||
48348482|NCT01120639|101184014|FG003|STARTED|Overall Study||12||
48637525|NCT01648764|101898576|FG009|COMPLETED|Overall Study||4||
48637526|NCT01648764|101898577|FG010|COMPLETED|Overall Study||3||
48760613|NCT03299556|102200564|FG000|COMPLETED|Overall Study||105||
48760614|NCT03299556|102200565|FG001|COMPLETED|Overall Study||146||
48186360|NCT03628924|100779793|FG001|STARTED|Placebo Controlled Period (Week 0 - 16)||59||
48186361|NCT03628924|100779794|FG002|STARTED|Placebo Controlled Period (Week 0 - 16)||60||
48186362|NCT03628924|100779795|FG003|STARTED|Placebo Controlled Period (Week 0 - 16)||0||
48348483|NCT01120639|101184011|FG000|COMPLETED|Overall Study||6||
48760615|NCT03299556|102200566|FG002|COMPLETED|Overall Study||161||
48760616|NCT03299556|102200564|FG000|NOT COMPLETED|Overall Study||8||
48186363|NCT03628924|100779796|FG004|STARTED|Placebo Controlled Period (Week 0 - 16)||0||
48186364|NCT03628924|100779797|FG005|STARTED|Placebo Controlled Period (Week 0 - 16)||0||
48186365|NCT03628924|100779798|FG006|STARTED|Placebo Controlled Period (Week 0 - 16)||0||
48186366|NCT03628924|100779792|FG000|COMPLETED|Placebo Controlled Period (Week 0 - 16)||56||
48186367|NCT03628924|100779793|FG001|COMPLETED|Placebo Controlled Period (Week 0 - 16)||56||
48186368|NCT03628924|100779794|FG002|COMPLETED|Placebo Controlled Period (Week 0 - 16)||57||
48186369|NCT03628924|100779795|FG003|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0||
48186370|NCT03628924|100779796|FG004|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0||
48186371|NCT03628924|100779797|FG005|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0||
48186372|NCT03628924|100779798|FG006|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0||
48186373|NCT03628924|100779792|FG000|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||6||
48186374|NCT03628924|100779793|FG001|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||3||
48186375|NCT03628924|100779794|FG002|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||3||
48186376|NCT03628924|100779795|FG003|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0||
48637527|NCT01648764|101898578|FG011|COMPLETED|Overall Study||4||
48637528|NCT01648764|101898579|FG012|COMPLETED|Overall Study||3||
48637529|NCT01648764|101898580|FG013|COMPLETED|Overall Study||9||
48637530|NCT01648764|101898567|FG000|NOT COMPLETED|Overall Study||0||
48637531|NCT01648764|101898568|FG001|NOT COMPLETED|Overall Study||1||
48637532|NCT01648764|101898569|FG002|NOT COMPLETED|Overall Study||0||
48186377|NCT03628924|100779796|FG004|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0||
48186378|NCT03628924|100779797|FG005|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0||
48186379|NCT03628924|100779798|FG006|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0||
48186380|NCT03628924|100779792|FG000|STARTED|Active Treatment Period (Week 16-48)||0||
48186381|NCT03628924|100779793|FG001|STARTED|Active Treatment Period (Week 16-48)||0||
48186382|NCT03628924|100779794|FG002|STARTED|Active Treatment Period (Week 16-48)||0||
48186383|NCT03628924|100779795|FG003|STARTED|Active Treatment Period (Week 16-48)||28||
48186384|NCT03628924|100779796|FG004|STARTED|Active Treatment Period (Week 16-48)||28||
48186385|NCT03628924|100779797|FG005|STARTED|Active Treatment Period (Week 16-48)||56||
48186386|NCT03628924|100779798|FG006|STARTED|Active Treatment Period (Week 16-48)||57||
48348484|NCT01120639|101184012|FG001|COMPLETED|Overall Study||6||
48416022|NCT02802735|101353300|FG000|NOT COMPLETED|Overall Study||0||
48186387|NCT03628924|100779792|FG000|COMPLETED|Active Treatment Period (Week 16-48)||0||
48186388|NCT03628924|100779793|FG001|COMPLETED|Active Treatment Period (Week 16-48)||0||
48186389|NCT03628924|100779794|FG002|COMPLETED|Active Treatment Period (Week 16-48)||0||
48186390|NCT03628924|100779795|FG003|COMPLETED|Active Treatment Period (Week 16-48)||20||
48186391|NCT03628924|100779796|FG004|COMPLETED|Active Treatment Period (Week 16-48)||24||
48637533|NCT01648764|101898570|FG003|NOT COMPLETED|Overall Study||0||
48637534|NCT01648764|101898571|FG004|NOT COMPLETED|Overall Study||0||
48637535|NCT01648764|101898572|FG005|NOT COMPLETED|Overall Study||2||
48637536|NCT01648764|101898573|FG006|NOT COMPLETED|Overall Study||5||
48637537|NCT01648764|101898574|FG007|NOT COMPLETED|Overall Study||0||
48760617|NCT03299556|102200565|FG001|NOT COMPLETED|Overall Study||0||
48760618|NCT03299556|102200566|FG002|NOT COMPLETED|Overall Study||0||
48760619|NCT00575185|102200567|FG000|STARTED|Overall Study||12||
48760620|NCT00575185|102200568|FG001|STARTED|Overall Study||11||
48760621|NCT00575185|102200567|FG000|COMPLETED|Overall Study||12||
48760622|NCT00575185|102200568|FG001|COMPLETED|Overall Study||11||
48760623|NCT00575185|102200567|FG000|NOT COMPLETED|Overall Study||0||
48760624|NCT00575185|102200568|FG001|NOT COMPLETED|Overall Study||0||
48760625|NCT01440959|102200569|FG000|STARTED|Overall Study||30||
48760626|NCT01440959|102200569|FG000|COMPLETED|Overall Study||30||
48760627|NCT01440959|102200569|FG000|NOT COMPLETED|Overall Study||0||
48186392|NCT03628924|100779797|FG005|COMPLETED|Active Treatment Period (Week 16-48)||43||
48186393|NCT03628924|100779798|FG006|COMPLETED|Active Treatment Period (Week 16-48)||46||
48186394|NCT03628924|100779792|FG000|NOT COMPLETED|Active Treatment Period (Week 16-48)||0||
48186395|NCT03628924|100779793|FG001|NOT COMPLETED|Active Treatment Period (Week 16-48)||0||
48186396|NCT03628924|100779794|FG002|NOT COMPLETED|Active Treatment Period (Week 16-48)||0||
48186397|NCT03628924|100779795|FG003|NOT COMPLETED|Active Treatment Period (Week 16-48)||8||
48416023|NCT02802735|101353301|FG001|NOT COMPLETED|Overall Study||1||
48637538|NCT01648764|101898575|FG008|NOT COMPLETED|Overall Study||0||
48637539|NCT01648764|101898576|FG009|NOT COMPLETED|Overall Study||3||
48637540|NCT01648764|101898577|FG010|NOT COMPLETED|Overall Study||0||
48416024|NCT02802735|101353302|FG002|NOT COMPLETED|Overall Study||0||
48760628|NCT04244253|102200570|FG000|STARTED|Overall Study||31||
48760629|NCT04244253|102200571|FG001|STARTED|Overall Study||121||
48760630|NCT04244253|102200572|FG002|STARTED|Overall Study||121||
48760631|NCT04244253|102200570|FG000|COMPLETED|Overall Study||28||
48760632|NCT04244253|102200571|FG001|COMPLETED|Overall Study||116||
48760633|NCT04244253|102200572|FG002|COMPLETED|Overall Study||109||
48760634|NCT04244253|102200570|FG000|NOT COMPLETED|Overall Study||3||
48760635|NCT04244253|102200571|FG001|NOT COMPLETED|Overall Study||5||
48760636|NCT04244253|102200572|FG002|NOT COMPLETED|Overall Study||12||
48416025|NCT02802735|101353303|FG003|NOT COMPLETED|Overall Study||0||
48637541|NCT01648764|101898578|FG011|NOT COMPLETED|Overall Study||5||
48637542|NCT01648764|101898579|FG012|NOT COMPLETED|Overall Study||4||
48760637|NCT00599872|102200573|FG000|STARTED|Overall Study||216||
48760638|NCT00599872|102200574|FG001|STARTED|Overall Study||214||
48760639|NCT00599872|102200573|FG000|COMPLETED|Overall Study||167||
48760640|NCT00599872|102200574|FG001|COMPLETED|Overall Study||181||
48760641|NCT00599872|102200573|FG000|NOT COMPLETED|Overall Study||49||
48760642|NCT00599872|102200574|FG001|NOT COMPLETED|Overall Study||33||
48760643|NCT00375999|102200575|FG000|STARTED|Overall Study||34||
48760644|NCT00375999|102200575|FG000|COMPLETED|Overall Study||32||
48760645|NCT00375999|102200575|FG000|NOT COMPLETED|Overall Study||2||
48760646|NCT02453737|102200576|FG000|STARTED|Overall Study||56||
48760647|NCT02453737|102200577|FG001|STARTED|Overall Study||58||
48760648|NCT02453737|102200578|FG002|STARTED|Overall Study||52||
48760649|NCT02453737|102200576|FG000|COMPLETED|Overall Study||56||
48760650|NCT02453737|102200577|FG001|COMPLETED|Overall Study||56||
48760651|NCT02453737|102200578|FG002|COMPLETED|Overall Study||49||
48760652|NCT02453737|102200576|FG000|NOT COMPLETED|Overall Study||0||
48760653|NCT02453737|102200577|FG001|NOT COMPLETED|Overall Study||2||
48760654|NCT02453737|102200578|FG002|NOT COMPLETED|Overall Study||3||
48760655|NCT05810740|102200579|FG000|STARTED|Treatment Period 1 (5 Days)||19||
48186398|NCT03628924|100779796|FG004|NOT COMPLETED|Active Treatment Period (Week 16-48)||4||
48186399|NCT03628924|100779797|FG005|NOT COMPLETED|Active Treatment Period (Week 16-48)||13||
48186400|NCT03628924|100779798|FG006|NOT COMPLETED|Active Treatment Period (Week 16-48)||11||
48186401|NCT02511561|100779799|FG000|STARTED|Overall Study||25||
48186402|NCT02511561|100779800|FG001|STARTED|Overall Study||25||
48186403|NCT02511561|100779801|FG002|STARTED|Overall Study||25||
48186404|NCT02511561|100779799|FG000|COMPLETED|Overall Study||25||
48186405|NCT02511561|100779800|FG001|COMPLETED|Overall Study||25||
48186406|NCT02511561|100779801|FG002|COMPLETED|Overall Study||25||
48186407|NCT02511561|100779799|FG000|NOT COMPLETED|Overall Study||0||
48186408|NCT02511561|100779800|FG001|NOT COMPLETED|Overall Study||0||
48186409|NCT02511561|100779801|FG002|NOT COMPLETED|Overall Study||0||
48186410|NCT04296942|100779802|FG000|STARTED|Overall Study||1||
48186411|NCT04296942|100779803|FG001|STARTED|Overall Study||0||
48186412|NCT04296942|100779804|FG002|STARTED|Overall Study||0||
48186413|NCT04296942|100779802|FG000|COMPLETED|Overall Study||0||
48186414|NCT04296942|100779803|FG001|COMPLETED|Overall Study||0||
48186415|NCT04296942|100779804|FG002|COMPLETED|Overall Study||0||
48186416|NCT04296942|100779802|FG000|NOT COMPLETED|Overall Study||1||
48186417|NCT04296942|100779803|FG001|NOT COMPLETED|Overall Study||0||
48186418|NCT04296942|100779804|FG002|NOT COMPLETED|Overall Study||0||
48186419|NCT03015740|100779805|FG000|STARTED|Overall Study||15||
48186420|NCT03015740|100779806|FG001|STARTED|Overall Study||24||
48186421|NCT03015740|100779807|FG002|STARTED|Overall Study||3||
48186422|NCT03015740|100779805|FG000|COMPLETED|Overall Study||9||
48186423|NCT03015740|100779806|FG001|COMPLETED|Overall Study||19||
48186424|NCT03015740|100779807|FG002|COMPLETED|Overall Study||3||
48186425|NCT03015740|100779805|FG000|NOT COMPLETED|Overall Study||6||
48186426|NCT03015740|100779806|FG001|NOT COMPLETED|Overall Study||5||
48186427|NCT03015740|100779807|FG002|NOT COMPLETED|Overall Study||0||
48186428|NCT04394624|100779808|FG000|STARTED|Overall Study||31||
48186429|NCT04394624|100779808|FG000|COMPLETED|Overall Study||0||
48186430|NCT04394624|100779808|FG000|NOT COMPLETED|Overall Study||31||
48186431|NCT04760444|100779809|FG000|STARTED|Overall Study||12||
48186432|NCT04760444|100779810|FG001|STARTED|Overall Study||13||
48760656|NCT05810740|102200580|FG001|STARTED|Treatment Period 1 (5 Days)||18||
48760657|NCT05810740|102200579|FG000|COMPLETED|Treatment Period 1 (5 Days)||19||
48760658|NCT05810740|102200580|FG001|COMPLETED|Treatment Period 1 (5 Days)||18||
48760659|NCT05810740|102200579|FG000|NOT COMPLETED|Treatment Period 1 (5 Days)||0||
48760660|NCT05810740|102200580|FG001|NOT COMPLETED|Treatment Period 1 (5 Days)||0||
48760661|NCT05810740|102200579|FG000|STARTED|Washout (7 Days)||19||
48760662|NCT05810740|102200580|FG001|STARTED|Washout (7 Days)||18||
48186433|NCT04760444|100779809|FG000|COMPLETED|Overall Study||11||
48186434|NCT04760444|100779810|FG001|COMPLETED|Overall Study||8||
48186435|NCT04760444|100779809|FG000|NOT COMPLETED|Overall Study||1||
48186436|NCT04760444|100779810|FG001|NOT COMPLETED|Overall Study||5||
48186437|NCT02554435|100779811|FG000|STARTED|Overall Study||20||
48186438|NCT02554435|100779812|FG001|STARTED|Overall Study||20||
48186439|NCT02554435|100779811|FG000|COMPLETED|Overall Study||14||
48760663|NCT05810740|102200579|FG000|COMPLETED|Washout (7 Days)||19||
48760664|NCT05810740|102200580|FG001|COMPLETED|Washout (7 Days)||18||
48760665|NCT05810740|102200579|FG000|NOT COMPLETED|Washout (7 Days)||0||
48186440|NCT02554435|100779812|FG001|COMPLETED|Overall Study||19||
48186441|NCT02554435|100779811|FG000|NOT COMPLETED|Overall Study||6||
48186442|NCT02554435|100779812|FG001|NOT COMPLETED|Overall Study||1||
48186443|NCT02223689|100779813|FG000|STARTED|Overall Study||35||
48186444|NCT02223689|100779813|FG000|COMPLETED|Overall Study||35||
48186445|NCT02223689|100779813|FG000|NOT COMPLETED|Overall Study||0||
48186446|NCT03050294|100779814|FG000|STARTED|Overall Study||6||
48760666|NCT05810740|102200580|FG001|NOT COMPLETED|Washout (7 Days)||0||
48760667|NCT05810740|102200579|FG000|STARTED|Treatment Period 2 (5 Days)||19||
48760668|NCT05810740|102200580|FG001|STARTED|Treatment Period 2 (5 Days)||18||
48186447|NCT03050294|100779815|FG001|STARTED|Overall Study||6||
48186448|NCT03050294|100779816|FG002|STARTED|Overall Study||6||
48186449|NCT03050294|100779817|FG003|STARTED|Overall Study||6||
48186450|NCT03050294|100779814|FG000|COMPLETED|Overall Study||6||
48186451|NCT03050294|100779815|FG001|COMPLETED|Overall Study||6||
48186452|NCT03050294|100779816|FG002|COMPLETED|Overall Study||6||
48186453|NCT03050294|100779817|FG003|COMPLETED|Overall Study||6||
48186454|NCT03050294|100779814|FG000|NOT COMPLETED|Overall Study||0||
48186455|NCT03050294|100779815|FG001|NOT COMPLETED|Overall Study||0||
48186456|NCT03050294|100779816|FG002|NOT COMPLETED|Overall Study||0||
48186457|NCT03050294|100779817|FG003|NOT COMPLETED|Overall Study||0||
48186458|NCT03663712|100779818|FG000|STARTED|Overall Study||3||
48186459|NCT03663712|100779819|FG001|STARTED|Overall Study||4||
48186460|NCT03663712|100779820|FG002|STARTED|Overall Study||11||
48348485|NCT01120639|101184013|FG002|COMPLETED|Overall Study||6||
48637543|NCT01648764|101898580|FG013|NOT COMPLETED|Overall Study||3||
48637544|NCT00639093|101898581|FG000|STARTED|Overall Study||45||
48637545|NCT00639093|101898582|FG001|STARTED|Overall Study||46||
48637546|NCT00639093|101898581|FG000|COMPLETED|Overall Study||45||
48637547|NCT00639093|101898582|FG001|COMPLETED|Overall Study||46||
48637548|NCT00639093|101898581|FG000|NOT COMPLETED|Overall Study||0||
48637549|NCT00639093|101898582|FG001|NOT COMPLETED|Overall Study||0||
48637550|NCT01991795|101898583|FG000|STARTED|Overall Study||9645|Includes patients that were randomised to study drug|
48637551|NCT01991795|101898584|FG001|STARTED|Overall Study||9626|Includes patients that were randomised to study drug|
48637552|NCT01991795|101898583|FG000|COMPLETED|Overall Study||9496|Patients who did not withdrew informed consent, were not LTFU and not excluded from the analyses|
48637553|NCT01991795|101898584|FG001|COMPLETED|Overall Study||9503|Patients who did not withdrew informed consent, were not LTFU and not excluded from the analyses|
48637554|NCT01991795|101898583|FG000|NOT COMPLETED|Overall Study||149||
48637555|NCT01991795|101898584|FG001|NOT COMPLETED|Overall Study||123||
48637556|NCT01712516|101898585|FG000|STARTED|Overall Study||250||
48637557|NCT01712516|101898586|FG001|STARTED|Overall Study||251||
48637558|NCT01712516|101898587|FG002|STARTED|Overall Study||251||
48637559|NCT01712516|101898588|FG003|STARTED|Overall Study||249||
48637560|NCT01712516|101898585|FG000|Safety Set|Overall Study||250||
48637561|NCT01712516|101898586|FG001|Safety Set|Overall Study||251||
48637562|NCT01712516|101898587|FG002|Safety Set|Overall Study||251||
48637563|NCT01712516|101898588|FG003|Safety Set|Overall Study||248||
48637564|NCT01712516|101898585|FG000|Full Analysis Set|Overall Study||250||
48637565|NCT01712516|101898586|FG001|Full Analysis Set|Overall Study||251||
48637566|NCT01712516|101898587|FG002|Full Analysis Set|Overall Study||250||
48637567|NCT01712516|101898588|FG003|Full Analysis Set|Overall Study||247||
48637568|NCT01712516|101898585|FG000|COMPLETED|Overall Study||244||
48637569|NCT01712516|101898586|FG001|COMPLETED|Overall Study||241||
48637570|NCT01712516|101898587|FG002|COMPLETED|Overall Study||245||
48186461|NCT03663712|100779818|FG000|COMPLETED|Overall Study||3||
48186462|NCT03663712|100779819|FG001|COMPLETED|Overall Study||4||
48186463|NCT03663712|100779820|FG002|COMPLETED|Overall Study||11||
48186464|NCT03663712|100779818|FG000|NOT COMPLETED|Overall Study||0||
48186465|NCT03663712|100779819|FG001|NOT COMPLETED|Overall Study||0||
48186466|NCT03663712|100779820|FG002|NOT COMPLETED|Overall Study||0||
48186467|NCT04714216|100779821|FG000|STARTED|Overall Study||22||
48186468|NCT04714216|100779821|FG000|COMPLETED|Overall Study||18||
48186469|NCT04714216|100779821|FG000|NOT COMPLETED|Overall Study||4||
48186470|NCT00741273|100779822|FG000|STARTED|Overall Study||8||
48186471|NCT00741273|100779823|FG001|STARTED|Overall Study||8||
48186472|NCT00741273|100779822|FG000|COMPLETED|Overall Study||8||
48186473|NCT00741273|100779823|FG001|COMPLETED|Overall Study||8||
48186474|NCT00741273|100779822|FG000|NOT COMPLETED|Overall Study||0||
48186475|NCT00741273|100779823|FG001|NOT COMPLETED|Overall Study||0||
48186476|NCT03212365|100779824|FG000|STARTED|Overall Study||151||
48186477|NCT03212365|100779825|FG001|STARTED|Overall Study||144||
48186478|NCT03212365|100779824|FG000|COMPLETED|Overall Study||128||
48186479|NCT03212365|100779825|FG001|COMPLETED|Overall Study||130||
48186480|NCT03212365|100779824|FG000|NOT COMPLETED|Overall Study||23||
48186481|NCT03212365|100779825|FG001|NOT COMPLETED|Overall Study||14||
48186482|NCT02535338|100779826|FG000|STARTED|Overall Study||3||
48348486|NCT01120639|101184014|FG003|COMPLETED|Overall Study||12||
48637571|NCT01712516|101898588|FG003|COMPLETED|Overall Study||236||
48637572|NCT01712516|101898585|FG000|NOT COMPLETED|Overall Study||6||
48637573|NCT01712516|101898586|FG001|NOT COMPLETED|Overall Study||10||
48637574|NCT01712516|101898587|FG002|NOT COMPLETED|Overall Study||6||
48637575|NCT01712516|101898588|FG003|NOT COMPLETED|Overall Study||13||
48348487|NCT01120639|101184011|FG000|NOT COMPLETED|Overall Study||0||
48637576|NCT00475332|101898589|FG000|STARTED|Overall Study||2||
48637577|NCT00475332|101898589|FG000|COMPLETED|Overall Study||2||
48637578|NCT00475332|101898589|FG000|NOT COMPLETED|Overall Study||0||
48637579|NCT02606305|101898590|FG000|STARTED|Dose Escalation: Regimens A, B, C and D||3||
48637580|NCT02606305|101898591|FG001|STARTED|Dose Escalation: Regimens A, B, C and D||11||
48186483|NCT02535338|100779827|FG001|STARTED|Overall Study||8||
48186484|NCT02535338|100779826|FG000|COMPLETED|Overall Study||3||
48186485|NCT02535338|100779827|FG001|COMPLETED|Overall Study||8||
48186486|NCT02535338|100779826|FG000|NOT COMPLETED|Overall Study||0||
48186487|NCT02535338|100779827|FG001|NOT COMPLETED|Overall Study||0||
48186488|NCT01260662|100779828|FG000|STARTED|Overall Study||90||
48348488|NCT01120639|101184012|FG001|NOT COMPLETED|Overall Study||0||
48186489|NCT01260662|100779829|FG001|STARTED|Overall Study||85||
48348489|NCT01120639|101184013|FG002|NOT COMPLETED|Overall Study||0||
48637581|NCT02606305|101898592|FG002|STARTED|Dose Escalation: Regimens A, B, C and D||0||
48637582|NCT02606305|101898593|FG003|STARTED|Dose Escalation: Regimens A, B, C and D||0||
48637583|NCT02606305|101898594|FG004|STARTED|Dose Escalation: Regimens A, B, C and D||0||
48637584|NCT02606305|101898595|FG005|STARTED|Dose Escalation: Regimens A, B, C and D||4||
48637585|NCT02606305|101898596|FG006|STARTED|Dose Escalation: Regimens A, B, C and D||4||
48637586|NCT02606305|101898597|FG007|STARTED|Dose Escalation: Regimens A, B, C and D||10||
48637587|NCT02606305|101898598|FG008|STARTED|Dose Escalation: Regimens A, B, C and D||4||
48637588|NCT02606305|101898599|FG009|STARTED|Dose Escalation: Regimens A, B, C and D||5||
48637589|NCT02606305|101898600|FG010|STARTED|Dose Escalation: Regimens A, B, C and D||7||
48637590|NCT02606305|101898601|FG011|STARTED|Dose Escalation: Regimens A, B, C and D||4||
48637591|NCT02606305|101898602|FG012|STARTED|Dose Escalation: Regimens A, B, C and D||10||
48637592|NCT02606305|101898603|FG013|STARTED|Dose Escalation: Regimens A, B, C and D||0||
48637593|NCT02606305|101898604|FG014|STARTED|Dose Escalation: Regimens A, B, C and D||0||
48637594|NCT02606305|101898590|FG000|Received at Least 1 Dose of Study Drug|Dose Escalation: Regimens A, B, C and D||3||
48637595|NCT02606305|101898591|FG001|Received at Least 1 Dose of Study Drug|Dose Escalation: Regimens A, B, C and D||11||
48637596|NCT02606305|101898592|FG002|Received at Least 1 Dose of Study Drug|Dose Escalation: Regimens A, B, C and D||0||
48637597|NCT02606305|101898593|FG003|Received at Least 1 Dose of Study Drug|Dose Escalation: Regimens A, B, C and D||0||
48637598|NCT02606305|101898594|FG004|Received at Least 1 Dose of Study Drug|Dose Escalation: Regimens A, B, C and D||0||
48637599|NCT02606305|101898595|FG005|Received at Least 1 Dose of Study Drug|Dose Escalation: Regimens A, B, C and D||4||
48637600|NCT02606305|101898596|FG006|Received at Least 1 Dose of Study Drug|Dose Escalation: Regimens A, B, C and D||4||
48637601|NCT02606305|101898597|FG007|Received at Least 1 Dose of Study Drug|Dose Escalation: Regimens A, B, C and D||10||
48637602|NCT02606305|101898598|FG008|Received at Least 1 Dose of Study Drug|Dose Escalation: Regimens A, B, C and D||4||
48637603|NCT02606305|101898599|FG009|Received at Least 1 Dose of Study Drug|Dose Escalation: Regimens A, B, C and D||5||
48637604|NCT02606305|101898600|FG010|Received at Least 1 Dose of Study Drug|Dose Escalation: Regimens A, B, C and D||7||
48637605|NCT02606305|101898601|FG011|Received at Least 1 Dose of Study Drug|Dose Escalation: Regimens A, B, C and D||4||
48637606|NCT02606305|101898602|FG012|Received at Least 1 Dose of Study Drug|Dose Escalation: Regimens A, B, C and D||10||
48637607|NCT02606305|101898603|FG013|Received at Least 1 Dose of Study Drug|Dose Escalation: Regimens A, B, C and D||0||
48637608|NCT02606305|101898604|FG014|Received at Least 1 Dose of Study Drug|Dose Escalation: Regimens A, B, C and D||0||
48637609|NCT02606305|101898590|FG000|COMPLETED|Dose Escalation: Regimens A, B, C and D||3||
48637610|NCT02606305|101898591|FG001|COMPLETED|Dose Escalation: Regimens A, B, C and D||11||
48637611|NCT02606305|101898592|FG002|COMPLETED|Dose Escalation: Regimens A, B, C and D||0||
48637612|NCT02606305|101898593|FG003|COMPLETED|Dose Escalation: Regimens A, B, C and D||0||
48637613|NCT02606305|101898594|FG004|COMPLETED|Dose Escalation: Regimens A, B, C and D||0||
48637614|NCT02606305|101898595|FG005|COMPLETED|Dose Escalation: Regimens A, B, C and D||4||
48637615|NCT02606305|101898596|FG006|COMPLETED|Dose Escalation: Regimens A, B, C and D||4||
48637616|NCT02606305|101898597|FG007|COMPLETED|Dose Escalation: Regimens A, B, C and D||10||
48186490|NCT01260662|100779830|FG002|STARTED|Overall Study||96||
48186491|NCT01260662|100779828|FG000|COMPLETED|Overall Study||90||
48186492|NCT01260662|100779829|FG001|COMPLETED|Overall Study||85||
48186493|NCT01260662|100779830|FG002|COMPLETED|Overall Study||96||
48186494|NCT01260662|100779828|FG000|NOT COMPLETED|Overall Study||0||
48186495|NCT01260662|100779829|FG001|NOT COMPLETED|Overall Study||0||
48186496|NCT01260662|100779830|FG002|NOT COMPLETED|Overall Study||0||
48186497|NCT02955277|100779831|FG000|STARTED|Pre-Post Intervention||30||
48186498|NCT02955277|100779832|FG001|STARTED|Pre-Post Intervention||31||
48186499|NCT02955277|100779831|FG000|COMPLETED|Pre-Post Intervention||25||
48186500|NCT02955277|100779832|FG001|COMPLETED|Pre-Post Intervention||25||
48186501|NCT02955277|100779831|FG000|NOT COMPLETED|Pre-Post Intervention||5||
48186502|NCT02955277|100779832|FG001|NOT COMPLETED|Pre-Post Intervention||6||
48186503|NCT02955277|100779831|FG000|STARTED|Post to Follow-up||25||
48186504|NCT02955277|100779832|FG001|STARTED|Post to Follow-up||25||
48186505|NCT02955277|100779831|FG000|COMPLETED|Post to Follow-up||17||
48186506|NCT02955277|100779832|FG001|COMPLETED|Post to Follow-up||14||
48186507|NCT02955277|100779831|FG000|NOT COMPLETED|Post to Follow-up||8||
48186508|NCT02955277|100779832|FG001|NOT COMPLETED|Post to Follow-up||11||
48186509|NCT03251378|100779833|FG000|STARTED|Overall Study||7||
48186510|NCT03251378|100779834|FG001|STARTED|Overall Study||7||
48186511|NCT03251378|100779835|FG002|STARTED|Overall Study||6||
48186512|NCT03251378|100779836|FG003|STARTED|Overall Study||41||
48186513|NCT03251378|100779837|FG004|STARTED|Overall Study||40||
48186514|NCT03251378|100779838|FG005|STARTED|Overall Study||14||
48186515|NCT03251378|100779839|FG006|STARTED|Overall Study||14||
48186516|NCT03251378|100779833|FG000|COMPLETED|Overall Study||0||
48186517|NCT03251378|100779834|FG001|COMPLETED|Overall Study||0||
48186518|NCT03251378|100779835|FG002|COMPLETED|Overall Study||0||
48186519|NCT03251378|100779836|FG003|COMPLETED|Overall Study||0||
48186520|NCT03251378|100779837|FG004|COMPLETED|Overall Study||0||
48186521|NCT03251378|100779838|FG005|COMPLETED|Overall Study||0||
48186522|NCT03251378|100779839|FG006|COMPLETED|Overall Study||0||
48186523|NCT03251378|100779833|FG000|NOT COMPLETED|Overall Study||7||
48186524|NCT03251378|100779834|FG001|NOT COMPLETED|Overall Study||7||
48186525|NCT03251378|100779835|FG002|NOT COMPLETED|Overall Study||6||
48186526|NCT03251378|100779836|FG003|NOT COMPLETED|Overall Study||41||
48186527|NCT03251378|100779837|FG004|NOT COMPLETED|Overall Study||40||
48186528|NCT03251378|100779838|FG005|NOT COMPLETED|Overall Study||14||
48186529|NCT03251378|100779839|FG006|NOT COMPLETED|Overall Study||14||
48186530|NCT01974687|100779840|FG000|STARTED|Overall Study||6||
48186531|NCT01974687|100779841|FG001|STARTED|Overall Study||6||
48186532|NCT01974687|100779842|FG002|STARTED|Overall Study||6||
48186533|NCT01974687|100779843|FG003|STARTED|Overall Study||6||
48186534|NCT01974687|100779844|FG004|STARTED|Overall Study||2||
48186535|NCT01974687|100779845|FG005|STARTED|Overall Study||6||
48186536|NCT01974687|100779846|FG006|STARTED|Overall Study||3||
48186537|NCT01974687|100779847|FG007|STARTED|Overall Study||3||
48186538|NCT01974687|100779848|FG008|STARTED|Overall Study||3||
48186539|NCT01974687|100779849|FG009|STARTED|Overall Study||3||
48186540|NCT01974687|100779850|FG010|STARTED|Overall Study||3||
48186541|NCT01974687|100779851|FG011|STARTED|Overall Study||13||
48186542|NCT01974687|100779852|FG012|STARTED|Overall Study||13||
48186543|NCT01974687|100779853|FG013|STARTED|Overall Study||10||
48186544|NCT01974687|100779854|FG014|STARTED|Overall Study||19||
48186545|NCT01974687|100779855|FG015|STARTED|Overall Study||9||
48186546|NCT01974687|100779856|FG016|STARTED|Overall Study||9||
48186547|NCT01974687|100779857|FG017|STARTED|Overall Study||11||
48186548|NCT01974687|100779858|FG018|STARTED|Overall Study||9||
48186549|NCT01974687|100779859|FG019|STARTED|Overall Study||3||
48186550|NCT01974687|100779860|FG020|STARTED|Overall Study||3||
48186551|NCT01974687|100779861|FG021|STARTED|Overall Study||8||
48186552|NCT01974687|100779862|FG022|STARTED|Overall Study||8||
48186553|NCT01974687|100779863|FG023|STARTED|Overall Study||6||
48760669|NCT05810740|102200579|FG000|COMPLETED|Treatment Period 2 (5 Days)||19||
48760670|NCT05810740|102200580|FG001|COMPLETED|Treatment Period 2 (5 Days)||18||
48760671|NCT05810740|102200579|FG000|NOT COMPLETED|Treatment Period 2 (5 Days)||0||
48760672|NCT05810740|102200580|FG001|NOT COMPLETED|Treatment Period 2 (5 Days)||0||
48760673|NCT04338321|102200581|FG000|STARTED|Overall Study||336||
48760674|NCT04338321|102200582|FG001|STARTED|Overall Study||340||
48186554|NCT01974687|100779864|FG024|STARTED|Overall Study||10||
48186555|NCT01974687|100779840|FG000|Treated|Overall Study||6||
48186556|NCT01974687|100779841|FG001|Treated|Overall Study||6||
48760675|NCT04338321|102200581|FG000|Treated (Safety Analysis Set)|Overall Study||334||
48760676|NCT04338321|102200582|FG001|Treated (Safety Analysis Set)|Overall Study||336||
48760677|NCT04338321|102200581|FG000|Completed Treatment|Overall Study||258||
48760678|NCT04338321|102200582|FG001|Completed Treatment|Overall Study||203||
48760679|NCT04338321|102200581|FG000|COMPLETED|Overall Study||274||
48760680|NCT04338321|102200582|FG001|COMPLETED|Overall Study||232||
48760681|NCT04338321|102200581|FG000|NOT COMPLETED|Overall Study||62||
48760682|NCT04338321|102200582|FG001|NOT COMPLETED|Overall Study||108||
48760683|NCT05005182|102200583|FG000|STARTED|Overall Study||1||
48186557|NCT01974687|100779842|FG002|Treated|Overall Study||6||
48186558|NCT01974687|100779843|FG003|Treated|Overall Study||6||
48186559|NCT01974687|100779844|FG004|Treated|Overall Study||2||
48186560|NCT01974687|100779845|FG005|Treated|Overall Study||6||
48186561|NCT01974687|100779846|FG006|Treated|Overall Study||3||
48186562|NCT01974687|100779847|FG007|Treated|Overall Study||3||
48186563|NCT01974687|100779848|FG008|Treated|Overall Study||3||
48186564|NCT01974687|100779849|FG009|Treated|Overall Study||3||
48186565|NCT01974687|100779850|FG010|Treated|Overall Study||3||
48186566|NCT01974687|100779851|FG011|Treated|Overall Study||11||
48186567|NCT01974687|100779852|FG012|Treated|Overall Study||10||
48186568|NCT01974687|100779853|FG013|Treated|Overall Study||8||
48186569|NCT01974687|100779854|FG014|Treated|Overall Study||18||
48186570|NCT01974687|100779855|FG015|Treated|Overall Study||8||
48186571|NCT01974687|100779856|FG016|Treated|Overall Study||8||
48186572|NCT01974687|100779857|FG017|Treated|Overall Study||8||
48186573|NCT01974687|100779858|FG018|Treated|Overall Study||9||
48186574|NCT01974687|100779859|FG019|Treated|Overall Study||3||
48186575|NCT01974687|100779860|FG020|Treated|Overall Study||3||
48186576|NCT01974687|100779861|FG021|Treated|Overall Study||8||
48186577|NCT01974687|100779862|FG022|Treated|Overall Study||8||
48760684|NCT05005182|102200584|FG001|STARTED|Overall Study||2||
48760685|NCT05005182|102200583|FG000|COMPLETED|Overall Study||1||
48186578|NCT01974687|100779863|FG023|Treated|Overall Study||6||
48186579|NCT01974687|100779864|FG024|Treated|Overall Study||10||
48186580|NCT01974687|100779840|FG000|COMPLETED|Overall Study||6||
48186581|NCT01974687|100779841|FG001|COMPLETED|Overall Study||6||
48186582|NCT01974687|100779842|FG002|COMPLETED|Overall Study||6||
48186583|NCT01974687|100779843|FG003|COMPLETED|Overall Study||6||
48186584|NCT01974687|100779844|FG004|COMPLETED|Overall Study||2||
48186585|NCT01974687|100779845|FG005|COMPLETED|Overall Study||6||
48186586|NCT01974687|100779846|FG006|COMPLETED|Overall Study||3||
48186587|NCT01974687|100779847|FG007|COMPLETED|Overall Study||3||
48186588|NCT01974687|100779848|FG008|COMPLETED|Overall Study||3||
48760686|NCT05005182|102200584|FG001|COMPLETED|Overall Study||2||
48186589|NCT01974687|100779849|FG009|COMPLETED|Overall Study||3||
48186590|NCT01974687|100779850|FG010|COMPLETED|Overall Study||3||
48186591|NCT01974687|100779851|FG011|COMPLETED|Overall Study||11||
48186592|NCT01974687|100779852|FG012|COMPLETED|Overall Study||10||
48760687|NCT05005182|102200583|FG000|NOT COMPLETED|Overall Study||0||
48760688|NCT05005182|102200584|FG001|NOT COMPLETED|Overall Study||0||
48760689|NCT01375140|102200585|FG000|STARTED|Overall Study||31||
48186593|NCT01974687|100779853|FG013|COMPLETED|Overall Study||8||
48186594|NCT01974687|100779854|FG014|COMPLETED|Overall Study||18||
48186595|NCT01974687|100779855|FG015|COMPLETED|Overall Study||8||
48186596|NCT01974687|100779856|FG016|COMPLETED|Overall Study||8||
48186597|NCT01974687|100779857|FG017|COMPLETED|Overall Study||8||
48186598|NCT01974687|100779858|FG018|COMPLETED|Overall Study||9||
48186599|NCT01974687|100779859|FG019|COMPLETED|Overall Study||3||
48186600|NCT01974687|100779860|FG020|COMPLETED|Overall Study||3||
48186601|NCT01974687|100779861|FG021|COMPLETED|Overall Study||8||
48186602|NCT01974687|100779862|FG022|COMPLETED|Overall Study||8||
48186603|NCT01974687|100779863|FG023|COMPLETED|Overall Study||6||
48186604|NCT01974687|100779864|FG024|COMPLETED|Overall Study||10||
48186605|NCT01974687|100779840|FG000|NOT COMPLETED|Overall Study||0||
48186606|NCT01974687|100779841|FG001|NOT COMPLETED|Overall Study||0||
48186607|NCT01974687|100779842|FG002|NOT COMPLETED|Overall Study||0||
48186608|NCT01974687|100779843|FG003|NOT COMPLETED|Overall Study||0||
48186609|NCT01974687|100779844|FG004|NOT COMPLETED|Overall Study||0||
48186610|NCT01974687|100779845|FG005|NOT COMPLETED|Overall Study||0||
48186611|NCT01974687|100779846|FG006|NOT COMPLETED|Overall Study||0||
48186612|NCT01974687|100779847|FG007|NOT COMPLETED|Overall Study||0||
48186613|NCT01974687|100779848|FG008|NOT COMPLETED|Overall Study||0||
48186614|NCT01974687|100779849|FG009|NOT COMPLETED|Overall Study||0||
48186615|NCT01974687|100779850|FG010|NOT COMPLETED|Overall Study||0||
48186616|NCT01974687|100779851|FG011|NOT COMPLETED|Overall Study||2||
48186617|NCT01974687|100779852|FG012|NOT COMPLETED|Overall Study||3||
48186618|NCT01974687|100779853|FG013|NOT COMPLETED|Overall Study||2||
48348490|NCT01120639|101184014|FG003|NOT COMPLETED|Overall Study||0||
48637617|NCT02606305|101898598|FG008|COMPLETED|Dose Escalation: Regimens A, B, C and D||4||
48760690|NCT01375140|102200585|FG000|COMPLETED|Overall Study||31||
48186619|NCT01974687|100779854|FG014|NOT COMPLETED|Overall Study||1||
48186620|NCT01974687|100779855|FG015|NOT COMPLETED|Overall Study||1||
48186621|NCT01974687|100779856|FG016|NOT COMPLETED|Overall Study||1||
48186622|NCT01974687|100779857|FG017|NOT COMPLETED|Overall Study||3||
48186623|NCT01974687|100779858|FG018|NOT COMPLETED|Overall Study||0||
48186624|NCT01974687|100779859|FG019|NOT COMPLETED|Overall Study||0||
48186625|NCT01974687|100779860|FG020|NOT COMPLETED|Overall Study||0||
48186626|NCT01974687|100779861|FG021|NOT COMPLETED|Overall Study||0||
48186627|NCT01974687|100779862|FG022|NOT COMPLETED|Overall Study||0||
48186628|NCT01974687|100779863|FG023|NOT COMPLETED|Overall Study||0||
48186629|NCT01974687|100779864|FG024|NOT COMPLETED|Overall Study||0||
48186630|NCT03300817|100779865|FG000|STARTED|Overall Study||49||
48186631|NCT03300817|100779865|FG000|COMPLETED|Overall Study||45||
48348491|NCT02091440|101184015|FG000|STARTED|Overall Study||6||
48348492|NCT02091440|101184015|FG000|Primary Endpoint (Success at 180 Days)|Overall Study||6||
48348493|NCT02091440|101184015|FG000|Overall Survival at 180 Days|Overall Study||6||
48348494|NCT02091440|101184015|FG000|COMPLETED|Overall Study||4||
48348495|NCT02091440|101184015|FG000|NOT COMPLETED|Overall Study||2||
48348496|NCT02485717|101184016|FG000|STARTED|Overall Study||142||
48348497|NCT02485717|101184017|FG001|STARTED|Overall Study||129||
48348498|NCT02485717|101184018|FG002|STARTED|Overall Study||20||
48348499|NCT02485717|101184016|FG000|COMPLETED|Overall Study||136||
48348500|NCT02485717|101184017|FG001|COMPLETED|Overall Study||127||
48348501|NCT02485717|101184018|FG002|COMPLETED|Overall Study||19||
48348502|NCT02485717|101184016|FG000|NOT COMPLETED|Overall Study||6||
48348503|NCT02485717|101184017|FG001|NOT COMPLETED|Overall Study||2||
48348504|NCT02485717|101184018|FG002|NOT COMPLETED|Overall Study||1||
48348505|NCT03277196|101184019|FG000|STARTED|Overall Study||86||
48348506|NCT03277196|101184019|FG000|Rollover Participants|Overall Study||38|Rollover Participants (who completed Study VX15-770-124 Part B or Part A/B).|
48348507|NCT03277196|101184019|FG000|IVA-Naïve Participants|Overall Study||48|IVA-naïve participants (who participated in study VX15-770-124 Part A only or who did not participate in VX15-770-124).|
48637618|NCT02606305|101898599|FG009|COMPLETED|Dose Escalation: Regimens A, B, C and D||5||
48637619|NCT02606305|101898600|FG010|COMPLETED|Dose Escalation: Regimens A, B, C and D||7||
48637620|NCT02606305|101898601|FG011|COMPLETED|Dose Escalation: Regimens A, B, C and D||4||
48637621|NCT02606305|101898602|FG012|COMPLETED|Dose Escalation: Regimens A, B, C and D||10||
48637622|NCT02606305|101898603|FG013|COMPLETED|Dose Escalation: Regimens A, B, C and D||0||
48186632|NCT03300817|100779865|FG000|NOT COMPLETED|Overall Study||4||
48186633|NCT04922021|100779866|FG000|STARTED|Overall Study||29||
48186634|NCT04922021|100779867|FG001|STARTED|Overall Study||29||
48186635|NCT04922021|100779866|FG000|COMPLETED|Overall Study||22||
48186636|NCT04922021|100779867|FG001|COMPLETED|Overall Study||16||
48186637|NCT04922021|100779866|FG000|NOT COMPLETED|Overall Study||7||
48186638|NCT04922021|100779867|FG001|NOT COMPLETED|Overall Study||13||
48186639|NCT04174560|100779868|FG000|STARTED|Overall Study||15||
48348508|NCT03277196|101184019|FG000|COMPLETED|Overall Study||58||
48348509|NCT03277196|101184019|FG000|NOT COMPLETED|Overall Study||28||
48348510|NCT00619229|101184020|FG000|STARTED|Overall Study||18||
48348511|NCT00619229|101184021|FG001|STARTED|Overall Study||18||
48186640|NCT04174560|100779869|FG001|STARTED|Overall Study||12||
48186641|NCT04174560|100779870|FG002|STARTED|Overall Study||18||
48186642|NCT04174560|100779871|FG003|STARTED|Overall Study||3||
48637623|NCT02606305|101898604|FG014|COMPLETED|Dose Escalation: Regimens A, B, C and D||0||
48637624|NCT02606305|101898590|FG000|NOT COMPLETED|Dose Escalation: Regimens A, B, C and D||0||
48637625|NCT02606305|101898591|FG001|NOT COMPLETED|Dose Escalation: Regimens A, B, C and D||0||
48637626|NCT02606305|101898592|FG002|NOT COMPLETED|Dose Escalation: Regimens A, B, C and D||0||
48637627|NCT02606305|101898593|FG003|NOT COMPLETED|Dose Escalation: Regimens A, B, C and D||0||
48637628|NCT02606305|101898594|FG004|NOT COMPLETED|Dose Escalation: Regimens A, B, C and D||0||
48416026|NCT02802735|101353304|FG004|NOT COMPLETED|Overall Study||0||
48416027|NCT02709889|101353305|FG000|STARTED|Overall Study||43||
48416028|NCT02709889|101353306|FG001|STARTED|Overall Study||57||
48416029|NCT02709889|101353307|FG002|STARTED|Overall Study||12||
48416030|NCT02709889|101353308|FG003|STARTED|Overall Study||88||
48416031|NCT02709889|101353305|FG000|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||3||
48186643|NCT04174560|100779868|FG000|COMPLETED|Overall Study||14||
48186644|NCT04174560|100779869|FG001|COMPLETED|Overall Study||12||
48186645|NCT04174560|100779870|FG002|COMPLETED|Overall Study||16||
48186646|NCT04174560|100779871|FG003|COMPLETED|Overall Study||3||
48186647|NCT04174560|100779868|FG000|NOT COMPLETED|Overall Study||1||
48186648|NCT04174560|100779869|FG001|NOT COMPLETED|Overall Study||0||
48186649|NCT04174560|100779870|FG002|NOT COMPLETED|Overall Study||2||
48186650|NCT04174560|100779871|FG003|NOT COMPLETED|Overall Study||0||
48186651|NCT04834362|100779872|FG000|STARTED|Overall Study||53||
48186652|NCT04834362|100779873|FG001|STARTED|Overall Study||52||
48186653|NCT04834362|100779872|FG000|COMPLETED|Overall Study||52||
48186654|NCT04834362|100779873|FG001|COMPLETED|Overall Study||50||
48416032|NCT02709889|101353306|FG001|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||4||
48416033|NCT02709889|101353307|FG002|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||2||
48416034|NCT02709889|101353308|FG003|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||4||
48637629|NCT02606305|101898595|FG005|NOT COMPLETED|Dose Escalation: Regimens A, B, C and D||0||
48637630|NCT02606305|101898596|FG006|NOT COMPLETED|Dose Escalation: Regimens A, B, C and D||0||
48637631|NCT02606305|101898597|FG007|NOT COMPLETED|Dose Escalation: Regimens A, B, C and D||0||
48186655|NCT04834362|100779872|FG000|NOT COMPLETED|Overall Study||1||
48186656|NCT04834362|100779873|FG001|NOT COMPLETED|Overall Study||2||
48186657|NCT00901485|100779874|FG000|STARTED|Overall Study||10||
48186658|NCT00901485|100779875|FG001|STARTED|Overall Study||13||
48186659|NCT00901485|100779874|FG000|COMPLETED|Overall Study||9||
48186660|NCT00901485|100779875|FG001|COMPLETED|Overall Study||9||
48186661|NCT00901485|100779874|FG000|NOT COMPLETED|Overall Study||1||
48186662|NCT00901485|100779875|FG001|NOT COMPLETED|Overall Study||4||
48186663|NCT03184428|100779876|FG000|STARTED|Overall Study||3785||5549
48186664|NCT03184428|100779876|FG000|COMPLETED|Overall Study||2963||4388
48637632|NCT02606305|101898598|FG008|NOT COMPLETED|Dose Escalation: Regimens A, B, C and D||0||
48637633|NCT02606305|101898599|FG009|NOT COMPLETED|Dose Escalation: Regimens A, B, C and D||0||
48186665|NCT03184428|100779876|FG000|NOT COMPLETED|Overall Study||822||1161
48186666|NCT00783718|100779877|FG000|STARTED|Induction Phase||149||
48186667|NCT00783718|100779878|FG001|STARTED|Induction Phase||225||
48186668|NCT00783718|100779879|FG002|STARTED|Induction Phase||521||
48186669|NCT00783718|100779880|FG003|STARTED|Induction Phase||0||
48186670|NCT00783718|100779881|FG004|STARTED|Induction Phase||0||
48186671|NCT00783718|100779882|FG005|STARTED|Induction Phase||0||
48186672|NCT00783718|100779883|FG006|STARTED|Induction Phase||0||
48186673|NCT00783718|100779877|FG000|COMPLETED|Induction Phase||135||
48186674|NCT00783718|100779878|FG001|COMPLETED|Induction Phase||218||
48186675|NCT00783718|100779879|FG002|COMPLETED|Induction Phase||485||
48186676|NCT00783718|100779880|FG003|COMPLETED|Induction Phase||0||
48186677|NCT00783718|100779881|FG004|COMPLETED|Induction Phase||0||
48186678|NCT00783718|100779882|FG005|COMPLETED|Induction Phase||0||
48416035|NCT02709889|101353305|FG000|Neuroendocrine Prostate Cancer|Overall Study||4||
48416036|NCT02709889|101353306|FG001|Neuroendocrine Prostate Cancer|Overall Study||7||
48416037|NCT02709889|101353307|FG002|Neuroendocrine Prostate Cancer|Overall Study||3||
48416038|NCT02709889|101353308|FG003|Neuroendocrine Prostate Cancer|Overall Study||7||
48637634|NCT02606305|101898600|FG010|NOT COMPLETED|Dose Escalation: Regimens A, B, C and D||0||
48186679|NCT00783718|100779883|FG006|COMPLETED|Induction Phase||0||
48186680|NCT00783718|100779877|FG000|NOT COMPLETED|Induction Phase||14||
48186681|NCT00783718|100779878|FG001|NOT COMPLETED|Induction Phase||7||
48186682|NCT00783718|100779879|FG002|NOT COMPLETED|Induction Phase||36||
48186683|NCT00783718|100779880|FG003|NOT COMPLETED|Induction Phase||0||
48416039|NCT02709889|101353305|FG000|Gastroenteropancreatic NEC|Overall Study||6||
48637635|NCT02606305|101898601|FG011|NOT COMPLETED|Dose Escalation: Regimens A, B, C and D||0||
48637636|NCT02606305|101898602|FG012|NOT COMPLETED|Dose Escalation: Regimens A, B, C and D||0||
48186684|NCT00783718|100779881|FG004|NOT COMPLETED|Induction Phase||0||
48186685|NCT00783718|100779882|FG005|NOT COMPLETED|Induction Phase||0||
48186686|NCT00783718|100779883|FG006|NOT COMPLETED|Induction Phase||0||
48186687|NCT00783718|100779877|FG000|STARTED|Maintenance Phase||135||
48186688|NCT00783718|100779878|FG001|STARTED|Maintenance Phase||0||
48186689|NCT00783718|100779879|FG002|STARTED|Maintenance Phase||0||
48186690|NCT00783718|100779880|FG003|STARTED|Maintenance Phase||126||
48439973|NCT01728376|101409995|FG000|COMPLETED|Overall Study||18||
48186691|NCT00783718|100779881|FG004|STARTED|Maintenance Phase||122||
48186692|NCT00783718|100779882|FG005|STARTED|Maintenance Phase||125||
48186693|NCT00783718|100779883|FG006|STARTED|Maintenance Phase||330||
48186694|NCT00783718|100779877|FG000|COMPLETED|Maintenance Phase||30||
48186695|NCT00783718|100779878|FG001|COMPLETED|Maintenance Phase||0||
48186696|NCT00783718|100779879|FG002|COMPLETED|Maintenance Phase||0||
48186697|NCT00783718|100779880|FG003|COMPLETED|Maintenance Phase||48||
48186698|NCT00783718|100779881|FG004|COMPLETED|Maintenance Phase||77||
48186699|NCT00783718|100779882|FG005|COMPLETED|Maintenance Phase||84||
48186700|NCT00783718|100779883|FG006|COMPLETED|Maintenance Phase||135||
48760691|NCT01375140|102200585|FG000|NOT COMPLETED|Overall Study||0||
48760692|NCT04515771|102200586|FG000|STARTED|Period 1: 6 Month Randomized Period||30||
48760693|NCT04515771|102200587|FG001|STARTED|Period 1: 6 Month Randomized Period||20||
48186701|NCT00783718|100779877|FG000|NOT COMPLETED|Maintenance Phase||105||
48186702|NCT00783718|100779878|FG001|NOT COMPLETED|Maintenance Phase||0||
48186703|NCT00783718|100779879|FG002|NOT COMPLETED|Maintenance Phase||0||
48186704|NCT00783718|100779880|FG003|NOT COMPLETED|Maintenance Phase||78||
48186705|NCT00783718|100779881|FG004|NOT COMPLETED|Maintenance Phase||45||
48186706|NCT00783718|100779882|FG005|NOT COMPLETED|Maintenance Phase||41||
48186707|NCT00783718|100779883|FG006|NOT COMPLETED|Maintenance Phase||195||
48186708|NCT00665561|100779884|FG000|STARTED|Overall Study||1316||
48186709|NCT00665561|100779885|FG001|STARTED|Overall Study||1130||
48186710|NCT00665561|100779884|FG000|COMPLETED|Overall Study||814||
48186711|NCT00665561|100779885|FG001|COMPLETED|Overall Study||596||
48186712|NCT00665561|100779884|FG000|NOT COMPLETED|Overall Study||502||
48186713|NCT00665561|100779885|FG001|NOT COMPLETED|Overall Study||534||
48186714|NCT03169361|100779886|FG000|STARTED|Overall Study||774||
48186715|NCT03169361|100779886|FG000|COMPLETED|Overall Study||742||
48186716|NCT03169361|100779886|FG000|NOT COMPLETED|Overall Study||32||
48760694|NCT04515771|102200586|FG000|COMPLETED|Period 1: 6 Month Randomized Period||18||
48760695|NCT04515771|102200587|FG001|COMPLETED|Period 1: 6 Month Randomized Period||18||
48760696|NCT04515771|102200586|FG000|NOT COMPLETED|Period 1: 6 Month Randomized Period||12||
48186717|NCT00628628|100779887|FG000|STARTED|Overall Study||40||
48186718|NCT00628628|100779888|FG001|STARTED|Overall Study||40||
48186719|NCT00628628|100779887|FG000|COMPLETED|Overall Study||40||
48348512|NCT00619229|101184020|FG000|Full Analysis Set (FAS)|Overall Study||16||
48760697|NCT04515771|102200587|FG001|NOT COMPLETED|Period 1: 6 Month Randomized Period||2||
48760698|NCT04515771|102200586|FG000|STARTED|Period 2. 6 Month Waitlist Crossover||0||
48760699|NCT04515771|102200587|FG001|STARTED|Period 2. 6 Month Waitlist Crossover||12||
48760700|NCT04515771|102200586|FG000|COMPLETED|Period 2. 6 Month Waitlist Crossover||0||
48760701|NCT04515771|102200587|FG001|COMPLETED|Period 2. 6 Month Waitlist Crossover||7||
48760702|NCT04515771|102200586|FG000|NOT COMPLETED|Period 2. 6 Month Waitlist Crossover||0||
48760703|NCT04515771|102200587|FG001|NOT COMPLETED|Period 2. 6 Month Waitlist Crossover||5||
48186720|NCT00628628|100779888|FG001|COMPLETED|Overall Study||40||
48186721|NCT00628628|100779887|FG000|NOT COMPLETED|Overall Study||0||
48186722|NCT00628628|100779888|FG001|NOT COMPLETED|Overall Study||0||
48760704|NCT05748275|102200588|FG000|STARTED|Overall Study||40||40
48760705|NCT05748275|102200589|FG001|STARTED|Overall Study||40||40
48348513|NCT00619229|101184021|FG001|Full Analysis Set (FAS)|Overall Study||17||
48348514|NCT00619229|101184020|FG000|COMPLETED|Overall Study||14||
48186723|NCT02186938|100779889|FG000|STARTED|Overall Study||47||
48186724|NCT02186938|100779890|FG001|STARTED|Overall Study||47||
48186725|NCT02186938|100779889|FG000|COMPLETED|Overall Study||38||
48186726|NCT02186938|100779890|FG001|COMPLETED|Overall Study||44||
48186727|NCT02186938|100779889|FG000|NOT COMPLETED|Overall Study||9||
48186728|NCT02186938|100779890|FG001|NOT COMPLETED|Overall Study||3||
48186729|NCT01982760|100779891|FG000|STARTED|Overall Study||14||
48348515|NCT00619229|101184021|FG001|COMPLETED|Overall Study||16||
48348516|NCT00619229|101184020|FG000|NOT COMPLETED|Overall Study||4||
48348517|NCT00619229|101184021|FG001|NOT COMPLETED|Overall Study||2||
48348518|NCT00190775|101184022|FG000|STARTED|Overall Study||268||
48348519|NCT00190775|101184023|FG001|STARTED|Overall Study||234||
48186730|NCT01982760|100779892|FG001|STARTED|Overall Study||0||
48186731|NCT01982760|100779891|FG000|COMPLETED|Overall Study||13||
48186732|NCT01982760|100779892|FG001|COMPLETED|Overall Study||0||
48186733|NCT01982760|100779891|FG000|NOT COMPLETED|Overall Study||1||
48760706|NCT05748275|102200588|FG000|COMPLETED|Overall Study||40||40
48760707|NCT05748275|102200589|FG001|COMPLETED|Overall Study||40||40
48760708|NCT05748275|102200588|FG000|NOT COMPLETED|Overall Study||0||0
48760709|NCT05748275|102200589|FG001|NOT COMPLETED|Overall Study||0||0
48186734|NCT01982760|100779892|FG001|NOT COMPLETED|Overall Study||0||
48186735|NCT01394991|100779893|FG000|STARTED|Overall Study||242||
48186736|NCT01394991|100779894|FG001|STARTED|Overall Study||262||
48186737|NCT01394991|100779893|FG000|COMPLETED|Overall Study||183||
48186738|NCT01394991|100779894|FG001|COMPLETED|Overall Study||190||
48186739|NCT01394991|100779893|FG000|NOT COMPLETED|Overall Study||59||
48186740|NCT01394991|100779894|FG001|NOT COMPLETED|Overall Study||72||
48186741|NCT02147990|100779895|FG000|STARTED|Overall Study||154||
48186742|NCT02147990|100779896|FG001|STARTED|Overall Study||100||
48186743|NCT02147990|100779897|FG002|STARTED|Overall Study||63||
48186744|NCT02147990|100779895|FG000|COMPLETED|Overall Study||154||
48348520|NCT00190775|101184022|FG000|Received Study Drug|Overall Study||266||
48348521|NCT00190775|101184023|FG001|Received Study Drug|Overall Study||234||
48348522|NCT00190775|101184022|FG000|COMPLETED|Overall Study||119||
48348523|NCT00190775|101184023|FG001|COMPLETED|Overall Study||134||
48348524|NCT00190775|101184022|FG000|NOT COMPLETED|Overall Study||149||
48348525|NCT00190775|101184023|FG001|NOT COMPLETED|Overall Study||100||
48348526|NCT01497171|101184024|FG000|STARTED|Overall Study||2||
48348527|NCT01497171|101184025|FG001|STARTED|Overall Study||3||
48348528|NCT01497171|101184024|FG000|COMPLETED|Overall Study||2||
48348529|NCT01497171|101184025|FG001|COMPLETED|Overall Study||3||
48348530|NCT01497171|101184024|FG000|NOT COMPLETED|Overall Study||0||
48348531|NCT01497171|101184025|FG001|NOT COMPLETED|Overall Study||0||
48348532|NCT00278876|101184026|FG000|STARTED|Overall Study||47||
48348533|NCT00278876|101184026|FG000|COMPLETED|Overall Study||38||
48348534|NCT00278876|101184026|FG000|NOT COMPLETED|Overall Study||9||
48348535|NCT03618030|101184027|FG000|STARTED|Overall Study||15|Randomized Treatment (in double-blind period) or Last Dose Administered (dose-optimization period)|
48348536|NCT03618030|101184028|FG001|STARTED|Overall Study||14|Randomized Treatment (in double-blind period) or Last Dose Administered (dose-optimization period)|
48348537|NCT03618030|101184029|FG002|STARTED|Overall Study||21|Randomized Treatment (in double-blind period) or Last Dose Administered (dose-optimization period)|
48348538|NCT03618030|101184030|FG003|STARTED|Overall Study||39|Randomized Treatment (in double-blind period) or Last Dose Administered (dose-optimization period)|
48348539|NCT03618030|101184031|FG004|STARTED|Overall Study||36|Randomized Treatment (in double-blind period) or Last Dose Administered (dose-optimization period)|
48348540|NCT03618030|101184032|FG005|STARTED|Overall Study||27|Randomized Treatment (in double-blind period) or Last Dose Administered (dose-optimization period)|
48348541|NCT03618030|101184033|FG006|STARTED|Overall Study||18|Randomized Treatment (in double-blind period) or Last Dose Administered (dose-optimization period)|
48348542|NCT03618030|101184034|FG007|STARTED|Overall Study||118|Randomized Treatment (in double-blind period) or Last Dose Administered (dose-optimization period)|
48348543|NCT03618030|101184027|FG000|COMPLETED|Overall Study||3||
48348544|NCT03618030|101184028|FG001|COMPLETED|Overall Study||3||
48348545|NCT03618030|101184029|FG002|COMPLETED|Overall Study||13||
48348546|NCT03618030|101184030|FG003|COMPLETED|Overall Study||30||
48348547|NCT03618030|101184031|FG004|COMPLETED|Overall Study||29||
48348548|NCT03618030|101184032|FG005|COMPLETED|Overall Study||21||
48348549|NCT03618030|101184033|FG006|COMPLETED|Overall Study||14||
48348550|NCT03618030|101184034|FG007|COMPLETED|Overall Study||108||
48348551|NCT03618030|101184027|FG000|NOT COMPLETED|Overall Study||12||
48348552|NCT03618030|101184028|FG001|NOT COMPLETED|Overall Study||11||
48348553|NCT03618030|101184029|FG002|NOT COMPLETED|Overall Study||8||
48348554|NCT03618030|101184030|FG003|NOT COMPLETED|Overall Study||9||
48348555|NCT03618030|101184031|FG004|NOT COMPLETED|Overall Study||7||
48348556|NCT03618030|101184032|FG005|NOT COMPLETED|Overall Study||6||
48348557|NCT03618030|101184033|FG006|NOT COMPLETED|Overall Study||4||
48348558|NCT03618030|101184034|FG007|NOT COMPLETED|Overall Study||10||
48348559|NCT01276821|101184035|FG000|STARTED|Overall Study||50||
48348560|NCT01276821|101184036|FG001|STARTED|Overall Study||50||
48348561|NCT01276821|101184035|FG000|COMPLETED|Overall Study||50||
48348562|NCT01276821|101184036|FG001|COMPLETED|Overall Study||49||
48348563|NCT01276821|101184035|FG000|NOT COMPLETED|Overall Study||0||
48348564|NCT01276821|101184036|FG001|NOT COMPLETED|Overall Study||1||
48348565|NCT01416129|101184037|FG000|STARTED|Control Condition: Ischial Containment||5||
48348566|NCT01416129|101184038|FG001|STARTED|Control Condition: Ischial Containment||5||
48348567|NCT01416129|101184037|FG000|COMPLETED|Control Condition: Ischial Containment||5||
48348568|NCT01416129|101184038|FG001|COMPLETED|Control Condition: Ischial Containment||5||
48348569|NCT01416129|101184037|FG000|NOT COMPLETED|Control Condition: Ischial Containment||0||
48348570|NCT01416129|101184038|FG001|NOT COMPLETED|Control Condition: Ischial Containment||0||
48348571|NCT01416129|101184037|FG000|STARTED|Experimental Condition: Brimless||5||
48348572|NCT01416129|101184038|FG001|STARTED|Experimental Condition: Brimless||5||
48348573|NCT01416129|101184037|FG000|COMPLETED|Experimental Condition: Brimless||5||
48348574|NCT01416129|101184038|FG001|COMPLETED|Experimental Condition: Brimless||5||
48760710|NCT05176314|102200590|FG000|STARTED|Overall Study||32||
48760711|NCT05176314|102200590|FG000|Safety Population Day 1, Day 6 and Days 7-12|Overall Study||32|All participants who received at least one dose of study drug for the specified period.|
48767760|NCT04004988|102222819|FG001|Received at Least One Dose of Study Drug|Period 2||20||
48348575|NCT01416129|101184037|FG000|NOT COMPLETED|Experimental Condition: Brimless||0||
48348576|NCT01416129|101184038|FG001|NOT COMPLETED|Experimental Condition: Brimless||0||
48348577|NCT02249052|101184039|FG000|STARTED|Overall Study||19||
48348578|NCT02249052|101184039|FG000|COMPLETED|Overall Study||19||
48348579|NCT02249052|101184039|FG000|NOT COMPLETED|Overall Study||0||
48348580|NCT01360996|101184040|FG000|STARTED|Overall Study||20||
48637637|NCT02606305|101898603|FG013|NOT COMPLETED|Dose Escalation: Regimens A, B, C and D||0||
48767761|NCT04004988|102222818|FG000|COMPLETED|Period 2||21||
48767762|NCT04004988|102222819|FG001|COMPLETED|Period 2||20||
48348581|NCT01360996|101184041|FG001|STARTED|Overall Study||21||
48348582|NCT01360996|101184042|FG002|STARTED|Overall Study||23||
48348583|NCT01360996|101184040|FG000|COMPLETED|Overall Study||14||
48348584|NCT01360996|101184041|FG001|COMPLETED|Overall Study||18||
48348585|NCT01360996|101184042|FG002|COMPLETED|Overall Study||21||
48348586|NCT01360996|101184040|FG000|NOT COMPLETED|Overall Study||6||
48348587|NCT01360996|101184041|FG001|NOT COMPLETED|Overall Study||3||
48348588|NCT01360996|101184042|FG002|NOT COMPLETED|Overall Study||2||
48348589|NCT02317510|101184043|FG000|STARTED|Overall Study||25||
48348590|NCT02317510|101184044|FG001|STARTED|Overall Study||25||
48348591|NCT02317510|101184043|FG000|COMPLETED|Overall Study||25||
48348592|NCT02317510|101184044|FG001|COMPLETED|Overall Study||24||
48348593|NCT02317510|101184043|FG000|NOT COMPLETED|Overall Study||0||
48348594|NCT02317510|101184044|FG001|NOT COMPLETED|Overall Study||1||
48348595|NCT01591005|101184045|FG000|STARTED|Overall Study||53||
48348596|NCT01591005|101184046|FG001|STARTED|Overall Study||53||
48348597|NCT01591005|101184047|FG002|STARTED|Overall Study||68||
48348598|NCT01591005|101184048|FG003|STARTED|Overall Study||68||
48348599|NCT01591005|101184045|FG000|COMPLETED|Overall Study||53||
48348600|NCT01591005|101184046|FG001|COMPLETED|Overall Study||53||
48348601|NCT01591005|101184047|FG002|COMPLETED|Overall Study||68||
48348602|NCT01591005|101184048|FG003|COMPLETED|Overall Study||68||
48348603|NCT01591005|101184045|FG000|NOT COMPLETED|Overall Study||0||
48348604|NCT01591005|101184046|FG001|NOT COMPLETED|Overall Study||0||
48348605|NCT01591005|101184047|FG002|NOT COMPLETED|Overall Study||0||
48348606|NCT01591005|101184048|FG003|NOT COMPLETED|Overall Study||0||
48348607|NCT03783195|101184049|FG000|STARTED|Overall Study||8||
48348608|NCT03783195|101184050|FG001|STARTED|Overall Study||7||
48348609|NCT03783195|101184049|FG000|COMPLETED|Overall Study||8||
48348610|NCT03783195|101184050|FG001|COMPLETED|Overall Study||7||
48348611|NCT03783195|101184049|FG000|NOT COMPLETED|Overall Study||0||
48439974|NCT01728376|101409996|FG001|COMPLETED|Overall Study||9||
48348612|NCT03783195|101184050|FG001|NOT COMPLETED|Overall Study||0||
48348613|NCT01099111|101184051|FG000|STARTED|Overall Study||50||
48348614|NCT01099111|101184052|FG001|STARTED|Overall Study||50||
48348615|NCT01099111|101184053|FG002|STARTED|Overall Study||46||
48348616|NCT01099111|101184054|FG003|STARTED|Overall Study||29||
48348617|NCT01099111|101184055|FG004|STARTED|Overall Study||50||
48348618|NCT01099111|101184051|FG000|COMPLETED|Overall Study||50||
48348619|NCT01099111|101184052|FG001|COMPLETED|Overall Study||50||
48186745|NCT02147990|100779896|FG001|COMPLETED|Overall Study||100||
48186746|NCT02147990|100779897|FG002|COMPLETED|Overall Study||63||
48348620|NCT01099111|101184053|FG002|COMPLETED|Overall Study||46||
48348621|NCT01099111|101184054|FG003|COMPLETED|Overall Study||29||
48348622|NCT01099111|101184055|FG004|COMPLETED|Overall Study||50||
48348623|NCT01099111|101184051|FG000|NOT COMPLETED|Overall Study||0||
48348624|NCT01099111|101184052|FG001|NOT COMPLETED|Overall Study||0||
48348625|NCT01099111|101184053|FG002|NOT COMPLETED|Overall Study||0||
48348626|NCT01099111|101184054|FG003|NOT COMPLETED|Overall Study||0||
48348627|NCT01099111|101184055|FG004|NOT COMPLETED|Overall Study||0||
48348628|NCT03617705|101184056|FG000|STARTED|Overall Study||49||
48348629|NCT03617705|101184056|FG000|COMPLETED|Overall Study||40||
48186747|NCT02147990|100779895|FG000|NOT COMPLETED|Overall Study||0||
48186748|NCT02147990|100779896|FG001|NOT COMPLETED|Overall Study||0||
48186749|NCT02147990|100779897|FG002|NOT COMPLETED|Overall Study||0||
48348630|NCT03617705|101184056|FG000|NOT COMPLETED|Overall Study||9||
48348631|NCT02513446|101184057|FG000|STARTED|Period 1||8||
48348632|NCT02513446|101184058|FG001|STARTED|Period 1||8||
48348633|NCT02513446|101184057|FG000|COMPLETED|Period 1||8||
48348634|NCT02513446|101184058|FG001|COMPLETED|Period 1||8||
48348635|NCT02513446|101184057|FG000|NOT COMPLETED|Period 1||0||
48348636|NCT02513446|101184058|FG001|NOT COMPLETED|Period 1||0||
48348637|NCT02513446|101184057|FG000|STARTED|Washout Period of 10 Days||8||
48186750|NCT02062905|100779898|FG000|STARTED|Overall Study||35||
48186751|NCT02062905|100779899|FG001|STARTED|Overall Study||33||
48186752|NCT02062905|100779898|FG000|COMPLETED|Overall Study||28||
48186753|NCT02062905|100779899|FG001|COMPLETED|Overall Study||31||
48348638|NCT02513446|101184058|FG001|STARTED|Washout Period of 10 Days||8||
48348639|NCT02513446|101184057|FG000|COMPLETED|Washout Period of 10 Days||8||
48348640|NCT02513446|101184058|FG001|COMPLETED|Washout Period of 10 Days||8||
48348641|NCT02513446|101184057|FG000|NOT COMPLETED|Washout Period of 10 Days||0||
48348642|NCT02513446|101184058|FG001|NOT COMPLETED|Washout Period of 10 Days||0||
48348643|NCT02513446|101184057|FG000|STARTED|Period 2||8||
48760712|NCT05176314|102200590|FG000|Safety Population Day 13, Days 14-17|Overall Study||31|All participants who received at least one dose of study drug for the specified period. One participant discontinued from the study at day 8 and didn't receive rosuvastatin + pirtobrutinib on day 13, and pirtobrutinib once daily (QD) on days 14 to 17, thus only 31 participants were analyzed for safety for that period.|
48760713|NCT05176314|102200590|FG000|COMPLETED|Overall Study||28||
48760714|NCT05176314|102200590|FG000|NOT COMPLETED|Overall Study||4||
48760715|NCT04851691|102200591|FG000|STARTED|Overall Study||67||
48760716|NCT04851691|102200592|FG001|STARTED|Overall Study||91||
48760717|NCT04851691|102200591|FG000|COMPLETED|Overall Study||67||
48760718|NCT04851691|102200592|FG001|COMPLETED|Overall Study||91||
48760719|NCT04851691|102200591|FG000|NOT COMPLETED|Overall Study||0||
48760720|NCT04851691|102200592|FG001|NOT COMPLETED|Overall Study||0||
48760721|NCT01527149|102200593|FG000|STARTED|Overall Study||37||
48760722|NCT01527149|102200593|FG000|COMPLETED|Overall Study||35||
48760723|NCT01527149|102200593|FG000|NOT COMPLETED|Overall Study||2||
48760724|NCT04825574|102200594|FG000|STARTED|Overall Study||2||
48760725|NCT04825574|102200594|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2||
48760726|NCT04825574|102200594|FG000|COMPLETED|Overall Study||0||
48348644|NCT02513446|101184058|FG001|STARTED|Period 2||8||
48348645|NCT02513446|101184057|FG000|COMPLETED|Period 2||8||
48348646|NCT02513446|101184058|FG001|COMPLETED|Period 2||8||
48348647|NCT02513446|101184057|FG000|NOT COMPLETED|Period 2||0||
48348648|NCT02513446|101184058|FG001|NOT COMPLETED|Period 2||0||
48760727|NCT04825574|102200594|FG000|NOT COMPLETED|Overall Study||2||
48348649|NCT05369806|101184059|FG000|STARTED|Overall Study||80||
48760728|NCT03632135|102200595|FG000|STARTED|Overall Study||35||
48760729|NCT03632135|102200596|FG001|STARTED|Overall Study||43||
48760730|NCT03632135|102200595|FG000|COMPLETED|Overall Study||35||
48760731|NCT03632135|102200596|FG001|COMPLETED|Overall Study||43||
48760732|NCT03632135|102200595|FG000|NOT COMPLETED|Overall Study||0||
48760733|NCT03632135|102200596|FG001|NOT COMPLETED|Overall Study||0||
48760734|NCT04613362|102200597|FG000|STARTED|Intervention Period||30||
48760735|NCT04613362|102200598|FG001|STARTED|Intervention Period||27||
48760736|NCT04613362|102200597|FG000|Received Intervention|Intervention Period||27||
48760737|NCT04613362|102200598|FG001|Received Intervention|Intervention Period||17||
48760738|NCT04613362|102200597|FG000|Did Not Receive Intervention|Intervention Period||3||
48760739|NCT04613362|102200598|FG001|Did Not Receive Intervention|Intervention Period||10||
48760740|NCT04613362|102200597|FG000|COMPLETED|Intervention Period||30||
48760741|NCT04613362|102200598|FG001|COMPLETED|Intervention Period||27||
48760742|NCT04613362|102200597|FG000|NOT COMPLETED|Intervention Period||0||
48760743|NCT04613362|102200598|FG001|NOT COMPLETED|Intervention Period||0||
48760744|NCT04613362|102200597|FG000|STARTED|3 Month Follow-up||30||
48760745|NCT04613362|102200598|FG001|STARTED|3 Month Follow-up||27||
48760746|NCT04613362|102200597|FG000|COMPLETED|3 Month Follow-up||29||
48760747|NCT04613362|102200598|FG001|COMPLETED|3 Month Follow-up||25||
48760748|NCT04613362|102200597|FG000|NOT COMPLETED|3 Month Follow-up||1||
48760749|NCT04613362|102200598|FG001|NOT COMPLETED|3 Month Follow-up||2||
48760750|NCT04613362|102200597|FG000|STARTED|6 Month Follow-up||29||
48760751|NCT04613362|102200598|FG001|STARTED|6 Month Follow-up||25||
48760752|NCT04613362|102200597|FG000|COMPLETED|6 Month Follow-up||29||
48760753|NCT04613362|102200598|FG001|COMPLETED|6 Month Follow-up||24||
48760754|NCT04613362|102200597|FG000|NOT COMPLETED|6 Month Follow-up||0||
48760755|NCT04613362|102200598|FG001|NOT COMPLETED|6 Month Follow-up||1||
48760756|NCT01849263|102202886|FG000|STARTED|Overall Study||40||
48760757|NCT01849263|102202886|FG000|COMPLETED|Overall Study||40||
48760758|NCT01849263|102202886|FG000|NOT COMPLETED|Overall Study||0||
48760759|NCT02711891|102202887|FG000|STARTED|Overall Study||17||
48760760|NCT02711891|102202888|FG001|STARTED|Overall Study||17||
48760761|NCT02711891|102202887|FG000|COMPLETED|Overall Study||17||
48760762|NCT02711891|102202888|FG001|COMPLETED|Overall Study||17||
48760763|NCT02711891|102202887|FG000|NOT COMPLETED|Overall Study||0||
48760764|NCT02711891|102202888|FG001|NOT COMPLETED|Overall Study||0||
48760765|NCT02205736|102202889|FG000|STARTED|Overall Study||329||
48760766|NCT02205736|102202889|FG000|COMPLETED|Overall Study||223||
48348650|NCT05369806|101184059|FG000|COMPLETED|Overall Study||79||
48348651|NCT05369806|101184059|FG000|NOT COMPLETED|Overall Study||1||
48348652|NCT02772783|101184060|FG000|STARTED|Experimental Condition 1, 1 Day||8||
48760767|NCT02205736|102202889|FG000|NOT COMPLETED|Overall Study||106||
48760768|NCT04709068|102202890|FG000|STARTED|Overall Study||8||
48760769|NCT04709068|102202890|FG000|COMPLETED|Overall Study||8||
48760770|NCT04709068|102202890|FG000|NOT COMPLETED|Overall Study||0||
48760771|NCT03536572|102202891|FG000|STARTED|Overall Study||134||
48348653|NCT02772783|101184061|FG001|STARTED|Experimental Condition 1, 1 Day||7||
48760772|NCT03536572|102202892|FG001|STARTED|Overall Study||136||
48760773|NCT03536572|102202891|FG000|COMPLETED|Overall Study||96||
48760774|NCT03536572|102202892|FG001|COMPLETED|Overall Study||113||
48760775|NCT03536572|102202891|FG000|NOT COMPLETED|Overall Study||38||
48760776|NCT03536572|102202892|FG001|NOT COMPLETED|Overall Study||23||
48348654|NCT02772783|101184060|FG000|COMPLETED|Experimental Condition 1, 1 Day||8||
48348655|NCT02772783|101184061|FG001|COMPLETED|Experimental Condition 1, 1 Day||7||
48760777|NCT00687596|102202893|FG000|STARTED|Overall Study||26||
48760778|NCT00687596|102202894|FG001|STARTED|Overall Study||26||
48760779|NCT00687596|102202893|FG000|COMPLETED|Overall Study||0||
48760780|NCT00687596|102202894|FG001|COMPLETED|Overall Study||0||
48186754|NCT02062905|100779898|FG000|NOT COMPLETED|Overall Study||7||
48186755|NCT02062905|100779899|FG001|NOT COMPLETED|Overall Study||2||
48186756|NCT01089556|100779900|FG000|STARTED|Study Period II (Weeks 1-8)||404||
48186757|NCT01089556|100779901|FG001|STARTED|Study Period II (Weeks 1-8)||407||
48348656|NCT02772783|101184060|FG000|NOT COMPLETED|Experimental Condition 1, 1 Day||0||
48348657|NCT02772783|101184061|FG001|NOT COMPLETED|Experimental Condition 1, 1 Day||0||
48348658|NCT02772783|101184060|FG000|STARTED|Wash-out, 1 Week||8||
48348659|NCT02772783|101184061|FG001|STARTED|Wash-out, 1 Week||7||
48348660|NCT02772783|101184060|FG000|COMPLETED|Wash-out, 1 Week||8||
48348661|NCT02772783|101184061|FG001|COMPLETED|Wash-out, 1 Week||7||
48348662|NCT02772783|101184060|FG000|NOT COMPLETED|Wash-out, 1 Week||0||
48348663|NCT02772783|101184061|FG001|NOT COMPLETED|Wash-out, 1 Week||0||
48348664|NCT02772783|101184060|FG000|STARTED|Comparison Condition, 1 Day||8||
48348665|NCT02772783|101184061|FG001|STARTED|Comparison Condition, 1 Day||7||
48348666|NCT02772783|101184060|FG000|COMPLETED|Comparison Condition, 1 Day||8||
48348667|NCT02772783|101184061|FG001|COMPLETED|Comparison Condition, 1 Day||7||
48348668|NCT02772783|101184060|FG000|NOT COMPLETED|Comparison Condition, 1 Day||0||
48348669|NCT02772783|101184061|FG001|NOT COMPLETED|Comparison Condition, 1 Day||0||
48348670|NCT02772783|101184060|FG000|STARTED|Wash-out, 1 Week||8||
48348671|NCT02772783|101184061|FG001|STARTED|Wash-out, 1 Week||7||
48348672|NCT02772783|101184060|FG000|COMPLETED|Wash-out, 1 Week||8||
48348673|NCT02772783|101184061|FG001|COMPLETED|Wash-out, 1 Week||7||
48348674|NCT02772783|101184060|FG000|NOT COMPLETED|Wash-out, 1 Week||0||
48348675|NCT02772783|101184061|FG001|NOT COMPLETED|Wash-out, 1 Week||0||
48348676|NCT02772783|101184060|FG000|STARTED|Experimental Condition 2, 1 Day||8||
48348677|NCT02772783|101184061|FG001|STARTED|Experimental Condition 2, 1 Day||7||
48348678|NCT02772783|101184060|FG000|COMPLETED|Experimental Condition 2, 1 Day||8||
48348679|NCT02772783|101184061|FG001|COMPLETED|Experimental Condition 2, 1 Day||7||
48348680|NCT02772783|101184060|FG000|NOT COMPLETED|Experimental Condition 2, 1 Day||0||
48348681|NCT02772783|101184061|FG001|NOT COMPLETED|Experimental Condition 2, 1 Day||0||
48348682|NCT00282243|101184062|FG000|STARTED|Pharmacokinetic Treatment Period||70||
48348683|NCT00282243|101184062|FG000|Received Tacrolimus|Pharmacokinetic Treatment Period||70||
48348684|NCT00282243|101184062|FG000|Received Tacrolimus MR|Pharmacokinetic Treatment Period||69||
48348685|NCT00282243|101184062|FG000|COMPLETED|Pharmacokinetic Treatment Period||65||
48760781|NCT00687596|102202893|FG000|NOT COMPLETED|Overall Study||26||
48760782|NCT00687596|102202894|FG001|NOT COMPLETED|Overall Study||26||
48760783|NCT04606134|102202895|FG000|STARTED|Overall Study||6||
48760784|NCT04606134|102202896|FG001|STARTED|Overall Study||4||
48760785|NCT04606134|102202895|FG000|COMPLETED|Overall Study||6||
48760786|NCT04606134|102202896|FG001|COMPLETED|Overall Study||3||
48760787|NCT04606134|102202895|FG000|NOT COMPLETED|Overall Study||0||
48760788|NCT04606134|102202896|FG001|NOT COMPLETED|Overall Study||1||
48760789|NCT01231906|102202897|FG000|STARTED|Overall Study||319|Eligible and began receiving protocol therapy|
48760790|NCT01231906|102202898|FG001|STARTED|Overall Study||323|Eligible and began receiving protocol therapy|
48760791|NCT01231906|102202897|FG000|Received Therapy|Overall Study||308||
48348686|NCT00282243|101184062|FG000|NOT COMPLETED|Pharmacokinetic Treatment Period||5||
48348687|NCT00282243|101184062|FG000|STARTED|Extension Treatment Period||65||
48348688|NCT00282243|101184062|FG000|COMPLETED|Extension Treatment Period||43||
48348689|NCT00282243|101184062|FG000|NOT COMPLETED|Extension Treatment Period||22||
48348690|NCT01049776|101184063|FG000|STARTED|Overall Study||32||
48348691|NCT01049776|101184063|FG000|COMPLETED|Overall Study||12||
48760792|NCT01231906|102202898|FG001|Received Therapy|Overall Study||318||
48760793|NCT01231906|102202897|FG000|COMPLETED|Overall Study||198|Completion of planned therapy with no event observed: disease progression, second malignant neoplasm (SMN), death regardless of cause|
48760794|NCT01231906|102202898|FG001|COMPLETED|Overall Study||222|Completion of planned therapy with no event observed: disease progression, second malignant neoplasm (SMN), death regardless of cause|
48760795|NCT01231906|102202897|FG000|NOT COMPLETED|Overall Study||121||
48348692|NCT01049776|101184063|FG000|NOT COMPLETED|Overall Study||20||
48348693|NCT03180736|101184064|FG000|STARTED|Overall Study||151||
48348694|NCT03180736|101184065|FG001|STARTED|Overall Study||153||
48416040|NCT02709889|101353306|FG001|Gastroenteropancreatic NEC|Overall Study||5||
48416041|NCT02709889|101353307|FG002|Gastroenteropancreatic NEC|Overall Study||2||
48416042|NCT02709889|101353308|FG003|Gastroenteropancreatic NEC|Overall Study||23||
48416043|NCT02709889|101353305|FG000|Other NEC|Overall Study||11||
48416044|NCT02709889|101353306|FG001|Other NEC|Overall Study||12||
48416045|NCT02709889|101353307|FG002|Other NEC|Overall Study||1||
48416046|NCT02709889|101353308|FG003|Other NEC|Overall Study||7||
48416047|NCT02709889|101353305|FG000|Malignant Melanoma|Overall Study||3||
48416048|NCT02709889|101353306|FG001|Malignant Melanoma|Overall Study||6||
48416049|NCT02709889|101353307|FG002|Malignant Melanoma|Overall Study||0||
48416050|NCT02709889|101353308|FG003|Malignant Melanoma|Overall Study||11||
48416051|NCT02709889|101353305|FG000|Medullary Thyroid Cancer|Overall Study||3||
48416052|NCT02709889|101353306|FG001|Medullary Thyroid Cancer|Overall Study||3||
48416053|NCT02709889|101353307|FG002|Medullary Thyroid Cancer|Overall Study||0||
48416054|NCT02709889|101353308|FG003|Medullary Thyroid Cancer|Overall Study||7||
48416055|NCT02709889|101353305|FG000|Glioblastoma|Overall Study||4||
48416056|NCT02709889|101353306|FG001|Glioblastoma|Overall Study||4||
48416057|NCT02709889|101353307|FG002|Glioblastoma|Overall Study||1||
48416058|NCT02709889|101353308|FG003|Glioblastoma|Overall Study||14||
48416059|NCT02709889|101353305|FG000|Other Solid Tumors|Overall Study||9||
48416060|NCT02709889|101353306|FG001|Other Solid Tumors|Overall Study||16||
48416061|NCT02709889|101353307|FG002|Other Solid Tumors|Overall Study||3||
48416062|NCT02709889|101353308|FG003|Other Solid Tumors|Overall Study||15||
48416063|NCT02709889|101353305|FG000|COMPLETED|Overall Study||0||
48416064|NCT02709889|101353306|FG001|COMPLETED|Overall Study||0||
48416065|NCT02709889|101353307|FG002|COMPLETED|Overall Study||0||
48416066|NCT02709889|101353308|FG003|COMPLETED|Overall Study||0||
48416067|NCT02709889|101353305|FG000|NOT COMPLETED|Overall Study||43||
48416068|NCT02709889|101353306|FG001|NOT COMPLETED|Overall Study||57||
48416069|NCT02709889|101353307|FG002|NOT COMPLETED|Overall Study||12||
48637638|NCT02606305|101898604|FG014|NOT COMPLETED|Dose Escalation: Regimens A, B, C and D||0||
48416070|NCT02709889|101353308|FG003|NOT COMPLETED|Overall Study||88||
48416071|NCT00125268|101353309|FG000|STARTED|Overall Study||16||
48416072|NCT00125268|101353310|FG001|STARTED|Overall Study||14||
48416073|NCT00125268|101353309|FG000|COMPLETED|Overall Study||15||
48416074|NCT00125268|101353310|FG001|COMPLETED|Overall Study||13||
48416075|NCT00125268|101353309|FG000|NOT COMPLETED|Overall Study||1||
48416076|NCT00125268|101353310|FG001|NOT COMPLETED|Overall Study||1||
48416077|NCT03770689|101353311|FG000|STARTED|Overall Study||1||
48416078|NCT03770689|101353312|FG001|STARTED|Overall Study||6||
48416079|NCT03770689|101353313|FG002|STARTED|Overall Study||6||
48416080|NCT03770689|101353314|FG003|STARTED|Overall Study||6||
48416081|NCT03770689|101353311|FG000|Pharmacokinetic Analysis Set|Overall Study||1||
48416082|NCT03770689|101353312|FG001|Pharmacokinetic Analysis Set|Overall Study||6||
48416083|NCT03770689|101353313|FG002|Pharmacokinetic Analysis Set|Overall Study||6||
48416084|NCT03770689|101353314|FG003|Pharmacokinetic Analysis Set|Overall Study||6||
48416085|NCT03770689|101353311|FG000|Full Analysis Set (FAS)|Overall Study||1||
48416086|NCT03770689|101353312|FG001|Full Analysis Set (FAS)|Overall Study||6||
48416087|NCT03770689|101353313|FG002|Full Analysis Set (FAS)|Overall Study||6||
48416088|NCT03770689|101353314|FG003|Full Analysis Set (FAS)|Overall Study||6||
48416089|NCT03770689|101353311|FG000|Safety Analysis Set (SAF)|Overall Study||1||
48416090|NCT03770689|101353312|FG001|Safety Analysis Set (SAF)|Overall Study||6||
48416091|NCT03770689|101353313|FG002|Safety Analysis Set (SAF)|Overall Study||6||
48416092|NCT03770689|101353314|FG003|Safety Analysis Set (SAF)|Overall Study||6||
48416093|NCT03770689|101353311|FG000|COMPLETED|Overall Study||1||
48416094|NCT03770689|101353312|FG001|COMPLETED|Overall Study||6||
48416095|NCT03770689|101353313|FG002|COMPLETED|Overall Study||6||
48416096|NCT03770689|101353314|FG003|COMPLETED|Overall Study||6||
48416097|NCT03770689|101353311|FG000|NOT COMPLETED|Overall Study||0||
48416098|NCT03770689|101353312|FG001|NOT COMPLETED|Overall Study||0||
48637639|NCT02606305|101898590|FG000|STARTED|Dose Expansion: Regimens A and D||0||
48637640|NCT02606305|101898591|FG001|STARTED|Dose Expansion: Regimens A and D||0||
48637641|NCT02606305|101898592|FG002|STARTED|Dose Expansion: Regimens A and D||21||
48637642|NCT02606305|101898593|FG003|STARTED|Dose Expansion: Regimens A and D||34||
48637643|NCT02606305|101898594|FG004|STARTED|Dose Expansion: Regimens A and D||60||
48416099|NCT03770689|101353313|FG002|NOT COMPLETED|Overall Study||0||
48416100|NCT03770689|101353314|FG003|NOT COMPLETED|Overall Study||0||
48416101|NCT00285246|101353315|FG000|STARTED|Overall Study||838||
48416102|NCT00285246|101353315|FG000|COMPLETED|Overall Study||790||
48416103|NCT00285246|101353315|FG000|NOT COMPLETED|Overall Study||48||
48416104|NCT04735432|101353316|FG000|STARTED|Overall Study||55||
48416105|NCT04735432|101353317|FG001|STARTED|Overall Study||55||
48416106|NCT04735432|101353316|FG000|COMPLETED|Overall Study||52||
48416107|NCT04735432|101353317|FG001|COMPLETED|Overall Study||55||
48416108|NCT04735432|101353316|FG000|NOT COMPLETED|Overall Study||3||
48416109|NCT04735432|101353317|FG001|NOT COMPLETED|Overall Study||0||
48416110|NCT02730546|101353318|FG000|STARTED|Overall Study||31||
48416111|NCT02730546|101353318|FG000|COMPLETED|Overall Study||31||
48416112|NCT02730546|101353318|FG000|NOT COMPLETED|Overall Study||0||
48637644|NCT02606305|101898595|FG005|STARTED|Dose Expansion: Regimens A and D||0||
48637645|NCT02606305|101898596|FG006|STARTED|Dose Expansion: Regimens A and D||0||
48637646|NCT02606305|101898597|FG007|STARTED|Dose Expansion: Regimens A and D||0||
48637647|NCT02606305|101898598|FG008|STARTED|Dose Expansion: Regimens A and D||0||
48637648|NCT02606305|101898599|FG009|STARTED|Dose Expansion: Regimens A and D||0||
48637649|NCT02606305|101898600|FG010|STARTED|Dose Expansion: Regimens A and D||0||
48637650|NCT02606305|101898601|FG011|STARTED|Dose Expansion: Regimens A and D||0||
48637651|NCT02606305|101898602|FG012|STARTED|Dose Expansion: Regimens A and D||0||
48637652|NCT02606305|101898603|FG013|STARTED|Dose Expansion: Regimens A and D||46||
48637653|NCT02606305|101898604|FG014|STARTED|Dose Expansion: Regimens A and D||0||
48637654|NCT02606305|101898590|FG000|Received at Least 1 Dose of Study Drug|Dose Expansion: Regimens A and D||0||
48637655|NCT02606305|101898591|FG001|Received at Least 1 Dose of Study Drug|Dose Expansion: Regimens A and D||0||
48637656|NCT02606305|101898592|FG002|Received at Least 1 Dose of Study Drug|Dose Expansion: Regimens A and D||21||
48637657|NCT02606305|101898593|FG003|Received at Least 1 Dose of Study Drug|Dose Expansion: Regimens A and D||34||
48637658|NCT02606305|101898594|FG004|Received at Least 1 Dose of Study Drug|Dose Expansion: Regimens A and D||60||
48637659|NCT02606305|101898595|FG005|Received at Least 1 Dose of Study Drug|Dose Expansion: Regimens A and D||0||
48637660|NCT02606305|101898596|FG006|Received at Least 1 Dose of Study Drug|Dose Expansion: Regimens A and D||0||
48637661|NCT02606305|101898597|FG007|Received at Least 1 Dose of Study Drug|Dose Expansion: Regimens A and D||0||
48637662|NCT02606305|101898598|FG008|Received at Least 1 Dose of Study Drug|Dose Expansion: Regimens A and D||0||
48416113|NCT01195636|101353319|FG000|STARTED|First Intervention (3 Weeks)||35||
48416114|NCT01195636|101353320|FG001|STARTED|First Intervention (3 Weeks)||35||
48416115|NCT01195636|101353319|FG000|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||33||
48416116|NCT01195636|101353320|FG001|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||35||
48416117|NCT01195636|101353319|FG000|COMPLETED|First Intervention (3 Weeks)||30||
48416118|NCT01195636|101353320|FG001|COMPLETED|First Intervention (3 Weeks)||32||
48416119|NCT01195636|101353319|FG000|NOT COMPLETED|First Intervention (3 Weeks)||5||
48416120|NCT01195636|101353320|FG001|NOT COMPLETED|First Intervention (3 Weeks)||3||
48416121|NCT01195636|101353319|FG000|STARTED|Washout Period (2 Weeks)||30||
48416122|NCT01195636|101353320|FG001|STARTED|Washout Period (2 Weeks)||32||
48416123|NCT01195636|101353319|FG000|COMPLETED|Washout Period (2 Weeks)||28||
48416124|NCT01195636|101353320|FG001|COMPLETED|Washout Period (2 Weeks)||29||
48416125|NCT01195636|101353319|FG000|NOT COMPLETED|Washout Period (2 Weeks)||2||
48416126|NCT01195636|101353320|FG001|NOT COMPLETED|Washout Period (2 Weeks)||3||
48416127|NCT01195636|101353319|FG000|STARTED|Second Intervention (3 Weeks)||28||
48416128|NCT01195636|101353320|FG001|STARTED|Second Intervention (3 Weeks)||29||
48416129|NCT01195636|101353319|FG000|COMPLETED|Second Intervention (3 Weeks)||27||
48416130|NCT01195636|101353320|FG001|COMPLETED|Second Intervention (3 Weeks)||27||
48416131|NCT01195636|101353319|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||1||
48416132|NCT01195636|101353320|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||2||
48416133|NCT00945594|101353321|FG000|STARTED|Overall Study||50||
48416134|NCT00945594|101353322|FG001|STARTED|Overall Study||50||
48416135|NCT00945594|101353321|FG000|COMPLETED|Overall Study||50||
48416136|NCT00945594|101353322|FG001|COMPLETED|Overall Study||50||
48416137|NCT00945594|101353321|FG000|NOT COMPLETED|Overall Study||0||
48416138|NCT00945594|101353322|FG001|NOT COMPLETED|Overall Study||0||
48416139|NCT02962102|101353323|FG000|STARTED|Overall Study||51||
48416140|NCT02962102|101353324|FG001|STARTED|Overall Study||50||
48416141|NCT02962102|101353325|FG002|STARTED|Overall Study||49||
48416142|NCT02962102|101353323|FG000|COMPLETED|Overall Study||51||
48416143|NCT02962102|101353324|FG001|COMPLETED|Overall Study||50||
48416144|NCT02962102|101353325|FG002|COMPLETED|Overall Study||49||
48416145|NCT02962102|101353323|FG000|NOT COMPLETED|Overall Study||0||
48416146|NCT02962102|101353324|FG001|NOT COMPLETED|Overall Study||0||
48416147|NCT02962102|101353325|FG002|NOT COMPLETED|Overall Study||0||
48416148|NCT00606931|101353326|FG000|STARTED|Overall Study||22||
48416149|NCT00606931|101353326|FG000|COMPLETED|Overall Study||19||
48416150|NCT00606931|101353326|FG000|NOT COMPLETED|Overall Study||3||
48416151|NCT01349491|101353327|FG000|STARTED|Overall Study||5||
48416152|NCT01349491|101353328|FG001|STARTED|Overall Study||5||
48416153|NCT01349491|101353327|FG000|COMPLETED|Overall Study||5||
48416154|NCT01349491|101353328|FG001|COMPLETED|Overall Study||5||
48416155|NCT01349491|101353327|FG000|NOT COMPLETED|Overall Study||0||
48416156|NCT01349491|101353328|FG001|NOT COMPLETED|Overall Study||0||
48637663|NCT02606305|101898599|FG009|Received at Least 1 Dose of Study Drug|Dose Expansion: Regimens A and D||0||
48637664|NCT02606305|101898600|FG010|Received at Least 1 Dose of Study Drug|Dose Expansion: Regimens A and D||0||
48416157|NCT01202643|101353329|FG000|STARTED|Period 1||6||
48416158|NCT01202643|101353330|FG001|STARTED|Period 1||6||
48416159|NCT01202643|101353329|FG000|COMPLETED|Period 1||6||
48416160|NCT01202643|101353330|FG001|COMPLETED|Period 1||6||
48416161|NCT01202643|101353329|FG000|NOT COMPLETED|Period 1||0||
48416162|NCT01202643|101353330|FG001|NOT COMPLETED|Period 1||0||
48416163|NCT01202643|101353329|FG000|STARTED|Crossover Cycle||1|Patients were invited to the crossover but most chose not to continue in the study|
48637665|NCT02606305|101898601|FG011|Received at Least 1 Dose of Study Drug|Dose Expansion: Regimens A and D||0||
48416164|NCT01202643|101353330|FG001|STARTED|Crossover Cycle||2|Patients were invited to the crossover but most chose not to continue in the study|
48637666|NCT02606305|101898602|FG012|Received at Least 1 Dose of Study Drug|Dose Expansion: Regimens A and D||0||
48637667|NCT02606305|101898603|FG013|Received at Least 1 Dose of Study Drug|Dose Expansion: Regimens A and D||0||
48637668|NCT02606305|101898604|FG014|Received at Least 1 Dose of Study Drug|Dose Expansion: Regimens A and D||0||
48637669|NCT02606305|101898590|FG000|COMPLETED|Dose Expansion: Regimens A and D||0||
48637670|NCT02606305|101898591|FG001|COMPLETED|Dose Expansion: Regimens A and D||0||
48637671|NCT02606305|101898592|FG002|COMPLETED|Dose Expansion: Regimens A and D||21||
48637672|NCT02606305|101898593|FG003|COMPLETED|Dose Expansion: Regimens A and D||34||
48637673|NCT02606305|101898594|FG004|COMPLETED|Dose Expansion: Regimens A and D||60||
48637674|NCT02606305|101898595|FG005|COMPLETED|Dose Expansion: Regimens A and D||0||
48637675|NCT02606305|101898596|FG006|COMPLETED|Dose Expansion: Regimens A and D||0||
48637676|NCT02606305|101898597|FG007|COMPLETED|Dose Expansion: Regimens A and D||0||
48637677|NCT02606305|101898598|FG008|COMPLETED|Dose Expansion: Regimens A and D||0||
48637678|NCT02606305|101898599|FG009|COMPLETED|Dose Expansion: Regimens A and D||0||
48637679|NCT02606305|101898600|FG010|COMPLETED|Dose Expansion: Regimens A and D||0||
48637680|NCT02606305|101898601|FG011|COMPLETED|Dose Expansion: Regimens A and D||0||
48637681|NCT02606305|101898602|FG012|COMPLETED|Dose Expansion: Regimens A and D||0||
48637682|NCT02606305|101898603|FG013|COMPLETED|Dose Expansion: Regimens A and D||0||
48637683|NCT02606305|101898604|FG014|COMPLETED|Dose Expansion: Regimens A and D||0||
48637684|NCT02606305|101898590|FG000|NOT COMPLETED|Dose Expansion: Regimens A and D||0||
48637685|NCT02606305|101898591|FG001|NOT COMPLETED|Dose Expansion: Regimens A and D||0||
48637686|NCT02606305|101898592|FG002|NOT COMPLETED|Dose Expansion: Regimens A and D||0||
48637687|NCT02606305|101898593|FG003|NOT COMPLETED|Dose Expansion: Regimens A and D||0||
48637688|NCT02606305|101898594|FG004|NOT COMPLETED|Dose Expansion: Regimens A and D||0||
48637689|NCT02606305|101898595|FG005|NOT COMPLETED|Dose Expansion: Regimens A and D||0||
48637690|NCT02606305|101898596|FG006|NOT COMPLETED|Dose Expansion: Regimens A and D||0||
48637691|NCT02606305|101898597|FG007|NOT COMPLETED|Dose Expansion: Regimens A and D||0||
48637692|NCT02606305|101898598|FG008|NOT COMPLETED|Dose Expansion: Regimens A and D||0||
48637693|NCT02606305|101898599|FG009|NOT COMPLETED|Dose Expansion: Regimens A and D||0||
48637694|NCT02606305|101898600|FG010|NOT COMPLETED|Dose Expansion: Regimens A and D||0||
48637695|NCT02606305|101898601|FG011|NOT COMPLETED|Dose Expansion: Regimens A and D||0||
48637696|NCT02606305|101898602|FG012|NOT COMPLETED|Dose Expansion: Regimens A and D||0||
48637697|NCT02606305|101898603|FG013|NOT COMPLETED|Dose Expansion: Regimens A and D||46||
48637698|NCT02606305|101898604|FG014|NOT COMPLETED|Dose Expansion: Regimens A and D||0||
48637699|NCT02606305|101898590|FG000|STARTED|Triplet Dose: Regimen E||0||
48637700|NCT02606305|101898591|FG001|STARTED|Triplet Dose: Regimen E||0||
48637701|NCT02606305|101898592|FG002|STARTED|Triplet Dose: Regimen E||0||
48637702|NCT02606305|101898593|FG003|STARTED|Triplet Dose: Regimen E||0||
48637703|NCT02606305|101898594|FG004|STARTED|Triplet Dose: Regimen E||0||
48637704|NCT02606305|101898595|FG005|STARTED|Triplet Dose: Regimen E||0||
48637705|NCT02606305|101898596|FG006|STARTED|Triplet Dose: Regimen E||0||
48637706|NCT02606305|101898597|FG007|STARTED|Triplet Dose: Regimen E||0||
48637707|NCT02606305|101898598|FG008|STARTED|Triplet Dose: Regimen E||0||
48637708|NCT02606305|101898599|FG009|STARTED|Triplet Dose: Regimen E||0||
48637709|NCT02606305|101898600|FG010|STARTED|Triplet Dose: Regimen E||0||
48637710|NCT02606305|101898601|FG011|STARTED|Triplet Dose: Regimen E||0||
48637711|NCT02606305|101898602|FG012|STARTED|Triplet Dose: Regimen E||0||
48637712|NCT02606305|101898603|FG013|STARTED|Triplet Dose: Regimen E||0||
48637713|NCT02606305|101898604|FG014|STARTED|Triplet Dose: Regimen E||41||
48637714|NCT02606305|101898590|FG000|Received at Least 1 Dose of Study Drug|Triplet Dose: Regimen E||0||
48637715|NCT02606305|101898591|FG001|Received at Least 1 Dose of Study Drug|Triplet Dose: Regimen E||0||
48637716|NCT02606305|101898592|FG002|Received at Least 1 Dose of Study Drug|Triplet Dose: Regimen E||0||
48637717|NCT02606305|101898593|FG003|Received at Least 1 Dose of Study Drug|Triplet Dose: Regimen E||0||
48637718|NCT02606305|101898594|FG004|Received at Least 1 Dose of Study Drug|Triplet Dose: Regimen E||0||
48637719|NCT02606305|101898595|FG005|Received at Least 1 Dose of Study Drug|Triplet Dose: Regimen E||0||
48637720|NCT02606305|101898596|FG006|Received at Least 1 Dose of Study Drug|Triplet Dose: Regimen E||0||
48637721|NCT02606305|101898597|FG007|Received at Least 1 Dose of Study Drug|Triplet Dose: Regimen E||0||
48637722|NCT02606305|101898598|FG008|Received at Least 1 Dose of Study Drug|Triplet Dose: Regimen E||0||
48637723|NCT02606305|101898599|FG009|Received at Least 1 Dose of Study Drug|Triplet Dose: Regimen E||0||
48637724|NCT02606305|101898600|FG010|Received at Least 1 Dose of Study Drug|Triplet Dose: Regimen E||0||
48637725|NCT02606305|101898601|FG011|Received at Least 1 Dose of Study Drug|Triplet Dose: Regimen E||0||
48637726|NCT02606305|101898602|FG012|Received at Least 1 Dose of Study Drug|Triplet Dose: Regimen E||0||
48637727|NCT02606305|101898603|FG013|Received at Least 1 Dose of Study Drug|Triplet Dose: Regimen E||0||
48637728|NCT02606305|101898604|FG014|Received at Least 1 Dose of Study Drug|Triplet Dose: Regimen E||41||
48637729|NCT02606305|101898590|FG000|COMPLETED|Triplet Dose: Regimen E||0||
48637730|NCT02606305|101898591|FG001|COMPLETED|Triplet Dose: Regimen E||0||
48637731|NCT02606305|101898592|FG002|COMPLETED|Triplet Dose: Regimen E||0||
48637732|NCT02606305|101898593|FG003|COMPLETED|Triplet Dose: Regimen E||0||
48637733|NCT02606305|101898594|FG004|COMPLETED|Triplet Dose: Regimen E||0||
48637734|NCT02606305|101898595|FG005|COMPLETED|Triplet Dose: Regimen E||0||
48637735|NCT02606305|101898596|FG006|COMPLETED|Triplet Dose: Regimen E||0||
48637736|NCT02606305|101898597|FG007|COMPLETED|Triplet Dose: Regimen E||0||
48637737|NCT02606305|101898598|FG008|COMPLETED|Triplet Dose: Regimen E||0||
48637738|NCT02606305|101898599|FG009|COMPLETED|Triplet Dose: Regimen E||0||
48637739|NCT02606305|101898600|FG010|COMPLETED|Triplet Dose: Regimen E||0||
48416165|NCT01202643|101353329|FG000|COMPLETED|Crossover Cycle||1||
48416166|NCT01202643|101353330|FG001|COMPLETED|Crossover Cycle||2||
48416167|NCT01202643|101353329|FG000|NOT COMPLETED|Crossover Cycle||0||
48637740|NCT02606305|101898601|FG011|COMPLETED|Triplet Dose: Regimen E||0||
48637741|NCT02606305|101898602|FG012|COMPLETED|Triplet Dose: Regimen E||0||
48637742|NCT02606305|101898603|FG013|COMPLETED|Triplet Dose: Regimen E||0||
48637743|NCT02606305|101898604|FG014|COMPLETED|Triplet Dose: Regimen E||41||
48637744|NCT02606305|101898590|FG000|NOT COMPLETED|Triplet Dose: Regimen E||0||
48637745|NCT02606305|101898591|FG001|NOT COMPLETED|Triplet Dose: Regimen E||0||
48637746|NCT02606305|101898592|FG002|NOT COMPLETED|Triplet Dose: Regimen E||0||
48637747|NCT02606305|101898593|FG003|NOT COMPLETED|Triplet Dose: Regimen E||0||
48637748|NCT02606305|101898594|FG004|NOT COMPLETED|Triplet Dose: Regimen E||0||
48637749|NCT02606305|101898595|FG005|NOT COMPLETED|Triplet Dose: Regimen E||0||
48637750|NCT02606305|101898596|FG006|NOT COMPLETED|Triplet Dose: Regimen E||0||
48637751|NCT02606305|101898597|FG007|NOT COMPLETED|Triplet Dose: Regimen E||0||
48637752|NCT02606305|101898598|FG008|NOT COMPLETED|Triplet Dose: Regimen E||0||
48637753|NCT02606305|101898599|FG009|NOT COMPLETED|Triplet Dose: Regimen E||0||
48637754|NCT02606305|101898600|FG010|NOT COMPLETED|Triplet Dose: Regimen E||0||
48637755|NCT02606305|101898601|FG011|NOT COMPLETED|Triplet Dose: Regimen E||0||
48637756|NCT02606305|101898602|FG012|NOT COMPLETED|Triplet Dose: Regimen E||0||
48637757|NCT02606305|101898603|FG013|NOT COMPLETED|Triplet Dose: Regimen E||0||
48637758|NCT02606305|101898604|FG014|NOT COMPLETED|Triplet Dose: Regimen E||0||
48637759|NCT00134719|101898605|FG000|STARTED|Primary Vaccination Phase||661||
48637760|NCT00134719|101898606|FG001|STARTED|Primary Vaccination Phase||221||
48637761|NCT00134719|101898607|FG002|STARTED|Primary Vaccination Phase||221||
48637762|NCT00134719|101898605|FG000|COMPLETED|Primary Vaccination Phase||647||
48637763|NCT00134719|101898606|FG001|COMPLETED|Primary Vaccination Phase||215||
48637764|NCT00134719|101898607|FG002|COMPLETED|Primary Vaccination Phase||216||
48637765|NCT00134719|101898605|FG000|NOT COMPLETED|Primary Vaccination Phase||14||
48637766|NCT00134719|101898606|FG001|NOT COMPLETED|Primary Vaccination Phase||6||
48637767|NCT00134719|101898607|FG002|NOT COMPLETED|Primary Vaccination Phase||5||
48637768|NCT00134719|101898605|FG000|STARTED|Fourth Dose Vaccination Phase||625||
48637769|NCT00134719|101898606|FG001|STARTED|Fourth Dose Vaccination Phase||206||
48637770|NCT00134719|101898607|FG002|STARTED|Fourth Dose Vaccination Phase||204||
48637771|NCT00134719|101898605|FG000|COMPLETED|Fourth Dose Vaccination Phase||623||
48637772|NCT00134719|101898606|FG001|COMPLETED|Fourth Dose Vaccination Phase||203||
48637773|NCT00134719|101898607|FG002|COMPLETED|Fourth Dose Vaccination Phase||203||
48637774|NCT00134719|101898605|FG000|NOT COMPLETED|Fourth Dose Vaccination Phase||2||
48637775|NCT00134719|101898606|FG001|NOT COMPLETED|Fourth Dose Vaccination Phase||3||
48637776|NCT00134719|101898607|FG002|NOT COMPLETED|Fourth Dose Vaccination Phase||1||
48637777|NCT02313155|101898608|FG000|STARTED|Overall Study||55||
48637778|NCT02313155|101898609|FG001|STARTED|Overall Study||55||
48637779|NCT02313155|101898608|FG000|COMPLETED|Overall Study||55||
48637780|NCT02313155|101898609|FG001|COMPLETED|Overall Study||54||
48637781|NCT02313155|101898608|FG000|NOT COMPLETED|Overall Study||0||
48637782|NCT02313155|101898609|FG001|NOT COMPLETED|Overall Study||1||
48637783|NCT04919161|101898610|FG000|STARTED|Overall Study||16||
48637784|NCT04919161|101898611|FG001|STARTED|Overall Study||16||
48637785|NCT04919161|101898610|FG000|COMPLETED|Overall Study||15||
48637786|NCT04919161|101898611|FG001|COMPLETED|Overall Study||14||
48637787|NCT04919161|101898610|FG000|NOT COMPLETED|Overall Study||1||
48637788|NCT04919161|101898611|FG001|NOT COMPLETED|Overall Study||2||
48637789|NCT03473197|101898612|FG000|STARTED|Overall Study||61||255
48637790|NCT03473197|101898612|FG000|Diacerein 1% Ointment Irradiated|Overall Study||51||51
48637791|NCT03473197|101898612|FG000|Vehicle Ointment Irradiated|Overall Study||51||51
48637792|NCT03473197|101898612|FG000|Diacerein 1% Ointment Non-irradiated|Overall Study||51||51
48760796|NCT01231906|102202898|FG001|NOT COMPLETED|Overall Study||101||
48760797|NCT03279081|102202899|FG000|STARTED|Overall Study||285||
48416168|NCT01202643|101353330|FG001|NOT COMPLETED|Crossover Cycle||0||
48637793|NCT03473197|101898612|FG000|Vehicle Ointment Non-irradiated|Overall Study||51||51
48637794|NCT03473197|101898612|FG000|Untreated Irradiated|Overall Study||51||51
48637795|NCT03473197|101898612|FG000|COMPLETED|Overall Study||51||255
48637796|NCT03473197|101898612|FG000|NOT COMPLETED|Overall Study||10||0
48637797|NCT02916927|101898613|FG000|STARTED|Overall Study||31||
48186758|NCT01089556|100779902|FG002|STARTED|Study Period II (Weeks 1-8)||0||
48186759|NCT01089556|100779903|FG003|STARTED|Study Period II (Weeks 1-8)||0||
48186760|NCT01089556|100779904|FG004|STARTED|Study Period II (Weeks 1-8)||0||
48186761|NCT01089556|100779905|FG005|STARTED|Study Period II (Weeks 1-8)||0||
48186762|NCT01089556|100779900|FG000|Safety Population|Study Period II (Weeks 1-8)||401||
48186763|NCT01089556|100779901|FG001|Safety Population|Study Period II (Weeks 1-8)||403||
48186764|NCT01089556|100779902|FG002|Safety Population|Study Period II (Weeks 1-8)||0||
48186765|NCT01089556|100779903|FG003|Safety Population|Study Period II (Weeks 1-8)||0||
48186766|NCT01089556|100779904|FG004|Safety Population|Study Period II (Weeks 1-8)||0||
48186767|NCT01089556|100779905|FG005|Safety Population|Study Period II (Weeks 1-8)||0||
48186768|NCT01089556|100779900|FG000|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||158||
48186769|NCT01089556|100779901|FG001|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||205||
48186770|NCT01089556|100779902|FG002|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0||
48186771|NCT01089556|100779903|FG003|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0||
48186772|NCT01089556|100779904|FG004|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0||
48186773|NCT01089556|100779905|FG005|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0||
48186774|NCT01089556|100779900|FG000|COMPLETED|Study Period II (Weeks 1-8)||333||
48186775|NCT01089556|100779901|FG001|COMPLETED|Study Period II (Weeks 1-8)||333||
48186776|NCT01089556|100779902|FG002|COMPLETED|Study Period II (Weeks 1-8)||0||
48186777|NCT01089556|100779903|FG003|COMPLETED|Study Period II (Weeks 1-8)||0||
48186778|NCT01089556|100779904|FG004|COMPLETED|Study Period II (Weeks 1-8)||0||
48186779|NCT01089556|100779905|FG005|COMPLETED|Study Period II (Weeks 1-8)||0||
48186780|NCT01089556|100779900|FG000|NOT COMPLETED|Study Period II (Weeks 1-8)||71||
48186781|NCT01089556|100779901|FG001|NOT COMPLETED|Study Period II (Weeks 1-8)||74||
48416169|NCT00089505|101353331|FG000|STARTED|Overall Study||121||
48416170|NCT00089505|101353332|FG001|STARTED|Overall Study||120||
48416171|NCT00089505|101353333|FG002|STARTED|Overall Study||249||
48416172|NCT00089505|101353334|FG003|STARTED|Overall Study||251||
48416173|NCT00089505|101353331|FG000|COMPLETED|Overall Study||112||
48760798|NCT03279081|102202900|FG001|STARTED|Overall Study||283||
48760799|NCT03279081|102202899|FG000|COMPLETED|Overall Study||246||
48760800|NCT03279081|102202900|FG001|COMPLETED|Overall Study||249||
48760801|NCT03279081|102202899|FG000|NOT COMPLETED|Overall Study||39||
48760802|NCT03279081|102202900|FG001|NOT COMPLETED|Overall Study||34||
48760803|NCT05106959|102202901|FG000|STARTED|Overall Study||20||
48186782|NCT01089556|100779902|FG002|NOT COMPLETED|Study Period II (Weeks 1-8)||0||
48186783|NCT01089556|100779903|FG003|NOT COMPLETED|Study Period II (Weeks 1-8)||0||
48186784|NCT01089556|100779904|FG004|NOT COMPLETED|Study Period II (Weeks 1-8)||0||
48186785|NCT01089556|100779905|FG005|NOT COMPLETED|Study Period II (Weeks 1-8)||0||
48186786|NCT01089556|100779900|FG000|STARTED|Study Period III (Weeks 9-16)||0||
48186787|NCT01089556|100779901|FG001|STARTED|Study Period III (Weeks 9-16)||0||
48186788|NCT01089556|100779902|FG002|STARTED|Study Period III (Weeks 9-16)||74||
48186789|NCT01089556|100779903|FG003|STARTED|Study Period III (Weeks 9-16)||75||
48186790|NCT01089556|100779904|FG004|STARTED|Study Period III (Weeks 9-16)||95||
48186791|NCT01089556|100779905|FG005|STARTED|Study Period III (Weeks 9-16)||99||
48186792|NCT01089556|100779900|FG000|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0||
48186793|NCT01089556|100779901|FG001|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0||
48416174|NCT00089505|101353332|FG001|COMPLETED|Overall Study||118||
48416175|NCT00089505|101353333|FG002|COMPLETED|Overall Study||228||
48416176|NCT00089505|101353334|FG003|COMPLETED|Overall Study||230||
48416177|NCT00089505|101353331|FG000|NOT COMPLETED|Overall Study||9||
48416178|NCT00089505|101353332|FG001|NOT COMPLETED|Overall Study||2||
48416179|NCT00089505|101353333|FG002|NOT COMPLETED|Overall Study||21||
48760804|NCT05106959|102202901|FG000|COMPLETED|Overall Study||19||
48760805|NCT05106959|102202901|FG000|NOT COMPLETED|Overall Study||1||
48760806|NCT00886379|102202902|FG000|STARTED|Overall Study||104||
48760807|NCT00886379|102202903|FG001|STARTED|Overall Study||143||
48186794|NCT01089556|100779902|FG002|Efficacy and Safety Population|Study Period III (Weeks 9-16)||73||
48416180|NCT00089505|101353334|FG003|NOT COMPLETED|Overall Study||21||
48416181|NCT00392210|101353335|FG000|STARTED|First Voiding Trial||36||
48416182|NCT00392210|101353336|FG001|STARTED|First Voiding Trial||33||
48416183|NCT00392210|101353335|FG000|COMPLETED|First Voiding Trial||34||
48760808|NCT00886379|102202904|FG002|STARTED|Overall Study||143||
48760809|NCT00886379|102202905|FG003|STARTED|Overall Study||112||
48416184|NCT00392210|101353336|FG001|COMPLETED|First Voiding Trial||31||
48416185|NCT00392210|101353335|FG000|NOT COMPLETED|First Voiding Trial||2||
48348695|NCT03180736|101184064|FG000|Treated|Overall Study||149||
48348696|NCT03180736|101184065|FG001|Treated|Overall Study||150||
48348697|NCT03180736|101184064|FG000|COMPLETED|Overall Study||60||
48348698|NCT03180736|101184065|FG001|COMPLETED|Overall Study||33||
48348699|NCT03180736|101184064|FG000|NOT COMPLETED|Overall Study||91||
48348700|NCT03180736|101184065|FG001|NOT COMPLETED|Overall Study||120||
48348701|NCT06105138|101184066|FG000|STARTED|Overall Study||6||
48348702|NCT06105138|101184067|FG001|STARTED|Overall Study||4||
48348703|NCT06105138|101184068|FG002|STARTED|Overall Study||4||
48348704|NCT06105138|101184069|FG003|STARTED|Overall Study||7||
48348705|NCT06105138|101184070|FG004|STARTED|Overall Study||12||
48348706|NCT06105138|101184071|FG005|STARTED|Overall Study||3||
48348707|NCT06105138|101184066|FG000|COMPLETED|Overall Study||3||
48348708|NCT06105138|101184067|FG001|COMPLETED|Overall Study||3||
48348709|NCT06105138|101184068|FG002|COMPLETED|Overall Study||0||
48348710|NCT06105138|101184069|FG003|COMPLETED|Overall Study||5||
48348711|NCT06105138|101184070|FG004|COMPLETED|Overall Study||8||
48637798|NCT02916927|101898614|FG001|STARTED|Overall Study||31||
48637799|NCT02916927|101898613|FG000|Received Study Drug|Overall Study||31||
48348712|NCT06105138|101184071|FG005|COMPLETED|Overall Study||3||
48348713|NCT06105138|101184066|FG000|NOT COMPLETED|Overall Study||3||
48416186|NCT00392210|101353336|FG001|NOT COMPLETED|First Voiding Trial||2||
48760810|NCT00886379|102202906|FG004|STARTED|Overall Study||95||
48760811|NCT00886379|102202902|FG000|COMPLETED|Overall Study||101||
48760812|NCT00886379|102202903|FG001|COMPLETED|Overall Study||140||
48760813|NCT00886379|102202904|FG002|COMPLETED|Overall Study||137||
48760814|NCT00886379|102202905|FG003|COMPLETED|Overall Study||109||
48760815|NCT00886379|102202906|FG004|COMPLETED|Overall Study||92||
48760816|NCT00886379|102202902|FG000|NOT COMPLETED|Overall Study||3||
48760817|NCT00886379|102202903|FG001|NOT COMPLETED|Overall Study||3||
48760818|NCT00886379|102202904|FG002|NOT COMPLETED|Overall Study||6||
48760819|NCT00886379|102202905|FG003|NOT COMPLETED|Overall Study||3||
48760820|NCT00886379|102202906|FG004|NOT COMPLETED|Overall Study||3||
48760821|NCT00904943|102202907|FG000|STARTED|Period 1||9||
48760822|NCT00904943|102202908|FG001|STARTED|Period 1||9||
48760823|NCT00904943|102202907|FG000|COMPLETED|Period 1||9||
48760824|NCT00904943|102202908|FG001|COMPLETED|Period 1||9||
48760825|NCT00904943|102202907|FG000|NOT COMPLETED|Period 1||0||
48760826|NCT00904943|102202908|FG001|NOT COMPLETED|Period 1||0||
48760827|NCT00904943|102202907|FG000|STARTED|Period 2||9||
48760828|NCT00904943|102202908|FG001|STARTED|Period 2||8||
48760829|NCT00904943|102202907|FG000|COMPLETED|Period 2||9||
48760830|NCT00904943|102202908|FG001|COMPLETED|Period 2||8||
48760831|NCT00904943|102202907|FG000|NOT COMPLETED|Period 2||0||
48760832|NCT00904943|102202908|FG001|NOT COMPLETED|Period 2||0||
48760833|NCT04936945|102202909|FG000|STARTED|Overall Study||10||
48760834|NCT04936945|102202910|FG001|STARTED|Overall Study||10||
48760835|NCT04936945|102202909|FG000|COMPLETED|Overall Study||10||
48760836|NCT04936945|102202910|FG001|COMPLETED|Overall Study||10||
48188686|NCT03639675|100783309|FG000|Received Treatment|Overall Study||16||
48760837|NCT04936945|102202909|FG000|NOT COMPLETED|Overall Study||0||
48348714|NCT06105138|101184067|FG001|NOT COMPLETED|Overall Study||1||
48348715|NCT06105138|101184068|FG002|NOT COMPLETED|Overall Study||4||
48348716|NCT06105138|101184069|FG003|NOT COMPLETED|Overall Study||2||
48348717|NCT06105138|101184070|FG004|NOT COMPLETED|Overall Study||4||
48348718|NCT06105138|101184071|FG005|NOT COMPLETED|Overall Study||0||
48348719|NCT00780403|101184072|FG000|STARTED|First Intervention||109||
48348720|NCT00780403|101184073|FG001|STARTED|First Intervention||111||
48348721|NCT00780403|101184072|FG000|COMPLETED|First Intervention||109||
48348722|NCT00780403|101184073|FG001|COMPLETED|First Intervention||111||
48348723|NCT00780403|101184072|FG000|NOT COMPLETED|First Intervention||0||
48348724|NCT00780403|101184073|FG001|NOT COMPLETED|First Intervention||0||
48348725|NCT00780403|101184072|FG000|STARTED|Interval Between Doses (8-10 Minutes)||109||
48348726|NCT00780403|101184073|FG001|STARTED|Interval Between Doses (8-10 Minutes)||111||
48348727|NCT00780403|101184072|FG000|COMPLETED|Interval Between Doses (8-10 Minutes)||109||
48348728|NCT00780403|101184073|FG001|COMPLETED|Interval Between Doses (8-10 Minutes)||111||
48348729|NCT00780403|101184072|FG000|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0||
48348730|NCT00780403|101184073|FG001|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0||
48348731|NCT00780403|101184072|FG000|STARTED|Second Intervention||109||
48348732|NCT00780403|101184073|FG001|STARTED|Second Intervention||111||
48348733|NCT00780403|101184072|FG000|COMPLETED|Second Intervention||109||
48348734|NCT00780403|101184073|FG001|COMPLETED|Second Intervention||111||
48348735|NCT00780403|101184072|FG000|NOT COMPLETED|Second Intervention||0||
48348736|NCT00780403|101184073|FG001|NOT COMPLETED|Second Intervention||0||
48348737|NCT00412529|101184074|FG000|STARTED|Overall Study||23||
48348738|NCT00412529|101184075|FG001|STARTED|Overall Study||21||
48348739|NCT00412529|101184074|FG000|COMPLETED|Overall Study||23||
48416187|NCT00392210|101353335|FG000|STARTED|Second Voiding Trial||34||
48416188|NCT00392210|101353336|FG001|STARTED|Second Voiding Trial||31||
48416189|NCT00392210|101353335|FG000|COMPLETED|Second Voiding Trial||34||
48760838|NCT04936945|102202910|FG001|NOT COMPLETED|Overall Study||0||
48348740|NCT00412529|101184075|FG001|COMPLETED|Overall Study||21||
48348741|NCT00412529|101184074|FG000|NOT COMPLETED|Overall Study||0||
48348742|NCT00412529|101184075|FG001|NOT COMPLETED|Overall Study||0||
48348743|NCT04433117|101184076|FG000|STARTED|Overall Study||15||
48348744|NCT04433117|101184077|FG001|STARTED|Overall Study||7||
48416190|NCT00392210|101353336|FG001|COMPLETED|Second Voiding Trial||31||
48760839|NCT02677493|102202911|FG000|STARTED|Overall Study||1197||
48760840|NCT02677493|102202912|FG001|STARTED|Overall Study||298||
48760841|NCT02677493|102202913|FG002|STARTED|Overall Study||299||
48760842|NCT02677493|102202911|FG000|COMPLETED|Overall Study||1186||
48760843|NCT02677493|102202912|FG001|COMPLETED|Overall Study||296||
48760844|NCT02677493|102202913|FG002|COMPLETED|Overall Study||296||
48760845|NCT02677493|102202911|FG000|NOT COMPLETED|Overall Study||11||
48760846|NCT02677493|102202912|FG001|NOT COMPLETED|Overall Study||2||
48760847|NCT02677493|102202913|FG002|NOT COMPLETED|Overall Study||3||
48760848|NCT03486912|102202914|FG000|STARTED|Randomized (Pre-Treatment)||39||
48760849|NCT03486912|102202915|FG001|STARTED|Randomized (Pre-Treatment)||38||
48760850|NCT03486912|102202916|FG002|STARTED|Randomized (Pre-Treatment)||39||
48760851|NCT03486912|102202917|FG003|STARTED|Randomized (Pre-Treatment)||39||
48760852|NCT03486912|102202914|FG000|COMPLETED|Randomized (Pre-Treatment)||39|Moved to treatment period|
48760853|NCT03486912|102202915|FG001|COMPLETED|Randomized (Pre-Treatment)||37|Moved to treatment period|
48760854|NCT03486912|102202916|FG002|COMPLETED|Randomized (Pre-Treatment)||39|Moved to treatment period|
48760855|NCT03486912|102202917|FG003|COMPLETED|Randomized (Pre-Treatment)||39|Moved to treatment period|
48760856|NCT03486912|102202914|FG000|NOT COMPLETED|Randomized (Pre-Treatment)||0||
48760857|NCT03486912|102202915|FG001|NOT COMPLETED|Randomized (Pre-Treatment)||1||
48760858|NCT03486912|102202916|FG002|NOT COMPLETED|Randomized (Pre-Treatment)||0||
48760859|NCT03486912|102202917|FG003|NOT COMPLETED|Randomized (Pre-Treatment)||0||
48760860|NCT03486912|102202914|FG000|STARTED|Treatment Period||39||
48760861|NCT03486912|102202915|FG001|STARTED|Treatment Period||37||
48760862|NCT03486912|102202916|FG002|STARTED|Treatment Period||39||
48760863|NCT03486912|102202917|FG003|STARTED|Treatment Period||39||
48760864|NCT03486912|102202914|FG000|COMPLETED|Treatment Period||35||
48760865|NCT03486912|102202915|FG001|COMPLETED|Treatment Period||31||
48760866|NCT03486912|102202916|FG002|COMPLETED|Treatment Period||34||
48760867|NCT03486912|102202917|FG003|COMPLETED|Treatment Period||34||
48348745|NCT04433117|101184076|FG000|COMPLETED|Overall Study||14||
48348746|NCT04433117|101184077|FG001|COMPLETED|Overall Study||7||
48348747|NCT04433117|101184076|FG000|NOT COMPLETED|Overall Study||1||
48348748|NCT04433117|101184077|FG001|NOT COMPLETED|Overall Study||0||
48348749|NCT00144170|101184078|FG000|STARTED|Overall Study||438||
48348750|NCT00144170|101184079|FG001|STARTED|Overall Study||428||
48348751|NCT00144170|101184078|FG000|COMPLETED|Overall Study||86||
48348752|NCT00144170|101184079|FG001|COMPLETED|Overall Study||32||
48416191|NCT00392210|101353335|FG000|NOT COMPLETED|Second Voiding Trial||0||
48416192|NCT00392210|101353336|FG001|NOT COMPLETED|Second Voiding Trial||0||
48416193|NCT00147082|101353337|FG000|STARTED|Overall Study||37||
48416194|NCT00147082|101353338|FG001|STARTED|Overall Study||33||
48348753|NCT00144170|101184078|FG000|NOT COMPLETED|Overall Study||352||
48416195|NCT00147082|101353339|FG002|STARTED|Overall Study||30||
48416196|NCT00147082|101353337|FG000|COMPLETED|Overall Study||37||
48348754|NCT00144170|101184079|FG001|NOT COMPLETED|Overall Study||396||
48348755|NCT02338843|101184080|FG000|STARTED|Overall Study||163|Discrepancy between enrollment and started numbers due to 23 pts who enrolled but were not treated.|
48348756|NCT02338843|101184081|FG001|STARTED|Overall Study||158|Discrepancy between enrollment and started numbers due to 23 pts who enrolled but were not treated.|
48348757|NCT02338843|101184080|FG000|COMPLETED|Overall Study||119||
48348758|NCT02338843|101184081|FG001|COMPLETED|Overall Study||100||
48348759|NCT02338843|101184080|FG000|NOT COMPLETED|Overall Study||44||
48348760|NCT02338843|101184081|FG001|NOT COMPLETED|Overall Study||58||
48348761|NCT03959189|101184082|FG000|STARTED|Overall Study||7||
48348762|NCT03959189|101184083|FG001|STARTED|Overall Study||5||
48348763|NCT03959189|101184082|FG000|COMPLETED|Overall Study||7||
48348764|NCT03959189|101184083|FG001|COMPLETED|Overall Study||5||
48348765|NCT03959189|101184082|FG000|NOT COMPLETED|Overall Study||0||
48348766|NCT03959189|101184083|FG001|NOT COMPLETED|Overall Study||0||
48348767|NCT01477450|101184084|FG000|STARTED|Overall Study||10||
48348768|NCT01477450|101184085|FG001|STARTED|Overall Study||10||
48348769|NCT01477450|101184086|FG002|STARTED|Overall Study||10||
48348770|NCT01477450|101184084|FG000|COMPLETED|Overall Study||10||
48348771|NCT01477450|101184085|FG001|COMPLETED|Overall Study||10||
48348772|NCT01477450|101184086|FG002|COMPLETED|Overall Study||10||
48348773|NCT01477450|101184084|FG000|NOT COMPLETED|Overall Study||0||
48348774|NCT01477450|101184085|FG001|NOT COMPLETED|Overall Study||0||
48348775|NCT01477450|101184086|FG002|NOT COMPLETED|Overall Study||0||
48348776|NCT01254344|101184087|FG000|STARTED|Overall Study||299||
48348777|NCT01254344|101184088|FG001|STARTED|Overall Study||300||
48348778|NCT01254344|101184087|FG000|Treated|Overall Study||290||
48348779|NCT01254344|101184088|FG001|Treated|Overall Study||297||
48416197|NCT00147082|101353338|FG001|COMPLETED|Overall Study||33||
48416198|NCT00147082|101353339|FG002|COMPLETED|Overall Study||30||
48348780|NCT01254344|101184087|FG000|COMPLETED|Overall Study||286||
48348781|NCT01254344|101184088|FG001|COMPLETED|Overall Study||281||
48348782|NCT01254344|101184087|FG000|NOT COMPLETED|Overall Study||13||
48348783|NCT01254344|101184088|FG001|NOT COMPLETED|Overall Study||19||
48348784|NCT00023322|101184089|FG000|STARTED|Overall Study||13||
48416199|NCT00147082|101353337|FG000|NOT COMPLETED|Overall Study||0||
48416200|NCT00147082|101353338|FG001|NOT COMPLETED|Overall Study||0||
48416201|NCT00147082|101353339|FG002|NOT COMPLETED|Overall Study||0||
48416202|NCT00934791|101353340|FG000|STARTED|Overall Study||1||
48416203|NCT00934791|101353341|FG001|STARTED|Overall Study||0||
48348785|NCT00023322|101184089|FG000|COMPLETED|Overall Study||12||
48348786|NCT00023322|101184089|FG000|NOT COMPLETED|Overall Study||1||
48348787|NCT02176486|101184090|FG000|STARTED|Overall Study||3||
48348788|NCT02176486|101184091|FG001|STARTED|Overall Study||5||
48348789|NCT02176486|101184092|FG002|STARTED|Overall Study||4||
48348790|NCT02176486|101184090|FG000|COMPLETED|Overall Study||3||
48348791|NCT02176486|101184091|FG001|COMPLETED|Overall Study||5||
48348792|NCT02176486|101184092|FG002|COMPLETED|Overall Study||4||
48348793|NCT02176486|101184090|FG000|NOT COMPLETED|Overall Study||0||
48348794|NCT02176486|101184091|FG001|NOT COMPLETED|Overall Study||0||
48348795|NCT02176486|101184092|FG002|NOT COMPLETED|Overall Study||0||
48348796|NCT00963807|101184093|FG000|STARTED|Overall Study||26||
48348797|NCT00963807|101184093|FG000|Completed Baseline Imaging|Overall Study||11||
48348798|NCT00963807|101184093|FG000|Completed Post-Cycle 1 Imaging|Overall Study||9||
48348799|NCT00963807|101184093|FG000|Completed Post-Cycle 2 FLT Imaging|Overall Study||9||
48348800|NCT00963807|101184093|FG000|Completed Post-Cycle 2 FDG Imaging|Overall Study||8||
48348801|NCT00963807|101184093|FG000|COMPLETED|Overall Study||8||
48348802|NCT00963807|101184093|FG000|NOT COMPLETED|Overall Study||18||
48348803|NCT00716443|101184094|FG000|STARTED|Overall Study||51||
48348804|NCT00716443|101184094|FG000|COMPLETED|Overall Study||51||
48348805|NCT00716443|101184094|FG000|NOT COMPLETED|Overall Study||0||
48348806|NCT03551522|101184095|FG000|STARTED|DB Phase||53||
48348807|NCT03551522|101184096|FG001|STARTED|DB Phase||51||
48348808|NCT03551522|101184097|FG002|STARTED|DB Phase||50||
48348809|NCT03551522|101184098|FG003|STARTED|DB Phase||27||
48348810|NCT03551522|101184099|FG004|STARTED|DB Phase||0||
48348811|NCT03551522|101184095|FG000|COMPLETED|DB Phase||27||
48348812|NCT03551522|101184096|FG001|COMPLETED|DB Phase||34||
48348813|NCT03551522|101184097|FG002|COMPLETED|DB Phase||32||
48348814|NCT03551522|101184098|FG003|COMPLETED|DB Phase||17||
48348815|NCT03551522|101184099|FG004|COMPLETED|DB Phase||0||
48348816|NCT03551522|101184095|FG000|NOT COMPLETED|DB Phase||26||
48348817|NCT03551522|101184096|FG001|NOT COMPLETED|DB Phase||17||
48348818|NCT03551522|101184097|FG002|NOT COMPLETED|DB Phase||18||
48348819|NCT03551522|101184098|FG003|NOT COMPLETED|DB Phase||10||
48348820|NCT03551522|101184099|FG004|NOT COMPLETED|DB Phase||0||
48348821|NCT03551522|101184095|FG000|STARTED|OLE Phase||0||
48348822|NCT03551522|101184096|FG001|STARTED|OLE Phase||0||
48348823|NCT03551522|101184097|FG002|STARTED|OLE Phase||0||
48348824|NCT03551522|101184098|FG003|STARTED|OLE Phase||0||
48348825|NCT03551522|101184099|FG004|STARTED|OLE Phase||12||
48348826|NCT03551522|101184095|FG000|COMPLETED|OLE Phase||0||
48348827|NCT03551522|101184096|FG001|COMPLETED|OLE Phase||0||
48348828|NCT03551522|101184097|FG002|COMPLETED|OLE Phase||0||
48348829|NCT03551522|101184098|FG003|COMPLETED|OLE Phase||0||
48348830|NCT03551522|101184099|FG004|COMPLETED|OLE Phase||0||
48348831|NCT03551522|101184095|FG000|NOT COMPLETED|OLE Phase||0||
48348832|NCT03551522|101184096|FG001|NOT COMPLETED|OLE Phase||0||
48348833|NCT03551522|101184097|FG002|NOT COMPLETED|OLE Phase||0||
48348834|NCT03551522|101184098|FG003|NOT COMPLETED|OLE Phase||0||
48348835|NCT03551522|101184099|FG004|NOT COMPLETED|OLE Phase||12||
48348836|NCT01039207|101184100|FG000|STARTED|Overall Study||31||
48348837|NCT01039207|101184100|FG000|COMPLETED|Overall Study||31|Eligible and treated patients.|
48348838|NCT01039207|101184100|FG000|NOT COMPLETED|Overall Study||0||
48348839|NCT00389207|101184101|FG000|STARTED|Overall Study||188||
48348840|NCT00389207|101184102|FG001|STARTED|Overall Study||188||
48348841|NCT00389207|101184103|FG002|STARTED|Overall Study||193||
48348842|NCT00389207|101184101|FG000|COMPLETED|Overall Study||125||
48348843|NCT00389207|101184102|FG001|COMPLETED|Overall Study||116||
48348844|NCT00389207|101184103|FG002|COMPLETED|Overall Study||152||
48348845|NCT00389207|101184101|FG000|NOT COMPLETED|Overall Study||63||
48416204|NCT00934791|101353340|FG000|COMPLETED|Overall Study||0||
48348846|NCT00389207|101184102|FG001|NOT COMPLETED|Overall Study||72||
48348847|NCT00389207|101184103|FG002|NOT COMPLETED|Overall Study||41||
48348848|NCT02226965|101184104|FG000|STARTED|Overall Study||45||
48416205|NCT00934791|101353341|FG001|COMPLETED|Overall Study||0||
48416206|NCT00934791|101353340|FG000|NOT COMPLETED|Overall Study||1||
48416207|NCT00934791|101353341|FG001|NOT COMPLETED|Overall Study||0||
48416208|NCT04411472|101353342|FG000|STARTED|Overall Study||277||
48348849|NCT02226965|101184104|FG000|COMPLETED|Overall Study||4|4 subjects completed the Induction Phase and 3 subjects started the Continuation Phase|
48348850|NCT02226965|101184104|FG000|NOT COMPLETED|Overall Study||41||
48348851|NCT03377634|101184105|FG000|STARTED|Intervention Usability Testing Period||5||
48348852|NCT03377634|101184106|FG001|STARTED|Intervention Usability Testing Period||0||
48348853|NCT03377634|101184105|FG000|COMPLETED|Intervention Usability Testing Period||5||
48348854|NCT03377634|101184106|FG001|COMPLETED|Intervention Usability Testing Period||0||
48348855|NCT03377634|101184105|FG000|NOT COMPLETED|Intervention Usability Testing Period||0||
48348856|NCT03377634|101184106|FG001|NOT COMPLETED|Intervention Usability Testing Period||0||
48348857|NCT03377634|101184105|FG000|STARTED|Study Period||15|Data from this period does not include the 5 subjects from the usability period because outcome measure information was not collected from those five subjects.|
48348858|NCT03377634|101184106|FG001|STARTED|Study Period||13|Data from this period does not include the 5 subjects from the usability period because outcome measure information was not collected from those five subjects.|
48416209|NCT04411472|101353343|FG001|STARTED|Overall Study||279||
48416210|NCT04411472|101353344|FG002|STARTED|Overall Study||31||
48348859|NCT03377634|101184105|FG000|COMPLETED|Study Period||13||
48348860|NCT03377634|101184106|FG001|COMPLETED|Study Period||13||
48348861|NCT03377634|101184105|FG000|NOT COMPLETED|Study Period||2||
48348862|NCT03377634|101184106|FG001|NOT COMPLETED|Study Period||0||
48348863|NCT01523821|101184107|FG000|STARTED|Overall Study||8||
48348864|NCT01523821|101184108|FG001|STARTED|Overall Study||6||
48348865|NCT01523821|101184109|FG002|STARTED|Overall Study||6||
48348866|NCT01523821|101184107|FG000|COMPLETED|Overall Study||8||
48348867|NCT01523821|101184108|FG001|COMPLETED|Overall Study||6||
48348868|NCT01523821|101184109|FG002|COMPLETED|Overall Study||6||
48348869|NCT01523821|101184107|FG000|NOT COMPLETED|Overall Study||0||
48348870|NCT01523821|101184108|FG001|NOT COMPLETED|Overall Study||0||
48348871|NCT01523821|101184109|FG002|NOT COMPLETED|Overall Study||0||
48348872|NCT01171612|101184110|FG000|STARTED|Overall Study||483||
48348873|NCT01171612|101184110|FG000|COMPLETED|Overall Study||432||
48348874|NCT01171612|101184110|FG000|NOT COMPLETED|Overall Study||51||
48348875|NCT00885365|101184111|FG000|STARTED|4 Weeks ON Treatment||159||
48348876|NCT00885365|101184112|FG001|STARTED|4 Weeks ON Treatment||165||
48348877|NCT00885365|101184111|FG000|Intent-to-Treat Population|4 Weeks ON Treatment||158||
48348878|NCT00885365|101184112|FG001|Intent-to-Treat Population|4 Weeks ON Treatment||163||
48348879|NCT00885365|101184111|FG000|Safety Population|4 Weeks ON Treatment||156||
48348880|NCT00885365|101184112|FG001|Safety Population|4 Weeks ON Treatment||168||
48348881|NCT00885365|101184111|FG000|COMPLETED|4 Weeks ON Treatment||155||
48348882|NCT00885365|101184112|FG001|COMPLETED|4 Weeks ON Treatment||159||
48348883|NCT00885365|101184111|FG000|NOT COMPLETED|4 Weeks ON Treatment||4||
48348884|NCT00885365|101184112|FG001|NOT COMPLETED|4 Weeks ON Treatment||6||
48348885|NCT00885365|101184111|FG000|STARTED|4 Weeks OFF Treatment||155||
48348886|NCT00885365|101184112|FG001|STARTED|4 Weeks OFF Treatment||159||
48348887|NCT00885365|101184111|FG000|COMPLETED|4 Weeks OFF Treatment||155||
48348888|NCT00885365|101184112|FG001|COMPLETED|4 Weeks OFF Treatment||159||
48348889|NCT00885365|101184111|FG000|NOT COMPLETED|4 Weeks OFF Treatment||0||
48348890|NCT00885365|101184112|FG001|NOT COMPLETED|4 Weeks OFF Treatment||0||
48348891|NCT02388295|101184113|FG000|STARTED|Dose Escalation Week 1||19||
48348892|NCT02388295|101184114|FG001|STARTED|Dose Escalation Week 1||19||
48348893|NCT02388295|101184115|FG002|STARTED|Dose Escalation Week 1||20||
48348894|NCT02388295|101184113|FG000|COMPLETED|Dose Escalation Week 1||17||
48348895|NCT02388295|101184114|FG001|COMPLETED|Dose Escalation Week 1||16||
48348896|NCT02388295|101184115|FG002|COMPLETED|Dose Escalation Week 1||18||
48348897|NCT02388295|101184113|FG000|NOT COMPLETED|Dose Escalation Week 1||2||
48348898|NCT02388295|101184114|FG001|NOT COMPLETED|Dose Escalation Week 1||3||
48348899|NCT02388295|101184115|FG002|NOT COMPLETED|Dose Escalation Week 1||2||
48348900|NCT02388295|101184113|FG000|STARTED|Dose Escalation Week 2||17||
48348901|NCT02388295|101184114|FG001|STARTED|Dose Escalation Week 2||16||
48348902|NCT02388295|101184115|FG002|STARTED|Dose Escalation Week 2||18||
48348903|NCT02388295|101184113|FG000|COMPLETED|Dose Escalation Week 2||16||
48348904|NCT02388295|101184114|FG001|COMPLETED|Dose Escalation Week 2||14||
48348905|NCT02388295|101184115|FG002|COMPLETED|Dose Escalation Week 2||17||
48348906|NCT02388295|101184113|FG000|NOT COMPLETED|Dose Escalation Week 2||1||
48348907|NCT02388295|101184114|FG001|NOT COMPLETED|Dose Escalation Week 2||2||
48348908|NCT02388295|101184115|FG002|NOT COMPLETED|Dose Escalation Week 2||1||
48348909|NCT02388295|101184113|FG000|STARTED|Treatment Weeks 3 to 12||16||
48348910|NCT02388295|101184114|FG001|STARTED|Treatment Weeks 3 to 12||14||
48348911|NCT02388295|101184115|FG002|STARTED|Treatment Weeks 3 to 12||17||
48348912|NCT02388295|101184113|FG000|COMPLETED|Treatment Weeks 3 to 12||15||
48348913|NCT02388295|101184114|FG001|COMPLETED|Treatment Weeks 3 to 12||13||
48348914|NCT02388295|101184115|FG002|COMPLETED|Treatment Weeks 3 to 12||17||
48348915|NCT02388295|101184113|FG000|NOT COMPLETED|Treatment Weeks 3 to 12||1||
48348916|NCT02388295|101184114|FG001|NOT COMPLETED|Treatment Weeks 3 to 12||1||
48348917|NCT02388295|101184115|FG002|NOT COMPLETED|Treatment Weeks 3 to 12||0||
48348918|NCT00843180|101184116|FG000|STARTED|Overall Study||16||
48348919|NCT00843180|101184117|FG001|STARTED|Overall Study||7||
48348920|NCT00843180|101184116|FG000|COMPLETED|Overall Study||16||
48348921|NCT00843180|101184117|FG001|COMPLETED|Overall Study||7||
48348922|NCT00843180|101184116|FG000|NOT COMPLETED|Overall Study||0||
48348923|NCT00843180|101184117|FG001|NOT COMPLETED|Overall Study||0||
48348924|NCT03617926|101184118|FG000|STARTED|Overall Study||35||
48348925|NCT03617926|101184119|FG001|STARTED|Overall Study||35||
48348926|NCT03617926|101184118|FG000|COMPLETED|Overall Study||35||
48348927|NCT03617926|101184119|FG001|COMPLETED|Overall Study||35||
48348928|NCT03617926|101184118|FG000|NOT COMPLETED|Overall Study||0||
48348929|NCT03617926|101184119|FG001|NOT COMPLETED|Overall Study||0||
48348930|NCT01307423|101184120|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||176||
48348931|NCT01307423|101184121|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||175||
48348932|NCT01307423|101184122|FG002|STARTED|Placebo-controlled Phase (Week 0 - 24)||177||
48348933|NCT01307423|101184123|FG003|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
48348934|NCT01307423|101184124|FG004|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
48348935|NCT01307423|101184125|FG005|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
48348936|NCT01307423|101184126|FG006|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
48348937|NCT01307423|101184127|FG007|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
48348938|NCT01307423|101184128|FG008|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
48348939|NCT01307423|101184120|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||176||
48348940|NCT01307423|101184121|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175||
48348941|NCT01307423|101184122|FG002|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175||
48348942|NCT01307423|101184123|FG003|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
48348943|NCT01307423|101184124|FG004|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
48348944|NCT01307423|101184125|FG005|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
48348945|NCT01307423|101184126|FG006|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
48348946|NCT01307423|101184127|FG007|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
48348947|NCT01307423|101184128|FG008|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
48348948|NCT01307423|101184120|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166||
48348949|NCT01307423|101184121|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||168||
48348950|NCT01307423|101184122|FG002|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166||
48348951|NCT01307423|101184123|FG003|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48348952|NCT01307423|101184124|FG004|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48348953|NCT01307423|101184125|FG005|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48348954|NCT01307423|101184126|FG006|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48348955|NCT01307423|101184127|FG007|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48348956|NCT01307423|101184128|FG008|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48348957|NCT01307423|101184120|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||103||
48348958|NCT01307423|101184121|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||73||
48348959|NCT01307423|101184122|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||79||
48348960|NCT01307423|101184123|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48348961|NCT01307423|101184124|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48348962|NCT01307423|101184125|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48348963|NCT01307423|101184126|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48348964|NCT01307423|101184127|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48348965|NCT01307423|101184128|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48348966|NCT01307423|101184120|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||156||
48348967|NCT01307423|101184121|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||160||
48348968|NCT01307423|101184122|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||155||
48348969|NCT01307423|101184123|FG003|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48348970|NCT01307423|101184124|FG004|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48348971|NCT01307423|101184125|FG005|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48348972|NCT01307423|101184126|FG006|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48348973|NCT01307423|101184127|FG007|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48348974|NCT01307423|101184128|FG008|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48348975|NCT01307423|101184120|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20||
48348976|NCT01307423|101184121|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||15||
48348977|NCT01307423|101184122|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22||
48416211|NCT04411472|101353345|FG003|STARTED|Overall Study||30||
48416212|NCT04411472|101353346|FG004|STARTED|Overall Study||13||
48416213|NCT04411472|101353347|FG005|STARTED|Overall Study||20||
48416214|NCT04411472|101353342|FG000|COMPLETED|Overall Study||253||
48416215|NCT04411472|101353343|FG001|COMPLETED|Overall Study||248||
48416216|NCT04411472|101353344|FG002|COMPLETED|Overall Study||27||
48416217|NCT04411472|101353345|FG003|COMPLETED|Overall Study||29||
48416218|NCT04411472|101353346|FG004|COMPLETED|Overall Study||13||
48416219|NCT04411472|101353347|FG005|COMPLETED|Overall Study||20||
48416220|NCT04411472|101353342|FG000|NOT COMPLETED|Overall Study||24||
48416221|NCT04411472|101353343|FG001|NOT COMPLETED|Overall Study||31||
48416222|NCT04411472|101353344|FG002|NOT COMPLETED|Overall Study||4||
48416223|NCT04411472|101353345|FG003|NOT COMPLETED|Overall Study||1||
48416224|NCT04411472|101353346|FG004|NOT COMPLETED|Overall Study||0||
48637800|NCT02916927|101898614|FG001|Received Study Drug|Overall Study||29||
48348978|NCT01307423|101184123|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48348979|NCT01307423|101184124|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48348980|NCT01307423|101184125|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48348981|NCT01307423|101184126|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48348982|NCT01307423|101184127|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48348983|NCT01307423|101184128|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48348984|NCT01307423|101184120|FG000|STARTED|Active Treatment Phase (Week 25-52)||0||
48348985|NCT01307423|101184121|FG001|STARTED|Active Treatment Phase (Week 25-52)||151||
48348986|NCT01307423|101184122|FG002|STARTED|Active Treatment Phase (Week 25-52)||150||
48416225|NCT04411472|101353347|FG005|NOT COMPLETED|Overall Study||0||
48416226|NCT01021553|101353348|FG000|STARTED|Overall Study||27||
48416227|NCT01021553|101353349|FG001|STARTED|Overall Study||22||
48416228|NCT01021553|101353350|FG002|STARTED|Overall Study||28||
48416229|NCT01021553|101353348|FG000|COMPLETED|Overall Study||23||
48416230|NCT01021553|101353349|FG001|COMPLETED|Overall Study||17||
48416231|NCT01021553|101353350|FG002|COMPLETED|Overall Study||25||
48416232|NCT01021553|101353348|FG000|NOT COMPLETED|Overall Study||4||
48348987|NCT01307423|101184123|FG003|STARTED|Active Treatment Phase (Week 25-52)||46||
48348988|NCT01307423|101184124|FG004|STARTED|Active Treatment Phase (Week 25-52)||26||
48348989|NCT01307423|101184125|FG005|STARTED|Active Treatment Phase (Week 25-52)||46||
48348990|NCT01307423|101184126|FG006|STARTED|Active Treatment Phase (Week 25-52)||26||
48348991|NCT01307423|101184127|FG007|STARTED|Active Treatment Phase (Week 25-52)||0||
48348992|NCT01307423|101184128|FG008|STARTED|Active Treatment Phase (Week 25-52)||0||
48348993|NCT01307423|101184120|FG000|COMPLETED|Active Treatment Phase (Week 25-52)||0||
48348994|NCT01307423|101184121|FG001|COMPLETED|Active Treatment Phase (Week 25-52)||132||
48348995|NCT01307423|101184122|FG002|COMPLETED|Active Treatment Phase (Week 25-52)||141||
48348996|NCT01307423|101184123|FG003|COMPLETED|Active Treatment Phase (Week 25-52)||38||
48348997|NCT01307423|101184124|FG004|COMPLETED|Active Treatment Phase (Week 25-52)||23||
48348998|NCT01307423|101184125|FG005|COMPLETED|Active Treatment Phase (Week 25-52)||43||
48348999|NCT01307423|101184126|FG006|COMPLETED|Active Treatment Phase (Week 25-52)||25||
48349000|NCT01307423|101184127|FG007|COMPLETED|Active Treatment Phase (Week 25-52)||0||
48349001|NCT01307423|101184128|FG008|COMPLETED|Active Treatment Phase (Week 25-52)||0||
48349002|NCT01307423|101184120|FG000|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0||
48349003|NCT01307423|101184121|FG001|NOT COMPLETED|Active Treatment Phase (Week 25-52)||19||
48349004|NCT01307423|101184122|FG002|NOT COMPLETED|Active Treatment Phase (Week 25-52)||9||
48349005|NCT01307423|101184123|FG003|NOT COMPLETED|Active Treatment Phase (Week 25-52)||8||
48349006|NCT01307423|101184124|FG004|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3||
48349007|NCT01307423|101184125|FG005|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3||
48349008|NCT01307423|101184126|FG006|NOT COMPLETED|Active Treatment Phase (Week 25-52)||1||
48349009|NCT01307423|101184127|FG007|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0||
48349010|NCT01307423|101184128|FG008|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0||
48349011|NCT01307423|101184120|FG000|STARTED|Long-term Safety Phase (Year 2)||0||
48349012|NCT01307423|101184121|FG001|STARTED|Long-term Safety Phase (Year 2)||122||
48349013|NCT01307423|101184122|FG002|STARTED|Long-term Safety Phase (Year 2)||134||
48349014|NCT01307423|101184123|FG003|STARTED|Long-term Safety Phase (Year 2)||0||
48349015|NCT01307423|101184124|FG004|STARTED|Long-term Safety Phase (Year 2)||0||
48349016|NCT01307423|101184125|FG005|STARTED|Long-term Safety Phase (Year 2)||0||
48349017|NCT01307423|101184126|FG006|STARTED|Long-term Safety Phase (Year 2)||0||
48349018|NCT01307423|101184127|FG007|STARTED|Long-term Safety Phase (Year 2)||57||
48349019|NCT01307423|101184128|FG008|STARTED|Long-term Safety Phase (Year 2)||67||
48349020|NCT01307423|101184120|FG000|COMPLETED|Long-term Safety Phase (Year 2)||0||
48349021|NCT01307423|101184121|FG001|COMPLETED|Long-term Safety Phase (Year 2)||99||
48349022|NCT01307423|101184122|FG002|COMPLETED|Long-term Safety Phase (Year 2)||109||
48349023|NCT01307423|101184123|FG003|COMPLETED|Long-term Safety Phase (Year 2)||0||
48349024|NCT01307423|101184124|FG004|COMPLETED|Long-term Safety Phase (Year 2)||0||
48349025|NCT01307423|101184125|FG005|COMPLETED|Long-term Safety Phase (Year 2)||0||
48349026|NCT01307423|101184126|FG006|COMPLETED|Long-term Safety Phase (Year 2)||0||
48349027|NCT01307423|101184127|FG007|COMPLETED|Long-term Safety Phase (Year 2)||48||
48349028|NCT01307423|101184128|FG008|COMPLETED|Long-term Safety Phase (Year 2)||60||
48349029|NCT01307423|101184120|FG000|NOT COMPLETED|Long-term Safety Phase (Year 2)||0||
48349030|NCT01307423|101184121|FG001|NOT COMPLETED|Long-term Safety Phase (Year 2)||23||
48349031|NCT01307423|101184122|FG002|NOT COMPLETED|Long-term Safety Phase (Year 2)||25||
48349032|NCT01307423|101184123|FG003|NOT COMPLETED|Long-term Safety Phase (Year 2)||0||
48349033|NCT01307423|101184124|FG004|NOT COMPLETED|Long-term Safety Phase (Year 2)||0||
48349034|NCT01307423|101184125|FG005|NOT COMPLETED|Long-term Safety Phase (Year 2)||0||
48349035|NCT01307423|101184126|FG006|NOT COMPLETED|Long-term Safety Phase (Year 2)||0||
48349036|NCT01307423|101184127|FG007|NOT COMPLETED|Long-term Safety Phase (Year 2)||9||
48349037|NCT01307423|101184128|FG008|NOT COMPLETED|Long-term Safety Phase (Year 2)||7||
48349038|NCT01307423|101184120|FG000|STARTED|Long-term Safety Phase (Year 3)||0|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
48349039|NCT01307423|101184121|FG001|STARTED|Long-term Safety Phase (Year 3)||99|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
48349040|NCT01307423|101184122|FG002|STARTED|Long-term Safety Phase (Year 3)||109|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
48349041|NCT01307423|101184123|FG003|STARTED|Long-term Safety Phase (Year 3)||0|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
48349042|NCT01307423|101184124|FG004|STARTED|Long-term Safety Phase (Year 3)||0|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
48349043|NCT01307423|101184125|FG005|STARTED|Long-term Safety Phase (Year 3)||0|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
48349044|NCT01307423|101184126|FG006|STARTED|Long-term Safety Phase (Year 3)||0|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
48349045|NCT01307423|101184127|FG007|STARTED|Long-term Safety Phase (Year 3)||48|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
48349046|NCT01307423|101184128|FG008|STARTED|Long-term Safety Phase (Year 3)||60|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
48349047|NCT01307423|101184120|FG000|COMPLETED|Long-term Safety Phase (Year 3)||0||
48349048|NCT01307423|101184121|FG001|COMPLETED|Long-term Safety Phase (Year 3)||90||
48349049|NCT01307423|101184122|FG002|COMPLETED|Long-term Safety Phase (Year 3)||91||
48637801|NCT02916927|101898613|FG000|COMPLETED|Overall Study||30||
48637802|NCT02916927|101898614|FG001|COMPLETED|Overall Study||28||
48349050|NCT01307423|101184123|FG003|COMPLETED|Long-term Safety Phase (Year 3)||0||
48349051|NCT01307423|101184124|FG004|COMPLETED|Long-term Safety Phase (Year 3)||0||
48349052|NCT01307423|101184125|FG005|COMPLETED|Long-term Safety Phase (Year 3)||0||
48349053|NCT01307423|101184126|FG006|COMPLETED|Long-term Safety Phase (Year 3)||0||
48349054|NCT01307423|101184127|FG007|COMPLETED|Long-term Safety Phase (Year 3)||40||
48349055|NCT01307423|101184128|FG008|COMPLETED|Long-term Safety Phase (Year 3)||49||
48349056|NCT01307423|101184120|FG000|NOT COMPLETED|Long-term Safety Phase (Year 3)||0||
48349057|NCT01307423|101184121|FG001|NOT COMPLETED|Long-term Safety Phase (Year 3)||9||
48349058|NCT01307423|101184122|FG002|NOT COMPLETED|Long-term Safety Phase (Year 3)||18||
48349059|NCT01307423|101184123|FG003|NOT COMPLETED|Long-term Safety Phase (Year 3)||0||
48349060|NCT01307423|101184124|FG004|NOT COMPLETED|Long-term Safety Phase (Year 3)||0||
48349061|NCT01307423|101184125|FG005|NOT COMPLETED|Long-term Safety Phase (Year 3)||0||
48349062|NCT01307423|101184126|FG006|NOT COMPLETED|Long-term Safety Phase (Year 3)||0||
48349063|NCT01307423|101184127|FG007|NOT COMPLETED|Long-term Safety Phase (Year 3)||8||
48349064|NCT01307423|101184128|FG008|NOT COMPLETED|Long-term Safety Phase (Year 3)||11||
48349065|NCT01307423|101184120|FG000|STARTED|Long-term Safety Phase (Year 4)||0|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
48349066|NCT01307423|101184121|FG001|STARTED|Long-term Safety Phase (Year 4)||89|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
48349067|NCT01307423|101184122|FG002|STARTED|Long-term Safety Phase (Year 4)||91|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
48349068|NCT01307423|101184123|FG003|STARTED|Long-term Safety Phase (Year 4)||0|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
48349069|NCT01307423|101184124|FG004|STARTED|Long-term Safety Phase (Year 4)||0|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
48349070|NCT01307423|101184125|FG005|STARTED|Long-term Safety Phase (Year 4)||0|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
48349071|NCT01307423|101184126|FG006|STARTED|Long-term Safety Phase (Year 4)||0|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
48349072|NCT01307423|101184127|FG007|STARTED|Long-term Safety Phase (Year 4)||40|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
48349073|NCT01307423|101184128|FG008|STARTED|Long-term Safety Phase (Year 4)||49|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
48349074|NCT01307423|101184120|FG000|COMPLETED|Long-term Safety Phase (Year 4)||0||
48349075|NCT01307423|101184121|FG001|COMPLETED|Long-term Safety Phase (Year 4)||81||
48349076|NCT01307423|101184122|FG002|COMPLETED|Long-term Safety Phase (Year 4)||86||
48349077|NCT01307423|101184123|FG003|COMPLETED|Long-term Safety Phase (Year 4)||0||
48349078|NCT01307423|101184124|FG004|COMPLETED|Long-term Safety Phase (Year 4)||0||
48349079|NCT01307423|101184125|FG005|COMPLETED|Long-term Safety Phase (Year 4)||0||
48349080|NCT01307423|101184126|FG006|COMPLETED|Long-term Safety Phase (Year 4)||0||
48349081|NCT01307423|101184127|FG007|COMPLETED|Long-term Safety Phase (Year 4)||38||
48349082|NCT01307423|101184128|FG008|COMPLETED|Long-term Safety Phase (Year 4)||44||
48349083|NCT01307423|101184120|FG000|NOT COMPLETED|Long-term Safety Phase (Year 4)||0||
48349084|NCT01307423|101184121|FG001|NOT COMPLETED|Long-term Safety Phase (Year 4)||8||
48349085|NCT01307423|101184122|FG002|NOT COMPLETED|Long-term Safety Phase (Year 4)||5||
48349086|NCT01307423|101184123|FG003|NOT COMPLETED|Long-term Safety Phase (Year 4)||0||
48349087|NCT01307423|101184124|FG004|NOT COMPLETED|Long-term Safety Phase (Year 4)||0||
48349088|NCT01307423|101184125|FG005|NOT COMPLETED|Long-term Safety Phase (Year 4)||0||
48349089|NCT01307423|101184126|FG006|NOT COMPLETED|Long-term Safety Phase (Year 4)||0||
48349090|NCT01307423|101184127|FG007|NOT COMPLETED|Long-term Safety Phase (Year 4)||2||
48349091|NCT01307423|101184128|FG008|NOT COMPLETED|Long-term Safety Phase (Year 4)||5||
48349092|NCT01307423|101184120|FG000|STARTED|Long-term Safety Phase (Year 5)||0|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
48349093|NCT01307423|101184121|FG001|STARTED|Long-term Safety Phase (Year 5)||81|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
48349094|NCT01307423|101184122|FG002|STARTED|Long-term Safety Phase (Year 5)||86|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
48349095|NCT01307423|101184123|FG003|STARTED|Long-term Safety Phase (Year 5)||0|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
48349096|NCT01307423|101184124|FG004|STARTED|Long-term Safety Phase (Year 5)||0|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
48349097|NCT01307423|101184125|FG005|STARTED|Long-term Safety Phase (Year 5)||0|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
48349098|NCT01307423|101184126|FG006|STARTED|Long-term Safety Phase (Year 5)||0|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
48349099|NCT01307423|101184127|FG007|STARTED|Long-term Safety Phase (Year 5)||38|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
48349100|NCT01307423|101184128|FG008|STARTED|Long-term Safety Phase (Year 5)||44|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
48349101|NCT01307423|101184120|FG000|COMPLETED|Long-term Safety Phase (Year 5)||0||
48349102|NCT01307423|101184121|FG001|COMPLETED|Long-term Safety Phase (Year 5)||71||
48349103|NCT01307423|101184122|FG002|COMPLETED|Long-term Safety Phase (Year 5)||80||
48349104|NCT01307423|101184123|FG003|COMPLETED|Long-term Safety Phase (Year 5)||0||
48349105|NCT01307423|101184124|FG004|COMPLETED|Long-term Safety Phase (Year 5)||0||
48349106|NCT01307423|101184125|FG005|COMPLETED|Long-term Safety Phase (Year 5)||0||
48349107|NCT01307423|101184126|FG006|COMPLETED|Long-term Safety Phase (Year 5)||0||
48349108|NCT01307423|101184127|FG007|COMPLETED|Long-term Safety Phase (Year 5)||37||
48349109|NCT01307423|101184128|FG008|COMPLETED|Long-term Safety Phase (Year 5)||41||
48349110|NCT01307423|101184120|FG000|NOT COMPLETED|Long-term Safety Phase (Year 5)||0||
48349111|NCT01307423|101184121|FG001|NOT COMPLETED|Long-term Safety Phase (Year 5)||10||
48349112|NCT01307423|101184122|FG002|NOT COMPLETED|Long-term Safety Phase (Year 5)||6||
48349113|NCT01307423|101184123|FG003|NOT COMPLETED|Long-term Safety Phase (Year 5)||0||
48349114|NCT01307423|101184124|FG004|NOT COMPLETED|Long-term Safety Phase (Year 5)||0||
48760868|NCT03486912|102202914|FG000|NOT COMPLETED|Treatment Period||4||
48760869|NCT03486912|102202915|FG001|NOT COMPLETED|Treatment Period||6||
48349115|NCT01307423|101184125|FG005|NOT COMPLETED|Long-term Safety Phase (Year 5)||0||
48349116|NCT01307423|101184126|FG006|NOT COMPLETED|Long-term Safety Phase (Year 5)||0||
48349117|NCT01307423|101184127|FG007|NOT COMPLETED|Long-term Safety Phase (Year 5)||1||
48349118|NCT01307423|101184128|FG008|NOT COMPLETED|Long-term Safety Phase (Year 5)||3||
48349119|NCT01564706|101184129|FG000|STARTED|Overall Study||9||
48349120|NCT01564706|101184129|FG000|COMPLETED|Overall Study||9||
48349121|NCT01564706|101184129|FG000|NOT COMPLETED|Overall Study||0||
48349122|NCT02582671|101184130|FG000|STARTED|Overall Study||101||
48349123|NCT02582671|101184130|FG000|COMPLETED|Overall Study||99||
48349124|NCT02582671|101184130|FG000|NOT COMPLETED|Overall Study||2||
48349125|NCT00686127|101184131|FG000|STARTED|Overall Study||14||
48349126|NCT00686127|101184132|FG001|STARTED|Overall Study||7||
48349127|NCT00686127|101184131|FG000|COMPLETED|Overall Study||0||
48349128|NCT00686127|101184132|FG001|COMPLETED|Overall Study||1||
48349129|NCT00686127|101184131|FG000|NOT COMPLETED|Overall Study||14||
48349130|NCT00686127|101184132|FG001|NOT COMPLETED|Overall Study||6||
48349131|NCT00680225|101184133|FG000|STARTED|Overall Study||10||
48349132|NCT00680225|101184133|FG000|COMPLETED|Overall Study||8||
48349133|NCT00680225|101184133|FG000|NOT COMPLETED|Overall Study||2||
48349134|NCT00270894|101184134|FG000|STARTED|Overall Study||30||
48349135|NCT00270894|101184134|FG000|COMPLETED|Overall Study||28||
48349136|NCT00270894|101184134|FG000|NOT COMPLETED|Overall Study||2||
48349137|NCT02048904|101184135|FG000|STARTED|Overall Study||142||
48349138|NCT02048904|101184135|FG000|COMPLETED|Overall Study||65||
48760870|NCT03486912|102202916|FG002|NOT COMPLETED|Treatment Period||5||
48760871|NCT03486912|102202917|FG003|NOT COMPLETED|Treatment Period||5||
48760872|NCT02753283|102202918|FG000|STARTED|Overall Study||62||
48760873|NCT02753283|102202919|FG001|STARTED|Overall Study||61||
48760874|NCT02753283|102202920|FG002|STARTED|Overall Study||40||
48760875|NCT02753283|102202921|FG003|STARTED|Overall Study||38||
48760876|NCT02753283|102202918|FG000|COMPLETED|Overall Study||45||
48760877|NCT02753283|102202919|FG001|COMPLETED|Overall Study||43||
48760878|NCT02753283|102202920|FG002|COMPLETED|Overall Study||28||
48760879|NCT02753283|102202921|FG003|COMPLETED|Overall Study||27||
48760880|NCT02753283|102202918|FG000|NOT COMPLETED|Overall Study||17||
48760881|NCT02753283|102202919|FG001|NOT COMPLETED|Overall Study||18||
48760882|NCT02753283|102202920|FG002|NOT COMPLETED|Overall Study||12||
48760883|NCT02753283|102202921|FG003|NOT COMPLETED|Overall Study||11||
48760884|NCT05550779|102202922|FG000|STARTED|Overall Study||54||
48760885|NCT05550779|102202923|FG001|STARTED|Overall Study||55||
48760886|NCT05550779|102202922|FG000|COMPLETED|Overall Study||54||
48760887|NCT05550779|102202923|FG001|COMPLETED|Overall Study||55||
48760888|NCT05550779|102202922|FG000|NOT COMPLETED|Overall Study||0||
48760889|NCT05550779|102202923|FG001|NOT COMPLETED|Overall Study||0||
48760890|NCT02177123|102202924|FG000|STARTED|Overall Study||107||
48760891|NCT02177123|102202924|FG000|COMPLETED|Overall Study||83||
48760892|NCT02177123|102202924|FG000|NOT COMPLETED|Overall Study||24||
48760893|NCT04227899|102202925|FG000|STARTED|Overall Study||173||
48760894|NCT04227899|102202926|FG001|STARTED|Overall Study||88||
48760895|NCT04227899|102202925|FG000|COMPLETED|Overall Study||153||
48760896|NCT04227899|102202926|FG001|COMPLETED|Overall Study||78||
48760897|NCT04227899|102202925|FG000|NOT COMPLETED|Overall Study||20||
48760898|NCT04227899|102202926|FG001|NOT COMPLETED|Overall Study||10||
48760899|NCT02374450|102202927|FG000|STARTED|Overall Study||9032||
48760900|NCT02374450|102202928|FG001|STARTED|Overall Study||9694||
48760901|NCT02374450|102202929|FG002|STARTED|Overall Study||4701||
48760902|NCT02374450|102202927|FG000|COMPLETED|Overall Study||8060||
48760903|NCT02374450|102202928|FG001|COMPLETED|Overall Study||8534||
48760904|NCT02374450|102202929|FG002|COMPLETED|Overall Study||4218||
48760905|NCT02374450|102202927|FG000|NOT COMPLETED|Overall Study||972||
48760906|NCT02374450|102202928|FG001|NOT COMPLETED|Overall Study||1160||
48760907|NCT02374450|102202929|FG002|NOT COMPLETED|Overall Study||483||
48760908|NCT02852655|102202930|FG000|STARTED|Registered and Ready to Initiate Tx||16||
48349139|NCT02048904|101184135|FG000|NOT COMPLETED|Overall Study||77||
48760909|NCT02852655|102202931|FG001|STARTED|Registered and Ready to Initiate Tx||25||
48760910|NCT02852655|102202932|FG002|STARTED|Registered and Ready to Initiate Tx||19||
48760911|NCT02852655|102202930|FG000|COMPLETED|Registered and Ready to Initiate Tx||16||
48760912|NCT02852655|102202931|FG001|COMPLETED|Registered and Ready to Initiate Tx||25||
48349140|NCT01624142|101184136|FG000|STARTED|Overall Study||106||
48349141|NCT01624142|101184137|FG001|STARTED|Overall Study||194||
48349142|NCT01624142|101184136|FG000|COMPLETED|Overall Study||74||
48349143|NCT01624142|101184137|FG001|COMPLETED|Overall Study||178||
48416233|NCT01021553|101353349|FG001|NOT COMPLETED|Overall Study||5||
48416234|NCT01021553|101353350|FG002|NOT COMPLETED|Overall Study||3||
48416235|NCT00852124|101353351|FG000|STARTED|Overall Study||3||
48416236|NCT00852124|101353352|FG001|STARTED|Overall Study||0||
48416237|NCT00852124|101353351|FG000|COMPLETED|Overall Study||3||
48416238|NCT00852124|101353352|FG001|COMPLETED|Overall Study||0||
48416239|NCT00852124|101353351|FG000|NOT COMPLETED|Overall Study||0||
48416240|NCT00852124|101353352|FG001|NOT COMPLETED|Overall Study||0||
48416241|NCT00984009|101353353|FG000|STARTED|Colchicine Alone||22||
48416242|NCT00984009|101353353|FG000|COMPLETED|Colchicine Alone||22||
48416243|NCT00984009|101353353|FG000|NOT COMPLETED|Colchicine Alone||0||
48416244|NCT00984009|101353353|FG000|STARTED|14 Day Washout Period||22||
48416245|NCT00984009|101353353|FG000|COMPLETED|14 Day Washout Period||22||
48416246|NCT00984009|101353353|FG000|NOT COMPLETED|14 Day Washout Period||0||
48416247|NCT00984009|101353353|FG000|STARTED|Grapefruit Juice Alone||22||
48416248|NCT00984009|101353353|FG000|COMPLETED|Grapefruit Juice Alone||21||
48416249|NCT00984009|101353353|FG000|NOT COMPLETED|Grapefruit Juice Alone||1||
48416250|NCT00984009|101353353|FG000|STARTED|Colchicine With Grapefruit Juice||21||
48416251|NCT00984009|101353353|FG000|COMPLETED|Colchicine With Grapefruit Juice||21||
48416252|NCT00984009|101353353|FG000|NOT COMPLETED|Colchicine With Grapefruit Juice||0||
48416253|NCT04905563|101353354|FG000|STARTED|Overall Study||15||
48416254|NCT04905563|101353355|FG001|STARTED|Overall Study||15||
48416255|NCT04905563|101353354|FG000|COMPLETED|Overall Study||13||
48416256|NCT04905563|101353355|FG001|COMPLETED|Overall Study||13||
48416257|NCT04905563|101353354|FG000|NOT COMPLETED|Overall Study||2||
48416258|NCT04905563|101353355|FG001|NOT COMPLETED|Overall Study||2||
48416259|NCT01054339|101353356|FG000|STARTED|Overall Study||3||
48416260|NCT01054339|101353357|FG001|STARTED|Overall Study||3||
48416261|NCT01054339|101353358|FG002|STARTED|Overall Study||3||
48416262|NCT01054339|101353356|FG000|COMPLETED|Overall Study||3||
48416263|NCT01054339|101353357|FG001|COMPLETED|Overall Study||3||
48416264|NCT01054339|101353358|FG002|COMPLETED|Overall Study||3||
48416265|NCT01054339|101353356|FG000|NOT COMPLETED|Overall Study||0||
48416266|NCT01054339|101353357|FG001|NOT COMPLETED|Overall Study||0||
48416267|NCT01054339|101353358|FG002|NOT COMPLETED|Overall Study||0||
48416268|NCT01714336|101353359|FG000|STARTED|Overall Study||69||
48416269|NCT01714336|101353360|FG001|STARTED|Overall Study||69||
48349144|NCT01624142|101184136|FG000|NOT COMPLETED|Overall Study||32||
48349145|NCT01624142|101184137|FG001|NOT COMPLETED|Overall Study||16||
48349146|NCT03367156|101184138|FG000|STARTED|Overall Study||85||
48349147|NCT03367156|101184139|FG001|STARTED|Overall Study||43||
48349148|NCT03367156|101184138|FG000|Completed 7 Days|Overall Study||76||
48349149|NCT03367156|101184139|FG001|Completed 7 Days|Overall Study||38||
48349150|NCT03367156|101184138|FG000|Completed 14 Days|Overall Study||61||
48349151|NCT03367156|101184139|FG001|Completed 14 Days|Overall Study||35||
48349152|NCT03367156|101184138|FG000|COMPLETED|Overall Study||61||
48349153|NCT03367156|101184139|FG001|COMPLETED|Overall Study||35||
48349154|NCT03367156|101184138|FG000|NOT COMPLETED|Overall Study||24||
48349155|NCT03367156|101184139|FG001|NOT COMPLETED|Overall Study||8||
48349156|NCT01331161|101184140|FG000|STARTED|Overall Study||44||
48349157|NCT01331161|101184141|FG001|STARTED|Overall Study||33||
48349158|NCT01331161|101184140|FG000|COMPLETED|Overall Study||43||
48349159|NCT01331161|101184141|FG001|COMPLETED|Overall Study||31||
48349160|NCT01331161|101184140|FG000|NOT COMPLETED|Overall Study||1||
48416270|NCT01714336|101353359|FG000|COMPLETED|Overall Study||69||
48760913|NCT02852655|102202932|FG002|COMPLETED|Registered and Ready to Initiate Tx||16||
48760914|NCT02852655|102202930|FG000|NOT COMPLETED|Registered and Ready to Initiate Tx||0||
48760915|NCT02852655|102202931|FG001|NOT COMPLETED|Registered and Ready to Initiate Tx||0||
48760916|NCT02852655|102202932|FG002|NOT COMPLETED|Registered and Ready to Initiate Tx||3||
48760917|NCT02852655|102202930|FG000|STARTED|Receive NeoAdjuvant Protocol Tx||16||
48760918|NCT02852655|102202931|FG001|STARTED|Receive NeoAdjuvant Protocol Tx||25||
48760919|NCT02852655|102202932|FG002|STARTED|Receive NeoAdjuvant Protocol Tx||16||
48760920|NCT02852655|102202930|FG000|COMPLETED|Receive NeoAdjuvant Protocol Tx||16||
48760921|NCT02852655|102202931|FG001|COMPLETED|Receive NeoAdjuvant Protocol Tx||25||
48760922|NCT02852655|102202932|FG002|COMPLETED|Receive NeoAdjuvant Protocol Tx||16||
48760923|NCT02852655|102202930|FG000|NOT COMPLETED|Receive NeoAdjuvant Protocol Tx||0||
48416271|NCT01714336|101353360|FG001|COMPLETED|Overall Study||69||
48760924|NCT02852655|102202931|FG001|NOT COMPLETED|Receive NeoAdjuvant Protocol Tx||0||
48760925|NCT02852655|102202932|FG002|NOT COMPLETED|Receive NeoAdjuvant Protocol Tx||0||
48349161|NCT01331161|101184141|FG001|NOT COMPLETED|Overall Study||2||
48349162|NCT01526148|101184142|FG000|STARTED|Overall Study||18||
48760926|NCT02852655|102202930|FG000|STARTED|Complete Surgical Resection||16||
48767763|NCT04004988|102222818|FG000|NOT COMPLETED|Period 2||0||
48416272|NCT01714336|101353359|FG000|NOT COMPLETED|Overall Study||0||
48416273|NCT01714336|101353360|FG001|NOT COMPLETED|Overall Study||0||
48416274|NCT01558791|101353361|FG000|STARTED|Overall Study||607||
48416275|NCT01558791|101353362|FG001|STARTED|Overall Study||629||
48416276|NCT01558791|101353361|FG000|COMPLETED|Overall Study||607||
48416277|NCT01558791|101353362|FG001|COMPLETED|Overall Study||629||
48416278|NCT01558791|101353361|FG000|NOT COMPLETED|Overall Study||0||
48349163|NCT01526148|101184143|FG001|STARTED|Overall Study||24||
48349164|NCT01526148|101184142|FG000|COMPLETED|Overall Study||4||
48416279|NCT01558791|101353362|FG001|NOT COMPLETED|Overall Study||0||
48416280|NCT01550315|101353363|FG000|STARTED|Overall Study||7||
48416281|NCT01550315|101353364|FG001|STARTED|Overall Study||7||
48416282|NCT01550315|101353365|FG002|STARTED|Overall Study||6||
48416283|NCT01550315|101353366|FG003|STARTED|Overall Study||7||
48416284|NCT01550315|101353363|FG000|COMPLETED|Overall Study||7||
48416285|NCT01550315|101353364|FG001|COMPLETED|Overall Study||7||
48416286|NCT01550315|101353365|FG002|COMPLETED|Overall Study||6||
48349165|NCT01526148|101184143|FG001|COMPLETED|Overall Study||11||
48349166|NCT01526148|101184142|FG000|NOT COMPLETED|Overall Study||14||
48349167|NCT01526148|101184143|FG001|NOT COMPLETED|Overall Study||13||
48349168|NCT02814721|101184144|FG000|STARTED|Overall Study||5||
48349169|NCT02814721|101184145|FG001|STARTED|Overall Study||5||
48349170|NCT02814721|101184144|FG000|COMPLETED|Overall Study||4||
48349171|NCT02814721|101184145|FG001|COMPLETED|Overall Study||5||
48349172|NCT02814721|101184144|FG000|NOT COMPLETED|Overall Study||1||
48349173|NCT02814721|101184145|FG001|NOT COMPLETED|Overall Study||0||
48760927|NCT02852655|102202931|FG001|STARTED|Complete Surgical Resection||25||
48760928|NCT02852655|102202932|FG002|STARTED|Complete Surgical Resection||16||
48760929|NCT02852655|102202930|FG000|COMPLETED|Complete Surgical Resection||16||
48760930|NCT02852655|102202931|FG001|COMPLETED|Complete Surgical Resection||25||
48760931|NCT02852655|102202932|FG002|COMPLETED|Complete Surgical Resection||16||
48760932|NCT02852655|102202930|FG000|NOT COMPLETED|Complete Surgical Resection||0||
48349174|NCT04690699|101184146|FG000|STARTED|Overall Study||4||
48349175|NCT04690699|101184147|FG001|STARTED|Overall Study||0||
48349176|NCT04690699|101184146|FG000|COMPLETED|Overall Study||4||
48349177|NCT04690699|101184147|FG001|COMPLETED|Overall Study||0||
48760933|NCT02852655|102202931|FG001|NOT COMPLETED|Complete Surgical Resection||0||
48760934|NCT02852655|102202932|FG002|NOT COMPLETED|Complete Surgical Resection||0||
48349178|NCT04690699|101184146|FG000|NOT COMPLETED|Overall Study||0||
48349179|NCT04690699|101184147|FG001|NOT COMPLETED|Overall Study||0||
48349180|NCT04052139|101184148|FG000|STARTED|Overall Study||15||
48349181|NCT04052139|101184149|FG001|STARTED|Overall Study||15||
48349182|NCT04052139|101184150|FG002|STARTED|Overall Study||15||
48349183|NCT04052139|101184148|FG000|4-weeks|Overall Study||14||
48349184|NCT04052139|101184149|FG001|4-weeks|Overall Study||15||
48349185|NCT04052139|101184150|FG002|4-weeks|Overall Study||15||
48349186|NCT04052139|101184148|FG000|8-weeks|Overall Study||12||
48349187|NCT04052139|101184149|FG001|8-weeks|Overall Study||15||
48349188|NCT04052139|101184150|FG002|8-weeks|Overall Study||15||
48349189|NCT04052139|101184148|FG000|12-weeks|Overall Study||12||
48349190|NCT04052139|101184149|FG001|12-weeks|Overall Study||15||
48349191|NCT04052139|101184150|FG002|12-weeks|Overall Study||15||
48349192|NCT04052139|101184148|FG000|COMPLETED|Overall Study||12||
48349193|NCT04052139|101184149|FG001|COMPLETED|Overall Study||15||
48349194|NCT04052139|101184150|FG002|COMPLETED|Overall Study||15||
48349195|NCT04052139|101184148|FG000|NOT COMPLETED|Overall Study||3||
48349196|NCT04052139|101184149|FG001|NOT COMPLETED|Overall Study||0||
48349197|NCT04052139|101184150|FG002|NOT COMPLETED|Overall Study||0||
48349198|NCT04533711|101184151|FG000|STARTED|Overall Study||120||
48349199|NCT04533711|101184152|FG001|STARTED|Overall Study||120||
48349200|NCT04533711|101184151|FG000|Completed 6-month Assessments|Overall Study||92||
48349201|NCT04533711|101184152|FG001|Completed 6-month Assessments|Overall Study||102||
48349202|NCT04533711|101184151|FG000|Completed 12-month Assessments|Overall Study||87||
48349203|NCT04533711|101184152|FG001|Completed 12-month Assessments|Overall Study||95||
48349204|NCT04533711|101184151|FG000|COMPLETED|Overall Study||87||
48349205|NCT04533711|101184152|FG001|COMPLETED|Overall Study||95||
48349206|NCT04533711|101184151|FG000|NOT COMPLETED|Overall Study||33||
48349207|NCT04533711|101184152|FG001|NOT COMPLETED|Overall Study||25||
48349208|NCT01822561|101184153|FG000|STARTED|Overall Study||15||15
48349209|NCT01822561|101184153|FG000|COMPLETED|Overall Study||13||13
48349210|NCT01822561|101184153|FG000|NOT COMPLETED|Overall Study||2||2
48416287|NCT01550315|101353366|FG003|COMPLETED|Overall Study||7||
48416288|NCT01550315|101353363|FG000|NOT COMPLETED|Overall Study||0||
48760935|NCT02852655|102202930|FG000|STARTED|Eligible to Initiate Adjuvant MK3475||16||
48760936|NCT02852655|102202931|FG001|STARTED|Eligible to Initiate Adjuvant MK3475||25||
48760937|NCT02852655|102202932|FG002|STARTED|Eligible to Initiate Adjuvant MK3475||16||
48760938|NCT02852655|102202930|FG000|COMPLETED|Eligible to Initiate Adjuvant MK3475||15||
48760939|NCT02852655|102202931|FG001|COMPLETED|Eligible to Initiate Adjuvant MK3475||22||
48760940|NCT02852655|102202932|FG002|COMPLETED|Eligible to Initiate Adjuvant MK3475||14||
48760941|NCT02852655|102202930|FG000|NOT COMPLETED|Eligible to Initiate Adjuvant MK3475||1||
48760942|NCT02852655|102202931|FG001|NOT COMPLETED|Eligible to Initiate Adjuvant MK3475||3||
48760943|NCT02852655|102202932|FG002|NOT COMPLETED|Eligible to Initiate Adjuvant MK3475||2||
48760944|NCT02852655|102202930|FG000|STARTED|Adjuvant MK3475 Therapy||15||
48349211|NCT02872103|101184154|FG000|STARTED|Cycle 1||83||
48349212|NCT02872103|101184155|FG001|STARTED|Cycle 1||39||
48349213|NCT02872103|101184154|FG000|COMPLETED|Cycle 1||83||
48349214|NCT02872103|101184155|FG001|COMPLETED|Cycle 1||38||
48349215|NCT02872103|101184154|FG000|NOT COMPLETED|Cycle 1||0||
48349216|NCT02872103|101184155|FG001|NOT COMPLETED|Cycle 1||1||
48349217|NCT02872103|101184154|FG000|STARTED|Cycle 2-4||83||
48416289|NCT01550315|101353364|FG001|NOT COMPLETED|Overall Study||0||
48349218|NCT02872103|101184155|FG001|STARTED|Cycle 2-4||38||
48349219|NCT02872103|101184154|FG000|COMPLETED|Cycle 2-4||81||
48349220|NCT02872103|101184155|FG001|COMPLETED|Cycle 2-4||37||
48349221|NCT02872103|101184154|FG000|NOT COMPLETED|Cycle 2-4||2||
48349222|NCT02872103|101184155|FG001|NOT COMPLETED|Cycle 2-4||1||
48349223|NCT00592683|101184156|FG000|STARTED|Overall Study||10||
48349224|NCT00592683|101184157|FG001|STARTED|Overall Study||10||
48349225|NCT00592683|101184156|FG000|COMPLETED|Overall Study||6||
48349226|NCT00592683|101184157|FG001|COMPLETED|Overall Study||6||
48349227|NCT00592683|101184156|FG000|NOT COMPLETED|Overall Study||4||
48349228|NCT00592683|101184157|FG001|NOT COMPLETED|Overall Study||4||
48349229|NCT00249379|101184158|FG000|STARTED|Overall Study||14||
48349230|NCT00249379|101184159|FG001|STARTED|Overall Study||12||
48349231|NCT00249379|101184158|FG000|COMPLETED|Overall Study||6||
48349232|NCT00249379|101184159|FG001|COMPLETED|Overall Study||4||
48349233|NCT00249379|101184158|FG000|NOT COMPLETED|Overall Study||8||
48349234|NCT00249379|101184159|FG001|NOT COMPLETED|Overall Study||8||
48349235|NCT01299025|101184160|FG000|STARTED|Overall Study||42||
48349236|NCT01299025|101184161|FG001|STARTED|Overall Study||42||
48349237|NCT01299025|101184160|FG000|COMPLETED|Overall Study||39||
48349238|NCT01299025|101184161|FG001|COMPLETED|Overall Study||41||
48349239|NCT01299025|101184160|FG000|NOT COMPLETED|Overall Study||3||
48349240|NCT01299025|101184161|FG001|NOT COMPLETED|Overall Study||1||
48349241|NCT02040142|101184162|FG000|STARTED|Overall Study||51||
48349242|NCT02040142|101184162|FG000|COMPLETED|Overall Study||15||
48349243|NCT02040142|101184162|FG000|NOT COMPLETED|Overall Study||36||
48349244|NCT02064764|101184163|FG000|STARTED|Overall Study||36||
48349245|NCT02064764|101184164|FG001|STARTED|Overall Study||34||
48349246|NCT02064764|101184163|FG000|COMPLETED|Overall Study||30||
48349247|NCT02064764|101184164|FG001|COMPLETED|Overall Study||30||
48349248|NCT02064764|101184163|FG000|NOT COMPLETED|Overall Study||6||
48349249|NCT02064764|101184164|FG001|NOT COMPLETED|Overall Study||4||
48349250|NCT00917384|101184165|FG000|STARTED|Overall Study||238||
48349251|NCT00917384|101184166|FG001|STARTED|Overall Study||117||
48349252|NCT00917384|101184165|FG000|Received at Least 1 Dose of Study Drug|Overall Study||236||
48349253|NCT00917384|101184166|FG001|Received at Least 1 Dose of Study Drug|Overall Study||115||
48349254|NCT00917384|101184165|FG000|COMPLETED|Overall Study||224||
48349255|NCT00917384|101184166|FG001|COMPLETED|Overall Study||113||
48349256|NCT00917384|101184165|FG000|NOT COMPLETED|Overall Study||14||
48349257|NCT00917384|101184166|FG001|NOT COMPLETED|Overall Study||4||
48349258|NCT01397851|101184167|FG000|STARTED|Overall Study||41634||
48349259|NCT01397851|101184168|FG001|STARTED|Overall Study||39963||
48349260|NCT01397851|101184167|FG000|COMPLETED|Overall Study||41555||
48349261|NCT01397851|101184168|FG001|COMPLETED|Overall Study||39917||
48349262|NCT01397851|101184167|FG000|NOT COMPLETED|Overall Study||79||
48349263|NCT01397851|101184168|FG001|NOT COMPLETED|Overall Study||46||
48349264|NCT03263091|101184169|FG000|STARTED|OL Component||8||
48349265|NCT03263091|101184170|FG001|STARTED|OL Component||8||
48349266|NCT03263091|101184171|FG002|STARTED|OL Component||8||
48349267|NCT03263091|101184172|FG003|STARTED|OL Component||0||
48349268|NCT03263091|101184173|FG004|STARTED|OL Component||0||
48349269|NCT03263091|101184174|FG005|STARTED|OL Component||0||
48349270|NCT03263091|101184169|FG000|Received at Least 1 Dose of Study Drug|OL Component||8||
48349271|NCT03263091|101184170|FG001|Received at Least 1 Dose of Study Drug|OL Component||8||
48349272|NCT03263091|101184171|FG002|Received at Least 1 Dose of Study Drug|OL Component||8||
48349273|NCT03263091|101184172|FG003|Received at Least 1 Dose of Study Drug|OL Component||0||
48349274|NCT03263091|101184173|FG004|Received at Least 1 Dose of Study Drug|OL Component||0||
48349275|NCT03263091|101184174|FG005|Received at Least 1 Dose of Study Drug|OL Component||0||
48349276|NCT03263091|101184169|FG000|COMPLETED|OL Component||6||
48349277|NCT03263091|101184170|FG001|COMPLETED|OL Component||6||
48349278|NCT03263091|101184171|FG002|COMPLETED|OL Component||6||
48349279|NCT03263091|101184172|FG003|COMPLETED|OL Component||0||
48349280|NCT03263091|101184173|FG004|COMPLETED|OL Component||0||
48349281|NCT03263091|101184174|FG005|COMPLETED|OL Component||0||
48349282|NCT03263091|101184169|FG000|NOT COMPLETED|OL Component||2||
48349283|NCT03263091|101184170|FG001|NOT COMPLETED|OL Component||2||
48349284|NCT03263091|101184171|FG002|NOT COMPLETED|OL Component||2||
48349285|NCT03263091|101184172|FG003|NOT COMPLETED|OL Component||0||
48349286|NCT03263091|101184173|FG004|NOT COMPLETED|OL Component||0||
48349287|NCT03263091|101184174|FG005|NOT COMPLETED|OL Component||0||
48349288|NCT03263091|101184169|FG000|STARTED|OL High-EPO Component||0||
48349289|NCT03263091|101184170|FG001|STARTED|OL High-EPO Component||0||
48349290|NCT03263091|101184171|FG002|STARTED|OL High-EPO Component||0||
48349291|NCT03263091|101184172|FG003|STARTED|OL High-EPO Component||20||
48349292|NCT03263091|101184173|FG004|STARTED|OL High-EPO Component||0||
48349293|NCT03263091|101184174|FG005|STARTED|OL High-EPO Component||0||
48416290|NCT01550315|101353365|FG002|NOT COMPLETED|Overall Study||0||
48349294|NCT03263091|101184169|FG000|Received at Least 1 Dose of Study Drug|OL High-EPO Component||0||
48349295|NCT03263091|101184170|FG001|Received at Least 1 Dose of Study Drug|OL High-EPO Component||0||
48349296|NCT03263091|101184171|FG002|Received at Least 1 Dose of Study Drug|OL High-EPO Component||0||
48349297|NCT03263091|101184172|FG003|Received at Least 1 Dose of Study Drug|OL High-EPO Component||20||
48349298|NCT03263091|101184173|FG004|Received at Least 1 Dose of Study Drug|OL High-EPO Component||0||
48349299|NCT03263091|101184174|FG005|Received at Least 1 Dose of Study Drug|OL High-EPO Component||0||
48349300|NCT03263091|101184169|FG000|COMPLETED|OL High-EPO Component||0||
48416291|NCT01550315|101353366|FG003|NOT COMPLETED|Overall Study||0||
48416292|NCT03500419|101353367|FG000|STARTED|Overall Study||27||
48416293|NCT03500419|101353368|FG001|STARTED|Overall Study||55||
48416294|NCT03500419|101353367|FG000|COMPLETED|Overall Study||25||
48416295|NCT03500419|101353368|FG001|COMPLETED|Overall Study||30||
48416296|NCT03500419|101353367|FG000|NOT COMPLETED|Overall Study||2||
48416297|NCT03500419|101353368|FG001|NOT COMPLETED|Overall Study||25||
48416298|NCT04852666|101353369|FG000|STARTED|Overall Study||141||
48416299|NCT04852666|101353370|FG001|STARTED|Overall Study||219||
48416300|NCT04852666|101353371|FG002|STARTED|Overall Study||72||
48416301|NCT04852666|101353372|FG003|STARTED|Overall Study||33||
48416302|NCT04852666|101353369|FG000|COMPLETED|Overall Study||141||
48416303|NCT04852666|101353370|FG001|COMPLETED|Overall Study||219||
48416304|NCT04852666|101353371|FG002|COMPLETED|Overall Study||72||
48416305|NCT04852666|101353372|FG003|COMPLETED|Overall Study||33||
48416306|NCT04852666|101353369|FG000|NOT COMPLETED|Overall Study||0||
48416307|NCT04852666|101353370|FG001|NOT COMPLETED|Overall Study||0||
48416308|NCT04852666|101353371|FG002|NOT COMPLETED|Overall Study||0||
48416309|NCT04852666|101353372|FG003|NOT COMPLETED|Overall Study||0||
48416310|NCT04912297|101353373|FG000|STARTED|Overall Study||99||
48416311|NCT04912297|101353374|FG001|STARTED|Overall Study||87||
48416312|NCT04912297|101353373|FG000|COMPLETED|Overall Study||68||
48416313|NCT04912297|101353374|FG001|COMPLETED|Overall Study||54||
48416314|NCT04912297|101353373|FG000|NOT COMPLETED|Overall Study||31||
48416315|NCT04912297|101353374|FG001|NOT COMPLETED|Overall Study||33||
48416316|NCT01813149|101353375|FG000|STARTED|Overall Study||90||
48416317|NCT01813149|101353376|FG001|STARTED|Overall Study||38||
48416318|NCT01813149|101353375|FG000|COMPLETED|Overall Study||90||
48416319|NCT01813149|101353376|FG001|COMPLETED|Overall Study||38||
48416320|NCT01813149|101353375|FG000|NOT COMPLETED|Overall Study||0||
48416321|NCT01813149|101353376|FG001|NOT COMPLETED|Overall Study||0||
48416322|NCT03040479|101353377|FG000|STARTED|Overall Study||8||
48416323|NCT03040479|101353378|FG001|STARTED|Overall Study||8||
48416324|NCT03040479|101353379|FG002|STARTED|Overall Study||8||
48416325|NCT03040479|101353377|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8||
48416326|NCT03040479|101353378|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8||
48416327|NCT03040479|101353379|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8||
48416328|NCT03040479|101353377|FG000|COMPLETED|Overall Study||8||
48416329|NCT03040479|101353378|FG001|COMPLETED|Overall Study||8||
48416330|NCT03040479|101353379|FG002|COMPLETED|Overall Study||8||
48416331|NCT03040479|101353377|FG000|NOT COMPLETED|Overall Study||0||
48416332|NCT03040479|101353378|FG001|NOT COMPLETED|Overall Study||0||
48416333|NCT03040479|101353379|FG002|NOT COMPLETED|Overall Study||0||
48416334|NCT01917136|101353380|FG000|STARTED|Overall Study||21||
48416335|NCT01917136|101353380|FG000|COMPLETED|Overall Study||21||
48416336|NCT01917136|101353380|FG000|NOT COMPLETED|Overall Study||0||
48416337|NCT02324049|101353381|FG000|STARTED|Part A||11||
48416338|NCT02324049|101353381|FG000|Safety Analysis Set|Part A||11||
48416339|NCT02324049|101353381|FG000|COMPLETED|Part A||11||
48416340|NCT02324049|101353381|FG000|NOT COMPLETED|Part A||0||
48416341|NCT02324049|101353381|FG000|STARTED|Part B||11||
48416342|NCT02324049|101353381|FG000|Safety Analysis Set|Part B||11||
48416343|NCT02324049|101353381|FG000|COMPLETED|Part B||11||
48416344|NCT02324049|101353381|FG000|NOT COMPLETED|Part B||0||
48416345|NCT02324049|101353381|FG000|STARTED|Part C||11||
48416346|NCT02324049|101353381|FG000|Safety Analysis Set|Part C||11||
48416347|NCT02324049|101353381|FG000|COMPLETED|Part C||0||
48416348|NCT02324049|101353381|FG000|NOT COMPLETED|Part C||11||
48416349|NCT01678794|101353382|FG000|STARTED|Overall Study||16||
48186795|NCT01089556|100779903|FG003|Efficacy and Safety Population|Study Period III (Weeks 9-16)||75||
48416350|NCT01678794|101353383|FG001|STARTED|Overall Study||17||
48416351|NCT01678794|101353382|FG000|COMPLETED|Overall Study||16||
48416352|NCT01678794|101353383|FG001|COMPLETED|Overall Study||17||
48416353|NCT01678794|101353382|FG000|NOT COMPLETED|Overall Study||0||
48416354|NCT01678794|101353383|FG001|NOT COMPLETED|Overall Study||0||
48416355|NCT00053482|101353384|FG000|STARTED|Overall Study||51||
48416356|NCT00053482|101353385|FG001|STARTED|Overall Study||102||
48416357|NCT00053482|101353386|FG002|STARTED|Overall Study||102||
48416358|NCT00053482|101353387|FG003|STARTED|Overall Study||50||
48416359|NCT00053482|101353388|FG004|STARTED|Overall Study||52||
48416360|NCT00053482|101353384|FG000|COMPLETED|Overall Study||51||
48416361|NCT00053482|101353385|FG001|COMPLETED|Overall Study||102||
48416362|NCT00053482|101353386|FG002|COMPLETED|Overall Study||102||
48416363|NCT00053482|101353387|FG003|COMPLETED|Overall Study||50||
48416364|NCT00053482|101353388|FG004|COMPLETED|Overall Study||52||
48416365|NCT00053482|101353384|FG000|NOT COMPLETED|Overall Study||0||
48416366|NCT00053482|101353385|FG001|NOT COMPLETED|Overall Study||0||
48637803|NCT02916927|101898613|FG000|NOT COMPLETED|Overall Study||1||
48637804|NCT02916927|101898614|FG001|NOT COMPLETED|Overall Study||3||
48637805|NCT02836769|101898615|FG000|STARTED|Overall Study||35||
48637806|NCT02836769|101898615|FG000|Received Intervention|Overall Study||30||
48637807|NCT02836769|101898615|FG000|Completed Post-test Assessment|Overall Study||21||
48637808|NCT02836769|101898615|FG000|COMPLETED|Overall Study||20||
48637809|NCT02836769|101898615|FG000|NOT COMPLETED|Overall Study||15||
48637810|NCT00112957|101898616|FG000|STARTED|Overall Study||23||
48637811|NCT00112957|101898616|FG000|COMPLETED|Overall Study||4|Completed through the 12-month follow-up|
48637812|NCT00112957|101898616|FG000|NOT COMPLETED|Overall Study||19||
48637813|NCT01794702|101898617|FG000|STARTED|Overall Study||18||
48637814|NCT01794702|101898618|FG001|STARTED|Overall Study||0||
48637815|NCT01794702|101898619|FG002|STARTED|Overall Study||47||
48637816|NCT01794702|101898617|FG000|COMPLETED|Overall Study||18||
48637817|NCT01794702|101898618|FG001|COMPLETED|Overall Study||0||
48760945|NCT02852655|102202931|FG001|STARTED|Adjuvant MK3475 Therapy||22||
48760946|NCT02852655|102202932|FG002|STARTED|Adjuvant MK3475 Therapy||14||
48760947|NCT02852655|102202930|FG000|COMPLETED|Adjuvant MK3475 Therapy||0||
48349301|NCT03263091|101184170|FG001|COMPLETED|OL High-EPO Component||0||
48349302|NCT03263091|101184171|FG002|COMPLETED|OL High-EPO Component||0||
48349303|NCT03263091|101184172|FG003|COMPLETED|OL High-EPO Component||10||
48349304|NCT03263091|101184173|FG004|COMPLETED|OL High-EPO Component||0||
48349305|NCT03263091|101184174|FG005|COMPLETED|OL High-EPO Component||0||
48349306|NCT03263091|101184169|FG000|NOT COMPLETED|OL High-EPO Component||0||
48349307|NCT03263091|101184170|FG001|NOT COMPLETED|OL High-EPO Component||0||
48349308|NCT03263091|101184171|FG002|NOT COMPLETED|OL High-EPO Component||0||
48416367|NCT00053482|101353386|FG002|NOT COMPLETED|Overall Study||0||
48416368|NCT00053482|101353387|FG003|NOT COMPLETED|Overall Study||0||
48416369|NCT00053482|101353388|FG004|NOT COMPLETED|Overall Study||0||
48416370|NCT02176226|101353389|FG000|STARTED|Overall Study||105||
48760948|NCT02852655|102202931|FG001|COMPLETED|Adjuvant MK3475 Therapy||0||
48760949|NCT02852655|102202932|FG002|COMPLETED|Adjuvant MK3475 Therapy||0||
48760950|NCT02852655|102202930|FG000|NOT COMPLETED|Adjuvant MK3475 Therapy||15||
48760951|NCT02852655|102202931|FG001|NOT COMPLETED|Adjuvant MK3475 Therapy||22||
48760952|NCT02852655|102202932|FG002|NOT COMPLETED|Adjuvant MK3475 Therapy||14||
48760953|NCT03818256|102202933|FG000|STARTED|Overall Study||35||
48760954|NCT03818256|102202934|FG001|STARTED|Overall Study||36||
48760955|NCT03818256|102202933|FG000|COMPLETED|Overall Study||27||
48760956|NCT03818256|102202934|FG001|COMPLETED|Overall Study||28||
48760957|NCT03818256|102202933|FG000|NOT COMPLETED|Overall Study||8||
48760958|NCT03818256|102202934|FG001|NOT COMPLETED|Overall Study||8||
48760959|NCT00581308|102202935|FG000|STARTED|Pre Discharge||215||
48760960|NCT00581308|102202935|FG000|COMPLETED|Pre Discharge||213||
48416371|NCT02176226|101353389|FG000|COMPLETED|Overall Study||96||
48416372|NCT02176226|101353389|FG000|NOT COMPLETED|Overall Study||9||
48416373|NCT00397891|101353390|FG000|STARTED|Overall Study||6||
48416374|NCT00397891|101353391|FG001|STARTED|Overall Study||6||
48416375|NCT00397891|101353392|FG002|STARTED|Overall Study||6||
48416376|NCT00397891|101353393|FG003|STARTED|Overall Study||6||
48416377|NCT00397891|101353394|FG004|STARTED|Overall Study||8||
48416378|NCT00397891|101353390|FG000|COMPLETED|Overall Study||5||
48416379|NCT00397891|101353391|FG001|COMPLETED|Overall Study||6||
48416380|NCT00397891|101353392|FG002|COMPLETED|Overall Study||6||
48637818|NCT01794702|101898619|FG002|COMPLETED|Overall Study||47||
48637819|NCT01794702|101898617|FG000|NOT COMPLETED|Overall Study||0||
48760961|NCT00581308|102202935|FG000|NOT COMPLETED|Pre Discharge||2||
48760962|NCT00581308|102202935|FG000|STARTED|Month 1||213||
48760963|NCT00581308|102202935|FG000|COMPLETED|Month 1||205||
48760964|NCT00581308|102202935|FG000|NOT COMPLETED|Month 1||8||
48760965|NCT00581308|102202935|FG000|STARTED|Month 6||205||
48760966|NCT00581308|102202935|FG000|COMPLETED|Month 6||202||
48760967|NCT00581308|102202935|FG000|NOT COMPLETED|Month 6||3||
48760968|NCT00581308|102202935|FG000|STARTED|Month 12||202||
48760969|NCT00581308|102202935|FG000|COMPLETED|Month 12||182||
48188687|NCT03639675|100783309|FG000|COMPLETED|Overall Study||15||
48760970|NCT00581308|102202935|FG000|NOT COMPLETED|Month 12||20||
48416381|NCT00397891|101353393|FG003|COMPLETED|Overall Study||6||
48416382|NCT00397891|101353394|FG004|COMPLETED|Overall Study||7||
48416383|NCT00397891|101353390|FG000|NOT COMPLETED|Overall Study||1||
48416384|NCT00397891|101353391|FG001|NOT COMPLETED|Overall Study||0||
48760971|NCT00581308|102202935|FG000|STARTED|24 Months||182||
48416385|NCT00397891|101353392|FG002|NOT COMPLETED|Overall Study||0||
48637820|NCT01794702|101898618|FG001|NOT COMPLETED|Overall Study||0||
48637821|NCT01794702|101898619|FG002|NOT COMPLETED|Overall Study||0||
48637822|NCT00724893|101898620|FG000|STARTED|Overall Study||1302||
48637823|NCT00724893|101898621|FG001|STARTED|Overall Study||1128||
48637824|NCT00724893|101898620|FG000|COMPLETED|Overall Study||938||
48349309|NCT03263091|101184172|FG003|NOT COMPLETED|OL High-EPO Component||10||
48349310|NCT03263091|101184173|FG004|NOT COMPLETED|OL High-EPO Component||0||
48349311|NCT03263091|101184174|FG005|NOT COMPLETED|OL High-EPO Component||0||
48349312|NCT03263091|101184169|FG000|STARTED|DB Component||0||
48349313|NCT03263091|101184170|FG001|STARTED|DB Component||0||
48349314|NCT03263091|101184171|FG002|STARTED|DB Component||0||
48349315|NCT03263091|101184172|FG003|STARTED|DB Component||0||
48349316|NCT03263091|101184173|FG004|STARTED|DB Component||82||
48637825|NCT00724893|101898621|FG001|COMPLETED|Overall Study||670||
48637826|NCT00724893|101898620|FG000|NOT COMPLETED|Overall Study||364||
48637827|NCT00724893|101898621|FG001|NOT COMPLETED|Overall Study||458||
48637828|NCT01858948|101898622|FG000|STARTED|Overall Study||9||
48637829|NCT01858948|101898623|FG001|STARTED|Overall Study||10||
48637830|NCT01858948|101898622|FG000|COMPLETED|Overall Study||5||
48637831|NCT01858948|101898623|FG001|COMPLETED|Overall Study||4||
48637832|NCT01858948|101898622|FG000|NOT COMPLETED|Overall Study||4||
48637833|NCT01858948|101898623|FG001|NOT COMPLETED|Overall Study||6||
48637834|NCT00676143|101898624|FG000|STARTED|Overall Study||441||
48349317|NCT03263091|101184174|FG005|STARTED|DB Component||58||
48416386|NCT00397891|101353393|FG003|NOT COMPLETED|Overall Study||0||
48637835|NCT00676143|101898625|FG001|STARTED|Overall Study||658||
48637836|NCT00676143|101898624|FG000|Treated|Overall Study||439||
48637837|NCT00676143|101898625|FG001|Treated|Overall Study||654||
48637838|NCT00676143|101898624|FG000|COMPLETED|Overall Study||285||
48637839|NCT00676143|101898625|FG001|COMPLETED|Overall Study||398||
48637840|NCT00676143|101898624|FG000|NOT COMPLETED|Overall Study||156||
48637841|NCT00676143|101898625|FG001|NOT COMPLETED|Overall Study||260||
48637842|NCT03726476|101898626|FG000|STARTED|Overall Study||86||
48637843|NCT03726476|101898627|FG001|STARTED|Overall Study||88||
48637844|NCT03726476|101898626|FG000|COMPLETED|Overall Study||86||
48637845|NCT03726476|101898627|FG001|COMPLETED|Overall Study||88||
48637846|NCT03726476|101898626|FG000|NOT COMPLETED|Overall Study||0||
48637847|NCT03726476|101898627|FG001|NOT COMPLETED|Overall Study||0||
48637848|NCT03915067|101898628|FG000|STARTED|Overall Study||57||
48637849|NCT03915067|101898629|FG001|STARTED|Overall Study||59||
48637850|NCT03915067|101898630|FG002|STARTED|Overall Study||55||
48637851|NCT03915067|101898628|FG000|Modified Intent-to-treat (mITT) Population|Overall Study||53|mITT population included all randomized participants who had at least 1 post-baseline assessment of the primary efficacy parameter, the C-APPS, as described in the protocol.|
48637852|NCT03915067|101898629|FG001|Modified Intent-to-treat (mITT) Population|Overall Study||58|mITT population included all randomized participants who had at least 1 post-baseline assessment of the primary efficacy parameter, the C-APPS, as described in the protocol.|
48637853|NCT03915067|101898630|FG002|Modified Intent-to-treat (mITT) Population|Overall Study||53|mITT population included all randomized participants who had at least 1 post-baseline assessment of the primary efficacy parameter, the C-APPS, as described in the protocol.|
48637854|NCT03915067|101898628|FG000|Safety Population|Overall Study||56|Safety population included all participants who were administered study intervention.|
48637855|NCT03915067|101898629|FG001|Safety Population|Overall Study||59|Safety population included all participants who were administered study intervention.|
48186796|NCT01089556|100779904|FG004|Efficacy and Safety Population|Study Period III (Weeks 9-16)||94||
48186797|NCT01089556|100779905|FG005|Efficacy and Safety Population|Study Period III (Weeks 9-16)||97||
48186798|NCT01089556|100779900|FG000|COMPLETED|Study Period III (Weeks 9-16)||0||
48349318|NCT03263091|101184169|FG000|Received at Least 1 Dose of Study Drug|DB Component||0||
48416387|NCT00397891|101353394|FG004|NOT COMPLETED|Overall Study||1||
48416388|NCT02910492|101353395|FG000|STARTED|Overall Study||10||
48637856|NCT03915067|101898630|FG002|Safety Population|Overall Study||54|Safety population included all participants who were administered study intervention.|
48637857|NCT03915067|101898628|FG000|COMPLETED|Overall Study||47||
48637858|NCT03915067|101898629|FG001|COMPLETED|Overall Study||50||
48637859|NCT03915067|101898630|FG002|COMPLETED|Overall Study||49||
48637860|NCT03915067|101898628|FG000|NOT COMPLETED|Overall Study||10||
48637861|NCT03915067|101898629|FG001|NOT COMPLETED|Overall Study||9||
48637862|NCT03915067|101898630|FG002|NOT COMPLETED|Overall Study||6||
48637863|NCT01510756|101898631|FG000|STARTED|Overall Study||4||
48637864|NCT01510756|101898631|FG000|COMPLETED|Overall Study||0||
48637865|NCT01510756|101898631|FG000|NOT COMPLETED|Overall Study||4||
48637866|NCT01373164|101898632|FG000|STARTED|Overall Study||5||
48637867|NCT01373164|101898633|FG001|STARTED|Overall Study||4||
48637868|NCT01373164|101898634|FG002|STARTED|Overall Study||5||
48637869|NCT01373164|101898635|FG003|STARTED|Overall Study||104||
48637870|NCT01373164|101898636|FG004|STARTED|Overall Study||52||
48637871|NCT01373164|101898632|FG000|Received at Least One Dose|Overall Study||5||
48637872|NCT01373164|101898633|FG001|Received at Least One Dose|Overall Study||4||
48637873|NCT01373164|101898634|FG002|Received at Least One Dose|Overall Study||5||
48637874|NCT01373164|101898635|FG003|Received at Least One Dose|Overall Study||103||
48637875|NCT01373164|101898636|FG004|Received at Least One Dose|Overall Study||52||
48637876|NCT01373164|101898632|FG000|COMPLETED|Overall Study||5||
48637877|NCT01373164|101898633|FG001|COMPLETED|Overall Study||3||
48637878|NCT01373164|101898634|FG002|COMPLETED|Overall Study||4||
48637879|NCT01373164|101898635|FG003|COMPLETED|Overall Study||92||
48637880|NCT01373164|101898636|FG004|COMPLETED|Overall Study||50||
48637881|NCT01373164|101898632|FG000|NOT COMPLETED|Overall Study||0||
48637882|NCT01373164|101898633|FG001|NOT COMPLETED|Overall Study||1||
48637883|NCT01373164|101898634|FG002|NOT COMPLETED|Overall Study||1||
48637884|NCT01373164|101898635|FG003|NOT COMPLETED|Overall Study||12||
48637885|NCT01373164|101898636|FG004|NOT COMPLETED|Overall Study||2||
48637886|NCT01881425|101898637|FG000|STARTED|Overall Study||395||
48637887|NCT01881425|101898638|FG001|STARTED|Overall Study||132||
48637888|NCT01881425|101898637|FG000|COMPLETED|Overall Study||370||
48637889|NCT01881425|101898638|FG001|COMPLETED|Overall Study||123||
48637890|NCT01881425|101898637|FG000|NOT COMPLETED|Overall Study||25||
48637891|NCT01881425|101898638|FG001|NOT COMPLETED|Overall Study||9||
48637892|NCT00658619|101898639|FG000|STARTED|Overall Study||3||
48637893|NCT00658619|101898640|FG001|STARTED|Overall Study||3||
48637894|NCT00658619|101898641|FG002|STARTED|Overall Study||41||
48637895|NCT00658619|101898642|FG003|STARTED|Overall Study||49||
48637896|NCT00658619|101898643|FG004|STARTED|Overall Study||23||
48637897|NCT00658619|101898639|FG000|COMPLETED|Overall Study||3||
48637898|NCT00658619|101898640|FG001|COMPLETED|Overall Study||2||
48637899|NCT00658619|101898641|FG002|COMPLETED|Overall Study||31||
48637900|NCT00658619|101898642|FG003|COMPLETED|Overall Study||37||
48637901|NCT00658619|101898643|FG004|COMPLETED|Overall Study||21||
48637902|NCT00658619|101898639|FG000|NOT COMPLETED|Overall Study||0||
48637903|NCT00658619|101898640|FG001|NOT COMPLETED|Overall Study||1||
48637904|NCT00658619|101898641|FG002|NOT COMPLETED|Overall Study||10||
48637905|NCT00658619|101898642|FG003|NOT COMPLETED|Overall Study||12||
48637906|NCT00658619|101898643|FG004|NOT COMPLETED|Overall Study||2||
48637907|NCT04057768|101898644|FG000|STARTED|Overall Study||10||
48637908|NCT04057768|101898644|FG000|COMPLETED|Overall Study||10||
48637909|NCT04057768|101898644|FG000|NOT COMPLETED|Overall Study||0||
48637910|NCT02452190|101898645|FG000|STARTED|Overall Study||232||
48637911|NCT02452190|101898646|FG001|STARTED|Overall Study||236||
48637912|NCT02452190|101898645|FG000|Intent to Treat (ITT) Population|Overall Study||230|All randomized participants, excluding 4 from a terminated study site.|
48637913|NCT02452190|101898646|FG001|Intent to Treat (ITT) Population|Overall Study||234|All randomized participants, excluding 4 from a terminated study site.|
48637914|NCT02452190|101898645|FG000|Safety Population|Overall Study||231|Placebo participant treated with reslizumab at 1 visit is counted in reslizumab arm for Safety.|
48637915|NCT02452190|101898646|FG001|Safety Population|Overall Study||237|Placebo participant treated with reslizumab at 1 visit is counted in reslizumab arm for Safety.|
48637916|NCT02452190|101898645|FG000|COMPLETED|Overall Study||197||
48637917|NCT02452190|101898646|FG001|COMPLETED|Overall Study||212||
48637918|NCT02452190|101898645|FG000|NOT COMPLETED|Overall Study||35||
48637919|NCT02452190|101898646|FG001|NOT COMPLETED|Overall Study||24||
48637920|NCT02556788|101898647|FG000|STARTED|Overall Study||602||
48637921|NCT02556788|101898648|FG001|STARTED|Overall Study||610||
48637922|NCT02556788|101898647|FG000|COMPLETED|Overall Study||558||
48637923|NCT02556788|101898648|FG001|COMPLETED|Overall Study||573||
48637924|NCT02556788|101898647|FG000|NOT COMPLETED|Overall Study||44||
48637925|NCT02556788|101898648|FG001|NOT COMPLETED|Overall Study||37||
48637926|NCT03600350|101898649|FG000|STARTED|Overall Study||19||
48637927|NCT03600350|101898649|FG000|On Treatment|Overall Study||19||
48637928|NCT03600350|101898649|FG000|Off Treatment|Overall Study||19||
48637929|NCT03600350|101898649|FG000|COMPLETED|Overall Study||0||
48637930|NCT03600350|101898649|FG000|NOT COMPLETED|Overall Study||19||
48637931|NCT00699751|101898650|FG000|STARTED|Period 1: Without/Before Drug Switch||614||
48637932|NCT00699751|101898651|FG001|STARTED|Period 1: Without/Before Drug Switch||307||
48637933|NCT00699751|101898650|FG000|Participants Received Treatment|Period 1: Without/Before Drug Switch||600||
48637934|NCT00699751|101898651|FG001|Participants Received Treatment|Period 1: Without/Before Drug Switch||301||
48637935|NCT00699751|101898650|FG000|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||407||
48637936|NCT00699751|101898651|FG001|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||168||
48637937|NCT00699751|101898650|FG000|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||49||
48637938|NCT00699751|101898651|FG001|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||12||
48637939|NCT00699751|101898650|FG000|COMPLETED|Period 1: Without/Before Drug Switch||389||
48637940|NCT00699751|101898651|FG001|COMPLETED|Period 1: Without/Before Drug Switch||145||
48637941|NCT00699751|101898650|FG000|NOT COMPLETED|Period 1: Without/Before Drug Switch||225||
48637942|NCT00699751|101898651|FG001|NOT COMPLETED|Period 1: Without/Before Drug Switch||162||
48637943|NCT00699751|101898650|FG000|STARTED|Period 2:Switched From Placebo to Xofigo||0||
48637944|NCT00699751|101898651|FG001|STARTED|Period 2:Switched From Placebo to Xofigo||26||
48637945|NCT00699751|101898650|FG000|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||0||
48637946|NCT00699751|101898651|FG001|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||24||
48637947|NCT00699751|101898650|FG000|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0||
48637948|NCT00699751|101898651|FG001|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||15||
48637949|NCT00699751|101898650|FG000|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0||
48637950|NCT00699751|101898651|FG001|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0||
48637951|NCT00699751|101898650|FG000|COMPLETED|Period 2:Switched From Placebo to Xofigo||0||
48637952|NCT00699751|101898651|FG001|COMPLETED|Period 2:Switched From Placebo to Xofigo||17||
48637953|NCT00699751|101898650|FG000|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||0||
48637954|NCT00699751|101898651|FG001|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||9||
48637955|NCT01270659|101898652|FG000|STARTED|Overall Study||6||
48637956|NCT01270659|101898653|FG001|STARTED|Overall Study||25||
48637957|NCT01270659|101898654|FG002|STARTED|Overall Study||4||
48637958|NCT01270659|101898655|FG003|STARTED|Overall Study||25||
48637959|NCT01270659|101898652|FG000|COMPLETED|Overall Study||6||
48637960|NCT01270659|101898653|FG001|COMPLETED|Overall Study||25||
48637961|NCT01270659|101898654|FG002|COMPLETED|Overall Study||4||
48637962|NCT01270659|101898655|FG003|COMPLETED|Overall Study||25||
48637963|NCT01270659|101898652|FG000|NOT COMPLETED|Overall Study||0||
48637964|NCT01270659|101898653|FG001|NOT COMPLETED|Overall Study||0||
48637965|NCT01270659|101898654|FG002|NOT COMPLETED|Overall Study||0||
48637966|NCT01270659|101898655|FG003|NOT COMPLETED|Overall Study||0||
48637967|NCT01462942|101898656|FG000|STARTED|Overall Study||194||
48637968|NCT01462942|101898657|FG001|STARTED|Overall Study||385||
48637969|NCT01462942|101898658|FG002|STARTED|Overall Study||381||
48637970|NCT01462942|101898659|FG003|STARTED|Overall Study||385||
48637971|NCT01462942|101898660|FG004|STARTED|Overall Study||384||
48637972|NCT01462942|101898656|FG000|COMPLETED|Overall Study||160||
48637973|NCT01462942|101898657|FG001|COMPLETED|Overall Study||351||
48637974|NCT01462942|101898658|FG002|COMPLETED|Overall Study||341||
48637975|NCT01462942|101898659|FG003|COMPLETED|Overall Study||335||
48637976|NCT01462942|101898660|FG004|COMPLETED|Overall Study||339||
48637977|NCT01462942|101898656|FG000|NOT COMPLETED|Overall Study||34||
48637978|NCT01462942|101898657|FG001|NOT COMPLETED|Overall Study||34||
48637979|NCT01462942|101898658|FG002|NOT COMPLETED|Overall Study||40||
48637980|NCT01462942|101898659|FG003|NOT COMPLETED|Overall Study||50||
48637981|NCT01462942|101898660|FG004|NOT COMPLETED|Overall Study||45||
48637982|NCT02555878|101898661|FG000|STARTED|Overall Study||421||
48637983|NCT02555878|101898662|FG001|STARTED|Overall Study||420||
48637984|NCT02555878|101898661|FG000|Treated|Overall Study||404||
48637985|NCT02555878|101898662|FG001|Treated|Overall Study||405||
48637986|NCT02555878|101898661|FG000|COMPLETED|Overall Study||255||
48637987|NCT02555878|101898662|FG001|COMPLETED|Overall Study||270||
48637988|NCT02555878|101898661|FG000|NOT COMPLETED|Overall Study||166||
48637989|NCT02555878|101898662|FG001|NOT COMPLETED|Overall Study||150||
48637990|NCT04900272|101898663|FG000|STARTED|Overall Study||21||
48637991|NCT04900272|101898663|FG000|COMPLETED|Overall Study||15|21 participants consented to participate and were enrolled. Two completed their first interviews but were lost to follow up, 3 were unable to connect their devices so were withdrawn, and 1 dropped out after consenting. Therefore, 15 participants completed the study, whereas 17 participants completed the baseline interview and were included in the Overall Number of Baseline Participants section.|
48637992|NCT04900272|101898663|FG000|NOT COMPLETED|Overall Study||6||
48637993|NCT01069939|101898664|FG000|STARTED|Randomised and Included in the Analyses||213||
48637994|NCT01069939|101898665|FG001|STARTED|Randomised and Included in the Analyses||214||
48637995|NCT01069939|101898664|FG000|COMPLETED|Randomised and Included in the Analyses||164||
48637996|NCT01069939|101898665|FG001|COMPLETED|Randomised and Included in the Analyses||137||
48637997|NCT01069939|101898664|FG000|NOT COMPLETED|Randomised and Included in the Analyses||49||
48637998|NCT01069939|101898665|FG001|NOT COMPLETED|Randomised and Included in the Analyses||77||
48637999|NCT01069939|101898664|FG000|STARTED|At Data Cut Off Date (26 Feb 2011)||213||
48638000|NCT01069939|101898665|FG001|STARTED|At Data Cut Off Date (26 Feb 2011)||214||
48638001|NCT01069939|101898664|FG000|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182||
48638002|NCT01069939|101898665|FG001|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182||
48638003|NCT01069939|101898664|FG000|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||31||
48638004|NCT01069939|101898665|FG001|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||32||
48638005|NCT02207608|101898666|FG000|STARTED|Overall Study||15||
48638006|NCT02207608|101898667|FG001|STARTED|Overall Study||15||
48638007|NCT02207608|101898666|FG000|COMPLETED|Overall Study||14||
48638008|NCT02207608|101898667|FG001|COMPLETED|Overall Study||15||
48638009|NCT02207608|101898666|FG000|NOT COMPLETED|Overall Study||1||
48638010|NCT02207608|101898667|FG001|NOT COMPLETED|Overall Study||0||
48638011|NCT05073315|101898668|FG000|STARTED|Period 1 (Lead-in Period)||425||
48638012|NCT05073315|101898669|FG001|STARTED|Period 1 (Lead-in Period)||0||
48638013|NCT05073315|101898670|FG002|STARTED|Period 1 (Lead-in Period)||0||
48638014|NCT05073315|101898668|FG000|COMPLETED|Period 1 (Lead-in Period)||380||
48638015|NCT05073315|101898669|FG001|COMPLETED|Period 1 (Lead-in Period)||0||
48638016|NCT05073315|101898670|FG002|COMPLETED|Period 1 (Lead-in Period)||0||
48638017|NCT05073315|101898668|FG000|NOT COMPLETED|Period 1 (Lead-in Period)||45||
48638018|NCT05073315|101898669|FG001|NOT COMPLETED|Period 1 (Lead-in Period)||0||
48638019|NCT05073315|101898670|FG002|NOT COMPLETED|Period 1 (Lead-in Period)||0||
48638020|NCT05073315|101898668|FG000|STARTED|Period 2||0||
48638021|NCT05073315|101898669|FG001|STARTED|Period 2||186||
48638022|NCT05073315|101898670|FG002|STARTED|Period 2||194||
48638023|NCT05073315|101898668|FG000|COMPLETED|Period 2||0||
48638024|NCT05073315|101898669|FG001|COMPLETED|Period 2||174||
48638025|NCT05073315|101898670|FG002|COMPLETED|Period 2||173||
48638026|NCT05073315|101898668|FG000|NOT COMPLETED|Period 2||0||
48638027|NCT05073315|101898669|FG001|NOT COMPLETED|Period 2||12||
48638028|NCT05073315|101898670|FG002|NOT COMPLETED|Period 2||21||
48638029|NCT00580840|101898671|FG000|STARTED|Run-in||333||
48638030|NCT00580840|101898672|FG001|STARTED|Run-in||0||
48638031|NCT00580840|101898673|FG002|STARTED|Run-in||0||
48638032|NCT00580840|101898674|FG003|STARTED|Run-in||0||
48638033|NCT00580840|101898671|FG000|COMPLETED|Run-in||209||
48638034|NCT00580840|101898672|FG001|COMPLETED|Run-in||0||
48638035|NCT00580840|101898673|FG002|COMPLETED|Run-in||0||
48638036|NCT00580840|101898674|FG003|COMPLETED|Run-in||0||
48638037|NCT00580840|101898671|FG000|NOT COMPLETED|Run-in||124||
48638038|NCT00580840|101898672|FG001|NOT COMPLETED|Run-in||0||
48638039|NCT00580840|101898673|FG002|NOT COMPLETED|Run-in||0||
48638040|NCT00580840|101898674|FG003|NOT COMPLETED|Run-in||0||
48638041|NCT00580840|101898671|FG000|STARTED|Double-Blind||0||
48638042|NCT00580840|101898672|FG001|STARTED|Double-Blind||70||
48638043|NCT00580840|101898673|FG002|STARTED|Double-Blind||70||
48638044|NCT00580840|101898674|FG003|STARTED|Double-Blind||69||
48638045|NCT00580840|101898671|FG000|COMPLETED|Double-Blind||0||
48638046|NCT00580840|101898672|FG001|COMPLETED|Double-Blind||63||
48638047|NCT00580840|101898673|FG002|COMPLETED|Double-Blind||61||
48638048|NCT00580840|101898674|FG003|COMPLETED|Double-Blind||54||
48638049|NCT00580840|101898671|FG000|NOT COMPLETED|Double-Blind||0||
48638050|NCT00580840|101898672|FG001|NOT COMPLETED|Double-Blind||7||
48638051|NCT00580840|101898673|FG002|NOT COMPLETED|Double-Blind||9||
48638052|NCT00580840|101898674|FG003|NOT COMPLETED|Double-Blind||15||
48638053|NCT00883181|101898675|FG000|STARTED|Overall Study||1347||
48638054|NCT00883181|101898675|FG000|COMPLETED|Overall Study||1069||
48638055|NCT00883181|101898675|FG000|NOT COMPLETED|Overall Study||278||
48638056|NCT04050605|101898676|FG000|STARTED|Overall Study||40||
48638057|NCT04050605|101898676|FG000|COMPLETED|Overall Study||40||
48638058|NCT04050605|101898676|FG000|NOT COMPLETED|Overall Study||0||
48638059|NCT00396292|101898677|FG000|STARTED|Overall Study||174||
48638060|NCT00396292|101898678|FG001|STARTED|Overall Study||178||
48638061|NCT00396292|101898677|FG000|COMPLETED|Overall Study||165||
48638062|NCT00396292|101898678|FG001|COMPLETED|Overall Study||162||
48638063|NCT00396292|101898677|FG000|NOT COMPLETED|Overall Study||9||
48638064|NCT00396292|101898678|FG001|NOT COMPLETED|Overall Study||16||
48638065|NCT01136954|101898679|FG000|STARTED|Overall Study||72||
48638066|NCT01136954|101898680|FG001|STARTED|Overall Study||72||
48638067|NCT01136954|101898679|FG000|COMPLETED|Overall Study||48||
48349319|NCT03263091|101184170|FG001|Received at Least 1 Dose of Study Drug|DB Component||0||
48638068|NCT01136954|101898680|FG001|COMPLETED|Overall Study||51||
48638069|NCT01136954|101898679|FG000|NOT COMPLETED|Overall Study||24||
48638070|NCT01136954|101898680|FG001|NOT COMPLETED|Overall Study||21||
48638071|NCT03743194|101898681|FG000|STARTED|Overall Study||105||
48638072|NCT03743194|101898682|FG001|STARTED|Overall Study||105||
48349320|NCT03263091|101184171|FG002|Received at Least 1 Dose of Study Drug|DB Component||0||
48349321|NCT03263091|101184172|FG003|Received at Least 1 Dose of Study Drug|DB Component||0||
48349322|NCT03263091|101184173|FG004|Received at Least 1 Dose of Study Drug|DB Component||82||
48349323|NCT03263091|101184174|FG005|Received at Least 1 Dose of Study Drug|DB Component||58||
48349324|NCT03263091|101184169|FG000|COMPLETED|DB Component||0||
48349325|NCT03263091|101184170|FG001|COMPLETED|DB Component||0||
48349326|NCT03263091|101184171|FG002|COMPLETED|DB Component||0||
48349327|NCT03263091|101184172|FG003|COMPLETED|DB Component||0||
48349328|NCT03263091|101184173|FG004|COMPLETED|DB Component||38||
48349329|NCT03263091|101184174|FG005|COMPLETED|DB Component||37||
48349330|NCT03263091|101184169|FG000|NOT COMPLETED|DB Component||0||
48349331|NCT03263091|101184170|FG001|NOT COMPLETED|DB Component||0||
48349332|NCT03263091|101184171|FG002|NOT COMPLETED|DB Component||0||
48349333|NCT03263091|101184172|FG003|NOT COMPLETED|DB Component||0||
48416389|NCT02910492|101353395|FG000|COMPLETED|Overall Study||4||
48416390|NCT02910492|101353395|FG000|NOT COMPLETED|Overall Study||6||
48416391|NCT03696576|101353396|FG000|STARTED|Overall Study||13||
48638073|NCT03743194|101898681|FG000|COMPLETED|Overall Study||98||
48186799|NCT01089556|100779901|FG001|COMPLETED|Study Period III (Weeks 9-16)||0||
48349334|NCT03263091|101184173|FG004|NOT COMPLETED|DB Component||44||
48349335|NCT03263091|101184174|FG005|NOT COMPLETED|DB Component||21||
48349336|NCT03293654|101184175|FG000|STARTED|Overall Study||38||
48349337|NCT03293654|101184176|FG001|STARTED|Overall Study||38||
48349338|NCT03293654|101184177|FG002|STARTED|Overall Study||38||
48416392|NCT03696576|101353397|FG001|STARTED|Overall Study||11||
48416393|NCT03696576|101353396|FG000|COMPLETED|Overall Study||10||
48349339|NCT03293654|101184175|FG000|COMPLETED|Overall Study||38||
48416394|NCT03696576|101353397|FG001|COMPLETED|Overall Study||6||
48638074|NCT03743194|101898682|FG001|COMPLETED|Overall Study||96||
48349340|NCT03293654|101184176|FG001|COMPLETED|Overall Study||37||
48349341|NCT03293654|101184177|FG002|COMPLETED|Overall Study||38||
48349342|NCT03293654|101184175|FG000|NOT COMPLETED|Overall Study||0||
48349343|NCT03293654|101184176|FG001|NOT COMPLETED|Overall Study||1||
48349344|NCT03293654|101184177|FG002|NOT COMPLETED|Overall Study||0||
48349345|NCT00947349|101184178|FG000|STARTED|Triple Treatment Combination Period||4||
48349346|NCT00947349|101184179|FG001|STARTED|Triple Treatment Combination Period||6||
48349347|NCT00947349|101184180|FG002|STARTED|Triple Treatment Combination Period||6||
48349348|NCT00947349|101184181|FG003|STARTED|Triple Treatment Combination Period||6||
48349349|NCT00947349|101184178|FG000|COMPLETED|Triple Treatment Combination Period||4||
48349350|NCT00947349|101184179|FG001|COMPLETED|Triple Treatment Combination Period||5||
48349351|NCT00947349|101184180|FG002|COMPLETED|Triple Treatment Combination Period||6||
48349352|NCT00947349|101184181|FG003|COMPLETED|Triple Treatment Combination Period||6||
48349353|NCT00947349|101184178|FG000|NOT COMPLETED|Triple Treatment Combination Period||0||
48349354|NCT00947349|101184179|FG001|NOT COMPLETED|Triple Treatment Combination Period||1||
48349355|NCT00947349|101184180|FG002|NOT COMPLETED|Triple Treatment Combination Period||0||
48349356|NCT00947349|101184181|FG003|NOT COMPLETED|Triple Treatment Combination Period||0||
48349357|NCT00947349|101184178|FG000|STARTED|Overall Study Standard of Care||4||
48349358|NCT00947349|101184179|FG001|STARTED|Overall Study Standard of Care||5||
48349359|NCT00947349|101184180|FG002|STARTED|Overall Study Standard of Care||6||
48349360|NCT00947349|101184181|FG003|STARTED|Overall Study Standard of Care||6||
48349361|NCT00947349|101184178|FG000|COMPLETED|Overall Study Standard of Care||4||
48349362|NCT00947349|101184179|FG001|COMPLETED|Overall Study Standard of Care||5||
48349363|NCT00947349|101184180|FG002|COMPLETED|Overall Study Standard of Care||4||
48349364|NCT00947349|101184181|FG003|COMPLETED|Overall Study Standard of Care||4||
48349365|NCT00947349|101184178|FG000|NOT COMPLETED|Overall Study Standard of Care||0||
48349366|NCT00947349|101184179|FG001|NOT COMPLETED|Overall Study Standard of Care||0||
48349367|NCT00947349|101184180|FG002|NOT COMPLETED|Overall Study Standard of Care||2||
48349368|NCT00947349|101184181|FG003|NOT COMPLETED|Overall Study Standard of Care||2||
48186800|NCT01089556|100779902|FG002|COMPLETED|Study Period III (Weeks 9-16)||60||
48186801|NCT01089556|100779903|FG003|COMPLETED|Study Period III (Weeks 9-16)||66||
48186802|NCT01089556|100779904|FG004|COMPLETED|Study Period III (Weeks 9-16)||83||
48186803|NCT01089556|100779905|FG005|COMPLETED|Study Period III (Weeks 9-16)||92||
48186804|NCT01089556|100779900|FG000|NOT COMPLETED|Study Period III (Weeks 9-16)||0||
48186805|NCT01089556|100779901|FG001|NOT COMPLETED|Study Period III (Weeks 9-16)||0||
48186806|NCT01089556|100779902|FG002|NOT COMPLETED|Study Period III (Weeks 9-16)||14||
48186807|NCT01089556|100779903|FG003|NOT COMPLETED|Study Period III (Weeks 9-16)||9||
48186808|NCT01089556|100779904|FG004|NOT COMPLETED|Study Period III (Weeks 9-16)||12||
48186809|NCT01089556|100779905|FG005|NOT COMPLETED|Study Period III (Weeks 9-16)||7||
48349369|NCT01607892|101184182|FG000|STARTED|Overall Study||58||
48349370|NCT01607892|101184183|FG001|STARTED|Overall Study||27||
48349371|NCT01607892|101184184|FG002|STARTED|Overall Study||81||
48349372|NCT01607892|101184185|FG003|STARTED|Overall Study||95||
48349373|NCT01607892|101184186|FG004|STARTED|Overall Study||24||
48349374|NCT01607892|101184182|FG000|COMPLETED|Overall Study||0||
48349375|NCT01607892|101184183|FG001|COMPLETED|Overall Study||0||
48349376|NCT01607892|101184184|FG002|COMPLETED|Overall Study||0||
48349377|NCT01607892|101184185|FG003|COMPLETED|Overall Study||0||
48349378|NCT01607892|101184186|FG004|COMPLETED|Overall Study||0||
48349379|NCT01607892|101184182|FG000|NOT COMPLETED|Overall Study||58||
48349380|NCT01607892|101184183|FG001|NOT COMPLETED|Overall Study||27||
48186810|NCT02748512|100779906|FG000|STARTED|Overall Study||14||27
48186811|NCT02748512|100779907|FG001|STARTED|Overall Study||12||11
48349381|NCT01607892|101184184|FG002|NOT COMPLETED|Overall Study||81||
48349382|NCT01607892|101184185|FG003|NOT COMPLETED|Overall Study||95||
48349383|NCT01607892|101184186|FG004|NOT COMPLETED|Overall Study||24||
48349384|NCT01802281|101184187|FG000|STARTED|Overall Study||93|Started indicates randomized into the SUPeR study|
48349385|NCT01802281|101184188|FG001|STARTED|Overall Study||90|Started indicates randomized into the SUPeR study|
48349386|NCT01802281|101184187|FG000|Eligible and Received Randomized Treatment|Overall Study||88|A small number of randomized participants received the randomized treatment but were found to be ineligible for the intervention|
48349387|NCT01802281|101184188|FG001|Eligible and Received Randomized Treatment|Overall Study||87|A small number of randomized participants received the randomized treatment but were found to be ineligible for the intervention|
48349388|NCT01802281|101184187|FG000|Completed Year 1 Follow-up|Overall Study||88||
48186812|NCT02748512|100779906|FG000|COMPLETED|Overall Study||13|14 subjects had 1 study eye treated and 12 subjects had 2 study eyes treated|26
48188688|NCT03639675|100783309|FG000|NOT COMPLETED|Overall Study||1||
48349389|NCT01802281|101184188|FG001|Completed Year 1 Follow-up|Overall Study||86||
48349390|NCT01802281|101184187|FG000|Completed Year 2 Follow-up|Overall Study||87||
48349391|NCT01802281|101184188|FG001|Completed Year 2 Follow-up|Overall Study||84||
48349392|NCT01802281|101184187|FG000|COMPLETED|Overall Study||85|Completed Year 3 Follow-up|
48349393|NCT01802281|101184188|FG001|COMPLETED|Overall Study||84|Completed Year 3 Follow-up|
48349394|NCT01802281|101184187|FG000|NOT COMPLETED|Overall Study||8||
48349395|NCT01802281|101184188|FG001|NOT COMPLETED|Overall Study||6||
48349396|NCT03539432|101184189|FG000|STARTED|Overall Study||2||
48349397|NCT03539432|101184190|FG001|STARTED|Overall Study||1||
48349398|NCT03539432|101184189|FG000|COMPLETED|Overall Study||2||
48349399|NCT03539432|101184190|FG001|COMPLETED|Overall Study||0||
48349400|NCT03539432|101184189|FG000|NOT COMPLETED|Overall Study||0||
48349401|NCT03539432|101184190|FG001|NOT COMPLETED|Overall Study||1||
48349402|NCT04358458|101184191|FG000|STARTED|Overall Study||3||
48349403|NCT04358458|101184192|FG001|STARTED|Overall Study||4||
48349404|NCT04358458|101184193|FG002|STARTED|Overall Study||7||
48349405|NCT04358458|101184194|FG003|STARTED|Overall Study||10||
48349406|NCT04358458|101184195|FG004|STARTED|Overall Study||3||
48349407|NCT04358458|101184196|FG005|STARTED|Overall Study||10||
48349408|NCT04358458|101184197|FG006|STARTED|Overall Study||3||
48349409|NCT04358458|101184198|FG007|STARTED|Overall Study||6||
48349410|NCT04358458|101184191|FG000|COMPLETED|Overall Study||0||
48349411|NCT04358458|101184192|FG001|COMPLETED|Overall Study||0||
48349412|NCT04358458|101184193|FG002|COMPLETED|Overall Study||0||
48349413|NCT04358458|101184194|FG003|COMPLETED|Overall Study||0||
48349414|NCT04358458|101184195|FG004|COMPLETED|Overall Study||0||
48349415|NCT04358458|101184196|FG005|COMPLETED|Overall Study||0||
48349416|NCT04358458|101184197|FG006|COMPLETED|Overall Study||0||
48349417|NCT04358458|101184198|FG007|COMPLETED|Overall Study||0||
48349418|NCT04358458|101184191|FG000|NOT COMPLETED|Overall Study||3||
48349419|NCT04358458|101184192|FG001|NOT COMPLETED|Overall Study||4||
48349420|NCT04358458|101184193|FG002|NOT COMPLETED|Overall Study||7||
48349421|NCT04358458|101184194|FG003|NOT COMPLETED|Overall Study||10||
48349422|NCT04358458|101184195|FG004|NOT COMPLETED|Overall Study||3||
48349423|NCT04358458|101184196|FG005|NOT COMPLETED|Overall Study||10||
48349424|NCT04358458|101184197|FG006|NOT COMPLETED|Overall Study||3||
48349425|NCT04358458|101184198|FG007|NOT COMPLETED|Overall Study||6||
48349426|NCT01075087|101184199|FG000|STARTED|Overall Study||9||
48349427|NCT01075087|101184200|FG001|STARTED|Overall Study||10||
48349428|NCT01075087|101184199|FG000|COMPLETED|Overall Study||9||
48349429|NCT01075087|101184200|FG001|COMPLETED|Overall Study||10||
48349430|NCT01075087|101184199|FG000|NOT COMPLETED|Overall Study||0||
48349431|NCT01075087|101184200|FG001|NOT COMPLETED|Overall Study||0||
48349432|NCT00748657|101184201|FG000|STARTED|Overall Study||36||
48349433|NCT00748657|101184201|FG000|COMPLETED|Overall Study||36||
48349434|NCT00748657|101184201|FG000|NOT COMPLETED|Overall Study||0||
48349435|NCT04579549|101184202|FG000|STARTED|Overall Study||464||
48349436|NCT04579549|101184202|FG000|Number of Individuals Trained In COVID-19 Assay|Overall Study||11||
48349437|NCT04579549|101184202|FG000|COMPLETED|Overall Study||464||
48349438|NCT04579549|101184202|FG000|NOT COMPLETED|Overall Study||0||
48349439|NCT03384329|101184203|FG000|STARTED|Overall Study||11||
48349440|NCT03384329|101184204|FG001|STARTED|Overall Study||11||
48349441|NCT03384329|101184203|FG000|COMPLETED|Overall Study||11||
48349442|NCT03384329|101184204|FG001|COMPLETED|Overall Study||11||
48349443|NCT03384329|101184203|FG000|NOT COMPLETED|Overall Study||0||
48349444|NCT03384329|101184204|FG001|NOT COMPLETED|Overall Study||0||
48349445|NCT02101437|101184205|FG000|STARTED|Overall Study||20||
48349446|NCT02101437|101184206|FG001|STARTED|Overall Study||54||
48349447|NCT02101437|101184207|FG002|STARTED|Overall Study||52||
48349448|NCT02101437|101184208|FG003|STARTED|Overall Study||49||
48349449|NCT02101437|101184205|FG000|COMPLETED|Overall Study||20||
48349450|NCT02101437|101184206|FG001|COMPLETED|Overall Study||54||
48349451|NCT02101437|101184207|FG002|COMPLETED|Overall Study||52||
48349452|NCT02101437|101184208|FG003|COMPLETED|Overall Study||49||
48349453|NCT02101437|101184205|FG000|NOT COMPLETED|Overall Study||0||
48349454|NCT02101437|101184206|FG001|NOT COMPLETED|Overall Study||0||
48349455|NCT02101437|101184207|FG002|NOT COMPLETED|Overall Study||0||
48349456|NCT02101437|101184208|FG003|NOT COMPLETED|Overall Study||0||
48349457|NCT02656472|101184209|FG000|STARTED|Overall Study||11||
48349458|NCT02656472|101184210|FG001|STARTED|Overall Study||10||
48349459|NCT02656472|101184209|FG000|COMPLETED|Overall Study||10||
48349460|NCT02656472|101184210|FG001|COMPLETED|Overall Study||10||
48349461|NCT02656472|101184209|FG000|NOT COMPLETED|Overall Study||1||
48349462|NCT02656472|101184210|FG001|NOT COMPLETED|Overall Study||0||
48349463|NCT01478958|101184211|FG000|STARTED|Overall Study||67||
48349464|NCT01478958|101184212|FG001|STARTED|Overall Study||66||
48349465|NCT01478958|101184213|FG002|STARTED|Overall Study||69||
48349466|NCT01478958|101184211|FG000|COMPLETED|Overall Study||65||
48349467|NCT01478958|101184212|FG001|COMPLETED|Overall Study||64||
48349468|NCT01478958|101184213|FG002|COMPLETED|Overall Study||66||
48349469|NCT01478958|101184211|FG000|NOT COMPLETED|Overall Study||2||
48349470|NCT01478958|101184212|FG001|NOT COMPLETED|Overall Study||2||
48349471|NCT01478958|101184213|FG002|NOT COMPLETED|Overall Study||3||
48349472|NCT00957853|101184214|FG000|STARTED|Overall Study||4||
48349473|NCT00957853|101184215|FG001|STARTED|Overall Study||6||
48349474|NCT00957853|101184216|FG002|STARTED|Overall Study||5||
48349475|NCT00957853|101184214|FG000|Randomization|Overall Study||4||
48349476|NCT00957853|101184215|FG001|Randomization|Overall Study||6||
48349477|NCT00957853|101184216|FG002|Randomization|Overall Study||5||
48349478|NCT00957853|101184214|FG000|Neoadjuvant Tx Completion|Overall Study||3||
48349479|NCT00957853|101184215|FG001|Neoadjuvant Tx Completion|Overall Study||6||
48349480|NCT00957853|101184216|FG002|Neoadjuvant Tx Completion|Overall Study||5||
48349481|NCT00957853|101184214|FG000|COMPLETED|Overall Study||3||
48349482|NCT00957853|101184215|FG001|COMPLETED|Overall Study||6||
48349483|NCT00957853|101184216|FG002|COMPLETED|Overall Study||5||
48349484|NCT00957853|101184214|FG000|NOT COMPLETED|Overall Study||1||
48349485|NCT00957853|101184215|FG001|NOT COMPLETED|Overall Study||0||
48349486|NCT00957853|101184216|FG002|NOT COMPLETED|Overall Study||0||
48349487|NCT00098787|101184217|FG000|STARTED|Overall Study||73||
48349488|NCT00098787|101184218|FG001|STARTED|Overall Study||75||
48349489|NCT00098787|101184219|FG002|STARTED|Overall Study||63||
48349490|NCT00098787|101184217|FG000|Treated|Overall Study||70||
48349491|NCT00098787|101184218|FG001|Treated|Overall Study||73||
48349492|NCT00098787|101184219|FG002|Treated|Overall Study||62||
48349493|NCT00098787|101184217|FG000|Eligible and Treated|Overall Study||61||
48349494|NCT00098787|101184218|FG001|Eligible and Treated|Overall Study||66||
48349495|NCT00098787|101184219|FG002|Eligible and Treated|Overall Study||59||
48349496|NCT00098787|101184217|FG000|COMPLETED|Overall Study||0||
48349497|NCT00098787|101184218|FG001|COMPLETED|Overall Study||0||
48349498|NCT00098787|101184219|FG002|COMPLETED|Overall Study||0||
48349499|NCT00098787|101184217|FG000|NOT COMPLETED|Overall Study||73||
48349500|NCT00098787|101184218|FG001|NOT COMPLETED|Overall Study||75||
48349501|NCT00098787|101184219|FG002|NOT COMPLETED|Overall Study||63||
48349502|NCT01591330|101184220|FG000|STARTED|Period 1||8||
48349503|NCT01591330|101184221|FG001|STARTED|Period 1||9||
48349504|NCT01591330|101184222|FG002|STARTED|Period 1||9||
48349505|NCT01591330|101184223|FG003|STARTED|Period 1||9||
48349506|NCT01591330|101184220|FG000|Received at Least 1 Dose of Study Drug|Period 1||8||
48349507|NCT01591330|101184221|FG001|Received at Least 1 Dose of Study Drug|Period 1||9||
48349508|NCT01591330|101184222|FG002|Received at Least 1 Dose of Study Drug|Period 1||9||
48349509|NCT01591330|101184223|FG003|Received at Least 1 Dose of Study Drug|Period 1||9||
48349510|NCT01591330|101184220|FG000|COMPLETED|Period 1||7||
48349511|NCT01591330|101184221|FG001|COMPLETED|Period 1||9||
48349512|NCT01591330|101184222|FG002|COMPLETED|Period 1||9||
48349513|NCT01591330|101184223|FG003|COMPLETED|Period 1||9||
48349514|NCT01591330|101184220|FG000|NOT COMPLETED|Period 1||1||
48349515|NCT01591330|101184221|FG001|NOT COMPLETED|Period 1||0||
48349516|NCT01591330|101184222|FG002|NOT COMPLETED|Period 1||0||
48349517|NCT01591330|101184223|FG003|NOT COMPLETED|Period 1||0||
48349518|NCT01591330|101184220|FG000|STARTED|Washout of at Least 3 Days||7||
48349519|NCT01591330|101184221|FG001|STARTED|Washout of at Least 3 Days||9||
48349520|NCT01591330|101184222|FG002|STARTED|Washout of at Least 3 Days||9||
48349521|NCT01591330|101184223|FG003|STARTED|Washout of at Least 3 Days||9||
48349522|NCT01591330|101184220|FG000|COMPLETED|Washout of at Least 3 Days||6||
48349523|NCT01591330|101184221|FG001|COMPLETED|Washout of at Least 3 Days||9||
48349524|NCT01591330|101184222|FG002|COMPLETED|Washout of at Least 3 Days||9||
48349525|NCT01591330|101184223|FG003|COMPLETED|Washout of at Least 3 Days||9||
48349526|NCT01591330|101184220|FG000|NOT COMPLETED|Washout of at Least 3 Days||1||
48349527|NCT01591330|101184221|FG001|NOT COMPLETED|Washout of at Least 3 Days||0||
48349528|NCT01591330|101184222|FG002|NOT COMPLETED|Washout of at Least 3 Days||0||
48349529|NCT01591330|101184223|FG003|NOT COMPLETED|Washout of at Least 3 Days||0||
48349530|NCT01591330|101184220|FG000|STARTED|Period 2||6||
48349531|NCT01591330|101184221|FG001|STARTED|Period 2||9||
48349532|NCT01591330|101184222|FG002|STARTED|Period 2||9||
48349533|NCT01591330|101184223|FG003|STARTED|Period 2||9||
48349534|NCT01591330|101184220|FG000|COMPLETED|Period 2||5||
48349535|NCT01591330|101184221|FG001|COMPLETED|Period 2||9||
48349536|NCT01591330|101184222|FG002|COMPLETED|Period 2||9||
48349537|NCT01591330|101184223|FG003|COMPLETED|Period 2||9||
48349538|NCT01591330|101184220|FG000|NOT COMPLETED|Period 2||1||
48349539|NCT01591330|101184221|FG001|NOT COMPLETED|Period 2||0||
48349540|NCT01591330|101184222|FG002|NOT COMPLETED|Period 2||0||
48349541|NCT01591330|101184223|FG003|NOT COMPLETED|Period 2||0||
48349542|NCT01591330|101184220|FG000|STARTED|Washout of at Least 3 Days||5||
48349543|NCT01591330|101184221|FG001|STARTED|Washout of at Least 3 Days||9||
48349544|NCT01591330|101184222|FG002|STARTED|Washout of at Least 3 Days||9||
48349545|NCT01591330|101184223|FG003|STARTED|Washout of at Least 3 Days||9||
48349546|NCT01591330|101184220|FG000|COMPLETED|Washout of at Least 3 Days||5||
48349547|NCT01591330|101184221|FG001|COMPLETED|Washout of at Least 3 Days||9||
48349548|NCT01591330|101184222|FG002|COMPLETED|Washout of at Least 3 Days||9||
48349549|NCT01591330|101184223|FG003|COMPLETED|Washout of at Least 3 Days||9||
48349550|NCT01591330|101184220|FG000|NOT COMPLETED|Washout of at Least 3 Days||0||
48349551|NCT01591330|101184221|FG001|NOT COMPLETED|Washout of at Least 3 Days||0||
48349552|NCT01591330|101184222|FG002|NOT COMPLETED|Washout of at Least 3 Days||0||
48416395|NCT03696576|101353396|FG000|NOT COMPLETED|Overall Study||3||
48349553|NCT01591330|101184223|FG003|NOT COMPLETED|Washout of at Least 3 Days||0||
48349554|NCT01591330|101184220|FG000|STARTED|Period 3||5||
48349555|NCT01591330|101184221|FG001|STARTED|Period 3||9||
48349556|NCT01591330|101184222|FG002|STARTED|Period 3||9||
48349557|NCT01591330|101184223|FG003|STARTED|Period 3||9||
48349558|NCT01591330|101184220|FG000|COMPLETED|Period 3||5||
48349559|NCT01591330|101184221|FG001|COMPLETED|Period 3||9||
48349560|NCT01591330|101184222|FG002|COMPLETED|Period 3||9||
48349561|NCT01591330|101184223|FG003|COMPLETED|Period 3||9||
48349562|NCT01591330|101184220|FG000|NOT COMPLETED|Period 3||0||
48349563|NCT01591330|101184221|FG001|NOT COMPLETED|Period 3||0||
48349564|NCT01591330|101184222|FG002|NOT COMPLETED|Period 3||0||
48349565|NCT01591330|101184223|FG003|NOT COMPLETED|Period 3||0||
48349566|NCT01591330|101184220|FG000|STARTED|Washout of at Least 3 Days||5||
48349567|NCT01591330|101184221|FG001|STARTED|Washout of at Least 3 Days||9||
48349568|NCT01591330|101184222|FG002|STARTED|Washout of at Least 3 Days||9||
48349569|NCT01591330|101184223|FG003|STARTED|Washout of at Least 3 Days||9||
48349570|NCT01591330|101184220|FG000|COMPLETED|Washout of at Least 3 Days||5||
48349571|NCT01591330|101184221|FG001|COMPLETED|Washout of at Least 3 Days||9||
48349572|NCT01591330|101184222|FG002|COMPLETED|Washout of at Least 3 Days||9||
48349573|NCT01591330|101184223|FG003|COMPLETED|Washout of at Least 3 Days||9||
48349574|NCT01591330|101184220|FG000|NOT COMPLETED|Washout of at Least 3 Days||0||
48349575|NCT01591330|101184221|FG001|NOT COMPLETED|Washout of at Least 3 Days||0||
48349576|NCT01591330|101184222|FG002|NOT COMPLETED|Washout of at Least 3 Days||0||
48349577|NCT01591330|101184223|FG003|NOT COMPLETED|Washout of at Least 3 Days||0||
48349578|NCT01591330|101184220|FG000|STARTED|Period 4||5||
48349579|NCT01591330|101184221|FG001|STARTED|Period 4||9||
48349580|NCT01591330|101184222|FG002|STARTED|Period 4||9||
48349581|NCT01591330|101184223|FG003|STARTED|Period 4||9||
48349582|NCT01591330|101184220|FG000|COMPLETED|Period 4||5||
48349583|NCT01591330|101184221|FG001|COMPLETED|Period 4||9||
48349584|NCT01591330|101184222|FG002|COMPLETED|Period 4||9||
48349585|NCT01591330|101184223|FG003|COMPLETED|Period 4||9||
48349586|NCT01591330|101184220|FG000|NOT COMPLETED|Period 4||0||
48349587|NCT01591330|101184221|FG001|NOT COMPLETED|Period 4||0||
48349588|NCT01591330|101184222|FG002|NOT COMPLETED|Period 4||0||
48349589|NCT01591330|101184223|FG003|NOT COMPLETED|Period 4||0||
48349590|NCT01748071|101184224|FG000|STARTED|Overall Study||40||
48349591|NCT01748071|101184225|FG001|STARTED|Overall Study||40||
48349592|NCT01748071|101184226|FG002|STARTED|Overall Study||40||
48349593|NCT01748071|101184224|FG000|COMPLETED|Overall Study||38||
48349594|NCT01748071|101184225|FG001|COMPLETED|Overall Study||38||
48349595|NCT01748071|101184226|FG002|COMPLETED|Overall Study||40||
48349596|NCT01748071|101184224|FG000|NOT COMPLETED|Overall Study||2||
48349597|NCT01748071|101184225|FG001|NOT COMPLETED|Overall Study||2||
48349598|NCT01748071|101184226|FG002|NOT COMPLETED|Overall Study||0||
48349599|NCT01687790|101184227|FG000|STARTED|Overall Study||60||
48349600|NCT01687790|101184227|FG000|COMPLETED|Overall Study||60||
48349601|NCT01687790|101184227|FG000|NOT COMPLETED|Overall Study||0||
48349602|NCT04325503|101184228|FG000|STARTED|Overall Study||14||
48349603|NCT04325503|101184228|FG000|COMPLETED|Overall Study||11||
48349604|NCT04325503|101184228|FG000|NOT COMPLETED|Overall Study||3||
48349605|NCT02511522|101184229|FG000|STARTED|Overall Study||33||
48349606|NCT02511522|101184230|FG001|STARTED|Overall Study||33||
48349607|NCT02511522|101184229|FG000|COMPLETED|Overall Study||33||
48349608|NCT02511522|101184230|FG001|COMPLETED|Overall Study||33||
48349609|NCT02511522|101184229|FG000|NOT COMPLETED|Overall Study||0||
48349610|NCT02511522|101184230|FG001|NOT COMPLETED|Overall Study||0||
48349611|NCT05408858|101184231|FG000|STARTED|Overall Study||9||
48349612|NCT05408858|101184231|FG000|COMPLETED|Overall Study||8||
48349613|NCT05408858|101184231|FG000|NOT COMPLETED|Overall Study||1||
48349614|NCT02054702|101187752|FG000|STARTED|Overall Study||64||
48349615|NCT02054702|101187753|FG001|STARTED|Overall Study||33||
48349616|NCT02054702|101187752|FG000|COMPLETED|Overall Study||40||
48349617|NCT02054702|101187753|FG001|COMPLETED|Overall Study||21||
48349618|NCT02054702|101187752|FG000|NOT COMPLETED|Overall Study||24||
48349619|NCT02054702|101187753|FG001|NOT COMPLETED|Overall Study||12||
48349620|NCT00278525|101187754|FG000|STARTED|Overall Study||9||
48349621|NCT00278525|101187755|FG001|STARTED|Overall Study||10||
48349622|NCT00278525|101187754|FG000|COMPLETED|Overall Study||9||
48349623|NCT00278525|101187755|FG001|COMPLETED|Overall Study||10||
48349624|NCT00278525|101187754|FG000|NOT COMPLETED|Overall Study||0||
48349625|NCT00278525|101187755|FG001|NOT COMPLETED|Overall Study||0||
48349626|NCT00752986|101187756|FG000|STARTED|Overall Study||16||
48349627|NCT00752986|101187757|FG001|STARTED|Overall Study||12||
48349628|NCT00752986|101187758|FG002|STARTED|Overall Study||11||
48349629|NCT00752986|101187756|FG000|COMPLETED|Overall Study||11||
48349630|NCT00752986|101187757|FG001|COMPLETED|Overall Study||11||
48349631|NCT00752986|101187758|FG002|COMPLETED|Overall Study||9||
48349632|NCT00752986|101187756|FG000|NOT COMPLETED|Overall Study||5||
48349633|NCT00752986|101187757|FG001|NOT COMPLETED|Overall Study||1||
48349634|NCT00752986|101187758|FG002|NOT COMPLETED|Overall Study||2||
48349635|NCT00296322|101187759|FG000|STARTED|Overall Study||258||
48349636|NCT00296322|101187760|FG001|STARTED|Overall Study||263||
48349637|NCT00296322|101187759|FG000|COMPLETED|Overall Study||237||
48349638|NCT00296322|101187760|FG001|COMPLETED|Overall Study||184||
48349639|NCT00296322|101187759|FG000|NOT COMPLETED|Overall Study||21||
48638075|NCT03743194|101898681|FG000|NOT COMPLETED|Overall Study||7||
48638076|NCT03743194|101898682|FG001|NOT COMPLETED|Overall Study||9||
48638077|NCT00768053|101898683|FG000|STARTED|Overall Study||108||
48638078|NCT00768053|101898683|FG000|COMPLETED|Overall Study||97||
48638079|NCT00768053|101898683|FG000|NOT COMPLETED|Overall Study||11||
48349640|NCT00296322|101187760|FG001|NOT COMPLETED|Overall Study||79||
48349641|NCT00541307|101187761|FG000|STARTED|Overall Study||119||
48349642|NCT00541307|101187761|FG000|COMPLETED|Overall Study||95||
48349643|NCT00541307|101187761|FG000|NOT COMPLETED|Overall Study||24||
48349644|NCT00684814|101187762|FG000|STARTED|First Intervention||19||
48349645|NCT00684814|101187763|FG001|STARTED|First Intervention||19||
48349646|NCT00684814|101187762|FG000|COMPLETED|First Intervention||19||
48349647|NCT00684814|101187763|FG001|COMPLETED|First Intervention||19||
48349648|NCT00684814|101187762|FG000|NOT COMPLETED|First Intervention||0||
48349649|NCT00684814|101187763|FG001|NOT COMPLETED|First Intervention||0||
48349650|NCT00684814|101187762|FG000|STARTED|Washout Period of 7 Days||19||
48416396|NCT03696576|101353397|FG001|NOT COMPLETED|Overall Study||5||
48416397|NCT01058395|101353398|FG000|STARTED|Overall Study||7||
48416398|NCT01058395|101353399|FG001|STARTED|Overall Study||8||
48416399|NCT01058395|101353398|FG000|COMPLETED|Overall Study||4||
48416400|NCT01058395|101353399|FG001|COMPLETED|Overall Study||7||
48638080|NCT03317496|101898684|FG000|STARTED|Phase 1b Lead-in: Treatment||6||
48638081|NCT03317496|101898685|FG001|STARTED|Phase 1b Lead-in: Treatment||13||
48349651|NCT00684814|101187763|FG001|STARTED|Washout Period of 7 Days||19||
48349652|NCT00684814|101187762|FG000|COMPLETED|Washout Period of 7 Days||17||
48349653|NCT00684814|101187763|FG001|COMPLETED|Washout Period of 7 Days||15||
48349654|NCT00684814|101187762|FG000|NOT COMPLETED|Washout Period of 7 Days||2||
48349655|NCT00684814|101187763|FG001|NOT COMPLETED|Washout Period of 7 Days||4||
48416401|NCT01058395|101353398|FG000|NOT COMPLETED|Overall Study||3||
48638082|NCT03317496|101898686|FG002|STARTED|Phase 1b Lead-in: Treatment||6||
48416402|NCT01058395|101353399|FG001|NOT COMPLETED|Overall Study||1||
48416403|NCT00366106|101353400|FG000|STARTED|Overall Study||32||
48416404|NCT00366106|101353400|FG000|COMPLETED|Overall Study||32||
48186813|NCT02748512|100779907|FG001|COMPLETED|Overall Study||11|14 subjects had 1 study eye treated and 12 subjects had 2 study eyes treated|10
48186814|NCT02748512|100779906|FG000|NOT COMPLETED|Overall Study||1||1
48416405|NCT00366106|101353400|FG000|NOT COMPLETED|Overall Study||0||
48416406|NCT02504424|101353401|FG000|STARTED|Overall Study||50||
48416407|NCT02504424|101353401|FG000|COMPLETED|Overall Study||48||
48416408|NCT02504424|101353401|FG000|NOT COMPLETED|Overall Study||2||
48416409|NCT00775138|101353402|FG000|STARTED|Overall Study||24||
48638083|NCT03317496|101898687|FG003|STARTED|Phase 1b Lead-in: Treatment||6||
48638084|NCT03317496|101898688|FG004|STARTED|Phase 1b Lead-in: Treatment||0||
48638085|NCT03317496|101898684|FG000|COMPLETED|Phase 1b Lead-in: Treatment||0||
48638086|NCT03317496|101898685|FG001|COMPLETED|Phase 1b Lead-in: Treatment||0||
48638087|NCT03317496|101898686|FG002|COMPLETED|Phase 1b Lead-in: Treatment||0||
48638088|NCT03317496|101898687|FG003|COMPLETED|Phase 1b Lead-in: Treatment||0||
48638089|NCT03317496|101898688|FG004|COMPLETED|Phase 1b Lead-in: Treatment||0||
48638090|NCT03317496|101898684|FG000|NOT COMPLETED|Phase 1b Lead-in: Treatment||6||
48638091|NCT03317496|101898685|FG001|NOT COMPLETED|Phase 1b Lead-in: Treatment||13||
48638092|NCT03317496|101898686|FG002|NOT COMPLETED|Phase 1b Lead-in: Treatment||6||
48638093|NCT03317496|101898687|FG003|NOT COMPLETED|Phase 1b Lead-in: Treatment||6||
48638094|NCT03317496|101898688|FG004|NOT COMPLETED|Phase 1b Lead-in: Treatment||0||
48638095|NCT03317496|101898684|FG000|STARTED|Phase 1b Lead-in: Follow-up||6||
48638096|NCT03317496|101898685|FG001|STARTED|Phase 1b Lead-in: Follow-up||12||
48638097|NCT03317496|101898686|FG002|STARTED|Phase 1b Lead-in: Follow-up||5||
48638098|NCT03317496|101898687|FG003|STARTED|Phase 1b Lead-in: Follow-up||6||
48638099|NCT03317496|101898688|FG004|STARTED|Phase 1b Lead-in: Follow-up||0||
48638100|NCT03317496|101898684|FG000|COMPLETED|Phase 1b Lead-in: Follow-up||0||
48638101|NCT03317496|101898685|FG001|COMPLETED|Phase 1b Lead-in: Follow-up||0||
48638102|NCT03317496|101898686|FG002|COMPLETED|Phase 1b Lead-in: Follow-up||0||
48638103|NCT03317496|101898687|FG003|COMPLETED|Phase 1b Lead-in: Follow-up||0||
48638104|NCT03317496|101898688|FG004|COMPLETED|Phase 1b Lead-in: Follow-up||0||
48638105|NCT03317496|101898684|FG000|NOT COMPLETED|Phase 1b Lead-in: Follow-up||6||
48638106|NCT03317496|101898685|FG001|NOT COMPLETED|Phase 1b Lead-in: Follow-up||12||
48638107|NCT03317496|101898686|FG002|NOT COMPLETED|Phase 1b Lead-in: Follow-up||5||
48638108|NCT03317496|101898687|FG003|NOT COMPLETED|Phase 1b Lead-in: Follow-up||6||
48638109|NCT03317496|101898688|FG004|NOT COMPLETED|Phase 1b Lead-in: Follow-up||0||
48638110|NCT03317496|101898684|FG000|STARTED|Phase 2: Treatment||0||
48638111|NCT03317496|101898685|FG001|STARTED|Phase 2: Treatment||0||
48638112|NCT03317496|101898686|FG002|STARTED|Phase 2: Treatment||0||
48638113|NCT03317496|101898687|FG003|STARTED|Phase 2: Treatment||0||
48638114|NCT03317496|101898688|FG004|STARTED|Phase 2: Treatment||35||
48349656|NCT00684814|101187762|FG000|STARTED|Second Intervention||17||
48349657|NCT00684814|101187763|FG001|STARTED|Second Intervention||15||
48349658|NCT00684814|101187762|FG000|COMPLETED|Second Intervention||16||
48349659|NCT00684814|101187763|FG001|COMPLETED|Second Intervention||15||
48638115|NCT03317496|101898684|FG000|COMPLETED|Phase 2: Treatment||0||
48638116|NCT03317496|101898685|FG001|COMPLETED|Phase 2: Treatment||0||
48638117|NCT03317496|101898686|FG002|COMPLETED|Phase 2: Treatment||0||
48638118|NCT03317496|101898687|FG003|COMPLETED|Phase 2: Treatment||0||
48638119|NCT03317496|101898688|FG004|COMPLETED|Phase 2: Treatment||0||
48638120|NCT03317496|101898684|FG000|NOT COMPLETED|Phase 2: Treatment||0||
48638121|NCT03317496|101898685|FG001|NOT COMPLETED|Phase 2: Treatment||0||
48638122|NCT03317496|101898686|FG002|NOT COMPLETED|Phase 2: Treatment||0||
48638123|NCT03317496|101898687|FG003|NOT COMPLETED|Phase 2: Treatment||0||
48638124|NCT03317496|101898688|FG004|NOT COMPLETED|Phase 2: Treatment||35||
48638125|NCT03317496|101898684|FG000|STARTED|Phase 2: Follow-up||0||
48638126|NCT03317496|101898685|FG001|STARTED|Phase 2: Follow-up||0||
48760972|NCT00581308|102202935|FG000|COMPLETED|24 Months||176||
48760973|NCT00581308|102202935|FG000|NOT COMPLETED|24 Months||6||
48760974|NCT00581308|102202935|FG000|STARTED|36 Months||176||
48760975|NCT00581308|102202935|FG000|COMPLETED|36 Months||170||
48760976|NCT00581308|102202935|FG000|NOT COMPLETED|36 Months||6||
48760977|NCT00581308|102202935|FG000|STARTED|48 Months||170||
48760978|NCT00581308|102202935|FG000|COMPLETED|48 Months||161||
48760979|NCT00581308|102202935|FG000|NOT COMPLETED|48 Months||9||
48760980|NCT00581308|102202935|FG000|STARTED|60 Months||161||
48760981|NCT00581308|102202935|FG000|COMPLETED|60 Months||158||
48760982|NCT00581308|102202935|FG000|NOT COMPLETED|60 Months||3||
48760983|NCT04629508|102202936|FG000|STARTED|Overall Study||4||
48760984|NCT04629508|102202936|FG000|COMPLETED|Overall Study||0||
48760985|NCT04629508|102202936|FG000|NOT COMPLETED|Overall Study||4||
48760986|NCT05417438|102202937|FG000|STARTED|Overall Study||31||
48760987|NCT05417438|102202937|FG000|COMPLETED|Overall Study||28||
48760988|NCT05417438|102202937|FG000|NOT COMPLETED|Overall Study||3||
48760989|NCT00979940|102202938|FG000|STARTED|Overall Study||32||
48760990|NCT00979940|102202939|FG001|STARTED|Overall Study||28||
48760991|NCT00979940|102202938|FG000|COMPLETED|Overall Study||32||
48349660|NCT00684814|101187762|FG000|NOT COMPLETED|Second Intervention||1||
48349661|NCT00684814|101187763|FG001|NOT COMPLETED|Second Intervention||0||
48638127|NCT03317496|101898686|FG002|STARTED|Phase 2: Follow-up||0||
48638128|NCT03317496|101898687|FG003|STARTED|Phase 2: Follow-up||0||
48638129|NCT03317496|101898688|FG004|STARTED|Phase 2: Follow-up||33||
48760992|NCT00979940|102202939|FG001|COMPLETED|Overall Study||28||
48760993|NCT00979940|102202938|FG000|NOT COMPLETED|Overall Study||0||
48760994|NCT00979940|102202939|FG001|NOT COMPLETED|Overall Study||0||
48760995|NCT01063049|102202940|FG000|STARTED|Overall Study||200||
48760996|NCT01063049|102202941|FG001|STARTED|Overall Study||200||
48760997|NCT01063049|102202942|FG002|STARTED|Overall Study||200||
48760998|NCT01063049|102202940|FG000|COMPLETED|Overall Study||200||
48760999|NCT01063049|102202941|FG001|COMPLETED|Overall Study||200||
48761000|NCT01063049|102202942|FG002|COMPLETED|Overall Study||200||
48761001|NCT01063049|102202940|FG000|NOT COMPLETED|Overall Study||0||
48761002|NCT01063049|102202941|FG001|NOT COMPLETED|Overall Study||0||
48761003|NCT01063049|102202942|FG002|NOT COMPLETED|Overall Study||0||
48761004|NCT00960622|102202943|FG000|STARTED|Overall Study||10||
48761005|NCT00960622|102202944|FG001|STARTED|Overall Study||10||
48761006|NCT00960622|102202943|FG000|COMPLETED|Overall Study||10||
48761007|NCT00960622|102202944|FG001|COMPLETED|Overall Study||7||
48761008|NCT00960622|102202943|FG000|NOT COMPLETED|Overall Study||0||
48761009|NCT00960622|102202944|FG001|NOT COMPLETED|Overall Study||3||
48761010|NCT04569240|102202945|FG000|STARTED|Overall Study||40||
48761011|NCT04569240|102202945|FG000|COMPLETED|Overall Study||29||
48761012|NCT04569240|102202945|FG000|NOT COMPLETED|Overall Study||11||
48761013|NCT03675126|102202946|FG000|STARTED|Overall Study||15||
48761014|NCT03675126|102202946|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15||
48761015|NCT03675126|102202946|FG000|COMPLETED|Overall Study||0||
48761016|NCT03675126|102202946|FG000|NOT COMPLETED|Overall Study||15||
48761017|NCT03199976|102202947|FG000|STARTED|Overall Study||27||
48761018|NCT03199976|102202948|FG001|STARTED|Overall Study||25||
48761019|NCT03199976|102202949|FG002|STARTED|Overall Study||28||
48761020|NCT03199976|102202947|FG000|COMPLETED|Overall Study||23||
48761021|NCT03199976|102202948|FG001|COMPLETED|Overall Study||18||
48761022|NCT03199976|102202949|FG002|COMPLETED|Overall Study||14||
48761023|NCT03199976|102202947|FG000|NOT COMPLETED|Overall Study||4||
48761024|NCT03199976|102202948|FG001|NOT COMPLETED|Overall Study||7||
48761025|NCT03199976|102202949|FG002|NOT COMPLETED|Overall Study||14||
48761026|NCT04760613|102202950|FG000|STARTED|Overall Study||5||
48761027|NCT04760613|102202951|FG001|STARTED|Overall Study||1||
48761028|NCT04760613|102202950|FG000|COMPLETED|Overall Study||5||
48638130|NCT03317496|101898684|FG000|COMPLETED|Phase 2: Follow-up||0||
48761029|NCT04760613|102202951|FG001|COMPLETED|Overall Study||1||
48761030|NCT04760613|102202950|FG000|NOT COMPLETED|Overall Study||0||
48761031|NCT04760613|102202951|FG001|NOT COMPLETED|Overall Study||0||
48761032|NCT02257138|102202952|FG000|STARTED|Overall Study||5||
48761033|NCT02257138|102202953|FG001|STARTED|Overall Study||3||
48349662|NCT00768560|101187764|FG000|STARTED|Intervention Set 1||5||
48349663|NCT00768560|101187765|FG001|STARTED|Intervention Set 1||6||
48349664|NCT00768560|101187766|FG002|STARTED|Intervention Set 1||6||
48349665|NCT00768560|101187767|FG003|STARTED|Intervention Set 1||6||
48349666|NCT00768560|101187768|FG004|STARTED|Intervention Set 1||6||
48349667|NCT00768560|101187769|FG005|STARTED|Intervention Set 1||6||
48416410|NCT00775138|101353403|FG001|STARTED|Overall Study||10||
48416411|NCT00775138|101353404|FG002|STARTED|Overall Study||20||
48416412|NCT00775138|101353405|FG003|STARTED|Overall Study||10||
48416413|NCT00775138|101353402|FG000|COMPLETED|Overall Study||24||
48416414|NCT00775138|101353403|FG001|COMPLETED|Overall Study||10||
48638131|NCT03317496|101898685|FG001|COMPLETED|Phase 2: Follow-up||0||
48638132|NCT03317496|101898686|FG002|COMPLETED|Phase 2: Follow-up||0||
48638133|NCT03317496|101898687|FG003|COMPLETED|Phase 2: Follow-up||0||
48638134|NCT03317496|101898688|FG004|COMPLETED|Phase 2: Follow-up||0||
48638135|NCT03317496|101898684|FG000|NOT COMPLETED|Phase 2: Follow-up||0||
48349668|NCT00768560|101187764|FG000|Subjects Received Treatment|Intervention Set 1||5||
48416415|NCT00775138|101353404|FG002|COMPLETED|Overall Study||17||
48416416|NCT00775138|101353405|FG003|COMPLETED|Overall Study||8||
48638136|NCT03317496|101898685|FG001|NOT COMPLETED|Phase 2: Follow-up||0||
48349669|NCT00768560|101187765|FG001|Subjects Received Treatment|Intervention Set 1||6||
48349670|NCT00768560|101187766|FG002|Subjects Received Treatment|Intervention Set 1||6||
48416417|NCT00775138|101353402|FG000|NOT COMPLETED|Overall Study||0||
48638137|NCT03317496|101898686|FG002|NOT COMPLETED|Phase 2: Follow-up||0||
48349671|NCT00768560|101187767|FG003|Subjects Received Treatment|Intervention Set 1||6||
48349672|NCT00768560|101187768|FG004|Subjects Received Treatment|Intervention Set 1||6||
48349673|NCT00768560|101187769|FG005|Subjects Received Treatment|Intervention Set 1||6||
48349674|NCT00768560|101187764|FG000|COMPLETED|Intervention Set 1||5||
48416418|NCT00775138|101353403|FG001|NOT COMPLETED|Overall Study||0||
48416419|NCT00775138|101353404|FG002|NOT COMPLETED|Overall Study||3||
48416420|NCT00775138|101353405|FG003|NOT COMPLETED|Overall Study||2||
48416421|NCT00951912|101353406|FG000|STARTED|Overall Study||54||
48416422|NCT00951912|101353407|FG001|STARTED|Overall Study||55||
48416423|NCT00951912|101353408|FG002|STARTED|Overall Study||56||
48416424|NCT00951912|101353406|FG000|COMPLETED|Overall Study||47||
48416425|NCT00951912|101353407|FG001|COMPLETED|Overall Study||50||
48416426|NCT00951912|101353408|FG002|COMPLETED|Overall Study||54||
48416427|NCT00951912|101353406|FG000|NOT COMPLETED|Overall Study||7||
48416428|NCT00951912|101353407|FG001|NOT COMPLETED|Overall Study||5||
48416429|NCT00951912|101353408|FG002|NOT COMPLETED|Overall Study||2||
48416430|NCT02382276|101353409|FG000|STARTED|Overall Study||137||
48416431|NCT02382276|101353410|FG001|STARTED|Overall Study||94||
48416432|NCT02382276|101353411|FG002|STARTED|Overall Study||172||
48416433|NCT02382276|101353409|FG000|COMPLETED|Overall Study||126||
48416434|NCT02382276|101353410|FG001|COMPLETED|Overall Study||84||
48416435|NCT02382276|101353411|FG002|COMPLETED|Overall Study||133||
48416436|NCT02382276|101353409|FG000|NOT COMPLETED|Overall Study||11||
48416437|NCT02382276|101353410|FG001|NOT COMPLETED|Overall Study||10||
48416438|NCT02382276|101353411|FG002|NOT COMPLETED|Overall Study||39||
48416439|NCT03480841|101353412|FG000|STARTED|Overall Study||10||
48416440|NCT03480841|101353412|FG000|Time 1 Data Collection (T1)|Overall Study||10||
48416441|NCT03480841|101353412|FG000|LENA Baseline|Overall Study||10||
48416442|NCT03480841|101353412|FG000|LENA Time 1|Overall Study||10||
48416443|NCT03480841|101353412|FG000|LENA Time 2|Overall Study||10||
48416444|NCT03480841|101353412|FG000|LENA Time 3|Overall Study||10||
48416445|NCT03480841|101353412|FG000|LENA Time 4|Overall Study||9||
48349675|NCT00768560|101187765|FG001|COMPLETED|Intervention Set 1||5||
48349676|NCT00768560|101187766|FG002|COMPLETED|Intervention Set 1||6||
48349677|NCT00768560|101187767|FG003|COMPLETED|Intervention Set 1||6||
48349678|NCT00768560|101187768|FG004|COMPLETED|Intervention Set 1||6||
48349679|NCT00768560|101187769|FG005|COMPLETED|Intervention Set 1||6||
48349680|NCT00768560|101187764|FG000|NOT COMPLETED|Intervention Set 1||0||
48349681|NCT00768560|101187765|FG001|NOT COMPLETED|Intervention Set 1||1||
48349682|NCT00768560|101187766|FG002|NOT COMPLETED|Intervention Set 1||0||
48349683|NCT00768560|101187767|FG003|NOT COMPLETED|Intervention Set 1||0||
48349684|NCT00768560|101187768|FG004|NOT COMPLETED|Intervention Set 1||0||
48349685|NCT00768560|101187769|FG005|NOT COMPLETED|Intervention Set 1||0||
48349686|NCT00768560|101187764|FG000|STARTED|Intervention Set 2||5||
48349687|NCT00768560|101187765|FG001|STARTED|Intervention Set 2||5||
48349688|NCT00768560|101187766|FG002|STARTED|Intervention Set 2||6||
48349689|NCT00768560|101187767|FG003|STARTED|Intervention Set 2||6||
48416446|NCT03480841|101353412|FG000|LENA Time 5|Overall Study||8||
48416447|NCT03480841|101353412|FG000|Time 2 Data Collection (T2)|Overall Study||8||
48416448|NCT03480841|101353412|FG000|COMPLETED|Overall Study||8||
48416449|NCT03480841|101353412|FG000|NOT COMPLETED|Overall Study||2||
48416450|NCT03961529|101353413|FG000|STARTED|Overall Study||166||
48416451|NCT03961529|101353414|FG001|STARTED|Overall Study||144||
48416452|NCT03961529|101353415|FG002|STARTED|Overall Study||56||
48416453|NCT03961529|101353413|FG000|COMPLETED|Overall Study||124||
48416454|NCT03961529|101353414|FG001|COMPLETED|Overall Study||127||
48416455|NCT03961529|101353415|FG002|COMPLETED|Overall Study||51||
48416456|NCT03961529|101353413|FG000|NOT COMPLETED|Overall Study||42||
48416457|NCT03961529|101353414|FG001|NOT COMPLETED|Overall Study||17||
48416458|NCT03961529|101353415|FG002|NOT COMPLETED|Overall Study||5||
48416459|NCT01078974|101353416|FG000|STARTED|Overall Study||7||
48416460|NCT01078974|101353416|FG000|COMPLETED|Overall Study||4||
48416461|NCT01078974|101353416|FG000|NOT COMPLETED|Overall Study||3||
48416462|NCT02260791|101353417|FG000|STARTED|Overall Study||366||
48416463|NCT02260791|101353418|FG001|STARTED|Overall Study||362||
48416464|NCT02260791|101353417|FG000|COMPLETED|Overall Study||333||
48416465|NCT02260791|101353418|FG001|COMPLETED|Overall Study||328||
48416466|NCT02260791|101353417|FG000|NOT COMPLETED|Overall Study||33||
48416467|NCT02260791|101353418|FG001|NOT COMPLETED|Overall Study||34||
48349690|NCT00768560|101187768|FG004|STARTED|Intervention Set 2||6||
48349691|NCT00768560|101187769|FG005|STARTED|Intervention Set 2||6||
48349692|NCT00768560|101187764|FG000|COMPLETED|Intervention Set 2||5||
48349693|NCT00768560|101187765|FG001|COMPLETED|Intervention Set 2||5||
48349694|NCT00768560|101187766|FG002|COMPLETED|Intervention Set 2||6||
48416468|NCT00090844|101353419|FG000|STARTED|Overall Study||27||
48416469|NCT00090844|101353420|FG001|STARTED|Overall Study||22||
48416470|NCT00090844|101353419|FG000|COMPLETED|Overall Study||26||
48416471|NCT00090844|101353420|FG001|COMPLETED|Overall Study||21||
48416472|NCT00090844|101353419|FG000|NOT COMPLETED|Overall Study||1||
48416473|NCT00090844|101353420|FG001|NOT COMPLETED|Overall Study||1||
48416474|NCT03258762|101353421|FG000|STARTED|Overall Study||7||
48416475|NCT03258762|101353422|FG001|STARTED|Overall Study||7||
48416476|NCT03258762|101353421|FG000|COMPLETED|Overall Study||7||
48416477|NCT03258762|101353422|FG001|COMPLETED|Overall Study||6||
48416478|NCT03258762|101353421|FG000|NOT COMPLETED|Overall Study||0||
48416479|NCT03258762|101353422|FG001|NOT COMPLETED|Overall Study||1||
48416480|NCT02811640|101353423|FG000|STARTED|Overall Study||12||
48416481|NCT02811640|101353423|FG000|COMPLETED|Overall Study||10||
48416482|NCT02811640|101353423|FG000|NOT COMPLETED|Overall Study||2||
48416483|NCT03590613|101353424|FG000|STARTED|Period 1, 4 Days||3||
48416484|NCT03590613|101353425|FG001|STARTED|Period 1, 4 Days||3||
48416485|NCT03590613|101353426|FG002|STARTED|Period 1, 4 Days||3||
48416486|NCT03590613|101353427|FG003|STARTED|Period 1, 4 Days||3||
48416487|NCT03590613|101353424|FG000|COMPLETED|Period 1, 4 Days||3||
48416488|NCT03590613|101353425|FG001|COMPLETED|Period 1, 4 Days||3||
48416489|NCT03590613|101353426|FG002|COMPLETED|Period 1, 4 Days||3||
48416490|NCT03590613|101353427|FG003|COMPLETED|Period 1, 4 Days||3||
48416491|NCT03590613|101353424|FG000|NOT COMPLETED|Period 1, 4 Days||0||
48416492|NCT03590613|101353425|FG001|NOT COMPLETED|Period 1, 4 Days||0||
48416493|NCT03590613|101353426|FG002|NOT COMPLETED|Period 1, 4 Days||0||
48416494|NCT03590613|101353427|FG003|NOT COMPLETED|Period 1, 4 Days||0||
48416495|NCT03590613|101353424|FG000|STARTED|Period 1, Wash-out, at Least 3 Days||3||
48416496|NCT03590613|101353425|FG001|STARTED|Period 1, Wash-out, at Least 3 Days||3||
48416497|NCT03590613|101353426|FG002|STARTED|Period 1, Wash-out, at Least 3 Days||3||
48416498|NCT03590613|101353427|FG003|STARTED|Period 1, Wash-out, at Least 3 Days||3||
48416499|NCT03590613|101353424|FG000|COMPLETED|Period 1, Wash-out, at Least 3 Days||3||
48349695|NCT00768560|101187767|FG003|COMPLETED|Intervention Set 2||6||
48349696|NCT00768560|101187768|FG004|COMPLETED|Intervention Set 2||6||
48349697|NCT00768560|101187769|FG005|COMPLETED|Intervention Set 2||6||
48349698|NCT00768560|101187764|FG000|NOT COMPLETED|Intervention Set 2||0||
48349699|NCT00768560|101187765|FG001|NOT COMPLETED|Intervention Set 2||0||
48349700|NCT00768560|101187766|FG002|NOT COMPLETED|Intervention Set 2||0||
48349701|NCT00768560|101187767|FG003|NOT COMPLETED|Intervention Set 2||0||
48349702|NCT00768560|101187768|FG004|NOT COMPLETED|Intervention Set 2||0||
48349703|NCT00768560|101187769|FG005|NOT COMPLETED|Intervention Set 2||0||
48349704|NCT00768560|101187764|FG000|STARTED|Intervention Set 3||5||
48349705|NCT00768560|101187765|FG001|STARTED|Intervention Set 3||5||
48349706|NCT00768560|101187766|FG002|STARTED|Intervention Set 3||6||
48349707|NCT00768560|101187767|FG003|STARTED|Intervention Set 3||6||
48349708|NCT00768560|101187768|FG004|STARTED|Intervention Set 3||6||
48349709|NCT00768560|101187769|FG005|STARTED|Intervention Set 3||6||
48349710|NCT00768560|101187764|FG000|COMPLETED|Intervention Set 3||5||
48349711|NCT00768560|101187765|FG001|COMPLETED|Intervention Set 3||5||
48349712|NCT00768560|101187766|FG002|COMPLETED|Intervention Set 3||6||
48349713|NCT00768560|101187767|FG003|COMPLETED|Intervention Set 3||6||
48349714|NCT00768560|101187768|FG004|COMPLETED|Intervention Set 3||6||
48349715|NCT00768560|101187769|FG005|COMPLETED|Intervention Set 3||6||
48349716|NCT00768560|101187764|FG000|NOT COMPLETED|Intervention Set 3||0||
48349717|NCT00768560|101187765|FG001|NOT COMPLETED|Intervention Set 3||0||
48349718|NCT00768560|101187766|FG002|NOT COMPLETED|Intervention Set 3||0||
48416500|NCT03590613|101353425|FG001|COMPLETED|Period 1, Wash-out, at Least 3 Days||3||
48416501|NCT03590613|101353426|FG002|COMPLETED|Period 1, Wash-out, at Least 3 Days||3||
48349719|NCT00768560|101187767|FG003|NOT COMPLETED|Intervention Set 3||0||
48349720|NCT00768560|101187768|FG004|NOT COMPLETED|Intervention Set 3||0||
48349721|NCT00768560|101187769|FG005|NOT COMPLETED|Intervention Set 3||0||
48349722|NCT03652909|101187770|FG000|STARTED|Overall Study||32||
48349723|NCT03652909|101187770|FG000|COMPLETED|Overall Study||32||
48349724|NCT03652909|101187770|FG000|NOT COMPLETED|Overall Study||0||
48349725|NCT03487445|101187771|FG000|STARTED|Randomization||25||
48349726|NCT03487445|101187772|FG001|STARTED|Randomization||23||
48349727|NCT03487445|101187771|FG000|COMPLETED|Randomization||24||
48349728|NCT03487445|101187772|FG001|COMPLETED|Randomization||23||
48349729|NCT03487445|101187771|FG000|NOT COMPLETED|Randomization||1||
48349730|NCT03487445|101187772|FG001|NOT COMPLETED|Randomization||0||
48349731|NCT03487445|101187771|FG000|STARTED|Treatment Period||24||
48349732|NCT03487445|101187772|FG001|STARTED|Treatment Period||23||
48349733|NCT03487445|101187771|FG000|Modified Full Analysis Set (mFAS)|Treatment Period||23|mFAS: all participants with a 30-min post dose VerifyNow® blood sample analysis.|
48349734|NCT03487445|101187772|FG001|Modified Full Analysis Set (mFAS)|Treatment Period||22|mFAS: all participants with a 30-min post dose VerifyNow® blood sample analysis.|
48349735|NCT03487445|101187771|FG000|Per Protocol Set|Treatment Period||20||
48416502|NCT03590613|101353427|FG003|COMPLETED|Period 1, Wash-out, at Least 3 Days||3||
48416503|NCT03590613|101353424|FG000|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0||
48416504|NCT03590613|101353425|FG001|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0||
48416505|NCT03590613|101353426|FG002|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0||
48416506|NCT03590613|101353427|FG003|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0||
48416507|NCT03590613|101353424|FG000|STARTED|Period 2, 4 Days||3||
48416508|NCT03590613|101353425|FG001|STARTED|Period 2, 4 Days||3||
48349736|NCT03487445|101187772|FG001|Per Protocol Set|Treatment Period||20||
48349737|NCT03487445|101187771|FG000|COMPLETED|Treatment Period||24||
48349738|NCT03487445|101187772|FG001|COMPLETED|Treatment Period||23||
48349739|NCT03487445|101187771|FG000|NOT COMPLETED|Treatment Period||0||
48349740|NCT03487445|101187772|FG001|NOT COMPLETED|Treatment Period||0||
48349741|NCT00002850|101187773|FG000|STARTED|Overall Study||69||
48349742|NCT00002850|101187774|FG001|STARTED|Overall Study||76||
48349743|NCT00002850|101187775|FG002|STARTED|Overall Study||67||
48349744|NCT00002850|101187773|FG000|COMPLETED|Overall Study||64||
48349745|NCT00002850|101187774|FG001|COMPLETED|Overall Study||74||
48349746|NCT00002850|101187775|FG002|COMPLETED|Overall Study||63||
48349747|NCT00002850|101187773|FG000|NOT COMPLETED|Overall Study||5||
48349748|NCT00002850|101187774|FG001|NOT COMPLETED|Overall Study||2||
48349749|NCT00002850|101187775|FG002|NOT COMPLETED|Overall Study||4||
48349750|NCT00503399|101187776|FG000|STARTED|Overall Study||45||
48349751|NCT00503399|101187777|FG001|STARTED|Overall Study||47||
48349752|NCT00503399|101187776|FG000|COMPLETED|Overall Study||38||
48349753|NCT00503399|101187777|FG001|COMPLETED|Overall Study||39||
48416509|NCT03590613|101353426|FG002|STARTED|Period 2, 4 Days||3||
48416510|NCT03590613|101353427|FG003|STARTED|Period 2, 4 Days||4||
48416511|NCT03590613|101353424|FG000|COMPLETED|Period 2, 4 Days||3||
48416512|NCT03590613|101353425|FG001|COMPLETED|Period 2, 4 Days||3||
48416513|NCT03590613|101353426|FG002|COMPLETED|Period 2, 4 Days||3||
48416514|NCT03590613|101353427|FG003|COMPLETED|Period 2, 4 Days||3||
48416515|NCT03590613|101353424|FG000|NOT COMPLETED|Period 2, 4 Days||0||
48349754|NCT00503399|101187776|FG000|NOT COMPLETED|Overall Study||7||
48349755|NCT00503399|101187777|FG001|NOT COMPLETED|Overall Study||8||
48349756|NCT00125034|101187778|FG000|STARTED|Overall Study||170||
48349757|NCT00125034|101187779|FG001|STARTED|Overall Study||168||
48349758|NCT00125034|101187778|FG000|COMPLETED|Overall Study||170||
48349759|NCT00125034|101187779|FG001|COMPLETED|Overall Study||168||
48349760|NCT00125034|101187778|FG000|NOT COMPLETED|Overall Study||0||
48349761|NCT00125034|101187779|FG001|NOT COMPLETED|Overall Study||0||
48349762|NCT00613626|101187780|FG000|STARTED|Overall Study||33||
48349763|NCT00613626|101187781|FG001|STARTED|Overall Study||34||
48349764|NCT00613626|101187782|FG002|STARTED|Overall Study||7||
48349765|NCT00613626|101187780|FG000|1st Dose ZD6474|Overall Study||33||
48349766|NCT00613626|101187781|FG001|1st Dose ZD6474|Overall Study||34||
48349767|NCT00613626|101187782|FG002|1st Dose ZD6474|Overall Study||7||
48349768|NCT00613626|101187780|FG000|COMPLETED|Overall Study||33||
48349769|NCT00613626|101187781|FG001|COMPLETED|Overall Study||33||
48349770|NCT00613626|101187782|FG002|COMPLETED|Overall Study||7||
48349771|NCT00613626|101187780|FG000|NOT COMPLETED|Overall Study||0||
48349772|NCT00613626|101187781|FG001|NOT COMPLETED|Overall Study||1||
48349773|NCT00613626|101187782|FG002|NOT COMPLETED|Overall Study||0||
48349774|NCT04398732|101187783|FG000|STARTED|Overall Study||486||
48349775|NCT04398732|101187783|FG000|COMPLETED|Overall Study||436||
48349776|NCT04398732|101187783|FG000|NOT COMPLETED|Overall Study||50||
48349777|NCT02978222|101187784|FG000|STARTED|Overall Study||62||
48349778|NCT02978222|101187785|FG001|STARTED|Overall Study||58||
48349779|NCT02978222|101187784|FG000|COMPLETED|Overall Study||1||
48349780|NCT02978222|101187785|FG001|COMPLETED|Overall Study||2||
48349781|NCT02978222|101187784|FG000|NOT COMPLETED|Overall Study||61||
48349782|NCT02978222|101187785|FG001|NOT COMPLETED|Overall Study||56||
48349783|NCT00538642|101187786|FG000|STARTED|Overall Study||10||
48349784|NCT00538642|101187787|FG001|STARTED|Overall Study||14||
48416516|NCT03590613|101353425|FG001|NOT COMPLETED|Period 2, 4 Days||0||
48349785|NCT00538642|101187786|FG000|COMPLETED|Overall Study||9||
48349786|NCT00538642|101187787|FG001|COMPLETED|Overall Study||9||
48349787|NCT00538642|101187786|FG000|NOT COMPLETED|Overall Study||1||
48349788|NCT00538642|101187787|FG001|NOT COMPLETED|Overall Study||5||
48349789|NCT02635204|101187788|FG000|STARTED|Overall Study||178||
48349790|NCT02635204|101187789|FG001|STARTED|Overall Study||89||
48349791|NCT02635204|101187788|FG000|COMPLETED|Overall Study||176||
48349792|NCT02635204|101187789|FG001|COMPLETED|Overall Study||88||
48349793|NCT02635204|101187788|FG000|NOT COMPLETED|Overall Study||2||
48349794|NCT02635204|101187789|FG001|NOT COMPLETED|Overall Study||1||
48349795|NCT01696461|101187790|FG000|STARTED|Overall Study||64||
48349796|NCT01696461|101187791|FG001|STARTED|Overall Study||33||
48349797|NCT01696461|101187792|FG002|STARTED|Overall Study||30||
48349798|NCT01696461|101187790|FG000|COMPLETED|Overall Study||64||
48416517|NCT03590613|101353426|FG002|NOT COMPLETED|Period 2, 4 Days||0||
48416518|NCT03590613|101353427|FG003|NOT COMPLETED|Period 2, 4 Days||1||
48416519|NCT03590613|101353424|FG000|STARTED|Period 2, Wash-out, at Least 3 Days||3||
48416520|NCT03590613|101353425|FG001|STARTED|Period 2, Wash-out, at Least 3 Days||3||
48416521|NCT03590613|101353426|FG002|STARTED|Period 2, Wash-out, at Least 3 Days||3||
48416522|NCT03590613|101353427|FG003|STARTED|Period 2, Wash-out, at Least 3 Days||3||
48416523|NCT03590613|101353424|FG000|COMPLETED|Period 2, Wash-out, at Least 3 Days||3||
48416524|NCT03590613|101353425|FG001|COMPLETED|Period 2, Wash-out, at Least 3 Days||3||
48349799|NCT01696461|101187791|FG001|COMPLETED|Overall Study||33||
48349800|NCT01696461|101187792|FG002|COMPLETED|Overall Study||30||
48349801|NCT01696461|101187790|FG000|NOT COMPLETED|Overall Study||0||
48349802|NCT01696461|101187791|FG001|NOT COMPLETED|Overall Study||0||
48349803|NCT01696461|101187792|FG002|NOT COMPLETED|Overall Study||0||
48416525|NCT03590613|101353426|FG002|COMPLETED|Period 2, Wash-out, at Least 3 Days||3||
48416526|NCT03590613|101353427|FG003|COMPLETED|Period 2, Wash-out, at Least 3 Days||3||
48416527|NCT03590613|101353424|FG000|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0||
48416528|NCT03590613|101353425|FG001|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0||
48416529|NCT03590613|101353426|FG002|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0||
48416530|NCT03590613|101353427|FG003|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0||
48416531|NCT03590613|101353424|FG000|STARTED|Period 3, 4 Days||3||
48416532|NCT03590613|101353425|FG001|STARTED|Period 3, 4 Days||3||
48416533|NCT03590613|101353426|FG002|STARTED|Period 3, 4 Days||3||
48416534|NCT03590613|101353427|FG003|STARTED|Period 3, 4 Days||3||
48416535|NCT03590613|101353424|FG000|COMPLETED|Period 3, 4 Days||3||
48416536|NCT03590613|101353425|FG001|COMPLETED|Period 3, 4 Days||3||
48416537|NCT03590613|101353426|FG002|COMPLETED|Period 3, 4 Days||3||
48416538|NCT03590613|101353427|FG003|COMPLETED|Period 3, 4 Days||3||
48416539|NCT03590613|101353424|FG000|NOT COMPLETED|Period 3, 4 Days||0||
48416540|NCT03590613|101353425|FG001|NOT COMPLETED|Period 3, 4 Days||0||
48416541|NCT03590613|101353426|FG002|NOT COMPLETED|Period 3, 4 Days||0||
48416542|NCT03590613|101353427|FG003|NOT COMPLETED|Period 3, 4 Days||0||
48416543|NCT03590613|101353424|FG000|STARTED|Period 3,Wash-out, at Least 3 Days||3||
48416544|NCT03590613|101353425|FG001|STARTED|Period 3,Wash-out, at Least 3 Days||3||
48349804|NCT01059448|101187793|FG000|STARTED|Overall Study||49||
48349805|NCT01059448|101187794|FG001|STARTED|Overall Study||55||
48349806|NCT01059448|101187795|FG002|STARTED|Overall Study||53||
48349807|NCT01059448|101187796|FG003|STARTED|Overall Study||54||
48349808|NCT01059448|101187793|FG000|COMPLETED|Overall Study||0||
48349809|NCT01059448|101187794|FG001|COMPLETED|Overall Study||0||
48349810|NCT01059448|101187795|FG002|COMPLETED|Overall Study||0||
48349811|NCT01059448|101187796|FG003|COMPLETED|Overall Study||0||
48416545|NCT03590613|101353426|FG002|STARTED|Period 3,Wash-out, at Least 3 Days||3||
48416546|NCT03590613|101353427|FG003|STARTED|Period 3,Wash-out, at Least 3 Days||3||
48416547|NCT03590613|101353424|FG000|COMPLETED|Period 3,Wash-out, at Least 3 Days||3||
48416548|NCT03590613|101353425|FG001|COMPLETED|Period 3,Wash-out, at Least 3 Days||3||
48416549|NCT03590613|101353426|FG002|COMPLETED|Period 3,Wash-out, at Least 3 Days||3||
48416550|NCT03590613|101353427|FG003|COMPLETED|Period 3,Wash-out, at Least 3 Days||3||
48416551|NCT03590613|101353424|FG000|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0||
48416552|NCT03590613|101353425|FG001|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0||
48416553|NCT03590613|101353426|FG002|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0||
48416554|NCT03590613|101353427|FG003|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0||
48416555|NCT03590613|101353424|FG000|STARTED|Period 4, 4 Days||3||
48416556|NCT03590613|101353425|FG001|STARTED|Period 4, 4 Days||3||
48416557|NCT03590613|101353426|FG002|STARTED|Period 4, 4 Days||3||
48416558|NCT03590613|101353427|FG003|STARTED|Period 4, 4 Days||3||
48349812|NCT01059448|101187793|FG000|NOT COMPLETED|Overall Study||49||
48349813|NCT01059448|101187794|FG001|NOT COMPLETED|Overall Study||55||
48349814|NCT01059448|101187795|FG002|NOT COMPLETED|Overall Study||53||
48349815|NCT01059448|101187796|FG003|NOT COMPLETED|Overall Study||54||
48349816|NCT03715465|101187797|FG000|STARTED|Overall Study||20||
48349817|NCT03715465|101187798|FG001|STARTED|Overall Study||20||
48349818|NCT03715465|101187797|FG000|COMPLETED|Overall Study||19||
48349819|NCT03715465|101187798|FG001|COMPLETED|Overall Study||18||
48349820|NCT03715465|101187797|FG000|NOT COMPLETED|Overall Study||1||
48349821|NCT03715465|101187798|FG001|NOT COMPLETED|Overall Study||2||
48349822|NCT03874234|101187799|FG000|STARTED|Part A: Cohort 1-Period 1 (Day1)||2||
48349823|NCT03874234|101187800|FG001|STARTED|Part A: Cohort 1-Period 1 (Day1)||2||
48349824|NCT03874234|101187801|FG002|STARTED|Part A: Cohort 1-Period 1 (Day1)||2||
48349825|NCT03874234|101187802|FG003|STARTED|Part A: Cohort 1-Period 1 (Day1)||2||
48349826|NCT03874234|101187803|FG004|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
48349827|NCT03874234|101187804|FG005|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
48349828|NCT03874234|101187805|FG006|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
48349829|NCT03874234|101187806|FG007|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
48349830|NCT03874234|101187807|FG008|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
48349831|NCT03874234|101187808|FG009|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
48349832|NCT03874234|101187809|FG010|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
48349833|NCT03874234|101187810|FG011|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
48349834|NCT03874234|101187811|FG012|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
48349835|NCT03874234|101187799|FG000|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 1 (Day1)||2||
48349836|NCT03874234|101187800|FG001|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 1 (Day1)||2||
48349837|NCT03874234|101187801|FG002|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 1 (Day1)||2||
48349838|NCT03874234|101187802|FG003|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 1 (Day1)||2||
48349839|NCT03874234|101187803|FG004|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 1 (Day1)||0||
48349840|NCT03874234|101187804|FG005|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 1 (Day1)||0||
48349841|NCT03874234|101187805|FG006|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 1 (Day1)||0||
48349842|NCT03874234|101187806|FG007|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 1 (Day1)||0||
48349843|NCT03874234|101187807|FG008|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 1 (Day1)||0||
48349844|NCT03874234|101187808|FG009|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 1 (Day1)||0||
48349845|NCT03874234|101187809|FG010|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 1 (Day1)||0||
48349846|NCT03874234|101187810|FG011|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 1 (Day1)||0||
48349847|NCT03874234|101187811|FG012|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 1 (Day1)||0||
48349848|NCT03874234|101187799|FG000|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||2||
48349849|NCT03874234|101187800|FG001|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||2||
48349850|NCT03874234|101187801|FG002|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||2||
48349851|NCT03874234|101187802|FG003|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1||
48349852|NCT03874234|101187803|FG004|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48349853|NCT03874234|101187804|FG005|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48349854|NCT03874234|101187805|FG006|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48349855|NCT03874234|101187806|FG007|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48349856|NCT03874234|101187807|FG008|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48349857|NCT03874234|101187808|FG009|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48349858|NCT03874234|101187809|FG010|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48349859|NCT03874234|101187810|FG011|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48349860|NCT03874234|101187811|FG012|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48349861|NCT03874234|101187799|FG000|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48349862|NCT03874234|101187800|FG001|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48349863|NCT03874234|101187801|FG002|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48349864|NCT03874234|101187802|FG003|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1||
48349865|NCT03874234|101187803|FG004|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48349866|NCT03874234|101187804|FG005|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48349867|NCT03874234|101187805|FG006|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48349868|NCT03874234|101187806|FG007|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48349869|NCT03874234|101187807|FG008|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48349870|NCT03874234|101187808|FG009|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48416559|NCT03590613|101353424|FG000|COMPLETED|Period 4, 4 Days||3||
48416560|NCT03590613|101353425|FG001|COMPLETED|Period 4, 4 Days||3||
48416561|NCT03590613|101353426|FG002|COMPLETED|Period 4, 4 Days||3||
48416562|NCT03590613|101353427|FG003|COMPLETED|Period 4, 4 Days||3||
48416563|NCT03590613|101353424|FG000|NOT COMPLETED|Period 4, 4 Days||0||
48416564|NCT03590613|101353425|FG001|NOT COMPLETED|Period 4, 4 Days||0||
48349871|NCT03874234|101187809|FG010|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48349872|NCT03874234|101187810|FG011|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48349873|NCT03874234|101187811|FG012|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48349874|NCT03874234|101187799|FG000|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||2||
48349875|NCT03874234|101187800|FG001|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||2||
48349876|NCT03874234|101187801|FG002|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||2||
48349877|NCT03874234|101187802|FG003|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||1||
48349878|NCT03874234|101187803|FG004|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
48349879|NCT03874234|101187804|FG005|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
48349880|NCT03874234|101187805|FG006|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
48349881|NCT03874234|101187806|FG007|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
48349882|NCT03874234|101187807|FG008|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
48349883|NCT03874234|101187808|FG009|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
48349884|NCT03874234|101187809|FG010|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
48349885|NCT03874234|101187810|FG011|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
48349886|NCT03874234|101187811|FG012|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
48349887|NCT03874234|101187799|FG000|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||2||
48349888|NCT03874234|101187800|FG001|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||2||
48349889|NCT03874234|101187801|FG002|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||2||
48349890|NCT03874234|101187802|FG003|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||1||
48349891|NCT03874234|101187803|FG004|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
48349892|NCT03874234|101187804|FG005|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
48349893|NCT03874234|101187805|FG006|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
48349894|NCT03874234|101187806|FG007|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
48349895|NCT03874234|101187807|FG008|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
48349896|NCT03874234|101187808|FG009|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
48349897|NCT03874234|101187809|FG010|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
48349898|NCT03874234|101187810|FG011|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
48416565|NCT03590613|101353426|FG002|NOT COMPLETED|Period 4, 4 Days||0||
48416566|NCT03590613|101353427|FG003|NOT COMPLETED|Period 4, 4 Days||0||
48416567|NCT03049852|101353428|FG000|STARTED|Overall Study||24||
48416568|NCT03049852|101353429|FG001|STARTED|Overall Study||25||
48416569|NCT03049852|101353430|FG002|STARTED|Overall Study||26||
48416570|NCT03049852|101353428|FG000|COMPLETED|Overall Study||24||
48416571|NCT03049852|101353429|FG001|COMPLETED|Overall Study||24||
48416572|NCT03049852|101353430|FG002|COMPLETED|Overall Study||26||
48416573|NCT03049852|101353428|FG000|NOT COMPLETED|Overall Study||0||
48416574|NCT03049852|101353429|FG001|NOT COMPLETED|Overall Study||1||
48416575|NCT03049852|101353430|FG002|NOT COMPLETED|Overall Study||0||
48761034|NCT02257138|102202954|FG002|STARTED|Overall Study||3||
48761035|NCT02257138|102202955|FG003|STARTED|Overall Study||3||
48761036|NCT02257138|102202956|FG004|STARTED|Overall Study||16||
48761037|NCT02257138|102202952|FG000|COMPLETED|Overall Study||5||
48761038|NCT02257138|102202953|FG001|COMPLETED|Overall Study||3||
48761039|NCT02257138|102202954|FG002|COMPLETED|Overall Study||3||
48761040|NCT02257138|102202955|FG003|COMPLETED|Overall Study||3||
48761041|NCT02257138|102202956|FG004|COMPLETED|Overall Study||16||
48761042|NCT02257138|102202952|FG000|NOT COMPLETED|Overall Study||0||
48761043|NCT02257138|102202953|FG001|NOT COMPLETED|Overall Study||0||
48761044|NCT02257138|102202954|FG002|NOT COMPLETED|Overall Study||0||
48761045|NCT02257138|102202955|FG003|NOT COMPLETED|Overall Study||0||
48761046|NCT02257138|102202956|FG004|NOT COMPLETED|Overall Study||0||
48761047|NCT01607957|102202957|FG000|STARTED|Overall Study||534||
48761048|NCT01607957|102202958|FG001|STARTED|Overall Study||266||
48761049|NCT01607957|102202957|FG000|Treated|Overall Study||533||
48761050|NCT01607957|102202958|FG001|Treated|Overall Study||265||
48761051|NCT01607957|102202957|FG000|COMPLETED|Overall Study||162||
48761052|NCT01607957|102202958|FG001|COMPLETED|Overall Study||51||
48416576|NCT02746991|101353431|FG000|STARTED|Overall Study||52||
48416577|NCT02746991|101353432|FG001|STARTED|Overall Study||101||
48416578|NCT02746991|101353431|FG000|COMPLETED|Overall Study||24||
48416579|NCT02746991|101353432|FG001|COMPLETED|Overall Study||67||
48416580|NCT02746991|101353431|FG000|NOT COMPLETED|Overall Study||28||
48416581|NCT02746991|101353432|FG001|NOT COMPLETED|Overall Study||34||
48416582|NCT00490477|101353433|FG000|STARTED|Overall Study||8||
48416583|NCT00490477|101353434|FG001|STARTED|Overall Study||8||
48416584|NCT00490477|101353433|FG000|COMPLETED|Overall Study||8||
48416585|NCT00490477|101353434|FG001|COMPLETED|Overall Study||8||
48416586|NCT00490477|101353433|FG000|NOT COMPLETED|Overall Study||0||
48416587|NCT00490477|101353434|FG001|NOT COMPLETED|Overall Study||0||
48416588|NCT00286156|101353435|FG000|STARTED|Overall Study||10||
48416589|NCT00286156|101353436|FG001|STARTED|Overall Study||10||
48416590|NCT00286156|101353437|FG002|STARTED|Overall Study||10||
48416591|NCT00286156|101353435|FG000|COMPLETED|Overall Study||8||
48761053|NCT01607957|102202957|FG000|NOT COMPLETED|Overall Study||372||
48761054|NCT01607957|102202958|FG001|NOT COMPLETED|Overall Study||215||
48761055|NCT02099864|102202959|FG000|STARTED|Overall Study||36||
48761056|NCT02099864|102202959|FG000|COMPLETED|Overall Study||36||
48349899|NCT03874234|101187811|FG012|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
48349900|NCT03874234|101187799|FG000|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
48349901|NCT03874234|101187800|FG001|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
48416592|NCT00286156|101353436|FG001|COMPLETED|Overall Study||9||
48416593|NCT00286156|101353437|FG002|COMPLETED|Overall Study||9||
48416594|NCT00286156|101353435|FG000|NOT COMPLETED|Overall Study||2||
48416595|NCT00286156|101353436|FG001|NOT COMPLETED|Overall Study||1||
48416596|NCT00286156|101353437|FG002|NOT COMPLETED|Overall Study||1||
48416597|NCT03574987|101353438|FG000|STARTED|Overall Study||20||
48416598|NCT03574987|101353439|FG001|STARTED|Overall Study||18||
48416599|NCT03574987|101353440|FG002|STARTED|Overall Study||22||
48416600|NCT03574987|101353438|FG000|COMPLETED|Overall Study||13||
48349902|NCT03874234|101187801|FG002|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
48349903|NCT03874234|101187802|FG003|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
48349904|NCT03874234|101187803|FG004|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
48349905|NCT03874234|101187804|FG005|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
48349906|NCT03874234|101187805|FG006|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
48349907|NCT03874234|101187806|FG007|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
48349908|NCT03874234|101187807|FG008|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
48349909|NCT03874234|101187808|FG009|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
48349910|NCT03874234|101187809|FG010|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
48349911|NCT03874234|101187810|FG011|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
48416601|NCT03574987|101353439|FG001|COMPLETED|Overall Study||16||
48416602|NCT03574987|101353440|FG002|COMPLETED|Overall Study||16||
48416603|NCT03574987|101353438|FG000|NOT COMPLETED|Overall Study||7||
48416604|NCT03574987|101353439|FG001|NOT COMPLETED|Overall Study||2||
48349912|NCT03874234|101187811|FG012|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
48349913|NCT03874234|101187799|FG000|STARTED|Part A: Cohort 1-Period 2 (Day1)||2||
48416605|NCT03574987|101353440|FG002|NOT COMPLETED|Overall Study||6||
48416606|NCT01682759|101353441|FG000|STARTED|Overall Study||376||
48416607|NCT01682759|101353442|FG001|STARTED|Overall Study||375||
48416608|NCT01682759|101353441|FG000|Treated|Overall Study||375||
48416609|NCT01682759|101353442|FG001|Treated|Overall Study||375||
48416610|NCT01682759|101353441|FG000|COMPLETED|Overall Study||307||
48416611|NCT01682759|101353442|FG001|COMPLETED|Overall Study||305||
48416612|NCT01682759|101353441|FG000|NOT COMPLETED|Overall Study||69||
48416613|NCT01682759|101353442|FG001|NOT COMPLETED|Overall Study||70||
48416614|NCT04109066|101353443|FG000|STARTED|Pre-treatment||263|Started = Randomized|
48416615|NCT04109066|101353444|FG001|STARTED|Pre-treatment||258|Started = Randomized|
48416616|NCT04109066|101353443|FG000|COMPLETED|Pre-treatment||260|Completed = Treated|
48416617|NCT04109066|101353444|FG001|COMPLETED|Pre-treatment||257|Completed = Treated|
48416618|NCT04109066|101353443|FG000|NOT COMPLETED|Pre-treatment||3||
48416619|NCT04109066|101353444|FG001|NOT COMPLETED|Pre-treatment||1||
48416620|NCT04109066|101353443|FG000|STARTED|Treatment||260|Started = Treated|
48416621|NCT04109066|101353444|FG001|STARTED|Treatment||257|Started = Treated|
48416622|NCT04109066|101353443|FG000|Received Arm A Treatment|Treatment||0||
48416623|NCT04109066|101353444|FG001|Received Arm A Treatment|Treatment||2||
48416624|NCT04109066|101353443|FG000|COMPLETED|Treatment||123||
48638138|NCT03317496|101898687|FG003|NOT COMPLETED|Phase 2: Follow-up||0||
48186815|NCT02748512|100779907|FG001|NOT COMPLETED|Overall Study||1||1
48349914|NCT03874234|101187800|FG001|STARTED|Part A: Cohort 1-Period 2 (Day1)||2||
48349915|NCT03874234|101187801|FG002|STARTED|Part A: Cohort 1-Period 2 (Day1)||2||
48349916|NCT03874234|101187802|FG003|STARTED|Part A: Cohort 1-Period 2 (Day1)||2||
48349917|NCT03874234|101187803|FG004|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
48349918|NCT03874234|101187804|FG005|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
48349919|NCT03874234|101187805|FG006|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
48349920|NCT03874234|101187806|FG007|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
48349921|NCT03874234|101187807|FG008|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
48349922|NCT03874234|101187808|FG009|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
48349923|NCT03874234|101187809|FG010|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
48349924|NCT03874234|101187810|FG011|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
48638139|NCT03317496|101898688|FG004|NOT COMPLETED|Phase 2: Follow-up||33||
48638140|NCT00976027|101898689|FG000|STARTED|Overall Study||6108||
48638141|NCT00976027|101898690|FG001|STARTED|Overall Study||3050||
48638142|NCT00976027|101898689|FG000|COMPLETED|Overall Study||5697||
48349925|NCT03874234|101187811|FG012|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
48349926|NCT03874234|101187799|FG000|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 2 (Day1)||0||
48349927|NCT03874234|101187800|FG001|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 2 (Day1)||0||
48349928|NCT03874234|101187801|FG002|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 2 (Day1)||0||
48349929|NCT03874234|101187802|FG003|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 2 (Day1)||1||
48349930|NCT03874234|101187803|FG004|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 2 (Day1)||0||
48349931|NCT03874234|101187804|FG005|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 2 (Day1)||0||
48349932|NCT03874234|101187805|FG006|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 2 (Day1)||0||
48349933|NCT03874234|101187806|FG007|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 2 (Day1)||0||
48349934|NCT03874234|101187807|FG008|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 2 (Day1)||0||
48349935|NCT03874234|101187808|FG009|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 2 (Day1)||0||
48349936|NCT03874234|101187809|FG010|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 2 (Day1)||0||
48368114|NCT03196297|101230110|FG000|Subject Analysis Set (SAS)|Main Period||36||
48416625|NCT04109066|101353444|FG001|COMPLETED|Treatment||125||
48416626|NCT04109066|101353443|FG000|NOT COMPLETED|Treatment||137||
48416627|NCT04109066|101353444|FG001|NOT COMPLETED|Treatment||132||
48416628|NCT03287830|101353445|FG000|STARTED|Overall Study||1050||
48638143|NCT00976027|101898690|FG001|COMPLETED|Overall Study||2835||
48638144|NCT00976027|101898689|FG000|NOT COMPLETED|Overall Study||411||
48638145|NCT00976027|101898690|FG001|NOT COMPLETED|Overall Study||215||
48416629|NCT03287830|101353446|FG001|STARTED|Overall Study||1055||
48416630|NCT03287830|101353445|FG000|COMPLETED|Overall Study||1044||
48416631|NCT03287830|101353446|FG001|COMPLETED|Overall Study||1042||
48416632|NCT03287830|101353445|FG000|NOT COMPLETED|Overall Study||6||
48416633|NCT03287830|101353446|FG001|NOT COMPLETED|Overall Study||13||
48416634|NCT01266876|101353447|FG000|STARTED|Overall Study||15||
48416635|NCT01266876|101353448|FG001|STARTED|Overall Study||15||
48638146|NCT00970944|101898691|FG000|STARTED|Overall Study||87||
48638147|NCT00970944|101898692|FG001|STARTED|Overall Study||97||
48638148|NCT00970944|101898691|FG000|COMPLETED|Overall Study||86||
48638149|NCT00970944|101898692|FG001|COMPLETED|Overall Study||95||
48416636|NCT01266876|101353449|FG002|STARTED|Overall Study||16||
48416637|NCT01266876|101353450|FG003|STARTED|Overall Study||15||
48416638|NCT01266876|101353451|FG004|STARTED|Overall Study||16||
48638150|NCT00970944|101898691|FG000|NOT COMPLETED|Overall Study||1||
48638151|NCT00970944|101898692|FG001|NOT COMPLETED|Overall Study||2||
48638152|NCT01947933|101898693|FG000|STARTED|Overall Study||7||
48416639|NCT01266876|101353447|FG000|COMPLETED|Overall Study||15||
48638153|NCT01947933|101898694|FG001|STARTED|Overall Study||3||
48638154|NCT01947933|101898695|FG002|STARTED|Overall Study||5||
48638155|NCT01947933|101898696|FG003|STARTED|Overall Study||5||
48638156|NCT01947933|101898697|FG004|STARTED|Overall Study||5||
48638157|NCT01947933|101898698|FG005|STARTED|Overall Study||5||
48416640|NCT01266876|101353448|FG001|COMPLETED|Overall Study||15||
48416641|NCT01266876|101353449|FG002|COMPLETED|Overall Study||16||
48416642|NCT01266876|101353450|FG003|COMPLETED|Overall Study||14||
48416643|NCT01266876|101353451|FG004|COMPLETED|Overall Study||16||
48416644|NCT01266876|101353447|FG000|NOT COMPLETED|Overall Study||0||
48638158|NCT01947933|101898699|FG006|STARTED|Overall Study||5||
48186816|NCT00614744|100779908|FG000|STARTED|Overall Study||83||
48638159|NCT01947933|101898700|FG007|STARTED|Overall Study||5||
48638160|NCT01947933|101898701|FG008|STARTED|Overall Study||5||
48638161|NCT01947933|101898693|FG000|COMPLETED|Overall Study||7||
48638162|NCT01947933|101898694|FG001|COMPLETED|Overall Study||3||
48638163|NCT01947933|101898695|FG002|COMPLETED|Overall Study||4||
48638164|NCT01947933|101898696|FG003|COMPLETED|Overall Study||5||
48638165|NCT01947933|101898697|FG004|COMPLETED|Overall Study||5||
48349937|NCT03874234|101187810|FG011|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 2 (Day1)||0||
48349938|NCT03874234|101187811|FG012|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 2 (Day1)||0||
48349939|NCT03874234|101187799|FG000|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1||
48349940|NCT03874234|101187800|FG001|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2||
48349941|NCT03874234|101187801|FG002|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2||
48349942|NCT03874234|101187802|FG003|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2||
48349943|NCT03874234|101187803|FG004|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48349944|NCT03874234|101187804|FG005|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48349945|NCT03874234|101187805|FG006|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48349946|NCT03874234|101187806|FG007|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48349947|NCT03874234|101187807|FG008|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48349948|NCT03874234|101187808|FG009|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48349949|NCT03874234|101187809|FG010|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48349950|NCT03874234|101187810|FG011|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48349951|NCT03874234|101187811|FG012|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48349952|NCT03874234|101187799|FG000|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1||
48349953|NCT03874234|101187800|FG001|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48349954|NCT03874234|101187801|FG002|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48349955|NCT03874234|101187802|FG003|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48349956|NCT03874234|101187803|FG004|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48349957|NCT03874234|101187804|FG005|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48349958|NCT03874234|101187805|FG006|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48349959|NCT03874234|101187806|FG007|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48349960|NCT03874234|101187807|FG008|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48349961|NCT03874234|101187808|FG009|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48349962|NCT03874234|101187809|FG010|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48349963|NCT03874234|101187810|FG011|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48349964|NCT03874234|101187811|FG012|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48349965|NCT03874234|101187799|FG000|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||1||
48349966|NCT03874234|101187800|FG001|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||2||
48638166|NCT01947933|101898698|FG005|COMPLETED|Overall Study||5||
48638167|NCT01947933|101898699|FG006|COMPLETED|Overall Study||5||
48638168|NCT01947933|101898700|FG007|COMPLETED|Overall Study||5||
48638169|NCT01947933|101898701|FG008|COMPLETED|Overall Study||4||
48638170|NCT01947933|101898693|FG000|NOT COMPLETED|Overall Study||0||
48638171|NCT01947933|101898694|FG001|NOT COMPLETED|Overall Study||0||
48638172|NCT01947933|101898695|FG002|NOT COMPLETED|Overall Study||1||
48349967|NCT03874234|101187801|FG002|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||2||
48349968|NCT03874234|101187802|FG003|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||2||
48349969|NCT03874234|101187803|FG004|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
48349970|NCT03874234|101187804|FG005|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
48349971|NCT03874234|101187805|FG006|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
48349972|NCT03874234|101187806|FG007|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
48349973|NCT03874234|101187807|FG008|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
48349974|NCT03874234|101187808|FG009|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
48349975|NCT03874234|101187809|FG010|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
48349976|NCT03874234|101187810|FG011|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
48349977|NCT03874234|101187811|FG012|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
48349978|NCT03874234|101187799|FG000|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||1||
48349979|NCT03874234|101187800|FG001|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||2||
48349980|NCT03874234|101187801|FG002|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||2||
48638173|NCT01947933|101898696|FG003|NOT COMPLETED|Overall Study||0||
48638174|NCT01947933|101898697|FG004|NOT COMPLETED|Overall Study||0||
48349981|NCT03874234|101187802|FG003|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||2||
48349982|NCT03874234|101187803|FG004|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
48349983|NCT03874234|101187804|FG005|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
48349984|NCT03874234|101187805|FG006|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
48349985|NCT03874234|101187806|FG007|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
48349986|NCT03874234|101187807|FG008|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
48349987|NCT03874234|101187808|FG009|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
48349988|NCT03874234|101187809|FG010|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
48349989|NCT03874234|101187810|FG011|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
48349990|NCT03874234|101187811|FG012|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
48349991|NCT03874234|101187799|FG000|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
48349992|NCT03874234|101187800|FG001|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
48349993|NCT03874234|101187801|FG002|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
48349994|NCT03874234|101187802|FG003|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
48349995|NCT03874234|101187803|FG004|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
48349996|NCT03874234|101187804|FG005|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
48349997|NCT03874234|101187805|FG006|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
48349998|NCT03874234|101187806|FG007|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
48349999|NCT03874234|101187807|FG008|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
48350000|NCT03874234|101187808|FG009|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
48350001|NCT03874234|101187809|FG010|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
48350002|NCT03874234|101187810|FG011|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
48350003|NCT03874234|101187811|FG012|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
48350004|NCT03874234|101187799|FG000|STARTED|Part A: Cohort 1-Period 3 (Day1)||2||
48350005|NCT03874234|101187800|FG001|STARTED|Part A: Cohort 1-Period 3 (Day1)||2||
48350006|NCT03874234|101187801|FG002|STARTED|Part A: Cohort 1-Period 3 (Day1)||2||
48350007|NCT03874234|101187802|FG003|STARTED|Part A: Cohort 1-Period 3 (Day1)||2||
48350008|NCT03874234|101187803|FG004|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
48350009|NCT03874234|101187804|FG005|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
48350010|NCT03874234|101187805|FG006|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
48350011|NCT03874234|101187806|FG007|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
48350012|NCT03874234|101187807|FG008|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
48350013|NCT03874234|101187808|FG009|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
48350014|NCT03874234|101187809|FG010|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
48350015|NCT03874234|101187810|FG011|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
48350016|NCT03874234|101187811|FG012|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
48350017|NCT03874234|101187799|FG000|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 3 (Day1)||1||
48350018|NCT03874234|101187800|FG001|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 3 (Day1)||0||
48350019|NCT03874234|101187801|FG002|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 3 (Day1)||0||
48350020|NCT03874234|101187802|FG003|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 3 (Day1)||0||
48761057|NCT02099864|102202959|FG000|NOT COMPLETED|Overall Study||0||
48350021|NCT03874234|101187803|FG004|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 3 (Day1)||0||
48350022|NCT03874234|101187804|FG005|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 3 (Day1)||0||
48638175|NCT01947933|101898698|FG005|NOT COMPLETED|Overall Study||0||
48638176|NCT01947933|101898699|FG006|NOT COMPLETED|Overall Study||0||
48638177|NCT01947933|101898700|FG007|NOT COMPLETED|Overall Study||0||
48638178|NCT01947933|101898701|FG008|NOT COMPLETED|Overall Study||1||
48638179|NCT00316004|101898702|FG000|STARTED|Overall Study||373||
48638180|NCT00316004|101898703|FG001|STARTED|Overall Study||355||
48638181|NCT00316004|101898704|FG002|STARTED|Overall Study||603||
48638182|NCT00316004|101898702|FG000|COMPLETED|Overall Study||359||
48638183|NCT00316004|101898703|FG001|COMPLETED|Overall Study||341||
48638184|NCT00316004|101898704|FG002|COMPLETED|Overall Study||582||
48638185|NCT00316004|101898702|FG000|NOT COMPLETED|Overall Study||14||
48638186|NCT00316004|101898703|FG001|NOT COMPLETED|Overall Study||14||
48638187|NCT00316004|101898704|FG002|NOT COMPLETED|Overall Study||21||
48638188|NCT03846479|101898705|FG000|STARTED|Overall Study||70||
48638189|NCT03846479|101898705|FG000|COMPLETED|Overall Study||61||
48638190|NCT03846479|101898705|FG000|NOT COMPLETED|Overall Study||9||
48638191|NCT01091259|101898706|FG000|STARTED|Overall Study||29||
48638192|NCT01091259|101898706|FG000|COMPLETED|Overall Study||24||
48638193|NCT01091259|101898706|FG000|NOT COMPLETED|Overall Study||5||
48638194|NCT03073759|101898707|FG000|STARTED|Overall Study||2||
48638195|NCT03073759|101898708|FG001|STARTED|Overall Study||2||
48761058|NCT04199351|102202960|FG000|STARTED|Overall Study||4||
48761059|NCT04199351|102202961|FG001|STARTED|Overall Study||7||
48761060|NCT04199351|102202962|FG002|STARTED|Overall Study||6||
48761061|NCT04199351|102202963|FG003|STARTED|Overall Study||2||
48761062|NCT04199351|102202964|FG004|STARTED|Overall Study||8||
48761063|NCT04199351|102202965|FG005|STARTED|Overall Study||7||
48350023|NCT03874234|101187805|FG006|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 3 (Day1)||0||
48350024|NCT03874234|101187806|FG007|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 3 (Day1)||0||
48350025|NCT03874234|101187807|FG008|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 3 (Day1)||0||
48350026|NCT03874234|101187808|FG009|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 3 (Day1)||0||
48350027|NCT03874234|101187809|FG010|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 3 (Day1)||0||
48350028|NCT03874234|101187810|FG011|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 3 (Day1)||0||
48350029|NCT03874234|101187811|FG012|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 3 (Day1)||0||
48350030|NCT03874234|101187799|FG000|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2||
48350031|NCT03874234|101187800|FG001|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2||
48350032|NCT03874234|101187801|FG002|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2||
48350033|NCT03874234|101187802|FG003|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1||
48350034|NCT03874234|101187803|FG004|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48350035|NCT03874234|101187804|FG005|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48350036|NCT03874234|101187805|FG006|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48350037|NCT03874234|101187806|FG007|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48350038|NCT03874234|101187807|FG008|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48350039|NCT03874234|101187808|FG009|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48350040|NCT03874234|101187809|FG010|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48350041|NCT03874234|101187810|FG011|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48350042|NCT03874234|101187811|FG012|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48350043|NCT03874234|101187799|FG000|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48350044|NCT03874234|101187800|FG001|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48350045|NCT03874234|101187801|FG002|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48350046|NCT03874234|101187802|FG003|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1||
48350047|NCT03874234|101187803|FG004|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48350048|NCT03874234|101187804|FG005|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48350049|NCT03874234|101187805|FG006|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48350050|NCT03874234|101187806|FG007|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48350051|NCT03874234|101187807|FG008|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48350052|NCT03874234|101187808|FG009|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48350053|NCT03874234|101187809|FG010|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48350054|NCT03874234|101187810|FG011|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48350055|NCT03874234|101187811|FG012|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48350056|NCT03874234|101187799|FG000|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||2||
48350057|NCT03874234|101187800|FG001|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||2||
48350058|NCT03874234|101187801|FG002|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||2||
48350059|NCT03874234|101187802|FG003|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||1||
48350060|NCT03874234|101187803|FG004|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
48350061|NCT03874234|101187804|FG005|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
48350062|NCT03874234|101187805|FG006|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
48350063|NCT03874234|101187806|FG007|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
48350064|NCT03874234|101187807|FG008|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
48350065|NCT03874234|101187808|FG009|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
48350066|NCT03874234|101187809|FG010|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
48350067|NCT03874234|101187810|FG011|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
48350068|NCT03874234|101187811|FG012|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
48350069|NCT03874234|101187799|FG000|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||2||
48350070|NCT03874234|101187800|FG001|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||2||
48350071|NCT03874234|101187801|FG002|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||2||
48350072|NCT03874234|101187802|FG003|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||1||
48350073|NCT03874234|101187803|FG004|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
48350074|NCT03874234|101187804|FG005|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
48350075|NCT03874234|101187805|FG006|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
48350076|NCT03874234|101187806|FG007|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
48350077|NCT03874234|101187807|FG008|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
48368115|NCT03196297|101230110|FG000|COMPLETED|Main Period||32||
48416645|NCT01266876|101353448|FG001|NOT COMPLETED|Overall Study||0||
48416646|NCT01266876|101353449|FG002|NOT COMPLETED|Overall Study||0||
48350078|NCT03874234|101187808|FG009|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
48350079|NCT03874234|101187809|FG010|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
48350080|NCT03874234|101187810|FG011|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
48350081|NCT03874234|101187811|FG012|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
48350082|NCT03874234|101187799|FG000|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
48350083|NCT03874234|101187800|FG001|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
48350084|NCT03874234|101187801|FG002|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
48350085|NCT03874234|101187802|FG003|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
48350086|NCT03874234|101187803|FG004|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
48350087|NCT03874234|101187804|FG005|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
48350088|NCT03874234|101187805|FG006|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
48350089|NCT03874234|101187806|FG007|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
48350090|NCT03874234|101187807|FG008|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
48350091|NCT03874234|101187808|FG009|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
48350092|NCT03874234|101187809|FG010|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
48350093|NCT03874234|101187810|FG011|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
48350094|NCT03874234|101187811|FG012|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
48350095|NCT03874234|101187799|FG000|STARTED|Part A: Cohort 1-Period 4 (Day1)||2||
48350096|NCT03874234|101187800|FG001|STARTED|Part A: Cohort 1-Period 4 (Day1)||2||
48350097|NCT03874234|101187801|FG002|STARTED|Part A: Cohort 1-Period 4 (Day1)||2||
48350098|NCT03874234|101187802|FG003|STARTED|Part A: Cohort 1-Period 4 (Day1)||2||
48350099|NCT03874234|101187803|FG004|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
48350100|NCT03874234|101187804|FG005|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
48350101|NCT03874234|101187805|FG006|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
48350102|NCT03874234|101187806|FG007|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
48350103|NCT03874234|101187807|FG008|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
48350104|NCT03874234|101187808|FG009|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
48350105|NCT03874234|101187809|FG010|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
48350106|NCT03874234|101187810|FG011|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
48350107|NCT03874234|101187811|FG012|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
48350108|NCT03874234|101187799|FG000|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 4 (Day1)||0||
48350109|NCT03874234|101187800|FG001|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 4 (Day1)||0||
48350110|NCT03874234|101187801|FG002|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 4 (Day1)||0||
48350111|NCT03874234|101187802|FG003|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 4 (Day1)||1||
48350112|NCT03874234|101187803|FG004|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 4 (Day1)||0||
48350113|NCT03874234|101187804|FG005|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 4 (Day1)||0||
48350114|NCT03874234|101187805|FG006|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 4 (Day1)||0||
48350115|NCT03874234|101187806|FG007|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 4 (Day1)||0||
48350116|NCT03874234|101187807|FG008|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 4 (Day1)||0||
48350117|NCT03874234|101187808|FG009|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 4 (Day1)||0||
48350118|NCT03874234|101187809|FG010|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 4 (Day1)||0||
48350119|NCT03874234|101187810|FG011|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 4 (Day1)||0||
48350120|NCT03874234|101187811|FG012|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 4 (Day1)||0||
48350121|NCT03874234|101187799|FG000|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2||
48350122|NCT03874234|101187800|FG001|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2||
48350123|NCT03874234|101187801|FG002|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2||
48350124|NCT03874234|101187802|FG003|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2||
48350125|NCT03874234|101187803|FG004|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48350126|NCT03874234|101187804|FG005|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48350127|NCT03874234|101187805|FG006|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48350128|NCT03874234|101187806|FG007|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48350129|NCT03874234|101187807|FG008|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48350130|NCT03874234|101187808|FG009|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48350131|NCT03874234|101187809|FG010|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48350132|NCT03874234|101187810|FG011|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48350133|NCT03874234|101187811|FG012|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48350134|NCT03874234|101187799|FG000|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48350135|NCT03874234|101187800|FG001|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48350136|NCT03874234|101187801|FG002|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48350137|NCT03874234|101187802|FG003|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48350138|NCT03874234|101187803|FG004|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48350139|NCT03874234|101187804|FG005|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48350140|NCT03874234|101187805|FG006|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48350141|NCT03874234|101187806|FG007|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48350142|NCT03874234|101187807|FG008|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48350143|NCT03874234|101187808|FG009|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48350144|NCT03874234|101187809|FG010|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48350145|NCT03874234|101187810|FG011|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48350146|NCT03874234|101187811|FG012|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48350147|NCT03874234|101187799|FG000|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
48350148|NCT03874234|101187800|FG001|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
48350149|NCT03874234|101187801|FG002|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
48350150|NCT03874234|101187802|FG003|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
48350151|NCT03874234|101187803|FG004|STARTED|Part A: Cohort 2-Period 1 (Day1)||3||
48350152|NCT03874234|101187804|FG005|STARTED|Part A: Cohort 2-Period 1 (Day1)||2||
48350153|NCT03874234|101187805|FG006|STARTED|Part A: Cohort 2-Period 1 (Day1)||2||
48350154|NCT03874234|101187806|FG007|STARTED|Part A: Cohort 2-Period 1 (Day1)||2||
48350155|NCT03874234|101187807|FG008|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
48350156|NCT03874234|101187808|FG009|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
48350157|NCT03874234|101187809|FG010|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
48350158|NCT03874234|101187810|FG011|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
48350159|NCT03874234|101187811|FG012|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
48350160|NCT03874234|101187799|FG000|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 1 (Day1)||0||
48350161|NCT03874234|101187800|FG001|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 1 (Day1)||0||
48350162|NCT03874234|101187801|FG002|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 1 (Day1)||0||
48350163|NCT03874234|101187802|FG003|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 1 (Day1)||0||
48350164|NCT03874234|101187803|FG004|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 1 (Day1)||2||
48350165|NCT03874234|101187804|FG005|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 1 (Day1)||2||
48350166|NCT03874234|101187805|FG006|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 1 (Day1)||2||
48350167|NCT03874234|101187806|FG007|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 1 (Day1)||2||
48350168|NCT03874234|101187807|FG008|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 1 (Day1)||0||
48350169|NCT03874234|101187808|FG009|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 1 (Day1)||0||
48350170|NCT03874234|101187809|FG010|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 1 (Day1)||0||
48350171|NCT03874234|101187810|FG011|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 1 (Day1)||0||
48350172|NCT03874234|101187811|FG012|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 1 (Day1)||0||
48350173|NCT03874234|101187799|FG000|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48350174|NCT03874234|101187800|FG001|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48350175|NCT03874234|101187801|FG002|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48350176|NCT03874234|101187802|FG003|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48350177|NCT03874234|101187803|FG004|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1||
48350178|NCT03874234|101187804|FG005|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1||
48350179|NCT03874234|101187805|FG006|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||2||
48350180|NCT03874234|101187806|FG007|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1||
48350181|NCT03874234|101187807|FG008|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48350182|NCT03874234|101187808|FG009|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48350183|NCT03874234|101187809|FG010|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48350184|NCT03874234|101187810|FG011|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48350185|NCT03874234|101187811|FG012|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48350186|NCT03874234|101187799|FG000|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48350187|NCT03874234|101187800|FG001|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48350188|NCT03874234|101187801|FG002|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48350189|NCT03874234|101187802|FG003|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48350190|NCT03874234|101187803|FG004|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||2||
48350191|NCT03874234|101187804|FG005|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1||
48350192|NCT03874234|101187805|FG006|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48350193|NCT03874234|101187806|FG007|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1||
48350194|NCT03874234|101187807|FG008|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48350195|NCT03874234|101187808|FG009|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48416647|NCT01266876|101353450|FG003|NOT COMPLETED|Overall Study||1||
48416648|NCT01266876|101353451|FG004|NOT COMPLETED|Overall Study||0||
48416649|NCT02059174|101353452|FG000|STARTED|Period 1||37||
48416650|NCT02059174|101353453|FG001|STARTED|Period 1||39||
48350196|NCT03874234|101187809|FG010|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48350197|NCT03874234|101187810|FG011|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48350198|NCT03874234|101187811|FG012|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48350199|NCT03874234|101187799|FG000|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
48761064|NCT04199351|102202966|FG006|STARTED|Overall Study||8||
48350200|NCT03874234|101187800|FG001|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
48350201|NCT03874234|101187801|FG002|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
48350202|NCT03874234|101187802|FG003|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
48350203|NCT03874234|101187803|FG004|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||1||
48350204|NCT03874234|101187804|FG005|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||1||
48350205|NCT03874234|101187805|FG006|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||2||
48350206|NCT03874234|101187806|FG007|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||1||
48350207|NCT03874234|101187807|FG008|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
48350208|NCT03874234|101187808|FG009|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
48350209|NCT03874234|101187809|FG010|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
48350210|NCT03874234|101187810|FG011|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
48350211|NCT03874234|101187811|FG012|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
48350212|NCT03874234|101187799|FG000|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
48350213|NCT03874234|101187800|FG001|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
48350214|NCT03874234|101187801|FG002|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
48350215|NCT03874234|101187802|FG003|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
48350216|NCT03874234|101187803|FG004|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||1||
48350217|NCT03874234|101187804|FG005|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||1||
48350218|NCT03874234|101187805|FG006|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||2||
48350219|NCT03874234|101187806|FG007|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||1||
48350220|NCT03874234|101187807|FG008|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
48350221|NCT03874234|101187808|FG009|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
48350222|NCT03874234|101187809|FG010|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
48350223|NCT03874234|101187810|FG011|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
48350224|NCT03874234|101187811|FG012|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
48350225|NCT03874234|101187799|FG000|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
48350226|NCT03874234|101187800|FG001|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
48350227|NCT03874234|101187801|FG002|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
48350228|NCT03874234|101187802|FG003|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
48350229|NCT03874234|101187803|FG004|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
48350230|NCT03874234|101187804|FG005|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
48350231|NCT03874234|101187805|FG006|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
48350232|NCT03874234|101187806|FG007|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
48350233|NCT03874234|101187807|FG008|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
48350234|NCT03874234|101187808|FG009|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
48350235|NCT03874234|101187809|FG010|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
48350236|NCT03874234|101187810|FG011|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
48350237|NCT03874234|101187811|FG012|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
48350238|NCT03874234|101187799|FG000|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
48350239|NCT03874234|101187800|FG001|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
48350240|NCT03874234|101187801|FG002|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
48416651|NCT02059174|101353452|FG000|COMPLETED|Period 1||37||
48416652|NCT02059174|101353453|FG001|COMPLETED|Period 1||37||
48416653|NCT02059174|101353452|FG000|NOT COMPLETED|Period 1||0||
48416654|NCT02059174|101353453|FG001|NOT COMPLETED|Period 1||2||
48416655|NCT02059174|101353452|FG000|STARTED|Period 2||37||
48416656|NCT02059174|101353453|FG001|STARTED|Period 2||37||
48638196|NCT03073759|101898707|FG000|COMPLETED|Overall Study||2||
48638197|NCT03073759|101898708|FG001|COMPLETED|Overall Study||2||
48638198|NCT03073759|101898707|FG000|NOT COMPLETED|Overall Study||0||
48638199|NCT03073759|101898708|FG001|NOT COMPLETED|Overall Study||0||
48638200|NCT00204737|101898709|FG000|STARTED|Overall Study||6||
48638201|NCT00204737|101898710|FG001|STARTED|Overall Study||6||
48638202|NCT00204737|101898709|FG000|COMPLETED|Overall Study||6||
48638203|NCT00204737|101898710|FG001|COMPLETED|Overall Study||6||
48638204|NCT00204737|101898709|FG000|NOT COMPLETED|Overall Study||0||
48638205|NCT00204737|101898710|FG001|NOT COMPLETED|Overall Study||0||
48638206|NCT02807259|101898711|FG000|STARTED|Baseline (3 Months)||405||24
48638207|NCT02807259|101898712|FG001|STARTED|Baseline (3 Months)||404||23
48638208|NCT02807259|101898711|FG000|COMPLETED|Baseline (3 Months)||328||24
48638209|NCT02807259|101898712|FG001|COMPLETED|Baseline (3 Months)||292||23
48638210|NCT02807259|101898711|FG000|NOT COMPLETED|Baseline (3 Months)||77||0
48638211|NCT02807259|101898712|FG001|NOT COMPLETED|Baseline (3 Months)||112||0
48761065|NCT04199351|102202967|FG007|STARTED|Overall Study||6||
48761066|NCT04199351|102202968|FG008|STARTED|Overall Study||6||
48761067|NCT04199351|102202969|FG009|STARTED|Overall Study||6||
48761068|NCT04199351|102202960|FG000|COMPLETED|Overall Study||4||
48761069|NCT04199351|102202961|FG001|COMPLETED|Overall Study||6||
48761070|NCT04199351|102202962|FG002|COMPLETED|Overall Study||5||
48350241|NCT03874234|101187802|FG003|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
48350242|NCT03874234|101187803|FG004|STARTED|Part A: Cohort 2-Period 2 (Day1)||2||
48350243|NCT03874234|101187804|FG005|STARTED|Part A: Cohort 2-Period 2 (Day1)||2||
48350244|NCT03874234|101187805|FG006|STARTED|Part A: Cohort 2-Period 2 (Day1)||2||
48350245|NCT03874234|101187806|FG007|STARTED|Part A: Cohort 2-Period 2 (Day1)||2||
48350246|NCT03874234|101187807|FG008|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
48350247|NCT03874234|101187808|FG009|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
48350248|NCT03874234|101187809|FG010|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
48350249|NCT03874234|101187810|FG011|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
48350250|NCT03874234|101187811|FG012|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
48350251|NCT03874234|101187799|FG000|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 2 (Day1)||0||
48350252|NCT03874234|101187800|FG001|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 2 (Day1)||0||
48350253|NCT03874234|101187801|FG002|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 2 (Day1)||0||
48350254|NCT03874234|101187802|FG003|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 2 (Day1)||0||
48350255|NCT03874234|101187803|FG004|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 2 (Day1)||1||
48350256|NCT03874234|101187804|FG005|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 2 (Day1)||1||
48350257|NCT03874234|101187805|FG006|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 2 (Day1)||0||
48350258|NCT03874234|101187806|FG007|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 2 (Day1)||1||
48350259|NCT03874234|101187807|FG008|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 2 (Day1)||0||
48350260|NCT03874234|101187808|FG009|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 2 (Day1)||0||
48350261|NCT03874234|101187809|FG010|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 2 (Day1)||0||
48350262|NCT03874234|101187810|FG011|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 2 (Day1)||0||
48350263|NCT03874234|101187811|FG012|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 2 (Day1)||0||
48350264|NCT03874234|101187799|FG000|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48350265|NCT03874234|101187800|FG001|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48350266|NCT03874234|101187801|FG002|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48350267|NCT03874234|101187802|FG003|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48350268|NCT03874234|101187803|FG004|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1||
48350269|NCT03874234|101187804|FG005|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2||
48350270|NCT03874234|101187805|FG006|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1||
48350271|NCT03874234|101187806|FG007|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2||
48350272|NCT03874234|101187807|FG008|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48350273|NCT03874234|101187808|FG009|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48350274|NCT03874234|101187809|FG010|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48350275|NCT03874234|101187810|FG011|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48350276|NCT03874234|101187811|FG012|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48350277|NCT03874234|101187799|FG000|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48350278|NCT03874234|101187800|FG001|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48350279|NCT03874234|101187801|FG002|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48350280|NCT03874234|101187802|FG003|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48350281|NCT03874234|101187803|FG004|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1||
48350282|NCT03874234|101187804|FG005|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48350283|NCT03874234|101187805|FG006|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1||
48350284|NCT03874234|101187806|FG007|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48350285|NCT03874234|101187807|FG008|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48350286|NCT03874234|101187808|FG009|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48350287|NCT03874234|101187809|FG010|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48350288|NCT03874234|101187810|FG011|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48350289|NCT03874234|101187811|FG012|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48350290|NCT03874234|101187799|FG000|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
48350291|NCT03874234|101187800|FG001|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
48350292|NCT03874234|101187801|FG002|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
48350293|NCT03874234|101187802|FG003|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
48350294|NCT03874234|101187803|FG004|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||1||
48350295|NCT03874234|101187804|FG005|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||2||
48350296|NCT03874234|101187805|FG006|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||1||
48350297|NCT03874234|101187806|FG007|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||2||
48350298|NCT03874234|101187807|FG008|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
48350299|NCT03874234|101187808|FG009|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
48350300|NCT03874234|101187809|FG010|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
48350301|NCT03874234|101187810|FG011|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
48761071|NCT04199351|102202963|FG003|COMPLETED|Overall Study||0||
48761072|NCT04199351|102202964|FG004|COMPLETED|Overall Study||7||
48761073|NCT04199351|102202965|FG005|COMPLETED|Overall Study||2||
48761074|NCT04199351|102202966|FG006|COMPLETED|Overall Study||6||
48761075|NCT04199351|102202967|FG007|COMPLETED|Overall Study||6||
48761076|NCT04199351|102202968|FG008|COMPLETED|Overall Study||3||
48761077|NCT04199351|102202969|FG009|COMPLETED|Overall Study||0||
48761078|NCT04199351|102202960|FG000|NOT COMPLETED|Overall Study||0||
48761079|NCT04199351|102202961|FG001|NOT COMPLETED|Overall Study||1||
48761080|NCT04199351|102202962|FG002|NOT COMPLETED|Overall Study||1||
48761081|NCT04199351|102202963|FG003|NOT COMPLETED|Overall Study||2||
48761082|NCT04199351|102202964|FG004|NOT COMPLETED|Overall Study||1||
48761083|NCT04199351|102202965|FG005|NOT COMPLETED|Overall Study||5||
48761084|NCT04199351|102202966|FG006|NOT COMPLETED|Overall Study||2||
48761085|NCT04199351|102202967|FG007|NOT COMPLETED|Overall Study||0||
48761086|NCT04199351|102202968|FG008|NOT COMPLETED|Overall Study||3||
48761087|NCT04199351|102202969|FG009|NOT COMPLETED|Overall Study||6||
48761088|NCT03496844|102202970|FG000|STARTED|Overall Study||15||
48761089|NCT03496844|102202970|FG000|COMPLETED|Overall Study||15||
48761090|NCT03496844|102202970|FG000|NOT COMPLETED|Overall Study||0||
48761091|NCT01856270|102202971|FG000|STARTED|Overall Study||24||
48761092|NCT01856270|102202972|FG001|STARTED|Overall Study||26||
48761093|NCT01856270|102202971|FG000|COMPLETED|Overall Study||13|Completed the 180 day assessment|
48761094|NCT01856270|102202972|FG001|COMPLETED|Overall Study||14|Completed the 180 day assessment|
48350302|NCT03874234|101187811|FG012|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
48350303|NCT03874234|101187799|FG000|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
48350304|NCT03874234|101187800|FG001|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
48350305|NCT03874234|101187801|FG002|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
48350306|NCT03874234|101187802|FG003|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
48350307|NCT03874234|101187803|FG004|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||1||
48350308|NCT03874234|101187804|FG005|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||2||
48350309|NCT03874234|101187805|FG006|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||1||
48350310|NCT03874234|101187806|FG007|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||2||
48350311|NCT03874234|101187807|FG008|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
48350312|NCT03874234|101187808|FG009|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
48350313|NCT03874234|101187809|FG010|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
48350314|NCT03874234|101187810|FG011|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
48350315|NCT03874234|101187811|FG012|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
48761095|NCT01856270|102202971|FG000|NOT COMPLETED|Overall Study||11||
48761096|NCT01856270|102202972|FG001|NOT COMPLETED|Overall Study||12||
48761097|NCT04771455|102202973|FG000|STARTED|Overall Study||10||
48761098|NCT04771455|102202974|FG001|STARTED|Overall Study||10||
48761099|NCT04771455|102202975|FG002|STARTED|Overall Study||10||
48761100|NCT04771455|102202976|FG003|STARTED|Overall Study||10||
48761101|NCT04771455|102202977|FG004|STARTED|Overall Study||11||
48761102|NCT04771455|102202978|FG005|STARTED|Overall Study||10||
48761103|NCT04771455|102202979|FG006|STARTED|Overall Study||10||
48761104|NCT04771455|102202980|FG007|STARTED|Overall Study||10||
48761105|NCT04771455|102202973|FG000|COMPLETED|Overall Study||9||
48761106|NCT04771455|102202974|FG001|COMPLETED|Overall Study||9||
48761107|NCT04771455|102202975|FG002|COMPLETED|Overall Study||8||
48761108|NCT04771455|102202976|FG003|COMPLETED|Overall Study||9||
48761109|NCT04771455|102202977|FG004|COMPLETED|Overall Study||11||
48761110|NCT04771455|102202978|FG005|COMPLETED|Overall Study||8||
48761111|NCT04771455|102202979|FG006|COMPLETED|Overall Study||10||
48761112|NCT04771455|102202980|FG007|COMPLETED|Overall Study||9||
48761113|NCT04771455|102202973|FG000|NOT COMPLETED|Overall Study||1||
48761114|NCT04771455|102202974|FG001|NOT COMPLETED|Overall Study||1||
48761115|NCT04771455|102202975|FG002|NOT COMPLETED|Overall Study||2||
48761116|NCT04771455|102202976|FG003|NOT COMPLETED|Overall Study||1||
48761117|NCT04771455|102202977|FG004|NOT COMPLETED|Overall Study||0||
48761118|NCT04771455|102202978|FG005|NOT COMPLETED|Overall Study||2||
48761119|NCT04771455|102202979|FG006|NOT COMPLETED|Overall Study||0||
48350316|NCT03874234|101187799|FG000|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
48350317|NCT03874234|101187800|FG001|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
48761120|NCT04771455|102202980|FG007|NOT COMPLETED|Overall Study||1||
48761121|NCT01500733|102202981|FG000|STARTED|Overall Study||35||
48761122|NCT01500733|102202982|FG001|STARTED|Overall Study||51||
48761123|NCT01500733|102202981|FG000|COMPLETED|Overall Study||33||
48761124|NCT01500733|102202982|FG001|COMPLETED|Overall Study||48||
48761125|NCT01500733|102202981|FG000|NOT COMPLETED|Overall Study||2||
48761126|NCT01500733|102202982|FG001|NOT COMPLETED|Overall Study||3||
48761127|NCT03995368|102202983|FG000|STARTED|Overall Study||28||
48761128|NCT03995368|102202984|FG001|STARTED|Overall Study||34||
48761129|NCT03995368|102202985|FG002|STARTED|Overall Study||31||
48761130|NCT03995368|102202983|FG000|COMPLETED|Overall Study||26||
48761131|NCT03995368|102202984|FG001|COMPLETED|Overall Study||23||
48761132|NCT03995368|102202985|FG002|COMPLETED|Overall Study||26||
48761133|NCT03995368|102202983|FG000|NOT COMPLETED|Overall Study||2||
48761134|NCT03995368|102202984|FG001|NOT COMPLETED|Overall Study||11||
48350318|NCT03874234|101187801|FG002|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
48350319|NCT03874234|101187802|FG003|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
48350320|NCT03874234|101187803|FG004|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
48350321|NCT03874234|101187804|FG005|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
48350322|NCT03874234|101187805|FG006|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
48350323|NCT03874234|101187806|FG007|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
48350324|NCT03874234|101187807|FG008|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
48350325|NCT03874234|101187808|FG009|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
48350326|NCT03874234|101187809|FG010|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
48350327|NCT03874234|101187810|FG011|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
48350328|NCT03874234|101187811|FG012|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
48350329|NCT03874234|101187799|FG000|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
48350330|NCT03874234|101187800|FG001|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
48350331|NCT03874234|101187801|FG002|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
48350332|NCT03874234|101187802|FG003|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
48350333|NCT03874234|101187803|FG004|STARTED|Part A: Cohort 2-Period 3 (Day1)||2||
48350334|NCT03874234|101187804|FG005|STARTED|Part A: Cohort 2-Period 3 (Day1)||2||
48350335|NCT03874234|101187805|FG006|STARTED|Part A: Cohort 2-Period 3 (Day1)||2||
48350336|NCT03874234|101187806|FG007|STARTED|Part A: Cohort 2-Period 3 (Day1)||2||
48350337|NCT03874234|101187807|FG008|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
48350338|NCT03874234|101187808|FG009|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
48350339|NCT03874234|101187809|FG010|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
48350340|NCT03874234|101187810|FG011|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
48350341|NCT03874234|101187811|FG012|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
48350342|NCT03874234|101187799|FG000|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 3 (Day1)||0||
48350343|NCT03874234|101187800|FG001|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 3 (Day1)||0||
48350344|NCT03874234|101187801|FG002|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 3 (Day1)||0||
48350345|NCT03874234|101187802|FG003|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 3 (Day1)||0||
48350346|NCT03874234|101187803|FG004|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 3 (Day1)||1||
48350347|NCT03874234|101187804|FG005|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 3 (Day1)||0||
48350348|NCT03874234|101187805|FG006|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 3 (Day1)||1||
48350349|NCT03874234|101187806|FG007|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 3 (Day1)||0||
48350350|NCT03874234|101187807|FG008|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 3 (Day1)||0||
48350351|NCT03874234|101187808|FG009|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 3 (Day1)||0||
48350352|NCT03874234|101187809|FG010|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 3 (Day1)||0||
48350353|NCT03874234|101187810|FG011|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 3 (Day1)||0||
48350354|NCT03874234|101187811|FG012|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 3 (Day1)||0||
48350355|NCT03874234|101187799|FG000|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48350356|NCT03874234|101187800|FG001|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48350357|NCT03874234|101187801|FG002|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48350358|NCT03874234|101187802|FG003|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48350359|NCT03874234|101187803|FG004|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2||
48350360|NCT03874234|101187804|FG005|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2||
48350361|NCT03874234|101187805|FG006|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2||
48350362|NCT03874234|101187806|FG007|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2||
48350363|NCT03874234|101187807|FG008|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48350364|NCT03874234|101187808|FG009|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48350365|NCT03874234|101187809|FG010|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48350366|NCT03874234|101187810|FG011|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48350367|NCT03874234|101187811|FG012|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48350368|NCT03874234|101187799|FG000|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48350369|NCT03874234|101187800|FG001|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48350370|NCT03874234|101187801|FG002|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48416657|NCT02059174|101353452|FG000|COMPLETED|Period 2||36||
48416658|NCT02059174|101353453|FG001|COMPLETED|Period 2||35||
48416659|NCT02059174|101353452|FG000|NOT COMPLETED|Period 2||1||
48416660|NCT02059174|101353453|FG001|NOT COMPLETED|Period 2||2||
48416661|NCT02059174|101353452|FG000|STARTED|Period 3||36||
48416662|NCT02059174|101353453|FG001|STARTED|Period 3||35||
48350371|NCT03874234|101187802|FG003|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48350372|NCT03874234|101187803|FG004|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48350373|NCT03874234|101187804|FG005|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48350374|NCT03874234|101187805|FG006|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48350375|NCT03874234|101187806|FG007|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48350376|NCT03874234|101187807|FG008|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48350377|NCT03874234|101187808|FG009|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48350378|NCT03874234|101187809|FG010|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48350379|NCT03874234|101187810|FG011|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48350380|NCT03874234|101187811|FG012|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48350381|NCT03874234|101187799|FG000|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
48350382|NCT03874234|101187800|FG001|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
48350383|NCT03874234|101187801|FG002|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
48350384|NCT03874234|101187802|FG003|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
48350385|NCT03874234|101187803|FG004|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||2||
48350386|NCT03874234|101187804|FG005|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||2||
48350387|NCT03874234|101187805|FG006|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||2||
48350388|NCT03874234|101187806|FG007|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||2||
48350389|NCT03874234|101187807|FG008|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
48350390|NCT03874234|101187808|FG009|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
48350391|NCT03874234|101187809|FG010|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
48350392|NCT03874234|101187810|FG011|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
48350393|NCT03874234|101187811|FG012|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
48350394|NCT03874234|101187799|FG000|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
48350395|NCT03874234|101187800|FG001|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
48350396|NCT03874234|101187801|FG002|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
48350397|NCT03874234|101187802|FG003|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
48350398|NCT03874234|101187803|FG004|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||2||
48350399|NCT03874234|101187804|FG005|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||2||
48350400|NCT03874234|101187805|FG006|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||2||
48350401|NCT03874234|101187806|FG007|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||2||
48350402|NCT03874234|101187807|FG008|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
48350403|NCT03874234|101187808|FG009|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
48350404|NCT03874234|101187809|FG010|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
48350405|NCT03874234|101187810|FG011|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
48350406|NCT03874234|101187811|FG012|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
48350407|NCT03874234|101187799|FG000|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
48350408|NCT03874234|101187800|FG001|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
48350409|NCT03874234|101187801|FG002|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
48350410|NCT03874234|101187802|FG003|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
48350411|NCT03874234|101187803|FG004|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
48350412|NCT03874234|101187804|FG005|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
48761135|NCT03995368|102202985|FG002|NOT COMPLETED|Overall Study||5||
48761136|NCT01752426|102202986|FG000|STARTED|Overall Study||30||
48761137|NCT01752426|102202986|FG000|COMPLETED|Overall Study||30||
48761138|NCT01752426|102202986|FG000|NOT COMPLETED|Overall Study||0||
48761139|NCT02864394|102202987|FG000|STARTED|Overall Study||213||
48761140|NCT02864394|102202988|FG001|STARTED|Overall Study||212||
48761141|NCT02864394|102202987|FG000|Treated|Overall Study||213||
48761142|NCT02864394|102202988|FG001|Treated|Overall Study||198||
48761143|NCT02864394|102202987|FG000|Received Second Course Pembrolizumab Treatment|Overall Study||10||
48761144|NCT02864394|102202988|FG001|Received Second Course Pembrolizumab Treatment|Overall Study||0||
48761145|NCT02864394|102202987|FG000|COMPLETED|Overall Study||0||
48761146|NCT02864394|102202988|FG001|COMPLETED|Overall Study||0||
48761147|NCT02864394|102202987|FG000|NOT COMPLETED|Overall Study||213||
48761148|NCT02864394|102202988|FG001|NOT COMPLETED|Overall Study||212||
48761149|NCT01280903|102202989|FG000|STARTED|Overall Study||91||
48761150|NCT01280903|102202990|FG001|STARTED|Overall Study||91||
48761151|NCT01280903|102202989|FG000|COMPLETED|Overall Study||68||
48761152|NCT01280903|102202990|FG001|COMPLETED|Overall Study||75||
48761153|NCT01280903|102202989|FG000|NOT COMPLETED|Overall Study||23||
48761154|NCT01280903|102202990|FG001|NOT COMPLETED|Overall Study||16||
48761155|NCT02946580|102202991|FG000|STARTED|Overall Study||28||
48761156|NCT02946580|102202992|FG001|STARTED|Overall Study||25||
48761157|NCT02946580|102202991|FG000|COMPLETED|Overall Study||27||
48761158|NCT02946580|102202992|FG001|COMPLETED|Overall Study||20||
48761159|NCT02946580|102202991|FG000|NOT COMPLETED|Overall Study||1||
48761160|NCT02946580|102202992|FG001|NOT COMPLETED|Overall Study||5||
48761161|NCT00072462|102202993|FG000|STARTED|Overall Study||1471||
48350413|NCT03874234|101187805|FG006|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
48350414|NCT03874234|101187806|FG007|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
48350415|NCT03874234|101187807|FG008|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
48350416|NCT03874234|101187808|FG009|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
48350417|NCT03874234|101187809|FG010|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
48350418|NCT03874234|101187810|FG011|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
48350419|NCT03874234|101187811|FG012|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
48350420|NCT03874234|101187799|FG000|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
48350421|NCT03874234|101187800|FG001|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
48350422|NCT03874234|101187801|FG002|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
48350423|NCT03874234|101187802|FG003|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
48350424|NCT03874234|101187803|FG004|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
48350425|NCT03874234|101187804|FG005|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
48350426|NCT03874234|101187805|FG006|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
48350427|NCT03874234|101187806|FG007|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
48350428|NCT03874234|101187807|FG008|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
48350429|NCT03874234|101187808|FG009|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
48350430|NCT03874234|101187809|FG010|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
48350431|NCT03874234|101187810|FG011|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
48350432|NCT03874234|101187811|FG012|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
48350433|NCT03874234|101187799|FG000|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48350434|NCT03874234|101187800|FG001|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48350435|NCT03874234|101187801|FG002|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48350436|NCT03874234|101187802|FG003|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48350437|NCT03874234|101187803|FG004|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48350438|NCT03874234|101187804|FG005|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48350439|NCT03874234|101187805|FG006|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48350440|NCT03874234|101187806|FG007|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48350441|NCT03874234|101187807|FG008|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48350442|NCT03874234|101187808|FG009|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48350443|NCT03874234|101187809|FG010|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48350444|NCT03874234|101187810|FG011|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48350445|NCT03874234|101187811|FG012|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48350446|NCT03874234|101187799|FG000|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48350447|NCT03874234|101187800|FG001|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48350448|NCT03874234|101187801|FG002|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48350449|NCT03874234|101187802|FG003|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48350450|NCT03874234|101187803|FG004|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48350451|NCT03874234|101187804|FG005|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48350452|NCT03874234|101187805|FG006|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48350453|NCT03874234|101187806|FG007|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48350454|NCT03874234|101187807|FG008|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48350455|NCT03874234|101187808|FG009|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48350456|NCT03874234|101187809|FG010|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48350457|NCT03874234|101187810|FG011|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48350458|NCT03874234|101187811|FG012|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48350459|NCT03874234|101187799|FG000|STARTED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350460|NCT03874234|101187800|FG001|STARTED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350461|NCT03874234|101187801|FG002|STARTED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350462|NCT03874234|101187802|FG003|STARTED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350463|NCT03874234|101187803|FG004|STARTED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350464|NCT03874234|101187804|FG005|STARTED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350465|NCT03874234|101187805|FG006|STARTED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350466|NCT03874234|101187806|FG007|STARTED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350467|NCT03874234|101187807|FG008|STARTED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350468|NCT03874234|101187808|FG009|STARTED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350469|NCT03874234|101187809|FG010|STARTED|Part A: Cohort 3- Period 1 (Day 1)||0||
48761162|NCT00072462|102202994|FG001|STARTED|Overall Study||1509||
48761163|NCT00072462|102202993|FG000|COMPLETED|Overall Study||1449||
48761164|NCT00072462|102202994|FG001|COMPLETED|Overall Study||1489||
48350470|NCT03874234|101187810|FG011|STARTED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350471|NCT03874234|101187811|FG012|STARTED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350472|NCT03874234|101187799|FG000|COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350473|NCT03874234|101187800|FG001|COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350474|NCT03874234|101187801|FG002|COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350475|NCT03874234|101187802|FG003|COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
48761165|NCT00072462|102202993|FG000|NOT COMPLETED|Overall Study||22||
48350476|NCT03874234|101187803|FG004|COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350477|NCT03874234|101187804|FG005|COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350478|NCT03874234|101187805|FG006|COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350479|NCT03874234|101187806|FG007|COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350480|NCT03874234|101187807|FG008|COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350481|NCT03874234|101187808|FG009|COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350482|NCT03874234|101187809|FG010|COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350483|NCT03874234|101187810|FG011|COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350484|NCT03874234|101187811|FG012|COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350485|NCT03874234|101187799|FG000|NOT COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350486|NCT03874234|101187800|FG001|NOT COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350487|NCT03874234|101187801|FG002|NOT COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350488|NCT03874234|101187802|FG003|NOT COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350489|NCT03874234|101187803|FG004|NOT COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350490|NCT03874234|101187804|FG005|NOT COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350491|NCT03874234|101187805|FG006|NOT COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350492|NCT03874234|101187806|FG007|NOT COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350493|NCT03874234|101187807|FG008|NOT COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350494|NCT03874234|101187808|FG009|NOT COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350495|NCT03874234|101187809|FG010|NOT COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350496|NCT03874234|101187810|FG011|NOT COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350497|NCT03874234|101187811|FG012|NOT COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
48350498|NCT03874234|101187799|FG000|STARTED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350499|NCT03874234|101187800|FG001|STARTED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350500|NCT03874234|101187801|FG002|STARTED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350501|NCT03874234|101187802|FG003|STARTED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350502|NCT03874234|101187803|FG004|STARTED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350503|NCT03874234|101187804|FG005|STARTED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350504|NCT03874234|101187805|FG006|STARTED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350505|NCT03874234|101187806|FG007|STARTED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350506|NCT03874234|101187807|FG008|STARTED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350507|NCT03874234|101187808|FG009|STARTED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350508|NCT03874234|101187809|FG010|STARTED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350509|NCT03874234|101187810|FG011|STARTED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350510|NCT03874234|101187811|FG012|STARTED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350511|NCT03874234|101187799|FG000|COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350512|NCT03874234|101187800|FG001|COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350513|NCT03874234|101187801|FG002|COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350514|NCT03874234|101187802|FG003|COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350515|NCT03874234|101187803|FG004|COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350516|NCT03874234|101187804|FG005|COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350517|NCT03874234|101187805|FG006|COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350518|NCT03874234|101187806|FG007|COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350519|NCT03874234|101187807|FG008|COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350520|NCT03874234|101187808|FG009|COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350521|NCT03874234|101187809|FG010|COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350522|NCT03874234|101187810|FG011|COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350523|NCT03874234|101187811|FG012|COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350524|NCT03874234|101187799|FG000|NOT COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350525|NCT03874234|101187800|FG001|NOT COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350526|NCT03874234|101187801|FG002|NOT COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350527|NCT03874234|101187802|FG003|NOT COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350528|NCT03874234|101187803|FG004|NOT COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350529|NCT03874234|101187804|FG005|NOT COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350530|NCT03874234|101187805|FG006|NOT COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350531|NCT03874234|101187806|FG007|NOT COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350532|NCT03874234|101187807|FG008|NOT COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350533|NCT03874234|101187808|FG009|NOT COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350534|NCT03874234|101187809|FG010|NOT COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350535|NCT03874234|101187810|FG011|NOT COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350536|NCT03874234|101187811|FG012|NOT COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
48350537|NCT03874234|101187799|FG000|STARTED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350538|NCT03874234|101187800|FG001|STARTED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350539|NCT03874234|101187801|FG002|STARTED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350540|NCT03874234|101187802|FG003|STARTED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350541|NCT03874234|101187803|FG004|STARTED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350542|NCT03874234|101187804|FG005|STARTED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350543|NCT03874234|101187805|FG006|STARTED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350544|NCT03874234|101187806|FG007|STARTED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350545|NCT03874234|101187807|FG008|STARTED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350546|NCT03874234|101187808|FG009|STARTED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350547|NCT03874234|101187809|FG010|STARTED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350548|NCT03874234|101187810|FG011|STARTED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350549|NCT03874234|101187811|FG012|STARTED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350550|NCT03874234|101187799|FG000|COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350551|NCT03874234|101187800|FG001|COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350552|NCT03874234|101187801|FG002|COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350553|NCT03874234|101187802|FG003|COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350554|NCT03874234|101187803|FG004|COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350555|NCT03874234|101187804|FG005|COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350556|NCT03874234|101187805|FG006|COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350557|NCT03874234|101187806|FG007|COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350558|NCT03874234|101187807|FG008|COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350559|NCT03874234|101187808|FG009|COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350560|NCT03874234|101187809|FG010|COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350561|NCT03874234|101187810|FG011|COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350562|NCT03874234|101187811|FG012|COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350563|NCT03874234|101187799|FG000|NOT COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350564|NCT03874234|101187800|FG001|NOT COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350565|NCT03874234|101187801|FG002|NOT COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350566|NCT03874234|101187802|FG003|NOT COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350567|NCT03874234|101187803|FG004|NOT COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350568|NCT03874234|101187804|FG005|NOT COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350569|NCT03874234|101187805|FG006|NOT COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350570|NCT03874234|101187806|FG007|NOT COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350571|NCT03874234|101187807|FG008|NOT COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350572|NCT03874234|101187808|FG009|NOT COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350573|NCT03874234|101187809|FG010|NOT COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350574|NCT03874234|101187810|FG011|NOT COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350575|NCT03874234|101187811|FG012|NOT COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
48350576|NCT03874234|101187799|FG000|STARTED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350577|NCT03874234|101187800|FG001|STARTED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350578|NCT03874234|101187801|FG002|STARTED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350579|NCT03874234|101187802|FG003|STARTED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350580|NCT03874234|101187803|FG004|STARTED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350581|NCT03874234|101187804|FG005|STARTED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350582|NCT03874234|101187805|FG006|STARTED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350583|NCT03874234|101187806|FG007|STARTED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350584|NCT03874234|101187807|FG008|STARTED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350585|NCT03874234|101187808|FG009|STARTED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350586|NCT03874234|101187809|FG010|STARTED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350587|NCT03874234|101187810|FG011|STARTED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350588|NCT03874234|101187811|FG012|STARTED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350589|NCT03874234|101187799|FG000|COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350590|NCT03874234|101187800|FG001|COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350591|NCT03874234|101187801|FG002|COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350592|NCT03874234|101187802|FG003|COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350593|NCT03874234|101187803|FG004|COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350594|NCT03874234|101187804|FG005|COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350595|NCT03874234|101187805|FG006|COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350596|NCT03874234|101187806|FG007|COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350597|NCT03874234|101187807|FG008|COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350598|NCT03874234|101187808|FG009|COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350599|NCT03874234|101187809|FG010|COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350600|NCT03874234|101187810|FG011|COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350601|NCT03874234|101187811|FG012|COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350602|NCT03874234|101187799|FG000|NOT COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350603|NCT03874234|101187800|FG001|NOT COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350604|NCT03874234|101187801|FG002|NOT COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350605|NCT03874234|101187802|FG003|NOT COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350606|NCT03874234|101187803|FG004|NOT COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350607|NCT03874234|101187804|FG005|NOT COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350608|NCT03874234|101187805|FG006|NOT COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350609|NCT03874234|101187806|FG007|NOT COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350610|NCT03874234|101187807|FG008|NOT COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350611|NCT03874234|101187808|FG009|NOT COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350612|NCT03874234|101187809|FG010|NOT COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350613|NCT03874234|101187810|FG011|NOT COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350614|NCT03874234|101187811|FG012|NOT COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
48350615|NCT02707770|101187812|FG000|STARTED|Overall Study||10||
48350616|NCT02707770|101187813|FG001|STARTED|Overall Study||10||
48350617|NCT02707770|101187812|FG000|COMPLETED|Overall Study||9||
48350618|NCT02707770|101187813|FG001|COMPLETED|Overall Study||10||
48350619|NCT02707770|101187812|FG000|NOT COMPLETED|Overall Study||1||
48350620|NCT02707770|101187813|FG001|NOT COMPLETED|Overall Study||0||
48350621|NCT03051633|101187814|FG000|STARTED|Overall Study||342||
48350622|NCT03051633|101187815|FG001|STARTED|Overall Study||186||
48350623|NCT03051633|101187814|FG000|COMPLETED|Overall Study||249||
48350624|NCT03051633|101187815|FG001|COMPLETED|Overall Study||179||
48350625|NCT03051633|101187814|FG000|NOT COMPLETED|Overall Study||93||
48350626|NCT03051633|101187815|FG001|NOT COMPLETED|Overall Study||7||
48350627|NCT00813995|101187816|FG000|STARTED|Overall Study||197||
48350628|NCT00813995|101187817|FG001|STARTED|Overall Study||198||
48350629|NCT00813995|101187816|FG000|COMPLETED|Overall Study||174||
48350630|NCT00813995|101187817|FG001|COMPLETED|Overall Study||182||
48350631|NCT00813995|101187816|FG000|NOT COMPLETED|Overall Study||23||
48350632|NCT00813995|101187817|FG001|NOT COMPLETED|Overall Study||16||
48350633|NCT03246074|101187818|FG000|STARTED|Overall Study||6||
48350634|NCT03246074|101187819|FG001|STARTED|Overall Study||3||
48350635|NCT03246074|101187820|FG002|STARTED|Overall Study||18||
48350636|NCT03246074|101187818|FG000|COMPLETED|Overall Study||6||
48350637|NCT03246074|101187819|FG001|COMPLETED|Overall Study||3||
48350638|NCT03246074|101187820|FG002|COMPLETED|Overall Study||18||
48350639|NCT03246074|101187818|FG000|NOT COMPLETED|Overall Study||0||
48350640|NCT03246074|101187819|FG001|NOT COMPLETED|Overall Study||0||
48350641|NCT03246074|101187820|FG002|NOT COMPLETED|Overall Study||0||
48350642|NCT05817045|101187821|FG000|STARTED|Overall Study||162||
48350643|NCT05817045|101187822|FG001|STARTED|Overall Study||168||
48350644|NCT05817045|101187821|FG000|COMPLETED|Overall Study||147||
48350645|NCT05817045|101187822|FG001|COMPLETED|Overall Study||157||
48350646|NCT05817045|101187821|FG000|NOT COMPLETED|Overall Study||15||
48350647|NCT05817045|101187822|FG001|NOT COMPLETED|Overall Study||11||
48350648|NCT00635102|101187823|FG000|STARTED|Overall Study||27||
48350649|NCT00635102|101187824|FG001|STARTED|Overall Study||30||
48350650|NCT00635102|101187823|FG000|COMPLETED|Overall Study||20||
48350651|NCT00635102|101187824|FG001|COMPLETED|Overall Study||22||
48350652|NCT00635102|101187823|FG000|NOT COMPLETED|Overall Study||7||
48350653|NCT00635102|101187824|FG001|NOT COMPLETED|Overall Study||8||
48350654|NCT00353977|101187825|FG000|STARTED|Overall Study||38||
48350655|NCT00353977|101187825|FG000|COMPLETED|Overall Study||38||
48350656|NCT00353977|101187825|FG000|NOT COMPLETED|Overall Study||0||
48350657|NCT00442598|101187826|FG000|STARTED|Overall Study||7||
48350658|NCT00442598|101187827|FG001|STARTED|Overall Study||10||
48350659|NCT00442598|101187828|FG002|STARTED|Overall Study||0||
48350660|NCT00442598|101187826|FG000|Two Cycles|Overall Study||5||
48350661|NCT00442598|101187827|FG001|Two Cycles|Overall Study||6||
48350662|NCT00442598|101187828|FG002|Two Cycles|Overall Study||0||
48350663|NCT00442598|101187826|FG000|COMPLETED|Overall Study||1||
48350664|NCT00442598|101187827|FG001|COMPLETED|Overall Study||2||
48350665|NCT00442598|101187828|FG002|COMPLETED|Overall Study||0||
48350666|NCT00442598|101187826|FG000|NOT COMPLETED|Overall Study||6||
48350667|NCT00442598|101187827|FG001|NOT COMPLETED|Overall Study||8||
48350668|NCT00442598|101187828|FG002|NOT COMPLETED|Overall Study||0||
48350669|NCT03596164|101187829|FG000|STARTED|Overall Study||4||
48350670|NCT03596164|101187830|FG001|STARTED|Overall Study||7||
48350671|NCT03596164|101187829|FG000|COMPLETED|Overall Study||3||
48350672|NCT03596164|101187830|FG001|COMPLETED|Overall Study||6||
48350673|NCT03596164|101187829|FG000|NOT COMPLETED|Overall Study||1||
48350674|NCT03596164|101187830|FG001|NOT COMPLETED|Overall Study||1||
48350675|NCT02318602|101187831|FG000|STARTED|Overall Study||9||
48350676|NCT02318602|101187832|FG001|STARTED|Overall Study||26||
48350677|NCT02318602|101187833|FG002|STARTED|Overall Study||17||
48350678|NCT02318602|101187831|FG000|COMPLETED|Overall Study||8||
48350679|NCT02318602|101187832|FG001|COMPLETED|Overall Study||22||
48350680|NCT02318602|101187833|FG002|COMPLETED|Overall Study||15||
48350681|NCT02318602|101187831|FG000|NOT COMPLETED|Overall Study||1||
48350682|NCT02318602|101187832|FG001|NOT COMPLETED|Overall Study||4||
48350683|NCT02318602|101187833|FG002|NOT COMPLETED|Overall Study||2||
48350684|NCT00813748|101187834|FG000|STARTED|Main Observational Study||30||
48350685|NCT00813748|101187835|FG001|STARTED|Main Observational Study||88||
48350686|NCT00813748|101187834|FG000|COMPLETED|Main Observational Study||30||
48350687|NCT00813748|101187835|FG001|COMPLETED|Main Observational Study||88||
48350688|NCT00813748|101187834|FG000|NOT COMPLETED|Main Observational Study||0||
48350689|NCT00813748|101187835|FG001|NOT COMPLETED|Main Observational Study||0||
48350690|NCT00813748|101187834|FG000|STARTED|Skin Test Substudy||3||
48350691|NCT00813748|101187835|FG001|STARTED|Skin Test Substudy||8||
48350692|NCT00813748|101187834|FG000|COMPLETED|Skin Test Substudy||3||
48350693|NCT00813748|101187835|FG001|COMPLETED|Skin Test Substudy||7||
48350694|NCT00813748|101187834|FG000|NOT COMPLETED|Skin Test Substudy||0||
48350695|NCT00813748|101187835|FG001|NOT COMPLETED|Skin Test Substudy||1||
48350696|NCT00817414|101187836|FG000|STARTED|Overall Study||12||
48350697|NCT00817414|101187837|FG001|STARTED|Overall Study||12||
48350698|NCT00817414|101187838|FG002|STARTED|Overall Study||13||
48350699|NCT00817414|101187839|FG003|STARTED|Overall Study||13||
48350700|NCT00817414|101187840|FG004|STARTED|Overall Study||13||
48350701|NCT00817414|101187836|FG000|COMPLETED|Overall Study||10||
48350702|NCT00817414|101187837|FG001|COMPLETED|Overall Study||9||
48350703|NCT00817414|101187838|FG002|COMPLETED|Overall Study||9||
48350704|NCT00817414|101187839|FG003|COMPLETED|Overall Study||1||
48350705|NCT00817414|101187840|FG004|COMPLETED|Overall Study||11||
48350706|NCT00817414|101187836|FG000|NOT COMPLETED|Overall Study||2||
48350707|NCT00817414|101187837|FG001|NOT COMPLETED|Overall Study||3||
48350708|NCT00817414|101187838|FG002|NOT COMPLETED|Overall Study||4||
48350709|NCT00817414|101187839|FG003|NOT COMPLETED|Overall Study||12||
48350710|NCT00817414|101187840|FG004|NOT COMPLETED|Overall Study||2||
48350711|NCT01819935|101187841|FG000|STARTED|Overall Study||328||
48350712|NCT01819935|101187842|FG001|STARTED|Overall Study||4943||
48350713|NCT01819935|101187841|FG000|COMPLETED|Overall Study||328||
48350714|NCT01819935|101187842|FG001|COMPLETED|Overall Study||4943||
48350715|NCT01819935|101187841|FG000|NOT COMPLETED|Overall Study||0||
48350716|NCT01819935|101187842|FG001|NOT COMPLETED|Overall Study||0||
48350717|NCT04513158|101187843|FG000|STARTED|Overall Study||2||
48350718|NCT04513158|101187843|FG000|COMPLETED|Overall Study||1||
48350719|NCT04513158|101187843|FG000|NOT COMPLETED|Overall Study||1||
48350720|NCT01389245|101187844|FG000|STARTED|Overall Study||42||110
48350721|NCT01389245|101187844|FG000|COMPLETED|Overall Study||27||66
48350722|NCT01389245|101187844|FG000|NOT COMPLETED|Overall Study||15||44
48350723|NCT03040024|101187845|FG000|STARTED|Overall Study||21||
48350724|NCT03040024|101187846|FG001|STARTED|Overall Study||26||
48350725|NCT03040024|101187847|FG002|STARTED|Overall Study||24||
48350726|NCT03040024|101187845|FG000|COMPLETED|Overall Study||21||
48350727|NCT03040024|101187846|FG001|COMPLETED|Overall Study||24||
48350728|NCT03040024|101187847|FG002|COMPLETED|Overall Study||23||
48350729|NCT03040024|101187845|FG000|NOT COMPLETED|Overall Study||0||
48350730|NCT03040024|101187846|FG001|NOT COMPLETED|Overall Study||2||
48350731|NCT03040024|101187847|FG002|NOT COMPLETED|Overall Study||1||
48350732|NCT01315574|101187848|FG000|STARTED|Overall Study||7||
48350733|NCT01315574|101187849|FG001|STARTED|Overall Study||7||
48350734|NCT01315574|101187848|FG000|COMPLETED|Overall Study||7||
48350735|NCT01315574|101187849|FG001|COMPLETED|Overall Study||7||
48350736|NCT01315574|101187848|FG000|NOT COMPLETED|Overall Study||0||
48350737|NCT01315574|101187849|FG001|NOT COMPLETED|Overall Study||0||
48350738|NCT00097539|101187850|FG000|STARTED|Overall Study||27286||
48350739|NCT00097539|101187851|FG001|STARTED|Overall Study||9356||
48350740|NCT00097539|101187852|FG002|STARTED|Overall Study||12519||
48350741|NCT00097539|101187853|FG003|STARTED|Overall Study||5651||
48350742|NCT00097539|101187854|FG004|STARTED|Overall Study||2144||
48350743|NCT00097539|101187855|FG005|STARTED|Overall Study||8010||
48350744|NCT00097539|101187856|FG006|STARTED|Overall Study||239||
48350745|NCT00097539|101187850|FG000|COMPLETED|Overall Study||8220||
48350746|NCT00097539|101187851|FG001|COMPLETED|Overall Study||2825||
48350747|NCT00097539|101187852|FG002|COMPLETED|Overall Study||3411||
48350748|NCT00097539|101187853|FG003|COMPLETED|Overall Study||2066||
48350749|NCT00097539|101187854|FG004|COMPLETED|Overall Study||386||
48350750|NCT00097539|101187855|FG005|COMPLETED|Overall Study||2118||
48350751|NCT00097539|101187856|FG006|COMPLETED|Overall Study||68||
48350752|NCT00097539|101187850|FG000|NOT COMPLETED|Overall Study||19066||
48350753|NCT00097539|101187851|FG001|NOT COMPLETED|Overall Study||6531||
48350754|NCT00097539|101187852|FG002|NOT COMPLETED|Overall Study||9108||
48350755|NCT00097539|101187853|FG003|NOT COMPLETED|Overall Study||3585||
48350756|NCT00097539|101187854|FG004|NOT COMPLETED|Overall Study||1758||
48350757|NCT00097539|101187855|FG005|NOT COMPLETED|Overall Study||5892||
48350758|NCT00097539|101187856|FG006|NOT COMPLETED|Overall Study||171||
48350759|NCT00462423|101187857|FG000|STARTED|Overall Study||50||
48350760|NCT00462423|101187857|FG000|COMPLETED|Overall Study||50||
48350761|NCT00462423|101187857|FG000|NOT COMPLETED|Overall Study||0||
48350762|NCT01903876|101187858|FG000|STARTED|Baseline to Post-Intervention Period||367||
48350763|NCT01903876|101187859|FG001|STARTED|Baseline to Post-Intervention Period||376||
48350764|NCT01903876|101187858|FG000|COMPLETED|Baseline to Post-Intervention Period||183||
48350765|NCT01903876|101187859|FG001|COMPLETED|Baseline to Post-Intervention Period||268||
48350766|NCT01903876|101187858|FG000|NOT COMPLETED|Baseline to Post-Intervention Period||184||
48350767|NCT01903876|101187859|FG001|NOT COMPLETED|Baseline to Post-Intervention Period||108||
48350768|NCT01903876|101187858|FG000|STARTED|Six-Month Follow-up Period||183||
48350769|NCT01903876|101187859|FG001|STARTED|Six-Month Follow-up Period||268||
48350770|NCT01903876|101187858|FG000|COMPLETED|Six-Month Follow-up Period||92||
48350771|NCT01903876|101187859|FG001|COMPLETED|Six-Month Follow-up Period||123||
48350772|NCT01903876|101187858|FG000|NOT COMPLETED|Six-Month Follow-up Period||91||
48350773|NCT01903876|101187859|FG001|NOT COMPLETED|Six-Month Follow-up Period||145||
48350774|NCT01667848|101187860|FG000|STARTED|Overall Study||67||
48350775|NCT01667848|101187861|FG001|STARTED|Overall Study||81||
48350776|NCT01667848|101187860|FG000|COMPLETED|Overall Study||67||
48350777|NCT01667848|101187861|FG001|COMPLETED|Overall Study||81||
48350778|NCT01667848|101187860|FG000|NOT COMPLETED|Overall Study||0||
48350779|NCT01667848|101187861|FG001|NOT COMPLETED|Overall Study||0||
48350780|NCT00960076|101187862|FG000|STARTED|Overall Study||138||
48350781|NCT00960076|101187863|FG001|STARTED|Overall Study||144||
48350782|NCT00960076|101187862|FG000|COMPLETED|Overall Study||130||
48350783|NCT00960076|101187863|FG001|COMPLETED|Overall Study||119||
48350784|NCT00960076|101187862|FG000|NOT COMPLETED|Overall Study||8||
48350785|NCT00960076|101187863|FG001|NOT COMPLETED|Overall Study||25||
48350786|NCT02589977|101187864|FG000|STARTED|Overall Study||23||
48350787|NCT02589977|101187865|FG001|STARTED|Overall Study||20||
48350788|NCT02589977|101187866|FG002|STARTED|Overall Study||12||
48350789|NCT02589977|101187864|FG000|COMPLETED|Overall Study||17||
48416663|NCT02059174|101353452|FG000|COMPLETED|Period 3||35||
48761166|NCT00072462|102202994|FG001|NOT COMPLETED|Overall Study||20||
48761167|NCT03804840|102202995|FG000|STARTED|Overall Study||24||
48761168|NCT03804840|102202996|FG001|STARTED|Overall Study||24||
48761169|NCT03804840|102202997|FG002|STARTED|Overall Study||24||
48761170|NCT03804840|102202995|FG000|COMPLETED|Overall Study||24||
48761171|NCT03804840|102202996|FG001|COMPLETED|Overall Study||24||
48761172|NCT03804840|102202997|FG002|COMPLETED|Overall Study||24||
48761173|NCT03804840|102202995|FG000|NOT COMPLETED|Overall Study||0||
48761174|NCT03804840|102202996|FG001|NOT COMPLETED|Overall Study||0||
48761175|NCT03804840|102202997|FG002|NOT COMPLETED|Overall Study||0||
48761176|NCT04905134|102202998|FG000|STARTED|Exam With Standard Nasopharyngoscope||53||
48761177|NCT04905134|102202998|FG000|COMPLETED|Exam With Standard Nasopharyngoscope||50||
48761178|NCT04905134|102202998|FG000|NOT COMPLETED|Exam With Standard Nasopharyngoscope||3||
48761179|NCT04905134|102202998|FG000|STARTED|Exam With Study Nasopharyngoscope||50||
48761180|NCT04905134|102202998|FG000|COMPLETED|Exam With Study Nasopharyngoscope||50||
48761181|NCT04905134|102202998|FG000|NOT COMPLETED|Exam With Study Nasopharyngoscope||0||
48761182|NCT03882021|102202999|FG000|STARTED|Consent||303||
48761183|NCT03882021|102202999|FG000|COMPLETED|Consent||303||
48761184|NCT03882021|102202999|FG000|NOT COMPLETED|Consent||0||
48761185|NCT03882021|102202999|FG000|STARTED|Enrollment||303||
48761186|NCT03882021|102202999|FG000|COMPLETED|Enrollment||300||
48761187|NCT03882021|102202999|FG000|NOT COMPLETED|Enrollment||3||
48761188|NCT03882021|102202999|FG000|STARTED|Enrollment to 3-Month||300||
48761189|NCT03882021|102202999|FG000|COMPLETED|Enrollment to 3-Month||291||
48761190|NCT03882021|102202999|FG000|NOT COMPLETED|Enrollment to 3-Month||9||
48761191|NCT03882021|102202999|FG000|STARTED|3-Month to 6-Month Visit||295||
48761192|NCT03882021|102202999|FG000|COMPLETED|3-Month to 6-Month Visit||294||
48761193|NCT03882021|102202999|FG000|NOT COMPLETED|3-Month to 6-Month Visit||1||
48761194|NCT03882021|102202999|FG000|STARTED|6-Month to 12-Month Visit||295||
48761195|NCT03882021|102202999|FG000|COMPLETED|6-Month to 12-Month Visit||287||
48761196|NCT03882021|102202999|FG000|NOT COMPLETED|6-Month to 12-Month Visit||8||
48761197|NCT03755934|102203000|FG000|STARTED|Overall Study||54||
48761198|NCT03755934|102203001|FG001|STARTED|Overall Study||6||
48761199|NCT03755934|102203002|FG002|STARTED|Overall Study||16||
48761200|NCT03755934|102203003|FG003|STARTED|Overall Study||36||
48761201|NCT03755934|102203000|FG000|Treated|Overall Study||54||
48761202|NCT03755934|102203001|FG001|Treated|Overall Study||4||
48761203|NCT03755934|102203002|FG002|Treated|Overall Study||14||
48761204|NCT03755934|102203003|FG003|Treated|Overall Study||35||
48761205|NCT03755934|102203000|FG000|COMPLETED|Overall Study||40||
48761206|NCT03755934|102203001|FG001|COMPLETED|Overall Study||4||
48761207|NCT03755934|102203002|FG002|COMPLETED|Overall Study||12||
48761208|NCT03755934|102203003|FG003|COMPLETED|Overall Study||30||
48761209|NCT03755934|102203000|FG000|NOT COMPLETED|Overall Study||14||
48761210|NCT03755934|102203001|FG001|NOT COMPLETED|Overall Study||2||
48350790|NCT02589977|101187865|FG001|COMPLETED|Overall Study||15||
48350791|NCT02589977|101187866|FG002|COMPLETED|Overall Study||8||
48350792|NCT02589977|101187864|FG000|NOT COMPLETED|Overall Study||6||
48350793|NCT02589977|101187865|FG001|NOT COMPLETED|Overall Study||5||
48350794|NCT02589977|101187866|FG002|NOT COMPLETED|Overall Study||4||
48350795|NCT04426630|101187867|FG000|STARTED|Overall Study||72||
48350796|NCT04426630|101187867|FG000|COMPLETED|Overall Study||66||
48350797|NCT04426630|101187867|FG000|NOT COMPLETED|Overall Study||6||
48350798|NCT00466505|101187868|FG000|STARTED|Overall Study||17||
48350799|NCT00466505|101187868|FG000|COMPLETED|Overall Study||0||
48350800|NCT00466505|101187868|FG000|NOT COMPLETED|Overall Study||17||
48350801|NCT03567187|101187869|FG000|STARTED|Overall Study||40||
48350802|NCT03567187|101187869|FG000|COMPLETED|Overall Study||22||
48350803|NCT03567187|101187869|FG000|NOT COMPLETED|Overall Study||18||
48350804|NCT01588821|101187870|FG000|STARTED|Overall Study||37||
48350805|NCT01588821|101187870|FG000|COMPLETED|Overall Study||37||
48350806|NCT01588821|101187870|FG000|NOT COMPLETED|Overall Study||0||
48350807|NCT03742427|101187871|FG000|STARTED|Overall Study||50||
48350808|NCT03742427|101187871|FG000|COMPLETED|Overall Study||50||
48350809|NCT03742427|101187871|FG000|NOT COMPLETED|Overall Study||0||
48350810|NCT01686568|101187872|FG000|STARTED|Main Study||16||
48350811|NCT01686568|101187873|FG001|STARTED|Main Study||15||
48350812|NCT01686568|101187872|FG000|COMPLETED|Main Study||14||
48350813|NCT01686568|101187873|FG001|COMPLETED|Main Study||11||
48350814|NCT01686568|101187872|FG000|NOT COMPLETED|Main Study||2||
48761211|NCT03755934|102203002|FG002|NOT COMPLETED|Overall Study||4||
48761212|NCT03755934|102203003|FG003|NOT COMPLETED|Overall Study||6||
48761213|NCT01652235|102203004|FG000|STARTED|Overall Study||28||
48761214|NCT01652235|102203004|FG000|COMPLETED|Overall Study||12||
48761215|NCT01652235|102203004|FG000|NOT COMPLETED|Overall Study||16||
48761216|NCT02484391|102203005|FG000|STARTED|Overall Study||21||
48761217|NCT02484391|102203006|FG001|STARTED|Overall Study||20||
48350815|NCT01686568|101187873|FG001|NOT COMPLETED|Main Study||4||
48350816|NCT01686568|101187872|FG000|STARTED|Sub-Study||14||
48350817|NCT01686568|101187873|FG001|STARTED|Sub-Study||11||
48350818|NCT01686568|101187872|FG000|COMPLETED|Sub-Study||12||
48350819|NCT01686568|101187873|FG001|COMPLETED|Sub-Study||9||
48350820|NCT01686568|101187872|FG000|NOT COMPLETED|Sub-Study||2||
48350821|NCT01686568|101187873|FG001|NOT COMPLETED|Sub-Study||2||
48350822|NCT03545282|101187874|FG000|STARTED|Overall Study||111||1
48350823|NCT03545282|101187875|FG001|STARTED|Overall Study||115||1
48350824|NCT03545282|101187874|FG000|Attended at Least One Session|Overall Study||103||1
48350825|NCT03545282|101187875|FG001|Attended at Least One Session|Overall Study||85||1
48350826|NCT03545282|101187874|FG000|Attended 50% of Sessions|Overall Study||88||1
48350827|NCT03545282|101187875|FG001|Attended 50% of Sessions|Overall Study||65||1
48350828|NCT03545282|101187874|FG000|Attended 75% of Intervention Sessions|Overall Study||56||1
48350829|NCT03545282|101187875|FG001|Attended 75% of Intervention Sessions|Overall Study||57||1
48350830|NCT03545282|101187874|FG000|Follow-up, 2 Months After Baseline|Overall Study||99||1
48350831|NCT03545282|101187875|FG001|Follow-up, 2 Months After Baseline|Overall Study||100||1
48350832|NCT03545282|101187874|FG000|Follow-up, 4 Months After Baseline|Overall Study||94||1
48350833|NCT03545282|101187875|FG001|Follow-up, 4 Months After Baseline|Overall Study||103||1
48350834|NCT03545282|101187874|FG000|COMPLETED|Overall Study||94||1
48350835|NCT03545282|101187875|FG001|COMPLETED|Overall Study||103||1
48350836|NCT03545282|101187874|FG000|NOT COMPLETED|Overall Study||17||0
48350837|NCT03545282|101187875|FG001|NOT COMPLETED|Overall Study||12||0
48350838|NCT05502289|101187876|FG000|STARTED|Period 1||35||
48350839|NCT05502289|101187877|FG001|STARTED|Period 1||31||
48350840|NCT05502289|101187876|FG000|COMPLETED|Period 1||34||
48350841|NCT05502289|101187877|FG001|COMPLETED|Period 1||31||
48350842|NCT05502289|101187876|FG000|NOT COMPLETED|Period 1||1||
48350843|NCT05502289|101187877|FG001|NOT COMPLETED|Period 1||0||
48350844|NCT05502289|101187876|FG000|STARTED|Period 2||34||
48350845|NCT05502289|101187877|FG001|STARTED|Period 2||31||
48350846|NCT05502289|101187876|FG000|COMPLETED|Period 2||34||
48350847|NCT05502289|101187877|FG001|COMPLETED|Period 2||31||
48638212|NCT02807259|101898711|FG000|STARTED|Midline (3 Months)||352||24
48638213|NCT02807259|101898712|FG001|STARTED|Midline (3 Months)||223||23
48638214|NCT02807259|101898711|FG000|COMPLETED|Midline (3 Months)||322||24
48638215|NCT02807259|101898712|FG001|COMPLETED|Midline (3 Months)||189||23
48638216|NCT02807259|101898711|FG000|NOT COMPLETED|Midline (3 Months)||30||0
48638217|NCT02807259|101898712|FG001|NOT COMPLETED|Midline (3 Months)||34||0
48638218|NCT02807259|101898711|FG000|STARTED|Endline (3 Months)||323||24
48638219|NCT02807259|101898712|FG001|STARTED|Endline (3 Months)||346||23
48638220|NCT02807259|101898711|FG000|COMPLETED|Endline (3 Months)||288||24
48638221|NCT02807259|101898712|FG001|COMPLETED|Endline (3 Months)||259||23
48350848|NCT05502289|101187876|FG000|NOT COMPLETED|Period 2||0||
48350849|NCT05502289|101187877|FG001|NOT COMPLETED|Period 2||0||
48350850|NCT04109599|101187878|FG000|STARTED|Overall Study||3||
48350851|NCT04109599|101187879|FG001|STARTED|Overall Study||4||
48350852|NCT04109599|101187880|FG002|STARTED|Overall Study||4||
48350853|NCT04109599|101187881|FG003|STARTED|Overall Study||4||
48350854|NCT04109599|101187882|FG004|STARTED|Overall Study||4||
48350855|NCT04109599|101187883|FG005|STARTED|Overall Study||4||
48350856|NCT04109599|101187884|FG006|STARTED|Overall Study||4||
48350857|NCT04109599|101187885|FG007|STARTED|Overall Study||3||
48350858|NCT04109599|101187886|FG008|STARTED|Overall Study||3||
48350859|NCT04109599|101187878|FG000|COMPLETED|Overall Study||3||
48350860|NCT04109599|101187879|FG001|COMPLETED|Overall Study||4||
48350861|NCT04109599|101187880|FG002|COMPLETED|Overall Study||4||
48350862|NCT04109599|101187881|FG003|COMPLETED|Overall Study||4||
48350863|NCT04109599|101187882|FG004|COMPLETED|Overall Study||4||
48350864|NCT04109599|101187883|FG005|COMPLETED|Overall Study||4||
48350865|NCT04109599|101187884|FG006|COMPLETED|Overall Study||4||
48350866|NCT04109599|101187885|FG007|COMPLETED|Overall Study||3||
48350867|NCT04109599|101187886|FG008|COMPLETED|Overall Study||3||
48350868|NCT04109599|101187878|FG000|NOT COMPLETED|Overall Study||0||
48350869|NCT04109599|101187879|FG001|NOT COMPLETED|Overall Study||0||
48350870|NCT04109599|101187880|FG002|NOT COMPLETED|Overall Study||0||
48350871|NCT04109599|101187881|FG003|NOT COMPLETED|Overall Study||0||
48350872|NCT04109599|101187882|FG004|NOT COMPLETED|Overall Study||0||
48350873|NCT04109599|101187883|FG005|NOT COMPLETED|Overall Study||0||
48350874|NCT04109599|101187884|FG006|NOT COMPLETED|Overall Study||0||
48350875|NCT04109599|101187885|FG007|NOT COMPLETED|Overall Study||0||
48350876|NCT04109599|101187886|FG008|NOT COMPLETED|Overall Study||0||
48350877|NCT02955329|101187887|FG000|STARTED|Tobacco Arm||8|Participants vaped tobacco leaves with nicotine out of the PAX device.|
48350878|NCT02955329|101187887|FG000|COMPLETED|Tobacco Arm||8||
48350879|NCT02955329|101187887|FG000|NOT COMPLETED|Tobacco Arm||0||
48350880|NCT02955329|101187887|FG000|STARTED|Cannabis Arm||8|Participants vaped marijuana leaves with Tetrahydrocannabinol (THC) out of the PAX device|
48350881|NCT02955329|101187887|FG000|COMPLETED|Cannabis Arm||8||
48350882|NCT02955329|101187887|FG000|NOT COMPLETED|Cannabis Arm||0||
48350883|NCT02955329|101187887|FG000|STARTED|Combined Cannabis and Tobacco Arm||8|Participants vaped flavorless 6% nicotine e-liquid, followed by THC out of the PAX device.|
48761218|NCT02484391|102203007|FG002|STARTED|Overall Study||7||
48761219|NCT02484391|102203005|FG000|Achieved Remission|Overall Study||9||
48761220|NCT02484391|102203006|FG001|Achieved Remission|Overall Study||7||
48761221|NCT02484391|102203007|FG002|Achieved Remission|Overall Study||5||
48761222|NCT02484391|102203005|FG000|Received Maintenance Therapy|Overall Study||0||
48761223|NCT02484391|102203006|FG001|Received Maintenance Therapy|Overall Study||0||
48350884|NCT02955329|101187887|FG000|COMPLETED|Combined Cannabis and Tobacco Arm||8||
48350885|NCT02955329|101187887|FG000|NOT COMPLETED|Combined Cannabis and Tobacco Arm||0||
48350886|NCT02649634|101187888|FG000|STARTED|Overall Study||69||
48350887|NCT02649634|101187889|FG001|STARTED|Overall Study||66||
48350888|NCT02649634|101187888|FG000|COMPLETED|Overall Study||66||
48350889|NCT02649634|101187889|FG001|COMPLETED|Overall Study||60||
48350890|NCT02649634|101187888|FG000|NOT COMPLETED|Overall Study||3||
48350891|NCT02649634|101187889|FG001|NOT COMPLETED|Overall Study||6||
48350892|NCT01355289|101187890|FG000|STARTED|Core Study||17||
48350893|NCT01355289|101187891|FG001|STARTED|Core Study||16||
48350894|NCT01355289|101187892|FG002|STARTED|Core Study||18||
48350895|NCT01355289|101187893|FG003|STARTED|Core Study||14||
48350896|NCT01355289|101187894|FG004|STARTED|Core Study||0||
48350897|NCT01355289|101187890|FG000|COMPLETED|Core Study||16||
48350898|NCT01355289|101187891|FG001|COMPLETED|Core Study||16||
48350899|NCT01355289|101187892|FG002|COMPLETED|Core Study||18||
48350900|NCT01355289|101187893|FG003|COMPLETED|Core Study||12||
48350901|NCT01355289|101187894|FG004|COMPLETED|Core Study||0||
48350902|NCT01355289|101187890|FG000|NOT COMPLETED|Core Study||1||
48350903|NCT01355289|101187891|FG001|NOT COMPLETED|Core Study||0||
48350904|NCT01355289|101187892|FG002|NOT COMPLETED|Core Study||0||
48350905|NCT01355289|101187893|FG003|NOT COMPLETED|Core Study||2||
48350906|NCT01355289|101187894|FG004|NOT COMPLETED|Core Study||0||
48350907|NCT01355289|101187890|FG000|STARTED|Open Label Extension||0||
48350908|NCT01355289|101187891|FG001|STARTED|Open Label Extension||0||
48350909|NCT01355289|101187892|FG002|STARTED|Open Label Extension||0||
48350910|NCT01355289|101187893|FG003|STARTED|Open Label Extension||0||
48350911|NCT01355289|101187894|FG004|STARTED|Open Label Extension||62||
48350912|NCT01355289|101187890|FG000|COMPLETED|Open Label Extension||0||
48350913|NCT01355289|101187891|FG001|COMPLETED|Open Label Extension||0||
48350914|NCT01355289|101187892|FG002|COMPLETED|Open Label Extension||0||
48350915|NCT01355289|101187893|FG003|COMPLETED|Open Label Extension||0||
48350916|NCT01355289|101187894|FG004|COMPLETED|Open Label Extension||28||
48350917|NCT01355289|101187890|FG000|NOT COMPLETED|Open Label Extension||0||
48761224|NCT02484391|102203007|FG002|Received Maintenance Therapy|Overall Study||2||
48761225|NCT02484391|102203005|FG000|COMPLETED|Overall Study||0||
48761226|NCT02484391|102203006|FG001|COMPLETED|Overall Study||0||
48761227|NCT02484391|102203007|FG002|COMPLETED|Overall Study||0||
48761228|NCT02484391|102203005|FG000|NOT COMPLETED|Overall Study||21||
48761229|NCT02484391|102203006|FG001|NOT COMPLETED|Overall Study||20||
48761230|NCT02484391|102203007|FG002|NOT COMPLETED|Overall Study||7||
48761231|NCT00412984|102203008|FG000|STARTED|Overall Study||9120||
48350918|NCT01355289|101187891|FG001|NOT COMPLETED|Open Label Extension||0||
48416664|NCT02059174|101353453|FG001|COMPLETED|Period 3||35||
48416665|NCT02059174|101353452|FG000|NOT COMPLETED|Period 3||1||
48416666|NCT02059174|101353453|FG001|NOT COMPLETED|Period 3||0||
48761232|NCT00412984|102203009|FG001|STARTED|Overall Study||9081||
48761233|NCT00412984|102203008|FG000|COMPLETED|Overall Study||6810||
48761234|NCT00412984|102203009|FG001|COMPLETED|Overall Study||6588||
48761235|NCT00412984|102203008|FG000|NOT COMPLETED|Overall Study||2310||
48761236|NCT00412984|102203009|FG001|NOT COMPLETED|Overall Study||2493||
48761237|NCT04019379|102203010|FG000|STARTED|Overall Study||1||
48761238|NCT04019379|102203011|FG001|STARTED|Overall Study||2||
48761239|NCT04019379|102203010|FG000|COMPLETED|Overall Study||1||
48761240|NCT04019379|102203011|FG001|COMPLETED|Overall Study||2||
48761241|NCT04019379|102203010|FG000|NOT COMPLETED|Overall Study||0||
48761242|NCT04019379|102203011|FG001|NOT COMPLETED|Overall Study||0||
48761243|NCT01210313|102203012|FG000|STARTED|Overall Study||30||
48761244|NCT01210313|102203012|FG000|COMPLETED|Overall Study||14||
48761245|NCT01210313|102203012|FG000|NOT COMPLETED|Overall Study||16||
48350919|NCT01355289|101187892|FG002|NOT COMPLETED|Open Label Extension||0||
48416667|NCT02059174|101353452|FG000|STARTED|Period 4||35||
48761246|NCT03173560|102203013|FG000|STARTED|Overall Study||172||
48416668|NCT02059174|101353453|FG001|STARTED|Period 4||35||
48416669|NCT02059174|101353452|FG000|COMPLETED|Period 4||35||
48416670|NCT02059174|101353453|FG001|COMPLETED|Period 4||35||
48761247|NCT03173560|102203014|FG001|STARTED|Overall Study||171||
48761248|NCT03173560|102203013|FG000|Treated Participants|Overall Study||172||
48761249|NCT03173560|102203014|FG001|Treated Participants|Overall Study||169||
48767764|NCT04004988|102222819|FG001|NOT COMPLETED|Period 2||0||
48767765|NCT02237417|102222820|FG000|STARTED|Overall Study||16||
48767766|NCT02237417|102222821|FG001|STARTED|Overall Study||15||
48350920|NCT01355289|101187893|FG003|NOT COMPLETED|Open Label Extension||0||
48350921|NCT01355289|101187894|FG004|NOT COMPLETED|Open Label Extension||34||
48350922|NCT05127486|101187895|FG000|STARTED|Overall Study||287||
48350923|NCT05127486|101187896|FG001|STARTED|Overall Study||293||
48350924|NCT05127486|101187895|FG000|Received at Least 1 Dose of the Study Drug|Overall Study||287||
48416671|NCT02059174|101353452|FG000|NOT COMPLETED|Period 4||0||
48761250|NCT03173560|102203013|FG000|Safety Set|Overall Study||173|One participant was randomized to lenvatinib 18 mg arm but received lenvatinib 14 mg as the starting dose and therefore was included in lenvatinib 14 mg arm in safety population.|
48761251|NCT03173560|102203014|FG001|Safety Set|Overall Study||168|One participant was randomized to lenvatinib 18 mg arm but received lenvatinib 14 mg as the starting dose and therefore was included in lenvatinib 14 mg arm in safety population.|
48761252|NCT03173560|102203013|FG000|COMPLETED|Overall Study||67||
48761253|NCT03173560|102203014|FG001|COMPLETED|Overall Study||54||
48761254|NCT03173560|102203013|FG000|NOT COMPLETED|Overall Study||105||
48761255|NCT03173560|102203014|FG001|NOT COMPLETED|Overall Study||117||
48761256|NCT05543265|102203015|FG000|STARTED|Overall Study||176||
48350925|NCT05127486|101187896|FG001|Received at Least 1 Dose of the Study Drug|Overall Study||293||
48350926|NCT05127486|101187895|FG000|COMPLETED|Overall Study||261||
48350927|NCT05127486|101187896|FG001|COMPLETED|Overall Study||266||
48350928|NCT05127486|101187895|FG000|NOT COMPLETED|Overall Study||26||
48350929|NCT05127486|101187896|FG001|NOT COMPLETED|Overall Study||27||
48350930|NCT04333966|101187897|FG000|STARTED|Overall Study||100|Overall number of participants who started the study by arm (parents and teens combined)|
48350931|NCT04333966|101187898|FG001|STARTED|Overall Study||102|Overall number of participants who started the study by arm (parents and teens combined)|
48350932|NCT04333966|101187897|FG000|Parents Started|Overall Study||50|Parents who started the study by arm.|
48350933|NCT04333966|101187898|FG001|Parents Started|Overall Study||51|Parents who started the study by arm.|
48350934|NCT04333966|101187897|FG000|Teens Who Started|Overall Study||50|Teens who started the study by arm|
48350935|NCT04333966|101187898|FG001|Teens Who Started|Overall Study||51|Teens who started the study by arm|
48350936|NCT04333966|101187897|FG000|Teen Completed|Overall Study||41|Teens who completed 6-month follow-up.|
48350937|NCT04333966|101187898|FG001|Teen Completed|Overall Study||42|Teens who completed 6-month follow-up.|
48350938|NCT04333966|101187897|FG000|Parent Completed|Overall Study||48|Parents who completed 6 month follow-up|
48350939|NCT04333966|101187898|FG001|Parent Completed|Overall Study||47|Parents who completed 6 month follow-up|
48350940|NCT04333966|101187897|FG000|COMPLETED|Overall Study||90|Overall number of participants who completed the study (6-month follow-up) by arm (parents and teens combined)|
48350941|NCT04333966|101187898|FG001|COMPLETED|Overall Study||89|Overall number of participants who completed the study (6-month follow-up) by arm (parents and teens combined)|
48350942|NCT04333966|101187897|FG000|NOT COMPLETED|Overall Study||10||
48350943|NCT04333966|101187898|FG001|NOT COMPLETED|Overall Study||13||
48350944|NCT04178590|101187899|FG000|STARTED|Overall Study||32|"split mouth - both treatment modalities were conducted in all patients"|64
48350945|NCT04178590|101187899|FG000|COMPLETED|Overall Study||30||60
48350946|NCT04178590|101187899|FG000|NOT COMPLETED|Overall Study||2||4
48350947|NCT04101890|101187900|FG000|STARTED|Routine Diaper Care||5||
48350948|NCT04101890|101187900|FG000|COMPLETED|Routine Diaper Care||5||
48350949|NCT04101890|101187900|FG000|NOT COMPLETED|Routine Diaper Care||0||
48350950|NCT04101890|101187900|FG000|STARTED|Diaper Care With Theraworx||5||
48350951|NCT04101890|101187900|FG000|COMPLETED|Diaper Care With Theraworx||5||
48350952|NCT04101890|101187900|FG000|NOT COMPLETED|Diaper Care With Theraworx||0||
48350953|NCT00397150|101187901|FG000|STARTED|Overall Study||1323||
48350954|NCT00397150|101187902|FG001|STARTED|Overall Study||1256||
48350955|NCT00397150|101187901|FG000|COMPLETED|Overall Study||1188||
48350956|NCT00397150|101187902|FG001|COMPLETED|Overall Study||1111||
48350957|NCT00397150|101187901|FG000|NOT COMPLETED|Overall Study||135||
48350958|NCT00397150|101187902|FG001|NOT COMPLETED|Overall Study||145||
48350959|NCT01009294|101187903|FG000|STARTED|Overall Study||6||
48350960|NCT01009294|101187903|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
48350961|NCT01009294|101187903|FG000|COMPLETED|Overall Study||0||
48350962|NCT01009294|101187903|FG000|NOT COMPLETED|Overall Study||6||
48350963|NCT00900796|101187904|FG000|STARTED|Phase 1||132||
48350964|NCT00900796|101187904|FG000|COMPLETED|Phase 1||121||
48350965|NCT00900796|101187904|FG000|NOT COMPLETED|Phase 1||11||
48350966|NCT00900796|101187904|FG000|STARTED|Between Phase 1 and Phase 2||121||
48350967|NCT00900796|101187904|FG000|COMPLETED|Between Phase 1 and Phase 2||11||
48350968|NCT00900796|101187904|FG000|NOT COMPLETED|Between Phase 1 and Phase 2||110||
48350969|NCT00900796|101187904|FG000|STARTED|Phase 2||11||
48350970|NCT00900796|101187904|FG000|COMPLETED|Phase 2||6||
48350971|NCT00900796|101187904|FG000|NOT COMPLETED|Phase 2||5||
48350972|NCT03643692|101187905|FG000|STARTED|Overall Study||12||
48350973|NCT03643692|101187905|FG000|COMPLETED|Overall Study||12||
48350974|NCT03643692|101187905|FG000|NOT COMPLETED|Overall Study||0||
48350975|NCT03293680|101187906|FG000|STARTED|Overall Study||83||
48761257|NCT05543265|102203016|FG001|STARTED|Overall Study||184||
48761258|NCT05543265|102203015|FG000|COMPLETED|Overall Study||173||
48761259|NCT05543265|102203016|FG001|COMPLETED|Overall Study||180||
48761260|NCT05543265|102203015|FG000|NOT COMPLETED|Overall Study||3||
48350976|NCT03293680|101187906|FG000|COMPLETED|Overall Study||74||
48761261|NCT05543265|102203016|FG001|NOT COMPLETED|Overall Study||4||
48761262|NCT05058365|102203017|FG000|STARTED|Overall Study||9||
48761263|NCT05058365|102203018|FG001|STARTED|Overall Study||9||
48761264|NCT05058365|102203017|FG000|COMPLETED|Overall Study||8||
48761265|NCT05058365|102203018|FG001|COMPLETED|Overall Study||8||
48761266|NCT05058365|102203017|FG000|NOT COMPLETED|Overall Study||1||
48761267|NCT05058365|102203018|FG001|NOT COMPLETED|Overall Study||1||
48761268|NCT03043794|102203019|FG000|STARTED|Overall Study||4||
48350977|NCT03293680|101187906|FG000|NOT COMPLETED|Overall Study||9||
48350978|NCT02360098|101187907|FG000|STARTED|Overall Study||36||
48350979|NCT02360098|101187907|FG000|COMPLETED|Overall Study||29||
48350980|NCT02360098|101187907|FG000|NOT COMPLETED|Overall Study||7||
48350981|NCT00826748|101187908|FG000|STARTED|Overall Study||6||
48350982|NCT00826748|101187909|FG001|STARTED|Overall Study||4||
48350983|NCT00826748|101187910|FG002|STARTED|Overall Study||12||
48350984|NCT00826748|101187908|FG000|COMPLETED|Overall Study||6||
48350985|NCT00826748|101187909|FG001|COMPLETED|Overall Study||4||
48350986|NCT00826748|101187910|FG002|COMPLETED|Overall Study||8||
48350987|NCT00826748|101187908|FG000|NOT COMPLETED|Overall Study||0||
48350988|NCT00826748|101187909|FG001|NOT COMPLETED|Overall Study||0||
48350989|NCT00826748|101187910|FG002|NOT COMPLETED|Overall Study||4||
48350990|NCT03370757|101187911|FG000|STARTED|Overall Study||20||
48350991|NCT03370757|101187912|FG001|STARTED|Overall Study||28||
48350992|NCT03370757|101187911|FG000|COMPLETED|Overall Study||20||
48350993|NCT03370757|101187912|FG001|COMPLETED|Overall Study||26||
48350994|NCT03370757|101187911|FG000|NOT COMPLETED|Overall Study||0||
48350995|NCT03370757|101187912|FG001|NOT COMPLETED|Overall Study||2||
48350996|NCT00749606|101187913|FG000|STARTED|Year 1||129||
48350997|NCT00749606|101187914|FG001|STARTED|Year 1||128||
48350998|NCT00749606|101187913|FG000|COMPLETED|Year 1||74||
48350999|NCT00749606|101187914|FG001|COMPLETED|Year 1||80||
48351000|NCT00749606|101187913|FG000|NOT COMPLETED|Year 1||55||
48351001|NCT00749606|101187914|FG001|NOT COMPLETED|Year 1||48||
48351002|NCT00749606|101187913|FG000|STARTED|Year 2||74||
48351003|NCT00749606|101187914|FG001|STARTED|Year 2||80||
48351004|NCT00749606|101187913|FG000|COMPLETED|Year 2||63||
48351005|NCT00749606|101187914|FG001|COMPLETED|Year 2||72||
48351006|NCT00749606|101187913|FG000|NOT COMPLETED|Year 2||11||
48351007|NCT00749606|101187914|FG001|NOT COMPLETED|Year 2||8||
48351008|NCT00749606|101187913|FG000|STARTED|Year 3 (Observation)||63||
48351009|NCT00749606|101187914|FG001|STARTED|Year 3 (Observation)||72||
48351010|NCT00749606|101187913|FG000|COMPLETED|Year 3 (Observation)||63||
48351011|NCT00749606|101187914|FG001|COMPLETED|Year 3 (Observation)||69||
48351012|NCT00749606|101187913|FG000|NOT COMPLETED|Year 3 (Observation)||0||
48351013|NCT00749606|101187914|FG001|NOT COMPLETED|Year 3 (Observation)||3||
48351014|NCT04246554|101187915|FG000|STARTED|Overall Study||26||
48351015|NCT04246554|101187916|FG001|STARTED|Overall Study||23||
48351016|NCT04246554|101187915|FG000|COMPLETED|Overall Study||26||
48351017|NCT04246554|101187916|FG001|COMPLETED|Overall Study||22||
48351018|NCT04246554|101187915|FG000|NOT COMPLETED|Overall Study||0||
48351019|NCT04246554|101187916|FG001|NOT COMPLETED|Overall Study||1||
48351020|NCT02582515|101187917|FG000|STARTED|Overall Study||9||
48351021|NCT02582515|101187918|FG001|STARTED|Overall Study||11||
48761269|NCT03043794|102203019|FG000|COMPLETED|Overall Study||3||
48761270|NCT03043794|102203019|FG000|NOT COMPLETED|Overall Study||1||
48761271|NCT05194969|102203020|FG000|STARTED|Overall Study||39||
48761272|NCT05194969|102203021|FG001|STARTED|Overall Study||35||
48761273|NCT05194969|102203020|FG000|COMPLETED|Overall Study||27||
48761274|NCT05194969|102203021|FG001|COMPLETED|Overall Study||26||
48351022|NCT02582515|101187917|FG000|Received Study Intervention|Overall Study||9||
48351023|NCT02582515|101187918|FG001|Received Study Intervention|Overall Study||10||
48351024|NCT02582515|101187917|FG000|COMPLETED|Overall Study||9||
48351025|NCT02582515|101187918|FG001|COMPLETED|Overall Study||10||
48351026|NCT02582515|101187917|FG000|NOT COMPLETED|Overall Study||0||
48351027|NCT02582515|101187918|FG001|NOT COMPLETED|Overall Study||1||
48351028|NCT00200057|101187919|FG000|STARTED|Overall Study||120||
48351029|NCT00200057|101187919|FG000|1 Month Follow-up|Overall Study||117||
48351030|NCT00200057|101187919|FG000|3 Month Follow-up|Overall Study||116||
48351031|NCT00200057|101187919|FG000|6 Month Follow-up|Overall Study||114||
48351032|NCT00200057|101187919|FG000|12 Month Follow-up|Overall Study||111||
48351033|NCT00200057|101187919|FG000|COMPLETED|Overall Study||111||
48351034|NCT00200057|101187919|FG000|NOT COMPLETED|Overall Study||9||
48351035|NCT01871506|101187920|FG000|STARTED|Overall Study||150||
48351036|NCT01871506|101187921|FG001|STARTED|Overall Study||153||
48351037|NCT01871506|101187920|FG000|COMPLETED|Overall Study||150||
48416672|NCT02059174|101353453|FG001|NOT COMPLETED|Period 4||0||
48638222|NCT02807259|101898711|FG000|NOT COMPLETED|Endline (3 Months)||35||0
48638223|NCT02807259|101898712|FG001|NOT COMPLETED|Endline (3 Months)||87||0
48638224|NCT03149770|101898713|FG000|STARTED|Overall Study||16||
48638225|NCT03149770|101898714|FG001|STARTED|Overall Study||14||
48638226|NCT03149770|101898713|FG000|COMPLETED|Overall Study||14||
48638227|NCT03149770|101898714|FG001|COMPLETED|Overall Study||14||
48638228|NCT03149770|101898713|FG000|NOT COMPLETED|Overall Study||2||
48638229|NCT03149770|101898714|FG001|NOT COMPLETED|Overall Study||0||
48638230|NCT02635035|101898715|FG000|STARTED|Overall Study||17||
48638231|NCT02635035|101898716|FG001|STARTED|Overall Study||21||
48351038|NCT01871506|101187921|FG001|COMPLETED|Overall Study||153||
48351039|NCT01871506|101187920|FG000|NOT COMPLETED|Overall Study||0||
48351040|NCT01871506|101187921|FG001|NOT COMPLETED|Overall Study||0||
48351041|NCT02148029|101187922|FG000|STARTED|Overall Study||48|Randomized and completed baseline visit|
48351042|NCT02148029|101187923|FG001|STARTED|Overall Study||54|Randomized and completed baseline visit|
48416673|NCT00928642|101353454|FG000|STARTED|Overall Study||8||
48638232|NCT02635035|101898715|FG000|COMPLETED|Overall Study||17||
48761275|NCT05194969|102203020|FG000|NOT COMPLETED|Overall Study||12||
48761276|NCT05194969|102203021|FG001|NOT COMPLETED|Overall Study||9||
48761277|NCT03848325|102203022|FG000|STARTED|Overall Study||20||
48351043|NCT02148029|101187922|FG000|COMPLETED|Overall Study||36|Came in for 2-year follow-up visit|
48351044|NCT02148029|101187923|FG001|COMPLETED|Overall Study||31|Came in for 2-year follow-up visit|
48351045|NCT02148029|101187922|FG000|NOT COMPLETED|Overall Study||12||
48351046|NCT02148029|101187923|FG001|NOT COMPLETED|Overall Study||23||
48351047|NCT00049127|101187924|FG000|STARTED|Overall Study||12||
48351048|NCT00049127|101187925|FG001|STARTED|Overall Study||0||
48351049|NCT00049127|101187926|FG002|STARTED|Overall Study||40||
48351050|NCT00049127|101187927|FG003|STARTED|Overall Study||0||
48351051|NCT00049127|101187928|FG004|STARTED|Overall Study||12||
48351052|NCT00049127|101187924|FG000|COMPLETED|Overall Study||12||
48351053|NCT00049127|101187925|FG001|COMPLETED|Overall Study||0||
48351054|NCT00049127|101187926|FG002|COMPLETED|Overall Study||39||
48351055|NCT00049127|101187927|FG003|COMPLETED|Overall Study||0||
48351056|NCT00049127|101187928|FG004|COMPLETED|Overall Study||12||
48351057|NCT00049127|101187924|FG000|NOT COMPLETED|Overall Study||0||
48351058|NCT00049127|101187925|FG001|NOT COMPLETED|Overall Study||0||
48351059|NCT00049127|101187926|FG002|NOT COMPLETED|Overall Study||1||
48351060|NCT00049127|101187927|FG003|NOT COMPLETED|Overall Study||0||
48351061|NCT00049127|101187928|FG004|NOT COMPLETED|Overall Study||0||
48351062|NCT01719757|101187929|FG000|STARTED|Overall Study||359||
48351063|NCT01719757|101187929|FG000|COMPLETED|Overall Study||258||
48351064|NCT01719757|101187929|FG000|NOT COMPLETED|Overall Study||101||
48351065|NCT01021007|101187930|FG000|STARTED|Overall Study||36||
48351066|NCT01021007|101187931|FG001|STARTED|Overall Study||37||
48351067|NCT01021007|101187930|FG000|COMPLETED|Overall Study||34||
48351068|NCT01021007|101187931|FG001|COMPLETED|Overall Study||33||
48351069|NCT01021007|101187930|FG000|NOT COMPLETED|Overall Study||2||
48351070|NCT01021007|101187931|FG001|NOT COMPLETED|Overall Study||4||
48351071|NCT02081963|101187932|FG000|STARTED|Overall Study||79||
48351072|NCT02081963|101187933|FG001|STARTED|Overall Study||73||
48351073|NCT02081963|101187932|FG000|COMPLETED|Overall Study||74||
48351074|NCT02081963|101187933|FG001|COMPLETED|Overall Study||69||
48351075|NCT02081963|101187932|FG000|NOT COMPLETED|Overall Study||5||
48351076|NCT02081963|101187933|FG001|NOT COMPLETED|Overall Study||4||
48351077|NCT04486560|101187934|FG000|STARTED|Overall Study||51||
48351078|NCT04486560|101187934|FG000|COMPLETED|Overall Study||50||
48351079|NCT04486560|101187934|FG000|NOT COMPLETED|Overall Study||1||
48351080|NCT03075839|101187935|FG000|STARTED|Overall Study||33||
48351081|NCT03075839|101187935|FG000|COMPLETED|Overall Study||29||
48351082|NCT03075839|101187935|FG000|NOT COMPLETED|Overall Study||4||
48351083|NCT01051739|101187936|FG000|STARTED|Overall Study||120||
48351084|NCT01051739|101187937|FG001|STARTED|Overall Study||60||
48351085|NCT01051739|101187936|FG000|COMPLETED|Overall Study||92||
48351086|NCT01051739|101187937|FG001|COMPLETED|Overall Study||47||
48351087|NCT01051739|101187936|FG000|NOT COMPLETED|Overall Study||28||
48351088|NCT01051739|101187937|FG001|NOT COMPLETED|Overall Study||13||
48351089|NCT00407355|101187938|FG000|STARTED|Overall Study||20||
48351090|NCT00407355|101187939|FG001|STARTED|Overall Study||20||
48351091|NCT00407355|101187938|FG000|COMPLETED|Overall Study||10||
48351092|NCT00407355|101187939|FG001|COMPLETED|Overall Study||9||
48351093|NCT00407355|101187938|FG000|NOT COMPLETED|Overall Study||10||
48351094|NCT00407355|101187939|FG001|NOT COMPLETED|Overall Study||11||
48351095|NCT01748227|101187940|FG000|STARTED|Overall Study||20||
48351096|NCT01748227|101187940|FG000|COMPLETED|Overall Study||17||
48351097|NCT01748227|101187940|FG000|NOT COMPLETED|Overall Study||3||
48351098|NCT02432807|101187941|FG000|STARTED|Overall Study||152||
48351099|NCT02432807|101187942|FG001|STARTED|Overall Study||151||
48351100|NCT02432807|101187941|FG000|COMPLETED|Overall Study||149||
48351101|NCT02432807|101187942|FG001|COMPLETED|Overall Study||147||
48761278|NCT03848325|102203022|FG000|COMPLETED|Overall Study||20||
48761279|NCT03848325|102203022|FG000|NOT COMPLETED|Overall Study||0||
48761280|NCT00734149|102203023|FG000|STARTED|Overall Study||45||
48761281|NCT00734149|102203023|FG000|COMPLETED|Overall Study||44||
48761282|NCT00734149|102203023|FG000|NOT COMPLETED|Overall Study||1||
48761283|NCT04179175|102203024|FG000|STARTED|Overall Study||136||
48761284|NCT04179175|102203025|FG001|STARTED|Overall Study||71||
48761285|NCT04179175|102203026|FG002|STARTED|Overall Study||121||
48761286|NCT04179175|102203027|FG003|STARTED|Overall Study||63||
48761287|NCT04179175|102203028|FG004|STARTED|Overall Study||151||
48761288|NCT04179175|102203029|FG005|STARTED|Overall Study||157||
48351102|NCT02432807|101187941|FG000|NOT COMPLETED|Overall Study||3||
48351103|NCT02432807|101187942|FG001|NOT COMPLETED|Overall Study||4||
48351104|NCT00283387|101187943|FG000|STARTED|First Intervention||6||
48351105|NCT00283387|101187944|FG001|STARTED|First Intervention||7||
48351106|NCT00283387|101187943|FG000|COMPLETED|First Intervention||5||
48351107|NCT00283387|101187944|FG001|COMPLETED|First Intervention||5||
48351108|NCT00283387|101187943|FG000|NOT COMPLETED|First Intervention||1||
48351109|NCT00283387|101187944|FG001|NOT COMPLETED|First Intervention||2||
48351110|NCT00283387|101187943|FG000|STARTED|Washout Period of 2 Months||5||
48351111|NCT00283387|101187944|FG001|STARTED|Washout Period of 2 Months||5||
48351112|NCT00283387|101187943|FG000|COMPLETED|Washout Period of 2 Months||5||
48351113|NCT00283387|101187944|FG001|COMPLETED|Washout Period of 2 Months||5||
48351114|NCT00283387|101187943|FG000|NOT COMPLETED|Washout Period of 2 Months||0||
48351115|NCT00283387|101187944|FG001|NOT COMPLETED|Washout Period of 2 Months||0||
48351116|NCT00283387|101187943|FG000|STARTED|Second Intervention||5||
48351117|NCT00283387|101187944|FG001|STARTED|Second Intervention||5||
48351118|NCT00283387|101187943|FG000|COMPLETED|Second Intervention||5||
48351119|NCT00283387|101187944|FG001|COMPLETED|Second Intervention||5||
48351120|NCT00283387|101187943|FG000|NOT COMPLETED|Second Intervention||0||
48351121|NCT00283387|101187944|FG001|NOT COMPLETED|Second Intervention||0||
48351122|NCT02499952|101187945|FG000|STARTED|Overall Study||12||
48351123|NCT02499952|101187945|FG000|COMPLETED|Overall Study||2||
48351124|NCT02499952|101187945|FG000|NOT COMPLETED|Overall Study||10||
48351125|NCT03198221|101187946|FG000|STARTED|Overall Study||3||
48351126|NCT03198221|101187947|FG001|STARTED|Overall Study||2||
48351127|NCT03198221|101187948|FG002|STARTED|Overall Study||7||
48351128|NCT03198221|101187949|FG003|STARTED|Overall Study||2||
48351129|NCT03198221|101187946|FG000|COMPLETED|Overall Study||3||
48351130|NCT03198221|101187947|FG001|COMPLETED|Overall Study||2||
48351131|NCT03198221|101187948|FG002|COMPLETED|Overall Study||7||
48351132|NCT03198221|101187949|FG003|COMPLETED|Overall Study||2||
48351133|NCT03198221|101187946|FG000|NOT COMPLETED|Overall Study||0||
48351134|NCT03198221|101187947|FG001|NOT COMPLETED|Overall Study||0||
48351135|NCT03198221|101187948|FG002|NOT COMPLETED|Overall Study||0||
48351136|NCT03198221|101187949|FG003|NOT COMPLETED|Overall Study||0||
48351137|NCT01028352|101187950|FG000|STARTED|Overall Study||35||
48351138|NCT01028352|101187950|FG000|COMPLETED|Overall Study||29||
48351139|NCT01028352|101187950|FG000|NOT COMPLETED|Overall Study||6||
48351140|NCT02300129|101187951|FG000|STARTED|Period 1 Session 1 (Day 1)||11||
48351141|NCT02300129|101187952|FG001|STARTED|Period 1 Session 1 (Day 1)||5||
48351142|NCT02300129|101187953|FG002|STARTED|Period 1 Session 1 (Day 1)||7||
48351143|NCT02300129|101187954|FG003|STARTED|Period 1 Session 1 (Day 1)||11||
48351144|NCT02300129|101187951|FG000|COMPLETED|Period 1 Session 1 (Day 1)||11||
48351145|NCT02300129|101187952|FG001|COMPLETED|Period 1 Session 1 (Day 1)||5||
48351146|NCT02300129|101187953|FG002|COMPLETED|Period 1 Session 1 (Day 1)||7||
48351147|NCT02300129|101187954|FG003|COMPLETED|Period 1 Session 1 (Day 1)||11||
48351148|NCT02300129|101187951|FG000|NOT COMPLETED|Period 1 Session 1 (Day 1)||0||
48351149|NCT02300129|101187952|FG001|NOT COMPLETED|Period 1 Session 1 (Day 1)||0||
48351150|NCT02300129|101187953|FG002|NOT COMPLETED|Period 1 Session 1 (Day 1)||0||
48351151|NCT02300129|101187954|FG003|NOT COMPLETED|Period 1 Session 1 (Day 1)||0||
48351152|NCT02300129|101187951|FG000|STARTED|Period 1 Session 2 (Day 3)||11||
48351153|NCT02300129|101187952|FG001|STARTED|Period 1 Session 2 (Day 3)||5||
48351154|NCT02300129|101187953|FG002|STARTED|Period 1 Session 2 (Day 3)||7||
48351155|NCT02300129|101187954|FG003|STARTED|Period 1 Session 2 (Day 3)||11||
48351156|NCT02300129|101187951|FG000|COMPLETED|Period 1 Session 2 (Day 3)||11||
48351157|NCT02300129|101187952|FG001|COMPLETED|Period 1 Session 2 (Day 3)||4||
48351158|NCT02300129|101187953|FG002|COMPLETED|Period 1 Session 2 (Day 3)||7||
48351159|NCT02300129|101187954|FG003|COMPLETED|Period 1 Session 2 (Day 3)||11||
48351160|NCT02300129|101187951|FG000|NOT COMPLETED|Period 1 Session 2 (Day 3)||0||
48351161|NCT02300129|101187952|FG001|NOT COMPLETED|Period 1 Session 2 (Day 3)||1||
48351162|NCT02300129|101187953|FG002|NOT COMPLETED|Period 1 Session 2 (Day 3)||0||
48351163|NCT02300129|101187954|FG003|NOT COMPLETED|Period 1 Session 2 (Day 3)||0||
48351164|NCT02300129|101187951|FG000|STARTED|Period 1 Session 3 (Day 5)||11||
48351165|NCT02300129|101187952|FG001|STARTED|Period 1 Session 3 (Day 5)||4||
48351166|NCT02300129|101187953|FG002|STARTED|Period 1 Session 3 (Day 5)||7||
48351167|NCT02300129|101187954|FG003|STARTED|Period 1 Session 3 (Day 5)||11||
48351168|NCT02300129|101187951|FG000|COMPLETED|Period 1 Session 3 (Day 5)||11||
48351169|NCT02300129|101187952|FG001|COMPLETED|Period 1 Session 3 (Day 5)||4||
48351170|NCT02300129|101187953|FG002|COMPLETED|Period 1 Session 3 (Day 5)||7||
48351171|NCT02300129|101187954|FG003|COMPLETED|Period 1 Session 3 (Day 5)||11||
48351172|NCT02300129|101187951|FG000|NOT COMPLETED|Period 1 Session 3 (Day 5)||0||
48351173|NCT02300129|101187952|FG001|NOT COMPLETED|Period 1 Session 3 (Day 5)||0||
48351174|NCT02300129|101187953|FG002|NOT COMPLETED|Period 1 Session 3 (Day 5)||0||
48351175|NCT02300129|101187954|FG003|NOT COMPLETED|Period 1 Session 3 (Day 5)||0||
48351176|NCT02300129|101187951|FG000|STARTED|Period 2 Treatment 1 (2 Weeks)||11||
48351177|NCT02300129|101187952|FG001|STARTED|Period 2 Treatment 1 (2 Weeks)||4||
48351178|NCT02300129|101187953|FG002|STARTED|Period 2 Treatment 1 (2 Weeks)||7||
48351179|NCT02300129|101187954|FG003|STARTED|Period 2 Treatment 1 (2 Weeks)||11||
48351180|NCT02300129|101187951|FG000|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10||
48351181|NCT02300129|101187952|FG001|COMPLETED|Period 2 Treatment 1 (2 Weeks)||4||
48351182|NCT02300129|101187953|FG002|COMPLETED|Period 2 Treatment 1 (2 Weeks)||7||
48351183|NCT02300129|101187954|FG003|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10||
48351184|NCT02300129|101187951|FG000|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1||
48351185|NCT02300129|101187952|FG001|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0||
48351186|NCT02300129|101187953|FG002|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0||
48351187|NCT02300129|101187954|FG003|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1||
48351188|NCT02300129|101187951|FG000|STARTED|Period 2 Treatment 2 (2 Weeks)||10||
48351189|NCT02300129|101187952|FG001|STARTED|Period 2 Treatment 2 (2 Weeks)||4||
48351190|NCT02300129|101187953|FG002|STARTED|Period 2 Treatment 2 (2 Weeks)||7||
48351191|NCT02300129|101187954|FG003|STARTED|Period 2 Treatment 2 (2 Weeks)||10||
48351192|NCT02300129|101187951|FG000|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10||
48351193|NCT02300129|101187952|FG001|COMPLETED|Period 2 Treatment 2 (2 Weeks)||4||
48351194|NCT02300129|101187953|FG002|COMPLETED|Period 2 Treatment 2 (2 Weeks)||7||
48351195|NCT02300129|101187954|FG003|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10||
48351196|NCT02300129|101187951|FG000|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0||
48351197|NCT02300129|101187952|FG001|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0||
48351198|NCT02300129|101187953|FG002|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0||
48351199|NCT02300129|101187954|FG003|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0||
48351200|NCT02966314|101187955|FG000|STARTED|Overall Study||5||
48351201|NCT02966314|101187956|FG001|STARTED|Overall Study||5||
48351202|NCT02966314|101187955|FG000|COMPLETED|Overall Study||4||
48351203|NCT02966314|101187956|FG001|COMPLETED|Overall Study||5||
48351204|NCT02966314|101187955|FG000|NOT COMPLETED|Overall Study||1||
48351205|NCT02966314|101187956|FG001|NOT COMPLETED|Overall Study||0||
48351206|NCT04340050|101187957|FG000|STARTED|Overall Study||10||
48351207|NCT04340050|101187957|FG000|COMPLETED|Overall Study||10||
48351208|NCT04340050|101187957|FG000|NOT COMPLETED|Overall Study||0||
48351209|NCT05089708|101187958|FG000|STARTED|Overall Study||60||
48351210|NCT05089708|101187959|FG001|STARTED|Overall Study||63||
48351211|NCT05089708|101187958|FG000|COMPLETED|Overall Study||45||
48351212|NCT05089708|101187959|FG001|COMPLETED|Overall Study||53||
48351213|NCT05089708|101187958|FG000|NOT COMPLETED|Overall Study||15||
48351214|NCT05089708|101187959|FG001|NOT COMPLETED|Overall Study||10||
48351215|NCT04785612|101187960|FG000|STARTED|Overall Study||35||
48351216|NCT04785612|101187961|FG001|STARTED|Overall Study||35||
48351217|NCT04785612|101187960|FG000|COMPLETED|Overall Study||31||
48351218|NCT04785612|101187961|FG001|COMPLETED|Overall Study||31||
48351219|NCT04785612|101187960|FG000|NOT COMPLETED|Overall Study||4||
48351220|NCT04785612|101187961|FG001|NOT COMPLETED|Overall Study||4||
48351221|NCT01295125|101187962|FG000|STARTED|Overall Study||9||
48351222|NCT01295125|101187962|FG000|COMPLETED|Overall Study||0||
48351223|NCT01295125|101187962|FG000|NOT COMPLETED|Overall Study||9||
48351224|NCT04800315|101187963|FG000|STARTED|Randomization||55||
48351225|NCT04800315|101187964|FG001|STARTED|Randomization||55||
48351226|NCT04800315|101187965|FG002|STARTED|Randomization||55||
48351227|NCT04800315|101187966|FG003|STARTED|Randomization||56||
48351228|NCT04800315|101187963|FG000|COMPLETED|Randomization||54|Completed = All randomized participants who recieved at least one dose of study treatment.|
48351229|NCT04800315|101187964|FG001|COMPLETED|Randomization||55|Completed = All randomized participants who recieved at least one dose of study treatment.|
48351230|NCT04800315|101187965|FG002|COMPLETED|Randomization||55|Completed = All randomized participants who recieved at least one dose of study treatment.|
48351231|NCT04800315|101187966|FG003|COMPLETED|Randomization||56|Completed = All randomized participants who recieved at least one dose of study treatment.|
48351232|NCT04800315|101187963|FG000|NOT COMPLETED|Randomization||1||
48351233|NCT04800315|101187964|FG001|NOT COMPLETED|Randomization||0||
48351234|NCT04800315|101187965|FG002|NOT COMPLETED|Randomization||0||
48351235|NCT04800315|101187966|FG003|NOT COMPLETED|Randomization||0||
48351236|NCT04800315|101187963|FG000|STARTED|Treatment Period||54||
48351237|NCT04800315|101187964|FG001|STARTED|Treatment Period||55||
48351238|NCT04800315|101187965|FG002|STARTED|Treatment Period||55||
48351239|NCT04800315|101187966|FG003|STARTED|Treatment Period||56||
48351240|NCT04800315|101187963|FG000|COMPLETED|Treatment Period||49||
48351241|NCT04800315|101187964|FG001|COMPLETED|Treatment Period||50||
48351242|NCT04800315|101187965|FG002|COMPLETED|Treatment Period||52||
48351243|NCT04800315|101187966|FG003|COMPLETED|Treatment Period||44||
48351244|NCT04800315|101187963|FG000|NOT COMPLETED|Treatment Period||5||
48351245|NCT04800315|101187964|FG001|NOT COMPLETED|Treatment Period||5||
48351246|NCT04800315|101187965|FG002|NOT COMPLETED|Treatment Period||3||
48351247|NCT04800315|101187966|FG003|NOT COMPLETED|Treatment Period||12||
48351248|NCT04091217|101187967|FG000|STARTED|Overall Study||43|Intention-to-treat Population, all enrolled|
48351249|NCT04091217|101187967|FG000|Stage I Analysis Population|Overall Study||22||
48351250|NCT04091217|101187967|FG000|Stage II Analysis Population|Overall Study||38||
48351251|NCT04091217|101187967|FG000|COMPLETED|Overall Study||41||
48351252|NCT04091217|101187967|FG000|NOT COMPLETED|Overall Study||2||
48351253|NCT00162773|101187968|FG000|STARTED|Overall Study||29||
48351254|NCT00162773|101187968|FG000|COMPLETED|Overall Study||7||
48351255|NCT00162773|101187968|FG000|NOT COMPLETED|Overall Study||22||
48351256|NCT02698410|101187969|FG000|STARTED|Overall Study||40||
48351257|NCT02698410|101187969|FG000|COMPLETED|Overall Study||36||
48351258|NCT02698410|101187969|FG000|NOT COMPLETED|Overall Study||4||
48351259|NCT04927312|101187970|FG000|STARTED|Overall Study||60||
48351260|NCT04927312|101187970|FG000|COMPLETED|Overall Study||56||
48416674|NCT00928642|101353454|FG000|COMPLETED|Overall Study||8||
48351261|NCT04927312|101187970|FG000|NOT COMPLETED|Overall Study||4||
48351262|NCT03577990|101187971|FG000|STARTED|Overall Study||45||
48351263|NCT03577990|101187972|FG001|STARTED|Overall Study||45||
48351264|NCT03577990|101187971|FG000|Month 1-3|Overall Study||42||
48351265|NCT03577990|101187972|FG001|Month 1-3|Overall Study||41||
48351266|NCT03577990|101187971|FG000|Month 4-6|Overall Study||41||
48351267|NCT03577990|101187972|FG001|Month 4-6|Overall Study||39||
48351268|NCT03577990|101187971|FG000|Month 7-9|Overall Study||38||
48351269|NCT03577990|101187972|FG001|Month 7-9|Overall Study||34||
48351270|NCT03577990|101187971|FG000|COMPLETED|Overall Study||37||
48351271|NCT03577990|101187972|FG001|COMPLETED|Overall Study||32||
48351272|NCT03577990|101187971|FG000|NOT COMPLETED|Overall Study||8||
48351273|NCT03577990|101187972|FG001|NOT COMPLETED|Overall Study||13||
48351274|NCT02209506|101187973|FG000|STARTED|Overall Study||3||
48351275|NCT02209506|101187974|FG001|STARTED|Overall Study||6||
48351276|NCT02209506|101187975|FG002|STARTED|Overall Study||6||
48351277|NCT02209506|101187976|FG003|STARTED|Overall Study||2||
48351278|NCT02209506|101187977|FG004|STARTED|Overall Study||6||
48351279|NCT02209506|101187973|FG000|COMPLETED|Overall Study||3||
48351280|NCT02209506|101187974|FG001|COMPLETED|Overall Study||6||
48351281|NCT02209506|101187975|FG002|COMPLETED|Overall Study||6||
48351282|NCT02209506|101187976|FG003|COMPLETED|Overall Study||2||
48351283|NCT02209506|101187977|FG004|COMPLETED|Overall Study||5||
48351284|NCT02209506|101187973|FG000|NOT COMPLETED|Overall Study||0||
48351285|NCT02209506|101187974|FG001|NOT COMPLETED|Overall Study||0||
48351286|NCT02209506|101187975|FG002|NOT COMPLETED|Overall Study||0||
48351287|NCT02209506|101187976|FG003|NOT COMPLETED|Overall Study||0||
48351288|NCT02209506|101187977|FG004|NOT COMPLETED|Overall Study||1||
48351289|NCT00391599|101187978|FG000|STARTED|Overall Study||65||
48351290|NCT00391599|101187979|FG001|STARTED|Overall Study||65||
48351291|NCT00391599|101187978|FG000|COMPLETED|Overall Study||65||
48351292|NCT00391599|101187979|FG001|COMPLETED|Overall Study||65||
48351293|NCT00391599|101187978|FG000|NOT COMPLETED|Overall Study||0||
48351294|NCT00391599|101187979|FG001|NOT COMPLETED|Overall Study||0||
48351295|NCT05745662|101187980|FG000|STARTED|Overall Study||11||
48351296|NCT05745662|101187980|FG000|COMPLETED|Overall Study||11||
48351297|NCT05745662|101187980|FG000|NOT COMPLETED|Overall Study||0||
48351298|NCT00961532|101187981|FG000|STARTED|Overall Study||14||
48351299|NCT00961532|101187981|FG000|COMPLETED|Overall Study||14||
48351300|NCT00961532|101187981|FG000|NOT COMPLETED|Overall Study||0||
48351301|NCT02379858|101187982|FG000|STARTED|Overall Study||6||
48351302|NCT02379858|101187983|FG001|STARTED|Overall Study||4||
48351303|NCT02379858|101187982|FG000|COMPLETED|Overall Study||6||
48351304|NCT02379858|101187983|FG001|COMPLETED|Overall Study||4||
48351305|NCT02379858|101187982|FG000|NOT COMPLETED|Overall Study||0||
48351306|NCT02379858|101187983|FG001|NOT COMPLETED|Overall Study||0||
48351307|NCT01053312|101187984|FG000|STARTED|Overall Study||7||
48351308|NCT01053312|101187984|FG000|COMPLETED|Overall Study||7||
48351309|NCT01053312|101187984|FG000|NOT COMPLETED|Overall Study||0||
48351310|NCT00476086|101187985|FG000|STARTED|Overall Study||20||
48351311|NCT00476086|101187985|FG000|Received Chemotherapy|Overall Study||19||
48351312|NCT00476086|101187985|FG000|Received Radiation|Overall Study||15||
48351313|NCT00476086|101187985|FG000|COMPLETED|Overall Study||15||
48351314|NCT00476086|101187985|FG000|NOT COMPLETED|Overall Study||5||
48351315|NCT01682044|101187986|FG000|STARTED|Overall Study||20||
48351316|NCT01682044|101187986|FG000|COMPLETED|Overall Study||16||
48351317|NCT01682044|101187986|FG000|NOT COMPLETED|Overall Study||4||
48351318|NCT02494141|101187987|FG000|STARTED|Overall Study||34||
48351319|NCT02494141|101187988|FG001|STARTED|Overall Study||34||
48351320|NCT02494141|101187987|FG000|COMPLETED|Overall Study||28||
48351321|NCT02494141|101187988|FG001|COMPLETED|Overall Study||29||
48351322|NCT02494141|101187987|FG000|NOT COMPLETED|Overall Study||6||
48351323|NCT02494141|101187988|FG001|NOT COMPLETED|Overall Study||5||
48351324|NCT05139030|101187989|FG000|STARTED|Overall Study||85||
48351325|NCT05139030|101187990|FG001|STARTED|Overall Study||82||
48351326|NCT05139030|101187989|FG000|COMPLETED|Overall Study||84||
48351327|NCT05139030|101187990|FG001|COMPLETED|Overall Study||77||
48351328|NCT05139030|101187989|FG000|NOT COMPLETED|Overall Study||1||
48351329|NCT05139030|101187990|FG001|NOT COMPLETED|Overall Study||5||
48351330|NCT02228499|101187991|FG000|STARTED|Overall Study||30||
48351331|NCT02228499|101187992|FG001|STARTED|Overall Study||36||
48351332|NCT02228499|101187991|FG000|COMPLETED|Overall Study||7||
48351333|NCT02228499|101187992|FG001|COMPLETED|Overall Study||10||
48351334|NCT02228499|101187991|FG000|NOT COMPLETED|Overall Study||23||
48351335|NCT02228499|101187992|FG001|NOT COMPLETED|Overall Study||26||
48351336|NCT02830165|101187993|FG000|STARTED|Overall Study||11||
48351337|NCT02830165|101187993|FG000|COMPLETED|Overall Study||11||
48351338|NCT02830165|101187993|FG000|NOT COMPLETED|Overall Study||0||
48351339|NCT01973283|101187994|FG000|STARTED|Overall Study||100||
48351340|NCT01973283|101187994|FG000|COMPLETED|Overall Study||96||
48351341|NCT01973283|101187994|FG000|NOT COMPLETED|Overall Study||4||
48351342|NCT01931865|101187995|FG000|STARTED|Overall Study||12||
48351343|NCT01931865|101187995|FG000|COMPLETED|Overall Study||8||
48351344|NCT01931865|101187995|FG000|NOT COMPLETED|Overall Study||4||
48351345|NCT02561156|101187996|FG000|STARTED|Part 1||12||
48351346|NCT02561156|101187997|FG001|STARTED|Part 1||6||
48351347|NCT02561156|101187998|FG002|STARTED|Part 1||6||
48351348|NCT02561156|101187999|FG003|STARTED|Part 1||6||
48351349|NCT02561156|101188000|FG004|STARTED|Part 1||6||
48351350|NCT02561156|101188001|FG005|STARTED|Part 1||6||
48351351|NCT02561156|101188002|FG006|STARTED|Part 1||6||
48351352|NCT02561156|101188003|FG007|STARTED|Part 1||0||
48351353|NCT02561156|101188004|FG008|STARTED|Part 1||0||
48351354|NCT02561156|101188005|FG009|STARTED|Part 1||0||
48351355|NCT02561156|101188006|FG010|STARTED|Part 1||0||
48351356|NCT02561156|101188007|FG011|STARTED|Part 1||0||
48351357|NCT02561156|101188008|FG012|STARTED|Part 1||0||
48351358|NCT02561156|101187996|FG000|COMPLETED|Part 1||12||
48351359|NCT02561156|101187997|FG001|COMPLETED|Part 1||6||
48351360|NCT02561156|101187998|FG002|COMPLETED|Part 1||6||
48351361|NCT02561156|101187999|FG003|COMPLETED|Part 1||6||
48351362|NCT02561156|101188000|FG004|COMPLETED|Part 1||6||
48351363|NCT02561156|101188001|FG005|COMPLETED|Part 1||6||
48351364|NCT02561156|101188002|FG006|COMPLETED|Part 1||6||
48351365|NCT02561156|101188003|FG007|COMPLETED|Part 1||0||
48351366|NCT02561156|101188004|FG008|COMPLETED|Part 1||0||
48351367|NCT02561156|101188005|FG009|COMPLETED|Part 1||0||
48351368|NCT02561156|101188006|FG010|COMPLETED|Part 1||0||
48761289|NCT04179175|102203024|FG000|Full Analysis Set of HiSCR Responders (FAS-R)|Overall Study||136|All HiSCR responders to whom study treatment was assigned at randomization. Subjects were analyzed according to the treatment assigned to at randomization.|
48761290|NCT04179175|102203025|FG001|Full Analysis Set of HiSCR Responders (FAS-R)|Overall Study||71|All HiSCR responders to whom study treatment was assigned at randomization. Subjects were analyzed according to the treatment assigned to at randomization.|
48761291|NCT04179175|102203026|FG002|Full Analysis Set of HiSCR Responders (FAS-R)|Overall Study||121|All HiSCR responders to whom study treatment was assigned at randomization. Subjects were analyzed according to the treatment assigned to at randomization.|
48761292|NCT04179175|102203027|FG003|Full Analysis Set of HiSCR Responders (FAS-R)|Overall Study||63|All HiSCR responders to whom study treatment was assigned at randomization. Subjects were analyzed according to the treatment assigned to at randomization.|
48761293|NCT04179175|102203028|FG004|Full Analysis Set of HiSCR Responders (FAS-R)|Overall Study||0|All HiSCR responders to whom study treatment was assigned at randomization. Subjects were analyzed according to the treatment assigned to at randomization.|
48761294|NCT04179175|102203029|FG005|Full Analysis Set of HiSCR Responders (FAS-R)|Overall Study||0|All HiSCR responders to whom study treatment was assigned at randomization. Subjects were analyzed according to the treatment assigned to at randomization.|
48761295|NCT04179175|102203024|FG000|Full Analysis Set of HiSCR Non-responders (FAS-NR)|Overall Study||0|All HiSCR non-responders to whom study treatment was assigned.|
48351369|NCT02561156|101188007|FG011|COMPLETED|Part 1||0||
48351370|NCT02561156|101188008|FG012|COMPLETED|Part 1||0||
48351371|NCT02561156|101187996|FG000|NOT COMPLETED|Part 1||0||
48351372|NCT02561156|101187997|FG001|NOT COMPLETED|Part 1||0||
48351373|NCT02561156|101187998|FG002|NOT COMPLETED|Part 1||0||
48351374|NCT02561156|101187999|FG003|NOT COMPLETED|Part 1||0||
48351375|NCT02561156|101188000|FG004|NOT COMPLETED|Part 1||0||
48351376|NCT02561156|101188001|FG005|NOT COMPLETED|Part 1||0||
48351377|NCT02561156|101188002|FG006|NOT COMPLETED|Part 1||0||
48351378|NCT02561156|101188003|FG007|NOT COMPLETED|Part 1||0||
48351379|NCT02561156|101188004|FG008|NOT COMPLETED|Part 1||0||
48351380|NCT02561156|101188005|FG009|NOT COMPLETED|Part 1||0||
48351381|NCT02561156|101188006|FG010|NOT COMPLETED|Part 1||0||
48351382|NCT02561156|101188007|FG011|NOT COMPLETED|Part 1||0||
48351383|NCT02561156|101188008|FG012|NOT COMPLETED|Part 1||0||
48351384|NCT02561156|101187996|FG000|STARTED|Part 2||0||
48351385|NCT02561156|101187997|FG001|STARTED|Part 2||0||
48351386|NCT02561156|101187998|FG002|STARTED|Part 2||0||
48351387|NCT02561156|101187999|FG003|STARTED|Part 2||0||
48351388|NCT02561156|101188000|FG004|STARTED|Part 2||0||
48351389|NCT02561156|101188001|FG005|STARTED|Part 2||0||
48351390|NCT02561156|101188002|FG006|STARTED|Part 2||0||
48351391|NCT02561156|101188003|FG007|STARTED|Part 2||10||
48351392|NCT02561156|101188004|FG008|STARTED|Part 2||6||
48351393|NCT02561156|101188005|FG009|STARTED|Part 2||6||
48761296|NCT04179175|102203025|FG001|Full Analysis Set of HiSCR Non-responders (FAS-NR)|Overall Study||0|All HiSCR non-responders to whom study treatment was assigned.|
48767767|NCT02237417|102222822|FG002|STARTED|Overall Study||16||
48351394|NCT02561156|101188006|FG010|STARTED|Part 2||6||
48351395|NCT02561156|101188007|FG011|STARTED|Part 2||6||
48351396|NCT02561156|101188008|FG012|STARTED|Part 2||6||
48351397|NCT02561156|101187996|FG000|COMPLETED|Part 2||0||
48351398|NCT02561156|101187997|FG001|COMPLETED|Part 2||0||
48351399|NCT02561156|101187998|FG002|COMPLETED|Part 2||0||
48351400|NCT02561156|101187999|FG003|COMPLETED|Part 2||0||
48351401|NCT02561156|101188000|FG004|COMPLETED|Part 2||0||
48351402|NCT02561156|101188001|FG005|COMPLETED|Part 2||0||
48351403|NCT02561156|101188002|FG006|COMPLETED|Part 2||0||
48351404|NCT02561156|101188003|FG007|COMPLETED|Part 2||10||
48351405|NCT02561156|101188004|FG008|COMPLETED|Part 2||6||
48351406|NCT02561156|101188005|FG009|COMPLETED|Part 2||6||
48351407|NCT02561156|101188006|FG010|COMPLETED|Part 2||6||
48351408|NCT02561156|101188007|FG011|COMPLETED|Part 2||5||
48351409|NCT02561156|101188008|FG012|COMPLETED|Part 2||6||
48416675|NCT00928642|101353454|FG000|NOT COMPLETED|Overall Study||0||
48351410|NCT02561156|101187996|FG000|NOT COMPLETED|Part 2||0||
48351411|NCT02561156|101187997|FG001|NOT COMPLETED|Part 2||0||
48351412|NCT02561156|101187998|FG002|NOT COMPLETED|Part 2||0||
48416676|NCT04465240|101353455|FG000|STARTED|Overall Study||50||
48351413|NCT02561156|101187999|FG003|NOT COMPLETED|Part 2||0||
48351414|NCT02561156|101188000|FG004|NOT COMPLETED|Part 2||0||
48351415|NCT02561156|101188001|FG005|NOT COMPLETED|Part 2||0||
48351416|NCT02561156|101188002|FG006|NOT COMPLETED|Part 2||0||
48351417|NCT02561156|101188003|FG007|NOT COMPLETED|Part 2||0||
48351418|NCT02561156|101188004|FG008|NOT COMPLETED|Part 2||0||
48351419|NCT02561156|101188005|FG009|NOT COMPLETED|Part 2||0||
48351420|NCT02561156|101188006|FG010|NOT COMPLETED|Part 2||0||
48761297|NCT04179175|102203026|FG002|Full Analysis Set of HiSCR Non-responders (FAS-NR)|Overall Study||0|All HiSCR non-responders to whom study treatment was assigned.|
48761298|NCT04179175|102203027|FG003|Full Analysis Set of HiSCR Non-responders (FAS-NR)|Overall Study||0|All HiSCR non-responders to whom study treatment was assigned.|
48761299|NCT04179175|102203028|FG004|Full Analysis Set of HiSCR Non-responders (FAS-NR)|Overall Study||151|All HiSCR non-responders to whom study treatment was assigned.|
48761300|NCT04179175|102203029|FG005|Full Analysis Set of HiSCR Non-responders (FAS-NR)|Overall Study||156|All HiSCR non-responders to whom study treatment was assigned.|
48761301|NCT04179175|102203024|FG000|Safety Set (SAF)|Overall Study||137|All subjects who received at least one dose of study treatment in the extension study. Subjects were analyzed according to the study treatment received.|
48761302|NCT04179175|102203025|FG001|Safety Set (SAF)|Overall Study||70|All subjects who received at least one dose of study treatment in the extension study. Subjects were analyzed according to the study treatment received.|
48761303|NCT04179175|102203026|FG002|Safety Set (SAF)|Overall Study||121|All subjects who received at least one dose of study treatment in the extension study. Subjects were analyzed according to the study treatment received.|
48761304|NCT04179175|102203027|FG003|Safety Set (SAF)|Overall Study||63|All subjects who received at least one dose of study treatment in the extension study. Subjects were analyzed according to the study treatment received.|
48351421|NCT02561156|101188007|FG011|NOT COMPLETED|Part 2||1||
48351422|NCT02561156|101188008|FG012|NOT COMPLETED|Part 2||0||
48351423|NCT03815175|101188009|FG000|STARTED|Overall Study||1605||
48351424|NCT03815175|101188009|FG000|COMPLETED|Overall Study||1439||
48351425|NCT03815175|101188009|FG000|NOT COMPLETED|Overall Study||166||
48351426|NCT03949673|101188010|FG000|STARTED|Overall Study||2||
48351427|NCT03949673|101188011|FG001|STARTED|Overall Study||5||
48351428|NCT03949673|101188012|FG002|STARTED|Overall Study||13||
48351429|NCT03949673|101188010|FG000|COMPLETED|Overall Study||2||
48351430|NCT03949673|101188011|FG001|COMPLETED|Overall Study||5||
48351431|NCT03949673|101188012|FG002|COMPLETED|Overall Study||13||
48351432|NCT03949673|101188010|FG000|NOT COMPLETED|Overall Study||0||
48351433|NCT03949673|101188011|FG001|NOT COMPLETED|Overall Study||0||
48351434|NCT03949673|101188012|FG002|NOT COMPLETED|Overall Study||0||
48351435|NCT02468193|101188013|FG000|STARTED|Overall Study||9||
48351436|NCT02468193|101188013|FG000|Completed Week-12 (Study Period I)|Overall Study||7||
48351437|NCT02468193|101188013|FG000|Discontinued at or Prior to Week-12|Overall Study||2||
48351438|NCT02468193|101188013|FG000|Completed Week-12, Did Not Enter Per. II|Overall Study||3||
48351439|NCT02468193|101188013|FG000|Completed Week-12, Entered Study Per. II|Overall Study||4||
48351440|NCT02468193|101188013|FG000|Completed Week-48 (Study Period II)|Overall Study||2||
48351441|NCT02468193|101188013|FG000|Discontinued at or Prior to Week48|Overall Study||2||
48351442|NCT02468193|101188013|FG000|Compl. Wk-48, Didn't Enter Opt. Ext. Per|Overall Study||0||
48351443|NCT02468193|101188013|FG000|Compl. Wk-48, Entered Opt. Ext. Period|Overall Study||2||
48351444|NCT02468193|101188013|FG000|Completed Optional Extension Period|Overall Study||0||
48351445|NCT02468193|101188013|FG000|Discontinued Study in Optional Ext. Per.|Overall Study||2||
48351446|NCT02468193|101188013|FG000|COMPLETED|Overall Study||3||
48351447|NCT02468193|101188013|FG000|NOT COMPLETED|Overall Study||6||
48351448|NCT00986349|101188014|FG000|STARTED|Overall Study||23||
48351449|NCT00986349|101188014|FG000|Successful Implant Procedure|Overall Study||20|Three subjects had anatomy that could not accommodate the device implant|
48351450|NCT00986349|101188014|FG000|Early Explant|Overall Study||4||
48351451|NCT00986349|101188014|FG000|COMPLETED|Overall Study||16||
48351452|NCT00986349|101188014|FG000|NOT COMPLETED|Overall Study||7||
48351453|NCT02120417|101188015|FG000|STARTED|Overall Study||76|Overall Number of Participants Analyzed|
48351454|NCT02120417|101188016|FG001|STARTED|Overall Study||73|Overall Number of Participants Analyzed|
48351455|NCT02120417|101188015|FG000|COMPLETED|Overall Study||16|Number of participants remaining on treatment at the 08 FEB 2016 data cutoff.|
48351456|NCT02120417|101188016|FG001|COMPLETED|Overall Study||5|Number of participants remaining on treatment at the 08 FEB 2016 data cutoff.|
48351457|NCT02120417|101188015|FG000|NOT COMPLETED|Overall Study||60||
48351458|NCT02120417|101188016|FG001|NOT COMPLETED|Overall Study||68||
48351459|NCT02532231|101188017|FG000|STARTED|Overall Study||15||
48351460|NCT02532231|101188017|FG000|COMPLETED|Overall Study||15||
48351461|NCT02532231|101188017|FG000|NOT COMPLETED|Overall Study||0||
48761305|NCT04179175|102203028|FG004|Safety Set (SAF)|Overall Study||151|All subjects who received at least one dose of study treatment in the extension study. Subjects were analyzed according to the study treatment received.|
48767768|NCT02237417|102222820|FG000|COMPLETED|Overall Study||16||
48767769|NCT02237417|102222821|FG001|COMPLETED|Overall Study||9||
48351462|NCT02469246|101188018|FG000|STARTED|Double-Blind Phase||285||
48351463|NCT02469246|101188019|FG001|STARTED|Double-Blind Phase||282||
48351464|NCT02469246|101188018|FG000|COMPLETED|Double-Blind Phase||218||
48351465|NCT02469246|101188019|FG001|COMPLETED|Double-Blind Phase||226||
48351466|NCT02469246|101188018|FG000|NOT COMPLETED|Double-Blind Phase||67||
48351467|NCT02469246|101188019|FG001|NOT COMPLETED|Double-Blind Phase||56||
48351468|NCT02469246|101188018|FG000|STARTED|Open-Label Extension (OLE)||6||
48416677|NCT04465240|101353456|FG001|STARTED|Overall Study||49||
48351469|NCT02469246|101188019|FG001|STARTED|Open-Label Extension (OLE)||5||
48351470|NCT02469246|101188018|FG000|COMPLETED|Open-Label Extension (OLE)||6||
48351471|NCT02469246|101188019|FG001|COMPLETED|Open-Label Extension (OLE)||5||
48351472|NCT02469246|101188018|FG000|NOT COMPLETED|Open-Label Extension (OLE)||0||
48416678|NCT04465240|101353455|FG000|COMPLETED|Overall Study||50||
48351473|NCT02469246|101188019|FG001|NOT COMPLETED|Open-Label Extension (OLE)||0||
48351474|NCT01012661|101188020|FG000|STARTED|Overall Study||50||
48351475|NCT01012661|101188020|FG000|COMPLETED|Overall Study||50||
48351476|NCT01012661|101188020|FG000|NOT COMPLETED|Overall Study||0||
48351477|NCT00742781|101188021|FG000|STARTED|Overall Study||21||
48351478|NCT00742781|101188021|FG000|COMPLETED|Overall Study||18||
48351479|NCT00742781|101188021|FG000|NOT COMPLETED|Overall Study||3||
48351480|NCT03830281|101188022|FG000|STARTED|Lead-in Period (2 Weeks)||471||
48351481|NCT03830281|101188023|FG001|STARTED|Lead-in Period (2 Weeks)||0||
48351482|NCT03830281|101188022|FG000|COMPLETED|Lead-in Period (2 Weeks)||432||
48351483|NCT03830281|101188023|FG001|COMPLETED|Lead-in Period (2 Weeks)||0||
48351484|NCT03830281|101188022|FG000|NOT COMPLETED|Lead-in Period (2 Weeks)||39||
48351485|NCT03830281|101188023|FG001|NOT COMPLETED|Lead-in Period (2 Weeks)||0||
48351486|NCT03830281|101188022|FG000|STARTED|Treatment Period (16 Weeks)||217||
48351487|NCT03830281|101188023|FG001|STARTED|Treatment Period (16 Weeks)||215||
48351488|NCT03830281|101188022|FG000|COMPLETED|Treatment Period (16 Weeks)||205||
48351489|NCT03830281|101188023|FG001|COMPLETED|Treatment Period (16 Weeks)||198||
48351490|NCT03830281|101188022|FG000|NOT COMPLETED|Treatment Period (16 Weeks)||12||
48351491|NCT03830281|101188023|FG001|NOT COMPLETED|Treatment Period (16 Weeks)||17||
48351492|NCT02951052|101188024|FG000|STARTED|Overall Study||308||
48351493|NCT02951052|101188025|FG001|STARTED|Overall Study||308||
48351494|NCT02951052|101188024|FG000|COMPLETED|Overall Study||281||
48351495|NCT02951052|101188025|FG001|COMPLETED|Overall Study||290||
48351496|NCT02951052|101188024|FG000|NOT COMPLETED|Overall Study||27||
48351497|NCT02951052|101188025|FG001|NOT COMPLETED|Overall Study||18||
48351498|NCT01552343|101188026|FG000|STARTED|Overall Study||29||
48351499|NCT01552343|101188027|FG001|STARTED|Overall Study||27||
48351500|NCT01552343|101188026|FG000|COMPLETED|Overall Study||29||
48351501|NCT01552343|101188027|FG001|COMPLETED|Overall Study||27||
48351502|NCT01552343|101188026|FG000|NOT COMPLETED|Overall Study||0||
48351503|NCT01552343|101188027|FG001|NOT COMPLETED|Overall Study||0||
48351504|NCT01905956|101188028|FG000|STARTED|Overall Study||60||
48351505|NCT01905956|101188029|FG001|STARTED|Overall Study||59||
48351506|NCT01905956|101188028|FG000|Intention-to-treat Population|Overall Study||57||
48351507|NCT01905956|101188029|FG001|Intention-to-treat Population|Overall Study||54||
48351508|NCT01905956|101188028|FG000|COMPLETED|Overall Study||54||
48351509|NCT01905956|101188029|FG001|COMPLETED|Overall Study||48||
48351510|NCT01905956|101188028|FG000|NOT COMPLETED|Overall Study||6||
48351511|NCT01905956|101188029|FG001|NOT COMPLETED|Overall Study||11||
48351512|NCT05391438|101188030|FG000|STARTED|Overall Study||22||
48351513|NCT05391438|101188030|FG000|COMPLETED|Overall Study||15||
48351514|NCT05391438|101188030|FG000|NOT COMPLETED|Overall Study||7||
48351515|NCT01076179|101188031|FG000|STARTED|Overall Study||502||
48351516|NCT01076179|101188031|FG000|COMPLETED|Overall Study||501||
48351517|NCT01076179|101188031|FG000|NOT COMPLETED|Overall Study||1||
48351518|NCT03323749|101188032|FG000|STARTED|Double-blind Period||109||
48351519|NCT03323749|101188033|FG001|STARTED|Double-blind Period||109||
48351520|NCT03323749|101188032|FG000|COMPLETED|Double-blind Period||102||
48351521|NCT03323749|101188033|FG001|COMPLETED|Double-blind Period||103||
48351522|NCT03323749|101188032|FG000|NOT COMPLETED|Double-blind Period||7||
48351523|NCT03323749|101188033|FG001|NOT COMPLETED|Double-blind Period||6||
48351524|NCT03323749|101188032|FG000|STARTED|Open-Label Period||93|A total of 196 subjects enrolled in Part 2 of the trial: 93 from the elamipretide group in Part 1, and 103 from the placebo group in Part 1. No subjects completed the trial: it was terminated early due to the Sponsor's decision.|
48351525|NCT03323749|101188033|FG001|STARTED|Open-Label Period||103|A total of 196 subjects enrolled in Part 2 of the trial: 93 from the elamipretide group in Part 1, and 103 from the placebo group in Part 1. No subjects completed the trial: it was terminated early due to the Sponsor's decision.|
48638233|NCT02635035|101898716|FG001|COMPLETED|Overall Study||21||
48761306|NCT04179175|102203029|FG005|Safety Set (SAF)|Overall Study||156|All subjects who received at least one dose of study treatment in the extension study. Subjects were analyzed according to the study treatment received.|
48761307|NCT04179175|102203024|FG000|Completed Randomized Withdrawal Period - Responders Only|Overall Study||127|This milestone is only applicable to HiSCR responders at Week 52 in the Core studies|
48761308|NCT04179175|102203025|FG001|Completed Randomized Withdrawal Period - Responders Only|Overall Study||64|This milestone is only applicable to HiSCR responders at Week 52 in the Core studies|
48351526|NCT03323749|101188032|FG000|COMPLETED|Open-Label Period||0||
48351527|NCT03323749|101188033|FG001|COMPLETED|Open-Label Period||0||
48351528|NCT03323749|101188032|FG000|NOT COMPLETED|Open-Label Period||93||
48351529|NCT03323749|101188033|FG001|NOT COMPLETED|Open-Label Period||103||
48351530|NCT04964258|101188034|FG000|STARTED|Overall Study||14||
48351531|NCT04964258|101188035|FG001|STARTED|Overall Study||6||
48351532|NCT04964258|101188036|FG002|STARTED|Overall Study||6||
48351533|NCT04964258|101188037|FG003|STARTED|Overall Study||6||
48351534|NCT04964258|101188038|FG004|STARTED|Overall Study||6||
48351535|NCT04964258|101188039|FG005|STARTED|Overall Study||6||
48351536|NCT04964258|101188040|FG006|STARTED|Overall Study||6||
48351537|NCT04964258|101188041|FG007|STARTED|Overall Study||6||
48351538|NCT04964258|101188042|FG008|STARTED|Overall Study||6||
48416679|NCT04465240|101353456|FG001|COMPLETED|Overall Study||49||
48638234|NCT02635035|101898715|FG000|NOT COMPLETED|Overall Study||0||
48638235|NCT02635035|101898716|FG001|NOT COMPLETED|Overall Study||0||
48761309|NCT04179175|102203026|FG002|Completed Randomized Withdrawal Period - Responders Only|Overall Study||114|This milestone is only applicable to HiSCR responders at Week 52 in the Core studies|
48351539|NCT04964258|101188043|FG009|STARTED|Overall Study||12||
48351540|NCT04964258|101188044|FG010|STARTED|Overall Study||6||
48351541|NCT04964258|101188034|FG000|COMPLETED|Overall Study||13||
48761310|NCT04179175|102203027|FG003|Completed Randomized Withdrawal Period - Responders Only|Overall Study||62|This milestone is only applicable to HiSCR responders at Week 52 in the Core studies|
48761311|NCT04179175|102203028|FG004|Completed Randomized Withdrawal Period - Responders Only|Overall Study||0|This milestone is only applicable to HiSCR responders at Week 52 in the Core studies|
48761312|NCT04179175|102203029|FG005|Completed Randomized Withdrawal Period - Responders Only|Overall Study||0|This milestone is only applicable to HiSCR responders at Week 52 in the Core studies|
48761313|NCT04179175|102203024|FG000|COMPLETED|Overall Study||0||
48761314|NCT04179175|102203025|FG001|COMPLETED|Overall Study||0||
48761315|NCT04179175|102203026|FG002|COMPLETED|Overall Study||0||
48761316|NCT04179175|102203027|FG003|COMPLETED|Overall Study||0||
48761317|NCT04179175|102203028|FG004|COMPLETED|Overall Study||0||
48761318|NCT04179175|102203029|FG005|COMPLETED|Overall Study||0||
48761319|NCT04179175|102203024|FG000|NOT COMPLETED|Overall Study||136||
48761320|NCT04179175|102203025|FG001|NOT COMPLETED|Overall Study||71||
48351542|NCT04964258|101188035|FG001|COMPLETED|Overall Study||6||
48351543|NCT04964258|101188036|FG002|COMPLETED|Overall Study||6||
48351544|NCT04964258|101188037|FG003|COMPLETED|Overall Study||6||
48351545|NCT04964258|101188038|FG004|COMPLETED|Overall Study||6||
48351546|NCT04964258|101188039|FG005|COMPLETED|Overall Study||5||
48351547|NCT04964258|101188040|FG006|COMPLETED|Overall Study||6||
48351548|NCT04964258|101188041|FG007|COMPLETED|Overall Study||6||
48351549|NCT04964258|101188042|FG008|COMPLETED|Overall Study||6||
48351550|NCT04964258|101188043|FG009|COMPLETED|Overall Study||12||
48351551|NCT04964258|101188044|FG010|COMPLETED|Overall Study||6||
48351552|NCT04964258|101188034|FG000|NOT COMPLETED|Overall Study||1||
48351553|NCT04964258|101188035|FG001|NOT COMPLETED|Overall Study||0||
48351554|NCT04964258|101188036|FG002|NOT COMPLETED|Overall Study||0||
48351555|NCT04964258|101188037|FG003|NOT COMPLETED|Overall Study||0||
48351556|NCT04964258|101188038|FG004|NOT COMPLETED|Overall Study||0||
48351557|NCT04964258|101188039|FG005|NOT COMPLETED|Overall Study||1||
48351558|NCT04964258|101188040|FG006|NOT COMPLETED|Overall Study||0||
48351559|NCT04964258|101188041|FG007|NOT COMPLETED|Overall Study||0||
48351560|NCT04964258|101188042|FG008|NOT COMPLETED|Overall Study||0||
48351561|NCT04964258|101188043|FG009|NOT COMPLETED|Overall Study||0||
48351562|NCT04964258|101188044|FG010|NOT COMPLETED|Overall Study||0||
48351563|NCT01475955|101188045|FG000|STARTED|Overall Study||48||
48351564|NCT01475955|101188046|FG001|STARTED|Overall Study||48||
48351565|NCT01475955|101188047|FG002|STARTED|Overall Study||47||
48351566|NCT01475955|101188048|FG003|STARTED|Overall Study||46||
48351567|NCT01475955|101188049|FG004|STARTED|Overall Study||46||
48351568|NCT01475955|101188045|FG000|COMPLETED|Overall Study||47||
48351569|NCT01475955|101188046|FG001|COMPLETED|Overall Study||48||
48351570|NCT01475955|101188047|FG002|COMPLETED|Overall Study||44||
48351571|NCT01475955|101188048|FG003|COMPLETED|Overall Study||46||
48351572|NCT01475955|101188049|FG004|COMPLETED|Overall Study||46||
48351573|NCT01475955|101188045|FG000|NOT COMPLETED|Overall Study||1||
48351574|NCT01475955|101188046|FG001|NOT COMPLETED|Overall Study||0||
48351575|NCT01475955|101188047|FG002|NOT COMPLETED|Overall Study||3||
48351576|NCT01475955|101188048|FG003|NOT COMPLETED|Overall Study||0||
48351577|NCT01475955|101188049|FG004|NOT COMPLETED|Overall Study||0||
48351578|NCT03311126|101188050|FG000|STARTED|Induction||21||
48351579|NCT03311126|101188050|FG000|Induction Chemotherapy Cycle 4|Induction||21||
48351580|NCT03311126|101188050|FG000|COMPLETED|Induction||20||
48351581|NCT03311126|101188050|FG000|NOT COMPLETED|Induction||1||
48351582|NCT03311126|101188050|FG000|STARTED|Consolidation||20||
48351583|NCT03311126|101188050|FG000|COMPLETED|Consolidation||20||
48351584|NCT03311126|101188050|FG000|NOT COMPLETED|Consolidation||0||
48416680|NCT04465240|101353455|FG000|NOT COMPLETED|Overall Study||0||
48416681|NCT04465240|101353456|FG001|NOT COMPLETED|Overall Study||0||
48351585|NCT03311126|101188050|FG000|STARTED|Restaging Imaging||20||
48351586|NCT03311126|101188050|FG000|Radiographic Complete Response|Restaging Imaging||10||
48351587|NCT03311126|101188050|FG000|Lack of Radiographic Complete Response|Restaging Imaging||10||
48351588|NCT03311126|101188050|FG000|COMPLETED|Restaging Imaging||10||
48351589|NCT03311126|101188050|FG000|NOT COMPLETED|Restaging Imaging||10||
48351590|NCT03311126|101188050|FG000|STARTED|Maintenance||10||
48351591|NCT03311126|101188050|FG000|Discontinued Maintenance Early|Maintenance||6||
48351592|NCT03311126|101188050|FG000|Completed All 8 Cycles|Maintenance||4||
48351593|NCT03311126|101188050|FG000|COMPLETED|Maintenance||10||
48351594|NCT03311126|101188050|FG000|NOT COMPLETED|Maintenance||0||
48351595|NCT01650805|101188051|FG000|STARTED|Overall Study||155||
48351596|NCT01650805|101188052|FG001|STARTED|Overall Study||152||
48351597|NCT01650805|101188051|FG000|COMPLETED|Overall Study||154||
48351598|NCT01650805|101188052|FG001|COMPLETED|Overall Study||152||
48351599|NCT01650805|101188051|FG000|NOT COMPLETED|Overall Study||1||
48351600|NCT01650805|101188052|FG001|NOT COMPLETED|Overall Study||0||
48351601|NCT02207907|101188053|FG000|STARTED|Overall Study||124||
48351602|NCT02207907|101188054|FG001|STARTED|Overall Study||123||
48351603|NCT02207907|101188053|FG000|COMPLETED|Overall Study||113||
48351604|NCT02207907|101188054|FG001|COMPLETED|Overall Study||115||
48351605|NCT02207907|101188053|FG000|NOT COMPLETED|Overall Study||11||
48351606|NCT02207907|101188054|FG001|NOT COMPLETED|Overall Study||8||
48351607|NCT00519077|101188055|FG000|STARTED|Overall Study||44||
48761321|NCT04179175|102203026|FG002|NOT COMPLETED|Overall Study||121||
48761322|NCT04179175|102203027|FG003|NOT COMPLETED|Overall Study||63||
48761323|NCT04179175|102203028|FG004|NOT COMPLETED|Overall Study||151||
48761324|NCT04179175|102203029|FG005|NOT COMPLETED|Overall Study||157||
48761325|NCT01263769|102203030|FG000|STARTED|Overall Study||25||
48761326|NCT01263769|102203030|FG000|COMPLETED|Overall Study||24||
48761327|NCT01263769|102203030|FG000|NOT COMPLETED|Overall Study||1||
48761328|NCT04196777|102203031|FG000|STARTED|Overall Study||525||
48761329|NCT04196777|102203031|FG000|COMPLETED|Overall Study||525||
48761330|NCT04196777|102203031|FG000|NOT COMPLETED|Overall Study||0||
48761331|NCT04375150|102203032|FG000|STARTED|Overall Study||340||
48761332|NCT04375150|102203033|FG001|STARTED|Overall Study||15||
48761333|NCT04375150|102203032|FG000|COMPLETED|Overall Study||340||
48761334|NCT04375150|102203033|FG001|COMPLETED|Overall Study||15||
48761335|NCT04375150|102203032|FG000|NOT COMPLETED|Overall Study||0||
48761336|NCT04375150|102203033|FG001|NOT COMPLETED|Overall Study||0||
48761337|NCT00626106|102203034|FG000|STARTED|Overall Study||106||
48761338|NCT00626106|102203035|FG001|STARTED|Overall Study||50||
48761339|NCT00626106|102203034|FG000|COMPLETED|Overall Study||39||
48761340|NCT00626106|102203035|FG001|COMPLETED|Overall Study||26||
48761341|NCT00626106|102203034|FG000|NOT COMPLETED|Overall Study||67||
48761342|NCT00626106|102203035|FG001|NOT COMPLETED|Overall Study||24||
48761343|NCT03025282|102203036|FG000|STARTED|Overall Study||24||144
48761344|NCT03025282|102203036|FG000|COMPLETED|Overall Study||24||144
48761345|NCT03025282|102203036|FG000|NOT COMPLETED|Overall Study||0||0
48761346|NCT02764385|102203037|FG000|STARTED|Overall Study||9145||
48761347|NCT02764385|102203038|FG001|STARTED|Overall Study||6641||
48351608|NCT00519077|101188055|FG000|COMPLETED|Overall Study||36||
48351609|NCT00519077|101188055|FG000|NOT COMPLETED|Overall Study||8||
48351610|NCT03486314|101191367|FG000|STARTED|Part A||20||
48351611|NCT03486314|101191368|FG001|STARTED|Part A||0||
48351612|NCT03486314|101191369|FG002|STARTED|Part A||0||
48351613|NCT03486314|101191367|FG000|COMPLETED|Part A||17||
48351614|NCT03486314|101191368|FG001|COMPLETED|Part A||0||
48351615|NCT03486314|101191369|FG002|COMPLETED|Part A||0||
48351616|NCT03486314|101191367|FG000|NOT COMPLETED|Part A||3||
48351617|NCT03486314|101191368|FG001|NOT COMPLETED|Part A||0||
48351618|NCT03486314|101191369|FG002|NOT COMPLETED|Part A||0||
48351619|NCT03486314|101191367|FG000|STARTED|Part B||0||
48351620|NCT03486314|101191368|FG001|STARTED|Part B||9||
48351621|NCT03486314|101191369|FG002|STARTED|Part B||8||
48351622|NCT03486314|101191367|FG000|COMPLETED|Part B||0||
48351623|NCT03486314|101191368|FG001|COMPLETED|Part B||9||
48351624|NCT03486314|101191369|FG002|COMPLETED|Part B||8||
48351625|NCT03486314|101191367|FG000|NOT COMPLETED|Part B||0||
48351626|NCT03486314|101191368|FG001|NOT COMPLETED|Part B||0||
48351627|NCT03486314|101191369|FG002|NOT COMPLETED|Part B||0||
48416682|NCT02129192|101353457|FG000|STARTED|Period 1 Including Washout Period||36||
48761348|NCT02764385|102203037|FG000|COMPLETED|Overall Study||9145||
48761349|NCT02764385|102203038|FG001|COMPLETED|Overall Study||6641||
48761350|NCT02764385|102203037|FG000|NOT COMPLETED|Overall Study||0||
48761351|NCT02764385|102203038|FG001|NOT COMPLETED|Overall Study||0||
48761352|NCT05737069|102203039|FG000|STARTED|Period 1 (2 Days)||17||
48761353|NCT05737069|102203040|FG001|STARTED|Period 1 (2 Days)||17||
48761354|NCT05737069|102203041|FG002|STARTED|Period 1 (2 Days)||25||
48761355|NCT05737069|102203042|FG003|STARTED|Period 1 (2 Days)||25||
48761356|NCT05737069|102203039|FG000|COMPLETED|Period 1 (2 Days)||17||
48761357|NCT05737069|102203040|FG001|COMPLETED|Period 1 (2 Days)||17||
48761358|NCT05737069|102203041|FG002|COMPLETED|Period 1 (2 Days)||25||
48761359|NCT05737069|102203042|FG003|COMPLETED|Period 1 (2 Days)||25||
48761360|NCT05737069|102203039|FG000|NOT COMPLETED|Period 1 (2 Days)||0||
48761361|NCT05737069|102203040|FG001|NOT COMPLETED|Period 1 (2 Days)||0||
48761362|NCT05737069|102203041|FG002|NOT COMPLETED|Period 1 (2 Days)||0||
48761363|NCT05737069|102203042|FG003|NOT COMPLETED|Period 1 (2 Days)||0||
48761364|NCT05737069|102203039|FG000|STARTED|Washout Period (2 Days)||17||
48761365|NCT05737069|102203040|FG001|STARTED|Washout Period (2 Days)||17||
48761366|NCT05737069|102203041|FG002|STARTED|Washout Period (2 Days)||25||
48761367|NCT05737069|102203042|FG003|STARTED|Washout Period (2 Days)||25||
48761368|NCT05737069|102203039|FG000|COMPLETED|Washout Period (2 Days)||17||
48351628|NCT01363843|101191370|FG000|STARTED|Overall Study||39||
48351629|NCT01363843|101191370|FG000|COMPLETED|Overall Study||38||
48351630|NCT01363843|101191370|FG000|NOT COMPLETED|Overall Study||1||
48416683|NCT02129192|101353458|FG001|STARTED|Period 1 Including Washout Period||36||
48761369|NCT05737069|102203040|FG001|COMPLETED|Washout Period (2 Days)||17||
48761370|NCT05737069|102203041|FG002|COMPLETED|Washout Period (2 Days)||25||
48761371|NCT05737069|102203042|FG003|COMPLETED|Washout Period (2 Days)||25||
48761372|NCT05737069|102203039|FG000|NOT COMPLETED|Washout Period (2 Days)||0||
48351631|NCT03542682|101191371|FG000|STARTED|Overall Study||5|Participants randomized|
48351632|NCT03542682|101191372|FG001|STARTED|Overall Study||4|Participants randomized|
48761373|NCT05737069|102203040|FG001|NOT COMPLETED|Washout Period (2 Days)||0||
48761374|NCT05737069|102203041|FG002|NOT COMPLETED|Washout Period (2 Days)||0||
48351633|NCT03542682|101191371|FG000|Completed First Stage|Overall Study||5||
48351634|NCT03542682|101191372|FG001|Completed First Stage|Overall Study||4||
48351635|NCT03542682|101191371|FG000|Completed Second Stage|Overall Study||5||
48351636|NCT03542682|101191372|FG001|Completed Second Stage|Overall Study||3||
48351637|NCT03542682|101191371|FG000|COMPLETED|Overall Study||5||
48351638|NCT03542682|101191372|FG001|COMPLETED|Overall Study||3||
48351639|NCT03542682|101191371|FG000|NOT COMPLETED|Overall Study||0||
48761375|NCT05737069|102203042|FG003|NOT COMPLETED|Washout Period (2 Days)||0||
48761376|NCT05737069|102203039|FG000|STARTED|Period 2 (2 Days)||17||
48761377|NCT05737069|102203040|FG001|STARTED|Period 2 (2 Days)||17||
48761378|NCT05737069|102203041|FG002|STARTED|Period 2 (2 Days)||25||
48761379|NCT05737069|102203042|FG003|STARTED|Period 2 (2 Days)||25||
48761380|NCT05737069|102203039|FG000|COMPLETED|Period 2 (2 Days)||17||
48351640|NCT03542682|101191372|FG001|NOT COMPLETED|Overall Study||1||
48351641|NCT00363415|101191373|FG000|STARTED|Overall Study||453||
48351642|NCT00363415|101191374|FG001|STARTED|Overall Study||455||
48351643|NCT00363415|101191373|FG000|Received at Least One Dose of Study Drug|Overall Study||433||
48351644|NCT00363415|101191374|FG001|Received at Least One Dose of Study Drug|Overall Study||447||
48351645|NCT00363415|101191373|FG000|COMPLETED|Overall Study||92||
48351646|NCT00363415|101191374|FG001|COMPLETED|Overall Study||206||
48351647|NCT00363415|101191373|FG000|NOT COMPLETED|Overall Study||361||
48351648|NCT00363415|101191374|FG001|NOT COMPLETED|Overall Study||249||
48351649|NCT02233842|101191375|FG000|STARTED|Questionnaire 1 Version 1||5||
48351650|NCT02233842|101191375|FG000|COMPLETED|Questionnaire 1 Version 1||5||
48351651|NCT02233842|101191375|FG000|NOT COMPLETED|Questionnaire 1 Version 1||0||
48351652|NCT02233842|101191375|FG000|STARTED|Questionnaire 1 Version 2||5||
48351653|NCT02233842|101191375|FG000|COMPLETED|Questionnaire 1 Version 2||5||
48351654|NCT02233842|101191375|FG000|NOT COMPLETED|Questionnaire 1 Version 2||0||
48351655|NCT02233842|101191375|FG000|STARTED|Questionnaire 2 Version 1||5||
48351656|NCT02233842|101191375|FG000|COMPLETED|Questionnaire 2 Version 1||5||
48351657|NCT02233842|101191375|FG000|NOT COMPLETED|Questionnaire 2 Version 1||0||
48351658|NCT02233842|101191375|FG000|STARTED|Questionnaire 2 Version 2||5||
48351659|NCT02233842|101191375|FG000|COMPLETED|Questionnaire 2 Version 2||5||
48351660|NCT02233842|101191375|FG000|NOT COMPLETED|Questionnaire 2 Version 2||0||
48351661|NCT02233842|101191375|FG000|STARTED|Questionnaire 3 Version 1||5||
48351662|NCT02233842|101191375|FG000|COMPLETED|Questionnaire 3 Version 1||5||
48351663|NCT02233842|101191375|FG000|NOT COMPLETED|Questionnaire 3 Version 1||0||
48351664|NCT02233842|101191375|FG000|STARTED|Questionnaire 3 Version 2||5||
48351665|NCT02233842|101191375|FG000|COMPLETED|Questionnaire 3 Version 2||5||
48351666|NCT02233842|101191375|FG000|NOT COMPLETED|Questionnaire 3 Version 2||0||
48351667|NCT00590161|101191376|FG000|STARTED|Overall Study||26||
48351668|NCT00590161|101191377|FG001|STARTED|Overall Study||29||
48351669|NCT00590161|101191376|FG000|COMPLETED|Overall Study||23||
48351670|NCT00590161|101191377|FG001|COMPLETED|Overall Study||26||
48351671|NCT00590161|101191376|FG000|NOT COMPLETED|Overall Study||3||
48351672|NCT00590161|101191377|FG001|NOT COMPLETED|Overall Study||3||
48351673|NCT04030195|101191378|FG000|STARTED|Overall Study||8|One participant who was retreated was dosed with Dose Level 3 at both initial and retreatment dosing. For the purposes of calculating and reporting participant flow and efficacy outcomes, the participant who was dosed twice was counted as 2 individual participants.|
48351674|NCT04030195|101191379|FG001|STARTED|Overall Study||3|One participant who was retreated was dosed with Dose Level 3 at both initial and retreatment dosing. For the purposes of calculating and reporting participant flow and efficacy outcomes, the participant who was dosed twice was counted as 2 individual participants.|
48351675|NCT04030195|101191380|FG002|STARTED|Overall Study||7|One participant who was retreated was dosed with Dose Level 3 at both initial and retreatment dosing. For the purposes of calculating and reporting participant flow and efficacy outcomes, the participant who was dosed twice was counted as 2 individual participants.|
48351676|NCT04030195|101191378|FG000|Participants in Demographic Population|Overall Study||8||
48761381|NCT05737069|102203040|FG001|COMPLETED|Period 2 (2 Days)||17||
48761382|NCT05737069|102203041|FG002|COMPLETED|Period 2 (2 Days)||25||
48761383|NCT05737069|102203042|FG003|COMPLETED|Period 2 (2 Days)||25||
48761384|NCT05737069|102203039|FG000|NOT COMPLETED|Period 2 (2 Days)||0||
48761385|NCT05737069|102203040|FG001|NOT COMPLETED|Period 2 (2 Days)||0||
48761386|NCT05737069|102203041|FG002|NOT COMPLETED|Period 2 (2 Days)||0||
48761387|NCT05737069|102203042|FG003|NOT COMPLETED|Period 2 (2 Days)||0||
48761388|NCT05941702|102203043|FG000|STARTED|Overall Study||8||
48761389|NCT05941702|102203043|FG000|COMPLETED|Overall Study||7||
48761390|NCT05941702|102203043|FG000|NOT COMPLETED|Overall Study||1||
48761391|NCT03112681|102203044|FG000|STARTED|Overall Study||14||
48761392|NCT03112681|102203045|FG001|STARTED|Overall Study||13||
48761393|NCT03112681|102203046|FG002|STARTED|Overall Study||10||
48761394|NCT03112681|102203044|FG000|COMPLETED|Overall Study||13||
48761395|NCT03112681|102203045|FG001|COMPLETED|Overall Study||10||
48761396|NCT03112681|102203046|FG002|COMPLETED|Overall Study||9||
48368116|NCT03196297|101230110|FG000|NOT COMPLETED|Main Period||4||
48761397|NCT03112681|102203044|FG000|NOT COMPLETED|Overall Study||1||
48761398|NCT03112681|102203045|FG001|NOT COMPLETED|Overall Study||3||
48761399|NCT03112681|102203046|FG002|NOT COMPLETED|Overall Study||1||
48761400|NCT00834977|102203047|FG000|STARTED|First Intervention||24||
48351677|NCT04030195|101191379|FG001|Participants in Demographic Population|Overall Study||3||
48351678|NCT04030195|101191380|FG002|Participants in Demographic Population|Overall Study||6||
48351679|NCT04030195|101191378|FG000|Participants in Safety Population|Overall Study||8||
48351680|NCT04030195|101191379|FG001|Participants in Safety Population|Overall Study||3||
48351681|NCT04030195|101191380|FG002|Participants in Safety Population|Overall Study||6||
48351682|NCT04030195|101191378|FG000|Participants Re-treated|Overall Study||0||
48351683|NCT04030195|101191379|FG001|Participants Re-treated|Overall Study||0||
48351684|NCT04030195|101191380|FG002|Participants Re-treated|Overall Study||1||
48351685|NCT04030195|101191378|FG000|Participants in Efficacy Population|Overall Study||8||
48351686|NCT04030195|101191379|FG001|Participants in Efficacy Population|Overall Study||3||
48351687|NCT04030195|101191380|FG002|Participants in Efficacy Population|Overall Study||7||
48351688|NCT04030195|101191378|FG000|COMPLETED|Overall Study||6||
48351689|NCT04030195|101191379|FG001|COMPLETED|Overall Study||3||
48351690|NCT04030195|101191380|FG002|COMPLETED|Overall Study||7||
48351691|NCT04030195|101191378|FG000|NOT COMPLETED|Overall Study||2||
48351692|NCT04030195|101191379|FG001|NOT COMPLETED|Overall Study||0||
48351693|NCT04030195|101191380|FG002|NOT COMPLETED|Overall Study||0||
48351694|NCT04322708|101191381|FG000|STARTED|Overall Study||92||
48351695|NCT04322708|101191382|FG001|STARTED|Overall Study||93||
48351696|NCT04322708|101191383|FG002|STARTED|Overall Study||91||
48351697|NCT04322708|101191381|FG000|COMPLETED|Overall Study||89||
48351698|NCT04322708|101191382|FG001|COMPLETED|Overall Study||89||
48351699|NCT04322708|101191383|FG002|COMPLETED|Overall Study||85||
48351700|NCT04322708|101191381|FG000|NOT COMPLETED|Overall Study||3||
48351701|NCT04322708|101191382|FG001|NOT COMPLETED|Overall Study||4||
48351702|NCT04322708|101191383|FG002|NOT COMPLETED|Overall Study||6||
48351703|NCT02101008|101191384|FG000|STARTED|Overall Study||12||
48351704|NCT02101008|101191384|FG000|COMPLETED|Overall Study||12||
48351705|NCT02101008|101191384|FG000|NOT COMPLETED|Overall Study||0||
48351706|NCT04122196|101191385|FG000|STARTED|Overall Study||59||
48351707|NCT04122196|101191386|FG001|STARTED|Overall Study||59||
48351708|NCT04122196|101191385|FG000|COMPLETED|Overall Study||59||
48351709|NCT04122196|101191386|FG001|COMPLETED|Overall Study||59||
48351710|NCT04122196|101191385|FG000|NOT COMPLETED|Overall Study||0||
48351711|NCT04122196|101191386|FG001|NOT COMPLETED|Overall Study||0||
48351712|NCT00246259|101191387|FG000|STARTED|Overall Study||44||
48351713|NCT00246259|101191388|FG001|STARTED|Overall Study||41||
48351714|NCT00246259|101191387|FG000|Eligible for Intent-to-treat (ITT)|Overall Study||42||
48351715|NCT00246259|101191388|FG001|Eligible for Intent-to-treat (ITT)|Overall Study||35||
48351716|NCT00246259|101191387|FG000|COMPLETED|Overall Study||16||
48351717|NCT00246259|101191388|FG001|COMPLETED|Overall Study||15||
48351718|NCT00246259|101191387|FG000|NOT COMPLETED|Overall Study||28||
48351719|NCT00246259|101191388|FG001|NOT COMPLETED|Overall Study||26||
48351720|NCT02580058|101191389|FG000|STARTED|Overall Study||188|This table included all randomized participants.|
48351721|NCT02580058|101191390|FG001|STARTED|Overall Study||188|This table included all randomized participants.|
48351722|NCT02580058|101191391|FG002|STARTED|Overall Study||190|This table included all randomized participants.|
48351723|NCT02580058|101191389|FG000|Treated|Overall Study||187|Participants received at least 1 dose of study drug.|
48351724|NCT02580058|101191390|FG001|Treated|Overall Study||182|Participants received at least 1 dose of study drug.|
48351725|NCT02580058|101191391|FG002|Treated|Overall Study||177|Participants received at least 1 dose of study drug.|
48351726|NCT02580058|101191389|FG000|COMPLETED|Overall Study||0|Participants were considered completed when at least one drug of the combination is completed.|
48761401|NCT00834977|102203048|FG001|STARTED|First Intervention||24||
48761402|NCT00834977|102203047|FG000|COMPLETED|First Intervention||24||
48761403|NCT00834977|102203048|FG001|COMPLETED|First Intervention||24||
48351727|NCT02580058|101191390|FG001|COMPLETED|Overall Study||0|Participants were considered completed when at least one drug of the combination is completed.|
48351728|NCT02580058|101191391|FG002|COMPLETED|Overall Study||0|Participants were considered completed when at least one drug of the combination is completed.|
48351729|NCT02580058|101191389|FG000|NOT COMPLETED|Overall Study||188||
48351730|NCT02580058|101191390|FG001|NOT COMPLETED|Overall Study||188||
48351731|NCT02580058|101191391|FG002|NOT COMPLETED|Overall Study||190||
48351732|NCT00768222|101191392|FG000|STARTED|Overall Study||50||
48351733|NCT00768222|101191393|FG001|STARTED|Overall Study||51||
48351734|NCT00768222|101191392|FG000|COMPLETED|Overall Study||46||
48351735|NCT00768222|101191393|FG001|COMPLETED|Overall Study||47||
48351736|NCT00768222|101191392|FG000|NOT COMPLETED|Overall Study||4||
48351737|NCT00768222|101191393|FG001|NOT COMPLETED|Overall Study||4||
48439975|NCT01728376|101409997|FG002|COMPLETED|Overall Study||17||
48761404|NCT00834977|102203047|FG000|NOT COMPLETED|First Intervention||0||
48761405|NCT00834977|102203048|FG001|NOT COMPLETED|First Intervention||0||
48351738|NCT00811252|101191394|FG000|STARTED|Overall Study||145||
48351739|NCT00811252|101191395|FG001|STARTED|Overall Study||156||
48351740|NCT00811252|101191396|FG002|STARTED|Overall Study||151||
48351741|NCT00811252|101191394|FG000|COMPLETED|Overall Study||128||
48351742|NCT00811252|101191395|FG001|COMPLETED|Overall Study||136||
48351743|NCT00811252|101191396|FG002|COMPLETED|Overall Study||128||
48351744|NCT00811252|101191394|FG000|NOT COMPLETED|Overall Study||17||
48351745|NCT00811252|101191395|FG001|NOT COMPLETED|Overall Study||20||
48351746|NCT00811252|101191396|FG002|NOT COMPLETED|Overall Study||23||
48351747|NCT02095561|101191397|FG000|STARTED|Overall Study||3049||
48351748|NCT02095561|101191398|FG001|STARTED|Overall Study||2964||
48351749|NCT02095561|101191397|FG000|Self-testing Acceptability|Overall Study||2616||
48351750|NCT02095561|101191398|FG001|Self-testing Acceptability|Overall Study||0||
48351751|NCT02095561|101191397|FG000|HPV Self-tested Women|Overall Study||2519||
48351752|NCT02095561|101191398|FG001|HPV Self-tested Women|Overall Study||0||
48351753|NCT02095561|101191397|FG000|HPV Tested at Health Centers|Overall Study||99||
48351754|NCT02095561|101191398|FG001|HPV Tested at Health Centers|Overall Study||599||
48351755|NCT02095561|101191397|FG000|COMPLETED|Overall Study||3049||
48351756|NCT02095561|101191398|FG001|COMPLETED|Overall Study||2964||
48351757|NCT02095561|101191397|FG000|NOT COMPLETED|Overall Study||0||
48351758|NCT02095561|101191398|FG001|NOT COMPLETED|Overall Study||0||
48351759|NCT03312218|101191399|FG000|STARTED|Overall Study||335||
48351760|NCT03312218|101191400|FG001|STARTED|Overall Study||299||
48351761|NCT03312218|101191399|FG000|COMPLETED|Overall Study||281||
48351762|NCT03312218|101191400|FG001|COMPLETED|Overall Study||241||
48351763|NCT03312218|101191399|FG000|NOT COMPLETED|Overall Study||54||
48638236|NCT00782067|101898717|FG000|STARTED|Overall Study||116|All patients to whom study treatment had been assigned (FAS)|
48638237|NCT00782067|101898717|FG000|Safety Set (SS)|Overall Study||116|All patients who received at least one dose of study drug|
48638238|NCT00782067|101898717|FG000|Primary Efficacy Population (PEP)|Overall Study||89|FAS patients meeting diagnostic criteria for ASM/MCL presenting at least one measurable C-finding|
48638239|NCT00782067|101898717|FG000|COMPLETED|Overall Study||0||
48638240|NCT00782067|101898717|FG000|NOT COMPLETED|Overall Study||116||
48638241|NCT02525523|101898718|FG000|STARTED|Overall Study||69||
48638242|NCT02525523|101898719|FG001|STARTED|Overall Study||69||
48638243|NCT02525523|101898718|FG000|COMPLETED|Overall Study||46||
48638244|NCT02525523|101898719|FG001|COMPLETED|Overall Study||44||
48351764|NCT03312218|101191400|FG001|NOT COMPLETED|Overall Study||58||
48351765|NCT03212261|101191401|FG000|STARTED|Overall Study||37||
48351766|NCT03212261|101191401|FG000|Remained Eligible|Overall Study||35||
48351767|NCT03212261|101191401|FG000|Baseline Completion|Overall Study||30|Eligible patients who completed the baseline survey|
48351768|NCT03212261|101191401|FG000|Program Initiation|Overall Study||26|4 people completed the baseline survey but did not start the program|
48351769|NCT03212261|101191401|FG000|Post-intervention Survey|Overall Study||22|# of people who completed the post-treatment survey (\~8 weeks)|
48351770|NCT03212261|101191401|FG000|One Month Follow-up|Overall Study||21|# of people who completed the one month follow-up survey (\~4 weeks after intervention completion).|
48351771|NCT03212261|101191401|FG000|COMPLETED|Overall Study||21||
48351772|NCT03212261|101191401|FG000|NOT COMPLETED|Overall Study||16||
48638245|NCT02525523|101898718|FG000|NOT COMPLETED|Overall Study||23||
48638246|NCT02525523|101898719|FG001|NOT COMPLETED|Overall Study||25||
48638247|NCT01348269|101898720|FG000|STARTED|Baseline||34||
48638248|NCT01348269|101898721|FG001|STARTED|Baseline||14||
48351773|NCT03220412|101191402|FG000|STARTED|Overall Study||54||
48351774|NCT03220412|101191403|FG001|STARTED|Overall Study||50||
48351775|NCT03220412|101191402|FG000|COMPLETED|Overall Study||54||
48351776|NCT03220412|101191403|FG001|COMPLETED|Overall Study||50||
48351777|NCT03220412|101191402|FG000|NOT COMPLETED|Overall Study||0||
48638249|NCT01348269|101898720|FG000|COMPLETED|Baseline||34||
48638250|NCT01348269|101898721|FG001|COMPLETED|Baseline||14||
48638251|NCT01348269|101898720|FG000|NOT COMPLETED|Baseline||0||
48638252|NCT01348269|101898721|FG001|NOT COMPLETED|Baseline||0||
48638253|NCT01348269|101898720|FG000|STARTED|"Treatment | Core Study (Until Week 6)"||34||
48351778|NCT03220412|101191403|FG001|NOT COMPLETED|Overall Study||0||
48351779|NCT02251743|101191404|FG000|STARTED|Overall Study||85||
48351780|NCT02251743|101191405|FG001|STARTED|Overall Study||59||
48351781|NCT02251743|101191404|FG000|COMPLETED|Overall Study||84||
48351782|NCT02251743|101191405|FG001|COMPLETED|Overall Study||58||
48351783|NCT02251743|101191404|FG000|NOT COMPLETED|Overall Study||1||
48351784|NCT02251743|101191405|FG001|NOT COMPLETED|Overall Study||1||
48351785|NCT03022461|101191406|FG000|STARTED|Overall Study||25||
48351786|NCT03022461|101191406|FG000|COMPLETED|Overall Study||22||
48351787|NCT03022461|101191406|FG000|NOT COMPLETED|Overall Study||3||
48351788|NCT03138564|101191407|FG000|STARTED|Overall Study||462||22
48351789|NCT03138564|101191408|FG001|STARTED|Overall Study||390||17
48351790|NCT03138564|101191407|FG000|Patients Beginning the Study|Overall Study||231||22
48351791|NCT03138564|101191408|FG001|Patients Beginning the Study|Overall Study||195||17
48351792|NCT03138564|101191407|FG000|Surrogates Beginning the Study|Overall Study||231||22
48351793|NCT03138564|101191408|FG001|Surrogates Beginning the Study|Overall Study||195||17
48351794|NCT03138564|101191407|FG000|Patients Completing the Week 2 Assessment|Overall Study||182||22
48351795|NCT03138564|101191408|FG001|Patients Completing the Week 2 Assessment|Overall Study||192||17
48351796|NCT03138564|101191407|FG000|Surrogates Completing the Week 2 Assessment|Overall Study||183||22
48351797|NCT03138564|101191408|FG001|Surrogates Completing the Week 2 Assessment|Overall Study||189||17
48351798|NCT03138564|101191407|FG000|Surrogates Eligible for Post-bereavement Visit|Overall Study||54||22
48351799|NCT03138564|101191408|FG001|Surrogates Eligible for Post-bereavement Visit|Overall Study||35||17
48351800|NCT03138564|101191407|FG000|Surrogates Completing Post-bereavement Visit|Overall Study||46||22
48351801|NCT03138564|101191408|FG001|Surrogates Completing Post-bereavement Visit|Overall Study||31||17
48761406|NCT00834977|102203047|FG000|STARTED|Second Intervention||24||
48351802|NCT03138564|101191407|FG000|COMPLETED|Overall Study||365|Completed Week 2 visit|22
48351803|NCT03138564|101191408|FG001|COMPLETED|Overall Study||381|Completed Week 2 visit|17
48351804|NCT03138564|101191407|FG000|NOT COMPLETED|Overall Study||97||0
48351805|NCT03138564|101191408|FG001|NOT COMPLETED|Overall Study||9||0
48351806|NCT01725165|101191409|FG000|STARTED|Overall Study||25||
48351807|NCT01725165|101191410|FG001|STARTED|Overall Study||24||
48351808|NCT01725165|101191409|FG000|COMPLETED|Overall Study||14||
48351809|NCT01725165|101191410|FG001|COMPLETED|Overall Study||6||
48351810|NCT01725165|101191409|FG000|NOT COMPLETED|Overall Study||11||
48351811|NCT01725165|101191410|FG001|NOT COMPLETED|Overall Study||18||
48351812|NCT01670500|101191411|FG000|STARTED|Overall Study||58||
48351813|NCT01670500|101191412|FG001|STARTED|Overall Study||60||
48351814|NCT01670500|101191411|FG000|COMPLETED|Overall Study||57|Participants received allocated intervention|
48351815|NCT01670500|101191412|FG001|COMPLETED|Overall Study||60|Participants received allocated intervention|
48351816|NCT01670500|101191411|FG000|NOT COMPLETED|Overall Study||1||
48351817|NCT01670500|101191412|FG001|NOT COMPLETED|Overall Study||0||
48351818|NCT01380899|101191413|FG000|STARTED|Overall Study||34||
48351819|NCT01380899|101191414|FG001|STARTED|Overall Study||33||
48351820|NCT01380899|101191415|FG002|STARTED|Overall Study||20||
48351821|NCT01380899|101191413|FG000|COMPLETED|Overall Study||34||
48351822|NCT01380899|101191414|FG001|COMPLETED|Overall Study||33||
48351823|NCT01380899|101191415|FG002|COMPLETED|Overall Study||20||
48351824|NCT01380899|101191413|FG000|NOT COMPLETED|Overall Study||0||
48351825|NCT01380899|101191414|FG001|NOT COMPLETED|Overall Study||0||
48351826|NCT01380899|101191415|FG002|NOT COMPLETED|Overall Study||0||
48351827|NCT02700529|101191416|FG000|STARTED|Overall Study||27||
48351828|NCT02700529|101191417|FG001|STARTED|Overall Study||27||
48351829|NCT02700529|101191416|FG000|COMPLETED|Overall Study||26||
48351830|NCT02700529|101191417|FG001|COMPLETED|Overall Study||27||
48351831|NCT02700529|101191416|FG000|NOT COMPLETED|Overall Study||1||
48351832|NCT02700529|101191417|FG001|NOT COMPLETED|Overall Study||0||
48351833|NCT00587223|101191418|FG000|STARTED|Overall Study||1||
48351834|NCT00587223|101191418|FG000|COMPLETED|Overall Study||0||
48351835|NCT00587223|101191418|FG000|NOT COMPLETED|Overall Study||1||
48351836|NCT02364778|101191419|FG000|STARTED|Overall Study||30||
48351837|NCT02364778|101191419|FG000|COMPLETED|Overall Study||30||
48351838|NCT02364778|101191419|FG000|NOT COMPLETED|Overall Study||0||
48351839|NCT03406962|101191420|FG000|STARTED|Overall Study||8||
48351840|NCT03406962|101191420|FG000|COMPLETED|Overall Study||5||
48351841|NCT03406962|101191420|FG000|NOT COMPLETED|Overall Study||3||
48351842|NCT01925703|101191421|FG000|STARTED|Overall Study||13||
48351843|NCT01925703|101191421|FG000|Dosing Regimen Completed|Overall Study||12||
48351844|NCT01925703|101191421|FG000|Full Iron Repletion Achieved|Overall Study||11||
48351845|NCT01925703|101191421|FG000|Follow-up Completed|Overall Study||9||
48351846|NCT01925703|101191421|FG000|COMPLETED|Overall Study||9||
48351847|NCT01925703|101191421|FG000|NOT COMPLETED|Overall Study||4||
48351848|NCT03002506|101191422|FG000|STARTED|Overall Study||6||
48351849|NCT03002506|101191422|FG000|COMPLETED|Overall Study||6||
48351850|NCT03002506|101191422|FG000|NOT COMPLETED|Overall Study||0||
48761407|NCT00834977|102203048|FG001|STARTED|Second Intervention||24||
48761408|NCT00834977|102203047|FG000|COMPLETED|Second Intervention||24||
48351851|NCT00561353|101191423|FG000|STARTED|Overall Study||18||
48351852|NCT00561353|101191424|FG001|STARTED|Overall Study||19||
48351853|NCT00561353|101191425|FG002|STARTED|Overall Study||13||
48351854|NCT00561353|101191426|FG003|STARTED|Overall Study||18||
48351855|NCT00561353|101191427|FG004|STARTED|Overall Study||6||
48351856|NCT00561353|101191428|FG005|STARTED|Overall Study||9||
48351857|NCT00561353|101191429|FG006|STARTED|Overall Study||9||
48351858|NCT00561353|101191430|FG007|STARTED|Overall Study||10||
48351859|NCT00561353|101191431|FG008|STARTED|Overall Study||9||
48351860|NCT00561353|101191432|FG009|STARTED|Overall Study||5||
48351861|NCT00561353|101191423|FG000|COMPLETED|Overall Study||13||
48351862|NCT00561353|101191424|FG001|COMPLETED|Overall Study||16||
48761409|NCT00834977|102203048|FG001|COMPLETED|Second Intervention||24||
48351863|NCT00561353|101191425|FG002|COMPLETED|Overall Study||10||
48351864|NCT00561353|101191426|FG003|COMPLETED|Overall Study||12||
48416684|NCT02129192|101353457|FG000|COMPLETED|Period 1 Including Washout Period||36||
48761410|NCT00834977|102203047|FG000|NOT COMPLETED|Second Intervention||0||
48761411|NCT00834977|102203048|FG001|NOT COMPLETED|Second Intervention||0||
48761412|NCT00400179|102203049|FG000|STARTED|Overall Study||527||
48351865|NCT00561353|101191427|FG004|COMPLETED|Overall Study||5||
48351866|NCT00561353|101191428|FG005|COMPLETED|Overall Study||3||
48761413|NCT00400179|102203050|FG001|STARTED|Overall Study||526||
48351867|NCT00561353|101191429|FG006|COMPLETED|Overall Study||3||
48351868|NCT00561353|101191430|FG007|COMPLETED|Overall Study||6||
48351869|NCT00561353|101191431|FG008|COMPLETED|Overall Study||2||
48351870|NCT00561353|101191432|FG009|COMPLETED|Overall Study||3||
48351871|NCT00561353|101191423|FG000|NOT COMPLETED|Overall Study||5||
48351872|NCT00561353|101191424|FG001|NOT COMPLETED|Overall Study||3||
48351873|NCT00561353|101191425|FG002|NOT COMPLETED|Overall Study||3||
48351874|NCT00561353|101191426|FG003|NOT COMPLETED|Overall Study||6||
48416685|NCT02129192|101353458|FG001|COMPLETED|Period 1 Including Washout Period||35||
48351875|NCT00561353|101191427|FG004|NOT COMPLETED|Overall Study||1||
48351876|NCT00561353|101191428|FG005|NOT COMPLETED|Overall Study||6||
48351877|NCT00561353|101191429|FG006|NOT COMPLETED|Overall Study||6||
48351878|NCT00561353|101191430|FG007|NOT COMPLETED|Overall Study||4||
48351879|NCT00561353|101191431|FG008|NOT COMPLETED|Overall Study||7||
48351880|NCT00561353|101191432|FG009|NOT COMPLETED|Overall Study||2||
48351881|NCT01856673|101191433|FG000|STARTED|Overall Study||175||
48351882|NCT01856673|101191434|FG001|STARTED|Overall Study||175||
48351883|NCT01856673|101191435|FG002|STARTED|Overall Study||171||
48351884|NCT01856673|101191433|FG000|Buenaventura Participants|Overall Study||92||
48351885|NCT01856673|101191434|FG001|Buenaventura Participants|Overall Study||89||
48351886|NCT01856673|101191435|FG002|Buenaventura Participants|Overall Study||88||
48761414|NCT00400179|102203049|FG000|COMPLETED|Overall Study||521||
48761415|NCT00400179|102203050|FG001|COMPLETED|Overall Study||508||
48761416|NCT00400179|102203049|FG000|NOT COMPLETED|Overall Study||6||
48351887|NCT01856673|101191433|FG000|Quibdó Participants|Overall Study||83||
48351888|NCT01856673|101191434|FG001|Quibdó Participants|Overall Study||86||
48351889|NCT01856673|101191435|FG002|Quibdó Participants|Overall Study||83||
48351890|NCT01856673|101191433|FG000|COMPLETED|Overall Study||80||
48351891|NCT01856673|101191434|FG001|COMPLETED|Overall Study||90||
48351892|NCT01856673|101191435|FG002|COMPLETED|Overall Study||137||
48761417|NCT00400179|102203050|FG001|NOT COMPLETED|Overall Study||18||
48761418|NCT04576988|102203051|FG000|STARTED|Double Blind Placebo Controlled (DBPC)||163||
48761419|NCT04576988|102203052|FG001|STARTED|Double Blind Placebo Controlled (DBPC)||160||
48761420|NCT04576988|102203051|FG000|Treated|Double Blind Placebo Controlled (DBPC)||163||
48761421|NCT04576988|102203052|FG001|Treated|Double Blind Placebo Controlled (DBPC)||160||
48761422|NCT04576988|102203051|FG000|COMPLETED|Double Blind Placebo Controlled (DBPC)||159||
48351893|NCT01856673|101191433|FG000|NOT COMPLETED|Overall Study||95||
48351894|NCT01856673|101191434|FG001|NOT COMPLETED|Overall Study||85||
48351895|NCT01856673|101191435|FG002|NOT COMPLETED|Overall Study||34||
48351896|NCT04214080|101191436|FG000|STARTED|Overall Study||20||
48351897|NCT04214080|101191437|FG001|STARTED|Overall Study||20||
48351898|NCT04214080|101191436|FG000|COMPLETED|Overall Study||20||
48351899|NCT04214080|101191437|FG001|COMPLETED|Overall Study||20||
48351900|NCT04214080|101191436|FG000|NOT COMPLETED|Overall Study||0||
48351901|NCT04214080|101191437|FG001|NOT COMPLETED|Overall Study||0||
48351902|NCT00004980|101191438|FG000|STARTED|Overall Study||27||
48351903|NCT00004980|101191439|FG001|STARTED|Overall Study||23||
48351904|NCT00004980|101191438|FG000|COMPLETED|Overall Study||25||
48761423|NCT04576988|102203052|FG001|COMPLETED|Double Blind Placebo Controlled (DBPC)||148||
48351905|NCT00004980|101191439|FG001|COMPLETED|Overall Study||21||
48351906|NCT00004980|101191438|FG000|NOT COMPLETED|Overall Study||2||
48351907|NCT00004980|101191439|FG001|NOT COMPLETED|Overall Study||2||
48351908|NCT01241786|101191440|FG000|STARTED|Overall Study||5||
48351909|NCT01241786|101191440|FG000|COMPLETED|Overall Study||0||
48351910|NCT01241786|101191440|FG000|NOT COMPLETED|Overall Study||5||
48351911|NCT01974323|101191441|FG000|STARTED|Overall Study||1118||
48351912|NCT01974323|101191442|FG001|STARTED|Overall Study||1120||
48351913|NCT01974323|101191441|FG000|COMPLETED|Overall Study||1026||
48351914|NCT01974323|101191442|FG001|COMPLETED|Overall Study||1027||
48351915|NCT01974323|101191441|FG000|NOT COMPLETED|Overall Study||92||
48351916|NCT01974323|101191442|FG001|NOT COMPLETED|Overall Study||93||
48351917|NCT00446030|101191443|FG000|STARTED|TREATMENT (up to 52 Weeks)||93||
48351918|NCT00446030|101191444|FG001|STARTED|TREATMENT (up to 52 Weeks)||34||
48761424|NCT04576988|102203051|FG000|NOT COMPLETED|Double Blind Placebo Controlled (DBPC)||4||
48761425|NCT04576988|102203052|FG001|NOT COMPLETED|Double Blind Placebo Controlled (DBPC)||12||
48761426|NCT04576988|102203051|FG000|STARTED|Long Term Double Blind (LTDB)||159||
48761427|NCT04576988|102203052|FG001|STARTED|Long Term Double Blind (LTDB)||142||
48761428|NCT04576988|102203051|FG000|Treated|Long Term Double Blind (LTDB)||158||
48761429|NCT04576988|102203052|FG001|Treated|Long Term Double Blind (LTDB)||142||
48761430|NCT04576988|102203051|FG000|COMPLETED|Long Term Double Blind (LTDB)||155||
48761431|NCT04576988|102203052|FG001|COMPLETED|Long Term Double Blind (LTDB)||136||
48351919|NCT00446030|101191443|FG000|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||92||
48351920|NCT00446030|101191444|FG001|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||34||
48351921|NCT00446030|101191443|FG000|COMPLETED|TREATMENT (up to 52 Weeks)||49||
48351922|NCT00446030|101191444|FG001|COMPLETED|TREATMENT (up to 52 Weeks)||25||
48351923|NCT00446030|101191443|FG000|NOT COMPLETED|TREATMENT (up to 52 Weeks)||44||
48368117|NCT03196297|101230110|FG000|STARTED|Extension Period||32||
48351924|NCT00446030|101191444|FG001|NOT COMPLETED|TREATMENT (up to 52 Weeks)||9||
48351925|NCT00446030|101191443|FG000|STARTED|FOLLOW-UP (up to 2-years)||93||
48351926|NCT00446030|101191444|FG001|STARTED|FOLLOW-UP (up to 2-years)||34||
48351927|NCT00446030|101191443|FG000|COMPLETED|FOLLOW-UP (up to 2-years)||63||
48351928|NCT00446030|101191444|FG001|COMPLETED|FOLLOW-UP (up to 2-years)||25||
48351929|NCT00446030|101191443|FG000|NOT COMPLETED|FOLLOW-UP (up to 2-years)||30||
48351930|NCT00446030|101191444|FG001|NOT COMPLETED|FOLLOW-UP (up to 2-years)||9||
48351931|NCT04925570|101191445|FG000|STARTED|Overall Study||131||
48351932|NCT04925570|101191446|FG001|STARTED|Overall Study||127||
48351933|NCT04925570|101191445|FG000|COMPLETED|Overall Study||107||
48351934|NCT04925570|101191446|FG001|COMPLETED|Overall Study||95||
48351935|NCT04925570|101191445|FG000|NOT COMPLETED|Overall Study||24||
48351936|NCT04925570|101191446|FG001|NOT COMPLETED|Overall Study||32||
48351937|NCT00659295|101191447|FG000|STARTED|Overall Study||13529||
48351938|NCT00659295|101191448|FG001|STARTED|Overall Study||37641||
48351939|NCT00659295|101191447|FG000|COMPLETED|Overall Study||10821||
48351940|NCT00659295|101191448|FG001|COMPLETED|Overall Study||32038||
48351941|NCT00659295|101191447|FG000|NOT COMPLETED|Overall Study||2708||
48351942|NCT00659295|101191448|FG001|NOT COMPLETED|Overall Study||5603||
48351943|NCT04714372|101191449|FG000|STARTED|Overall Study||1||
48351944|NCT04714372|101191450|FG001|STARTED|Overall Study||1||
48351945|NCT04714372|101191451|FG002|STARTED|Overall Study||1||
48351946|NCT04714372|101191452|FG003|STARTED|Overall Study||6||
48351947|NCT04714372|101191449|FG000|COMPLETED|Overall Study||1||
48351948|NCT04714372|101191450|FG001|COMPLETED|Overall Study||1||
48351949|NCT04714372|101191451|FG002|COMPLETED|Overall Study||1||
48351950|NCT04714372|101191452|FG003|COMPLETED|Overall Study||2||
48351951|NCT04714372|101191449|FG000|NOT COMPLETED|Overall Study||0||
48351952|NCT04714372|101191450|FG001|NOT COMPLETED|Overall Study||0||
48351953|NCT04714372|101191451|FG002|NOT COMPLETED|Overall Study||0||
48351954|NCT04714372|101191452|FG003|NOT COMPLETED|Overall Study||4||
48351955|NCT00942162|101191453|FG000|STARTED|Overall Study||71||
48351956|NCT00942162|101191454|FG001|STARTED|Overall Study||50||
48351957|NCT00942162|101191455|FG002|STARTED|Overall Study||2||
48351958|NCT00942162|101191453|FG000|COMPLETED|Overall Study||1||
48351959|NCT00942162|101191454|FG001|COMPLETED|Overall Study||0||
48351960|NCT00942162|101191455|FG002|COMPLETED|Overall Study||0||
48351961|NCT00942162|101191453|FG000|NOT COMPLETED|Overall Study||70||
48351962|NCT00942162|101191454|FG001|NOT COMPLETED|Overall Study||50||
48351963|NCT00942162|101191455|FG002|NOT COMPLETED|Overall Study||2||
48351964|NCT01901224|101191456|FG000|STARTED|Overall Study||2||
48351965|NCT01901224|101191456|FG000|COMPLETED|Overall Study||0||
48351966|NCT01901224|101191456|FG000|NOT COMPLETED|Overall Study||2||
48351967|NCT03456115|101191457|FG000|STARTED|Overall Study||36||
48351968|NCT03456115|101191457|FG000|COMPLETED|Overall Study||36||
48351969|NCT03456115|101191457|FG000|NOT COMPLETED|Overall Study||0||
48351970|NCT03723447|101191458|FG000|STARTED|Overall Study||50||
48351971|NCT03723447|101191459|FG001|STARTED|Overall Study||51||
48351972|NCT03723447|101191458|FG000|COMPLETED|Overall Study||50||
48761432|NCT04576988|102203051|FG000|NOT COMPLETED|Long Term Double Blind (LTDB)||4||
48761433|NCT04576988|102203052|FG001|NOT COMPLETED|Long Term Double Blind (LTDB)||6||
48761434|NCT04052334|102203053|FG000|STARTED|Overall Study||9||
48761435|NCT04052334|102203053|FG000|COMPLETED|Overall Study||5||
48761436|NCT04052334|102203053|FG000|NOT COMPLETED|Overall Study||4||
48351973|NCT03723447|101191459|FG001|COMPLETED|Overall Study||51||
48351974|NCT03723447|101191458|FG000|NOT COMPLETED|Overall Study||0||
48351975|NCT03723447|101191459|FG001|NOT COMPLETED|Overall Study||0||
48351976|NCT04084392|101191460|FG000|STARTED|Overall Study||168||
48351977|NCT04084392|101191461|FG001|STARTED|Overall Study||167||
48351978|NCT04084392|101191460|FG000|COMPLETED|Overall Study||168||
48351979|NCT04084392|101191461|FG001|COMPLETED|Overall Study||167||
48351980|NCT04084392|101191460|FG000|NOT COMPLETED|Overall Study||0||
48351981|NCT04084392|101191461|FG001|NOT COMPLETED|Overall Study||0||
48351982|NCT02863848|101191462|FG000|STARTED|Overall Study||11||
48351983|NCT02863848|101191463|FG001|STARTED|Overall Study||11||
48761437|NCT02380573|102203054|FG000|STARTED|Overall Study||22||
48761438|NCT02380573|102203055|FG001|STARTED|Overall Study||21||
48761439|NCT02380573|102203056|FG002|STARTED|Overall Study||28||
48761440|NCT02380573|102203057|FG003|STARTED|Overall Study||24||
48761441|NCT02380573|102203058|FG004|STARTED|Overall Study||1||
48761442|NCT02380573|102203059|FG005|STARTED|Overall Study||2||
48761443|NCT02380573|102203060|FG006|STARTED|Overall Study||0||
48351984|NCT02863848|101191462|FG000|COMPLETED|Overall Study||9||
48351985|NCT02863848|101191463|FG001|COMPLETED|Overall Study||8||
48351986|NCT02863848|101191462|FG000|NOT COMPLETED|Overall Study||2||
48351987|NCT02863848|101191463|FG001|NOT COMPLETED|Overall Study||3||
48761444|NCT02380573|102203061|FG007|STARTED|Overall Study||0||
48761445|NCT02380573|102203054|FG000|COMPLETED|Overall Study||12||
48351988|NCT00538681|101191464|FG000|STARTED|Overall Study||9||
48351989|NCT00538681|101191465|FG001|STARTED|Overall Study||4||
48351990|NCT00538681|101191466|FG002|STARTED|Overall Study||11||
48351991|NCT00538681|101191467|FG003|STARTED|Overall Study||11||
48351992|NCT00538681|101191464|FG000|Received ≥1 Dose of Any Study Drug|Overall Study||9||
48351993|NCT00538681|101191465|FG001|Received ≥1 Dose of Any Study Drug|Overall Study||4||
48351994|NCT00538681|101191466|FG002|Received ≥1 Dose of Any Study Drug|Overall Study||11||
48351995|NCT00538681|101191467|FG003|Received ≥1 Dose of Any Study Drug|Overall Study||11||
48351996|NCT00538681|101191464|FG000|COMPLETED|Overall Study||0||
48351997|NCT00538681|101191465|FG001|COMPLETED|Overall Study||0||
48351998|NCT00538681|101191466|FG002|COMPLETED|Overall Study||0||
48351999|NCT00538681|101191467|FG003|COMPLETED|Overall Study||0||
48352000|NCT00538681|101191464|FG000|NOT COMPLETED|Overall Study||9||
48761446|NCT02380573|102203055|FG001|COMPLETED|Overall Study||13||
48761447|NCT02380573|102203056|FG002|COMPLETED|Overall Study||12||
48761448|NCT02380573|102203057|FG003|COMPLETED|Overall Study||16||
48761449|NCT02380573|102203058|FG004|COMPLETED|Overall Study||1||
48761450|NCT02380573|102203059|FG005|COMPLETED|Overall Study||1||
48761451|NCT02380573|102203060|FG006|COMPLETED|Overall Study||0||
48761452|NCT02380573|102203061|FG007|COMPLETED|Overall Study||0||
48761453|NCT02380573|102203054|FG000|NOT COMPLETED|Overall Study||10||
48761454|NCT02380573|102203055|FG001|NOT COMPLETED|Overall Study||8||
48761455|NCT02380573|102203056|FG002|NOT COMPLETED|Overall Study||16||
48761456|NCT02380573|102203057|FG003|NOT COMPLETED|Overall Study||8||
48761457|NCT02380573|102203058|FG004|NOT COMPLETED|Overall Study||0||
48761458|NCT02380573|102203059|FG005|NOT COMPLETED|Overall Study||1||
48761459|NCT02380573|102203060|FG006|NOT COMPLETED|Overall Study||0||
48761460|NCT02380573|102203061|FG007|NOT COMPLETED|Overall Study||0||
48761461|NCT04966013|102203062|FG000|STARTED|Overall Study||28||
48761462|NCT04966013|102203063|FG001|STARTED|Overall Study||117||
48761463|NCT04966013|102203064|FG002|STARTED|Overall Study||71||
48761464|NCT04966013|102203062|FG000|COMPLETED|Overall Study||26||
48761465|NCT04966013|102203063|FG001|COMPLETED|Overall Study||114||
48761466|NCT04966013|102203064|FG002|COMPLETED|Overall Study||69||
48761467|NCT04966013|102203062|FG000|NOT COMPLETED|Overall Study||2||
48761468|NCT04966013|102203063|FG001|NOT COMPLETED|Overall Study||3||
48761469|NCT04966013|102203064|FG002|NOT COMPLETED|Overall Study||2||
48761470|NCT02052778|102203065|FG000|STARTED|Dose Escalation(Approximately 60 Months)||6|Participants who were enrolled and treated.|
48761471|NCT02052778|102203066|FG001|STARTED|Dose Escalation(Approximately 60 Months)||3|Participants who were enrolled and treated.|
48761472|NCT02052778|102203067|FG002|STARTED|Dose Escalation(Approximately 60 Months)||3|Participants who were enrolled and treated.|
48761473|NCT02052778|102203068|FG003|STARTED|Dose Escalation(Approximately 60 Months)||3|Participants who were enrolled and treated.|
48761474|NCT02052778|102203069|FG004|STARTED|Dose Escalation(Approximately 60 Months)||3|Participants who were enrolled and treated.|
48761475|NCT02052778|102203070|FG005|STARTED|Dose Escalation(Approximately 60 Months)||5|Participants who were enrolled and treated.|
48352001|NCT00538681|101191465|FG001|NOT COMPLETED|Overall Study||4||
48352002|NCT00538681|101191466|FG002|NOT COMPLETED|Overall Study||11||
48352003|NCT00538681|101191467|FG003|NOT COMPLETED|Overall Study||11||
48352004|NCT03716726|101191468|FG000|STARTED|Completed Baseline Assessment||51||2
48352005|NCT03716726|101191469|FG001|STARTED|Completed Baseline Assessment||61||2
48352006|NCT03716726|101191468|FG000|COMPLETED|Completed Baseline Assessment||41||2
48352007|NCT03716726|101191469|FG001|COMPLETED|Completed Baseline Assessment||49||2
48352008|NCT03716726|101191468|FG000|NOT COMPLETED|Completed Baseline Assessment||10||0
48352009|NCT03716726|101191469|FG001|NOT COMPLETED|Completed Baseline Assessment||12||0
48352010|NCT03716726|101191468|FG000|STARTED|12 Months Followup||41||2
48352011|NCT03716726|101191469|FG001|STARTED|12 Months Followup||49||2
48352012|NCT03716726|101191468|FG000|COMPLETED|12 Months Followup||31||2
48352013|NCT03716726|101191469|FG001|COMPLETED|12 Months Followup||32||2
48352014|NCT03716726|101191468|FG000|NOT COMPLETED|12 Months Followup||10||0
48352015|NCT03716726|101191469|FG001|NOT COMPLETED|12 Months Followup||17||0
48352016|NCT02665689|101191470|FG000|STARTED|Overall Study||2||
48352017|NCT02665689|101191471|FG001|STARTED|Overall Study||2||
48352018|NCT02665689|101191470|FG000|COMPLETED|Overall Study||0||
48352019|NCT02665689|101191471|FG001|COMPLETED|Overall Study||0||
48761476|NCT02052778|102203071|FG006|STARTED|Dose Escalation(Approximately 60 Months)||4|Participants who were enrolled and treated.|
48761477|NCT02052778|102203072|FG007|STARTED|Dose Escalation(Approximately 60 Months)||8|Participants who were enrolled and treated.|
48761478|NCT02052778|102203073|FG008|STARTED|Dose Escalation(Approximately 60 Months)||7|Participants who were enrolled and treated.|
48761479|NCT02052778|102203074|FG009|STARTED|Dose Escalation(Approximately 60 Months)||4|Participants who were enrolled and treated.|
48761480|NCT02052778|102203075|FG010|STARTED|Dose Escalation(Approximately 60 Months)||5|Participants who were enrolled and treated.|
48352020|NCT02665689|101191470|FG000|NOT COMPLETED|Overall Study||2||
48352021|NCT02665689|101191471|FG001|NOT COMPLETED|Overall Study||2||
48352022|NCT02495779|101191472|FG000|STARTED|Overall Study||54||
48416686|NCT02129192|101353457|FG000|NOT COMPLETED|Period 1 Including Washout Period||0||
48352023|NCT02495779|101191472|FG000|COMPLETED|Overall Study||48||
48352024|NCT02495779|101191472|FG000|NOT COMPLETED|Overall Study||6||
48352025|NCT02043574|101191473|FG000|STARTED|Overall Study||25||
48352026|NCT02043574|101191474|FG001|STARTED|Overall Study||26||
48352027|NCT02043574|101191473|FG000|COMPLETED|Overall Study||19||
48352028|NCT02043574|101191474|FG001|COMPLETED|Overall Study||20||
48352029|NCT02043574|101191473|FG000|NOT COMPLETED|Overall Study||6||
48352030|NCT02043574|101191474|FG001|NOT COMPLETED|Overall Study||6||
48352031|NCT01379625|101191475|FG000|STARTED|Overall Study||16||
48352032|NCT01379625|101191476|FG001|STARTED|Overall Study||16||
48352033|NCT01379625|101191475|FG000|COMPLETED|Overall Study||16||
48352034|NCT01379625|101191476|FG001|COMPLETED|Overall Study||16||
48352035|NCT01379625|101191475|FG000|NOT COMPLETED|Overall Study||0||
48352036|NCT01379625|101191476|FG001|NOT COMPLETED|Overall Study||0||
48352037|NCT03431012|101191477|FG000|STARTED|Overall Study||47||
48352038|NCT03431012|101191478|FG001|STARTED|Overall Study||60||
48352039|NCT03431012|101191479|FG002|STARTED|Overall Study||56||
48352040|NCT03431012|101191480|FG003|STARTED|Overall Study||53||
48352041|NCT03431012|101191477|FG000|COMPLETED|Overall Study||47||
48352042|NCT03431012|101191478|FG001|COMPLETED|Overall Study||60||
48352043|NCT03431012|101191479|FG002|COMPLETED|Overall Study||56||
48352044|NCT03431012|101191480|FG003|COMPLETED|Overall Study||53||
48352045|NCT03431012|101191477|FG000|NOT COMPLETED|Overall Study||0||
48352046|NCT03431012|101191478|FG001|NOT COMPLETED|Overall Study||0||
48352047|NCT03431012|101191479|FG002|NOT COMPLETED|Overall Study||0||
48352048|NCT03431012|101191480|FG003|NOT COMPLETED|Overall Study||0||
48352049|NCT01740362|101191481|FG000|STARTED|Overall Study||6||
48352050|NCT01740362|101191482|FG001|STARTED|Overall Study||6||
48352051|NCT01740362|101191483|FG002|STARTED|Overall Study||6||
48352052|NCT01740362|101191484|FG003|STARTED|Overall Study||6||
48352053|NCT01740362|101191481|FG000|COMPLETED|Overall Study||6||
48352054|NCT01740362|101191482|FG001|COMPLETED|Overall Study||6||
48352055|NCT01740362|101191483|FG002|COMPLETED|Overall Study||6||
48352056|NCT01740362|101191484|FG003|COMPLETED|Overall Study||6||
48352057|NCT01740362|101191481|FG000|NOT COMPLETED|Overall Study||0||
48352058|NCT01740362|101191482|FG001|NOT COMPLETED|Overall Study||0||
48352059|NCT01740362|101191483|FG002|NOT COMPLETED|Overall Study||0||
48352060|NCT01740362|101191484|FG003|NOT COMPLETED|Overall Study||0||
48352061|NCT01714921|101191485|FG000|STARTED|Overall Study||504||
48352062|NCT01714921|101191485|FG000|COMPLETED|Overall Study||311||
48352063|NCT01714921|101191485|FG000|NOT COMPLETED|Overall Study||193||
48352064|NCT03717922|101191486|FG000|STARTED|Overall Study||10||
48352065|NCT03717922|101191487|FG001|STARTED|Overall Study||11||
48352066|NCT03717922|101191486|FG000|Completed Visit 1|Overall Study||10||
48352067|NCT03717922|101191487|FG001|Completed Visit 1|Overall Study||11||
48352068|NCT03717922|101191486|FG000|COMPLETED|Overall Study||8|Completed Visits 1 \& 2|
48352069|NCT03717922|101191487|FG001|COMPLETED|Overall Study||9|Completed Visits 1 \& 2|
48352070|NCT03717922|101191486|FG000|NOT COMPLETED|Overall Study||2||
48352071|NCT03717922|101191487|FG001|NOT COMPLETED|Overall Study||2||
48352072|NCT03615222|101191488|FG000|STARTED|Overall Study||377||
48352073|NCT03615222|101191488|FG000|COMPLETED|Overall Study||343||
48352074|NCT03615222|101191488|FG000|NOT COMPLETED|Overall Study||34||
48352075|NCT00384956|101191489|FG000|STARTED|Overall Study||25||
48352076|NCT00384956|101191489|FG000|COMPLETED|Overall Study||22||
48352077|NCT00384956|101191489|FG000|NOT COMPLETED|Overall Study||3||
48352078|NCT01670201|101191490|FG000|STARTED|Overall Study||8||
48352079|NCT01670201|101191490|FG000|COMPLETED|Overall Study||8||
48352080|NCT01670201|101191490|FG000|NOT COMPLETED|Overall Study||0||
48352081|NCT02951273|101191491|FG000|STARTED|Overall Study||30||
48352082|NCT02951273|101191491|FG000|COMPLETED|Overall Study||27||
48352083|NCT02951273|101191491|FG000|NOT COMPLETED|Overall Study||3||
48352084|NCT01451515|101191492|FG000|STARTED|Overall Study||12||
48352085|NCT01451515|101191493|FG001|STARTED|Overall Study||7||
48352086|NCT01451515|101191494|FG002|STARTED|Overall Study||4||
48352087|NCT01451515|101191492|FG000|COMPLETED|Overall Study||11||
48352088|NCT01451515|101191493|FG001|COMPLETED|Overall Study||4||
48352089|NCT01451515|101191494|FG002|COMPLETED|Overall Study||3||
48352090|NCT01451515|101191492|FG000|NOT COMPLETED|Overall Study||1||
48352091|NCT01451515|101191493|FG001|NOT COMPLETED|Overall Study||3||
48352092|NCT01451515|101191494|FG002|NOT COMPLETED|Overall Study||1||
48352093|NCT00934895|101191495|FG000|STARTED|Overall Study||0||
48352094|NCT00934895|101191496|FG001|STARTED|Overall Study||0||
48352095|NCT00934895|101191497|FG002|STARTED|Overall Study||3||
48352096|NCT00934895|101191498|FG003|STARTED|Overall Study||6||
48352097|NCT00934895|101191499|FG004|STARTED|Overall Study||4||
48416687|NCT02129192|101353458|FG001|NOT COMPLETED|Period 1 Including Washout Period||1||
48352098|NCT00934895|101191500|FG005|STARTED|Overall Study||0||
48416688|NCT02129192|101353457|FG000|STARTED|Period 2 Including Washout Period||36||
48352099|NCT00934895|101191501|FG006|STARTED|Overall Study||14||
48352100|NCT00934895|101191495|FG000|COMPLETED|Overall Study||0||
48352101|NCT00934895|101191496|FG001|COMPLETED|Overall Study||0||
48352102|NCT00934895|101191497|FG002|COMPLETED|Overall Study||3||
48352103|NCT00934895|101191498|FG003|COMPLETED|Overall Study||6||
48352104|NCT00934895|101191499|FG004|COMPLETED|Overall Study||4||
48352105|NCT00934895|101191500|FG005|COMPLETED|Overall Study||0||
48352106|NCT00934895|101191501|FG006|COMPLETED|Overall Study||14||
48352107|NCT00934895|101191495|FG000|NOT COMPLETED|Overall Study||0||
48352108|NCT00934895|101191496|FG001|NOT COMPLETED|Overall Study||0||
48352109|NCT00934895|101191497|FG002|NOT COMPLETED|Overall Study||0||
48352110|NCT00934895|101191498|FG003|NOT COMPLETED|Overall Study||0||
48352111|NCT00934895|101191499|FG004|NOT COMPLETED|Overall Study||0||
48352112|NCT00934895|101191500|FG005|NOT COMPLETED|Overall Study||0||
48352113|NCT00934895|101191501|FG006|NOT COMPLETED|Overall Study||0||
48352114|NCT02201940|101191502|FG000|STARTED|Overall Study||625||
48352115|NCT02201940|101191503|FG001|STARTED|Overall Study||116||
48352116|NCT02201940|101191502|FG000|COMPLETED|Overall Study||613||
48352117|NCT02201940|101191503|FG001|COMPLETED|Overall Study||0||
48352118|NCT02201940|101191502|FG000|NOT COMPLETED|Overall Study||12||
48352119|NCT02201940|101191503|FG001|NOT COMPLETED|Overall Study||116||
48352120|NCT02717507|101191504|FG000|STARTED|Overall Study||89||
48352121|NCT02717507|101191505|FG001|STARTED|Overall Study||93||
48352122|NCT02717507|101191504|FG000|2nd Timepoint Assessment of Echocardiology Required to be Analyzable|Overall Study||75|31 participants who did not have a second timepoint assessment of echocardiography were excluded, resulting in 151 analyzable participants.|
48352123|NCT02717507|101191505|FG001|2nd Timepoint Assessment of Echocardiology Required to be Analyzable|Overall Study||76|31 participants who did not have a second timepoint assessment of echocardiography were excluded, resulting in 151 analyzable participants.|
48352124|NCT02717507|101191504|FG000|COMPLETED|Overall Study||58||
48352125|NCT02717507|101191505|FG001|COMPLETED|Overall Study||55||
48352126|NCT02717507|101191504|FG000|NOT COMPLETED|Overall Study||31||
48352127|NCT02717507|101191505|FG001|NOT COMPLETED|Overall Study||38||
48352128|NCT02010203|101191506|FG000|STARTED|Overall Study||10||
48352129|NCT02010203|101191507|FG001|STARTED|Overall Study||26||
48352130|NCT02010203|101191508|FG002|STARTED|Overall Study||26||
48352131|NCT02010203|101191509|FG003|STARTED|Overall Study||26||
48352132|NCT02010203|101191510|FG004|STARTED|Overall Study||16||
48352133|NCT02010203|101191506|FG000|COMPLETED|Overall Study||10||
48352134|NCT02010203|101191507|FG001|COMPLETED|Overall Study||17||
48352135|NCT02010203|101191508|FG002|COMPLETED|Overall Study||16||
48352136|NCT02010203|101191509|FG003|COMPLETED|Overall Study||23||
48352137|NCT02010203|101191510|FG004|COMPLETED|Overall Study||3||
48352138|NCT02010203|101191506|FG000|NOT COMPLETED|Overall Study||0||
48352139|NCT02010203|101191507|FG001|NOT COMPLETED|Overall Study||9||
48352140|NCT02010203|101191508|FG002|NOT COMPLETED|Overall Study||10||
48352141|NCT02010203|101191509|FG003|NOT COMPLETED|Overall Study||3||
48352142|NCT02010203|101191510|FG004|NOT COMPLETED|Overall Study||13||
48352143|NCT04488822|101191511|FG000|STARTED|Overall Study||40||
48352144|NCT04488822|101191511|FG000|COMPLETED|Overall Study||31|Completed = Participants ongoing treatment as of 27 Oct 2021, Not Completed =Participants who discontinued treatment|
48352145|NCT04488822|101191511|FG000|NOT COMPLETED|Overall Study||9||
48352146|NCT00967941|101191512|FG000|STARTED|Overall Study||67||
48352147|NCT00967941|101191513|FG001|STARTED|Overall Study||54||
48352148|NCT00967941|101191514|FG002|STARTED|Overall Study||60||
48352149|NCT00967941|101191512|FG000|COMPLETED|Overall Study||62||
48352150|NCT00967941|101191513|FG001|COMPLETED|Overall Study||51||
48352151|NCT00967941|101191514|FG002|COMPLETED|Overall Study||56||
48352152|NCT00967941|101191512|FG000|NOT COMPLETED|Overall Study||5||
48352153|NCT00967941|101191513|FG001|NOT COMPLETED|Overall Study||3||
48352154|NCT00967941|101191514|FG002|NOT COMPLETED|Overall Study||4||
48352155|NCT02351115|101191515|FG000|STARTED|Overall Study||1||
48352156|NCT02351115|101191516|FG001|STARTED|Overall Study||1||
48352157|NCT02351115|101191517|FG002|STARTED|Overall Study||1||
48352158|NCT02351115|101191518|FG003|STARTED|Overall Study||1||
48352159|NCT02351115|101191519|FG004|STARTED|Overall Study||1||
48352160|NCT02351115|101191515|FG000|COMPLETED|Overall Study||1||
48352161|NCT02351115|101191516|FG001|COMPLETED|Overall Study||1||
48352162|NCT02351115|101191517|FG002|COMPLETED|Overall Study||1||
48352163|NCT02351115|101191518|FG003|COMPLETED|Overall Study||1||
48352164|NCT02351115|101191519|FG004|COMPLETED|Overall Study||1||
48352165|NCT02351115|101191515|FG000|NOT COMPLETED|Overall Study||0||
48352166|NCT02351115|101191516|FG001|NOT COMPLETED|Overall Study||0||
48761481|NCT02052778|102203076|FG011|STARTED|Dose Escalation(Approximately 60 Months)||14|Participants who were enrolled and treated.|
48761482|NCT02052778|102203077|FG012|STARTED|Dose Escalation(Approximately 60 Months)||7|Participants who were enrolled and treated.|
48761483|NCT02052778|102203078|FG013|STARTED|Dose Escalation(Approximately 60 Months)||14|Participants who were enrolled and treated.|
48352167|NCT02351115|101191517|FG002|NOT COMPLETED|Overall Study||0||
48352168|NCT02351115|101191518|FG003|NOT COMPLETED|Overall Study||0||
48352169|NCT02351115|101191519|FG004|NOT COMPLETED|Overall Study||0||
48352170|NCT02015819|101191520|FG000|STARTED|Overall Study||3||
48352171|NCT02015819|101191521|FG001|STARTED|Overall Study||3||
48352172|NCT02015819|101191522|FG002|STARTED|Overall Study||3||
48352173|NCT02015819|101191523|FG003|STARTED|Overall Study||7||
48352174|NCT02015819|101191520|FG000|COMPLETED|Overall Study||3||
48352175|NCT02015819|101191521|FG001|COMPLETED|Overall Study||3||
48352176|NCT02015819|101191522|FG002|COMPLETED|Overall Study||3||
48761484|NCT02052778|102203079|FG014|STARTED|Dose Escalation(Approximately 60 Months)||0|Participants who were enrolled and treated.|
48352177|NCT02015819|101191523|FG003|COMPLETED|Overall Study||6||
48352178|NCT02015819|101191520|FG000|NOT COMPLETED|Overall Study||0||
48352179|NCT02015819|101191521|FG001|NOT COMPLETED|Overall Study||0||
48352180|NCT02015819|101191522|FG002|NOT COMPLETED|Overall Study||0||
48352181|NCT02015819|101191523|FG003|NOT COMPLETED|Overall Study||1||
48352182|NCT02017444|101191524|FG000|STARTED|Overall Study||14||
48352183|NCT02017444|101191525|FG001|STARTED|Overall Study||17||
48352184|NCT02017444|101191524|FG000|COMPLETED|Overall Study||12||
48352185|NCT02017444|101191525|FG001|COMPLETED|Overall Study||17||
48352186|NCT02017444|101191524|FG000|NOT COMPLETED|Overall Study||2||
48352187|NCT02017444|101191525|FG001|NOT COMPLETED|Overall Study||0||
48352188|NCT01154101|101191526|FG000|STARTED|Overall Study||7||
48352189|NCT01154101|101191527|FG001|STARTED|Overall Study||9||
48352190|NCT01154101|101191528|FG002|STARTED|Overall Study||12||
48352191|NCT01154101|101191529|FG003|STARTED|Overall Study||11||
48352192|NCT01154101|101191530|FG004|STARTED|Overall Study||1||
48352193|NCT01154101|101191526|FG000|COMPLETED|Overall Study||7||
48352194|NCT01154101|101191527|FG001|COMPLETED|Overall Study||5||
48352195|NCT01154101|101191528|FG002|COMPLETED|Overall Study||9||
48352196|NCT01154101|101191529|FG003|COMPLETED|Overall Study||9||
48352197|NCT01154101|101191530|FG004|COMPLETED|Overall Study||0||
48352198|NCT01154101|101191526|FG000|NOT COMPLETED|Overall Study||0||
48352199|NCT01154101|101191527|FG001|NOT COMPLETED|Overall Study||4||
48352200|NCT01154101|101191528|FG002|NOT COMPLETED|Overall Study||3||
48352201|NCT01154101|101191529|FG003|NOT COMPLETED|Overall Study||2||
48352202|NCT01154101|101191530|FG004|NOT COMPLETED|Overall Study||1||
48352203|NCT00613314|101191531|FG000|STARTED|Overall Study||15268||
48352204|NCT00613314|101191531|FG000|COMPLETED|Overall Study||15113||
48352205|NCT00613314|101191531|FG000|NOT COMPLETED|Overall Study||155||
48352206|NCT02923271|101191532|FG000|STARTED|Overall Study||18||
48352207|NCT02923271|101191533|FG001|STARTED|Overall Study||16||
48352208|NCT02923271|101191532|FG000|COMPLETED|Overall Study||10||
48352209|NCT02923271|101191533|FG001|COMPLETED|Overall Study||14||
48352210|NCT02923271|101191532|FG000|NOT COMPLETED|Overall Study||8||
48352211|NCT02923271|101191533|FG001|NOT COMPLETED|Overall Study||2||
48352212|NCT02704104|101191534|FG000|STARTED|Overall Study||46||
48352213|NCT02704104|101191534|FG000|COMPLETED|Overall Study||46||
48352214|NCT02704104|101191534|FG000|NOT COMPLETED|Overall Study||0||
48352215|NCT00504257|101191535|FG000|STARTED|Overall Study||45||
48352216|NCT00504257|101191535|FG000|COMPLETED|Overall Study||41||
48352217|NCT00504257|101191535|FG000|NOT COMPLETED|Overall Study||4||
48352218|NCT03459040|101191536|FG000|STARTED|Overall Study||30||
48352219|NCT03459040|101191536|FG000|COMPLETED|Overall Study||21||
48352220|NCT03459040|101191536|FG000|NOT COMPLETED|Overall Study||9||
48352221|NCT03822884|101191537|FG000|STARTED|Overall Study||4||
48352222|NCT03822884|101191538|FG001|STARTED|Overall Study||4||
48352223|NCT03822884|101191539|FG002|STARTED|Overall Study||4||
48352224|NCT03822884|101191540|FG003|STARTED|Overall Study||4||
48352225|NCT03822884|101191541|FG004|STARTED|Overall Study||4||
48352226|NCT03822884|101191542|FG005|STARTED|Overall Study||4||
48352227|NCT03822884|101191537|FG000|COMPLETED|Overall Study||4||
48352228|NCT03822884|101191538|FG001|COMPLETED|Overall Study||4||
48352229|NCT03822884|101191539|FG002|COMPLETED|Overall Study||4||
48352230|NCT03822884|101191540|FG003|COMPLETED|Overall Study||4||
48352231|NCT03822884|101191541|FG004|COMPLETED|Overall Study||3||
48761485|NCT02052778|102203080|FG015|STARTED|Dose Escalation(Approximately 60 Months)||0|Participants who were enrolled and treated.|
48761486|NCT02052778|102203081|FG016|STARTED|Dose Escalation(Approximately 60 Months)||0|Participants who were enrolled and treated.|
48761487|NCT02052778|102203082|FG017|STARTED|Dose Escalation(Approximately 60 Months)||0|Participants who were enrolled and treated.|
48761488|NCT02052778|102203083|FG018|STARTED|Dose Escalation(Approximately 60 Months)||0|Participants who were enrolled and treated.|
48352232|NCT03822884|101191542|FG005|COMPLETED|Overall Study||4||
48352233|NCT03822884|101191537|FG000|NOT COMPLETED|Overall Study||0||
48352234|NCT03822884|101191538|FG001|NOT COMPLETED|Overall Study||0||
48352235|NCT03822884|101191539|FG002|NOT COMPLETED|Overall Study||0||
48352236|NCT03822884|101191540|FG003|NOT COMPLETED|Overall Study||0||
48352237|NCT03822884|101191541|FG004|NOT COMPLETED|Overall Study||1||
48352238|NCT03822884|101191542|FG005|NOT COMPLETED|Overall Study||0||
48416689|NCT02129192|101353458|FG001|STARTED|Period 2 Including Washout Period||35||
48416690|NCT02129192|101353457|FG000|COMPLETED|Period 2 Including Washout Period||36||
48416691|NCT02129192|101353458|FG001|COMPLETED|Period 2 Including Washout Period||35||
48352239|NCT02265913|101191543|FG000|STARTED|Overall Study||1357||
48761489|NCT02052778|102203084|FG019|STARTED|Dose Escalation(Approximately 60 Months)||0|Participants who were enrolled and treated.|
48761490|NCT02052778|102203085|FG020|STARTED|Dose Escalation(Approximately 60 Months)||0|Participants who were enrolled and treated.|
48767770|NCT02237417|102222822|FG002|COMPLETED|Overall Study||7||
48352240|NCT02265913|101191544|FG001|STARTED|Overall Study||1361||
48352241|NCT02265913|101191545|FG002|STARTED|Overall Study||1358||
48352242|NCT02265913|101191543|FG000|COMPLETED|Overall Study||793||
48352243|NCT02265913|101191544|FG001|COMPLETED|Overall Study||810||
48416692|NCT02129192|101353457|FG000|NOT COMPLETED|Period 2 Including Washout Period||0||
48416693|NCT02129192|101353458|FG001|NOT COMPLETED|Period 2 Including Washout Period||0||
48352244|NCT02265913|101191545|FG002|COMPLETED|Overall Study||813||
48352245|NCT02265913|101191543|FG000|NOT COMPLETED|Overall Study||564||
48352246|NCT02265913|101191544|FG001|NOT COMPLETED|Overall Study||551||
48352247|NCT02265913|101191545|FG002|NOT COMPLETED|Overall Study||545||
48352248|NCT00673855|101191546|FG000|STARTED|First Intervention||10||
48352249|NCT00673855|101191547|FG001|STARTED|First Intervention||10||
48352250|NCT00673855|101191546|FG000|COMPLETED|First Intervention||10||
48352251|NCT00673855|101191547|FG001|COMPLETED|First Intervention||10||
48352252|NCT00673855|101191546|FG000|NOT COMPLETED|First Intervention||0||
48352253|NCT00673855|101191547|FG001|NOT COMPLETED|First Intervention||0||
48352254|NCT00673855|101191546|FG000|STARTED|Second Intervention||10||
48352255|NCT00673855|101191547|FG001|STARTED|Second Intervention||10||
48352256|NCT00673855|101191546|FG000|COMPLETED|Second Intervention||10||
48352257|NCT00673855|101191547|FG001|COMPLETED|Second Intervention||10||
48352258|NCT00673855|101191546|FG000|NOT COMPLETED|Second Intervention||0||
48352259|NCT00673855|101191547|FG001|NOT COMPLETED|Second Intervention||0||
48352260|NCT03191786|101191548|FG000|STARTED|Overall Study||302||
48352261|NCT03191786|101191549|FG001|STARTED|Overall Study||151||
48352262|NCT03191786|101191548|FG000|Safety Evaluable Population|Overall Study||300|Safety-evaluable population included all randomized participants who received any amount of study treatment.|
48352263|NCT03191786|101191549|FG001|Safety Evaluable Population|Overall Study||147|Safety-evaluable population included all randomized participants who received any amount of study treatment.|
48352264|NCT03191786|101191548|FG000|COMPLETED|Overall Study||0||
48352265|NCT03191786|101191549|FG001|COMPLETED|Overall Study||0||
48352266|NCT03191786|101191548|FG000|NOT COMPLETED|Overall Study||302||
48352267|NCT03191786|101191549|FG001|NOT COMPLETED|Overall Study||151||
48352268|NCT02868892|101191550|FG000|STARTED|Overall Study||6||
48352269|NCT02868892|101191550|FG000|COMPLETED|Overall Study||0||
48352270|NCT02868892|101191550|FG000|NOT COMPLETED|Overall Study||6||
48352271|NCT02216695|101191551|FG000|STARTED|Overall Study||64882||
48352272|NCT02216695|101191551|FG000|COMPLETED|Overall Study||64882||
48352273|NCT02216695|101191551|FG000|NOT COMPLETED|Overall Study||0||
48352274|NCT00892437|101191552|FG000|STARTED|Randomized Phase||56||
48352275|NCT00892437|101191553|FG001|STARTED|Randomized Phase||29||
48352276|NCT00892437|101191552|FG000|Randomized and Treated|Randomized Phase||50||
48352277|NCT00892437|101191553|FG001|Randomized and Treated|Randomized Phase||29||
48352278|NCT00892437|101191552|FG000|COMPLETED|Randomized Phase||45||
48352279|NCT00892437|101191553|FG001|COMPLETED|Randomized Phase||24||
48352280|NCT00892437|101191552|FG000|NOT COMPLETED|Randomized Phase||11||
48352281|NCT00892437|101191553|FG001|NOT COMPLETED|Randomized Phase||5||
48352282|NCT00892437|101191552|FG000|STARTED|Open-Label Extension Phase||44||
48352283|NCT00892437|101191553|FG001|STARTED|Open-Label Extension Phase||19||
48352284|NCT00892437|101191552|FG000|COMPLETED|Open-Label Extension Phase||32||
48352285|NCT00892437|101191553|FG001|COMPLETED|Open-Label Extension Phase||15||
48352286|NCT00892437|101191552|FG000|NOT COMPLETED|Open-Label Extension Phase||12||
48352287|NCT00892437|101191553|FG001|NOT COMPLETED|Open-Label Extension Phase||4||
48352288|NCT03832387|101191554|FG000|STARTED|Overall Study||38||
48352289|NCT03832387|101191555|FG001|STARTED|Overall Study||39||
48352290|NCT03832387|101191554|FG000|COMPLETED|Overall Study||33||
48352291|NCT03832387|101191555|FG001|COMPLETED|Overall Study||32||
48352292|NCT03832387|101191554|FG000|NOT COMPLETED|Overall Study||5||
48352293|NCT03832387|101191555|FG001|NOT COMPLETED|Overall Study||7||
48352294|NCT01492673|101191556|FG000|STARTED|Overall Study||9||
48416694|NCT02129192|101353457|FG000|STARTED|Period 3 Including Washout Period||36||
48761491|NCT02052778|102203086|FG021|STARTED|Dose Escalation(Approximately 60 Months)||0|Participants who were enrolled and treated.|
48761492|NCT02052778|102203087|FG022|STARTED|Dose Escalation(Approximately 60 Months)||0|Participants who were enrolled and treated.|
48761493|NCT02052778|102203065|FG000|COMPLETED|Dose Escalation(Approximately 60 Months)||0||
48761494|NCT02052778|102203066|FG001|COMPLETED|Dose Escalation(Approximately 60 Months)||0||
48761495|NCT02052778|102203067|FG002|COMPLETED|Dose Escalation(Approximately 60 Months)||0||
48761496|NCT02052778|102203068|FG003|COMPLETED|Dose Escalation(Approximately 60 Months)||0||
48761497|NCT02052778|102203069|FG004|COMPLETED|Dose Escalation(Approximately 60 Months)||0||
48761498|NCT02052778|102203070|FG005|COMPLETED|Dose Escalation(Approximately 60 Months)||0||
48761499|NCT02052778|102203071|FG006|COMPLETED|Dose Escalation(Approximately 60 Months)||0||
48761500|NCT02052778|102203072|FG007|COMPLETED|Dose Escalation(Approximately 60 Months)||0||
48761501|NCT02052778|102203073|FG008|COMPLETED|Dose Escalation(Approximately 60 Months)||0||
48352295|NCT01492673|101191556|FG000|COMPLETED|Overall Study||9||
48352296|NCT01492673|101191556|FG000|NOT COMPLETED|Overall Study||0||
48352297|NCT00775021|101191557|FG000|STARTED|First Intervention||63||
48352298|NCT00775021|101191558|FG001|STARTED|First Intervention||60||
48352299|NCT00775021|101191557|FG000|COMPLETED|First Intervention||62||
48352300|NCT00775021|101191558|FG001|COMPLETED|First Intervention||60||
48352301|NCT00775021|101191557|FG000|NOT COMPLETED|First Intervention||1||
48352302|NCT00775021|101191558|FG001|NOT COMPLETED|First Intervention||0||
48352303|NCT00775021|101191557|FG000|STARTED|Second Intervention||62||
48352304|NCT00775021|101191558|FG001|STARTED|Second Intervention||60||
48352305|NCT00775021|101191557|FG000|COMPLETED|Second Intervention||62||
48352306|NCT00775021|101191558|FG001|COMPLETED|Second Intervention||59||
48352307|NCT00775021|101191557|FG000|NOT COMPLETED|Second Intervention||0||
48352308|NCT00775021|101191558|FG001|NOT COMPLETED|Second Intervention||1||
48352309|NCT00816036|101191559|FG000|STARTED|Overall Study||503||
48352310|NCT00816036|101191560|FG001|STARTED|Overall Study||395||
48352311|NCT00816036|101191559|FG000|COMPLETED|Overall Study||327||
48416695|NCT02129192|101353458|FG001|STARTED|Period 3 Including Washout Period||35||
48352312|NCT00816036|101191560|FG001|COMPLETED|Overall Study||287||
48352313|NCT00816036|101191559|FG000|NOT COMPLETED|Overall Study||176||
48352314|NCT00816036|101191560|FG001|NOT COMPLETED|Overall Study||108||
48352315|NCT01531725|101191561|FG000|STARTED|Overall Study||202||
48352316|NCT01531725|101191561|FG000|COMPLETED|Overall Study||197||
48352317|NCT01531725|101191561|FG000|NOT COMPLETED|Overall Study||5||
48352318|NCT01330290|101191562|FG000|STARTED|Overall Study||148||
48352319|NCT01330290|101191562|FG000|COMPLETED|Overall Study||148||
48352320|NCT01330290|101191562|FG000|NOT COMPLETED|Overall Study||0||
48352321|NCT01217606|101191563|FG000|STARTED|Initial Treatment Phase||90||
48352322|NCT01217606|101191564|FG001|STARTED|Initial Treatment Phase||95||
48352323|NCT01217606|101191563|FG000|COMPLETED|Initial Treatment Phase||76||
48352324|NCT01217606|101191564|FG001|COMPLETED|Initial Treatment Phase||83||
48352325|NCT01217606|101191563|FG000|NOT COMPLETED|Initial Treatment Phase||14||
48352326|NCT01217606|101191564|FG001|NOT COMPLETED|Initial Treatment Phase||12||
48352327|NCT01217606|101191563|FG000|STARTED|9-Month Masked Extension||67||
48352328|NCT01217606|101191564|FG001|STARTED|9-Month Masked Extension||73||
48352329|NCT01217606|101191563|FG000|Not Enrolled in Masked Extension|9-Month Masked Extension||9||
48352330|NCT01217606|101191564|FG001|Not Enrolled in Masked Extension|9-Month Masked Extension||10||
48352331|NCT01217606|101191563|FG000|COMPLETED|9-Month Masked Extension||54||
48352332|NCT01217606|101191564|FG001|COMPLETED|9-Month Masked Extension||62||
48352333|NCT01217606|101191563|FG000|NOT COMPLETED|9-Month Masked Extension||13||
48352334|NCT01217606|101191564|FG001|NOT COMPLETED|9-Month Masked Extension||11||
48352335|NCT01967225|101191565|FG000|STARTED|Overall Study||84||
48352336|NCT01967225|101191566|FG001|STARTED|Overall Study||41||
48352337|NCT01967225|101191565|FG000|Participants Received Treatment|Overall Study||83||
48761502|NCT02052778|102203074|FG009|COMPLETED|Dose Escalation(Approximately 60 Months)||0||
48761503|NCT02052778|102203075|FG010|COMPLETED|Dose Escalation(Approximately 60 Months)||0||
48761504|NCT02052778|102203076|FG011|COMPLETED|Dose Escalation(Approximately 60 Months)||0||
48761505|NCT02052778|102203077|FG012|COMPLETED|Dose Escalation(Approximately 60 Months)||0||
48761506|NCT02052778|102203078|FG013|COMPLETED|Dose Escalation(Approximately 60 Months)||0||
48761507|NCT02052778|102203079|FG014|COMPLETED|Dose Escalation(Approximately 60 Months)||0||
48761508|NCT02052778|102203080|FG015|COMPLETED|Dose Escalation(Approximately 60 Months)||0||
48761509|NCT02052778|102203081|FG016|COMPLETED|Dose Escalation(Approximately 60 Months)||0||
48761510|NCT02052778|102203082|FG017|COMPLETED|Dose Escalation(Approximately 60 Months)||0||
48761511|NCT02052778|102203083|FG018|COMPLETED|Dose Escalation(Approximately 60 Months)||0||
48761512|NCT02052778|102203084|FG019|COMPLETED|Dose Escalation(Approximately 60 Months)||0||
48761513|NCT02052778|102203085|FG020|COMPLETED|Dose Escalation(Approximately 60 Months)||0||
48761514|NCT02052778|102203086|FG021|COMPLETED|Dose Escalation(Approximately 60 Months)||0||
48761515|NCT02052778|102203087|FG022|COMPLETED|Dose Escalation(Approximately 60 Months)||0||
48761516|NCT02052778|102203065|FG000|NOT COMPLETED|Dose Escalation(Approximately 60 Months)||6||
48761517|NCT02052778|102203066|FG001|NOT COMPLETED|Dose Escalation(Approximately 60 Months)||3||
48761518|NCT02052778|102203067|FG002|NOT COMPLETED|Dose Escalation(Approximately 60 Months)||3||
48761519|NCT02052778|102203068|FG003|NOT COMPLETED|Dose Escalation(Approximately 60 Months)||3||
48761520|NCT02052778|102203069|FG004|NOT COMPLETED|Dose Escalation(Approximately 60 Months)||3||
48761521|NCT02052778|102203070|FG005|NOT COMPLETED|Dose Escalation(Approximately 60 Months)||5||
48761522|NCT02052778|102203071|FG006|NOT COMPLETED|Dose Escalation(Approximately 60 Months)||4||
48761523|NCT02052778|102203072|FG007|NOT COMPLETED|Dose Escalation(Approximately 60 Months)||8||
48761524|NCT02052778|102203073|FG008|NOT COMPLETED|Dose Escalation(Approximately 60 Months)||7||
48761525|NCT02052778|102203074|FG009|NOT COMPLETED|Dose Escalation(Approximately 60 Months)||4||
48761526|NCT02052778|102203075|FG010|NOT COMPLETED|Dose Escalation(Approximately 60 Months)||5||
48761527|NCT02052778|102203076|FG011|NOT COMPLETED|Dose Escalation(Approximately 60 Months)||14||
48352338|NCT01967225|101191566|FG001|Participants Received Treatment|Overall Study||41||
48352339|NCT01967225|101191565|FG000|COMPLETED|Overall Study||72||
48352340|NCT01967225|101191566|FG001|COMPLETED|Overall Study||38||
48352341|NCT01967225|101191565|FG000|NOT COMPLETED|Overall Study||12||
48352342|NCT01967225|101191566|FG001|NOT COMPLETED|Overall Study||3||
48352343|NCT00278629|101191567|FG000|STARTED|Overall Study||80||
48352344|NCT00278629|101191567|FG000|COMPLETED|Overall Study||66||
48352345|NCT00278629|101191567|FG000|NOT COMPLETED|Overall Study||14||
48352346|NCT05087030|101191568|FG000|STARTED|Main Period (Week 0 to Week 52)||242||
48352347|NCT05087030|101191569|FG001|STARTED|Main Period (Week 0 to Week 52)||231||
48352348|NCT05087030|101191570|FG002|STARTED|Main Period (Week 0 to Week 52)||0||
48352349|NCT05087030|101191571|FG003|STARTED|Main Period (Week 0 to Week 52)||0||
48352350|NCT05087030|101191572|FG004|STARTED|Main Period (Week 0 to Week 52)||0||
48761528|NCT02052778|102203077|FG012|NOT COMPLETED|Dose Escalation(Approximately 60 Months)||7||
48761529|NCT02052778|102203078|FG013|NOT COMPLETED|Dose Escalation(Approximately 60 Months)||14||
48352351|NCT05087030|101191568|FG000|COMPLETED|Main Period (Week 0 to Week 52)||225||
48352352|NCT05087030|101191569|FG001|COMPLETED|Main Period (Week 0 to Week 52)||211||
48352353|NCT05087030|101191570|FG002|COMPLETED|Main Period (Week 0 to Week 52)||0||
48352354|NCT05087030|101191571|FG003|COMPLETED|Main Period (Week 0 to Week 52)||0||
48352355|NCT05087030|101191572|FG004|COMPLETED|Main Period (Week 0 to Week 52)||0||
48352356|NCT05087030|101191568|FG000|NOT COMPLETED|Main Period (Week 0 to Week 52)||17||
48352357|NCT05087030|101191569|FG001|NOT COMPLETED|Main Period (Week 0 to Week 52)||20||
48352358|NCT05087030|101191570|FG002|NOT COMPLETED|Main Period (Week 0 to Week 52)||0||
48352359|NCT05087030|101191571|FG003|NOT COMPLETED|Main Period (Week 0 to Week 52)||0||
48352360|NCT05087030|101191572|FG004|NOT COMPLETED|Main Period (Week 0 to Week 52)||0||
48352361|NCT05087030|101191568|FG000|STARTED|Transition Period (Week 52 to Week 78)||0||
48352362|NCT05087030|101191569|FG001|STARTED|Transition Period (Week 52 to Week 78)||0||
48352363|NCT05087030|101191570|FG002|STARTED|Transition Period (Week 52 to Week 78)||63||
48352364|NCT05087030|101191571|FG003|STARTED|Transition Period (Week 52 to Week 78)||62||
48352365|NCT05087030|101191572|FG004|STARTED|Transition Period (Week 52 to Week 78)||63||
48352366|NCT05087030|101191568|FG000|COMPLETED|Transition Period (Week 52 to Week 78)||0||
48352367|NCT05087030|101191569|FG001|COMPLETED|Transition Period (Week 52 to Week 78)||0||
48416696|NCT02129192|101353457|FG000|COMPLETED|Period 3 Including Washout Period||36||
48416697|NCT02129192|101353458|FG001|COMPLETED|Period 3 Including Washout Period||35||
48416698|NCT02129192|101353457|FG000|NOT COMPLETED|Period 3 Including Washout Period||0||
48416699|NCT02129192|101353458|FG001|NOT COMPLETED|Period 3 Including Washout Period||0||
48416700|NCT02129192|101353457|FG000|STARTED|Period 4 Including Washout Period||36||
48416701|NCT02129192|101353458|FG001|STARTED|Period 4 Including Washout Period||35||
48416702|NCT02129192|101353457|FG000|COMPLETED|Period 4 Including Washout Period||36||
48416703|NCT02129192|101353458|FG001|COMPLETED|Period 4 Including Washout Period||35||
48416704|NCT02129192|101353457|FG000|NOT COMPLETED|Period 4 Including Washout Period||0||
48416705|NCT02129192|101353458|FG001|NOT COMPLETED|Period 4 Including Washout Period||0||
48416706|NCT02129192|101353457|FG000|STARTED|Period 5||36||
48352368|NCT05087030|101191570|FG002|COMPLETED|Transition Period (Week 52 to Week 78)||63||
48352369|NCT05087030|101191571|FG003|COMPLETED|Transition Period (Week 52 to Week 78)||62||
48352370|NCT05087030|101191572|FG004|COMPLETED|Transition Period (Week 52 to Week 78)||62||
48352371|NCT05087030|101191568|FG000|NOT COMPLETED|Transition Period (Week 52 to Week 78)||0||
48352372|NCT05087030|101191569|FG001|NOT COMPLETED|Transition Period (Week 52 to Week 78)||0||
48352373|NCT05087030|101191570|FG002|NOT COMPLETED|Transition Period (Week 52 to Week 78)||0||
48352374|NCT05087030|101191571|FG003|NOT COMPLETED|Transition Period (Week 52 to Week 78)||0||
48352375|NCT05087030|101191572|FG004|NOT COMPLETED|Transition Period (Week 52 to Week 78)||1||
48352376|NCT01241539|101191573|FG000|STARTED|Period 1||7||
48416707|NCT02129192|101353458|FG001|STARTED|Period 5||0||
48416708|NCT02129192|101353457|FG000|COMPLETED|Period 5||36||
48761530|NCT02052778|102203079|FG014|NOT COMPLETED|Dose Escalation(Approximately 60 Months)||0||
48761531|NCT02052778|102203080|FG015|NOT COMPLETED|Dose Escalation(Approximately 60 Months)||0||
48761532|NCT02052778|102203081|FG016|NOT COMPLETED|Dose Escalation(Approximately 60 Months)||0||
48761533|NCT02052778|102203082|FG017|NOT COMPLETED|Dose Escalation(Approximately 60 Months)||0||
48761534|NCT02052778|102203083|FG018|NOT COMPLETED|Dose Escalation(Approximately 60 Months)||0||
48761535|NCT02052778|102203084|FG019|NOT COMPLETED|Dose Escalation(Approximately 60 Months)||0||
48761536|NCT02052778|102203085|FG020|NOT COMPLETED|Dose Escalation(Approximately 60 Months)||0||
48761537|NCT02052778|102203086|FG021|NOT COMPLETED|Dose Escalation(Approximately 60 Months)||0||
48761538|NCT02052778|102203087|FG022|NOT COMPLETED|Dose Escalation(Approximately 60 Months)||0||
48761539|NCT02052778|102203065|FG000|STARTED|Dose Expansion (Approximately 59 Months)||0|Participants who were enrolled.|
48761540|NCT02052778|102203066|FG001|STARTED|Dose Expansion (Approximately 59 Months)||0|Participants who were enrolled.|
48761541|NCT02052778|102203067|FG002|STARTED|Dose Expansion (Approximately 59 Months)||0|Participants who were enrolled.|
48761542|NCT02052778|102203068|FG003|STARTED|Dose Expansion (Approximately 59 Months)||0|Participants who were enrolled.|
48761543|NCT02052778|102203069|FG004|STARTED|Dose Expansion (Approximately 59 Months)||0|Participants who were enrolled.|
48761544|NCT02052778|102203070|FG005|STARTED|Dose Expansion (Approximately 59 Months)||0|Participants who were enrolled.|
48761545|NCT02052778|102203071|FG006|STARTED|Dose Expansion (Approximately 59 Months)||0|Participants who were enrolled.|
48761546|NCT02052778|102203072|FG007|STARTED|Dose Expansion (Approximately 59 Months)||0|Participants who were enrolled.|
48761547|NCT02052778|102203073|FG008|STARTED|Dose Expansion (Approximately 59 Months)||0|Participants who were enrolled.|
48761548|NCT02052778|102203074|FG009|STARTED|Dose Expansion (Approximately 59 Months)||0|Participants who were enrolled.|
48761549|NCT02052778|102203075|FG010|STARTED|Dose Expansion (Approximately 59 Months)||0|Participants who were enrolled.|
48761550|NCT02052778|102203076|FG011|STARTED|Dose Expansion (Approximately 59 Months)||0|Participants who were enrolled.|
48761551|NCT02052778|102203077|FG012|STARTED|Dose Expansion (Approximately 59 Months)||0|Participants who were enrolled.|
48761552|NCT02052778|102203078|FG013|STARTED|Dose Expansion (Approximately 59 Months)||0|Participants who were enrolled.|
48761553|NCT02052778|102203079|FG014|STARTED|Dose Expansion (Approximately 59 Months)||58|Participants who were enrolled.|
48761554|NCT02052778|102203080|FG015|STARTED|Dose Expansion (Approximately 59 Months)||35|Participants who were enrolled.|
48352377|NCT01241539|101191573|FG000|COMPLETED|Period 1||7||
48352378|NCT01241539|101191573|FG000|NOT COMPLETED|Period 1||0||
48352379|NCT01241539|101191573|FG000|STARTED|Period 2||7||
48352380|NCT01241539|101191573|FG000|COMPLETED|Period 2||7||
48416709|NCT02129192|101353458|FG001|COMPLETED|Period 5||0||
48416710|NCT02129192|101353457|FG000|NOT COMPLETED|Period 5||0||
48416711|NCT02129192|101353458|FG001|NOT COMPLETED|Period 5||0||
48352381|NCT01241539|101191573|FG000|NOT COMPLETED|Period 2||0||
48416712|NCT01038635|101353459|FG000|STARTED|Overall Study||5||
48761555|NCT02052778|102203081|FG016|STARTED|Dose Expansion (Approximately 59 Months)||16|Participants who were enrolled.|
48761556|NCT02052778|102203082|FG017|STARTED|Dose Expansion (Approximately 59 Months)||13|Participants who were enrolled.|
48761557|NCT02052778|102203083|FG018|STARTED|Dose Expansion (Approximately 59 Months)||25|Participants who were enrolled.|
48761558|NCT02052778|102203084|FG019|STARTED|Dose Expansion (Approximately 59 Months)||27|Participants who were enrolled.|
48761559|NCT02052778|102203085|FG020|STARTED|Dose Expansion (Approximately 59 Months)||19|Participants who were enrolled.|
48761560|NCT02052778|102203086|FG021|STARTED|Dose Expansion (Approximately 59 Months)||8|Participants who were enrolled.|
48761561|NCT02052778|102203087|FG022|STARTED|Dose Expansion (Approximately 59 Months)||0|Participants who were enrolled.|
48761562|NCT02052778|102203065|FG000|Treated|Dose Expansion (Approximately 59 Months)||0||
48761563|NCT02052778|102203066|FG001|Treated|Dose Expansion (Approximately 59 Months)||0||
48761564|NCT02052778|102203067|FG002|Treated|Dose Expansion (Approximately 59 Months)||0||
48761565|NCT02052778|102203068|FG003|Treated|Dose Expansion (Approximately 59 Months)||0||
48761566|NCT02052778|102203069|FG004|Treated|Dose Expansion (Approximately 59 Months)||0||
48761567|NCT02052778|102203070|FG005|Treated|Dose Expansion (Approximately 59 Months)||0||
48761568|NCT02052778|102203071|FG006|Treated|Dose Expansion (Approximately 59 Months)||0||
48761569|NCT02052778|102203072|FG007|Treated|Dose Expansion (Approximately 59 Months)||0||
48761570|NCT02052778|102203073|FG008|Treated|Dose Expansion (Approximately 59 Months)||0||
48761571|NCT02052778|102203074|FG009|Treated|Dose Expansion (Approximately 59 Months)||0||
48761572|NCT02052778|102203075|FG010|Treated|Dose Expansion (Approximately 59 Months)||0||
48761573|NCT02052778|102203076|FG011|Treated|Dose Expansion (Approximately 59 Months)||0||
48761574|NCT02052778|102203077|FG012|Treated|Dose Expansion (Approximately 59 Months)||0||
48761575|NCT02052778|102203078|FG013|Treated|Dose Expansion (Approximately 59 Months)||0||
48761576|NCT02052778|102203079|FG014|Treated|Dose Expansion (Approximately 59 Months)||57||
48761577|NCT02052778|102203080|FG015|Treated|Dose Expansion (Approximately 59 Months)||34||
48761578|NCT02052778|102203081|FG016|Treated|Dose Expansion (Approximately 59 Months)||15||
48416713|NCT01038635|101353460|FG001|STARTED|Overall Study||3||
48416714|NCT01038635|101353461|FG002|STARTED|Overall Study||3||
48416715|NCT01038635|101353462|FG003|STARTED|Overall Study||3||
48416716|NCT01038635|101353463|FG004|STARTED|Overall Study||4||
48416717|NCT01038635|101353464|FG005|STARTED|Overall Study||3||
48416718|NCT01038635|101353465|FG006|STARTED|Overall Study||7||
48761579|NCT02052778|102203082|FG017|Treated|Dose Expansion (Approximately 59 Months)||13||
48761580|NCT02052778|102203083|FG018|Treated|Dose Expansion (Approximately 59 Months)||24||
48761581|NCT02052778|102203084|FG019|Treated|Dose Expansion (Approximately 59 Months)||27||
48416719|NCT01038635|101353466|FG007|STARTED|Overall Study||20||
48416720|NCT01038635|101353467|FG008|STARTED|Overall Study||40||
48416721|NCT01038635|101353459|FG000|COMPLETED|Overall Study||3||
48416722|NCT01038635|101353460|FG001|COMPLETED|Overall Study||3||
48761582|NCT02052778|102203085|FG020|Treated|Dose Expansion (Approximately 59 Months)||19||
48761583|NCT02052778|102203086|FG021|Treated|Dose Expansion (Approximately 59 Months)||8||
48761584|NCT02052778|102203087|FG022|Treated|Dose Expansion (Approximately 59 Months)||0||
48761585|NCT02052778|102203065|FG000|COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761586|NCT02052778|102203066|FG001|COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761587|NCT02052778|102203067|FG002|COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761588|NCT02052778|102203068|FG003|COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761589|NCT02052778|102203069|FG004|COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761590|NCT02052778|102203070|FG005|COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761591|NCT02052778|102203071|FG006|COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761592|NCT02052778|102203072|FG007|COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761593|NCT02052778|102203073|FG008|COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761594|NCT02052778|102203074|FG009|COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761595|NCT02052778|102203075|FG010|COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761596|NCT02052778|102203076|FG011|COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761597|NCT02052778|102203077|FG012|COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761598|NCT02052778|102203078|FG013|COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761599|NCT02052778|102203079|FG014|COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761600|NCT02052778|102203080|FG015|COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761601|NCT02052778|102203081|FG016|COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761602|NCT02052778|102203082|FG017|COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48416723|NCT01038635|101353461|FG002|COMPLETED|Overall Study||3||
48416724|NCT01038635|101353462|FG003|COMPLETED|Overall Study||3||
48416725|NCT01038635|101353463|FG004|COMPLETED|Overall Study||3||
48761603|NCT02052778|102203083|FG018|COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761604|NCT02052778|102203084|FG019|COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761605|NCT02052778|102203085|FG020|COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48416726|NCT01038635|101353464|FG005|COMPLETED|Overall Study||3||
48416727|NCT01038635|101353465|FG006|COMPLETED|Overall Study||5||
48416728|NCT01038635|101353466|FG007|COMPLETED|Overall Study||15||
48416729|NCT01038635|101353467|FG008|COMPLETED|Overall Study||38||
48416730|NCT01038635|101353459|FG000|NOT COMPLETED|Overall Study||2||
48416731|NCT01038635|101353460|FG001|NOT COMPLETED|Overall Study||0||
48761606|NCT02052778|102203086|FG021|COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761607|NCT02052778|102203087|FG022|COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761608|NCT02052778|102203065|FG000|NOT COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761609|NCT02052778|102203066|FG001|NOT COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761610|NCT02052778|102203067|FG002|NOT COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761611|NCT02052778|102203068|FG003|NOT COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761612|NCT02052778|102203069|FG004|NOT COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761613|NCT02052778|102203070|FG005|NOT COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761614|NCT02052778|102203071|FG006|NOT COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761615|NCT02052778|102203072|FG007|NOT COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761616|NCT02052778|102203073|FG008|NOT COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761617|NCT02052778|102203074|FG009|NOT COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761618|NCT02052778|102203075|FG010|NOT COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761619|NCT02052778|102203076|FG011|NOT COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761620|NCT02052778|102203077|FG012|NOT COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761621|NCT02052778|102203078|FG013|NOT COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761622|NCT02052778|102203079|FG014|NOT COMPLETED|Dose Expansion (Approximately 59 Months)||58||
48761623|NCT02052778|102203080|FG015|NOT COMPLETED|Dose Expansion (Approximately 59 Months)||35||
48761624|NCT02052778|102203081|FG016|NOT COMPLETED|Dose Expansion (Approximately 59 Months)||16||
48761625|NCT02052778|102203082|FG017|NOT COMPLETED|Dose Expansion (Approximately 59 Months)||13||
48761626|NCT02052778|102203083|FG018|NOT COMPLETED|Dose Expansion (Approximately 59 Months)||25||
48761627|NCT02052778|102203084|FG019|NOT COMPLETED|Dose Expansion (Approximately 59 Months)||27||
48761628|NCT02052778|102203085|FG020|NOT COMPLETED|Dose Expansion (Approximately 59 Months)||19||
48761629|NCT02052778|102203086|FG021|NOT COMPLETED|Dose Expansion (Approximately 59 Months)||8||
48761630|NCT02052778|102203087|FG022|NOT COMPLETED|Dose Expansion (Approximately 59 Months)||0||
48761631|NCT02052778|102203065|FG000|STARTED|Phase 2 (Approximately 63 Months)||0|Participants who were enrolled.|
48761632|NCT02052778|102203066|FG001|STARTED|Phase 2 (Approximately 63 Months)||0|Participants who were enrolled.|
48761633|NCT02052778|102203067|FG002|STARTED|Phase 2 (Approximately 63 Months)||0|Participants who were enrolled.|
48761634|NCT02052778|102203068|FG003|STARTED|Phase 2 (Approximately 63 Months)||0|Participants who were enrolled.|
48761635|NCT02052778|102203069|FG004|STARTED|Phase 2 (Approximately 63 Months)||0|Participants who were enrolled.|
48761636|NCT02052778|102203070|FG005|STARTED|Phase 2 (Approximately 63 Months)||0|Participants who were enrolled.|
48761637|NCT02052778|102203071|FG006|STARTED|Phase 2 (Approximately 63 Months)||0|Participants who were enrolled.|
48761638|NCT02052778|102203072|FG007|STARTED|Phase 2 (Approximately 63 Months)||0|Participants who were enrolled.|
48761639|NCT02052778|102203073|FG008|STARTED|Phase 2 (Approximately 63 Months)||0|Participants who were enrolled.|
48761640|NCT02052778|102203074|FG009|STARTED|Phase 2 (Approximately 63 Months)||0|Participants who were enrolled.|
48761641|NCT02052778|102203075|FG010|STARTED|Phase 2 (Approximately 63 Months)||0|Participants who were enrolled.|
48761642|NCT02052778|102203076|FG011|STARTED|Phase 2 (Approximately 63 Months)||0|Participants who were enrolled.|
48761643|NCT02052778|102203077|FG012|STARTED|Phase 2 (Approximately 63 Months)||0|Participants who were enrolled.|
48761644|NCT02052778|102203078|FG013|STARTED|Phase 2 (Approximately 63 Months)||0|Participants who were enrolled.|
48761645|NCT02052778|102203079|FG014|STARTED|Phase 2 (Approximately 63 Months)||0|Participants who were enrolled.|
48761646|NCT02052778|102203080|FG015|STARTED|Phase 2 (Approximately 63 Months)||0|Participants who were enrolled.|
48761647|NCT02052778|102203081|FG016|STARTED|Phase 2 (Approximately 63 Months)||0|Participants who were enrolled.|
48761648|NCT02052778|102203082|FG017|STARTED|Phase 2 (Approximately 63 Months)||0|Participants who were enrolled.|
48761649|NCT02052778|102203083|FG018|STARTED|Phase 2 (Approximately 63 Months)||0|Participants who were enrolled.|
48761650|NCT02052778|102203084|FG019|STARTED|Phase 2 (Approximately 63 Months)||0|Participants who were enrolled.|
48761651|NCT02052778|102203085|FG020|STARTED|Phase 2 (Approximately 63 Months)||0|Participants who were enrolled.|
48761652|NCT02052778|102203086|FG021|STARTED|Phase 2 (Approximately 63 Months)||0|Participants who were enrolled.|
48761653|NCT02052778|102203087|FG022|STARTED|Phase 2 (Approximately 63 Months)||120|Participants who were enrolled.|
48761654|NCT02052778|102203065|FG000|Treated|Phase 2 (Approximately 63 Months)||0||
48761655|NCT02052778|102203066|FG001|Treated|Phase 2 (Approximately 63 Months)||0||
48761656|NCT02052778|102203067|FG002|Treated|Phase 2 (Approximately 63 Months)||0||
48761657|NCT02052778|102203068|FG003|Treated|Phase 2 (Approximately 63 Months)||0||
48761658|NCT02052778|102203069|FG004|Treated|Phase 2 (Approximately 63 Months)||0||
48761659|NCT02052778|102203070|FG005|Treated|Phase 2 (Approximately 63 Months)||0||
48761660|NCT02052778|102203071|FG006|Treated|Phase 2 (Approximately 63 Months)||0||
48761661|NCT02052778|102203072|FG007|Treated|Phase 2 (Approximately 63 Months)||0||
48761662|NCT02052778|102203073|FG008|Treated|Phase 2 (Approximately 63 Months)||0||
48761663|NCT02052778|102203074|FG009|Treated|Phase 2 (Approximately 63 Months)||0||
48761664|NCT02052778|102203075|FG010|Treated|Phase 2 (Approximately 63 Months)||0||
48761665|NCT02052778|102203076|FG011|Treated|Phase 2 (Approximately 63 Months)||0||
48761666|NCT02052778|102203077|FG012|Treated|Phase 2 (Approximately 63 Months)||0||
48761667|NCT02052778|102203078|FG013|Treated|Phase 2 (Approximately 63 Months)||0||
48761668|NCT02052778|102203079|FG014|Treated|Phase 2 (Approximately 63 Months)||0||
48761669|NCT02052778|102203080|FG015|Treated|Phase 2 (Approximately 63 Months)||0||
48761670|NCT02052778|102203081|FG016|Treated|Phase 2 (Approximately 63 Months)||0||
48761671|NCT02052778|102203082|FG017|Treated|Phase 2 (Approximately 63 Months)||0||
48761672|NCT02052778|102203083|FG018|Treated|Phase 2 (Approximately 63 Months)||0||
48761673|NCT02052778|102203084|FG019|Treated|Phase 2 (Approximately 63 Months)||0||
48761674|NCT02052778|102203085|FG020|Treated|Phase 2 (Approximately 63 Months)||0||
48761675|NCT02052778|102203086|FG021|Treated|Phase 2 (Approximately 63 Months)||0||
48761676|NCT02052778|102203087|FG022|Treated|Phase 2 (Approximately 63 Months)||103||
48761677|NCT02052778|102203065|FG000|COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761678|NCT02052778|102203066|FG001|COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761679|NCT02052778|102203067|FG002|COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761680|NCT02052778|102203068|FG003|COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761681|NCT02052778|102203069|FG004|COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761682|NCT02052778|102203070|FG005|COMPLETED|Phase 2 (Approximately 63 Months)||0||
48352382|NCT02591615|101191574|FG000|STARTED|Arm B Pembro Lead in Phase||9||
48352383|NCT02591615|101191575|FG001|STARTED|Arm B Pembro Lead in Phase||34||
48352384|NCT02591615|101191576|FG002|STARTED|Arm B Pembro Lead in Phase||11||
48352385|NCT02591615|101191577|FG003|STARTED|Arm B Pembro Lead in Phase||37||
48416732|NCT01038635|101353461|FG002|NOT COMPLETED|Overall Study||0||
48416733|NCT01038635|101353462|FG003|NOT COMPLETED|Overall Study||0||
48416734|NCT01038635|101353463|FG004|NOT COMPLETED|Overall Study||1||
48416735|NCT01038635|101353464|FG005|NOT COMPLETED|Overall Study||0||
48416736|NCT01038635|101353465|FG006|NOT COMPLETED|Overall Study||2||
48416737|NCT01038635|101353466|FG007|NOT COMPLETED|Overall Study||5||
48416738|NCT01038635|101353467|FG008|NOT COMPLETED|Overall Study||2||
48416739|NCT00643851|101353468|FG000|STARTED|Overall Study||194||
48416740|NCT00643851|101353469|FG001|STARTED|Overall Study||203||
48416741|NCT00643851|101353470|FG002|STARTED|Overall Study||201||
48416742|NCT00643851|101353468|FG000|COMPLETED|Overall Study||177||
48416743|NCT00643851|101353469|FG001|COMPLETED|Overall Study||170||
48416744|NCT00643851|101353470|FG002|COMPLETED|Overall Study||171||
48416745|NCT00643851|101353468|FG000|NOT COMPLETED|Overall Study||17||
48416746|NCT00643851|101353469|FG001|NOT COMPLETED|Overall Study||33||
48416747|NCT00643851|101353470|FG002|NOT COMPLETED|Overall Study||30||
48416748|NCT02065479|101353471|FG000|STARTED|Overall Study||33||
48416749|NCT02065479|101353472|FG001|STARTED|Overall Study||32||
48416750|NCT02065479|101353471|FG000|COMPLETED|Overall Study||33||
48416751|NCT02065479|101353472|FG001|COMPLETED|Overall Study||32||
48416752|NCT02065479|101353471|FG000|NOT COMPLETED|Overall Study||0||
48416753|NCT02065479|101353472|FG001|NOT COMPLETED|Overall Study||0||
48416754|NCT00305773|101353473|FG000|STARTED|Overall Study||15||
48416755|NCT00305773|101353474|FG001|STARTED|Overall Study||22||
48416756|NCT00305773|101353473|FG000|COMPLETED|Overall Study||1||
48416757|NCT00305773|101353474|FG001|COMPLETED|Overall Study||4||
48416758|NCT00305773|101353473|FG000|NOT COMPLETED|Overall Study||14||
48416759|NCT00305773|101353474|FG001|NOT COMPLETED|Overall Study||18||
48416760|NCT01997333|101353475|FG000|STARTED|Randomization and Treatment||109||
48416761|NCT01997333|101353476|FG001|STARTED|Randomization and Treatment||218||
48416762|NCT01997333|101353475|FG000|COMPLETED|Randomization and Treatment||6|Completed = continuing to receive treatment at time of analysis|
48416763|NCT01997333|101353476|FG001|COMPLETED|Randomization and Treatment||15|Completed = continuing to receive treatment at time of analysis|
48416764|NCT01997333|101353475|FG000|NOT COMPLETED|Randomization and Treatment||103||
48416765|NCT01997333|101353476|FG001|NOT COMPLETED|Randomization and Treatment||203||
48416766|NCT01997333|101353475|FG000|STARTED|Survival Follow up||92|Only patients who received treatment are included in survival follow up.|
48416767|NCT01997333|101353476|FG001|STARTED|Survival Follow up||213|Only patients who received treatment are included in survival follow up.|
48416768|NCT01997333|101353475|FG000|COMPLETED|Survival Follow up||76||
48416769|NCT01997333|101353476|FG001|COMPLETED|Survival Follow up||199||
48352386|NCT02591615|101191574|FG000|COMPLETED|Arm B Pembro Lead in Phase||9||
48352387|NCT02591615|101191575|FG001|COMPLETED|Arm B Pembro Lead in Phase||34||
48352388|NCT02591615|101191576|FG002|COMPLETED|Arm B Pembro Lead in Phase||10||
48416770|NCT01997333|101353475|FG000|NOT COMPLETED|Survival Follow up||16||
48416771|NCT01997333|101353476|FG001|NOT COMPLETED|Survival Follow up||14||
48416772|NCT00170846|101353477|FG000|STARTED|Overall Study||123||
48416773|NCT00170846|101353478|FG001|STARTED|Overall Study||127||
48416774|NCT00170846|101353479|FG002|STARTED|Overall Study||144||
48416775|NCT00170846|101353477|FG000|COMPLETED|Overall Study||112||
48416776|NCT00170846|101353478|FG001|COMPLETED|Overall Study||108||
48416777|NCT00170846|101353479|FG002|COMPLETED|Overall Study||131||
48416778|NCT00170846|101353477|FG000|NOT COMPLETED|Overall Study||11||
48416779|NCT00170846|101353478|FG001|NOT COMPLETED|Overall Study||19||
48416780|NCT00170846|101353479|FG002|NOT COMPLETED|Overall Study||13||
48416781|NCT00529152|101353480|FG000|STARTED|Overall Study||100||
48416782|NCT00529152|101353480|FG000|COMPLETED|Overall Study||95||
48416783|NCT00529152|101353480|FG000|NOT COMPLETED|Overall Study||5||
48416784|NCT02853318|101353481|FG000|STARTED|Overall Study||40||
48416785|NCT02853318|101353481|FG000|COMPLETED|Overall Study||39||
48416786|NCT02853318|101353481|FG000|NOT COMPLETED|Overall Study||1||
48416787|NCT01089933|101353482|FG000|STARTED|Overall Study||65||
48761683|NCT02052778|102203071|FG006|COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761684|NCT02052778|102203072|FG007|COMPLETED|Phase 2 (Approximately 63 Months)||0||
48352389|NCT02591615|101191577|FG003|COMPLETED|Arm B Pembro Lead in Phase||37||
48352390|NCT02591615|101191574|FG000|NOT COMPLETED|Arm B Pembro Lead in Phase||0||
48352391|NCT02591615|101191575|FG001|NOT COMPLETED|Arm B Pembro Lead in Phase||0||
48352392|NCT02591615|101191576|FG002|NOT COMPLETED|Arm B Pembro Lead in Phase||1||
48352393|NCT02591615|101191577|FG003|NOT COMPLETED|Arm B Pembro Lead in Phase||0||
48352394|NCT02591615|101191574|FG000|STARTED|Platinum Doublet Arm A, MK-3475 Arm B||9||
48352395|NCT02591615|101191575|FG001|STARTED|Platinum Doublet Arm A, MK-3475 Arm B||34||
48352396|NCT02591615|101191576|FG002|STARTED|Platinum Doublet Arm A, MK-3475 Arm B||10||
48352397|NCT02591615|101191577|FG003|STARTED|Platinum Doublet Arm A, MK-3475 Arm B||37||
48352398|NCT02591615|101191574|FG000|COMPLETED|Platinum Doublet Arm A, MK-3475 Arm B||4||
48352399|NCT02591615|101191575|FG001|COMPLETED|Platinum Doublet Arm A, MK-3475 Arm B||25||
48352400|NCT02591615|101191576|FG002|COMPLETED|Platinum Doublet Arm A, MK-3475 Arm B||6||
48352401|NCT02591615|101191577|FG003|COMPLETED|Platinum Doublet Arm A, MK-3475 Arm B||20||
48352402|NCT02591615|101191574|FG000|NOT COMPLETED|Platinum Doublet Arm A, MK-3475 Arm B||5||
48352403|NCT02591615|101191575|FG001|NOT COMPLETED|Platinum Doublet Arm A, MK-3475 Arm B||9||
48352404|NCT02591615|101191576|FG002|NOT COMPLETED|Platinum Doublet Arm A, MK-3475 Arm B||4||
48352405|NCT02591615|101191577|FG003|NOT COMPLETED|Platinum Doublet Arm A, MK-3475 Arm B||17||
48352406|NCT02591615|101191574|FG000|STARTED|MK-3475 Arm A, Platinum Doublet Arm B||4||
48352407|NCT02591615|101191575|FG001|STARTED|MK-3475 Arm A, Platinum Doublet Arm B||25||
48352408|NCT02591615|101191576|FG002|STARTED|MK-3475 Arm A, Platinum Doublet Arm B||6||
48352409|NCT02591615|101191577|FG003|STARTED|MK-3475 Arm A, Platinum Doublet Arm B||20||
48352410|NCT02591615|101191574|FG000|COMPLETED|MK-3475 Arm A, Platinum Doublet Arm B||2||
48352411|NCT02591615|101191575|FG001|COMPLETED|MK-3475 Arm A, Platinum Doublet Arm B||17||
48352412|NCT02591615|101191576|FG002|COMPLETED|MK-3475 Arm A, Platinum Doublet Arm B||4||
48352413|NCT02591615|101191577|FG003|COMPLETED|MK-3475 Arm A, Platinum Doublet Arm B||18||
48352414|NCT02591615|101191574|FG000|NOT COMPLETED|MK-3475 Arm A, Platinum Doublet Arm B||2||
48352415|NCT02591615|101191575|FG001|NOT COMPLETED|MK-3475 Arm A, Platinum Doublet Arm B||8||
48352416|NCT02591615|101191576|FG002|NOT COMPLETED|MK-3475 Arm A, Platinum Doublet Arm B||2||
48352417|NCT02591615|101191577|FG003|NOT COMPLETED|MK-3475 Arm A, Platinum Doublet Arm B||2||
48352418|NCT02591615|101191574|FG000|STARTED|Maintenance MK-3475||2||
48352419|NCT02591615|101191575|FG001|STARTED|Maintenance MK-3475||17||
48352420|NCT02591615|101191576|FG002|STARTED|Maintenance MK-3475||4||
48352421|NCT02591615|101191577|FG003|STARTED|Maintenance MK-3475||18||
48352422|NCT02591615|101191574|FG000|COMPLETED|Maintenance MK-3475||0||
48352423|NCT02591615|101191575|FG001|COMPLETED|Maintenance MK-3475||3||
48352424|NCT02591615|101191576|FG002|COMPLETED|Maintenance MK-3475||1||
48352425|NCT02591615|101191577|FG003|COMPLETED|Maintenance MK-3475||7||
48352426|NCT02591615|101191574|FG000|NOT COMPLETED|Maintenance MK-3475||2||
48352427|NCT02591615|101191575|FG001|NOT COMPLETED|Maintenance MK-3475||14||
48352428|NCT02591615|101191576|FG002|NOT COMPLETED|Maintenance MK-3475||3||
48352429|NCT02591615|101191577|FG003|NOT COMPLETED|Maintenance MK-3475||11||
48352430|NCT03794986|101191578|FG000|STARTED|Overall Study||178||
48352431|NCT03794986|101191579|FG001|STARTED|Overall Study||178||
48352432|NCT03794986|101191578|FG000|Partial Completion|Overall Study||35||
48352433|NCT03794986|101191579|FG001|Partial Completion|Overall Study||31||
48352434|NCT03794986|101191578|FG000|Completed Intervention|Overall Study||104||
48352435|NCT03794986|101191579|FG001|Completed Intervention|Overall Study||104||
48352436|NCT03794986|101191578|FG000|COMPLETED|Overall Study||139||
48352437|NCT03794986|101191579|FG001|COMPLETED|Overall Study||135||
48352438|NCT03794986|101191578|FG000|NOT COMPLETED|Overall Study||39||
48352439|NCT03794986|101191579|FG001|NOT COMPLETED|Overall Study||43||
48352440|NCT00805207|101191580|FG000|STARTED|Overall Study||1||
48352441|NCT00805207|101191581|FG001|STARTED|Overall Study||9||
48352442|NCT00805207|101191582|FG002|STARTED|Overall Study||12||
48352443|NCT00805207|101191583|FG003|STARTED|Overall Study||6||
48352444|NCT00805207|101191584|FG004|STARTED|Overall Study||3||
48352445|NCT00805207|101191585|FG005|STARTED|Overall Study||12||
48352446|NCT00805207|101191586|FG006|STARTED|Overall Study||6||
48352447|NCT00805207|101191587|FG007|STARTED|Overall Study||6||
48352448|NCT00805207|101191588|FG008|STARTED|Overall Study||6||
48352449|NCT00805207|101191580|FG000|COMPLETED|Overall Study||1||
48352450|NCT00805207|101191581|FG001|COMPLETED|Overall Study||7||
48352451|NCT00805207|101191582|FG002|COMPLETED|Overall Study||11||
48352452|NCT00805207|101191583|FG003|COMPLETED|Overall Study||6||
48352453|NCT00805207|101191584|FG004|COMPLETED|Overall Study||2||
48352454|NCT00805207|101191585|FG005|COMPLETED|Overall Study||9||
48352455|NCT00805207|101191586|FG006|COMPLETED|Overall Study||6||
48352456|NCT00805207|101191587|FG007|COMPLETED|Overall Study||6||
48352457|NCT00805207|101191588|FG008|COMPLETED|Overall Study||6||
48352458|NCT00805207|101191580|FG000|NOT COMPLETED|Overall Study||0||
48352459|NCT00805207|101191581|FG001|NOT COMPLETED|Overall Study||2||
48352460|NCT00805207|101191582|FG002|NOT COMPLETED|Overall Study||1||
48352461|NCT00805207|101191583|FG003|NOT COMPLETED|Overall Study||0||
48352462|NCT00805207|101191584|FG004|NOT COMPLETED|Overall Study||1||
48352463|NCT00805207|101191585|FG005|NOT COMPLETED|Overall Study||3||
48352464|NCT00805207|101191586|FG006|NOT COMPLETED|Overall Study||0||
48352465|NCT00805207|101191587|FG007|NOT COMPLETED|Overall Study||0||
48352466|NCT00805207|101191588|FG008|NOT COMPLETED|Overall Study||0||
48352467|NCT00824564|101191589|FG000|STARTED|Overall Study||42||
48352468|NCT00824564|101191590|FG001|STARTED|Overall Study||40||
48352469|NCT00824564|101191589|FG000|Treated|Overall Study||41||
48352470|NCT00824564|101191590|FG001|Treated|Overall Study||40||
48352471|NCT00824564|101191589|FG000|COMPLETED|Overall Study||34||
48352472|NCT00824564|101191590|FG001|COMPLETED|Overall Study||30||
48352473|NCT00824564|101191589|FG000|NOT COMPLETED|Overall Study||8||
48352474|NCT00824564|101191590|FG001|NOT COMPLETED|Overall Study||10||
48352475|NCT00995371|101191591|FG000|STARTED|Prior to ESI Cross-over, 6 Weeks||21||
48352476|NCT00995371|101191592|FG001|STARTED|Prior to ESI Cross-over, 6 Weeks||17||
48352477|NCT00995371|101191591|FG000|COMPLETED|Prior to ESI Cross-over, 6 Weeks||21||
48352478|NCT00995371|101191592|FG001|COMPLETED|Prior to ESI Cross-over, 6 Weeks||17||
48352479|NCT00995371|101191591|FG000|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0||
48416788|NCT01089933|101353483|FG001|STARTED|Overall Study||64||
48416789|NCT01089933|101353482|FG000|COMPLETED|Overall Study||65||
48761685|NCT02052778|102203073|FG008|COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761686|NCT02052778|102203074|FG009|COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761687|NCT02052778|102203075|FG010|COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761688|NCT02052778|102203076|FG011|COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761689|NCT02052778|102203077|FG012|COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761690|NCT02052778|102203078|FG013|COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761691|NCT02052778|102203079|FG014|COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761692|NCT02052778|102203080|FG015|COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761693|NCT02052778|102203081|FG016|COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761694|NCT02052778|102203082|FG017|COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761695|NCT02052778|102203083|FG018|COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761696|NCT02052778|102203084|FG019|COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761697|NCT02052778|102203085|FG020|COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761698|NCT02052778|102203086|FG021|COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761699|NCT02052778|102203087|FG022|COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761700|NCT02052778|102203065|FG000|NOT COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761701|NCT02052778|102203066|FG001|NOT COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761702|NCT02052778|102203067|FG002|NOT COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761703|NCT02052778|102203068|FG003|NOT COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761704|NCT02052778|102203069|FG004|NOT COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761705|NCT02052778|102203070|FG005|NOT COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761706|NCT02052778|102203071|FG006|NOT COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761707|NCT02052778|102203072|FG007|NOT COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761708|NCT02052778|102203073|FG008|NOT COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761709|NCT02052778|102203074|FG009|NOT COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761710|NCT02052778|102203075|FG010|NOT COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761711|NCT02052778|102203076|FG011|NOT COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761712|NCT02052778|102203077|FG012|NOT COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761713|NCT02052778|102203078|FG013|NOT COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761714|NCT02052778|102203079|FG014|NOT COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761715|NCT02052778|102203080|FG015|NOT COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761716|NCT02052778|102203081|FG016|NOT COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761717|NCT02052778|102203082|FG017|NOT COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761718|NCT02052778|102203083|FG018|NOT COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761719|NCT02052778|102203084|FG019|NOT COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761720|NCT02052778|102203085|FG020|NOT COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761721|NCT02052778|102203086|FG021|NOT COMPLETED|Phase 2 (Approximately 63 Months)||0||
48761722|NCT02052778|102203087|FG022|NOT COMPLETED|Phase 2 (Approximately 63 Months)||120||
48761723|NCT04245111|102203088|FG000|STARTED|Overall Study||13||
48761724|NCT04245111|102203089|FG001|STARTED|Overall Study||6||
48761725|NCT04245111|102203090|FG002|STARTED|Overall Study||1||
48761726|NCT04245111|102203088|FG000|Imaging Completed|Overall Study||13||
48761727|NCT04245111|102203089|FG001|Imaging Completed|Overall Study||6||
48352480|NCT00995371|101191592|FG001|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0||
48352481|NCT00995371|101191591|FG000|STARTED|After ESI Cross-over to Mild, 26 Weeks||21||
48352482|NCT00995371|101191592|FG001|STARTED|After ESI Cross-over to Mild, 26 Weeks||17||
48352483|NCT00995371|101191591|FG000|COMPLETED|After ESI Cross-over to Mild, 26 Weeks||16||
48352484|NCT00995371|101191592|FG001|COMPLETED|After ESI Cross-over to Mild, 26 Weeks||12||
48416790|NCT01089933|101353483|FG001|COMPLETED|Overall Study||64||
48416791|NCT01089933|101353482|FG000|NOT COMPLETED|Overall Study||0||
48416792|NCT01089933|101353483|FG001|NOT COMPLETED|Overall Study||0||
48416793|NCT01309646|101353484|FG000|STARTED|Overall Study||224||
48416794|NCT01309646|101353485|FG001|STARTED|Overall Study||227||
48761728|NCT04245111|102203090|FG002|Imaging Completed|Overall Study||1||
48761729|NCT04245111|102203088|FG000|COMPLETED|Overall Study||8||
48761730|NCT04245111|102203089|FG001|COMPLETED|Overall Study||5||
48352485|NCT00995371|101191591|FG000|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5||
48352486|NCT00995371|101191592|FG001|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5||
48352487|NCT02561897|101191593|FG000|STARTED|Overall Study||2||
48416795|NCT01309646|101353484|FG000|COMPLETED|Overall Study||224||
48761731|NCT04245111|102203090|FG002|COMPLETED|Overall Study||0||
48761732|NCT04245111|102203088|FG000|NOT COMPLETED|Overall Study||5||
48761733|NCT04245111|102203089|FG001|NOT COMPLETED|Overall Study||1||
48761734|NCT04245111|102203090|FG002|NOT COMPLETED|Overall Study||1||
48761735|NCT03264404|102203091|FG000|STARTED|Overall Study||36||
48761736|NCT03264404|102203091|FG000|COMPLETED|Overall Study||2||
48761737|NCT03264404|102203091|FG000|NOT COMPLETED|Overall Study||34||
48761738|NCT01502293|102203092|FG000|STARTED|Overall Study||30||
48761739|NCT01502293|102203093|FG001|STARTED|Overall Study||17||
48761740|NCT01502293|102203094|FG002|STARTED|Overall Study||4||
48761741|NCT01502293|102203092|FG000|COMPLETED|Overall Study||5||
48761742|NCT01502293|102203093|FG001|COMPLETED|Overall Study||0||
48761743|NCT01502293|102203094|FG002|COMPLETED|Overall Study||0||
48761744|NCT01502293|102203092|FG000|NOT COMPLETED|Overall Study||25||
48761745|NCT01502293|102203093|FG001|NOT COMPLETED|Overall Study||17||
48761746|NCT01502293|102203094|FG002|NOT COMPLETED|Overall Study||4||
48761747|NCT03353688|102203095|FG000|STARTED|First Intervention (2 Months)||17||
48761748|NCT03353688|102203096|FG001|STARTED|First Intervention (2 Months)||14||
48761749|NCT03353688|102203097|FG002|STARTED|First Intervention (2 Months)||0||
48761750|NCT03353688|102203095|FG000|COMPLETED|First Intervention (2 Months)||17||
48761751|NCT03353688|102203096|FG001|COMPLETED|First Intervention (2 Months)||14||
48761752|NCT03353688|102203097|FG002|COMPLETED|First Intervention (2 Months)||0||
48761753|NCT03353688|102203095|FG000|NOT COMPLETED|First Intervention (2 Months)||0||
48761754|NCT03353688|102203096|FG001|NOT COMPLETED|First Intervention (2 Months)||0||
48761755|NCT03353688|102203097|FG002|NOT COMPLETED|First Intervention (2 Months)||0||
48761756|NCT03353688|102203095|FG000|STARTED|Second Intervention (2 Months)||14||
48761757|NCT03353688|102203096|FG001|STARTED|Second Intervention (2 Months)||17||
48761758|NCT03353688|102203097|FG002|STARTED|Second Intervention (2 Months)||0||
48761759|NCT03353688|102203095|FG000|COMPLETED|Second Intervention (2 Months)||14||
48761760|NCT03353688|102203096|FG001|COMPLETED|Second Intervention (2 Months)||17||
48761761|NCT03353688|102203097|FG002|COMPLETED|Second Intervention (2 Months)||0||
48761762|NCT03353688|102203095|FG000|NOT COMPLETED|Second Intervention (2 Months)||0||
48761763|NCT03353688|102203096|FG001|NOT COMPLETED|Second Intervention (2 Months)||0||
48761764|NCT03353688|102203097|FG002|NOT COMPLETED|Second Intervention (2 Months)||0||
48761765|NCT03353688|102203095|FG000|STARTED|Third Intervention (2 Months)||0||
48761766|NCT03353688|102203096|FG001|STARTED|Third Intervention (2 Months)||0||
48761767|NCT03353688|102203097|FG002|STARTED|Third Intervention (2 Months)||31||
48761768|NCT03353688|102203095|FG000|COMPLETED|Third Intervention (2 Months)||0||
48761769|NCT03353688|102203096|FG001|COMPLETED|Third Intervention (2 Months)||0||
48761770|NCT03353688|102203097|FG002|COMPLETED|Third Intervention (2 Months)||31||
48761771|NCT03353688|102203095|FG000|NOT COMPLETED|Third Intervention (2 Months)||0||
48761772|NCT03353688|102203096|FG001|NOT COMPLETED|Third Intervention (2 Months)||0||
48761773|NCT03353688|102203097|FG002|NOT COMPLETED|Third Intervention (2 Months)||0||
48761774|NCT02435212|102203098|FG000|STARTED|Core Phase||112||
48761775|NCT02435212|102203099|FG001|STARTED|Core Phase||112||
48761776|NCT02435212|102203098|FG000|COMPLETED|Core Phase||87||
48416796|NCT01309646|101353485|FG001|COMPLETED|Overall Study||227||
48416797|NCT01309646|101353484|FG000|NOT COMPLETED|Overall Study||0||
48416798|NCT01309646|101353485|FG001|NOT COMPLETED|Overall Study||0||
48416799|NCT03350724|101353486|FG000|STARTED|Overall Study||17||
48416800|NCT03350724|101353487|FG001|STARTED|Overall Study||17||
48416801|NCT03350724|101353486|FG000|COMPLETED|Overall Study||17||
48416802|NCT03350724|101353487|FG001|COMPLETED|Overall Study||17||
48416803|NCT03350724|101353486|FG000|NOT COMPLETED|Overall Study||0||
48761777|NCT02435212|102203099|FG001|COMPLETED|Core Phase||99||
48761778|NCT02435212|102203098|FG000|NOT COMPLETED|Core Phase||25||
48761779|NCT02435212|102203099|FG001|NOT COMPLETED|Core Phase||13||
48761780|NCT02435212|102203098|FG000|STARTED|Optional Extension Phase||69||
48761781|NCT02435212|102203099|FG001|STARTED|Optional Extension Phase||77||
48761782|NCT02435212|102203098|FG000|COMPLETED|Optional Extension Phase||42||
48761783|NCT02435212|102203099|FG001|COMPLETED|Optional Extension Phase||46||
48761784|NCT02435212|102203098|FG000|NOT COMPLETED|Optional Extension Phase||27||
48416804|NCT03350724|101353487|FG001|NOT COMPLETED|Overall Study||0||
48416805|NCT03018028|101353488|FG000|STARTED|Overall Study||49||
48416806|NCT03018028|101353489|FG001|STARTED|Overall Study||49||
48416807|NCT03018028|101353490|FG002|STARTED|Overall Study||48||
48416808|NCT03018028|101353491|FG003|STARTED|Overall Study||48||
48416809|NCT03018028|101353492|FG004|STARTED|Overall Study||49||
48416810|NCT03018028|101353488|FG000|Full Analysis Set (FAS)|Overall Study||49||
48761785|NCT02435212|102203099|FG001|NOT COMPLETED|Optional Extension Phase||31||
48761786|NCT03240601|102203100|FG000|STARTED|Overall Study||9||
48416811|NCT03018028|101353489|FG001|Full Analysis Set (FAS)|Overall Study||49||
48416812|NCT03018028|101353490|FG002|Full Analysis Set (FAS)|Overall Study||48||
48761787|NCT03240601|102203101|FG001|STARTED|Overall Study||9||
48761788|NCT03240601|102203100|FG000|COMPLETED|Overall Study||8||
48761789|NCT03240601|102203101|FG001|COMPLETED|Overall Study||8||
48761790|NCT03240601|102203100|FG000|NOT COMPLETED|Overall Study||1||
48761791|NCT03240601|102203101|FG001|NOT COMPLETED|Overall Study||1||
48416813|NCT03018028|101353491|FG003|Full Analysis Set (FAS)|Overall Study||48||
48638254|NCT01348269|101898721|FG001|STARTED|"Treatment | Core Study (Until Week 6)"||14||
48416814|NCT03018028|101353492|FG004|Full Analysis Set (FAS)|Overall Study||49||
48416815|NCT03018028|101353488|FG000|Safety Analysis Set (SAS)|Overall Study||49||
48416816|NCT03018028|101353489|FG001|Safety Analysis Set (SAS)|Overall Study||49||
48416817|NCT03018028|101353490|FG002|Safety Analysis Set (SAS)|Overall Study||48||
48416818|NCT03018028|101353491|FG003|Safety Analysis Set (SAS)|Overall Study||48||
48416819|NCT03018028|101353492|FG004|Safety Analysis Set (SAS)|Overall Study||49||
48416820|NCT03018028|101353488|FG000|COMPLETED|Overall Study||46||
48416821|NCT03018028|101353489|FG001|COMPLETED|Overall Study||49||
48416822|NCT03018028|101353490|FG002|COMPLETED|Overall Study||47||
48416823|NCT03018028|101353491|FG003|COMPLETED|Overall Study||46||
48416824|NCT03018028|101353492|FG004|COMPLETED|Overall Study||49||
48416825|NCT03018028|101353488|FG000|NOT COMPLETED|Overall Study||3||
48416826|NCT03018028|101353489|FG001|NOT COMPLETED|Overall Study||0||
48416827|NCT03018028|101353490|FG002|NOT COMPLETED|Overall Study||1||
48416828|NCT03018028|101353491|FG003|NOT COMPLETED|Overall Study||2||
48416829|NCT03018028|101353492|FG004|NOT COMPLETED|Overall Study||0||
48416830|NCT01977040|101353493|FG000|STARTED|Overall Study||68||
48416831|NCT01977040|101353493|FG000|COMPLETED|Overall Study||66||
48416832|NCT01977040|101353493|FG000|NOT COMPLETED|Overall Study||2||
48416833|NCT03539900|101353494|FG000|STARTED|Overall Study||43||
48416834|NCT03539900|101353495|FG001|STARTED|Overall Study||46||
48416835|NCT03539900|101353494|FG000|COMPLETED|Overall Study||38||
48416836|NCT03539900|101353495|FG001|COMPLETED|Overall Study||44||
48416837|NCT03539900|101353494|FG000|NOT COMPLETED|Overall Study||5||
48416838|NCT03539900|101353495|FG001|NOT COMPLETED|Overall Study||2||
48416839|NCT01842334|101353496|FG000|STARTED|Overall Study||5||
48416840|NCT01842334|101353497|FG001|STARTED|Overall Study||7||
48416841|NCT01842334|101353496|FG000|COMPLETED|Overall Study||2||
48416842|NCT01842334|101353497|FG001|COMPLETED|Overall Study||3||
48416843|NCT01842334|101353496|FG000|NOT COMPLETED|Overall Study||3||
48416844|NCT01842334|101353497|FG001|NOT COMPLETED|Overall Study||4||
48416845|NCT02268942|101353498|FG000|STARTED|Overall Study||144||
48416846|NCT02268942|101353498|FG000|COMPLETED|Overall Study||144||
48416847|NCT02268942|101353498|FG000|NOT COMPLETED|Overall Study||0||
48416848|NCT00807456|101353499|FG000|STARTED|Overall Study||65||
48416849|NCT00807456|101353499|FG000|Surgical Re-entry (Implant Placement + 16-17 Weeks)|Overall Study||65||
48416850|NCT00807456|101353499|FG000|COMPLETED|Overall Study||57||
48416851|NCT00807456|101353499|FG000|NOT COMPLETED|Overall Study||8||
48416852|NCT02036476|101353500|FG000|STARTED|Overall Study||8||
48416853|NCT02036476|101353500|FG000|COMPLETED|Overall Study||0||
48416854|NCT02036476|101353500|FG000|NOT COMPLETED|Overall Study||8||
48416855|NCT02219516|101353501|FG000|STARTED|Overall Study||8||
48761792|NCT04104256|102203102|FG000|STARTED|Overall Study||269||
48761793|NCT04104256|102203103|FG001|STARTED|Overall Study||267||
48761794|NCT04104256|102203104|FG002|STARTED|Overall Study||272||
48761795|NCT04104256|102203105|FG003|STARTED|Overall Study||237||
48761796|NCT04104256|102203102|FG000|COMPLETED|Overall Study||269||
48761797|NCT04104256|102203103|FG001|COMPLETED|Overall Study||267||
48761798|NCT04104256|102203104|FG002|COMPLETED|Overall Study||272||
48761799|NCT04104256|102203105|FG003|COMPLETED|Overall Study||237||
48761800|NCT04104256|102203102|FG000|NOT COMPLETED|Overall Study||0||
48761801|NCT04104256|102203103|FG001|NOT COMPLETED|Overall Study||0||
48416856|NCT02219516|101353502|FG001|STARTED|Overall Study||8||
48416857|NCT02219516|101353503|FG002|STARTED|Overall Study||7||
48416858|NCT02219516|101353504|FG003|STARTED|Overall Study||8||
48416859|NCT02219516|101353501|FG000|COMPLETED|Overall Study||8||
48416860|NCT02219516|101353502|FG001|COMPLETED|Overall Study||8||
48416861|NCT02219516|101353503|FG002|COMPLETED|Overall Study||7||
48416862|NCT02219516|101353504|FG003|COMPLETED|Overall Study||8||
48416863|NCT02219516|101353501|FG000|NOT COMPLETED|Overall Study||0||
48416864|NCT02219516|101353502|FG001|NOT COMPLETED|Overall Study||0||
48416865|NCT02219516|101353503|FG002|NOT COMPLETED|Overall Study||0||
48416866|NCT02219516|101353504|FG003|NOT COMPLETED|Overall Study||0||
48416867|NCT00323479|101353505|FG000|STARTED|Overall Study||114||
48638255|NCT01348269|101898720|FG000|COMPLETED|"Treatment | Core Study (Until Week 6)"||34||
48638256|NCT01348269|101898721|FG001|COMPLETED|"Treatment | Core Study (Until Week 6)"||14||
48638257|NCT01348269|101898720|FG000|NOT COMPLETED|"Treatment | Core Study (Until Week 6)"||0||
48638258|NCT01348269|101898721|FG001|NOT COMPLETED|"Treatment | Core Study (Until Week 6)"||0||
48638259|NCT01348269|101898720|FG000|STARTED|Follow-up (Until Week 12)||34||
48638260|NCT01348269|101898721|FG001|STARTED|Follow-up (Until Week 12)||14||
48638261|NCT01348269|101898720|FG000|COMPLETED|Follow-up (Until Week 12)||32||
48638262|NCT01348269|101898721|FG001|COMPLETED|Follow-up (Until Week 12)||13||
48638263|NCT01348269|101898720|FG000|NOT COMPLETED|Follow-up (Until Week 12)||2||
48638264|NCT01348269|101898721|FG001|NOT COMPLETED|Follow-up (Until Week 12)||1||
48638265|NCT00544882|101898722|FG000|STARTED|Cycle 1: Run-in Cycle||61||
48638266|NCT00544882|101898723|FG001|STARTED|Cycle 1: Run-in Cycle||0||
48638267|NCT00544882|101898724|FG002|STARTED|Cycle 1: Run-in Cycle||0||
48416868|NCT00323479|101353505|FG000|Safety Population|Overall Study||110||
48761802|NCT04104256|102203104|FG002|NOT COMPLETED|Overall Study||0||
48761803|NCT04104256|102203105|FG003|NOT COMPLETED|Overall Study||0||
48761804|NCT04897711|102203106|FG000|STARTED|Overall Study||49||
48761805|NCT04897711|102203107|FG001|STARTED|Overall Study||54||
48761806|NCT04897711|102203108|FG002|STARTED|Overall Study||53||
48761807|NCT04897711|102203109|FG003|STARTED|Overall Study||32||
48761808|NCT04897711|102203110|FG004|STARTED|Overall Study||27||
48761809|NCT04897711|102203106|FG000|COMPLETED|Overall Study||49||
48761810|NCT04897711|102203107|FG001|COMPLETED|Overall Study||54||
48761811|NCT04897711|102203108|FG002|COMPLETED|Overall Study||53||
48761812|NCT04897711|102203109|FG003|COMPLETED|Overall Study||32||
48761813|NCT04897711|102203110|FG004|COMPLETED|Overall Study||27||
48761814|NCT04897711|102203106|FG000|NOT COMPLETED|Overall Study||0||
48761815|NCT04897711|102203107|FG001|NOT COMPLETED|Overall Study||0||
48761816|NCT04897711|102203108|FG002|NOT COMPLETED|Overall Study||0||
48761817|NCT04897711|102203109|FG003|NOT COMPLETED|Overall Study||0||
48761818|NCT04897711|102203110|FG004|NOT COMPLETED|Overall Study||0||
48761819|NCT03896438|102203111|FG000|STARTED|Overall Study||1||
48761820|NCT03896438|102203112|FG001|STARTED|Overall Study||4||
48761821|NCT03896438|102203113|FG002|STARTED|Overall Study||4||
48761822|NCT03896438|102203111|FG000|COMPLETED|Overall Study||0||
48761823|NCT03896438|102203112|FG001|COMPLETED|Overall Study||1||
48761824|NCT03896438|102203113|FG002|COMPLETED|Overall Study||2||
48761825|NCT03896438|102203111|FG000|NOT COMPLETED|Overall Study||1||
48761826|NCT03896438|102203112|FG001|NOT COMPLETED|Overall Study||3||
48761827|NCT03896438|102203113|FG002|NOT COMPLETED|Overall Study||2||
48761828|NCT03453164|102203114|FG000|STARTED|Overall Study||41||
48761829|NCT03453164|102203114|FG000|COMPLETED|Overall Study||22||
48761830|NCT03453164|102203114|FG000|NOT COMPLETED|Overall Study||19||
48761831|NCT01775501|102203115|FG000|STARTED|Overall Study||40||
48761832|NCT01775501|102203115|FG000|COMPLETED|Overall Study||39||
48761833|NCT01775501|102203115|FG000|NOT COMPLETED|Overall Study||1||
48761834|NCT02689427|102203116|FG000|STARTED|Overall Study||24||
48761835|NCT02689427|102203116|FG000|COMPLETED|Overall Study||24||
48761836|NCT02689427|102203116|FG000|NOT COMPLETED|Overall Study||0||
48761837|NCT05615922|102203117|FG000|STARTED|Overall Study||11||
48761838|NCT05615922|102203117|FG000|COMPLETED|Overall Study||10||
48761839|NCT05615922|102203117|FG000|NOT COMPLETED|Overall Study||1||
48761840|NCT03668873|102203118|FG000|STARTED|Overall Study||38||
48761841|NCT03668873|102203119|FG001|STARTED|Overall Study||39||
48761842|NCT03668873|102203118|FG000|COMPLETED|Overall Study||32||
48761843|NCT03668873|102203119|FG001|COMPLETED|Overall Study||36||
48761844|NCT03668873|102203118|FG000|NOT COMPLETED|Overall Study||6||
48761845|NCT03668873|102203119|FG001|NOT COMPLETED|Overall Study||3||
48761846|NCT02006472|102203120|FG000|STARTED|Period 1 (Through Week 26)||82||
48761847|NCT02006472|102203121|FG001|STARTED|Period 1 (Through Week 26)||81||
48761848|NCT02006472|102203122|FG002|STARTED|Period 1 (Through Week 26)||82||
48761849|NCT02006472|102203123|FG003|STARTED|Period 1 (Through Week 26)||81||
48761850|NCT02006472|102203124|FG004|STARTED|Period 1 (Through Week 26)||82||
48761851|NCT02006472|102203120|FG000|ITT|Period 1 (Through Week 26)||82|Intention-to-treat: patients randomised into the study and dispensed study drug.|
48761852|NCT02006472|102203121|FG001|ITT|Period 1 (Through Week 26)||81|Intention-to-treat: patients randomised into the study and dispensed study drug.|
48761853|NCT02006472|102203122|FG002|ITT|Period 1 (Through Week 26)||82|Intention-to-treat: patients randomised into the study and dispensed study drug.|
48761854|NCT02006472|102203123|FG003|ITT|Period 1 (Through Week 26)||81|Intention-to-treat: patients randomised into the study and dispensed study drug.|
48761855|NCT02006472|102203124|FG004|ITT|Period 1 (Through Week 26)||82|Intention-to-treat: patients randomised into the study and dispensed study drug.|
48761856|NCT02006472|102203120|FG000|FAS|Period 1 (Through Week 26)||81|Full analysis set: patients from the ITT who received at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment. The FAS included efficacy observations measured up to Week 52.|
48761857|NCT02006472|102203121|FG001|FAS|Period 1 (Through Week 26)||75|Full analysis set: patients from the ITT who received at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment. The FAS included efficacy observations measured up to Week 52.|
48761858|NCT02006472|102203122|FG002|FAS|Period 1 (Through Week 26)||79|Full analysis set: patients from the ITT who received at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment. The FAS included efficacy observations measured up to Week 52.|
48761859|NCT02006472|102203123|FG003|FAS|Period 1 (Through Week 26)||81|Full analysis set: patients from the ITT who received at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment. The FAS included efficacy observations measured up to Week 52.|
48761860|NCT02006472|102203124|FG004|FAS|Period 1 (Through Week 26)||81|Full analysis set: patients from the ITT who received at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment. The FAS included efficacy observations measured up to Week 52.|
48761861|NCT02006472|102203120|FG000|Safety Set|Period 1 (Through Week 26)||82|Including all patients who took at least 1 dose of study drug. The analysis set included safety observations measured up to Week 52.|
48761862|NCT02006472|102203121|FG001|Safety Set|Period 1 (Through Week 26)||81|Including all patients who took at least 1 dose of study drug. The analysis set included safety observations measured up to Week 52.|
48761863|NCT02006472|102203122|FG002|Safety Set|Period 1 (Through Week 26)||82|Including all patients who took at least 1 dose of study drug. The analysis set included safety observations measured up to Week 52.|
48761864|NCT02006472|102203123|FG003|Safety Set|Period 1 (Through Week 26)||81|Including all patients who took at least 1 dose of study drug. The analysis set included safety observations measured up to Week 52.|
48761865|NCT02006472|102203124|FG004|Safety Set|Period 1 (Through Week 26)||82|Including all patients who took at least 1 dose of study drug. The analysis set included safety observations measured up to Week 52.|
48761866|NCT02006472|102203120|FG000|COMPLETED|Period 1 (Through Week 26)||70||
48761867|NCT02006472|102203121|FG001|COMPLETED|Period 1 (Through Week 26)||59||
48761868|NCT02006472|102203122|FG002|COMPLETED|Period 1 (Through Week 26)||65||
48416869|NCT00323479|101353505|FG000|COMPLETED|Overall Study||106||
48416870|NCT00323479|101353505|FG000|NOT COMPLETED|Overall Study||8||
48416871|NCT01072656|101353506|FG000|STARTED|First Intervention||5||
48416872|NCT01072656|101353507|FG001|STARTED|First Intervention||4||
48416873|NCT01072656|101353506|FG000|COMPLETED|First Intervention||5||
48416874|NCT01072656|101353507|FG001|COMPLETED|First Intervention||4||
48416875|NCT01072656|101353506|FG000|NOT COMPLETED|First Intervention||0||
48416876|NCT01072656|101353507|FG001|NOT COMPLETED|First Intervention||0||
48416877|NCT01072656|101353506|FG000|STARTED|Second Intervention||5||
48416878|NCT01072656|101353507|FG001|STARTED|Second Intervention||4||
48416879|NCT01072656|101353506|FG000|COMPLETED|Second Intervention||5||
48416880|NCT01072656|101353507|FG001|COMPLETED|Second Intervention||4||
48416881|NCT01072656|101353506|FG000|NOT COMPLETED|Second Intervention||0||
48416882|NCT01072656|101353507|FG001|NOT COMPLETED|Second Intervention||0||
48416883|NCT01173874|101353508|FG000|STARTED|Overall Study||56||
48416884|NCT01173874|101353509|FG001|STARTED|Overall Study||64||
48416885|NCT01173874|101353508|FG000|COMPLETED|Overall Study||33||
48416886|NCT01173874|101353509|FG001|COMPLETED|Overall Study||41||
48761869|NCT02006472|102203123|FG003|COMPLETED|Period 1 (Through Week 26)||67||
48761870|NCT02006472|102203124|FG004|COMPLETED|Period 1 (Through Week 26)||62||
48761871|NCT02006472|102203120|FG000|NOT COMPLETED|Period 1 (Through Week 26)||12||
48761872|NCT02006472|102203121|FG001|NOT COMPLETED|Period 1 (Through Week 26)||22||
48761873|NCT02006472|102203122|FG002|NOT COMPLETED|Period 1 (Through Week 26)||17||
48761874|NCT02006472|102203123|FG003|NOT COMPLETED|Period 1 (Through Week 26)||14||
48761875|NCT02006472|102203124|FG004|NOT COMPLETED|Period 1 (Through Week 26)||20||
48761876|NCT02006472|102203120|FG000|STARTED|Period 2 (Through Week 52)||57|The trial was extended from 26 to 52 weeks to evaluate the effect of pridopidine on Total Functional Capacity (TFC). Approximately 20% of patients completed 26 weeks of the study before IRB approvals for this extension, and did not continue into the 2nd treatment period up to 52 weeks.|
48761877|NCT02006472|102203121|FG001|STARTED|Period 2 (Through Week 52)||49|The trial was extended from 26 to 52 weeks to evaluate the effect of pridopidine on Total Functional Capacity (TFC). Approximately 20% of patients completed 26 weeks of the study before IRB approvals for this extension, and did not continue into the 2nd treatment period up to 52 weeks.|
48761878|NCT02006472|102203122|FG002|STARTED|Period 2 (Through Week 52)||54|The trial was extended from 26 to 52 weeks to evaluate the effect of pridopidine on Total Functional Capacity (TFC). Approximately 20% of patients completed 26 weeks of the study before IRB approvals for this extension, and did not continue into the 2nd treatment period up to 52 weeks.|
48761879|NCT02006472|102203123|FG003|STARTED|Period 2 (Through Week 52)||56|The trial was extended from 26 to 52 weeks to evaluate the effect of pridopidine on Total Functional Capacity (TFC). Approximately 20% of patients completed 26 weeks of the study before IRB approvals for this extension, and did not continue into the 2nd treatment period up to 52 weeks.|
48761880|NCT02006472|102203124|FG004|STARTED|Period 2 (Through Week 52)||46|The trial was extended from 26 to 52 weeks to evaluate the effect of pridopidine on Total Functional Capacity (TFC). Approximately 20% of patients completed 26 weeks of the study before IRB approvals for this extension, and did not continue into the 2nd treatment period up to 52 weeks.|
48761881|NCT02006472|102203120|FG000|Started Treatment in Period 2|Period 2 (Through Week 52)||57||
48761882|NCT02006472|102203121|FG001|Started Treatment in Period 2|Period 2 (Through Week 52)||49||
48761883|NCT02006472|102203122|FG002|Started Treatment in Period 2|Period 2 (Through Week 52)||52||
48761884|NCT02006472|102203123|FG003|Started Treatment in Period 2|Period 2 (Through Week 52)||56||
48761885|NCT02006472|102203124|FG004|Started Treatment in Period 2|Period 2 (Through Week 52)||46||
48761886|NCT02006472|102203120|FG000|COMPLETED|Period 2 (Through Week 52)||52||
48761887|NCT02006472|102203121|FG001|COMPLETED|Period 2 (Through Week 52)||43||
48761888|NCT02006472|102203122|FG002|COMPLETED|Period 2 (Through Week 52)||44||
48761889|NCT02006472|102203123|FG003|COMPLETED|Period 2 (Through Week 52)||53||
48761890|NCT02006472|102203124|FG004|COMPLETED|Period 2 (Through Week 52)||44||
48761891|NCT02006472|102203120|FG000|NOT COMPLETED|Period 2 (Through Week 52)||5||
48761892|NCT02006472|102203121|FG001|NOT COMPLETED|Period 2 (Through Week 52)||6||
48761893|NCT02006472|102203122|FG002|NOT COMPLETED|Period 2 (Through Week 52)||10||
48761894|NCT02006472|102203123|FG003|NOT COMPLETED|Period 2 (Through Week 52)||3||
48761895|NCT02006472|102203124|FG004|NOT COMPLETED|Period 2 (Through Week 52)||2||
48416887|NCT01173874|101353508|FG000|NOT COMPLETED|Overall Study||23||
48416888|NCT01173874|101353509|FG001|NOT COMPLETED|Overall Study||23||
48416889|NCT00434876|101353510|FG000|STARTED|Overall Study||11||
48761896|NCT04346745|102203125|FG000|STARTED|Overall Study||19||
48761897|NCT04346745|102203126|FG001|STARTED|Overall Study||19||
48761898|NCT04346745|102203125|FG000|COMPLETED|Overall Study||18||
48761899|NCT04346745|102203126|FG001|COMPLETED|Overall Study||16||
48416890|NCT00434876|101353511|FG001|STARTED|Overall Study||11||
48416891|NCT00434876|101353510|FG000|COMPLETED|Overall Study||10||
48416892|NCT00434876|101353511|FG001|COMPLETED|Overall Study||10||
48416893|NCT00434876|101353510|FG000|NOT COMPLETED|Overall Study||1||
48416894|NCT00434876|101353511|FG001|NOT COMPLETED|Overall Study||1||
48416895|NCT04374149|101353512|FG000|STARTED|Overall Study||10||
48416896|NCT04374149|101353513|FG001|STARTED|Overall Study||10||
48761900|NCT04346745|102203125|FG000|NOT COMPLETED|Overall Study||1||
48761901|NCT04346745|102203126|FG001|NOT COMPLETED|Overall Study||3||
48761902|NCT05467007|102203127|FG000|STARTED|Overall Study||205||
48761903|NCT05467007|102203128|FG001|STARTED|Overall Study||155||
48761904|NCT05467007|102203127|FG000|COMPLETED|Overall Study||205||
48352488|NCT02561897|101191594|FG001|STARTED|Overall Study||3||
48352489|NCT02561897|101191593|FG000|COMPLETED|Overall Study||2||
48352490|NCT02561897|101191594|FG001|COMPLETED|Overall Study||3||
48352491|NCT02561897|101191593|FG000|NOT COMPLETED|Overall Study||0||
48352492|NCT02561897|101191594|FG001|NOT COMPLETED|Overall Study||0||
48352493|NCT01161225|101191595|FG000|STARTED|Overall Study||59||
48352494|NCT01161225|101191596|FG001|STARTED|Overall Study||53||
48352495|NCT01161225|101191597|FG002|STARTED|Overall Study||14||
48352496|NCT01161225|101191595|FG000|COMPLETED|Overall Study||45||
48352497|NCT01161225|101191596|FG001|COMPLETED|Overall Study||44||
48352498|NCT01161225|101191597|FG002|COMPLETED|Overall Study||12||
48352499|NCT01161225|101191595|FG000|NOT COMPLETED|Overall Study||14||
48761905|NCT05467007|102203128|FG001|COMPLETED|Overall Study||155||
48761906|NCT05467007|102203127|FG000|NOT COMPLETED|Overall Study||0||
48761907|NCT05467007|102203128|FG001|NOT COMPLETED|Overall Study||0||
48761908|NCT03221556|102203129|FG000|STARTED|Allocation||115||
48352500|NCT01161225|101191596|FG001|NOT COMPLETED|Overall Study||9||
48352501|NCT01161225|101191597|FG002|NOT COMPLETED|Overall Study||2||
48352502|NCT03932240|101191598|FG000|STARTED|Overall Study||18||
48352503|NCT03932240|101191599|FG001|STARTED|Overall Study||18||
48352504|NCT03932240|101191598|FG000|Completed Study Per Protocol|Overall Study||17||
48352505|NCT03932240|101191599|FG001|Completed Study Per Protocol|Overall Study||13||
48352506|NCT03932240|101191598|FG000|COMPLETED|Overall Study||18|Intent to Treat Population|
48352507|NCT03932240|101191599|FG001|COMPLETED|Overall Study||18|Intent to Treat Population|
48352508|NCT03932240|101191598|FG000|NOT COMPLETED|Overall Study||0||
48352509|NCT03932240|101191599|FG001|NOT COMPLETED|Overall Study||0||
48352510|NCT01672892|101191600|FG000|STARTED|Overall Study||137||
48352511|NCT01672892|101191601|FG001|STARTED|Overall Study||152||
48352512|NCT01672892|101191600|FG000|Eligible Population|Overall Study||130||
48352513|NCT01672892|101191601|FG001|Eligible Population|Overall Study||149||
48352514|NCT01672892|101191600|FG000|Adverse Event Population|Overall Study||125|Eligible participants with adverse event data collected anytime during the study.|
48352515|NCT01672892|101191601|FG001|Adverse Event Population|Overall Study||144|Eligible participants with adverse event data collected anytime during the study.|
48352516|NCT01672892|101191600|FG000|COMPLETED|Overall Study||130|Participants contributing data to any results are considered to have completed the study.|
48352517|NCT01672892|101191601|FG001|COMPLETED|Overall Study||149|Participants contributing data to any results are considered to have completed the study.|
48352518|NCT01672892|101191600|FG000|NOT COMPLETED|Overall Study||7||
48352519|NCT01672892|101191601|FG001|NOT COMPLETED|Overall Study||3||
48352520|NCT00310310|101191602|FG000|STARTED|Overall Study||120||
48352521|NCT00310310|101191603|FG001|STARTED|Overall Study||120||
48352522|NCT00310310|101191602|FG000|COMPLETED|Overall Study||90||
48352523|NCT00310310|101191603|FG001|COMPLETED|Overall Study||100||
48352524|NCT00310310|101191602|FG000|NOT COMPLETED|Overall Study||30||
48352525|NCT00310310|101191603|FG001|NOT COMPLETED|Overall Study||20||
48352526|NCT01750918|101191604|FG000|STARTED|Overall Study||3|All patients who were treated with at least one dose of the study drug at the time of the final analysis.|
48352527|NCT01750918|101191605|FG001|STARTED|Overall Study||4|All patients who were treated with at least one dose of the study drug at the time of the final analysis.|
48352528|NCT01750918|101191606|FG002|STARTED|Overall Study||36|All patients who were treated with at least one dose of the study drug at the time of the final analysis.|
48352529|NCT01750918|101191607|FG003|STARTED|Overall Study||50|All patients who were treated with at least one dose of the study drug at the time of the final analysis.|
48352530|NCT01750918|101191608|FG004|STARTED|Overall Study||13|All patients who were treated with at least one dose of the study drug at the time of the final analysis.|
48352531|NCT01750918|101191609|FG005|STARTED|Overall Study||20|All patients who were treated with at least one dose of the study drug at the time of the final analysis.|
48352532|NCT01750918|101191610|FG006|STARTED|Overall Study||20|All patients who were treated with at least one dose of the study drug at the time of the final analysis.|
48352533|NCT01750918|101191611|FG007|STARTED|Overall Study||20|All patients who were treated with at least one dose of the study drug at the time of the final analysis.|
48352534|NCT01750918|101191604|FG000|Pharmacokinetic Population|Overall Study||3|All patients in the All Treated Population for whom a PK sample was obtained and analyzed.|
48416897|NCT04374149|101353512|FG000|COMPLETED|Overall Study||10||
48761909|NCT03221556|102203130|FG001|STARTED|Allocation||116||
48761910|NCT03221556|102203129|FG000|Received Allocated Intervention|Allocation||88||
48761911|NCT03221556|102203130|FG001|Received Allocated Intervention|Allocation||96||
48761912|NCT03221556|102203129|FG000|Did Not Receive Allocated Intervention|Allocation||27||
48761913|NCT03221556|102203130|FG001|Did Not Receive Allocated Intervention|Allocation||19||
48761914|NCT03221556|102203129|FG000|COMPLETED|Allocation||115||
48761915|NCT03221556|102203130|FG001|COMPLETED|Allocation||115||
48761916|NCT03221556|102203129|FG000|NOT COMPLETED|Allocation||0||
48761917|NCT03221556|102203130|FG001|NOT COMPLETED|Allocation||1||
48761918|NCT03221556|102203129|FG000|STARTED|Follow-Up||115||
48761919|NCT03221556|102203130|FG001|STARTED|Follow-Up||115||
48761920|NCT03221556|102203129|FG000|COMPLETED|Follow-Up||115||
48761921|NCT03221556|102203130|FG001|COMPLETED|Follow-Up||114||
48416898|NCT04374149|101353513|FG001|COMPLETED|Overall Study||10||
48416899|NCT04374149|101353512|FG000|NOT COMPLETED|Overall Study||0||
48416900|NCT04374149|101353513|FG001|NOT COMPLETED|Overall Study||0||
48416901|NCT01696396|101353514|FG000|STARTED|Overall Study||100||
48761922|NCT03221556|102203129|FG000|NOT COMPLETED|Follow-Up||0||
48761923|NCT03221556|102203130|FG001|NOT COMPLETED|Follow-Up||1||
48761924|NCT03221556|102203129|FG000|STARTED|Analysis||115||
48761925|NCT03221556|102203130|FG001|STARTED|Analysis||115||
48761926|NCT03221556|102203129|FG000|Assessed at 2 Months|Analysis||113||
48761927|NCT03221556|102203130|FG001|Assessed at 2 Months|Analysis||110||
48761928|NCT03221556|102203129|FG000|Assessed at 4 Months|Analysis||112||
48761929|NCT03221556|102203130|FG001|Assessed at 4 Months|Analysis||109||
48761930|NCT03221556|102203129|FG000|Assessed at 6 Months|Analysis||105||
48761931|NCT03221556|102203130|FG001|Assessed at 6 Months|Analysis||97||
48761932|NCT03221556|102203129|FG000|Assessed at 8 Months|Analysis||109||
48761933|NCT03221556|102203130|FG001|Assessed at 8 Months|Analysis||107||
48761934|NCT03221556|102203129|FG000|Assessed at 10 Months|Analysis||112||
48761935|NCT03221556|102203130|FG001|Assessed at 10 Months|Analysis||109||
48761936|NCT03221556|102203129|FG000|Assessed at 12 Months|Analysis||112||
48761937|NCT03221556|102203130|FG001|Assessed at 12 Months|Analysis||108||
48761938|NCT03221556|102203129|FG000|COMPLETED|Analysis||115||
48761939|NCT03221556|102203130|FG001|COMPLETED|Analysis||115||
48761940|NCT03221556|102203129|FG000|NOT COMPLETED|Analysis||0||
48761941|NCT03221556|102203130|FG001|NOT COMPLETED|Analysis||0||
48761942|NCT00248625|102203131|FG000|STARTED|Overall Study||92||
48761943|NCT00248625|102203132|FG001|STARTED|Overall Study||92||
48761944|NCT00248625|102203131|FG000|COMPLETED|Overall Study||92||
48761945|NCT00248625|102203132|FG001|COMPLETED|Overall Study||90||
48761946|NCT00248625|102203131|FG000|NOT COMPLETED|Overall Study||0||
48761947|NCT00248625|102203132|FG001|NOT COMPLETED|Overall Study||2||
48761948|NCT02535481|102203133|FG000|STARTED|Overall Study||22||
48761949|NCT02535481|102203134|FG001|STARTED|Overall Study||22||
48761950|NCT02535481|102203133|FG000|COMPLETED|Overall Study||22||
48761951|NCT02535481|102203134|FG001|COMPLETED|Overall Study||22||
48761952|NCT02535481|102203133|FG000|NOT COMPLETED|Overall Study||0||
48761953|NCT02535481|102203134|FG001|NOT COMPLETED|Overall Study||0||
48761954|NCT01285557|102203135|FG000|STARTED|Overall Study||239||
48761955|NCT01285557|102203136|FG001|STARTED|Overall Study||122||
48761956|NCT01285557|102203135|FG000|Treated|Overall Study||238||
48761957|NCT01285557|102203136|FG001|Treated|Overall Study||121||
48761958|NCT01285557|102203135|FG000|As Treated (AT) Population|Overall Study||230|Participants started either of 2 treatment regimens assigned according to actual treatment received.|
48761959|NCT01285557|102203136|FG001|As Treated (AT) Population|Overall Study||118|Participants started either of 2 treatment regimens assigned according to actual treatment received.|
48761960|NCT01285557|102203135|FG000|COMPLETED|Overall Study||0||
48761961|NCT01285557|102203136|FG001|COMPLETED|Overall Study||0||
48761962|NCT01285557|102203135|FG000|NOT COMPLETED|Overall Study||239||
48761963|NCT01285557|102203136|FG001|NOT COMPLETED|Overall Study||122||
48761964|NCT03532451|102203137|FG000|STARTED|Overall Study||13||
48761965|NCT03532451|102203138|FG001|STARTED|Overall Study||30||
48761966|NCT03532451|102203137|FG000|COMPLETED|Overall Study||12||
48761967|NCT03532451|102203138|FG001|COMPLETED|Overall Study||28||
48761968|NCT03532451|102203137|FG000|NOT COMPLETED|Overall Study||1||
48761969|NCT03532451|102203138|FG001|NOT COMPLETED|Overall Study||2||
48761970|NCT04531176|102203139|FG000|STARTED|Overall Study||24||
48761971|NCT04531176|102203140|FG001|STARTED|Overall Study||26||
48761972|NCT04531176|102203141|FG002|STARTED|Overall Study||24||
48761973|NCT04531176|102203139|FG000|COMPLETED|Overall Study||0||
48761974|NCT04531176|102203140|FG001|COMPLETED|Overall Study||0||
48761975|NCT04531176|102203141|FG002|COMPLETED|Overall Study||0||
48761976|NCT04531176|102203139|FG000|NOT COMPLETED|Overall Study||24||
48761977|NCT04531176|102203140|FG001|NOT COMPLETED|Overall Study||26||
48761978|NCT04531176|102203141|FG002|NOT COMPLETED|Overall Study||24||
48761979|NCT03459079|102203142|FG000|STARTED|Overall Study||20||
48761980|NCT03459079|102203143|FG001|STARTED|Overall Study||18||
48761981|NCT03459079|102203144|FG002|STARTED|Overall Study||10||
48761982|NCT03459079|102203142|FG000|COMPLETED|Overall Study||14||
48761983|NCT03459079|102203143|FG001|COMPLETED|Overall Study||14||
48761984|NCT03459079|102203144|FG002|COMPLETED|Overall Study||10||
48761985|NCT03459079|102203142|FG000|NOT COMPLETED|Overall Study||6||
48761986|NCT03459079|102203143|FG001|NOT COMPLETED|Overall Study||4||
48761987|NCT03459079|102203144|FG002|NOT COMPLETED|Overall Study||0||
48761988|NCT02039115|102205902|FG000|STARTED|Overall Study||1||
48761989|NCT02039115|102205903|FG001|STARTED|Overall Study||0||
48761990|NCT02039115|102205902|FG000|COMPLETED|Overall Study||1||
48761991|NCT02039115|102205903|FG001|COMPLETED|Overall Study||0||
48761992|NCT02039115|102205902|FG000|NOT COMPLETED|Overall Study||0||
48761993|NCT02039115|102205903|FG001|NOT COMPLETED|Overall Study||0||
48761994|NCT04570930|102205904|FG000|STARTED|Overall Study||129||
48761995|NCT04570930|102205905|FG001|STARTED|Overall Study||128||
48761996|NCT04570930|102205904|FG000|COMPLETED|Overall Study||122||
48761997|NCT04570930|102205905|FG001|COMPLETED|Overall Study||122||
48761998|NCT04570930|102205904|FG000|NOT COMPLETED|Overall Study||7||
48352535|NCT01750918|101191605|FG001|Pharmacokinetic Population|Overall Study||4|All patients in the All Treated Population for whom a PK sample was obtained and analyzed.|
48352536|NCT01750918|101191606|FG002|Pharmacokinetic Population|Overall Study||35|All patients in the All Treated Population for whom a PK sample was obtained and analyzed.|
48352537|NCT01750918|101191607|FG003|Pharmacokinetic Population|Overall Study||48|All patients in the All Treated Population for whom a PK sample was obtained and analyzed.|
48352538|NCT01750918|101191608|FG004|Pharmacokinetic Population|Overall Study||12|All patients in the All Treated Population for whom a PK sample was obtained and analyzed.|
48352539|NCT01750918|101191609|FG005|Pharmacokinetic Population|Overall Study||19|All patients in the All Treated Population for whom a PK sample was obtained and analyzed.|
48352540|NCT01750918|101191610|FG006|Pharmacokinetic Population|Overall Study||18|All patients in the All Treated Population for whom a PK sample was obtained and analyzed.|
48352541|NCT01750918|101191611|FG007|Pharmacokinetic Population|Overall Study||20|All patients in the All Treated Population for whom a PK sample was obtained and analyzed.|
48352542|NCT01750918|101191604|FG000|Biomarker Population|Overall Study||3|All patients in the All Treated Population whom a tumor biopsy/tissue was obtained and analyzed.|
48352543|NCT01750918|101191605|FG001|Biomarker Population|Overall Study||4|All patients in the All Treated Population whom a tumor biopsy/tissue was obtained and analyzed.|
48352544|NCT01750918|101191606|FG002|Biomarker Population|Overall Study||36|All patients in the All Treated Population whom a tumor biopsy/tissue was obtained and analyzed.|
48352545|NCT01750918|101191607|FG003|Biomarker Population|Overall Study||50|All patients in the All Treated Population whom a tumor biopsy/tissue was obtained and analyzed.|
48352546|NCT01750918|101191608|FG004|Biomarker Population|Overall Study||13|All patients in the All Treated Population whom a tumor biopsy/tissue was obtained and analyzed.|
48352547|NCT01750918|101191609|FG005|Biomarker Population|Overall Study||17|All patients in the All Treated Population whom a tumor biopsy/tissue was obtained and analyzed.|
48352548|NCT01750918|101191610|FG006|Biomarker Population|Overall Study||19|All patients in the All Treated Population whom a tumor biopsy/tissue was obtained and analyzed.|
48368118|NCT03196297|101230110|FG000|FAS|Extension Period||32||
48416902|NCT01696396|101353515|FG001|STARTED|Overall Study||27||
48416903|NCT01696396|101353516|FG002|STARTED|Overall Study||85||
48416904|NCT01696396|101353517|FG003|STARTED|Overall Study||42||
48416905|NCT01696396|101353514|FG000|Received Study Drug|Overall Study||98||
48416906|NCT01696396|101353515|FG001|Received Study Drug|Overall Study||26||
48416907|NCT01696396|101353516|FG002|Received Study Drug|Overall Study||84||
48416908|NCT01696396|101353517|FG003|Received Study Drug|Overall Study||41||
48416909|NCT01696396|101353514|FG000|Entered Open-label Period|Overall Study||84||
48416910|NCT01696396|101353515|FG001|Entered Open-label Period|Overall Study||21||
48416911|NCT01696396|101353516|FG002|Entered Open-label Period|Overall Study||75||
48416912|NCT01696396|101353517|FG003|Entered Open-label Period|Overall Study||37||
48416913|NCT01696396|101353514|FG000|COMPLETED|Overall Study||69|Participants who completed the safety follow-up period|
48416914|NCT01696396|101353515|FG001|COMPLETED|Overall Study||20|Participants who completed the safety follow-up period|
48416915|NCT01696396|101353516|FG002|COMPLETED|Overall Study||59|Participants who completed the safety follow-up period|
48416916|NCT01696396|101353517|FG003|COMPLETED|Overall Study||28|Participants who completed the safety follow-up period|
48416917|NCT01696396|101353514|FG000|NOT COMPLETED|Overall Study||31||
48416918|NCT01696396|101353515|FG001|NOT COMPLETED|Overall Study||7||
48416919|NCT01696396|101353516|FG002|NOT COMPLETED|Overall Study||26||
48416920|NCT01696396|101353517|FG003|NOT COMPLETED|Overall Study||14||
48416921|NCT04129242|101353518|FG000|STARTED|Overall Study||10||
48416922|NCT04129242|101353519|FG001|STARTED|Overall Study||10||
48416923|NCT04129242|101353518|FG000|COMPLETED|Overall Study||9||
48416924|NCT04129242|101353519|FG001|COMPLETED|Overall Study||8||
48416925|NCT04129242|101353518|FG000|NOT COMPLETED|Overall Study||1||
48416926|NCT04129242|101353519|FG001|NOT COMPLETED|Overall Study||2||
48416927|NCT02405091|101353520|FG000|STARTED|Overall Study||49||
48416928|NCT02405091|101353521|FG001|STARTED|Overall Study||107||
48416929|NCT02405091|101353522|FG002|STARTED|Overall Study||11||
48416930|NCT02405091|101353520|FG000|COMPLETED|Overall Study||20||
48416931|NCT02405091|101353521|FG001|COMPLETED|Overall Study||74||
48416932|NCT02405091|101353522|FG002|COMPLETED|Overall Study||9||
48416933|NCT02405091|101353520|FG000|NOT COMPLETED|Overall Study||29||
48416934|NCT02405091|101353521|FG001|NOT COMPLETED|Overall Study||33||
48416935|NCT02405091|101353522|FG002|NOT COMPLETED|Overall Study||2||
48416936|NCT05158244|101353523|FG000|STARTED|Overall Study||6||
48416937|NCT05158244|101353524|FG001|STARTED|Overall Study||8||
48416938|NCT05158244|101353525|FG002|STARTED|Overall Study||9||
48416939|NCT05158244|101353526|FG003|STARTED|Overall Study||2||
48416940|NCT05158244|101353527|FG004|STARTED|Overall Study||9||
48416941|NCT05158244|101353523|FG000|Received Treatment|Overall Study||6||
48416942|NCT05158244|101353524|FG001|Received Treatment|Overall Study||8||
48761999|NCT04570930|102205905|FG001|NOT COMPLETED|Overall Study||6||
48762000|NCT01292486|102205906|FG000|STARTED|Overall Study||32||
48416943|NCT05158244|101353525|FG002|Received Treatment|Overall Study||9||
48416944|NCT05158244|101353526|FG003|Received Treatment|Overall Study||2||
48416945|NCT05158244|101353527|FG004|Received Treatment|Overall Study||9||
48416946|NCT05158244|101353523|FG000|COMPLETED|Overall Study||5||
48416947|NCT05158244|101353524|FG001|COMPLETED|Overall Study||8||
48762001|NCT01292486|102205906|FG000|COMPLETED|Overall Study||26||
48416948|NCT05158244|101353525|FG002|COMPLETED|Overall Study||8||
48416949|NCT05158244|101353526|FG003|COMPLETED|Overall Study||2||
48416950|NCT05158244|101353527|FG004|COMPLETED|Overall Study||9||
48762002|NCT01292486|102205906|FG000|NOT COMPLETED|Overall Study||6||
48762003|NCT00632229|102205907|FG000|STARTED|Overall Study||17||
48762004|NCT00632229|102205908|FG001|STARTED|Overall Study||17||
48762005|NCT00632229|102205907|FG000|COMPLETED|Overall Study||11||
48762006|NCT00632229|102205908|FG001|COMPLETED|Overall Study||11||
48762007|NCT00632229|102205907|FG000|NOT COMPLETED|Overall Study||6||
48762008|NCT00632229|102205908|FG001|NOT COMPLETED|Overall Study||6||
48416951|NCT05158244|101353523|FG000|NOT COMPLETED|Overall Study||1||
48416952|NCT05158244|101353524|FG001|NOT COMPLETED|Overall Study||0||
48416953|NCT05158244|101353525|FG002|NOT COMPLETED|Overall Study||1||
48416954|NCT05158244|101353526|FG003|NOT COMPLETED|Overall Study||0||
48416955|NCT05158244|101353527|FG004|NOT COMPLETED|Overall Study||0||
48416956|NCT03225833|101353528|FG000|STARTED|Overall Study||16||
48416957|NCT03225833|101353529|FG001|STARTED|Overall Study||9||
48416958|NCT03225833|101353530|FG002|STARTED|Overall Study||9||
48416959|NCT03225833|101353531|FG003|STARTED|Overall Study||9||
48416960|NCT03225833|101353532|FG004|STARTED|Overall Study||8||
48416961|NCT03225833|101353533|FG005|STARTED|Overall Study||10||
48416962|NCT03225833|101353528|FG000|Single Dose Period Only|Overall Study||1||
48416963|NCT03225833|101353529|FG001|Single Dose Period Only|Overall Study||1||
48416964|NCT03225833|101353530|FG002|Single Dose Period Only|Overall Study||2||
48416965|NCT03225833|101353531|FG003|Single Dose Period Only|Overall Study||0||
48416966|NCT03225833|101353532|FG004|Single Dose Period Only|Overall Study||0||
48416967|NCT03225833|101353533|FG005|Single Dose Period Only|Overall Study||4||
48416968|NCT03225833|101353528|FG000|Multiple Dose Period Only|Overall Study||0||
48416969|NCT03225833|101353529|FG001|Multiple Dose Period Only|Overall Study||0||
48416970|NCT03225833|101353530|FG002|Multiple Dose Period Only|Overall Study||0||
48416971|NCT03225833|101353531|FG003|Multiple Dose Period Only|Overall Study||0||
48416972|NCT03225833|101353532|FG004|Multiple Dose Period Only|Overall Study||0||
48416973|NCT03225833|101353533|FG005|Multiple Dose Period Only|Overall Study||1||
48416974|NCT03225833|101353528|FG000|Single Dose and Multiple Dose Periods|Overall Study||15||
48416975|NCT03225833|101353529|FG001|Single Dose and Multiple Dose Periods|Overall Study||8||
48416976|NCT03225833|101353530|FG002|Single Dose and Multiple Dose Periods|Overall Study||7||
48416977|NCT03225833|101353531|FG003|Single Dose and Multiple Dose Periods|Overall Study||9||
48416978|NCT03225833|101353532|FG004|Single Dose and Multiple Dose Periods|Overall Study||8||
48416979|NCT03225833|101353533|FG005|Single Dose and Multiple Dose Periods|Overall Study||5||
48416980|NCT03225833|101353528|FG000|COMPLETED|Overall Study||11||
48416981|NCT03225833|101353529|FG001|COMPLETED|Overall Study||8||
48416982|NCT03225833|101353530|FG002|COMPLETED|Overall Study||7||
48416983|NCT03225833|101353531|FG003|COMPLETED|Overall Study||9||
48416984|NCT03225833|101353532|FG004|COMPLETED|Overall Study||7||
48416985|NCT03225833|101353533|FG005|COMPLETED|Overall Study||0||
48416986|NCT03225833|101353528|FG000|NOT COMPLETED|Overall Study||5||
48416987|NCT03225833|101353529|FG001|NOT COMPLETED|Overall Study||1||
48416988|NCT03225833|101353530|FG002|NOT COMPLETED|Overall Study||2||
48416989|NCT03225833|101353531|FG003|NOT COMPLETED|Overall Study||0||
48416990|NCT03225833|101353532|FG004|NOT COMPLETED|Overall Study||1||
48416991|NCT03225833|101353533|FG005|NOT COMPLETED|Overall Study||10||
48416992|NCT00413231|101353534|FG000|STARTED|0 to 30-day Post Treatment||160||
48416993|NCT00413231|101353534|FG000|COMPLETED|0 to 30-day Post Treatment||152||
48416994|NCT00413231|101353534|FG000|NOT COMPLETED|0 to 30-day Post Treatment||8||
48416995|NCT00413231|101353534|FG000|STARTED|30-day to 365-day Post Treatment||152||
48416996|NCT00413231|101353534|FG000|COMPLETED|30-day to 365-day Post Treatment||139||
48416997|NCT00413231|101353534|FG000|NOT COMPLETED|30-day to 365-day Post Treatment||13||
48416998|NCT00413231|101353534|FG000|STARTED|365-day to 60-month Post Treatment||139||
48416999|NCT00413231|101353534|FG000|COMPLETED|365-day to 60-month Post Treatment||93||
48417000|NCT00413231|101353534|FG000|NOT COMPLETED|365-day to 60-month Post Treatment||46||
48417001|NCT01058356|101353535|FG000|STARTED|Overall Study||214||
48417002|NCT01058356|101353535|FG000|COMPLETED|Overall Study||172||
48417003|NCT01058356|101353535|FG000|NOT COMPLETED|Overall Study||42||
48417004|NCT02067104|101353536|FG000|STARTED|Overall Study||4||
48762009|NCT01394016|102205909|FG000|STARTED|Overall Study||4||
48762010|NCT01394016|102205910|FG001|STARTED|Overall Study||3||
48762011|NCT01394016|102205911|FG002|STARTED|Overall Study||3||
48762012|NCT01394016|102205912|FG003|STARTED|Overall Study||3||
48762013|NCT01394016|102205913|FG004|STARTED|Overall Study||3||
48417005|NCT02067104|101353537|FG001|STARTED|Overall Study||5||
48417006|NCT02067104|101353536|FG000|COMPLETED|Overall Study||0||
48417007|NCT02067104|101353537|FG001|COMPLETED|Overall Study||0||
48417008|NCT02067104|101353536|FG000|NOT COMPLETED|Overall Study||4||
48417009|NCT02067104|101353537|FG001|NOT COMPLETED|Overall Study||5||
48417010|NCT01077193|101353538|FG000|STARTED|Overall Study||44||
48762014|NCT01394016|102205914|FG005|STARTED|Overall Study||4||
48762015|NCT01394016|102205915|FG006|STARTED|Overall Study||3||
48417011|NCT01077193|101353538|FG000|COMPLETED|Overall Study||0||
48417012|NCT01077193|101353538|FG000|NOT COMPLETED|Overall Study||44||
48417013|NCT02646332|101353539|FG000|STARTED|Overall Study||124||
48762016|NCT01394016|102205916|FG007|STARTED|Overall Study||7||
48417014|NCT02646332|101353540|FG001|STARTED|Overall Study||124||
48417015|NCT02646332|101353539|FG000|COMPLETED|Overall Study||124||
48417016|NCT02646332|101353540|FG001|COMPLETED|Overall Study||121||
48417017|NCT02646332|101353539|FG000|NOT COMPLETED|Overall Study||0||
48417018|NCT02646332|101353540|FG001|NOT COMPLETED|Overall Study||3||
48417019|NCT04610827|101353541|FG000|STARTED|Overall Study||1||
48417020|NCT04610827|101353542|FG001|STARTED|Overall Study||2||
48417021|NCT04610827|101353543|FG002|STARTED|Overall Study||3||
48417022|NCT04610827|101353541|FG000|COMPLETED|Overall Study||0||
48417023|NCT04610827|101353542|FG001|COMPLETED|Overall Study||1||
48417024|NCT04610827|101353543|FG002|COMPLETED|Overall Study||3||
48417025|NCT04610827|101353541|FG000|NOT COMPLETED|Overall Study||1||
48417026|NCT04610827|101353542|FG001|NOT COMPLETED|Overall Study||1||
48417027|NCT04610827|101353543|FG002|NOT COMPLETED|Overall Study||0||
48417028|NCT01852591|101353544|FG000|STARTED|Overall Study||8||
48417029|NCT01852591|101353544|FG000|COMPLETED|Overall Study||5||
48417030|NCT01852591|101353544|FG000|NOT COMPLETED|Overall Study||3||
48417031|NCT02630459|101353545|FG000|STARTED|Double-Blind Treatment Phase (DBTP)||136||
48417032|NCT02630459|101353546|FG001|STARTED|Double-Blind Treatment Phase (DBTP)||67||
48417033|NCT02630459|101353547|FG002|STARTED|Double-Blind Treatment Phase (DBTP)||135||
48417034|NCT02630459|101353548|FG003|STARTED|Double-Blind Treatment Phase (DBTP)||137||
48417035|NCT02630459|101353549|FG004|STARTED|Double-Blind Treatment Phase (DBTP)||0||
48417036|NCT02630459|101353550|FG005|STARTED|Double-Blind Treatment Phase (DBTP)||0||
48417037|NCT02630459|101353551|FG006|STARTED|Double-Blind Treatment Phase (DBTP)||0||
48417038|NCT02630459|101353552|FG007|STARTED|Double-Blind Treatment Phase (DBTP)||0||
48417039|NCT02630459|101353545|FG000|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||136||
48417040|NCT02630459|101353546|FG001|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||66||
48417041|NCT02630459|101353547|FG002|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||135||
48417042|NCT02630459|101353548|FG003|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||137||
48417043|NCT02630459|101353549|FG004|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0||
48417044|NCT02630459|101353550|FG005|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0||
48417045|NCT02630459|101353551|FG006|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0||
48417046|NCT02630459|101353552|FG007|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0||
48417047|NCT02630459|101353545|FG000|COMPLETED|Double-Blind Treatment Phase (DBTP)||133|Completed week 24 assessment of double-blind treatment phase|
48417048|NCT02630459|101353546|FG001|COMPLETED|Double-Blind Treatment Phase (DBTP)||65|Completed week 24 assessment of double-blind treatment phase|
48417049|NCT02630459|101353547|FG002|COMPLETED|Double-Blind Treatment Phase (DBTP)||130|Completed week 24 assessment of double-blind treatment phase|
48417050|NCT02630459|101353548|FG003|COMPLETED|Double-Blind Treatment Phase (DBTP)||134|Completed week 24 assessment of double-blind treatment phase|
48417051|NCT02630459|101353549|FG004|COMPLETED|Double-Blind Treatment Phase (DBTP)||0|Completed week 24 assessment of double-blind treatment phase|
48417052|NCT02630459|101353550|FG005|COMPLETED|Double-Blind Treatment Phase (DBTP)||0|Completed week 24 assessment of double-blind treatment phase|
48417053|NCT02630459|101353551|FG006|COMPLETED|Double-Blind Treatment Phase (DBTP)||0|Completed week 24 assessment of double-blind treatment phase|
48417054|NCT02630459|101353552|FG007|COMPLETED|Double-Blind Treatment Phase (DBTP)||0|Completed week 24 assessment of double-blind treatment phase|
48417055|NCT02630459|101353545|FG000|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||3||
48417056|NCT02630459|101353546|FG001|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||2||
48417057|NCT02630459|101353547|FG002|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||5||
48417058|NCT02630459|101353548|FG003|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||3||
48417059|NCT02630459|101353549|FG004|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0||
48417060|NCT02630459|101353550|FG005|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0||
48352549|NCT01750918|101191611|FG007|Biomarker Population|Overall Study||20|All patients in the All Treated Population whom a tumor biopsy/tissue was obtained and analyzed.|
48352550|NCT01750918|101191604|FG000|Crossover Population|Overall Study||0|Subset of patients in double combination who crossed over to triplet combination.|
48352551|NCT01750918|101191605|FG001|Crossover Population|Overall Study||0|Subset of patients in double combination who crossed over to triplet combination.|
48352552|NCT01750918|101191606|FG002|Crossover Population|Overall Study||0|Subset of patients in double combination who crossed over to triplet combination.|
48352553|NCT01750918|101191607|FG003|Crossover Population|Overall Study||0|Subset of patients in double combination who crossed over to triplet combination.|
48352554|NCT01750918|101191608|FG004|Crossover Population|Overall Study||4|Subset of patients in double combination who crossed over to triplet combination.|
48352555|NCT01750918|101191609|FG005|Crossover Population|Overall Study||2|Subset of patients in double combination who crossed over to triplet combination.|
48352556|NCT01750918|101191610|FG006|Crossover Population|Overall Study||5|Subset of patients in double combination who crossed over to triplet combination.|
48352557|NCT01750918|101191611|FG007|Crossover Population|Overall Study||5|Subset of patients in double combination who crossed over to triplet combination.|
48352558|NCT01750918|101191604|FG000|COMPLETED|Overall Study||3||
48352559|NCT01750918|101191605|FG001|COMPLETED|Overall Study||4||
48352560|NCT01750918|101191606|FG002|COMPLETED|Overall Study||28||
48417061|NCT02630459|101353551|FG006|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0||
48417062|NCT02630459|101353552|FG007|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0||
48417063|NCT02630459|101353545|FG000|STARTED|Open-Label Treatment Phase (OLTP)||0||
48352561|NCT01750918|101191607|FG003|COMPLETED|Overall Study||44||
48352562|NCT01750918|101191608|FG004|COMPLETED|Overall Study||12||
48352563|NCT01750918|101191609|FG005|COMPLETED|Overall Study||17||
48352564|NCT01750918|101191610|FG006|COMPLETED|Overall Study||17||
48352565|NCT01750918|101191611|FG007|COMPLETED|Overall Study||16||
48352566|NCT01750918|101191604|FG000|NOT COMPLETED|Overall Study||0||
48352567|NCT01750918|101191605|FG001|NOT COMPLETED|Overall Study||0||
48352568|NCT01750918|101191606|FG002|NOT COMPLETED|Overall Study||8||
48352569|NCT01750918|101191607|FG003|NOT COMPLETED|Overall Study||6||
48352570|NCT01750918|101191608|FG004|NOT COMPLETED|Overall Study||1||
48352571|NCT01750918|101191609|FG005|NOT COMPLETED|Overall Study||3||
48352572|NCT01750918|101191610|FG006|NOT COMPLETED|Overall Study||3||
48352573|NCT01750918|101191611|FG007|NOT COMPLETED|Overall Study||4||
48352574|NCT00826514|101191612|FG000|STARTED|Overall Study||30||
48352575|NCT00826514|101191613|FG001|STARTED|Overall Study||32||
48352576|NCT00826514|101191612|FG000|COMPLETED|Overall Study||27||
48352577|NCT00826514|101191613|FG001|COMPLETED|Overall Study||27||
48352578|NCT00826514|101191612|FG000|NOT COMPLETED|Overall Study||3||
48352579|NCT00826514|101191613|FG001|NOT COMPLETED|Overall Study||5||
48352580|NCT00687453|101191614|FG000|STARTED|Overall Study||11||
48352581|NCT00687453|101191615|FG001|STARTED|Overall Study||13||
48352582|NCT00687453|101191614|FG000|COMPLETED|Overall Study||8||
48352583|NCT00687453|101191615|FG001|COMPLETED|Overall Study||7||
48352584|NCT00687453|101191614|FG000|NOT COMPLETED|Overall Study||3||
48352585|NCT00687453|101191615|FG001|NOT COMPLETED|Overall Study||6||
48352586|NCT00488631|101191616|FG000|STARTED|Double Blind Period (Week 0-54)||156||
48352587|NCT00488631|101191617|FG001|STARTED|Double Blind Period (Week 0-54)||154||
48352588|NCT00488631|101191618|FG002|STARTED|Double Blind Period (Week 0-54)||154||
48352589|NCT00488631|101191619|FG003|STARTED|Double Blind Period (Week 0-54)||129||
48352590|NCT00488631|101191620|FG004|STARTED|Double Blind Period (Week 0-54)||230||
48352591|NCT00488631|101191621|FG005|STARTED|Double Blind Period (Week 0-54)||405||
48352592|NCT00488631|101191622|FG006|STARTED|Double Blind Period (Week 0-54)||0||
48352593|NCT00488631|101191623|FG007|STARTED|Double Blind Period (Week 0-54)||0||
48352594|NCT00488631|101191624|FG008|STARTED|Double Blind Period (Week 0-54)||0||
48352595|NCT00488631|101191625|FG009|STARTED|Double Blind Period (Week 0-54)||0||
48352596|NCT00488631|101191616|FG000|COMPLETED|Double Blind Period (Week 0-54)||113||
48352597|NCT00488631|101191617|FG001|COMPLETED|Double Blind Period (Week 0-54)||111||
48352598|NCT00488631|101191618|FG002|COMPLETED|Double Blind Period (Week 0-54)||109||
48352599|NCT00488631|101191619|FG003|COMPLETED|Double Blind Period (Week 0-54)||88||
48352600|NCT00488631|101191620|FG004|COMPLETED|Double Blind Period (Week 0-54)||127||
48352601|NCT00488631|101191621|FG005|COMPLETED|Double Blind Period (Week 0-54)||189||
48352602|NCT00488631|101191622|FG006|COMPLETED|Double Blind Period (Week 0-54)||0||
48352603|NCT00488631|101191623|FG007|COMPLETED|Double Blind Period (Week 0-54)||0||
48352604|NCT00488631|101191624|FG008|COMPLETED|Double Blind Period (Week 0-54)||0||
48352605|NCT00488631|101191625|FG009|COMPLETED|Double Blind Period (Week 0-54)||0||
48352606|NCT00488631|101191616|FG000|NOT COMPLETED|Double Blind Period (Week 0-54)||43||
48352607|NCT00488631|101191617|FG001|NOT COMPLETED|Double Blind Period (Week 0-54)||43||
48352608|NCT00488631|101191618|FG002|NOT COMPLETED|Double Blind Period (Week 0-54)||45||
48352609|NCT00488631|101191619|FG003|NOT COMPLETED|Double Blind Period (Week 0-54)||41||
48352610|NCT00488631|101191620|FG004|NOT COMPLETED|Double Blind Period (Week 0-54)||103||
48352611|NCT00488631|101191621|FG005|NOT COMPLETED|Double Blind Period (Week 0-54)||216||
48417064|NCT02630459|101353546|FG001|STARTED|Open-Label Treatment Phase (OLTP)||0||
48417065|NCT02630459|101353547|FG002|STARTED|Open-Label Treatment Phase (OLTP)||0||
48352612|NCT00488631|101191622|FG006|NOT COMPLETED|Double Blind Period (Week 0-54)||0||
48352613|NCT00488631|101191623|FG007|NOT COMPLETED|Double Blind Period (Week 0-54)||0||
48352614|NCT00488631|101191624|FG008|NOT COMPLETED|Double Blind Period (Week 0-54)||0||
48352615|NCT00488631|101191625|FG009|NOT COMPLETED|Double Blind Period (Week 0-54)||0||
48352616|NCT00488631|101191616|FG000|STARTED|Open Label Study Extension (Week 54-228)||0||
48352617|NCT00488631|101191617|FG001|STARTED|Open Label Study Extension (Week 54-228)||0||
48352618|NCT00488631|101191618|FG002|STARTED|Open Label Study Extension (Week 54-228)||0||
48352619|NCT00488631|101191619|FG003|STARTED|Open Label Study Extension (Week 54-228)||0||
48352620|NCT00488631|101191620|FG004|STARTED|Open Label Study Extension (Week 54-228)||0||
48352621|NCT00488631|101191621|FG005|STARTED|Open Label Study Extension (Week 54-228)||0||
48352622|NCT00488631|101191622|FG006|STARTED|Open Label Study Extension (Week 54-228)||96||
48352623|NCT00488631|101191623|FG007|STARTED|Open Label Study Extension (Week 54-228)||93||
48417066|NCT02630459|101353548|FG003|STARTED|Open-Label Treatment Phase (OLTP)||0||
48417067|NCT02630459|101353549|FG004|STARTED|Open-Label Treatment Phase (OLTP)||386||
48352624|NCT00488631|101191624|FG008|STARTED|Open Label Study Extension (Week 54-228)||470||
48352625|NCT00488631|101191625|FG009|STARTED|Open Label Study Extension (Week 54-228)||7||
48352626|NCT00488631|101191616|FG000|COMPLETED|Open Label Study Extension (Week 54-228)||0||
48352627|NCT00488631|101191617|FG001|COMPLETED|Open Label Study Extension (Week 54-228)||0||
48417068|NCT02630459|101353550|FG005|STARTED|Open-Label Treatment Phase (OLTP)||73||
48352628|NCT00488631|101191618|FG002|COMPLETED|Open Label Study Extension (Week 54-228)||0||
48352629|NCT00488631|101191619|FG003|COMPLETED|Open Label Study Extension (Week 54-228)||0||
48352630|NCT00488631|101191620|FG004|COMPLETED|Open Label Study Extension (Week 54-228)||0||
48352631|NCT00488631|101191621|FG005|COMPLETED|Open Label Study Extension (Week 54-228)||0||
48352632|NCT00488631|101191622|FG006|COMPLETED|Open Label Study Extension (Week 54-228)||16||
48352633|NCT00488631|101191623|FG007|COMPLETED|Open Label Study Extension (Week 54-228)||66||
48352634|NCT00488631|101191624|FG008|COMPLETED|Open Label Study Extension (Week 54-228)||288||
48352635|NCT00488631|101191625|FG009|COMPLETED|Open Label Study Extension (Week 54-228)||4||
48352636|NCT00488631|101191616|FG000|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0||
48352637|NCT00488631|101191617|FG001|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0||
48352638|NCT00488631|101191618|FG002|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0||
48352639|NCT00488631|101191619|FG003|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0||
48352640|NCT00488631|101191620|FG004|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0||
48352641|NCT00488631|101191621|FG005|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0||
48352642|NCT00488631|101191622|FG006|NOT COMPLETED|Open Label Study Extension (Week 54-228)||80||
48352643|NCT00488631|101191623|FG007|NOT COMPLETED|Open Label Study Extension (Week 54-228)||27||
48352644|NCT00488631|101191624|FG008|NOT COMPLETED|Open Label Study Extension (Week 54-228)||182||
48352645|NCT00488631|101191625|FG009|NOT COMPLETED|Open Label Study Extension (Week 54-228)||3||
48352646|NCT00761215|101191626|FG000|STARTED|Overall Study||64||
48352647|NCT00761215|101191627|FG001|STARTED|Overall Study||64||
48352648|NCT00761215|101191628|FG002|STARTED|Overall Study||64||
48352649|NCT00761215|101191626|FG000|COMPLETED|Overall Study||55||
48352650|NCT00761215|101191627|FG001|COMPLETED|Overall Study||60||
48352651|NCT00761215|101191628|FG002|COMPLETED|Overall Study||56||
48352652|NCT00761215|101191626|FG000|NOT COMPLETED|Overall Study||9||
48352653|NCT00761215|101191627|FG001|NOT COMPLETED|Overall Study||4||
48352654|NCT00761215|101191628|FG002|NOT COMPLETED|Overall Study||8||
48352655|NCT03633331|101191629|FG000|STARTED|Overall Study||93||
48352656|NCT03633331|101191629|FG000|COMPLETED|Overall Study||92||
48352657|NCT03633331|101191629|FG000|NOT COMPLETED|Overall Study||1||
48352658|NCT01120626|101191630|FG000|STARTED|Overall Study||20||
48352659|NCT01120626|101191631|FG001|STARTED|Overall Study||22||
48352660|NCT01120626|101191630|FG000|COMPLETED|Overall Study||19||
48352661|NCT01120626|101191631|FG001|COMPLETED|Overall Study||22||
48352662|NCT01120626|101191630|FG000|NOT COMPLETED|Overall Study||1||
48352663|NCT01120626|101191631|FG001|NOT COMPLETED|Overall Study||0||
48352664|NCT00765765|101191632|FG000|STARTED|Overall Study||6||
48352665|NCT00765765|101191632|FG000|COMPLETED|Overall Study||6||
48352666|NCT00765765|101191632|FG000|NOT COMPLETED|Overall Study||0||
48352667|NCT00644592|101191633|FG000|STARTED|Overall Study||5||
48352668|NCT00644592|101191634|FG001|STARTED|Overall Study||6||
48352669|NCT00644592|101191633|FG000|COMPLETED|Overall Study||5||
48352670|NCT00644592|101191634|FG001|COMPLETED|Overall Study||6||
48352671|NCT00644592|101191633|FG000|NOT COMPLETED|Overall Study||0||
48352672|NCT00644592|101191634|FG001|NOT COMPLETED|Overall Study||0||
48352673|NCT03476239|101191635|FG000|STARTED|Overall Study||121||
48352674|NCT03476239|101191635|FG000|Received Blinatumomab|Overall Study||120||
48352675|NCT03476239|101191635|FG000|Interim Analysis Set|Overall Study||90|Protocol-specified number of dosed subjects with the opportunity for 2 cycles of treatment|
48352676|NCT03476239|101191635|FG000|COMPLETED|Overall Study||23||
48352677|NCT03476239|101191635|FG000|NOT COMPLETED|Overall Study||98||
48352678|NCT01025635|101191636|FG000|STARTED|Overall Study||198||
48352679|NCT01025635|101191637|FG001|STARTED|Overall Study||203||
48352680|NCT01025635|101191636|FG000|COMPLETED|Overall Study||175||
48352681|NCT01025635|101191637|FG001|COMPLETED|Overall Study||178||
48352682|NCT01025635|101191636|FG000|NOT COMPLETED|Overall Study||23||
48352683|NCT01025635|101191637|FG001|NOT COMPLETED|Overall Study||25||
48352684|NCT01829048|101191638|FG000|STARTED|Overall Study||6||
48352685|NCT01829048|101191639|FG001|STARTED|Overall Study||8||
48352686|NCT01829048|101191640|FG002|STARTED|Overall Study||7||
48352687|NCT01829048|101191641|FG003|STARTED|Overall Study||14||
48352688|NCT01829048|101191642|FG004|STARTED|Overall Study||2||
48352689|NCT01829048|101191638|FG000|COMPLETED|Overall Study||6||
48352690|NCT01829048|101191639|FG001|COMPLETED|Overall Study||8||
48352691|NCT01829048|101191640|FG002|COMPLETED|Overall Study||7||
48352692|NCT01829048|101191641|FG003|COMPLETED|Overall Study||12||
48352693|NCT01829048|101191642|FG004|COMPLETED|Overall Study||2||
48352694|NCT01829048|101191638|FG000|NOT COMPLETED|Overall Study||0||
48352695|NCT01829048|101191639|FG001|NOT COMPLETED|Overall Study||0||
48352696|NCT01829048|101191640|FG002|NOT COMPLETED|Overall Study||0||
48352697|NCT01829048|101191641|FG003|NOT COMPLETED|Overall Study||2||
48352698|NCT01829048|101191642|FG004|NOT COMPLETED|Overall Study||0||
48352699|NCT05029622|101191643|FG000|STARTED|Overall Study||66||
48352700|NCT05029622|101191643|FG000|COMPLETED|Overall Study||65||
48352701|NCT05029622|101191643|FG000|NOT COMPLETED|Overall Study||1||
48352702|NCT02609399|101191644|FG000|STARTED|Influenza Season 2015-2016||27||
48352703|NCT02609399|101191645|FG001|STARTED|Influenza Season 2015-2016||31||
48352704|NCT02609399|101191644|FG000|COMPLETED|Influenza Season 2015-2016||24||
48352705|NCT02609399|101191645|FG001|COMPLETED|Influenza Season 2015-2016||29||
48352706|NCT02609399|101191644|FG000|NOT COMPLETED|Influenza Season 2015-2016||3||
48352707|NCT02609399|101191645|FG001|NOT COMPLETED|Influenza Season 2015-2016||2||
48352708|NCT02609399|101191644|FG000|STARTED|Influenza Season 2016-2017||58||
48352709|NCT02609399|101191645|FG001|STARTED|Influenza Season 2016-2017||64||
48352710|NCT02609399|101191644|FG000|COMPLETED|Influenza Season 2016-2017||49||
48352711|NCT02609399|101191645|FG001|COMPLETED|Influenza Season 2016-2017||59||
48352712|NCT02609399|101191644|FG000|NOT COMPLETED|Influenza Season 2016-2017||9||
48352713|NCT02609399|101191645|FG001|NOT COMPLETED|Influenza Season 2016-2017||5||
48352714|NCT00460993|101191646|FG000|STARTED|Phase 1 (6 Days)||14||
48352715|NCT00460993|101191647|FG001|STARTED|Phase 1 (6 Days)||17||
48352716|NCT00460993|101191646|FG000|COMPLETED|Phase 1 (6 Days)||14||
48352717|NCT00460993|101191647|FG001|COMPLETED|Phase 1 (6 Days)||17||
48352718|NCT00460993|101191646|FG000|NOT COMPLETED|Phase 1 (6 Days)||0||
48352719|NCT00460993|101191647|FG001|NOT COMPLETED|Phase 1 (6 Days)||0||
48352720|NCT00460993|101191646|FG000|STARTED|Phase 2 (6 Days)||14||
48352721|NCT00460993|101191647|FG001|STARTED|Phase 2 (6 Days)||17||
48352722|NCT00460993|101191646|FG000|COMPLETED|Phase 2 (6 Days)||14||
48352723|NCT00460993|101191647|FG001|COMPLETED|Phase 2 (6 Days)||17||
48352724|NCT00460993|101191646|FG000|NOT COMPLETED|Phase 2 (6 Days)||0||
48352725|NCT00460993|101191647|FG001|NOT COMPLETED|Phase 2 (6 Days)||0||
48352726|NCT02718820|101191648|FG000|STARTED|Overall Study||22||
48352727|NCT02718820|101191648|FG000|COMPLETED|Overall Study||22||
48352728|NCT02718820|101191648|FG000|NOT COMPLETED|Overall Study||0||
48352729|NCT02424149|101191649|FG000|STARTED|Overall Study||54||
48352730|NCT02424149|101191650|FG001|STARTED|Overall Study||53||
48352731|NCT02424149|101191649|FG000|COMPLETED|Overall Study||52||
48352732|NCT02424149|101191650|FG001|COMPLETED|Overall Study||52||
48352733|NCT02424149|101191649|FG000|NOT COMPLETED|Overall Study||2||
48352734|NCT02424149|101191650|FG001|NOT COMPLETED|Overall Study||1||
48352735|NCT03301857|101191651|FG000|STARTED|Overall Study||51||
48352736|NCT03301857|101191652|FG001|STARTED|Overall Study||34||
48352737|NCT03301857|101191651|FG000|Received Denosumab|Overall Study||51||
48352738|NCT03301857|101191652|FG001|Received Denosumab|Overall Study||0||
48352739|NCT03301857|101191651|FG000|COMPLETED|Overall Study||29||
48352740|NCT03301857|101191652|FG001|COMPLETED|Overall Study||26||
48352741|NCT03301857|101191651|FG000|NOT COMPLETED|Overall Study||22||
48352742|NCT03301857|101191652|FG001|NOT COMPLETED|Overall Study||8||
48352743|NCT01854177|101191653|FG000|STARTED|Overall Study||10||
48352744|NCT01854177|101191653|FG000|COMPLETED|Overall Study||10||
48352745|NCT01854177|101191653|FG000|NOT COMPLETED|Overall Study||0||
48352746|NCT03116113|101191654|FG000|STARTED|Part 1 (Day 0 up to Month 24)||3||
48352747|NCT03116113|101191655|FG001|STARTED|Part 1 (Day 0 up to Month 24)||3||
48352748|NCT03116113|101191656|FG002|STARTED|Part 1 (Day 0 up to Month 24)||3||
48352749|NCT03116113|101191657|FG003|STARTED|Part 1 (Day 0 up to Month 24)||3||
48352750|NCT03116113|101191658|FG004|STARTED|Part 1 (Day 0 up to Month 24)||3||
48352751|NCT03116113|101191659|FG005|STARTED|Part 1 (Day 0 up to Month 24)||3||
48352752|NCT03116113|101191660|FG006|STARTED|Part 1 (Day 0 up to Month 24)||0||
48352753|NCT03116113|101191661|FG007|STARTED|Part 1 (Day 0 up to Month 24)||0||
48352754|NCT03116113|101191662|FG008|STARTED|Part 1 (Day 0 up to Month 24)||0||
48352755|NCT03116113|101191654|FG000|COMPLETED|Part 1 (Day 0 up to Month 24)||3||
48352756|NCT03116113|101191655|FG001|COMPLETED|Part 1 (Day 0 up to Month 24)||3||
48352757|NCT03116113|101191656|FG002|COMPLETED|Part 1 (Day 0 up to Month 24)||3||
48352758|NCT03116113|101191657|FG003|COMPLETED|Part 1 (Day 0 up to Month 24)||3||
48352759|NCT03116113|101191658|FG004|COMPLETED|Part 1 (Day 0 up to Month 24)||3||
48352760|NCT03116113|101191659|FG005|COMPLETED|Part 1 (Day 0 up to Month 24)||3||
48352761|NCT03116113|101191660|FG006|COMPLETED|Part 1 (Day 0 up to Month 24)||0||
48352762|NCT03116113|101191661|FG007|COMPLETED|Part 1 (Day 0 up to Month 24)||0||
48352763|NCT03116113|101191662|FG008|COMPLETED|Part 1 (Day 0 up to Month 24)||0||
48352764|NCT03116113|101191654|FG000|NOT COMPLETED|Part 1 (Day 0 up to Month 24)||0||
48352765|NCT03116113|101191655|FG001|NOT COMPLETED|Part 1 (Day 0 up to Month 24)||0||
48352766|NCT03116113|101191656|FG002|NOT COMPLETED|Part 1 (Day 0 up to Month 24)||0||
48352767|NCT03116113|101191657|FG003|NOT COMPLETED|Part 1 (Day 0 up to Month 24)||0||
48352768|NCT03116113|101191658|FG004|NOT COMPLETED|Part 1 (Day 0 up to Month 24)||0||
48352769|NCT03116113|101191659|FG005|NOT COMPLETED|Part 1 (Day 0 up to Month 24)||0||
48352770|NCT03116113|101191660|FG006|NOT COMPLETED|Part 1 (Day 0 up to Month 24)||0||
48352771|NCT03116113|101191661|FG007|NOT COMPLETED|Part 1 (Day 0 up to Month 24)||0||
48352772|NCT03116113|101191662|FG008|NOT COMPLETED|Part 1 (Day 0 up to Month 24)||0||
48352773|NCT03116113|101191654|FG000|STARTED|Part 2 (Month 25 up to Month 36)||0||
48352774|NCT03116113|101191655|FG001|STARTED|Part 2 (Month 25 up to Month 36)||0||
48352775|NCT03116113|101191656|FG002|STARTED|Part 2 (Month 25 up to Month 36)||0||
48352776|NCT03116113|101191657|FG003|STARTED|Part 2 (Month 25 up to Month 36)||0||
48352777|NCT03116113|101191658|FG004|STARTED|Part 2 (Month 25 up to Month 36)||0||
48352778|NCT03116113|101191659|FG005|STARTED|Part 2 (Month 25 up to Month 36)||0||
48352779|NCT03116113|101191660|FG006|STARTED|Part 2 (Month 25 up to Month 36)||9||
48352780|NCT03116113|101191661|FG007|STARTED|Part 2 (Month 25 up to Month 36)||11||
48352781|NCT03116113|101191662|FG008|STARTED|Part 2 (Month 25 up to Month 36)||12||
48352782|NCT03116113|101191654|FG000|COMPLETED|Part 2 (Month 25 up to Month 36)||0||
48352783|NCT03116113|101191655|FG001|COMPLETED|Part 2 (Month 25 up to Month 36)||0||
48352784|NCT03116113|101191656|FG002|COMPLETED|Part 2 (Month 25 up to Month 36)||0||
48352785|NCT03116113|101191657|FG003|COMPLETED|Part 2 (Month 25 up to Month 36)||0||
48352786|NCT03116113|101191658|FG004|COMPLETED|Part 2 (Month 25 up to Month 36)||0||
48352787|NCT03116113|101191659|FG005|COMPLETED|Part 2 (Month 25 up to Month 36)||0||
48352788|NCT03116113|101191660|FG006|COMPLETED|Part 2 (Month 25 up to Month 36)||9||
48352789|NCT03116113|101191661|FG007|COMPLETED|Part 2 (Month 25 up to Month 36)||10||
48352790|NCT03116113|101191662|FG008|COMPLETED|Part 2 (Month 25 up to Month 36)||10||
48352791|NCT03116113|101191654|FG000|NOT COMPLETED|Part 2 (Month 25 up to Month 36)||0||
48352792|NCT03116113|101191655|FG001|NOT COMPLETED|Part 2 (Month 25 up to Month 36)||0||
48352793|NCT03116113|101191656|FG002|NOT COMPLETED|Part 2 (Month 25 up to Month 36)||0||
48352794|NCT03116113|101191657|FG003|NOT COMPLETED|Part 2 (Month 25 up to Month 36)||0||
48352795|NCT03116113|101191658|FG004|NOT COMPLETED|Part 2 (Month 25 up to Month 36)||0||
48352796|NCT03116113|101191659|FG005|NOT COMPLETED|Part 2 (Month 25 up to Month 36)||0||
48352797|NCT03116113|101191660|FG006|NOT COMPLETED|Part 2 (Month 25 up to Month 36)||0||
48352798|NCT03116113|101191661|FG007|NOT COMPLETED|Part 2 (Month 25 up to Month 36)||1||
48352799|NCT03116113|101191662|FG008|NOT COMPLETED|Part 2 (Month 25 up to Month 36)||2||
48352800|NCT01021111|101191663|FG000|STARTED|Overall Study||17||
48352801|NCT01021111|101191663|FG000|COMPLETED|Overall Study||17||
48352802|NCT01021111|101191663|FG000|NOT COMPLETED|Overall Study||0||
48352803|NCT00730236|101191664|FG000|STARTED|Overall Study||29||
48352804|NCT00730236|101191664|FG000|COMPLETED|Overall Study||23||
48417069|NCT02630459|101353551|FG006|STARTED|Open-Label Treatment Phase (OLTP)||0||
48417070|NCT02630459|101353552|FG007|STARTED|Open-Label Treatment Phase (OLTP)||0||
48352805|NCT00730236|101191664|FG000|NOT COMPLETED|Overall Study||6||
48352806|NCT00937235|101191665|FG000|STARTED|Overall Study||72||
48352807|NCT00937235|101191666|FG001|STARTED|Overall Study||70||
48352808|NCT00937235|101191665|FG000|COMPLETED|Overall Study||72||
48352809|NCT00937235|101191666|FG001|COMPLETED|Overall Study||70||
48352810|NCT00937235|101191665|FG000|NOT COMPLETED|Overall Study||0||
48352811|NCT00937235|101191666|FG001|NOT COMPLETED|Overall Study||0||
48352812|NCT01244737|101191667|FG000|STARTED|Overall Study||16||
48352813|NCT01244737|101191668|FG001|STARTED|Overall Study||28||
48352814|NCT01244737|101191669|FG002|STARTED|Overall Study||6||
48352815|NCT01244737|101191667|FG000|Successful Completion of FLT-PET|Overall Study||14||
48352816|NCT01244737|101191668|FG001|Successful Completion of FLT-PET|Overall Study||26||
48352817|NCT01244737|101191669|FG002|Successful Completion of FLT-PET|Overall Study||5||
48352818|NCT01244737|101191667|FG000|Surgery Within 30 Days of FLT-PET|Overall Study||13||
48352819|NCT01244737|101191668|FG001|Surgery Within 30 Days of FLT-PET|Overall Study||8||
48352820|NCT01244737|101191669|FG002|Surgery Within 30 Days of FLT-PET|Overall Study||0||
48352821|NCT01244737|101191667|FG000|Surgical Pathology Demonstrated Evaluable Brain Tumor|Overall Study||11||
48352822|NCT01244737|101191668|FG001|Surgical Pathology Demonstrated Evaluable Brain Tumor|Overall Study||7||
48352823|NCT01244737|101191669|FG002|Surgical Pathology Demonstrated Evaluable Brain Tumor|Overall Study||0||
48352824|NCT01244737|101191667|FG000|MIB Immunohistology Available|Overall Study||8||
48352825|NCT01244737|101191668|FG001|MIB Immunohistology Available|Overall Study||5||
48352826|NCT01244737|101191669|FG002|MIB Immunohistology Available|Overall Study||0||
48352827|NCT01244737|101191667|FG000|COMPLETED|Overall Study||8||
48352828|NCT01244737|101191668|FG001|COMPLETED|Overall Study||5||
48352829|NCT01244737|101191669|FG002|COMPLETED|Overall Study||0||
48352830|NCT01244737|101191667|FG000|NOT COMPLETED|Overall Study||8||
48352831|NCT01244737|101191668|FG001|NOT COMPLETED|Overall Study||23||
48352832|NCT01244737|101191669|FG002|NOT COMPLETED|Overall Study||6||
48352833|NCT03885284|101191670|FG000|STARTED|Overall Study||3||
48352834|NCT03885284|101191671|FG001|STARTED|Overall Study||6||
48352835|NCT03885284|101191670|FG000|COMPLETED|Overall Study||2||
48352836|NCT03885284|101191671|FG001|COMPLETED|Overall Study||2||
48352837|NCT03885284|101191670|FG000|NOT COMPLETED|Overall Study||1||
48352838|NCT03885284|101191671|FG001|NOT COMPLETED|Overall Study||4||
48352839|NCT01167608|101191672|FG000|STARTED|Overall Study||883||
48417071|NCT02630459|101353545|FG000|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
48417072|NCT02630459|101353546|FG001|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
48417073|NCT02630459|101353547|FG002|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
48417074|NCT02630459|101353548|FG003|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
48417075|NCT02630459|101353549|FG004|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||270||
48417076|NCT02630459|101353550|FG005|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
48417077|NCT02630459|101353551|FG006|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
48417078|NCT02630459|101353552|FG007|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
48352840|NCT01167608|101191672|FG000|COMPLETED|Overall Study||769||
48352841|NCT01167608|101191672|FG000|NOT COMPLETED|Overall Study||114||
48352842|NCT01057121|101191673|FG000|STARTED|Phase I: 10 mg/Day Lenalidomide||3||
48352843|NCT01057121|101191674|FG001|STARTED|Phase I: 10 mg/Day Lenalidomide||0||
48352844|NCT01057121|101191675|FG002|STARTED|Phase I: 10 mg/Day Lenalidomide||0||
48352845|NCT01057121|101191676|FG003|STARTED|Phase I: 10 mg/Day Lenalidomide||0||
48352846|NCT01057121|101191677|FG004|STARTED|Phase I: 10 mg/Day Lenalidomide||0||
48186817|NCT00614744|100779909|FG001|STARTED|Overall Study||85||
48186818|NCT00614744|100779908|FG000|COMPLETED|Overall Study||78||
48186819|NCT00614744|100779909|FG001|COMPLETED|Overall Study||79||
48352847|NCT01057121|101191673|FG000|COMPLETED|Phase I: 10 mg/Day Lenalidomide||3||
48352848|NCT01057121|101191674|FG001|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0||
48352849|NCT01057121|101191675|FG002|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0||
48352850|NCT01057121|101191676|FG003|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0||
48352851|NCT01057121|101191677|FG004|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0||
48352852|NCT01057121|101191673|FG000|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0||
48352853|NCT01057121|101191674|FG001|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0||
48352854|NCT01057121|101191675|FG002|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0||
48352855|NCT01057121|101191676|FG003|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0||
48352856|NCT01057121|101191677|FG004|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0||
48352857|NCT01057121|101191673|FG000|STARTED|Phase I: 15 mg/Day Lenolidomide||0||
48352858|NCT01057121|101191674|FG001|STARTED|Phase I: 15 mg/Day Lenolidomide||3||
48352859|NCT01057121|101191675|FG002|STARTED|Phase I: 15 mg/Day Lenolidomide||0||
48352860|NCT01057121|101191676|FG003|STARTED|Phase I: 15 mg/Day Lenolidomide||0||
48352861|NCT01057121|101191677|FG004|STARTED|Phase I: 15 mg/Day Lenolidomide||0||
48352862|NCT01057121|101191673|FG000|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0||
48352863|NCT01057121|101191674|FG001|COMPLETED|Phase I: 15 mg/Day Lenolidomide||3||
48352864|NCT01057121|101191675|FG002|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0||
48352865|NCT01057121|101191676|FG003|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0||
48352866|NCT01057121|101191677|FG004|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0||
48352867|NCT01057121|101191673|FG000|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0||
48352868|NCT01057121|101191674|FG001|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0||
48417079|NCT02630459|101353545|FG000|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
48417080|NCT02630459|101353546|FG001|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
48417081|NCT02630459|101353547|FG002|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
48417082|NCT02630459|101353548|FG003|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
48417083|NCT02630459|101353549|FG004|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
48417084|NCT02630459|101353550|FG005|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||73||
48417085|NCT02630459|101353551|FG006|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
48417086|NCT02630459|101353552|FG007|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
48417087|NCT02630459|101353545|FG000|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
48417088|NCT02630459|101353546|FG001|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
48417089|NCT02630459|101353547|FG002|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
48417090|NCT02630459|101353548|FG003|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
48417091|NCT02630459|101353549|FG004|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||116||
48417092|NCT02630459|101353550|FG005|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
48417093|NCT02630459|101353551|FG006|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
48417094|NCT02630459|101353552|FG007|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
48417095|NCT02630459|101353545|FG000|COMPLETED|Open-Label Treatment Phase (OLTP)||0||
48417096|NCT02630459|101353546|FG001|COMPLETED|Open-Label Treatment Phase (OLTP)||0||
48417097|NCT02630459|101353547|FG002|COMPLETED|Open-Label Treatment Phase (OLTP)||0||
48417098|NCT02630459|101353548|FG003|COMPLETED|Open-Label Treatment Phase (OLTP)||0||
48417099|NCT02630459|101353549|FG004|COMPLETED|Open-Label Treatment Phase (OLTP)||357||
48417100|NCT02630459|101353550|FG005|COMPLETED|Open-Label Treatment Phase (OLTP)||69||
48417101|NCT02630459|101353551|FG006|COMPLETED|Open-Label Treatment Phase (OLTP)||0||
48417102|NCT02630459|101353552|FG007|COMPLETED|Open-Label Treatment Phase (OLTP)||0||
48417103|NCT02630459|101353545|FG000|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0||
48417104|NCT02630459|101353546|FG001|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0||
48417105|NCT02630459|101353547|FG002|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0||
48417106|NCT02630459|101353548|FG003|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0||
48417107|NCT02630459|101353549|FG004|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||29||
48417108|NCT02630459|101353550|FG005|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||4||
48417109|NCT02630459|101353551|FG006|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0||
48417110|NCT02630459|101353552|FG007|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0||
48417111|NCT02630459|101353545|FG000|STARTED|Optional CHU Sub-Study (During OLTP)||0||
48638268|NCT00544882|101898722|FG000|COMPLETED|Cycle 1: Run-in Cycle||58||
48352869|NCT01057121|101191675|FG002|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0||
48352870|NCT01057121|101191676|FG003|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0||
48352871|NCT01057121|101191677|FG004|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0||
48352872|NCT01057121|101191673|FG000|STARTED|Phase I: 20 mg/Day Lenalidomide||0||
48352873|NCT01057121|101191674|FG001|STARTED|Phase I: 20 mg/Day Lenalidomide||0||
48417112|NCT02630459|101353546|FG001|STARTED|Optional CHU Sub-Study (During OLTP)||0||
48417113|NCT02630459|101353547|FG002|STARTED|Optional CHU Sub-Study (During OLTP)||0||
48417114|NCT02630459|101353548|FG003|STARTED|Optional CHU Sub-Study (During OLTP)||0||
48417115|NCT02630459|101353549|FG004|STARTED|Optional CHU Sub-Study (During OLTP)||0||
48417116|NCT02630459|101353550|FG005|STARTED|Optional CHU Sub-Study (During OLTP)||0||
48417117|NCT02630459|101353551|FG006|STARTED|Optional CHU Sub-Study (During OLTP)||24||
48417118|NCT02630459|101353552|FG007|STARTED|Optional CHU Sub-Study (During OLTP)||25||
48417119|NCT02630459|101353545|FG000|COMPLETED|Optional CHU Sub-Study (During OLTP)||0|Completed week 12 sub-study visit (day 85)|
48352874|NCT01057121|101191675|FG002|STARTED|Phase I: 20 mg/Day Lenalidomide||3||
48352875|NCT01057121|101191676|FG003|STARTED|Phase I: 20 mg/Day Lenalidomide||0||
48352876|NCT01057121|101191677|FG004|STARTED|Phase I: 20 mg/Day Lenalidomide||0||
48352877|NCT01057121|101191673|FG000|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0||
48352878|NCT01057121|101191674|FG001|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0||
48352879|NCT01057121|101191675|FG002|COMPLETED|Phase I: 20 mg/Day Lenalidomide||3||
48352880|NCT01057121|101191676|FG003|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0||
48352881|NCT01057121|101191677|FG004|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0||
48352882|NCT01057121|101191673|FG000|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0||
48352883|NCT01057121|101191674|FG001|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0||
48352884|NCT01057121|101191675|FG002|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0||
48352885|NCT01057121|101191676|FG003|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0||
48352886|NCT01057121|101191677|FG004|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0||
48352887|NCT01057121|101191673|FG000|STARTED|Phase I: 25 mg/Day Lenalidomide||0||
48352888|NCT01057121|101191674|FG001|STARTED|Phase I: 25 mg/Day Lenalidomide||0||
48352889|NCT01057121|101191675|FG002|STARTED|Phase I: 25 mg/Day Lenalidomide||0||
48352890|NCT01057121|101191676|FG003|STARTED|Phase I: 25 mg/Day Lenalidomide||6||
48352891|NCT01057121|101191677|FG004|STARTED|Phase I: 25 mg/Day Lenalidomide||0||
48352892|NCT01057121|101191673|FG000|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0||
48352893|NCT01057121|101191674|FG001|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0||
48352894|NCT01057121|101191675|FG002|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0||
48352895|NCT01057121|101191676|FG003|COMPLETED|Phase I: 25 mg/Day Lenalidomide||6||
48352896|NCT01057121|101191677|FG004|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0||
48352897|NCT01057121|101191673|FG000|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0||
48352898|NCT01057121|101191674|FG001|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0||
48352899|NCT01057121|101191675|FG002|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0||
48352900|NCT01057121|101191676|FG003|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0||
48352901|NCT01057121|101191677|FG004|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0||
48352902|NCT01057121|101191673|FG000|STARTED|Phase II: 25 mg/Day Lenalidomide||0||
48352903|NCT01057121|101191674|FG001|STARTED|Phase II: 25 mg/Day Lenalidomide||0||
48352904|NCT01057121|101191675|FG002|STARTED|Phase II: 25 mg/Day Lenalidomide||0||
48352905|NCT01057121|101191676|FG003|STARTED|Phase II: 25 mg/Day Lenalidomide||0||
48352906|NCT01057121|101191677|FG004|STARTED|Phase II: 25 mg/Day Lenalidomide||23||
48352907|NCT01057121|101191673|FG000|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0||
48352908|NCT01057121|101191674|FG001|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0||
48352909|NCT01057121|101191675|FG002|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0||
48352910|NCT01057121|101191676|FG003|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0||
48352911|NCT01057121|101191677|FG004|COMPLETED|Phase II: 25 mg/Day Lenalidomide||23||
48352912|NCT01057121|101191673|FG000|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0||
48352913|NCT01057121|101191674|FG001|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0||
48352914|NCT01057121|101191675|FG002|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0||
48352915|NCT01057121|101191676|FG003|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0||
48352916|NCT01057121|101191677|FG004|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0||
48352917|NCT04321343|101191678|FG000|STARTED|Overall Study||25||
48352918|NCT04321343|101191679|FG001|STARTED|Overall Study||32||
48352919|NCT04321343|101191680|FG002|STARTED|Overall Study||30||
48352920|NCT04321343|101191681|FG003|STARTED|Overall Study||30||
48352921|NCT04321343|101191678|FG000|Completed the Double-blind Period|Overall Study||21||
48417120|NCT02630459|101353546|FG001|COMPLETED|Optional CHU Sub-Study (During OLTP)||0|Completed week 12 sub-study visit (day 85)|
48417121|NCT02630459|101353547|FG002|COMPLETED|Optional CHU Sub-Study (During OLTP)||0|Completed week 12 sub-study visit (day 85)|
48417122|NCT02630459|101353548|FG003|COMPLETED|Optional CHU Sub-Study (During OLTP)||0|Completed week 12 sub-study visit (day 85)|
48638269|NCT00544882|101898723|FG001|COMPLETED|Cycle 1: Run-in Cycle||0||
48638270|NCT00544882|101898724|FG002|COMPLETED|Cycle 1: Run-in Cycle||0||
48638271|NCT00544882|101898722|FG000|NOT COMPLETED|Cycle 1: Run-in Cycle||3||
48638272|NCT00544882|101898723|FG001|NOT COMPLETED|Cycle 1: Run-in Cycle||0||
48638273|NCT00544882|101898724|FG002|NOT COMPLETED|Cycle 1: Run-in Cycle||0||
48638274|NCT00544882|101898722|FG000|STARTED|Cycle 2: Randomized Treatment Cycle||0||
48417123|NCT02630459|101353549|FG004|COMPLETED|Optional CHU Sub-Study (During OLTP)||0|Completed week 12 sub-study visit (day 85)|
48417124|NCT02630459|101353550|FG005|COMPLETED|Optional CHU Sub-Study (During OLTP)||0|Completed week 12 sub-study visit (day 85)|
48638275|NCT00544882|101898723|FG001|STARTED|Cycle 2: Randomized Treatment Cycle||29||
48417125|NCT02630459|101353551|FG006|COMPLETED|Optional CHU Sub-Study (During OLTP)||24|Completed week 12 sub-study visit (day 85)|
48417126|NCT02630459|101353552|FG007|COMPLETED|Optional CHU Sub-Study (During OLTP)||25|Completed week 12 sub-study visit (day 85)|
48417127|NCT02630459|101353545|FG000|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0||
48417128|NCT02630459|101353546|FG001|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0||
48417129|NCT02630459|101353547|FG002|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0||
48417130|NCT02630459|101353548|FG003|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0||
48417131|NCT02630459|101353549|FG004|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0||
48417132|NCT02630459|101353550|FG005|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0||
48417133|NCT02630459|101353551|FG006|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0||
48417134|NCT02630459|101353552|FG007|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0||
48417135|NCT01657903|101353553|FG000|STARTED|Overall Study||56||
48417136|NCT01657903|101353553|FG000|Received Placebo (No NaF/KNO3)Toothpaste|Overall Study||56||
48352922|NCT04321343|101191679|FG001|Completed the Double-blind Period|Overall Study||23||
48352923|NCT04321343|101191680|FG002|Completed the Double-blind Period|Overall Study||27||
48352924|NCT04321343|101191681|FG003|Completed the Double-blind Period|Overall Study||24||
48352925|NCT04321343|101191678|FG000|COMPLETED|Overall Study||21||
48352926|NCT04321343|101191679|FG001|COMPLETED|Overall Study||23||
48352927|NCT04321343|101191680|FG002|COMPLETED|Overall Study||27||
48352928|NCT04321343|101191681|FG003|COMPLETED|Overall Study||23||
48352929|NCT04321343|101191678|FG000|NOT COMPLETED|Overall Study||4||
48352930|NCT04321343|101191679|FG001|NOT COMPLETED|Overall Study||9||
48352931|NCT04321343|101191680|FG002|NOT COMPLETED|Overall Study||3||
48352932|NCT04321343|101191681|FG003|NOT COMPLETED|Overall Study||7||
48352933|NCT01472276|101191682|FG000|STARTED|Overall Study||33|Randomized|
48352934|NCT01472276|101191683|FG001|STARTED|Overall Study||32|Randomized|
48352935|NCT01472276|101191682|FG000|3-month Follow-up|Overall Study||32||
48352936|NCT01472276|101191683|FG001|3-month Follow-up|Overall Study||25||
48352937|NCT01472276|101191682|FG000|6-month Follow-up|Overall Study||31||
48352938|NCT01472276|101191683|FG001|6-month Follow-up|Overall Study||21||
48352939|NCT01472276|101191682|FG000|COMPLETED|Overall Study||29|12-month follow-up|
48352940|NCT01472276|101191683|FG001|COMPLETED|Overall Study||17|12-month follow-up|
48352941|NCT01472276|101191682|FG000|NOT COMPLETED|Overall Study||4||
48638276|NCT00544882|101898724|FG002|STARTED|Cycle 2: Randomized Treatment Cycle||29||
48638277|NCT00544882|101898722|FG000|Treated|Cycle 2: Randomized Treatment Cycle||0||
48638278|NCT00544882|101898723|FG001|Treated|Cycle 2: Randomized Treatment Cycle||28||
48638279|NCT00544882|101898724|FG002|Treated|Cycle 2: Randomized Treatment Cycle||28||
48638280|NCT00544882|101898722|FG000|COMPLETED|Cycle 2: Randomized Treatment Cycle||0||
48638281|NCT00544882|101898723|FG001|COMPLETED|Cycle 2: Randomized Treatment Cycle||28||
48638282|NCT00544882|101898724|FG002|COMPLETED|Cycle 2: Randomized Treatment Cycle||28||
48638283|NCT00544882|101898722|FG000|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||0||
48638284|NCT00544882|101898723|FG001|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1||
48638285|NCT00544882|101898724|FG002|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1||
48638286|NCT00544882|101898722|FG000|STARTED|Cycle 3: Follow-up||0||
48352942|NCT01472276|101191683|FG001|NOT COMPLETED|Overall Study||15||
48352943|NCT02919306|101191684|FG000|STARTED|Overall Study||18||
48352944|NCT02919306|101191685|FG001|STARTED|Overall Study||9||
48352945|NCT02919306|101191684|FG000|COMPLETED|Overall Study||16||
48352946|NCT02919306|101191685|FG001|COMPLETED|Overall Study||9||
48352947|NCT02919306|101191684|FG000|NOT COMPLETED|Overall Study||2||
48352948|NCT02919306|101191685|FG001|NOT COMPLETED|Overall Study||0||
48352949|NCT01225354|101191686|FG000|STARTED|Overall Study||20||
48352950|NCT01225354|101191686|FG000|COMPLETED|Overall Study||19||
48352951|NCT01225354|101191686|FG000|NOT COMPLETED|Overall Study||1||
48352952|NCT02240706|101191687|FG000|STARTED|Overall Study||3||
48352953|NCT02240706|101191688|FG001|STARTED|Overall Study||3||
48352954|NCT02240706|101191689|FG002|STARTED|Overall Study||6||
48352955|NCT02240706|101191690|FG003|STARTED|Overall Study||4||
48417137|NCT01657903|101353553|FG000|Received NaF/KNO3 Toothpaste 1|Overall Study||55||
48417138|NCT01657903|101353553|FG000|Received NaF/KNO3 Toothpaste 3|Overall Study||54||
48417139|NCT01657903|101353553|FG000|Received NaF/KNO3 Toothpaste 2|Overall Study||55||
48638287|NCT00544882|101898723|FG001|STARTED|Cycle 3: Follow-up||28||
48638288|NCT00544882|101898724|FG002|STARTED|Cycle 3: Follow-up||28||
48352956|NCT02240706|101191691|FG004|STARTED|Overall Study||11||
48352957|NCT02240706|101191692|FG005|STARTED|Overall Study||0||
48352958|NCT02240706|101191693|FG006|STARTED|Overall Study||0||
48352959|NCT02240706|101191687|FG000|COMPLETED|Overall Study||0||
48352960|NCT02240706|101191688|FG001|COMPLETED|Overall Study||0||
48417140|NCT01657903|101353553|FG000|COMPLETED|Overall Study||54||
48352961|NCT02240706|101191689|FG002|COMPLETED|Overall Study||0||
48352962|NCT02240706|101191690|FG003|COMPLETED|Overall Study||0||
48352963|NCT02240706|101191691|FG004|COMPLETED|Overall Study||0||
48352964|NCT02240706|101191692|FG005|COMPLETED|Overall Study||0||
48352965|NCT02240706|101191693|FG006|COMPLETED|Overall Study||0||
48638289|NCT00544882|101898722|FG000|COMPLETED|Cycle 3: Follow-up||0||
48638290|NCT00544882|101898723|FG001|COMPLETED|Cycle 3: Follow-up||26||
48638291|NCT00544882|101898724|FG002|COMPLETED|Cycle 3: Follow-up||28||
48638292|NCT00544882|101898722|FG000|NOT COMPLETED|Cycle 3: Follow-up||0||
48352966|NCT02240706|101191687|FG000|NOT COMPLETED|Overall Study||3||
48352967|NCT02240706|101191688|FG001|NOT COMPLETED|Overall Study||3||
48352968|NCT02240706|101191689|FG002|NOT COMPLETED|Overall Study||6||
48352969|NCT02240706|101191690|FG003|NOT COMPLETED|Overall Study||4||
48352970|NCT02240706|101191691|FG004|NOT COMPLETED|Overall Study||11||
48352971|NCT02240706|101191692|FG005|NOT COMPLETED|Overall Study||0||
48417141|NCT01657903|101353553|FG000|NOT COMPLETED|Overall Study||2||
48417142|NCT03419741|101353554|FG000|STARTED|Overall Study||5||
48417143|NCT03419741|101353555|FG001|STARTED|Overall Study||6||
48417144|NCT03419741|101353554|FG000|Treated|Overall Study||4|Treated: to indicate the number of participants who began treatment.|
48417145|NCT03419741|101353555|FG001|Treated|Overall Study||4|Treated: to indicate the number of participants who began treatment.|
48417146|NCT03419741|101353554|FG000|COMPLETED|Overall Study||3||
48417147|NCT03419741|101353555|FG001|COMPLETED|Overall Study||4||
48417148|NCT03419741|101353554|FG000|NOT COMPLETED|Overall Study||2||
48417149|NCT03419741|101353555|FG001|NOT COMPLETED|Overall Study||2||
48417150|NCT00751335|101353556|FG000|STARTED|Overall Study||0||
48417151|NCT00751335|101353557|FG001|STARTED|Overall Study||0||
48417152|NCT00751335|101353556|FG000|COMPLETED|Overall Study||0||
48417153|NCT00751335|101353557|FG001|COMPLETED|Overall Study||0||
48417154|NCT00751335|101353556|FG000|NOT COMPLETED|Overall Study||0||
48417155|NCT00751335|101353557|FG001|NOT COMPLETED|Overall Study||0||
48417156|NCT01072500|101353558|FG000|STARTED|Overall Study||818||
48417157|NCT01072500|101353559|FG001|STARTED|Overall Study||817||
48417158|NCT01072500|101353558|FG000|COMPLETED|Overall Study||794||
48417159|NCT01072500|101353559|FG001|COMPLETED|Overall Study||803||
48417160|NCT01072500|101353558|FG000|NOT COMPLETED|Overall Study||24||
48417161|NCT01072500|101353559|FG001|NOT COMPLETED|Overall Study||14||
48417162|NCT02168816|101353560|FG000|STARTED|Overall Study||5||
48417163|NCT02168816|101353561|FG001|STARTED|Overall Study||7||
48417164|NCT02168816|101353560|FG000|COMPLETED|Overall Study||3||
48762017|NCT01394016|102205917|FG008|STARTED|Overall Study||3||
48762018|NCT01394016|102205918|FG009|STARTED|Overall Study||26||
48762019|NCT01394016|102205919|FG010|STARTED|Overall Study||42||
48762020|NCT01394016|102205920|FG011|STARTED|Overall Study||2||
48762021|NCT01394016|102205921|FG012|STARTED|Overall Study||15||
48762022|NCT01394016|102205922|FG013|STARTED|Overall Study||25||
48762023|NCT01394016|102205923|FG014|STARTED|Overall Study||22||
48762024|NCT01394016|102205924|FG015|STARTED|Overall Study||13||
48762025|NCT01394016|102205925|FG016|STARTED|Overall Study||13||
48762026|NCT01394016|102205926|FG017|STARTED|Overall Study||15||
48762027|NCT01394016|102205927|FG018|STARTED|Overall Study||19||
48762028|NCT01394016|102205909|FG000|Received At Least One Dose of Study Drug|Overall Study||4||
48762029|NCT01394016|102205910|FG001|Received At Least One Dose of Study Drug|Overall Study||3||
48762030|NCT01394016|102205911|FG002|Received At Least One Dose of Study Drug|Overall Study||3||
48762031|NCT01394016|102205912|FG003|Received At Least One Dose of Study Drug|Overall Study||3||
48762032|NCT01394016|102205913|FG004|Received At Least One Dose of Study Drug|Overall Study||3||
48762033|NCT01394016|102205914|FG005|Received At Least One Dose of Study Drug|Overall Study||4||
48762034|NCT01394016|102205915|FG006|Received At Least One Dose of Study Drug|Overall Study||3||
48762035|NCT01394016|102205916|FG007|Received At Least One Dose of Study Drug|Overall Study||7||
48762036|NCT01394016|102205917|FG008|Received At Least One Dose of Study Drug|Overall Study||3||
48762037|NCT01394016|102205918|FG009|Received At Least One Dose of Study Drug|Overall Study||26||
48762038|NCT01394016|102205919|FG010|Received At Least One Dose of Study Drug|Overall Study||42||
48762039|NCT01394016|102205920|FG011|Received At Least One Dose of Study Drug|Overall Study||2||
48762040|NCT01394016|102205921|FG012|Received At Least One Dose of Study Drug|Overall Study||15||
48762041|NCT01394016|102205922|FG013|Received At Least One Dose of Study Drug|Overall Study||25||
48762042|NCT01394016|102205923|FG014|Received At Least One Dose of Study Drug|Overall Study||22||
48762043|NCT01394016|102205924|FG015|Received At Least One Dose of Study Drug|Overall Study||13||
48352972|NCT02240706|101191693|FG006|NOT COMPLETED|Overall Study||0||
48352973|NCT01877655|101191694|FG000|STARTED|Overall Study||263||
48352974|NCT01877655|101191695|FG001|STARTED|Overall Study||251||
48352975|NCT01877655|101191694|FG000|Received Treatment|Overall Study||255||
48417165|NCT02168816|101353561|FG001|COMPLETED|Overall Study||5||
48417166|NCT02168816|101353560|FG000|NOT COMPLETED|Overall Study||2||
48417167|NCT02168816|101353561|FG001|NOT COMPLETED|Overall Study||2||
48417168|NCT01728454|101353562|FG000|STARTED|Stage 1 and 2||17||
48186820|NCT00614744|100779908|FG000|NOT COMPLETED|Overall Study||5||
48352976|NCT01877655|101191695|FG001|Received Treatment|Overall Study||246||
48352977|NCT01877655|101191694|FG000|COMPLETED|Overall Study||165||
48352978|NCT01877655|101191695|FG001|COMPLETED|Overall Study||154||
48352979|NCT01877655|101191694|FG000|NOT COMPLETED|Overall Study||98||
48352980|NCT01877655|101191695|FG001|NOT COMPLETED|Overall Study||97||
48352981|NCT00886938|101191696|FG000|STARTED|Overall Study||12||
48352982|NCT00886938|101191696|FG000|COMPLETED|Overall Study||10||
48352983|NCT00886938|101191696|FG000|NOT COMPLETED|Overall Study||2||
48352984|NCT02031679|101191697|FG000|STARTED|Overall Study||14||
48352985|NCT02031679|101191698|FG001|STARTED|Overall Study||14||
48352986|NCT02031679|101191697|FG000|COMPLETED|Overall Study||14||
48417169|NCT01728454|101353563|FG001|STARTED|Stage 1 and 2||20||
48417170|NCT01728454|101353564|FG002|STARTED|Stage 1 and 2||23||
48417171|NCT01728454|101353562|FG000|COMPLETED|Stage 1 and 2||12||
48417172|NCT01728454|101353563|FG001|COMPLETED|Stage 1 and 2||16||
48417173|NCT01728454|101353564|FG002|COMPLETED|Stage 1 and 2||19||
48417174|NCT01728454|101353562|FG000|NOT COMPLETED|Stage 1 and 2||5||
48417175|NCT01728454|101353563|FG001|NOT COMPLETED|Stage 1 and 2||4||
48417176|NCT01728454|101353564|FG002|NOT COMPLETED|Stage 1 and 2||4||
48417177|NCT01728454|101353562|FG000|STARTED|Stage 3||6||
48417178|NCT01728454|101353563|FG001|STARTED|Stage 3||5||
48417179|NCT01728454|101353564|FG002|STARTED|Stage 3||11||
48417180|NCT01728454|101353562|FG000|COMPLETED|Stage 3||3||
48417181|NCT01728454|101353563|FG001|COMPLETED|Stage 3||1||
48417182|NCT01728454|101353564|FG002|COMPLETED|Stage 3||7||
48417183|NCT01728454|101353562|FG000|NOT COMPLETED|Stage 3||3||
48417184|NCT01728454|101353563|FG001|NOT COMPLETED|Stage 3||4||
48417185|NCT01728454|101353564|FG002|NOT COMPLETED|Stage 3||4||
48417186|NCT01603628|101353565|FG000|STARTED|Overall Study||128||
48417187|NCT01603628|101353566|FG001|STARTED|Overall Study||126||
48417188|NCT01603628|101353567|FG002|STARTED|Overall Study||130||
48417189|NCT01603628|101353565|FG000|Safety Population: Received Treatment|Overall Study||128||
48417190|NCT01603628|101353566|FG001|Safety Population: Received Treatment|Overall Study||126||
48417191|NCT01603628|101353567|FG002|Safety Population: Received Treatment|Overall Study||128||
48417192|NCT01603628|101353565|FG000|COMPLETED|Overall Study||125||
48417193|NCT01603628|101353566|FG001|COMPLETED|Overall Study||123||
48417194|NCT01603628|101353567|FG002|COMPLETED|Overall Study||128||
48417195|NCT01603628|101353565|FG000|NOT COMPLETED|Overall Study||3||
48417196|NCT01603628|101353566|FG001|NOT COMPLETED|Overall Study||3||
48417197|NCT01603628|101353567|FG002|NOT COMPLETED|Overall Study||2||
48417198|NCT02055872|101353568|FG000|STARTED|Overall Study||24||
48417199|NCT02055872|101353569|FG001|STARTED|Overall Study||21||
48417200|NCT02055872|101353568|FG000|COMPLETED|Overall Study||24||
48417201|NCT02055872|101353569|FG001|COMPLETED|Overall Study||21||
48417202|NCT02055872|101353568|FG000|NOT COMPLETED|Overall Study||0||
48417203|NCT02055872|101353569|FG001|NOT COMPLETED|Overall Study||0||
48417204|NCT02205177|101356814|FG000|STARTED|Overall Study||8||
48417205|NCT02205177|101356815|FG001|STARTED|Overall Study||2||
48417206|NCT02205177|101356814|FG000|COMPLETED|Overall Study||6||
48417207|NCT02205177|101356815|FG001|COMPLETED|Overall Study||2||
48417208|NCT02205177|101356814|FG000|NOT COMPLETED|Overall Study||2||
48417209|NCT02205177|101356815|FG001|NOT COMPLETED|Overall Study||0||
48417210|NCT01888367|101356816|FG000|STARTED|Overall Study||296||
48417211|NCT01888367|101356817|FG001|STARTED|Overall Study||71||
48352987|NCT02031679|101191698|FG001|COMPLETED|Overall Study||12||
48352988|NCT02031679|101191697|FG000|NOT COMPLETED|Overall Study||0||
48352989|NCT02031679|101191698|FG001|NOT COMPLETED|Overall Study||2||
48352990|NCT01794780|101195246|FG000|STARTED|Overall Study||32||
48417212|NCT01888367|101356818|FG002|STARTED|Overall Study||78||
48417213|NCT01888367|101356816|FG000|COMPLETED|Overall Study||288||
48417214|NCT01888367|101356817|FG001|COMPLETED|Overall Study||66||
48417215|NCT01888367|101356818|FG002|COMPLETED|Overall Study||73||
48417216|NCT01888367|101356816|FG000|NOT COMPLETED|Overall Study||8||
48417217|NCT01888367|101356817|FG001|NOT COMPLETED|Overall Study||5||
48417218|NCT01888367|101356818|FG002|NOT COMPLETED|Overall Study||5||
48417219|NCT00266695|101356819|FG000|STARTED|Overall Study||203||
48417220|NCT00266695|101356819|FG000|COMPLETED|Overall Study||174||
48417221|NCT00266695|101356819|FG000|NOT COMPLETED|Overall Study||29||
48186821|NCT00614744|100779909|FG001|NOT COMPLETED|Overall Study||6||
48186822|NCT03114995|100779910|FG000|STARTED|Overall Study||31||
48352991|NCT01794780|101195247|FG001|STARTED|Overall Study||276||
48352992|NCT01794780|101195248|FG002|STARTED|Overall Study||813||
48352993|NCT01794780|101195249|FG003|STARTED|Overall Study||283||
48352994|NCT01794780|101195250|FG004|STARTED|Overall Study||9||
48352995|NCT01794780|101195251|FG005|STARTED|Overall Study||632||
48352996|NCT01794780|101195252|FG006|STARTED|Overall Study||154||
48352997|NCT01794780|101195253|FG007|STARTED|Overall Study||30||
48352998|NCT01794780|101195246|FG000|COMPLETED|Overall Study||15||
48352999|NCT01794780|101195247|FG001|COMPLETED|Overall Study||180||
48353000|NCT01794780|101195248|FG002|COMPLETED|Overall Study||571||
48353001|NCT01794780|101195249|FG003|COMPLETED|Overall Study||200||
48353002|NCT01794780|101195250|FG004|COMPLETED|Overall Study||6||
48353003|NCT01794780|101195251|FG005|COMPLETED|Overall Study||452||
48417222|NCT01957111|101356820|FG000|STARTED|Overall Study||16||
48417223|NCT01957111|101356821|FG001|STARTED|Overall Study||16||
48353004|NCT01794780|101195252|FG006|COMPLETED|Overall Study||112||
48353005|NCT01794780|101195253|FG007|COMPLETED|Overall Study||21||
48353006|NCT01794780|101195246|FG000|NOT COMPLETED|Overall Study||17||
48353007|NCT01794780|101195247|FG001|NOT COMPLETED|Overall Study||96||
48353008|NCT01794780|101195248|FG002|NOT COMPLETED|Overall Study||242||
48353009|NCT01794780|101195249|FG003|NOT COMPLETED|Overall Study||83||
48353010|NCT01794780|101195250|FG004|NOT COMPLETED|Overall Study||3||
48353011|NCT01794780|101195251|FG005|NOT COMPLETED|Overall Study||180||
48353012|NCT01794780|101195252|FG006|NOT COMPLETED|Overall Study||42||
48353013|NCT01794780|101195253|FG007|NOT COMPLETED|Overall Study||9||
48353014|NCT03240081|101195254|FG000|STARTED|Overall Study||25||
48353015|NCT03240081|101195255|FG001|STARTED|Overall Study||25||
48353016|NCT03240081|101195254|FG000|COMPLETED|Overall Study||25||
48353017|NCT03240081|101195255|FG001|COMPLETED|Overall Study||22||
48353018|NCT03240081|101195254|FG000|NOT COMPLETED|Overall Study||0||
48353019|NCT03240081|101195255|FG001|NOT COMPLETED|Overall Study||3||
48353020|NCT01363050|101195256|FG000|STARTED|Overall Study||15||
48353021|NCT01363050|101195256|FG000|COMPLETED|Overall Study||15||
48353022|NCT01363050|101195256|FG000|NOT COMPLETED|Overall Study||0||
48353023|NCT01586091|101195257|FG000|STARTED|Overall Study||6||
48353024|NCT01586091|101195258|FG001|STARTED|Overall Study||6||
48353025|NCT01586091|101195259|FG002|STARTED|Overall Study||6||
48417224|NCT01957111|101356820|FG000|COMPLETED|Overall Study||15||
48417225|NCT01957111|101356821|FG001|COMPLETED|Overall Study||15||
48417226|NCT01957111|101356820|FG000|NOT COMPLETED|Overall Study||1||
48417227|NCT01957111|101356821|FG001|NOT COMPLETED|Overall Study||1||
48417228|NCT02306928|101356822|FG000|STARTED|Overall Study||15||
48638293|NCT00544882|101898723|FG001|NOT COMPLETED|Cycle 3: Follow-up||2||
48638294|NCT00544882|101898724|FG002|NOT COMPLETED|Cycle 3: Follow-up||0||
48353026|NCT01586091|101195257|FG000|COMPLETED|Overall Study||6||
48353027|NCT01586091|101195258|FG001|COMPLETED|Overall Study||6||
48353028|NCT01586091|101195259|FG002|COMPLETED|Overall Study||6||
48353029|NCT01586091|101195257|FG000|NOT COMPLETED|Overall Study||0||
48353030|NCT01586091|101195258|FG001|NOT COMPLETED|Overall Study||0||
48353031|NCT01586091|101195259|FG002|NOT COMPLETED|Overall Study||0||
48353032|NCT01662999|101195260|FG000|STARTED|Period 1||7||
48353033|NCT01662999|101195261|FG001|STARTED|Period 1||7||
48353034|NCT01662999|101195262|FG002|STARTED|Period 1||7||
48353035|NCT01662999|101195263|FG003|STARTED|Period 1||7||
48353036|NCT01662999|101195264|FG004|STARTED|Period 1||7||
48353037|NCT01662999|101195265|FG005|STARTED|Period 1||7||
48353038|NCT01662999|101195260|FG000|COMPLETED|Period 1||7||
48353039|NCT01662999|101195261|FG001|COMPLETED|Period 1||7||
48353040|NCT01662999|101195262|FG002|COMPLETED|Period 1||7||
48353041|NCT01662999|101195263|FG003|COMPLETED|Period 1||7||
48353042|NCT01662999|101195264|FG004|COMPLETED|Period 1||7||
48353043|NCT01662999|101195265|FG005|COMPLETED|Period 1||7||
48353044|NCT01662999|101195260|FG000|NOT COMPLETED|Period 1||0||
48353045|NCT01662999|101195261|FG001|NOT COMPLETED|Period 1||0||
48353046|NCT01662999|101195262|FG002|NOT COMPLETED|Period 1||0||
48353047|NCT01662999|101195263|FG003|NOT COMPLETED|Period 1||0||
48353048|NCT01662999|101195264|FG004|NOT COMPLETED|Period 1||0||
48353049|NCT01662999|101195265|FG005|NOT COMPLETED|Period 1||0||
48353050|NCT01662999|101195260|FG000|STARTED|Period 2||7||
48353051|NCT01662999|101195261|FG001|STARTED|Period 2||7||
48353052|NCT01662999|101195262|FG002|STARTED|Period 2||7||
48353053|NCT01662999|101195263|FG003|STARTED|Period 2||7||
48353054|NCT01662999|101195264|FG004|STARTED|Period 2||7||
48353055|NCT01662999|101195265|FG005|STARTED|Period 2||7||
48353056|NCT01662999|101195260|FG000|COMPLETED|Period 2||7||
48638295|NCT01286324|101898725|FG000|STARTED|Overall Study||17||
48762044|NCT01394016|102205925|FG016|Received At Least One Dose of Study Drug|Overall Study||13||
48353057|NCT01662999|101195261|FG001|COMPLETED|Period 2||7||
48353058|NCT01662999|101195262|FG002|COMPLETED|Period 2||7||
48353059|NCT01662999|101195263|FG003|COMPLETED|Period 2||7||
48353060|NCT01662999|101195264|FG004|COMPLETED|Period 2||7||
48353061|NCT01662999|101195265|FG005|COMPLETED|Period 2||7||
48353062|NCT01662999|101195260|FG000|NOT COMPLETED|Period 2||0||
48353063|NCT01662999|101195261|FG001|NOT COMPLETED|Period 2||0||
48353064|NCT01662999|101195262|FG002|NOT COMPLETED|Period 2||0||
48353065|NCT01662999|101195263|FG003|NOT COMPLETED|Period 2||0||
48353066|NCT01662999|101195264|FG004|NOT COMPLETED|Period 2||0||
48353067|NCT01662999|101195265|FG005|NOT COMPLETED|Period 2||0||
48353068|NCT01662999|101195260|FG000|STARTED|Period 3||7||
48353069|NCT01662999|101195261|FG001|STARTED|Period 3||7||
48353070|NCT01662999|101195262|FG002|STARTED|Period 3||7||
48353071|NCT01662999|101195263|FG003|STARTED|Period 3||7||
48353072|NCT01662999|101195264|FG004|STARTED|Period 3||7||
48353073|NCT01662999|101195265|FG005|STARTED|Period 3||7||
48417229|NCT02306928|101356822|FG000|COMPLETED|Overall Study||15||
48417230|NCT02306928|101356822|FG000|NOT COMPLETED|Overall Study||0||
48417231|NCT03818399|101356823|FG000|STARTED|Overall Study||19||
48417232|NCT03818399|101356823|FG000|COMPLETED|Overall Study||5||
48353074|NCT01662999|101195260|FG000|COMPLETED|Period 3||7||
48353075|NCT01662999|101195261|FG001|COMPLETED|Period 3||6||
48353076|NCT01662999|101195262|FG002|COMPLETED|Period 3||7||
48353077|NCT01662999|101195263|FG003|COMPLETED|Period 3||7||
48417233|NCT03818399|101356823|FG000|NOT COMPLETED|Overall Study||14||
48353078|NCT01662999|101195264|FG004|COMPLETED|Period 3||7||
48353079|NCT01662999|101195265|FG005|COMPLETED|Period 3||7||
48353080|NCT01662999|101195260|FG000|NOT COMPLETED|Period 3||0||
48353081|NCT01662999|101195261|FG001|NOT COMPLETED|Period 3||1||
48353082|NCT01662999|101195262|FG002|NOT COMPLETED|Period 3||0||
48353083|NCT01662999|101195263|FG003|NOT COMPLETED|Period 3||0||
48353084|NCT01662999|101195264|FG004|NOT COMPLETED|Period 3||0||
48353085|NCT01662999|101195265|FG005|NOT COMPLETED|Period 3||0||
48353086|NCT00784758|101195266|FG000|STARTED|Overall Study||42||
48353087|NCT00784758|101195267|FG001|STARTED|Overall Study||39||
48353088|NCT00784758|101195266|FG000|Began Treatment|Overall Study||41||
48353089|NCT00784758|101195267|FG001|Began Treatment|Overall Study||39||
48353090|NCT00784758|101195266|FG000|Completed Treatment|Overall Study||40||
48353091|NCT00784758|101195267|FG001|Completed Treatment|Overall Study||39||
48353092|NCT00784758|101195266|FG000|COMPLETED|Overall Study||38||
48353093|NCT00784758|101195267|FG001|COMPLETED|Overall Study||39||
48353094|NCT00784758|101195266|FG000|NOT COMPLETED|Overall Study||4||
48353095|NCT00784758|101195267|FG001|NOT COMPLETED|Overall Study||0||
48353096|NCT00364793|101195268|FG000|STARTED|Overall Study||15||
48353097|NCT00364793|101195269|FG001|STARTED|Overall Study||10||
48353098|NCT00364793|101195270|FG002|STARTED|Overall Study||4||
48353099|NCT00364793|101195271|FG003|STARTED|Overall Study||8||
48353100|NCT00364793|101195268|FG000|COMPLETED|Overall Study||7||
48353101|NCT00364793|101195269|FG001|COMPLETED|Overall Study||5||
48353102|NCT00364793|101195270|FG002|COMPLETED|Overall Study||0||
48353103|NCT00364793|101195271|FG003|COMPLETED|Overall Study||5||
48353104|NCT00364793|101195268|FG000|NOT COMPLETED|Overall Study||8||
48353105|NCT00364793|101195269|FG001|NOT COMPLETED|Overall Study||5||
48353106|NCT00364793|101195270|FG002|NOT COMPLETED|Overall Study||4||
48353107|NCT00364793|101195271|FG003|NOT COMPLETED|Overall Study||3||
48353108|NCT03185130|101195272|FG000|STARTED|Overall Study||23||
48353109|NCT03185130|101195273|FG001|STARTED|Overall Study||35||
48353110|NCT03185130|101195272|FG000|COMPLETED|Overall Study||23||
48353111|NCT03185130|101195273|FG001|COMPLETED|Overall Study||33||
48353112|NCT03185130|101195272|FG000|NOT COMPLETED|Overall Study||0||
48353113|NCT03185130|101195273|FG001|NOT COMPLETED|Overall Study||2||
48353114|NCT05113940|101195274|FG000|STARTED|Part A (18 Days)||6||
48353115|NCT05113940|101195275|FG001|STARTED|Part A (18 Days)||8||
48353116|NCT05113940|101195276|FG002|STARTED|Part A (18 Days)||8||
48353117|NCT05113940|101195277|FG003|STARTED|Part A (18 Days)||7||
48353118|NCT05113940|101195278|FG004|STARTED|Part A (18 Days)||10||
48353119|NCT05113940|101195279|FG005|STARTED|Part A (18 Days)||8||
48353120|NCT05113940|101195280|FG006|STARTED|Part A (18 Days)||8||
48353121|NCT05113940|101195281|FG007|STARTED|Part A (18 Days)||8||
48353122|NCT05113940|101195282|FG008|STARTED|Part A (18 Days)||8||
48353123|NCT05113940|101195283|FG009|STARTED|Part A (18 Days)||8||
48353124|NCT05113940|101195284|FG010|STARTED|Part A (18 Days)||12||
48353125|NCT05113940|101195285|FG011|STARTED|Part A (18 Days)||12||
48353126|NCT05113940|101195286|FG012|STARTED|Part A (18 Days)||1||
48353127|NCT05113940|101195287|FG013|STARTED|Part A (18 Days)||5||
48353128|NCT05113940|101195288|FG014|STARTED|Part A (18 Days)||0||
48353129|NCT05113940|101195274|FG000|COMPLETED|Part A (18 Days)||6||
48353130|NCT05113940|101195275|FG001|COMPLETED|Part A (18 Days)||8||
48353131|NCT05113940|101195276|FG002|COMPLETED|Part A (18 Days)||7||
48353132|NCT05113940|101195277|FG003|COMPLETED|Part A (18 Days)||6||
48353133|NCT05113940|101195278|FG004|COMPLETED|Part A (18 Days)||9||
48353134|NCT05113940|101195279|FG005|COMPLETED|Part A (18 Days)||8||
48353135|NCT05113940|101195280|FG006|COMPLETED|Part A (18 Days)||8||
48353136|NCT05113940|101195281|FG007|COMPLETED|Part A (18 Days)||8||
48353137|NCT05113940|101195282|FG008|COMPLETED|Part A (18 Days)||8||
48353138|NCT05113940|101195283|FG009|COMPLETED|Part A (18 Days)||8||
48353139|NCT05113940|101195284|FG010|COMPLETED|Part A (18 Days)||12||
48353140|NCT05113940|101195285|FG011|COMPLETED|Part A (18 Days)||10||
48353141|NCT05113940|101195286|FG012|COMPLETED|Part A (18 Days)||1||
48353142|NCT05113940|101195287|FG013|COMPLETED|Part A (18 Days)||5||
48353143|NCT05113940|101195288|FG014|COMPLETED|Part A (18 Days)||0||
48353144|NCT05113940|101195274|FG000|NOT COMPLETED|Part A (18 Days)||0||
48353145|NCT05113940|101195275|FG001|NOT COMPLETED|Part A (18 Days)||0||
48353146|NCT05113940|101195276|FG002|NOT COMPLETED|Part A (18 Days)||1||
48353147|NCT05113940|101195277|FG003|NOT COMPLETED|Part A (18 Days)||1||
48353148|NCT05113940|101195278|FG004|NOT COMPLETED|Part A (18 Days)||1||
48353149|NCT05113940|101195279|FG005|NOT COMPLETED|Part A (18 Days)||0||
48353150|NCT05113940|101195280|FG006|NOT COMPLETED|Part A (18 Days)||0||
48353151|NCT05113940|101195281|FG007|NOT COMPLETED|Part A (18 Days)||0||
48353152|NCT05113940|101195282|FG008|NOT COMPLETED|Part A (18 Days)||0||
48353153|NCT05113940|101195283|FG009|NOT COMPLETED|Part A (18 Days)||0||
48353154|NCT05113940|101195284|FG010|NOT COMPLETED|Part A (18 Days)||0||
48353155|NCT05113940|101195285|FG011|NOT COMPLETED|Part A (18 Days)||2||
48353156|NCT05113940|101195286|FG012|NOT COMPLETED|Part A (18 Days)||0||
48353157|NCT05113940|101195287|FG013|NOT COMPLETED|Part A (18 Days)||0||
48353158|NCT05113940|101195288|FG014|NOT COMPLETED|Part A (18 Days)||0||
48353159|NCT05113940|101195274|FG000|STARTED|Part B- Period 1 (3 Days)||0||
48353160|NCT05113940|101195275|FG001|STARTED|Part B- Period 1 (3 Days)||0||
48353161|NCT05113940|101195276|FG002|STARTED|Part B- Period 1 (3 Days)||0||
48353162|NCT05113940|101195277|FG003|STARTED|Part B- Period 1 (3 Days)||0||
48417234|NCT00911326|101356824|FG000|STARTED|Overall Study||101||
48417235|NCT00911326|101356824|FG000|COMPLETED|Overall Study||85||
48417236|NCT00911326|101356824|FG000|NOT COMPLETED|Overall Study||16||
48417237|NCT02576652|101356825|FG000|STARTED|Overall Study||6||
48417238|NCT02576652|101356825|FG000|COMPLETED|Overall Study||4||
48417239|NCT02576652|101356825|FG000|NOT COMPLETED|Overall Study||2||
48353163|NCT05113940|101195278|FG004|STARTED|Part B- Period 1 (3 Days)||0||
48353164|NCT05113940|101195279|FG005|STARTED|Part B- Period 1 (3 Days)||0||
48353165|NCT05113940|101195280|FG006|STARTED|Part B- Period 1 (3 Days)||0||
48353166|NCT05113940|101195281|FG007|STARTED|Part B- Period 1 (3 Days)||0||
48353167|NCT05113940|101195282|FG008|STARTED|Part B- Period 1 (3 Days)||0||
48353168|NCT05113940|101195283|FG009|STARTED|Part B- Period 1 (3 Days)||0||
48353169|NCT05113940|101195284|FG010|STARTED|Part B- Period 1 (3 Days)||0||
48353170|NCT05113940|101195285|FG011|STARTED|Part B- Period 1 (3 Days)||0||
48353171|NCT05113940|101195286|FG012|STARTED|Part B- Period 1 (3 Days)||0||
48353172|NCT05113940|101195287|FG013|STARTED|Part B- Period 1 (3 Days)||0||
48353173|NCT05113940|101195288|FG014|STARTED|Part B- Period 1 (3 Days)||11||
48353174|NCT05113940|101195274|FG000|COMPLETED|Part B- Period 1 (3 Days)||0||
48417240|NCT02023515|101356826|FG000|STARTED|Overall Study||24||
48417241|NCT02023515|101356827|FG001|STARTED|Overall Study||25||
48417242|NCT02023515|101356826|FG000|COMPLETED|Overall Study||23||
48417243|NCT02023515|101356827|FG001|COMPLETED|Overall Study||22||
48417244|NCT02023515|101356826|FG000|NOT COMPLETED|Overall Study||1||
48417245|NCT02023515|101356827|FG001|NOT COMPLETED|Overall Study||3||
48417246|NCT01849289|101356828|FG000|STARTED|Overall Study||555||
48417247|NCT01849289|101356829|FG001|STARTED|Overall Study||278||
48417248|NCT01849289|101356828|FG000|Exposed|Overall Study||553||
48417249|NCT01849289|101356829|FG001|Exposed|Overall Study||278||
48417250|NCT01849289|101356828|FG000|COMPLETED|Overall Study||523||
48417251|NCT01849289|101356829|FG001|COMPLETED|Overall Study||254||
48417252|NCT01849289|101356828|FG000|NOT COMPLETED|Overall Study||32||
48417253|NCT01849289|101356829|FG001|NOT COMPLETED|Overall Study||24||
48417254|NCT00732199|101356830|FG000|STARTED|Overall Study||50||
48417255|NCT00732199|101356831|FG001|STARTED|Overall Study||42||
48417256|NCT00732199|101356830|FG000|COMPLETED|Overall Study||16||
48417257|NCT00732199|101356831|FG001|COMPLETED|Overall Study||16||
48417258|NCT00732199|101356830|FG000|NOT COMPLETED|Overall Study||34||
48417259|NCT00732199|101356831|FG001|NOT COMPLETED|Overall Study||26||
48417260|NCT03691649|101356832|FG000|STARTED|Double Masked Treatment Period (DMTP)||212||
48417261|NCT03691649|101356833|FG001|STARTED|Double Masked Treatment Period (DMTP)||214||
48417262|NCT03691649|101356832|FG000|Full Analysis Set Participants|Double Masked Treatment Period (DMTP)||212||
48417263|NCT03691649|101356833|FG001|Full Analysis Set Participants|Double Masked Treatment Period (DMTP)||213||
48417264|NCT03691649|101356832|FG000|Safety Analysis Set Participants|Double Masked Treatment Period (DMTP)||211||
48417265|NCT03691649|101356833|FG001|Safety Analysis Set Participants|Double Masked Treatment Period (DMTP)||215||
48417266|NCT03691649|101356832|FG000|COMPLETED|Double Masked Treatment Period (DMTP)||189||
48417267|NCT03691649|101356833|FG001|COMPLETED|Double Masked Treatment Period (DMTP)||204||
48417268|NCT03691649|101356832|FG000|NOT COMPLETED|Double Masked Treatment Period (DMTP)||23||
48417269|NCT03691649|101356833|FG001|NOT COMPLETED|Double Masked Treatment Period (DMTP)||10||
48417270|NCT03691649|101356832|FG000|STARTED|Open Label Treatment Period (OLTP)||377||
48417271|NCT03691649|101356833|FG001|STARTED|Open Label Treatment Period (OLTP)||0||
48417272|NCT03691649|101356832|FG000|COMPLETED|Open Label Treatment Period (OLTP)||304||
48417273|NCT03691649|101356833|FG001|COMPLETED|Open Label Treatment Period (OLTP)||0||
48417274|NCT03691649|101356832|FG000|NOT COMPLETED|Open Label Treatment Period (OLTP)||73||
48417275|NCT03691649|101356833|FG001|NOT COMPLETED|Open Label Treatment Period (OLTP)||0||
48417276|NCT02512094|101356834|FG000|STARTED|Overall Study||53||
48417277|NCT02512094|101356834|FG000|COMPLETED|Overall Study||53||
48417278|NCT02512094|101356834|FG000|NOT COMPLETED|Overall Study||0||
48417279|NCT04107935|101356835|FG000|STARTED|Overall Study||43||
48417280|NCT04107935|101356836|FG001|STARTED|Overall Study||30||
48417281|NCT04107935|101356835|FG000|COMPLETED|Overall Study||42||
48353175|NCT05113940|101195275|FG001|COMPLETED|Part B- Period 1 (3 Days)||0||
48353176|NCT05113940|101195276|FG002|COMPLETED|Part B- Period 1 (3 Days)||0||
48353177|NCT05113940|101195277|FG003|COMPLETED|Part B- Period 1 (3 Days)||0||
48353178|NCT05113940|101195278|FG004|COMPLETED|Part B- Period 1 (3 Days)||0||
48353179|NCT05113940|101195279|FG005|COMPLETED|Part B- Period 1 (3 Days)||0||
48353180|NCT05113940|101195280|FG006|COMPLETED|Part B- Period 1 (3 Days)||0||
48417282|NCT04107935|101356836|FG001|COMPLETED|Overall Study||30||
48417283|NCT04107935|101356835|FG000|NOT COMPLETED|Overall Study||1||
48417284|NCT04107935|101356836|FG001|NOT COMPLETED|Overall Study||0||
48417285|NCT01901809|101356837|FG000|STARTED|Overall Study||19||
48417286|NCT01901809|101356838|FG001|STARTED|Overall Study||23||
48417287|NCT01901809|101356839|FG002|STARTED|Overall Study||24||
48417288|NCT01901809|101356840|FG003|STARTED|Overall Study||24||
48417289|NCT01901809|101356837|FG000|COMPLETED|Overall Study||19||
48417290|NCT01901809|101356838|FG001|COMPLETED|Overall Study||23||
48353181|NCT05113940|101195281|FG007|COMPLETED|Part B- Period 1 (3 Days)||0||
48417291|NCT01901809|101356839|FG002|COMPLETED|Overall Study||21||
48417292|NCT01901809|101356840|FG003|COMPLETED|Overall Study||22||
48417293|NCT01901809|101356837|FG000|NOT COMPLETED|Overall Study||0||
48417294|NCT01901809|101356838|FG001|NOT COMPLETED|Overall Study||0||
48417295|NCT01901809|101356839|FG002|NOT COMPLETED|Overall Study||3||
48417296|NCT01901809|101356840|FG003|NOT COMPLETED|Overall Study||2||
48417297|NCT01523613|101356841|FG000|STARTED|Overall Study||30||30
48417298|NCT01523613|101356842|FG001|STARTED|Overall Study||30||30
48417299|NCT01523613|101356843|FG002|STARTED|Overall Study||33||66
48417300|NCT01523613|101356841|FG000|COMPLETED|Overall Study||23||23
48417301|NCT01523613|101356842|FG001|COMPLETED|Overall Study||25||25
48417302|NCT01523613|101356843|FG002|COMPLETED|Overall Study||21||42
48417303|NCT01523613|101356841|FG000|NOT COMPLETED|Overall Study||7||7
48417304|NCT01523613|101356842|FG001|NOT COMPLETED|Overall Study||5||5
48417305|NCT01523613|101356843|FG002|NOT COMPLETED|Overall Study||12||24
48417306|NCT01314261|101356844|FG000|STARTED|Overall Study||9||
48417307|NCT01314261|101356845|FG001|STARTED|Overall Study||9||
48417308|NCT01314261|101356846|FG002|STARTED|Overall Study||10||
48417309|NCT01314261|101356847|FG003|STARTED|Overall Study||9||
48417310|NCT01314261|101356844|FG000|Discontinued ABT-267 or Placebo|Overall Study||1||
48417311|NCT01314261|101356845|FG001|Discontinued ABT-267 or Placebo|Overall Study||0||
48417312|NCT01314261|101356846|FG002|Discontinued ABT-267 or Placebo|Overall Study||1||
48417313|NCT01314261|101356847|FG003|Discontinued ABT-267 or Placebo|Overall Study||0||
48762045|NCT01394016|102205926|FG017|Received At Least One Dose of Study Drug|Overall Study||15||
48762046|NCT01394016|102205927|FG018|Received At Least One Dose of Study Drug|Overall Study||19||
48762047|NCT01394016|102205909|FG000|COMPLETED|Overall Study||2||
48762048|NCT01394016|102205910|FG001|COMPLETED|Overall Study||3||
48762049|NCT01394016|102205911|FG002|COMPLETED|Overall Study||3||
48762050|NCT01394016|102205912|FG003|COMPLETED|Overall Study||3||
48762051|NCT01394016|102205913|FG004|COMPLETED|Overall Study||3||
48762052|NCT01394016|102205914|FG005|COMPLETED|Overall Study||4||
48762053|NCT01394016|102205915|FG006|COMPLETED|Overall Study||3||
48762054|NCT01394016|102205916|FG007|COMPLETED|Overall Study||6||
48417314|NCT01314261|101356844|FG000|Discontinued pegIFN/RBV|Overall Study||1||
48417315|NCT01314261|101356845|FG001|Discontinued pegIFN/RBV|Overall Study||4||
48417316|NCT01314261|101356846|FG002|Discontinued pegIFN/RBV|Overall Study||5||
48417317|NCT01314261|101356847|FG003|Discontinued pegIFN/RBV|Overall Study||1||
48638296|NCT01286324|101898726|FG001|STARTED|Overall Study||17||
48638297|NCT01286324|101898725|FG000|COMPLETED|Overall Study||17||
48638298|NCT01286324|101898726|FG001|COMPLETED|Overall Study||17||
48638299|NCT01286324|101898725|FG000|NOT COMPLETED|Overall Study||0||
48638300|NCT01286324|101898726|FG001|NOT COMPLETED|Overall Study||0||
48638301|NCT00958074|101898727|FG000|STARTED|Overall Study||4||
48638302|NCT00958074|101898728|FG001|STARTED|Overall Study||7||
48638303|NCT00958074|101898727|FG000|COMPLETED|Overall Study||4||
48638304|NCT00958074|101898728|FG001|COMPLETED|Overall Study||6||
48638305|NCT00958074|101898727|FG000|NOT COMPLETED|Overall Study||0||
48638306|NCT00958074|101898728|FG001|NOT COMPLETED|Overall Study||1||
48638307|NCT04386785|101898729|FG000|STARTED|Overall Study||27||30
48638308|NCT04386785|101898729|FG000|COMPLETED|Overall Study||27||30
48638309|NCT04386785|101898729|FG000|NOT COMPLETED|Overall Study||0||0
48638310|NCT00542308|101898730|FG000|STARTED|Overall Study||90||
48638311|NCT00542308|101898730|FG000|COMPLETED|Overall Study||90||
48638312|NCT00542308|101898730|FG000|NOT COMPLETED|Overall Study||0||
48638313|NCT01027845|101898731|FG000|STARTED|Primary Vaccination Phase||237||
48638314|NCT01027845|101898732|FG001|STARTED|Primary Vaccination Phase||123||
48638315|NCT01027845|101898733|FG002|STARTED|Primary Vaccination Phase||0||
48638316|NCT01027845|101898734|FG003|STARTED|Primary Vaccination Phase||0||
48638317|NCT01027845|101898731|FG000|COMPLETED|Primary Vaccination Phase||233||
48638318|NCT01027845|101898732|FG001|COMPLETED|Primary Vaccination Phase||122||
48638319|NCT01027845|101898733|FG002|COMPLETED|Primary Vaccination Phase||0||
48638320|NCT01027845|101898734|FG003|COMPLETED|Primary Vaccination Phase||0||
48638321|NCT01027845|101898731|FG000|NOT COMPLETED|Primary Vaccination Phase||4||
48638322|NCT01027845|101898732|FG001|NOT COMPLETED|Primary Vaccination Phase||1||
48638323|NCT01027845|101898733|FG002|NOT COMPLETED|Primary Vaccination Phase||0||
48638324|NCT01027845|101898734|FG003|NOT COMPLETED|Primary Vaccination Phase||0||
48638325|NCT01027845|101898731|FG000|STARTED|Booster Vaccination Phase||228||
48638326|NCT01027845|101898732|FG001|STARTED|Booster Vaccination Phase||0||
48638327|NCT01027845|101898733|FG002|STARTED|Booster Vaccination Phase||119||
48638328|NCT01027845|101898734|FG003|STARTED|Booster Vaccination Phase||1||
48638329|NCT01027845|101898731|FG000|COMPLETED|Booster Vaccination Phase||226||
48638330|NCT01027845|101898732|FG001|COMPLETED|Booster Vaccination Phase||0||
48638331|NCT01027845|101898733|FG002|COMPLETED|Booster Vaccination Phase||119||
48638332|NCT01027845|101898734|FG003|COMPLETED|Booster Vaccination Phase||1||
48762055|NCT01394016|102205917|FG008|COMPLETED|Overall Study||2||
48762056|NCT01394016|102205918|FG009|COMPLETED|Overall Study||24||
48762057|NCT01394016|102205919|FG010|COMPLETED|Overall Study||38||
48417318|NCT01314261|101356844|FG000|COMPLETED|Overall Study||7||
48417319|NCT01314261|101356845|FG001|COMPLETED|Overall Study||5||
48417320|NCT01314261|101356846|FG002|COMPLETED|Overall Study||7||
48417321|NCT01314261|101356847|FG003|COMPLETED|Overall Study||6||
48638333|NCT01027845|101898731|FG000|NOT COMPLETED|Booster Vaccination Phase||2||
48638334|NCT01027845|101898732|FG001|NOT COMPLETED|Booster Vaccination Phase||0||
48762058|NCT01394016|102205920|FG011|COMPLETED|Overall Study||2||
48762059|NCT01394016|102205921|FG012|COMPLETED|Overall Study||14||
48762060|NCT01394016|102205922|FG013|COMPLETED|Overall Study||22||
48762061|NCT01394016|102205923|FG014|COMPLETED|Overall Study||21||
48762062|NCT01394016|102205924|FG015|COMPLETED|Overall Study||10||
48762063|NCT01394016|102205925|FG016|COMPLETED|Overall Study||11||
48762064|NCT01394016|102205926|FG017|COMPLETED|Overall Study||13||
48762065|NCT01394016|102205927|FG018|COMPLETED|Overall Study||16||
48762066|NCT01394016|102205909|FG000|NOT COMPLETED|Overall Study||2||
48762067|NCT01394016|102205910|FG001|NOT COMPLETED|Overall Study||0||
48762068|NCT01394016|102205911|FG002|NOT COMPLETED|Overall Study||0||
48762069|NCT01394016|102205912|FG003|NOT COMPLETED|Overall Study||0||
48762070|NCT01394016|102205913|FG004|NOT COMPLETED|Overall Study||0||
48762071|NCT01394016|102205914|FG005|NOT COMPLETED|Overall Study||0||
48762072|NCT01394016|102205915|FG006|NOT COMPLETED|Overall Study||0||
48762073|NCT01394016|102205916|FG007|NOT COMPLETED|Overall Study||1||
48762074|NCT01394016|102205917|FG008|NOT COMPLETED|Overall Study||1||
48762075|NCT01394016|102205918|FG009|NOT COMPLETED|Overall Study||2||
48762076|NCT01394016|102205919|FG010|NOT COMPLETED|Overall Study||4||
48762077|NCT01394016|102205920|FG011|NOT COMPLETED|Overall Study||0||
48762078|NCT01394016|102205921|FG012|NOT COMPLETED|Overall Study||1||
48762079|NCT01394016|102205922|FG013|NOT COMPLETED|Overall Study||3||
48762080|NCT01394016|102205923|FG014|NOT COMPLETED|Overall Study||1||
48762081|NCT01394016|102205924|FG015|NOT COMPLETED|Overall Study||3||
48762082|NCT01394016|102205925|FG016|NOT COMPLETED|Overall Study||2||
48353182|NCT05113940|101195282|FG008|COMPLETED|Part B- Period 1 (3 Days)||0||
48638335|NCT01027845|101898733|FG002|NOT COMPLETED|Booster Vaccination Phase||0||
48638336|NCT01027845|101898734|FG003|NOT COMPLETED|Booster Vaccination Phase||0||
48638337|NCT01925794|101898735|FG000|STARTED|30 Days||296||
48638338|NCT01925794|101898735|FG000|COMPLETED|30 Days||296||
48638339|NCT01925794|101898735|FG000|NOT COMPLETED|30 Days||0||
48638340|NCT01925794|101898735|FG000|STARTED|180 Days||296||
48638341|NCT01925794|101898735|FG000|COMPLETED|180 Days||292||
48353183|NCT05113940|101195283|FG009|COMPLETED|Part B- Period 1 (3 Days)||0||
48353184|NCT05113940|101195284|FG010|COMPLETED|Part B- Period 1 (3 Days)||0||
48353185|NCT05113940|101195285|FG011|COMPLETED|Part B- Period 1 (3 Days)||0||
48353186|NCT05113940|101195286|FG012|COMPLETED|Part B- Period 1 (3 Days)||0||
48353187|NCT05113940|101195287|FG013|COMPLETED|Part B- Period 1 (3 Days)||0||
48353188|NCT05113940|101195288|FG014|COMPLETED|Part B- Period 1 (3 Days)||11||
48353189|NCT05113940|101195274|FG000|NOT COMPLETED|Part B- Period 1 (3 Days)||0||
48353190|NCT05113940|101195275|FG001|NOT COMPLETED|Part B- Period 1 (3 Days)||0||
48353191|NCT05113940|101195276|FG002|NOT COMPLETED|Part B- Period 1 (3 Days)||0||
48638342|NCT01925794|101898735|FG000|NOT COMPLETED|180 Days||4||
48762083|NCT01394016|102205926|FG017|NOT COMPLETED|Overall Study||2||
48762084|NCT01394016|102205927|FG018|NOT COMPLETED|Overall Study||3||
48762085|NCT02867436|102205928|FG000|STARTED|Overall Study||26||
48762086|NCT02867436|102205929|FG001|STARTED|Overall Study||19||
48186823|NCT03114995|100779911|FG001|STARTED|Overall Study||31||
48353192|NCT05113940|101195277|FG003|NOT COMPLETED|Part B- Period 1 (3 Days)||0||
48353193|NCT05113940|101195278|FG004|NOT COMPLETED|Part B- Period 1 (3 Days)||0||
48353194|NCT05113940|101195279|FG005|NOT COMPLETED|Part B- Period 1 (3 Days)||0||
48353195|NCT05113940|101195280|FG006|NOT COMPLETED|Part B- Period 1 (3 Days)||0||
48353196|NCT05113940|101195281|FG007|NOT COMPLETED|Part B- Period 1 (3 Days)||0||
48353197|NCT05113940|101195282|FG008|NOT COMPLETED|Part B- Period 1 (3 Days)||0||
48638343|NCT01925794|101898735|FG000|STARTED|270 Days||292||
48638344|NCT01925794|101898735|FG000|COMPLETED|270 Days||287||
48638345|NCT01925794|101898735|FG000|NOT COMPLETED|270 Days||5||
48638346|NCT00576758|101898736|FG000|STARTED|Induction Treatment Period||87||
48762087|NCT02867436|102205928|FG000|COMPLETED|Overall Study||20||
48762088|NCT02867436|102205929|FG001|COMPLETED|Overall Study||19||
48762089|NCT02867436|102205928|FG000|NOT COMPLETED|Overall Study||6||
48762090|NCT02867436|102205929|FG001|NOT COMPLETED|Overall Study||0||
48762091|NCT02731469|102205930|FG000|STARTED|Overall Study||3||
48762092|NCT02731469|102205931|FG001|STARTED|Overall Study||3||
48353198|NCT05113940|101195283|FG009|NOT COMPLETED|Part B- Period 1 (3 Days)||0||
48353199|NCT05113940|101195284|FG010|NOT COMPLETED|Part B- Period 1 (3 Days)||0||
48353200|NCT05113940|101195285|FG011|NOT COMPLETED|Part B- Period 1 (3 Days)||0||
48353201|NCT05113940|101195286|FG012|NOT COMPLETED|Part B- Period 1 (3 Days)||0||
48353202|NCT05113940|101195287|FG013|NOT COMPLETED|Part B- Period 1 (3 Days)||0||
48353203|NCT05113940|101195288|FG014|NOT COMPLETED|Part B- Period 1 (3 Days)||0||
48353204|NCT05113940|101195274|FG000|STARTED|Part B- Period 2 (8 Days)||0||
48353205|NCT05113940|101195275|FG001|STARTED|Part B- Period 2 (8 Days)||0||
48353206|NCT05113940|101195276|FG002|STARTED|Part B- Period 2 (8 Days)||0||
48353207|NCT05113940|101195277|FG003|STARTED|Part B- Period 2 (8 Days)||0||
48353208|NCT05113940|101195278|FG004|STARTED|Part B- Period 2 (8 Days)||0||
48353209|NCT05113940|101195279|FG005|STARTED|Part B- Period 2 (8 Days)||0||
48353210|NCT05113940|101195280|FG006|STARTED|Part B- Period 2 (8 Days)||0||
48353211|NCT05113940|101195281|FG007|STARTED|Part B- Period 2 (8 Days)||0||
48353212|NCT05113940|101195282|FG008|STARTED|Part B- Period 2 (8 Days)||0||
48353213|NCT05113940|101195283|FG009|STARTED|Part B- Period 2 (8 Days)||0||
48353214|NCT05113940|101195284|FG010|STARTED|Part B- Period 2 (8 Days)||0||
48353215|NCT05113940|101195285|FG011|STARTED|Part B- Period 2 (8 Days)||0||
48353216|NCT05113940|101195286|FG012|STARTED|Part B- Period 2 (8 Days)||0||
48353217|NCT05113940|101195287|FG013|STARTED|Part B- Period 2 (8 Days)||0||
48353218|NCT05113940|101195288|FG014|STARTED|Part B- Period 2 (8 Days)||11||
48353219|NCT05113940|101195274|FG000|COMPLETED|Part B- Period 2 (8 Days)||0||
48353220|NCT05113940|101195275|FG001|COMPLETED|Part B- Period 2 (8 Days)||0||
48353221|NCT05113940|101195276|FG002|COMPLETED|Part B- Period 2 (8 Days)||0||
48353222|NCT05113940|101195277|FG003|COMPLETED|Part B- Period 2 (8 Days)||0||
48353223|NCT05113940|101195278|FG004|COMPLETED|Part B- Period 2 (8 Days)||0||
48353224|NCT05113940|101195279|FG005|COMPLETED|Part B- Period 2 (8 Days)||0||
48353225|NCT05113940|101195280|FG006|COMPLETED|Part B- Period 2 (8 Days)||0||
48353226|NCT05113940|101195281|FG007|COMPLETED|Part B- Period 2 (8 Days)||0||
48353227|NCT05113940|101195282|FG008|COMPLETED|Part B- Period 2 (8 Days)||0||
48353228|NCT05113940|101195283|FG009|COMPLETED|Part B- Period 2 (8 Days)||0||
48353229|NCT05113940|101195284|FG010|COMPLETED|Part B- Period 2 (8 Days)||0||
48353230|NCT05113940|101195285|FG011|COMPLETED|Part B- Period 2 (8 Days)||0||
48353231|NCT05113940|101195286|FG012|COMPLETED|Part B- Period 2 (8 Days)||0||
48353232|NCT05113940|101195287|FG013|COMPLETED|Part B- Period 2 (8 Days)||0||
48353233|NCT05113940|101195288|FG014|COMPLETED|Part B- Period 2 (8 Days)||9||
48353234|NCT05113940|101195274|FG000|NOT COMPLETED|Part B- Period 2 (8 Days)||0||
48353235|NCT05113940|101195275|FG001|NOT COMPLETED|Part B- Period 2 (8 Days)||0||
48353236|NCT05113940|101195276|FG002|NOT COMPLETED|Part B- Period 2 (8 Days)||0||
48353237|NCT05113940|101195277|FG003|NOT COMPLETED|Part B- Period 2 (8 Days)||0||
48353238|NCT05113940|101195278|FG004|NOT COMPLETED|Part B- Period 2 (8 Days)||0||
48353239|NCT05113940|101195279|FG005|NOT COMPLETED|Part B- Period 2 (8 Days)||0||
48353240|NCT05113940|101195280|FG006|NOT COMPLETED|Part B- Period 2 (8 Days)||0||
48353241|NCT05113940|101195281|FG007|NOT COMPLETED|Part B- Period 2 (8 Days)||0||
48353242|NCT05113940|101195282|FG008|NOT COMPLETED|Part B- Period 2 (8 Days)||0||
48353243|NCT05113940|101195283|FG009|NOT COMPLETED|Part B- Period 2 (8 Days)||0||
48353244|NCT05113940|101195284|FG010|NOT COMPLETED|Part B- Period 2 (8 Days)||0||
48353245|NCT05113940|101195285|FG011|NOT COMPLETED|Part B- Period 2 (8 Days)||0||
48353246|NCT05113940|101195286|FG012|NOT COMPLETED|Part B- Period 2 (8 Days)||0||
48353247|NCT05113940|101195287|FG013|NOT COMPLETED|Part B- Period 2 (8 Days)||0||
48353248|NCT05113940|101195288|FG014|NOT COMPLETED|Part B- Period 2 (8 Days)||2||
48353249|NCT03263806|101195289|FG000|STARTED|Overall Study||6||
48353250|NCT03263806|101195290|FG001|STARTED|Overall Study||7||
48353251|NCT03263806|101195289|FG000|COMPLETED|Overall Study||0||
48353252|NCT03263806|101195290|FG001|COMPLETED|Overall Study||0||
48353253|NCT03263806|101195289|FG000|NOT COMPLETED|Overall Study||6||
48353254|NCT03263806|101195290|FG001|NOT COMPLETED|Overall Study||7||
48353255|NCT00847613|101195291|FG000|STARTED|Overall Study||321||
48417322|NCT01314261|101356844|FG000|NOT COMPLETED|Overall Study||2||
48417323|NCT01314261|101356845|FG001|NOT COMPLETED|Overall Study||4||
48417324|NCT01314261|101356846|FG002|NOT COMPLETED|Overall Study||3||
48417325|NCT01314261|101356847|FG003|NOT COMPLETED|Overall Study||3||
48417326|NCT02009501|101356848|FG000|STARTED|Overall Study||9||
48417327|NCT02009501|101356849|FG001|STARTED|Overall Study||11||
48417328|NCT02009501|101356848|FG000|COMPLETED|Overall Study||9||
48417329|NCT02009501|101356849|FG001|COMPLETED|Overall Study||11||
48417330|NCT02009501|101356848|FG000|NOT COMPLETED|Overall Study||0||
48417331|NCT02009501|101356849|FG001|NOT COMPLETED|Overall Study||0||
48417332|NCT04337203|101356850|FG000|STARTED|Overall Study||40||
48417333|NCT04337203|101356850|FG000|COMPLETED|Overall Study||40||
48353256|NCT00847613|101195292|FG001|STARTED|Overall Study||319||
48353257|NCT00847613|101195293|FG002|STARTED|Overall Study||81||
48353258|NCT00847613|101195294|FG003|STARTED|Overall Study||79||
48353259|NCT00847613|101195291|FG000|Treated|Overall Study||321||
48353260|NCT00847613|101195292|FG001|Treated|Overall Study||316||
48417334|NCT04337203|101356850|FG000|NOT COMPLETED|Overall Study||0||
48353261|NCT00847613|101195293|FG002|Treated|Overall Study||81||
48353262|NCT00847613|101195294|FG003|Treated|Overall Study||79||
48353263|NCT00847613|101195291|FG000|COMPLETED|Overall Study||0||
48417335|NCT01183728|101356851|FG000|STARTED|Overall Study||12||
48417336|NCT01183728|101356851|FG000|COMPLETED|Overall Study||12||
48417337|NCT01183728|101356851|FG000|NOT COMPLETED|Overall Study||0||
48417338|NCT02155712|101356852|FG000|STARTED|Overall Study||397||
48417339|NCT02155712|101356853|FG001|STARTED|Overall Study||216||
48417340|NCT02155712|101356852|FG000|COMPLETED|Overall Study||0||
48417341|NCT02155712|101356853|FG001|COMPLETED|Overall Study||37||
48417342|NCT02155712|101356852|FG000|NOT COMPLETED|Overall Study||397||
48417343|NCT02155712|101356853|FG001|NOT COMPLETED|Overall Study||179||
48417344|NCT00198042|101356854|FG000|STARTED|Overall Study||18||
48417345|NCT00198042|101356854|FG000|COMPLETED|Overall Study||18||
48417346|NCT00198042|101356854|FG000|NOT COMPLETED|Overall Study||0||
48417347|NCT04834375|101356855|FG000|STARTED|Overall Study||72||
48762093|NCT02731469|102205932|FG002|STARTED|Overall Study||3||
48762094|NCT02731469|102205933|FG003|STARTED|Overall Study||3||
48762095|NCT02731469|102205934|FG004|STARTED|Overall Study||3||
48762096|NCT02731469|102205935|FG005|STARTED|Overall Study||3||
48762097|NCT02731469|102205936|FG006|STARTED|Overall Study||3||
48762098|NCT02731469|102205937|FG007|STARTED|Overall Study||6||
48762099|NCT02731469|102205938|FG008|STARTED|Overall Study||6||
48762100|NCT02731469|102205939|FG009|STARTED|Overall Study||6||
48762101|NCT02731469|102205940|FG010|STARTED|Overall Study||6||
48762102|NCT02731469|102205930|FG000|COMPLETED|Overall Study||3||
48762103|NCT02731469|102205931|FG001|COMPLETED|Overall Study||3||
48353264|NCT00847613|101195292|FG001|COMPLETED|Overall Study||0||
48353265|NCT00847613|101195293|FG002|COMPLETED|Overall Study||0||
48353266|NCT00847613|101195294|FG003|COMPLETED|Overall Study||0||
48353267|NCT00847613|101195291|FG000|NOT COMPLETED|Overall Study||321||
48353268|NCT00847613|101195292|FG001|NOT COMPLETED|Overall Study||319||
48353269|NCT00847613|101195293|FG002|NOT COMPLETED|Overall Study||81||
48353270|NCT00847613|101195294|FG003|NOT COMPLETED|Overall Study||79||
48353271|NCT02112448|101195295|FG000|STARTED|Overall Study||38||
48353272|NCT02112448|101195296|FG001|STARTED|Overall Study||40||
48353273|NCT02112448|101195295|FG000|COMPLETED|Overall Study||30||
48353274|NCT02112448|101195296|FG001|COMPLETED|Overall Study||30||
48353275|NCT02112448|101195295|FG000|NOT COMPLETED|Overall Study||8||
48353276|NCT02112448|101195296|FG001|NOT COMPLETED|Overall Study||10||
48353277|NCT01982630|101195297|FG000|STARTED|Overall Study||10||
48353278|NCT01982630|101195298|FG001|STARTED|Overall Study||8||
48353279|NCT01982630|101195299|FG002|STARTED|Overall Study||13||
48353280|NCT01982630|101195300|FG003|STARTED|Overall Study||9||
48353281|NCT01982630|101195301|FG004|STARTED|Overall Study||19||
48353282|NCT01982630|101195302|FG005|STARTED|Overall Study||14||
48353283|NCT01982630|101195303|FG006|STARTED|Overall Study||6||
48353284|NCT01982630|101195304|FG007|STARTED|Overall Study||8||
48353285|NCT01982630|101195297|FG000|Treated|Overall Study||9||
48353286|NCT01982630|101195298|FG001|Treated|Overall Study||8||
48353287|NCT01982630|101195299|FG002|Treated|Overall Study||11||
48353288|NCT01982630|101195300|FG003|Treated|Overall Study||9||
48762104|NCT02731469|102205932|FG002|COMPLETED|Overall Study||3||
48762105|NCT02731469|102205933|FG003|COMPLETED|Overall Study||3||
48762106|NCT02731469|102205934|FG004|COMPLETED|Overall Study||3||
48762107|NCT02731469|102205935|FG005|COMPLETED|Overall Study||3||
48762108|NCT02731469|102205936|FG006|COMPLETED|Overall Study||3||
48762109|NCT02731469|102205937|FG007|COMPLETED|Overall Study||6||
48762110|NCT02731469|102205938|FG008|COMPLETED|Overall Study||6||
48762111|NCT02731469|102205939|FG009|COMPLETED|Overall Study||6||
48353289|NCT01982630|101195301|FG004|Treated|Overall Study||18||
48353290|NCT01982630|101195302|FG005|Treated|Overall Study||14||
48353291|NCT01982630|101195303|FG006|Treated|Overall Study||6||
48353292|NCT01982630|101195304|FG007|Treated|Overall Study||8||
48353293|NCT01982630|101195297|FG000|COMPLETED|Overall Study||7||
48353294|NCT01982630|101195298|FG001|COMPLETED|Overall Study||8||
48353295|NCT01982630|101195299|FG002|COMPLETED|Overall Study||8||
48762112|NCT02731469|102205940|FG010|COMPLETED|Overall Study||6||
48762113|NCT02731469|102205930|FG000|NOT COMPLETED|Overall Study||0||
48353296|NCT01982630|101195300|FG003|COMPLETED|Overall Study||8||
48417348|NCT04834375|101356856|FG001|STARTED|Overall Study||70||
48417349|NCT04834375|101356855|FG000|COMPLETED|Overall Study||72||
48417350|NCT04834375|101356856|FG001|COMPLETED|Overall Study||70||
48417351|NCT04834375|101356855|FG000|NOT COMPLETED|Overall Study||0||
48417352|NCT04834375|101356856|FG001|NOT COMPLETED|Overall Study||0||
48417353|NCT01591044|101356857|FG000|STARTED|Overall Study||101||
48417354|NCT01591044|101356858|FG001|STARTED|Overall Study||100||
48417355|NCT01591044|101356859|FG002|STARTED|Overall Study||100||
48762114|NCT02731469|102205931|FG001|NOT COMPLETED|Overall Study||0||
48762115|NCT02731469|102205932|FG002|NOT COMPLETED|Overall Study||0||
48762116|NCT02731469|102205933|FG003|NOT COMPLETED|Overall Study||0||
48353297|NCT01982630|101195301|FG004|COMPLETED|Overall Study||16||
48353298|NCT01982630|101195302|FG005|COMPLETED|Overall Study||11||
48353299|NCT01982630|101195303|FG006|COMPLETED|Overall Study||5||
48417356|NCT01591044|101356857|FG000|COMPLETED|Overall Study||94||
48353300|NCT01982630|101195304|FG007|COMPLETED|Overall Study||8||
48353301|NCT01982630|101195297|FG000|NOT COMPLETED|Overall Study||3||
48353302|NCT01982630|101195298|FG001|NOT COMPLETED|Overall Study||0||
48762117|NCT02731469|102205934|FG004|NOT COMPLETED|Overall Study||0||
48762118|NCT02731469|102205935|FG005|NOT COMPLETED|Overall Study||0||
48762119|NCT02731469|102205936|FG006|NOT COMPLETED|Overall Study||0||
48353303|NCT01982630|101195299|FG002|NOT COMPLETED|Overall Study||5||
48353304|NCT01982630|101195300|FG003|NOT COMPLETED|Overall Study||1||
48353305|NCT01982630|101195301|FG004|NOT COMPLETED|Overall Study||3||
48353306|NCT01982630|101195302|FG005|NOT COMPLETED|Overall Study||3||
48353307|NCT01982630|101195303|FG006|NOT COMPLETED|Overall Study||1||
48353308|NCT01982630|101195304|FG007|NOT COMPLETED|Overall Study||0||
48353309|NCT00491530|101195305|FG000|STARTED|Overall Study||174||
48353310|NCT00491530|101195306|FG001|STARTED|Overall Study||50||
48353311|NCT00491530|101195307|FG002|STARTED|Overall Study||86||
48353312|NCT00491530|101195305|FG000|COMPLETED|Overall Study||162||
48353313|NCT00491530|101195306|FG001|COMPLETED|Overall Study||44||
48353314|NCT00491530|101195307|FG002|COMPLETED|Overall Study||81||
48353315|NCT00491530|101195305|FG000|NOT COMPLETED|Overall Study||12||
48353316|NCT00491530|101195306|FG001|NOT COMPLETED|Overall Study||6||
48353317|NCT00491530|101195307|FG002|NOT COMPLETED|Overall Study||5||
48353318|NCT01697332|101195308|FG000|STARTED|Overall Study||1||
48353319|NCT01697332|101195308|FG000|COMPLETED|Overall Study||1||
48353320|NCT01697332|101195308|FG000|NOT COMPLETED|Overall Study||0||
48353321|NCT03429075|101195309|FG000|STARTED|Overall Study||30||
48353322|NCT03429075|101195310|FG001|STARTED|Overall Study||29||
48353323|NCT03429075|101195309|FG000|COMPLETED|Overall Study||30||
48353324|NCT03429075|101195310|FG001|COMPLETED|Overall Study||29||
48353325|NCT03429075|101195309|FG000|NOT COMPLETED|Overall Study||0||
48353326|NCT03429075|101195310|FG001|NOT COMPLETED|Overall Study||0||
48353327|NCT01896232|101195311|FG000|STARTED|Overall Study||343||
48353328|NCT01896232|101195312|FG001|STARTED|Overall Study||340||
48353329|NCT01896232|101195311|FG000|Received Treatment|Overall Study||341||
48762120|NCT02731469|102205937|FG007|NOT COMPLETED|Overall Study||0||
48762121|NCT02731469|102205938|FG008|NOT COMPLETED|Overall Study||0||
48762122|NCT02731469|102205939|FG009|NOT COMPLETED|Overall Study||0||
48353330|NCT01896232|101195312|FG001|Received Treatment|Overall Study||338||
48353331|NCT01896232|101195311|FG000|COMPLETED|Overall Study||294||
48353332|NCT01896232|101195312|FG001|COMPLETED|Overall Study||287||
48353333|NCT01896232|101195311|FG000|NOT COMPLETED|Overall Study||49||
48353334|NCT01896232|101195312|FG001|NOT COMPLETED|Overall Study||53||
48353335|NCT02986373|101195313|FG000|STARTED|Overall Study||145||
48353336|NCT02986373|101195313|FG000|COMPLETED|Overall Study||106||
48353337|NCT02986373|101195313|FG000|NOT COMPLETED|Overall Study||39||
48353338|NCT01844076|101195314|FG000|STARTED|Overall Study||3||
48353339|NCT01844076|101195315|FG001|STARTED|Overall Study||6||
48353340|NCT01844076|101195316|FG002|STARTED|Overall Study||3||
48353341|NCT01844076|101195317|FG003|STARTED|Overall Study||7||
48353342|NCT01844076|101195314|FG000|COMPLETED|Overall Study||1||
48353343|NCT01844076|101195315|FG001|COMPLETED|Overall Study||6||
48353344|NCT01844076|101195316|FG002|COMPLETED|Overall Study||3||
48353345|NCT01844076|101195317|FG003|COMPLETED|Overall Study||7||
48353346|NCT01844076|101195314|FG000|NOT COMPLETED|Overall Study||2||
48353347|NCT01844076|101195315|FG001|NOT COMPLETED|Overall Study||0||
48353348|NCT01844076|101195316|FG002|NOT COMPLETED|Overall Study||0||
48353349|NCT01844076|101195317|FG003|NOT COMPLETED|Overall Study||0||
48353350|NCT00468715|101195318|FG000|STARTED|Overall Study||28||
48353351|NCT00468715|101195318|FG000|COMPLETED|Overall Study||28||
48353352|NCT00468715|101195318|FG000|NOT COMPLETED|Overall Study||0||
48353353|NCT00586690|101195319|FG000|STARTED|Overall Study||21||
48353354|NCT00586690|101195320|FG001|STARTED|Overall Study||22||
48353355|NCT00586690|101195319|FG000|COMPLETED|Overall Study||5||
48353356|NCT00586690|101195320|FG001|COMPLETED|Overall Study||22||
48353357|NCT00586690|101195319|FG000|NOT COMPLETED|Overall Study||16||
48353358|NCT00586690|101195320|FG001|NOT COMPLETED|Overall Study||0||
48353359|NCT02032524|101195321|FG000|STARTED|Period 1: TDR12857 Study||4||
48353360|NCT02032524|101195322|FG001|STARTED|Period 1: TDR12857 Study||3||
48353361|NCT02032524|101195323|FG002|STARTED|Period 1: TDR12857 Study||3||
48353362|NCT02032524|101195324|FG003|STARTED|Period 1: TDR12857 Study||4||
48353363|NCT02032524|101195325|FG004|STARTED|Period 1: TDR12857 Study||4||
48417357|NCT01591044|101356858|FG001|COMPLETED|Overall Study||91||
48417358|NCT01591044|101356859|FG002|COMPLETED|Overall Study||96||
48417359|NCT01591044|101356857|FG000|NOT COMPLETED|Overall Study||7||
48638347|NCT00576758|101898737|FG001|STARTED|Induction Treatment Period||88||
48762123|NCT02731469|102205940|FG010|NOT COMPLETED|Overall Study||0||
48762124|NCT01474317|102205941|FG000|STARTED|Overall Study||226||
48762125|NCT01474317|102205941|FG000|COMPLETED|Overall Study||224||
48762126|NCT01474317|102205941|FG000|NOT COMPLETED|Overall Study||2||
48762127|NCT02231086|102205942|FG000|STARTED|Overall Study||102||
48762128|NCT02231086|102205943|FG001|STARTED|Overall Study||102||
48353364|NCT02032524|101195326|FG005|STARTED|Period 1: TDR12857 Study||6||
48353365|NCT02032524|101195321|FG000|COMPLETED|Period 1: TDR12857 Study||3||
48417360|NCT01591044|101356858|FG001|NOT COMPLETED|Overall Study||9||
48353366|NCT02032524|101195322|FG001|COMPLETED|Period 1: TDR12857 Study||3||
48353367|NCT02032524|101195323|FG002|COMPLETED|Period 1: TDR12857 Study||3||
48353368|NCT02032524|101195324|FG003|COMPLETED|Period 1: TDR12857 Study||3||
48353369|NCT02032524|101195325|FG004|COMPLETED|Period 1: TDR12857 Study||4||
48353370|NCT02032524|101195326|FG005|COMPLETED|Period 1: TDR12857 Study||5||
48353371|NCT02032524|101195321|FG000|NOT COMPLETED|Period 1: TDR12857 Study||1||
48353372|NCT02032524|101195322|FG001|NOT COMPLETED|Period 1: TDR12857 Study||0||
48353373|NCT02032524|101195323|FG002|NOT COMPLETED|Period 1: TDR12857 Study||0||
48353374|NCT02032524|101195324|FG003|NOT COMPLETED|Period 1: TDR12857 Study||1||
48353375|NCT02032524|101195325|FG004|NOT COMPLETED|Period 1: TDR12857 Study||0||
48353376|NCT02032524|101195326|FG005|NOT COMPLETED|Period 1: TDR12857 Study||1||
48353377|NCT02032524|101195321|FG000|STARTED|Period 2: LTS13769 Study||3|Enrolled and treated participants in LTS13769 study.|
48353378|NCT02032524|101195322|FG001|STARTED|Period 2: LTS13769 Study||2|Enrolled and treated participants in LTS13769 study.|
48353379|NCT02032524|101195323|FG002|STARTED|Period 2: LTS13769 Study||3|Enrolled and treated participants in LTS13769 study.|
48353380|NCT02032524|101195324|FG003|STARTED|Period 2: LTS13769 Study||3|Enrolled and treated participants in LTS13769 study.|
48353381|NCT02032524|101195325|FG004|STARTED|Period 2: LTS13769 Study||3|Enrolled and treated participants in LTS13769 study.|
48353382|NCT02032524|101195326|FG005|STARTED|Period 2: LTS13769 Study||5|Enrolled and treated participants in LTS13769 study.|
48353383|NCT02032524|101195321|FG000|COMPLETED|Period 2: LTS13769 Study||3||
48353384|NCT02032524|101195322|FG001|COMPLETED|Period 2: LTS13769 Study||1||
48353385|NCT02032524|101195323|FG002|COMPLETED|Period 2: LTS13769 Study||2||
48353386|NCT02032524|101195324|FG003|COMPLETED|Period 2: LTS13769 Study||3||
48353387|NCT02032524|101195325|FG004|COMPLETED|Period 2: LTS13769 Study||2||
48353388|NCT02032524|101195326|FG005|COMPLETED|Period 2: LTS13769 Study||4||
48353389|NCT02032524|101195321|FG000|NOT COMPLETED|Period 2: LTS13769 Study||0||
48353390|NCT02032524|101195322|FG001|NOT COMPLETED|Period 2: LTS13769 Study||1||
48353391|NCT02032524|101195323|FG002|NOT COMPLETED|Period 2: LTS13769 Study||1||
48353392|NCT02032524|101195324|FG003|NOT COMPLETED|Period 2: LTS13769 Study||0||
48353393|NCT02032524|101195325|FG004|NOT COMPLETED|Period 2: LTS13769 Study||1||
48353394|NCT02032524|101195326|FG005|NOT COMPLETED|Period 2: LTS13769 Study||1||
48353395|NCT01173653|101195327|FG000|STARTED|Overall Study||109||
48353396|NCT01173653|101195328|FG001|STARTED|Overall Study||90||
48353397|NCT01173653|101195327|FG000|COMPLETED|Overall Study||56||
48353398|NCT01173653|101195328|FG001|COMPLETED|Overall Study||49||
48353399|NCT01173653|101195327|FG000|NOT COMPLETED|Overall Study||53||
48353400|NCT01173653|101195328|FG001|NOT COMPLETED|Overall Study||41||
48353401|NCT00509106|101195329|FG000|STARTED|Overall Study||315||
48353402|NCT00509106|101195330|FG001|STARTED|Overall Study||307||
48353403|NCT00509106|101195329|FG000|COMPLETED|Overall Study||284||
48353404|NCT00509106|101195330|FG001|COMPLETED|Overall Study||278||
48353405|NCT00509106|101195329|FG000|NOT COMPLETED|Overall Study||31||
48353406|NCT00509106|101195330|FG001|NOT COMPLETED|Overall Study||29||
48353407|NCT00659438|101195331|FG000|STARTED|Overall Study||47||
48353408|NCT00659438|101195332|FG001|STARTED|Overall Study||48||
48353409|NCT00659438|101195331|FG000|Assessable Set : Primary Analysis|Overall Study||44||
48353410|NCT00659438|101195332|FG001|Assessable Set : Primary Analysis|Overall Study||45||
48353411|NCT00659438|101195331|FG000|Secondary Analysis Set|Overall Study||47||
48353412|NCT00659438|101195332|FG001|Secondary Analysis Set|Overall Study||48||
48353413|NCT00659438|101195331|FG000|Safety Analysis Set|Overall Study||48||
48353414|NCT00659438|101195332|FG001|Safety Analysis Set|Overall Study||47||
48353415|NCT00659438|101195331|FG000|COMPLETED|Overall Study||33||
48353416|NCT00659438|101195332|FG001|COMPLETED|Overall Study||40||
48353417|NCT00659438|101195331|FG000|NOT COMPLETED|Overall Study||14||
48353418|NCT00659438|101195332|FG001|NOT COMPLETED|Overall Study||8||
48353419|NCT03333577|101195333|FG000|STARTED|Overall Study||32||
48353420|NCT03333577|101195333|FG000|COMPLETED|Overall Study||25||
48353421|NCT03333577|101195333|FG000|NOT COMPLETED|Overall Study||7||
48353422|NCT00374556|101195334|FG000|STARTED|Overall Study||14||
48353423|NCT00374556|101195335|FG001|STARTED|Overall Study||16||
48353424|NCT00374556|101195334|FG000|COMPLETED|Overall Study||13||
48353425|NCT00374556|101195335|FG001|COMPLETED|Overall Study||15||
48353426|NCT00374556|101195334|FG000|NOT COMPLETED|Overall Study||1||
48353427|NCT00374556|101195335|FG001|NOT COMPLETED|Overall Study||1||
48353428|NCT02675777|101195336|FG000|STARTED|Usual Care||27543|Given the open cohort design, these are the patients whose first visit to the participating sites within the given wave occurred during the Usual Care period (Period 1).|3
48353429|NCT02675777|101195337|FG001|STARTED|Usual Care||34989|Given the open cohort design, these are the patients whose first visit to the participating sites within the given wave occurred during the Usual Care period (Period 1).|3
48353430|NCT02675777|101195338|FG002|STARTED|Usual Care||39357|Given the open cohort design, these are the patients whose first visit to the participating sites within the given wave occurred during the Usual Care period (Period 1).|3
48353431|NCT02675777|101195339|FG003|STARTED|Usual Care||75377|Given the open cohort design, these are the patients whose first visit to the participating sites within the given wave occurred during the Usual Care period (Period 1).|3
48353432|NCT02675777|101195340|FG004|STARTED|Usual Care||35287|Given the open cohort design, these are the patients whose first visit to the participating sites within the given wave occurred during the Usual Care period (Period 1).|3
48368119|NCT03196297|101230110|FG000|SAS|Extension Period||32||
48762129|NCT02231086|102205942|FG000|COMPLETED|Overall Study||63||
48762130|NCT02231086|102205943|FG001|COMPLETED|Overall Study||65||
48762131|NCT02231086|102205942|FG000|NOT COMPLETED|Overall Study||39||
48762132|NCT02231086|102205943|FG001|NOT COMPLETED|Overall Study||37||
48762133|NCT04583618|102205944|FG000|STARTED|Overall Study||151||
48762134|NCT04583618|102205945|FG001|STARTED|Overall Study||151||
48762135|NCT04583618|102205946|FG002|STARTED|Overall Study||149||
48762136|NCT04583618|102205947|FG003|STARTED|Overall Study||149||
48353433|NCT02675777|101195341|FG005|STARTED|Usual Care||41503|Given the open cohort design, these are the patients whose first visit to the participating sites within the given wave occurred during the Usual Care period (Period 1).|2
48353434|NCT02675777|101195342|FG006|STARTED|Usual Care||31248|Given the open cohort design, these are the patients whose first visit to the participating sites within the given wave occurred during the Usual Care period (Period 1).|2
48353435|NCT02675777|101195336|FG000|COMPLETED|Usual Care||27543||3
48353436|NCT02675777|101195337|FG001|COMPLETED|Usual Care||34989||3
48353437|NCT02675777|101195338|FG002|COMPLETED|Usual Care||39357||3
48353438|NCT02675777|101195339|FG003|COMPLETED|Usual Care||75377||3
48353439|NCT02675777|101195340|FG004|COMPLETED|Usual Care||35287||3
48353440|NCT02675777|101195341|FG005|COMPLETED|Usual Care||41503||2
48353441|NCT02675777|101195342|FG006|COMPLETED|Usual Care||31248||2
48353442|NCT02675777|101195336|FG000|NOT COMPLETED|Usual Care||0||0
48353443|NCT02675777|101195337|FG001|NOT COMPLETED|Usual Care||0||0
48353444|NCT02675777|101195338|FG002|NOT COMPLETED|Usual Care||0||0
48353445|NCT02675777|101195339|FG003|NOT COMPLETED|Usual Care||0||0
48353446|NCT02675777|101195340|FG004|NOT COMPLETED|Usual Care||0||0
48353447|NCT02675777|101195341|FG005|NOT COMPLETED|Usual Care||0||0
48353448|NCT02675777|101195342|FG006|NOT COMPLETED|Usual Care||0||0
48353449|NCT02675777|101195336|FG000|STARTED|Quality Improvement Intervention||23888|Given the open cohort design, these are only the patients whose first visit to the sites randomized to each wave occurred during the Quality Improvement Intervention (Period 2). This does not include individuals who started in the Usual Care (Period 1) period and had a subsequent visit during the Quality Improvement Intervention period.|3
48353450|NCT02675777|101195337|FG001|STARTED|Quality Improvement Intervention||20146|Given the open cohort design, these are only the patients whose first visit to the sites randomized to each wave occurred during the Quality Improvement Intervention (Period 2). This does not include individuals who started in the Usual Care (Period 1) period and had a subsequent visit during the Quality Improvement Intervention period.|3
48353451|NCT02675777|101195338|FG002|STARTED|Quality Improvement Intervention||17973|Given the open cohort design, these are only the patients whose first visit to the sites randomized to each wave occurred during the Quality Improvement Intervention (Period 2). This does not include individuals who started in the Usual Care (Period 1) period and had a subsequent visit during the Quality Improvement Intervention period.|3
48353452|NCT02675777|101195339|FG003|STARTED|Quality Improvement Intervention||23917|Given the open cohort design, these are only the patients whose first visit to the sites randomized to each wave occurred during the Quality Improvement Intervention (Period 2). This does not include individuals who started in the Usual Care (Period 1) period and had a subsequent visit during the Quality Improvement Intervention period.|3
48353453|NCT02675777|101195340|FG004|STARTED|Quality Improvement Intervention||8837|Given the open cohort design, these are only the patients whose first visit to the sites randomized to each wave occurred during the Quality Improvement Intervention (Period 2). This does not include individuals who started in the Usual Care (Period 1) period and had a subsequent visit during the Quality Improvement Intervention period.|3
48353454|NCT02675777|101195341|FG005|STARTED|Quality Improvement Intervention||6345|Given the open cohort design, these are only the patients whose first visit to the sites randomized to each wave occurred during the Quality Improvement Intervention (Period 2). This does not include individuals who started in the Usual Care (Period 1) period and had a subsequent visit during the Quality Improvement Intervention period.|2
48353455|NCT02675777|101195342|FG006|STARTED|Quality Improvement Intervention||2226|Given the open cohort design, these are only the patients whose first visit to the sites randomized to each wave occurred during the Quality Improvement Intervention (Period 2). This does not include individuals who started in the Usual Care (Period 1) period and had a subsequent visit during the Quality Improvement Intervention period.|2
48353456|NCT02675777|101195336|FG000|COMPLETED|Quality Improvement Intervention||23888||3
48353457|NCT02675777|101195337|FG001|COMPLETED|Quality Improvement Intervention||20146||3
48353458|NCT02675777|101195338|FG002|COMPLETED|Quality Improvement Intervention||17973||3
48353459|NCT02675777|101195339|FG003|COMPLETED|Quality Improvement Intervention||23917||3
48353460|NCT02675777|101195340|FG004|COMPLETED|Quality Improvement Intervention||8837||3
48353461|NCT02675777|101195341|FG005|COMPLETED|Quality Improvement Intervention||6345||2
48353462|NCT02675777|101195342|FG006|COMPLETED|Quality Improvement Intervention||2226||2
48353463|NCT02675777|101195336|FG000|NOT COMPLETED|Quality Improvement Intervention||0||0
48353464|NCT02675777|101195337|FG001|NOT COMPLETED|Quality Improvement Intervention||0||0
48353465|NCT02675777|101195338|FG002|NOT COMPLETED|Quality Improvement Intervention||0||0
48353466|NCT02675777|101195339|FG003|NOT COMPLETED|Quality Improvement Intervention||0||0
48353467|NCT02675777|101195340|FG004|NOT COMPLETED|Quality Improvement Intervention||0||0
48353468|NCT02675777|101195341|FG005|NOT COMPLETED|Quality Improvement Intervention||0||0
48353469|NCT02675777|101195342|FG006|NOT COMPLETED|Quality Improvement Intervention||0||0
48353470|NCT02500550|101195343|FG000|STARTED|Overall Study||15||
48353471|NCT02500550|101195343|FG000|COMPLETED|Overall Study||8||
48353472|NCT02500550|101195343|FG000|NOT COMPLETED|Overall Study||7||
48353473|NCT03981029|101195344|FG000|STARTED|Overall Study||19||
48353474|NCT03981029|101195345|FG001|STARTED|Overall Study||32||
48353475|NCT03981029|101195344|FG000|COMPLETED|Overall Study||19||
48353476|NCT03981029|101195345|FG001|COMPLETED|Overall Study||31||
48353477|NCT03981029|101195344|FG000|NOT COMPLETED|Overall Study||0||
48353478|NCT03981029|101195345|FG001|NOT COMPLETED|Overall Study||1||
48353479|NCT03968965|101195346|FG000|STARTED|Overall Study||32||
48353480|NCT03968965|101195347|FG001|STARTED|Overall Study||32||
48353481|NCT03968965|101195346|FG000|COMPLETED|Overall Study||32||
48353482|NCT03968965|101195347|FG001|COMPLETED|Overall Study||30||
48353483|NCT03968965|101195346|FG000|NOT COMPLETED|Overall Study||0||
48353484|NCT03968965|101195347|FG001|NOT COMPLETED|Overall Study||2||
48762137|NCT04583618|102205948|FG004|STARTED|Overall Study||150||
48353485|NCT03842137|101195348|FG000|STARTED|Overall Study||27||
48353486|NCT03842137|101195349|FG001|STARTED|Overall Study||27||
48353487|NCT03842137|101195348|FG000|COMPLETED|Overall Study||26||
48353488|NCT03842137|101195349|FG001|COMPLETED|Overall Study||25||
48353489|NCT03842137|101195348|FG000|NOT COMPLETED|Overall Study||1||
48353490|NCT03842137|101195349|FG001|NOT COMPLETED|Overall Study||2||
48353491|NCT02397655|101195350|FG000|STARTED|Overall Study||12012||
48353492|NCT02397655|101195350|FG000|COMPLETED|Overall Study||10711||
48353493|NCT02397655|101195350|FG000|NOT COMPLETED|Overall Study||1301||
48353494|NCT04375878|101195351|FG000|STARTED|Crossover First and Second Interventions||7||
48353495|NCT04375878|101195352|FG001|STARTED|Crossover First and Second Interventions||7||
48353496|NCT04375878|101195353|FG002|STARTED|Crossover First and Second Interventions||6||
48353497|NCT04375878|101195354|FG003|STARTED|Crossover First and Second Interventions||7||
48353498|NCT04375878|101195355|FG004|STARTED|Crossover First and Second Interventions||0||
48353499|NCT04375878|101195356|FG005|STARTED|Crossover First and Second Interventions||0||
48353500|NCT04375878|101195351|FG000|COMPLETED|Crossover First and Second Interventions||6||
48353501|NCT04375878|101195352|FG001|COMPLETED|Crossover First and Second Interventions||6||
48353502|NCT04375878|101195353|FG002|COMPLETED|Crossover First and Second Interventions||5||
48353503|NCT04375878|101195354|FG003|COMPLETED|Crossover First and Second Interventions||7||
48353504|NCT04375878|101195355|FG004|COMPLETED|Crossover First and Second Interventions||0||
48353505|NCT04375878|101195356|FG005|COMPLETED|Crossover First and Second Interventions||0||
48353506|NCT04375878|101195351|FG000|NOT COMPLETED|Crossover First and Second Interventions||1||
48353507|NCT04375878|101195352|FG001|NOT COMPLETED|Crossover First and Second Interventions||1||
48353508|NCT04375878|101195353|FG002|NOT COMPLETED|Crossover First and Second Interventions||1||
48353509|NCT04375878|101195354|FG003|NOT COMPLETED|Crossover First and Second Interventions||0||
48353510|NCT04375878|101195355|FG004|NOT COMPLETED|Crossover First and Second Interventions||0||
48353511|NCT04375878|101195356|FG005|NOT COMPLETED|Crossover First and Second Interventions||0||
48353512|NCT04375878|101195351|FG000|STARTED|Extension Phase||0||
48353513|NCT04375878|101195352|FG001|STARTED|Extension Phase||0||
48353514|NCT04375878|101195353|FG002|STARTED|Extension Phase||0||
48353515|NCT04375878|101195354|FG003|STARTED|Extension Phase||0||
48353516|NCT04375878|101195355|FG004|STARTED|Extension Phase||9||
48353517|NCT04375878|101195356|FG005|STARTED|Extension Phase||8||
48353518|NCT04375878|101195351|FG000|COMPLETED|Extension Phase||0||
48353519|NCT04375878|101195352|FG001|COMPLETED|Extension Phase||0||
48353520|NCT04375878|101195353|FG002|COMPLETED|Extension Phase||0||
48353521|NCT04375878|101195354|FG003|COMPLETED|Extension Phase||0||
48353522|NCT04375878|101195355|FG004|COMPLETED|Extension Phase||8||
48353523|NCT04375878|101195356|FG005|COMPLETED|Extension Phase||8||
48353524|NCT04375878|101195351|FG000|NOT COMPLETED|Extension Phase||0||
48353525|NCT04375878|101195352|FG001|NOT COMPLETED|Extension Phase||0||
48353526|NCT04375878|101195353|FG002|NOT COMPLETED|Extension Phase||0||
48353527|NCT04375878|101195354|FG003|NOT COMPLETED|Extension Phase||0||
48353528|NCT04375878|101195355|FG004|NOT COMPLETED|Extension Phase||1||
48353529|NCT04375878|101195356|FG005|NOT COMPLETED|Extension Phase||0||
48353530|NCT03163342|101195357|FG000|STARTED|Overall Study||20||
48353531|NCT03163342|101195357|FG000|COMPLETED|Overall Study||20||
48353532|NCT03163342|101195357|FG000|NOT COMPLETED|Overall Study||0||
48353533|NCT04661813|101195358|FG000|STARTED|Overall Study||74||
48353534|NCT04661813|101195358|FG000|COMPLETED|Overall Study||55||
48353535|NCT04661813|101195358|FG000|NOT COMPLETED|Overall Study||19||
48353536|NCT02256358|101195359|FG000|STARTED|Overall Study||34||
48353537|NCT02256358|101195360|FG001|STARTED|Overall Study||34||
48638348|NCT00576758|101898736|FG000|Received Treatment|Induction Treatment Period||86||
48353538|NCT02256358|101195359|FG000|COMPLETED|Overall Study||34||
48353539|NCT02256358|101195360|FG001|COMPLETED|Overall Study||33||
48353540|NCT02256358|101195359|FG000|NOT COMPLETED|Overall Study||0||
48353541|NCT02256358|101195360|FG001|NOT COMPLETED|Overall Study||1||
48353542|NCT01242111|101195361|FG000|STARTED|Overall Study||20||
48353543|NCT01242111|101195361|FG000|COMPLETED|Overall Study||17||
48353544|NCT01242111|101195361|FG000|NOT COMPLETED|Overall Study||3||
48353545|NCT00195351|101195362|FG000|STARTED|Overall Study||236||
48353546|NCT00195351|101195363|FG001|STARTED|Overall Study||231||
48353547|NCT00195351|101195362|FG000|COMPLETED|Overall Study||215||
48353548|NCT00195351|101195363|FG001|COMPLETED|Overall Study||215||
48353549|NCT00195351|101195362|FG000|NOT COMPLETED|Overall Study||21||
48353550|NCT00195351|101195363|FG001|NOT COMPLETED|Overall Study||16||
48353551|NCT03368859|101195364|FG000|STARTED|Overall Study||36||
48353552|NCT03368859|101195365|FG001|STARTED|Overall Study||34||
48353553|NCT03368859|101195364|FG000|COMPLETED|Overall Study||0||
48638349|NCT00576758|101898737|FG001|Received Treatment|Induction Treatment Period||87||
48638350|NCT00576758|101898736|FG000|COMPLETED|Induction Treatment Period||79||
48638351|NCT00576758|101898737|FG001|COMPLETED|Induction Treatment Period||83||
48638352|NCT00576758|101898736|FG000|NOT COMPLETED|Induction Treatment Period||8||
48638353|NCT00576758|101898737|FG001|NOT COMPLETED|Induction Treatment Period||5||
48638354|NCT00576758|101898736|FG000|STARTED|Extension Treatment Period||72||
48638355|NCT00576758|101898737|FG001|STARTED|Extension Treatment Period||73||
48638356|NCT00576758|101898736|FG000|COMPLETED|Extension Treatment Period||30||
48353554|NCT03368859|101195365|FG001|COMPLETED|Overall Study||0||
48353555|NCT03368859|101195364|FG000|NOT COMPLETED|Overall Study||36||
48762138|NCT04583618|102205944|FG000|Safety Analysis Set (SafAS) Population|Overall Study||151||
48762139|NCT04583618|102205945|FG001|Safety Analysis Set (SafAS) Population|Overall Study||151||
48762140|NCT04583618|102205946|FG002|Safety Analysis Set (SafAS) Population|Overall Study||148||
48762141|NCT04583618|102205947|FG003|Safety Analysis Set (SafAS) Population|Overall Study||149||
48762142|NCT04583618|102205948|FG004|Safety Analysis Set (SafAS) Population|Overall Study||150||
48762143|NCT04583618|102205944|FG000|COMPLETED|Overall Study||148||
48417361|NCT01591044|101356859|FG002|NOT COMPLETED|Overall Study||4||
48417362|NCT02253173|101356860|FG000|STARTED|Overall Study||191||
48762144|NCT04583618|102205945|FG001|COMPLETED|Overall Study||148||
48353556|NCT03368859|101195365|FG001|NOT COMPLETED|Overall Study||34||
48353557|NCT01123889|101195366|FG000|STARTED|Overall Study||5||
48353558|NCT01123889|101195367|FG001|STARTED|Overall Study||7||
48353559|NCT01123889|101195366|FG000|COMPLETED|Overall Study||2||
48353560|NCT01123889|101195367|FG001|COMPLETED|Overall Study||6||
48353561|NCT01123889|101195366|FG000|NOT COMPLETED|Overall Study||3||
48353562|NCT01123889|101195367|FG001|NOT COMPLETED|Overall Study||1||
48353563|NCT03853694|101195368|FG000|STARTED|Overall Study||56||
48353564|NCT03853694|101195369|FG001|STARTED|Overall Study||56||
48353565|NCT03853694|101195370|FG002|STARTED|Overall Study||55||
48353566|NCT03853694|101195368|FG000|COMPLETED|Overall Study||53||
48353567|NCT03853694|101195369|FG001|COMPLETED|Overall Study||47||
48353568|NCT03853694|101195370|FG002|COMPLETED|Overall Study||51||
48353569|NCT03853694|101195368|FG000|NOT COMPLETED|Overall Study||3||
48353570|NCT03853694|101195369|FG001|NOT COMPLETED|Overall Study||9||
48353571|NCT03853694|101195370|FG002|NOT COMPLETED|Overall Study||4||
48353572|NCT05480514|101195371|FG000|STARTED|Period 1||38||
48353573|NCT05480514|101195372|FG001|STARTED|Period 1||39||
48417363|NCT02253173|101356861|FG001|STARTED|Overall Study||191||
48417364|NCT02253173|101356862|FG002|STARTED|Overall Study||190||
48417365|NCT02253173|101356863|FG003|STARTED|Overall Study||192||
48417366|NCT02253173|101356860|FG000|COMPLETED|Overall Study||175||
48417367|NCT02253173|101356861|FG001|COMPLETED|Overall Study||174||
48417368|NCT02253173|101356862|FG002|COMPLETED|Overall Study||177||
48417369|NCT02253173|101356863|FG003|COMPLETED|Overall Study||178||
48417370|NCT02253173|101356860|FG000|NOT COMPLETED|Overall Study||16||
48417371|NCT02253173|101356861|FG001|NOT COMPLETED|Overall Study||17||
48417372|NCT02253173|101356862|FG002|NOT COMPLETED|Overall Study||13||
48417373|NCT02253173|101356863|FG003|NOT COMPLETED|Overall Study||14||
48417374|NCT00554229|101356864|FG000|STARTED|Overall Study||299||
48417375|NCT00554229|101356865|FG001|STARTED|Overall Study||295||
48417376|NCT00554229|101356864|FG000|Patients Who Received Treatment|Overall Study||298||
48417377|NCT00554229|101356865|FG001|Patients Who Received Treatment|Overall Study||295||
48417378|NCT00554229|101356864|FG000|COMPLETED|Overall Study||73||
48417379|NCT00554229|101356865|FG001|COMPLETED|Overall Study||70||
48417380|NCT00554229|101356864|FG000|NOT COMPLETED|Overall Study||226||
48417381|NCT00554229|101356865|FG001|NOT COMPLETED|Overall Study||225||
48417382|NCT01134328|101356866|FG000|STARTED|Overall Study||21||
48417383|NCT01134328|101356867|FG001|STARTED|Overall Study||21||
48417384|NCT01134328|101356868|FG002|STARTED|Overall Study||20||
48417385|NCT01134328|101356869|FG003|STARTED|Overall Study||21||
48762145|NCT04583618|102205946|FG002|COMPLETED|Overall Study||141||
48762146|NCT04583618|102205947|FG003|COMPLETED|Overall Study||147||
48762147|NCT04583618|102205948|FG004|COMPLETED|Overall Study||148||
48762148|NCT04583618|102205944|FG000|NOT COMPLETED|Overall Study||3||
48353574|NCT05480514|101195371|FG000|COMPLETED|Period 1||32||
48353575|NCT05480514|101195372|FG001|COMPLETED|Period 1||30||
48353576|NCT05480514|101195371|FG000|NOT COMPLETED|Period 1||6||
48353577|NCT05480514|101195372|FG001|NOT COMPLETED|Period 1||9||
48353578|NCT05480514|101195371|FG000|STARTED|Period 2||32||
48353579|NCT05480514|101195372|FG001|STARTED|Period 2||30||
48353580|NCT05480514|101195371|FG000|COMPLETED|Period 2||28||
48353581|NCT05480514|101195372|FG001|COMPLETED|Period 2||26||
48353582|NCT05480514|101195371|FG000|NOT COMPLETED|Period 2||4||
48353583|NCT05480514|101195372|FG001|NOT COMPLETED|Period 2||4||
48353584|NCT02835495|101195373|FG000|STARTED|Overall Study||26||
48353585|NCT02835495|101195374|FG001|STARTED|Overall Study||25||
48353586|NCT02835495|101195373|FG000|Intervention Start|Overall Study||25||
48353587|NCT02835495|101195374|FG001|Intervention Start|Overall Study||25||
48353588|NCT02835495|101195373|FG000|COMPLETED|Overall Study||21||
48353589|NCT02835495|101195374|FG001|COMPLETED|Overall Study||23||
48353590|NCT02835495|101195373|FG000|NOT COMPLETED|Overall Study||5||
48353591|NCT02835495|101195374|FG001|NOT COMPLETED|Overall Study||2||
48417386|NCT01134328|101356866|FG000|COMPLETED|Overall Study||19||
48417387|NCT01134328|101356867|FG001|COMPLETED|Overall Study||18||
48762149|NCT04583618|102205945|FG001|NOT COMPLETED|Overall Study||3||
48762150|NCT04583618|102205946|FG002|NOT COMPLETED|Overall Study||8||
48762151|NCT04583618|102205947|FG003|NOT COMPLETED|Overall Study||2||
48762152|NCT04583618|102205948|FG004|NOT COMPLETED|Overall Study||2||
48762153|NCT04272242|102205949|FG000|STARTED|Overall Study||37||
48762154|NCT04272242|102205949|FG000|COMPLETED|Overall Study||32||
48762155|NCT04272242|102205949|FG000|NOT COMPLETED|Overall Study||5||
48762156|NCT01048593|102205950|FG000|STARTED|Overall Study||3||
48762157|NCT01048593|102205951|FG001|STARTED|Overall Study||2||
48762158|NCT01048593|102205952|FG002|STARTED|Overall Study||1||
48762159|NCT01048593|102205950|FG000|COMPLETED|Overall Study||3||
48762160|NCT01048593|102205951|FG001|COMPLETED|Overall Study||2||
48762161|NCT01048593|102205952|FG002|COMPLETED|Overall Study||1||
48762162|NCT01048593|102205950|FG000|NOT COMPLETED|Overall Study||0||
48762163|NCT01048593|102205951|FG001|NOT COMPLETED|Overall Study||0||
48762164|NCT01048593|102205952|FG002|NOT COMPLETED|Overall Study||0||
48353592|NCT02240134|101195375|FG000|STARTED|Overall Study||176||118
48353593|NCT02240134|101195376|FG001|STARTED|Overall Study||176||115
48353594|NCT02240134|101195377|FG002|STARTED|Overall Study||171||114
48353595|NCT02240134|101195375|FG000|COMPLETED|Overall Study||126||81
48353596|NCT02240134|101195376|FG001|COMPLETED|Overall Study||123||79
48353597|NCT02240134|101195377|FG002|COMPLETED|Overall Study||118||78
48353598|NCT02240134|101195375|FG000|NOT COMPLETED|Overall Study||50||37
48353599|NCT02240134|101195376|FG001|NOT COMPLETED|Overall Study||53||36
48353600|NCT02240134|101195377|FG002|NOT COMPLETED|Overall Study||53||36
48353601|NCT03638011|101195378|FG000|STARTED|Overall Study||38||
48353602|NCT03638011|101195379|FG001|STARTED|Overall Study||33||
48353603|NCT03638011|101195378|FG000|COMPLETED|Overall Study||38||
48353604|NCT03638011|101195379|FG001|COMPLETED|Overall Study||33||
48353605|NCT03638011|101195378|FG000|NOT COMPLETED|Overall Study||0||
48353606|NCT03638011|101195379|FG001|NOT COMPLETED|Overall Study||0||
48353607|NCT01739595|101195380|FG000|STARTED|Overall Study||112||
48353608|NCT01739595|101195381|FG001|STARTED|Overall Study||22||
48353609|NCT01739595|101195382|FG002|STARTED|Overall Study||47||
48353610|NCT01739595|101195380|FG000|COMPLETED|Overall Study||99||
48353611|NCT01739595|101195381|FG001|COMPLETED|Overall Study||21||
48353612|NCT01739595|101195382|FG002|COMPLETED|Overall Study||45||
48353613|NCT01739595|101195380|FG000|NOT COMPLETED|Overall Study||13||
48353614|NCT01739595|101195381|FG001|NOT COMPLETED|Overall Study||1||
48353615|NCT01739595|101195382|FG002|NOT COMPLETED|Overall Study||2||
48353616|NCT01071070|101195383|FG000|STARTED|Overall Study||108||
48353617|NCT01071070|101195384|FG001|STARTED|Overall Study||108||
48353618|NCT01071070|101195383|FG000|COMPLETED|Overall Study||104||
48353619|NCT01071070|101195384|FG001|COMPLETED|Overall Study||105||
48353620|NCT01071070|101195383|FG000|NOT COMPLETED|Overall Study||4||
48353621|NCT01071070|101195384|FG001|NOT COMPLETED|Overall Study||3||
48353622|NCT05847881|101195385|FG000|STARTED|Overall Study||23||
48353623|NCT05847881|101195385|FG000|COMPLETED|Overall Study||13||
48353624|NCT05847881|101195385|FG000|NOT COMPLETED|Overall Study||10||
48353625|NCT00391976|101195386|FG000|STARTED|Overall Study||45||
48353626|NCT00391976|101195387|FG001|STARTED|Overall Study||43||
48353627|NCT00391976|101195388|FG002|STARTED|Overall Study||35||
48353628|NCT00391976|101195386|FG000|Randomized|Overall Study||45||
48353629|NCT00391976|101195387|FG001|Randomized|Overall Study||43||
48353630|NCT00391976|101195388|FG002|Randomized|Overall Study||0||
48353631|NCT00391976|101195386|FG000|Safety Population|Overall Study||44||
48353632|NCT00391976|101195387|FG001|Safety Population|Overall Study||43||
48353633|NCT00391976|101195388|FG002|Safety Population|Overall Study||35||
48353634|NCT00391976|101195386|FG000|COMPLETED|Overall Study||18||
48353635|NCT00391976|101195387|FG001|COMPLETED|Overall Study||18||
48353636|NCT00391976|101195388|FG002|COMPLETED|Overall Study||0||
48353637|NCT00391976|101195386|FG000|NOT COMPLETED|Overall Study||27||
48353638|NCT00391976|101195387|FG001|NOT COMPLETED|Overall Study||25||
48353639|NCT00391976|101195388|FG002|NOT COMPLETED|Overall Study||35||
48762165|NCT02208310|102205953|FG000|STARTED|Overall Study||6||
48762166|NCT02208310|102205954|FG001|STARTED|Overall Study||5||
48762167|NCT02208310|102205953|FG000|Day 180|Overall Study||0||
48762168|NCT02208310|102205954|FG001|Day 180|Overall Study||1||
48762169|NCT02208310|102205953|FG000|COMPLETED|Overall Study||0||
48353640|NCT02224664|101195389|FG000|STARTED|Lead-in Period (3 Days)||50||
48353641|NCT02224664|101195390|FG001|STARTED|Lead-in Period (3 Days)||0||
48353642|NCT02224664|101195391|FG002|STARTED|Lead-in Period (3 Days)||0||
48353643|NCT02224664|101195392|FG003|STARTED|Lead-in Period (3 Days)||0||
48353644|NCT02224664|101195393|FG004|STARTED|Lead-in Period (3 Days)||0||
48353645|NCT02224664|101195389|FG000|COMPLETED|Lead-in Period (3 Days)||45||
48353646|NCT02224664|101195390|FG001|COMPLETED|Lead-in Period (3 Days)||0||
48353647|NCT02224664|101195391|FG002|COMPLETED|Lead-in Period (3 Days)||0||
48353648|NCT02224664|101195392|FG003|COMPLETED|Lead-in Period (3 Days)||0||
48353649|NCT02224664|101195393|FG004|COMPLETED|Lead-in Period (3 Days)||0||
48353650|NCT02224664|101195389|FG000|NOT COMPLETED|Lead-in Period (3 Days)||5||
48353651|NCT02224664|101195390|FG001|NOT COMPLETED|Lead-in Period (3 Days)||0||
48762170|NCT02208310|102205954|FG001|COMPLETED|Overall Study||0||
48762171|NCT02208310|102205953|FG000|NOT COMPLETED|Overall Study||6||
48762172|NCT02208310|102205954|FG001|NOT COMPLETED|Overall Study||5||
48762173|NCT04163341|102205955|FG000|STARTED|Overall Study||30||
48762174|NCT04163341|102205956|FG001|STARTED|Overall Study||30||
48353652|NCT02224664|101195391|FG002|NOT COMPLETED|Lead-in Period (3 Days)||0||
48353653|NCT02224664|101195392|FG003|NOT COMPLETED|Lead-in Period (3 Days)||0||
48353654|NCT02224664|101195393|FG004|NOT COMPLETED|Lead-in Period (3 Days)||0||
48353655|NCT02224664|101195389|FG000|STARTED|Dose Escalation Period (21 Days)||0||
48353656|NCT02224664|101195390|FG001|STARTED|Dose Escalation Period (21 Days)||9||
48353657|NCT02224664|101195391|FG002|STARTED|Dose Escalation Period (21 Days)||11||
48353658|NCT02224664|101195392|FG003|STARTED|Dose Escalation Period (21 Days)||6||
48353659|NCT02224664|101195393|FG004|STARTED|Dose Escalation Period (21 Days)||19||
48353660|NCT02224664|101195389|FG000|COMPLETED|Dose Escalation Period (21 Days)||0||
48353661|NCT02224664|101195390|FG001|COMPLETED|Dose Escalation Period (21 Days)||9||
48353662|NCT02224664|101195391|FG002|COMPLETED|Dose Escalation Period (21 Days)||9||
48353663|NCT02224664|101195392|FG003|COMPLETED|Dose Escalation Period (21 Days)||3||
48353664|NCT02224664|101195393|FG004|COMPLETED|Dose Escalation Period (21 Days)||8||
48353665|NCT02224664|101195389|FG000|NOT COMPLETED|Dose Escalation Period (21 Days)||0||
48353666|NCT02224664|101195390|FG001|NOT COMPLETED|Dose Escalation Period (21 Days)||0||
48353667|NCT02224664|101195391|FG002|NOT COMPLETED|Dose Escalation Period (21 Days)||2||
48353668|NCT02224664|101195392|FG003|NOT COMPLETED|Dose Escalation Period (21 Days)||3||
48353669|NCT02224664|101195393|FG004|NOT COMPLETED|Dose Escalation Period (21 Days)||11||
48353670|NCT02389881|101195394|FG000|STARTED|Overall Study||6||
48353671|NCT02389881|101195395|FG001|STARTED|Overall Study||6||
48353672|NCT02389881|101195396|FG002|STARTED|Overall Study||6||
48353673|NCT02389881|101195397|FG003|STARTED|Overall Study||6||
48353674|NCT02389881|101195398|FG004|STARTED|Overall Study||6||
48353675|NCT02389881|101195399|FG005|STARTED|Overall Study||8||
48417388|NCT01134328|101356868|FG002|COMPLETED|Overall Study||17||
48417389|NCT01134328|101356869|FG003|COMPLETED|Overall Study||17||
48417390|NCT01134328|101356866|FG000|NOT COMPLETED|Overall Study||2||
48417391|NCT01134328|101356867|FG001|NOT COMPLETED|Overall Study||3||
48417392|NCT01134328|101356868|FG002|NOT COMPLETED|Overall Study||3||
48417393|NCT01134328|101356869|FG003|NOT COMPLETED|Overall Study||4||
48417394|NCT00679354|101356870|FG000|STARTED|Overall Study||30||
48417395|NCT00679354|101356870|FG000|COMPLETED|Overall Study||0||
48417396|NCT00679354|101356870|FG000|NOT COMPLETED|Overall Study||30||
48417397|NCT02807376|101356871|FG000|STARTED|Overall Study||139||
48417398|NCT02807376|101356872|FG001|STARTED|Overall Study||131||
48417399|NCT02807376|101356871|FG000|COMPLETED|Overall Study||136||
48417400|NCT02807376|101356872|FG001|COMPLETED|Overall Study||130||
48417401|NCT02807376|101356871|FG000|NOT COMPLETED|Overall Study||3||
48417402|NCT02807376|101356872|FG001|NOT COMPLETED|Overall Study||1||
48417403|NCT03452397|101356873|FG000|STARTED|Overall Study||41||
48762175|NCT04163341|102205955|FG000|COMPLETED|Overall Study||25||
48762176|NCT04163341|102205956|FG001|COMPLETED|Overall Study||26||
48762177|NCT04163341|102205955|FG000|NOT COMPLETED|Overall Study||5||
48762178|NCT04163341|102205956|FG001|NOT COMPLETED|Overall Study||4||
48762179|NCT01056822|102205957|FG000|STARTED|Overall Study||47||
48762180|NCT01056822|102205958|FG001|STARTED|Overall Study||42||
48762181|NCT01056822|102205957|FG000|Intention-to-treat (ITT) Population: YES|Overall Study||43||
48762182|NCT01056822|102205958|FG001|Intention-to-treat (ITT) Population: YES|Overall Study||38||
48762183|NCT01056822|102205957|FG000|Intention-to-treat (ITT) Population: NO|Overall Study||4||
48762184|NCT01056822|102205958|FG001|Intention-to-treat (ITT) Population: NO|Overall Study||4||
48762185|NCT01056822|102205957|FG000|Per-protocol (PP) Population: YES|Overall Study||29||
48762186|NCT01056822|102205958|FG001|Per-protocol (PP) Population: YES|Overall Study||25||
48353676|NCT02389881|101195400|FG006|STARTED|Overall Study||2||
48353677|NCT02389881|101195394|FG000|COMPLETED|Overall Study||6||
48353678|NCT02389881|101195395|FG001|COMPLETED|Overall Study||6||
48353679|NCT02389881|101195396|FG002|COMPLETED|Overall Study||6||
48417404|NCT03452397|101356874|FG001|STARTED|Overall Study||41||
48417405|NCT03452397|101356875|FG002|STARTED|Overall Study||41||
48417406|NCT03452397|101356876|FG003|STARTED|Overall Study||42||
48417407|NCT03452397|101356873|FG000|COMPLETED|Overall Study||40||
48417408|NCT03452397|101356874|FG001|COMPLETED|Overall Study||41||
48417409|NCT03452397|101356875|FG002|COMPLETED|Overall Study||39||
48417410|NCT03452397|101356876|FG003|COMPLETED|Overall Study||41||
48417411|NCT03452397|101356873|FG000|NOT COMPLETED|Overall Study||1||
48417412|NCT03452397|101356874|FG001|NOT COMPLETED|Overall Study||0||
48417413|NCT03452397|101356875|FG002|NOT COMPLETED|Overall Study||2||
48417414|NCT03452397|101356876|FG003|NOT COMPLETED|Overall Study||1||
48417415|NCT01148836|101356877|FG000|STARTED|Overall Study||8||
48417416|NCT01148836|101356878|FG001|STARTED|Overall Study||10||
48417417|NCT01148836|101356877|FG000|COMPLETED|Overall Study||7||
48762187|NCT01056822|102205957|FG000|Per-protocol (PP) Population: NO|Overall Study||18||
48762188|NCT01056822|102205958|FG001|Per-protocol (PP) Population: NO|Overall Study||17||
48762189|NCT01056822|102205957|FG000|Safety (SAF) Population: YES|Overall Study||46||
48762190|NCT01056822|102205958|FG001|Safety (SAF) Population: YES|Overall Study||40||
48762191|NCT01056822|102205957|FG000|Safety (SAF) Population: NO|Overall Study||1||
48762192|NCT01056822|102205958|FG001|Safety (SAF) Population: NO|Overall Study||2||
48762193|NCT01056822|102205957|FG000|COMPLETED|Overall Study||39||
48762194|NCT01056822|102205958|FG001|COMPLETED|Overall Study||35||
48762195|NCT01056822|102205957|FG000|NOT COMPLETED|Overall Study||8||
48762196|NCT01056822|102205958|FG001|NOT COMPLETED|Overall Study||7||
48762197|NCT05082857|102205959|FG000|STARTED|Overall Study||6||
48762198|NCT05082857|102205960|FG001|STARTED|Overall Study||9||
48762199|NCT05082857|102205959|FG000|COMPLETED|Overall Study||3||
48762200|NCT05082857|102205960|FG001|COMPLETED|Overall Study||5||
48762201|NCT05082857|102205959|FG000|NOT COMPLETED|Overall Study||3||
48762202|NCT05082857|102205960|FG001|NOT COMPLETED|Overall Study||4||
48762203|NCT04825678|102205961|FG000|STARTED|Overall Study||53||
48762204|NCT04825678|102205962|FG001|STARTED|Overall Study||187||
48762205|NCT04825678|102205961|FG000|Received Investigational Product|Overall Study||52||
48762206|NCT04825678|102205962|FG001|Received Investigational Product|Overall Study||186||
48762207|NCT04825678|102205961|FG000|Received Erenumab QM 70 mg|Overall Study||32|Participants who remained on 70 mg and did not receive any 140 mg dose|
48762208|NCT04825678|102205962|FG001|Received Erenumab QM 70 mg|Overall Study||124|Participants who remained on 70 mg and did not receive any 140 mg dose|
48762209|NCT04825678|102205961|FG000|Received Erenumab QM 140 mg|Overall Study||20|Participants who increased dose to 140 mg|
48762210|NCT04825678|102205962|FG001|Received Erenumab QM 140 mg|Overall Study||62|Participants who increased dose to 140 mg|
48762211|NCT04825678|102205961|FG000|Continued Standard of Care (SoC)|Overall Study||41|Participants who continued SoC migraine prevention therapy throughout the study|
48762212|NCT04825678|102205962|FG001|Continued Standard of Care (SoC)|Overall Study||171|Participants who continued SoC migraine prevention therapy throughout the study|
48762213|NCT04825678|102205961|FG000|Discontinued SoC|Overall Study||12|Participants who discontinued SoC migraine prevention therapy during the study|
48762214|NCT04825678|102205962|FG001|Discontinued SoC|Overall Study||16|Participants who discontinued SoC migraine prevention therapy during the study|
48762215|NCT04825678|102205961|FG000|COMPLETED|Overall Study||40||
48762216|NCT04825678|102205962|FG001|COMPLETED|Overall Study||170||
48762217|NCT04825678|102205961|FG000|NOT COMPLETED|Overall Study||13||
48762218|NCT04825678|102205962|FG001|NOT COMPLETED|Overall Study||17||
48762219|NCT04914364|102205963|FG000|STARTED|Overall Study||28||
48762220|NCT04914364|102205963|FG000|COMPLETED|Overall Study||25||
48762221|NCT04914364|102205963|FG000|NOT COMPLETED|Overall Study||3||
48762222|NCT00399308|102205964|FG000|STARTED|Overall Study||13||
48762223|NCT00399308|102205965|FG001|STARTED|Overall Study||15||
48762224|NCT00399308|102205966|FG002|STARTED|Overall Study||12||
48762225|NCT00399308|102205964|FG000|COMPLETED|Overall Study||13||
48762226|NCT00399308|102205965|FG001|COMPLETED|Overall Study||15||
48762227|NCT00399308|102205966|FG002|COMPLETED|Overall Study||11||
48762228|NCT00399308|102205964|FG000|NOT COMPLETED|Overall Study||0||
48762229|NCT00399308|102205965|FG001|NOT COMPLETED|Overall Study||0||
48762230|NCT00399308|102205966|FG002|NOT COMPLETED|Overall Study||1||
48762231|NCT01074970|102205967|FG000|STARTED|Overall Study||7||
48762232|NCT01074970|102205968|FG001|STARTED|Overall Study||6||
48762233|NCT01074970|102205969|FG002|STARTED|Overall Study||65||
48762234|NCT01074970|102205970|FG003|STARTED|Overall Study||57||
48762235|NCT01074970|102205967|FG000|COMPLETED|Overall Study||3||
48762236|NCT01074970|102205968|FG001|COMPLETED|Overall Study||5||
48762237|NCT01074970|102205969|FG002|COMPLETED|Overall Study||44||
48762238|NCT01074970|102205970|FG003|COMPLETED|Overall Study||40||
48762239|NCT01074970|102205967|FG000|NOT COMPLETED|Overall Study||4||
48762240|NCT01074970|102205968|FG001|NOT COMPLETED|Overall Study||1||
48762241|NCT01074970|102205969|FG002|NOT COMPLETED|Overall Study||21||
48762242|NCT01074970|102205970|FG003|NOT COMPLETED|Overall Study||17||
48762243|NCT04033926|102205971|FG000|STARTED|Treatment Period 1||13||
48762244|NCT04033926|102205972|FG001|STARTED|Treatment Period 1||12||
48762245|NCT04033926|102205971|FG000|COMPLETED|Treatment Period 1||10||
48762246|NCT04033926|102205972|FG001|COMPLETED|Treatment Period 1||12||
48762247|NCT04033926|102205971|FG000|NOT COMPLETED|Treatment Period 1||3||
48762248|NCT04033926|102205972|FG001|NOT COMPLETED|Treatment Period 1||0||
48762249|NCT04033926|102205971|FG000|STARTED|Treatment Period 2||10||
48762250|NCT04033926|102205972|FG001|STARTED|Treatment Period 2||12||
48762251|NCT04033926|102205971|FG000|COMPLETED|Treatment Period 2||8||
48762252|NCT04033926|102205972|FG001|COMPLETED|Treatment Period 2||12||
48762253|NCT04033926|102205971|FG000|NOT COMPLETED|Treatment Period 2||2||
48762254|NCT04033926|102205972|FG001|NOT COMPLETED|Treatment Period 2||0||
48762255|NCT00904969|102205973|FG000|STARTED|Overall Study||50||
48762256|NCT00904969|102205973|FG000|COMPLETED|Overall Study||31||
48762257|NCT00904969|102205973|FG000|NOT COMPLETED|Overall Study||19||
48762258|NCT03913455|102205974|FG000|STARTED|Overall Study||24||
48762259|NCT03913455|102205974|FG000|COMPLETED|Overall Study||24||
48762260|NCT03913455|102205974|FG000|NOT COMPLETED|Overall Study||0||
48186824|NCT03114995|100779912|FG002|STARTED|Overall Study||78||
48762261|NCT02681523|102205975|FG000|STARTED|Overall Study||8||
48186825|NCT03114995|100779910|FG000|COMPLETED|Overall Study||30||
48186826|NCT03114995|100779911|FG001|COMPLETED|Overall Study||30||
48762262|NCT02681523|102205975|FG000|COMPLETED|Overall Study||6||
48762263|NCT02681523|102205975|FG000|NOT COMPLETED|Overall Study||2||
48762264|NCT02422745|102205976|FG000|STARTED|Overall Study||5360||
48762265|NCT02422745|102205977|FG001|STARTED|Overall Study||5359||
48762266|NCT02422745|102205978|FG002|STARTED|Overall Study||5360||
48762267|NCT02422745|102205979|FG003|STARTED|Overall Study||5363||
48762268|NCT02422745|102205976|FG000|COMPLETED|Overall Study||5360||
48762269|NCT02422745|102205977|FG001|COMPLETED|Overall Study||5359||
48762270|NCT02422745|102205978|FG002|COMPLETED|Overall Study||5360||
48762271|NCT02422745|102205979|FG003|COMPLETED|Overall Study||5363||
48762272|NCT02422745|102205976|FG000|NOT COMPLETED|Overall Study||0||
48762273|NCT02422745|102205977|FG001|NOT COMPLETED|Overall Study||0||
48762274|NCT02422745|102205978|FG002|NOT COMPLETED|Overall Study||0||
48762275|NCT02422745|102205979|FG003|NOT COMPLETED|Overall Study||0||
48762276|NCT00907426|102205980|FG000|STARTED|Treatment Period 1 (0 to 6 Months)||215||
48762277|NCT00907426|102205981|FG001|STARTED|Treatment Period 1 (0 to 6 Months)||60||
48762278|NCT00907426|102205982|FG002|STARTED|Treatment Period 1 (0 to 6 Months)||93||
48353680|NCT02389881|101195397|FG003|COMPLETED|Overall Study||6||
48353681|NCT02389881|101195398|FG004|COMPLETED|Overall Study||6||
48353682|NCT02389881|101195399|FG005|COMPLETED|Overall Study||8||
48353683|NCT02389881|101195400|FG006|COMPLETED|Overall Study||2||
48353684|NCT02389881|101195394|FG000|NOT COMPLETED|Overall Study||0||
48353685|NCT02389881|101195395|FG001|NOT COMPLETED|Overall Study||0||
48353686|NCT02389881|101195396|FG002|NOT COMPLETED|Overall Study||0||
48353687|NCT02389881|101195397|FG003|NOT COMPLETED|Overall Study||0||
48353688|NCT02389881|101195398|FG004|NOT COMPLETED|Overall Study||0||
48353689|NCT02389881|101195399|FG005|NOT COMPLETED|Overall Study||0||
48353690|NCT02389881|101195400|FG006|NOT COMPLETED|Overall Study||0||
48353691|NCT03245814|101195401|FG000|STARTED|Overall Study||91||
48353692|NCT03245814|101195402|FG001|STARTED|Overall Study||79||
48353693|NCT03245814|101195401|FG000|Received Allocated Condition|Overall Study||81||
48353694|NCT03245814|101195402|FG001|Received Allocated Condition|Overall Study||75||
48353695|NCT03245814|101195401|FG000|COMPLETED|Overall Study||76||
48353696|NCT03245814|101195402|FG001|COMPLETED|Overall Study||67||
48353697|NCT03245814|101195401|FG000|NOT COMPLETED|Overall Study||15||
48353698|NCT03245814|101195402|FG001|NOT COMPLETED|Overall Study||12||
48353699|NCT00987415|101195403|FG000|STARTED|Overall Study||128||
48353700|NCT00987415|101195404|FG001|STARTED|Overall Study||125||
48353701|NCT00987415|101195403|FG000|COMPLETED|Overall Study||119||
48353702|NCT00987415|101195404|FG001|COMPLETED|Overall Study||116||
48353703|NCT00987415|101195403|FG000|NOT COMPLETED|Overall Study||9||
48353704|NCT00987415|101195404|FG001|NOT COMPLETED|Overall Study||9||
48353705|NCT00524303|101195405|FG000|STARTED|Overall Study||33||
48353706|NCT00524303|101195406|FG001|STARTED|Overall Study||34||
48353707|NCT00524303|101195407|FG002|STARTED|Overall Study||33||
48353708|NCT00524303|101195405|FG000|COMPLETED|Overall Study||21||
48353709|NCT00524303|101195406|FG001|COMPLETED|Overall Study||24||
48353710|NCT00524303|101195407|FG002|COMPLETED|Overall Study||15||
48353711|NCT00524303|101195405|FG000|NOT COMPLETED|Overall Study||12||
48353712|NCT00524303|101195406|FG001|NOT COMPLETED|Overall Study||10||
48353713|NCT00524303|101195407|FG002|NOT COMPLETED|Overall Study||18||
48353714|NCT00594399|101195408|FG000|STARTED|Initial 3 Month Counseling||180||
48353715|NCT00594399|101195409|FG001|STARTED|Initial 3 Month Counseling||122||
48353716|NCT00594399|101195410|FG002|STARTED|Initial 3 Month Counseling||0||
48353717|NCT00594399|101195408|FG000|COMPLETED|Initial 3 Month Counseling||163||
48353718|NCT00594399|101195409|FG001|COMPLETED|Initial 3 Month Counseling||118||
48353719|NCT00594399|101195410|FG002|COMPLETED|Initial 3 Month Counseling||0||
48353720|NCT00594399|101195408|FG000|NOT COMPLETED|Initial 3 Month Counseling||17||
48353721|NCT00594399|101195409|FG001|NOT COMPLETED|Initial 3 Month Counseling||4||
48353722|NCT00594399|101195410|FG002|NOT COMPLETED|Initial 3 Month Counseling||0||
48353723|NCT00594399|101195408|FG000|STARTED|Rerandomization Arm 1 Only||81||
48353724|NCT00594399|101195409|FG001|STARTED|Rerandomization Arm 1 Only||118||
48353725|NCT00594399|101195410|FG002|STARTED|Rerandomization Arm 1 Only||82||
48353726|NCT00594399|101195408|FG000|Rerandomization|Rerandomization Arm 1 Only||81||
48353727|NCT00594399|101195409|FG001|Rerandomization|Rerandomization Arm 1 Only||114||
48353728|NCT00594399|101195410|FG002|Rerandomization|Rerandomization Arm 1 Only||82||
48353729|NCT00594399|101195408|FG000|COMPLETED|Rerandomization Arm 1 Only||79||
48353730|NCT00594399|101195409|FG001|COMPLETED|Rerandomization Arm 1 Only||114||
48417418|NCT01148836|101356878|FG001|COMPLETED|Overall Study||8||
48417419|NCT01148836|101356877|FG000|NOT COMPLETED|Overall Study||1||
48417420|NCT01148836|101356878|FG001|NOT COMPLETED|Overall Study||2||
48762279|NCT00907426|102205980|FG000|COMPLETED|Treatment Period 1 (0 to 6 Months)||195||
48762280|NCT00907426|102205981|FG001|COMPLETED|Treatment Period 1 (0 to 6 Months)||55||
48762281|NCT00907426|102205982|FG002|COMPLETED|Treatment Period 1 (0 to 6 Months)||84||
48762282|NCT00907426|102205980|FG000|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||20||
48762283|NCT00907426|102205981|FG001|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||5||
48762284|NCT00907426|102205982|FG002|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||9||
48762285|NCT00907426|102205980|FG000|STARTED|Treatment Period 2 (6 to 12 Months)||195||
48762286|NCT00907426|102205981|FG001|STARTED|Treatment Period 2 (6 to 12 Months)||55||
48353731|NCT00594399|101195410|FG002|COMPLETED|Rerandomization Arm 1 Only||82||
48353732|NCT00594399|101195408|FG000|NOT COMPLETED|Rerandomization Arm 1 Only||2||
48353733|NCT00594399|101195409|FG001|NOT COMPLETED|Rerandomization Arm 1 Only||4||
48353734|NCT00594399|101195410|FG002|NOT COMPLETED|Rerandomization Arm 1 Only||0||
48353735|NCT02725788|101195411|FG000|STARTED|Overall Study||123||
48353736|NCT02725788|101195412|FG001|STARTED|Overall Study||124||
48353737|NCT02725788|101195411|FG000|COMPLETED|Overall Study||122||
48353738|NCT02725788|101195412|FG001|COMPLETED|Overall Study||122||
48353739|NCT02725788|101195411|FG000|NOT COMPLETED|Overall Study||1||
48417421|NCT03557801|101356879|FG000|STARTED|Overall Study||34||
48762287|NCT00907426|102205982|FG002|STARTED|Treatment Period 2 (6 to 12 Months)||84||
48762288|NCT00907426|102205980|FG000|COMPLETED|Treatment Period 2 (6 to 12 Months)||184||
48762289|NCT00907426|102205981|FG001|COMPLETED|Treatment Period 2 (6 to 12 Months)||52||
48353740|NCT02725788|101195412|FG001|NOT COMPLETED|Overall Study||2||
48353741|NCT01059812|101195413|FG000|STARTED|Overall Study||282||
48353742|NCT01059812|101195414|FG001|STARTED|Overall Study||142||
48353743|NCT01059812|101195413|FG000|Exposed|Overall Study||279||
48353744|NCT01059812|101195414|FG001|Exposed|Overall Study||141||
48353745|NCT01059812|101195413|FG000|COMPLETED|Overall Study||245||
48353746|NCT01059812|101195414|FG001|COMPLETED|Overall Study||126||
48353747|NCT01059812|101195413|FG000|NOT COMPLETED|Overall Study||37||
48353748|NCT01059812|101195414|FG001|NOT COMPLETED|Overall Study||16||
48353749|NCT01328873|101195415|FG000|STARTED|Overall Study||49||
48353750|NCT01328873|101195415|FG000|COMPLETED|Overall Study||49||
48353751|NCT01328873|101195415|FG000|NOT COMPLETED|Overall Study||0||
48353752|NCT03022422|101195416|FG000|STARTED|Overall Study||8||
48353753|NCT03022422|101195417|FG001|STARTED|Overall Study||10||
48353754|NCT03022422|101195418|FG002|STARTED|Overall Study||23||
48353755|NCT03022422|101195419|FG003|STARTED|Overall Study||12||
48353756|NCT03022422|101195420|FG004|STARTED|Overall Study||5||
48353757|NCT03022422|101195421|FG005|STARTED|Overall Study||5||
48353758|NCT03022422|101195416|FG000|COMPLETED|Overall Study||8||
48353759|NCT03022422|101195417|FG001|COMPLETED|Overall Study||10||
48353760|NCT03022422|101195418|FG002|COMPLETED|Overall Study||20||
48353761|NCT03022422|101195419|FG003|COMPLETED|Overall Study||12||
48353762|NCT03022422|101195420|FG004|COMPLETED|Overall Study||5||
48353763|NCT03022422|101195421|FG005|COMPLETED|Overall Study||5||
48353764|NCT03022422|101195416|FG000|NOT COMPLETED|Overall Study||0||
48353765|NCT03022422|101195417|FG001|NOT COMPLETED|Overall Study||0||
48353766|NCT03022422|101195418|FG002|NOT COMPLETED|Overall Study||3||
48353767|NCT03022422|101195419|FG003|NOT COMPLETED|Overall Study||0||
48353768|NCT03022422|101195420|FG004|NOT COMPLETED|Overall Study||0||
48353769|NCT03022422|101195421|FG005|NOT COMPLETED|Overall Study||0||
48353770|NCT01584024|101195422|FG000|STARTED|Overall Study||42||84
48353771|NCT01584024|101195422|FG000|COMPLETED|Overall Study||29||58
48353772|NCT01584024|101195422|FG000|NOT COMPLETED|Overall Study||13||26
48353773|NCT00631319|101195423|FG000|STARTED|Conversion and Titration Phase||343||
48353774|NCT00631319|101195424|FG001|STARTED|Conversion and Titration Phase||0||
48353775|NCT00631319|101195423|FG000|COMPLETED|Conversion and Titration Phase||200||
48353776|NCT00631319|101195424|FG001|COMPLETED|Conversion and Titration Phase||0||
48353777|NCT00631319|101195423|FG000|NOT COMPLETED|Conversion and Titration Phase||143||
48353778|NCT00631319|101195424|FG001|NOT COMPLETED|Conversion and Titration Phase||0||
48353779|NCT00631319|101195423|FG000|STARTED|Double-blind Phase||100|Patients who completed titration and conversion were allowed in the double-blind phase.|
48353780|NCT00631319|101195424|FG001|STARTED|Double-blind Phase||100|Patients who completed titration and conversion were allowed in the double-blind phase.|
48353781|NCT00631319|101195423|FG000|COMPLETED|Double-blind Phase||60||
48353782|NCT00631319|101195424|FG001|COMPLETED|Double-blind Phase||65||
48353783|NCT00631319|101195423|FG000|NOT COMPLETED|Double-blind Phase||40||
48353784|NCT00631319|101195424|FG001|NOT COMPLETED|Double-blind Phase||35||
48353785|NCT01157169|101195425|FG000|STARTED|First Intervention||20||
48353786|NCT01157169|101195426|FG001|STARTED|First Intervention||20||
48353787|NCT01157169|101195425|FG000|COMPLETED|First Intervention||16||
48353788|NCT01157169|101195426|FG001|COMPLETED|First Intervention||18||
48353789|NCT01157169|101195425|FG000|NOT COMPLETED|First Intervention||4||
48353790|NCT01157169|101195426|FG001|NOT COMPLETED|First Intervention||2||
48353791|NCT01157169|101195425|FG000|STARTED|Washout of 10 Days||16||
48353792|NCT01157169|101195426|FG001|STARTED|Washout of 10 Days||18||
48353793|NCT01157169|101195425|FG000|COMPLETED|Washout of 10 Days||16||
48353794|NCT01157169|101195426|FG001|COMPLETED|Washout of 10 Days||18||
48353795|NCT01157169|101195425|FG000|NOT COMPLETED|Washout of 10 Days||0||
48353796|NCT01157169|101195426|FG001|NOT COMPLETED|Washout of 10 Days||0||
48353797|NCT01157169|101195425|FG000|STARTED|Second Intervention||16||
48762290|NCT00907426|102205982|FG002|COMPLETED|Treatment Period 2 (6 to 12 Months)||77||
48762291|NCT00907426|102205980|FG000|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||11||
48762292|NCT00907426|102205981|FG001|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||3||
48762293|NCT00907426|102205982|FG002|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||7||
48762294|NCT05228470|102205983|FG000|STARTED|Overall Study||8||
48762295|NCT05228470|102205984|FG001|STARTED|Overall Study||30||
48353798|NCT01157169|101195426|FG001|STARTED|Second Intervention||18||
48353799|NCT01157169|101195425|FG000|COMPLETED|Second Intervention||16||
48353800|NCT01157169|101195426|FG001|COMPLETED|Second Intervention||17||
48353801|NCT01157169|101195425|FG000|NOT COMPLETED|Second Intervention||0||
48353802|NCT01157169|101195426|FG001|NOT COMPLETED|Second Intervention||1||
48353803|NCT00998738|101195427|FG000|STARTED|Overall Study||1||
48353804|NCT00998738|101195427|FG000|COMPLETED|Overall Study||0||
48353805|NCT00998738|101195427|FG000|NOT COMPLETED|Overall Study||1||
48762296|NCT05228470|102205983|FG000|COMPLETED|Overall Study||0||
48353806|NCT04191668|101195428|FG000|STARTED|Overall Study||106||
48353807|NCT04191668|101195428|FG000|COMPLETED|Overall Study||106||
48353808|NCT04191668|101195428|FG000|NOT COMPLETED|Overall Study||0||
48353809|NCT01444716|101195429|FG000|STARTED|Overall Study||34||
48353810|NCT01444716|101195429|FG000|COMPLETED|Overall Study||34||
48353811|NCT01444716|101195429|FG000|NOT COMPLETED|Overall Study||0||
48353812|NCT03815292|101195430|FG000|STARTED|Overall Study||135||
48353813|NCT03815292|101195431|FG001|STARTED|Overall Study||140||
48353814|NCT03815292|101195430|FG000|COMPLETED|Overall Study||135||
48353815|NCT03815292|101195431|FG001|COMPLETED|Overall Study||140||
48353816|NCT03815292|101195430|FG000|NOT COMPLETED|Overall Study||0||
48353817|NCT03815292|101195431|FG001|NOT COMPLETED|Overall Study||0||
48353818|NCT04802837|101195432|FG000|STARTED|Overall Study||1||
48353819|NCT04802837|101195433|FG001|STARTED|Overall Study||1||
48353820|NCT04802837|101195432|FG000|COMPLETED|Overall Study||1||
48353821|NCT04802837|101195433|FG001|COMPLETED|Overall Study||1||
48353822|NCT04802837|101195432|FG000|NOT COMPLETED|Overall Study||0||
48353823|NCT04802837|101195433|FG001|NOT COMPLETED|Overall Study||0||
48353824|NCT03195140|101195434|FG000|STARTED|Overall Study||52||
48353825|NCT03195140|101195435|FG001|STARTED|Overall Study||51||
48353826|NCT03195140|101195434|FG000|COMPLETED|Overall Study||52||
48353827|NCT03195140|101195435|FG001|COMPLETED|Overall Study||51||
48353828|NCT03195140|101195434|FG000|NOT COMPLETED|Overall Study||0||
48417422|NCT03557801|101356880|FG001|STARTED|Overall Study||33||
48417423|NCT03557801|101356881|FG002|STARTED|Overall Study||33||
48417424|NCT03557801|101356879|FG000|COMPLETED|Overall Study||32||
48417425|NCT03557801|101356880|FG001|COMPLETED|Overall Study||32||
48417426|NCT03557801|101356881|FG002|COMPLETED|Overall Study||30||
48762297|NCT05228470|102205984|FG001|COMPLETED|Overall Study||0||
48762298|NCT05228470|102205983|FG000|NOT COMPLETED|Overall Study||8||
48762299|NCT05228470|102205984|FG001|NOT COMPLETED|Overall Study||30||
48762300|NCT03558737|102205985|FG000|STARTED|Overall Study||2||
48762301|NCT03558737|102205986|FG001|STARTED|Overall Study||2||
48762302|NCT03558737|102205985|FG000|COMPLETED|Overall Study||1||
48762303|NCT03558737|102205986|FG001|COMPLETED|Overall Study||1||
48762304|NCT03558737|102205985|FG000|NOT COMPLETED|Overall Study||1||
48762305|NCT03558737|102205986|FG001|NOT COMPLETED|Overall Study||1||
48762306|NCT02783690|102205987|FG000|STARTED|Overall Study||44||
48762307|NCT02783690|102205988|FG001|STARTED|Overall Study||44||
48762308|NCT02783690|102205987|FG000|COMPLETED|Overall Study||41||
48762309|NCT02783690|102205988|FG001|COMPLETED|Overall Study||41||
48762310|NCT02783690|102205987|FG000|NOT COMPLETED|Overall Study||3||
48762311|NCT02783690|102205988|FG001|NOT COMPLETED|Overall Study||3||
48762312|NCT04876521|102205989|FG000|STARTED|Overall Study||30||
48762313|NCT04876521|102205990|FG001|STARTED|Overall Study||30||
48762314|NCT04876521|102205989|FG000|COMPLETED|Overall Study||25||
48762315|NCT04876521|102205990|FG001|COMPLETED|Overall Study||23||
48762316|NCT04876521|102205989|FG000|NOT COMPLETED|Overall Study||5||
48353829|NCT03195140|101195435|FG001|NOT COMPLETED|Overall Study||0||
48353830|NCT02286960|101195436|FG000|STARTED|Overall Study||19||
48353831|NCT02286960|101195437|FG001|STARTED|Overall Study||17||
48353832|NCT02286960|101195436|FG000|COMPLETED|Overall Study||16||
48353833|NCT02286960|101195437|FG001|COMPLETED|Overall Study||14||
48353834|NCT02286960|101195436|FG000|NOT COMPLETED|Overall Study||3||
48353835|NCT02286960|101195437|FG001|NOT COMPLETED|Overall Study||3||
48353836|NCT01660815|101195438|FG000|STARTED|Overall Study||7||
48353837|NCT01660815|101195438|FG000|COMPLETED|Overall Study||7||
48353838|NCT01660815|101195438|FG000|NOT COMPLETED|Overall Study||0||
48353839|NCT01503021|101195439|FG000|STARTED|Overall Study||360||
48353840|NCT01503021|101195440|FG001|STARTED|Overall Study||358||
48353841|NCT01503021|101195439|FG000|Dosed|Overall Study||351||
48417427|NCT03557801|101356879|FG000|NOT COMPLETED|Overall Study||2||
48417428|NCT03557801|101356880|FG001|NOT COMPLETED|Overall Study||1||
48417429|NCT03557801|101356881|FG002|NOT COMPLETED|Overall Study||3||
48417430|NCT01524900|101356882|FG000|STARTED|Overall Study||49||
48417431|NCT01524900|101356883|FG001|STARTED|Overall Study||246||
48417432|NCT01524900|101356884|FG002|STARTED|Overall Study||30||
48417433|NCT01524900|101356885|FG003|STARTED|Overall Study||22||
48353842|NCT01503021|101195440|FG001|Dosed|Overall Study||352||
48353843|NCT01503021|101195439|FG000|Completed Treatment|Overall Study||333||
48353844|NCT01503021|101195440|FG001|Completed Treatment|Overall Study||333||
48353845|NCT01503021|101195439|FG000|COMPLETED|Overall Study||333||
48353846|NCT01503021|101195440|FG001|COMPLETED|Overall Study||332||
48353847|NCT01503021|101195439|FG000|NOT COMPLETED|Overall Study||27||
48353848|NCT01503021|101195440|FG001|NOT COMPLETED|Overall Study||26||
48353849|NCT00467649|101195441|FG000|STARTED|Phase 1 (Randomized Population)||57||
48353850|NCT00467649|101195442|FG001|STARTED|Phase 1 (Randomized Population)||56||
48353851|NCT00467649|101195443|FG002|STARTED|Phase 1 (Randomized Population)||0||
48353852|NCT00467649|101195444|FG003|STARTED|Phase 1 (Randomized Population)||0||
48353853|NCT00467649|101195445|FG004|STARTED|Phase 1 (Randomized Population)||0||
48353854|NCT00467649|101195446|FG005|STARTED|Phase 1 (Randomized Population)||0||
48353855|NCT00467649|101195441|FG000|Intent to Treat|Phase 1 (Randomized Population)||56||
48368120|NCT03196297|101230110|FG000|COMPLETED|Extension Period||29||
48417434|NCT01524900|101356886|FG004|STARTED|Overall Study||40||
48417435|NCT01524900|101356882|FG000|COMPLETED|Overall Study||43||
48762317|NCT04876521|102205990|FG001|NOT COMPLETED|Overall Study||7||
48762318|NCT00181168|102205991|FG000|STARTED|Overall Study||30||
48762319|NCT00181168|102205992|FG001|STARTED|Overall Study||33||
48762320|NCT00181168|102205991|FG000|COMPLETED|Overall Study||30||
48353856|NCT00467649|101195442|FG001|Intent to Treat|Phase 1 (Randomized Population)||56||
48353857|NCT00467649|101195443|FG002|Intent to Treat|Phase 1 (Randomized Population)||0||
48353858|NCT00467649|101195444|FG003|Intent to Treat|Phase 1 (Randomized Population)||0||
48353859|NCT00467649|101195445|FG004|Intent to Treat|Phase 1 (Randomized Population)||0||
48353860|NCT00467649|101195446|FG005|Intent to Treat|Phase 1 (Randomized Population)||0||
48353861|NCT00467649|101195441|FG000|COMPLETED|Phase 1 (Randomized Population)||48||
48353862|NCT00467649|101195442|FG001|COMPLETED|Phase 1 (Randomized Population)||50||
48353863|NCT00467649|101195443|FG002|COMPLETED|Phase 1 (Randomized Population)||0||
48353864|NCT00467649|101195444|FG003|COMPLETED|Phase 1 (Randomized Population)||0||
48353865|NCT00467649|101195445|FG004|COMPLETED|Phase 1 (Randomized Population)||0||
48353866|NCT00467649|101195446|FG005|COMPLETED|Phase 1 (Randomized Population)||0||
48353867|NCT00467649|101195441|FG000|NOT COMPLETED|Phase 1 (Randomized Population)||9||
48353868|NCT00467649|101195442|FG001|NOT COMPLETED|Phase 1 (Randomized Population)||6||
48353869|NCT00467649|101195443|FG002|NOT COMPLETED|Phase 1 (Randomized Population)||0||
48417436|NCT01524900|101356883|FG001|COMPLETED|Overall Study||232||
48417437|NCT01524900|101356884|FG002|COMPLETED|Overall Study||29||
48417438|NCT01524900|101356885|FG003|COMPLETED|Overall Study||21||
48417439|NCT01524900|101356886|FG004|COMPLETED|Overall Study||40||
48417440|NCT01524900|101356882|FG000|NOT COMPLETED|Overall Study||6||
48417441|NCT01524900|101356883|FG001|NOT COMPLETED|Overall Study||14||
48353870|NCT00467649|101195444|FG003|NOT COMPLETED|Phase 1 (Randomized Population)||0||
48353871|NCT00467649|101195445|FG004|NOT COMPLETED|Phase 1 (Randomized Population)||0||
48353872|NCT00467649|101195446|FG005|NOT COMPLETED|Phase 1 (Randomized Population)||0||
48353873|NCT00467649|101195441|FG000|STARTED|Phase 2 (Intent-to-Treat Population)||0||
48353874|NCT00467649|101195442|FG001|STARTED|Phase 2 (Intent-to-Treat Population)||0||
48353875|NCT00467649|101195443|FG002|STARTED|Phase 2 (Intent-to-Treat Population)||17||
48353876|NCT00467649|101195444|FG003|STARTED|Phase 2 (Intent-to-Treat Population)||31||
48353877|NCT00467649|101195445|FG004|STARTED|Phase 2 (Intent-to-Treat Population)||14||
48353878|NCT00467649|101195446|FG005|STARTED|Phase 2 (Intent-to-Treat Population)||36||
48353879|NCT00467649|101195441|FG000|COMPLETED|Phase 2 (Intent-to-Treat Population)||0||
48353880|NCT00467649|101195442|FG001|COMPLETED|Phase 2 (Intent-to-Treat Population)||0||
48353881|NCT00467649|101195443|FG002|COMPLETED|Phase 2 (Intent-to-Treat Population)||17||
48353882|NCT00467649|101195444|FG003|COMPLETED|Phase 2 (Intent-to-Treat Population)||29||
48353883|NCT00467649|101195445|FG004|COMPLETED|Phase 2 (Intent-to-Treat Population)||14||
48353884|NCT00467649|101195446|FG005|COMPLETED|Phase 2 (Intent-to-Treat Population)||35||
48353885|NCT00467649|101195441|FG000|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0||
48353886|NCT00467649|101195442|FG001|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0||
48353887|NCT00467649|101195443|FG002|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0||
48353888|NCT00467649|101195444|FG003|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||2||
48353889|NCT00467649|101195445|FG004|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0||
48353890|NCT00467649|101195446|FG005|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||1||
48353891|NCT00942409|101195447|FG000|STARTED|Overall Study||5||
48353892|NCT00942409|101195447|FG000|COMPLETED|Overall Study||2||
48417442|NCT01524900|101356884|FG002|NOT COMPLETED|Overall Study||1||
48417443|NCT01524900|101356885|FG003|NOT COMPLETED|Overall Study||1||
48417444|NCT01524900|101356886|FG004|NOT COMPLETED|Overall Study||0||
48417445|NCT02334813|101356887|FG000|STARTED|Overall Study||12||
48353893|NCT00942409|101195447|FG000|NOT COMPLETED|Overall Study||3||
48353894|NCT02111811|101195448|FG000|STARTED|Treatment Phase||139||
48353895|NCT02111811|101195449|FG001|STARTED|Treatment Phase||114||
48353896|NCT02111811|101195448|FG000|COMPLETED|Treatment Phase||115||
48353897|NCT02111811|101195449|FG001|COMPLETED|Treatment Phase||96||
48353898|NCT02111811|101195448|FG000|NOT COMPLETED|Treatment Phase||24||
48353899|NCT02111811|101195449|FG001|NOT COMPLETED|Treatment Phase||18||
48353900|NCT02111811|101195448|FG000|STARTED|Follow up Period (Aim 2)||139||
48353901|NCT02111811|101195449|FG001|STARTED|Follow up Period (Aim 2)||114||
48353902|NCT02111811|101195448|FG000|COMPLETED|Follow up Period (Aim 2)||111||
48353903|NCT02111811|101195449|FG001|COMPLETED|Follow up Period (Aim 2)||97||
48353904|NCT02111811|101195448|FG000|NOT COMPLETED|Follow up Period (Aim 2)||28||
48353905|NCT02111811|101195449|FG001|NOT COMPLETED|Follow up Period (Aim 2)||17||
48353906|NCT03026803|101195450|FG000|STARTED|Overall Study||4||
48353907|NCT03026803|101195450|FG000|COMPLETED|Overall Study||4||
48353908|NCT03026803|101195450|FG000|NOT COMPLETED|Overall Study||0||
48353909|NCT03590457|101195451|FG000|STARTED|Overall Study||18||
48353910|NCT03590457|101195451|FG000|COMPLETED|Overall Study||18||
48353911|NCT03590457|101195451|FG000|NOT COMPLETED|Overall Study||0||
48353912|NCT03114969|101195452|FG000|STARTED|Overall Study||50||
48353913|NCT03114969|101195453|FG001|STARTED|Overall Study||50||
48353914|NCT03114969|101195454|FG002|STARTED|Overall Study||50||
48353915|NCT03114969|101195455|FG003|STARTED|Overall Study||50||
48353916|NCT03114969|101195456|FG004|STARTED|Overall Study||51||
48353917|NCT03114969|101195457|FG005|STARTED|Overall Study||49||
48353918|NCT03114969|101195458|FG006|STARTED|Overall Study||50||
48353919|NCT03114969|101195459|FG007|STARTED|Overall Study||50||
48353920|NCT03114969|101195460|FG008|STARTED|Overall Study||50||
48353921|NCT03114969|101195452|FG000|COMPLETED|Overall Study||50||
48353922|NCT03114969|101195453|FG001|COMPLETED|Overall Study||50||
48353923|NCT03114969|101195454|FG002|COMPLETED|Overall Study||46||
48353924|NCT03114969|101195455|FG003|COMPLETED|Overall Study||48||
48353925|NCT03114969|101195456|FG004|COMPLETED|Overall Study||51||
48353926|NCT03114969|101195457|FG005|COMPLETED|Overall Study||48||
48353927|NCT03114969|101195458|FG006|COMPLETED|Overall Study||49||
48353928|NCT03114969|101195459|FG007|COMPLETED|Overall Study||50||
48353929|NCT03114969|101195460|FG008|COMPLETED|Overall Study||48||
48353930|NCT03114969|101195452|FG000|NOT COMPLETED|Overall Study||0||
48353931|NCT03114969|101195453|FG001|NOT COMPLETED|Overall Study||0||
48353932|NCT03114969|101195454|FG002|NOT COMPLETED|Overall Study||4||
48353933|NCT03114969|101195455|FG003|NOT COMPLETED|Overall Study||2||
48353934|NCT03114969|101195456|FG004|NOT COMPLETED|Overall Study||0||
48353935|NCT03114969|101195457|FG005|NOT COMPLETED|Overall Study||1||
48353936|NCT03114969|101195458|FG006|NOT COMPLETED|Overall Study||1||
48353937|NCT03114969|101195459|FG007|NOT COMPLETED|Overall Study||0||
48353938|NCT03114969|101195460|FG008|NOT COMPLETED|Overall Study||2||
48353939|NCT05483127|101195461|FG000|STARTED|First Wear Period, 8 (-0/+3) Days||77||
48353940|NCT05483127|101195462|FG001|STARTED|First Wear Period, 8 (-0/+3) Days||75||
48353941|NCT05483127|101195461|FG000|COMPLETED|First Wear Period, 8 (-0/+3) Days||77||
48353942|NCT05483127|101195462|FG001|COMPLETED|First Wear Period, 8 (-0/+3) Days||75||
48353943|NCT05483127|101195461|FG000|NOT COMPLETED|First Wear Period, 8 (-0/+3) Days||0||
48353944|NCT05483127|101195462|FG001|NOT COMPLETED|First Wear Period, 8 (-0/+3) Days||0||
48353945|NCT05483127|101195461|FG000|STARTED|Second Wear Period, 8 (-0/+3) Days||76|One participant discontinued between First Wear Period and Second Wear Period due to an adverse event.|
48353946|NCT05483127|101195462|FG001|STARTED|Second Wear Period, 8 (-0/+3) Days||75|One participant discontinued between First Wear Period and Second Wear Period due to an adverse event.|
48353947|NCT05483127|101195461|FG000|COMPLETED|Second Wear Period, 8 (-0/+3) Days||76||
48353948|NCT05483127|101195462|FG001|COMPLETED|Second Wear Period, 8 (-0/+3) Days||75||
48353949|NCT05483127|101195461|FG000|NOT COMPLETED|Second Wear Period, 8 (-0/+3) Days||0||
48353950|NCT05483127|101195462|FG001|NOT COMPLETED|Second Wear Period, 8 (-0/+3) Days||0||
48353951|NCT03215277|101195463|FG000|STARTED|Overall Study||25||
48353952|NCT03215277|101195464|FG001|STARTED|Overall Study||51||
48353953|NCT03215277|101195463|FG000|COMPLETED|Overall Study||22||
48353954|NCT03215277|101195464|FG001|COMPLETED|Overall Study||46||
48353955|NCT03215277|101195463|FG000|NOT COMPLETED|Overall Study||3||
48353956|NCT03215277|101195464|FG001|NOT COMPLETED|Overall Study||5||
48417446|NCT02334813|101356888|FG001|STARTED|Overall Study||14||
48417447|NCT02334813|101356887|FG000|COMPLETED|Overall Study||9||
48417448|NCT02334813|101356888|FG001|COMPLETED|Overall Study||13||
48417449|NCT02334813|101356887|FG000|NOT COMPLETED|Overall Study||3||
48417450|NCT02334813|101356888|FG001|NOT COMPLETED|Overall Study||1||
48417451|NCT01365468|101356889|FG000|STARTED|Overall Study||4||
48417452|NCT01365468|101356890|FG001|STARTED|Overall Study||5||
48417453|NCT01365468|101356889|FG000|COMPLETED|Overall Study||0||
48638357|NCT00576758|101898737|FG001|COMPLETED|Extension Treatment Period||30||
48638358|NCT00576758|101898736|FG000|NOT COMPLETED|Extension Treatment Period||42||
48657031|NCT02018809|101943754|FG001|COMPLETED|Overall Study||50||
48353957|NCT00046566|101195465|FG000|STARTED|Intervention 1 (8 Weeks)||117||
48353958|NCT00046566|101195466|FG001|STARTED|Intervention 1 (8 Weeks)||117||
48353959|NCT00046566|101195467|FG002|STARTED|Intervention 1 (8 Weeks)||118||
48353960|NCT00046566|101195465|FG000|COMPLETED|Intervention 1 (8 Weeks)||101||
48353961|NCT00046566|101195466|FG001|COMPLETED|Intervention 1 (8 Weeks)||104||
48353962|NCT00046566|101195467|FG002|COMPLETED|Intervention 1 (8 Weeks)||101||
48353963|NCT00046566|101195465|FG000|NOT COMPLETED|Intervention 1 (8 Weeks)||16||
48353964|NCT00046566|101195466|FG001|NOT COMPLETED|Intervention 1 (8 Weeks)||13||
48353965|NCT00046566|101195467|FG002|NOT COMPLETED|Intervention 1 (8 Weeks)||17||
48353966|NCT00046566|101195465|FG000|STARTED|Intervention 2 (8 Weeks)||101||
48353967|NCT00046566|101195466|FG001|STARTED|Intervention 2 (8 Weeks)||104||
48353968|NCT00046566|101195467|FG002|STARTED|Intervention 2 (8 Weeks)||101||
48353969|NCT00046566|101195465|FG000|COMPLETED|Intervention 2 (8 Weeks)||93||
48353970|NCT00046566|101195466|FG001|COMPLETED|Intervention 2 (8 Weeks)||92||
48353971|NCT00046566|101195467|FG002|COMPLETED|Intervention 2 (8 Weeks)||88||
48353972|NCT00046566|101195465|FG000|NOT COMPLETED|Intervention 2 (8 Weeks)||8||
48353973|NCT00046566|101195466|FG001|NOT COMPLETED|Intervention 2 (8 Weeks)||12||
48353974|NCT00046566|101195467|FG002|NOT COMPLETED|Intervention 2 (8 Weeks)||13||
48353975|NCT00046566|101195465|FG000|STARTED|Intervention 3 (8 Weeks)||93||
48353976|NCT00046566|101195466|FG001|STARTED|Intervention 3 (8 Weeks)||92||
48353977|NCT00046566|101195467|FG002|STARTED|Intervention 3 (8 Weeks)||88||
48353978|NCT00046566|101195465|FG000|COMPLETED|Intervention 3 (8 Weeks)||93||
48353979|NCT00046566|101195466|FG001|COMPLETED|Intervention 3 (8 Weeks)||92||
48417454|NCT01365468|101356890|FG001|COMPLETED|Overall Study||5||
48417455|NCT01365468|101356889|FG000|NOT COMPLETED|Overall Study||4||
48417456|NCT01365468|101356890|FG001|NOT COMPLETED|Overall Study||0||
48417457|NCT00758420|101356891|FG000|STARTED|Overall Study||39||
48353980|NCT00046566|101195467|FG002|COMPLETED|Intervention 3 (8 Weeks)||88||
48353981|NCT00046566|101195465|FG000|NOT COMPLETED|Intervention 3 (8 Weeks)||0||
48353982|NCT00046566|101195466|FG001|NOT COMPLETED|Intervention 3 (8 Weeks)||0||
48417458|NCT00758420|101356892|FG001|STARTED|Overall Study||38||
48417459|NCT00758420|101356891|FG000|COMPLETED|Overall Study||39||
48417460|NCT00758420|101356892|FG001|COMPLETED|Overall Study||38||
48353983|NCT00046566|101195467|FG002|NOT COMPLETED|Intervention 3 (8 Weeks)||0||
48353984|NCT00833859|101195468|FG000|STARTED|Overall Study||2||
48353985|NCT00833859|101195468|FG000|COMPLETED|Overall Study||2||
48353986|NCT00833859|101195468|FG000|NOT COMPLETED|Overall Study||0||
48353987|NCT03401749|101195469|FG000|STARTED|Overall Study||59||
48353988|NCT03401749|101195470|FG001|STARTED|Overall Study||67||
48353989|NCT03401749|101195471|FG002|STARTED|Overall Study||77||
48353990|NCT03401749|101195469|FG000|COMPLETED|Overall Study||39|"Completion was determined as patients who completed the 2 week, 6 week, and 3 month postoperative surgical site questionnaire. If patients did not complete all 3 post operative questionnaires, they were marked as lost to follow up. This does not suggest any adverse event occurred, simply that patients stopped coming to their postoperative clinical visits."|
48353991|NCT03401749|101195470|FG001|COMPLETED|Overall Study||51|"Completion was determined as patients who completed the 2 week, 6 week, and 3 month postoperative surgical site questionnaire. If patients did not complete all 3 post operative questionnaires, they were marked as lost to follow up. This does not suggest any adverse event occurred, simply that patients stopped coming to their postoperative clinical visits."|
48353992|NCT03401749|101195471|FG002|COMPLETED|Overall Study||51|"Completion was determined as patients who completed the 2 week, 6 week, and 3 month postoperative surgical site questionnaire. If patients did not complete all 3 post operative questionnaires, they were marked as lost to follow up. This does not suggest any adverse event occurred, simply that patients stopped coming to their postoperative clinical visits."|
48353993|NCT03401749|101195469|FG000|NOT COMPLETED|Overall Study||20||
48353994|NCT03401749|101195470|FG001|NOT COMPLETED|Overall Study||16||
48353995|NCT03401749|101195471|FG002|NOT COMPLETED|Overall Study||26||
48353996|NCT01273818|101195472|FG000|STARTED|Overall Study||100||
48353997|NCT01273818|101195473|FG001|STARTED|Overall Study||100||
48353998|NCT01273818|101195474|FG002|STARTED|Overall Study||100||
48353999|NCT01273818|101195472|FG000|COMPLETED|Overall Study||87||
48354000|NCT01273818|101195473|FG001|COMPLETED|Overall Study||98||
48354001|NCT01273818|101195474|FG002|COMPLETED|Overall Study||91||
48354002|NCT01273818|101195472|FG000|NOT COMPLETED|Overall Study||13||
48354003|NCT01273818|101195473|FG001|NOT COMPLETED|Overall Study||2||
48354004|NCT01273818|101195474|FG002|NOT COMPLETED|Overall Study||9||
48354005|NCT04207710|101195475|FG000|STARTED|Overall Study||72||288
48354006|NCT04207710|101195475|FG000|Left Wrist: ChloraPrep, Then Gebauer's Ethyl Chloride|Overall Study||72||72
48354007|NCT04207710|101195475|FG000|Right Wrist: ChloraPrep, Then Gebauer's Pain Ease|Overall Study||72||72
48354008|NCT04207710|101195475|FG000|Low Back: ChloraPrep, Then Gebauer's Ethyl Chloride|Overall Study||72||72
48354009|NCT04207710|101195475|FG000|Low Back: ChloraPrep, Then Gebauer's Pain Ease|Overall Study||72||72
48354010|NCT04207710|101195475|FG000|COMPLETED|Overall Study||72||288
48354011|NCT04207710|101195475|FG000|NOT COMPLETED|Overall Study||0||0
48354012|NCT04840667|101195476|FG000|STARTED|Overall Study||17||
48354013|NCT04840667|101195476|FG000|Treated|Overall Study||0||
48354014|NCT04840667|101195476|FG000|COMPLETED|Overall Study||0||
48354015|NCT04840667|101195476|FG000|NOT COMPLETED|Overall Study||17||
48354016|NCT03015532|101195477|FG000|STARTED|Overall Study||20||
48354017|NCT03015532|101195478|FG001|STARTED|Overall Study||22||
48354018|NCT03015532|101195479|FG002|STARTED|Overall Study||11||
48354019|NCT03015532|101195480|FG003|STARTED|Overall Study||10||
48354020|NCT03015532|101195481|FG004|STARTED|Overall Study||58||
48417461|NCT00758420|101356891|FG000|NOT COMPLETED|Overall Study||0||
48417462|NCT00758420|101356892|FG001|NOT COMPLETED|Overall Study||0||
48417463|NCT00307736|101356893|FG000|STARTED|Overall Study||3||
48417464|NCT00307736|101356894|FG001|STARTED|Overall Study||3||
48417465|NCT00307736|101356895|FG002|STARTED|Overall Study||3||
48417466|NCT00307736|101356896|FG003|STARTED|Overall Study||23||
48417467|NCT00307736|101356893|FG000|COMPLETED|Overall Study||3||
48417468|NCT00307736|101356894|FG001|COMPLETED|Overall Study||3||
48417469|NCT00307736|101356895|FG002|COMPLETED|Overall Study||0||
48417470|NCT00307736|101356896|FG003|COMPLETED|Overall Study||20||
48417471|NCT00307736|101356893|FG000|NOT COMPLETED|Overall Study||0||
48354021|NCT03015532|101195482|FG005|STARTED|Overall Study||56||
48354022|NCT03015532|101195483|FG006|STARTED|Overall Study||53||
48354023|NCT03015532|101195484|FG007|STARTED|Overall Study||55||
48354024|NCT03015532|101195477|FG000|COMPLETED|Overall Study||20||
48354025|NCT03015532|101195478|FG001|COMPLETED|Overall Study||22||
48354026|NCT03015532|101195479|FG002|COMPLETED|Overall Study||11||
48354027|NCT03015532|101195480|FG003|COMPLETED|Overall Study||10||
48354028|NCT03015532|101195481|FG004|COMPLETED|Overall Study||58||
48354029|NCT03015532|101195482|FG005|COMPLETED|Overall Study||54||
48354030|NCT03015532|101195483|FG006|COMPLETED|Overall Study||51||
48354031|NCT03015532|101195484|FG007|COMPLETED|Overall Study||55||
48354032|NCT03015532|101195477|FG000|NOT COMPLETED|Overall Study||0||
48354033|NCT03015532|101195478|FG001|NOT COMPLETED|Overall Study||0||
48354034|NCT03015532|101195479|FG002|NOT COMPLETED|Overall Study||0||
48417472|NCT00307736|101356894|FG001|NOT COMPLETED|Overall Study||0||
48417473|NCT00307736|101356895|FG002|NOT COMPLETED|Overall Study||3||
48417474|NCT00307736|101356896|FG003|NOT COMPLETED|Overall Study||3||
48417475|NCT00554840|101356897|FG000|STARTED|Overall Study||4||
48417476|NCT00554840|101356898|FG001|STARTED|Overall Study||5||
48417477|NCT00554840|101356897|FG000|COMPLETED|Overall Study||4||
48417478|NCT00554840|101356898|FG001|COMPLETED|Overall Study||4||
48417479|NCT00554840|101356897|FG000|NOT COMPLETED|Overall Study||0||
48638359|NCT00576758|101898737|FG001|NOT COMPLETED|Extension Treatment Period||43||
48354035|NCT03015532|101195480|FG003|NOT COMPLETED|Overall Study||0||
48354036|NCT03015532|101195481|FG004|NOT COMPLETED|Overall Study||0||
48354037|NCT03015532|101195482|FG005|NOT COMPLETED|Overall Study||2||
48354038|NCT03015532|101195483|FG006|NOT COMPLETED|Overall Study||2||
48354039|NCT03015532|101195484|FG007|NOT COMPLETED|Overall Study||0||
48354040|NCT02724033|101195485|FG000|STARTED|Overall Study||11||
48354041|NCT02724033|101195486|FG001|STARTED|Overall Study||14||
48354042|NCT02724033|101195487|FG002|STARTED|Overall Study||12||
48354043|NCT02724033|101195485|FG000|COMPLETED|Overall Study||11||
48354044|NCT02724033|101195486|FG001|COMPLETED|Overall Study||14||
48354045|NCT02724033|101195487|FG002|COMPLETED|Overall Study||12||
48354046|NCT02724033|101195485|FG000|NOT COMPLETED|Overall Study||0||
48354047|NCT02724033|101195486|FG001|NOT COMPLETED|Overall Study||0||
48762321|NCT00181168|102205992|FG001|COMPLETED|Overall Study||33||
48762322|NCT00181168|102205991|FG000|NOT COMPLETED|Overall Study||0||
48762323|NCT00181168|102205992|FG001|NOT COMPLETED|Overall Study||0||
48417480|NCT00554840|101356898|FG001|NOT COMPLETED|Overall Study||1||
48417481|NCT03137433|101356899|FG000|STARTED|Overall Study||63||
48417482|NCT03137433|101356900|FG001|STARTED|Overall Study||63||
48417483|NCT03137433|101356899|FG000|COMPLETED|Overall Study||44||
48417484|NCT03137433|101356900|FG001|COMPLETED|Overall Study||45||
48417485|NCT03137433|101356899|FG000|NOT COMPLETED|Overall Study||19||
48417486|NCT03137433|101356900|FG001|NOT COMPLETED|Overall Study||18||
48417487|NCT01738672|101356901|FG000|STARTED|Overall Study||16||
48762324|NCT03988400|102205993|FG000|STARTED|Overall Study||22||
48762325|NCT03988400|102205994|FG001|STARTED|Overall Study||22||
48762326|NCT03988400|102205993|FG000|COMPLETED|Overall Study||20||
48762327|NCT03988400|102205994|FG001|COMPLETED|Overall Study||21||
48762328|NCT03988400|102205993|FG000|NOT COMPLETED|Overall Study||2||
48762329|NCT03988400|102205994|FG001|NOT COMPLETED|Overall Study||1||
48762330|NCT04179500|102205995|FG000|STARTED|Treatment||26||
48762331|NCT04179500|102205995|FG000|COMPLETED|Treatment||22||
48762332|NCT04179500|102205995|FG000|NOT COMPLETED|Treatment||4||
48762333|NCT04179500|102205995|FG000|STARTED|Follow-up||22||
48762334|NCT04179500|102205995|FG000|COMPLETED|Follow-up||18||
48762335|NCT04179500|102205995|FG000|NOT COMPLETED|Follow-up||4||
48762336|NCT04109547|102205996|FG000|STARTED|Overall Study||130||
48762337|NCT04109547|102205997|FG001|STARTED|Overall Study||130||
48762338|NCT04109547|102205998|FG002|STARTED|Overall Study||130||
48762339|NCT04109547|102205999|FG003|STARTED|Overall Study||131||
48762340|NCT04109547|102205996|FG000|Treated|Overall Study||130||
48762341|NCT04109547|102205997|FG001|Treated|Overall Study||130||
48762342|NCT04109547|102205998|FG002|Treated|Overall Study||129||
48762343|NCT04109547|102205999|FG003|Treated|Overall Study||131||
48762344|NCT04109547|102205996|FG000|Full Analysis Set|Overall Study||130||
48762345|NCT04109547|102205997|FG001|Full Analysis Set|Overall Study||130||
48762346|NCT04109547|102205998|FG002|Full Analysis Set|Overall Study||130||
48762347|NCT04109547|102205999|FG003|Full Analysis Set|Overall Study||131||
48354048|NCT02724033|101195487|FG002|NOT COMPLETED|Overall Study||0||
48354049|NCT05309083|101195488|FG000|STARTED|Overall Study||9||
48354050|NCT05309083|101195488|FG000|COMPLETED|Overall Study||7||
48354051|NCT05309083|101195488|FG000|NOT COMPLETED|Overall Study||2||
48354052|NCT02863263|101195489|FG000|STARTED|Overall Study||3||
48354053|NCT02863263|101195490|FG001|STARTED|Overall Study||2||
48762348|NCT04109547|102205996|FG000|Safety Analysis Set|Overall Study||130||
48762349|NCT04109547|102205997|FG001|Safety Analysis Set|Overall Study||130||
48762350|NCT04109547|102205998|FG002|Safety Analysis Set|Overall Study||129||
48762351|NCT04109547|102205999|FG003|Safety Analysis Set|Overall Study||131||
48762352|NCT04109547|102205996|FG000|COMPLETED|Overall Study||126||
48762353|NCT04109547|102205997|FG001|COMPLETED|Overall Study||126||
48762354|NCT04109547|102205998|FG002|COMPLETED|Overall Study||124||
48762355|NCT04109547|102205999|FG003|COMPLETED|Overall Study||124||
48762356|NCT04109547|102205996|FG000|NOT COMPLETED|Overall Study||4||
48762357|NCT04109547|102205997|FG001|NOT COMPLETED|Overall Study||4||
48354054|NCT02863263|101195489|FG000|COMPLETED|Overall Study||2||
48417488|NCT01738672|101356901|FG000|COMPLETED|Overall Study||11||
48417489|NCT01738672|101356901|FG000|NOT COMPLETED|Overall Study||5||
48417490|NCT01432236|101356902|FG000|STARTED|Overall Study||96||
48417491|NCT01432236|101356903|FG001|STARTED|Overall Study||97||
48417492|NCT01432236|101356902|FG000|COMPLETED|Overall Study||70||
48417493|NCT01432236|101356903|FG001|COMPLETED|Overall Study||79||
48417494|NCT01432236|101356902|FG000|NOT COMPLETED|Overall Study||26||
48417495|NCT01432236|101356903|FG001|NOT COMPLETED|Overall Study||18||
48354055|NCT02863263|101195490|FG001|COMPLETED|Overall Study||1||
48354056|NCT02863263|101195489|FG000|NOT COMPLETED|Overall Study||1||
48354057|NCT02863263|101195490|FG001|NOT COMPLETED|Overall Study||1||
48354058|NCT01440101|101195491|FG000|STARTED|Overall Study||12||
48762358|NCT04109547|102205998|FG002|NOT COMPLETED|Overall Study||6||
48762359|NCT04109547|102205999|FG003|NOT COMPLETED|Overall Study||7||
48762360|NCT02415608|102206000|FG000|STARTED|Overall Study||3||
48354059|NCT01440101|101195492|FG001|STARTED|Overall Study||47||
48417496|NCT02054572|101356904|FG000|STARTED|Overall Study||6||
48417497|NCT02054572|101356904|FG000|COMPLETED|Overall Study||6||
48417498|NCT02054572|101356904|FG000|NOT COMPLETED|Overall Study||0||
48762361|NCT02415608|102206001|FG001|STARTED|Overall Study||1||
48762362|NCT02415608|102206000|FG000|COMPLETED|Overall Study||3||
48417499|NCT01930487|101356905|FG000|STARTED|First Intervention (30 Days)||21||
48417500|NCT01930487|101356906|FG001|STARTED|First Intervention (30 Days)||25||
48762363|NCT02415608|102206001|FG001|COMPLETED|Overall Study||1||
48762364|NCT02415608|102206000|FG000|NOT COMPLETED|Overall Study||0||
48354060|NCT01440101|101195493|FG002|STARTED|Overall Study||47||
48354061|NCT01440101|101195491|FG000|COMPLETED|Overall Study||10||
48354062|NCT01440101|101195492|FG001|COMPLETED|Overall Study||43||
48354063|NCT01440101|101195493|FG002|COMPLETED|Overall Study||46||
48354064|NCT01440101|101195491|FG000|NOT COMPLETED|Overall Study||2||
48354065|NCT01440101|101195492|FG001|NOT COMPLETED|Overall Study||4||
48354066|NCT01440101|101195493|FG002|NOT COMPLETED|Overall Study||1||
48354067|NCT00142506|101195494|FG000|STARTED|Overall Study||184||
48354068|NCT00142506|101195495|FG001|STARTED|Overall Study||106||
48354069|NCT00142506|101195494|FG000|COMPLETED|Overall Study||112||
48354070|NCT00142506|101195495|FG001|COMPLETED|Overall Study||77||
48354071|NCT00142506|101195494|FG000|NOT COMPLETED|Overall Study||72||
48354072|NCT00142506|101195495|FG001|NOT COMPLETED|Overall Study||29||
48354073|NCT01697345|101195496|FG000|STARTED|Overall Study||13||
48354074|NCT01697345|101195496|FG000|COMPLETED|Overall Study||12||
48354075|NCT01697345|101195496|FG000|NOT COMPLETED|Overall Study||1||
48354076|NCT02371629|101195497|FG000|STARTED|Overall Study||388||
48354077|NCT02371629|101195498|FG001|STARTED|Overall Study||388||
48354078|NCT02371629|101195497|FG000|COMPLETED|Overall Study||362||
48354079|NCT02371629|101195498|FG001|COMPLETED|Overall Study||363||
48354080|NCT02371629|101195497|FG000|NOT COMPLETED|Overall Study||26||
48354081|NCT02371629|101195498|FG001|NOT COMPLETED|Overall Study||25||
48354082|NCT00499915|101195499|FG000|STARTED|Overall Study||83||
48354083|NCT00499915|101195500|FG001|STARTED|Overall Study||82||
48354084|NCT00499915|101195499|FG000|COMPLETED|Overall Study||68||
48354085|NCT00499915|101195500|FG001|COMPLETED|Overall Study||76||
48354086|NCT00499915|101195499|FG000|NOT COMPLETED|Overall Study||15||
48354087|NCT00499915|101195500|FG001|NOT COMPLETED|Overall Study||6||
48354088|NCT00860470|101195501|FG000|STARTED|Overall Study||22162||
48354089|NCT00860470|101195502|FG001|STARTED|Overall Study||22405||
48354090|NCT00860470|101195501|FG000|COMPLETED|Overall Study||22114||
48354091|NCT00860470|101195502|FG001|COMPLETED|Overall Study||22346||
48354092|NCT00860470|101195501|FG000|NOT COMPLETED|Overall Study||48||
48354093|NCT00860470|101195502|FG001|NOT COMPLETED|Overall Study||59||
48354094|NCT00290472|101195503|FG000|STARTED|Overall Study||32||
48354095|NCT00290472|101195504|FG001|STARTED|Overall Study||39||
48354096|NCT00290472|101195505|FG002|STARTED|Overall Study||18||
48354097|NCT00290472|101195503|FG000|COMPLETED|Overall Study||32||
48354098|NCT00290472|101195504|FG001|COMPLETED|Overall Study||39||
48354099|NCT00290472|101195505|FG002|COMPLETED|Overall Study||18||
48354100|NCT00290472|101195503|FG000|NOT COMPLETED|Overall Study||0||
48354101|NCT00290472|101195504|FG001|NOT COMPLETED|Overall Study||0||
48354102|NCT00290472|101195505|FG002|NOT COMPLETED|Overall Study||0||
48354103|NCT03340350|101195506|FG000|STARTED|Overall Study||10||
48354104|NCT03340350|101195506|FG000|COMPLETED|Overall Study||4||
48354105|NCT03340350|101195506|FG000|NOT COMPLETED|Overall Study||6||
48354106|NCT04919564|101195507|FG000|STARTED|Overall Study||45||
48354107|NCT04919564|101195508|FG001|STARTED|Overall Study||45||
48417501|NCT01930487|101356905|FG000|COMPLETED|First Intervention (30 Days)||19||
48762365|NCT02415608|102206001|FG001|NOT COMPLETED|Overall Study||0||
48762366|NCT03104868|102206002|FG000|STARTED|Baseline||225||
48762367|NCT03104868|102206003|FG001|STARTED|Baseline||224||
48762368|NCT03104868|102206002|FG000|COMPLETED|Baseline||225||
48762369|NCT03104868|102206003|FG001|COMPLETED|Baseline||224||
48354108|NCT04919564|101195507|FG000|COMPLETED|Overall Study||43||
48354109|NCT04919564|101195508|FG001|COMPLETED|Overall Study||44||
48354110|NCT04919564|101195507|FG000|NOT COMPLETED|Overall Study||2||
48354111|NCT04919564|101195508|FG001|NOT COMPLETED|Overall Study||1||
48354112|NCT00845429|101195509|FG000|STARTED|Overall Study||244||
48354113|NCT00845429|101195510|FG001|STARTED|Overall Study||241||
48354114|NCT00845429|101195511|FG002|STARTED|Overall Study||244||
48354115|NCT00845429|101195509|FG000|COMPLETED|Overall Study||230||
48354116|NCT00845429|101195510|FG001|COMPLETED|Overall Study||226||
48354117|NCT00845429|101195511|FG002|COMPLETED|Overall Study||224||
48354118|NCT00845429|101195509|FG000|NOT COMPLETED|Overall Study||14||
48354119|NCT00845429|101195510|FG001|NOT COMPLETED|Overall Study||15||
48354120|NCT00845429|101195511|FG002|NOT COMPLETED|Overall Study||20||
48354121|NCT05614011|101195512|FG000|STARTED|Overall Study||877||
48354122|NCT05614011|101195512|FG000|COMPLETED|Overall Study||877||
48354123|NCT05614011|101195512|FG000|NOT COMPLETED|Overall Study||0||
48354124|NCT04544566|101195513|FG000|STARTED|Overall Study||2||
48417502|NCT01930487|101356906|FG001|COMPLETED|First Intervention (30 Days)||23||
48762370|NCT03104868|102206002|FG000|NOT COMPLETED|Baseline||0||
48762371|NCT03104868|102206003|FG001|NOT COMPLETED|Baseline||0||
48762372|NCT03104868|102206002|FG000|STARTED|6 Week Follow up||225||
48354125|NCT04544566|101195514|FG001|STARTED|Overall Study||2||
48354126|NCT04544566|101195515|FG002|STARTED|Overall Study||2||
48354127|NCT04544566|101195516|FG003|STARTED|Overall Study||2||
48354128|NCT04544566|101195517|FG004|STARTED|Overall Study||2||
48354129|NCT04544566|101195518|FG005|STARTED|Overall Study||2||
48354130|NCT04544566|101195513|FG000|COMPLETED|Overall Study||2||
48762373|NCT03104868|102206003|FG001|STARTED|6 Week Follow up||224||
48354131|NCT04544566|101195514|FG001|COMPLETED|Overall Study||2||
48354132|NCT04544566|101195515|FG002|COMPLETED|Overall Study||2||
48354133|NCT04544566|101195516|FG003|COMPLETED|Overall Study||2||
48354134|NCT04544566|101195517|FG004|COMPLETED|Overall Study||2||
48354135|NCT04544566|101195518|FG005|COMPLETED|Overall Study||2||
48354136|NCT04544566|101195513|FG000|NOT COMPLETED|Overall Study||0||
48354137|NCT04544566|101195514|FG001|NOT COMPLETED|Overall Study||0||
48354138|NCT04544566|101195515|FG002|NOT COMPLETED|Overall Study||0||
48354139|NCT04544566|101195516|FG003|NOT COMPLETED|Overall Study||0||
48354140|NCT04544566|101195517|FG004|NOT COMPLETED|Overall Study||0||
48354141|NCT04544566|101195518|FG005|NOT COMPLETED|Overall Study||0||
48354142|NCT01756157|101195519|FG000|STARTED|First Intervention Period||23||
48354143|NCT01756157|101195520|FG001|STARTED|First Intervention Period||24||
48354144|NCT01756157|101195519|FG000|COMPLETED|First Intervention Period||22||
48354145|NCT01756157|101195520|FG001|COMPLETED|First Intervention Period||22||
48354146|NCT01756157|101195519|FG000|NOT COMPLETED|First Intervention Period||1||
48354147|NCT01756157|101195520|FG001|NOT COMPLETED|First Intervention Period||2||
48354148|NCT01756157|101195519|FG000|STARTED|Washout Period (at Least 7 Days)||22||
48354149|NCT01756157|101195520|FG001|STARTED|Washout Period (at Least 7 Days)||22||
48354150|NCT01756157|101195519|FG000|COMPLETED|Washout Period (at Least 7 Days)||22||
48354151|NCT01756157|101195520|FG001|COMPLETED|Washout Period (at Least 7 Days)||22||
48354152|NCT01756157|101195519|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48354153|NCT01756157|101195520|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48354154|NCT01756157|101195519|FG000|STARTED|Second Intervention Period||22||
48354155|NCT01756157|101195520|FG001|STARTED|Second Intervention Period||22||
48354156|NCT01756157|101195519|FG000|COMPLETED|Second Intervention Period||22||
48354157|NCT01756157|101195520|FG001|COMPLETED|Second Intervention Period||22||
48354158|NCT01756157|101195519|FG000|NOT COMPLETED|Second Intervention Period||0||
48354159|NCT01756157|101195520|FG001|NOT COMPLETED|Second Intervention Period||0||
48354160|NCT01937312|101195521|FG000|STARTED|Overall Study||94||
48354161|NCT01937312|101195522|FG001|STARTED|Overall Study||95||
48354162|NCT01937312|101195521|FG000|Treated|Overall Study||93||
48354163|NCT01937312|101195522|FG001|Treated|Overall Study||95||
48354164|NCT01937312|101195521|FG000|COMPLETED|Overall Study||83||
48354165|NCT01937312|101195522|FG001|COMPLETED|Overall Study||92||
48354166|NCT01937312|101195521|FG000|NOT COMPLETED|Overall Study||11||
48354167|NCT01937312|101195522|FG001|NOT COMPLETED|Overall Study||3||
48354168|NCT01733329|101195523|FG000|STARTED|Overall Study||62||
48354169|NCT01733329|101195524|FG001|STARTED|Overall Study||61||
48354170|NCT01733329|101195523|FG000|COMPLETED|Overall Study||60||
48354171|NCT01733329|101195524|FG001|COMPLETED|Overall Study||60||
48354172|NCT01733329|101195523|FG000|NOT COMPLETED|Overall Study||2||
48354173|NCT01733329|101195524|FG001|NOT COMPLETED|Overall Study||1||
48354174|NCT01676961|101195525|FG000|STARTED|Overall Study||5||
48354175|NCT01676961|101195525|FG000|COMPLETED|Overall Study||0||
48354176|NCT01676961|101195525|FG000|NOT COMPLETED|Overall Study||5||
48354177|NCT00513344|101195526|FG000|STARTED|Diet Restriction (3 Days)||5||
48354178|NCT00513344|101195526|FG000|COMPLETED|Diet Restriction (3 Days)||5||
48354179|NCT00513344|101195526|FG000|NOT COMPLETED|Diet Restriction (3 Days)||0||
48354180|NCT00513344|101195526|FG000|STARTED|1st Intervention 1 Day||5||
48354181|NCT00513344|101195526|FG000|COMPLETED|1st Intervention 1 Day||5||
48354182|NCT00513344|101195526|FG000|NOT COMPLETED|1st Intervention 1 Day||0||
48354183|NCT00513344|101195526|FG000|STARTED|Washout Period 3 Days||5||
48354184|NCT00513344|101195526|FG000|COMPLETED|Washout Period 3 Days||5||
48354185|NCT00513344|101195526|FG000|NOT COMPLETED|Washout Period 3 Days||0||
48354186|NCT00513344|101195526|FG000|STARTED|2nd Intervention 1 Day||5||
48354187|NCT00513344|101195526|FG000|COMPLETED|2nd Intervention 1 Day||5||
48354188|NCT00513344|101195526|FG000|NOT COMPLETED|2nd Intervention 1 Day||0||
48354189|NCT00513344|101195526|FG000|STARTED|Washout Period 3 Days||5||
48354190|NCT00513344|101195526|FG000|COMPLETED|Washout Period 3 Days||5||
48354191|NCT00513344|101195526|FG000|NOT COMPLETED|Washout Period 3 Days||0||
48354192|NCT00513344|101195526|FG000|STARTED|3rd Intervention 1 Day||5||
48354193|NCT00513344|101195526|FG000|COMPLETED|3rd Intervention 1 Day||5||
48417503|NCT01930487|101356905|FG000|NOT COMPLETED|First Intervention (30 Days)||2||
48354194|NCT00513344|101195526|FG000|NOT COMPLETED|3rd Intervention 1 Day||0||
48354195|NCT04331899|101195527|FG000|STARTED|Trial Period (28 Days)||60||
48354196|NCT04331899|101195528|FG001|STARTED|Trial Period (28 Days)||60||
48354197|NCT04331899|101195527|FG000|COMPLETED|Trial Period (28 Days)||58||
48354198|NCT04331899|101195528|FG001|COMPLETED|Trial Period (28 Days)||58||
48354199|NCT04331899|101195527|FG000|NOT COMPLETED|Trial Period (28 Days)||2||
48354200|NCT04331899|101195528|FG001|NOT COMPLETED|Trial Period (28 Days)||2||
48354201|NCT04331899|101195527|FG000|STARTED|Follow-up Period (10 Months)||42||
48354202|NCT04331899|101195528|FG001|STARTED|Follow-up Period (10 Months)||43||
48354203|NCT04331899|101195527|FG000|COMPLETED|Follow-up Period (10 Months)||42||
48354204|NCT04331899|101195528|FG001|COMPLETED|Follow-up Period (10 Months)||43||
48354205|NCT04331899|101195527|FG000|NOT COMPLETED|Follow-up Period (10 Months)||0||
48417504|NCT01930487|101356906|FG001|NOT COMPLETED|First Intervention (30 Days)||2||
48417505|NCT01930487|101356905|FG000|STARTED|Washout Period (3 Weeks)||19||
48638360|NCT00576758|101898736|FG000|STARTED|Follow-up Period||55||
48638361|NCT00576758|101898737|FG001|STARTED|Follow-up Period||51||
48354206|NCT04331899|101195528|FG001|NOT COMPLETED|Follow-up Period (10 Months)||0||
48354207|NCT02509546|101195529|FG000|STARTED|Overall Study||3||
48354208|NCT02509546|101195530|FG001|STARTED|Overall Study||3||
48354209|NCT02509546|101195531|FG002|STARTED|Overall Study||4||
48354210|NCT02509546|101195532|FG003|STARTED|Overall Study||2||
48354211|NCT02509546|101195533|FG004|STARTED|Overall Study||2||
48354212|NCT02509546|101195534|FG005|STARTED|Overall Study||6||
48354213|NCT02509546|101195529|FG000|COMPLETED|Overall Study||3||
48354214|NCT02509546|101195530|FG001|COMPLETED|Overall Study||3||
48354215|NCT02509546|101195531|FG002|COMPLETED|Overall Study||4||
48354216|NCT02509546|101195532|FG003|COMPLETED|Overall Study||2||
48354217|NCT02509546|101195533|FG004|COMPLETED|Overall Study||2||
48354218|NCT02509546|101195534|FG005|COMPLETED|Overall Study||6||
48354219|NCT02509546|101195529|FG000|NOT COMPLETED|Overall Study||0||
48354220|NCT02509546|101195530|FG001|NOT COMPLETED|Overall Study||0||
48354221|NCT02509546|101195531|FG002|NOT COMPLETED|Overall Study||0||
48354222|NCT02509546|101195532|FG003|NOT COMPLETED|Overall Study||0||
48354223|NCT02509546|101195533|FG004|NOT COMPLETED|Overall Study||0||
48354224|NCT02509546|101195534|FG005|NOT COMPLETED|Overall Study||0||
48354225|NCT02833311|101195535|FG000|STARTED|Overall Study||15||
48354226|NCT02833311|101195536|FG001|STARTED|Overall Study||16||
48354227|NCT02833311|101195537|FG002|STARTED|Overall Study||15||
48354228|NCT02833311|101195535|FG000|COMPLETED|Overall Study||13||
48354229|NCT02833311|101195536|FG001|COMPLETED|Overall Study||15||
48354230|NCT02833311|101195537|FG002|COMPLETED|Overall Study||15||
48354231|NCT02833311|101195535|FG000|NOT COMPLETED|Overall Study||2||
48354232|NCT02833311|101195536|FG001|NOT COMPLETED|Overall Study||1||
48354233|NCT02833311|101195537|FG002|NOT COMPLETED|Overall Study||0||
48354234|NCT00605826|101195538|FG000|STARTED|Overall Study||136||
48354235|NCT00605826|101195539|FG001|STARTED|Overall Study||70||
48354236|NCT00605826|101195538|FG000|COMPLETED|Overall Study||129||
48354237|NCT00605826|101195539|FG001|COMPLETED|Overall Study||60||
48354238|NCT00605826|101195538|FG000|NOT COMPLETED|Overall Study||7||
48354239|NCT00605826|101195539|FG001|NOT COMPLETED|Overall Study||10||
48354240|NCT00075881|101195540|FG000|STARTED|Overall Study||44||
48354241|NCT00075881|101195540|FG000|Eligible|Overall Study||43||
48354242|NCT00075881|101195540|FG000|Treated|Overall Study||42||
48354243|NCT00075881|101195540|FG000|Induction Treatment|Overall Study||42||
48354244|NCT00075881|101195540|FG000|Maintenance Treatment|Overall Study||15||
48354245|NCT00075881|101195540|FG000|Reinduction Treatment|Overall Study||7||
48354246|NCT00075881|101195540|FG000|COMPLETED|Overall Study||1||
48354247|NCT00075881|101195540|FG000|NOT COMPLETED|Overall Study||43||
48354248|NCT02108457|101195541|FG000|STARTED|Overall Study||3||
48354249|NCT02108457|101195542|FG001|STARTED|Overall Study||12||
48354250|NCT02108457|101195541|FG000|COMPLETED|Overall Study||3||
48354251|NCT02108457|101195542|FG001|COMPLETED|Overall Study||10||
48354252|NCT02108457|101195541|FG000|NOT COMPLETED|Overall Study||0||
48354253|NCT02108457|101195542|FG001|NOT COMPLETED|Overall Study||2||
48354254|NCT00356915|101195543|FG000|STARTED|Overall Study||593||
48354255|NCT00356915|101195544|FG001|STARTED|Overall Study||590||
48354256|NCT00356915|101195545|FG002|STARTED|Overall Study||198||
48354257|NCT00356915|101195543|FG000|COMPLETED|Overall Study||517||
48354258|NCT00356915|101195544|FG001|COMPLETED|Overall Study||496||
48354259|NCT00356915|101195545|FG002|COMPLETED|Overall Study||156||
48354260|NCT00356915|101195543|FG000|NOT COMPLETED|Overall Study||76||
48354261|NCT00356915|101195544|FG001|NOT COMPLETED|Overall Study||94||
48354262|NCT00356915|101195545|FG002|NOT COMPLETED|Overall Study||42||
48354263|NCT00843986|101195546|FG000|STARTED|Overall Study||3||
48354264|NCT00843986|101195547|FG001|STARTED|Overall Study||6||
48354265|NCT00843986|101195546|FG000|Completed Treatment (Infusion)|Overall Study||2||
48354266|NCT00843986|101195547|FG001|Completed Treatment (Infusion)|Overall Study||6||
48354267|NCT00843986|101195546|FG000|COMPLETED|Overall Study||2||
48354268|NCT00843986|101195547|FG001|COMPLETED|Overall Study||5||
48354269|NCT00843986|101195546|FG000|NOT COMPLETED|Overall Study||1||
48354270|NCT00843986|101195547|FG001|NOT COMPLETED|Overall Study||1||
48354271|NCT02799381|101195548|FG000|STARTED|Overall Study||33||
48354272|NCT02799381|101195549|FG001|STARTED|Overall Study||28||
48354273|NCT02799381|101195548|FG000|COMPLETED|Overall Study||29||
48354274|NCT02799381|101195549|FG001|COMPLETED|Overall Study||25||
48354275|NCT02799381|101195548|FG000|NOT COMPLETED|Overall Study||4||
48354276|NCT02799381|101195549|FG001|NOT COMPLETED|Overall Study||3||
48354277|NCT04938648|101195550|FG000|STARTED|Overall Study||34||
48354278|NCT04938648|101195551|FG001|STARTED|Overall Study||35||
48354279|NCT04938648|101195550|FG000|COMPLETED|Overall Study||27||
48354280|NCT04938648|101195551|FG001|COMPLETED|Overall Study||28||
48354281|NCT04938648|101195550|FG000|NOT COMPLETED|Overall Study||7||
48354282|NCT04938648|101195551|FG001|NOT COMPLETED|Overall Study||7||
48354283|NCT00224016|101195552|FG000|STARTED|Titration Period||39||
48354284|NCT00224016|101195553|FG001|STARTED|Titration Period||16||
48354285|NCT00224016|101195552|FG000|COMPLETED|Titration Period||38||
48354286|NCT00224016|101195553|FG001|COMPLETED|Titration Period||15||
48354287|NCT00224016|101195552|FG000|NOT COMPLETED|Titration Period||1||
48354288|NCT00224016|101195553|FG001|NOT COMPLETED|Titration Period||1||
48354289|NCT00224016|101195552|FG000|STARTED|Maintenance Period||38||
48354290|NCT00224016|101195553|FG001|STARTED|Maintenance Period||15||
48354291|NCT00224016|101195552|FG000|COMPLETED|Maintenance Period||36||
48354292|NCT00224016|101195553|FG001|COMPLETED|Maintenance Period||14||
48354293|NCT00224016|101195552|FG000|NOT COMPLETED|Maintenance Period||2||
48354294|NCT00224016|101195553|FG001|NOT COMPLETED|Maintenance Period||1||
48354295|NCT00224016|101195552|FG000|STARTED|Follow-Up Period||35||
48354296|NCT00224016|101195553|FG001|STARTED|Follow-Up Period||0||
48354297|NCT00224016|101195552|FG000|COMPLETED|Follow-Up Period||35||
48354298|NCT00224016|101195553|FG001|COMPLETED|Follow-Up Period||0||
48354299|NCT00224016|101195552|FG000|NOT COMPLETED|Follow-Up Period||0||
48354300|NCT00224016|101195553|FG001|NOT COMPLETED|Follow-Up Period||0||
48354301|NCT01985321|101195554|FG000|STARTED|Overall Study||90||
48354302|NCT01985321|101195555|FG001|STARTED|Overall Study||83||
48354303|NCT01985321|101195554|FG000|COMPLETED|Overall Study||79||
48354304|NCT01985321|101195555|FG001|COMPLETED|Overall Study||78||
48354305|NCT01985321|101195554|FG000|NOT COMPLETED|Overall Study||11||
48354306|NCT01985321|101195555|FG001|NOT COMPLETED|Overall Study||5||
48354307|NCT00472303|101195556|FG000|STARTED|Titration Phase||338||
48354308|NCT00472303|101195557|FG001|STARTED|Titration Phase||158||
48354309|NCT00472303|101195558|FG002|STARTED|Titration Phase||0||
48354310|NCT00472303|101195556|FG000|COMPLETED|Titration Phase||279||
48354311|NCT00472303|101195557|FG001|COMPLETED|Titration Phase||129||
48354312|NCT00472303|101195558|FG002|COMPLETED|Titration Phase||0||
48354313|NCT00472303|101195556|FG000|NOT COMPLETED|Titration Phase||59||
48417506|NCT01930487|101356906|FG001|STARTED|Washout Period (3 Weeks)||23||
48417507|NCT01930487|101356905|FG000|COMPLETED|Washout Period (3 Weeks)||19||
48417508|NCT01930487|101356906|FG001|COMPLETED|Washout Period (3 Weeks)||23||
48417509|NCT01930487|101356905|FG000|NOT COMPLETED|Washout Period (3 Weeks)||0||
48417510|NCT01930487|101356906|FG001|NOT COMPLETED|Washout Period (3 Weeks)||0||
48417511|NCT01930487|101356905|FG000|STARTED|Second Intervention (30 Days)||19||
48417512|NCT01930487|101356906|FG001|STARTED|Second Intervention (30 Days)||23||
48417513|NCT01930487|101356905|FG000|COMPLETED|Second Intervention (30 Days)||19||
48417514|NCT01930487|101356906|FG001|COMPLETED|Second Intervention (30 Days)||23||
48417515|NCT01930487|101356905|FG000|NOT COMPLETED|Second Intervention (30 Days)||0||
48417516|NCT01930487|101356906|FG001|NOT COMPLETED|Second Intervention (30 Days)||0||
48417517|NCT03322540|101356907|FG000|STARTED|Overall Study||77||
48417518|NCT03322540|101356908|FG001|STARTED|Overall Study||77||
48417519|NCT03322540|101356907|FG000|Number of Subjects Received Treatment (Actual Treatment) (ASaT)|Overall Study||75||
48417520|NCT03322540|101356908|FG001|Number of Subjects Received Treatment (Actual Treatment) (ASaT)|Overall Study||77||
48417521|NCT03322540|101356907|FG000|COMPLETED|Overall Study||46||
48417522|NCT03322540|101356908|FG001|COMPLETED|Overall Study||40||
48417523|NCT03322540|101356907|FG000|NOT COMPLETED|Overall Study||31||
48417524|NCT03322540|101356908|FG001|NOT COMPLETED|Overall Study||37||
48417525|NCT00959192|101356909|FG000|STARTED|Overall Study||6||
48417526|NCT00959192|101356910|FG001|STARTED|Overall Study||9||
48417527|NCT00959192|101356911|FG002|STARTED|Overall Study||9||
48417528|NCT00959192|101356912|FG003|STARTED|Overall Study||8||
48417529|NCT00959192|101356909|FG000|COMPLETED|Overall Study||4||
48417530|NCT00959192|101356910|FG001|COMPLETED|Overall Study||8||
48417531|NCT00959192|101356911|FG002|COMPLETED|Overall Study||6||
48417532|NCT00959192|101356912|FG003|COMPLETED|Overall Study||7||
48417533|NCT00959192|101356909|FG000|NOT COMPLETED|Overall Study||2||
48417534|NCT00959192|101356910|FG001|NOT COMPLETED|Overall Study||1||
48417535|NCT00959192|101356911|FG002|NOT COMPLETED|Overall Study||3||
48417536|NCT00959192|101356912|FG003|NOT COMPLETED|Overall Study||1||
48417537|NCT02347124|101356913|FG000|STARTED|Overall Study||360||
48417538|NCT02347124|101356914|FG001|STARTED|Overall Study||358||
48417539|NCT02347124|101356913|FG000|2 Month Follow-up|Overall Study||298||
48417540|NCT02347124|101356914|FG001|2 Month Follow-up|Overall Study||275||
48417541|NCT02347124|101356913|FG000|COMPLETED|Overall Study||267||
48417542|NCT02347124|101356914|FG001|COMPLETED|Overall Study||259||
48417543|NCT02347124|101356913|FG000|NOT COMPLETED|Overall Study||93||
48417544|NCT02347124|101356914|FG001|NOT COMPLETED|Overall Study||99||
48417545|NCT05060003|101356915|FG000|STARTED|Overall Study||7||
48417546|NCT05060003|101356915|FG000|COMPLETED|Overall Study||0||
48417547|NCT05060003|101356915|FG000|NOT COMPLETED|Overall Study||7||
48417548|NCT02736149|101356916|FG000|STARTED|Overall Study||51||
48417549|NCT02736149|101356916|FG000|COMPLETED|Overall Study||0||
48417550|NCT02736149|101356916|FG000|NOT COMPLETED|Overall Study||51||
48417551|NCT03474172|101356917|FG000|STARTED|Overall Study||30||
48417552|NCT03474172|101356918|FG001|STARTED|Overall Study||30||
48417553|NCT03474172|101356917|FG000|COMPLETED|Overall Study||30||
48417554|NCT03474172|101356918|FG001|COMPLETED|Overall Study||30||
48354314|NCT00472303|101195557|FG001|NOT COMPLETED|Titration Phase||29||
48354315|NCT00472303|101195558|FG002|NOT COMPLETED|Titration Phase||0||
48354316|NCT00472303|101195556|FG000|STARTED|Discontinuations After Titration Phase||279||
48354317|NCT00472303|101195557|FG001|STARTED|Discontinuations After Titration Phase||129||
48354318|NCT00472303|101195558|FG002|STARTED|Discontinuations After Titration Phase||0||
48354319|NCT00472303|101195556|FG000|COMPLETED|Discontinuations After Titration Phase||218||
48354320|NCT00472303|101195557|FG001|COMPLETED|Discontinuations After Titration Phase||109||
48354321|NCT00472303|101195558|FG002|COMPLETED|Discontinuations After Titration Phase||0||
48354322|NCT00472303|101195556|FG000|NOT COMPLETED|Discontinuations After Titration Phase||61||
48417555|NCT03474172|101356917|FG000|NOT COMPLETED|Overall Study||0||
48417556|NCT03474172|101356918|FG001|NOT COMPLETED|Overall Study||0||
48417557|NCT02425891|101356919|FG000|STARTED|Overall Study||451||
48417558|NCT02425891|101356920|FG001|STARTED|Overall Study||451||
48417559|NCT02425891|101356919|FG000|COMPLETED|Overall Study||0||
48417560|NCT02425891|101356920|FG001|COMPLETED|Overall Study||0||
48417561|NCT02425891|101356919|FG000|NOT COMPLETED|Overall Study||451||
48417562|NCT02425891|101356920|FG001|NOT COMPLETED|Overall Study||451||
48417563|NCT00672139|101356921|FG000|STARTED|Overall Study||57||
48417564|NCT00672139|101356922|FG001|STARTED|Overall Study||92||
48417565|NCT00672139|101356921|FG000|COMPLETED|Overall Study||27||
48417566|NCT00672139|101356922|FG001|COMPLETED|Overall Study||47||
48417567|NCT00672139|101356921|FG000|NOT COMPLETED|Overall Study||30||
48417568|NCT00672139|101356922|FG001|NOT COMPLETED|Overall Study||45||
48417569|NCT03369340|101356923|FG000|STARTED|Day 2||3||
48417570|NCT03369340|101356924|FG001|STARTED|Day 2||3||
48417571|NCT03369340|101356925|FG002|STARTED|Day 2||3||
48417572|NCT03369340|101356926|FG003|STARTED|Day 2||3||
48417573|NCT03369340|101356927|FG004|STARTED|Day 2||3||
48417574|NCT03369340|101356928|FG005|STARTED|Day 2||3||
48417575|NCT03369340|101356923|FG000|COMPLETED|Day 2||3||
48417576|NCT03369340|101356924|FG001|COMPLETED|Day 2||3||
48417577|NCT03369340|101356925|FG002|COMPLETED|Day 2||3||
48417578|NCT03369340|101356926|FG003|COMPLETED|Day 2||3||
48417579|NCT03369340|101356927|FG004|COMPLETED|Day 2||3||
48417580|NCT03369340|101356928|FG005|COMPLETED|Day 2||3||
48417581|NCT03369340|101356923|FG000|NOT COMPLETED|Day 2||0||
48417582|NCT03369340|101356924|FG001|NOT COMPLETED|Day 2||0||
48417583|NCT03369340|101356925|FG002|NOT COMPLETED|Day 2||0||
48417584|NCT03369340|101356926|FG003|NOT COMPLETED|Day 2||0||
48417585|NCT03369340|101356927|FG004|NOT COMPLETED|Day 2||0||
48417586|NCT03369340|101356928|FG005|NOT COMPLETED|Day 2||0||
48417587|NCT03369340|101356923|FG000|STARTED|Day 3||3||
48417588|NCT03369340|101356924|FG001|STARTED|Day 3||3||
48417589|NCT03369340|101356925|FG002|STARTED|Day 3||3||
48417590|NCT03369340|101356926|FG003|STARTED|Day 3||3||
48417591|NCT03369340|101356927|FG004|STARTED|Day 3||3||
48417592|NCT03369340|101356928|FG005|STARTED|Day 3||3||
48417593|NCT03369340|101356923|FG000|COMPLETED|Day 3||3||
48417594|NCT03369340|101356924|FG001|COMPLETED|Day 3||3||
48417595|NCT03369340|101356925|FG002|COMPLETED|Day 3||3||
48417596|NCT03369340|101356926|FG003|COMPLETED|Day 3||3||
48417597|NCT03369340|101356927|FG004|COMPLETED|Day 3||3||
48417598|NCT03369340|101356928|FG005|COMPLETED|Day 3||3||
48417599|NCT03369340|101356923|FG000|NOT COMPLETED|Day 3||0||
48417600|NCT03369340|101356924|FG001|NOT COMPLETED|Day 3||0||
48417601|NCT03369340|101356925|FG002|NOT COMPLETED|Day 3||0||
48417602|NCT03369340|101356926|FG003|NOT COMPLETED|Day 3||0||
48417603|NCT03369340|101356927|FG004|NOT COMPLETED|Day 3||0||
48417604|NCT03369340|101356928|FG005|NOT COMPLETED|Day 3||0||
48417605|NCT03369340|101356923|FG000|STARTED|Day 4||3||
48417606|NCT03369340|101356924|FG001|STARTED|Day 4||3||
48417607|NCT03369340|101356925|FG002|STARTED|Day 4||3||
48417608|NCT03369340|101356926|FG003|STARTED|Day 4||3||
48417609|NCT03369340|101356927|FG004|STARTED|Day 4||3||
48417610|NCT03369340|101356928|FG005|STARTED|Day 4||3||
48417611|NCT03369340|101356923|FG000|COMPLETED|Day 4||3||
48186827|NCT03114995|100779912|FG002|COMPLETED|Overall Study||78||
48417612|NCT03369340|101356924|FG001|COMPLETED|Day 4||3||
48417613|NCT03369340|101356925|FG002|COMPLETED|Day 4||3||
48417614|NCT03369340|101356926|FG003|COMPLETED|Day 4||3||
48417615|NCT03369340|101356927|FG004|COMPLETED|Day 4||3||
48417616|NCT03369340|101356928|FG005|COMPLETED|Day 4||3||
48417617|NCT03369340|101356923|FG000|NOT COMPLETED|Day 4||0||
48638362|NCT00576758|101898736|FG000|COMPLETED|Follow-up Period||28||
48417618|NCT03369340|101356924|FG001|NOT COMPLETED|Day 4||0||
48417619|NCT03369340|101356925|FG002|NOT COMPLETED|Day 4||0||
48417620|NCT03369340|101356926|FG003|NOT COMPLETED|Day 4||0||
48417621|NCT03369340|101356927|FG004|NOT COMPLETED|Day 4||0||
48417622|NCT03369340|101356928|FG005|NOT COMPLETED|Day 4||0||
48417623|NCT02192190|101356929|FG000|STARTED|Overall Study||76||
48417624|NCT02192190|101356930|FG001|STARTED|Overall Study||39||
48417625|NCT02192190|101356931|FG002|STARTED|Overall Study||38||
48417626|NCT02192190|101356932|FG003|STARTED|Overall Study||38||
48417627|NCT02192190|101356933|FG004|STARTED|Overall Study||39||
48417628|NCT02192190|101356934|FG005|STARTED|Overall Study||38||
48417629|NCT02192190|101356929|FG000|Received at Least 1 Dose of Study Drug|Overall Study||76||
48417630|NCT02192190|101356930|FG001|Received at Least 1 Dose of Study Drug|Overall Study||39||
48417631|NCT02192190|101356931|FG002|Received at Least 1 Dose of Study Drug|Overall Study||38||
48417632|NCT02192190|101356932|FG003|Received at Least 1 Dose of Study Drug|Overall Study||38||
48417633|NCT02192190|101356933|FG004|Received at Least 1 Dose of Study Drug|Overall Study||38||
48417634|NCT02192190|101356934|FG005|Received at Least 1 Dose of Study Drug|Overall Study||37||
48417635|NCT02192190|101356929|FG000|COMPLETED|Overall Study||22||
48417636|NCT02192190|101356930|FG001|COMPLETED|Overall Study||10||
48417637|NCT02192190|101356931|FG002|COMPLETED|Overall Study||13||
48417638|NCT02192190|101356932|FG003|COMPLETED|Overall Study||12||
48417639|NCT02192190|101356933|FG004|COMPLETED|Overall Study||9||
48417640|NCT02192190|101356934|FG005|COMPLETED|Overall Study||9||
48417641|NCT02192190|101356929|FG000|NOT COMPLETED|Overall Study||54||
48417642|NCT02192190|101356930|FG001|NOT COMPLETED|Overall Study||29||
48417643|NCT02192190|101356931|FG002|NOT COMPLETED|Overall Study||25||
48417644|NCT02192190|101356932|FG003|NOT COMPLETED|Overall Study||26||
48417645|NCT02192190|101356933|FG004|NOT COMPLETED|Overall Study||30||
48417646|NCT02192190|101356934|FG005|NOT COMPLETED|Overall Study||29||
48417647|NCT00724594|101356935|FG000|STARTED|Overall Study||12||
48417648|NCT00724594|101356936|FG001|STARTED|Overall Study||12||
48417649|NCT00724594|101356937|FG002|STARTED|Overall Study||11||
48417650|NCT00724594|101356938|FG003|STARTED|Overall Study||11||
48417651|NCT00724594|101356935|FG000|COMPLETED|Overall Study||12||
48417652|NCT00724594|101356936|FG001|COMPLETED|Overall Study||12||
48417653|NCT00724594|101356937|FG002|COMPLETED|Overall Study||11||
48417654|NCT00724594|101356938|FG003|COMPLETED|Overall Study||10||
48417655|NCT00724594|101356935|FG000|NOT COMPLETED|Overall Study||0||
48417656|NCT00724594|101356936|FG001|NOT COMPLETED|Overall Study||0||
48417657|NCT00724594|101356937|FG002|NOT COMPLETED|Overall Study||0||
48417658|NCT00724594|101356938|FG003|NOT COMPLETED|Overall Study||1||
48417659|NCT02607735|101356939|FG000|STARTED|Primary Study||264||
48417660|NCT02607735|101356940|FG001|STARTED|Primary Study||152||
48417661|NCT02607735|101356941|FG002|STARTED|Primary Study||0||
48417662|NCT02607735|101356939|FG000|COMPLETED|Primary Study||257||
48417663|NCT02607735|101356940|FG001|COMPLETED|Primary Study||152||
48417664|NCT02607735|101356941|FG002|COMPLETED|Primary Study||0||
48417665|NCT02607735|101356939|FG000|NOT COMPLETED|Primary Study||7||
48354323|NCT00472303|101195557|FG001|NOT COMPLETED|Discontinuations After Titration Phase||20||
48354324|NCT00472303|101195558|FG002|NOT COMPLETED|Discontinuations After Titration Phase||0||
48354325|NCT00472303|101195556|FG000|STARTED|Maintenance Phase||106||
48354326|NCT00472303|101195557|FG001|STARTED|Maintenance Phase||109||
48354327|NCT00472303|101195558|FG002|STARTED|Maintenance Phase||112||
48354328|NCT00472303|101195556|FG000|COMPLETED|Maintenance Phase||89||
48354329|NCT00472303|101195557|FG001|COMPLETED|Maintenance Phase||93||
48417666|NCT02607735|101356940|FG001|NOT COMPLETED|Primary Study||0||
48417667|NCT02607735|101356941|FG002|NOT COMPLETED|Primary Study||0||
48417668|NCT02607735|101356939|FG000|STARTED|Deferred Treatment Substudy||0||
48417669|NCT02607735|101356940|FG001|STARTED|Deferred Treatment Substudy||0||
48417670|NCT02607735|101356941|FG002|STARTED|Deferred Treatment Substudy||147||
48417671|NCT02607735|101356939|FG000|COMPLETED|Deferred Treatment Substudy||0||
48417672|NCT02607735|101356940|FG001|COMPLETED|Deferred Treatment Substudy||0||
48417673|NCT02607735|101356941|FG002|COMPLETED|Deferred Treatment Substudy||142||
48417674|NCT02607735|101356939|FG000|NOT COMPLETED|Deferred Treatment Substudy||0||
48417675|NCT02607735|101356940|FG001|NOT COMPLETED|Deferred Treatment Substudy||0||
48417676|NCT02607735|101356941|FG002|NOT COMPLETED|Deferred Treatment Substudy||5||
48417677|NCT00195702|101356942|FG000|STARTED|Double-blind Phase||212||
48417678|NCT00195702|101356943|FG001|STARTED|Double-blind Phase||207||
48417679|NCT00195702|101356944|FG002|STARTED|Double-blind Phase||200||
48354330|NCT00472303|101195558|FG002|COMPLETED|Maintenance Phase||95||
48354331|NCT00472303|101195556|FG000|NOT COMPLETED|Maintenance Phase||17||
48354332|NCT00472303|101195557|FG001|NOT COMPLETED|Maintenance Phase||16||
48354333|NCT00472303|101195558|FG002|NOT COMPLETED|Maintenance Phase||17||
48354334|NCT01073943|101195559|FG000|STARTED|Overall Study||300||
48354335|NCT01073943|101195560|FG001|STARTED|Overall Study||303||
48354336|NCT01073943|101195559|FG000|Safety Population (Treated)|Overall Study||296||
48354337|NCT01073943|101195560|FG001|Safety Population (Treated)|Overall Study||302||
48354338|NCT01073943|101195559|FG000|Intent to Treat Population|Overall Study||294||
48417680|NCT00195702|101356945|FG003|STARTED|Double-blind Phase||0||
48417681|NCT00195702|101356946|FG004|STARTED|Double-blind Phase||0||
48417682|NCT00195702|101356947|FG005|STARTED|Double-blind Phase||0||
48417683|NCT00195702|101356942|FG000|COMPLETED|Double-blind Phase||168||
48417684|NCT00195702|101356943|FG001|COMPLETED|Double-blind Phase||159||
48417685|NCT00195702|101356944|FG002|COMPLETED|Double-blind Phase||140||
48417686|NCT00195702|101356945|FG003|COMPLETED|Double-blind Phase||0||
48417687|NCT00195702|101356946|FG004|COMPLETED|Double-blind Phase||0||
48417688|NCT00195702|101356947|FG005|COMPLETED|Double-blind Phase||0||
48417689|NCT00195702|101356942|FG000|NOT COMPLETED|Double-blind Phase||44||
48417690|NCT00195702|101356943|FG001|NOT COMPLETED|Double-blind Phase||48||
48417691|NCT00195702|101356944|FG002|NOT COMPLETED|Double-blind Phase||60||
48417692|NCT00195702|101356945|FG003|NOT COMPLETED|Double-blind Phase||0||
48417693|NCT00195702|101356946|FG004|NOT COMPLETED|Double-blind Phase||0||
48417694|NCT00195702|101356947|FG005|NOT COMPLETED|Double-blind Phase||0||
48417695|NCT00195702|101356942|FG000|STARTED|Open-label Extension Phase||0||
48417696|NCT00195702|101356943|FG001|STARTED|Open-label Extension Phase||0||
48417697|NCT00195702|101356944|FG002|STARTED|Open-label Extension Phase||0||
48417698|NCT00195702|101356945|FG003|STARTED|Open-label Extension Phase||165||
48417699|NCT00195702|101356946|FG004|STARTED|Open-label Extension Phase||158||
48417700|NCT00195702|101356947|FG005|STARTED|Open-label Extension Phase||134||
48354339|NCT01073943|101195560|FG001|Intent to Treat Population|Overall Study||300||
48354340|NCT01073943|101195559|FG000|COMPLETED|Overall Study||287||
48354341|NCT01073943|101195560|FG001|COMPLETED|Overall Study||295||
48354342|NCT01073943|101195559|FG000|NOT COMPLETED|Overall Study||13||
48354343|NCT01073943|101195560|FG001|NOT COMPLETED|Overall Study||8||
48354344|NCT00996840|101195561|FG000|STARTED|Overall Study||20||
48354345|NCT00996840|101195562|FG001|STARTED|Overall Study||9||
48354346|NCT00996840|101195563|FG002|STARTED|Overall Study||12||
48354347|NCT00996840|101195564|FG003|STARTED|Overall Study||18||
48354348|NCT00996840|101195565|FG004|STARTED|Overall Study||18||
48354349|NCT00996840|101195561|FG000|COMPLETED|Overall Study||19||
48354350|NCT00996840|101195562|FG001|COMPLETED|Overall Study||7||
48354351|NCT00996840|101195563|FG002|COMPLETED|Overall Study||11||
48354352|NCT00996840|101195564|FG003|COMPLETED|Overall Study||17||
48354353|NCT00996840|101195565|FG004|COMPLETED|Overall Study||16||
48354354|NCT00996840|101195561|FG000|NOT COMPLETED|Overall Study||1||
48354355|NCT00996840|101195562|FG001|NOT COMPLETED|Overall Study||2||
48354356|NCT00996840|101195563|FG002|NOT COMPLETED|Overall Study||1||
48354357|NCT00996840|101195564|FG003|NOT COMPLETED|Overall Study||1||
48354358|NCT00996840|101195565|FG004|NOT COMPLETED|Overall Study||2||
48354359|NCT02886715|101195566|FG000|STARTED|Overall Study||442|Randomized - Safety Population|
48354360|NCT02886715|101195567|FG001|STARTED|Overall Study||445|Randomized - Safety Population|
48354361|NCT02886715|101195568|FG002|STARTED|Overall Study||223|Randomized - Safety Population|
48354362|NCT02886715|101195566|FG000|Modified ITT (mITT)|Overall Study||421||
48354363|NCT02886715|101195567|FG001|Modified ITT (mITT)|Overall Study||418||
48354364|NCT02886715|101195568|FG002|Modified ITT (mITT)|Overall Study||217||
48354365|NCT02886715|101195566|FG000|Per Protocol (PP) Population|Overall Study||346||
48354366|NCT02886715|101195567|FG001|Per Protocol (PP) Population|Overall Study||351||
48354367|NCT02886715|101195568|FG002|Per Protocol (PP) Population|Overall Study||176||
48354368|NCT02886715|101195566|FG000|COMPLETED|Overall Study||378||
48354369|NCT02886715|101195567|FG001|COMPLETED|Overall Study||390||
48354370|NCT02886715|101195568|FG002|COMPLETED|Overall Study||203||
48354371|NCT02886715|101195566|FG000|NOT COMPLETED|Overall Study||64||
48354372|NCT02886715|101195567|FG001|NOT COMPLETED|Overall Study||55||
48354373|NCT02886715|101195568|FG002|NOT COMPLETED|Overall Study||20||
48354374|NCT02039947|101195569|FG000|STARTED|Overall Study||76||
48354375|NCT02039947|101195570|FG001|STARTED|Overall Study||16||
48417701|NCT00195702|101356942|FG000|COMPLETED|Open-label Extension Phase||0||
48417702|NCT00195702|101356943|FG001|COMPLETED|Open-label Extension Phase||0||
48417703|NCT00195702|101356944|FG002|COMPLETED|Open-label Extension Phase||0||
48417704|NCT00195702|101356945|FG003|COMPLETED|Open-label Extension Phase||66||
48417705|NCT00195702|101356946|FG004|COMPLETED|Open-label Extension Phase||80||
48417706|NCT00195702|101356947|FG005|COMPLETED|Open-label Extension Phase||56||
48417707|NCT00195702|101356942|FG000|NOT COMPLETED|Open-label Extension Phase||0||
48417708|NCT00195702|101356943|FG001|NOT COMPLETED|Open-label Extension Phase||0||
48417709|NCT00195702|101356944|FG002|NOT COMPLETED|Open-label Extension Phase||0||
48417710|NCT00195702|101356945|FG003|NOT COMPLETED|Open-label Extension Phase||99||
48638363|NCT00576758|101898737|FG001|COMPLETED|Follow-up Period||34||
48354376|NCT02039947|101195571|FG002|STARTED|Overall Study||16||
48354377|NCT02039947|101195572|FG003|STARTED|Overall Study||17||
48354378|NCT02039947|101195569|FG000|COMPLETED|Overall Study||76||
48354379|NCT02039947|101195570|FG001|COMPLETED|Overall Study||16||
48354380|NCT02039947|101195571|FG002|COMPLETED|Overall Study||16||
48354381|NCT02039947|101195572|FG003|COMPLETED|Overall Study||17||
48354382|NCT02039947|101195569|FG000|NOT COMPLETED|Overall Study||0||
48354383|NCT02039947|101195570|FG001|NOT COMPLETED|Overall Study||0||
48354384|NCT02039947|101195571|FG002|NOT COMPLETED|Overall Study||0||
48354385|NCT02039947|101195572|FG003|NOT COMPLETED|Overall Study||0||
48354386|NCT01919307|101195573|FG000|STARTED|Overall Study||29||
48354387|NCT01919307|101195573|FG000|COMPLETED|Overall Study||20||
48354388|NCT01919307|101195573|FG000|NOT COMPLETED|Overall Study||9||
48354389|NCT00609609|101195574|FG000|STARTED|Overall Study||30||
48354390|NCT00609609|101195575|FG001|STARTED|Overall Study||51||
48354391|NCT00609609|101195574|FG000|COMPLETED|Overall Study||24||
48354392|NCT00609609|101195575|FG001|COMPLETED|Overall Study||49||
48354393|NCT00609609|101195574|FG000|NOT COMPLETED|Overall Study||6||
48354394|NCT00609609|101195575|FG001|NOT COMPLETED|Overall Study||2||
48354395|NCT02111369|101195576|FG000|STARTED|Overall Study||18||
48354396|NCT02111369|101195576|FG000|COMPLETED|Overall Study||15||
48417711|NCT00195702|101356946|FG004|NOT COMPLETED|Open-label Extension Phase||78||
48417712|NCT00195702|101356947|FG005|NOT COMPLETED|Open-label Extension Phase||78||
48417713|NCT01326481|101356948|FG000|STARTED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||4||
48417714|NCT01326481|101356948|FG000|COMPLETED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||3||
48417715|NCT01326481|101356948|FG000|NOT COMPLETED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||1||
48417716|NCT01326481|101356948|FG000|STARTED|10 mg/kg TRC105, 1000 mg/m2 Cape||15||
48417717|NCT01326481|101356948|FG000|COMPLETED|10 mg/kg TRC105, 1000 mg/m2 Cape||15||
48417718|NCT01326481|101356948|FG000|NOT COMPLETED|10 mg/kg TRC105, 1000 mg/m2 Cape||0||
48417719|NCT02532998|101356949|FG000|STARTED|Overall Study||23||
48417720|NCT02532998|101356949|FG000|COMPLETED|Overall Study||23||
48417721|NCT02532998|101356949|FG000|NOT COMPLETED|Overall Study||0||
48417722|NCT01272245|101356950|FG000|STARTED|Overall Study||36||
48417723|NCT01272245|101356950|FG000|COMPLETED|Overall Study||36||
48417724|NCT01272245|101356950|FG000|NOT COMPLETED|Overall Study||0||
48417725|NCT01662752|101356951|FG000|STARTED|Overall Study||30||
48417726|NCT01662752|101356951|FG000|COMPLETED|Overall Study||30||
48417727|NCT01662752|101356951|FG000|NOT COMPLETED|Overall Study||0||
48417728|NCT00638989|101356952|FG000|STARTED|Overall Study||10||
48417729|NCT00638989|101356953|FG001|STARTED|Overall Study||10||
48417730|NCT00638989|101356954|FG002|STARTED|Overall Study||10||
48417731|NCT00638989|101356952|FG000|COMPLETED|Overall Study||10||
48417732|NCT00638989|101356953|FG001|COMPLETED|Overall Study||10||
48417733|NCT00638989|101356954|FG002|COMPLETED|Overall Study||9||
48417734|NCT00638989|101356952|FG000|NOT COMPLETED|Overall Study||0||
48417735|NCT00638989|101356953|FG001|NOT COMPLETED|Overall Study||0||
48638364|NCT00576758|101898736|FG000|NOT COMPLETED|Follow-up Period||27||
48638365|NCT00576758|101898737|FG001|NOT COMPLETED|Follow-up Period||17||
48638366|NCT01715285|101898738|FG000|STARTED|Double Blind Period (Up to 23 Months)||597||
48354397|NCT02111369|101195576|FG000|NOT COMPLETED|Overall Study||3||
48354398|NCT01687673|101195577|FG000|STARTED|Overall Study||29||
48354399|NCT01687673|101195577|FG000|COMPLETED|Overall Study||28|One patient was removed for hepatic decompensation before starting study treatment|
48354400|NCT01687673|101195577|FG000|NOT COMPLETED|Overall Study||1||
48354401|NCT01491945|101195578|FG000|STARTED|Overall Study||76||
48354402|NCT01491945|101195578|FG000|COMPLETED|Overall Study||25||
48354403|NCT01491945|101195578|FG000|NOT COMPLETED|Overall Study||51||
48354404|NCT00551707|101195579|FG000|STARTED|Overall Study||4||
48354405|NCT00551707|101195580|FG001|STARTED|Overall Study||22||
48354406|NCT00551707|101195581|FG002|STARTED|Overall Study||13||
48354407|NCT00551707|101195582|FG003|STARTED|Overall Study||8||
48354408|NCT00551707|101195583|FG004|STARTED|Overall Study||4||
48354409|NCT00551707|101195579|FG000|COMPLETED|Overall Study||4||
48354410|NCT00551707|101195580|FG001|COMPLETED|Overall Study||16||
48354411|NCT00551707|101195581|FG002|COMPLETED|Overall Study||10||
48354412|NCT00551707|101195582|FG003|COMPLETED|Overall Study||4||
48354413|NCT00551707|101195583|FG004|COMPLETED|Overall Study||3||
48354414|NCT00551707|101195579|FG000|NOT COMPLETED|Overall Study||0||
48417736|NCT00638989|101356954|FG002|NOT COMPLETED|Overall Study||1||
48417737|NCT03812224|101356955|FG000|STARTED|Double-blind Treatment Period||131||
48417738|NCT03812224|101356956|FG001|STARTED|Double-blind Treatment Period||130||
48638367|NCT01715285|101898739|FG001|STARTED|Double Blind Period (Up to 23 Months)||602||
48638368|NCT01715285|101898740|FG002|STARTED|Double Blind Period (Up to 23 Months)||0||
48638369|NCT01715285|101898738|FG000|COMPLETED|Double Blind Period (Up to 23 Months)||0||
48638370|NCT01715285|101898739|FG001|COMPLETED|Double Blind Period (Up to 23 Months)||0||
48638371|NCT01715285|101898740|FG002|COMPLETED|Double Blind Period (Up to 23 Months)||0||
48638372|NCT01715285|101898738|FG000|NOT COMPLETED|Double Blind Period (Up to 23 Months)||597||
48638373|NCT01715285|101898739|FG001|NOT COMPLETED|Double Blind Period (Up to 23 Months)||602||
48638374|NCT01715285|101898740|FG002|NOT COMPLETED|Double Blind Period (Up to 23 Months)||0||
48638375|NCT01715285|101898738|FG000|STARTED|OLE Phase (Up to 15.6 Months)||0||
48638376|NCT01715285|101898739|FG001|STARTED|OLE Phase (Up to 15.6 Months)||0||
48638377|NCT01715285|101898740|FG002|STARTED|OLE Phase (Up to 15.6 Months)||72||
48638378|NCT01715285|101898738|FG000|COMPLETED|OLE Phase (Up to 15.6 Months)||0||
48638379|NCT01715285|101898739|FG001|COMPLETED|OLE Phase (Up to 15.6 Months)||0||
48638380|NCT01715285|101898740|FG002|COMPLETED|OLE Phase (Up to 15.6 Months)||0||
48638381|NCT01715285|101898738|FG000|NOT COMPLETED|OLE Phase (Up to 15.6 Months)||0||
48638382|NCT01715285|101898739|FG001|NOT COMPLETED|OLE Phase (Up to 15.6 Months)||0||
48638383|NCT01715285|101898740|FG002|NOT COMPLETED|OLE Phase (Up to 15.6 Months)||72||
48638384|NCT02780388|101898741|FG000|STARTED|Overall Study||15||
48638385|NCT02780388|101898742|FG001|STARTED|Overall Study||8||
48354415|NCT00551707|101195580|FG001|NOT COMPLETED|Overall Study||6||
48354416|NCT00551707|101195581|FG002|NOT COMPLETED|Overall Study||3||
48354417|NCT00551707|101195582|FG003|NOT COMPLETED|Overall Study||4||
48354418|NCT00551707|101195583|FG004|NOT COMPLETED|Overall Study||1||
48354419|NCT00315302|101195584|FG000|STARTED|Overall Study||90||
48354420|NCT00315302|101195585|FG001|STARTED|Overall Study||90||
48354421|NCT00315302|101195586|FG002|STARTED|Overall Study||26||
48354422|NCT00315302|101195587|FG003|STARTED|Overall Study||34||
48354423|NCT00315302|101195584|FG000|5 Week Visit|Overall Study||85||
48354424|NCT00315302|101195585|FG001|5 Week Visit|Overall Study||86||
48417739|NCT03812224|101356955|FG000|COMPLETED|Double-blind Treatment Period||127||
48417740|NCT03812224|101356956|FG001|COMPLETED|Double-blind Treatment Period||127||
48417741|NCT03812224|101356955|FG000|NOT COMPLETED|Double-blind Treatment Period||4||
48417742|NCT03812224|101356956|FG001|NOT COMPLETED|Double-blind Treatment Period||3||
48354425|NCT00315302|101195586|FG002|5 Week Visit|Overall Study||26||
48417743|NCT03812224|101356955|FG000|STARTED|Open-label Treatment Period||127||
48417744|NCT03812224|101356956|FG001|STARTED|Open-label Treatment Period||127||
48417745|NCT03812224|101356955|FG000|COMPLETED|Open-label Treatment Period||125||
48417746|NCT03812224|101356956|FG001|COMPLETED|Open-label Treatment Period||124||
48417747|NCT03812224|101356955|FG000|NOT COMPLETED|Open-label Treatment Period||2||
48417748|NCT03812224|101356956|FG001|NOT COMPLETED|Open-label Treatment Period||3||
48417749|NCT00621764|101356957|FG000|STARTED|Overall Study||50||
48417750|NCT00621764|101356958|FG001|STARTED|Overall Study||50||
48417751|NCT00621764|101356959|FG002|STARTED|Overall Study||101||
48417752|NCT00621764|101356960|FG003|STARTED|Overall Study||99||
48417753|NCT00621764|101356957|FG000|COMPLETED|Overall Study||50||
48417754|NCT00621764|101356958|FG001|COMPLETED|Overall Study||50||
48417755|NCT00621764|101356959|FG002|COMPLETED|Overall Study||101||
48417756|NCT00621764|101356960|FG003|COMPLETED|Overall Study||98||
48417757|NCT00621764|101356957|FG000|NOT COMPLETED|Overall Study||0||
48417758|NCT00621764|101356958|FG001|NOT COMPLETED|Overall Study||0||
48417759|NCT00621764|101356959|FG002|NOT COMPLETED|Overall Study||0||
48417760|NCT00621764|101356960|FG003|NOT COMPLETED|Overall Study||1||
48417761|NCT02308709|101356961|FG000|STARTED|Overall Study||34||
48417762|NCT02308709|101356961|FG000|COMPLETED|Overall Study||33||
48417763|NCT02308709|101356961|FG000|NOT COMPLETED|Overall Study||1||
48417764|NCT01906489|101356962|FG000|STARTED|Overall Study||138||
48417765|NCT01906489|101356963|FG001|STARTED|Overall Study||72||
48417766|NCT01906489|101356962|FG000|COMPLETED|Overall Study||112||
48417767|NCT01906489|101356963|FG001|COMPLETED|Overall Study||63||
48354426|NCT00315302|101195587|FG003|5 Week Visit|Overall Study||30||
48354427|NCT00315302|101195584|FG000|10 Week Visit|Overall Study||86||
48354428|NCT00315302|101195585|FG001|10 Week Visit|Overall Study||85||
48354429|NCT00315302|101195586|FG002|10 Week Visit|Overall Study||24||
48354430|NCT00315302|101195587|FG003|10 Week Visit|Overall Study||29||
48354431|NCT00315302|101195584|FG000|18 Week Primary Outcome Visit|Overall Study||84||
48354432|NCT00315302|101195585|FG001|18 Week Primary Outcome Visit|Overall Study||88||
48354433|NCT00315302|101195586|FG002|18 Week Primary Outcome Visit|Overall Study||24||
48354434|NCT00315302|101195587|FG003|18 Week Primary Outcome Visit|Overall Study||31||
48354435|NCT00315302|101195584|FG000|Partial Responder Phase (Post 18 Weeks)|Overall Study||16||
48354436|NCT00315302|101195585|FG001|Partial Responder Phase (Post 18 Weeks)|Overall Study||13||
48354437|NCT00315302|101195586|FG002|Partial Responder Phase (Post 18 Weeks)|Overall Study||9||
48354438|NCT00315302|101195587|FG003|Partial Responder Phase (Post 18 Weeks)|Overall Study||11||
48354439|NCT00315302|101195584|FG000|COMPLETED|Overall Study||84||
48354440|NCT00315302|101195585|FG001|COMPLETED|Overall Study||88||
48417768|NCT01906489|101356962|FG000|NOT COMPLETED|Overall Study||26||
48417769|NCT01906489|101356963|FG001|NOT COMPLETED|Overall Study||9||
48417770|NCT02909504|101356964|FG000|STARTED|Overall Study||24||
48417771|NCT02909504|101356964|FG000|COMPLETED|Overall Study||12||
48417772|NCT02909504|101356964|FG000|NOT COMPLETED|Overall Study||12||
48417773|NCT00955682|101356965|FG000|STARTED|Year 2 Period||253||
48417774|NCT00955682|101356966|FG001|STARTED|Year 2 Period||42||
48417775|NCT00955682|101356965|FG000|COMPLETED|Year 2 Period||253||
48354441|NCT00315302|101195586|FG002|COMPLETED|Overall Study||24||
48354442|NCT00315302|101195587|FG003|COMPLETED|Overall Study||31||
48354443|NCT00315302|101195584|FG000|NOT COMPLETED|Overall Study||6||
48354444|NCT00315302|101195585|FG001|NOT COMPLETED|Overall Study||2||
48354445|NCT00315302|101195586|FG002|NOT COMPLETED|Overall Study||2||
48354446|NCT00315302|101195587|FG003|NOT COMPLETED|Overall Study||3||
48354447|NCT01587963|101195588|FG000|STARTED|Overall Study||7||
48354448|NCT01587963|101195589|FG001|STARTED|Overall Study||4||
48354449|NCT01587963|101195588|FG000|COMPLETED|Overall Study||6||
48354450|NCT01587963|101195589|FG001|COMPLETED|Overall Study||4||
48354451|NCT01587963|101195588|FG000|NOT COMPLETED|Overall Study||1||
48354452|NCT01587963|101195589|FG001|NOT COMPLETED|Overall Study||0||
48354453|NCT01078753|101195590|FG000|STARTED|Treatment Period I||45||
48354454|NCT01078753|101195591|FG001|STARTED|Treatment Period I||44||
48417776|NCT00955682|101356966|FG001|COMPLETED|Year 2 Period||42||
48417777|NCT00955682|101356965|FG000|NOT COMPLETED|Year 2 Period||0||
48417778|NCT00955682|101356966|FG001|NOT COMPLETED|Year 2 Period||0||
48417779|NCT00955682|101356965|FG000|STARTED|Year 3 Period||273||
48417780|NCT00955682|101356966|FG001|STARTED|Year 3 Period||47||
48417781|NCT00955682|101356965|FG000|COMPLETED|Year 3 Period||273||
48417782|NCT00955682|101356966|FG001|COMPLETED|Year 3 Period||47||
48417783|NCT00955682|101356965|FG000|NOT COMPLETED|Year 3 Period||0||
48417784|NCT00955682|101356966|FG001|NOT COMPLETED|Year 3 Period||0||
48354455|NCT01078753|101195590|FG000|Full Analysis Set|Treatment Period I||44||
48354456|NCT01078753|101195591|FG001|Full Analysis Set|Treatment Period I||44||
48354457|NCT01078753|101195590|FG000|COMPLETED|Treatment Period I||45||
48354458|NCT01078753|101195591|FG001|COMPLETED|Treatment Period I||44||
48354459|NCT01078753|101195590|FG000|NOT COMPLETED|Treatment Period I||0||
48354460|NCT01078753|101195591|FG001|NOT COMPLETED|Treatment Period I||0||
48354461|NCT01078753|101195590|FG000|STARTED|Treatment Period II||45||
48354462|NCT01078753|101195591|FG001|STARTED|Treatment Period II||44||
48354463|NCT01078753|101195590|FG000|Full Analysis Set|Treatment Period II||44||
48354464|NCT01078753|101195591|FG001|Full Analysis Set|Treatment Period II||44||
48354465|NCT01078753|101195590|FG000|COMPLETED|Treatment Period II||45||
48354466|NCT01078753|101195591|FG001|COMPLETED|Treatment Period II||44||
48354467|NCT01078753|101195590|FG000|NOT COMPLETED|Treatment Period II||0||
48354468|NCT01078753|101195591|FG001|NOT COMPLETED|Treatment Period II||0||
48354469|NCT03095703|101198294|FG000|STARTED|Overall Study||4||
48354470|NCT03095703|101198294|FG000|COMPLETED|Overall Study||3||
48354471|NCT03095703|101198294|FG000|NOT COMPLETED|Overall Study||1||
48354472|NCT00753636|101198295|FG000|STARTED|Overall Study||31||
48354473|NCT00753636|101198295|FG000|COMPLETED|Overall Study||25||
48354474|NCT00753636|101198295|FG000|NOT COMPLETED|Overall Study||6||
48354475|NCT03427073|101198296|FG000|STARTED|Overall Study||1||
48354476|NCT03427073|101198297|FG001|STARTED|Overall Study||1||
48354477|NCT03427073|101198298|FG002|STARTED|Overall Study||1||
48354478|NCT03427073|101198299|FG003|STARTED|Overall Study||3||
48354479|NCT03427073|101198300|FG004|STARTED|Overall Study||3||
48354480|NCT03427073|101198301|FG005|STARTED|Overall Study||4||
48354481|NCT03427073|101198302|FG006|STARTED|Overall Study||3||
48354482|NCT03427073|101198303|FG007|STARTED|Overall Study||4||
48354483|NCT03427073|101198296|FG000|COMPLETED|Overall Study||0||
48354484|NCT03427073|101198297|FG001|COMPLETED|Overall Study||0||
48354485|NCT03427073|101198298|FG002|COMPLETED|Overall Study||0||
48354486|NCT03427073|101198299|FG003|COMPLETED|Overall Study||0||
48354487|NCT03427073|101198300|FG004|COMPLETED|Overall Study||0||
48354488|NCT03427073|101198301|FG005|COMPLETED|Overall Study||0||
48354489|NCT03427073|101198302|FG006|COMPLETED|Overall Study||0||
48354490|NCT03427073|101198303|FG007|COMPLETED|Overall Study||0||
48354491|NCT03427073|101198296|FG000|NOT COMPLETED|Overall Study||1||
48354492|NCT03427073|101198297|FG001|NOT COMPLETED|Overall Study||1||
48354493|NCT03427073|101198298|FG002|NOT COMPLETED|Overall Study||1||
48354494|NCT03427073|101198299|FG003|NOT COMPLETED|Overall Study||3||
48354495|NCT03427073|101198300|FG004|NOT COMPLETED|Overall Study||3||
48354496|NCT03427073|101198301|FG005|NOT COMPLETED|Overall Study||4||
48354497|NCT03427073|101198302|FG006|NOT COMPLETED|Overall Study||3||
48354498|NCT03427073|101198303|FG007|NOT COMPLETED|Overall Study||4||
48354499|NCT02888626|101198304|FG000|STARTED|Overall Study||7||
48354500|NCT02888626|101198304|FG000|COMPLETED|Overall Study||7||
48354501|NCT02888626|101198304|FG000|NOT COMPLETED|Overall Study||0||
48354502|NCT02286102|101198305|FG000|STARTED|Overall Study||36||
48354503|NCT02286102|101198306|FG001|STARTED|Overall Study||34||
48354504|NCT02286102|101198305|FG000|COMPLETED|Overall Study||35||
48354505|NCT02286102|101198306|FG001|COMPLETED|Overall Study||33||
48354506|NCT02286102|101198305|FG000|NOT COMPLETED|Overall Study||1||
48354507|NCT02286102|101198306|FG001|NOT COMPLETED|Overall Study||1||
48354508|NCT00883753|101198307|FG000|STARTED|Overall Study||934||
48354509|NCT00883753|101198307|FG000|COMPLETED|Overall Study||827||
48354510|NCT00883753|101198307|FG000|NOT COMPLETED|Overall Study||107||
48354511|NCT02504541|101198308|FG000|STARTED|Overall Study||133||
48354512|NCT02504541|101198308|FG000|COMPLETED|Overall Study||113||
48354513|NCT02504541|101198308|FG000|NOT COMPLETED|Overall Study||20||
48354514|NCT03818815|101198309|FG000|STARTED|Overall Study||56||
48354515|NCT03818815|101198310|FG001|STARTED|Overall Study||47||
48354516|NCT03818815|101198309|FG000|COMPLETED|Overall Study||48||
48354517|NCT03818815|101198310|FG001|COMPLETED|Overall Study||42||
48354518|NCT03818815|101198309|FG000|NOT COMPLETED|Overall Study||8||
48354519|NCT03818815|101198310|FG001|NOT COMPLETED|Overall Study||5||
48354520|NCT03652454|101198311|FG000|STARTED|Overall Study||14||
48354521|NCT03652454|101198312|FG001|STARTED|Overall Study||14||
48354522|NCT03652454|101198311|FG000|COMPLETED|Overall Study||14||
48354523|NCT03652454|101198312|FG001|COMPLETED|Overall Study||14||
48354524|NCT03652454|101198311|FG000|NOT COMPLETED|Overall Study||0||
48354525|NCT03652454|101198312|FG001|NOT COMPLETED|Overall Study||0||
48762374|NCT03104868|102206002|FG000|COMPLETED|6 Week Follow up||188||
48762375|NCT03104868|102206003|FG001|COMPLETED|6 Week Follow up||187||
48762376|NCT03104868|102206002|FG000|NOT COMPLETED|6 Week Follow up||37||
48762377|NCT03104868|102206003|FG001|NOT COMPLETED|6 Week Follow up||37||
48762378|NCT03104868|102206002|FG000|STARTED|6 Month Follow up||212|Participants who started the 6 month period included those who completed the 6 week period and those who were unavailable for the 6 week period.|
48767771|NCT02237417|102222820|FG000|NOT COMPLETED|Overall Study||0||
48354526|NCT02498652|101198313|FG000|STARTED|Overall Study||20||
48354527|NCT02498652|101198314|FG001|STARTED|Overall Study||21||
48354528|NCT02498652|101198313|FG000|COMPLETED|Overall Study||20||
48354529|NCT02498652|101198314|FG001|COMPLETED|Overall Study||20||
48354530|NCT02498652|101198313|FG000|NOT COMPLETED|Overall Study||0||
48354531|NCT02498652|101198314|FG001|NOT COMPLETED|Overall Study||1||
48354532|NCT03119649|101198315|FG000|STARTED|Overall Study||11||
48354533|NCT03119649|101198316|FG001|STARTED|Overall Study||10||
48354534|NCT03119649|101198317|FG002|STARTED|Overall Study||10||
48354535|NCT03119649|101198318|FG003|STARTED|Overall Study||14||
48354536|NCT03119649|101198319|FG004|STARTED|Overall Study||14||
48417785|NCT00955682|101356965|FG000|STARTED|Year 4 Period||246||
48767772|NCT02237417|102222821|FG001|NOT COMPLETED|Overall Study||6||
48354537|NCT03119649|101198315|FG000|COMPLETED|Overall Study||11||
48354538|NCT03119649|101198316|FG001|COMPLETED|Overall Study||10||
48354539|NCT03119649|101198317|FG002|COMPLETED|Overall Study||10||
48354540|NCT03119649|101198318|FG003|COMPLETED|Overall Study||14||
48762379|NCT03104868|102206003|FG001|STARTED|6 Month Follow up||209|Participants who started the 6 month period included those who completed the 6 week period and those who were unavailable for the 6 week period.|
48354541|NCT03119649|101198319|FG004|COMPLETED|Overall Study||14||
48354542|NCT03119649|101198315|FG000|NOT COMPLETED|Overall Study||0||
48354543|NCT03119649|101198316|FG001|NOT COMPLETED|Overall Study||0||
48354544|NCT03119649|101198317|FG002|NOT COMPLETED|Overall Study||0||
48354545|NCT03119649|101198318|FG003|NOT COMPLETED|Overall Study||0||
48354546|NCT03119649|101198319|FG004|NOT COMPLETED|Overall Study||0||
48354547|NCT04278573|101198320|FG000|STARTED|Overall Study||41||
48354548|NCT04278573|101198321|FG001|STARTED|Overall Study||36||
48354549|NCT04278573|101198320|FG000|COMPLETED|Overall Study||41||
48354550|NCT04278573|101198321|FG001|COMPLETED|Overall Study||36||
48354551|NCT04278573|101198320|FG000|NOT COMPLETED|Overall Study||0||
48354552|NCT04278573|101198321|FG001|NOT COMPLETED|Overall Study||0||
48354553|NCT01486264|101198322|FG000|STARTED|Overall Study||142||
48354554|NCT01486264|101198323|FG001|STARTED|Overall Study||141||
48354555|NCT01486264|101198322|FG000|Treated|Overall Study||142||
48354556|NCT01486264|101198323|FG001|Treated|Overall Study||140||
48354557|NCT01486264|101198322|FG000|COMPLETED|Overall Study||113||
48354558|NCT01486264|101198323|FG001|COMPLETED|Overall Study||94||
48354559|NCT01486264|101198322|FG000|NOT COMPLETED|Overall Study||29||
48354560|NCT01486264|101198323|FG001|NOT COMPLETED|Overall Study||47||
48354561|NCT01195025|101198324|FG000|STARTED|First Intervention A||2||
48354562|NCT01195025|101198325|FG001|STARTED|First Intervention A||3||
48354563|NCT01195025|101198326|FG002|STARTED|First Intervention A||2||
48354564|NCT01195025|101198327|FG003|STARTED|First Intervention A||2||
48354565|NCT01195025|101198328|FG004|STARTED|First Intervention A||1||
48354566|NCT01195025|101198324|FG000|COMPLETED|First Intervention A||2||
48354567|NCT01195025|101198325|FG001|COMPLETED|First Intervention A||3||
48354568|NCT01195025|101198326|FG002|COMPLETED|First Intervention A||2||
48354569|NCT01195025|101198327|FG003|COMPLETED|First Intervention A||2||
48354570|NCT01195025|101198328|FG004|COMPLETED|First Intervention A||1||
48354571|NCT01195025|101198324|FG000|NOT COMPLETED|First Intervention A||0||
48354572|NCT01195025|101198325|FG001|NOT COMPLETED|First Intervention A||0||
48354573|NCT01195025|101198326|FG002|NOT COMPLETED|First Intervention A||0||
48354574|NCT01195025|101198327|FG003|NOT COMPLETED|First Intervention A||0||
48354575|NCT01195025|101198328|FG004|NOT COMPLETED|First Intervention A||0||
48354576|NCT01195025|101198324|FG000|STARTED|Second Intervention B||2||
48354577|NCT01195025|101198325|FG001|STARTED|Second Intervention B||3||
48354578|NCT01195025|101198326|FG002|STARTED|Second Intervention B||2||
48354579|NCT01195025|101198327|FG003|STARTED|Second Intervention B||2||
48354580|NCT01195025|101198328|FG004|STARTED|Second Intervention B||1||
48354581|NCT01195025|101198324|FG000|COMPLETED|Second Intervention B||2||
48354582|NCT01195025|101198325|FG001|COMPLETED|Second Intervention B||3||
48354583|NCT01195025|101198326|FG002|COMPLETED|Second Intervention B||2||
48354584|NCT01195025|101198327|FG003|COMPLETED|Second Intervention B||2||
48354585|NCT01195025|101198328|FG004|COMPLETED|Second Intervention B||1||
48354586|NCT01195025|101198324|FG000|NOT COMPLETED|Second Intervention B||0||
48354587|NCT01195025|101198325|FG001|NOT COMPLETED|Second Intervention B||0||
48354588|NCT01195025|101198326|FG002|NOT COMPLETED|Second Intervention B||0||
48354589|NCT01195025|101198327|FG003|NOT COMPLETED|Second Intervention B||0||
48354590|NCT01195025|101198328|FG004|NOT COMPLETED|Second Intervention B||0||
48354591|NCT01195025|101198324|FG000|STARTED|Third Intervention C||2||
48354592|NCT01195025|101198325|FG001|STARTED|Third Intervention C||3||
48354593|NCT01195025|101198326|FG002|STARTED|Third Intervention C||2||
48354594|NCT01195025|101198327|FG003|STARTED|Third Intervention C||2||
48354595|NCT01195025|101198328|FG004|STARTED|Third Intervention C||1||
48354596|NCT01195025|101198324|FG000|COMPLETED|Third Intervention C||2||
48354597|NCT01195025|101198325|FG001|COMPLETED|Third Intervention C||3||
48354598|NCT01195025|101198326|FG002|COMPLETED|Third Intervention C||2||
48417786|NCT00955682|101356966|FG001|STARTED|Year 4 Period||48||
48417787|NCT00955682|101356965|FG000|COMPLETED|Year 4 Period||246||
48762380|NCT03104868|102206002|FG000|COMPLETED|6 Month Follow up||188||
48762381|NCT03104868|102206003|FG001|COMPLETED|6 Month Follow up||174||
48762382|NCT03104868|102206002|FG000|NOT COMPLETED|6 Month Follow up||24||
48762383|NCT03104868|102206003|FG001|NOT COMPLETED|6 Month Follow up||35||
48354599|NCT01195025|101198327|FG003|COMPLETED|Third Intervention C||2||
48354600|NCT01195025|101198328|FG004|COMPLETED|Third Intervention C||1||
48354601|NCT01195025|101198324|FG000|NOT COMPLETED|Third Intervention C||0||
48354602|NCT01195025|101198325|FG001|NOT COMPLETED|Third Intervention C||0||
48354603|NCT01195025|101198326|FG002|NOT COMPLETED|Third Intervention C||0||
48354604|NCT01195025|101198327|FG003|NOT COMPLETED|Third Intervention C||0||
48354605|NCT01195025|101198328|FG004|NOT COMPLETED|Third Intervention C||0||
48354606|NCT04112914|101198329|FG000|STARTED|Overall Study||75||
48354607|NCT04112914|101198330|FG001|STARTED|Overall Study||23||
48354608|NCT04112914|101198329|FG000|COMPLETED|Overall Study||61||
48354609|NCT04112914|101198330|FG001|COMPLETED|Overall Study||14||
48354610|NCT04112914|101198329|FG000|NOT COMPLETED|Overall Study||14||
48354611|NCT04112914|101198330|FG001|NOT COMPLETED|Overall Study||9||
48354612|NCT00815308|101198331|FG000|STARTED|Overall Study||55||
48354613|NCT00815308|101198331|FG000|COMPLETED|Overall Study||45||
48354614|NCT00815308|101198331|FG000|NOT COMPLETED|Overall Study||10||
48354615|NCT00957372|101198332|FG000|STARTED|PART I||80||
48354616|NCT00957372|101198333|FG001|STARTED|PART I||85||
48354617|NCT00957372|101198334|FG002|STARTED|PART I||88||
48354618|NCT00957372|101198335|FG003|STARTED|PART I||0||
48354619|NCT00957372|101198332|FG000|Safety Population|PART I||80||
48354620|NCT00957372|101198333|FG001|Safety Population|PART I||85||
48354621|NCT00957372|101198334|FG002|Safety Population|PART I||87||
48354622|NCT00957372|101198335|FG003|Safety Population|PART I||0||
48354623|NCT00957372|101198332|FG000|Intention-to-Treat Population|PART I||77||
48354624|NCT00957372|101198333|FG001|Intention-to-Treat Population|PART I||84||
48354625|NCT00957372|101198334|FG002|Intention-to-Treat Population|PART I||84||
48354626|NCT00957372|101198335|FG003|Intention-to-Treat Population|PART I||0||
48354627|NCT00957372|101198332|FG000|Per-Protocol Population|PART I||35||
48354628|NCT00957372|101198333|FG001|Per-Protocol Population|PART I||47||
48354629|NCT00957372|101198334|FG002|Per-Protocol Population|PART I||51||
48354630|NCT00957372|101198335|FG003|Per-Protocol Population|PART I||0||
48354631|NCT00957372|101198332|FG000|Randomized But Not Treated|PART I||0||
48354632|NCT00957372|101198333|FG001|Randomized But Not Treated|PART I||0||
48354633|NCT00957372|101198334|FG002|Randomized But Not Treated|PART I||1||
48354634|NCT00957372|101198335|FG003|Randomized But Not Treated|PART I||0||
48354635|NCT00957372|101198332|FG000|COMPLETED|PART I||80||
48354636|NCT00957372|101198333|FG001|COMPLETED|PART I||85||
48354637|NCT00957372|101198334|FG002|COMPLETED|PART I||87||
48354638|NCT00957372|101198335|FG003|COMPLETED|PART I||0||
48354639|NCT00957372|101198332|FG000|NOT COMPLETED|PART I||0||
48354640|NCT00957372|101198333|FG001|NOT COMPLETED|PART I||0||
48354641|NCT00957372|101198334|FG002|NOT COMPLETED|PART I||1||
48354642|NCT00957372|101198335|FG003|NOT COMPLETED|PART I||0||
48354643|NCT00957372|101198332|FG000|STARTED|PART II||0||
48354644|NCT00957372|101198333|FG001|STARTED|PART II||0||
48354645|NCT00957372|101198334|FG002|STARTED|PART II||0||
48354646|NCT00957372|101198335|FG003|STARTED|PART II||194||
48354647|NCT00957372|101198332|FG000|Safety Population|PART II||0||
48354648|NCT00957372|101198333|FG001|Safety Population|PART II||0||
48354649|NCT00957372|101198334|FG002|Safety Population|PART II||0||
48354650|NCT00957372|101198335|FG003|Safety Population|PART II||194||
48354651|NCT00957372|101198332|FG000|Intention-to-treat (ITT) Population|PART II||0||
48354652|NCT00957372|101198333|FG001|Intention-to-treat (ITT) Population|PART II||0||
48354653|NCT00957372|101198334|FG002|Intention-to-treat (ITT) Population|PART II||0||
48354654|NCT00957372|101198335|FG003|Intention-to-treat (ITT) Population|PART II||191||
48354655|NCT00957372|101198332|FG000|Per-Protocol Population|PART II||0||
48354656|NCT00957372|101198333|FG001|Per-Protocol Population|PART II||0||
48354657|NCT00957372|101198334|FG002|Per-Protocol Population|PART II||0||
48354658|NCT00957372|101198335|FG003|Per-Protocol Population|PART II||108||
48354659|NCT00957372|101198332|FG000|COMPLETED|PART II||0||
48354660|NCT00957372|101198333|FG001|COMPLETED|PART II||0||
48354661|NCT00957372|101198334|FG002|COMPLETED|PART II||0||
48354662|NCT00957372|101198335|FG003|COMPLETED|PART II||150||
48354663|NCT00957372|101198332|FG000|NOT COMPLETED|PART II||0||
48354664|NCT00957372|101198333|FG001|NOT COMPLETED|PART II||0||
48354665|NCT00957372|101198334|FG002|NOT COMPLETED|PART II||0||
48354666|NCT00957372|101198335|FG003|NOT COMPLETED|PART II||44||
48354667|NCT03102411|101198336|FG000|STARTED|Overall Study||1881||
48354668|NCT03102411|101198336|FG000|COMPLETED|Overall Study||1718||
48354669|NCT03102411|101198336|FG000|NOT COMPLETED|Overall Study||163||
48354670|NCT02362373|101198337|FG000|STARTED|Overall Study||20||
48354671|NCT02362373|101198337|FG000|COMPLETED|Overall Study||20||
48354672|NCT02362373|101198337|FG000|NOT COMPLETED|Overall Study||0||
48354673|NCT00327392|101198338|FG000|STARTED|Overall Study||123||
48354674|NCT00327392|101198338|FG000|COMPLETED|Overall Study||123||
48354675|NCT00327392|101198338|FG000|NOT COMPLETED|Overall Study||0||
48354676|NCT01826214|101198339|FG000|STARTED|Overall Study||35||
48354677|NCT01826214|101198340|FG001|STARTED|Overall Study||34||
48354678|NCT01826214|101198339|FG000|Untreated|Overall Study||0||
48354679|NCT01826214|101198340|FG001|Untreated|Overall Study||1||
48354680|NCT01826214|101198339|FG000|Treated|Overall Study||35||
48354681|NCT01826214|101198340|FG001|Treated|Overall Study||34||
48354682|NCT01826214|101198339|FG000|COMPLETED|Overall Study||0||
48354683|NCT01826214|101198340|FG001|COMPLETED|Overall Study||0||
48354684|NCT01826214|101198339|FG000|NOT COMPLETED|Overall Study||35||
48354685|NCT01826214|101198340|FG001|NOT COMPLETED|Overall Study||34||
48354686|NCT04884243|101198341|FG000|STARTED|Overall Study||32||
48354687|NCT04884243|101198342|FG001|STARTED|Overall Study||30||
48354688|NCT04884243|101198343|FG002|STARTED|Overall Study||30||
48354689|NCT04884243|101198341|FG000|COMPLETED|Overall Study||32||
48354690|NCT04884243|101198342|FG001|COMPLETED|Overall Study||29||
48354691|NCT04884243|101198343|FG002|COMPLETED|Overall Study||28||
48354692|NCT04884243|101198341|FG000|NOT COMPLETED|Overall Study||0||
48354693|NCT04884243|101198342|FG001|NOT COMPLETED|Overall Study||1||
48354694|NCT04884243|101198343|FG002|NOT COMPLETED|Overall Study||2||
48354695|NCT02626338|101198344|FG000|STARTED|Overall Study||9||
48354696|NCT02626338|101198345|FG001|STARTED|Overall Study||6||
48354697|NCT02626338|101198346|FG002|STARTED|Overall Study||1||
48354698|NCT02626338|101198344|FG000|COMPLETED|Overall Study||6||
48354699|NCT02626338|101198345|FG001|COMPLETED|Overall Study||4||
48354700|NCT02626338|101198346|FG002|COMPLETED|Overall Study||1||
48354701|NCT02626338|101198344|FG000|NOT COMPLETED|Overall Study||3||
48354702|NCT02626338|101198345|FG001|NOT COMPLETED|Overall Study||2||
48354703|NCT02626338|101198346|FG002|NOT COMPLETED|Overall Study||0||
48354704|NCT01712360|101198347|FG000|STARTED|Overall Study||22||
48354705|NCT01712360|101198348|FG001|STARTED|Overall Study||22||
48354706|NCT01712360|101198349|FG002|STARTED|Overall Study||6||
48417788|NCT00955682|101356966|FG001|COMPLETED|Year 4 Period||48||
48417789|NCT00955682|101356965|FG000|NOT COMPLETED|Year 4 Period||0||
48417790|NCT00955682|101356966|FG001|NOT COMPLETED|Year 4 Period||0||
48417791|NCT00955682|101356965|FG000|STARTED|Booster Period (Month 48- 49)||245||
48417792|NCT00955682|101356966|FG001|STARTED|Booster Period (Month 48- 49)||48||
48417793|NCT00955682|101356965|FG000|COMPLETED|Booster Period (Month 48- 49)||244||
48417794|NCT00955682|101356966|FG001|COMPLETED|Booster Period (Month 48- 49)||47||
48417795|NCT00955682|101356965|FG000|NOT COMPLETED|Booster Period (Month 48- 49)||1||
48417796|NCT00955682|101356966|FG001|NOT COMPLETED|Booster Period (Month 48- 49)||1||
48417797|NCT00955682|101356965|FG000|STARTED|Year 5 Period||239||
48417798|NCT00955682|101356966|FG001|STARTED|Year 5 Period||47||
48417799|NCT00955682|101356965|FG000|COMPLETED|Year 5 Period||239||
48417800|NCT00955682|101356966|FG001|COMPLETED|Year 5 Period||47||
48417801|NCT00955682|101356965|FG000|NOT COMPLETED|Year 5 Period||0||
48417802|NCT00955682|101356966|FG001|NOT COMPLETED|Year 5 Period||0||
48417803|NCT03276494|101356967|FG000|STARTED|Overall Study||6||
48354707|NCT01712360|101198350|FG003|STARTED|Overall Study||6||
48354708|NCT01712360|101198347|FG000|COMPLETED|Overall Study||22||
48354709|NCT01712360|101198348|FG001|COMPLETED|Overall Study||21||
48354710|NCT01712360|101198349|FG002|COMPLETED|Overall Study||6||
48354711|NCT01712360|101198350|FG003|COMPLETED|Overall Study||4||
48354712|NCT01712360|101198347|FG000|NOT COMPLETED|Overall Study||0||
48354713|NCT01712360|101198348|FG001|NOT COMPLETED|Overall Study||1||
48354714|NCT01712360|101198349|FG002|NOT COMPLETED|Overall Study||0||
48354715|NCT01712360|101198350|FG003|NOT COMPLETED|Overall Study||2||
48354716|NCT03846947|101198351|FG000|STARTED|Overall Study||28||
48354717|NCT03846947|101198351|FG000|COMPLETED|Overall Study||26||
48354718|NCT03846947|101198351|FG000|NOT COMPLETED|Overall Study||2||
48354719|NCT00736229|101198352|FG000|STARTED|Overall Study||40||
48354720|NCT00736229|101198353|FG001|STARTED|Overall Study||71||
48354721|NCT00736229|101198354|FG002|STARTED|Overall Study||84||
48354722|NCT00736229|101198352|FG000|COMPLETED|Overall Study||40||
48354723|NCT00736229|101198353|FG001|COMPLETED|Overall Study||71||
48354724|NCT00736229|101198354|FG002|COMPLETED|Overall Study||84||
48354725|NCT00736229|101198352|FG000|NOT COMPLETED|Overall Study||0||
48354726|NCT00736229|101198353|FG001|NOT COMPLETED|Overall Study||0||
48354727|NCT00736229|101198354|FG002|NOT COMPLETED|Overall Study||0||
48354728|NCT02258412|101198355|FG000|STARTED|Overall Study||26||
48354729|NCT02258412|101198356|FG001|STARTED|Overall Study||25||
48354730|NCT02258412|101198357|FG002|STARTED|Overall Study||61||
48354731|NCT02258412|101198355|FG000|COMPLETED|Overall Study||26||
48354732|NCT02258412|101198356|FG001|COMPLETED|Overall Study||25||
48354733|NCT02258412|101198357|FG002|COMPLETED|Overall Study||61||
48354734|NCT02258412|101198355|FG000|NOT COMPLETED|Overall Study||0||
48417804|NCT03276494|101356967|FG000|COMPLETED|Overall Study||5||
48417805|NCT03276494|101356967|FG000|NOT COMPLETED|Overall Study||1||
48417806|NCT01032265|101356968|FG000|STARTED|Overall Study||126||
48417807|NCT01032265|101356969|FG001|STARTED|Overall Study||124||
48417808|NCT01032265|101356968|FG000|COMPLETED|Overall Study||113||
48417809|NCT01032265|101356969|FG001|COMPLETED|Overall Study||107||
48417810|NCT01032265|101356968|FG000|NOT COMPLETED|Overall Study||13||
48417811|NCT01032265|101356969|FG001|NOT COMPLETED|Overall Study||17||
48417812|NCT02561273|101356970|FG000|STARTED|Overall Study||40||
48417813|NCT02561273|101356971|FG001|STARTED|Overall Study||4||
48417814|NCT02561273|101356970|FG000|COMPLETED|Overall Study||39||
48354735|NCT02258412|101198356|FG001|NOT COMPLETED|Overall Study||0||
48354736|NCT02258412|101198357|FG002|NOT COMPLETED|Overall Study||0||
48354737|NCT01773473|101198358|FG000|STARTED|Overall Study||207||
48354738|NCT01773473|101198359|FG001|STARTED|Overall Study||196||
48354739|NCT01773473|101198358|FG000|Received at Least 1 Dose of Study Drug|Overall Study||207||
48354740|NCT01773473|101198359|FG001|Received at Least 1 Dose of Study Drug|Overall Study||196||
48354741|NCT01773473|101198358|FG000|COMPLETED|Overall Study||191||
48354742|NCT01773473|101198359|FG001|COMPLETED|Overall Study||177||
48354743|NCT01773473|101198358|FG000|NOT COMPLETED|Overall Study||16||
48354744|NCT01773473|101198359|FG001|NOT COMPLETED|Overall Study||19||
48354745|NCT00104104|101198360|FG000|STARTED|Overall Study||90||
48354746|NCT00104104|101198361|FG001|STARTED|Overall Study||89||
48354747|NCT00104104|101198360|FG000|Safety Population (Including Site 74)|Overall Study||88||
48354748|NCT00104104|101198361|FG001|Safety Population (Including Site 74)|Overall Study||88||
48354749|NCT00104104|101198360|FG000|Safety Population (Excluding Site 74)|Overall Study||85||
48354750|NCT00104104|101198361|FG001|Safety Population (Excluding Site 74)|Overall Study||84||
48354751|NCT00104104|101198360|FG000|COMPLETED|Overall Study||15||
48354752|NCT00104104|101198361|FG001|COMPLETED|Overall Study||17||
48354753|NCT00104104|101198360|FG000|NOT COMPLETED|Overall Study||75||
48354754|NCT00104104|101198361|FG001|NOT COMPLETED|Overall Study||72||
48354755|NCT00608140|101198362|FG000|STARTED|Overall Study||1||
48354756|NCT00608140|101198363|FG001|STARTED|Overall Study||1||
48354757|NCT00608140|101198362|FG000|COMPLETED|Overall Study||0||
48354758|NCT00608140|101198363|FG001|COMPLETED|Overall Study||0||
48354759|NCT00608140|101198362|FG000|NOT COMPLETED|Overall Study||1||
48354760|NCT00608140|101198363|FG001|NOT COMPLETED|Overall Study||1||
48354761|NCT00938548|101198364|FG000|STARTED|Overall Study||35||
48767773|NCT02237417|102222822|FG002|NOT COMPLETED|Overall Study||9||
48767774|NCT04139018|102222823|FG000|STARTED|Overall Study||14||
48354762|NCT00938548|101198365|FG001|STARTED|Overall Study||35||
48354763|NCT00938548|101198364|FG000|COMPLETED|Overall Study||35||
48354764|NCT00938548|101198365|FG001|COMPLETED|Overall Study||35||
48354765|NCT00938548|101198364|FG000|NOT COMPLETED|Overall Study||0||
48354766|NCT00938548|101198365|FG001|NOT COMPLETED|Overall Study||0||
48354767|NCT01498991|101198366|FG000|STARTED|Overall Study||2||
48354768|NCT01498991|101198366|FG000|COMPLETED|Overall Study||2||
48354769|NCT01498991|101198366|FG000|NOT COMPLETED|Overall Study||0||
48354770|NCT02452359|101198367|FG000|STARTED|Overall Study||54||
48354771|NCT02452359|101198367|FG000|COMPLETED|Overall Study||33||
48354772|NCT02452359|101198367|FG000|NOT COMPLETED|Overall Study||21||
48354773|NCT02904226|101198368|FG000|STARTED|Overall Study||40||
48354774|NCT02904226|101198369|FG001|STARTED|Overall Study||31||
48354775|NCT02904226|101198370|FG002|STARTED|Overall Study||30||
48354776|NCT02904226|101198371|FG003|STARTED|Overall Study||100||
48354777|NCT02904226|101198372|FG004|STARTED|Overall Study||11||
48354778|NCT02904226|101198373|FG005|STARTED|Overall Study||0||
48354779|NCT02904226|101198374|FG006|STARTED|Overall Study||6||
48354780|NCT02904226|101198375|FG007|STARTED|Overall Study||0||
48354781|NCT02904226|101198368|FG000|COMPLETED|Overall Study||0||
48354782|NCT02904226|101198369|FG001|COMPLETED|Overall Study||2||
48354783|NCT02904226|101198370|FG002|COMPLETED|Overall Study||0||
48354784|NCT02904226|101198371|FG003|COMPLETED|Overall Study||4||
48354785|NCT02904226|101198372|FG004|COMPLETED|Overall Study||0||
48354786|NCT02904226|101198373|FG005|COMPLETED|Overall Study||0||
48354787|NCT02904226|101198374|FG006|COMPLETED|Overall Study||0||
48354788|NCT02904226|101198375|FG007|COMPLETED|Overall Study||0||
48354789|NCT02904226|101198368|FG000|NOT COMPLETED|Overall Study||40||
48354790|NCT02904226|101198369|FG001|NOT COMPLETED|Overall Study||29||
48354791|NCT02904226|101198370|FG002|NOT COMPLETED|Overall Study||30||
48354792|NCT02904226|101198371|FG003|NOT COMPLETED|Overall Study||96||
48354793|NCT02904226|101198372|FG004|NOT COMPLETED|Overall Study||11||
48354794|NCT02904226|101198373|FG005|NOT COMPLETED|Overall Study||0||
48354795|NCT02904226|101198374|FG006|NOT COMPLETED|Overall Study||6||
48354796|NCT02904226|101198375|FG007|NOT COMPLETED|Overall Study||0||
48354797|NCT01538615|101198376|FG000|STARTED|Overall Study||162||
48354798|NCT01538615|101198377|FG001|STARTED|Overall Study||158||
48354799|NCT01538615|101198376|FG000|COMPLETED|Overall Study||140||
48354800|NCT01538615|101198377|FG001|COMPLETED|Overall Study||146||
48354801|NCT01538615|101198376|FG000|NOT COMPLETED|Overall Study||22||
48354802|NCT01538615|101198377|FG001|NOT COMPLETED|Overall Study||12||
48354803|NCT00662155|101198378|FG000|STARTED|Overall Study||16||
48354804|NCT00662155|101198379|FG001|STARTED|Overall Study||20||
48354805|NCT00662155|101198380|FG002|STARTED|Overall Study||20||
48354806|NCT00662155|101198381|FG003|STARTED|Overall Study||18||
48354807|NCT00662155|101198378|FG000|COMPLETED|Overall Study||13||
48354808|NCT00662155|101198379|FG001|COMPLETED|Overall Study||15||
48354809|NCT00662155|101198380|FG002|COMPLETED|Overall Study||13||
48354810|NCT00662155|101198381|FG003|COMPLETED|Overall Study||14||
48354811|NCT00662155|101198378|FG000|NOT COMPLETED|Overall Study||3||
48354812|NCT00662155|101198379|FG001|NOT COMPLETED|Overall Study||5||
48354813|NCT00662155|101198380|FG002|NOT COMPLETED|Overall Study||7||
48417815|NCT02561273|101356971|FG001|COMPLETED|Overall Study||4||
48417816|NCT02561273|101356970|FG000|NOT COMPLETED|Overall Study||1||
48354814|NCT00662155|101198381|FG003|NOT COMPLETED|Overall Study||4||
48354815|NCT00101361|101198382|FG000|STARTED|Overall Study||108||
48354816|NCT00101361|101198383|FG001|STARTED|Overall Study||104||
48354817|NCT00101361|101198382|FG000|COMPLETED|Overall Study||108||
48354818|NCT00101361|101198383|FG001|COMPLETED|Overall Study||104||
48354819|NCT00101361|101198382|FG000|NOT COMPLETED|Overall Study||0||
48354820|NCT00101361|101198383|FG001|NOT COMPLETED|Overall Study||0||
48354821|NCT01981187|101198384|FG000|STARTED|Overall Study||12||
48354822|NCT01981187|101198384|FG000|COMPLETED|Overall Study||0||
48354823|NCT01981187|101198384|FG000|NOT COMPLETED|Overall Study||12||
48354824|NCT03572634|101198385|FG000|STARTED|Overall Study||1||
48354825|NCT03572634|101198386|FG001|STARTED|Overall Study||2||
48354826|NCT03572634|101198385|FG000|COMPLETED|Overall Study||1||
48354827|NCT03572634|101198386|FG001|COMPLETED|Overall Study||2||
48354828|NCT03572634|101198385|FG000|NOT COMPLETED|Overall Study||0||
48354829|NCT03572634|101198386|FG001|NOT COMPLETED|Overall Study||0||
48354830|NCT01575912|101198387|FG000|STARTED|Overall Study||30||
48354831|NCT01575912|101198388|FG001|STARTED|Overall Study||32||
48354832|NCT01575912|101198389|FG002|STARTED|Overall Study||30||
48354833|NCT01575912|101198387|FG000|COMPLETED|Overall Study||30||
48354834|NCT01575912|101198388|FG001|COMPLETED|Overall Study||32||
48354835|NCT01575912|101198389|FG002|COMPLETED|Overall Study||30||
48354836|NCT01575912|101198387|FG000|NOT COMPLETED|Overall Study||0||
48354837|NCT01575912|101198388|FG001|NOT COMPLETED|Overall Study||0||
48417817|NCT02561273|101356971|FG001|NOT COMPLETED|Overall Study||0||
48417818|NCT00137267|101356972|FG000|STARTED|Overall Study||55||
48417819|NCT00137267|101356973|FG001|STARTED|Overall Study||47||
48417820|NCT00137267|101356972|FG000|COMPLETED|Overall Study||40||
48417821|NCT00137267|101356973|FG001|COMPLETED|Overall Study||26||
48417822|NCT00137267|101356972|FG000|NOT COMPLETED|Overall Study||15||
48417823|NCT00137267|101356973|FG001|NOT COMPLETED|Overall Study||21||
48417824|NCT00696774|101356974|FG000|STARTED|Period II||115||
48417825|NCT00696774|101356975|FG001|STARTED|Period II||91||
48417826|NCT00696774|101356976|FG002|STARTED|Period II||36||
48417827|NCT00696774|101356974|FG000|COMPLETED|Period II||115||
48417828|NCT00696774|101356975|FG001|COMPLETED|Period II||91||
48417829|NCT00696774|101356976|FG002|COMPLETED|Period II||0||
48417830|NCT00696774|101356974|FG000|NOT COMPLETED|Period II||0||
48417831|NCT00696774|101356975|FG001|NOT COMPLETED|Period II||0||
48417832|NCT00696774|101356976|FG002|NOT COMPLETED|Period II||36||
48417833|NCT00696774|101356974|FG000|STARTED|Period III||113||
48417834|NCT00696774|101356975|FG001|STARTED|Period III||88||
48417835|NCT00696774|101356976|FG002|STARTED|Period III||0||
48417836|NCT00696774|101356974|FG000|COMPLETED|Period III||106||
48417837|NCT00696774|101356975|FG001|COMPLETED|Period III||81||
48417838|NCT00696774|101356976|FG002|COMPLETED|Period III||0||
48417839|NCT00696774|101356974|FG000|NOT COMPLETED|Period III||7||
48417840|NCT00696774|101356975|FG001|NOT COMPLETED|Period III||7||
48417841|NCT00696774|101356976|FG002|NOT COMPLETED|Period III||0||
48417842|NCT01536418|101356977|FG000|STARTED|Overall Study||127||
48417843|NCT01536418|101356978|FG001|STARTED|Overall Study||126||
48417844|NCT01536418|101356977|FG000|COMPLETED|Overall Study||58||
48417845|NCT01536418|101356978|FG001|COMPLETED|Overall Study||60||
48417846|NCT01536418|101356977|FG000|NOT COMPLETED|Overall Study||69||
48417847|NCT01536418|101356978|FG001|NOT COMPLETED|Overall Study||66||
48417848|NCT04880642|101356979|FG000|STARTED|Randomization||136||
48417849|NCT04880642|101356980|FG001|STARTED|Randomization||136||
48417850|NCT04880642|101356979|FG000|COMPLETED|Randomization||134||
48417851|NCT04880642|101356980|FG001|COMPLETED|Randomization||133||
48417852|NCT04880642|101356979|FG000|NOT COMPLETED|Randomization||2||
48417853|NCT04880642|101356980|FG001|NOT COMPLETED|Randomization||3||
48417854|NCT04880642|101356979|FG000|STARTED|Treatment Period||134||
48417855|NCT04880642|101356980|FG001|STARTED|Treatment Period||133||
48417856|NCT04880642|101356979|FG000|COMPLETED|Treatment Period||122||
48354838|NCT01575912|101198389|FG002|NOT COMPLETED|Overall Study||0||
48354839|NCT03348514|101198390|FG000|STARTED|Overall Study||1||
48354840|NCT03348514|101198391|FG001|STARTED|Overall Study||1||
48354841|NCT03348514|101198392|FG002|STARTED|Overall Study||1||
48354842|NCT03348514|101198393|FG003|STARTED|Overall Study||1||
48354843|NCT03348514|101198394|FG004|STARTED|Overall Study||3||
48354844|NCT03348514|101198395|FG005|STARTED|Overall Study||4||
48417857|NCT04880642|101356980|FG001|COMPLETED|Treatment Period||121||
48417858|NCT04880642|101356979|FG000|NOT COMPLETED|Treatment Period||12||
48417859|NCT04880642|101356980|FG001|NOT COMPLETED|Treatment Period||12||
48417860|NCT04880642|101356979|FG000|STARTED|Follow-up||122|A total of 8 subjects (5 subjects in the C21 group and 3 subjects in the placebo group) discontinued treatment but continued to participate in the trial.|
48417861|NCT04880642|101356980|FG001|STARTED|Follow-up||121|A total of 8 subjects (5 subjects in the C21 group and 3 subjects in the placebo group) discontinued treatment but continued to participate in the trial.|
48417862|NCT04880642|101356979|FG000|COMPLETED|Follow-up||117||
48417863|NCT04880642|101356980|FG001|COMPLETED|Follow-up||118||
48417864|NCT04880642|101356979|FG000|NOT COMPLETED|Follow-up||5||
48417865|NCT04880642|101356980|FG001|NOT COMPLETED|Follow-up||3||
48417866|NCT00848172|101356981|FG000|STARTED|Visit 2 - Drug Administration||10||
48417867|NCT00848172|101356982|FG001|STARTED|Visit 2 - Drug Administration||9||
48417868|NCT00848172|101356981|FG000|COMPLETED|Visit 2 - Drug Administration||10||
48417869|NCT00848172|101356982|FG001|COMPLETED|Visit 2 - Drug Administration||8||
48417870|NCT00848172|101356981|FG000|NOT COMPLETED|Visit 2 - Drug Administration||0||
48417871|NCT00848172|101356982|FG001|NOT COMPLETED|Visit 2 - Drug Administration||1||
48417872|NCT00848172|101356981|FG000|STARTED|Visit 3 - Follow Up||10||
48417873|NCT00848172|101356982|FG001|STARTED|Visit 3 - Follow Up||8||
48762384|NCT03104868|102206002|FG000|STARTED|12 Month Follow up||210|Participants who started the 12 month period included those who completed the 6 month period and those who were unavailable for the 6 month period|
48762385|NCT03104868|102206003|FG001|STARTED|12 Month Follow up||206|Participants who started the 12 month period included those who completed the 6 month period and those who were unavailable for the 6 month period|
48762386|NCT03104868|102206002|FG000|COMPLETED|12 Month Follow up||177||
48354845|NCT03348514|101198396|FG006|STARTED|Overall Study||6||
48354846|NCT03348514|101198397|FG007|STARTED|Overall Study||2||
48762387|NCT03104868|102206003|FG001|COMPLETED|12 Month Follow up||171||
48762388|NCT03104868|102206002|FG000|NOT COMPLETED|12 Month Follow up||33||
48762389|NCT03104868|102206003|FG001|NOT COMPLETED|12 Month Follow up||35||
48762390|NCT03104868|102206002|FG000|STARTED|18 Month Follow up||209|Participants who started the 18 month period included those who completed the 12 month period and those who were unavailable for the 12 month period|
48762391|NCT03104868|102206003|FG001|STARTED|18 Month Follow up||200|Participants who started the 18 month period included those who completed the 12 month period and those who were unavailable for the 12 month period|
48762392|NCT03104868|102206002|FG000|COMPLETED|18 Month Follow up||179||
48354847|NCT03348514|101198390|FG000|COMPLETED|Overall Study||1||
48354848|NCT03348514|101198391|FG001|COMPLETED|Overall Study||1||
48354849|NCT03348514|101198392|FG002|COMPLETED|Overall Study||1||
48354850|NCT03348514|101198393|FG003|COMPLETED|Overall Study||1||
48354851|NCT03348514|101198394|FG004|COMPLETED|Overall Study||3||
48417874|NCT00848172|101356981|FG000|COMPLETED|Visit 3 - Follow Up||10||
48417875|NCT00848172|101356982|FG001|COMPLETED|Visit 3 - Follow Up||8||
48417876|NCT00848172|101356981|FG000|NOT COMPLETED|Visit 3 - Follow Up||0||
48417877|NCT00848172|101356982|FG001|NOT COMPLETED|Visit 3 - Follow Up||0||
48417878|NCT05241470|101356983|FG000|STARTED|Placebo Run-In||0||0
48417879|NCT05241470|101356984|FG001|STARTED|Placebo Run-In||0||0
48417880|NCT05241470|101356985|FG002|STARTED|Placebo Run-In||0||0
48417881|NCT05241470|101356986|FG003|STARTED|Placebo Run-In||160||320
48417882|NCT05241470|101356983|FG000|COMPLETED|Placebo Run-In||0||0
48417883|NCT05241470|101356984|FG001|COMPLETED|Placebo Run-In||0||0
48354852|NCT03348514|101198395|FG005|COMPLETED|Overall Study||4||
48354853|NCT03348514|101198396|FG006|COMPLETED|Overall Study||6||
48354854|NCT03348514|101198397|FG007|COMPLETED|Overall Study||2||
48354855|NCT03348514|101198390|FG000|NOT COMPLETED|Overall Study||0||
48354856|NCT03348514|101198391|FG001|NOT COMPLETED|Overall Study||0||
48354857|NCT03348514|101198392|FG002|NOT COMPLETED|Overall Study||0||
48354858|NCT03348514|101198393|FG003|NOT COMPLETED|Overall Study||0||
48354859|NCT03348514|101198394|FG004|NOT COMPLETED|Overall Study||0||
48354860|NCT03348514|101198395|FG005|NOT COMPLETED|Overall Study||0||
48354861|NCT03348514|101198396|FG006|NOT COMPLETED|Overall Study||0||
48354862|NCT03348514|101198397|FG007|NOT COMPLETED|Overall Study||0||
48354863|NCT01811030|101198398|FG000|STARTED|Overall Study||33||
48354864|NCT01811030|101198398|FG000|COMPLETED|Overall Study||20||
48354865|NCT01811030|101198398|FG000|NOT COMPLETED|Overall Study||13||
48354866|NCT02259231|101198399|FG000|STARTED|Overall Study||6||
48354867|NCT02259231|101198400|FG001|STARTED|Overall Study||6||
48417884|NCT05241470|101356985|FG002|COMPLETED|Placebo Run-In||0||0
48417885|NCT05241470|101356986|FG003|COMPLETED|Placebo Run-In||160||320
48417886|NCT05241470|101356983|FG000|NOT COMPLETED|Placebo Run-In||0||0
48417887|NCT05241470|101356984|FG001|NOT COMPLETED|Placebo Run-In||0||0
48417888|NCT05241470|101356985|FG002|NOT COMPLETED|Placebo Run-In||0||0
48638386|NCT02780388|101898743|FG002|STARTED|Overall Study||10||
48638387|NCT02780388|101898744|FG003|STARTED|Overall Study||12||
48638388|NCT02780388|101898745|FG004|STARTED|Overall Study||12||
48638389|NCT02780388|101898741|FG000|COMPLETED|Overall Study||14||
48638390|NCT02780388|101898742|FG001|COMPLETED|Overall Study||6||
48638391|NCT02780388|101898743|FG002|COMPLETED|Overall Study||10||
48638392|NCT02780388|101898744|FG003|COMPLETED|Overall Study||12||
48638393|NCT02780388|101898745|FG004|COMPLETED|Overall Study||12||
48638394|NCT02780388|101898741|FG000|NOT COMPLETED|Overall Study||1||
48638395|NCT02780388|101898742|FG001|NOT COMPLETED|Overall Study||2||
48638396|NCT02780388|101898743|FG002|NOT COMPLETED|Overall Study||0||
48638397|NCT02780388|101898744|FG003|NOT COMPLETED|Overall Study||0||
48638398|NCT02780388|101898745|FG004|NOT COMPLETED|Overall Study||0||
48638399|NCT03416179|101898746|FG000|STARTED|Overall Study||201||
48638400|NCT03416179|101898747|FG001|STARTED|Overall Study||203||
48638401|NCT03416179|101898748|FG002|STARTED|Overall Study||163||
48638402|NCT03416179|101898749|FG003|STARTED|Overall Study||162||
48638403|NCT03416179|101898746|FG000|Treated|Overall Study||198||
48638404|NCT03416179|101898747|FG001|Treated|Overall Study||201||
48638405|NCT03416179|101898748|FG002|Treated|Overall Study||162||
48638406|NCT03416179|101898749|FG003|Treated|Overall Study||160||
48638407|NCT03416179|101898746|FG000|COMPLETED|Overall Study||0||
48638408|NCT03416179|101898747|FG001|COMPLETED|Overall Study||1||
48638409|NCT03416179|101898748|FG002|COMPLETED|Overall Study||13||
48638410|NCT03416179|101898749|FG003|COMPLETED|Overall Study||6||
48638411|NCT03416179|101898746|FG000|NOT COMPLETED|Overall Study||201||
48638412|NCT03416179|101898747|FG001|NOT COMPLETED|Overall Study||202||
48638413|NCT03416179|101898748|FG002|NOT COMPLETED|Overall Study||150||
48638414|NCT03416179|101898749|FG003|NOT COMPLETED|Overall Study||156||
48638415|NCT01134042|101898750|FG000|STARTED|Overall Study||194||
48638416|NCT01134042|101898751|FG001|STARTED|Overall Study||197||
48354868|NCT02259231|101198401|FG002|STARTED|Overall Study||6||
48354869|NCT02259231|101198402|FG003|STARTED|Overall Study||6||
48354870|NCT02259231|101198403|FG004|STARTED|Overall Study||6||
48354871|NCT02259231|101198404|FG005|STARTED|Overall Study||6||
48354872|NCT02259231|101198405|FG006|STARTED|Overall Study||5||
48354873|NCT02259231|101198399|FG000|COMPLETED|Overall Study||0||
48354874|NCT02259231|101198400|FG001|COMPLETED|Overall Study||0||
48354875|NCT02259231|101198401|FG002|COMPLETED|Overall Study||0||
48354876|NCT02259231|101198402|FG003|COMPLETED|Overall Study||0||
48417889|NCT05241470|101356986|FG003|NOT COMPLETED|Placebo Run-In||0||0
48354877|NCT02259231|101198403|FG004|COMPLETED|Overall Study||0||
48354878|NCT02259231|101198404|FG005|COMPLETED|Overall Study||0||
48354879|NCT02259231|101198405|FG006|COMPLETED|Overall Study||0||
48354880|NCT02259231|101198399|FG000|NOT COMPLETED|Overall Study||6||
48638417|NCT01134042|101898752|FG002|STARTED|Overall Study||195||
48638418|NCT01134042|101898750|FG000|COMPLETED|Overall Study||146||
48638419|NCT01134042|101898751|FG001|COMPLETED|Overall Study||169||
48638420|NCT01134042|101898752|FG002|COMPLETED|Overall Study||161||
48354881|NCT02259231|101198400|FG001|NOT COMPLETED|Overall Study||6||
48354882|NCT02259231|101198401|FG002|NOT COMPLETED|Overall Study||6||
48354883|NCT02259231|101198402|FG003|NOT COMPLETED|Overall Study||6||
48354884|NCT02259231|101198403|FG004|NOT COMPLETED|Overall Study||6||
48354885|NCT02259231|101198404|FG005|NOT COMPLETED|Overall Study||6||
48354886|NCT02259231|101198405|FG006|NOT COMPLETED|Overall Study||5||
48354887|NCT00484354|101198406|FG000|STARTED|Overall Study||64||
48354888|NCT00484354|101198407|FG001|STARTED|Overall Study||59||
48354889|NCT00484354|101198406|FG000|COMPLETED|Overall Study||63||
48354890|NCT00484354|101198407|FG001|COMPLETED|Overall Study||57||
48186828|NCT03114995|100779910|FG000|NOT COMPLETED|Overall Study||1||
48186829|NCT03114995|100779911|FG001|NOT COMPLETED|Overall Study||1||
48186830|NCT03114995|100779912|FG002|NOT COMPLETED|Overall Study||0||
48186831|NCT05160025|100779913|FG000|STARTED|Overall Study||22||
48186832|NCT05160025|100779913|FG000|COMPLETED|Overall Study||22||
48186833|NCT05160025|100779913|FG000|NOT COMPLETED|Overall Study||0||
48186834|NCT01421771|100779914|FG000|STARTED|Overall Study||62||
48186835|NCT01421771|100779915|FG001|STARTED|Overall Study||64||
48186836|NCT01421771|100779914|FG000|COMPLETED|Overall Study||62||
48354891|NCT00484354|101198406|FG000|NOT COMPLETED|Overall Study||1||
48354892|NCT00484354|101198407|FG001|NOT COMPLETED|Overall Study||2||
48354893|NCT00440401|101198408|FG000|STARTED|Overall Study||59||
48354894|NCT00440401|101198409|FG001|STARTED|Overall Study||60||
48354895|NCT00440401|101198408|FG000|COMPLETED|Overall Study||55||
48354896|NCT00440401|101198409|FG001|COMPLETED|Overall Study||54||
48354897|NCT00440401|101198408|FG000|NOT COMPLETED|Overall Study||4||
48354898|NCT00440401|101198409|FG001|NOT COMPLETED|Overall Study||6||
48354899|NCT01860170|101198410|FG000|STARTED|Overall Study||3||
48354900|NCT01860170|101198411|FG001|STARTED|Overall Study||3||
48354901|NCT01860170|101198412|FG002|STARTED|Overall Study||22||
48354902|NCT01860170|101198410|FG000|COMPLETED|Overall Study||3||
48354903|NCT01860170|101198411|FG001|COMPLETED|Overall Study||3||
48354904|NCT01860170|101198412|FG002|COMPLETED|Overall Study||22||
48354905|NCT01860170|101198410|FG000|NOT COMPLETED|Overall Study||0||
48354906|NCT01860170|101198411|FG001|NOT COMPLETED|Overall Study||0||
48354907|NCT01860170|101198412|FG002|NOT COMPLETED|Overall Study||0||
48354908|NCT01673061|101198413|FG000|STARTED|Overall Study||0||
48354909|NCT01673061|101198414|FG001|STARTED|Overall Study||0||
48354910|NCT01673061|101198413|FG000|COMPLETED|Overall Study||0||
48354911|NCT01673061|101198414|FG001|COMPLETED|Overall Study||0||
48354912|NCT01673061|101198413|FG000|NOT COMPLETED|Overall Study||0||
48354913|NCT01673061|101198414|FG001|NOT COMPLETED|Overall Study||0||
48354914|NCT03958201|101198415|FG000|STARTED|Overall Study||189||
48354915|NCT03958201|101198415|FG000|COMPLETED|Overall Study||189||
48354916|NCT03958201|101198415|FG000|NOT COMPLETED|Overall Study||0||
48354917|NCT03014648|101198416|FG000|STARTED|Overall Study||28||
48354918|NCT03014648|101198416|FG000|COMPLETED|Overall Study||28||
48354919|NCT03014648|101198416|FG000|NOT COMPLETED|Overall Study||0||
48354920|NCT00117312|101198417|FG000|STARTED|Overall Study||10||
48354921|NCT00117312|101198418|FG001|STARTED|Overall Study||24||
48354922|NCT00117312|101198419|FG002|STARTED|Overall Study||24||
48354923|NCT00117312|101198420|FG003|STARTED|Overall Study||24||
48354924|NCT00117312|101198417|FG000|Started FE200486 CS06A|Overall Study||1||
48354925|NCT00117312|101198418|FG001|Started FE200486 CS06A|Overall Study||11||
48354926|NCT00117312|101198419|FG002|Started FE200486 CS06A|Overall Study||16||
48354927|NCT00117312|101198420|FG003|Started FE200486 CS06A|Overall Study||9||
48354928|NCT00117312|101198417|FG000|COMPLETED|Overall Study||0||
48354929|NCT00117312|101198418|FG001|COMPLETED|Overall Study||4||
48354930|NCT00117312|101198419|FG002|COMPLETED|Overall Study||0||
48354931|NCT00117312|101198420|FG003|COMPLETED|Overall Study||3||
48354932|NCT00117312|101198417|FG000|NOT COMPLETED|Overall Study||10||
48354933|NCT00117312|101198418|FG001|NOT COMPLETED|Overall Study||20||
48354934|NCT00117312|101198419|FG002|NOT COMPLETED|Overall Study||24||
48354935|NCT00117312|101198420|FG003|NOT COMPLETED|Overall Study||21||
48354936|NCT01548638|101198421|FG000|STARTED|Overall Study||13||
48186837|NCT01421771|100779915|FG001|COMPLETED|Overall Study||64||
48354937|NCT01548638|101198421|FG000|COMPLETED|Overall Study||9||
48354938|NCT01548638|101198421|FG000|NOT COMPLETED|Overall Study||4||
48354939|NCT00702624|101198422|FG000|STARTED|Base Study P05690 (NCT00702845)||268||
48354940|NCT00702624|101198423|FG001|STARTED|Base Study P05690 (NCT00702845)||128||
48354941|NCT00702624|101198424|FG002|STARTED|Base Study P05690 (NCT00702845)||0||
48354942|NCT00702624|101198425|FG003|STARTED|Base Study P05690 (NCT00702845)||0||
48354943|NCT00702624|101198422|FG000|COMPLETED|Base Study P05690 (NCT00702845)||246||
48354944|NCT00702624|101198423|FG001|COMPLETED|Base Study P05690 (NCT00702845)||121||
48354945|NCT00702624|101198424|FG002|COMPLETED|Base Study P05690 (NCT00702845)||0||
48354946|NCT00702624|101198425|FG003|COMPLETED|Base Study P05690 (NCT00702845)||0||
48354947|NCT00702624|101198422|FG000|NOT COMPLETED|Base Study P05690 (NCT00702845)||22||
48354948|NCT00702624|101198423|FG001|NOT COMPLETED|Base Study P05690 (NCT00702845)||7||
48186838|NCT01421771|100779914|FG000|NOT COMPLETED|Overall Study||0||
48186839|NCT01421771|100779915|FG001|NOT COMPLETED|Overall Study||0||
48354949|NCT00702624|101198424|FG002|NOT COMPLETED|Base Study P05690 (NCT00702845)||0||
48354950|NCT00702624|101198425|FG003|NOT COMPLETED|Base Study P05690 (NCT00702845)||0||
48354951|NCT00702624|101198422|FG000|STARTED|Expectant Mother Follow-up||68||
48354952|NCT00702624|101198423|FG001|STARTED|Expectant Mother Follow-up||45||
48354953|NCT00702624|101198424|FG002|STARTED|Expectant Mother Follow-up||0||
48354954|NCT00702624|101198425|FG003|STARTED|Expectant Mother Follow-up||0||
48354955|NCT00702624|101198422|FG000|COMPLETED|Expectant Mother Follow-up||61||
48354956|NCT00702624|101198423|FG001|COMPLETED|Expectant Mother Follow-up||45||
48354957|NCT00702624|101198424|FG002|COMPLETED|Expectant Mother Follow-up||0||
48354958|NCT00702624|101198425|FG003|COMPLETED|Expectant Mother Follow-up||0||
48354959|NCT00702624|101198422|FG000|NOT COMPLETED|Expectant Mother Follow-up||7||
48354960|NCT00702624|101198423|FG001|NOT COMPLETED|Expectant Mother Follow-up||0||
48354961|NCT00702624|101198424|FG002|NOT COMPLETED|Expectant Mother Follow-up||0||
48354962|NCT00702624|101198425|FG003|NOT COMPLETED|Expectant Mother Follow-up||0||
48354963|NCT00702624|101198422|FG000|STARTED|Fetuses/Infant Follow-up||0||
48354964|NCT00702624|101198423|FG001|STARTED|Fetuses/Infant Follow-up||0||
48354965|NCT00702624|101198424|FG002|STARTED|Fetuses/Infant Follow-up||88||
48354966|NCT00702624|101198425|FG003|STARTED|Fetuses/Infant Follow-up||55||
48354967|NCT00702624|101198422|FG000|Live Born Infants|Fetuses/Infant Follow-up||0||
48354968|NCT00702624|101198423|FG001|Live Born Infants|Fetuses/Infant Follow-up||0||
48354969|NCT00702624|101198424|FG002|Live Born Infants|Fetuses/Infant Follow-up||80||
48417890|NCT05241470|101356983|FG000|STARTED|Randomized Study||53||106
48417891|NCT05241470|101356984|FG001|STARTED|Randomized Study||53||106
48417892|NCT05241470|101356985|FG002|STARTED|Randomized Study||54||108
48354970|NCT00702624|101198425|FG003|Live Born Infants|Fetuses/Infant Follow-up||55||
48354971|NCT00702624|101198422|FG000|COMPLETED|Fetuses/Infant Follow-up||0||
48354972|NCT00702624|101198423|FG001|COMPLETED|Fetuses/Infant Follow-up||0||
48417893|NCT05241470|101356986|FG003|STARTED|Randomized Study||0||0
48417894|NCT05241470|101356983|FG000|COMPLETED|Randomized Study||48||96
48417895|NCT05241470|101356984|FG001|COMPLETED|Randomized Study||50||100
48354973|NCT00702624|101198424|FG002|COMPLETED|Fetuses/Infant Follow-up||78||
48354974|NCT00702624|101198425|FG003|COMPLETED|Fetuses/Infant Follow-up||55||
48354975|NCT00702624|101198422|FG000|NOT COMPLETED|Fetuses/Infant Follow-up||0||
48354976|NCT00702624|101198423|FG001|NOT COMPLETED|Fetuses/Infant Follow-up||0||
48354977|NCT00702624|101198424|FG002|NOT COMPLETED|Fetuses/Infant Follow-up||10||
48354978|NCT00702624|101198425|FG003|NOT COMPLETED|Fetuses/Infant Follow-up||0||
48354979|NCT01025336|101198426|FG000|STARTED|Overall Study||130||
48354980|NCT01025336|101198427|FG001|STARTED|Overall Study||210||
48354981|NCT01025336|101198428|FG002|STARTED|Overall Study||179||
48354982|NCT01025336|101198429|FG003|STARTED|Overall Study||221||
48354983|NCT01025336|101198430|FG004|STARTED|Overall Study||222||
48417896|NCT05241470|101356985|FG002|COMPLETED|Randomized Study||48||96
48417897|NCT05241470|101356986|FG003|COMPLETED|Randomized Study||0||0
48417898|NCT05241470|101356983|FG000|NOT COMPLETED|Randomized Study||5||10
48417899|NCT05241470|101356984|FG001|NOT COMPLETED|Randomized Study||3||6
48417900|NCT05241470|101356985|FG002|NOT COMPLETED|Randomized Study||6||12
48417901|NCT05241470|101356986|FG003|NOT COMPLETED|Randomized Study||0||0
48417902|NCT03088345|101356987|FG000|STARTED|Overall Study||10||
48417903|NCT03088345|101356988|FG001|STARTED|Overall Study||10||
48417904|NCT03088345|101356987|FG000|COMPLETED|Overall Study||10||
48417905|NCT03088345|101356988|FG001|COMPLETED|Overall Study||10||
48417906|NCT03088345|101356987|FG000|NOT COMPLETED|Overall Study||0||
48417907|NCT03088345|101356988|FG001|NOT COMPLETED|Overall Study||0||
48417908|NCT02098733|101356989|FG000|STARTED|Overall Study||1168||
48417909|NCT02098733|101356989|FG000|COMPLETED|Overall Study||1158||
48417910|NCT02098733|101356989|FG000|NOT COMPLETED|Overall Study||10||
48417911|NCT00890396|101356990|FG000|STARTED|Overall Study||127||
48417912|NCT00890396|101356991|FG001|STARTED|Overall Study||36||
48417913|NCT00890396|101356990|FG000|COMPLETED|Overall Study||122||
48417914|NCT00890396|101356991|FG001|COMPLETED|Overall Study||34||
48417915|NCT00890396|101356990|FG000|NOT COMPLETED|Overall Study||5||
48417916|NCT00890396|101356991|FG001|NOT COMPLETED|Overall Study||2||
48417917|NCT01969565|101356992|FG000|STARTED|Overall Study||1||
48417918|NCT01969565|101356992|FG000|COMPLETED|Overall Study||0||
48417919|NCT01969565|101356992|FG000|NOT COMPLETED|Overall Study||1||
48417920|NCT00718887|101356993|FG000|STARTED|Overall Study||89||
48417921|NCT00718887|101356994|FG001|STARTED|Overall Study||77||
48417922|NCT00718887|101356993|FG000|COMPLETED|Overall Study||84||
48417923|NCT00718887|101356994|FG001|COMPLETED|Overall Study||68||
48354984|NCT01025336|101198426|FG000|COMPLETED|Overall Study||130||
48354985|NCT01025336|101198427|FG001|COMPLETED|Overall Study||210||
48354986|NCT01025336|101198428|FG002|COMPLETED|Overall Study||179||
48354987|NCT01025336|101198429|FG003|COMPLETED|Overall Study||219||
48354988|NCT01025336|101198430|FG004|COMPLETED|Overall Study||222||
48417924|NCT00718887|101356993|FG000|NOT COMPLETED|Overall Study||5||
48417925|NCT00718887|101356994|FG001|NOT COMPLETED|Overall Study||9||
48417926|NCT02246309|101356995|FG000|STARTED|Overall Study||16||
48417927|NCT02246309|101356996|FG001|STARTED|Overall Study||15||
48417928|NCT02246309|101356995|FG000|COMPLETED|Overall Study||16||
48417929|NCT02246309|101356996|FG001|COMPLETED|Overall Study||15||
48417930|NCT02246309|101356995|FG000|NOT COMPLETED|Overall Study||0||
48417931|NCT02246309|101356996|FG001|NOT COMPLETED|Overall Study||0||
48417932|NCT00082628|101356997|FG000|STARTED|Treatment Period I (Week 1 to Week 12)||81||
48417933|NCT00082628|101356998|FG001|STARTED|Treatment Period I (Week 1 to Week 12)||245||
48417934|NCT00082628|101356999|FG002|STARTED|Treatment Period I (Week 1 to Week 12)||0||
48417935|NCT00082628|101357000|FG003|STARTED|Treatment Period I (Week 1 to Week 12)||0||
48417936|NCT00082628|101357001|FG004|STARTED|Treatment Period I (Week 1 to Week 12)||0||
48417937|NCT00082628|101356997|FG000|COMPLETED|Treatment Period I (Week 1 to Week 12)||73||
48417938|NCT00082628|101356998|FG001|COMPLETED|Treatment Period I (Week 1 to Week 12)||185||
48417939|NCT00082628|101356999|FG002|COMPLETED|Treatment Period I (Week 1 to Week 12)||0||
48417940|NCT00082628|101357000|FG003|COMPLETED|Treatment Period I (Week 1 to Week 12)||0||
48417941|NCT00082628|101357001|FG004|COMPLETED|Treatment Period I (Week 1 to Week 12)||0||
48417942|NCT00082628|101356997|FG000|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||8||
48417943|NCT00082628|101356998|FG001|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||60||
48417944|NCT00082628|101356999|FG002|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0||
48417945|NCT00082628|101357000|FG003|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0||
48417946|NCT00082628|101357001|FG004|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0||
48417947|NCT00082628|101356997|FG000|STARTED|Treatment Period II: Week 12 to Week 36||0||
48417948|NCT00082628|101356998|FG001|STARTED|Treatment Period II: Week 12 to Week 36||0||
48417949|NCT00082628|101356999|FG002|STARTED|Treatment Period II: Week 12 to Week 36||93||
48417950|NCT00082628|101357000|FG003|STARTED|Treatment Period II: Week 12 to Week 36||92||
48417951|NCT00082628|101357001|FG004|STARTED|Treatment Period II: Week 12 to Week 36||73||
48417952|NCT00082628|101356997|FG000|COMPLETED|Treatment Period II: Week 12 to Week 36||0||
48417953|NCT00082628|101356998|FG001|COMPLETED|Treatment Period II: Week 12 to Week 36||0||
48417954|NCT00082628|101356999|FG002|COMPLETED|Treatment Period II: Week 12 to Week 36||78||
48417955|NCT00082628|101357000|FG003|COMPLETED|Treatment Period II: Week 12 to Week 36||76||
48417956|NCT00082628|101357001|FG004|COMPLETED|Treatment Period II: Week 12 to Week 36||55||
48417957|NCT00082628|101356997|FG000|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||0||
48417958|NCT00082628|101356998|FG001|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||0||
48417959|NCT00082628|101356999|FG002|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||15||
48417960|NCT00082628|101357000|FG003|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||16||
48417961|NCT00082628|101357001|FG004|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||18||
48354989|NCT01025336|101198426|FG000|NOT COMPLETED|Overall Study||0||
48354990|NCT01025336|101198427|FG001|NOT COMPLETED|Overall Study||0||
48354991|NCT01025336|101198428|FG002|NOT COMPLETED|Overall Study||0||
48354992|NCT01025336|101198429|FG003|NOT COMPLETED|Overall Study||2||
48354993|NCT01025336|101198430|FG004|NOT COMPLETED|Overall Study||0||
48354994|NCT00215150|101198431|FG000|STARTED|Open Label Phase||51||
48354995|NCT00215150|101198431|FG000|COMPLETED|Open Label Phase||21||
48354996|NCT00215150|101198431|FG000|NOT COMPLETED|Open Label Phase||30||
48354997|NCT00215150|101198431|FG000|STARTED|Randomization Phase Ziprasidone||10||
48354998|NCT00215150|101198431|FG000|COMPLETED|Randomization Phase Ziprasidone||7||
48354999|NCT00215150|101198431|FG000|NOT COMPLETED|Randomization Phase Ziprasidone||3||
48355000|NCT00215150|101198431|FG000|STARTED|Randomization Phase Placebo||11||
48355001|NCT00215150|101198431|FG000|COMPLETED|Randomization Phase Placebo||10||
48355002|NCT00215150|101198431|FG000|NOT COMPLETED|Randomization Phase Placebo||1||
48355003|NCT02750410|101198432|FG000|STARTED|Double-Blind Treatment Period||39||
48417962|NCT03845504|101357002|FG000|STARTED|Overall Study||2||
48762393|NCT03104868|102206003|FG001|COMPLETED|18 Month Follow up||165||
48762394|NCT03104868|102206002|FG000|NOT COMPLETED|18 Month Follow up||30||
48762395|NCT03104868|102206003|FG001|NOT COMPLETED|18 Month Follow up||35||
48762396|NCT03104868|102206002|FG000|STARTED|24 Month Follow up||198|Participants who started the 24 month period included those who completed the 18 month period and those who were unavailable for the 18 month period|
48762397|NCT03104868|102206003|FG001|STARTED|24 Month Follow up||185|Participants who started the 24 month period included those who completed the 18 month period and those who were unavailable for the 18 month period|
48762398|NCT03104868|102206002|FG000|COMPLETED|24 Month Follow up||177||
48762399|NCT03104868|102206003|FG001|COMPLETED|24 Month Follow up||167||
48762400|NCT03104868|102206002|FG000|NOT COMPLETED|24 Month Follow up||21||
48355004|NCT02750410|101198433|FG001|STARTED|Double-Blind Treatment Period||120||
48355005|NCT02750410|101198432|FG000|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||39||
48355006|NCT02750410|101198433|FG001|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||120||
48355007|NCT02750410|101198432|FG000|COMPLETED|Double-Blind Treatment Period||37||
48355008|NCT02750410|101198433|FG001|COMPLETED|Double-Blind Treatment Period||117||
48417963|NCT03845504|101357002|FG000|COMPLETED|Overall Study||2||
48417964|NCT03845504|101357002|FG000|NOT COMPLETED|Overall Study||0||
48417965|NCT01412333|101357003|FG000|STARTED|Overall Study||418||
48417966|NCT01412333|101357004|FG001|STARTED|Overall Study||417||
48417967|NCT01412333|101357003|FG000|Entered OLE Period|Overall Study||297||
48417968|NCT01412333|101357004|FG001|Entered OLE Period|Overall Study||350||
48417969|NCT01412333|101357003|FG000|COMPLETED|Overall Study||229||
48417970|NCT01412333|101357004|FG001|COMPLETED|Overall Study||225||
48355009|NCT02750410|101198432|FG000|NOT COMPLETED|Double-Blind Treatment Period||2||
48355010|NCT02750410|101198433|FG001|NOT COMPLETED|Double-Blind Treatment Period||3||
48355011|NCT02750410|101198432|FG000|STARTED|Open-Label Extension Period||37||
48355012|NCT02750410|101198433|FG001|STARTED|Open-Label Extension Period||117||
48355013|NCT02750410|101198432|FG000|COMPLETED|Open-Label Extension Period||31||
48355014|NCT02750410|101198433|FG001|COMPLETED|Open-Label Extension Period||111||
48355015|NCT02750410|101198432|FG000|NOT COMPLETED|Open-Label Extension Period||6||
48355016|NCT02750410|101198433|FG001|NOT COMPLETED|Open-Label Extension Period||6||
48355017|NCT00577590|101198434|FG000|STARTED|Overall Study||28||
48355018|NCT00577590|101198435|FG001|STARTED|Overall Study||27||
48355019|NCT00577590|101198436|FG002|STARTED|Overall Study||23||
48355020|NCT00577590|101198434|FG000|COMPLETED|Overall Study||28||
48355021|NCT00577590|101198435|FG001|COMPLETED|Overall Study||27||
48355022|NCT00577590|101198436|FG002|COMPLETED|Overall Study||23||
48355023|NCT00577590|101198434|FG000|NOT COMPLETED|Overall Study||0||
48355024|NCT00577590|101198435|FG001|NOT COMPLETED|Overall Study||0||
48355025|NCT00577590|101198436|FG002|NOT COMPLETED|Overall Study||0||
48355026|NCT00840463|101198437|FG000|STARTED|Overall Study||3||
48355027|NCT00840463|101198438|FG001|STARTED|Overall Study||1||
48355028|NCT00840463|101198437|FG000|COMPLETED|Overall Study||2||
48355029|NCT00840463|101198438|FG001|COMPLETED|Overall Study||1||
48355030|NCT00840463|101198437|FG000|NOT COMPLETED|Overall Study||1||
48355031|NCT00840463|101198438|FG001|NOT COMPLETED|Overall Study||0||
48355032|NCT02158533|101198439|FG000|STARTED|Stage 1||265||
48355033|NCT02158533|101198440|FG001|STARTED|Stage 1||59||
48355034|NCT02158533|101198441|FG002|STARTED|Stage 1||60||
48355035|NCT02158533|101198442|FG003|STARTED|Stage 1||0||
48355036|NCT02158533|101198443|FG004|STARTED|Stage 1||0||
48355037|NCT02158533|101198444|FG005|STARTED|Stage 1||0||
48355038|NCT02158533|101198439|FG000|COMPLETED|Stage 1||251||
48355039|NCT02158533|101198440|FG001|COMPLETED|Stage 1||51||
48355040|NCT02158533|101198441|FG002|COMPLETED|Stage 1||52||
48355041|NCT02158533|101198442|FG003|COMPLETED|Stage 1||0||
48355042|NCT02158533|101198443|FG004|COMPLETED|Stage 1||0||
48355043|NCT02158533|101198444|FG005|COMPLETED|Stage 1||0||
48417971|NCT01412333|101357003|FG000|NOT COMPLETED|Overall Study||189||
48417972|NCT01412333|101357004|FG001|NOT COMPLETED|Overall Study||192||
48417973|NCT03037489|101357005|FG000|STARTED|Overall Study||46||
48417974|NCT03037489|101357006|FG001|STARTED|Overall Study||4||
48417975|NCT03037489|101357005|FG000|COMPLETED|Overall Study||39||
48417976|NCT03037489|101357006|FG001|COMPLETED|Overall Study||4||
48417977|NCT03037489|101357005|FG000|NOT COMPLETED|Overall Study||7||
48417978|NCT03037489|101357006|FG001|NOT COMPLETED|Overall Study||0||
48417979|NCT00963469|101357007|FG000|STARTED|Overall Study||451||
48417980|NCT00963469|101357008|FG001|STARTED|Overall Study||448||
48638421|NCT01134042|101898750|FG000|NOT COMPLETED|Overall Study||48||
48638422|NCT01134042|101898751|FG001|NOT COMPLETED|Overall Study||28||
48355044|NCT02158533|101198439|FG000|NOT COMPLETED|Stage 1||14||
48355045|NCT02158533|101198440|FG001|NOT COMPLETED|Stage 1||8||
48417981|NCT00963469|101357009|FG002|STARTED|Overall Study||180||
48417982|NCT00963469|101357007|FG000|COMPLETED|Overall Study||410||
48417983|NCT00963469|101357008|FG001|COMPLETED|Overall Study||420||
48417984|NCT00963469|101357009|FG002|COMPLETED|Overall Study||170||
48417985|NCT00963469|101357007|FG000|NOT COMPLETED|Overall Study||41||
48417986|NCT00963469|101357008|FG001|NOT COMPLETED|Overall Study||28||
48417987|NCT00963469|101357009|FG002|NOT COMPLETED|Overall Study||10||
48417988|NCT01024946|101357010|FG000|STARTED|Overall Study||11||
48417989|NCT01024946|101357010|FG000|COMPLETED|Overall Study||6||
48417990|NCT01024946|101357010|FG000|NOT COMPLETED|Overall Study||5||
48417991|NCT02610231|101357011|FG000|STARTED|Overall Study||239||
48417992|NCT02610231|101357011|FG000|COMPLETED|Overall Study||179||
48417993|NCT02610231|101357011|FG000|NOT COMPLETED|Overall Study||60||
48417994|NCT03529162|101357012|FG000|STARTED|Overall Study||2||
48417995|NCT03529162|101357013|FG001|STARTED|Overall Study||2||
48417996|NCT03529162|101357012|FG000|COMPLETED|Overall Study||0||
48417997|NCT03529162|101357013|FG001|COMPLETED|Overall Study||0||
48417998|NCT03529162|101357012|FG000|NOT COMPLETED|Overall Study||2||
48417999|NCT03529162|101357013|FG001|NOT COMPLETED|Overall Study||2||
48418000|NCT01869686|101357014|FG000|STARTED|Overall Study||12||
48418001|NCT01869686|101357014|FG000|COMPLETED|Overall Study||12||
48418002|NCT01869686|101357014|FG000|NOT COMPLETED|Overall Study||0||
48418003|NCT00596622|101357015|FG000|STARTED|Overall Study||46||
48418004|NCT00596622|101357015|FG000|COMPLETED|Overall Study||33||
48418005|NCT00596622|101357015|FG000|NOT COMPLETED|Overall Study||13||
48418006|NCT01432756|101357016|FG000|STARTED|Overall Study||32||
48418007|NCT01432756|101357017|FG001|STARTED|Overall Study||34||
48418008|NCT01432756|101357018|FG002|STARTED|Overall Study||32||
48418009|NCT01432756|101357019|FG003|STARTED|Overall Study||34||
48355046|NCT02158533|101198441|FG002|NOT COMPLETED|Stage 1||8||
48355047|NCT02158533|101198442|FG003|NOT COMPLETED|Stage 1||0||
48355048|NCT02158533|101198443|FG004|NOT COMPLETED|Stage 1||0||
48355049|NCT02158533|101198444|FG005|NOT COMPLETED|Stage 1||0||
48418010|NCT01432756|101357016|FG000|COMPLETED|Overall Study||31||
48418011|NCT01432756|101357017|FG001|COMPLETED|Overall Study||34||
48418012|NCT01432756|101357018|FG002|COMPLETED|Overall Study||30||
48418013|NCT01432756|101357019|FG003|COMPLETED|Overall Study||33||
48355050|NCT02158533|101198439|FG000|STARTED|Stage 2||0|Subjects randomized in Stage 2 are a subset of those randomized to placebo in Stage 1.|
48355051|NCT02158533|101198440|FG001|STARTED|Stage 2||0|Subjects randomized in Stage 2 are a subset of those randomized to placebo in Stage 1.|
48368121|NCT03196297|101230110|FG000|NOT COMPLETED|Extension Period||3||
48418014|NCT01432756|101357016|FG000|NOT COMPLETED|Overall Study||1||
48418015|NCT01432756|101357017|FG001|NOT COMPLETED|Overall Study||0||
48762401|NCT03104868|102206003|FG001|NOT COMPLETED|24 Month Follow up||18||
48762402|NCT05523089|102206004|FG000|STARTED|Overall Study||29|All participants received their assigned treatment, and all but 1 participant in the placebo arm received challenge virus.|
48762403|NCT05523089|102206005|FG001|STARTED|Overall Study||2|All participants received their assigned treatment, and all but 1 participant in the placebo arm received challenge virus.|
48762404|NCT05523089|102206006|FG002|STARTED|Overall Study||28|All participants received their assigned treatment, and all but 1 participant in the placebo arm received challenge virus.|
48762405|NCT05523089|102206004|FG000|COMPLETED|Overall Study||27|Two participants, both in the placebo arm, discontinued the study prior to completion. For all other participants (n=57), including the participant in the placebo arm who was not inoculated with the challenge virus, the study status was reported as completed.|
48762406|NCT05523089|102206005|FG001|COMPLETED|Overall Study||2|Two participants, both in the placebo arm, discontinued the study prior to completion. For all other participants (n=57), including the participant in the placebo arm who was not inoculated with the challenge virus, the study status was reported as completed.|
48355052|NCT02158533|101198441|FG002|STARTED|Stage 2||0|Subjects randomized in Stage 2 are a subset of those randomized to placebo in Stage 1.|
48355053|NCT02158533|101198442|FG003|STARTED|Stage 2||56|Subjects randomized in Stage 2 are a subset of those randomized to placebo in Stage 1.|
48355054|NCT02158533|101198443|FG004|STARTED|Stage 2||56|Subjects randomized in Stage 2 are a subset of those randomized to placebo in Stage 1.|
48355055|NCT02158533|101198444|FG005|STARTED|Stage 2||56|Subjects randomized in Stage 2 are a subset of those randomized to placebo in Stage 1.|
48355056|NCT02158533|101198439|FG000|COMPLETED|Stage 2||0||
48355057|NCT02158533|101198440|FG001|COMPLETED|Stage 2||0||
48355058|NCT02158533|101198441|FG002|COMPLETED|Stage 2||0||
48355059|NCT02158533|101198442|FG003|COMPLETED|Stage 2||53||
48355060|NCT02158533|101198443|FG004|COMPLETED|Stage 2||52||
48355061|NCT02158533|101198444|FG005|COMPLETED|Stage 2||50||
48355062|NCT02158533|101198439|FG000|NOT COMPLETED|Stage 2||0||
48355063|NCT02158533|101198440|FG001|NOT COMPLETED|Stage 2||0||
48355064|NCT02158533|101198441|FG002|NOT COMPLETED|Stage 2||0||
48355065|NCT02158533|101198442|FG003|NOT COMPLETED|Stage 2||3||
48355066|NCT02158533|101198443|FG004|NOT COMPLETED|Stage 2||4||
48355067|NCT02158533|101198444|FG005|NOT COMPLETED|Stage 2||6||
48355068|NCT02388776|101198445|FG000|STARTED|Overall Study||2||
48355069|NCT02388776|101198445|FG000|COMPLETED|Overall Study||0||
48355070|NCT02388776|101198445|FG000|NOT COMPLETED|Overall Study||2||
48355071|NCT03896425|101198446|FG000|STARTED|Overall Study||20||
48355072|NCT03896425|101198447|FG001|STARTED|Overall Study||18||
48355073|NCT03896425|101198448|FG002|STARTED|Overall Study||20||
48355074|NCT03896425|101198446|FG000|COMPLETED|Overall Study||13||
48355075|NCT03896425|101198447|FG001|COMPLETED|Overall Study||10||
48355076|NCT03896425|101198448|FG002|COMPLETED|Overall Study||15||
48355077|NCT03896425|101198446|FG000|NOT COMPLETED|Overall Study||7||
48355078|NCT03896425|101198447|FG001|NOT COMPLETED|Overall Study||8||
48355079|NCT03896425|101198448|FG002|NOT COMPLETED|Overall Study||5||
48355080|NCT04734873|101198449|FG000|STARTED|Overall Study||16||
48418016|NCT01432756|101357018|FG002|NOT COMPLETED|Overall Study||2||
48418017|NCT01432756|101357019|FG003|NOT COMPLETED|Overall Study||1||
48418018|NCT02500706|101357020|FG000|STARTED|Overall Study||342||
48418019|NCT02500706|101357021|FG001|STARTED|Overall Study||341||
48762407|NCT05523089|102206006|FG002|COMPLETED|Overall Study||28|Two participants, both in the placebo arm, discontinued the study prior to completion. For all other participants (n=57), including the participant in the placebo arm who was not inoculated with the challenge virus, the study status was reported as completed.|
48762408|NCT05523089|102206004|FG000|NOT COMPLETED|Overall Study||2||
48762409|NCT05523089|102206005|FG001|NOT COMPLETED|Overall Study||0||
48762410|NCT05523089|102206006|FG002|NOT COMPLETED|Overall Study||0||
48762411|NCT02230410|102206007|FG000|STARTED|Overall Study||18||
48762412|NCT02230410|102206007|FG000|COMPLETED|Overall Study||15||
48762413|NCT02230410|102206007|FG000|NOT COMPLETED|Overall Study||3||
48762414|NCT05522153|102206008|FG000|STARTED|Overall Study||31||
48762415|NCT05522153|102206009|FG001|STARTED|Overall Study||30||
48762416|NCT05522153|102206008|FG000|COMPLETED|Overall Study||31||
48762417|NCT05522153|102206009|FG001|COMPLETED|Overall Study||28||
48762418|NCT05522153|102206008|FG000|NOT COMPLETED|Overall Study||0||
48762419|NCT05522153|102206009|FG001|NOT COMPLETED|Overall Study||2||
48762420|NCT01772472|102206010|FG000|STARTED|Overall Study||743||
48355081|NCT04734873|101198450|FG001|STARTED|Overall Study||14||
48355082|NCT04734873|101198451|FG002|STARTED|Overall Study||12||
48418020|NCT02500706|101357022|FG002|STARTED|Overall Study||342||
48418021|NCT02500706|101357020|FG000|Exposed|Overall Study||342||
48418022|NCT02500706|101357021|FG001|Exposed|Overall Study||341||
48418023|NCT02500706|101357022|FG002|Exposed|Overall Study||342||
48418024|NCT02500706|101357020|FG000|COMPLETED|Overall Study||338||
48355083|NCT04734873|101198449|FG000|COMPLETED|Overall Study||14||
48418025|NCT02500706|101357021|FG001|COMPLETED|Overall Study||334||
48638423|NCT01134042|101898752|FG002|NOT COMPLETED|Overall Study||34||
48355084|NCT04734873|101198450|FG001|COMPLETED|Overall Study||11||
48355085|NCT04734873|101198451|FG002|COMPLETED|Overall Study||9||
48355086|NCT04734873|101198449|FG000|NOT COMPLETED|Overall Study||2||
48355087|NCT04734873|101198450|FG001|NOT COMPLETED|Overall Study||3||
48355088|NCT04734873|101198451|FG002|NOT COMPLETED|Overall Study||3||
48418026|NCT02500706|101357022|FG002|COMPLETED|Overall Study||335||
48418027|NCT02500706|101357020|FG000|NOT COMPLETED|Overall Study||4||
48638424|NCT01048424|101898753|FG000|STARTED|Overall Study||10||
48418028|NCT02500706|101357021|FG001|NOT COMPLETED|Overall Study||7||
48418029|NCT02500706|101357022|FG002|NOT COMPLETED|Overall Study||7||
48418030|NCT02939326|101357023|FG000|STARTED|Overall Study||7||
48418031|NCT02939326|101357024|FG001|STARTED|Overall Study||5||
48418032|NCT02939326|101357025|FG002|STARTED|Overall Study||5||
48418033|NCT02939326|101357026|FG003|STARTED|Overall Study||5||
48762421|NCT01772472|102206011|FG001|STARTED|Overall Study||743||
48762422|NCT01772472|102206010|FG000|COMPLETED|Overall Study||0||
48762423|NCT01772472|102206011|FG001|COMPLETED|Overall Study||0||
48762424|NCT01772472|102206010|FG000|NOT COMPLETED|Overall Study||743||
48762425|NCT01772472|102206011|FG001|NOT COMPLETED|Overall Study||743||
48762426|NCT02698215|102206012|FG000|STARTED|Overall Study||83||
48762427|NCT02698215|102206013|FG001|STARTED|Overall Study||82||
48762428|NCT02698215|102206012|FG000|COMPLETED|Overall Study||55||
48762429|NCT02698215|102206013|FG001|COMPLETED|Overall Study||64||
48762430|NCT02698215|102206012|FG000|NOT COMPLETED|Overall Study||28||
48762431|NCT02698215|102206013|FG001|NOT COMPLETED|Overall Study||18||
48762432|NCT04780061|102206014|FG000|STARTED|Overall Study||44||
48762433|NCT04780061|102206015|FG001|STARTED|Overall Study||46||
48762434|NCT04780061|102206014|FG000|Treated|Overall Study||42||
48762435|NCT04780061|102206015|FG001|Treated|Overall Study||44||
48762436|NCT04780061|102206014|FG000|COMPLETED|Overall Study||36||
48762437|NCT04780061|102206015|FG001|COMPLETED|Overall Study||31||
48762438|NCT04780061|102206014|FG000|NOT COMPLETED|Overall Study||8||
48762439|NCT04780061|102206015|FG001|NOT COMPLETED|Overall Study||15||
48762440|NCT03317405|102206016|FG000|STARTED|Overall Study||16||
48762441|NCT03317405|102206017|FG001|STARTED|Overall Study||8||
48762442|NCT03317405|102206018|FG002|STARTED|Overall Study||8||
48186840|NCT00772928|100779916|FG000|STARTED|Overall Study||587||
48186841|NCT00772928|100779917|FG001|STARTED|Overall Study||579||
48186842|NCT00772928|100779916|FG000|COMPLETED|Overall Study||543||
48355089|NCT01491958|101198452|FG000|STARTED|Overall Study||40||
48355090|NCT01491958|101198453|FG001|STARTED|Overall Study||40||
48355091|NCT01491958|101198452|FG000|COMPLETED|Overall Study||40||
48355092|NCT01491958|101198453|FG001|COMPLETED|Overall Study||40||
48355093|NCT01491958|101198452|FG000|NOT COMPLETED|Overall Study||0||
48355094|NCT01491958|101198453|FG001|NOT COMPLETED|Overall Study||0||
48355095|NCT02782715|101198454|FG000|STARTED|Overall Study||3||
48355096|NCT02782715|101198454|FG000|On Treatment|Overall Study||3||
48355097|NCT02782715|101198454|FG000|Off Treatment|Overall Study||3||
48355098|NCT02782715|101198454|FG000|Completed Ablation|Overall Study||2||
48355099|NCT02782715|101198454|FG000|COMPLETED|Overall Study||2||
48355100|NCT02782715|101198454|FG000|NOT COMPLETED|Overall Study||1||
48355101|NCT02900092|101198455|FG000|STARTED|Overall Study||10||
48355102|NCT02900092|101198455|FG000|COMPLETED|Overall Study||9||
48355103|NCT02900092|101198455|FG000|NOT COMPLETED|Overall Study||1||
48355104|NCT03658889|101198456|FG000|STARTED|Overall Study||308||
48355105|NCT03658889|101198457|FG001|STARTED|Overall Study||69||
48355106|NCT03658889|101198456|FG000|COMPLETED|Overall Study||306||
48355107|NCT03658889|101198457|FG001|COMPLETED|Overall Study||69||
48355108|NCT03658889|101198456|FG000|NOT COMPLETED|Overall Study||2||
48355109|NCT03658889|101198457|FG001|NOT COMPLETED|Overall Study||0||
48418034|NCT02939326|101357027|FG004|STARTED|Overall Study||5||
48418035|NCT02939326|101357028|FG005|STARTED|Overall Study||5||
48418036|NCT02939326|101357029|FG006|STARTED|Overall Study||5||
48418037|NCT02939326|101357030|FG007|STARTED|Overall Study||5||
48418038|NCT02939326|101357023|FG000|COMPLETED|Overall Study||7||
48418039|NCT02939326|101357024|FG001|COMPLETED|Overall Study||5||
48418040|NCT02939326|101357025|FG002|COMPLETED|Overall Study||5||
48418041|NCT02939326|101357026|FG003|COMPLETED|Overall Study||5||
48418042|NCT02939326|101357027|FG004|COMPLETED|Overall Study||5||
48418043|NCT02939326|101357028|FG005|COMPLETED|Overall Study||5||
48418044|NCT02939326|101357029|FG006|COMPLETED|Overall Study||5||
48355110|NCT01259466|101198458|FG000|STARTED|Overall Study||27||
48355111|NCT01259466|101198459|FG001|STARTED|Overall Study||27||
48762443|NCT03317405|102206016|FG000|COMPLETED|Overall Study||15||
48762444|NCT03317405|102206017|FG001|COMPLETED|Overall Study||7||
48762445|NCT03317405|102206018|FG002|COMPLETED|Overall Study||7||
48186843|NCT00772928|100779917|FG001|COMPLETED|Overall Study||538||
48355112|NCT01259466|101198458|FG000|COMPLETED|Overall Study||26||
48355113|NCT01259466|101198459|FG001|COMPLETED|Overall Study||18||
48355114|NCT01259466|101198458|FG000|NOT COMPLETED|Overall Study||1||
48355115|NCT01259466|101198459|FG001|NOT COMPLETED|Overall Study||9||
48355116|NCT04902885|101198460|FG000|STARTED|Overall Study||12||
48355117|NCT04902885|101198461|FG001|STARTED|Overall Study||41||
48355118|NCT04902885|101198462|FG002|STARTED|Overall Study||42||
48355119|NCT04902885|101198460|FG000|COMPLETED|Overall Study||12||
48355120|NCT04902885|101198461|FG001|COMPLETED|Overall Study||41||
48418045|NCT02939326|101357030|FG007|COMPLETED|Overall Study||5||
48418046|NCT02939326|101357023|FG000|NOT COMPLETED|Overall Study||0||
48418047|NCT02939326|101357024|FG001|NOT COMPLETED|Overall Study||0||
48418048|NCT02939326|101357025|FG002|NOT COMPLETED|Overall Study||0||
48418049|NCT02939326|101357026|FG003|NOT COMPLETED|Overall Study||0||
48762446|NCT03317405|102206016|FG000|NOT COMPLETED|Overall Study||1||
48762447|NCT03317405|102206017|FG001|NOT COMPLETED|Overall Study||1||
48762448|NCT03317405|102206018|FG002|NOT COMPLETED|Overall Study||1||
48418050|NCT02939326|101357027|FG004|NOT COMPLETED|Overall Study||0||
48418051|NCT02939326|101357028|FG005|NOT COMPLETED|Overall Study||0||
48762449|NCT01473134|102206019|FG000|STARTED|Overall Study||207||241
48762450|NCT01473134|102206020|FG001|STARTED|Overall Study||113||137
48762451|NCT01473134|102206019|FG000|COMPLETED|Overall Study||152||181
48762452|NCT01473134|102206020|FG001|COMPLETED|Overall Study||78||95
48762453|NCT01473134|102206019|FG000|NOT COMPLETED|Overall Study||55||60
48762454|NCT01473134|102206020|FG001|NOT COMPLETED|Overall Study||35||42
48762455|NCT03119259|102206021|FG000|STARTED|Overall Study||27|This table displays number of dyads. Each dyad comprises one patient and their informal caregiver|
48762456|NCT03119259|102206022|FG001|STARTED|Overall Study||26|This table displays number of dyads. Each dyad comprises one patient and their informal caregiver|
48762457|NCT03119259|102206021|FG000|COMPLETED|Overall Study||22|This table displays number of dyads. Each dyad comprises one patient and their informal caregiver|
48762458|NCT03119259|102206022|FG001|COMPLETED|Overall Study||23|This table displays number of dyads. Each dyad comprises one patient and their informal caregiver|
48762459|NCT03119259|102206021|FG000|NOT COMPLETED|Overall Study||5||
48762460|NCT03119259|102206022|FG001|NOT COMPLETED|Overall Study||3||
48762461|NCT03175679|102206023|FG000|STARTED|Overall Study||3||
48762462|NCT03175679|102206024|FG001|STARTED|Overall Study||3||
48762463|NCT03175679|102206025|FG002|STARTED|Overall Study||3||
48762464|NCT03175679|102206026|FG003|STARTED|Overall Study||1||
48762465|NCT03175679|102206023|FG000|COMPLETED|Overall Study||3||
48762466|NCT03175679|102206024|FG001|COMPLETED|Overall Study||3||
48762467|NCT03175679|102206025|FG002|COMPLETED|Overall Study||3||
48762468|NCT03175679|102206026|FG003|COMPLETED|Overall Study||1||
48762469|NCT03175679|102206023|FG000|NOT COMPLETED|Overall Study||0||
48762470|NCT03175679|102206024|FG001|NOT COMPLETED|Overall Study||0||
48762471|NCT03175679|102206025|FG002|NOT COMPLETED|Overall Study||0||
48762472|NCT03175679|102206026|FG003|NOT COMPLETED|Overall Study||0||
48762473|NCT02212015|102206027|FG000|STARTED|Overall Study||26||
48762474|NCT02212015|102206027|FG000|COMPLETED|Overall Study||25||
48762475|NCT02212015|102206027|FG000|NOT COMPLETED|Overall Study||1||
48762476|NCT00107198|102206028|FG000|STARTED|Overall Study||188||
48762477|NCT00107198|102206028|FG000|COMPLETED|Overall Study||136||
48762478|NCT00107198|102206028|FG000|NOT COMPLETED|Overall Study||52||
48762479|NCT01967238|102206029|FG000|STARTED|Overall Study||53||
48762480|NCT01967238|102206030|FG001|STARTED|Overall Study||22||
48762481|NCT01967238|102206031|FG002|STARTED|Overall Study||16||
48762482|NCT01967238|102206029|FG000|COMPLETED|Overall Study||51||
48762483|NCT01967238|102206030|FG001|COMPLETED|Overall Study||21||
48762484|NCT01967238|102206031|FG002|COMPLETED|Overall Study||14||
48762485|NCT01967238|102206029|FG000|NOT COMPLETED|Overall Study||2||
48762486|NCT01967238|102206030|FG001|NOT COMPLETED|Overall Study||1||
48762487|NCT01967238|102206031|FG002|NOT COMPLETED|Overall Study||2||
48762488|NCT00809185|102206032|FG000|STARTED|Overall Study||7||
48762489|NCT00809185|102206032|FG000|COMPLETED|Overall Study||7||
48762490|NCT00809185|102206032|FG000|NOT COMPLETED|Overall Study||0||
48762491|NCT00453206|102206033|FG000|STARTED|Overall Study||66||
48762492|NCT00453206|102206033|FG000|COMPLETED|Overall Study||65||
48762493|NCT00453206|102206033|FG000|NOT COMPLETED|Overall Study||1||
48186844|NCT00772928|100779916|FG000|NOT COMPLETED|Overall Study||44||
48186845|NCT00772928|100779917|FG001|NOT COMPLETED|Overall Study||41||
48355121|NCT04902885|101198462|FG002|COMPLETED|Overall Study||42||
48355122|NCT04902885|101198460|FG000|NOT COMPLETED|Overall Study||0||
48355123|NCT04902885|101198461|FG001|NOT COMPLETED|Overall Study||0||
48355124|NCT04902885|101198462|FG002|NOT COMPLETED|Overall Study||0||
48355125|NCT01357239|101198463|FG000|STARTED|Stratum: All Patients||31||
48355126|NCT01357239|101198464|FG001|STARTED|Stratum: All Patients||27||
48355127|NCT01357239|101198465|FG002|STARTED|Stratum: All Patients||39||
48355128|NCT01357239|101198466|FG003|STARTED|Stratum: All Patients||42||
48355129|NCT01357239|101198463|FG000|COMPLETED|Stratum: All Patients||31||
48355130|NCT01357239|101198464|FG001|COMPLETED|Stratum: All Patients||27||
48355131|NCT01357239|101198465|FG002|COMPLETED|Stratum: All Patients||37||
48355132|NCT01357239|101198466|FG003|COMPLETED|Stratum: All Patients||40||
48355133|NCT01357239|101198463|FG000|NOT COMPLETED|Stratum: All Patients||0||
48355134|NCT01357239|101198464|FG001|NOT COMPLETED|Stratum: All Patients||0||
48355135|NCT01357239|101198465|FG002|NOT COMPLETED|Stratum: All Patients||2||
48418052|NCT02939326|101357029|FG006|NOT COMPLETED|Overall Study||0||
48418053|NCT02939326|101357030|FG007|NOT COMPLETED|Overall Study||0||
48418054|NCT04601194|101357031|FG000|STARTED|Overall Study||29||
48418055|NCT04601194|101357031|FG000|COMPLETED|Overall Study||22||
48418056|NCT04601194|101357031|FG000|NOT COMPLETED|Overall Study||7||
48762494|NCT02443688|102206034|FG000|STARTED|Overall Study||66||
48762495|NCT02443688|102206035|FG001|STARTED|Overall Study||67||
48762496|NCT02443688|102206036|FG002|STARTED|Overall Study||67||
48762497|NCT02443688|102206034|FG000|COMPLETED|Overall Study||54||
48186846|NCT01859195|100779918|FG000|STARTED|Overall Study||24||
48355136|NCT01357239|101198466|FG003|NOT COMPLETED|Stratum: All Patients||2||
48355137|NCT01357239|101198463|FG000|STARTED|Stratum I: Fully-Methylated||8||
48418057|NCT03006276|101357032|FG000|STARTED|Double-blind Period 1 (DB1)||311|Randomized in DB1|
48762498|NCT02443688|102206035|FG001|COMPLETED|Overall Study||58||
48762499|NCT02443688|102206036|FG002|COMPLETED|Overall Study||55||
48762500|NCT02443688|102206034|FG000|NOT COMPLETED|Overall Study||12||
48355138|NCT01357239|101198464|FG001|STARTED|Stratum I: Fully-Methylated||6||
48355139|NCT01357239|101198465|FG002|STARTED|Stratum I: Fully-Methylated||17||
48355140|NCT01357239|101198466|FG003|STARTED|Stratum I: Fully-Methylated||22||
48355141|NCT01357239|101198463|FG000|COMPLETED|Stratum I: Fully-Methylated||8||
48418058|NCT03006276|101357033|FG001|STARTED|Double-blind Period 1 (DB1)||311|Randomized in DB1|
48418059|NCT03006276|101357032|FG000|Not Completed|Double-blind Period 1 (DB1)||43||
48418060|NCT03006276|101357033|FG001|Not Completed|Double-blind Period 1 (DB1)||42||
48418061|NCT03006276|101357032|FG000|COMPLETED|Double-blind Period 1 (DB1)||266|Completed DB1|
48418062|NCT03006276|101357033|FG001|COMPLETED|Double-blind Period 1 (DB1)||265|Completed DB1|
48418063|NCT03006276|101357032|FG000|NOT COMPLETED|Double-blind Period 1 (DB1)||45||
48418064|NCT03006276|101357033|FG001|NOT COMPLETED|Double-blind Period 1 (DB1)||46||
48418065|NCT03006276|101357032|FG000|STARTED|Double-blind Period 2 (DB2)||278|Randomized in DB2|
48418066|NCT03006276|101357033|FG001|STARTED|Double-blind Period 2 (DB2)||267|Randomized in DB2|
48418067|NCT03006276|101357032|FG000|Not Completed|Double-blind Period 2 (DB2)||16||
48418068|NCT03006276|101357033|FG001|Not Completed|Double-blind Period 2 (DB2)||20||
48418069|NCT03006276|101357032|FG000|COMPLETED|Double-blind Period 2 (DB2)||249|Completed DB2|
48762501|NCT02443688|102206035|FG001|NOT COMPLETED|Overall Study||9||
48762502|NCT02443688|102206036|FG002|NOT COMPLETED|Overall Study||12||
48762503|NCT00541658|102206037|FG000|STARTED|Overall Study||308||
48762504|NCT00541658|102206038|FG001|STARTED|Overall Study||307||
48762505|NCT00541658|102206039|FG002|STARTED|Overall Study||308||
48762506|NCT00541658|102206037|FG000|ITT Population|Overall Study||307||
48762507|NCT00541658|102206038|FG001|ITT Population|Overall Study||307||
48762508|NCT00541658|102206039|FG002|ITT Population|Overall Study||308||
48762509|NCT00541658|102206037|FG000|COMPLETED|Overall Study||248||
48762510|NCT00541658|102206038|FG001|COMPLETED|Overall Study||234||
48762511|NCT00541658|102206039|FG002|COMPLETED|Overall Study||240||
48762512|NCT00541658|102206037|FG000|NOT COMPLETED|Overall Study||60||
48762513|NCT00541658|102206038|FG001|NOT COMPLETED|Overall Study||73||
48762514|NCT00541658|102206039|FG002|NOT COMPLETED|Overall Study||68||
48762515|NCT01527370|102206040|FG000|STARTED|Overall Study||250||
48762516|NCT01527370|102206040|FG000|COMPLETED|Overall Study||244||
48762517|NCT01527370|102206040|FG000|NOT COMPLETED|Overall Study||6||
48762518|NCT01183689|102206041|FG000|STARTED|Overall Study||202||
48762519|NCT01183689|102206042|FG001|STARTED|Overall Study||200||
48762520|NCT01183689|102206043|FG002|STARTED|Overall Study||197||
48762521|NCT01183689|102206041|FG000|Month 4 Visit|Overall Study||197||
48762522|NCT01183689|102206042|FG001|Month 4 Visit|Overall Study||192||
48762523|NCT01183689|102206043|FG002|Month 4 Visit|Overall Study||187||
48762524|NCT01183689|102206041|FG000|Year 1 Visit|Overall Study||187||
48762525|NCT01183689|102206042|FG001|Year 1 Visit|Overall Study||172||
48762526|NCT01183689|102206043|FG002|Year 1 Visit|Overall Study||183||
48762527|NCT01183689|102206041|FG000|Year 2 Visit|Overall Study||178||
48762528|NCT01183689|102206042|FG001|Year 2 Visit|Overall Study||172||
48762529|NCT01183689|102206043|FG002|Year 2 Visit|Overall Study||174||
48762530|NCT01183689|102206041|FG000|Year 3 Visit|Overall Study||139||
48762531|NCT01183689|102206042|FG001|Year 3 Visit|Overall Study||125||
48355142|NCT01357239|101198464|FG001|COMPLETED|Stratum I: Fully-Methylated||6||
48355143|NCT01357239|101198465|FG002|COMPLETED|Stratum I: Fully-Methylated||16||
48355144|NCT01357239|101198466|FG003|COMPLETED|Stratum I: Fully-Methylated||22||
48355145|NCT01357239|101198463|FG000|NOT COMPLETED|Stratum I: Fully-Methylated||0||
48418070|NCT03006276|101357033|FG001|COMPLETED|Double-blind Period 2 (DB2)||242|Completed DB2|
48418071|NCT03006276|101357032|FG000|NOT COMPLETED|Double-blind Period 2 (DB2)||29||
48418072|NCT03006276|101357033|FG001|NOT COMPLETED|Double-blind Period 2 (DB2)||25||
48418073|NCT02275559|101357034|FG000|STARTED|Overall Study||115||
48762532|NCT01183689|102206043|FG002|Year 3 Visit|Overall Study||126||
48762533|NCT01183689|102206041|FG000|Year 4 Visit|Overall Study||38||
48762534|NCT01183689|102206042|FG001|Year 4 Visit|Overall Study||33||
48762535|NCT01183689|102206043|FG002|Year 4 Visit|Overall Study||30||
48762536|NCT01183689|102206041|FG000|COMPLETED|Overall Study||202||
48762537|NCT01183689|102206042|FG001|COMPLETED|Overall Study||200||
48762538|NCT01183689|102206043|FG002|COMPLETED|Overall Study||197||
48762539|NCT01183689|102206041|FG000|NOT COMPLETED|Overall Study||0||
48355146|NCT01357239|101198464|FG001|NOT COMPLETED|Stratum I: Fully-Methylated||0||
48418074|NCT02275559|101357035|FG001|STARTED|Overall Study||118||
48418075|NCT02275559|101357034|FG000|COMPLETED|Overall Study||115||
48418076|NCT02275559|101357035|FG001|COMPLETED|Overall Study||118||
48418077|NCT02275559|101357034|FG000|NOT COMPLETED|Overall Study||0||
48418078|NCT02275559|101357035|FG001|NOT COMPLETED|Overall Study||0||
48418079|NCT04604015|101357036|FG000|STARTED|Overall Study||154||
48762540|NCT01183689|102206042|FG001|NOT COMPLETED|Overall Study||0||
48762541|NCT01183689|102206043|FG002|NOT COMPLETED|Overall Study||0||
48762542|NCT03894124|102206044|FG000|STARTED|Overall Study||14||
48762543|NCT03894124|102206044|FG000|COMPLETED|Overall Study||14||
48762544|NCT03894124|102206044|FG000|NOT COMPLETED|Overall Study||0||
48762545|NCT00593346|102206045|FG000|STARTED|Overall Study||151||
48762546|NCT00593346|102206045|FG000|COMPLETED|Overall Study||151||
48355147|NCT01357239|101198465|FG002|NOT COMPLETED|Stratum I: Fully-Methylated||1||
48355148|NCT01357239|101198466|FG003|NOT COMPLETED|Stratum I: Fully-Methylated||0||
48355149|NCT01357239|101198463|FG000|STARTED|Stratum II: Partially-Methylated||23||
48355150|NCT01357239|101198464|FG001|STARTED|Stratum II: Partially-Methylated||21||
48355151|NCT01357239|101198465|FG002|STARTED|Stratum II: Partially-Methylated||22||
48355152|NCT01357239|101198466|FG003|STARTED|Stratum II: Partially-Methylated||20||
48355153|NCT01357239|101198463|FG000|COMPLETED|Stratum II: Partially-Methylated||23||
48355154|NCT01357239|101198464|FG001|COMPLETED|Stratum II: Partially-Methylated||21||
48355155|NCT01357239|101198465|FG002|COMPLETED|Stratum II: Partially-Methylated||21||
48355156|NCT01357239|101198466|FG003|COMPLETED|Stratum II: Partially-Methylated||18||
48355157|NCT01357239|101198463|FG000|NOT COMPLETED|Stratum II: Partially-Methylated||0||
48355158|NCT01357239|101198464|FG001|NOT COMPLETED|Stratum II: Partially-Methylated||0||
48355159|NCT01357239|101198465|FG002|NOT COMPLETED|Stratum II: Partially-Methylated||1||
48355160|NCT01357239|101198466|FG003|NOT COMPLETED|Stratum II: Partially-Methylated||2||
48355161|NCT01882725|101198467|FG000|STARTED|Overall Study||14||
48355162|NCT01882725|101198467|FG000|COMPLETED|Overall Study||14||
48355163|NCT01882725|101198467|FG000|NOT COMPLETED|Overall Study||0||
48355164|NCT04090164|101198468|FG000|STARTED|Overall Study||650||
48355165|NCT04090164|101198469|FG001|STARTED|Overall Study||145||
48355166|NCT04090164|101198468|FG000|COMPLETED|Overall Study||405||
48355167|NCT04090164|101198469|FG001|COMPLETED|Overall Study||145||
48355168|NCT04090164|101198468|FG000|NOT COMPLETED|Overall Study||245||
48355169|NCT04090164|101198469|FG001|NOT COMPLETED|Overall Study||0||
48355170|NCT04246047|101198470|FG000|STARTED|Overall Study||243|Intent-to-Treat (ITT) Population included of all randomized participants whether or not randomized treatment was administered.|
48355171|NCT04246047|101198471|FG001|STARTED|Overall Study||251|Intent-to-Treat (ITT) Population included of all randomized participants whether or not randomized treatment was administered.|
48355172|NCT04246047|101198470|FG000|Safety Population|Overall Study||242|Participants randomized who took at least 1 dose of study treatment.|
48762547|NCT00593346|102206045|FG000|NOT COMPLETED|Overall Study||0||
48186847|NCT01859195|100779919|FG001|STARTED|Overall Study||12||
48355173|NCT04246047|101198471|FG001|Safety Population|Overall Study||246|Participants randomized who took at least 1 dose of study treatment.|
48355174|NCT04246047|101198470|FG000|COMPLETED|Overall Study||0||
48355175|NCT04246047|101198471|FG001|COMPLETED|Overall Study||0||
48355176|NCT04246047|101198470|FG000|NOT COMPLETED|Overall Study||243||
48355177|NCT04246047|101198471|FG001|NOT COMPLETED|Overall Study||251||
48355178|NCT01362322|101198472|FG000|STARTED|Overall Study||335||
48355179|NCT01362322|101198473|FG001|STARTED|Overall Study||336||
48355180|NCT01362322|101198472|FG000|COMPLETED|Overall Study||330||
48355181|NCT01362322|101198473|FG001|COMPLETED|Overall Study||329||
48418080|NCT04604015|101357036|FG000|COMPLETED|Overall Study||121||
48418081|NCT04604015|101357036|FG000|NOT COMPLETED|Overall Study||33||
48418082|NCT03531918|101357037|FG000|STARTED|Overall Study||6||
48418083|NCT03531918|101357038|FG001|STARTED|Overall Study||60||
48418084|NCT03531918|101357037|FG000|COMPLETED|Overall Study||6||
48355182|NCT01362322|101198472|FG000|NOT COMPLETED|Overall Study||5||
48355183|NCT01362322|101198473|FG001|NOT COMPLETED|Overall Study||7||
48355184|NCT00650585|101198474|FG000|STARTED|Overall Study||4348||
48355185|NCT00650585|101198475|FG001|STARTED|Overall Study||3990||
48355186|NCT00650585|101198474|FG000|COMPLETED|Overall Study||2551||
48355187|NCT00650585|101198475|FG001|COMPLETED|Overall Study||2513||
48355188|NCT00650585|101198474|FG000|NOT COMPLETED|Overall Study||1797||
48355189|NCT00650585|101198475|FG001|NOT COMPLETED|Overall Study||1477||
48355190|NCT01035151|101198476|FG000|STARTED|Overall Study||209||
48355191|NCT01035151|101198477|FG001|STARTED|Overall Study||200||
48355192|NCT01035151|101198476|FG000|COMPLETED|Overall Study||188||
48355193|NCT01035151|101198477|FG001|COMPLETED|Overall Study||185||
48355194|NCT01035151|101198476|FG000|NOT COMPLETED|Overall Study||21||
48355195|NCT01035151|101198477|FG001|NOT COMPLETED|Overall Study||15||
48355196|NCT01466751|101198478|FG000|STARTED|Overall Study||14||
48418085|NCT03531918|101357038|FG001|COMPLETED|Overall Study||56||
48418086|NCT03531918|101357037|FG000|NOT COMPLETED|Overall Study||0||
48418087|NCT03531918|101357038|FG001|NOT COMPLETED|Overall Study||4||
48418088|NCT04524507|101357039|FG000|STARTED|Overall Study||15||
48638425|NCT01048424|101898754|FG001|STARTED|Overall Study||10||
48355197|NCT01466751|101198479|FG001|STARTED|Overall Study||14||
48355198|NCT01466751|101198478|FG000|COMPLETED|Overall Study||13||
48418089|NCT04524507|101357040|FG001|STARTED|Overall Study||41||
48418090|NCT04524507|101357039|FG000|Received Intervention|Overall Study||14||
48418091|NCT04524507|101357040|FG001|Received Intervention|Overall Study||41||
48638426|NCT01048424|101898753|FG000|COMPLETED|Overall Study||8||
48638427|NCT01048424|101898754|FG001|COMPLETED|Overall Study||10||
48638428|NCT01048424|101898753|FG000|NOT COMPLETED|Overall Study||2||
48638429|NCT01048424|101898754|FG001|NOT COMPLETED|Overall Study||0||
48638430|NCT01040819|101898755|FG000|STARTED|Overall Study||13||
48638431|NCT01040819|101898756|FG001|STARTED|Overall Study||12||
48638432|NCT01040819|101898755|FG000|COMPLETED|Overall Study||13||
48638433|NCT01040819|101898756|FG001|COMPLETED|Overall Study||12||
48762548|NCT02954536|102206046|FG000|STARTED|Overall Study||37||
48762549|NCT02954536|102206046|FG000|COMPLETED|Overall Study||23||
48638434|NCT01040819|101898755|FG000|NOT COMPLETED|Overall Study||0||
48355199|NCT01466751|101198479|FG001|COMPLETED|Overall Study||14||
48355200|NCT01466751|101198478|FG000|NOT COMPLETED|Overall Study||1||
48355201|NCT01466751|101198479|FG001|NOT COMPLETED|Overall Study||0||
48355202|NCT01217749|101198480|FG000|STARTED|Overall Study||27||
48355203|NCT01217749|101198481|FG001|STARTED|Overall Study||20||
48355204|NCT01217749|101198482|FG002|STARTED|Overall Study||24||
48355205|NCT01217749|101198480|FG000|COMPLETED|Overall Study||24||
48355206|NCT01217749|101198481|FG001|COMPLETED|Overall Study||17||
48355207|NCT01217749|101198482|FG002|COMPLETED|Overall Study||22||
48355208|NCT01217749|101198480|FG000|NOT COMPLETED|Overall Study||3||
48355209|NCT01217749|101198481|FG001|NOT COMPLETED|Overall Study||3||
48355210|NCT01217749|101198482|FG002|NOT COMPLETED|Overall Study||2||
48355211|NCT01006356|101198483|FG000|STARTED|Overall Study||141||
48355212|NCT01006356|101198483|FG000|COMPLETED|Overall Study||99||
48355213|NCT01006356|101198483|FG000|NOT COMPLETED|Overall Study||42||
48355214|NCT06046560|101198484|FG000|STARTED|Overall Study||116||
48355215|NCT06046560|101198485|FG001|STARTED|Overall Study||84||
48355216|NCT06046560|101198484|FG000|COMPLETED|Overall Study||116||
48355217|NCT06046560|101198485|FG001|COMPLETED|Overall Study||84||
48355218|NCT06046560|101198484|FG000|NOT COMPLETED|Overall Study||0||
48355219|NCT06046560|101198485|FG001|NOT COMPLETED|Overall Study||0||
48355220|NCT00467844|101198486|FG000|STARTED|Overall Study||53||
48355221|NCT00467844|101198487|FG001|STARTED|Overall Study||54||
48355222|NCT00467844|101198488|FG002|STARTED|Overall Study||52||
48355223|NCT00467844|101198486|FG000|COMPLETED|Overall Study||34||
48355224|NCT00467844|101198487|FG001|COMPLETED|Overall Study||34||
48355225|NCT00467844|101198488|FG002|COMPLETED|Overall Study||38||
48355226|NCT00467844|101198486|FG000|NOT COMPLETED|Overall Study||19||
48355227|NCT00467844|101198487|FG001|NOT COMPLETED|Overall Study||20||
48355228|NCT00467844|101198488|FG002|NOT COMPLETED|Overall Study||14||
48355229|NCT00691574|101198489|FG000|STARTED|Overall Study||0||
48355230|NCT00691574|101198490|FG001|STARTED|Overall Study||0||
48355231|NCT00691574|101198489|FG000|COMPLETED|Overall Study||0||
48355232|NCT00691574|101198490|FG001|COMPLETED|Overall Study||0||
48355233|NCT00691574|101198489|FG000|NOT COMPLETED|Overall Study||0||
48355234|NCT00691574|101198490|FG001|NOT COMPLETED|Overall Study||0||
48355235|NCT01634243|101198491|FG000|STARTED|Overall Study||21||
48355236|NCT01634243|101198492|FG001|STARTED|Overall Study||43||
48355237|NCT01634243|101198491|FG000|COMPLETED|Overall Study||15||
48355238|NCT01634243|101198492|FG001|COMPLETED|Overall Study||38||
48355239|NCT01634243|101198491|FG000|NOT COMPLETED|Overall Study||6||
48355240|NCT01634243|101198492|FG001|NOT COMPLETED|Overall Study||5||
48355241|NCT00824421|101198493|FG000|STARTED|Overall Study||66||
48355242|NCT00824421|101198494|FG001|STARTED|Overall Study||66||
48355243|NCT00824421|101198495|FG002|STARTED|Overall Study||63||
48355244|NCT00824421|101198493|FG000|Treated|Overall Study||65||
48355245|NCT00824421|101198494|FG001|Treated|Overall Study||65||
48355246|NCT00824421|101198495|FG002|Treated|Overall Study||63||
48355247|NCT00824421|101198493|FG000|COMPLETED|Overall Study||49||
48355248|NCT00824421|101198494|FG001|COMPLETED|Overall Study||44||
48355249|NCT00824421|101198495|FG002|COMPLETED|Overall Study||49||
48355250|NCT00824421|101198493|FG000|NOT COMPLETED|Overall Study||17||
48355251|NCT00824421|101198494|FG001|NOT COMPLETED|Overall Study||22||
48355252|NCT00824421|101198495|FG002|NOT COMPLETED|Overall Study||14||
48355253|NCT03826914|101198496|FG000|STARTED|Overall Study||35||
48355254|NCT03826914|101198497|FG001|STARTED|Overall Study||34||
48355255|NCT03826914|101198496|FG000|COMPLETED|Overall Study||34||
48355256|NCT03826914|101198497|FG001|COMPLETED|Overall Study||33||
48355257|NCT03826914|101198496|FG000|NOT COMPLETED|Overall Study||1||
48355258|NCT03826914|101198497|FG001|NOT COMPLETED|Overall Study||1||
48355259|NCT01772134|101198498|FG000|STARTED|Overall Study||207||
48355260|NCT01772134|101198499|FG001|STARTED|Overall Study||204||
48355261|NCT01772134|101198500|FG002|STARTED|Overall Study||206||
48355262|NCT01772134|101198498|FG000|Received Randomized Study Medication|Overall Study||205||
48355263|NCT01772134|101198499|FG001|Received Randomized Study Medication|Overall Study||204||
48355264|NCT01772134|101198500|FG002|Received Randomized Study Medication|Overall Study||205||
48355265|NCT01772134|101198498|FG000|COMPLETED|Overall Study||178||
48355266|NCT01772134|101198499|FG001|COMPLETED|Overall Study||190||
48355267|NCT01772134|101198500|FG002|COMPLETED|Overall Study||184||
48355268|NCT01772134|101198498|FG000|NOT COMPLETED|Overall Study||29||
48355269|NCT01772134|101198499|FG001|NOT COMPLETED|Overall Study||14||
48355270|NCT01772134|101198500|FG002|NOT COMPLETED|Overall Study||22||
48355271|NCT03037905|101198501|FG000|STARTED|Overall Study||50||
48355272|NCT03037905|101198502|FG001|STARTED|Overall Study||50||
48355273|NCT03037905|101198501|FG000|COMPLETED|Overall Study||50||
48355274|NCT03037905|101198502|FG001|COMPLETED|Overall Study||50||
48355275|NCT03037905|101198501|FG000|NOT COMPLETED|Overall Study||0||
48355276|NCT03037905|101198502|FG001|NOT COMPLETED|Overall Study||0||
48418092|NCT04524507|101357039|FG000|Hospital Discharge|Overall Study||13|Discharged at or before Day 28.|
48418093|NCT04524507|101357040|FG001|Hospital Discharge|Overall Study||27|Discharged at or before Day 28.|
48418094|NCT04524507|101357039|FG000|COMPLETED|Overall Study||9|Day 28|
48355277|NCT00618956|101198503|FG000|STARTED|Overall Study||111||
48355278|NCT00618956|101198504|FG001|STARTED|Overall Study||210||
48355279|NCT00618956|101198503|FG000|COMPLETED|Overall Study||86||
48355280|NCT00618956|101198504|FG001|COMPLETED|Overall Study||160||
48355281|NCT00618956|101198503|FG000|NOT COMPLETED|Overall Study||25||
48355282|NCT00618956|101198504|FG001|NOT COMPLETED|Overall Study||50||
48418095|NCT04524507|101357040|FG001|COMPLETED|Overall Study||18|Day 28|
48418096|NCT04524507|101357039|FG000|NOT COMPLETED|Overall Study||6||
48418097|NCT04524507|101357040|FG001|NOT COMPLETED|Overall Study||23||
48418098|NCT00808132|101357041|FG000|STARTED|Overall Study||455||
48418099|NCT00808132|101357042|FG001|STARTED|Overall Study||481||
48418100|NCT00808132|101357043|FG002|STARTED|Overall Study||239||
48418101|NCT00808132|101357044|FG003|STARTED|Overall Study||228||
48418102|NCT00808132|101357045|FG004|STARTED|Overall Study||483||
48418103|NCT00808132|101357041|FG000|Treated|Overall Study||445||
48418104|NCT00808132|101357042|FG001|Treated|Overall Study||474||
48418105|NCT00808132|101357043|FG002|Treated|Overall Study||230||
48418106|NCT00808132|101357044|FG003|Treated|Overall Study||220||
48418107|NCT00808132|101357045|FG004|Treated|Overall Study||474||
48418108|NCT00808132|101357041|FG000|COMPLETED|Overall Study||357||
48418109|NCT00808132|101357042|FG001|COMPLETED|Overall Study||393||
48418110|NCT00808132|101357043|FG002|COMPLETED|Overall Study||185||
48418111|NCT00808132|101357044|FG003|COMPLETED|Overall Study||159||
48418112|NCT00808132|101357045|FG004|COMPLETED|Overall Study||383||
48418113|NCT00808132|101357041|FG000|NOT COMPLETED|Overall Study||98||
48418114|NCT00808132|101357042|FG001|NOT COMPLETED|Overall Study||88||
48418115|NCT00808132|101357043|FG002|NOT COMPLETED|Overall Study||54||
48355283|NCT03490344|101198505|FG000|STARTED|Overall Study||10||
48355284|NCT03490344|101198505|FG000|COMPLETED|Overall Study||10||
48355285|NCT03490344|101198505|FG000|NOT COMPLETED|Overall Study||0||
48355286|NCT00608465|101198506|FG000|STARTED|Overall Study||4||
48355287|NCT00608465|101198506|FG000|COMPLETED|Overall Study||4||
48355288|NCT00608465|101198506|FG000|NOT COMPLETED|Overall Study||0||
48355289|NCT01480180|101198507|FG000|STARTED|Main Phase||174||
48355290|NCT01480180|101198508|FG001|STARTED|Main Phase||12||
48355291|NCT01480180|101198509|FG002|STARTED|Main Phase||0||
48355292|NCT01480180|101198510|FG003|STARTED|Main Phase||0||
48355293|NCT01480180|101198511|FG004|STARTED|Main Phase||0||
48355294|NCT01480180|101198512|FG005|STARTED|Main Phase||0||
48355295|NCT01480180|101198507|FG000|Max. Participants After Switching|Main Phase||175||
48418116|NCT00808132|101357044|FG003|NOT COMPLETED|Overall Study||69||
48418117|NCT00808132|101357045|FG004|NOT COMPLETED|Overall Study||100||
48418118|NCT02908841|101357046|FG000|STARTED|Overall Study||10||
48418119|NCT02908841|101357047|FG001|STARTED|Overall Study||12||
48418120|NCT02908841|101357046|FG000|COMPLETED|Overall Study||6||
48418121|NCT02908841|101357047|FG001|COMPLETED|Overall Study||12||
48355296|NCT01480180|101198508|FG001|Max. Participants After Switching|Main Phase||11||
48355297|NCT01480180|101198509|FG002|Max. Participants After Switching|Main Phase||0||
48355298|NCT01480180|101198510|FG003|Max. Participants After Switching|Main Phase||0||
48355299|NCT01480180|101198511|FG004|Max. Participants After Switching|Main Phase||0||
48355300|NCT01480180|101198512|FG005|Max. Participants After Switching|Main Phase||0||
48355301|NCT01480180|101198507|FG000|COMPLETED|Main Phase||155||
48355302|NCT01480180|101198508|FG001|COMPLETED|Main Phase||11||
48418122|NCT02908841|101357046|FG000|NOT COMPLETED|Overall Study||4||
48418123|NCT02908841|101357047|FG001|NOT COMPLETED|Overall Study||0||
48418124|NCT01474993|101357048|FG000|STARTED|Overall Study||15||
48355303|NCT01480180|101198509|FG002|COMPLETED|Main Phase||0||
48355304|NCT01480180|101198510|FG003|COMPLETED|Main Phase||0||
48355305|NCT01480180|101198511|FG004|COMPLETED|Main Phase||0||
48355306|NCT01480180|101198512|FG005|COMPLETED|Main Phase||0||
48355307|NCT01480180|101198507|FG000|NOT COMPLETED|Main Phase||19||
48355308|NCT01480180|101198508|FG001|NOT COMPLETED|Main Phase||1||
48355309|NCT01480180|101198509|FG002|NOT COMPLETED|Main Phase||0||
48355310|NCT01480180|101198510|FG003|NOT COMPLETED|Main Phase||0||
48355311|NCT01480180|101198511|FG004|NOT COMPLETED|Main Phase||0||
48355312|NCT01480180|101198512|FG005|NOT COMPLETED|Main Phase||0||
48355313|NCT01480180|101198507|FG000|STARTED|Extension Phase, Part 1||0||
48418125|NCT01474993|101357049|FG001|STARTED|Overall Study||29||
48418126|NCT01474993|101357048|FG000|COMPLETED|Overall Study||14||
48418127|NCT01474993|101357049|FG001|COMPLETED|Overall Study||26||
48418128|NCT01474993|101357048|FG000|NOT COMPLETED|Overall Study||1||
48355314|NCT01480180|101198508|FG001|STARTED|Extension Phase, Part 1||0||
48355315|NCT01480180|101198509|FG002|STARTED|Extension Phase, Part 1||105||
48355316|NCT01480180|101198510|FG003|STARTED|Extension Phase, Part 1||38||
48355317|NCT01480180|101198511|FG004|STARTED|Extension Phase, Part 1||7||
48355318|NCT01480180|101198512|FG005|STARTED|Extension Phase, Part 1||0||
48355319|NCT01480180|101198507|FG000|COMPLETED|Extension Phase, Part 1||0||
48418129|NCT01474993|101357049|FG001|NOT COMPLETED|Overall Study||3||
48355320|NCT01480180|101198508|FG001|COMPLETED|Extension Phase, Part 1||0||
48355321|NCT01480180|101198509|FG002|COMPLETED|Extension Phase, Part 1||95||
48418130|NCT03347279|101357050|FG000|STARTED|Overall Study||529||
48355322|NCT01480180|101198510|FG003|COMPLETED|Extension Phase, Part 1||28||
48355323|NCT01480180|101198511|FG004|COMPLETED|Extension Phase, Part 1||7||
48355324|NCT01480180|101198512|FG005|COMPLETED|Extension Phase, Part 1||0||
48355325|NCT01480180|101198507|FG000|NOT COMPLETED|Extension Phase, Part 1||0||
48355326|NCT01480180|101198508|FG001|NOT COMPLETED|Extension Phase, Part 1||0||
48355327|NCT01480180|101198509|FG002|NOT COMPLETED|Extension Phase, Part 1||10||
48355328|NCT01480180|101198510|FG003|NOT COMPLETED|Extension Phase, Part 1||10||
48355329|NCT01480180|101198511|FG004|NOT COMPLETED|Extension Phase, Part 1||0||
48355330|NCT01480180|101198512|FG005|NOT COMPLETED|Extension Phase, Part 1||0||
48355331|NCT01480180|101198507|FG000|STARTED|Extension Phase, Part 2||0||
48355332|NCT01480180|101198508|FG001|STARTED|Extension Phase, Part 2||0||
48355333|NCT01480180|101198509|FG002|STARTED|Extension Phase, Part 2||94||
48355334|NCT01480180|101198510|FG003|STARTED|Extension Phase, Part 2||40||
48355335|NCT01480180|101198511|FG004|STARTED|Extension Phase, Part 2||5||
48355336|NCT01480180|101198512|FG005|STARTED|Extension Phase, Part 2||0||
48355337|NCT01480180|101198507|FG000|COMPLETED|Extension Phase, Part 2||0||
48355338|NCT01480180|101198508|FG001|COMPLETED|Extension Phase, Part 2||0||
48355339|NCT01480180|101198509|FG002|COMPLETED|Extension Phase, Part 2||77||
48355340|NCT01480180|101198510|FG003|COMPLETED|Extension Phase, Part 2||33||
48355341|NCT01480180|101198511|FG004|COMPLETED|Extension Phase, Part 2||3||
48355342|NCT01480180|101198512|FG005|COMPLETED|Extension Phase, Part 2||0||
48355343|NCT01480180|101198507|FG000|NOT COMPLETED|Extension Phase, Part 2||0||
48355344|NCT01480180|101198508|FG001|NOT COMPLETED|Extension Phase, Part 2||0||
48355345|NCT01480180|101198509|FG002|NOT COMPLETED|Extension Phase, Part 2||17||
48355346|NCT01480180|101198510|FG003|NOT COMPLETED|Extension Phase, Part 2||7||
48355347|NCT01480180|101198511|FG004|NOT COMPLETED|Extension Phase, Part 2||2||
48355348|NCT01480180|101198512|FG005|NOT COMPLETED|Extension Phase, Part 2||0||
48355349|NCT03215914|101198513|FG000|STARTED|Overall Study||10||
48355350|NCT03215914|101198513|FG000|COMPLETED|Overall Study||10||
48355351|NCT03215914|101198513|FG000|NOT COMPLETED|Overall Study||0||
48355352|NCT02493751|101198514|FG000|STARTED|Overall Study||16||
48418131|NCT03347279|101357051|FG001|STARTED|Overall Study||532||
48418132|NCT03347279|101357050|FG000|Received Treatment|Overall Study||528||
48418133|NCT03347279|101357051|FG001|Received Treatment|Overall Study||531||
48418134|NCT03347279|101357050|FG000|COMPLETED|Overall Study||513||
48418135|NCT03347279|101357051|FG001|COMPLETED|Overall Study||509||
48418136|NCT03347279|101357050|FG000|NOT COMPLETED|Overall Study||16||
48418137|NCT03347279|101357051|FG001|NOT COMPLETED|Overall Study||23||
48418138|NCT01680835|101357052|FG000|STARTED|Overall Study||108||
48418139|NCT01680835|101357052|FG000|COMPLETED|Overall Study||83||
48418140|NCT01680835|101357052|FG000|NOT COMPLETED|Overall Study||25||
48418141|NCT00095836|101357053|FG000|STARTED|Overall Study||27||
48418142|NCT00095836|101357053|FG000|COMPLETED|Overall Study||23||
48418143|NCT00095836|101357053|FG000|NOT COMPLETED|Overall Study||4||
48418144|NCT04098172|101357054|FG000|STARTED|Overall Study||39||
48418145|NCT04098172|101357054|FG000|COMPLETED|Overall Study||39||
48418146|NCT04098172|101357054|FG000|NOT COMPLETED|Overall Study||0||
48418147|NCT00736385|101357055|FG000|STARTED|Overall Study||4||
48418148|NCT00736385|101357056|FG001|STARTED|Overall Study||5||
48418149|NCT00736385|101357055|FG000|COMPLETED|Overall Study||2||
48418150|NCT00736385|101357056|FG001|COMPLETED|Overall Study||2||
48418151|NCT00736385|101357055|FG000|NOT COMPLETED|Overall Study||2||
48418152|NCT00736385|101357056|FG001|NOT COMPLETED|Overall Study||3||
48418153|NCT02358876|101357057|FG000|STARTED|Overall Study||32||
48418154|NCT02358876|101357057|FG000|COMPLETED|Overall Study||30||
48418155|NCT02358876|101357057|FG000|NOT COMPLETED|Overall Study||2||
48418156|NCT02200510|101357058|FG000|STARTED|Overall Study||31||
48418157|NCT02200510|101357059|FG001|STARTED|Overall Study||47||
48418158|NCT02200510|101357058|FG000|COMPLETED|Overall Study||22||
48418159|NCT02200510|101357059|FG001|COMPLETED|Overall Study||44||
48762550|NCT02954536|102206046|FG000|NOT COMPLETED|Overall Study||14||
48355353|NCT02493751|101198515|FG001|STARTED|Overall Study||39||
48355354|NCT02493751|101198514|FG000|COMPLETED|Overall Study||0||
48355355|NCT02493751|101198515|FG001|COMPLETED|Overall Study||0||
48355356|NCT02493751|101198514|FG000|NOT COMPLETED|Overall Study||16||
48355357|NCT02493751|101198515|FG001|NOT COMPLETED|Overall Study||39||
48355358|NCT01887912|101198516|FG000|STARTED|Overall Study||6201||
48355359|NCT01887912|101198517|FG001|STARTED|Overall Study||3101||
48355360|NCT01887912|101198516|FG000|Safety Population|Overall Study||6113|Participants who had received the study or control vaccine, analyzed according to vaccine received|
48355361|NCT01887912|101198517|FG001|Safety Population|Overall Study||3057|Participants who had received the study or control vaccine, analyzed according to vaccine received|
48355362|NCT01887912|101198516|FG000|COMPLETED|Overall Study||4809||
48355363|NCT01887912|101198517|FG001|COMPLETED|Overall Study||2370||
48355364|NCT01887912|101198516|FG000|NOT COMPLETED|Overall Study||1392||
48355365|NCT01887912|101198517|FG001|NOT COMPLETED|Overall Study||731||
48355366|NCT02515669|101198518|FG000|STARTED|24 Week Double-Blind Phase||11||
48355367|NCT02515669|101198519|FG001|STARTED|24 Week Double-Blind Phase||7||
48418160|NCT02200510|101357058|FG000|NOT COMPLETED|Overall Study||9||
48418161|NCT02200510|101357059|FG001|NOT COMPLETED|Overall Study||3||
48418162|NCT03233308|101357060|FG000|STARTED|Overall Study||20||
48762551|NCT00456846|102206047|FG000|STARTED|Overall Study||47||
48762552|NCT00456846|102206048|FG001|STARTED|Overall Study||76||
48355368|NCT02515669|101198520|FG002|STARTED|24 Week Double-Blind Phase||6||
48355369|NCT02515669|101198521|FG003|STARTED|24 Week Double-Blind Phase||19||
48355370|NCT02515669|101198518|FG000|COMPLETED|24 Week Double-Blind Phase||11||
48355371|NCT02515669|101198519|FG001|COMPLETED|24 Week Double-Blind Phase||7||
48355372|NCT02515669|101198520|FG002|COMPLETED|24 Week Double-Blind Phase||6||
48355373|NCT02515669|101198521|FG003|COMPLETED|24 Week Double-Blind Phase||19||
48355374|NCT02515669|101198518|FG000|NOT COMPLETED|24 Week Double-Blind Phase||0||
48355375|NCT02515669|101198519|FG001|NOT COMPLETED|24 Week Double-Blind Phase||0||
48355376|NCT02515669|101198520|FG002|NOT COMPLETED|24 Week Double-Blind Phase||0||
48355377|NCT02515669|101198521|FG003|NOT COMPLETED|24 Week Double-Blind Phase||0||
48355378|NCT02515669|101198518|FG000|STARTED|228 Week Open-Label Phase||0|Participants assigned to placebo in the double blind phase switched to RO for the open-label phase|
48355379|NCT02515669|101198519|FG001|STARTED|228 Week Open-Label Phase||9|Participants assigned to placebo in the double blind phase switched to RO for the open-label phase|
48355380|NCT02515669|101198520|FG002|STARTED|228 Week Open-Label Phase||8|Participants assigned to placebo in the double blind phase switched to RO for the open-label phase|
48355381|NCT02515669|101198521|FG003|STARTED|228 Week Open-Label Phase||26|Participants assigned to placebo in the double blind phase switched to RO for the open-label phase|
48355382|NCT02515669|101198518|FG000|COMPLETED|228 Week Open-Label Phase||0||
48355383|NCT02515669|101198519|FG001|COMPLETED|228 Week Open-Label Phase||0||
48355384|NCT02515669|101198520|FG002|COMPLETED|228 Week Open-Label Phase||0||
48355385|NCT02515669|101198521|FG003|COMPLETED|228 Week Open-Label Phase||0||
48355386|NCT02515669|101198518|FG000|NOT COMPLETED|228 Week Open-Label Phase||0||
48355387|NCT02515669|101198519|FG001|NOT COMPLETED|228 Week Open-Label Phase||9||
48355388|NCT02515669|101198520|FG002|NOT COMPLETED|228 Week Open-Label Phase||8||
48355389|NCT02515669|101198521|FG003|NOT COMPLETED|228 Week Open-Label Phase||26||
48355390|NCT02522377|101198522|FG000|STARTED|Overall Study||7||
48355391|NCT02522377|101198523|FG001|STARTED|Overall Study||5||
48355392|NCT02522377|101198522|FG000|COMPLETED|Overall Study||3||
48355393|NCT02522377|101198523|FG001|COMPLETED|Overall Study||5||
48355394|NCT02522377|101198522|FG000|NOT COMPLETED|Overall Study||4||
48355395|NCT02522377|101198523|FG001|NOT COMPLETED|Overall Study||0||
48355396|NCT01609933|101198524|FG000|STARTED|Overall Study||32||
48355397|NCT01609933|101198524|FG000|COMPLETED|Overall Study||28||
48355398|NCT01609933|101198524|FG000|NOT COMPLETED|Overall Study||4||
48355399|NCT02296346|101198525|FG000|STARTED|Overall Study||7||
48355400|NCT02296346|101198526|FG001|STARTED|Overall Study||6||
48355401|NCT02296346|101198525|FG000|COMPLETED|Overall Study||2||
48355402|NCT02296346|101198526|FG001|COMPLETED|Overall Study||0||
48355403|NCT02296346|101198525|FG000|NOT COMPLETED|Overall Study||5||
48418163|NCT03233308|101357060|FG000|COMPLETED|Overall Study||18||
48418164|NCT03233308|101357060|FG000|NOT COMPLETED|Overall Study||2||
48418165|NCT01512849|101357061|FG000|STARTED|Crossover Period 1||6||
48418166|NCT01512849|101357062|FG001|STARTED|Crossover Period 1||6||
48638435|NCT01040819|101898756|FG001|NOT COMPLETED|Overall Study||0||
48638436|NCT03122106|101898757|FG000|STARTED|Overall Study||15||
48638437|NCT03122106|101898757|FG000|COMPLETED|Overall Study||11||
48638438|NCT03122106|101898757|FG000|NOT COMPLETED|Overall Study||4||
48638439|NCT03134768|101898758|FG000|STARTED|Overall Study||50||
48638440|NCT03134768|101898758|FG000|COMPLETED|Overall Study||50||
48638441|NCT03134768|101898758|FG000|NOT COMPLETED|Overall Study||0||
48638442|NCT02583269|101898759|FG000|STARTED|Overall Study||3||
48638443|NCT02583269|101898760|FG001|STARTED|Overall Study||7||
48638444|NCT02583269|101898761|FG002|STARTED|Overall Study||3||
48638445|NCT02583269|101898762|FG003|STARTED|Overall Study||5||
48638446|NCT02583269|101898763|FG004|STARTED|Overall Study||6||
48638447|NCT02583269|101898759|FG000|COMPLETED|Overall Study||2||
48638448|NCT02583269|101898760|FG001|COMPLETED|Overall Study||7||
48638449|NCT02583269|101898761|FG002|COMPLETED|Overall Study||3||
48638450|NCT02583269|101898762|FG003|COMPLETED|Overall Study||5||
48638451|NCT02583269|101898763|FG004|COMPLETED|Overall Study||6||
48638452|NCT02583269|101898759|FG000|NOT COMPLETED|Overall Study||1||
48638453|NCT02583269|101898760|FG001|NOT COMPLETED|Overall Study||0||
48638454|NCT02583269|101898761|FG002|NOT COMPLETED|Overall Study||0||
48638455|NCT02583269|101898762|FG003|NOT COMPLETED|Overall Study||0||
48638456|NCT02583269|101898763|FG004|NOT COMPLETED|Overall Study||0||
48638457|NCT01431976|101898764|FG000|STARTED|Overall Study||20||
48638458|NCT01431976|101898764|FG000|COMPLETED|Overall Study||6||
48638459|NCT01431976|101898764|FG000|NOT COMPLETED|Overall Study||14||
48762553|NCT00456846|102206047|FG000|COMPLETED|Overall Study||31||
48762554|NCT00456846|102206048|FG001|COMPLETED|Overall Study||48||
48355404|NCT02296346|101198526|FG001|NOT COMPLETED|Overall Study||6||
48355405|NCT00327444|101198527|FG000|STARTED|Double Blind Treatment (DB) Period||26||
48355406|NCT00327444|101198528|FG001|STARTED|Double Blind Treatment (DB) Period||29||
48355407|NCT00327444|101198527|FG000|SAFETY|Double Blind Treatment (DB) Period||25||
48355408|NCT00327444|101198528|FG001|SAFETY|Double Blind Treatment (DB) Period||30||
48355409|NCT00327444|101198527|FG000|COMPLETED|Double Blind Treatment (DB) Period||0||
48418167|NCT01512849|101357063|FG002|STARTED|Crossover Period 1||6||
48638460|NCT01769586|101898765|FG000|STARTED|Overall Study||100||
48638461|NCT01769586|101898766|FG001|STARTED|Overall Study||100||
48638462|NCT01769586|101898765|FG000|COMPLETED|Overall Study||100||
48638463|NCT01769586|101898766|FG001|COMPLETED|Overall Study||100||
48418168|NCT01512849|101357064|FG003|STARTED|Crossover Period 1||6||
48418169|NCT01512849|101357061|FG000|COMPLETED|Crossover Period 1||6||
48418170|NCT01512849|101357062|FG001|COMPLETED|Crossover Period 1||6||
48355410|NCT00327444|101198528|FG001|COMPLETED|Double Blind Treatment (DB) Period||0||
48355411|NCT00327444|101198527|FG000|NOT COMPLETED|Double Blind Treatment (DB) Period||26||
48355412|NCT00327444|101198528|FG001|NOT COMPLETED|Double Blind Treatment (DB) Period||29||
48355413|NCT00327444|101198527|FG000|STARTED|Open Label Treatment (OL) Period||11||
48355414|NCT00327444|101198528|FG001|STARTED|Open Label Treatment (OL) Period||10||
48355415|NCT00327444|101198527|FG000|ONGOING TREATMENT|Open Label Treatment (OL) Period||1||
48355416|NCT00327444|101198528|FG001|ONGOING TREATMENT|Open Label Treatment (OL) Period||0||
48355417|NCT00327444|101198527|FG000|COMPLETED|Open Label Treatment (OL) Period||0||
48355418|NCT00327444|101198528|FG001|COMPLETED|Open Label Treatment (OL) Period||0||
48355419|NCT00327444|101198527|FG000|NOT COMPLETED|Open Label Treatment (OL) Period||11||
48355420|NCT00327444|101198528|FG001|NOT COMPLETED|Open Label Treatment (OL) Period||10||
48355421|NCT02109029|101198529|FG000|STARTED|Part A||2||
48355422|NCT02109029|101198530|FG001|STARTED|Part A||2||
48355423|NCT02109029|101198531|FG002|STARTED|Part A||4||
48355424|NCT02109029|101198532|FG003|STARTED|Part A||4||
48355425|NCT02109029|101198533|FG004|STARTED|Part A||0||
48355426|NCT02109029|101198534|FG005|STARTED|Part A||0||
48355427|NCT02109029|101198529|FG000|Received One Dose of Study Drug|Part A||2||
48355428|NCT02109029|101198530|FG001|Received One Dose of Study Drug|Part A||2||
48418171|NCT01512849|101357063|FG002|COMPLETED|Crossover Period 1||6||
48418172|NCT01512849|101357064|FG003|COMPLETED|Crossover Period 1||6||
48638464|NCT01769586|101898765|FG000|NOT COMPLETED|Overall Study||0||
48186848|NCT01859195|100779918|FG000|COMPLETED|Overall Study||24||
48355429|NCT02109029|101198531|FG002|Received One Dose of Study Drug|Part A||4||
48418173|NCT01512849|101357061|FG000|NOT COMPLETED|Crossover Period 1||0||
48418174|NCT01512849|101357062|FG001|NOT COMPLETED|Crossover Period 1||0||
48638465|NCT01769586|101898766|FG001|NOT COMPLETED|Overall Study||0||
48186849|NCT01859195|100779919|FG001|COMPLETED|Overall Study||12||
48355430|NCT02109029|101198532|FG003|Received One Dose of Study Drug|Part A||4||
48355431|NCT02109029|101198533|FG004|Received One Dose of Study Drug|Part A||0||
48355432|NCT02109029|101198534|FG005|Received One Dose of Study Drug|Part A||0||
48355433|NCT02109029|101198529|FG000|COMPLETED|Part A||2||
48355434|NCT02109029|101198530|FG001|COMPLETED|Part A||2||
48355435|NCT02109029|101198531|FG002|COMPLETED|Part A||4||
48355436|NCT02109029|101198532|FG003|COMPLETED|Part A||4||
48418175|NCT01512849|101357063|FG002|NOT COMPLETED|Crossover Period 1||0||
48355437|NCT02109029|101198533|FG004|COMPLETED|Part A||0||
48355438|NCT02109029|101198534|FG005|COMPLETED|Part A||0||
48355439|NCT02109029|101198529|FG000|NOT COMPLETED|Part A||0||
48355440|NCT02109029|101198530|FG001|NOT COMPLETED|Part A||0||
48355441|NCT02109029|101198531|FG002|NOT COMPLETED|Part A||0||
48355442|NCT02109029|101198532|FG003|NOT COMPLETED|Part A||0||
48355443|NCT02109029|101198533|FG004|NOT COMPLETED|Part A||0||
48355444|NCT02109029|101198534|FG005|NOT COMPLETED|Part A||0||
48418176|NCT01512849|101357064|FG003|NOT COMPLETED|Crossover Period 1||0||
48418177|NCT01512849|101357061|FG000|STARTED|Crossover Period 2||6||
48418178|NCT01512849|101357062|FG001|STARTED|Crossover Period 2||6||
48418179|NCT01512849|101357063|FG002|STARTED|Crossover Period 2||6||
48418180|NCT01512849|101357064|FG003|STARTED|Crossover Period 2||6||
48418181|NCT01512849|101357061|FG000|COMPLETED|Crossover Period 2||6||
48418182|NCT01512849|101357062|FG001|COMPLETED|Crossover Period 2||6||
48418183|NCT01512849|101357063|FG002|COMPLETED|Crossover Period 2||6||
48418184|NCT01512849|101357064|FG003|COMPLETED|Crossover Period 2||6||
48418185|NCT01512849|101357061|FG000|NOT COMPLETED|Crossover Period 2||0||
48418186|NCT01512849|101357062|FG001|NOT COMPLETED|Crossover Period 2||0||
48418187|NCT01512849|101357063|FG002|NOT COMPLETED|Crossover Period 2||0||
48418188|NCT01512849|101357064|FG003|NOT COMPLETED|Crossover Period 2||0||
48418189|NCT01875731|101357065|FG000|STARTED|Overall Study||34||
48418190|NCT01875731|101357066|FG001|STARTED|Overall Study||32||
48418191|NCT01875731|101357065|FG000|COMPLETED|Overall Study||33||
48418192|NCT01875731|101357066|FG001|COMPLETED|Overall Study||32||
48418193|NCT01875731|101357065|FG000|NOT COMPLETED|Overall Study||1||
48418194|NCT01875731|101357066|FG001|NOT COMPLETED|Overall Study||0||
48418195|NCT01694966|101357067|FG000|STARTED|Overall Study||504||
48418196|NCT01694966|101357068|FG001|STARTED|Overall Study||247||
48418197|NCT01694966|101357069|FG002|STARTED|Overall Study||498||
48418198|NCT01694966|101357067|FG000|COMPLETED|Overall Study||470||
48418199|NCT01694966|101357068|FG001|COMPLETED|Overall Study||232||
48418200|NCT01694966|101357069|FG002|COMPLETED|Overall Study||464||
48418201|NCT01694966|101357067|FG000|NOT COMPLETED|Overall Study||34||
48418202|NCT01694966|101357068|FG001|NOT COMPLETED|Overall Study||15||
48418203|NCT01694966|101357069|FG002|NOT COMPLETED|Overall Study||34||
48418204|NCT01373294|101357070|FG000|STARTED|Overall Study||15||
48418205|NCT01373294|101357071|FG001|STARTED|Overall Study||2||
48418206|NCT01373294|101357070|FG000|COMPLETED|Overall Study||14||
48418207|NCT01373294|101357071|FG001|COMPLETED|Overall Study||2||
48418208|NCT01373294|101357070|FG000|NOT COMPLETED|Overall Study||1||
48418209|NCT01373294|101357071|FG001|NOT COMPLETED|Overall Study||0||
48418210|NCT01979003|101357072|FG000|STARTED|Overall Study||100||
48418211|NCT01979003|101357072|FG000|COMPLETED|Overall Study||72||
48418212|NCT01979003|101357072|FG000|NOT COMPLETED|Overall Study||28||
48418213|NCT00932399|101357073|FG000|STARTED|Overall Study||759||
48418214|NCT00932399|101357074|FG001|STARTED|Overall Study||3790||
48418215|NCT00932399|101357073|FG000|COMPLETED|Overall Study||759||
48418216|NCT00932399|101357074|FG001|COMPLETED|Overall Study||3790||
48418217|NCT00932399|101357073|FG000|NOT COMPLETED|Overall Study||0||
48355445|NCT02109029|101198529|FG000|STARTED|Part B||0||
48355446|NCT02109029|101198530|FG001|STARTED|Part B||0||
48355447|NCT02109029|101198531|FG002|STARTED|Part B||0||
48355448|NCT02109029|101198532|FG003|STARTED|Part B||0||
48355449|NCT02109029|101198533|FG004|STARTED|Part B||6||
48355450|NCT02109029|101198534|FG005|STARTED|Part B||6||
48355451|NCT02109029|101198529|FG000|Received at Least One Dose of Study Drug|Part B||0||
48355452|NCT02109029|101198530|FG001|Received at Least One Dose of Study Drug|Part B||0||
48355453|NCT02109029|101198531|FG002|Received at Least One Dose of Study Drug|Part B||0||
48355454|NCT02109029|101198532|FG003|Received at Least One Dose of Study Drug|Part B||0||
48418218|NCT00932399|101357074|FG001|NOT COMPLETED|Overall Study||0||
48418219|NCT03109418|101357075|FG000|STARTED|Overall Study||2||
48418220|NCT03109418|101357076|FG001|STARTED|Overall Study||4||
48418221|NCT03109418|101357075|FG000|COMPLETED|Overall Study||2||
48418222|NCT03109418|101357076|FG001|COMPLETED|Overall Study||3||
48418223|NCT03109418|101357075|FG000|NOT COMPLETED|Overall Study||0||
48418224|NCT03109418|101357076|FG001|NOT COMPLETED|Overall Study||1||
48418225|NCT01901679|101357077|FG000|STARTED|Overall Study||5||
48355455|NCT02109029|101198533|FG004|Received at Least One Dose of Study Drug|Part B||6||
48355456|NCT02109029|101198534|FG005|Received at Least One Dose of Study Drug|Part B||6||
48355457|NCT02109029|101198529|FG000|COMPLETED|Part B||0||
48355458|NCT02109029|101198530|FG001|COMPLETED|Part B||0||
48355459|NCT02109029|101198531|FG002|COMPLETED|Part B||0||
48355460|NCT02109029|101198532|FG003|COMPLETED|Part B||0||
48355461|NCT02109029|101198533|FG004|COMPLETED|Part B||5||
48355462|NCT02109029|101198534|FG005|COMPLETED|Part B||5||
48355463|NCT02109029|101198529|FG000|NOT COMPLETED|Part B||0||
48355464|NCT02109029|101198530|FG001|NOT COMPLETED|Part B||0||
48355465|NCT02109029|101198531|FG002|NOT COMPLETED|Part B||0||
48355466|NCT02109029|101198532|FG003|NOT COMPLETED|Part B||0||
48355467|NCT02109029|101198533|FG004|NOT COMPLETED|Part B||1||
48355468|NCT02109029|101198534|FG005|NOT COMPLETED|Part B||1||
48355469|NCT05036785|101198535|FG000|STARTED|Overall Study||30||
48355470|NCT05036785|101198536|FG001|STARTED|Overall Study||30||
48355471|NCT05036785|101198535|FG000|COMPLETED|Overall Study||21||
48355472|NCT05036785|101198536|FG001|COMPLETED|Overall Study||18||
48355473|NCT05036785|101198535|FG000|NOT COMPLETED|Overall Study||9||
48355474|NCT05036785|101198536|FG001|NOT COMPLETED|Overall Study||12||
48355475|NCT01043640|101198537|FG000|STARTED|Overall Study||46||
48355476|NCT01043640|101198537|FG000|COMPLETED|Overall Study||46||
48355477|NCT01043640|101198537|FG000|NOT COMPLETED|Overall Study||0||
48355478|NCT01748760|101198538|FG000|STARTED|Overall Study||25||
48355479|NCT01748760|101198539|FG001|STARTED|Overall Study||25||
48355480|NCT01748760|101198538|FG000|COMPLETED|Overall Study||19||
48355481|NCT01748760|101198539|FG001|COMPLETED|Overall Study||23||
48355482|NCT01748760|101198538|FG000|NOT COMPLETED|Overall Study||6||
48355483|NCT01748760|101198539|FG001|NOT COMPLETED|Overall Study||2||
48355484|NCT00117962|101198540|FG000|STARTED|Overall Study||48||
48355485|NCT00117962|101198541|FG001|STARTED|Overall Study||53||
48355486|NCT00117962|101198540|FG000|COMPLETED|Overall Study||26||
48355487|NCT00117962|101198541|FG001|COMPLETED|Overall Study||28||
48355488|NCT00117962|101198540|FG000|NOT COMPLETED|Overall Study||22||
48355489|NCT00117962|101198541|FG001|NOT COMPLETED|Overall Study||25||
48355490|NCT03233048|101198542|FG000|STARTED|Overall Study||5||
48355491|NCT03233048|101198542|FG000|COMPLETED|Overall Study||4||
48355492|NCT03233048|101198542|FG000|NOT COMPLETED|Overall Study||1||
48355493|NCT01508676|101198543|FG000|STARTED|Phase I (2 Weeks)||18||
48355494|NCT01508676|101198544|FG001|STARTED|Phase I (2 Weeks)||17||
48355495|NCT01508676|101198543|FG000|COMPLETED|Phase I (2 Weeks)||16||
48355496|NCT01508676|101198544|FG001|COMPLETED|Phase I (2 Weeks)||14||
48355497|NCT01508676|101198543|FG000|NOT COMPLETED|Phase I (2 Weeks)||2||
48355498|NCT01508676|101198544|FG001|NOT COMPLETED|Phase I (2 Weeks)||3||
48355499|NCT01508676|101198543|FG000|STARTED|Washout Period (1 Week)||16||
48355500|NCT01508676|101198544|FG001|STARTED|Washout Period (1 Week)||14||
48355501|NCT01508676|101198543|FG000|COMPLETED|Washout Period (1 Week)||16||
48355502|NCT01508676|101198544|FG001|COMPLETED|Washout Period (1 Week)||14||
48355503|NCT01508676|101198543|FG000|NOT COMPLETED|Washout Period (1 Week)||0||
48355504|NCT01508676|101198544|FG001|NOT COMPLETED|Washout Period (1 Week)||0||
48355505|NCT01508676|101198543|FG000|STARTED|Phase II (2 Weeks)||16||
48355506|NCT01508676|101198544|FG001|STARTED|Phase II (2 Weeks)||14||
48355507|NCT01508676|101198543|FG000|COMPLETED|Phase II (2 Weeks)||15||
48355508|NCT01508676|101198544|FG001|COMPLETED|Phase II (2 Weeks)||13||
48355509|NCT01508676|101198543|FG000|NOT COMPLETED|Phase II (2 Weeks)||1||
48355510|NCT01508676|101198544|FG001|NOT COMPLETED|Phase II (2 Weeks)||1||
48355511|NCT00754390|101198545|FG000|STARTED|Ca/Phytate Test Meal 1 (Randomized)||17||
48355512|NCT00754390|101198545|FG000|COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||12||
48355513|NCT00754390|101198545|FG000|NOT COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||5||
48355514|NCT00754390|101198545|FG000|STARTED|Ca/Phytate Test Meal 2 (Randomized)||12||
48418226|NCT01901679|101357078|FG001|STARTED|Overall Study||5||
48355515|NCT00754390|101198545|FG000|COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||12||
48355516|NCT00754390|101198545|FG000|NOT COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||0||
48355517|NCT00754390|101198545|FG000|STARTED|Ca/Phytate Test Meal 3 (Randomized)||12||
48355518|NCT00754390|101198545|FG000|COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||11||
48355519|NCT00754390|101198545|FG000|NOT COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||1||
48355520|NCT00754390|101198545|FG000|STARTED|Ca/Phytate Test Meal 4 (Randomized)||11||
48355521|NCT00754390|101198545|FG000|COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||10||
48355522|NCT00754390|101198545|FG000|NOT COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||1||
48355523|NCT00553787|101198546|FG000|STARTED|Overall Study||994||
48355524|NCT00553787|101198547|FG001|STARTED|Overall Study||498||
48355525|NCT00553787|101198548|FG002|STARTED|Overall Study||995||
48355526|NCT00553787|101198546|FG000|COMPLETED|Overall Study||616||
48355527|NCT00553787|101198547|FG001|COMPLETED|Overall Study||374||
48355528|NCT00553787|101198548|FG002|COMPLETED|Overall Study||733||
48355529|NCT00553787|101198546|FG000|NOT COMPLETED|Overall Study||378||
48355530|NCT00553787|101198547|FG001|NOT COMPLETED|Overall Study||124||
48355531|NCT00553787|101198548|FG002|NOT COMPLETED|Overall Study||262||
48355532|NCT02579603|101198549|FG000|STARTED|Overall Study||52||
48355533|NCT02579603|101198550|FG001|STARTED|Overall Study||53||
48355534|NCT02579603|101198549|FG000|Number of Patients Treated|Overall Study||51||
48355535|NCT02579603|101198550|FG001|Number of Patients Treated|Overall Study||53||
48418227|NCT01901679|101357077|FG000|COMPLETED|Overall Study||5||
48418228|NCT01901679|101357078|FG001|COMPLETED|Overall Study||5||
48418229|NCT01901679|101357077|FG000|NOT COMPLETED|Overall Study||0||
48418230|NCT01901679|101357078|FG001|NOT COMPLETED|Overall Study||0||
48418231|NCT03793010|101357079|FG000|STARTED|Overall Study||35||
48418232|NCT03793010|101357080|FG001|STARTED|Overall Study||35||
48418233|NCT03793010|101357079|FG000|Randomized But Not Dosed|Overall Study||2||
48418234|NCT03793010|101357080|FG001|Randomized But Not Dosed|Overall Study||0||
48418235|NCT03793010|101357079|FG000|COMPLETED|Overall Study||7||
48418236|NCT03793010|101357080|FG001|COMPLETED|Overall Study||8||
48418237|NCT03793010|101357079|FG000|NOT COMPLETED|Overall Study||28||
48418238|NCT03793010|101357080|FG001|NOT COMPLETED|Overall Study||27||
48418239|NCT01205646|101357081|FG000|STARTED|Overall Study||11||
48418240|NCT01205646|101357081|FG000|COMPLETED|Overall Study||11||
48418241|NCT01205646|101357081|FG000|NOT COMPLETED|Overall Study||0||
48418242|NCT03125902|101357082|FG000|STARTED|Overall Study||220||
48418243|NCT03125902|101357083|FG001|STARTED|Overall Study||431||
48418244|NCT03125902|101357082|FG000|COMPLETED|Overall Study||0||
48418245|NCT03125902|101357083|FG001|COMPLETED|Overall Study||0||
48418246|NCT03125902|101357082|FG000|NOT COMPLETED|Overall Study||220||
48418247|NCT03125902|101357083|FG001|NOT COMPLETED|Overall Study||431||
48418248|NCT00606021|101357084|FG000|STARTED|Induction Phase||106||
48418249|NCT00606021|101357085|FG001|STARTED|Induction Phase||0||
48418250|NCT00606021|101357086|FG002|STARTED|Induction Phase||0||
48418251|NCT00606021|101357084|FG000|COMPLETED|Induction Phase||19||
48418252|NCT00606021|101357085|FG001|COMPLETED|Induction Phase||0||
48418253|NCT00606021|101357086|FG002|COMPLETED|Induction Phase||0||
48418254|NCT00606021|101357084|FG000|NOT COMPLETED|Induction Phase||87||
48418255|NCT00606021|101357085|FG001|NOT COMPLETED|Induction Phase||0||
48418256|NCT00606021|101357086|FG002|NOT COMPLETED|Induction Phase||0||
48418257|NCT00606021|101357084|FG000|STARTED|Maintenance Phase||0||
48418258|NCT00606021|101357085|FG001|STARTED|Maintenance Phase||28||
48418259|NCT00606021|101357086|FG002|STARTED|Maintenance Phase||27||
48418260|NCT00606021|101357084|FG000|COMPLETED|Maintenance Phase||0||
48418261|NCT00606021|101357085|FG001|COMPLETED|Maintenance Phase||5||
48418262|NCT00606021|101357086|FG002|COMPLETED|Maintenance Phase||10||
48418263|NCT00606021|101357084|FG000|NOT COMPLETED|Maintenance Phase||0||
48418264|NCT00606021|101357085|FG001|NOT COMPLETED|Maintenance Phase||23||
48418265|NCT00606021|101357086|FG002|NOT COMPLETED|Maintenance Phase||17||
48418266|NCT00695318|101357087|FG000|STARTED|Overall Study||10||
48418267|NCT00695318|101357088|FG001|STARTED|Overall Study||7||
48418268|NCT00695318|101357087|FG000|COMPLETED|Overall Study||5||
48418269|NCT00695318|101357088|FG001|COMPLETED|Overall Study||6||
48418270|NCT00695318|101357087|FG000|NOT COMPLETED|Overall Study||5||
48418271|NCT00695318|101357088|FG001|NOT COMPLETED|Overall Study||1||
48418272|NCT00585104|101357089|FG000|STARTED|Overall Study||10||
48418273|NCT00585104|101357089|FG000|COMPLETED|Overall Study||6||
48418274|NCT00585104|101357089|FG000|NOT COMPLETED|Overall Study||4||
48418275|NCT01766401|101357090|FG000|STARTED|Overall Study||198||
48418276|NCT01766401|101357091|FG001|STARTED|Overall Study||200||
48418277|NCT01766401|101357090|FG000|COMPLETED|Overall Study||161||
48418278|NCT01766401|101357091|FG001|COMPLETED|Overall Study||144||
48418279|NCT01766401|101357090|FG000|NOT COMPLETED|Overall Study||37||
48418280|NCT01766401|101357091|FG001|NOT COMPLETED|Overall Study||56||
48418281|NCT00087594|101357092|FG000|STARTED|Overall Study||24||
48418282|NCT00087594|101357093|FG001|STARTED|Overall Study||24||
48418283|NCT00087594|101357092|FG000|COMPLETED|Overall Study||16||
48418284|NCT00087594|101357093|FG001|COMPLETED|Overall Study||12||
48418285|NCT00087594|101357092|FG000|NOT COMPLETED|Overall Study||8||
48418286|NCT00087594|101357093|FG001|NOT COMPLETED|Overall Study||12||
48418287|NCT00925522|101357094|FG000|STARTED|Overall Study||20||
48418288|NCT00925522|101357094|FG000|COMPLETED|Overall Study||0||
48418289|NCT00925522|101357094|FG000|NOT COMPLETED|Overall Study||20||
48418290|NCT02510885|101357095|FG000|STARTED|Overall Study||39||
48418291|NCT02510885|101357095|FG000|COMPLETED|Overall Study||39||
48418292|NCT02510885|101357095|FG000|NOT COMPLETED|Overall Study||0||
48418293|NCT01218477|101357096|FG000|STARTED|Overall Study||3||
48418294|NCT01218477|101357097|FG001|STARTED|Overall Study||8||
48418295|NCT01218477|101357098|FG002|STARTED|Overall Study||14||
48418296|NCT01218477|101357099|FG003|STARTED|Overall Study||2||
48418297|NCT01218477|101357096|FG000|COMPLETED|Overall Study||0||
48418298|NCT01218477|101357097|FG001|COMPLETED|Overall Study||0||
48418299|NCT01218477|101357098|FG002|COMPLETED|Overall Study||0||
48418300|NCT01218477|101357099|FG003|COMPLETED|Overall Study||0||
48418301|NCT01218477|101357096|FG000|NOT COMPLETED|Overall Study||3||
48418302|NCT01218477|101357097|FG001|NOT COMPLETED|Overall Study||8||
48418303|NCT01218477|101357098|FG002|NOT COMPLETED|Overall Study||14||
48418304|NCT01218477|101357099|FG003|NOT COMPLETED|Overall Study||2||
48418305|NCT05095779|101357100|FG000|STARTED|Overall Study||81||
48418306|NCT05095779|101357101|FG001|STARTED|Overall Study||84||
48418307|NCT05095779|101357100|FG000|COMPLETED|Overall Study||65||
48418308|NCT05095779|101357101|FG001|COMPLETED|Overall Study||73||
48418309|NCT05095779|101357100|FG000|NOT COMPLETED|Overall Study||16||
48418310|NCT05095779|101357101|FG001|NOT COMPLETED|Overall Study||11||
48418311|NCT02987205|101357102|FG000|STARTED|Overall Study||163||
48418312|NCT02987205|101357102|FG000|Treated - Bilateral NLF Injection|Overall Study||163||
48418313|NCT02987205|101357102|FG000|COMPLETED|Overall Study||159||
48418314|NCT02987205|101357102|FG000|NOT COMPLETED|Overall Study||4||
48418315|NCT00661362|101357103|FG000|STARTED|Overall Study||283||
48418316|NCT00661362|101357104|FG001|STARTED|Overall Study||287||
48418317|NCT00661362|101357103|FG000|COMPLETED|Overall Study||254||
48418318|NCT00661362|101357104|FG001|COMPLETED|Overall Study||247||
48418319|NCT00661362|101357103|FG000|NOT COMPLETED|Overall Study||29||
48418320|NCT00661362|101357104|FG001|NOT COMPLETED|Overall Study||40||
48418321|NCT02390323|101357105|FG000|STARTED|Overall Study||13||
48418322|NCT02390323|101357105|FG000|COMPLETED|Overall Study||13||
48418323|NCT02390323|101357105|FG000|NOT COMPLETED|Overall Study||0||
48418324|NCT04126187|101357106|FG000|STARTED|Overall Study||30||
48638466|NCT00724945|101898767|FG000|STARTED|Period 1||58||
48638467|NCT00724945|101898768|FG001|STARTED|Period 1||55||
48638468|NCT00724945|101898767|FG000|COMPLETED|Period 1||55||
48638469|NCT00724945|101898768|FG001|COMPLETED|Period 1||54||
48638470|NCT00724945|101898767|FG000|NOT COMPLETED|Period 1||3||
48638471|NCT00724945|101898768|FG001|NOT COMPLETED|Period 1||1||
48638472|NCT00724945|101898767|FG000|STARTED|Period 2||55||
48638473|NCT00724945|101898768|FG001|STARTED|Period 2||54||
48638474|NCT00724945|101898767|FG000|COMPLETED|Period 2||51||
48638475|NCT00724945|101898768|FG001|COMPLETED|Period 2||54||
48638476|NCT00724945|101898767|FG000|NOT COMPLETED|Period 2||4||
48355536|NCT02579603|101198549|FG000|COMPLETED|Overall Study||48||
48355537|NCT02579603|101198550|FG001|COMPLETED|Overall Study||51||
48355538|NCT02579603|101198549|FG000|NOT COMPLETED|Overall Study||4||
48355539|NCT02579603|101198550|FG001|NOT COMPLETED|Overall Study||2||
48355540|NCT02334267|101198551|FG000|STARTED|Overall Study||6||
48355541|NCT02334267|101198552|FG001|STARTED|Overall Study||5||
48355542|NCT02334267|101198551|FG000|COMPLETED|Overall Study||5||
48355543|NCT02334267|101198552|FG001|COMPLETED|Overall Study||5||
48355544|NCT02334267|101198551|FG000|NOT COMPLETED|Overall Study||1||
48355545|NCT02334267|101198552|FG001|NOT COMPLETED|Overall Study||0||
48355546|NCT03368898|101198553|FG000|STARTED|Overall Study||37||
48355547|NCT03368898|101198554|FG001|STARTED|Overall Study||33||
48355548|NCT03368898|101198555|FG002|STARTED|Overall Study||34||
48355549|NCT03368898|101198553|FG000|COMPLETED|Overall Study||37||
48355550|NCT03368898|101198554|FG001|COMPLETED|Overall Study||33||
48355551|NCT03368898|101198555|FG002|COMPLETED|Overall Study||34||
48355552|NCT03368898|101198553|FG000|NOT COMPLETED|Overall Study||0||
48355553|NCT03368898|101198554|FG001|NOT COMPLETED|Overall Study||0||
48355554|NCT03368898|101198555|FG002|NOT COMPLETED|Overall Study||0||
48355555|NCT01333189|101198556|FG000|STARTED|Overall Study||13||
48355556|NCT01333189|101198557|FG001|STARTED|Overall Study||13||
48418325|NCT04126187|101357106|FG000|COMPLETED|Overall Study||30||
48418326|NCT04126187|101357106|FG000|NOT COMPLETED|Overall Study||0||
48418327|NCT04657003|101357107|FG000|STARTED|Overall Study||315||
48418328|NCT04657003|101357108|FG001|STARTED|Overall Study||312||
48418329|NCT04657003|101357109|FG002|STARTED|Overall Study||311||
48418330|NCT04657003|101357107|FG000|Received at Least One Dose of Study Drug|Overall Study||315||
48418331|NCT04657003|101357108|FG001|Received at Least One Dose of Study Drug|Overall Study||312||
48418332|NCT04657003|101357109|FG002|Received at Least One Dose of Study Drug|Overall Study||311||
48638477|NCT00724945|101898768|FG001|NOT COMPLETED|Period 2||0||
48638478|NCT02842866|101898769|FG000|STARTED|Overall Study||451|Randomized|
48355557|NCT01333189|101198556|FG000|COMPLETED|Overall Study||11||
48355558|NCT01333189|101198557|FG001|COMPLETED|Overall Study||11||
48418333|NCT04657003|101357107|FG000|COMPLETED|Overall Study||281||
48418334|NCT04657003|101357108|FG001|COMPLETED|Overall Study||296||
48418335|NCT04657003|101357109|FG002|COMPLETED|Overall Study||282||
48418336|NCT04657003|101357107|FG000|NOT COMPLETED|Overall Study||34||
48418337|NCT04657003|101357108|FG001|NOT COMPLETED|Overall Study||16||
48418338|NCT04657003|101357109|FG002|NOT COMPLETED|Overall Study||29||
48418339|NCT03395704|101357110|FG000|STARTED|Overall Study||34||
48418340|NCT03395704|101357111|FG001|STARTED|Overall Study||36||
48418341|NCT03395704|101357110|FG000|Safety Population|Overall Study||34|The Safety Population included all patients who received at least one dose of study drug.|
48418342|NCT03395704|101357111|FG001|Safety Population|Overall Study||35|The Safety Population included all patients who received at least one dose of study drug.|
48418343|NCT03395704|101357110|FG000|Analysis Population|Overall Study||21|The Analysis Population included enrolled patients under global protocol Version 4.0 or later, as randomized, who received study drug, and who completed 4 months (Week 16) on study or who had at least 1 phlebotomy after the SOC therapeutic phlebotomy on Day 1 (predose) and before Week 16.|
48638479|NCT02842866|101898770|FG001|STARTED|Overall Study||455|Randomized|
48638480|NCT02842866|101898769|FG000|Vaccinated|Overall Study||448||
48355559|NCT01333189|101198556|FG000|NOT COMPLETED|Overall Study||2||
48355560|NCT01333189|101198557|FG001|NOT COMPLETED|Overall Study||2||
48355561|NCT00291343|101198558|FG000|STARTED|Overall Study||203||
48355562|NCT00291343|101198559|FG001|STARTED|Overall Study||93||
48355563|NCT00291343|101198558|FG000|COMPLETED|Overall Study||203||
48355564|NCT00291343|101198559|FG001|COMPLETED|Overall Study||93||
48355565|NCT00291343|101198558|FG000|NOT COMPLETED|Overall Study||0||
48355566|NCT00291343|101198559|FG001|NOT COMPLETED|Overall Study||0||
48638481|NCT02842866|101898770|FG001|Vaccinated|Overall Study||453||
48638482|NCT02842866|101898769|FG000|COMPLETED|Overall Study||444||
48186850|NCT01859195|100779918|FG000|NOT COMPLETED|Overall Study||0||
48355567|NCT00907738|101198560|FG000|STARTED|Overall Study||13||
48355568|NCT00907738|101198561|FG001|STARTED|Overall Study||1||
48355569|NCT00907738|101198562|FG002|STARTED|Overall Study||7||
48355570|NCT00907738|101198563|FG003|STARTED|Overall Study||4||
48355571|NCT00907738|101198564|FG004|STARTED|Overall Study||2||
48355572|NCT00907738|101198560|FG000|COMPLETED|Overall Study||0||
48355573|NCT00907738|101198561|FG001|COMPLETED|Overall Study||0||
48355574|NCT00907738|101198562|FG002|COMPLETED|Overall Study||0||
48355575|NCT00907738|101198563|FG003|COMPLETED|Overall Study||0||
48355576|NCT00907738|101198564|FG004|COMPLETED|Overall Study||0||
48355577|NCT00907738|101198560|FG000|NOT COMPLETED|Overall Study||13||
48355578|NCT00907738|101198561|FG001|NOT COMPLETED|Overall Study||1||
48638483|NCT02842866|101898770|FG001|COMPLETED|Overall Study||452||
48638484|NCT02842866|101898769|FG000|NOT COMPLETED|Overall Study||7||
48638485|NCT02842866|101898770|FG001|NOT COMPLETED|Overall Study||3||
48638486|NCT02052635|101898771|FG000|STARTED|Overall Study||7||
48638487|NCT02052635|101898772|FG001|STARTED|Overall Study||6||
48638488|NCT02052635|101898771|FG000|COMPLETED|Overall Study||7||
48638489|NCT02052635|101898772|FG001|COMPLETED|Overall Study||6||
48638490|NCT02052635|101898771|FG000|NOT COMPLETED|Overall Study||0||
48638491|NCT02052635|101898772|FG001|NOT COMPLETED|Overall Study||0||
48638492|NCT01440920|101898773|FG000|STARTED|Overall Study||3||
48638493|NCT01440920|101898774|FG001|STARTED|Overall Study||3||
48638494|NCT01440920|101898775|FG002|STARTED|Overall Study||3||
48638495|NCT01440920|101898773|FG000|COMPLETED|Overall Study||3||
48638496|NCT01440920|101898774|FG001|COMPLETED|Overall Study||3||
48638497|NCT01440920|101898775|FG002|COMPLETED|Overall Study||3||
48638498|NCT01440920|101898773|FG000|NOT COMPLETED|Overall Study||0||
48638499|NCT01440920|101898774|FG001|NOT COMPLETED|Overall Study||0||
48638500|NCT01440920|101898775|FG002|NOT COMPLETED|Overall Study||0||
48638501|NCT01147458|101898776|FG000|STARTED|First Intervention||48||
48638502|NCT01147458|101898777|FG001|STARTED|First Intervention||47||
48762555|NCT00456846|102206047|FG000|NOT COMPLETED|Overall Study||16||
48762556|NCT00456846|102206048|FG001|NOT COMPLETED|Overall Study||28||
48762557|NCT00278343|102206049|FG000|STARTED|Overall Study||74||
48762558|NCT00278343|102206049|FG000|COMPLETED|Overall Study||74||
48762559|NCT00278343|102206049|FG000|NOT COMPLETED|Overall Study||0||
48762560|NCT01684917|102206050|FG000|STARTED|Overall Study||11||
48762561|NCT01684917|102206051|FG001|STARTED|Overall Study||7||
48762562|NCT01684917|102206052|FG002|STARTED|Overall Study||13||
48762563|NCT01684917|102206053|FG003|STARTED|Overall Study||5||
48762564|NCT01684917|102206050|FG000|COMPLETED|Overall Study||11||
48762565|NCT01684917|102206051|FG001|COMPLETED|Overall Study||7||
48762566|NCT01684917|102206052|FG002|COMPLETED|Overall Study||13||
48762567|NCT01684917|102206053|FG003|COMPLETED|Overall Study||5||
48762568|NCT01684917|102206050|FG000|NOT COMPLETED|Overall Study||0||
48762569|NCT01684917|102206051|FG001|NOT COMPLETED|Overall Study||0||
48762570|NCT01684917|102206052|FG002|NOT COMPLETED|Overall Study||0||
48762571|NCT01684917|102206053|FG003|NOT COMPLETED|Overall Study||0||
48186851|NCT01859195|100779919|FG001|NOT COMPLETED|Overall Study||0||
48638503|NCT01147458|101898778|FG002|STARTED|First Intervention||47||
48638504|NCT01147458|101898779|FG003|STARTED|First Intervention||48||
48638505|NCT01147458|101898776|FG000|COMPLETED|First Intervention||34||
48638506|NCT01147458|101898777|FG001|COMPLETED|First Intervention||31||
48638507|NCT01147458|101898778|FG002|COMPLETED|First Intervention||35||
48638508|NCT01147458|101898779|FG003|COMPLETED|First Intervention||34||
48638509|NCT01147458|101898776|FG000|NOT COMPLETED|First Intervention||14||
48638510|NCT01147458|101898777|FG001|NOT COMPLETED|First Intervention||16||
48638511|NCT01147458|101898778|FG002|NOT COMPLETED|First Intervention||12||
48638512|NCT01147458|101898779|FG003|NOT COMPLETED|First Intervention||14||
48638513|NCT01147458|101898776|FG000|STARTED|Washout Period of 2 Weeks||34||
48638514|NCT01147458|101898777|FG001|STARTED|Washout Period of 2 Weeks||31||
48638515|NCT01147458|101898778|FG002|STARTED|Washout Period of 2 Weeks||35||
48638516|NCT01147458|101898779|FG003|STARTED|Washout Period of 2 Weeks||34||
48638517|NCT01147458|101898776|FG000|COMPLETED|Washout Period of 2 Weeks||34||
48638518|NCT01147458|101898777|FG001|COMPLETED|Washout Period of 2 Weeks||31||
48638519|NCT01147458|101898778|FG002|COMPLETED|Washout Period of 2 Weeks||35||
48638520|NCT01147458|101898779|FG003|COMPLETED|Washout Period of 2 Weeks||34||
48638521|NCT01147458|101898776|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0||
48638522|NCT01147458|101898777|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0||
48355579|NCT00907738|101198562|FG002|NOT COMPLETED|Overall Study||7||
48638523|NCT01147458|101898778|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0||
48762572|NCT03777982|102206054|FG000|STARTED|Overall Study||6||
48762573|NCT03777982|102206055|FG001|STARTED|Overall Study||6||
48762574|NCT03777982|102206054|FG000|COMPLETED|Overall Study||6||
48762575|NCT03777982|102206055|FG001|COMPLETED|Overall Study||5||
48762576|NCT03777982|102206054|FG000|NOT COMPLETED|Overall Study||0||
48355580|NCT00907738|101198563|FG003|NOT COMPLETED|Overall Study||4||
48638524|NCT01147458|101898779|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0||
48638525|NCT01147458|101898776|FG000|STARTED|Second Intervention||34||
48638526|NCT01147458|101898777|FG001|STARTED|Second Intervention||31||
48638527|NCT01147458|101898778|FG002|STARTED|Second Intervention||35||
48355581|NCT00907738|101198564|FG004|NOT COMPLETED|Overall Study||2||
48355582|NCT01233726|101198565|FG000|STARTED|Overall Study||53||
48355583|NCT01233726|101198566|FG001|STARTED|Overall Study||53||
48355584|NCT01233726|101198567|FG002|STARTED|Overall Study||53||
48355585|NCT01233726|101198565|FG000|COMPLETED|Overall Study||52||
48355586|NCT01233726|101198566|FG001|COMPLETED|Overall Study||53||
48355587|NCT01233726|101198567|FG002|COMPLETED|Overall Study||52||
48355588|NCT01233726|101198565|FG000|NOT COMPLETED|Overall Study||1||
48355589|NCT01233726|101198566|FG001|NOT COMPLETED|Overall Study||0||
48355590|NCT01233726|101198567|FG002|NOT COMPLETED|Overall Study||1||
48355591|NCT02696083|101198568|FG000|STARTED|Overall Study||19||
48355592|NCT02696083|101198568|FG000|COMPLETED|Overall Study||13||
48355593|NCT02696083|101198568|FG000|NOT COMPLETED|Overall Study||6||
48355594|NCT02179398|101198569|FG000|STARTED|Overall Study||134||
48355595|NCT02179398|101198570|FG001|STARTED|Overall Study||144||
48355596|NCT02179398|101198569|FG000|COMPLETED|Overall Study||131||
48355597|NCT02179398|101198570|FG001|COMPLETED|Overall Study||140||
48355598|NCT02179398|101198569|FG000|NOT COMPLETED|Overall Study||3||
48355599|NCT02179398|101198570|FG001|NOT COMPLETED|Overall Study||4||
48355600|NCT02730247|101198571|FG000|STARTED|Overall Study||7||
48355601|NCT02730247|101198571|FG000|COMPLETED|Overall Study||7||
48355602|NCT02730247|101198571|FG000|NOT COMPLETED|Overall Study||0||
48355603|NCT00473694|101198572|FG000|STARTED|Overall Study||48||
48355604|NCT00473694|101198573|FG001|STARTED|Overall Study||41||
48355605|NCT00473694|101198574|FG002|STARTED|Overall Study||51||
48355606|NCT00473694|101198575|FG003|STARTED|Overall Study||42||
48355607|NCT00473694|101198572|FG000|Treated|Overall Study||37||
48355608|NCT00473694|101198573|FG001|Treated|Overall Study||38||
48355609|NCT00473694|101198574|FG002|Treated|Overall Study||46||
48355610|NCT00473694|101198575|FG003|Treated|Overall Study||36||
48355611|NCT00473694|101198572|FG000|COMPLETED|Overall Study||37||
48355612|NCT00473694|101198573|FG001|COMPLETED|Overall Study||37||
48355613|NCT00473694|101198574|FG002|COMPLETED|Overall Study||46||
48355614|NCT00473694|101198575|FG003|COMPLETED|Overall Study||35||
48355615|NCT00473694|101198572|FG000|NOT COMPLETED|Overall Study||11||
48355616|NCT00473694|101198573|FG001|NOT COMPLETED|Overall Study||4||
48355617|NCT00473694|101198574|FG002|NOT COMPLETED|Overall Study||5||
48355618|NCT00473694|101198575|FG003|NOT COMPLETED|Overall Study||7||
48355619|NCT03842709|101198576|FG000|STARTED|Overall Study||7||
48355620|NCT03842709|101198577|FG001|STARTED|Overall Study||6||
48355621|NCT03842709|101198576|FG000|Initiated Treatment|Overall Study||6||
48355622|NCT03842709|101198577|FG001|Initiated Treatment|Overall Study||5||
48355623|NCT03842709|101198576|FG000|COMPLETED|Overall Study||3||
48355624|NCT03842709|101198577|FG001|COMPLETED|Overall Study||3||
48355625|NCT03842709|101198576|FG000|NOT COMPLETED|Overall Study||4||
48355626|NCT03842709|101198577|FG001|NOT COMPLETED|Overall Study||3||
48355627|NCT03414359|101198578|FG000|STARTED|Overall Study||35||
48355628|NCT03414359|101198579|FG001|STARTED|Overall Study||35||
48355629|NCT03414359|101198578|FG000|COMPLETED|Overall Study||34||
48355630|NCT03414359|101198579|FG001|COMPLETED|Overall Study||33||
48355631|NCT03414359|101198578|FG000|NOT COMPLETED|Overall Study||1||
48355632|NCT03414359|101198579|FG001|NOT COMPLETED|Overall Study||2||
48355633|NCT01435512|101198580|FG000|STARTED|Overall Study||67||
48355634|NCT01435512|101198581|FG001|STARTED|Overall Study||68||
48355635|NCT01435512|101198580|FG000|COMPLETED|Overall Study||67||
48355636|NCT01435512|101198581|FG001|COMPLETED|Overall Study||68||
48355637|NCT01435512|101198580|FG000|NOT COMPLETED|Overall Study||0||
48355638|NCT01435512|101198581|FG001|NOT COMPLETED|Overall Study||0||
48355639|NCT00506389|101198582|FG000|STARTED|In-treatment Period||143||
48355640|NCT00506389|101198583|FG001|STARTED|In-treatment Period||139||
48355641|NCT00506389|101198584|FG002|STARTED|In-treatment Period||137||
48355642|NCT00506389|101198582|FG000|All Participants Treated|In-treatment Period||139||
48355643|NCT00506389|101198583|FG001|All Participants Treated|In-treatment Period||138||
48355644|NCT00506389|101198584|FG002|All Participants Treated|In-treatment Period||136||
48355645|NCT00506389|101198582|FG000|COMPLETED|In-treatment Period||117||
48355646|NCT00506389|101198583|FG001|COMPLETED|In-treatment Period||124||
48355647|NCT00506389|101198584|FG002|COMPLETED|In-treatment Period||125||
48355648|NCT00506389|101198582|FG000|NOT COMPLETED|In-treatment Period||26||
48355649|NCT00506389|101198583|FG001|NOT COMPLETED|In-treatment Period||15||
48355650|NCT00506389|101198584|FG002|NOT COMPLETED|In-treatment Period||12||
48355651|NCT00506389|101198582|FG000|STARTED|Follow-up Period||139||
48355652|NCT00506389|101198583|FG001|STARTED|Follow-up Period||138||
48355653|NCT00506389|101198584|FG002|STARTED|Follow-up Period||136||
48355654|NCT00506389|101198582|FG000|COMPLETED|Follow-up Period||139||
48355655|NCT00506389|101198583|FG001|COMPLETED|Follow-up Period||138||
48355656|NCT00506389|101198584|FG002|COMPLETED|Follow-up Period||136||
48355657|NCT00506389|101198582|FG000|NOT COMPLETED|Follow-up Period||0||
48355658|NCT00506389|101198583|FG001|NOT COMPLETED|Follow-up Period||0||
48355659|NCT00506389|101198584|FG002|NOT COMPLETED|Follow-up Period||0||
48355660|NCT01576471|101198585|FG000|STARTED|Overall Study||125||
48355661|NCT01576471|101198586|FG001|STARTED|Overall Study||125||
48355662|NCT01576471|101198585|FG000|COMPLETED|Overall Study||117||
48355663|NCT01576471|101198586|FG001|COMPLETED|Overall Study||116||
48355664|NCT01576471|101198585|FG000|NOT COMPLETED|Overall Study||8||
48355665|NCT01576471|101198586|FG001|NOT COMPLETED|Overall Study||9||
48355666|NCT02704429|101198587|FG000|STARTED|Part A: 24 Weeks||27||
48355667|NCT02704429|101198588|FG001|STARTED|Part A: 24 Weeks||0||
48355668|NCT02704429|101198587|FG000|COMPLETED|Part A: 24 Weeks||24||
48355669|NCT02704429|101198588|FG001|COMPLETED|Part A: 24 Weeks||0||
48355670|NCT02704429|101198587|FG000|NOT COMPLETED|Part A: 24 Weeks||3||
48418344|NCT03395704|101357111|FG001|Analysis Population|Overall Study||28|The Analysis Population included enrolled patients under global protocol Version 4.0 or later, as randomized, who received study drug, and who completed 4 months (Week 16) on study or who had at least 1 phlebotomy after the SOC therapeutic phlebotomy on Day 1 (predose) and before Week 16.|
48418345|NCT03395704|101357110|FG000|COMPLETED|Overall Study||30||
48418346|NCT03395704|101357111|FG001|COMPLETED|Overall Study||33||
48418347|NCT03395704|101357110|FG000|NOT COMPLETED|Overall Study||4||
48418348|NCT03395704|101357111|FG001|NOT COMPLETED|Overall Study||3||
48418349|NCT01066546|101357112|FG000|STARTED|Overall Study||5||
48418350|NCT01066546|101357112|FG000|COMPLETED|Overall Study||0||
48418351|NCT01066546|101357112|FG000|NOT COMPLETED|Overall Study||5||
48355671|NCT02704429|101198588|FG001|NOT COMPLETED|Part A: 24 Weeks||0||
48355672|NCT02704429|101198587|FG000|STARTED|Part B: 28 Weeks||0||
48355673|NCT02704429|101198588|FG001|STARTED|Part B: 28 Weeks||15||
48355674|NCT02704429|101198587|FG000|COMPLETED|Part B: 28 Weeks||0||
48355675|NCT02704429|101198588|FG001|COMPLETED|Part B: 28 Weeks||14||
48355676|NCT02704429|101198587|FG000|NOT COMPLETED|Part B: 28 Weeks||0||
48355677|NCT02704429|101198588|FG001|NOT COMPLETED|Part B: 28 Weeks||1||
48355678|NCT02732951|101198589|FG000|STARTED|Overall Study||53|Randomised and treated|
48355679|NCT02732951|101198590|FG001|STARTED|Overall Study||52|Randomised and treated|
48355680|NCT02732951|101198589|FG000|COMPLETED|Overall Study||48|Completed trial|
48355681|NCT02732951|101198590|FG001|COMPLETED|Overall Study||46|Completed trial|
48355682|NCT02732951|101198589|FG000|NOT COMPLETED|Overall Study||5||
48355683|NCT02732951|101198590|FG001|NOT COMPLETED|Overall Study||6||
48355684|NCT05299892|101198591|FG000|STARTED|Overall Study||36||
48355685|NCT05299892|101198591|FG000|COMPLETED|Overall Study||34||
48355686|NCT05299892|101198591|FG000|NOT COMPLETED|Overall Study||2||
48355687|NCT02519231|101198592|FG000|STARTED|Overall Study||14||
48355688|NCT02519231|101198593|FG001|STARTED|Overall Study||14||
48355689|NCT02519231|101198592|FG000|COMPLETED|Overall Study||12||
48355690|NCT02519231|101198593|FG001|COMPLETED|Overall Study||8||
48355691|NCT02519231|101198592|FG000|NOT COMPLETED|Overall Study||2||
48355692|NCT02519231|101198593|FG001|NOT COMPLETED|Overall Study||6||
48355693|NCT02638012|101198594|FG000|STARTED|Overall Study||8||
48355694|NCT02638012|101198594|FG000|COMPLETED|Overall Study||7||
48355695|NCT02638012|101198594|FG000|NOT COMPLETED|Overall Study||1||
48355696|NCT00756002|101198595|FG000|STARTED|Placebo Run-in||488||
48355697|NCT00756002|101198596|FG001|STARTED|Placebo Run-in||0||
48355698|NCT00756002|101198595|FG000|COMPLETED|Placebo Run-in||259||
48355699|NCT00756002|101198596|FG001|COMPLETED|Placebo Run-in||0||
48355700|NCT00756002|101198595|FG000|NOT COMPLETED|Placebo Run-in||229||
48355701|NCT00756002|101198596|FG001|NOT COMPLETED|Placebo Run-in||0||
48355702|NCT00756002|101198595|FG000|STARTED|Double-Blind Treatment Period||129||
48355703|NCT00756002|101198596|FG001|STARTED|Double-Blind Treatment Period||130||
48355704|NCT00756002|101198595|FG000|COMPLETED|Double-Blind Treatment Period||114||
48355705|NCT00756002|101198596|FG001|COMPLETED|Double-Blind Treatment Period||115||
48355706|NCT00756002|101198595|FG000|NOT COMPLETED|Double-Blind Treatment Period||15||
48355707|NCT00756002|101198596|FG001|NOT COMPLETED|Double-Blind Treatment Period||15||
48355708|NCT00756002|101198595|FG000|STARTED|Placebo Run-out||114||
48355709|NCT00756002|101198596|FG001|STARTED|Placebo Run-out||0||
48355710|NCT00756002|101198595|FG000|COMPLETED|Placebo Run-out||114||
48355711|NCT00756002|101198596|FG001|COMPLETED|Placebo Run-out||0||
48355712|NCT00756002|101198595|FG000|NOT COMPLETED|Placebo Run-out||0||
48355713|NCT00756002|101198596|FG001|NOT COMPLETED|Placebo Run-out||0||
48355714|NCT05593432|101198597|FG000|STARTED|16-Week DBVC Period||32||
48355715|NCT05593432|101198598|FG001|STARTED|16-Week DBVC Period||32||
48355716|NCT05593432|101198599|FG002|STARTED|16-Week DBVC Period||0||
48418352|NCT03524664|101357113|FG000|STARTED|Overall Study||33||
48418353|NCT03524664|101357114|FG001|STARTED|Overall Study||54||
48418354|NCT03524664|101357113|FG000|Completed Allocated Condition|Overall Study||33||
48418355|NCT03524664|101357114|FG001|Completed Allocated Condition|Overall Study||37||
48418356|NCT03524664|101357113|FG000|Immediate Post-Intervention Follow-up Assessments (T2)|Overall Study||32||
48418357|NCT03524664|101357114|FG001|Immediate Post-Intervention Follow-up Assessments (T2)|Overall Study||45||
48418358|NCT03524664|101357113|FG000|3-month Post-Intervention Follow-up Assessments (T3)|Overall Study||28||
48439976|NCT01728376|101409998|FG003|COMPLETED|Overall Study||7||
48355717|NCT05593432|101198600|FG003|STARTED|16-Week DBVC Period||0||
48355718|NCT05593432|101198597|FG000|COMPLETED|16-Week DBVC Period||30||
48355719|NCT05593432|101198598|FG001|COMPLETED|16-Week DBVC Period||29||
48355720|NCT05593432|101198599|FG002|COMPLETED|16-Week DBVC Period||0||
48355721|NCT05593432|101198600|FG003|COMPLETED|16-Week DBVC Period||0||
48355722|NCT05593432|101198597|FG000|NOT COMPLETED|16-Week DBVC Period||2||
48355723|NCT05593432|101198598|FG001|NOT COMPLETED|16-Week DBVC Period||3||
48355724|NCT05593432|101198599|FG002|NOT COMPLETED|16-Week DBVC Period||0||
48355725|NCT05593432|101198600|FG003|NOT COMPLETED|16-Week DBVC Period||0||
48355726|NCT05593432|101198597|FG000|STARTED|16-Week OLE Period||0||
48355727|NCT05593432|101198598|FG001|STARTED|16-Week OLE Period||0||
48355728|NCT05593432|101198599|FG002|STARTED|16-Week OLE Period||30||
48355729|NCT05593432|101198600|FG003|STARTED|16-Week OLE Period||29||
48355730|NCT05593432|101198597|FG000|COMPLETED|16-Week OLE Period||0||
48355731|NCT05593432|101198598|FG001|COMPLETED|16-Week OLE Period||0||
48355732|NCT05593432|101198599|FG002|COMPLETED|16-Week OLE Period||29||
48355733|NCT05593432|101198600|FG003|COMPLETED|16-Week OLE Period||23||
48355734|NCT05593432|101198597|FG000|NOT COMPLETED|16-Week OLE Period||0||
48355735|NCT05593432|101198598|FG001|NOT COMPLETED|16-Week OLE Period||0||
48355736|NCT05593432|101198599|FG002|NOT COMPLETED|16-Week OLE Period||1||
48355737|NCT05593432|101198600|FG003|NOT COMPLETED|16-Week OLE Period||6||
48355738|NCT00658333|101201045|FG000|STARTED|Overall Study||15||
48355739|NCT00658333|101201046|FG001|STARTED|Overall Study||15||
48355740|NCT00658333|101201045|FG000|COMPLETED|Overall Study||13||
48355741|NCT00658333|101201046|FG001|COMPLETED|Overall Study||14||
48355742|NCT00658333|101201045|FG000|NOT COMPLETED|Overall Study||2||
48355743|NCT00658333|101201046|FG001|NOT COMPLETED|Overall Study||1||
48418359|NCT03524664|101357114|FG001|3-month Post-Intervention Follow-up Assessments (T3)|Overall Study||39||
48418360|NCT03524664|101357113|FG000|COMPLETED|Overall Study||28||
48418361|NCT03524664|101357114|FG001|COMPLETED|Overall Study||39||
48355744|NCT02299934|101201047|FG000|STARTED|Overall Study||13||
48355745|NCT02299934|101201047|FG000|COMPLETED|Overall Study||0||
48355746|NCT02299934|101201047|FG000|NOT COMPLETED|Overall Study||13||
48355747|NCT02189382|101201048|FG000|STARTED|Overall Study||35||
48355748|NCT02189382|101201049|FG001|STARTED|Overall Study||35||
48355749|NCT02189382|101201048|FG000|COMPLETED|Overall Study||35||
48355750|NCT02189382|101201049|FG001|COMPLETED|Overall Study||35||
48355751|NCT02189382|101201048|FG000|NOT COMPLETED|Overall Study||0||
48355752|NCT02189382|101201049|FG001|NOT COMPLETED|Overall Study||0||
48355753|NCT00474253|101201050|FG000|STARTED|Overall Study||58||
48355754|NCT00474253|101201051|FG001|STARTED|Overall Study||57||
48355755|NCT00474253|101201050|FG000|Treated|Overall Study||56||
48355756|NCT00474253|101201051|FG001|Treated|Overall Study||54||
48355757|NCT00474253|101201050|FG000|COMPLETED|Overall Study||55||
48355758|NCT00474253|101201051|FG001|COMPLETED|Overall Study||53||
48355759|NCT00474253|101201050|FG000|NOT COMPLETED|Overall Study||3||
48355760|NCT00474253|101201051|FG001|NOT COMPLETED|Overall Study||4||
48355761|NCT00630032|101201052|FG000|STARTED|Overall Study||398||
48355762|NCT00630032|101201053|FG001|STARTED|Overall Study||364||
48355763|NCT00630032|101201052|FG000|COMPLETED|Overall Study||308||
48355764|NCT00630032|101201053|FG001|COMPLETED|Overall Study||269||
48355765|NCT00630032|101201052|FG000|NOT COMPLETED|Overall Study||90||
48355766|NCT00630032|101201053|FG001|NOT COMPLETED|Overall Study||95||
48355767|NCT01144637|101201054|FG000|STARTED|Overall Study||999||
48355768|NCT01144637|101201055|FG001|STARTED|Overall Study||1005||
48355769|NCT01144637|101201056|FG002|STARTED|Overall Study||999||
48355770|NCT01144637|101201057|FG003|STARTED|Overall Study||1002||
48355771|NCT01144637|101201054|FG000|COMPLETED|Overall Study||925|active trial phase|
48355772|NCT01144637|101201055|FG001|COMPLETED|Overall Study||929|active trial phase|
48355773|NCT01144637|101201056|FG002|COMPLETED|Overall Study||939|active trial phase|
48355774|NCT01144637|101201057|FG003|COMPLETED|Overall Study||946|active trial phase|
48355775|NCT01144637|101201054|FG000|NOT COMPLETED|Overall Study||74||
48355776|NCT01144637|101201055|FG001|NOT COMPLETED|Overall Study||76||
48355777|NCT01144637|101201056|FG002|NOT COMPLETED|Overall Study||60||
48355778|NCT01144637|101201057|FG003|NOT COMPLETED|Overall Study||56||
48355779|NCT01024244|101201058|FG000|STARTED|Overall Study||22||
48355780|NCT01024244|101201059|FG001|STARTED|Overall Study||12||
48355781|NCT01024244|101201060|FG002|STARTED|Overall Study||15||
48355782|NCT01024244|101201061|FG003|STARTED|Overall Study||14||
48355783|NCT01024244|101201062|FG004|STARTED|Overall Study||15||
48355784|NCT01024244|101201058|FG000|COMPLETED|Overall Study||5||
48355785|NCT01024244|101201059|FG001|COMPLETED|Overall Study||1||
48355786|NCT01024244|101201060|FG002|COMPLETED|Overall Study||1||
48355787|NCT01024244|101201061|FG003|COMPLETED|Overall Study||1||
48355788|NCT01024244|101201062|FG004|COMPLETED|Overall Study||1||
48355789|NCT01024244|101201058|FG000|NOT COMPLETED|Overall Study||17||
48418362|NCT03524664|101357113|FG000|NOT COMPLETED|Overall Study||5||
48418363|NCT03524664|101357114|FG001|NOT COMPLETED|Overall Study||15||
48355790|NCT01024244|101201059|FG001|NOT COMPLETED|Overall Study||11||
48355791|NCT01024244|101201060|FG002|NOT COMPLETED|Overall Study||14||
48355792|NCT01024244|101201061|FG003|NOT COMPLETED|Overall Study||13||
48355793|NCT01024244|101201062|FG004|NOT COMPLETED|Overall Study||14||
48355794|NCT02262130|101201063|FG000|STARTED|Overall Study||10||
48355795|NCT02262130|101201063|FG000|COMPLETED|Overall Study||10||
48355796|NCT02262130|101201063|FG000|NOT COMPLETED|Overall Study||0||
48355797|NCT01341912|101201064|FG000|STARTED|Overall Study||3||
48355798|NCT01341912|101201064|FG000|COMPLETED|Overall Study||3||
48418364|NCT04249076|101357115|FG000|STARTED|Overall Study||141||
48355799|NCT01341912|101201064|FG000|NOT COMPLETED|Overall Study||0||
48355800|NCT03067311|101201065|FG000|STARTED|Overall Study||19||
48355801|NCT03067311|101201066|FG001|STARTED|Overall Study||19||
48355802|NCT03067311|101201065|FG000|COMPLETED|Overall Study||17||
48355803|NCT03067311|101201066|FG001|COMPLETED|Overall Study||17||
48355804|NCT03067311|101201065|FG000|NOT COMPLETED|Overall Study||2||
48355805|NCT03067311|101201066|FG001|NOT COMPLETED|Overall Study||2||
48355806|NCT04901507|101201067|FG000|STARTED|Overall Study||16||
48355807|NCT04901507|101201067|FG000|COMPLETED|Overall Study||13||
48355808|NCT04901507|101201067|FG000|NOT COMPLETED|Overall Study||3||
48355809|NCT03291379|101201068|FG000|STARTED|Overall Study||8||
48355810|NCT03291379|101201068|FG000|COMPLETED|Overall Study||8||
48355811|NCT03291379|101201068|FG000|NOT COMPLETED|Overall Study||0||
48355812|NCT00844883|101201069|FG000|STARTED|Overall Study||50|Patients evaluable for survival and safety analysis, and started on sorafenib|
48355813|NCT00844883|101201069|FG000|Patients Who Received TACE|Overall Study||48||
48355814|NCT00844883|101201069|FG000|COMPLETED|Overall Study||46|Patients evaluable for time to progression analysis|
48418365|NCT04249076|101357116|FG001|STARTED|Overall Study||74||
48418366|NCT04249076|101357115|FG000|COMPLETED|Overall Study||139||
48418367|NCT04249076|101357116|FG001|COMPLETED|Overall Study||69||
48418368|NCT04249076|101357115|FG000|NOT COMPLETED|Overall Study||2||
48418369|NCT04249076|101357116|FG001|NOT COMPLETED|Overall Study||5||
48418370|NCT02943577|101357117|FG000|STARTED|Overall Study||209||
48418371|NCT02943577|101357118|FG001|STARTED|Overall Study||206||
48418372|NCT02943577|101357117|FG000|COMPLETED|Overall Study||204||
48762577|NCT03777982|102206055|FG001|NOT COMPLETED|Overall Study||1||
48762578|NCT03962491|102206056|FG000|STARTED|Overall Study||35||
48762579|NCT03962491|102206057|FG001|STARTED|Overall Study||46||
48762580|NCT03962491|102206056|FG000|COMPLETED|Overall Study||31||
48762581|NCT03962491|102206057|FG001|COMPLETED|Overall Study||41||
48762582|NCT03962491|102206056|FG000|NOT COMPLETED|Overall Study||4||
48762583|NCT03962491|102206057|FG001|NOT COMPLETED|Overall Study||5||
48762584|NCT04689139|102206058|FG000|STARTED|Overall Study||132||
48762585|NCT04689139|102206058|FG000|COMPLETED|Overall Study||132||
48762586|NCT04689139|102206058|FG000|NOT COMPLETED|Overall Study||0||
48762587|NCT03467750|102206059|FG000|STARTED|Overall Study||30||
48762588|NCT03467750|102206060|FG001|STARTED|Overall Study||33||
48418373|NCT02943577|101357118|FG001|COMPLETED|Overall Study||201||
48418374|NCT02943577|101357117|FG000|NOT COMPLETED|Overall Study||5||
48418375|NCT02943577|101357118|FG001|NOT COMPLETED|Overall Study||5||
48418376|NCT04806334|101361433|FG000|STARTED|Overall Study||11||
48762589|NCT03467750|102206059|FG000|COMPLETED|Overall Study||28||
48762590|NCT03467750|102206060|FG001|COMPLETED|Overall Study||31||
48762591|NCT03467750|102206059|FG000|NOT COMPLETED|Overall Study||2||
48762592|NCT03467750|102206060|FG001|NOT COMPLETED|Overall Study||2||
48762593|NCT04385277|102206061|FG000|STARTED|Overall Study||41||
48762594|NCT04385277|102206061|FG000|COMPLETED|Overall Study||36||
48762595|NCT04385277|102206061|FG000|NOT COMPLETED|Overall Study||5||
48762596|NCT03475004|102206062|FG000|STARTED|Overall Study||11||
48762597|NCT03475004|102206063|FG001|STARTED|Overall Study||21||
48762598|NCT03475004|102206064|FG002|STARTED|Overall Study||21||
48762599|NCT03475004|102206062|FG000|COMPLETED|Overall Study||10||
48762600|NCT03475004|102206063|FG001|COMPLETED|Overall Study||20||
48762601|NCT03475004|102206064|FG002|COMPLETED|Overall Study||20||
48762602|NCT03475004|102206062|FG000|NOT COMPLETED|Overall Study||1||
48762603|NCT03475004|102206063|FG001|NOT COMPLETED|Overall Study||1||
48355815|NCT00844883|101201069|FG000|NOT COMPLETED|Overall Study||4||
48355816|NCT03062917|101201070|FG000|STARTED|Overall Study||32||
48355817|NCT03062917|101201071|FG001|STARTED|Overall Study||51||
48355818|NCT03062917|101201072|FG002|STARTED|Overall Study||49||
48355819|NCT03062917|101201073|FG003|STARTED|Overall Study||20||
48355820|NCT03062917|101201074|FG004|STARTED|Overall Study||0||
48355821|NCT03062917|101201070|FG000|COMPLETED|Overall Study||32||
48355822|NCT03062917|101201071|FG001|COMPLETED|Overall Study||51||
48355823|NCT03062917|101201072|FG002|COMPLETED|Overall Study||49||
48355824|NCT03062917|101201073|FG003|COMPLETED|Overall Study||20||
48355825|NCT03062917|101201074|FG004|COMPLETED|Overall Study||0||
48355826|NCT03062917|101201070|FG000|NOT COMPLETED|Overall Study||0||
48355827|NCT03062917|101201071|FG001|NOT COMPLETED|Overall Study||0||
48355828|NCT03062917|101201072|FG002|NOT COMPLETED|Overall Study||0||
48355829|NCT03062917|101201073|FG003|NOT COMPLETED|Overall Study||0||
48355830|NCT03062917|101201074|FG004|NOT COMPLETED|Overall Study||0||
48418377|NCT04806334|101361433|FG000|COMPLETED|Overall Study||10||
48355831|NCT00410891|101201075|FG000|STARTED|Overall Study||129||
48355832|NCT00410891|101201075|FG000|COMPLETED|Overall Study||129||
48355833|NCT00410891|101201075|FG000|NOT COMPLETED|Overall Study||0||
48355834|NCT01938170|101201076|FG000|STARTED|Overall Study||41||
48355835|NCT01938170|101201076|FG000|COMPLETED|Overall Study||41||
48355836|NCT01938170|101201076|FG000|NOT COMPLETED|Overall Study||0||
48418378|NCT04806334|101361433|FG000|NOT COMPLETED|Overall Study||1||
48418379|NCT01944462|101361434|FG000|STARTED|PPPP Educational Program||203||
48418380|NCT01944462|101361434|FG000|Baseline|PPPP Educational Program||203||
48762604|NCT03475004|102206064|FG002|NOT COMPLETED|Overall Study||1||
48762605|NCT03631940|102206065|FG000|STARTED|Initial Randomized Intervention Period 1||366|In the initial period, ten sites were randomized to perform either umbilical cord milking or early cord clamping for all neonates meeting inclusion criteria and born during the participating hospitals' study recruitment period.|5
48767775|NCT04139018|102222824|FG001|STARTED|Overall Study||13||
48767776|NCT04139018|102222823|FG000|COMPLETED|Overall Study||11||
48767777|NCT04139018|102222824|FG001|COMPLETED|Overall Study||12||
48439977|NCT01728376|101409999|FG004|COMPLETED|Overall Study||12||
48762606|NCT03631940|102206066|FG001|STARTED|Initial Randomized Intervention Period 1||494|In the initial period, ten sites were randomized to perform either umbilical cord milking or early cord clamping for all neonates meeting inclusion criteria and born during the participating hospitals' study recruitment period.|5
48762607|NCT03631940|102206065|FG000|COMPLETED|Initial Randomized Intervention Period 1||366||5
48762608|NCT03631940|102206066|FG001|COMPLETED|Initial Randomized Intervention Period 1||494||5
48762609|NCT03631940|102206065|FG000|NOT COMPLETED|Initial Randomized Intervention Period 1||0||0
48762610|NCT03631940|102206066|FG001|NOT COMPLETED|Initial Randomized Intervention Period 1||0||0
48762611|NCT03631940|102206065|FG000|STARTED|Crossover Intervention Period 2||364|Crossover involved the Hospitals changing the assigned procedure performed for neonates who met eligibility criteria during the participating hospital's crossover recruitment period. Because the procedure (umbilical cord management at the time of delivery) can only be performed once per neonate the counts of participants in the crossover period are independent from the initial period.|5
48762612|NCT03631940|102206066|FG001|STARTED|Crossover Intervention Period 2||506|Crossover involved the Hospitals changing the assigned procedure performed for neonates who met eligibility criteria during the participating hospital's crossover recruitment period. Because the procedure (umbilical cord management at the time of delivery) can only be performed once per neonate the counts of participants in the crossover period are independent from the initial period.|5
48355837|NCT02046135|101201077|FG000|STARTED|Overall Study||26||
48355838|NCT02046135|101201078|FG001|STARTED|Overall Study||25||
48355839|NCT02046135|101201077|FG000|COMPLETED|Overall Study||26||
48355840|NCT02046135|101201078|FG001|COMPLETED|Overall Study||25||
48355841|NCT02046135|101201077|FG000|NOT COMPLETED|Overall Study||0||
48355842|NCT02046135|101201078|FG001|NOT COMPLETED|Overall Study||0||
48355843|NCT00469508|101201079|FG000|STARTED|Overall Study||34||
48355844|NCT00469508|101201080|FG001|STARTED|Overall Study||37||
48355845|NCT00469508|101201079|FG000|COMPLETED|Overall Study||14||
48355846|NCT00469508|101201080|FG001|COMPLETED|Overall Study||13||
48355847|NCT00469508|101201079|FG000|NOT COMPLETED|Overall Study||20||
48355848|NCT00469508|101201080|FG001|NOT COMPLETED|Overall Study||24||
48418381|NCT01944462|101361434|FG000|Post-Test|PPPP Educational Program||187||
48418382|NCT01944462|101361434|FG000|3 Month Follow-Up|PPPP Educational Program||143||
48762613|NCT03631940|102206065|FG000|COMPLETED|Crossover Intervention Period 2||364||5
48762614|NCT03631940|102206066|FG001|COMPLETED|Crossover Intervention Period 2||506||5
48762615|NCT03631940|102206065|FG000|NOT COMPLETED|Crossover Intervention Period 2||0||0
48762616|NCT03631940|102206066|FG001|NOT COMPLETED|Crossover Intervention Period 2||0||0
48355849|NCT03669133|101201081|FG000|STARTED|Overall Study||1||
48355850|NCT03669133|101201082|FG001|STARTED|Overall Study||1||
48355851|NCT03669133|101201081|FG000|COMPLETED|Overall Study||1||
48355852|NCT03669133|101201082|FG001|COMPLETED|Overall Study||1||
48355853|NCT03669133|101201081|FG000|NOT COMPLETED|Overall Study||0||
48355854|NCT03669133|101201082|FG001|NOT COMPLETED|Overall Study||0||
48355855|NCT04974307|101201083|FG000|STARTED|Overall Study||9||
48355856|NCT04974307|101201084|FG001|STARTED|Overall Study||1||
48355857|NCT04974307|101201083|FG000|COMPLETED|Overall Study||9||
48355858|NCT04974307|101201084|FG001|COMPLETED|Overall Study||1||
48355859|NCT04974307|101201083|FG000|NOT COMPLETED|Overall Study||0||
48355860|NCT04974307|101201084|FG001|NOT COMPLETED|Overall Study||0||
48355861|NCT03517436|101201085|FG000|STARTED|Overall Study||101||
48355862|NCT03517436|101201085|FG000|COMPLETED|Overall Study||93||
48355863|NCT03517436|101201085|FG000|NOT COMPLETED|Overall Study||8||
48355864|NCT03019549|101201086|FG000|STARTED|Period 1||42||
48355865|NCT03019549|101201086|FG000|Received 1 Dose of Study Drug|Period 1||42||
48355866|NCT03019549|101201086|FG000|COMPLETED|Period 1||42||
48355867|NCT03019549|101201086|FG000|NOT COMPLETED|Period 1||0||
48355868|NCT03019549|101201086|FG000|STARTED|Washout||42||
48355869|NCT03019549|101201086|FG000|COMPLETED|Washout||31||
48355870|NCT03019549|101201086|FG000|NOT COMPLETED|Washout||11||
48355871|NCT03019549|101201086|FG000|STARTED|Period 2||31||
48355872|NCT03019549|101201086|FG000|Received at Least 1 Dose of Study Drug|Period 2||29||
48355873|NCT03019549|101201086|FG000|COMPLETED|Period 2||26||
48355874|NCT03019549|101201086|FG000|NOT COMPLETED|Period 2||5||
48355875|NCT01252966|101201087|FG000|STARTED|Overall Study||108||
48355876|NCT01252966|101201088|FG001|STARTED|Overall Study||105||
48418383|NCT01944462|101361434|FG000|COMPLETED|PPPP Educational Program||143||
48418384|NCT01944462|101361434|FG000|NOT COMPLETED|PPPP Educational Program||60||
48355877|NCT01252966|101201087|FG000|COMPLETED|Overall Study||85||
48355878|NCT01252966|101201088|FG001|COMPLETED|Overall Study||92||
48355879|NCT01252966|101201087|FG000|NOT COMPLETED|Overall Study||23||
48355880|NCT01252966|101201088|FG001|NOT COMPLETED|Overall Study||13||
48355881|NCT04285723|101201089|FG000|STARTED|Overall Study||39|Ful study population|
48355882|NCT04285723|101201090|FG001|STARTED|Overall Study||18|Ful study population|
48355883|NCT04285723|101201089|FG000|COMPLETED|Overall Study||36||
48355884|NCT04285723|101201090|FG001|COMPLETED|Overall Study||16||
48355885|NCT04285723|101201089|FG000|NOT COMPLETED|Overall Study||3||
48418385|NCT01944462|101361434|FG000|STARTED|Optional Vaccination||20||
48418386|NCT01944462|101361434|FG000|COMPLETED|Optional Vaccination||20||
48418387|NCT01944462|101361434|FG000|NOT COMPLETED|Optional Vaccination||0||
48418388|NCT00396266|101361435|FG000|STARTED|Overall Study||8||
48418389|NCT00396266|101361436|FG001|STARTED|Overall Study||14||
48418390|NCT00396266|101361435|FG000|COMPLETED|Overall Study||8||
48418391|NCT00396266|101361436|FG001|COMPLETED|Overall Study||14||
48418392|NCT00396266|101361435|FG000|NOT COMPLETED|Overall Study||0||
48418393|NCT00396266|101361436|FG001|NOT COMPLETED|Overall Study||0||
48418394|NCT00504595|101361437|FG000|STARTED|Overall Study||50||
48418395|NCT00504595|101361438|FG001|STARTED|Overall Study||10||
48418396|NCT00504595|101361439|FG002|STARTED|Overall Study||10||
48418397|NCT00504595|101361440|FG003|STARTED|Overall Study||10||
48418398|NCT00504595|101361437|FG000|COMPLETED|Overall Study||49||
48418399|NCT00504595|101361438|FG001|COMPLETED|Overall Study||10||
48355886|NCT04285723|101201090|FG001|NOT COMPLETED|Overall Study||2||
48355887|NCT04037085|101201091|FG000|STARTED|Overall Study||8||
48355888|NCT04037085|101201091|FG000|COMPLETED|Overall Study||8||
48355889|NCT04037085|101201091|FG000|NOT COMPLETED|Overall Study||0||
48355890|NCT03455543|101201092|FG000|STARTED|Part A: Randomized Treatment (17 Weeks)||92||
48355891|NCT03455543|101201093|FG001|STARTED|Part A: Randomized Treatment (17 Weeks)||90||
48355892|NCT03455543|101201094|FG002|STARTED|Part A: Randomized Treatment (17 Weeks)||0||
48355893|NCT03455543|101201092|FG000|COMPLETED|Part A: Randomized Treatment (17 Weeks)||81||
48355894|NCT03455543|101201093|FG001|COMPLETED|Part A: Randomized Treatment (17 Weeks)||83||
48355895|NCT03455543|101201094|FG002|COMPLETED|Part A: Randomized Treatment (17 Weeks)||0||
48355896|NCT03455543|101201092|FG000|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||11||
48355897|NCT03455543|101201093|FG001|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||7||
48355898|NCT03455543|101201094|FG002|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||0||
48355899|NCT03455543|101201092|FG000|STARTED|Part B: Open-label Extension (24 Weeks)||0||
48355900|NCT03455543|101201093|FG001|STARTED|Part B: Open-label Extension (24 Weeks)||0||
48355901|NCT03455543|101201094|FG002|STARTED|Part B: Open-label Extension (24 Weeks)||152||
48355902|NCT03455543|101201092|FG000|COMPLETED|Part B: Open-label Extension (24 Weeks)||0||
48355903|NCT03455543|101201093|FG001|COMPLETED|Part B: Open-label Extension (24 Weeks)||0||
48355904|NCT03455543|101201094|FG002|COMPLETED|Part B: Open-label Extension (24 Weeks)||115||
48355905|NCT03455543|101201092|FG000|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||0||
48418400|NCT00504595|101361439|FG002|COMPLETED|Overall Study||8||
48418401|NCT00504595|101361440|FG003|COMPLETED|Overall Study||10||
48418402|NCT00504595|101361437|FG000|NOT COMPLETED|Overall Study||1||
48418403|NCT00504595|101361438|FG001|NOT COMPLETED|Overall Study||0||
48418404|NCT00504595|101361439|FG002|NOT COMPLETED|Overall Study||2||
48418405|NCT00504595|101361440|FG003|NOT COMPLETED|Overall Study||0||
48418406|NCT02381795|101361441|FG000|STARTED|Overall Study||10||
48418407|NCT02381795|101361441|FG000|COMPLETED|Overall Study||7||
48418408|NCT02381795|101361441|FG000|NOT COMPLETED|Overall Study||3||
48418409|NCT02145429|101361442|FG000|STARTED|Overall Study||91||
48418410|NCT02145429|101361443|FG001|STARTED|Overall Study||90||
48418411|NCT02145429|101361442|FG000|COMPLETED|Overall Study||75||
48418412|NCT02145429|101361443|FG001|COMPLETED|Overall Study||79||
48418413|NCT02145429|101361442|FG000|NOT COMPLETED|Overall Study||16||
48418414|NCT02145429|101361443|FG001|NOT COMPLETED|Overall Study||11||
48418415|NCT00078715|101361444|FG000|STARTED|First Intervention||2||
48418416|NCT00078715|101361445|FG001|STARTED|First Intervention||4||
48418417|NCT00078715|101361444|FG000|COMPLETED|First Intervention||2||
48418418|NCT00078715|101361445|FG001|COMPLETED|First Intervention||4||
48418419|NCT00078715|101361444|FG000|NOT COMPLETED|First Intervention||0||
48355906|NCT03455543|101201093|FG001|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||0||
48355907|NCT03455543|101201094|FG002|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||37||
48355908|NCT01776268|101201095|FG000|STARTED|Overall Study||48||
48355909|NCT01776268|101201096|FG001|STARTED|Overall Study||51||
48355910|NCT01776268|101201095|FG000|COMPLETED|Overall Study||48||
48355911|NCT01776268|101201096|FG001|COMPLETED|Overall Study||51||
48355912|NCT01776268|101201095|FG000|NOT COMPLETED|Overall Study||0||
48418420|NCT00078715|101361445|FG001|NOT COMPLETED|First Intervention||0||
48418421|NCT00078715|101361444|FG000|STARTED|Second Intervention||2||
48418422|NCT00078715|101361445|FG001|STARTED|Second Intervention||4||
48418423|NCT00078715|101361444|FG000|COMPLETED|Second Intervention||2||
48418424|NCT00078715|101361445|FG001|COMPLETED|Second Intervention||4||
48418425|NCT00078715|101361444|FG000|NOT COMPLETED|Second Intervention||0||
48418426|NCT00078715|101361445|FG001|NOT COMPLETED|Second Intervention||0||
48418427|NCT00424463|101361446|FG000|STARTED|Overall Study||45||
48418428|NCT00424463|101361447|FG001|STARTED|Overall Study||48||
48418429|NCT00424463|101361448|FG002|STARTED|Overall Study||88||
48418430|NCT00424463|101361446|FG000|COMPLETED|Overall Study||38||
48418431|NCT00424463|101361447|FG001|COMPLETED|Overall Study||34||
48418432|NCT00424463|101361448|FG002|COMPLETED|Overall Study||72||
48418433|NCT00424463|101361446|FG000|NOT COMPLETED|Overall Study||7||
48418434|NCT00424463|101361447|FG001|NOT COMPLETED|Overall Study||14||
48418435|NCT00424463|101361448|FG002|NOT COMPLETED|Overall Study||16||
48418436|NCT01904760|101361449|FG000|STARTED|Overall Study||40||
48418437|NCT01904760|101361450|FG001|STARTED|Overall Study||40||
48418438|NCT01904760|101361449|FG000|COMPLETED|Overall Study||39||
48418439|NCT01904760|101361450|FG001|COMPLETED|Overall Study||40||
48418440|NCT01904760|101361449|FG000|NOT COMPLETED|Overall Study||1||
48418441|NCT01904760|101361450|FG001|NOT COMPLETED|Overall Study||0||
48418442|NCT01539720|101361451|FG000|STARTED|Overall Study||198||
48418443|NCT01539720|101361452|FG001|STARTED|Overall Study||76||
48418444|NCT01539720|101361451|FG000|5 WEEKS|Overall Study||183||
48418445|NCT01539720|101361452|FG001|5 WEEKS|Overall Study||73||
48418446|NCT01539720|101361451|FG000|6 MONTHS|Overall Study||169||
48418447|NCT01539720|101361452|FG001|6 MONTHS|Overall Study||66||
48418448|NCT01539720|101361451|FG000|COMPLETED|Overall Study||169||
48418449|NCT01539720|101361452|FG001|COMPLETED|Overall Study||66||
48418450|NCT01539720|101361451|FG000|NOT COMPLETED|Overall Study||29||
48418451|NCT01539720|101361452|FG001|NOT COMPLETED|Overall Study||10||
48418452|NCT01196793|101361453|FG000|STARTED|Overall Study||108||
48418453|NCT01196793|101361453|FG000|COMPLETED|Overall Study||108||
48418454|NCT01196793|101361453|FG000|NOT COMPLETED|Overall Study||0||
48418455|NCT03428230|101361454|FG000|STARTED|Overall Study||15||
48418456|NCT03428230|101361455|FG001|STARTED|Overall Study||15||
48418457|NCT03428230|101361456|FG002|STARTED|Overall Study||15||
48418458|NCT03428230|101361457|FG003|STARTED|Overall Study||15||
48355913|NCT01776268|101201096|FG001|NOT COMPLETED|Overall Study||0||
48355914|NCT00847561|101201097|FG000|STARTED|Overall Study||70||
48355915|NCT00847561|101201098|FG001|STARTED|Overall Study||66||
48355916|NCT00847561|101201097|FG000|COMPLETED|Overall Study||57||
48355917|NCT00847561|101201098|FG001|COMPLETED|Overall Study||62||
48355918|NCT00847561|101201097|FG000|NOT COMPLETED|Overall Study||13||
48355919|NCT00847561|101201098|FG001|NOT COMPLETED|Overall Study||4||
48355920|NCT01389128|101201099|FG000|STARTED|Overall Study||40||
48355921|NCT01389128|101201100|FG001|STARTED|Overall Study||40||
48355922|NCT01389128|101201099|FG000|COMPLETED|Overall Study||35||
48355923|NCT01389128|101201100|FG001|COMPLETED|Overall Study||34||
48355924|NCT01389128|101201099|FG000|NOT COMPLETED|Overall Study||5||
48418459|NCT03428230|101361454|FG000|COMPLETED|Overall Study||15||
48418460|NCT03428230|101361455|FG001|COMPLETED|Overall Study||15||
48418461|NCT03428230|101361456|FG002|COMPLETED|Overall Study||15||
48418462|NCT03428230|101361457|FG003|COMPLETED|Overall Study||15||
48418463|NCT03428230|101361454|FG000|NOT COMPLETED|Overall Study||0||
48418464|NCT03428230|101361455|FG001|NOT COMPLETED|Overall Study||0||
48418465|NCT03428230|101361456|FG002|NOT COMPLETED|Overall Study||0||
48418466|NCT03428230|101361457|FG003|NOT COMPLETED|Overall Study||0||
48418467|NCT01521494|101361458|FG000|STARTED|Overall Study||39||
48762617|NCT04797585|102206067|FG000|STARTED|Overall Study||1||
48762618|NCT04797585|102206068|FG001|STARTED|Overall Study||2||
48762619|NCT04797585|102206067|FG000|COMPLETED|Overall Study||1||
48762620|NCT04797585|102206068|FG001|COMPLETED|Overall Study||2||
48762621|NCT04797585|102206067|FG000|NOT COMPLETED|Overall Study||0||
48762622|NCT04797585|102206068|FG001|NOT COMPLETED|Overall Study||0||
48762623|NCT02121158|102206069|FG000|STARTED|Overall Study||85||
48762624|NCT02121158|102206070|FG001|STARTED|Overall Study||82||
48355925|NCT01389128|101201100|FG001|NOT COMPLETED|Overall Study||6||
48355926|NCT00759577|101201101|FG000|STARTED|Overall Study||36||
48355927|NCT00759577|101201101|FG000|COMPLETED|Overall Study||36||
48355928|NCT00759577|101201101|FG000|NOT COMPLETED|Overall Study||0||
48355929|NCT04407507|101201102|FG000|STARTED|Overall Study||33||
48355930|NCT04407507|101201103|FG001|STARTED|Overall Study||33||
48355931|NCT04407507|101201102|FG000|COMPLETED|Overall Study||33||
48355932|NCT04407507|101201103|FG001|COMPLETED|Overall Study||32||
48355933|NCT04407507|101201102|FG000|NOT COMPLETED|Overall Study||0||
48418468|NCT01521494|101361459|FG001|STARTED|Overall Study||36||
48418469|NCT01521494|101361460|FG002|STARTED|Overall Study||35||
48418470|NCT01521494|101361461|FG003|STARTED|Overall Study||36||
48418471|NCT01521494|101361462|FG004|STARTED|Overall Study||37||
48418472|NCT01521494|101361458|FG000|COMPLETED|Overall Study||37||
48418473|NCT01521494|101361459|FG001|COMPLETED|Overall Study||31||
48418474|NCT01521494|101361460|FG002|COMPLETED|Overall Study||23||
48418475|NCT01521494|101361461|FG003|COMPLETED|Overall Study||15||
48418476|NCT01521494|101361462|FG004|COMPLETED|Overall Study||30||
48418477|NCT01521494|101361458|FG000|NOT COMPLETED|Overall Study||2||
48418478|NCT01521494|101361459|FG001|NOT COMPLETED|Overall Study||5||
48418479|NCT01521494|101361460|FG002|NOT COMPLETED|Overall Study||12||
48418480|NCT01521494|101361461|FG003|NOT COMPLETED|Overall Study||21||
48762625|NCT02121158|102206069|FG000|COMPLETED|Overall Study||85||
48762626|NCT02121158|102206070|FG001|COMPLETED|Overall Study||82||
48762627|NCT02121158|102206069|FG000|NOT COMPLETED|Overall Study||0||
48762628|NCT02121158|102206070|FG001|NOT COMPLETED|Overall Study||0||
48355934|NCT04407507|101201103|FG001|NOT COMPLETED|Overall Study||1||
48355935|NCT00542815|101201104|FG000|STARTED|Overall Study||432||
48355936|NCT00542815|101201105|FG001|STARTED|Overall Study||76||
48355937|NCT00542815|101201106|FG002|STARTED|Overall Study||124||
48355938|NCT00542815|101201104|FG000|COMPLETED|Overall Study||326||
48418481|NCT01521494|101361462|FG004|NOT COMPLETED|Overall Study||7||
48418482|NCT01222767|101361463|FG000|STARTED|Overall Study||17||
48418483|NCT01222767|101361463|FG000|Received Treatment|Overall Study||16||
48418484|NCT01222767|101361463|FG000|COMPLETED|Overall Study||0||
48418485|NCT01222767|101361463|FG000|NOT COMPLETED|Overall Study||17||
48355939|NCT00542815|101201105|FG001|COMPLETED|Overall Study||44||
48355940|NCT00542815|101201106|FG002|COMPLETED|Overall Study||92||
48355941|NCT00542815|101201104|FG000|NOT COMPLETED|Overall Study||106||
48355942|NCT00542815|101201105|FG001|NOT COMPLETED|Overall Study||32||
48355943|NCT00542815|101201106|FG002|NOT COMPLETED|Overall Study||32||
48355944|NCT01444391|101201107|FG000|STARTED|Overall Study||42||
48355945|NCT01444391|101201107|FG000|COMPLETED|Overall Study||41||
48355946|NCT01444391|101201107|FG000|NOT COMPLETED|Overall Study||1||
48355947|NCT01633060|101201108|FG000|STARTED|Randomization Phase||289|All randomized patients|
48355948|NCT01633060|101201109|FG001|STARTED|Randomization Phase||143|All randomized patients|
48355949|NCT01633060|101201108|FG000|COMPLETED|Randomization Phase||288|Randomized and treated|
48418486|NCT02481440|101361464|FG000|STARTED|Overall Study||102||
48418487|NCT02481440|101361464|FG000|COMPLETED|Overall Study||41||
48418488|NCT02481440|101361464|FG000|NOT COMPLETED|Overall Study||61||
48418489|NCT03523390|101361465|FG000|STARTED|Overall Study||3||
48418490|NCT03523390|101361466|FG001|STARTED|Overall Study||7||
48418491|NCT03523390|101361467|FG002|STARTED|Overall Study||6||
48418492|NCT03523390|101361468|FG003|STARTED|Overall Study||8||
48418493|NCT03523390|101361465|FG000|COMPLETED|Overall Study||3||
48418494|NCT03523390|101361466|FG001|COMPLETED|Overall Study||7||
48418495|NCT03523390|101361467|FG002|COMPLETED|Overall Study||6||
48418496|NCT03523390|101361468|FG003|COMPLETED|Overall Study||8||
48418497|NCT03523390|101361465|FG000|NOT COMPLETED|Overall Study||0||
48418498|NCT03523390|101361466|FG001|NOT COMPLETED|Overall Study||0||
48418499|NCT03523390|101361467|FG002|NOT COMPLETED|Overall Study||0||
48418500|NCT03523390|101361468|FG003|NOT COMPLETED|Overall Study||0||
48418501|NCT01853397|101361469|FG000|STARTED|Overall Study||18||
48418502|NCT01853397|101361470|FG001|STARTED|Overall Study||20||
48418503|NCT01853397|101361471|FG002|STARTED|Overall Study||17||
48638528|NCT01147458|101898779|FG003|STARTED|Second Intervention||34||
48638529|NCT01147458|101898776|FG000|COMPLETED|Second Intervention||25||
48638530|NCT01147458|101898777|FG001|COMPLETED|Second Intervention||24||
48638531|NCT01147458|101898778|FG002|COMPLETED|Second Intervention||27||
48638532|NCT01147458|101898779|FG003|COMPLETED|Second Intervention||30||
48638533|NCT01147458|101898776|FG000|NOT COMPLETED|Second Intervention||9||
48638534|NCT01147458|101898777|FG001|NOT COMPLETED|Second Intervention||7||
48355950|NCT01633060|101201109|FG001|COMPLETED|Randomization Phase||140|Randomized and treated|
48355951|NCT01633060|101201108|FG000|NOT COMPLETED|Randomization Phase||1||
48355952|NCT01633060|101201109|FG001|NOT COMPLETED|Randomization Phase||3||
48355953|NCT01633060|101201108|FG000|STARTED|Treatment Phase||288|All patients in FAS that were treated|
48355954|NCT01633060|101201109|FG001|STARTED|Treatment Phase||140|All patients in FAS that were treated|
48355955|NCT01633060|101201108|FG000|FAS - ctDNA PIK3CA Mutant|Treatment Phase||100|All patients in FAS with ctDNA sample and PIK3CA mutation|
48355956|NCT01633060|101201109|FG001|FAS - ctDNA PIK3CA Mutant|Treatment Phase||35|All patients in FAS with ctDNA sample and PIK3CA mutation|
48186852|NCT02559817|100779920|FG000|STARTED|Treatment Period||19||
48186853|NCT02559817|100779921|FG001|STARTED|Treatment Period||29||
48186854|NCT02559817|100779922|FG002|STARTED|Treatment Period||21||
48186855|NCT02559817|100779923|FG003|STARTED|Treatment Period||24||
48186856|NCT02559817|100779924|FG004|STARTED|Treatment Period||8||
48186857|NCT02559817|100779920|FG000|COMPLETED|Treatment Period||18||
48186858|NCT02559817|100779921|FG001|COMPLETED|Treatment Period||27||
48186859|NCT02559817|100779922|FG002|COMPLETED|Treatment Period||19||
48186860|NCT02559817|100779923|FG003|COMPLETED|Treatment Period||22||
48186861|NCT02559817|100779924|FG004|COMPLETED|Treatment Period||8||
48186862|NCT02559817|100779920|FG000|NOT COMPLETED|Treatment Period||1||
48186863|NCT02559817|100779921|FG001|NOT COMPLETED|Treatment Period||2||
48186864|NCT02559817|100779922|FG002|NOT COMPLETED|Treatment Period||2||
48186865|NCT02559817|100779923|FG003|NOT COMPLETED|Treatment Period||2||
48186866|NCT02559817|100779924|FG004|NOT COMPLETED|Treatment Period||0||
48186867|NCT02559817|100779920|FG000|STARTED|Post-treatment Period||18||
48355957|NCT01633060|101201108|FG000|FAS - ctDNA PIK3CA Non-mutant|Treatment Phase||132|All patients in FAS with ctDNA sample and no PIK3CA mutation|
48355958|NCT01633060|101201109|FG001|FAS - ctDNA PIK3CA Non-mutant|Treatment Phase||81|All patients in FAS with ctDNA sample and no PIK3CA mutation|
48418504|NCT01853397|101361472|FG003|STARTED|Overall Study||17||
48418505|NCT01853397|101361469|FG000|COMPLETED|Overall Study||18||
48418506|NCT01853397|101361470|FG001|COMPLETED|Overall Study||20||
48418507|NCT01853397|101361471|FG002|COMPLETED|Overall Study||17||
48418508|NCT01853397|101361472|FG003|COMPLETED|Overall Study||15||
48638535|NCT01147458|101898778|FG002|NOT COMPLETED|Second Intervention||8||
48638536|NCT01147458|101898779|FG003|NOT COMPLETED|Second Intervention||4||
48638537|NCT01164475|101898780|FG000|STARTED|Overall Study||30||
48638538|NCT01164475|101898781|FG001|STARTED|Overall Study||31||
48638539|NCT01164475|101898780|FG000|COMPLETED|Overall Study||28||
48638540|NCT01164475|101898781|FG001|COMPLETED|Overall Study||29||
48638541|NCT01164475|101898780|FG000|NOT COMPLETED|Overall Study||2||
48418509|NCT01853397|101361469|FG000|NOT COMPLETED|Overall Study||0||
48638542|NCT01164475|101898781|FG001|NOT COMPLETED|Overall Study||2||
48762629|NCT03435211|102206071|FG000|STARTED|Overall Study||26||
48186868|NCT02559817|100779921|FG001|STARTED|Post-treatment Period||27||
48186869|NCT02559817|100779922|FG002|STARTED|Post-treatment Period||20||
48186870|NCT02559817|100779923|FG003|STARTED|Post-treatment Period||22||
48355959|NCT01633060|101201108|FG000|Safety Set (SS)|Treatment Phase||288|At least 1 dose of study treatment and a 1 post baseline safety assessment|
48355960|NCT01633060|101201109|FG001|Safety Set (SS)|Treatment Phase||140|At least 1 dose of study treatment and a 1 post baseline safety assessment|
48355961|NCT01633060|101201108|FG000|Pharmacokinetic Analysis Set (PAS)|Treatment Phase||63|At least one dose of Buparlisib and had at least 1 evaluable buparlisib concentration measurement|
48355962|NCT01633060|101201109|FG001|Pharmacokinetic Analysis Set (PAS)|Treatment Phase||0|At least one dose of Buparlisib and had at least 1 evaluable buparlisib concentration measurement|
48355963|NCT01633060|101201108|FG000|COMPLETED|Treatment Phase||0||
48355964|NCT01633060|101201109|FG001|COMPLETED|Treatment Phase||0||
48355965|NCT01633060|101201108|FG000|NOT COMPLETED|Treatment Phase||288||
48355966|NCT01633060|101201109|FG001|NOT COMPLETED|Treatment Phase||140||
48355967|NCT01633060|101201108|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase||16|All patients who discontinued treatment and entered Post-Treatment Efficacy Follow-Up Phase|
48355968|NCT01633060|101201109|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase||2|All patients who discontinued treatment and entered Post-Treatment Efficacy Follow-Up Phase|
48355969|NCT01633060|101201108|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
48355970|NCT01633060|101201109|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
48355971|NCT01633060|101201108|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||16||
48355972|NCT01633060|101201109|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2||
48355973|NCT00231478|101201110|FG000|STARTED|Overall Study||87||
48355974|NCT00231478|101201111|FG001|STARTED|Overall Study||84||
48355975|NCT00231478|101201110|FG000|COMPLETED|Overall Study||79||
48355976|NCT00231478|101201111|FG001|COMPLETED|Overall Study||78||
48355977|NCT00231478|101201110|FG000|NOT COMPLETED|Overall Study||8||
48355978|NCT00231478|101201111|FG001|NOT COMPLETED|Overall Study||6||
48355979|NCT00812110|101201112|FG000|STARTED|Overall Study||292||
48355980|NCT00812110|101201112|FG000|COMPLETED|Overall Study||292||
48355981|NCT00812110|101201112|FG000|NOT COMPLETED|Overall Study||0||
48355982|NCT00649961|101201113|FG000|STARTED|Overall Study||18||
48355983|NCT00649961|101201113|FG000|COMPLETED|Overall Study||18||
48355984|NCT00649961|101201113|FG000|NOT COMPLETED|Overall Study||0||
48355985|NCT02990338|101201114|FG000|STARTED|Overall Study||153||
48355986|NCT02990338|101201115|FG001|STARTED|Overall Study||154||
48355987|NCT02990338|101201114|FG000|Treated|Overall Study||149||
48355988|NCT02990338|101201115|FG001|Treated|Overall Study||152||
48355989|NCT02990338|101201114|FG000|COMPLETED|Overall Study||123||
48355990|NCT02990338|101201115|FG001|COMPLETED|Overall Study||118||
48355991|NCT02990338|101201114|FG000|NOT COMPLETED|Overall Study||30||
48355992|NCT02990338|101201115|FG001|NOT COMPLETED|Overall Study||36||
48355993|NCT02453841|101201116|FG000|STARTED|Overall Study||30||
48355994|NCT02453841|101201116|FG000|COMPLETED|Overall Study||27||
48355995|NCT02453841|101201116|FG000|NOT COMPLETED|Overall Study||3||
48355996|NCT02624700|101201117|FG000|STARTED|Overall Study||9||
48355997|NCT02624700|101201118|FG001|STARTED|Overall Study||4||
48355998|NCT02624700|101201117|FG000|COMPLETED|Overall Study||9||
48355999|NCT02624700|101201118|FG001|COMPLETED|Overall Study||4||
48356000|NCT02624700|101201117|FG000|NOT COMPLETED|Overall Study||0||
48356001|NCT02624700|101201118|FG001|NOT COMPLETED|Overall Study||0||
48356002|NCT00201201|101201119|FG000|STARTED|Overall Study||87||
48356003|NCT00201201|101201120|FG001|STARTED|Overall Study||73||
48356004|NCT00201201|101201119|FG000|COMPLETED|Overall Study||82||
48356005|NCT00201201|101201120|FG001|COMPLETED|Overall Study||66||
48356006|NCT00201201|101201119|FG000|NOT COMPLETED|Overall Study||5||
48356007|NCT00201201|101201120|FG001|NOT COMPLETED|Overall Study||7||
48356008|NCT02123329|101201121|FG000|STARTED|3 Month Outcome Measure||147||
48356009|NCT02123329|101201122|FG001|STARTED|3 Month Outcome Measure||167||
48356010|NCT02123329|101201121|FG000|COMPLETED|3 Month Outcome Measure||98||
48356011|NCT02123329|101201122|FG001|COMPLETED|3 Month Outcome Measure||101||
48356012|NCT02123329|101201121|FG000|NOT COMPLETED|3 Month Outcome Measure||49||
48356013|NCT02123329|101201122|FG001|NOT COMPLETED|3 Month Outcome Measure||66||
48356014|NCT02123329|101201121|FG000|STARTED|6 Month Outcome Measure||147||
48356015|NCT02123329|101201122|FG001|STARTED|6 Month Outcome Measure||167||
48356016|NCT02123329|101201121|FG000|COMPLETED|6 Month Outcome Measure||99||
48356017|NCT02123329|101201122|FG001|COMPLETED|6 Month Outcome Measure||100||
48356018|NCT02123329|101201121|FG000|NOT COMPLETED|6 Month Outcome Measure||48||
48356019|NCT02123329|101201122|FG001|NOT COMPLETED|6 Month Outcome Measure||67||
48356020|NCT02123329|101201121|FG000|STARTED|12 Month Outcome Measure||147||
48356021|NCT02123329|101201122|FG001|STARTED|12 Month Outcome Measure||167||
48356022|NCT02123329|101201121|FG000|COMPLETED|12 Month Outcome Measure||83||
48356023|NCT02123329|101201122|FG001|COMPLETED|12 Month Outcome Measure||88||
48356024|NCT02123329|101201121|FG000|NOT COMPLETED|12 Month Outcome Measure||64||
48356025|NCT02123329|101201122|FG001|NOT COMPLETED|12 Month Outcome Measure||79||
48356026|NCT01450540|101201123|FG000|STARTED|Overall Study||123||
48356027|NCT01450540|101201124|FG001|STARTED|Overall Study||118||
48356028|NCT01450540|101201123|FG000|COMPLETED|Overall Study||101||
48356029|NCT01450540|101201124|FG001|COMPLETED|Overall Study||82||
48356030|NCT01450540|101201123|FG000|NOT COMPLETED|Overall Study||22||
48356031|NCT01450540|101201124|FG001|NOT COMPLETED|Overall Study||36||
48356032|NCT02985801|101201125|FG000|STARTED|Overall Study||8||
48356033|NCT02985801|101201126|FG001|STARTED|Overall Study||8||
48356034|NCT02985801|101201125|FG000|COMPLETED|Overall Study||8||
48356035|NCT02985801|101201126|FG001|COMPLETED|Overall Study||8||
48356036|NCT02985801|101201125|FG000|NOT COMPLETED|Overall Study||0||
48356037|NCT02985801|101201126|FG001|NOT COMPLETED|Overall Study||0||
48356038|NCT00308620|101201127|FG000|STARTED|Overall Study||3||
48356039|NCT00308620|101201128|FG001|STARTED|Overall Study||4||
48356040|NCT00308620|101201129|FG002|STARTED|Overall Study||6||
48418510|NCT01853397|101361470|FG001|NOT COMPLETED|Overall Study||0||
48418511|NCT01853397|101361471|FG002|NOT COMPLETED|Overall Study||0||
48418512|NCT01853397|101361472|FG003|NOT COMPLETED|Overall Study||2||
48418513|NCT02583399|101361473|FG000|STARTED|Overall Study||30||
48418514|NCT02583399|101361473|FG000|COMPLETED|Overall Study||24||
48418515|NCT02583399|101361473|FG000|NOT COMPLETED|Overall Study||6||
48418516|NCT00352794|101361474|FG000|STARTED|Overall Study||40||
48418517|NCT00352794|101361474|FG000|COMPLETED|Overall Study||40||
48418518|NCT00352794|101361474|FG000|NOT COMPLETED|Overall Study||0||
48418519|NCT01143818|101361475|FG000|STARTED|Overall Study||1049||
48418520|NCT01143818|101361475|FG000|COMPLETED|Overall Study||799||
48418521|NCT01143818|101361475|FG000|NOT COMPLETED|Overall Study||250||
48418522|NCT03010358|101361476|FG000|STARTED|Stage 1 - Dose Escalation||6||
48418523|NCT03010358|101361477|FG001|STARTED|Stage 1 - Dose Escalation||3||
48418524|NCT03010358|101361478|FG002|STARTED|Stage 1 - Dose Escalation||0||
48418525|NCT03010358|101361476|FG000|COMPLETED|Stage 1 - Dose Escalation||6||
48418526|NCT03010358|101361477|FG001|COMPLETED|Stage 1 - Dose Escalation||3||
48418527|NCT03010358|101361478|FG002|COMPLETED|Stage 1 - Dose Escalation||0||
48418528|NCT03010358|101361476|FG000|NOT COMPLETED|Stage 1 - Dose Escalation||0||
48418529|NCT03010358|101361477|FG001|NOT COMPLETED|Stage 1 - Dose Escalation||0||
48418530|NCT03010358|101361478|FG002|NOT COMPLETED|Stage 1 - Dose Escalation||0||
48418531|NCT03010358|101361476|FG000|STARTED|Stage 2 - Dose Expansion||0||
48418532|NCT03010358|101361477|FG001|STARTED|Stage 2 - Dose Expansion||0||
48418533|NCT03010358|101361478|FG002|STARTED|Stage 2 - Dose Expansion||15||
48418534|NCT03010358|101361476|FG000|COMPLETED|Stage 2 - Dose Expansion||0||
48418535|NCT03010358|101361477|FG001|COMPLETED|Stage 2 - Dose Expansion||0||
48418536|NCT03010358|101361478|FG002|COMPLETED|Stage 2 - Dose Expansion||14||
48418537|NCT03010358|101361476|FG000|NOT COMPLETED|Stage 2 - Dose Expansion||0||
48418538|NCT03010358|101361477|FG001|NOT COMPLETED|Stage 2 - Dose Expansion||0||
48418539|NCT03010358|101361478|FG002|NOT COMPLETED|Stage 2 - Dose Expansion||1||
48418540|NCT00982111|101361479|FG000|STARTED|Overall Study||315||
48418541|NCT00982111|101361480|FG001|STARTED|Overall Study||318||
48418542|NCT00982111|101361479|FG000|Received at Least 1 Dose of Study Drug|Overall Study||304||
48418543|NCT00982111|101361480|FG001|Received at Least 1 Dose of Study Drug|Overall Study||312||
48418544|NCT00982111|101361479|FG000|Death Due to Any Cause|Overall Study||236||
48418545|NCT00982111|101361480|FG001|Death Due to Any Cause|Overall Study||246||
48418546|NCT00982111|101361479|FG000|COMPLETED|Overall Study||236||
48418547|NCT00982111|101361480|FG001|COMPLETED|Overall Study||246||
48418548|NCT00982111|101361479|FG000|NOT COMPLETED|Overall Study||79||
48356041|NCT00308620|101201127|FG000|COMPLETED|Overall Study||2||
48356042|NCT00308620|101201128|FG001|COMPLETED|Overall Study||3||
48356043|NCT00308620|101201129|FG002|COMPLETED|Overall Study||5||
48356044|NCT00308620|101201127|FG000|NOT COMPLETED|Overall Study||1||
48356045|NCT00308620|101201128|FG001|NOT COMPLETED|Overall Study||1||
48356046|NCT00308620|101201129|FG002|NOT COMPLETED|Overall Study||1||
48356047|NCT00707577|101201130|FG000|STARTED|Overall Study||174||
48356048|NCT00707577|101201131|FG001|STARTED|Overall Study||156||
48356049|NCT00707577|101201130|FG000|COMPLETED|Overall Study||120||
48356050|NCT00707577|101201131|FG001|COMPLETED|Overall Study||118||
48356051|NCT00707577|101201130|FG000|NOT COMPLETED|Overall Study||54||
48356052|NCT00707577|101201131|FG001|NOT COMPLETED|Overall Study||38||
48356053|NCT01499576|101201132|FG000|STARTED|Overall Study||126||
48356054|NCT01499576|101201132|FG000|COMPLETED|Overall Study||105||
48356055|NCT01499576|101201132|FG000|NOT COMPLETED|Overall Study||21||
48356056|NCT01137435|101201133|FG000|STARTED|Overall Study||687||
48356057|NCT01137435|101201133|FG000|COMPLETED|Overall Study||659||
48418549|NCT00982111|101361480|FG001|NOT COMPLETED|Overall Study||72||
48418550|NCT00758394|101361481|FG000|STARTED|1st Intervention||8||
48418551|NCT00758394|101361482|FG001|STARTED|1st Intervention||7||
48418552|NCT00758394|101361483|FG002|STARTED|1st Intervention||6||
48356058|NCT01137435|101201133|FG000|NOT COMPLETED|Overall Study||28||
48356059|NCT00463437|101201134|FG000|STARTED|Overall Study||359||
48356060|NCT00463437|101201135|FG001|STARTED|Overall Study||363||
48356061|NCT00463437|101201136|FG002|STARTED|Overall Study||358||
48356062|NCT00463437|101201137|FG003|STARTED|Overall Study||357||
48356063|NCT00463437|101201134|FG000|COMPLETED|Overall Study||355||
48356064|NCT00463437|101201135|FG001|COMPLETED|Overall Study||352||
48356065|NCT00463437|101201136|FG002|COMPLETED|Overall Study||352||
48418553|NCT00758394|101361484|FG003|STARTED|1st Intervention||8||
48418554|NCT00758394|101361481|FG000|COMPLETED|1st Intervention||8||
48356066|NCT00463437|101201137|FG003|COMPLETED|Overall Study||350||
48356067|NCT00463437|101201134|FG000|NOT COMPLETED|Overall Study||4||
48356068|NCT00463437|101201135|FG001|NOT COMPLETED|Overall Study||11||
48418555|NCT00758394|101361482|FG001|COMPLETED|1st Intervention||7||
48418556|NCT00758394|101361483|FG002|COMPLETED|1st Intervention||6||
48418557|NCT00758394|101361484|FG003|COMPLETED|1st Intervention||8||
48418558|NCT00758394|101361481|FG000|NOT COMPLETED|1st Intervention||0||
48418559|NCT00758394|101361482|FG001|NOT COMPLETED|1st Intervention||0||
48418560|NCT00758394|101361483|FG002|NOT COMPLETED|1st Intervention||0||
48418561|NCT00758394|101361484|FG003|NOT COMPLETED|1st Intervention||0||
48418562|NCT00758394|101361481|FG000|STARTED|Washout After 1st Intervention||8||
48418563|NCT00758394|101361482|FG001|STARTED|Washout After 1st Intervention||7||
48418564|NCT00758394|101361483|FG002|STARTED|Washout After 1st Intervention||6||
48418565|NCT00758394|101361484|FG003|STARTED|Washout After 1st Intervention||8||
48356069|NCT00463437|101201136|FG002|NOT COMPLETED|Overall Study||6||
48356070|NCT00463437|101201137|FG003|NOT COMPLETED|Overall Study||7||
48356071|NCT03228186|101201138|FG000|STARTED|Overall Study||31||
48356072|NCT03228186|101201138|FG000|COMPLETED|Overall Study||30||
48356073|NCT03228186|101201138|FG000|NOT COMPLETED|Overall Study||1||
48356074|NCT01933984|101201139|FG000|STARTED|Overall Study||26||
48356075|NCT01933984|101201140|FG001|STARTED|Overall Study||25||
48356076|NCT01933984|101201139|FG000|COMPLETED|Overall Study||26||
48356077|NCT01933984|101201140|FG001|COMPLETED|Overall Study||25||
48356078|NCT01933984|101201139|FG000|NOT COMPLETED|Overall Study||0||
48356079|NCT01933984|101201140|FG001|NOT COMPLETED|Overall Study||0||
48356080|NCT00500071|101201141|FG000|STARTED|Screening and Washout Phase||318||
48356081|NCT00500071|101201141|FG000|COMPLETED|Screening and Washout Phase||317||
48356082|NCT00500071|101201141|FG000|NOT COMPLETED|Screening and Washout Phase||1||
48356083|NCT00500071|101201141|FG000|STARTED|Dose-optimization and Maintenance Phase||317||
48356084|NCT00500071|101201141|FG000|COMPLETED|Dose-optimization and Maintenance Phase||295||
48356085|NCT00500071|101201141|FG000|NOT COMPLETED|Dose-optimization and Maintenance Phase||22||
48356086|NCT00500071|101201141|FG000|STARTED|30-day Safety Follow-up||295||
48356087|NCT00500071|101201141|FG000|COMPLETED|30-day Safety Follow-up||278||
48356088|NCT00500071|101201141|FG000|NOT COMPLETED|30-day Safety Follow-up||17||
48356089|NCT02088034|101201142|FG000|STARTED|Overall Study||33||
48356090|NCT02088034|101201143|FG001|STARTED|Overall Study||30||
48356091|NCT02088034|101201144|FG002|STARTED|Overall Study||29||
48356092|NCT02088034|101201142|FG000|COMPLETED|Overall Study||30||
48356093|NCT02088034|101201143|FG001|COMPLETED|Overall Study||28||
48356094|NCT02088034|101201144|FG002|COMPLETED|Overall Study||27||
48356095|NCT02088034|101201142|FG000|NOT COMPLETED|Overall Study||3||
48356096|NCT02088034|101201143|FG001|NOT COMPLETED|Overall Study||2||
48356097|NCT02088034|101201144|FG002|NOT COMPLETED|Overall Study||2||
48356098|NCT02586207|101201145|FG000|STARTED|Overall Study||59||
48356099|NCT02586207|101201145|FG000|COMPLETED|Overall Study||57||
48356100|NCT02586207|101201145|FG000|NOT COMPLETED|Overall Study||2||
48356101|NCT01486238|101201146|FG000|STARTED|Overall Study||23||
48356102|NCT01486238|101201147|FG001|STARTED|Overall Study||49||
48356103|NCT01486238|101201146|FG000|COMPLETED|Overall Study||21||
48356104|NCT01486238|101201147|FG001|COMPLETED|Overall Study||43||
48356105|NCT01486238|101201146|FG000|NOT COMPLETED|Overall Study||2||
48356106|NCT01486238|101201147|FG001|NOT COMPLETED|Overall Study||6||
48356107|NCT02428140|101201148|FG000|STARTED|Overall Study||150||
48356108|NCT02428140|101201149|FG001|STARTED|Overall Study||150||
48356109|NCT02428140|101201148|FG000|COMPLETED|Overall Study||150||
48356110|NCT02428140|101201149|FG001|COMPLETED|Overall Study||150||
48356111|NCT02428140|101201148|FG000|NOT COMPLETED|Overall Study||0||
48356112|NCT02428140|101201149|FG001|NOT COMPLETED|Overall Study||0||
48356113|NCT04045912|101201150|FG000|STARTED|Overall Study||10||10
48356114|NCT04045912|101201151|FG001|STARTED|Overall Study||10||10
48356115|NCT04045912|101201150|FG000|COMPLETED|Overall Study||10||10
48356116|NCT04045912|101201151|FG001|COMPLETED|Overall Study||10||10
48356117|NCT04045912|101201150|FG000|NOT COMPLETED|Overall Study||0||0
48356118|NCT04045912|101201151|FG001|NOT COMPLETED|Overall Study||0||0
48356119|NCT01684826|101201152|FG000|STARTED|Overall Study||49||
48356120|NCT01684826|101201152|FG000|Collected Dose and Image Information|Overall Study||39||
48356121|NCT01684826|101201152|FG000|COMPLETED|Overall Study||39||
48356122|NCT01684826|101201152|FG000|NOT COMPLETED|Overall Study||10||
48418566|NCT00758394|101361481|FG000|COMPLETED|Washout After 1st Intervention||8||
48418567|NCT00758394|101361482|FG001|COMPLETED|Washout After 1st Intervention||7||
48418568|NCT00758394|101361483|FG002|COMPLETED|Washout After 1st Intervention||6||
48418569|NCT00758394|101361484|FG003|COMPLETED|Washout After 1st Intervention||8||
48418570|NCT00758394|101361481|FG000|NOT COMPLETED|Washout After 1st Intervention||0||
48418571|NCT00758394|101361482|FG001|NOT COMPLETED|Washout After 1st Intervention||0||
48418572|NCT00758394|101361483|FG002|NOT COMPLETED|Washout After 1st Intervention||0||
48418573|NCT00758394|101361484|FG003|NOT COMPLETED|Washout After 1st Intervention||0||
48418574|NCT00758394|101361481|FG000|STARTED|2nd Intervention Order||8||
48418575|NCT00758394|101361482|FG001|STARTED|2nd Intervention Order||7||
48418576|NCT00758394|101361483|FG002|STARTED|2nd Intervention Order||6||
48418577|NCT00758394|101361484|FG003|STARTED|2nd Intervention Order||8||
48418578|NCT00758394|101361481|FG000|COMPLETED|2nd Intervention Order||8||
48418579|NCT00758394|101361482|FG001|COMPLETED|2nd Intervention Order||6||
48356123|NCT03065530|101201153|FG000|STARTED|Overall Study||30||
48356124|NCT03065530|101201154|FG001|STARTED|Overall Study||30||
48356125|NCT03065530|101201155|FG002|STARTED|Overall Study||30||
48356126|NCT03065530|101201156|FG003|STARTED|Overall Study||30||
48418580|NCT00758394|101361483|FG002|COMPLETED|2nd Intervention Order||6||
48418581|NCT00758394|101361484|FG003|COMPLETED|2nd Intervention Order||8||
48356127|NCT03065530|101201153|FG000|COMPLETED|Overall Study||28||
48356128|NCT03065530|101201154|FG001|COMPLETED|Overall Study||29||
48356129|NCT03065530|101201155|FG002|COMPLETED|Overall Study||29||
48356130|NCT03065530|101201156|FG003|COMPLETED|Overall Study||28||
48356131|NCT03065530|101201153|FG000|NOT COMPLETED|Overall Study||2||
48356132|NCT03065530|101201154|FG001|NOT COMPLETED|Overall Study||1||
48356133|NCT03065530|101201155|FG002|NOT COMPLETED|Overall Study||1||
48356134|NCT03065530|101201156|FG003|NOT COMPLETED|Overall Study||2||
48356135|NCT03983941|101201157|FG000|STARTED|Overall Study||2||
48356136|NCT03983941|101201158|FG001|STARTED|Overall Study||5||
48356137|NCT03983941|101201157|FG000|COMPLETED|Overall Study||2||
48356138|NCT03983941|101201158|FG001|COMPLETED|Overall Study||5||
48356139|NCT03983941|101201157|FG000|NOT COMPLETED|Overall Study||0||
48418582|NCT00758394|101361481|FG000|NOT COMPLETED|2nd Intervention Order||0||
48356140|NCT03983941|101201158|FG001|NOT COMPLETED|Overall Study||0||
48356141|NCT03497689|101201159|FG000|STARTED|Overall Study||35||
48356142|NCT03497689|101201159|FG000|COMPLETED|Overall Study||28||
48356143|NCT03497689|101201159|FG000|NOT COMPLETED|Overall Study||7||
48356144|NCT03187379|101201160|FG000|STARTED|Overall Study||50||
48356145|NCT03187379|101201161|FG001|STARTED|Overall Study||52||
48356146|NCT03187379|101201160|FG000|COMPLETED|Overall Study||50||
48356147|NCT03187379|101201161|FG001|COMPLETED|Overall Study||52||
48356148|NCT03187379|101201160|FG000|NOT COMPLETED|Overall Study||0||
48356149|NCT03187379|101201161|FG001|NOT COMPLETED|Overall Study||0||
48356150|NCT03443024|101201162|FG000|STARTED|Overall Study||73||
48356151|NCT03443024|101201163|FG001|STARTED|Overall Study||80||
48356152|NCT03443024|101201164|FG002|STARTED|Overall Study||75||
48356153|NCT03443024|101201165|FG003|STARTED|Overall Study||52||
48356154|NCT03443024|101201162|FG000|Received at Least One Dose of Study Drug|Overall Study||73||
48356155|NCT03443024|101201163|FG001|Received at Least One Dose of Study Drug|Overall Study||80||
48356156|NCT03443024|101201164|FG002|Received at Least One Dose of Study Drug|Overall Study||75||
48356157|NCT03443024|101201165|FG003|Received at Least One Dose of Study Drug|Overall Study||52||
48356158|NCT03443024|101201162|FG000|COMPLETED|Overall Study||52||
48356159|NCT03443024|101201163|FG001|COMPLETED|Overall Study||49||
48356160|NCT03443024|101201164|FG002|COMPLETED|Overall Study||56||
48356161|NCT03443024|101201165|FG003|COMPLETED|Overall Study||20||
48356162|NCT03443024|101201162|FG000|NOT COMPLETED|Overall Study||21||
48356163|NCT03443024|101201163|FG001|NOT COMPLETED|Overall Study||31||
48356164|NCT03443024|101201164|FG002|NOT COMPLETED|Overall Study||19||
48356165|NCT03443024|101201165|FG003|NOT COMPLETED|Overall Study||32||
48356166|NCT04538950|101201166|FG000|STARTED|Overall Study||6||
48356167|NCT04538950|101201166|FG000|COMPLETED|Overall Study||2||
48356168|NCT04538950|101201166|FG000|NOT COMPLETED|Overall Study||4||
48356169|NCT03694522|101201167|FG000|STARTED|Overall Study||77||
48356170|NCT03694522|101201168|FG001|STARTED|Overall Study||78||
48356171|NCT03694522|101201167|FG000|Received Any Study Treatment|Overall Study||76||
48356172|NCT03694522|101201168|FG001|Received Any Study Treatment|Overall Study||77||
48356173|NCT03694522|101201167|FG000|COMPLETED|Overall Study||15||
48356174|NCT03694522|101201168|FG001|COMPLETED|Overall Study||12||
48356175|NCT03694522|101201167|FG000|NOT COMPLETED|Overall Study||62||
48356176|NCT03694522|101201168|FG001|NOT COMPLETED|Overall Study||66||
48356177|NCT04429932|101201169|FG000|STARTED|Overall Study||4||
48356178|NCT04429932|101201170|FG001|STARTED|Overall Study||5||
48356179|NCT04429932|101201171|FG002|STARTED|Overall Study||5||
48418583|NCT00758394|101361482|FG001|NOT COMPLETED|2nd Intervention Order||1||
48356180|NCT04429932|101201172|FG003|STARTED|Overall Study||5||
48356181|NCT04429932|101201173|FG004|STARTED|Overall Study||5||
48356182|NCT04429932|101201174|FG005|STARTED|Overall Study||5||
48356183|NCT04429932|101201175|FG006|STARTED|Overall Study||5||
48356184|NCT04429932|101201176|FG007|STARTED|Overall Study||5||
48356185|NCT04429932|101201169|FG000|COMPLETED|Overall Study||3||
48356186|NCT04429932|101201170|FG001|COMPLETED|Overall Study||5||
48356187|NCT04429932|101201171|FG002|COMPLETED|Overall Study||5||
48356188|NCT04429932|101201172|FG003|COMPLETED|Overall Study||2||
48356189|NCT04429932|101201173|FG004|COMPLETED|Overall Study||5||
48356190|NCT04429932|101201174|FG005|COMPLETED|Overall Study||5||
48356191|NCT04429932|101201175|FG006|COMPLETED|Overall Study||5||
48356192|NCT04429932|101201176|FG007|COMPLETED|Overall Study||5||
48356193|NCT04429932|101201169|FG000|NOT COMPLETED|Overall Study||1||
48439978|NCT01728376|101410000|FG005|COMPLETED|Overall Study||5||
48762630|NCT03435211|102206071|FG000|COMPLETED|Overall Study||25||
48356194|NCT04429932|101201170|FG001|NOT COMPLETED|Overall Study||0||
48356195|NCT04429932|101201171|FG002|NOT COMPLETED|Overall Study||0||
48356196|NCT04429932|101201172|FG003|NOT COMPLETED|Overall Study||3||
48356197|NCT04429932|101201173|FG004|NOT COMPLETED|Overall Study||0||
48356198|NCT04429932|101201174|FG005|NOT COMPLETED|Overall Study||0||
48356199|NCT04429932|101201175|FG006|NOT COMPLETED|Overall Study||0||
48356200|NCT04429932|101201176|FG007|NOT COMPLETED|Overall Study||0||
48356201|NCT01495819|101201177|FG000|STARTED|Overall Study||34||
48356202|NCT01495819|101201177|FG000|Nicotine 0.0125|Overall Study||31||
48356203|NCT01495819|101201177|FG000|Nicotine 0.025|Overall Study||32||
48356204|NCT01495819|101201177|FG000|Nicotine 0.05|Overall Study||33||
48356205|NCT01495819|101201177|FG000|Nicotine 0.1|Overall Study||31||
48356206|NCT01495819|101201177|FG000|NIcotine 0.2|Overall Study||33||
48356207|NCT01495819|101201177|FG000|COMPLETED|Overall Study||30||
48356208|NCT01495819|101201177|FG000|NOT COMPLETED|Overall Study||4||
48356209|NCT04332419|101201178|FG000|STARTED|Overall Study||11||
48356210|NCT04332419|101201178|FG000|COMPLETED|Overall Study||10||
48356211|NCT04332419|101201178|FG000|NOT COMPLETED|Overall Study||1||
48356212|NCT00624338|101201179|FG000|STARTED|Overall Study||159||
48356213|NCT00624338|101201180|FG001|STARTED|Overall Study||145||
48356214|NCT00624338|101201181|FG002|STARTED|Overall Study||157||
48356215|NCT00624338|101201179|FG000|Treated|Overall Study||157||
48356216|NCT00624338|101201180|FG001|Treated|Overall Study||144||
48356217|NCT00624338|101201181|FG002|Treated|Overall Study||154||
48356218|NCT00624338|101201179|FG000|COMPLETED|Overall Study||112||
48356219|NCT00624338|101201180|FG001|COMPLETED|Overall Study||62||
48356220|NCT00624338|101201181|FG002|COMPLETED|Overall Study||111||
48418584|NCT00758394|101361483|FG002|NOT COMPLETED|2nd Intervention Order||0||
48418585|NCT00758394|101361484|FG003|NOT COMPLETED|2nd Intervention Order||0||
48418586|NCT00758394|101361481|FG000|STARTED|Washout After 2nd Intervention||8||
48418587|NCT00758394|101361482|FG001|STARTED|Washout After 2nd Intervention||6||
48418588|NCT00758394|101361483|FG002|STARTED|Washout After 2nd Intervention||6||
48418589|NCT00758394|101361484|FG003|STARTED|Washout After 2nd Intervention||8||
48418590|NCT00758394|101361481|FG000|COMPLETED|Washout After 2nd Intervention||8||
48418591|NCT00758394|101361482|FG001|COMPLETED|Washout After 2nd Intervention||6||
48418592|NCT00758394|101361483|FG002|COMPLETED|Washout After 2nd Intervention||6||
48418593|NCT00758394|101361484|FG003|COMPLETED|Washout After 2nd Intervention||8||
48418594|NCT00758394|101361481|FG000|NOT COMPLETED|Washout After 2nd Intervention||0||
48418595|NCT00758394|101361482|FG001|NOT COMPLETED|Washout After 2nd Intervention||0||
48762631|NCT03435211|102206071|FG000|NOT COMPLETED|Overall Study||1||
48762632|NCT04359810|102206072|FG000|STARTED|Overall Study||150||
48762633|NCT04359810|102206073|FG001|STARTED|Overall Study||73||
48356221|NCT00624338|101201179|FG000|NOT COMPLETED|Overall Study||47||
48356222|NCT00624338|101201180|FG001|NOT COMPLETED|Overall Study||83||
48356223|NCT00624338|101201181|FG002|NOT COMPLETED|Overall Study||46||
48356224|NCT01901328|101201182|FG000|STARTED|Overall Study||26||
48356225|NCT01901328|101201183|FG001|STARTED|Overall Study||23||
48356226|NCT01901328|101201182|FG000|Received at Least 1 Dose of Study Drug|Overall Study||26||
48356227|NCT01901328|101201183|FG001|Received at Least 1 Dose of Study Drug|Overall Study||23||
48356228|NCT01901328|101201182|FG000|COMPLETED|Overall Study||4||
48356229|NCT01901328|101201183|FG001|COMPLETED|Overall Study||2||
48356230|NCT01901328|101201182|FG000|NOT COMPLETED|Overall Study||22||
48356231|NCT01901328|101201183|FG001|NOT COMPLETED|Overall Study||21||
48356232|NCT03118843|101201184|FG000|STARTED|Overall Study||31||
48356233|NCT03118843|101201184|FG000|COMPLETED|Overall Study||31||
48356234|NCT03118843|101201184|FG000|NOT COMPLETED|Overall Study||0||
48356235|NCT03004846|101201185|FG000|STARTED|Part A (Up to 14 Weeks)||8||
48356236|NCT03004846|101201186|FG001|STARTED|Part A (Up to 14 Weeks)||0||
48356237|NCT03004846|101201187|FG002|STARTED|Part A (Up to 14 Weeks)||0||
48418596|NCT00758394|101361483|FG002|NOT COMPLETED|Washout After 2nd Intervention||0||
48418597|NCT00758394|101361484|FG003|NOT COMPLETED|Washout After 2nd Intervention||0||
48356238|NCT03004846|101201185|FG000|COMPLETED|Part A (Up to 14 Weeks)||8||
48356239|NCT03004846|101201186|FG001|COMPLETED|Part A (Up to 14 Weeks)||0||
48356240|NCT03004846|101201187|FG002|COMPLETED|Part A (Up to 14 Weeks)||0||
48356241|NCT03004846|101201185|FG000|NOT COMPLETED|Part A (Up to 14 Weeks)||0||
48356242|NCT03004846|101201186|FG001|NOT COMPLETED|Part A (Up to 14 Weeks)||0||
48356243|NCT03004846|101201187|FG002|NOT COMPLETED|Part A (Up to 14 Weeks)||0||
48356244|NCT03004846|101201185|FG000|STARTED|Part B (Up to 14 Weeks)||0||
48356245|NCT03004846|101201186|FG001|STARTED|Part B (Up to 14 Weeks)||0||
48356246|NCT03004846|101201187|FG002|STARTED|Part B (Up to 14 Weeks)||0||
48356247|NCT03004846|101201185|FG000|COMPLETED|Part B (Up to 14 Weeks)||0||
48356248|NCT03004846|101201186|FG001|COMPLETED|Part B (Up to 14 Weeks)||0||
48356249|NCT03004846|101201187|FG002|COMPLETED|Part B (Up to 14 Weeks)||0||
48356250|NCT03004846|101201185|FG000|NOT COMPLETED|Part B (Up to 14 Weeks)||0||
48356251|NCT03004846|101201186|FG001|NOT COMPLETED|Part B (Up to 14 Weeks)||0||
48356252|NCT03004846|101201187|FG002|NOT COMPLETED|Part B (Up to 14 Weeks)||0||
48356253|NCT01845077|101201188|FG000|STARTED|Treatment Period 1||12||
48356254|NCT01845077|101201189|FG001|STARTED|Treatment Period 1||12||
48418598|NCT00758394|101361481|FG000|STARTED|3rd Intervention||8||
48762634|NCT04359810|102206072|FG000|COMPLETED|Overall Study||150||
48762635|NCT04359810|102206073|FG001|COMPLETED|Overall Study||73||
48762636|NCT04359810|102206072|FG000|NOT COMPLETED|Overall Study||0||
48762637|NCT04359810|102206073|FG001|NOT COMPLETED|Overall Study||0||
48356255|NCT01845077|101201190|FG002|STARTED|Treatment Period 1||12||
48356256|NCT01845077|101201191|FG003|STARTED|Treatment Period 1||12||
48356257|NCT01845077|101201192|FG004|STARTED|Treatment Period 1||12||
48356258|NCT01845077|101201193|FG005|STARTED|Treatment Period 1||12||
48356259|NCT01845077|101201188|FG000|COMPLETED|Treatment Period 1||12||
48356260|NCT01845077|101201189|FG001|COMPLETED|Treatment Period 1||12||
48356261|NCT01845077|101201190|FG002|COMPLETED|Treatment Period 1||12||
48356262|NCT01845077|101201191|FG003|COMPLETED|Treatment Period 1||12||
48356263|NCT01845077|101201192|FG004|COMPLETED|Treatment Period 1||12||
48356264|NCT01845077|101201193|FG005|COMPLETED|Treatment Period 1||12||
48356265|NCT01845077|101201188|FG000|NOT COMPLETED|Treatment Period 1||0||
48356266|NCT01845077|101201189|FG001|NOT COMPLETED|Treatment Period 1||0||
48356267|NCT01845077|101201190|FG002|NOT COMPLETED|Treatment Period 1||0||
48356268|NCT01845077|101201191|FG003|NOT COMPLETED|Treatment Period 1||0||
48356269|NCT01845077|101201192|FG004|NOT COMPLETED|Treatment Period 1||0||
48356270|NCT01845077|101201193|FG005|NOT COMPLETED|Treatment Period 1||0||
48356271|NCT01845077|101201188|FG000|STARTED|Washout Period||12||
48418599|NCT00758394|101361482|FG001|STARTED|3rd Intervention||6||
48418600|NCT00758394|101361483|FG002|STARTED|3rd Intervention||6||
48418601|NCT00758394|101361484|FG003|STARTED|3rd Intervention||8||
48762638|NCT04298697|102206074|FG000|STARTED|Overall Study||15||
48762639|NCT04298697|102206075|FG001|STARTED|Overall Study||17||
48762640|NCT04298697|102206076|FG002|STARTED|Overall Study||6||
48356272|NCT01845077|101201189|FG001|STARTED|Washout Period||12||
48356273|NCT01845077|101201190|FG002|STARTED|Washout Period||12||
48356274|NCT01845077|101201191|FG003|STARTED|Washout Period||12||
48356275|NCT01845077|101201192|FG004|STARTED|Washout Period||12||
48356276|NCT01845077|101201193|FG005|STARTED|Washout Period||12||
48356277|NCT01845077|101201188|FG000|COMPLETED|Washout Period||11||
48356278|NCT01845077|101201189|FG001|COMPLETED|Washout Period||11||
48356279|NCT01845077|101201190|FG002|COMPLETED|Washout Period||11||
48356280|NCT01845077|101201191|FG003|COMPLETED|Washout Period||10||
48356281|NCT01845077|101201192|FG004|COMPLETED|Washout Period||11||
48356282|NCT01845077|101201193|FG005|COMPLETED|Washout Period||11||
48356283|NCT01845077|101201188|FG000|NOT COMPLETED|Washout Period||1||
48356284|NCT01845077|101201189|FG001|NOT COMPLETED|Washout Period||1||
48356285|NCT01845077|101201190|FG002|NOT COMPLETED|Washout Period||1||
48356286|NCT01845077|101201191|FG003|NOT COMPLETED|Washout Period||2||
48356287|NCT01845077|101201192|FG004|NOT COMPLETED|Washout Period||1||
48356288|NCT01845077|101201193|FG005|NOT COMPLETED|Washout Period||1||
48356289|NCT01845077|101201188|FG000|STARTED|Treatment Period 2||11||
48356290|NCT01845077|101201189|FG001|STARTED|Treatment Period 2||11||
48356291|NCT01845077|101201190|FG002|STARTED|Treatment Period 2||11||
48356292|NCT01845077|101201191|FG003|STARTED|Treatment Period 2||10||
48356293|NCT01845077|101201192|FG004|STARTED|Treatment Period 2||11||
48356294|NCT01845077|101201193|FG005|STARTED|Treatment Period 2||11||
48356295|NCT01845077|101201188|FG000|COMPLETED|Treatment Period 2||11||
48356296|NCT01845077|101201189|FG001|COMPLETED|Treatment Period 2||11||
48356297|NCT01845077|101201190|FG002|COMPLETED|Treatment Period 2||11||
48356298|NCT01845077|101201191|FG003|COMPLETED|Treatment Period 2||10||
48356299|NCT01845077|101201192|FG004|COMPLETED|Treatment Period 2||11||
48356300|NCT01845077|101201193|FG005|COMPLETED|Treatment Period 2||11||
48356301|NCT01845077|101201188|FG000|NOT COMPLETED|Treatment Period 2||0||
48356302|NCT01845077|101201189|FG001|NOT COMPLETED|Treatment Period 2||0||
48356303|NCT01845077|101201190|FG002|NOT COMPLETED|Treatment Period 2||0||
48356304|NCT01845077|101201191|FG003|NOT COMPLETED|Treatment Period 2||0||
48356305|NCT01845077|101201192|FG004|NOT COMPLETED|Treatment Period 2||0||
48356306|NCT01845077|101201193|FG005|NOT COMPLETED|Treatment Period 2||0||
48356307|NCT00206518|101201194|FG000|STARTED|Overall Study||83||
48356308|NCT00206518|101201195|FG001|STARTED|Overall Study||84||
48356309|NCT00206518|101201194|FG000|COMPLETED|Overall Study||73||
48356310|NCT00206518|101201195|FG001|COMPLETED|Overall Study||78||
48356311|NCT00206518|101201194|FG000|NOT COMPLETED|Overall Study||10||
48356312|NCT00206518|101201195|FG001|NOT COMPLETED|Overall Study||6||
48356313|NCT02190591|101201196|FG000|STARTED|Overall Study||102||
48356314|NCT02190591|101201197|FG001|STARTED|Overall Study||102||
48356315|NCT02190591|101201196|FG000|COMPLETED|Overall Study||100||
48356316|NCT02190591|101201197|FG001|COMPLETED|Overall Study||91||
48356317|NCT02190591|101201196|FG000|NOT COMPLETED|Overall Study||2||
48762641|NCT04298697|102206077|FG003|STARTED|Overall Study||5||
48762642|NCT04298697|102206074|FG000|COMPLETED|Overall Study||10|Attended the study visit occurring 24 hours post-final dose of study medication.|
48762643|NCT04298697|102206075|FG001|COMPLETED|Overall Study||9|Attended the study visit occurring 24 hours post-final dose of study medication.|
48762644|NCT04298697|102206076|FG002|COMPLETED|Overall Study||3|Attended the study visit occurring 24 hours post-final dose of study medication.|
48762645|NCT04298697|102206077|FG003|COMPLETED|Overall Study||2|Attended the study visit occurring 24 hours post-final dose of study medication.|
48762646|NCT04298697|102206074|FG000|NOT COMPLETED|Overall Study||5||
48762647|NCT04298697|102206075|FG001|NOT COMPLETED|Overall Study||8||
48762648|NCT04298697|102206076|FG002|NOT COMPLETED|Overall Study||3||
48356318|NCT02190591|101201197|FG001|NOT COMPLETED|Overall Study||11||
48356319|NCT00196937|101201198|FG000|STARTED|Overall Study||229||
48356320|NCT00196937|101201199|FG001|STARTED|Overall Study||226||
48356321|NCT00196937|101201200|FG002|STARTED|Overall Study||211||
48356322|NCT00196937|101201198|FG000|COMPLETED|Overall Study||220||
48356323|NCT00196937|101201199|FG001|COMPLETED|Overall Study||221||
48356324|NCT00196937|101201200|FG002|COMPLETED|Overall Study||204||
48418602|NCT00758394|101361481|FG000|COMPLETED|3rd Intervention||7||
48418603|NCT00758394|101361482|FG001|COMPLETED|3rd Intervention||6||
48418604|NCT00758394|101361483|FG002|COMPLETED|3rd Intervention||6||
48418605|NCT00758394|101361484|FG003|COMPLETED|3rd Intervention||7||
48418606|NCT00758394|101361481|FG000|NOT COMPLETED|3rd Intervention||1||
48418607|NCT00758394|101361482|FG001|NOT COMPLETED|3rd Intervention||0||
48418608|NCT00758394|101361483|FG002|NOT COMPLETED|3rd Intervention||0||
48418609|NCT00758394|101361484|FG003|NOT COMPLETED|3rd Intervention||1||
48418610|NCT00758394|101361481|FG000|STARTED|Washout After 3rd Intervention||7||
48418611|NCT00758394|101361482|FG001|STARTED|Washout After 3rd Intervention||6||
48418612|NCT00758394|101361483|FG002|STARTED|Washout After 3rd Intervention||6||
48418613|NCT00758394|101361484|FG003|STARTED|Washout After 3rd Intervention||7||
48418614|NCT00758394|101361481|FG000|COMPLETED|Washout After 3rd Intervention||7||
48418615|NCT00758394|101361482|FG001|COMPLETED|Washout After 3rd Intervention||6||
48418616|NCT00758394|101361483|FG002|COMPLETED|Washout After 3rd Intervention||6||
48418617|NCT00758394|101361484|FG003|COMPLETED|Washout After 3rd Intervention||7||
48418618|NCT00758394|101361481|FG000|NOT COMPLETED|Washout After 3rd Intervention||0||
48418619|NCT00758394|101361482|FG001|NOT COMPLETED|Washout After 3rd Intervention||0||
48418620|NCT00758394|101361483|FG002|NOT COMPLETED|Washout After 3rd Intervention||0||
48418621|NCT00758394|101361484|FG003|NOT COMPLETED|Washout After 3rd Intervention||0||
48418622|NCT00758394|101361481|FG000|STARTED|4th Intervention||7||
48418623|NCT00758394|101361482|FG001|STARTED|4th Intervention||6||
48418624|NCT00758394|101361483|FG002|STARTED|4th Intervention||6||
48418625|NCT00758394|101361484|FG003|STARTED|4th Intervention||7||
48418626|NCT00758394|101361481|FG000|COMPLETED|4th Intervention||7||
48762649|NCT04298697|102206077|FG003|NOT COMPLETED|Overall Study||3||
48762650|NCT03645122|102206078|FG000|STARTED|Overall Study||3||
48762651|NCT03645122|102206079|FG001|STARTED|Overall Study||3||
48762652|NCT03645122|102206080|FG002|STARTED|Overall Study||4||
48762653|NCT03645122|102206081|FG003|STARTED|Overall Study||5||
48356325|NCT00196937|101201198|FG000|NOT COMPLETED|Overall Study||9||
48356326|NCT00196937|101201199|FG001|NOT COMPLETED|Overall Study||5||
48356327|NCT00196937|101201200|FG002|NOT COMPLETED|Overall Study||7||
48356328|NCT02981472|101201201|FG000|STARTED|Pre-Treatment Period||129||
48356329|NCT02981472|101201202|FG001|STARTED|Pre-Treatment Period||63||
48356330|NCT02981472|101201201|FG000|COMPLETED|Pre-Treatment Period||126||
48356331|NCT02981472|101201202|FG001|COMPLETED|Pre-Treatment Period||62||
48356332|NCT02981472|101201201|FG000|NOT COMPLETED|Pre-Treatment Period||3||
48356333|NCT02981472|101201202|FG001|NOT COMPLETED|Pre-Treatment Period||1||
48356334|NCT02981472|101201201|FG000|STARTED|Treatment Period||126||
48356335|NCT02981472|101201202|FG001|STARTED|Treatment Period||62||
48356336|NCT02981472|101201201|FG000|COMPLETED|Treatment Period||119|completed treatment for up to 12 months or until anticoagulation is no longer needed, whichever is shorter|
48356337|NCT02981472|101201202|FG001|COMPLETED|Treatment Period||60|completed treatment for up to 12 months or until anticoagulation is no longer needed, whichever is shorter|
48356338|NCT02981472|101201201|FG000|NOT COMPLETED|Treatment Period||7||
48356339|NCT02981472|101201202|FG001|NOT COMPLETED|Treatment Period||2||
48356340|NCT00377962|101201203|FG000|STARTED|Core Study: 0-12 Months||140||
48356341|NCT00377962|101201204|FG001|STARTED|Core Study: 0-12 Months||142||
48356342|NCT00377962|101201203|FG000|COMPLETED|Core Study: 0-12 Months||112||
48356343|NCT00377962|101201204|FG001|COMPLETED|Core Study: 0-12 Months||133||
48356344|NCT00377962|101201203|FG000|NOT COMPLETED|Core Study: 0-12 Months||28||
48356345|NCT00377962|101201204|FG001|NOT COMPLETED|Core Study: 0-12 Months||9||
48356346|NCT00377962|101201203|FG000|STARTED|Extension Study: 12-24 Months||108||
48356347|NCT00377962|101201204|FG001|STARTED|Extension Study: 12-24 Months||127||
48356348|NCT00377962|101201203|FG000|COMPLETED|Extension Study: 12-24 Months||98||
48356349|NCT00377962|101201204|FG001|COMPLETED|Extension Study: 12-24 Months||123||
48356350|NCT00377962|101201203|FG000|NOT COMPLETED|Extension Study: 12-24 Months||10||
48356351|NCT00377962|101201204|FG001|NOT COMPLETED|Extension Study: 12-24 Months||4||
48356352|NCT02124798|101201205|FG000|STARTED|Overall Study||95||
48356353|NCT02124798|101201205|FG000|COMPLETED|Overall Study||91||
48356354|NCT02124798|101201205|FG000|NOT COMPLETED|Overall Study||4||
48356355|NCT01532453|101201206|FG000|STARTED|Overall Study||81||
48356356|NCT01532453|101201207|FG001|STARTED|Overall Study||160||
48356357|NCT01532453|101201206|FG000|COMPLETED|Overall Study||54||
48356358|NCT01532453|101201207|FG001|COMPLETED|Overall Study||90||
48418627|NCT00758394|101361482|FG001|COMPLETED|4th Intervention||6||
48418628|NCT00758394|101361483|FG002|COMPLETED|4th Intervention||6||
48418629|NCT00758394|101361484|FG003|COMPLETED|4th Intervention||7||
48418630|NCT00758394|101361481|FG000|NOT COMPLETED|4th Intervention||0||
48418631|NCT00758394|101361482|FG001|NOT COMPLETED|4th Intervention||0||
48762654|NCT03645122|102206082|FG004|STARTED|Overall Study||4||
48762655|NCT03645122|102206083|FG005|STARTED|Overall Study||4||
48762656|NCT03645122|102206078|FG000|COMPLETED|Overall Study||3||
48356359|NCT01532453|101201206|FG000|NOT COMPLETED|Overall Study||27||
48356360|NCT01532453|101201207|FG001|NOT COMPLETED|Overall Study||70||
48356361|NCT01926886|101201208|FG000|STARTED|Overall Study||102||
48356362|NCT01926886|101201209|FG001|STARTED|Overall Study||21||
48356363|NCT01926886|101201208|FG000|Received at Least 1 Dose of Study Drug|Overall Study||101||
48356364|NCT01926886|101201209|FG001|Received at Least 1 Dose of Study Drug|Overall Study||0||
48356365|NCT01926886|101201208|FG000|COMPLETED|Overall Study||70||
48356366|NCT01926886|101201209|FG001|COMPLETED|Overall Study||21||
48356367|NCT01926886|101201208|FG000|NOT COMPLETED|Overall Study||32||
48356368|NCT01926886|101201209|FG001|NOT COMPLETED|Overall Study||0||
48418632|NCT00758394|101361483|FG002|NOT COMPLETED|4th Intervention||0||
48418633|NCT00758394|101361484|FG003|NOT COMPLETED|4th Intervention||0||
48418634|NCT02576951|101361485|FG000|STARTED|Overall Study||15||
48418635|NCT02576951|101361486|FG001|STARTED|Overall Study||3||
48638543|NCT03188185|101898782|FG000|STARTED|Stage 1||198||
48638544|NCT03188185|101898783|FG001|STARTED|Stage 1||80||
48356369|NCT01707147|101201210|FG000|STARTED|Overall Study||3219|Number of patients in case report form (CRF) collection|
48356370|NCT01707147|101201210|FG000|COMPLETED|Overall Study||3119|Number of patients in safety analysis set|
48356371|NCT01707147|101201210|FG000|NOT COMPLETED|Overall Study||100||
48356372|NCT00066781|101201211|FG000|STARTED|Overall Study||14||
48356373|NCT00066781|101201212|FG001|STARTED|Overall Study||17||
48638545|NCT03188185|101898784|FG002|STARTED|Stage 1||0||
48638546|NCT03188185|101898785|FG003|STARTED|Stage 1||0||
48638547|NCT03188185|101898782|FG000|COMPLETED|Stage 1||179||
48638548|NCT03188185|101898783|FG001|COMPLETED|Stage 1||64||
48638549|NCT03188185|101898784|FG002|COMPLETED|Stage 1||0||
48638550|NCT03188185|101898785|FG003|COMPLETED|Stage 1||0||
48638551|NCT03188185|101898782|FG000|NOT COMPLETED|Stage 1||19||
48638552|NCT03188185|101898783|FG001|NOT COMPLETED|Stage 1||16||
48638553|NCT03188185|101898784|FG002|NOT COMPLETED|Stage 1||0||
48638554|NCT03188185|101898785|FG003|NOT COMPLETED|Stage 1||0||
48356374|NCT00066781|101201211|FG000|COMPLETED|Overall Study||14||
48356375|NCT00066781|101201212|FG001|COMPLETED|Overall Study||17||
48356376|NCT00066781|101201211|FG000|NOT COMPLETED|Overall Study||0||
48356377|NCT00066781|101201212|FG001|NOT COMPLETED|Overall Study||0||
48356378|NCT00654927|101201213|FG000|STARTED|Overall Study||177||
48356379|NCT00654927|101201213|FG000|COMPLETED|Overall Study||70||
48356380|NCT00654927|101201213|FG000|NOT COMPLETED|Overall Study||107||
48356381|NCT03767738|101201214|FG000|STARTED|Overall Study||35||35
48356382|NCT03767738|101201215|FG001|STARTED|Overall Study||30||30
48356383|NCT03767738|101201214|FG000|COMPLETED|Overall Study||35||35
48356384|NCT03767738|101201215|FG001|COMPLETED|Overall Study||30||30
48356385|NCT03767738|101201214|FG000|NOT COMPLETED|Overall Study||0||0
48356386|NCT03767738|101201215|FG001|NOT COMPLETED|Overall Study||0||0
48356387|NCT00793585|101201216|FG000|STARTED|Overall Study||19||
48356388|NCT00793585|101201217|FG001|STARTED|Overall Study||21||
48356389|NCT00793585|101201216|FG000|COMPLETED|Overall Study||17||
48356390|NCT00793585|101201217|FG001|COMPLETED|Overall Study||18||
48356391|NCT00793585|101201216|FG000|NOT COMPLETED|Overall Study||2||
48356392|NCT00793585|101201217|FG001|NOT COMPLETED|Overall Study||3||
48356393|NCT02357992|101201218|FG000|STARTED|Overall Study||36||
48356394|NCT02357992|101201219|FG001|STARTED|Overall Study||80||
48356395|NCT02357992|101201218|FG000|COMPLETED|Overall Study||36||
48356396|NCT02357992|101201219|FG001|COMPLETED|Overall Study||80||
48356397|NCT02357992|101201218|FG000|NOT COMPLETED|Overall Study||0||
48356398|NCT02357992|101201219|FG001|NOT COMPLETED|Overall Study||0||
48356399|NCT03665155|101201220|FG000|STARTED|Overall Study||3||
48418636|NCT02576951|101361487|FG002|STARTED|Overall Study||80||
48418637|NCT02576951|101361488|FG003|STARTED|Overall Study||80||
48356400|NCT03665155|101201221|FG001|STARTED|Overall Study||7||
48356401|NCT03665155|101201222|FG002|STARTED|Overall Study||1||
48356402|NCT03665155|101201220|FG000|COMPLETED|Overall Study||3||
48356403|NCT03665155|101201221|FG001|COMPLETED|Overall Study||7||
48356404|NCT03665155|101201222|FG002|COMPLETED|Overall Study||1||
48356405|NCT03665155|101201220|FG000|NOT COMPLETED|Overall Study||0||
48356406|NCT03665155|101201221|FG001|NOT COMPLETED|Overall Study||0||
48356407|NCT03665155|101201222|FG002|NOT COMPLETED|Overall Study||0||
48356408|NCT04063761|101201223|FG000|STARTED|Overall Study||20||
48356409|NCT04063761|101201223|FG000|COMPLETED|Overall Study||20||
48356410|NCT04063761|101201223|FG000|NOT COMPLETED|Overall Study||0||
48356411|NCT05370157|101201224|FG000|STARTED|Participants Entering at Baseline||100||4
48356412|NCT05370157|101201225|FG001|STARTED|Participants Entering at Baseline||50||2
48356413|NCT05370157|101201224|FG000|Completed Baseline|Participants Entering at Baseline||87||4
48356414|NCT05370157|101201225|FG001|Completed Baseline|Participants Entering at Baseline||48||2
48356415|NCT05370157|101201224|FG000|Started Followup|Participants Entering at Baseline||83||4
48418638|NCT02576951|101361485|FG000|Received at Least One Dose of Study Drug|Overall Study||15||
48638555|NCT03188185|101898782|FG000|STARTED|Stage 2||0||
48638556|NCT03188185|101898783|FG001|STARTED|Stage 2||0||
48638557|NCT03188185|101898784|FG002|STARTED|Stage 2||64||
48356416|NCT05370157|101201225|FG001|Started Followup|Participants Entering at Baseline||46||2
48356417|NCT05370157|101201224|FG000|COMPLETED|Participants Entering at Baseline||72||4
48356418|NCT05370157|101201225|FG001|COMPLETED|Participants Entering at Baseline||35||2
48356419|NCT05370157|101201224|FG000|NOT COMPLETED|Participants Entering at Baseline||28||0
48356420|NCT05370157|101201225|FG001|NOT COMPLETED|Participants Entering at Baseline||15||0
48356421|NCT05370157|101201224|FG000|STARTED|Participants Entering at Follow-Up||17|Participants who were not part of the team at baseline. All new participants were affiliated with participating Children's Advocacy Centers; no centers entered at follow-up.|4
48356422|NCT05370157|101201225|FG001|STARTED|Participants Entering at Follow-Up||5|Participants who were not part of the team at baseline. All new participants were affiliated with participating Children's Advocacy Centers; no centers entered at follow-up.|2
48356423|NCT05370157|101201224|FG000|COMPLETED|Participants Entering at Follow-Up||17||4
48356424|NCT05370157|101201225|FG001|COMPLETED|Participants Entering at Follow-Up||5||2
48356425|NCT05370157|101201224|FG000|NOT COMPLETED|Participants Entering at Follow-Up||0||0
48356426|NCT05370157|101201225|FG001|NOT COMPLETED|Participants Entering at Follow-Up||0||0
48356427|NCT01521845|101201226|FG000|STARTED|Overall Study||52||
48356428|NCT01521845|101201227|FG001|STARTED|Overall Study||52||
48418639|NCT02576951|101361486|FG001|Received at Least One Dose of Study Drug|Overall Study||3||
48418640|NCT02576951|101361487|FG002|Received at Least One Dose of Study Drug|Overall Study||80||
48418641|NCT02576951|101361488|FG003|Received at Least One Dose of Study Drug|Overall Study||80||
48418642|NCT02576951|101361485|FG000|COMPLETED|Overall Study||14||
48418643|NCT02576951|101361486|FG001|COMPLETED|Overall Study||3||
48418644|NCT02576951|101361487|FG002|COMPLETED|Overall Study||78||
48418645|NCT02576951|101361488|FG003|COMPLETED|Overall Study||75||
48418646|NCT02576951|101361485|FG000|NOT COMPLETED|Overall Study||1||
48418647|NCT02576951|101361486|FG001|NOT COMPLETED|Overall Study||0||
48418648|NCT02576951|101361487|FG002|NOT COMPLETED|Overall Study||2||
48418649|NCT02576951|101361488|FG003|NOT COMPLETED|Overall Study||5||
48638558|NCT03188185|101898785|FG003|STARTED|Stage 2||63||
48638559|NCT03188185|101898782|FG000|COMPLETED|Stage 2||0||
48638560|NCT03188185|101898783|FG001|COMPLETED|Stage 2||0||
48638561|NCT03188185|101898784|FG002|COMPLETED|Stage 2||55||
48638562|NCT03188185|101898785|FG003|COMPLETED|Stage 2||57||
48638563|NCT03188185|101898782|FG000|NOT COMPLETED|Stage 2||0||
48638564|NCT03188185|101898783|FG001|NOT COMPLETED|Stage 2||0||
48638565|NCT03188185|101898784|FG002|NOT COMPLETED|Stage 2||9||
48638566|NCT03188185|101898785|FG003|NOT COMPLETED|Stage 2||6||
48638567|NCT00141921|101898786|FG000|STARTED|Overall Study||182||
48638568|NCT00141921|101898786|FG000|Received Treatment|Overall Study||181||
48638569|NCT00141921|101898786|FG000|COMPLETED|Overall Study||41||
48638570|NCT00141921|101898786|FG000|NOT COMPLETED|Overall Study||141||
48638571|NCT02700841|101898787|FG000|STARTED|Overall Study||4||
48638572|NCT02700841|101898788|FG001|STARTED|Overall Study||4||
48638573|NCT02700841|101898787|FG000|COMPLETED|Overall Study||4||
48356429|NCT01521845|101201226|FG000|COMPLETED|Overall Study||43||
48356430|NCT01521845|101201227|FG001|COMPLETED|Overall Study||47||
48356431|NCT01521845|101201226|FG000|NOT COMPLETED|Overall Study||9||
48356432|NCT01521845|101201227|FG001|NOT COMPLETED|Overall Study||5||
48356433|NCT01096667|101201228|FG000|STARTED|Overall Study||39||
48356434|NCT01096667|101201229|FG001|STARTED|Overall Study||39||
48356435|NCT01096667|101201230|FG002|STARTED|Overall Study||38||
48356436|NCT01096667|101201231|FG003|STARTED|Overall Study||39||
48356437|NCT01096667|101201232|FG004|STARTED|Overall Study||39||
48356438|NCT01096667|101201228|FG000|Treated|Overall Study||38||
48356439|NCT01096667|101201229|FG001|Treated|Overall Study||39||
48356440|NCT01096667|101201230|FG002|Treated|Overall Study||38||
48418650|NCT00303719|101361489|FG000|STARTED|Overall Study||13||
48418651|NCT00303719|101361490|FG001|STARTED|Overall Study||329||
48418652|NCT00303719|101361489|FG000|COMPLETED|Overall Study||13||
48418653|NCT00303719|101361490|FG001|COMPLETED|Overall Study||292||
48638574|NCT02700841|101898788|FG001|COMPLETED|Overall Study||4||
48638575|NCT02700841|101898787|FG000|NOT COMPLETED|Overall Study||0||
48638576|NCT02700841|101898788|FG001|NOT COMPLETED|Overall Study||0||
48638577|NCT03653741|101898789|FG000|STARTED|Overall Study||12||
48356441|NCT01096667|101201231|FG003|Treated|Overall Study||39||
48356442|NCT01096667|101201232|FG004|Treated|Overall Study||39||
48356443|NCT01096667|101201228|FG000|COMPLETED|Overall Study||36||
48356444|NCT01096667|101201229|FG001|COMPLETED|Overall Study||37||
48356445|NCT01096667|101201230|FG002|COMPLETED|Overall Study||36||
48356446|NCT01096667|101201231|FG003|COMPLETED|Overall Study||36||
48356447|NCT01096667|101201232|FG004|COMPLETED|Overall Study||39||
48356448|NCT01096667|101201228|FG000|NOT COMPLETED|Overall Study||3||
48356449|NCT01096667|101201229|FG001|NOT COMPLETED|Overall Study||2||
48356450|NCT01096667|101201230|FG002|NOT COMPLETED|Overall Study||2||
48356451|NCT01096667|101201231|FG003|NOT COMPLETED|Overall Study||3||
48356452|NCT01096667|101201232|FG004|NOT COMPLETED|Overall Study||0||
48356453|NCT02255838|101201233|FG000|STARTED|Overall Study||6||
48356454|NCT02255838|101201234|FG001|STARTED|Overall Study||6||
48418654|NCT00303719|101361489|FG000|NOT COMPLETED|Overall Study||0||
48418655|NCT00303719|101361490|FG001|NOT COMPLETED|Overall Study||37||
48638578|NCT03653741|101898789|FG000|COMPLETED|Overall Study||12||
48638579|NCT03653741|101898789|FG000|NOT COMPLETED|Overall Study||0||
48638580|NCT01104285|101898790|FG000|STARTED|Overall Study||112||
48356455|NCT02255838|101201233|FG000|COMPLETED|Overall Study||6||
48356456|NCT02255838|101201234|FG001|COMPLETED|Overall Study||6||
48356457|NCT02255838|101201233|FG000|NOT COMPLETED|Overall Study||0||
48356458|NCT02255838|101201234|FG001|NOT COMPLETED|Overall Study||0||
48356459|NCT03047005|101201235|FG000|STARTED|Overall Study||32||
48356460|NCT03047005|101201236|FG001|STARTED|Overall Study||34||
48356461|NCT03047005|101201235|FG000|COMPLETED|Overall Study||29||
48356462|NCT03047005|101201236|FG001|COMPLETED|Overall Study||28||
48356463|NCT03047005|101201235|FG000|NOT COMPLETED|Overall Study||3||
48356464|NCT03047005|101201236|FG001|NOT COMPLETED|Overall Study||6||
48356465|NCT02707757|101201237|FG000|STARTED|Overall Study||88|"This refers to the number of times to which a participant was allocated to each respective treatment.~A participant could be re-randomised 6 months following initial randomisation. Not all participants were randomised due to not meeting randomisation criteria."|
48356466|NCT02707757|101201238|FG001|STARTED|Overall Study||96|"This refers to the number of times to which a participant was allocated to each respective treatment.~A participant could be re-randomised 6 months following initial randomisation. Not all participants were randomised due to not meeting randomisation criteria."|
48356467|NCT02707757|101201237|FG000|COMPLETED|Overall Study||76||
48356468|NCT02707757|101201238|FG001|COMPLETED|Overall Study||84||
48418656|NCT02400281|101361491|FG000|STARTED|Overall Study||3||
48418657|NCT02400281|101361492|FG001|STARTED|Overall Study||5||
48418658|NCT02400281|101361493|FG002|STARTED|Overall Study||12||
48418659|NCT02400281|101361494|FG003|STARTED|Overall Study||5||
48418660|NCT02400281|101361495|FG004|STARTED|Overall Study||3||
48418661|NCT02400281|101361496|FG005|STARTED|Overall Study||0||
48418662|NCT02400281|101361491|FG000|COMPLETED|Overall Study||3||
48418663|NCT02400281|101361492|FG001|COMPLETED|Overall Study||5||
48418664|NCT02400281|101361493|FG002|COMPLETED|Overall Study||10||
48418665|NCT02400281|101361494|FG003|COMPLETED|Overall Study||5||
48418666|NCT02400281|101361495|FG004|COMPLETED|Overall Study||2||
48418667|NCT02400281|101361496|FG005|COMPLETED|Overall Study||0||
48418668|NCT02400281|101361491|FG000|NOT COMPLETED|Overall Study||0||
48418669|NCT02400281|101361492|FG001|NOT COMPLETED|Overall Study||0||
48418670|NCT02400281|101361493|FG002|NOT COMPLETED|Overall Study||2||
48418671|NCT02400281|101361494|FG003|NOT COMPLETED|Overall Study||0||
48418672|NCT02400281|101361495|FG004|NOT COMPLETED|Overall Study||1||
48418673|NCT02400281|101361496|FG005|NOT COMPLETED|Overall Study||0||
48418674|NCT02795182|101361497|FG000|STARTED|Overall Study||15||
48418675|NCT02795182|101361498|FG001|STARTED|Overall Study||10||
48418676|NCT02795182|101361499|FG002|STARTED|Overall Study||7||
48418677|NCT02795182|101361500|FG003|STARTED|Overall Study||43||
48418678|NCT02795182|101361497|FG000|COMPLETED|Overall Study||0||
48418679|NCT02795182|101361498|FG001|COMPLETED|Overall Study||0||
48418680|NCT02795182|101361499|FG002|COMPLETED|Overall Study||0||
48418681|NCT02795182|101361500|FG003|COMPLETED|Overall Study||0||
48418682|NCT02795182|101361497|FG000|NOT COMPLETED|Overall Study||15||
48356469|NCT02707757|101201237|FG000|NOT COMPLETED|Overall Study||12||
48356470|NCT02707757|101201238|FG001|NOT COMPLETED|Overall Study||12||
48356471|NCT01416181|101201239|FG000|STARTED|Part 1||449||
48356472|NCT01416181|101201240|FG001|STARTED|Part 1||440||
48356473|NCT01416181|101201239|FG000|Withdrew Prior to Dosing|Part 1||0||
48356474|NCT01416181|101201240|FG001|Withdrew Prior to Dosing|Part 1||1||
48356475|NCT01416181|101201239|FG000|COMPLETED|Part 1||312||
48356476|NCT01416181|101201240|FG001|COMPLETED|Part 1||326||
48356477|NCT01416181|101201239|FG000|NOT COMPLETED|Part 1||137||
48418683|NCT02795182|101361498|FG001|NOT COMPLETED|Overall Study||10||
48418684|NCT02795182|101361499|FG002|NOT COMPLETED|Overall Study||7||
48418685|NCT02795182|101361500|FG003|NOT COMPLETED|Overall Study||43||
48356478|NCT01416181|101201240|FG001|NOT COMPLETED|Part 1||114||
48356479|NCT01416181|101201239|FG000|STARTED|Part 2||274||
48356480|NCT01416181|101201240|FG001|STARTED|Part 2||292||
48356481|NCT01416181|101201239|FG000|Completed Treatment for 48 Weeks|Part 2||98||
48356482|NCT01416181|101201240|FG001|Completed Treatment for 48 Weeks|Part 2||111||
48356483|NCT01416181|101201239|FG000|Completed Treatment for 96 Weeks|Part 2||1||
48356484|NCT01416181|101201240|FG001|Completed Treatment for 96 Weeks|Part 2||0||
48356485|NCT01416181|101201239|FG000|Completed Treatment for > 96 Weeks|Part 2||1||
48356486|NCT01416181|101201240|FG001|Completed Treatment for > 96 Weeks|Part 2||0||
48356487|NCT01416181|101201239|FG000|COMPLETED|Part 2||3||
48356488|NCT01416181|101201240|FG001|COMPLETED|Part 2||6||
48356489|NCT01416181|101201239|FG000|NOT COMPLETED|Part 2||271||
48356490|NCT01416181|101201240|FG001|NOT COMPLETED|Part 2||286||
48356491|NCT00174941|101201241|FG000|STARTED|Overall Study||8||
48356492|NCT00174941|101201242|FG001|STARTED|Overall Study||79||
48356493|NCT00174941|101201243|FG002|STARTED|Overall Study||29||
48356494|NCT00174941|101201244|FG003|STARTED|Overall Study||116||
48356495|NCT00174941|101201241|FG000|COMPLETED|Overall Study||6||
48356496|NCT00174941|101201242|FG001|COMPLETED|Overall Study||41||
48356497|NCT00174941|101201243|FG002|COMPLETED|Overall Study||11||
48418686|NCT02195895|101361501|FG000|STARTED|Overall Study||17||
48418687|NCT02195895|101361501|FG000|COMPLETED|Overall Study||17||
48418688|NCT02195895|101361501|FG000|NOT COMPLETED|Overall Study||0||
48418689|NCT04369742|101361502|FG000|STARTED|Overall Study||67||
48418690|NCT04369742|101361503|FG001|STARTED|Overall Study||61||
48418691|NCT04369742|101361502|FG000|COMPLETED|Overall Study||53||
48418692|NCT04369742|101361503|FG001|COMPLETED|Overall Study||50||
48356498|NCT00174941|101201244|FG003|COMPLETED|Overall Study||58||
48356499|NCT00174941|101201241|FG000|NOT COMPLETED|Overall Study||2||
48356500|NCT00174941|101201242|FG001|NOT COMPLETED|Overall Study||38||
48356501|NCT00174941|101201243|FG002|NOT COMPLETED|Overall Study||18||
48356502|NCT00174941|101201244|FG003|NOT COMPLETED|Overall Study||58||
48356503|NCT01873950|101201245|FG000|STARTED|Period 1||5||
48356504|NCT01873950|101201246|FG001|STARTED|Period 1||4||
48356505|NCT01873950|101201247|FG002|STARTED|Period 1||5||
48356506|NCT01873950|101201248|FG003|STARTED|Period 1||4||
48356507|NCT01873950|101201249|FG004|STARTED|Period 1||4||
48356508|NCT01873950|101201245|FG000|COMPLETED|Period 1||5||
48356509|NCT01873950|101201246|FG001|COMPLETED|Period 1||4||
48356510|NCT01873950|101201247|FG002|COMPLETED|Period 1||5||
48356511|NCT01873950|101201248|FG003|COMPLETED|Period 1||4||
48356512|NCT01873950|101201249|FG004|COMPLETED|Period 1||4||
48356513|NCT01873950|101201245|FG000|NOT COMPLETED|Period 1||0||
48356514|NCT01873950|101201246|FG001|NOT COMPLETED|Period 1||0||
48356515|NCT01873950|101201247|FG002|NOT COMPLETED|Period 1||0||
48356516|NCT01873950|101201248|FG003|NOT COMPLETED|Period 1||0||
48356517|NCT01873950|101201249|FG004|NOT COMPLETED|Period 1||0||
48356518|NCT01873950|101201245|FG000|STARTED|Period 2||5||
48356519|NCT01873950|101201246|FG001|STARTED|Period 2||4||
48356520|NCT01873950|101201247|FG002|STARTED|Period 2||4||
48356521|NCT01873950|101201248|FG003|STARTED|Period 2||4||
48418693|NCT04369742|101361502|FG000|NOT COMPLETED|Overall Study||14||
48418694|NCT04369742|101361503|FG001|NOT COMPLETED|Overall Study||11||
48418695|NCT00381810|101361504|FG000|STARTED|Treatment and Safety Follow-up||31||
48418696|NCT00381810|101361504|FG000|COMPLETED|Treatment and Safety Follow-up||16||
48418697|NCT00381810|101361504|FG000|NOT COMPLETED|Treatment and Safety Follow-up||15||
48418698|NCT00381810|101361504|FG000|STARTED|B Cell Follow-up||7||
48638581|NCT01104285|101898791|FG001|STARTED|Overall Study||86||
48638582|NCT01104285|101898790|FG000|COMPLETED|Overall Study||112||
48638583|NCT01104285|101898791|FG001|COMPLETED|Overall Study||86||
48638584|NCT01104285|101898790|FG000|NOT COMPLETED|Overall Study||0||
48638585|NCT01104285|101898791|FG001|NOT COMPLETED|Overall Study||0||
48762657|NCT03645122|102206079|FG001|COMPLETED|Overall Study||3||
48762658|NCT03645122|102206080|FG002|COMPLETED|Overall Study||4||
48762659|NCT03645122|102206081|FG003|COMPLETED|Overall Study||5||
48762660|NCT03645122|102206082|FG004|COMPLETED|Overall Study||4||
48356522|NCT01873950|101201249|FG004|STARTED|Period 2||5||
48356523|NCT01873950|101201245|FG000|COMPLETED|Period 2||5||
48356524|NCT01873950|101201246|FG001|COMPLETED|Period 2||4||
48356525|NCT01873950|101201247|FG002|COMPLETED|Period 2||4||
48356526|NCT01873950|101201248|FG003|COMPLETED|Period 2||4||
48356527|NCT01873950|101201249|FG004|COMPLETED|Period 2||5||
48356528|NCT01873950|101201245|FG000|NOT COMPLETED|Period 2||0||
48356529|NCT01873950|101201246|FG001|NOT COMPLETED|Period 2||0||
48356530|NCT01873950|101201247|FG002|NOT COMPLETED|Period 2||0||
48356531|NCT01873950|101201248|FG003|NOT COMPLETED|Period 2||0||
48356532|NCT01873950|101201249|FG004|NOT COMPLETED|Period 2||0||
48356533|NCT01873950|101201245|FG000|STARTED|Period 3||4||
48356534|NCT01873950|101201246|FG001|STARTED|Period 3||4||
48356535|NCT01873950|101201247|FG002|STARTED|Period 3||5||
48356536|NCT01873950|101201248|FG003|STARTED|Period 3||5||
48356537|NCT01873950|101201249|FG004|STARTED|Period 3||4||
48356538|NCT01873950|101201245|FG000|COMPLETED|Period 3||4||
48356539|NCT01873950|101201246|FG001|COMPLETED|Period 3||4||
48356540|NCT01873950|101201247|FG002|COMPLETED|Period 3||5||
48356541|NCT01873950|101201248|FG003|COMPLETED|Period 3||5||
48356542|NCT01873950|101201249|FG004|COMPLETED|Period 3||4||
48356543|NCT01873950|101201245|FG000|NOT COMPLETED|Period 3||0||
48356544|NCT01873950|101201246|FG001|NOT COMPLETED|Period 3||0||
48356545|NCT01873950|101201247|FG002|NOT COMPLETED|Period 3||0||
48418699|NCT00381810|101361504|FG000|COMPLETED|B Cell Follow-up||0||
48418700|NCT00381810|101361504|FG000|NOT COMPLETED|B Cell Follow-up||7||
48418701|NCT00286234|101361505|FG000|STARTED|Overall Study||17||
48356546|NCT01873950|101201248|FG003|NOT COMPLETED|Period 3||0||
48356547|NCT01873950|101201249|FG004|NOT COMPLETED|Period 3||0||
48356548|NCT01873950|101201245|FG000|STARTED|Period 4||4||
48356549|NCT01873950|101201246|FG001|STARTED|Period 4||5||
48356550|NCT01873950|101201247|FG002|STARTED|Period 4||4||
48356551|NCT01873950|101201248|FG003|STARTED|Period 4||4||
48356552|NCT01873950|101201249|FG004|STARTED|Period 4||5||
48356553|NCT01873950|101201245|FG000|COMPLETED|Period 4||4||
48356554|NCT01873950|101201246|FG001|COMPLETED|Period 4||5||
48356555|NCT01873950|101201247|FG002|COMPLETED|Period 4||4||
48356556|NCT01873950|101201248|FG003|COMPLETED|Period 4||4||
48356557|NCT01873950|101201249|FG004|COMPLETED|Period 4||5||
48356558|NCT01873950|101201245|FG000|NOT COMPLETED|Period 4||0||
48356559|NCT01873950|101201246|FG001|NOT COMPLETED|Period 4||0||
48356560|NCT01873950|101201247|FG002|NOT COMPLETED|Period 4||0||
48418702|NCT00286234|101361506|FG001|STARTED|Overall Study||17||
48356561|NCT01873950|101201248|FG003|NOT COMPLETED|Period 4||0||
48418703|NCT00286234|101361507|FG002|STARTED|Overall Study||17||
48638586|NCT02691572|101898792|FG000|STARTED|Overall Study||40||
48638587|NCT02691572|101898793|FG001|STARTED|Overall Study||40||
48638588|NCT02691572|101898792|FG000|COMPLETED|Overall Study||39||
48638589|NCT02691572|101898793|FG001|COMPLETED|Overall Study||39||
48356562|NCT01873950|101201249|FG004|NOT COMPLETED|Period 4||0||
48356563|NCT01873950|101201245|FG000|STARTED|Period 5||4||
48356564|NCT01873950|101201246|FG001|STARTED|Period 5||5||
48356565|NCT01873950|101201247|FG002|STARTED|Period 5||4||
48356566|NCT01873950|101201248|FG003|STARTED|Period 5||4||
48356567|NCT01873950|101201249|FG004|STARTED|Period 5||4||
48356568|NCT01873950|101201245|FG000|COMPLETED|Period 5||4||
48356569|NCT01873950|101201246|FG001|COMPLETED|Period 5||5||
48356570|NCT01873950|101201247|FG002|COMPLETED|Period 5||4||
48356571|NCT01873950|101201248|FG003|COMPLETED|Period 5||3||
48356572|NCT01873950|101201249|FG004|COMPLETED|Period 5||4||
48356573|NCT01873950|101201245|FG000|NOT COMPLETED|Period 5||0||
48638590|NCT02691572|101898792|FG000|NOT COMPLETED|Overall Study||1||
48418704|NCT00286234|101361508|FG003|STARTED|Overall Study||17||
48418705|NCT00286234|101361505|FG000|COMPLETED|Overall Study||15||
48418706|NCT00286234|101361506|FG001|COMPLETED|Overall Study||15||
48418707|NCT00286234|101361507|FG002|COMPLETED|Overall Study||17||
48418708|NCT00286234|101361508|FG003|COMPLETED|Overall Study||13||
48418709|NCT00286234|101361505|FG000|NOT COMPLETED|Overall Study||2||
48418710|NCT00286234|101361506|FG001|NOT COMPLETED|Overall Study||2||
48418711|NCT00286234|101361507|FG002|NOT COMPLETED|Overall Study||0||
48418712|NCT00286234|101361508|FG003|NOT COMPLETED|Overall Study||4||
48418713|NCT03986671|101361509|FG000|STARTED|Overall Study||36||
48418714|NCT03986671|101361510|FG001|STARTED|Overall Study||9||
48418715|NCT03986671|101361511|FG002|STARTED|Overall Study||5||
48418716|NCT03986671|101361509|FG000|Passed a Screening Visit With ENT|Overall Study||6||
48418717|NCT03986671|101361510|FG001|Passed a Screening Visit With ENT|Overall Study||5||
48418718|NCT03986671|101361511|FG002|Passed a Screening Visit With ENT|Overall Study||5||
48418719|NCT03986671|101361509|FG000|COMPLETED|Overall Study||6||
48418720|NCT03986671|101361510|FG001|COMPLETED|Overall Study||5||
48418721|NCT03986671|101361511|FG002|COMPLETED|Overall Study||5||
48418722|NCT03986671|101361509|FG000|NOT COMPLETED|Overall Study||30||
48418723|NCT03986671|101361510|FG001|NOT COMPLETED|Overall Study||4||
48418724|NCT03986671|101361511|FG002|NOT COMPLETED|Overall Study||0||
48418725|NCT03245372|101361512|FG000|STARTED|Overall Study||15||
48418726|NCT03245372|101361513|FG001|STARTED|Overall Study||15||
48638591|NCT02691572|101898793|FG001|NOT COMPLETED|Overall Study||1||
48638592|NCT00674297|101898794|FG000|STARTED|Overall Study||18|41 patients recruited.|
48638593|NCT00674297|101898795|FG001|STARTED|Overall Study||7|41 patients recruited.|
48638594|NCT00674297|101898796|FG002|STARTED|Overall Study||9|41 patients recruited.|
48638595|NCT00674297|101898797|FG003|STARTED|Overall Study||7|41 patients recruited.|
48638596|NCT00674297|101898794|FG000|COMPLETED|Overall Study||8|24 patients completed the study.|
48638597|NCT00674297|101898795|FG001|COMPLETED|Overall Study||7|24 patients completed the study.|
48638598|NCT00674297|101898796|FG002|COMPLETED|Overall Study||5|24 patients completed the study.|
48638599|NCT00674297|101898797|FG003|COMPLETED|Overall Study||4|24 patients completed the study.|
48638600|NCT00674297|101898794|FG000|NOT COMPLETED|Overall Study||10||
48638601|NCT00674297|101898795|FG001|NOT COMPLETED|Overall Study||0||
48638602|NCT00674297|101898796|FG002|NOT COMPLETED|Overall Study||4||
48638603|NCT00674297|101898797|FG003|NOT COMPLETED|Overall Study||3||
48638604|NCT03881371|101901448|FG000|STARTED|Overall Study||153||
48638605|NCT03881371|101901449|FG001|STARTED|Overall Study||154||
48638606|NCT03881371|101901448|FG000|Number Treated|Overall Study||151||
48638607|NCT03881371|101901449|FG001|Number Treated|Overall Study||154||
48638608|NCT03881371|101901448|FG000|COMPLETED|Overall Study||137||
48638609|NCT03881371|101901449|FG001|COMPLETED|Overall Study||130||
48356574|NCT01873950|101201246|FG001|NOT COMPLETED|Period 5||0||
48356575|NCT01873950|101201247|FG002|NOT COMPLETED|Period 5||0||
48356576|NCT01873950|101201248|FG003|NOT COMPLETED|Period 5||1||
48356577|NCT01873950|101201249|FG004|NOT COMPLETED|Period 5||0||
48418727|NCT03245372|101361512|FG000|COMPLETED|Overall Study||15||
48418728|NCT03245372|101361513|FG001|COMPLETED|Overall Study||15||
48356578|NCT05780281|101201250|FG000|STARTED|Overall Study||184||
48638610|NCT03881371|101901448|FG000|NOT COMPLETED|Overall Study||16||
48638611|NCT03881371|101901449|FG001|NOT COMPLETED|Overall Study||24||
48638612|NCT03838874|101901450|FG000|STARTED|Overall Study||80||
48638613|NCT03838874|101901451|FG001|STARTED|Overall Study||74||
48638614|NCT03838874|101901450|FG000|COMPLETED|Overall Study||80||
48638615|NCT03838874|101901451|FG001|COMPLETED|Overall Study||74||
48638616|NCT03838874|101901450|FG000|NOT COMPLETED|Overall Study||0||
48638617|NCT03838874|101901451|FG001|NOT COMPLETED|Overall Study||0||
48356579|NCT05780281|101201251|FG001|STARTED|Overall Study||183||
48356580|NCT05780281|101201250|FG000|COMPLETED|Overall Study||182||
48356581|NCT05780281|101201251|FG001|COMPLETED|Overall Study||178||
48356582|NCT05780281|101201250|FG000|NOT COMPLETED|Overall Study||2||
48356583|NCT05780281|101201251|FG001|NOT COMPLETED|Overall Study||5||
48356584|NCT00858832|101201252|FG000|STARTED|Overall Study||21||
48356585|NCT00858832|101201253|FG001|STARTED|Overall Study||23||
48418729|NCT03245372|101361512|FG000|NOT COMPLETED|Overall Study||0||
48418730|NCT03245372|101361513|FG001|NOT COMPLETED|Overall Study||0||
48418731|NCT02475564|101361514|FG000|STARTED|Overall Study||22||
48418732|NCT02475564|101361515|FG001|STARTED|Overall Study||22||
48418733|NCT02475564|101361514|FG000|COMPLETED|Overall Study||18||
48638618|NCT01188447|101901452|FG000|STARTED|Overall Study||4034||
48356586|NCT00858832|101201252|FG000|COMPLETED|Overall Study||20||
48356587|NCT00858832|101201253|FG001|COMPLETED|Overall Study||22||
48356588|NCT00858832|101201252|FG000|NOT COMPLETED|Overall Study||1||
48356589|NCT00858832|101201253|FG001|NOT COMPLETED|Overall Study||1||
48356590|NCT00670111|101201254|FG000|STARTED|Enrollment to One Month||5||
48356591|NCT00670111|101201255|FG001|STARTED|Enrollment to One Month||8||
48356592|NCT00670111|101201256|FG002|STARTED|Enrollment to One Month||19||
48356593|NCT00670111|101201254|FG000|COMPLETED|Enrollment to One Month||4||
48356594|NCT00670111|101201255|FG001|COMPLETED|Enrollment to One Month||8||
48356595|NCT00670111|101201256|FG002|COMPLETED|Enrollment to One Month||0||
48356596|NCT00670111|101201254|FG000|NOT COMPLETED|Enrollment to One Month||1||
48356597|NCT00670111|101201255|FG001|NOT COMPLETED|Enrollment to One Month||0||
48356598|NCT00670111|101201256|FG002|NOT COMPLETED|Enrollment to One Month||19||
48356599|NCT00670111|101201254|FG000|STARTED|One Month Period A||4||
48356600|NCT00670111|101201255|FG001|STARTED|One Month Period A||8||
48356601|NCT00670111|101201256|FG002|STARTED|One Month Period A||0||
48356602|NCT00670111|101201254|FG000|COMPLETED|One Month Period A||4||
48356603|NCT00670111|101201255|FG001|COMPLETED|One Month Period A||8||
48356604|NCT00670111|101201256|FG002|COMPLETED|One Month Period A||0||
48356605|NCT00670111|101201254|FG000|NOT COMPLETED|One Month Period A||0||
48356606|NCT00670111|101201255|FG001|NOT COMPLETED|One Month Period A||0||
48356607|NCT00670111|101201256|FG002|NOT COMPLETED|One Month Period A||0||
48356608|NCT00670111|101201254|FG000|STARTED|One Month Period B||4||
48356609|NCT00670111|101201255|FG001|STARTED|One Month Period B||8||
48356610|NCT00670111|101201256|FG002|STARTED|One Month Period B||0||
48356611|NCT00670111|101201254|FG000|COMPLETED|One Month Period B||4||
48356612|NCT00670111|101201255|FG001|COMPLETED|One Month Period B||8||
48356613|NCT00670111|101201256|FG002|COMPLETED|One Month Period B||0||
48356614|NCT00670111|101201254|FG000|NOT COMPLETED|One Month Period B||0||
48356615|NCT00670111|101201255|FG001|NOT COMPLETED|One Month Period B||0||
48356616|NCT00670111|101201256|FG002|NOT COMPLETED|One Month Period B||0||
48356617|NCT00670111|101201254|FG000|STARTED|One Month to Six Months||4||
48356618|NCT00670111|101201255|FG001|STARTED|One Month to Six Months||8||
48356619|NCT00670111|101201256|FG002|STARTED|One Month to Six Months||0||
48356620|NCT00670111|101201254|FG000|COMPLETED|One Month to Six Months||4||
48356621|NCT00670111|101201255|FG001|COMPLETED|One Month to Six Months||8||
48356622|NCT00670111|101201256|FG002|COMPLETED|One Month to Six Months||0||
48356623|NCT00670111|101201254|FG000|NOT COMPLETED|One Month to Six Months||0||
48356624|NCT00670111|101201255|FG001|NOT COMPLETED|One Month to Six Months||0||
48356625|NCT00670111|101201256|FG002|NOT COMPLETED|One Month to Six Months||0||
48356626|NCT00670111|101201254|FG000|STARTED|Six Months to Twelve Months||4||
48356627|NCT00670111|101201255|FG001|STARTED|Six Months to Twelve Months||8||
48356628|NCT00670111|101201256|FG002|STARTED|Six Months to Twelve Months||0||
48356629|NCT00670111|101201254|FG000|COMPLETED|Six Months to Twelve Months||4||
48356630|NCT00670111|101201255|FG001|COMPLETED|Six Months to Twelve Months||8||
48356631|NCT00670111|101201256|FG002|COMPLETED|Six Months to Twelve Months||0||
48356632|NCT00670111|101201254|FG000|NOT COMPLETED|Six Months to Twelve Months||0||
48356633|NCT00670111|101201255|FG001|NOT COMPLETED|Six Months to Twelve Months||0||
48356634|NCT00670111|101201256|FG002|NOT COMPLETED|Six Months to Twelve Months||0||
48356635|NCT01134510|101201257|FG000|STARTED|Overall Study||10||
48356636|NCT01134510|101201258|FG001|STARTED|Overall Study||10||
48356637|NCT01134510|101201257|FG000|Day 2|Overall Study||10||
48356638|NCT01134510|101201258|FG001|Day 2|Overall Study||10||
48356639|NCT01134510|101201257|FG000|Week 2|Overall Study||10||
48356640|NCT01134510|101201258|FG001|Week 2|Overall Study||10||
48356641|NCT01134510|101201257|FG000|Week 2|Overall Study||10||
48356642|NCT01134510|101201258|FG001|Week 2|Overall Study||10||
48356643|NCT01134510|101201257|FG000|Week 3|Overall Study||10||
48356644|NCT01134510|101201258|FG001|Week 3|Overall Study||10||
48356645|NCT01134510|101201257|FG000|Week 3|Overall Study||10||
48356646|NCT01134510|101201258|FG001|Week 3|Overall Study||10||
48356647|NCT01134510|101201257|FG000|Week 4|Overall Study||10||
48356648|NCT01134510|101201258|FG001|Week 4|Overall Study||10||
48356649|NCT01134510|101201257|FG000|Week 4|Overall Study||10||
48356650|NCT01134510|101201258|FG001|Week 4|Overall Study||10||
48356651|NCT01134510|101201257|FG000|Month 1|Overall Study||10||
48356652|NCT01134510|101201258|FG001|Month 1|Overall Study||10||
48356653|NCT01134510|101201257|FG000|Month 3|Overall Study||10||
48356654|NCT01134510|101201258|FG001|Month 3|Overall Study||9||
48356655|NCT01134510|101201257|FG000|COMPLETED|Overall Study||10||
48356656|NCT01134510|101201258|FG001|COMPLETED|Overall Study||9||
48356657|NCT01134510|101201257|FG000|NOT COMPLETED|Overall Study||0||
48356658|NCT01134510|101201258|FG001|NOT COMPLETED|Overall Study||1||
48356659|NCT02902809|101201259|FG000|STARTED|Overall Study||28||
48356660|NCT02902809|101201259|FG000|Treatment Received|Overall Study||28||
48356661|NCT02902809|101201259|FG000|Treatment Completed|Overall Study||2||
48356662|NCT02902809|101201259|FG000|COMPLETED|Overall Study||0||
48356663|NCT02902809|101201259|FG000|NOT COMPLETED|Overall Study||28||
48356664|NCT00479466|101201260|FG000|STARTED|Overall Study||57||
48356665|NCT00479466|101201261|FG001|STARTED|Overall Study||57||
48356666|NCT00479466|101201262|FG002|STARTED|Overall Study||57||
48356667|NCT00479466|101201263|FG003|STARTED|Overall Study||58||
48356668|NCT00479466|101201264|FG004|STARTED|Overall Study||56||
48356669|NCT00479466|101201265|FG005|STARTED|Overall Study||57||
48356670|NCT00479466|101201260|FG000|COMPLETED|Overall Study||44||
48356671|NCT00479466|101201261|FG001|COMPLETED|Overall Study||49||
48356672|NCT00479466|101201262|FG002|COMPLETED|Overall Study||54||
48356673|NCT00479466|101201263|FG003|COMPLETED|Overall Study||55||
48356674|NCT00479466|101201264|FG004|COMPLETED|Overall Study||48||
48356675|NCT00479466|101201265|FG005|COMPLETED|Overall Study||53||
48356676|NCT00479466|101201260|FG000|NOT COMPLETED|Overall Study||13||
48356677|NCT00479466|101201261|FG001|NOT COMPLETED|Overall Study||8||
48356678|NCT00479466|101201262|FG002|NOT COMPLETED|Overall Study||3||
48356679|NCT00479466|101201263|FG003|NOT COMPLETED|Overall Study||3||
48356680|NCT00479466|101201264|FG004|NOT COMPLETED|Overall Study||8||
48356681|NCT00479466|101201265|FG005|NOT COMPLETED|Overall Study||4||
48356682|NCT02436239|101201266|FG000|STARTED|Open-Lable Treatment Period||122||
48356683|NCT02436239|101201267|FG001|STARTED|Open-Lable Treatment Period||131||
48356684|NCT02436239|101201268|FG002|STARTED|Open-Lable Treatment Period||65||
48356685|NCT02436239|101201269|FG003|STARTED|Open-Lable Treatment Period||12||
48356686|NCT02436239|101201266|FG000|COMPLETED|Open-Lable Treatment Period||89||
48356687|NCT02436239|101201267|FG001|COMPLETED|Open-Lable Treatment Period||97||
48418734|NCT02475564|101361515|FG001|COMPLETED|Overall Study||21||
48418735|NCT02475564|101361514|FG000|NOT COMPLETED|Overall Study||4||
48418736|NCT02475564|101361515|FG001|NOT COMPLETED|Overall Study||1||
48418737|NCT01633398|101361516|FG000|STARTED|Overall Study||4779||
48418738|NCT01633398|101361517|FG001|STARTED|Overall Study||1550||
48418739|NCT01633398|101361516|FG000|COMPLETED|Overall Study||4779||
48418740|NCT01633398|101361517|FG001|COMPLETED|Overall Study||1550||
48418741|NCT01633398|101361516|FG000|NOT COMPLETED|Overall Study||0||
48418742|NCT01633398|101361517|FG001|NOT COMPLETED|Overall Study||0||
48418743|NCT03824704|101361518|FG000|STARTED|Overall Study||1||
48418744|NCT03824704|101361518|FG000|COMPLETED|Overall Study||0||
48418745|NCT03824704|101361518|FG000|NOT COMPLETED|Overall Study||1||
48418746|NCT01671176|101361519|FG000|STARTED|Overall Study||30||
48356688|NCT02436239|101201268|FG002|COMPLETED|Open-Lable Treatment Period||38||
48356689|NCT02436239|101201269|FG003|COMPLETED|Open-Lable Treatment Period||7||
48356690|NCT02436239|101201266|FG000|NOT COMPLETED|Open-Lable Treatment Period||33||
48356691|NCT02436239|101201267|FG001|NOT COMPLETED|Open-Lable Treatment Period||34||
48356692|NCT02436239|101201268|FG002|NOT COMPLETED|Open-Lable Treatment Period||27||
48356693|NCT02436239|101201269|FG003|NOT COMPLETED|Open-Lable Treatment Period||5||
48356694|NCT02436239|101201266|FG000|STARTED|Down-Taper Period||90||
48356695|NCT02436239|101201267|FG001|STARTED|Down-Taper Period||103||
48356696|NCT02436239|101201268|FG002|STARTED|Down-Taper Period||44||
48356697|NCT02436239|101201269|FG003|STARTED|Down-Taper Period||6||
48356698|NCT02436239|101201266|FG000|COMPLETED|Down-Taper Period||86||
48356699|NCT02436239|101201267|FG001|COMPLETED|Down-Taper Period||99||
48356700|NCT02436239|101201268|FG002|COMPLETED|Down-Taper Period||43||
48356701|NCT02436239|101201269|FG003|COMPLETED|Down-Taper Period||4||
48356702|NCT02436239|101201266|FG000|NOT COMPLETED|Down-Taper Period||4||
48356703|NCT02436239|101201267|FG001|NOT COMPLETED|Down-Taper Period||4||
48356704|NCT02436239|101201268|FG002|NOT COMPLETED|Down-Taper Period||1||
48356705|NCT02436239|101201269|FG003|NOT COMPLETED|Down-Taper Period||2||
48356706|NCT04352660|101201270|FG000|STARTED|Overall Study||50||
48356707|NCT04352660|101201271|FG001|STARTED|Overall Study||50||
48356708|NCT04352660|101201270|FG000|COMPLETED|Overall Study||36||
48418747|NCT01671176|101361519|FG000|COMPLETED|Overall Study||30||
48418748|NCT01671176|101361519|FG000|NOT COMPLETED|Overall Study||0||
48356709|NCT04352660|101201271|FG001|COMPLETED|Overall Study||40||
48356710|NCT04352660|101201270|FG000|NOT COMPLETED|Overall Study||14||
48356711|NCT04352660|101201271|FG001|NOT COMPLETED|Overall Study||10||
48356712|NCT01050660|101201272|FG000|STARTED|Overall Study||67||
48356713|NCT01050660|101201273|FG001|STARTED|Overall Study||69||
48356714|NCT01050660|101201272|FG000|COMPLETED|Overall Study||67||
48418749|NCT03044730|101361520|FG000|STARTED|3 Cycles of Pembro + Capecitab||30||
48418750|NCT03044730|101361520|FG000|Attempted Cycle 1|3 Cycles of Pembro + Capecitab||30||
48356715|NCT01050660|101201273|FG001|COMPLETED|Overall Study||69||
48356716|NCT01050660|101201272|FG000|NOT COMPLETED|Overall Study||0||
48356717|NCT01050660|101201273|FG001|NOT COMPLETED|Overall Study||0||
48356718|NCT02396147|101201274|FG000|STARTED|Period 1||27||
48356719|NCT02396147|101201275|FG001|STARTED|Period 1||27||
48356720|NCT02396147|101201274|FG000|COMPLETED|Period 1||27||
48356721|NCT02396147|101201275|FG001|COMPLETED|Period 1||27||
48356722|NCT02396147|101201274|FG000|NOT COMPLETED|Period 1||0||
48418751|NCT03044730|101361520|FG000|Attempted Cycle 2|3 Cycles of Pembro + Capecitab||28||
48418752|NCT03044730|101361520|FG000|Attempted Cycle 3|3 Cycles of Pembro + Capecitab||26||
48418753|NCT03044730|101361520|FG000|COMPLETED|3 Cycles of Pembro + Capecitab||26||
48418754|NCT03044730|101361520|FG000|NOT COMPLETED|3 Cycles of Pembro + Capecitab||4||
48418755|NCT03044730|101361520|FG000|STARTED|Cycles 4 and Beyond||26||
48418756|NCT03044730|101361520|FG000|Assessed for Cycle 4|Cycles 4 and Beyond||26||
48418757|NCT03044730|101361520|FG000|Started Cycle 4|Cycles 4 and Beyond||20||
48418758|NCT03044730|101361520|FG000|Went on to Cycle 5 and Beyond|Cycles 4 and Beyond||16||
48418759|NCT03044730|101361520|FG000|COMPLETED|Cycles 4 and Beyond||16||
48418760|NCT03044730|101361520|FG000|NOT COMPLETED|Cycles 4 and Beyond||10||
48418761|NCT03044730|101361520|FG000|STARTED|On Follow-up for 2 Years||29|Pts who received at least 1 cycle of treatment go in follow-up. One pt is still on treatment.|
48418762|NCT03044730|101361520|FG000|COMPLETED|On Follow-up for 2 Years||4||
48356723|NCT02396147|101201275|FG001|NOT COMPLETED|Period 1||0||
48356724|NCT02396147|101201274|FG000|STARTED|Period 2||27||
48356725|NCT02396147|101201275|FG001|STARTED|Period 2||27||
48356726|NCT02396147|101201274|FG000|COMPLETED|Period 2||27||
48356727|NCT02396147|101201275|FG001|COMPLETED|Period 2||27||
48356728|NCT02396147|101201274|FG000|NOT COMPLETED|Period 2||0||
48356729|NCT02396147|101201275|FG001|NOT COMPLETED|Period 2||0||
48356730|NCT02396147|101201274|FG000|STARTED|Period 3||27||
48356731|NCT02396147|101201275|FG001|STARTED|Period 3||27||
48356732|NCT02396147|101201274|FG000|COMPLETED|Period 3||27||
48356733|NCT02396147|101201275|FG001|COMPLETED|Period 3||27||
48356734|NCT02396147|101201274|FG000|NOT COMPLETED|Period 3||0||
48356735|NCT02396147|101201275|FG001|NOT COMPLETED|Period 3||0||
48356736|NCT00636818|101201276|FG000|STARTED|Overall Study||45||
48356737|NCT00636818|101201276|FG000|Received at Least One Dose of Study Drug|Overall Study||44||
48356738|NCT00636818|101201276|FG000|COMPLETED|Overall Study||34||
48356739|NCT00636818|101201276|FG000|NOT COMPLETED|Overall Study||11||
48356740|NCT01695369|101201277|FG000|STARTED|Overall Study||61||
48356741|NCT01695369|101201277|FG000|COMPLETED|Overall Study||61||
48356742|NCT01695369|101201277|FG000|NOT COMPLETED|Overall Study||0||
48356743|NCT04021472|101201278|FG000|STARTED|Overall Study||1||
48356744|NCT04021472|101201278|FG000|COMPLETED|Overall Study||1||
48356745|NCT04021472|101201278|FG000|NOT COMPLETED|Overall Study||0||
48356746|NCT00408681|101201279|FG000|STARTED|Overall Study||20||
48356747|NCT00408681|101201279|FG000|COMPLETED|Overall Study||11||
48356748|NCT00408681|101201279|FG000|NOT COMPLETED|Overall Study||9||
48356749|NCT00430040|101201280|FG000|STARTED|Overall Study||7||
48356750|NCT00430040|101201281|FG001|STARTED|Overall Study||7||
48356751|NCT00430040|101201280|FG000|COMPLETED|Overall Study||5||
48356752|NCT00430040|101201281|FG001|COMPLETED|Overall Study||6||
48356753|NCT00430040|101201280|FG000|NOT COMPLETED|Overall Study||2||
48356754|NCT00430040|101201281|FG001|NOT COMPLETED|Overall Study||1||
48356755|NCT01938625|101201282|FG000|STARTED|Overall Study||10||
48356756|NCT01938625|101201283|FG001|STARTED|Overall Study||25||
48356757|NCT01938625|101201282|FG000|COMPLETED|Overall Study||10||
48356758|NCT01938625|101201283|FG001|COMPLETED|Overall Study||23||
48356759|NCT01938625|101201282|FG000|NOT COMPLETED|Overall Study||0||
48356760|NCT01938625|101201283|FG001|NOT COMPLETED|Overall Study||2||
48356761|NCT00968344|101201284|FG000|STARTED|Overall Study||20||
48356762|NCT00968344|101201285|FG001|STARTED|Overall Study||20||
48356763|NCT00968344|101201284|FG000|COMPLETED|Overall Study||10||
48356764|NCT00968344|101201285|FG001|COMPLETED|Overall Study||9||
48356765|NCT00968344|101201284|FG000|NOT COMPLETED|Overall Study||10||
48356766|NCT00968344|101201285|FG001|NOT COMPLETED|Overall Study||11||
48356767|NCT01208181|101201286|FG000|STARTED|Part 1||818||
48356768|NCT01208181|101201287|FG001|STARTED|Part 1||468||
48356769|NCT01208181|101201288|FG002|STARTED|Part 1||0||
48356770|NCT01208181|101201289|FG003|STARTED|Part 1||0||
48356771|NCT01208181|101201290|FG004|STARTED|Part 1||118||
48418763|NCT03044730|101361520|FG000|NOT COMPLETED|On Follow-up for 2 Years||25||
48418764|NCT03575975|101361521|FG000|STARTED|Overall Study||4||
48418765|NCT03575975|101361522|FG001|STARTED|Overall Study||5||
48418766|NCT03575975|101361523|FG002|STARTED|Overall Study||0||
48418767|NCT03575975|101361521|FG000|COMPLETED|Overall Study||3||
48418768|NCT03575975|101361522|FG001|COMPLETED|Overall Study||5||
48418769|NCT03575975|101361523|FG002|COMPLETED|Overall Study||0||
48418770|NCT03575975|101361521|FG000|NOT COMPLETED|Overall Study||1||
48418771|NCT03575975|101361522|FG001|NOT COMPLETED|Overall Study||0||
48418772|NCT03575975|101361523|FG002|NOT COMPLETED|Overall Study||0||
48356772|NCT01208181|101201286|FG000|COMPLETED|Part 1||719||
48356773|NCT01208181|101201287|FG001|COMPLETED|Part 1||413||
48356774|NCT01208181|101201288|FG002|COMPLETED|Part 1||0||
48356775|NCT01208181|101201289|FG003|COMPLETED|Part 1||0||
48356776|NCT01208181|101201290|FG004|COMPLETED|Part 1||96||
48356777|NCT01208181|101201286|FG000|NOT COMPLETED|Part 1||99||
48356778|NCT01208181|101201287|FG001|NOT COMPLETED|Part 1||55||
48356779|NCT01208181|101201288|FG002|NOT COMPLETED|Part 1||0||
48356780|NCT01208181|101201289|FG003|NOT COMPLETED|Part 1||0||
48356781|NCT01208181|101201290|FG004|NOT COMPLETED|Part 1||22||
48356782|NCT01208181|101201286|FG000|STARTED|Part 2||0||
48356783|NCT01208181|101201287|FG001|STARTED|Part 2||0||
48356784|NCT01208181|101201288|FG002|STARTED|Part 2||350||
48356785|NCT01208181|101201289|FG003|STARTED|Part 2||363||
48418773|NCT01108068|101361524|FG000|STARTED|Overall Study||10||
48418774|NCT01108068|101361525|FG001|STARTED|Overall Study||16||
48418775|NCT01108068|101361524|FG000|COMPLETED|Overall Study||4||
48418776|NCT01108068|101361525|FG001|COMPLETED|Overall Study||16||
48418777|NCT01108068|101361524|FG000|NOT COMPLETED|Overall Study||6||
48418778|NCT01108068|101361525|FG001|NOT COMPLETED|Overall Study||0||
48418779|NCT01520727|101361526|FG000|STARTED|Overall Study||6||
48418780|NCT01520727|101361527|FG001|STARTED|Overall Study||6||
48418781|NCT01520727|101361528|FG002|STARTED|Overall Study||6||
48418782|NCT01520727|101361529|FG003|STARTED|Overall Study||6||
48356786|NCT01208181|101201290|FG004|STARTED|Part 2||0||
48356787|NCT01208181|101201286|FG000|COMPLETED|Part 2||0||
48356788|NCT01208181|101201287|FG001|COMPLETED|Part 2||0||
48356789|NCT01208181|101201288|FG002|COMPLETED|Part 2||334||
48356790|NCT01208181|101201289|FG003|COMPLETED|Part 2||343||
48356791|NCT01208181|101201290|FG004|COMPLETED|Part 2||0||
48356792|NCT01208181|101201286|FG000|NOT COMPLETED|Part 2||0||
48356793|NCT01208181|101201287|FG001|NOT COMPLETED|Part 2||0||
48356794|NCT01208181|101201288|FG002|NOT COMPLETED|Part 2||16||
48356795|NCT01208181|101201289|FG003|NOT COMPLETED|Part 2||20||
48356796|NCT01208181|101201290|FG004|NOT COMPLETED|Part 2||0||
48356797|NCT03476850|101201291|FG000|STARTED|Overall Study||24||
48356798|NCT03476850|101201292|FG001|STARTED|Overall Study||24||
48356799|NCT03476850|101201291|FG000|COMPLETED|Overall Study||24||
48356800|NCT03476850|101201292|FG001|COMPLETED|Overall Study||24||
48356801|NCT03476850|101201291|FG000|NOT COMPLETED|Overall Study||0||
48356802|NCT03476850|101201292|FG001|NOT COMPLETED|Overall Study||0||
48356803|NCT00820040|101201293|FG000|STARTED|Overall Study||10||
48356804|NCT00820040|101201293|FG000|Safety Evaluable Population|Overall Study||8||
48356805|NCT00820040|101201293|FG000|Full Analysis Set|Overall Study||8||
48356806|NCT00820040|101201293|FG000|COMPLETED|Overall Study||7||
48356807|NCT00820040|101201293|FG000|NOT COMPLETED|Overall Study||3||
48356808|NCT00849212|101201294|FG000|STARTED|Overall Study||30||
48418783|NCT01520727|101361530|FG004|STARTED|Overall Study||6||
48418784|NCT01520727|101361531|FG005|STARTED|Overall Study||6||
48638619|NCT01188447|101901452|FG000|COMPLETED|Overall Study||4034||
48638620|NCT01188447|101901452|FG000|NOT COMPLETED|Overall Study||0||
48638621|NCT01271855|101901453|FG000|STARTED|Overall Study||48||
48638622|NCT01271855|101901454|FG001|STARTED|Overall Study||52||
48638623|NCT01271855|101901453|FG000|COMPLETED|Overall Study||48||
48638624|NCT01271855|101901454|FG001|COMPLETED|Overall Study||52||
48638625|NCT01271855|101901453|FG000|NOT COMPLETED|Overall Study||0||
48638626|NCT01271855|101901454|FG001|NOT COMPLETED|Overall Study||0||
48638627|NCT00961415|101901455|FG000|STARTED|Induction Treatment Phase||376||
48638628|NCT00961415|101901456|FG001|STARTED|Induction Treatment Phase||0||
48638629|NCT00961415|101901457|FG002|STARTED|Induction Treatment Phase||0||
48638630|NCT00961415|101901455|FG000|COMPLETED|Induction Treatment Phase||253||
48638631|NCT00961415|101901456|FG001|COMPLETED|Induction Treatment Phase||0||
48638632|NCT00961415|101901457|FG002|COMPLETED|Induction Treatment Phase||0||
48638633|NCT00961415|101901455|FG000|NOT COMPLETED|Induction Treatment Phase||123||
48762661|NCT03645122|102206083|FG005|COMPLETED|Overall Study||4||
48762662|NCT03645122|102206078|FG000|NOT COMPLETED|Overall Study||0||
48356809|NCT00849212|101201294|FG000|COMPLETED|Overall Study||23||
48356810|NCT00849212|101201294|FG000|NOT COMPLETED|Overall Study||7||
48356811|NCT00981435|101201295|FG000|STARTED|Overall Study||31||
48356812|NCT00981435|101201296|FG001|STARTED|Overall Study||29||
48356813|NCT00981435|101201297|FG002|STARTED|Overall Study||37||
48418785|NCT01520727|101361532|FG006|STARTED|Overall Study||6||
48418786|NCT01520727|101361533|FG007|STARTED|Overall Study||6||
48418787|NCT01520727|101361534|FG008|STARTED|Overall Study||16||
48638634|NCT00961415|101901456|FG001|NOT COMPLETED|Induction Treatment Phase||0||
48638635|NCT00961415|101901457|FG002|NOT COMPLETED|Induction Treatment Phase||0||
48638636|NCT00961415|101901455|FG000|STARTED|Maintenance Treatment Phase||0||
48638637|NCT00961415|101901456|FG001|STARTED|Maintenance Treatment Phase||125||
48638638|NCT00961415|101901457|FG002|STARTED|Maintenance Treatment Phase||128||
48638639|NCT00961415|101901455|FG000|COMPLETED|Maintenance Treatment Phase||0||
48638640|NCT00961415|101901456|FG001|COMPLETED|Maintenance Treatment Phase||77||
48638641|NCT00961415|101901457|FG002|COMPLETED|Maintenance Treatment Phase||83||
48638642|NCT00961415|101901455|FG000|NOT COMPLETED|Maintenance Treatment Phase||0||
48638643|NCT00961415|101901456|FG001|NOT COMPLETED|Maintenance Treatment Phase||48||
48638644|NCT00961415|101901457|FG002|NOT COMPLETED|Maintenance Treatment Phase||45||
48356814|NCT00981435|101201295|FG000|COMPLETED|Overall Study||31||
48356815|NCT00981435|101201296|FG001|COMPLETED|Overall Study||29||
48356816|NCT00981435|101201297|FG002|COMPLETED|Overall Study||37||
48356817|NCT00981435|101201295|FG000|NOT COMPLETED|Overall Study||0||
48356818|NCT00981435|101201296|FG001|NOT COMPLETED|Overall Study||0||
48356819|NCT00981435|101201297|FG002|NOT COMPLETED|Overall Study||0||
48356820|NCT04585763|101201298|FG000|STARTED|Overall Study||37||51
48418788|NCT01520727|101361526|FG000|COMPLETED|Overall Study||6||
48418789|NCT01520727|101361527|FG001|COMPLETED|Overall Study||6||
48638645|NCT00313170|101901458|FG000|STARTED|Overall Study||47||
48638646|NCT00313170|101901459|FG001|STARTED|Overall Study||51||
48762663|NCT03645122|102206079|FG001|NOT COMPLETED|Overall Study||0||
48762664|NCT03645122|102206080|FG002|NOT COMPLETED|Overall Study||0||
48356821|NCT04585763|101201298|FG000|COMPLETED|Overall Study||35||48
48356822|NCT04585763|101201298|FG000|NOT COMPLETED|Overall Study||2||3
48356823|NCT02489630|101201299|FG000|STARTED|Overall Study||53||
48356824|NCT02489630|101201300|FG001|STARTED|Overall Study||63||
48356825|NCT02489630|101201299|FG000|COMPLETED|Overall Study||51||
48356826|NCT02489630|101201300|FG001|COMPLETED|Overall Study||61||
48356827|NCT02489630|101201299|FG000|NOT COMPLETED|Overall Study||2||
48356828|NCT02489630|101201300|FG001|NOT COMPLETED|Overall Study||2||
48356829|NCT00069121|101201301|FG000|STARTED|Overall Study||942||
48356830|NCT00069121|101201302|FG001|STARTED|Overall Study||944||
48356831|NCT00069121|101201301|FG000|Received Treatment|Overall Study||926||
48356832|NCT00069121|101201302|FG001|Received Treatment|Overall Study||938||
48356833|NCT00069121|101201301|FG000|COMPLETED|Overall Study||575||
48356834|NCT00069121|101201302|FG001|COMPLETED|Overall Study||619||
48356835|NCT00069121|101201301|FG000|NOT COMPLETED|Overall Study||367||
48356836|NCT00069121|101201302|FG001|NOT COMPLETED|Overall Study||325||
48356837|NCT00947154|101204342|FG000|STARTED|Overall Study||12||
48356838|NCT00947154|101204342|FG000|COMPLETED|Overall Study||11||
48356839|NCT00947154|101204342|FG000|NOT COMPLETED|Overall Study||1||
48356840|NCT03348683|101204343|FG000|STARTED|Overall Study||121||
48356841|NCT03348683|101204344|FG001|STARTED|Overall Study||119||
48356842|NCT03348683|101204343|FG000|COMPLETED|Overall Study||121||
48356843|NCT03348683|101204344|FG001|COMPLETED|Overall Study||119||
48356844|NCT03348683|101204343|FG000|NOT COMPLETED|Overall Study||0||
48356845|NCT03348683|101204344|FG001|NOT COMPLETED|Overall Study||0||
48356846|NCT02694029|101204345|FG000|STARTED|Overall Study||5||
48356847|NCT02694029|101204346|FG001|STARTED|Overall Study||5||
48356848|NCT02694029|101204345|FG000|First Intervention|Overall Study||5||
48356849|NCT02694029|101204346|FG001|First Intervention|Overall Study||5||
48356850|NCT02694029|101204345|FG000|Second Intervention|Overall Study||5||
48356851|NCT02694029|101204346|FG001|Second Intervention|Overall Study||5||
48356852|NCT02694029|101204345|FG000|COMPLETED|Overall Study||5||
48762665|NCT03645122|102206081|FG003|NOT COMPLETED|Overall Study||0||
48762666|NCT03645122|102206082|FG004|NOT COMPLETED|Overall Study||0||
48762667|NCT03645122|102206083|FG005|NOT COMPLETED|Overall Study||0||
48762668|NCT04929249|102206084|FG000|STARTED|Overall Study||225||
48762669|NCT04929249|102206085|FG001|STARTED|Overall Study||225||
48762670|NCT04929249|102206084|FG000|Full Analysis Set (FAS)|Overall Study||225|The Full Analysis Set (FAS) comprised of all randomized patients. According to the intent to treat principle, patients were analyzed according to the treatment group they were assigned to during the randomization period.|
48762671|NCT04929249|102206085|FG001|Full Analysis Set (FAS)|Overall Study||225|The Full Analysis Set (FAS) comprised of all randomized patients. According to the intent to treat principle, patients were analyzed according to the treatment group they were assigned to during the randomization period.|
48762672|NCT04929249|102206084|FG000|Safety Set|Overall Study||234|The Safety Set included all patients who received study treatment. Patients were analyzed according to the study treatment received. Patients in the usual care treatment group who had data collected at the Baseline Visit were included in the safety set.|
48762673|NCT04929249|102206085|FG001|Safety Set|Overall Study||216|The Safety Set included all patients who received study treatment. Patients were analyzed according to the study treatment received. Patients in the usual care treatment group who had data collected at the Baseline Visit were included in the safety set.|
48762674|NCT04929249|102206084|FG000|COMPLETED|Overall Study||212||
48762675|NCT04929249|102206085|FG001|COMPLETED|Overall Study||195||
48762676|NCT04929249|102206084|FG000|NOT COMPLETED|Overall Study||13||
48762677|NCT04929249|102206085|FG001|NOT COMPLETED|Overall Study||30||
48762678|NCT03815929|102206086|FG000|STARTED|Overall Study||15||
48762679|NCT03815929|102206087|FG001|STARTED|Overall Study||15||
48762680|NCT03815929|102206088|FG002|STARTED|Overall Study||5||
48762681|NCT03815929|102206086|FG000|Baseline|Overall Study||15||
48762682|NCT03815929|102206087|FG001|Baseline|Overall Study||15||
48762683|NCT03815929|102206088|FG002|Baseline|Overall Study||5||
48762684|NCT03815929|102206086|FG000|6-month|Overall Study||12||
48762685|NCT03815929|102206087|FG001|6-month|Overall Study||12||
48762686|NCT03815929|102206088|FG002|6-month|Overall Study||4||
48762687|NCT03815929|102206086|FG000|12-month|Overall Study||11||
48762688|NCT03815929|102206087|FG001|12-month|Overall Study||12||
48356853|NCT02694029|101204346|FG001|COMPLETED|Overall Study||5||
48356854|NCT02694029|101204345|FG000|NOT COMPLETED|Overall Study||0||
48356855|NCT02694029|101204346|FG001|NOT COMPLETED|Overall Study||0||
48356856|NCT02162979|101204347|FG000|STARTED|Overall Study||0||
48356857|NCT02162979|101204348|FG001|STARTED|Overall Study||0||
48356858|NCT02162979|101204347|FG000|COMPLETED|Overall Study||0||
48356859|NCT02162979|101204348|FG001|COMPLETED|Overall Study||0||
48356860|NCT02162979|101204347|FG000|NOT COMPLETED|Overall Study||0||
48356861|NCT02162979|101204348|FG001|NOT COMPLETED|Overall Study||0||
48356862|NCT00545818|101204349|FG000|STARTED|Overall Study||49||108
48356863|NCT00545818|101204350|FG001|STARTED|Overall Study||46||101
48356864|NCT00545818|101204349|FG000|COMPLETED|Overall Study||46||98
48356865|NCT00545818|101204350|FG001|COMPLETED|Overall Study||39||86
48356866|NCT00545818|101204349|FG000|NOT COMPLETED|Overall Study||3||10
48356867|NCT00545818|101204350|FG001|NOT COMPLETED|Overall Study||7||15
48356868|NCT00964795|101204351|FG000|STARTED|Overall Study||323||
48356869|NCT00964795|101204351|FG000|Number of Participants Treated|Overall Study||320||
48356870|NCT00964795|101204351|FG000|COMPLETED|Overall Study||16||
48418790|NCT01520727|101361528|FG002|COMPLETED|Overall Study||6||
48638647|NCT00313170|101901460|FG002|STARTED|Overall Study||46||
48638648|NCT00313170|101901458|FG000|COMPLETED|Overall Study||11||
48638649|NCT00313170|101901459|FG001|COMPLETED|Overall Study||17||
48356871|NCT00964795|101204351|FG000|NOT COMPLETED|Overall Study||307||
48356872|NCT00376688|101204352|FG000|STARTED|Overall Study||31||
48356873|NCT00376688|101204352|FG000|COMPLETED|Overall Study||27||
48356874|NCT00376688|101204352|FG000|NOT COMPLETED|Overall Study||4||
48356875|NCT00465569|101204353|FG000|STARTED|Overall Study||13||
48356876|NCT00465569|101204354|FG001|STARTED|Overall Study||7||
48356877|NCT00465569|101204353|FG000|COMPLETED|Overall Study||12||
48356878|NCT00465569|101204354|FG001|COMPLETED|Overall Study||7||
48356879|NCT00465569|101204353|FG000|NOT COMPLETED|Overall Study||1||
48356880|NCT00465569|101204354|FG001|NOT COMPLETED|Overall Study||0||
48356881|NCT01287117|101204355|FG000|STARTED|Overall Study||80||
48356882|NCT01287117|101204356|FG001|STARTED|Overall Study||78||
48356883|NCT01287117|101204357|FG002|STARTED|Overall Study||80||
48356884|NCT01287117|101204358|FG003|STARTED|Overall Study||81||
48356885|NCT01287117|101204355|FG000|Received Treatment|Overall Study||80||
48356886|NCT01287117|101204356|FG001|Received Treatment|Overall Study||77||
48356887|NCT01287117|101204357|FG002|Received Treatment|Overall Study||80||
48356888|NCT01287117|101204358|FG003|Received Treatment|Overall Study||81||
48356889|NCT01287117|101204355|FG000|COMPLETED|Overall Study||65||
48418791|NCT01520727|101361529|FG003|COMPLETED|Overall Study||6||
48638650|NCT00313170|101901460|FG002|COMPLETED|Overall Study||14||
48638651|NCT00313170|101901458|FG000|NOT COMPLETED|Overall Study||36||
48638652|NCT00313170|101901459|FG001|NOT COMPLETED|Overall Study||34||
48638653|NCT00313170|101901460|FG002|NOT COMPLETED|Overall Study||32||
48638654|NCT01733953|101901461|FG000|STARTED|Overall Study||14||
48762689|NCT03815929|102206088|FG002|12-month|Overall Study||4||
48762690|NCT03815929|102206086|FG000|COMPLETED|Overall Study||11||
48762691|NCT03815929|102206087|FG001|COMPLETED|Overall Study||12||
48762692|NCT03815929|102206088|FG002|COMPLETED|Overall Study||4||
48762693|NCT03815929|102206086|FG000|NOT COMPLETED|Overall Study||4||
48762694|NCT03815929|102206087|FG001|NOT COMPLETED|Overall Study||3||
48762695|NCT03815929|102206088|FG002|NOT COMPLETED|Overall Study||1||
48762696|NCT02849418|102206089|FG000|STARTED|Double-blinded (Up to 48 Weeks)||10||
48762697|NCT02849418|102206090|FG001|STARTED|Double-blinded (Up to 48 Weeks)||11||
48762698|NCT02849418|102206091|FG002|STARTED|Double-blinded (Up to 48 Weeks)||0||
48762699|NCT02849418|102206092|FG003|STARTED|Double-blinded (Up to 48 Weeks)||0||
48762700|NCT02849418|102206093|FG004|STARTED|Double-blinded (Up to 48 Weeks)||0||
48762701|NCT02849418|102206094|FG005|STARTED|Double-blinded (Up to 48 Weeks)||0||
48762702|NCT02849418|102206089|FG000|COMPLETED|Double-blinded (Up to 48 Weeks)||10||
48762703|NCT02849418|102206090|FG001|COMPLETED|Double-blinded (Up to 48 Weeks)||11||
48762704|NCT02849418|102206091|FG002|COMPLETED|Double-blinded (Up to 48 Weeks)||0||
48418792|NCT01520727|101361530|FG004|COMPLETED|Overall Study||6||
48418793|NCT01520727|101361531|FG005|COMPLETED|Overall Study||6||
48638655|NCT01733953|101901462|FG001|STARTED|Overall Study||13||
48418794|NCT01520727|101361532|FG006|COMPLETED|Overall Study||6||
48418795|NCT01520727|101361533|FG007|COMPLETED|Overall Study||6||
48418796|NCT01520727|101361534|FG008|COMPLETED|Overall Study||16||
48762705|NCT02849418|102206092|FG003|COMPLETED|Double-blinded (Up to 48 Weeks)||0||
48762706|NCT02849418|102206093|FG004|COMPLETED|Double-blinded (Up to 48 Weeks)||0||
48356890|NCT01287117|101204356|FG001|COMPLETED|Overall Study||64||
48356891|NCT01287117|101204357|FG002|COMPLETED|Overall Study||64||
48356892|NCT01287117|101204358|FG003|COMPLETED|Overall Study||69||
48356893|NCT01287117|101204355|FG000|NOT COMPLETED|Overall Study||15||
48418797|NCT01520727|101361526|FG000|NOT COMPLETED|Overall Study||0||
48418798|NCT01520727|101361527|FG001|NOT COMPLETED|Overall Study||0||
48356894|NCT01287117|101204356|FG001|NOT COMPLETED|Overall Study||14||
48356895|NCT01287117|101204357|FG002|NOT COMPLETED|Overall Study||16||
48356896|NCT01287117|101204358|FG003|NOT COMPLETED|Overall Study||12||
48356897|NCT01065480|101204359|FG000|STARTED|Overall Study||48||
48356898|NCT01065480|101204360|FG001|STARTED|Overall Study||43||
48356899|NCT01065480|101204359|FG000|COMPLETED|Overall Study||48||
48356900|NCT01065480|101204360|FG001|COMPLETED|Overall Study||43||
48356901|NCT01065480|101204359|FG000|NOT COMPLETED|Overall Study||0||
48356902|NCT01065480|101204360|FG001|NOT COMPLETED|Overall Study||0||
48356903|NCT00095121|101204361|FG000|STARTED|Double-Blind (Study Weeks 0 Through 48)||115||
48356904|NCT00095121|101204362|FG001|STARTED|Double-Blind (Study Weeks 0 Through 48)||58||
48356905|NCT00095121|101204361|FG000|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||112||
48356906|NCT00095121|101204362|FG001|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||58||
48356907|NCT00095121|101204361|FG000|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||3||
48356908|NCT00095121|101204362|FG001|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||0||
48356909|NCT00095121|101204361|FG000|STARTED|Open-Label (Study Weeks 49 Through 240)||108||
48356910|NCT00095121|101204362|FG001|STARTED|Open-Label (Study Weeks 49 Through 240)||54||
48356911|NCT00095121|101204361|FG000|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||21||
48356912|NCT00095121|101204362|FG001|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||11||
48356913|NCT00095121|101204361|FG000|COMPLETED|Open-Label (Study Weeks 49 Through 240)||46||
48356914|NCT00095121|101204362|FG001|COMPLETED|Open-Label (Study Weeks 49 Through 240)||35||
48356915|NCT00095121|101204361|FG000|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||62||
48356916|NCT00095121|101204362|FG001|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||19||
48356917|NCT01457339|101204363|FG000|STARTED|Period 1 (50 mg)||7||
48356918|NCT01457339|101204364|FG001|STARTED|Period 1 (50 mg)||24||
48356919|NCT01457339|101204363|FG000|COMPLETED|Period 1 (50 mg)||7||
48356920|NCT01457339|101204364|FG001|COMPLETED|Period 1 (50 mg)||24||
48418799|NCT01520727|101361528|FG002|NOT COMPLETED|Overall Study||0||
48418800|NCT01520727|101361529|FG003|NOT COMPLETED|Overall Study||0||
48418801|NCT01520727|101361530|FG004|NOT COMPLETED|Overall Study||0||
48418802|NCT01520727|101361531|FG005|NOT COMPLETED|Overall Study||0||
48418803|NCT01520727|101361532|FG006|NOT COMPLETED|Overall Study||0||
48418804|NCT01520727|101361533|FG007|NOT COMPLETED|Overall Study||0||
48418805|NCT01520727|101361534|FG008|NOT COMPLETED|Overall Study||0||
48418806|NCT02679222|101361535|FG000|STARTED|Overall Study||10||
48418807|NCT02679222|101361535|FG000|COMPLETED|Overall Study||9||
48418808|NCT02679222|101361535|FG000|NOT COMPLETED|Overall Study||1||
48418809|NCT01145833|101361536|FG000|STARTED|Overall Study||25||
48418810|NCT01145833|101361537|FG001|STARTED|Overall Study||25||
48418811|NCT01145833|101361536|FG000|COMPLETED|Overall Study||22||
48418812|NCT01145833|101361537|FG001|COMPLETED|Overall Study||25||
48418813|NCT01145833|101361536|FG000|NOT COMPLETED|Overall Study||3||
48418814|NCT01145833|101361537|FG001|NOT COMPLETED|Overall Study||0||
48762707|NCT02849418|102206094|FG005|COMPLETED|Double-blinded (Up to 48 Weeks)||0||
48762708|NCT02849418|102206089|FG000|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0||
48762709|NCT02849418|102206090|FG001|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0||
48767778|NCT04139018|102222823|FG000|NOT COMPLETED|Overall Study||3||
48356921|NCT01457339|101204363|FG000|NOT COMPLETED|Period 1 (50 mg)||0||
48356922|NCT01457339|101204364|FG001|NOT COMPLETED|Period 1 (50 mg)||0||
48356923|NCT01457339|101204363|FG000|STARTED|Period 2 (70 mg)||7||
48356924|NCT01457339|101204364|FG001|STARTED|Period 2 (70 mg)||24||
48356925|NCT01457339|101204363|FG000|COMPLETED|Period 2 (70 mg)||7||
48356926|NCT01457339|101204364|FG001|COMPLETED|Period 2 (70 mg)||24||
48356927|NCT01457339|101204363|FG000|NOT COMPLETED|Period 2 (70 mg)||0||
48356928|NCT01457339|101204364|FG001|NOT COMPLETED|Period 2 (70 mg)||0||
48356929|NCT01457339|101204363|FG000|STARTED|Period 3 (100 mg)||7||
48356930|NCT01457339|101204364|FG001|STARTED|Period 3 (100 mg)||24||
48356931|NCT01457339|101204363|FG000|COMPLETED|Period 3 (100 mg)||7||
48356932|NCT01457339|101204364|FG001|COMPLETED|Period 3 (100 mg)||23||
48356933|NCT01457339|101204363|FG000|NOT COMPLETED|Period 3 (100 mg)||0||
48356934|NCT01457339|101204364|FG001|NOT COMPLETED|Period 3 (100 mg)||1||
48356935|NCT01457339|101204363|FG000|STARTED|Period 4 (150 mg)||7||
48356936|NCT01457339|101204364|FG001|STARTED|Period 4 (150 mg)||23||
48356937|NCT01457339|101204363|FG000|COMPLETED|Period 4 (150 mg)||7||
48356938|NCT01457339|101204364|FG001|COMPLETED|Period 4 (150 mg)||23||
48418815|NCT02183792|101361538|FG000|STARTED|Overall Study||18||
48418816|NCT02183792|101361539|FG001|STARTED|Overall Study||15||
48418817|NCT02183792|101361538|FG000|COMPLETED|Overall Study||18||
48418818|NCT02183792|101361539|FG001|COMPLETED|Overall Study||15||
48356939|NCT01457339|101204363|FG000|NOT COMPLETED|Period 4 (150 mg)||0||
48356940|NCT01457339|101204364|FG001|NOT COMPLETED|Period 4 (150 mg)||0||
48356941|NCT01457339|101204363|FG000|STARTED|Period 5 (200 mg)||7||
48356942|NCT01457339|101204364|FG001|STARTED|Period 5 (200 mg)||23||
48356943|NCT01457339|101204363|FG000|COMPLETED|Period 5 (200 mg)||7||
48356944|NCT01457339|101204364|FG001|COMPLETED|Period 5 (200 mg)||22||
48356945|NCT01457339|101204363|FG000|NOT COMPLETED|Period 5 (200 mg)||0||
48356946|NCT01457339|101204364|FG001|NOT COMPLETED|Period 5 (200 mg)||1||
48356947|NCT01457339|101204363|FG000|STARTED|Period 6 (250 mg)||7||
48356948|NCT01457339|101204364|FG001|STARTED|Period 6 (250 mg)||22||
48356949|NCT01457339|101204363|FG000|COMPLETED|Period 6 (250 mg)||6||
48356950|NCT01457339|101204364|FG001|COMPLETED|Period 6 (250 mg)||21||
48356951|NCT01457339|101204363|FG000|NOT COMPLETED|Period 6 (250 mg)||1||
48356952|NCT01457339|101204364|FG001|NOT COMPLETED|Period 6 (250 mg)||1||
48418819|NCT02183792|101361538|FG000|NOT COMPLETED|Overall Study||0||
48418820|NCT02183792|101361539|FG001|NOT COMPLETED|Overall Study||0||
48418821|NCT04005885|101361540|FG000|STARTED|First Intervention||26||
48418822|NCT04005885|101361541|FG001|STARTED|First Intervention||29||
48418823|NCT04005885|101361540|FG000|COMPLETED|First Intervention||25||
48418824|NCT04005885|101361541|FG001|COMPLETED|First Intervention||28||
48418825|NCT04005885|101361540|FG000|NOT COMPLETED|First Intervention||1||
48418826|NCT04005885|101361541|FG001|NOT COMPLETED|First Intervention||1||
48418827|NCT04005885|101361540|FG000|STARTED|Second Intervention||25||
48418828|NCT04005885|101361541|FG001|STARTED|Second Intervention||28||
48418829|NCT04005885|101361540|FG000|COMPLETED|Second Intervention||25||
48418830|NCT04005885|101361541|FG001|COMPLETED|Second Intervention||26||
48418831|NCT04005885|101361540|FG000|NOT COMPLETED|Second Intervention||0||
48418832|NCT04005885|101361541|FG001|NOT COMPLETED|Second Intervention||2||
48418833|NCT04005885|101361540|FG000|STARTED|Third Intervention||25||
48418834|NCT04005885|101361541|FG001|STARTED|Third Intervention||26||
48418835|NCT04005885|101361540|FG000|COMPLETED|Third Intervention||25||
48418836|NCT04005885|101361541|FG001|COMPLETED|Third Intervention||26||
48418837|NCT04005885|101361540|FG000|NOT COMPLETED|Third Intervention||0||
48418838|NCT04005885|101361541|FG001|NOT COMPLETED|Third Intervention||0||
48638656|NCT01733953|101901461|FG000|COMPLETED|Overall Study||9||
48638657|NCT01733953|101901462|FG001|COMPLETED|Overall Study||6||
48638658|NCT01733953|101901461|FG000|NOT COMPLETED|Overall Study||5||
48638659|NCT01733953|101901462|FG001|NOT COMPLETED|Overall Study||7||
48638660|NCT00662259|101901463|FG000|STARTED|Overall Study||21||
48638661|NCT00662259|101901464|FG001|STARTED|Overall Study||11||
48638662|NCT00662259|101901463|FG000|COMPLETED|Overall Study||19||
48638663|NCT00662259|101901464|FG001|COMPLETED|Overall Study||11||
48638664|NCT00662259|101901463|FG000|NOT COMPLETED|Overall Study||2||
48638665|NCT00662259|101901464|FG001|NOT COMPLETED|Overall Study||0||
48638666|NCT01035788|101901465|FG000|STARTED|Overall Study||23||
48638667|NCT01035788|101901466|FG001|STARTED|Overall Study||23||
48638668|NCT01035788|101901465|FG000|COMPLETED|Overall Study||17||
48638669|NCT01035788|101901466|FG001|COMPLETED|Overall Study||9||
48638670|NCT01035788|101901465|FG000|NOT COMPLETED|Overall Study||6||
48638671|NCT01035788|101901466|FG001|NOT COMPLETED|Overall Study||14||
48638672|NCT04507321|101901467|FG000|STARTED|Treatment Period 1 (8 Days)||5||
48638673|NCT04507321|101901467|FG000|COMPLETED|Treatment Period 1 (8 Days)||5||
48638674|NCT04507321|101901467|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
48638675|NCT04507321|101901467|FG000|STARTED|Treatment Period 2 (8 Days)||5||
48638676|NCT04507321|101901467|FG000|COMPLETED|Treatment Period 2 (8 Days)||5||
48638677|NCT04507321|101901467|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
48638678|NCT04739709|101901468|FG000|STARTED|Overall Study||181||
48638679|NCT04739709|101901469|FG001|STARTED|Overall Study||197||
48418839|NCT00721136|101361542|FG000|STARTED|Overall Study||42||
48418840|NCT00721136|101361543|FG001|STARTED|Overall Study||42||
48418841|NCT00721136|101361544|FG002|STARTED|Overall Study||8||
48418842|NCT00721136|101361545|FG003|STARTED|Overall Study||8||
48418843|NCT00721136|101361542|FG000|COMPLETED|Overall Study||42||
48418844|NCT00721136|101361543|FG001|COMPLETED|Overall Study||42||
48418845|NCT00721136|101361544|FG002|COMPLETED|Overall Study||8||
48418846|NCT00721136|101361545|FG003|COMPLETED|Overall Study||8||
48638680|NCT04739709|101901468|FG000|COMPLETED|Overall Study||180||
48638681|NCT04739709|101901469|FG001|COMPLETED|Overall Study||197||
48762710|NCT02849418|102206091|FG002|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0||
48762711|NCT02849418|102206092|FG003|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0||
48356953|NCT01015443|101204365|FG000|STARTED|Overall Study||191||
48356954|NCT01015443|101204366|FG001|STARTED|Overall Study||94||
48356955|NCT01015443|101204365|FG000|Treated|Overall Study||191||
48356956|NCT01015443|101204366|FG001|Treated|Overall Study||93||
48356957|NCT01015443|101204365|FG000|COMPLETED|Overall Study||191||
48356958|NCT01015443|101204366|FG001|COMPLETED|Overall Study||94||
48356959|NCT01015443|101204365|FG000|NOT COMPLETED|Overall Study||0||
48638682|NCT04739709|101901468|FG000|NOT COMPLETED|Overall Study||1||
48638683|NCT04739709|101901469|FG001|NOT COMPLETED|Overall Study||0||
48418847|NCT00721136|101361542|FG000|NOT COMPLETED|Overall Study||0||
48638684|NCT00038610|101901470|FG000|STARTED|Overall Study||54||
48638685|NCT00038610|101901470|FG000|COMPLETED|Overall Study||54||
48638686|NCT00038610|101901470|FG000|NOT COMPLETED|Overall Study||0||
48418848|NCT00721136|101361543|FG001|NOT COMPLETED|Overall Study||0||
48418849|NCT00721136|101361544|FG002|NOT COMPLETED|Overall Study||0||
48418850|NCT00721136|101361545|FG003|NOT COMPLETED|Overall Study||0||
48418851|NCT01309581|101361546|FG000|STARTED|Overall Study||2||
48418852|NCT01309581|101361547|FG001|STARTED|Overall Study||1||
48418853|NCT01309581|101361546|FG000|COMPLETED|Overall Study||2||
48418854|NCT01309581|101361547|FG001|COMPLETED|Overall Study||1||
48418855|NCT01309581|101361546|FG000|NOT COMPLETED|Overall Study||0||
48418856|NCT01309581|101361547|FG001|NOT COMPLETED|Overall Study||0||
48418857|NCT00963820|101361548|FG000|STARTED|Dose Escalation Phase||3||
48418858|NCT00963820|101361549|FG001|STARTED|Dose Escalation Phase||3||
48418859|NCT00963820|101361550|FG002|STARTED|Dose Escalation Phase||3||
48418860|NCT00963820|101361551|FG003|STARTED|Dose Escalation Phase||3||
48418861|NCT00963820|101361552|FG004|STARTED|Dose Escalation Phase||4||
48356960|NCT01015443|101204366|FG001|NOT COMPLETED|Overall Study||0||
48356961|NCT00121225|101204367|FG000|STARTED|Overall Study||32||
48356962|NCT00121225|101204367|FG000|COMPLETED|Overall Study||32||
48356963|NCT00121225|101204367|FG000|NOT COMPLETED|Overall Study||0||
48356964|NCT00532259|101204368|FG000|STARTED|Overall Study||72||
48356965|NCT00532259|101204368|FG000|COMPLETED|Overall Study||40||
48356966|NCT00532259|101204368|FG000|NOT COMPLETED|Overall Study||32||
48356967|NCT00603044|101204369|FG000|STARTED|Overall Study||11||
48356968|NCT00603044|101204370|FG001|STARTED|Overall Study||13||
48356969|NCT00603044|101204369|FG000|COMPLETED|Overall Study||11||
48356970|NCT00603044|101204370|FG001|COMPLETED|Overall Study||13||
48356971|NCT00603044|101204369|FG000|NOT COMPLETED|Overall Study||0||
48356972|NCT00603044|101204370|FG001|NOT COMPLETED|Overall Study||0||
48356973|NCT00003270|101204371|FG000|STARTED|Overall Study||20||
48356974|NCT00003270|101204371|FG000|COMPLETED|Overall Study||20||
48356975|NCT00003270|101204371|FG000|NOT COMPLETED|Overall Study||0||
48356976|NCT02798523|101204372|FG000|STARTED|2 Hour or 4 Hour Post Infusion||4||
48356977|NCT02798523|101204373|FG001|STARTED|2 Hour or 4 Hour Post Infusion||21||
48356978|NCT02798523|101204372|FG000|COMPLETED|2 Hour or 4 Hour Post Infusion||4||
48356979|NCT02798523|101204373|FG001|COMPLETED|2 Hour or 4 Hour Post Infusion||21||
48356980|NCT02798523|101204372|FG000|NOT COMPLETED|2 Hour or 4 Hour Post Infusion||0||
48356981|NCT02798523|101204373|FG001|NOT COMPLETED|2 Hour or 4 Hour Post Infusion||0||
48356982|NCT02798523|101204372|FG000|STARTED|4 Hours Then 2 Hours Post Infusion||0||
48356983|NCT02798523|101204373|FG001|STARTED|4 Hours Then 2 Hours Post Infusion||1||
48356984|NCT02798523|101204372|FG000|COMPLETED|4 Hours Then 2 Hours Post Infusion||0||
48356985|NCT02798523|101204373|FG001|COMPLETED|4 Hours Then 2 Hours Post Infusion||1||
48356986|NCT02798523|101204372|FG000|NOT COMPLETED|4 Hours Then 2 Hours Post Infusion||0||
48356987|NCT02798523|101204373|FG001|NOT COMPLETED|4 Hours Then 2 Hours Post Infusion||0||
48356988|NCT01243593|101204374|FG000|STARTED|Overall Study||16||
48356989|NCT01243593|101204375|FG001|STARTED|Overall Study||16||
48356990|NCT01243593|101204374|FG000|COMPLETED|Overall Study||16||
48356991|NCT01243593|101204375|FG001|COMPLETED|Overall Study||16||
48356992|NCT01243593|101204374|FG000|NOT COMPLETED|Overall Study||0||
48356993|NCT01243593|101204375|FG001|NOT COMPLETED|Overall Study||0||
48356994|NCT00217438|101204376|FG000|STARTED|Overall Study||66||
48356995|NCT00217438|101204377|FG001|STARTED|Overall Study||64||
48356996|NCT00217438|101204376|FG000|COMPLETED|Overall Study||66||
48356997|NCT00217438|101204377|FG001|COMPLETED|Overall Study||63||
48418862|NCT00963820|101361553|FG005|STARTED|Dose Escalation Phase||3||
48418863|NCT00963820|101361554|FG006|STARTED|Dose Escalation Phase||8||
48418864|NCT00963820|101361555|FG007|STARTED|Dose Escalation Phase||5||
48418865|NCT00963820|101361556|FG008|STARTED|Dose Escalation Phase||0||
48418866|NCT00963820|101361557|FG009|STARTED|Dose Escalation Phase||0||
48418867|NCT00963820|101361558|FG010|STARTED|Dose Escalation Phase||0||
48418868|NCT00963820|101361559|FG011|STARTED|Dose Escalation Phase||0||
48418869|NCT00963820|101361548|FG000|COMPLETED|Dose Escalation Phase||0||
48418870|NCT00963820|101361549|FG001|COMPLETED|Dose Escalation Phase||0||
48418871|NCT00963820|101361550|FG002|COMPLETED|Dose Escalation Phase||0||
48356998|NCT00217438|101204376|FG000|NOT COMPLETED|Overall Study||0||
48356999|NCT00217438|101204377|FG001|NOT COMPLETED|Overall Study||1||
48357000|NCT02629393|101204378|FG000|STARTED|Overall Study||5||
48357001|NCT02629393|101204378|FG000|COMPLETED|Overall Study||2||
48357002|NCT02629393|101204378|FG000|NOT COMPLETED|Overall Study||3||
48357003|NCT02234011|101204379|FG000|STARTED|Overall Study||0||
48357004|NCT02234011|101204379|FG000|COMPLETED|Overall Study||0||
48357005|NCT02234011|101204379|FG000|NOT COMPLETED|Overall Study||0||
48357006|NCT01676116|101204380|FG000|STARTED|Overall Study||292||
48357007|NCT01676116|101204381|FG001|STARTED|Overall Study||146||
48357008|NCT01676116|101204380|FG000|COMPLETED|Overall Study||276||
48357009|NCT01676116|101204381|FG001|COMPLETED|Overall Study||117||
48357010|NCT01676116|101204380|FG000|NOT COMPLETED|Overall Study||16||
48357011|NCT01676116|101204381|FG001|NOT COMPLETED|Overall Study||29||
48357012|NCT01325493|101204382|FG000|STARTED|Overall Study||30||
48357013|NCT01325493|101204383|FG001|STARTED|Overall Study||24||
48357014|NCT01325493|101204382|FG000|COMPLETED|Overall Study||29||
48357015|NCT01325493|101204383|FG001|COMPLETED|Overall Study||21||
48357016|NCT01325493|101204382|FG000|NOT COMPLETED|Overall Study||1||
48418872|NCT00963820|101361551|FG003|COMPLETED|Dose Escalation Phase||0||
48357017|NCT01325493|101204383|FG001|NOT COMPLETED|Overall Study||3||
48357018|NCT03275870|101204384|FG000|STARTED|Overall Study||17||
48357019|NCT03275870|101204384|FG000|COMPLETED|Overall Study||3||
48357020|NCT03275870|101204384|FG000|NOT COMPLETED|Overall Study||14||
48357021|NCT03429556|101204385|FG000|STARTED|Overall Study||12||
48357022|NCT03429556|101204386|FG001|STARTED|Overall Study||4||
48357023|NCT03429556|101204387|FG002|STARTED|Overall Study||4||
48357024|NCT03429556|101204388|FG003|STARTED|Overall Study||3||
48357025|NCT03429556|101204385|FG000|COMPLETED|Overall Study||12||
48357026|NCT03429556|101204386|FG001|COMPLETED|Overall Study||3||
48357027|NCT03429556|101204387|FG002|COMPLETED|Overall Study||4||
48357028|NCT03429556|101204388|FG003|COMPLETED|Overall Study||3||
48357029|NCT03429556|101204385|FG000|NOT COMPLETED|Overall Study||0||
48357030|NCT03429556|101204386|FG001|NOT COMPLETED|Overall Study||1||
48357031|NCT03429556|101204387|FG002|NOT COMPLETED|Overall Study||0||
48357032|NCT03429556|101204388|FG003|NOT COMPLETED|Overall Study||0||
48357033|NCT00064701|101204389|FG000|STARTED|One Year Post-transplant||219||
48357034|NCT00064701|101204390|FG001|STARTED|One Year Post-transplant||226||
48357035|NCT00064701|101204391|FG002|STARTED|One Year Post-transplant||223||
48357036|NCT00064701|101204389|FG000|Received Study Drug|One Year Post-transplant||212||
48357037|NCT00064701|101204390|FG001|Received Study Drug|One Year Post-transplant||214||
48357038|NCT00064701|101204391|FG002|Received Study Drug|One Year Post-transplant||212||
48357039|NCT00064701|101204389|FG000|COMPLETED|One Year Post-transplant||179||
48357040|NCT00064701|101204390|FG001|COMPLETED|One Year Post-transplant||183||
48357041|NCT00064701|101204391|FG002|COMPLETED|One Year Post-transplant||151||
48357042|NCT00064701|101204389|FG000|NOT COMPLETED|One Year Post-transplant||40||
48357043|NCT00064701|101204390|FG001|NOT COMPLETED|One Year Post-transplant||43||
48357044|NCT00064701|101204391|FG002|NOT COMPLETED|One Year Post-transplant||72||
48357045|NCT00064701|101204389|FG000|STARTED|Clinical Continuation Phase||179||
48357046|NCT00064701|101204390|FG001|STARTED|Clinical Continuation Phase||182||
48357047|NCT00064701|101204391|FG002|STARTED|Clinical Continuation Phase||151||
48357048|NCT00064701|101204389|FG000|COMPLETED|Clinical Continuation Phase||9||
48357049|NCT00064701|101204390|FG001|COMPLETED|Clinical Continuation Phase||4||
48357050|NCT00064701|101204391|FG002|COMPLETED|Clinical Continuation Phase||11||
48357051|NCT00064701|101204389|FG000|NOT COMPLETED|Clinical Continuation Phase||170||
48357052|NCT00064701|101204390|FG001|NOT COMPLETED|Clinical Continuation Phase||178||
48357053|NCT00064701|101204391|FG002|NOT COMPLETED|Clinical Continuation Phase||140||
48418873|NCT00963820|101361552|FG004|COMPLETED|Dose Escalation Phase||0||
48762712|NCT02849418|102206093|FG004|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0||
48762713|NCT02849418|102206094|FG005|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0||
48762714|NCT02849418|102206089|FG000|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0||
48762715|NCT02849418|102206090|FG001|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0||
48762716|NCT02849418|102206091|FG002|STARTED|Open-label(2nd Treatment-Week 12 to 48)||10||
48762717|NCT02849418|102206092|FG003|STARTED|Open-label(2nd Treatment-Week 12 to 48)||6||
48762718|NCT02849418|102206093|FG004|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0||
48762719|NCT02849418|102206094|FG005|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0||
48762720|NCT02849418|102206089|FG000|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0||
48762721|NCT02849418|102206090|FG001|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0||
48762722|NCT02849418|102206091|FG002|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||10||
48762723|NCT02849418|102206092|FG003|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||6||
48762724|NCT02849418|102206093|FG004|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0||
48762725|NCT02849418|102206094|FG005|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0||
48762726|NCT02849418|102206089|FG000|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0||
48762727|NCT02849418|102206090|FG001|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0||
48762728|NCT02849418|102206091|FG002|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0||
48762729|NCT02849418|102206092|FG003|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0||
48762730|NCT02849418|102206093|FG004|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0||
48762731|NCT02849418|102206094|FG005|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0||
48762732|NCT02849418|102206089|FG000|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0||
48762733|NCT02849418|102206090|FG001|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0||
48762734|NCT02849418|102206091|FG002|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0||
48762735|NCT02849418|102206092|FG003|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0||
48762736|NCT02849418|102206093|FG004|STARTED|Open-label(3rd Treatment-Week 12 to 48)||5||
48762737|NCT02849418|102206094|FG005|STARTED|Open-label(3rd Treatment-Week 12 to 48)||3||
48762738|NCT02849418|102206089|FG000|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0||
48762739|NCT02849418|102206090|FG001|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0||
48762740|NCT02849418|102206091|FG002|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0||
48762741|NCT02849418|102206092|FG003|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0||
48357054|NCT02048878|101204392|FG000|STARTED|Overall Study||13||
48357055|NCT02048878|101204393|FG001|STARTED|Overall Study||15||
48357056|NCT02048878|101204392|FG000|COMPLETED|Overall Study||12||
48357057|NCT02048878|101204393|FG001|COMPLETED|Overall Study||12||
48357058|NCT02048878|101204392|FG000|NOT COMPLETED|Overall Study||1||
48357059|NCT02048878|101204393|FG001|NOT COMPLETED|Overall Study||3||
48357060|NCT00814710|101204394|FG000|STARTED|Overall Study||240||
48762742|NCT02849418|102206093|FG004|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||5||
48762743|NCT02849418|102206094|FG005|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||3||
48762744|NCT02849418|102206089|FG000|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0||
48762745|NCT02849418|102206090|FG001|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0||
48762746|NCT02849418|102206091|FG002|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0||
48762747|NCT02849418|102206092|FG003|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0||
48762748|NCT02849418|102206093|FG004|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0||
48762749|NCT02849418|102206094|FG005|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0||
48762750|NCT03521570|102206095|FG000|STARTED|Overall Study||62||
48762751|NCT03521570|102206095|FG000|COMPLETED|Overall Study||51||
48762752|NCT03521570|102206095|FG000|NOT COMPLETED|Overall Study||11||
48762753|NCT00966654|102206096|FG000|STARTED|Overall Study||12||
48762754|NCT00966654|102206096|FG000|COMPLETED|Overall Study||0||
48762755|NCT00966654|102206096|FG000|NOT COMPLETED|Overall Study||12||
48762756|NCT02991768|102206097|FG000|STARTED|Overall Study||9||
48762757|NCT02991768|102206097|FG000|COMPLETED|Overall Study||5||
48762758|NCT02991768|102206097|FG000|NOT COMPLETED|Overall Study||4||
48762759|NCT02967991|102206098|FG000|STARTED|Overall Study||10||
48762760|NCT02967991|102206099|FG001|STARTED|Overall Study||10||
48762761|NCT02967991|102206098|FG000|COMPLETED|Overall Study||10||
48762762|NCT02967991|102206099|FG001|COMPLETED|Overall Study||10||
48762763|NCT02967991|102206098|FG000|NOT COMPLETED|Overall Study||0||
48762764|NCT02967991|102206099|FG001|NOT COMPLETED|Overall Study||0||
48762765|NCT02514083|102206100|FG000|STARTED|Overall Study||29||
48762766|NCT02514083|102206100|FG000|COMPLETED|Overall Study||28||
48762767|NCT02514083|102206100|FG000|NOT COMPLETED|Overall Study||1||
48762768|NCT05249582|102206101|FG000|STARTED|Overall Study||33||
48762769|NCT05249582|102206102|FG001|STARTED|Overall Study||31||
48762770|NCT05249582|102206101|FG000|COMPLETED|Overall Study||30||
48762771|NCT05249582|102206102|FG001|COMPLETED|Overall Study||30||
48762772|NCT05249582|102206101|FG000|NOT COMPLETED|Overall Study||3||
48762773|NCT05249582|102206102|FG001|NOT COMPLETED|Overall Study||1||
48762774|NCT06047210|102206103|FG000|STARTED|Overall Study||10||
48762775|NCT06047210|102206104|FG001|STARTED|Overall Study||4||
48762776|NCT06047210|102206103|FG000|COMPLETED|Overall Study||10||
48762777|NCT06047210|102206104|FG001|COMPLETED|Overall Study||4||
48762778|NCT06047210|102206103|FG000|NOT COMPLETED|Overall Study||0||
48762779|NCT06047210|102206104|FG001|NOT COMPLETED|Overall Study||0||
48762780|NCT00281463|102206105|FG000|STARTED|Overall Study||45||
48762781|NCT00281463|102206105|FG000|COMPLETED|Overall Study||45||
48762782|NCT00281463|102206105|FG000|NOT COMPLETED|Overall Study||0||
48762783|NCT01243190|102206106|FG000|STARTED|Overall Study||44||
48762784|NCT01243190|102206106|FG000|COMPLETED|Overall Study||44||
48762785|NCT01243190|102206106|FG000|NOT COMPLETED|Overall Study||0||
48762786|NCT03094416|102206107|FG000|STARTED|Run-in||66||
48762787|NCT03094416|102206107|FG000|COMPLETED|Run-in||47||
48762788|NCT03094416|102206107|FG000|NOT COMPLETED|Run-in||19||
48762789|NCT03094416|102206107|FG000|STARTED|Treatment Period||47||
48762790|NCT03094416|102206107|FG000|COMPLETED|Treatment Period||45||
48762791|NCT03094416|102206107|FG000|NOT COMPLETED|Treatment Period||2||
48762792|NCT03557294|102206108|FG000|STARTED|Overall Study||104||
48762793|NCT03557294|102206109|FG001|STARTED|Overall Study||104||
48762794|NCT03557294|102206110|FG002|STARTED|Overall Study||105||
48762795|NCT03557294|102206108|FG000|COMPLETED|Overall Study||70||
48762796|NCT03557294|102206109|FG001|COMPLETED|Overall Study||66||
48762797|NCT03557294|102206110|FG002|COMPLETED|Overall Study||76||
48762798|NCT03557294|102206108|FG000|NOT COMPLETED|Overall Study||34||
48762799|NCT03557294|102206109|FG001|NOT COMPLETED|Overall Study||38||
48762800|NCT03557294|102206110|FG002|NOT COMPLETED|Overall Study||29||
48762801|NCT03133221|102206111|FG000|STARTED|Overall Study||17||
48762802|NCT03133221|102206111|FG000|COMPLETED|Overall Study||17||
48762803|NCT03133221|102206111|FG000|NOT COMPLETED|Overall Study||0||
48762804|NCT02903771|102206112|FG000|STARTED|Part A: Dose Escalation Cohort||2||
48762805|NCT02903771|102206113|FG001|STARTED|Part A: Dose Escalation Cohort||1||
48762806|NCT02903771|102206114|FG002|STARTED|Part A: Dose Escalation Cohort||1||
48762807|NCT02903771|102206115|FG003|STARTED|Part A: Dose Escalation Cohort||1||
48762808|NCT02903771|102206116|FG004|STARTED|Part A: Dose Escalation Cohort||3||
48762809|NCT02903771|102206117|FG005|STARTED|Part A: Dose Escalation Cohort||2||
48762810|NCT02903771|102206118|FG006|STARTED|Part A: Dose Escalation Cohort||1||
48762811|NCT02903771|102206112|FG000|COMPLETED|Part A: Dose Escalation Cohort||1|Completed 8 cycles of Cantrixil therapy|
48762812|NCT02903771|102206113|FG001|COMPLETED|Part A: Dose Escalation Cohort||0|Completed 8 cycles of Cantrixil therapy|
48762813|NCT02903771|102206114|FG002|COMPLETED|Part A: Dose Escalation Cohort||0|Completed 8 cycles of Cantrixil therapy|
48762814|NCT02903771|102206115|FG003|COMPLETED|Part A: Dose Escalation Cohort||1|Completed 8 cycles of Cantrixil therapy|
48767779|NCT04139018|102222824|FG001|NOT COMPLETED|Overall Study||1||
48762815|NCT02903771|102206116|FG004|COMPLETED|Part A: Dose Escalation Cohort||2|Completed 8 cycles of Cantrixil therapy|
48762816|NCT02903771|102206117|FG005|COMPLETED|Part A: Dose Escalation Cohort||0|Completed 8 cycles of Cantrixil therapy|
48762817|NCT02903771|102206118|FG006|COMPLETED|Part A: Dose Escalation Cohort||0|Completed 8 cycles of Cantrixil therapy|
48762818|NCT02903771|102206112|FG000|NOT COMPLETED|Part A: Dose Escalation Cohort||1||
48762819|NCT02903771|102206113|FG001|NOT COMPLETED|Part A: Dose Escalation Cohort||1||
48762820|NCT02903771|102206114|FG002|NOT COMPLETED|Part A: Dose Escalation Cohort||1||
48762821|NCT02903771|102206115|FG003|NOT COMPLETED|Part A: Dose Escalation Cohort||0||
48762822|NCT02903771|102206116|FG004|NOT COMPLETED|Part A: Dose Escalation Cohort||1||
48762823|NCT02903771|102206117|FG005|NOT COMPLETED|Part A: Dose Escalation Cohort||2||
48762824|NCT02903771|102206118|FG006|NOT COMPLETED|Part A: Dose Escalation Cohort||1||
48357061|NCT00814710|101204395|FG001|STARTED|Overall Study||120||
48357062|NCT00814710|101204394|FG000|COMPLETED|Overall Study||232||
48357063|NCT00814710|101204395|FG001|COMPLETED|Overall Study||117||
48357064|NCT00814710|101204394|FG000|NOT COMPLETED|Overall Study||8||
48357065|NCT00814710|101204395|FG001|NOT COMPLETED|Overall Study||3||
48357066|NCT01745055|101204396|FG000|STARTED|Overall Study||12||
48357067|NCT01745055|101204396|FG000|COMPLETED|Overall Study||12||
48357068|NCT01745055|101204396|FG000|NOT COMPLETED|Overall Study||0||
48357069|NCT00850499|101204397|FG000|STARTED|Overall Study||4||
48357070|NCT00850499|101204398|FG001|STARTED|Overall Study||8||
48357071|NCT00850499|101204397|FG000|COMPLETED|Overall Study||1||
48357072|NCT00850499|101204398|FG001|COMPLETED|Overall Study||6||
48357073|NCT00850499|101204397|FG000|NOT COMPLETED|Overall Study||3||
48357074|NCT00850499|101204398|FG001|NOT COMPLETED|Overall Study||2||
48357075|NCT00852930|101204399|FG000|STARTED|Overall Study||16||
48357076|NCT00852930|101204400|FG001|STARTED|Overall Study||17||
48357077|NCT00852930|101204401|FG002|STARTED|Overall Study||17||
48357078|NCT00852930|101204399|FG000|COMPLETED|Overall Study||15||
48357079|NCT00852930|101204400|FG001|COMPLETED|Overall Study||16||
48357080|NCT00852930|101204401|FG002|COMPLETED|Overall Study||15||
48357081|NCT00852930|101204399|FG000|NOT COMPLETED|Overall Study||1||
48357082|NCT00852930|101204400|FG001|NOT COMPLETED|Overall Study||1||
48357083|NCT00852930|101204401|FG002|NOT COMPLETED|Overall Study||2||
48357084|NCT02786537|101204402|FG000|STARTED|As Randomized||56||
48357085|NCT02786537|101204403|FG001|STARTED|As Randomized||644||
48357086|NCT02786537|101204404|FG002|STARTED|As Randomized||15||
48357087|NCT02786537|101204405|FG003|STARTED|As Randomized||413||
48357088|NCT02786537|101204406|FG004|STARTED|As Randomized||99||
48357089|NCT02786537|101204407|FG005|STARTED|As Randomized||48||
48357090|NCT02786537|101204402|FG000|COMPLETED|As Randomized||50||
48357091|NCT02786537|101204403|FG001|COMPLETED|As Randomized||582||
48357092|NCT02786537|101204404|FG002|COMPLETED|As Randomized||15||
48357093|NCT02786537|101204405|FG003|COMPLETED|As Randomized||378||
48357094|NCT02786537|101204406|FG004|COMPLETED|As Randomized||87||
48762825|NCT02903771|102206112|FG000|STARTED|Part B: Expansion Cohort (5 mg/kg)||0||
48762826|NCT02903771|102206113|FG001|STARTED|Part B: Expansion Cohort (5 mg/kg)||0||
48762827|NCT02903771|102206114|FG002|STARTED|Part B: Expansion Cohort (5 mg/kg)||0||
48762828|NCT02903771|102206115|FG003|STARTED|Part B: Expansion Cohort (5 mg/kg)||0||
48762829|NCT02903771|102206116|FG004|STARTED|Part B: Expansion Cohort (5 mg/kg)||14||
48762830|NCT02903771|102206117|FG005|STARTED|Part B: Expansion Cohort (5 mg/kg)||0||
48762831|NCT02903771|102206118|FG006|STARTED|Part B: Expansion Cohort (5 mg/kg)||0||
48762832|NCT02903771|102206112|FG000|COMPLETED|Part B: Expansion Cohort (5 mg/kg)||0|Completed 8 cycles of Cantrixil therapy|
48762833|NCT02903771|102206113|FG001|COMPLETED|Part B: Expansion Cohort (5 mg/kg)||0|Completed 8 cycles of Cantrixil therapy|
48762834|NCT02903771|102206114|FG002|COMPLETED|Part B: Expansion Cohort (5 mg/kg)||0|Completed 8 cycles of Cantrixil therapy|
48762835|NCT02903771|102206115|FG003|COMPLETED|Part B: Expansion Cohort (5 mg/kg)||0|Completed 8 cycles of Cantrixil therapy|
48762836|NCT02903771|102206116|FG004|COMPLETED|Part B: Expansion Cohort (5 mg/kg)||2|Completed 8 cycles of Cantrixil therapy|
48762837|NCT02903771|102206117|FG005|COMPLETED|Part B: Expansion Cohort (5 mg/kg)||0|Completed 8 cycles of Cantrixil therapy|
48762838|NCT02903771|102206118|FG006|COMPLETED|Part B: Expansion Cohort (5 mg/kg)||0|Completed 8 cycles of Cantrixil therapy|
48762839|NCT02903771|102206112|FG000|NOT COMPLETED|Part B: Expansion Cohort (5 mg/kg)||0||
48762840|NCT02903771|102206113|FG001|NOT COMPLETED|Part B: Expansion Cohort (5 mg/kg)||0||
48762841|NCT02903771|102206114|FG002|NOT COMPLETED|Part B: Expansion Cohort (5 mg/kg)||0||
48762842|NCT02903771|102206115|FG003|NOT COMPLETED|Part B: Expansion Cohort (5 mg/kg)||0||
48357095|NCT02786537|101204407|FG005|COMPLETED|As Randomized||41||
48357096|NCT02786537|101204402|FG000|NOT COMPLETED|As Randomized||6||
48357097|NCT02786537|101204403|FG001|NOT COMPLETED|As Randomized||62||
48357098|NCT02786537|101204404|FG002|NOT COMPLETED|As Randomized||0||
48357099|NCT02786537|101204405|FG003|NOT COMPLETED|As Randomized||35||
48357100|NCT02786537|101204406|FG004|NOT COMPLETED|As Randomized||12||
48357101|NCT02786537|101204407|FG005|NOT COMPLETED|As Randomized||7||
48357102|NCT02786537|101204402|FG000|STARTED|As Treated||56|Numbers represent treatment regimen that study participant actually started (received).|
48357103|NCT02786537|101204403|FG001|STARTED|As Treated||664|Numbers represent treatment regimen that study participant actually started (received).|
48357104|NCT02786537|101204404|FG002|STARTED|As Treated||15|Numbers represent treatment regimen that study participant actually started (received).|
48357105|NCT02786537|101204405|FG003|STARTED|As Treated||394|Numbers represent treatment regimen that study participant actually started (received).|
48357106|NCT02786537|101204406|FG004|STARTED|As Treated||99|Numbers represent treatment regimen that study participant actually started (received).|
48357107|NCT02786537|101204407|FG005|STARTED|As Treated||47|Numbers represent treatment regimen that study participant actually started (received).|
48357108|NCT02786537|101204402|FG000|COMPLETED|As Treated||50||
48357109|NCT02786537|101204403|FG001|COMPLETED|As Treated||602||
48357110|NCT02786537|101204404|FG002|COMPLETED|As Treated||15||
48357111|NCT02786537|101204405|FG003|COMPLETED|As Treated||359||
48357112|NCT02786537|101204406|FG004|COMPLETED|As Treated||87||
48357113|NCT02786537|101204407|FG005|COMPLETED|As Treated||40||
48357114|NCT02786537|101204402|FG000|NOT COMPLETED|As Treated||6||
48357115|NCT02786537|101204403|FG001|NOT COMPLETED|As Treated||62||
48357116|NCT02786537|101204404|FG002|NOT COMPLETED|As Treated||0||
48357117|NCT02786537|101204405|FG003|NOT COMPLETED|As Treated||35||
48357118|NCT02786537|101204406|FG004|NOT COMPLETED|As Treated||12||
48357119|NCT02786537|101204407|FG005|NOT COMPLETED|As Treated||7||
48357120|NCT01824602|101204408|FG000|STARTED|Overall Study||11||
48762843|NCT02903771|102206116|FG004|NOT COMPLETED|Part B: Expansion Cohort (5 mg/kg)||12||
48762844|NCT02903771|102206117|FG005|NOT COMPLETED|Part B: Expansion Cohort (5 mg/kg)||0||
48762845|NCT02903771|102206118|FG006|NOT COMPLETED|Part B: Expansion Cohort (5 mg/kg)||0||
48762846|NCT01349543|102206119|FG000|STARTED|Overall Study||58||
48762847|NCT01349543|102206119|FG000|COMPLETED|Overall Study||58||
48762848|NCT01349543|102206119|FG000|NOT COMPLETED|Overall Study||0||
48357121|NCT01824602|101204409|FG001|STARTED|Overall Study||8||
48357122|NCT01824602|101204410|FG002|STARTED|Overall Study||9||
48357123|NCT01824602|101204411|FG003|STARTED|Overall Study||10||
48418874|NCT00963820|101361553|FG005|COMPLETED|Dose Escalation Phase||0||
48418875|NCT00963820|101361554|FG006|COMPLETED|Dose Escalation Phase||0||
48418876|NCT00963820|101361555|FG007|COMPLETED|Dose Escalation Phase||0||
48418877|NCT00963820|101361556|FG008|COMPLETED|Dose Escalation Phase||0||
48418878|NCT00963820|101361557|FG009|COMPLETED|Dose Escalation Phase||0||
48418879|NCT00963820|101361558|FG010|COMPLETED|Dose Escalation Phase||0||
48418880|NCT00963820|101361559|FG011|COMPLETED|Dose Escalation Phase||0||
48418881|NCT00963820|101361548|FG000|NOT COMPLETED|Dose Escalation Phase||3||
48418882|NCT00963820|101361549|FG001|NOT COMPLETED|Dose Escalation Phase||3||
48357124|NCT01824602|101204408|FG000|Safety Population|Overall Study||11||
48357125|NCT01824602|101204409|FG001|Safety Population|Overall Study||8||
48418883|NCT00963820|101361550|FG002|NOT COMPLETED|Dose Escalation Phase||3||
48418884|NCT00963820|101361551|FG003|NOT COMPLETED|Dose Escalation Phase||3||
48418885|NCT00963820|101361552|FG004|NOT COMPLETED|Dose Escalation Phase||4||
48418886|NCT00963820|101361553|FG005|NOT COMPLETED|Dose Escalation Phase||3||
48418887|NCT00963820|101361554|FG006|NOT COMPLETED|Dose Escalation Phase||8||
48418888|NCT00963820|101361555|FG007|NOT COMPLETED|Dose Escalation Phase||5||
48418889|NCT00963820|101361556|FG008|NOT COMPLETED|Dose Escalation Phase||0||
48418890|NCT00963820|101361557|FG009|NOT COMPLETED|Dose Escalation Phase||0||
48418891|NCT00963820|101361558|FG010|NOT COMPLETED|Dose Escalation Phase||0||
48418892|NCT00963820|101361559|FG011|NOT COMPLETED|Dose Escalation Phase||0||
48418893|NCT00963820|101361548|FG000|STARTED|Expansion Phase||0||
48418894|NCT00963820|101361549|FG001|STARTED|Expansion Phase||0||
48418895|NCT00963820|101361550|FG002|STARTED|Expansion Phase||0||
48418896|NCT00963820|101361551|FG003|STARTED|Expansion Phase||0||
48418897|NCT00963820|101361552|FG004|STARTED|Expansion Phase||0||
48418898|NCT00963820|101361553|FG005|STARTED|Expansion Phase||0||
48418899|NCT00963820|101361554|FG006|STARTED|Expansion Phase||0||
48418900|NCT00963820|101361555|FG007|STARTED|Expansion Phase||0||
48418901|NCT00963820|101361556|FG008|STARTED|Expansion Phase||11||
48418902|NCT00963820|101361557|FG009|STARTED|Expansion Phase||10||
48418903|NCT00963820|101361558|FG010|STARTED|Expansion Phase||6||
48418904|NCT00963820|101361559|FG011|STARTED|Expansion Phase||4||
48418905|NCT00963820|101361548|FG000|COMPLETED|Expansion Phase||0||
48418906|NCT00963820|101361549|FG001|COMPLETED|Expansion Phase||0||
48418907|NCT00963820|101361550|FG002|COMPLETED|Expansion Phase||0||
48357126|NCT01824602|101204410|FG002|Safety Population|Overall Study||9||
48418908|NCT00963820|101361551|FG003|COMPLETED|Expansion Phase||0||
48418909|NCT00963820|101361552|FG004|COMPLETED|Expansion Phase||0||
48418910|NCT00963820|101361553|FG005|COMPLETED|Expansion Phase||0||
48762849|NCT04532528|102206120|FG000|STARTED|Overall Study||441|Subjects who started the study.|
48762850|NCT04532528|102206121|FG001|STARTED|Overall Study||432|Subjects who started the study.|
48762851|NCT04532528|102206120|FG000|3 Months|Overall Study||368|Subjects who completed the 3 months visit.|
48762852|NCT04532528|102206121|FG001|3 Months|Overall Study||366|Subjects who completed the 3 months visit.|
48762853|NCT04532528|102206120|FG000|6 Months|Overall Study||308|Subjects who completed the 6 months visit.|
48418911|NCT00963820|101361554|FG006|COMPLETED|Expansion Phase||0||
48357127|NCT01824602|101204411|FG003|Safety Population|Overall Study||10||
48418912|NCT00963820|101361555|FG007|COMPLETED|Expansion Phase||0||
48418913|NCT00963820|101361556|FG008|COMPLETED|Expansion Phase||1||
48418914|NCT00963820|101361557|FG009|COMPLETED|Expansion Phase||1||
48418915|NCT00963820|101361558|FG010|COMPLETED|Expansion Phase||1||
48418916|NCT00963820|101361559|FG011|COMPLETED|Expansion Phase||0||
48418917|NCT00963820|101361548|FG000|NOT COMPLETED|Expansion Phase||0||
48418918|NCT00963820|101361549|FG001|NOT COMPLETED|Expansion Phase||0||
48418919|NCT00963820|101361550|FG002|NOT COMPLETED|Expansion Phase||0||
48418920|NCT00963820|101361551|FG003|NOT COMPLETED|Expansion Phase||0||
48418921|NCT00963820|101361552|FG004|NOT COMPLETED|Expansion Phase||0||
48418922|NCT00963820|101361553|FG005|NOT COMPLETED|Expansion Phase||0||
48418923|NCT00963820|101361554|FG006|NOT COMPLETED|Expansion Phase||0||
48418924|NCT00963820|101361555|FG007|NOT COMPLETED|Expansion Phase||0||
48418925|NCT00963820|101361556|FG008|NOT COMPLETED|Expansion Phase||10||
48418926|NCT00963820|101361557|FG009|NOT COMPLETED|Expansion Phase||9||
48418927|NCT00963820|101361558|FG010|NOT COMPLETED|Expansion Phase||5||
48418928|NCT00963820|101361559|FG011|NOT COMPLETED|Expansion Phase||4||
48418929|NCT00352027|101361560|FG000|STARTED|Overall Study||80||
48418930|NCT00352027|101361560|FG000|COMPLETED|Overall Study||77||
48418931|NCT00352027|101361560|FG000|NOT COMPLETED|Overall Study||3||
48418932|NCT02269709|101361561|FG000|STARTED|Time of Enrollment||21||
48418933|NCT02269709|101361561|FG000|COMPLETED|Time of Enrollment||18|Three patients withdrew before the start of the study.|
48762854|NCT04532528|102206121|FG001|6 Months|Overall Study||312|Subjects who completed the 6 months visit.|
48762855|NCT04532528|102206120|FG000|9 Months|Overall Study||286|Subjects who completed the 9 months visit.|
48762856|NCT04532528|102206121|FG001|9 Months|Overall Study||266|Subjects who completed the 9 months visit.|
48762857|NCT04532528|102206120|FG000|12 Months|Overall Study||271|Subjects who completed the 12 months visit.|
48762858|NCT04532528|102206121|FG001|12 Months|Overall Study||246|Subjects who completed the 12 months visit.|
48762859|NCT04532528|102206120|FG000|COMPLETED|Overall Study||269|Subjects who completed the study completion visit.|
48762860|NCT04532528|102206121|FG001|COMPLETED|Overall Study||243|Subjects who completed the study completion visit.|
48762861|NCT04532528|102206120|FG000|NOT COMPLETED|Overall Study||172||
48762862|NCT04532528|102206121|FG001|NOT COMPLETED|Overall Study||189||
48762863|NCT05220436|102206122|FG000|STARTED|Overall Study||10||
48762864|NCT05220436|102206122|FG000|COMPLETED|Overall Study||7||
48357128|NCT01824602|101204408|FG000|Intent-to-treat Population|Overall Study||11||
48357129|NCT01824602|101204409|FG001|Intent-to-treat Population|Overall Study||8||
48357130|NCT01824602|101204410|FG002|Intent-to-treat Population|Overall Study||9||
48357131|NCT01824602|101204411|FG003|Intent-to-treat Population|Overall Study||9||
48357132|NCT01824602|101204408|FG000|COMPLETED|Overall Study||10||
48357133|NCT01824602|101204409|FG001|COMPLETED|Overall Study||8||
48357134|NCT01824602|101204410|FG002|COMPLETED|Overall Study||5||
48357135|NCT01824602|101204411|FG003|COMPLETED|Overall Study||5||
48357136|NCT01824602|101204408|FG000|NOT COMPLETED|Overall Study||1||
48357137|NCT01824602|101204409|FG001|NOT COMPLETED|Overall Study||0||
48357138|NCT01824602|101204410|FG002|NOT COMPLETED|Overall Study||4||
48357139|NCT01824602|101204411|FG003|NOT COMPLETED|Overall Study||5||
48418934|NCT02269709|101361561|FG000|NOT COMPLETED|Time of Enrollment||3||
48418935|NCT02269709|101361561|FG000|STARTED|Follow-up #1 (24-72 Hours Post-surgery)||18||
48418936|NCT02269709|101361561|FG000|COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||17||
48418937|NCT02269709|101361561|FG000|NOT COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||1||
48418938|NCT02269709|101361561|FG000|STARTED|Prior to Hospital Discharge||17||
48418939|NCT02269709|101361561|FG000|COMPLETED|Prior to Hospital Discharge||17||
48418940|NCT02269709|101361561|FG000|NOT COMPLETED|Prior to Hospital Discharge||0||
48418941|NCT02269709|101361561|FG000|STARTED|Six Month Follow-up||17||
48638687|NCT02143648|101901471|FG000|STARTED|Overall Study||128||
48638688|NCT02143648|101901472|FG001|STARTED|Overall Study||120||
48638689|NCT02143648|101901473|FG002|STARTED|Overall Study||125||
48638690|NCT02143648|101901471|FG000|COMPLETED|Overall Study||74||
48638691|NCT02143648|101901472|FG001|COMPLETED|Overall Study||78||
48638692|NCT02143648|101901473|FG002|COMPLETED|Overall Study||101||
48638693|NCT02143648|101901471|FG000|NOT COMPLETED|Overall Study||54||
48638694|NCT02143648|101901472|FG001|NOT COMPLETED|Overall Study||42||
48638695|NCT02143648|101901473|FG002|NOT COMPLETED|Overall Study||24||
48638696|NCT02880176|101901474|FG000|STARTED|Overall Study||23||
48638697|NCT02880176|101901475|FG001|STARTED|Overall Study||11||
48638698|NCT02880176|101901474|FG000|Underwent Cystectomy|Overall Study||22||
48638699|NCT02880176|101901475|FG001|Underwent Cystectomy|Overall Study||11||
48638700|NCT02880176|101901474|FG000|Collected Postop Step Data|Overall Study||22||
48762865|NCT05220436|102206122|FG000|NOT COMPLETED|Overall Study||3||
48762866|NCT02081677|102206123|FG000|STARTED|Overall Study||19||
48762867|NCT02081677|102206124|FG001|STARTED|Overall Study||19||
48762868|NCT02081677|102206125|FG002|STARTED|Overall Study||19||
48762869|NCT02081677|102206126|FG003|STARTED|Overall Study||19||
48762870|NCT02081677|102206123|FG000|COMPLETED|Overall Study||18||
48762871|NCT02081677|102206124|FG001|COMPLETED|Overall Study||18||
48762872|NCT02081677|102206125|FG002|COMPLETED|Overall Study||17||
48638701|NCT02880176|101901475|FG001|Collected Postop Step Data|Overall Study||11||
48357140|NCT05444244|101204412|FG000|STARTED|Overall Study||182||
48418942|NCT02269709|101361561|FG000|COMPLETED|Six Month Follow-up||5||
48357141|NCT05444244|101204413|FG001|STARTED|Overall Study||0||
48418943|NCT02269709|101361561|FG000|NOT COMPLETED|Six Month Follow-up||12||
48638702|NCT02880176|101901474|FG000|Responded to 30 Day Survey|Overall Study||20||
48657032|NCT02018809|101943755|FG002|COMPLETED|Overall Study||50||
48357142|NCT05444244|101204412|FG000|COMPLETED|Overall Study||182||
48357143|NCT05444244|101204413|FG001|COMPLETED|Overall Study||0||
48357144|NCT05444244|101204412|FG000|NOT COMPLETED|Overall Study||0||
48357145|NCT05444244|101204413|FG001|NOT COMPLETED|Overall Study||0||
48357146|NCT03294304|101204414|FG000|STARTED|Overall Study||43||
48357147|NCT03294304|101204414|FG000|COMPLETED|Overall Study||43||
48357148|NCT03294304|101204414|FG000|NOT COMPLETED|Overall Study||0||
48357149|NCT02623361|101204415|FG000|STARTED|Overall Study||40||
48357150|NCT02623361|101204416|FG001|STARTED|Overall Study||40||
48357151|NCT02623361|101204415|FG000|COMPLETED|Overall Study||40||
48357152|NCT02623361|101204416|FG001|COMPLETED|Overall Study||38||
48357153|NCT02623361|101204415|FG000|NOT COMPLETED|Overall Study||0||
48357154|NCT02623361|101204416|FG001|NOT COMPLETED|Overall Study||2||
48357155|NCT00946270|101204417|FG000|STARTED|Overall Study||21||
48357156|NCT00946270|101204418|FG001|STARTED|Overall Study||20||
48357157|NCT00946270|101204419|FG002|STARTED|Overall Study||29||
48357158|NCT00946270|101204417|FG000|COMPLETED|Overall Study||21||
48357159|NCT00946270|101204418|FG001|COMPLETED|Overall Study||20||
48357160|NCT00946270|101204419|FG002|COMPLETED|Overall Study||29||
48357161|NCT00946270|101204417|FG000|NOT COMPLETED|Overall Study||0||
48357162|NCT00946270|101204418|FG001|NOT COMPLETED|Overall Study||0||
48357163|NCT00946270|101204419|FG002|NOT COMPLETED|Overall Study||0||
48357164|NCT02873221|101204420|FG000|STARTED|Treatment Period||417||
48357165|NCT02873221|101204421|FG001|STARTED|Treatment Period||417||
48357166|NCT02873221|101204422|FG002|STARTED|Treatment Period||420||
48357167|NCT02873221|101204420|FG000|Safety Population: Received Study Drug|Treatment Period||417||
48357168|NCT02873221|101204421|FG001|Safety Population: Received Study Drug|Treatment Period||404||
48357169|NCT02873221|101204422|FG002|Safety Population: Received Study Drug|Treatment Period||409||
48357170|NCT02873221|101204420|FG000|COMPLETED|Treatment Period||329||
48357171|NCT02873221|101204421|FG001|COMPLETED|Treatment Period||291||
48357172|NCT02873221|101204422|FG002|COMPLETED|Treatment Period||315||
48357173|NCT02873221|101204420|FG000|NOT COMPLETED|Treatment Period||88||
48357174|NCT02873221|101204421|FG001|NOT COMPLETED|Treatment Period||126||
48357175|NCT02873221|101204422|FG002|NOT COMPLETED|Treatment Period||105||
48357176|NCT02873221|101204420|FG000|STARTED|Safety Follow-up Period||350||
48357177|NCT02873221|101204421|FG001|STARTED|Safety Follow-up Period||356||
48357178|NCT02873221|101204422|FG002|STARTED|Safety Follow-up Period||364||
48357179|NCT02873221|101204420|FG000|COMPLETED|Safety Follow-up Period||343||
48357180|NCT02873221|101204421|FG001|COMPLETED|Safety Follow-up Period||339||
48357181|NCT02873221|101204422|FG002|COMPLETED|Safety Follow-up Period||350||
48357182|NCT02873221|101204420|FG000|NOT COMPLETED|Safety Follow-up Period||7||
48357183|NCT02873221|101204421|FG001|NOT COMPLETED|Safety Follow-up Period||17||
48357184|NCT02873221|101204422|FG002|NOT COMPLETED|Safety Follow-up Period||14||
48357185|NCT01593748|101204423|FG000|STARTED|Overall Study||45||
48357186|NCT01593748|101204424|FG001|STARTED|Overall Study||45||
48357187|NCT01593748|101204423|FG000|COMPLETED|Overall Study||45||
48357188|NCT01593748|101204424|FG001|COMPLETED|Overall Study||45||
48357189|NCT01593748|101204423|FG000|NOT COMPLETED|Overall Study||0||
48357190|NCT01593748|101204424|FG001|NOT COMPLETED|Overall Study||0||
48357191|NCT01919411|101204425|FG000|STARTED|Overall Study||43||
48357192|NCT01919411|101204426|FG001|STARTED|Overall Study||46||
48357193|NCT01919411|101204425|FG000|COMPLETED|Overall Study||38||
48357194|NCT01919411|101204426|FG001|COMPLETED|Overall Study||41||
48357195|NCT01919411|101204425|FG000|NOT COMPLETED|Overall Study||5||
48357196|NCT01919411|101204426|FG001|NOT COMPLETED|Overall Study||5||
48357197|NCT05421754|101204427|FG000|STARTED|Overall Study||30||
48357198|NCT05421754|101204427|FG000|COMPLETED|Overall Study||29||
48357199|NCT05421754|101204427|FG000|NOT COMPLETED|Overall Study||1||
48357200|NCT01450137|101204428|FG000|STARTED|Up to Week 12||20||
48357201|NCT01450137|101204429|FG001|STARTED|Up to Week 12||10||
48357202|NCT01450137|101204428|FG000|COMPLETED|Up to Week 12||18||
48357203|NCT01450137|101204429|FG001|COMPLETED|Up to Week 12||7||
48357204|NCT01450137|101204428|FG000|NOT COMPLETED|Up to Week 12||2||
48357205|NCT01450137|101204429|FG001|NOT COMPLETED|Up to Week 12||3||
48357206|NCT01450137|101204428|FG000|STARTED|Week 12 to Study End||18||
48357207|NCT01450137|101204429|FG001|STARTED|Week 12 to Study End||7||
48357208|NCT01450137|101204428|FG000|COMPLETED|Week 12 to Study End||18||
48357209|NCT01450137|101204429|FG001|COMPLETED|Week 12 to Study End||5||
48357210|NCT01450137|101204428|FG000|NOT COMPLETED|Week 12 to Study End||0||
48357211|NCT01450137|101204429|FG001|NOT COMPLETED|Week 12 to Study End||2||
48357212|NCT02032875|101204430|FG000|STARTED|Treatment Period||53||
48357213|NCT02032875|101204431|FG001|STARTED|Treatment Period||60||
48357214|NCT02032875|101204430|FG000|COMPLETED|Treatment Period||52||
48357215|NCT02032875|101204431|FG001|COMPLETED|Treatment Period||56||
48357216|NCT02032875|101204430|FG000|NOT COMPLETED|Treatment Period||1||
48357217|NCT02032875|101204431|FG001|NOT COMPLETED|Treatment Period||4||
48357218|NCT02032875|101204430|FG000|STARTED|Follow-up Period||53||
48357219|NCT02032875|101204431|FG001|STARTED|Follow-up Period||57||
48357220|NCT02032875|101204430|FG000|COMPLETED|Follow-up Period||50||
48357221|NCT02032875|101204431|FG001|COMPLETED|Follow-up Period||46||
48357222|NCT02032875|101204430|FG000|NOT COMPLETED|Follow-up Period||3||
48357223|NCT02032875|101204431|FG001|NOT COMPLETED|Follow-up Period||11||
48357224|NCT01821963|101204432|FG000|STARTED|Overall Study||1||
48357225|NCT01821963|101204432|FG000|COMPLETED|Overall Study||0||
48418944|NCT02993731|101361562|FG000|STARTED|Overall Study||565||
48418945|NCT02993731|101361563|FG001|STARTED|Overall Study||569||
48418946|NCT02993731|101361562|FG000|COMPLETED|Overall Study||464||
48418947|NCT02993731|101361563|FG001|COMPLETED|Overall Study||464||
48418948|NCT02993731|101361562|FG000|NOT COMPLETED|Overall Study||101||
48418949|NCT02993731|101361563|FG001|NOT COMPLETED|Overall Study||105||
48418950|NCT01835964|101361564|FG000|STARTED|Overall Study||30||
48418951|NCT01835964|101361564|FG000|Training|Overall Study||30||
48418952|NCT01835964|101361564|FG000|Observation Period|Overall Study||28||
48418953|NCT01835964|101361564|FG000|Physiological Test|Overall Study||28||
48418954|NCT01835964|101361564|FG000|COMPLETED|Overall Study||28||
48418955|NCT01835964|101361564|FG000|NOT COMPLETED|Overall Study||2||
48418956|NCT04335552|101361565|FG000|STARTED|Overall Study||2||
48418957|NCT04335552|101361566|FG001|STARTED|Overall Study||4||
48418958|NCT04335552|101361567|FG002|STARTED|Overall Study||3||
48418959|NCT04335552|101361568|FG003|STARTED|Overall Study||2||
48418960|NCT04335552|101361565|FG000|COMPLETED|Overall Study||1||
48357226|NCT01821963|101204432|FG000|NOT COMPLETED|Overall Study||1||
48357227|NCT02104180|101204433|FG000|STARTED|Overall Study||31||
48357228|NCT02104180|101204434|FG001|STARTED|Overall Study||31||
48357229|NCT02104180|101204433|FG000|COMPLETED|Overall Study||30||
48357230|NCT02104180|101204434|FG001|COMPLETED|Overall Study||31||
48357231|NCT02104180|101204433|FG000|NOT COMPLETED|Overall Study||1||
48357232|NCT02104180|101204434|FG001|NOT COMPLETED|Overall Study||0||
48357233|NCT02677740|101204435|FG000|STARTED|Overall Study||7||
48357234|NCT02677740|101204436|FG001|STARTED|Overall Study||1||
48357235|NCT02677740|101204435|FG000|COMPLETED|Overall Study||7||
48357236|NCT02677740|101204436|FG001|COMPLETED|Overall Study||1||
48418961|NCT04335552|101361566|FG001|COMPLETED|Overall Study||4||
48418962|NCT04335552|101361567|FG002|COMPLETED|Overall Study||3||
48418963|NCT04335552|101361568|FG003|COMPLETED|Overall Study||2||
48418964|NCT04335552|101361565|FG000|NOT COMPLETED|Overall Study||1||
48418965|NCT04335552|101361566|FG001|NOT COMPLETED|Overall Study||0||
48418966|NCT04335552|101361567|FG002|NOT COMPLETED|Overall Study||0||
48418967|NCT04335552|101361568|FG003|NOT COMPLETED|Overall Study||0||
48418968|NCT00574340|101361569|FG000|STARTED|Study 1 (2 Days)||10||
48357237|NCT02677740|101204435|FG000|NOT COMPLETED|Overall Study||0||
48357238|NCT02677740|101204436|FG001|NOT COMPLETED|Overall Study||0||
48357239|NCT02417415|101204437|FG000|STARTED|Overall Study||13||
48357240|NCT02417415|101204438|FG001|STARTED|Overall Study||9||
48357241|NCT02417415|101204437|FG000|COMPLETED|Overall Study||13||
48357242|NCT02417415|101204438|FG001|COMPLETED|Overall Study||9||
48357243|NCT02417415|101204437|FG000|NOT COMPLETED|Overall Study||0||
48357244|NCT02417415|101204438|FG001|NOT COMPLETED|Overall Study||0||
48357245|NCT01183858|101204439|FG000|STARTED|Overall Study||154||
48357246|NCT01183858|101204440|FG001|STARTED|Overall Study||159||
48357247|NCT01183858|101204439|FG000|Safety Population|Overall Study||154||
48357248|NCT01183858|101204440|FG001|Safety Population|Overall Study||158||
48357249|NCT01183858|101204439|FG000|COMPLETED|Overall Study||1||
48357250|NCT01183858|101204440|FG001|COMPLETED|Overall Study||3||
48357251|NCT01183858|101204439|FG000|NOT COMPLETED|Overall Study||153||
48357252|NCT01183858|101204440|FG001|NOT COMPLETED|Overall Study||156||
48357253|NCT01165229|101204441|FG000|STARTED|Overall Study||6950||
48357254|NCT01165229|101204442|FG001|STARTED|Overall Study||6950||
48357255|NCT01165229|101204441|FG000|COMPLETED|Overall Study||5770||
48357256|NCT01165229|101204442|FG001|COMPLETED|Overall Study||5760||
48357257|NCT01165229|101204441|FG000|NOT COMPLETED|Overall Study||1180||
48357258|NCT01165229|101204442|FG001|NOT COMPLETED|Overall Study||1190||
48357259|NCT01507246|101204443|FG000|STARTED|Overall Study||20||
48357260|NCT01507246|101204444|FG001|STARTED|Overall Study||22||
48357261|NCT01507246|101204443|FG000|COMPLETED|Overall Study||18||
48357262|NCT01507246|101204444|FG001|COMPLETED|Overall Study||21||
48418969|NCT00574340|101361570|FG001|STARTED|Study 1 (2 Days)||10||
48418970|NCT00574340|101361569|FG000|COMPLETED|Study 1 (2 Days)||10||
48418971|NCT00574340|101361570|FG001|COMPLETED|Study 1 (2 Days)||10||
48418972|NCT00574340|101361569|FG000|NOT COMPLETED|Study 1 (2 Days)||0||
48418973|NCT00574340|101361570|FG001|NOT COMPLETED|Study 1 (2 Days)||0||
48418974|NCT00574340|101361569|FG000|STARTED|Study 2 (2 Days)||6||
48357263|NCT01507246|101204443|FG000|NOT COMPLETED|Overall Study||2||
48357264|NCT01507246|101204444|FG001|NOT COMPLETED|Overall Study||1||
48357265|NCT00393458|101204445|FG000|STARTED|Overall Study||437||
48357266|NCT00393458|101204446|FG001|STARTED|Overall Study||428||
48357267|NCT00393458|101204447|FG002|STARTED|Overall Study||435||
48418975|NCT00574340|101361570|FG001|STARTED|Study 2 (2 Days)||6||
48357268|NCT00393458|101204448|FG003|STARTED|Overall Study||432||
48418976|NCT00574340|101361569|FG000|COMPLETED|Study 2 (2 Days)||6||
48418977|NCT00574340|101361570|FG001|COMPLETED|Study 2 (2 Days)||6||
48357269|NCT00393458|101204445|FG000|Exposed to Study Medication or Placebo|Overall Study||437||
48357270|NCT00393458|101204446|FG001|Exposed to Study Medication or Placebo|Overall Study||425||
48357271|NCT00393458|101204447|FG002|Exposed to Study Medication or Placebo|Overall Study||434||
48357272|NCT00393458|101204448|FG003|Exposed to Study Medication or Placebo|Overall Study||432||
48357273|NCT00393458|101204445|FG000|COMPLETED|Overall Study||338||
48357274|NCT00393458|101204446|FG001|COMPLETED|Overall Study||326||
48357275|NCT00393458|101204447|FG002|COMPLETED|Overall Study||323||
48357276|NCT00393458|101204448|FG003|COMPLETED|Overall Study||295||
48357277|NCT00393458|101204445|FG000|NOT COMPLETED|Overall Study||99||
48357278|NCT00393458|101204446|FG001|NOT COMPLETED|Overall Study||102||
48357279|NCT00393458|101204447|FG002|NOT COMPLETED|Overall Study||112||
48357280|NCT00393458|101204448|FG003|NOT COMPLETED|Overall Study||137||
48357281|NCT04723537|101204449|FG000|STARTED|Overall Study||20||
48357282|NCT04723537|101204450|FG001|STARTED|Overall Study||21||
48357283|NCT04723537|101204451|FG002|STARTED|Overall Study||20||
48357284|NCT04723537|101204449|FG000|COMPLETED|Overall Study||16||
48357285|NCT04723537|101204450|FG001|COMPLETED|Overall Study||20||
48357286|NCT04723537|101204451|FG002|COMPLETED|Overall Study||18||
48357287|NCT04723537|101204449|FG000|NOT COMPLETED|Overall Study||4||
48357288|NCT04723537|101204450|FG001|NOT COMPLETED|Overall Study||1||
48357289|NCT04723537|101204451|FG002|NOT COMPLETED|Overall Study||2||
48638703|NCT02880176|101901475|FG001|Responded to 30 Day Survey|Overall Study||9||
48638704|NCT02880176|101901474|FG000|COMPLETED|Overall Study||20||
48638705|NCT02880176|101901475|FG001|COMPLETED|Overall Study||9||
48638706|NCT02880176|101901474|FG000|NOT COMPLETED|Overall Study||3||
48638707|NCT02880176|101901475|FG001|NOT COMPLETED|Overall Study||2||
48638708|NCT01913353|101901476|FG000|STARTED|Overall Study||221|Randomized including subjects not vaccinated|
48186871|NCT02559817|100779924|FG004|STARTED|Post-treatment Period||8||
48638709|NCT01913353|101901477|FG001|STARTED|Overall Study||219|Randomized including subjects not vaccinated|
48638710|NCT01913353|101901476|FG000|COMPLETED|Overall Study||189|Active trial phase|
48638711|NCT01913353|101901477|FG001|COMPLETED|Overall Study||204|Active trial phase|
48638712|NCT01913353|101901476|FG000|NOT COMPLETED|Overall Study||32||
48638713|NCT01913353|101901477|FG001|NOT COMPLETED|Overall Study||15||
48638714|NCT00435942|101901478|FG000|STARTED|Overall Study||120||
48638715|NCT00435942|101901479|FG001|STARTED|Overall Study||60||
48638716|NCT00435942|101901478|FG000|COMPLETED|Overall Study||97|97 patients|
48638717|NCT00435942|101901479|FG001|COMPLETED|Overall Study||33|97 patients|
48638718|NCT00435942|101901478|FG000|NOT COMPLETED|Overall Study||23||
48638719|NCT00435942|101901479|FG001|NOT COMPLETED|Overall Study||27||
48638720|NCT02242630|101901480|FG000|STARTED|Overall Study||15||
48638721|NCT02242630|101901481|FG001|STARTED|Overall Study||15||
48638722|NCT02242630|101901482|FG002|STARTED|Overall Study||15||
48638723|NCT02242630|101901483|FG003|STARTED|Overall Study||16||
48357290|NCT02082184|101204452|FG000|STARTED|Overall Study||149||
48357291|NCT02082184|101204453|FG001|STARTED|Overall Study||75||
48357292|NCT02082184|101204452|FG000|COMPLETED|Overall Study||139||
48357293|NCT02082184|101204453|FG001|COMPLETED|Overall Study||62||
48357294|NCT02082184|101204452|FG000|NOT COMPLETED|Overall Study||10||
48357295|NCT02082184|101204453|FG001|NOT COMPLETED|Overall Study||13||
48357296|NCT01614457|101204454|FG000|STARTED|Overall Study||34||
48357297|NCT01614457|101204455|FG001|STARTED|Overall Study||35||
48357298|NCT01614457|101204454|FG000|COMPLETED|Overall Study||32||
48357299|NCT01614457|101204455|FG001|COMPLETED|Overall Study||35||
48357300|NCT01614457|101204454|FG000|NOT COMPLETED|Overall Study||2||
48357301|NCT01614457|101204455|FG001|NOT COMPLETED|Overall Study||0||
48357302|NCT01282814|101204456|FG000|STARTED|First Intervention||12||
48357303|NCT01282814|101204457|FG001|STARTED|First Intervention||12||
48357304|NCT01282814|101204456|FG000|COMPLETED|First Intervention||12||
48357305|NCT01282814|101204457|FG001|COMPLETED|First Intervention||9||
48357306|NCT01282814|101204456|FG000|NOT COMPLETED|First Intervention||0||
48357307|NCT01282814|101204457|FG001|NOT COMPLETED|First Intervention||3||
48357308|NCT01282814|101204456|FG000|STARTED|Washout of 7 Days||12||
48357309|NCT01282814|101204457|FG001|STARTED|Washout of 7 Days||9||
48357310|NCT01282814|101204456|FG000|COMPLETED|Washout of 7 Days||10||
48357311|NCT01282814|101204457|FG001|COMPLETED|Washout of 7 Days||9||
48418978|NCT00574340|101361569|FG000|NOT COMPLETED|Study 2 (2 Days)||0||
48638724|NCT02242630|101901480|FG000|COMPLETED|Overall Study||15||
48638725|NCT02242630|101901481|FG001|COMPLETED|Overall Study||15||
48638726|NCT02242630|101901482|FG002|COMPLETED|Overall Study||15||
48357312|NCT01282814|101204456|FG000|NOT COMPLETED|Washout of 7 Days||2||
48357313|NCT01282814|101204457|FG001|NOT COMPLETED|Washout of 7 Days||0||
48357314|NCT01282814|101204456|FG000|STARTED|Second Intervention||10||
48357315|NCT01282814|101204457|FG001|STARTED|Second Intervention||9||
48357316|NCT01282814|101204456|FG000|COMPLETED|Second Intervention||10||
48357317|NCT01282814|101204457|FG001|COMPLETED|Second Intervention||9||
48357318|NCT01282814|101204456|FG000|NOT COMPLETED|Second Intervention||0||
48357319|NCT01282814|101204457|FG001|NOT COMPLETED|Second Intervention||0||
48357320|NCT02285010|101204458|FG000|STARTED|Overall Study||63||
48357321|NCT02285010|101204459|FG001|STARTED|Overall Study||62||
48357322|NCT02285010|101204458|FG000|COMPLETED|Overall Study||58||
48357323|NCT02285010|101204459|FG001|COMPLETED|Overall Study||61||
48357324|NCT02285010|101204458|FG000|NOT COMPLETED|Overall Study||5||
48357325|NCT02285010|101204459|FG001|NOT COMPLETED|Overall Study||1||
48418979|NCT00574340|101361570|FG001|NOT COMPLETED|Study 2 (2 Days)||0||
48357326|NCT02907944|101204460|FG000|STARTED|Overall Study||3517|Control Stage|4
48357327|NCT02907944|101204461|FG001|STARTED|Overall Study||70|Control Stage|4
48357328|NCT02907944|101204460|FG000|Control Period|Overall Study||4259||4
48357329|NCT02907944|101204461|FG001|Control Period|Overall Study||69||4
48638727|NCT02242630|101901483|FG003|COMPLETED|Overall Study||16||
48357330|NCT02907944|101204460|FG000|Intervention Period|Overall Study||3780||4
48357331|NCT02907944|101204461|FG001|Intervention Period|Overall Study||59||4
48357332|NCT02907944|101204460|FG000|Evaluation Period|Overall Study||3786||4
48357333|NCT02907944|101204461|FG001|Evaluation Period|Overall Study||58||3
48357334|NCT02907944|101204460|FG000|Maintenance Period|Overall Study||4036||4
48357335|NCT02907944|101204461|FG001|Maintenance Period|Overall Study||88||4
48357336|NCT02907944|101204460|FG000|COMPLETED|Overall Study||3514||4
48357337|NCT02907944|101204461|FG001|COMPLETED|Overall Study||62||4
48357338|NCT02907944|101204460|FG000|NOT COMPLETED|Overall Study||3||0
48357339|NCT02907944|101204461|FG001|NOT COMPLETED|Overall Study||8||0
48357340|NCT03063255|101204462|FG000|STARTED|Overall Study||30||
48357341|NCT03063255|101204463|FG001|STARTED|Overall Study||30||
48357342|NCT03063255|101204462|FG000|COMPLETED|Overall Study||29||
48357343|NCT03063255|101204463|FG001|COMPLETED|Overall Study||30||
48357344|NCT03063255|101204462|FG000|NOT COMPLETED|Overall Study||1||
48357345|NCT03063255|101204463|FG001|NOT COMPLETED|Overall Study||0||
48357346|NCT02426086|101204464|FG000|STARTED|Overall Study||48||
48357347|NCT02426086|101204465|FG001|STARTED|Overall Study||59||
48357348|NCT02426086|101204464|FG000|Treated|Overall Study||48||
48357349|NCT02426086|101204465|FG001|Treated|Overall Study||59||
48357350|NCT02426086|101204464|FG000|COMPLETED|Overall Study||0|Disposition data is reported until the end of study.|
48357351|NCT02426086|101204465|FG001|COMPLETED|Overall Study||0|Disposition data is reported until the end of study.|
48357352|NCT02426086|101204464|FG000|NOT COMPLETED|Overall Study||48||
48357353|NCT02426086|101204465|FG001|NOT COMPLETED|Overall Study||59||
48357354|NCT01515072|101204466|FG000|STARTED|Overall Study||166||
48357355|NCT01515072|101204467|FG001|STARTED|Overall Study||155||
48357356|NCT01515072|101204466|FG000|COMPLETED|Overall Study||166||
48357357|NCT01515072|101204467|FG001|COMPLETED|Overall Study||155||
48357358|NCT01515072|101204466|FG000|NOT COMPLETED|Overall Study||0||
48357359|NCT01515072|101204467|FG001|NOT COMPLETED|Overall Study||0||
48357360|NCT05165394|101204468|FG000|STARTED|Overall Study||47||
48357361|NCT05165394|101204469|FG001|STARTED|Overall Study||46||
48357362|NCT05165394|101204468|FG000|Received at Least 1 Dose of Study Drug|Overall Study||47||
48357363|NCT05165394|101204469|FG001|Received at Least 1 Dose of Study Drug|Overall Study||46||
48357364|NCT05165394|101204468|FG000|COMPLETED|Overall Study||41||
48357365|NCT05165394|101204469|FG001|COMPLETED|Overall Study||42||
48357366|NCT05165394|101204468|FG000|NOT COMPLETED|Overall Study||6||
48357367|NCT05165394|101204469|FG001|NOT COMPLETED|Overall Study||4||
48357368|NCT01765712|101204470|FG000|STARTED|Overall Study||27||
48357369|NCT01765712|101204471|FG001|STARTED|Overall Study||23||
48357370|NCT01765712|101204470|FG000|COMPLETED|Overall Study||27||
48357371|NCT01765712|101204471|FG001|COMPLETED|Overall Study||23||
48357372|NCT01765712|101204470|FG000|NOT COMPLETED|Overall Study||0||
48357373|NCT01765712|101204471|FG001|NOT COMPLETED|Overall Study||0||
48357374|NCT00519623|101204472|FG000|STARTED|Overall Study||9||
48357375|NCT00519623|101204472|FG000|COMPLETED|Overall Study||8||
48357376|NCT00519623|101204472|FG000|NOT COMPLETED|Overall Study||1||
48357377|NCT00651040|101204473|FG000|STARTED|Overall Study||16||
48357378|NCT00651040|101204474|FG001|STARTED|Overall Study||15||
48357379|NCT00651040|101204473|FG000|COMPLETED|Overall Study||13||
48357380|NCT00651040|101204474|FG001|COMPLETED|Overall Study||14||
48357381|NCT00651040|101204473|FG000|NOT COMPLETED|Overall Study||3||
48357382|NCT00651040|101204474|FG001|NOT COMPLETED|Overall Study||1||
48357383|NCT03811951|101204475|FG000|STARTED|First Intervention (1 Day)||2||
48357384|NCT03811951|101204476|FG001|STARTED|First Intervention (1 Day)||2||
48357385|NCT03811951|101204475|FG000|COMPLETED|First Intervention (1 Day)||2||
48357386|NCT03811951|101204476|FG001|COMPLETED|First Intervention (1 Day)||2||
48357387|NCT03811951|101204475|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48357388|NCT03811951|101204476|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48357389|NCT03811951|101204475|FG000|STARTED|Washout (1 Week)||2||
48357390|NCT03811951|101204476|FG001|STARTED|Washout (1 Week)||2||
48357391|NCT03811951|101204475|FG000|COMPLETED|Washout (1 Week)||2||
48357392|NCT03811951|101204476|FG001|COMPLETED|Washout (1 Week)||2||
48357393|NCT03811951|101204475|FG000|NOT COMPLETED|Washout (1 Week)||0||
48357394|NCT03811951|101204476|FG001|NOT COMPLETED|Washout (1 Week)||0||
48357395|NCT03811951|101204475|FG000|STARTED|Second Intervention (1 Day)||2||
48357396|NCT03811951|101204476|FG001|STARTED|Second Intervention (1 Day)||2||
48357397|NCT03811951|101204475|FG000|COMPLETED|Second Intervention (1 Day)||2||
48357398|NCT03811951|101204476|FG001|COMPLETED|Second Intervention (1 Day)||2||
48357399|NCT03811951|101204475|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48357400|NCT03811951|101204476|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48357401|NCT02400346|101204477|FG000|STARTED|Overall Study||132||
48357402|NCT02400346|101204477|FG000|COMPLETED|Overall Study||88||
48357403|NCT02400346|101204477|FG000|NOT COMPLETED|Overall Study||44||
48357404|NCT00621933|101204478|FG000|STARTED|Overall Study||399||
48357405|NCT00621933|101204478|FG000|COMPLETED|Overall Study||399||
48357406|NCT00621933|101204478|FG000|NOT COMPLETED|Overall Study||0||
48357407|NCT03322657|101204479|FG000|STARTED|Overall Study||34||
48357408|NCT03322657|101204480|FG001|STARTED|Overall Study||35||
48357409|NCT03322657|101204479|FG000|COMPLETED|Overall Study||33||
48357410|NCT03322657|101204480|FG001|COMPLETED|Overall Study||35||
48357411|NCT03322657|101204479|FG000|NOT COMPLETED|Overall Study||1||
48357412|NCT03322657|101204480|FG001|NOT COMPLETED|Overall Study||0||
48357413|NCT00920309|101204481|FG000|STARTED|Overall Study||14||
48357414|NCT00920309|101204482|FG001|STARTED|Overall Study||7||
48357415|NCT00920309|101204481|FG000|COMPLETED|Overall Study||14||
48357416|NCT00920309|101204482|FG001|COMPLETED|Overall Study||7||
48357417|NCT00920309|101204481|FG000|NOT COMPLETED|Overall Study||0||
48357418|NCT00920309|101204482|FG001|NOT COMPLETED|Overall Study||0||
48357419|NCT01478347|101204483|FG000|STARTED|Visit 1-Visit 3 (Day 0-91) - Part I||18||
48357420|NCT01478347|101204483|FG000|COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||17||
48762873|NCT02081677|102206126|FG003|COMPLETED|Overall Study||19||
48762874|NCT02081677|102206123|FG000|NOT COMPLETED|Overall Study||1||
48762875|NCT02081677|102206124|FG001|NOT COMPLETED|Overall Study||1||
48762876|NCT02081677|102206125|FG002|NOT COMPLETED|Overall Study||2||
48762877|NCT02081677|102206126|FG003|NOT COMPLETED|Overall Study||0||
48762878|NCT04639245|102206127|FG000|STARTED|Overall Study||1||
48762879|NCT04639245|102206127|FG000|COMPLETED|Overall Study||0||
48762880|NCT04639245|102206127|FG000|NOT COMPLETED|Overall Study||1||
48762881|NCT04701814|102206128|FG000|STARTED|Overall Study||20||
48762882|NCT04701814|102206129|FG001|STARTED|Overall Study||18||
48762883|NCT04701814|102206128|FG000|COMPLETED|Overall Study||15||
48762884|NCT04701814|102206129|FG001|COMPLETED|Overall Study||15||
48762885|NCT04701814|102206128|FG000|NOT COMPLETED|Overall Study||5||
48762886|NCT04701814|102206129|FG001|NOT COMPLETED|Overall Study||3||
48762887|NCT03994081|102206130|FG000|STARTED|Overall Study||10||
48762888|NCT03994081|102206131|FG001|STARTED|Overall Study||10||
48762889|NCT03994081|102206130|FG000|COMPLETED|Overall Study||10||
48357421|NCT01478347|101204483|FG000|NOT COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||1||
48357422|NCT01478347|101204483|FG000|STARTED|Visit 4-Visit 7 (Day 151-331) - Part II||12||
48357423|NCT01478347|101204483|FG000|COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||4||
48357424|NCT01478347|101204483|FG000|NOT COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||8||
48357425|NCT01050062|101204484|FG000|STARTED|Overall Study||1070||
48357426|NCT01050062|101204485|FG001|STARTED|Overall Study||355||
48357427|NCT01050062|101204484|FG000|COMPLETED|Overall Study||799||
48357428|NCT01050062|101204485|FG001|COMPLETED|Overall Study||243||
48357429|NCT01050062|101204484|FG000|NOT COMPLETED|Overall Study||271||
48357430|NCT01050062|101204485|FG001|NOT COMPLETED|Overall Study||112||
48357431|NCT00283712|101204486|FG000|STARTED|Overall Study||10||
48357432|NCT00283712|101204487|FG001|STARTED|Overall Study||10||
48357433|NCT00283712|101204486|FG000|Intent-to-treat Sample|Overall Study||10||
48357434|NCT00283712|101204487|FG001|Intent-to-treat Sample|Overall Study||10||
48357435|NCT00283712|101204486|FG000|Safety Sample|Overall Study||10||
48357436|NCT00283712|101204487|FG001|Safety Sample|Overall Study||10||
48418980|NCT01028131|101361571|FG000|STARTED|Overall Study||26||
48418981|NCT01028131|101361572|FG001|STARTED|Overall Study||26||
48418982|NCT01028131|101361573|FG002|STARTED|Overall Study||28||
48418983|NCT01028131|101361574|FG003|STARTED|Overall Study||30||
48418984|NCT01028131|101361571|FG000|Completed Intervention/Control Session|Overall Study||26||
48418985|NCT01028131|101361572|FG001|Completed Intervention/Control Session|Overall Study||26||
48762890|NCT03994081|102206131|FG001|COMPLETED|Overall Study||10||
48762891|NCT03994081|102206130|FG000|NOT COMPLETED|Overall Study||0||
48762892|NCT03994081|102206131|FG001|NOT COMPLETED|Overall Study||0||
48762893|NCT01521117|102208597|FG000|STARTED|First Intervention (6 Weeks)||10||
48762894|NCT01521117|102208598|FG001|STARTED|First Intervention (6 Weeks)||11||
48762895|NCT01521117|102208597|FG000|COMPLETED|First Intervention (6 Weeks)||5||
48357437|NCT00283712|101204486|FG000|Per-Protocol Sample|Overall Study||6||
48357438|NCT00283712|101204487|FG001|Per-Protocol Sample|Overall Study||7||
48357439|NCT00283712|101204486|FG000|COMPLETED|Overall Study||10||
48357440|NCT00283712|101204487|FG001|COMPLETED|Overall Study||9||
48357441|NCT00283712|101204486|FG000|NOT COMPLETED|Overall Study||0||
48357442|NCT00283712|101204487|FG001|NOT COMPLETED|Overall Study||1||
48357443|NCT03607682|101204488|FG000|STARTED|Overall Study||2||
48357444|NCT03607682|101204488|FG000|COMPLETED|Overall Study||0||
48357445|NCT03607682|101204488|FG000|NOT COMPLETED|Overall Study||2||
48357446|NCT02273973|101204489|FG000|STARTED|Overall Study||166||
48357447|NCT02273973|101204490|FG001|STARTED|Overall Study||168||
48357448|NCT02273973|101204489|FG000|COMPLETED|Overall Study||157||
48357449|NCT02273973|101204490|FG001|COMPLETED|Overall Study||160||
48357450|NCT02273973|101204489|FG000|NOT COMPLETED|Overall Study||9||
48357451|NCT02273973|101204490|FG001|NOT COMPLETED|Overall Study||8||
48357452|NCT03941548|101204491|FG000|STARTED|Overall Study||34||
48357453|NCT03941548|101204492|FG001|STARTED|Overall Study||32||
48357454|NCT03941548|101204491|FG000|Safety Population|Overall Study||34|Safety population included all participants who received at least one dose of study drug. Participants were summarized according to study drug regimen received.|
48357455|NCT03941548|101204492|FG001|Safety Population|Overall Study||32|Safety population included all participants who received at least one dose of study drug. Participants were summarized according to study drug regimen received.|
48368122|NCT01555463|101230111|FG000|STARTED|Treatment||483||
48368123|NCT01555463|101230112|FG001|STARTED|Treatment||478||
48418986|NCT01028131|101361573|FG002|Completed Intervention/Control Session|Overall Study||28||
48762896|NCT01521117|102208598|FG001|COMPLETED|First Intervention (6 Weeks)||8||
48762897|NCT01521117|102208597|FG000|NOT COMPLETED|First Intervention (6 Weeks)||5||
48762898|NCT01521117|102208598|FG001|NOT COMPLETED|First Intervention (6 Weeks)||3||
48762899|NCT01521117|102208597|FG000|STARTED|Washout (4 Weeks)||5||
48762900|NCT01521117|102208598|FG001|STARTED|Washout (4 Weeks)||8||
48762901|NCT01521117|102208597|FG000|COMPLETED|Washout (4 Weeks)||5||
48762902|NCT01521117|102208598|FG001|COMPLETED|Washout (4 Weeks)||8||
48762903|NCT01521117|102208597|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
48357456|NCT03941548|101204491|FG000|mITT Population|Overall Study||34|Modified Intent-to-treat (mITT) population included all randomized participants who received at least one dose of study drug and had at least 1 post-treatment SALT assessment. Participants were summarized according to study drug regimen to which they were randomized.|
48357457|NCT03941548|101204492|FG001|mITT Population|Overall Study||32|Modified Intent-to-treat (mITT) population included all randomized participants who received at least one dose of study drug and had at least 1 post-treatment SALT assessment. Participants were summarized according to study drug regimen to which they were randomized.|
48357458|NCT03941548|101204491|FG000|COMPLETED|Overall Study||33||
48357459|NCT03941548|101204492|FG001|COMPLETED|Overall Study||30||
48357460|NCT03941548|101204491|FG000|NOT COMPLETED|Overall Study||1||
48357461|NCT03941548|101204492|FG001|NOT COMPLETED|Overall Study||2||
48357462|NCT02648230|101204493|FG000|STARTED|Overall Study||74||
48357463|NCT02648230|101204493|FG000|COMPLETED|Overall Study||74||
48357464|NCT02648230|101204493|FG000|NOT COMPLETED|Overall Study||0||
48357465|NCT00663858|101204494|FG000|STARTED|Overall Study||212||
48418987|NCT01028131|101361574|FG003|Completed Intervention/Control Session|Overall Study||30||
48418988|NCT01028131|101361571|FG000|COMPLETED|Overall Study||23||
48418989|NCT01028131|101361572|FG001|COMPLETED|Overall Study||23||
48357466|NCT00663858|101204495|FG001|STARTED|Overall Study||106||
48357467|NCT00663858|101204496|FG002|STARTED|Overall Study||102||
48357468|NCT00663858|101204494|FG000|COMPLETED|Overall Study||178||
48357469|NCT00663858|101204495|FG001|COMPLETED|Overall Study||96||
48357470|NCT00663858|101204496|FG002|COMPLETED|Overall Study||82||
48357471|NCT00663858|101204494|FG000|NOT COMPLETED|Overall Study||34||
48357472|NCT00663858|101204495|FG001|NOT COMPLETED|Overall Study||10||
48418990|NCT01028131|101361573|FG002|COMPLETED|Overall Study||22||
48418991|NCT01028131|101361574|FG003|COMPLETED|Overall Study||26||
48418992|NCT01028131|101361571|FG000|NOT COMPLETED|Overall Study||3||
48418993|NCT01028131|101361572|FG001|NOT COMPLETED|Overall Study||3||
48418994|NCT01028131|101361573|FG002|NOT COMPLETED|Overall Study||6||
48418995|NCT01028131|101361574|FG003|NOT COMPLETED|Overall Study||4||
48418996|NCT00515021|101361575|FG000|STARTED|Overall Study||9||
48418997|NCT00515021|101361576|FG001|STARTED|Overall Study||11||
48418998|NCT00515021|101361575|FG000|COMPLETED|Overall Study||9||
48418999|NCT00515021|101361576|FG001|COMPLETED|Overall Study||11||
48419000|NCT00515021|101361575|FG000|NOT COMPLETED|Overall Study||0||
48762904|NCT01521117|102208598|FG001|NOT COMPLETED|Washout (4 Weeks)||0||
48762905|NCT01521117|102208597|FG000|STARTED|Second Intervention (6 Weeks)||5||
48762906|NCT01521117|102208598|FG001|STARTED|Second Intervention (6 Weeks)||8||
48762907|NCT01521117|102208597|FG000|COMPLETED|Second Intervention (6 Weeks)||5||
48762908|NCT01521117|102208598|FG001|COMPLETED|Second Intervention (6 Weeks)||5||
48357473|NCT00663858|101204496|FG002|NOT COMPLETED|Overall Study||20||
48357474|NCT02559505|101204497|FG000|STARTED|Overall Study||49||
48357475|NCT02559505|101204498|FG001|STARTED|Overall Study||84||
48357476|NCT02559505|101204497|FG000|COMPLETED|Overall Study||22||
48357477|NCT02559505|101204498|FG001|COMPLETED|Overall Study||62||
48762909|NCT01521117|102208597|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0||
48762910|NCT01521117|102208598|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||3||
48762911|NCT01747447|102208599|FG000|STARTED|Overall Study||193||
48762912|NCT01747447|102208600|FG001|STARTED|Overall Study||195||
48762913|NCT01747447|102208601|FG002|STARTED|Overall Study||195||
48357478|NCT02559505|101204497|FG000|NOT COMPLETED|Overall Study||27||
48357479|NCT02559505|101204498|FG001|NOT COMPLETED|Overall Study||22||
48357480|NCT01269034|101204499|FG000|STARTED|Overall Study||1||
48357481|NCT01269034|101204500|FG001|STARTED|Overall Study||2||
48357482|NCT01269034|101204501|FG002|STARTED|Overall Study||1||
48357483|NCT01269034|101204502|FG003|STARTED|Overall Study||9||
48357484|NCT01269034|101204499|FG000|COMPLETED|Overall Study||0||
48357485|NCT01269034|101204500|FG001|COMPLETED|Overall Study||2||
48357486|NCT01269034|101204501|FG002|COMPLETED|Overall Study||1||
48357487|NCT01269034|101204502|FG003|COMPLETED|Overall Study||9||
48357488|NCT01269034|101204499|FG000|NOT COMPLETED|Overall Study||1||
48357489|NCT01269034|101204500|FG001|NOT COMPLETED|Overall Study||0||
48419001|NCT00515021|101361576|FG001|NOT COMPLETED|Overall Study||0||
48419002|NCT02172820|101361577|FG000|STARTED|Overall Study||65||
48419003|NCT02172820|101361578|FG001|STARTED|Overall Study||65||
48419004|NCT02172820|101361577|FG000|COMPLETED|Overall Study||65||
48419005|NCT02172820|101361578|FG001|COMPLETED|Overall Study||65||
48419006|NCT02172820|101361577|FG000|NOT COMPLETED|Overall Study||0||
48419007|NCT02172820|101361578|FG001|NOT COMPLETED|Overall Study||0||
48419008|NCT03091920|101361579|FG000|STARTED|Overall Study||6||
48419009|NCT03091920|101361580|FG001|STARTED|Overall Study||10||
48419010|NCT03091920|101361581|FG002|STARTED|Overall Study||10||
48419011|NCT03091920|101361579|FG000|COMPLETED|Overall Study||6||
48762914|NCT01747447|102208602|FG003|STARTED|Overall Study||188||
48357490|NCT01269034|101204501|FG002|NOT COMPLETED|Overall Study||0||
48357491|NCT01269034|101204502|FG003|NOT COMPLETED|Overall Study||0||
48357492|NCT02280811|101204503|FG000|STARTED|Drug Administration||1||
48357493|NCT02280811|101204504|FG001|STARTED|Drug Administration||2||
48357494|NCT02280811|101204505|FG002|STARTED|Drug Administration||1||
48419012|NCT03091920|101361580|FG001|COMPLETED|Overall Study||9||
48762915|NCT01747447|102208599|FG000|COMPLETED|Overall Study||170||
48762916|NCT01747447|102208600|FG001|COMPLETED|Overall Study||177||
48762917|NCT01747447|102208601|FG002|COMPLETED|Overall Study||176||
48357495|NCT02280811|101204506|FG003|STARTED|Drug Administration||6||
48419013|NCT03091920|101361581|FG002|COMPLETED|Overall Study||10||
48419014|NCT03091920|101361579|FG000|NOT COMPLETED|Overall Study||0||
48419015|NCT03091920|101361580|FG001|NOT COMPLETED|Overall Study||1||
48419016|NCT03091920|101361581|FG002|NOT COMPLETED|Overall Study||0||
48419017|NCT00673075|101361582|FG000|STARTED|Overall Study||21||
48419018|NCT00673075|101361583|FG001|STARTED|Overall Study||18||
48419019|NCT00673075|101361582|FG000|COMPLETED|Overall Study||12||
48419020|NCT00673075|101361583|FG001|COMPLETED|Overall Study||11||
48638728|NCT02242630|101901480|FG000|NOT COMPLETED|Overall Study||0||
48638729|NCT02242630|101901481|FG001|NOT COMPLETED|Overall Study||0||
48638730|NCT02242630|101901482|FG002|NOT COMPLETED|Overall Study||0||
48638731|NCT02242630|101901483|FG003|NOT COMPLETED|Overall Study||0||
48638732|NCT00000142|101901484|FG000|STARTED|Overall Study||26||
48638733|NCT00000142|101901485|FG001|STARTED|Overall Study||26||
48638734|NCT00000142|101901486|FG002|STARTED|Overall Study||12||
48638735|NCT00000142|101901484|FG000|COMPLETED|Overall Study||26||
48638736|NCT00000142|101901485|FG001|COMPLETED|Overall Study||26||
48638737|NCT00000142|101901486|FG002|COMPLETED|Overall Study||12||
48638738|NCT00000142|101901484|FG000|NOT COMPLETED|Overall Study||0||
48638739|NCT00000142|101901485|FG001|NOT COMPLETED|Overall Study||0||
48638740|NCT00000142|101901486|FG002|NOT COMPLETED|Overall Study||0||
48638741|NCT00479232|101901487|FG000|STARTED|Overall Study||3||
48638742|NCT00479232|101901488|FG001|STARTED|Overall Study||3||
48638743|NCT00479232|101901489|FG002|STARTED|Overall Study||28||
48638744|NCT00479232|101901490|FG003|STARTED|Overall Study||3||
48638745|NCT00479232|101901491|FG004|STARTED|Overall Study||4||
48638746|NCT00479232|101901492|FG005|STARTED|Overall Study||30||
48638747|NCT00479232|101901487|FG000|COMPLETED|Overall Study||0||
48638748|NCT00479232|101901488|FG001|COMPLETED|Overall Study||0||
48638749|NCT00479232|101901489|FG002|COMPLETED|Overall Study||0||
48762918|NCT01747447|102208602|FG003|COMPLETED|Overall Study||164||
48357496|NCT02280811|101204507|FG004|STARTED|Drug Administration||2||
48357497|NCT02280811|101204503|FG000|COMPLETED|Drug Administration||1||
48357498|NCT02280811|101204504|FG001|COMPLETED|Drug Administration||2||
48357499|NCT02280811|101204505|FG002|COMPLETED|Drug Administration||1||
48357500|NCT02280811|101204506|FG003|COMPLETED|Drug Administration||6||
48357501|NCT02280811|101204507|FG004|COMPLETED|Drug Administration||2||
48357502|NCT02280811|101204503|FG000|NOT COMPLETED|Drug Administration||0||
48357503|NCT02280811|101204504|FG001|NOT COMPLETED|Drug Administration||0||
48357504|NCT02280811|101204505|FG002|NOT COMPLETED|Drug Administration||0||
48357505|NCT02280811|101204506|FG003|NOT COMPLETED|Drug Administration||0||
48357506|NCT02280811|101204507|FG004|NOT COMPLETED|Drug Administration||0||
48357507|NCT02280811|101204503|FG000|STARTED|Retreated at the MTD||0||
48357508|NCT02280811|101204504|FG001|STARTED|Retreated at the MTD||0||
48357509|NCT02280811|101204505|FG002|STARTED|Retreated at the MTD||0||
48357510|NCT02280811|101204506|FG003|STARTED|Retreated at the MTD||0||
48357511|NCT02280811|101204507|FG004|STARTED|Retreated at the MTD||1||
48357512|NCT02280811|101204503|FG000|COMPLETED|Retreated at the MTD||0||
48357513|NCT02280811|101204504|FG001|COMPLETED|Retreated at the MTD||0||
48357514|NCT02280811|101204505|FG002|COMPLETED|Retreated at the MTD||0||
48357515|NCT02280811|101204506|FG003|COMPLETED|Retreated at the MTD||0||
48357516|NCT02280811|101204507|FG004|COMPLETED|Retreated at the MTD||1||
48357517|NCT02280811|101204503|FG000|NOT COMPLETED|Retreated at the MTD||0||
48357518|NCT02280811|101204504|FG001|NOT COMPLETED|Retreated at the MTD||0||
48419021|NCT00673075|101361582|FG000|NOT COMPLETED|Overall Study||9||
48638750|NCT00479232|101901490|FG003|COMPLETED|Overall Study||0||
48357519|NCT02280811|101204505|FG002|NOT COMPLETED|Retreated at the MTD||0||
48357520|NCT02280811|101204506|FG003|NOT COMPLETED|Retreated at the MTD||0||
48357521|NCT02280811|101204507|FG004|NOT COMPLETED|Retreated at the MTD||0||
48357522|NCT03338556|101204508|FG000|STARTED|Overall Study||25||
48357523|NCT03338556|101204509|FG001|STARTED|Overall Study||27||
48357524|NCT03338556|101204510|FG002|STARTED|Overall Study||24||
48638751|NCT00479232|101901491|FG004|COMPLETED|Overall Study||0||
48357525|NCT03338556|101204511|FG003|STARTED|Overall Study||26||
48419022|NCT00673075|101361583|FG001|NOT COMPLETED|Overall Study||7||
48419023|NCT04241627|101361584|FG000|STARTED|Overall Study||11||
48638752|NCT00479232|101901492|FG005|COMPLETED|Overall Study||0||
48638753|NCT00479232|101901487|FG000|NOT COMPLETED|Overall Study||3||
48638754|NCT00479232|101901488|FG001|NOT COMPLETED|Overall Study||3||
48638755|NCT00479232|101901489|FG002|NOT COMPLETED|Overall Study||28||
48762919|NCT01747447|102208599|FG000|NOT COMPLETED|Overall Study||23||
48762920|NCT01747447|102208600|FG001|NOT COMPLETED|Overall Study||18||
48762921|NCT01747447|102208601|FG002|NOT COMPLETED|Overall Study||19||
48762922|NCT01747447|102208602|FG003|NOT COMPLETED|Overall Study||24||
48762923|NCT05452486|102208603|FG000|STARTED|Overall Study||12||
48762924|NCT05452486|102208604|FG001|STARTED|Overall Study||13||
48762925|NCT05452486|102208603|FG000|COMPLETED|Overall Study||12||
48762926|NCT05452486|102208604|FG001|COMPLETED|Overall Study||13||
48419024|NCT04241627|101361585|FG001|STARTED|Overall Study||12||
48419025|NCT04241627|101361586|FG002|STARTED|Overall Study||11||
48419026|NCT04241627|101361584|FG000|COMPLETED|Overall Study||11||
48419027|NCT04241627|101361585|FG001|COMPLETED|Overall Study||12||
48419028|NCT04241627|101361586|FG002|COMPLETED|Overall Study||11||
48419029|NCT04241627|101361584|FG000|NOT COMPLETED|Overall Study||0||
48419030|NCT04241627|101361585|FG001|NOT COMPLETED|Overall Study||0||
48419031|NCT04241627|101361586|FG002|NOT COMPLETED|Overall Study||0||
48419032|NCT01117428|101361587|FG000|STARTED|Overall Study||20||
48419033|NCT01117428|101361588|FG001|STARTED|Overall Study||29||
48419034|NCT01117428|101361589|FG002|STARTED|Overall Study||13||
48419035|NCT01117428|101361590|FG003|STARTED|Overall Study||12||
48419036|NCT01117428|101361591|FG004|STARTED|Overall Study||17||
48419037|NCT01117428|101361592|FG005|STARTED|Overall Study||20||
48419038|NCT01117428|101361587|FG000|COMPLETED|Overall Study||0||
48419039|NCT01117428|101361588|FG001|COMPLETED|Overall Study||0||
48419040|NCT01117428|101361589|FG002|COMPLETED|Overall Study||0||
48419041|NCT01117428|101361590|FG003|COMPLETED|Overall Study||0||
48419042|NCT01117428|101361591|FG004|COMPLETED|Overall Study||0||
48419043|NCT01117428|101361592|FG005|COMPLETED|Overall Study||0||
48762927|NCT05452486|102208603|FG000|NOT COMPLETED|Overall Study||0||
48762928|NCT05452486|102208604|FG001|NOT COMPLETED|Overall Study||0||
48762929|NCT03448406|102208605|FG000|STARTED|Overall Study||158||
48762930|NCT03448406|102208606|FG001|STARTED|Overall Study||157||
48762931|NCT03448406|102208605|FG000|COMPLETED|Overall Study||147||
48762932|NCT03448406|102208606|FG001|COMPLETED|Overall Study||144||
48762933|NCT03448406|102208605|FG000|NOT COMPLETED|Overall Study||11||
48762934|NCT03448406|102208606|FG001|NOT COMPLETED|Overall Study||13||
48762935|NCT05408429|102208607|FG000|STARTED|Overall Study||121||
48762936|NCT05408429|102208608|FG001|STARTED|Overall Study||118||
48357526|NCT03338556|101204508|FG000|COMPLETED|Overall Study||23||
48357527|NCT03338556|101204509|FG001|COMPLETED|Overall Study||23||
48357528|NCT03338556|101204510|FG002|COMPLETED|Overall Study||22||
48762937|NCT05408429|102208609|FG002|STARTED|Overall Study||117||
48762938|NCT05408429|102208607|FG000|COMPLETED|Overall Study||115||
48762939|NCT05408429|102208608|FG001|COMPLETED|Overall Study||117||
48762940|NCT05408429|102208609|FG002|COMPLETED|Overall Study||116||
48762941|NCT05408429|102208607|FG000|NOT COMPLETED|Overall Study||6||
48762942|NCT05408429|102208608|FG001|NOT COMPLETED|Overall Study||1||
48762943|NCT05408429|102208609|FG002|NOT COMPLETED|Overall Study||1||
48762944|NCT05179785|102208610|FG000|STARTED|Overall Study||3||
48762945|NCT05179785|102208611|FG001|STARTED|Overall Study||2||
48762946|NCT05179785|102208612|FG002|STARTED|Overall Study||1||
48762947|NCT05179785|102208613|FG003|STARTED|Overall Study||2||
48762948|NCT05179785|102208614|FG004|STARTED|Overall Study||3||
48762949|NCT05179785|102208615|FG005|STARTED|Overall Study||2||
48357529|NCT03338556|101204511|FG003|COMPLETED|Overall Study||24||
48357530|NCT03338556|101204508|FG000|NOT COMPLETED|Overall Study||2||
48357531|NCT03338556|101204509|FG001|NOT COMPLETED|Overall Study||4||
48357532|NCT03338556|101204510|FG002|NOT COMPLETED|Overall Study||2||
48419044|NCT01117428|101361587|FG000|NOT COMPLETED|Overall Study||20||
48419045|NCT01117428|101361588|FG001|NOT COMPLETED|Overall Study||29||
48419046|NCT01117428|101361589|FG002|NOT COMPLETED|Overall Study||13||
48762950|NCT05179785|102208610|FG000|COMPLETED|Overall Study||3||
48357533|NCT03338556|101204511|FG003|NOT COMPLETED|Overall Study||2||
48357534|NCT00091793|101204512|FG000|STARTED|Overall Study||166||
48357535|NCT00091793|101204513|FG001|STARTED|Overall Study||166||
48357536|NCT00091793|101204512|FG000|COMPLETED|Overall Study||142||
48357537|NCT00091793|101204513|FG001|COMPLETED|Overall Study||144||
48357538|NCT00091793|101204512|FG000|NOT COMPLETED|Overall Study||24||
48762951|NCT05179785|102208611|FG001|COMPLETED|Overall Study||2||
48762952|NCT05179785|102208612|FG002|COMPLETED|Overall Study||1||
48762953|NCT05179785|102208613|FG003|COMPLETED|Overall Study||2||
48357539|NCT00091793|101204513|FG001|NOT COMPLETED|Overall Study||22||
48357540|NCT02403206|101204514|FG000|STARTED|Overall Study||194||
48357541|NCT02403206|101204515|FG001|STARTED|Overall Study||196||
48357542|NCT02403206|101204514|FG000|Treated Prior to Randomization|Overall Study||0||
48357543|NCT02403206|101204515|FG001|Treated Prior to Randomization|Overall Study||1||
48357544|NCT02403206|101204514|FG000|Randomized and Treated|Overall Study||188||
48357545|NCT02403206|101204515|FG001|Randomized and Treated|Overall Study||190||
48419047|NCT01117428|101361590|FG003|NOT COMPLETED|Overall Study||12||
48419048|NCT01117428|101361591|FG004|NOT COMPLETED|Overall Study||17||
48419049|NCT01117428|101361592|FG005|NOT COMPLETED|Overall Study||20||
48419050|NCT00104299|101361593|FG000|STARTED|Overall Study||99||
48419051|NCT00104299|101361594|FG001|STARTED|Overall Study||98||
48762954|NCT05179785|102208614|FG004|COMPLETED|Overall Study||3||
48762955|NCT05179785|102208615|FG005|COMPLETED|Overall Study||2||
48762956|NCT05179785|102208610|FG000|NOT COMPLETED|Overall Study||0||
48762957|NCT05179785|102208611|FG001|NOT COMPLETED|Overall Study||0||
48762958|NCT05179785|102208612|FG002|NOT COMPLETED|Overall Study||0||
48357546|NCT02403206|101204514|FG000|COMPLETED|Overall Study||183||
48357547|NCT02403206|101204515|FG001|COMPLETED|Overall Study||186||
48357548|NCT02403206|101204514|FG000|NOT COMPLETED|Overall Study||11||
48357549|NCT02403206|101204515|FG001|NOT COMPLETED|Overall Study||10||
48357550|NCT03019055|101204516|FG000|STARTED|Overall Study||0||
48357551|NCT03019055|101204517|FG001|STARTED|Overall Study||3||
48357552|NCT03019055|101204518|FG002|STARTED|Overall Study||3||
48357553|NCT03019055|101204519|FG003|STARTED|Overall Study||20||
48357554|NCT03019055|101204516|FG000|COMPLETED|Overall Study||0||
48357555|NCT03019055|101204517|FG001|COMPLETED|Overall Study||3||
48357556|NCT03019055|101204518|FG002|COMPLETED|Overall Study||3||
48357557|NCT03019055|101204519|FG003|COMPLETED|Overall Study||20||
48357558|NCT03019055|101204516|FG000|NOT COMPLETED|Overall Study||0||
48357559|NCT03019055|101204517|FG001|NOT COMPLETED|Overall Study||0||
48357560|NCT03019055|101204518|FG002|NOT COMPLETED|Overall Study||0||
48357561|NCT03019055|101204519|FG003|NOT COMPLETED|Overall Study||0||
48357562|NCT00783289|101204520|FG000|STARTED|Overall Study||6||
48357563|NCT00783289|101204521|FG001|STARTED|Overall Study||7||
48357564|NCT00783289|101204522|FG002|STARTED|Overall Study||6||
48357565|NCT00783289|101204523|FG003|STARTED|Overall Study||6||
48357566|NCT00783289|101204520|FG000|COMPLETED|Overall Study||6||
48357567|NCT00783289|101204521|FG001|COMPLETED|Overall Study||6||
48357568|NCT00783289|101204522|FG002|COMPLETED|Overall Study||6||
48357569|NCT00783289|101204523|FG003|COMPLETED|Overall Study||6||
48357570|NCT00783289|101204520|FG000|NOT COMPLETED|Overall Study||0||
48357571|NCT00783289|101204521|FG001|NOT COMPLETED|Overall Study||1||
48357572|NCT00783289|101204522|FG002|NOT COMPLETED|Overall Study||0||
48357573|NCT00783289|101204523|FG003|NOT COMPLETED|Overall Study||0||
48357574|NCT03502746|101204524|FG000|STARTED|Overall Study||34||
48357575|NCT03502746|101204524|FG000|COMPLETED|Overall Study||34||
48357576|NCT03502746|101204524|FG000|NOT COMPLETED|Overall Study||0||
48357577|NCT01164501|101204525|FG000|STARTED|Overall Study||321||
48357578|NCT01164501|101204526|FG001|STARTED|Overall Study||98||
48357579|NCT01164501|101204527|FG002|STARTED|Overall Study||322||
48357580|NCT01164501|101204525|FG000|COMPLETED|Overall Study||278||
48357581|NCT01164501|101204526|FG001|COMPLETED|Overall Study||88||
48357582|NCT01164501|101204527|FG002|COMPLETED|Overall Study||280||
48357583|NCT01164501|101204525|FG000|NOT COMPLETED|Overall Study||43||
48357584|NCT01164501|101204526|FG001|NOT COMPLETED|Overall Study||10||
48357585|NCT01164501|101204527|FG002|NOT COMPLETED|Overall Study||42||
48357586|NCT04901897|101204528|FG000|STARTED|Overall Study||398||
48357587|NCT04901897|101204529|FG001|STARTED|Overall Study||202||
48638756|NCT00479232|101901490|FG003|NOT COMPLETED|Overall Study||3||
48638757|NCT00479232|101901491|FG004|NOT COMPLETED|Overall Study||4||
48638758|NCT00479232|101901492|FG005|NOT COMPLETED|Overall Study||30||
48357588|NCT04901897|101204530|FG002|STARTED|Overall Study||205||
48357589|NCT04901897|101204528|FG000|COMPLETED|Overall Study||393||
48357590|NCT04901897|101204529|FG001|COMPLETED|Overall Study||200||
48357591|NCT04901897|101204530|FG002|COMPLETED|Overall Study||203||
48357592|NCT04901897|101204528|FG000|NOT COMPLETED|Overall Study||5||
48357593|NCT04901897|101204529|FG001|NOT COMPLETED|Overall Study||2||
48357594|NCT04901897|101204530|FG002|NOT COMPLETED|Overall Study||2||
48357595|NCT00852644|101204531|FG000|STARTED|Overall Study||3||
48357596|NCT00852644|101204532|FG001|STARTED|Overall Study||3||
48357597|NCT00852644|101204533|FG002|STARTED|Overall Study||0||
48357598|NCT00852644|101204534|FG003|STARTED|Overall Study||3||
48357599|NCT00852644|101204535|FG004|STARTED|Overall Study||0||
48357600|NCT00852644|101204536|FG005|STARTED|Overall Study||0||
48357601|NCT00852644|101204531|FG000|COMPLETED|Overall Study||3||
48357602|NCT00852644|101204532|FG001|COMPLETED|Overall Study||3||
48357603|NCT00852644|101204533|FG002|COMPLETED|Overall Study||0||
48357604|NCT00852644|101204534|FG003|COMPLETED|Overall Study||3||
48357605|NCT00852644|101204535|FG004|COMPLETED|Overall Study||0||
48357606|NCT00852644|101204536|FG005|COMPLETED|Overall Study||0||
48357607|NCT00852644|101204531|FG000|NOT COMPLETED|Overall Study||0||
48357608|NCT00852644|101204532|FG001|NOT COMPLETED|Overall Study||0||
48357609|NCT00852644|101204533|FG002|NOT COMPLETED|Overall Study||0||
48357610|NCT00852644|101204534|FG003|NOT COMPLETED|Overall Study||0||
48357611|NCT00852644|101204535|FG004|NOT COMPLETED|Overall Study||0||
48357612|NCT00852644|101204536|FG005|NOT COMPLETED|Overall Study||0||
48357613|NCT00546351|101204537|FG000|STARTED|Overall Study||621||
48357614|NCT00546351|101204537|FG000|COMPLETED|Overall Study||385||
48357615|NCT00546351|101204537|FG000|NOT COMPLETED|Overall Study||236||
48357616|NCT00465738|101204538|FG000|STARTED|Overall Study||97||
48357617|NCT00465738|101204539|FG001|STARTED|Overall Study||95||
48357618|NCT00465738|101204538|FG000|COMPLETED|Overall Study||91||
48357619|NCT00465738|101204539|FG001|COMPLETED|Overall Study||89||
48357620|NCT00465738|101204538|FG000|NOT COMPLETED|Overall Study||6||
48357621|NCT00465738|101204539|FG001|NOT COMPLETED|Overall Study||6||
48357622|NCT00550238|101204540|FG000|STARTED|Overall Study||459||
48357623|NCT00550238|101204540|FG000|COMPLETED|Overall Study||0||
48357624|NCT00550238|101204540|FG000|NOT COMPLETED|Overall Study||459||
48357625|NCT01570491|101204541|FG000|STARTED|Overall Study||19||
48357626|NCT01570491|101204542|FG001|STARTED|Overall Study||19||
48357627|NCT01570491|101204541|FG000|COMPLETED|Overall Study||14||
48638759|NCT01529268|101901493|FG000|STARTED|Overall Study||88||
48357628|NCT01570491|101204542|FG001|COMPLETED|Overall Study||18||
48357629|NCT01570491|101204541|FG000|NOT COMPLETED|Overall Study||5||
48357630|NCT01570491|101204542|FG001|NOT COMPLETED|Overall Study||1||
48357631|NCT02332915|101204543|FG000|STARTED|Overall Study||18||
48357632|NCT02332915|101204544|FG001|STARTED|Overall Study||18||
48357633|NCT02332915|101204543|FG000|COMPLETED|Overall Study||12||
48357634|NCT02332915|101204544|FG001|COMPLETED|Overall Study||12||
48357635|NCT02332915|101204543|FG000|NOT COMPLETED|Overall Study||6||
48357636|NCT02332915|101204544|FG001|NOT COMPLETED|Overall Study||6||
48357637|NCT04125745|101204545|FG000|STARTED|Overall Study||1||
48357638|NCT04125745|101204545|FG000|COMPLETED|Overall Study||1||
48357639|NCT04125745|101204545|FG000|NOT COMPLETED|Overall Study||0||
48357640|NCT01535937|101204546|FG000|STARTED|Overall Study||27||
48357641|NCT01535937|101204547|FG001|STARTED|Overall Study||28||
48357642|NCT01535937|101204546|FG000|COMPLETED|Overall Study||27||
48357643|NCT01535937|101204547|FG001|COMPLETED|Overall Study||28||
48357644|NCT01535937|101204546|FG000|NOT COMPLETED|Overall Study||0||
48357645|NCT01535937|101204547|FG001|NOT COMPLETED|Overall Study||0||
48357646|NCT02234622|101204548|FG000|STARTED|Overall Study||108||
48357647|NCT02234622|101204549|FG001|STARTED|Overall Study||104||
48357648|NCT02234622|101204548|FG000|COMPLETED|Overall Study||65||
48357649|NCT02234622|101204549|FG001|COMPLETED|Overall Study||68||
48357650|NCT02234622|101204548|FG000|NOT COMPLETED|Overall Study||43||
48357651|NCT02234622|101204549|FG001|NOT COMPLETED|Overall Study||36||
48357652|NCT00753922|101204550|FG000|STARTED|Overall Study||552||
48357653|NCT00753922|101204551|FG001|STARTED|Overall Study||251||
48357654|NCT00753922|101204552|FG002|STARTED|Overall Study||145||
48357655|NCT00753922|101204553|FG003|STARTED|Overall Study||60||
48357656|NCT00753922|101204550|FG000|COMPLETED|Overall Study||306||
48357657|NCT00753922|101204551|FG001|COMPLETED|Overall Study||157||
48357658|NCT00753922|101204552|FG002|COMPLETED|Overall Study||82||
48357659|NCT00753922|101204553|FG003|COMPLETED|Overall Study||37||
48357660|NCT00753922|101204550|FG000|NOT COMPLETED|Overall Study||246||
48357661|NCT00753922|101204551|FG001|NOT COMPLETED|Overall Study||94||
48357662|NCT00753922|101204552|FG002|NOT COMPLETED|Overall Study||63||
48357663|NCT00753922|101204553|FG003|NOT COMPLETED|Overall Study||23||
48357664|NCT01720667|101204554|FG000|STARTED|Overall Study||64||
48357665|NCT01720667|101204555|FG001|STARTED|Overall Study||42||
48357666|NCT01720667|101204554|FG000|Recieved Second Infusion of Same Drug|Overall Study||50||
48357667|NCT01720667|101204555|FG001|Recieved Second Infusion of Same Drug|Overall Study||20||
48357668|NCT01720667|101204554|FG000|Recieved Alternate Intervention|Overall Study||45||
48357669|NCT01720667|101204555|FG001|Recieved Alternate Intervention|Overall Study||10||
48357670|NCT01720667|101204554|FG000|Received 2nd Infusion of Alternate Drug|Overall Study||27||
48357671|NCT01720667|101204555|FG001|Received 2nd Infusion of Alternate Drug|Overall Study||6||
48357672|NCT01720667|101204554|FG000|Modified ITT|Overall Study||53||
48357673|NCT01720667|101204555|FG001|Modified ITT|Overall Study||30||
48357674|NCT01720667|101204554|FG000|COMPLETED|Overall Study||60||
48357675|NCT01720667|101204555|FG001|COMPLETED|Overall Study||41||
48357676|NCT01720667|101204554|FG000|NOT COMPLETED|Overall Study||4||
48357677|NCT01720667|101204555|FG001|NOT COMPLETED|Overall Study||1||
48357678|NCT01380093|101204556|FG000|STARTED|Naloxone Challenge Phase||80||
48357679|NCT01380093|101204557|FG001|STARTED|Naloxone Challenge Phase||0||
48357680|NCT01380093|101204558|FG002|STARTED|Naloxone Challenge Phase||0||
48357681|NCT01380093|101204559|FG003|STARTED|Naloxone Challenge Phase||0||
48357682|NCT01380093|101204560|FG004|STARTED|Naloxone Challenge Phase||0||
48357683|NCT01380093|101204561|FG005|STARTED|Naloxone Challenge Phase||0||
48357684|NCT01380093|101204562|FG006|STARTED|Naloxone Challenge Phase||0||
48357685|NCT01380093|101204563|FG007|STARTED|Naloxone Challenge Phase||0||
48357686|NCT01380093|101204564|FG008|STARTED|Naloxone Challenge Phase||0||
48357687|NCT01380093|101204556|FG000|TREATED|Naloxone Challenge Phase||59||
48357688|NCT01380093|101204557|FG001|TREATED|Naloxone Challenge Phase||0||
48357689|NCT01380093|101204558|FG002|TREATED|Naloxone Challenge Phase||0||
48357690|NCT01380093|101204559|FG003|TREATED|Naloxone Challenge Phase||0||
48357691|NCT01380093|101204560|FG004|TREATED|Naloxone Challenge Phase||0||
48357692|NCT01380093|101204561|FG005|TREATED|Naloxone Challenge Phase||0||
48357693|NCT01380093|101204562|FG006|TREATED|Naloxone Challenge Phase||0||
48357694|NCT01380093|101204563|FG007|TREATED|Naloxone Challenge Phase||0||
48357695|NCT01380093|101204564|FG008|TREATED|Naloxone Challenge Phase||0||
48357696|NCT01380093|101204556|FG000|COMPLETED|Naloxone Challenge Phase||59||
48357697|NCT01380093|101204557|FG001|COMPLETED|Naloxone Challenge Phase||0||
48357698|NCT01380093|101204558|FG002|COMPLETED|Naloxone Challenge Phase||0||
48357699|NCT01380093|101204559|FG003|COMPLETED|Naloxone Challenge Phase||0||
48357700|NCT01380093|101204560|FG004|COMPLETED|Naloxone Challenge Phase||0||
48357701|NCT01380093|101204561|FG005|COMPLETED|Naloxone Challenge Phase||0||
48357702|NCT01380093|101204562|FG006|COMPLETED|Naloxone Challenge Phase||0||
48357703|NCT01380093|101204563|FG007|COMPLETED|Naloxone Challenge Phase||0||
48357704|NCT01380093|101204564|FG008|COMPLETED|Naloxone Challenge Phase||0||
48357705|NCT01380093|101204556|FG000|NOT COMPLETED|Naloxone Challenge Phase||21||
48357706|NCT01380093|101204557|FG001|NOT COMPLETED|Naloxone Challenge Phase||0||
48357707|NCT01380093|101204558|FG002|NOT COMPLETED|Naloxone Challenge Phase||0||
48357708|NCT01380093|101204559|FG003|NOT COMPLETED|Naloxone Challenge Phase||0||
48357709|NCT01380093|101204560|FG004|NOT COMPLETED|Naloxone Challenge Phase||0||
48357710|NCT01380093|101204561|FG005|NOT COMPLETED|Naloxone Challenge Phase||0||
48357711|NCT01380093|101204562|FG006|NOT COMPLETED|Naloxone Challenge Phase||0||
48357712|NCT01380093|101204563|FG007|NOT COMPLETED|Naloxone Challenge Phase||0||
48357713|NCT01380093|101204564|FG008|NOT COMPLETED|Naloxone Challenge Phase||0||
48357714|NCT01380093|101204556|FG000|STARTED|Drug Discrimination Phase: Day 1||0||
48357715|NCT01380093|101204557|FG001|STARTED|Drug Discrimination Phase: Day 1||30||
48357716|NCT01380093|101204558|FG002|STARTED|Drug Discrimination Phase: Day 1||29||
48357717|NCT01380093|101204559|FG003|STARTED|Drug Discrimination Phase: Day 1||0||
48357718|NCT01380093|101204560|FG004|STARTED|Drug Discrimination Phase: Day 1||0||
48357719|NCT01380093|101204561|FG005|STARTED|Drug Discrimination Phase: Day 1||0||
48357720|NCT01380093|101204562|FG006|STARTED|Drug Discrimination Phase: Day 1||0||
48357721|NCT01380093|101204563|FG007|STARTED|Drug Discrimination Phase: Day 1||0||
48357722|NCT01380093|101204564|FG008|STARTED|Drug Discrimination Phase: Day 1||0||
48357723|NCT01380093|101204556|FG000|COMPLETED|Drug Discrimination Phase: Day 1||0||
48357724|NCT01380093|101204557|FG001|COMPLETED|Drug Discrimination Phase: Day 1||29||
48357725|NCT01380093|101204558|FG002|COMPLETED|Drug Discrimination Phase: Day 1||29||
48357726|NCT01380093|101204559|FG003|COMPLETED|Drug Discrimination Phase: Day 1||0||
48357727|NCT01380093|101204560|FG004|COMPLETED|Drug Discrimination Phase: Day 1||0||
48357728|NCT01380093|101204561|FG005|COMPLETED|Drug Discrimination Phase: Day 1||0||
48357729|NCT01380093|101204562|FG006|COMPLETED|Drug Discrimination Phase: Day 1||0||
48762959|NCT05179785|102208613|FG003|NOT COMPLETED|Overall Study||0||
48762960|NCT05179785|102208614|FG004|NOT COMPLETED|Overall Study||0||
48762961|NCT05179785|102208615|FG005|NOT COMPLETED|Overall Study||0||
48357730|NCT01380093|101204563|FG007|COMPLETED|Drug Discrimination Phase: Day 1||0||
48357731|NCT01380093|101204564|FG008|COMPLETED|Drug Discrimination Phase: Day 1||0||
48357732|NCT01380093|101204556|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
48357733|NCT01380093|101204557|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 1||1||
48357734|NCT01380093|101204558|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
48357735|NCT01380093|101204559|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
48357736|NCT01380093|101204560|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
48357737|NCT01380093|101204561|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
48357738|NCT01380093|101204562|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
48357739|NCT01380093|101204563|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
48357740|NCT01380093|101204564|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
48357741|NCT01380093|101204556|FG000|STARTED|Drug Discrimination Phase: Day 2||0||
48357742|NCT01380093|101204557|FG001|STARTED|Drug Discrimination Phase: Day 2||29||
48357743|NCT01380093|101204558|FG002|STARTED|Drug Discrimination Phase: Day 2||29||
48357744|NCT01380093|101204559|FG003|STARTED|Drug Discrimination Phase: Day 2||0||
48357745|NCT01380093|101204560|FG004|STARTED|Drug Discrimination Phase: Day 2||0||
48357746|NCT01380093|101204561|FG005|STARTED|Drug Discrimination Phase: Day 2||0||
48357747|NCT01380093|101204562|FG006|STARTED|Drug Discrimination Phase: Day 2||0||
48357748|NCT01380093|101204563|FG007|STARTED|Drug Discrimination Phase: Day 2||0||
48357749|NCT01380093|101204564|FG008|STARTED|Drug Discrimination Phase: Day 2||0||
48357750|NCT01380093|101204556|FG000|COMPLETED|Drug Discrimination Phase: Day 2||0||
48357751|NCT01380093|101204557|FG001|COMPLETED|Drug Discrimination Phase: Day 2||20||
48357752|NCT01380093|101204558|FG002|COMPLETED|Drug Discrimination Phase: Day 2||16||
48357753|NCT01380093|101204559|FG003|COMPLETED|Drug Discrimination Phase: Day 2||0||
48357754|NCT01380093|101204560|FG004|COMPLETED|Drug Discrimination Phase: Day 2||0||
48357755|NCT01380093|101204561|FG005|COMPLETED|Drug Discrimination Phase: Day 2||0||
48357756|NCT01380093|101204562|FG006|COMPLETED|Drug Discrimination Phase: Day 2||0||
48357757|NCT01380093|101204563|FG007|COMPLETED|Drug Discrimination Phase: Day 2||0||
48357758|NCT01380093|101204564|FG008|COMPLETED|Drug Discrimination Phase: Day 2||0||
48357759|NCT01380093|101204556|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
48357760|NCT01380093|101204557|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 2||9||
48357761|NCT01380093|101204558|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 2||13||
48357762|NCT01380093|101204559|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
48357763|NCT01380093|101204560|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
48357764|NCT01380093|101204561|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
48357765|NCT01380093|101204562|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
48357766|NCT01380093|101204563|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
48357767|NCT01380093|101204564|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
48357768|NCT01380093|101204556|FG000|STARTED|Treatment Phase: First Intervention||0||
48357769|NCT01380093|101204557|FG001|STARTED|Treatment Phase: First Intervention||0||
48762962|NCT00821795|102208616|FG000|STARTED|Overall Study||50||
48762963|NCT00821795|102208617|FG001|STARTED|Overall Study||64||
48762964|NCT00821795|102208616|FG000|COMPLETED|Overall Study||44||
48762965|NCT00821795|102208617|FG001|COMPLETED|Overall Study||60||
48357770|NCT01380093|101204558|FG002|STARTED|Treatment Phase: First Intervention||0||
48357771|NCT01380093|101204559|FG003|STARTED|Treatment Phase: First Intervention||6||
48357772|NCT01380093|101204560|FG004|STARTED|Treatment Phase: First Intervention||6||
48357773|NCT01380093|101204561|FG005|STARTED|Treatment Phase: First Intervention||6||
48762966|NCT00821795|102208616|FG000|NOT COMPLETED|Overall Study||6||
48357774|NCT01380093|101204562|FG006|STARTED|Treatment Phase: First Intervention||6||
48357775|NCT01380093|101204563|FG007|STARTED|Treatment Phase: First Intervention||6||
48357776|NCT01380093|101204564|FG008|STARTED|Treatment Phase: First Intervention||6||
48357777|NCT01380093|101204556|FG000|COMPLETED|Treatment Phase: First Intervention||0||
48357778|NCT01380093|101204557|FG001|COMPLETED|Treatment Phase: First Intervention||0||
48357779|NCT01380093|101204558|FG002|COMPLETED|Treatment Phase: First Intervention||0||
48357780|NCT01380093|101204559|FG003|COMPLETED|Treatment Phase: First Intervention||6||
48357781|NCT01380093|101204560|FG004|COMPLETED|Treatment Phase: First Intervention||6||
48357782|NCT01380093|101204561|FG005|COMPLETED|Treatment Phase: First Intervention||6||
48357783|NCT01380093|101204562|FG006|COMPLETED|Treatment Phase: First Intervention||6||
48357784|NCT01380093|101204563|FG007|COMPLETED|Treatment Phase: First Intervention||6||
48357785|NCT01380093|101204564|FG008|COMPLETED|Treatment Phase: First Intervention||6||
48762967|NCT00821795|102208617|FG001|NOT COMPLETED|Overall Study||4||
48762968|NCT02796170|102208618|FG000|STARTED|Overall Study||8||
48762969|NCT02796170|102208619|FG001|STARTED|Overall Study||3||
48762970|NCT02796170|102208618|FG000|COMPLETED|Overall Study||5||
48762971|NCT02796170|102208619|FG001|COMPLETED|Overall Study||3||
48762972|NCT02796170|102208618|FG000|NOT COMPLETED|Overall Study||3||
48762973|NCT02796170|102208619|FG001|NOT COMPLETED|Overall Study||0||
48762974|NCT02002598|102208620|FG000|STARTED|Dose Level 1||2||
48762975|NCT02002598|102208621|FG001|STARTED|Dose Level 1||0||
48762976|NCT02002598|102208622|FG002|STARTED|Dose Level 1||0||
48762977|NCT02002598|102208623|FG003|STARTED|Dose Level 1||0||
48762978|NCT02002598|102208624|FG004|STARTED|Dose Level 1||0||
48762979|NCT02002598|102208620|FG000|COMPLETED|Dose Level 1||1||
48762980|NCT02002598|102208621|FG001|COMPLETED|Dose Level 1||0||
48762981|NCT02002598|102208622|FG002|COMPLETED|Dose Level 1||0||
48762982|NCT02002598|102208623|FG003|COMPLETED|Dose Level 1||0||
48762983|NCT02002598|102208624|FG004|COMPLETED|Dose Level 1||0||
48762984|NCT02002598|102208620|FG000|NOT COMPLETED|Dose Level 1||1||
48762985|NCT02002598|102208621|FG001|NOT COMPLETED|Dose Level 1||0||
48762986|NCT02002598|102208622|FG002|NOT COMPLETED|Dose Level 1||0||
48762987|NCT02002598|102208623|FG003|NOT COMPLETED|Dose Level 1||0||
48762988|NCT02002598|102208624|FG004|NOT COMPLETED|Dose Level 1||0||
48762989|NCT02002598|102208620|FG000|STARTED|Dose Level 2||0||
48762990|NCT02002598|102208621|FG001|STARTED|Dose Level 2||1||
48762991|NCT02002598|102208622|FG002|STARTED|Dose Level 2||0||
48762992|NCT02002598|102208623|FG003|STARTED|Dose Level 2||0||
48762993|NCT02002598|102208624|FG004|STARTED|Dose Level 2||0||
48762994|NCT02002598|102208620|FG000|COMPLETED|Dose Level 2||0||
48762995|NCT02002598|102208621|FG001|COMPLETED|Dose Level 2||1||
48357786|NCT01380093|101204556|FG000|NOT COMPLETED|Treatment Phase: First Intervention||0||
48357787|NCT01380093|101204557|FG001|NOT COMPLETED|Treatment Phase: First Intervention||0||
48357788|NCT01380093|101204558|FG002|NOT COMPLETED|Treatment Phase: First Intervention||0||
48357789|NCT01380093|101204559|FG003|NOT COMPLETED|Treatment Phase: First Intervention||0||
48357790|NCT01380093|101204560|FG004|NOT COMPLETED|Treatment Phase: First Intervention||0||
48357791|NCT01380093|101204561|FG005|NOT COMPLETED|Treatment Phase: First Intervention||0||
48357792|NCT01380093|101204562|FG006|NOT COMPLETED|Treatment Phase: First Intervention||0||
48357793|NCT01380093|101204563|FG007|NOT COMPLETED|Treatment Phase: First Intervention||0||
48357794|NCT01380093|101204564|FG008|NOT COMPLETED|Treatment Phase: First Intervention||0||
48357795|NCT01380093|101204556|FG000|STARTED|Treatment Phase: Washout Period||0||
48762996|NCT02002598|102208622|FG002|COMPLETED|Dose Level 2||0||
48762997|NCT02002598|102208623|FG003|COMPLETED|Dose Level 2||0||
48762998|NCT02002598|102208624|FG004|COMPLETED|Dose Level 2||0||
48762999|NCT02002598|102208620|FG000|NOT COMPLETED|Dose Level 2||0||
48763000|NCT02002598|102208621|FG001|NOT COMPLETED|Dose Level 2||0||
48763001|NCT02002598|102208622|FG002|NOT COMPLETED|Dose Level 2||0||
48763002|NCT02002598|102208623|FG003|NOT COMPLETED|Dose Level 2||0||
48763003|NCT02002598|102208624|FG004|NOT COMPLETED|Dose Level 2||0||
48357796|NCT01380093|101204557|FG001|STARTED|Treatment Phase: Washout Period||0||
48357797|NCT01380093|101204558|FG002|STARTED|Treatment Phase: Washout Period||0||
48357798|NCT01380093|101204559|FG003|STARTED|Treatment Phase: Washout Period||6||
48357799|NCT01380093|101204560|FG004|STARTED|Treatment Phase: Washout Period||6||
48357800|NCT01380093|101204561|FG005|STARTED|Treatment Phase: Washout Period||6||
48357801|NCT01380093|101204562|FG006|STARTED|Treatment Phase: Washout Period||6||
48357802|NCT01380093|101204563|FG007|STARTED|Treatment Phase: Washout Period||6||
48357803|NCT01380093|101204564|FG008|STARTED|Treatment Phase: Washout Period||6||
48357804|NCT01380093|101204556|FG000|COMPLETED|Treatment Phase: Washout Period||0||
48357805|NCT01380093|101204557|FG001|COMPLETED|Treatment Phase: Washout Period||0||
48357806|NCT01380093|101204558|FG002|COMPLETED|Treatment Phase: Washout Period||0||
48357807|NCT01380093|101204559|FG003|COMPLETED|Treatment Phase: Washout Period||6||
48357808|NCT01380093|101204560|FG004|COMPLETED|Treatment Phase: Washout Period||6||
48357809|NCT01380093|101204561|FG005|COMPLETED|Treatment Phase: Washout Period||6||
48763004|NCT02002598|102208620|FG000|STARTED|Dose Level 3||0||
48763005|NCT02002598|102208621|FG001|STARTED|Dose Level 3||0||
48763006|NCT02002598|102208622|FG002|STARTED|Dose Level 3||1||
48763007|NCT02002598|102208623|FG003|STARTED|Dose Level 3||0||
48763008|NCT02002598|102208624|FG004|STARTED|Dose Level 3||0||
48763009|NCT02002598|102208620|FG000|COMPLETED|Dose Level 3||0||
48763010|NCT02002598|102208621|FG001|COMPLETED|Dose Level 3||0||
48763011|NCT02002598|102208622|FG002|COMPLETED|Dose Level 3||1||
48763012|NCT02002598|102208623|FG003|COMPLETED|Dose Level 3||0||
48763013|NCT02002598|102208624|FG004|COMPLETED|Dose Level 3||0||
48419052|NCT00104299|101361593|FG000|COMPLETED|Overall Study||90||
48419053|NCT00104299|101361594|FG001|COMPLETED|Overall Study||88||
48419054|NCT00104299|101361593|FG000|NOT COMPLETED|Overall Study||9||
48419055|NCT00104299|101361594|FG001|NOT COMPLETED|Overall Study||10||
48419056|NCT02776904|101361595|FG000|STARTED|Overall Study||281||
48419057|NCT02776904|101361596|FG001|STARTED|Overall Study||46||
48419058|NCT02776904|101361595|FG000|Gait Assessment|Overall Study||178||
48419059|NCT02776904|101361596|FG001|Gait Assessment|Overall Study||32||
48419060|NCT02776904|101361595|FG000|ImPACT|Overall Study||21||
48419061|NCT02776904|101361596|FG001|ImPACT|Overall Study||46||
48419062|NCT02776904|101361595|FG000|COMPLETED|Overall Study||281||
48419063|NCT02776904|101361596|FG001|COMPLETED|Overall Study||46||
48419064|NCT02776904|101361595|FG000|NOT COMPLETED|Overall Study||0||
48419065|NCT02776904|101361596|FG001|NOT COMPLETED|Overall Study||0||
48419066|NCT02194699|101361597|FG000|STARTED|Randomised||428||
48419067|NCT02194699|101361598|FG001|STARTED|Randomised||428||
48419068|NCT02194699|101361597|FG000|COMPLETED|Randomised||420||
48419069|NCT02194699|101361598|FG001|COMPLETED|Randomised||417||
48419070|NCT02194699|101361597|FG000|NOT COMPLETED|Randomised||8||
48419071|NCT02194699|101361598|FG001|NOT COMPLETED|Randomised||11||
48419072|NCT02194699|101361597|FG000|STARTED|With Potential to Receive 52 Weeks of IP||420||
48419073|NCT02194699|101361598|FG001|STARTED|With Potential to Receive 52 Weeks of IP||417||
48419074|NCT02194699|101361597|FG000|COMPLETED|With Potential to Receive 52 Weeks of IP||370||
48419075|NCT02194699|101361598|FG001|COMPLETED|With Potential to Receive 52 Weeks of IP||365||
48419076|NCT02194699|101361597|FG000|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||50||
48419077|NCT02194699|101361598|FG001|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||52||
48419078|NCT01749930|101361599|FG000|STARTED|Overall Study||283||
48419079|NCT01749930|101361600|FG001|STARTED|Overall Study||137||
48419080|NCT01749930|101361599|FG000|COMPLETED|Overall Study||253||
48419081|NCT01749930|101361600|FG001|COMPLETED|Overall Study||125||
48419082|NCT01749930|101361599|FG000|NOT COMPLETED|Overall Study||30||
48419083|NCT01749930|101361600|FG001|NOT COMPLETED|Overall Study||12||
48419084|NCT02530281|101361601|FG000|STARTED|Overall Study||229||
48419085|NCT02530281|101361602|FG001|STARTED|Overall Study||115||
48419086|NCT02530281|101361601|FG000|COMPLETED|Overall Study||208||
48419087|NCT02530281|101361602|FG001|COMPLETED|Overall Study||112||
48419088|NCT02530281|101361601|FG000|NOT COMPLETED|Overall Study||21||
48419089|NCT02530281|101361602|FG001|NOT COMPLETED|Overall Study||3||
48419090|NCT02698176|101361603|FG000|STARTED|Overall Study||9||
48419091|NCT02698176|101361604|FG001|STARTED|Overall Study||3||
48419092|NCT02698176|101361605|FG002|STARTED|Overall Study||1||
48419093|NCT02698176|101361606|FG003|STARTED|Overall Study||0||
48419094|NCT02698176|101361603|FG000|COMPLETED|Overall Study||0||
48419095|NCT02698176|101361604|FG001|COMPLETED|Overall Study||0||
48419096|NCT02698176|101361605|FG002|COMPLETED|Overall Study||0||
48419097|NCT02698176|101361606|FG003|COMPLETED|Overall Study||0||
48419098|NCT02698176|101361603|FG000|NOT COMPLETED|Overall Study||9||
48419099|NCT02698176|101361604|FG001|NOT COMPLETED|Overall Study||3||
48419100|NCT02698176|101361605|FG002|NOT COMPLETED|Overall Study||1||
48419101|NCT02698176|101361606|FG003|NOT COMPLETED|Overall Study||0||
48419102|NCT00461851|101361607|FG000|STARTED|Overall Study||17||
48419103|NCT00461851|101361607|FG000|COMPLETED|Overall Study||17||
48419104|NCT00461851|101361607|FG000|NOT COMPLETED|Overall Study||0||
48419105|NCT01920061|101361608|FG000|STARTED|Overall Study||4||
48419106|NCT01920061|101361609|FG001|STARTED|Overall Study||5||
48419107|NCT01920061|101361610|FG002|STARTED|Overall Study||3||
48763014|NCT02002598|102208620|FG000|NOT COMPLETED|Dose Level 3||0||
48763015|NCT02002598|102208621|FG001|NOT COMPLETED|Dose Level 3||0||
48186872|NCT02559817|100779920|FG000|COMPLETED|Post-treatment Period||18||
48419108|NCT01920061|101361611|FG003|STARTED|Overall Study||4||
48763016|NCT02002598|102208622|FG002|NOT COMPLETED|Dose Level 3||0||
48763017|NCT02002598|102208623|FG003|NOT COMPLETED|Dose Level 3||0||
48763018|NCT02002598|102208624|FG004|NOT COMPLETED|Dose Level 3||0||
48419109|NCT01920061|101361612|FG004|STARTED|Overall Study||5||
48419110|NCT01920061|101361613|FG005|STARTED|Overall Study||4||
48419111|NCT01920061|101361614|FG006|STARTED|Overall Study||3||
48419112|NCT01920061|101361615|FG007|STARTED|Overall Study||3||
48419113|NCT01920061|101361616|FG008|STARTED|Overall Study||3||
48419114|NCT01920061|101361617|FG009|STARTED|Overall Study||3||
48419115|NCT01920061|101361618|FG010|STARTED|Overall Study||10||
48419116|NCT01920061|101361619|FG011|STARTED|Overall Study||5||
48419117|NCT01920061|101361620|FG012|STARTED|Overall Study||3||
48419118|NCT01920061|101361621|FG013|STARTED|Overall Study||16||
48419119|NCT01920061|101361622|FG014|STARTED|Overall Study||4||
48419120|NCT01920061|101361623|FG015|STARTED|Overall Study||7||
48763019|NCT02002598|102208620|FG000|STARTED|Dose Level 4||0||
48419121|NCT01920061|101361624|FG016|STARTED|Overall Study||3||
48419122|NCT01920061|101361625|FG017|STARTED|Overall Study||3||
48419123|NCT01920061|101361626|FG018|STARTED|Overall Study||10||
48419124|NCT01920061|101361627|FG019|STARTED|Overall Study||12||
48419125|NCT01920061|101361608|FG000|Received Treatment|Overall Study||4||
48419126|NCT01920061|101361609|FG001|Received Treatment|Overall Study||5||
48419127|NCT01920061|101361610|FG002|Received Treatment|Overall Study||3||
48419128|NCT01920061|101361611|FG003|Received Treatment|Overall Study||3||
48419129|NCT01920061|101361612|FG004|Received Treatment|Overall Study||5||
48763020|NCT02002598|102208621|FG001|STARTED|Dose Level 4||0||
48763021|NCT02002598|102208622|FG002|STARTED|Dose Level 4||0||
48763022|NCT02002598|102208623|FG003|STARTED|Dose Level 4||1||
48763023|NCT02002598|102208624|FG004|STARTED|Dose Level 4||0||
48419130|NCT01920061|101361613|FG005|Received Treatment|Overall Study||4||
48419131|NCT01920061|101361614|FG006|Received Treatment|Overall Study||3||
48419132|NCT01920061|101361615|FG007|Received Treatment|Overall Study||3||
48419133|NCT01920061|101361616|FG008|Received Treatment|Overall Study||3||
48419134|NCT01920061|101361617|FG009|Received Treatment|Overall Study||3||
48419135|NCT01920061|101361618|FG010|Received Treatment|Overall Study||10||
48419136|NCT01920061|101361619|FG011|Received Treatment|Overall Study||5||
48419137|NCT01920061|101361620|FG012|Received Treatment|Overall Study||2||
48419138|NCT01920061|101361621|FG013|Received Treatment|Overall Study||15||
48419139|NCT01920061|101361622|FG014|Received Treatment|Overall Study||4||
48638760|NCT01529268|101901494|FG001|STARTED|Overall Study||81||
48638761|NCT01529268|101901493|FG000|Completed 52-week Biopsy|Overall Study||71||
48638762|NCT01529268|101901494|FG001|Completed 52-week Biopsy|Overall Study||75||
48638763|NCT01529268|101901493|FG000|COMPLETED|Overall Study||76||
48638764|NCT01529268|101901494|FG001|COMPLETED|Overall Study||78||
48419140|NCT01920061|101361623|FG015|Received Treatment|Overall Study||7||
48419141|NCT01920061|101361624|FG016|Received Treatment|Overall Study||3||
48419142|NCT01920061|101361625|FG017|Received Treatment|Overall Study||3||
48419143|NCT01920061|101361626|FG018|Received Treatment|Overall Study||10||
48419144|NCT01920061|101361627|FG019|Received Treatment|Overall Study||12||
48419145|NCT01920061|101361608|FG000|COMPLETED|Overall Study||2||
48419146|NCT01920061|101361609|FG001|COMPLETED|Overall Study||1||
48419147|NCT01920061|101361610|FG002|COMPLETED|Overall Study||1||
48419148|NCT01920061|101361611|FG003|COMPLETED|Overall Study||2||
48419149|NCT01920061|101361612|FG004|COMPLETED|Overall Study||3||
48419150|NCT01920061|101361613|FG005|COMPLETED|Overall Study||2||
48419151|NCT01920061|101361614|FG006|COMPLETED|Overall Study||2||
48419152|NCT01920061|101361615|FG007|COMPLETED|Overall Study||2||
48419153|NCT01920061|101361616|FG008|COMPLETED|Overall Study||2||
48638765|NCT01529268|101901493|FG000|NOT COMPLETED|Overall Study||12||
48638766|NCT01529268|101901494|FG001|NOT COMPLETED|Overall Study||3||
48638767|NCT05166876|101901495|FG000|STARTED|Overall Study||7||
48638768|NCT05166876|101901496|FG001|STARTED|Overall Study||6||
48638769|NCT05166876|101901497|FG002|STARTED|Overall Study||13||
48638770|NCT05166876|101901495|FG000|COMPLETED|Overall Study||6||
48763024|NCT02002598|102208620|FG000|COMPLETED|Dose Level 4||0||
48763025|NCT02002598|102208621|FG001|COMPLETED|Dose Level 4||0||
48763026|NCT02002598|102208622|FG002|COMPLETED|Dose Level 4||0||
48763027|NCT02002598|102208623|FG003|COMPLETED|Dose Level 4||1||
48763028|NCT02002598|102208624|FG004|COMPLETED|Dose Level 4||0||
48419154|NCT01920061|101361617|FG009|COMPLETED|Overall Study||1||
48419155|NCT01920061|101361618|FG010|COMPLETED|Overall Study||5||
48638771|NCT05166876|101901496|FG001|COMPLETED|Overall Study||6||
48638772|NCT05166876|101901497|FG002|COMPLETED|Overall Study||13||
48638773|NCT05166876|101901495|FG000|NOT COMPLETED|Overall Study||1||
48638774|NCT05166876|101901496|FG001|NOT COMPLETED|Overall Study||0||
48638775|NCT05166876|101901497|FG002|NOT COMPLETED|Overall Study||0||
48638776|NCT03018730|101901498|FG000|STARTED|Overall Study||22||
48638777|NCT03018730|101901498|FG000|COMPLETED|Overall Study||20||
48638778|NCT03018730|101901498|FG000|NOT COMPLETED|Overall Study||2||
48638779|NCT04000724|101901499|FG000|STARTED|Overall Study||85||
48638780|NCT04000724|101901500|FG001|STARTED|Overall Study||82||
48638781|NCT04000724|101901501|FG002|STARTED|Overall Study||87||
48419156|NCT01920061|101361619|FG011|COMPLETED|Overall Study||2||
48419157|NCT01920061|101361620|FG012|COMPLETED|Overall Study||1||
48638782|NCT04000724|101901499|FG000|3-month Follow-up|Overall Study||73||
48638783|NCT04000724|101901500|FG001|3-month Follow-up|Overall Study||78||
48419158|NCT01920061|101361621|FG013|COMPLETED|Overall Study||10||
48638784|NCT04000724|101901501|FG002|3-month Follow-up|Overall Study||77||
48638785|NCT04000724|101901499|FG000|6-month Follow-up|Overall Study||67||
48763029|NCT02002598|102208620|FG000|NOT COMPLETED|Dose Level 4||0||
48763030|NCT02002598|102208621|FG001|NOT COMPLETED|Dose Level 4||0||
48419159|NCT01920061|101361622|FG014|COMPLETED|Overall Study||3||
48419160|NCT01920061|101361623|FG015|COMPLETED|Overall Study||4||
48419161|NCT01920061|101361624|FG016|COMPLETED|Overall Study||1||
48419162|NCT01920061|101361625|FG017|COMPLETED|Overall Study||1||
48419163|NCT01920061|101361626|FG018|COMPLETED|Overall Study||4||
48419164|NCT01920061|101361627|FG019|COMPLETED|Overall Study||8||
48419165|NCT01920061|101361608|FG000|NOT COMPLETED|Overall Study||2||
48638786|NCT04000724|101901500|FG001|6-month Follow-up|Overall Study||71||
48638787|NCT04000724|101901501|FG002|6-month Follow-up|Overall Study||67||
48638788|NCT04000724|101901499|FG000|COMPLETED|Overall Study||69||
48763031|NCT02002598|102208622|FG002|NOT COMPLETED|Dose Level 4||0||
48763032|NCT02002598|102208623|FG003|NOT COMPLETED|Dose Level 4||0||
48763033|NCT02002598|102208624|FG004|NOT COMPLETED|Dose Level 4||0||
48763034|NCT02002598|102208620|FG000|STARTED|Dose Level 5||0||
48763035|NCT02002598|102208621|FG001|STARTED|Dose Level 5||0||
48763036|NCT02002598|102208622|FG002|STARTED|Dose Level 5||0||
48763037|NCT02002598|102208623|FG003|STARTED|Dose Level 5||0||
48357810|NCT01380093|101204562|FG006|COMPLETED|Treatment Phase: Washout Period||6||
48357811|NCT01380093|101204563|FG007|COMPLETED|Treatment Phase: Washout Period||6||
48357812|NCT01380093|101204564|FG008|COMPLETED|Treatment Phase: Washout Period||6||
48357813|NCT01380093|101204556|FG000|NOT COMPLETED|Treatment Phase: Washout Period||0||
48419166|NCT01920061|101361609|FG001|NOT COMPLETED|Overall Study||4||
48419167|NCT01920061|101361610|FG002|NOT COMPLETED|Overall Study||2||
48419168|NCT01920061|101361611|FG003|NOT COMPLETED|Overall Study||2||
48419169|NCT01920061|101361612|FG004|NOT COMPLETED|Overall Study||2||
48419170|NCT01920061|101361613|FG005|NOT COMPLETED|Overall Study||2||
48419171|NCT01920061|101361614|FG006|NOT COMPLETED|Overall Study||1||
48419172|NCT01920061|101361615|FG007|NOT COMPLETED|Overall Study||1||
48419173|NCT01920061|101361616|FG008|NOT COMPLETED|Overall Study||1||
48357814|NCT01380093|101204557|FG001|NOT COMPLETED|Treatment Phase: Washout Period||0||
48357815|NCT01380093|101204558|FG002|NOT COMPLETED|Treatment Phase: Washout Period||0||
48357816|NCT01380093|101204559|FG003|NOT COMPLETED|Treatment Phase: Washout Period||0||
48357817|NCT01380093|101204560|FG004|NOT COMPLETED|Treatment Phase: Washout Period||0||
48357818|NCT01380093|101204561|FG005|NOT COMPLETED|Treatment Phase: Washout Period||0||
48357819|NCT01380093|101204562|FG006|NOT COMPLETED|Treatment Phase: Washout Period||0||
48357820|NCT01380093|101204563|FG007|NOT COMPLETED|Treatment Phase: Washout Period||0||
48357821|NCT01380093|101204564|FG008|NOT COMPLETED|Treatment Phase: Washout Period||0||
48357822|NCT01380093|101204556|FG000|STARTED|Treatment Phase: Second Intervention||0||
48357823|NCT01380093|101204557|FG001|STARTED|Treatment Phase: Second Intervention||0||
48357824|NCT01380093|101204558|FG002|STARTED|Treatment Phase: Second Intervention||0||
48357825|NCT01380093|101204559|FG003|STARTED|Treatment Phase: Second Intervention||6||
48357826|NCT01380093|101204560|FG004|STARTED|Treatment Phase: Second Intervention||6||
48357827|NCT01380093|101204561|FG005|STARTED|Treatment Phase: Second Intervention||6||
48357828|NCT01380093|101204562|FG006|STARTED|Treatment Phase: Second Intervention||6||
48357829|NCT01380093|101204563|FG007|STARTED|Treatment Phase: Second Intervention||6||
48357830|NCT01380093|101204564|FG008|STARTED|Treatment Phase: Second Intervention||6||
48357831|NCT01380093|101204556|FG000|COMPLETED|Treatment Phase: Second Intervention||0||
48357832|NCT01380093|101204557|FG001|COMPLETED|Treatment Phase: Second Intervention||0||
48419174|NCT01920061|101361617|FG009|NOT COMPLETED|Overall Study||2||
48419175|NCT01920061|101361618|FG010|NOT COMPLETED|Overall Study||5||
48419176|NCT01920061|101361619|FG011|NOT COMPLETED|Overall Study||3||
48419177|NCT01920061|101361620|FG012|NOT COMPLETED|Overall Study||2||
48357833|NCT01380093|101204558|FG002|COMPLETED|Treatment Phase: Second Intervention||0||
48357834|NCT01380093|101204559|FG003|COMPLETED|Treatment Phase: Second Intervention||5||
48357835|NCT01380093|101204560|FG004|COMPLETED|Treatment Phase: Second Intervention||6||
48357836|NCT01380093|101204561|FG005|COMPLETED|Treatment Phase: Second Intervention||6||
48357837|NCT01380093|101204562|FG006|COMPLETED|Treatment Phase: Second Intervention||6||
48357838|NCT01380093|101204563|FG007|COMPLETED|Treatment Phase: Second Intervention||6||
48357839|NCT01380093|101204564|FG008|COMPLETED|Treatment Phase: Second Intervention||6||
48357840|NCT01380093|101204556|FG000|NOT COMPLETED|Treatment Phase: Second Intervention||0||
48357841|NCT01380093|101204557|FG001|NOT COMPLETED|Treatment Phase: Second Intervention||0||
48357842|NCT01380093|101204558|FG002|NOT COMPLETED|Treatment Phase: Second Intervention||0||
48357843|NCT01380093|101204559|FG003|NOT COMPLETED|Treatment Phase: Second Intervention||1||
48357844|NCT01380093|101204560|FG004|NOT COMPLETED|Treatment Phase: Second Intervention||0||
48357845|NCT01380093|101204561|FG005|NOT COMPLETED|Treatment Phase: Second Intervention||0||
48357846|NCT01380093|101204562|FG006|NOT COMPLETED|Treatment Phase: Second Intervention||0||
48357847|NCT01380093|101204563|FG007|NOT COMPLETED|Treatment Phase: Second Intervention||0||
48357848|NCT01380093|101204564|FG008|NOT COMPLETED|Treatment Phase: Second Intervention||0||
48357849|NCT01380093|101204556|FG000|STARTED|Treatment Phase: Washout Period||0||
48357850|NCT01380093|101204557|FG001|STARTED|Treatment Phase: Washout Period||0||
48419178|NCT01920061|101361621|FG013|NOT COMPLETED|Overall Study||6||
48357851|NCT01380093|101204558|FG002|STARTED|Treatment Phase: Washout Period||0||
48357852|NCT01380093|101204559|FG003|STARTED|Treatment Phase: Washout Period||5||
48357853|NCT01380093|101204560|FG004|STARTED|Treatment Phase: Washout Period||6||
48357854|NCT01380093|101204561|FG005|STARTED|Treatment Phase: Washout Period||6||
48357855|NCT01380093|101204562|FG006|STARTED|Treatment Phase: Washout Period||6||
48419179|NCT01920061|101361622|FG014|NOT COMPLETED|Overall Study||1||
48419180|NCT01920061|101361623|FG015|NOT COMPLETED|Overall Study||3||
48763038|NCT02002598|102208624|FG004|STARTED|Dose Level 5||15||
48763039|NCT02002598|102208620|FG000|COMPLETED|Dose Level 5||0||
48357856|NCT01380093|101204563|FG007|STARTED|Treatment Phase: Washout Period||6||
48357857|NCT01380093|101204564|FG008|STARTED|Treatment Phase: Washout Period||6||
48357858|NCT01380093|101204556|FG000|COMPLETED|Treatment Phase: Washout Period||0||
48357859|NCT01380093|101204557|FG001|COMPLETED|Treatment Phase: Washout Period||0||
48357860|NCT01380093|101204558|FG002|COMPLETED|Treatment Phase: Washout Period||0||
48357861|NCT01380093|101204559|FG003|COMPLETED|Treatment Phase: Washout Period||5||
48357862|NCT01380093|101204560|FG004|COMPLETED|Treatment Phase: Washout Period||6||
48357863|NCT01380093|101204561|FG005|COMPLETED|Treatment Phase: Washout Period||6||
48357864|NCT01380093|101204562|FG006|COMPLETED|Treatment Phase: Washout Period||6||
48357865|NCT01380093|101204563|FG007|COMPLETED|Treatment Phase: Washout Period||6||
48357866|NCT01380093|101204564|FG008|COMPLETED|Treatment Phase: Washout Period||6||
48357867|NCT01380093|101204556|FG000|NOT COMPLETED|Treatment Phase: Washout Period||0||
48357868|NCT01380093|101204557|FG001|NOT COMPLETED|Treatment Phase: Washout Period||0||
48357869|NCT01380093|101204558|FG002|NOT COMPLETED|Treatment Phase: Washout Period||0||
48357870|NCT01380093|101204559|FG003|NOT COMPLETED|Treatment Phase: Washout Period||0||
48357871|NCT01380093|101204560|FG004|NOT COMPLETED|Treatment Phase: Washout Period||0||
48419181|NCT01920061|101361624|FG016|NOT COMPLETED|Overall Study||2||
48419182|NCT01920061|101361625|FG017|NOT COMPLETED|Overall Study||2||
48419183|NCT01920061|101361626|FG018|NOT COMPLETED|Overall Study||6||
48419184|NCT01920061|101361627|FG019|NOT COMPLETED|Overall Study||4||
48419185|NCT03055806|101361628|FG000|STARTED|Overall Study||48||
48419186|NCT03055806|101361629|FG001|STARTED|Overall Study||48||
48419187|NCT03055806|101361630|FG002|STARTED|Overall Study||71||
48419188|NCT03055806|101361631|FG003|STARTED|Overall Study||72||
48419189|NCT03055806|101361628|FG000|COMPLETED|Overall Study||42||
48419190|NCT03055806|101361629|FG001|COMPLETED|Overall Study||41||
48419191|NCT03055806|101361630|FG002|COMPLETED|Overall Study||58||
48419192|NCT03055806|101361631|FG003|COMPLETED|Overall Study||57||
48419193|NCT03055806|101361628|FG000|NOT COMPLETED|Overall Study||6||
48419194|NCT03055806|101361629|FG001|NOT COMPLETED|Overall Study||7||
48419195|NCT03055806|101361630|FG002|NOT COMPLETED|Overall Study||13||
48419196|NCT03055806|101361631|FG003|NOT COMPLETED|Overall Study||15||
48419197|NCT02813681|101361632|FG000|STARTED|Overall Study||27||
48419198|NCT02813681|101361633|FG001|STARTED|Overall Study||34||
48419199|NCT02813681|101361634|FG002|STARTED|Overall Study||19||
48419200|NCT02813681|101361632|FG000|COMPLETED|Overall Study||22||
48419201|NCT02813681|101361633|FG001|COMPLETED|Overall Study||28||
48419202|NCT02813681|101361634|FG002|COMPLETED|Overall Study||19||
48419203|NCT02813681|101361632|FG000|NOT COMPLETED|Overall Study||5||
48419204|NCT02813681|101361633|FG001|NOT COMPLETED|Overall Study||6||
48419205|NCT02813681|101361634|FG002|NOT COMPLETED|Overall Study||0||
48419206|NCT03969589|101361635|FG000|STARTED|Overall Study||20||
48419207|NCT03969589|101361636|FG001|STARTED|Overall Study||20||
48419208|NCT03969589|101361635|FG000|COMPLETED|Overall Study||17||
48419209|NCT03969589|101361636|FG001|COMPLETED|Overall Study||17||
48419210|NCT03969589|101361635|FG000|NOT COMPLETED|Overall Study||3||
48419211|NCT03969589|101361636|FG001|NOT COMPLETED|Overall Study||3||
48357872|NCT01380093|101204561|FG005|NOT COMPLETED|Treatment Phase: Washout Period||0||
48357873|NCT01380093|101204562|FG006|NOT COMPLETED|Treatment Phase: Washout Period||0||
48357874|NCT01380093|101204563|FG007|NOT COMPLETED|Treatment Phase: Washout Period||0||
48357875|NCT01380093|101204564|FG008|NOT COMPLETED|Treatment Phase: Washout Period||0||
48357876|NCT01380093|101204556|FG000|STARTED|Treatment Phase: Third Intervention||0||
48357877|NCT01380093|101204557|FG001|STARTED|Treatment Phase: Third Intervention||0||
48357878|NCT01380093|101204558|FG002|STARTED|Treatment Phase: Third Intervention||0||
48357879|NCT01380093|101204559|FG003|STARTED|Treatment Phase: Third Intervention||5||
48357880|NCT01380093|101204560|FG004|STARTED|Treatment Phase: Third Intervention||6||
48357881|NCT01380093|101204561|FG005|STARTED|Treatment Phase: Third Intervention||6||
48357882|NCT01380093|101204562|FG006|STARTED|Treatment Phase: Third Intervention||6||
48357883|NCT01380093|101204563|FG007|STARTED|Treatment Phase: Third Intervention||6||
48357884|NCT01380093|101204564|FG008|STARTED|Treatment Phase: Third Intervention||6||
48357885|NCT01380093|101204556|FG000|COMPLETED|Treatment Phase: Third Intervention||0||
48357886|NCT01380093|101204557|FG001|COMPLETED|Treatment Phase: Third Intervention||0||
48419212|NCT00615420|101361637|FG000|STARTED|Overall Study||54||
48419213|NCT00615420|101361638|FG001|STARTED|Overall Study||52||
48419214|NCT00615420|101361637|FG000|COMPLETED|Overall Study||23||
48419215|NCT00615420|101361638|FG001|COMPLETED|Overall Study||25||
48419216|NCT00615420|101361637|FG000|NOT COMPLETED|Overall Study||31||
48419217|NCT00615420|101361638|FG001|NOT COMPLETED|Overall Study||27||
48419218|NCT00356434|101361639|FG000|STARTED|Overall Study||4||
48419219|NCT00356434|101361640|FG001|STARTED|Overall Study||7||
48419220|NCT00356434|101361639|FG000|COMPLETED|Overall Study||4||
48419221|NCT00356434|101361640|FG001|COMPLETED|Overall Study||7||
48419222|NCT00356434|101361639|FG000|NOT COMPLETED|Overall Study||0||
48419223|NCT00356434|101361640|FG001|NOT COMPLETED|Overall Study||0||
48419224|NCT00416572|101361641|FG000|STARTED|Overall Study||83||
48419225|NCT00416572|101361642|FG001|STARTED|Overall Study||85||
48357887|NCT01380093|101204558|FG002|COMPLETED|Treatment Phase: Third Intervention||0||
48357888|NCT01380093|101204559|FG003|COMPLETED|Treatment Phase: Third Intervention||5||
48357889|NCT01380093|101204560|FG004|COMPLETED|Treatment Phase: Third Intervention||6||
48357890|NCT01380093|101204561|FG005|COMPLETED|Treatment Phase: Third Intervention||6||
48357891|NCT01380093|101204562|FG006|COMPLETED|Treatment Phase: Third Intervention||6||
48357892|NCT01380093|101204563|FG007|COMPLETED|Treatment Phase: Third Intervention||6||
48357893|NCT01380093|101204564|FG008|COMPLETED|Treatment Phase: Third Intervention||4||
48357894|NCT01380093|101204556|FG000|NOT COMPLETED|Treatment Phase: Third Intervention||0||
48357895|NCT01380093|101204557|FG001|NOT COMPLETED|Treatment Phase: Third Intervention||0||
48357896|NCT01380093|101204558|FG002|NOT COMPLETED|Treatment Phase: Third Intervention||0||
48357897|NCT01380093|101204559|FG003|NOT COMPLETED|Treatment Phase: Third Intervention||0||
48357898|NCT01380093|101204560|FG004|NOT COMPLETED|Treatment Phase: Third Intervention||0||
48357899|NCT01380093|101204561|FG005|NOT COMPLETED|Treatment Phase: Third Intervention||0||
48357900|NCT01380093|101204562|FG006|NOT COMPLETED|Treatment Phase: Third Intervention||0||
48357901|NCT01380093|101204563|FG007|NOT COMPLETED|Treatment Phase: Third Intervention||0||
48357902|NCT01380093|101204564|FG008|NOT COMPLETED|Treatment Phase: Third Intervention||2||
48357903|NCT03285529|101204565|FG000|STARTED|Overall Study||30||
48357904|NCT03285529|101204566|FG001|STARTED|Overall Study||30||
48357905|NCT03285529|101204565|FG000|COMPLETED|Overall Study||30||
48357906|NCT03285529|101204566|FG001|COMPLETED|Overall Study||30||
48357907|NCT03285529|101204565|FG000|NOT COMPLETED|Overall Study||0||
48357908|NCT03285529|101204566|FG001|NOT COMPLETED|Overall Study||0||
48357909|NCT03679494|101204567|FG000|STARTED|Overall Study||67||
48357910|NCT03679494|101204568|FG001|STARTED|Overall Study||63||
48357911|NCT03679494|101204567|FG000|COMPLETED|Overall Study||67||
48419226|NCT00416572|101361643|FG002|STARTED|Overall Study||84||
48419227|NCT00416572|101361641|FG000|COMPLETED|Overall Study||70||
48419228|NCT00416572|101361642|FG001|COMPLETED|Overall Study||78||
48419229|NCT00416572|101361643|FG002|COMPLETED|Overall Study||76||
48419230|NCT00416572|101361641|FG000|NOT COMPLETED|Overall Study||13||
48419231|NCT00416572|101361642|FG001|NOT COMPLETED|Overall Study||7||
48419232|NCT00416572|101361643|FG002|NOT COMPLETED|Overall Study||8||
48419233|NCT01160458|101361644|FG000|STARTED|Overall Study||20||
48419234|NCT01160458|101361644|FG000|COMPLETED|Overall Study||20||
48419235|NCT01160458|101361644|FG000|NOT COMPLETED|Overall Study||0||
48419236|NCT01952041|101361645|FG000|STARTED|Overall Study||62||
48419237|NCT01952041|101361646|FG001|STARTED|Overall Study||64||
48419238|NCT01952041|101361645|FG000|COMPLETED|Overall Study||45||
48419239|NCT01952041|101361646|FG001|COMPLETED|Overall Study||43||
48419240|NCT01952041|101361645|FG000|NOT COMPLETED|Overall Study||17||
48419241|NCT01952041|101361646|FG001|NOT COMPLETED|Overall Study||21||
48419242|NCT03143855|101361647|FG000|STARTED|Overall Study||17||
48419243|NCT03143855|101361648|FG001|STARTED|Overall Study||10||
48419244|NCT03143855|101361647|FG000|COMPLETED|Overall Study||12||
48357912|NCT03679494|101204568|FG001|COMPLETED|Overall Study||63||
48357913|NCT03679494|101204567|FG000|NOT COMPLETED|Overall Study||0||
48357914|NCT03679494|101204568|FG001|NOT COMPLETED|Overall Study||0||
48357915|NCT02024464|101204569|FG000|STARTED|Overall Study||154||
48357916|NCT02024464|101204570|FG001|STARTED|Overall Study||152||
48357917|NCT02024464|101204569|FG000|COMPLETED|Overall Study||144||
48357918|NCT02024464|101204570|FG001|COMPLETED|Overall Study||141||
48357919|NCT02024464|101204569|FG000|NOT COMPLETED|Overall Study||10||
48357920|NCT02024464|101204570|FG001|NOT COMPLETED|Overall Study||11||
48357921|NCT04786210|101204571|FG000|STARTED|Overall Study||19||38
48357922|NCT04786210|101204571|FG000|Received 5-fluorouracil (5-FU)|Overall Study||19||19
48357923|NCT04786210|101204571|FG000|Received Triamcinolone Acetonide|Overall Study||19||19
48357924|NCT04786210|101204571|FG000|COMPLETED|Overall Study||13||26
48357925|NCT04786210|101204571|FG000|NOT COMPLETED|Overall Study||6||12
48357926|NCT02420652|101204572|FG000|STARTED|Overall Study||18||
48357927|NCT02420652|101204573|FG001|STARTED|Overall Study||9||
48357928|NCT02420652|101204572|FG000|COMPLETED|Overall Study||8||
48357929|NCT02420652|101204573|FG001|COMPLETED|Overall Study||5||
48357930|NCT02420652|101204572|FG000|NOT COMPLETED|Overall Study||10||
48357931|NCT02420652|101204573|FG001|NOT COMPLETED|Overall Study||4||
48419245|NCT03143855|101361648|FG001|COMPLETED|Overall Study||6||
48419246|NCT03143855|101361647|FG000|NOT COMPLETED|Overall Study||5||
48357932|NCT03489291|101204574|FG000|STARTED|Overall Study||3||
48357933|NCT03489291|101204574|FG000|COMPLETED|Overall Study||3||
48357934|NCT03489291|101204574|FG000|NOT COMPLETED|Overall Study||0||
48419247|NCT03143855|101361648|FG001|NOT COMPLETED|Overall Study||4||
48419248|NCT02363322|101361649|FG000|STARTED|Overall Study||36||
48419249|NCT02363322|101361650|FG001|STARTED|Overall Study||36||
48419250|NCT02363322|101361649|FG000|COMPLETED|Overall Study||35||
48419251|NCT02363322|101361650|FG001|COMPLETED|Overall Study||36||
48419252|NCT02363322|101361649|FG000|NOT COMPLETED|Overall Study||1||
48419253|NCT02363322|101361650|FG001|NOT COMPLETED|Overall Study||0||
48419254|NCT05064449|101361651|FG000|STARTED|Period 1 (1 Day)||14||
48419255|NCT05064449|101361652|FG001|STARTED|Period 1 (1 Day)||14||
48419256|NCT05064449|101361651|FG000|COMPLETED|Period 1 (1 Day)||14||
48419257|NCT05064449|101361652|FG001|COMPLETED|Period 1 (1 Day)||14||
48419258|NCT05064449|101361651|FG000|NOT COMPLETED|Period 1 (1 Day)||0||
48419259|NCT05064449|101361652|FG001|NOT COMPLETED|Period 1 (1 Day)||0||
48419260|NCT05064449|101361651|FG000|STARTED|Washout Period (4 Days)||14||
48419261|NCT05064449|101361652|FG001|STARTED|Washout Period (4 Days)||14||
48419262|NCT05064449|101361651|FG000|COMPLETED|Washout Period (4 Days)||14||
48419263|NCT05064449|101361652|FG001|COMPLETED|Washout Period (4 Days)||14||
48419264|NCT05064449|101361651|FG000|NOT COMPLETED|Washout Period (4 Days)||0||
48419265|NCT05064449|101361652|FG001|NOT COMPLETED|Washout Period (4 Days)||0||
48419266|NCT05064449|101361651|FG000|STARTED|Period 2(Part 1:Day 1-12;Part 2:Day 1-8)||14||
48419267|NCT05064449|101361652|FG001|STARTED|Period 2(Part 1:Day 1-12;Part 2:Day 1-8)||14||
48419268|NCT05064449|101361651|FG000|COMPLETED|Period 2(Part 1:Day 1-12;Part 2:Day 1-8)||14||
48419269|NCT05064449|101361652|FG001|COMPLETED|Period 2(Part 1:Day 1-12;Part 2:Day 1-8)||14||
48419270|NCT05064449|101361651|FG000|NOT COMPLETED|Period 2(Part 1:Day 1-12;Part 2:Day 1-8)||0||
48419271|NCT05064449|101361652|FG001|NOT COMPLETED|Period 2(Part 1:Day 1-12;Part 2:Day 1-8)||0||
48357935|NCT03863496|101204575|FG000|STARTED|Overall Study||71||
48357936|NCT03863496|101204575|FG000|COMPLETED|Overall Study||71||
48357937|NCT03863496|101204575|FG000|NOT COMPLETED|Overall Study||0||
48357938|NCT04655586|101204576|FG000|STARTED|Overall Study||40||
48357939|NCT04655586|101204577|FG001|STARTED|Overall Study||40||
48357940|NCT04655586|101204578|FG002|STARTED|Overall Study||80||
48357941|NCT04655586|101204576|FG000|COMPLETED|Overall Study||38|The primary reason for participants not receiving all three doses of drug and completing the study were hospital discharges.|
48419272|NCT00544674|101361653|FG000|STARTED|Overall Study||5||
48419273|NCT00544674|101361653|FG000|COMPLETED|Overall Study||4||
48763040|NCT02002598|102208621|FG001|COMPLETED|Dose Level 5||0||
48763041|NCT02002598|102208622|FG002|COMPLETED|Dose Level 5||0||
48763042|NCT02002598|102208623|FG003|COMPLETED|Dose Level 5||0||
48763043|NCT02002598|102208624|FG004|COMPLETED|Dose Level 5||15||
48763044|NCT02002598|102208620|FG000|NOT COMPLETED|Dose Level 5||0||
48763045|NCT02002598|102208621|FG001|NOT COMPLETED|Dose Level 5||0||
48763046|NCT02002598|102208622|FG002|NOT COMPLETED|Dose Level 5||0||
48763047|NCT02002598|102208623|FG003|NOT COMPLETED|Dose Level 5||0||
48763048|NCT02002598|102208624|FG004|NOT COMPLETED|Dose Level 5||0||
48763049|NCT04558125|102208625|FG000|STARTED|Overall Study||2||
48763050|NCT04558125|102208625|FG000|COMPLETED|Overall Study||1||
48763051|NCT04558125|102208625|FG000|NOT COMPLETED|Overall Study||1||
48763052|NCT02638220|102208626|FG000|STARTED|Overall Study||442||
48763053|NCT02638220|102208626|FG000|COMPLETED|Overall Study||426||
48763054|NCT02638220|102208626|FG000|NOT COMPLETED|Overall Study||16||
48763055|NCT03081117|102208627|FG000|STARTED|Overall Study||10||
48763056|NCT03081117|102208628|FG001|STARTED|Overall Study||11||
48763057|NCT03081117|102208627|FG000|Primary Outcome 1 (SAE)|Overall Study||10|Participants who received at least 12 weeks of follow-up monitoring to collect serious adverse event (SAE) data.|
48763058|NCT03081117|102208628|FG001|Primary Outcome 1 (SAE)|Overall Study||11|Participants who received at least 12 weeks of follow-up monitoring to collect serious adverse event (SAE) data.|
48763059|NCT03081117|102208627|FG000|Secondary Measures Collected at Week 24|Overall Study||8|Participants with at least secondary measures collected at 24 weeks.|
48763060|NCT03081117|102208628|FG001|Secondary Measures Collected at Week 24|Overall Study||9|Participants with at least secondary measures collected at 24 weeks.|
48763061|NCT03081117|102208627|FG000|Completed (ITT): Primary Outcome 2 (GDS)|Overall Study||7|Participants who completed neurocognitive test measures with valid Global Deficit Score (GDS) at 24 weeks.|
48763062|NCT03081117|102208628|FG001|Completed (ITT): Primary Outcome 2 (GDS)|Overall Study||9|Participants who completed neurocognitive test measures with valid Global Deficit Score (GDS) at 24 weeks.|
48763063|NCT03081117|102208627|FG000|COMPLETED|Overall Study||6|Valid primary outcome measures and compliance with study intervention \>66% (16 Weeks).|
48763064|NCT03081117|102208628|FG001|COMPLETED|Overall Study||8|Valid primary outcome measures and compliance with study intervention \>66% (16 Weeks).|
48763065|NCT03081117|102208627|FG000|NOT COMPLETED|Overall Study||4||
48763066|NCT03081117|102208628|FG001|NOT COMPLETED|Overall Study||3||
48763067|NCT03363841|102208629|FG000|STARTED|Overall Study||30||
48419274|NCT00544674|101361653|FG000|NOT COMPLETED|Overall Study||1||
48419275|NCT01711359|101361654|FG000|STARTED|Treatment Period||213||
48419276|NCT01711359|101361655|FG001|STARTED|Treatment Period||160||
48419277|NCT01711359|101361656|FG002|STARTED|Treatment Period||215||
48763068|NCT03363841|102208629|FG000|COMPLETED|Overall Study||20||
48186873|NCT02559817|100779921|FG001|COMPLETED|Post-treatment Period||27||
48357942|NCT04655586|101204577|FG001|COMPLETED|Overall Study||34|The primary reason for participants not receiving all three doses of drug and completing the study were hospital discharges.|
48357943|NCT04655586|101204578|FG002|COMPLETED|Overall Study||75|The primary reason for participants not receiving all three doses of drug and completing the study were hospital discharges.|
48357944|NCT04655586|101204576|FG000|NOT COMPLETED|Overall Study||2||
48419278|NCT01711359|101361654|FG000|Received at Least One Dose of Study Drug|Treatment Period||210||
48419279|NCT01711359|101361655|FG001|Received at Least One Dose of Study Drug|Treatment Period||159||
48419280|NCT01711359|101361656|FG002|Received at Least One Dose of Study Drug|Treatment Period||215||
48419281|NCT01711359|101361654|FG000|Rescued|Treatment Period||26||
48419282|NCT01711359|101361655|FG001|Rescued|Treatment Period||7||
48419283|NCT01711359|101361656|FG002|Rescued|Treatment Period||6||
48419284|NCT01711359|101361654|FG000|COMPLETED|Treatment Period||161||
48419285|NCT01711359|101361655|FG001|COMPLETED|Treatment Period||136||
48419286|NCT01711359|101361656|FG002|COMPLETED|Treatment Period||173||
48419287|NCT01711359|101361654|FG000|NOT COMPLETED|Treatment Period||52||
48419288|NCT01711359|101361655|FG001|NOT COMPLETED|Treatment Period||24||
48419289|NCT01711359|101361656|FG002|NOT COMPLETED|Treatment Period||42||
48419290|NCT01711359|101361654|FG000|STARTED|Follow Up||25||
48419291|NCT01711359|101361655|FG001|STARTED|Follow Up||15||
48419292|NCT01711359|101361656|FG002|STARTED|Follow Up||28||
48419293|NCT01711359|101361654|FG000|COMPLETED|Follow Up||0||
48419294|NCT01711359|101361655|FG001|COMPLETED|Follow Up||0||
48419295|NCT01711359|101361656|FG002|COMPLETED|Follow Up||0||
48419296|NCT01711359|101361654|FG000|NOT COMPLETED|Follow Up||25||
48419297|NCT01711359|101361655|FG001|NOT COMPLETED|Follow Up||15||
48419298|NCT01711359|101361656|FG002|NOT COMPLETED|Follow Up||28||
48419299|NCT00557362|101361657|FG000|STARTED|Overall Study||30||
48419300|NCT00557362|101361658|FG001|STARTED|Overall Study||30||
48419301|NCT00557362|101361659|FG002|STARTED|Overall Study||30||
48419302|NCT00557362|101361660|FG003|STARTED|Overall Study||30||
48419303|NCT00557362|101361657|FG000|COMPLETED|Overall Study||28||
48357945|NCT04655586|101204577|FG001|NOT COMPLETED|Overall Study||6||
48357946|NCT04655586|101204578|FG002|NOT COMPLETED|Overall Study||5||
48357947|NCT01215318|101204579|FG000|STARTED|Overall Study||20||
48357948|NCT01215318|101204580|FG001|STARTED|Overall Study||24||
48357949|NCT01215318|101204579|FG000|COMPLETED|Overall Study||20||
48357950|NCT01215318|101204580|FG001|COMPLETED|Overall Study||24||
48357951|NCT01215318|101204579|FG000|NOT COMPLETED|Overall Study||0||
48357952|NCT01215318|101204580|FG001|NOT COMPLETED|Overall Study||0||
48357953|NCT04946344|101204581|FG000|STARTED|Overall Study||8||
48357954|NCT04946344|101204582|FG001|STARTED|Overall Study||8||
48357955|NCT04946344|101204581|FG000|COMPLETED|Overall Study||6||
48357956|NCT04946344|101204582|FG001|COMPLETED|Overall Study||6||
48357957|NCT04946344|101204581|FG000|NOT COMPLETED|Overall Study||2||
48357958|NCT04946344|101204582|FG001|NOT COMPLETED|Overall Study||2||
48357959|NCT01171521|101204583|FG000|STARTED|Overall Study||6||
48357960|NCT01171521|101204583|FG000|COMPLETED|Overall Study||0||
48357961|NCT01171521|101204583|FG000|NOT COMPLETED|Overall Study||6||
48357962|NCT03750838|101204584|FG000|STARTED|Overall Study||49||
48357963|NCT03750838|101204585|FG001|STARTED|Overall Study||50||
48357964|NCT03750838|101204584|FG000|6 Week Follow-up|Overall Study||40||
48357965|NCT03750838|101204585|FG001|6 Week Follow-up|Overall Study||43||
48357966|NCT03750838|101204584|FG000|3 Month Follow-up|Overall Study||32||
48357967|NCT03750838|101204585|FG001|3 Month Follow-up|Overall Study||40||
48357968|NCT03750838|101204584|FG000|6 Month Follow-up|Overall Study||37||
48357969|NCT03750838|101204585|FG001|6 Month Follow-up|Overall Study||44||
48357970|NCT03750838|101204584|FG000|COMPLETED|Overall Study||39|9 month follow-up|
48357971|NCT03750838|101204585|FG001|COMPLETED|Overall Study||44|9 month follow-up|
48357972|NCT03750838|101204584|FG000|NOT COMPLETED|Overall Study||10||
48357973|NCT03750838|101204585|FG001|NOT COMPLETED|Overall Study||6||
48357974|NCT01568944|101204586|FG000|STARTED|Overall Study||8||
48357975|NCT01568944|101204587|FG001|STARTED|Overall Study||10||
48419304|NCT00557362|101361658|FG001|COMPLETED|Overall Study||28||
48419305|NCT00557362|101361659|FG002|COMPLETED|Overall Study||26||
48419306|NCT00557362|101361660|FG003|COMPLETED|Overall Study||27||
48419307|NCT00557362|101361657|FG000|NOT COMPLETED|Overall Study||2||
48419308|NCT00557362|101361658|FG001|NOT COMPLETED|Overall Study||2||
48419309|NCT00557362|101361659|FG002|NOT COMPLETED|Overall Study||4||
48419310|NCT00557362|101361660|FG003|NOT COMPLETED|Overall Study||3||
48419311|NCT03604159|101361661|FG000|STARTED|Overall Study||26||
48419312|NCT03604159|101361662|FG001|STARTED|Overall Study||26||
48419313|NCT03604159|101361661|FG000|COMPLETED|Overall Study||20||
48419314|NCT03604159|101361662|FG001|COMPLETED|Overall Study||19||
48419315|NCT03604159|101361661|FG000|NOT COMPLETED|Overall Study||6||
48419316|NCT03604159|101361662|FG001|NOT COMPLETED|Overall Study||7||
48357976|NCT01568944|101204586|FG000|COMPLETED|Overall Study||8||
48357977|NCT01568944|101204587|FG001|COMPLETED|Overall Study||10||
48357978|NCT01568944|101204586|FG000|NOT COMPLETED|Overall Study||0||
48357979|NCT01568944|101204587|FG001|NOT COMPLETED|Overall Study||0||
48357980|NCT00098059|101204588|FG000|STARTED|Overall Study||27||
48357981|NCT00098059|101204589|FG001|STARTED|Overall Study||47||
48357982|NCT00098059|101204588|FG000|COMPLETED|Overall Study||27||
48357983|NCT00098059|101204589|FG001|COMPLETED|Overall Study||46||
48357984|NCT00098059|101204588|FG000|NOT COMPLETED|Overall Study||0||
48357985|NCT00098059|101204589|FG001|NOT COMPLETED|Overall Study||1||
48419317|NCT02555722|101361663|FG000|STARTED|Lens Dispensed||60||
48419318|NCT02555722|101361664|FG001|STARTED|Lens Dispensed||30||
48419319|NCT02555722|101361663|FG000|COMPLETED|Lens Dispensed||60||
48419320|NCT02555722|101361664|FG001|COMPLETED|Lens Dispensed||30||
48419321|NCT02555722|101361663|FG000|NOT COMPLETED|Lens Dispensed||0||
48419322|NCT02555722|101361664|FG001|NOT COMPLETED|Lens Dispensed||0||
48419323|NCT02555722|101361663|FG000|STARTED|Week 1||60||
48419324|NCT02555722|101361664|FG001|STARTED|Week 1||30||
48357986|NCT02677779|101204590|FG000|STARTED|Overall Study||10||
48357987|NCT02677779|101204591|FG001|STARTED|Overall Study||10||
48357988|NCT02677779|101204590|FG000|COMPLETED|Overall Study||10||
48357989|NCT02677779|101204591|FG001|COMPLETED|Overall Study||10||
48357990|NCT02677779|101204590|FG000|NOT COMPLETED|Overall Study||0||
48357991|NCT02677779|101204591|FG001|NOT COMPLETED|Overall Study||0||
48357992|NCT04430348|101204592|FG000|STARTED|Overall Study||3||
48357993|NCT04430348|101204593|FG001|STARTED|Overall Study||3||
48357994|NCT04430348|101204594|FG002|STARTED|Overall Study||4||
48357995|NCT04430348|101204595|FG003|STARTED|Overall Study||3||
48357996|NCT04430348|101204596|FG004|STARTED|Overall Study||3||
48357997|NCT04430348|101204597|FG005|STARTED|Overall Study||6||
48357998|NCT04430348|101204592|FG000|COMPLETED|Overall Study||0||
48357999|NCT04430348|101204593|FG001|COMPLETED|Overall Study||0||
48358000|NCT04430348|101204594|FG002|COMPLETED|Overall Study||0||
48358001|NCT04430348|101204595|FG003|COMPLETED|Overall Study||0||
48358002|NCT04430348|101204596|FG004|COMPLETED|Overall Study||0||
48358003|NCT04430348|101204597|FG005|COMPLETED|Overall Study||0||
48358004|NCT04430348|101204592|FG000|NOT COMPLETED|Overall Study||3||
48358005|NCT04430348|101204593|FG001|NOT COMPLETED|Overall Study||3||
48358006|NCT04430348|101204594|FG002|NOT COMPLETED|Overall Study||4||
48358007|NCT04430348|101204595|FG003|NOT COMPLETED|Overall Study||3||
48358008|NCT04430348|101204596|FG004|NOT COMPLETED|Overall Study||3||
48358009|NCT04430348|101204597|FG005|NOT COMPLETED|Overall Study||6||
48358010|NCT04425850|101204598|FG000|STARTED|Overall Study||131||
48358011|NCT04425850|101204599|FG001|STARTED|Overall Study||98||
48358012|NCT04425850|101204598|FG000|COMPLETED|Overall Study||131||
48358013|NCT04425850|101204599|FG001|COMPLETED|Overall Study||98||
48358014|NCT04425850|101204598|FG000|NOT COMPLETED|Overall Study||0||
48358015|NCT04425850|101204599|FG001|NOT COMPLETED|Overall Study||0||
48358016|NCT00482001|101204600|FG000|STARTED|Overall Study||11||
48358017|NCT00482001|101204601|FG001|STARTED|Overall Study||11||
48358018|NCT00482001|101204600|FG000|COMPLETED|Overall Study||10||
48358019|NCT00482001|101204601|FG001|COMPLETED|Overall Study||10||
48358020|NCT00482001|101204600|FG000|NOT COMPLETED|Overall Study||1||
48358021|NCT00482001|101204601|FG001|NOT COMPLETED|Overall Study||1||
48358022|NCT01088412|101204602|FG000|STARTED|Overall Study||22311||
48358023|NCT01088412|101204603|FG001|STARTED|Overall Study||457||
48358024|NCT01088412|101204604|FG002|STARTED|Overall Study||77||
48358025|NCT01088412|101204602|FG000|Safety Modified Evaluable (SME)|Overall Study||22294||
48358026|NCT01088412|101204603|FG001|Safety Modified Evaluable (SME)|Overall Study||456||
48358027|NCT01088412|101204604|FG002|Safety Modified Evaluable (SME)|Overall Study||0||
48358028|NCT01088412|101204602|FG000|SME With at Least 1 Follow Up (FU)|Overall Study||21178||
48358029|NCT01088412|101204603|FG001|SME With at Least 1 Follow Up (FU)|Overall Study||306||
48358030|NCT01088412|101204604|FG002|SME With at Least 1 Follow Up (FU)|Overall Study||0||
48358031|NCT01088412|101204602|FG000|SME+ >= 1 FU and Unknown Arm|Overall Study||21177||
48358032|NCT01088412|101204603|FG001|SME+ >= 1 FU and Unknown Arm|Overall Study||306||
48358033|NCT01088412|101204604|FG002|SME+ >= 1 FU and Unknown Arm|Overall Study||40||
48358034|NCT01088412|101204602|FG000|SME+ >= 1 FU and No Previous Cancer|Overall Study||20556||
48358035|NCT01088412|101204603|FG001|SME+ >= 1 FU and No Previous Cancer|Overall Study||192||
48358036|NCT01088412|101204604|FG002|SME+ >= 1 FU and No Previous Cancer|Overall Study||0||
48358037|NCT01088412|101204602|FG000|SME+ >= 1 FU and Previous Cancer|Overall Study||622||
48358038|NCT01088412|101204603|FG001|SME+ >= 1 FU and Previous Cancer|Overall Study||114||
48358039|NCT01088412|101204604|FG002|SME+ >= 1 FU and Previous Cancer|Overall Study||0||
48358040|NCT01088412|101204602|FG000|COMPLETED|Overall Study||4294||
48358041|NCT01088412|101204603|FG001|COMPLETED|Overall Study||21||
48358042|NCT01088412|101204604|FG002|COMPLETED|Overall Study||5||
48358043|NCT01088412|101204602|FG000|NOT COMPLETED|Overall Study||18017||
48358044|NCT01088412|101204603|FG001|NOT COMPLETED|Overall Study||436||
48358045|NCT01088412|101204604|FG002|NOT COMPLETED|Overall Study||72||
48358046|NCT02424539|101204605|FG000|STARTED|Overall Study||120||
48358047|NCT02424539|101204606|FG001|STARTED|Overall Study||119||
48358048|NCT02424539|101204607|FG002|STARTED|Overall Study||119||
48358049|NCT02424539|101204605|FG000|COMPLETED|Overall Study||106||
48358050|NCT02424539|101204606|FG001|COMPLETED|Overall Study||111||
48358051|NCT02424539|101204607|FG002|COMPLETED|Overall Study||111||
48358052|NCT02424539|101204605|FG000|NOT COMPLETED|Overall Study||14||
48358053|NCT02424539|101204606|FG001|NOT COMPLETED|Overall Study||8||
48358054|NCT02424539|101204607|FG002|NOT COMPLETED|Overall Study||8||
48358055|NCT01479725|101204608|FG000|STARTED|Overall Study||6||
48358056|NCT01479725|101204609|FG001|STARTED|Overall Study||2||
48358057|NCT01479725|101204608|FG000|COMPLETED|Overall Study||4||
48358058|NCT01479725|101204609|FG001|COMPLETED|Overall Study||1||
48358059|NCT01479725|101204608|FG000|NOT COMPLETED|Overall Study||2||
48358060|NCT01479725|101204609|FG001|NOT COMPLETED|Overall Study||1||
48358061|NCT00519532|101204610|FG000|STARTED|Overall Study||84||
48358062|NCT00519532|101204610|FG000|COMPLETED|Overall Study||66||
48358063|NCT00519532|101204610|FG000|NOT COMPLETED|Overall Study||18||
48358064|NCT02441803|101204611|FG000|STARTED|Overall Study||1||
48358065|NCT02441803|101204612|FG001|STARTED|Overall Study||8||
48358066|NCT02441803|101204613|FG002|STARTED|Overall Study||2||
48358067|NCT02441803|101204611|FG000|COMPLETED|Overall Study||1||
48358068|NCT02441803|101204612|FG001|COMPLETED|Overall Study||6||
48419325|NCT02555722|101361663|FG000|COMPLETED|Week 1||60||
48419326|NCT02555722|101361664|FG001|COMPLETED|Week 1||30||
48419327|NCT02555722|101361663|FG000|NOT COMPLETED|Week 1||0||
48419328|NCT02555722|101361664|FG001|NOT COMPLETED|Week 1||0||
48419329|NCT02555722|101361663|FG000|STARTED|Week 2||60||
48419330|NCT02555722|101361664|FG001|STARTED|Week 2||30||
48419331|NCT02555722|101361663|FG000|COMPLETED|Week 2||59||
48419332|NCT02555722|101361664|FG001|COMPLETED|Week 2||29||
48419333|NCT02555722|101361663|FG000|NOT COMPLETED|Week 2||1||
48419334|NCT02555722|101361664|FG001|NOT COMPLETED|Week 2||1||
48419335|NCT02555722|101361663|FG000|STARTED|Month 1||59||
48419336|NCT02555722|101361664|FG001|STARTED|Month 1||29||
48419337|NCT02555722|101361663|FG000|COMPLETED|Month 1||58||
48419338|NCT02555722|101361664|FG001|COMPLETED|Month 1||29||
48419339|NCT02555722|101361663|FG000|NOT COMPLETED|Month 1||1||
48419340|NCT02555722|101361664|FG001|NOT COMPLETED|Month 1||0||
48419341|NCT02555722|101361663|FG000|STARTED|Month 2||58||
48419342|NCT02555722|101361664|FG001|STARTED|Month 2||29||
48419343|NCT02555722|101361663|FG000|COMPLETED|Month 2||54||
48419344|NCT02555722|101361664|FG001|COMPLETED|Month 2||29||
48419345|NCT02555722|101361663|FG000|NOT COMPLETED|Month 2||4||
48419346|NCT02555722|101361664|FG001|NOT COMPLETED|Month 2||0||
48419347|NCT02555722|101361663|FG000|STARTED|Month 3||54||
48419348|NCT02555722|101361664|FG001|STARTED|Month 3||29||
48419349|NCT02555722|101361663|FG000|COMPLETED|Month 3||54||
48419350|NCT02555722|101361664|FG001|COMPLETED|Month 3||29||
48419351|NCT02555722|101361663|FG000|NOT COMPLETED|Month 3||0||
48419352|NCT02555722|101361664|FG001|NOT COMPLETED|Month 3||0||
48419353|NCT02743494|101361665|FG000|STARTED|Pre-treatment Period||532|Started = randomized|
48419354|NCT02743494|101361666|FG001|STARTED|Pre-treatment Period||262|Started = randomized|
48419355|NCT02743494|101361665|FG000|COMPLETED|Pre-treatment Period||532|Completed = Entering the treatment period|
48419356|NCT02743494|101361666|FG001|COMPLETED|Pre-treatment Period||260|Completed = Entering the treatment period|
48419357|NCT02743494|101361665|FG000|NOT COMPLETED|Pre-treatment Period||0||
48419358|NCT02743494|101361666|FG001|NOT COMPLETED|Pre-treatment Period||2||
48419359|NCT02743494|101361665|FG000|STARTED|Treatment Period||532||
48419360|NCT02743494|101361666|FG001|STARTED|Treatment Period||260||
48419361|NCT02743494|101361665|FG000|COMPLETED|Treatment Period||31|Completed = continuing in the treatment|
48419362|NCT02743494|101361666|FG001|COMPLETED|Treatment Period||19|Completed = continuing in the treatment|
48419363|NCT02743494|101361665|FG000|NOT COMPLETED|Treatment Period||501||
48419364|NCT02743494|101361666|FG001|NOT COMPLETED|Treatment Period||241||
48419365|NCT00568399|101361667|FG000|STARTED|Overall Study||37||
48419366|NCT00568399|101361667|FG000|COMPLETED|Overall Study||22||
48419367|NCT00568399|101361667|FG000|NOT COMPLETED|Overall Study||15||
48419368|NCT00412360|101361668|FG000|STARTED|Overall Study||113||
48419369|NCT00412360|101361669|FG001|STARTED|Overall Study||111||
48419370|NCT00412360|101361668|FG000|COMPLETED|Overall Study||112||
48419371|NCT00412360|101361669|FG001|COMPLETED|Overall Study||108||
48419372|NCT00412360|101361668|FG000|NOT COMPLETED|Overall Study||1||
48419373|NCT00412360|101361669|FG001|NOT COMPLETED|Overall Study||3||
48419374|NCT02500901|101361670|FG000|STARTED|Overall Study||2||
48419375|NCT02500901|101361670|FG000|COMPLETED|Overall Study||0||
48419376|NCT02500901|101361670|FG000|NOT COMPLETED|Overall Study||2||
48419377|NCT03417999|101361671|FG000|STARTED|Overall Study||10||
48419378|NCT03417999|101361672|FG001|STARTED|Overall Study||5||
48419379|NCT03417999|101361673|FG002|STARTED|Overall Study||13||
48419380|NCT03417999|101361671|FG000|Evaluable Subjects|Overall Study||7|"Completed is defined here as having received study drug. However, subjects were only considered evaluable if they had at least 90 minutes of sampling data to ensure that Tmax was achieved."|
48419381|NCT03417999|101361672|FG001|Evaluable Subjects|Overall Study||3|"Completed is defined here as having received study drug. However, subjects were only considered evaluable if they had at least 90 minutes of sampling data to ensure that Tmax was achieved."|
48419382|NCT03417999|101361673|FG002|Evaluable Subjects|Overall Study||6|"Completed is defined here as having received study drug. However, subjects were only considered evaluable if they had at least 90 minutes of sampling data to ensure that Tmax was achieved."|
48419383|NCT03417999|101361671|FG000|COMPLETED|Overall Study||7|"Completed is defined here as having received study drug. However, subjects were only considered evaluable if they had at least 90 minutes of sampling data to ensure that Tmax was achieved. The number of subjects that were evaluable are listed as a Milestone."|
48419384|NCT03417999|101361672|FG001|COMPLETED|Overall Study||5|"Completed is defined here as having received study drug. However, subjects were only considered evaluable if they had at least 90 minutes of sampling data to ensure that Tmax was achieved. The number of subjects that were evaluable are listed as a Milestone."|
48419385|NCT03417999|101361673|FG002|COMPLETED|Overall Study||9|"Completed is defined here as having received study drug. However, subjects were only considered evaluable if they had at least 90 minutes of sampling data to ensure that Tmax was achieved. The number of subjects that were evaluable are listed as a Milestone."|
48419386|NCT03417999|101361671|FG000|NOT COMPLETED|Overall Study||3||
48419387|NCT03417999|101361672|FG001|NOT COMPLETED|Overall Study||0||
48419388|NCT03417999|101361673|FG002|NOT COMPLETED|Overall Study||4||
48419389|NCT02358863|101361674|FG000|STARTED|Overall Study||13||
48419390|NCT02358863|101361674|FG000|COMPLETED|Overall Study||10||
48419391|NCT02358863|101361674|FG000|NOT COMPLETED|Overall Study||3||
48419392|NCT01747655|101361675|FG000|STARTED|Temporary Naso-jejunal Tube Period||64||
48419393|NCT01747655|101361676|FG001|STARTED|Temporary Naso-jejunal Tube Period||0||
48419394|NCT01747655|101361675|FG000|COMPLETED|Temporary Naso-jejunal Tube Period||64||
48419395|NCT01747655|101361676|FG001|COMPLETED|Temporary Naso-jejunal Tube Period||0||
48419396|NCT01747655|101361675|FG000|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0||
48419397|NCT01747655|101361676|FG001|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0||
48419398|NCT01747655|101361675|FG000|STARTED|PEG-J Period (Duodopa Treatment)||58||
48419399|NCT01747655|101361676|FG001|STARTED|PEG-J Period (Duodopa Treatment)||6||
48419400|NCT01747655|101361675|FG000|COMPLETED|PEG-J Period (Duodopa Treatment)||44||
48419401|NCT01747655|101361676|FG001|COMPLETED|PEG-J Period (Duodopa Treatment)||6||
48419402|NCT01747655|101361675|FG000|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||14||
48419403|NCT01747655|101361676|FG001|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||0||
48419404|NCT01747655|101361675|FG000|STARTED|PEG-J Period (Continued Treatment)||41||
48419405|NCT01747655|101361676|FG001|STARTED|PEG-J Period (Continued Treatment)||15||
48419406|NCT01747655|101361675|FG000|COMPLETED|PEG-J Period (Continued Treatment)||41||
48419407|NCT01747655|101361676|FG001|COMPLETED|PEG-J Period (Continued Treatment)||15||
48419408|NCT01747655|101361675|FG000|NOT COMPLETED|PEG-J Period (Continued Treatment)||0||
48419409|NCT01747655|101361676|FG001|NOT COMPLETED|PEG-J Period (Continued Treatment)||0||
48419410|NCT01259388|101361677|FG000|STARTED|Overall Study||11||
48419411|NCT01259388|101361678|FG001|STARTED|Overall Study||12||
48419412|NCT01259388|101361677|FG000|COMPLETED|Overall Study||6||
48419413|NCT01259388|101361678|FG001|COMPLETED|Overall Study||11||
48419414|NCT01259388|101361677|FG000|NOT COMPLETED|Overall Study||5||
48419415|NCT01259388|101361678|FG001|NOT COMPLETED|Overall Study||1||
48419416|NCT01783223|101361679|FG000|STARTED|Overall Study||668||
48419417|NCT01783223|101361679|FG000|COMPLETED|Overall Study||668||
48419418|NCT01783223|101361679|FG000|NOT COMPLETED|Overall Study||0||
48419419|NCT00824746|101361680|FG000|STARTED|Overall Study||23||
48419420|NCT00824746|101361680|FG000|COMPLETED|Overall Study||23||
48419421|NCT00824746|101361680|FG000|NOT COMPLETED|Overall Study||0||
48419422|NCT02465957|101361681|FG000|STARTED|Overall Study||3||
48419423|NCT02465957|101361682|FG001|STARTED|Overall Study||4||
48763069|NCT03363841|102208629|FG000|NOT COMPLETED|Overall Study||10||
48763070|NCT03793751|102208630|FG000|STARTED|Overall Study||60||
48763071|NCT03793751|102208631|FG001|STARTED|Overall Study||60||
48763072|NCT03793751|102208630|FG000|COMPLETED|Overall Study||60||
48763073|NCT03793751|102208631|FG001|COMPLETED|Overall Study||60||
48763074|NCT03793751|102208630|FG000|NOT COMPLETED|Overall Study||0||
48763075|NCT03793751|102208631|FG001|NOT COMPLETED|Overall Study||0||
48763076|NCT02694185|102208632|FG000|STARTED|Overall Study||476||
48763077|NCT02694185|102208633|FG001|STARTED|Overall Study||4793||
48763078|NCT02694185|102208632|FG000|COMPLETED|Overall Study||431||
48419424|NCT02465957|101361681|FG000|COMPLETED|Overall Study||3||
48419425|NCT02465957|101361682|FG001|COMPLETED|Overall Study||4||
48419426|NCT02465957|101361681|FG000|NOT COMPLETED|Overall Study||0||
48419427|NCT02465957|101361682|FG001|NOT COMPLETED|Overall Study||0||
48419428|NCT00805142|101361683|FG000|STARTED|Titration Period||36||
48419429|NCT00805142|101361684|FG001|STARTED|Titration Period||42||
48419430|NCT00805142|101361683|FG000|COMPLETED|Titration Period||30||
48419431|NCT00805142|101361684|FG001|COMPLETED|Titration Period||32||
48419432|NCT00805142|101361683|FG000|NOT COMPLETED|Titration Period||6||
48419433|NCT00805142|101361684|FG001|NOT COMPLETED|Titration Period||10||
48419434|NCT00805142|101361683|FG000|STARTED|Maintenance Period||30||
48419435|NCT00805142|101361684|FG001|STARTED|Maintenance Period||32||
48419436|NCT00805142|101361683|FG000|COMPLETED|Maintenance Period||30||
48419437|NCT00805142|101361684|FG001|COMPLETED|Maintenance Period||30||
48419438|NCT00805142|101361683|FG000|NOT COMPLETED|Maintenance Period||0||
48419439|NCT00805142|101361684|FG001|NOT COMPLETED|Maintenance Period||2||
48419440|NCT04806165|101361685|FG000|STARTED|Overall Study||13||
48419441|NCT04806165|101361686|FG001|STARTED|Overall Study||12||
48419442|NCT04806165|101361687|FG002|STARTED|Overall Study||11||
48419443|NCT04806165|101361688|FG003|STARTED|Overall Study||14||
48419444|NCT04806165|101361689|FG004|STARTED|Overall Study||13||
48419445|NCT04806165|101361690|FG005|STARTED|Overall Study||13||
48419446|NCT04806165|101361691|FG006|STARTED|Overall Study||14||
48763079|NCT02694185|102208633|FG001|COMPLETED|Overall Study||4793||
48763080|NCT02694185|102208632|FG000|NOT COMPLETED|Overall Study||45||
48763081|NCT02694185|102208633|FG001|NOT COMPLETED|Overall Study||0||
48763082|NCT04008745|102208634|FG000|STARTED|Overall Study||25||
48763083|NCT04008745|102208635|FG001|STARTED|Overall Study||25||
48763084|NCT04008745|102208634|FG000|COMPLETED|Overall Study||18||
48763085|NCT04008745|102208635|FG001|COMPLETED|Overall Study||20||
48763086|NCT04008745|102208634|FG000|NOT COMPLETED|Overall Study||7||
48763087|NCT04008745|102208635|FG001|NOT COMPLETED|Overall Study||5||
48763088|NCT00791934|102208636|FG000|STARTED|Overall Study||63||
48763089|NCT00791934|102208636|FG000|COMPLETED|Overall Study||48||
48763090|NCT00791934|102208636|FG000|NOT COMPLETED|Overall Study||15||
48419447|NCT04806165|101361692|FG007|STARTED|Overall Study||13||
48419448|NCT04806165|101361693|FG008|STARTED|Overall Study||13||
48763091|NCT02603146|102208637|FG000|STARTED|Overall Study||71||
48763092|NCT02603146|102208638|FG001|STARTED|Overall Study||73||
48763093|NCT02603146|102208637|FG000|COMPLETED|Overall Study||40||
48763094|NCT02603146|102208638|FG001|COMPLETED|Overall Study||39||
48763095|NCT02603146|102208637|FG000|NOT COMPLETED|Overall Study||31||
48763096|NCT02603146|102208638|FG001|NOT COMPLETED|Overall Study||34||
48763097|NCT01194830|102208639|FG000|STARTED|Overall Study||124||
48763098|NCT01194830|102208640|FG001|STARTED|Overall Study||110||
48419449|NCT04806165|101361694|FG009|STARTED|Overall Study||12||
48419450|NCT04806165|101361695|FG010|STARTED|Overall Study||13||
48419451|NCT04806165|101361696|FG011|STARTED|Overall Study||13||
48419452|NCT04806165|101361697|FG012|STARTED|Overall Study||13||
48419453|NCT04806165|101361698|FG013|STARTED|Overall Study||13||
48419454|NCT04806165|101361699|FG014|STARTED|Overall Study||12||
48419455|NCT04806165|101361700|FG015|STARTED|Overall Study||13||
48419456|NCT04806165|101361685|FG000|Completed 2-Week Follow-Up Assessment|Overall Study||10||
48419457|NCT04806165|101361686|FG001|Completed 2-Week Follow-Up Assessment|Overall Study||9||
48419458|NCT04806165|101361687|FG002|Completed 2-Week Follow-Up Assessment|Overall Study||10||
48419459|NCT04806165|101361688|FG003|Completed 2-Week Follow-Up Assessment|Overall Study||12||
48419460|NCT04806165|101361689|FG004|Completed 2-Week Follow-Up Assessment|Overall Study||11||
48419461|NCT04806165|101361690|FG005|Completed 2-Week Follow-Up Assessment|Overall Study||8||
48419462|NCT04806165|101361691|FG006|Completed 2-Week Follow-Up Assessment|Overall Study||10||
48419463|NCT04806165|101361692|FG007|Completed 2-Week Follow-Up Assessment|Overall Study||9||
48419464|NCT04806165|101361693|FG008|Completed 2-Week Follow-Up Assessment|Overall Study||10||
48419465|NCT04806165|101361694|FG009|Completed 2-Week Follow-Up Assessment|Overall Study||10||
48419466|NCT04806165|101361695|FG010|Completed 2-Week Follow-Up Assessment|Overall Study||10||
48419467|NCT04806165|101361696|FG011|Completed 2-Week Follow-Up Assessment|Overall Study||8||
48419468|NCT04806165|101361697|FG012|Completed 2-Week Follow-Up Assessment|Overall Study||10||
48419469|NCT04806165|101361698|FG013|Completed 2-Week Follow-Up Assessment|Overall Study||9||
48419470|NCT04806165|101361699|FG014|Completed 2-Week Follow-Up Assessment|Overall Study||9||
48419471|NCT04806165|101361700|FG015|Completed 2-Week Follow-Up Assessment|Overall Study||11||
48419472|NCT04806165|101361685|FG000|Completed 6-Week Follow-Up Assessment|Overall Study||9||
48419473|NCT04806165|101361686|FG001|Completed 6-Week Follow-Up Assessment|Overall Study||8||
48419474|NCT04806165|101361687|FG002|Completed 6-Week Follow-Up Assessment|Overall Study||9||
48419475|NCT04806165|101361688|FG003|Completed 6-Week Follow-Up Assessment|Overall Study||10||
48419476|NCT04806165|101361689|FG004|Completed 6-Week Follow-Up Assessment|Overall Study||9||
48419477|NCT04806165|101361690|FG005|Completed 6-Week Follow-Up Assessment|Overall Study||7||
48419478|NCT04806165|101361691|FG006|Completed 6-Week Follow-Up Assessment|Overall Study||8||
48419479|NCT04806165|101361692|FG007|Completed 6-Week Follow-Up Assessment|Overall Study||9||
48419480|NCT04806165|101361693|FG008|Completed 6-Week Follow-Up Assessment|Overall Study||9||
48419481|NCT04806165|101361694|FG009|Completed 6-Week Follow-Up Assessment|Overall Study||11||
48419482|NCT04806165|101361695|FG010|Completed 6-Week Follow-Up Assessment|Overall Study||9||
48419483|NCT04806165|101361696|FG011|Completed 6-Week Follow-Up Assessment|Overall Study||8||
48419484|NCT04806165|101361697|FG012|Completed 6-Week Follow-Up Assessment|Overall Study||10||
48419485|NCT04806165|101361698|FG013|Completed 6-Week Follow-Up Assessment|Overall Study||9||
48419486|NCT04806165|101361699|FG014|Completed 6-Week Follow-Up Assessment|Overall Study||9||
48419487|NCT04806165|101361700|FG015|Completed 6-Week Follow-Up Assessment|Overall Study||10||
48419488|NCT04806165|101361685|FG000|Completed 14-Week Follow-Up Assessment|Overall Study||9||
48419489|NCT04806165|101361686|FG001|Completed 14-Week Follow-Up Assessment|Overall Study||10||
48419490|NCT04806165|101361687|FG002|Completed 14-Week Follow-Up Assessment|Overall Study||9||
48419491|NCT04806165|101361688|FG003|Completed 14-Week Follow-Up Assessment|Overall Study||10||
48419492|NCT04806165|101361689|FG004|Completed 14-Week Follow-Up Assessment|Overall Study||10||
48419493|NCT04806165|101361690|FG005|Completed 14-Week Follow-Up Assessment|Overall Study||6||
48419494|NCT04806165|101361691|FG006|Completed 14-Week Follow-Up Assessment|Overall Study||10||
48419495|NCT04806165|101361692|FG007|Completed 14-Week Follow-Up Assessment|Overall Study||9||
48419496|NCT04806165|101361693|FG008|Completed 14-Week Follow-Up Assessment|Overall Study||9||
48419497|NCT04806165|101361694|FG009|Completed 14-Week Follow-Up Assessment|Overall Study||11||
48419498|NCT04806165|101361695|FG010|Completed 14-Week Follow-Up Assessment|Overall Study||10||
48419499|NCT04806165|101361696|FG011|Completed 14-Week Follow-Up Assessment|Overall Study||8||
48419500|NCT04806165|101361697|FG012|Completed 14-Week Follow-Up Assessment|Overall Study||9||
48419501|NCT04806165|101361698|FG013|Completed 14-Week Follow-Up Assessment|Overall Study||8||
48419502|NCT04806165|101361699|FG014|Completed 14-Week Follow-Up Assessment|Overall Study||6||
48419503|NCT04806165|101361700|FG015|Completed 14-Week Follow-Up Assessment|Overall Study||11||
48419504|NCT04806165|101361685|FG000|COMPLETED|Overall Study||13||
48419505|NCT04806165|101361686|FG001|COMPLETED|Overall Study||12||
48419506|NCT04806165|101361687|FG002|COMPLETED|Overall Study||11||
48419507|NCT04806165|101361688|FG003|COMPLETED|Overall Study||14||
48419508|NCT04806165|101361689|FG004|COMPLETED|Overall Study||13||
48763099|NCT01194830|102208639|FG000|COMPLETED|Overall Study||88||
48763100|NCT01194830|102208640|FG001|COMPLETED|Overall Study||83||
48763101|NCT01194830|102208639|FG000|NOT COMPLETED|Overall Study||36||
48763102|NCT01194830|102208640|FG001|NOT COMPLETED|Overall Study||27||
48763103|NCT00087152|102208641|FG000|STARTED|Overall Study||27||
48763104|NCT00087152|102208641|FG000|COMPLETED|Overall Study||21||
48763105|NCT00087152|102208641|FG000|NOT COMPLETED|Overall Study||6||
48763106|NCT04756427|102208642|FG000|STARTED|Overall Study||1||
48763107|NCT04756427|102208642|FG000|COMPLETED|Overall Study||1||
48763108|NCT04756427|102208642|FG000|NOT COMPLETED|Overall Study||0||
48763109|NCT01899521|102208643|FG000|STARTED|Overall Study||23||
48763110|NCT01899521|102208644|FG001|STARTED|Overall Study||25||
48763111|NCT01899521|102208645|FG002|STARTED|Overall Study||25||
48763112|NCT01899521|102208646|FG003|STARTED|Overall Study||22||
48358069|NCT02441803|101204613|FG002|COMPLETED|Overall Study||0||
48358070|NCT02441803|101204611|FG000|NOT COMPLETED|Overall Study||0||
48358071|NCT02441803|101204612|FG001|NOT COMPLETED|Overall Study||2||
48358072|NCT02441803|101204613|FG002|NOT COMPLETED|Overall Study||2||
48358073|NCT01625169|101204614|FG000|STARTED|Overall Study||9||
48358074|NCT01625169|101204614|FG000|COMPLETED|Overall Study||9||
48358075|NCT01625169|101204614|FG000|NOT COMPLETED|Overall Study||0||
48358076|NCT00201851|101204615|FG000|STARTED|Overall Study||252||
48358077|NCT00201851|101204616|FG001|STARTED|Overall Study||257||
48358078|NCT00201851|101204617|FG002|STARTED|Overall Study||231||
48358079|NCT00201851|101204615|FG000|COMPLETED|Overall Study||244||
48358080|NCT00201851|101204616|FG001|COMPLETED|Overall Study||255||
48358081|NCT00201851|101204617|FG002|COMPLETED|Overall Study||230||
48358082|NCT00201851|101204615|FG000|NOT COMPLETED|Overall Study||8||
48358083|NCT00201851|101204616|FG001|NOT COMPLETED|Overall Study||2||
48358084|NCT00201851|101204617|FG002|NOT COMPLETED|Overall Study||1||
48358085|NCT03478683|101204618|FG000|STARTED|Overall Study||363||
48358086|NCT03478683|101204619|FG001|STARTED|Overall Study||365||
48358087|NCT03478683|101204618|FG000|COMPLETED|Overall Study||350||
48358088|NCT03478683|101204619|FG001|COMPLETED|Overall Study||347||
48358089|NCT03478683|101204618|FG000|NOT COMPLETED|Overall Study||13||
48358090|NCT03478683|101204619|FG001|NOT COMPLETED|Overall Study||18||
48358091|NCT00949650|101204620|FG000|STARTED|Overall Study||230||
48358092|NCT00949650|101204621|FG001|STARTED|Overall Study||115||
48358093|NCT00949650|101204620|FG000|COMPLETED|Overall Study||0||
48358094|NCT00949650|101204621|FG001|COMPLETED|Overall Study||0||
48358095|NCT00949650|101204620|FG000|NOT COMPLETED|Overall Study||230||
48358096|NCT00949650|101204621|FG001|NOT COMPLETED|Overall Study||115||
48358097|NCT03126227|101204622|FG000|STARTED|Overall Study||338||
48358098|NCT03126227|101204623|FG001|STARTED|Overall Study||168||
48358099|NCT03126227|101204622|FG000|COMPLETED|Overall Study||260||
48358100|NCT03126227|101204623|FG001|COMPLETED|Overall Study||158||
48358101|NCT03126227|101204622|FG000|NOT COMPLETED|Overall Study||78||
48358102|NCT03126227|101204623|FG001|NOT COMPLETED|Overall Study||10||
48358103|NCT03894540|101204624|FG000|STARTED|Overall Study||1|Received IPN60090 treatment in Part A.|
48358104|NCT03894540|101204625|FG001|STARTED|Overall Study||1|Received IPN60090 treatment in Part A.|
48358105|NCT03894540|101204626|FG002|STARTED|Overall Study||1|Received IPN60090 treatment in Part A.|
48358106|NCT03894540|101204627|FG003|STARTED|Overall Study||4|Received IPN60090 treatment in Part A.|
48358107|NCT03894540|101204628|FG004|STARTED|Overall Study||11|Received IPN60090 treatment in Part A.|
48358108|NCT03894540|101204629|FG005|STARTED|Overall Study||4|Received IPN60090 treatment in Part A.|
48358109|NCT03894540|101204624|FG000|COMPLETED|Overall Study||0|Completed IPN60090 treatment in Part A.|
48358110|NCT03894540|101204625|FG001|COMPLETED|Overall Study||0|Completed IPN60090 treatment in Part A.|
48358111|NCT03894540|101204626|FG002|COMPLETED|Overall Study||0|Completed IPN60090 treatment in Part A.|
48358112|NCT03894540|101204627|FG003|COMPLETED|Overall Study||0|Completed IPN60090 treatment in Part A.|
48358113|NCT03894540|101204628|FG004|COMPLETED|Overall Study||0|Completed IPN60090 treatment in Part A.|
48358114|NCT03894540|101204629|FG005|COMPLETED|Overall Study||0|Completed IPN60090 treatment in Part A.|
48358115|NCT03894540|101204624|FG000|NOT COMPLETED|Overall Study||1||
48358116|NCT03894540|101204625|FG001|NOT COMPLETED|Overall Study||1||
48358117|NCT03894540|101204626|FG002|NOT COMPLETED|Overall Study||1||
48358118|NCT03894540|101204627|FG003|NOT COMPLETED|Overall Study||4||
48358119|NCT03894540|101204628|FG004|NOT COMPLETED|Overall Study||11||
48358120|NCT03894540|101204629|FG005|NOT COMPLETED|Overall Study||4||
48358121|NCT00906789|101204630|FG000|STARTED|Overall Study||15||
48358122|NCT00906789|101204630|FG000|COMPLETED|Overall Study||15||
48358123|NCT00906789|101204630|FG000|NOT COMPLETED|Overall Study||0||
48358124|NCT03088605|101204631|FG000|STARTED|Overall Study||37||
48358125|NCT03088605|101204632|FG001|STARTED|Overall Study||32||
48358126|NCT03088605|101204631|FG000|COMPLETED|Overall Study||36||
48358127|NCT03088605|101204632|FG001|COMPLETED|Overall Study||32||
48763113|NCT01899521|102208643|FG000|COMPLETED|Overall Study||18||
48763114|NCT01899521|102208644|FG001|COMPLETED|Overall Study||24||
48763115|NCT01899521|102208645|FG002|COMPLETED|Overall Study||24||
48763116|NCT01899521|102208646|FG003|COMPLETED|Overall Study||20||
48763117|NCT01899521|102208643|FG000|NOT COMPLETED|Overall Study||5||
48763118|NCT01899521|102208644|FG001|NOT COMPLETED|Overall Study||1||
48763119|NCT01899521|102208645|FG002|NOT COMPLETED|Overall Study||1||
48763120|NCT01899521|102208646|FG003|NOT COMPLETED|Overall Study||2||
48358128|NCT03088605|101204631|FG000|NOT COMPLETED|Overall Study||1||
48358129|NCT03088605|101204632|FG001|NOT COMPLETED|Overall Study||0||
48358130|NCT02862912|101204633|FG000|STARTED|Overall Study||23||
48358131|NCT02862912|101204634|FG001|STARTED|Overall Study||20||
48763121|NCT01648751|102208647|FG000|STARTED|Overall Study||9||
48763122|NCT01648751|102208648|FG001|STARTED|Overall Study||11||
48763123|NCT01648751|102208647|FG000|COMPLETED|Overall Study||7||
48763124|NCT01648751|102208648|FG001|COMPLETED|Overall Study||8||
48763125|NCT01648751|102208647|FG000|NOT COMPLETED|Overall Study||2||
48763126|NCT01648751|102208648|FG001|NOT COMPLETED|Overall Study||3||
48358132|NCT02862912|101204633|FG000|COMPLETED|Overall Study||22||
48358133|NCT02862912|101204634|FG001|COMPLETED|Overall Study||20||
48358134|NCT02862912|101204633|FG000|NOT COMPLETED|Overall Study||1||
48358135|NCT02862912|101204634|FG001|NOT COMPLETED|Overall Study||0||
48358136|NCT01857986|101204635|FG000|STARTED|Overall Study||39||
48358137|NCT01857986|101204636|FG001|STARTED|Overall Study||37||
48358138|NCT01857986|101204635|FG000|COMPLETED|Overall Study||34||
48358139|NCT01857986|101204636|FG001|COMPLETED|Overall Study||30||
48358140|NCT01857986|101204635|FG000|NOT COMPLETED|Overall Study||5||
48358141|NCT01857986|101204636|FG001|NOT COMPLETED|Overall Study||7||
48358142|NCT03340805|101207318|FG000|STARTED|Overall Study||24||
48358143|NCT03340805|101207319|FG001|STARTED|Overall Study||26||
48358144|NCT03340805|101207318|FG000|COMPLETED|Overall Study||24||
48358145|NCT03340805|101207319|FG001|COMPLETED|Overall Study||26||
48358146|NCT03340805|101207318|FG000|NOT COMPLETED|Overall Study||0||
48358147|NCT03340805|101207319|FG001|NOT COMPLETED|Overall Study||0||
48358148|NCT00149214|101207320|FG000|STARTED|Overall Study||135||
48358149|NCT00149214|101207321|FG001|STARTED|Overall Study||122||
48358150|NCT00149214|101207320|FG000|COMPLETED|Overall Study||109||
48358151|NCT00149214|101207321|FG001|COMPLETED|Overall Study||105||
48358152|NCT00149214|101207320|FG000|NOT COMPLETED|Overall Study||26||
48358153|NCT00149214|101207321|FG001|NOT COMPLETED|Overall Study||17||
48358154|NCT02527304|101207322|FG000|STARTED|Overall Study||24||
48358155|NCT02527304|101207322|FG000|COMPLETED|Overall Study||12||
48358156|NCT02527304|101207322|FG000|NOT COMPLETED|Overall Study||12||
48358157|NCT03227861|101207323|FG000|STARTED|Main Study Period (Week 0 to Week 48)||109||
48638789|NCT04000724|101901500|FG001|COMPLETED|Overall Study||72||
48638790|NCT04000724|101901501|FG002|COMPLETED|Overall Study||70||
48638791|NCT04000724|101901499|FG000|NOT COMPLETED|Overall Study||16||
48638792|NCT04000724|101901500|FG001|NOT COMPLETED|Overall Study||10||
48638793|NCT04000724|101901501|FG002|NOT COMPLETED|Overall Study||17||
48638794|NCT02019069|101901502|FG000|STARTED|Overall Study||11||
48638795|NCT02019069|101901502|FG000|COMPLETED|Overall Study||11||
48638796|NCT02019069|101901502|FG000|NOT COMPLETED|Overall Study||0||
48638797|NCT02328105|101901503|FG000|STARTED|Overall Study||11||
48638798|NCT02328105|101901503|FG000|COMPLETED|Overall Study||0||
48638799|NCT02328105|101901503|FG000|NOT COMPLETED|Overall Study||11||
48638800|NCT02711137|101901504|FG000|STARTED|Overall Study||4||
48638801|NCT02711137|101901505|FG001|STARTED|Overall Study||5||
48638802|NCT02711137|101901506|FG002|STARTED|Overall Study||8||
48358158|NCT03227861|101207323|FG000|COMPLETED|Main Study Period (Week 0 to Week 48)||97||
48358159|NCT03227861|101207323|FG000|NOT COMPLETED|Main Study Period (Week 0 to Week 48)||12||
48358160|NCT03227861|101207323|FG000|STARTED|Extension Period (Week 48 to Week 96)||80||
48358161|NCT03227861|101207323|FG000|COMPLETED|Extension Period (Week 48 to Week 96)||0||
48358162|NCT03227861|101207323|FG000|NOT COMPLETED|Extension Period (Week 48 to Week 96)||80||
48358163|NCT00637728|101207324|FG000|STARTED|Double-blind Phase||4||
48358164|NCT00637728|101207325|FG001|STARTED|Double-blind Phase||1||
48358165|NCT00637728|101207326|FG002|STARTED|Double-blind Phase||0||
48358166|NCT00637728|101207324|FG000|COMPLETED|Double-blind Phase||0||
48358167|NCT00637728|101207325|FG001|COMPLETED|Double-blind Phase||0||
48358168|NCT00637728|101207326|FG002|COMPLETED|Double-blind Phase||0||
48358169|NCT00637728|101207324|FG000|NOT COMPLETED|Double-blind Phase||4||
48358170|NCT00637728|101207325|FG001|NOT COMPLETED|Double-blind Phase||1||
48358171|NCT00637728|101207326|FG002|NOT COMPLETED|Double-blind Phase||0||
48358172|NCT00637728|101207324|FG000|STARTED|Extension Phase||0||
48358173|NCT00637728|101207325|FG001|STARTED|Extension Phase||0||
48358174|NCT00637728|101207326|FG002|STARTED|Extension Phase||0||
48358175|NCT00637728|101207324|FG000|COMPLETED|Extension Phase||0||
48358176|NCT00637728|101207325|FG001|COMPLETED|Extension Phase||0||
48358177|NCT00637728|101207326|FG002|COMPLETED|Extension Phase||0||
48358178|NCT00637728|101207324|FG000|NOT COMPLETED|Extension Phase||0||
48358179|NCT00637728|101207325|FG001|NOT COMPLETED|Extension Phase||0||
48358180|NCT00637728|101207326|FG002|NOT COMPLETED|Extension Phase||0||
48358181|NCT00072189|101207327|FG000|STARTED|Overall Study||17||
48358182|NCT00072189|101207327|FG000|COMPLETED|Overall Study||16||
48358183|NCT00072189|101207327|FG000|NOT COMPLETED|Overall Study||1||
48358184|NCT02273115|101207328|FG000|STARTED|Overall Study||94||
48358185|NCT02273115|101207329|FG001|STARTED|Overall Study||90||
48638803|NCT02711137|101901507|FG003|STARTED|Overall Study||7||
48638804|NCT02711137|101901508|FG004|STARTED|Overall Study||5||
48763127|NCT05328102|102208649|FG000|STARTED|Overall Study||3||
48763128|NCT05328102|102208649|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
48358186|NCT02273115|101207330|FG002|STARTED|Overall Study||67||
48638805|NCT02711137|101901509|FG005|STARTED|Overall Study||1||
48638806|NCT02711137|101901510|FG006|STARTED|Overall Study||86||
48638807|NCT02711137|101901511|FG007|STARTED|Overall Study||5||
48763129|NCT05328102|102208649|FG000|COMPLETED|Overall Study||0||
48358187|NCT02273115|101207331|FG003|STARTED|Overall Study||72||
48638808|NCT02711137|101901512|FG008|STARTED|Overall Study||1||
48638809|NCT02711137|101901513|FG009|STARTED|Overall Study||2||
48638810|NCT02711137|101901514|FG010|STARTED|Overall Study||4||
48358188|NCT02273115|101207328|FG000|COMPLETED|Overall Study||94||
48358189|NCT02273115|101207329|FG001|COMPLETED|Overall Study||90||
48358190|NCT02273115|101207330|FG002|COMPLETED|Overall Study||67||
48358191|NCT02273115|101207331|FG003|COMPLETED|Overall Study||71||
48358192|NCT02273115|101207328|FG000|NOT COMPLETED|Overall Study||0||
48358193|NCT02273115|101207329|FG001|NOT COMPLETED|Overall Study||0||
48358194|NCT02273115|101207330|FG002|NOT COMPLETED|Overall Study||0||
48358195|NCT02273115|101207331|FG003|NOT COMPLETED|Overall Study||1||
48358196|NCT01847547|101207332|FG000|STARTED|Overall Study||2991||
48358197|NCT01847547|101207333|FG001|STARTED|Overall Study||2991||
48358198|NCT01847547|101207332|FG000|COMPLETED|Overall Study||2991||
48358199|NCT01847547|101207333|FG001|COMPLETED|Overall Study||2991||
48358200|NCT01847547|101207332|FG000|NOT COMPLETED|Overall Study||0||
48358201|NCT01847547|101207333|FG001|NOT COMPLETED|Overall Study||0||
48358202|NCT00542828|101207334|FG000|STARTED|Overall Study||16||
48358203|NCT00542828|101207334|FG000|COMPLETED|Overall Study||3||
48358204|NCT00542828|101207334|FG000|NOT COMPLETED|Overall Study||13||
48358205|NCT01720251|101207335|FG000|STARTED|Overall Study||79||
48358206|NCT01720251|101207336|FG001|STARTED|Overall Study||79||
48358207|NCT01720251|101207337|FG002|STARTED|Overall Study||82||
48358208|NCT01720251|101207335|FG000|COMPLETED|Overall Study||78||
48358209|NCT01720251|101207336|FG001|COMPLETED|Overall Study||77||
48358210|NCT01720251|101207337|FG002|COMPLETED|Overall Study||82||
48358211|NCT01720251|101207335|FG000|NOT COMPLETED|Overall Study||1||
48358212|NCT01720251|101207336|FG001|NOT COMPLETED|Overall Study||2||
48358213|NCT01720251|101207337|FG002|NOT COMPLETED|Overall Study||0||
48358214|NCT00745030|101207338|FG000|STARTED|Overall Study||1||
48358215|NCT00745030|101207339|FG001|STARTED|Overall Study||2||
48358216|NCT00745030|101207338|FG000|COMPLETED|Overall Study||1||
48358217|NCT00745030|101207339|FG001|COMPLETED|Overall Study||2||
48358218|NCT00745030|101207338|FG000|NOT COMPLETED|Overall Study||0||
48358219|NCT00745030|101207339|FG001|NOT COMPLETED|Overall Study||0||
48358220|NCT02767570|101207340|FG000|STARTED|Overall Study||34||
48358221|NCT02767570|101207341|FG001|STARTED|Overall Study||34||
48358222|NCT02767570|101207340|FG000|Per Protocol Week 6|Overall Study||31||
48358223|NCT02767570|101207341|FG001|Per Protocol Week 6|Overall Study||33||
48358224|NCT02767570|101207340|FG000|COMPLETED|Overall Study||25||
48419509|NCT04806165|101361690|FG005|COMPLETED|Overall Study||13||
48419510|NCT04806165|101361691|FG006|COMPLETED|Overall Study||14||
48419511|NCT04806165|101361692|FG007|COMPLETED|Overall Study||13||
48419512|NCT04806165|101361693|FG008|COMPLETED|Overall Study||13||
48419513|NCT04806165|101361694|FG009|COMPLETED|Overall Study||12||
48419514|NCT04806165|101361695|FG010|COMPLETED|Overall Study||13||
48419515|NCT04806165|101361696|FG011|COMPLETED|Overall Study||13||
48358225|NCT02767570|101207341|FG001|COMPLETED|Overall Study||24||
48358226|NCT02767570|101207340|FG000|NOT COMPLETED|Overall Study||9||
48358227|NCT02767570|101207341|FG001|NOT COMPLETED|Overall Study||10||
48358228|NCT02770287|101207342|FG000|STARTED|Overall Study||11||
48358229|NCT02770287|101207342|FG000|COMPLETED|Overall Study||11||
48358230|NCT02770287|101207342|FG000|NOT COMPLETED|Overall Study||0||
48358231|NCT01505062|101207343|FG000|STARTED|Overall Study||3||
48358232|NCT01505062|101207344|FG001|STARTED|Overall Study||3||
48358233|NCT01505062|101207345|FG002|STARTED|Overall Study||3||
48358234|NCT01505062|101207343|FG000|COMPLETED|Overall Study||3||
48358235|NCT01505062|101207344|FG001|COMPLETED|Overall Study||3||
48358236|NCT01505062|101207345|FG002|COMPLETED|Overall Study||3||
48358237|NCT01505062|101207343|FG000|NOT COMPLETED|Overall Study||0||
48358238|NCT01505062|101207344|FG001|NOT COMPLETED|Overall Study||0||
48419516|NCT04806165|101361697|FG012|COMPLETED|Overall Study||13||
48419517|NCT04806165|101361698|FG013|COMPLETED|Overall Study||13||
48419518|NCT04806165|101361699|FG014|COMPLETED|Overall Study||12||
48419519|NCT04806165|101361700|FG015|COMPLETED|Overall Study||13||
48419520|NCT04806165|101361685|FG000|NOT COMPLETED|Overall Study||0||
48186874|NCT02559817|100779922|FG002|COMPLETED|Post-treatment Period||20||
48186875|NCT02559817|100779923|FG003|COMPLETED|Post-treatment Period||22||
48186876|NCT02559817|100779924|FG004|COMPLETED|Post-treatment Period||8||
48358239|NCT01505062|101207345|FG002|NOT COMPLETED|Overall Study||0||
48419521|NCT04806165|101361686|FG001|NOT COMPLETED|Overall Study||0||
48419522|NCT04806165|101361687|FG002|NOT COMPLETED|Overall Study||0||
48358240|NCT00447421|101207346|FG000|STARTED|Overall Study||9||
48358241|NCT00447421|101207346|FG000|COMPLETED|Overall Study||3||
48358242|NCT00447421|101207346|FG000|NOT COMPLETED|Overall Study||6||
48358243|NCT05652660|101207347|FG000|STARTED|Period 1 (5 Days)||12||
48358244|NCT05652660|101207347|FG000|Treated|Period 1 (5 Days)||12||
48638811|NCT02711137|101901515|FG011|STARTED|Overall Study||3||
48358245|NCT05652660|101207347|FG000|COMPLETED|Period 1 (5 Days)||12||
48358246|NCT05652660|101207347|FG000|NOT COMPLETED|Period 1 (5 Days)||0||
48358247|NCT05652660|101207347|FG000|STARTED|Period 2 (4 Days)||12||
48358248|NCT05652660|101207347|FG000|Treated|Period 2 (4 Days)||12||
48358249|NCT05652660|101207347|FG000|COMPLETED|Period 2 (4 Days)||12||
48358250|NCT05652660|101207347|FG000|NOT COMPLETED|Period 2 (4 Days)||0||
48358251|NCT00678496|101207348|FG000|STARTED|Overall Study||12||
48358252|NCT00678496|101207349|FG001|STARTED|Overall Study||12||
48419523|NCT04806165|101361688|FG003|NOT COMPLETED|Overall Study||0||
48358253|NCT00678496|101207348|FG000|Completed 8 Weeks Follow-up|Overall Study||9||
48358254|NCT00678496|101207349|FG001|Completed 8 Weeks Follow-up|Overall Study||12||
48358255|NCT00678496|101207348|FG000|COMPLETED|Overall Study||10||
48358256|NCT00678496|101207349|FG001|COMPLETED|Overall Study||8||
48358257|NCT00678496|101207348|FG000|NOT COMPLETED|Overall Study||2||
48358258|NCT00678496|101207349|FG001|NOT COMPLETED|Overall Study||4||
48358259|NCT02053246|101207350|FG000|STARTED|Overall Study||11||
48358260|NCT02053246|101207350|FG000|COMPLETED|Overall Study||7||
48358261|NCT02053246|101207350|FG000|NOT COMPLETED|Overall Study||4||
48763130|NCT05328102|102208649|FG000|NOT COMPLETED|Overall Study||3||
48763131|NCT00687193|102208650|FG000|STARTED|Overall Study||53||
48763132|NCT00687193|102208651|FG001|STARTED|Overall Study||53||
48763133|NCT00687193|102208652|FG002|STARTED|Overall Study||52||
48763134|NCT00687193|102208653|FG003|STARTED|Overall Study||53||
48763135|NCT00687193|102208654|FG004|STARTED|Overall Study||54||
48763136|NCT00687193|102208655|FG005|STARTED|Overall Study||52||
48763137|NCT00687193|102208650|FG000|COMPLETED|Overall Study||51||
48763138|NCT00687193|102208651|FG001|COMPLETED|Overall Study||49||
48763139|NCT00687193|102208652|FG002|COMPLETED|Overall Study||50||
48763140|NCT00687193|102208653|FG003|COMPLETED|Overall Study||49||
48763141|NCT00687193|102208654|FG004|COMPLETED|Overall Study||52||
48763142|NCT00687193|102208655|FG005|COMPLETED|Overall Study||48||
48763143|NCT00687193|102208650|FG000|NOT COMPLETED|Overall Study||2||
48763144|NCT00687193|102208651|FG001|NOT COMPLETED|Overall Study||4||
48763145|NCT00687193|102208652|FG002|NOT COMPLETED|Overall Study||2||
48763146|NCT00687193|102208653|FG003|NOT COMPLETED|Overall Study||4||
48763147|NCT00687193|102208654|FG004|NOT COMPLETED|Overall Study||2||
48763148|NCT00687193|102208655|FG005|NOT COMPLETED|Overall Study||4||
48763149|NCT03205423|102208656|FG000|STARTED|Overall Study||8||
48763150|NCT03205423|102208657|FG001|STARTED|Overall Study||9||
48763151|NCT03205423|102208656|FG000|COMPLETED|Overall Study||7||
48763152|NCT03205423|102208657|FG001|COMPLETED|Overall Study||6||
48763153|NCT03205423|102208656|FG000|NOT COMPLETED|Overall Study||1||
48763154|NCT03205423|102208657|FG001|NOT COMPLETED|Overall Study||3||
48763155|NCT03760718|102208658|FG000|STARTED|Overall Study||5||
48763156|NCT03760718|102208659|FG001|STARTED|Overall Study||5||
48763157|NCT03760718|102208660|FG002|STARTED|Overall Study||5||
48763158|NCT03760718|102208658|FG000|COMPLETED|Overall Study||5||
48763159|NCT03760718|102208659|FG001|COMPLETED|Overall Study||5||
48763160|NCT03760718|102208660|FG002|COMPLETED|Overall Study||5||
48763161|NCT03760718|102208658|FG000|NOT COMPLETED|Overall Study||0||
48763162|NCT03760718|102208659|FG001|NOT COMPLETED|Overall Study||0||
48763163|NCT03760718|102208660|FG002|NOT COMPLETED|Overall Study||0||
48763164|NCT01195701|102208661|FG000|STARTED|Overall Study||10||
48763165|NCT01195701|102208662|FG001|STARTED|Overall Study||25||
48763166|NCT01195701|102208661|FG000|COMPLETED|Overall Study||10||
48763167|NCT01195701|102208662|FG001|COMPLETED|Overall Study||20||
48763168|NCT01195701|102208661|FG000|NOT COMPLETED|Overall Study||0||
48763169|NCT01195701|102208662|FG001|NOT COMPLETED|Overall Study||5||
48763170|NCT02623972|102208663|FG000|STARTED|Overall Study||16||
48763171|NCT02623972|102208664|FG001|STARTED|Overall Study||6||
48763172|NCT02623972|102208663|FG000|COMPLETED|Overall Study||16||
48358262|NCT02312986|101207351|FG000|STARTED|Overall Study||1||
48358263|NCT02312986|101207351|FG000|COMPLETED|Overall Study||1||
48358264|NCT02312986|101207351|FG000|NOT COMPLETED|Overall Study||0||
48763173|NCT02623972|102208664|FG001|COMPLETED|Overall Study||6||
48763174|NCT02623972|102208663|FG000|NOT COMPLETED|Overall Study||0||
48763175|NCT02623972|102208664|FG001|NOT COMPLETED|Overall Study||0||
48763176|NCT00976183|102208665|FG000|STARTED|Overall Study||18||
48763177|NCT00976183|102208665|FG000|COMPLETED|Overall Study||18||
48763178|NCT00976183|102208665|FG000|NOT COMPLETED|Overall Study||0||
48763179|NCT01664975|102208666|FG000|STARTED|Overall Study||57||
48763180|NCT01664975|102208667|FG001|STARTED|Overall Study||54||
48358265|NCT01040832|101207352|FG000|STARTED|Overall Study||54||
48358266|NCT01040832|101207353|FG001|STARTED|Overall Study||53||
48358267|NCT01040832|101207352|FG000|COMPLETED|Overall Study||8||
48358268|NCT01040832|101207353|FG001|COMPLETED|Overall Study||16||
48358269|NCT01040832|101207352|FG000|NOT COMPLETED|Overall Study||46||
48358270|NCT01040832|101207353|FG001|NOT COMPLETED|Overall Study||37||
48358271|NCT00969618|101207354|FG000|STARTED|Overall Study||211||
48358272|NCT00969618|101207354|FG000|COMPLETED|Overall Study||133||
48763181|NCT01664975|102208666|FG000|COMPLETED|Overall Study||52||
48763182|NCT01664975|102208667|FG001|COMPLETED|Overall Study||51||
48763183|NCT01664975|102208666|FG000|NOT COMPLETED|Overall Study||5||
48763184|NCT01664975|102208667|FG001|NOT COMPLETED|Overall Study||3||
48763185|NCT03052829|102208668|FG000|STARTED|Overall Study||11||
48763186|NCT03052829|102208669|FG001|STARTED|Overall Study||10||
48763187|NCT03052829|102208668|FG000|COMPLETED|Overall Study||7||
48763188|NCT03052829|102208669|FG001|COMPLETED|Overall Study||6||
48763189|NCT03052829|102208668|FG000|NOT COMPLETED|Overall Study||4||
48763190|NCT03052829|102208669|FG001|NOT COMPLETED|Overall Study||4||
48419524|NCT04806165|101361689|FG004|NOT COMPLETED|Overall Study||0||
48419525|NCT04806165|101361690|FG005|NOT COMPLETED|Overall Study||0||
48419526|NCT04806165|101361691|FG006|NOT COMPLETED|Overall Study||0||
48419527|NCT04806165|101361692|FG007|NOT COMPLETED|Overall Study||0||
48419528|NCT04806165|101361693|FG008|NOT COMPLETED|Overall Study||0||
48419529|NCT04806165|101361694|FG009|NOT COMPLETED|Overall Study||0||
48419530|NCT04806165|101361695|FG010|NOT COMPLETED|Overall Study||0||
48419531|NCT04806165|101361696|FG011|NOT COMPLETED|Overall Study||0||
48419532|NCT04806165|101361697|FG012|NOT COMPLETED|Overall Study||0||
48419533|NCT04806165|101361698|FG013|NOT COMPLETED|Overall Study||0||
48419534|NCT04806165|101361699|FG014|NOT COMPLETED|Overall Study||0||
48419535|NCT04806165|101361700|FG015|NOT COMPLETED|Overall Study||0||
48419536|NCT00935766|101361701|FG000|STARTED|Overall Study||42||
48419537|NCT00935766|101361702|FG001|STARTED|Overall Study||34||
48419538|NCT00935766|101361701|FG000|COMPLETED|Overall Study||35||
48419539|NCT00935766|101361702|FG001|COMPLETED|Overall Study||27||
48419540|NCT00935766|101361701|FG000|NOT COMPLETED|Overall Study||7||
48419541|NCT00935766|101361702|FG001|NOT COMPLETED|Overall Study||7||
48419542|NCT01990339|101361703|FG000|STARTED|Overall Study||14965||
48419543|NCT01990339|101361703|FG000|COMPLETED|Overall Study||12653||
48419544|NCT01990339|101361703|FG000|NOT COMPLETED|Overall Study||2312||
48419545|NCT01811693|101361704|FG000|STARTED|Overall Study||4||
48419546|NCT01811693|101361705|FG001|STARTED|Overall Study||0||
48419547|NCT01811693|101361706|FG002|STARTED|Overall Study||0||
48419548|NCT01811693|101361704|FG000|COMPLETED|Overall Study||4||
48419549|NCT01811693|101361705|FG001|COMPLETED|Overall Study||0||
48419550|NCT01811693|101361706|FG002|COMPLETED|Overall Study||0||
48419551|NCT01811693|101361704|FG000|NOT COMPLETED|Overall Study||0||
48419552|NCT01811693|101361705|FG001|NOT COMPLETED|Overall Study||0||
48419553|NCT01811693|101361706|FG002|NOT COMPLETED|Overall Study||0||
48419554|NCT00329836|101361707|FG000|STARTED|Overall Study||41||
48419555|NCT00329836|101361707|FG000|COMPLETED|Overall Study||41||
48419556|NCT00329836|101361707|FG000|NOT COMPLETED|Overall Study||0||
48419557|NCT04680273|101361708|FG000|STARTED|Overall Study||6||
48419558|NCT04680273|101361709|FG001|STARTED|Overall Study||5||
48419559|NCT04680273|101361710|FG002|STARTED|Overall Study||5||
48419560|NCT04680273|101361708|FG000|Part 1: Received the Planned Dose of Study Drug|Overall Study||6||
48419561|NCT04680273|101361709|FG001|Part 1: Received the Planned Dose of Study Drug|Overall Study||0||
48419562|NCT04680273|101361710|FG002|Part 1: Received the Planned Dose of Study Drug|Overall Study||0||
48419563|NCT04680273|101361708|FG000|Part 2: Received All 3 Planned Doses of Study Drug|Overall Study||0||
48419564|NCT04680273|101361709|FG001|Part 2: Received All 3 Planned Doses of Study Drug|Overall Study||5||
48419565|NCT04680273|101361710|FG002|Part 2: Received All 3 Planned Doses of Study Drug|Overall Study||5||
48419566|NCT04680273|101361708|FG000|COMPLETED|Overall Study||6||
48419567|NCT04680273|101361709|FG001|COMPLETED|Overall Study||5||
48419568|NCT04680273|101361710|FG002|COMPLETED|Overall Study||5||
48419569|NCT04680273|101361708|FG000|NOT COMPLETED|Overall Study||0||
48419570|NCT04680273|101361709|FG001|NOT COMPLETED|Overall Study||0||
48419571|NCT04680273|101361710|FG002|NOT COMPLETED|Overall Study||0||
48419572|NCT02026193|101361711|FG000|STARTED|Overall Study||3||
48419573|NCT02026193|101361712|FG001|STARTED|Overall Study||8||
48419574|NCT02026193|101361711|FG000|COMPLETED|Overall Study||3||
48419575|NCT02026193|101361712|FG001|COMPLETED|Overall Study||8||
48419576|NCT02026193|101361711|FG000|NOT COMPLETED|Overall Study||0||
48419577|NCT02026193|101361712|FG001|NOT COMPLETED|Overall Study||0||
48419578|NCT01483378|101361713|FG000|STARTED|Overall Study||100||
48419579|NCT01483378|101361714|FG001|STARTED|Overall Study||66||
48419580|NCT01483378|101361713|FG000|COMPLETED|Overall Study||100||
48419581|NCT01483378|101361714|FG001|COMPLETED|Overall Study||66||
48419582|NCT01483378|101361713|FG000|NOT COMPLETED|Overall Study||0||
48419583|NCT01483378|101361714|FG001|NOT COMPLETED|Overall Study||0||
48419584|NCT00364351|101361715|FG000|STARTED|Overall Study||623||
48419585|NCT00364351|101361716|FG001|STARTED|Overall Study||617||
48419586|NCT00364351|101361715|FG000|COMPLETED|Overall Study||31||
48763191|NCT02364700|102208670|FG000|STARTED|Overall Study||12||
48763192|NCT02364700|102208670|FG000|COMPLETED|Overall Study||12||
48763193|NCT02364700|102208670|FG000|NOT COMPLETED|Overall Study||0||
48763194|NCT00811590|102208671|FG000|STARTED|Overall Study||3||
48763195|NCT00811590|102208671|FG000|COMPLETED|Overall Study||3||
48419587|NCT00364351|101361716|FG001|COMPLETED|Overall Study||34||
48419588|NCT00364351|101361715|FG000|NOT COMPLETED|Overall Study||592||
48419589|NCT00364351|101361716|FG001|NOT COMPLETED|Overall Study||583||
48419590|NCT05223478|101361717|FG000|STARTED|Overall Study||11||
48419591|NCT05223478|101361718|FG001|STARTED|Overall Study||12||
48419592|NCT05223478|101361717|FG000|COMPLETED|Overall Study||11||
48419593|NCT05223478|101361718|FG001|COMPLETED|Overall Study||12||
48419594|NCT05223478|101361717|FG000|NOT COMPLETED|Overall Study||0||
48419595|NCT05223478|101361718|FG001|NOT COMPLETED|Overall Study||0||
48419596|NCT01797302|101361719|FG000|STARTED|Overall Study||75||
48419597|NCT01797302|101361720|FG001|STARTED|Overall Study||74||
48419598|NCT01797302|101361721|FG002|STARTED|Overall Study||76||
48419599|NCT01797302|101361719|FG000|3 Month Visit|Overall Study||60||
48419600|NCT01797302|101361720|FG001|3 Month Visit|Overall Study||57||
48419601|NCT01797302|101361721|FG002|3 Month Visit|Overall Study||57||
48419602|NCT01797302|101361719|FG000|COMPLETED|Overall Study||58||
48419603|NCT01797302|101361720|FG001|COMPLETED|Overall Study||48||
48419604|NCT01797302|101361721|FG002|COMPLETED|Overall Study||50||
48419605|NCT01797302|101361719|FG000|NOT COMPLETED|Overall Study||17||
48419606|NCT01797302|101361720|FG001|NOT COMPLETED|Overall Study||26||
48419607|NCT01797302|101361721|FG002|NOT COMPLETED|Overall Study||26||
48419608|NCT00412425|101361722|FG000|STARTED|Overall Study||15||
48419609|NCT00412425|101361723|FG001|STARTED|Overall Study||15||
48419610|NCT00412425|101361722|FG000|COMPLETED|Overall Study||15||
48419611|NCT00412425|101361723|FG001|COMPLETED|Overall Study||15||
48419612|NCT00412425|101361722|FG000|NOT COMPLETED|Overall Study||0||
48419613|NCT00412425|101361723|FG001|NOT COMPLETED|Overall Study||0||
48419614|NCT02041533|101361724|FG000|STARTED|Pre-Treatment Period||271|Started = Participants Randomized|
48419615|NCT02041533|101361725|FG001|STARTED|Pre-Treatment Period||270|Started = Participants Randomized|
48419616|NCT02041533|101361724|FG000|COMPLETED|Pre-Treatment Period||267|Completed = Participants Treated|
48419617|NCT02041533|101361725|FG001|COMPLETED|Pre-Treatment Period||263|Completed = Participants Treated|
48419618|NCT02041533|101361724|FG000|NOT COMPLETED|Pre-Treatment Period||4||
48419619|NCT02041533|101361725|FG001|NOT COMPLETED|Pre-Treatment Period||7||
48419620|NCT02041533|101361724|FG000|STARTED|Treatment Period||267||
48419621|NCT02041533|101361725|FG001|STARTED|Treatment Period||263||
48419622|NCT02041533|101361724|FG000|Received Optional Nivolumab|Treatment Period||0|Participants in the Investigator Choice Arm who progressed on or after chemotherapy could be eligible to receive optional crossover nivolumab.|
48419623|NCT02041533|101361725|FG001|Received Optional Nivolumab|Treatment Period||159|Participants in the Investigator Choice Arm who progressed on or after chemotherapy could be eligible to receive optional crossover nivolumab.|
48419624|NCT02041533|101361724|FG000|COMPLETED|Treatment Period||0||
48419625|NCT02041533|101361725|FG001|COMPLETED|Treatment Period||28||
48358273|NCT00969618|101207354|FG000|NOT COMPLETED|Overall Study||78||
48358274|NCT00772967|101207355|FG000|STARTED|Crossover Treatment 1||3||
48358275|NCT00772967|101207356|FG001|STARTED|Crossover Treatment 1||5||
48358276|NCT00772967|101207357|FG002|STARTED|Crossover Treatment 1||3||
48358277|NCT00772967|101207358|FG003|STARTED|Crossover Treatment 1||4||
48358278|NCT00772967|101207359|FG004|STARTED|Crossover Treatment 1||4||
48358279|NCT00772967|101207360|FG005|STARTED|Crossover Treatment 1||3||
48358280|NCT00772967|101207355|FG000|COMPLETED|Crossover Treatment 1||3||
48358281|NCT00772967|101207356|FG001|COMPLETED|Crossover Treatment 1||5||
48358282|NCT00772967|101207357|FG002|COMPLETED|Crossover Treatment 1||3||
48358283|NCT00772967|101207358|FG003|COMPLETED|Crossover Treatment 1||3||
48358284|NCT00772967|101207359|FG004|COMPLETED|Crossover Treatment 1||4||
48358285|NCT00772967|101207360|FG005|COMPLETED|Crossover Treatment 1||3||
48358286|NCT00772967|101207355|FG000|NOT COMPLETED|Crossover Treatment 1||0||
48358287|NCT00772967|101207356|FG001|NOT COMPLETED|Crossover Treatment 1||0||
48358288|NCT00772967|101207357|FG002|NOT COMPLETED|Crossover Treatment 1||0||
48358289|NCT00772967|101207358|FG003|NOT COMPLETED|Crossover Treatment 1||1||
48358290|NCT00772967|101207359|FG004|NOT COMPLETED|Crossover Treatment 1||0||
48358291|NCT00772967|101207360|FG005|NOT COMPLETED|Crossover Treatment 1||0||
48358292|NCT00772967|101207355|FG000|STARTED|Break 1 (4-7 Days)||3||
48358293|NCT00772967|101207356|FG001|STARTED|Break 1 (4-7 Days)||5||
48358294|NCT00772967|101207357|FG002|STARTED|Break 1 (4-7 Days)||3||
48358295|NCT00772967|101207358|FG003|STARTED|Break 1 (4-7 Days)||3||
48358296|NCT00772967|101207359|FG004|STARTED|Break 1 (4-7 Days)||4||
48358297|NCT00772967|101207360|FG005|STARTED|Break 1 (4-7 Days)||3||
48358298|NCT00772967|101207355|FG000|COMPLETED|Break 1 (4-7 Days)||3||
48419626|NCT02041533|101361724|FG000|NOT COMPLETED|Treatment Period||267||
48419627|NCT02041533|101361725|FG001|NOT COMPLETED|Treatment Period||235||
48419628|NCT02694562|101361726|FG000|STARTED|Overall Study||20||
48419629|NCT02694562|101361726|FG000|COMPLETED|Overall Study||2||
48419630|NCT02694562|101361726|FG000|NOT COMPLETED|Overall Study||18||
48419631|NCT01747928|101361727|FG000|STARTED|Overall Study||6||
48419632|NCT01747928|101361728|FG001|STARTED|Overall Study||6||
48419633|NCT01747928|101361729|FG002|STARTED|Overall Study||6||
48419634|NCT01747928|101361730|FG003|STARTED|Overall Study||6||
48419635|NCT01747928|101361731|FG004|STARTED|Overall Study||6||
48419636|NCT01747928|101361732|FG005|STARTED|Overall Study||6||
48419637|NCT01747928|101361733|FG006|STARTED|Overall Study||6||
48419638|NCT01747928|101361734|FG007|STARTED|Overall Study||6||
48419639|NCT01747928|101361727|FG000|COMPLETED|Overall Study||6||
48419640|NCT01747928|101361728|FG001|COMPLETED|Overall Study||6||
48358299|NCT00772967|101207356|FG001|COMPLETED|Break 1 (4-7 Days)||4||
48358300|NCT00772967|101207357|FG002|COMPLETED|Break 1 (4-7 Days)||3||
48358301|NCT00772967|101207358|FG003|COMPLETED|Break 1 (4-7 Days)||3||
48358302|NCT00772967|101207359|FG004|COMPLETED|Break 1 (4-7 Days)||4||
48358303|NCT00772967|101207360|FG005|COMPLETED|Break 1 (4-7 Days)||3||
48358304|NCT00772967|101207355|FG000|NOT COMPLETED|Break 1 (4-7 Days)||0||
48358305|NCT00772967|101207356|FG001|NOT COMPLETED|Break 1 (4-7 Days)||1||
48419641|NCT01747928|101361729|FG002|COMPLETED|Overall Study||6||
48419642|NCT01747928|101361730|FG003|COMPLETED|Overall Study||6||
48419643|NCT01747928|101361731|FG004|COMPLETED|Overall Study||6||
48419644|NCT01747928|101361732|FG005|COMPLETED|Overall Study||6||
48419645|NCT01747928|101361733|FG006|COMPLETED|Overall Study||6||
48419646|NCT01747928|101361734|FG007|COMPLETED|Overall Study||6||
48419647|NCT01747928|101361727|FG000|NOT COMPLETED|Overall Study||0||
48419648|NCT01747928|101361728|FG001|NOT COMPLETED|Overall Study||0||
48419649|NCT01747928|101361729|FG002|NOT COMPLETED|Overall Study||0||
48763196|NCT00811590|102208671|FG000|NOT COMPLETED|Overall Study||0||
48763197|NCT03955146|102208672|FG000|STARTED|DB Period (48 Weeks)||181||
48763198|NCT03955146|102208673|FG001|STARTED|DB Period (48 Weeks)||175||
48763199|NCT03955146|102208674|FG002|STARTED|DB Period (48 Weeks)||18||
48358306|NCT00772967|101207357|FG002|NOT COMPLETED|Break 1 (4-7 Days)||0||
48358307|NCT00772967|101207358|FG003|NOT COMPLETED|Break 1 (4-7 Days)||0||
48419650|NCT01747928|101361730|FG003|NOT COMPLETED|Overall Study||0||
48419651|NCT01747928|101361731|FG004|NOT COMPLETED|Overall Study||0||
48419652|NCT01747928|101361732|FG005|NOT COMPLETED|Overall Study||0||
48419653|NCT01747928|101361733|FG006|NOT COMPLETED|Overall Study||0||
48419654|NCT01747928|101361734|FG007|NOT COMPLETED|Overall Study||0||
48419655|NCT01192139|101361735|FG000|STARTED|Period 1||5||
48419656|NCT01192139|101361736|FG001|STARTED|Period 1||5||
48419657|NCT01192139|101361737|FG002|STARTED|Period 1||5||
48419658|NCT01192139|101361738|FG003|STARTED|Period 1||5||
48358308|NCT00772967|101207359|FG004|NOT COMPLETED|Break 1 (4-7 Days)||0||
48358309|NCT00772967|101207360|FG005|NOT COMPLETED|Break 1 (4-7 Days)||0||
48358310|NCT00772967|101207355|FG000|STARTED|Crossover Treatment 2||3||
48358311|NCT00772967|101207356|FG001|STARTED|Crossover Treatment 2||4||
48358312|NCT00772967|101207357|FG002|STARTED|Crossover Treatment 2||3||
48358313|NCT00772967|101207358|FG003|STARTED|Crossover Treatment 2||3||
48358314|NCT00772967|101207359|FG004|STARTED|Crossover Treatment 2||4||
48358315|NCT00772967|101207360|FG005|STARTED|Crossover Treatment 2||3||
48358316|NCT00772967|101207355|FG000|COMPLETED|Crossover Treatment 2||3||
48419659|NCT01192139|101361739|FG004|STARTED|Period 1||5||
48419660|NCT01192139|101361740|FG005|STARTED|Period 1||5||
48419661|NCT01192139|101361735|FG000|COMPLETED|Period 1||5||
48419662|NCT01192139|101361736|FG001|COMPLETED|Period 1||5||
48419663|NCT01192139|101361737|FG002|COMPLETED|Period 1||5||
48419664|NCT01192139|101361738|FG003|COMPLETED|Period 1||5||
48419665|NCT01192139|101361739|FG004|COMPLETED|Period 1||5||
48419666|NCT01192139|101361740|FG005|COMPLETED|Period 1||5||
48419667|NCT01192139|101361735|FG000|NOT COMPLETED|Period 1||0||
48419668|NCT01192139|101361736|FG001|NOT COMPLETED|Period 1||0||
48419669|NCT01192139|101361737|FG002|NOT COMPLETED|Period 1||0||
48358317|NCT00772967|101207356|FG001|COMPLETED|Crossover Treatment 2||4||
48358318|NCT00772967|101207357|FG002|COMPLETED|Crossover Treatment 2||3||
48358319|NCT00772967|101207358|FG003|COMPLETED|Crossover Treatment 2||3||
48358320|NCT00772967|101207359|FG004|COMPLETED|Crossover Treatment 2||4||
48358321|NCT00772967|101207360|FG005|COMPLETED|Crossover Treatment 2||3||
48358322|NCT00772967|101207355|FG000|NOT COMPLETED|Crossover Treatment 2||0||
48358323|NCT00772967|101207356|FG001|NOT COMPLETED|Crossover Treatment 2||0||
48358324|NCT00772967|101207357|FG002|NOT COMPLETED|Crossover Treatment 2||0||
48358325|NCT00772967|101207358|FG003|NOT COMPLETED|Crossover Treatment 2||0||
48358326|NCT00772967|101207359|FG004|NOT COMPLETED|Crossover Treatment 2||0||
48358327|NCT00772967|101207360|FG005|NOT COMPLETED|Crossover Treatment 2||0||
48358328|NCT00772967|101207355|FG000|STARTED|Break 2 (4-7 Days)||3||
48358329|NCT00772967|101207356|FG001|STARTED|Break 2 (4-7 Days)||4||
48358330|NCT00772967|101207357|FG002|STARTED|Break 2 (4-7 Days)||3||
48358331|NCT00772967|101207358|FG003|STARTED|Break 2 (4-7 Days)||3||
48358332|NCT00772967|101207359|FG004|STARTED|Break 2 (4-7 Days)||4||
48358333|NCT00772967|101207360|FG005|STARTED|Break 2 (4-7 Days)||3||
48419670|NCT01192139|101361738|FG003|NOT COMPLETED|Period 1||0||
48419671|NCT01192139|101361739|FG004|NOT COMPLETED|Period 1||0||
48358334|NCT00772967|101207355|FG000|COMPLETED|Break 2 (4-7 Days)||3||
48358335|NCT00772967|101207356|FG001|COMPLETED|Break 2 (4-7 Days)||4||
48358336|NCT00772967|101207357|FG002|COMPLETED|Break 2 (4-7 Days)||3||
48358337|NCT00772967|101207358|FG003|COMPLETED|Break 2 (4-7 Days)||3||
48358338|NCT00772967|101207359|FG004|COMPLETED|Break 2 (4-7 Days)||4||
48358339|NCT00772967|101207360|FG005|COMPLETED|Break 2 (4-7 Days)||3||
48358340|NCT00772967|101207355|FG000|NOT COMPLETED|Break 2 (4-7 Days)||0||
48358341|NCT00772967|101207356|FG001|NOT COMPLETED|Break 2 (4-7 Days)||0||
48358342|NCT00772967|101207357|FG002|NOT COMPLETED|Break 2 (4-7 Days)||0||
48358343|NCT00772967|101207358|FG003|NOT COMPLETED|Break 2 (4-7 Days)||0||
48358344|NCT00772967|101207359|FG004|NOT COMPLETED|Break 2 (4-7 Days)||0||
48358345|NCT00772967|101207360|FG005|NOT COMPLETED|Break 2 (4-7 Days)||0||
48358346|NCT00772967|101207355|FG000|STARTED|Crossover Treatment 3||3||
48419672|NCT01192139|101361740|FG005|NOT COMPLETED|Period 1||0||
48419673|NCT01192139|101361735|FG000|STARTED|Period 2||5||
48419674|NCT01192139|101361736|FG001|STARTED|Period 2||5||
48763200|NCT03955146|102208675|FG003|STARTED|DB Period (48 Weeks)||19||
48763201|NCT03955146|102208672|FG000|Received at Least 1 Dose of Study Drug|DB Period (48 Weeks)||181||
48419675|NCT01192139|101361737|FG002|STARTED|Period 2||5||
48419676|NCT01192139|101361738|FG003|STARTED|Period 2||5||
48419677|NCT01192139|101361739|FG004|STARTED|Period 2||5||
48419678|NCT01192139|101361740|FG005|STARTED|Period 2||5||
48419679|NCT01192139|101361735|FG000|COMPLETED|Period 2||5||
48419680|NCT01192139|101361736|FG001|COMPLETED|Period 2||5||
48419681|NCT01192139|101361737|FG002|COMPLETED|Period 2||5||
48358347|NCT00772967|101207356|FG001|STARTED|Crossover Treatment 3||4||
48358348|NCT00772967|101207357|FG002|STARTED|Crossover Treatment 3||3||
48763202|NCT03955146|102208673|FG001|Received at Least 1 Dose of Study Drug|DB Period (48 Weeks)||175||
48763203|NCT03955146|102208674|FG002|Received at Least 1 Dose of Study Drug|DB Period (48 Weeks)||18||
48763204|NCT03955146|102208675|FG003|Received at Least 1 Dose of Study Drug|DB Period (48 Weeks)||19||
48763205|NCT03955146|102208672|FG000|COMPLETED|DB Period (48 Weeks)||146||
48763206|NCT03955146|102208673|FG001|COMPLETED|DB Period (48 Weeks)||134||
48763207|NCT03955146|102208674|FG002|COMPLETED|DB Period (48 Weeks)||14||
48763208|NCT03955146|102208675|FG003|COMPLETED|DB Period (48 Weeks)||11||
48763209|NCT03955146|102208672|FG000|NOT COMPLETED|DB Period (48 Weeks)||35||
48763210|NCT03955146|102208673|FG001|NOT COMPLETED|DB Period (48 Weeks)||41||
48763211|NCT03955146|102208674|FG002|NOT COMPLETED|DB Period (48 Weeks)||4||
48763212|NCT03955146|102208675|FG003|NOT COMPLETED|DB Period (48 Weeks)||8||
48763213|NCT03955146|102208672|FG000|STARTED|OLE (Maximum Exposure: 153.1 Weeks)||129||
48763214|NCT03955146|102208673|FG001|STARTED|OLE (Maximum Exposure: 153.1 Weeks)||123||
48763215|NCT03955146|102208674|FG002|STARTED|OLE (Maximum Exposure: 153.1 Weeks)||0||
48763216|NCT03955146|102208675|FG003|STARTED|OLE (Maximum Exposure: 153.1 Weeks)||0||
48763217|NCT03955146|102208672|FG000|Received at Least 1 Dose of Study Drug|OLE (Maximum Exposure: 153.1 Weeks)||129||
48763218|NCT03955146|102208673|FG001|Received at Least 1 Dose of Study Drug|OLE (Maximum Exposure: 153.1 Weeks)||123||
48763219|NCT03955146|102208674|FG002|Received at Least 1 Dose of Study Drug|OLE (Maximum Exposure: 153.1 Weeks)||0||
48763220|NCT03955146|102208675|FG003|Received at Least 1 Dose of Study Drug|OLE (Maximum Exposure: 153.1 Weeks)||0||
48763221|NCT03955146|102208672|FG000|COMPLETED|OLE (Maximum Exposure: 153.1 Weeks)||0||
48763222|NCT03955146|102208673|FG001|COMPLETED|OLE (Maximum Exposure: 153.1 Weeks)||0||
48763223|NCT03955146|102208674|FG002|COMPLETED|OLE (Maximum Exposure: 153.1 Weeks)||0||
48763224|NCT03955146|102208675|FG003|COMPLETED|OLE (Maximum Exposure: 153.1 Weeks)||0||
48763225|NCT03955146|102208672|FG000|NOT COMPLETED|OLE (Maximum Exposure: 153.1 Weeks)||129||
48763226|NCT03955146|102208673|FG001|NOT COMPLETED|OLE (Maximum Exposure: 153.1 Weeks)||123||
48763227|NCT03955146|102208674|FG002|NOT COMPLETED|OLE (Maximum Exposure: 153.1 Weeks)||0||
48763228|NCT03955146|102208675|FG003|NOT COMPLETED|OLE (Maximum Exposure: 153.1 Weeks)||0||
48763229|NCT03312231|102208676|FG000|STARTED|Overall Study||184|One subject allocated to Group 4 and received Group 5 treatment due to error was analyzed as Group 5|
48763230|NCT03312231|102208677|FG001|STARTED|Overall Study||176|One subject allocated to Group 4 and received Group 5 treatment due to error was analyzed as Group 5|
48358349|NCT00772967|101207358|FG003|STARTED|Crossover Treatment 3||3||
48358350|NCT00772967|101207359|FG004|STARTED|Crossover Treatment 3||4||
48358351|NCT00772967|101207360|FG005|STARTED|Crossover Treatment 3||3||
48358352|NCT00772967|101207355|FG000|COMPLETED|Crossover Treatment 3||3||
48358353|NCT00772967|101207356|FG001|COMPLETED|Crossover Treatment 3||4||
48358354|NCT00772967|101207357|FG002|COMPLETED|Crossover Treatment 3||3||
48358355|NCT00772967|101207358|FG003|COMPLETED|Crossover Treatment 3||3||
48358356|NCT00772967|101207359|FG004|COMPLETED|Crossover Treatment 3||3||
48358357|NCT00772967|101207360|FG005|COMPLETED|Crossover Treatment 3||3||
48358358|NCT00772967|101207355|FG000|NOT COMPLETED|Crossover Treatment 3||0||
48358359|NCT00772967|101207356|FG001|NOT COMPLETED|Crossover Treatment 3||0||
48358360|NCT00772967|101207357|FG002|NOT COMPLETED|Crossover Treatment 3||0||
48358361|NCT00772967|101207358|FG003|NOT COMPLETED|Crossover Treatment 3||0||
48358362|NCT00772967|101207359|FG004|NOT COMPLETED|Crossover Treatment 3||1||
48358363|NCT00772967|101207360|FG005|NOT COMPLETED|Crossover Treatment 3||0||
48358364|NCT01031095|101207361|FG000|STARTED|Overall Study||100||
48763231|NCT03312231|102208678|FG002|STARTED|Overall Study||181|One subject allocated to Group 4 and received Group 5 treatment due to error was analyzed as Group 5|
48763232|NCT03312231|102208679|FG003|STARTED|Overall Study||89|One subject allocated to Group 4 and received Group 5 treatment due to error was analyzed as Group 5|
48763233|NCT03312231|102208680|FG004|STARTED|Overall Study||90|One subject allocated to Group 4 and received Group 5 treatment due to error was analyzed as Group 5|
48763234|NCT03312231|102208676|FG000|COMPLETED|Overall Study||181||
48763235|NCT03312231|102208677|FG001|COMPLETED|Overall Study||165||
48763236|NCT03312231|102208678|FG002|COMPLETED|Overall Study||177||
48763237|NCT03312231|102208679|FG003|COMPLETED|Overall Study||86||
48763238|NCT03312231|102208680|FG004|COMPLETED|Overall Study||89||
48763239|NCT03312231|102208676|FG000|NOT COMPLETED|Overall Study||3||
48358365|NCT01031095|101207362|FG001|STARTED|Overall Study||100||
48358366|NCT01031095|101207361|FG000|COMPLETED|Overall Study||100||
48358367|NCT01031095|101207362|FG001|COMPLETED|Overall Study||100||
48358368|NCT01031095|101207361|FG000|NOT COMPLETED|Overall Study||0||
48638812|NCT02711137|101901516|FG012|STARTED|Overall Study||1||
48763240|NCT03312231|102208677|FG001|NOT COMPLETED|Overall Study||11||
48763241|NCT03312231|102208678|FG002|NOT COMPLETED|Overall Study||4||
48763242|NCT03312231|102208679|FG003|NOT COMPLETED|Overall Study||3||
48763243|NCT03312231|102208680|FG004|NOT COMPLETED|Overall Study||1||
48763244|NCT03850899|102208681|FG000|STARTED|Overall Study||718||
48763245|NCT03850899|102208682|FG001|STARTED|Overall Study||257||
48763246|NCT03850899|102208683|FG002|STARTED|Overall Study||159||
48763247|NCT03850899|102208681|FG000|COMPLETED|Overall Study||230||
48763248|NCT03850899|102208682|FG001|COMPLETED|Overall Study||118||
48358369|NCT01031095|101207362|FG001|NOT COMPLETED|Overall Study||0||
48358370|NCT02908477|101207363|FG000|STARTED|Overall Study||136||
48763249|NCT03850899|102208683|FG002|COMPLETED|Overall Study||159||
48763250|NCT03850899|102208681|FG000|NOT COMPLETED|Overall Study||488||
48763251|NCT03850899|102208682|FG001|NOT COMPLETED|Overall Study||139||
48763252|NCT03850899|102208683|FG002|NOT COMPLETED|Overall Study||0||
48763253|NCT01761877|102208684|FG000|STARTED|Overall Study||58|A total of 58 patients enrolled and initiated a 4-month NSAID washout, of which 50 started sulindac treatment and 43 completed to 12 months.|
48763254|NCT01761877|102208685|FG001|STARTED|Overall Study||56|A total of 58 patients enrolled and initiated a 4-month NSAID washout, of which 50 started sulindac treatment and 43 completed to 12 months.|
48763255|NCT01761877|102208684|FG000|COMPLETED|Overall Study||43||
48358371|NCT02908477|101207364|FG001|STARTED|Overall Study||92||
48358372|NCT02908477|101207363|FG000|COMPLETED|Overall Study||128||
48358373|NCT02908477|101207364|FG001|COMPLETED|Overall Study||64||
48358374|NCT02908477|101207363|FG000|NOT COMPLETED|Overall Study||8||
48358375|NCT02908477|101207364|FG001|NOT COMPLETED|Overall Study||28||
48358376|NCT03952650|101207365|FG000|STARTED|Overall Study||4||
48358377|NCT03952650|101207366|FG001|STARTED|Overall Study||90||
48358378|NCT03952650|101207367|FG002|STARTED|Overall Study||4||
48358379|NCT03952650|101207368|FG003|STARTED|Overall Study||60||
48358380|NCT03952650|101207369|FG004|STARTED|Overall Study||4||
48358381|NCT03952650|101207370|FG005|STARTED|Overall Study||54||
48358382|NCT03952650|101207371|FG006|STARTED|Overall Study||36||
48358383|NCT03952650|101207365|FG000|COMPLETED|Overall Study||4||
48358384|NCT03952650|101207366|FG001|COMPLETED|Overall Study||83||
48358385|NCT03952650|101207367|FG002|COMPLETED|Overall Study||4||
48358386|NCT03952650|101207368|FG003|COMPLETED|Overall Study||53||
48358387|NCT03952650|101207369|FG004|COMPLETED|Overall Study||4||
48358388|NCT03952650|101207370|FG005|COMPLETED|Overall Study||47||
48358389|NCT03952650|101207371|FG006|COMPLETED|Overall Study||32||
48358390|NCT03952650|101207365|FG000|NOT COMPLETED|Overall Study||0||
48358391|NCT03952650|101207366|FG001|NOT COMPLETED|Overall Study||7||
48358392|NCT03952650|101207367|FG002|NOT COMPLETED|Overall Study||0||
48358393|NCT03952650|101207368|FG003|NOT COMPLETED|Overall Study||7||
48358394|NCT03952650|101207369|FG004|NOT COMPLETED|Overall Study||0||
48358395|NCT03952650|101207370|FG005|NOT COMPLETED|Overall Study||7||
48358396|NCT03952650|101207371|FG006|NOT COMPLETED|Overall Study||4||
48358397|NCT00770861|101207372|FG000|STARTED|Overall Study||141||
48358398|NCT00770861|101207373|FG001|STARTED|Overall Study||136||
48358399|NCT00770861|101207372|FG000|COMPLETED|Overall Study||131||
48358400|NCT00770861|101207373|FG001|COMPLETED|Overall Study||120||
48358401|NCT00770861|101207372|FG000|NOT COMPLETED|Overall Study||10||
48358402|NCT00770861|101207373|FG001|NOT COMPLETED|Overall Study||16||
48358403|NCT01520922|101207374|FG000|STARTED|Treatment Phase||44||
48358404|NCT01520922|101207375|FG001|STARTED|Treatment Phase||53||
48358405|NCT01520922|101207374|FG000|COMPLETED|Treatment Phase||39||
48358406|NCT01520922|101207375|FG001|COMPLETED|Treatment Phase||45||
48358407|NCT01520922|101207374|FG000|NOT COMPLETED|Treatment Phase||5||
48358408|NCT01520922|101207375|FG001|NOT COMPLETED|Treatment Phase||8||
48763256|NCT01761877|102208685|FG001|COMPLETED|Overall Study||40||
48358409|NCT01520922|101207374|FG000|STARTED|Follow up||44||
48358410|NCT01520922|101207375|FG001|STARTED|Follow up||45||
48358411|NCT01520922|101207374|FG000|COMPLETED|Follow up||44||
48358412|NCT01520922|101207375|FG001|COMPLETED|Follow up||44||
48358413|NCT01520922|101207374|FG000|NOT COMPLETED|Follow up||0||
48358414|NCT01520922|101207375|FG001|NOT COMPLETED|Follow up||1||
48358415|NCT01520922|101207374|FG000|STARTED|Survival Follow-up||21||
48358416|NCT01520922|101207375|FG001|STARTED|Survival Follow-up||40||
48358417|NCT01520922|101207374|FG000|COMPLETED|Survival Follow-up||20||
48358418|NCT01520922|101207375|FG001|COMPLETED|Survival Follow-up||40||
48358419|NCT01520922|101207374|FG000|NOT COMPLETED|Survival Follow-up||1||
48358420|NCT01520922|101207375|FG001|NOT COMPLETED|Survival Follow-up||0||
48763257|NCT01761877|102208684|FG000|NOT COMPLETED|Overall Study||15||
48763258|NCT01761877|102208685|FG001|NOT COMPLETED|Overall Study||16||
48763259|NCT00926237|102208686|FG000|STARTED|Overall Study||19||
48763260|NCT00926237|102208687|FG001|STARTED|Overall Study||20||
48763261|NCT00926237|102208686|FG000|COMPLETED|Overall Study||17||
48763262|NCT00926237|102208687|FG001|COMPLETED|Overall Study||19||
48763263|NCT00926237|102208686|FG000|NOT COMPLETED|Overall Study||2||
48358421|NCT01121406|101207376|FG000|STARTED|Overall Study||55||
48358422|NCT01121406|101207377|FG001|STARTED|Overall Study||55||
48358423|NCT01121406|101207376|FG000|COMPLETED|Overall Study||0||
48358424|NCT01121406|101207377|FG001|COMPLETED|Overall Study||0||
48358425|NCT01121406|101207376|FG000|NOT COMPLETED|Overall Study||55||
48419682|NCT01192139|101361738|FG003|COMPLETED|Period 2||5||
48419683|NCT01192139|101361739|FG004|COMPLETED|Period 2||5||
48419684|NCT01192139|101361740|FG005|COMPLETED|Period 2||5||
48419685|NCT01192139|101361735|FG000|NOT COMPLETED|Period 2||0||
48419686|NCT01192139|101361736|FG001|NOT COMPLETED|Period 2||0||
48419687|NCT01192139|101361737|FG002|NOT COMPLETED|Period 2||0||
48419688|NCT01192139|101361738|FG003|NOT COMPLETED|Period 2||0||
48419689|NCT01192139|101361739|FG004|NOT COMPLETED|Period 2||0||
48419690|NCT01192139|101361740|FG005|NOT COMPLETED|Period 2||0||
48419691|NCT01192139|101361735|FG000|STARTED|Period 3||5||
48419692|NCT01192139|101361736|FG001|STARTED|Period 3||5||
48419693|NCT01192139|101361737|FG002|STARTED|Period 3||5||
48419694|NCT01192139|101361738|FG003|STARTED|Period 3||5||
48419695|NCT01192139|101361739|FG004|STARTED|Period 3||5||
48419696|NCT01192139|101361740|FG005|STARTED|Period 3||5||
48419697|NCT01192139|101361735|FG000|COMPLETED|Period 3||5||
48419698|NCT01192139|101361736|FG001|COMPLETED|Period 3||5||
48419699|NCT01192139|101361737|FG002|COMPLETED|Period 3||5||
48419700|NCT01192139|101361738|FG003|COMPLETED|Period 3||5||
48419701|NCT01192139|101361739|FG004|COMPLETED|Period 3||5||
48419702|NCT01192139|101361740|FG005|COMPLETED|Period 3||5||
48419703|NCT01192139|101361735|FG000|NOT COMPLETED|Period 3||0||
48419704|NCT01192139|101361736|FG001|NOT COMPLETED|Period 3||0||
48419705|NCT01192139|101361737|FG002|NOT COMPLETED|Period 3||0||
48419706|NCT01192139|101361738|FG003|NOT COMPLETED|Period 3||0||
48419707|NCT01192139|101361739|FG004|NOT COMPLETED|Period 3||0||
48419708|NCT01192139|101361740|FG005|NOT COMPLETED|Period 3||0||
48419709|NCT03558503|101361741|FG000|STARTED|Overall Study||63||
48419710|NCT03558503|101361741|FG000|COMPLETED|Overall Study||60||
48419711|NCT03558503|101361741|FG000|NOT COMPLETED|Overall Study||3||
48419712|NCT01231620|101361742|FG000|STARTED|Overall Study||201||
48419713|NCT01231620|101361743|FG001|STARTED|Overall Study||209||
48419714|NCT01231620|101361744|FG002|STARTED|Overall Study||205||
48419715|NCT01231620|101361742|FG000|COMPLETED|Overall Study||175||
48419716|NCT01231620|101361743|FG001|COMPLETED|Overall Study||178||
48358426|NCT01121406|101207377|FG001|NOT COMPLETED|Overall Study||55||
48358427|NCT01903148|101207378|FG000|STARTED|Overall Study||441||
48358428|NCT01903148|101207378|FG000|COMPLETED|Overall Study||441||
48358429|NCT01903148|101207378|FG000|NOT COMPLETED|Overall Study||0||
48358430|NCT00673673|101207379|FG000|STARTED|Overall Study||39||
48358431|NCT00673673|101207379|FG000|COMPLETED|Overall Study||3||
48358432|NCT00673673|101207379|FG000|NOT COMPLETED|Overall Study||36||
48358433|NCT00638846|101207380|FG000|STARTED|Overall Study||137||
48358434|NCT00638846|101207381|FG001|STARTED|Overall Study||139||
48358435|NCT00638846|101207380|FG000|COMPLETED|Overall Study||133||
48358436|NCT00638846|101207381|FG001|COMPLETED|Overall Study||133||
48358437|NCT00638846|101207380|FG000|NOT COMPLETED|Overall Study||4||
48358438|NCT00638846|101207381|FG001|NOT COMPLETED|Overall Study||6||
48419717|NCT01231620|101361744|FG002|COMPLETED|Overall Study||166||
48419718|NCT01231620|101361742|FG000|NOT COMPLETED|Overall Study||26||
48419719|NCT01231620|101361743|FG001|NOT COMPLETED|Overall Study||31||
48419720|NCT01231620|101361744|FG002|NOT COMPLETED|Overall Study||39||
48419721|NCT00591786|101361745|FG000|STARTED|Overall Study||9||
48419722|NCT00591786|101361746|FG001|STARTED|Overall Study||9||
48419723|NCT00591786|101361747|FG002|STARTED|Overall Study||11||
48419724|NCT00591786|101361748|FG003|STARTED|Overall Study||11||
48419725|NCT00591786|101361749|FG004|STARTED|Overall Study||10||
48419726|NCT00591786|101361750|FG005|STARTED|Overall Study||10||
48419727|NCT00591786|101361751|FG006|STARTED|Overall Study||10||
48419728|NCT00591786|101361752|FG007|STARTED|Overall Study||10||
48419729|NCT00591786|101361753|FG008|STARTED|Overall Study||10||
48358439|NCT00871858|101207382|FG000|STARTED|Overall Study||61||
48358440|NCT00871858|101207383|FG001|STARTED|Overall Study||59||
48358441|NCT00871858|101207382|FG000|Evaluable for Safety|Overall Study||60||
48358442|NCT00871858|101207383|FG001|Evaluable for Safety|Overall Study||58||
48358443|NCT00871858|101207382|FG000|COMPLETED|Overall Study||56||
48358444|NCT00871858|101207383|FG001|COMPLETED|Overall Study||52||
48358445|NCT00871858|101207382|FG000|NOT COMPLETED|Overall Study||5||
48358446|NCT00871858|101207383|FG001|NOT COMPLETED|Overall Study||7||
48358447|NCT00404768|101207384|FG000|STARTED|Part A and B||20||
48358448|NCT00404768|101207385|FG001|STARTED|Part A and B||9||
48358449|NCT00404768|101207386|FG002|STARTED|Part A and B||0||
48419730|NCT00591786|101361754|FG009|STARTED|Overall Study||10||
48419731|NCT00591786|101361745|FG000|Treated Participants|Overall Study||9||
48419732|NCT00591786|101361746|FG001|Treated Participants|Overall Study||9||
48419733|NCT00591786|101361747|FG002|Treated Participants|Overall Study||10||
48419734|NCT00591786|101361748|FG003|Treated Participants|Overall Study||11||
48419735|NCT00591786|101361749|FG004|Treated Participants|Overall Study||10||
48419736|NCT00591786|101361750|FG005|Treated Participants|Overall Study||10||
48419737|NCT00591786|101361751|FG006|Treated Participants|Overall Study||10||
48419738|NCT00591786|101361752|FG007|Treated Participants|Overall Study||10||
48419739|NCT00591786|101361753|FG008|Treated Participants|Overall Study||10||
48419740|NCT00591786|101361754|FG009|Treated Participants|Overall Study||10||
48419741|NCT00591786|101361745|FG000|COMPLETED|Overall Study||9||
48419742|NCT00591786|101361746|FG001|COMPLETED|Overall Study||9||
48419743|NCT00591786|101361747|FG002|COMPLETED|Overall Study||10||
48358450|NCT00404768|101207387|FG003|STARTED|Part A and B||0||
48358451|NCT00404768|101207384|FG000|COMPLETED|Part A and B||19||
48358452|NCT00404768|101207385|FG001|COMPLETED|Part A and B||8||
48358453|NCT00404768|101207386|FG002|COMPLETED|Part A and B||0||
48358454|NCT00404768|101207387|FG003|COMPLETED|Part A and B||0||
48358455|NCT00404768|101207384|FG000|NOT COMPLETED|Part A and B||1||
48358456|NCT00404768|101207385|FG001|NOT COMPLETED|Part A and B||1||
48358457|NCT00404768|101207386|FG002|NOT COMPLETED|Part A and B||0||
48358458|NCT00404768|101207387|FG003|NOT COMPLETED|Part A and B||0||
48358459|NCT00404768|101207384|FG000|STARTED|Part C||0||
48358460|NCT00404768|101207385|FG001|STARTED|Part C||0||
48358461|NCT00404768|101207386|FG002|STARTED|Part C||30||
48358462|NCT00404768|101207387|FG003|STARTED|Part C||34||
48358463|NCT00404768|101207384|FG000|COMPLETED|Part C||0||
48358464|NCT00404768|101207385|FG001|COMPLETED|Part C||0||
48358465|NCT00404768|101207386|FG002|COMPLETED|Part C||22||
48358466|NCT00404768|101207387|FG003|COMPLETED|Part C||20||
48358467|NCT00404768|101207384|FG000|NOT COMPLETED|Part C||0||
48358468|NCT00404768|101207385|FG001|NOT COMPLETED|Part C||0||
48358469|NCT00404768|101207386|FG002|NOT COMPLETED|Part C||8||
48358470|NCT00404768|101207387|FG003|NOT COMPLETED|Part C||14||
48358471|NCT01415440|101207388|FG000|STARTED|Overall Study||41||
48358472|NCT01415440|101207389|FG001|STARTED|Overall Study||29||
48358473|NCT01415440|101207390|FG002|STARTED|Overall Study||29||
48358474|NCT01415440|101207388|FG000|COMPLETED|Overall Study||37||
48358475|NCT01415440|101207389|FG001|COMPLETED|Overall Study||28||
48358476|NCT01415440|101207390|FG002|COMPLETED|Overall Study||27||
48358477|NCT01415440|101207388|FG000|NOT COMPLETED|Overall Study||4||
48358478|NCT01415440|101207389|FG001|NOT COMPLETED|Overall Study||1||
48358479|NCT01415440|101207390|FG002|NOT COMPLETED|Overall Study||2||
48358480|NCT01359982|101207391|FG000|STARTED|Overall Study||6||
48358481|NCT01359982|101207392|FG001|STARTED|Overall Study||3||
48358482|NCT01359982|101207393|FG002|STARTED|Overall Study||3||
48358483|NCT01359982|101207394|FG003|STARTED|Overall Study||4||
48358484|NCT01359982|101207395|FG004|STARTED|Overall Study||3||
48358485|NCT01359982|101207396|FG005|STARTED|Overall Study||6||
48358486|NCT01359982|101207391|FG000|COMPLETED|Overall Study||3||
48358487|NCT01359982|101207392|FG001|COMPLETED|Overall Study||3||
48358488|NCT01359982|101207393|FG002|COMPLETED|Overall Study||3||
48358489|NCT01359982|101207394|FG003|COMPLETED|Overall Study||3||
48358490|NCT01359982|101207395|FG004|COMPLETED|Overall Study||3||
48358491|NCT01359982|101207396|FG005|COMPLETED|Overall Study||6||
48358492|NCT01359982|101207391|FG000|NOT COMPLETED|Overall Study||3||
48358493|NCT01359982|101207392|FG001|NOT COMPLETED|Overall Study||0||
48358494|NCT01359982|101207393|FG002|NOT COMPLETED|Overall Study||0||
48358495|NCT01359982|101207394|FG003|NOT COMPLETED|Overall Study||1||
48358496|NCT01359982|101207395|FG004|NOT COMPLETED|Overall Study||0||
48358497|NCT01359982|101207396|FG005|NOT COMPLETED|Overall Study||0||
48358498|NCT00295893|101207397|FG000|STARTED|Overall Study||37||
48358499|NCT00295893|101207398|FG001|STARTED|Overall Study||40||
48358500|NCT00295893|101207399|FG002|STARTED|Overall Study||44||
48358501|NCT00295893|101207397|FG000|COMPLETED|Overall Study||37||
48358502|NCT00295893|101207398|FG001|COMPLETED|Overall Study||40||
48358503|NCT00295893|101207399|FG002|COMPLETED|Overall Study||44||
48358504|NCT00295893|101207397|FG000|NOT COMPLETED|Overall Study||0||
48358505|NCT00295893|101207398|FG001|NOT COMPLETED|Overall Study||0||
48358506|NCT00295893|101207399|FG002|NOT COMPLETED|Overall Study||0||
48358507|NCT04419506|101207400|FG000|STARTED|Overall Study||25||
48358508|NCT04419506|101207401|FG001|STARTED|Overall Study||49||
48358509|NCT04419506|101207402|FG002|STARTED|Overall Study||25||
48358510|NCT04419506|101207403|FG003|STARTED|Overall Study||48||
48358511|NCT04419506|101207400|FG000|COMPLETED|Overall Study||25|Completion of trial medication|
48358512|NCT04419506|101207401|FG001|COMPLETED|Overall Study||39|Completion of trial medication|
48358513|NCT04419506|101207402|FG002|COMPLETED|Overall Study||25|Completion of trial medication|
48358514|NCT04419506|101207403|FG003|COMPLETED|Overall Study||43|Completion of trial medication|
48358515|NCT04419506|101207400|FG000|NOT COMPLETED|Overall Study||0||
48358516|NCT04419506|101207401|FG001|NOT COMPLETED|Overall Study||10||
48358517|NCT04419506|101207402|FG002|NOT COMPLETED|Overall Study||0||
48358518|NCT04419506|101207403|FG003|NOT COMPLETED|Overall Study||5||
48358519|NCT01426386|101207404|FG000|STARTED|Overall Study||42||
48358520|NCT01426386|101207405|FG001|STARTED|Overall Study||45||
48358521|NCT01426386|101207406|FG002|STARTED|Overall Study||44||
48358522|NCT01426386|101207407|FG003|STARTED|Overall Study||44||
48358523|NCT01426386|101207408|FG004|STARTED|Overall Study||47||
48358524|NCT01426386|101207409|FG005|STARTED|Overall Study||43||
48358525|NCT01426386|101207404|FG000|COMPLETED|Overall Study||39||
48358526|NCT01426386|101207405|FG001|COMPLETED|Overall Study||39||
48358527|NCT01426386|101207406|FG002|COMPLETED|Overall Study||42||
48358528|NCT01426386|101207407|FG003|COMPLETED|Overall Study||44||
48358529|NCT01426386|101207408|FG004|COMPLETED|Overall Study||43||
48358530|NCT01426386|101207409|FG005|COMPLETED|Overall Study||42||
48358531|NCT01426386|101207404|FG000|NOT COMPLETED|Overall Study||3||
48358532|NCT01426386|101207405|FG001|NOT COMPLETED|Overall Study||6||
48358533|NCT01426386|101207406|FG002|NOT COMPLETED|Overall Study||2||
48358534|NCT01426386|101207407|FG003|NOT COMPLETED|Overall Study||0||
48358535|NCT01426386|101207408|FG004|NOT COMPLETED|Overall Study||4||
48358536|NCT01426386|101207409|FG005|NOT COMPLETED|Overall Study||1||
48358537|NCT00414440|101207410|FG000|STARTED|Core Period||214||
48358538|NCT00414440|101207411|FG001|STARTED|Core Period||217||
48358539|NCT00414440|101207410|FG000|COMPLETED|Core Period||144||
48358540|NCT00414440|101207411|FG001|COMPLETED|Core Period||185||
48358541|NCT00414440|101207410|FG000|NOT COMPLETED|Core Period||70||
48358542|NCT00414440|101207411|FG001|NOT COMPLETED|Core Period||32||
48358543|NCT00414440|101207410|FG000|STARTED|Extension Period||214||
48358544|NCT00414440|101207411|FG001|STARTED|Extension Period||217||
48358545|NCT00414440|101207410|FG000|COMPLETED|Extension Period||64||
48358546|NCT00414440|101207411|FG001|COMPLETED|Extension Period||77||
48358547|NCT00414440|101207410|FG000|NOT COMPLETED|Extension Period||150||
48358548|NCT00414440|101207411|FG001|NOT COMPLETED|Extension Period||140||
48358549|NCT01158950|101207412|FG000|STARTED|1st Intervention (1 Day)||13||
48358550|NCT01158950|101207413|FG001|STARTED|1st Intervention (1 Day)||13||
48358551|NCT01158950|101207412|FG000|Data Collected|1st Intervention (1 Day)||12||
48358552|NCT01158950|101207413|FG001|Data Collected|1st Intervention (1 Day)||11||
48358553|NCT01158950|101207412|FG000|COMPLETED|1st Intervention (1 Day)||12|Data included in analysis|
48358554|NCT01158950|101207413|FG001|COMPLETED|1st Intervention (1 Day)||11|Data included in analysis|
48358555|NCT01158950|101207412|FG000|NOT COMPLETED|1st Intervention (1 Day)||1||
48358556|NCT01158950|101207413|FG001|NOT COMPLETED|1st Intervention (1 Day)||2||
48358557|NCT01158950|101207412|FG000|STARTED|Washout (1 Week)||12||
48358558|NCT01158950|101207413|FG001|STARTED|Washout (1 Week)||11||
48358559|NCT01158950|101207412|FG000|COMPLETED|Washout (1 Week)||12||
48358560|NCT01158950|101207413|FG001|COMPLETED|Washout (1 Week)||11||
48358561|NCT01158950|101207412|FG000|NOT COMPLETED|Washout (1 Week)||0||
48358562|NCT01158950|101207413|FG001|NOT COMPLETED|Washout (1 Week)||0||
48358563|NCT01158950|101207412|FG000|STARTED|2nd Intervention (1 Day)||12||
48358564|NCT01158950|101207413|FG001|STARTED|2nd Intervention (1 Day)||11||
48358565|NCT01158950|101207412|FG000|COMPLETED|2nd Intervention (1 Day)||12||
48358566|NCT01158950|101207413|FG001|COMPLETED|2nd Intervention (1 Day)||11||
48358567|NCT01158950|101207412|FG000|NOT COMPLETED|2nd Intervention (1 Day)||0||
48358568|NCT01158950|101207413|FG001|NOT COMPLETED|2nd Intervention (1 Day)||0||
48358569|NCT02437669|101207414|FG000|STARTED|Overall Study||35||
48358570|NCT02437669|101207414|FG000|COMPLETED|Overall Study||35||
48358571|NCT02437669|101207414|FG000|NOT COMPLETED|Overall Study||0||
48358572|NCT00754767|101207415|FG000|STARTED|Overall Study||2||
48358573|NCT00754767|101207416|FG001|STARTED|Overall Study||0||
48358574|NCT00754767|101207415|FG000|COMPLETED|Overall Study||2||
48358575|NCT00754767|101207416|FG001|COMPLETED|Overall Study||0||
48358576|NCT00754767|101207415|FG000|NOT COMPLETED|Overall Study||0||
48358577|NCT00754767|101207416|FG001|NOT COMPLETED|Overall Study||0||
48358578|NCT00922935|101207417|FG000|STARTED|Overall Study||10||
48358579|NCT00922935|101207418|FG001|STARTED|Overall Study||16||
48358580|NCT00922935|101207419|FG002|STARTED|Overall Study||10||
48358581|NCT00922935|101207417|FG000|COMPLETED|Overall Study||9||
48358582|NCT00922935|101207418|FG001|COMPLETED|Overall Study||11||
48358583|NCT00922935|101207419|FG002|COMPLETED|Overall Study||10||
48358584|NCT00922935|101207417|FG000|NOT COMPLETED|Overall Study||1||
48358585|NCT00922935|101207418|FG001|NOT COMPLETED|Overall Study||5||
48358586|NCT00922935|101207419|FG002|NOT COMPLETED|Overall Study||0||
48358587|NCT03167619|101207420|FG000|STARTED|Overall Study||23||
48358588|NCT03167619|101207421|FG001|STARTED|Overall Study||22||
48358589|NCT03167619|101207420|FG000|COMPLETED|Overall Study||11||
48358590|NCT03167619|101207421|FG001|COMPLETED|Overall Study||11||
48358591|NCT03167619|101207420|FG000|NOT COMPLETED|Overall Study||12||
48358592|NCT03167619|101207421|FG001|NOT COMPLETED|Overall Study||11||
48358593|NCT04373369|101207422|FG000|STARTED|Overall Study||11||
48358594|NCT04373369|101207422|FG000|COMPLETED|Overall Study||11||
48358595|NCT04373369|101207422|FG000|NOT COMPLETED|Overall Study||0||
48358596|NCT01596595|101207423|FG000|STARTED|Overall Study||1779||
48358597|NCT01596595|101207423|FG000|COMPLETED|Overall Study||814||
48358598|NCT01596595|101207423|FG000|NOT COMPLETED|Overall Study||965||
48358599|NCT01583647|101207424|FG000|STARTED|Overall Study||10||
48358600|NCT01583647|101207425|FG001|STARTED|Overall Study||0||
48358601|NCT01583647|101207424|FG000|COMPLETED|Overall Study||10||
48358602|NCT01583647|101207425|FG001|COMPLETED|Overall Study||0||
48358603|NCT01583647|101207424|FG000|NOT COMPLETED|Overall Study||0||
48358604|NCT01583647|101207425|FG001|NOT COMPLETED|Overall Study||0||
48358605|NCT00443560|101207426|FG000|STARTED|Overall Study||1081||
48358606|NCT00443560|101207427|FG001|STARTED|Overall Study||1081||
48358607|NCT00443560|101207426|FG000|COMPLETED|Overall Study||1021||
48358608|NCT00443560|101207427|FG001|COMPLETED|Overall Study||1051||
48358609|NCT00443560|101207426|FG000|NOT COMPLETED|Overall Study||60||
48358610|NCT00443560|101207427|FG001|NOT COMPLETED|Overall Study||30||
48358611|NCT03937986|101207428|FG000|STARTED|Overall Study||8||
48358612|NCT03937986|101207428|FG000|COMPLETED|Overall Study||7||
48358613|NCT03937986|101207428|FG000|NOT COMPLETED|Overall Study||1||
48358614|NCT01197573|101207429|FG000|STARTED|Overall Study||33||
48358615|NCT01197573|101207430|FG001|STARTED|Overall Study||46||
48358616|NCT01197573|101207431|FG002|STARTED|Overall Study||12||
48358617|NCT01197573|101207432|FG003|STARTED|Overall Study||12||
48358618|NCT01197573|101207429|FG000|COMPLETED|Overall Study||33||
48358619|NCT01197573|101207430|FG001|COMPLETED|Overall Study||46||
48358620|NCT01197573|101207431|FG002|COMPLETED|Overall Study||12||
48358621|NCT01197573|101207432|FG003|COMPLETED|Overall Study||12||
48358622|NCT01197573|101207429|FG000|NOT COMPLETED|Overall Study||0||
48358623|NCT01197573|101207430|FG001|NOT COMPLETED|Overall Study||0||
48358624|NCT01197573|101207431|FG002|NOT COMPLETED|Overall Study||0||
48358625|NCT01197573|101207432|FG003|NOT COMPLETED|Overall Study||0||
48358626|NCT01787591|101207433|FG000|STARTED|Period 1 (Cross-over Arm 1)||5||
48358627|NCT01787591|101207434|FG001|STARTED|Period 1 (Cross-over Arm 1)||5||
48358628|NCT01787591|101207435|FG002|STARTED|Period 1 (Cross-over Arm 1)||5||
48358629|NCT01787591|101207436|FG003|STARTED|Period 1 (Cross-over Arm 1)||6||
48358630|NCT01787591|101207433|FG000|COMPLETED|Period 1 (Cross-over Arm 1)||5||
48358631|NCT01787591|101207434|FG001|COMPLETED|Period 1 (Cross-over Arm 1)||5||
48358632|NCT01787591|101207435|FG002|COMPLETED|Period 1 (Cross-over Arm 1)||5||
48358633|NCT01787591|101207436|FG003|COMPLETED|Period 1 (Cross-over Arm 1)||5||
48358634|NCT01787591|101207433|FG000|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0||
48358635|NCT01787591|101207434|FG001|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0||
48358636|NCT01787591|101207435|FG002|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0||
48358637|NCT01787591|101207436|FG003|NOT COMPLETED|Period 1 (Cross-over Arm 1)||1||
48358638|NCT01787591|101207433|FG000|STARTED|Period 2 (Cross-over Arm 2)||5||
48358639|NCT01787591|101207434|FG001|STARTED|Period 2 (Cross-over Arm 2)||5||
48358640|NCT01787591|101207435|FG002|STARTED|Period 2 (Cross-over Arm 2)||5||
48358641|NCT01787591|101207436|FG003|STARTED|Period 2 (Cross-over Arm 2)||5||
48358642|NCT01787591|101207433|FG000|COMPLETED|Period 2 (Cross-over Arm 2)||5||
48358643|NCT01787591|101207434|FG001|COMPLETED|Period 2 (Cross-over Arm 2)||5||
48358644|NCT01787591|101207435|FG002|COMPLETED|Period 2 (Cross-over Arm 2)||5||
48358645|NCT01787591|101207436|FG003|COMPLETED|Period 2 (Cross-over Arm 2)||5||
48358646|NCT01787591|101207433|FG000|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0||
48763264|NCT00926237|102208687|FG001|NOT COMPLETED|Overall Study||1||
48763265|NCT02839096|102208688|FG000|STARTED|Overall Study||11||
48763266|NCT02839096|102208689|FG001|STARTED|Overall Study||9||
48763267|NCT02839096|102208688|FG000|GI Questionnaire Data|Overall Study||10||
48763268|NCT02839096|102208689|FG001|GI Questionnaire Data|Overall Study||9||
48763269|NCT02839096|102208688|FG000|Delivery Data|Overall Study||10||
48763270|NCT02839096|102208689|FG001|Delivery Data|Overall Study||9||
48763271|NCT02839096|102208688|FG000|COMPLETED|Overall Study||11||
48358647|NCT01787591|101207434|FG001|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0||
48358648|NCT01787591|101207435|FG002|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0||
48358649|NCT01787591|101207436|FG003|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0||
48358650|NCT01787591|101207433|FG000|STARTED|Period 3 (Cross-over Arm 3)||5||
48358651|NCT01787591|101207434|FG001|STARTED|Period 3 (Cross-over Arm 3)||5||
48358652|NCT01787591|101207435|FG002|STARTED|Period 3 (Cross-over Arm 3)||5||
48358653|NCT01787591|101207436|FG003|STARTED|Period 3 (Cross-over Arm 3)||5||
48358654|NCT01787591|101207433|FG000|COMPLETED|Period 3 (Cross-over Arm 3)||5||
48358655|NCT01787591|101207434|FG001|COMPLETED|Period 3 (Cross-over Arm 3)||5||
48358656|NCT01787591|101207435|FG002|COMPLETED|Period 3 (Cross-over Arm 3)||5||
48358657|NCT01787591|101207436|FG003|COMPLETED|Period 3 (Cross-over Arm 3)||5||
48358658|NCT01787591|101207433|FG000|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0||
48358659|NCT01787591|101207434|FG001|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0||
48358660|NCT01787591|101207435|FG002|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0||
48358661|NCT01787591|101207436|FG003|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0||
48358662|NCT01787591|101207433|FG000|STARTED|Period 4 (Cross-over Arm 4)||5||
48358663|NCT01787591|101207434|FG001|STARTED|Period 4 (Cross-over Arm 4)||5||
48358664|NCT01787591|101207435|FG002|STARTED|Period 4 (Cross-over Arm 4)||5||
48358665|NCT01787591|101207436|FG003|STARTED|Period 4 (Cross-over Arm 4)||5||
48358666|NCT01787591|101207433|FG000|COMPLETED|Period 4 (Cross-over Arm 4)||5||
48358667|NCT01787591|101207434|FG001|COMPLETED|Period 4 (Cross-over Arm 4)||5||
48763272|NCT02839096|102208689|FG001|COMPLETED|Overall Study||9||
48763273|NCT02839096|102208688|FG000|NOT COMPLETED|Overall Study||0||
48763274|NCT02839096|102208689|FG001|NOT COMPLETED|Overall Study||0||
48763275|NCT05232682|102208690|FG000|STARTED|Overall Study||16||
48763276|NCT05232682|102208690|FG000|COMPLETED|Overall Study||14||
48763277|NCT05232682|102208690|FG000|NOT COMPLETED|Overall Study||2||
48763278|NCT01977547|102208691|FG000|STARTED|Overall Study||768||
48763279|NCT01977547|102208692|FG001|STARTED|Overall Study||770||
48763280|NCT01977547|102208691|FG000|COMPLETED|Overall Study||728||
48358668|NCT01787591|101207435|FG002|COMPLETED|Period 4 (Cross-over Arm 4)||5||
48358669|NCT01787591|101207436|FG003|COMPLETED|Period 4 (Cross-over Arm 4)||5||
48358670|NCT01787591|101207433|FG000|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0||
48358671|NCT01787591|101207434|FG001|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0||
48358672|NCT01787591|101207435|FG002|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0||
48358673|NCT01787591|101207436|FG003|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0||
48358674|NCT02263365|101207437|FG000|STARTED|Overall Study||22||
48358675|NCT02263365|101207438|FG001|STARTED|Overall Study||18||
48358676|NCT02263365|101207437|FG000|COMPLETED|Overall Study||0||
48763281|NCT01977547|102208692|FG001|COMPLETED|Overall Study||733||
48358677|NCT02263365|101207438|FG001|COMPLETED|Overall Study||0||
48358678|NCT02263365|101207437|FG000|NOT COMPLETED|Overall Study||22||
48358679|NCT02263365|101207438|FG001|NOT COMPLETED|Overall Study||18||
48358680|NCT04075604|101207439|FG000|STARTED|Overall Study||2||
48358681|NCT04075604|101207440|FG001|STARTED|Overall Study||9||
48358682|NCT04075604|101207441|FG002|STARTED|Overall Study||12||
48358683|NCT04075604|101207439|FG000|COMPLETED|Overall Study||1||
48358684|NCT04075604|101207440|FG001|COMPLETED|Overall Study||3||
48358685|NCT04075604|101207441|FG002|COMPLETED|Overall Study||6||
48358686|NCT04075604|101207439|FG000|NOT COMPLETED|Overall Study||1||
48358687|NCT04075604|101207440|FG001|NOT COMPLETED|Overall Study||6||
48358688|NCT04075604|101207441|FG002|NOT COMPLETED|Overall Study||6||
48358689|NCT00642616|101207442|FG000|STARTED|Overall Study||9||
48358690|NCT00642616|101207443|FG001|STARTED|Overall Study||8||
48358691|NCT00642616|101207444|FG002|STARTED|Overall Study||9||
48358692|NCT00642616|101207445|FG003|STARTED|Overall Study||8||
48358693|NCT00642616|101207442|FG000|COMPLETED|Overall Study||0||
48358694|NCT00642616|101207443|FG001|COMPLETED|Overall Study||1||
48358695|NCT00642616|101207444|FG002|COMPLETED|Overall Study||0||
48358696|NCT00642616|101207445|FG003|COMPLETED|Overall Study||1||
48358697|NCT00642616|101207442|FG000|NOT COMPLETED|Overall Study||9||
48358698|NCT00642616|101207443|FG001|NOT COMPLETED|Overall Study||7||
48358699|NCT00642616|101207444|FG002|NOT COMPLETED|Overall Study||9||
48358700|NCT00642616|101207445|FG003|NOT COMPLETED|Overall Study||7||
48358701|NCT01678846|101207446|FG000|STARTED|Overall Study||1921||
48358702|NCT01678846|101207447|FG001|STARTED|Overall Study||1899||
48358703|NCT01678846|101207446|FG000|COMPLETED|Overall Study||1921||
48358704|NCT01678846|101207447|FG001|COMPLETED|Overall Study||1899||
48419744|NCT00591786|101361748|FG003|COMPLETED|Overall Study||11||
48419745|NCT00591786|101361749|FG004|COMPLETED|Overall Study||10||
48419746|NCT00591786|101361750|FG005|COMPLETED|Overall Study||10||
48419747|NCT00591786|101361751|FG006|COMPLETED|Overall Study||10||
48419748|NCT00591786|101361752|FG007|COMPLETED|Overall Study||10||
48419749|NCT00591786|101361753|FG008|COMPLETED|Overall Study||10||
48419750|NCT00591786|101361754|FG009|COMPLETED|Overall Study||10||
48763282|NCT01977547|102208691|FG000|NOT COMPLETED|Overall Study||40||
48419751|NCT00591786|101361745|FG000|NOT COMPLETED|Overall Study||0||
48419752|NCT00591786|101361746|FG001|NOT COMPLETED|Overall Study||0||
48419753|NCT00591786|101361747|FG002|NOT COMPLETED|Overall Study||1||
48419754|NCT00591786|101361748|FG003|NOT COMPLETED|Overall Study||0||
48419755|NCT00591786|101361749|FG004|NOT COMPLETED|Overall Study||0||
48419756|NCT00591786|101361750|FG005|NOT COMPLETED|Overall Study||0||
48419757|NCT00591786|101361751|FG006|NOT COMPLETED|Overall Study||0||
48419758|NCT00591786|101361752|FG007|NOT COMPLETED|Overall Study||0||
48419759|NCT00591786|101361753|FG008|NOT COMPLETED|Overall Study||0||
48419760|NCT00591786|101361754|FG009|NOT COMPLETED|Overall Study||0||
48419761|NCT02918006|101361755|FG000|STARTED|Allocation and Follow-Up||71||
48419762|NCT02918006|101361756|FG001|STARTED|Allocation and Follow-Up||72||
48419763|NCT02918006|101361757|FG002|STARTED|Allocation and Follow-Up||36||
48419764|NCT02918006|101361755|FG000|COMPLETED|Allocation and Follow-Up||69||
48419765|NCT02918006|101361756|FG001|COMPLETED|Allocation and Follow-Up||70||
48419766|NCT02918006|101361757|FG002|COMPLETED|Allocation and Follow-Up||35||
48419767|NCT02918006|101361755|FG000|NOT COMPLETED|Allocation and Follow-Up||2||
48419768|NCT02918006|101361756|FG001|NOT COMPLETED|Allocation and Follow-Up||2||
48419769|NCT02918006|101361757|FG002|NOT COMPLETED|Allocation and Follow-Up||1||
48419770|NCT02918006|101361755|FG000|STARTED|Vaccination Phase Analysis||69||
48419771|NCT02918006|101361756|FG001|STARTED|Vaccination Phase Analysis||70||
48419772|NCT02918006|101361757|FG002|STARTED|Vaccination Phase Analysis||35||
48419773|NCT02918006|101361755|FG000|COMPLETED|Vaccination Phase Analysis||58||
48419774|NCT02918006|101361756|FG001|COMPLETED|Vaccination Phase Analysis||54||
48419775|NCT02918006|101361757|FG002|COMPLETED|Vaccination Phase Analysis||31||
48419776|NCT02918006|101361755|FG000|NOT COMPLETED|Vaccination Phase Analysis||11||
48419777|NCT02918006|101361756|FG001|NOT COMPLETED|Vaccination Phase Analysis||16||
48419778|NCT02918006|101361757|FG002|NOT COMPLETED|Vaccination Phase Analysis||4||
48763283|NCT01977547|102208692|FG001|NOT COMPLETED|Overall Study||37||
48358705|NCT01678846|101207446|FG000|NOT COMPLETED|Overall Study||0||
48419779|NCT02918006|101361755|FG000|STARTED|Challenge Phase Analysis||58||
48763284|NCT01033019|102208693|FG000|STARTED|Overall Study||16||
48358706|NCT01678846|101207447|FG001|NOT COMPLETED|Overall Study||0||
48358707|NCT04329949|101207448|FG000|STARTED|Overall Study||43||
48358708|NCT04329949|101207448|FG000|COMPLETED|Overall Study||0||
48358709|NCT04329949|101207448|FG000|NOT COMPLETED|Overall Study||43||
48358710|NCT01174784|101207449|FG000|STARTED|Overall Study||88||
48358711|NCT01174784|101207449|FG000|COMPLETED|Overall Study||84||
48358712|NCT01174784|101207449|FG000|NOT COMPLETED|Overall Study||4||
48358713|NCT01753518|101207450|FG000|STARTED|Intention-to-Treat Analysis||110||
48419780|NCT02918006|101361756|FG001|STARTED|Challenge Phase Analysis||54||
48419781|NCT02918006|101361757|FG002|STARTED|Challenge Phase Analysis||31||
48419782|NCT02918006|101361755|FG000|COMPLETED|Challenge Phase Analysis||58||
48419783|NCT02918006|101361756|FG001|COMPLETED|Challenge Phase Analysis||54||
48419784|NCT02918006|101361757|FG002|COMPLETED|Challenge Phase Analysis||29||
48419785|NCT02918006|101361755|FG000|NOT COMPLETED|Challenge Phase Analysis||0||
48439979|NCT01728376|101409995|FG000|NOT COMPLETED|Overall Study||4||
48419786|NCT02918006|101361756|FG001|NOT COMPLETED|Challenge Phase Analysis||0||
48419787|NCT02918006|101361757|FG002|NOT COMPLETED|Challenge Phase Analysis||2||
48419788|NCT00750360|101361758|FG000|STARTED|Overall Study||294||
48419789|NCT00750360|101361759|FG001|STARTED|Overall Study||1||
48419790|NCT00750360|101361760|FG002|STARTED|Overall Study||384||
48419791|NCT00750360|101361761|FG003|STARTED|Overall Study||79||
48419792|NCT00750360|101361762|FG004|STARTED|Overall Study||46||
48419793|NCT00750360|101361763|FG005|STARTED|Overall Study||71||
48419794|NCT00750360|101361758|FG000|COMPLETED|Overall Study||294||
48419795|NCT00750360|101361759|FG001|COMPLETED|Overall Study||1||
48419796|NCT00750360|101361760|FG002|COMPLETED|Overall Study||384||
48419797|NCT00750360|101361761|FG003|COMPLETED|Overall Study||79||
48419798|NCT00750360|101361762|FG004|COMPLETED|Overall Study||46||
48419799|NCT00750360|101361763|FG005|COMPLETED|Overall Study||71||
48419800|NCT00750360|101361758|FG000|NOT COMPLETED|Overall Study||0||
48419801|NCT00750360|101361759|FG001|NOT COMPLETED|Overall Study||0||
48419802|NCT00750360|101361760|FG002|NOT COMPLETED|Overall Study||0||
48419803|NCT00750360|101361761|FG003|NOT COMPLETED|Overall Study||0||
48419804|NCT00750360|101361762|FG004|NOT COMPLETED|Overall Study||0||
48419805|NCT00750360|101361763|FG005|NOT COMPLETED|Overall Study||0||
48419806|NCT00689611|101361764|FG000|STARTED|Overall Study||200||
48419807|NCT00689611|101361765|FG001|STARTED|Overall Study||192||
48419808|NCT00689611|101361764|FG000|COMPLETED|Overall Study||159||
48419809|NCT00689611|101361765|FG001|COMPLETED|Overall Study||146||
48763285|NCT01033019|102208694|FG001|STARTED|Overall Study||8||
48763286|NCT01033019|102208693|FG000|COMPLETED|Overall Study||15||
48763287|NCT01033019|102208694|FG001|COMPLETED|Overall Study||8||
48763288|NCT01033019|102208693|FG000|NOT COMPLETED|Overall Study||1||
48763289|NCT01033019|102208694|FG001|NOT COMPLETED|Overall Study||0||
48763290|NCT02891447|102208695|FG000|STARTED|Overall Study||20||
48763291|NCT02891447|102208695|FG000|Subtotal Gastrectomy|Overall Study||11||
48763292|NCT02891447|102208695|FG000|Total Gastrectomy|Overall Study||9||
48763293|NCT02891447|102208695|FG000|COMPLETED|Overall Study||20||
48763294|NCT02891447|102208695|FG000|NOT COMPLETED|Overall Study||0||
48763295|NCT02388269|102208696|FG000|STARTED|Overall Study||41|Run-in period|
48763296|NCT02388269|102208697|FG001|STARTED|Overall Study||40|Run-in period|
48763297|NCT02388269|102208698|FG002|STARTED|Overall Study||10|Run-in period|
48763298|NCT02388269|102208696|FG000|Randomised Period|Overall Study||41||
48358714|NCT01753518|101207451|FG001|STARTED|Intention-to-Treat Analysis||110||
48358715|NCT01753518|101207450|FG000|COMPLETED|Intention-to-Treat Analysis||103||
48358716|NCT01753518|101207451|FG001|COMPLETED|Intention-to-Treat Analysis||103||
48358717|NCT01753518|101207450|FG000|NOT COMPLETED|Intention-to-Treat Analysis||7||
48358718|NCT01753518|101207451|FG001|NOT COMPLETED|Intention-to-Treat Analysis||7||
48358719|NCT01753518|101207450|FG000|STARTED|Postpartum Follow-up||103||
48358720|NCT01753518|101207451|FG001|STARTED|Postpartum Follow-up||103||
48358721|NCT01753518|101207450|FG000|COMPLETED|Postpartum Follow-up||81||
48358722|NCT01753518|101207451|FG001|COMPLETED|Postpartum Follow-up||88||
48358723|NCT01753518|101207450|FG000|NOT COMPLETED|Postpartum Follow-up||22||
48419810|NCT00689611|101361764|FG000|NOT COMPLETED|Overall Study||41||
48419811|NCT00689611|101361765|FG001|NOT COMPLETED|Overall Study||46||
48419812|NCT01066624|101361766|FG000|STARTED|Overall Study||38||
48419813|NCT01066624|101361767|FG001|STARTED|Overall Study||40||
48419814|NCT01066624|101361768|FG002|STARTED|Overall Study||39||
48419815|NCT01066624|101361766|FG000|COMPLETED|Overall Study||38||
48419816|NCT01066624|101361767|FG001|COMPLETED|Overall Study||40||
48419817|NCT01066624|101361768|FG002|COMPLETED|Overall Study||39||
48419818|NCT01066624|101361766|FG000|NOT COMPLETED|Overall Study||0||
48419819|NCT01066624|101361767|FG001|NOT COMPLETED|Overall Study||0||
48419820|NCT01066624|101361768|FG002|NOT COMPLETED|Overall Study||0||
48419821|NCT02545504|101361769|FG000|STARTED|Overall Study||218||
48419822|NCT02545504|101361770|FG001|STARTED|Overall Study||214||
48763299|NCT02388269|102208697|FG001|Randomised Period|Overall Study||40||
48763300|NCT02388269|102208698|FG002|Randomised Period|Overall Study||0||
48763301|NCT02388269|102208696|FG000|Open Label|Overall Study||37||
48763302|NCT02388269|102208697|FG001|Open Label|Overall Study||38||
48763303|NCT02388269|102208698|FG002|Open Label|Overall Study||0||
48763304|NCT02388269|102208696|FG000|COMPLETED|Overall Study||32|completed = run-in + randomised + open label periods|
48763305|NCT02388269|102208697|FG001|COMPLETED|Overall Study||38|completed = run-in + randomised + open label periods|
48763306|NCT02388269|102208698|FG002|COMPLETED|Overall Study||0|completed = run-in + randomised + open label periods|
48763307|NCT02388269|102208696|FG000|NOT COMPLETED|Overall Study||9||
48763308|NCT02388269|102208697|FG001|NOT COMPLETED|Overall Study||2||
48419823|NCT02545504|101361769|FG000|COMPLETED|Overall Study||0||
48419824|NCT02545504|101361770|FG001|COMPLETED|Overall Study||0||
48419825|NCT02545504|101361769|FG000|NOT COMPLETED|Overall Study||218||
48419826|NCT02545504|101361770|FG001|NOT COMPLETED|Overall Study||214||
48419827|NCT04422951|101361771|FG000|STARTED|Overall Study||0||
48419828|NCT04422951|101361772|FG001|STARTED|Overall Study||2||
48419829|NCT04422951|101361771|FG000|COMPLETED|Overall Study||0||
48419830|NCT04422951|101361772|FG001|COMPLETED|Overall Study||0||
48419831|NCT04422951|101361771|FG000|NOT COMPLETED|Overall Study||0||
48419832|NCT04422951|101361772|FG001|NOT COMPLETED|Overall Study||2||
48763309|NCT02388269|102208698|FG002|NOT COMPLETED|Overall Study||10||
48358724|NCT01753518|101207451|FG001|NOT COMPLETED|Postpartum Follow-up||15||
48358725|NCT00058370|101207452|FG000|STARTED|Overall Study||6||
48358726|NCT00058370|101207452|FG000|COMPLETED|Overall Study||6||
48358727|NCT00058370|101207452|FG000|NOT COMPLETED|Overall Study||0||
48358728|NCT04601272|101207453|FG000|STARTED|Overall Study||73||
48358729|NCT04601272|101207454|FG001|STARTED|Overall Study||89||
48358730|NCT04601272|101207455|FG002|STARTED|Overall Study||78||
48358731|NCT04601272|101207453|FG000|COMPLETED|Overall Study||71||
48358732|NCT04601272|101207454|FG001|COMPLETED|Overall Study||86||
48358733|NCT04601272|101207455|FG002|COMPLETED|Overall Study||76||
48358734|NCT04601272|101207453|FG000|NOT COMPLETED|Overall Study||2||
48358735|NCT04601272|101207454|FG001|NOT COMPLETED|Overall Study||3||
48358736|NCT04601272|101207455|FG002|NOT COMPLETED|Overall Study||2||
48358737|NCT04460027|101207456|FG000|STARTED|Overall Study||88||
48358738|NCT04460027|101207457|FG001|STARTED|Overall Study||92||
48358739|NCT04460027|101207456|FG000|COMPLETED|Overall Study||71||
48358740|NCT04460027|101207457|FG001|COMPLETED|Overall Study||81||
48358741|NCT04460027|101207456|FG000|NOT COMPLETED|Overall Study||17||
48358742|NCT04460027|101207457|FG001|NOT COMPLETED|Overall Study||11||
48358743|NCT01845025|101207458|FG000|STARTED|Overall Study||411||
48358744|NCT01845025|101207459|FG001|STARTED|Overall Study||409||
48358745|NCT01845025|101207458|FG000|COMPLETED|Overall Study||326||
48358746|NCT01845025|101207459|FG001|COMPLETED|Overall Study||332||
48358747|NCT01845025|101207458|FG000|NOT COMPLETED|Overall Study||85||
48358748|NCT01845025|101207459|FG001|NOT COMPLETED|Overall Study||77||
48358749|NCT04430582|101207460|FG000|STARTED|Overall Study||8||
48358750|NCT04430582|101207461|FG001|STARTED|Overall Study||8||
48358751|NCT04430582|101207460|FG000|COMPLETED|Overall Study||7||
48358752|NCT04430582|101207461|FG001|COMPLETED|Overall Study||7||
48358753|NCT04430582|101207460|FG000|NOT COMPLETED|Overall Study||1||
48358754|NCT04430582|101207461|FG001|NOT COMPLETED|Overall Study||1||
48358755|NCT02340104|101207462|FG000|STARTED|Overall Study||8||
48358756|NCT02340104|101207462|FG000|COMPLETED|Overall Study||8||
48358757|NCT02340104|101207462|FG000|NOT COMPLETED|Overall Study||0||
48358758|NCT05590403|101207463|FG000|STARTED|Overall Study||383||
48358759|NCT05590403|101207464|FG001|STARTED|Overall Study||192||
48358760|NCT05590403|101207465|FG002|STARTED|Overall Study||386||
48358761|NCT05590403|101207466|FG003|STARTED|Overall Study||191||
48358762|NCT05590403|101207467|FG004|STARTED|Overall Study||381||
48358763|NCT05590403|101207463|FG000|COMPLETED|Overall Study||380||
48358764|NCT05590403|101207464|FG001|COMPLETED|Overall Study||191||
48358765|NCT05590403|101207465|FG002|COMPLETED|Overall Study||384||
48358766|NCT05590403|101207466|FG003|COMPLETED|Overall Study||190||
48358767|NCT05590403|101207467|FG004|COMPLETED|Overall Study||381||
48358768|NCT05590403|101207463|FG000|NOT COMPLETED|Overall Study||3||
48358769|NCT05590403|101207464|FG001|NOT COMPLETED|Overall Study||1||
48358770|NCT05590403|101207465|FG002|NOT COMPLETED|Overall Study||2||
48358771|NCT05590403|101207466|FG003|NOT COMPLETED|Overall Study||1||
48358772|NCT05590403|101207467|FG004|NOT COMPLETED|Overall Study||0||
48358773|NCT02240628|101207468|FG000|STARTED|Overall Study||38||
48358774|NCT02240628|101207469|FG001|STARTED|Overall Study||38||
48358775|NCT02240628|101207468|FG000|COMPLETED|Overall Study||32||
48358776|NCT02240628|101207469|FG001|COMPLETED|Overall Study||33||
48358777|NCT02240628|101207468|FG000|NOT COMPLETED|Overall Study||6||
48358778|NCT02240628|101207469|FG001|NOT COMPLETED|Overall Study||5||
48358779|NCT00510692|101207470|FG000|STARTED|Overall Study||29||
48358780|NCT00510692|101207471|FG001|STARTED|Overall Study||29||
48358781|NCT00510692|101207470|FG000|COMPLETED|Overall Study||27||
48358782|NCT00510692|101207471|FG001|COMPLETED|Overall Study||26||
48358783|NCT00510692|101207470|FG000|NOT COMPLETED|Overall Study||2||
48358784|NCT00510692|101207471|FG001|NOT COMPLETED|Overall Study||3||
48358785|NCT04410783|101207472|FG000|STARTED|Overall Study||876||
48358786|NCT04410783|101207473|FG001|STARTED|Overall Study||895||
48358787|NCT04410783|101207472|FG000|COMPLETED|Overall Study||196||
48358788|NCT04410783|101207473|FG001|COMPLETED|Overall Study||219||
48358789|NCT04410783|101207472|FG000|NOT COMPLETED|Overall Study||680||
48358790|NCT04410783|101207473|FG001|NOT COMPLETED|Overall Study||676||
48358791|NCT02062177|101207474|FG000|STARTED|Overall Study||70||
48358792|NCT02062177|101207475|FG001|STARTED|Overall Study||70||
48358793|NCT02062177|101207474|FG000|COMPLETED|Overall Study||70||
48358794|NCT02062177|101207475|FG001|COMPLETED|Overall Study||70||
48358795|NCT02062177|101207474|FG000|NOT COMPLETED|Overall Study||0||
48358796|NCT02062177|101207475|FG001|NOT COMPLETED|Overall Study||0||
48358797|NCT01319760|101207476|FG000|STARTED|Overall Study||0||
48358798|NCT01319760|101207477|FG001|STARTED|Overall Study||5||
48358799|NCT01319760|101207476|FG000|COMPLETED|Overall Study||0||
48358800|NCT01319760|101207477|FG001|COMPLETED|Overall Study||5||
48358801|NCT01319760|101207476|FG000|NOT COMPLETED|Overall Study||0||
48358802|NCT01319760|101207477|FG001|NOT COMPLETED|Overall Study||0||
48358803|NCT01959204|101207478|FG000|STARTED|Overall Study||97||
48358804|NCT01959204|101207478|FG000|COMPLETED|Overall Study||89||
48358805|NCT01959204|101207478|FG000|NOT COMPLETED|Overall Study||8||
48358806|NCT05537428|101207479|FG000|STARTED|Overall Study||39||
48358807|NCT05537428|101207479|FG000|COMPLETED|Overall Study||35||
48358808|NCT05537428|101207479|FG000|NOT COMPLETED|Overall Study||4||
48358809|NCT03721328|101207480|FG000|STARTED|Overall Study||15||
48358810|NCT03721328|101207480|FG000|COMPLETED|Overall Study||15||
48358811|NCT03721328|101207480|FG000|NOT COMPLETED|Overall Study||0||
48358812|NCT00090285|101207481|FG000|STARTED|Base Study Vaccination Period||2032||
48358813|NCT00090285|101207482|FG001|STARTED|Base Study Vaccination Period||2033||
48358814|NCT00090285|101207483|FG002|STARTED|Base Study Vaccination Period||0||
48358815|NCT00090285|101207484|FG003|STARTED|Base Study Vaccination Period||0||
48358816|NCT00090285|101207485|FG004|STARTED|Base Study Vaccination Period||0||
48358817|NCT00090285|101207486|FG005|STARTED|Base Study Vaccination Period||0||
48358818|NCT00090285|101207481|FG000|Vaccinated|Base Study Vaccination Period||2025||
48358819|NCT00090285|101207482|FG001|Vaccinated|Base Study Vaccination Period||2030||
48358820|NCT00090285|101207483|FG002|Vaccinated|Base Study Vaccination Period||0||
48358821|NCT00090285|101207484|FG003|Vaccinated|Base Study Vaccination Period||0||
48358822|NCT00090285|101207485|FG004|Vaccinated|Base Study Vaccination Period||0||
48358823|NCT00090285|101207486|FG005|Vaccinated|Base Study Vaccination Period||0||
48358824|NCT00090285|101207481|FG000|COMPLETED|Base Study Vaccination Period||1818||
48358825|NCT00090285|101207482|FG001|COMPLETED|Base Study Vaccination Period||1814||
48358826|NCT00090285|101207483|FG002|COMPLETED|Base Study Vaccination Period||0||
48358827|NCT00090285|101207484|FG003|COMPLETED|Base Study Vaccination Period||0||
48358828|NCT00090285|101207485|FG004|COMPLETED|Base Study Vaccination Period||0||
48358829|NCT00090285|101207486|FG005|COMPLETED|Base Study Vaccination Period||0||
48358830|NCT00090285|101207481|FG000|NOT COMPLETED|Base Study Vaccination Period||214||
48358831|NCT00090285|101207482|FG001|NOT COMPLETED|Base Study Vaccination Period||219||
48358832|NCT00090285|101207483|FG002|NOT COMPLETED|Base Study Vaccination Period||0||
48358833|NCT00090285|101207484|FG003|NOT COMPLETED|Base Study Vaccination Period||0||
48358834|NCT00090285|101207485|FG004|NOT COMPLETED|Base Study Vaccination Period||0||
48358835|NCT00090285|101207486|FG005|NOT COMPLETED|Base Study Vaccination Period||0||
48358836|NCT00090285|101207481|FG000|STARTED|Base Study Follow-up Period||1822||
48358837|NCT00090285|101207482|FG001|STARTED|Base Study Follow-up Period||1821||
48358838|NCT00090285|101207483|FG002|STARTED|Base Study Follow-up Period||0||
48358839|NCT00090285|101207484|FG003|STARTED|Base Study Follow-up Period||0||
48763310|NCT02105740|102208699|FG000|STARTED|Overall Study||12||
48763311|NCT02105740|102208700|FG001|STARTED|Overall Study||12||
48763312|NCT02105740|102208699|FG000|Second|Overall Study||12||
48763313|NCT02105740|102208700|FG001|Second|Overall Study||11||
48763314|NCT02105740|102208699|FG000|COMPLETED|Overall Study||12||
48763315|NCT02105740|102208700|FG001|COMPLETED|Overall Study||11||
48763316|NCT02105740|102208699|FG000|NOT COMPLETED|Overall Study||0||
48763317|NCT02105740|102208700|FG001|NOT COMPLETED|Overall Study||1||
48763318|NCT03365102|102208701|FG000|STARTED|Overall Study||22||
48358840|NCT00090285|101207485|FG004|STARTED|Base Study Follow-up Period||0||
48358841|NCT00090285|101207486|FG005|STARTED|Base Study Follow-up Period||0||
48358842|NCT00090285|101207481|FG000|COMPLETED|Base Study Follow-up Period||1487||
48358843|NCT00090285|101207482|FG001|COMPLETED|Base Study Follow-up Period||1479||
48358844|NCT00090285|101207483|FG002|COMPLETED|Base Study Follow-up Period||0||
48358845|NCT00090285|101207484|FG003|COMPLETED|Base Study Follow-up Period||0||
48358846|NCT00090285|101207485|FG004|COMPLETED|Base Study Follow-up Period||0||
48358847|NCT00090285|101207486|FG005|COMPLETED|Base Study Follow-up Period||0||
48358848|NCT00090285|101207481|FG000|NOT COMPLETED|Base Study Follow-up Period||335||
48358849|NCT00090285|101207482|FG001|NOT COMPLETED|Base Study Follow-up Period||342||
48358850|NCT00090285|101207483|FG002|NOT COMPLETED|Base Study Follow-up Period||0||
48358851|NCT00090285|101207484|FG003|NOT COMPLETED|Base Study Follow-up Period||0||
48358852|NCT00090285|101207485|FG004|NOT COMPLETED|Base Study Follow-up Period||0||
48358853|NCT00090285|101207486|FG005|NOT COMPLETED|Base Study Follow-up Period||0||
48358854|NCT00090285|101207481|FG000|STARTED|Extension 1||0||
48763319|NCT03365102|102208702|FG001|STARTED|Overall Study||22||
48763320|NCT03365102|102208703|FG002|STARTED|Overall Study||20||
48763321|NCT03365102|102208701|FG000|COMPLETED|Overall Study||18||
48763322|NCT03365102|102208702|FG001|COMPLETED|Overall Study||21||
48763323|NCT03365102|102208703|FG002|COMPLETED|Overall Study||19||
48763324|NCT03365102|102208701|FG000|NOT COMPLETED|Overall Study||4||
48763325|NCT03365102|102208702|FG001|NOT COMPLETED|Overall Study||1||
48358855|NCT00090285|101207482|FG001|STARTED|Extension 1||0||
48358856|NCT00090285|101207483|FG002|STARTED|Extension 1||1098||
48358857|NCT00090285|101207484|FG003|STARTED|Extension 1||16||
48358858|NCT00090285|101207485|FG004|STARTED|Extension 1||0||
48358859|NCT00090285|101207486|FG005|STARTED|Extension 1||0||
48358860|NCT00090285|101207481|FG000|COMPLETED|Extension 1||0||
48358861|NCT00090285|101207482|FG001|COMPLETED|Extension 1||0||
48358862|NCT00090285|101207483|FG002|COMPLETED|Extension 1||1041||
48358863|NCT00090285|101207484|FG003|COMPLETED|Extension 1||15||
48358864|NCT00090285|101207485|FG004|COMPLETED|Extension 1||0||
48358865|NCT00090285|101207486|FG005|COMPLETED|Extension 1||0||
48358866|NCT00090285|101207481|FG000|NOT COMPLETED|Extension 1||0||
48763326|NCT03365102|102208703|FG002|NOT COMPLETED|Overall Study||1||
48358867|NCT00090285|101207482|FG001|NOT COMPLETED|Extension 1||0||
48358868|NCT00090285|101207483|FG002|NOT COMPLETED|Extension 1||57||
48358869|NCT00090285|101207484|FG003|NOT COMPLETED|Extension 1||1||
48358870|NCT00090285|101207485|FG004|NOT COMPLETED|Extension 1||0||
48763327|NCT00751296|102208704|FG000|STARTED|Overall Study||27||
48763328|NCT00751296|102208704|FG000|COMPLETED|Overall Study||25||
48358871|NCT00090285|101207486|FG005|NOT COMPLETED|Extension 1||0||
48358872|NCT00090285|101207481|FG000|STARTED|Long-term Follow-up (EXT2)||0||
48358873|NCT00090285|101207482|FG001|STARTED|Long-term Follow-up (EXT2)||0||
48358874|NCT00090285|101207483|FG002|STARTED|Long-term Follow-up (EXT2)||0||
48358875|NCT00090285|101207484|FG003|STARTED|Long-term Follow-up (EXT2)||0||
48358876|NCT00090285|101207485|FG004|STARTED|Long-term Follow-up (EXT2)||936||
48358877|NCT00090285|101207486|FG005|STARTED|Long-term Follow-up (EXT2)||867||
48358878|NCT00090285|101207481|FG000|COMPLETED|Long-term Follow-up (EXT2)||0||
48358879|NCT00090285|101207482|FG001|COMPLETED|Long-term Follow-up (EXT2)||0||
48358880|NCT00090285|101207483|FG002|COMPLETED|Long-term Follow-up (EXT2)||0||
48358881|NCT00090285|101207484|FG003|COMPLETED|Long-term Follow-up (EXT2)||0||
48358882|NCT00090285|101207485|FG004|COMPLETED|Long-term Follow-up (EXT2)||709||
48358883|NCT00090285|101207486|FG005|COMPLETED|Long-term Follow-up (EXT2)||664||
48358884|NCT00090285|101207481|FG000|NOT COMPLETED|Long-term Follow-up (EXT2)||0||
48358885|NCT00090285|101207482|FG001|NOT COMPLETED|Long-term Follow-up (EXT2)||0||
48358886|NCT00090285|101207483|FG002|NOT COMPLETED|Long-term Follow-up (EXT2)||0||
48358887|NCT00090285|101207484|FG003|NOT COMPLETED|Long-term Follow-up (EXT2)||0||
48358888|NCT00090285|101207485|FG004|NOT COMPLETED|Long-term Follow-up (EXT2)||227||
48419833|NCT03289676|101361773|FG000|STARTED|Overall Study||27||
48419834|NCT03289676|101361774|FG001|STARTED|Overall Study||26||
48419835|NCT03289676|101361773|FG000|COMPLETED|Overall Study||23|Received 80% of the allotted intervention|
48419836|NCT03289676|101361774|FG001|COMPLETED|Overall Study||25|Received 80% of the allotted intervention|
48419837|NCT03289676|101361773|FG000|NOT COMPLETED|Overall Study||4||
48419838|NCT03289676|101361774|FG001|NOT COMPLETED|Overall Study||1||
48419839|NCT00391443|101361775|FG000|STARTED|Overall Study||209||
48419840|NCT00391443|101361776|FG001|STARTED|Overall Study||407||
48419841|NCT00391443|101361775|FG000|COMPLETED|Overall Study||209||
48419842|NCT00391443|101361776|FG001|COMPLETED|Overall Study||407||
48419843|NCT00391443|101361775|FG000|NOT COMPLETED|Overall Study||0||
48419844|NCT00391443|101361776|FG001|NOT COMPLETED|Overall Study||0||
48419845|NCT00579527|101361777|FG000|STARTED|Overall Study||14||
48419846|NCT00579527|101361777|FG000|COMPLETED|Overall Study||10||
48358889|NCT00090285|101207486|FG005|NOT COMPLETED|Long-term Follow-up (EXT2)||203||
48358890|NCT01524289|101207487|FG000|STARTED|Overall Study||204||
48358891|NCT01524289|101207488|FG001|STARTED|Overall Study||102||
48358892|NCT01524289|101207487|FG000|Treated|Overall Study||203||
48358893|NCT01524289|101207488|FG001|Treated|Overall Study||102||
48358894|NCT01524289|101207487|FG000|COMPLETED|Overall Study||174||
48358895|NCT01524289|101207488|FG001|COMPLETED|Overall Study||88||
48358896|NCT01524289|101207487|FG000|NOT COMPLETED|Overall Study||30||
48358897|NCT01524289|101207488|FG001|NOT COMPLETED|Overall Study||14||
48358898|NCT02532543|101207489|FG000|STARTED|Overall Study||3||
48358899|NCT02532543|101207490|FG001|STARTED|Overall Study||4||
48358900|NCT02532543|101207491|FG002|STARTED|Overall Study||5||
48358901|NCT02532543|101207492|FG003|STARTED|Overall Study||4||
48358902|NCT02532543|101207489|FG000|COMPLETED|Overall Study||3||
48358903|NCT02532543|101207490|FG001|COMPLETED|Overall Study||4||
48358904|NCT02532543|101207491|FG002|COMPLETED|Overall Study||4||
48358905|NCT02532543|101207492|FG003|COMPLETED|Overall Study||4||
48358906|NCT02532543|101207489|FG000|NOT COMPLETED|Overall Study||0||
48358907|NCT02532543|101207490|FG001|NOT COMPLETED|Overall Study||0||
48358908|NCT02532543|101207491|FG002|NOT COMPLETED|Overall Study||1||
48358909|NCT02532543|101207492|FG003|NOT COMPLETED|Overall Study||0||
48358910|NCT01623466|101207493|FG000|STARTED|Overall Study||18||
48358911|NCT01623466|101207494|FG001|STARTED|Overall Study||18||
48358912|NCT01623466|101207493|FG000|COMPLETED|Overall Study||17||
48358913|NCT01623466|101207494|FG001|COMPLETED|Overall Study||18||
48358914|NCT01623466|101207493|FG000|NOT COMPLETED|Overall Study||1||
48358915|NCT01623466|101207494|FG001|NOT COMPLETED|Overall Study||0||
48358916|NCT01225068|101207495|FG000|STARTED|Overall Study||20||
48358917|NCT01225068|101207496|FG001|STARTED|Overall Study||20||
48358918|NCT01225068|101207495|FG000|COMPLETED|Overall Study||16||
48358919|NCT01225068|101207496|FG001|COMPLETED|Overall Study||19||
48358920|NCT01225068|101207495|FG000|NOT COMPLETED|Overall Study||4||
48358921|NCT01225068|101207496|FG001|NOT COMPLETED|Overall Study||1||
48358922|NCT00095303|101207497|FG000|STARTED|Main Study||245||
48358923|NCT00095303|101207498|FG001|STARTED|Main Study||235||
48358924|NCT00095303|101207497|FG000|COMPLETED|Main Study||154||
48358925|NCT00095303|101207498|FG001|COMPLETED|Main Study||148||
48358926|NCT00095303|101207497|FG000|NOT COMPLETED|Main Study||91||
48358927|NCT00095303|101207498|FG001|NOT COMPLETED|Main Study||87||
48358928|NCT00095303|101207497|FG000|STARTED|Follow Up Study||199||
48358929|NCT00095303|101207498|FG001|STARTED|Follow Up Study||179||
48358930|NCT00095303|101207497|FG000|COMPLETED|Follow Up Study||140||
48358931|NCT00095303|101207498|FG001|COMPLETED|Follow Up Study||121||
48358932|NCT00095303|101207497|FG000|NOT COMPLETED|Follow Up Study||59||
48419847|NCT00579527|101361777|FG000|NOT COMPLETED|Overall Study||4||
48419848|NCT03243981|101361778|FG000|STARTED|Overall Study||5||
48419849|NCT03243981|101361778|FG000|COMPLETED|Overall Study||5||
48419850|NCT03243981|101361778|FG000|NOT COMPLETED|Overall Study||0||
48419851|NCT01552408|101361779|FG000|STARTED|Overall Study||20||20
48419852|NCT01552408|101361780|FG001|STARTED|Overall Study||20||20
48419853|NCT01552408|101361779|FG000|COMPLETED|Overall Study||16||16
48358933|NCT00095303|101207498|FG001|NOT COMPLETED|Follow Up Study||58||
48358934|NCT04382651|101207499|FG000|STARTED|Overall Study||69|All randomized participants|
48358935|NCT04382651|101207500|FG001|STARTED|Overall Study||71|All randomized participants|
48358936|NCT04382651|101207499|FG000|Safety Analysis Set|Overall Study||68|All randomized participants that have received any study drug|
48358937|NCT04382651|101207500|FG001|Safety Analysis Set|Overall Study||70|All randomized participants that have received any study drug|
48358938|NCT04382651|101207499|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||63|All randomized participants with at least one valid PK concentration measurement, who received MAS825 and no protocol deviations with relevant impact on PK data.|
48358939|NCT04382651|101207500|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||0|All randomized participants with at least one valid PK concentration measurement, who received MAS825 and no protocol deviations with relevant impact on PK data.|
48358940|NCT04382651|101207499|FG000|COMPLETED|Overall Study||38||
48358941|NCT04382651|101207500|FG001|COMPLETED|Overall Study||43||
48358942|NCT04382651|101207499|FG000|NOT COMPLETED|Overall Study||31||
48358943|NCT04382651|101207500|FG001|NOT COMPLETED|Overall Study||28||
48358944|NCT03671369|101207501|FG000|STARTED|Overall Study||669||
48358945|NCT03671369|101207501|FG000|COMPLETED|Overall Study||378||
48358946|NCT03671369|101207501|FG000|NOT COMPLETED|Overall Study||291||
48358947|NCT00971321|101207502|FG000|STARTED|Up to Day 42||104||
48358948|NCT00971321|101207503|FG001|STARTED|Up to Day 42||53||
48358949|NCT00971321|101207502|FG000|COMPLETED|Up to Day 42||104||
48358950|NCT00971321|101207503|FG001|COMPLETED|Up to Day 42||53||
48358951|NCT00971321|101207502|FG000|NOT COMPLETED|Up to Day 42||0||
48358952|NCT00971321|101207503|FG001|NOT COMPLETED|Up to Day 42||0||
48358953|NCT00971321|101207502|FG000|STARTED|Up to Month 7||104||
48358954|NCT00971321|101207503|FG001|STARTED|Up to Month 7||53||
48358955|NCT00971321|101207502|FG000|COMPLETED|Up to Month 7||100||
48358956|NCT00971321|101207503|FG001|COMPLETED|Up to Month 7||51||
48358957|NCT00971321|101207502|FG000|NOT COMPLETED|Up to Month 7||4||
48358958|NCT00971321|101207503|FG001|NOT COMPLETED|Up to Month 7||2||
48358959|NCT00971321|101207502|FG000|STARTED|Up to Month 11-12||104||
48358960|NCT00971321|101207503|FG001|STARTED|Up to Month 11-12||53||
48358961|NCT00971321|101207502|FG000|COMPLETED|Up to Month 11-12||99||
48358962|NCT00971321|101207503|FG001|COMPLETED|Up to Month 11-12||50||
48358963|NCT00971321|101207502|FG000|NOT COMPLETED|Up to Month 11-12||5||
48358964|NCT00971321|101207503|FG001|NOT COMPLETED|Up to Month 11-12||3||
48358965|NCT00853905|101207504|FG000|STARTED|Overall Study||37||
48358966|NCT00853905|101207505|FG001|STARTED|Overall Study||40||
48358967|NCT00853905|101207504|FG000|COMPLETED|Overall Study||35||
48358968|NCT00853905|101207505|FG001|COMPLETED|Overall Study||36||
48358969|NCT00853905|101207504|FG000|NOT COMPLETED|Overall Study||2||
48358970|NCT00853905|101207505|FG001|NOT COMPLETED|Overall Study||4||
48358971|NCT00609271|101207506|FG000|STARTED|Overall Study||75||
48358972|NCT00609271|101207507|FG001|STARTED|Overall Study||73||
48358973|NCT00609271|101207506|FG000|COMPLETED|Overall Study||59||
48358974|NCT00609271|101207507|FG001|COMPLETED|Overall Study||60||
48358975|NCT00609271|101207506|FG000|NOT COMPLETED|Overall Study||16||
48358976|NCT00609271|101207507|FG001|NOT COMPLETED|Overall Study||13||
48358977|NCT01417286|101207508|FG000|STARTED|Overall Study||67||
48358978|NCT01417286|101207508|FG000|COMPLETED|Overall Study||67||
48419854|NCT01552408|101361780|FG001|COMPLETED|Overall Study||18||18
48419855|NCT01552408|101361779|FG000|NOT COMPLETED|Overall Study||4||4
48419856|NCT01552408|101361780|FG001|NOT COMPLETED|Overall Study||2||2
48419857|NCT02994043|101361781|FG000|STARTED|Overall Study||90||
48419858|NCT02994043|101361782|FG001|STARTED|Overall Study||92||
48419859|NCT02994043|101361781|FG000|COMPLETED|Overall Study||71||
48638813|NCT02711137|101901517|FG013|STARTED|Overall Study||2||
48638814|NCT02711137|101901518|FG014|STARTED|Overall Study||3||
48638815|NCT02711137|101901504|FG000|COMPLETED|Overall Study||0||
48638816|NCT02711137|101901505|FG001|COMPLETED|Overall Study||0||
48638817|NCT02711137|101901506|FG002|COMPLETED|Overall Study||0||
48638818|NCT02711137|101901507|FG003|COMPLETED|Overall Study||0||
48638819|NCT02711137|101901508|FG004|COMPLETED|Overall Study||0||
48638820|NCT02711137|101901509|FG005|COMPLETED|Overall Study||0||
48638821|NCT02711137|101901510|FG006|COMPLETED|Overall Study||0||
48638822|NCT02711137|101901511|FG007|COMPLETED|Overall Study||0||
48638823|NCT02711137|101901512|FG008|COMPLETED|Overall Study||0||
48638824|NCT02711137|101901513|FG009|COMPLETED|Overall Study||0||
48638825|NCT02711137|101901514|FG010|COMPLETED|Overall Study||0||
48638826|NCT02711137|101901515|FG011|COMPLETED|Overall Study||0||
48638827|NCT02711137|101901516|FG012|COMPLETED|Overall Study||0||
48358979|NCT01417286|101207508|FG000|NOT COMPLETED|Overall Study||0||
48358980|NCT01645930|101207509|FG000|STARTED|Overall Study||43||
48358981|NCT01645930|101207509|FG000|COMPLETED|Overall Study||0||
48638828|NCT02711137|101901517|FG013|COMPLETED|Overall Study||0||
48638829|NCT02711137|101901518|FG014|COMPLETED|Overall Study||0||
48638830|NCT02711137|101901504|FG000|NOT COMPLETED|Overall Study||4||
48358982|NCT01645930|101207509|FG000|NOT COMPLETED|Overall Study||43||
48358983|NCT03517722|101207510|FG000|STARTED|Double Blind Period: Week 0-52||208||
48419860|NCT02994043|101361782|FG001|COMPLETED|Overall Study||75||
48419861|NCT02994043|101361781|FG000|NOT COMPLETED|Overall Study||19||
48638831|NCT02711137|101901505|FG001|NOT COMPLETED|Overall Study||5||
48638832|NCT02711137|101901506|FG002|NOT COMPLETED|Overall Study||8||
48638833|NCT02711137|101901507|FG003|NOT COMPLETED|Overall Study||7||
48763329|NCT00751296|102208704|FG000|NOT COMPLETED|Overall Study||2||
48763330|NCT04106557|102208705|FG000|STARTED|Overall Study||47||
48763331|NCT04106557|102208706|FG001|STARTED|Overall Study||50||
48763332|NCT04106557|102208707|FG002|STARTED|Overall Study||7||
48763333|NCT04106557|102208705|FG000|COMPLETED|Overall Study||47||
48763334|NCT04106557|102208706|FG001|COMPLETED|Overall Study||48||
48763335|NCT04106557|102208707|FG002|COMPLETED|Overall Study||7||
48763336|NCT04106557|102208705|FG000|NOT COMPLETED|Overall Study||0||
48763337|NCT04106557|102208706|FG001|NOT COMPLETED|Overall Study||2||
48763338|NCT04106557|102208707|FG002|NOT COMPLETED|Overall Study||0||
48763339|NCT04973449|102208708|FG000|STARTED|Overall Study||409||
48763340|NCT04973449|102208709|FG001|STARTED|Overall Study||413||
48763341|NCT04973449|102208710|FG002|STARTED|Overall Study||411||
48763342|NCT04973449|102208711|FG003|STARTED|Overall Study||208||
48763343|NCT04973449|102208712|FG004|STARTED|Overall Study||373||
48763344|NCT04973449|102208713|FG005|STARTED|Overall Study||377||
48763345|NCT04973449|102208714|FG006|STARTED|Overall Study||322||
48763346|NCT04973449|102208715|FG007|STARTED|Overall Study||321||
48763347|NCT04973449|102208708|FG000|COMPLETED|Overall Study||389||
48763348|NCT04973449|102208709|FG001|COMPLETED|Overall Study||393||
48763349|NCT04973449|102208710|FG002|COMPLETED|Overall Study||391||
48763350|NCT04973449|102208711|FG003|COMPLETED|Overall Study||189||
48763351|NCT04973449|102208712|FG004|COMPLETED|Overall Study||359||
48763352|NCT04973449|102208713|FG005|COMPLETED|Overall Study||366||
48763353|NCT04973449|102208714|FG006|COMPLETED|Overall Study||303||
48763354|NCT04973449|102208715|FG007|COMPLETED|Overall Study||308||
48763355|NCT04973449|102208708|FG000|NOT COMPLETED|Overall Study||20||
48763356|NCT04973449|102208709|FG001|NOT COMPLETED|Overall Study||20||
48763357|NCT04973449|102208710|FG002|NOT COMPLETED|Overall Study||20||
48763358|NCT04973449|102208711|FG003|NOT COMPLETED|Overall Study||19||
48763359|NCT04973449|102208712|FG004|NOT COMPLETED|Overall Study||14||
48763360|NCT04973449|102208713|FG005|NOT COMPLETED|Overall Study||11||
48763361|NCT04973449|102208714|FG006|NOT COMPLETED|Overall Study||19||
48763362|NCT04973449|102208715|FG007|NOT COMPLETED|Overall Study||13||
48763363|NCT03130738|102208716|FG000|STARTED|Overall Study||23||
48763364|NCT03130738|102208717|FG001|STARTED|Overall Study||22||
48763365|NCT03130738|102208718|FG002|STARTED|Overall Study||20||
48763366|NCT03130738|102208716|FG000|COMPLETED|Overall Study||20||
48763367|NCT03130738|102208717|FG001|COMPLETED|Overall Study||20||
48763368|NCT03130738|102208718|FG002|COMPLETED|Overall Study||14||
48763369|NCT03130738|102208716|FG000|NOT COMPLETED|Overall Study||3||
48763370|NCT03130738|102208717|FG001|NOT COMPLETED|Overall Study||2||
48763371|NCT03130738|102208718|FG002|NOT COMPLETED|Overall Study||6||
48763372|NCT01391962|102208719|FG000|STARTED|Part I||7||
48763373|NCT01391962|102208720|FG001|STARTED|Part I||9||
48763374|NCT01391962|102208721|FG002|STARTED|Part I||5||
48763375|NCT01391962|102208722|FG003|STARTED|Part I||13||
48763376|NCT01391962|102208719|FG000|Restaging|Part I||6||
48358984|NCT03517722|101207511|FG001|STARTED|Double Blind Period: Week 0-52||308||
48358985|NCT03517722|101207510|FG000|Treated|Double Blind Period: Week 0-52||208||
48358986|NCT03517722|101207511|FG001|Treated|Double Blind Period: Week 0-52||307||
48358987|NCT03517722|101207510|FG000|COMPLETED|Double Blind Period: Week 0-52||105||
48358988|NCT03517722|101207511|FG001|COMPLETED|Double Blind Period: Week 0-52||153||
48358989|NCT03517722|101207510|FG000|NOT COMPLETED|Double Blind Period: Week 0-52||103||
48358990|NCT03517722|101207511|FG001|NOT COMPLETED|Double Blind Period: Week 0-52||155||
48358991|NCT03517722|101207510|FG000|STARTED|Open-label Extension Period: Week 52-113||88||
48358992|NCT03517722|101207511|FG001|STARTED|Open-label Extension Period: Week 52-113||137||
48358993|NCT03517722|101207510|FG000|COMPLETED|Open-label Extension Period: Week 52-113||0||
48763377|NCT01391962|102208720|FG001|Restaging|Part I||9||
48763378|NCT01391962|102208721|FG002|Restaging|Part I||4||
48763379|NCT01391962|102208722|FG003|Restaging|Part I||12||
48763380|NCT01391962|102208719|FG000|Pharmacokinetic Sampling|Part I||2||
48763381|NCT01391962|102208720|FG001|Pharmacokinetic Sampling|Part I||6||
48763382|NCT01391962|102208721|FG002|Pharmacokinetic Sampling|Part I||0||
48763383|NCT01391962|102208722|FG003|Pharmacokinetic Sampling|Part I||0||
48763384|NCT01391962|102208719|FG000|COMPLETED|Part I||7||
48763385|NCT01391962|102208720|FG001|COMPLETED|Part I||9||
48763386|NCT01391962|102208721|FG002|COMPLETED|Part I||5||
48763387|NCT01391962|102208722|FG003|COMPLETED|Part I||13||
48763388|NCT01391962|102208719|FG000|NOT COMPLETED|Part I||0||
48763389|NCT01391962|102208720|FG001|NOT COMPLETED|Part I||0||
48763390|NCT01391962|102208721|FG002|NOT COMPLETED|Part I||0||
48763391|NCT01391962|102208722|FG003|NOT COMPLETED|Part I||0||
48763392|NCT01391962|102208719|FG000|STARTED|Washout - 2 Weeks||0||
48763393|NCT01391962|102208720|FG001|STARTED|Washout - 2 Weeks||9||
48763394|NCT01391962|102208721|FG002|STARTED|Washout - 2 Weeks||0||
48763395|NCT01391962|102208722|FG003|STARTED|Washout - 2 Weeks||13||
48763396|NCT01391962|102208719|FG000|COMPLETED|Washout - 2 Weeks||0||
48763397|NCT01391962|102208720|FG001|COMPLETED|Washout - 2 Weeks||9||
48763398|NCT01391962|102208721|FG002|COMPLETED|Washout - 2 Weeks||0||
48763399|NCT01391962|102208722|FG003|COMPLETED|Washout - 2 Weeks||13||
48763400|NCT01391962|102208719|FG000|NOT COMPLETED|Washout - 2 Weeks||0||
48763401|NCT01391962|102208720|FG001|NOT COMPLETED|Washout - 2 Weeks||0||
48763402|NCT01391962|102208721|FG002|NOT COMPLETED|Washout - 2 Weeks||0||
48763403|NCT01391962|102208722|FG003|NOT COMPLETED|Washout - 2 Weeks||0||
48763404|NCT01391962|102208719|FG000|STARTED|Part II||0||
48763405|NCT01391962|102208720|FG001|STARTED|Part II||9||
48763406|NCT01391962|102208721|FG002|STARTED|Part II||0||
48763407|NCT01391962|102208722|FG003|STARTED|Part II||13||
48763408|NCT01391962|102208719|FG000|Restaging|Part II||0||
48763409|NCT01391962|102208720|FG001|Restaging|Part II||9||
48763410|NCT01391962|102208721|FG002|Restaging|Part II||0||
48763411|NCT01391962|102208722|FG003|Restaging|Part II||13||
48763412|NCT01391962|102208719|FG000|Pharmacokinetic Sampling|Part II||0||
48763413|NCT01391962|102208720|FG001|Pharmacokinetic Sampling|Part II||0||
48763414|NCT01391962|102208721|FG002|Pharmacokinetic Sampling|Part II||0||
48763415|NCT01391962|102208722|FG003|Pharmacokinetic Sampling|Part II||7||
48763416|NCT01391962|102208719|FG000|COMPLETED|Part II||0||
48763417|NCT01391962|102208720|FG001|COMPLETED|Part II||9||
48763418|NCT01391962|102208721|FG002|COMPLETED|Part II||0||
48763419|NCT01391962|102208722|FG003|COMPLETED|Part II||13||
48763420|NCT01391962|102208719|FG000|NOT COMPLETED|Part II||0||
48763421|NCT01391962|102208720|FG001|NOT COMPLETED|Part II||0||
48763422|NCT01391962|102208721|FG002|NOT COMPLETED|Part II||0||
48763423|NCT01391962|102208722|FG003|NOT COMPLETED|Part II||0||
48763424|NCT01710501|102208723|FG000|STARTED|Overall Study||29||
48763425|NCT01710501|102208724|FG001|STARTED|Overall Study||28||
48763426|NCT01710501|102208725|FG002|STARTED|Overall Study||30||
48763427|NCT01710501|102208723|FG000|COMPLETED|Overall Study||27||
48763428|NCT01710501|102208724|FG001|COMPLETED|Overall Study||28||
48763429|NCT01710501|102208725|FG002|COMPLETED|Overall Study||30||
48763430|NCT01710501|102208723|FG000|NOT COMPLETED|Overall Study||2||
48763431|NCT01710501|102208724|FG001|NOT COMPLETED|Overall Study||0||
48763432|NCT01710501|102208725|FG002|NOT COMPLETED|Overall Study||0||
48763433|NCT04701762|102208726|FG000|STARTED|Overall Study||4301||4481
48763434|NCT04701762|102208727|FG001|STARTED|Overall Study||3607||3948
48763435|NCT04701762|102208726|FG000|Direct Laryngoscopy|Overall Study||1945||1995
48358994|NCT03517722|101207511|FG001|COMPLETED|Open-label Extension Period: Week 52-113||0||
48358995|NCT03517722|101207510|FG000|NOT COMPLETED|Open-label Extension Period: Week 52-113||88||
48358996|NCT03517722|101207511|FG001|NOT COMPLETED|Open-label Extension Period: Week 52-113||137||
48358997|NCT00153166|101207512|FG000|STARTED|Overall Study||11||
48358998|NCT00153166|101207513|FG001|STARTED|Overall Study||37||
48358999|NCT00153166|101207514|FG002|STARTED|Overall Study||28||
48359000|NCT00153166|101207512|FG000|Received Atorvastatin and Pioglitazone|Overall Study||3||
48359001|NCT00153166|101207513|FG001|Received Atorvastatin and Pioglitazone|Overall Study||9||
48359002|NCT00153166|101207514|FG002|Received Atorvastatin and Pioglitazone|Overall Study||7||
48359003|NCT00153166|101207512|FG000|Received Atorvastatin and Placebo|Overall Study||2||
48359004|NCT00153166|101207513|FG001|Received Atorvastatin and Placebo|Overall Study||9||
48359005|NCT00153166|101207514|FG002|Received Atorvastatin and Placebo|Overall Study||7||
48359006|NCT00153166|101207512|FG000|Received Placebo and Pioglitazone|Overall Study||3||
48359007|NCT00153166|101207513|FG001|Received Placebo and Pioglitazone|Overall Study||10||
48359008|NCT00153166|101207514|FG002|Received Placebo and Pioglitazone|Overall Study||7||
48359009|NCT00153166|101207512|FG000|Received Placebo and Placebo|Overall Study||3||
48359010|NCT00153166|101207513|FG001|Received Placebo and Placebo|Overall Study||9||
48359011|NCT00153166|101207514|FG002|Received Placebo and Placebo|Overall Study||7||
48359012|NCT00153166|101207512|FG000|COMPLETED|Overall Study||11||
48359013|NCT00153166|101207513|FG001|COMPLETED|Overall Study||37||
48359014|NCT00153166|101207514|FG002|COMPLETED|Overall Study||28||
48359015|NCT00153166|101207512|FG000|NOT COMPLETED|Overall Study||0||
48359016|NCT00153166|101207513|FG001|NOT COMPLETED|Overall Study||0||
48359017|NCT00153166|101207514|FG002|NOT COMPLETED|Overall Study||0||
48419862|NCT02994043|101361782|FG001|NOT COMPLETED|Overall Study||17||
48763436|NCT04701762|102208727|FG001|Direct Laryngoscopy|Overall Study||1916||2021
48763437|NCT04701762|102208726|FG000|Videolaryngoscopy|Overall Study||2418||2486
48763438|NCT04701762|102208727|FG001|Videolaryngoscopy|Overall Study||1828||1927
48763439|NCT04701762|102208726|FG000|COMPLETED|Overall Study||4301||4481
48763440|NCT04701762|102208727|FG001|COMPLETED|Overall Study||3607||3948
48763441|NCT04701762|102208726|FG000|NOT COMPLETED|Overall Study||0||0
48763442|NCT04701762|102208727|FG001|NOT COMPLETED|Overall Study||0||0
48763443|NCT04029883|102208728|FG000|STARTED|Overall Study||20||
48359018|NCT01396525|101207515|FG000|STARTED|Overall Study||153||
48359019|NCT01396525|101207515|FG000|COMPLETED|Overall Study||127||
48359020|NCT01396525|101207515|FG000|NOT COMPLETED|Overall Study||26||
48763444|NCT04029883|102208729|FG001|STARTED|Overall Study||20||
48763445|NCT04029883|102208730|FG002|STARTED|Overall Study||20||
48763446|NCT04029883|102208728|FG000|COMPLETED|Overall Study||17||
48763447|NCT04029883|102208729|FG001|COMPLETED|Overall Study||13||
48763448|NCT04029883|102208730|FG002|COMPLETED|Overall Study||18||
48763449|NCT04029883|102208728|FG000|NOT COMPLETED|Overall Study||3||
48763450|NCT04029883|102208729|FG001|NOT COMPLETED|Overall Study||7||
48763451|NCT04029883|102208730|FG002|NOT COMPLETED|Overall Study||2||
48763452|NCT01285323|102208731|FG000|STARTED|Overall Study||232||
48763453|NCT01285323|102208732|FG001|STARTED|Overall Study||232||
48763454|NCT01285323|102208731|FG000|Full Analysis Set|Overall Study||232||
48763455|NCT01285323|102208732|FG001|Full Analysis Set|Overall Study||232||
48359021|NCT00881205|101207516|FG000|STARTED|Overall Study||45||
48359022|NCT00881205|101207517|FG001|STARTED|Overall Study||41||
48359023|NCT00881205|101207516|FG000|COMPLETED|Overall Study||34||
48359024|NCT00881205|101207517|FG001|COMPLETED|Overall Study||34||
48359025|NCT00881205|101207516|FG000|NOT COMPLETED|Overall Study||11||
48359026|NCT00881205|101207517|FG001|NOT COMPLETED|Overall Study||7||
48419863|NCT01230021|101361783|FG000|STARTED|Overall Study||6||
48419864|NCT01230021|101361783|FG000|COMPLETED|Overall Study||6||
48419865|NCT01230021|101361783|FG000|NOT COMPLETED|Overall Study||0||
48419866|NCT01293123|101361784|FG000|STARTED|Overall Study||1||
48419867|NCT01293123|101361785|FG001|STARTED|Overall Study||1||
48419868|NCT01293123|101361784|FG000|COMPLETED|Overall Study||1||
48419869|NCT01293123|101361785|FG001|COMPLETED|Overall Study||0||
48419870|NCT01293123|101361784|FG000|NOT COMPLETED|Overall Study||0||
48419871|NCT01293123|101361785|FG001|NOT COMPLETED|Overall Study||1||
48419872|NCT01116661|101361786|FG000|STARTED|Overall Study||199||
48419873|NCT01116661|101361786|FG000|COMPLETED|Overall Study||197||
48419874|NCT01116661|101361786|FG000|NOT COMPLETED|Overall Study||2||
48419875|NCT03384316|101361787|FG000|STARTED|Overall Study||6||
48419876|NCT03384316|101361788|FG001|STARTED|Overall Study||5||
48419877|NCT03384316|101361787|FG000|COMPLETED|Overall Study||6||
48419878|NCT03384316|101361788|FG001|COMPLETED|Overall Study||4||
48419879|NCT03384316|101361787|FG000|NOT COMPLETED|Overall Study||0||
48419880|NCT03384316|101361788|FG001|NOT COMPLETED|Overall Study||1||
48419881|NCT03459794|101361789|FG000|STARTED|Overall Study||8||
48419882|NCT03459794|101361790|FG001|STARTED|Overall Study||4||
48419883|NCT03459794|101361789|FG000|COMPLETED|Overall Study||8||
48419884|NCT03459794|101361790|FG001|COMPLETED|Overall Study||4||
48419885|NCT03459794|101361789|FG000|NOT COMPLETED|Overall Study||0||
48419886|NCT03459794|101361790|FG001|NOT COMPLETED|Overall Study||0||
48419887|NCT05414422|101361791|FG000|STARTED|Overall Study||33||
48419888|NCT05414422|101361792|FG001|STARTED|Overall Study||35||
48419889|NCT05414422|101361793|FG002|STARTED|Overall Study||34||
48763456|NCT01285323|102208731|FG000|Safety Analysis Set|Overall Study||232||
48763457|NCT01285323|102208732|FG001|Safety Analysis Set|Overall Study||232||
48763458|NCT01285323|102208731|FG000|COMPLETED|Overall Study||199||
48763459|NCT01285323|102208732|FG001|COMPLETED|Overall Study||202||
48419890|NCT05414422|101361791|FG000|COMPLETED|Overall Study||31||
48419891|NCT05414422|101361792|FG001|COMPLETED|Overall Study||35||
48419892|NCT05414422|101361793|FG002|COMPLETED|Overall Study||31||
48419893|NCT05414422|101361791|FG000|NOT COMPLETED|Overall Study||2||
48419894|NCT05414422|101361792|FG001|NOT COMPLETED|Overall Study||0||
48419895|NCT05414422|101361793|FG002|NOT COMPLETED|Overall Study||3||
48419896|NCT03432819|101361794|FG000|STARTED|Overall Study||38||
48419897|NCT03432819|101361795|FG001|STARTED|Overall Study||38||
48763460|NCT01285323|102208731|FG000|NOT COMPLETED|Overall Study||33||
48763461|NCT01285323|102208732|FG001|NOT COMPLETED|Overall Study||30||
48763462|NCT05316597|102208733|FG000|STARTED|First Session||21||
48763463|NCT05316597|102208734|FG001|STARTED|First Session||22||
48763464|NCT05316597|102208733|FG000|COMPLETED|First Session||21||
48763465|NCT05316597|102208734|FG001|COMPLETED|First Session||21||
48763466|NCT05316597|102208733|FG000|NOT COMPLETED|First Session||0||
48763467|NCT05316597|102208734|FG001|NOT COMPLETED|First Session||1||
48359027|NCT02243176|101207518|FG000|STARTED|Overall Study||244||
48359028|NCT02243176|101207519|FG001|STARTED|Overall Study||244||
48419898|NCT03432819|101361794|FG000|COMPLETED|Overall Study||31||
48419899|NCT03432819|101361795|FG001|COMPLETED|Overall Study||33||
48763468|NCT05316597|102208733|FG000|STARTED|Washout Period||21||
48359029|NCT02243176|101207518|FG000|COMPLETED|Overall Study||230||
48359030|NCT02243176|101207519|FG001|COMPLETED|Overall Study||229||
48359031|NCT02243176|101207518|FG000|NOT COMPLETED|Overall Study||14||
48359032|NCT02243176|101207519|FG001|NOT COMPLETED|Overall Study||15||
48359033|NCT02333045|101207520|FG000|STARTED|Overall Study||1||
48359034|NCT02333045|101207521|FG001|STARTED|Overall Study||3||
48359035|NCT02333045|101207520|FG000|COMPLETED|Overall Study||1||
48359036|NCT02333045|101207521|FG001|COMPLETED|Overall Study||3||
48359037|NCT02333045|101207520|FG000|NOT COMPLETED|Overall Study||0||
48359038|NCT02333045|101207521|FG001|NOT COMPLETED|Overall Study||0||
48359039|NCT01004107|101207522|FG000|STARTED|Overall Study||76||
48763469|NCT05316597|102208734|FG001|STARTED|Washout Period||21||
48359040|NCT01004107|101207523|FG001|STARTED|Overall Study||25||
48419900|NCT03432819|101361794|FG000|NOT COMPLETED|Overall Study||7||
48419901|NCT03432819|101361795|FG001|NOT COMPLETED|Overall Study||5||
48419902|NCT01362062|101361796|FG000|STARTED|Overall Study||48||
48419903|NCT01362062|101361797|FG001|STARTED|Overall Study||62||
48419904|NCT01362062|101361796|FG000|COMPLETED|Overall Study||22||
48419905|NCT01362062|101361797|FG001|COMPLETED|Overall Study||62||
48419906|NCT01362062|101361796|FG000|NOT COMPLETED|Overall Study||26||
48419907|NCT01362062|101361797|FG001|NOT COMPLETED|Overall Study||0||
48419908|NCT04269629|101361798|FG000|STARTED|Overall Study||1425||
48419909|NCT04269629|101361798|FG000|Number of Patients Who Performed VIT|Overall Study||1342||
48419910|NCT04269629|101361798|FG000|COMPLETED|Overall Study||1186||
48419911|NCT04269629|101361798|FG000|NOT COMPLETED|Overall Study||239||
48419912|NCT01716585|101361799|FG000|STARTED|Double-blind Treatment||477||
48419913|NCT01716585|101361800|FG001|STARTED|Double-blind Treatment||159||
48419914|NCT01716585|101361799|FG000|Randomized But Not Treated|Double-blind Treatment||4||
48419915|NCT01716585|101361800|FG001|Randomized But Not Treated|Double-blind Treatment||1||
48419916|NCT01716585|101361799|FG000|COMPLETED|Double-blind Treatment||464||
48419917|NCT01716585|101361800|FG001|COMPLETED|Double-blind Treatment||157||
48419918|NCT01716585|101361799|FG000|NOT COMPLETED|Double-blind Treatment||13||
48419919|NCT01716585|101361800|FG001|NOT COMPLETED|Double-blind Treatment||2||
48419920|NCT01716585|101361799|FG000|STARTED|Open-label Treatment||0||
48419921|NCT01716585|101361800|FG001|STARTED|Open-label Treatment||157||
48419922|NCT01716585|101361799|FG000|COMPLETED|Open-label Treatment||0||
48419923|NCT01716585|101361800|FG001|COMPLETED|Open-label Treatment||150||
48419924|NCT01716585|101361799|FG000|NOT COMPLETED|Open-label Treatment||0||
48419925|NCT01716585|101361800|FG001|NOT COMPLETED|Open-label Treatment||7||
48419926|NCT03769753|101361801|FG000|STARTED|Overall Study||8||
48419927|NCT03769753|101361801|FG000|COMPLETED|Overall Study||1||
48419928|NCT03769753|101361801|FG000|NOT COMPLETED|Overall Study||7||
48419929|NCT01683058|101361802|FG000|STARTED|Overall Study||74||
48419930|NCT01683058|101361802|FG000|COMPLETED|Overall Study||45||
48419931|NCT01683058|101361802|FG000|NOT COMPLETED|Overall Study||29||
48419932|NCT01385098|101361803|FG000|STARTED|Overall Study||37||
48419933|NCT01385098|101361803|FG000|COMPLETED|Overall Study||23||
48419934|NCT01385098|101361803|FG000|NOT COMPLETED|Overall Study||14||
48419935|NCT04509024|101361804|FG000|STARTED|Overall Study||18||
48419936|NCT04509024|101361805|FG001|STARTED|Overall Study||17||
48419937|NCT04509024|101361806|FG002|STARTED|Overall Study||19||
48419938|NCT04509024|101361807|FG003|STARTED|Overall Study||17||
48419939|NCT04509024|101361808|FG004|STARTED|Overall Study||18||
48419940|NCT04509024|101361809|FG005|STARTED|Overall Study||17||
48419941|NCT04509024|101361804|FG000|COMPLETED|Overall Study||18||
48419942|NCT04509024|101361805|FG001|COMPLETED|Overall Study||17||
48419943|NCT04509024|101361806|FG002|COMPLETED|Overall Study||19||
48419944|NCT04509024|101361807|FG003|COMPLETED|Overall Study||17||
48763470|NCT05316597|102208733|FG000|COMPLETED|Washout Period||18||
48763471|NCT05316597|102208734|FG001|COMPLETED|Washout Period||13||
48763472|NCT05316597|102208733|FG000|NOT COMPLETED|Washout Period||3||
48763473|NCT05316597|102208734|FG001|NOT COMPLETED|Washout Period||8||
48763474|NCT05316597|102208733|FG000|STARTED|Second Session||18||
48763475|NCT05316597|102208734|FG001|STARTED|Second Session||13||
48359041|NCT01004107|101207522|FG000|COMPLETED|Overall Study||75||
48359042|NCT01004107|101207523|FG001|COMPLETED|Overall Study||23||
48359043|NCT01004107|101207522|FG000|NOT COMPLETED|Overall Study||1||
48359044|NCT01004107|101207523|FG001|NOT COMPLETED|Overall Study||2||
48359045|NCT03952130|101207524|FG000|STARTED|Overall Study||178||
48359046|NCT03952130|101207525|FG001|STARTED|Overall Study||176||
48359047|NCT03952130|101207524|FG000|Received at Least One Dose of Study Drug|Overall Study||178||
48359048|NCT03952130|101207525|FG001|Received at Least One Dose of Study Drug|Overall Study||176||
48359049|NCT03952130|101207524|FG000|COMPLETED|Overall Study||176||
48359050|NCT03952130|101207525|FG001|COMPLETED|Overall Study||170||
48359051|NCT03952130|101207524|FG000|NOT COMPLETED|Overall Study||2||
48359052|NCT03952130|101207525|FG001|NOT COMPLETED|Overall Study||6||
48359053|NCT01318902|101207526|FG000|STARTED|Overall Study||6||
48763476|NCT05316597|102208733|FG000|COMPLETED|Second Session||18||
48359054|NCT01318902|101207527|FG001|STARTED|Overall Study||5||
48763477|NCT05316597|102208734|FG001|COMPLETED|Second Session||13||
48763478|NCT05316597|102208733|FG000|NOT COMPLETED|Second Session||0||
48359055|NCT01318902|101207528|FG002|STARTED|Overall Study||5||
48359056|NCT01318902|101207529|FG003|STARTED|Overall Study||11||
48359057|NCT01318902|101207526|FG000|COMPLETED|Overall Study||5|Completed=participants who completed maximum cycles per protocol and who had progressive disease.|
48359058|NCT01318902|101207527|FG001|COMPLETED|Overall Study||2|Completed=participants who completed maximum cycles per protocol and who had progressive disease.|
48359059|NCT01318902|101207528|FG002|COMPLETED|Overall Study||3|Completed=participants who completed maximum cycles per protocol and who had progressive disease.|
48359060|NCT01318902|101207529|FG003|COMPLETED|Overall Study||5|Completed=participants who completed maximum cycles per protocol and who had progressive disease.|
48359061|NCT01318902|101207526|FG000|NOT COMPLETED|Overall Study||1||
48359062|NCT01318902|101207527|FG001|NOT COMPLETED|Overall Study||3||
48359063|NCT01318902|101207528|FG002|NOT COMPLETED|Overall Study||2||
48359064|NCT01318902|101207529|FG003|NOT COMPLETED|Overall Study||6||
48359065|NCT04024228|101207530|FG000|STARTED|Overall Study||774|Randomized|
48763479|NCT05316597|102208734|FG001|NOT COMPLETED|Second Session||0||
48359066|NCT04024228|101207531|FG001|STARTED|Overall Study||765|Randomized|
48359067|NCT04024228|101207530|FG000|Vaccinated|Overall Study||772||
48419945|NCT04509024|101361808|FG004|COMPLETED|Overall Study||18||
48419946|NCT04509024|101361809|FG005|COMPLETED|Overall Study||17||
48419947|NCT04509024|101361804|FG000|NOT COMPLETED|Overall Study||0||
48419948|NCT04509024|101361805|FG001|NOT COMPLETED|Overall Study||0||
48419949|NCT04509024|101361806|FG002|NOT COMPLETED|Overall Study||0||
48419950|NCT04509024|101361807|FG003|NOT COMPLETED|Overall Study||0||
48419951|NCT04509024|101361808|FG004|NOT COMPLETED|Overall Study||0||
48359068|NCT04024228|101207531|FG001|Vaccinated|Overall Study||761||
48359069|NCT04024228|101207530|FG000|Full Analysis Set (FAS)|Overall Study||769|FAS included all randomized participants who received the study vaccine and had a post-vaccination blood sample.|
48359070|NCT04024228|101207531|FG001|Full Analysis Set (FAS)|Overall Study||758|FAS included all randomized participants who received the study vaccine and had a post-vaccination blood sample.|
48359071|NCT04024228|101207530|FG000|COMPLETED|Overall Study||770||
48359072|NCT04024228|101207531|FG001|COMPLETED|Overall Study||759||
48359073|NCT04024228|101207530|FG000|NOT COMPLETED|Overall Study||4||
48359074|NCT04024228|101207531|FG001|NOT COMPLETED|Overall Study||6||
48419952|NCT04509024|101361809|FG005|NOT COMPLETED|Overall Study||0||
48419953|NCT01513460|101361810|FG000|STARTED|Overall Study||258||
48419954|NCT01513460|101361811|FG001|STARTED|Overall Study||258||
48419955|NCT01513460|101361812|FG002|STARTED|Overall Study||257||
48419956|NCT01513460|101361810|FG000|Full Analysis Set|Overall Study||257||
48419957|NCT01513460|101361811|FG001|Full Analysis Set|Overall Study||258||
48419958|NCT01513460|101361812|FG002|Full Analysis Set|Overall Study||257||
48419959|NCT01513460|101361810|FG000|Per-protocol Set|Overall Study||196||
48419960|NCT01513460|101361811|FG001|Per-protocol Set|Overall Study||186||
48419961|NCT01513460|101361812|FG002|Per-protocol Set|Overall Study||166||
48419962|NCT01513460|101361810|FG000|COMPLETED|Overall Study||229||
48419963|NCT01513460|101361811|FG001|COMPLETED|Overall Study||226||
48419964|NCT01513460|101361812|FG002|COMPLETED|Overall Study||201||
48419965|NCT01513460|101361810|FG000|NOT COMPLETED|Overall Study||29||
48763480|NCT00385216|102208735|FG000|STARTED|First Intervention||11||
48763481|NCT00385216|102208736|FG001|STARTED|First Intervention||9||
48763482|NCT00385216|102208735|FG000|COMPLETED|First Intervention||11||
48763483|NCT00385216|102208736|FG001|COMPLETED|First Intervention||9||
48763484|NCT00385216|102208735|FG000|NOT COMPLETED|First Intervention||0||
48763485|NCT00385216|102208736|FG001|NOT COMPLETED|First Intervention||0||
48763486|NCT00385216|102208735|FG000|STARTED|Second Intervention||11||
48763487|NCT00385216|102208736|FG001|STARTED|Second Intervention||9||
48763488|NCT00385216|102208735|FG000|COMPLETED|Second Intervention||11||
48359075|NCT01954628|101207532|FG000|STARTED|Overall Study||200||
48359076|NCT01954628|101207533|FG001|STARTED|Overall Study||200||
48359077|NCT01954628|101207532|FG000|Full Analysis Set (FAS)|Overall Study||200||
48419966|NCT01513460|101361811|FG001|NOT COMPLETED|Overall Study||32||
48419967|NCT01513460|101361812|FG002|NOT COMPLETED|Overall Study||56||
48419968|NCT00283062|101361813|FG000|STARTED|Overall Study||55||
48419969|NCT00283062|101361814|FG001|STARTED|Overall Study||55||
48419970|NCT00283062|101361815|FG002|STARTED|Overall Study||56||
48419971|NCT00283062|101361816|FG003|STARTED|Overall Study||62||
48419972|NCT00283062|101361813|FG000|ADMINISTERED STUDY TREATMENT|Overall Study||50||
48419973|NCT00283062|101361814|FG001|ADMINISTERED STUDY TREATMENT|Overall Study||51||
48419974|NCT00283062|101361815|FG002|ADMINISTERED STUDY TREATMENT|Overall Study||20||
48419975|NCT00283062|101361816|FG003|ADMINISTERED STUDY TREATMENT|Overall Study||17||
48419976|NCT00283062|101361813|FG000|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||44||
48419977|NCT00283062|101361814|FG001|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||48||
48419978|NCT00283062|101361815|FG002|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||15||
48419979|NCT00283062|101361816|FG003|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||13||
48419980|NCT00283062|101361813|FG000|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||43||
48419981|NCT00283062|101361814|FG001|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||0||
48419982|NCT00283062|101361815|FG002|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||15||
48419983|NCT00283062|101361816|FG003|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||0||
48419984|NCT00283062|101361813|FG000|COMPLETED|Overall Study||43||
48419985|NCT00283062|101361814|FG001|COMPLETED|Overall Study||48||
48419986|NCT00283062|101361815|FG002|COMPLETED|Overall Study||15||
48763489|NCT00385216|102208736|FG001|COMPLETED|Second Intervention||9||
48763490|NCT00385216|102208735|FG000|NOT COMPLETED|Second Intervention||0||
48763491|NCT00385216|102208736|FG001|NOT COMPLETED|Second Intervention||0||
48763492|NCT03902418|102208737|FG000|STARTED|Overall Study||1195||
48763493|NCT03902418|102208737|FG000|COMPLETED|Overall Study||1092||
48763494|NCT03902418|102208737|FG000|NOT COMPLETED|Overall Study||103||
48763495|NCT02170376|102208738|FG000|STARTED|Overall Study||16||
48763496|NCT02170376|102208739|FG001|STARTED|Overall Study||16||
48763497|NCT02170376|102208740|FG002|STARTED|Overall Study||16||
48763498|NCT02170376|102208741|FG003|STARTED|Overall Study||16||
48359078|NCT01954628|101207533|FG001|Full Analysis Set (FAS)|Overall Study||198||
48359079|NCT01954628|101207532|FG000|Safety Set|Overall Study||200||
48359080|NCT01954628|101207533|FG001|Safety Set|Overall Study||200||
48359081|NCT01954628|101207532|FG000|Pharmacokinetic Population|Overall Study||181||
48419987|NCT00283062|101361816|FG003|COMPLETED|Overall Study||13||
48419988|NCT00283062|101361813|FG000|NOT COMPLETED|Overall Study||12||
48419989|NCT00283062|101361814|FG001|NOT COMPLETED|Overall Study||7||
48419990|NCT00283062|101361815|FG002|NOT COMPLETED|Overall Study||41||
48419991|NCT00283062|101361816|FG003|NOT COMPLETED|Overall Study||49||
48763499|NCT02170376|102208742|FG004|STARTED|Overall Study||16||
48763500|NCT02170376|102208738|FG000|Pharmacokinetic Population|Overall Study||16||
48763501|NCT02170376|102208739|FG001|Pharmacokinetic Population|Overall Study||15||
48419992|NCT01143116|101361817|FG000|STARTED|Overall Study||10||
48419993|NCT01143116|101361818|FG001|STARTED|Overall Study||10||
48419994|NCT01143116|101361817|FG000|COMPLETED|Overall Study||10||
48419995|NCT01143116|101361818|FG001|COMPLETED|Overall Study||10||
48419996|NCT01143116|101361817|FG000|NOT COMPLETED|Overall Study||0||
48419997|NCT01143116|101361818|FG001|NOT COMPLETED|Overall Study||0||
48419998|NCT02394457|101361819|FG000|STARTED|Overall Study||15||
48419999|NCT02394457|101361820|FG001|STARTED|Overall Study||13||
48420000|NCT02394457|101361819|FG000|COMPLETED|Overall Study||15||
48420001|NCT02394457|101361820|FG001|COMPLETED|Overall Study||13||
48420002|NCT02394457|101361819|FG000|NOT COMPLETED|Overall Study||0||
48420003|NCT02394457|101361820|FG001|NOT COMPLETED|Overall Study||0||
48420004|NCT01482598|101361821|FG000|STARTED|Overall Study||66|1st subject was enrolled on 19th October 2011|
48420005|NCT01482598|101361822|FG001|STARTED|Overall Study||73|1st subject was enrolled on 19th October 2011|
48420006|NCT01482598|101361821|FG000|COMPLETED|Overall Study||50|last subject was enrolled on 9th June 2014|
48420007|NCT01482598|101361822|FG001|COMPLETED|Overall Study||51|last subject was enrolled on 9th June 2014|
48420008|NCT01482598|101361821|FG000|NOT COMPLETED|Overall Study||16||
48420009|NCT01482598|101361822|FG001|NOT COMPLETED|Overall Study||22||
48420010|NCT04097925|101361823|FG000|STARTED|Overall Study||30||
48420011|NCT04097925|101361823|FG000|COMPLETED|Overall Study||29||
48420012|NCT04097925|101361823|FG000|NOT COMPLETED|Overall Study||1||
48420013|NCT01488994|101361824|FG000|STARTED|Overall Study||11||
48359082|NCT01954628|101207533|FG001|Pharmacokinetic Population|Overall Study||0||
48359083|NCT01954628|101207532|FG000|US 6 Month Ophthalmology Safety Visit|Overall Study||37||
48359084|NCT01954628|101207533|FG001|US 6 Month Ophthalmology Safety Visit|Overall Study||32||
48359085|NCT01954628|101207532|FG000|COMPLETED|Overall Study||169||
48359086|NCT01954628|101207533|FG001|COMPLETED|Overall Study||173||
48359087|NCT01954628|101207532|FG000|NOT COMPLETED|Overall Study||31||
48359088|NCT01954628|101207533|FG001|NOT COMPLETED|Overall Study||27||
48359089|NCT03598777|101207534|FG000|STARTED|Overall Study||13||
48359090|NCT03598777|101207535|FG001|STARTED|Overall Study||8||
48359091|NCT03598777|101207536|FG002|STARTED|Overall Study||8||
48359092|NCT03598777|101207537|FG003|STARTED|Overall Study||14||
48359093|NCT03598777|101207538|FG004|STARTED|Overall Study||17||
48359094|NCT03598777|101207534|FG000|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||13||
48359095|NCT03598777|101207535|FG001|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||8||
48359096|NCT03598777|101207536|FG002|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||8||
48420014|NCT01488994|101361825|FG001|STARTED|Overall Study||12||
48420015|NCT01488994|101361824|FG000|COMPLETED|Overall Study||11||
48420016|NCT01488994|101361825|FG001|COMPLETED|Overall Study||11||
48638834|NCT02711137|101901508|FG004|NOT COMPLETED|Overall Study||5||
48638835|NCT02711137|101901509|FG005|NOT COMPLETED|Overall Study||1||
48638836|NCT02711137|101901510|FG006|NOT COMPLETED|Overall Study||86||
48359097|NCT03598777|101207537|FG003|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||14||
48359098|NCT03598777|101207538|FG004|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||17||
48359099|NCT03598777|101207534|FG000|Retreated in Cycle 2 OL Treatment Period|Overall Study||13||
48359100|NCT03598777|101207535|FG001|Retreated in Cycle 2 OL Treatment Period|Overall Study||7||
48359101|NCT03598777|101207536|FG002|Retreated in Cycle 2 OL Treatment Period|Overall Study||8||
48359102|NCT03598777|101207537|FG003|Retreated in Cycle 2 OL Treatment Period|Overall Study||13||
48359103|NCT03598777|101207538|FG004|Retreated in Cycle 2 OL Treatment Period|Overall Study||11||
48359104|NCT03598777|101207534|FG000|Retreated in Cycle 3 OL Treatment Period|Overall Study||8||
48359105|NCT03598777|101207535|FG001|Retreated in Cycle 3 OL Treatment Period|Overall Study||6||
48359106|NCT03598777|101207536|FG002|Retreated in Cycle 3 OL Treatment Period|Overall Study||6||
48359107|NCT03598777|101207537|FG003|Retreated in Cycle 3 OL Treatment Period|Overall Study||12||
48420017|NCT01488994|101361824|FG000|NOT COMPLETED|Overall Study||0||
48420018|NCT01488994|101361825|FG001|NOT COMPLETED|Overall Study||1||
48420019|NCT03525613|101361826|FG000|STARTED|Overall Study||213||
48420020|NCT03525613|101361827|FG001|STARTED|Overall Study||212||
48420021|NCT03525613|101361828|FG002|STARTED|Overall Study||106||
48638837|NCT02711137|101901511|FG007|NOT COMPLETED|Overall Study||5||
48638838|NCT02711137|101901512|FG008|NOT COMPLETED|Overall Study||1||
48638839|NCT02711137|101901513|FG009|NOT COMPLETED|Overall Study||2||
48638840|NCT02711137|101901514|FG010|NOT COMPLETED|Overall Study||4||
48763502|NCT02170376|102208740|FG002|Pharmacokinetic Population|Overall Study||16||
48359108|NCT03598777|101207538|FG004|Retreated in Cycle 3 OL Treatment Period|Overall Study||2||
48359109|NCT03598777|101207534|FG000|Retreated in Cycle 4 OL Treatment Period|Overall Study||1||
48359110|NCT03598777|101207535|FG001|Retreated in Cycle 4 OL Treatment Period|Overall Study||0||
48359111|NCT03598777|101207536|FG002|Retreated in Cycle 4 OL Treatment Period|Overall Study||1||
48359112|NCT03598777|101207537|FG003|Retreated in Cycle 4 OL Treatment Period|Overall Study||3||
48359113|NCT03598777|101207538|FG004|Retreated in Cycle 4 OL Treatment Period|Overall Study||0||
48359114|NCT03598777|101207534|FG000|COMPLETED|Overall Study||7||
48359115|NCT03598777|101207535|FG001|COMPLETED|Overall Study||7||
48359116|NCT03598777|101207536|FG002|COMPLETED|Overall Study||8||
48359117|NCT03598777|101207537|FG003|COMPLETED|Overall Study||14||
48359118|NCT03598777|101207538|FG004|COMPLETED|Overall Study||2||
48420022|NCT03525613|101361829|FG003|STARTED|Overall Study||106||
48763503|NCT02170376|102208741|FG003|Pharmacokinetic Population|Overall Study||16||
48763504|NCT02170376|102208742|FG004|Pharmacokinetic Population|Overall Study||16||
48763505|NCT02170376|102208738|FG000|COMPLETED|Overall Study||16||
48763506|NCT02170376|102208739|FG001|COMPLETED|Overall Study||15||
48359119|NCT03598777|101207534|FG000|NOT COMPLETED|Overall Study||6||
48359120|NCT03598777|101207535|FG001|NOT COMPLETED|Overall Study||1||
48359121|NCT03598777|101207536|FG002|NOT COMPLETED|Overall Study||0||
48359122|NCT03598777|101207537|FG003|NOT COMPLETED|Overall Study||0||
48359123|NCT03598777|101207538|FG004|NOT COMPLETED|Overall Study||15||
48359124|NCT02282332|101207539|FG000|STARTED|Overall Study||0||
48359125|NCT02282332|101207539|FG000|COMPLETED|Overall Study||0||
48359126|NCT02282332|101207539|FG000|NOT COMPLETED|Overall Study||0||
48359127|NCT04243369|101207540|FG000|STARTED|Overall Study||30||
48359128|NCT04243369|101207540|FG000|COMPLETED|Overall Study||30||
48359129|NCT04243369|101207540|FG000|NOT COMPLETED|Overall Study||0||
48359130|NCT02640612|101207541|FG000|STARTED|Overall Study||225||
48359131|NCT02640612|101207542|FG001|STARTED|Overall Study||103||
48359132|NCT02640612|101207543|FG002|STARTED|Overall Study||102||
48359133|NCT02640612|101207541|FG000|COMPLETED|Overall Study||203||
48359134|NCT02640612|101207542|FG001|COMPLETED|Overall Study||89||
48359135|NCT02640612|101207543|FG002|COMPLETED|Overall Study||96||
48359136|NCT02640612|101207541|FG000|NOT COMPLETED|Overall Study||22||
48359137|NCT02640612|101207542|FG001|NOT COMPLETED|Overall Study||14||
48359138|NCT02640612|101207543|FG002|NOT COMPLETED|Overall Study||6||
48359139|NCT03320512|101207544|FG000|STARTED|Overall Study||82||
48359140|NCT03320512|101207545|FG001|STARTED|Overall Study||81||
48359141|NCT03320512|101207546|FG002|STARTED|Overall Study||83||
48359142|NCT03320512|101207544|FG000|Month 3 Survey Started|Overall Study||69||
48359143|NCT03320512|101207545|FG001|Month 3 Survey Started|Overall Study||72||
48359144|NCT03320512|101207546|FG002|Month 3 Survey Started|Overall Study||71||
48359145|NCT03320512|101207544|FG000|Month 3 Survey Completed|Overall Study||69||
48359146|NCT03320512|101207545|FG001|Month 3 Survey Completed|Overall Study||72||
48359147|NCT03320512|101207546|FG002|Month 3 Survey Completed|Overall Study||68||
48359148|NCT03320512|101207544|FG000|Month 3 Lab Sample Collected|Overall Study||51||
48359149|NCT03320512|101207545|FG001|Month 3 Lab Sample Collected|Overall Study||54||
48359150|NCT03320512|101207546|FG002|Month 3 Lab Sample Collected|Overall Study||51||
48359151|NCT03320512|101207544|FG000|Month 6 Survey Started|Overall Study||67||
48359152|NCT03320512|101207545|FG001|Month 6 Survey Started|Overall Study||72||
48359153|NCT03320512|101207546|FG002|Month 6 Survey Started|Overall Study||69||
48359154|NCT03320512|101207544|FG000|Month 6 Survey Completed|Overall Study||65||
48359155|NCT03320512|101207545|FG001|Month 6 Survey Completed|Overall Study||71||
48359156|NCT03320512|101207546|FG002|Month 6 Survey Completed|Overall Study||68||
48359157|NCT03320512|101207544|FG000|Month 6 Lab Sample Collected|Overall Study||53||
48359158|NCT03320512|101207545|FG001|Month 6 Lab Sample Collected|Overall Study||59||
48359159|NCT03320512|101207546|FG002|Month 6 Lab Sample Collected|Overall Study||51||
48359160|NCT03320512|101207544|FG000|COMPLETED|Overall Study||82||
48359161|NCT03320512|101207545|FG001|COMPLETED|Overall Study||81||
48359162|NCT03320512|101207546|FG002|COMPLETED|Overall Study||83||
48359163|NCT03320512|101207544|FG000|NOT COMPLETED|Overall Study||0||
48359164|NCT03320512|101207545|FG001|NOT COMPLETED|Overall Study||0||
48359165|NCT03320512|101207546|FG002|NOT COMPLETED|Overall Study||0||
48359166|NCT03881163|101207547|FG000|STARTED|Overall Study||24||
48359167|NCT03881163|101207547|FG000|COMPLETED|Overall Study||24||
48359168|NCT03881163|101207547|FG000|NOT COMPLETED|Overall Study||0||
48763507|NCT02170376|102208740|FG002|COMPLETED|Overall Study||16||
48763508|NCT02170376|102208741|FG003|COMPLETED|Overall Study||16||
48763509|NCT02170376|102208742|FG004|COMPLETED|Overall Study||16||
48763510|NCT02170376|102208738|FG000|NOT COMPLETED|Overall Study||0||
48763511|NCT02170376|102208739|FG001|NOT COMPLETED|Overall Study||1||
48763512|NCT02170376|102208740|FG002|NOT COMPLETED|Overall Study||0||
48763513|NCT02170376|102208741|FG003|NOT COMPLETED|Overall Study||0||
48763514|NCT02170376|102208742|FG004|NOT COMPLETED|Overall Study||0||
48763515|NCT04386291|102208743|FG000|STARTED|Overall Study||83||
48763516|NCT04386291|102208744|FG001|STARTED|Overall Study||88||
48763517|NCT04386291|102208745|FG002|STARTED|Overall Study||85||
48359169|NCT02128490|101207548|FG000|STARTED|Overall Study||38||
48359170|NCT02128490|101207549|FG001|STARTED|Overall Study||37||
48359171|NCT02128490|101207550|FG002|STARTED|Overall Study||39||
48359172|NCT02128490|101207551|FG003|STARTED|Overall Study||37||
48359173|NCT02128490|101207552|FG004|STARTED|Overall Study||38||
48359174|NCT02128490|101207548|FG000|COMPLETED|Overall Study||33||
48359175|NCT02128490|101207549|FG001|COMPLETED|Overall Study||31||
48359176|NCT02128490|101207550|FG002|COMPLETED|Overall Study||34||
48359177|NCT02128490|101207551|FG003|COMPLETED|Overall Study||31||
48359178|NCT02128490|101207552|FG004|COMPLETED|Overall Study||31||
48359179|NCT02128490|101207548|FG000|NOT COMPLETED|Overall Study||5||
48359180|NCT02128490|101207549|FG001|NOT COMPLETED|Overall Study||6||
48359181|NCT02128490|101207550|FG002|NOT COMPLETED|Overall Study||5||
48359182|NCT02128490|101207551|FG003|NOT COMPLETED|Overall Study||6||
48359183|NCT02128490|101207552|FG004|NOT COMPLETED|Overall Study||7||
48359184|NCT00552305|101207553|FG000|STARTED|Overall Study||370||
48359185|NCT00552305|101207553|FG000|COMPLETED|Overall Study||120||
48359186|NCT00552305|101207553|FG000|NOT COMPLETED|Overall Study||250||
48359187|NCT01716169|101207554|FG000|STARTED|Overall Study||10||
48359188|NCT01716169|101207554|FG000|Standard of Care Dressings Used|Overall Study||7||
48359189|NCT01716169|101207554|FG000|COMPLETED|Overall Study||6||
48359190|NCT01716169|101207554|FG000|NOT COMPLETED|Overall Study||4||
48359191|NCT00686205|101207555|FG000|STARTED|Overall Study||21606||
48359192|NCT00686205|101207556|FG001|STARTED|Overall Study||2505||
48359193|NCT00686205|101207555|FG000|COMPLETED|Overall Study||15599||
48359194|NCT00686205|101207556|FG001|COMPLETED|Overall Study||1524||
48359195|NCT00686205|101207555|FG000|NOT COMPLETED|Overall Study||6007||
48359196|NCT00686205|101207556|FG001|NOT COMPLETED|Overall Study||981||
48359197|NCT04814823|101207557|FG000|STARTED|Overall Study||13||
48359198|NCT04814823|101207557|FG000|COMPLETED|Overall Study||11||
48359199|NCT04814823|101207557|FG000|NOT COMPLETED|Overall Study||2||
48359200|NCT01119040|101207558|FG000|STARTED|Overall Study||1||
48359201|NCT01119040|101207558|FG000|COMPLETED|Overall Study||0||
48420023|NCT03525613|101361826|FG000|COMPLETED|Overall Study||144||
48420024|NCT03525613|101361827|FG001|COMPLETED|Overall Study||169||
48420025|NCT03525613|101361828|FG002|COMPLETED|Overall Study||76||
48420026|NCT03525613|101361829|FG003|COMPLETED|Overall Study||82||
48420027|NCT03525613|101361826|FG000|NOT COMPLETED|Overall Study||69||
48420028|NCT03525613|101361827|FG001|NOT COMPLETED|Overall Study||43||
48420029|NCT03525613|101361828|FG002|NOT COMPLETED|Overall Study||30||
48420030|NCT03525613|101361829|FG003|NOT COMPLETED|Overall Study||24||
48420031|NCT01535638|101361830|FG000|STARTED|Treatment 1 (Single Dose)||3||
48420032|NCT01535638|101361831|FG001|STARTED|Treatment 1 (Single Dose)||3||
48420033|NCT01535638|101361832|FG002|STARTED|Treatment 1 (Single Dose)||3||
48420034|NCT01535638|101361833|FG003|STARTED|Treatment 1 (Single Dose)||3||
48420035|NCT01535638|101361834|FG004|STARTED|Treatment 1 (Single Dose)||3||
48420036|NCT01535638|101361835|FG005|STARTED|Treatment 1 (Single Dose)||3||
48420037|NCT01535638|101361830|FG000|COMPLETED|Treatment 1 (Single Dose)||3||
48420038|NCT01535638|101361831|FG001|COMPLETED|Treatment 1 (Single Dose)||3||
48420039|NCT01535638|101361832|FG002|COMPLETED|Treatment 1 (Single Dose)||3||
48420040|NCT01535638|101361833|FG003|COMPLETED|Treatment 1 (Single Dose)||3||
48420041|NCT01535638|101361834|FG004|COMPLETED|Treatment 1 (Single Dose)||3||
48420042|NCT01535638|101361835|FG005|COMPLETED|Treatment 1 (Single Dose)||2||
48420043|NCT01535638|101361830|FG000|NOT COMPLETED|Treatment 1 (Single Dose)||0||
48420044|NCT01535638|101361831|FG001|NOT COMPLETED|Treatment 1 (Single Dose)||0||
48420045|NCT01535638|101361832|FG002|NOT COMPLETED|Treatment 1 (Single Dose)||0||
48420046|NCT01535638|101361833|FG003|NOT COMPLETED|Treatment 1 (Single Dose)||0||
48420047|NCT01535638|101361834|FG004|NOT COMPLETED|Treatment 1 (Single Dose)||0||
48420048|NCT01535638|101361835|FG005|NOT COMPLETED|Treatment 1 (Single Dose)||1||
48420049|NCT01535638|101361830|FG000|STARTED|Treatment 2 (Single Dose)||3||
48420050|NCT01535638|101361831|FG001|STARTED|Treatment 2 (Single Dose)||3||
48420051|NCT01535638|101361832|FG002|STARTED|Treatment 2 (Single Dose)||3||
48420052|NCT01535638|101361833|FG003|STARTED|Treatment 2 (Single Dose)||3||
48420053|NCT01535638|101361834|FG004|STARTED|Treatment 2 (Single Dose)||3||
48420054|NCT01535638|101361835|FG005|STARTED|Treatment 2 (Single Dose)||2||
48420055|NCT01535638|101361830|FG000|COMPLETED|Treatment 2 (Single Dose)||3||
48420056|NCT01535638|101361831|FG001|COMPLETED|Treatment 2 (Single Dose)||3||
48420057|NCT01535638|101361832|FG002|COMPLETED|Treatment 2 (Single Dose)||3||
48420058|NCT01535638|101361833|FG003|COMPLETED|Treatment 2 (Single Dose)||3||
48420059|NCT01535638|101361834|FG004|COMPLETED|Treatment 2 (Single Dose)||3||
48420060|NCT01535638|101361835|FG005|COMPLETED|Treatment 2 (Single Dose)||2||
48420061|NCT01535638|101361830|FG000|NOT COMPLETED|Treatment 2 (Single Dose)||0||
48420062|NCT01535638|101361831|FG001|NOT COMPLETED|Treatment 2 (Single Dose)||0||
48420063|NCT01535638|101361832|FG002|NOT COMPLETED|Treatment 2 (Single Dose)||0||
48420064|NCT01535638|101361833|FG003|NOT COMPLETED|Treatment 2 (Single Dose)||0||
48420065|NCT01535638|101361834|FG004|NOT COMPLETED|Treatment 2 (Single Dose)||0||
48420066|NCT01535638|101361835|FG005|NOT COMPLETED|Treatment 2 (Single Dose)||0||
48420067|NCT01535638|101361830|FG000|STARTED|Treatment 3 (Single Dose)||3||
48420068|NCT01535638|101361831|FG001|STARTED|Treatment 3 (Single Dose)||3||
48420069|NCT01535638|101361832|FG002|STARTED|Treatment 3 (Single Dose)||3||
48359202|NCT01119040|101207558|FG000|NOT COMPLETED|Overall Study||1||
48359203|NCT05134974|101207559|FG000|STARTED|Overall Study||124||
48359204|NCT05134974|101207560|FG001|STARTED|Overall Study||244||
48359205|NCT05134974|101207559|FG000|COMPLETED|Overall Study||124||
48359206|NCT05134974|101207560|FG001|COMPLETED|Overall Study||244||
48420070|NCT01535638|101361833|FG003|STARTED|Treatment 3 (Single Dose)||3||
48420071|NCT01535638|101361834|FG004|STARTED|Treatment 3 (Single Dose)||3||
48420072|NCT01535638|101361835|FG005|STARTED|Treatment 3 (Single Dose)||2||
48420073|NCT01535638|101361830|FG000|COMPLETED|Treatment 3 (Single Dose)||3||
48420074|NCT01535638|101361831|FG001|COMPLETED|Treatment 3 (Single Dose)||3||
48420075|NCT01535638|101361832|FG002|COMPLETED|Treatment 3 (Single Dose)||3||
48420076|NCT01535638|101361833|FG003|COMPLETED|Treatment 3 (Single Dose)||2||
48420077|NCT01535638|101361834|FG004|COMPLETED|Treatment 3 (Single Dose)||3||
48359207|NCT05134974|101207559|FG000|NOT COMPLETED|Overall Study||0||
48359208|NCT05134974|101207560|FG001|NOT COMPLETED|Overall Study||0||
48359209|NCT03557372|101207561|FG000|STARTED|Overall Study||14||
48420078|NCT01535638|101361835|FG005|COMPLETED|Treatment 3 (Single Dose)||2||
48420079|NCT01535638|101361830|FG000|NOT COMPLETED|Treatment 3 (Single Dose)||0||
48420080|NCT01535638|101361831|FG001|NOT COMPLETED|Treatment 3 (Single Dose)||0||
48420081|NCT01535638|101361832|FG002|NOT COMPLETED|Treatment 3 (Single Dose)||0||
48420082|NCT01535638|101361833|FG003|NOT COMPLETED|Treatment 3 (Single Dose)||1||
48420083|NCT01535638|101361834|FG004|NOT COMPLETED|Treatment 3 (Single Dose)||0||
48420084|NCT01535638|101361835|FG005|NOT COMPLETED|Treatment 3 (Single Dose)||0||
48420085|NCT00527722|101361836|FG000|STARTED|Overall Study||22||
48420086|NCT00527722|101361837|FG001|STARTED|Overall Study||25||
48420087|NCT00527722|101361836|FG000|COMPLETED|Overall Study||22||
48420088|NCT00527722|101361837|FG001|COMPLETED|Overall Study||25||
48420089|NCT00527722|101361836|FG000|NOT COMPLETED|Overall Study||0||
48420090|NCT00527722|101361837|FG001|NOT COMPLETED|Overall Study||0||
48420091|NCT03474380|101361838|FG000|STARTED|Month 1-6||70||2
48420092|NCT03474380|101361839|FG001|STARTED|Month 1-6||111||2
48420093|NCT03474380|101361840|FG002|STARTED|Month 1-6||0||0
48420094|NCT03474380|101361841|FG003|STARTED|Month 1-6||0||0
48420095|NCT03474380|101361838|FG000|Veterans|Month 1-6||42||2
48420096|NCT03474380|101361839|FG001|Veterans|Month 1-6||77||2
48420097|NCT03474380|101361840|FG002|Veterans|Month 1-6||0||0
48420098|NCT03474380|101361841|FG003|Veterans|Month 1-6||0||0
48420099|NCT03474380|101361838|FG000|Caregivers Started|Month 1-6||18||2
48420100|NCT03474380|101361839|FG001|Caregivers Started|Month 1-6||34||2
48420101|NCT03474380|101361840|FG002|Caregivers Started|Month 1-6||0||0
48420102|NCT03474380|101361841|FG003|Caregivers Started|Month 1-6||0||0
48420103|NCT03474380|101361838|FG000|Caregivers Completed|Month 1-6||13||2
48420104|NCT03474380|101361839|FG001|Caregivers Completed|Month 1-6||28||2
48420105|NCT03474380|101361840|FG002|Caregivers Completed|Month 1-6||0||0
48420106|NCT03474380|101361841|FG003|Caregivers Completed|Month 1-6||0||0
48420107|NCT03474380|101361838|FG000|Providers Pre-Implementation|Month 1-6||10||2
48420108|NCT03474380|101361839|FG001|Providers Pre-Implementation|Month 1-6||0||0
48420109|NCT03474380|101361840|FG002|Providers Pre-Implementation|Month 1-6||0||0
48420110|NCT03474380|101361841|FG003|Providers Pre-Implementation|Month 1-6||0||0
48420111|NCT03474380|101361838|FG000|Providers Post-Implementation|Month 1-6||0||0
48420112|NCT03474380|101361839|FG001|Providers Post-Implementation|Month 1-6||0||0
48420113|NCT03474380|101361840|FG002|Providers Post-Implementation|Month 1-6||0||0
48420114|NCT03474380|101361841|FG003|Providers Post-Implementation|Month 1-6||0||0
48420115|NCT03474380|101361838|FG000|COMPLETED|Month 1-6||65||2
48420116|NCT03474380|101361839|FG001|COMPLETED|Month 1-6||105||2
48420117|NCT03474380|101361840|FG002|COMPLETED|Month 1-6||0||0
48420118|NCT03474380|101361841|FG003|COMPLETED|Month 1-6||0||0
48420119|NCT03474380|101361838|FG000|NOT COMPLETED|Month 1-6||5||0
48420120|NCT03474380|101361839|FG001|NOT COMPLETED|Month 1-6||6||0
48420121|NCT03474380|101361840|FG002|NOT COMPLETED|Month 1-6||0||0
48420122|NCT03474380|101361841|FG003|NOT COMPLETED|Month 1-6||0||0
48420123|NCT03474380|101361838|FG000|STARTED|Month 7-12||79||2
48420124|NCT03474380|101361839|FG001|STARTED|Month 7-12||102||2
48420125|NCT03474380|101361840|FG002|STARTED|Month 7-12||0||0
48420126|NCT03474380|101361841|FG003|STARTED|Month 7-12||0||0
48420127|NCT03474380|101361838|FG000|Veterans|Month 7-12||55||2
48420128|NCT03474380|101361839|FG001|Veterans|Month 7-12||61||2
48420129|NCT03474380|101361840|FG002|Veterans|Month 7-12||0||0
48420130|NCT03474380|101361841|FG003|Veterans|Month 7-12||0||0
48420131|NCT03474380|101361838|FG000|Caregiver Started|Month 7-12||22||2
48420132|NCT03474380|101361839|FG001|Caregiver Started|Month 7-12||34||2
48420133|NCT03474380|101361840|FG002|Caregiver Started|Month 7-12||0||0
48420134|NCT03474380|101361841|FG003|Caregiver Started|Month 7-12||0||0
48420135|NCT03474380|101361838|FG000|Caregiver Completed|Month 7-12||17||2
48420136|NCT03474380|101361839|FG001|Caregiver Completed|Month 7-12||28||2
48420137|NCT03474380|101361840|FG002|Caregiver Completed|Month 7-12||0||0
48420138|NCT03474380|101361841|FG003|Caregiver Completed|Month 7-12||0||0
48420139|NCT03474380|101361838|FG000|Providers Pre-Implementation|Month 7-12||0||0
48420140|NCT03474380|101361839|FG001|Providers Pre-Implementation|Month 7-12||7||2
48420141|NCT03474380|101361840|FG002|Providers Pre-Implementation|Month 7-12||0||0
48420142|NCT03474380|101361841|FG003|Providers Pre-Implementation|Month 7-12||0||0
48420143|NCT03474380|101361838|FG000|Providers Post-Implementation|Month 7-12||2||2
48420144|NCT03474380|101361839|FG001|Providers Post-Implementation|Month 7-12||0||0
48420145|NCT03474380|101361840|FG002|Providers Post-Implementation|Month 7-12||0||0
48420146|NCT03474380|101361841|FG003|Providers Post-Implementation|Month 7-12||0||0
48420147|NCT03474380|101361838|FG000|COMPLETED|Month 7-12||74||2
48420148|NCT03474380|101361839|FG001|COMPLETED|Month 7-12||96||2
48420149|NCT03474380|101361840|FG002|COMPLETED|Month 7-12||0||0
48420150|NCT03474380|101361841|FG003|COMPLETED|Month 7-12||0||0
48420151|NCT03474380|101361838|FG000|NOT COMPLETED|Month 7-12||5||0
48420152|NCT03474380|101361839|FG001|NOT COMPLETED|Month 7-12||6||0
48420153|NCT03474380|101361840|FG002|NOT COMPLETED|Month 7-12||0||0
48420154|NCT03474380|101361841|FG003|NOT COMPLETED|Month 7-12||0||0
48420155|NCT03474380|101361838|FG000|STARTED|Month 13-18||94||2
48420156|NCT03474380|101361839|FG001|STARTED|Month 13-18||87||2
48420157|NCT03474380|101361840|FG002|STARTED|Month 13-18||93||2
48420158|NCT03474380|101361841|FG003|STARTED|Month 13-18||70||2
48420159|NCT03474380|101361838|FG000|Veterans|Month 13-18||67||2
48420160|NCT03474380|101361839|FG001|Veterans|Month 13-18||58||2
48420161|NCT03474380|101361840|FG002|Veterans|Month 13-18||52||2
48420162|NCT03474380|101361841|FG003|Veterans|Month 13-18||43||2
48420163|NCT03474380|101361838|FG000|Caregiver Started|Month 13-18||27||2
48420164|NCT03474380|101361839|FG001|Caregiver Started|Month 13-18||28||2
48420165|NCT03474380|101361840|FG002|Caregiver Started|Month 13-18||31||2
48420166|NCT03474380|101361841|FG003|Caregiver Started|Month 13-18||27||2
48420167|NCT03474380|101361838|FG000|Caregiver Completed|Month 13-18||19||2
48420168|NCT03474380|101361839|FG001|Caregiver Completed|Month 13-18||23||2
48420169|NCT03474380|101361840|FG002|Caregiver Completed|Month 13-18||21||2
48420170|NCT03474380|101361841|FG003|Caregiver Completed|Month 13-18||25||2
48420171|NCT03474380|101361838|FG000|Providers Pre-Implementation|Month 13-18||0||0
48420172|NCT03474380|101361839|FG001|Providers Pre-Implementation|Month 13-18||0||0
48420173|NCT03474380|101361840|FG002|Providers Pre-Implementation|Month 13-18||10||2
48420174|NCT03474380|101361841|FG003|Providers Pre-Implementation|Month 13-18||0||0
48420175|NCT03474380|101361838|FG000|Providers Post-Implementation|Month 13-18||0||0
48420176|NCT03474380|101361839|FG001|Providers Post-Implementation|Month 13-18||1||2
48420177|NCT03474380|101361840|FG002|Providers Post-Implementation|Month 13-18||0||0
48420178|NCT03474380|101361841|FG003|Providers Post-Implementation|Month 13-18||0||0
48420179|NCT03474380|101361838|FG000|COMPLETED|Month 13-18||86||2
48420180|NCT03474380|101361839|FG001|COMPLETED|Month 13-18||82||2
48420181|NCT03474380|101361840|FG002|COMPLETED|Month 13-18||83||2
48420182|NCT03474380|101361841|FG003|COMPLETED|Month 13-18||68||2
48359210|NCT03557372|101207561|FG000|COMPLETED|Overall Study||14||
48359211|NCT03557372|101207561|FG000|NOT COMPLETED|Overall Study||0||
48359212|NCT02859415|101207562|FG000|STARTED|Overall Study||1||
48359213|NCT02859415|101207563|FG001|STARTED|Overall Study||2||
48359214|NCT02859415|101207562|FG000|COMPLETED|Overall Study||0||
48359215|NCT02859415|101207563|FG001|COMPLETED|Overall Study||1||
48359216|NCT02859415|101207562|FG000|NOT COMPLETED|Overall Study||1||
48359217|NCT02859415|101207563|FG001|NOT COMPLETED|Overall Study||1||
48359218|NCT00345371|101207564|FG000|STARTED|Overall Study||69||
48359219|NCT00345371|101207565|FG001|STARTED|Overall Study||71||
48359220|NCT00345371|101207564|FG000|COMPLETED|Overall Study||39||
48359221|NCT00345371|101207565|FG001|COMPLETED|Overall Study||38||
48359222|NCT00345371|101207564|FG000|NOT COMPLETED|Overall Study||30||
48359223|NCT00345371|101207565|FG001|NOT COMPLETED|Overall Study||33||
48359224|NCT02514070|101207566|FG000|STARTED|Weeks 0 to Week 6||19||
48359225|NCT02514070|101207567|FG001|STARTED|Weeks 0 to Week 6||20||
48359226|NCT02514070|101207566|FG000|COMPLETED|Weeks 0 to Week 6||17||
48359227|NCT02514070|101207567|FG001|COMPLETED|Weeks 0 to Week 6||16||
48359228|NCT02514070|101207566|FG000|NOT COMPLETED|Weeks 0 to Week 6||2||
48359229|NCT02514070|101207567|FG001|NOT COMPLETED|Weeks 0 to Week 6||4||
48359230|NCT02514070|101207566|FG000|STARTED|Week 6 to Week 14 - Washout Period||17||
48359231|NCT02514070|101207567|FG001|STARTED|Week 6 to Week 14 - Washout Period||16||
48359232|NCT02514070|101207566|FG000|COMPLETED|Week 6 to Week 14 - Washout Period||17||
48359233|NCT02514070|101207567|FG001|COMPLETED|Week 6 to Week 14 - Washout Period||16||
48359234|NCT02514070|101207566|FG000|NOT COMPLETED|Week 6 to Week 14 - Washout Period||0||
48359235|NCT02514070|101207567|FG001|NOT COMPLETED|Week 6 to Week 14 - Washout Period||0||
48359236|NCT02514070|101207566|FG000|STARTED|Week 14 to Week 20||17||
48359237|NCT02514070|101207567|FG001|STARTED|Week 14 to Week 20||16||
48359238|NCT02514070|101207566|FG000|COMPLETED|Week 14 to Week 20||16||
48359239|NCT02514070|101207567|FG001|COMPLETED|Week 14 to Week 20||14||
48359240|NCT02514070|101207566|FG000|NOT COMPLETED|Week 14 to Week 20||1||
48359241|NCT02514070|101207567|FG001|NOT COMPLETED|Week 14 to Week 20||2||
48359242|NCT03534271|101207568|FG000|STARTED|Overall Study||47||
48359243|NCT03534271|101207568|FG000|COMPLETED|Overall Study||47||
48359244|NCT03534271|101207568|FG000|NOT COMPLETED|Overall Study||0||
48359245|NCT02369510|101207569|FG000|STARTED|Overall Study||23||
48359246|NCT02369510|101207570|FG001|STARTED|Overall Study||22||
48359247|NCT02369510|101207571|FG002|STARTED|Overall Study||23||
48359248|NCT02369510|101207569|FG000|COMPLETED|Overall Study||21||
48420183|NCT03474380|101361838|FG000|NOT COMPLETED|Month 13-18||8||0
48420184|NCT03474380|101361839|FG001|NOT COMPLETED|Month 13-18||5||0
48420185|NCT03474380|101361840|FG002|NOT COMPLETED|Month 13-18||10||0
48420186|NCT03474380|101361841|FG003|NOT COMPLETED|Month 13-18||2||0
48359249|NCT02369510|101207570|FG001|COMPLETED|Overall Study||19||
48359250|NCT02369510|101207571|FG002|COMPLETED|Overall Study||17||
48359251|NCT02369510|101207569|FG000|NOT COMPLETED|Overall Study||2||
48359252|NCT02369510|101207570|FG001|NOT COMPLETED|Overall Study||3||
48359253|NCT02369510|101207571|FG002|NOT COMPLETED|Overall Study||6||
48420187|NCT03474380|101361838|FG000|STARTED|Month 19-24||85||2
48420188|NCT03474380|101361839|FG001|STARTED|Month 19-24||85||2
48359254|NCT04101422|101207572|FG000|STARTED|Overall Study||11||
48359255|NCT04101422|101207573|FG001|STARTED|Overall Study||17||
48359256|NCT04101422|101207574|FG002|STARTED|Overall Study||126||
48359257|NCT04101422|101207575|FG003|STARTED|Overall Study||43||
48359258|NCT04101422|101207572|FG000|Extinction Group|Overall Study||0||
48420189|NCT03474380|101361840|FG002|STARTED|Month 19-24||92||2
48420190|NCT03474380|101361841|FG003|STARTED|Month 19-24||86||2
48420191|NCT03474380|101361838|FG000|Veterans|Month 19-24||59||2
48359259|NCT04101422|101207573|FG001|Extinction Group|Overall Study||10||
48359260|NCT04101422|101207574|FG002|Extinction Group|Overall Study||59||
48359261|NCT04101422|101207575|FG003|Extinction Group|Overall Study||0||
48359262|NCT04101422|101207572|FG000|Control Group|Overall Study||0||
48359263|NCT04101422|101207573|FG001|Control Group|Overall Study||7||
48359264|NCT04101422|101207574|FG002|Control Group|Overall Study||67||
48359265|NCT04101422|101207575|FG003|Control Group|Overall Study||0||
48763518|NCT04386291|102208743|FG000|COMPLETED|Overall Study||21||
48763519|NCT04386291|102208744|FG001|COMPLETED|Overall Study||12||
48763520|NCT04386291|102208745|FG002|COMPLETED|Overall Study||23||
48763521|NCT04386291|102208743|FG000|NOT COMPLETED|Overall Study||62||
48763522|NCT04386291|102208744|FG001|NOT COMPLETED|Overall Study||76||
48763523|NCT04386291|102208745|FG002|NOT COMPLETED|Overall Study||62||
48763524|NCT04792645|102208746|FG000|STARTED|Overall Study||45||
48763525|NCT04792645|102208747|FG001|STARTED|Overall Study||55||
48763526|NCT04792645|102208746|FG000|COMPLETED|Overall Study||36||
48763527|NCT04792645|102208747|FG001|COMPLETED|Overall Study||43||
48763528|NCT04792645|102208746|FG000|NOT COMPLETED|Overall Study||9||
48763529|NCT04792645|102208747|FG001|NOT COMPLETED|Overall Study||12||
48763530|NCT03103542|102208748|FG000|STARTED|Overall Study||16||
48763531|NCT03103542|102208748|FG000|COMPLETED|Overall Study||9||
48763532|NCT03103542|102208748|FG000|NOT COMPLETED|Overall Study||7||
48763533|NCT01490151|102208749|FG000|STARTED|Overall Study||22||
48763534|NCT01490151|102208749|FG000|COMPLETED|Overall Study||22||
48763535|NCT01490151|102208749|FG000|NOT COMPLETED|Overall Study||0||
48763536|NCT03175367|102208750|FG000|STARTED|Double-blind Treatment Period (DBTP)||39||
48763537|NCT03175367|102208751|FG001|STARTED|Double-blind Treatment Period (DBTP)||39||
48763538|NCT03175367|102208752|FG002|STARTED|Double-blind Treatment Period (DBTP)||42||
48763539|NCT03175367|102208753|FG003|STARTED|Double-blind Treatment Period (DBTP)||40||
48763540|NCT03175367|102208754|FG004|STARTED|Double-blind Treatment Period (DBTP)||33||
48763541|NCT03175367|102208755|FG005|STARTED|Double-blind Treatment Period (DBTP)||35||
48763542|NCT03175367|102208756|FG006|STARTED|Double-blind Treatment Period (DBTP)||38||
48763543|NCT03175367|102208750|FG000|COMPLETED|Double-blind Treatment Period (DBTP)||30||
48763544|NCT03175367|102208751|FG001|COMPLETED|Double-blind Treatment Period (DBTP)||31||
48763545|NCT03175367|102208752|FG002|COMPLETED|Double-blind Treatment Period (DBTP)||30||
48763546|NCT03175367|102208753|FG003|COMPLETED|Double-blind Treatment Period (DBTP)||30||
48763547|NCT03175367|102208754|FG004|COMPLETED|Double-blind Treatment Period (DBTP)||31||
48763548|NCT03175367|102208755|FG005|COMPLETED|Double-blind Treatment Period (DBTP)||32||
48763549|NCT03175367|102208756|FG006|COMPLETED|Double-blind Treatment Period (DBTP)||34||
48359266|NCT04101422|101207572|FG000|COMPLETED|Overall Study||10||
48359267|NCT04101422|101207573|FG001|COMPLETED|Overall Study||17||
48359268|NCT04101422|101207574|FG002|COMPLETED|Overall Study||112||
48359269|NCT04101422|101207575|FG003|COMPLETED|Overall Study||23||
48359270|NCT04101422|101207572|FG000|NOT COMPLETED|Overall Study||1||
48359271|NCT04101422|101207573|FG001|NOT COMPLETED|Overall Study||0||
48359272|NCT04101422|101207574|FG002|NOT COMPLETED|Overall Study||14||
48359273|NCT04101422|101207575|FG003|NOT COMPLETED|Overall Study||20||
48359274|NCT01200511|101207576|FG000|STARTED|Overall Study||49||
48359275|NCT01200511|101207576|FG000|COMPLETED|Overall Study||44||
48359276|NCT01200511|101207576|FG000|NOT COMPLETED|Overall Study||5||
48359277|NCT01464697|101207577|FG000|STARTED|Overall Study||93||
48359278|NCT01464697|101207578|FG001|STARTED|Overall Study||96||
48359279|NCT01464697|101207577|FG000|COMPLETED|Overall Study||90||
48359280|NCT01464697|101207578|FG001|COMPLETED|Overall Study||86||
48359281|NCT01464697|101207577|FG000|NOT COMPLETED|Overall Study||3||
48359282|NCT01464697|101207578|FG001|NOT COMPLETED|Overall Study||10||
48359283|NCT00667277|101207579|FG000|STARTED|Overall Study||13||
48359284|NCT00667277|101207579|FG000|COMPLETED|Overall Study||11||
48763550|NCT03175367|102208750|FG000|NOT COMPLETED|Double-blind Treatment Period (DBTP)||9||
48763551|NCT03175367|102208751|FG001|NOT COMPLETED|Double-blind Treatment Period (DBTP)||8||
48763552|NCT03175367|102208752|FG002|NOT COMPLETED|Double-blind Treatment Period (DBTP)||12||
48763553|NCT03175367|102208753|FG003|NOT COMPLETED|Double-blind Treatment Period (DBTP)||10||
48763554|NCT03175367|102208754|FG004|NOT COMPLETED|Double-blind Treatment Period (DBTP)||2||
48359285|NCT00667277|101207579|FG000|NOT COMPLETED|Overall Study||2||
48359286|NCT04315363|101207580|FG000|STARTED|Overall Study||21||
48359287|NCT04315363|101207581|FG001|STARTED|Overall Study||19||
48359288|NCT04315363|101207580|FG000|COMPLETED|Overall Study||21||
48359289|NCT04315363|101207581|FG001|COMPLETED|Overall Study||17||
48359290|NCT04315363|101207580|FG000|NOT COMPLETED|Overall Study||0||
48359291|NCT04315363|101207581|FG001|NOT COMPLETED|Overall Study||2||
48359292|NCT01887210|101207582|FG000|STARTED|Overall Study||33||
48359293|NCT01887210|101207583|FG001|STARTED|Overall Study||33||
48359294|NCT01887210|101207582|FG000|COMPLETED|Overall Study||32||
48359295|NCT01887210|101207583|FG001|COMPLETED|Overall Study||29||
48359296|NCT01887210|101207582|FG000|NOT COMPLETED|Overall Study||1||
48359297|NCT01887210|101207583|FG001|NOT COMPLETED|Overall Study||4||
48359298|NCT00793104|101207584|FG000|STARTED|Overall Study||10||
48359299|NCT00793104|101207584|FG000|COMPLETED|Overall Study||9||
48359300|NCT00793104|101207584|FG000|NOT COMPLETED|Overall Study||1||
48359301|NCT01300286|101207585|FG000|STARTED|Overall Study||23||
48763555|NCT03175367|102208755|FG005|NOT COMPLETED|Double-blind Treatment Period (DBTP)||3||
48763556|NCT03175367|102208756|FG006|NOT COMPLETED|Double-blind Treatment Period (DBTP)||4||
48763557|NCT03175367|102208750|FG000|STARTED|Open-Label Treatment Period (OLTP)||0|Treated in OLTP|
48763558|NCT03175367|102208751|FG001|STARTED|Open-Label Treatment Period (OLTP)||0|Treated in OLTP|
48763559|NCT03175367|102208752|FG002|STARTED|Open-Label Treatment Period (OLTP)||0|Treated in OLTP|
48763560|NCT03175367|102208753|FG003|STARTED|Open-Label Treatment Period (OLTP)||0|Treated in OLTP|
48763561|NCT03175367|102208754|FG004|STARTED|Open-Label Treatment Period (OLTP)||31|Treated in OLTP|
48763562|NCT03175367|102208755|FG005|STARTED|Open-Label Treatment Period (OLTP)||32|Treated in OLTP|
48763563|NCT03175367|102208756|FG006|STARTED|Open-Label Treatment Period (OLTP)||33|Treated in OLTP|
48763564|NCT03175367|102208750|FG000|COMPLETED|Open-Label Treatment Period (OLTP)||0|Completed Study|
48763565|NCT03175367|102208751|FG001|COMPLETED|Open-Label Treatment Period (OLTP)||0|Completed Study|
48763566|NCT03175367|102208752|FG002|COMPLETED|Open-Label Treatment Period (OLTP)||0|Completed Study|
48763567|NCT03175367|102208753|FG003|COMPLETED|Open-Label Treatment Period (OLTP)||0|Completed Study|
48763568|NCT03175367|102208754|FG004|COMPLETED|Open-Label Treatment Period (OLTP)||31|Completed Study|
48763569|NCT03175367|102208755|FG005|COMPLETED|Open-Label Treatment Period (OLTP)||30|Completed Study|
48763570|NCT03175367|102208756|FG006|COMPLETED|Open-Label Treatment Period (OLTP)||31|Completed Study|
48763571|NCT03175367|102208750|FG000|NOT COMPLETED|Open-Label Treatment Period (OLTP)||0||
48763572|NCT03175367|102208751|FG001|NOT COMPLETED|Open-Label Treatment Period (OLTP)||0||
48763573|NCT03175367|102208752|FG002|NOT COMPLETED|Open-Label Treatment Period (OLTP)||0||
48763574|NCT03175367|102208753|FG003|NOT COMPLETED|Open-Label Treatment Period (OLTP)||0||
48763575|NCT03175367|102208754|FG004|NOT COMPLETED|Open-Label Treatment Period (OLTP)||0||
48763576|NCT03175367|102208755|FG005|NOT COMPLETED|Open-Label Treatment Period (OLTP)||2||
48763577|NCT03175367|102208756|FG006|NOT COMPLETED|Open-Label Treatment Period (OLTP)||2||
48763578|NCT01350947|102208757|FG000|STARTED|Overall Study||11||
48763579|NCT01350947|102208757|FG000|COMPLETED|Overall Study||11||
48763580|NCT01350947|102208757|FG000|NOT COMPLETED|Overall Study||0||
48763581|NCT00603408|102208758|FG000|STARTED|Overall Study||5||
48763582|NCT00603408|102208758|FG000|COMPLETED|Overall Study||5||
48763583|NCT00603408|102208758|FG000|NOT COMPLETED|Overall Study||0||
48763584|NCT00289653|102208759|FG000|STARTED|Overall Study||23||
48763585|NCT00289653|102208759|FG000|COMPLETED|Overall Study||12||
48763586|NCT00289653|102208759|FG000|NOT COMPLETED|Overall Study||11||
48763587|NCT01600326|102208760|FG000|STARTED|Overall Study||15||
48763588|NCT01600326|102208761|FG001|STARTED|Overall Study||15||
48763589|NCT01600326|102208760|FG000|Primary Outcome Measure Data Collection|Overall Study||15||
48763590|NCT01600326|102208761|FG001|Primary Outcome Measure Data Collection|Overall Study||15||
48763591|NCT01600326|102208760|FG000|COMPLETED|Overall Study||14||
48763592|NCT01600326|102208761|FG001|COMPLETED|Overall Study||14||
48763593|NCT01600326|102208760|FG000|NOT COMPLETED|Overall Study||1||
48763594|NCT01600326|102208761|FG001|NOT COMPLETED|Overall Study||1||
48763595|NCT04945733|102208762|FG000|STARTED|Overall Study||29||
48763596|NCT04945733|102208763|FG001|STARTED|Overall Study||30||
48763597|NCT04945733|102208764|FG002|STARTED|Overall Study||3||
48763598|NCT04945733|102208762|FG000|COMPLETED|Overall Study||25||
48763599|NCT04945733|102208763|FG001|COMPLETED|Overall Study||24||
48763600|NCT04945733|102208764|FG002|COMPLETED|Overall Study||3||
48763601|NCT04945733|102208762|FG000|NOT COMPLETED|Overall Study||4||
48763602|NCT04945733|102208763|FG001|NOT COMPLETED|Overall Study||6||
48763603|NCT04945733|102208764|FG002|NOT COMPLETED|Overall Study||0||
48763604|NCT03205709|102208765|FG000|STARTED|Overall Study||51||
48763605|NCT03205709|102208766|FG001|STARTED|Overall Study||56||
48763606|NCT03205709|102208765|FG000|COMPLETED|Overall Study||44||
48763607|NCT03205709|102208766|FG001|COMPLETED|Overall Study||49||
48763608|NCT03205709|102208765|FG000|NOT COMPLETED|Overall Study||7||
48763609|NCT03205709|102208766|FG001|NOT COMPLETED|Overall Study||7||
48763610|NCT04552301|102208767|FG000|STARTED|Overall Study||19||
48763611|NCT04552301|102208768|FG001|STARTED|Overall Study||19||
48763612|NCT04552301|102208767|FG000|COMPLETED|Overall Study||19||
48763613|NCT04552301|102208768|FG001|COMPLETED|Overall Study||19||
48763614|NCT04552301|102208767|FG000|NOT COMPLETED|Overall Study||0||
48763615|NCT04552301|102208768|FG001|NOT COMPLETED|Overall Study||0||
48763616|NCT00870740|102208769|FG000|STARTED|Overall Study||86||
48763617|NCT00870740|102208770|FG001|STARTED|Overall Study||84||
48763618|NCT00870740|102208771|FG002|STARTED|Overall Study||86||
48763619|NCT00870740|102208772|FG003|STARTED|Overall Study||86||
48763620|NCT00870740|102208773|FG004|STARTED|Overall Study||88||
48763621|NCT00870740|102208774|FG005|STARTED|Overall Study||87||
48763622|NCT00870740|102208769|FG000|COMPLETED|Overall Study||74||
48763623|NCT00870740|102208770|FG001|COMPLETED|Overall Study||75||
48763624|NCT00870740|102208771|FG002|COMPLETED|Overall Study||76||
48763625|NCT00870740|102208772|FG003|COMPLETED|Overall Study||74||
48763626|NCT00870740|102208773|FG004|COMPLETED|Overall Study||77||
48763627|NCT00870740|102208774|FG005|COMPLETED|Overall Study||70||
48763628|NCT00870740|102208769|FG000|NOT COMPLETED|Overall Study||12||
48763629|NCT00870740|102208770|FG001|NOT COMPLETED|Overall Study||9||
48763630|NCT00870740|102208771|FG002|NOT COMPLETED|Overall Study||10||
48186877|NCT02559817|100779920|FG000|NOT COMPLETED|Post-treatment Period||0||
48186878|NCT02559817|100779921|FG001|NOT COMPLETED|Post-treatment Period||0||
48186879|NCT02559817|100779922|FG002|NOT COMPLETED|Post-treatment Period||0||
48186880|NCT02559817|100779923|FG003|NOT COMPLETED|Post-treatment Period||0||
48186881|NCT02559817|100779924|FG004|NOT COMPLETED|Post-treatment Period||0||
48186882|NCT02988375|100779925|FG000|STARTED|Overall Study||946||
48186883|NCT02988375|100779926|FG001|STARTED|Overall Study||439||
48186884|NCT02988375|100779925|FG000|COMPLETED|Overall Study||358||
48186885|NCT02988375|100779926|FG001|COMPLETED|Overall Study||300||
48186886|NCT02988375|100779925|FG000|NOT COMPLETED|Overall Study||588||
48186887|NCT02988375|100779926|FG001|NOT COMPLETED|Overall Study||139||
48186888|NCT00681811|100779927|FG000|STARTED|Overall Study||6||
48186889|NCT00681811|100779928|FG001|STARTED|Overall Study||5||
48186890|NCT00681811|100779927|FG000|COMPLETED|Overall Study||3||
48186891|NCT00681811|100779928|FG001|COMPLETED|Overall Study||1||
48186892|NCT00681811|100779927|FG000|NOT COMPLETED|Overall Study||3||
48186893|NCT00681811|100779928|FG001|NOT COMPLETED|Overall Study||4||
48186894|NCT01515319|100779929|FG000|STARTED|Overall Study||3||
48186895|NCT01515319|100779930|FG001|STARTED|Overall Study||3||
48186896|NCT01515319|100779931|FG002|STARTED|Overall Study||6||
48186897|NCT01515319|100779932|FG003|STARTED|Overall Study||6||
48186898|NCT01515319|100779933|FG004|STARTED|Overall Study||6||
48186899|NCT01515319|100779934|FG005|STARTED|Overall Study||6||
48186900|NCT01515319|100779935|FG006|STARTED|Overall Study||10||
48763631|NCT00870740|102208772|FG003|NOT COMPLETED|Overall Study||12||
48763632|NCT00870740|102208773|FG004|NOT COMPLETED|Overall Study||11||
48763633|NCT00870740|102208774|FG005|NOT COMPLETED|Overall Study||17||
48763634|NCT00385671|102208775|FG000|STARTED|Overall Study||134||
48763635|NCT00385671|102208776|FG001|STARTED|Overall Study||138||
48763636|NCT00385671|102208777|FG002|STARTED|Overall Study||135||
48763637|NCT00385671|102208775|FG000|COMPLETED|Overall Study||96||
48763638|NCT00385671|102208776|FG001|COMPLETED|Overall Study||87||
48763639|NCT00385671|102208777|FG002|COMPLETED|Overall Study||99||
48763640|NCT00385671|102208775|FG000|NOT COMPLETED|Overall Study||38||
48763641|NCT00385671|102208776|FG001|NOT COMPLETED|Overall Study||51||
48763642|NCT00385671|102208777|FG002|NOT COMPLETED|Overall Study||36||
48763643|NCT01668784|102208778|FG000|STARTED|Randomized (Pre-treatment)||410||
48763644|NCT01668784|102208779|FG001|STARTED|Randomized (Pre-treatment)||411||
48763645|NCT01668784|102208778|FG000|COMPLETED|Randomized (Pre-treatment)||406||
48763646|NCT01668784|102208779|FG001|COMPLETED|Randomized (Pre-treatment)||397||
48763647|NCT01668784|102208778|FG000|NOT COMPLETED|Randomized (Pre-treatment)||4||
48763648|NCT01668784|102208779|FG001|NOT COMPLETED|Randomized (Pre-treatment)||14||
48763649|NCT01668784|102208778|FG000|STARTED|Treatment Period||406||
48763650|NCT01668784|102208779|FG001|STARTED|Treatment Period||397||
48763651|NCT01668784|102208778|FG000|COMPLETED|Treatment Period||0||
48763652|NCT01668784|102208779|FG001|COMPLETED|Treatment Period||0||
48763653|NCT01668784|102208778|FG000|NOT COMPLETED|Treatment Period||406||
48763654|NCT01668784|102208779|FG001|NOT COMPLETED|Treatment Period||397||
48763655|NCT00910650|102208780|FG000|STARTED|Overall Study||14||
48763656|NCT00910650|102208780|FG000|COMPLETED|Overall Study||12||
48763657|NCT00910650|102208780|FG000|NOT COMPLETED|Overall Study||2||
48763658|NCT02023086|102208781|FG000|STARTED|Overall Study||8||
48763659|NCT02023086|102208782|FG001|STARTED|Overall Study||8||
48763660|NCT02023086|102208781|FG000|COMPLETED|Overall Study||6||
48763661|NCT02023086|102208782|FG001|COMPLETED|Overall Study||8||
48763662|NCT02023086|102208781|FG000|NOT COMPLETED|Overall Study||2||
48763663|NCT02023086|102208782|FG001|NOT COMPLETED|Overall Study||0||
48763664|NCT04351334|102208783|FG000|STARTED|Overall Study||161||
48763665|NCT04351334|102208783|FG000|COMPLETED|Overall Study||161||
48763666|NCT04351334|102208783|FG000|NOT COMPLETED|Overall Study||0||
48763667|NCT05444855|102208784|FG000|STARTED|Overall Study||18||
48763668|NCT05444855|102208785|FG001|STARTED|Overall Study||33||
48763669|NCT05444855|102208784|FG000|COMPLETED|Overall Study||11||
48763670|NCT05444855|102208785|FG001|COMPLETED|Overall Study||14||
48763671|NCT05444855|102208784|FG000|NOT COMPLETED|Overall Study||7||
48763672|NCT05444855|102208785|FG001|NOT COMPLETED|Overall Study||19||
48763673|NCT02992288|102208786|FG000|STARTED|Overall Study||106||
48763674|NCT02992288|102208787|FG001|STARTED|Overall Study||37||
48763675|NCT02992288|102208788|FG002|STARTED|Overall Study||70||
48763676|NCT02992288|102208789|FG003|STARTED|Overall Study||73||
48763677|NCT02992288|102208790|FG004|STARTED|Overall Study||69||
48186901|NCT01515319|100779936|FG007|STARTED|Overall Study||6||
48186902|NCT01515319|100779937|FG008|STARTED|Overall Study||14||
48186903|NCT01515319|100779938|FG009|STARTED|Overall Study||8||
48186904|NCT01515319|100779929|FG000|COMPLETED|Overall Study||3||
48186905|NCT01515319|100779930|FG001|COMPLETED|Overall Study||3||
48186906|NCT01515319|100779931|FG002|COMPLETED|Overall Study||6||
48186907|NCT01515319|100779932|FG003|COMPLETED|Overall Study||6||
48186908|NCT01515319|100779933|FG004|COMPLETED|Overall Study||6||
48186909|NCT01515319|100779934|FG005|COMPLETED|Overall Study||6||
48763678|NCT02992288|102208791|FG005|STARTED|Overall Study||72||
48763679|NCT02992288|102208786|FG000|Treated|Overall Study||106||
48763680|NCT02992288|102208787|FG001|Treated|Overall Study||37||
48763681|NCT02992288|102208788|FG002|Treated|Overall Study||70||
48763682|NCT02992288|102208789|FG003|Treated|Overall Study||72||
48420192|NCT03474380|101361839|FG001|Veterans|Month 19-24||59||2
48420193|NCT03474380|101361840|FG002|Veterans|Month 19-24||61||2
48420194|NCT03474380|101361841|FG003|Veterans|Month 19-24||52||2
48420195|NCT03474380|101361838|FG000|Caregiver Started|Month 19-24||26||2
48420196|NCT03474380|101361839|FG001|Caregiver Started|Month 19-24||26||2
48420197|NCT03474380|101361840|FG002|Caregiver Started|Month 19-24||25||2
48420198|NCT03474380|101361841|FG003|Caregiver Started|Month 19-24||26||2
48420199|NCT03474380|101361838|FG000|Caregiver Completed|Month 19-24||19||2
48420200|NCT03474380|101361839|FG001|Caregiver Completed|Month 19-24||23||2
48420201|NCT03474380|101361840|FG002|Caregiver Completed|Month 19-24||17||2
48420202|NCT03474380|101361841|FG003|Caregiver Completed|Month 19-24||24||2
48420203|NCT03474380|101361838|FG000|Providers Pre-Implementation|Month 19-24||0||0
48420204|NCT03474380|101361839|FG001|Providers Pre-Implementation|Month 19-24||0||0
48420205|NCT03474380|101361840|FG002|Providers Pre-Implementation|Month 19-24||0||0
48420206|NCT03474380|101361841|FG003|Providers Pre-Implementation|Month 19-24||8||2
48420207|NCT03474380|101361838|FG000|Providers Post-Implementation|Month 19-24||0||0
48420208|NCT03474380|101361839|FG001|Providers Post-Implementation|Month 19-24||0||0
48420209|NCT03474380|101361840|FG002|Providers Post-Implementation|Month 19-24||6||2
48420210|NCT03474380|101361841|FG003|Providers Post-Implementation|Month 19-24||0||0
48420211|NCT03474380|101361838|FG000|COMPLETED|Month 19-24||78||2
48420212|NCT03474380|101361839|FG001|COMPLETED|Month 19-24||82||2
48420213|NCT03474380|101361840|FG002|COMPLETED|Month 19-24||84||2
48420214|NCT03474380|101361841|FG003|COMPLETED|Month 19-24||84||2
48420215|NCT03474380|101361838|FG000|NOT COMPLETED|Month 19-24||7||0
48420216|NCT03474380|101361839|FG001|NOT COMPLETED|Month 19-24||3||0
48420217|NCT03474380|101361840|FG002|NOT COMPLETED|Month 19-24||8||0
48420218|NCT03474380|101361841|FG003|NOT COMPLETED|Month 19-24||2||0
48420219|NCT03474380|101361838|FG000|STARTED|Month 25-30||76||2
48420220|NCT03474380|101361839|FG001|STARTED|Month 25-30||101||2
48420221|NCT03474380|101361840|FG002|STARTED|Month 25-30||65||2
48420222|NCT03474380|101361841|FG003|STARTED|Month 25-30||83||2
48420223|NCT03474380|101361838|FG000|Veterans|Month 25-30||53||2
48420224|NCT03474380|101361839|FG001|Veterans|Month 25-30||68||2
48420225|NCT03474380|101361840|FG002|Veterans|Month 25-30||37||2
48420226|NCT03474380|101361841|FG003|Veterans|Month 25-30||54||2
48420227|NCT03474380|101361838|FG000|Caregiver Started|Month 25-30||23||2
48420228|NCT03474380|101361839|FG001|Caregiver Started|Month 25-30||33||2
48420229|NCT03474380|101361840|FG002|Caregiver Started|Month 25-30||28||2
48420230|NCT03474380|101361841|FG003|Caregiver Started|Month 25-30||27||2
48420231|NCT03474380|101361838|FG000|Caregiver Completed|Month 25-30||16||2
48420232|NCT03474380|101361839|FG001|Caregiver Completed|Month 25-30||25||2
48420233|NCT03474380|101361840|FG002|Caregiver Completed|Month 25-30||21||2
48420234|NCT03474380|101361841|FG003|Caregiver Completed|Month 25-30||21||2
48420235|NCT03474380|101361838|FG000|Providers Pre-Implementation|Month 25-30||0||0
48420236|NCT03474380|101361839|FG001|Providers Pre-Implementation|Month 25-30||0||0
48420237|NCT03474380|101361840|FG002|Providers Pre-Implementation|Month 25-30||0||0
48763683|NCT02992288|102208790|FG004|Treated|Overall Study||69||
48763684|NCT02992288|102208791|FG005|Treated|Overall Study||72||
48763685|NCT02992288|102208786|FG000|COMPLETED|Overall Study||89||
48763686|NCT02992288|102208787|FG001|COMPLETED|Overall Study||32||
48763687|NCT02992288|102208788|FG002|COMPLETED|Overall Study||63||
48763688|NCT02992288|102208789|FG003|COMPLETED|Overall Study||64||
48763689|NCT02992288|102208790|FG004|COMPLETED|Overall Study||61||
48763690|NCT02992288|102208791|FG005|COMPLETED|Overall Study||59||
48763691|NCT02992288|102208786|FG000|NOT COMPLETED|Overall Study||17||
48763692|NCT02992288|102208787|FG001|NOT COMPLETED|Overall Study||5||
48186910|NCT01515319|100779935|FG006|COMPLETED|Overall Study||9||
48186911|NCT01515319|100779936|FG007|COMPLETED|Overall Study||6||
48420238|NCT03474380|101361841|FG003|Providers Pre-Implementation|Month 25-30||0||0
48420239|NCT03474380|101361838|FG000|Providers Post-Implementation|Month 25-30||0||0
48420240|NCT03474380|101361839|FG001|Providers Post-Implementation|Month 25-30||0||0
48763693|NCT02992288|102208788|FG002|NOT COMPLETED|Overall Study||7||
48186912|NCT01515319|100779937|FG008|COMPLETED|Overall Study||9||
48420241|NCT03474380|101361840|FG002|Providers Post-Implementation|Month 25-30||0||0
48420242|NCT03474380|101361841|FG003|Providers Post-Implementation|Month 25-30||2||2
48420243|NCT03474380|101361838|FG000|COMPLETED|Month 25-30||69||2
48420244|NCT03474380|101361839|FG001|COMPLETED|Month 25-30||93||2
48420245|NCT03474380|101361840|FG002|COMPLETED|Month 25-30||58||2
48763694|NCT02992288|102208789|FG003|NOT COMPLETED|Overall Study||9||
48763695|NCT02992288|102208790|FG004|NOT COMPLETED|Overall Study||8||
48420246|NCT03474380|101361841|FG003|COMPLETED|Month 25-30||77||2
48420247|NCT03474380|101361838|FG000|NOT COMPLETED|Month 25-30||7||0
48420248|NCT03474380|101361839|FG001|NOT COMPLETED|Month 25-30||8||0
48420249|NCT03474380|101361840|FG002|NOT COMPLETED|Month 25-30||7||0
48420250|NCT03474380|101361841|FG003|NOT COMPLETED|Month 25-30||6||0
48420251|NCT01594424|101365334|FG000|STARTED|Overall Study||10||
48420252|NCT01594424|101365334|FG000|COMPLETED|Overall Study||8||
48420253|NCT01594424|101365334|FG000|NOT COMPLETED|Overall Study||2||
48420254|NCT00540228|101365335|FG000|STARTED|Overall Study||200||
48420255|NCT00540228|101365336|FG001|STARTED|Overall Study||198||
48420256|NCT00540228|101365337|FG002|STARTED|Overall Study||204||
48420257|NCT00540228|101365338|FG003|STARTED|Overall Study||202||
48420258|NCT00540228|101365339|FG004|STARTED|Overall Study||202||
48420259|NCT00540228|101365335|FG000|COMPLETED|Overall Study||197||
48420260|NCT00540228|101365336|FG001|COMPLETED|Overall Study||197||
48420261|NCT00540228|101365337|FG002|COMPLETED|Overall Study||204||
48420262|NCT00540228|101365338|FG003|COMPLETED|Overall Study||202||
48420263|NCT00540228|101365339|FG004|COMPLETED|Overall Study||202||
48420264|NCT00540228|101365335|FG000|NOT COMPLETED|Overall Study||3||
48420265|NCT00540228|101365336|FG001|NOT COMPLETED|Overall Study||1||
48420266|NCT00540228|101365337|FG002|NOT COMPLETED|Overall Study||0||
48420267|NCT00540228|101365338|FG003|NOT COMPLETED|Overall Study||0||
48420268|NCT00540228|101365339|FG004|NOT COMPLETED|Overall Study||0||
48420269|NCT00087685|101365340|FG000|STARTED|Overall Study||35||
48420270|NCT00087685|101365340|FG000|COMPLETED|Overall Study||21||
48420271|NCT00087685|101365340|FG000|NOT COMPLETED|Overall Study||14||
48420272|NCT01454531|101365341|FG000|STARTED|Overall Study||196||
48420273|NCT01454531|101365341|FG000|Subjects Treated|Overall Study||192||
48420274|NCT01454531|101365341|FG000|COMPLETED|Overall Study||173||
48420275|NCT01454531|101365341|FG000|NOT COMPLETED|Overall Study||23||
48420276|NCT02608099|101365342|FG000|STARTED|Overall Study||148|This number represents the intention-to-treat population.|
48420277|NCT02608099|101365343|FG001|STARTED|Overall Study||152|This number represents the intention-to-treat population.|
48420278|NCT02608099|101365342|FG000|Safety|Overall Study||149|This number represents the safety population (analyzed under the actual treatment received).|
48420279|NCT02608099|101365343|FG001|Safety|Overall Study||151|This number represents the safety population (analyzed under the actual treatment received).|
48420280|NCT02608099|101365342|FG000|COMPLETED|Overall Study||145|This represents the evaluable population (analyzed under assigned/randomized treatment).|
48420281|NCT02608099|101365343|FG001|COMPLETED|Overall Study||150|This represents the evaluable population (analyzed under assigned/randomized treatment).|
48420282|NCT02608099|101365342|FG000|NOT COMPLETED|Overall Study||3||
48420283|NCT02608099|101365343|FG001|NOT COMPLETED|Overall Study||2||
48420284|NCT01455064|101365344|FG000|STARTED|Overall Study||31||
48420285|NCT01455064|101365344|FG000|COMPLETED|Overall Study||30||
48420286|NCT01455064|101365344|FG000|NOT COMPLETED|Overall Study||1||
48420287|NCT00141297|101365345|FG000|STARTED|Overall Study||3||
48420288|NCT00141297|101365346|FG001|STARTED|Overall Study||3||
48420289|NCT00141297|101365347|FG002|STARTED|Overall Study||7||
48420290|NCT00141297|101365348|FG003|STARTED|Overall Study||3||
48420291|NCT00141297|101365349|FG004|STARTED|Overall Study||22||
48420292|NCT00141297|101365350|FG005|STARTED|Overall Study||3||
48420293|NCT00141297|101365351|FG006|STARTED|Overall Study||3||
48420294|NCT00141297|101365352|FG007|STARTED|Overall Study||4||
48420295|NCT00141297|101365353|FG008|STARTED|Overall Study||20||
48420296|NCT00141297|101365354|FG009|STARTED|Overall Study||6||
48420297|NCT00141297|101365345|FG000|COMPLETED|Overall Study||0||
48420298|NCT00141297|101365346|FG001|COMPLETED|Overall Study||0||
48420299|NCT00141297|101365347|FG002|COMPLETED|Overall Study||0||
48420300|NCT00141297|101365348|FG003|COMPLETED|Overall Study||0||
48420301|NCT00141297|101365349|FG004|COMPLETED|Overall Study||0||
48420302|NCT00141297|101365350|FG005|COMPLETED|Overall Study||0||
48420303|NCT00141297|101365351|FG006|COMPLETED|Overall Study||0||
48763696|NCT02992288|102208791|FG005|NOT COMPLETED|Overall Study||13||
48763697|NCT03413891|102208792|FG000|STARTED|Overall Study||108||
48763698|NCT03413891|102208793|FG001|STARTED|Overall Study||114||
48763699|NCT03413891|102208792|FG000|COMPLETED|Overall Study||106||
48763700|NCT03413891|102208793|FG001|COMPLETED|Overall Study||112||
48763701|NCT03413891|102208792|FG000|NOT COMPLETED|Overall Study||2||
48763702|NCT03413891|102208793|FG001|NOT COMPLETED|Overall Study||2||
48763703|NCT03712358|102208794|FG000|STARTED|Overall Study||3||
48763704|NCT03712358|102208795|FG001|STARTED|Overall Study||3||
48763705|NCT03712358|102208796|FG002|STARTED|Overall Study||3||
48763706|NCT03712358|102208797|FG003|STARTED|Overall Study||3||
48763707|NCT03712358|102208798|FG004|STARTED|Overall Study||0||
48763708|NCT03712358|102208794|FG000|COMPLETED|Overall Study||3||
48763709|NCT03712358|102208795|FG001|COMPLETED|Overall Study||3||
48763710|NCT03712358|102208796|FG002|COMPLETED|Overall Study||3||
48763711|NCT03712358|102208797|FG003|COMPLETED|Overall Study||3||
48763712|NCT03712358|102208798|FG004|COMPLETED|Overall Study||0||
48420304|NCT00141297|101365352|FG007|COMPLETED|Overall Study||0||
48420305|NCT00141297|101365353|FG008|COMPLETED|Overall Study||0||
48420306|NCT00141297|101365354|FG009|COMPLETED|Overall Study||0||
48420307|NCT00141297|101365345|FG000|NOT COMPLETED|Overall Study||3||
48420308|NCT00141297|101365346|FG001|NOT COMPLETED|Overall Study||3||
48420309|NCT00141297|101365347|FG002|NOT COMPLETED|Overall Study||7||
48420310|NCT00141297|101365348|FG003|NOT COMPLETED|Overall Study||3||
48420311|NCT00141297|101365349|FG004|NOT COMPLETED|Overall Study||22||
48420312|NCT00141297|101365350|FG005|NOT COMPLETED|Overall Study||3||
48420313|NCT00141297|101365351|FG006|NOT COMPLETED|Overall Study||3||
48420314|NCT00141297|101365352|FG007|NOT COMPLETED|Overall Study||4||
48420315|NCT00141297|101365353|FG008|NOT COMPLETED|Overall Study||20||
48420316|NCT00141297|101365354|FG009|NOT COMPLETED|Overall Study||6||
48420317|NCT04168775|101365355|FG000|STARTED|Overall Study||80||
48420318|NCT04168775|101365355|FG000|COMPLETED|Overall Study||75||
48420319|NCT04168775|101365355|FG000|NOT COMPLETED|Overall Study||5||
48420320|NCT01191190|101365356|FG000|STARTED|Overall Study||21||
48420321|NCT01191190|101365356|FG000|COMPLETED|Overall Study||20||
48420322|NCT01191190|101365356|FG000|NOT COMPLETED|Overall Study||1||
48420323|NCT00374452|101365357|FG000|STARTED|Overall Study||34|Randomization of the clinic sites.|10
48420324|NCT00374452|101365358|FG001|STARTED|Overall Study||48|Randomization of the clinic sites.|10
48420325|NCT00374452|101365357|FG000|Intervention Started|Overall Study||30||10
48420326|NCT00374452|101365358|FG001|Intervention Started|Overall Study||46||10
48420327|NCT00374452|101365357|FG000|COMPLETED|Overall Study||29||10
48420328|NCT00374452|101365358|FG001|COMPLETED|Overall Study||43||10
48420329|NCT00374452|101365357|FG000|NOT COMPLETED|Overall Study||5||0
48420330|NCT00374452|101365358|FG001|NOT COMPLETED|Overall Study||5||0
48420331|NCT01333865|101365359|FG000|STARTED|Overall Study||19||
48420332|NCT01333865|101365359|FG000|COMPLETED|Overall Study||17||
48420333|NCT01333865|101365359|FG000|NOT COMPLETED|Overall Study||2||
48420334|NCT02117024|101365360|FG000|STARTED|Overall Study||45||
48420335|NCT02117024|101365361|FG001|STARTED|Overall Study||21||
48420336|NCT02117024|101365360|FG000|COMPLETED|Overall Study||1||
48420337|NCT02117024|101365361|FG001|COMPLETED|Overall Study||1||
48420338|NCT02117024|101365360|FG000|NOT COMPLETED|Overall Study||44||
48420339|NCT02117024|101365361|FG001|NOT COMPLETED|Overall Study||20||
48420340|NCT00103207|101365362|FG000|STARTED|Overall Study||72||
48420341|NCT00103207|101365362|FG000|Eligible Patients w/ Confirmed Diagnosis|Overall Study||41||
48420342|NCT00103207|101365362|FG000|Eligible Patients w/ Smoking Status Data|Overall Study||37||
48420343|NCT00103207|101365362|FG000|COMPLETED|Overall Study||34||
48420344|NCT00103207|101365362|FG000|NOT COMPLETED|Overall Study||38||
48420345|NCT02146352|101365363|FG000|STARTED|Overall Study||30||
48420346|NCT02146352|101365363|FG000|30 or 60 Days Post-procedure|Overall Study||30||
48420347|NCT02146352|101365363|FG000|7 Days Post-stent Removal|Overall Study||28||
48420348|NCT02146352|101365363|FG000|COMPLETED|Overall Study||28||
48420349|NCT02146352|101365363|FG000|NOT COMPLETED|Overall Study||2||
48420350|NCT01497899|101365364|FG000|STARTED|Double-Blind Phase||113||
48420351|NCT01497899|101365365|FG001|STARTED|Double-Blind Phase||58||
48420352|NCT01497899|101365366|FG002|STARTED|Double-Blind Phase||0||
48420353|NCT01497899|101365367|FG003|STARTED|Double-Blind Phase||0||
48420354|NCT01497899|101365364|FG000|COMPLETED|Double-Blind Phase||107||
48420355|NCT01497899|101365365|FG001|COMPLETED|Double-Blind Phase||53||
48420356|NCT01497899|101365366|FG002|COMPLETED|Double-Blind Phase||0||
48420357|NCT01497899|101365367|FG003|COMPLETED|Double-Blind Phase||0||
48420358|NCT01497899|101365364|FG000|NOT COMPLETED|Double-Blind Phase||6||
48420359|NCT01497899|101365365|FG001|NOT COMPLETED|Double-Blind Phase||5||
48420360|NCT01497899|101365366|FG002|NOT COMPLETED|Double-Blind Phase||0||
48420361|NCT01497899|101365367|FG003|NOT COMPLETED|Double-Blind Phase||0||
48420362|NCT01497899|101365364|FG000|STARTED|Open-Label Extension Phase||105||
48420363|NCT01497899|101365365|FG001|STARTED|Open-Label Extension Phase||53||
48420364|NCT01497899|101365366|FG002|STARTED|Open-Label Extension Phase||70||
48420365|NCT01497899|101365367|FG003|STARTED|Open-Label Extension Phase||38||
48420366|NCT01497899|101365364|FG000|COMPLETED|Open-Label Extension Phase||86||
48420367|NCT01497899|101365365|FG001|COMPLETED|Open-Label Extension Phase||46||
48420368|NCT01497899|101365366|FG002|COMPLETED|Open-Label Extension Phase||61||
48420369|NCT01497899|101365367|FG003|COMPLETED|Open-Label Extension Phase||33||
48420370|NCT01497899|101365364|FG000|NOT COMPLETED|Open-Label Extension Phase||19||
48420371|NCT01497899|101365365|FG001|NOT COMPLETED|Open-Label Extension Phase||7||
48420372|NCT01497899|101365366|FG002|NOT COMPLETED|Open-Label Extension Phase||9||
48420373|NCT01497899|101365367|FG003|NOT COMPLETED|Open-Label Extension Phase||5||
48420374|NCT01375491|101365368|FG000|STARTED|Overall Study||11||
48420375|NCT01375491|101365369|FG001|STARTED|Overall Study||13||
48638841|NCT02711137|101901515|FG011|NOT COMPLETED|Overall Study||3||
48638842|NCT02711137|101901516|FG012|NOT COMPLETED|Overall Study||1||
48420376|NCT01375491|101365370|FG002|STARTED|Overall Study||15||
48420377|NCT01375491|101365368|FG000|COMPLETED|Overall Study||9||
48420378|NCT01375491|101365369|FG001|COMPLETED|Overall Study||12||
48420379|NCT01375491|101365370|FG002|COMPLETED|Overall Study||15||
48420380|NCT01375491|101365368|FG000|NOT COMPLETED|Overall Study||2||
48420381|NCT01375491|101365369|FG001|NOT COMPLETED|Overall Study||1||
48638843|NCT02711137|101901517|FG013|NOT COMPLETED|Overall Study||2||
48420382|NCT01375491|101365370|FG002|NOT COMPLETED|Overall Study||0||
48420383|NCT00431132|101365371|FG000|STARTED|Overall Study||336||
48420384|NCT00431132|101365371|FG000|COMPLETED|Overall Study||292||
48420385|NCT00431132|101365371|FG000|NOT COMPLETED|Overall Study||44||
48420386|NCT00760994|101365372|FG000|STARTED|Overall Study||29||
48420387|NCT00760994|101365373|FG001|STARTED|Overall Study||31||
48420388|NCT00760994|101365374|FG002|STARTED|Overall Study||20||
48420389|NCT00760994|101365372|FG000|COMPLETED|Overall Study||25||
48420390|NCT00760994|101365373|FG001|COMPLETED|Overall Study||27||
48420391|NCT00760994|101365374|FG002|COMPLETED|Overall Study||17||
48420392|NCT00760994|101365372|FG000|NOT COMPLETED|Overall Study||4||
48420393|NCT00760994|101365373|FG001|NOT COMPLETED|Overall Study||4||
48420394|NCT00760994|101365374|FG002|NOT COMPLETED|Overall Study||3||
48420395|NCT00060333|101365375|FG000|STARTED|Overall Study||20||
48420396|NCT00060333|101365375|FG000|COMPLETED|Overall Study||20||
48420397|NCT00060333|101365375|FG000|NOT COMPLETED|Overall Study||0||
48420398|NCT02584660|101365376|FG000|STARTED|Overall Study||51||
48420399|NCT02584660|101365377|FG001|STARTED|Overall Study||63||
48420400|NCT02584660|101365376|FG000|Treated|Overall Study||49||
48420401|NCT02584660|101365377|FG001|Treated|Overall Study||63||
48420402|NCT02584660|101365376|FG000|COMPLETED|Overall Study||44||
48420403|NCT02584660|101365377|FG001|COMPLETED|Overall Study||55||
48420404|NCT02584660|101365376|FG000|NOT COMPLETED|Overall Study||7||
48420405|NCT02584660|101365377|FG001|NOT COMPLETED|Overall Study||8||
48420406|NCT04047342|101365378|FG000|STARTED|Overall Study||409||
48420407|NCT04047342|101365379|FG001|STARTED|Overall Study||415||
48420408|NCT04047342|101365378|FG000|COMPLETED|Overall Study||409|We did not receive information on bounced emails, so we assumed that all participants in the data set started and completed the study.|
48420409|NCT04047342|101365379|FG001|COMPLETED|Overall Study||415|We did not receive information on bounced emails, so we assumed that all participants in the data set started and completed the study.|
48420410|NCT04047342|101365378|FG000|NOT COMPLETED|Overall Study||0||
48420411|NCT04047342|101365379|FG001|NOT COMPLETED|Overall Study||0||
48420412|NCT00917553|101365380|FG000|STARTED|Overall Study||17||
48420413|NCT00917553|101365381|FG001|STARTED|Overall Study||16||
48420414|NCT00917553|101365380|FG000|COMPLETED|Overall Study||15||
48420415|NCT00917553|101365381|FG001|COMPLETED|Overall Study||15||
48420416|NCT00917553|101365380|FG000|NOT COMPLETED|Overall Study||2||
48420417|NCT00917553|101365381|FG001|NOT COMPLETED|Overall Study||1||
48420418|NCT01230489|101365382|FG000|STARTED|Overall Study||13||
48420419|NCT01230489|101365382|FG000|COMPLETED|Overall Study||8||
48420420|NCT01230489|101365382|FG000|NOT COMPLETED|Overall Study||5||
48420421|NCT01005875|101365383|FG000|STARTED|Overall Study||5||
48420422|NCT01005875|101365383|FG000|COMPLETED|Overall Study||2||
48420423|NCT01005875|101365383|FG000|NOT COMPLETED|Overall Study||3||
48420424|NCT01866839|101365384|FG000|STARTED|Overall Study||40||
48420425|NCT01866839|101365384|FG000|COMPLETED|Overall Study||30||
48420426|NCT01866839|101365384|FG000|NOT COMPLETED|Overall Study||10||
48420427|NCT00211692|101365385|FG000|STARTED|Overall Study||33||
48420428|NCT00211692|101365386|FG001|STARTED|Overall Study||31||
48420429|NCT00211692|101365385|FG000|COMPLETED|Overall Study||33||
48420430|NCT00211692|101365386|FG001|COMPLETED|Overall Study||31||
48420431|NCT00211692|101365385|FG000|NOT COMPLETED|Overall Study||0||
48420432|NCT00211692|101365386|FG001|NOT COMPLETED|Overall Study||0||
48420433|NCT01880320|101365387|FG000|STARTED|Overall Study||217||
48420434|NCT01880320|101365388|FG001|STARTED|Overall Study||217||
48420435|NCT01880320|101365389|FG002|STARTED|Overall Study||69||
48420436|NCT01880320|101365387|FG000|COMPLETED|Overall Study||197||
48420437|NCT01880320|101365388|FG001|COMPLETED|Overall Study||192||
48420438|NCT01880320|101365389|FG002|COMPLETED|Overall Study||61||
48420439|NCT01880320|101365387|FG000|NOT COMPLETED|Overall Study||20||
48420440|NCT01880320|101365388|FG001|NOT COMPLETED|Overall Study||25||
48420441|NCT01880320|101365389|FG002|NOT COMPLETED|Overall Study||8||
48420442|NCT00001151|101365390|FG000|STARTED|Overall Study||6||
48420443|NCT00001151|101365390|FG000|COMPLETED|Overall Study||1||
48420444|NCT00001151|101365390|FG000|NOT COMPLETED|Overall Study||5||
48420445|NCT00386152|101365391|FG000|STARTED|Overall Study||75||
48420446|NCT00386152|101365392|FG001|STARTED|Overall Study||77||
48420447|NCT00386152|101365393|FG002|STARTED|Overall Study||75||
48420448|NCT00386152|101365391|FG000|COMPLETED|Overall Study||31||
48420449|NCT00386152|101365392|FG001|COMPLETED|Overall Study||37||
48420450|NCT00386152|101365393|FG002|COMPLETED|Overall Study||42||
48420451|NCT00386152|101365391|FG000|NOT COMPLETED|Overall Study||44||
48420452|NCT00386152|101365392|FG001|NOT COMPLETED|Overall Study||40||
48420453|NCT00386152|101365393|FG002|NOT COMPLETED|Overall Study||33||
48420454|NCT02728804|101365394|FG000|STARTED|Overall Study||380||
48420455|NCT02728804|101365394|FG000|Eligible and Completed Baseline Questionnaire|Overall Study||368||
48420456|NCT02728804|101365394|FG000|COMPLETED|Overall Study||269||
48420457|NCT02728804|101365394|FG000|NOT COMPLETED|Overall Study||111||
48420458|NCT01097057|101365395|FG000|STARTED|Overall Study||20||
48420459|NCT01097057|101365395|FG000|COMPLETED|Overall Study||17||
48420460|NCT01097057|101365395|FG000|NOT COMPLETED|Overall Study||3||
48420461|NCT01130831|101365396|FG000|STARTED|Overall Study||66||
48420462|NCT01130831|101365396|FG000|COMPLETED|Overall Study||52||
48420463|NCT01130831|101365396|FG000|NOT COMPLETED|Overall Study||14||
48420464|NCT02229513|101365397|FG000|STARTED|Overall Study||100||
48420465|NCT02229513|101365398|FG001|STARTED|Overall Study||100||
48420466|NCT02229513|101365397|FG000|COMPLETED|Overall Study||100||
48420467|NCT02229513|101365398|FG001|COMPLETED|Overall Study||100||
48420468|NCT02229513|101365397|FG000|NOT COMPLETED|Overall Study||0||
48420469|NCT02229513|101365398|FG001|NOT COMPLETED|Overall Study||0||
48420470|NCT01212627|101365399|FG000|STARTED|Overall Study||12||
48420471|NCT01212627|101365399|FG000|COMPLETED|Overall Study||12||
48420472|NCT01212627|101365399|FG000|NOT COMPLETED|Overall Study||0||
48420473|NCT02134912|101365400|FG000|STARTED|Overall Study||0||
48420474|NCT02134912|101365401|FG001|STARTED|Overall Study||0||
48420475|NCT02134912|101365400|FG000|COMPLETED|Overall Study||0||
48420476|NCT02134912|101365401|FG001|COMPLETED|Overall Study||0||
48420477|NCT02134912|101365400|FG000|NOT COMPLETED|Overall Study||0||
48420478|NCT02134912|101365401|FG001|NOT COMPLETED|Overall Study||0||
48420479|NCT02350660|101365402|FG000|STARTED|Overall Study||7||
48420480|NCT02350660|101365403|FG001|STARTED|Overall Study||17||
48420481|NCT02350660|101365402|FG000|COMPLETED|Overall Study||7||
48420482|NCT02350660|101365403|FG001|COMPLETED|Overall Study||17||
48420483|NCT02350660|101365402|FG000|NOT COMPLETED|Overall Study||0||
48420484|NCT02350660|101365403|FG001|NOT COMPLETED|Overall Study||0||
48420485|NCT00372905|101365404|FG000|STARTED|Cohort 1: Dose Level 1.0mg/m2||3||
48420486|NCT00372905|101365405|FG001|STARTED|Cohort 1: Dose Level 1.0mg/m2||0||
48420487|NCT00372905|101365406|FG002|STARTED|Cohort 1: Dose Level 1.0mg/m2||0||
48420488|NCT00372905|101365407|FG003|STARTED|Cohort 1: Dose Level 1.0mg/m2||0||
48420489|NCT00372905|101365404|FG000|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||3||
48420490|NCT00372905|101365405|FG001|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0||
48420491|NCT00372905|101365406|FG002|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0||
48420492|NCT00372905|101365407|FG003|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0||
48420493|NCT00372905|101365404|FG000|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||3||
48420494|NCT00372905|101365405|FG001|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0||
48420495|NCT00372905|101365406|FG002|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0||
48420496|NCT00372905|101365407|FG003|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0||
48420497|NCT00372905|101365404|FG000|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||1||
48420498|NCT00372905|101365405|FG001|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0||
48420499|NCT00372905|101365406|FG002|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0||
48420500|NCT00372905|101365407|FG003|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0||
48420501|NCT00372905|101365404|FG000|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||1||
48420502|NCT00372905|101365405|FG001|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0||
48420503|NCT00372905|101365406|FG002|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0||
48420504|NCT00372905|101365407|FG003|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0||
48420505|NCT00372905|101365404|FG000|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||2||
48420506|NCT00372905|101365405|FG001|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0||
48420507|NCT00372905|101365406|FG002|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0||
48420508|NCT00372905|101365407|FG003|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0||
48420509|NCT00372905|101365404|FG000|STARTED|Cohort 2: Dose Level 1.3mg/m2||0||
48420510|NCT00372905|101365405|FG001|STARTED|Cohort 2: Dose Level 1.3mg/m2||3||
48420511|NCT00372905|101365406|FG002|STARTED|Cohort 2: Dose Level 1.3mg/m2||0||
48420512|NCT00372905|101365407|FG003|STARTED|Cohort 2: Dose Level 1.3mg/m2||0||
48420513|NCT00372905|101365404|FG000|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0||
48420514|NCT00372905|101365405|FG001|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||3||
48420515|NCT00372905|101365406|FG002|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0||
48420516|NCT00372905|101365407|FG003|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0||
48420517|NCT00372905|101365404|FG000|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0||
48420518|NCT00372905|101365405|FG001|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||3||
48420519|NCT00372905|101365406|FG002|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0||
48420520|NCT00372905|101365407|FG003|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0||
48420521|NCT00372905|101365404|FG000|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0||
48420522|NCT00372905|101365405|FG001|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||3||
48420523|NCT00372905|101365406|FG002|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0||
48420524|NCT00372905|101365407|FG003|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0||
48420525|NCT00372905|101365404|FG000|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0||
48420526|NCT00372905|101365405|FG001|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||3||
48420527|NCT00372905|101365406|FG002|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0||
48420528|NCT00372905|101365407|FG003|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0||
48420529|NCT00372905|101365404|FG000|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0||
48420530|NCT00372905|101365405|FG001|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0||
48420531|NCT00372905|101365406|FG002|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0||
48420532|NCT00372905|101365407|FG003|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0||
48420533|NCT00372905|101365404|FG000|STARTED|Cohort 3: Dose Level 1.6mg/m2||0||
48420534|NCT00372905|101365405|FG001|STARTED|Cohort 3: Dose Level 1.6mg/m2||0||
48420535|NCT00372905|101365406|FG002|STARTED|Cohort 3: Dose Level 1.6mg/m2||4||
48420536|NCT00372905|101365407|FG003|STARTED|Cohort 3: Dose Level 1.6mg/m2||0||
48420537|NCT00372905|101365404|FG000|Registered|Cohort 3: Dose Level 1.6mg/m2||0||
48420538|NCT00372905|101365405|FG001|Registered|Cohort 3: Dose Level 1.6mg/m2||0||
48420539|NCT00372905|101365406|FG002|Registered|Cohort 3: Dose Level 1.6mg/m2||4||
48420540|NCT00372905|101365407|FG003|Registered|Cohort 3: Dose Level 1.6mg/m2||0||
48420541|NCT00372905|101365404|FG000|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0||
48420542|NCT00372905|101365405|FG001|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0||
48420543|NCT00372905|101365406|FG002|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||3||
48420544|NCT00372905|101365407|FG003|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0||
48420545|NCT00372905|101365404|FG000|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0||
48420546|NCT00372905|101365405|FG001|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0||
48420547|NCT00372905|101365406|FG002|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||1||
48420548|NCT00372905|101365407|FG003|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0||
48420549|NCT00372905|101365404|FG000|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0||
48420550|NCT00372905|101365405|FG001|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0||
48420551|NCT00372905|101365406|FG002|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||1||
48420552|NCT00372905|101365407|FG003|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0||
48420553|NCT00372905|101365404|FG000|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0||
48420554|NCT00372905|101365405|FG001|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0||
48420555|NCT00372905|101365406|FG002|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||3||
48420556|NCT00372905|101365407|FG003|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0||
48420557|NCT00372905|101365404|FG000|STARTED|Expansion Phase at Dose 1.3mg/m2||0||
48420558|NCT00372905|101365405|FG001|STARTED|Expansion Phase at Dose 1.3mg/m2||0||
48420559|NCT00372905|101365406|FG002|STARTED|Expansion Phase at Dose 1.3mg/m2||0||
48420560|NCT00372905|101365407|FG003|STARTED|Expansion Phase at Dose 1.3mg/m2||8||
48420561|NCT00372905|101365404|FG000|Registration|Expansion Phase at Dose 1.3mg/m2||0||
48420562|NCT00372905|101365405|FG001|Registration|Expansion Phase at Dose 1.3mg/m2||0||
48420563|NCT00372905|101365406|FG002|Registration|Expansion Phase at Dose 1.3mg/m2||0||
48420564|NCT00372905|101365407|FG003|Registration|Expansion Phase at Dose 1.3mg/m2||8||
48420565|NCT00372905|101365404|FG000|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0||
48420566|NCT00372905|101365405|FG001|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0||
48420567|NCT00372905|101365406|FG002|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0||
48420568|NCT00372905|101365407|FG003|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||8||
48420569|NCT00372905|101365404|FG000|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0||
48420570|NCT00372905|101365405|FG001|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0||
48420571|NCT00372905|101365406|FG002|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0||
48420572|NCT00372905|101365407|FG003|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||6||
48420573|NCT00372905|101365404|FG000|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0||
48420574|NCT00372905|101365405|FG001|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0||
48420575|NCT00372905|101365406|FG002|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0||
48420576|NCT00372905|101365407|FG003|COMPLETED|Expansion Phase at Dose 1.3mg/m2||6||
48420577|NCT00372905|101365404|FG000|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0||
48420578|NCT00372905|101365405|FG001|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0||
48420579|NCT00372905|101365406|FG002|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0||
48420580|NCT00372905|101365407|FG003|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||2||
48420581|NCT00372905|101365404|FG000|STARTED|Follow up Until Relapse or Progression||3||
48420582|NCT00372905|101365405|FG001|STARTED|Follow up Until Relapse or Progression||3||
48420583|NCT00372905|101365406|FG002|STARTED|Follow up Until Relapse or Progression||3||
48420584|NCT00372905|101365407|FG003|STARTED|Follow up Until Relapse or Progression||8||
48420585|NCT00372905|101365404|FG000|COMPLETED|Follow up Until Relapse or Progression||3||
48420586|NCT00372905|101365405|FG001|COMPLETED|Follow up Until Relapse or Progression||2||
48420587|NCT00372905|101365406|FG002|COMPLETED|Follow up Until Relapse or Progression||3||
48420588|NCT00372905|101365407|FG003|COMPLETED|Follow up Until Relapse or Progression||5||
48420589|NCT00372905|101365404|FG000|NOT COMPLETED|Follow up Until Relapse or Progression||0||
48420590|NCT00372905|101365405|FG001|NOT COMPLETED|Follow up Until Relapse or Progression||1||
48420591|NCT00372905|101365406|FG002|NOT COMPLETED|Follow up Until Relapse or Progression||0||
48420592|NCT00372905|101365407|FG003|NOT COMPLETED|Follow up Until Relapse or Progression||3||
48420593|NCT05230693|101365408|FG000|STARTED|Overall Study||25||
48420594|NCT05230693|101365409|FG001|STARTED|Overall Study||25||
48420595|NCT05230693|101365408|FG000|COMPLETED|Overall Study||21||
48420596|NCT05230693|101365409|FG001|COMPLETED|Overall Study||18||
48420597|NCT05230693|101365408|FG000|NOT COMPLETED|Overall Study||4||
48420598|NCT05230693|101365409|FG001|NOT COMPLETED|Overall Study||7||
48420599|NCT00041119|101365410|FG000|STARTED|Overall Study||1142||
48420600|NCT00041119|101365411|FG001|STARTED|Overall Study||789||
48420601|NCT00041119|101365412|FG002|STARTED|Overall Study||1151||
48420602|NCT00041119|101365413|FG003|STARTED|Overall Study||789||
48420603|NCT00041119|101365410|FG000|COMPLETED|Overall Study||1142||
48420604|NCT00041119|101365411|FG001|COMPLETED|Overall Study||789||
48420605|NCT00041119|101365412|FG002|COMPLETED|Overall Study||1151||
48420606|NCT00041119|101365413|FG003|COMPLETED|Overall Study||789||
48420607|NCT00041119|101365410|FG000|NOT COMPLETED|Overall Study||0||
48420608|NCT00041119|101365411|FG001|NOT COMPLETED|Overall Study||0||
48420609|NCT00041119|101365412|FG002|NOT COMPLETED|Overall Study||0||
48420610|NCT00041119|101365413|FG003|NOT COMPLETED|Overall Study||0||
48420611|NCT03520842|101365414|FG000|STARTED|Overall Study||18||
48420612|NCT03520842|101365414|FG000|COMPLETED|Overall Study||18||
48420613|NCT03520842|101365414|FG000|NOT COMPLETED|Overall Study||0||
48420614|NCT00952133|101365415|FG000|STARTED|Overall Study||59||
48420615|NCT00952133|101365416|FG001|STARTED|Overall Study||59||
48420616|NCT00952133|101365415|FG000|COMPLETED|Overall Study||59||
48420617|NCT00952133|101365416|FG001|COMPLETED|Overall Study||59||
48420618|NCT00952133|101365415|FG000|NOT COMPLETED|Overall Study||0||
48420619|NCT00952133|101365416|FG001|NOT COMPLETED|Overall Study||0||
48420620|NCT02816255|101365417|FG000|STARTED|Overall Study||6||
48420621|NCT02816255|101365418|FG001|STARTED|Overall Study||5||
48420622|NCT02816255|101365417|FG000|COMPLETED|Overall Study||6||
48420623|NCT02816255|101365418|FG001|COMPLETED|Overall Study||5||
48420624|NCT02816255|101365417|FG000|NOT COMPLETED|Overall Study||0||
48420625|NCT02816255|101365418|FG001|NOT COMPLETED|Overall Study||0||
48420626|NCT00962780|101365419|FG000|STARTED|Overall Study||151||
48420627|NCT00962780|101365420|FG001|STARTED|Overall Study||152||
48420628|NCT00962780|101365419|FG000|Vaccinated 13vPnC Dose 1|Overall Study||150||
48420629|NCT00962780|101365420|FG001|Vaccinated 13vPnC Dose 1|Overall Study||151||
48420630|NCT00962780|101365419|FG000|Vaccinated 13vPnC Dose 2|Overall Study||145||
48420631|NCT00962780|101365420|FG001|Vaccinated 13vPnC Dose 2|Overall Study||145||
48420632|NCT00962780|101365419|FG000|Vaccinated 13vPnC Dose 3|Overall Study||144||
48420633|NCT00962780|101365420|FG001|Vaccinated 13vPnC Dose 3|Overall Study||142||
48420634|NCT00962780|101365419|FG000|Vaccinated 23vPS Dose|Overall Study||143||
48420635|NCT00962780|101365420|FG001|Vaccinated 23vPS Dose|Overall Study||139||
48420636|NCT00962780|101365419|FG000|COMPLETED|Overall Study||141||
48420637|NCT00962780|101365420|FG001|COMPLETED|Overall Study||138||
48420638|NCT00962780|101365419|FG000|NOT COMPLETED|Overall Study||10||
48420639|NCT00962780|101365420|FG001|NOT COMPLETED|Overall Study||14||
48420640|NCT01756209|101365421|FG000|STARTED|Overall Study||40||
48420641|NCT01756209|101365422|FG001|STARTED|Overall Study||40||
48420642|NCT01756209|101365423|FG002|STARTED|Overall Study||40||
48420643|NCT01756209|101365424|FG003|STARTED|Overall Study||40||
48420644|NCT01756209|101365421|FG000|COMPLETED|Overall Study||40||
48420645|NCT01756209|101365422|FG001|COMPLETED|Overall Study||40||
48420646|NCT01756209|101365423|FG002|COMPLETED|Overall Study||40||
48420647|NCT01756209|101365424|FG003|COMPLETED|Overall Study||40||
48420648|NCT01756209|101365421|FG000|NOT COMPLETED|Overall Study||0||
48420649|NCT01756209|101365422|FG001|NOT COMPLETED|Overall Study||0||
48420650|NCT01756209|101365423|FG002|NOT COMPLETED|Overall Study||0||
48420651|NCT01756209|101365424|FG003|NOT COMPLETED|Overall Study||0||
48420652|NCT00784836|101365425|FG000|STARTED|Overall Study||3||
48420653|NCT00784836|101365425|FG000|COMPLETED|Overall Study||0||
48420654|NCT00784836|101365425|FG000|NOT COMPLETED|Overall Study||3||
48420655|NCT03763942|101365426|FG000|STARTED|Overall Study||437||
48420656|NCT03763942|101365427|FG001|STARTED|Overall Study||221||
48420657|NCT03763942|101365426|FG000|COMPLETED|Overall Study||318||
48638844|NCT02711137|101901518|FG014|NOT COMPLETED|Overall Study||3||
48638845|NCT01403584|101901519|FG000|STARTED|First Intervention (1 Night)||11||
48420658|NCT03763942|101365427|FG001|COMPLETED|Overall Study||164||
48420659|NCT03763942|101365426|FG000|NOT COMPLETED|Overall Study||119||
48420660|NCT03763942|101365427|FG001|NOT COMPLETED|Overall Study||57||
48420661|NCT01611558|101365428|FG000|STARTED|Induction Phase||40||
48420662|NCT01611558|101365428|FG000|COMPLETED|Induction Phase||2||
48420663|NCT01611558|101365428|FG000|NOT COMPLETED|Induction Phase||38||
48420664|NCT01611558|101365428|FG000|STARTED|Maintenance Phase||2||
48638846|NCT01403584|101901520|FG001|STARTED|First Intervention (1 Night)||10||
48420665|NCT01611558|101365428|FG000|COMPLETED|Maintenance Phase||0||
48420666|NCT01611558|101365428|FG000|NOT COMPLETED|Maintenance Phase||2||
48420667|NCT01408862|101365429|FG000|STARTED|Overall Study||20||
48420668|NCT01408862|101365429|FG000|COMPLETED|Overall Study||20||
48420669|NCT01408862|101365429|FG000|NOT COMPLETED|Overall Study||0||
48420670|NCT01982942|101365430|FG000|STARTED|Overall Study||129||
48420671|NCT01982942|101365431|FG001|STARTED|Overall Study||126||
48420672|NCT01982942|101365430|FG000|COMPLETED|Overall Study||108||
48420673|NCT01982942|101365431|FG001|COMPLETED|Overall Study||112||
48420674|NCT01982942|101365430|FG000|NOT COMPLETED|Overall Study||21||
48420675|NCT01982942|101365431|FG001|NOT COMPLETED|Overall Study||14||
48420676|NCT00426842|101365432|FG000|STARTED|Overall Study||11||
48420677|NCT00426842|101365432|FG000|COMPLETED|Overall Study||10||
48420678|NCT00426842|101365432|FG000|NOT COMPLETED|Overall Study||1||
48420679|NCT00570089|101365433|FG000|STARTED|Period 1||10||
48420680|NCT00570089|101365434|FG001|STARTED|Period 1||10||
48420681|NCT00570089|101365433|FG000|COMPLETED|Period 1||10||
48420682|NCT00570089|101365434|FG001|COMPLETED|Period 1||10||
48420683|NCT00570089|101365433|FG000|NOT COMPLETED|Period 1||0||
48420684|NCT00570089|101365434|FG001|NOT COMPLETED|Period 1||0||
48420685|NCT00570089|101365433|FG000|STARTED|Perod 2||10||
48420686|NCT00570089|101365434|FG001|STARTED|Perod 2||10||
48420687|NCT00570089|101365433|FG000|COMPLETED|Perod 2||10||
48420688|NCT00570089|101365434|FG001|COMPLETED|Perod 2||10||
48420689|NCT00570089|101365433|FG000|NOT COMPLETED|Perod 2||0||
48420690|NCT00570089|101365434|FG001|NOT COMPLETED|Perod 2||0||
48420691|NCT01140646|101365435|FG000|STARTED|Overall Study||43||
48420692|NCT01140646|101365435|FG000|COMPLETED|Overall Study||34||
48420693|NCT01140646|101365435|FG000|NOT COMPLETED|Overall Study||9||
48420694|NCT01453439|101365436|FG000|STARTED|Treatment Phase||61||
48420695|NCT01453439|101365437|FG001|STARTED|Treatment Phase||59||
48420696|NCT01453439|101365436|FG000|COMPLETED|Treatment Phase||44||
48420697|NCT01453439|101365437|FG001|COMPLETED|Treatment Phase||48||
48420698|NCT01453439|101365436|FG000|NOT COMPLETED|Treatment Phase||17||
48420699|NCT01453439|101365437|FG001|NOT COMPLETED|Treatment Phase||11||
48420700|NCT01453439|101365436|FG000|STARTED|Follow-up||44||
48420701|NCT01453439|101365437|FG001|STARTED|Follow-up||48||
48420702|NCT01453439|101365436|FG000|COMPLETED|Follow-up||39||
48420703|NCT01453439|101365437|FG001|COMPLETED|Follow-up||37||
48420704|NCT01453439|101365436|FG000|NOT COMPLETED|Follow-up||5||
48420705|NCT01453439|101365437|FG001|NOT COMPLETED|Follow-up||11||
48420706|NCT03223649|101365438|FG000|STARTED|Overall Study||52||
48420707|NCT03223649|101365439|FG001|STARTED|Overall Study||57||
48420708|NCT03223649|101365438|FG000|COMPLETED|Overall Study||42||
48420709|NCT03223649|101365439|FG001|COMPLETED|Overall Study||51||
48420710|NCT03223649|101365438|FG000|NOT COMPLETED|Overall Study||10||
48420711|NCT03223649|101365439|FG001|NOT COMPLETED|Overall Study||6||
48420712|NCT03702439|101365440|FG000|STARTED|Overall Study||408||
48420713|NCT03702439|101365440|FG000|COMPLETED|Overall Study||408||
48420714|NCT03702439|101365440|FG000|NOT COMPLETED|Overall Study||0||
48420715|NCT01353976|101365441|FG000|STARTED|Overall Study||130||
48420716|NCT01353976|101365442|FG001|STARTED|Overall Study||134||
48420717|NCT01353976|101365441|FG000|COMPLETED|Overall Study||82||
48420718|NCT01353976|101365442|FG001|COMPLETED|Overall Study||83||
48420719|NCT01353976|101365441|FG000|NOT COMPLETED|Overall Study||48||
48420720|NCT01353976|101365442|FG001|NOT COMPLETED|Overall Study||51||
48420721|NCT01070381|101365443|FG000|STARTED|Period 1, 1 Week of Wear||109||
48420722|NCT01070381|101365444|FG001|STARTED|Period 1, 1 Week of Wear||107||
48420723|NCT01070381|101365443|FG000|COMPLETED|Period 1, 1 Week of Wear||109||
48420724|NCT01070381|101365444|FG001|COMPLETED|Period 1, 1 Week of Wear||107||
48420725|NCT01070381|101365443|FG000|NOT COMPLETED|Period 1, 1 Week of Wear||0||
48420726|NCT01070381|101365444|FG001|NOT COMPLETED|Period 1, 1 Week of Wear||0||
48420727|NCT01070381|101365443|FG000|STARTED|Period 2, 1 Week of Wear||109||
48420728|NCT01070381|101365444|FG001|STARTED|Period 2, 1 Week of Wear||107||
48420729|NCT01070381|101365443|FG000|COMPLETED|Period 2, 1 Week of Wear||108||
48420730|NCT01070381|101365444|FG001|COMPLETED|Period 2, 1 Week of Wear||106||
48420731|NCT01070381|101365443|FG000|NOT COMPLETED|Period 2, 1 Week of Wear||1||
48420732|NCT01070381|101365444|FG001|NOT COMPLETED|Period 2, 1 Week of Wear||1||
48420733|NCT00842829|101365445|FG000|STARTED|Dose Titration Period||156||
48420734|NCT00842829|101365446|FG001|STARTED|Dose Titration Period||174||
48420735|NCT00842829|101365447|FG002|STARTED|Dose Titration Period||0||
48420736|NCT00842829|101365445|FG000|Titration Safety Analysis Set|Dose Titration Period||145||
48420737|NCT00842829|101365446|FG001|Titration Safety Analysis Set|Dose Titration Period||167||
48420738|NCT00842829|101365447|FG002|Titration Safety Analysis Set|Dose Titration Period||0||
48420739|NCT00842829|101365445|FG000|COMPLETED|Dose Titration Period||130||
48420740|NCT00842829|101365446|FG001|COMPLETED|Dose Titration Period||151||
48420741|NCT00842829|101365447|FG002|COMPLETED|Dose Titration Period||0||
48420742|NCT00842829|101365445|FG000|NOT COMPLETED|Dose Titration Period||26||
48420743|NCT00842829|101365446|FG001|NOT COMPLETED|Dose Titration Period||23||
48420744|NCT00842829|101365447|FG002|NOT COMPLETED|Dose Titration Period||0||
48420745|NCT00842829|101365445|FG000|STARTED|Treatment Period||0||
48420746|NCT00842829|101365446|FG001|STARTED|Treatment Period||0||
48420747|NCT00842829|101365447|FG002|STARTED|Treatment Period||281||
48420748|NCT00842829|101365445|FG000|Safety Analysis Set|Treatment Period||0||
48420749|NCT00842829|101365446|FG001|Safety Analysis Set|Treatment Period||0||
48420750|NCT00842829|101365447|FG002|Safety Analysis Set|Treatment Period||223||
48420751|NCT00842829|101365445|FG000|COMPLETED|Treatment Period||0||
48420752|NCT00842829|101365446|FG001|COMPLETED|Treatment Period||0||
48420753|NCT00842829|101365447|FG002|COMPLETED|Treatment Period||218||
48420754|NCT00842829|101365445|FG000|NOT COMPLETED|Treatment Period||0||
48420755|NCT00842829|101365446|FG001|NOT COMPLETED|Treatment Period||0||
48420756|NCT00842829|101365447|FG002|NOT COMPLETED|Treatment Period||63||
48420757|NCT00842829|101365445|FG000|STARTED|Continuation Period||0||
48420758|NCT00842829|101365446|FG001|STARTED|Continuation Period||0||
48420759|NCT00842829|101365447|FG002|STARTED|Continuation Period||88||
48420760|NCT00842829|101365445|FG000|Continuation Safety Analysis Set|Continuation Period||0||
48420761|NCT00842829|101365446|FG001|Continuation Safety Analysis Set|Continuation Period||0||
48420762|NCT00842829|101365447|FG002|Continuation Safety Analysis Set|Continuation Period||87||
48420763|NCT00842829|101365445|FG000|COMPLETED|Continuation Period||0||
48420764|NCT00842829|101365446|FG001|COMPLETED|Continuation Period||0||
48420765|NCT00842829|101365447|FG002|COMPLETED|Continuation Period||27||
48420766|NCT00842829|101365445|FG000|NOT COMPLETED|Continuation Period||0||
48420767|NCT00842829|101365446|FG001|NOT COMPLETED|Continuation Period||0||
48420768|NCT00842829|101365447|FG002|NOT COMPLETED|Continuation Period||61||
48420769|NCT01935622|101365448|FG000|STARTED|Overall Study||3||
48420770|NCT01935622|101365449|FG001|STARTED|Overall Study||3||
48420771|NCT01935622|101365450|FG002|STARTED|Overall Study||4||
48420772|NCT01935622|101365448|FG000|COMPLETED|Overall Study||1||
48420773|NCT01935622|101365449|FG001|COMPLETED|Overall Study||1||
48420774|NCT01935622|101365450|FG002|COMPLETED|Overall Study||4||
48420775|NCT01935622|101365448|FG000|NOT COMPLETED|Overall Study||2||
48420776|NCT01935622|101365449|FG001|NOT COMPLETED|Overall Study||2||
48420777|NCT01935622|101365450|FG002|NOT COMPLETED|Overall Study||0||
48420778|NCT01756391|101365451|FG000|STARTED|Overall Study||351||
48420779|NCT01756391|101365451|FG000|COMPLETED|Overall Study||319||
48420780|NCT01756391|101365451|FG000|NOT COMPLETED|Overall Study||32||
48420781|NCT01728194|101365452|FG000|STARTED|Overall Study||54||
48420782|NCT01728194|101365453|FG001|STARTED|Overall Study||67||
48420783|NCT01728194|101365452|FG000|COMPLETED|Overall Study||34||
48420784|NCT01728194|101365453|FG001|COMPLETED|Overall Study||61||
48420785|NCT01728194|101365452|FG000|NOT COMPLETED|Overall Study||20||
48420786|NCT01728194|101365453|FG001|NOT COMPLETED|Overall Study||6||
48420787|NCT05047601|101365454|FG000|STARTED|Overall Study||921||
48420788|NCT05047601|101365455|FG001|STARTED|Overall Study||917||
48420789|NCT05047601|101365456|FG002|STARTED|Overall Study||898||
48420790|NCT05047601|101365454|FG000|Treated|Overall Study||913||
48420791|NCT05047601|101365455|FG001|Treated|Overall Study||911||
48420792|NCT05047601|101365456|FG002|Treated|Overall Study||897||
48420793|NCT05047601|101365454|FG000|COMPLETED|Overall Study||877||
48420794|NCT05047601|101365455|FG001|COMPLETED|Overall Study||864||
48420795|NCT05047601|101365456|FG002|COMPLETED|Overall Study||863||
48420796|NCT05047601|101365454|FG000|NOT COMPLETED|Overall Study||44||
48420797|NCT05047601|101365455|FG001|NOT COMPLETED|Overall Study||53||
48420798|NCT05047601|101365456|FG002|NOT COMPLETED|Overall Study||35||
48420799|NCT02499380|101365457|FG000|STARTED|Overall Study||20||
48420800|NCT02499380|101365457|FG000|COMPLETED|Overall Study||17||
48420801|NCT02499380|101365457|FG000|NOT COMPLETED|Overall Study||3||
48420802|NCT02452034|101365458|FG000|STARTED|Overall Study||16||
48420803|NCT02452034|101365459|FG001|STARTED|Overall Study||21||
48420804|NCT02452034|101365460|FG002|STARTED|Overall Study||15||
48420805|NCT02452034|101365461|FG003|STARTED|Overall Study||17||
48420806|NCT02452034|101365462|FG004|STARTED|Overall Study||20||
48420807|NCT02452034|101365463|FG005|STARTED|Overall Study||29||
48420808|NCT02452034|101365458|FG000|Treated|Overall Study||14||
48420809|NCT02452034|101365459|FG001|Treated|Overall Study||21||
48420810|NCT02452034|101365460|FG002|Treated|Overall Study||15||
48420811|NCT02452034|101365461|FG003|Treated|Overall Study||16||
48420812|NCT02452034|101365462|FG004|Treated|Overall Study||20||
48420813|NCT02452034|101365463|FG005|Treated|Overall Study||29||
48420814|NCT02452034|101365458|FG000|COMPLETED|Overall Study||14||
48420815|NCT02452034|101365459|FG001|COMPLETED|Overall Study||20||
48420816|NCT02452034|101365460|FG002|COMPLETED|Overall Study||14||
48420817|NCT02452034|101365461|FG003|COMPLETED|Overall Study||16||
48420818|NCT02452034|101365462|FG004|COMPLETED|Overall Study||19||
48420819|NCT02452034|101365463|FG005|COMPLETED|Overall Study||26||
48420820|NCT02452034|101365458|FG000|NOT COMPLETED|Overall Study||2||
48420821|NCT02452034|101365459|FG001|NOT COMPLETED|Overall Study||1||
48420822|NCT02452034|101365460|FG002|NOT COMPLETED|Overall Study||1||
48420823|NCT02452034|101365461|FG003|NOT COMPLETED|Overall Study||1||
48420824|NCT02452034|101365462|FG004|NOT COMPLETED|Overall Study||1||
48420825|NCT02452034|101365463|FG005|NOT COMPLETED|Overall Study||3||
48420826|NCT03927703|101365464|FG000|STARTED|Overall Study||237||
48420827|NCT03927703|101365465|FG001|STARTED|Overall Study||118||
48420828|NCT03927703|101365464|FG000|COMPLETED|Overall Study||192||
48420829|NCT03927703|101365465|FG001|COMPLETED|Overall Study||102||
48420830|NCT03927703|101365464|FG000|NOT COMPLETED|Overall Study||45||
48420831|NCT03927703|101365465|FG001|NOT COMPLETED|Overall Study||16||
48420832|NCT02365961|101365466|FG000|STARTED|Overall Study||41||
48420833|NCT02365961|101365467|FG001|STARTED|Overall Study||43||
48420834|NCT02365961|101365466|FG000|COMPLETED|Overall Study||41||
48420835|NCT02365961|101365467|FG001|COMPLETED|Overall Study||43||
48420836|NCT02365961|101365466|FG000|NOT COMPLETED|Overall Study||0||
48420837|NCT02365961|101365467|FG001|NOT COMPLETED|Overall Study||0||
48420838|NCT04419558|101365468|FG000|STARTED|DB Period (48 Weeks)||184||
48420839|NCT04419558|101365469|FG001|STARTED|DB Period (48 Weeks)||188||
48420840|NCT04419558|101365468|FG000|Received at Least 1 Dose of Study Drug|DB Period (48 Weeks)||183||
48420841|NCT04419558|101365469|FG001|Received at Least 1 Dose of Study Drug|DB Period (48 Weeks)||188||
48420842|NCT04419558|101365468|FG000|COMPLETED|DB Period (48 Weeks)||47||
48420843|NCT04419558|101365469|FG001|COMPLETED|DB Period (48 Weeks)||56||
48420844|NCT04419558|101365468|FG000|NOT COMPLETED|DB Period (48 Weeks)||137||
48420845|NCT04419558|101365469|FG001|NOT COMPLETED|DB Period (48 Weeks)||132||
48420846|NCT04419558|101365468|FG000|STARTED|OLE Period (48 Weeks)||41||
48420847|NCT04419558|101365469|FG001|STARTED|OLE Period (48 Weeks)||45||
48420848|NCT04419558|101365468|FG000|COMPLETED|OLE Period (48 Weeks)||0||
48420849|NCT04419558|101365469|FG001|COMPLETED|OLE Period (48 Weeks)||0||
48420850|NCT04419558|101365468|FG000|NOT COMPLETED|OLE Period (48 Weeks)||41||
48420851|NCT04419558|101365469|FG001|NOT COMPLETED|OLE Period (48 Weeks)||45||
48420852|NCT00298766|101365470|FG000|STARTED|Overall Study||70||
48420853|NCT00298766|101365470|FG000|COMPLETED|Overall Study||24||
48420854|NCT00298766|101365470|FG000|NOT COMPLETED|Overall Study||46||
48420855|NCT01562327|101365471|FG000|STARTED|Overall Study||50||
48420856|NCT01562327|101365471|FG000|COMPLETED|Overall Study||42||
48420857|NCT01562327|101365471|FG000|NOT COMPLETED|Overall Study||8||
48420858|NCT01371721|101365472|FG000|STARTED|Overall Study||88||
48420859|NCT01371721|101365473|FG001|STARTED|Overall Study||89||
48420860|NCT01371721|101365474|FG002|STARTED|Overall Study||92||
48420861|NCT01371721|101365472|FG000|Treated|Overall Study||87||
48420862|NCT01371721|101365473|FG001|Treated|Overall Study||89||
48420863|NCT01371721|101365474|FG002|Treated|Overall Study||92||
48420864|NCT01371721|101365472|FG000|COMPLETED|Overall Study||59||
48420865|NCT01371721|101365473|FG001|COMPLETED|Overall Study||65||
48420866|NCT01371721|101365474|FG002|COMPLETED|Overall Study||62||
48420867|NCT01371721|101365472|FG000|NOT COMPLETED|Overall Study||29||
48420868|NCT01371721|101365473|FG001|NOT COMPLETED|Overall Study||24||
48420869|NCT01371721|101365474|FG002|NOT COMPLETED|Overall Study||30||
48420870|NCT03655951|101365475|FG000|STARTED|Overall Study||358|Randomized|
48420871|NCT03655951|101365476|FG001|STARTED|Overall Study||372|Randomized|
48420872|NCT03655951|101365475|FG000|Completed Pretest|Overall Study||344||
48420873|NCT03655951|101365476|FG001|Completed Pretest|Overall Study||366||
48420874|NCT03655951|101365475|FG000|COMPLETED|Overall Study||319|Completed posttest|
48420875|NCT03655951|101365476|FG001|COMPLETED|Overall Study||351|Completed posttest|
48420876|NCT03655951|101365475|FG000|NOT COMPLETED|Overall Study||39||
48420877|NCT03655951|101365476|FG001|NOT COMPLETED|Overall Study||21||
48420878|NCT03958149|101365477|FG000|STARTED|Overall Study||20||
48420879|NCT03958149|101365478|FG001|STARTED|Overall Study||18||
48420880|NCT03958149|101365477|FG000|COMPLETED|Overall Study||20||
48420881|NCT03958149|101365478|FG001|COMPLETED|Overall Study||17||
48420882|NCT03958149|101365477|FG000|NOT COMPLETED|Overall Study||0||
48420883|NCT03958149|101365478|FG001|NOT COMPLETED|Overall Study||1||
48420884|NCT01466972|101365479|FG000|STARTED|Overall Study||30||
48420885|NCT01466972|101365479|FG000|COMPLETED|Overall Study||30||
48420886|NCT01466972|101365479|FG000|NOT COMPLETED|Overall Study||0||
48420887|NCT01493024|101365480|FG000|STARTED|Overall Study||30||
48420888|NCT01493024|101365481|FG001|STARTED|Overall Study||12||
48420889|NCT01493024|101365482|FG002|STARTED|Overall Study||24||
48420890|NCT01493024|101365483|FG003|STARTED|Overall Study||24||
48420891|NCT01493024|101365480|FG000|COMPLETED|Overall Study||30||
48420892|NCT01493024|101365481|FG001|COMPLETED|Overall Study||12||
48420893|NCT01493024|101365482|FG002|COMPLETED|Overall Study||24||
48420894|NCT01493024|101365483|FG003|COMPLETED|Overall Study||24||
48420895|NCT01493024|101365480|FG000|NOT COMPLETED|Overall Study||0||
48420896|NCT01493024|101365481|FG001|NOT COMPLETED|Overall Study||0||
48420897|NCT01493024|101365482|FG002|NOT COMPLETED|Overall Study||0||
48420898|NCT01493024|101365483|FG003|NOT COMPLETED|Overall Study||0||
48420899|NCT00495794|101365484|FG000|STARTED|Overall Study||2319||
48420900|NCT00495794|101365485|FG001|STARTED|Overall Study||2303||
48420901|NCT00495794|101365484|FG000|COMPLETED|Overall Study||1797||
48420902|NCT00495794|101365485|FG001|COMPLETED|Overall Study||2303||
48420903|NCT00495794|101365484|FG000|NOT COMPLETED|Overall Study||522||
48420904|NCT00495794|101365485|FG001|NOT COMPLETED|Overall Study||0||
48420905|NCT01284127|101365486|FG000|STARTED|Overall Study||38||
48420906|NCT01284127|101365486|FG000|COMPLETED|Overall Study||31||
48420907|NCT01284127|101365486|FG000|NOT COMPLETED|Overall Study||7||
48420908|NCT00626327|101365487|FG000|STARTED|Overall Study||504||
48420909|NCT00626327|101365488|FG001|STARTED|Overall Study||616||
48420910|NCT00626327|101365489|FG002|STARTED|Overall Study||510||
48420911|NCT00626327|101365487|FG000|COMPLETED|Overall Study||426||
48420912|NCT00626327|101365488|FG001|COMPLETED|Overall Study||557||
48420913|NCT00626327|101365489|FG002|COMPLETED|Overall Study||422||
48420914|NCT00626327|101365487|FG000|NOT COMPLETED|Overall Study||78||
48420915|NCT00626327|101365488|FG001|NOT COMPLETED|Overall Study||59||
48420916|NCT00626327|101365489|FG002|NOT COMPLETED|Overall Study||88||
48420917|NCT00702949|101365490|FG000|STARTED|Overall Study||63||
48420918|NCT00702949|101365491|FG001|STARTED|Overall Study||66||
48420919|NCT00702949|101365492|FG002|STARTED|Overall Study||62||
48420920|NCT00702949|101365490|FG000|Evaluable for Primary Endpoint|Overall Study||56||
48420921|NCT00702949|101365491|FG001|Evaluable for Primary Endpoint|Overall Study||56||
48420922|NCT00702949|101365492|FG002|Evaluable for Primary Endpoint|Overall Study||51||
48420923|NCT00702949|101365490|FG000|COMPLETED|Overall Study||58||
48420924|NCT00702949|101365491|FG001|COMPLETED|Overall Study||57||
48420925|NCT00702949|101365492|FG002|COMPLETED|Overall Study||54||
48420926|NCT00702949|101365490|FG000|NOT COMPLETED|Overall Study||5||
48420927|NCT00702949|101365491|FG001|NOT COMPLETED|Overall Study||9||
48420928|NCT00702949|101365492|FG002|NOT COMPLETED|Overall Study||8||
48420929|NCT00526227|101365493|FG000|STARTED|Overall Study||81||
48420930|NCT00526227|101365493|FG000|COMPLETED|Overall Study||79||
48420931|NCT00526227|101365493|FG000|NOT COMPLETED|Overall Study||2||
48420932|NCT02249377|101365494|FG000|STARTED|Overall Study||25||
48420933|NCT02249377|101365495|FG001|STARTED|Overall Study||25||
48420934|NCT02249377|101365494|FG000|COMPLETED|Overall Study||0||
48420935|NCT02249377|101365495|FG001|COMPLETED|Overall Study||1||
48638847|NCT01403584|101901519|FG000|COMPLETED|First Intervention (1 Night)||11||
48638848|NCT01403584|101901520|FG001|COMPLETED|First Intervention (1 Night)||10||
48638849|NCT01403584|101901519|FG000|NOT COMPLETED|First Intervention (1 Night)||0||
48638850|NCT01403584|101901520|FG001|NOT COMPLETED|First Intervention (1 Night)||0||
48638851|NCT01403584|101901519|FG000|STARTED|Second Intervention(1 Night)||10||
48638852|NCT01403584|101901520|FG001|STARTED|Second Intervention(1 Night)||11||
48638853|NCT01403584|101901519|FG000|COMPLETED|Second Intervention(1 Night)||10||
48638854|NCT01403584|101901520|FG001|COMPLETED|Second Intervention(1 Night)||11||
48638855|NCT01403584|101901519|FG000|NOT COMPLETED|Second Intervention(1 Night)||0||
48763713|NCT03712358|102208794|FG000|NOT COMPLETED|Overall Study||0||
48763714|NCT03712358|102208795|FG001|NOT COMPLETED|Overall Study||0||
48763715|NCT03712358|102208796|FG002|NOT COMPLETED|Overall Study||0||
48763716|NCT03712358|102208797|FG003|NOT COMPLETED|Overall Study||0||
48763717|NCT03712358|102208798|FG004|NOT COMPLETED|Overall Study||0||
48359302|NCT01300286|101207585|FG000|COMPLETED|Overall Study||22||
48763718|NCT06271993|102208799|FG000|STARTED|Overall Study||27||27
48186913|NCT01515319|100779938|FG009|COMPLETED|Overall Study||8||
48359303|NCT01300286|101207585|FG000|NOT COMPLETED|Overall Study||1||
48359304|NCT03270085|101207586|FG000|STARTED|Overall Study||15||
48359305|NCT03270085|101207587|FG001|STARTED|Overall Study||15||
48359306|NCT03270085|101207586|FG000|COMPLETED|Overall Study||14||
48359307|NCT03270085|101207587|FG001|COMPLETED|Overall Study||15||
48359308|NCT03270085|101207586|FG000|NOT COMPLETED|Overall Study||1||
48359309|NCT03270085|101207587|FG001|NOT COMPLETED|Overall Study||0||
48359310|NCT02723630|101207588|FG000|STARTED|Intervention Period 1||10||
48359311|NCT02723630|101207589|FG001|STARTED|Intervention Period 1||10||
48359312|NCT02723630|101207590|FG002|STARTED|Intervention Period 1||10||
48359313|NCT02723630|101207591|FG003|STARTED|Intervention Period 1||10||
48359314|NCT02723630|101207592|FG004|STARTED|Intervention Period 1||10||
48359315|NCT02723630|101207593|FG005|STARTED|Intervention Period 1||10||
48359316|NCT02723630|101207588|FG000|COMPLETED|Intervention Period 1||9||
48359317|NCT02723630|101207589|FG001|COMPLETED|Intervention Period 1||10||
48359318|NCT02723630|101207590|FG002|COMPLETED|Intervention Period 1||10||
48359319|NCT02723630|101207591|FG003|COMPLETED|Intervention Period 1||10||
48359320|NCT02723630|101207592|FG004|COMPLETED|Intervention Period 1||10||
48359321|NCT02723630|101207593|FG005|COMPLETED|Intervention Period 1||10||
48359322|NCT02723630|101207588|FG000|NOT COMPLETED|Intervention Period 1||1||
48359323|NCT02723630|101207589|FG001|NOT COMPLETED|Intervention Period 1||0||
48359324|NCT02723630|101207590|FG002|NOT COMPLETED|Intervention Period 1||0||
48359325|NCT02723630|101207591|FG003|NOT COMPLETED|Intervention Period 1||0||
48359326|NCT02723630|101207592|FG004|NOT COMPLETED|Intervention Period 1||0||
48359327|NCT02723630|101207593|FG005|NOT COMPLETED|Intervention Period 1||0||
48359328|NCT02723630|101207588|FG000|STARTED|Intervention Period 2||9||
48359329|NCT02723630|101207589|FG001|STARTED|Intervention Period 2||10||
48359330|NCT02723630|101207590|FG002|STARTED|Intervention Period 2||10||
48359331|NCT02723630|101207591|FG003|STARTED|Intervention Period 2||10||
48359332|NCT02723630|101207592|FG004|STARTED|Intervention Period 2||10||
48359333|NCT02723630|101207593|FG005|STARTED|Intervention Period 2||10||
48359334|NCT02723630|101207588|FG000|COMPLETED|Intervention Period 2||9||
48359335|NCT02723630|101207589|FG001|COMPLETED|Intervention Period 2||10||
48359336|NCT02723630|101207590|FG002|COMPLETED|Intervention Period 2||10||
48359337|NCT02723630|101207591|FG003|COMPLETED|Intervention Period 2||10||
48359338|NCT02723630|101207592|FG004|COMPLETED|Intervention Period 2||10||
48359339|NCT02723630|101207593|FG005|COMPLETED|Intervention Period 2||10||
48359340|NCT02723630|101207588|FG000|NOT COMPLETED|Intervention Period 2||0||
48359341|NCT02723630|101207589|FG001|NOT COMPLETED|Intervention Period 2||0||
48359342|NCT02723630|101207590|FG002|NOT COMPLETED|Intervention Period 2||0||
48359343|NCT02723630|101207591|FG003|NOT COMPLETED|Intervention Period 2||0||
48359344|NCT02723630|101207592|FG004|NOT COMPLETED|Intervention Period 2||0||
48359345|NCT02723630|101207593|FG005|NOT COMPLETED|Intervention Period 2||0||
48359346|NCT02723630|101207588|FG000|STARTED|Intervention Period 3||9||
48359347|NCT02723630|101207589|FG001|STARTED|Intervention Period 3||10||
48359348|NCT02723630|101207590|FG002|STARTED|Intervention Period 3||10||
48359349|NCT02723630|101207591|FG003|STARTED|Intervention Period 3||10||
48359350|NCT02723630|101207592|FG004|STARTED|Intervention Period 3||10||
48359351|NCT02723630|101207593|FG005|STARTED|Intervention Period 3||10||
48359352|NCT02723630|101207588|FG000|COMPLETED|Intervention Period 3||9||
48638856|NCT01403584|101901520|FG001|NOT COMPLETED|Second Intervention(1 Night)||0||
48638857|NCT01143792|101901521|FG000|STARTED|Overall Study||93||
48638858|NCT01143792|101901522|FG001|STARTED|Overall Study||86||
48763719|NCT06271993|102208800|FG001|STARTED|Overall Study||27||27
48638859|NCT01143792|101901523|FG002|STARTED|Overall Study||91||
48763720|NCT06271993|102208801|FG002|STARTED|Overall Study||27||27
48420936|NCT02249377|101365494|FG000|NOT COMPLETED|Overall Study||25||
48420937|NCT02249377|101365495|FG001|NOT COMPLETED|Overall Study||24||
48420938|NCT00954356|101365496|FG000|STARTED|Overall Study||41||
48420939|NCT00954356|101365497|FG001|STARTED|Overall Study||20||
48420940|NCT00954356|101365496|FG000|COMPLETED|Overall Study||41||
48420941|NCT00954356|101365497|FG001|COMPLETED|Overall Study||20||
48420942|NCT00954356|101365496|FG000|NOT COMPLETED|Overall Study||0||
48420943|NCT00954356|101365497|FG001|NOT COMPLETED|Overall Study||0||
48420944|NCT02155660|101365498|FG000|STARTED|Overall Study||562||
48420945|NCT02155660|101365499|FG001|STARTED|Overall Study||562||
48420946|NCT02155660|101365500|FG002|STARTED|Overall Study||562||
48420947|NCT02155660|101365501|FG003|STARTED|Overall Study||568||
48420948|NCT02155660|101365498|FG000|COMPLETED|Overall Study||504||
48420949|NCT02155660|101365499|FG001|COMPLETED|Overall Study||489||
48420950|NCT02155660|101365500|FG002|COMPLETED|Overall Study||502||
48420951|NCT02155660|101365501|FG003|COMPLETED|Overall Study||507||
48420952|NCT02155660|101365498|FG000|NOT COMPLETED|Overall Study||58||
48420953|NCT02155660|101365499|FG001|NOT COMPLETED|Overall Study||73||
48420954|NCT02155660|101365500|FG002|NOT COMPLETED|Overall Study||60||
48420955|NCT02155660|101365501|FG003|NOT COMPLETED|Overall Study||61||
48420956|NCT00129220|101365502|FG000|STARTED|Study Period II||105||
48420957|NCT00129220|101365503|FG001|STARTED|Study Period II||20||
48420958|NCT00129220|101365504|FG002|STARTED|Study Period II||99||
48420959|NCT00129220|101365502|FG000|Received at Least One Dose of Study Drug|Study Period II||104||
48420960|NCT00129220|101365503|FG001|Received at Least One Dose of Study Drug|Study Period II||20||
48420961|NCT00129220|101365504|FG002|Received at Least One Dose of Study Drug|Study Period II||97||
48420962|NCT00129220|101365502|FG000|COMPLETED|Study Period II||72||
48420963|NCT00129220|101365503|FG001|COMPLETED|Study Period II||8||
48420964|NCT00129220|101365504|FG002|COMPLETED|Study Period II||52||
48420965|NCT00129220|101365502|FG000|NOT COMPLETED|Study Period II||33||
48420966|NCT00129220|101365503|FG001|NOT COMPLETED|Study Period II||12||
48420967|NCT00129220|101365504|FG002|NOT COMPLETED|Study Period II||47||
48420968|NCT00129220|101365502|FG000|STARTED|Study Period III||72||
48420969|NCT00129220|101365503|FG001|STARTED|Study Period III||8||
48420970|NCT00129220|101365504|FG002|STARTED|Study Period III||52||
48420971|NCT00129220|101365502|FG000|COMPLETED|Study Period III||59||
48420972|NCT00129220|101365503|FG001|COMPLETED|Study Period III||7||
48420973|NCT00129220|101365504|FG002|COMPLETED|Study Period III||42||
48420974|NCT00129220|101365502|FG000|NOT COMPLETED|Study Period III||13||
48420975|NCT00129220|101365503|FG001|NOT COMPLETED|Study Period III||1||
48420976|NCT00129220|101365504|FG002|NOT COMPLETED|Study Period III||10||
48420977|NCT01265511|101365505|FG000|STARTED|Overall Study||2||
48420978|NCT01265511|101365506|FG001|STARTED|Overall Study||8||
48420979|NCT01265511|101365505|FG000|COMPLETED|Overall Study||0||
48420980|NCT01265511|101365506|FG001|COMPLETED|Overall Study||5||
48420981|NCT01265511|101365505|FG000|NOT COMPLETED|Overall Study||2||
48420982|NCT01265511|101365506|FG001|NOT COMPLETED|Overall Study||3||
48420983|NCT00877929|101365507|FG000|STARTED|Overall Study||352||
48420984|NCT00877929|101365508|FG001|STARTED|Overall Study||354||
48420985|NCT00877929|101365507|FG000|COMPLETED|Overall Study||332||
48420986|NCT00877929|101365508|FG001|COMPLETED|Overall Study||319||
48420987|NCT00877929|101365507|FG000|NOT COMPLETED|Overall Study||20||
48420988|NCT00877929|101365508|FG001|NOT COMPLETED|Overall Study||35||
48420989|NCT01854918|101365509|FG000|STARTED|SOC-controlled Period (Year 1)||1227||
48420990|NCT01854918|101365510|FG001|STARTED|SOC-controlled Period (Year 1)||2454||
48420991|NCT01854918|101365509|FG000|Received Evolocumab|SOC-controlled Period (Year 1)||5||
48420992|NCT01854918|101365510|FG001|Received Evolocumab|SOC-controlled Period (Year 1)||2452||
48420993|NCT01854918|101365509|FG000|COMPLETED|SOC-controlled Period (Year 1)||1197||
48420994|NCT01854918|101365510|FG001|COMPLETED|SOC-controlled Period (Year 1)||2391||
48420995|NCT01854918|101365509|FG000|NOT COMPLETED|SOC-controlled Period (Year 1)||30||
48420996|NCT01854918|101365510|FG001|NOT COMPLETED|SOC-controlled Period (Year 1)||63||
48420997|NCT01854918|101365509|FG000|STARTED|All-IP Period (Years 2 and 3)||1197||
48420998|NCT01854918|101365510|FG001|STARTED|All-IP Period (Years 2 and 3)||2391||
48420999|NCT01854918|101365509|FG000|Received Evolocumab|All-IP Period (Years 2 and 3)||1152||
48421000|NCT01854918|101365510|FG001|Received Evolocumab|All-IP Period (Years 2 and 3)||2291||
48421001|NCT01854918|101365509|FG000|COMPLETED|All-IP Period (Years 2 and 3)||1079||
48421002|NCT01854918|101365510|FG001|COMPLETED|All-IP Period (Years 2 and 3)||2196||
48421003|NCT01854918|101365509|FG000|NOT COMPLETED|All-IP Period (Years 2 and 3)||118||
48421004|NCT01854918|101365510|FG001|NOT COMPLETED|All-IP Period (Years 2 and 3)||195||
48421005|NCT03490734|101365511|FG000|STARTED|Pre-intervention Baseline Visit||47||
48421006|NCT03490734|101365512|FG001|STARTED|Pre-intervention Baseline Visit||38||
48421007|NCT03490734|101365513|FG002|STARTED|Pre-intervention Baseline Visit||34||
48421008|NCT03490734|101365514|FG003|STARTED|Pre-intervention Baseline Visit||41||
48421009|NCT03490734|101365511|FG000|COMPLETED|Pre-intervention Baseline Visit||47||
48421010|NCT03490734|101365512|FG001|COMPLETED|Pre-intervention Baseline Visit||38||
48421011|NCT03490734|101365513|FG002|COMPLETED|Pre-intervention Baseline Visit||34||
48421012|NCT03490734|101365514|FG003|COMPLETED|Pre-intervention Baseline Visit||41||
48421013|NCT03490734|101365511|FG000|NOT COMPLETED|Pre-intervention Baseline Visit||0||
48421014|NCT03490734|101365512|FG001|NOT COMPLETED|Pre-intervention Baseline Visit||0||
48421015|NCT03490734|101365513|FG002|NOT COMPLETED|Pre-intervention Baseline Visit||0||
48421016|NCT03490734|101365514|FG003|NOT COMPLETED|Pre-intervention Baseline Visit||0||
48421017|NCT03490734|101365511|FG000|STARTED|Pre-intervention Scan Visit||47||
48421018|NCT03490734|101365512|FG001|STARTED|Pre-intervention Scan Visit||38||
48421019|NCT03490734|101365513|FG002|STARTED|Pre-intervention Scan Visit||34||
48421020|NCT03490734|101365514|FG003|STARTED|Pre-intervention Scan Visit||41||
48421021|NCT03490734|101365511|FG000|COMPLETED|Pre-intervention Scan Visit||45||
48421022|NCT03490734|101365512|FG001|COMPLETED|Pre-intervention Scan Visit||37||
48421023|NCT03490734|101365513|FG002|COMPLETED|Pre-intervention Scan Visit||34||
48421024|NCT03490734|101365514|FG003|COMPLETED|Pre-intervention Scan Visit||37||
48421025|NCT03490734|101365511|FG000|NOT COMPLETED|Pre-intervention Scan Visit||2||
48421026|NCT03490734|101365512|FG001|NOT COMPLETED|Pre-intervention Scan Visit||1||
48421027|NCT03490734|101365513|FG002|NOT COMPLETED|Pre-intervention Scan Visit||0||
48421028|NCT03490734|101365514|FG003|NOT COMPLETED|Pre-intervention Scan Visit||4||
48421029|NCT03490734|101365511|FG000|STARTED|Post-intervention Scan Visit||45||
48421030|NCT03490734|101365512|FG001|STARTED|Post-intervention Scan Visit||37||
48421031|NCT03490734|101365513|FG002|STARTED|Post-intervention Scan Visit||34||
48421032|NCT03490734|101365514|FG003|STARTED|Post-intervention Scan Visit||37||
48421033|NCT03490734|101365511|FG000|COMPLETED|Post-intervention Scan Visit||43||
48421034|NCT03490734|101365512|FG001|COMPLETED|Post-intervention Scan Visit||34||
48421035|NCT03490734|101365513|FG002|COMPLETED|Post-intervention Scan Visit||34||
48421036|NCT03490734|101365514|FG003|COMPLETED|Post-intervention Scan Visit||34||
48421037|NCT03490734|101365511|FG000|NOT COMPLETED|Post-intervention Scan Visit||2||
48421038|NCT03490734|101365512|FG001|NOT COMPLETED|Post-intervention Scan Visit||3||
48421039|NCT03490734|101365513|FG002|NOT COMPLETED|Post-intervention Scan Visit||0||
48421040|NCT03490734|101365514|FG003|NOT COMPLETED|Post-intervention Scan Visit||3||
48421041|NCT03490734|101365511|FG000|STARTED|Post-intervention Behavioral Visit||43||
48421042|NCT03490734|101365512|FG001|STARTED|Post-intervention Behavioral Visit||34||
48421043|NCT03490734|101365513|FG002|STARTED|Post-intervention Behavioral Visit||34||
48421044|NCT03490734|101365514|FG003|STARTED|Post-intervention Behavioral Visit||34||
48421045|NCT03490734|101365511|FG000|COMPLETED|Post-intervention Behavioral Visit||43||
48421046|NCT03490734|101365512|FG001|COMPLETED|Post-intervention Behavioral Visit||34||
48421047|NCT03490734|101365513|FG002|COMPLETED|Post-intervention Behavioral Visit||34||
48421048|NCT03490734|101365514|FG003|COMPLETED|Post-intervention Behavioral Visit||34||
48421049|NCT03490734|101365511|FG000|NOT COMPLETED|Post-intervention Behavioral Visit||0||
48421050|NCT03490734|101365512|FG001|NOT COMPLETED|Post-intervention Behavioral Visit||0||
48421051|NCT03490734|101365513|FG002|NOT COMPLETED|Post-intervention Behavioral Visit||0||
48421052|NCT03490734|101365514|FG003|NOT COMPLETED|Post-intervention Behavioral Visit||0||
48421053|NCT00792922|101365515|FG000|STARTED|At Baseline||0||32
48421054|NCT00792922|101365516|FG001|STARTED|At Baseline||0||32
48421055|NCT00792922|101365517|FG002|STARTED|At Baseline||0||32
48421056|NCT00792922|101365518|FG003|STARTED|At Baseline||0||32
48421057|NCT00792922|101365515|FG000|Niger|At Baseline||0||12
48421058|NCT00792922|101365516|FG001|Niger|At Baseline||0||12
48421059|NCT00792922|101365517|FG002|Niger|At Baseline||0||12
48421060|NCT00792922|101365518|FG003|Niger|At Baseline||0||12
48421061|NCT00792922|101365515|FG000|Gambia|At Baseline||0||12
48421062|NCT00792922|101365516|FG001|Gambia|At Baseline||0||12
48421063|NCT00792922|101365517|FG002|Gambia|At Baseline||0||12
48421064|NCT00792922|101365518|FG003|Gambia|At Baseline||0||12
48421065|NCT00792922|101365515|FG000|Tanzania|At Baseline||0||8
48421066|NCT00792922|101365516|FG001|Tanzania|At Baseline||0||8
48421067|NCT00792922|101365517|FG002|Tanzania|At Baseline||0||8
48421068|NCT00792922|101365518|FG003|Tanzania|At Baseline||0||8
48421069|NCT00792922|101365515|FG000|COMPLETED|At Baseline||0||32
48421070|NCT00792922|101365516|FG001|COMPLETED|At Baseline||0||32
48421071|NCT00792922|101365517|FG002|COMPLETED|At Baseline||0||32
48421072|NCT00792922|101365518|FG003|COMPLETED|At Baseline||0||32
48421073|NCT00792922|101365515|FG000|NOT COMPLETED|At Baseline||0||0
48421074|NCT00792922|101365516|FG001|NOT COMPLETED|At Baseline||0||0
48421075|NCT00792922|101365517|FG002|NOT COMPLETED|At Baseline||0||0
48421076|NCT00792922|101365518|FG003|NOT COMPLETED|At Baseline||0||0
48421077|NCT00792922|101365515|FG000|STARTED|At 3 Years||0||40
48421078|NCT00792922|101365516|FG001|STARTED|At 3 Years||0||40
48421079|NCT00792922|101365517|FG002|STARTED|At 3 Years||0||24
48421080|NCT00792922|101365518|FG003|STARTED|At 3 Years||0||24
48421081|NCT00792922|101365515|FG000|Niger|At 3 Years||0||12
48421082|NCT00792922|101365516|FG001|Niger|At 3 Years||0||12
48421083|NCT00792922|101365517|FG002|Niger|At 3 Years||0||12
48421084|NCT00792922|101365518|FG003|Niger|At 3 Years||0||12
48421085|NCT00792922|101365515|FG000|Gambia|At 3 Years||0||12
48421086|NCT00792922|101365516|FG001|Gambia|At 3 Years||0||12
48421087|NCT00792922|101365517|FG002|Gambia|At 3 Years||0||12
48421088|NCT00792922|101365518|FG003|Gambia|At 3 Years||0||12
48421089|NCT00792922|101365515|FG000|Tanzania|At 3 Years||0||16
48421090|NCT00792922|101365516|FG001|Tanzania|At 3 Years||0||16
48421091|NCT00792922|101365517|FG002|Tanzania|At 3 Years||0||0
48421092|NCT00792922|101365518|FG003|Tanzania|At 3 Years||0||0
48421093|NCT00792922|101365515|FG000|COMPLETED|At 3 Years||0||40
48421094|NCT00792922|101365516|FG001|COMPLETED|At 3 Years||0||40
48421095|NCT00792922|101365517|FG002|COMPLETED|At 3 Years||0||24
48421096|NCT00792922|101365518|FG003|COMPLETED|At 3 Years||0||24
48421097|NCT00792922|101365515|FG000|NOT COMPLETED|At 3 Years||0||0
48421098|NCT00792922|101365516|FG001|NOT COMPLETED|At 3 Years||0||0
48421099|NCT00792922|101365517|FG002|NOT COMPLETED|At 3 Years||0||0
48421100|NCT00792922|101365518|FG003|NOT COMPLETED|At 3 Years||0||0
48421101|NCT03341728|101365519|FG000|STARTED|Session 1||7||
48421102|NCT03341728|101365520|FG001|STARTED|Session 1||7||
48421103|NCT03341728|101365519|FG000|COMPLETED|Session 1||7||
48421104|NCT03341728|101365520|FG001|COMPLETED|Session 1||7||
48421105|NCT03341728|101365519|FG000|NOT COMPLETED|Session 1||0||
48421106|NCT03341728|101365520|FG001|NOT COMPLETED|Session 1||0||
48421107|NCT03341728|101365519|FG000|STARTED|Washout (1 Week)||7||
48421108|NCT03341728|101365520|FG001|STARTED|Washout (1 Week)||7||
48421109|NCT03341728|101365519|FG000|COMPLETED|Washout (1 Week)||7||
48421110|NCT03341728|101365520|FG001|COMPLETED|Washout (1 Week)||7||
48421111|NCT03341728|101365519|FG000|NOT COMPLETED|Washout (1 Week)||0||
48421112|NCT03341728|101365520|FG001|NOT COMPLETED|Washout (1 Week)||0||
48421113|NCT03341728|101365519|FG000|STARTED|Session 2||7||
48421114|NCT03341728|101365520|FG001|STARTED|Session 2||7||
48421115|NCT03341728|101365519|FG000|COMPLETED|Session 2||7||
48421116|NCT03341728|101365520|FG001|COMPLETED|Session 2||7||
48421117|NCT03341728|101365519|FG000|NOT COMPLETED|Session 2||0||
48421118|NCT03341728|101365520|FG001|NOT COMPLETED|Session 2||0||
48421119|NCT01638546|101365521|FG000|STARTED|Overall Study||52||
48421120|NCT01638546|101365522|FG001|STARTED|Overall Study||45||
48421121|NCT01638546|101365521|FG000|COMPLETED|Overall Study||51||
48421122|NCT01638546|101365522|FG001|COMPLETED|Overall Study||42||
48421123|NCT01638546|101365521|FG000|NOT COMPLETED|Overall Study||1||
48421124|NCT01638546|101365522|FG001|NOT COMPLETED|Overall Study||3||
48421125|NCT00242658|101365523|FG000|STARTED|Overall Study||187||
48421126|NCT00242658|101365524|FG001|STARTED|Overall Study||207||
48421127|NCT00242658|101365523|FG000|COMPLETED|Overall Study||165||
48421128|NCT00242658|101365524|FG001|COMPLETED|Overall Study||188||
48421129|NCT00242658|101365523|FG000|NOT COMPLETED|Overall Study||22||
48421130|NCT00242658|101365524|FG001|NOT COMPLETED|Overall Study||19||
48421131|NCT01979029|101365525|FG000|STARTED|Overall Study||29||
48421132|NCT01979029|101365526|FG001|STARTED|Overall Study||28||
48421133|NCT01979029|101365525|FG000|COMPLETED|Overall Study||29||
48421134|NCT01979029|101365526|FG001|COMPLETED|Overall Study||28||
48421135|NCT01979029|101365525|FG000|NOT COMPLETED|Overall Study||0||
48421136|NCT01979029|101365526|FG001|NOT COMPLETED|Overall Study||0||
48421137|NCT00166504|101365527|FG000|STARTED|Overall Study||108||
48421138|NCT00166504|101365528|FG001|STARTED|Overall Study||95||
48421139|NCT00166504|101365527|FG000|COMPLETED|Overall Study||103||
48421140|NCT00166504|101365528|FG001|COMPLETED|Overall Study||91||
48421141|NCT00166504|101365527|FG000|NOT COMPLETED|Overall Study||5||
48421142|NCT00166504|101365528|FG001|NOT COMPLETED|Overall Study||4||
48421143|NCT04118127|101365529|FG000|STARTED|Overall Study||35||
48421144|NCT04118127|101365530|FG001|STARTED|Overall Study||38||
48421145|NCT04118127|101365529|FG000|COMPLETED|Overall Study||32||
48421146|NCT04118127|101365530|FG001|COMPLETED|Overall Study||22||
48421147|NCT04118127|101365529|FG000|NOT COMPLETED|Overall Study||3||
48421148|NCT04118127|101365530|FG001|NOT COMPLETED|Overall Study||16||
48421149|NCT01522391|101365531|FG000|STARTED|Overall Study||20||
48421150|NCT01522391|101365532|FG001|STARTED|Overall Study||21||
48421151|NCT01522391|101365531|FG000|COMPLETED|Overall Study||19||
48421152|NCT01522391|101365532|FG001|COMPLETED|Overall Study||20||
48421153|NCT01522391|101365531|FG000|NOT COMPLETED|Overall Study||1||
48421154|NCT01522391|101365532|FG001|NOT COMPLETED|Overall Study||1||
48421155|NCT02275052|101365533|FG000|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99||
48421156|NCT02275052|101365534|FG001|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99||
48421157|NCT02275052|101365535|FG002|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0||
48421158|NCT02275052|101365536|FG003|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0||
48421159|NCT02275052|101365533|FG000|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||90||
48421160|NCT02275052|101365534|FG001|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||93||
48421161|NCT02275052|101365535|FG002|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0||
48421162|NCT02275052|101365536|FG003|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0||
48421163|NCT02275052|101365533|FG000|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||9||
48421164|NCT02275052|101365534|FG001|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||6||
48421165|NCT02275052|101365535|FG002|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0||
48421166|NCT02275052|101365536|FG003|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0||
48421167|NCT02275052|101365533|FG000|STARTED|Washout Period (12-17 Days)||90||
48421168|NCT02275052|101365534|FG001|STARTED|Washout Period (12-17 Days)||93||
48421169|NCT02275052|101365535|FG002|STARTED|Washout Period (12-17 Days)||0||
48421170|NCT02275052|101365536|FG003|STARTED|Washout Period (12-17 Days)||0||
48421171|NCT02275052|101365533|FG000|COMPLETED|Washout Period (12-17 Days)||86||
48421172|NCT02275052|101365534|FG001|COMPLETED|Washout Period (12-17 Days)||93||
48421173|NCT02275052|101365535|FG002|COMPLETED|Washout Period (12-17 Days)||0||
48421174|NCT02275052|101365536|FG003|COMPLETED|Washout Period (12-17 Days)||0||
48421175|NCT02275052|101365533|FG000|NOT COMPLETED|Washout Period (12-17 Days)||4||
48421176|NCT02275052|101365534|FG001|NOT COMPLETED|Washout Period (12-17 Days)||0||
48421177|NCT02275052|101365535|FG002|NOT COMPLETED|Washout Period (12-17 Days)||0||
48421178|NCT02275052|101365536|FG003|NOT COMPLETED|Washout Period (12-17 Days)||0||
48421179|NCT02275052|101365533|FG000|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0||
48421180|NCT02275052|101365534|FG001|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0||
48421181|NCT02275052|101365535|FG002|STARTED|Period 2: Treatment Period 2 (12 Weeks)||93||
48421182|NCT02275052|101365536|FG003|STARTED|Period 2: Treatment Period 2 (12 Weeks)||86||
48421183|NCT02275052|101365533|FG000|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0||
48421184|NCT02275052|101365534|FG001|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0||
48421185|NCT02275052|101365535|FG002|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||88||
48421186|NCT02275052|101365536|FG003|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||72||
48421187|NCT02275052|101365533|FG000|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0||
48421188|NCT02275052|101365534|FG001|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0||
48421189|NCT02275052|101365535|FG002|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||5||
48421190|NCT02275052|101365536|FG003|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||14||
48421191|NCT02132312|101365537|FG000|STARTED|Overall Study||37||
48421192|NCT02132312|101365538|FG001|STARTED|Overall Study||41||
48421193|NCT02132312|101365537|FG000|COMPLETED|Overall Study||31||
48421194|NCT02132312|101365538|FG001|COMPLETED|Overall Study||38||
48421195|NCT02132312|101365537|FG000|NOT COMPLETED|Overall Study||6||
48421196|NCT02132312|101365538|FG001|NOT COMPLETED|Overall Study||3||
48421197|NCT01736176|101365539|FG000|STARTED|Overall Study||39||
48421198|NCT01736176|101365539|FG000|Received LCIG|Overall Study||38||
48421199|NCT01736176|101365539|FG000|COMPLETED|Overall Study||28||
48421200|NCT01736176|101365539|FG000|NOT COMPLETED|Overall Study||11||
48421201|NCT00983827|101365540|FG000|STARTED|Overall Study||8||
48421202|NCT00983827|101365540|FG000|COMPLETED|Overall Study||7||
48421203|NCT00983827|101365540|FG000|NOT COMPLETED|Overall Study||1||
48421204|NCT02936206|101365541|FG000|STARTED|Overall Study||0||
48421205|NCT02936206|101365542|FG001|STARTED|Overall Study||2||
48421206|NCT02936206|101365541|FG000|COMPLETED|Overall Study||0||
48421207|NCT02936206|101365542|FG001|COMPLETED|Overall Study||2||
48421208|NCT02936206|101365541|FG000|NOT COMPLETED|Overall Study||0||
48421209|NCT02936206|101365542|FG001|NOT COMPLETED|Overall Study||0||
48421210|NCT04542525|101365543|FG000|STARTED|Overall Study||32||41
48421211|NCT04542525|101365543|FG000|Attempted Implantation|Overall Study||32||41
48421212|NCT04542525|101365543|FG000|Successful Implantation|Overall Study||32||41
48421213|NCT04542525|101365543|FG000|COMPLETED|Overall Study||32||41
48421214|NCT04542525|101365543|FG000|NOT COMPLETED|Overall Study||0||0
48421215|NCT03798366|101365544|FG000|STARTED|Overall Study||21||
48421216|NCT03798366|101365545|FG001|STARTED|Overall Study||12||
48421217|NCT03798366|101365544|FG000|COMPLETED|Overall Study||21||
48421218|NCT03798366|101365545|FG001|COMPLETED|Overall Study||11||
48421219|NCT03798366|101365544|FG000|NOT COMPLETED|Overall Study||0||
48421220|NCT03798366|101365545|FG001|NOT COMPLETED|Overall Study||1||
48421221|NCT03370133|101365546|FG000|STARTED|Initial Treatment Period (WK 16)||83||
48421222|NCT03370133|101365547|FG001|STARTED|Initial Treatment Period (WK 16)||321||
48421223|NCT03370133|101365548|FG002|STARTED|Initial Treatment Period (WK 16)||163||
48421224|NCT03370133|101365549|FG003|STARTED|Initial Treatment Period (WK 16)||0||
48421225|NCT03370133|101365550|FG004|STARTED|Initial Treatment Period (WK 16)||0||
48421226|NCT03370133|101365551|FG005|STARTED|Initial Treatment Period (WK 16)||0||
48421227|NCT03370133|101365546|FG000|COMPLETED|Initial Treatment Period (WK 16)||74||
48421228|NCT03370133|101365547|FG001|COMPLETED|Initial Treatment Period (WK 16)||306||
48421229|NCT03370133|101365548|FG002|COMPLETED|Initial Treatment Period (WK 16)||157||
48421230|NCT03370133|101365549|FG003|COMPLETED|Initial Treatment Period (WK 16)||0||
48421231|NCT03370133|101365550|FG004|COMPLETED|Initial Treatment Period (WK 16)||0||
48421232|NCT03370133|101365551|FG005|COMPLETED|Initial Treatment Period (WK 16)||0||
48421233|NCT03370133|101365546|FG000|NOT COMPLETED|Initial Treatment Period (WK 16)||9||
48421234|NCT03370133|101365547|FG001|NOT COMPLETED|Initial Treatment Period (WK 16)||15||
48421235|NCT03370133|101365548|FG002|NOT COMPLETED|Initial Treatment Period (WK 16)||6||
48421236|NCT03370133|101365549|FG003|NOT COMPLETED|Initial Treatment Period (WK 16)||0||
48421237|NCT03370133|101365550|FG004|NOT COMPLETED|Initial Treatment Period (WK 16)||0||
48421238|NCT03370133|101365551|FG005|NOT COMPLETED|Initial Treatment Period (WK 16)||0||
48421239|NCT03370133|101365546|FG000|STARTED|Maintenance Treatment Period (WK 52)||0||
48421240|NCT03370133|101365547|FG001|STARTED|Maintenance Treatment Period (WK 52)||0||
48421241|NCT03370133|101365548|FG002|STARTED|Maintenance Treatment Period (WK 52)||0||
48421242|NCT03370133|101365549|FG003|STARTED|Maintenance Treatment Period (WK 52)||74||
48421243|NCT03370133|101365550|FG004|STARTED|Maintenance Treatment Period (WK 52)||306||
48421244|NCT03370133|101365551|FG005|STARTED|Maintenance Treatment Period (WK 52)||157||
48421245|NCT03370133|101365546|FG000|COMPLETED|Maintenance Treatment Period (WK 52)||0||
48421246|NCT03370133|101365547|FG001|COMPLETED|Maintenance Treatment Period (WK 52)||0||
48421247|NCT03370133|101365548|FG002|COMPLETED|Maintenance Treatment Period (WK 52)||0||
48421248|NCT03370133|101365549|FG003|COMPLETED|Maintenance Treatment Period (WK 52)||69||
48421249|NCT03370133|101365550|FG004|COMPLETED|Maintenance Treatment Period (WK 52)||283||
48421250|NCT03370133|101365551|FG005|COMPLETED|Maintenance Treatment Period (WK 52)||141||
48421251|NCT03370133|101365546|FG000|NOT COMPLETED|Maintenance Treatment Period (WK 52)||0||
48421252|NCT03370133|101365547|FG001|NOT COMPLETED|Maintenance Treatment Period (WK 52)||0||
48421253|NCT03370133|101365548|FG002|NOT COMPLETED|Maintenance Treatment Period (WK 52)||0||
48421254|NCT03370133|101365549|FG003|NOT COMPLETED|Maintenance Treatment Period (WK 52)||5||
48421255|NCT03370133|101365550|FG004|NOT COMPLETED|Maintenance Treatment Period (WK 52)||23||
48421256|NCT03370133|101365551|FG005|NOT COMPLETED|Maintenance Treatment Period (WK 52)||16||
48421257|NCT00107536|101365552|FG000|STARTED|Overall Study||26||
48421258|NCT00107536|101365552|FG000|COMPLETED|Overall Study||26||
48421259|NCT00107536|101365552|FG000|NOT COMPLETED|Overall Study||0||
48421260|NCT02636049|101365553|FG000|STARTED|Overall Study||12||
48421261|NCT02636049|101365553|FG000|Triferic 6 mg IV Over 3 Hours|Overall Study||12||
48421262|NCT02636049|101365553|FG000|Triferic 35 Micrograms/kg IV Push|Overall Study||12||
48421263|NCT02636049|101365553|FG000|COMPLETED|Overall Study||12||
48421264|NCT02636049|101365553|FG000|NOT COMPLETED|Overall Study||0||
48421265|NCT02519777|101365554|FG000|STARTED|Overall Study||63||
48421266|NCT02519777|101365555|FG001|STARTED|Overall Study||67||
48421267|NCT02519777|101365556|FG002|STARTED|Overall Study||61||
48421268|NCT02519777|101365554|FG000|COMPLETED|Overall Study||57||
48421269|NCT02519777|101365555|FG001|COMPLETED|Overall Study||59||
48421270|NCT02519777|101365556|FG002|COMPLETED|Overall Study||57||
48421271|NCT02519777|101365554|FG000|NOT COMPLETED|Overall Study||6||
48421272|NCT02519777|101365555|FG001|NOT COMPLETED|Overall Study||8||
48421273|NCT02519777|101365556|FG002|NOT COMPLETED|Overall Study||4||
48421274|NCT00723489|101365557|FG000|STARTED|Overall Study||21||
48421275|NCT00723489|101365558|FG001|STARTED|Overall Study||19||
48421276|NCT00723489|101365559|FG002|STARTED|Overall Study||19||
48421277|NCT00723489|101365560|FG003|STARTED|Overall Study||23||
48421278|NCT00723489|101365557|FG000|COMPLETED|Overall Study||20||
48421279|NCT00723489|101365558|FG001|COMPLETED|Overall Study||15||
48421280|NCT00723489|101365559|FG002|COMPLETED|Overall Study||19||
48421281|NCT00723489|101365560|FG003|COMPLETED|Overall Study||20||
48421282|NCT00723489|101365557|FG000|NOT COMPLETED|Overall Study||1||
48421283|NCT00723489|101365558|FG001|NOT COMPLETED|Overall Study||4||
48421284|NCT00723489|101365559|FG002|NOT COMPLETED|Overall Study||0||
48421285|NCT00723489|101365560|FG003|NOT COMPLETED|Overall Study||3||
48421286|NCT01029691|101365561|FG000|STARTED|APAP Initiation to Week 1 or Delivery||20|Assignment to APAP or Standard, not actual beginning of use of APAP vs. standard of care|
48421287|NCT01029691|101365562|FG001|STARTED|APAP Initiation to Week 1 or Delivery||27|Assignment to APAP or Standard, not actual beginning of use of APAP vs. standard of care|
48421288|NCT01029691|101365563|FG002|STARTED|APAP Initiation to Week 1 or Delivery||77|Assignment to APAP or Standard, not actual beginning of use of APAP vs. standard of care|
48421289|NCT01029691|101365561|FG000|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||20||
48421290|NCT01029691|101365562|FG001|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||23||
48421291|NCT01029691|101365563|FG002|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||77||
48421292|NCT01029691|101365561|FG000|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||20||
48421293|NCT01029691|101365562|FG001|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||16||
48421294|NCT01029691|101365563|FG002|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||77||
48421295|NCT01029691|101365561|FG000|COMPLETED|APAP Initiation to Week 1 or Delivery||20|Women in APAP arm who reached the 1 week blood pressure measure|
48421296|NCT01029691|101365562|FG001|COMPLETED|APAP Initiation to Week 1 or Delivery||16|Women in APAP arm who reached the 1 week blood pressure measure|
48421297|NCT01029691|101365563|FG002|COMPLETED|APAP Initiation to Week 1 or Delivery||77|Women in APAP arm who reached the 1 week blood pressure measure|
48421298|NCT01029691|101365561|FG000|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0||
48421299|NCT01029691|101365562|FG001|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||11||
48421300|NCT01029691|101365563|FG002|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0||
48421301|NCT01029691|101365561|FG000|STARTED|Continued APAP to Delivery||20||
48421302|NCT01029691|101365562|FG001|STARTED|Continued APAP to Delivery||16||
48421303|NCT01029691|101365563|FG002|STARTED|Continued APAP to Delivery||77||
48421304|NCT01029691|101365561|FG000|COMPLETED|Continued APAP to Delivery||20||
48421305|NCT01029691|101365562|FG001|COMPLETED|Continued APAP to Delivery||16||
48421306|NCT01029691|101365563|FG002|COMPLETED|Continued APAP to Delivery||76||
48421307|NCT01029691|101365561|FG000|NOT COMPLETED|Continued APAP to Delivery||0||
48421308|NCT01029691|101365562|FG001|NOT COMPLETED|Continued APAP to Delivery||0||
48421309|NCT01029691|101365563|FG002|NOT COMPLETED|Continued APAP to Delivery||1||
48421310|NCT00186121|101365564|FG000|STARTED|Overall Study||35|Consented|
48421311|NCT00186121|101365564|FG000|COMPLETED|Overall Study||32||
48421312|NCT00186121|101365564|FG000|NOT COMPLETED|Overall Study||3||
48421313|NCT00465894|101365565|FG000|STARTED|Treatment For 12 Weeks||30||
48421314|NCT00465894|101365566|FG001|STARTED|Treatment For 12 Weeks||28||
48421315|NCT00465894|101365565|FG000|COMPLETED|Treatment For 12 Weeks||25||
48421316|NCT00465894|101365566|FG001|COMPLETED|Treatment For 12 Weeks||25||
48421317|NCT00465894|101365565|FG000|NOT COMPLETED|Treatment For 12 Weeks||5||
48421318|NCT00465894|101365566|FG001|NOT COMPLETED|Treatment For 12 Weeks||3||
48421319|NCT00465894|101365565|FG000|STARTED|Treatment From 12 Weeks To 24 Weeks||14||
48421320|NCT00465894|101365566|FG001|STARTED|Treatment From 12 Weeks To 24 Weeks||14||
48421321|NCT00465894|101365565|FG000|COMPLETED|Treatment From 12 Weeks To 24 Weeks||14||
48421322|NCT00465894|101365566|FG001|COMPLETED|Treatment From 12 Weeks To 24 Weeks||14||
48439980|NCT01728376|101409996|FG001|NOT COMPLETED|Overall Study||2||
48421323|NCT00465894|101365565|FG000|NOT COMPLETED|Treatment From 12 Weeks To 24 Weeks||0||
48421324|NCT00465894|101365566|FG001|NOT COMPLETED|Treatment From 12 Weeks To 24 Weeks||0||
48421325|NCT00465894|101365565|FG000|STARTED|Treatment From 24 Weeks to 52 Weeks||11||
48421326|NCT00465894|101365566|FG001|STARTED|Treatment From 24 Weeks to 52 Weeks||14||
48421327|NCT00465894|101365565|FG000|COMPLETED|Treatment From 24 Weeks to 52 Weeks||11||
48421328|NCT00465894|101365566|FG001|COMPLETED|Treatment From 24 Weeks to 52 Weeks||14||
48421329|NCT00465894|101365565|FG000|NOT COMPLETED|Treatment From 24 Weeks to 52 Weeks||0||
48421330|NCT00465894|101365566|FG001|NOT COMPLETED|Treatment From 24 Weeks to 52 Weeks||0||
48421331|NCT00665002|101365567|FG000|STARTED|Overall Study||16||
48421332|NCT00665002|101365567|FG000|COMPLETED|Overall Study||4||
48421333|NCT00665002|101365567|FG000|NOT COMPLETED|Overall Study||12||
48421334|NCT01475214|101365568|FG000|STARTED|Overall Study||84||
48421335|NCT01475214|101365569|FG001|STARTED|Overall Study||79||
48421336|NCT01475214|101365570|FG002|STARTED|Overall Study||81||
48421337|NCT01475214|101365568|FG000|COMPLETED|Overall Study||79||
48421338|NCT01475214|101365569|FG001|COMPLETED|Overall Study||75||
48421339|NCT01475214|101365570|FG002|COMPLETED|Overall Study||79||
48421340|NCT01475214|101365568|FG000|NOT COMPLETED|Overall Study||5||
48421341|NCT01475214|101365569|FG001|NOT COMPLETED|Overall Study||4||
48421342|NCT01475214|101365570|FG002|NOT COMPLETED|Overall Study||2||
48421343|NCT02514889|101365571|FG000|STARTED|Randomization/Allocation to Condition||131||
48421344|NCT02514889|101365572|FG001|STARTED|Randomization/Allocation to Condition||130||
48421345|NCT02514889|101365571|FG000|COMPLETED|Randomization/Allocation to Condition||111||
48421346|NCT02514889|101365572|FG001|COMPLETED|Randomization/Allocation to Condition||106||
48421347|NCT02514889|101365571|FG000|NOT COMPLETED|Randomization/Allocation to Condition||20||
48421348|NCT02514889|101365572|FG001|NOT COMPLETED|Randomization/Allocation to Condition||24||
48421349|NCT02514889|101365571|FG000|STARTED|Intervention Participation||111||
48421350|NCT02514889|101365572|FG001|STARTED|Intervention Participation||106||
48421351|NCT02514889|101365571|FG000|COMPLETED|Intervention Participation||102||
48421352|NCT02514889|101365572|FG001|COMPLETED|Intervention Participation||98||
48421353|NCT02514889|101365571|FG000|NOT COMPLETED|Intervention Participation||9||
48421354|NCT02514889|101365572|FG001|NOT COMPLETED|Intervention Participation||8||
48421355|NCT02514889|101365571|FG000|STARTED|Follow-up Assessment Participation||102|179 participants provided survey data via in-person interviews; 21 provided survey data via phone|
48421356|NCT02514889|101365572|FG001|STARTED|Follow-up Assessment Participation||98|179 participants provided survey data via in-person interviews; 21 provided survey data via phone|
48421357|NCT02514889|101365571|FG000|COMPLETED|Follow-up Assessment Participation||92|179 participants completed in-person follow-up but 1 in-person visit did not include waist measure|
48421358|NCT02514889|101365572|FG001|COMPLETED|Follow-up Assessment Participation||86|179 participants completed in-person follow-up but 1 in-person visit did not include waist measure|
48421359|NCT02514889|101365571|FG000|NOT COMPLETED|Follow-up Assessment Participation||10||
48421360|NCT02514889|101365572|FG001|NOT COMPLETED|Follow-up Assessment Participation||12||
48421361|NCT02242305|101365573|FG000|STARTED|Overall Study||151||
48421362|NCT02242305|101365574|FG001|STARTED|Overall Study||151||
48421363|NCT02242305|101365573|FG000|COMPLETED|Overall Study||145||
48421364|NCT02242305|101365574|FG001|COMPLETED|Overall Study||141||
48421365|NCT02242305|101365573|FG000|NOT COMPLETED|Overall Study||6||
48421366|NCT02242305|101365574|FG001|NOT COMPLETED|Overall Study||10||
48421367|NCT00417248|101365575|FG000|STARTED|Overall Study||8||
48421368|NCT00417248|101365575|FG000|COMPLETED|Overall Study||0||
48421369|NCT00417248|101365575|FG000|NOT COMPLETED|Overall Study||8||
48421370|NCT00106626|101365576|FG000|STARTED|Overall Study||13||
48421371|NCT00106626|101365577|FG001|STARTED|Overall Study||9||
48421372|NCT00106626|101365578|FG002|STARTED|Overall Study||14||
48421373|NCT00106626|101365579|FG003|STARTED|Overall Study||16||
48421374|NCT00106626|101365576|FG000|COMPLETED|Overall Study||3||
48421375|NCT00106626|101365577|FG001|COMPLETED|Overall Study||3||
48421376|NCT00106626|101365578|FG002|COMPLETED|Overall Study||2||
48421377|NCT00106626|101365579|FG003|COMPLETED|Overall Study||3||
48421378|NCT00106626|101365576|FG000|NOT COMPLETED|Overall Study||10||
48421379|NCT00106626|101365577|FG001|NOT COMPLETED|Overall Study||6||
48421380|NCT00106626|101365578|FG002|NOT COMPLETED|Overall Study||12||
48421381|NCT00106626|101365579|FG003|NOT COMPLETED|Overall Study||13||
48421382|NCT00014560|101365580|FG000|STARTED|Overall Study||3||
48421383|NCT00014560|101365580|FG000|COMPLETED|Overall Study||0||
48421384|NCT00014560|101365580|FG000|NOT COMPLETED|Overall Study||3||
48421385|NCT02354599|101365581|FG000|STARTED|Overall Study||6||
48421386|NCT02354599|101365582|FG001|STARTED|Overall Study||6||
48421387|NCT02354599|101365583|FG002|STARTED|Overall Study||6||
48421388|NCT02354599|101365584|FG003|STARTED|Overall Study||6||
48421389|NCT02354599|101365585|FG004|STARTED|Overall Study||2||
48421390|NCT02354599|101365586|FG005|STARTED|Overall Study||6||
48421391|NCT02354599|101365581|FG000|COMPLETED|Overall Study||5||
48421392|NCT02354599|101365582|FG001|COMPLETED|Overall Study||5||
48421393|NCT02354599|101365583|FG002|COMPLETED|Overall Study||6||
48421394|NCT02354599|101365584|FG003|COMPLETED|Overall Study||6||
48421395|NCT02354599|101365585|FG004|COMPLETED|Overall Study||2||
48421396|NCT02354599|101365586|FG005|COMPLETED|Overall Study||5||
48421397|NCT02354599|101365581|FG000|NOT COMPLETED|Overall Study||1||
48421398|NCT02354599|101365582|FG001|NOT COMPLETED|Overall Study||1||
48421399|NCT02354599|101365583|FG002|NOT COMPLETED|Overall Study||0||
48421400|NCT02354599|101365584|FG003|NOT COMPLETED|Overall Study||0||
48421401|NCT02354599|101365585|FG004|NOT COMPLETED|Overall Study||0||
48421402|NCT02354599|101365586|FG005|NOT COMPLETED|Overall Study||1||
48421403|NCT02058966|101365587|FG000|STARTED|Open-Label Methamphetamine||19||
48421404|NCT02058966|101365587|FG000|Received Methamphetamine|Open-Label Methamphetamine||18||
48421405|NCT02058966|101365587|FG000|COMPLETED|Open-Label Methamphetamine||18||
48421406|NCT02058966|101365587|FG000|NOT COMPLETED|Open-Label Methamphetamine||1||
48421407|NCT02058966|101365587|FG000|STARTED|First Intervention||15|3 subjects dropped out between Open-Label Methamphetamine and First Intervention.|
48421408|NCT02058966|101365587|FG000|Received Placebo-Placebo|First Intervention||3||
48421409|NCT02058966|101365587|FG000|Received Placebo-Meth|First Intervention||4||
48421410|NCT02058966|101365587|FG000|Received Entacapone-Placebo|First Intervention||2||
48421411|NCT02058966|101365587|FG000|Received Entacapone-Meth|First Intervention||5||
48421412|NCT02058966|101365587|FG000|COMPLETED|First Intervention||14||
48421413|NCT02058966|101365587|FG000|NOT COMPLETED|First Intervention||1||
48421414|NCT02058966|101365587|FG000|STARTED|Second Intervention||13|1 subject dropped out between First and Second Intervention.|
48421415|NCT02058966|101365587|FG000|Received Placebo-Placebo|Second Intervention||2||
48421416|NCT02058966|101365587|FG000|Received Placebo-Meth|Second Intervention||2||
48421417|NCT02058966|101365587|FG000|Received Entacapone-Placebo|Second Intervention||6||
48421418|NCT02058966|101365587|FG000|Received Entacapone-Meth|Second Intervention||3||
48421419|NCT02058966|101365587|FG000|COMPLETED|Second Intervention||13||
48421420|NCT02058966|101365587|FG000|NOT COMPLETED|Second Intervention||0||
48421421|NCT02058966|101365587|FG000|STARTED|Third Intervention||12|1 subjects dropped out between Second and Third Intervention.|
48421422|NCT02058966|101365587|FG000|Received Placebo-Placebo|Third Intervention||4||
48421423|NCT02058966|101365587|FG000|Received Placebo-Meth|Third Intervention||4||
48421424|NCT02058966|101365587|FG000|Received Entacapone-Placebo|Third Intervention||1||
48421425|NCT02058966|101365587|FG000|Received Entacapone-Meth|Third Intervention||3||
48421426|NCT02058966|101365587|FG000|COMPLETED|Third Intervention||12||
48421427|NCT02058966|101365587|FG000|NOT COMPLETED|Third Intervention||0||
48421428|NCT02058966|101365587|FG000|STARTED|Fourth Intervention||12||
48421429|NCT02058966|101365587|FG000|Received Placebo-Placebo|Fourth Intervention||4||
48421430|NCT02058966|101365587|FG000|Received Placebo-Meth|Fourth Intervention||3||
48421431|NCT02058966|101365587|FG000|Received Entacapone-Placebo|Fourth Intervention||3||
48421432|NCT02058966|101365587|FG000|Received Entacapone-Meth|Fourth Intervention||2||
48421433|NCT02058966|101365587|FG000|COMPLETED|Fourth Intervention||12||
48421434|NCT02058966|101365587|FG000|NOT COMPLETED|Fourth Intervention||0||
48421435|NCT03514394|101365588|FG000|STARTED|Overall Study||17||
48359353|NCT02723630|101207589|FG001|COMPLETED|Intervention Period 3||9||
48359354|NCT02723630|101207590|FG002|COMPLETED|Intervention Period 3||10||
48359355|NCT02723630|101207591|FG003|COMPLETED|Intervention Period 3||10||
48421436|NCT03514394|101365589|FG001|STARTED|Overall Study||16||
48421437|NCT03514394|101365590|FG002|STARTED|Overall Study||11||
48421438|NCT03514394|101365588|FG000|COMPLETED|Overall Study||17||
48421439|NCT03514394|101365589|FG001|COMPLETED|Overall Study||16||
48421440|NCT03514394|101365590|FG002|COMPLETED|Overall Study||10||
48421441|NCT03514394|101365588|FG000|NOT COMPLETED|Overall Study||0||
48421442|NCT03514394|101365589|FG001|NOT COMPLETED|Overall Study||0||
48421443|NCT03514394|101365590|FG002|NOT COMPLETED|Overall Study||1||
48421444|NCT02612194|101365591|FG000|STARTED|Overall Study||6||
48421445|NCT02612194|101365592|FG001|STARTED|Overall Study||0||
48421446|NCT02612194|101365593|FG002|STARTED|Overall Study||2||
48421447|NCT02612194|101365591|FG000|COMPLETED|Overall Study||0||
48421448|NCT02612194|101365592|FG001|COMPLETED|Overall Study||0||
48421449|NCT02612194|101365593|FG002|COMPLETED|Overall Study||0||
48421450|NCT02612194|101365591|FG000|NOT COMPLETED|Overall Study||6||
48421451|NCT02612194|101365592|FG001|NOT COMPLETED|Overall Study||0||
48359356|NCT02723630|101207592|FG004|COMPLETED|Intervention Period 3||10||
48359357|NCT02723630|101207593|FG005|COMPLETED|Intervention Period 3||10||
48359358|NCT02723630|101207588|FG000|NOT COMPLETED|Intervention Period 3||0||
48359359|NCT02723630|101207589|FG001|NOT COMPLETED|Intervention Period 3||1||
48359360|NCT02723630|101207590|FG002|NOT COMPLETED|Intervention Period 3||0||
48359361|NCT02723630|101207591|FG003|NOT COMPLETED|Intervention Period 3||0||
48359362|NCT02723630|101207592|FG004|NOT COMPLETED|Intervention Period 3||0||
48359363|NCT02723630|101207593|FG005|NOT COMPLETED|Intervention Period 3||0||
48359364|NCT03103750|101207594|FG000|STARTED|Overall Study||12||
48359365|NCT03103750|101207595|FG001|STARTED|Overall Study||12||
48421452|NCT02612194|101365593|FG002|NOT COMPLETED|Overall Study||2||
48421453|NCT01230827|101365594|FG000|STARTED|Overall Study||19||
48421454|NCT01230827|101365595|FG001|STARTED|Overall Study||11||
48421455|NCT01230827|101365596|FG002|STARTED|Overall Study||65||
48421456|NCT01230827|101365597|FG003|STARTED|Overall Study||78||
48421457|NCT01230827|101365594|FG000|COMPLETED|Overall Study||0||
48421458|NCT01230827|101365595|FG001|COMPLETED|Overall Study||0||
48421459|NCT01230827|101365596|FG002|COMPLETED|Overall Study||0||
48421460|NCT01230827|101365597|FG003|COMPLETED|Overall Study||0||
48421461|NCT01230827|101365594|FG000|NOT COMPLETED|Overall Study||19||
48421462|NCT01230827|101365595|FG001|NOT COMPLETED|Overall Study||11||
48421463|NCT01230827|101365596|FG002|NOT COMPLETED|Overall Study||65||
48421464|NCT01230827|101365597|FG003|NOT COMPLETED|Overall Study||78||
48421465|NCT03570476|101365598|FG000|STARTED|Overall Study||2||
48421466|NCT03570476|101365598|FG000|COMPLETED|Overall Study||2||
48421467|NCT03570476|101365598|FG000|NOT COMPLETED|Overall Study||0||
48421468|NCT00638651|101365599|FG000|STARTED|Overall Study||3||
48421469|NCT00638651|101365599|FG000|COMPLETED|Overall Study||3||
48421470|NCT00638651|101365599|FG000|NOT COMPLETED|Overall Study||0||
48421471|NCT03860181|101365600|FG000|STARTED|Overall Study||21||
48421472|NCT03860181|101365601|FG001|STARTED|Overall Study||22||
48421473|NCT03860181|101365602|FG002|STARTED|Overall Study||25||
48421474|NCT03860181|101365603|FG003|STARTED|Overall Study||21||
48421475|NCT03860181|101365600|FG000|COMPLETED|Overall Study||21||
48421476|NCT03860181|101365601|FG001|COMPLETED|Overall Study||22||
48421477|NCT03860181|101365602|FG002|COMPLETED|Overall Study||25||
48421478|NCT03860181|101365603|FG003|COMPLETED|Overall Study||21||
48421479|NCT03860181|101365600|FG000|NOT COMPLETED|Overall Study||0||
48421480|NCT03860181|101365601|FG001|NOT COMPLETED|Overall Study||0||
48421481|NCT03860181|101365602|FG002|NOT COMPLETED|Overall Study||0||
48421482|NCT03860181|101365603|FG003|NOT COMPLETED|Overall Study||0||
48421483|NCT01592773|101365604|FG000|STARTED|Overall Study||747||
48421484|NCT01592773|101365604|FG000|COMPLETED|Overall Study||81||
48421485|NCT01592773|101365604|FG000|NOT COMPLETED|Overall Study||666||
48421486|NCT00863434|101365605|FG000|STARTED|Overall Study||2||
48421487|NCT00863434|101365605|FG000|COMPLETED|Overall Study||2||
48421488|NCT00863434|101365605|FG000|NOT COMPLETED|Overall Study||0||
48421489|NCT04450394|101365606|FG000|STARTED|Overall Study||129||
48421490|NCT04450394|101365607|FG001|STARTED|Overall Study||135||
48421491|NCT04450394|101365608|FG002|STARTED|Overall Study||14||
48421492|NCT04450394|101365606|FG000|Received at Least One Dose of Study Drug|Overall Study||129||
48421493|NCT04450394|101365607|FG001|Received at Least One Dose of Study Drug|Overall Study||135||
48421494|NCT04450394|101365608|FG002|Received at Least One Dose of Study Drug|Overall Study||14||
48421495|NCT04450394|101365606|FG000|COMPLETED|Overall Study||119||
48421496|NCT04450394|101365607|FG001|COMPLETED|Overall Study||121||
48421497|NCT04450394|101365608|FG002|COMPLETED|Overall Study||14||
48421498|NCT04450394|101365606|FG000|NOT COMPLETED|Overall Study||10||
48421499|NCT04450394|101365607|FG001|NOT COMPLETED|Overall Study||14||
48421500|NCT04450394|101365608|FG002|NOT COMPLETED|Overall Study||0||
48421501|NCT03637959|101365609|FG000|STARTED|Overall Study||270||
48421502|NCT03637959|101365609|FG000|COMPLETED|Overall Study||270||
48421503|NCT03637959|101365609|FG000|NOT COMPLETED|Overall Study||0||
48421504|NCT03373006|101365610|FG000|STARTED|Overall Study||20||
48421505|NCT03373006|101365610|FG000|COMPLETED|Overall Study||20||
48421506|NCT03373006|101365610|FG000|NOT COMPLETED|Overall Study||0||
48421507|NCT01673373|101365611|FG000|STARTED|Overall Study||68||
48421508|NCT01673373|101365611|FG000|COMPLETED|Overall Study||66||
48421509|NCT01673373|101365611|FG000|NOT COMPLETED|Overall Study||2||
48421510|NCT00551200|101365612|FG000|STARTED|Overall Study||14||
48421511|NCT00551200|101365612|FG000|COMPLETED|Overall Study||10||
48421512|NCT00551200|101365612|FG000|NOT COMPLETED|Overall Study||4||
48421513|NCT00735839|101365613|FG000|STARTED|Overall Study||30||
48421514|NCT00735839|101365614|FG001|STARTED|Overall Study||10||
48421515|NCT00735839|101365613|FG000|COMPLETED|Overall Study||30||
48421516|NCT00735839|101365614|FG001|COMPLETED|Overall Study||10||
48421517|NCT00735839|101365613|FG000|NOT COMPLETED|Overall Study||0||
48421518|NCT00735839|101365614|FG001|NOT COMPLETED|Overall Study||0||
48421519|NCT02055976|101365615|FG000|STARTED|Overall Study||25||
48421520|NCT02055976|101365616|FG001|STARTED|Overall Study||24||
48421521|NCT02055976|101365617|FG002|STARTED|Overall Study||24||
48421522|NCT02055976|101365618|FG003|STARTED|Overall Study||26||
48421523|NCT02055976|101365619|FG004|STARTED|Overall Study||22||
48421524|NCT02055976|101365620|FG005|STARTED|Overall Study||25||
48421525|NCT02055976|101365621|FG006|STARTED|Overall Study||25||
48421526|NCT02055976|101365622|FG007|STARTED|Overall Study||24||
48421527|NCT02055976|101365623|FG008|STARTED|Overall Study||23||
48421528|NCT02055976|101365615|FG000|COMPLETED|Overall Study||25||
48421529|NCT02055976|101365616|FG001|COMPLETED|Overall Study||24||
48421530|NCT02055976|101365617|FG002|COMPLETED|Overall Study||23||
48421531|NCT02055976|101365618|FG003|COMPLETED|Overall Study||25||
48421532|NCT02055976|101365619|FG004|COMPLETED|Overall Study||22||
48421533|NCT02055976|101365620|FG005|COMPLETED|Overall Study||24||
48421534|NCT02055976|101365621|FG006|COMPLETED|Overall Study||23||
48421535|NCT02055976|101365622|FG007|COMPLETED|Overall Study||24||
48421536|NCT02055976|101365623|FG008|COMPLETED|Overall Study||23||
48421537|NCT02055976|101365615|FG000|NOT COMPLETED|Overall Study||0||
48421538|NCT02055976|101365616|FG001|NOT COMPLETED|Overall Study||0||
48421539|NCT02055976|101365617|FG002|NOT COMPLETED|Overall Study||1||
48421540|NCT02055976|101365618|FG003|NOT COMPLETED|Overall Study||1||
48421541|NCT02055976|101365619|FG004|NOT COMPLETED|Overall Study||0||
48421542|NCT02055976|101365620|FG005|NOT COMPLETED|Overall Study||1||
48421543|NCT02055976|101365621|FG006|NOT COMPLETED|Overall Study||2||
48421544|NCT02055976|101365622|FG007|NOT COMPLETED|Overall Study||0||
48421545|NCT02055976|101365623|FG008|NOT COMPLETED|Overall Study||0||
48421546|NCT03480360|101365624|FG000|STARTED|Overall Study||20||
48421547|NCT03480360|101365624|FG000|COMPLETED|Overall Study||18||
48421548|NCT03480360|101365624|FG000|NOT COMPLETED|Overall Study||2||
48421549|NCT00003389|101365625|FG000|STARTED|Overall Study||428||
48421550|NCT00003389|101365626|FG001|STARTED|Overall Study||426||
48421551|NCT00003389|101365625|FG000|Treated Pts w/ Toxicity Data Available|Overall Study||414||
48421552|NCT00003389|101365626|FG001|Treated Pts w/ Toxicity Data Available|Overall Study||422||
48421553|NCT00003389|101365625|FG000|Eligible Patients|Overall Study||395||
48421554|NCT00003389|101365626|FG001|Eligible Patients|Overall Study||399||
48421555|NCT00003389|101365625|FG000|COMPLETED|Overall Study||330||
48421556|NCT00003389|101365626|FG001|COMPLETED|Overall Study||366||
48421557|NCT00003389|101365625|FG000|NOT COMPLETED|Overall Study||98||
48421558|NCT00003389|101365626|FG001|NOT COMPLETED|Overall Study||60||
48421559|NCT02665273|101365627|FG000|STARTED|Overall Study||13||
48421560|NCT02665273|101365628|FG001|STARTED|Overall Study||15||
48421561|NCT02665273|101365627|FG000|COMPLETED|Overall Study||13||
48421562|NCT02665273|101365628|FG001|COMPLETED|Overall Study||15||
48421563|NCT02665273|101365627|FG000|NOT COMPLETED|Overall Study||0||
48421564|NCT02665273|101365628|FG001|NOT COMPLETED|Overall Study||0||
48421565|NCT01004159|101365629|FG000|STARTED|Overall Study||20||
48421566|NCT01004159|101365629|FG000|COMPLETED|Overall Study||0||
48421567|NCT01004159|101365629|FG000|NOT COMPLETED|Overall Study||20||
48421568|NCT01823991|101365630|FG000|STARTED|Overall Study||18||
48421569|NCT01823991|101365631|FG001|STARTED|Overall Study||18||
48421570|NCT01823991|101365630|FG000|COMPLETED|Overall Study||10||
48421571|NCT01823991|101365631|FG001|COMPLETED|Overall Study||13||
48421572|NCT01823991|101365630|FG000|NOT COMPLETED|Overall Study||8||
48421573|NCT01823991|101365631|FG001|NOT COMPLETED|Overall Study||5||
48421574|NCT02911324|101365632|FG000|STARTED|Overall Study||9||
48421575|NCT02911324|101365633|FG001|STARTED|Overall Study||7||
48421576|NCT02911324|101365632|FG000|COMPLETED|Overall Study||6||
48421577|NCT02911324|101365633|FG001|COMPLETED|Overall Study||6||
48421578|NCT02911324|101365632|FG000|NOT COMPLETED|Overall Study||3||
48421579|NCT02911324|101365633|FG001|NOT COMPLETED|Overall Study||1||
48421580|NCT00620815|101365634|FG000|STARTED|Overall Study||199||
48421581|NCT00620815|101365635|FG001|STARTED|Overall Study||203||
48421582|NCT00620815|101365636|FG002|STARTED|Overall Study||199||
48421583|NCT00620815|101365634|FG000|COMPLETED|Overall Study||195||
48421584|NCT00620815|101365635|FG001|COMPLETED|Overall Study||192||
48421585|NCT00620815|101365636|FG002|COMPLETED|Overall Study||192||
48421586|NCT00620815|101365634|FG000|NOT COMPLETED|Overall Study||4||
48421587|NCT00620815|101365635|FG001|NOT COMPLETED|Overall Study||11||
48421588|NCT00620815|101365636|FG002|NOT COMPLETED|Overall Study||7||
48421589|NCT02815982|101369287|FG000|STARTED|Overall Study||27||
48421590|NCT02815982|101369288|FG001|STARTED|Overall Study||26||
48421591|NCT02815982|101369289|FG002|STARTED|Overall Study||27||
48421592|NCT02815982|101369290|FG003|STARTED|Overall Study||26||
48421593|NCT02815982|101369287|FG000|COMPLETED|Overall Study||27|All participants completed at least baseline measurements|
48421594|NCT02815982|101369288|FG001|COMPLETED|Overall Study||26|All participants completed at least baseline measurements|
48421595|NCT02815982|101369289|FG002|COMPLETED|Overall Study||27|All participants completed at least baseline measurements|
48421596|NCT02815982|101369290|FG003|COMPLETED|Overall Study||26|All participants completed at least baseline measurements|
48421597|NCT02815982|101369287|FG000|NOT COMPLETED|Overall Study||0||
48421598|NCT02815982|101369288|FG001|NOT COMPLETED|Overall Study||0||
48421599|NCT02815982|101369289|FG002|NOT COMPLETED|Overall Study||0||
48421600|NCT02815982|101369290|FG003|NOT COMPLETED|Overall Study||0||
48421601|NCT00508118|101369291|FG000|STARTED|Overall Study||3||
48421602|NCT00508118|101369292|FG001|STARTED|Overall Study||4||
48421603|NCT00508118|101369291|FG000|COMPLETED|Overall Study||3||
48421604|NCT00508118|101369292|FG001|COMPLETED|Overall Study||4||
48421605|NCT00508118|101369291|FG000|NOT COMPLETED|Overall Study||0||
48421606|NCT00508118|101369292|FG001|NOT COMPLETED|Overall Study||0||
48421607|NCT02408016|101369293|FG000|STARTED|Overall Study||6||
48421608|NCT02408016|101369294|FG001|STARTED|Overall Study||4||
48763721|NCT06271993|102208799|FG000|COMPLETED|Overall Study||22||22
48421609|NCT02408016|101369295|FG002|STARTED|Overall Study||0||
48421610|NCT02408016|101369293|FG000|COMPLETED|Overall Study||0||
48421611|NCT02408016|101369294|FG001|COMPLETED|Overall Study||1||
48421612|NCT02408016|101369295|FG002|COMPLETED|Overall Study||0||
48421613|NCT02408016|101369293|FG000|NOT COMPLETED|Overall Study||6||
48421614|NCT02408016|101369294|FG001|NOT COMPLETED|Overall Study||3||
48421615|NCT02408016|101369295|FG002|NOT COMPLETED|Overall Study||0||
48421616|NCT01005355|101369296|FG000|STARTED|Overall Study||3||
48421617|NCT01005355|101369297|FG001|STARTED|Overall Study||6||
48421618|NCT01005355|101369298|FG002|STARTED|Overall Study||6||
48421619|NCT01005355|101369296|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
48421620|NCT01005355|101369297|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
48421621|NCT01005355|101369298|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
48421622|NCT01005355|101369296|FG000|COMPLETED|Overall Study||3||
48421623|NCT01005355|101369297|FG001|COMPLETED|Overall Study||6||
48421624|NCT01005355|101369298|FG002|COMPLETED|Overall Study||6||
48421625|NCT01005355|101369296|FG000|NOT COMPLETED|Overall Study||0||
48421626|NCT01005355|101369297|FG001|NOT COMPLETED|Overall Study||0||
48421627|NCT01005355|101369298|FG002|NOT COMPLETED|Overall Study||0||
48421628|NCT02785588|101369299|FG000|STARTED|Phase 1: Initial Feasibility Assessment||49||
48421629|NCT02785588|101369299|FG000|COMPLETED|Phase 1: Initial Feasibility Assessment||47||
48421630|NCT02785588|101369299|FG000|NOT COMPLETED|Phase 1: Initial Feasibility Assessment||2||
48421631|NCT02785588|101369299|FG000|STARTED|Phase2 Controlled Image &Data Collection||5||
48421632|NCT02785588|101369299|FG000|COMPLETED|Phase2 Controlled Image &Data Collection||5||
48421633|NCT02785588|101369299|FG000|NOT COMPLETED|Phase2 Controlled Image &Data Collection||0||
48421634|NCT02195349|101369300|FG000|STARTED|Overall Study||14||
48421635|NCT02195349|101369301|FG001|STARTED|Overall Study||1||
48421636|NCT02195349|101369302|FG002|STARTED|Overall Study||1||
48421637|NCT02195349|101369303|FG003|STARTED|Overall Study||6||
48421638|NCT02195349|101369304|FG004|STARTED|Overall Study||6||
48421639|NCT02195349|101369305|FG005|STARTED|Overall Study||6||
48421640|NCT02195349|101369306|FG006|STARTED|Overall Study||6||
48421641|NCT02195349|101369307|FG007|STARTED|Overall Study||9||
48421642|NCT02195349|101369308|FG008|STARTED|Overall Study||6||
48421643|NCT02195349|101369309|FG009|STARTED|Overall Study||6||
48421644|NCT02195349|101369310|FG010|STARTED|Overall Study||6||
48421645|NCT02195349|101369300|FG000|COMPLETED|Overall Study||14||
48421646|NCT02195349|101369301|FG001|COMPLETED|Overall Study||1||
48421647|NCT02195349|101369302|FG002|COMPLETED|Overall Study||1||
48421648|NCT02195349|101369303|FG003|COMPLETED|Overall Study||6||
48421649|NCT02195349|101369304|FG004|COMPLETED|Overall Study||6||
48421650|NCT02195349|101369305|FG005|COMPLETED|Overall Study||6||
48421651|NCT02195349|101369306|FG006|COMPLETED|Overall Study||6||
48421652|NCT02195349|101369307|FG007|COMPLETED|Overall Study||9||
48421653|NCT02195349|101369308|FG008|COMPLETED|Overall Study||6||
48421654|NCT02195349|101369309|FG009|COMPLETED|Overall Study||6||
48421655|NCT02195349|101369310|FG010|COMPLETED|Overall Study||6||
48421656|NCT02195349|101369300|FG000|NOT COMPLETED|Overall Study||0||
48421657|NCT02195349|101369301|FG001|NOT COMPLETED|Overall Study||0||
48421658|NCT02195349|101369302|FG002|NOT COMPLETED|Overall Study||0||
48421659|NCT02195349|101369303|FG003|NOT COMPLETED|Overall Study||0||
48421660|NCT02195349|101369304|FG004|NOT COMPLETED|Overall Study||0||
48421661|NCT02195349|101369305|FG005|NOT COMPLETED|Overall Study||0||
48421662|NCT02195349|101369306|FG006|NOT COMPLETED|Overall Study||0||
48421663|NCT02195349|101369307|FG007|NOT COMPLETED|Overall Study||0||
48421664|NCT02195349|101369308|FG008|NOT COMPLETED|Overall Study||0||
48421665|NCT02195349|101369309|FG009|NOT COMPLETED|Overall Study||0||
48421666|NCT02195349|101369310|FG010|NOT COMPLETED|Overall Study||0||
48421667|NCT02600715|101369311|FG000|STARTED|Overall Study||13||
48421668|NCT02600715|101369312|FG001|STARTED|Overall Study||13||
48421669|NCT02600715|101369311|FG000|Allocated to Randomization|Overall Study||13||
48421670|NCT02600715|101369312|FG001|Allocated to Randomization|Overall Study||13||
48421671|NCT02600715|101369311|FG000|Received Treatment and Suppository|Overall Study||13||
48421672|NCT02600715|101369312|FG001|Received Treatment and Suppository|Overall Study||13||
48421673|NCT02600715|101369311|FG000|Completed 2-week Follow-up Appointment|Overall Study||13||
48421674|NCT02600715|101369312|FG001|Completed 2-week Follow-up Appointment|Overall Study||12||
48421675|NCT02600715|101369311|FG000|COMPLETED|Overall Study||13|Included in final analysis|
48421676|NCT02600715|101369312|FG001|COMPLETED|Overall Study||13|Included in final analysis|
48421677|NCT02600715|101369311|FG000|NOT COMPLETED|Overall Study||0||
48421678|NCT02600715|101369312|FG001|NOT COMPLETED|Overall Study||0||
48421679|NCT02386605|101369313|FG000|STARTED|Overall Study||41||
48421680|NCT02386605|101369314|FG001|STARTED|Overall Study||38||
48421681|NCT02386605|101369313|FG000|COMPLETED|Overall Study||34||
48421682|NCT02386605|101369314|FG001|COMPLETED|Overall Study||28||
48421683|NCT02386605|101369313|FG000|NOT COMPLETED|Overall Study||7||
48421684|NCT02386605|101369314|FG001|NOT COMPLETED|Overall Study||10||
48421685|NCT00851721|101369315|FG000|STARTED|Overall Study||19||
48421686|NCT00851721|101369316|FG001|STARTED|Overall Study||17||
48421687|NCT00851721|101369315|FG000|COMPLETED|Overall Study||17||
48421688|NCT00851721|101369316|FG001|COMPLETED|Overall Study||16||
48421689|NCT00851721|101369315|FG000|NOT COMPLETED|Overall Study||2||
48421690|NCT00851721|101369316|FG001|NOT COMPLETED|Overall Study||1||
48421691|NCT00027027|101369317|FG000|STARTED|Overall Study||3||
48421692|NCT00027027|101369318|FG001|STARTED|Overall Study||3||
48421693|NCT00027027|101369319|FG002|STARTED|Overall Study||4||
48421694|NCT00027027|101369320|FG003|STARTED|Overall Study||3||
48421695|NCT00027027|101369321|FG004|STARTED|Overall Study||8||
48421696|NCT00027027|101369317|FG000|Discontinued Before 2 Treatment Cycles|Overall Study||0||
48421697|NCT00027027|101369318|FG001|Discontinued Before 2 Treatment Cycles|Overall Study||0||
48421698|NCT00027027|101369319|FG002|Discontinued Before 2 Treatment Cycles|Overall Study||1||
48421699|NCT00027027|101369320|FG003|Discontinued Before 2 Treatment Cycles|Overall Study||0||
48421700|NCT00027027|101369321|FG004|Discontinued Before 2 Treatment Cycles|Overall Study||1||
48421701|NCT00027027|101369317|FG000|Completed 2 Cycles of Treatment|Overall Study||3||
48421702|NCT00027027|101369318|FG001|Completed 2 Cycles of Treatment|Overall Study||3||
48421703|NCT00027027|101369319|FG002|Completed 2 Cycles of Treatment|Overall Study||3||
48421704|NCT00027027|101369320|FG003|Completed 2 Cycles of Treatment|Overall Study||3||
48421705|NCT00027027|101369321|FG004|Completed 2 Cycles of Treatment|Overall Study||7||
48421706|NCT00027027|101369317|FG000|Discontinued at Cycle 2|Overall Study||2||
48421707|NCT00027027|101369318|FG001|Discontinued at Cycle 2|Overall Study||2||
48439981|NCT01728376|101409997|FG002|NOT COMPLETED|Overall Study||2||
48421708|NCT00027027|101369319|FG002|Discontinued at Cycle 2|Overall Study||1||
48421709|NCT00027027|101369320|FG003|Discontinued at Cycle 2|Overall Study||1||
48421710|NCT00027027|101369321|FG004|Discontinued at Cycle 2|Overall Study||3||
48421711|NCT00027027|101369317|FG000|Treated Beyond Cycle 2|Overall Study||1||
48421712|NCT00027027|101369318|FG001|Treated Beyond Cycle 2|Overall Study||1||
48421713|NCT00027027|101369319|FG002|Treated Beyond Cycle 2|Overall Study||2||
48421714|NCT00027027|101369320|FG003|Treated Beyond Cycle 2|Overall Study||2||
48421715|NCT00027027|101369321|FG004|Treated Beyond Cycle 2|Overall Study||4||
48421716|NCT00027027|101369317|FG000|COMPLETED|Overall Study||0||
48421717|NCT00027027|101369318|FG001|COMPLETED|Overall Study||0||
48421718|NCT00027027|101369319|FG002|COMPLETED|Overall Study||0||
48421719|NCT00027027|101369320|FG003|COMPLETED|Overall Study||0||
48421720|NCT00027027|101369321|FG004|COMPLETED|Overall Study||0||
48421721|NCT00027027|101369317|FG000|NOT COMPLETED|Overall Study||3||
48421722|NCT00027027|101369318|FG001|NOT COMPLETED|Overall Study||3||
48421723|NCT00027027|101369319|FG002|NOT COMPLETED|Overall Study||4||
48421724|NCT00027027|101369320|FG003|NOT COMPLETED|Overall Study||3||
48421725|NCT00027027|101369321|FG004|NOT COMPLETED|Overall Study||8||
48421726|NCT00508001|101369322|FG000|STARTED|Overall Study||19||
48421727|NCT00508001|101369323|FG001|STARTED|Overall Study||25||
48421728|NCT00508001|101369324|FG002|STARTED|Overall Study||23||
48421729|NCT00508001|101369322|FG000|Secondary Treatment Phase|Overall Study||0||
48421730|NCT00508001|101369323|FG001|Secondary Treatment Phase|Overall Study||13||
48421731|NCT00508001|101369324|FG002|Secondary Treatment Phase|Overall Study||16||
48421732|NCT00508001|101369322|FG000|COMPLETED|Overall Study||0||
48421733|NCT00508001|101369323|FG001|COMPLETED|Overall Study||13||
48421734|NCT00508001|101369324|FG002|COMPLETED|Overall Study||16||
48421735|NCT00508001|101369322|FG000|NOT COMPLETED|Overall Study||19||
48421736|NCT00508001|101369323|FG001|NOT COMPLETED|Overall Study||12||
48421737|NCT00508001|101369324|FG002|NOT COMPLETED|Overall Study||7||
48421738|NCT00461552|101369325|FG000|STARTED|Overall Study||7||
48421739|NCT00461552|101369326|FG001|STARTED|Overall Study||7||
48421740|NCT00461552|101369325|FG000|COMPLETED|Overall Study||7||
48421741|NCT00461552|101369326|FG001|COMPLETED|Overall Study||5||
48421742|NCT00461552|101369325|FG000|NOT COMPLETED|Overall Study||0||
48421743|NCT00461552|101369326|FG001|NOT COMPLETED|Overall Study||2||
48421744|NCT01135368|101369327|FG000|STARTED|Overall Study||506||
48421745|NCT01135368|101369327|FG000|COMPLETED|Overall Study||255||
48421746|NCT01135368|101369327|FG000|NOT COMPLETED|Overall Study||251||
48421747|NCT00733096|101369328|FG000|STARTED|Overall Study||28||
48421748|NCT00733096|101369329|FG001|STARTED|Overall Study||26||
48421749|NCT00733096|101369330|FG002|STARTED|Overall Study||30||
48421750|NCT00733096|101369328|FG000|COMPLETED|Overall Study||28||
48421751|NCT00733096|101369329|FG001|COMPLETED|Overall Study||26||
48421752|NCT00733096|101369330|FG002|COMPLETED|Overall Study||30||
48421753|NCT00733096|101369328|FG000|NOT COMPLETED|Overall Study||0||
48421754|NCT00733096|101369329|FG001|NOT COMPLETED|Overall Study||0||
48421755|NCT00733096|101369330|FG002|NOT COMPLETED|Overall Study||0||
48421756|NCT04051320|101369331|FG000|STARTED|Overall Study||13||
48421757|NCT04051320|101369332|FG001|STARTED|Overall Study||10||
48421758|NCT04051320|101369331|FG000|COMPLETED|Overall Study||13||
48421759|NCT04051320|101369332|FG001|COMPLETED|Overall Study||10||
48421760|NCT04051320|101369331|FG000|NOT COMPLETED|Overall Study||0||
48421761|NCT04051320|101369332|FG001|NOT COMPLETED|Overall Study||0||
48421762|NCT02561572|101369333|FG000|STARTED|Overall Study||64||
48421763|NCT02561572|101369334|FG001|STARTED|Overall Study||64||
48421764|NCT02561572|101369333|FG000|COMPLETED|Overall Study||62||
48421765|NCT02561572|101369334|FG001|COMPLETED|Overall Study||62||
48421766|NCT02561572|101369333|FG000|NOT COMPLETED|Overall Study||2||
48421767|NCT02561572|101369334|FG001|NOT COMPLETED|Overall Study||2||
48421768|NCT01365195|101369335|FG000|STARTED|Overall Study||6||
48421769|NCT01365195|101369336|FG001|STARTED|Overall Study||8||
48421770|NCT01365195|101369337|FG002|STARTED|Overall Study||7||
48421771|NCT01365195|101369335|FG000|COMPLETED|Overall Study||6||
48421772|NCT01365195|101369336|FG001|COMPLETED|Overall Study||8||
48421773|NCT01365195|101369337|FG002|COMPLETED|Overall Study||7||
48421774|NCT01365195|101369335|FG000|NOT COMPLETED|Overall Study||0||
48421775|NCT01365195|101369336|FG001|NOT COMPLETED|Overall Study||0||
48421776|NCT01365195|101369337|FG002|NOT COMPLETED|Overall Study||0||
48421777|NCT04927858|101369338|FG000|STARTED|Overall Study||460558||
48421778|NCT04927858|101369338|FG000|Treated With Empagliflozin|Overall Study||16985|Patients with Type 2 Diabetes Mellitus (T2DM) who were initiated on Empagliflozin between 1st of January 2015 and 31st of December 2017, who had at least one registration in the Swedish National Diabetes Register (NDR).|
48421779|NCT04927858|101369338|FG000|COMPLETED|Overall Study||460558||
48763722|NCT06271993|102208800|FG001|COMPLETED|Overall Study||22||22
48421780|NCT04927858|101369338|FG000|NOT COMPLETED|Overall Study||0||
48421781|NCT00931515|101369339|FG000|STARTED|Overall Study||15||
48421782|NCT00931515|101369340|FG001|STARTED|Overall Study||15||
48421783|NCT00931515|101369339|FG000|COMPLETED|Overall Study||13||
48421784|NCT00931515|101369340|FG001|COMPLETED|Overall Study||10||
48421785|NCT00931515|101369339|FG000|NOT COMPLETED|Overall Study||2||
48421786|NCT00931515|101369340|FG001|NOT COMPLETED|Overall Study||5||
48421787|NCT00408408|101369341|FG000|STARTED|Overall Study||201||
48421788|NCT00408408|101369342|FG001|STARTED|Overall Study||199||
48421789|NCT00408408|101369343|FG002|STARTED|Overall Study||204||
48421790|NCT00408408|101369344|FG003|STARTED|Overall Study||201||
48421791|NCT00408408|101369345|FG004|STARTED|Overall Study||197||
48421792|NCT00408408|101369346|FG005|STARTED|Overall Study||204||
48421793|NCT00408408|101369341|FG000|COMPLETED|Overall Study||199||
48421794|NCT00408408|101369342|FG001|COMPLETED|Overall Study||196||
48421795|NCT00408408|101369343|FG002|COMPLETED|Overall Study||204||
48421796|NCT00408408|101369344|FG003|COMPLETED|Overall Study||194||
48421797|NCT00408408|101369345|FG004|COMPLETED|Overall Study||192||
48421798|NCT00408408|101369346|FG005|COMPLETED|Overall Study||201||
48421799|NCT00408408|101369341|FG000|NOT COMPLETED|Overall Study||2||
48421800|NCT00408408|101369342|FG001|NOT COMPLETED|Overall Study||3||
48421801|NCT00408408|101369343|FG002|NOT COMPLETED|Overall Study||0||
48421802|NCT00408408|101369344|FG003|NOT COMPLETED|Overall Study||7||
48421803|NCT00408408|101369345|FG004|NOT COMPLETED|Overall Study||5||
48421804|NCT00408408|101369346|FG005|NOT COMPLETED|Overall Study||3||
48421805|NCT00765726|101369347|FG000|STARTED|Overall Study||12||
48421806|NCT00765726|101369347|FG000|COMPLETED|Overall Study||3||
48421807|NCT00765726|101369347|FG000|NOT COMPLETED|Overall Study||9||
48421808|NCT00348686|101369348|FG000|STARTED|Overall Study||315||
48421809|NCT00348686|101369348|FG000|COMPLETED|Overall Study||249||
48421810|NCT00348686|101369348|FG000|NOT COMPLETED|Overall Study||66||
48421811|NCT03241485|101369349|FG000|STARTED|Overall Study||42||
48421812|NCT03241485|101369350|FG001|STARTED|Overall Study||37||
48421813|NCT03241485|101369349|FG000|COMPLETED|Overall Study||37||
48421814|NCT03241485|101369350|FG001|COMPLETED|Overall Study||33||
48421815|NCT03241485|101369349|FG000|NOT COMPLETED|Overall Study||5||
48421816|NCT03241485|101369350|FG001|NOT COMPLETED|Overall Study||4||
48421817|NCT00578331|101369351|FG000|STARTED|Overall Study||445||
48421818|NCT00578331|101369352|FG001|STARTED|Overall Study||445||
48421819|NCT00578331|101369351|FG000|COMPLETED|Overall Study||329||
48421820|NCT00578331|101369352|FG001|COMPLETED|Overall Study||320||
48421821|NCT00578331|101369351|FG000|NOT COMPLETED|Overall Study||116||
48421822|NCT00578331|101369352|FG001|NOT COMPLETED|Overall Study||125||
48421823|NCT01038609|101369353|FG000|STARTED|Overall Study||50||
48421824|NCT01038609|101369354|FG001|STARTED|Overall Study||52||
48421825|NCT01038609|101369355|FG002|STARTED|Overall Study||49||
48421826|NCT01038609|101369356|FG003|STARTED|Overall Study||48||
48421827|NCT01038609|101369357|FG004|STARTED|Overall Study||51||
48421828|NCT01038609|101369353|FG000|COMPLETED|Overall Study||49||
48421829|NCT01038609|101369354|FG001|COMPLETED|Overall Study||51||
48421830|NCT01038609|101369355|FG002|COMPLETED|Overall Study||48||
48421831|NCT01038609|101369356|FG003|COMPLETED|Overall Study||47||
48421832|NCT01038609|101369357|FG004|COMPLETED|Overall Study||50||
48421833|NCT01038609|101369353|FG000|NOT COMPLETED|Overall Study||1||
48421834|NCT01038609|101369354|FG001|NOT COMPLETED|Overall Study||1||
48421835|NCT01038609|101369355|FG002|NOT COMPLETED|Overall Study||1||
48421836|NCT01038609|101369356|FG003|NOT COMPLETED|Overall Study||1||
48421837|NCT01038609|101369357|FG004|NOT COMPLETED|Overall Study||1||
48421838|NCT00635804|101369358|FG000|STARTED|Overall Study||7||
48421839|NCT00635804|101369359|FG001|STARTED|Overall Study||6||
48421840|NCT00635804|101369360|FG002|STARTED|Overall Study||6||
48421841|NCT00635804|101369361|FG003|STARTED|Overall Study||6||
48421842|NCT00635804|101369362|FG004|STARTED|Overall Study||6||
48638860|NCT01143792|101901521|FG000|COMPLETED|Overall Study||93||
48638861|NCT01143792|101901522|FG001|COMPLETED|Overall Study||86||
48638862|NCT01143792|101901523|FG002|COMPLETED|Overall Study||91||
48638863|NCT01143792|101901521|FG000|NOT COMPLETED|Overall Study||0||
48638864|NCT01143792|101901522|FG001|NOT COMPLETED|Overall Study||0||
48638865|NCT01143792|101901523|FG002|NOT COMPLETED|Overall Study||0||
48638866|NCT00820534|101901524|FG000|STARTED|Overall Study||64||
48638867|NCT00820534|101901525|FG001|STARTED|Overall Study||62||
48638868|NCT00820534|101901524|FG000|COMPLETED|Overall Study||64||
48421843|NCT00635804|101369363|FG005|STARTED|Overall Study||12||
48421844|NCT00635804|101369364|FG006|STARTED|Overall Study||3||
48421845|NCT00635804|101369365|FG007|STARTED|Overall Study||14||
48421846|NCT00635804|101369358|FG000|COMPLETED|Overall Study||6||
48421847|NCT00635804|101369359|FG001|COMPLETED|Overall Study||6||
48421848|NCT00635804|101369360|FG002|COMPLETED|Overall Study||6||
48421849|NCT00635804|101369361|FG003|COMPLETED|Overall Study||6||
48421850|NCT00635804|101369362|FG004|COMPLETED|Overall Study||6||
48421851|NCT00635804|101369363|FG005|COMPLETED|Overall Study||11||
48421852|NCT00635804|101369364|FG006|COMPLETED|Overall Study||3||
48421853|NCT00635804|101369365|FG007|COMPLETED|Overall Study||14||
48421854|NCT00635804|101369358|FG000|NOT COMPLETED|Overall Study||1||
48421855|NCT00635804|101369359|FG001|NOT COMPLETED|Overall Study||0||
48421856|NCT00635804|101369360|FG002|NOT COMPLETED|Overall Study||0||
48763723|NCT06271993|102208801|FG002|COMPLETED|Overall Study||22||22
48421857|NCT00635804|101369361|FG003|NOT COMPLETED|Overall Study||0||
48421858|NCT00635804|101369362|FG004|NOT COMPLETED|Overall Study||0||
48421859|NCT00635804|101369363|FG005|NOT COMPLETED|Overall Study||1||
48421860|NCT00635804|101369364|FG006|NOT COMPLETED|Overall Study||0||
48421861|NCT00635804|101369365|FG007|NOT COMPLETED|Overall Study||0||
48421862|NCT01066819|101369366|FG000|STARTED|Overall Study||1006||
48638869|NCT00820534|101901525|FG001|COMPLETED|Overall Study||62||
48638870|NCT00820534|101901524|FG000|NOT COMPLETED|Overall Study||0||
48763724|NCT06271993|102208799|FG000|NOT COMPLETED|Overall Study||5||5
48763725|NCT06271993|102208800|FG001|NOT COMPLETED|Overall Study||5||5
48763726|NCT06271993|102208801|FG002|NOT COMPLETED|Overall Study||5||5
48421863|NCT01066819|101369367|FG001|STARTED|Overall Study||348||
48421864|NCT01066819|101369368|FG002|STARTED|Overall Study||257||
48421865|NCT01066819|101369369|FG003|STARTED|Overall Study||25||
48421866|NCT01066819|101369370|FG004|STARTED|Overall Study||7||
48421867|NCT01066819|101369371|FG005|STARTED|Overall Study||13||
48421868|NCT01066819|101369366|FG000|COMPLETED|Overall Study||317||
48421869|NCT01066819|101369367|FG001|COMPLETED|Overall Study||177||
48421870|NCT01066819|101369368|FG002|COMPLETED|Overall Study||111||
48421871|NCT01066819|101369369|FG003|COMPLETED|Overall Study||8||
48421872|NCT01066819|101369370|FG004|COMPLETED|Overall Study||3||
48421873|NCT01066819|101369371|FG005|COMPLETED|Overall Study||7||
48421874|NCT01066819|101369366|FG000|NOT COMPLETED|Overall Study||689||
48421875|NCT01066819|101369367|FG001|NOT COMPLETED|Overall Study||171||
48421876|NCT01066819|101369368|FG002|NOT COMPLETED|Overall Study||146||
48421877|NCT01066819|101369369|FG003|NOT COMPLETED|Overall Study||17||
48421878|NCT01066819|101369370|FG004|NOT COMPLETED|Overall Study||4||
48421879|NCT01066819|101369371|FG005|NOT COMPLETED|Overall Study||6||
48421880|NCT02719028|101369372|FG000|STARTED|Overall Study||30||
48421881|NCT02719028|101369373|FG001|STARTED|Overall Study||30||
48421882|NCT02719028|101369374|FG002|STARTED|Overall Study||30||
48421883|NCT02719028|101369375|FG003|STARTED|Overall Study||30||
48421884|NCT02719028|101369372|FG000|COMPLETED|Overall Study||28||
48421885|NCT02719028|101369373|FG001|COMPLETED|Overall Study||28||
48421886|NCT02719028|101369374|FG002|COMPLETED|Overall Study||24||
48421887|NCT02719028|101369375|FG003|COMPLETED|Overall Study||20||
48421888|NCT02719028|101369372|FG000|NOT COMPLETED|Overall Study||2||
48421889|NCT02719028|101369373|FG001|NOT COMPLETED|Overall Study||2||
48421890|NCT02719028|101369374|FG002|NOT COMPLETED|Overall Study||6||
48421891|NCT02719028|101369375|FG003|NOT COMPLETED|Overall Study||10||
48421892|NCT00535236|101369376|FG000|STARTED|Overall Study||40||
48421893|NCT00535236|101369377|FG001|STARTED|Overall Study||10||
48421894|NCT00535236|101369378|FG002|STARTED|Overall Study||41||
48421895|NCT00535236|101369379|FG003|STARTED|Overall Study||10||
48421896|NCT00535236|101369380|FG004|STARTED|Overall Study||59||
48421897|NCT00535236|101369381|FG005|STARTED|Overall Study||20||
48421898|NCT00535236|101369382|FG006|STARTED|Overall Study||62||
48421899|NCT00535236|101369383|FG007|STARTED|Overall Study||19||
48421900|NCT00535236|101369384|FG008|STARTED|Overall Study||60||
48421901|NCT00535236|101369385|FG009|STARTED|Overall Study||20||
48421902|NCT00535236|101369376|FG000|Vaccination 1|Overall Study||40||
48421903|NCT00535236|101369377|FG001|Vaccination 1|Overall Study||10||
48421904|NCT00535236|101369378|FG002|Vaccination 1|Overall Study||40||
48421905|NCT00535236|101369379|FG003|Vaccination 1|Overall Study||10||
48421906|NCT00535236|101369380|FG004|Vaccination 1|Overall Study||58||
48763727|NCT02003924|102208802|FG000|STARTED|Double-blind Phase||933||
48763728|NCT02003924|102208803|FG001|STARTED|Double-blind Phase||468||
48421907|NCT00535236|101369381|FG005|Vaccination 1|Overall Study||19||
48421908|NCT00535236|101369382|FG006|Vaccination 1|Overall Study||61||
48421909|NCT00535236|101369383|FG007|Vaccination 1|Overall Study||19||
48421910|NCT00535236|101369384|FG008|Vaccination 1|Overall Study||60||
48421911|NCT00535236|101369385|FG009|Vaccination 1|Overall Study||20||
48421912|NCT00535236|101369376|FG000|Vaccination 2|Overall Study||35||
48421913|NCT00535236|101369377|FG001|Vaccination 2|Overall Study||10||
48421914|NCT00535236|101369378|FG002|Vaccination 2|Overall Study||37||
48421915|NCT00535236|101369379|FG003|Vaccination 2|Overall Study||8||
48421916|NCT00535236|101369380|FG004|Vaccination 2|Overall Study||52||
48421917|NCT00535236|101369381|FG005|Vaccination 2|Overall Study||19||
48421918|NCT00535236|101369382|FG006|Vaccination 2|Overall Study||58||
48763729|NCT02003924|102208804|FG002|STARTED|Double-blind Phase||0||
48763730|NCT02003924|102208802|FG000|Treated|Double-blind Phase||930||
48763731|NCT02003924|102208803|FG001|Treated|Double-blind Phase||465||
48421919|NCT00535236|101369383|FG007|Vaccination 2|Overall Study||19||
48421920|NCT00535236|101369384|FG008|Vaccination 2|Overall Study||57||
48421921|NCT00535236|101369385|FG009|Vaccination 2|Overall Study||19||
48421922|NCT00535236|101369376|FG000|Vaccination 3|Overall Study||34||
48421923|NCT00535236|101369377|FG001|Vaccination 3|Overall Study||10||
48421924|NCT00535236|101369378|FG002|Vaccination 3|Overall Study||35||
48421925|NCT00535236|101369379|FG003|Vaccination 3|Overall Study||8||
48421926|NCT00535236|101369380|FG004|Vaccination 3|Overall Study||48||
48421927|NCT00535236|101369381|FG005|Vaccination 3|Overall Study||19||
48421928|NCT00535236|101369382|FG006|Vaccination 3|Overall Study||51||
48421929|NCT00535236|101369383|FG007|Vaccination 3|Overall Study||18||
48421930|NCT00535236|101369384|FG008|Vaccination 3|Overall Study||53||
48421931|NCT00535236|101369385|FG009|Vaccination 3|Overall Study||18||
48421932|NCT00535236|101369376|FG000|Vaccination 4|Overall Study||34||
48421933|NCT00535236|101369377|FG001|Vaccination 4|Overall Study||10||
48421934|NCT00535236|101369378|FG002|Vaccination 4|Overall Study||32||
48421935|NCT00535236|101369379|FG003|Vaccination 4|Overall Study||6||
48421936|NCT00535236|101369380|FG004|Vaccination 4|Overall Study||47||
48421937|NCT00535236|101369381|FG005|Vaccination 4|Overall Study||19||
48359366|NCT03103750|101207594|FG000|Completed First Leg of Crossover|Overall Study||8||
48359367|NCT03103750|101207595|FG001|Completed First Leg of Crossover|Overall Study||10||
48359368|NCT03103750|101207594|FG000|COMPLETED|Overall Study||8||
48359369|NCT03103750|101207595|FG001|COMPLETED|Overall Study||10||
48359370|NCT03103750|101207594|FG000|NOT COMPLETED|Overall Study||4||
48359371|NCT03103750|101207595|FG001|NOT COMPLETED|Overall Study||2||
48359372|NCT02523586|101207596|FG000|STARTED|Overall Study||14||
48359373|NCT02523586|101207596|FG000|COMPLETED|Overall Study||10||
48359374|NCT02523586|101207596|FG000|NOT COMPLETED|Overall Study||4||
48359375|NCT03425656|101207597|FG000|STARTED|Overall Study||54||
48359376|NCT03425656|101207598|FG001|STARTED|Overall Study||54||
48359377|NCT03425656|101207597|FG000|COMPLETED|Overall Study||48||
48359378|NCT03425656|101207598|FG001|COMPLETED|Overall Study||44||
48359379|NCT03425656|101207597|FG000|NOT COMPLETED|Overall Study||6||
48359380|NCT03425656|101207598|FG001|NOT COMPLETED|Overall Study||10||
48359381|NCT02792777|101207599|FG000|STARTED|Overall Study||96||
48359382|NCT02792777|101207600|FG001|STARTED|Overall Study||52||
48359383|NCT02792777|101207599|FG000|COMPLETED|Overall Study||89||
48359384|NCT02792777|101207600|FG001|COMPLETED|Overall Study||52||
48359385|NCT02792777|101207599|FG000|NOT COMPLETED|Overall Study||7||
48359386|NCT02792777|101207600|FG001|NOT COMPLETED|Overall Study||0||
48359387|NCT02385123|101207601|FG000|STARTED|Overall Study||60||
48359388|NCT02385123|101207601|FG000|COMPLETED|Overall Study||45||
48359389|NCT02385123|101207601|FG000|NOT COMPLETED|Overall Study||15||
48359390|NCT03060577|101207602|FG000|STARTED|Overall Study||290|All enrolled participants|
48359391|NCT03060577|101207603|FG001|STARTED|Overall Study||92|All enrolled participants|
48359392|NCT03060577|101207602|FG000|Safety Analysis Set|Overall Study||284|All enrolled participants who received at least one dose of study treatment|
48359393|NCT03060577|101207603|FG001|Safety Analysis Set|Overall Study||90|All enrolled participants who received at least one dose of study treatment|
48359394|NCT03060577|101207602|FG000|COMPLETED|Overall Study||233||
48359395|NCT03060577|101207603|FG001|COMPLETED|Overall Study||80||
48359396|NCT03060577|101207602|FG000|NOT COMPLETED|Overall Study||57||
48359397|NCT03060577|101207603|FG001|NOT COMPLETED|Overall Study||12||
48359398|NCT04334148|101207604|FG000|STARTED|Overall Study||683||
48359399|NCT04334148|101207605|FG001|STARTED|Overall Study||677||
48359400|NCT04334148|101207604|FG000|COMPLETED|Overall Study||683||
48359401|NCT04334148|101207605|FG001|COMPLETED|Overall Study||676||
48359402|NCT04334148|101207604|FG000|NOT COMPLETED|Overall Study||0||
48359403|NCT04334148|101207605|FG001|NOT COMPLETED|Overall Study||1||
48359404|NCT01821677|101207606|FG000|STARTED|Overall Study||117||141
48359405|NCT01821677|101207607|FG001|STARTED|Overall Study||117||142
48359406|NCT01821677|101207608|FG002|STARTED|Overall Study||120||142
48359407|NCT01821677|101207606|FG000|COMPLETED|Overall Study||94||114
48359408|NCT01821677|101207607|FG001|COMPLETED|Overall Study||102||126
48359409|NCT01821677|101207608|FG002|COMPLETED|Overall Study||105||124
48359410|NCT01821677|101207606|FG000|NOT COMPLETED|Overall Study||23||27
48359411|NCT01821677|101207607|FG001|NOT COMPLETED|Overall Study||15||16
48359412|NCT01821677|101207608|FG002|NOT COMPLETED|Overall Study||15||18
48359413|NCT01777438|101210636|FG000|STARTED|Overall Study||352||
48359414|NCT01777438|101210637|FG001|STARTED|Overall Study||82||
48359415|NCT01777438|101210636|FG000|COMPLETED|Overall Study||352||
48359416|NCT01777438|101210637|FG001|COMPLETED|Overall Study||82||
48359417|NCT01777438|101210636|FG000|NOT COMPLETED|Overall Study||0||
48359418|NCT01777438|101210637|FG001|NOT COMPLETED|Overall Study||0||
48359419|NCT02628223|101210638|FG000|STARTED|Overall Study||38||
48359420|NCT02628223|101210639|FG001|STARTED|Overall Study||38||
48359421|NCT02628223|101210638|FG000|COMPLETED|Overall Study||38||
48359422|NCT02628223|101210639|FG001|COMPLETED|Overall Study||36||
48359423|NCT02628223|101210638|FG000|NOT COMPLETED|Overall Study||0||
48359424|NCT02628223|101210639|FG001|NOT COMPLETED|Overall Study||2||
48359425|NCT05099991|101210640|FG000|STARTED|Overall Study||16||
48359426|NCT05099991|101210641|FG001|STARTED|Overall Study||16||
48359427|NCT05099991|101210640|FG000|Received Allocated Intervention|Overall Study||16||
48359428|NCT05099991|101210641|FG001|Received Allocated Intervention|Overall Study||16||
48359429|NCT05099991|101210640|FG000|COMPLETED|Overall Study||16||
48359430|NCT05099991|101210641|FG001|COMPLETED|Overall Study||16||
48359431|NCT05099991|101210640|FG000|NOT COMPLETED|Overall Study||0||
48359432|NCT05099991|101210641|FG001|NOT COMPLETED|Overall Study||0||
48359433|NCT01618955|101210642|FG000|STARTED|Overall Study||20||
48359434|NCT01618955|101210643|FG001|STARTED|Overall Study||30||
48359435|NCT01618955|101210644|FG002|STARTED|Overall Study||31||
48359436|NCT01618955|101210645|FG003|STARTED|Overall Study||20||
48359437|NCT01618955|101210642|FG000|COMPLETED|Overall Study||20||
48359438|NCT01618955|101210643|FG001|COMPLETED|Overall Study||30||
48359439|NCT01618955|101210644|FG002|COMPLETED|Overall Study||31||
48359440|NCT01618955|101210645|FG003|COMPLETED|Overall Study||20||
48359441|NCT01618955|101210642|FG000|NOT COMPLETED|Overall Study||0||
48359442|NCT01618955|101210643|FG001|NOT COMPLETED|Overall Study||0||
48359443|NCT01618955|101210644|FG002|NOT COMPLETED|Overall Study||0||
48359444|NCT01618955|101210645|FG003|NOT COMPLETED|Overall Study||0||
48359445|NCT01415960|101210646|FG000|STARTED|Overall Study||163||
48359446|NCT01415960|101210646|FG000|ITT|Overall Study||161||
48359447|NCT01415960|101210646|FG000|PK Subgroup|Overall Study||30||
48763732|NCT02003924|102208804|FG002|Treated|Double-blind Phase||0||
48763733|NCT02003924|102208802|FG000|COMPLETED|Double-blind Phase||478||
48763734|NCT02003924|102208803|FG001|COMPLETED|Double-blind Phase||87||
48763735|NCT02003924|102208804|FG002|COMPLETED|Double-blind Phase||0||
48763736|NCT02003924|102208802|FG000|NOT COMPLETED|Double-blind Phase||455||
48421938|NCT00535236|101369382|FG006|Vaccination 4|Overall Study||51||
48421939|NCT00535236|101369383|FG007|Vaccination 4|Overall Study||18||
48421940|NCT00535236|101369384|FG008|Vaccination 4|Overall Study||50||
48421941|NCT00535236|101369385|FG009|Vaccination 4|Overall Study||17||
48421942|NCT00535236|101369376|FG000|COMPLETED|Overall Study||33||
48421943|NCT00535236|101369377|FG001|COMPLETED|Overall Study||8||
48421944|NCT00535236|101369378|FG002|COMPLETED|Overall Study||29||
48421945|NCT00535236|101369379|FG003|COMPLETED|Overall Study||6||
48421946|NCT00535236|101369380|FG004|COMPLETED|Overall Study||47||
48421947|NCT00535236|101369381|FG005|COMPLETED|Overall Study||19||
48421948|NCT00535236|101369382|FG006|COMPLETED|Overall Study||51||
48421949|NCT00535236|101369383|FG007|COMPLETED|Overall Study||18||
48421950|NCT00535236|101369384|FG008|COMPLETED|Overall Study||47||
48421951|NCT00535236|101369385|FG009|COMPLETED|Overall Study||16||
48421952|NCT00535236|101369376|FG000|NOT COMPLETED|Overall Study||7||
48421953|NCT00535236|101369377|FG001|NOT COMPLETED|Overall Study||2||
48421954|NCT00535236|101369378|FG002|NOT COMPLETED|Overall Study||12||
48421955|NCT00535236|101369379|FG003|NOT COMPLETED|Overall Study||4||
48421956|NCT00535236|101369380|FG004|NOT COMPLETED|Overall Study||12||
48421957|NCT00535236|101369381|FG005|NOT COMPLETED|Overall Study||1||
48421958|NCT00535236|101369382|FG006|NOT COMPLETED|Overall Study||11||
48421959|NCT00535236|101369383|FG007|NOT COMPLETED|Overall Study||1||
48421960|NCT00535236|101369384|FG008|NOT COMPLETED|Overall Study||13||
48421961|NCT00535236|101369385|FG009|NOT COMPLETED|Overall Study||4||
48421962|NCT03026556|101369386|FG000|STARTED|Overall Study||12763||
48421963|NCT03026556|101369387|FG001|STARTED|Overall Study||17177||
48421964|NCT03026556|101369388|FG002|STARTED|Overall Study||12594||
48763737|NCT02003924|102208803|FG001|NOT COMPLETED|Double-blind Phase||381||
48763738|NCT02003924|102208804|FG002|NOT COMPLETED|Double-blind Phase||0||
48763739|NCT02003924|102208802|FG000|STARTED|Open-label Phase||478||
48763740|NCT02003924|102208803|FG001|STARTED|Open-label Phase||0||
48763741|NCT02003924|102208804|FG002|STARTED|Open-label Phase||87||
48763742|NCT02003924|102208802|FG000|Treated|Open-label Phase||478||
48421965|NCT03026556|101369386|FG000|COMPLETED|Overall Study||12763||
48421966|NCT03026556|101369387|FG001|COMPLETED|Overall Study||17177||
48421967|NCT03026556|101369388|FG002|COMPLETED|Overall Study||12594||
48421968|NCT03026556|101369386|FG000|NOT COMPLETED|Overall Study||0||
48421969|NCT03026556|101369387|FG001|NOT COMPLETED|Overall Study||0||
48421970|NCT03026556|101369388|FG002|NOT COMPLETED|Overall Study||0||
48421971|NCT01832753|101369389|FG000|STARTED|Observation Phase (Months 0-6)||5||
48421972|NCT01832753|101369390|FG001|STARTED|Observation Phase (Months 0-6)||4||
48421973|NCT01832753|101369391|FG002|STARTED|Observation Phase (Months 0-6)||3||
48421974|NCT01832753|101369389|FG000|COMPLETED|Observation Phase (Months 0-6)||5||
48421975|NCT01832753|101369390|FG001|COMPLETED|Observation Phase (Months 0-6)||4||
48421976|NCT01832753|101369391|FG002|COMPLETED|Observation Phase (Months 0-6)||1||
48421977|NCT01832753|101369389|FG000|NOT COMPLETED|Observation Phase (Months 0-6)||0||
48421978|NCT01832753|101369390|FG001|NOT COMPLETED|Observation Phase (Months 0-6)||0||
48421979|NCT01832753|101369391|FG002|NOT COMPLETED|Observation Phase (Months 0-6)||2||
48421980|NCT01832753|101369389|FG000|STARTED|Randomization Phase (Months 6-12)||5||
48421981|NCT01832753|101369390|FG001|STARTED|Randomization Phase (Months 6-12)||4||
48421982|NCT01832753|101369391|FG002|STARTED|Randomization Phase (Months 6-12)||0||
48421983|NCT01832753|101369389|FG000|COMPLETED|Randomization Phase (Months 6-12)||4||
48421984|NCT01832753|101369390|FG001|COMPLETED|Randomization Phase (Months 6-12)||3||
48421985|NCT01832753|101369391|FG002|COMPLETED|Randomization Phase (Months 6-12)||0||
48421986|NCT01832753|101369389|FG000|NOT COMPLETED|Randomization Phase (Months 6-12)||1||
48421987|NCT01832753|101369390|FG001|NOT COMPLETED|Randomization Phase (Months 6-12)||1||
48421988|NCT01832753|101369391|FG002|NOT COMPLETED|Randomization Phase (Months 6-12)||0||
48421989|NCT01832753|101369389|FG000|STARTED|Open Label Dose Phase (Months 12-18)||3||
48421990|NCT01832753|101369390|FG001|STARTED|Open Label Dose Phase (Months 12-18)||3||
48421991|NCT01832753|101369391|FG002|STARTED|Open Label Dose Phase (Months 12-18)||0||
48421992|NCT01832753|101369389|FG000|COMPLETED|Open Label Dose Phase (Months 12-18)||3||
48421993|NCT01832753|101369390|FG001|COMPLETED|Open Label Dose Phase (Months 12-18)||3||
48421994|NCT01832753|101369391|FG002|COMPLETED|Open Label Dose Phase (Months 12-18)||0||
48421995|NCT01832753|101369389|FG000|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0||
48421996|NCT01832753|101369390|FG001|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0||
48421997|NCT01832753|101369391|FG002|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0||
48763743|NCT02003924|102208803|FG001|Treated|Open-label Phase||0||
48763744|NCT02003924|102208804|FG002|Treated|Open-label Phase||87||
48763745|NCT02003924|102208802|FG000|COMPLETED|Open-label Phase||378||
48763746|NCT02003924|102208803|FG001|COMPLETED|Open-label Phase||0||
48763747|NCT02003924|102208804|FG002|COMPLETED|Open-label Phase||70||
48763748|NCT02003924|102208802|FG000|NOT COMPLETED|Open-label Phase||100||
48186914|NCT01515319|100779929|FG000|NOT COMPLETED|Overall Study||0||
48186915|NCT01515319|100779930|FG001|NOT COMPLETED|Overall Study||0||
48186916|NCT01515319|100779931|FG002|NOT COMPLETED|Overall Study||0||
48186917|NCT01515319|100779932|FG003|NOT COMPLETED|Overall Study||0||
48186918|NCT01515319|100779933|FG004|NOT COMPLETED|Overall Study||0||
48186919|NCT01515319|100779934|FG005|NOT COMPLETED|Overall Study||0||
48186920|NCT01515319|100779935|FG006|NOT COMPLETED|Overall Study||1||
48186921|NCT01515319|100779936|FG007|NOT COMPLETED|Overall Study||0||
48186922|NCT01515319|100779937|FG008|NOT COMPLETED|Overall Study||5||
48186923|NCT01515319|100779938|FG009|NOT COMPLETED|Overall Study||0||
48186924|NCT04003974|100779939|FG000|STARTED|Overall Study||40||
48186925|NCT04003974|100779940|FG001|STARTED|Overall Study||40||
48186926|NCT04003974|100779939|FG000|COMPLETED|Overall Study||39||
48186927|NCT04003974|100779940|FG001|COMPLETED|Overall Study||38||
48186928|NCT04003974|100779939|FG000|NOT COMPLETED|Overall Study||1||
48186929|NCT04003974|100779940|FG001|NOT COMPLETED|Overall Study||2||
48186930|NCT01232556|100779941|FG000|STARTED|Overall Study||166||
48186931|NCT01232556|100779942|FG001|STARTED|Overall Study||172||
48186932|NCT01232556|100779941|FG000|Treated|Overall Study||165||
48186933|NCT01232556|100779942|FG001|Treated|Overall Study||167||
48186934|NCT01232556|100779941|FG000|COMPLETED|Overall Study||7||
48186935|NCT01232556|100779942|FG001|COMPLETED|Overall Study||1||
48186936|NCT01232556|100779941|FG000|NOT COMPLETED|Overall Study||159||
48186937|NCT01232556|100779942|FG001|NOT COMPLETED|Overall Study||171||
48421998|NCT00634933|101369392|FG000|STARTED|Part A: Baseline to Week 24||74||
48421999|NCT00634933|101369393|FG001|STARTED|Part A: Baseline to Week 24||75||
48422000|NCT00634933|101369394|FG002|STARTED|Part A: Baseline to Week 24||73||
48422001|NCT00634933|101369395|FG003|STARTED|Part A: Baseline to Week 24||0||
48422002|NCT00634933|101369396|FG004|STARTED|Part A: Baseline to Week 24||0||
48422003|NCT00634933|101369392|FG000|COMPLETED|Part A: Baseline to Week 24||63||
48422004|NCT00634933|101369393|FG001|COMPLETED|Part A: Baseline to Week 24||57||
48422005|NCT00634933|101369394|FG002|COMPLETED|Part A: Baseline to Week 24||55||
48422006|NCT00634933|101369395|FG003|COMPLETED|Part A: Baseline to Week 24||0||
48763749|NCT02003924|102208803|FG001|NOT COMPLETED|Open-label Phase||0||
48763750|NCT02003924|102208804|FG002|NOT COMPLETED|Open-label Phase||17||
48763751|NCT02003924|102208802|FG000|STARTED|Long-term Follow-up Phase||933||
48186938|NCT00557505|100779943|FG000|STARTED|Overall Study||3||
48186939|NCT00557505|100779944|FG001|STARTED|Overall Study||3||
48186940|NCT00557505|100779945|FG002|STARTED|Overall Study||4||
48186941|NCT00557505|100779946|FG003|STARTED|Overall Study||3||
48422007|NCT00634933|101369396|FG004|COMPLETED|Part A: Baseline to Week 24||0||
48422008|NCT00634933|101369392|FG000|NOT COMPLETED|Part A: Baseline to Week 24||11||
48422009|NCT00634933|101369393|FG001|NOT COMPLETED|Part A: Baseline to Week 24||18||
48422010|NCT00634933|101369394|FG002|NOT COMPLETED|Part A: Baseline to Week 24||18||
48763752|NCT02003924|102208803|FG001|STARTED|Long-term Follow-up Phase||381||
48763753|NCT02003924|102208804|FG002|STARTED|Long-term Follow-up Phase||87||
48763754|NCT02003924|102208802|FG000|COMPLETED|Long-term Follow-up Phase||566||
48763755|NCT02003924|102208803|FG001|COMPLETED|Long-term Follow-up Phase||144||
48763756|NCT02003924|102208804|FG002|COMPLETED|Long-term Follow-up Phase||80||
48763757|NCT02003924|102208802|FG000|NOT COMPLETED|Long-term Follow-up Phase||367||
48763758|NCT02003924|102208803|FG001|NOT COMPLETED|Long-term Follow-up Phase||237||
48763759|NCT02003924|102208804|FG002|NOT COMPLETED|Long-term Follow-up Phase||7||
48186942|NCT00557505|100779947|FG004|STARTED|Overall Study||2||
48186943|NCT00557505|100779948|FG005|STARTED|Overall Study||3||
48186944|NCT00557505|100779949|FG006|STARTED|Overall Study||3||
48186945|NCT00557505|100779950|FG007|STARTED|Overall Study||5||
48186946|NCT00557505|100779951|FG008|STARTED|Overall Study||17||
48186947|NCT00557505|100779943|FG000|COMPLETED|Overall Study||0||
48186948|NCT00557505|100779944|FG001|COMPLETED|Overall Study||0||
48186949|NCT00557505|100779945|FG002|COMPLETED|Overall Study||0||
48439982|NCT01728376|101409998|FG003|NOT COMPLETED|Overall Study||2||
48763760|NCT04047602|102208805|FG000|STARTED|Overall Study||18||
48763761|NCT04047602|102208805|FG000|COMPLETED|Overall Study||18||
48422011|NCT00634933|101369395|FG003|NOT COMPLETED|Part A: Baseline to Week 24||0||
48422012|NCT00634933|101369396|FG004|NOT COMPLETED|Part A: Baseline to Week 24||0||
48422013|NCT00634933|101369392|FG000|STARTED|Between Part A and Part B||0||
48422014|NCT00634933|101369393|FG001|STARTED|Between Part A and Part B||57||
48422015|NCT00634933|101369394|FG002|STARTED|Between Part A and Part B||55||
48422016|NCT00634933|101369395|FG003|STARTED|Between Part A and Part B||31||
48422017|NCT00634933|101369396|FG004|STARTED|Between Part A and Part B||32||
48422018|NCT00634933|101369392|FG000|COMPLETED|Between Part A and Part B||0||
48422019|NCT00634933|101369393|FG001|COMPLETED|Between Part A and Part B||56||
48422020|NCT00634933|101369394|FG002|COMPLETED|Between Part A and Part B||55||
48422021|NCT00634933|101369395|FG003|COMPLETED|Between Part A and Part B||31||
48422022|NCT00634933|101369396|FG004|COMPLETED|Between Part A and Part B||32||
48422023|NCT00634933|101369392|FG000|NOT COMPLETED|Between Part A and Part B||0||
48422024|NCT00634933|101369393|FG001|NOT COMPLETED|Between Part A and Part B||1||
48422025|NCT00634933|101369394|FG002|NOT COMPLETED|Between Part A and Part B||0||
48422026|NCT00634933|101369395|FG003|NOT COMPLETED|Between Part A and Part B||0||
48422027|NCT00634933|101369396|FG004|NOT COMPLETED|Between Part A and Part B||0||
48422028|NCT00634933|101369392|FG000|STARTED|Part B: Week 24 to Week 52||0||
48422029|NCT00634933|101369393|FG001|STARTED|Part B: Week 24 to Week 52||56||
48422030|NCT00634933|101369394|FG002|STARTED|Part B: Week 24 to Week 52||55||
48422031|NCT00634933|101369395|FG003|STARTED|Part B: Week 24 to Week 52||31||
48422032|NCT00634933|101369396|FG004|STARTED|Part B: Week 24 to Week 52||32||
48422033|NCT00634933|101369392|FG000|COMPLETED|Part B: Week 24 to Week 52||0||
48422034|NCT00634933|101369393|FG001|COMPLETED|Part B: Week 24 to Week 52||42||
48422035|NCT00634933|101369394|FG002|COMPLETED|Part B: Week 24 to Week 52||33||
48422036|NCT00634933|101369395|FG003|COMPLETED|Part B: Week 24 to Week 52||25||
48422037|NCT00634933|101369396|FG004|COMPLETED|Part B: Week 24 to Week 52||22||
48422038|NCT00634933|101369392|FG000|NOT COMPLETED|Part B: Week 24 to Week 52||0||
48422039|NCT00634933|101369393|FG001|NOT COMPLETED|Part B: Week 24 to Week 52||14||
48422040|NCT00634933|101369394|FG002|NOT COMPLETED|Part B: Week 24 to Week 52||22||
48422041|NCT00634933|101369395|FG003|NOT COMPLETED|Part B: Week 24 to Week 52||6||
48422042|NCT00634933|101369396|FG004|NOT COMPLETED|Part B: Week 24 to Week 52||10||
48422043|NCT03891199|101369397|FG000|STARTED|Overall Study||20||
48422044|NCT03891199|101369398|FG001|STARTED|Overall Study||20||
48422045|NCT03891199|101369397|FG000|COMPLETED|Overall Study||20||
48422046|NCT03891199|101369398|FG001|COMPLETED|Overall Study||17||
48422047|NCT03891199|101369397|FG000|NOT COMPLETED|Overall Study||0||
48422048|NCT03891199|101369398|FG001|NOT COMPLETED|Overall Study||3||
48422049|NCT01842282|101369399|FG000|STARTED|Overall Study||7||
48422050|NCT01842282|101369399|FG000|COMPLETED|Overall Study||6||
48422051|NCT01842282|101369399|FG000|NOT COMPLETED|Overall Study||1||
48422052|NCT00149227|101369400|FG000|STARTED|Overall Study||1517||
48422053|NCT00149227|101369401|FG001|STARTED|Overall Study||1514||
48422054|NCT00149227|101369400|FG000|COMPLETED|Overall Study||1517||
48422055|NCT00149227|101369401|FG001|COMPLETED|Overall Study||1514||
48422056|NCT00149227|101369400|FG000|NOT COMPLETED|Overall Study||0||
48422057|NCT00149227|101369401|FG001|NOT COMPLETED|Overall Study||0||
48422058|NCT01049360|101369402|FG000|STARTED|Period 1||6||
48422059|NCT01049360|101369403|FG001|STARTED|Period 1||6||
48422060|NCT01049360|101369404|FG002|STARTED|Period 1||7||
48422061|NCT01049360|101369405|FG003|STARTED|Period 1||7||
48422062|NCT01049360|101369406|FG004|STARTED|Period 1||7||
48422063|NCT01049360|101369407|FG005|STARTED|Period 1||6||
48422064|NCT01049360|101369408|FG006|STARTED|Period 1||6||
48422065|NCT01049360|101369409|FG007|STARTED|Period 1||6||
48422066|NCT01049360|101369410|FG008|STARTED|Period 1||7||
48422067|NCT01049360|101369411|FG009|STARTED|Period 1||6||
48422068|NCT01049360|101369412|FG010|STARTED|Period 1||6||
48422069|NCT01049360|101369413|FG011|STARTED|Period 1||6||
48422070|NCT01049360|101369414|FG012|STARTED|Period 1||6||
48422071|NCT01049360|101369415|FG013|STARTED|Period 1||7||
48422072|NCT01049360|101369416|FG014|STARTED|Period 1||7||
48422073|NCT01049360|101369417|FG015|STARTED|Period 1||7||
48422074|NCT01049360|101369418|FG016|STARTED|Period 1||6||
48422075|NCT01049360|101369419|FG017|STARTED|Period 1||6||
48422076|NCT01049360|101369420|FG018|STARTED|Period 1||6||
48422077|NCT01049360|101369421|FG019|STARTED|Period 1||7||
48422078|NCT01049360|101369402|FG000|COMPLETED|Period 1||6||
48422079|NCT01049360|101369403|FG001|COMPLETED|Period 1||5||
48422080|NCT01049360|101369404|FG002|COMPLETED|Period 1||7||
48422081|NCT01049360|101369405|FG003|COMPLETED|Period 1||6||
48422082|NCT01049360|101369406|FG004|COMPLETED|Period 1||7||
48422083|NCT01049360|101369407|FG005|COMPLETED|Period 1||6||
48422084|NCT01049360|101369408|FG006|COMPLETED|Period 1||6||
48422085|NCT01049360|101369409|FG007|COMPLETED|Period 1||4||
48422086|NCT01049360|101369410|FG008|COMPLETED|Period 1||5||
48422087|NCT01049360|101369411|FG009|COMPLETED|Period 1||6||
48422088|NCT01049360|101369412|FG010|COMPLETED|Period 1||5||
48422089|NCT01049360|101369413|FG011|COMPLETED|Period 1||6||
48422090|NCT01049360|101369414|FG012|COMPLETED|Period 1||4||
48422091|NCT01049360|101369415|FG013|COMPLETED|Period 1||6||
48422092|NCT01049360|101369416|FG014|COMPLETED|Period 1||7||
48422093|NCT01049360|101369417|FG015|COMPLETED|Period 1||7||
48422094|NCT01049360|101369418|FG016|COMPLETED|Period 1||5||
48422095|NCT01049360|101369419|FG017|COMPLETED|Period 1||6||
48422096|NCT01049360|101369420|FG018|COMPLETED|Period 1||5||
48422097|NCT01049360|101369421|FG019|COMPLETED|Period 1||7||
48422098|NCT01049360|101369402|FG000|NOT COMPLETED|Period 1||0||
48422099|NCT01049360|101369403|FG001|NOT COMPLETED|Period 1||1||
48422100|NCT01049360|101369404|FG002|NOT COMPLETED|Period 1||0||
48422101|NCT01049360|101369405|FG003|NOT COMPLETED|Period 1||1||
48422102|NCT01049360|101369406|FG004|NOT COMPLETED|Period 1||0||
48422103|NCT01049360|101369407|FG005|NOT COMPLETED|Period 1||0||
48422104|NCT01049360|101369408|FG006|NOT COMPLETED|Period 1||0||
48422105|NCT01049360|101369409|FG007|NOT COMPLETED|Period 1||2||
48422106|NCT01049360|101369410|FG008|NOT COMPLETED|Period 1||2||
48422107|NCT01049360|101369411|FG009|NOT COMPLETED|Period 1||0||
48422108|NCT01049360|101369412|FG010|NOT COMPLETED|Period 1||1||
48422109|NCT01049360|101369413|FG011|NOT COMPLETED|Period 1||0||
48422110|NCT01049360|101369414|FG012|NOT COMPLETED|Period 1||2||
48422111|NCT01049360|101369415|FG013|NOT COMPLETED|Period 1||1||
48186950|NCT00557505|100779946|FG003|COMPLETED|Overall Study||0||
48186951|NCT00557505|100779947|FG004|COMPLETED|Overall Study||0||
48186952|NCT00557505|100779948|FG005|COMPLETED|Overall Study||0||
48186953|NCT00557505|100779949|FG006|COMPLETED|Overall Study||0||
48186954|NCT00557505|100779950|FG007|COMPLETED|Overall Study||0||
48186955|NCT00557505|100779951|FG008|COMPLETED|Overall Study||0||
48186956|NCT00557505|100779943|FG000|NOT COMPLETED|Overall Study||3||
48186957|NCT00557505|100779944|FG001|NOT COMPLETED|Overall Study||3||
48186958|NCT00557505|100779945|FG002|NOT COMPLETED|Overall Study||4||
48186959|NCT00557505|100779946|FG003|NOT COMPLETED|Overall Study||3||
48186960|NCT00557505|100779947|FG004|NOT COMPLETED|Overall Study||2||
48186961|NCT00557505|100779948|FG005|NOT COMPLETED|Overall Study||3||
48186962|NCT00557505|100779949|FG006|NOT COMPLETED|Overall Study||3||
48186963|NCT00557505|100779950|FG007|NOT COMPLETED|Overall Study||5||
48186964|NCT00557505|100779951|FG008|NOT COMPLETED|Overall Study||17||
48186965|NCT02451930|100779952|FG000|STARTED|Overall Study||3||
48186966|NCT02451930|100779953|FG001|STARTED|Overall Study||68||
48186967|NCT02451930|100779952|FG000|Received at Least One Dose of Study Drug|Overall Study||3||
48422112|NCT01049360|101369416|FG014|NOT COMPLETED|Period 1||0||
48422113|NCT01049360|101369417|FG015|NOT COMPLETED|Period 1||0||
48422114|NCT01049360|101369418|FG016|NOT COMPLETED|Period 1||1||
48422115|NCT01049360|101369419|FG017|NOT COMPLETED|Period 1||0||
48186968|NCT02451930|100779953|FG001|Received at Least One Dose of Study Drug|Overall Study||68||
48186969|NCT02451930|100779952|FG000|Part A Cohort 2 Participants|Overall Study||0||
48422116|NCT01049360|101369420|FG018|NOT COMPLETED|Period 1||1||
48422117|NCT01049360|101369421|FG019|NOT COMPLETED|Period 1||0||
48422118|NCT01049360|101369402|FG000|STARTED|Period 2||6||
48422119|NCT01049360|101369403|FG001|STARTED|Period 2||5||
48422120|NCT01049360|101369404|FG002|STARTED|Period 2||7||
48422121|NCT01049360|101369405|FG003|STARTED|Period 2||6||
48422122|NCT01049360|101369406|FG004|STARTED|Period 2||7||
48422123|NCT01049360|101369407|FG005|STARTED|Period 2||6||
48422124|NCT01049360|101369408|FG006|STARTED|Period 2||6||
48422125|NCT01049360|101369409|FG007|STARTED|Period 2||4||
48422126|NCT01049360|101369410|FG008|STARTED|Period 2||5||
48422127|NCT01049360|101369411|FG009|STARTED|Period 2||6||
48422128|NCT01049360|101369412|FG010|STARTED|Period 2||5||
48422129|NCT01049360|101369413|FG011|STARTED|Period 2||6||
48422130|NCT01049360|101369414|FG012|STARTED|Period 2||4||
48422131|NCT01049360|101369415|FG013|STARTED|Period 2||6||
48422132|NCT01049360|101369416|FG014|STARTED|Period 2||7||
48422133|NCT01049360|101369417|FG015|STARTED|Period 2||7||
48422134|NCT01049360|101369418|FG016|STARTED|Period 2||5||
48422135|NCT01049360|101369419|FG017|STARTED|Period 2||6||
48422136|NCT01049360|101369420|FG018|STARTED|Period 2||5||
48422137|NCT01049360|101369421|FG019|STARTED|Period 2||7||
48422138|NCT01049360|101369402|FG000|COMPLETED|Period 2||6||
48422139|NCT01049360|101369403|FG001|COMPLETED|Period 2||4||
48422140|NCT01049360|101369404|FG002|COMPLETED|Period 2||7||
48422141|NCT01049360|101369405|FG003|COMPLETED|Period 2||4||
48422142|NCT01049360|101369406|FG004|COMPLETED|Period 2||7||
48422143|NCT01049360|101369407|FG005|COMPLETED|Period 2||5||
48422144|NCT01049360|101369408|FG006|COMPLETED|Period 2||6||
48422145|NCT01049360|101369409|FG007|COMPLETED|Period 2||4||
48422146|NCT01049360|101369410|FG008|COMPLETED|Period 2||4||
48186970|NCT02451930|100779953|FG001|Part A Cohort 2 Participants|Overall Study||6||
48186971|NCT02451930|100779952|FG000|Part B Participants|Overall Study||0||
48186972|NCT02451930|100779953|FG001|Part B Participants|Overall Study||55||
48186973|NCT02451930|100779952|FG000|Part C Participants|Overall Study||0||
48186974|NCT02451930|100779953|FG001|Part C Participants|Overall Study||7||
48422147|NCT01049360|101369411|FG009|COMPLETED|Period 2||6||
48422148|NCT01049360|101369412|FG010|COMPLETED|Period 2||5||
48422149|NCT01049360|101369413|FG011|COMPLETED|Period 2||6||
48422150|NCT01049360|101369414|FG012|COMPLETED|Period 2||4||
48422151|NCT01049360|101369415|FG013|COMPLETED|Period 2||6||
48422152|NCT01049360|101369416|FG014|COMPLETED|Period 2||5||
48422153|NCT01049360|101369417|FG015|COMPLETED|Period 2||6||
48422154|NCT01049360|101369418|FG016|COMPLETED|Period 2||5||
48422155|NCT01049360|101369419|FG017|COMPLETED|Period 2||6||
48422156|NCT01049360|101369420|FG018|COMPLETED|Period 2||5||
48422157|NCT01049360|101369421|FG019|COMPLETED|Period 2||5||
48422158|NCT01049360|101369402|FG000|NOT COMPLETED|Period 2||0||
48422159|NCT01049360|101369403|FG001|NOT COMPLETED|Period 2||1||
48422160|NCT01049360|101369404|FG002|NOT COMPLETED|Period 2||0||
48422161|NCT01049360|101369405|FG003|NOT COMPLETED|Period 2||2||
48422162|NCT01049360|101369406|FG004|NOT COMPLETED|Period 2||0||
48422163|NCT01049360|101369407|FG005|NOT COMPLETED|Period 2||1||
48422164|NCT01049360|101369408|FG006|NOT COMPLETED|Period 2||0||
48422165|NCT01049360|101369409|FG007|NOT COMPLETED|Period 2||0||
48422166|NCT01049360|101369410|FG008|NOT COMPLETED|Period 2||1||
48422167|NCT01049360|101369411|FG009|NOT COMPLETED|Period 2||0||
48422168|NCT01049360|101369412|FG010|NOT COMPLETED|Period 2||0||
48422169|NCT01049360|101369413|FG011|NOT COMPLETED|Period 2||0||
48422170|NCT01049360|101369414|FG012|NOT COMPLETED|Period 2||0||
48422171|NCT01049360|101369415|FG013|NOT COMPLETED|Period 2||0||
48422172|NCT01049360|101369416|FG014|NOT COMPLETED|Period 2||2||
48422173|NCT01049360|101369417|FG015|NOT COMPLETED|Period 2||1||
48422174|NCT01049360|101369418|FG016|NOT COMPLETED|Period 2||0||
48422175|NCT01049360|101369419|FG017|NOT COMPLETED|Period 2||0||
48422176|NCT01049360|101369420|FG018|NOT COMPLETED|Period 2||0||
48422177|NCT01049360|101369421|FG019|NOT COMPLETED|Period 2||2||
48422178|NCT01049360|101369402|FG000|STARTED|Period 3||6||
48422179|NCT01049360|101369403|FG001|STARTED|Period 3||4||
48422180|NCT01049360|101369404|FG002|STARTED|Period 3||7||
48422181|NCT01049360|101369405|FG003|STARTED|Period 3||4||
48422182|NCT01049360|101369406|FG004|STARTED|Period 3||7||
48422183|NCT01049360|101369407|FG005|STARTED|Period 3||5||
48422184|NCT01049360|101369408|FG006|STARTED|Period 3||6||
48422185|NCT01049360|101369409|FG007|STARTED|Period 3||4||
48422186|NCT01049360|101369410|FG008|STARTED|Period 3||4||
48422187|NCT01049360|101369411|FG009|STARTED|Period 3||6||
48422188|NCT01049360|101369412|FG010|STARTED|Period 3||5||
48422189|NCT01049360|101369413|FG011|STARTED|Period 3||6||
48422190|NCT01049360|101369414|FG012|STARTED|Period 3||4||
48422191|NCT01049360|101369415|FG013|STARTED|Period 3||6||
48422192|NCT01049360|101369416|FG014|STARTED|Period 3||5||
48422193|NCT01049360|101369417|FG015|STARTED|Period 3||6||
48422194|NCT01049360|101369418|FG016|STARTED|Period 3||5||
48422195|NCT01049360|101369419|FG017|STARTED|Period 3||6||
48422196|NCT01049360|101369420|FG018|STARTED|Period 3||5||
48422197|NCT01049360|101369421|FG019|STARTED|Period 3||5||
48422198|NCT01049360|101369402|FG000|COMPLETED|Period 3||6||
48422199|NCT01049360|101369403|FG001|COMPLETED|Period 3||4||
48422200|NCT01049360|101369404|FG002|COMPLETED|Period 3||7||
48422201|NCT01049360|101369405|FG003|COMPLETED|Period 3||4||
48422202|NCT01049360|101369406|FG004|COMPLETED|Period 3||7||
48422203|NCT01049360|101369407|FG005|COMPLETED|Period 3||5||
48422204|NCT01049360|101369408|FG006|COMPLETED|Period 3||6||
48422205|NCT01049360|101369409|FG007|COMPLETED|Period 3||4||
48422206|NCT01049360|101369410|FG008|COMPLETED|Period 3||4||
48422207|NCT01049360|101369411|FG009|COMPLETED|Period 3||6||
48422208|NCT01049360|101369412|FG010|COMPLETED|Period 3||5||
48422209|NCT01049360|101369413|FG011|COMPLETED|Period 3||6||
48422210|NCT01049360|101369414|FG012|COMPLETED|Period 3||4||
48422211|NCT01049360|101369415|FG013|COMPLETED|Period 3||6||
48422212|NCT01049360|101369416|FG014|COMPLETED|Period 3||5||
48422213|NCT01049360|101369417|FG015|COMPLETED|Period 3||6||
48422214|NCT01049360|101369418|FG016|COMPLETED|Period 3||5||
48422215|NCT01049360|101369419|FG017|COMPLETED|Period 3||6||
48422216|NCT01049360|101369420|FG018|COMPLETED|Period 3||5||
48422217|NCT01049360|101369421|FG019|COMPLETED|Period 3||5||
48422218|NCT01049360|101369402|FG000|NOT COMPLETED|Period 3||0||
48422219|NCT01049360|101369403|FG001|NOT COMPLETED|Period 3||0||
48422220|NCT01049360|101369404|FG002|NOT COMPLETED|Period 3||0||
48422221|NCT01049360|101369405|FG003|NOT COMPLETED|Period 3||0||
48422222|NCT01049360|101369406|FG004|NOT COMPLETED|Period 3||0||
48422223|NCT01049360|101369407|FG005|NOT COMPLETED|Period 3||0||
48422224|NCT01049360|101369408|FG006|NOT COMPLETED|Period 3||0||
48422225|NCT01049360|101369409|FG007|NOT COMPLETED|Period 3||0||
48422226|NCT01049360|101369410|FG008|NOT COMPLETED|Period 3||0||
48422227|NCT01049360|101369411|FG009|NOT COMPLETED|Period 3||0||
48422228|NCT01049360|101369412|FG010|NOT COMPLETED|Period 3||0||
48422229|NCT01049360|101369413|FG011|NOT COMPLETED|Period 3||0||
48422230|NCT01049360|101369414|FG012|NOT COMPLETED|Period 3||0||
48422231|NCT01049360|101369415|FG013|NOT COMPLETED|Period 3||0||
48422232|NCT01049360|101369416|FG014|NOT COMPLETED|Period 3||0||
48422233|NCT01049360|101369417|FG015|NOT COMPLETED|Period 3||0||
48422234|NCT01049360|101369418|FG016|NOT COMPLETED|Period 3||0||
48422235|NCT01049360|101369419|FG017|NOT COMPLETED|Period 3||0||
48422236|NCT01049360|101369420|FG018|NOT COMPLETED|Period 3||0||
48422237|NCT01049360|101369421|FG019|NOT COMPLETED|Period 3||0||
48422238|NCT01049360|101369402|FG000|STARTED|Period 4||6||
48422239|NCT01049360|101369403|FG001|STARTED|Period 4||4||
48422240|NCT01049360|101369404|FG002|STARTED|Period 4||7||
48422241|NCT01049360|101369405|FG003|STARTED|Period 4||4||
48422242|NCT01049360|101369406|FG004|STARTED|Period 4||7||
48422243|NCT01049360|101369407|FG005|STARTED|Period 4||5||
48422244|NCT01049360|101369408|FG006|STARTED|Period 4||6||
48422245|NCT01049360|101369409|FG007|STARTED|Period 4||4||
48422246|NCT01049360|101369410|FG008|STARTED|Period 4||4||
48422247|NCT01049360|101369411|FG009|STARTED|Period 4||6||
48422248|NCT01049360|101369412|FG010|STARTED|Period 4||5||
48422249|NCT01049360|101369413|FG011|STARTED|Period 4||6||
48422250|NCT01049360|101369414|FG012|STARTED|Period 4||4||
48422251|NCT01049360|101369415|FG013|STARTED|Period 4||6||
48422252|NCT01049360|101369416|FG014|STARTED|Period 4||5||
48422253|NCT01049360|101369417|FG015|STARTED|Period 4||6||
48422254|NCT01049360|101369418|FG016|STARTED|Period 4||5||
48422255|NCT01049360|101369419|FG017|STARTED|Period 4||6||
48422256|NCT01049360|101369420|FG018|STARTED|Period 4||5||
48422257|NCT01049360|101369421|FG019|STARTED|Period 4||5||
48422258|NCT01049360|101369402|FG000|COMPLETED|Period 4||6||
48422259|NCT01049360|101369403|FG001|COMPLETED|Period 4||4||
48422260|NCT01049360|101369404|FG002|COMPLETED|Period 4||7||
48422261|NCT01049360|101369405|FG003|COMPLETED|Period 4||3||
48422262|NCT01049360|101369406|FG004|COMPLETED|Period 4||7||
48422263|NCT01049360|101369407|FG005|COMPLETED|Period 4||5||
48422264|NCT01049360|101369408|FG006|COMPLETED|Period 4||6||
48422265|NCT01049360|101369409|FG007|COMPLETED|Period 4||4||
48422266|NCT01049360|101369410|FG008|COMPLETED|Period 4||4||
48422267|NCT01049360|101369411|FG009|COMPLETED|Period 4||6||
48422268|NCT01049360|101369412|FG010|COMPLETED|Period 4||5||
48422269|NCT01049360|101369413|FG011|COMPLETED|Period 4||6||
48422270|NCT01049360|101369414|FG012|COMPLETED|Period 4||4||
48422271|NCT01049360|101369415|FG013|COMPLETED|Period 4||6||
48422272|NCT01049360|101369416|FG014|COMPLETED|Period 4||5||
48422273|NCT01049360|101369417|FG015|COMPLETED|Period 4||6||
48422274|NCT01049360|101369418|FG016|COMPLETED|Period 4||5||
48422275|NCT01049360|101369419|FG017|COMPLETED|Period 4||5||
48422276|NCT01049360|101369420|FG018|COMPLETED|Period 4||5||
48422277|NCT01049360|101369421|FG019|COMPLETED|Period 4||5||
48422278|NCT01049360|101369402|FG000|NOT COMPLETED|Period 4||0||
48422279|NCT01049360|101369403|FG001|NOT COMPLETED|Period 4||0||
48422280|NCT01049360|101369404|FG002|NOT COMPLETED|Period 4||0||
48422281|NCT01049360|101369405|FG003|NOT COMPLETED|Period 4||1||
48422282|NCT01049360|101369406|FG004|NOT COMPLETED|Period 4||0||
48422283|NCT01049360|101369407|FG005|NOT COMPLETED|Period 4||0||
48422284|NCT01049360|101369408|FG006|NOT COMPLETED|Period 4||0||
48186975|NCT02451930|100779952|FG000|COMPLETED|Overall Study||1||
48186976|NCT02451930|100779953|FG001|COMPLETED|Overall Study||38||
48186977|NCT02451930|100779952|FG000|NOT COMPLETED|Overall Study||2||
48186978|NCT02451930|100779953|FG001|NOT COMPLETED|Overall Study||30||
48186979|NCT02237079|100779954|FG000|STARTED|Overall Study||10||
48186980|NCT02237079|100779955|FG001|STARTED|Overall Study||7||
48186981|NCT02237079|100779954|FG000|COMPLETED|Overall Study||7||
48422285|NCT01049360|101369409|FG007|NOT COMPLETED|Period 4||0||
48422286|NCT01049360|101369410|FG008|NOT COMPLETED|Period 4||0||
48422287|NCT01049360|101369411|FG009|NOT COMPLETED|Period 4||0||
48422288|NCT01049360|101369412|FG010|NOT COMPLETED|Period 4||0||
48422289|NCT01049360|101369413|FG011|NOT COMPLETED|Period 4||0||
48422290|NCT01049360|101369414|FG012|NOT COMPLETED|Period 4||0||
48422291|NCT01049360|101369415|FG013|NOT COMPLETED|Period 4||0||
48422292|NCT01049360|101369416|FG014|NOT COMPLETED|Period 4||0||
48422293|NCT01049360|101369417|FG015|NOT COMPLETED|Period 4||0||
48422294|NCT01049360|101369418|FG016|NOT COMPLETED|Period 4||0||
48422295|NCT01049360|101369419|FG017|NOT COMPLETED|Period 4||1||
48422296|NCT01049360|101369420|FG018|NOT COMPLETED|Period 4||0||
48422297|NCT01049360|101369421|FG019|NOT COMPLETED|Period 4||0||
48422298|NCT03802331|101369422|FG000|STARTED|Treatment Period 1 (P1) + Washout||6||
48422299|NCT03802331|101369423|FG001|STARTED|Treatment Period 1 (P1) + Washout||6||
48422300|NCT03802331|101369422|FG000|COMPLETED|Treatment Period 1 (P1) + Washout||5||
48422301|NCT03802331|101369423|FG001|COMPLETED|Treatment Period 1 (P1) + Washout||6||
48422302|NCT03802331|101369422|FG000|NOT COMPLETED|Treatment Period 1 (P1) + Washout||1||
48422303|NCT03802331|101369423|FG001|NOT COMPLETED|Treatment Period 1 (P1) + Washout||0||
48422304|NCT03802331|101369422|FG000|STARTED|Treatment Period 2 (P2)||5||
48422305|NCT03802331|101369423|FG001|STARTED|Treatment Period 2 (P2)||6||
48422306|NCT03802331|101369422|FG000|COMPLETED|Treatment Period 2 (P2)||5||
48422307|NCT03802331|101369423|FG001|COMPLETED|Treatment Period 2 (P2)||6||
48422308|NCT03802331|101369422|FG000|NOT COMPLETED|Treatment Period 2 (P2)||0||
48422309|NCT03802331|101369423|FG001|NOT COMPLETED|Treatment Period 2 (P2)||0||
48422310|NCT03820388|101369424|FG000|STARTED|Overall Study||25||
48422311|NCT03820388|101369425|FG001|STARTED|Overall Study||25||
48422312|NCT03820388|101369426|FG002|STARTED|Overall Study||25||
48422313|NCT03820388|101369424|FG000|COMPLETED|Overall Study||25||
48422314|NCT03820388|101369425|FG001|COMPLETED|Overall Study||25||
48422315|NCT03820388|101369426|FG002|COMPLETED|Overall Study||25||
48422316|NCT03820388|101369424|FG000|NOT COMPLETED|Overall Study||0||
48422317|NCT03820388|101369425|FG001|NOT COMPLETED|Overall Study||0||
48422318|NCT03820388|101369426|FG002|NOT COMPLETED|Overall Study||0||
48422319|NCT02185040|101369427|FG000|STARTED|Part 1 Treatment Phase||8||
48422320|NCT02185040|101369428|FG001|STARTED|Part 1 Treatment Phase||8||
48422321|NCT02185040|101369429|FG002|STARTED|Part 1 Treatment Phase||8||
48422322|NCT02185040|101369430|FG003|STARTED|Part 1 Treatment Phase||9||
48422323|NCT02185040|101369431|FG004|STARTED|Part 1 Treatment Phase||9||
48422324|NCT02185040|101369432|FG005|STARTED|Part 1 Treatment Phase||0||
48422325|NCT02185040|101369433|FG006|STARTED|Part 1 Treatment Phase||0||
48422326|NCT02185040|101369427|FG000|COMPLETED|Part 1 Treatment Phase||7||
48422327|NCT02185040|101369428|FG001|COMPLETED|Part 1 Treatment Phase||6||
48422328|NCT02185040|101369429|FG002|COMPLETED|Part 1 Treatment Phase||7||
48422329|NCT02185040|101369430|FG003|COMPLETED|Part 1 Treatment Phase||7||
48422330|NCT02185040|101369431|FG004|COMPLETED|Part 1 Treatment Phase||6||
48422331|NCT02185040|101369432|FG005|COMPLETED|Part 1 Treatment Phase||0||
48422332|NCT02185040|101369433|FG006|COMPLETED|Part 1 Treatment Phase||0||
48422333|NCT02185040|101369427|FG000|NOT COMPLETED|Part 1 Treatment Phase||1||
48422334|NCT02185040|101369428|FG001|NOT COMPLETED|Part 1 Treatment Phase||2||
48422335|NCT02185040|101369429|FG002|NOT COMPLETED|Part 1 Treatment Phase||1||
48422336|NCT02185040|101369430|FG003|NOT COMPLETED|Part 1 Treatment Phase||2||
48422337|NCT02185040|101369431|FG004|NOT COMPLETED|Part 1 Treatment Phase||3||
48422338|NCT02185040|101369432|FG005|NOT COMPLETED|Part 1 Treatment Phase||0||
48422339|NCT02185040|101369433|FG006|NOT COMPLETED|Part 1 Treatment Phase||0||
48422340|NCT02185040|101369427|FG000|STARTED|Active Treatment Extension Phase||0||
48422341|NCT02185040|101369428|FG001|STARTED|Active Treatment Extension Phase||0||
48422342|NCT02185040|101369429|FG002|STARTED|Active Treatment Extension Phase||0||
48422343|NCT02185040|101369430|FG003|STARTED|Active Treatment Extension Phase||0||
48422344|NCT02185040|101369431|FG004|STARTED|Active Treatment Extension Phase||0||
48422345|NCT02185040|101369432|FG005|STARTED|Active Treatment Extension Phase||9||
48422346|NCT02185040|101369433|FG006|STARTED|Active Treatment Extension Phase||8||
48422347|NCT02185040|101369427|FG000|COMPLETED|Active Treatment Extension Phase||0||
48422348|NCT02185040|101369428|FG001|COMPLETED|Active Treatment Extension Phase||0||
48422349|NCT02185040|101369429|FG002|COMPLETED|Active Treatment Extension Phase||0||
48422350|NCT02185040|101369430|FG003|COMPLETED|Active Treatment Extension Phase||0||
48422351|NCT02185040|101369431|FG004|COMPLETED|Active Treatment Extension Phase||0||
48422352|NCT02185040|101369432|FG005|COMPLETED|Active Treatment Extension Phase||6||
48422353|NCT02185040|101369433|FG006|COMPLETED|Active Treatment Extension Phase||1||
48422354|NCT02185040|101369427|FG000|NOT COMPLETED|Active Treatment Extension Phase||0||
48422355|NCT02185040|101369428|FG001|NOT COMPLETED|Active Treatment Extension Phase||0||
48422356|NCT02185040|101369429|FG002|NOT COMPLETED|Active Treatment Extension Phase||0||
48422357|NCT02185040|101369430|FG003|NOT COMPLETED|Active Treatment Extension Phase||0||
48422358|NCT02185040|101369431|FG004|NOT COMPLETED|Active Treatment Extension Phase||0||
48422359|NCT02185040|101369432|FG005|NOT COMPLETED|Active Treatment Extension Phase||3||
48422360|NCT02185040|101369433|FG006|NOT COMPLETED|Active Treatment Extension Phase||7||
48422361|NCT01731951|101369434|FG000|STARTED|Overall Study||19||
48422362|NCT01731951|101369435|FG001|STARTED|Overall Study||16||
48422363|NCT01731951|101369436|FG002|STARTED|Overall Study||9||
48422364|NCT01731951|101369437|FG003|STARTED|Overall Study||9||
48422365|NCT01731951|101369438|FG004|STARTED|Overall Study||18||
48422366|NCT01731951|101369439|FG005|STARTED|Overall Study||9||
48422367|NCT01731951|101369434|FG000|COMPLETED|Overall Study||2||
48422368|NCT01731951|101369435|FG001|COMPLETED|Overall Study||1||
48422369|NCT01731951|101369436|FG002|COMPLETED|Overall Study||0||
48422370|NCT01731951|101369437|FG003|COMPLETED|Overall Study||0||
48422371|NCT01731951|101369438|FG004|COMPLETED|Overall Study||6||
48422372|NCT01731951|101369439|FG005|COMPLETED|Overall Study||0||
48422373|NCT01731951|101369434|FG000|NOT COMPLETED|Overall Study||17||
48422374|NCT01731951|101369435|FG001|NOT COMPLETED|Overall Study||15||
48422375|NCT01731951|101369436|FG002|NOT COMPLETED|Overall Study||9||
48422376|NCT01731951|101369437|FG003|NOT COMPLETED|Overall Study||9||
48422377|NCT01731951|101369438|FG004|NOT COMPLETED|Overall Study||12||
48422378|NCT01731951|101369439|FG005|NOT COMPLETED|Overall Study||9||
48422379|NCT00701064|101369440|FG000|STARTED|Overall Study||35||
48422380|NCT00701064|101369441|FG001|STARTED|Overall Study||36||
48422381|NCT00701064|101369440|FG000|COMPLETED|Overall Study||31||
48422382|NCT00701064|101369441|FG001|COMPLETED|Overall Study||32||
48422383|NCT00701064|101369440|FG000|NOT COMPLETED|Overall Study||4||
48422384|NCT00701064|101369441|FG001|NOT COMPLETED|Overall Study||4||
48422385|NCT02127970|101369442|FG000|STARTED|Overall Study||349||
48422386|NCT02127970|101369443|FG001|STARTED|Overall Study||349||
48422387|NCT02127970|101369442|FG000|COMPLETED|Overall Study||323||
48422388|NCT02127970|101369443|FG001|COMPLETED|Overall Study||322||
48422389|NCT02127970|101369442|FG000|NOT COMPLETED|Overall Study||26||
48422390|NCT02127970|101369443|FG001|NOT COMPLETED|Overall Study||27||
48422391|NCT02699632|101369444|FG000|STARTED|Overall Study||360||
48422392|NCT02699632|101369444|FG000|COMPLETED|Overall Study||358||
48422393|NCT02699632|101369444|FG000|NOT COMPLETED|Overall Study||2||
48422394|NCT01977573|101369445|FG000|STARTED|Overall Study||136||
48422395|NCT01977573|101369446|FG001|STARTED|Overall Study||44||
48422396|NCT01977573|101369447|FG002|STARTED|Overall Study||36||
48422397|NCT01977573|101369448|FG003|STARTED|Overall Study||36||
48422398|NCT01977573|101369445|FG000|COMPLETED|Overall Study||116||
48422399|NCT01977573|101369446|FG001|COMPLETED|Overall Study||41||
48422400|NCT01977573|101369447|FG002|COMPLETED|Overall Study||32||
48422401|NCT01977573|101369448|FG003|COMPLETED|Overall Study||33||
48422402|NCT01977573|101369445|FG000|NOT COMPLETED|Overall Study||20||
48422403|NCT01977573|101369446|FG001|NOT COMPLETED|Overall Study||3||
48422404|NCT01977573|101369447|FG002|NOT COMPLETED|Overall Study||4||
48422405|NCT01977573|101369448|FG003|NOT COMPLETED|Overall Study||3||
48422406|NCT02681094|101369449|FG000|STARTED|1 -Modified Enrolled Participants Set||293|7 participants of 1 US site were excluded due to serious Good Clinical Practice (GCP)|
48422407|NCT02681094|101369450|FG001|STARTED|1 -Modified Enrolled Participants Set||294|7 participants of 1 US site were excluded due to serious Good Clinical Practice (GCP)|
48422408|NCT02681094|101369451|FG002|STARTED|1 -Modified Enrolled Participants Set||296|7 participants of 1 US site were excluded due to serious Good Clinical Practice (GCP)|
48422409|NCT02681094|101369449|FG000|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||273||
48422410|NCT02681094|101369450|FG001|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||276||
48422411|NCT02681094|101369451|FG002|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||283||
48422412|NCT02681094|101369449|FG000|COMPLETED|1 -Modified Enrolled Participants Set||256|Participants who completed study treatment|
48422413|NCT02681094|101369450|FG001|COMPLETED|1 -Modified Enrolled Participants Set||255|Participants who completed study treatment|
48422414|NCT02681094|101369451|FG002|COMPLETED|1 -Modified Enrolled Participants Set||243|Participants who completed study treatment|
48422415|NCT02681094|101369449|FG000|NOT COMPLETED|1 -Modified Enrolled Participants Set||37||
48422416|NCT02681094|101369450|FG001|NOT COMPLETED|1 -Modified Enrolled Participants Set||39||
48422417|NCT02681094|101369451|FG002|NOT COMPLETED|1 -Modified Enrolled Participants Set||53||
48422418|NCT02681094|101369449|FG000|STARTED|2 - Enrolled Participants Set||301|Includes 7 participants of one US site which was excluded in Modified Enrolled participants set|
48422419|NCT02681094|101369450|FG001|STARTED|2 - Enrolled Participants Set||302|Includes 7 participants of one US site which was excluded in Modified Enrolled participants set|
48422420|NCT02681094|101369451|FG002|STARTED|2 - Enrolled Participants Set||302|Includes 7 participants of one US site which was excluded in Modified Enrolled participants set|
48422421|NCT02681094|101369449|FG000|Participants Completed Treatment Period|2 - Enrolled Participants Set||281||
48422422|NCT02681094|101369450|FG001|Participants Completed Treatment Period|2 - Enrolled Participants Set||284||
48422423|NCT02681094|101369451|FG002|Participants Completed Treatment Period|2 - Enrolled Participants Set||289||
48422424|NCT02681094|101369449|FG000|COMPLETED|2 - Enrolled Participants Set||261|Participants who completed study treatment|
48422425|NCT02681094|101369450|FG001|COMPLETED|2 - Enrolled Participants Set||261|Participants who completed study treatment|
48422426|NCT02681094|101369451|FG002|COMPLETED|2 - Enrolled Participants Set||248|Participants who completed study treatment|
48422427|NCT02681094|101369449|FG000|NOT COMPLETED|2 - Enrolled Participants Set||40||
48422428|NCT02681094|101369450|FG001|NOT COMPLETED|2 - Enrolled Participants Set||41||
48422429|NCT02681094|101369451|FG002|NOT COMPLETED|2 - Enrolled Participants Set||54||
48422430|NCT01612494|101369452|FG000|STARTED|Overall Study||21||
48422431|NCT01612494|101369453|FG001|STARTED|Overall Study||23||
48422432|NCT01612494|101369452|FG000|COMPLETED|Overall Study||21||
48422433|NCT01612494|101369453|FG001|COMPLETED|Overall Study||23||
48422434|NCT01612494|101369452|FG000|NOT COMPLETED|Overall Study||0||
48422435|NCT01612494|101369453|FG001|NOT COMPLETED|Overall Study||0||
48422436|NCT03417102|101369454|FG000|STARTED|Overall Study||19||
48422437|NCT03417102|101369455|FG001|STARTED|Overall Study||38||
48422438|NCT03417102|101369454|FG000|Safety Analysis Set|Overall Study||19|Participants received at least 1 dose of study drug or randomized to on-demand arm, analyzed per treatment received.|
48422439|NCT03417102|101369455|FG001|Safety Analysis Set|Overall Study||41|Participants received at least 1 dose of study drug or randomized to on-demand arm, analyzed per treatment received.|
48422440|NCT03417102|101369454|FG000|COMPLETED|Overall Study||19||
48422441|NCT03417102|101369455|FG001|COMPLETED|Overall Study||33||
48422442|NCT03417102|101369454|FG000|NOT COMPLETED|Overall Study||0||
48422443|NCT03417102|101369455|FG001|NOT COMPLETED|Overall Study||5||
48638871|NCT00820534|101901525|FG001|NOT COMPLETED|Overall Study||0||
48422444|NCT01667731|101369456|FG000|STARTED|Overall Study||26||
48422445|NCT01667731|101369457|FG001|STARTED|Overall Study||42||
48422446|NCT01667731|101369458|FG002|STARTED|Overall Study||24||
48422447|NCT01667731|101369459|FG003|STARTED|Overall Study||17||
48422448|NCT01667731|101369460|FG004|STARTED|Overall Study||115||
48422449|NCT01667731|101369456|FG000|COMPLETED|Overall Study||21||
48422450|NCT01667731|101369457|FG001|COMPLETED|Overall Study||26||
48422451|NCT01667731|101369458|FG002|COMPLETED|Overall Study||22||
48422452|NCT01667731|101369459|FG003|COMPLETED|Overall Study||15||
48422453|NCT01667731|101369460|FG004|COMPLETED|Overall Study||87||
48422454|NCT01667731|101369456|FG000|NOT COMPLETED|Overall Study||5||
48422455|NCT01667731|101369457|FG001|NOT COMPLETED|Overall Study||16||
48422456|NCT01667731|101369458|FG002|NOT COMPLETED|Overall Study||2||
48422457|NCT01667731|101369459|FG003|NOT COMPLETED|Overall Study||2||
48422458|NCT01667731|101369460|FG004|NOT COMPLETED|Overall Study||28||
48422459|NCT03145207|101369461|FG000|STARTED|Overall Study||14||
48422460|NCT03145207|101369461|FG000|COMPLETED|Overall Study||12||
48422461|NCT03145207|101369461|FG000|NOT COMPLETED|Overall Study||2||
48638872|NCT03010501|101901526|FG000|STARTED|Study Week 1||9||
48638873|NCT03010501|101901527|FG001|STARTED|Study Week 1||15||
48638874|NCT03010501|101901528|FG002|STARTED|Study Week 1||7||
48638875|NCT03010501|101901529|FG003|STARTED|Study Week 1||7||
48638876|NCT03010501|101901530|FG004|STARTED|Study Week 1||7||
48638877|NCT03010501|101901531|FG005|STARTED|Study Week 1||11||
48638878|NCT03010501|101901526|FG000|COMPLETED|Study Week 1||7||
48638879|NCT03010501|101901527|FG001|COMPLETED|Study Week 1||14||
48638880|NCT03010501|101901528|FG002|COMPLETED|Study Week 1||7||
48638881|NCT03010501|101901529|FG003|COMPLETED|Study Week 1||5||
48422462|NCT00612573|101369462|FG000|STARTED|Overall Study||64||
48422463|NCT00612573|101369463|FG001|STARTED|Overall Study||65||
48422464|NCT00612573|101369464|FG002|STARTED|Overall Study||61||
48422465|NCT00612573|101369465|FG003|STARTED|Overall Study||67||
48422466|NCT00612573|101369462|FG000|COMPLETED|Overall Study||52||
48422467|NCT00612573|101369463|FG001|COMPLETED|Overall Study||51||
48422468|NCT00612573|101369464|FG002|COMPLETED|Overall Study||52||
48422469|NCT00612573|101369465|FG003|COMPLETED|Overall Study||54||
48422470|NCT00612573|101369462|FG000|NOT COMPLETED|Overall Study||12||
48422471|NCT00612573|101369463|FG001|NOT COMPLETED|Overall Study||14||
48422472|NCT00612573|101369464|FG002|NOT COMPLETED|Overall Study||9||
48422473|NCT00612573|101369465|FG003|NOT COMPLETED|Overall Study||13||
48422474|NCT01078389|101369466|FG000|STARTED|Overall Study||157||
48422475|NCT01078389|101369467|FG001|STARTED|Overall Study||157||
48422476|NCT01078389|101369466|FG000|COMPLETED|Overall Study||93||
48422477|NCT01078389|101369467|FG001|COMPLETED|Overall Study||90||
48422478|NCT01078389|101369466|FG000|NOT COMPLETED|Overall Study||64||
48422479|NCT01078389|101369467|FG001|NOT COMPLETED|Overall Study||67||
48422480|NCT01298661|101369468|FG000|STARTED|Overall Study||33||
48422481|NCT01298661|101369469|FG001|STARTED|Overall Study||24||
48763762|NCT04047602|102208805|FG000|NOT COMPLETED|Overall Study||0||
48422482|NCT01298661|101369470|FG002|STARTED|Overall Study||34||
48422483|NCT01298661|101369468|FG000|COMPLETED|Overall Study||31||
48422484|NCT01298661|101369469|FG001|COMPLETED|Overall Study||24||
48422485|NCT01298661|101369470|FG002|COMPLETED|Overall Study||32||
48422486|NCT01298661|101369468|FG000|NOT COMPLETED|Overall Study||2||
48422487|NCT01298661|101369469|FG001|NOT COMPLETED|Overall Study||0||
48422488|NCT01298661|101369470|FG002|NOT COMPLETED|Overall Study||2||
48422489|NCT00667381|101369471|FG000|STARTED|Overall Study||501||
48422490|NCT00667381|101369472|FG001|STARTED|Overall Study||503||
48422491|NCT00667381|101369471|FG000|COMPLETED|Overall Study||501||
48422492|NCT00667381|101369472|FG001|COMPLETED|Overall Study||503||
48422493|NCT00667381|101369471|FG000|NOT COMPLETED|Overall Study||0||
48422494|NCT00667381|101369472|FG001|NOT COMPLETED|Overall Study||0||
48422495|NCT01636076|101369473|FG000|STARTED|Overall Study||316||
48422496|NCT01636076|101369474|FG001|STARTED|Overall Study||313||
48422497|NCT01636076|101369473|FG000|COMPLETED|Overall Study||299||
48422498|NCT01636076|101369474|FG001|COMPLETED|Overall Study||288||
48422499|NCT01636076|101369473|FG000|NOT COMPLETED|Overall Study||17||
48422500|NCT01636076|101369474|FG001|NOT COMPLETED|Overall Study||25||
48422501|NCT02074059|101369475|FG000|STARTED|Overall Study||8||
48422502|NCT02074059|101369476|FG001|STARTED|Overall Study||8||
48422503|NCT02074059|101369477|FG002|STARTED|Overall Study||8||
48422504|NCT02074059|101369478|FG003|STARTED|Overall Study||8||
48422505|NCT02074059|101369479|FG004|STARTED|Overall Study||8||
48422506|NCT02074059|101369480|FG005|STARTED|Overall Study||40||
48422507|NCT02074059|101369475|FG000|COMPLETED|Overall Study||8||
48422508|NCT02074059|101369476|FG001|COMPLETED|Overall Study||8||
48422509|NCT02074059|101369477|FG002|COMPLETED|Overall Study||8||
48422510|NCT02074059|101369478|FG003|COMPLETED|Overall Study||8||
48422511|NCT02074059|101369479|FG004|COMPLETED|Overall Study||7||
48422512|NCT02074059|101369480|FG005|COMPLETED|Overall Study||39||
48422513|NCT02074059|101369475|FG000|NOT COMPLETED|Overall Study||0||
48422514|NCT02074059|101369476|FG001|NOT COMPLETED|Overall Study||0||
48422515|NCT02074059|101369477|FG002|NOT COMPLETED|Overall Study||0||
48422516|NCT02074059|101369478|FG003|NOT COMPLETED|Overall Study||0||
48422517|NCT02074059|101369479|FG004|NOT COMPLETED|Overall Study||1||
48422518|NCT02074059|101369480|FG005|NOT COMPLETED|Overall Study||1||
48422519|NCT00612456|101369481|FG000|STARTED|Overall Study||27||
48422520|NCT00612456|101369482|FG001|STARTED|Overall Study||27||
48422521|NCT00612456|101369483|FG002|STARTED|Overall Study||16||
48422522|NCT00612456|101369481|FG000|COMPLETED|Overall Study||25||
48422523|NCT00612456|101369482|FG001|COMPLETED|Overall Study||25||
48422524|NCT00612456|101369483|FG002|COMPLETED|Overall Study||16||
48422525|NCT00612456|101369481|FG000|NOT COMPLETED|Overall Study||2||
48422526|NCT00612456|101369482|FG001|NOT COMPLETED|Overall Study||2||
48422527|NCT00612456|101369483|FG002|NOT COMPLETED|Overall Study||0||
48638882|NCT03010501|101901530|FG004|COMPLETED|Study Week 1||7||
48638883|NCT03010501|101901531|FG005|COMPLETED|Study Week 1||11||
48638884|NCT03010501|101901526|FG000|NOT COMPLETED|Study Week 1||2||
48638885|NCT03010501|101901527|FG001|NOT COMPLETED|Study Week 1||1||
48638886|NCT03010501|101901528|FG002|NOT COMPLETED|Study Week 1||0||
48638887|NCT03010501|101901529|FG003|NOT COMPLETED|Study Week 1||2||
48638888|NCT03010501|101901530|FG004|NOT COMPLETED|Study Week 1||0||
48638889|NCT03010501|101901531|FG005|NOT COMPLETED|Study Week 1||0||
48638890|NCT03010501|101901526|FG000|STARTED|Study Week 2||7||
48638891|NCT03010501|101901527|FG001|STARTED|Study Week 2||14||
48763763|NCT00762164|102208806|FG000|STARTED|Overall Study||17||
48422528|NCT03907072|101369484|FG000|STARTED|Overall Study||2||
48422529|NCT03907072|101369485|FG001|STARTED|Overall Study||2||
48422530|NCT03907072|101369486|FG002|STARTED|Overall Study||2||
48422531|NCT03907072|101369484|FG000|COMPLETED|Overall Study||0||
48422532|NCT03907072|101369485|FG001|COMPLETED|Overall Study||0||
48422533|NCT03907072|101369486|FG002|COMPLETED|Overall Study||0||
48422534|NCT03907072|101369484|FG000|NOT COMPLETED|Overall Study||2||
48638892|NCT03010501|101901528|FG002|STARTED|Study Week 2||7||
48422535|NCT03907072|101369485|FG001|NOT COMPLETED|Overall Study||2||
48422536|NCT03907072|101369486|FG002|NOT COMPLETED|Overall Study||2||
48422537|NCT00361504|101369487|FG000|STARTED|Overall Study||894||
48422538|NCT00361504|101369488|FG001|STARTED|Overall Study||223||
48422539|NCT00361504|101369487|FG000|COMPLETED|Overall Study||413||
48422540|NCT00361504|101369488|FG001|COMPLETED|Overall Study||78||
48422541|NCT00361504|101369487|FG000|NOT COMPLETED|Overall Study||481||
48422542|NCT00361504|101369488|FG001|NOT COMPLETED|Overall Study||145||
48422543|NCT01632345|101369489|FG000|STARTED|Randomized Participants||41||
48422544|NCT01632345|101369490|FG001|STARTED|Randomized Participants||43||
48422545|NCT01632345|101369491|FG002|STARTED|Randomized Participants||42||
48422546|NCT01632345|101369492|FG003|STARTED|Randomized Participants||41||
48422547|NCT01632345|101369493|FG004|STARTED|Randomized Participants||43||
48422548|NCT01632345|101369494|FG005|STARTED|Randomized Participants||66||
48422549|NCT01632345|101369495|FG006|STARTED|Randomized Participants||66||
48422550|NCT01632345|101369489|FG000|COMPLETED|Randomized Participants||41||
48422551|NCT01632345|101369490|FG001|COMPLETED|Randomized Participants||43||
48422552|NCT01632345|101369491|FG002|COMPLETED|Randomized Participants||42||
48422553|NCT01632345|101369492|FG003|COMPLETED|Randomized Participants||41||
48422554|NCT01632345|101369493|FG004|COMPLETED|Randomized Participants||43||
48422555|NCT01632345|101369494|FG005|COMPLETED|Randomized Participants||66||
48422556|NCT01632345|101369495|FG006|COMPLETED|Randomized Participants||66||
48422557|NCT01632345|101369489|FG000|NOT COMPLETED|Randomized Participants||0||
48422558|NCT01632345|101369490|FG001|NOT COMPLETED|Randomized Participants||0||
48422559|NCT01632345|101369491|FG002|NOT COMPLETED|Randomized Participants||0||
48422560|NCT01632345|101369492|FG003|NOT COMPLETED|Randomized Participants||0||
48422561|NCT01632345|101369493|FG004|NOT COMPLETED|Randomized Participants||0||
48422562|NCT01632345|101369494|FG005|NOT COMPLETED|Randomized Participants||0||
48422563|NCT01632345|101369495|FG006|NOT COMPLETED|Randomized Participants||0||
48422564|NCT01632345|101369489|FG000|STARTED|Treatment: Part I||41||
48422565|NCT01632345|101369490|FG001|STARTED|Treatment: Part I||43||
48422566|NCT01632345|101369491|FG002|STARTED|Treatment: Part I||42||
48422567|NCT01632345|101369492|FG003|STARTED|Treatment: Part I||41||
48422568|NCT01632345|101369493|FG004|STARTED|Treatment: Part I||43||
48422569|NCT01632345|101369494|FG005|STARTED|Treatment: Part I||0||
48422570|NCT01632345|101369495|FG006|STARTED|Treatment: Part I||0||
48422571|NCT01632345|101369489|FG000|Treated|Treatment: Part I||40||
48422572|NCT01632345|101369490|FG001|Treated|Treatment: Part I||43||
48422573|NCT01632345|101369491|FG002|Treated|Treatment: Part I||42||
48422574|NCT01632345|101369492|FG003|Treated|Treatment: Part I||41||
48422575|NCT01632345|101369493|FG004|Treated|Treatment: Part I||43||
48422576|NCT01632345|101369494|FG005|Treated|Treatment: Part I||0||
48422577|NCT01632345|101369495|FG006|Treated|Treatment: Part I||0||
48422578|NCT01632345|101369489|FG000|COMPLETED|Treatment: Part I||29||
48422579|NCT01632345|101369490|FG001|COMPLETED|Treatment: Part I||28||
48422580|NCT01632345|101369491|FG002|COMPLETED|Treatment: Part I||32||
48422581|NCT01632345|101369492|FG003|COMPLETED|Treatment: Part I||33||
48422582|NCT01632345|101369493|FG004|COMPLETED|Treatment: Part I||30||
48422583|NCT01632345|101369494|FG005|COMPLETED|Treatment: Part I||0||
48422584|NCT01632345|101369495|FG006|COMPLETED|Treatment: Part I||0||
48422585|NCT01632345|101369489|FG000|NOT COMPLETED|Treatment: Part I||12||
48422586|NCT01632345|101369490|FG001|NOT COMPLETED|Treatment: Part I||15||
48422587|NCT01632345|101369491|FG002|NOT COMPLETED|Treatment: Part I||10||
48422588|NCT01632345|101369492|FG003|NOT COMPLETED|Treatment: Part I||8||
48422589|NCT01632345|101369493|FG004|NOT COMPLETED|Treatment: Part I||13||
48422590|NCT01632345|101369494|FG005|NOT COMPLETED|Treatment: Part I||0||
48422591|NCT01632345|101369495|FG006|NOT COMPLETED|Treatment: Part I||0||
48422592|NCT01632345|101369489|FG000|STARTED|Treatment: Part II||0||
48422593|NCT01632345|101369490|FG001|STARTED|Treatment: Part II||0||
48422594|NCT01632345|101369491|FG002|STARTED|Treatment: Part II||0||
48422595|NCT01632345|101369492|FG003|STARTED|Treatment: Part II||0||
48422596|NCT01632345|101369493|FG004|STARTED|Treatment: Part II||0||
48422597|NCT01632345|101369494|FG005|STARTED|Treatment: Part II||66||
48422598|NCT01632345|101369495|FG006|STARTED|Treatment: Part II||66||
48422599|NCT01632345|101369489|FG000|Treated|Treatment: Part II||0||
48422600|NCT01632345|101369490|FG001|Treated|Treatment: Part II||0||
48422601|NCT01632345|101369491|FG002|Treated|Treatment: Part II||0||
48422602|NCT01632345|101369492|FG003|Treated|Treatment: Part II||0||
48422603|NCT01632345|101369493|FG004|Treated|Treatment: Part II||0||
48422604|NCT01632345|101369494|FG005|Treated|Treatment: Part II||66||
48422605|NCT01632345|101369495|FG006|Treated|Treatment: Part II||66||
48422606|NCT01632345|101369489|FG000|COMPLETED|Treatment: Part II||0||
48422607|NCT01632345|101369490|FG001|COMPLETED|Treatment: Part II||0||
48422608|NCT01632345|101369491|FG002|COMPLETED|Treatment: Part II||0||
48422609|NCT01632345|101369492|FG003|COMPLETED|Treatment: Part II||0||
48422610|NCT01632345|101369493|FG004|COMPLETED|Treatment: Part II||0||
48422611|NCT01632345|101369494|FG005|COMPLETED|Treatment: Part II||55||
48422612|NCT01632345|101369495|FG006|COMPLETED|Treatment: Part II||55||
48422613|NCT01632345|101369489|FG000|NOT COMPLETED|Treatment: Part II||0||
48763764|NCT00762164|102208807|FG001|STARTED|Overall Study||17||
48422614|NCT01632345|101369490|FG001|NOT COMPLETED|Treatment: Part II||0||
48422615|NCT01632345|101369491|FG002|NOT COMPLETED|Treatment: Part II||0||
48359448|NCT01415960|101210646|FG000|COMPLETED|Overall Study||151||
48359449|NCT01415960|101210646|FG000|NOT COMPLETED|Overall Study||12||
48359450|NCT01542372|101210647|FG000|STARTED|Overall Study||11||
48359451|NCT01542372|101210648|FG001|STARTED|Overall Study||11||
48359452|NCT01542372|101210647|FG000|COMPLETED|Overall Study||11||
48359453|NCT01542372|101210648|FG001|COMPLETED|Overall Study||11||
48359454|NCT01542372|101210647|FG000|NOT COMPLETED|Overall Study||0||
48359455|NCT01542372|101210648|FG001|NOT COMPLETED|Overall Study||0||
48359456|NCT01274897|101210649|FG000|STARTED|Overall Study||297||
48359457|NCT01274897|101210650|FG001|STARTED|Overall Study||153||
48359458|NCT01274897|101210649|FG000|COMPLETED|Overall Study||297||
48359459|NCT01274897|101210650|FG001|COMPLETED|Overall Study||153||
48359460|NCT01274897|101210649|FG000|NOT COMPLETED|Overall Study||0||
48359461|NCT01274897|101210650|FG001|NOT COMPLETED|Overall Study||0||
48359462|NCT00144300|101210651|FG000|STARTED|Overall Study||121||
48359463|NCT00144300|101210652|FG001|STARTED|Overall Study||125||
48359464|NCT00144300|101210651|FG000|COMPLETED|Overall Study||92||
48359465|NCT00144300|101210652|FG001|COMPLETED|Overall Study||97||
48359466|NCT00144300|101210651|FG000|NOT COMPLETED|Overall Study||29||
48359467|NCT00144300|101210652|FG001|NOT COMPLETED|Overall Study||28||
48359468|NCT03551028|101210653|FG000|STARTED|Overall Study||33||
48359469|NCT03551028|101210653|FG000|COMPLETED|Overall Study||33||
48359470|NCT03551028|101210653|FG000|NOT COMPLETED|Overall Study||0||
48359471|NCT00377299|101210654|FG000|STARTED|Overall Study||32||
48359472|NCT00377299|101210655|FG001|STARTED|Overall Study||28||
48359473|NCT00377299|101210654|FG000|COMPLETED|Overall Study||13||
48359474|NCT00377299|101210655|FG001|COMPLETED|Overall Study||4||
48359475|NCT00377299|101210654|FG000|NOT COMPLETED|Overall Study||19||
48359476|NCT00377299|101210655|FG001|NOT COMPLETED|Overall Study||24||
48359477|NCT02102230|101210656|FG000|STARTED|Overall Study||42||
48359478|NCT02102230|101210657|FG001|STARTED|Overall Study||28||
48359479|NCT02102230|101210658|FG002|STARTED|Overall Study||41||
48359480|NCT02102230|101210656|FG000|COMPLETED|Overall Study||25||
48359481|NCT02102230|101210657|FG001|COMPLETED|Overall Study||11||
48359482|NCT02102230|101210658|FG002|COMPLETED|Overall Study||24||
48359483|NCT02102230|101210656|FG000|NOT COMPLETED|Overall Study||17||
48359484|NCT02102230|101210657|FG001|NOT COMPLETED|Overall Study||17||
48359485|NCT02102230|101210658|FG002|NOT COMPLETED|Overall Study||17||
48359486|NCT00875420|101210659|FG000|STARTED|Overall Study||22||
48359487|NCT00875420|101210660|FG001|STARTED|Overall Study||20||
48359488|NCT00875420|101210661|FG002|STARTED|Overall Study||21||
48359489|NCT00875420|101210662|FG003|STARTED|Overall Study||18||
48359490|NCT00875420|101210663|FG004|STARTED|Overall Study||19||
48359491|NCT00875420|101210659|FG000|COMPLETED|Overall Study||20||
48359492|NCT00875420|101210660|FG001|COMPLETED|Overall Study||18||
48359493|NCT00875420|101210661|FG002|COMPLETED|Overall Study||18||
48359494|NCT00875420|101210662|FG003|COMPLETED|Overall Study||16||
48359495|NCT00875420|101210663|FG004|COMPLETED|Overall Study||17||
48359496|NCT00875420|101210659|FG000|NOT COMPLETED|Overall Study||2||
48359497|NCT00875420|101210660|FG001|NOT COMPLETED|Overall Study||2||
48359498|NCT00875420|101210661|FG002|NOT COMPLETED|Overall Study||3||
48359499|NCT00875420|101210662|FG003|NOT COMPLETED|Overall Study||2||
48359500|NCT00875420|101210663|FG004|NOT COMPLETED|Overall Study||2||
48359501|NCT04170621|101210664|FG000|STARTED|Overall Study||28||
48359502|NCT04170621|101210664|FG000|COMPLETED|Overall Study||28||
48359503|NCT04170621|101210664|FG000|NOT COMPLETED|Overall Study||0||
48359504|NCT00878228|101210665|FG000|STARTED|Overall Study||49||
48359505|NCT00878228|101210666|FG001|STARTED|Overall Study||49||
48359506|NCT00878228|101210665|FG000|COMPLETED|Overall Study||39||
48359507|NCT00878228|101210666|FG001|COMPLETED|Overall Study||37||
48359508|NCT00878228|101210665|FG000|NOT COMPLETED|Overall Study||10||
48359509|NCT00878228|101210666|FG001|NOT COMPLETED|Overall Study||12||
48359510|NCT03825042|101210667|FG000|STARTED|Overall Study||40||
48422616|NCT01632345|101369492|FG003|NOT COMPLETED|Treatment: Part II||0||
48359511|NCT03825042|101210668|FG001|STARTED|Overall Study||40||
48359512|NCT03825042|101210667|FG000|COMPLETED|Overall Study||38||
48359513|NCT03825042|101210668|FG001|COMPLETED|Overall Study||40||
48359514|NCT03825042|101210667|FG000|NOT COMPLETED|Overall Study||2||
48359515|NCT03825042|101210668|FG001|NOT COMPLETED|Overall Study||0||
48359516|NCT01416610|101210669|FG000|STARTED|Overall Study||88||
48359517|NCT01416610|101210669|FG000|Intention to Treat|Overall Study||88||
48359518|NCT01416610|101210669|FG000|Safety Population|Overall Study||86||
48359519|NCT01416610|101210669|FG000|Per Protocol|Overall Study||83||
48359520|NCT01416610|101210669|FG000|Completed Treatment|Overall Study||47||
48359521|NCT01416610|101210669|FG000|Completed Follow-up|Overall Study||45||
48359522|NCT01416610|101210669|FG000|COMPLETED|Overall Study||45||
48359523|NCT01416610|101210669|FG000|NOT COMPLETED|Overall Study||43||
48359524|NCT03976401|101210670|FG000|STARTED|Overall Study||19||
48359525|NCT03976401|101210671|FG001|STARTED|Overall Study||20||
48359526|NCT03976401|101210672|FG002|STARTED|Overall Study||20||
48359527|NCT03976401|101210673|FG003|STARTED|Overall Study||21||
48359528|NCT03976401|101210674|FG004|STARTED|Overall Study||20||
48359529|NCT03976401|101210675|FG005|STARTED|Overall Study||10||
48359530|NCT03976401|101210670|FG000|COMPLETED|Overall Study||16||
48359531|NCT03976401|101210671|FG001|COMPLETED|Overall Study||16||
48359532|NCT03976401|101210672|FG002|COMPLETED|Overall Study||15||
48422617|NCT01632345|101369493|FG004|NOT COMPLETED|Treatment: Part II||0||
48422618|NCT01632345|101369494|FG005|NOT COMPLETED|Treatment: Part II||11||
48422619|NCT01632345|101369495|FG006|NOT COMPLETED|Treatment: Part II||11||
48422620|NCT00795717|101369496|FG000|STARTED|Phase I Followed by Wash Out x 4 Weeks||20||
48422621|NCT00795717|101369497|FG001|STARTED|Phase I Followed by Wash Out x 4 Weeks||21||
48422622|NCT00795717|101369496|FG000|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||18||
48422623|NCT00795717|101369497|FG001|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||19||
48422624|NCT00795717|101369496|FG000|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2||
48422625|NCT00795717|101369497|FG001|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2||
48422626|NCT00795717|101369496|FG000|STARTED|Phase II||18||
48422627|NCT00795717|101369497|FG001|STARTED|Phase II||19||
48422628|NCT00795717|101369496|FG000|COMPLETED|Phase II||18||
48422629|NCT00795717|101369497|FG001|COMPLETED|Phase II||18||
48422630|NCT00795717|101369496|FG000|NOT COMPLETED|Phase II||0||
48422631|NCT00795717|101369497|FG001|NOT COMPLETED|Phase II||1||
48422632|NCT00027846|101369498|FG000|STARTED|Overall Study||13||
48422633|NCT00027846|101369499|FG001|STARTED|Overall Study||287||
48422634|NCT00027846|101369500|FG002|STARTED|Overall Study||78||
48422635|NCT00027846|101369498|FG000|COMPLETED|Overall Study||11||
48422636|NCT00027846|101369499|FG001|COMPLETED|Overall Study||219||
48422637|NCT00027846|101369500|FG002|COMPLETED|Overall Study||41||
48422638|NCT00027846|101369498|FG000|NOT COMPLETED|Overall Study||2||
48422639|NCT00027846|101369499|FG001|NOT COMPLETED|Overall Study||68||
48422640|NCT00027846|101369500|FG002|NOT COMPLETED|Overall Study||37||
48422641|NCT01522963|101369501|FG000|STARTED|Overall Study||24||
48422642|NCT01522963|101369502|FG001|STARTED|Overall Study||25||
48422643|NCT01522963|101369503|FG002|STARTED|Overall Study||25||
48422644|NCT01522963|101369504|FG003|STARTED|Overall Study||24||
48422645|NCT01522963|101369501|FG000|COMPLETED|Overall Study||22||
48422646|NCT01522963|101369502|FG001|COMPLETED|Overall Study||22||
48422647|NCT01522963|101369503|FG002|COMPLETED|Overall Study||22||
48422648|NCT01522963|101369504|FG003|COMPLETED|Overall Study||18||
48422649|NCT01522963|101369501|FG000|NOT COMPLETED|Overall Study||2||
48422650|NCT01522963|101369502|FG001|NOT COMPLETED|Overall Study||3||
48422651|NCT01522963|101369503|FG002|NOT COMPLETED|Overall Study||3||
48422652|NCT01522963|101369504|FG003|NOT COMPLETED|Overall Study||6||
48422653|NCT00211536|101369505|FG000|STARTED|Overall Study||53||
48422654|NCT00211536|101369506|FG001|STARTED|Overall Study||54||
48422655|NCT00211536|101369505|FG000|As Treated Data Analysis Set|Overall Study||52||
48422656|NCT00211536|101369506|FG001|As Treated Data Analysis Set|Overall Study||48||
48422657|NCT00211536|101369505|FG000|COMPLETED|Overall Study||49||
48422658|NCT00211536|101369506|FG001|COMPLETED|Overall Study||47||
48422659|NCT00211536|101369505|FG000|NOT COMPLETED|Overall Study||4||
48422660|NCT00211536|101369506|FG001|NOT COMPLETED|Overall Study||7||
48422661|NCT02184520|101369507|FG000|STARTED|Overall Study||0||
48422662|NCT02184520|101369508|FG001|STARTED|Overall Study||0||
48422663|NCT02184520|101369507|FG000|COMPLETED|Overall Study||0||
48422664|NCT02184520|101369508|FG001|COMPLETED|Overall Study||0||
48422665|NCT02184520|101369507|FG000|NOT COMPLETED|Overall Study||0||
48422666|NCT02184520|101369508|FG001|NOT COMPLETED|Overall Study||0||
48422667|NCT00224952|101369509|FG000|STARTED|Overall Study||53||
48422668|NCT00224952|101369510|FG001|STARTED|Overall Study||87||
48422669|NCT00224952|101369511|FG002|STARTED|Overall Study||134||
48422670|NCT00224952|101369509|FG000|COMPLETED|Overall Study||53||
48422671|NCT00224952|101369510|FG001|COMPLETED|Overall Study||87||
48422672|NCT00224952|101369511|FG002|COMPLETED|Overall Study||134||
48422673|NCT00224952|101369509|FG000|NOT COMPLETED|Overall Study||0||
48422674|NCT00224952|101369510|FG001|NOT COMPLETED|Overall Study||0||
48422675|NCT00224952|101369511|FG002|NOT COMPLETED|Overall Study||0||
48422676|NCT01654224|101369512|FG000|STARTED|Overall Study||95||
48422677|NCT01654224|101369513|FG001|STARTED|Overall Study||110||
48422678|NCT01654224|101369512|FG000|COMPLETED|Overall Study||89||
48422679|NCT01654224|101369513|FG001|COMPLETED|Overall Study||98||
48422680|NCT01654224|101369512|FG000|NOT COMPLETED|Overall Study||6||
48422681|NCT01654224|101369513|FG001|NOT COMPLETED|Overall Study||12||
48422682|NCT01724021|101369514|FG000|STARTED|Overall Study||371||
48422683|NCT01724021|101369515|FG001|STARTED|Overall Study||369||
48422684|NCT01724021|101369514|FG000|COMPLETED|Overall Study||244||
48422685|NCT01724021|101369515|FG001|COMPLETED|Overall Study||236||
48422686|NCT01724021|101369514|FG000|NOT COMPLETED|Overall Study||127||
48422687|NCT01724021|101369515|FG001|NOT COMPLETED|Overall Study||133||
48422688|NCT01397409|101369516|FG000|STARTED|Stage 1||9||
48422689|NCT01397409|101369517|FG001|STARTED|Stage 1||6||
48422690|NCT01397409|101369518|FG002|STARTED|Stage 1||6||
48422691|NCT01397409|101369519|FG003|STARTED|Stage 1||3||
48422692|NCT01397409|101369520|FG004|STARTED|Stage 1||0||
48422693|NCT01397409|101369521|FG005|STARTED|Stage 1||0||
48422694|NCT01397409|101369522|FG006|STARTED|Stage 1||0||
48422695|NCT01397409|101369523|FG007|STARTED|Stage 1||0||
48422696|NCT01397409|101369524|FG008|STARTED|Stage 1||0||
48422697|NCT01397409|101369525|FG009|STARTED|Stage 1||0||
48422698|NCT01397409|101369516|FG000|COMPLETED|Stage 1||9||
48422699|NCT01397409|101369517|FG001|COMPLETED|Stage 1||6||
48422700|NCT01397409|101369518|FG002|COMPLETED|Stage 1||6||
48422701|NCT01397409|101369519|FG003|COMPLETED|Stage 1||3||
48422702|NCT01397409|101369520|FG004|COMPLETED|Stage 1||0||
48422703|NCT01397409|101369521|FG005|COMPLETED|Stage 1||0||
48422704|NCT01397409|101369522|FG006|COMPLETED|Stage 1||0||
48422705|NCT01397409|101369523|FG007|COMPLETED|Stage 1||0||
48422706|NCT01397409|101369524|FG008|COMPLETED|Stage 1||0||
48422707|NCT01397409|101369525|FG009|COMPLETED|Stage 1||0||
48422708|NCT01397409|101369516|FG000|NOT COMPLETED|Stage 1||0||
48422709|NCT01397409|101369517|FG001|NOT COMPLETED|Stage 1||0||
48422710|NCT01397409|101369518|FG002|NOT COMPLETED|Stage 1||0||
48422711|NCT01397409|101369519|FG003|NOT COMPLETED|Stage 1||0||
48422712|NCT01397409|101369520|FG004|NOT COMPLETED|Stage 1||0||
48422713|NCT01397409|101369521|FG005|NOT COMPLETED|Stage 1||0||
48422714|NCT01397409|101369522|FG006|NOT COMPLETED|Stage 1||0||
48422715|NCT01397409|101369523|FG007|NOT COMPLETED|Stage 1||0||
48422716|NCT01397409|101369524|FG008|NOT COMPLETED|Stage 1||0||
48422717|NCT01397409|101369525|FG009|NOT COMPLETED|Stage 1||0||
48422718|NCT01397409|101369516|FG000|STARTED|Stage 2||0||
48422719|NCT01397409|101369517|FG001|STARTED|Stage 2||0||
48422720|NCT01397409|101369518|FG002|STARTED|Stage 2||0||
48422721|NCT01397409|101369519|FG003|STARTED|Stage 2||0||
48422722|NCT01397409|101369520|FG004|STARTED|Stage 2||67||
48422723|NCT01397409|101369521|FG005|STARTED|Stage 2||58||
48422724|NCT01397409|101369522|FG006|STARTED|Stage 2||58||
48422725|NCT01397409|101369523|FG007|STARTED|Stage 2||0||
48422726|NCT01397409|101369524|FG008|STARTED|Stage 2||0||
48422727|NCT01397409|101369525|FG009|STARTED|Stage 2||0||
48422728|NCT01397409|101369516|FG000|COMPLETED|Stage 2||0||
48422729|NCT01397409|101369517|FG001|COMPLETED|Stage 2||0||
48422730|NCT01397409|101369518|FG002|COMPLETED|Stage 2||0||
48422731|NCT01397409|101369519|FG003|COMPLETED|Stage 2||0||
48422732|NCT01397409|101369520|FG004|COMPLETED|Stage 2||59||
48422733|NCT01397409|101369521|FG005|COMPLETED|Stage 2||54||
48422734|NCT01397409|101369522|FG006|COMPLETED|Stage 2||58||
48422735|NCT01397409|101369523|FG007|COMPLETED|Stage 2||0||
48422736|NCT01397409|101369524|FG008|COMPLETED|Stage 2||0||
48422737|NCT01397409|101369525|FG009|COMPLETED|Stage 2||0||
48422738|NCT01397409|101369516|FG000|NOT COMPLETED|Stage 2||0||
48422739|NCT01397409|101369517|FG001|NOT COMPLETED|Stage 2||0||
48422740|NCT01397409|101369518|FG002|NOT COMPLETED|Stage 2||0||
48422741|NCT01397409|101369519|FG003|NOT COMPLETED|Stage 2||0||
48422742|NCT01397409|101369520|FG004|NOT COMPLETED|Stage 2||8||
48422743|NCT01397409|101369521|FG005|NOT COMPLETED|Stage 2||4||
48422744|NCT01397409|101369522|FG006|NOT COMPLETED|Stage 2||0||
48422745|NCT01397409|101369523|FG007|NOT COMPLETED|Stage 2||0||
48422746|NCT01397409|101369524|FG008|NOT COMPLETED|Stage 2||0||
48422747|NCT01397409|101369525|FG009|NOT COMPLETED|Stage 2||0||
48422748|NCT01397409|101369516|FG000|STARTED|Stage 3||0||
48422749|NCT01397409|101369517|FG001|STARTED|Stage 3||0||
48422750|NCT01397409|101369518|FG002|STARTED|Stage 3||0||
48422751|NCT01397409|101369519|FG003|STARTED|Stage 3||0||
48422752|NCT01397409|101369520|FG004|STARTED|Stage 3||0||
48422753|NCT01397409|101369521|FG005|STARTED|Stage 3||0||
48422754|NCT01397409|101369522|FG006|STARTED|Stage 3||0||
48422755|NCT01397409|101369523|FG007|STARTED|Stage 3||23||
48422756|NCT01397409|101369524|FG008|STARTED|Stage 3||25||
48422757|NCT01397409|101369525|FG009|STARTED|Stage 3||16||
48422758|NCT01397409|101369516|FG000|COMPLETED|Stage 3||0||
48422759|NCT01397409|101369517|FG001|COMPLETED|Stage 3||0||
48422760|NCT01397409|101369518|FG002|COMPLETED|Stage 3||0||
48422761|NCT01397409|101369519|FG003|COMPLETED|Stage 3||0||
48422762|NCT01397409|101369520|FG004|COMPLETED|Stage 3||0||
48422763|NCT01397409|101369521|FG005|COMPLETED|Stage 3||0||
48422764|NCT01397409|101369522|FG006|COMPLETED|Stage 3||0||
48422765|NCT01397409|101369523|FG007|COMPLETED|Stage 3||21||
48422766|NCT01397409|101369524|FG008|COMPLETED|Stage 3||25||
48422767|NCT01397409|101369525|FG009|COMPLETED|Stage 3||16||
48422768|NCT01397409|101369516|FG000|NOT COMPLETED|Stage 3||0||
48422769|NCT01397409|101369517|FG001|NOT COMPLETED|Stage 3||0||
48422770|NCT01397409|101369518|FG002|NOT COMPLETED|Stage 3||0||
48763765|NCT00762164|102208806|FG000|COMPLETED|Overall Study||14||
48422771|NCT01397409|101369519|FG003|NOT COMPLETED|Stage 3||0||
48422772|NCT01397409|101369520|FG004|NOT COMPLETED|Stage 3||0||
48422773|NCT01397409|101369521|FG005|NOT COMPLETED|Stage 3||0||
48422774|NCT01397409|101369522|FG006|NOT COMPLETED|Stage 3||0||
48422775|NCT01397409|101369523|FG007|NOT COMPLETED|Stage 3||2||
48422776|NCT01397409|101369524|FG008|NOT COMPLETED|Stage 3||0||
48422777|NCT01397409|101369525|FG009|NOT COMPLETED|Stage 3||0||
48422778|NCT03730987|101369526|FG000|STARTED|Overall Study||61||
48422779|NCT03730987|101369527|FG001|STARTED|Overall Study||61||
48422780|NCT03730987|101369528|FG002|STARTED|Overall Study||61||
48422781|NCT03730987|101369529|FG003|STARTED|Overall Study||61||
48422782|NCT03730987|101369526|FG000|COMPLETED|Overall Study||59||
48422783|NCT03730987|101369527|FG001|COMPLETED|Overall Study||61||
48422784|NCT03730987|101369528|FG002|COMPLETED|Overall Study||59||
48422785|NCT03730987|101369529|FG003|COMPLETED|Overall Study||61||
48422786|NCT03730987|101369526|FG000|NOT COMPLETED|Overall Study||2||
48422787|NCT03730987|101369527|FG001|NOT COMPLETED|Overall Study||0||
48422788|NCT03730987|101369528|FG002|NOT COMPLETED|Overall Study||2||
48422789|NCT03730987|101369529|FG003|NOT COMPLETED|Overall Study||0||
48422790|NCT01273207|101369530|FG000|STARTED|Overall Study||7||
48422791|NCT01273207|101369530|FG000|COMPLETED|Overall Study||2||
48422792|NCT01273207|101369530|FG000|NOT COMPLETED|Overall Study||5||
48422793|NCT03188991|101369531|FG000|STARTED|Overall Study||3||
48422794|NCT03188991|101369532|FG001|STARTED|Overall Study||3||
48422795|NCT03188991|101369533|FG002|STARTED|Overall Study||3||
48422796|NCT03188991|101369534|FG003|STARTED|Overall Study||11||
48422797|NCT03188991|101369531|FG000|COMPLETED|Overall Study||3||
48422798|NCT03188991|101369532|FG001|COMPLETED|Overall Study||3||
48422799|NCT03188991|101369533|FG002|COMPLETED|Overall Study||3||
48422800|NCT03188991|101369534|FG003|COMPLETED|Overall Study||10||
48422801|NCT03188991|101369531|FG000|NOT COMPLETED|Overall Study||0||
48422802|NCT03188991|101369532|FG001|NOT COMPLETED|Overall Study||0||
48422803|NCT03188991|101369533|FG002|NOT COMPLETED|Overall Study||0||
48422804|NCT03188991|101369534|FG003|NOT COMPLETED|Overall Study||1||
48422805|NCT00686894|101369535|FG000|STARTED|Overall Study||7||
48422806|NCT00686894|101369535|FG000|COMPLETED|Overall Study||1||
48422807|NCT00686894|101369535|FG000|NOT COMPLETED|Overall Study||6||
48422808|NCT01091116|101369536|FG000|STARTED|Overall Study||83||
48422809|NCT01091116|101369537|FG001|STARTED|Overall Study||88||
48422810|NCT01091116|101369538|FG002|STARTED|Overall Study||84||
48422811|NCT01091116|101369539|FG003|STARTED|Overall Study||84||
48422812|NCT01091116|101369540|FG004|STARTED|Overall Study||84||
48422813|NCT01091116|101369536|FG000|COMPLETED|Overall Study||77||
48422814|NCT01091116|101369537|FG001|COMPLETED|Overall Study||80||
48422815|NCT01091116|101369538|FG002|COMPLETED|Overall Study||73||
48422816|NCT01091116|101369539|FG003|COMPLETED|Overall Study||80||
48422817|NCT01091116|101369540|FG004|COMPLETED|Overall Study||73||
48422818|NCT01091116|101369536|FG000|NOT COMPLETED|Overall Study||6||
48422819|NCT01091116|101369537|FG001|NOT COMPLETED|Overall Study||8||
48422820|NCT01091116|101369538|FG002|NOT COMPLETED|Overall Study||11||
48422821|NCT01091116|101369539|FG003|NOT COMPLETED|Overall Study||4||
48422822|NCT01091116|101369540|FG004|NOT COMPLETED|Overall Study||11||
48422823|NCT01790633|101369541|FG000|STARTED|Overall Study||163||
48422824|NCT01790633|101369542|FG001|STARTED|Overall Study||164||
48422825|NCT01790633|101369541|FG000|COMPLETED|Overall Study||115||
48422826|NCT01790633|101369542|FG001|COMPLETED|Overall Study||159||
48422827|NCT01790633|101369541|FG000|NOT COMPLETED|Overall Study||48||
48422828|NCT01790633|101369542|FG001|NOT COMPLETED|Overall Study||5||
48422829|NCT00266799|101369543|FG000|STARTED|Overall Study||98||
48422830|NCT00266799|101369544|FG001|STARTED|Overall Study||102||
48422831|NCT00266799|101369543|FG000|COMPLETED|Overall Study||62||
48422832|NCT00266799|101369544|FG001|COMPLETED|Overall Study||68||
48422833|NCT00266799|101369543|FG000|NOT COMPLETED|Overall Study||36||
48422834|NCT00266799|101369544|FG001|NOT COMPLETED|Overall Study||34||
48422835|NCT00453349|101369545|FG000|STARTED|Randomized||228||
48422836|NCT00453349|101369546|FG001|STARTED|Randomized||232||
48422837|NCT00453349|101369545|FG000|COMPLETED|Randomized||203||
48422838|NCT00453349|101369546|FG001|COMPLETED|Randomized||209||
48422839|NCT00453349|101369545|FG000|NOT COMPLETED|Randomized||25||
48422840|NCT00453349|101369546|FG001|NOT COMPLETED|Randomized||23||
48422841|NCT00453349|101369545|FG000|STARTED|Reaching of Primary Endpoint (TOC)||225||
48422842|NCT00453349|101369546|FG001|STARTED|Reaching of Primary Endpoint (TOC)||230||
48422843|NCT00453349|101369545|FG000|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||194||
48422844|NCT00453349|101369546|FG001|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||190||
48422845|NCT00453349|101369545|FG000|COMPLETED|Reaching of Primary Endpoint (TOC)||215||
48422846|NCT00453349|101369546|FG001|COMPLETED|Reaching of Primary Endpoint (TOC)||219||
48422847|NCT00453349|101369545|FG000|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||10||
48422848|NCT00453349|101369546|FG001|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||11||
48422849|NCT00453349|101369545|FG000|STARTED|Completed Study||228||
48422850|NCT00453349|101369546|FG001|STARTED|Completed Study||232||
48422851|NCT00453349|101369545|FG000|Completed Study Treatment|Completed Study||203||
48422852|NCT00453349|101369546|FG001|Completed Study Treatment|Completed Study||209||
48422853|NCT00453349|101369545|FG000|COMPLETED|Completed Study||201||
48422854|NCT00453349|101369546|FG001|COMPLETED|Completed Study||198||
48422855|NCT00453349|101369545|FG000|NOT COMPLETED|Completed Study||27||
48422856|NCT00453349|101369546|FG001|NOT COMPLETED|Completed Study||34||
48422857|NCT02828982|101369547|FG000|STARTED|First Intervention (3 Weeks)||5||
48422858|NCT02828982|101369548|FG001|STARTED|First Intervention (3 Weeks)||7||
48422859|NCT02828982|101369547|FG000|Received Intervention|First Intervention (3 Weeks)||5||
48422860|NCT02828982|101369548|FG001|Received Intervention|First Intervention (3 Weeks)||7||
48422861|NCT02828982|101369547|FG000|COMPLETED|First Intervention (3 Weeks)||4||
48422862|NCT02828982|101369548|FG001|COMPLETED|First Intervention (3 Weeks)||6||
48422863|NCT02828982|101369547|FG000|NOT COMPLETED|First Intervention (3 Weeks)||1||
48422864|NCT02828982|101369548|FG001|NOT COMPLETED|First Intervention (3 Weeks)||1||
48422865|NCT02828982|101369547|FG000|STARTED|Second Intervention (3 Weeks)||4||
48422866|NCT02828982|101369548|FG001|STARTED|Second Intervention (3 Weeks)||6||
48422867|NCT02828982|101369547|FG000|Received Intervention|Second Intervention (3 Weeks)||4||
48422868|NCT02828982|101369548|FG001|Received Intervention|Second Intervention (3 Weeks)||6||
48422869|NCT02828982|101369547|FG000|COMPLETED|Second Intervention (3 Weeks)||4||
48422870|NCT02828982|101369548|FG001|COMPLETED|Second Intervention (3 Weeks)||6||
48422871|NCT02828982|101369547|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0||
48422872|NCT02828982|101369548|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0||
48422873|NCT00669240|101369549|FG000|STARTED|Overall Study||567||
48422874|NCT00669240|101369549|FG000|Assigned to Treatment|Overall Study||566||
48422875|NCT00669240|101369549|FG000|Received Treatment|Overall Study||551||
48422876|NCT00669240|101369549|FG000|COMPLETED|Overall Study||402||
48422877|NCT00669240|101369549|FG000|NOT COMPLETED|Overall Study||165||
48422878|NCT04704869|101369550|FG000|STARTED|Overall Study||805||
48422879|NCT04704869|101369551|FG001|STARTED|Overall Study||799||
48422880|NCT04704869|101369550|FG000|Completed 28-day Follow up|Overall Study||771||
48422881|NCT04704869|101369551|FG001|Completed 28-day Follow up|Overall Study||760||
48422882|NCT04704869|101369550|FG000|COMPLETED|Overall Study||771||
48422883|NCT04704869|101369551|FG001|COMPLETED|Overall Study||760||
48422884|NCT04704869|101369550|FG000|NOT COMPLETED|Overall Study||34||
48422885|NCT04704869|101369551|FG001|NOT COMPLETED|Overall Study||39||
48422886|NCT01598831|101369552|FG000|STARTED|Overall Study||402||
48422887|NCT01598831|101369553|FG001|STARTED|Overall Study||414||
48422888|NCT01598831|101369552|FG000|Received at Least 1 Dose Study Treatment|Overall Study||395||
48422889|NCT01598831|101369553|FG001|Received at Least 1 Dose Study Treatment|Overall Study||405||
48422890|NCT01598831|101369552|FG000|COMPLETED|Overall Study||283||
48422891|NCT01598831|101369553|FG001|COMPLETED|Overall Study||278||
48422892|NCT01598831|101369552|FG000|NOT COMPLETED|Overall Study||119||
48422893|NCT01598831|101369553|FG001|NOT COMPLETED|Overall Study||136||
48422894|NCT00740116|101369554|FG000|STARTED|Overall Study||50||
48422895|NCT00740116|101369555|FG001|STARTED|Overall Study||50||
48422896|NCT00740116|101369554|FG000|COMPLETED|Overall Study||48||
48422897|NCT00740116|101369555|FG001|COMPLETED|Overall Study||45||
48422898|NCT00740116|101369554|FG000|NOT COMPLETED|Overall Study||2||
48422899|NCT00740116|101369555|FG001|NOT COMPLETED|Overall Study||5||
48422900|NCT01177943|101369556|FG000|STARTED|First Intervention||21||
48422901|NCT01177943|101369557|FG001|STARTED|First Intervention||21||
48422902|NCT01177943|101369556|FG000|COMPLETED|First Intervention||19||
48422903|NCT01177943|101369557|FG001|COMPLETED|First Intervention||21||
48422904|NCT01177943|101369556|FG000|NOT COMPLETED|First Intervention||2||
48422905|NCT01177943|101369557|FG001|NOT COMPLETED|First Intervention||0||
48422906|NCT01177943|101369556|FG000|STARTED|Second Intervention||19||
48422907|NCT01177943|101369557|FG001|STARTED|Second Intervention||21||
48422908|NCT01177943|101369556|FG000|COMPLETED|Second Intervention||19||
48422909|NCT01177943|101369557|FG001|COMPLETED|Second Intervention||21||
48422910|NCT01177943|101369556|FG000|NOT COMPLETED|Second Intervention||0||
48422911|NCT01177943|101369557|FG001|NOT COMPLETED|Second Intervention||0||
48422912|NCT00598585|101369558|FG000|STARTED|Overall Study||6||
48422913|NCT00598585|101369559|FG001|STARTED|Overall Study||6||
48422914|NCT00598585|101369558|FG000|COMPLETED|Overall Study||5||
48422915|NCT00598585|101369559|FG001|COMPLETED|Overall Study||6||
48422916|NCT00598585|101369558|FG000|NOT COMPLETED|Overall Study||1||
48422917|NCT00598585|101369559|FG001|NOT COMPLETED|Overall Study||0||
48422918|NCT04354870|101369560|FG000|STARTED|Overall Study||83||
48422919|NCT04354870|101369561|FG001|STARTED|Overall Study||47||
48422920|NCT04354870|101369560|FG000|COMPLETED|Overall Study||35||
48422921|NCT04354870|101369561|FG001|COMPLETED|Overall Study||14||
48422922|NCT04354870|101369560|FG000|NOT COMPLETED|Overall Study||48||
48422923|NCT04354870|101369561|FG001|NOT COMPLETED|Overall Study||33||
48422924|NCT01116895|101369562|FG000|STARTED|Overall Study||16||
48422925|NCT01116895|101369563|FG001|STARTED|Overall Study||15||
48422926|NCT01116895|101369564|FG002|STARTED|Overall Study||18||
48422927|NCT01116895|101369565|FG003|STARTED|Overall Study||14||
48422928|NCT01116895|101369562|FG000|COMPLETED|Overall Study||12||
48422929|NCT01116895|101369563|FG001|COMPLETED|Overall Study||8||
48422930|NCT01116895|101369564|FG002|COMPLETED|Overall Study||14||
48422931|NCT01116895|101369565|FG003|COMPLETED|Overall Study||11||
48422932|NCT01116895|101369562|FG000|NOT COMPLETED|Overall Study||4||
48422933|NCT01116895|101369563|FG001|NOT COMPLETED|Overall Study||7||
48422934|NCT01116895|101369564|FG002|NOT COMPLETED|Overall Study||4||
48422935|NCT01116895|101369565|FG003|NOT COMPLETED|Overall Study||3||
48422936|NCT00365872|101369566|FG000|STARTED|Overall Study||5||
48422937|NCT00365872|101369567|FG001|STARTED|Overall Study||6||
48422938|NCT00365872|101369568|FG002|STARTED|Overall Study||6||
48422939|NCT00365872|101369566|FG000|COMPLETED|Overall Study||5||
48422940|NCT00365872|101369567|FG001|COMPLETED|Overall Study||6||
48422941|NCT00365872|101369568|FG002|COMPLETED|Overall Study||6||
48422942|NCT00365872|101369566|FG000|NOT COMPLETED|Overall Study||0||
48422943|NCT00365872|101369567|FG001|NOT COMPLETED|Overall Study||0||
48422944|NCT00365872|101369568|FG002|NOT COMPLETED|Overall Study||0||
48422945|NCT04212221|101369569|FG000|STARTED|Overall Study||1||
48422946|NCT04212221|101369570|FG001|STARTED|Overall Study||3||
48422947|NCT04212221|101369571|FG002|STARTED|Overall Study||3||
48422948|NCT04212221|101369572|FG003|STARTED|Overall Study||6||
48422949|NCT04212221|101369573|FG004|STARTED|Overall Study||3||
48422950|NCT04212221|101369574|FG005|STARTED|Overall Study||4||
48422951|NCT04212221|101369575|FG006|STARTED|Overall Study||33||
48422952|NCT04212221|101369576|FG007|STARTED|Overall Study||36||
48422953|NCT04212221|101369569|FG000|COMPLETED|Overall Study||0||
48422954|NCT04212221|101369570|FG001|COMPLETED|Overall Study||0||
48422955|NCT04212221|101369571|FG002|COMPLETED|Overall Study||0||
48422956|NCT04212221|101369572|FG003|COMPLETED|Overall Study||0||
48422957|NCT04212221|101369573|FG004|COMPLETED|Overall Study||0||
48422958|NCT04212221|101369574|FG005|COMPLETED|Overall Study||0||
48422959|NCT04212221|101369575|FG006|COMPLETED|Overall Study||0||
48422960|NCT04212221|101369576|FG007|COMPLETED|Overall Study||0||
48422961|NCT04212221|101369569|FG000|NOT COMPLETED|Overall Study||1||
48422962|NCT04212221|101369570|FG001|NOT COMPLETED|Overall Study||3||
48422963|NCT04212221|101369571|FG002|NOT COMPLETED|Overall Study||3||
48422964|NCT04212221|101369572|FG003|NOT COMPLETED|Overall Study||6||
48422965|NCT04212221|101369573|FG004|NOT COMPLETED|Overall Study||3||
48422966|NCT04212221|101369574|FG005|NOT COMPLETED|Overall Study||4||
48422967|NCT04212221|101369575|FG006|NOT COMPLETED|Overall Study||33||
48422968|NCT04212221|101369576|FG007|NOT COMPLETED|Overall Study||36||
48422969|NCT00976521|101369577|FG000|STARTED|Overall Study||118||
48422970|NCT00976521|101369578|FG001|STARTED|Overall Study||111||
48422971|NCT00976521|101369579|FG002|STARTED|Overall Study||111||
48422972|NCT00976521|101369580|FG003|STARTED|Overall Study||112||
48422973|NCT00976521|101369577|FG000|COMPLETED|Overall Study||109||
48422974|NCT00976521|101369578|FG001|COMPLETED|Overall Study||99||
48422975|NCT00976521|101369579|FG002|COMPLETED|Overall Study||102||
48422976|NCT00976521|101369580|FG003|COMPLETED|Overall Study||93||
48422977|NCT00976521|101369577|FG000|NOT COMPLETED|Overall Study||9||
48422978|NCT00976521|101369578|FG001|NOT COMPLETED|Overall Study||12||
48422979|NCT00976521|101369579|FG002|NOT COMPLETED|Overall Study||9||
48422980|NCT00976521|101369580|FG003|NOT COMPLETED|Overall Study||19||
48422981|NCT01475513|101369581|FG000|STARTED|Overall Study||20||
48422982|NCT01475513|101369582|FG001|STARTED|Overall Study||26||
48422983|NCT01475513|101369581|FG000|COMPLETED|Overall Study||17||
48422984|NCT01475513|101369582|FG001|COMPLETED|Overall Study||16||
48422985|NCT01475513|101369581|FG000|NOT COMPLETED|Overall Study||3||
48422986|NCT01475513|101369582|FG001|NOT COMPLETED|Overall Study||10||
48422987|NCT00805194|101369583|FG000|STARTED|Overall Study||655||
48422988|NCT00805194|101369584|FG001|STARTED|Overall Study||659||
48422989|NCT00805194|101369583|FG000|COMPLETED|Overall Study||6||
48422990|NCT00805194|101369584|FG001|COMPLETED|Overall Study||5||
48422991|NCT00805194|101369583|FG000|NOT COMPLETED|Overall Study||649||
48422992|NCT00805194|101369584|FG001|NOT COMPLETED|Overall Study||654||
48422993|NCT00948389|101369585|FG000|STARTED|Overall Study||6||
48422994|NCT00948389|101369586|FG001|STARTED|Overall Study||3||
48422995|NCT00948389|101369587|FG002|STARTED|Overall Study||7||
48422996|NCT00948389|101369588|FG003|STARTED|Overall Study||9||
48422997|NCT00948389|101369589|FG004|STARTED|Overall Study||1||
48422998|NCT00948389|101369585|FG000|COMPLETED|Overall Study||0||
48422999|NCT00948389|101369586|FG001|COMPLETED|Overall Study||0||
48423000|NCT00948389|101369587|FG002|COMPLETED|Overall Study||0||
48423001|NCT00948389|101369588|FG003|COMPLETED|Overall Study||0||
48423002|NCT00948389|101369589|FG004|COMPLETED|Overall Study||0||
48423003|NCT00948389|101369585|FG000|NOT COMPLETED|Overall Study||6||
48423004|NCT00948389|101369586|FG001|NOT COMPLETED|Overall Study||3||
48423005|NCT00948389|101369587|FG002|NOT COMPLETED|Overall Study||7||
48423006|NCT00948389|101369588|FG003|NOT COMPLETED|Overall Study||9||
48423007|NCT00948389|101369589|FG004|NOT COMPLETED|Overall Study||1||
48423008|NCT03328325|101369590|FG000|STARTED|Overall Study||152||
48423009|NCT03328325|101369590|FG000|COMPLETED|Overall Study||141||
48423010|NCT03328325|101369590|FG000|NOT COMPLETED|Overall Study||11||
48423011|NCT00836342|101369591|FG000|STARTED|Overall Study||22||
48423012|NCT00836342|101369592|FG001|STARTED|Overall Study||23||
48423013|NCT00836342|101369593|FG002|STARTED|Overall Study||36||
48423014|NCT00836342|101369591|FG000|COMPLETED|Overall Study||22||
48423015|NCT00836342|101369592|FG001|COMPLETED|Overall Study||23||
48423016|NCT00836342|101369593|FG002|COMPLETED|Overall Study||36||
48423017|NCT00836342|101369591|FG000|NOT COMPLETED|Overall Study||0||
48423018|NCT00836342|101369592|FG001|NOT COMPLETED|Overall Study||0||
48423019|NCT00836342|101369593|FG002|NOT COMPLETED|Overall Study||0||
48423020|NCT00945945|101369594|FG000|STARTED|Overall Study||207||
48423021|NCT00945945|101369595|FG001|STARTED|Overall Study||217||
48423022|NCT00945945|101369594|FG000|COMPLETED|Overall Study||171||
48423023|NCT00945945|101369595|FG001|COMPLETED|Overall Study||162||
48423024|NCT00945945|101369594|FG000|NOT COMPLETED|Overall Study||36||
48423025|NCT00945945|101369595|FG001|NOT COMPLETED|Overall Study||55||
48423026|NCT01861587|101369596|FG000|STARTED|Overall Study||14||
48423027|NCT01861587|101369597|FG001|STARTED|Overall Study||13||
48423028|NCT01861587|101369596|FG000|COMPLETED|Overall Study||14||
48423029|NCT01861587|101369597|FG001|COMPLETED|Overall Study||13||
48423030|NCT01861587|101369596|FG000|NOT COMPLETED|Overall Study||0||
48423031|NCT01861587|101369597|FG001|NOT COMPLETED|Overall Study||0||
48423032|NCT00545584|101369598|FG000|STARTED|Overall Study||412||
48423033|NCT00545584|101369599|FG001|STARTED|Overall Study||414||
48423034|NCT00545584|101369600|FG002|STARTED|Overall Study||306||
48423035|NCT00545584|101369598|FG000|COMPLETED|Overall Study||333||
48423036|NCT00545584|101369599|FG001|COMPLETED|Overall Study||334||
48423037|NCT00545584|101369600|FG002|COMPLETED|Overall Study||250||
48423038|NCT00545584|101369598|FG000|NOT COMPLETED|Overall Study||79||
48423039|NCT00545584|101369599|FG001|NOT COMPLETED|Overall Study||80||
48423040|NCT00545584|101369600|FG002|NOT COMPLETED|Overall Study||56||
48423041|NCT00787527|101369601|FG000|STARTED|Overall Study||14||
48423042|NCT00787527|101369601|FG000|COMPLETED|Overall Study||11||
48423043|NCT00787527|101369601|FG000|NOT COMPLETED|Overall Study||3||
48423044|NCT01668017|101369602|FG000|STARTED|Overall Study||4||
48423045|NCT01668017|101369603|FG001|STARTED|Overall Study||9||
48423046|NCT01668017|101369604|FG002|STARTED|Overall Study||6||
48423047|NCT01668017|101369605|FG003|STARTED|Overall Study||5||
48423048|NCT01668017|101369606|FG004|STARTED|Overall Study||2||
48423049|NCT01668017|101369602|FG000|COMPLETED|Overall Study||4||
48423050|NCT01668017|101369603|FG001|COMPLETED|Overall Study||9||
48423051|NCT01668017|101369604|FG002|COMPLETED|Overall Study||6||
48423052|NCT01668017|101369605|FG003|COMPLETED|Overall Study||5||
48423053|NCT01668017|101369606|FG004|COMPLETED|Overall Study||2||
48423054|NCT01668017|101369602|FG000|NOT COMPLETED|Overall Study||0||
48423055|NCT01668017|101369603|FG001|NOT COMPLETED|Overall Study||0||
48423056|NCT01668017|101369604|FG002|NOT COMPLETED|Overall Study||0||
48423057|NCT01668017|101369605|FG003|NOT COMPLETED|Overall Study||0||
48423058|NCT01668017|101369606|FG004|NOT COMPLETED|Overall Study||0||
48423059|NCT01672827|101369607|FG000|STARTED|Overall Study||276||
48423060|NCT01672827|101369607|FG000|COMPLETED|Overall Study||276||
48423061|NCT01672827|101369607|FG000|NOT COMPLETED|Overall Study||0||
48423062|NCT02968277|101369608|FG000|STARTED|Overall Study||10||
48423063|NCT02968277|101369609|FG001|STARTED|Overall Study||7||
48423064|NCT02968277|101369610|FG002|STARTED|Overall Study||13||
48423065|NCT02968277|101369608|FG000|COMPLETED|Overall Study||10||
48423066|NCT02968277|101369609|FG001|COMPLETED|Overall Study||7||
48423067|NCT02968277|101369610|FG002|COMPLETED|Overall Study||13||
48423068|NCT02968277|101369608|FG000|NOT COMPLETED|Overall Study||0||
48423069|NCT02968277|101369609|FG001|NOT COMPLETED|Overall Study||0||
48423070|NCT02968277|101369610|FG002|NOT COMPLETED|Overall Study||0||
48423071|NCT00699582|101369611|FG000|STARTED|Overall Study||138||
48423072|NCT00699582|101369612|FG001|STARTED|Overall Study||130||
48423073|NCT00699582|101369613|FG002|STARTED|Overall Study||121||
48423074|NCT00699582|101369611|FG000|COMPLETED|Overall Study||120||
48423075|NCT00699582|101369612|FG001|COMPLETED|Overall Study||108||
48423076|NCT00699582|101369613|FG002|COMPLETED|Overall Study||93||
48423077|NCT00699582|101369611|FG000|NOT COMPLETED|Overall Study||18||
48423078|NCT00699582|101369612|FG001|NOT COMPLETED|Overall Study||22||
48423079|NCT00699582|101369613|FG002|NOT COMPLETED|Overall Study||28||
48423080|NCT03279731|101369614|FG000|STARTED|Overall Study||19||
48423081|NCT03279731|101369615|FG001|STARTED|Overall Study||17||
48423082|NCT03279731|101369614|FG000|COMPLETED|Overall Study||13||
48423083|NCT03279731|101369615|FG001|COMPLETED|Overall Study||14||
48423084|NCT03279731|101369614|FG000|NOT COMPLETED|Overall Study||6||
48423085|NCT03279731|101369615|FG001|NOT COMPLETED|Overall Study||3||
48423086|NCT00660816|101369616|FG000|STARTED|Overall Study||24||
48423087|NCT00660816|101369617|FG001|STARTED|Overall Study||22||
48423088|NCT00660816|101369616|FG000|COMPLETED|Overall Study||4||
48423089|NCT00660816|101369617|FG001|COMPLETED|Overall Study||3||
48423090|NCT00660816|101369616|FG000|NOT COMPLETED|Overall Study||20||
48423091|NCT00660816|101369617|FG001|NOT COMPLETED|Overall Study||19||
48423092|NCT00469391|101369618|FG000|STARTED|Overall Study||27||
48423093|NCT00469391|101369619|FG001|STARTED|Overall Study||29||
48423094|NCT00469391|101369618|FG000|Discontinued Prior to Procedure|Overall Study||2||
48423095|NCT00469391|101369619|FG001|Discontinued Prior to Procedure|Overall Study||3||
48423096|NCT00469391|101369618|FG000|Unsuccessful Implant Procedure|Overall Study||4||
48423097|NCT00469391|101369619|FG001|Unsuccessful Implant Procedure|Overall Study||0||
48423098|NCT00469391|101369618|FG000|Adverse Event|Overall Study||8||
48423099|NCT00469391|101369619|FG001|Adverse Event|Overall Study||0||
48423100|NCT00469391|101369618|FG000|Lost to Follow up|Overall Study||0||
48423101|NCT00469391|101369619|FG001|Lost to Follow up|Overall Study||1||
48423102|NCT00469391|101369618|FG000|Patient Preference|Overall Study||0||
48423103|NCT00469391|101369619|FG001|Patient Preference|Overall Study||1||
48423104|NCT00469391|101369618|FG000|COMPLETED|Overall Study||13||
48423105|NCT00469391|101369619|FG001|COMPLETED|Overall Study||24||
48423106|NCT00469391|101369618|FG000|NOT COMPLETED|Overall Study||14||
48423107|NCT00469391|101369619|FG001|NOT COMPLETED|Overall Study||5||
48423108|NCT00611351|101369620|FG000|STARTED|Overall Study||5||
48423109|NCT00611351|101369620|FG000|COMPLETED|Overall Study||3||
48423110|NCT00611351|101369620|FG000|NOT COMPLETED|Overall Study||2||
48763766|NCT00762164|102208807|FG001|COMPLETED|Overall Study||15||
48423111|NCT02898662|101369621|FG000|STARTED|Overall Study||40||
48423112|NCT02898662|101369622|FG001|STARTED|Overall Study||41||
48423113|NCT02898662|101369621|FG000|Completed Treatment|Overall Study||25||
48423114|NCT02898662|101369622|FG001|Completed Treatment|Overall Study||29||
48423115|NCT02898662|101369621|FG000|COMPLETED|Overall Study||11|Completed the study|
48423116|NCT02898662|101369622|FG001|COMPLETED|Overall Study||13|Completed the study|
48423117|NCT02898662|101369621|FG000|NOT COMPLETED|Overall Study||29||
48423118|NCT02898662|101369622|FG001|NOT COMPLETED|Overall Study||28||
48423119|NCT00950755|101369623|FG000|STARTED|Dosimetric and Therapeutic Treatment||41||
48423120|NCT00950755|101369623|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0||
48423121|NCT00950755|101369623|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||41||
48423122|NCT00950755|101369623|FG000|STARTED|Long-Term Follow-Up||18||
48423123|NCT00950755|101369623|FG000|COMPLETED|Long-Term Follow-Up||9||
48423124|NCT00950755|101369623|FG000|NOT COMPLETED|Long-Term Follow-Up||9||
48423125|NCT00804596|101369624|FG000|STARTED|Overall Study||74||
48423126|NCT00804596|101369624|FG000|COMPLETED|Overall Study||74||
48423127|NCT00804596|101369624|FG000|NOT COMPLETED|Overall Study||0||
48423128|NCT02549040|101369625|FG000|STARTED|Period 1||16||
48423129|NCT02549040|101369625|FG000|COMPLETED|Period 1||16||
48423130|NCT02549040|101369625|FG000|NOT COMPLETED|Period 1||0||
48423131|NCT02549040|101369625|FG000|STARTED|Period 2||16||
48423132|NCT02549040|101369625|FG000|COMPLETED|Period 2||16||
48423133|NCT02549040|101369625|FG000|NOT COMPLETED|Period 2||0||
48423134|NCT02549040|101369625|FG000|STARTED|Period 3||16||
48423135|NCT02549040|101369625|FG000|COMPLETED|Period 3||16||
48423136|NCT02549040|101369625|FG000|NOT COMPLETED|Period 3||0||
48423137|NCT02549040|101369625|FG000|STARTED|Period 4||16||
48423138|NCT02549040|101369625|FG000|COMPLETED|Period 4||16||
48423139|NCT02549040|101369625|FG000|NOT COMPLETED|Period 4||0||
48423140|NCT02549040|101369625|FG000|STARTED|Period 5||16||
48423141|NCT02549040|101369625|FG000|COMPLETED|Period 5||16||
48423142|NCT02549040|101369625|FG000|NOT COMPLETED|Period 5||0||
48423143|NCT02906644|101369626|FG000|STARTED|First 2 Weeks||31||
48423144|NCT02906644|101369627|FG001|STARTED|First 2 Weeks||30||
48423145|NCT02906644|101369626|FG000|COMPLETED|First 2 Weeks||30||
48423146|NCT02906644|101369627|FG001|COMPLETED|First 2 Weeks||27||
48423147|NCT02906644|101369626|FG000|NOT COMPLETED|First 2 Weeks||1||
48423148|NCT02906644|101369627|FG001|NOT COMPLETED|First 2 Weeks||3||
48423149|NCT02906644|101369626|FG000|STARTED|Weeks 3 to 14||30||
48423150|NCT02906644|101369627|FG001|STARTED|Weeks 3 to 14||27||
48423151|NCT02906644|101369626|FG000|Final Study Visit|Weeks 3 to 14||17||
48423152|NCT02906644|101369627|FG001|Final Study Visit|Weeks 3 to 14||20||
48423153|NCT02906644|101369626|FG000|Follow-up (6 Months Post Quit Day)|Weeks 3 to 14||14||
48423154|NCT02906644|101369627|FG001|Follow-up (6 Months Post Quit Day)|Weeks 3 to 14||16||
48423155|NCT02906644|101369626|FG000|COMPLETED|Weeks 3 to 14||14||
48423156|NCT02906644|101369627|FG001|COMPLETED|Weeks 3 to 14||16||
48423157|NCT02906644|101369626|FG000|NOT COMPLETED|Weeks 3 to 14||16||
48423158|NCT02906644|101369627|FG001|NOT COMPLETED|Weeks 3 to 14||11||
48423159|NCT01569568|101369628|FG000|STARTED|Overall Study||20||
48423160|NCT01569568|101369629|FG001|STARTED|Overall Study||29||
48423161|NCT01569568|101369628|FG000|COMPLETED|Overall Study||20||
48423162|NCT01569568|101369629|FG001|COMPLETED|Overall Study||27||
48423163|NCT01569568|101369628|FG000|NOT COMPLETED|Overall Study||0||
48423164|NCT01569568|101369629|FG001|NOT COMPLETED|Overall Study||2||
48423165|NCT02127931|101369630|FG000|STARTED|Overall Study||18||
48423166|NCT02127931|101369630|FG000|COMPLETED|Overall Study||17||
48423167|NCT02127931|101369630|FG000|NOT COMPLETED|Overall Study||1||
48423168|NCT00056472|101369631|FG000|STARTED|Overall Study||129||
48423169|NCT00056472|101369632|FG001|STARTED|Overall Study||130||
48423170|NCT00056472|101369631|FG000|COMPLETED|Overall Study||81||
48423171|NCT00056472|101369632|FG001|COMPLETED|Overall Study||61||
48423172|NCT00056472|101369631|FG000|NOT COMPLETED|Overall Study||48||
48423173|NCT00056472|101369632|FG001|NOT COMPLETED|Overall Study||69||
48423174|NCT00302731|101369633|FG000|STARTED|Overall Study||6||
48423175|NCT00302731|101369634|FG001|STARTED|Overall Study||6||
48423176|NCT00302731|101369635|FG002|STARTED|Overall Study||5||
48423177|NCT00302731|101369636|FG003|STARTED|Overall Study||4||
48423178|NCT00302731|101369633|FG000|COMPLETED|Overall Study||2||
48423179|NCT00302731|101369634|FG001|COMPLETED|Overall Study||1||
48423180|NCT00302731|101369635|FG002|COMPLETED|Overall Study||2||
48423181|NCT00302731|101369636|FG003|COMPLETED|Overall Study||4||
48423182|NCT00302731|101369633|FG000|NOT COMPLETED|Overall Study||4||
48423183|NCT00302731|101369634|FG001|NOT COMPLETED|Overall Study||5||
48423184|NCT00302731|101369635|FG002|NOT COMPLETED|Overall Study||3||
48423185|NCT00302731|101369636|FG003|NOT COMPLETED|Overall Study||0||
48423186|NCT02049385|101369637|FG000|STARTED|First Intervention||4||
48423187|NCT02049385|101369638|FG001|STARTED|First Intervention||2||
48423188|NCT02049385|101369637|FG000|COMPLETED|First Intervention||1||
48423189|NCT02049385|101369638|FG001|COMPLETED|First Intervention||2||
48423190|NCT02049385|101369637|FG000|NOT COMPLETED|First Intervention||3||
48423191|NCT02049385|101369638|FG001|NOT COMPLETED|First Intervention||0||
48423192|NCT02049385|101369637|FG000|STARTED|Second Intervention||1||
48423193|NCT02049385|101369638|FG001|STARTED|Second Intervention||2||
48423194|NCT02049385|101369637|FG000|COMPLETED|Second Intervention||1||
48423195|NCT02049385|101369638|FG001|COMPLETED|Second Intervention||0||
48423196|NCT02049385|101369637|FG000|NOT COMPLETED|Second Intervention||0||
48423197|NCT02049385|101369638|FG001|NOT COMPLETED|Second Intervention||2||
48423198|NCT00689299|101369639|FG000|STARTED|Overall Study||58||
48423199|NCT00689299|101369640|FG001|STARTED|Overall Study||57||
48423200|NCT00689299|101369641|FG002|STARTED|Overall Study||54||
48423201|NCT00689299|101369639|FG000|COMPLETED|Overall Study||51||
48423202|NCT00689299|101369640|FG001|COMPLETED|Overall Study||54||
48423203|NCT00689299|101369641|FG002|COMPLETED|Overall Study||49||
48186982|NCT02237079|100779955|FG001|COMPLETED|Overall Study||5||
48186983|NCT02237079|100779954|FG000|NOT COMPLETED|Overall Study||3||
48186984|NCT02237079|100779955|FG001|NOT COMPLETED|Overall Study||2||
48186985|NCT00231179|100779956|FG000|STARTED|Overall Study||152||
48186986|NCT00231179|100779957|FG001|STARTED|Overall Study||150||
48186987|NCT00231179|100779956|FG000|COMPLETED|Overall Study||128||
48186988|NCT00231179|100779957|FG001|COMPLETED|Overall Study||126||
48186989|NCT00231179|100779956|FG000|NOT COMPLETED|Overall Study||24||
48186990|NCT00231179|100779957|FG001|NOT COMPLETED|Overall Study||24||
48186991|NCT01786343|100779958|FG000|STARTED|Overall Study||28||
48186992|NCT01786343|100779959|FG001|STARTED|Overall Study||46||
48186993|NCT01786343|100779958|FG000|COMPLETED|Overall Study||28||
48186994|NCT01786343|100779959|FG001|COMPLETED|Overall Study||46||
48186995|NCT01786343|100779958|FG000|NOT COMPLETED|Overall Study||0||
48186996|NCT01786343|100779959|FG001|NOT COMPLETED|Overall Study||0||
48186997|NCT00062868|100779960|FG000|STARTED|Dose Level 1||3||
48186998|NCT00062868|100779961|FG001|STARTED|Dose Level 1||0||
48186999|NCT00062868|100779962|FG002|STARTED|Dose Level 1||0||
48187000|NCT00062868|100779963|FG003|STARTED|Dose Level 1||3||
48187001|NCT00062868|100779964|FG004|STARTED|Dose Level 1||0||
48187002|NCT00062868|100779965|FG005|STARTED|Dose Level 1||0||
48187003|NCT00062868|100779966|FG006|STARTED|Dose Level 1||4||
48187004|NCT00062868|100779967|FG007|STARTED|Dose Level 1||0||
48187005|NCT00062868|100779968|FG008|STARTED|Dose Level 1||0||
48187006|NCT00062868|100779969|FG009|STARTED|Dose Level 1||3||
48187007|NCT00062868|100779970|FG010|STARTED|Dose Level 1||0||
48187008|NCT00062868|100779971|FG011|STARTED|Dose Level 1||0||
48187009|NCT00062868|100779972|FG012|STARTED|Dose Level 1||3||
48187010|NCT00062868|100779973|FG013|STARTED|Dose Level 1||0||
48187011|NCT00062868|100779974|FG014|STARTED|Dose Level 1||0||
48187012|NCT00062868|100779975|FG015|STARTED|Dose Level 1||3||
48187013|NCT00062868|100779976|FG016|STARTED|Dose Level 1||0||
48187014|NCT00062868|100779977|FG017|STARTED|Dose Level 1||0||
48187015|NCT00062868|100779978|FG018|STARTED|Dose Level 1||16||
48187016|NCT00062868|100779979|FG019|STARTED|Dose Level 1||2||
48187017|NCT00062868|100779980|FG020|STARTED|Dose Level 1||3||
48187018|NCT00062868|100779960|FG000|COMPLETED|Dose Level 1||1||
48187019|NCT00062868|100779961|FG001|COMPLETED|Dose Level 1||0||
48187020|NCT00062868|100779962|FG002|COMPLETED|Dose Level 1||0||
48187021|NCT00062868|100779963|FG003|COMPLETED|Dose Level 1||1||
48187022|NCT00062868|100779964|FG004|COMPLETED|Dose Level 1||0||
48187023|NCT00062868|100779965|FG005|COMPLETED|Dose Level 1||0||
48187024|NCT00062868|100779966|FG006|COMPLETED|Dose Level 1||1||
48187025|NCT00062868|100779967|FG007|COMPLETED|Dose Level 1||0||
48187026|NCT00062868|100779968|FG008|COMPLETED|Dose Level 1||0||
48187027|NCT00062868|100779969|FG009|COMPLETED|Dose Level 1||3||
48187028|NCT00062868|100779970|FG010|COMPLETED|Dose Level 1||0||
48187029|NCT00062868|100779971|FG011|COMPLETED|Dose Level 1||0||
48187030|NCT00062868|100779972|FG012|COMPLETED|Dose Level 1||2||
48187031|NCT00062868|100779973|FG013|COMPLETED|Dose Level 1||0||
48187032|NCT00062868|100779974|FG014|COMPLETED|Dose Level 1||0||
48187033|NCT00062868|100779975|FG015|COMPLETED|Dose Level 1||3||
48187034|NCT00062868|100779976|FG016|COMPLETED|Dose Level 1||0||
48187035|NCT00062868|100779977|FG017|COMPLETED|Dose Level 1||0||
48187036|NCT00062868|100779978|FG018|COMPLETED|Dose Level 1||7||
48187037|NCT00062868|100779979|FG019|COMPLETED|Dose Level 1||2||
48187038|NCT00062868|100779980|FG020|COMPLETED|Dose Level 1||1||
48187039|NCT00062868|100779960|FG000|NOT COMPLETED|Dose Level 1||2||
48187040|NCT00062868|100779961|FG001|NOT COMPLETED|Dose Level 1||0||
48187041|NCT00062868|100779962|FG002|NOT COMPLETED|Dose Level 1||0||
48187042|NCT00062868|100779963|FG003|NOT COMPLETED|Dose Level 1||2||
48187043|NCT00062868|100779964|FG004|NOT COMPLETED|Dose Level 1||0||
48359533|NCT03976401|101210673|FG003|COMPLETED|Overall Study||19||
48359534|NCT03976401|101210674|FG004|COMPLETED|Overall Study||19||
48359535|NCT03976401|101210675|FG005|COMPLETED|Overall Study||9||
48359536|NCT03976401|101210670|FG000|NOT COMPLETED|Overall Study||3||
48359537|NCT03976401|101210671|FG001|NOT COMPLETED|Overall Study||4||
48187044|NCT00062868|100779965|FG005|NOT COMPLETED|Dose Level 1||0||
48187045|NCT00062868|100779966|FG006|NOT COMPLETED|Dose Level 1||3||
48187046|NCT00062868|100779967|FG007|NOT COMPLETED|Dose Level 1||0||
48187047|NCT00062868|100779968|FG008|NOT COMPLETED|Dose Level 1||0||
48187048|NCT00062868|100779969|FG009|NOT COMPLETED|Dose Level 1||0||
48187049|NCT00062868|100779970|FG010|NOT COMPLETED|Dose Level 1||0||
48187050|NCT00062868|100779971|FG011|NOT COMPLETED|Dose Level 1||0||
48187051|NCT00062868|100779972|FG012|NOT COMPLETED|Dose Level 1||1||
48187052|NCT00062868|100779973|FG013|NOT COMPLETED|Dose Level 1||0||
48187053|NCT00062868|100779974|FG014|NOT COMPLETED|Dose Level 1||0||
48187054|NCT00062868|100779975|FG015|NOT COMPLETED|Dose Level 1||0||
48187055|NCT00062868|100779976|FG016|NOT COMPLETED|Dose Level 1||0||
48187056|NCT00062868|100779977|FG017|NOT COMPLETED|Dose Level 1||0||
48187057|NCT00062868|100779978|FG018|NOT COMPLETED|Dose Level 1||9||
48187058|NCT00062868|100779979|FG019|NOT COMPLETED|Dose Level 1||0||
48359538|NCT03976401|101210672|FG002|NOT COMPLETED|Overall Study||5||
48187059|NCT00062868|100779980|FG020|NOT COMPLETED|Dose Level 1||2||
48187060|NCT00062868|100779960|FG000|STARTED|Dose Level 2||0||
48187061|NCT00062868|100779961|FG001|STARTED|Dose Level 2||6||
48423204|NCT00689299|101369639|FG000|NOT COMPLETED|Overall Study||7||
48423205|NCT00689299|101369640|FG001|NOT COMPLETED|Overall Study||3||
48423206|NCT00689299|101369641|FG002|NOT COMPLETED|Overall Study||5||
48423207|NCT02885506|101369642|FG000|STARTED|Part A||6||
48423208|NCT02885506|101369643|FG001|STARTED|Part A||6||
48423209|NCT02885506|101369644|FG002|STARTED|Part A||6||
48423210|NCT02885506|101369645|FG003|STARTED|Part A||6||
48423211|NCT02885506|101369646|FG004|STARTED|Part A||6||
48423212|NCT02885506|101369647|FG005|STARTED|Part A||6||
48423213|NCT02885506|101369648|FG006|STARTED|Part A||6||
48423214|NCT02885506|101369649|FG007|STARTED|Part A||14||
48423215|NCT02885506|101369650|FG008|STARTED|Part A||0||
48423216|NCT02885506|101369651|FG009|STARTED|Part A||0||
48423217|NCT02885506|101369642|FG000|COMPLETED|Part A||6||
48423218|NCT02885506|101369643|FG001|COMPLETED|Part A||6||
48423219|NCT02885506|101369644|FG002|COMPLETED|Part A||6||
48423220|NCT02885506|101369645|FG003|COMPLETED|Part A||6||
48423221|NCT02885506|101369646|FG004|COMPLETED|Part A||6||
48423222|NCT02885506|101369647|FG005|COMPLETED|Part A||6||
48423223|NCT02885506|101369648|FG006|COMPLETED|Part A||6||
48423224|NCT02885506|101369649|FG007|COMPLETED|Part A||14||
48423225|NCT02885506|101369650|FG008|COMPLETED|Part A||0||
48423226|NCT02885506|101369651|FG009|COMPLETED|Part A||0||
48423227|NCT02885506|101369642|FG000|NOT COMPLETED|Part A||0||
48423228|NCT02885506|101369643|FG001|NOT COMPLETED|Part A||0||
48423229|NCT02885506|101369644|FG002|NOT COMPLETED|Part A||0||
48423230|NCT02885506|101369645|FG003|NOT COMPLETED|Part A||0||
48423231|NCT02885506|101369646|FG004|NOT COMPLETED|Part A||0||
48423232|NCT02885506|101369647|FG005|NOT COMPLETED|Part A||0||
48423233|NCT02885506|101369648|FG006|NOT COMPLETED|Part A||0||
48423234|NCT02885506|101369649|FG007|NOT COMPLETED|Part A||0||
48423235|NCT02885506|101369650|FG008|NOT COMPLETED|Part A||0||
48423236|NCT02885506|101369651|FG009|NOT COMPLETED|Part A||0||
48423237|NCT02885506|101369642|FG000|STARTED|Part B||0||
48423238|NCT02885506|101369643|FG001|STARTED|Part B||0||
48423239|NCT02885506|101369644|FG002|STARTED|Part B||0||
48423240|NCT02885506|101369645|FG003|STARTED|Part B||0||
48423241|NCT02885506|101369646|FG004|STARTED|Part B||0||
48423242|NCT02885506|101369647|FG005|STARTED|Part B||0||
48423243|NCT02885506|101369648|FG006|STARTED|Part B||0||
48423244|NCT02885506|101369649|FG007|STARTED|Part B||0||
48423245|NCT02885506|101369650|FG008|STARTED|Part B||4||
48423246|NCT02885506|101369651|FG009|STARTED|Part B||4||
48423247|NCT02885506|101369642|FG000|COMPLETED|Part B||0||
48423248|NCT02885506|101369643|FG001|COMPLETED|Part B||0||
48423249|NCT02885506|101369644|FG002|COMPLETED|Part B||0||
48423250|NCT02885506|101369645|FG003|COMPLETED|Part B||0||
48423251|NCT02885506|101369646|FG004|COMPLETED|Part B||0||
48423252|NCT02885506|101369647|FG005|COMPLETED|Part B||0||
48423253|NCT02885506|101369648|FG006|COMPLETED|Part B||0||
48423254|NCT02885506|101369649|FG007|COMPLETED|Part B||0||
48423255|NCT02885506|101369650|FG008|COMPLETED|Part B||4||
48423256|NCT02885506|101369651|FG009|COMPLETED|Part B||4||
48423257|NCT02885506|101369642|FG000|NOT COMPLETED|Part B||0||
48423258|NCT02885506|101369643|FG001|NOT COMPLETED|Part B||0||
48423259|NCT02885506|101369644|FG002|NOT COMPLETED|Part B||0||
48423260|NCT02885506|101369645|FG003|NOT COMPLETED|Part B||0||
48423261|NCT02885506|101369646|FG004|NOT COMPLETED|Part B||0||
48423262|NCT02885506|101369647|FG005|NOT COMPLETED|Part B||0||
48423263|NCT02885506|101369648|FG006|NOT COMPLETED|Part B||0||
48423264|NCT02885506|101369649|FG007|NOT COMPLETED|Part B||0||
48423265|NCT02885506|101369650|FG008|NOT COMPLETED|Part B||0||
48423266|NCT02885506|101369651|FG009|NOT COMPLETED|Part B||0||
48423267|NCT00987558|101369652|FG000|STARTED|Overall Study||13||
48423268|NCT00987558|101369653|FG001|STARTED|Overall Study||17||
48423269|NCT00987558|101369652|FG000|Simvastatin|Overall Study||13||
48423270|NCT00987558|101369653|FG001|Simvastatin|Overall Study||12||
48423271|NCT00987558|101369652|FG000|Washout|Overall Study||13||
48423272|NCT00987558|101369653|FG001|Washout|Overall Study||12||
48423273|NCT00987558|101369652|FG000|Eslicarbazepine Acetate + Simvastatin|Overall Study||13||
48423274|NCT00987558|101369653|FG001|Eslicarbazepine Acetate + Simvastatin|Overall Study||17||
48423275|NCT00987558|101369652|FG000|COMPLETED|Overall Study||12||
48423276|NCT00987558|101369653|FG001|COMPLETED|Overall Study||12||
48423277|NCT00987558|101369652|FG000|NOT COMPLETED|Overall Study||1||
48423278|NCT00987558|101369653|FG001|NOT COMPLETED|Overall Study||5||
48423279|NCT00387621|101369654|FG000|STARTED|First Intervention||29||
48423280|NCT00387621|101369655|FG001|STARTED|First Intervention||29||
48423281|NCT00387621|101369654|FG000|COMPLETED|First Intervention||29||
48423282|NCT00387621|101369655|FG001|COMPLETED|First Intervention||29||
48423283|NCT00387621|101369654|FG000|NOT COMPLETED|First Intervention||0||
48423284|NCT00387621|101369655|FG001|NOT COMPLETED|First Intervention||0||
48423285|NCT00387621|101369654|FG000|STARTED|Washout Period of 2 Weeks||29||
48423286|NCT00387621|101369655|FG001|STARTED|Washout Period of 2 Weeks||29||
48423287|NCT00387621|101369654|FG000|COMPLETED|Washout Period of 2 Weeks||29||
48423288|NCT00387621|101369655|FG001|COMPLETED|Washout Period of 2 Weeks||29||
48423289|NCT00387621|101369654|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0||
48423290|NCT00387621|101369655|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0||
48423291|NCT00387621|101369654|FG000|STARTED|Second Intervention||29||
48423292|NCT00387621|101369655|FG001|STARTED|Second Intervention||29||
48763767|NCT00762164|102208806|FG000|NOT COMPLETED|Overall Study||3||
48187062|NCT00062868|100779962|FG002|STARTED|Dose Level 2||0||
48187063|NCT00062868|100779963|FG003|STARTED|Dose Level 2||0||
48187064|NCT00062868|100779964|FG004|STARTED|Dose Level 2||3||
48187065|NCT00062868|100779965|FG005|STARTED|Dose Level 2||0||
48187066|NCT00062868|100779966|FG006|STARTED|Dose Level 2||0||
48187067|NCT00062868|100779967|FG007|STARTED|Dose Level 2||0||
48187068|NCT00062868|100779968|FG008|STARTED|Dose Level 2||0||
48187069|NCT00062868|100779969|FG009|STARTED|Dose Level 2||0||
48187070|NCT00062868|100779970|FG010|STARTED|Dose Level 2||4||
48187071|NCT00062868|100779971|FG011|STARTED|Dose Level 2||0||
48187072|NCT00062868|100779972|FG012|STARTED|Dose Level 2||0||
48187073|NCT00062868|100779973|FG013|STARTED|Dose Level 2||3||
48187074|NCT00062868|100779974|FG014|STARTED|Dose Level 2||0||
48359539|NCT03976401|101210673|FG003|NOT COMPLETED|Overall Study||2||
48359540|NCT03976401|101210674|FG004|NOT COMPLETED|Overall Study||1||
48359541|NCT03976401|101210675|FG005|NOT COMPLETED|Overall Study||1||
48359542|NCT00477451|101210676|FG000|STARTED|Overall Study||20||
48359543|NCT00477451|101210677|FG001|STARTED|Overall Study||20||
48359544|NCT00477451|101210678|FG002|STARTED|Overall Study||7||
48359545|NCT00477451|101210679|FG003|STARTED|Overall Study||2||
48359546|NCT00477451|101210676|FG000|COMPLETED|Overall Study||20||
48359547|NCT00477451|101210677|FG001|COMPLETED|Overall Study||20||
48359548|NCT00477451|101210678|FG002|COMPLETED|Overall Study||7||
48359549|NCT00477451|101210679|FG003|COMPLETED|Overall Study||2||
48359550|NCT00477451|101210676|FG000|NOT COMPLETED|Overall Study||0||
48359551|NCT00477451|101210677|FG001|NOT COMPLETED|Overall Study||0||
48187075|NCT00062868|100779975|FG015|STARTED|Dose Level 2||0||
48187076|NCT00062868|100779976|FG016|STARTED|Dose Level 2||3||
48187077|NCT00062868|100779977|FG017|STARTED|Dose Level 2||0||
48187078|NCT00062868|100779978|FG018|STARTED|Dose Level 2||0||
48187079|NCT00062868|100779979|FG019|STARTED|Dose Level 2||0||
48187080|NCT00062868|100779980|FG020|STARTED|Dose Level 2||0||
48187081|NCT00062868|100779960|FG000|COMPLETED|Dose Level 2||0||
48187082|NCT00062868|100779961|FG001|COMPLETED|Dose Level 2||3||
48187083|NCT00062868|100779962|FG002|COMPLETED|Dose Level 2||0||
48187084|NCT00062868|100779963|FG003|COMPLETED|Dose Level 2||0||
48187085|NCT00062868|100779964|FG004|COMPLETED|Dose Level 2||1||
48187086|NCT00062868|100779965|FG005|COMPLETED|Dose Level 2||0||
48187087|NCT00062868|100779966|FG006|COMPLETED|Dose Level 2||0||
48187088|NCT00062868|100779967|FG007|COMPLETED|Dose Level 2||0||
48187089|NCT00062868|100779968|FG008|COMPLETED|Dose Level 2||0||
48187090|NCT00062868|100779969|FG009|COMPLETED|Dose Level 2||0||
48187091|NCT00062868|100779970|FG010|COMPLETED|Dose Level 2||3||
48187092|NCT00062868|100779971|FG011|COMPLETED|Dose Level 2||0||
48187093|NCT00062868|100779972|FG012|COMPLETED|Dose Level 2||0||
48187094|NCT00062868|100779973|FG013|COMPLETED|Dose Level 2||2||
48187095|NCT00062868|100779974|FG014|COMPLETED|Dose Level 2||0||
48187096|NCT00062868|100779975|FG015|COMPLETED|Dose Level 2||0||
48187097|NCT00062868|100779976|FG016|COMPLETED|Dose Level 2||0||
48187098|NCT00062868|100779977|FG017|COMPLETED|Dose Level 2||0||
48187099|NCT00062868|100779978|FG018|COMPLETED|Dose Level 2||0||
48187100|NCT00062868|100779979|FG019|COMPLETED|Dose Level 2||0||
48187101|NCT00062868|100779980|FG020|COMPLETED|Dose Level 2||0||
48187102|NCT00062868|100779960|FG000|NOT COMPLETED|Dose Level 2||0||
48187103|NCT00062868|100779961|FG001|NOT COMPLETED|Dose Level 2||3||
48187104|NCT00062868|100779962|FG002|NOT COMPLETED|Dose Level 2||0||
48187105|NCT00062868|100779963|FG003|NOT COMPLETED|Dose Level 2||0||
48187106|NCT00062868|100779964|FG004|NOT COMPLETED|Dose Level 2||2||
48187107|NCT00062868|100779965|FG005|NOT COMPLETED|Dose Level 2||0||
48187108|NCT00062868|100779966|FG006|NOT COMPLETED|Dose Level 2||0||
48187109|NCT00062868|100779967|FG007|NOT COMPLETED|Dose Level 2||0||
48187110|NCT00062868|100779968|FG008|NOT COMPLETED|Dose Level 2||0||
48187111|NCT00062868|100779969|FG009|NOT COMPLETED|Dose Level 2||0||
48187112|NCT00062868|100779970|FG010|NOT COMPLETED|Dose Level 2||1||
48187113|NCT00062868|100779971|FG011|NOT COMPLETED|Dose Level 2||0||
48187114|NCT00062868|100779972|FG012|NOT COMPLETED|Dose Level 2||0||
48187115|NCT00062868|100779973|FG013|NOT COMPLETED|Dose Level 2||1||
48187116|NCT00062868|100779974|FG014|NOT COMPLETED|Dose Level 2||0||
48187117|NCT00062868|100779975|FG015|NOT COMPLETED|Dose Level 2||0||
48187118|NCT00062868|100779976|FG016|NOT COMPLETED|Dose Level 2||3||
48187119|NCT00062868|100779977|FG017|NOT COMPLETED|Dose Level 2||0||
48187120|NCT00062868|100779978|FG018|NOT COMPLETED|Dose Level 2||0||
48187121|NCT00062868|100779979|FG019|NOT COMPLETED|Dose Level 2||0||
48187122|NCT00062868|100779980|FG020|NOT COMPLETED|Dose Level 2||0||
48187123|NCT00062868|100779960|FG000|STARTED|Dose Level 3||0||
48187124|NCT00062868|100779961|FG001|STARTED|Dose Level 3||0||
48187125|NCT00062868|100779962|FG002|STARTED|Dose Level 3||3||
48187126|NCT00062868|100779963|FG003|STARTED|Dose Level 3||0||
48187127|NCT00062868|100779964|FG004|STARTED|Dose Level 3||0||
48187128|NCT00062868|100779965|FG005|STARTED|Dose Level 3||0||
48187129|NCT00062868|100779966|FG006|STARTED|Dose Level 3||0||
48187130|NCT00062868|100779967|FG007|STARTED|Dose Level 3||0||
48187131|NCT00062868|100779968|FG008|STARTED|Dose Level 3||0||
48187132|NCT00062868|100779969|FG009|STARTED|Dose Level 3||0||
48359552|NCT00477451|101210678|FG002|NOT COMPLETED|Overall Study||0||
48423293|NCT00387621|101369654|FG000|COMPLETED|Second Intervention||29||
48423294|NCT00387621|101369655|FG001|COMPLETED|Second Intervention||29||
48423295|NCT00387621|101369654|FG000|NOT COMPLETED|Second Intervention||0||
48423296|NCT00387621|101369655|FG001|NOT COMPLETED|Second Intervention||0||
48423297|NCT00736840|101369656|FG000|STARTED|Overall Study||414||
48423298|NCT00736840|101369656|FG000|COMPLETED|Overall Study||401||
48423299|NCT00736840|101369656|FG000|NOT COMPLETED|Overall Study||13||
48423300|NCT02155725|101369657|FG000|STARTED|Treatment Period||224||
48423301|NCT02155725|101369658|FG001|STARTED|Treatment Period||213||
48423302|NCT02155725|101369657|FG000|COMPLETED|Treatment Period||224||
48423303|NCT02155725|101369658|FG001|COMPLETED|Treatment Period||213||
48423304|NCT02155725|101369657|FG000|NOT COMPLETED|Treatment Period||0||
48423305|NCT02155725|101369658|FG001|NOT COMPLETED|Treatment Period||0||
48423306|NCT02155725|101369657|FG000|STARTED|Follow-up Period||224||
48423307|NCT02155725|101369658|FG001|STARTED|Follow-up Period||213||
48423308|NCT02155725|101369657|FG000|COMPLETED|Follow-up Period||207||
48423309|NCT02155725|101369658|FG001|COMPLETED|Follow-up Period||202||
48423310|NCT02155725|101369657|FG000|NOT COMPLETED|Follow-up Period||17||
48423311|NCT02155725|101369658|FG001|NOT COMPLETED|Follow-up Period||11||
48423312|NCT02990325|101369659|FG000|STARTED|Overall Study||11||
48423313|NCT02990325|101369660|FG001|STARTED|Overall Study||12||
48423314|NCT02990325|101369661|FG002|STARTED|Overall Study||13||
48423315|NCT02990325|101369659|FG000|COMPLETED|Overall Study||11||
48423316|NCT02990325|101369660|FG001|COMPLETED|Overall Study||12||
48423317|NCT02990325|101369661|FG002|COMPLETED|Overall Study||13||
48423318|NCT02990325|101369659|FG000|NOT COMPLETED|Overall Study||0||
48423319|NCT02990325|101369660|FG001|NOT COMPLETED|Overall Study||0||
48423320|NCT02990325|101369661|FG002|NOT COMPLETED|Overall Study||0||
48423321|NCT02926833|101369662|FG000|STARTED|Overall Study||3||
48423322|NCT02926833|101369663|FG001|STARTED|Overall Study||4||
48423323|NCT02926833|101369664|FG002|STARTED|Overall Study||7||
48423324|NCT02926833|101369665|FG003|STARTED|Overall Study||23||
48423325|NCT02926833|101369662|FG000|COMPLETED|Overall Study||1||
48423326|NCT02926833|101369663|FG001|COMPLETED|Overall Study||0||
48423327|NCT02926833|101369664|FG002|COMPLETED|Overall Study||1||
48423328|NCT02926833|101369665|FG003|COMPLETED|Overall Study||0||
48423329|NCT02926833|101369662|FG000|NOT COMPLETED|Overall Study||2||
48423330|NCT02926833|101369663|FG001|NOT COMPLETED|Overall Study||4||
48423331|NCT02926833|101369664|FG002|NOT COMPLETED|Overall Study||6||
48423332|NCT02926833|101369665|FG003|NOT COMPLETED|Overall Study||23||
48423333|NCT00768040|101369666|FG000|STARTED|Overall Study||20||
48423334|NCT00768040|101369667|FG001|STARTED|Overall Study||19||
48423335|NCT00768040|101369666|FG000|COMPLETED|Overall Study||16||
48423336|NCT00768040|101369667|FG001|COMPLETED|Overall Study||16||
48423337|NCT00768040|101369666|FG000|NOT COMPLETED|Overall Study||4||
48423338|NCT00768040|101369667|FG001|NOT COMPLETED|Overall Study||3||
48423339|NCT03288987|101369668|FG000|STARTED|Overall Study||82||
48423340|NCT03288987|101369669|FG001|STARTED|Overall Study||44||
48423341|NCT03288987|101369668|FG000|Patients Receiving Medication|Overall Study||80||
48423342|NCT03288987|101369669|FG001|Patients Receiving Medication|Overall Study||44||
48423343|NCT03288987|101369668|FG000|COMPLETED|Overall Study||72||
48423344|NCT03288987|101369669|FG001|COMPLETED|Overall Study||40||
48423345|NCT03288987|101369668|FG000|NOT COMPLETED|Overall Study||10||
48423346|NCT03288987|101369669|FG001|NOT COMPLETED|Overall Study||4||
48423347|NCT00247962|101369670|FG000|STARTED|Overall Study||379||
48423348|NCT00247962|101369671|FG001|STARTED|Overall Study||187||
48423349|NCT00247962|101369670|FG000|COMPLETED|Overall Study||353||
48423350|NCT00247962|101369671|FG001|COMPLETED|Overall Study||168||
48423351|NCT00247962|101369670|FG000|NOT COMPLETED|Overall Study||26||
48423352|NCT00247962|101369671|FG001|NOT COMPLETED|Overall Study||19||
48423353|NCT02711306|101369672|FG000|STARTED|Overall Study||18||
48423354|NCT02711306|101369673|FG001|STARTED|Overall Study||18||
48423355|NCT02711306|101369672|FG000|COMPLETED|Overall Study||16||
48423356|NCT02711306|101369673|FG001|COMPLETED|Overall Study||16||
48423357|NCT02711306|101369672|FG000|NOT COMPLETED|Overall Study||2||
48423358|NCT02711306|101369673|FG001|NOT COMPLETED|Overall Study||2||
48423359|NCT02390167|101369674|FG000|STARTED|Overall Study||376||
48423360|NCT02390167|101369674|FG000|With Diabetes|Overall Study||333||
48423361|NCT02390167|101369674|FG000|Without Diabetes|Overall Study||43||
48423362|NCT02390167|101369674|FG000|COMPLETED|Overall Study||375||
48423363|NCT02390167|101369674|FG000|NOT COMPLETED|Overall Study||1||
48423364|NCT03550989|101373217|FG000|STARTED|Overall Study||190||
48423365|NCT03550989|101373218|FG001|STARTED|Overall Study||74||
48423366|NCT03550989|101373219|FG002|STARTED|Overall Study||77||
48423367|NCT03550989|101373220|FG003|STARTED|Overall Study||60||
48423368|NCT03550989|101373217|FG000|COMPLETED|Overall Study||188||
48423369|NCT03550989|101373218|FG001|COMPLETED|Overall Study||73||
48423370|NCT03550989|101373219|FG002|COMPLETED|Overall Study||76||
48423371|NCT03550989|101373220|FG003|COMPLETED|Overall Study||60||
48423372|NCT03550989|101373217|FG000|NOT COMPLETED|Overall Study||2||
48423373|NCT03550989|101373218|FG001|NOT COMPLETED|Overall Study||1||
48423374|NCT03550989|101373219|FG002|NOT COMPLETED|Overall Study||1||
48423375|NCT03550989|101373220|FG003|NOT COMPLETED|Overall Study||0||
48423376|NCT04511533|101373221|FG000|STARTED|Treatment||101||
48423377|NCT04511533|101373221|FG000|COMPLETED|Treatment||21||
48423378|NCT04511533|101373221|FG000|NOT COMPLETED|Treatment||80||
48423379|NCT04511533|101373221|FG000|STARTED|Follow-Up||96||
48423380|NCT04511533|101373221|FG000|COMPLETED|Follow-Up||78||
48423381|NCT04511533|101373221|FG000|NOT COMPLETED|Follow-Up||18||
48423382|NCT01512758|101373222|FG000|STARTED|Overall Study||30||
48423383|NCT01512758|101373223|FG001|STARTED|Overall Study||6||
48423384|NCT01512758|101373222|FG000|COMPLETED|Overall Study||30||
48423385|NCT01512758|101373223|FG001|COMPLETED|Overall Study||6||
48423386|NCT01512758|101373222|FG000|NOT COMPLETED|Overall Study||0||
48423387|NCT01512758|101373223|FG001|NOT COMPLETED|Overall Study||0||
48423388|NCT00370994|101373224|FG000|STARTED|Overall Study||60||
48423389|NCT00370994|101373225|FG001|STARTED|Overall Study||60||
48423390|NCT00370994|101373224|FG000|COMPLETED|Overall Study||60||
48423391|NCT00370994|101373225|FG001|COMPLETED|Overall Study||60||
48423392|NCT00370994|101373224|FG000|NOT COMPLETED|Overall Study||0||
48423393|NCT00370994|101373225|FG001|NOT COMPLETED|Overall Study||0||
48423394|NCT03382639|101373226|FG000|STARTED|Overall Study||87||
48423395|NCT03382639|101373227|FG001|STARTED|Overall Study||58||
48423396|NCT03382639|101373228|FG002|STARTED|Overall Study||56||
48423397|NCT03382639|101373229|FG003|STARTED|Overall Study||55||
48423398|NCT03382639|101373226|FG000|COMPLETED|Overall Study||76||
48423399|NCT03382639|101373227|FG001|COMPLETED|Overall Study||53||
48423400|NCT03382639|101373228|FG002|COMPLETED|Overall Study||52||
48423401|NCT03382639|101373229|FG003|COMPLETED|Overall Study||47||
48423402|NCT03382639|101373226|FG000|NOT COMPLETED|Overall Study||11||
48423403|NCT03382639|101373227|FG001|NOT COMPLETED|Overall Study||5||
48423404|NCT03382639|101373228|FG002|NOT COMPLETED|Overall Study||4||
48763768|NCT00762164|102208807|FG001|NOT COMPLETED|Overall Study||2||
48763769|NCT01533207|102208808|FG000|STARTED|Overall Study||20||
48763770|NCT01533207|102208809|FG001|STARTED|Overall Study||18||
48763771|NCT01533207|102208808|FG000|COMPLETED|Overall Study||20||
48763772|NCT01533207|102208809|FG001|COMPLETED|Overall Study||18||
48423405|NCT03382639|101373229|FG003|NOT COMPLETED|Overall Study||8||
48423406|NCT03301272|101373230|FG000|STARTED|First Intervention (30 Days)||7||
48423407|NCT03301272|101373231|FG001|STARTED|First Intervention (30 Days)||9||
48423408|NCT03301272|101373230|FG000|COMPLETED|First Intervention (30 Days)||7||
48423409|NCT03301272|101373231|FG001|COMPLETED|First Intervention (30 Days)||9||
48423410|NCT03301272|101373230|FG000|NOT COMPLETED|First Intervention (30 Days)||0||
48423411|NCT03301272|101373231|FG001|NOT COMPLETED|First Intervention (30 Days)||0||
48423412|NCT03301272|101373230|FG000|STARTED|Washout (90 Days From 1st Intervention)||7||
48423413|NCT03301272|101373231|FG001|STARTED|Washout (90 Days From 1st Intervention)||9||
48423414|NCT03301272|101373230|FG000|COMPLETED|Washout (90 Days From 1st Intervention)||7||
48423415|NCT03301272|101373231|FG001|COMPLETED|Washout (90 Days From 1st Intervention)||9||
48423416|NCT03301272|101373230|FG000|NOT COMPLETED|Washout (90 Days From 1st Intervention)||0||
48423417|NCT03301272|101373231|FG001|NOT COMPLETED|Washout (90 Days From 1st Intervention)||0||
48423418|NCT03301272|101373230|FG000|STARTED|Second Intervention (30 Days)||7||
48423419|NCT03301272|101373231|FG001|STARTED|Second Intervention (30 Days)||9||
48423420|NCT03301272|101373230|FG000|COMPLETED|Second Intervention (30 Days)||7||
48423421|NCT03301272|101373231|FG001|COMPLETED|Second Intervention (30 Days)||9||
48423422|NCT03301272|101373230|FG000|NOT COMPLETED|Second Intervention (30 Days)||0||
48423423|NCT03301272|101373231|FG001|NOT COMPLETED|Second Intervention (30 Days)||0||
48423424|NCT03815006|101373232|FG000|STARTED|Overall Study||78||
48423425|NCT03815006|101373233|FG001|STARTED|Overall Study||78||
48423426|NCT03815006|101373232|FG000|COMPLETED|Overall Study||78||
48423427|NCT03815006|101373233|FG001|COMPLETED|Overall Study||78||
48763773|NCT01533207|102208808|FG000|NOT COMPLETED|Overall Study||0||
48763774|NCT01533207|102208809|FG001|NOT COMPLETED|Overall Study||0||
48763775|NCT01980017|102208810|FG000|STARTED|Overall Study||114||
48763776|NCT01980017|102208811|FG001|STARTED|Overall Study||199||
48763777|NCT01980017|102208810|FG000|COMPLETED|Overall Study||84||
48763778|NCT01980017|102208811|FG001|COMPLETED|Overall Study||177||
48763779|NCT01980017|102208810|FG000|NOT COMPLETED|Overall Study||30||
48763780|NCT01980017|102208811|FG001|NOT COMPLETED|Overall Study||22||
48763781|NCT00771277|102208812|FG000|STARTED|Overall Study||6||
48763782|NCT00771277|102208812|FG000|COMPLETED|Overall Study||6||
48763783|NCT00771277|102208812|FG000|NOT COMPLETED|Overall Study||0||
48763784|NCT01838694|102208813|FG000|STARTED|Overall Study||8||
48763785|NCT01838694|102208814|FG001|STARTED|Overall Study||22||
48763786|NCT01838694|102208813|FG000|COMPLETED|Overall Study||8||
48763787|NCT01838694|102208814|FG001|COMPLETED|Overall Study||21||
48763788|NCT01838694|102208813|FG000|NOT COMPLETED|Overall Study||0||
48763789|NCT01838694|102208814|FG001|NOT COMPLETED|Overall Study||1||
48763790|NCT04456504|102208815|FG000|STARTED|Overall Study||49||
48763791|NCT04456504|102208815|FG000|Number of Participants Who Received First Dose|Overall Study||49||
48763792|NCT04456504|102208815|FG000|Number of Participants Who Had Blood Draw After First Dose|Overall Study||49||
48763793|NCT04456504|102208815|FG000|Number of Participants Who Received Second Dose|Overall Study||48||
48763794|NCT04456504|102208815|FG000|Number of Participants Who Had Blood Draw After Second Dose|Overall Study||47||
48423428|NCT03815006|101373232|FG000|NOT COMPLETED|Overall Study||0||
48423429|NCT03815006|101373233|FG001|NOT COMPLETED|Overall Study||0||
48423430|NCT02911285|101373234|FG000|STARTED|Overall Study||49||
48423431|NCT02911285|101373235|FG001|STARTED|Overall Study||41||
48359553|NCT00477451|101210679|FG003|NOT COMPLETED|Overall Study||0||
48359554|NCT05253807|101210680|FG000|STARTED|Overall Study||3||
48359555|NCT05253807|101210681|FG001|STARTED|Overall Study||5||
48359556|NCT05253807|101210680|FG000|COMPLETED|Overall Study||0||
48359557|NCT05253807|101210681|FG001|COMPLETED|Overall Study||0||
48359558|NCT05253807|101210680|FG000|NOT COMPLETED|Overall Study||3||
48359559|NCT05253807|101210681|FG001|NOT COMPLETED|Overall Study||5||
48359560|NCT00953121|101210682|FG000|STARTED|Overall Study||40||
48359561|NCT00953121|101210683|FG001|STARTED|Overall Study||39||
48359562|NCT00953121|101210684|FG002|STARTED|Overall Study||25||
48359563|NCT00953121|101210682|FG000|COMPLETED|Overall Study||40||
48359564|NCT00953121|101210683|FG001|COMPLETED|Overall Study||39||
48359565|NCT00953121|101210684|FG002|COMPLETED|Overall Study||25||
48359566|NCT00953121|101210682|FG000|NOT COMPLETED|Overall Study||0||
48359567|NCT00953121|101210683|FG001|NOT COMPLETED|Overall Study||0||
48359568|NCT00953121|101210684|FG002|NOT COMPLETED|Overall Study||0||
48359569|NCT02955186|101210685|FG000|STARTED|Overall Study||33||
48359570|NCT02955186|101210686|FG001|STARTED|Overall Study||17||
48359571|NCT02955186|101210685|FG000|COMPLETED|Overall Study||26||
48359572|NCT02955186|101210686|FG001|COMPLETED|Overall Study||15||
48359573|NCT02955186|101210685|FG000|NOT COMPLETED|Overall Study||7||
48359574|NCT02955186|101210686|FG001|NOT COMPLETED|Overall Study||2||
48359575|NCT00893789|101210687|FG000|STARTED|Overall Study||29||
48359576|NCT00893789|101210688|FG001|STARTED|Overall Study||30||
48359577|NCT00893789|101210689|FG002|STARTED|Overall Study||29||
48359578|NCT00893789|101210690|FG003|STARTED|Overall Study||29||
48359579|NCT00893789|101210687|FG000|Safety Analysis Set (SAS)|Overall Study||29||
48359580|NCT00893789|101210688|FG001|Safety Analysis Set (SAS)|Overall Study||30||
48359581|NCT00893789|101210689|FG002|Safety Analysis Set (SAS)|Overall Study||29||
48359582|NCT00893789|101210690|FG003|Safety Analysis Set (SAS)|Overall Study||29||
48359583|NCT00893789|101210687|FG000|Full Analysis Set (FAS)|Overall Study||29||
48359584|NCT00893789|101210688|FG001|Full Analysis Set (FAS)|Overall Study||29||
48359585|NCT00893789|101210689|FG002|Full Analysis Set (FAS)|Overall Study||28||
48359586|NCT00893789|101210690|FG003|Full Analysis Set (FAS)|Overall Study||27||
48359587|NCT00893789|101210687|FG000|COMPLETED|Overall Study||23||
48359588|NCT00893789|101210688|FG001|COMPLETED|Overall Study||26||
48359589|NCT00893789|101210689|FG002|COMPLETED|Overall Study||22||
48359590|NCT00893789|101210690|FG003|COMPLETED|Overall Study||16||
48359591|NCT00893789|101210687|FG000|NOT COMPLETED|Overall Study||6||
48359592|NCT00893789|101210688|FG001|NOT COMPLETED|Overall Study||4||
48359593|NCT00893789|101210689|FG002|NOT COMPLETED|Overall Study||7||
48359594|NCT00893789|101210690|FG003|NOT COMPLETED|Overall Study||13||
48359595|NCT04392011|101210691|FG000|STARTED|Kratom Only||8||
48359596|NCT04392011|101210692|FG001|STARTED|Kratom Only||0||
48359597|NCT04392011|101210691|FG000|COMPLETED|Kratom Only||6||
48359598|NCT04392011|101210692|FG001|COMPLETED|Kratom Only||0||
48359599|NCT04392011|101210691|FG000|NOT COMPLETED|Kratom Only||2||
48359600|NCT04392011|101210692|FG001|NOT COMPLETED|Kratom Only||0||
48359601|NCT04392011|101210691|FG000|STARTED|Washout||6||
48359602|NCT04392011|101210692|FG001|STARTED|Washout||0||
48359603|NCT04392011|101210691|FG000|COMPLETED|Washout||6||
48359604|NCT04392011|101210692|FG001|COMPLETED|Washout||0||
48359605|NCT04392011|101210691|FG000|NOT COMPLETED|Washout||0||
48359606|NCT04392011|101210692|FG001|NOT COMPLETED|Washout||0||
48359607|NCT04392011|101210691|FG000|STARTED|Drug Cocktail Only||6||
48359608|NCT04392011|101210692|FG001|STARTED|Drug Cocktail Only||7||
48359609|NCT04392011|101210691|FG000|COMPLETED|Drug Cocktail Only||6||
48359610|NCT04392011|101210692|FG001|COMPLETED|Drug Cocktail Only||7||
48359611|NCT04392011|101210691|FG000|NOT COMPLETED|Drug Cocktail Only||0||
48359612|NCT04392011|101210692|FG001|NOT COMPLETED|Drug Cocktail Only||0||
48359613|NCT04392011|101210691|FG000|STARTED|Washout||6||
48359614|NCT04392011|101210692|FG001|STARTED|Washout||7||
48359615|NCT04392011|101210691|FG000|COMPLETED|Washout||6||
48359616|NCT04392011|101210692|FG001|COMPLETED|Washout||6||
48359617|NCT04392011|101210691|FG000|NOT COMPLETED|Washout||0||
48359618|NCT04392011|101210692|FG001|NOT COMPLETED|Washout||1||
48359619|NCT04392011|101210691|FG000|STARTED|Kratom + Drug Cocktail||6||
48359620|NCT04392011|101210692|FG001|STARTED|Kratom + Drug Cocktail||6||
48359621|NCT04392011|101210691|FG000|COMPLETED|Kratom + Drug Cocktail||6||
48359622|NCT04392011|101210692|FG001|COMPLETED|Kratom + Drug Cocktail||6||
48359623|NCT04392011|101210691|FG000|NOT COMPLETED|Kratom + Drug Cocktail||0||
48359624|NCT04392011|101210692|FG001|NOT COMPLETED|Kratom + Drug Cocktail||0||
48359625|NCT01566838|101210693|FG000|STARTED|Overall Study||41||
48359626|NCT01566838|101210694|FG001|STARTED|Overall Study||42||
48359627|NCT01566838|101210693|FG000|COMPLETED|Overall Study||38||
48359628|NCT01566838|101210694|FG001|COMPLETED|Overall Study||42||
48359629|NCT01566838|101210693|FG000|NOT COMPLETED|Overall Study||3||
48359630|NCT01566838|101210694|FG001|NOT COMPLETED|Overall Study||0||
48359631|NCT04442581|101210695|FG000|STARTED|Stage 1||2||
48359632|NCT04442581|101210695|FG000|COMPLETED|Stage 1||2||
48359633|NCT04442581|101210695|FG000|NOT COMPLETED|Stage 1||0||
48359634|NCT04442581|101210695|FG000|STARTED|Stage 2||0||
48359635|NCT04442581|101210695|FG000|COMPLETED|Stage 2||0||
48359636|NCT04442581|101210695|FG000|NOT COMPLETED|Stage 2||0||
48359637|NCT03334214|101210696|FG000|STARTED|Overall Study||15||
48359638|NCT03334214|101210697|FG001|STARTED|Overall Study||29||
48423432|NCT02911285|101373234|FG000|COMPLETED|Overall Study||40||
48423433|NCT02911285|101373235|FG001|COMPLETED|Overall Study||36||
48423434|NCT02911285|101373234|FG000|NOT COMPLETED|Overall Study||9||
48423435|NCT02911285|101373235|FG001|NOT COMPLETED|Overall Study||5||
48423436|NCT02924129|101373236|FG000|STARTED|Overall Study||67||
48423437|NCT02924129|101373237|FG001|STARTED|Overall Study||67||
48423438|NCT02924129|101373236|FG000|COMPLETED|Overall Study||62||
48423439|NCT02924129|101373237|FG001|COMPLETED|Overall Study||63||
48423440|NCT02924129|101373236|FG000|NOT COMPLETED|Overall Study||5||
48763795|NCT04456504|102208815|FG000|COMPLETED|Overall Study||47||
48763796|NCT04456504|102208815|FG000|NOT COMPLETED|Overall Study||2||
48763797|NCT02063724|102208816|FG000|STARTED|Overall Study||15||
48763798|NCT02063724|102208816|FG000|COMPLETED|Overall Study||14||
48763799|NCT02063724|102208816|FG000|NOT COMPLETED|Overall Study||1||
48763800|NCT00904982|102211807|FG000|STARTED|Overall Study||68||
48763801|NCT00904982|102211808|FG001|STARTED|Overall Study||67||
48763802|NCT00904982|102211809|FG002|STARTED|Overall Study||67||
48763803|NCT00904982|102211810|FG003|STARTED|Overall Study||68||
48423441|NCT02924129|101373237|FG001|NOT COMPLETED|Overall Study||4||
48423442|NCT02135848|101373238|FG000|STARTED|Overall Study||26||
48423443|NCT02135848|101373239|FG001|STARTED|Overall Study||20||
48423444|NCT02135848|101373238|FG000|COMPLETED|Overall Study||23||
48423445|NCT02135848|101373239|FG001|COMPLETED|Overall Study||19||
48423446|NCT02135848|101373238|FG000|NOT COMPLETED|Overall Study||3||
48423447|NCT02135848|101373239|FG001|NOT COMPLETED|Overall Study||1||
48423448|NCT01004861|101373240|FG000|STARTED|Overall Study||3||
48423449|NCT01004861|101373241|FG001|STARTED|Overall Study||6||
48423450|NCT01004861|101373242|FG002|STARTED|Overall Study||6||
48423451|NCT01004861|101373243|FG003|STARTED|Overall Study||6||
48423452|NCT01004861|101373244|FG004|STARTED|Overall Study||7||
48423453|NCT01004861|101373245|FG005|STARTED|Overall Study||6||
48423454|NCT01004861|101373246|FG006|STARTED|Overall Study||7||
48423455|NCT01004861|101373247|FG007|STARTED|Overall Study||4||
48423456|NCT01004861|101373248|FG008|STARTED|Overall Study||39||
48423457|NCT01004861|101373249|FG009|STARTED|Overall Study||11||
48423458|NCT01004861|101373250|FG010|STARTED|Overall Study||9||
48423459|NCT01004861|101373251|FG011|STARTED|Overall Study||8||
48423460|NCT01004861|101373252|FG012|STARTED|Overall Study||20||
48423461|NCT01004861|101373240|FG000|COMPLETED|Overall Study||0||
48423462|NCT01004861|101373241|FG001|COMPLETED|Overall Study||0||
48423463|NCT01004861|101373242|FG002|COMPLETED|Overall Study||0||
48423464|NCT01004861|101373243|FG003|COMPLETED|Overall Study||0||
48423465|NCT01004861|101373244|FG004|COMPLETED|Overall Study||0||
48423466|NCT01004861|101373245|FG005|COMPLETED|Overall Study||0||
48423467|NCT01004861|101373246|FG006|COMPLETED|Overall Study||0||
48423468|NCT01004861|101373247|FG007|COMPLETED|Overall Study||0||
48423469|NCT01004861|101373248|FG008|COMPLETED|Overall Study||0||
48423470|NCT01004861|101373249|FG009|COMPLETED|Overall Study||0||
48423471|NCT01004861|101373250|FG010|COMPLETED|Overall Study||0||
48423472|NCT01004861|101373251|FG011|COMPLETED|Overall Study||0||
48423473|NCT01004861|101373252|FG012|COMPLETED|Overall Study||0||
48763804|NCT00904982|102211807|FG000|COMPLETED|Overall Study||66||
48763805|NCT00904982|102211808|FG001|COMPLETED|Overall Study||67||
48763806|NCT00904982|102211809|FG002|COMPLETED|Overall Study||67||
48763807|NCT00904982|102211810|FG003|COMPLETED|Overall Study||68||
48763808|NCT00904982|102211807|FG000|NOT COMPLETED|Overall Study||2||
48763809|NCT00904982|102211808|FG001|NOT COMPLETED|Overall Study||0||
48763810|NCT00904982|102211809|FG002|NOT COMPLETED|Overall Study||0||
48763811|NCT00904982|102211810|FG003|NOT COMPLETED|Overall Study||0||
48763812|NCT00665652|102211811|FG000|STARTED|Overall Study||8||
48763813|NCT00665652|102211811|FG000|COMPLETED|Overall Study||2||
48763814|NCT00665652|102211811|FG000|NOT COMPLETED|Overall Study||6||
48423474|NCT01004861|101373240|FG000|NOT COMPLETED|Overall Study||3||
48423475|NCT01004861|101373241|FG001|NOT COMPLETED|Overall Study||6||
48423476|NCT01004861|101373242|FG002|NOT COMPLETED|Overall Study||6||
48423477|NCT01004861|101373243|FG003|NOT COMPLETED|Overall Study||6||
48423478|NCT01004861|101373244|FG004|NOT COMPLETED|Overall Study||7||
48423479|NCT01004861|101373245|FG005|NOT COMPLETED|Overall Study||6||
48423480|NCT01004861|101373246|FG006|NOT COMPLETED|Overall Study||7||
48423481|NCT01004861|101373247|FG007|NOT COMPLETED|Overall Study||4||
48763815|NCT02993107|102211812|FG000|STARTED|Overall Study||113||
48763816|NCT02993107|102211813|FG001|STARTED|Overall Study||120||
48763817|NCT02993107|102211814|FG002|STARTED|Overall Study||50||
48763818|NCT02993107|102211815|FG003|STARTED|Overall Study||35||
48423482|NCT01004861|101373248|FG008|NOT COMPLETED|Overall Study||39||
48423483|NCT01004861|101373249|FG009|NOT COMPLETED|Overall Study||11||
48423484|NCT01004861|101373250|FG010|NOT COMPLETED|Overall Study||9||
48423485|NCT01004861|101373251|FG011|NOT COMPLETED|Overall Study||8||
48423486|NCT01004861|101373252|FG012|NOT COMPLETED|Overall Study||20||
48423487|NCT02569996|101373253|FG000|STARTED|Overall Study||124||
48423488|NCT02569996|101373253|FG000|COMPLETED|Overall Study||69||
48423489|NCT02569996|101373253|FG000|NOT COMPLETED|Overall Study||55||
48423490|NCT00808665|101373254|FG000|STARTED|Overall Study||31||
48423491|NCT00808665|101373255|FG001|STARTED|Overall Study||32||
48763819|NCT02993107|102211816|FG004|STARTED|Overall Study||34||
48763820|NCT02993107|102211817|FG005|STARTED|Overall Study||36||
48423492|NCT00808665|101373254|FG000|Medication Started|Overall Study||30||
48423493|NCT00808665|101373255|FG001|Medication Started|Overall Study||32||
48423494|NCT00808665|101373254|FG000|Completed Intra-operative Dose|Overall Study||26||
48423495|NCT00808665|101373255|FG001|Completed Intra-operative Dose|Overall Study||32||
48423496|NCT00808665|101373254|FG000|Completed Post Operative Doses|Overall Study||25||
48423497|NCT00808665|101373255|FG001|Completed Post Operative Doses|Overall Study||29||
48423498|NCT00808665|101373254|FG000|COMPLETED|Overall Study||25||
48423499|NCT00808665|101373255|FG001|COMPLETED|Overall Study||29||
48423500|NCT00808665|101373254|FG000|NOT COMPLETED|Overall Study||6||
48423501|NCT00808665|101373255|FG001|NOT COMPLETED|Overall Study||3||
48423502|NCT04334876|101373256|FG000|STARTED|Overall Study||571||
48423503|NCT04334876|101373256|FG000|COMPLETED|Overall Study||500||
48423504|NCT04334876|101373256|FG000|NOT COMPLETED|Overall Study||71||
48423505|NCT01294319|101373257|FG000|STARTED|Overall Study||4||
48423506|NCT01294319|101373258|FG001|STARTED|Overall Study||6||
48423507|NCT01294319|101373259|FG002|STARTED|Overall Study||5||
48423508|NCT01294319|101373260|FG003|STARTED|Overall Study||5||
48423509|NCT01294319|101373261|FG004|STARTED|Overall Study||5||
48423510|NCT01294319|101373262|FG005|STARTED|Overall Study||4||
48423511|NCT01294319|101373263|FG006|STARTED|Overall Study||5||
48423512|NCT01294319|101373264|FG007|STARTED|Overall Study||5||
48423513|NCT01294319|101373257|FG000|COMPLETED|Overall Study||4||
48423514|NCT01294319|101373258|FG001|COMPLETED|Overall Study||6||
48423515|NCT01294319|101373259|FG002|COMPLETED|Overall Study||5||
48423516|NCT01294319|101373260|FG003|COMPLETED|Overall Study||5||
48423517|NCT01294319|101373261|FG004|COMPLETED|Overall Study||5||
48423518|NCT01294319|101373262|FG005|COMPLETED|Overall Study||4||
48423519|NCT01294319|101373263|FG006|COMPLETED|Overall Study||5||
48423520|NCT01294319|101373264|FG007|COMPLETED|Overall Study||5||
48423521|NCT01294319|101373257|FG000|NOT COMPLETED|Overall Study||0||
48423522|NCT01294319|101373258|FG001|NOT COMPLETED|Overall Study||0||
48423523|NCT01294319|101373259|FG002|NOT COMPLETED|Overall Study||0||
48423524|NCT01294319|101373260|FG003|NOT COMPLETED|Overall Study||0||
48423525|NCT01294319|101373261|FG004|NOT COMPLETED|Overall Study||0||
48423526|NCT01294319|101373262|FG005|NOT COMPLETED|Overall Study||0||
48423527|NCT01294319|101373263|FG006|NOT COMPLETED|Overall Study||0||
48423528|NCT01294319|101373264|FG007|NOT COMPLETED|Overall Study||0||
48423529|NCT02718131|101373265|FG000|STARTED|Overall Study||5||
48423530|NCT02718131|101373266|FG001|STARTED|Overall Study||0||
48423531|NCT02718131|101373265|FG000|Completed 12 Months|Overall Study||2||
48423532|NCT02718131|101373266|FG001|Completed 12 Months|Overall Study||0||
48423533|NCT02718131|101373265|FG000|COMPLETED|Overall Study||2||
48423534|NCT02718131|101373266|FG001|COMPLETED|Overall Study||0||
48423535|NCT02718131|101373265|FG000|NOT COMPLETED|Overall Study||3||
48423536|NCT02718131|101373266|FG001|NOT COMPLETED|Overall Study||0||
48423537|NCT00617942|101373267|FG000|STARTED|Overall Study||37||
48423538|NCT00617942|101373268|FG001|STARTED|Overall Study||23||
48423539|NCT00617942|101373267|FG000|COMPLETED|Overall Study||29||
48423540|NCT00617942|101373268|FG001|COMPLETED|Overall Study||19||
48423541|NCT00617942|101373267|FG000|NOT COMPLETED|Overall Study||8||
48423542|NCT00617942|101373268|FG001|NOT COMPLETED|Overall Study||4||
48423543|NCT04246996|101373269|FG000|STARTED|Overall Study||185|Randomized to study arm|
48423544|NCT04246996|101373270|FG001|STARTED|Overall Study||185|Randomized to study arm|
48423545|NCT04246996|101373269|FG000|COMPLETED|Overall Study||183|Analyzed|
48423546|NCT04246996|101373270|FG001|COMPLETED|Overall Study||180|Analyzed|
48423547|NCT04246996|101373269|FG000|NOT COMPLETED|Overall Study||2||
48423548|NCT04246996|101373270|FG001|NOT COMPLETED|Overall Study||5||
48423549|NCT02702115|101373271|FG000|STARTED|Overall Study||1||
48423550|NCT02702115|101373272|FG001|STARTED|Overall Study||2||
48423551|NCT02702115|101373273|FG002|STARTED|Overall Study||0||
48423552|NCT02702115|101373271|FG000|COMPLETED|Overall Study||1||
48423553|NCT02702115|101373272|FG001|COMPLETED|Overall Study||2||
48423554|NCT02702115|101373273|FG002|COMPLETED|Overall Study||0||
48423555|NCT02702115|101373271|FG000|NOT COMPLETED|Overall Study||0||
48423556|NCT02702115|101373272|FG001|NOT COMPLETED|Overall Study||0||
48423557|NCT02702115|101373273|FG002|NOT COMPLETED|Overall Study||0||
48423558|NCT02207413|101373274|FG000|STARTED|Overall Study||60||
48423559|NCT02207413|101373275|FG001|STARTED|Overall Study||60||
48423560|NCT02207413|101373276|FG002|STARTED|Overall Study||410||
48423561|NCT02207413|101373277|FG003|STARTED|Overall Study||411||
48423562|NCT02207413|101373278|FG004|STARTED|Overall Study||466||
48423563|NCT02207413|101373279|FG005|STARTED|Overall Study||474||
48423564|NCT02207413|101373274|FG000|COMPLETED|Overall Study||59||
48423565|NCT02207413|101373275|FG001|COMPLETED|Overall Study||60||
48423566|NCT02207413|101373276|FG002|COMPLETED|Overall Study||410||
48423567|NCT02207413|101373277|FG003|COMPLETED|Overall Study||410||
48423568|NCT02207413|101373278|FG004|COMPLETED|Overall Study||459||
48423569|NCT02207413|101373279|FG005|COMPLETED|Overall Study||461||
48423570|NCT02207413|101373274|FG000|NOT COMPLETED|Overall Study||1||
48423571|NCT02207413|101373275|FG001|NOT COMPLETED|Overall Study||0||
48423572|NCT02207413|101373276|FG002|NOT COMPLETED|Overall Study||0||
48423573|NCT02207413|101373277|FG003|NOT COMPLETED|Overall Study||1||
48423574|NCT02207413|101373278|FG004|NOT COMPLETED|Overall Study||7||
48423575|NCT02207413|101373279|FG005|NOT COMPLETED|Overall Study||13||
48423576|NCT00422942|101373280|FG000|STARTED|Overall Study||3||
48423577|NCT00422942|101373280|FG000|COMPLETED|Overall Study||0||
48423578|NCT00422942|101373280|FG000|NOT COMPLETED|Overall Study||3||
48423579|NCT02276274|101373281|FG000|STARTED|First Intervention Period||6||
48423580|NCT02276274|101373282|FG001|STARTED|First Intervention Period||6||
48423581|NCT02276274|101373281|FG000|COMPLETED|First Intervention Period||6||
48423582|NCT02276274|101373282|FG001|COMPLETED|First Intervention Period||6||
48423583|NCT02276274|101373281|FG000|NOT COMPLETED|First Intervention Period||0||
48423584|NCT02276274|101373282|FG001|NOT COMPLETED|First Intervention Period||0||
48423585|NCT02276274|101373281|FG000|STARTED|Washout Period (at Least 15 Days)||6||
48423586|NCT02276274|101373282|FG001|STARTED|Washout Period (at Least 15 Days)||6||
48423587|NCT02276274|101373281|FG000|COMPLETED|Washout Period (at Least 15 Days)||6||
48423588|NCT02276274|101373282|FG001|COMPLETED|Washout Period (at Least 15 Days)||6||
48423589|NCT02276274|101373281|FG000|NOT COMPLETED|Washout Period (at Least 15 Days)||0||
48423590|NCT02276274|101373282|FG001|NOT COMPLETED|Washout Period (at Least 15 Days)||0||
48423591|NCT02276274|101373281|FG000|STARTED|Second Intervention Period||6||
48423592|NCT02276274|101373282|FG001|STARTED|Second Intervention Period||6||
48423593|NCT02276274|101373281|FG000|COMPLETED|Second Intervention Period||6||
48423594|NCT02276274|101373282|FG001|COMPLETED|Second Intervention Period||6||
48423595|NCT02276274|101373281|FG000|NOT COMPLETED|Second Intervention Period||0||
48423596|NCT02276274|101373282|FG001|NOT COMPLETED|Second Intervention Period||0||
48423597|NCT02438787|101373283|FG000|STARTED|Overall Study||104||
48423598|NCT02438787|101373284|FG001|STARTED|Overall Study||106||
48423599|NCT02438787|101373285|FG002|STARTED|Overall Study||105||
48423600|NCT02438787|101373283|FG000|Early Escape at Week 16|Overall Study||21||
48423601|NCT02438787|101373284|FG001|Early Escape at Week 16|Overall Study||21||
48423602|NCT02438787|101373285|FG002|Early Escape at Week 16|Overall Study||20||
48423603|NCT02438787|101373283|FG000|Cross Over at Week 24|Overall Study||43||
48423604|NCT02438787|101373284|FG001|Cross Over at Week 24|Overall Study||0||
48423605|NCT02438787|101373285|FG002|Cross Over at Week 24|Overall Study||0||
48423606|NCT02438787|101373283|FG000|COMPLETED|Overall Study||23||
48423607|NCT02438787|101373284|FG001|COMPLETED|Overall Study||23||
48423608|NCT02438787|101373285|FG002|COMPLETED|Overall Study||22||
48423609|NCT02438787|101373283|FG000|NOT COMPLETED|Overall Study||81||
48423610|NCT02438787|101373284|FG001|NOT COMPLETED|Overall Study||83||
48423611|NCT02438787|101373285|FG002|NOT COMPLETED|Overall Study||83||
48423612|NCT01922336|101373286|FG000|STARTED|Overall Study||53||
48423613|NCT01922336|101373287|FG001|STARTED|Overall Study||53||
48423614|NCT01922336|101373288|FG002|STARTED|Overall Study||53||
48423615|NCT01922336|101373286|FG000|COMPLETED|Overall Study||53||
48423616|NCT01922336|101373287|FG001|COMPLETED|Overall Study||53||
48423617|NCT01922336|101373288|FG002|COMPLETED|Overall Study||53||
48423618|NCT01922336|101373286|FG000|NOT COMPLETED|Overall Study||0||
48423619|NCT01922336|101373287|FG001|NOT COMPLETED|Overall Study||0||
48423620|NCT01922336|101373288|FG002|NOT COMPLETED|Overall Study||0||
48423621|NCT02033369|101373289|FG000|STARTED|Overall Study||26||
48423622|NCT02033369|101373290|FG001|STARTED|Overall Study||26||
48423623|NCT02033369|101373289|FG000|COMPLETED|Overall Study||21||
48423624|NCT02033369|101373290|FG001|COMPLETED|Overall Study||21||
48423625|NCT02033369|101373289|FG000|NOT COMPLETED|Overall Study||5||
48423626|NCT02033369|101373290|FG001|NOT COMPLETED|Overall Study||5||
48423627|NCT01200758|101373291|FG000|STARTED|Stage I||64||
48423628|NCT01200758|101373292|FG001|STARTED|Stage I||63||
48423629|NCT01200758|101373293|FG002|STARTED|Stage I||0||
48423630|NCT01200758|101373294|FG003|STARTED|Stage I||0||
48423631|NCT01200758|101373291|FG000|COMPLETED|Stage I||46||
48423632|NCT01200758|101373292|FG001|COMPLETED|Stage I||46||
48423633|NCT01200758|101373293|FG002|COMPLETED|Stage I||0||
48423634|NCT01200758|101373294|FG003|COMPLETED|Stage I||0||
48423635|NCT01200758|101373291|FG000|NOT COMPLETED|Stage I||18||
48423636|NCT01200758|101373292|FG001|NOT COMPLETED|Stage I||17||
48423637|NCT01200758|101373293|FG002|NOT COMPLETED|Stage I||0||
48423638|NCT01200758|101373294|FG003|NOT COMPLETED|Stage I||0||
48423639|NCT01200758|101373291|FG000|STARTED|Stage 2||0||
48423640|NCT01200758|101373292|FG001|STARTED|Stage 2||0||
48423641|NCT01200758|101373293|FG002|STARTED|Stage 2||141||
48423642|NCT01200758|101373294|FG003|STARTED|Stage 2||142||
48423643|NCT01200758|101373291|FG000|COMPLETED|Stage 2||0||
48423644|NCT01200758|101373292|FG001|COMPLETED|Stage 2||0||
48423645|NCT01200758|101373293|FG002|COMPLETED|Stage 2||100||
48423646|NCT01200758|101373294|FG003|COMPLETED|Stage 2||92||
48423647|NCT01200758|101373291|FG000|NOT COMPLETED|Stage 2||0||
48423648|NCT01200758|101373292|FG001|NOT COMPLETED|Stage 2||0||
48423649|NCT01200758|101373293|FG002|NOT COMPLETED|Stage 2||41||
48423650|NCT01200758|101373294|FG003|NOT COMPLETED|Stage 2||50||
48423651|NCT03852901|101373295|FG000|STARTED|Overall Study||21||
48423652|NCT03852901|101373295|FG000|COMPLETED|Overall Study||20||
48423653|NCT03852901|101373295|FG000|NOT COMPLETED|Overall Study||1||
48423654|NCT01258738|101373296|FG000|STARTED|Double-blind Period||111||
48423655|NCT01258738|101373297|FG001|STARTED|Double-blind Period||114||
48423656|NCT01258738|101373296|FG000|Treated|Double-blind Period||111||
48423657|NCT01258738|101373297|FG001|Treated|Double-blind Period||113||
48423658|NCT01258738|101373296|FG000|COMPLETED|Double-blind Period||102||
48423659|NCT01258738|101373297|FG001|COMPLETED|Double-blind Period||107||
48423660|NCT01258738|101373296|FG000|NOT COMPLETED|Double-blind Period||9||
48423661|NCT01258738|101373297|FG001|NOT COMPLETED|Double-blind Period||7||
48423662|NCT01258738|101373296|FG000|STARTED|Open-label Period||102||
48423663|NCT01258738|101373297|FG001|STARTED|Open-label Period||106||
48423664|NCT01258738|101373296|FG000|COMPLETED|Open-label Period||85||
48423665|NCT01258738|101373297|FG001|COMPLETED|Open-label Period||85||
48423666|NCT01258738|101373296|FG000|NOT COMPLETED|Open-label Period||17||
48423667|NCT01258738|101373297|FG001|NOT COMPLETED|Open-label Period||21||
48423668|NCT04495166|101373298|FG000|STARTED|Overall Study||37||
48423669|NCT04495166|101373299|FG001|STARTED|Overall Study||44||
48423670|NCT04495166|101373298|FG000|COMPLETED|Overall Study||30||
48423671|NCT04495166|101373299|FG001|COMPLETED|Overall Study||41||
48423672|NCT04495166|101373298|FG000|NOT COMPLETED|Overall Study||7||
48423673|NCT04495166|101373299|FG001|NOT COMPLETED|Overall Study||3||
48423674|NCT02062385|101373300|FG000|STARTED|Overall Study||1620||
48423675|NCT02062385|101373301|FG001|STARTED|Overall Study||1620||
48423676|NCT02062385|101373302|FG002|STARTED|Overall Study||400||
48423677|NCT02062385|101373303|FG003|STARTED|Overall Study||400||
48423678|NCT02062385|101373300|FG000|Received Vaccination 1|Overall Study||1618||
48423679|NCT02062385|101373301|FG001|Received Vaccination 1|Overall Study||1619||
48423680|NCT02062385|101373302|FG002|Received Vaccination 1|Overall Study||400||
48423681|NCT02062385|101373303|FG003|Received Vaccination 1|Overall Study||400||
48423682|NCT02062385|101373300|FG000|Received Vaccination 2|Overall Study||1554||
48423683|NCT02062385|101373301|FG001|Received Vaccination 2|Overall Study||1566||
48423684|NCT02062385|101373302|FG002|Received Vaccination 2|Overall Study||392||
48423685|NCT02062385|101373303|FG003|Received Vaccination 2|Overall Study||393||
48423686|NCT02062385|101373300|FG000|Received Vaccination 3|Overall Study||1543||
48423687|NCT02062385|101373301|FG001|Received Vaccination 3|Overall Study||1554||
48423688|NCT02062385|101373302|FG002|Received Vaccination 3|Overall Study||389||
48423689|NCT02062385|101373303|FG003|Received Vaccination 3|Overall Study||392||
48423690|NCT02062385|101373300|FG000|COMPLETED|Overall Study||1542||
48423691|NCT02062385|101373301|FG001|COMPLETED|Overall Study||1555||
48423692|NCT02062385|101373302|FG002|COMPLETED|Overall Study||388||
48423693|NCT02062385|101373303|FG003|COMPLETED|Overall Study||391||
48423694|NCT02062385|101373300|FG000|NOT COMPLETED|Overall Study||78||
48423695|NCT02062385|101373301|FG001|NOT COMPLETED|Overall Study||65||
48423696|NCT02062385|101373302|FG002|NOT COMPLETED|Overall Study||12||
48423697|NCT02062385|101373303|FG003|NOT COMPLETED|Overall Study||9||
48423698|NCT00310440|101373304|FG000|STARTED|Overall Study||165||
48423699|NCT00310440|101373305|FG001|STARTED|Overall Study||154||
48423700|NCT00310440|101373304|FG000|COMPLETED|Overall Study||139||
48423701|NCT00310440|101373305|FG001|COMPLETED|Overall Study||141||
48423702|NCT00310440|101373304|FG000|NOT COMPLETED|Overall Study||26||
48423703|NCT00310440|101373305|FG001|NOT COMPLETED|Overall Study||13||
48423704|NCT00489216|101373306|FG000|STARTED|Overall Study||2||
48423705|NCT00489216|101373306|FG000|COMPLETED|Overall Study||1||
48423706|NCT00489216|101373306|FG000|NOT COMPLETED|Overall Study||1||
48423707|NCT03724552|101373307|FG000|STARTED|Overall Study||0||
48423708|NCT03724552|101373308|FG001|STARTED|Overall Study||12||
48423709|NCT03724552|101373307|FG000|COMPLETED|Overall Study||0||
48423710|NCT03724552|101373308|FG001|COMPLETED|Overall Study||10||
48423711|NCT03724552|101373307|FG000|NOT COMPLETED|Overall Study||0||
48423712|NCT03724552|101373308|FG001|NOT COMPLETED|Overall Study||2||
48423713|NCT01874288|101373309|FG000|STARTED|Overall Study||3||
48423714|NCT01874288|101373310|FG001|STARTED|Overall Study||3||
48423715|NCT01874288|101373311|FG002|STARTED|Overall Study||9||
48423716|NCT01874288|101373312|FG003|STARTED|Overall Study||7||
48423717|NCT01874288|101373313|FG004|STARTED|Overall Study||2||
48423718|NCT01874288|101373309|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
48423719|NCT01874288|101373310|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3||
48423720|NCT01874288|101373311|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9||
48423721|NCT01874288|101373312|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7||
48423722|NCT01874288|101373313|FG004|Received at Least 1 Dose of Study Drug|Overall Study||2||
48423723|NCT01874288|101373309|FG000|COMPLETED|Overall Study||0||
48763821|NCT02993107|102211812|FG000|Adverse Event|Overall Study||12||
48423724|NCT01874288|101373310|FG001|COMPLETED|Overall Study||3||
48423725|NCT01874288|101373311|FG002|COMPLETED|Overall Study||4||
48423726|NCT01874288|101373312|FG003|COMPLETED|Overall Study||0||
48423727|NCT01874288|101373313|FG004|COMPLETED|Overall Study||0||
48423728|NCT01874288|101373309|FG000|NOT COMPLETED|Overall Study||3||
48423729|NCT01874288|101373310|FG001|NOT COMPLETED|Overall Study||0||
48423730|NCT01874288|101373311|FG002|NOT COMPLETED|Overall Study||5||
48423731|NCT01874288|101373312|FG003|NOT COMPLETED|Overall Study||7||
48423732|NCT01874288|101373313|FG004|NOT COMPLETED|Overall Study||2||
48423733|NCT00265109|101373314|FG000|STARTED|Overall Study||17||
48423734|NCT00265109|101373314|FG000|COMPLETED|Overall Study||11||
48423735|NCT00265109|101373314|FG000|NOT COMPLETED|Overall Study||6||
48423736|NCT00689728|101373315|FG000|STARTED|Double-Blind Treatment||35||
48423737|NCT00689728|101373316|FG001|STARTED|Double-Blind Treatment||30||
48423738|NCT00689728|101373317|FG002|STARTED|Double-Blind Treatment||35||
48423739|NCT00689728|101373315|FG000|COMPLETED|Double-Blind Treatment||31||
48423740|NCT00689728|101373316|FG001|COMPLETED|Double-Blind Treatment||26||
48423741|NCT00689728|101373317|FG002|COMPLETED|Double-Blind Treatment||30||
48423742|NCT00689728|101373315|FG000|NOT COMPLETED|Double-Blind Treatment||4||
48423743|NCT00689728|101373316|FG001|NOT COMPLETED|Double-Blind Treatment||4||
48423744|NCT00689728|101373317|FG002|NOT COMPLETED|Double-Blind Treatment||5||
48423745|NCT00689728|101373315|FG000|STARTED|Rescue||31||
48423746|NCT00689728|101373316|FG001|STARTED|Rescue||26||
48423747|NCT00689728|101373317|FG002|STARTED|Rescue||30||
48423748|NCT00689728|101373315|FG000|COMPLETED|Rescue||30||
48423749|NCT00689728|101373316|FG001|COMPLETED|Rescue||24||
48423750|NCT00689728|101373317|FG002|COMPLETED|Rescue||29||
48423751|NCT00689728|101373315|FG000|NOT COMPLETED|Rescue||1||
48423752|NCT00689728|101373316|FG001|NOT COMPLETED|Rescue||2||
48423753|NCT00689728|101373317|FG002|NOT COMPLETED|Rescue||1||
48423754|NCT00689728|101373315|FG000|STARTED|Optional Follow-Up||9||
48423755|NCT00689728|101373316|FG001|STARTED|Optional Follow-Up||11||
48423756|NCT00689728|101373317|FG002|STARTED|Optional Follow-Up||10||
48423757|NCT00689728|101373315|FG000|COMPLETED|Optional Follow-Up||6||
48423758|NCT00689728|101373316|FG001|COMPLETED|Optional Follow-Up||5||
48423759|NCT00689728|101373317|FG002|COMPLETED|Optional Follow-Up||4||
48423760|NCT00689728|101373315|FG000|NOT COMPLETED|Optional Follow-Up||3||
48423761|NCT00689728|101373316|FG001|NOT COMPLETED|Optional Follow-Up||6||
48423762|NCT00689728|101373317|FG002|NOT COMPLETED|Optional Follow-Up||6||
48423763|NCT02730234|101373318|FG000|STARTED|Overall Study||60||
48423764|NCT02730234|101373318|FG000|COMPLETED|Overall Study||52||
48423765|NCT02730234|101373318|FG000|NOT COMPLETED|Overall Study||8||
48423766|NCT00182793|101373319|FG000|STARTED|Overall Study||32||
48423767|NCT00182793|101373319|FG000|COMPLETED|Overall Study||32||
48423768|NCT00182793|101373319|FG000|NOT COMPLETED|Overall Study||0||
48423769|NCT01967134|101373320|FG000|STARTED|Overall Study||8||
48423770|NCT01967134|101373321|FG001|STARTED|Overall Study||8||
48423771|NCT01967134|101373322|FG002|STARTED|Overall Study||9||
48423772|NCT01967134|101373320|FG000|COMPLETED|Overall Study||8||
48423773|NCT01967134|101373321|FG001|COMPLETED|Overall Study||7||
48423774|NCT01967134|101373322|FG002|COMPLETED|Overall Study||9||
48423775|NCT01967134|101373320|FG000|NOT COMPLETED|Overall Study||0||
48423776|NCT01967134|101373321|FG001|NOT COMPLETED|Overall Study||1||
48423777|NCT01967134|101373322|FG002|NOT COMPLETED|Overall Study||0||
48423778|NCT05489146|101373323|FG000|STARTED|Overall Study||8||
48423779|NCT05489146|101373324|FG001|STARTED|Overall Study||6||
48423780|NCT05489146|101373323|FG000|COMPLETED|Overall Study||8||
48423781|NCT05489146|101373324|FG001|COMPLETED|Overall Study||6||
48423782|NCT05489146|101373323|FG000|NOT COMPLETED|Overall Study||0||
48423783|NCT05489146|101373324|FG001|NOT COMPLETED|Overall Study||0||
48423784|NCT04794491|101373325|FG000|STARTED|Overall Study||62||
48423785|NCT04794491|101373325|FG000|Baseline Period|Overall Study||62||
48423786|NCT04794491|101373325|FG000|Intervention (XYWAV) Period|Overall Study||60||
48423787|NCT04794491|101373325|FG000|Safety Follow-Up Period|Overall Study||59||
48423788|NCT04794491|101373325|FG000|COMPLETED|Overall Study||54||
48423789|NCT04794491|101373325|FG000|NOT COMPLETED|Overall Study||8||
48423790|NCT05604781|101373326|FG000|STARTED|Overall Study||41||
48423791|NCT05604781|101373326|FG000|COMPLETED|Overall Study||37||
48423792|NCT05604781|101373326|FG000|NOT COMPLETED|Overall Study||4||
48423793|NCT00113321|101373327|FG000|STARTED|Overall Study||16||
48423794|NCT00113321|101373327|FG000|COMPLETED|Overall Study||16||
48423795|NCT00113321|101373327|FG000|NOT COMPLETED|Overall Study||0||
48423796|NCT03672006|101373328|FG000|STARTED|Overall Study||10||
48423797|NCT03672006|101373329|FG001|STARTED|Overall Study||10||
48423798|NCT03672006|101373328|FG000|COMPLETED|Overall Study||10||
48423799|NCT03672006|101373329|FG001|COMPLETED|Overall Study||9||
48423800|NCT03672006|101373328|FG000|NOT COMPLETED|Overall Study||0||
48423801|NCT03672006|101373329|FG001|NOT COMPLETED|Overall Study||1||
48423802|NCT02146274|101373330|FG000|STARTED|Overall Study||1877||
48423803|NCT02146274|101373330|FG000|COMPLETED|Overall Study||1804||
48423804|NCT02146274|101373330|FG000|NOT COMPLETED|Overall Study||73||
48423805|NCT01224171|101373331|FG000|STARTED|Overall Study||207||
48423806|NCT01224171|101373332|FG001|STARTED|Overall Study||209||
48423807|NCT01224171|101373331|FG000|TNFα Antagonist Failure Population|Overall Study||157||
48423808|NCT01224171|101373332|FG001|TNFα Antagonist Failure Population|Overall Study||158||
48423809|NCT01224171|101373331|FG000|COMPLETED|Overall Study||192||
48423810|NCT01224171|101373332|FG001|COMPLETED|Overall Study||196||
48423811|NCT01224171|101373331|FG000|NOT COMPLETED|Overall Study||15||
48423812|NCT01224171|101373332|FG001|NOT COMPLETED|Overall Study||13||
48423813|NCT02903121|101373333|FG000|STARTED|Overall Study||57||
48423814|NCT02903121|101373334|FG001|STARTED|Overall Study||52||
48423815|NCT02903121|101373333|FG000|COMPLETED|Overall Study||34||
48423816|NCT02903121|101373334|FG001|COMPLETED|Overall Study||38||
48423817|NCT02903121|101373333|FG000|NOT COMPLETED|Overall Study||23||
48423818|NCT02903121|101373334|FG001|NOT COMPLETED|Overall Study||14||
48423819|NCT04557189|101373335|FG000|STARTED|Overall Study||44||
48423820|NCT04557189|101373336|FG001|STARTED|Overall Study||45||
48423821|NCT04557189|101373335|FG000|Full Analysis Set (FAS)|Overall Study||41|FAS included all participants who were randomized to treatment and received both doses of double-blind study drug before and during surgery.|
48423822|NCT04557189|101373336|FG001|Full Analysis Set (FAS)|Overall Study||39|FAS included all participants who were randomized to treatment and received both doses of double-blind study drug before and during surgery.|
48423823|NCT04557189|101373335|FG000|Pharmacokinetic (PK) Set|Overall Study||0|PK Set included all participants who received study drug and had at least 1 evaluable PK sample. Due to dosing error, an unintended mis-dose of TAK-951 redacted mg was administered to 18 participants from the TAK-951 4 mg group. Data for these participants were collected and reported separately.|
48423824|NCT04557189|101373336|FG001|Pharmacokinetic (PK) Set|Overall Study||21|PK Set included all participants who received study drug and had at least 1 evaluable PK sample. Due to dosing error, an unintended mis-dose of TAK-951 redacted mg was administered to 18 participants from the TAK-951 4 mg group. Data for these participants were collected and reported separately.|
48423825|NCT04557189|101373335|FG000|Immunogenicity Set|Overall Study||0|Immunogenicity Set included all participants who received at least 1 dose of study drug, had an ADA status assessment at baseline, and at least 1 postbaseline sample. Due to dosing error, an unintended mis-dose of TAK-951 redacted mg was administered to 18 participants from the TAK-951 4 mg group. Data for these participants were collected and reported separately.|
48423826|NCT04557189|101373336|FG001|Immunogenicity Set|Overall Study||21|Immunogenicity Set included all participants who received at least 1 dose of study drug, had an ADA status assessment at baseline, and at least 1 postbaseline sample. Due to dosing error, an unintended mis-dose of TAK-951 redacted mg was administered to 18 participants from the TAK-951 4 mg group. Data for these participants were collected and reported separately.|
48423827|NCT04557189|101373335|FG000|Unintended Mis-dose Due to Dosing Error|Overall Study||0|Of the 39 participants in the TAK-951 4 mg SC group, 18 participants received an unintended mis-dose of TAK-951 redacted mg.|
48423828|NCT04557189|101373336|FG001|Unintended Mis-dose Due to Dosing Error|Overall Study||18|Of the 39 participants in the TAK-951 4 mg SC group, 18 participants received an unintended mis-dose of TAK-951 redacted mg.|
48423829|NCT04557189|101373335|FG000|COMPLETED|Overall Study||38||
48423830|NCT04557189|101373336|FG001|COMPLETED|Overall Study||36||
48423831|NCT04557189|101373335|FG000|NOT COMPLETED|Overall Study||6||
48423832|NCT04557189|101373336|FG001|NOT COMPLETED|Overall Study||9||
48423833|NCT03577028|101373337|FG000|STARTED|Overall Study||64||
48423834|NCT03577028|101373338|FG001|STARTED|Overall Study||6||
48423835|NCT03577028|101373339|FG002|STARTED|Overall Study||12||
48423836|NCT03577028|101373340|FG003|STARTED|Overall Study||10||
48423837|NCT03577028|101373341|FG004|STARTED|Overall Study||9||
48423838|NCT03577028|101373342|FG005|STARTED|Overall Study||3||
48423839|NCT03577028|101373337|FG000|COMPLETED|Overall Study||64||
48423840|NCT03577028|101373338|FG001|COMPLETED|Overall Study||6||
48423841|NCT03577028|101373339|FG002|COMPLETED|Overall Study||12||
48423842|NCT03577028|101373340|FG003|COMPLETED|Overall Study||10||
48423843|NCT03577028|101373341|FG004|COMPLETED|Overall Study||9||
48423844|NCT03577028|101373342|FG005|COMPLETED|Overall Study||3||
48423845|NCT03577028|101373337|FG000|NOT COMPLETED|Overall Study||0||
48423846|NCT03577028|101373338|FG001|NOT COMPLETED|Overall Study||0||
48423847|NCT03577028|101373339|FG002|NOT COMPLETED|Overall Study||0||
48423848|NCT03577028|101373340|FG003|NOT COMPLETED|Overall Study||0||
48423849|NCT03577028|101373341|FG004|NOT COMPLETED|Overall Study||0||
48423850|NCT03577028|101373342|FG005|NOT COMPLETED|Overall Study||0||
48423851|NCT03216499|101373343|FG000|STARTED|Overall Study||24||
48423852|NCT03216499|101373343|FG000|COMPLETED|Overall Study||24||
48423853|NCT03216499|101373343|FG000|NOT COMPLETED|Overall Study||0||
48423854|NCT04646668|101373344|FG000|STARTED|Overall Study||11||
48423855|NCT04646668|101373345|FG001|STARTED|Overall Study||11||
48423856|NCT04646668|101373344|FG000|COMPLETED|Overall Study||11||
48423857|NCT04646668|101373345|FG001|COMPLETED|Overall Study||11||
48423858|NCT04646668|101373344|FG000|NOT COMPLETED|Overall Study||0||
48423859|NCT04646668|101373345|FG001|NOT COMPLETED|Overall Study||0||
48423860|NCT03650387|101373346|FG000|STARTED|Overall Study||207||
48423861|NCT03650387|101373346|FG000|COMPLETED|Overall Study||173||
48423862|NCT03650387|101373346|FG000|NOT COMPLETED|Overall Study||34||
48423863|NCT02176031|101373347|FG000|STARTED|Overall Study||21||
48423864|NCT02176031|101373347|FG000|COMPLETED|Overall Study||9||
48359639|NCT03334214|101210696|FG000|COMPLETED|Overall Study||14||
48359640|NCT03334214|101210697|FG001|COMPLETED|Overall Study||27||
48359641|NCT03334214|101210696|FG000|NOT COMPLETED|Overall Study||1||
48359642|NCT03334214|101210697|FG001|NOT COMPLETED|Overall Study||2||
48359643|NCT04635735|101210698|FG000|STARTED|Overall Study||3||
48359644|NCT04635735|101210698|FG000|COMPLETED|Overall Study||3||
48359645|NCT04635735|101210698|FG000|NOT COMPLETED|Overall Study||0||
48359646|NCT00918723|101210699|FG000|STARTED|Overall Study||40||
48359647|NCT00918723|101210699|FG000|COMPLETED|Overall Study||40||
48359648|NCT00918723|101210699|FG000|NOT COMPLETED|Overall Study||0||
48359649|NCT01928030|101210700|FG000|STARTED|Overall Study||3||
48359650|NCT01928030|101210701|FG001|STARTED|Overall Study||0||
48359651|NCT01928030|101210702|FG002|STARTED|Overall Study||0||
48359652|NCT01928030|101210700|FG000|COMPLETED|Overall Study||3||
48359653|NCT01928030|101210701|FG001|COMPLETED|Overall Study||0||
48359654|NCT01928030|101210702|FG002|COMPLETED|Overall Study||0||
48359655|NCT01928030|101210700|FG000|NOT COMPLETED|Overall Study||0||
48359656|NCT01928030|101210701|FG001|NOT COMPLETED|Overall Study||0||
48359657|NCT01928030|101210702|FG002|NOT COMPLETED|Overall Study||0||
48359658|NCT02658656|101210703|FG000|STARTED|Screening||78||
48359659|NCT02658656|101210704|FG001|STARTED|Screening||83||
48359660|NCT02658656|101210705|FG002|STARTED|Screening||263||
48359661|NCT02658656|101210703|FG000|COMPLETED|Screening||78||
48359662|NCT02658656|101210704|FG001|COMPLETED|Screening||83||
48359663|NCT02658656|101210705|FG002|COMPLETED|Screening||0||
48359664|NCT02658656|101210703|FG000|NOT COMPLETED|Screening||0||
48359665|NCT02658656|101210704|FG001|NOT COMPLETED|Screening||0||
48359666|NCT02658656|101210705|FG002|NOT COMPLETED|Screening||263||
48359667|NCT02658656|101210703|FG000|STARTED|Randomization||78||
48359668|NCT02658656|101210704|FG001|STARTED|Randomization||83||
48359669|NCT02658656|101210705|FG002|STARTED|Randomization||0||
48359670|NCT02658656|101210703|FG000|COMPLETED|Randomization||45||
48359671|NCT02658656|101210704|FG001|COMPLETED|Randomization||57||
48359672|NCT02658656|101210705|FG002|COMPLETED|Randomization||0||
48359673|NCT02658656|101210703|FG000|NOT COMPLETED|Randomization||33||
48359674|NCT02658656|101210704|FG001|NOT COMPLETED|Randomization||26||
48359675|NCT02658656|101210705|FG002|NOT COMPLETED|Randomization||0||
48359676|NCT04441931|101210706|FG000|STARTED|Overall Study||6||
48359677|NCT04441931|101210707|FG001|STARTED|Overall Study||7||
48359678|NCT04441931|101210708|FG002|STARTED|Overall Study||7||
48359679|NCT04441931|101210709|FG003|STARTED|Overall Study||6||
48359680|NCT04441931|101210706|FG000|Received at Least One Dose of Study Drug|Overall Study||6||
48359681|NCT04441931|101210707|FG001|Received at Least One Dose of Study Drug|Overall Study||7||
48359682|NCT04441931|101210708|FG002|Received at Least One Dose of Study Drug|Overall Study||7||
48359683|NCT04441931|101210709|FG003|Received at Least One Dose of Study Drug|Overall Study||6||
48359684|NCT04441931|101210706|FG000|COMPLETED|Overall Study||6||
48359685|NCT04441931|101210707|FG001|COMPLETED|Overall Study||7||
48359686|NCT04441931|101210708|FG002|COMPLETED|Overall Study||7||
48359687|NCT04441931|101210709|FG003|COMPLETED|Overall Study||6||
48359688|NCT04441931|101210706|FG000|NOT COMPLETED|Overall Study||0||
48359689|NCT04441931|101210707|FG001|NOT COMPLETED|Overall Study||0||
48359690|NCT04441931|101210708|FG002|NOT COMPLETED|Overall Study||0||
48359691|NCT04441931|101210709|FG003|NOT COMPLETED|Overall Study||0||
48359692|NCT02796144|101210710|FG000|STARTED|Overall Study||23||
48359693|NCT02796144|101210711|FG001|STARTED|Overall Study||24||
48359694|NCT02796144|101210712|FG002|STARTED|Overall Study||24||
48359695|NCT02796144|101210710|FG000|COMPLETED|Overall Study||18||
48359696|NCT02796144|101210711|FG001|COMPLETED|Overall Study||21||
48359697|NCT02796144|101210712|FG002|COMPLETED|Overall Study||18||
48359698|NCT02796144|101210710|FG000|NOT COMPLETED|Overall Study||5||
48359699|NCT02796144|101210711|FG001|NOT COMPLETED|Overall Study||3||
48359700|NCT02796144|101210712|FG002|NOT COMPLETED|Overall Study||6||
48359701|NCT02660580|101210713|FG000|STARTED|Core Treatment Period (Week 1 to 16)||222||
48359702|NCT02660580|101210714|FG001|STARTED|Core Treatment Period (Week 1 to 16)||221||
48359703|NCT02660580|101210715|FG002|STARTED|Core Treatment Period (Week 1 to 16)||0||
48359704|NCT02660580|101210716|FG003|STARTED|Core Treatment Period (Week 1 to 16)||0||
48359705|NCT02660580|101210717|FG004|STARTED|Core Treatment Period (Week 1 to 16)||0||
48359706|NCT02660580|101210713|FG000|Treated|Core Treatment Period (Week 1 to 16)||221||
48359707|NCT02660580|101210714|FG001|Treated|Core Treatment Period (Week 1 to 16)||220||
48359708|NCT02660580|101210715|FG002|Treated|Core Treatment Period (Week 1 to 16)||0||
48359709|NCT02660580|101210716|FG003|Treated|Core Treatment Period (Week 1 to 16)||0||
48359710|NCT02660580|101210717|FG004|Treated|Core Treatment Period (Week 1 to 16)||0||
48359711|NCT02660580|101210713|FG000|COMPLETED|Core Treatment Period (Week 1 to 16)||213||
48359712|NCT02660580|101210714|FG001|COMPLETED|Core Treatment Period (Week 1 to 16)||202||
48359713|NCT02660580|101210715|FG002|COMPLETED|Core Treatment Period (Week 1 to 16)||0||
48359714|NCT02660580|101210716|FG003|COMPLETED|Core Treatment Period (Week 1 to 16)||0||
48359715|NCT02660580|101210717|FG004|COMPLETED|Core Treatment Period (Week 1 to 16)||0||
48359716|NCT02660580|101210713|FG000|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||9||
48359717|NCT02660580|101210714|FG001|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||19||
48359718|NCT02660580|101210715|FG002|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0||
48359719|NCT02660580|101210716|FG003|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0||
48359720|NCT02660580|101210717|FG004|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0||
48359721|NCT02660580|101210713|FG000|STARTED|Extended Treatment Period(Week 16 to 52)||0||
48359722|NCT02660580|101210714|FG001|STARTED|Extended Treatment Period(Week 16 to 52)||0||
48359723|NCT02660580|101210715|FG002|STARTED|Extended Treatment Period(Week 16 to 52)||213||
48359724|NCT02660580|101210716|FG003|STARTED|Extended Treatment Period(Week 16 to 52)||101||
48359725|NCT02660580|101210717|FG004|STARTED|Extended Treatment Period(Week 16 to 52)||101||
48359726|NCT02660580|101210713|FG000|COMPLETED|Extended Treatment Period(Week 16 to 52)||0||
48359727|NCT02660580|101210714|FG001|COMPLETED|Extended Treatment Period(Week 16 to 52)||0||
48359728|NCT02660580|101210715|FG002|COMPLETED|Extended Treatment Period(Week 16 to 52)||195||
48359729|NCT02660580|101210716|FG003|COMPLETED|Extended Treatment Period(Week 16 to 52)||90||
48359730|NCT02660580|101210717|FG004|COMPLETED|Extended Treatment Period(Week 16 to 52)||90||
48359731|NCT02660580|101210713|FG000|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||0||
48359732|NCT02660580|101210714|FG001|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||0||
48359733|NCT02660580|101210715|FG002|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||18||
48423865|NCT02176031|101373347|FG000|NOT COMPLETED|Overall Study||12||
48423866|NCT04034225|101373348|FG000|STARTED|Overall Study||25||
48423867|NCT04034225|101373348|FG000|COMPLETED|Overall Study||0||
48423868|NCT04034225|101373348|FG000|NOT COMPLETED|Overall Study||25||
48423869|NCT04409262|101373349|FG000|STARTED|Overall Study||215||
48423870|NCT04409262|101373350|FG001|STARTED|Overall Study||434||
48423871|NCT04409262|101373349|FG000|COMPLETED|Overall Study||140||
48423872|NCT04409262|101373350|FG001|COMPLETED|Overall Study||300||
48423873|NCT04409262|101373349|FG000|NOT COMPLETED|Overall Study||75||
48423874|NCT04409262|101373350|FG001|NOT COMPLETED|Overall Study||134||
48423875|NCT01345162|101373351|FG000|STARTED|Overall Study||100||
48423876|NCT01345162|101373352|FG001|STARTED|Overall Study||100||
48423877|NCT01345162|101373351|FG000|COMPLETED|Overall Study||98||
48423878|NCT01345162|101373352|FG001|COMPLETED|Overall Study||96||
48423879|NCT01345162|101373351|FG000|NOT COMPLETED|Overall Study||2||
48423880|NCT01345162|101373352|FG001|NOT COMPLETED|Overall Study||4||
48423881|NCT03285581|101373353|FG000|STARTED|Overall Study||39||
48423882|NCT03285581|101373353|FG000|COMPLETED|Overall Study||25||
48423883|NCT03285581|101373353|FG000|NOT COMPLETED|Overall Study||14||
48423884|NCT02486263|101373354|FG000|STARTED|Overall Study||40||
48423885|NCT02486263|101373355|FG001|STARTED|Overall Study||36||
48423886|NCT02486263|101373354|FG000|COMPLETED|Overall Study||37||
48423887|NCT02486263|101373355|FG001|COMPLETED|Overall Study||35||
48423888|NCT02486263|101373354|FG000|NOT COMPLETED|Overall Study||3||
48423889|NCT02486263|101373355|FG001|NOT COMPLETED|Overall Study||1||
48423890|NCT00026559|101373356|FG000|STARTED|Healthy Volunteers||1418||
48423891|NCT00026559|101373356|FG000|COMPLETED|Healthy Volunteers||1418||
48423892|NCT00026559|101373356|FG000|NOT COMPLETED|Healthy Volunteers||0||
48423893|NCT00026559|101373356|FG000|STARTED|Working Memory Task||115||
48423894|NCT00026559|101373356|FG000|COMPLETED|Working Memory Task||115||
48423895|NCT00026559|101373356|FG000|NOT COMPLETED|Working Memory Task||0||
48423896|NCT00026559|101373356|FG000|STARTED|Sustained Attention to Response Task||61||
48423897|NCT00026559|101373356|FG000|COMPLETED|Sustained Attention to Response Task||61||
48423898|NCT00026559|101373356|FG000|NOT COMPLETED|Sustained Attention to Response Task||0||
48423899|NCT00026559|101373356|FG000|STARTED|Stroop Task||69||
48423900|NCT00026559|101373356|FG000|COMPLETED|Stroop Task||69||
48423901|NCT00026559|101373356|FG000|NOT COMPLETED|Stroop Task||0||
48423902|NCT00026559|101373356|FG000|STARTED|Pilot Studies||1210||
48423903|NCT00026559|101373356|FG000|COMPLETED|Pilot Studies||1210||
48423904|NCT00026559|101373356|FG000|NOT COMPLETED|Pilot Studies||0||
48423905|NCT00724243|101373357|FG000|STARTED|Overall Study||33||
48423906|NCT00724243|101373357|FG000|COMPLETED|Overall Study||18||
48423907|NCT00724243|101373357|FG000|NOT COMPLETED|Overall Study||15||
48423908|NCT01354964|101373358|FG000|STARTED|Overall Study||11||
48423909|NCT01354964|101373359|FG001|STARTED|Overall Study||8||
48423910|NCT01354964|101373358|FG000|COMPLETED|Overall Study||7||
48423911|NCT01354964|101373359|FG001|COMPLETED|Overall Study||7||
48423912|NCT01354964|101373358|FG000|NOT COMPLETED|Overall Study||4||
48423913|NCT01354964|101373359|FG001|NOT COMPLETED|Overall Study||1||
48423914|NCT00660829|101373360|FG000|STARTED|Overall Study||268||
48423915|NCT00660829|101373361|FG001|STARTED|Overall Study||268||
48423916|NCT00660829|101373360|FG000|COMPLETED|Overall Study||250||
48423917|NCT00660829|101373361|FG001|COMPLETED|Overall Study||249||
48423918|NCT00660829|101373360|FG000|NOT COMPLETED|Overall Study||18||
48423919|NCT00660829|101373361|FG001|NOT COMPLETED|Overall Study||19||
48423920|NCT00683852|101373362|FG000|STARTED|30-Day Phase 1 Period||56||
48423921|NCT00683852|101373363|FG001|STARTED|30-Day Phase 1 Period||84||
48423922|NCT00683852|101373364|FG002|STARTED|30-Day Phase 1 Period||85||
48423923|NCT00683852|101373362|FG000|COMPLETED|30-Day Phase 1 Period||54||
48423924|NCT00683852|101373363|FG001|COMPLETED|30-Day Phase 1 Period||83||
48423925|NCT00683852|101373364|FG002|COMPLETED|30-Day Phase 1 Period||84||
48423926|NCT00683852|101373362|FG000|NOT COMPLETED|30-Day Phase 1 Period||2||
48423927|NCT00683852|101373363|FG001|NOT COMPLETED|30-Day Phase 1 Period||1||
48423928|NCT00683852|101373364|FG002|NOT COMPLETED|30-Day Phase 1 Period||1||
48423929|NCT00683852|101373362|FG000|STARTED|30-Day Phase 2 Period||54||
48423930|NCT00683852|101373363|FG001|STARTED|30-Day Phase 2 Period||83||
48423931|NCT00683852|101373364|FG002|STARTED|30-Day Phase 2 Period||84||
48423932|NCT00683852|101373362|FG000|COMPLETED|30-Day Phase 2 Period||48||
48423933|NCT00683852|101373363|FG001|COMPLETED|30-Day Phase 2 Period||78||
48423934|NCT00683852|101373364|FG002|COMPLETED|30-Day Phase 2 Period||75||
48423935|NCT00683852|101373362|FG000|NOT COMPLETED|30-Day Phase 2 Period||6||
48423936|NCT00683852|101373363|FG001|NOT COMPLETED|30-Day Phase 2 Period||5||
48423937|NCT00683852|101373364|FG002|NOT COMPLETED|30-Day Phase 2 Period||9||
48423938|NCT02759939|101373365|FG000|STARTED|Overall Study||1256|Represents participants who consented to the study and were eligible.|
48423939|NCT02759939|101373366|FG001|STARTED|Overall Study||1143|Represents participants who consented to the study and were eligible.|
48423940|NCT02759939|101373367|FG002|STARTED|Overall Study||1393|Represents participants who consented to the study and were eligible.|
48423941|NCT02759939|101373368|FG003|STARTED|Overall Study||1246|Represents participants who consented to the study and were eligible.|
48423942|NCT02759939|101373365|FG000|Analyzed at T1|Overall Study||1245|Participants with valid data on the item assessing occurrence of a conversation about contraception.|
48439983|NCT01728376|101409999|FG004|NOT COMPLETED|Overall Study||2||
48423943|NCT02759939|101373366|FG001|Analyzed at T1|Overall Study||1141|Participants with valid data on the item assessing occurrence of a conversation about contraception.|
48423944|NCT02759939|101373367|FG002|Analyzed at T1|Overall Study||1388|Participants with valid data on the item assessing occurrence of a conversation about contraception.|
48423945|NCT02759939|101373368|FG003|Analyzed at T1|Overall Study||1244|Participants with valid data on the item assessing occurrence of a conversation about contraception.|
48423946|NCT02759939|101373365|FG000|Eligible for T2 and T3|Overall Study||935|We imposed additional eligibility criteria for the T2 and T3 surveys to minimize participant burden.|
48423947|NCT02759939|101373366|FG001|Eligible for T2 and T3|Overall Study||962|We imposed additional eligibility criteria for the T2 and T3 surveys to minimize participant burden.|
48423948|NCT02759939|101373367|FG002|Eligible for T2 and T3|Overall Study||1022|We imposed additional eligibility criteria for the T2 and T3 surveys to minimize participant burden.|
48423949|NCT02759939|101373368|FG003|Eligible for T2 and T3|Overall Study||853|We imposed additional eligibility criteria for the T2 and T3 surveys to minimize participant burden.|
48423950|NCT02759939|101373365|FG000|Analyzed at T2 and/or T3|Overall Study||303|Participants were not required to have completed the T2 survey to be eligible for the T3 survey.|
48423951|NCT02759939|101373366|FG001|Analyzed at T2 and/or T3|Overall Study||278|Participants were not required to have completed the T2 survey to be eligible for the T3 survey.|
48423952|NCT02759939|101373367|FG002|Analyzed at T2 and/or T3|Overall Study||373|Participants were not required to have completed the T2 survey to be eligible for the T3 survey.|
48423953|NCT02759939|101373368|FG003|Analyzed at T2 and/or T3|Overall Study||304|Participants were not required to have completed the T2 survey to be eligible for the T3 survey.|
48423954|NCT02759939|101373365|FG000|Consented to T2 and T3|Overall Study||579||
48423955|NCT02759939|101373366|FG001|Consented to T2 and T3|Overall Study||626||
48423956|NCT02759939|101373367|FG002|Consented to T2 and T3|Overall Study||702||
48423957|NCT02759939|101373368|FG003|Consented to T2 and T3|Overall Study||564||
48423958|NCT02759939|101373365|FG000|COMPLETED|Overall Study||200||
48423959|NCT02759939|101373366|FG001|COMPLETED|Overall Study||171||
48423960|NCT02759939|101373367|FG002|COMPLETED|Overall Study||239||
48423961|NCT02759939|101373368|FG003|COMPLETED|Overall Study||203||
48423962|NCT02759939|101373365|FG000|NOT COMPLETED|Overall Study||1056||
48423963|NCT02759939|101373366|FG001|NOT COMPLETED|Overall Study||972||
48423964|NCT02759939|101373367|FG002|NOT COMPLETED|Overall Study||1154||
48423965|NCT02759939|101373368|FG003|NOT COMPLETED|Overall Study||1043||
48423966|NCT01383317|101373369|FG000|STARTED|Overall Study||29||
48423967|NCT01383317|101373370|FG001|STARTED|Overall Study||35||
48423968|NCT01383317|101373369|FG000|COMPLETED|Overall Study||26||
48423969|NCT01383317|101373370|FG001|COMPLETED|Overall Study||33||
48423970|NCT01383317|101373369|FG000|NOT COMPLETED|Overall Study||3||
48423971|NCT01383317|101373370|FG001|NOT COMPLETED|Overall Study||2||
48423972|NCT02087085|101373371|FG000|STARTED|Overall Study||154||
48423973|NCT02087085|101373372|FG001|STARTED|Overall Study||156||
48423974|NCT02087085|101373371|FG000|COMPLETED|Overall Study||34||
48423975|NCT02087085|101373372|FG001|COMPLETED|Overall Study||40||
48423976|NCT02087085|101373371|FG000|NOT COMPLETED|Overall Study||120||
48187133|NCT00062868|100779970|FG010|STARTED|Dose Level 3||0||
48423977|NCT02087085|101373372|FG001|NOT COMPLETED|Overall Study||116||
48423978|NCT01722552|101373373|FG000|STARTED|Overall Study||120||
48763822|NCT02993107|102211813|FG001|Adverse Event|Overall Study||4||
48763823|NCT02993107|102211814|FG002|Adverse Event|Overall Study||1||
48763824|NCT02993107|102211815|FG003|Adverse Event|Overall Study||1||
48763825|NCT02993107|102211816|FG004|Adverse Event|Overall Study||3||
48763826|NCT02993107|102211817|FG005|Adverse Event|Overall Study||5||
48763827|NCT02993107|102211812|FG000|Physician Decision|Overall Study||1||
48763828|NCT02993107|102211813|FG001|Physician Decision|Overall Study||0||
48763829|NCT02993107|102211814|FG002|Physician Decision|Overall Study||1||
48763830|NCT02993107|102211815|FG003|Physician Decision|Overall Study||0||
48763831|NCT02993107|102211816|FG004|Physician Decision|Overall Study||0||
48763832|NCT02993107|102211817|FG005|Physician Decision|Overall Study||0||
48763833|NCT02993107|102211812|FG000|Withdrawal by Subject|Overall Study||32||
48763834|NCT02993107|102211813|FG001|Withdrawal by Subject|Overall Study||7||
48763835|NCT02993107|102211814|FG002|Withdrawal by Subject|Overall Study||7||
48763836|NCT02993107|102211815|FG003|Withdrawal by Subject|Overall Study||3||
48763837|NCT02993107|102211816|FG004|Withdrawal by Subject|Overall Study||6||
48763838|NCT02993107|102211817|FG005|Withdrawal by Subject|Overall Study||2||
48763839|NCT02993107|102211812|FG000|Lost to Follow-up|Overall Study||0||
48763840|NCT02993107|102211813|FG001|Lost to Follow-up|Overall Study||1||
48763841|NCT02993107|102211814|FG002|Lost to Follow-up|Overall Study||0||
48763842|NCT02993107|102211815|FG003|Lost to Follow-up|Overall Study||0||
48763843|NCT02993107|102211816|FG004|Lost to Follow-up|Overall Study||0||
48763844|NCT02993107|102211817|FG005|Lost to Follow-up|Overall Study||1||
48763845|NCT02993107|102211812|FG000|Sponsor Decision|Overall Study||4||
48763846|NCT02993107|102211813|FG001|Sponsor Decision|Overall Study||0||
48763847|NCT02993107|102211814|FG002|Sponsor Decision|Overall Study||1||
48763848|NCT02993107|102211815|FG003|Sponsor Decision|Overall Study||1||
48763849|NCT02993107|102211816|FG004|Sponsor Decision|Overall Study||0||
48423979|NCT01722552|101373373|FG000|COMPLETED|Overall Study||116||
48763850|NCT02993107|102211817|FG005|Sponsor Decision|Overall Study||4||
48763851|NCT02993107|102211812|FG000|Protocol Deviation|Overall Study||0||
48187134|NCT00062868|100779971|FG011|STARTED|Dose Level 3||5||
48423980|NCT01722552|101373373|FG000|NOT COMPLETED|Overall Study||4||
48423981|NCT04550234|101373374|FG000|STARTED|Overall Study||5||
48423982|NCT04550234|101373375|FG001|STARTED|Overall Study||5||
48423983|NCT04550234|101373376|FG002|STARTED|Overall Study||5||
48423984|NCT04550234|101373377|FG003|STARTED|Overall Study||5||
48423985|NCT04550234|101373378|FG004|STARTED|Overall Study||5||
48423986|NCT04550234|101373374|FG000|COMPLETED|Overall Study||5||
48423987|NCT04550234|101373375|FG001|COMPLETED|Overall Study||5||
48423988|NCT04550234|101373376|FG002|COMPLETED|Overall Study||5||
48423989|NCT04550234|101373377|FG003|COMPLETED|Overall Study||5||
48423990|NCT04550234|101373378|FG004|COMPLETED|Overall Study||5||
48423991|NCT04550234|101373374|FG000|NOT COMPLETED|Overall Study||0||
48423992|NCT04550234|101373375|FG001|NOT COMPLETED|Overall Study||0||
48423993|NCT04550234|101373376|FG002|NOT COMPLETED|Overall Study||0||
48423994|NCT04550234|101373377|FG003|NOT COMPLETED|Overall Study||0||
48423995|NCT04550234|101373378|FG004|NOT COMPLETED|Overall Study||0||
48423996|NCT04678557|101373379|FG000|STARTED|Overall Study||17||
48423997|NCT04678557|101373380|FG001|STARTED|Overall Study||14||
48423998|NCT04678557|101373379|FG000|COMPLETED|Overall Study||16||
48423999|NCT04678557|101373380|FG001|COMPLETED|Overall Study||0||
48424000|NCT04678557|101373379|FG000|NOT COMPLETED|Overall Study||1||
48424001|NCT04678557|101373380|FG001|NOT COMPLETED|Overall Study||14||
48424002|NCT02780869|101373381|FG000|STARTED|Overall Study||175||
48424003|NCT02780869|101373382|FG001|STARTED|Overall Study||83||
48424004|NCT02780869|101373381|FG000|COMPLETED|Overall Study||162||
48424005|NCT02780869|101373382|FG001|COMPLETED|Overall Study||74||
48424006|NCT02780869|101373381|FG000|NOT COMPLETED|Overall Study||13||
48424007|NCT02780869|101373382|FG001|NOT COMPLETED|Overall Study||9||
48424008|NCT00401726|101373383|FG000|STARTED|Overall Study||269||
48424009|NCT00401726|101373384|FG001|STARTED|Overall Study||268||
48424010|NCT00401726|101373383|FG000|COMPLETED|Overall Study||172||
48424011|NCT00401726|101373384|FG001|COMPLETED|Overall Study||156||
48424012|NCT00401726|101373383|FG000|NOT COMPLETED|Overall Study||97||
48424013|NCT00401726|101373384|FG001|NOT COMPLETED|Overall Study||112||
48424014|NCT00290329|101373385|FG000|STARTED|Overall Study||102||
48424015|NCT00290329|101373386|FG001|STARTED|Overall Study||86||
48424016|NCT00290329|101373387|FG002|STARTED|Overall Study||61||
48424017|NCT00290329|101373385|FG000|COMPLETED|Overall Study||102||
48424018|NCT00290329|101373386|FG001|COMPLETED|Overall Study||86||
48424019|NCT00290329|101373387|FG002|COMPLETED|Overall Study||61||
48424020|NCT00290329|101373385|FG000|NOT COMPLETED|Overall Study||0||
48424021|NCT00290329|101373386|FG001|NOT COMPLETED|Overall Study||0||
48424022|NCT00290329|101373387|FG002|NOT COMPLETED|Overall Study||0||
48424023|NCT00033514|101373388|FG000|STARTED|Overall Study||16||
48424024|NCT00033514|101373389|FG001|STARTED|Overall Study||11||
48424025|NCT00033514|101373388|FG000|COMPLETED|Overall Study||15||
48424026|NCT00033514|101373389|FG001|COMPLETED|Overall Study||7||
48424027|NCT00033514|101373388|FG000|NOT COMPLETED|Overall Study||1||
48424028|NCT00033514|101373389|FG001|NOT COMPLETED|Overall Study||4||
48424029|NCT01519648|101373390|FG000|STARTED|Overall Study||502||
48424030|NCT01519648|101373391|FG001|STARTED|Overall Study||306||
48424031|NCT01519648|101373390|FG000|COMPLETED|Overall Study||502||
48424032|NCT01519648|101373391|FG001|COMPLETED|Overall Study||306||
48424033|NCT01519648|101373390|FG000|NOT COMPLETED|Overall Study||0||
48424034|NCT01519648|101373391|FG001|NOT COMPLETED|Overall Study||0||
48424035|NCT00134563|101373392|FG000|STARTED|Overall Study||363||
48424036|NCT00134563|101373393|FG001|STARTED|Overall Study||366||
48424037|NCT00134563|101373394|FG002|STARTED|Overall Study||359||
48424038|NCT00134563|101373392|FG000|Treated|Overall Study||363||
48424039|NCT00134563|101373393|FG001|Treated|Overall Study||365||
48424040|NCT00134563|101373394|FG002|Treated|Overall Study||358||
48424041|NCT00134563|101373392|FG000|COMPLETED|Overall Study||259||
48424042|NCT00134563|101373393|FG001|COMPLETED|Overall Study||274||
48424043|NCT00134563|101373394|FG002|COMPLETED|Overall Study||263||
48424044|NCT00134563|101373392|FG000|NOT COMPLETED|Overall Study||104||
48424045|NCT00134563|101373393|FG001|NOT COMPLETED|Overall Study||92||
48424046|NCT00134563|101373394|FG002|NOT COMPLETED|Overall Study||96||
48424047|NCT00367380|101373395|FG000|STARTED|Overall Study||6||
48424048|NCT00367380|101373396|FG001|STARTED|Overall Study||6||
48424049|NCT00367380|101373397|FG002|STARTED|Overall Study||6||
48424050|NCT00367380|101373395|FG000|COMPLETED|Overall Study||6||
48424051|NCT00367380|101373396|FG001|COMPLETED|Overall Study||6||
48424052|NCT00367380|101373397|FG002|COMPLETED|Overall Study||6||
48424053|NCT00367380|101373395|FG000|NOT COMPLETED|Overall Study||0||
48424054|NCT00367380|101373396|FG001|NOT COMPLETED|Overall Study||0||
48424055|NCT00367380|101373397|FG002|NOT COMPLETED|Overall Study||0||
48424056|NCT02984228|101373398|FG000|STARTED|Overall Study||34||
48424057|NCT02984228|101373399|FG001|STARTED|Overall Study||36||
48424058|NCT02984228|101373398|FG000|COMPLETED|Overall Study||34||
48424059|NCT02984228|101373399|FG001|COMPLETED|Overall Study||35||
48424060|NCT02984228|101373398|FG000|NOT COMPLETED|Overall Study||0||
48424061|NCT02984228|101373399|FG001|NOT COMPLETED|Overall Study||1||
48424062|NCT03217565|101373400|FG000|STARTED|Overall Study||4||
48424063|NCT03217565|101373401|FG001|STARTED|Overall Study||6||
48424064|NCT03217565|101373402|FG002|STARTED|Overall Study||8||
48424065|NCT03217565|101373403|FG003|STARTED|Overall Study||4||
48763852|NCT02993107|102211813|FG001|Protocol Deviation|Overall Study||0||
48763853|NCT02993107|102211814|FG002|Protocol Deviation|Overall Study||0||
48763854|NCT02993107|102211815|FG003|Protocol Deviation|Overall Study||0||
48359734|NCT02660580|101210716|FG003|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||11||
48424066|NCT03217565|101373404|FG004|STARTED|Overall Study||9||
48424067|NCT03217565|101373405|FG005|STARTED|Overall Study||4||
48424068|NCT03217565|101373406|FG006|STARTED|Overall Study||4||
48424069|NCT03217565|101373407|FG007|STARTED|Overall Study||4||
48424070|NCT03217565|101373408|FG008|STARTED|Overall Study||4||
48424071|NCT03217565|101373400|FG000|COMPLETED|Overall Study||4||
48424072|NCT03217565|101373401|FG001|COMPLETED|Overall Study||6||
48424073|NCT03217565|101373402|FG002|COMPLETED|Overall Study||8||
48424074|NCT03217565|101373403|FG003|COMPLETED|Overall Study||4||
48424075|NCT03217565|101373404|FG004|COMPLETED|Overall Study||9||
48763855|NCT02993107|102211816|FG004|Protocol Deviation|Overall Study||1||
48359735|NCT02660580|101210717|FG004|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||11||
48359736|NCT01065428|101210718|FG000|STARTED|Overall Study||17||
48359737|NCT01065428|101210719|FG001|STARTED|Overall Study||35||
48359738|NCT01065428|101210718|FG000|COMPLETED|Overall Study||17||
48359739|NCT01065428|101210719|FG001|COMPLETED|Overall Study||35||
48359740|NCT01065428|101210718|FG000|NOT COMPLETED|Overall Study||0||
48359741|NCT01065428|101210719|FG001|NOT COMPLETED|Overall Study||0||
48359742|NCT03575468|101210720|FG000|STARTED|Overall Study||56||
48359743|NCT03575468|101210721|FG001|STARTED|Overall Study||54||
48359744|NCT03575468|101210720|FG000|COMPLETED|Overall Study||30||
48359745|NCT03575468|101210721|FG001|COMPLETED|Overall Study||33||
48359746|NCT03575468|101210720|FG000|NOT COMPLETED|Overall Study||26||
48359747|NCT03575468|101210721|FG001|NOT COMPLETED|Overall Study||21||
48359748|NCT01713348|101210722|FG000|STARTED|Overall Study||29||
48359749|NCT01713348|101210723|FG001|STARTED|Overall Study||13||
48359750|NCT01713348|101210724|FG002|STARTED|Overall Study||30||
48359751|NCT01713348|101210725|FG003|STARTED|Overall Study||15||
48359752|NCT01713348|101210722|FG000|COMPLETED|Overall Study||25||
48359753|NCT01713348|101210723|FG001|COMPLETED|Overall Study||11||
48359754|NCT01713348|101210724|FG002|COMPLETED|Overall Study||28||
48359755|NCT01713348|101210725|FG003|COMPLETED|Overall Study||15||
48359756|NCT01713348|101210722|FG000|NOT COMPLETED|Overall Study||4||
48359757|NCT01713348|101210723|FG001|NOT COMPLETED|Overall Study||2||
48359758|NCT01713348|101210724|FG002|NOT COMPLETED|Overall Study||2||
48359759|NCT01713348|101210725|FG003|NOT COMPLETED|Overall Study||0||
48359760|NCT01564654|101210726|FG000|STARTED|Overall Study||89||
48359761|NCT01564654|101210726|FG000|COMPLETED|Overall Study||89||
48359762|NCT01564654|101210726|FG000|NOT COMPLETED|Overall Study||0||
48359763|NCT01541254|101210727|FG000|STARTED|Overall Study||36||
48359764|NCT01541254|101210727|FG000|COMPLETED|Overall Study||30||
48359765|NCT01541254|101210727|FG000|NOT COMPLETED|Overall Study||6||
48359766|NCT03626415|101210728|FG000|STARTED|Overall Study||8||
48359767|NCT03626415|101210729|FG001|STARTED|Overall Study||8||
48359768|NCT03626415|101210730|FG002|STARTED|Overall Study||8||
48359769|NCT03626415|101210728|FG000|COMPLETED|Overall Study||8||
48359770|NCT03626415|101210729|FG001|COMPLETED|Overall Study||8||
48359771|NCT03626415|101210730|FG002|COMPLETED|Overall Study||8||
48424076|NCT03217565|101373405|FG005|COMPLETED|Overall Study||4||
48424077|NCT03217565|101373406|FG006|COMPLETED|Overall Study||4||
48763856|NCT02993107|102211817|FG005|Protocol Deviation|Overall Study||0||
48763857|NCT02993107|102211812|FG000|Other Reasons|Overall Study||2||
48763858|NCT02993107|102211813|FG001|Other Reasons|Overall Study||1||
48763859|NCT02993107|102211814|FG002|Other Reasons|Overall Study||1||
48763860|NCT02993107|102211815|FG003|Other Reasons|Overall Study||1||
48763861|NCT02993107|102211816|FG004|Other Reasons|Overall Study||2||
48763862|NCT02993107|102211817|FG005|Other Reasons|Overall Study||3||
48763863|NCT02993107|102211812|FG000|COMPLETED|Overall Study||62||
48359772|NCT03626415|101210728|FG000|NOT COMPLETED|Overall Study||0||
48359773|NCT03626415|101210729|FG001|NOT COMPLETED|Overall Study||0||
48359774|NCT03626415|101210730|FG002|NOT COMPLETED|Overall Study||0||
48359775|NCT01462292|101210731|FG000|STARTED|Overall Study||16||
48359776|NCT01462292|101210732|FG001|STARTED|Overall Study||17||
48359777|NCT01462292|101210733|FG002|STARTED|Overall Study||18||
48359778|NCT01462292|101210731|FG000|COMPLETED|Overall Study||16||
48359779|NCT01462292|101210732|FG001|COMPLETED|Overall Study||17||
48359780|NCT01462292|101210733|FG002|COMPLETED|Overall Study||18||
48359781|NCT01462292|101210731|FG000|NOT COMPLETED|Overall Study||0||
48359782|NCT01462292|101210732|FG001|NOT COMPLETED|Overall Study||0||
48359783|NCT01462292|101210733|FG002|NOT COMPLETED|Overall Study||0||
48359784|NCT00652093|101210734|FG000|STARTED|Overall Study||4||
48359785|NCT00652093|101210735|FG001|STARTED|Overall Study||4||
48359786|NCT00652093|101210736|FG002|STARTED|Overall Study||4||
48359787|NCT00652093|101210737|FG003|STARTED|Overall Study||4||
48359788|NCT00652093|101210738|FG004|STARTED|Overall Study||4||
48359789|NCT00652093|101210739|FG005|STARTED|Overall Study||4||
48359790|NCT00652093|101210734|FG000|COMPLETED|Overall Study||4||
48359791|NCT00652093|101210735|FG001|COMPLETED|Overall Study||4||
48424078|NCT03217565|101373407|FG007|COMPLETED|Overall Study||4||
48424079|NCT03217565|101373408|FG008|COMPLETED|Overall Study||4||
48424080|NCT03217565|101373400|FG000|NOT COMPLETED|Overall Study||0||
48424081|NCT03217565|101373401|FG001|NOT COMPLETED|Overall Study||0||
48424082|NCT03217565|101373402|FG002|NOT COMPLETED|Overall Study||0||
48424083|NCT03217565|101373403|FG003|NOT COMPLETED|Overall Study||0||
48424084|NCT03217565|101373404|FG004|NOT COMPLETED|Overall Study||0||
48424085|NCT03217565|101373405|FG005|NOT COMPLETED|Overall Study||0||
48424086|NCT03217565|101373406|FG006|NOT COMPLETED|Overall Study||0||
48424087|NCT03217565|101373407|FG007|NOT COMPLETED|Overall Study||0||
48424088|NCT03217565|101373408|FG008|NOT COMPLETED|Overall Study||0||
48424089|NCT01207427|101373409|FG000|STARTED|Run-in Placebo Period||43||
48424090|NCT01207427|101373410|FG001|STARTED|Run-in Placebo Period||45||
48424091|NCT01207427|101373411|FG002|STARTED|Run-in Placebo Period||43||
48424092|NCT01207427|101373409|FG000|COMPLETED|Run-in Placebo Period||43||
48424093|NCT01207427|101373410|FG001|COMPLETED|Run-in Placebo Period||45||
48424094|NCT01207427|101373411|FG002|COMPLETED|Run-in Placebo Period||43||
48424095|NCT01207427|101373409|FG000|NOT COMPLETED|Run-in Placebo Period||0||
48424096|NCT01207427|101373410|FG001|NOT COMPLETED|Run-in Placebo Period||0||
48424097|NCT01207427|101373411|FG002|NOT COMPLETED|Run-in Placebo Period||0||
48424098|NCT01207427|101373409|FG000|STARTED|Double-blind Treatment Period||43||
48424099|NCT01207427|101373410|FG001|STARTED|Double-blind Treatment Period||45||
48424100|NCT01207427|101373411|FG002|STARTED|Double-blind Treatment Period||43||
48424101|NCT01207427|101373409|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43||
48424102|NCT01207427|101373410|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||45||
48424103|NCT01207427|101373411|FG002|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43||
48424104|NCT01207427|101373409|FG000|COMPLETED|Double-blind Treatment Period||40||
48424105|NCT01207427|101373410|FG001|COMPLETED|Double-blind Treatment Period||43||
48424106|NCT01207427|101373411|FG002|COMPLETED|Double-blind Treatment Period||41||
48424107|NCT01207427|101373409|FG000|NOT COMPLETED|Double-blind Treatment Period||3||
48424108|NCT01207427|101373410|FG001|NOT COMPLETED|Double-blind Treatment Period||2||
48424109|NCT01207427|101373411|FG002|NOT COMPLETED|Double-blind Treatment Period||2||
48424110|NCT01207427|101373409|FG000|STARTED|Run-out Placebo Period||40||
48424111|NCT01207427|101373410|FG001|STARTED|Run-out Placebo Period||43||
48424112|NCT01207427|101373411|FG002|STARTED|Run-out Placebo Period||41||
48424113|NCT01207427|101373409|FG000|COMPLETED|Run-out Placebo Period||40||
48424114|NCT01207427|101373410|FG001|COMPLETED|Run-out Placebo Period||43||
48424115|NCT01207427|101373411|FG002|COMPLETED|Run-out Placebo Period||41||
48424116|NCT01207427|101373409|FG000|NOT COMPLETED|Run-out Placebo Period||0||
48424117|NCT01207427|101373410|FG001|NOT COMPLETED|Run-out Placebo Period||0||
48424118|NCT01207427|101373411|FG002|NOT COMPLETED|Run-out Placebo Period||0||
48424119|NCT03502265|101373412|FG000|STARTED|Overall Study||4||
48424120|NCT03502265|101373412|FG000|COMPLETED|Overall Study||4||
48424121|NCT03502265|101373412|FG000|NOT COMPLETED|Overall Study||0||
48424122|NCT00203294|101373413|FG000|STARTED|Overall Study||22||
48424123|NCT00203294|101373414|FG001|STARTED|Overall Study||23||
48424124|NCT00203294|101373413|FG000|COMPLETED|Overall Study||14||
48424125|NCT00203294|101373414|FG001|COMPLETED|Overall Study||10||
48424126|NCT00203294|101373413|FG000|NOT COMPLETED|Overall Study||8||
48424127|NCT00203294|101373414|FG001|NOT COMPLETED|Overall Study||13||
48424128|NCT01111331|101373415|FG000|STARTED|Overall Study||9||
48424129|NCT01111331|101373416|FG001|STARTED|Overall Study||9||
48424130|NCT01111331|101373415|FG000|COMPLETED|Overall Study||9||
48424131|NCT01111331|101373416|FG001|COMPLETED|Overall Study||9||
48424132|NCT01111331|101373415|FG000|NOT COMPLETED|Overall Study||0||
48424133|NCT01111331|101373416|FG001|NOT COMPLETED|Overall Study||0||
48424134|NCT02972658|101373417|FG000|STARTED|Overall Study||76||
48424135|NCT02972658|101373418|FG001|STARTED|Overall Study||139||
48424136|NCT02972658|101373419|FG002|STARTED|Overall Study||75||
48424137|NCT02972658|101373420|FG003|STARTED|Overall Study||131||
48424138|NCT02972658|101373417|FG000|Received at Least 1 Dose of Study Drug|Overall Study||76||
48424139|NCT02972658|101373418|FG001|Received at Least 1 Dose of Study Drug|Overall Study||139||
48424140|NCT02972658|101373419|FG002|Received at Least 1 Dose of Study Drug|Overall Study||74||
48424141|NCT02972658|101373420|FG003|Received at Least 1 Dose of Study Drug|Overall Study||131||
48424142|NCT02972658|101373417|FG000|COMPLETED|Overall Study||0||
48424143|NCT02972658|101373418|FG001|COMPLETED|Overall Study||1||
48424144|NCT02972658|101373419|FG002|COMPLETED|Overall Study||0||
48424145|NCT02972658|101373420|FG003|COMPLETED|Overall Study||0||
48424146|NCT02972658|101373417|FG000|NOT COMPLETED|Overall Study||76||
48424147|NCT02972658|101373418|FG001|NOT COMPLETED|Overall Study||138||
48424148|NCT02972658|101373419|FG002|NOT COMPLETED|Overall Study||75||
48424149|NCT02972658|101373420|FG003|NOT COMPLETED|Overall Study||131||
48424150|NCT03172026|101373421|FG000|STARTED|Overall Study||2||
48424151|NCT03172026|101373422|FG001|STARTED|Overall Study||0||
48424152|NCT03172026|101373421|FG000|8 Week Assessment|Overall Study||0||
48424153|NCT03172026|101373422|FG001|8 Week Assessment|Overall Study||0||
48424154|NCT03172026|101373421|FG000|6 Month Assessment|Overall Study||0||
48424155|NCT03172026|101373422|FG001|6 Month Assessment|Overall Study||0||
48424156|NCT03172026|101373421|FG000|COMPLETED|Overall Study||0||
48424157|NCT03172026|101373422|FG001|COMPLETED|Overall Study||0||
48424158|NCT03172026|101373421|FG000|NOT COMPLETED|Overall Study||2||
48424159|NCT03172026|101373422|FG001|NOT COMPLETED|Overall Study||0||
48424160|NCT01159665|101373423|FG000|STARTED|Overall Study||9||
48424161|NCT01159665|101373424|FG001|STARTED|Overall Study||9||
48424162|NCT01159665|101373425|FG002|STARTED|Overall Study||8||
48424163|NCT01159665|101373426|FG003|STARTED|Overall Study||4||
48424164|NCT01159665|101373427|FG004|STARTED|Overall Study||4||
48424165|NCT01159665|101373428|FG005|STARTED|Overall Study||4||
48424166|NCT01159665|101373423|FG000|COMPLETED|Overall Study||9||
48424167|NCT01159665|101373424|FG001|COMPLETED|Overall Study||8||
48424168|NCT01159665|101373425|FG002|COMPLETED|Overall Study||8||
48424169|NCT01159665|101373426|FG003|COMPLETED|Overall Study||4||
48424170|NCT01159665|101373427|FG004|COMPLETED|Overall Study||4||
48424171|NCT01159665|101373428|FG005|COMPLETED|Overall Study||4||
48424172|NCT01159665|101373423|FG000|NOT COMPLETED|Overall Study||0||
48424173|NCT01159665|101373424|FG001|NOT COMPLETED|Overall Study||1||
48424174|NCT01159665|101373425|FG002|NOT COMPLETED|Overall Study||0||
48424175|NCT01159665|101373426|FG003|NOT COMPLETED|Overall Study||0||
48424176|NCT01159665|101373427|FG004|NOT COMPLETED|Overall Study||0||
48424177|NCT01159665|101373428|FG005|NOT COMPLETED|Overall Study||0||
48424178|NCT01941472|101373429|FG000|STARTED|Overall Study||40||
48424179|NCT01941472|101373429|FG000|COMPLETED|Overall Study||40||
48424180|NCT01941472|101373429|FG000|NOT COMPLETED|Overall Study||0||
48424181|NCT02361307|101373430|FG000|STARTED|Overall Study||18||
48424182|NCT02361307|101373431|FG001|STARTED|Overall Study||18||
48424183|NCT02361307|101373430|FG000|COMPLETED|Overall Study||18||
48424184|NCT02361307|101373431|FG001|COMPLETED|Overall Study||17||
48424185|NCT02361307|101373430|FG000|NOT COMPLETED|Overall Study||0||
48424186|NCT02361307|101373431|FG001|NOT COMPLETED|Overall Study||1||
48424187|NCT02978339|101373432|FG000|STARTED|Overall Study||15||
48424188|NCT02978339|101373432|FG000|COMPLETED|Overall Study||15||
48424189|NCT02978339|101373432|FG000|NOT COMPLETED|Overall Study||0||
48424190|NCT01766024|101373433|FG000|STARTED|Overall Study||16||
48424191|NCT01766024|101373434|FG001|STARTED|Overall Study||16||
48424192|NCT01766024|101373433|FG000|COMPLETED|Overall Study||16||
48424193|NCT01766024|101373434|FG001|COMPLETED|Overall Study||16||
48424194|NCT01766024|101373433|FG000|NOT COMPLETED|Overall Study||0||
48424195|NCT01766024|101373434|FG001|NOT COMPLETED|Overall Study||0||
48424196|NCT02624713|101373435|FG000|STARTED|Overall Study||78||
48424197|NCT02624713|101373436|FG001|STARTED|Overall Study||81||
48424198|NCT02624713|101373435|FG000|COMPLETED|Overall Study||64||
48424199|NCT02624713|101373436|FG001|COMPLETED|Overall Study||81||
48424200|NCT02624713|101373435|FG000|NOT COMPLETED|Overall Study||14||
48424201|NCT02624713|101373436|FG001|NOT COMPLETED|Overall Study||0||
48424202|NCT01791543|101373437|FG000|STARTED|Overall Study||76||
48424203|NCT01791543|101373437|FG000|COMPLETED|Overall Study||74||
48424204|NCT01791543|101373437|FG000|NOT COMPLETED|Overall Study||2||
48424205|NCT01287403|101373438|FG000|STARTED|Diet Restriction (7 Days)||14||
48424206|NCT01287403|101373438|FG000|COMPLETED|Diet Restriction (7 Days)||14||
48424207|NCT01287403|101373438|FG000|NOT COMPLETED|Diet Restriction (7 Days)||0||
48424208|NCT01287403|101373438|FG000|STARTED|1st Intervention (1 Day)||14||
48424209|NCT01287403|101373438|FG000|COMPLETED|1st Intervention (1 Day)||13||
48424210|NCT01287403|101373438|FG000|NOT COMPLETED|1st Intervention (1 Day)||1||
48424211|NCT01287403|101373438|FG000|STARTED|Washout 7 Days||13||
48424212|NCT01287403|101373438|FG000|COMPLETED|Washout 7 Days||13||
48424213|NCT01287403|101373438|FG000|NOT COMPLETED|Washout 7 Days||0||
48424214|NCT01287403|101373438|FG000|STARTED|2nd Intervention (1 Day)||13||
48424215|NCT01287403|101373438|FG000|COMPLETED|2nd Intervention (1 Day)||13||
48424216|NCT01287403|101373438|FG000|NOT COMPLETED|2nd Intervention (1 Day)||0||
48424217|NCT01287403|101373438|FG000|STARTED|Washout (7 Days)||13||
48424218|NCT01287403|101373438|FG000|COMPLETED|Washout (7 Days)||13||
48424219|NCT01287403|101373438|FG000|NOT COMPLETED|Washout (7 Days)||0||
48424220|NCT01287403|101373438|FG000|STARTED|3rd Intervention (1 Day)||13||
48424221|NCT01287403|101373438|FG000|COMPLETED|3rd Intervention (1 Day)||13||
48424222|NCT01287403|101373438|FG000|NOT COMPLETED|3rd Intervention (1 Day)||0||
48424223|NCT01287403|101373438|FG000|STARTED|Washout (7 Days)||13||
48424224|NCT01287403|101373438|FG000|COMPLETED|Washout (7 Days)||13||
48424225|NCT01287403|101373438|FG000|NOT COMPLETED|Washout (7 Days)||0||
48424226|NCT01287403|101373438|FG000|STARTED|4th Intervention (1 Day)||13||
48424227|NCT01287403|101373438|FG000|COMPLETED|4th Intervention (1 Day)||13||
48424228|NCT01287403|101373438|FG000|NOT COMPLETED|4th Intervention (1 Day)||0||
48424229|NCT01287403|101373438|FG000|STARTED|Washout (7 Days)||13||
48424230|NCT01287403|101373438|FG000|COMPLETED|Washout (7 Days)||13||
48424231|NCT01287403|101373438|FG000|NOT COMPLETED|Washout (7 Days)||0||
48424232|NCT01287403|101373438|FG000|STARTED|5th Intervention (1 Day)||13||
48424233|NCT01287403|101373438|FG000|COMPLETED|5th Intervention (1 Day)||13||
48424234|NCT01287403|101373438|FG000|NOT COMPLETED|5th Intervention (1 Day)||0||
48424235|NCT01287403|101373438|FG000|STARTED|Washout (7 Days)||13||
48424236|NCT01287403|101373438|FG000|COMPLETED|Washout (7 Days)||13||
48424237|NCT01287403|101373438|FG000|NOT COMPLETED|Washout (7 Days)||0||
48424238|NCT01287403|101373438|FG000|STARTED|6th and Last Intervention (1 Day)||13||
48424239|NCT01287403|101373438|FG000|COMPLETED|6th and Last Intervention (1 Day)||13||
48424240|NCT01287403|101373438|FG000|NOT COMPLETED|6th and Last Intervention (1 Day)||0||
48424241|NCT02039687|101373439|FG000|STARTED|Overall Study||16||
48424242|NCT02039687|101373440|FG001|STARTED|Overall Study||16||
48359792|NCT00652093|101210736|FG002|COMPLETED|Overall Study||3||
48359793|NCT00652093|101210737|FG003|COMPLETED|Overall Study||4||
48359794|NCT00652093|101210738|FG004|COMPLETED|Overall Study||2||
48359795|NCT00652093|101210739|FG005|COMPLETED|Overall Study||4||
48359796|NCT00652093|101210734|FG000|NOT COMPLETED|Overall Study||0||
48359797|NCT00652093|101210735|FG001|NOT COMPLETED|Overall Study||0||
48359798|NCT00652093|101210736|FG002|NOT COMPLETED|Overall Study||1||
48359799|NCT00652093|101210737|FG003|NOT COMPLETED|Overall Study||0||
48359800|NCT00652093|101210738|FG004|NOT COMPLETED|Overall Study||2||
48359801|NCT00652093|101210739|FG005|NOT COMPLETED|Overall Study||0||
48359802|NCT02029430|101210740|FG000|STARTED|Overall Study||1||
48359803|NCT02029430|101210741|FG001|STARTED|Overall Study||7||
48359804|NCT02029430|101210742|FG002|STARTED|Overall Study||7||
48359805|NCT02029430|101210740|FG000|COMPLETED|Overall Study||1|Completed defined as receiving at least one dose of study drug.|
48359806|NCT02029430|101210741|FG001|COMPLETED|Overall Study||7|Completed defined as receiving at least one dose of study drug.|
48359807|NCT02029430|101210742|FG002|COMPLETED|Overall Study||7|Completed defined as receiving at least one dose of study drug.|
48359808|NCT02029430|101210740|FG000|NOT COMPLETED|Overall Study||0||
48359809|NCT02029430|101210741|FG001|NOT COMPLETED|Overall Study||0||
48359810|NCT02029430|101210742|FG002|NOT COMPLETED|Overall Study||0||
48359811|NCT00609128|101210743|FG000|STARTED|Overall Study||21||
48359812|NCT00609128|101210743|FG000|COMPLETED|Overall Study||21||
48359813|NCT00609128|101210743|FG000|NOT COMPLETED|Overall Study||0||
48359814|NCT00943878|101210744|FG000|STARTED|Overall Study||202||
48359815|NCT00943878|101210745|FG001|STARTED|Overall Study||200||
48359816|NCT00943878|101210746|FG002|STARTED|Overall Study||203||
48359817|NCT00943878|101210747|FG003|STARTED|Overall Study||200||
48359818|NCT00943878|101210744|FG000|COMPLETED|Overall Study||200||
48359819|NCT00943878|101210745|FG001|COMPLETED|Overall Study||198||
48359820|NCT00943878|101210746|FG002|COMPLETED|Overall Study||197||
48359821|NCT00943878|101210747|FG003|COMPLETED|Overall Study||198||
48359822|NCT00943878|101210744|FG000|NOT COMPLETED|Overall Study||2||
48359823|NCT00943878|101210745|FG001|NOT COMPLETED|Overall Study||2||
48359824|NCT00943878|101210746|FG002|NOT COMPLETED|Overall Study||6||
48359825|NCT00943878|101210747|FG003|NOT COMPLETED|Overall Study||2||
48359826|NCT02996305|101210748|FG000|STARTED|Overall Study||29||
48359827|NCT02996305|101210749|FG001|STARTED|Overall Study||29||
48359828|NCT02996305|101210750|FG002|STARTED|Overall Study||30||
48359829|NCT02996305|101210748|FG000|COMPLETED|Overall Study||26||
48359830|NCT02996305|101210749|FG001|COMPLETED|Overall Study||27||
48359831|NCT02996305|101210750|FG002|COMPLETED|Overall Study||25||
48359832|NCT02996305|101210748|FG000|NOT COMPLETED|Overall Study||3||
48359833|NCT02996305|101210749|FG001|NOT COMPLETED|Overall Study||2||
48359834|NCT02996305|101210750|FG002|NOT COMPLETED|Overall Study||5||
48359835|NCT01364467|101210751|FG000|STARTED|Overall Study||10||
48359836|NCT01364467|101210752|FG001|STARTED|Overall Study||20||
48359837|NCT01364467|101210751|FG000|COMPLETED|Overall Study||9||
48359838|NCT01364467|101210752|FG001|COMPLETED|Overall Study||18||
48359839|NCT01364467|101210751|FG000|NOT COMPLETED|Overall Study||1||
48359840|NCT01364467|101210752|FG001|NOT COMPLETED|Overall Study||2||
48359841|NCT02988986|101210753|FG000|STARTED|Overall Study||28||
48359842|NCT02988986|101210753|FG000|COMPLETED|Overall Study||25||
48359843|NCT02988986|101210753|FG000|NOT COMPLETED|Overall Study||3||
48359844|NCT00003820|101210754|FG000|STARTED|Cycle 1 (Initial Treatment)||23||
48359845|NCT00003820|101210755|FG001|STARTED|Cycle 1 (Initial Treatment)||16||
48359846|NCT00003820|101210754|FG000|COMPLETED|Cycle 1 (Initial Treatment)||23||
48359847|NCT00003820|101210755|FG001|COMPLETED|Cycle 1 (Initial Treatment)||16||
48359848|NCT00003820|101210754|FG000|NOT COMPLETED|Cycle 1 (Initial Treatment)||0||
48359849|NCT00003820|101210755|FG001|NOT COMPLETED|Cycle 1 (Initial Treatment)||0||
48359850|NCT00003820|101210754|FG000|STARTED|Cycle 2 (Maintenance Treatment)||0||
48359851|NCT00003820|101210755|FG001|STARTED|Cycle 2 (Maintenance Treatment)||16||
48359852|NCT00003820|101210754|FG000|COMPLETED|Cycle 2 (Maintenance Treatment)||0||
48359853|NCT00003820|101210755|FG001|COMPLETED|Cycle 2 (Maintenance Treatment)||16||
48359854|NCT00003820|101210754|FG000|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0||
48359855|NCT00003820|101210755|FG001|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0||
48359856|NCT00003820|101210754|FG000|STARTED|Cycle 3 (Maintenance Treatment)||0||
48359857|NCT00003820|101210755|FG001|STARTED|Cycle 3 (Maintenance Treatment)||16||
48359858|NCT00003820|101210754|FG000|COMPLETED|Cycle 3 (Maintenance Treatment)||0||
48359859|NCT00003820|101210755|FG001|COMPLETED|Cycle 3 (Maintenance Treatment)||16||
48359860|NCT00003820|101210754|FG000|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0||
48359861|NCT00003820|101210755|FG001|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0||
48359862|NCT00003820|101210754|FG000|STARTED|Cycle 4 (Maintenance Treatment)||0||
48359863|NCT00003820|101210755|FG001|STARTED|Cycle 4 (Maintenance Treatment)||16||
48359864|NCT00003820|101210754|FG000|COMPLETED|Cycle 4 (Maintenance Treatment)||0||
48359865|NCT00003820|101210755|FG001|COMPLETED|Cycle 4 (Maintenance Treatment)||16||
48359866|NCT00003820|101210754|FG000|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0||
48359867|NCT00003820|101210755|FG001|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0||
48359868|NCT02213757|101210756|FG000|STARTED|Overall Study||15||
48359869|NCT02213757|101210757|FG001|STARTED|Overall Study||14||
48359870|NCT02213757|101210756|FG000|COMPLETED|Overall Study||10||
48359871|NCT02213757|101210757|FG001|COMPLETED|Overall Study||10||
48424243|NCT02039687|101373441|FG002|STARTED|Overall Study||16||
48424244|NCT02039687|101373442|FG003|STARTED|Overall Study||16||
48424245|NCT02039687|101373439|FG000|COMPLETED|Overall Study||16||
48424246|NCT02039687|101373440|FG001|COMPLETED|Overall Study||15||
48424247|NCT02039687|101373441|FG002|COMPLETED|Overall Study||13||
48424248|NCT02039687|101373442|FG003|COMPLETED|Overall Study||16||
48424249|NCT02039687|101373439|FG000|NOT COMPLETED|Overall Study||0||
48424250|NCT02039687|101373440|FG001|NOT COMPLETED|Overall Study||1||
48424251|NCT02039687|101373441|FG002|NOT COMPLETED|Overall Study||3||
48424252|NCT02039687|101373442|FG003|NOT COMPLETED|Overall Study||0||
48424253|NCT03077646|101373443|FG000|STARTED|Overall Study||76||
48424254|NCT03077646|101373444|FG001|STARTED|Overall Study||75||
48424255|NCT03077646|101373445|FG002|STARTED|Overall Study||74||
48424256|NCT03077646|101373443|FG000|COMPLETED|Overall Study||47||
48424257|NCT03077646|101373444|FG001|COMPLETED|Overall Study||45||
48424258|NCT03077646|101373445|FG002|COMPLETED|Overall Study||43||
48424259|NCT03077646|101373443|FG000|NOT COMPLETED|Overall Study||29||
48424260|NCT03077646|101373444|FG001|NOT COMPLETED|Overall Study||30||
48424261|NCT03077646|101373445|FG002|NOT COMPLETED|Overall Study||31||
48424262|NCT00275834|101373446|FG000|STARTED|Overall Study||74||
48424263|NCT00275834|101373447|FG001|STARTED|Overall Study||76||
48424264|NCT00275834|101373448|FG002|STARTED|Overall Study||75||
48424265|NCT00275834|101373446|FG000|Completed Study While on Study Drug|Overall Study||54||
48424266|NCT00275834|101373447|FG001|Completed Study While on Study Drug|Overall Study||51||
48424267|NCT00275834|101373448|FG002|Completed Study While on Study Drug|Overall Study||62||
48424268|NCT00275834|101373446|FG000|COMPLETED|Overall Study||71||
48424269|NCT00275834|101373447|FG001|COMPLETED|Overall Study||73||
48424270|NCT00275834|101373448|FG002|COMPLETED|Overall Study||74||
48424271|NCT00275834|101373446|FG000|NOT COMPLETED|Overall Study||3||
48424272|NCT00275834|101373447|FG001|NOT COMPLETED|Overall Study||3||
48424273|NCT00275834|101373448|FG002|NOT COMPLETED|Overall Study||1||
48424274|NCT00218439|101373449|FG000|STARTED|First Intervention (4 Weeks)||58||
48424275|NCT00218439|101373450|FG001|STARTED|First Intervention (4 Weeks)||47||
48424276|NCT00218439|101373449|FG000|COMPLETED|First Intervention (4 Weeks)||40||
48424277|NCT00218439|101373450|FG001|COMPLETED|First Intervention (4 Weeks)||35||
48424278|NCT00218439|101373449|FG000|NOT COMPLETED|First Intervention (4 Weeks)||18||
48424279|NCT00218439|101373450|FG001|NOT COMPLETED|First Intervention (4 Weeks)||12||
48424280|NCT00218439|101373449|FG000|STARTED|Second Intervention (4 Weeks)||40||
48424281|NCT00218439|101373450|FG001|STARTED|Second Intervention (4 Weeks)||35||
48424282|NCT00218439|101373449|FG000|COMPLETED|Second Intervention (4 Weeks)||33||
48424283|NCT00218439|101373450|FG001|COMPLETED|Second Intervention (4 Weeks)||30||
48424284|NCT00218439|101373449|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||7||
48424285|NCT00218439|101373450|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||5||
48424286|NCT02384096|101373451|FG000|STARTED|First Intervention (7 Days)||5||
48424287|NCT02384096|101373452|FG001|STARTED|First Intervention (7 Days)||7||
48424288|NCT02384096|101373451|FG000|COMPLETED|First Intervention (7 Days)||4||
48424289|NCT02384096|101373452|FG001|COMPLETED|First Intervention (7 Days)||7||
48424290|NCT02384096|101373451|FG000|NOT COMPLETED|First Intervention (7 Days)||1||
48424291|NCT02384096|101373452|FG001|NOT COMPLETED|First Intervention (7 Days)||0||
48424292|NCT02384096|101373451|FG000|STARTED|Second Intervention (7 Days)||4||
48424293|NCT02384096|101373452|FG001|STARTED|Second Intervention (7 Days)||7||
48424294|NCT02384096|101373451|FG000|COMPLETED|Second Intervention (7 Days)||4||
48424295|NCT02384096|101373452|FG001|COMPLETED|Second Intervention (7 Days)||6||
48424296|NCT02384096|101373451|FG000|NOT COMPLETED|Second Intervention (7 Days)||0||
48424297|NCT02384096|101373452|FG001|NOT COMPLETED|Second Intervention (7 Days)||1||
48424298|NCT02554721|101373453|FG000|STARTED|Overall Study||20||
48424299|NCT02554721|101373454|FG001|STARTED|Overall Study||19||
48424300|NCT02554721|101373455|FG002|STARTED|Overall Study||19||
48424301|NCT02554721|101373456|FG003|STARTED|Overall Study||17||
48424302|NCT02554721|101373457|FG004|STARTED|Overall Study||2||
48424303|NCT02554721|101373453|FG000|COMPLETED|Overall Study||19||
48424304|NCT02554721|101373454|FG001|COMPLETED|Overall Study||19||
48424305|NCT02554721|101373455|FG002|COMPLETED|Overall Study||19||
48424306|NCT02554721|101373456|FG003|COMPLETED|Overall Study||17||
48424307|NCT02554721|101373457|FG004|COMPLETED|Overall Study||0||
48424308|NCT02554721|101373453|FG000|NOT COMPLETED|Overall Study||1||
48424309|NCT02554721|101373454|FG001|NOT COMPLETED|Overall Study||0||
48424310|NCT02554721|101373455|FG002|NOT COMPLETED|Overall Study||0||
48424311|NCT02554721|101373456|FG003|NOT COMPLETED|Overall Study||0||
48424312|NCT02554721|101373457|FG004|NOT COMPLETED|Overall Study||2||
48424313|NCT02308839|101373458|FG000|STARTED|Overall Study||181||
48424314|NCT02308839|101373458|FG000|COMPLETED|Overall Study||72||
48424315|NCT02308839|101373458|FG000|NOT COMPLETED|Overall Study||109||
48424316|NCT01270139|101373459|FG000|STARTED|Overall Study||60||
48424317|NCT01270139|101373460|FG001|STARTED|Overall Study||60||
48424318|NCT01270139|101373461|FG002|STARTED|Overall Study||60||
48424319|NCT01270139|101373459|FG000|COMPLETED|Overall Study||42||
48424320|NCT01270139|101373460|FG001|COMPLETED|Overall Study||34||
48424321|NCT01270139|101373461|FG002|COMPLETED|Overall Study||40||
48424322|NCT01270139|101373459|FG000|NOT COMPLETED|Overall Study||18||
48424323|NCT01270139|101373460|FG001|NOT COMPLETED|Overall Study||26||
48424324|NCT01270139|101373461|FG002|NOT COMPLETED|Overall Study||20||
48424325|NCT02312934|101373462|FG000|STARTED|Overall Study||11||
48424326|NCT02312934|101373463|FG001|STARTED|Overall Study||11||
48424327|NCT02312934|101373462|FG000|COMPLETED|Overall Study||9|Number Completed|
48424328|NCT02312934|101373463|FG001|COMPLETED|Overall Study||11|Number Completed|
48424329|NCT02312934|101373462|FG000|NOT COMPLETED|Overall Study||2||
48424330|NCT02312934|101373463|FG001|NOT COMPLETED|Overall Study||0||
48424331|NCT00125138|101373464|FG000|STARTED|Overall Study||15||
48424332|NCT00125138|101373465|FG001|STARTED|Overall Study||20||
48424333|NCT00125138|101373466|FG002|STARTED|Overall Study||25||
48424334|NCT00125138|101373467|FG003|STARTED|Overall Study||30||
48424335|NCT00125138|101373464|FG000|COMPLETED|Overall Study||12||
48424336|NCT00125138|101373465|FG001|COMPLETED|Overall Study||17||
48424337|NCT00125138|101373466|FG002|COMPLETED|Overall Study||21||
48424338|NCT00125138|101373467|FG003|COMPLETED|Overall Study||25||
48424339|NCT00125138|101373464|FG000|NOT COMPLETED|Overall Study||3||
48424340|NCT00125138|101373465|FG001|NOT COMPLETED|Overall Study||3||
48424341|NCT00125138|101373466|FG002|NOT COMPLETED|Overall Study||4||
48424342|NCT00125138|101373467|FG003|NOT COMPLETED|Overall Study||5||
48424343|NCT02441517|101373468|FG000|STARTED|Overall Study||4||
48424344|NCT02441517|101373468|FG000|Received Treatment|Overall Study||4||
48424345|NCT02441517|101373468|FG000|COMPLETED|Overall Study||0||
48424346|NCT02441517|101373468|FG000|NOT COMPLETED|Overall Study||4||
48424347|NCT02980211|101373469|FG000|STARTED|Overall Study||17||
48424348|NCT02980211|101373469|FG000|COMPLETED|Overall Study||17||
48424349|NCT02980211|101373469|FG000|NOT COMPLETED|Overall Study||0||
48424350|NCT02477215|101373470|FG000|STARTED|Dose Escalation Phase||4||
48424351|NCT02477215|101373471|FG001|STARTED|Dose Escalation Phase||8||
48424352|NCT02477215|101373472|FG002|STARTED|Dose Escalation Phase||6||
48424353|NCT02477215|101373470|FG000|COMPLETED|Dose Escalation Phase||3||
48424354|NCT02477215|101373471|FG001|COMPLETED|Dose Escalation Phase||6||
48424355|NCT02477215|101373472|FG002|COMPLETED|Dose Escalation Phase||6||
48424356|NCT02477215|101373470|FG000|NOT COMPLETED|Dose Escalation Phase||1||
48424357|NCT02477215|101373471|FG001|NOT COMPLETED|Dose Escalation Phase||2||
48424358|NCT02477215|101373472|FG002|NOT COMPLETED|Dose Escalation Phase||0||
48424359|NCT02477215|101373470|FG000|STARTED|Fixed Dose Phase||0||
48424360|NCT02477215|101373471|FG001|STARTED|Fixed Dose Phase||20||
48424361|NCT02477215|101373472|FG002|STARTED|Fixed Dose Phase||0||
48424362|NCT02477215|101373470|FG000|COMPLETED|Fixed Dose Phase||0||
48424363|NCT02477215|101373471|FG001|COMPLETED|Fixed Dose Phase||13||
48424364|NCT02477215|101373472|FG002|COMPLETED|Fixed Dose Phase||0||
48424365|NCT02477215|101373470|FG000|NOT COMPLETED|Fixed Dose Phase||0||
48424366|NCT02477215|101373471|FG001|NOT COMPLETED|Fixed Dose Phase||7||
48424367|NCT02477215|101373472|FG002|NOT COMPLETED|Fixed Dose Phase||0||
48424368|NCT05386368|101373473|FG000|STARTED|Overall Study||1||
48424369|NCT05386368|101373474|FG001|STARTED|Overall Study||0||
48424370|NCT05386368|101373473|FG000|COMPLETED|Overall Study||1||
48424371|NCT05386368|101373474|FG001|COMPLETED|Overall Study||0||
48187135|NCT00062868|100779972|FG012|STARTED|Dose Level 3||0||
48187136|NCT00062868|100779973|FG013|STARTED|Dose Level 3||0||
48187137|NCT00062868|100779974|FG014|STARTED|Dose Level 3||3||
48187138|NCT00062868|100779975|FG015|STARTED|Dose Level 3||0||
48187139|NCT00062868|100779976|FG016|STARTED|Dose Level 3||0||
48187140|NCT00062868|100779977|FG017|STARTED|Dose Level 3||4||
48187141|NCT00062868|100779978|FG018|STARTED|Dose Level 3||0||
48187142|NCT00062868|100779979|FG019|STARTED|Dose Level 3||0||
48187143|NCT00062868|100779980|FG020|STARTED|Dose Level 3||0||
48187144|NCT00062868|100779960|FG000|COMPLETED|Dose Level 3||0||
48187145|NCT00062868|100779961|FG001|COMPLETED|Dose Level 3||0||
48187146|NCT00062868|100779962|FG002|COMPLETED|Dose Level 3||1||
48187147|NCT00062868|100779963|FG003|COMPLETED|Dose Level 3||0||
48187148|NCT00062868|100779964|FG004|COMPLETED|Dose Level 3||0||
48187149|NCT00062868|100779965|FG005|COMPLETED|Dose Level 3||0||
48187150|NCT00062868|100779966|FG006|COMPLETED|Dose Level 3||0||
48187151|NCT00062868|100779967|FG007|COMPLETED|Dose Level 3||0||
48187152|NCT00062868|100779968|FG008|COMPLETED|Dose Level 3||0||
48187153|NCT00062868|100779969|FG009|COMPLETED|Dose Level 3||0||
48187154|NCT00062868|100779970|FG010|COMPLETED|Dose Level 3||0||
48187155|NCT00062868|100779971|FG011|COMPLETED|Dose Level 3||4||
48424372|NCT05386368|101373473|FG000|NOT COMPLETED|Overall Study||0||
48424373|NCT05386368|101373474|FG001|NOT COMPLETED|Overall Study||0||
48187156|NCT00062868|100779972|FG012|COMPLETED|Dose Level 3||0||
48187157|NCT00062868|100779973|FG013|COMPLETED|Dose Level 3||0||
48424374|NCT00656136|101373475|FG000|STARTED|Overall Study||195||
48424375|NCT00656136|101373476|FG001|STARTED|Overall Study||390||
48424376|NCT00656136|101373475|FG000|COMPLETED|Overall Study||0||
48187158|NCT00062868|100779974|FG014|COMPLETED|Dose Level 3||2||
48187159|NCT00062868|100779975|FG015|COMPLETED|Dose Level 3||0||
48187160|NCT00062868|100779976|FG016|COMPLETED|Dose Level 3||0||
48187161|NCT00062868|100779977|FG017|COMPLETED|Dose Level 3||3||
48187162|NCT00062868|100779978|FG018|COMPLETED|Dose Level 3||0||
48424377|NCT00656136|101373476|FG001|COMPLETED|Overall Study||0||
48424378|NCT00656136|101373475|FG000|NOT COMPLETED|Overall Study||195||
48424379|NCT00656136|101373476|FG001|NOT COMPLETED|Overall Study||390||
48424380|NCT01640353|101373477|FG000|STARTED|Overall Study||194||
48763864|NCT02993107|102211813|FG001|COMPLETED|Overall Study||107||
48763865|NCT02993107|102211814|FG002|COMPLETED|Overall Study||39||
48763866|NCT02993107|102211815|FG003|COMPLETED|Overall Study||29||
48763867|NCT02993107|102211816|FG004|COMPLETED|Overall Study||22||
48763868|NCT02993107|102211817|FG005|COMPLETED|Overall Study||21||
48763869|NCT02993107|102211812|FG000|NOT COMPLETED|Overall Study||51||
48763870|NCT02993107|102211813|FG001|NOT COMPLETED|Overall Study||13||
48763871|NCT02993107|102211814|FG002|NOT COMPLETED|Overall Study||11||
48763872|NCT02993107|102211815|FG003|NOT COMPLETED|Overall Study||6||
48763873|NCT02993107|102211816|FG004|NOT COMPLETED|Overall Study||12||
48763874|NCT02993107|102211817|FG005|NOT COMPLETED|Overall Study||15||
48763875|NCT02603887|102211818|FG000|STARTED|Stage 1||12||
48763876|NCT02603887|102211818|FG000|Cycle 1|Stage 1||12||
48763877|NCT02603887|102211818|FG000|Cycle 8|Stage 1||7||
48763878|NCT02603887|102211818|FG000|COMPLETED|Stage 1||7||
48763879|NCT02603887|102211818|FG000|NOT COMPLETED|Stage 1||5||
48763880|NCT02603887|102211818|FG000|STARTED|Stage 2||1||
48763881|NCT02603887|102211818|FG000|Cycle 1|Stage 2||1||
48763882|NCT02603887|102211818|FG000|Cycle 8|Stage 2||0||
48763883|NCT02603887|102211818|FG000|COMPLETED|Stage 2||0||
48763884|NCT02603887|102211818|FG000|NOT COMPLETED|Stage 2||1||
48763885|NCT01488890|102211819|FG000|STARTED|Overall Study||120||
48763886|NCT01488890|102211820|FG001|STARTED|Overall Study||120||
48763887|NCT01488890|102211821|FG002|STARTED|Overall Study||120||
48359872|NCT02213757|101210756|FG000|NOT COMPLETED|Overall Study||5||
48359873|NCT02213757|101210757|FG001|NOT COMPLETED|Overall Study||4||
48359874|NCT01770353|101210758|FG000|STARTED|Overall Study||15||
48359875|NCT01770353|101210759|FG001|STARTED|Overall Study||30||
48359876|NCT01770353|101210758|FG000|Received FMX|Overall Study||15|2 subjects in Pilot + 1 in Expansion died due to progressive disease before MM-398 treatment|
48359877|NCT01770353|101210759|FG001|Received FMX|Overall Study||30|2 subjects in Pilot + 1 in Expansion died due to progressive disease before MM-398 treatment|
48359878|NCT01770353|101210758|FG000|Received FMX and MM-398|Overall Study||13|MM-398 safety population.|
48359879|NCT01770353|101210759|FG001|Received FMX and MM-398|Overall Study||29|MM-398 safety population.|
48359880|NCT01770353|101210758|FG000|COMPLETED|Overall Study||9|Received MM-398 treatment up to disease progression.|
48359881|NCT01770353|101210759|FG001|COMPLETED|Overall Study||18|Received MM-398 treatment up to disease progression.|
48359882|NCT01770353|101210758|FG000|NOT COMPLETED|Overall Study||6||
48359883|NCT01770353|101210759|FG001|NOT COMPLETED|Overall Study||12||
48359884|NCT03419533|101210760|FG000|STARTED|Overall Study||4107||
48359885|NCT03419533|101210761|FG001|STARTED|Overall Study||2695||
48359886|NCT03419533|101210760|FG000|COMPLETED|Overall Study||4107||
48359887|NCT03419533|101210761|FG001|COMPLETED|Overall Study||2695||
48359888|NCT03419533|101210760|FG000|NOT COMPLETED|Overall Study||0||
48359889|NCT03419533|101210761|FG001|NOT COMPLETED|Overall Study||0||
48359890|NCT01458340|101210762|FG000|STARTED|Overall Study||97|Intent-to-treat (ITT) population|
48359891|NCT01458340|101210763|FG001|STARTED|Overall Study||99|Intent-to-treat (ITT) population|
48359892|NCT01458340|101210764|FG002|STARTED|Overall Study||99|Intent-to-treat (ITT) population|
48359893|NCT01458340|101210762|FG000|Received Study Treatment|Overall Study||97|Safety Analysis Group|
48359894|NCT01458340|101210763|FG001|Received Study Treatment|Overall Study||98|Safety Analysis Group|
48359895|NCT01458340|101210764|FG002|Received Study Treatment|Overall Study||98|Safety Analysis Group|
48359896|NCT01458340|101210762|FG000|COMPLETED|Overall Study||70||
48359897|NCT01458340|101210763|FG001|COMPLETED|Overall Study||78||
48359898|NCT01458340|101210764|FG002|COMPLETED|Overall Study||76||
48359899|NCT01458340|101210762|FG000|NOT COMPLETED|Overall Study||27||
48763888|NCT01488890|102211822|FG003|STARTED|Overall Study||30||
48763889|NCT01488890|102211819|FG000|Treated|Overall Study||120||
48763890|NCT01488890|102211820|FG001|Treated|Overall Study||120||
48763891|NCT01488890|102211821|FG002|Treated|Overall Study||119||
48763892|NCT01488890|102211822|FG003|Treated|Overall Study||30||
48763893|NCT01488890|102211819|FG000|COMPLETED|Overall Study||88||
48763894|NCT01488890|102211820|FG001|COMPLETED|Overall Study||100||
48763895|NCT01488890|102211821|FG002|COMPLETED|Overall Study||85||
48763896|NCT01488890|102211822|FG003|COMPLETED|Overall Study||25||
48763897|NCT01488890|102211819|FG000|NOT COMPLETED|Overall Study||32||
48763898|NCT01488890|102211820|FG001|NOT COMPLETED|Overall Study||20||
48763899|NCT01488890|102211821|FG002|NOT COMPLETED|Overall Study||35||
48763900|NCT01488890|102211822|FG003|NOT COMPLETED|Overall Study||5||
48763901|NCT01774721|102211823|FG000|STARTED|Overall Study||227||
48763902|NCT01774721|102211824|FG001|STARTED|Overall Study||225||
48763903|NCT01774721|102211823|FG000|Treated|Overall Study||227||
48763904|NCT01774721|102211824|FG001|Treated|Overall Study||224||
48763905|NCT01774721|102211823|FG000|COMPLETED|Overall Study||0||
48763906|NCT01774721|102211824|FG001|COMPLETED|Overall Study||0||
48763907|NCT01774721|102211823|FG000|NOT COMPLETED|Overall Study||227||
48359900|NCT01458340|101210763|FG001|NOT COMPLETED|Overall Study||21||
48359901|NCT01458340|101210764|FG002|NOT COMPLETED|Overall Study||23||
48763908|NCT01774721|102211824|FG001|NOT COMPLETED|Overall Study||225||
48763909|NCT02491684|102211825|FG000|STARTED|Pre-treatment Phase||61||
48763910|NCT02491684|102211826|FG001|STARTED|Pre-treatment Phase||60||
48763911|NCT02491684|102211825|FG000|COMPLETED|Pre-treatment Phase||61||
48763912|NCT02491684|102211826|FG001|COMPLETED|Pre-treatment Phase||60||
48763913|NCT02491684|102211825|FG000|NOT COMPLETED|Pre-treatment Phase||0||
48763914|NCT02491684|102211826|FG001|NOT COMPLETED|Pre-treatment Phase||0||
48763915|NCT02491684|102211825|FG000|STARTED|Treatment Phase||61||
48763916|NCT02491684|102211826|FG001|STARTED|Treatment Phase||60||
48763917|NCT02491684|102211825|FG000|COMPLETED|Treatment Phase||58||
48763918|NCT02491684|102211826|FG001|COMPLETED|Treatment Phase||57||
48763919|NCT02491684|102211825|FG000|NOT COMPLETED|Treatment Phase||3||
48763920|NCT02491684|102211826|FG001|NOT COMPLETED|Treatment Phase||3||
48763921|NCT03592186|102211827|FG000|STARTED|Overall Study||60||30
48763922|NCT03592186|102211828|FG001|STARTED|Overall Study||62||31
48763923|NCT03592186|102211827|FG000|6-week Follow-up|Overall Study||49|At 6-week follow-up, 25 PW+ dyads (25 parents, 24 teens) and 29 TAU dyads (29 parents, 27 teens)|25
48763924|NCT03592186|102211828|FG001|6-week Follow-up|Overall Study||56|At 6-week follow-up, 25 PW+ dyads (25 parents, 24 teens) and 29 TAU dyads (29 parents, 27 teens)|29
48763925|NCT03592186|102211827|FG000|12-week Follow-up|Overall Study||47|At 12-week follow-up, 27 PW+ dyads (25 parents, 22 teens) and 27 TAU dyads (26 parents, 25 teens)|27
48763926|NCT03592186|102211828|FG001|12-week Follow-up|Overall Study||51|At 12-week follow-up, 27 PW+ dyads (25 parents, 22 teens) and 27 TAU dyads (26 parents, 25 teens)|27
48763927|NCT03592186|102211827|FG000|COMPLETED|Overall Study||43|At 24-week (final), 24 PW+ dyads (23 parents, 20 teens) and 27 TAU dyads (25 parents, 26 teens).|24
48763928|NCT03592186|102211828|FG001|COMPLETED|Overall Study||51|At 24-week (final), 24 PW+ dyads (23 parents, 20 teens) and 27 TAU dyads (25 parents, 26 teens).|27
48763929|NCT03592186|102211827|FG000|NOT COMPLETED|Overall Study||17||6
48763930|NCT03592186|102211828|FG001|NOT COMPLETED|Overall Study||11||4
48763931|NCT02855125|102211829|FG000|STARTED|Overall Study||64||
48763932|NCT02855125|102211830|FG001|STARTED|Overall Study||64||
48763933|NCT02855125|102211829|FG000|Treated|Overall Study||64||
48763934|NCT02855125|102211830|FG001|Treated|Overall Study||63||
48424381|NCT01640353|101373477|FG000|Treated|Overall Study||172||
48424382|NCT01640353|101373477|FG000|Month 1|Overall Study||171||
48424383|NCT01640353|101373477|FG000|Month 3|Overall Study||169||
48424384|NCT01640353|101373477|FG000|Month 6|Overall Study||168||
48424385|NCT01640353|101373477|FG000|Month 12|Overall Study||160||
48424386|NCT01640353|101373477|FG000|Month 18|Overall Study||150||
48424387|NCT01640353|101373477|FG000|COMPLETED|Overall Study||149||
48424388|NCT01640353|101373477|FG000|NOT COMPLETED|Overall Study||45||
48424389|NCT01003691|101373478|FG000|STARTED|Overall Study||6||
48424390|NCT01003691|101373479|FG001|STARTED|Overall Study||6||
48424391|NCT01003691|101373480|FG002|STARTED|Overall Study||6||
48424392|NCT01003691|101373481|FG003|STARTED|Overall Study||6||
48424393|NCT01003691|101373478|FG000|COMPLETED|Overall Study||6||
48424394|NCT01003691|101373479|FG001|COMPLETED|Overall Study||6||
48424395|NCT01003691|101373480|FG002|COMPLETED|Overall Study||6||
48424396|NCT01003691|101373481|FG003|COMPLETED|Overall Study||5||
48424397|NCT01003691|101373478|FG000|NOT COMPLETED|Overall Study||0||
48424398|NCT01003691|101373479|FG001|NOT COMPLETED|Overall Study||0||
48424399|NCT01003691|101373480|FG002|NOT COMPLETED|Overall Study||0||
48424400|NCT01003691|101373481|FG003|NOT COMPLETED|Overall Study||1||
48424401|NCT02451137|101373482|FG000|STARTED|Overall Study||1651||
48424402|NCT02451137|101373483|FG001|STARTED|Overall Study||1653||
48424403|NCT02451137|101373482|FG000|Treated|Overall Study||1632||
48424404|NCT02451137|101373483|FG001|Treated|Overall Study||1626||
48424405|NCT02451137|101373482|FG000|Safety Population|Overall Study||1637|Randomized participants who received atleast 1 dose of drug analyzed according to treatment received|
48424406|NCT02451137|101373483|FG001|Safety Population|Overall Study||1621|Randomized participants who received atleast 1 dose of drug analyzed according to treatment received|
48424407|NCT02451137|101373482|FG000|COMPLETED|Overall Study||1405|Completed 12 month on treatment period(time from 1st IMP intake upto last IMP + 1 day)|
48424408|NCT02451137|101373483|FG001|COMPLETED|Overall Study||1355|Completed 12 month on treatment period(time from 1st IMP intake upto last IMP + 1 day)|
48424409|NCT02451137|101373482|FG000|NOT COMPLETED|Overall Study||246||
48424410|NCT02451137|101373483|FG001|NOT COMPLETED|Overall Study||298||
48424411|NCT04235959|101373484|FG000|STARTED|Overall Study||4||
48424412|NCT04235959|101373485|FG001|STARTED|Overall Study||10||
48424413|NCT04235959|101373486|FG002|STARTED|Overall Study||10||
48424414|NCT04235959|101373484|FG000|Received At Least One Dose of Study Drug|Overall Study||4||
48424415|NCT04235959|101373485|FG001|Received At Least One Dose of Study Drug|Overall Study||10||
48424416|NCT04235959|101373486|FG002|Received At Least One Dose of Study Drug|Overall Study||10||
48424417|NCT04235959|101373484|FG000|COMPLETED|Overall Study||3||
48424418|NCT04235959|101373485|FG001|COMPLETED|Overall Study||9||
48424419|NCT04235959|101373486|FG002|COMPLETED|Overall Study||10||
48424420|NCT04235959|101373484|FG000|NOT COMPLETED|Overall Study||1||
48424421|NCT04235959|101373485|FG001|NOT COMPLETED|Overall Study||1||
48424422|NCT04235959|101373486|FG002|NOT COMPLETED|Overall Study||0||
48424423|NCT02043704|101373487|FG000|STARTED|Overall Study||50||
48424424|NCT02043704|101373488|FG001|STARTED|Overall Study||50||
48763935|NCT02855125|102211829|FG000|COMPLETED|Overall Study||0||
48763936|NCT02855125|102211830|FG001|COMPLETED|Overall Study||0||
48763937|NCT02855125|102211829|FG000|NOT COMPLETED|Overall Study||64||
48763938|NCT02855125|102211830|FG001|NOT COMPLETED|Overall Study||64||
48763939|NCT02920632|102211831|FG000|STARTED|Overall Study||68||
48763940|NCT02920632|102211832|FG001|STARTED|Overall Study||68||
48763941|NCT02920632|102211833|FG002|STARTED|Overall Study||31||
48763942|NCT02920632|102211831|FG000|T1 (After Training)|Overall Study||67||
48424425|NCT02043704|101373487|FG000|COMPLETED|Overall Study||47||
48424426|NCT02043704|101373488|FG001|COMPLETED|Overall Study||43||
48424427|NCT02043704|101373487|FG000|NOT COMPLETED|Overall Study||3||
48424428|NCT02043704|101373488|FG001|NOT COMPLETED|Overall Study||7||
48424429|NCT01365182|101373489|FG000|STARTED|Overall Study||91||
48424430|NCT01365182|101373490|FG001|STARTED|Overall Study||94||
48424431|NCT01365182|101373491|FG002|STARTED|Overall Study||94||
48424432|NCT01365182|101373489|FG000|COMPLETED|Overall Study||81||
48424433|NCT01365182|101373490|FG001|COMPLETED|Overall Study||81||
48424434|NCT01365182|101373491|FG002|COMPLETED|Overall Study||82||
48424435|NCT01365182|101373489|FG000|NOT COMPLETED|Overall Study||10||
48424436|NCT01365182|101373490|FG001|NOT COMPLETED|Overall Study||13||
48424437|NCT01365182|101373491|FG002|NOT COMPLETED|Overall Study||12||
48424438|NCT01377194|101373492|FG000|STARTED|Overall Study||186||
48424439|NCT01377194|101373493|FG001|STARTED|Overall Study||188||
48424440|NCT01377194|101373494|FG002|STARTED|Overall Study||188||
48424441|NCT01377194|101373492|FG000|COMPLETED|Overall Study||154||
48424442|NCT01377194|101373493|FG001|COMPLETED|Overall Study||145||
48424443|NCT01377194|101373494|FG002|COMPLETED|Overall Study||142||
48424444|NCT01377194|101373492|FG000|NOT COMPLETED|Overall Study||32||
48424445|NCT01377194|101373493|FG001|NOT COMPLETED|Overall Study||43||
48424446|NCT01377194|101373494|FG002|NOT COMPLETED|Overall Study||46||
48424447|NCT01616173|101373495|FG000|STARTED|Overall Study||27||
48424448|NCT01616173|101373496|FG001|STARTED|Overall Study||26||
48424449|NCT01616173|101373497|FG002|STARTED|Overall Study||27||
48424450|NCT01616173|101373495|FG000|COMPLETED|Overall Study||27||
48424451|NCT01616173|101373496|FG001|COMPLETED|Overall Study||24||
48424452|NCT01616173|101373497|FG002|COMPLETED|Overall Study||27||
48424453|NCT01616173|101373495|FG000|NOT COMPLETED|Overall Study||0||
48424454|NCT01616173|101373496|FG001|NOT COMPLETED|Overall Study||2||
48424455|NCT01616173|101373497|FG002|NOT COMPLETED|Overall Study||0||
48424456|NCT00963040|101373498|FG000|STARTED|TI-004 Protocol||22||
48424457|NCT00963040|101373499|FG001|STARTED|TI-004 Protocol||18||
48424458|NCT00963040|101373500|FG002|STARTED|TI-004 Protocol||0||
48424459|NCT00963040|101373501|FG003|STARTED|TI-004 Protocol||0||
48424460|NCT00963040|101373498|FG000|COMPLETED|TI-004 Protocol||22||
48424461|NCT00963040|101373499|FG001|COMPLETED|TI-004 Protocol||18||
48424462|NCT00963040|101373500|FG002|COMPLETED|TI-004 Protocol||0||
48424463|NCT00963040|101373501|FG003|COMPLETED|TI-004 Protocol||0||
48424464|NCT00963040|101373498|FG000|NOT COMPLETED|TI-004 Protocol||0||
48424465|NCT00963040|101373499|FG001|NOT COMPLETED|TI-004 Protocol||0||
48424466|NCT00963040|101373500|FG002|NOT COMPLETED|TI-004 Protocol||0||
48638893|NCT03010501|101901529|FG003|STARTED|Study Week 2||5||
48638894|NCT03010501|101901530|FG004|STARTED|Study Week 2||7||
48638895|NCT03010501|101901531|FG005|STARTED|Study Week 2||11||
48638896|NCT03010501|101901526|FG000|COMPLETED|Study Week 2||7||
48638897|NCT03010501|101901527|FG001|COMPLETED|Study Week 2||14||
48638898|NCT03010501|101901528|FG002|COMPLETED|Study Week 2||7||
48638899|NCT03010501|101901529|FG003|COMPLETED|Study Week 2||5||
48638900|NCT03010501|101901530|FG004|COMPLETED|Study Week 2||7||
48638901|NCT03010501|101901531|FG005|COMPLETED|Study Week 2||11||
48638902|NCT03010501|101901526|FG000|NOT COMPLETED|Study Week 2||0||
48638903|NCT03010501|101901527|FG001|NOT COMPLETED|Study Week 2||0||
48638904|NCT03010501|101901528|FG002|NOT COMPLETED|Study Week 2||0||
48638905|NCT03010501|101901529|FG003|NOT COMPLETED|Study Week 2||0||
48638906|NCT03010501|101901530|FG004|NOT COMPLETED|Study Week 2||0||
48638907|NCT03010501|101901531|FG005|NOT COMPLETED|Study Week 2||0||
48638908|NCT03010501|101901526|FG000|STARTED|Study Week 3||7||
48638909|NCT03010501|101901527|FG001|STARTED|Study Week 3||14||
48638910|NCT03010501|101901528|FG002|STARTED|Study Week 3||7||
48638911|NCT03010501|101901529|FG003|STARTED|Study Week 3||5||
48638912|NCT03010501|101901530|FG004|STARTED|Study Week 3||7||
48638913|NCT03010501|101901531|FG005|STARTED|Study Week 3||11||
48638914|NCT03010501|101901526|FG000|COMPLETED|Study Week 3||7||
48638915|NCT03010501|101901527|FG001|COMPLETED|Study Week 3||14||
48638916|NCT03010501|101901528|FG002|COMPLETED|Study Week 3||7||
48638917|NCT03010501|101901529|FG003|COMPLETED|Study Week 3||4||
48424467|NCT00963040|101373501|FG003|NOT COMPLETED|TI-004 Protocol||0||
48424468|NCT00963040|101373498|FG000|STARTED|TI-005 Protocol||0||
48424469|NCT00963040|101373499|FG001|STARTED|TI-005 Protocol||0||
48424470|NCT00963040|101373500|FG002|STARTED|TI-005 Protocol||12||
48424471|NCT00963040|101373501|FG003|STARTED|TI-005 Protocol||8||
48763943|NCT02920632|102211832|FG001|T1 (After Training)|Overall Study||66||
48424472|NCT00963040|101373498|FG000|COMPLETED|TI-005 Protocol||0||
48424473|NCT00963040|101373499|FG001|COMPLETED|TI-005 Protocol||0||
48424474|NCT00963040|101373500|FG002|COMPLETED|TI-005 Protocol||12||
48424475|NCT00963040|101373501|FG003|COMPLETED|TI-005 Protocol||8||
48424476|NCT00963040|101373498|FG000|NOT COMPLETED|TI-005 Protocol||0||
48638918|NCT03010501|101901530|FG004|COMPLETED|Study Week 3||7||
48638919|NCT03010501|101901531|FG005|COMPLETED|Study Week 3||11||
48638920|NCT03010501|101901526|FG000|NOT COMPLETED|Study Week 3||0||
48638921|NCT03010501|101901527|FG001|NOT COMPLETED|Study Week 3||0||
48424477|NCT00963040|101373499|FG001|NOT COMPLETED|TI-005 Protocol||0||
48638922|NCT03010501|101901528|FG002|NOT COMPLETED|Study Week 3||0||
48638923|NCT03010501|101901529|FG003|NOT COMPLETED|Study Week 3||1||
48638924|NCT03010501|101901530|FG004|NOT COMPLETED|Study Week 3||0||
48638925|NCT03010501|101901531|FG005|NOT COMPLETED|Study Week 3||0||
48187163|NCT00062868|100779979|FG019|COMPLETED|Dose Level 3||0||
48187164|NCT00062868|100779980|FG020|COMPLETED|Dose Level 3||0||
48187165|NCT00062868|100779960|FG000|NOT COMPLETED|Dose Level 3||0||
48187166|NCT00062868|100779961|FG001|NOT COMPLETED|Dose Level 3||0||
48187167|NCT00062868|100779962|FG002|NOT COMPLETED|Dose Level 3||2||
48187168|NCT00062868|100779963|FG003|NOT COMPLETED|Dose Level 3||0||
48187169|NCT00062868|100779964|FG004|NOT COMPLETED|Dose Level 3||0||
48187170|NCT00062868|100779965|FG005|NOT COMPLETED|Dose Level 3||0||
48187171|NCT00062868|100779966|FG006|NOT COMPLETED|Dose Level 3||0||
48187172|NCT00062868|100779967|FG007|NOT COMPLETED|Dose Level 3||0||
48187173|NCT00062868|100779968|FG008|NOT COMPLETED|Dose Level 3||0||
48187174|NCT00062868|100779969|FG009|NOT COMPLETED|Dose Level 3||0||
48187175|NCT00062868|100779970|FG010|NOT COMPLETED|Dose Level 3||0||
48187176|NCT00062868|100779971|FG011|NOT COMPLETED|Dose Level 3||1||
48187177|NCT00062868|100779972|FG012|NOT COMPLETED|Dose Level 3||0||
48187178|NCT00062868|100779973|FG013|NOT COMPLETED|Dose Level 3||0||
48187179|NCT00062868|100779974|FG014|NOT COMPLETED|Dose Level 3||1||
48187180|NCT00062868|100779975|FG015|NOT COMPLETED|Dose Level 3||0||
48187181|NCT00062868|100779976|FG016|NOT COMPLETED|Dose Level 3||0||
48187182|NCT00062868|100779977|FG017|NOT COMPLETED|Dose Level 3||1||
48187183|NCT00062868|100779978|FG018|NOT COMPLETED|Dose Level 3||0||
48187184|NCT00062868|100779979|FG019|NOT COMPLETED|Dose Level 3||0||
48187185|NCT00062868|100779980|FG020|NOT COMPLETED|Dose Level 3||0||
48187186|NCT02300311|100779981|FG000|STARTED|Overall Study||69||
48187187|NCT02300311|100779982|FG001|STARTED|Overall Study||69||
48187188|NCT02300311|100779981|FG000|COMPLETED|Overall Study||50||
48187189|NCT02300311|100779982|FG001|COMPLETED|Overall Study||69||
48187190|NCT02300311|100779981|FG000|NOT COMPLETED|Overall Study||19||
48187191|NCT02300311|100779982|FG001|NOT COMPLETED|Overall Study||0||
48187192|NCT01627340|100779983|FG000|STARTED|Overall Study||416||
48187193|NCT01627340|100779984|FG001|STARTED|Overall Study||258||
48187194|NCT01627340|100779983|FG000|COMPLETED|Overall Study||404||
48187195|NCT01627340|100779984|FG001|COMPLETED|Overall Study||254||
48187196|NCT01627340|100779983|FG000|NOT COMPLETED|Overall Study||12||
48187197|NCT01627340|100779984|FG001|NOT COMPLETED|Overall Study||4||
48187198|NCT03633903|100779985|FG000|STARTED|Overall Study||22||
48187199|NCT03633903|100779986|FG001|STARTED|Overall Study||18||
48187200|NCT03633903|100779985|FG000|Intent to Treat|Overall Study||0||
48187201|NCT03633903|100779986|FG001|Intent to Treat|Overall Study||18||
48187202|NCT03633903|100779985|FG000|COMPLETED|Overall Study||16||
48187203|NCT03633903|100779986|FG001|COMPLETED|Overall Study||11||
48187204|NCT03633903|100779985|FG000|NOT COMPLETED|Overall Study||6||
48187205|NCT03633903|100779986|FG001|NOT COMPLETED|Overall Study||7||
48187206|NCT01712685|100779987|FG000|STARTED|Overall Study||12||
48187207|NCT01712685|100779987|FG000|COMPLETED|Overall Study||11||
48187208|NCT01712685|100779987|FG000|NOT COMPLETED|Overall Study||1||
48187209|NCT03699124|100779988|FG000|STARTED|Overall Study||377|Randomized|
48187210|NCT03699124|100779989|FG001|STARTED|Overall Study||375|Randomized|
48187211|NCT03699124|100779990|FG002|STARTED|Overall Study||377|Randomized|
48187212|NCT03699124|100779988|FG000|COMPLETED|Overall Study||332|Active study period|
48187213|NCT03699124|100779989|FG001|COMPLETED|Overall Study||335|Active study period|
48187214|NCT03699124|100779990|FG002|COMPLETED|Overall Study||337|Active study period|
48187215|NCT03699124|100779988|FG000|NOT COMPLETED|Overall Study||45||
48187216|NCT03699124|100779989|FG001|NOT COMPLETED|Overall Study||40||
48187217|NCT03699124|100779990|FG002|NOT COMPLETED|Overall Study||40||
48187218|NCT01031043|100779991|FG000|STARTED|Overall Study||5||
48187219|NCT01031043|100779991|FG000|COMPLETED|Overall Study||4||
48187220|NCT01031043|100779991|FG000|NOT COMPLETED|Overall Study||1||
48187221|NCT00410384|100779992|FG000|STARTED|Overall Study||275||
48187222|NCT00410384|100779993|FG001|STARTED|Overall Study||271||
48187223|NCT00410384|100779994|FG002|STARTED|Overall Study||273||
48187224|NCT00410384|100779992|FG000|COMPLETED|Overall Study||186||
48187225|NCT00410384|100779993|FG001|COMPLETED|Overall Study||199||
48187226|NCT00410384|100779994|FG002|COMPLETED|Overall Study||191||
48187227|NCT00410384|100779992|FG000|NOT COMPLETED|Overall Study||89||
48187228|NCT00410384|100779993|FG001|NOT COMPLETED|Overall Study||72||
48187229|NCT00410384|100779994|FG002|NOT COMPLETED|Overall Study||82||
48187230|NCT01272011|100779995|FG000|STARTED|Overall Study||3||
48187231|NCT01272011|100779996|FG001|STARTED|Overall Study||10||
48187232|NCT01272011|100779997|FG002|STARTED|Overall Study||3||
48187233|NCT01272011|100779995|FG000|COMPLETED|Overall Study||3||
48187234|NCT01272011|100779996|FG001|COMPLETED|Overall Study||8||
48187235|NCT01272011|100779997|FG002|COMPLETED|Overall Study||3||
48187236|NCT01272011|100779995|FG000|NOT COMPLETED|Overall Study||0||
48187237|NCT01272011|100779996|FG001|NOT COMPLETED|Overall Study||2||
48187238|NCT01272011|100779997|FG002|NOT COMPLETED|Overall Study||0||
48187239|NCT01359410|100779998|FG000|STARTED|Overall Study||54||
48187240|NCT01359410|100779999|FG001|STARTED|Overall Study||46||
48187241|NCT01359410|100779998|FG000|COMPLETED|Overall Study||54||
48187242|NCT01359410|100779999|FG001|COMPLETED|Overall Study||46||
48187243|NCT01359410|100779998|FG000|NOT COMPLETED|Overall Study||0||
48187244|NCT01359410|100779999|FG001|NOT COMPLETED|Overall Study||0||
48187245|NCT04822298|100780000|FG000|STARTED|Overall Study||3||
48187246|NCT04822298|100780000|FG000|COMPLETED|Overall Study||0||
48424478|NCT00963040|101373500|FG002|NOT COMPLETED|TI-005 Protocol||0||
48424479|NCT00963040|101373501|FG003|NOT COMPLETED|TI-005 Protocol||0||
48424480|NCT00280059|101373502|FG000|STARTED|Efficacy Assessment Phase||330||
48424481|NCT00280059|101373503|FG001|STARTED|Efficacy Assessment Phase||330||
48424482|NCT00280059|101373502|FG000|COMPLETED|Efficacy Assessment Phase||236||
48424483|NCT00280059|101373503|FG001|COMPLETED|Efficacy Assessment Phase||250||
48424484|NCT00280059|101373502|FG000|NOT COMPLETED|Efficacy Assessment Phase||94||
48424485|NCT00280059|101373503|FG001|NOT COMPLETED|Efficacy Assessment Phase||80||
48424486|NCT00280059|101373502|FG000|STARTED|Extension Phase||194||
48424487|NCT00280059|101373503|FG001|STARTED|Extension Phase||215||
48424488|NCT00280059|101373502|FG000|COMPLETED|Extension Phase||145||
48424489|NCT00280059|101373503|FG001|COMPLETED|Extension Phase||177||
48424490|NCT00280059|101373502|FG000|NOT COMPLETED|Extension Phase||49||
48424491|NCT00280059|101373503|FG001|NOT COMPLETED|Extension Phase||38||
48424492|NCT03839446|101373504|FG000|STARTED|Overall Study||16||
48424493|NCT03839446|101373504|FG000|COMPLETED|Overall Study||16||
48424494|NCT03839446|101373504|FG000|NOT COMPLETED|Overall Study||0||
48424495|NCT02418000|101373505|FG000|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||7||
48424496|NCT02418000|101373506|FG001|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0||
48424497|NCT02418000|101373507|FG002|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0||
48424498|NCT02418000|101373508|FG003|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0||
48424499|NCT02418000|101373509|FG004|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0||
48424500|NCT02418000|101373505|FG000|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0||
48424501|NCT02418000|101373506|FG001|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0||
48424502|NCT02418000|101373507|FG002|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0||
48424503|NCT02418000|101373508|FG003|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0||
48424504|NCT02418000|101373509|FG004|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0||
48424505|NCT02418000|101373505|FG000|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||7||
48424506|NCT02418000|101373506|FG001|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0||
48424507|NCT02418000|101373507|FG002|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0||
48424508|NCT02418000|101373508|FG003|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0||
48424509|NCT02418000|101373509|FG004|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0||
48424510|NCT02418000|101373505|FG000|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0||
48424511|NCT02418000|101373506|FG001|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||10||
48424512|NCT02418000|101373507|FG002|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0||
48424513|NCT02418000|101373508|FG003|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0||
48424514|NCT02418000|101373509|FG004|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0||
48424515|NCT02418000|101373505|FG000|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0||
48424516|NCT02418000|101373506|FG001|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0||
48424517|NCT02418000|101373507|FG002|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0||
48424518|NCT02418000|101373508|FG003|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0||
48424519|NCT02418000|101373509|FG004|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0||
48424520|NCT02418000|101373505|FG000|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0||
48424521|NCT02418000|101373506|FG001|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||10||
48424522|NCT02418000|101373507|FG002|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0||
48424523|NCT02418000|101373508|FG003|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0||
48424524|NCT02418000|101373509|FG004|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0||
48424525|NCT02418000|101373505|FG000|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0||
48424526|NCT02418000|101373506|FG001|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0||
48424527|NCT02418000|101373507|FG002|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||3||
48424528|NCT02418000|101373508|FG003|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0||
48424529|NCT02418000|101373509|FG004|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0||
48424530|NCT02418000|101373505|FG000|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0||
48424531|NCT02418000|101373506|FG001|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0||
48424532|NCT02418000|101373507|FG002|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0||
48424533|NCT02418000|101373508|FG003|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0||
48424534|NCT02418000|101373509|FG004|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0||
48424535|NCT02418000|101373505|FG000|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0||
48424536|NCT02418000|101373506|FG001|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0||
48424537|NCT02418000|101373507|FG002|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||3||
48424538|NCT02418000|101373508|FG003|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0||
48424539|NCT02418000|101373509|FG004|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0||
48424540|NCT02418000|101373505|FG000|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0||
48424541|NCT02418000|101373506|FG001|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0||
48424542|NCT02418000|101373507|FG002|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0||
48424543|NCT02418000|101373508|FG003|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||3||
48424544|NCT02418000|101373509|FG004|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0||
48424545|NCT02418000|101373505|FG000|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0||
48424546|NCT02418000|101373506|FG001|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0||
48424547|NCT02418000|101373507|FG002|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0||
48424548|NCT02418000|101373508|FG003|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0||
48424549|NCT02418000|101373509|FG004|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0||
48424550|NCT02418000|101373505|FG000|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0||
48424551|NCT02418000|101373506|FG001|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0||
48424552|NCT02418000|101373507|FG002|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0||
48424553|NCT02418000|101373508|FG003|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||3||
48424554|NCT02418000|101373509|FG004|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0||
48424555|NCT02418000|101373505|FG000|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0||
48424556|NCT02418000|101373506|FG001|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0||
48424557|NCT02418000|101373507|FG002|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0||
48424558|NCT02418000|101373508|FG003|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0||
48424559|NCT02418000|101373509|FG004|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||4||
48424560|NCT02418000|101373505|FG000|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0||
48424561|NCT02418000|101373506|FG001|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0||
48424562|NCT02418000|101373507|FG002|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0||
48424563|NCT02418000|101373508|FG003|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0||
48424564|NCT02418000|101373509|FG004|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0||
48424565|NCT02418000|101373505|FG000|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0||
48424566|NCT02418000|101373506|FG001|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0||
48424567|NCT02418000|101373507|FG002|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0||
48424568|NCT02418000|101373508|FG003|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0||
48424569|NCT02418000|101373509|FG004|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||4||
48424570|NCT02347345|101373510|FG000|STARTED|Overall Study||10||
48424571|NCT02347345|101373511|FG001|STARTED|Overall Study||12||
48424572|NCT02347345|101373512|FG002|STARTED|Overall Study||12||
48424573|NCT02347345|101373510|FG000|COMPLETED|Overall Study||10||
48424574|NCT02347345|101373511|FG001|COMPLETED|Overall Study||12||
48424575|NCT02347345|101373512|FG002|COMPLETED|Overall Study||12||
48424576|NCT02347345|101373510|FG000|NOT COMPLETED|Overall Study||0||
48424577|NCT02347345|101373511|FG001|NOT COMPLETED|Overall Study||0||
48424578|NCT02347345|101373512|FG002|NOT COMPLETED|Overall Study||0||
48424579|NCT01219959|101373513|FG000|STARTED|Overall Study||127||
48424580|NCT01219959|101373514|FG001|STARTED|Overall Study||124||
48424581|NCT01219959|101373513|FG000|COMPLETED|Overall Study||120||
48424582|NCT01219959|101373514|FG001|COMPLETED|Overall Study||101||
48424583|NCT01219959|101373513|FG000|NOT COMPLETED|Overall Study||7||
48424584|NCT01219959|101373514|FG001|NOT COMPLETED|Overall Study||23||
48424585|NCT01905241|101373515|FG000|STARTED|Overall Study||20||
48424586|NCT01905241|101373515|FG000|COMPLETED|Overall Study||20||
48424587|NCT01905241|101373515|FG000|NOT COMPLETED|Overall Study||0||
48424588|NCT04462731|101373516|FG000|STARTED|Overall Study||97||
48424589|NCT04462731|101373517|FG001|STARTED|Overall Study||97||
48424590|NCT04462731|101373516|FG000|COMPLETED|Overall Study||41||
48424591|NCT04462731|101373517|FG001|COMPLETED|Overall Study||51||
48424592|NCT04462731|101373516|FG000|NOT COMPLETED|Overall Study||56||
48424593|NCT04462731|101373517|FG001|NOT COMPLETED|Overall Study||46||
48424594|NCT02569398|101373518|FG000|STARTED|Overall Study||185||
48424595|NCT02569398|101373519|FG001|STARTED|Overall Study||189||
48424596|NCT02569398|101373520|FG002|STARTED|Overall Study||183||
48424597|NCT02569398|101373518|FG000|COMPLETED|Overall Study||0||
48424598|NCT02569398|101373519|FG001|COMPLETED|Overall Study||0||
48424599|NCT02569398|101373520|FG002|COMPLETED|Overall Study||0||
48424600|NCT02569398|101373518|FG000|NOT COMPLETED|Overall Study||185||
48424601|NCT02569398|101373519|FG001|NOT COMPLETED|Overall Study||189||
48424602|NCT02569398|101373520|FG002|NOT COMPLETED|Overall Study||183||
48424603|NCT03982069|101373521|FG000|STARTED|Overall Study||108||
48424604|NCT03982069|101373522|FG001|STARTED|Overall Study||110||
48424605|NCT03982069|101373523|FG002|STARTED|Overall Study||127||
48424606|NCT03982069|101373524|FG003|STARTED|Overall Study||120||
48424607|NCT03982069|101373521|FG000|COMPLETED|Overall Study||98||
48424608|NCT03982069|101373522|FG001|COMPLETED|Overall Study||100||
48424609|NCT03982069|101373523|FG002|COMPLETED|Overall Study||118||
48424610|NCT03982069|101373524|FG003|COMPLETED|Overall Study||112||
48424611|NCT03982069|101373521|FG000|NOT COMPLETED|Overall Study||10||
48424612|NCT03982069|101373522|FG001|NOT COMPLETED|Overall Study||10||
48424613|NCT03982069|101373523|FG002|NOT COMPLETED|Overall Study||9||
48424614|NCT03982069|101373524|FG003|NOT COMPLETED|Overall Study||8||
48424615|NCT01319539|101373525|FG000|STARTED|Overall Study||12||
48424616|NCT01319539|101373525|FG000|COMPLETED|Overall Study||12||
48424617|NCT01319539|101373525|FG000|NOT COMPLETED|Overall Study||0||
48424618|NCT00121485|101373526|FG000|STARTED|Overall Study||134||
48424619|NCT00121485|101373527|FG001|STARTED|Overall Study||66||
48424620|NCT00121485|101373526|FG000|COMPLETED|Overall Study||133||
48424621|NCT00121485|101373527|FG001|COMPLETED|Overall Study||59||
48424622|NCT00121485|101373526|FG000|NOT COMPLETED|Overall Study||1||
48424623|NCT00121485|101373527|FG001|NOT COMPLETED|Overall Study||7||
48424624|NCT01757821|101373528|FG000|STARTED|Overall Study||11||
48424625|NCT01757821|101373528|FG000|COMPLETED|Overall Study||10||
48424626|NCT01757821|101373528|FG000|NOT COMPLETED|Overall Study||1||
48424627|NCT00486720|101373529|FG000|STARTED|Overall Study||10||
48424628|NCT00486720|101373530|FG001|STARTED|Overall Study||12||
48424629|NCT00486720|101373529|FG000|COMPLETED|Overall Study||0||
48424630|NCT00486720|101373530|FG001|COMPLETED|Overall Study||0||
48424631|NCT00486720|101373529|FG000|NOT COMPLETED|Overall Study||10||
48424632|NCT00486720|101373530|FG001|NOT COMPLETED|Overall Study||12||
48424633|NCT01526343|101373531|FG000|STARTED|Overall Study||47||
48424634|NCT01526343|101373531|FG000|COMPLETED|Overall Study||47||
48424635|NCT01526343|101373531|FG000|NOT COMPLETED|Overall Study||0||
48424636|NCT02173158|101373532|FG000|STARTED|Efficacy Phase||9||
48424637|NCT02173158|101373532|FG000|COMPLETED|Efficacy Phase||8||
48424638|NCT02173158|101373532|FG000|NOT COMPLETED|Efficacy Phase||1||
48424639|NCT02173158|101373532|FG000|STARTED|Safety Phase||8||
48424640|NCT02173158|101373532|FG000|COMPLETED|Safety Phase||8||
48424641|NCT02173158|101373532|FG000|NOT COMPLETED|Safety Phase||0||
48424642|NCT02218424|101373533|FG000|STARTED|Overall Study||30||
48424643|NCT02218424|101373534|FG001|STARTED|Overall Study||30||
48424644|NCT02218424|101373533|FG000|COMPLETED|Overall Study||30||
48424645|NCT02218424|101373534|FG001|COMPLETED|Overall Study||30||
48424646|NCT02218424|101373533|FG000|NOT COMPLETED|Overall Study||0||
48424647|NCT02218424|101373534|FG001|NOT COMPLETED|Overall Study||0||
48424648|NCT01681004|101373535|FG000|STARTED|Primary Endpoint: 6 Months||102||
48424649|NCT01681004|101373536|FG001|STARTED|Primary Endpoint: 6 Months||46||
48424650|NCT01681004|101373535|FG000|Crossover to Surgical Treatment|Primary Endpoint: 6 Months||0||
48424651|NCT01681004|101373536|FG001|Crossover to Surgical Treatment|Primary Endpoint: 6 Months||39||
48424652|NCT01681004|101373535|FG000|COMPLETED|Primary Endpoint: 6 Months||101||
48424653|NCT01681004|101373536|FG001|COMPLETED|Primary Endpoint: 6 Months||44||
48424654|NCT01681004|101373535|FG000|NOT COMPLETED|Primary Endpoint: 6 Months||1||
48424655|NCT01681004|101373536|FG001|NOT COMPLETED|Primary Endpoint: 6 Months||2||
48424656|NCT01681004|101373535|FG000|STARTED|Study Completion||101||
48424657|NCT01681004|101373536|FG001|STARTED|Study Completion||44||
48424658|NCT01681004|101373535|FG000|COMPLETED|Study Completion||89||
48424659|NCT01681004|101373536|FG001|COMPLETED|Study Completion||36||
48424660|NCT01681004|101373535|FG000|NOT COMPLETED|Study Completion||12||
48424661|NCT01681004|101373536|FG001|NOT COMPLETED|Study Completion||8||
48424662|NCT00174460|101373537|FG000|STARTED|Overall Study||18||
48424663|NCT00174460|101373538|FG001|STARTED|Overall Study||15||
48424664|NCT00174460|101373537|FG000|Received Study Treatment|Overall Study||18||
48424665|NCT00174460|101373538|FG001|Received Study Treatment|Overall Study||14||
48424666|NCT00174460|101373537|FG000|COMPLETED|Overall Study||18||
48424667|NCT00174460|101373538|FG001|COMPLETED|Overall Study||14||
48424668|NCT00174460|101373537|FG000|NOT COMPLETED|Overall Study||0||
48424669|NCT00174460|101373538|FG001|NOT COMPLETED|Overall Study||1||
48424670|NCT00516217|101373539|FG000|STARTED|Overall Study||29||
48424671|NCT00516217|101373539|FG000|COMPLETED|Overall Study||29||
48424672|NCT00516217|101373539|FG000|NOT COMPLETED|Overall Study||0||
48424673|NCT01822886|101373540|FG000|STARTED|Overall Study||20||
48424674|NCT01822886|101373540|FG000|COMPLETED|Overall Study||5||
48424675|NCT01822886|101373540|FG000|NOT COMPLETED|Overall Study||15||
48424676|NCT00409565|101377506|FG000|STARTED|Overall Study||46||
48424677|NCT00409565|101377506|FG000|Overall Response Rate|Overall Study||7||
48424678|NCT00409565|101377506|FG000|COMPLETED|Overall Study||45||
48424679|NCT00409565|101377506|FG000|NOT COMPLETED|Overall Study||1||
48424680|NCT02079077|101377507|FG000|STARTED|Overall Study||43||
48424681|NCT02079077|101377508|FG001|STARTED|Overall Study||48||
48424682|NCT02079077|101377507|FG000|COMPLETED|Overall Study||37||
48424683|NCT02079077|101377508|FG001|COMPLETED|Overall Study||39||
48424684|NCT02079077|101377507|FG000|NOT COMPLETED|Overall Study||6||
48424685|NCT02079077|101377508|FG001|NOT COMPLETED|Overall Study||9||
48424686|NCT00960323|101377509|FG000|STARTED|Colchicine Alone||24||
48424687|NCT00960323|101377509|FG000|COMPLETED|Colchicine Alone||24||
48424688|NCT00960323|101377509|FG000|NOT COMPLETED|Colchicine Alone||0||
48424689|NCT00960323|101377509|FG000|STARTED|14 Day Washout Period||24||
48424690|NCT00960323|101377509|FG000|COMPLETED|14 Day Washout Period||24||
48424691|NCT00960323|101377509|FG000|NOT COMPLETED|14 Day Washout Period||0||
48424692|NCT00960323|101377509|FG000|STARTED|Atorvastatin Alone||24||
48424693|NCT00960323|101377509|FG000|COMPLETED|Atorvastatin Alone||23||
48424694|NCT00960323|101377509|FG000|NOT COMPLETED|Atorvastatin Alone||1||
48424695|NCT00960323|101377509|FG000|STARTED|Colchicine and Atorvastatin||23||
48424696|NCT00960323|101377509|FG000|COMPLETED|Colchicine and Atorvastatin||23||
48424697|NCT00960323|101377509|FG000|NOT COMPLETED|Colchicine and Atorvastatin||0||
48424698|NCT03303144|101377510|FG000|STARTED|Triferic Via Hemodialysate (Day 3)||26||
48424699|NCT03303144|101377511|FG001|STARTED|Triferic Via Hemodialysate (Day 3)||0||
48424700|NCT03303144|101377512|FG002|STARTED|Triferic Via Hemodialysate (Day 3)||0||
48424701|NCT03303144|101377510|FG000|COMPLETED|Triferic Via Hemodialysate (Day 3)||26||
48424702|NCT03303144|101377511|FG001|COMPLETED|Triferic Via Hemodialysate (Day 3)||0||
48424703|NCT03303144|101377512|FG002|COMPLETED|Triferic Via Hemodialysate (Day 3)||0||
48424704|NCT03303144|101377510|FG000|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0||
48424705|NCT03303144|101377511|FG001|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0||
48424706|NCT03303144|101377512|FG002|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0||
48424707|NCT03303144|101377510|FG000|STARTED|Triferic Via IV Infusion (Day 8)||0||
48424708|NCT03303144|101377511|FG001|STARTED|Triferic Via IV Infusion (Day 8)||26||
48424709|NCT03303144|101377512|FG002|STARTED|Triferic Via IV Infusion (Day 8)||0||
48424710|NCT03303144|101377510|FG000|COMPLETED|Triferic Via IV Infusion (Day 8)||0||
48424711|NCT03303144|101377511|FG001|COMPLETED|Triferic Via IV Infusion (Day 8)||25||
48424712|NCT03303144|101377512|FG002|COMPLETED|Triferic Via IV Infusion (Day 8)||0||
48424713|NCT03303144|101377510|FG000|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||0||
48424714|NCT03303144|101377511|FG001|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||1||
48424715|NCT03303144|101377512|FG002|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||0||
48424716|NCT03303144|101377510|FG000|STARTED|Triferic Via IV Infusion (Day 10)||0||
48424717|NCT03303144|101377511|FG001|STARTED|Triferic Via IV Infusion (Day 10)||0||
48424718|NCT03303144|101377512|FG002|STARTED|Triferic Via IV Infusion (Day 10)||26||
48424719|NCT03303144|101377510|FG000|COMPLETED|Triferic Via IV Infusion (Day 10)||0||
48424720|NCT03303144|101377511|FG001|COMPLETED|Triferic Via IV Infusion (Day 10)||0||
48424721|NCT03303144|101377512|FG002|COMPLETED|Triferic Via IV Infusion (Day 10)||25||
48424722|NCT03303144|101377510|FG000|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||0||
48424723|NCT03303144|101377511|FG001|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||0||
48424724|NCT03303144|101377512|FG002|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||1||
48424725|NCT04853368|101377513|FG000|STARTED|Part 1 (Day -29 to -1)||24||
48424726|NCT04853368|101377514|FG001|STARTED|Part 1 (Day -29 to -1)||0||
48424727|NCT04853368|101377515|FG002|STARTED|Part 1 (Day -29 to -1)||0||
48424728|NCT04853368|101377516|FG003|STARTED|Part 1 (Day -29 to -1)||0||
48424729|NCT04853368|101377517|FG004|STARTED|Part 1 (Day -29 to -1)||0||
48424730|NCT04853368|101377518|FG005|STARTED|Part 1 (Day -29 to -1)||0||
48424731|NCT04853368|101377513|FG000|COMPLETED|Part 1 (Day -29 to -1)||24||
48424732|NCT04853368|101377514|FG001|COMPLETED|Part 1 (Day -29 to -1)||0||
48424733|NCT04853368|101377515|FG002|COMPLETED|Part 1 (Day -29 to -1)||0||
48424734|NCT04853368|101377516|FG003|COMPLETED|Part 1 (Day -29 to -1)||0||
48424735|NCT04853368|101377517|FG004|COMPLETED|Part 1 (Day -29 to -1)||0||
48424736|NCT04853368|101377518|FG005|COMPLETED|Part 1 (Day -29 to -1)||0||
48424737|NCT04853368|101377513|FG000|NOT COMPLETED|Part 1 (Day -29 to -1)||0||
48424738|NCT04853368|101377514|FG001|NOT COMPLETED|Part 1 (Day -29 to -1)||0||
48424739|NCT04853368|101377515|FG002|NOT COMPLETED|Part 1 (Day -29 to -1)||0||
48424740|NCT04853368|101377516|FG003|NOT COMPLETED|Part 1 (Day -29 to -1)||0||
48424741|NCT04853368|101377517|FG004|NOT COMPLETED|Part 1 (Day -29 to -1)||0||
48424742|NCT04853368|101377518|FG005|NOT COMPLETED|Part 1 (Day -29 to -1)||0||
48424743|NCT04853368|101377513|FG000|STARTED|Part 2 (Day 1-29)||0||
48424744|NCT04853368|101377514|FG001|STARTED|Part 2 (Day 1-29)||24||
48424745|NCT04853368|101377515|FG002|STARTED|Part 2 (Day 1-29)||9||
48424746|NCT04853368|101377516|FG003|STARTED|Part 2 (Day 1-29)||4||
48424747|NCT04853368|101377517|FG004|STARTED|Part 2 (Day 1-29)||9||
48424748|NCT04853368|101377518|FG005|STARTED|Part 2 (Day 1-29)||2||
48424749|NCT04853368|101377513|FG000|COMPLETED|Part 2 (Day 1-29)||0||
48424750|NCT04853368|101377514|FG001|COMPLETED|Part 2 (Day 1-29)||22||
48424751|NCT04853368|101377515|FG002|COMPLETED|Part 2 (Day 1-29)||9||
48424752|NCT04853368|101377516|FG003|COMPLETED|Part 2 (Day 1-29)||4||
48424753|NCT04853368|101377517|FG004|COMPLETED|Part 2 (Day 1-29)||8||
48424754|NCT04853368|101377518|FG005|COMPLETED|Part 2 (Day 1-29)||2||
48424755|NCT04853368|101377513|FG000|NOT COMPLETED|Part 2 (Day 1-29)||0||
48424756|NCT04853368|101377514|FG001|NOT COMPLETED|Part 2 (Day 1-29)||2||
48424757|NCT04853368|101377515|FG002|NOT COMPLETED|Part 2 (Day 1-29)||0||
48424758|NCT04853368|101377516|FG003|NOT COMPLETED|Part 2 (Day 1-29)||0||
48424759|NCT04853368|101377517|FG004|NOT COMPLETED|Part 2 (Day 1-29)||1||
48424760|NCT04853368|101377518|FG005|NOT COMPLETED|Part 2 (Day 1-29)||0||
48424761|NCT00948896|101377519|FG000|STARTED|Randomization to 24 Months of Age||98||
48424762|NCT00948896|101377520|FG001|STARTED|Randomization to 24 Months of Age||98||
48424763|NCT00948896|101377521|FG002|STARTED|Randomization to 24 Months of Age||99||
48424764|NCT00948896|101377522|FG003|STARTED|Randomization to 24 Months of Age||98||
48424765|NCT00948896|101377523|FG004|STARTED|Randomization to 24 Months of Age||46||
48424766|NCT00948896|101377524|FG005|STARTED|Randomization to 24 Months of Age||46||
48424767|NCT00948896|101377525|FG006|STARTED|Randomization to 24 Months of Age||47||
48424768|NCT00948896|101377526|FG007|STARTED|Randomization to 24 Months of Age||47||
48424769|NCT00948896|101377519|FG000|COMPLETED|Randomization to 24 Months of Age||90||
48424770|NCT00948896|101377520|FG001|COMPLETED|Randomization to 24 Months of Age||85||
48424771|NCT00948896|101377521|FG002|COMPLETED|Randomization to 24 Months of Age||90||
48424772|NCT00948896|101377522|FG003|COMPLETED|Randomization to 24 Months of Age||87||
48424773|NCT00948896|101377523|FG004|COMPLETED|Randomization to 24 Months of Age||44||
48424774|NCT00948896|101377524|FG005|COMPLETED|Randomization to 24 Months of Age||42||
48424775|NCT00948896|101377525|FG006|COMPLETED|Randomization to 24 Months of Age||43||
48424776|NCT00948896|101377526|FG007|COMPLETED|Randomization to 24 Months of Age||45||
48424777|NCT00948896|101377519|FG000|NOT COMPLETED|Randomization to 24 Months of Age||8||
48424778|NCT00948896|101377520|FG001|NOT COMPLETED|Randomization to 24 Months of Age||13||
48424779|NCT00948896|101377521|FG002|NOT COMPLETED|Randomization to 24 Months of Age||9||
48424780|NCT00948896|101377522|FG003|NOT COMPLETED|Randomization to 24 Months of Age||11||
48424781|NCT00948896|101377523|FG004|NOT COMPLETED|Randomization to 24 Months of Age||2||
48424782|NCT00948896|101377524|FG005|NOT COMPLETED|Randomization to 24 Months of Age||4||
48424783|NCT00948896|101377525|FG006|NOT COMPLETED|Randomization to 24 Months of Age||4||
48439984|NCT01728376|101410000|FG005|NOT COMPLETED|Overall Study||2||
48424784|NCT00948896|101377526|FG007|NOT COMPLETED|Randomization to 24 Months of Age||2||
48424785|NCT00948896|101377519|FG000|STARTED|24 Months of Age to 36 Months of Age||90||
48424786|NCT00948896|101377520|FG001|STARTED|24 Months of Age to 36 Months of Age||85||
48424787|NCT00948896|101377521|FG002|STARTED|24 Months of Age to 36 Months of Age||90||
48424788|NCT00948896|101377522|FG003|STARTED|24 Months of Age to 36 Months of Age||87||
48424789|NCT00948896|101377523|FG004|STARTED|24 Months of Age to 36 Months of Age||44||
48424790|NCT00948896|101377524|FG005|STARTED|24 Months of Age to 36 Months of Age||42||
48424791|NCT00948896|101377525|FG006|STARTED|24 Months of Age to 36 Months of Age||43||
48424792|NCT00948896|101377526|FG007|STARTED|24 Months of Age to 36 Months of Age||45||
48424793|NCT00948896|101377519|FG000|COMPLETED|24 Months of Age to 36 Months of Age||87||
48424794|NCT00948896|101377520|FG001|COMPLETED|24 Months of Age to 36 Months of Age||83||
48424795|NCT00948896|101377521|FG002|COMPLETED|24 Months of Age to 36 Months of Age||85||
48424796|NCT00948896|101377522|FG003|COMPLETED|24 Months of Age to 36 Months of Age||85||
48424797|NCT00948896|101377523|FG004|COMPLETED|24 Months of Age to 36 Months of Age||43||
48424798|NCT00948896|101377524|FG005|COMPLETED|24 Months of Age to 36 Months of Age||40||
48424799|NCT00948896|101377525|FG006|COMPLETED|24 Months of Age to 36 Months of Age||43||
48424800|NCT00948896|101377526|FG007|COMPLETED|24 Months of Age to 36 Months of Age||45||
48424801|NCT00948896|101377519|FG000|NOT COMPLETED|24 Months of Age to 36 Months of Age||3||
48424802|NCT00948896|101377520|FG001|NOT COMPLETED|24 Months of Age to 36 Months of Age||2||
48424803|NCT00948896|101377521|FG002|NOT COMPLETED|24 Months of Age to 36 Months of Age||5||
48424804|NCT00948896|101377522|FG003|NOT COMPLETED|24 Months of Age to 36 Months of Age||2||
48424805|NCT00948896|101377523|FG004|NOT COMPLETED|24 Months of Age to 36 Months of Age||1||
48424806|NCT00948896|101377524|FG005|NOT COMPLETED|24 Months of Age to 36 Months of Age||2||
48424807|NCT00948896|101377525|FG006|NOT COMPLETED|24 Months of Age to 36 Months of Age||0||
48424808|NCT00948896|101377526|FG007|NOT COMPLETED|24 Months of Age to 36 Months of Age||0||
48424809|NCT01005966|101377527|FG000|STARTED|Treatment Period 1 (14 Days)||13||
48424810|NCT01005966|101377528|FG001|STARTED|Treatment Period 1 (14 Days)||13||
48424811|NCT01005966|101377529|FG002|STARTED|Treatment Period 1 (14 Days)||13||
48424812|NCT01005966|101377530|FG003|STARTED|Treatment Period 1 (14 Days)||13||
48424813|NCT01005966|101377531|FG004|STARTED|Treatment Period 1 (14 Days)||13||
48424814|NCT01005966|101377527|FG000|COMPLETED|Treatment Period 1 (14 Days)||11||
48424815|NCT01005966|101377528|FG001|COMPLETED|Treatment Period 1 (14 Days)||13||
48424816|NCT01005966|101377529|FG002|COMPLETED|Treatment Period 1 (14 Days)||12||
48424817|NCT01005966|101377530|FG003|COMPLETED|Treatment Period 1 (14 Days)||13||
48424818|NCT01005966|101377531|FG004|COMPLETED|Treatment Period 1 (14 Days)||13||
48424819|NCT01005966|101377527|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||2||
48424820|NCT01005966|101377528|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||0||
48424821|NCT01005966|101377529|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||1||
48424822|NCT01005966|101377530|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||0||
48424823|NCT01005966|101377531|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||0||
48424824|NCT01005966|101377527|FG000|STARTED|Washout Period 1 (4 Days)||11||
48424825|NCT01005966|101377528|FG001|STARTED|Washout Period 1 (4 Days)||13||
48424826|NCT01005966|101377529|FG002|STARTED|Washout Period 1 (4 Days)||12||
48424827|NCT01005966|101377530|FG003|STARTED|Washout Period 1 (4 Days)||13||
48424828|NCT01005966|101377531|FG004|STARTED|Washout Period 1 (4 Days)||13||
48424829|NCT01005966|101377527|FG000|COMPLETED|Washout Period 1 (4 Days)||11||
48424830|NCT01005966|101377528|FG001|COMPLETED|Washout Period 1 (4 Days)||13||
48424831|NCT01005966|101377529|FG002|COMPLETED|Washout Period 1 (4 Days)||12||
48424832|NCT01005966|101377530|FG003|COMPLETED|Washout Period 1 (4 Days)||12||
48424833|NCT01005966|101377531|FG004|COMPLETED|Washout Period 1 (4 Days)||13||
48424834|NCT01005966|101377527|FG000|NOT COMPLETED|Washout Period 1 (4 Days)||0||
48424835|NCT01005966|101377528|FG001|NOT COMPLETED|Washout Period 1 (4 Days)||0||
48424836|NCT01005966|101377529|FG002|NOT COMPLETED|Washout Period 1 (4 Days)||0||
48424837|NCT01005966|101377530|FG003|NOT COMPLETED|Washout Period 1 (4 Days)||1||
48424838|NCT01005966|101377531|FG004|NOT COMPLETED|Washout Period 1 (4 Days)||0||
48424839|NCT01005966|101377527|FG000|STARTED|Treatment Period 2 (14 Days)||13||
48424840|NCT01005966|101377528|FG001|STARTED|Treatment Period 2 (14 Days)||13||
48424841|NCT01005966|101377529|FG002|STARTED|Treatment Period 2 (14 Days)||12||
48424842|NCT01005966|101377530|FG003|STARTED|Treatment Period 2 (14 Days)||12||
48424843|NCT01005966|101377531|FG004|STARTED|Treatment Period 2 (14 Days)||11||
48424844|NCT01005966|101377527|FG000|COMPLETED|Treatment Period 2 (14 Days)||13||
48424845|NCT01005966|101377528|FG001|COMPLETED|Treatment Period 2 (14 Days)||12||
48424846|NCT01005966|101377529|FG002|COMPLETED|Treatment Period 2 (14 Days)||10||
48424847|NCT01005966|101377530|FG003|COMPLETED|Treatment Period 2 (14 Days)||11||
48424848|NCT01005966|101377531|FG004|COMPLETED|Treatment Period 2 (14 Days)||11||
48424849|NCT01005966|101377527|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
48424850|NCT01005966|101377528|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||1||
48424851|NCT01005966|101377529|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||2||
48424852|NCT01005966|101377530|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||1||
48424853|NCT01005966|101377531|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
48424854|NCT01005966|101377527|FG000|STARTED|Washout Period 2 (4 Days)||13||
48424855|NCT01005966|101377528|FG001|STARTED|Washout Period 2 (4 Days)||12||
48424856|NCT01005966|101377529|FG002|STARTED|Washout Period 2 (4 Days)||10||
48424857|NCT01005966|101377530|FG003|STARTED|Washout Period 2 (4 Days)||11||
48424858|NCT01005966|101377531|FG004|STARTED|Washout Period 2 (4 Days)||11||
48424859|NCT01005966|101377527|FG000|COMPLETED|Washout Period 2 (4 Days)||13||
48424860|NCT01005966|101377528|FG001|COMPLETED|Washout Period 2 (4 Days)||12||
48424861|NCT01005966|101377529|FG002|COMPLETED|Washout Period 2 (4 Days)||10||
48424862|NCT01005966|101377530|FG003|COMPLETED|Washout Period 2 (4 Days)||11||
48424863|NCT01005966|101377531|FG004|COMPLETED|Washout Period 2 (4 Days)||11||
48424864|NCT01005966|101377527|FG000|NOT COMPLETED|Washout Period 2 (4 Days)||0||
48424865|NCT01005966|101377528|FG001|NOT COMPLETED|Washout Period 2 (4 Days)||0||
48424866|NCT01005966|101377529|FG002|NOT COMPLETED|Washout Period 2 (4 Days)||0||
48424867|NCT01005966|101377530|FG003|NOT COMPLETED|Washout Period 2 (4 Days)||0||
48424868|NCT01005966|101377531|FG004|NOT COMPLETED|Washout Period 2 (4 Days)||0||
48424869|NCT01005966|101377527|FG000|STARTED|Treatment Period 3 (14 Days)||12||
48424870|NCT01005966|101377528|FG001|STARTED|Treatment Period 3 (14 Days)||8||
48424871|NCT01005966|101377529|FG002|STARTED|Treatment Period 3 (14 Days)||12||
48424872|NCT01005966|101377530|FG003|STARTED|Treatment Period 3 (14 Days)||13||
48424873|NCT01005966|101377531|FG004|STARTED|Treatment Period 3 (14 Days)||12||
48424874|NCT01005966|101377527|FG000|COMPLETED|Treatment Period 3 (14 Days)||12||
48424875|NCT01005966|101377528|FG001|COMPLETED|Treatment Period 3 (14 Days)||7||
48424876|NCT01005966|101377529|FG002|COMPLETED|Treatment Period 3 (14 Days)||12||
48424877|NCT01005966|101377530|FG003|COMPLETED|Treatment Period 3 (14 Days)||13||
48424878|NCT01005966|101377531|FG004|COMPLETED|Treatment Period 3 (14 Days)||11||
48424879|NCT01005966|101377527|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0||
48424880|NCT01005966|101377528|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||1||
48424881|NCT01005966|101377529|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||0||
48424882|NCT01005966|101377530|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0||
48424883|NCT01005966|101377531|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||1||
48424884|NCT01005966|101377527|FG000|STARTED|Washout Period 3 ( 4 Days)||12||
48424885|NCT01005966|101377528|FG001|STARTED|Washout Period 3 ( 4 Days)||7||
48424886|NCT01005966|101377529|FG002|STARTED|Washout Period 3 ( 4 Days)||12||
48424887|NCT01005966|101377530|FG003|STARTED|Washout Period 3 ( 4 Days)||13||
48424888|NCT01005966|101377531|FG004|STARTED|Washout Period 3 ( 4 Days)||11||
48424889|NCT01005966|101377527|FG000|COMPLETED|Washout Period 3 ( 4 Days)||12||
48424890|NCT01005966|101377528|FG001|COMPLETED|Washout Period 3 ( 4 Days)||7||
48424891|NCT01005966|101377529|FG002|COMPLETED|Washout Period 3 ( 4 Days)||12||
48424892|NCT01005966|101377530|FG003|COMPLETED|Washout Period 3 ( 4 Days)||13||
48424893|NCT01005966|101377531|FG004|COMPLETED|Washout Period 3 ( 4 Days)||11||
48424894|NCT01005966|101377527|FG000|NOT COMPLETED|Washout Period 3 ( 4 Days)||0||
48424895|NCT01005966|101377528|FG001|NOT COMPLETED|Washout Period 3 ( 4 Days)||0||
48424896|NCT01005966|101377529|FG002|NOT COMPLETED|Washout Period 3 ( 4 Days)||0||
48424897|NCT01005966|101377530|FG003|NOT COMPLETED|Washout Period 3 ( 4 Days)||0||
48424898|NCT01005966|101377531|FG004|NOT COMPLETED|Washout Period 3 ( 4 Days)||0||
48424899|NCT01005966|101377527|FG000|STARTED|Treatment Period 4 (14 Days)||10||
48424900|NCT01005966|101377528|FG001|STARTED|Treatment Period 4 (14 Days)||11||
48424901|NCT01005966|101377529|FG002|STARTED|Treatment Period 4 (14 Days)||11||
48424902|NCT01005966|101377530|FG003|STARTED|Treatment Period 4 (14 Days)||10||
48424903|NCT01005966|101377531|FG004|STARTED|Treatment Period 4 (14 Days)||13||
48424904|NCT01005966|101377527|FG000|COMPLETED|Treatment Period 4 (14 Days)||10||
48424905|NCT01005966|101377528|FG001|COMPLETED|Treatment Period 4 (14 Days)||10||
48424906|NCT01005966|101377529|FG002|COMPLETED|Treatment Period 4 (14 Days)||11||
48424907|NCT01005966|101377530|FG003|COMPLETED|Treatment Period 4 (14 Days)||10||
48424908|NCT01005966|101377531|FG004|COMPLETED|Treatment Period 4 (14 Days)||12||
48424909|NCT01005966|101377527|FG000|NOT COMPLETED|Treatment Period 4 (14 Days)||0||
48424910|NCT01005966|101377528|FG001|NOT COMPLETED|Treatment Period 4 (14 Days)||1||
48424911|NCT01005966|101377529|FG002|NOT COMPLETED|Treatment Period 4 (14 Days)||0||
48424912|NCT01005966|101377530|FG003|NOT COMPLETED|Treatment Period 4 (14 Days)||0||
48424913|NCT01005966|101377531|FG004|NOT COMPLETED|Treatment Period 4 (14 Days)||1||
48424914|NCT01005966|101377527|FG000|STARTED|Washout Period 4 (4 Days)||10||
48424915|NCT01005966|101377528|FG001|STARTED|Washout Period 4 (4 Days)||10||
48424916|NCT01005966|101377529|FG002|STARTED|Washout Period 4 (4 Days)||11||
48424917|NCT01005966|101377530|FG003|STARTED|Washout Period 4 (4 Days)||10||
48424918|NCT01005966|101377531|FG004|STARTED|Washout Period 4 (4 Days)||12||
48424919|NCT01005966|101377527|FG000|COMPLETED|Washout Period 4 (4 Days)||10||
48424920|NCT01005966|101377528|FG001|COMPLETED|Washout Period 4 (4 Days)||10||
48424921|NCT01005966|101377529|FG002|COMPLETED|Washout Period 4 (4 Days)||11||
48424922|NCT01005966|101377530|FG003|COMPLETED|Washout Period 4 (4 Days)||10||
48424923|NCT01005966|101377531|FG004|COMPLETED|Washout Period 4 (4 Days)||12||
48424924|NCT01005966|101377527|FG000|NOT COMPLETED|Washout Period 4 (4 Days)||0||
48424925|NCT01005966|101377528|FG001|NOT COMPLETED|Washout Period 4 (4 Days)||0||
48424926|NCT01005966|101377529|FG002|NOT COMPLETED|Washout Period 4 (4 Days)||0||
48424927|NCT01005966|101377530|FG003|NOT COMPLETED|Washout Period 4 (4 Days)||0||
48424928|NCT01005966|101377531|FG004|NOT COMPLETED|Washout Period 4 (4 Days)||0||
48424929|NCT01005966|101377527|FG000|STARTED|Treatment Period 5 (14 Days)||9||
48424930|NCT01005966|101377528|FG001|STARTED|Treatment Period 5 (14 Days)||12||
48424931|NCT01005966|101377529|FG002|STARTED|Treatment Period 5 (14 Days)||11||
48424932|NCT01005966|101377530|FG003|STARTED|Treatment Period 5 (14 Days)||11||
48424933|NCT01005966|101377531|FG004|STARTED|Treatment Period 5 (14 Days)||10||
48424934|NCT01005966|101377527|FG000|COMPLETED|Treatment Period 5 (14 Days)||9||
48424935|NCT01005966|101377528|FG001|COMPLETED|Treatment Period 5 (14 Days)||12||
48424936|NCT01005966|101377529|FG002|COMPLETED|Treatment Period 5 (14 Days)||11||
48424937|NCT01005966|101377530|FG003|COMPLETED|Treatment Period 5 (14 Days)||11||
48424938|NCT01005966|101377531|FG004|COMPLETED|Treatment Period 5 (14 Days)||10||
48424939|NCT01005966|101377527|FG000|NOT COMPLETED|Treatment Period 5 (14 Days)||0||
48424940|NCT01005966|101377528|FG001|NOT COMPLETED|Treatment Period 5 (14 Days)||0||
48424941|NCT01005966|101377529|FG002|NOT COMPLETED|Treatment Period 5 (14 Days)||0||
48424942|NCT01005966|101377530|FG003|NOT COMPLETED|Treatment Period 5 (14 Days)||0||
48424943|NCT01005966|101377531|FG004|NOT COMPLETED|Treatment Period 5 (14 Days)||0||
48424944|NCT03570658|101377532|FG000|STARTED|Single Ascending Dose (SAD)||6||
48424945|NCT03570658|101377533|FG001|STARTED|Single Ascending Dose (SAD)||2||
48424946|NCT03570658|101377534|FG002|STARTED|Single Ascending Dose (SAD)||10||
48424947|NCT03570658|101377535|FG003|STARTED|Single Ascending Dose (SAD)||10||
48424948|NCT03570658|101377532|FG000|COMPLETED|Single Ascending Dose (SAD)||6||
48424949|NCT03570658|101377533|FG001|COMPLETED|Single Ascending Dose (SAD)||2||
48424950|NCT03570658|101377534|FG002|COMPLETED|Single Ascending Dose (SAD)||10||
48424951|NCT03570658|101377535|FG003|COMPLETED|Single Ascending Dose (SAD)||10||
48424952|NCT03570658|101377532|FG000|NOT COMPLETED|Single Ascending Dose (SAD)||0||
48424953|NCT03570658|101377533|FG001|NOT COMPLETED|Single Ascending Dose (SAD)||0||
48424954|NCT03570658|101377534|FG002|NOT COMPLETED|Single Ascending Dose (SAD)||0||
48424955|NCT03570658|101377535|FG003|NOT COMPLETED|Single Ascending Dose (SAD)||0||
48424956|NCT03570658|101377532|FG000|STARTED|Multiple Ascending Dose (MAD)||4||
48424957|NCT03570658|101377533|FG001|STARTED|Multiple Ascending Dose (MAD)||0||
48424958|NCT03570658|101377534|FG002|STARTED|Multiple Ascending Dose (MAD)||10||
48424959|NCT03570658|101377535|FG003|STARTED|Multiple Ascending Dose (MAD)||10||
48424960|NCT03570658|101377532|FG000|COMPLETED|Multiple Ascending Dose (MAD)||4||
48424961|NCT03570658|101377533|FG001|COMPLETED|Multiple Ascending Dose (MAD)||0||
48424962|NCT03570658|101377534|FG002|COMPLETED|Multiple Ascending Dose (MAD)||10||
48424963|NCT03570658|101377535|FG003|COMPLETED|Multiple Ascending Dose (MAD)||10||
48424964|NCT03570658|101377532|FG000|NOT COMPLETED|Multiple Ascending Dose (MAD)||0||
48424965|NCT03570658|101377533|FG001|NOT COMPLETED|Multiple Ascending Dose (MAD)||0||
48424966|NCT03570658|101377534|FG002|NOT COMPLETED|Multiple Ascending Dose (MAD)||0||
48424967|NCT03570658|101377535|FG003|NOT COMPLETED|Multiple Ascending Dose (MAD)||0||
48424968|NCT03260699|101377536|FG000|STARTED|Overall Study||5||
48424969|NCT03260699|101377537|FG001|STARTED|Overall Study||4||
48424970|NCT03260699|101377536|FG000|COMPLETED|Overall Study||5||
48763944|NCT02920632|102211833|FG002|T1 (After Training)|Overall Study||0||
48763945|NCT02920632|102211831|FG000|T2 (6-mnth FU)|Overall Study||64||
48763946|NCT02920632|102211832|FG001|T2 (6-mnth FU)|Overall Study||62||
48763947|NCT02920632|102211833|FG002|T2 (6-mnth FU)|Overall Study||0||
48763948|NCT02920632|102211831|FG000|T3 (1-y FU)|Overall Study||56||
48424971|NCT03260699|101377537|FG001|COMPLETED|Overall Study||2||
48424972|NCT03260699|101377536|FG000|NOT COMPLETED|Overall Study||0||
48424973|NCT03260699|101377537|FG001|NOT COMPLETED|Overall Study||2||
48424974|NCT00911508|101377538|FG000|STARTED|Overall Study||1108||
48424975|NCT00911508|101377539|FG001|STARTED|Overall Study||1096||
48424976|NCT00911508|101377538|FG000|COMPLETED|Overall Study||1002||
48424977|NCT00911508|101377539|FG001|COMPLETED|Overall Study||966||
48424978|NCT00911508|101377538|FG000|NOT COMPLETED|Overall Study||106||
48424979|NCT00911508|101377539|FG001|NOT COMPLETED|Overall Study||130||
48424980|NCT03449342|101377540|FG000|STARTED|Overall Study||10||
48424981|NCT03449342|101377541|FG001|STARTED|Overall Study||50||
48424982|NCT03449342|101377540|FG000|COMPLETED|Overall Study||10||
48424983|NCT03449342|101377541|FG001|COMPLETED|Overall Study||50||
48424984|NCT03449342|101377540|FG000|NOT COMPLETED|Overall Study||0||
48424985|NCT03449342|101377541|FG001|NOT COMPLETED|Overall Study||0||
48424986|NCT03740724|101377542|FG000|STARTED|Overall Study||1||
48424987|NCT03740724|101377542|FG000|COMPLETED|Overall Study||0||
48424988|NCT03740724|101377542|FG000|NOT COMPLETED|Overall Study||1||
48424989|NCT01072175|101377543|FG000|STARTED|Part A (Drug-Drug Interaction)||8||
48424990|NCT01072175|101377544|FG001|STARTED|Part A (Drug-Drug Interaction)||0||
48763949|NCT02920632|102211832|FG001|T3 (1-y FU)|Overall Study||53||
48763950|NCT02920632|102211833|FG002|T3 (1-y FU)|Overall Study||0||
48424991|NCT01072175|101377545|FG002|STARTED|Part A (Drug-Drug Interaction)||0||
48763951|NCT02920632|102211831|FG000|COMPLETED|Overall Study||52||
48763952|NCT02920632|102211832|FG001|COMPLETED|Overall Study||51||
48763953|NCT02920632|102211833|FG002|COMPLETED|Overall Study||29||
48763954|NCT02920632|102211831|FG000|NOT COMPLETED|Overall Study||16||
48424992|NCT01072175|101377546|FG003|STARTED|Part A (Drug-Drug Interaction)||0||
48424993|NCT01072175|101377547|FG004|STARTED|Part A (Drug-Drug Interaction)||0||
48424994|NCT01072175|101377548|FG005|STARTED|Part A (Drug-Drug Interaction)||0||
48424995|NCT01072175|101377549|FG006|STARTED|Part A (Drug-Drug Interaction)||0||
48424996|NCT01072175|101377550|FG007|STARTED|Part A (Drug-Drug Interaction)||0||
48424997|NCT01072175|101377551|FG008|STARTED|Part A (Drug-Drug Interaction)||0||
48424998|NCT01072175|101377552|FG009|STARTED|Part A (Drug-Drug Interaction)||0||
48424999|NCT01072175|101377553|FG010|STARTED|Part A (Drug-Drug Interaction)||0||
48425000|NCT01072175|101377554|FG011|STARTED|Part A (Drug-Drug Interaction)||0||
48425001|NCT01072175|101377555|FG012|STARTED|Part A (Drug-Drug Interaction)||0||
48425002|NCT01072175|101377543|FG000|COMPLETED|Part A (Drug-Drug Interaction)||0||
48425003|NCT01072175|101377544|FG001|COMPLETED|Part A (Drug-Drug Interaction)||0||
48425004|NCT01072175|101377545|FG002|COMPLETED|Part A (Drug-Drug Interaction)||0||
48425005|NCT01072175|101377546|FG003|COMPLETED|Part A (Drug-Drug Interaction)||0||
48425006|NCT01072175|101377547|FG004|COMPLETED|Part A (Drug-Drug Interaction)||0||
48425007|NCT01072175|101377548|FG005|COMPLETED|Part A (Drug-Drug Interaction)||0||
48425008|NCT01072175|101377549|FG006|COMPLETED|Part A (Drug-Drug Interaction)||0||
48425009|NCT01072175|101377550|FG007|COMPLETED|Part A (Drug-Drug Interaction)||0||
48425010|NCT01072175|101377551|FG008|COMPLETED|Part A (Drug-Drug Interaction)||0||
48425011|NCT01072175|101377552|FG009|COMPLETED|Part A (Drug-Drug Interaction)||0||
48425012|NCT01072175|101377553|FG010|COMPLETED|Part A (Drug-Drug Interaction)||0||
48425013|NCT01072175|101377554|FG011|COMPLETED|Part A (Drug-Drug Interaction)||0||
48425014|NCT01072175|101377555|FG012|COMPLETED|Part A (Drug-Drug Interaction)||0||
48425015|NCT01072175|101377543|FG000|NOT COMPLETED|Part A (Drug-Drug Interaction)||8||
48425016|NCT01072175|101377544|FG001|NOT COMPLETED|Part A (Drug-Drug Interaction)||0||
48425017|NCT01072175|101377545|FG002|NOT COMPLETED|Part A (Drug-Drug Interaction)||0||
48425018|NCT01072175|101377546|FG003|NOT COMPLETED|Part A (Drug-Drug Interaction)||0||
48425019|NCT01072175|101377547|FG004|NOT COMPLETED|Part A (Drug-Drug Interaction)||0||
48425020|NCT01072175|101377548|FG005|NOT COMPLETED|Part A (Drug-Drug Interaction)||0||
48425021|NCT01072175|101377549|FG006|NOT COMPLETED|Part A (Drug-Drug Interaction)||0||
48425022|NCT01072175|101377550|FG007|NOT COMPLETED|Part A (Drug-Drug Interaction)||0||
48425023|NCT01072175|101377551|FG008|NOT COMPLETED|Part A (Drug-Drug Interaction)||0||
48425024|NCT01072175|101377552|FG009|NOT COMPLETED|Part A (Drug-Drug Interaction)||0||
48425025|NCT01072175|101377553|FG010|NOT COMPLETED|Part A (Drug-Drug Interaction)||0||
48425026|NCT01072175|101377554|FG011|NOT COMPLETED|Part A (Drug-Drug Interaction)||0||
48425027|NCT01072175|101377555|FG012|NOT COMPLETED|Part A (Drug-Drug Interaction)||0||
48425028|NCT01072175|101377543|FG000|STARTED|Part B (Dose Escalation and Expansion)||0||
48425029|NCT01072175|101377544|FG001|STARTED|Part B (Dose Escalation and Expansion)||6||
48425030|NCT01072175|101377545|FG002|STARTED|Part B (Dose Escalation and Expansion)||23||
48425031|NCT01072175|101377546|FG003|STARTED|Part B (Dose Escalation and Expansion)||27||
48425032|NCT01072175|101377547|FG004|STARTED|Part B (Dose Escalation and Expansion)||94||
48425033|NCT01072175|101377548|FG005|STARTED|Part B (Dose Escalation and Expansion)||0||
48425034|NCT01072175|101377549|FG006|STARTED|Part B (Dose Escalation and Expansion)||0||
48425035|NCT01072175|101377550|FG007|STARTED|Part B (Dose Escalation and Expansion)||0||
48425036|NCT01072175|101377551|FG008|STARTED|Part B (Dose Escalation and Expansion)||0||
48425037|NCT01072175|101377552|FG009|STARTED|Part B (Dose Escalation and Expansion)||0||
48425038|NCT01072175|101377553|FG010|STARTED|Part B (Dose Escalation and Expansion)||0||
48425039|NCT01072175|101377554|FG011|STARTED|Part B (Dose Escalation and Expansion)||0||
48425040|NCT01072175|101377555|FG012|STARTED|Part B (Dose Escalation and Expansion)||0||
48425041|NCT01072175|101377543|FG000|COMPLETED|Part B (Dose Escalation and Expansion)||0||
48425042|NCT01072175|101377544|FG001|COMPLETED|Part B (Dose Escalation and Expansion)||0||
48425043|NCT01072175|101377545|FG002|COMPLETED|Part B (Dose Escalation and Expansion)||0||
48425044|NCT01072175|101377546|FG003|COMPLETED|Part B (Dose Escalation and Expansion)||0||
48425045|NCT01072175|101377547|FG004|COMPLETED|Part B (Dose Escalation and Expansion)||0||
48425046|NCT01072175|101377548|FG005|COMPLETED|Part B (Dose Escalation and Expansion)||0||
48425047|NCT01072175|101377549|FG006|COMPLETED|Part B (Dose Escalation and Expansion)||0||
48425048|NCT01072175|101377550|FG007|COMPLETED|Part B (Dose Escalation and Expansion)||0||
48425049|NCT01072175|101377551|FG008|COMPLETED|Part B (Dose Escalation and Expansion)||0||
48425050|NCT01072175|101377552|FG009|COMPLETED|Part B (Dose Escalation and Expansion)||0||
48425051|NCT01072175|101377553|FG010|COMPLETED|Part B (Dose Escalation and Expansion)||0||
48425052|NCT01072175|101377554|FG011|COMPLETED|Part B (Dose Escalation and Expansion)||0||
48425053|NCT01072175|101377555|FG012|COMPLETED|Part B (Dose Escalation and Expansion)||0||
48425054|NCT01072175|101377543|FG000|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0||
48425055|NCT01072175|101377544|FG001|NOT COMPLETED|Part B (Dose Escalation and Expansion)||6||
48425056|NCT01072175|101377545|FG002|NOT COMPLETED|Part B (Dose Escalation and Expansion)||23||
48425057|NCT01072175|101377546|FG003|NOT COMPLETED|Part B (Dose Escalation and Expansion)||27||
48425058|NCT01072175|101377547|FG004|NOT COMPLETED|Part B (Dose Escalation and Expansion)||94||
48425059|NCT01072175|101377548|FG005|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0||
48425060|NCT01072175|101377549|FG006|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0||
48425061|NCT01072175|101377550|FG007|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0||
48425062|NCT01072175|101377551|FG008|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0||
48425063|NCT01072175|101377552|FG009|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0||
48425064|NCT01072175|101377553|FG010|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0||
48425065|NCT01072175|101377554|FG011|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0||
48425066|NCT01072175|101377555|FG012|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0||
48425067|NCT01072175|101377543|FG000|STARTED|Part C (Phase II: Randomized Phase)||0||
48425068|NCT01072175|101377544|FG001|STARTED|Part C (Phase II: Randomized Phase)||0||
48763955|NCT02920632|102211832|FG001|NOT COMPLETED|Overall Study||17||
48763956|NCT02920632|102211833|FG002|NOT COMPLETED|Overall Study||2||
48425069|NCT01072175|101377545|FG002|STARTED|Part C (Phase II: Randomized Phase)||0||
48425070|NCT01072175|101377546|FG003|STARTED|Part C (Phase II: Randomized Phase)||0||
48425071|NCT01072175|101377547|FG004|STARTED|Part C (Phase II: Randomized Phase)||0||
48425072|NCT01072175|101377548|FG005|STARTED|Part C (Phase II: Randomized Phase)||54||
48425073|NCT01072175|101377549|FG006|STARTED|Part C (Phase II: Randomized Phase)||54||
48425074|NCT01072175|101377550|FG007|STARTED|Part C (Phase II: Randomized Phase)||54||
48425075|NCT01072175|101377551|FG008|STARTED|Part C (Phase II: Randomized Phase)||0||
48425076|NCT01072175|101377552|FG009|STARTED|Part C (Phase II: Randomized Phase)||0||
48425077|NCT01072175|101377553|FG010|STARTED|Part C (Phase II: Randomized Phase)||0||
48425078|NCT01072175|101377554|FG011|STARTED|Part C (Phase II: Randomized Phase)||0||
48425079|NCT01072175|101377555|FG012|STARTED|Part C (Phase II: Randomized Phase)||0||
48425080|NCT01072175|101377543|FG000|COMPLETED|Part C (Phase II: Randomized Phase)||0||
48425081|NCT01072175|101377544|FG001|COMPLETED|Part C (Phase II: Randomized Phase)||0||
48425082|NCT01072175|101377545|FG002|COMPLETED|Part C (Phase II: Randomized Phase)||0||
48425083|NCT01072175|101377546|FG003|COMPLETED|Part C (Phase II: Randomized Phase)||0||
48425084|NCT01072175|101377547|FG004|COMPLETED|Part C (Phase II: Randomized Phase)||0||
48425085|NCT01072175|101377548|FG005|COMPLETED|Part C (Phase II: Randomized Phase)||0||
48425086|NCT01072175|101377549|FG006|COMPLETED|Part C (Phase II: Randomized Phase)||0||
48425087|NCT01072175|101377550|FG007|COMPLETED|Part C (Phase II: Randomized Phase)||0||
48425088|NCT01072175|101377551|FG008|COMPLETED|Part C (Phase II: Randomized Phase)||0||
48425089|NCT01072175|101377552|FG009|COMPLETED|Part C (Phase II: Randomized Phase)||0||
48425090|NCT01072175|101377553|FG010|COMPLETED|Part C (Phase II: Randomized Phase)||0||
48425091|NCT01072175|101377554|FG011|COMPLETED|Part C (Phase II: Randomized Phase)||0||
48425092|NCT01072175|101377555|FG012|COMPLETED|Part C (Phase II: Randomized Phase)||0||
48425093|NCT01072175|101377543|FG000|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0||
48425094|NCT01072175|101377544|FG001|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0||
48425095|NCT01072175|101377545|FG002|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0||
48425096|NCT01072175|101377546|FG003|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0||
48425097|NCT01072175|101377547|FG004|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0||
48425098|NCT01072175|101377548|FG005|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54||
48425099|NCT01072175|101377549|FG006|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54||
48425100|NCT01072175|101377550|FG007|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54||
48425101|NCT01072175|101377551|FG008|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0||
48425102|NCT01072175|101377552|FG009|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0||
48425103|NCT01072175|101377553|FG010|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0||
48425104|NCT01072175|101377554|FG011|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0||
48425105|NCT01072175|101377555|FG012|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0||
48425106|NCT01072175|101377543|FG000|STARTED|Part C (Phase II: Crossover Phase [CP])||0||
48425107|NCT01072175|101377544|FG001|STARTED|Part C (Phase II: Crossover Phase [CP])||0||
48425108|NCT01072175|101377545|FG002|STARTED|Part C (Phase II: Crossover Phase [CP])||0||
48425109|NCT01072175|101377546|FG003|STARTED|Part C (Phase II: Crossover Phase [CP])||0||
48425110|NCT01072175|101377547|FG004|STARTED|Part C (Phase II: Crossover Phase [CP])||0||
48425111|NCT01072175|101377548|FG005|STARTED|Part C (Phase II: Crossover Phase [CP])||0||
48425112|NCT01072175|101377549|FG006|STARTED|Part C (Phase II: Crossover Phase [CP])||0||
48425113|NCT01072175|101377550|FG007|STARTED|Part C (Phase II: Crossover Phase [CP])||0||
48425114|NCT01072175|101377551|FG008|STARTED|Part C (Phase II: Crossover Phase [CP])||45||
48425115|NCT01072175|101377552|FG009|STARTED|Part C (Phase II: Crossover Phase [CP])||0||
48425116|NCT01072175|101377553|FG010|STARTED|Part C (Phase II: Crossover Phase [CP])||0||
48425117|NCT01072175|101377554|FG011|STARTED|Part C (Phase II: Crossover Phase [CP])||0||
48425118|NCT01072175|101377555|FG012|STARTED|Part C (Phase II: Crossover Phase [CP])||0||
48425119|NCT01072175|101377543|FG000|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
48425120|NCT01072175|101377544|FG001|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
48425121|NCT01072175|101377545|FG002|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
48425122|NCT01072175|101377546|FG003|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
48425123|NCT01072175|101377547|FG004|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
48425124|NCT01072175|101377548|FG005|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
48425125|NCT01072175|101377549|FG006|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
48425126|NCT01072175|101377550|FG007|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
48425127|NCT01072175|101377551|FG008|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
48763957|NCT03406377|102211834|FG000|STARTED|Overall Study||41||
48763958|NCT03406377|102211835|FG001|STARTED|Overall Study||72||
48763959|NCT03406377|102211834|FG000|COMPLETED|Overall Study||25||
48763960|NCT03406377|102211835|FG001|COMPLETED|Overall Study||51||
48763961|NCT03406377|102211834|FG000|NOT COMPLETED|Overall Study||16||
48763962|NCT03406377|102211835|FG001|NOT COMPLETED|Overall Study||21||
48763963|NCT00726063|102211836|FG000|STARTED|Overall Study||122||
48425128|NCT01072175|101377552|FG009|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
48425129|NCT01072175|101377553|FG010|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
48425130|NCT01072175|101377554|FG011|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
48439985|NCT03176953|101410001|FG000|STARTED|Overall Study||50||
48425131|NCT01072175|101377555|FG012|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
48425132|NCT01072175|101377543|FG000|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
48425133|NCT01072175|101377544|FG001|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
48425134|NCT01072175|101377545|FG002|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
48425135|NCT01072175|101377546|FG003|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
48425136|NCT01072175|101377547|FG004|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
48425137|NCT01072175|101377548|FG005|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
48425138|NCT01072175|101377549|FG006|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
48425139|NCT01072175|101377550|FG007|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
48425140|NCT01072175|101377551|FG008|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||45||
48425141|NCT01072175|101377552|FG009|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
48425142|NCT01072175|101377553|FG010|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
48425143|NCT01072175|101377554|FG011|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
48425144|NCT01072175|101377555|FG012|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
48425145|NCT01072175|101377543|FG000|STARTED|Part D (HPMC Capsules)||0||
48425146|NCT01072175|101377544|FG001|STARTED|Part D (HPMC Capsules)||0||
48425147|NCT01072175|101377545|FG002|STARTED|Part D (HPMC Capsules)||0||
48425148|NCT01072175|101377546|FG003|STARTED|Part D (HPMC Capsules)||0||
48425149|NCT01072175|101377547|FG004|STARTED|Part D (HPMC Capsules)||0||
48425150|NCT01072175|101377548|FG005|STARTED|Part D (HPMC Capsules)||0||
48425151|NCT01072175|101377549|FG006|STARTED|Part D (HPMC Capsules)||0||
48425152|NCT01072175|101377550|FG007|STARTED|Part D (HPMC Capsules)||0||
48425153|NCT01072175|101377551|FG008|STARTED|Part D (HPMC Capsules)||0||
48425154|NCT01072175|101377552|FG009|STARTED|Part D (HPMC Capsules)||12||
48425155|NCT01072175|101377553|FG010|STARTED|Part D (HPMC Capsules)||16||
48425156|NCT01072175|101377554|FG011|STARTED|Part D (HPMC Capsules)||43||
48425157|NCT01072175|101377555|FG012|STARTED|Part D (HPMC Capsules)||39||
48425158|NCT01072175|101377543|FG000|COMPLETED|Part D (HPMC Capsules)||0||
48425159|NCT01072175|101377544|FG001|COMPLETED|Part D (HPMC Capsules)||0||
48425160|NCT01072175|101377545|FG002|COMPLETED|Part D (HPMC Capsules)||0||
48425161|NCT01072175|101377546|FG003|COMPLETED|Part D (HPMC Capsules)||0||
48425162|NCT01072175|101377547|FG004|COMPLETED|Part D (HPMC Capsules)||0||
48425163|NCT01072175|101377548|FG005|COMPLETED|Part D (HPMC Capsules)||0||
48425164|NCT01072175|101377549|FG006|COMPLETED|Part D (HPMC Capsules)||0||
48425165|NCT01072175|101377550|FG007|COMPLETED|Part D (HPMC Capsules)||0||
48425166|NCT01072175|101377551|FG008|COMPLETED|Part D (HPMC Capsules)||0||
48425167|NCT01072175|101377552|FG009|COMPLETED|Part D (HPMC Capsules)||0||
48425168|NCT01072175|101377553|FG010|COMPLETED|Part D (HPMC Capsules)||0||
48425169|NCT01072175|101377554|FG011|COMPLETED|Part D (HPMC Capsules)||0||
48425170|NCT01072175|101377555|FG012|COMPLETED|Part D (HPMC Capsules)||0||
48425171|NCT01072175|101377543|FG000|NOT COMPLETED|Part D (HPMC Capsules)||0||
48425172|NCT01072175|101377544|FG001|NOT COMPLETED|Part D (HPMC Capsules)||0||
48425173|NCT01072175|101377545|FG002|NOT COMPLETED|Part D (HPMC Capsules)||0||
48425174|NCT01072175|101377546|FG003|NOT COMPLETED|Part D (HPMC Capsules)||0||
48425175|NCT01072175|101377547|FG004|NOT COMPLETED|Part D (HPMC Capsules)||0||
48425176|NCT01072175|101377548|FG005|NOT COMPLETED|Part D (HPMC Capsules)||0||
48425177|NCT01072175|101377549|FG006|NOT COMPLETED|Part D (HPMC Capsules)||0||
48425178|NCT01072175|101377550|FG007|NOT COMPLETED|Part D (HPMC Capsules)||0||
48425179|NCT01072175|101377551|FG008|NOT COMPLETED|Part D (HPMC Capsules)||0||
48425180|NCT01072175|101377552|FG009|NOT COMPLETED|Part D (HPMC Capsules)||12||
48425181|NCT01072175|101377553|FG010|NOT COMPLETED|Part D (HPMC Capsules)||16||
48425182|NCT01072175|101377554|FG011|NOT COMPLETED|Part D (HPMC Capsules)||43||
48425183|NCT01072175|101377555|FG012|NOT COMPLETED|Part D (HPMC Capsules)||39||
48425184|NCT01928758|101377556|FG000|STARTED|Overall Study||94||
48425185|NCT01928758|101377557|FG001|STARTED|Overall Study||94||
48425186|NCT01928758|101377556|FG000|COMPLETED|Overall Study||69||
48425187|NCT01928758|101377557|FG001|COMPLETED|Overall Study||74||
48425188|NCT01928758|101377556|FG000|NOT COMPLETED|Overall Study||25||
48425189|NCT01928758|101377557|FG001|NOT COMPLETED|Overall Study||20||
48425190|NCT00883896|101377558|FG000|STARTED|Overall Study||66||
48425191|NCT00883896|101377559|FG001|STARTED|Overall Study||39||
48425192|NCT00883896|101377560|FG002|STARTED|Overall Study||42||
48425193|NCT00883896|101377561|FG003|STARTED|Overall Study||48||
48425194|NCT00883896|101377558|FG000|COMPLETED|Overall Study||60||
48425195|NCT00883896|101377559|FG001|COMPLETED|Overall Study||39||
48425196|NCT00883896|101377560|FG002|COMPLETED|Overall Study||41||
48425197|NCT00883896|101377561|FG003|COMPLETED|Overall Study||41||
48425198|NCT00883896|101377558|FG000|NOT COMPLETED|Overall Study||6||
48425199|NCT00883896|101377559|FG001|NOT COMPLETED|Overall Study||0||
48425200|NCT00883896|101377560|FG002|NOT COMPLETED|Overall Study||1||
48425201|NCT00883896|101377561|FG003|NOT COMPLETED|Overall Study||7||
48425202|NCT00711009|101377562|FG000|STARTED|Overall Study||105||
48425203|NCT00711009|101377563|FG001|STARTED|Overall Study||101||
48425204|NCT00711009|101377562|FG000|COMPLETED|Overall Study||90||
48425205|NCT00711009|101377563|FG001|COMPLETED|Overall Study||82||
48425206|NCT00711009|101377562|FG000|NOT COMPLETED|Overall Study||15||
48425207|NCT00711009|101377563|FG001|NOT COMPLETED|Overall Study||19||
48425208|NCT01233284|101377564|FG000|STARTED|Period 1 (4 Weeks)||37||
48638926|NCT00306488|101901532|FG000|STARTED|Overall Study||11||
48638927|NCT00306488|101901532|FG000|COMPLETED|Overall Study||10||
48638928|NCT00306488|101901532|FG000|NOT COMPLETED|Overall Study||1||
48638929|NCT03233217|101901533|FG000|STARTED|Overall Study||5|Randomized and vaccinated.|
48638930|NCT03233217|101901534|FG001|STARTED|Overall Study||5|Randomized and vaccinated.|
48638931|NCT03233217|101901535|FG002|STARTED|Overall Study||55|Randomized and vaccinated.|
48359902|NCT00538733|101210765|FG000|STARTED|Overall Study||26||
48359903|NCT00538733|101210765|FG000|Removed Due to Progression of Disease|Overall Study||1||
48359904|NCT00538733|101210765|FG000|Removed to Pursue a Stem Cell Transplant|Overall Study||11||
48359905|NCT00538733|101210765|FG000|Removed to Pursue Alternative Theray|Overall Study||2||
48359906|NCT00538733|101210765|FG000|COMPLETED|Overall Study||14||
48359907|NCT00538733|101210765|FG000|NOT COMPLETED|Overall Study||12||
48359908|NCT03705494|101210766|FG000|STARTED|Overall Study||10||
48359909|NCT03705494|101210767|FG001|STARTED|Overall Study||10||
48359910|NCT03705494|101210766|FG000|COMPLETED|Overall Study||3||
48359911|NCT03705494|101210767|FG001|COMPLETED|Overall Study||7||
48359912|NCT03705494|101210766|FG000|NOT COMPLETED|Overall Study||7||
48359913|NCT03705494|101210767|FG001|NOT COMPLETED|Overall Study||3||
48359914|NCT03440112|101210768|FG000|STARTED|Overall Study||11||
48359915|NCT03440112|101210769|FG001|STARTED|Overall Study||11||
48359916|NCT03440112|101210770|FG002|STARTED|Overall Study||3||
48359917|NCT03440112|101210768|FG000|COMPLETED|Overall Study||11||
48359918|NCT03440112|101210769|FG001|COMPLETED|Overall Study||11||
48359919|NCT03440112|101210770|FG002|COMPLETED|Overall Study||3||
48359920|NCT03440112|101210768|FG000|NOT COMPLETED|Overall Study||0||
48359921|NCT03440112|101210769|FG001|NOT COMPLETED|Overall Study||0||
48359922|NCT03440112|101210770|FG002|NOT COMPLETED|Overall Study||0||
48359923|NCT04331730|101210771|FG000|STARTED|Overall Study||36||
48359924|NCT04331730|101210772|FG001|STARTED|Overall Study||35||
48359925|NCT04331730|101210773|FG002|STARTED|Overall Study||36||
48359926|NCT04331730|101210771|FG000|COMPLETED|Overall Study||36||
48359927|NCT04331730|101210772|FG001|COMPLETED|Overall Study||29||
48359928|NCT04331730|101210773|FG002|COMPLETED|Overall Study||34||
48359929|NCT04331730|101210771|FG000|NOT COMPLETED|Overall Study||0||
48359930|NCT04331730|101210772|FG001|NOT COMPLETED|Overall Study||6||
48359931|NCT04331730|101210773|FG002|NOT COMPLETED|Overall Study||2||
48359932|NCT01092442|101210774|FG000|STARTED|Overall Study||80||
48359933|NCT01092442|101210775|FG001|STARTED|Overall Study||60||
48359934|NCT01092442|101210774|FG000|COMPLETED|Overall Study||80||
48359935|NCT01092442|101210775|FG001|COMPLETED|Overall Study||60||
48359936|NCT01092442|101210774|FG000|NOT COMPLETED|Overall Study||0||
48359937|NCT01092442|101210775|FG001|NOT COMPLETED|Overall Study||0||
48359938|NCT02435173|101210776|FG000|STARTED|Overall Study||6|All participants who were enrolled in Part I or randomized in Part II.|
48359939|NCT02435173|101210777|FG001|STARTED|Overall Study||21|All participants who were enrolled in Part I or randomized in Part II.|
48359940|NCT02435173|101210778|FG002|STARTED|Overall Study||10|All participants who were enrolled in Part I or randomized in Part II.|
48359941|NCT02435173|101210776|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||6|All enrolled participants with at least one available valid PK concentration measurement, who received CDZ173 study drug and experienced no protocol deviations with relevant impact on PK data.|
48359942|NCT02435173|101210777|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||19|All enrolled participants with at least one available valid PK concentration measurement, who received CDZ173 study drug and experienced no protocol deviations with relevant impact on PK data.|
48359943|NCT02435173|101210778|FG002|Pharmacokinetics (PK) Analysis Set|Overall Study||0|All enrolled participants with at least one available valid PK concentration measurement, who received CDZ173 study drug and experienced no protocol deviations with relevant impact on PK data.|
48359944|NCT02435173|101210776|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||6|All enrolled participants who received any study drug and with no protocol deviations with relevant impact on PD data.|
48359945|NCT02435173|101210777|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||19|All enrolled participants who received any study drug and with no protocol deviations with relevant impact on PD data.|
48359946|NCT02435173|101210778|FG002|Pharmacodynamic (PD) Analysis Set|Overall Study||8|All enrolled participants who received any study drug and with no protocol deviations with relevant impact on PD data.|
48359947|NCT02435173|101210776|FG000|COMPLETED|Overall Study||6||
48359948|NCT02435173|101210777|FG001|COMPLETED|Overall Study||21||
48359949|NCT02435173|101210778|FG002|COMPLETED|Overall Study||10||
48359950|NCT02435173|101210776|FG000|NOT COMPLETED|Overall Study||0||
48359951|NCT02435173|101210777|FG001|NOT COMPLETED|Overall Study||0||
48359952|NCT02435173|101210778|FG002|NOT COMPLETED|Overall Study||0||
48359953|NCT02732912|101210779|FG000|STARTED|Overall Study||97||
48359954|NCT02732912|101210780|FG001|STARTED|Overall Study||109||
48359955|NCT02732912|101210779|FG000|COMPLETED|Overall Study||87||
48359956|NCT02732912|101210780|FG001|COMPLETED|Overall Study||91||
48359957|NCT02732912|101210779|FG000|NOT COMPLETED|Overall Study||10||
48359958|NCT02732912|101210780|FG001|NOT COMPLETED|Overall Study||18||
48359959|NCT04651777|101210781|FG000|STARTED|Overall Study||31||
48359960|NCT04651777|101210781|FG000|Completed V1+V2|Overall Study||28||
48359961|NCT04651777|101210781|FG000|COMPLETED|Overall Study||28||
48359962|NCT04651777|101210781|FG000|NOT COMPLETED|Overall Study||3||
48359963|NCT01326962|101210782|FG000|STARTED|Overall Study||28||
48638932|NCT03233217|101901536|FG003|STARTED|Overall Study||55|Randomized and vaccinated.|
48763964|NCT00726063|102211837|FG001|STARTED|Overall Study||119||
48425209|NCT01233284|101377565|FG001|STARTED|Period 1 (4 Weeks)||38||
48425210|NCT01233284|101377566|FG002|STARTED|Period 1 (4 Weeks)||38||
48425211|NCT01233284|101377567|FG003|STARTED|Period 1 (4 Weeks)||35||
48425212|NCT01233284|101377568|FG004|STARTED|Period 1 (4 Weeks)||1||
48425213|NCT01233284|101377564|FG000|COMPLETED|Period 1 (4 Weeks)||36||
48425214|NCT01233284|101377565|FG001|COMPLETED|Period 1 (4 Weeks)||37||
48425215|NCT01233284|101377566|FG002|COMPLETED|Period 1 (4 Weeks)||37||
48425216|NCT01233284|101377567|FG003|COMPLETED|Period 1 (4 Weeks)||35||
48425217|NCT01233284|101377568|FG004|COMPLETED|Period 1 (4 Weeks)||1||
48425218|NCT01233284|101377564|FG000|NOT COMPLETED|Period 1 (4 Weeks)||1||
48425219|NCT01233284|101377565|FG001|NOT COMPLETED|Period 1 (4 Weeks)||1||
48425220|NCT01233284|101377566|FG002|NOT COMPLETED|Period 1 (4 Weeks)||1||
48425221|NCT01233284|101377567|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0||
48425222|NCT01233284|101377568|FG004|NOT COMPLETED|Period 1 (4 Weeks)||0||
48425223|NCT01233284|101377564|FG000|STARTED|Period 2 (4 Weeks)||36||
48425224|NCT01233284|101377565|FG001|STARTED|Period 2 (4 Weeks)||37||
48425225|NCT01233284|101377566|FG002|STARTED|Period 2 (4 Weeks)||37||
48425226|NCT01233284|101377567|FG003|STARTED|Period 2 (4 Weeks)||35||
48425227|NCT01233284|101377568|FG004|STARTED|Period 2 (4 Weeks)||1||
48425228|NCT01233284|101377564|FG000|COMPLETED|Period 2 (4 Weeks)||36||
48425229|NCT01233284|101377565|FG001|COMPLETED|Period 2 (4 Weeks)||37||
48425230|NCT01233284|101377566|FG002|COMPLETED|Period 2 (4 Weeks)||36||
48425231|NCT01233284|101377567|FG003|COMPLETED|Period 2 (4 Weeks)||35||
48425232|NCT01233284|101377568|FG004|COMPLETED|Period 2 (4 Weeks)||1||
48425233|NCT01233284|101377564|FG000|NOT COMPLETED|Period 2 (4 Weeks)||0||
48425234|NCT01233284|101377565|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0||
48425235|NCT01233284|101377566|FG002|NOT COMPLETED|Period 2 (4 Weeks)||1||
48425236|NCT01233284|101377567|FG003|NOT COMPLETED|Period 2 (4 Weeks)||0||
48425237|NCT01233284|101377568|FG004|NOT COMPLETED|Period 2 (4 Weeks)||0||
48425238|NCT01233284|101377564|FG000|STARTED|Period 3 (4 Weeks)||36||
48425239|NCT01233284|101377565|FG001|STARTED|Period 3 (4 Weeks)||37||
48425240|NCT01233284|101377566|FG002|STARTED|Period 3 (4 Weeks)||36||
48425241|NCT01233284|101377567|FG003|STARTED|Period 3 (4 Weeks)||35||
48425242|NCT01233284|101377568|FG004|STARTED|Period 3 (4 Weeks)||1||
48425243|NCT01233284|101377564|FG000|COMPLETED|Period 3 (4 Weeks)||36||
48425244|NCT01233284|101377565|FG001|COMPLETED|Period 3 (4 Weeks)||37||
48425245|NCT01233284|101377566|FG002|COMPLETED|Period 3 (4 Weeks)||35||
48425246|NCT01233284|101377567|FG003|COMPLETED|Period 3 (4 Weeks)||34||
48425247|NCT01233284|101377568|FG004|COMPLETED|Period 3 (4 Weeks)||1||
48425248|NCT01233284|101377564|FG000|NOT COMPLETED|Period 3 (4 Weeks)||0||
48425249|NCT01233284|101377565|FG001|NOT COMPLETED|Period 3 (4 Weeks)||0||
48425250|NCT01233284|101377566|FG002|NOT COMPLETED|Period 3 (4 Weeks)||1||
48425251|NCT01233284|101377567|FG003|NOT COMPLETED|Period 3 (4 Weeks)||1||
48425252|NCT01233284|101377568|FG004|NOT COMPLETED|Period 3 (4 Weeks)||0||
48425253|NCT01233284|101377564|FG000|STARTED|Period 4 (4 Weeks)||36||
48425254|NCT01233284|101377565|FG001|STARTED|Period 4 (4 Weeks)||37||
48425255|NCT01233284|101377566|FG002|STARTED|Period 4 (4 Weeks)||35||
48425256|NCT01233284|101377567|FG003|STARTED|Period 4 (4 Weeks)||34||
48425257|NCT01233284|101377568|FG004|STARTED|Period 4 (4 Weeks)||1||
48425258|NCT01233284|101377564|FG000|COMPLETED|Period 4 (4 Weeks)||36||
48425259|NCT01233284|101377565|FG001|COMPLETED|Period 4 (4 Weeks)||36||
48425260|NCT01233284|101377566|FG002|COMPLETED|Period 4 (4 Weeks)||35||
48425261|NCT01233284|101377567|FG003|COMPLETED|Period 4 (4 Weeks)||33||
48425262|NCT01233284|101377568|FG004|COMPLETED|Period 4 (4 Weeks)||1||
48425263|NCT01233284|101377564|FG000|NOT COMPLETED|Period 4 (4 Weeks)||0||
48425264|NCT01233284|101377565|FG001|NOT COMPLETED|Period 4 (4 Weeks)||1||
48425265|NCT01233284|101377566|FG002|NOT COMPLETED|Period 4 (4 Weeks)||0||
48425266|NCT01233284|101377567|FG003|NOT COMPLETED|Period 4 (4 Weeks)||1||
48425267|NCT01233284|101377568|FG004|NOT COMPLETED|Period 4 (4 Weeks)||0||
48425268|NCT02996981|101377569|FG000|STARTED|Overall Study||96||
48425269|NCT02996981|101377570|FG001|STARTED|Overall Study||71||
48425270|NCT02996981|101377569|FG000|COMPLETED|Overall Study||96||
48425271|NCT02996981|101377570|FG001|COMPLETED|Overall Study||71||
48425272|NCT02996981|101377569|FG000|NOT COMPLETED|Overall Study||0||
48425273|NCT02996981|101377570|FG001|NOT COMPLETED|Overall Study||0||
48425274|NCT01087944|101377571|FG000|STARTED|Period 1 (Week 1-3)||30||
48425275|NCT01087944|101377572|FG001|STARTED|Period 1 (Week 1-3)||30||
48425276|NCT01087944|101377571|FG000|COMPLETED|Period 1 (Week 1-3)||29||
48425277|NCT01087944|101377572|FG001|COMPLETED|Period 1 (Week 1-3)||30||
48425278|NCT01087944|101377571|FG000|NOT COMPLETED|Period 1 (Week 1-3)||1||
48425279|NCT01087944|101377572|FG001|NOT COMPLETED|Period 1 (Week 1-3)||0||
48425280|NCT01087944|101377571|FG000|STARTED|Period 2 (Week 4-6)||29||
48425281|NCT01087944|101377572|FG001|STARTED|Period 2 (Week 4-6)||30||
48425282|NCT01087944|101377571|FG000|COMPLETED|Period 2 (Week 4-6)||29||
48425283|NCT01087944|101377572|FG001|COMPLETED|Period 2 (Week 4-6)||28||
48425284|NCT01087944|101377571|FG000|NOT COMPLETED|Period 2 (Week 4-6)||0||
48425285|NCT01087944|101377572|FG001|NOT COMPLETED|Period 2 (Week 4-6)||2||
48425286|NCT01883362|101377573|FG000|STARTED|Treatment||30||
48425287|NCT01883362|101377574|FG001|STARTED|Treatment||30||
48425288|NCT01883362|101377573|FG000|COMPLETED|Treatment||14||
48425289|NCT01883362|101377574|FG001|COMPLETED|Treatment||16||
48425290|NCT01883362|101377573|FG000|NOT COMPLETED|Treatment||16||
48425291|NCT01883362|101377574|FG001|NOT COMPLETED|Treatment||14||
48425292|NCT01883362|101377573|FG000|STARTED|Post Treatment Follow-up||26||
48425293|NCT01883362|101377574|FG001|STARTED|Post Treatment Follow-up||27||
48425294|NCT01883362|101377573|FG000|COMPLETED|Post Treatment Follow-up||10||
48425295|NCT01883362|101377574|FG001|COMPLETED|Post Treatment Follow-up||13||
48425296|NCT01883362|101377573|FG000|NOT COMPLETED|Post Treatment Follow-up||16||
48425297|NCT01883362|101377574|FG001|NOT COMPLETED|Post Treatment Follow-up||14||
48425298|NCT04084210|101377575|FG000|STARTED|Overall Study||34||
48425299|NCT04084210|101377576|FG001|STARTED|Overall Study||32||
48425300|NCT04084210|101377577|FG002|STARTED|Overall Study||37||
48425301|NCT04084210|101377578|FG003|STARTED|Overall Study||36||
48425302|NCT04084210|101377579|FG004|STARTED|Overall Study||34||
48425303|NCT04084210|101377580|FG005|STARTED|Overall Study||36||
48425304|NCT04084210|101377575|FG000|COMPLETED|Overall Study||27||
48425305|NCT04084210|101377576|FG001|COMPLETED|Overall Study||27||
48425306|NCT04084210|101377577|FG002|COMPLETED|Overall Study||29||
48425307|NCT04084210|101377578|FG003|COMPLETED|Overall Study||24||
48425308|NCT04084210|101377579|FG004|COMPLETED|Overall Study||26||
48425309|NCT04084210|101377580|FG005|COMPLETED|Overall Study||27||
48425310|NCT04084210|101377575|FG000|NOT COMPLETED|Overall Study||7||
48425311|NCT04084210|101377576|FG001|NOT COMPLETED|Overall Study||5||
48425312|NCT04084210|101377577|FG002|NOT COMPLETED|Overall Study||8||
48425313|NCT04084210|101377578|FG003|NOT COMPLETED|Overall Study||12||
48425314|NCT04084210|101377579|FG004|NOT COMPLETED|Overall Study||8||
48425315|NCT04084210|101377580|FG005|NOT COMPLETED|Overall Study||9||
48425316|NCT04382066|101377581|FG000|STARTED|Overall Study||15|One patient withdrew the Informed Consent before any study procedure was performed.|
48425317|NCT04382066|101377582|FG001|STARTED|Overall Study||15|One patient withdrew the Informed Consent before any study procedure was performed.|
48425318|NCT04382066|101377583|FG002|STARTED|Overall Study||15|One patient withdrew the Informed Consent before any study procedure was performed.|
48425319|NCT04382066|101377581|FG000|Completed 3-day Treatment|Overall Study||14||
48425320|NCT04382066|101377582|FG001|Completed 3-day Treatment|Overall Study||15||
48425321|NCT04382066|101377583|FG002|Completed 3-day Treatment|Overall Study||15||
48425322|NCT04382066|101377581|FG000|COMPLETED|Overall Study||13|Completed Day 31 follow-up|
48425323|NCT04382066|101377582|FG001|COMPLETED|Overall Study||15|Completed Day 31 follow-up|
48425324|NCT04382066|101377583|FG002|COMPLETED|Overall Study||14|Completed Day 31 follow-up|
48425325|NCT04382066|101377581|FG000|NOT COMPLETED|Overall Study||2||
48425326|NCT04382066|101377582|FG001|NOT COMPLETED|Overall Study||0||
48425327|NCT04382066|101377583|FG002|NOT COMPLETED|Overall Study||1||
48425328|NCT03014700|101377584|FG000|STARTED|Overall Study||30||
48425329|NCT03014700|101377585|FG001|STARTED|Overall Study||30||
48425330|NCT03014700|101377584|FG000|COMPLETED|Overall Study||25||
48425331|NCT03014700|101377585|FG001|COMPLETED|Overall Study||29||
48425332|NCT03014700|101377584|FG000|NOT COMPLETED|Overall Study||5||
48425333|NCT03014700|101377585|FG001|NOT COMPLETED|Overall Study||1||
48425334|NCT04491591|101377586|FG000|STARTED|Overall Study||187||
48425335|NCT04491591|101377587|FG001|STARTED|Overall Study||186||
48425336|NCT04491591|101377588|FG002|STARTED|Overall Study||23||
48425337|NCT04491591|101377586|FG000|COMPLETED|Overall Study||156||
48425338|NCT04491591|101377587|FG001|COMPLETED|Overall Study||165||
48425339|NCT04491591|101377588|FG002|COMPLETED|Overall Study||20||
48425340|NCT04491591|101377586|FG000|NOT COMPLETED|Overall Study||31||
48425341|NCT04491591|101377587|FG001|NOT COMPLETED|Overall Study||21||
48425342|NCT04491591|101377588|FG002|NOT COMPLETED|Overall Study||3||
48425343|NCT01756846|101377589|FG000|STARTED|Overall Study||1833||
48425344|NCT01756846|101377590|FG001|STARTED|Overall Study||1833||
48425345|NCT01756846|101377589|FG000|COMPLETED|Overall Study||1827||
48425346|NCT01756846|101377590|FG001|COMPLETED|Overall Study||1821||
48425347|NCT01756846|101377589|FG000|NOT COMPLETED|Overall Study||6||
48425348|NCT01756846|101377590|FG001|NOT COMPLETED|Overall Study||12||
48425349|NCT02505945|101377591|FG000|STARTED|Overall Study||102||
48425350|NCT02505945|101377592|FG001|STARTED|Overall Study||50||
48425351|NCT02505945|101377591|FG000|COMPLETED|Overall Study||80||
48425352|NCT02505945|101377592|FG001|COMPLETED|Overall Study||46||
48425353|NCT02505945|101377591|FG000|NOT COMPLETED|Overall Study||22||
48425354|NCT02505945|101377592|FG001|NOT COMPLETED|Overall Study||4||
48425355|NCT00579059|101377593|FG000|STARTED|Overall Study||21||
48425356|NCT00579059|101377594|FG001|STARTED|Overall Study||10||
48425357|NCT00579059|101377593|FG000|Immediate Post-Op|Overall Study||20||
48425358|NCT00579059|101377594|FG001|Immediate Post-Op|Overall Study||9||
48425359|NCT00579059|101377593|FG000|6 Months|Overall Study||11||
48425360|NCT00579059|101377594|FG001|6 Months|Overall Study||4||
48425361|NCT00579059|101377593|FG000|1 Year|Overall Study||8||
48425362|NCT00579059|101377594|FG001|1 Year|Overall Study||3||
48425363|NCT00579059|101377593|FG000|3 Years|Overall Study||0||
48425364|NCT00579059|101377594|FG001|3 Years|Overall Study||0||
48425365|NCT00579059|101377593|FG000|5 Years|Overall Study||0||
48425366|NCT00579059|101377594|FG001|5 Years|Overall Study||0||
48425367|NCT00579059|101377593|FG000|COMPLETED|Overall Study||0||
48425368|NCT00579059|101377594|FG001|COMPLETED|Overall Study||0||
48425369|NCT00579059|101377593|FG000|NOT COMPLETED|Overall Study||21||
48425370|NCT00579059|101377594|FG001|NOT COMPLETED|Overall Study||10||
48439986|NCT03176953|101410002|FG001|STARTED|Overall Study||50||
48425371|NCT04391894|101377595|FG000|STARTED|Overall Study||111|All randomized treated subjects were included in Full Analysis Set 1 (FAS1) and Safety Set 1 (SAF1)|
48425372|NCT04391894|101377596|FG001|STARTED|Overall Study||112|All randomized treated subjects were included in Full Analysis Set 1 (FAS1) and Safety Set 1 (SAF1)|
48425373|NCT04391894|101377597|FG002|STARTED|Overall Study||112|All randomized treated subjects were included in Full Analysis Set 1 (FAS1) and Safety Set 1 (SAF1)|
48425374|NCT04391894|101377598|FG003|STARTED|Overall Study||109|All randomized treated subjects were included in Full Analysis Set 1 (FAS1) and Safety Set 1 (SAF1)|
48425375|NCT04391894|101377599|FG004|STARTED|Overall Study||114|All randomized treated subjects were included in Full Analysis Set 1 (FAS1) and Safety Set 1 (SAF1)|
48425376|NCT04391894|101377595|FG000|COMPLETED|Overall Study||107||
48425377|NCT04391894|101377596|FG001|COMPLETED|Overall Study||111||
48425378|NCT04391894|101377597|FG002|COMPLETED|Overall Study||108||
48425379|NCT04391894|101377598|FG003|COMPLETED|Overall Study||107||
48425380|NCT04391894|101377599|FG004|COMPLETED|Overall Study||111||
48425381|NCT04391894|101377595|FG000|NOT COMPLETED|Overall Study||4||
48425382|NCT04391894|101377596|FG001|NOT COMPLETED|Overall Study||1||
48425383|NCT04391894|101377597|FG002|NOT COMPLETED|Overall Study||4||
48425384|NCT04391894|101377598|FG003|NOT COMPLETED|Overall Study||2||
48425385|NCT04391894|101377599|FG004|NOT COMPLETED|Overall Study||3||
48425386|NCT01189201|101377600|FG000|STARTED|Overall Study||42||
48425387|NCT01189201|101377600|FG000|Received Empa/Linagliptin FDC A1(Fasted)|Overall Study||42||
48425388|NCT01189201|101377600|FG000|Rec. Empa/Linagliptin Ind.Tablet(Fasted)|Overall Study||41||
48425389|NCT01189201|101377600|FG000|Received Empa/Linagliptin FDC A1 (Fed)|Overall Study||18||
48425390|NCT01189201|101377600|FG000|Received Empa/Linagliptin FDC A3(Fasted)|Overall Study||24||
48425391|NCT01189201|101377600|FG000|COMPLETED|Overall Study||41||
48425392|NCT01189201|101377600|FG000|NOT COMPLETED|Overall Study||1||
48425393|NCT02404792|101377601|FG000|STARTED|Overall Study||32||
48425394|NCT02404792|101377602|FG001|STARTED|Overall Study||37||
48425395|NCT02404792|101377601|FG000|COMPLETED|Overall Study||27||
48425396|NCT02404792|101377602|FG001|COMPLETED|Overall Study||29||
48425397|NCT02404792|101377601|FG000|NOT COMPLETED|Overall Study||5||
48425398|NCT02404792|101377602|FG001|NOT COMPLETED|Overall Study||8||
48425399|NCT03521089|101377603|FG000|STARTED|Overall Study||8||
48425400|NCT03521089|101377604|FG001|STARTED|Overall Study||8||
48425401|NCT03521089|101377603|FG000|COMPLETED|Overall Study||8||
48425402|NCT03521089|101377604|FG001|COMPLETED|Overall Study||8||
48425403|NCT03521089|101377603|FG000|NOT COMPLETED|Overall Study||0||
48425404|NCT03521089|101377604|FG001|NOT COMPLETED|Overall Study||0||
48425405|NCT00972309|101377605|FG000|STARTED|Overall Study||21||
48425406|NCT00972309|101377606|FG001|STARTED|Overall Study||20||
48425407|NCT00972309|101377605|FG000|COMPLETED|Overall Study||9||
48425408|NCT00972309|101377606|FG001|COMPLETED|Overall Study||7||
48425409|NCT00972309|101377605|FG000|NOT COMPLETED|Overall Study||12||
48425410|NCT00972309|101377606|FG001|NOT COMPLETED|Overall Study||13||
48425411|NCT04563845|101377607|FG000|STARTED|Part 1: (Up to Day 9)||2||
48425412|NCT04563845|101377608|FG001|STARTED|Part 1: (Up to Day 9)||6||
48425413|NCT04563845|101377609|FG002|STARTED|Part 1: (Up to Day 9)||0||
48425414|NCT04563845|101377610|FG003|STARTED|Part 1: (Up to Day 9)||0||
48425415|NCT04563845|101377611|FG004|STARTED|Part 1: (Up to Day 9)||0||
48425416|NCT04563845|101377612|FG005|STARTED|Part 1: (Up to Day 9)||0||
48425417|NCT04563845|101377613|FG006|STARTED|Part 1: (Up to Day 9)||0||
48425418|NCT04563845|101377614|FG007|STARTED|Part 1: (Up to Day 9)||0||
48425419|NCT04563845|101377615|FG008|STARTED|Part 1: (Up to Day 9)||0||
48425420|NCT04563845|101377616|FG009|STARTED|Part 1: (Up to Day 9)||0||
48425421|NCT04563845|101377617|FG010|STARTED|Part 1: (Up to Day 9)||0||
48425422|NCT04563845|101377618|FG011|STARTED|Part 1: (Up to Day 9)||0||
48425423|NCT04563845|101377619|FG012|STARTED|Part 1: (Up to Day 9)||0||
48425424|NCT04563845|101377620|FG013|STARTED|Part 1: (Up to Day 9)||0||
48425425|NCT04563845|101377607|FG000|COMPLETED|Part 1: (Up to Day 9)||2||
48425426|NCT04563845|101377608|FG001|COMPLETED|Part 1: (Up to Day 9)||6||
48425427|NCT04563845|101377609|FG002|COMPLETED|Part 1: (Up to Day 9)||0||
48425428|NCT04563845|101377610|FG003|COMPLETED|Part 1: (Up to Day 9)||0||
48425429|NCT04563845|101377611|FG004|COMPLETED|Part 1: (Up to Day 9)||0||
48425430|NCT04563845|101377612|FG005|COMPLETED|Part 1: (Up to Day 9)||0||
48425431|NCT04563845|101377613|FG006|COMPLETED|Part 1: (Up to Day 9)||0||
48425432|NCT04563845|101377614|FG007|COMPLETED|Part 1: (Up to Day 9)||0||
48425433|NCT04563845|101377615|FG008|COMPLETED|Part 1: (Up to Day 9)||0||
48425434|NCT04563845|101377616|FG009|COMPLETED|Part 1: (Up to Day 9)||0||
48425435|NCT04563845|101377617|FG010|COMPLETED|Part 1: (Up to Day 9)||0||
48425436|NCT04563845|101377618|FG011|COMPLETED|Part 1: (Up to Day 9)||0||
48425437|NCT04563845|101377619|FG012|COMPLETED|Part 1: (Up to Day 9)||0||
48425438|NCT04563845|101377620|FG013|COMPLETED|Part 1: (Up to Day 9)||0||
48425439|NCT04563845|101377607|FG000|NOT COMPLETED|Part 1: (Up to Day 9)||0||
48425440|NCT04563845|101377608|FG001|NOT COMPLETED|Part 1: (Up to Day 9)||0||
48425441|NCT04563845|101377609|FG002|NOT COMPLETED|Part 1: (Up to Day 9)||0||
48425442|NCT04563845|101377610|FG003|NOT COMPLETED|Part 1: (Up to Day 9)||0||
48425443|NCT04563845|101377611|FG004|NOT COMPLETED|Part 1: (Up to Day 9)||0||
48425444|NCT04563845|101377612|FG005|NOT COMPLETED|Part 1: (Up to Day 9)||0||
48425445|NCT04563845|101377613|FG006|NOT COMPLETED|Part 1: (Up to Day 9)||0||
48425446|NCT04563845|101377614|FG007|NOT COMPLETED|Part 1: (Up to Day 9)||0||
48425447|NCT04563845|101377615|FG008|NOT COMPLETED|Part 1: (Up to Day 9)||0||
48425448|NCT04563845|101377616|FG009|NOT COMPLETED|Part 1: (Up to Day 9)||0||
48425449|NCT04563845|101377617|FG010|NOT COMPLETED|Part 1: (Up to Day 9)||0||
48425450|NCT04563845|101377618|FG011|NOT COMPLETED|Part 1: (Up to Day 9)||0||
48425451|NCT04563845|101377619|FG012|NOT COMPLETED|Part 1: (Up to Day 9)||0||
48425452|NCT04563845|101377620|FG013|NOT COMPLETED|Part 1: (Up to Day 9)||0||
48425453|NCT04563845|101377607|FG000|STARTED|Part 2:Treatment Period 1(Up to 7 Days)||0||
48425454|NCT04563845|101377608|FG001|STARTED|Part 2:Treatment Period 1(Up to 7 Days)||0||
48425455|NCT04563845|101377609|FG002|STARTED|Part 2:Treatment Period 1(Up to 7 Days)||3||
48425456|NCT04563845|101377610|FG003|STARTED|Part 2:Treatment Period 1(Up to 7 Days)||4||
48425457|NCT04563845|101377611|FG004|STARTED|Part 2:Treatment Period 1(Up to 7 Days)||4||
48425458|NCT04563845|101377612|FG005|STARTED|Part 2:Treatment Period 1(Up to 7 Days)||4||
48425459|NCT04563845|101377613|FG006|STARTED|Part 2:Treatment Period 1(Up to 7 Days)||4||
48425460|NCT04563845|101377614|FG007|STARTED|Part 2:Treatment Period 1(Up to 7 Days)||3||
48425461|NCT04563845|101377615|FG008|STARTED|Part 2:Treatment Period 1(Up to 7 Days)||3||
48425462|NCT04563845|101377616|FG009|STARTED|Part 2:Treatment Period 1(Up to 7 Days)||3||
48425463|NCT04563845|101377617|FG010|STARTED|Part 2:Treatment Period 1(Up to 7 Days)||4||
48425464|NCT04563845|101377618|FG011|STARTED|Part 2:Treatment Period 1(Up to 7 Days)||4||
48425465|NCT04563845|101377619|FG012|STARTED|Part 2:Treatment Period 1(Up to 7 Days)||3||
48425466|NCT04563845|101377620|FG013|STARTED|Part 2:Treatment Period 1(Up to 7 Days)||3||
48425467|NCT04563845|101377607|FG000|COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||0||
48425468|NCT04563845|101377608|FG001|COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||0||
48425469|NCT04563845|101377609|FG002|COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||3||
48425470|NCT04563845|101377610|FG003|COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||4||
48425471|NCT04563845|101377611|FG004|COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||4||
48425472|NCT04563845|101377612|FG005|COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||4||
48425473|NCT04563845|101377613|FG006|COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||4||
48425474|NCT04563845|101377614|FG007|COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||2||
48425475|NCT04563845|101377615|FG008|COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||3||
48425476|NCT04563845|101377616|FG009|COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||3||
48425477|NCT04563845|101377617|FG010|COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||4||
48425478|NCT04563845|101377618|FG011|COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||4||
48425479|NCT04563845|101377619|FG012|COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||3||
48425480|NCT04563845|101377620|FG013|COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||3||
48425481|NCT04563845|101377607|FG000|NOT COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||0||
48425482|NCT04563845|101377608|FG001|NOT COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||0||
48425483|NCT04563845|101377609|FG002|NOT COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||0||
48425484|NCT04563845|101377610|FG003|NOT COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||0||
48425485|NCT04563845|101377611|FG004|NOT COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||0||
48425486|NCT04563845|101377612|FG005|NOT COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||0||
48425487|NCT04563845|101377613|FG006|NOT COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||0||
48425488|NCT04563845|101377614|FG007|NOT COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||1||
48425489|NCT04563845|101377615|FG008|NOT COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||0||
48425490|NCT04563845|101377616|FG009|NOT COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||0||
48425491|NCT04563845|101377617|FG010|NOT COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||0||
48425492|NCT04563845|101377618|FG011|NOT COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||0||
48425493|NCT04563845|101377619|FG012|NOT COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||0||
48425494|NCT04563845|101377620|FG013|NOT COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||0||
48425495|NCT04563845|101377607|FG000|STARTED|Part 2:Washout Period 1(Up to 7 Days)||0||
48425496|NCT04563845|101377608|FG001|STARTED|Part 2:Washout Period 1(Up to 7 Days)||0||
48425497|NCT04563845|101377609|FG002|STARTED|Part 2:Washout Period 1(Up to 7 Days)||3||
48425498|NCT04563845|101377610|FG003|STARTED|Part 2:Washout Period 1(Up to 7 Days)||4||
48425499|NCT04563845|101377611|FG004|STARTED|Part 2:Washout Period 1(Up to 7 Days)||4||
48425500|NCT04563845|101377612|FG005|STARTED|Part 2:Washout Period 1(Up to 7 Days)||4||
48425501|NCT04563845|101377613|FG006|STARTED|Part 2:Washout Period 1(Up to 7 Days)||4||
48425502|NCT04563845|101377614|FG007|STARTED|Part 2:Washout Period 1(Up to 7 Days)||2||
48425503|NCT04563845|101377615|FG008|STARTED|Part 2:Washout Period 1(Up to 7 Days)||3||
48425504|NCT04563845|101377616|FG009|STARTED|Part 2:Washout Period 1(Up to 7 Days)||3||
48638933|NCT03233217|101901537|FG004|STARTED|Overall Study||55|Randomized and vaccinated.|
48638934|NCT03233217|101901533|FG000|Safety Analysis Set (SafAS)|Overall Study||5||
48425505|NCT04563845|101377617|FG010|STARTED|Part 2:Washout Period 1(Up to 7 Days)||4||
48425506|NCT04563845|101377618|FG011|STARTED|Part 2:Washout Period 1(Up to 7 Days)||4||
48425507|NCT04563845|101377619|FG012|STARTED|Part 2:Washout Period 1(Up to 7 Days)||3||
48425508|NCT04563845|101377620|FG013|STARTED|Part 2:Washout Period 1(Up to 7 Days)||3||
48425509|NCT04563845|101377607|FG000|COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||0||
48425510|NCT04563845|101377608|FG001|COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||0||
48425511|NCT04563845|101377609|FG002|COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||3||
48425512|NCT04563845|101377610|FG003|COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||4||
48425513|NCT04563845|101377611|FG004|COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||3||
48425514|NCT04563845|101377612|FG005|COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||4||
48439987|NCT03176953|101410001|FG000|COMPLETED|Overall Study||41||
48425515|NCT04563845|101377613|FG006|COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||4||
48425516|NCT04563845|101377614|FG007|COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||2||
48425517|NCT04563845|101377615|FG008|COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||3||
48425518|NCT04563845|101377616|FG009|COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||3||
48425519|NCT04563845|101377617|FG010|COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||4||
48425520|NCT04563845|101377618|FG011|COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||4||
48425521|NCT04563845|101377619|FG012|COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||3||
48425522|NCT04563845|101377620|FG013|COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||3||
48425523|NCT04563845|101377607|FG000|NOT COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||0||
48425524|NCT04563845|101377608|FG001|NOT COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||0||
48638935|NCT03233217|101901534|FG001|Safety Analysis Set (SafAS)|Overall Study||5||
48638936|NCT03233217|101901535|FG002|Safety Analysis Set (SafAS)|Overall Study||55||
48638937|NCT03233217|101901536|FG003|Safety Analysis Set (SafAS)|Overall Study||55||
48187247|NCT04822298|100780000|FG000|NOT COMPLETED|Overall Study||3||
48187248|NCT02162732|100780001|FG000|STARTED|Overall Study||186||
48187249|NCT02162732|100780001|FG000|COMPLETED|Overall Study||168||
48187250|NCT02162732|100780001|FG000|NOT COMPLETED|Overall Study||18||
48187251|NCT03824236|100780002|FG000|STARTED|Overall Study||25||
48187252|NCT03824236|100780003|FG001|STARTED|Overall Study||24||
48187253|NCT03824236|100780004|FG002|STARTED|Overall Study||12||
48187254|NCT03824236|100780002|FG000|COMPLETED|Overall Study||25||
48187255|NCT03824236|100780003|FG001|COMPLETED|Overall Study||24||
48187256|NCT03824236|100780004|FG002|COMPLETED|Overall Study||11||
48187257|NCT03824236|100780002|FG000|NOT COMPLETED|Overall Study||0||
48187258|NCT03824236|100780003|FG001|NOT COMPLETED|Overall Study||0||
48187259|NCT03824236|100780004|FG002|NOT COMPLETED|Overall Study||1||
48187260|NCT02968940|100780005|FG000|STARTED|Overall Study||6||
48187261|NCT02968940|100780005|FG000|COMPLETED|Overall Study||6||
48187262|NCT02968940|100780005|FG000|NOT COMPLETED|Overall Study||0||
48187263|NCT01146808|100780006|FG000|STARTED|Overall Study||16||
48187264|NCT01146808|100780006|FG000|COMPLETED|Overall Study||16||
48187265|NCT01146808|100780006|FG000|NOT COMPLETED|Overall Study||0||
48187266|NCT02081391|100780007|FG000|STARTED|12-hour Treatment||108||
48187267|NCT02081391|100780008|FG001|STARTED|12-hour Treatment||52||
48187268|NCT02081391|100780009|FG002|STARTED|12-hour Treatment||11||
48187269|NCT02081391|100780010|FG003|STARTED|12-hour Treatment||4||
48187270|NCT02081391|100780007|FG000|COMPLETED|12-hour Treatment||90||
48187271|NCT02081391|100780008|FG001|COMPLETED|12-hour Treatment||46||
48187272|NCT02081391|100780009|FG002|COMPLETED|12-hour Treatment||10||
48187273|NCT02081391|100780010|FG003|COMPLETED|12-hour Treatment||4||
48187274|NCT02081391|100780007|FG000|NOT COMPLETED|12-hour Treatment||18||
48187275|NCT02081391|100780008|FG001|NOT COMPLETED|12-hour Treatment||6||
48187276|NCT02081391|100780009|FG002|NOT COMPLETED|12-hour Treatment||1||
48187277|NCT02081391|100780010|FG003|NOT COMPLETED|12-hour Treatment||0||
48187278|NCT02081391|100780007|FG000|STARTED|24-hour Treatment and Trial Completion||90||
48187279|NCT02081391|100780008|FG001|STARTED|24-hour Treatment and Trial Completion||46||
48187280|NCT02081391|100780009|FG002|STARTED|24-hour Treatment and Trial Completion||10||
48187281|NCT02081391|100780010|FG003|STARTED|24-hour Treatment and Trial Completion||4||
48187282|NCT02081391|100780007|FG000|COMPLETED|24-hour Treatment and Trial Completion||63||
48187283|NCT02081391|100780008|FG001|COMPLETED|24-hour Treatment and Trial Completion||28||
48187284|NCT02081391|100780009|FG002|COMPLETED|24-hour Treatment and Trial Completion||9||
48187285|NCT02081391|100780010|FG003|COMPLETED|24-hour Treatment and Trial Completion||4||
48187286|NCT02081391|100780007|FG000|NOT COMPLETED|24-hour Treatment and Trial Completion||27||
48187287|NCT02081391|100780008|FG001|NOT COMPLETED|24-hour Treatment and Trial Completion||18||
48187288|NCT02081391|100780009|FG002|NOT COMPLETED|24-hour Treatment and Trial Completion||1||
48187289|NCT02081391|100780010|FG003|NOT COMPLETED|24-hour Treatment and Trial Completion||0||
48187290|NCT01600950|100780011|FG000|STARTED|Period 1||10||
48187291|NCT01600950|100780012|FG001|STARTED|Period 1||10||
48187292|NCT01600950|100780011|FG000|COMPLETED|Period 1||10||
48187293|NCT01600950|100780012|FG001|COMPLETED|Period 1||10||
48187294|NCT01600950|100780011|FG000|NOT COMPLETED|Period 1||0||
48187295|NCT01600950|100780012|FG001|NOT COMPLETED|Period 1||0||
48187296|NCT01600950|100780011|FG000|STARTED|Period 2||10||
48187297|NCT01600950|100780012|FG001|STARTED|Period 2||10||
48187298|NCT01600950|100780011|FG000|COMPLETED|Period 2||10||
48187299|NCT01600950|100780012|FG001|COMPLETED|Period 2||10||
48187300|NCT01600950|100780011|FG000|NOT COMPLETED|Period 2||0||
48187301|NCT01600950|100780012|FG001|NOT COMPLETED|Period 2||0||
48187302|NCT01996644|100780013|FG000|STARTED|Overall Study||20||
48187303|NCT01996644|100780014|FG001|STARTED|Overall Study||16||
48425525|NCT04563845|101377609|FG002|NOT COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||0||
48425526|NCT04563845|101377610|FG003|NOT COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||0||
48425527|NCT04563845|101377611|FG004|NOT COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||1||
48425528|NCT04563845|101377612|FG005|NOT COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||0||
48425529|NCT04563845|101377613|FG006|NOT COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||0||
48425530|NCT04563845|101377614|FG007|NOT COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||0||
48425531|NCT04563845|101377615|FG008|NOT COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||0||
48425532|NCT04563845|101377616|FG009|NOT COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||0||
48425533|NCT04563845|101377617|FG010|NOT COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||0||
48425534|NCT04563845|101377618|FG011|NOT COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||0||
48425535|NCT04563845|101377619|FG012|NOT COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||0||
48425536|NCT04563845|101377620|FG013|NOT COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||0||
48425537|NCT04563845|101377607|FG000|STARTED|Part 2:Treatment Period 2(Up to 7 Days)||0||
48425538|NCT04563845|101377608|FG001|STARTED|Part 2:Treatment Period 2(Up to 7 Days)||0||
48425539|NCT04563845|101377609|FG002|STARTED|Part 2:Treatment Period 2(Up to 7 Days)||3||
48425540|NCT04563845|101377610|FG003|STARTED|Part 2:Treatment Period 2(Up to 7 Days)||4||
48425541|NCT04563845|101377611|FG004|STARTED|Part 2:Treatment Period 2(Up to 7 Days)||3||
48425542|NCT04563845|101377612|FG005|STARTED|Part 2:Treatment Period 2(Up to 7 Days)||4||
48425543|NCT04563845|101377613|FG006|STARTED|Part 2:Treatment Period 2(Up to 7 Days)||4||
48425544|NCT04563845|101377614|FG007|STARTED|Part 2:Treatment Period 2(Up to 7 Days)||2||
48425545|NCT04563845|101377615|FG008|STARTED|Part 2:Treatment Period 2(Up to 7 Days)||3||
48425546|NCT04563845|101377616|FG009|STARTED|Part 2:Treatment Period 2(Up to 7 Days)||3||
48425547|NCT04563845|101377617|FG010|STARTED|Part 2:Treatment Period 2(Up to 7 Days)||4||
48425548|NCT04563845|101377618|FG011|STARTED|Part 2:Treatment Period 2(Up to 7 Days)||4||
48425549|NCT04563845|101377619|FG012|STARTED|Part 2:Treatment Period 2(Up to 7 Days)||3||
48425550|NCT04563845|101377620|FG013|STARTED|Part 2:Treatment Period 2(Up to 7 Days)||3||
48425551|NCT04563845|101377607|FG000|COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||0||
48425552|NCT04563845|101377608|FG001|COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||0||
48425553|NCT04563845|101377609|FG002|COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||3||
48425554|NCT04563845|101377610|FG003|COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||4||
48425555|NCT04563845|101377611|FG004|COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||3||
48425556|NCT04563845|101377612|FG005|COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||4||
48638938|NCT03233217|101901537|FG004|Safety Analysis Set (SafAS)|Overall Study||55||
48638939|NCT03233217|101901533|FG000|Per-protocol Analysis Set (PPAS)|Overall Study||5|Cohort 1 = 10 participants, and Cohort 2 = 164 participants|
48638940|NCT03233217|101901534|FG001|Per-protocol Analysis Set (PPAS)|Overall Study||5|Cohort 1 = 10 participants, and Cohort 2 = 164 participants|
48359964|NCT01326962|101210782|FG000|COMPLETED|Overall Study||21||
48359965|NCT01326962|101210782|FG000|NOT COMPLETED|Overall Study||7||
48359966|NCT02725177|101210783|FG000|STARTED|Overall Study||9||
48359967|NCT02725177|101210783|FG000|COMPLETED|Overall Study||4||
48359968|NCT02725177|101210783|FG000|NOT COMPLETED|Overall Study||5||
48359969|NCT01736683|101210784|FG000|STARTED|Overall Study||7||
48359970|NCT01736683|101210785|FG001|STARTED|Overall Study||6||
48359971|NCT01736683|101210786|FG002|STARTED|Overall Study||21||
48359972|NCT01736683|101210787|FG003|STARTED|Overall Study||35||
48359973|NCT01736683|101210788|FG004|STARTED|Overall Study||5||
48359974|NCT01736683|101210784|FG000|COMPLETED|Overall Study||0||
48359975|NCT01736683|101210785|FG001|COMPLETED|Overall Study||0||
48359976|NCT01736683|101210786|FG002|COMPLETED|Overall Study||0||
48359977|NCT01736683|101210787|FG003|COMPLETED|Overall Study||0||
48359978|NCT01736683|101210788|FG004|COMPLETED|Overall Study||0||
48359979|NCT01736683|101210784|FG000|NOT COMPLETED|Overall Study||7||
48359980|NCT01736683|101210785|FG001|NOT COMPLETED|Overall Study||6||
48359981|NCT01736683|101210786|FG002|NOT COMPLETED|Overall Study||21||
48359982|NCT01736683|101210787|FG003|NOT COMPLETED|Overall Study||35||
48359983|NCT01736683|101210788|FG004|NOT COMPLETED|Overall Study||5||
48359984|NCT01589094|101210789|FG000|STARTED|Overall Study||51||
48359985|NCT01589094|101210789|FG000|COMPLETED|Overall Study||49||
48359986|NCT01589094|101210789|FG000|NOT COMPLETED|Overall Study||2||
48359987|NCT01251575|101210790|FG000|STARTED|Overall Study||77||
48359988|NCT01251575|101210790|FG000|COMPLETED|Overall Study||76||
48359989|NCT01251575|101210790|FG000|NOT COMPLETED|Overall Study||1||
48359990|NCT03033108|101210791|FG000|STARTED|Overall Study||7||
48359991|NCT03033108|101210792|FG001|STARTED|Overall Study||9||
48359992|NCT03033108|101210793|FG002|STARTED|Overall Study||7||
48359993|NCT03033108|101210791|FG000|COMPLETED|Overall Study||7||
48359994|NCT03033108|101210792|FG001|COMPLETED|Overall Study||8||
48359995|NCT03033108|101210793|FG002|COMPLETED|Overall Study||7||
48359996|NCT03033108|101210791|FG000|NOT COMPLETED|Overall Study||0||
48359997|NCT03033108|101210792|FG001|NOT COMPLETED|Overall Study||1||
48359998|NCT03033108|101210793|FG002|NOT COMPLETED|Overall Study||0||
48359999|NCT01056107|101210794|FG000|STARTED|Overall Study||11||
48360000|NCT01056107|101210795|FG001|STARTED|Overall Study||11||
48360001|NCT01056107|101210796|FG002|STARTED|Overall Study||12||
48360002|NCT01056107|101210797|FG003|STARTED|Overall Study||12||
48360003|NCT01056107|101210794|FG000|COMPLETED|Overall Study||11||
48360004|NCT01056107|101210795|FG001|COMPLETED|Overall Study||10||
48360005|NCT01056107|101210796|FG002|COMPLETED|Overall Study||9||
48360006|NCT01056107|101210797|FG003|COMPLETED|Overall Study||12||
48360007|NCT01056107|101210794|FG000|NOT COMPLETED|Overall Study||0||
48425557|NCT04563845|101377613|FG006|COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||4||
48425558|NCT04563845|101377614|FG007|COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||2||
48425559|NCT04563845|101377615|FG008|COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||3||
48425560|NCT04563845|101377616|FG009|COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||3||
48425561|NCT04563845|101377617|FG010|COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||4||
48425562|NCT04563845|101377618|FG011|COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||4||
48425563|NCT04563845|101377619|FG012|COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||3||
48425564|NCT04563845|101377620|FG013|COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||3||
48425565|NCT04563845|101377607|FG000|NOT COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||0||
48425566|NCT04563845|101377608|FG001|NOT COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||0||
48425567|NCT04563845|101377609|FG002|NOT COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||0||
48425568|NCT04563845|101377610|FG003|NOT COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||0||
48425569|NCT04563845|101377611|FG004|NOT COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||0||
48425570|NCT04563845|101377612|FG005|NOT COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||0||
48425571|NCT04563845|101377613|FG006|NOT COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||0||
48425572|NCT04563845|101377614|FG007|NOT COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||0||
48425573|NCT04563845|101377615|FG008|NOT COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||0||
48425574|NCT04563845|101377616|FG009|NOT COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||0||
48425575|NCT04563845|101377617|FG010|NOT COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||0||
48425576|NCT04563845|101377618|FG011|NOT COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||0||
48425577|NCT04563845|101377619|FG012|NOT COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||0||
48425578|NCT04563845|101377620|FG013|NOT COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||0||
48425579|NCT04563845|101377607|FG000|STARTED|Part 2:Washout Period 2(Up to 7 Days)||0||
48425580|NCT04563845|101377608|FG001|STARTED|Part 2:Washout Period 2(Up to 7 Days)||0||
48425581|NCT04563845|101377609|FG002|STARTED|Part 2:Washout Period 2(Up to 7 Days)||3||
48425582|NCT04563845|101377610|FG003|STARTED|Part 2:Washout Period 2(Up to 7 Days)||4||
48425583|NCT04563845|101377611|FG004|STARTED|Part 2:Washout Period 2(Up to 7 Days)||3||
48425584|NCT04563845|101377612|FG005|STARTED|Part 2:Washout Period 2(Up to 7 Days)||4||
48425585|NCT04563845|101377613|FG006|STARTED|Part 2:Washout Period 2(Up to 7 Days)||4||
48425586|NCT04563845|101377614|FG007|STARTED|Part 2:Washout Period 2(Up to 7 Days)||2||
48425587|NCT04563845|101377615|FG008|STARTED|Part 2:Washout Period 2(Up to 7 Days)||3||
48425588|NCT04563845|101377616|FG009|STARTED|Part 2:Washout Period 2(Up to 7 Days)||3||
48425589|NCT04563845|101377617|FG010|STARTED|Part 2:Washout Period 2(Up to 7 Days)||4||
48425590|NCT04563845|101377618|FG011|STARTED|Part 2:Washout Period 2(Up to 7 Days)||4||
48425591|NCT04563845|101377619|FG012|STARTED|Part 2:Washout Period 2(Up to 7 Days)||3||
48425592|NCT04563845|101377620|FG013|STARTED|Part 2:Washout Period 2(Up to 7 Days)||3||
48425593|NCT04563845|101377607|FG000|COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||0||
48425594|NCT04563845|101377608|FG001|COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||0||
48425595|NCT04563845|101377609|FG002|COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||3||
48425596|NCT04563845|101377610|FG003|COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||4||
48425597|NCT04563845|101377611|FG004|COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||3||
48425598|NCT04563845|101377612|FG005|COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||4||
48425599|NCT04563845|101377613|FG006|COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||4||
48425600|NCT04563845|101377614|FG007|COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||2||
48425601|NCT04563845|101377615|FG008|COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||3||
48425602|NCT04563845|101377616|FG009|COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||3||
48425603|NCT04563845|101377617|FG010|COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||4||
48425604|NCT04563845|101377618|FG011|COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||4||
48425605|NCT04563845|101377619|FG012|COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||3||
48425606|NCT04563845|101377620|FG013|COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||3||
48425607|NCT04563845|101377607|FG000|NOT COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||0||
48425608|NCT04563845|101377608|FG001|NOT COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||0||
48425609|NCT04563845|101377609|FG002|NOT COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||0||
48360008|NCT01056107|101210795|FG001|NOT COMPLETED|Overall Study||1||
48360009|NCT01056107|101210796|FG002|NOT COMPLETED|Overall Study||3||
48360010|NCT01056107|101210797|FG003|NOT COMPLETED|Overall Study||0||
48360011|NCT02614794|101210798|FG000|STARTED|Overall Study||410||
48360012|NCT02614794|101210799|FG001|STARTED|Overall Study||202||
48360013|NCT02614794|101210798|FG000|COMPLETED|Overall Study||0||
48360014|NCT02614794|101210799|FG001|COMPLETED|Overall Study||0||
48360015|NCT02614794|101210798|FG000|NOT COMPLETED|Overall Study||410||
48360016|NCT02614794|101210799|FG001|NOT COMPLETED|Overall Study||202||
48360017|NCT00003641|101210800|FG000|STARTED|Overall Study||569||
48425610|NCT04563845|101377610|FG003|NOT COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||0||
48425611|NCT04563845|101377611|FG004|NOT COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||0||
48425612|NCT04563845|101377612|FG005|NOT COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||0||
48425613|NCT04563845|101377613|FG006|NOT COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||0||
48425614|NCT04563845|101377614|FG007|NOT COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||0||
48425615|NCT04563845|101377615|FG008|NOT COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||0||
48425616|NCT04563845|101377616|FG009|NOT COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||0||
48425617|NCT04563845|101377617|FG010|NOT COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||0||
48425618|NCT04563845|101377618|FG011|NOT COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||0||
48425619|NCT04563845|101377619|FG012|NOT COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||0||
48360018|NCT00003641|101210801|FG001|STARTED|Overall Study||581||
48360019|NCT00003641|101210800|FG000|Treated|Overall Study||2||
48360020|NCT00003641|101210801|FG001|Treated|Overall Study||569||
48425620|NCT04563845|101377620|FG013|NOT COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||0||
48425621|NCT04563845|101377607|FG000|STARTED|Part 2:Treatment Period 3(Up to 7 Days)||0||
48425622|NCT04563845|101377608|FG001|STARTED|Part 2:Treatment Period 3(Up to 7 Days)||0||
48425623|NCT04563845|101377609|FG002|STARTED|Part 2:Treatment Period 3(Up to 7 Days)||3||
48425624|NCT04563845|101377610|FG003|STARTED|Part 2:Treatment Period 3(Up to 7 Days)||4||
48425625|NCT04563845|101377611|FG004|STARTED|Part 2:Treatment Period 3(Up to 7 Days)||3||
48425626|NCT04563845|101377612|FG005|STARTED|Part 2:Treatment Period 3(Up to 7 Days)||4||
48425627|NCT04563845|101377613|FG006|STARTED|Part 2:Treatment Period 3(Up to 7 Days)||4||
48425628|NCT04563845|101377614|FG007|STARTED|Part 2:Treatment Period 3(Up to 7 Days)||2||
48425629|NCT04563845|101377615|FG008|STARTED|Part 2:Treatment Period 3(Up to 7 Days)||3||
48425630|NCT04563845|101377616|FG009|STARTED|Part 2:Treatment Period 3(Up to 7 Days)||3||
48425631|NCT04563845|101377617|FG010|STARTED|Part 2:Treatment Period 3(Up to 7 Days)||4||
48425632|NCT04563845|101377618|FG011|STARTED|Part 2:Treatment Period 3(Up to 7 Days)||4||
48425633|NCT04563845|101377619|FG012|STARTED|Part 2:Treatment Period 3(Up to 7 Days)||3||
48425634|NCT04563845|101377620|FG013|STARTED|Part 2:Treatment Period 3(Up to 7 Days)||3||
48425635|NCT04563845|101377607|FG000|COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||0||
48425636|NCT04563845|101377608|FG001|COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||0||
48425637|NCT04563845|101377609|FG002|COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||3||
48425638|NCT04563845|101377610|FG003|COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||4||
48425639|NCT04563845|101377611|FG004|COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||3||
48425640|NCT04563845|101377612|FG005|COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||4||
48425641|NCT04563845|101377613|FG006|COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||4||
48425642|NCT04563845|101377614|FG007|COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||2||
48425643|NCT04563845|101377615|FG008|COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||3||
48425644|NCT04563845|101377616|FG009|COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||3||
48425645|NCT04563845|101377617|FG010|COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||4||
48425646|NCT04563845|101377618|FG011|COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||4||
48425647|NCT04563845|101377619|FG012|COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||3||
48425648|NCT04563845|101377620|FG013|COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||3||
48425649|NCT04563845|101377607|FG000|NOT COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||0||
48425650|NCT04563845|101377608|FG001|NOT COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||0||
48425651|NCT04563845|101377609|FG002|NOT COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||0||
48425652|NCT04563845|101377610|FG003|NOT COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||0||
48425653|NCT04563845|101377611|FG004|NOT COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||0||
48425654|NCT04563845|101377612|FG005|NOT COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||0||
48425655|NCT04563845|101377613|FG006|NOT COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||0||
48425656|NCT04563845|101377614|FG007|NOT COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||0||
48425657|NCT04563845|101377615|FG008|NOT COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||0||
48425658|NCT04563845|101377616|FG009|NOT COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||0||
48425659|NCT04563845|101377617|FG010|NOT COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||0||
48425660|NCT04563845|101377618|FG011|NOT COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||0||
48425661|NCT04563845|101377619|FG012|NOT COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||0||
48425662|NCT04563845|101377620|FG013|NOT COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||0||
48425663|NCT04563845|101377607|FG000|STARTED|Part 2:Washout Period 3(Up to 7 Days)||0||
48425664|NCT04563845|101377608|FG001|STARTED|Part 2:Washout Period 3(Up to 7 Days)||0||
48425665|NCT04563845|101377609|FG002|STARTED|Part 2:Washout Period 3(Up to 7 Days)||3||
48425666|NCT04563845|101377610|FG003|STARTED|Part 2:Washout Period 3(Up to 7 Days)||4||
48425667|NCT04563845|101377611|FG004|STARTED|Part 2:Washout Period 3(Up to 7 Days)||3||
48425668|NCT04563845|101377612|FG005|STARTED|Part 2:Washout Period 3(Up to 7 Days)||4||
48425669|NCT04563845|101377613|FG006|STARTED|Part 2:Washout Period 3(Up to 7 Days)||4||
48425670|NCT04563845|101377614|FG007|STARTED|Part 2:Washout Period 3(Up to 7 Days)||2||
48425671|NCT04563845|101377615|FG008|STARTED|Part 2:Washout Period 3(Up to 7 Days)||3||
48425672|NCT04563845|101377616|FG009|STARTED|Part 2:Washout Period 3(Up to 7 Days)||3||
48425673|NCT04563845|101377617|FG010|STARTED|Part 2:Washout Period 3(Up to 7 Days)||4||
48425674|NCT04563845|101377618|FG011|STARTED|Part 2:Washout Period 3(Up to 7 Days)||4||
48425675|NCT04563845|101377619|FG012|STARTED|Part 2:Washout Period 3(Up to 7 Days)||3||
48425676|NCT04563845|101377620|FG013|STARTED|Part 2:Washout Period 3(Up to 7 Days)||3||
48425677|NCT04563845|101377607|FG000|COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||0||
48425678|NCT04563845|101377608|FG001|COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||0||
48425679|NCT04563845|101377609|FG002|COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||3||
48425680|NCT04563845|101377610|FG003|COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||4||
48425681|NCT04563845|101377611|FG004|COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||3||
48425682|NCT04563845|101377612|FG005|COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||4||
48425683|NCT04563845|101377613|FG006|COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||4||
48425684|NCT04563845|101377614|FG007|COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||2||
48425685|NCT04563845|101377615|FG008|COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||3||
48425686|NCT04563845|101377616|FG009|COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||3||
48425687|NCT04563845|101377617|FG010|COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||4||
48425688|NCT04563845|101377618|FG011|COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||4||
48425689|NCT04563845|101377619|FG012|COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||3||
48425690|NCT04563845|101377620|FG013|COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||3||
48425691|NCT04563845|101377607|FG000|NOT COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||0||
48425692|NCT04563845|101377608|FG001|NOT COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||0||
48425693|NCT04563845|101377609|FG002|NOT COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||0||
48425694|NCT04563845|101377610|FG003|NOT COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||0||
48425695|NCT04563845|101377611|FG004|NOT COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||0||
48425696|NCT04563845|101377612|FG005|NOT COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||0||
48425697|NCT04563845|101377613|FG006|NOT COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||0||
48425698|NCT04563845|101377614|FG007|NOT COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||0||
48425699|NCT04563845|101377615|FG008|NOT COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||0||
48425700|NCT04563845|101377616|FG009|NOT COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||0||
48425701|NCT04563845|101377617|FG010|NOT COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||0||
48425702|NCT04563845|101377618|FG011|NOT COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||0||
48425703|NCT04563845|101377619|FG012|NOT COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||0||
48425704|NCT04563845|101377620|FG013|NOT COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||0||
48425705|NCT04563845|101377607|FG000|STARTED|Part 2:Treatment Period 4(Up to 7 Days)||0||
48425706|NCT04563845|101377608|FG001|STARTED|Part 2:Treatment Period 4(Up to 7 Days)||0||
48425707|NCT04563845|101377609|FG002|STARTED|Part 2:Treatment Period 4(Up to 7 Days)||3||
48425708|NCT04563845|101377610|FG003|STARTED|Part 2:Treatment Period 4(Up to 7 Days)||4||
48425709|NCT04563845|101377611|FG004|STARTED|Part 2:Treatment Period 4(Up to 7 Days)||3||
48425710|NCT04563845|101377612|FG005|STARTED|Part 2:Treatment Period 4(Up to 7 Days)||4||
48425711|NCT04563845|101377613|FG006|STARTED|Part 2:Treatment Period 4(Up to 7 Days)||4||
48425712|NCT04563845|101377614|FG007|STARTED|Part 2:Treatment Period 4(Up to 7 Days)||2||
48425713|NCT04563845|101377615|FG008|STARTED|Part 2:Treatment Period 4(Up to 7 Days)||3||
48425714|NCT04563845|101377616|FG009|STARTED|Part 2:Treatment Period 4(Up to 7 Days)||3||
48425715|NCT04563845|101377617|FG010|STARTED|Part 2:Treatment Period 4(Up to 7 Days)||4||
48425716|NCT04563845|101377618|FG011|STARTED|Part 2:Treatment Period 4(Up to 7 Days)||4||
48425717|NCT04563845|101377619|FG012|STARTED|Part 2:Treatment Period 4(Up to 7 Days)||3||
48425718|NCT04563845|101377620|FG013|STARTED|Part 2:Treatment Period 4(Up to 7 Days)||3||
48425719|NCT04563845|101377607|FG000|COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||0||
48425720|NCT04563845|101377608|FG001|COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||0||
48425721|NCT04563845|101377609|FG002|COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||3||
48425722|NCT04563845|101377610|FG003|COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||4||
48425723|NCT04563845|101377611|FG004|COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||3||
48425724|NCT04563845|101377612|FG005|COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||4||
48425725|NCT04563845|101377613|FG006|COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||4||
48425726|NCT04563845|101377614|FG007|COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||2||
48425727|NCT04563845|101377615|FG008|COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||3||
48425728|NCT04563845|101377616|FG009|COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||3||
48425729|NCT04563845|101377617|FG010|COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||4||
48425730|NCT04563845|101377618|FG011|COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||4||
48425731|NCT04563845|101377619|FG012|COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||3||
48425732|NCT04563845|101377620|FG013|COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||3||
48425733|NCT04563845|101377607|FG000|NOT COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||0||
48425734|NCT04563845|101377608|FG001|NOT COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||0||
48425735|NCT04563845|101377609|FG002|NOT COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||0||
48425736|NCT04563845|101377610|FG003|NOT COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||0||
48425737|NCT04563845|101377611|FG004|NOT COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||0||
48425738|NCT04563845|101377612|FG005|NOT COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||0||
48425739|NCT04563845|101377613|FG006|NOT COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||0||
48425740|NCT04563845|101377614|FG007|NOT COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||0||
48425741|NCT04563845|101377615|FG008|NOT COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||0||
48425742|NCT04563845|101377616|FG009|NOT COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||0||
48425743|NCT04563845|101377617|FG010|NOT COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||0||
48425744|NCT04563845|101377618|FG011|NOT COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||0||
48425745|NCT04563845|101377619|FG012|NOT COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||0||
48425746|NCT04563845|101377620|FG013|NOT COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||0||
48425747|NCT00821886|101377621|FG000|STARTED|Overall Study||58||
48425748|NCT00821886|101377621|FG000|COMPLETED|Overall Study||49||
48425749|NCT00821886|101377621|FG000|NOT COMPLETED|Overall Study||9||
48425750|NCT01610752|101377622|FG000|STARTED|Overall Study||18||
48425751|NCT01610752|101377623|FG001|STARTED|Overall Study||19||
48425752|NCT01610752|101377624|FG002|STARTED|Overall Study||17||
48425753|NCT01610752|101377622|FG000|COMPLETED|Overall Study||18||
48425754|NCT01610752|101377623|FG001|COMPLETED|Overall Study||19||
48425755|NCT01610752|101377624|FG002|COMPLETED|Overall Study||13||
48425756|NCT01610752|101377622|FG000|NOT COMPLETED|Overall Study||0||
48425757|NCT01610752|101377623|FG001|NOT COMPLETED|Overall Study||0||
48425758|NCT01610752|101377624|FG002|NOT COMPLETED|Overall Study||4||
48360021|NCT00003641|101210800|FG000|Toxicity Assessed|Overall Study||439||
48360022|NCT00003641|101210801|FG001|Toxicity Assessed|Overall Study||568||
48360023|NCT00003641|101210800|FG000|COMPLETED|Overall Study||0||
48360024|NCT00003641|101210801|FG001|COMPLETED|Overall Study||407||
48360025|NCT00003641|101210800|FG000|NOT COMPLETED|Overall Study||569||
48360026|NCT00003641|101210801|FG001|NOT COMPLETED|Overall Study||174||
48360027|NCT01348919|101210802|FG000|STARTED|Overall Study||3||
48360028|NCT01348919|101210803|FG001|STARTED|Overall Study||5||
48360029|NCT01348919|101210804|FG002|STARTED|Overall Study||3||
48360030|NCT01348919|101210802|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
48360031|NCT01348919|101210803|FG001|Received at Least 1 Dose of Study Drug|Overall Study||5||
48360032|NCT01348919|101210804|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
48360033|NCT01348919|101210802|FG000|COMPLETED|Overall Study||0||
48360034|NCT01348919|101210803|FG001|COMPLETED|Overall Study||2||
48360035|NCT01348919|101210804|FG002|COMPLETED|Overall Study||2||
48360036|NCT01348919|101210802|FG000|NOT COMPLETED|Overall Study||3||
48360037|NCT01348919|101210803|FG001|NOT COMPLETED|Overall Study||3||
48360038|NCT01348919|101210804|FG002|NOT COMPLETED|Overall Study||1||
48360039|NCT02708212|101210805|FG000|STARTED|Overall Study||60||
48360040|NCT02708212|101210806|FG001|STARTED|Overall Study||60||
48360041|NCT02708212|101210805|FG000|COMPLETED|Overall Study||60||
48360042|NCT02708212|101210806|FG001|COMPLETED|Overall Study||60||
48360043|NCT02708212|101210805|FG000|NOT COMPLETED|Overall Study||0||
48360044|NCT02708212|101210806|FG001|NOT COMPLETED|Overall Study||0||
48360045|NCT02768129|101210807|FG000|STARTED|Overall Study||11||
48360046|NCT02768129|101210808|FG001|STARTED|Overall Study||10||
48360047|NCT02768129|101210807|FG000|COMPLETED|Overall Study||11||
48360048|NCT02768129|101210808|FG001|COMPLETED|Overall Study||10||
48360049|NCT02768129|101210807|FG000|NOT COMPLETED|Overall Study||0||
48360050|NCT02768129|101210808|FG001|NOT COMPLETED|Overall Study||0||
48360051|NCT02333331|101210809|FG000|STARTED|Overall Study||19||
48360052|NCT02333331|101210810|FG001|STARTED|Overall Study||18||
48360053|NCT02333331|101210811|FG002|STARTED|Overall Study||113||
48360054|NCT02333331|101210812|FG003|STARTED|Overall Study||67||
48360055|NCT02333331|101210809|FG000|COMPLETED|Overall Study||17||
48360056|NCT02333331|101210810|FG001|COMPLETED|Overall Study||12||
48360057|NCT02333331|101210811|FG002|COMPLETED|Overall Study||95||
48360058|NCT02333331|101210812|FG003|COMPLETED|Overall Study||64||
48360059|NCT02333331|101210809|FG000|NOT COMPLETED|Overall Study||2||
48360060|NCT02333331|101210810|FG001|NOT COMPLETED|Overall Study||6||
48360061|NCT02333331|101210811|FG002|NOT COMPLETED|Overall Study||18||
48360062|NCT02333331|101210812|FG003|NOT COMPLETED|Overall Study||3||
48360063|NCT02278146|101210813|FG000|STARTED|Overall Study||6||
48360064|NCT02278146|101210814|FG001|STARTED|Overall Study||10||
48360065|NCT02278146|101210813|FG000|COMPLETED|Overall Study||6||
48360066|NCT02278146|101210814|FG001|COMPLETED|Overall Study||8||
48360067|NCT02278146|101210813|FG000|NOT COMPLETED|Overall Study||0||
48360068|NCT02278146|101210814|FG001|NOT COMPLETED|Overall Study||2||
48360069|NCT03451825|101210815|FG000|STARTED|Overall Study||6||
48360070|NCT03451825|101210816|FG001|STARTED|Overall Study||15||
48360071|NCT03451825|101210815|FG000|COMPLETED|Overall Study||6||
48360072|NCT03451825|101210816|FG001|COMPLETED|Overall Study||15||
48360073|NCT03451825|101210815|FG000|NOT COMPLETED|Overall Study||0||
48360074|NCT03451825|101210816|FG001|NOT COMPLETED|Overall Study||0||
48360075|NCT00641147|101210817|FG000|STARTED|Completed 4 Months.||21||
48360076|NCT00641147|101210818|FG001|STARTED|Completed 4 Months.||23||
48360077|NCT00641147|101210817|FG000|COMPLETED|Completed 4 Months.||19||
48360078|NCT00641147|101210818|FG001|COMPLETED|Completed 4 Months.||23||
48360079|NCT00641147|101210817|FG000|NOT COMPLETED|Completed 4 Months.||2||
48360080|NCT00641147|101210818|FG001|NOT COMPLETED|Completed 4 Months.||0||
48360081|NCT00641147|101210817|FG000|STARTED|Completed 8 Months.||19||
48360082|NCT00641147|101210818|FG001|STARTED|Completed 8 Months.||23||
48360083|NCT00641147|101210817|FG000|COMPLETED|Completed 8 Months.||16||
48360084|NCT00641147|101210818|FG001|COMPLETED|Completed 8 Months.||21||
48360085|NCT00641147|101210817|FG000|NOT COMPLETED|Completed 8 Months.||3||
48360086|NCT00641147|101210818|FG001|NOT COMPLETED|Completed 8 Months.||2||
48360087|NCT00641147|101210817|FG000|STARTED|Completed 12 Months.||16||
48360088|NCT00641147|101210818|FG001|STARTED|Completed 12 Months.||21||
48360089|NCT00641147|101210817|FG000|COMPLETED|Completed 12 Months.||15||
48360090|NCT00641147|101210818|FG001|COMPLETED|Completed 12 Months.||19||
48360091|NCT00641147|101210817|FG000|NOT COMPLETED|Completed 12 Months.||1||
48360092|NCT00641147|101210818|FG001|NOT COMPLETED|Completed 12 Months.||2||
48360093|NCT00641147|101210817|FG000|STARTED|Completed 16 Months.||15||
48360094|NCT00641147|101210818|FG001|STARTED|Completed 16 Months.||19||
48360095|NCT00641147|101210817|FG000|COMPLETED|Completed 16 Months.||13||
48360096|NCT00641147|101210818|FG001|COMPLETED|Completed 16 Months.||19||
48360097|NCT00641147|101210817|FG000|NOT COMPLETED|Completed 16 Months.||2||
48360098|NCT00641147|101210818|FG001|NOT COMPLETED|Completed 16 Months.||0||
48360099|NCT02378753|101210819|FG000|STARTED|Overall Study||4319||
48360100|NCT02378753|101210820|FG001|STARTED|Overall Study||4332||
48360101|NCT02378753|101210819|FG000|COMPLETED|Overall Study||4101||
48360102|NCT02378753|101210820|FG001|COMPLETED|Overall Study||3637||
48360103|NCT02378753|101210819|FG000|NOT COMPLETED|Overall Study||218||
48425759|NCT01425268|101377625|FG000|STARTED|Overall Study||106||
48425760|NCT01425268|101377626|FG001|STARTED|Overall Study||52||
48425761|NCT01425268|101377625|FG000|COMPLETED|Overall Study||98||
48425762|NCT01425268|101377626|FG001|COMPLETED|Overall Study||52||
48425763|NCT01425268|101377625|FG000|NOT COMPLETED|Overall Study||8||
48425764|NCT01425268|101377626|FG001|NOT COMPLETED|Overall Study||0||
48425765|NCT04278846|101377627|FG000|STARTED|Overall Study||25||
48425766|NCT04278846|101377628|FG001|STARTED|Overall Study||25||
48425767|NCT04278846|101377627|FG000|COMPLETED|Overall Study||25||
48425768|NCT04278846|101377628|FG001|COMPLETED|Overall Study||25||
48425769|NCT04278846|101377627|FG000|NOT COMPLETED|Overall Study||0||
48425770|NCT04278846|101377628|FG001|NOT COMPLETED|Overall Study||0||
48425771|NCT01205399|101377629|FG000|STARTED|Overall Study||78||
48425772|NCT01205399|101377629|FG000|COMPLETED|Overall Study||78||
48425773|NCT01205399|101377629|FG000|NOT COMPLETED|Overall Study||0||
48425774|NCT03970330|101377630|FG000|STARTED|Overall Study||5||
48425775|NCT03970330|101377631|FG001|STARTED|Overall Study||4||
48425776|NCT03970330|101377630|FG000|COMPLETED|Overall Study||5||
48425777|NCT03970330|101377631|FG001|COMPLETED|Overall Study||4||
48425778|NCT03970330|101377630|FG000|NOT COMPLETED|Overall Study||0||
48425779|NCT03970330|101377631|FG001|NOT COMPLETED|Overall Study||0||
48425780|NCT02756182|101377632|FG000|STARTED|Overall Study||25||
48425781|NCT02756182|101377632|FG000|COMPLETED|Overall Study||21||
48425782|NCT02756182|101377632|FG000|NOT COMPLETED|Overall Study||4||
48425783|NCT03734601|101377633|FG000|STARTED|Overall Study||22||
48425784|NCT03734601|101377633|FG000|COMPLETED|Overall Study||22||
48425785|NCT03734601|101377633|FG000|NOT COMPLETED|Overall Study||0||
48425786|NCT03999203|101377634|FG000|STARTED|Overall Study||22||
48425787|NCT03999203|101377635|FG001|STARTED|Overall Study||6||
48425788|NCT03999203|101377636|FG002|STARTED|Overall Study||19||
48425789|NCT03999203|101377637|FG003|STARTED|Overall Study||14||
48425790|NCT03999203|101377634|FG000|COMPLETED|Overall Study||22||
48425791|NCT03999203|101377635|FG001|COMPLETED|Overall Study||6||
48425792|NCT03999203|101377636|FG002|COMPLETED|Overall Study||19||
48425793|NCT03999203|101377637|FG003|COMPLETED|Overall Study||14||
48425794|NCT03999203|101377634|FG000|NOT COMPLETED|Overall Study||0||
48425795|NCT03999203|101377635|FG001|NOT COMPLETED|Overall Study||0||
48425796|NCT03999203|101377636|FG002|NOT COMPLETED|Overall Study||0||
48425797|NCT03999203|101377637|FG003|NOT COMPLETED|Overall Study||0||
48425798|NCT01265719|101377638|FG000|STARTED|Overall Study||102||
48425799|NCT01265719|101377639|FG001|STARTED|Overall Study||73||
48425800|NCT01265719|101377638|FG000|COMPLETED|Overall Study||88||
48425801|NCT01265719|101377639|FG001|COMPLETED|Overall Study||60||
48425802|NCT01265719|101377638|FG000|NOT COMPLETED|Overall Study||14||
48425803|NCT01265719|101377639|FG001|NOT COMPLETED|Overall Study||13||
48425804|NCT00553319|101377640|FG000|STARTED|Overall Study||43||
48425805|NCT00553319|101377641|FG001|STARTED|Overall Study||40||
48425806|NCT00553319|101377642|FG002|STARTED|Overall Study||43||
48425807|NCT00553319|101377640|FG000|COMPLETED|Overall Study||29||
48425808|NCT00553319|101377641|FG001|COMPLETED|Overall Study||30||
48425809|NCT00553319|101377642|FG002|COMPLETED|Overall Study||34||
48425810|NCT00553319|101377640|FG000|NOT COMPLETED|Overall Study||14||
48425811|NCT00553319|101377641|FG001|NOT COMPLETED|Overall Study||10||
48425812|NCT00553319|101377642|FG002|NOT COMPLETED|Overall Study||9||
48425813|NCT03938857|101377643|FG000|STARTED|Overall Study||6||
48425814|NCT03938857|101377644|FG001|STARTED|Overall Study||12||
48425815|NCT03938857|101377645|FG002|STARTED|Overall Study||12||
48425816|NCT03938857|101377646|FG003|STARTED|Overall Study||0||
48425817|NCT03938857|101377643|FG000|COMPLETED|Overall Study||5||
48425818|NCT03938857|101377644|FG001|COMPLETED|Overall Study||12||
48425819|NCT03938857|101377645|FG002|COMPLETED|Overall Study||12||
48425820|NCT03938857|101377646|FG003|COMPLETED|Overall Study||0||
48425821|NCT03938857|101377643|FG000|NOT COMPLETED|Overall Study||1||
48425822|NCT03938857|101377644|FG001|NOT COMPLETED|Overall Study||0||
48425823|NCT03938857|101377645|FG002|NOT COMPLETED|Overall Study||0||
48425824|NCT03938857|101377646|FG003|NOT COMPLETED|Overall Study||0||
48425825|NCT00764465|101377647|FG000|STARTED|Overall Study||9||
48425826|NCT00764465|101377648|FG001|STARTED|Overall Study||7||
48425827|NCT00764465|101377649|FG002|STARTED|Overall Study||7||
48425828|NCT00764465|101377650|FG003|STARTED|Overall Study||7||
48425829|NCT00764465|101377651|FG004|STARTED|Overall Study||7||
48425830|NCT00764465|101377652|FG005|STARTED|Overall Study||8||
48425831|NCT00764465|101377647|FG000|COMPLETED|Overall Study||7||
48425832|NCT00764465|101377648|FG001|COMPLETED|Overall Study||6||
48425833|NCT00764465|101377649|FG002|COMPLETED|Overall Study||6||
48425834|NCT00764465|101377650|FG003|COMPLETED|Overall Study||6||
48425835|NCT00764465|101377651|FG004|COMPLETED|Overall Study||6||
48425836|NCT00764465|101377652|FG005|COMPLETED|Overall Study||7||
48425837|NCT00764465|101377647|FG000|NOT COMPLETED|Overall Study||2||
48425838|NCT00764465|101377648|FG001|NOT COMPLETED|Overall Study||1||
48425839|NCT00764465|101377649|FG002|NOT COMPLETED|Overall Study||1||
48425840|NCT00764465|101377650|FG003|NOT COMPLETED|Overall Study||1||
48425841|NCT00764465|101377651|FG004|NOT COMPLETED|Overall Study||1||
48425842|NCT00764465|101377652|FG005|NOT COMPLETED|Overall Study||1||
48425843|NCT03039699|101377653|FG000|STARTED|Overall Study||127||
48425844|NCT03039699|101377654|FG001|STARTED|Overall Study||132||
48425845|NCT03039699|101377653|FG000|COMPLETED|Overall Study||105||
48425846|NCT03039699|101377654|FG001|COMPLETED|Overall Study||97||
48425847|NCT03039699|101377653|FG000|NOT COMPLETED|Overall Study||22||
48425848|NCT03039699|101377654|FG001|NOT COMPLETED|Overall Study||35||
48425849|NCT02206776|101377655|FG000|STARTED|Overall Study||1||
48425850|NCT02206776|101377656|FG001|STARTED|Overall Study||1||
48425851|NCT02206776|101377655|FG000|COMPLETED|Overall Study||1||
48425852|NCT02206776|101377656|FG001|COMPLETED|Overall Study||1||
48425853|NCT02206776|101377655|FG000|NOT COMPLETED|Overall Study||0||
48425854|NCT02206776|101377656|FG001|NOT COMPLETED|Overall Study||0||
48425855|NCT00758576|101377657|FG000|STARTED|Overall Study||64||
48425856|NCT00758576|101377657|FG000|COMPLETED|Overall Study||63||
48425857|NCT00758576|101377657|FG000|NOT COMPLETED|Overall Study||1||
48425858|NCT02383966|101377658|FG000|STARTED|Overall Study||164||
48425859|NCT02383966|101377659|FG001|STARTED|Overall Study||79||
48425860|NCT02383966|101377658|FG000|COMPLETED|Overall Study||138||
48425861|NCT02383966|101377659|FG001|COMPLETED|Overall Study||72||
48425862|NCT02383966|101377658|FG000|NOT COMPLETED|Overall Study||26||
48425863|NCT02383966|101377659|FG001|NOT COMPLETED|Overall Study||7||
48425864|NCT00490815|101377660|FG000|STARTED|Overall Study||20||
48425865|NCT00490815|101377661|FG001|STARTED|Overall Study||17||
48425866|NCT00490815|101377660|FG000|COMPLETED|Overall Study||12||
48425867|NCT00490815|101377661|FG001|COMPLETED|Overall Study||8||
48425868|NCT00490815|101377660|FG000|NOT COMPLETED|Overall Study||8||
48425869|NCT00490815|101377661|FG001|NOT COMPLETED|Overall Study||9||
48425870|NCT02967393|101377662|FG000|STARTED|Overall Study||20||
48425871|NCT02967393|101377663|FG001|STARTED|Overall Study||20||
48425872|NCT02967393|101377662|FG000|COMPLETED|Overall Study||20||
48425873|NCT02967393|101377663|FG001|COMPLETED|Overall Study||20||
48425874|NCT02967393|101377662|FG000|NOT COMPLETED|Overall Study||0||
48425875|NCT02967393|101377663|FG001|NOT COMPLETED|Overall Study||0||
48425876|NCT01012765|101377664|FG000|STARTED|Treatment Period 1||20||
48425877|NCT01012765|101377665|FG001|STARTED|Treatment Period 1||21||
48425878|NCT01012765|101377666|FG002|STARTED|Treatment Period 1||23||
48425879|NCT01012765|101377667|FG003|STARTED|Treatment Period 1||18||
48425880|NCT01012765|101377668|FG004|STARTED|Treatment Period 1||22||
48425881|NCT01012765|101377669|FG005|STARTED|Treatment Period 1||25||
48425882|NCT01012765|101377664|FG000|COMPLETED|Treatment Period 1||17||
48425883|NCT01012765|101377665|FG001|COMPLETED|Treatment Period 1||21||
48425884|NCT01012765|101377666|FG002|COMPLETED|Treatment Period 1||21||
48425885|NCT01012765|101377667|FG003|COMPLETED|Treatment Period 1||15||
48425886|NCT01012765|101377668|FG004|COMPLETED|Treatment Period 1||19||
48425887|NCT01012765|101377669|FG005|COMPLETED|Treatment Period 1||25||
48425888|NCT01012765|101377664|FG000|NOT COMPLETED|Treatment Period 1||3||
48425889|NCT01012765|101377665|FG001|NOT COMPLETED|Treatment Period 1||0||
48425890|NCT01012765|101377666|FG002|NOT COMPLETED|Treatment Period 1||2||
48425891|NCT01012765|101377667|FG003|NOT COMPLETED|Treatment Period 1||3||
48425892|NCT01012765|101377668|FG004|NOT COMPLETED|Treatment Period 1||3||
48425893|NCT01012765|101377669|FG005|NOT COMPLETED|Treatment Period 1||0||
48425894|NCT01012765|101377664|FG000|STARTED|Treatment Period 2||17||
48425895|NCT01012765|101377665|FG001|STARTED|Treatment Period 2||21||
48425896|NCT01012765|101377666|FG002|STARTED|Treatment Period 2||21||
48425897|NCT01012765|101377667|FG003|STARTED|Treatment Period 2||15||
48425898|NCT01012765|101377668|FG004|STARTED|Treatment Period 2||19||
48425899|NCT01012765|101377669|FG005|STARTED|Treatment Period 2||25||
48425900|NCT01012765|101377664|FG000|COMPLETED|Treatment Period 2||16||
48425901|NCT01012765|101377665|FG001|COMPLETED|Treatment Period 2||19||
48425902|NCT01012765|101377666|FG002|COMPLETED|Treatment Period 2||18||
48425903|NCT01012765|101377667|FG003|COMPLETED|Treatment Period 2||15||
48425904|NCT01012765|101377668|FG004|COMPLETED|Treatment Period 2||18||
48425905|NCT01012765|101377669|FG005|COMPLETED|Treatment Period 2||24||
48425906|NCT01012765|101377664|FG000|NOT COMPLETED|Treatment Period 2||1||
48425907|NCT01012765|101377665|FG001|NOT COMPLETED|Treatment Period 2||2||
48425908|NCT01012765|101377666|FG002|NOT COMPLETED|Treatment Period 2||3||
48425909|NCT01012765|101377667|FG003|NOT COMPLETED|Treatment Period 2||0||
48425910|NCT01012765|101377668|FG004|NOT COMPLETED|Treatment Period 2||1||
48425911|NCT01012765|101377669|FG005|NOT COMPLETED|Treatment Period 2||1||
48425912|NCT01012765|101377664|FG000|STARTED|Treatment Period 3||16||
48425913|NCT01012765|101377665|FG001|STARTED|Treatment Period 3||19||
48425914|NCT01012765|101377666|FG002|STARTED|Treatment Period 3||18||
48425915|NCT01012765|101377667|FG003|STARTED|Treatment Period 3||15||
48425916|NCT01012765|101377668|FG004|STARTED|Treatment Period 3||18||
48425917|NCT01012765|101377669|FG005|STARTED|Treatment Period 3||24||
48425918|NCT01012765|101377664|FG000|COMPLETED|Treatment Period 3||16||
48425919|NCT01012765|101377665|FG001|COMPLETED|Treatment Period 3||19||
48425920|NCT01012765|101377666|FG002|COMPLETED|Treatment Period 3||18||
48425921|NCT01012765|101377667|FG003|COMPLETED|Treatment Period 3||15||
48425922|NCT01012765|101377668|FG004|COMPLETED|Treatment Period 3||18||
48425923|NCT01012765|101377669|FG005|COMPLETED|Treatment Period 3||24||
48425924|NCT01012765|101377664|FG000|NOT COMPLETED|Treatment Period 3||0||
48425925|NCT01012765|101377665|FG001|NOT COMPLETED|Treatment Period 3||0||
48425926|NCT01012765|101377666|FG002|NOT COMPLETED|Treatment Period 3||0||
48425927|NCT01012765|101377667|FG003|NOT COMPLETED|Treatment Period 3||0||
48425928|NCT01012765|101377668|FG004|NOT COMPLETED|Treatment Period 3||0||
48425929|NCT01012765|101377669|FG005|NOT COMPLETED|Treatment Period 3||0||
48425930|NCT02195531|101377670|FG000|STARTED|Overall Study||64||
48425931|NCT02195531|101377671|FG001|STARTED|Overall Study||49||
48425932|NCT02195531|101377672|FG002|STARTED|Overall Study||56||
48425933|NCT02195531|101377670|FG000|COMPLETED|Overall Study||63||
48425934|NCT02195531|101377671|FG001|COMPLETED|Overall Study||48||
48425935|NCT02195531|101377672|FG002|COMPLETED|Overall Study||55||
48425936|NCT02195531|101377670|FG000|NOT COMPLETED|Overall Study||1||
48425937|NCT02195531|101377671|FG001|NOT COMPLETED|Overall Study||1||
48425938|NCT02195531|101377672|FG002|NOT COMPLETED|Overall Study||1||
48425939|NCT03554798|101377673|FG000|STARTED|Overall Study||50||
48425940|NCT03554798|101377674|FG001|STARTED|Overall Study||50||
48425941|NCT03554798|101377675|FG002|STARTED|Overall Study||51||
48425942|NCT03554798|101377676|FG003|STARTED|Overall Study||156||
48425943|NCT03554798|101377677|FG004|STARTED|Overall Study||144||
48425944|NCT03554798|101377678|FG005|STARTED|Overall Study||138||
48425945|NCT03554798|101377679|FG006|STARTED|Overall Study||150||
48425946|NCT03554798|101377680|FG007|STARTED|Overall Study||135||
48425947|NCT03554798|101377681|FG008|STARTED|Overall Study||151||
48425948|NCT03554798|101377673|FG000|COMPLETED|Overall Study||45||
48425949|NCT03554798|101377674|FG001|COMPLETED|Overall Study||47||
48425950|NCT03554798|101377675|FG002|COMPLETED|Overall Study||48||
48425951|NCT03554798|101377676|FG003|COMPLETED|Overall Study||154||
48425952|NCT03554798|101377677|FG004|COMPLETED|Overall Study||141||
48425953|NCT03554798|101377678|FG005|COMPLETED|Overall Study||137||
48425954|NCT03554798|101377679|FG006|COMPLETED|Overall Study||149||
48425955|NCT03554798|101377680|FG007|COMPLETED|Overall Study||133||
48425956|NCT03554798|101377681|FG008|COMPLETED|Overall Study||149||
48425957|NCT03554798|101377673|FG000|NOT COMPLETED|Overall Study||5||
48425958|NCT03554798|101377674|FG001|NOT COMPLETED|Overall Study||3||
48425959|NCT03554798|101377675|FG002|NOT COMPLETED|Overall Study||3||
48425960|NCT03554798|101377676|FG003|NOT COMPLETED|Overall Study||2||
48425961|NCT03554798|101377677|FG004|NOT COMPLETED|Overall Study||3||
48425962|NCT03554798|101377678|FG005|NOT COMPLETED|Overall Study||1||
48425963|NCT03554798|101377679|FG006|NOT COMPLETED|Overall Study||1||
48425964|NCT03554798|101377680|FG007|NOT COMPLETED|Overall Study||2||
48425965|NCT03554798|101377681|FG008|NOT COMPLETED|Overall Study||2||
48425966|NCT03691831|101377682|FG000|STARTED|Overall Study||251||
48425967|NCT03691831|101377683|FG001|STARTED|Overall Study||251||
48425968|NCT03691831|101377682|FG000|COMPLETED|Overall Study||224||
48425969|NCT03691831|101377683|FG001|COMPLETED|Overall Study||220||
48425970|NCT03691831|101377682|FG000|NOT COMPLETED|Overall Study||27||
48425971|NCT03691831|101377683|FG001|NOT COMPLETED|Overall Study||31||
48425972|NCT01205568|101377684|FG000|STARTED|Overall Study||65||107
48425973|NCT01205568|101377685|FG001|STARTED|Overall Study||47||66
48425974|NCT01205568|101377684|FG000|COMPLETED|Overall Study||65||106
48425975|NCT01205568|101377685|FG001|COMPLETED|Overall Study||47||65
48425976|NCT01205568|101377684|FG000|NOT COMPLETED|Overall Study||0||1
48425977|NCT01205568|101377685|FG001|NOT COMPLETED|Overall Study||0||1
48425978|NCT02577107|101377686|FG000|STARTED|Overall Study||6||
48425979|NCT02577107|101377687|FG001|STARTED|Overall Study||6||
48425980|NCT02577107|101377686|FG000|COMPLETED|Overall Study||6||
48425981|NCT02577107|101377687|FG001|COMPLETED|Overall Study||5||
48425982|NCT02577107|101377686|FG000|NOT COMPLETED|Overall Study||0||
48425983|NCT02577107|101377687|FG001|NOT COMPLETED|Overall Study||1||
48425984|NCT01363999|101377688|FG000|STARTED|A: RO5317116/F01 Bilayer Tablet||24||
48425985|NCT01363999|101377688|FG000|COMPLETED|A: RO5317116/F01 Bilayer Tablet||24||
48425986|NCT01363999|101377688|FG000|NOT COMPLETED|A: RO5317116/F01 Bilayer Tablet||0||
48425987|NCT01363999|101377688|FG000|STARTED|B: RO5317116/F03 Bilayer Tablet||24||
48425988|NCT01363999|101377688|FG000|COMPLETED|B: RO5317116/F03 Bilayer Tablet||24||
48425989|NCT01363999|101377688|FG000|NOT COMPLETED|B: RO5317116/F03 Bilayer Tablet||0||
48425990|NCT01363999|101377688|FG000|STARTED|C: RO5317116/ F04 Active-coated Tablet||24||
48425991|NCT01363999|101377688|FG000|COMPLETED|C: RO5317116/ F04 Active-coated Tablet||24||
48425992|NCT01363999|101377688|FG000|NOT COMPLETED|C: RO5317116/ F04 Active-coated Tablet||0||
48425993|NCT01363999|101377688|FG000|STARTED|D: RO4607381/ F49 Tablet||24||
48425994|NCT01363999|101377688|FG000|COMPLETED|D: RO4607381/ F49 Tablet||24||
48425995|NCT01363999|101377688|FG000|NOT COMPLETED|D: RO4607381/ F49 Tablet||0||
48425996|NCT04335929|101377689|FG000|STARTED|Overall Study||32||
48425997|NCT04335929|101377689|FG000|COMPLETED|Overall Study||22||
48425998|NCT04335929|101377689|FG000|NOT COMPLETED|Overall Study||10||
48425999|NCT03747497|101377690|FG000|STARTED|Overall Study||131||
48426000|NCT03747497|101377691|FG001|STARTED|Overall Study||65||
48426001|NCT03747497|101377690|FG000|COMPLETED|Overall Study||106||
48426002|NCT03747497|101377691|FG001|COMPLETED|Overall Study||55||
48426003|NCT03747497|101377690|FG000|NOT COMPLETED|Overall Study||25||
48426004|NCT03747497|101377691|FG001|NOT COMPLETED|Overall Study||10||
48426005|NCT03693846|101377692|FG000|STARTED|Overall Study||11||
48426006|NCT03693846|101377692|FG000|COMPLETED|Overall Study||11||
48426007|NCT03693846|101377692|FG000|NOT COMPLETED|Overall Study||0||
48426008|NCT05102734|101377693|FG000|STARTED|Overall Study||24||
48426009|NCT05102734|101377694|FG001|STARTED|Overall Study||20||
48426010|NCT05102734|101377693|FG000|COMPLETED|Overall Study||20||
48426011|NCT05102734|101377694|FG001|COMPLETED|Overall Study||20||
48426012|NCT05102734|101377693|FG000|NOT COMPLETED|Overall Study||4||
48426013|NCT05102734|101377694|FG001|NOT COMPLETED|Overall Study||0||
48426014|NCT03558230|101377695|FG000|STARTED|Overall Study||7||
48426015|NCT03558230|101377696|FG001|STARTED|Overall Study||6||
48426016|NCT03558230|101377695|FG000|COMPLETED|Overall Study||7||
48426017|NCT03558230|101377696|FG001|COMPLETED|Overall Study||6||
48426018|NCT03558230|101377695|FG000|NOT COMPLETED|Overall Study||0||
48426019|NCT03558230|101377696|FG001|NOT COMPLETED|Overall Study||0||
48426020|NCT00303602|101377697|FG000|STARTED|Overall Study||84||
48426021|NCT00303602|101377698|FG001|STARTED|Overall Study||65||
48426022|NCT00303602|101377697|FG000|COMPLETED|Overall Study||65||
48426023|NCT00303602|101377698|FG001|COMPLETED|Overall Study||50||
48426024|NCT00303602|101377697|FG000|NOT COMPLETED|Overall Study||19||
48426025|NCT00303602|101377698|FG001|NOT COMPLETED|Overall Study||15||
48426026|NCT02493712|101377699|FG000|STARTED|Overall Study||16||
48426027|NCT02493712|101377700|FG001|STARTED|Overall Study||18||
48426028|NCT02493712|101377701|FG002|STARTED|Overall Study||17||
48426029|NCT02493712|101377699|FG000|COMPLETED|Overall Study||14||
48426030|NCT02493712|101377700|FG001|COMPLETED|Overall Study||12||
48426031|NCT02493712|101377701|FG002|COMPLETED|Overall Study||11||
48426032|NCT02493712|101377699|FG000|NOT COMPLETED|Overall Study||2||
48426033|NCT02493712|101377700|FG001|NOT COMPLETED|Overall Study||6||
48426034|NCT02493712|101377701|FG002|NOT COMPLETED|Overall Study||6||
48426035|NCT02203305|101377702|FG000|STARTED|Overall Study||20||
48426036|NCT02203305|101377703|FG001|STARTED|Overall Study||3||
48426037|NCT02203305|101377704|FG002|STARTED|Overall Study||20||
48426038|NCT02203305|101377702|FG000|COMPLETED|Overall Study||20||
48426039|NCT02203305|101377703|FG001|COMPLETED|Overall Study||3||
48426040|NCT02203305|101377704|FG002|COMPLETED|Overall Study||19||
48426041|NCT02203305|101377702|FG000|NOT COMPLETED|Overall Study||0||
48426042|NCT02203305|101377703|FG001|NOT COMPLETED|Overall Study||0||
48426043|NCT02203305|101377704|FG002|NOT COMPLETED|Overall Study||1||
48426044|NCT02643420|101377705|FG000|STARTED|Overall Study||196||
48426045|NCT02643420|101377706|FG001|STARTED|Overall Study||210||
48426046|NCT02643420|101377705|FG000|Safety Population|Overall Study||197|Safety Population included all participants who had received at least one dose of any protocol specified drug (TC, SPI-2012, or pegfilgrastim).|
48426047|NCT02643420|101377706|FG001|Safety Population|Overall Study||208|Safety Population included all participants who had received at least one dose of any protocol specified drug (TC, SPI-2012, or pegfilgrastim).|
48426048|NCT02643420|101377705|FG000|COMPLETED|Overall Study||142||
48426049|NCT02643420|101377706|FG001|COMPLETED|Overall Study||145||
48426050|NCT02643420|101377705|FG000|NOT COMPLETED|Overall Study||54||
48426051|NCT02643420|101377706|FG001|NOT COMPLETED|Overall Study||65||
48426052|NCT00337935|101377707|FG000|STARTED|Overall Study||39||
48426053|NCT00337935|101377708|FG001|STARTED|Overall Study||118||
48426054|NCT00337935|101377707|FG000|COMPLETED|Overall Study||29||
48426055|NCT00337935|101377708|FG001|COMPLETED|Overall Study||91||
48426056|NCT00337935|101377707|FG000|NOT COMPLETED|Overall Study||10||
48426057|NCT00337935|101377708|FG001|NOT COMPLETED|Overall Study||27||
48426058|NCT00933543|101377709|FG000|STARTED|Overall Study||54||
48426059|NCT00933543|101377710|FG001|STARTED|Overall Study||53||
48426060|NCT00933543|101377709|FG000|COMPLETED|Overall Study||51||
48426061|NCT00933543|101377710|FG001|COMPLETED|Overall Study||46||
48426062|NCT00933543|101377709|FG000|NOT COMPLETED|Overall Study||3||
48426063|NCT00933543|101377710|FG001|NOT COMPLETED|Overall Study||7||
48426064|NCT00005803|101377711|FG000|STARTED|Overall Study||76||
48426065|NCT00005803|101377711|FG000|COMPLETED|Overall Study||54||
48426066|NCT00005803|101377711|FG000|NOT COMPLETED|Overall Study||22||
48426067|NCT03922945|101377712|FG000|STARTED|Overall Study||56||
48426068|NCT03922945|101377713|FG001|STARTED|Overall Study||54||
48426069|NCT03922945|101377714|FG002|STARTED|Overall Study||113||
48426070|NCT03922945|101377712|FG000|COMPLETED|Overall Study||29||
48426071|NCT03922945|101377713|FG001|COMPLETED|Overall Study||37||
48426072|NCT03922945|101377714|FG002|COMPLETED|Overall Study||73||
48426073|NCT03922945|101377712|FG000|NOT COMPLETED|Overall Study||27||
48426074|NCT03922945|101377713|FG001|NOT COMPLETED|Overall Study||17||
48426075|NCT03922945|101377714|FG002|NOT COMPLETED|Overall Study||40||
48426076|NCT00157157|101377715|FG000|STARTED|Overall Study||55||
48426077|NCT00157157|101377715|FG000|COMPLETED|Overall Study||44||
48426078|NCT00157157|101377715|FG000|NOT COMPLETED|Overall Study||11||
48426079|NCT00643006|101377716|FG000|STARTED|Overall Study||34||
48426080|NCT00643006|101377717|FG001|STARTED|Overall Study||33||
48426081|NCT00643006|101377716|FG000|COMPLETED|Overall Study||29||
48426082|NCT00643006|101377717|FG001|COMPLETED|Overall Study||29||
48426083|NCT00643006|101377716|FG000|NOT COMPLETED|Overall Study||5||
48426084|NCT00643006|101377717|FG001|NOT COMPLETED|Overall Study||4||
48426085|NCT01370499|101377718|FG000|STARTED|Overall Study||195||
48426086|NCT01370499|101377719|FG001|STARTED|Overall Study||93||
48657033|NCT02018809|101943756|FG003|COMPLETED|Overall Study||50||
48426087|NCT01370499|101377718|FG000|Entered Abrupt Discontinuation Phase|Overall Study||188||
48426088|NCT01370499|101377719|FG001|Entered Abrupt Discontinuation Phase|Overall Study||85||
48426089|NCT01370499|101377718|FG000|Received at Least 1 Dose of Study Drug|Overall Study||195||
48426090|NCT01370499|101377719|FG001|Received at Least 1 Dose of Study Drug|Overall Study||92||
48426091|NCT01370499|101377718|FG000|COMPLETED|Overall Study||84||
48426092|NCT01370499|101377719|FG001|COMPLETED|Overall Study||49||
48426093|NCT01370499|101377718|FG000|NOT COMPLETED|Overall Study||111||
48426094|NCT01370499|101377719|FG001|NOT COMPLETED|Overall Study||44||
48426095|NCT03485976|101377720|FG000|STARTED|Overall Study||12||
48426096|NCT03485976|101377720|FG000|COMPLETED|Overall Study||11||
48426097|NCT03485976|101377720|FG000|NOT COMPLETED|Overall Study||1||
48426098|NCT02030067|101377721|FG000|STARTED|Overall Study||1||
48426099|NCT02030067|101377722|FG001|STARTED|Overall Study||1||
48426100|NCT02030067|101377723|FG002|STARTED|Overall Study||3||
48426101|NCT02030067|101377724|FG003|STARTED|Overall Study||3||
48426102|NCT02030067|101377725|FG004|STARTED|Overall Study||3||
48426103|NCT02030067|101377726|FG005|STARTED|Overall Study||3||
48426104|NCT02030067|101377727|FG006|STARTED|Overall Study||3||
48426105|NCT02030067|101377728|FG007|STARTED|Overall Study||4||
48426106|NCT02030067|101377729|FG008|STARTED|Overall Study||6||
48426107|NCT02030067|101377730|FG009|STARTED|Overall Study||3||
48426108|NCT02030067|101377731|FG010|STARTED|Overall Study||11||
48426109|NCT02030067|101377732|FG011|STARTED|Overall Study||3||
48426110|NCT02030067|101377733|FG012|STARTED|Overall Study||80||
48426111|NCT02030067|101377721|FG000|COMPLETED|Overall Study||0||
48426112|NCT02030067|101377722|FG001|COMPLETED|Overall Study||0||
48426113|NCT02030067|101377723|FG002|COMPLETED|Overall Study||1||
48426114|NCT02030067|101377724|FG003|COMPLETED|Overall Study||0||
48426115|NCT02030067|101377725|FG004|COMPLETED|Overall Study||0||
48426116|NCT02030067|101377726|FG005|COMPLETED|Overall Study||0||
48426117|NCT02030067|101377727|FG006|COMPLETED|Overall Study||0||
48426118|NCT02030067|101377728|FG007|COMPLETED|Overall Study||0||
48426119|NCT02030067|101377729|FG008|COMPLETED|Overall Study||0||
48426120|NCT02030067|101377730|FG009|COMPLETED|Overall Study||0||
48426121|NCT02030067|101377731|FG010|COMPLETED|Overall Study||0||
48426122|NCT02030067|101377732|FG011|COMPLETED|Overall Study||0||
48426123|NCT02030067|101377733|FG012|COMPLETED|Overall Study||0||
48426124|NCT02030067|101377721|FG000|NOT COMPLETED|Overall Study||1||
48426125|NCT02030067|101377722|FG001|NOT COMPLETED|Overall Study||1||
48426126|NCT02030067|101377723|FG002|NOT COMPLETED|Overall Study||2||
48426127|NCT02030067|101377724|FG003|NOT COMPLETED|Overall Study||3||
48426128|NCT02030067|101377725|FG004|NOT COMPLETED|Overall Study||3||
48426129|NCT02030067|101377726|FG005|NOT COMPLETED|Overall Study||3||
48426130|NCT02030067|101377727|FG006|NOT COMPLETED|Overall Study||3||
48426131|NCT02030067|101377728|FG007|NOT COMPLETED|Overall Study||4||
48426132|NCT02030067|101377729|FG008|NOT COMPLETED|Overall Study||6||
48426133|NCT02030067|101377730|FG009|NOT COMPLETED|Overall Study||3||
48426134|NCT02030067|101377731|FG010|NOT COMPLETED|Overall Study||11||
48426135|NCT02030067|101377732|FG011|NOT COMPLETED|Overall Study||3||
48426136|NCT02030067|101377733|FG012|NOT COMPLETED|Overall Study||80||
48426137|NCT04576702|101377734|FG000|STARTED|Overall Study||116||
48426138|NCT04576702|101377735|FG001|STARTED|Overall Study||119||
48426139|NCT04576702|101377736|FG002|STARTED|Overall Study||116||
48426140|NCT04576702|101377737|FG003|STARTED|Overall Study||120||
48426141|NCT04576702|101377734|FG000|COMPLETED|Overall Study||112||
48426142|NCT04576702|101377735|FG001|COMPLETED|Overall Study||114||
48426143|NCT04576702|101377736|FG002|COMPLETED|Overall Study||112||
48426144|NCT04576702|101377737|FG003|COMPLETED|Overall Study||116||
48426145|NCT04576702|101377734|FG000|NOT COMPLETED|Overall Study||4||
48426146|NCT04576702|101377735|FG001|NOT COMPLETED|Overall Study||5||
48426147|NCT04576702|101377736|FG002|NOT COMPLETED|Overall Study||4||
48426148|NCT04576702|101377737|FG003|NOT COMPLETED|Overall Study||4||
48426149|NCT01220024|101377738|FG000|STARTED|Overall Study||25||
48426150|NCT01220024|101377739|FG001|STARTED|Overall Study||25||
48426151|NCT01220024|101377738|FG000|COMPLETED|Overall Study||24||
48426152|NCT01220024|101377739|FG001|COMPLETED|Overall Study||24||
48638941|NCT03233217|101901535|FG002|Per-protocol Analysis Set (PPAS)|Overall Study||55|Cohort 1 = 10 participants, and Cohort 2 = 164 participants|
48638942|NCT03233217|101901536|FG003|Per-protocol Analysis Set (PPAS)|Overall Study||55|Cohort 1 = 10 participants, and Cohort 2 = 164 participants|
48638943|NCT03233217|101901537|FG004|Per-protocol Analysis Set (PPAS)|Overall Study||54|Cohort 1 = 10 participants, and Cohort 2 = 164 participants|
48426153|NCT01220024|101377738|FG000|NOT COMPLETED|Overall Study||1||
48426154|NCT01220024|101377739|FG001|NOT COMPLETED|Overall Study||1||
48426155|NCT00565721|101377740|FG000|STARTED|Overall Study||33||
48426156|NCT00565721|101377740|FG000|COMPLETED|Overall Study||16||
48426157|NCT00565721|101377740|FG000|NOT COMPLETED|Overall Study||17||
48426158|NCT04889989|101377741|FG000|STARTED|Overall Study||13|13|14
48426159|NCT04889989|101377741|FG000|Run-In|Overall Study||4|4|4
48426160|NCT04889989|101377741|FG000|Withdrew Consent|Overall Study||1|Withdrew consent after being treated and before the 1-month follow-up visit.|1
48763965|NCT00726063|102211836|FG000|COMPLETED|Overall Study||113||
48426161|NCT04889989|101377741|FG000|Died|Overall Study||1||1
48426162|NCT04889989|101377741|FG000|Lost to Follow-Up|Overall Study||1||2
48426163|NCT04889989|101377741|FG000|COMPLETED|Overall Study||6|6|6
48763966|NCT00726063|102211837|FG001|COMPLETED|Overall Study||112||
48426164|NCT04889989|101377741|FG000|NOT COMPLETED|Overall Study||7||8
48426165|NCT00285857|101377742|FG000|STARTED|Overall Study||30||
48426166|NCT00285857|101377742|FG000|COMPLETED|Overall Study||26||
48426167|NCT00285857|101377742|FG000|NOT COMPLETED|Overall Study||4||
48426168|NCT02985996|101377743|FG000|STARTED|Overall Study||5||
48426169|NCT02985996|101377744|FG001|STARTED|Overall Study||8||
48426170|NCT02985996|101377745|FG002|STARTED|Overall Study||10||
48426171|NCT02985996|101377746|FG003|STARTED|Overall Study||7||
48426172|NCT02985996|101377747|FG004|STARTED|Overall Study||9||
48426173|NCT02985996|101377743|FG000|COMPLETED|Overall Study||5||
48426174|NCT02985996|101377744|FG001|COMPLETED|Overall Study||7||
48426175|NCT02985996|101377745|FG002|COMPLETED|Overall Study||9||
48426176|NCT02985996|101377746|FG003|COMPLETED|Overall Study||7||
48426177|NCT02985996|101377747|FG004|COMPLETED|Overall Study||9||
48426178|NCT02985996|101377743|FG000|NOT COMPLETED|Overall Study||0||
48426179|NCT02985996|101377744|FG001|NOT COMPLETED|Overall Study||1||
48426180|NCT02985996|101377745|FG002|NOT COMPLETED|Overall Study||1||
48426181|NCT02985996|101377746|FG003|NOT COMPLETED|Overall Study||0||
48426182|NCT02985996|101377747|FG004|NOT COMPLETED|Overall Study||0||
48426183|NCT00957827|101377748|FG000|STARTED|Overall Study||2||
48426184|NCT00957827|101377749|FG001|STARTED|Overall Study||2||
48426185|NCT00957827|101377748|FG000|COMPLETED|Overall Study||2||
48426186|NCT00957827|101377749|FG001|COMPLETED|Overall Study||2||
48426187|NCT00957827|101377748|FG000|NOT COMPLETED|Overall Study||0||
48426188|NCT00957827|101377749|FG001|NOT COMPLETED|Overall Study||0||
48426189|NCT02815670|101377750|FG000|STARTED|Overall Study||1||
48426190|NCT02815670|101377750|FG000|COMPLETED|Overall Study||0||
48426191|NCT02815670|101377750|FG000|NOT COMPLETED|Overall Study||1||
48426192|NCT00039377|101377751|FG000|STARTED|Initial Registration||57||
48426193|NCT00039377|101377752|FG001|STARTED|Initial Registration||0||
48426194|NCT00039377|101377753|FG002|STARTED|Initial Registration||0||
48426195|NCT00039377|101377754|FG003|STARTED|Initial Registration||0||
48426196|NCT00039377|101377751|FG000|COMPLETED|Initial Registration||35||
48426197|NCT00039377|101377752|FG001|COMPLETED|Initial Registration||0||
48426198|NCT00039377|101377753|FG002|COMPLETED|Initial Registration||0||
48426199|NCT00039377|101377754|FG003|COMPLETED|Initial Registration||0||
48426200|NCT00039377|101377751|FG000|NOT COMPLETED|Initial Registration||22||
48426201|NCT00039377|101377752|FG001|NOT COMPLETED|Initial Registration||0||
48426202|NCT00039377|101377753|FG002|NOT COMPLETED|Initial Registration||0||
48426203|NCT00039377|101377754|FG003|NOT COMPLETED|Initial Registration||0||
48426204|NCT00039377|101377751|FG000|STARTED|Course 5 (Transplant Assignments)||0||
48426205|NCT00039377|101377752|FG001|STARTED|Course 5 (Transplant Assignments)||15||
48426206|NCT00039377|101377753|FG002|STARTED|Course 5 (Transplant Assignments)||19||
48426207|NCT00039377|101377754|FG003|STARTED|Course 5 (Transplant Assignments)||1||
48426208|NCT00039377|101377751|FG000|COMPLETED|Course 5 (Transplant Assignments)||0||
48426209|NCT00039377|101377752|FG001|COMPLETED|Course 5 (Transplant Assignments)||15||
48426210|NCT00039377|101377753|FG002|COMPLETED|Course 5 (Transplant Assignments)||19||
48426211|NCT00039377|101377754|FG003|COMPLETED|Course 5 (Transplant Assignments)||1||
48426212|NCT00039377|101377751|FG000|NOT COMPLETED|Course 5 (Transplant Assignments)||0||
48426213|NCT00039377|101377752|FG001|NOT COMPLETED|Course 5 (Transplant Assignments)||0||
48426214|NCT00039377|101377753|FG002|NOT COMPLETED|Course 5 (Transplant Assignments)||0||
48426215|NCT00039377|101377754|FG003|NOT COMPLETED|Course 5 (Transplant Assignments)||0||
48426216|NCT02625610|101377755|FG000|STARTED|Overall Study||250||
48426217|NCT02625610|101377756|FG001|STARTED|Overall Study||249||
48426218|NCT02625610|101377755|FG000|Safety-Maintenance Analysis Set|Overall Study||238||
48426219|NCT02625610|101377756|FG001|Safety-Maintenance Analysis Set|Overall Study||243||
48426220|NCT02625610|101377755|FG000|COMPLETED|Overall Study||250||
48426221|NCT02625610|101377756|FG001|COMPLETED|Overall Study||249||
48426222|NCT02625610|101377755|FG000|NOT COMPLETED|Overall Study||0||
48426223|NCT02625610|101377756|FG001|NOT COMPLETED|Overall Study||0||
48426224|NCT01199952|101377757|FG000|STARTED|Overall Study||103||
48426225|NCT01199952|101377758|FG001|STARTED|Overall Study||104||
48426226|NCT01199952|101377757|FG000|COMPLETED|Overall Study||51||
48426227|NCT01199952|101377758|FG001|COMPLETED|Overall Study||59||
48426228|NCT01199952|101377757|FG000|NOT COMPLETED|Overall Study||52||
48426229|NCT01199952|101377758|FG001|NOT COMPLETED|Overall Study||45||
48426230|NCT00505765|101377759|FG000|STARTED|Overall Study||21||
48426231|NCT00505765|101377760|FG001|STARTED|Overall Study||20||
48426232|NCT00505765|101377761|FG002|STARTED|Overall Study||22||
48426233|NCT00505765|101377759|FG000|Mid-Point Assessment|Overall Study||20||
48426234|NCT00505765|101377760|FG001|Mid-Point Assessment|Overall Study||19||
48426235|NCT00505765|101377761|FG002|Mid-Point Assessment|Overall Study||21||
48426236|NCT00505765|101377759|FG000|COMPLETED|Overall Study||19||
48426237|NCT00505765|101377760|FG001|COMPLETED|Overall Study||17||
48426238|NCT00505765|101377761|FG002|COMPLETED|Overall Study||19||
48426239|NCT00505765|101377759|FG000|NOT COMPLETED|Overall Study||2||
48426240|NCT00505765|101377760|FG001|NOT COMPLETED|Overall Study||3||
48426241|NCT00505765|101377761|FG002|NOT COMPLETED|Overall Study||3||
48426242|NCT03633461|101377762|FG000|STARTED|Overall Study||34||
48426243|NCT03633461|101377763|FG001|STARTED|Overall Study||19||
48426244|NCT03633461|101377762|FG000|COMPLETED|Overall Study||34||
48426245|NCT03633461|101377763|FG001|COMPLETED|Overall Study||18||
48426246|NCT03633461|101377762|FG000|NOT COMPLETED|Overall Study||0||
48426247|NCT03633461|101377763|FG001|NOT COMPLETED|Overall Study||1||
48426248|NCT03374982|101377764|FG000|STARTED|Overall Study||12||
48426249|NCT03374982|101377765|FG001|STARTED|Overall Study||11||
48426250|NCT03374982|101377764|FG000|COMPLETED|Overall Study||12||
48426251|NCT03374982|101377765|FG001|COMPLETED|Overall Study||11||
48426252|NCT03374982|101377764|FG000|NOT COMPLETED|Overall Study||0||
48426253|NCT03374982|101377765|FG001|NOT COMPLETED|Overall Study||0||
48426254|NCT02534324|101377766|FG000|STARTED|Overall Study||98||
48426255|NCT02534324|101377767|FG001|STARTED|Overall Study||48||
48426256|NCT02534324|101377766|FG000|COMPLETED|Overall Study||73||
48426257|NCT02534324|101377767|FG001|COMPLETED|Overall Study||40||
48426258|NCT02534324|101377766|FG000|NOT COMPLETED|Overall Study||25||
48426259|NCT02534324|101377767|FG001|NOT COMPLETED|Overall Study||8||
48426260|NCT04138758|101377768|FG000|STARTED|Overall Study||2600||
48426261|NCT04138758|101377769|FG001|STARTED|Overall Study||40353||
48426262|NCT04138758|101377768|FG000|COMPLETED|Overall Study||2600||
48426263|NCT04138758|101377769|FG001|COMPLETED|Overall Study||40353||
48426264|NCT04138758|101377768|FG000|NOT COMPLETED|Overall Study||0||
48426265|NCT04138758|101377769|FG001|NOT COMPLETED|Overall Study||0||
48426266|NCT00450814|101377770|FG000|STARTED|Overall Study||3||
48426267|NCT00450814|101377771|FG001|STARTED|Overall Study||3||
48426268|NCT00450814|101377772|FG002|STARTED|Overall Study||3||
48426269|NCT00450814|101377773|FG003|STARTED|Overall Study||4||
48426270|NCT00450814|101377774|FG004|STARTED|Overall Study||4||
48426271|NCT00450814|101377775|FG005|STARTED|Overall Study||7||
48426272|NCT00450814|101377776|FG006|STARTED|Overall Study||3||
48426273|NCT00450814|101377777|FG007|STARTED|Overall Study||3||
48426274|NCT00450814|101377778|FG008|STARTED|Overall Study||2||
48426275|NCT00450814|101377779|FG009|STARTED|Overall Study||12||
48426276|NCT00450814|101377780|FG010|STARTED|Overall Study||4||
48426277|NCT00450814|101377770|FG000|COMPLETED|Overall Study||3||
48426278|NCT00450814|101377771|FG001|COMPLETED|Overall Study||3||
48426279|NCT00450814|101377772|FG002|COMPLETED|Overall Study||3||
48426280|NCT00450814|101377773|FG003|COMPLETED|Overall Study||3||
48426281|NCT00450814|101377774|FG004|COMPLETED|Overall Study||3||
48426282|NCT00450814|101377775|FG005|COMPLETED|Overall Study||6||
48426283|NCT00450814|101377776|FG006|COMPLETED|Overall Study||3||
48426284|NCT00450814|101377777|FG007|COMPLETED|Overall Study||3||
48426285|NCT00450814|101377778|FG008|COMPLETED|Overall Study||2||
48426286|NCT00450814|101377779|FG009|COMPLETED|Overall Study||11||
48426287|NCT00450814|101377780|FG010|COMPLETED|Overall Study||4||
48426288|NCT00450814|101377770|FG000|NOT COMPLETED|Overall Study||0||
48426289|NCT00450814|101377771|FG001|NOT COMPLETED|Overall Study||0||
48426290|NCT00450814|101377772|FG002|NOT COMPLETED|Overall Study||0||
48426291|NCT00450814|101377773|FG003|NOT COMPLETED|Overall Study||1||
48426292|NCT00450814|101377774|FG004|NOT COMPLETED|Overall Study||1||
48426293|NCT00450814|101377775|FG005|NOT COMPLETED|Overall Study||1||
48426294|NCT00450814|101377776|FG006|NOT COMPLETED|Overall Study||0||
48426295|NCT00450814|101377777|FG007|NOT COMPLETED|Overall Study||0||
48426296|NCT00450814|101377778|FG008|NOT COMPLETED|Overall Study||0||
48426297|NCT00450814|101377779|FG009|NOT COMPLETED|Overall Study||1||
48426298|NCT00450814|101377780|FG010|NOT COMPLETED|Overall Study||0||
48426299|NCT01255449|101377781|FG000|STARTED|Overall Study||26||
48426300|NCT01255449|101377781|FG000|COMPLETED|Overall Study||26||
48426301|NCT01255449|101377781|FG000|NOT COMPLETED|Overall Study||0||
48426302|NCT04533204|101377782|FG000|STARTED|Overall Study||29||
48426303|NCT04533204|101377783|FG001|STARTED|Overall Study||30||
48426304|NCT04533204|101377782|FG000|COMPLETED|Overall Study||28||
48426305|NCT04533204|101377783|FG001|COMPLETED|Overall Study||29||
48426306|NCT04533204|101377782|FG000|NOT COMPLETED|Overall Study||1||
48426307|NCT04533204|101377783|FG001|NOT COMPLETED|Overall Study||1||
48426308|NCT00422227|101377784|FG000|STARTED|Overall Study||197||
48426309|NCT00422227|101377785|FG001|STARTED|Overall Study||103||
48426310|NCT00422227|101377784|FG000|COMPLETED|Overall Study||193||
48426311|NCT00422227|101377785|FG001|COMPLETED|Overall Study||88||
48426312|NCT00422227|101377784|FG000|NOT COMPLETED|Overall Study||4||
48426313|NCT00422227|101377785|FG001|NOT COMPLETED|Overall Study||15||
48426314|NCT00532441|101377786|FG000|STARTED|Overall Study||14||
48426315|NCT00532441|101377787|FG001|STARTED|Overall Study||11||
48426316|NCT00532441|101377786|FG000|COMPLETED|Overall Study||13||
48426317|NCT00532441|101377787|FG001|COMPLETED|Overall Study||11||
48426318|NCT00532441|101377786|FG000|NOT COMPLETED|Overall Study||1||
48638944|NCT03233217|101901533|FG000|COMPLETED|Overall Study||5||
48426319|NCT00532441|101377787|FG001|NOT COMPLETED|Overall Study||0||
48426320|NCT02283411|101377788|FG000|STARTED|Overall Study||156||
48426321|NCT02283411|101377788|FG000|COMPLETED|Overall Study||125||
48426322|NCT02283411|101377788|FG000|NOT COMPLETED|Overall Study||31||
48426323|NCT00887822|101377789|FG000|STARTED|Overall Study||100||
48426324|NCT00887822|101377790|FG001|STARTED|Overall Study||102||
48426325|NCT00887822|101377789|FG000|Treated (Safety Population)|Overall Study||100||
48426326|NCT00887822|101377790|FG001|Treated (Safety Population)|Overall Study||101||
48426327|NCT00887822|101377789|FG000|COMPLETED|Overall Study||3||
48426328|NCT00887822|101377790|FG001|COMPLETED|Overall Study||0||
48426329|NCT00887822|101377789|FG000|NOT COMPLETED|Overall Study||97||
48426330|NCT00887822|101377790|FG001|NOT COMPLETED|Overall Study||102||
48426331|NCT02399345|101377791|FG000|STARTED|Overall Study||10||
48426332|NCT02399345|101377791|FG000|COMPLETED|Overall Study||10||
48638945|NCT03233217|101901534|FG001|COMPLETED|Overall Study||5||
48638946|NCT03233217|101901535|FG002|COMPLETED|Overall Study||55||
48638947|NCT03233217|101901536|FG003|COMPLETED|Overall Study||55||
48426333|NCT02399345|101377791|FG000|NOT COMPLETED|Overall Study||0||
48426334|NCT01474291|101377792|FG000|STARTED|Overall Study||603||
48426335|NCT01474291|101377792|FG000|Evaluable for Efficacy|Overall Study||577||
48426336|NCT01474291|101377792|FG000|COMPLETED|Overall Study||383||
48426337|NCT01474291|101377792|FG000|NOT COMPLETED|Overall Study||220||
48426338|NCT03164629|101377793|FG000|STARTED|Overall Study||25||
48426339|NCT03164629|101377794|FG001|STARTED|Overall Study||25||
48426340|NCT03164629|101377793|FG000|COMPLETED|Overall Study||25||
48426341|NCT03164629|101377794|FG001|COMPLETED|Overall Study||25||
48426342|NCT03164629|101377793|FG000|NOT COMPLETED|Overall Study||0||
48426343|NCT03164629|101377794|FG001|NOT COMPLETED|Overall Study||0||
48426344|NCT00703729|101377795|FG000|STARTED|Overall Study||25||
48426345|NCT00703729|101377796|FG001|STARTED|Overall Study||24||
48426346|NCT00703729|101377795|FG000|COMPLETED|Overall Study||25||
48426347|NCT00703729|101377796|FG001|COMPLETED|Overall Study||21||
48426348|NCT00703729|101377795|FG000|NOT COMPLETED|Overall Study||0||
48426349|NCT00703729|101377796|FG001|NOT COMPLETED|Overall Study||3||
48426350|NCT02083406|101377797|FG000|STARTED|Overall Study||7||
48426351|NCT02083406|101377798|FG001|STARTED|Overall Study||8||
48426352|NCT02083406|101377799|FG002|STARTED|Overall Study||7||
48426353|NCT02083406|101377797|FG000|COMPLETED|Overall Study||7||
48426354|NCT02083406|101377798|FG001|COMPLETED|Overall Study||8||
48426355|NCT02083406|101377799|FG002|COMPLETED|Overall Study||7||
48426356|NCT02083406|101377797|FG000|NOT COMPLETED|Overall Study||0||
48426357|NCT02083406|101377798|FG001|NOT COMPLETED|Overall Study||0||
48426358|NCT02083406|101377799|FG002|NOT COMPLETED|Overall Study||0||
48426359|NCT00923481|101377800|FG000|STARTED|Overall Study||37||
48426360|NCT00923481|101377800|FG000|COMPLETED|Overall Study||37||
48426361|NCT00923481|101377800|FG000|NOT COMPLETED|Overall Study||0||
48426362|NCT01619176|101377801|FG000|STARTED|Overall Study||6||
48426363|NCT01619176|101377802|FG001|STARTED|Overall Study||4||
48426364|NCT01619176|101377801|FG000|COMPLETED|Overall Study||6||
48426365|NCT01619176|101377802|FG001|COMPLETED|Overall Study||4||
48426366|NCT01619176|101377801|FG000|NOT COMPLETED|Overall Study||0||
48426367|NCT01619176|101377802|FG001|NOT COMPLETED|Overall Study||0||
48426368|NCT02720627|101377803|FG000|STARTED|Overall Study||27||
48426369|NCT02720627|101377803|FG000|COMPLETED|Overall Study||27||
48426370|NCT02720627|101377803|FG000|NOT COMPLETED|Overall Study||0||
48426371|NCT01349816|101377804|FG000|STARTED|Overall Study||185||
48426372|NCT01349816|101377804|FG000|GP MDI 36 µg|Overall Study||61||
48426373|NCT01349816|101377804|FG000|GFF MDI 36/7.2 µg|Overall Study||58||
48426374|NCT01349816|101377804|FG000|GFF MDI 36/9.6 µg|Overall Study||56||
48426375|NCT01349816|101377804|FG000|GFF MDI 18/9.6 µg|Overall Study||57||
48426376|NCT01349816|101377804|FG000|GFF MDI 9/9.6 µg|Overall Study||57||
48426377|NCT01349816|101377804|FG000|FF MDI 9.6 µg|Overall Study||61||
48426378|NCT01349816|101377804|FG000|COMPLETED|Overall Study||155||
48426379|NCT01349816|101377804|FG000|NOT COMPLETED|Overall Study||30||
48426380|NCT01973205|101377805|FG000|STARTED|Overall Study||453||
48426381|NCT01973205|101377806|FG001|STARTED|Overall Study||447||
48426382|NCT01973205|101377805|FG000|COMPLETED|Overall Study||423||
48426383|NCT01973205|101377806|FG001|COMPLETED|Overall Study||425||
48426384|NCT01973205|101377805|FG000|NOT COMPLETED|Overall Study||30||
48426385|NCT01973205|101377806|FG001|NOT COMPLETED|Overall Study||22||
48426386|NCT05600101|101377807|FG000|STARTED|Overall Study||18||
48426387|NCT05600101|101377808|FG001|STARTED|Overall Study||10||
48426388|NCT05600101|101377807|FG000|COMPLETED|Overall Study||18||
48426389|NCT05600101|101377808|FG001|COMPLETED|Overall Study||10||
48426390|NCT05600101|101377807|FG000|NOT COMPLETED|Overall Study||0||
48426391|NCT05600101|101377808|FG001|NOT COMPLETED|Overall Study||0||
48426392|NCT03726320|101377809|FG000|STARTED|Overall Study||66||
48426393|NCT03726320|101377810|FG001|STARTED|Overall Study||68||
48426394|NCT03726320|101377811|FG002|STARTED|Overall Study||12||
48426395|NCT03726320|101377809|FG000|COMPLETED|Overall Study||54||
48426396|NCT03726320|101377810|FG001|COMPLETED|Overall Study||60||
48426397|NCT03726320|101377811|FG002|COMPLETED|Overall Study||11||
48426398|NCT03726320|101377809|FG000|NOT COMPLETED|Overall Study||12||
48426399|NCT03726320|101377810|FG001|NOT COMPLETED|Overall Study||8||
48426400|NCT03726320|101377811|FG002|NOT COMPLETED|Overall Study||1||
48426401|NCT01855919|101377812|FG000|STARTED|Overall Study||232||
48426402|NCT01855919|101377813|FG001|STARTED|Overall Study||226||
48426403|NCT01855919|101377812|FG000|Received at Least 1 Dose of Study Drug|Overall Study||232||
48426404|NCT01855919|101377813|FG001|Received at Least 1 Dose of Study Drug|Overall Study||226||
48426405|NCT01855919|101377812|FG000|COMPLETED|Overall Study||209||
48426406|NCT01855919|101377813|FG001|COMPLETED|Overall Study||200||
48426407|NCT01855919|101377812|FG000|NOT COMPLETED|Overall Study||23||
48426408|NCT01855919|101377813|FG001|NOT COMPLETED|Overall Study||26||
48426409|NCT00135694|101377814|FG000|STARTED|Overall Study||180||
48426410|NCT00135694|101377815|FG001|STARTED|Overall Study||77||
48426411|NCT00135694|101377816|FG002|STARTED|Overall Study||18||
48426412|NCT00135694|101377814|FG000|COMPLETED|Overall Study||0||
48426413|NCT00135694|101377815|FG001|COMPLETED|Overall Study||56||
48426414|NCT00135694|101377816|FG002|COMPLETED|Overall Study||11||
48426415|NCT00135694|101377814|FG000|NOT COMPLETED|Overall Study||180||
48426416|NCT00135694|101377815|FG001|NOT COMPLETED|Overall Study||21||
48426417|NCT00135694|101377816|FG002|NOT COMPLETED|Overall Study||7||
48426418|NCT01396434|101377817|FG000|STARTED|Overall Study||2817||
48426419|NCT01396434|101377818|FG001|STARTED|Overall Study||175||
48426420|NCT01396434|101377819|FG002|STARTED|Overall Study||14||
48426421|NCT01396434|101377817|FG000|COMPLETED|Overall Study||2806||
48426422|NCT01396434|101377818|FG001|COMPLETED|Overall Study||175||
48426423|NCT01396434|101377819|FG002|COMPLETED|Overall Study||14||
48426424|NCT01396434|101377817|FG000|NOT COMPLETED|Overall Study||11||
48426425|NCT01396434|101377818|FG001|NOT COMPLETED|Overall Study||0||
48426426|NCT01396434|101377819|FG002|NOT COMPLETED|Overall Study||0||
48426427|NCT02516605|101377820|FG000|STARTED|Overall Study||11||
48426428|NCT02516605|101377821|FG001|STARTED|Overall Study||9||
48426429|NCT02516605|101377822|FG002|STARTED|Overall Study||12||
48426430|NCT02516605|101377823|FG003|STARTED|Overall Study||8||
48426431|NCT02516605|101377824|FG004|STARTED|Overall Study||21||
48426432|NCT02516605|101377820|FG000|COMPLETED|Overall Study||11||
48426433|NCT02516605|101377821|FG001|COMPLETED|Overall Study||9||
48426434|NCT02516605|101377822|FG002|COMPLETED|Overall Study||12||
48426435|NCT02516605|101377823|FG003|COMPLETED|Overall Study||7||
48426436|NCT02516605|101377824|FG004|COMPLETED|Overall Study||20||
48426437|NCT02516605|101377820|FG000|NOT COMPLETED|Overall Study||0||
48426438|NCT02516605|101377821|FG001|NOT COMPLETED|Overall Study||0||
48426439|NCT02516605|101377822|FG002|NOT COMPLETED|Overall Study||0||
48426440|NCT02516605|101377823|FG003|NOT COMPLETED|Overall Study||1||
48426441|NCT02516605|101377824|FG004|NOT COMPLETED|Overall Study||1||
48426442|NCT00561795|101377825|FG000|STARTED|Overall Study||6||
48426443|NCT00561795|101377826|FG001|STARTED|Overall Study||6||
48426444|NCT00561795|101377827|FG002|STARTED|Overall Study||0||
48426445|NCT00561795|101377828|FG003|STARTED|Overall Study||0||
48426446|NCT00561795|101377825|FG000|COMPLETED|Overall Study||2||
48426447|NCT00561795|101377826|FG001|COMPLETED|Overall Study||0||
48426448|NCT00561795|101377827|FG002|COMPLETED|Overall Study||0||
48426449|NCT00561795|101377828|FG003|COMPLETED|Overall Study||0||
48426450|NCT00561795|101377825|FG000|NOT COMPLETED|Overall Study||4||
48426451|NCT00561795|101377826|FG001|NOT COMPLETED|Overall Study||6||
48426452|NCT00561795|101377827|FG002|NOT COMPLETED|Overall Study||0||
48426453|NCT00561795|101377828|FG003|NOT COMPLETED|Overall Study||0||
48426454|NCT03359811|101377829|FG000|STARTED|Overall Study||35||
48426455|NCT03359811|101377830|FG001|STARTED|Overall Study||35||
48426456|NCT03359811|101377829|FG000|COMPLETED|Overall Study||33||
48426457|NCT03359811|101377830|FG001|COMPLETED|Overall Study||35||
48426458|NCT03359811|101377829|FG000|NOT COMPLETED|Overall Study||2||
48426459|NCT03359811|101377830|FG001|NOT COMPLETED|Overall Study||0||
48426460|NCT01233076|101377831|FG000|STARTED|Period 1, One Week||30||
48426461|NCT01233076|101377832|FG001|STARTED|Period 1, One Week||30||
48426462|NCT01233076|101377831|FG000|COMPLETED|Period 1, One Week||30||
48426463|NCT01233076|101377832|FG001|COMPLETED|Period 1, One Week||30||
48426464|NCT01233076|101377831|FG000|NOT COMPLETED|Period 1, One Week||0||
48426465|NCT01233076|101377832|FG001|NOT COMPLETED|Period 1, One Week||0||
48426466|NCT01233076|101377831|FG000|STARTED|Period 2, One Week||30||
48426467|NCT01233076|101377832|FG001|STARTED|Period 2, One Week||30||
48426468|NCT01233076|101377831|FG000|COMPLETED|Period 2, One Week||29||
48426469|NCT01233076|101377832|FG001|COMPLETED|Period 2, One Week||30||
48426470|NCT01233076|101377831|FG000|NOT COMPLETED|Period 2, One Week||1||
48426471|NCT01233076|101377832|FG001|NOT COMPLETED|Period 2, One Week||0||
48426472|NCT03053180|101377833|FG000|STARTED|Overall Study||60||
48426473|NCT03053180|101377833|FG000|COMPLETED|Overall Study||59||
48426474|NCT03053180|101377833|FG000|NOT COMPLETED|Overall Study||1||
48426475|NCT01277757|101377834|FG000|STARTED|Overall Study||30||
48426476|NCT01277757|101377834|FG000|COMPLETED|Overall Study||28||
48426477|NCT01277757|101377834|FG000|NOT COMPLETED|Overall Study||2||
48426478|NCT00602043|101377835|FG000|STARTED|Overall Study||20||
48426479|NCT00602043|101377835|FG000|COMPLETED|Overall Study||15||
48426480|NCT00602043|101377835|FG000|NOT COMPLETED|Overall Study||5||
48426481|NCT02260804|101377836|FG000|STARTED|Induction Study Period||130||
48426482|NCT02260804|101377837|FG001|STARTED|Induction Study Period||128||
48426483|NCT02260804|101377836|FG000|COMPLETED|Induction Study Period||128||
48426484|NCT02260804|101377837|FG001|COMPLETED|Induction Study Period||128||
48426485|NCT02260804|101377836|FG000|NOT COMPLETED|Induction Study Period||2||
48426486|NCT02260804|101377837|FG001|NOT COMPLETED|Induction Study Period||0||
48426487|NCT02260804|101377836|FG000|STARTED|1st Year of the Maintenance Period (MP1)||123||
48426488|NCT02260804|101377837|FG001|STARTED|1st Year of the Maintenance Period (MP1)||120||
48426489|NCT02260804|101377836|FG000|COMPLETED|1st Year of the Maintenance Period (MP1)||111||
48426490|NCT02260804|101377837|FG001|COMPLETED|1st Year of the Maintenance Period (MP1)||105||
48426491|NCT02260804|101377836|FG000|NOT COMPLETED|1st Year of the Maintenance Period (MP1)||12||
48426492|NCT02260804|101377837|FG001|NOT COMPLETED|1st Year of the Maintenance Period (MP1)||15||
48426493|NCT02260804|101377836|FG000|STARTED|2nd Year of the Maintenance Period (MP2)||110||
48426494|NCT02260804|101377837|FG001|STARTED|2nd Year of the Maintenance Period (MP2)||103||
48426495|NCT02260804|101377836|FG000|COMPLETED|2nd Year of the Maintenance Period (MP2)||101||
48426496|NCT02260804|101377837|FG001|COMPLETED|2nd Year of the Maintenance Period (MP2)||97||
48426497|NCT02260804|101377836|FG000|NOT COMPLETED|2nd Year of the Maintenance Period (MP2)||9||
48426498|NCT02260804|101377837|FG001|NOT COMPLETED|2nd Year of the Maintenance Period (MP2)||6||
48426499|NCT04540627|101377838|FG000|STARTED|Open-label Treatment: PK Sentinel||6||
48426500|NCT04540627|101377839|FG001|STARTED|Open-label Treatment: PK Sentinel||0||
48426501|NCT04540627|101377840|FG002|STARTED|Open-label Treatment: PK Sentinel||0||
48426502|NCT04540627|101377838|FG000|COMPLETED|Open-label Treatment: PK Sentinel||6||
48426503|NCT04540627|101377839|FG001|COMPLETED|Open-label Treatment: PK Sentinel||0||
48426504|NCT04540627|101377840|FG002|COMPLETED|Open-label Treatment: PK Sentinel||0||
48426505|NCT04540627|101377838|FG000|NOT COMPLETED|Open-label Treatment: PK Sentinel||0||
48426506|NCT04540627|101377839|FG001|NOT COMPLETED|Open-label Treatment: PK Sentinel||0||
48426507|NCT04540627|101377840|FG002|NOT COMPLETED|Open-label Treatment: PK Sentinel||0||
48426508|NCT04540627|101377838|FG000|STARTED|Double-blind Treatment: Viral Challenge||0||
48426509|NCT04540627|101377839|FG001|STARTED|Double-blind Treatment: Viral Challenge||25||
48426510|NCT04540627|101377840|FG002|STARTED|Double-blind Treatment: Viral Challenge||25||
48426511|NCT04540627|101377838|FG000|COMPLETED|Double-blind Treatment: Viral Challenge||0||
48426512|NCT04540627|101377839|FG001|COMPLETED|Double-blind Treatment: Viral Challenge||25||
48426513|NCT04540627|101377840|FG002|COMPLETED|Double-blind Treatment: Viral Challenge||25||
48426514|NCT04540627|101377838|FG000|NOT COMPLETED|Double-blind Treatment: Viral Challenge||0||
48426515|NCT04540627|101377839|FG001|NOT COMPLETED|Double-blind Treatment: Viral Challenge||0||
48426516|NCT04540627|101377840|FG002|NOT COMPLETED|Double-blind Treatment: Viral Challenge||0||
48426517|NCT00967473|101377841|FG000|STARTED|Overall Study||15||
48426518|NCT00967473|101377841|FG000|COMPLETED|Overall Study||15||
48426519|NCT00967473|101377841|FG000|NOT COMPLETED|Overall Study||0||
48426520|NCT03306589|101377842|FG000|STARTED|Part 1 (69 Days)||2||
48426521|NCT03306589|101377843|FG001|STARTED|Part 1 (69 Days)||4||
48426522|NCT03306589|101377844|FG002|STARTED|Part 1 (69 Days)||2||
48426523|NCT03306589|101377845|FG003|STARTED|Part 1 (69 Days)||4||
48426524|NCT03306589|101377846|FG004|STARTED|Part 1 (69 Days)||0||
48426525|NCT03306589|101377847|FG005|STARTED|Part 1 (69 Days)||0||
48426526|NCT03306589|101377842|FG000|COMPLETED|Part 1 (69 Days)||2||
48426527|NCT03306589|101377843|FG001|COMPLETED|Part 1 (69 Days)||4||
48426528|NCT03306589|101377844|FG002|COMPLETED|Part 1 (69 Days)||2||
48426529|NCT03306589|101377845|FG003|COMPLETED|Part 1 (69 Days)||4||
48426530|NCT03306589|101377846|FG004|COMPLETED|Part 1 (69 Days)||0||
48426531|NCT03306589|101377847|FG005|COMPLETED|Part 1 (69 Days)||0||
48426532|NCT03306589|101377842|FG000|NOT COMPLETED|Part 1 (69 Days)||0||
48426533|NCT03306589|101377843|FG001|NOT COMPLETED|Part 1 (69 Days)||0||
48426534|NCT03306589|101377844|FG002|NOT COMPLETED|Part 1 (69 Days)||0||
48426535|NCT03306589|101377845|FG003|NOT COMPLETED|Part 1 (69 Days)||0||
48426536|NCT03306589|101377846|FG004|NOT COMPLETED|Part 1 (69 Days)||0||
48426537|NCT03306589|101377847|FG005|NOT COMPLETED|Part 1 (69 Days)||0||
48426538|NCT03306589|101377842|FG000|STARTED|Part 2 (69 Days)||0||
48426539|NCT03306589|101377843|FG001|STARTED|Part 2 (69 Days)||0||
48426540|NCT03306589|101377844|FG002|STARTED|Part 2 (69 Days)||0||
48426541|NCT03306589|101377845|FG003|STARTED|Part 2 (69 Days)||0||
48426542|NCT03306589|101377846|FG004|STARTED|Part 2 (69 Days)||0||
48426543|NCT03306589|101377847|FG005|STARTED|Part 2 (69 Days)||0||
48426544|NCT03306589|101377842|FG000|COMPLETED|Part 2 (69 Days)||0||
48426545|NCT03306589|101377843|FG001|COMPLETED|Part 2 (69 Days)||0||
48426546|NCT03306589|101377844|FG002|COMPLETED|Part 2 (69 Days)||0||
48426547|NCT03306589|101377845|FG003|COMPLETED|Part 2 (69 Days)||0||
48426548|NCT03306589|101377846|FG004|COMPLETED|Part 2 (69 Days)||0||
48426549|NCT03306589|101377847|FG005|COMPLETED|Part 2 (69 Days)||0||
48426550|NCT03306589|101377842|FG000|NOT COMPLETED|Part 2 (69 Days)||0||
48426551|NCT03306589|101377843|FG001|NOT COMPLETED|Part 2 (69 Days)||0||
48426552|NCT03306589|101377844|FG002|NOT COMPLETED|Part 2 (69 Days)||0||
48426553|NCT03306589|101377845|FG003|NOT COMPLETED|Part 2 (69 Days)||0||
48426554|NCT03306589|101377846|FG004|NOT COMPLETED|Part 2 (69 Days)||0||
48426555|NCT03306589|101377847|FG005|NOT COMPLETED|Part 2 (69 Days)||0||
48426556|NCT00542321|101377848|FG000|STARTED|Overall Study||8||
48426557|NCT00542321|101377849|FG001|STARTED|Overall Study||8||
48426558|NCT00542321|101377848|FG000|COMPLETED|Overall Study||8||
48426559|NCT00542321|101377849|FG001|COMPLETED|Overall Study||7||
48426560|NCT00542321|101377848|FG000|NOT COMPLETED|Overall Study||0||
48426561|NCT00542321|101377849|FG001|NOT COMPLETED|Overall Study||1||
48426562|NCT02406586|101377850|FG000|STARTED|Overall Study||12||
48426563|NCT02406586|101377851|FG001|STARTED|Overall Study||12||
48426564|NCT02406586|101377852|FG002|STARTED|Overall Study||12||
48426565|NCT02406586|101377850|FG000|COMPLETED|Overall Study||11||
48426566|NCT02406586|101377851|FG001|COMPLETED|Overall Study||8||
48426567|NCT02406586|101377852|FG002|COMPLETED|Overall Study||10||
48426568|NCT02406586|101377850|FG000|NOT COMPLETED|Overall Study||1||
48426569|NCT02406586|101377851|FG001|NOT COMPLETED|Overall Study||4||
48426570|NCT02406586|101377852|FG002|NOT COMPLETED|Overall Study||2||
48426571|NCT02467504|101377853|FG000|STARTED|Overall Study||23||
48426572|NCT02467504|101377854|FG001|STARTED|Overall Study||24||
48426573|NCT02467504|101377853|FG000|COMPLETED|Overall Study||17||
48426574|NCT02467504|101377854|FG001|COMPLETED|Overall Study||23||
48426575|NCT02467504|101377853|FG000|NOT COMPLETED|Overall Study||6||
48426576|NCT02467504|101377854|FG001|NOT COMPLETED|Overall Study||1||
48426577|NCT00545974|101377855|FG000|STARTED|Overall Study||39||
48426578|NCT00545974|101377856|FG001|STARTED|Overall Study||42||
48426579|NCT00545974|101377855|FG000|COMPLETED|Overall Study||37||
48426580|NCT00545974|101377856|FG001|COMPLETED|Overall Study||39||
48426581|NCT00545974|101377855|FG000|NOT COMPLETED|Overall Study||2||
48426582|NCT00545974|101377856|FG001|NOT COMPLETED|Overall Study||3||
48426583|NCT01016912|101377857|FG000|STARTED|End of Treatment Period||8||
48426584|NCT01016912|101377858|FG001|STARTED|End of Treatment Period||9||
48426585|NCT01016912|101377859|FG002|STARTED|End of Treatment Period||10||
48426586|NCT01016912|101377860|FG003|STARTED|End of Treatment Period||9||
48426587|NCT01016912|101377861|FG004|STARTED|End of Treatment Period||9||
48426588|NCT01016912|101377857|FG000|Received Treatment|End of Treatment Period||8||
48426589|NCT01016912|101377858|FG001|Received Treatment|End of Treatment Period||9||
48426590|NCT01016912|101377859|FG002|Received Treatment|End of Treatment Period||10||
48426591|NCT01016912|101377860|FG003|Received Treatment|End of Treatment Period||9||
48426592|NCT01016912|101377861|FG004|Received Treatment|End of Treatment Period||9||
48426593|NCT01016912|101377857|FG000|COMPLETED|End of Treatment Period||8||
48426594|NCT01016912|101377858|FG001|COMPLETED|End of Treatment Period||6||
48426595|NCT01016912|101377859|FG002|COMPLETED|End of Treatment Period||9||
48426596|NCT01016912|101377860|FG003|COMPLETED|End of Treatment Period||5||
48426597|NCT01016912|101377861|FG004|COMPLETED|End of Treatment Period||5||
48426598|NCT01016912|101377857|FG000|NOT COMPLETED|End of Treatment Period||0||
48426599|NCT01016912|101377858|FG001|NOT COMPLETED|End of Treatment Period||3||
48426600|NCT01016912|101377859|FG002|NOT COMPLETED|End of Treatment Period||1||
48426601|NCT01016912|101377860|FG003|NOT COMPLETED|End of Treatment Period||4||
48426602|NCT01016912|101377861|FG004|NOT COMPLETED|End of Treatment Period||4||
48426603|NCT01016912|101377857|FG000|STARTED|Follow-up Period||8||
48426604|NCT01016912|101377858|FG001|STARTED|Follow-up Period||9||
48426605|NCT01016912|101377859|FG002|STARTED|Follow-up Period||10||
48426606|NCT01016912|101377860|FG003|STARTED|Follow-up Period||9||
48426607|NCT01016912|101377861|FG004|STARTED|Follow-up Period||9||
48426608|NCT01016912|101377857|FG000|COMPLETED|Follow-up Period||8||
48426609|NCT01016912|101377858|FG001|COMPLETED|Follow-up Period||9||
48426610|NCT01016912|101377859|FG002|COMPLETED|Follow-up Period||9||
48426611|NCT01016912|101377860|FG003|COMPLETED|Follow-up Period||8||
48426612|NCT01016912|101377861|FG004|COMPLETED|Follow-up Period||9||
48426613|NCT01016912|101377857|FG000|NOT COMPLETED|Follow-up Period||0||
48426614|NCT01016912|101377858|FG001|NOT COMPLETED|Follow-up Period||0||
48426615|NCT01016912|101377859|FG002|NOT COMPLETED|Follow-up Period||1||
48426616|NCT01016912|101377860|FG003|NOT COMPLETED|Follow-up Period||1||
48426617|NCT01016912|101377861|FG004|NOT COMPLETED|Follow-up Period||0||
48426618|NCT02927990|101377862|FG000|STARTED|Overall Study||80||
48426619|NCT02927990|101377862|FG000|COMPLETED|Overall Study||24||
48426620|NCT02927990|101377862|FG000|NOT COMPLETED|Overall Study||56||
48426621|NCT00985114|101377863|FG000|STARTED|Overall Study||34||
48426622|NCT00985114|101377864|FG001|STARTED|Overall Study||39||
48426623|NCT00985114|101377863|FG000|Diet + Lifestyle Counseling Cross-over|Overall Study||0||
48426624|NCT00985114|101377864|FG001|Diet + Lifestyle Counseling Cross-over|Overall Study||28||
48426625|NCT00985114|101377863|FG000|COMPLETED|Overall Study||33||
48426626|NCT00985114|101377864|FG001|COMPLETED|Overall Study||37||
48426627|NCT00985114|101377863|FG000|NOT COMPLETED|Overall Study||1||
48426628|NCT00985114|101377864|FG001|NOT COMPLETED|Overall Study||2||
48426629|NCT01083121|101377865|FG000|STARTED|Overall Study||1779||
48426630|NCT01083121|101377865|FG000|COMPLETED|Overall Study||1698||
48426631|NCT01083121|101377865|FG000|NOT COMPLETED|Overall Study||81||
48426632|NCT02680158|101377866|FG000|STARTED|Overall Study||8||8
48426633|NCT02680158|101377867|FG001|STARTED|Overall Study||8||8
48426634|NCT02680158|101377868|FG002|STARTED|Overall Study||8||8
48426635|NCT02680158|101377869|FG003|STARTED|Overall Study||8||8
48426636|NCT02680158|101377870|FG004|STARTED|Overall Study||8||8
48426637|NCT02680158|101377871|FG005|STARTED|Overall Study||8||8
48426638|NCT02680158|101377866|FG000|COMPLETED|Overall Study||8||8
48426639|NCT02680158|101377867|FG001|COMPLETED|Overall Study||8||8
48426640|NCT02680158|101377868|FG002|COMPLETED|Overall Study||8||8
48426641|NCT02680158|101377869|FG003|COMPLETED|Overall Study||8||8
48426642|NCT02680158|101377870|FG004|COMPLETED|Overall Study||8||8
48426643|NCT02680158|101377871|FG005|COMPLETED|Overall Study||8||8
48426644|NCT02680158|101377866|FG000|NOT COMPLETED|Overall Study||0||0
48426645|NCT02680158|101377867|FG001|NOT COMPLETED|Overall Study||0||0
48426646|NCT02680158|101377868|FG002|NOT COMPLETED|Overall Study||0||0
48426647|NCT02680158|101377869|FG003|NOT COMPLETED|Overall Study||0||0
48426648|NCT02680158|101377870|FG004|NOT COMPLETED|Overall Study||0||0
48426649|NCT02680158|101377871|FG005|NOT COMPLETED|Overall Study||0||0
48426650|NCT00859495|101380533|FG000|STARTED|Overall Study||9||
48426651|NCT00859495|101380533|FG000|COMPLETED|Overall Study||9||
48426652|NCT00859495|101380533|FG000|NOT COMPLETED|Overall Study||0||
48426653|NCT02988115|101380534|FG000|STARTED|Overall Study||234||
48426654|NCT02988115|101380535|FG001|STARTED|Overall Study||111||
48426655|NCT02988115|101380534|FG000|COMPLETED|Overall Study||220||
48426656|NCT02988115|101380535|FG001|COMPLETED|Overall Study||107||
48426657|NCT02988115|101380534|FG000|NOT COMPLETED|Overall Study||14||
48426658|NCT02988115|101380535|FG001|NOT COMPLETED|Overall Study||4||
48426659|NCT01811004|101380536|FG000|STARTED|Overall Study||9||
48426660|NCT01811004|101380537|FG001|STARTED|Overall Study||8||
48426661|NCT01811004|101380536|FG000|COMPLETED|Overall Study||8||
48426662|NCT01811004|101380537|FG001|COMPLETED|Overall Study||5||
48426663|NCT01811004|101380536|FG000|NOT COMPLETED|Overall Study||1||
48426664|NCT01811004|101380537|FG001|NOT COMPLETED|Overall Study||3||
48426665|NCT01407068|101380538|FG000|STARTED|Overall Study||60||
48426666|NCT01407068|101380538|FG000|COMPLETED|Overall Study||60||
48426667|NCT01407068|101380538|FG000|NOT COMPLETED|Overall Study||0||
48426668|NCT01928186|101380539|FG000|STARTED|Overall Study||28||
48426669|NCT01928186|101380539|FG000|COMPLETED|Overall Study||28||
48426670|NCT01928186|101380539|FG000|NOT COMPLETED|Overall Study||0||
48426671|NCT00348348|101380540|FG000|STARTED|Overall Study||579||
48426672|NCT00348348|101380541|FG001|STARTED|Overall Study||582||
48426673|NCT00348348|101380540|FG000|COMPLETED|Overall Study||554||
48426674|NCT00348348|101380541|FG001|COMPLETED|Overall Study||555||
48426675|NCT00348348|101380540|FG000|NOT COMPLETED|Overall Study||25||
48426676|NCT00348348|101380541|FG001|NOT COMPLETED|Overall Study||27||
48426677|NCT04225026|101380542|FG000|STARTED|Overall Study||39|Safety analysis Population: This population included all subjects who received at least 1 dose of study medication.|
48426678|NCT04225026|101380542|FG000|Primary Efficacy Population|Overall Study||35||
48426679|NCT04225026|101380542|FG000|Per Protocol Population|Overall Study||29|The Per Protocol Population included those subjects that completed chemoradiotherapy and at least 5 weeks of GC4419|
48426680|NCT04225026|101380542|FG000|COMPLETED|Overall Study||15||
48426681|NCT04225026|101380542|FG000|NOT COMPLETED|Overall Study||24||
48426682|NCT02899884|101380543|FG000|STARTED|Overall Study||3765||
48426683|NCT02899884|101380543|FG000|COMPLETED|Overall Study||3765||
48426684|NCT02899884|101380543|FG000|NOT COMPLETED|Overall Study||0||
48426685|NCT01256424|101380544|FG000|STARTED|Overall Study||65||
48426686|NCT01256424|101380545|FG001|STARTED|Overall Study||67||
48426687|NCT01256424|101380546|FG002|STARTED|Overall Study||62||
48426688|NCT01256424|101380547|FG003|STARTED|Overall Study||68||
48426689|NCT01256424|101380544|FG000|COMPLETED|Overall Study||56||
48426690|NCT01256424|101380545|FG001|COMPLETED|Overall Study||59||
48426691|NCT01256424|101380546|FG002|COMPLETED|Overall Study||55||
48426692|NCT01256424|101380547|FG003|COMPLETED|Overall Study||61||
48426693|NCT01256424|101380544|FG000|NOT COMPLETED|Overall Study||9||
48426694|NCT01256424|101380545|FG001|NOT COMPLETED|Overall Study||8||
48426695|NCT01256424|101380546|FG002|NOT COMPLETED|Overall Study||7||
48426696|NCT01256424|101380547|FG003|NOT COMPLETED|Overall Study||7||
48426697|NCT00779506|101380548|FG000|STARTED|Overall Study||96||
48426698|NCT00779506|101380548|FG000|Enrolled|Overall Study||96||
48426699|NCT00779506|101380548|FG000|Screen Failed|Overall Study||2||
48426700|NCT00779506|101380548|FG000|Assigned|Overall Study||94||
48426701|NCT00779506|101380548|FG000|MITT|Overall Study||89||
48426702|NCT00779506|101380548|FG000|Treatment Complete|Overall Study||67||
48426703|NCT00779506|101380548|FG000|Withdrawal Treatment|Overall Study||27||
48426704|NCT00779506|101380548|FG000|COMPLETED|Overall Study||67||
48426705|NCT00779506|101380548|FG000|NOT COMPLETED|Overall Study||29||
48426706|NCT01014442|101380549|FG000|STARTED|Overall Study||33||
48426707|NCT01014442|101380550|FG001|STARTED|Overall Study||35||
48426708|NCT01014442|101380549|FG000|COMPLETED|Overall Study||26||
48426709|NCT01014442|101380550|FG001|COMPLETED|Overall Study||16||
48426710|NCT01014442|101380549|FG000|NOT COMPLETED|Overall Study||7||
48426711|NCT01014442|101380550|FG001|NOT COMPLETED|Overall Study||19||
48426712|NCT02506101|101380551|FG000|STARTED|Overall Study||2||
48426713|NCT02506101|101380552|FG001|STARTED|Overall Study||0||
48426714|NCT02506101|101380551|FG000|COMPLETED|Overall Study||0||
48426715|NCT02506101|101380552|FG001|COMPLETED|Overall Study||0||
48426716|NCT02506101|101380551|FG000|NOT COMPLETED|Overall Study||2||
48426717|NCT02506101|101380552|FG001|NOT COMPLETED|Overall Study||0||
48426718|NCT03287960|101380553|FG000|STARTED|Titration Period (2 to 12 Weeks)||15||
48426719|NCT03287960|101380553|FG000|COMPLETED|Titration Period (2 to 12 Weeks)||15||
48426720|NCT03287960|101380553|FG000|NOT COMPLETED|Titration Period (2 to 12 Weeks)||0||
48426721|NCT03287960|101380553|FG000|STARTED|Open-Label Period (10 Weeks)||15||
48426722|NCT03287960|101380553|FG000|COMPLETED|Open-Label Period (10 Weeks)||14||
48426723|NCT03287960|101380553|FG000|NOT COMPLETED|Open-Label Period (10 Weeks)||1||
48426724|NCT03287960|101380553|FG000|STARTED|Double-Blind Withdrawal Period (8 Weeks)||14||
48426725|NCT03287960|101380553|FG000|COMPLETED|Double-Blind Withdrawal Period (8 Weeks)||14||
48426726|NCT03287960|101380553|FG000|NOT COMPLETED|Double-Blind Withdrawal Period (8 Weeks)||0||
48426727|NCT03287960|101380553|FG000|STARTED|Open-Label Period (32 Weeks)||14||
48426728|NCT03287960|101380553|FG000|COMPLETED|Open-Label Period (32 Weeks)||13||
48426729|NCT03287960|101380553|FG000|NOT COMPLETED|Open-Label Period (32 Weeks)||1||
48426730|NCT01508221|101380554|FG000|STARTED|Overall Study||31||
48426731|NCT01508221|101380554|FG000|COMPLETED|Overall Study||31||
48426732|NCT01508221|101380554|FG000|NOT COMPLETED|Overall Study||0||
48426733|NCT01858701|101380555|FG000|STARTED|Period 1, First 30 Days of Wear||20||
48426734|NCT01858701|101380556|FG001|STARTED|Period 1, First 30 Days of Wear||20||
48426735|NCT01858701|101380555|FG000|COMPLETED|Period 1, First 30 Days of Wear||20||
48426736|NCT01858701|101380556|FG001|COMPLETED|Period 1, First 30 Days of Wear||19||
48426737|NCT01858701|101380555|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||0||
48426738|NCT01858701|101380556|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||1||
48426739|NCT01858701|101380555|FG000|STARTED|Washout Period, 1-13 Days||20||
48426740|NCT01858701|101380556|FG001|STARTED|Washout Period, 1-13 Days||19||
48426741|NCT01858701|101380555|FG000|COMPLETED|Washout Period, 1-13 Days||18||
48426742|NCT01858701|101380556|FG001|COMPLETED|Washout Period, 1-13 Days||17||
48426743|NCT01858701|101380555|FG000|NOT COMPLETED|Washout Period, 1-13 Days||2||
48426744|NCT01858701|101380556|FG001|NOT COMPLETED|Washout Period, 1-13 Days||2||
48426745|NCT01858701|101380555|FG000|STARTED|Period 2, Second 30 Days of Wear||18||
48426746|NCT01858701|101380556|FG001|STARTED|Period 2, Second 30 Days of Wear||17||
48426747|NCT01858701|101380555|FG000|COMPLETED|Period 2, Second 30 Days of Wear||18||
48426748|NCT01858701|101380556|FG001|COMPLETED|Period 2, Second 30 Days of Wear||16||
48426749|NCT01858701|101380555|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||0||
48426750|NCT01858701|101380556|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||1||
48426751|NCT00423137|101380557|FG000|STARTED|Overall Study||11||
48426752|NCT00423137|101380558|FG001|STARTED|Overall Study||12||
48426753|NCT00423137|101380559|FG002|STARTED|Overall Study||13||
48426754|NCT00423137|101380560|FG003|STARTED|Overall Study||12||
48426755|NCT00423137|101380557|FG000|COMPLETED|Overall Study||10||
48426756|NCT00423137|101380558|FG001|COMPLETED|Overall Study||12||
48426757|NCT00423137|101380559|FG002|COMPLETED|Overall Study||7||
48426758|NCT00423137|101380560|FG003|COMPLETED|Overall Study||10||
48426759|NCT00423137|101380557|FG000|NOT COMPLETED|Overall Study||1||
48426760|NCT00423137|101380558|FG001|NOT COMPLETED|Overall Study||0||
48426761|NCT00423137|101380559|FG002|NOT COMPLETED|Overall Study||6||
48426762|NCT00423137|101380560|FG003|NOT COMPLETED|Overall Study||2||
48426763|NCT00953849|101380561|FG000|STARTED|Overall Study||6||
48426764|NCT00953849|101380562|FG001|STARTED|Overall Study||6||
48426765|NCT00953849|101380563|FG002|STARTED|Overall Study||4||
48426766|NCT00953849|101380564|FG003|STARTED|Overall Study||5||
48426767|NCT00953849|101380561|FG000|COMPLETED|Overall Study||6||
48426768|NCT00953849|101380562|FG001|COMPLETED|Overall Study||6||
48426769|NCT00953849|101380563|FG002|COMPLETED|Overall Study||4||
48426770|NCT00953849|101380564|FG003|COMPLETED|Overall Study||5||
48426771|NCT00953849|101380561|FG000|NOT COMPLETED|Overall Study||0||
48426772|NCT00953849|101380562|FG001|NOT COMPLETED|Overall Study||0||
48426773|NCT00953849|101380563|FG002|NOT COMPLETED|Overall Study||0||
48426774|NCT00953849|101380564|FG003|NOT COMPLETED|Overall Study||0||
48426775|NCT01684930|101380565|FG000|STARTED|Overall Study||12||
48426776|NCT01684930|101380566|FG001|STARTED|Overall Study||14||
48426777|NCT01684930|101380565|FG000|COMPLETED|Overall Study||9||
48426778|NCT01684930|101380566|FG001|COMPLETED|Overall Study||13||
48426779|NCT01684930|101380565|FG000|NOT COMPLETED|Overall Study||3||
48426780|NCT01684930|101380566|FG001|NOT COMPLETED|Overall Study||1||
48426781|NCT00772031|101380567|FG000|STARTED|Overall Study||96||
48426782|NCT00772031|101380568|FG001|STARTED|Overall Study||95||
48426783|NCT00772031|101380567|FG000|COMPLETED|Overall Study||64||
48426784|NCT00772031|101380568|FG001|COMPLETED|Overall Study||52||
48426785|NCT00772031|101380567|FG000|NOT COMPLETED|Overall Study||32||
48426786|NCT00772031|101380568|FG001|NOT COMPLETED|Overall Study||43||
48426787|NCT02304484|101380569|FG000|STARTED|Overall Study||770||
48426788|NCT02304484|101380569|FG000|COMPLETED|Overall Study||745||
48426789|NCT02304484|101380569|FG000|NOT COMPLETED|Overall Study||25||
48426790|NCT00438815|101380570|FG000|STARTED|Overall Study||113||
48426791|NCT00438815|101380570|FG000|COMPLETED|Overall Study||43||
48426792|NCT00438815|101380570|FG000|NOT COMPLETED|Overall Study||70||
48426793|NCT03427931|101380571|FG000|STARTED|Overall Study||7||
48426794|NCT03427931|101380571|FG000|COMPLETED|Overall Study||5||
48426795|NCT03427931|101380571|FG000|NOT COMPLETED|Overall Study||2||
48426796|NCT03099096|101380572|FG000|STARTED|Overall Study||159||
48426797|NCT03099096|101380572|FG000|COMPLETED|Overall Study||157||
48426798|NCT03099096|101380572|FG000|NOT COMPLETED|Overall Study||2||
48426799|NCT01101321|101380573|FG000|STARTED|Period 1||30||
48426800|NCT01101321|101380574|FG001|STARTED|Period 1||28||
48426801|NCT01101321|101380573|FG000|COMPLETED|Period 1||26||
48426802|NCT01101321|101380574|FG001|COMPLETED|Period 1||24||
48426803|NCT01101321|101380573|FG000|NOT COMPLETED|Period 1||4||
48426804|NCT01101321|101380574|FG001|NOT COMPLETED|Period 1||4||
48426805|NCT01101321|101380573|FG000|STARTED|Period 2||26||
48426806|NCT01101321|101380574|FG001|STARTED|Period 2||24||
48426807|NCT01101321|101380573|FG000|COMPLETED|Period 2||26||
48426808|NCT01101321|101380574|FG001|COMPLETED|Period 2||24||
48426809|NCT01101321|101380573|FG000|NOT COMPLETED|Period 2||0||
48426810|NCT01101321|101380574|FG001|NOT COMPLETED|Period 2||0||
48426811|NCT01430559|101380575|FG000|STARTED|Overall Study||146||
48426812|NCT01430559|101380576|FG001|STARTED|Overall Study||147||
48426813|NCT01430559|101380575|FG000|Treated|Overall Study||143||
48426814|NCT01430559|101380576|FG001|Treated|Overall Study||144||
48426815|NCT01430559|101380575|FG000|COMPLETED|Overall Study||126||
48426816|NCT01430559|101380576|FG001|COMPLETED|Overall Study||135||
48426817|NCT01430559|101380575|FG000|NOT COMPLETED|Overall Study||20||
48426818|NCT01430559|101380576|FG001|NOT COMPLETED|Overall Study||12||
48426819|NCT00561912|101380577|FG000|STARTED|Overall Study||2||
48426820|NCT00561912|101380577|FG000|COMPLETED|Overall Study||1||
48426821|NCT00561912|101380577|FG000|NOT COMPLETED|Overall Study||1||
48426822|NCT01710709|101380578|FG000|STARTED|Overall Study||464||
48426823|NCT01710709|101380578|FG000|COMPLETED|Overall Study||291||
48426824|NCT01710709|101380578|FG000|NOT COMPLETED|Overall Study||173||
48426825|NCT03795233|101380579|FG000|STARTED|Overall Study||4||
48426826|NCT03795233|101380580|FG001|STARTED|Overall Study||1||
48426827|NCT03795233|101380579|FG000|COMPLETED|Overall Study||0||
48426828|NCT03795233|101380580|FG001|COMPLETED|Overall Study||0||
48426829|NCT03795233|101380579|FG000|NOT COMPLETED|Overall Study||4||
48426830|NCT03795233|101380580|FG001|NOT COMPLETED|Overall Study||1||
48426831|NCT02615158|101380581|FG000|STARTED|Overall Study||94||
48426832|NCT02615158|101380582|FG001|STARTED|Overall Study||92||
48426833|NCT02615158|101380583|FG002|STARTED|Overall Study||91||
48426834|NCT02615158|101380581|FG000|COMPLETED|Overall Study||73||
48426835|NCT02615158|101380582|FG001|COMPLETED|Overall Study||76||
48426836|NCT02615158|101380583|FG002|COMPLETED|Overall Study||75||
48426837|NCT02615158|101380581|FG000|NOT COMPLETED|Overall Study||21||
48426838|NCT02615158|101380582|FG001|NOT COMPLETED|Overall Study||16||
48426839|NCT02615158|101380583|FG002|NOT COMPLETED|Overall Study||16||
48426840|NCT01503229|101380584|FG000|STARTED|Overall Study||30||
48426841|NCT01503229|101380584|FG000|COMPLETED|Overall Study||29||
48426842|NCT01503229|101380584|FG000|NOT COMPLETED|Overall Study||1||
48426843|NCT03814499|101380585|FG000|STARTED|Overall Study||53||
48426844|NCT03814499|101380585|FG000|COMPLETED|Overall Study||50||
48426845|NCT03814499|101380585|FG000|NOT COMPLETED|Overall Study||3||
48426846|NCT00187655|101380586|FG000|STARTED|Overall Study||24||
48426847|NCT00187655|101380586|FG000|COMPLETED|Overall Study||24||
48426848|NCT00187655|101380586|FG000|NOT COMPLETED|Overall Study||0||
48426849|NCT00635362|101380587|FG000|STARTED|Overall Study||22||
48426850|NCT00635362|101380588|FG001|STARTED|Overall Study||20||
48426851|NCT00635362|101380587|FG000|COMPLETED|Overall Study||9||
48426852|NCT00635362|101380588|FG001|COMPLETED|Overall Study||12||
48426853|NCT00635362|101380587|FG000|NOT COMPLETED|Overall Study||13||
48426854|NCT00635362|101380588|FG001|NOT COMPLETED|Overall Study||8||
48426855|NCT02357394|101380589|FG000|STARTED|Overall Study||4||
48426856|NCT02357394|101380590|FG001|STARTED|Overall Study||3||
48426857|NCT02357394|101380589|FG000|COMPLETED|Overall Study||4||
48426858|NCT02357394|101380590|FG001|COMPLETED|Overall Study||3||
48426859|NCT02357394|101380589|FG000|NOT COMPLETED|Overall Study||0||
48426860|NCT02357394|101380590|FG001|NOT COMPLETED|Overall Study||0||
48426861|NCT01499498|101380591|FG000|STARTED|Overall Study||13||
48426862|NCT01499498|101380591|FG000|COMPLETED|Overall Study||13||
48426863|NCT01499498|101380591|FG000|NOT COMPLETED|Overall Study||0||
48426864|NCT02539160|101380592|FG000|STARTED|Phase 1 Pre-crossover||24||
48426865|NCT02539160|101380593|FG001|STARTED|Phase 1 Pre-crossover||24||
48426866|NCT02539160|101380594|FG002|STARTED|Phase 1 Pre-crossover||22||
48426867|NCT02539160|101380595|FG003|STARTED|Phase 1 Pre-crossover||22||
48426868|NCT02539160|101380592|FG000|COMPLETED|Phase 1 Pre-crossover||19||
48426869|NCT02539160|101380593|FG001|COMPLETED|Phase 1 Pre-crossover||20||
48426870|NCT02539160|101380594|FG002|COMPLETED|Phase 1 Pre-crossover||19||
48426871|NCT02539160|101380595|FG003|COMPLETED|Phase 1 Pre-crossover||19||
48426872|NCT02539160|101380592|FG000|NOT COMPLETED|Phase 1 Pre-crossover||5||
48426873|NCT02539160|101380593|FG001|NOT COMPLETED|Phase 1 Pre-crossover||4||
48426874|NCT02539160|101380594|FG002|NOT COMPLETED|Phase 1 Pre-crossover||3||
48426875|NCT02539160|101380595|FG003|NOT COMPLETED|Phase 1 Pre-crossover||3||
48426876|NCT02539160|101380592|FG000|STARTED|Phase 2 Post-crossover||19||
48426877|NCT02539160|101380593|FG001|STARTED|Phase 2 Post-crossover||20||
48426878|NCT02539160|101380594|FG002|STARTED|Phase 2 Post-crossover||19||
48426879|NCT02539160|101380595|FG003|STARTED|Phase 2 Post-crossover||19||
48426880|NCT02539160|101380592|FG000|COMPLETED|Phase 2 Post-crossover||19||
48426881|NCT02539160|101380593|FG001|COMPLETED|Phase 2 Post-crossover||20||
48426882|NCT02539160|101380594|FG002|COMPLETED|Phase 2 Post-crossover||19||
48426883|NCT02539160|101380595|FG003|COMPLETED|Phase 2 Post-crossover||19||
48426884|NCT02539160|101380592|FG000|NOT COMPLETED|Phase 2 Post-crossover||0||
48426885|NCT02539160|101380593|FG001|NOT COMPLETED|Phase 2 Post-crossover||0||
48426886|NCT02539160|101380594|FG002|NOT COMPLETED|Phase 2 Post-crossover||0||
48426887|NCT02539160|101380595|FG003|NOT COMPLETED|Phase 2 Post-crossover||0||
48426888|NCT01766466|101380596|FG000|STARTED|Day 1||6||
48426889|NCT01766466|101380597|FG001|STARTED|Day 1||0||
48426890|NCT01766466|101380598|FG002|STARTED|Day 1||6||
48426891|NCT01766466|101380599|FG003|STARTED|Day 1||0||
48426892|NCT01766466|101380596|FG000|COMPLETED|Day 1||6||
48426893|NCT01766466|101380597|FG001|COMPLETED|Day 1||0||
48426894|NCT01766466|101380598|FG002|COMPLETED|Day 1||6||
48426895|NCT01766466|101380599|FG003|COMPLETED|Day 1||0||
48426896|NCT01766466|101380596|FG000|NOT COMPLETED|Day 1||0||
48426897|NCT01766466|101380597|FG001|NOT COMPLETED|Day 1||0||
48426898|NCT01766466|101380598|FG002|NOT COMPLETED|Day 1||0||
48426899|NCT01766466|101380599|FG003|NOT COMPLETED|Day 1||0||
48426900|NCT01766466|101380596|FG000|STARTED|Day 5||0||
48426901|NCT01766466|101380597|FG001|STARTED|Day 5||6||
48426902|NCT01766466|101380598|FG002|STARTED|Day 5||0||
48426903|NCT01766466|101380599|FG003|STARTED|Day 5||6||
48426904|NCT01766466|101380596|FG000|COMPLETED|Day 5||0||
48426905|NCT01766466|101380597|FG001|COMPLETED|Day 5||6||
48426906|NCT01766466|101380598|FG002|COMPLETED|Day 5||0||
48426907|NCT01766466|101380599|FG003|COMPLETED|Day 5||6||
48763967|NCT00726063|102211836|FG000|NOT COMPLETED|Overall Study||9||
48426908|NCT01766466|101380596|FG000|NOT COMPLETED|Day 5||0||
48426909|NCT01766466|101380597|FG001|NOT COMPLETED|Day 5||0||
48426910|NCT01766466|101380598|FG002|NOT COMPLETED|Day 5||0||
48426911|NCT01766466|101380599|FG003|NOT COMPLETED|Day 5||0||
48426912|NCT00329433|101380600|FG000|STARTED|Overall Study||61||
48426913|NCT00329433|101380601|FG001|STARTED|Overall Study||59||
48426914|NCT00329433|101380600|FG000|COMPLETED|Overall Study||61||
48426915|NCT00329433|101380601|FG001|COMPLETED|Overall Study||59||
48426916|NCT00329433|101380600|FG000|NOT COMPLETED|Overall Study||0||
48426917|NCT00329433|101380601|FG001|NOT COMPLETED|Overall Study||0||
48426918|NCT03418727|101380602|FG000|STARTED|Overall Study||29||
48426919|NCT03418727|101380603|FG001|STARTED|Overall Study||28||
48426920|NCT03418727|101380604|FG002|STARTED|Overall Study||27||
48426921|NCT03418727|101380602|FG000|Received at Least 1 Study Treatment|Overall Study||29||
48426922|NCT03418727|101380603|FG001|Received at Least 1 Study Treatment|Overall Study||28||
48426923|NCT03418727|101380604|FG002|Received at Least 1 Study Treatment|Overall Study||27||
48426924|NCT03418727|101380602|FG000|COMPLETED|Overall Study||28||
48426925|NCT03418727|101380603|FG001|COMPLETED|Overall Study||26||
48426926|NCT03418727|101380604|FG002|COMPLETED|Overall Study||25||
48426927|NCT03418727|101380602|FG000|NOT COMPLETED|Overall Study||1||
48426928|NCT03418727|101380603|FG001|NOT COMPLETED|Overall Study||2||
48426929|NCT03418727|101380604|FG002|NOT COMPLETED|Overall Study||2||
48426930|NCT01827462|101380605|FG000|STARTED|Overall Study||59||
48426931|NCT01827462|101380606|FG001|STARTED|Overall Study||37||
48426932|NCT01827462|101380607|FG002|STARTED|Overall Study||40||
48426933|NCT01827462|101380605|FG000|COMPLETED|Overall Study||18||
48426934|NCT01827462|101380606|FG001|COMPLETED|Overall Study||19||
48426935|NCT01827462|101380607|FG002|COMPLETED|Overall Study||12||
48426936|NCT01827462|101380605|FG000|NOT COMPLETED|Overall Study||41||
48426937|NCT01827462|101380606|FG001|NOT COMPLETED|Overall Study||18||
48426938|NCT01827462|101380607|FG002|NOT COMPLETED|Overall Study||28||
48426939|NCT02109731|101380608|FG000|STARTED|Overall Study||15||
48426940|NCT02109731|101380608|FG000|COMPLETED|Overall Study||15||
48426941|NCT02109731|101380608|FG000|NOT COMPLETED|Overall Study||0||
48426942|NCT03258710|101380609|FG000|STARTED|Overall Study||75||
48426943|NCT03258710|101380609|FG000|COMPLETED|Overall Study||72||
48426944|NCT03258710|101380609|FG000|NOT COMPLETED|Overall Study||3||
48426945|NCT01100931|101380610|FG000|STARTED|Phase I||22||
48426946|NCT01100931|101380611|FG001|STARTED|Phase I||0||
48426947|NCT01100931|101380610|FG000|COMPLETED|Phase I||22||
48426948|NCT01100931|101380611|FG001|COMPLETED|Phase I||0||
48426949|NCT01100931|101380610|FG000|NOT COMPLETED|Phase I||0||
48426950|NCT01100931|101380611|FG001|NOT COMPLETED|Phase I||0||
48426951|NCT01100931|101380610|FG000|STARTED|Phase II||0||
48426952|NCT01100931|101380611|FG001|STARTED|Phase II||19||
48426953|NCT01100931|101380610|FG000|COMPLETED|Phase II||0||
48426954|NCT01100931|101380611|FG001|COMPLETED|Phase II||19||
48426955|NCT01100931|101380610|FG000|NOT COMPLETED|Phase II||0||
48426956|NCT01100931|101380611|FG001|NOT COMPLETED|Phase II||0||
48426957|NCT01639599|101380612|FG000|STARTED|Overall Study||50||
48426958|NCT01639599|101380613|FG001|STARTED|Overall Study||50||
48426959|NCT01639599|101380614|FG002|STARTED|Overall Study||50||
48426960|NCT01639599|101380612|FG000|COMPLETED|Overall Study||50||
48426961|NCT01639599|101380613|FG001|COMPLETED|Overall Study||49||
48426962|NCT01639599|101380614|FG002|COMPLETED|Overall Study||50||
48426963|NCT01639599|101380612|FG000|NOT COMPLETED|Overall Study||0||
48426964|NCT01639599|101380613|FG001|NOT COMPLETED|Overall Study||1||
48426965|NCT01639599|101380614|FG002|NOT COMPLETED|Overall Study||0||
48426966|NCT00617994|101380615|FG000|STARTED|Overall Study||5||
48426967|NCT00617994|101380616|FG001|STARTED|Overall Study||5||
48426968|NCT00617994|101380617|FG002|STARTED|Overall Study||5||
48426969|NCT00617994|101380618|FG003|STARTED|Overall Study||5||
48426970|NCT00617994|101380619|FG004|STARTED|Overall Study||5||
48426971|NCT00617994|101380615|FG000|COMPLETED|Overall Study||5||
48426972|NCT00617994|101380616|FG001|COMPLETED|Overall Study||5||
48426973|NCT00617994|101380617|FG002|COMPLETED|Overall Study||5||
48426974|NCT00617994|101380618|FG003|COMPLETED|Overall Study||5||
48426975|NCT00617994|101380619|FG004|COMPLETED|Overall Study||5||
48426976|NCT00617994|101380615|FG000|NOT COMPLETED|Overall Study||0||
48426977|NCT00617994|101380616|FG001|NOT COMPLETED|Overall Study||0||
48426978|NCT00617994|101380617|FG002|NOT COMPLETED|Overall Study||0||
48426979|NCT00617994|101380618|FG003|NOT COMPLETED|Overall Study||0||
48426980|NCT00617994|101380619|FG004|NOT COMPLETED|Overall Study||0||
48426981|NCT01398176|101380620|FG000|STARTED|Overall Study||26||
48426982|NCT01398176|101380621|FG001|STARTED|Overall Study||25||
48426983|NCT01398176|101380620|FG000|COMPLETED|Overall Study||23||
48426984|NCT01398176|101380621|FG001|COMPLETED|Overall Study||19||
48426985|NCT01398176|101380620|FG000|NOT COMPLETED|Overall Study||3||
48426986|NCT01398176|101380621|FG001|NOT COMPLETED|Overall Study||6||
48426987|NCT01190839|101380622|FG000|STARTED|Overall Study||150||
48426988|NCT01190839|101380623|FG001|STARTED|Overall Study||147||
48426989|NCT01190839|101380622|FG000|Treated|Overall Study||148||
48426990|NCT01190839|101380623|FG001|Treated|Overall Study||143||
48426991|NCT01190839|101380622|FG000|COMPLETED|Overall Study||0||
48426992|NCT01190839|101380623|FG001|COMPLETED|Overall Study||0||
48426993|NCT01190839|101380622|FG000|NOT COMPLETED|Overall Study||150||
48426994|NCT01190839|101380623|FG001|NOT COMPLETED|Overall Study||147||
48426995|NCT03031327|101380624|FG000|STARTED|Overall Study||10||
48426996|NCT03031327|101380625|FG001|STARTED|Overall Study||10||
48426997|NCT03031327|101380626|FG002|STARTED|Overall Study||10||
48426998|NCT03031327|101380624|FG000|Full Analysis Set Population (FAS)|Overall Study||10||
48426999|NCT03031327|101380625|FG001|Full Analysis Set Population (FAS)|Overall Study||10||
48427000|NCT03031327|101380626|FG002|Full Analysis Set Population (FAS)|Overall Study||9||
48427001|NCT03031327|101380624|FG000|Safety Population (SAF)|Overall Study||10||
48427002|NCT03031327|101380625|FG001|Safety Population (SAF)|Overall Study||10||
48427003|NCT03031327|101380626|FG002|Safety Population (SAF)|Overall Study||10||
48427004|NCT03031327|101380624|FG000|Patients in Which Left Eye is the Study Eye|Overall Study||6||
48427005|NCT03031327|101380625|FG001|Patients in Which Left Eye is the Study Eye|Overall Study||6||
48427006|NCT03031327|101380626|FG002|Patients in Which Left Eye is the Study Eye|Overall Study||5||
48427007|NCT03031327|101380624|FG000|Patients in Which Right Eye is the Study Eye|Overall Study||4||
48427008|NCT03031327|101380625|FG001|Patients in Which Right Eye is the Study Eye|Overall Study||4||
48427009|NCT03031327|101380626|FG002|Patients in Which Right Eye is the Study Eye|Overall Study||5||
48427010|NCT03031327|101380624|FG000|COMPLETED|Overall Study||10||
48427011|NCT03031327|101380625|FG001|COMPLETED|Overall Study||9||
48427012|NCT03031327|101380626|FG002|COMPLETED|Overall Study||9||
48427013|NCT03031327|101380624|FG000|NOT COMPLETED|Overall Study||0||
48427014|NCT03031327|101380625|FG001|NOT COMPLETED|Overall Study||1||
48427015|NCT03031327|101380626|FG002|NOT COMPLETED|Overall Study||1||
48427016|NCT04594213|101380627|FG000|STARTED|Main Period (Up to 22 Weeks)||91||
48427017|NCT04594213|101380628|FG001|STARTED|Main Period (Up to 22 Weeks)||179||
48427018|NCT04594213|101380629|FG002|STARTED|Main Period (Up to 22 Weeks)||92||
48427019|NCT04594213|101380630|FG003|STARTED|Main Period (Up to 22 Weeks)||0||
48427020|NCT04594213|101380631|FG004|STARTED|Main Period (Up to 22 Weeks)||0||
48427021|NCT04594213|101380632|FG005|STARTED|Main Period (Up to 22 Weeks)||0||
48427022|NCT04594213|101380627|FG000|COMPLETED|Main Period (Up to 22 Weeks)||88||
48427023|NCT04594213|101380628|FG001|COMPLETED|Main Period (Up to 22 Weeks)||172||
48427024|NCT04594213|101380629|FG002|COMPLETED|Main Period (Up to 22 Weeks)||90||
48427025|NCT04594213|101380630|FG003|COMPLETED|Main Period (Up to 22 Weeks)||0||
48427026|NCT04594213|101380631|FG004|COMPLETED|Main Period (Up to 22 Weeks)||0||
48427027|NCT04594213|101380632|FG005|COMPLETED|Main Period (Up to 22 Weeks)||0||
48427028|NCT04594213|101380627|FG000|NOT COMPLETED|Main Period (Up to 22 Weeks)||3||
48427029|NCT04594213|101380628|FG001|NOT COMPLETED|Main Period (Up to 22 Weeks)||7||
48427030|NCT04594213|101380629|FG002|NOT COMPLETED|Main Period (Up to 22 Weeks)||2||
48427031|NCT04594213|101380630|FG003|NOT COMPLETED|Main Period (Up to 22 Weeks)||0||
48427032|NCT04594213|101380631|FG004|NOT COMPLETED|Main Period (Up to 22 Weeks)||0||
48427033|NCT04594213|101380632|FG005|NOT COMPLETED|Main Period (Up to 22 Weeks)||0||
48427034|NCT04594213|101380627|FG000|STARTED|OLEX Period (Up to 39 Weeks)||0||
48427035|NCT04594213|101380628|FG001|STARTED|OLEX Period (Up to 39 Weeks)||0||
48427036|NCT04594213|101380629|FG002|STARTED|OLEX Period (Up to 39 Weeks)||0||
48427037|NCT04594213|101380630|FG003|STARTED|OLEX Period (Up to 39 Weeks)||86||
48427038|NCT04594213|101380631|FG004|STARTED|OLEX Period (Up to 39 Weeks)||144||
48427039|NCT04594213|101380632|FG005|STARTED|OLEX Period (Up to 39 Weeks)||73||
48427040|NCT04594213|101380627|FG000|COMPLETED|OLEX Period (Up to 39 Weeks)||0||
48427041|NCT04594213|101380628|FG001|COMPLETED|OLEX Period (Up to 39 Weeks)||0||
48427042|NCT04594213|101380629|FG002|COMPLETED|OLEX Period (Up to 39 Weeks)||0||
48427043|NCT04594213|101380630|FG003|COMPLETED|OLEX Period (Up to 39 Weeks)||66||
48427044|NCT04594213|101380631|FG004|COMPLETED|OLEX Period (Up to 39 Weeks)||100||
48427045|NCT04594213|101380632|FG005|COMPLETED|OLEX Period (Up to 39 Weeks)||60||
48427046|NCT04594213|101380627|FG000|NOT COMPLETED|OLEX Period (Up to 39 Weeks)||0||
48427047|NCT04594213|101380628|FG001|NOT COMPLETED|OLEX Period (Up to 39 Weeks)||0||
48427048|NCT04594213|101380629|FG002|NOT COMPLETED|OLEX Period (Up to 39 Weeks)||0||
48427049|NCT04594213|101380630|FG003|NOT COMPLETED|OLEX Period (Up to 39 Weeks)||20||
48427050|NCT04594213|101380631|FG004|NOT COMPLETED|OLEX Period (Up to 39 Weeks)||44||
48427051|NCT04594213|101380632|FG005|NOT COMPLETED|OLEX Period (Up to 39 Weeks)||13||
48427052|NCT03219372|101380633|FG000|STARTED|Overall Study||1||
48427053|NCT03219372|101380634|FG001|STARTED|Overall Study||0||
48427054|NCT03219372|101380633|FG000|COMPLETED|Overall Study||0||
48427055|NCT03219372|101380634|FG001|COMPLETED|Overall Study||0||
48427056|NCT03219372|101380633|FG000|NOT COMPLETED|Overall Study||1||
48427057|NCT03219372|101380634|FG001|NOT COMPLETED|Overall Study||0||
48427058|NCT00807768|101380635|FG000|STARTED|Overall Study||301||
48427059|NCT00807768|101380636|FG001|STARTED|Overall Study||300||
48763968|NCT00726063|102211837|FG001|NOT COMPLETED|Overall Study||7||
48763969|NCT00651742|102211838|FG000|STARTED|Overall Study||28|Enrolled|
48427060|NCT00807768|101380635|FG000|COMPLETED|Overall Study||301||
48427061|NCT00807768|101380636|FG001|COMPLETED|Overall Study||300||
48427062|NCT00807768|101380635|FG000|NOT COMPLETED|Overall Study||0||
48427063|NCT00807768|101380636|FG001|NOT COMPLETED|Overall Study||0||
48427064|NCT01856920|101380637|FG000|STARTED|Overall Study||17||
48427065|NCT01856920|101380638|FG001|STARTED|Overall Study||18||
48427066|NCT01856920|101380637|FG000|COMPLETED|Overall Study||7||
48427067|NCT01856920|101380638|FG001|COMPLETED|Overall Study||9||
48427068|NCT01856920|101380637|FG000|NOT COMPLETED|Overall Study||10||
48427069|NCT01856920|101380638|FG001|NOT COMPLETED|Overall Study||9||
48427070|NCT00267202|101380639|FG000|STARTED|Overall Study||136||
48360104|NCT02378753|101210820|FG001|NOT COMPLETED|Overall Study||695||
48360105|NCT00258154|101210821|FG000|STARTED|Overall Study||201||
48360106|NCT00258154|101210822|FG001|STARTED|Overall Study||202||
48360107|NCT00258154|101210821|FG000|Vaccinated at Visit 1|Overall Study||201||
48360108|NCT00258154|101210822|FG001|Vaccinated at Visit 1|Overall Study||202||
48360109|NCT00258154|101210821|FG000|Vaccinated at Visit 2|Overall Study||198||
48360110|NCT00258154|101210822|FG001|Vaccinated at Visit 2|Overall Study||198||
48360111|NCT00258154|101210821|FG000|Vaccinated at Visit 3|Overall Study||195||
48360112|NCT00258154|101210822|FG001|Vaccinated at Visit 3|Overall Study||197||
48360113|NCT00258154|101210821|FG000|COMPLETED|Overall Study||192||
48360114|NCT00258154|101210822|FG001|COMPLETED|Overall Study||195||
48360115|NCT00258154|101210821|FG000|NOT COMPLETED|Overall Study||9||
48360116|NCT00258154|101210822|FG001|NOT COMPLETED|Overall Study||7||
48360117|NCT01756976|101210823|FG000|STARTED|Overall Study||76||
48360118|NCT01756976|101210824|FG001|STARTED|Overall Study||8||
48360119|NCT01756976|101210823|FG000|COMPLETED|Overall Study||73||
48360120|NCT01756976|101210824|FG001|COMPLETED|Overall Study||8||
48360121|NCT01756976|101210823|FG000|NOT COMPLETED|Overall Study||3||
48360122|NCT01756976|101210824|FG001|NOT COMPLETED|Overall Study||0||
48360123|NCT00621023|101210825|FG000|STARTED|Overall Study||6||
48360124|NCT00621023|101210825|FG000|COMPLETED|Overall Study||0||
48360125|NCT00621023|101210825|FG000|NOT COMPLETED|Overall Study||6||
48360126|NCT04312997|101210826|FG000|STARTED|Overall Study||51||
48360127|NCT04312997|101210827|FG001|STARTED|Overall Study||50||
48360128|NCT04312997|101210826|FG000|COMPLETED|Overall Study||45||
48360129|NCT04312997|101210827|FG001|COMPLETED|Overall Study||47||
48360130|NCT04312997|101210826|FG000|NOT COMPLETED|Overall Study||6||
48360131|NCT04312997|101210827|FG001|NOT COMPLETED|Overall Study||3||
48360132|NCT01842464|101210828|FG000|STARTED|Overall Study||44||
48360133|NCT01842464|101210828|FG000|COMPLETED|Overall Study||44||
48360134|NCT01842464|101210828|FG000|NOT COMPLETED|Overall Study||0||
48360135|NCT02031146|101210829|FG000|STARTED|Overall Study||11|There were 231 entry visits for 219 unique individuals. There were 12 re enrollments.|
48360136|NCT02031146|101210830|FG001|STARTED|Overall Study||3|There were 231 entry visits for 219 unique individuals. There were 12 re enrollments.|
48360137|NCT02031146|101210831|FG002|STARTED|Overall Study||18|There were 231 entry visits for 219 unique individuals. There were 12 re enrollments.|
48360138|NCT02031146|101210832|FG003|STARTED|Overall Study||148|There were 231 entry visits for 219 unique individuals. There were 12 re enrollments.|
48360139|NCT02031146|101210833|FG004|STARTED|Overall Study||42|There were 231 entry visits for 219 unique individuals. There were 12 re enrollments.|
48360140|NCT02031146|101210834|FG005|STARTED|Overall Study||4|There were 231 entry visits for 219 unique individuals. There were 12 re enrollments.|
48360141|NCT02031146|101210835|FG006|STARTED|Overall Study||5|There were 231 entry visits for 219 unique individuals. There were 12 re enrollments.|
48360142|NCT02031146|101210829|FG000|Considered in Analysis|Overall Study||11|All participants who were randomized were included in the analysis. The first entry visit for those who were not randomized were included in the analysis if: 1) serum RPR was at or above 1:32 or 2) for PLWH, peripheral blood CD4 + T cells were at or below 350/ul. All included had to have undergone the entry CogState battery.|
48360143|NCT02031146|101210830|FG001|Considered in Analysis|Overall Study||3|All participants who were randomized were included in the analysis. The first entry visit for those who were not randomized were included in the analysis if: 1) serum RPR was at or above 1:32 or 2) for PLWH, peripheral blood CD4 + T cells were at or below 350/ul. All included had to have undergone the entry CogState battery.|
48360144|NCT02031146|101210831|FG002|Considered in Analysis|Overall Study||18|All participants who were randomized were included in the analysis. The first entry visit for those who were not randomized were included in the analysis if: 1) serum RPR was at or above 1:32 or 2) for PLWH, peripheral blood CD4 + T cells were at or below 350/ul. All included had to have undergone the entry CogState battery.|
48360145|NCT02031146|101210832|FG003|Considered in Analysis|Overall Study||48|All participants who were randomized were included in the analysis. The first entry visit for those who were not randomized were included in the analysis if: 1) serum RPR was at or above 1:32 or 2) for PLWH, peripheral blood CD4 + T cells were at or below 350/ul. All included had to have undergone the entry CogState battery.|
48360146|NCT02031146|101210833|FG004|Considered in Analysis|Overall Study||16|All participants who were randomized were included in the analysis. The first entry visit for those who were not randomized were included in the analysis if: 1) serum RPR was at or above 1:32 or 2) for PLWH, peripheral blood CD4 + T cells were at or below 350/ul. All included had to have undergone the entry CogState battery.|
48360147|NCT02031146|101210834|FG005|Considered in Analysis|Overall Study||0|All participants who were randomized were included in the analysis. The first entry visit for those who were not randomized were included in the analysis if: 1) serum RPR was at or above 1:32 or 2) for PLWH, peripheral blood CD4 + T cells were at or below 350/ul. All included had to have undergone the entry CogState battery.|
48368124|NCT01555463|101230111|FG000|COMPLETED|Treatment||419||
48368125|NCT01555463|101230112|FG001|COMPLETED|Treatment||399||
48368126|NCT01555463|101230111|FG000|NOT COMPLETED|Treatment||64||
48638948|NCT03233217|101901537|FG004|COMPLETED|Overall Study||55||
48638949|NCT03233217|101901533|FG000|NOT COMPLETED|Overall Study||0||
48638950|NCT03233217|101901534|FG001|NOT COMPLETED|Overall Study||0||
48638951|NCT03233217|101901535|FG002|NOT COMPLETED|Overall Study||0||
48763970|NCT00651742|102211838|FG000|Treated|Overall Study||27||
48187304|NCT01996644|100780013|FG000|COMPLETED|Overall Study||20||
48427071|NCT00267202|101380640|FG001|STARTED|Overall Study||139||
48427072|NCT00267202|101380639|FG000|COMPLETED|Overall Study||83||
48427073|NCT00267202|101380640|FG001|COMPLETED|Overall Study||105||
48427074|NCT00267202|101380639|FG000|NOT COMPLETED|Overall Study||53||
48427075|NCT00267202|101380640|FG001|NOT COMPLETED|Overall Study||34||
48427076|NCT03947333|101380641|FG000|STARTED|Overall Study||135||
48427077|NCT03947333|101380642|FG001|STARTED|Overall Study||135||
48427078|NCT03947333|101380641|FG000|COMPLETED|Overall Study||135||
48427079|NCT03947333|101380642|FG001|COMPLETED|Overall Study||135||
48427080|NCT03947333|101380641|FG000|NOT COMPLETED|Overall Study||0||
48427081|NCT03947333|101380642|FG001|NOT COMPLETED|Overall Study||0||
48427082|NCT00591305|101380643|FG000|STARTED|Overall Study||1||
48427083|NCT00591305|101380644|FG001|STARTED|Overall Study||0||
48427084|NCT00591305|101380643|FG000|1st Follow-up in 2 Wks After Surgery|Overall Study||1||
48427085|NCT00591305|101380644|FG001|1st Follow-up in 2 Wks After Surgery|Overall Study||0||
48427086|NCT00591305|101380643|FG000|COMPLETED|Overall Study||1||
48427087|NCT00591305|101380644|FG001|COMPLETED|Overall Study||0||
48427088|NCT00591305|101380643|FG000|NOT COMPLETED|Overall Study||0||
48427089|NCT00591305|101380644|FG001|NOT COMPLETED|Overall Study||0||
48427090|NCT04676022|101380645|FG000|STARTED|Overall Study||79||
48427091|NCT04676022|101380646|FG001|STARTED|Overall Study||68||
48427092|NCT04676022|101380647|FG002|STARTED|Overall Study||94||
48427093|NCT04676022|101380645|FG000|COMPLETED|Overall Study||57||
48427094|NCT04676022|101380646|FG001|COMPLETED|Overall Study||64||
48427095|NCT04676022|101380647|FG002|COMPLETED|Overall Study||0||
48427096|NCT04676022|101380645|FG000|NOT COMPLETED|Overall Study||22||
48427097|NCT04676022|101380646|FG001|NOT COMPLETED|Overall Study||4||
48427098|NCT04676022|101380647|FG002|NOT COMPLETED|Overall Study||94||
48427099|NCT01084096|101380648|FG000|STARTED|Overall Study||49744|Women enrolled in the Global Network Maternal Newborn Health Registry during the ACT trial period.|51
48427100|NCT01084096|101380649|FG001|STARTED|Overall Study||53373|Women enrolled in the Global Network Maternal Newborn Health Registry during the ACT trial period.|51
48427101|NCT01084096|101380648|FG000|COMPLETED|Overall Study||48219|Delivery and outcome data available from the GN MNHR.|51
48427102|NCT01084096|101380649|FG001|COMPLETED|Overall Study||51523|Delivery and outcome data available from the GN MNHR.|50
48427103|NCT01084096|101380648|FG000|NOT COMPLETED|Overall Study||1525||0
48427104|NCT01084096|101380649|FG001|NOT COMPLETED|Overall Study||1850||1
48427105|NCT04001790|101380650|FG000|STARTED|Overall Study||22||
48427106|NCT04001790|101380651|FG001|STARTED|Overall Study||26||
48427107|NCT04001790|101380650|FG000|COMPLETED|Overall Study||21||
48427108|NCT04001790|101380651|FG001|COMPLETED|Overall Study||24||
48427109|NCT04001790|101380650|FG000|NOT COMPLETED|Overall Study||1||
48427110|NCT04001790|101380651|FG001|NOT COMPLETED|Overall Study||2||
48427111|NCT01054443|101380652|FG000|STARTED|Overall Study||5||
48427112|NCT01054443|101380653|FG001|STARTED|Overall Study||5||
48427113|NCT01054443|101380654|FG002|STARTED|Overall Study||5||
48427114|NCT01054443|101380655|FG003|STARTED|Overall Study||5||
48427115|NCT01054443|101380652|FG000|COMPLETED|Overall Study||5||
48427116|NCT01054443|101380653|FG001|COMPLETED|Overall Study||5||
48427117|NCT01054443|101380654|FG002|COMPLETED|Overall Study||5||
48427118|NCT01054443|101380655|FG003|COMPLETED|Overall Study||4||
48427119|NCT01054443|101380652|FG000|NOT COMPLETED|Overall Study||0||
48427120|NCT01054443|101380653|FG001|NOT COMPLETED|Overall Study||0||
48427121|NCT01054443|101380654|FG002|NOT COMPLETED|Overall Study||0||
48427122|NCT01054443|101380655|FG003|NOT COMPLETED|Overall Study||1||
48427123|NCT05602818|101380656|FG000|STARTED|Qualification Phase (3 Days)||50||
48427124|NCT05602818|101380657|FG001|STARTED|Qualification Phase (3 Days)||50||
48427125|NCT05602818|101380658|FG002|STARTED|Qualification Phase (3 Days)||0||
48427126|NCT05602818|101380659|FG003|STARTED|Qualification Phase (3 Days)||0||
48427127|NCT05602818|101380660|FG004|STARTED|Qualification Phase (3 Days)||0||
48427128|NCT05602818|101380661|FG005|STARTED|Qualification Phase (3 Days)||0||
48427129|NCT05602818|101380662|FG006|STARTED|Qualification Phase (3 Days)||0||
48427130|NCT05602818|101380663|FG007|STARTED|Qualification Phase (3 Days)||0||
48427131|NCT05602818|101380664|FG008|STARTED|Qualification Phase (3 Days)||0||
48427132|NCT05602818|101380665|FG009|STARTED|Qualification Phase (3 Days)||0||
48427133|NCT05602818|101380666|FG010|STARTED|Qualification Phase (3 Days)||0||
48427134|NCT05602818|101380667|FG011|STARTED|Qualification Phase (3 Days)||0||
48427135|NCT05602818|101380656|FG000|Qualification Safety Analysis Set (Treated)|Qualification Phase (3 Days)||49||
48427136|NCT05602818|101380657|FG001|Qualification Safety Analysis Set (Treated)|Qualification Phase (3 Days)||49||
48427137|NCT05602818|101380658|FG002|Qualification Safety Analysis Set (Treated)|Qualification Phase (3 Days)||0||
48427138|NCT05602818|101380659|FG003|Qualification Safety Analysis Set (Treated)|Qualification Phase (3 Days)||0||
48427139|NCT05602818|101380660|FG004|Qualification Safety Analysis Set (Treated)|Qualification Phase (3 Days)||0||
48427140|NCT05602818|101380661|FG005|Qualification Safety Analysis Set (Treated)|Qualification Phase (3 Days)||0||
48427141|NCT05602818|101380662|FG006|Qualification Safety Analysis Set (Treated)|Qualification Phase (3 Days)||0||
48427142|NCT05602818|101380663|FG007|Qualification Safety Analysis Set (Treated)|Qualification Phase (3 Days)||0||
48427143|NCT05602818|101380664|FG008|Qualification Safety Analysis Set (Treated)|Qualification Phase (3 Days)||0||
48427144|NCT05602818|101380665|FG009|Qualification Safety Analysis Set (Treated)|Qualification Phase (3 Days)||0||
48427145|NCT05602818|101380666|FG010|Qualification Safety Analysis Set (Treated)|Qualification Phase (3 Days)||0||
48427146|NCT05602818|101380667|FG011|Qualification Safety Analysis Set (Treated)|Qualification Phase (3 Days)||0||
48427147|NCT05602818|101380656|FG000|COMPLETED|Qualification Phase (3 Days)||33||
48427148|NCT05602818|101380657|FG001|COMPLETED|Qualification Phase (3 Days)||36||
48427149|NCT05602818|101380658|FG002|COMPLETED|Qualification Phase (3 Days)||0||
48427150|NCT05602818|101380659|FG003|COMPLETED|Qualification Phase (3 Days)||0||
48427151|NCT05602818|101380660|FG004|COMPLETED|Qualification Phase (3 Days)||0||
48427152|NCT05602818|101380661|FG005|COMPLETED|Qualification Phase (3 Days)||0||
48427153|NCT05602818|101380662|FG006|COMPLETED|Qualification Phase (3 Days)||0||
48427154|NCT05602818|101380663|FG007|COMPLETED|Qualification Phase (3 Days)||0||
48427155|NCT05602818|101380664|FG008|COMPLETED|Qualification Phase (3 Days)||0||
48427156|NCT05602818|101380665|FG009|COMPLETED|Qualification Phase (3 Days)||0||
48427157|NCT05602818|101380666|FG010|COMPLETED|Qualification Phase (3 Days)||0||
48427158|NCT05602818|101380667|FG011|COMPLETED|Qualification Phase (3 Days)||0||
48427159|NCT05602818|101380656|FG000|NOT COMPLETED|Qualification Phase (3 Days)||17||
48427160|NCT05602818|101380657|FG001|NOT COMPLETED|Qualification Phase (3 Days)||14||
48427161|NCT05602818|101380658|FG002|NOT COMPLETED|Qualification Phase (3 Days)||0||
48427162|NCT05602818|101380659|FG003|NOT COMPLETED|Qualification Phase (3 Days)||0||
48427163|NCT05602818|101380660|FG004|NOT COMPLETED|Qualification Phase (3 Days)||0||
48427164|NCT05602818|101380661|FG005|NOT COMPLETED|Qualification Phase (3 Days)||0||
48427165|NCT05602818|101380662|FG006|NOT COMPLETED|Qualification Phase (3 Days)||0||
48427166|NCT05602818|101380663|FG007|NOT COMPLETED|Qualification Phase (3 Days)||0||
48427167|NCT05602818|101380664|FG008|NOT COMPLETED|Qualification Phase (3 Days)||0||
48427168|NCT05602818|101380665|FG009|NOT COMPLETED|Qualification Phase (3 Days)||0||
48427169|NCT05602818|101380666|FG010|NOT COMPLETED|Qualification Phase (3 Days)||0||
48427170|NCT05602818|101380667|FG011|NOT COMPLETED|Qualification Phase (3 Days)||0||
48427171|NCT05602818|101380656|FG000|STARTED|Treatment Phase (29 Days)||0|Participants who completed Qualification Phase and met the qualification criteria were randomized to Treatment Phase. However, one participant was lost to follow-up after meeting the Qualification criteria and was not randomized in Treatment Phase.|
48427172|NCT05602818|101380657|FG001|STARTED|Treatment Phase (29 Days)||0|Participants who completed Qualification Phase and met the qualification criteria were randomized to Treatment Phase. However, one participant was lost to follow-up after meeting the Qualification criteria and was not randomized in Treatment Phase.|
48427173|NCT05602818|101380658|FG002|STARTED|Treatment Phase (29 Days)||7|Participants who completed Qualification Phase and met the qualification criteria were randomized to Treatment Phase. However, one participant was lost to follow-up after meeting the Qualification criteria and was not randomized in Treatment Phase.|
48427174|NCT05602818|101380659|FG003|STARTED|Treatment Phase (29 Days)||6|Participants who completed Qualification Phase and met the qualification criteria were randomized to Treatment Phase. However, one participant was lost to follow-up after meeting the Qualification criteria and was not randomized in Treatment Phase.|
48427175|NCT05602818|101380660|FG004|STARTED|Treatment Phase (29 Days)||6|Participants who completed Qualification Phase and met the qualification criteria were randomized to Treatment Phase. However, one participant was lost to follow-up after meeting the Qualification criteria and was not randomized in Treatment Phase.|
48427176|NCT05602818|101380661|FG005|STARTED|Treatment Phase (29 Days)||6|Participants who completed Qualification Phase and met the qualification criteria were randomized to Treatment Phase. However, one participant was lost to follow-up after meeting the Qualification criteria and was not randomized in Treatment Phase.|
48427177|NCT05602818|101380662|FG006|STARTED|Treatment Phase (29 Days)||8|Participants who completed Qualification Phase and met the qualification criteria were randomized to Treatment Phase. However, one participant was lost to follow-up after meeting the Qualification criteria and was not randomized in Treatment Phase.|
48427178|NCT05602818|101380663|FG007|STARTED|Treatment Phase (29 Days)||8|Participants who completed Qualification Phase and met the qualification criteria were randomized to Treatment Phase. However, one participant was lost to follow-up after meeting the Qualification criteria and was not randomized in Treatment Phase.|
48427179|NCT05602818|101380664|FG008|STARTED|Treatment Phase (29 Days)||6|Participants who completed Qualification Phase and met the qualification criteria were randomized to Treatment Phase. However, one participant was lost to follow-up after meeting the Qualification criteria and was not randomized in Treatment Phase.|
48427180|NCT05602818|101380665|FG009|STARTED|Treatment Phase (29 Days)||6|Participants who completed Qualification Phase and met the qualification criteria were randomized to Treatment Phase. However, one participant was lost to follow-up after meeting the Qualification criteria and was not randomized in Treatment Phase.|
48427181|NCT05602818|101380666|FG010|STARTED|Treatment Phase (29 Days)||8|Participants who completed Qualification Phase and met the qualification criteria were randomized to Treatment Phase. However, one participant was lost to follow-up after meeting the Qualification criteria and was not randomized in Treatment Phase.|
48427182|NCT05602818|101380667|FG011|STARTED|Treatment Phase (29 Days)||7|Participants who completed Qualification Phase and met the qualification criteria were randomized to Treatment Phase. However, one participant was lost to follow-up after meeting the Qualification criteria and was not randomized in Treatment Phase.|
48427183|NCT05602818|101380656|FG000|Safety Analysis Set (Treated)|Treatment Phase (29 Days)||0||
48427184|NCT05602818|101380657|FG001|Safety Analysis Set (Treated)|Treatment Phase (29 Days)||0||
48427185|NCT05602818|101380658|FG002|Safety Analysis Set (Treated)|Treatment Phase (29 Days)||7||
48427186|NCT05602818|101380659|FG003|Safety Analysis Set (Treated)|Treatment Phase (29 Days)||6||
48427187|NCT05602818|101380660|FG004|Safety Analysis Set (Treated)|Treatment Phase (29 Days)||6||
48427188|NCT05602818|101380661|FG005|Safety Analysis Set (Treated)|Treatment Phase (29 Days)||6||
48427189|NCT05602818|101380662|FG006|Safety Analysis Set (Treated)|Treatment Phase (29 Days)||8||
48427190|NCT05602818|101380663|FG007|Safety Analysis Set (Treated)|Treatment Phase (29 Days)||8||
48427191|NCT05602818|101380664|FG008|Safety Analysis Set (Treated)|Treatment Phase (29 Days)||6||
48427192|NCT05602818|101380665|FG009|Safety Analysis Set (Treated)|Treatment Phase (29 Days)||6||
48427193|NCT05602818|101380666|FG010|Safety Analysis Set (Treated)|Treatment Phase (29 Days)||7||
48427194|NCT05602818|101380667|FG011|Safety Analysis Set (Treated)|Treatment Phase (29 Days)||7||
48427195|NCT05602818|101380656|FG000|COMPLETED|Treatment Phase (29 Days)||0||
48427196|NCT05602818|101380657|FG001|COMPLETED|Treatment Phase (29 Days)||0||
48427197|NCT05602818|101380658|FG002|COMPLETED|Treatment Phase (29 Days)||4||
48427198|NCT05602818|101380659|FG003|COMPLETED|Treatment Phase (29 Days)||5||
48427199|NCT05602818|101380660|FG004|COMPLETED|Treatment Phase (29 Days)||5||
48427200|NCT05602818|101380661|FG005|COMPLETED|Treatment Phase (29 Days)||5||
48427201|NCT05602818|101380662|FG006|COMPLETED|Treatment Phase (29 Days)||5||
48427202|NCT05602818|101380663|FG007|COMPLETED|Treatment Phase (29 Days)||6||
48427203|NCT05602818|101380664|FG008|COMPLETED|Treatment Phase (29 Days)||5||
48427204|NCT05602818|101380665|FG009|COMPLETED|Treatment Phase (29 Days)||5||
48427205|NCT05602818|101380666|FG010|COMPLETED|Treatment Phase (29 Days)||4||
48427206|NCT05602818|101380667|FG011|COMPLETED|Treatment Phase (29 Days)||5||
48427207|NCT05602818|101380656|FG000|NOT COMPLETED|Treatment Phase (29 Days)||0||
48427208|NCT05602818|101380657|FG001|NOT COMPLETED|Treatment Phase (29 Days)||0||
48427209|NCT05602818|101380658|FG002|NOT COMPLETED|Treatment Phase (29 Days)||3||
48427210|NCT05602818|101380659|FG003|NOT COMPLETED|Treatment Phase (29 Days)||1||
48427211|NCT05602818|101380660|FG004|NOT COMPLETED|Treatment Phase (29 Days)||1||
48427212|NCT05602818|101380661|FG005|NOT COMPLETED|Treatment Phase (29 Days)||1||
48427213|NCT05602818|101380662|FG006|NOT COMPLETED|Treatment Phase (29 Days)||3||
48427214|NCT05602818|101380663|FG007|NOT COMPLETED|Treatment Phase (29 Days)||2||
48427215|NCT05602818|101380664|FG008|NOT COMPLETED|Treatment Phase (29 Days)||1||
48427216|NCT05602818|101380665|FG009|NOT COMPLETED|Treatment Phase (29 Days)||1||
48427217|NCT05602818|101380666|FG010|NOT COMPLETED|Treatment Phase (29 Days)||4||
48427218|NCT05602818|101380667|FG011|NOT COMPLETED|Treatment Phase (29 Days)||2||
48427219|NCT04553497|101380668|FG000|STARTED|Overall Study||17||
48427220|NCT04553497|101380669|FG001|STARTED|Overall Study||18||
48427221|NCT04553497|101380668|FG000|COMPLETED|Overall Study||15||
48427222|NCT04553497|101380669|FG001|COMPLETED|Overall Study||17||
48427223|NCT04553497|101380668|FG000|NOT COMPLETED|Overall Study||2||
48427224|NCT04553497|101380669|FG001|NOT COMPLETED|Overall Study||1||
48427225|NCT01411917|101380670|FG000|STARTED|Overall Study||32||
48427226|NCT01411917|101380671|FG001|STARTED|Overall Study||37||
48427227|NCT01411917|101380670|FG000|COMPLETED|Overall Study||32||
48427228|NCT01411917|101380671|FG001|COMPLETED|Overall Study||36||
48427229|NCT01411917|101380670|FG000|NOT COMPLETED|Overall Study||0||
48427230|NCT01411917|101380671|FG001|NOT COMPLETED|Overall Study||1||
48427231|NCT03414372|101380672|FG000|STARTED|Overall Study||53||
48427232|NCT03414372|101380673|FG001|STARTED|Overall Study||51||
48427233|NCT03414372|101380674|FG002|STARTED|Overall Study||52||
48427234|NCT03414372|101380672|FG000|COMPLETED|Overall Study||43||
48427235|NCT03414372|101380673|FG001|COMPLETED|Overall Study||42||
48427236|NCT03414372|101380674|FG002|COMPLETED|Overall Study||44||
48427237|NCT03414372|101380672|FG000|NOT COMPLETED|Overall Study||10||
48427238|NCT03414372|101380673|FG001|NOT COMPLETED|Overall Study||9||
48427239|NCT03414372|101380674|FG002|NOT COMPLETED|Overall Study||8||
48427240|NCT00387829|101380675|FG000|STARTED|Safety Population||178||
48427241|NCT00387829|101380676|FG001|STARTED|Safety Population||169||
48427242|NCT00387829|101380675|FG000|COMPLETED|Safety Population||139||
48427243|NCT00387829|101380676|FG001|COMPLETED|Safety Population||136||
48427244|NCT00387829|101380675|FG000|NOT COMPLETED|Safety Population||39||
48427245|NCT00387829|101380676|FG001|NOT COMPLETED|Safety Population||33||
48427246|NCT00387829|101380675|FG000|STARTED|Intent-to-treat Population||177||
48427247|NCT00387829|101380676|FG001|STARTED|Intent-to-treat Population||166||
48427248|NCT00387829|101380675|FG000|COMPLETED|Intent-to-treat Population||139||
48427249|NCT00387829|101380676|FG001|COMPLETED|Intent-to-treat Population||136||
48427250|NCT00387829|101380675|FG000|NOT COMPLETED|Intent-to-treat Population||38||
48427251|NCT00387829|101380676|FG001|NOT COMPLETED|Intent-to-treat Population||30||
48427252|NCT00991458|101380677|FG000|STARTED|Overall Study||207||
48427253|NCT00991458|101380678|FG001|STARTED|Overall Study||209||
48427254|NCT00991458|101380679|FG002|STARTED|Overall Study||205||
48427255|NCT00991458|101380677|FG000|COMPLETED|Overall Study||187||
48427256|NCT00991458|101380678|FG001|COMPLETED|Overall Study||181||
48427257|NCT00991458|101380679|FG002|COMPLETED|Overall Study||180||
48427258|NCT00991458|101380677|FG000|NOT COMPLETED|Overall Study||20||
48427259|NCT00991458|101380678|FG001|NOT COMPLETED|Overall Study||28||
48427260|NCT00991458|101380679|FG002|NOT COMPLETED|Overall Study||25||
48427261|NCT02198040|101380680|FG000|STARTED|Overall Study||9||
48427262|NCT02198040|101380681|FG001|STARTED|Overall Study||9||
48427263|NCT02198040|101380682|FG002|STARTED|Overall Study||9||
48427264|NCT02198040|101380680|FG000|COMPLETED|Overall Study||9||
48427265|NCT02198040|101380681|FG001|COMPLETED|Overall Study||8||
48427266|NCT02198040|101380682|FG002|COMPLETED|Overall Study||8||
48427267|NCT02198040|101380680|FG000|NOT COMPLETED|Overall Study||0||
48427268|NCT02198040|101380681|FG001|NOT COMPLETED|Overall Study||1||
48427269|NCT02198040|101380682|FG002|NOT COMPLETED|Overall Study||1||
48427270|NCT00405756|101380683|FG000|STARTED|Double-blind Treatment||152||
48427271|NCT00405756|101380684|FG001|STARTED|Double-blind Treatment||153||
48427272|NCT00405756|101380685|FG002|STARTED|Double-blind Treatment||154||
48763971|NCT00651742|102211838|FG000|Efficacy Analysis Per Investigator|Overall Study||21||
48763972|NCT00651742|102211838|FG000|Efficacy Analysis Per Independent Reader|Overall Study||25||
48427273|NCT00405756|101380683|FG000|Safety Population|Double-blind Treatment||150||
48427274|NCT00405756|101380684|FG001|Safety Population|Double-blind Treatment||152||
48427275|NCT00405756|101380685|FG002|Safety Population|Double-blind Treatment||153||
48427276|NCT00405756|101380683|FG000|COMPLETED|Double-blind Treatment||0||
48427277|NCT00405756|101380684|FG001|COMPLETED|Double-blind Treatment||0||
48427278|NCT00405756|101380685|FG002|COMPLETED|Double-blind Treatment||0||
48427279|NCT00405756|101380683|FG000|NOT COMPLETED|Double-blind Treatment||152||
48427280|NCT00405756|101380684|FG001|NOT COMPLETED|Double-blind Treatment||153||
48427281|NCT00405756|101380685|FG002|NOT COMPLETED|Double-blind Treatment||154||
48427282|NCT00405756|101380683|FG000|STARTED|Open-label Extension||19||
48427283|NCT00405756|101380684|FG001|STARTED|Open-label Extension||47||
48427284|NCT00405756|101380685|FG002|STARTED|Open-label Extension||72||
48427285|NCT00405756|101380683|FG000|COMPLETED|Open-label Extension||0||
48427286|NCT00405756|101380684|FG001|COMPLETED|Open-label Extension||0||
48427287|NCT00405756|101380685|FG002|COMPLETED|Open-label Extension||0||
48427288|NCT00405756|101380683|FG000|NOT COMPLETED|Open-label Extension||19||
48427289|NCT00405756|101380684|FG001|NOT COMPLETED|Open-label Extension||47||
48427290|NCT00405756|101380685|FG002|NOT COMPLETED|Open-label Extension||72||
48427291|NCT00405756|101380683|FG000|STARTED|Follow-up||75||
48427292|NCT00405756|101380684|FG001|STARTED|Follow-up||90||
48427293|NCT00405756|101380685|FG002|STARTED|Follow-up||88||
48427294|NCT00405756|101380683|FG000|COMPLETED|Follow-up||0||
48427295|NCT00405756|101380684|FG001|COMPLETED|Follow-up||0||
48427296|NCT00405756|101380685|FG002|COMPLETED|Follow-up||0||
48427297|NCT00405756|101380683|FG000|NOT COMPLETED|Follow-up||75||
48427298|NCT00405756|101380684|FG001|NOT COMPLETED|Follow-up||90||
48427299|NCT00405756|101380685|FG002|NOT COMPLETED|Follow-up||88||
48427300|NCT02985541|101380686|FG000|STARTED|Overall Study||364||
48427301|NCT02985541|101380686|FG000|Valid for FAS|Overall Study||362||
48427302|NCT02985541|101380686|FG000|Continued Into Year 7 of Mirena Use|Overall Study||305||
48427303|NCT02985541|101380686|FG000|Continued Into Year 8 of Mirena Use|Overall Study||243||
48427304|NCT02985541|101380686|FG000|COMPLETED|Overall Study||223||
48763973|NCT00651742|102211838|FG000|COMPLETED|Overall Study||0||
48763974|NCT00651742|102211838|FG000|NOT COMPLETED|Overall Study||28||
48763975|NCT02587637|102211839|FG000|STARTED|Overall Study||20||
48763976|NCT02587637|102211839|FG000|Received Intervention|Overall Study||15||
48763977|NCT02587637|102211839|FG000|COMPLETED|Overall Study||14||
48427305|NCT02985541|101380686|FG000|NOT COMPLETED|Overall Study||141||
48427306|NCT00953173|101380687|FG000|STARTED|Overall Study||671||
48427307|NCT00953173|101380687|FG000|COMPLETED|Overall Study||389||
48427308|NCT00953173|101380687|FG000|NOT COMPLETED|Overall Study||282||
48427309|NCT02442284|101380688|FG000|STARTED|Overall Study||99||
48427310|NCT02442284|101380688|FG000|COMPLETED|Overall Study||92||
48427311|NCT02442284|101380688|FG000|NOT COMPLETED|Overall Study||7||
48427312|NCT01471197|101380689|FG000|STARTED|Overall Study||6||
48427313|NCT01471197|101380690|FG001|STARTED|Overall Study||2||
48427314|NCT01471197|101380689|FG000|COMPLETED|Overall Study||0||
48427315|NCT01471197|101380690|FG001|COMPLETED|Overall Study||0||
48427316|NCT01471197|101380689|FG000|NOT COMPLETED|Overall Study||6||
48427317|NCT01471197|101380690|FG001|NOT COMPLETED|Overall Study||2||
48427318|NCT00761891|101380691|FG000|STARTED|Overall Study||64||
48427319|NCT00761891|101380691|FG000|COMPLETED|Overall Study||54||
48427320|NCT00761891|101380691|FG000|NOT COMPLETED|Overall Study||10||
48427321|NCT03205605|101380692|FG000|STARTED|Overall Study||13||
48427322|NCT03205605|101380692|FG000|COMPLETED|Overall Study||12||
48427323|NCT03205605|101380692|FG000|NOT COMPLETED|Overall Study||1||
48427324|NCT01533974|101380693|FG000|STARTED|Overall Study||224||
48427325|NCT01533974|101380694|FG001|STARTED|Overall Study||226||
48427326|NCT01533974|101380693|FG000|COMPLETED|Overall Study||173||
48427327|NCT01533974|101380694|FG001|COMPLETED|Overall Study||176||
48427328|NCT01533974|101380693|FG000|NOT COMPLETED|Overall Study||51||
48427329|NCT01533974|101380694|FG001|NOT COMPLETED|Overall Study||50||
48427330|NCT02713490|101380695|FG000|STARTED|Overall Study||71||
48427331|NCT02713490|101380696|FG001|STARTED|Overall Study||69||
48427332|NCT02713490|101380695|FG000|COMPLETED|Overall Study||68||
48427333|NCT02713490|101380696|FG001|COMPLETED|Overall Study||67||
48427334|NCT02713490|101380695|FG000|NOT COMPLETED|Overall Study||3||
48427335|NCT02713490|101380696|FG001|NOT COMPLETED|Overall Study||2||
48427336|NCT01494753|101380697|FG000|STARTED|Day0-Day42||15||
48427337|NCT01494753|101380698|FG001|STARTED|Day0-Day42||15||
48427338|NCT01494753|101380697|FG000|COMPLETED|Day0-Day42||15||
48427339|NCT01494753|101380698|FG001|COMPLETED|Day0-Day42||15||
48427340|NCT01494753|101380697|FG000|NOT COMPLETED|Day0-Day42||0||
48427341|NCT01494753|101380698|FG001|NOT COMPLETED|Day0-Day42||0||
48427342|NCT01494753|101380697|FG000|STARTED|Day42-Day84||15||
48427343|NCT01494753|101380698|FG001|STARTED|Day42-Day84||15||
48427344|NCT01494753|101380697|FG000|COMPLETED|Day42-Day84||15||
48427345|NCT01494753|101380698|FG001|COMPLETED|Day42-Day84||15||
48427346|NCT01494753|101380697|FG000|NOT COMPLETED|Day42-Day84||0||
48763978|NCT02587637|102211839|FG000|NOT COMPLETED|Overall Study||6||
48427347|NCT01494753|101380698|FG001|NOT COMPLETED|Day42-Day84||0||
48427348|NCT00958282|101380699|FG000|STARTED|Overall Study||22||
48427349|NCT00958282|101380700|FG001|STARTED|Overall Study||21||
48427350|NCT00958282|101380699|FG000|COMPLETED|Overall Study||12||
48427351|NCT00958282|101380700|FG001|COMPLETED|Overall Study||15||
48427352|NCT00958282|101380699|FG000|NOT COMPLETED|Overall Study||10||
48427353|NCT00958282|101380700|FG001|NOT COMPLETED|Overall Study||6||
48427354|NCT03455556|101380701|FG000|STARTED|Overall Study||1||
48427355|NCT03455556|101380701|FG000|COMPLETED|Overall Study||1||
48427356|NCT03455556|101380701|FG000|NOT COMPLETED|Overall Study||0||
48427357|NCT01786707|101380702|FG000|STARTED|Overall Study||1||
48427358|NCT01786707|101380703|FG001|STARTED|Overall Study||1||
48427359|NCT01786707|101380702|FG000|COMPLETED|Overall Study||0||
48427360|NCT01786707|101380703|FG001|COMPLETED|Overall Study||0||
48427361|NCT01786707|101380702|FG000|NOT COMPLETED|Overall Study||1||
48427362|NCT01786707|101380703|FG001|NOT COMPLETED|Overall Study||1||
48427363|NCT01955005|101380704|FG000|STARTED|Overall Study||30||
48427364|NCT01955005|101380705|FG001|STARTED|Overall Study||30||
48427365|NCT01955005|101380704|FG000|COMPLETED|Overall Study||27||
48427366|NCT01955005|101380705|FG001|COMPLETED|Overall Study||25||
48427367|NCT01955005|101380704|FG000|NOT COMPLETED|Overall Study||3||
48427368|NCT01955005|101380705|FG001|NOT COMPLETED|Overall Study||5||
48427369|NCT00792467|101380706|FG000|STARTED|Overall Study||24||
48427370|NCT00792467|101380706|FG000|COMPLETED|Overall Study||2||
48427371|NCT00792467|101380706|FG000|NOT COMPLETED|Overall Study||22||
48427372|NCT02463097|101380707|FG000|STARTED|Overall Study||124||
48427373|NCT02463097|101380707|FG000|COMPLETED|Overall Study||123||
48427374|NCT02463097|101380707|FG000|NOT COMPLETED|Overall Study||1||
48427375|NCT00672490|101380708|FG000|STARTED|Overall Study||187||
48427376|NCT00672490|101380709|FG001|STARTED|Overall Study||189||
48427377|NCT00672490|101380708|FG000|COMPLETED|Overall Study||163||
48427378|NCT00672490|101380709|FG001|COMPLETED|Overall Study||157||
48427379|NCT00672490|101380708|FG000|NOT COMPLETED|Overall Study||24||
48427380|NCT00672490|101380709|FG001|NOT COMPLETED|Overall Study||32||
48427381|NCT04298229|101380710|FG000|STARTED|Overall Study||120||
48427382|NCT04298229|101380711|FG001|STARTED|Overall Study||120||
48427383|NCT04298229|101380710|FG000|COMPLETED|Overall Study||116||
48427384|NCT04298229|101380711|FG001|COMPLETED|Overall Study||118||
48427385|NCT04298229|101380710|FG000|NOT COMPLETED|Overall Study||4||
48427386|NCT04298229|101380711|FG001|NOT COMPLETED|Overall Study||2||
48427387|NCT00784225|101380712|FG000|STARTED|Overall Study||3375||
48427388|NCT00784225|101380713|FG001|STARTED|Overall Study||3357||
48427389|NCT00784225|101380714|FG002|STARTED|Overall Study||3369||
48427390|NCT00784225|101380715|FG003|STARTED|Overall Study||3374||
48427391|NCT00784225|101380712|FG000|COMPLETED|Overall Study||3375||
48427392|NCT00784225|101380713|FG001|COMPLETED|Overall Study||3357||
48427393|NCT00784225|101380714|FG002|COMPLETED|Overall Study||3369||
48427394|NCT00784225|101380715|FG003|COMPLETED|Overall Study||3374||
48427395|NCT00784225|101380712|FG000|NOT COMPLETED|Overall Study||0||
48427396|NCT00784225|101380713|FG001|NOT COMPLETED|Overall Study||0||
48427397|NCT00784225|101380714|FG002|NOT COMPLETED|Overall Study||0||
48427398|NCT00784225|101380715|FG003|NOT COMPLETED|Overall Study||0||
48427399|NCT04805892|101380716|FG000|STARTED|Overall Study||84||
48427400|NCT04805892|101380716|FG000|COMPLETED|Overall Study||84||
48427401|NCT04805892|101380716|FG000|NOT COMPLETED|Overall Study||0||
48427402|NCT00121251|101380717|FG000|STARTED|Overall Study||17||
48427403|NCT00121251|101380717|FG000|COMPLETED|Overall Study||17||
48427404|NCT00121251|101380717|FG000|NOT COMPLETED|Overall Study||0||
48427405|NCT02557308|101380718|FG000|STARTED|Overall Study||124||
48427406|NCT02557308|101380719|FG001|STARTED|Overall Study||23||
48427407|NCT02557308|101380720|FG002|STARTED|Overall Study||10||
48427408|NCT02557308|101380721|FG003|STARTED|Overall Study||3||
48427409|NCT02557308|101380722|FG004|STARTED|Overall Study||5||
48427410|NCT02557308|101380723|FG005|STARTED|Overall Study||0||
48427411|NCT02557308|101380724|FG006|STARTED|Overall Study||146||
48427412|NCT02557308|101380725|FG007|STARTED|Overall Study||18||
48427413|NCT02557308|101380718|FG000|COMPLETED|Overall Study||0||
48427414|NCT02557308|101380719|FG001|COMPLETED|Overall Study||0||
48427415|NCT02557308|101380720|FG002|COMPLETED|Overall Study||0||
48427416|NCT02557308|101380721|FG003|COMPLETED|Overall Study||0||
48427417|NCT02557308|101380722|FG004|COMPLETED|Overall Study||0||
48427418|NCT02557308|101380723|FG005|COMPLETED|Overall Study||0||
48427419|NCT02557308|101380724|FG006|COMPLETED|Overall Study||0||
48427420|NCT02557308|101380725|FG007|COMPLETED|Overall Study||1||
48427421|NCT02557308|101380718|FG000|NOT COMPLETED|Overall Study||124||
48427422|NCT02557308|101380719|FG001|NOT COMPLETED|Overall Study||23||
48427423|NCT02557308|101380720|FG002|NOT COMPLETED|Overall Study||10||
48427424|NCT02557308|101380721|FG003|NOT COMPLETED|Overall Study||3||
48427425|NCT02557308|101380722|FG004|NOT COMPLETED|Overall Study||5||
48427426|NCT02557308|101380723|FG005|NOT COMPLETED|Overall Study||0||
48427427|NCT02557308|101380724|FG006|NOT COMPLETED|Overall Study||146||
48427428|NCT02557308|101380725|FG007|NOT COMPLETED|Overall Study||17||
48427429|NCT04969653|101380726|FG000|STARTED|Overall Study||150975||
48427430|NCT04969653|101380727|FG001|STARTED|Overall Study||603770||
48427431|NCT04969653|101380726|FG000|COMPLETED|Overall Study||150975||
48427432|NCT04969653|101380727|FG001|COMPLETED|Overall Study||603770||
48427433|NCT04969653|101380726|FG000|NOT COMPLETED|Overall Study||0||
48427434|NCT04969653|101380727|FG001|NOT COMPLETED|Overall Study||0||
48427435|NCT02675933|101380728|FG000|STARTED|Overall Study||32||
48427436|NCT02675933|101380729|FG001|STARTED|Overall Study||31||
48427437|NCT02675933|101380728|FG000|COMPLETED|Overall Study||32||
48427438|NCT02675933|101380729|FG001|COMPLETED|Overall Study||31||
48427439|NCT02675933|101380728|FG000|NOT COMPLETED|Overall Study||0||
48427440|NCT02675933|101380729|FG001|NOT COMPLETED|Overall Study||0||
48427441|NCT05261126|101380730|FG000|STARTED|Overall Study||77||
48427442|NCT05261126|101380731|FG001|STARTED|Overall Study||76||
48427443|NCT05261126|101380732|FG002|STARTED|Overall Study||76||
48427444|NCT05261126|101380733|FG003|STARTED|Overall Study||76||
48427445|NCT05261126|101380734|FG004|STARTED|Overall Study||76||
48427446|NCT05261126|101380730|FG000|Treated|Overall Study||77||
48427447|NCT05261126|101380731|FG001|Treated|Overall Study||76||
48427448|NCT05261126|101380732|FG002|Treated|Overall Study||76||
48427449|NCT05261126|101380733|FG003|Treated|Overall Study||76||
48427450|NCT05261126|101380734|FG004|Treated|Overall Study||75||
48427451|NCT05261126|101380730|FG000|COMPLETED|Overall Study||75||
48427452|NCT05261126|101380731|FG001|COMPLETED|Overall Study||76||
48427453|NCT05261126|101380732|FG002|COMPLETED|Overall Study||74||
48427454|NCT05261126|101380733|FG003|COMPLETED|Overall Study||74||
48427455|NCT05261126|101380734|FG004|COMPLETED|Overall Study||74||
48427456|NCT05261126|101380730|FG000|NOT COMPLETED|Overall Study||2||
48427457|NCT05261126|101380731|FG001|NOT COMPLETED|Overall Study||0||
48427458|NCT05261126|101380732|FG002|NOT COMPLETED|Overall Study||2||
48427459|NCT05261126|101380733|FG003|NOT COMPLETED|Overall Study||2||
48427460|NCT05261126|101380734|FG004|NOT COMPLETED|Overall Study||2||
48427461|NCT03287089|101380735|FG000|STARTED|Overall Study||82||
48427462|NCT03287089|101380736|FG001|STARTED|Overall Study||82||
48427463|NCT03287089|101380735|FG000|COMPLETED|Overall Study||82||
48427464|NCT03287089|101380736|FG001|COMPLETED|Overall Study||76||
48427465|NCT03287089|101380735|FG000|NOT COMPLETED|Overall Study||0||
48427466|NCT03287089|101380736|FG001|NOT COMPLETED|Overall Study||6||
48427467|NCT04524663|101380737|FG000|STARTED|Overall Study||25||
48427468|NCT04524663|101380738|FG001|STARTED|Overall Study||24||
48427469|NCT04524663|101380737|FG000|COMPLETED|Overall Study||25||
48427470|NCT04524663|101380738|FG001|COMPLETED|Overall Study||22||
48427471|NCT04524663|101380737|FG000|NOT COMPLETED|Overall Study||0||
48427472|NCT04524663|101380738|FG001|NOT COMPLETED|Overall Study||2||
48427473|NCT00223990|101380739|FG000|STARTED|Overall Study||200||
48427474|NCT00223990|101380740|FG001|STARTED|Overall Study||200||
48427475|NCT00223990|101380739|FG000|COMPLETED|Overall Study||193||
48427476|NCT00223990|101380740|FG001|COMPLETED|Overall Study||191||
48427477|NCT00223990|101380739|FG000|NOT COMPLETED|Overall Study||7||
48427478|NCT00223990|101380740|FG001|NOT COMPLETED|Overall Study||9||
48427479|NCT01080794|101380741|FG000|STARTED|Overall Study||20||
48427480|NCT01080794|101380742|FG001|STARTED|Overall Study||14||
48427481|NCT01080794|101380743|FG002|STARTED|Overall Study||12||
48427482|NCT01080794|101380744|FG003|STARTED|Overall Study||15||
48427483|NCT01080794|101380741|FG000|COMPLETED|Overall Study||15||
48427484|NCT01080794|101380742|FG001|COMPLETED|Overall Study||12||
48427485|NCT01080794|101380743|FG002|COMPLETED|Overall Study||10||
48427486|NCT01080794|101380744|FG003|COMPLETED|Overall Study||13||
48427487|NCT01080794|101380741|FG000|NOT COMPLETED|Overall Study||5||
48427488|NCT01080794|101380742|FG001|NOT COMPLETED|Overall Study||2||
48427489|NCT01080794|101380743|FG002|NOT COMPLETED|Overall Study||2||
48427490|NCT01080794|101380744|FG003|NOT COMPLETED|Overall Study||2||
48427491|NCT00383292|101380745|FG000|STARTED|Overall Study||68||
48427492|NCT00383292|101380746|FG001|STARTED|Overall Study||32||
48427493|NCT00383292|101380747|FG002|STARTED|Overall Study||30||
48427494|NCT00383292|101380745|FG000|Received at Least One Dose of Study Drug|Overall Study||68||
48427495|NCT00383292|101380746|FG001|Received at Least One Dose of Study Drug|Overall Study||32||
48427496|NCT00383292|101380747|FG002|Received at Least One Dose of Study Drug|Overall Study||30||
48427497|NCT00383292|101380745|FG000|COMPLETED|Overall Study||53||
48427498|NCT00383292|101380746|FG001|COMPLETED|Overall Study||26||
48427499|NCT00383292|101380747|FG002|COMPLETED|Overall Study||22||
48427500|NCT00383292|101380745|FG000|NOT COMPLETED|Overall Study||15||
48427501|NCT00383292|101380746|FG001|NOT COMPLETED|Overall Study||6||
48427502|NCT00383292|101380747|FG002|NOT COMPLETED|Overall Study||8||
48427503|NCT03758612|101380748|FG000|STARTED|Period 1||6||
48427504|NCT03758612|101380749|FG001|STARTED|Period 1||6||
48427505|NCT03758612|101380750|FG002|STARTED|Period 1||6||
48427506|NCT03758612|101380751|FG003|STARTED|Period 1||6||
48427507|NCT03758612|101380752|FG004|STARTED|Period 1||8||
48427508|NCT03758612|101380753|FG005|STARTED|Period 1||6||
48427509|NCT03758612|101380754|FG006|STARTED|Period 1||8||
48427510|NCT03758612|101380755|FG007|STARTED|Period 1||14||
48427511|NCT03758612|101380756|FG008|STARTED|Period 1||6||
48427512|NCT03758612|101380757|FG009|STARTED|Period 1||6||
48427513|NCT03758612|101380758|FG010|STARTED|Period 1||6||
48427514|NCT03758612|101380759|FG011|STARTED|Period 1||6||
48427515|NCT03758612|101380748|FG000|COMPLETED|Period 1||6||
48427516|NCT03758612|101380749|FG001|COMPLETED|Period 1||6||
48427517|NCT03758612|101380750|FG002|COMPLETED|Period 1||6||
48427518|NCT03758612|101380751|FG003|COMPLETED|Period 1||6||
48427519|NCT03758612|101380752|FG004|COMPLETED|Period 1||8||
48427520|NCT03758612|101380753|FG005|COMPLETED|Period 1||6||
48427521|NCT03758612|101380754|FG006|COMPLETED|Period 1||8||
48427522|NCT03758612|101380755|FG007|COMPLETED|Period 1||14||
48427523|NCT03758612|101380756|FG008|COMPLETED|Period 1||6||
48427524|NCT03758612|101380757|FG009|COMPLETED|Period 1||6||
48427525|NCT03758612|101380758|FG010|COMPLETED|Period 1||6||
48427526|NCT03758612|101380759|FG011|COMPLETED|Period 1||6||
48427527|NCT03758612|101380748|FG000|NOT COMPLETED|Period 1||0||
48427528|NCT03758612|101380749|FG001|NOT COMPLETED|Period 1||0||
48427529|NCT03758612|101380750|FG002|NOT COMPLETED|Period 1||0||
48427530|NCT03758612|101380751|FG003|NOT COMPLETED|Period 1||0||
48427531|NCT03758612|101380752|FG004|NOT COMPLETED|Period 1||0||
48427532|NCT03758612|101380753|FG005|NOT COMPLETED|Period 1||0||
48427533|NCT03758612|101380754|FG006|NOT COMPLETED|Period 1||0||
48427534|NCT03758612|101380755|FG007|NOT COMPLETED|Period 1||0||
48427535|NCT03758612|101380756|FG008|NOT COMPLETED|Period 1||0||
48427536|NCT03758612|101380757|FG009|NOT COMPLETED|Period 1||0||
48427537|NCT03758612|101380758|FG010|NOT COMPLETED|Period 1||0||
48427538|NCT03758612|101380759|FG011|NOT COMPLETED|Period 1||0||
48427539|NCT03758612|101380748|FG000|STARTED|Washout Period||0||
48427540|NCT03758612|101380749|FG001|STARTED|Washout Period||0||
48427541|NCT03758612|101380750|FG002|STARTED|Washout Period||6||
48427542|NCT03758612|101380751|FG003|STARTED|Washout Period||0||
48427543|NCT03758612|101380752|FG004|STARTED|Washout Period||8||
48427544|NCT03758612|101380753|FG005|STARTED|Washout Period||0||
48427545|NCT03758612|101380754|FG006|STARTED|Washout Period||0||
48427546|NCT03758612|101380755|FG007|STARTED|Washout Period||2||
48427547|NCT03758612|101380756|FG008|STARTED|Washout Period||0||
48427548|NCT03758612|101380757|FG009|STARTED|Washout Period||0||
48427549|NCT03758612|101380758|FG010|STARTED|Washout Period||0||
48427550|NCT03758612|101380759|FG011|STARTED|Washout Period||6||
48427551|NCT03758612|101380748|FG000|COMPLETED|Washout Period||0||
48427552|NCT03758612|101380749|FG001|COMPLETED|Washout Period||0||
48427553|NCT03758612|101380750|FG002|COMPLETED|Washout Period||4||
48427554|NCT03758612|101380751|FG003|COMPLETED|Washout Period||0||
48427555|NCT03758612|101380752|FG004|COMPLETED|Washout Period||8||
48427556|NCT03758612|101380753|FG005|COMPLETED|Washout Period||0||
48427557|NCT03758612|101380754|FG006|COMPLETED|Washout Period||0||
48427558|NCT03758612|101380755|FG007|COMPLETED|Washout Period||2||
48427559|NCT03758612|101380756|FG008|COMPLETED|Washout Period||0||
48427560|NCT03758612|101380757|FG009|COMPLETED|Washout Period||0||
48427561|NCT03758612|101380758|FG010|COMPLETED|Washout Period||0||
48427562|NCT03758612|101380759|FG011|COMPLETED|Washout Period||6||
48427563|NCT03758612|101380748|FG000|NOT COMPLETED|Washout Period||0||
48427564|NCT03758612|101380749|FG001|NOT COMPLETED|Washout Period||0||
48427565|NCT03758612|101380750|FG002|NOT COMPLETED|Washout Period||2||
48427566|NCT03758612|101380751|FG003|NOT COMPLETED|Washout Period||0||
48427567|NCT03758612|101380752|FG004|NOT COMPLETED|Washout Period||0||
48427568|NCT03758612|101380753|FG005|NOT COMPLETED|Washout Period||0||
48427569|NCT03758612|101380754|FG006|NOT COMPLETED|Washout Period||0||
48427570|NCT03758612|101380755|FG007|NOT COMPLETED|Washout Period||0||
48427571|NCT03758612|101380756|FG008|NOT COMPLETED|Washout Period||0||
48427572|NCT03758612|101380757|FG009|NOT COMPLETED|Washout Period||0||
48427573|NCT03758612|101380758|FG010|NOT COMPLETED|Washout Period||0||
48427574|NCT03758612|101380759|FG011|NOT COMPLETED|Washout Period||0||
48427575|NCT03758612|101380748|FG000|STARTED|Period 2||0||
48427576|NCT03758612|101380749|FG001|STARTED|Period 2||0||
48427577|NCT03758612|101380750|FG002|STARTED|Period 2||6||
48427578|NCT03758612|101380751|FG003|STARTED|Period 2||0||
48427579|NCT03758612|101380752|FG004|STARTED|Period 2||8||
48427580|NCT03758612|101380753|FG005|STARTED|Period 2||0||
48427581|NCT03758612|101380754|FG006|STARTED|Period 2||0||
48427582|NCT03758612|101380755|FG007|STARTED|Period 2||2||
48427583|NCT03758612|101380756|FG008|STARTED|Period 2||0||
48427584|NCT03758612|101380757|FG009|STARTED|Period 2||0||
48427585|NCT03758612|101380758|FG010|STARTED|Period 2||0||
48427586|NCT03758612|101380759|FG011|STARTED|Period 2||6||
48427587|NCT03758612|101380748|FG000|COMPLETED|Period 2||0||
48427588|NCT03758612|101380749|FG001|COMPLETED|Period 2||0||
48427589|NCT03758612|101380750|FG002|COMPLETED|Period 2||6||
48427590|NCT03758612|101380751|FG003|COMPLETED|Period 2||0||
48427591|NCT03758612|101380752|FG004|COMPLETED|Period 2||7||
48427592|NCT03758612|101380753|FG005|COMPLETED|Period 2||0||
48427593|NCT03758612|101380754|FG006|COMPLETED|Period 2||0||
48427594|NCT03758612|101380755|FG007|COMPLETED|Period 2||2||
48427595|NCT03758612|101380756|FG008|COMPLETED|Period 2||0||
48427596|NCT03758612|101380757|FG009|COMPLETED|Period 2||0||
48427597|NCT03758612|101380758|FG010|COMPLETED|Period 2||0||
48427598|NCT03758612|101380759|FG011|COMPLETED|Period 2||6||
48427599|NCT03758612|101380748|FG000|NOT COMPLETED|Period 2||0||
48427600|NCT03758612|101380749|FG001|NOT COMPLETED|Period 2||0||
48427601|NCT03758612|101380750|FG002|NOT COMPLETED|Period 2||0||
48427602|NCT03758612|101380751|FG003|NOT COMPLETED|Period 2||0||
48427603|NCT03758612|101380752|FG004|NOT COMPLETED|Period 2||1||
48427604|NCT03758612|101380753|FG005|NOT COMPLETED|Period 2||0||
48427605|NCT03758612|101380754|FG006|NOT COMPLETED|Period 2||0||
48427606|NCT03758612|101380755|FG007|NOT COMPLETED|Period 2||0||
48427607|NCT03758612|101380756|FG008|NOT COMPLETED|Period 2||0||
48427608|NCT03758612|101380757|FG009|NOT COMPLETED|Period 2||0||
48427609|NCT03758612|101380758|FG010|NOT COMPLETED|Period 2||0||
48427610|NCT03758612|101380759|FG011|NOT COMPLETED|Period 2||0||
48427611|NCT04152200|101380760|FG000|STARTED|Primary Analysis Period||6||
48427612|NCT04152200|101380761|FG001|STARTED|Primary Analysis Period||15||
48427613|NCT04152200|101380760|FG000|COMPLETED|Primary Analysis Period||6||
48427614|NCT04152200|101380761|FG001|COMPLETED|Primary Analysis Period||15||
48427615|NCT04152200|101380760|FG000|NOT COMPLETED|Primary Analysis Period||0||
48427616|NCT04152200|101380761|FG001|NOT COMPLETED|Primary Analysis Period||0||
48427617|NCT04152200|101380760|FG000|STARTED|Long-term Extension Period||6||
48427618|NCT04152200|101380761|FG001|STARTED|Long-term Extension Period||15||
48427619|NCT04152200|101380760|FG000|COMPLETED|Long-term Extension Period||0||
48427620|NCT04152200|101380761|FG001|COMPLETED|Long-term Extension Period||0||
48427621|NCT04152200|101380760|FG000|NOT COMPLETED|Long-term Extension Period||6||
48427622|NCT04152200|101380761|FG001|NOT COMPLETED|Long-term Extension Period||15||
48427623|NCT04067310|101380762|FG000|STARTED|Overall Study||36||
48427624|NCT04067310|101380763|FG001|STARTED|Overall Study||36||
48427625|NCT04067310|101380762|FG000|COMPLETED|Overall Study||31||
48427626|NCT04067310|101380763|FG001|COMPLETED|Overall Study||29||
48427627|NCT04067310|101380762|FG000|NOT COMPLETED|Overall Study||5||
48427628|NCT04067310|101380763|FG001|NOT COMPLETED|Overall Study||7||
48427629|NCT01062230|101380764|FG000|STARTED|Overall Study||6||
48427630|NCT01062230|101380764|FG000|COMPLETED|Overall Study||6||
48427631|NCT01062230|101380764|FG000|NOT COMPLETED|Overall Study||0||
48427632|NCT04259749|101380765|FG000|STARTED|Overall Study||89||
48427633|NCT04259749|101380766|FG001|STARTED|Overall Study||91||
48427634|NCT04259749|101380767|FG002|STARTED|Overall Study||87||
48427635|NCT04259749|101380765|FG000|COMPLETED|Overall Study||89||
48427636|NCT04259749|101380766|FG001|COMPLETED|Overall Study||91||
48427637|NCT04259749|101380767|FG002|COMPLETED|Overall Study||87||
48427638|NCT04259749|101380765|FG000|NOT COMPLETED|Overall Study||0||
48427639|NCT04259749|101380766|FG001|NOT COMPLETED|Overall Study||0||
48427640|NCT04259749|101380767|FG002|NOT COMPLETED|Overall Study||0||
48427641|NCT02950831|101380768|FG000|STARTED|Overall Study||27||
48427642|NCT02950831|101380768|FG000|Complete Trial|Overall Study||26||
48427643|NCT02950831|101380768|FG000|Permanent Implant|Overall Study||20||
48427644|NCT02950831|101380768|FG000|4 Week Follow up|Overall Study||20||
48427645|NCT02950831|101380768|FG000|8 Weeks Follow up|Overall Study||19||
48427646|NCT02950831|101380768|FG000|COMPLETED|Overall Study||18||
48427647|NCT02950831|101380768|FG000|NOT COMPLETED|Overall Study||9||
48427648|NCT05807464|101380769|FG000|STARTED|Overall Study||12||
48427649|NCT05807464|101380769|FG000|COMPLETED|Overall Study||11||
48427650|NCT05807464|101380769|FG000|NOT COMPLETED|Overall Study||1||
48427651|NCT00863265|101380770|FG000|STARTED|Overall Study||4||
48427652|NCT00863265|101380771|FG001|STARTED|Overall Study||3||
48427653|NCT00863265|101380772|FG002|STARTED|Overall Study||4||
48427654|NCT00863265|101380773|FG003|STARTED|Overall Study||4||
48427655|NCT00863265|101380774|FG004|STARTED|Overall Study||4||
48427656|NCT00863265|101380775|FG005|STARTED|Overall Study||3||
48427657|NCT00863265|101380770|FG000|COMPLETED|Overall Study||4||
48427658|NCT00863265|101380771|FG001|COMPLETED|Overall Study||3||
48427659|NCT00863265|101380772|FG002|COMPLETED|Overall Study||4||
48638952|NCT03233217|101901536|FG003|NOT COMPLETED|Overall Study||0||
48638953|NCT03233217|101901537|FG004|NOT COMPLETED|Overall Study||0||
48427660|NCT00863265|101380773|FG003|COMPLETED|Overall Study||4||
48427661|NCT00863265|101380774|FG004|COMPLETED|Overall Study||3||
48427662|NCT00863265|101380775|FG005|COMPLETED|Overall Study||3||
48427663|NCT00863265|101380770|FG000|NOT COMPLETED|Overall Study||0||
48427664|NCT00863265|101380771|FG001|NOT COMPLETED|Overall Study||0||
48427665|NCT00863265|101380772|FG002|NOT COMPLETED|Overall Study||0||
48427666|NCT00863265|101380773|FG003|NOT COMPLETED|Overall Study||0||
48427667|NCT00863265|101380774|FG004|NOT COMPLETED|Overall Study||1||
48427668|NCT00863265|101380775|FG005|NOT COMPLETED|Overall Study||0||
48427669|NCT04047472|101380776|FG000|STARTED|Overall Study||199||
48638954|NCT01139879|101901538|FG000|STARTED|Overall Study||10||
48638955|NCT01139879|101901538|FG000|COMPLETED|Overall Study||10||
48638956|NCT01139879|101901538|FG000|NOT COMPLETED|Overall Study||0||
48638957|NCT00866320|101901539|FG000|STARTED|Overall Study||49||
48638958|NCT00866320|101901539|FG000|COMPLETED|Overall Study||43||
48427670|NCT04047472|101380777|FG001|STARTED|Overall Study||198||
48427671|NCT04047472|101380776|FG000|COMPLETED|Overall Study||183||
48638959|NCT00866320|101901539|FG000|NOT COMPLETED|Overall Study||6||
48427672|NCT04047472|101380777|FG001|COMPLETED|Overall Study||182||
48427673|NCT04047472|101380776|FG000|NOT COMPLETED|Overall Study||16||
48427674|NCT04047472|101380777|FG001|NOT COMPLETED|Overall Study||16||
48427675|NCT03547960|101380778|FG000|STARTED|Overall Study||30||
48427676|NCT03547960|101380779|FG001|STARTED|Overall Study||30||
48427677|NCT03547960|101380778|FG000|COMPLETED|Overall Study||10||
48427678|NCT03547960|101380779|FG001|COMPLETED|Overall Study||10||
48427679|NCT03547960|101380778|FG000|NOT COMPLETED|Overall Study||20||
48427680|NCT03547960|101380779|FG001|NOT COMPLETED|Overall Study||20||
48427681|NCT01000311|101380780|FG000|STARTED|Overall Study||258||
48638960|NCT04426656|101901540|FG000|STARTED|Overall Study||24||
48360148|NCT02031146|101210835|FG006|Considered in Analysis|Overall Study||0|All participants who were randomized were included in the analysis. The first entry visit for those who were not randomized were included in the analysis if: 1) serum RPR was at or above 1:32 or 2) for PLWH, peripheral blood CD4 + T cells were at or below 350/ul. All included had to have undergone the entry CogState battery.|
48360149|NCT02031146|101210829|FG000|COMPLETED|Overall Study||11|Completed = considered in analysis|
48360150|NCT02031146|101210830|FG001|COMPLETED|Overall Study||3|Completed = considered in analysis|
48360151|NCT02031146|101210831|FG002|COMPLETED|Overall Study||18|Completed = considered in analysis|
48360152|NCT02031146|101210832|FG003|COMPLETED|Overall Study||48|Completed = considered in analysis|
48360153|NCT02031146|101210833|FG004|COMPLETED|Overall Study||16|Completed = considered in analysis|
48360154|NCT02031146|101210834|FG005|COMPLETED|Overall Study||0|Completed = considered in analysis|
48360155|NCT02031146|101210835|FG006|COMPLETED|Overall Study||0|Completed = considered in analysis|
48360156|NCT02031146|101210829|FG000|NOT COMPLETED|Overall Study||0||
48360157|NCT02031146|101210830|FG001|NOT COMPLETED|Overall Study||0||
48360158|NCT02031146|101210831|FG002|NOT COMPLETED|Overall Study||0||
48360159|NCT02031146|101210832|FG003|NOT COMPLETED|Overall Study||100||
48360160|NCT02031146|101210833|FG004|NOT COMPLETED|Overall Study||26||
48360161|NCT02031146|101210834|FG005|NOT COMPLETED|Overall Study||4||
48360162|NCT02031146|101210835|FG006|NOT COMPLETED|Overall Study||5||
48360163|NCT01161524|101210836|FG000|STARTED|Core Study (23 Weeks)||85||
48360164|NCT01161524|101210837|FG001|STARTED|Core Study (23 Weeks)||48||
48360165|NCT01161524|101210838|FG002|STARTED|Core Study (23 Weeks)||0||
48360166|NCT01161524|101210836|FG000|COMPLETED|Core Study (23 Weeks)||76||
48360167|NCT01161524|101210837|FG001|COMPLETED|Core Study (23 Weeks)||43||
48360168|NCT01161524|101210838|FG002|COMPLETED|Core Study (23 Weeks)||0||
48360169|NCT01161524|101210836|FG000|NOT COMPLETED|Core Study (23 Weeks)||9||
48360170|NCT01161524|101210837|FG001|NOT COMPLETED|Core Study (23 Weeks)||5||
48360171|NCT01161524|101210838|FG002|NOT COMPLETED|Core Study (23 Weeks)||0||
48360172|NCT01161524|101210836|FG000|STARTED|Extension Phase (Approximately 83 Weeks)||0||
48360173|NCT01161524|101210837|FG001|STARTED|Extension Phase (Approximately 83 Weeks)||0||
48360174|NCT01161524|101210838|FG002|STARTED|Extension Phase (Approximately 83 Weeks)||114||
48360175|NCT01161524|101210836|FG000|COMPLETED|Extension Phase (Approximately 83 Weeks)||0||
48360176|NCT01161524|101210837|FG001|COMPLETED|Extension Phase (Approximately 83 Weeks)||0||
48360177|NCT01161524|101210838|FG002|COMPLETED|Extension Phase (Approximately 83 Weeks)||90||
48360178|NCT01161524|101210836|FG000|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||0||
48360179|NCT01161524|101210837|FG001|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||0||
48360180|NCT01161524|101210838|FG002|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||24||
48360181|NCT02522481|101210839|FG000|STARTED|Overall Study||175||
48360182|NCT02522481|101210839|FG000|COMPLETED|Overall Study||172||
48360183|NCT02522481|101210839|FG000|NOT COMPLETED|Overall Study||3||
48360184|NCT01743027|101210840|FG000|STARTED|Overall Study||98||
48360185|NCT01743027|101210841|FG001|STARTED|Overall Study||99||
48360186|NCT01743027|101210842|FG002|STARTED|Overall Study||99||
48360187|NCT01743027|101210843|FG003|STARTED|Overall Study||49||
48360188|NCT01743027|101210840|FG000|COMPLETED|Overall Study||93||
48360189|NCT01743027|101210841|FG001|COMPLETED|Overall Study||94||
48360190|NCT01743027|101210842|FG002|COMPLETED|Overall Study||90||
48360191|NCT01743027|101210843|FG003|COMPLETED|Overall Study||48||
48360192|NCT01743027|101210840|FG000|NOT COMPLETED|Overall Study||5||
48187305|NCT01996644|100780014|FG001|COMPLETED|Overall Study||16||
48360193|NCT01743027|101210841|FG001|NOT COMPLETED|Overall Study||5||
48360194|NCT01743027|101210842|FG002|NOT COMPLETED|Overall Study||9||
48360195|NCT01743027|101210843|FG003|NOT COMPLETED|Overall Study||1||
48360196|NCT00824538|101210844|FG000|STARTED|Overall Study||13||
48360197|NCT00824538|101210844|FG000|COMPLETED|Overall Study||11||
48360198|NCT00824538|101210844|FG000|NOT COMPLETED|Overall Study||2||
48763979|NCT01624350|102211840|FG000|STARTED|Overall Study||100||
48763980|NCT01624350|102211840|FG000|COMPLETED|Overall Study||75||
48360199|NCT03518840|101210845|FG000|STARTED|Overall Study||63||
48360200|NCT03518840|101210845|FG000|COMPLETED|Overall Study||57||
48360201|NCT03518840|101210845|FG000|NOT COMPLETED|Overall Study||6||
48360202|NCT01933672|101210846|FG000|STARTED|Metformin Run-in Period||43||
48360203|NCT01933672|101210847|FG001|STARTED|Metformin Run-in Period||0||
48360204|NCT01933672|101210848|FG002|STARTED|Metformin Run-in Period||0||
48360205|NCT01933672|101210849|FG003|STARTED|Metformin Run-in Period||0||
48360206|NCT01933672|101210850|FG004|STARTED|Metformin Run-in Period||0||
48360207|NCT01933672|101210851|FG005|STARTED|Metformin Run-in Period||0||
48360208|NCT01933672|101210852|FG006|STARTED|Metformin Run-in Period||0||
48360209|NCT01933672|101210846|FG000|Received Treatment|Metformin Run-in Period||43||
48360210|NCT01933672|101210847|FG001|Received Treatment|Metformin Run-in Period||0||
48360211|NCT01933672|101210848|FG002|Received Treatment|Metformin Run-in Period||0||
48360212|NCT01933672|101210849|FG003|Received Treatment|Metformin Run-in Period||0||
48360213|NCT01933672|101210850|FG004|Received Treatment|Metformin Run-in Period||0||
48427682|NCT01000311|101380781|FG001|STARTED|Overall Study||271||
48427683|NCT01000311|101380780|FG000|COMPLETED|Overall Study||213||
48427684|NCT01000311|101380781|FG001|COMPLETED|Overall Study||201||
48427685|NCT01000311|101380780|FG000|NOT COMPLETED|Overall Study||45||
48427686|NCT01000311|101380781|FG001|NOT COMPLETED|Overall Study||70||
48427687|NCT05689554|101380782|FG000|STARTED|Overall Study||1106||9
48427688|NCT05689554|101380783|FG001|STARTED|Overall Study||1261||9
48427689|NCT05689554|101380782|FG000|COMPLETED|Overall Study||1106||9
48427690|NCT05689554|101380783|FG001|COMPLETED|Overall Study||1261||9
48427691|NCT05689554|101380782|FG000|NOT COMPLETED|Overall Study||0||0
48427692|NCT05689554|101380783|FG001|NOT COMPLETED|Overall Study||0||0
48427693|NCT00608426|101380784|FG000|STARTED|Overall Study||2604||
48427694|NCT00608426|101380785|FG001|STARTED|Overall Study||2519||
48427695|NCT00608426|101380784|FG000|COMPLETED|Overall Study||1768||
48427696|NCT00608426|101380785|FG001|COMPLETED|Overall Study||1614||
48427697|NCT00608426|101380784|FG000|NOT COMPLETED|Overall Study||836||
48427698|NCT00608426|101380785|FG001|NOT COMPLETED|Overall Study||905||
48427699|NCT03927209|101380786|FG000|STARTED|Overall Study||5||
48427700|NCT03927209|101380787|FG001|STARTED|Overall Study||5||
48427701|NCT03927209|101380786|FG000|COMPLETED|Overall Study||5||
48427702|NCT03927209|101380787|FG001|COMPLETED|Overall Study||5||
48427703|NCT03927209|101380786|FG000|NOT COMPLETED|Overall Study||0||
48427704|NCT03927209|101380787|FG001|NOT COMPLETED|Overall Study||0||
48427705|NCT04052425|101380788|FG000|STARTED|24-Week Double-blind Period||221||
48427706|NCT04052425|101380789|FG001|STARTED|24-Week Double-blind Period||109||
48427707|NCT04052425|101380790|FG002|STARTED|24-Week Double-blind Period||0||
48427708|NCT04052425|101380791|FG003|STARTED|24-Week Double-blind Period||0||
48427709|NCT04052425|101380788|FG000|COMPLETED|24-Week Double-blind Period||193||
48427710|NCT04052425|101380789|FG001|COMPLETED|24-Week Double-blind Period||90||
48427711|NCT04052425|101380790|FG002|COMPLETED|24-Week Double-blind Period||0||
48427712|NCT04052425|101380791|FG003|COMPLETED|24-Week Double-blind Period||0||
48427713|NCT04052425|101380788|FG000|NOT COMPLETED|24-Week Double-blind Period||28||
48427714|NCT04052425|101380789|FG001|NOT COMPLETED|24-Week Double-blind Period||19||
48427715|NCT04052425|101380790|FG002|NOT COMPLETED|24-Week Double-blind Period||0||
48427716|NCT04052425|101380791|FG003|NOT COMPLETED|24-Week Double-blind Period||0||
48427717|NCT04052425|101380788|FG000|STARTED|28-Week Treatment-Extension Period||0||
48427718|NCT04052425|101380789|FG001|STARTED|28-Week Treatment-Extension Period||0||
48427719|NCT04052425|101380790|FG002|STARTED|28-Week Treatment-Extension Period||193||
48427720|NCT04052425|101380791|FG003|STARTED|28-Week Treatment-Extension Period||90||
48427721|NCT04052425|101380788|FG000|COMPLETED|28-Week Treatment-Extension Period||0||
48427722|NCT04052425|101380789|FG001|COMPLETED|28-Week Treatment-Extension Period||0||
48427723|NCT04052425|101380790|FG002|COMPLETED|28-Week Treatment-Extension Period||174||
48427724|NCT04052425|101380791|FG003|COMPLETED|28-Week Treatment-Extension Period||80||
48427725|NCT04052425|101380788|FG000|NOT COMPLETED|28-Week Treatment-Extension Period||0||
48427726|NCT04052425|101380789|FG001|NOT COMPLETED|28-Week Treatment-Extension Period||0||
48427727|NCT04052425|101380790|FG002|NOT COMPLETED|28-Week Treatment-Extension Period||19||
48427728|NCT04052425|101380791|FG003|NOT COMPLETED|28-Week Treatment-Extension Period||10||
48427729|NCT01288911|101380792|FG000|STARTED|Double-blind Period||184||
48427730|NCT01288911|101380793|FG001|STARTED|Double-blind Period||191||
48427731|NCT01288911|101380792|FG000|Received Treatment|Double-blind Period||183||
48427732|NCT01288911|101380793|FG001|Received Treatment|Double-blind Period||189||
48427733|NCT01288911|101380792|FG000|COMPLETED|Double-blind Period||42||
48427734|NCT01288911|101380793|FG001|COMPLETED|Double-blind Period||9||
48427735|NCT01288911|101380792|FG000|NOT COMPLETED|Double-blind Period||142||
48427736|NCT01288911|101380793|FG001|NOT COMPLETED|Double-blind Period||182||
48427737|NCT01288911|101380792|FG000|STARTED|Open-label Period (All Enzalutamide)||42||
48427738|NCT01288911|101380793|FG001|STARTED|Open-label Period (All Enzalutamide)||9||
48427739|NCT01288911|101380792|FG000|Received Treatment|Open-label Period (All Enzalutamide)||42||
48427740|NCT01288911|101380793|FG001|Received Treatment|Open-label Period (All Enzalutamide)||9||
48427741|NCT01288911|101380792|FG000|COMPLETED|Open-label Period (All Enzalutamide)||0||
48427742|NCT01288911|101380793|FG001|COMPLETED|Open-label Period (All Enzalutamide)||0||
48427743|NCT01288911|101380792|FG000|NOT COMPLETED|Open-label Period (All Enzalutamide)||42||
48427744|NCT01288911|101380793|FG001|NOT COMPLETED|Open-label Period (All Enzalutamide)||9||
48427745|NCT01654666|101380794|FG000|STARTED|Overall Study||63||
48427746|NCT01654666|101380795|FG001|STARTED|Overall Study||63||
48427747|NCT01654666|101380796|FG002|STARTED|Overall Study||63||
48427748|NCT01654666|101380794|FG000|Primary Analysis|Overall Study||52||
48427749|NCT01654666|101380795|FG001|Primary Analysis|Overall Study||56||
48427750|NCT01654666|101380796|FG002|Primary Analysis|Overall Study||54||
48427751|NCT01654666|101380794|FG000|COMPLETED|Overall Study||48||
48427752|NCT01654666|101380795|FG001|COMPLETED|Overall Study||50||
48427753|NCT01654666|101380796|FG002|COMPLETED|Overall Study||49||
48427754|NCT01654666|101380794|FG000|NOT COMPLETED|Overall Study||15||
48427755|NCT01654666|101380795|FG001|NOT COMPLETED|Overall Study||13||
48427756|NCT01654666|101380796|FG002|NOT COMPLETED|Overall Study||14||
48427757|NCT03759340|101380797|FG000|STARTED|Overall Study||56||
48427758|NCT03759340|101380797|FG000|COMPLETED|Overall Study||0||
48763981|NCT01624350|102211840|FG000|NOT COMPLETED|Overall Study||25||
48187306|NCT01996644|100780013|FG000|NOT COMPLETED|Overall Study||0||
48187307|NCT01996644|100780014|FG001|NOT COMPLETED|Overall Study||0||
48187308|NCT03875495|100780015|FG000|STARTED|Overall Study||3||
48187309|NCT03875495|100780015|FG000|COMPLETED|Overall Study||0||
48187310|NCT03875495|100780015|FG000|NOT COMPLETED|Overall Study||3||
48187311|NCT00365417|100780016|FG000|STARTED|Overall Study||45||
48187312|NCT00365417|100780016|FG000|COMPLETED|Overall Study||45||
48187313|NCT00365417|100780016|FG000|NOT COMPLETED|Overall Study||0||
48187314|NCT04482855|100780017|FG000|STARTED|Overall Study||12||
48187315|NCT04482855|100780018|FG001|STARTED|Overall Study||13||
48187316|NCT04482855|100780017|FG000|COMPLETED|Overall Study||9||
48187317|NCT04482855|100780018|FG001|COMPLETED|Overall Study||13||
48187318|NCT04482855|100780017|FG000|NOT COMPLETED|Overall Study||3||
48187319|NCT04482855|100780018|FG001|NOT COMPLETED|Overall Study||0||
48187320|NCT01161160|100780019|FG000|STARTED|Overall Study||76||
48187321|NCT01161160|100780020|FG001|STARTED|Overall Study||75||
48187322|NCT01161160|100780021|FG002|STARTED|Overall Study||58||
48187323|NCT01161160|100780019|FG000|COMPLETED|Overall Study||76||
48187324|NCT01161160|100780020|FG001|COMPLETED|Overall Study||75||
48187325|NCT01161160|100780021|FG002|COMPLETED|Overall Study||58||
48187326|NCT01161160|100780019|FG000|NOT COMPLETED|Overall Study||0||
48187327|NCT01161160|100780020|FG001|NOT COMPLETED|Overall Study||0||
48187328|NCT01161160|100780021|FG002|NOT COMPLETED|Overall Study||0||
48187329|NCT02376933|100780022|FG000|STARTED|Overall Study||10||
48187330|NCT02376933|100780022|FG000|COMPLETED|Overall Study||8||
48187331|NCT02376933|100780022|FG000|NOT COMPLETED|Overall Study||2||
48187332|NCT03483077|100780023|FG000|STARTED|Overall Study||12||
48187333|NCT03483077|100780024|FG001|STARTED|Overall Study||6||
48187334|NCT03483077|100780025|FG002|STARTED|Overall Study||6||
48187335|NCT03483077|100780026|FG003|STARTED|Overall Study||6||
48187336|NCT03483077|100780027|FG004|STARTED|Overall Study||6||
48187337|NCT03483077|100780028|FG005|STARTED|Overall Study||6||
48187338|NCT03483077|100780029|FG006|STARTED|Overall Study||6||
48187339|NCT03483077|100780023|FG000|COMPLETED|Overall Study||12||
48187340|NCT03483077|100780024|FG001|COMPLETED|Overall Study||6||
48187341|NCT03483077|100780025|FG002|COMPLETED|Overall Study||6||
48187342|NCT03483077|100780026|FG003|COMPLETED|Overall Study||6||
48187343|NCT03483077|100780027|FG004|COMPLETED|Overall Study||6||
48187344|NCT03483077|100780028|FG005|COMPLETED|Overall Study||6||
48187345|NCT03483077|100780029|FG006|COMPLETED|Overall Study||6||
48187346|NCT03483077|100780023|FG000|NOT COMPLETED|Overall Study||0||
48187347|NCT03483077|100780024|FG001|NOT COMPLETED|Overall Study||0||
48187348|NCT03483077|100780025|FG002|NOT COMPLETED|Overall Study||0||
48187349|NCT03483077|100780026|FG003|NOT COMPLETED|Overall Study||0||
48187350|NCT03483077|100780027|FG004|NOT COMPLETED|Overall Study||0||
48187351|NCT03483077|100780028|FG005|NOT COMPLETED|Overall Study||0||
48187352|NCT03483077|100780029|FG006|NOT COMPLETED|Overall Study||0||
48187353|NCT01809210|100780030|FG000|STARTED|Overall Study||3||
48187354|NCT01809210|100780031|FG001|STARTED|Overall Study||9||
48187355|NCT01809210|100780032|FG002|STARTED|Overall Study||7||
48187356|NCT01809210|100780033|FG003|STARTED|Overall Study||3||
48187357|NCT01809210|100780034|FG004|STARTED|Overall Study||6||
48187358|NCT01809210|100780035|FG005|STARTED|Overall Study||15||
48187359|NCT01809210|100780036|FG006|STARTED|Overall Study||12||
48187360|NCT01809210|100780030|FG000|COMPLETED|Overall Study||2||
48187361|NCT01809210|100780031|FG001|COMPLETED|Overall Study||8||
48187362|NCT01809210|100780032|FG002|COMPLETED|Overall Study||4||
48187363|NCT01809210|100780033|FG003|COMPLETED|Overall Study||2||
48187364|NCT01809210|100780034|FG004|COMPLETED|Overall Study||4||
48187365|NCT01809210|100780035|FG005|COMPLETED|Overall Study||12||
48187366|NCT01809210|100780036|FG006|COMPLETED|Overall Study||7||
48187367|NCT01809210|100780030|FG000|NOT COMPLETED|Overall Study||1||
48187368|NCT01809210|100780031|FG001|NOT COMPLETED|Overall Study||1||
48187369|NCT01809210|100780032|FG002|NOT COMPLETED|Overall Study||3||
48187370|NCT01809210|100780033|FG003|NOT COMPLETED|Overall Study||1||
48187371|NCT01809210|100780034|FG004|NOT COMPLETED|Overall Study||2||
48187372|NCT01809210|100780035|FG005|NOT COMPLETED|Overall Study||3||
48187373|NCT01809210|100780036|FG006|NOT COMPLETED|Overall Study||5||
48187374|NCT02584790|100780037|FG000|STARTED|Overall Study||55||
48187375|NCT02584790|100780037|FG000|COMPLETED|Overall Study||40||
48187376|NCT02584790|100780037|FG000|NOT COMPLETED|Overall Study||15||
48187377|NCT02950545|100780038|FG000|STARTED|Session 1 (70 Minutes)||9||
48187378|NCT02950545|100780039|FG001|STARTED|Session 1 (70 Minutes)||9||
48187379|NCT02950545|100780040|FG002|STARTED|Session 1 (70 Minutes)||7||
48187380|NCT02950545|100780041|FG003|STARTED|Session 1 (70 Minutes)||8||
48187381|NCT02950545|100780042|FG004|STARTED|Session 1 (70 Minutes)||8||
48187382|NCT02950545|100780043|FG005|STARTED|Session 1 (70 Minutes)||10||
48187383|NCT02950545|100780038|FG000|COMPLETED|Session 1 (70 Minutes)||9||
48187384|NCT02950545|100780039|FG001|COMPLETED|Session 1 (70 Minutes)||9||
48187385|NCT02950545|100780040|FG002|COMPLETED|Session 1 (70 Minutes)||7||
48187386|NCT02950545|100780041|FG003|COMPLETED|Session 1 (70 Minutes)||8||
48427759|NCT03759340|101380797|FG000|NOT COMPLETED|Overall Study||56||
48427760|NCT04668157|101380798|FG000|STARTED|Run-in Period (2 Weeks)||10||
48427761|NCT04668157|101380799|FG001|STARTED|Run-in Period (2 Weeks)||0||
48427762|NCT04668157|101380798|FG000|COMPLETED|Run-in Period (2 Weeks)||9||
48427763|NCT04668157|101380799|FG001|COMPLETED|Run-in Period (2 Weeks)||0||
48427764|NCT04668157|101380798|FG000|NOT COMPLETED|Run-in Period (2 Weeks)||1||
48427765|NCT04668157|101380799|FG001|NOT COMPLETED|Run-in Period (2 Weeks)||0||
48427766|NCT04668157|101380798|FG000|STARTED|Treatment Period (52 Weeks)||0||
48427767|NCT04668157|101380799|FG001|STARTED|Treatment Period (52 Weeks)||9||
48427768|NCT04668157|101380798|FG000|COMPLETED|Treatment Period (52 Weeks)||0||
48427769|NCT04668157|101380799|FG001|COMPLETED|Treatment Period (52 Weeks)||7||
48427770|NCT04668157|101380798|FG000|NOT COMPLETED|Treatment Period (52 Weeks)||0||
48427771|NCT04668157|101380799|FG001|NOT COMPLETED|Treatment Period (52 Weeks)||2||
48427772|NCT00519090|101380800|FG000|STARTED|Overall Study||2||
48427773|NCT00519090|101380801|FG001|STARTED|Overall Study||4||
48427774|NCT00519090|101380800|FG000|COMPLETED|Overall Study||2||
48427775|NCT00519090|101380801|FG001|COMPLETED|Overall Study||4||
48427776|NCT00519090|101380800|FG000|NOT COMPLETED|Overall Study||0||
48427777|NCT00519090|101380801|FG001|NOT COMPLETED|Overall Study||0||
48427778|NCT04738123|101380802|FG000|STARTED|Overall Study||125|Started=Randomized|
48427779|NCT04738123|101380803|FG001|STARTED|Overall Study||131|Started=Randomized|
48427780|NCT04738123|101380802|FG000|Recieved Treatment|Overall Study||125||
48427781|NCT04738123|101380803|FG001|Recieved Treatment|Overall Study||128||
48427782|NCT04738123|101380802|FG000|COMPLETED|Overall Study||79||
48427783|NCT04738123|101380803|FG001|COMPLETED|Overall Study||93||
48427784|NCT04738123|101380802|FG000|NOT COMPLETED|Overall Study||46||
48427785|NCT04738123|101380803|FG001|NOT COMPLETED|Overall Study||38||
48427786|NCT04882072|101380804|FG000|STARTED|Double Blind: Week 0 to Week 71.1||8||
48427787|NCT04882072|101380805|FG001|STARTED|Double Blind: Week 0 to Week 71.1||6||
48427788|NCT04882072|101380804|FG000|COMPLETED|Double Blind: Week 0 to Week 71.1||6||
48427789|NCT04882072|101380805|FG001|COMPLETED|Double Blind: Week 0 to Week 71.1||6||
48427790|NCT04882072|101380804|FG000|NOT COMPLETED|Double Blind: Week 0 to Week 71.1||2||
48427791|NCT04882072|101380805|FG001|NOT COMPLETED|Double Blind: Week 0 to Week 71.1||0||
48427792|NCT04882072|101380804|FG000|STARTED|OL Extension: OL Week 0 to OL Week 63.1||3||
48427793|NCT04882072|101380805|FG001|STARTED|OL Extension: OL Week 0 to OL Week 63.1||4||
48427794|NCT04882072|101380804|FG000|COMPLETED|OL Extension: OL Week 0 to OL Week 63.1||3||
48427795|NCT04882072|101380805|FG001|COMPLETED|OL Extension: OL Week 0 to OL Week 63.1||3||
48427796|NCT04882072|101380804|FG000|NOT COMPLETED|OL Extension: OL Week 0 to OL Week 63.1||0||
48427797|NCT04882072|101380805|FG001|NOT COMPLETED|OL Extension: OL Week 0 to OL Week 63.1||1||
48427798|NCT05403502|101380806|FG000|STARTED|Humalog Lead-In Period||183||
48427799|NCT05403502|101380806|FG000|COMPLETED|Humalog Lead-In Period||179||
48427800|NCT05403502|101380806|FG000|NOT COMPLETED|Humalog Lead-In Period||4||
48427801|NCT05403502|101380806|FG000|STARTED|Lyumjev Treatment Period||179||
48427802|NCT05403502|101380806|FG000|COMPLETED|Lyumjev Treatment Period||173||
48427803|NCT05403502|101380806|FG000|NOT COMPLETED|Lyumjev Treatment Period||6||
48427804|NCT01694849|101382999|FG000|STARTED|Treatment Period (Visit 2 to Visit 8)||93||
48427805|NCT01694849|101383000|FG001|STARTED|Treatment Period (Visit 2 to Visit 8)||90||
48427806|NCT01694849|101383001|FG002|STARTED|Treatment Period (Visit 2 to Visit 8)||92||
48427807|NCT01694849|101382999|FG000|Randomized|Treatment Period (Visit 2 to Visit 8)||93||
48427808|NCT01694849|101383000|FG001|Randomized|Treatment Period (Visit 2 to Visit 8)||90||
48427809|NCT01694849|101383001|FG002|Randomized|Treatment Period (Visit 2 to Visit 8)||92||
48427810|NCT01694849|101382999|FG000|Randomised and Received Treatment (Full Analysis Set and Safety Set)|Treatment Period (Visit 2 to Visit 8)||93||
48427811|NCT01694849|101383000|FG001|Randomised and Received Treatment (Full Analysis Set and Safety Set)|Treatment Period (Visit 2 to Visit 8)||89||
48427812|NCT01694849|101383001|FG002|Randomised and Received Treatment (Full Analysis Set and Safety Set)|Treatment Period (Visit 2 to Visit 8)||92||
48427813|NCT01694849|101382999|FG000|Efficacy Evaluable Set|Treatment Period (Visit 2 to Visit 8)||82|The Efficacy Evaluable Set included participants who completed the treatment period and did not have missing liver biopsies.|
48427814|NCT01694849|101383000|FG001|Efficacy Evaluable Set|Treatment Period (Visit 2 to Visit 8)||78|The Efficacy Evaluable Set included participants who completed the treatment period and did not have missing liver biopsies.|
48427815|NCT01694849|101383001|FG002|Efficacy Evaluable Set|Treatment Period (Visit 2 to Visit 8)||77|The Efficacy Evaluable Set included participants who completed the treatment period and did not have missing liver biopsies.|
48427816|NCT01694849|101382999|FG000|COMPLETED|Treatment Period (Visit 2 to Visit 8)||84||
48427817|NCT01694849|101383000|FG001|COMPLETED|Treatment Period (Visit 2 to Visit 8)||79||
48427818|NCT01694849|101383001|FG002|COMPLETED|Treatment Period (Visit 2 to Visit 8)||78||
48427819|NCT01694849|101382999|FG000|NOT COMPLETED|Treatment Period (Visit 2 to Visit 8)||9||
48427820|NCT01694849|101383000|FG001|NOT COMPLETED|Treatment Period (Visit 2 to Visit 8)||11||
48427821|NCT01694849|101383001|FG002|NOT COMPLETED|Treatment Period (Visit 2 to Visit 8)||14||
48427822|NCT01694849|101382999|FG000|STARTED|Follow-up Period (to Visit 9)||84||
48427823|NCT01694849|101383000|FG001|STARTED|Follow-up Period (to Visit 9)||79||
48427824|NCT01694849|101383001|FG002|STARTED|Follow-up Period (to Visit 9)||78||
48427825|NCT01694849|101382999|FG000|COMPLETED|Follow-up Period (to Visit 9)||83||
48427826|NCT01694849|101383000|FG001|COMPLETED|Follow-up Period (to Visit 9)||76||
48427827|NCT01694849|101383001|FG002|COMPLETED|Follow-up Period (to Visit 9)||77||
48427828|NCT01694849|101382999|FG000|NOT COMPLETED|Follow-up Period (to Visit 9)||1||
48427829|NCT01694849|101383000|FG001|NOT COMPLETED|Follow-up Period (to Visit 9)||3||
48427830|NCT01694849|101383001|FG002|NOT COMPLETED|Follow-up Period (to Visit 9)||1||
48427831|NCT04446039|101383002|FG000|STARTED|Overall Study||370212||
48427832|NCT04446039|101383002|FG000|COMPLETED|Overall Study||370212||
48427833|NCT04446039|101383002|FG000|NOT COMPLETED|Overall Study||0||
48427834|NCT04652245|101383003|FG000|STARTED|Treatment Administration Period 1||108||
48427835|NCT04652245|101383004|FG001|STARTED|Treatment Administration Period 1||108||
48427836|NCT04652245|101383003|FG000|COMPLETED|Treatment Administration Period 1||108||
48427837|NCT04652245|101383004|FG001|COMPLETED|Treatment Administration Period 1||108||
48427838|NCT04652245|101383003|FG000|NOT COMPLETED|Treatment Administration Period 1||0||
48427839|NCT04652245|101383004|FG001|NOT COMPLETED|Treatment Administration Period 1||0||
48427840|NCT04652245|101383003|FG000|STARTED|Wash-Out Period||108||
48427841|NCT04652245|101383004|FG001|STARTED|Wash-Out Period||108||
48427842|NCT04652245|101383003|FG000|COMPLETED|Wash-Out Period||108||
48427843|NCT04652245|101383004|FG001|COMPLETED|Wash-Out Period||104||
48427844|NCT04652245|101383003|FG000|NOT COMPLETED|Wash-Out Period||0||
48427845|NCT04652245|101383004|FG001|NOT COMPLETED|Wash-Out Period||4||
48427846|NCT04652245|101383003|FG000|STARTED|Treatment Administration Period 2||108||
48427847|NCT04652245|101383004|FG001|STARTED|Treatment Administration Period 2||104||
48427848|NCT04652245|101383003|FG000|COMPLETED|Treatment Administration Period 2||108||
48427849|NCT04652245|101383004|FG001|COMPLETED|Treatment Administration Period 2||104||
48427850|NCT04652245|101383003|FG000|NOT COMPLETED|Treatment Administration Period 2||0||
48427851|NCT04652245|101383004|FG001|NOT COMPLETED|Treatment Administration Period 2||0||
48427852|NCT02918968|101383005|FG000|STARTED|1st Line AAT||102||
48427853|NCT02918968|101383006|FG001|STARTED|1st Line AAT||104||
48427854|NCT02918968|101383005|FG000|Maintained 1st Line AAT Without Progression|1st Line AAT||25||
48427855|NCT02918968|101383006|FG001|Maintained 1st Line AAT Without Progression|1st Line AAT||8||
48427856|NCT02918968|101383005|FG000|COMPLETED|1st Line AAT||73||
48427857|NCT02918968|101383006|FG001|COMPLETED|1st Line AAT||93||
48427858|NCT02918968|101383005|FG000|NOT COMPLETED|1st Line AAT||29||
48427859|NCT02918968|101383006|FG001|NOT COMPLETED|1st Line AAT||11||
48427860|NCT02918968|101383005|FG000|STARTED|2nd Line AAT||48||
48427861|NCT02918968|101383006|FG001|STARTED|2nd Line AAT||85||
48427862|NCT02918968|101383005|FG000|COMPLETED|2nd Line AAT||23||
48427863|NCT02918968|101383006|FG001|COMPLETED|2nd Line AAT||73||
48427864|NCT02918968|101383005|FG000|NOT COMPLETED|2nd Line AAT||25||
48427865|NCT02918968|101383006|FG001|NOT COMPLETED|2nd Line AAT||12||
48427866|NCT02630992|101383007|FG000|STARTED|Overall Study||112||
48427867|NCT02630992|101383007|FG000|COMPLETED|Overall Study||99||
48427868|NCT02630992|101383007|FG000|NOT COMPLETED|Overall Study||13||
48427869|NCT03799198|101383008|FG000|STARTED|Overall Study||100||
48427870|NCT03799198|101383009|FG001|STARTED|Overall Study||100||
48427871|NCT03799198|101383008|FG000|Full Analysis Set (FAS)|Overall Study||100||
48427872|NCT03799198|101383009|FG001|Full Analysis Set (FAS)|Overall Study||100||
48427873|NCT03799198|101383008|FG000|COMPLETED|Overall Study||96||
48427874|NCT03799198|101383009|FG001|COMPLETED|Overall Study||91||
48427875|NCT03799198|101383008|FG000|NOT COMPLETED|Overall Study||4||
48427876|NCT03799198|101383009|FG001|NOT COMPLETED|Overall Study||9||
48427877|NCT02452320|101383010|FG000|STARTED|Overall Study||64||
48427878|NCT02452320|101383011|FG001|STARTED|Overall Study||64||
48427879|NCT02452320|101383010|FG000|COMPLETED|Overall Study||64||
48427880|NCT02452320|101383011|FG001|COMPLETED|Overall Study||63||
48427881|NCT02452320|101383010|FG000|NOT COMPLETED|Overall Study||0||
48427882|NCT02452320|101383011|FG001|NOT COMPLETED|Overall Study||1||
48427883|NCT03737812|101383012|FG000|STARTED|Overall Study||43||
48427884|NCT03737812|101383013|FG001|STARTED|Overall Study||40||
48427885|NCT03737812|101383014|FG002|STARTED|Overall Study||40||
48427886|NCT03737812|101383012|FG000|COMPLETED|Overall Study||38||
48427887|NCT03737812|101383013|FG001|COMPLETED|Overall Study||34||
48427888|NCT03737812|101383014|FG002|COMPLETED|Overall Study||36||
48427889|NCT03737812|101383012|FG000|NOT COMPLETED|Overall Study||5||
48427890|NCT03737812|101383013|FG001|NOT COMPLETED|Overall Study||6||
48427891|NCT03737812|101383014|FG002|NOT COMPLETED|Overall Study||4||
48427892|NCT05784129|101383015|FG000|STARTED|Overall Study||2||
48427893|NCT05784129|101383016|FG001|STARTED|Overall Study||2||
48427894|NCT05784129|101383015|FG000|Treated at Weeks 0, 8 and 16|Overall Study||1||
48427895|NCT05784129|101383016|FG001|Treated at Weeks 0, 8 and 16|Overall Study||2||
48427896|NCT05784129|101383015|FG000|Treated at Weeks 0, 8|Overall Study||1||
48427897|NCT05784129|101383016|FG001|Treated at Weeks 0, 8|Overall Study||0||
48427898|NCT05784129|101383015|FG000|COMPLETED|Overall Study||0||
48427899|NCT05784129|101383016|FG001|COMPLETED|Overall Study||0||
48427900|NCT05784129|101383015|FG000|NOT COMPLETED|Overall Study||2||
48427901|NCT05784129|101383016|FG001|NOT COMPLETED|Overall Study||2||
48427902|NCT02335411|101383017|FG000|STARTED|Overall Study||259|First Course Pembrolizumab|
48427903|NCT02335411|101383018|FG001|STARTED|Overall Study||25|First Course Pembrolizumab|
48427904|NCT02335411|101383019|FG002|STARTED|Overall Study||31|First Course Pembrolizumab|
48427905|NCT02335411|101383017|FG000|Second Course Pembrolizumab|Overall Study||3||
48427906|NCT02335411|101383018|FG001|Second Course Pembrolizumab|Overall Study||1||
48427907|NCT02335411|101383019|FG002|Second Course Pembrolizumab|Overall Study||2||
48427908|NCT02335411|101383017|FG000|COMPLETED|Overall Study||0||
48427909|NCT02335411|101383018|FG001|COMPLETED|Overall Study||0||
48427910|NCT02335411|101383019|FG002|COMPLETED|Overall Study||0||
48427911|NCT02335411|101383017|FG000|NOT COMPLETED|Overall Study||259||
48427912|NCT02335411|101383018|FG001|NOT COMPLETED|Overall Study||25||
48427913|NCT02335411|101383019|FG002|NOT COMPLETED|Overall Study||31||
48427914|NCT00499694|101383020|FG000|STARTED|Overall Study||31||
48427915|NCT00499694|101383020|FG000|COMPLETED|Overall Study||30||
48427916|NCT00499694|101383020|FG000|NOT COMPLETED|Overall Study||1||
48427917|NCT01151085|101383021|FG000|STARTED|Overall Study||1002||
48427918|NCT01151085|101383021|FG000|COMPLETED|Overall Study||946||
48427919|NCT01151085|101383021|FG000|NOT COMPLETED|Overall Study||56||
48427920|NCT05643573|101383022|FG000|STARTED|Overall Study||7383||
48427921|NCT05643573|101383023|FG001|STARTED|Overall Study||7374||
48427922|NCT05643573|101383022|FG000|COMPLETED|Overall Study||6901||
48427923|NCT05643573|101383023|FG001|COMPLETED|Overall Study||7012||
48427924|NCT05643573|101383022|FG000|NOT COMPLETED|Overall Study||482||
48427925|NCT05643573|101383023|FG001|NOT COMPLETED|Overall Study||362||
48427926|NCT00508872|101383024|FG000|STARTED|Overall Study||2||
48427927|NCT00508872|101383024|FG000|COMPLETED|Overall Study||0||
48427928|NCT00508872|101383024|FG000|NOT COMPLETED|Overall Study||2||
48427929|NCT01182480|101383025|FG000|STARTED|Overall Study||47||
48427930|NCT01182480|101383025|FG000|COMPLETED|Overall Study||47||
48427931|NCT01182480|101383025|FG000|NOT COMPLETED|Overall Study||0||
48427932|NCT02138227|101383026|FG000|STARTED|Overall Study||55||
48427933|NCT02138227|101383027|FG001|STARTED|Overall Study||218||
48427934|NCT02138227|101383026|FG000|COMPLETED|Overall Study||55||
48427935|NCT02138227|101383027|FG001|COMPLETED|Overall Study||218||
48427936|NCT02138227|101383026|FG000|NOT COMPLETED|Overall Study||0||
48427937|NCT02138227|101383027|FG001|NOT COMPLETED|Overall Study||0||
48427938|NCT00847002|101383028|FG000|STARTED|Overall Study||4||
48427939|NCT00847002|101383029|FG001|STARTED|Overall Study||4||
48427940|NCT00847002|101383028|FG000|COMPLETED|Overall Study||4||
48427941|NCT00847002|101383029|FG001|COMPLETED|Overall Study||4||
48427942|NCT00847002|101383028|FG000|NOT COMPLETED|Overall Study||0||
48427943|NCT00847002|101383029|FG001|NOT COMPLETED|Overall Study||0||
48427944|NCT04881149|101383030|FG000|STARTED|Overall Study||7||14
48427945|NCT04881149|101383030|FG000|Control Biopsy|Overall Study||7||7
48427946|NCT04881149|101383030|FG000|Treatment Biopsy|Overall Study||7||7
48427947|NCT04881149|101383030|FG000|COMPLETED|Overall Study||7||14
48427948|NCT04881149|101383030|FG000|NOT COMPLETED|Overall Study||0||0
48427949|NCT01636102|101383031|FG000|STARTED|Overall Study||63||
48427950|NCT01636102|101383032|FG001|STARTED|Overall Study||63||
48427951|NCT01636102|101383031|FG000|COMPLETED|Overall Study||63||
48427952|NCT01636102|101383032|FG001|COMPLETED|Overall Study||63||
48427953|NCT01636102|101383031|FG000|NOT COMPLETED|Overall Study||0||
48427954|NCT01636102|101383032|FG001|NOT COMPLETED|Overall Study||0||
48427955|NCT03503617|101383033|FG000|STARTED|Overall Study||14||
48427956|NCT03503617|101383034|FG001|STARTED|Overall Study||13||
48427957|NCT03503617|101383033|FG000|COMPLETED|Overall Study||14||
48427958|NCT03503617|101383034|FG001|COMPLETED|Overall Study||10||
48427959|NCT03503617|101383033|FG000|NOT COMPLETED|Overall Study||0||
48427960|NCT03503617|101383034|FG001|NOT COMPLETED|Overall Study||3||
48427961|NCT04535544|101383035|FG000|STARTED|Double-blind (Day 1 up to Week 52)||17||
48427962|NCT04535544|101383036|FG001|STARTED|Double-blind (Day 1 up to Week 52)||5||
48427963|NCT04535544|101383037|FG002|STARTED|Double-blind (Day 1 up to Week 52)||24||
48427964|NCT04535544|101383038|FG003|STARTED|Double-blind (Day 1 up to Week 52)||6||
48427965|NCT04535544|101383035|FG000|COMPLETED|Double-blind (Day 1 up to Week 52)||16||
48427966|NCT04535544|101383036|FG001|COMPLETED|Double-blind (Day 1 up to Week 52)||5||
48427967|NCT04535544|101383037|FG002|COMPLETED|Double-blind (Day 1 up to Week 52)||20||
48427968|NCT04535544|101383038|FG003|COMPLETED|Double-blind (Day 1 up to Week 52)||5||
48427969|NCT04535544|101383035|FG000|NOT COMPLETED|Double-blind (Day 1 up to Week 52)||1||
48427970|NCT04535544|101383036|FG001|NOT COMPLETED|Double-blind (Day 1 up to Week 52)||0||
48427971|NCT04535544|101383037|FG002|NOT COMPLETED|Double-blind (Day 1 up to Week 52)||4||
48427972|NCT04535544|101383038|FG003|NOT COMPLETED|Double-blind (Day 1 up to Week 52)||1||
48427973|NCT04535544|101383035|FG000|STARTED|Open-label (Week 52 up to Week 148)||5||
48427974|NCT04535544|101383036|FG001|STARTED|Open-label (Week 52 up to Week 148)||4||
48427975|NCT04535544|101383037|FG002|STARTED|Open-label (Week 52 up to Week 148)||14||
48427976|NCT04535544|101383038|FG003|STARTED|Open-label (Week 52 up to Week 148)||5||
48427977|NCT04535544|101383035|FG000|COMPLETED|Open-label (Week 52 up to Week 148)||5||
48427978|NCT04535544|101383036|FG001|COMPLETED|Open-label (Week 52 up to Week 148)||2||
48427979|NCT04535544|101383037|FG002|COMPLETED|Open-label (Week 52 up to Week 148)||0||
48427980|NCT04535544|101383038|FG003|COMPLETED|Open-label (Week 52 up to Week 148)||0||
48427981|NCT04535544|101383035|FG000|NOT COMPLETED|Open-label (Week 52 up to Week 148)||0||
48427982|NCT04535544|101383036|FG001|NOT COMPLETED|Open-label (Week 52 up to Week 148)||2||
48427983|NCT04535544|101383037|FG002|NOT COMPLETED|Open-label (Week 52 up to Week 148)||14||
48427984|NCT04535544|101383038|FG003|NOT COMPLETED|Open-label (Week 52 up to Week 148)||5||
48427985|NCT04535544|101383035|FG000|STARTED|Follow-up (Week 148 up to Week 161)||16||
48360214|NCT01933672|101210851|FG005|Received Treatment|Metformin Run-in Period||0||
48360215|NCT01933672|101210852|FG006|Received Treatment|Metformin Run-in Period||0||
48360216|NCT01933672|101210846|FG000|COMPLETED|Metformin Run-in Period||33||
48360217|NCT01933672|101210847|FG001|COMPLETED|Metformin Run-in Period||0||
48360218|NCT01933672|101210848|FG002|COMPLETED|Metformin Run-in Period||0||
48360219|NCT01933672|101210849|FG003|COMPLETED|Metformin Run-in Period||0||
48360220|NCT01933672|101210850|FG004|COMPLETED|Metformin Run-in Period||0||
48360221|NCT01933672|101210851|FG005|COMPLETED|Metformin Run-in Period||0||
48360222|NCT01933672|101210852|FG006|COMPLETED|Metformin Run-in Period||0||
48360223|NCT01933672|101210846|FG000|NOT COMPLETED|Metformin Run-in Period||10||
48360224|NCT01933672|101210847|FG001|NOT COMPLETED|Metformin Run-in Period||0||
48360225|NCT01933672|101210848|FG002|NOT COMPLETED|Metformin Run-in Period||0||
48360226|NCT01933672|101210849|FG003|NOT COMPLETED|Metformin Run-in Period||0||
48360227|NCT01933672|101210850|FG004|NOT COMPLETED|Metformin Run-in Period||0||
48360228|NCT01933672|101210851|FG005|NOT COMPLETED|Metformin Run-in Period||0||
48360229|NCT01933672|101210852|FG006|NOT COMPLETED|Metformin Run-in Period||0||
48360230|NCT01933672|101210846|FG000|STARTED|First Intervention Period (12-16 Days)||0||
48360231|NCT01933672|101210847|FG001|STARTED|First Intervention Period (12-16 Days)||7||
48360232|NCT01933672|101210848|FG002|STARTED|First Intervention Period (12-16 Days)||3||
48360233|NCT01933672|101210849|FG003|STARTED|First Intervention Period (12-16 Days)||5||
48360234|NCT01933672|101210850|FG004|STARTED|First Intervention Period (12-16 Days)||7||
48360235|NCT01933672|101210851|FG005|STARTED|First Intervention Period (12-16 Days)||5||
48360236|NCT01933672|101210852|FG006|STARTED|First Intervention Period (12-16 Days)||6||
48360237|NCT01933672|101210846|FG000|COMPLETED|First Intervention Period (12-16 Days)||0||
48360238|NCT01933672|101210847|FG001|COMPLETED|First Intervention Period (12-16 Days)||7||
48360239|NCT01933672|101210848|FG002|COMPLETED|First Intervention Period (12-16 Days)||2||
48360240|NCT01933672|101210849|FG003|COMPLETED|First Intervention Period (12-16 Days)||5||
48360241|NCT01933672|101210850|FG004|COMPLETED|First Intervention Period (12-16 Days)||6||
48360242|NCT01933672|101210851|FG005|COMPLETED|First Intervention Period (12-16 Days)||4||
48360243|NCT01933672|101210852|FG006|COMPLETED|First Intervention Period (12-16 Days)||6||
48360244|NCT01933672|101210846|FG000|NOT COMPLETED|First Intervention Period (12-16 Days)||0||
48360245|NCT01933672|101210847|FG001|NOT COMPLETED|First Intervention Period (12-16 Days)||0||
48360246|NCT01933672|101210848|FG002|NOT COMPLETED|First Intervention Period (12-16 Days)||1||
48360247|NCT01933672|101210849|FG003|NOT COMPLETED|First Intervention Period (12-16 Days)||0||
48360248|NCT01933672|101210850|FG004|NOT COMPLETED|First Intervention Period (12-16 Days)||1||
48360249|NCT01933672|101210851|FG005|NOT COMPLETED|First Intervention Period (12-16 Days)||1||
48360250|NCT01933672|101210852|FG006|NOT COMPLETED|First Intervention Period (12-16 Days)||0||
48360251|NCT01933672|101210846|FG000|STARTED|First Washout Period (7-14 Days)||0||
48360252|NCT01933672|101210847|FG001|STARTED|First Washout Period (7-14 Days)||7||
48360253|NCT01933672|101210848|FG002|STARTED|First Washout Period (7-14 Days)||2||
48360254|NCT01933672|101210849|FG003|STARTED|First Washout Period (7-14 Days)||5||
48360255|NCT01933672|101210850|FG004|STARTED|First Washout Period (7-14 Days)||6||
48360256|NCT01933672|101210851|FG005|STARTED|First Washout Period (7-14 Days)||4||
48360257|NCT01933672|101210852|FG006|STARTED|First Washout Period (7-14 Days)||6||
48360258|NCT01933672|101210846|FG000|COMPLETED|First Washout Period (7-14 Days)||0||
48360259|NCT01933672|101210847|FG001|COMPLETED|First Washout Period (7-14 Days)||7||
48360260|NCT01933672|101210848|FG002|COMPLETED|First Washout Period (7-14 Days)||2||
48360261|NCT01933672|101210849|FG003|COMPLETED|First Washout Period (7-14 Days)||5||
48360262|NCT01933672|101210850|FG004|COMPLETED|First Washout Period (7-14 Days)||6||
48360263|NCT01933672|101210851|FG005|COMPLETED|First Washout Period (7-14 Days)||4||
48360264|NCT01933672|101210852|FG006|COMPLETED|First Washout Period (7-14 Days)||6||
48360265|NCT01933672|101210846|FG000|NOT COMPLETED|First Washout Period (7-14 Days)||0||
48360266|NCT01933672|101210847|FG001|NOT COMPLETED|First Washout Period (7-14 Days)||0||
48360267|NCT01933672|101210848|FG002|NOT COMPLETED|First Washout Period (7-14 Days)||0||
48360268|NCT01933672|101210849|FG003|NOT COMPLETED|First Washout Period (7-14 Days)||0||
48360269|NCT01933672|101210850|FG004|NOT COMPLETED|First Washout Period (7-14 Days)||0||
48360270|NCT01933672|101210851|FG005|NOT COMPLETED|First Washout Period (7-14 Days)||0||
48360271|NCT01933672|101210852|FG006|NOT COMPLETED|First Washout Period (7-14 Days)||0||
48360272|NCT01933672|101210846|FG000|STARTED|Second Intervention Period (12-16 Days)||0||
48360273|NCT01933672|101210847|FG001|STARTED|Second Intervention Period (12-16 Days)||7||
48360274|NCT01933672|101210848|FG002|STARTED|Second Intervention Period (12-16 Days)||2||
48360275|NCT01933672|101210849|FG003|STARTED|Second Intervention Period (12-16 Days)||5||
48360276|NCT01933672|101210850|FG004|STARTED|Second Intervention Period (12-16 Days)||6||
48360277|NCT01933672|101210851|FG005|STARTED|Second Intervention Period (12-16 Days)||4||
48360278|NCT01933672|101210852|FG006|STARTED|Second Intervention Period (12-16 Days)||6||
48360279|NCT01933672|101210846|FG000|COMPLETED|Second Intervention Period (12-16 Days)||0||
48360280|NCT01933672|101210847|FG001|COMPLETED|Second Intervention Period (12-16 Days)||6||
48360281|NCT01933672|101210848|FG002|COMPLETED|Second Intervention Period (12-16 Days)||1||
48360282|NCT01933672|101210849|FG003|COMPLETED|Second Intervention Period (12-16 Days)||5||
48360283|NCT01933672|101210850|FG004|COMPLETED|Second Intervention Period (12-16 Days)||6||
48360284|NCT01933672|101210851|FG005|COMPLETED|Second Intervention Period (12-16 Days)||4||
48368127|NCT01555463|101230112|FG001|NOT COMPLETED|Treatment||79||
48427986|NCT04535544|101383036|FG001|STARTED|Follow-up (Week 148 up to Week 161)||3||
48427987|NCT04535544|101383037|FG002|STARTED|Follow-up (Week 148 up to Week 161)||6||
48427988|NCT04535544|101383038|FG003|STARTED|Follow-up (Week 148 up to Week 161)||0||
48427989|NCT04535544|101383035|FG000|COMPLETED|Follow-up (Week 148 up to Week 161)||7||
48427990|NCT04535544|101383036|FG001|COMPLETED|Follow-up (Week 148 up to Week 161)||3||
48427991|NCT04535544|101383037|FG002|COMPLETED|Follow-up (Week 148 up to Week 161)||1||
48427992|NCT04535544|101383038|FG003|COMPLETED|Follow-up (Week 148 up to Week 161)||0||
48427993|NCT04535544|101383035|FG000|NOT COMPLETED|Follow-up (Week 148 up to Week 161)||9||
48427994|NCT04535544|101383036|FG001|NOT COMPLETED|Follow-up (Week 148 up to Week 161)||0||
48427995|NCT04535544|101383037|FG002|NOT COMPLETED|Follow-up (Week 148 up to Week 161)||5||
48427996|NCT04535544|101383038|FG003|NOT COMPLETED|Follow-up (Week 148 up to Week 161)||0||
48427997|NCT02790476|101383039|FG000|STARTED|Overall Study||404||
48427998|NCT02790476|101383040|FG001|STARTED|Overall Study||447||
48427999|NCT02790476|101383039|FG000|COMPLETED|Overall Study||386||
48428000|NCT02790476|101383040|FG001|COMPLETED|Overall Study||425||
48428001|NCT02790476|101383039|FG000|NOT COMPLETED|Overall Study||18||
48428002|NCT02790476|101383040|FG001|NOT COMPLETED|Overall Study||22||
48428003|NCT04492514|101383041|FG000|STARTED|Overall Study||1||
48428004|NCT04492514|101383042|FG001|STARTED|Overall Study||0||
48428005|NCT04492514|101383041|FG000|COMPLETED|Overall Study||1||
48428006|NCT04492514|101383042|FG001|COMPLETED|Overall Study||0||
48428007|NCT04492514|101383041|FG000|NOT COMPLETED|Overall Study||0||
48428008|NCT04492514|101383042|FG001|NOT COMPLETED|Overall Study||0||
48428009|NCT03159455|101383043|FG000|STARTED|Overall Study||9||
48428010|NCT03159455|101383044|FG001|STARTED|Overall Study||9||
48428011|NCT03159455|101383045|FG002|STARTED|Overall Study||9||
48428012|NCT03159455|101383046|FG003|STARTED|Overall Study||9||
48428013|NCT03159455|101383047|FG004|STARTED|Overall Study||3||
48428014|NCT03159455|101383048|FG005|STARTED|Overall Study||9||
48428015|NCT03159455|101383043|FG000|COMPLETED|Overall Study||9||
48428016|NCT03159455|101383044|FG001|COMPLETED|Overall Study||9||
48428017|NCT03159455|101383045|FG002|COMPLETED|Overall Study||9||
48428018|NCT03159455|101383046|FG003|COMPLETED|Overall Study||9||
48428019|NCT03159455|101383047|FG004|COMPLETED|Overall Study||3||
48428020|NCT03159455|101383048|FG005|COMPLETED|Overall Study||8||
48428021|NCT03159455|101383043|FG000|NOT COMPLETED|Overall Study||0||
48428022|NCT03159455|101383044|FG001|NOT COMPLETED|Overall Study||0||
48428023|NCT03159455|101383045|FG002|NOT COMPLETED|Overall Study||0||
48187387|NCT02950545|100780042|FG004|COMPLETED|Session 1 (70 Minutes)||8||
48187388|NCT02950545|100780043|FG005|COMPLETED|Session 1 (70 Minutes)||9||
48428024|NCT03159455|101383046|FG003|NOT COMPLETED|Overall Study||0||
48428025|NCT03159455|101383047|FG004|NOT COMPLETED|Overall Study||0||
48428026|NCT03159455|101383048|FG005|NOT COMPLETED|Overall Study||1||
48428027|NCT01393444|101383049|FG000|STARTED|Overall Study||6||
48428028|NCT01393444|101383049|FG000|First (1st Implanted) Subject Enrolled|Overall Study||1||
48428029|NCT01393444|101383049|FG000|Second Subject Enrolled|Overall Study||1||
48428030|NCT01393444|101383049|FG000|Third Subject Enrolled|Overall Study||1||
48428031|NCT01393444|101383049|FG000|Fourth Subject Enrolled|Overall Study||1||
48428032|NCT01393444|101383049|FG000|Fifth (2nd Implanted) Subject Enrolled|Overall Study||1||
48428033|NCT01393444|101383049|FG000|Sixth (3rd Implanted) Subject|Overall Study||1||
48428034|NCT01393444|101383049|FG000|COMPLETED|Overall Study||3||
48428035|NCT01393444|101383049|FG000|NOT COMPLETED|Overall Study||3||
48428036|NCT02058849|101383050|FG000|STARTED|Overall Study||11||
48428037|NCT02058849|101383051|FG001|STARTED|Overall Study||2||
48428038|NCT02058849|101383050|FG000|COMPLETED|Overall Study||4||
48428039|NCT02058849|101383051|FG001|COMPLETED|Overall Study||1||
48428040|NCT02058849|101383050|FG000|NOT COMPLETED|Overall Study||7||
48428041|NCT02058849|101383051|FG001|NOT COMPLETED|Overall Study||1||
48428042|NCT01977651|101383052|FG000|STARTED|4 Month Treatment Period||423||
48428043|NCT01977651|101383052|FG000|COMPLETED|4 Month Treatment Period||322||
48428044|NCT01977651|101383052|FG000|NOT COMPLETED|4 Month Treatment Period||101||
48428045|NCT01977651|101383052|FG000|STARTED|1 Year Extension Period||287||
48428046|NCT01977651|101383052|FG000|COMPLETED|1 Year Extension Period||157||
48428047|NCT01977651|101383052|FG000|NOT COMPLETED|1 Year Extension Period||130||
48428048|NCT01977651|101383052|FG000|STARTED|Post 1 Year Extension Period||145||
48428049|NCT01977651|101383052|FG000|COMPLETED|Post 1 Year Extension Period||1||
48428050|NCT01977651|101383052|FG000|NOT COMPLETED|Post 1 Year Extension Period||144||
48428051|NCT00596466|101383053|FG000|STARTED|Overall Study||75||
48428052|NCT00596466|101383053|FG000|Enrolled, Treated|Overall Study||73||
48428053|NCT00596466|101383053|FG000|COMPLETED|Overall Study||58||
48428054|NCT00596466|101383053|FG000|NOT COMPLETED|Overall Study||17||
48187389|NCT02950545|100780038|FG000|NOT COMPLETED|Session 1 (70 Minutes)||0||
48428055|NCT02708524|101383054|FG000|STARTED|Overall Study||139||
48428056|NCT02708524|101383055|FG001|STARTED|Overall Study||136||
48428057|NCT02708524|101383056|FG002|STARTED|Overall Study||137||
48428058|NCT02708524|101383057|FG003|STARTED|Overall Study||136||
48428059|NCT02708524|101383054|FG000|COMPLETED|Overall Study||135||
48428060|NCT02708524|101383055|FG001|COMPLETED|Overall Study||130||
48428061|NCT02708524|101383056|FG002|COMPLETED|Overall Study||134||
48428062|NCT02708524|101383057|FG003|COMPLETED|Overall Study||136||
48428063|NCT02708524|101383054|FG000|NOT COMPLETED|Overall Study||4||
48428064|NCT02708524|101383055|FG001|NOT COMPLETED|Overall Study||6||
48428065|NCT02708524|101383056|FG002|NOT COMPLETED|Overall Study||3||
48428066|NCT02708524|101383057|FG003|NOT COMPLETED|Overall Study||0||
48428067|NCT00556140|101383058|FG000|STARTED|Overall Study||16||
48428068|NCT00556140|101383058|FG000|COMPLETED|Overall Study||13||
48428069|NCT00556140|101383058|FG000|NOT COMPLETED|Overall Study||3||
48428070|NCT02735382|101383059|FG000|STARTED|Overall Study||7481||
48428071|NCT02735382|101383060|FG001|STARTED|Overall Study||7155||
48428072|NCT02735382|101383061|FG002|STARTED|Overall Study||184||
48428073|NCT02735382|101383062|FG003|STARTED|Overall Study||110||
48428074|NCT02735382|101383059|FG000|COMPLETED|Overall Study||7481||
48428075|NCT02735382|101383060|FG001|COMPLETED|Overall Study||7155||
48428076|NCT02735382|101383061|FG002|COMPLETED|Overall Study||184||
48428077|NCT02735382|101383062|FG003|COMPLETED|Overall Study||110||
48428078|NCT02735382|101383059|FG000|NOT COMPLETED|Overall Study||0||
48428079|NCT02735382|101383060|FG001|NOT COMPLETED|Overall Study||0||
48428080|NCT02735382|101383061|FG002|NOT COMPLETED|Overall Study||0||
48428081|NCT02735382|101383062|FG003|NOT COMPLETED|Overall Study||0||
48428082|NCT01590628|101383063|FG000|STARTED|Overall Study||13||
48428083|NCT01590628|101383064|FG001|STARTED|Overall Study||3||
48428084|NCT01590628|101383063|FG000|COMPLETED|Overall Study||11||
48428085|NCT01590628|101383064|FG001|COMPLETED|Overall Study||3||
48428086|NCT01590628|101383063|FG000|NOT COMPLETED|Overall Study||2||
48428087|NCT01590628|101383064|FG001|NOT COMPLETED|Overall Study||0||
48428088|NCT03772574|101383065|FG000|STARTED|Overall Study||42||
48428089|NCT03772574|101383066|FG001|STARTED|Overall Study||25||
48428090|NCT03772574|101383067|FG002|STARTED|Overall Study||24||
48428091|NCT03772574|101383065|FG000|COMPLETED|Overall Study||40||
48428092|NCT03772574|101383066|FG001|COMPLETED|Overall Study||20||
48428093|NCT03772574|101383067|FG002|COMPLETED|Overall Study||20||
48428094|NCT03772574|101383065|FG000|NOT COMPLETED|Overall Study||2||
48428095|NCT03772574|101383066|FG001|NOT COMPLETED|Overall Study||5||
48428096|NCT03772574|101383067|FG002|NOT COMPLETED|Overall Study||4||
48428097|NCT03007472|101383068|FG000|STARTED|Overall Study||96||
48428098|NCT03007472|101383068|FG000|COMPLETED|Overall Study||91||
48428099|NCT03007472|101383068|FG000|NOT COMPLETED|Overall Study||5||
48428100|NCT01479777|101383069|FG000|STARTED|Overall Study||12||
48428101|NCT01479777|101383069|FG000|COMPLETED|Overall Study||10||
48428102|NCT01479777|101383069|FG000|NOT COMPLETED|Overall Study||2||
48428103|NCT03457701|101383070|FG000|STARTED|Treatment Period 1 (up to Day 28)||7|Randomized|
48428104|NCT03457701|101383071|FG001|STARTED|Treatment Period 1 (up to Day 28)||8|Randomized|
48428105|NCT03457701|101383070|FG000|Safety Population|Treatment Period 1 (up to Day 28)||7||
48428106|NCT03457701|101383071|FG001|Safety Population|Treatment Period 1 (up to Day 28)||7||
48428107|NCT03457701|101383070|FG000|COMPLETED|Treatment Period 1 (up to Day 28)||6||
48428108|NCT03457701|101383071|FG001|COMPLETED|Treatment Period 1 (up to Day 28)||7||
48428109|NCT03457701|101383070|FG000|NOT COMPLETED|Treatment Period 1 (up to Day 28)||1||
48428110|NCT03457701|101383071|FG001|NOT COMPLETED|Treatment Period 1 (up to Day 28)||1||
48428111|NCT03457701|101383070|FG000|STARTED|Treatment Period 2 (Up to Day 28)||6||
48428112|NCT03457701|101383071|FG001|STARTED|Treatment Period 2 (Up to Day 28)||7||
48428113|NCT03457701|101383070|FG000|COMPLETED|Treatment Period 2 (Up to Day 28)||6||
48428114|NCT03457701|101383071|FG001|COMPLETED|Treatment Period 2 (Up to Day 28)||6||
48428115|NCT03457701|101383070|FG000|NOT COMPLETED|Treatment Period 2 (Up to Day 28)||0||
48428116|NCT03457701|101383071|FG001|NOT COMPLETED|Treatment Period 2 (Up to Day 28)||1||
48428117|NCT00848965|101383072|FG000|STARTED|Overall Study||59||
48428118|NCT00848965|101383072|FG000|COMPLETED|Overall Study||57||
48428119|NCT00848965|101383072|FG000|NOT COMPLETED|Overall Study||2||
48428120|NCT02370173|101383073|FG000|STARTED|Overall Study||43||
48428121|NCT02370173|101383074|FG001|STARTED|Overall Study||47||
48428122|NCT02370173|101383073|FG000|COMPLETED|Overall Study||40||
48428123|NCT02370173|101383074|FG001|COMPLETED|Overall Study||44||
48428124|NCT02370173|101383073|FG000|NOT COMPLETED|Overall Study||3||
48428125|NCT02370173|101383074|FG001|NOT COMPLETED|Overall Study||3||
48428126|NCT00457951|101383075|FG000|STARTED|Overall Study||13|In the double-blind phase, 145 subjects consented and 138 met criteria and were randomized.|
48428127|NCT00457951|101383076|FG001|STARTED|Overall Study||66|In the double-blind phase, 145 subjects consented and 138 met criteria and were randomized.|
48428128|NCT00457951|101383077|FG002|STARTED|Overall Study||72|In the double-blind phase, 145 subjects consented and 138 met criteria and were randomized.|
48428129|NCT00457951|101383075|FG000|COMPLETED|Overall Study||13||
48428130|NCT00457951|101383076|FG001|COMPLETED|Overall Study||50||
48428131|NCT00457951|101383077|FG002|COMPLETED|Overall Study||60||
48428132|NCT00457951|101383075|FG000|NOT COMPLETED|Overall Study||0||
48428133|NCT00457951|101383076|FG001|NOT COMPLETED|Overall Study||16||
48428134|NCT00457951|101383077|FG002|NOT COMPLETED|Overall Study||12||
48428135|NCT00421928|101383078|FG000|STARTED|Overall Study||344||
48428136|NCT00421928|101383079|FG001|STARTED|Overall Study||342||
48428137|NCT00421928|101383080|FG002|STARTED|Overall Study||337||
48428138|NCT00421928|101383078|FG000|COMPLETED|Overall Study||181||
48428139|NCT00421928|101383079|FG001|COMPLETED|Overall Study||118||
48428140|NCT00421928|101383080|FG002|COMPLETED|Overall Study||203||
48428141|NCT00421928|101383078|FG000|NOT COMPLETED|Overall Study||163||
48428142|NCT00421928|101383079|FG001|NOT COMPLETED|Overall Study||224||
48428143|NCT00421928|101383080|FG002|NOT COMPLETED|Overall Study||134||
48428144|NCT04502862|101383081|FG000|STARTED|Overall Study||101|Randomized|
48428145|NCT04502862|101383082|FG001|STARTED|Overall Study||101|Randomized|
48428146|NCT04502862|101383081|FG000|Randomized and Treated|Overall Study||100||
48428147|NCT04502862|101383082|FG001|Randomized and Treated|Overall Study||101||
48428148|NCT04502862|101383081|FG000|COMPLETED|Overall Study||95||
48428149|NCT04502862|101383082|FG001|COMPLETED|Overall Study||94||
48428150|NCT04502862|101383081|FG000|NOT COMPLETED|Overall Study||6||
48428151|NCT04502862|101383082|FG001|NOT COMPLETED|Overall Study||7||
48428152|NCT04236986|101383083|FG000|STARTED|Overall Study||18||
48428153|NCT04236986|101383084|FG001|STARTED|Overall Study||16||
48428154|NCT04236986|101383083|FG000|COMPLETED|Overall Study||15||
48428155|NCT04236986|101383084|FG001|COMPLETED|Overall Study||15||
48428156|NCT04236986|101383083|FG000|NOT COMPLETED|Overall Study||3||
48428157|NCT04236986|101383084|FG001|NOT COMPLETED|Overall Study||1||
48428158|NCT02928900|101383085|FG000|STARTED|Baseline||0|All 24 sites started as control sites. Sites were randomized to training in groups of 6 clinics every 9 months.|0
48428159|NCT02928900|101383086|FG001|STARTED|Baseline||0|All 24 sites started as control sites. Sites were randomized to training in groups of 6 clinics every 9 months.|24
48428160|NCT02928900|101383085|FG000|COMPLETED|Baseline||0||0
48428161|NCT02928900|101383086|FG001|COMPLETED|Baseline||0||24
48428162|NCT02928900|101383085|FG000|NOT COMPLETED|Baseline||0||0
48428163|NCT02928900|101383086|FG001|NOT COMPLETED|Baseline||0||0
48428164|NCT02928900|101383085|FG000|STARTED|Wave 1||0||6
48428165|NCT02928900|101383086|FG001|STARTED|Wave 1||0||18
48428166|NCT02928900|101383085|FG000|COMPLETED|Wave 1||0||6
48428167|NCT02928900|101383086|FG001|COMPLETED|Wave 1||0||18
48428168|NCT02928900|101383085|FG000|NOT COMPLETED|Wave 1||0||0
48428169|NCT02928900|101383086|FG001|NOT COMPLETED|Wave 1||0||0
48428170|NCT02928900|101383085|FG000|STARTED|Wave 2||0||12
48428171|NCT02928900|101383086|FG001|STARTED|Wave 2||0||12
48428172|NCT02928900|101383085|FG000|COMPLETED|Wave 2||0||12
48428173|NCT02928900|101383086|FG001|COMPLETED|Wave 2||0||12
48428174|NCT02928900|101383085|FG000|NOT COMPLETED|Wave 2||0||0
48428175|NCT02928900|101383086|FG001|NOT COMPLETED|Wave 2||0||0
48428176|NCT02928900|101383085|FG000|STARTED|Wave 3||0||18
48428177|NCT02928900|101383086|FG001|STARTED|Wave 3||0||6
48428178|NCT02928900|101383085|FG000|COMPLETED|Wave 3||0||18
48428179|NCT02928900|101383086|FG001|COMPLETED|Wave 3||0||6
48428180|NCT02928900|101383085|FG000|NOT COMPLETED|Wave 3||0||0
48428181|NCT02928900|101383086|FG001|NOT COMPLETED|Wave 3||0||0
48428182|NCT02928900|101383085|FG000|STARTED|Wave 4||0||24
48428183|NCT02928900|101383086|FG001|STARTED|Wave 4||0||0
48428184|NCT02928900|101383085|FG000|COMPLETED|Wave 4||0||24
48428185|NCT02928900|101383086|FG001|COMPLETED|Wave 4||0||0
48428186|NCT02928900|101383085|FG000|NOT COMPLETED|Wave 4||0||0
48428187|NCT02928900|101383086|FG001|NOT COMPLETED|Wave 4||0||0
48428188|NCT03360695|101383087|FG000|STARTED|Overall Study||60||
48428189|NCT03360695|101383088|FG001|STARTED|Overall Study||60||
48428190|NCT03360695|101383089|FG002|STARTED|Overall Study||32||
48428191|NCT03360695|101383090|FG003|STARTED|Overall Study||33||
48428192|NCT03360695|101383087|FG000|COMPLETED|Overall Study||57||
48428193|NCT03360695|101383088|FG001|COMPLETED|Overall Study||58||
48428194|NCT03360695|101383089|FG002|COMPLETED|Overall Study||32||
48428195|NCT03360695|101383090|FG003|COMPLETED|Overall Study||33||
48428196|NCT03360695|101383087|FG000|NOT COMPLETED|Overall Study||3||
48428197|NCT03360695|101383088|FG001|NOT COMPLETED|Overall Study||2||
48428198|NCT03360695|101383089|FG002|NOT COMPLETED|Overall Study||0||
48428199|NCT03360695|101383090|FG003|NOT COMPLETED|Overall Study||0||
48428200|NCT00649220|101383091|FG000|STARTED|Overall Study||19||
48428201|NCT00649220|101383091|FG000|COMPLETED|Overall Study||16||
48428202|NCT00649220|101383091|FG000|NOT COMPLETED|Overall Study||3||
48428203|NCT04338685|101383092|FG000|STARTED|Overall Study||4||
48428204|NCT04338685|101383093|FG001|STARTED|Overall Study||6||
48428205|NCT04338685|101383094|FG002|STARTED|Overall Study||3||
48428206|NCT04338685|101383095|FG003|STARTED|Overall Study||10||
48428207|NCT04338685|101383096|FG004|STARTED|Overall Study||4||
48428208|NCT04338685|101383097|FG005|STARTED|Overall Study||18||
48428209|NCT04338685|101383098|FG006|STARTED|Overall Study||4||
48428210|NCT04338685|101383099|FG007|STARTED|Overall Study||5||
48428211|NCT04338685|101383100|FG008|STARTED|Overall Study||1||
48428212|NCT04338685|101383092|FG000|COMPLETED|Overall Study||0||
48428213|NCT04338685|101383093|FG001|COMPLETED|Overall Study||0||
48428214|NCT04338685|101383094|FG002|COMPLETED|Overall Study||0||
48428215|NCT04338685|101383095|FG003|COMPLETED|Overall Study||0||
48428216|NCT04338685|101383096|FG004|COMPLETED|Overall Study||0||
48428217|NCT04338685|101383097|FG005|COMPLETED|Overall Study||0||
48428218|NCT04338685|101383098|FG006|COMPLETED|Overall Study||0||
48428219|NCT04338685|101383099|FG007|COMPLETED|Overall Study||0||
48428220|NCT04338685|101383100|FG008|COMPLETED|Overall Study||0||
48428221|NCT04338685|101383092|FG000|NOT COMPLETED|Overall Study||4||
48428222|NCT04338685|101383093|FG001|NOT COMPLETED|Overall Study||6||
48428223|NCT04338685|101383094|FG002|NOT COMPLETED|Overall Study||3||
48428224|NCT04338685|101383095|FG003|NOT COMPLETED|Overall Study||10||
48428225|NCT04338685|101383096|FG004|NOT COMPLETED|Overall Study||4||
48428226|NCT04338685|101383097|FG005|NOT COMPLETED|Overall Study||18||
48428227|NCT04338685|101383098|FG006|NOT COMPLETED|Overall Study||4||
48428228|NCT04338685|101383099|FG007|NOT COMPLETED|Overall Study||5||
48428229|NCT04338685|101383100|FG008|NOT COMPLETED|Overall Study||1||
48428230|NCT02185729|101383101|FG000|STARTED|0 Hour (Baseline) of Saline Infusion||12||
48428231|NCT02185729|101383101|FG000|COMPLETED|0 Hour (Baseline) of Saline Infusion||12||
48428232|NCT02185729|101383101|FG000|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0||
48428233|NCT02185729|101383101|FG000|STARTED|4 Hours Into Saline Infusion||12||
48428234|NCT02185729|101383101|FG000|COMPLETED|4 Hours Into Saline Infusion||12||
48428235|NCT02185729|101383101|FG000|NOT COMPLETED|4 Hours Into Saline Infusion||0||
48428236|NCT02185729|101383101|FG000|STARTED|24 Hours Into Saline Infusion||12||
48428237|NCT02185729|101383101|FG000|COMPLETED|24 Hours Into Saline Infusion||12||
48428238|NCT02185729|101383101|FG000|NOT COMPLETED|24 Hours Into Saline Infusion||0||
48428239|NCT02185729|101383101|FG000|STARTED|0 Hour (Baseline) of Intralipid Infusion||12||
48428240|NCT02185729|101383101|FG000|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12||
48428241|NCT02185729|101383101|FG000|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0||
48428242|NCT02185729|101383101|FG000|STARTED|4 Hours Into Intralipid Infusion||12||
48428243|NCT02185729|101383101|FG000|COMPLETED|4 Hours Into Intralipid Infusion||12||
48428244|NCT02185729|101383101|FG000|NOT COMPLETED|4 Hours Into Intralipid Infusion||0||
48428245|NCT02185729|101383101|FG000|STARTED|24 Hours Into Intralipid Infusion||12||
48428246|NCT02185729|101383101|FG000|COMPLETED|24 Hours Into Intralipid Infusion||12||
48428247|NCT02185729|101383101|FG000|NOT COMPLETED|24 Hours Into Intralipid Infusion||0||
48428248|NCT02185729|101383101|FG000|STARTED|0 Hour (Baseline) of ClinOleic Infusion||12||
48428249|NCT02185729|101383101|FG000|COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||12||
48428250|NCT02185729|101383101|FG000|NOT COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||0||
48428251|NCT02185729|101383101|FG000|STARTED|4 Hours Into ClinOleic Infusion||12||
48428252|NCT02185729|101383101|FG000|COMPLETED|4 Hours Into ClinOleic Infusion||12||
48428253|NCT02185729|101383101|FG000|NOT COMPLETED|4 Hours Into ClinOleic Infusion||0||
48428254|NCT02185729|101383101|FG000|STARTED|24 Hours Into ClinOleic Infusion||12||
48428255|NCT02185729|101383101|FG000|COMPLETED|24 Hours Into ClinOleic Infusion||12||
48428256|NCT02185729|101383101|FG000|NOT COMPLETED|24 Hours Into ClinOleic Infusion||0||
48428257|NCT02185729|101383101|FG000|STARTED|0 Hour (Baseline) of Dextrose Infusion||12||
48428258|NCT02185729|101383101|FG000|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12||
48428259|NCT02185729|101383101|FG000|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0||
48428260|NCT02185729|101383101|FG000|STARTED|4 Hours Into Dextrose Infusion||12||
48428261|NCT02185729|101383101|FG000|COMPLETED|4 Hours Into Dextrose Infusion||12||
48428262|NCT02185729|101383101|FG000|NOT COMPLETED|4 Hours Into Dextrose Infusion||0||
48428263|NCT02185729|101383101|FG000|STARTED|24 Hours Into Dextrose Infusion||12||
48428264|NCT02185729|101383101|FG000|COMPLETED|24 Hours Into Dextrose Infusion||12||
48428265|NCT02185729|101383101|FG000|NOT COMPLETED|24 Hours Into Dextrose Infusion||0||
48428266|NCT02889861|101383102|FG000|STARTED|Overall Study||3||
48428267|NCT02889861|101383102|FG000|COMPLETED|Overall Study||1||
48428268|NCT02889861|101383102|FG000|NOT COMPLETED|Overall Study||2||
48428269|NCT02028182|101383103|FG000|STARTED|Overall Study||22||
48428270|NCT02028182|101383103|FG000|COMPLETED|Overall Study||20||
48428271|NCT02028182|101383103|FG000|NOT COMPLETED|Overall Study||2||
48428272|NCT01451203|101383104|FG000|STARTED|Double-blind Treatment Period||158||
48428273|NCT01451203|101383105|FG001|STARTED|Double-blind Treatment Period||161||
48428274|NCT01451203|101383104|FG000|Received Treatment|Double-blind Treatment Period||157||
48428275|NCT01451203|101383105|FG001|Received Treatment|Double-blind Treatment Period||159||
48428276|NCT01451203|101383104|FG000|Received Rescue Treatment|Double-blind Treatment Period||70||
48428277|NCT01451203|101383105|FG001|Received Rescue Treatment|Double-blind Treatment Period||36||
48428278|NCT01451203|101383104|FG000|COMPLETED|Double-blind Treatment Period||73||
48428279|NCT01451203|101383105|FG001|COMPLETED|Double-blind Treatment Period||111||
48428280|NCT01451203|101383104|FG000|NOT COMPLETED|Double-blind Treatment Period||85||
48428281|NCT01451203|101383105|FG001|NOT COMPLETED|Double-blind Treatment Period||50||
48428282|NCT01451203|101383104|FG000|STARTED|Post-treatment Period||71||
48428283|NCT01451203|101383105|FG001|STARTED|Post-treatment Period||108||
48428284|NCT01451203|101383104|FG000|Received Rescue Treatment|Post-treatment Period||12||
48428285|NCT01451203|101383105|FG001|Received Rescue Treatment|Post-treatment Period||28||
48428286|NCT01451203|101383104|FG000|COMPLETED|Post-treatment Period||57||
48428287|NCT01451203|101383105|FG001|COMPLETED|Post-treatment Period||74||
48428288|NCT01451203|101383104|FG000|NOT COMPLETED|Post-treatment Period||14||
48428289|NCT01451203|101383105|FG001|NOT COMPLETED|Post-treatment Period||34||
48428290|NCT04140942|101383106|FG000|STARTED|Overall Study||16||
48428291|NCT04140942|101383107|FG001|STARTED|Overall Study||28||
48428292|NCT04140942|101383106|FG000|Completed Post Test Only|Overall Study||11|Reason for incompletion of post test included: COVID-19 shutdown, early release from prison, and drop out.|
48638961|NCT04426656|101901541|FG001|STARTED|Overall Study||46||
48428293|NCT04140942|101383107|FG001|Completed Post Test Only|Overall Study||22|Reason for incompletion of post test included: COVID-19 shutdown, early release from prison, and drop out.|
48428294|NCT04140942|101383106|FG000|COMPLETED|Overall Study||16|Included in employment analysis|
48428295|NCT04140942|101383107|FG001|COMPLETED|Overall Study||28|Included in employment analysis|
48428296|NCT04140942|101383106|FG000|NOT COMPLETED|Overall Study||0||
48428297|NCT04140942|101383107|FG001|NOT COMPLETED|Overall Study||0||
48428298|NCT02546193|101383108|FG000|STARTED|Overall Study||10||
48428299|NCT02546193|101383109|FG001|STARTED|Overall Study||10||
48428300|NCT02546193|101383110|FG002|STARTED|Overall Study||2||
48428301|NCT02546193|101383111|FG003|STARTED|Overall Study||0||
48428302|NCT02546193|101383108|FG000|COMPLETED|Overall Study||4||
48428303|NCT02546193|101383109|FG001|COMPLETED|Overall Study||4||
48428304|NCT02546193|101383110|FG002|COMPLETED|Overall Study||0||
48428305|NCT02546193|101383111|FG003|COMPLETED|Overall Study||0||
48428306|NCT02546193|101383108|FG000|NOT COMPLETED|Overall Study||6||
48428307|NCT02546193|101383109|FG001|NOT COMPLETED|Overall Study||6||
48428308|NCT02546193|101383110|FG002|NOT COMPLETED|Overall Study||2||
48428309|NCT02546193|101383111|FG003|NOT COMPLETED|Overall Study||0||
48428310|NCT02515890|101383112|FG000|STARTED|Overall Study||7||
48428311|NCT02515890|101383113|FG001|STARTED|Overall Study||4||
48428312|NCT02515890|101383114|FG002|STARTED|Overall Study||5||
48428313|NCT02515890|101383115|FG003|STARTED|Overall Study||8||
48428314|NCT02515890|101383116|FG004|STARTED|Overall Study||8||
48428315|NCT02515890|101383112|FG000|COMPLETED|Overall Study||7||
48428316|NCT02515890|101383113|FG001|COMPLETED|Overall Study||4||
48428317|NCT02515890|101383114|FG002|COMPLETED|Overall Study||5||
48428318|NCT02515890|101383115|FG003|COMPLETED|Overall Study||8||
48428319|NCT02515890|101383116|FG004|COMPLETED|Overall Study||8||
48428320|NCT02515890|101383112|FG000|NOT COMPLETED|Overall Study||0||
48428321|NCT02515890|101383113|FG001|NOT COMPLETED|Overall Study||0||
48428322|NCT02515890|101383114|FG002|NOT COMPLETED|Overall Study||0||
48428323|NCT02515890|101383115|FG003|NOT COMPLETED|Overall Study||0||
48428324|NCT02515890|101383116|FG004|NOT COMPLETED|Overall Study||0||
48428325|NCT03911401|101383117|FG000|STARTED|Overall Study||83||
48428326|NCT03911401|101383118|FG001|STARTED|Overall Study||85||
48428327|NCT03911401|101383119|FG002|STARTED|Overall Study||83||
48360285|NCT01933672|101210852|FG006|COMPLETED|Second Intervention Period (12-16 Days)||6||
48360286|NCT01933672|101210846|FG000|NOT COMPLETED|Second Intervention Period (12-16 Days)||0||
48360287|NCT01933672|101210847|FG001|NOT COMPLETED|Second Intervention Period (12-16 Days)||1||
48360288|NCT01933672|101210848|FG002|NOT COMPLETED|Second Intervention Period (12-16 Days)||1||
48360289|NCT01933672|101210849|FG003|NOT COMPLETED|Second Intervention Period (12-16 Days)||0||
48360290|NCT01933672|101210850|FG004|NOT COMPLETED|Second Intervention Period (12-16 Days)||0||
48360291|NCT01933672|101210851|FG005|NOT COMPLETED|Second Intervention Period (12-16 Days)||0||
48360292|NCT01933672|101210852|FG006|NOT COMPLETED|Second Intervention Period (12-16 Days)||0||
48360293|NCT01933672|101210846|FG000|STARTED|Second Washout Period (7-14 Days)||0||
48360294|NCT01933672|101210847|FG001|STARTED|Second Washout Period (7-14 Days)||6||
48360295|NCT01933672|101210848|FG002|STARTED|Second Washout Period (7-14 Days)||1||
48360296|NCT01933672|101210849|FG003|STARTED|Second Washout Period (7-14 Days)||5||
48360297|NCT01933672|101210850|FG004|STARTED|Second Washout Period (7-14 Days)||6||
48360298|NCT01933672|101210851|FG005|STARTED|Second Washout Period (7-14 Days)||4||
48360299|NCT01933672|101210852|FG006|STARTED|Second Washout Period (7-14 Days)||6||
48360300|NCT01933672|101210846|FG000|COMPLETED|Second Washout Period (7-14 Days)||0||
48360301|NCT01933672|101210847|FG001|COMPLETED|Second Washout Period (7-14 Days)||6||
48360302|NCT01933672|101210848|FG002|COMPLETED|Second Washout Period (7-14 Days)||1||
48360303|NCT01933672|101210849|FG003|COMPLETED|Second Washout Period (7-14 Days)||5||
48360304|NCT01933672|101210850|FG004|COMPLETED|Second Washout Period (7-14 Days)||6||
48360305|NCT01933672|101210851|FG005|COMPLETED|Second Washout Period (7-14 Days)||4||
48360306|NCT01933672|101210852|FG006|COMPLETED|Second Washout Period (7-14 Days)||6||
48360307|NCT01933672|101210846|FG000|NOT COMPLETED|Second Washout Period (7-14 Days)||0||
48360308|NCT01933672|101210847|FG001|NOT COMPLETED|Second Washout Period (7-14 Days)||0||
48360309|NCT01933672|101210848|FG002|NOT COMPLETED|Second Washout Period (7-14 Days)||0||
48360310|NCT01933672|101210849|FG003|NOT COMPLETED|Second Washout Period (7-14 Days)||0||
48360311|NCT01933672|101210850|FG004|NOT COMPLETED|Second Washout Period (7-14 Days)||0||
48360312|NCT01933672|101210851|FG005|NOT COMPLETED|Second Washout Period (7-14 Days)||0||
48360313|NCT01933672|101210852|FG006|NOT COMPLETED|Second Washout Period (7-14 Days)||0||
48360314|NCT01933672|101210846|FG000|STARTED|Third Intervention Period (12-16 Days)||0||
48360315|NCT01933672|101210847|FG001|STARTED|Third Intervention Period (12-16 Days)||6||
48360316|NCT01933672|101210848|FG002|STARTED|Third Intervention Period (12-16 Days)||1||
48360317|NCT01933672|101210849|FG003|STARTED|Third Intervention Period (12-16 Days)||5||
48360318|NCT01933672|101210850|FG004|STARTED|Third Intervention Period (12-16 Days)||6||
48428328|NCT03911401|101383117|FG000|COMPLETED|Overall Study||76||
48428329|NCT03911401|101383118|FG001|COMPLETED|Overall Study||76||
48428330|NCT03911401|101383119|FG002|COMPLETED|Overall Study||58||
48428331|NCT03911401|101383117|FG000|NOT COMPLETED|Overall Study||7||
48360319|NCT01933672|101210851|FG005|STARTED|Third Intervention Period (12-16 Days)||4||
48428332|NCT03911401|101383118|FG001|NOT COMPLETED|Overall Study||9||
48428333|NCT03911401|101383119|FG002|NOT COMPLETED|Overall Study||25||
48428334|NCT04548349|101383120|FG000|STARTED|Overall Study||12||
48428335|NCT04548349|101383121|FG001|STARTED|Overall Study||12||
48428336|NCT04548349|101383122|FG002|STARTED|Overall Study||1||
48428337|NCT04548349|101383120|FG000|COMPLETED|Overall Study||8||
48428338|NCT04548349|101383121|FG001|COMPLETED|Overall Study||8||
48428339|NCT04548349|101383122|FG002|COMPLETED|Overall Study||1||
48428340|NCT04548349|101383120|FG000|NOT COMPLETED|Overall Study||4||
48428341|NCT04548349|101383121|FG001|NOT COMPLETED|Overall Study||4||
48360320|NCT01933672|101210852|FG006|STARTED|Third Intervention Period (12-16 Days)||6||
48360321|NCT01933672|101210846|FG000|COMPLETED|Third Intervention Period (12-16 Days)||0||
48360322|NCT01933672|101210847|FG001|COMPLETED|Third Intervention Period (12-16 Days)||5||
48360323|NCT01933672|101210848|FG002|COMPLETED|Third Intervention Period (12-16 Days)||1||
48360324|NCT01933672|101210849|FG003|COMPLETED|Third Intervention Period (12-16 Days)||4||
48360325|NCT01933672|101210850|FG004|COMPLETED|Third Intervention Period (12-16 Days)||6||
48360326|NCT01933672|101210851|FG005|COMPLETED|Third Intervention Period (12-16 Days)||4||
48360327|NCT01933672|101210852|FG006|COMPLETED|Third Intervention Period (12-16 Days)||6||
48360328|NCT01933672|101210846|FG000|NOT COMPLETED|Third Intervention Period (12-16 Days)||0||
48360329|NCT01933672|101210847|FG001|NOT COMPLETED|Third Intervention Period (12-16 Days)||1||
48360330|NCT01933672|101210848|FG002|NOT COMPLETED|Third Intervention Period (12-16 Days)||0||
48360331|NCT01933672|101210849|FG003|NOT COMPLETED|Third Intervention Period (12-16 Days)||1||
48360332|NCT01933672|101210850|FG004|NOT COMPLETED|Third Intervention Period (12-16 Days)||0||
48360333|NCT01933672|101210851|FG005|NOT COMPLETED|Third Intervention Period (12-16 Days)||0||
48360334|NCT01933672|101210852|FG006|NOT COMPLETED|Third Intervention Period (12-16 Days)||0||
48360335|NCT02218203|101210853|FG000|STARTED|Overall Study||26||
48360336|NCT02218203|101210853|FG000|Placebo Dex v. 0mg/km LBM Lidocaine|Overall Study||24||
48360337|NCT02218203|101210853|FG000|Placebo Dex v. 1mg/km LBM Lidocaine|Overall Study||24||
48360338|NCT02218203|101210853|FG000|Placebo Dex v. 2mg/km LBM Lidocaine|Overall Study||24||
48360339|NCT02218203|101210853|FG000|Placebo Dex v. 4mg/km LBM Lidocaine|Overall Study||24||
48360340|NCT02218203|101210853|FG000|Low Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||26||
48360341|NCT02218203|101210853|FG000|Low Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||26||
48360342|NCT02218203|101210853|FG000|Low Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||26||
48360343|NCT02218203|101210853|FG000|Low Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||26||
48360344|NCT02218203|101210853|FG000|Medium Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24||
48360345|NCT02218203|101210853|FG000|Medium Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24||
48360346|NCT02218203|101210853|FG000|Medium Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24||
48360347|NCT02218203|101210853|FG000|Medium Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24||
48360348|NCT02218203|101210853|FG000|High Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24||
48360349|NCT02218203|101210853|FG000|High Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24||
48360350|NCT02218203|101210853|FG000|High Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24||
48360351|NCT02218203|101210853|FG000|High Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24||
48360352|NCT02218203|101210853|FG000|COMPLETED|Overall Study||26||
48360353|NCT02218203|101210853|FG000|NOT COMPLETED|Overall Study||0||
48360354|NCT00035815|101210854|FG000|STARTED|Overall Study||167||
48360355|NCT00035815|101210855|FG001|STARTED|Overall Study||163||
48360356|NCT00035815|101210854|FG000|COMPLETED|Overall Study||150||
48360357|NCT00035815|101210855|FG001|COMPLETED|Overall Study||152||
48360358|NCT00035815|101210854|FG000|NOT COMPLETED|Overall Study||17||
48360359|NCT00035815|101210855|FG001|NOT COMPLETED|Overall Study||11||
48360360|NCT01172288|101210856|FG000|STARTED|Overall Study||17||
48360361|NCT01172288|101210857|FG001|STARTED|Overall Study||14||
48360362|NCT01172288|101210856|FG000|COMPLETED|Overall Study||16||
48360363|NCT01172288|101210857|FG001|COMPLETED|Overall Study||13||
48360364|NCT01172288|101210856|FG000|NOT COMPLETED|Overall Study||1||
48360365|NCT01172288|101210857|FG001|NOT COMPLETED|Overall Study||1||
48360366|NCT02984878|101210858|FG000|STARTED|Overall Study||30||
48360367|NCT02984878|101210859|FG001|STARTED|Overall Study||41||
48360368|NCT02984878|101210858|FG000|COMPLETED|Overall Study||30||
48360369|NCT02984878|101210859|FG001|COMPLETED|Overall Study||41||
48360370|NCT02984878|101210858|FG000|NOT COMPLETED|Overall Study||0||
48428342|NCT04548349|101383122|FG002|NOT COMPLETED|Overall Study||0||
48428343|NCT01020812|101383123|FG000|STARTED|Overall Study||11||
48428344|NCT01020812|101383123|FG000|COMPLETED|Overall Study||8||
48428345|NCT01020812|101383123|FG000|NOT COMPLETED|Overall Study||3||
48187390|NCT02950545|100780039|FG001|NOT COMPLETED|Session 1 (70 Minutes)||0||
48187391|NCT02950545|100780040|FG002|NOT COMPLETED|Session 1 (70 Minutes)||0||
48187392|NCT02950545|100780041|FG003|NOT COMPLETED|Session 1 (70 Minutes)||0||
48187393|NCT02950545|100780042|FG004|NOT COMPLETED|Session 1 (70 Minutes)||0||
48187394|NCT02950545|100780043|FG005|NOT COMPLETED|Session 1 (70 Minutes)||1||
48428346|NCT02843282|101383124|FG000|STARTED|Overall Study||27||
48428347|NCT02843282|101383124|FG000|COMPLETED|Overall Study||27||
48428348|NCT02843282|101383124|FG000|NOT COMPLETED|Overall Study||0||
48428349|NCT03198559|101383125|FG000|STARTED|Overall Study||2||
48428350|NCT03198559|101383125|FG000|COMPLETED|Overall Study||0||
48428351|NCT03198559|101383125|FG000|NOT COMPLETED|Overall Study||2||
48428352|NCT03679117|101383126|FG000|STARTED|Overall Study||15||
48428353|NCT03679117|101383127|FG001|STARTED|Overall Study||14||
48428354|NCT03679117|101383126|FG000|COMPLETED|Overall Study||12||
48428355|NCT03679117|101383127|FG001|COMPLETED|Overall Study||14||
48428356|NCT03679117|101383126|FG000|NOT COMPLETED|Overall Study||3||
48428357|NCT03679117|101383127|FG001|NOT COMPLETED|Overall Study||0||
48428358|NCT00489411|101383128|FG000|STARTED|Initial Treatment Period (Weeks 1-5)||115||
48428359|NCT00489411|101383129|FG001|STARTED|Initial Treatment Period (Weeks 1-5)||116||
48428360|NCT00489411|101383128|FG000|COMPLETED|Initial Treatment Period (Weeks 1-5)||87||
48428361|NCT00489411|101383129|FG001|COMPLETED|Initial Treatment Period (Weeks 1-5)||94||
48428362|NCT00489411|101383128|FG000|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||28||
48428363|NCT00489411|101383129|FG001|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||22||
48428364|NCT00489411|101383128|FG000|STARTED|Washout Period (Weeks 6-7)||87||
48428365|NCT00489411|101383129|FG001|STARTED|Washout Period (Weeks 6-7)||94||
48428366|NCT00489411|101383128|FG000|COMPLETED|Washout Period (Weeks 6-7)||85|Reasons for why patients did not participate in the crossover treatment period were not captured.|
48428367|NCT00489411|101383129|FG001|COMPLETED|Washout Period (Weeks 6-7)||93|Reasons for why patients did not participate in the crossover treatment period were not captured.|
48428368|NCT00489411|101383128|FG000|NOT COMPLETED|Washout Period (Weeks 6-7)||2||
48428369|NCT00489411|101383129|FG001|NOT COMPLETED|Washout Period (Weeks 6-7)||1||
48428370|NCT00489411|101383128|FG000|STARTED|Crossover Treatment Period (Weeks 8-12)||85||
48428371|NCT00489411|101383129|FG001|STARTED|Crossover Treatment Period (Weeks 8-12)||93||
48428372|NCT00489411|101383128|FG000|COMPLETED|Crossover Treatment Period (Weeks 8-12)||67||
48428373|NCT00489411|101383129|FG001|COMPLETED|Crossover Treatment Period (Weeks 8-12)||74||
48428374|NCT00489411|101383128|FG000|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||18||
48428375|NCT00489411|101383129|FG001|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||19||
48428376|NCT01491802|101383130|FG000|STARTED|Overall Study||9||
48428377|NCT01491802|101383131|FG001|STARTED|Overall Study||8||
48428378|NCT01491802|101383130|FG000|COMPLETED|Overall Study||8||
48428379|NCT01491802|101383131|FG001|COMPLETED|Overall Study||6||
48428380|NCT01491802|101383130|FG000|NOT COMPLETED|Overall Study||1||
48428381|NCT01491802|101383131|FG001|NOT COMPLETED|Overall Study||2||
48428382|NCT01559649|101383132|FG000|STARTED|Overall Study||269||
48428383|NCT01559649|101383133|FG001|STARTED|Overall Study||15||
48428384|NCT01559649|101383132|FG000|COMPLETED|Overall Study||250||
48428385|NCT01559649|101383133|FG001|COMPLETED|Overall Study||9||
48428386|NCT01559649|101383132|FG000|NOT COMPLETED|Overall Study||19||
48428387|NCT01559649|101383133|FG001|NOT COMPLETED|Overall Study||6||
48428388|NCT02500732|101383134|FG000|STARTED|Overall Study||27||
48428389|NCT02500732|101383135|FG001|STARTED|Overall Study||30||
48428390|NCT02500732|101383134|FG000|COMPLETED|Overall Study||27||
48428391|NCT02500732|101383135|FG001|COMPLETED|Overall Study||29||
48428392|NCT02500732|101383134|FG000|NOT COMPLETED|Overall Study||0||
48428393|NCT02500732|101383135|FG001|NOT COMPLETED|Overall Study||1||
48428394|NCT02226276|101383136|FG000|STARTED|Overall Study||10||
48428395|NCT02226276|101383136|FG000|COMPLETED|Overall Study||10||
48428396|NCT02226276|101383136|FG000|NOT COMPLETED|Overall Study||0||
48428397|NCT01111058|101383137|FG000|STARTED|Overall Study||28||
48428398|NCT01111058|101383138|FG001|STARTED|Overall Study||24||
48428399|NCT01111058|101383137|FG000|COMPLETED|Overall Study||28||
48428400|NCT01111058|101383138|FG001|COMPLETED|Overall Study||24||
48428401|NCT01111058|101383137|FG000|NOT COMPLETED|Overall Study||0||
48428402|NCT01111058|101383138|FG001|NOT COMPLETED|Overall Study||0||
48428403|NCT04056325|101383139|FG000|STARTED|Phase 2a||31||
48428404|NCT04056325|101383140|FG001|STARTED|Phase 2a||33||
48428405|NCT04056325|101383141|FG002|STARTED|Phase 2a||33||
48428406|NCT04056325|101383142|FG003|STARTED|Phase 2a||32||
48428407|NCT04056325|101383143|FG004|STARTED|Phase 2a||32||
48428408|NCT04056325|101383144|FG005|STARTED|Phase 2a||30||
48428409|NCT04056325|101383145|FG006|STARTED|Phase 2a||32||
48428410|NCT04056325|101383146|FG007|STARTED|Phase 2a||0||
48428411|NCT04056325|101383147|FG008|STARTED|Phase 2a||0||
48187395|NCT02950545|100780038|FG000|STARTED|Washout 1 (5 Minutes)||9||
48187396|NCT02950545|100780039|FG001|STARTED|Washout 1 (5 Minutes)||9||
48428412|NCT04056325|101383139|FG000|COMPLETED|Phase 2a||30||
48428413|NCT04056325|101383140|FG001|COMPLETED|Phase 2a||29||
48428414|NCT04056325|101383141|FG002|COMPLETED|Phase 2a||32||
48428415|NCT04056325|101383142|FG003|COMPLETED|Phase 2a||29||
48428416|NCT04056325|101383143|FG004|COMPLETED|Phase 2a||30||
48428417|NCT04056325|101383144|FG005|COMPLETED|Phase 2a||30||
48428418|NCT04056325|101383145|FG006|COMPLETED|Phase 2a||29||
48428419|NCT04056325|101383146|FG007|COMPLETED|Phase 2a||0||
48428420|NCT04056325|101383147|FG008|COMPLETED|Phase 2a||0||
48428421|NCT04056325|101383139|FG000|NOT COMPLETED|Phase 2a||1||
48428422|NCT04056325|101383140|FG001|NOT COMPLETED|Phase 2a||4||
48428423|NCT04056325|101383141|FG002|NOT COMPLETED|Phase 2a||1||
48428424|NCT04056325|101383142|FG003|NOT COMPLETED|Phase 2a||3||
48428425|NCT04056325|101383143|FG004|NOT COMPLETED|Phase 2a||2||
48428426|NCT04056325|101383144|FG005|NOT COMPLETED|Phase 2a||0||
48428427|NCT04056325|101383145|FG006|NOT COMPLETED|Phase 2a||3||
48428428|NCT04056325|101383146|FG007|NOT COMPLETED|Phase 2a||0||
48428429|NCT04056325|101383147|FG008|NOT COMPLETED|Phase 2a||0||
48428430|NCT04056325|101383139|FG000|STARTED|Phase 2b||0||
48428431|NCT04056325|101383140|FG001|STARTED|Phase 2b||0||
48428432|NCT04056325|101383141|FG002|STARTED|Phase 2b||0||
48428433|NCT04056325|101383142|FG003|STARTED|Phase 2b||0||
48428434|NCT04056325|101383143|FG004|STARTED|Phase 2b||0||
48428435|NCT04056325|101383144|FG005|STARTED|Phase 2b||0||
48428436|NCT04056325|101383145|FG006|STARTED|Phase 2b||0||
48428437|NCT04056325|101383146|FG007|STARTED|Phase 2b||197||
48428438|NCT04056325|101383147|FG008|STARTED|Phase 2b||197||
48428439|NCT04056325|101383139|FG000|COMPLETED|Phase 2b||0||
48428440|NCT04056325|101383140|FG001|COMPLETED|Phase 2b||0||
48428441|NCT04056325|101383141|FG002|COMPLETED|Phase 2b||0||
48428442|NCT04056325|101383142|FG003|COMPLETED|Phase 2b||0||
48428443|NCT04056325|101383143|FG004|COMPLETED|Phase 2b||0||
48428444|NCT04056325|101383144|FG005|COMPLETED|Phase 2b||0||
48428445|NCT04056325|101383145|FG006|COMPLETED|Phase 2b||0||
48428446|NCT04056325|101383146|FG007|COMPLETED|Phase 2b||192||
48428447|NCT04056325|101383147|FG008|COMPLETED|Phase 2b||189||
48428448|NCT04056325|101383139|FG000|NOT COMPLETED|Phase 2b||0||
48428449|NCT04056325|101383140|FG001|NOT COMPLETED|Phase 2b||0||
48428450|NCT04056325|101383141|FG002|NOT COMPLETED|Phase 2b||0||
48428451|NCT04056325|101383142|FG003|NOT COMPLETED|Phase 2b||0||
48428452|NCT04056325|101383143|FG004|NOT COMPLETED|Phase 2b||0||
48428453|NCT04056325|101383144|FG005|NOT COMPLETED|Phase 2b||0||
48428454|NCT04056325|101383145|FG006|NOT COMPLETED|Phase 2b||0||
48428455|NCT04056325|101383146|FG007|NOT COMPLETED|Phase 2b||5||
48428456|NCT04056325|101383147|FG008|NOT COMPLETED|Phase 2b||8||
48428457|NCT01348828|101383148|FG000|STARTED|Overall Study||49||
48428458|NCT01348828|101383148|FG000|COMPLETED|Overall Study||16||
48428459|NCT01348828|101383148|FG000|NOT COMPLETED|Overall Study||33||
48428460|NCT01319422|101383149|FG000|STARTED|Overall Study||20||
48428461|NCT01319422|101383150|FG001|STARTED|Overall Study||20||
48428462|NCT01319422|101383149|FG000|COMPLETED|Overall Study||19||
48428463|NCT01319422|101383150|FG001|COMPLETED|Overall Study||20||
48428464|NCT01319422|101383149|FG000|NOT COMPLETED|Overall Study||1||
48428465|NCT01319422|101383150|FG001|NOT COMPLETED|Overall Study||0||
48428466|NCT05814367|101383151|FG000|STARTED|Period 1||22||
48428467|NCT05814367|101383152|FG001|STARTED|Period 1||22||
48428468|NCT05814367|101383151|FG000|COMPLETED|Period 1||22||
48428469|NCT05814367|101383152|FG001|COMPLETED|Period 1||22||
48428470|NCT05814367|101383151|FG000|NOT COMPLETED|Period 1||0||
48428471|NCT05814367|101383152|FG001|NOT COMPLETED|Period 1||0||
48428472|NCT05814367|101383151|FG000|STARTED|Period 2||22||
48428473|NCT05814367|101383152|FG001|STARTED|Period 2||22||
48428474|NCT05814367|101383151|FG000|COMPLETED|Period 2||22||
48428475|NCT05814367|101383152|FG001|COMPLETED|Period 2||22||
48428476|NCT05814367|101383151|FG000|NOT COMPLETED|Period 2||0||
48428477|NCT05814367|101383152|FG001|NOT COMPLETED|Period 2||0||
48428478|NCT02491463|101383153|FG000|STARTED|Overall Study||7||
48428479|NCT02491463|101383154|FG001|STARTED|Overall Study||31||
48428480|NCT02491463|101383155|FG002|STARTED|Overall Study||19||
48428481|NCT02491463|101383156|FG003|STARTED|Overall Study||15||
48428482|NCT02491463|101383153|FG000|COMPLETED|Overall Study||5||
48428483|NCT02491463|101383154|FG001|COMPLETED|Overall Study||21||
48428484|NCT02491463|101383155|FG002|COMPLETED|Overall Study||15||
48428485|NCT02491463|101383156|FG003|COMPLETED|Overall Study||14||
48428486|NCT02491463|101383153|FG000|NOT COMPLETED|Overall Study||2||
48428487|NCT02491463|101383154|FG001|NOT COMPLETED|Overall Study||10||
48428488|NCT02491463|101383155|FG002|NOT COMPLETED|Overall Study||4||
48428489|NCT02491463|101383156|FG003|NOT COMPLETED|Overall Study||1||
48428490|NCT04081727|101383157|FG000|STARTED|Overall Study||2||
48428491|NCT04081727|101383158|FG001|STARTED|Overall Study||0||
48428492|NCT04081727|101383157|FG000|As-treated Analysis|Overall Study||1||
48428493|NCT04081727|101383158|FG001|As-treated Analysis|Overall Study||1||
48428494|NCT04081727|101383157|FG000|COMPLETED|Overall Study||2||
48428495|NCT04081727|101383158|FG001|COMPLETED|Overall Study||0||
48428496|NCT04081727|101383157|FG000|NOT COMPLETED|Overall Study||0||
48428497|NCT04081727|101383158|FG001|NOT COMPLETED|Overall Study||0||
48428498|NCT00462501|101383159|FG000|STARTED|Overall Study||35||
48428499|NCT00462501|101383159|FG000|COMPLETED|Overall Study||30||
48428500|NCT00462501|101383159|FG000|NOT COMPLETED|Overall Study||5||
48428501|NCT00934661|101383160|FG000|STARTED|Overall Study||20||
48428502|NCT00934661|101383161|FG001|STARTED|Overall Study||20||
48428503|NCT00934661|101383160|FG000|COMPLETED|Overall Study||19||
48428504|NCT00934661|101383161|FG001|COMPLETED|Overall Study||20||
48428505|NCT00934661|101383160|FG000|NOT COMPLETED|Overall Study||1||
48428506|NCT00934661|101383161|FG001|NOT COMPLETED|Overall Study||0||
48428507|NCT04620356|101383162|FG000|STARTED|Overall Study||35||
48428508|NCT04620356|101383163|FG001|STARTED|Overall Study||70||
48428509|NCT04620356|101383162|FG000|COMPLETED|Overall Study||31||
48428510|NCT04620356|101383163|FG001|COMPLETED|Overall Study||49||
48428511|NCT04620356|101383162|FG000|NOT COMPLETED|Overall Study||4||
48428512|NCT04620356|101383163|FG001|NOT COMPLETED|Overall Study||21||
48428513|NCT02452892|101383164|FG000|STARTED|Week 1 Initial Randommization||41|Week 1 subjects were randomized 1:1:1 allocation to LFMS Sham, LFMS 20min,or LFMS 60min|
48428514|NCT02452892|101383165|FG001|STARTED|Week 1 Initial Randommization||40|Week 1 subjects were randomized 1:1:1 allocation to LFMS Sham, LFMS 20min,or LFMS 60min|
48428515|NCT02452892|101383166|FG002|STARTED|Week 1 Initial Randommization||41|Week 1 subjects were randomized 1:1:1 allocation to LFMS Sham, LFMS 20min,or LFMS 60min|
48428516|NCT02452892|101383167|FG003|STARTED|Week 1 Initial Randommization||0|Week 1 subjects were randomized 1:1:1 allocation to LFMS Sham, LFMS 20min,or LFMS 60min|
48428517|NCT02452892|101383164|FG000|COMPLETED|Week 1 Initial Randommization||40||
48428518|NCT02452892|101383165|FG001|COMPLETED|Week 1 Initial Randommization||40||
48428519|NCT02452892|101383166|FG002|COMPLETED|Week 1 Initial Randommization||40||
48428520|NCT02452892|101383167|FG003|COMPLETED|Week 1 Initial Randommization||0||
48428521|NCT02452892|101383164|FG000|NOT COMPLETED|Week 1 Initial Randommization||1||
48428522|NCT02452892|101383165|FG001|NOT COMPLETED|Week 1 Initial Randommization||0||
48428523|NCT02452892|101383166|FG002|NOT COMPLETED|Week 1 Initial Randommization||1||
48428524|NCT02452892|101383167|FG003|NOT COMPLETED|Week 1 Initial Randommization||0||
48428525|NCT02452892|101383164|FG000|STARTED|Week 2 Stratification & Re-Randomization||65|Subjects stratified by response \& re-randomized to LFMS Sham, LFMS 20min, LFMS 60min, or LFMS 120min|
48428526|NCT02452892|101383165|FG001|STARTED|Week 2 Stratification & Re-Randomization||7|Subjects stratified by response \& re-randomized to LFMS Sham, LFMS 20min, LFMS 60min, or LFMS 120min|
48428527|NCT02452892|101383166|FG002|STARTED|Week 2 Stratification & Re-Randomization||7|Subjects stratified by response \& re-randomized to LFMS Sham, LFMS 20min, LFMS 60min, or LFMS 120min|
48428528|NCT02452892|101383167|FG003|STARTED|Week 2 Stratification & Re-Randomization||41|Subjects stratified by response \& re-randomized to LFMS Sham, LFMS 20min, LFMS 60min, or LFMS 120min|
48428529|NCT02452892|101383164|FG000|Non-reponders|Week 2 Stratification & Re-Randomization||38||
48428530|NCT02452892|101383165|FG001|Non-reponders|Week 2 Stratification & Re-Randomization||0||
48428531|NCT02452892|101383166|FG002|Non-reponders|Week 2 Stratification & Re-Randomization||0||
48428532|NCT02452892|101383167|FG003|Non-reponders|Week 2 Stratification & Re-Randomization||41||
48428533|NCT02452892|101383164|FG000|Responders|Week 2 Stratification & Re-Randomization||27||
48428534|NCT02452892|101383165|FG001|Responders|Week 2 Stratification & Re-Randomization||7||
48428535|NCT02452892|101383166|FG002|Responders|Week 2 Stratification & Re-Randomization||7||
48428536|NCT02452892|101383167|FG003|Responders|Week 2 Stratification & Re-Randomization||0||
48428537|NCT02452892|101383164|FG000|COMPLETED|Week 2 Stratification & Re-Randomization||63||
48428538|NCT02452892|101383165|FG001|COMPLETED|Week 2 Stratification & Re-Randomization||7||
48428539|NCT02452892|101383166|FG002|COMPLETED|Week 2 Stratification & Re-Randomization||7||
48428540|NCT02452892|101383167|FG003|COMPLETED|Week 2 Stratification & Re-Randomization||39||
48428541|NCT02452892|101383164|FG000|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2||
48428542|NCT02452892|101383165|FG001|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0||
48428543|NCT02452892|101383166|FG002|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0||
48428544|NCT02452892|101383167|FG003|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2||
48428545|NCT02452892|101383164|FG000|STARTED|Follow-up||63||
48763982|NCT03146585|102211841|FG000|STARTED|Overall Study||25||
48763983|NCT03146585|102211842|FG001|STARTED|Overall Study||10||
48763984|NCT03146585|102211843|FG002|STARTED|Overall Study||5||
48428546|NCT02452892|101383165|FG001|STARTED|Follow-up||7||
48428547|NCT02452892|101383166|FG002|STARTED|Follow-up||7||
48428548|NCT02452892|101383167|FG003|STARTED|Follow-up||39||
48428549|NCT02452892|101383164|FG000|COMPLETED|Follow-up||62||
48428550|NCT02452892|101383165|FG001|COMPLETED|Follow-up||7||
48428551|NCT02452892|101383166|FG002|COMPLETED|Follow-up||7||
48763985|NCT03146585|102211841|FG000|COMPLETED|Overall Study||25||
48428552|NCT02452892|101383167|FG003|COMPLETED|Follow-up||38||
48428553|NCT02452892|101383164|FG000|NOT COMPLETED|Follow-up||1||
48428554|NCT02452892|101383165|FG001|NOT COMPLETED|Follow-up||0||
48763986|NCT03146585|102211842|FG001|COMPLETED|Overall Study||10||
48763987|NCT03146585|102211843|FG002|COMPLETED|Overall Study||5||
48360371|NCT02984878|101210859|FG001|NOT COMPLETED|Overall Study||0||
48360372|NCT02795156|101210860|FG000|STARTED|Overall Study||39||
48360373|NCT02795156|101210861|FG001|STARTED|Overall Study||10||
48360374|NCT02795156|101210862|FG002|STARTED|Overall Study||42||
48360375|NCT02795156|101210863|FG003|STARTED|Overall Study||9||
48360376|NCT02795156|101210860|FG000|COMPLETED|Overall Study||0||
48360377|NCT02795156|101210861|FG001|COMPLETED|Overall Study||0||
48360378|NCT02795156|101210862|FG002|COMPLETED|Overall Study||0||
48360379|NCT02795156|101210863|FG003|COMPLETED|Overall Study||0||
48360380|NCT02795156|101210860|FG000|NOT COMPLETED|Overall Study||39||
48360381|NCT02795156|101210861|FG001|NOT COMPLETED|Overall Study||10||
48360382|NCT02795156|101210862|FG002|NOT COMPLETED|Overall Study||42||
48360383|NCT02795156|101210863|FG003|NOT COMPLETED|Overall Study||9||
48360384|NCT03425799|101210864|FG000|STARTED|Overall Study||0||
48360385|NCT03425799|101210865|FG001|STARTED|Overall Study||0||
48360386|NCT03425799|101210864|FG000|COMPLETED|Overall Study||0|Study terminated due to low recruitment|
48360387|NCT03425799|101210865|FG001|COMPLETED|Overall Study||0|Study terminated due to low recruitment|
48360388|NCT03425799|101210864|FG000|NOT COMPLETED|Overall Study||0||
48360389|NCT03425799|101210865|FG001|NOT COMPLETED|Overall Study||0||
48360390|NCT02989727|101210866|FG000|STARTED|Overall Study||46|We only analyzed data from treatment completers (n=150) in the original study (n=221), NCT00274677.|
48360391|NCT02989727|101210867|FG001|STARTED|Overall Study||44|We only analyzed data from treatment completers (n=150) in the original study (n=221), NCT00274677.|
48360392|NCT02989727|101210868|FG002|STARTED|Overall Study||30|We only analyzed data from treatment completers (n=150) in the original study (n=221), NCT00274677.|
48360393|NCT02989727|101210869|FG003|STARTED|Overall Study||30|We only analyzed data from treatment completers (n=150) in the original study (n=221), NCT00274677.|
48360394|NCT02989727|101210866|FG000|COMPLETED|Overall Study||46||
48360395|NCT02989727|101210867|FG001|COMPLETED|Overall Study||44||
48360396|NCT02989727|101210868|FG002|COMPLETED|Overall Study||30||
48360397|NCT02989727|101210869|FG003|COMPLETED|Overall Study||30||
48360398|NCT02989727|101210866|FG000|NOT COMPLETED|Overall Study||0||
48360399|NCT02989727|101210867|FG001|NOT COMPLETED|Overall Study||0||
48360400|NCT02989727|101210868|FG002|NOT COMPLETED|Overall Study||0||
48360401|NCT02989727|101210869|FG003|NOT COMPLETED|Overall Study||0||
48360402|NCT00940927|101210870|FG000|STARTED|Overall Study||81||
48360403|NCT00940927|101210870|FG000|COMPLETED|Overall Study||81||
48360404|NCT00940927|101210870|FG000|NOT COMPLETED|Overall Study||0||
48360405|NCT02492711|101210871|FG000|STARTED|Overall Study||266||
48360406|NCT02492711|101210872|FG001|STARTED|Overall Study||270||
48360407|NCT02492711|101210873|FG002|STARTED|Overall Study||88||
48360408|NCT02492711|101210871|FG000|Intent-to-treat (ITT) Population|Overall Study||266||
48360409|NCT02492711|101210872|FG001|Intent-to-treat (ITT) Population|Overall Study||270||
48360410|NCT02492711|101210873|FG002|Intent-to-treat (ITT) Population|Overall Study||88||
48360411|NCT02492711|101210871|FG000|Safety Population|Overall Study||264||
48360412|NCT02492711|101210872|FG001|Safety Population|Overall Study||266||
48360413|NCT02492711|101210873|FG002|Safety Population|Overall Study||88||
48360414|NCT02492711|101210871|FG000|COMPLETED|Overall Study||230||
48360415|NCT02492711|101210872|FG001|COMPLETED|Overall Study||230||
48360416|NCT02492711|101210873|FG002|COMPLETED|Overall Study||75||
48360417|NCT02492711|101210871|FG000|NOT COMPLETED|Overall Study||36||
48360418|NCT02492711|101210872|FG001|NOT COMPLETED|Overall Study||40||
48360419|NCT02492711|101210873|FG002|NOT COMPLETED|Overall Study||13||
48360420|NCT01419171|101210874|FG000|STARTED|Overall Study||328||
48360421|NCT01419171|101210874|FG000|COMPLETED|Overall Study||328||
48360422|NCT01419171|101210874|FG000|NOT COMPLETED|Overall Study||0||
48360423|NCT01686503|101210875|FG000|STARTED|Overall Study||66||
48360424|NCT01686503|101210876|FG001|STARTED|Overall Study||66||
48360425|NCT01686503|101210877|FG002|STARTED|Overall Study||66||
48360426|NCT01686503|101210878|FG003|STARTED|Overall Study||33||
48360427|NCT01686503|101210875|FG000|COMPLETED|Overall Study||65||
48360428|NCT01686503|101210876|FG001|COMPLETED|Overall Study||63||
48360429|NCT01686503|101210877|FG002|COMPLETED|Overall Study||64||
48360430|NCT01686503|101210878|FG003|COMPLETED|Overall Study||32||
48763988|NCT03146585|102211841|FG000|NOT COMPLETED|Overall Study||0||
48360431|NCT01686503|101210875|FG000|NOT COMPLETED|Overall Study||1||
48360432|NCT01686503|101210876|FG001|NOT COMPLETED|Overall Study||3||
48360433|NCT01686503|101210877|FG002|NOT COMPLETED|Overall Study||2||
48763989|NCT03146585|102211842|FG001|NOT COMPLETED|Overall Study||0||
48763990|NCT03146585|102211843|FG002|NOT COMPLETED|Overall Study||0||
48763991|NCT01887327|102211844|FG000|STARTED|Overall Study||30||
48360434|NCT01686503|101210878|FG003|NOT COMPLETED|Overall Study||1||
48428555|NCT02452892|101383166|FG002|NOT COMPLETED|Follow-up||0||
48360435|NCT01927562|101210879|FG000|STARTED|Overall Study||57||
48360436|NCT01927562|101210879|FG000|COMPLETED|Overall Study||19||
48360437|NCT01927562|101210879|FG000|NOT COMPLETED|Overall Study||38||
48360438|NCT01810991|101210880|FG000|STARTED|Overall Study||19||
48360439|NCT01810991|101210880|FG000|COMPLETED|Overall Study||17||
48763992|NCT01887327|102211845|FG001|STARTED|Overall Study||31||
48428556|NCT02452892|101383167|FG003|NOT COMPLETED|Follow-up||1||
48428557|NCT02679560|101383168|FG000|STARTED|Overall Study||1||
48428558|NCT02679560|101383169|FG001|STARTED|Overall Study||2||
48428559|NCT02679560|101383168|FG000|COMPLETED|Overall Study||1||
48428560|NCT02679560|101383169|FG001|COMPLETED|Overall Study||2||
48428561|NCT02679560|101383168|FG000|NOT COMPLETED|Overall Study||0||
48428562|NCT02679560|101383169|FG001|NOT COMPLETED|Overall Study||0||
48428563|NCT03378921|101383170|FG000|STARTED|Overall Study||13||
48428564|NCT03378921|101383171|FG001|STARTED|Overall Study||13||
48428565|NCT03378921|101383170|FG000|COMPLETED|Overall Study||13||
48428566|NCT03378921|101383171|FG001|COMPLETED|Overall Study||13||
48428567|NCT03378921|101383170|FG000|NOT COMPLETED|Overall Study||0||
48428568|NCT03378921|101383171|FG001|NOT COMPLETED|Overall Study||0||
48428569|NCT03158532|101383172|FG000|STARTED|Overall Study||510||
48428570|NCT03158532|101383173|FG001|STARTED|Overall Study||510||
48428571|NCT03158532|101383174|FG002|STARTED|Overall Study||510||
48428572|NCT03158532|101383175|FG003|STARTED|Overall Study||510||
48428573|NCT03158532|101383172|FG000|COMPLETED|Overall Study||510||
48428574|NCT03158532|101383173|FG001|COMPLETED|Overall Study||510||
48428575|NCT03158532|101383174|FG002|COMPLETED|Overall Study||510||
48428576|NCT03158532|101383175|FG003|COMPLETED|Overall Study||510||
48428577|NCT03158532|101383172|FG000|NOT COMPLETED|Overall Study||0||
48428578|NCT03158532|101383173|FG001|NOT COMPLETED|Overall Study||0||
48428579|NCT03158532|101383174|FG002|NOT COMPLETED|Overall Study||0||
48428580|NCT03158532|101383175|FG003|NOT COMPLETED|Overall Study||0||
48428581|NCT00938457|101383176|FG000|STARTED|Overall Study||3||
48428582|NCT00938457|101383176|FG000|COMPLETED|Overall Study||3||
48428583|NCT00938457|101383176|FG000|NOT COMPLETED|Overall Study||0||
48428584|NCT01021423|101383177|FG000|STARTED|Overall Study||4||
48428585|NCT01021423|101383178|FG001|STARTED|Overall Study||5||
48428586|NCT01021423|101383177|FG000|COMPLETED|Overall Study||0||
48428587|NCT01021423|101383178|FG001|COMPLETED|Overall Study||0||
48428588|NCT01021423|101383177|FG000|NOT COMPLETED|Overall Study||4||
48428589|NCT01021423|101383178|FG001|NOT COMPLETED|Overall Study||5||
48428590|NCT00148109|101383179|FG000|STARTED|Overall Study||15||
48428591|NCT00148109|101383180|FG001|STARTED|Overall Study||21||
48428592|NCT00148109|101383179|FG000|COMPLETED|Overall Study||3||
48428593|NCT00148109|101383180|FG001|COMPLETED|Overall Study||1||
48428594|NCT00148109|101383179|FG000|NOT COMPLETED|Overall Study||12||
48428595|NCT00148109|101383180|FG001|NOT COMPLETED|Overall Study||20||
48428596|NCT06212310|101383181|FG000|STARTED|Overall Study||212||
48428597|NCT06212310|101383182|FG001|STARTED|Overall Study||207||
48428598|NCT06212310|101383181|FG000|COMPLETED|Overall Study||100||
48428599|NCT06212310|101383182|FG001|COMPLETED|Overall Study||101||
48428600|NCT06212310|101383181|FG000|NOT COMPLETED|Overall Study||112||
48428601|NCT06212310|101383182|FG001|NOT COMPLETED|Overall Study||106||
48428602|NCT03491384|101383183|FG000|STARTED|Overall Study||44||
48428603|NCT03491384|101383184|FG001|STARTED|Overall Study||105||
48428604|NCT03491384|101383185|FG002|STARTED|Overall Study||117||
48428605|NCT03491384|101383186|FG003|STARTED|Overall Study||95||
48428606|NCT03491384|101383183|FG000|COMPLETED|Overall Study||42||
48428607|NCT03491384|101383184|FG001|COMPLETED|Overall Study||86||
48428608|NCT03491384|101383185|FG002|COMPLETED|Overall Study||92||
48428609|NCT03491384|101383186|FG003|COMPLETED|Overall Study||80||
48428610|NCT03491384|101383183|FG000|NOT COMPLETED|Overall Study||2||
48428611|NCT03491384|101383184|FG001|NOT COMPLETED|Overall Study||19||
48428612|NCT03491384|101383185|FG002|NOT COMPLETED|Overall Study||25||
48428613|NCT03491384|101383186|FG003|NOT COMPLETED|Overall Study||15||
48428614|NCT02613910|101383187|FG000|STARTED|Overall Study||1||
48428615|NCT02613910|101383187|FG000|COMPLETED|Overall Study||0||
48428616|NCT02613910|101383187|FG000|NOT COMPLETED|Overall Study||1||
48428617|NCT02788981|101383188|FG000|STARTED|Overall Study||13||
48428618|NCT02788981|101383189|FG001|STARTED|Overall Study||16||
48428619|NCT02788981|101383188|FG000|COMPLETED|Overall Study||13||
48428620|NCT02788981|101383189|FG001|COMPLETED|Overall Study||15||
48428621|NCT02788981|101383188|FG000|NOT COMPLETED|Overall Study||0||
48428622|NCT02788981|101383189|FG001|NOT COMPLETED|Overall Study||1||
48428623|NCT02763566|101383190|FG000|STARTED|Overall Study||207||
48428624|NCT02763566|101383191|FG001|STARTED|Overall Study||99||
48428625|NCT02763566|101383192|FG002|STARTED|Overall Study||104||
48428626|NCT02763566|101383193|FG003|STARTED|Overall Study||53||
48428627|NCT02763566|101383190|FG000|COMPLETED|Overall Study||89||
48428628|NCT02763566|101383191|FG001|COMPLETED|Overall Study||60||
48428629|NCT02763566|101383192|FG002|COMPLETED|Overall Study||50||
48428630|NCT02763566|101383193|FG003|COMPLETED|Overall Study||39||
48428631|NCT02763566|101383190|FG000|NOT COMPLETED|Overall Study||118||
48428632|NCT02763566|101383191|FG001|NOT COMPLETED|Overall Study||39||
48428633|NCT02763566|101383192|FG002|NOT COMPLETED|Overall Study||54||
48428634|NCT02763566|101383193|FG003|NOT COMPLETED|Overall Study||14||
48428635|NCT01388946|101383194|FG000|STARTED|Overall Study||55||
48428636|NCT01388946|101383195|FG001|STARTED|Overall Study||55||
48428637|NCT01388946|101383194|FG000|COMPLETED|Overall Study||49||
48428638|NCT01388946|101383195|FG001|COMPLETED|Overall Study||52||
48428639|NCT01388946|101383194|FG000|NOT COMPLETED|Overall Study||6||
48428640|NCT01388946|101383195|FG001|NOT COMPLETED|Overall Study||3||
48428641|NCT00496782|101383196|FG000|STARTED|Overall Study||9||
48428642|NCT00496782|101383197|FG001|STARTED|Overall Study||7||
48428643|NCT00496782|101383196|FG000|COMPLETED|Overall Study||8||
48428644|NCT00496782|101383197|FG001|COMPLETED|Overall Study||5||
48428645|NCT00496782|101383196|FG000|NOT COMPLETED|Overall Study||1||
48428646|NCT00496782|101383197|FG001|NOT COMPLETED|Overall Study||2||
48428647|NCT03319160|101383198|FG000|STARTED|Overall Study||1164||
48428648|NCT03319160|101383198|FG000|COMPLETED|Overall Study||1157||
48428649|NCT03319160|101383198|FG000|NOT COMPLETED|Overall Study||7||
48428650|NCT00945815|101383199|FG000|STARTED|Overall Study||35||
48428651|NCT00945815|101383199|FG000|Eligible|Overall Study||32||
48428652|NCT00945815|101383199|FG000|Eligible and Began Protocol Therapy|Overall Study||31||
48428653|NCT00945815|101383199|FG000|COMPLETED|Overall Study||27||
48428654|NCT00945815|101383199|FG000|NOT COMPLETED|Overall Study||8||
48428655|NCT02221882|101383200|FG000|STARTED|Overall Study||3||
48428656|NCT02221882|101383201|FG001|STARTED|Overall Study||3||
48428657|NCT02221882|101383202|FG002|STARTED|Overall Study||11||
48428658|NCT02221882|101383203|FG003|STARTED|Overall Study||3||
48428659|NCT02221882|101383204|FG004|STARTED|Overall Study||5||
48428660|NCT02221882|101383205|FG005|STARTED|Overall Study||4||
48428661|NCT02221882|101383200|FG000|Received at Least One Dose of Study Drug|Overall Study||3||
48428662|NCT02221882|101383201|FG001|Received at Least One Dose of Study Drug|Overall Study||3||
48428663|NCT02221882|101383202|FG002|Received at Least One Dose of Study Drug|Overall Study||11||
48428664|NCT02221882|101383203|FG003|Received at Least One Dose of Study Drug|Overall Study||3||
48428665|NCT02221882|101383204|FG004|Received at Least One Dose of Study Drug|Overall Study||5||
48428666|NCT02221882|101383205|FG005|Received at Least One Dose of Study Drug|Overall Study||4||
48428667|NCT02221882|101383200|FG000|COMPLETED|Overall Study||3||
48428668|NCT02221882|101383201|FG001|COMPLETED|Overall Study||2||
48428669|NCT02221882|101383202|FG002|COMPLETED|Overall Study||7||
48428670|NCT02221882|101383203|FG003|COMPLETED|Overall Study||1||
48428671|NCT02221882|101383204|FG004|COMPLETED|Overall Study||3||
48428672|NCT02221882|101383205|FG005|COMPLETED|Overall Study||2||
48428673|NCT02221882|101383200|FG000|NOT COMPLETED|Overall Study||0||
48428674|NCT02221882|101383201|FG001|NOT COMPLETED|Overall Study||1||
48428675|NCT02221882|101383202|FG002|NOT COMPLETED|Overall Study||4||
48428676|NCT02221882|101383203|FG003|NOT COMPLETED|Overall Study||2||
48428677|NCT02221882|101383204|FG004|NOT COMPLETED|Overall Study||2||
48428678|NCT02221882|101383205|FG005|NOT COMPLETED|Overall Study||2||
48428679|NCT01539512|101383206|FG000|STARTED|Overall Study||110||
48428680|NCT01539512|101383207|FG001|STARTED|Overall Study||110||
48428681|NCT01539512|101383206|FG000|COMPLETED|Overall Study||87||
48428682|NCT01539512|101383207|FG001|COMPLETED|Overall Study||97||
48428683|NCT01539512|101383206|FG000|NOT COMPLETED|Overall Study||23||
48428684|NCT01539512|101383207|FG001|NOT COMPLETED|Overall Study||13||
48428685|NCT03319368|101383208|FG000|STARTED|Overall Study||158||
48428686|NCT03319368|101383209|FG001|STARTED|Overall Study||167||
48428687|NCT03319368|101383208|FG000|COMPLETED|Overall Study||101||
48428688|NCT03319368|101383209|FG001|COMPLETED|Overall Study||121||
48428689|NCT03319368|101383208|FG000|NOT COMPLETED|Overall Study||57||
48428690|NCT03319368|101383209|FG001|NOT COMPLETED|Overall Study||46||
48428691|NCT01641952|101383210|FG000|STARTED|Overall Study||505||
48428692|NCT01641952|101383210|FG000|Treated|Overall Study||504||
48428693|NCT01641952|101383210|FG000|COMPLETED|Overall Study||471||
48428694|NCT01641952|101383210|FG000|NOT COMPLETED|Overall Study||34||
48428695|NCT01315158|101383211|FG000|STARTED|Overall Study||17||
48428696|NCT01315158|101383212|FG001|STARTED|Overall Study||19||
48428697|NCT01315158|101383211|FG000|COMPLETED|Overall Study||17||
48428698|NCT01315158|101383212|FG001|COMPLETED|Overall Study||19||
48428699|NCT01315158|101383211|FG000|NOT COMPLETED|Overall Study||0||
48428700|NCT01315158|101383212|FG001|NOT COMPLETED|Overall Study||0||
48428701|NCT02369874|101383213|FG000|STARTED|Overall Study||247||
48428702|NCT02369874|101383214|FG001|STARTED|Overall Study||240||
48428703|NCT02369874|101383215|FG002|STARTED|Overall Study||249||
48428704|NCT02369874|101383213|FG000|Received Treatment|Overall Study||246||
48428705|NCT02369874|101383214|FG001|Received Treatment|Overall Study||237||
48428706|NCT02369874|101383215|FG002|Received Treatment|Overall Study||240||
48428707|NCT02369874|101383213|FG000|COMPLETED|Overall Study||203||
48428708|NCT02369874|101383214|FG001|COMPLETED|Overall Study||183||
48428709|NCT02369874|101383215|FG002|COMPLETED|Overall Study||188||
48428710|NCT02369874|101383213|FG000|NOT COMPLETED|Overall Study||44||
48428711|NCT02369874|101383214|FG001|NOT COMPLETED|Overall Study||57||
48428712|NCT02369874|101383215|FG002|NOT COMPLETED|Overall Study||61||
48428713|NCT00682539|101383216|FG000|STARTED|Bevacizumab vs Triamcinolone||18||
48428714|NCT00682539|101383217|FG001|STARTED|Bevacizumab vs Triamcinolone||16||
48428715|NCT00682539|101383218|FG002|STARTED|Bevacizumab vs Triamcinolone||0||
48428716|NCT00682539|101383216|FG000|COMPLETED|Bevacizumab vs Triamcinolone||15||
48428717|NCT00682539|101383217|FG001|COMPLETED|Bevacizumab vs Triamcinolone||15||
48428718|NCT00682539|101383218|FG002|COMPLETED|Bevacizumab vs Triamcinolone||0||
48428719|NCT00682539|101383216|FG000|NOT COMPLETED|Bevacizumab vs Triamcinolone||3||
48428720|NCT00682539|101383217|FG001|NOT COMPLETED|Bevacizumab vs Triamcinolone||1||
48428721|NCT00682539|101383218|FG002|NOT COMPLETED|Bevacizumab vs Triamcinolone||0||
48428722|NCT00682539|101383216|FG000|STARTED|Ranibizumab vs Triamcinolone||0||
48428723|NCT00682539|101383217|FG001|STARTED|Ranibizumab vs Triamcinolone||18||
48428724|NCT00682539|101383218|FG002|STARTED|Ranibizumab vs Triamcinolone||18||
48428725|NCT00682539|101383216|FG000|COMPLETED|Ranibizumab vs Triamcinolone||0||
48428726|NCT00682539|101383217|FG001|COMPLETED|Ranibizumab vs Triamcinolone||15||
48428727|NCT00682539|101383218|FG002|COMPLETED|Ranibizumab vs Triamcinolone||10||
48428728|NCT00682539|101383216|FG000|NOT COMPLETED|Ranibizumab vs Triamcinolone||0||
48428729|NCT00682539|101383217|FG001|NOT COMPLETED|Ranibizumab vs Triamcinolone||3||
48428730|NCT00682539|101383218|FG002|NOT COMPLETED|Ranibizumab vs Triamcinolone||8||
48428731|NCT01753765|101383219|FG000|STARTED|Overall Study||26||
48428732|NCT01753765|101383219|FG000|COMPLETED|Overall Study||26||
48428733|NCT01753765|101383219|FG000|NOT COMPLETED|Overall Study||0||
48428734|NCT01161173|101383220|FG000|STARTED|Overall Study||347||
48428735|NCT01161173|101383220|FG000|COMPLETED|Overall Study||0||
48428736|NCT01161173|101383220|FG000|NOT COMPLETED|Overall Study||347||
48428737|NCT02049476|101383221|FG000|STARTED|Overall Study||20||28
48428738|NCT02049476|101383221|FG000|COMPLETED|Overall Study||20||28
48428739|NCT02049476|101383221|FG000|NOT COMPLETED|Overall Study||0||0
48428740|NCT05807477|101383222|FG000|STARTED|Overall Study||12||
48428741|NCT05807477|101383222|FG000|COMPLETED|Overall Study||12||
48428742|NCT05807477|101383222|FG000|NOT COMPLETED|Overall Study||0||
48428743|NCT03877484|101386003|FG000|STARTED|Overall Study||40||
48428744|NCT03877484|101386003|FG000|COMPLETED|Overall Study||30||
48428745|NCT03877484|101386003|FG000|NOT COMPLETED|Overall Study||10||
48428746|NCT00706901|101386004|FG000|STARTED|Overall Study||59||
48428747|NCT00706901|101386005|FG001|STARTED|Overall Study||62||
48428748|NCT00706901|101386006|FG002|STARTED|Overall Study||59||
48428749|NCT00706901|101386004|FG000|COMPLETED|Overall Study||51||
48428750|NCT00706901|101386005|FG001|COMPLETED|Overall Study||57||
48428751|NCT00706901|101386006|FG002|COMPLETED|Overall Study||51||
48428752|NCT00706901|101386004|FG000|NOT COMPLETED|Overall Study||8||
48428753|NCT00706901|101386005|FG001|NOT COMPLETED|Overall Study||5||
48428754|NCT00706901|101386006|FG002|NOT COMPLETED|Overall Study||8||
48428755|NCT03785782|101386007|FG000|STARTED|Overall Study||40||
48428756|NCT03785782|101386008|FG001|STARTED|Overall Study||5||
48428757|NCT03785782|101386007|FG000|COMPLETED|Overall Study||34||
48428758|NCT03785782|101386008|FG001|COMPLETED|Overall Study||4||
48428759|NCT03785782|101386007|FG000|NOT COMPLETED|Overall Study||6||
48428760|NCT03785782|101386008|FG001|NOT COMPLETED|Overall Study||1||
48638962|NCT04426656|101901540|FG000|COMPLETED|Overall Study||21||
48763993|NCT01887327|102211846|FG002|STARTED|Overall Study||30||
48428761|NCT00887562|101386009|FG000|STARTED|Overall Study||10||
48428762|NCT00887562|101386010|FG001|STARTED|Overall Study||9||
48428763|NCT00887562|101386011|FG002|STARTED|Overall Study||8||
48428764|NCT00887562|101386009|FG000|COMPLETED|Overall Study||7||
48428765|NCT00887562|101386010|FG001|COMPLETED|Overall Study||7||
48428766|NCT00887562|101386011|FG002|COMPLETED|Overall Study||7||
48428767|NCT00887562|101386009|FG000|NOT COMPLETED|Overall Study||3||
48428768|NCT00887562|101386010|FG001|NOT COMPLETED|Overall Study||2||
48428769|NCT00887562|101386011|FG002|NOT COMPLETED|Overall Study||1||
48428770|NCT02180659|101386012|FG000|STARTED|Overall Study||87||
48428771|NCT02180659|101386013|FG001|STARTED|Overall Study||89||
48428772|NCT02180659|101386012|FG000|COMPLETED|Overall Study||81||
48428773|NCT02180659|101386013|FG001|COMPLETED|Overall Study||84||
48428774|NCT02180659|101386012|FG000|NOT COMPLETED|Overall Study||6||
48428775|NCT02180659|101386013|FG001|NOT COMPLETED|Overall Study||5||
48428776|NCT03380091|101386014|FG000|STARTED|Overall Study||3||
48428777|NCT03380091|101386015|FG001|STARTED|Overall Study||2||
48428778|NCT03380091|101386014|FG000|Began Arm Treatment|Overall Study||1||
48428779|NCT03380091|101386015|FG001|Began Arm Treatment|Overall Study||1||
48428780|NCT03380091|101386014|FG000|COMPLETED|Overall Study||1||
48428781|NCT03380091|101386015|FG001|COMPLETED|Overall Study||1||
48428782|NCT03380091|101386014|FG000|NOT COMPLETED|Overall Study||2||
48428783|NCT03380091|101386015|FG001|NOT COMPLETED|Overall Study||1||
48428784|NCT04148508|101386016|FG000|STARTED|Overall Study||847||
48428785|NCT04148508|101386017|FG001|STARTED|Overall Study||841||
48428786|NCT04148508|101386018|FG002|STARTED|Overall Study||844||
48428787|NCT04148508|101386019|FG003|STARTED|Overall Study||417||
48428788|NCT04148508|101386020|FG004|STARTED|Overall Study||423||
48428789|NCT04148508|101386021|FG005|STARTED|Overall Study||422||
48428790|NCT04148508|101386016|FG000|1 Month Follow up|Overall Study||449||
48428791|NCT04148508|101386017|FG001|1 Month Follow up|Overall Study||457||
48428792|NCT04148508|101386018|FG002|1 Month Follow up|Overall Study||475||
48428793|NCT04148508|101386019|FG003|1 Month Follow up|Overall Study||208||
48428794|NCT04148508|101386020|FG004|1 Month Follow up|Overall Study||212||
48428795|NCT04148508|101386021|FG005|1 Month Follow up|Overall Study||209||
48428796|NCT04148508|101386016|FG000|3 Month Follow up|Overall Study||425||
48428797|NCT04148508|101386017|FG001|3 Month Follow up|Overall Study||443||
48428798|NCT04148508|101386018|FG002|3 Month Follow up|Overall Study||447||
48428799|NCT04148508|101386019|FG003|3 Month Follow up|Overall Study||178||
48428800|NCT04148508|101386020|FG004|3 Month Follow up|Overall Study||191||
48428801|NCT04148508|101386021|FG005|3 Month Follow up|Overall Study||199||
48428802|NCT04148508|101386016|FG000|12 Month Follow up|Overall Study||410||
48428803|NCT04148508|101386017|FG001|12 Month Follow up|Overall Study||426||
48428804|NCT04148508|101386018|FG002|12 Month Follow up|Overall Study||424||
48428805|NCT04148508|101386019|FG003|12 Month Follow up|Overall Study||176||
48428806|NCT04148508|101386020|FG004|12 Month Follow up|Overall Study||174||
48428807|NCT04148508|101386021|FG005|12 Month Follow up|Overall Study||186||
48428808|NCT04148508|101386016|FG000|COMPLETED|Overall Study||410||
48428809|NCT04148508|101386017|FG001|COMPLETED|Overall Study||426||
48428810|NCT04148508|101386018|FG002|COMPLETED|Overall Study||424||
48428811|NCT04148508|101386019|FG003|COMPLETED|Overall Study||176||
48428812|NCT04148508|101386020|FG004|COMPLETED|Overall Study||174||
48428813|NCT04148508|101386021|FG005|COMPLETED|Overall Study||186||
48428814|NCT04148508|101386016|FG000|NOT COMPLETED|Overall Study||437||
48428815|NCT04148508|101386017|FG001|NOT COMPLETED|Overall Study||415||
48428816|NCT04148508|101386018|FG002|NOT COMPLETED|Overall Study||420||
48428817|NCT04148508|101386019|FG003|NOT COMPLETED|Overall Study||241||
48428818|NCT04148508|101386020|FG004|NOT COMPLETED|Overall Study||249||
48428819|NCT04148508|101386021|FG005|NOT COMPLETED|Overall Study||236||
48428820|NCT02839330|101386022|FG000|STARTED|Overall Study||804|as randomized population|
48428821|NCT02839330|101386023|FG001|STARTED|Overall Study||799|as randomized population|
48428822|NCT02839330|101386024|FG002|STARTED|Overall Study||795|as randomized population|
48428823|NCT02839330|101386025|FG003|STARTED|Overall Study||798|as randomized population|
48428824|NCT02839330|101386022|FG000|Exposed|Overall Study||804||
48428825|NCT02839330|101386023|FG001|Exposed|Overall Study||797||
48428826|NCT02839330|101386024|FG002|Exposed|Overall Study||793||
48428827|NCT02839330|101386025|FG003|Exposed|Overall Study||797||
48428828|NCT02839330|101386022|FG000|COMPLETED|Overall Study||746||
48428829|NCT02839330|101386023|FG001|COMPLETED|Overall Study||741||
48428830|NCT02839330|101386024|FG002|COMPLETED|Overall Study||747||
48428831|NCT02839330|101386025|FG003|COMPLETED|Overall Study||747||
48428832|NCT02839330|101386022|FG000|NOT COMPLETED|Overall Study||58||
48428833|NCT02839330|101386023|FG001|NOT COMPLETED|Overall Study||58||
48428834|NCT02839330|101386024|FG002|NOT COMPLETED|Overall Study||48||
48428835|NCT02839330|101386025|FG003|NOT COMPLETED|Overall Study||51||
48428836|NCT03447015|101386026|FG000|STARTED|Overall Study||140||
48428837|NCT03447015|101386027|FG001|STARTED|Overall Study||150||
48428838|NCT03447015|101386026|FG000|COMPLETED|Overall Study||95||
48428839|NCT03447015|101386027|FG001|COMPLETED|Overall Study||106||
48428840|NCT03447015|101386026|FG000|NOT COMPLETED|Overall Study||45||
48428841|NCT03447015|101386027|FG001|NOT COMPLETED|Overall Study||44||
48428842|NCT00976989|101386028|FG000|STARTED|Overall Study||73||
48428843|NCT00976989|101386029|FG001|STARTED|Overall Study||75||
48428844|NCT00976989|101386030|FG002|STARTED|Overall Study||77||
48428845|NCT00976989|101386028|FG000|COMPLETED|Overall Study||60||
48428846|NCT00976989|101386029|FG001|COMPLETED|Overall Study||63||
48428847|NCT00976989|101386030|FG002|COMPLETED|Overall Study||60||
48428848|NCT00976989|101386028|FG000|NOT COMPLETED|Overall Study||13||
48428849|NCT00976989|101386029|FG001|NOT COMPLETED|Overall Study||12||
48428850|NCT00976989|101386030|FG002|NOT COMPLETED|Overall Study||17||
48428851|NCT03326323|101386031|FG000|STARTED|Overall Study||43||
48428852|NCT03326323|101386031|FG000|COMPLETED|Overall Study||40||
48428853|NCT03326323|101386031|FG000|NOT COMPLETED|Overall Study||3||
48428854|NCT01050998|101386032|FG000|STARTED|Overall Study||48||
48428855|NCT01050998|101386033|FG001|STARTED|Overall Study||49||
48428856|NCT01050998|101386034|FG002|STARTED|Overall Study||49||
48428857|NCT01050998|101386035|FG003|STARTED|Overall Study||48||
48428858|NCT01050998|101386036|FG004|STARTED|Overall Study||96||
48428859|NCT01050998|101386032|FG000|COMPLETED|Overall Study||44||
48428860|NCT01050998|101386033|FG001|COMPLETED|Overall Study||47||
48428861|NCT01050998|101386034|FG002|COMPLETED|Overall Study||46||
48428862|NCT01050998|101386035|FG003|COMPLETED|Overall Study||45||
48428863|NCT01050998|101386036|FG004|COMPLETED|Overall Study||82||
48428864|NCT01050998|101386032|FG000|NOT COMPLETED|Overall Study||4||
48428865|NCT01050998|101386033|FG001|NOT COMPLETED|Overall Study||2||
48428866|NCT01050998|101386034|FG002|NOT COMPLETED|Overall Study||3||
48428867|NCT01050998|101386035|FG003|NOT COMPLETED|Overall Study||3||
48428868|NCT01050998|101386036|FG004|NOT COMPLETED|Overall Study||14||
48428869|NCT03740152|101386037|FG000|STARTED|Overall Study||10||
48428870|NCT03740152|101386037|FG000|COMPLETED|Overall Study||10||
48428871|NCT03740152|101386037|FG000|NOT COMPLETED|Overall Study||0||
48428872|NCT02996266|101386038|FG000|STARTED|Overall Study||339||
48428873|NCT02996266|101386039|FG001|STARTED|Overall Study||338||
48428874|NCT02996266|101386038|FG000|COMPLETED|Overall Study||211||
48428875|NCT02996266|101386039|FG001|COMPLETED|Overall Study||222||
48428876|NCT02996266|101386038|FG000|NOT COMPLETED|Overall Study||128||
48428877|NCT02996266|101386039|FG001|NOT COMPLETED|Overall Study||116||
48428878|NCT00003526|101386040|FG000|STARTED|Overall Study||8||
48428879|NCT00003526|101386040|FG000|COMPLETED|Overall Study||2||
48428880|NCT00003526|101386040|FG000|NOT COMPLETED|Overall Study||6||
48428881|NCT00750061|101386041|FG000|STARTED|Overall Study||20||
48428882|NCT00750061|101386042|FG001|STARTED|Overall Study||20||
48428883|NCT00750061|101386041|FG000|COMPLETED|Overall Study||18||
48428884|NCT00750061|101386042|FG001|COMPLETED|Overall Study||18||
48428885|NCT00750061|101386041|FG000|NOT COMPLETED|Overall Study||2||
48428886|NCT00750061|101386042|FG001|NOT COMPLETED|Overall Study||2||
48428887|NCT01138995|101386043|FG000|STARTED|Overall Study||98||
48428888|NCT01138995|101386044|FG001|STARTED|Overall Study||99||
48428889|NCT01138995|101386043|FG000|COMPLETED|Overall Study||88||
48428890|NCT01138995|101386044|FG001|COMPLETED|Overall Study||74||
48428891|NCT01138995|101386043|FG000|NOT COMPLETED|Overall Study||10||
48428892|NCT01138995|101386044|FG001|NOT COMPLETED|Overall Study||25||
48428893|NCT02930889|101386045|FG000|STARTED|Overall Study||21||
48428894|NCT02930889|101386045|FG000|COMPLETED|Overall Study||5||
48428895|NCT02930889|101386045|FG000|NOT COMPLETED|Overall Study||16||
48428896|NCT03993314|101386046|FG000|STARTED|Overall Study||9||
48428897|NCT03993314|101386047|FG001|STARTED|Overall Study||6||
48428898|NCT03993314|101386046|FG000|COMPLETED|Overall Study||9||
48428899|NCT03993314|101386047|FG001|COMPLETED|Overall Study||6||
48428900|NCT03993314|101386046|FG000|NOT COMPLETED|Overall Study||0||
48428901|NCT03993314|101386047|FG001|NOT COMPLETED|Overall Study||0||
48428902|NCT04586127|101386048|FG000|STARTED|Overall Study||26||
48428903|NCT04586127|101386048|FG000|COMPLETED|Overall Study||21||
48428904|NCT04586127|101386048|FG000|NOT COMPLETED|Overall Study||5||
48428905|NCT01336647|101386049|FG000|STARTED|Overall Study||46||
48428906|NCT01336647|101386050|FG001|STARTED|Overall Study||49||
48428907|NCT01336647|101386051|FG002|STARTED|Overall Study||47||
48428908|NCT01336647|101386049|FG000|COMPLETED|Overall Study||42||
48428909|NCT01336647|101386050|FG001|COMPLETED|Overall Study||48||
48428910|NCT01336647|101386051|FG002|COMPLETED|Overall Study||44||
48428911|NCT01336647|101386049|FG000|NOT COMPLETED|Overall Study||4||
48428912|NCT01336647|101386050|FG001|NOT COMPLETED|Overall Study||1||
48428913|NCT01336647|101386051|FG002|NOT COMPLETED|Overall Study||3||
48428914|NCT01266967|101386052|FG000|STARTED|Overall Study||89||
48428915|NCT01266967|101386053|FG001|STARTED|Overall Study||83||
48428916|NCT01266967|101386052|FG000|COMPLETED|Overall Study||0||
48428917|NCT01266967|101386053|FG001|COMPLETED|Overall Study||0||
48428918|NCT01266967|101386052|FG000|NOT COMPLETED|Overall Study||89||
48428919|NCT01266967|101386053|FG001|NOT COMPLETED|Overall Study||83||
48428920|NCT03841331|101386054|FG000|STARTED|Overall Study||117||
48428921|NCT03841331|101386055|FG001|STARTED|Overall Study||116||
48428922|NCT03841331|101386054|FG000|COMPLETED|Overall Study||108||
48428923|NCT03841331|101386055|FG001|COMPLETED|Overall Study||106||
48428924|NCT03841331|101386054|FG000|NOT COMPLETED|Overall Study||9||
48428925|NCT03841331|101386055|FG001|NOT COMPLETED|Overall Study||10||
48428926|NCT03764813|101386056|FG000|STARTED|From Enrollment to the Age of 32 Weeks||14||127
48428927|NCT03764813|101386057|FG001|STARTED|From Enrollment to the Age of 32 Weeks||3||27
48428928|NCT03764813|101386058|FG002|STARTED|From Enrollment to the Age of 32 Weeks||4||38
48428929|NCT03764813|101386059|FG003|STARTED|From Enrollment to the Age of 32 Weeks||4||85
48428930|NCT03764813|101386056|FG000|COMPLETED|From Enrollment to the Age of 32 Weeks||14||127
48428931|NCT03764813|101386057|FG001|COMPLETED|From Enrollment to the Age of 32 Weeks||2||19
48428932|NCT03764813|101386058|FG002|COMPLETED|From Enrollment to the Age of 32 Weeks||3||33
48428933|NCT03764813|101386059|FG003|COMPLETED|From Enrollment to the Age of 32 Weeks||4||85
48428934|NCT03764813|101386056|FG000|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||0||0
48428935|NCT03764813|101386057|FG001|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||1||8
48428936|NCT03764813|101386058|FG002|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||1||5
48428937|NCT03764813|101386059|FG003|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||0||0
48428938|NCT03764813|101386056|FG000|STARTED|From Enrollment to the Last HbF Test||13||224
48428939|NCT03764813|101386057|FG001|STARTED|From Enrollment to the Last HbF Test||3||46
48428940|NCT03764813|101386058|FG002|STARTED|From Enrollment to the Last HbF Test||4||68
48428941|NCT03764813|101386059|FG003|STARTED|From Enrollment to the Last HbF Test||5||140
48428942|NCT03764813|101386056|FG000|COMPLETED|From Enrollment to the Last HbF Test||13||224
48428943|NCT03764813|101386057|FG001|COMPLETED|From Enrollment to the Last HbF Test||3||46
48428944|NCT03764813|101386058|FG002|COMPLETED|From Enrollment to the Last HbF Test||4||68
48428945|NCT03764813|101386059|FG003|COMPLETED|From Enrollment to the Last HbF Test||5||140
48428946|NCT03764813|101386056|FG000|NOT COMPLETED|From Enrollment to the Last HbF Test||0||0
48428947|NCT03764813|101386057|FG001|NOT COMPLETED|From Enrollment to the Last HbF Test||0||0
48428948|NCT03764813|101386058|FG002|NOT COMPLETED|From Enrollment to the Last HbF Test||0||0
48428949|NCT03764813|101386059|FG003|NOT COMPLETED|From Enrollment to the Last HbF Test||0||0
48428950|NCT00620126|101386060|FG000|STARTED|Overall Study||25||
48428951|NCT00620126|101386061|FG001|STARTED|Overall Study||22||
48428952|NCT00620126|101386060|FG000|COMPLETED|Overall Study||14||
48428953|NCT00620126|101386061|FG001|COMPLETED|Overall Study||17||
48428954|NCT00620126|101386060|FG000|NOT COMPLETED|Overall Study||11||
48428955|NCT00620126|101386061|FG001|NOT COMPLETED|Overall Study||5||
48428956|NCT02600559|101386062|FG000|STARTED|Overall Study||501||
48428957|NCT02600559|101386062|FG000|COMPLETED|Overall Study||478||
48428958|NCT02600559|101386062|FG000|NOT COMPLETED|Overall Study||23||
48428959|NCT02528643|101386063|FG000|STARTED|DB (Median Duration up to 14.65 Months)||55||
48428960|NCT02528643|101386064|FG001|STARTED|DB (Median Duration up to 14.65 Months)||110||
48428961|NCT02528643|101386063|FG000|Treated|DB (Median Duration up to 14.65 Months)||55||
48428962|NCT02528643|101386064|FG001|Treated|DB (Median Duration up to 14.65 Months)||107||
48428963|NCT02528643|101386063|FG000|COMPLETED|DB (Median Duration up to 14.65 Months)||0||
48428964|NCT02528643|101386064|FG001|COMPLETED|DB (Median Duration up to 14.65 Months)||0||
48428965|NCT02528643|101386063|FG000|NOT COMPLETED|DB (Median Duration up to 14.65 Months)||55||
48428966|NCT02528643|101386064|FG001|NOT COMPLETED|DB (Median Duration up to 14.65 Months)||110||
48439988|NCT03176953|101410002|FG001|COMPLETED|Overall Study||40||
48428967|NCT02528643|101386063|FG000|STARTED|OL (Median Duration up to 27.56 Months)||0||
48428968|NCT02528643|101386064|FG001|STARTED|OL (Median Duration up to 27.56 Months)||1||
48428969|NCT02528643|101386063|FG000|COMPLETED|OL (Median Duration up to 27.56 Months)||0||
48428970|NCT02528643|101386064|FG001|COMPLETED|OL (Median Duration up to 27.56 Months)||0||
48428971|NCT02528643|101386063|FG000|NOT COMPLETED|OL (Median Duration up to 27.56 Months)||0||
48428972|NCT02528643|101386064|FG001|NOT COMPLETED|OL (Median Duration up to 27.56 Months)||1||
48428973|NCT00444028|101386065|FG000|STARTED|Overall Study||14||
48428974|NCT00444028|101386066|FG001|STARTED|Overall Study||7||
48428975|NCT00444028|101386067|FG002|STARTED|Overall Study||8||
48428976|NCT00444028|101386068|FG003|STARTED|Overall Study||6||
48428977|NCT00444028|101386069|FG004|STARTED|Overall Study||7||
48428978|NCT00444028|101386070|FG005|STARTED|Overall Study||8||
48428979|NCT00444028|101386065|FG000|COMPLETED|Overall Study||14||
48428980|NCT00444028|101386066|FG001|COMPLETED|Overall Study||7||
48428981|NCT00444028|101386067|FG002|COMPLETED|Overall Study||8||
48428982|NCT00444028|101386068|FG003|COMPLETED|Overall Study||6||
48428983|NCT00444028|101386069|FG004|COMPLETED|Overall Study||7||
48428984|NCT00444028|101386070|FG005|COMPLETED|Overall Study||8||
48428985|NCT00444028|101386065|FG000|NOT COMPLETED|Overall Study||0||
48428986|NCT00444028|101386066|FG001|NOT COMPLETED|Overall Study||0||
48428987|NCT00444028|101386067|FG002|NOT COMPLETED|Overall Study||0||
48428988|NCT00444028|101386068|FG003|NOT COMPLETED|Overall Study||0||
48428989|NCT00444028|101386069|FG004|NOT COMPLETED|Overall Study||0||
48428990|NCT00444028|101386070|FG005|NOT COMPLETED|Overall Study||0||
48428991|NCT02146365|101386071|FG000|STARTED|Overall Study||49||
48428992|NCT02146365|101386072|FG001|STARTED|Overall Study||49||
48428993|NCT02146365|101386073|FG002|STARTED|Overall Study||50||
48428994|NCT02146365|101386074|FG003|STARTED|Overall Study||50||
48428995|NCT02146365|101386075|FG004|STARTED|Overall Study||24||
48428996|NCT02146365|101386076|FG005|STARTED|Overall Study||25||
48428997|NCT02146365|101386077|FG006|STARTED|Overall Study||25||
48428998|NCT02146365|101386078|FG007|STARTED|Overall Study||25||
48428999|NCT02146365|101386071|FG000|COMPLETED|Overall Study||45||
48429000|NCT02146365|101386072|FG001|COMPLETED|Overall Study||45||
48429001|NCT02146365|101386073|FG002|COMPLETED|Overall Study||43||
48429002|NCT02146365|101386074|FG003|COMPLETED|Overall Study||41||
48429003|NCT02146365|101386075|FG004|COMPLETED|Overall Study||22||
48429004|NCT02146365|101386076|FG005|COMPLETED|Overall Study||24||
48638963|NCT04426656|101901541|FG001|COMPLETED|Overall Study||43||
48429005|NCT02146365|101386077|FG006|COMPLETED|Overall Study||25||
48429006|NCT02146365|101386078|FG007|COMPLETED|Overall Study||24||
48429007|NCT02146365|101386071|FG000|NOT COMPLETED|Overall Study||4||
48429008|NCT02146365|101386072|FG001|NOT COMPLETED|Overall Study||4||
48429009|NCT02146365|101386073|FG002|NOT COMPLETED|Overall Study||7||
48429010|NCT02146365|101386074|FG003|NOT COMPLETED|Overall Study||9||
48429011|NCT02146365|101386075|FG004|NOT COMPLETED|Overall Study||2||
48429012|NCT02146365|101386076|FG005|NOT COMPLETED|Overall Study||1||
48429013|NCT02146365|101386077|FG006|NOT COMPLETED|Overall Study||0||
48429014|NCT02146365|101386078|FG007|NOT COMPLETED|Overall Study||1||
48429015|NCT02195479|101386079|FG000|STARTED|Overall Study||356||
48429016|NCT02195479|101386080|FG001|STARTED|Overall Study||350||
48429017|NCT02195479|101386079|FG000|Treated|Overall Study||354||
48429018|NCT02195479|101386080|FG001|Treated|Overall Study||346||
48429019|NCT02195479|101386079|FG000|COMPLETED|Overall Study||0||
48429020|NCT02195479|101386080|FG001|COMPLETED|Overall Study||0||
48429021|NCT02195479|101386079|FG000|NOT COMPLETED|Overall Study||356||
48429022|NCT02195479|101386080|FG001|NOT COMPLETED|Overall Study||350||
48429023|NCT01886105|101386081|FG000|STARTED|Overall Study||4||
48429024|NCT01886105|101386081|FG000|COMPLETED|Overall Study||1||
48429025|NCT01886105|101386081|FG000|NOT COMPLETED|Overall Study||3||
48429026|NCT00368069|101386082|FG000|STARTED|Overall Study||79||
48429027|NCT00368069|101386083|FG001|STARTED|Overall Study||79||
48429028|NCT00368069|101386082|FG000|COMPLETED|Overall Study||71||
48429029|NCT00368069|101386083|FG001|COMPLETED|Overall Study||72||
48429030|NCT00368069|101386082|FG000|NOT COMPLETED|Overall Study||8||
48429031|NCT00368069|101386083|FG001|NOT COMPLETED|Overall Study||7||
48429032|NCT03814746|101386084|FG000|STARTED|Overall Study||84||
48429033|NCT03814746|101386085|FG001|STARTED|Overall Study||83||
48429034|NCT03814746|101386086|FG002|STARTED|Overall Study||85||
48429035|NCT03814746|101386084|FG000|COMPLETED|Overall Study||66|Completed = Ongoing|
48429036|NCT03814746|101386085|FG001|COMPLETED|Overall Study||68|Completed = Ongoing|
48429037|NCT03814746|101386086|FG002|COMPLETED|Overall Study||58|Completed = Ongoing|
48429038|NCT03814746|101386084|FG000|NOT COMPLETED|Overall Study||18||
48429039|NCT03814746|101386085|FG001|NOT COMPLETED|Overall Study||15||
48429040|NCT03814746|101386086|FG002|NOT COMPLETED|Overall Study||27||
48429041|NCT01428882|101386087|FG000|STARTED|Overall Study||67||
48429042|NCT01428882|101386088|FG001|STARTED|Overall Study||68||
48429043|NCT01428882|101386087|FG000|COMPLETED|Overall Study||61||
48429044|NCT01428882|101386088|FG001|COMPLETED|Overall Study||58||
48429045|NCT01428882|101386087|FG000|NOT COMPLETED|Overall Study||6||
48429046|NCT01428882|101386088|FG001|NOT COMPLETED|Overall Study||10||
48429047|NCT00830310|101386089|FG000|STARTED|Overall Study||43||
48429048|NCT00830310|101386089|FG000|COMPLETED|Overall Study||30||
48638964|NCT04426656|101901540|FG000|NOT COMPLETED|Overall Study||3||
48429049|NCT00830310|101386089|FG000|NOT COMPLETED|Overall Study||13||
48429050|NCT04823494|101386090|FG000|STARTED|Overall Study||21||
48429051|NCT04823494|101386091|FG001|STARTED|Overall Study||19||
48429052|NCT04823494|101386090|FG000|COMPLETED|Overall Study||19||
48429053|NCT04823494|101386091|FG001|COMPLETED|Overall Study||18||
48429054|NCT04823494|101386090|FG000|NOT COMPLETED|Overall Study||2||
48429055|NCT04823494|101386091|FG001|NOT COMPLETED|Overall Study||1||
48429056|NCT05664672|101386092|FG000|STARTED|Overall Study||3||
48429057|NCT05664672|101386093|FG001|STARTED|Overall Study||29||
48429058|NCT05664672|101386094|FG002|STARTED|Overall Study||28||
48429059|NCT05664672|101386095|FG003|STARTED|Overall Study||30||
48429060|NCT05664672|101386096|FG004|STARTED|Overall Study||30||
48429061|NCT05664672|101386097|FG005|STARTED|Overall Study||29||
48429062|NCT05664672|101386092|FG000|COMPLETED|Overall Study||0||
48429063|NCT05664672|101386093|FG001|COMPLETED|Overall Study||28||
48429064|NCT05664672|101386094|FG002|COMPLETED|Overall Study||25||
48429065|NCT05664672|101386095|FG003|COMPLETED|Overall Study||30||
48429066|NCT05664672|101386096|FG004|COMPLETED|Overall Study||25||
48429067|NCT05664672|101386097|FG005|COMPLETED|Overall Study||22||
48429068|NCT05664672|101386092|FG000|NOT COMPLETED|Overall Study||3||
48429069|NCT05664672|101386093|FG001|NOT COMPLETED|Overall Study||1||
48429070|NCT05664672|101386094|FG002|NOT COMPLETED|Overall Study||3||
48429071|NCT05664672|101386095|FG003|NOT COMPLETED|Overall Study||0||
48429072|NCT05664672|101386096|FG004|NOT COMPLETED|Overall Study||5||
48429073|NCT05664672|101386097|FG005|NOT COMPLETED|Overall Study||7||
48429074|NCT04308668|101386098|FG000|STARTED|Overall Study||658||
48429075|NCT04308668|101386099|FG001|STARTED|Overall Study||654||
48429076|NCT04308668|101386098|FG000|COMPLETED|Overall Study||622||
48429077|NCT04308668|101386099|FG001|COMPLETED|Overall Study||612||
48429078|NCT04308668|101386098|FG000|NOT COMPLETED|Overall Study||36||
48429079|NCT04308668|101386099|FG001|NOT COMPLETED|Overall Study||42||
48429080|NCT01119118|101386100|FG000|STARTED|Overall Study||6||
48429081|NCT01119118|101386100|FG000|COMPLETED|Overall Study||5||
48429082|NCT01119118|101386100|FG000|NOT COMPLETED|Overall Study||1||
48429083|NCT02061293|101386101|FG000|STARTED|Overall Study||49||
48429084|NCT02061293|101386102|FG001|STARTED|Overall Study||46||
48429085|NCT02061293|101386101|FG000|COMPLETED|Overall Study||48||
48429086|NCT02061293|101386102|FG001|COMPLETED|Overall Study||45||
48429087|NCT02061293|101386101|FG000|NOT COMPLETED|Overall Study||1||
48429088|NCT02061293|101386102|FG001|NOT COMPLETED|Overall Study||1||
48429089|NCT01249404|101386103|FG000|STARTED|Overall Study||127||
48429090|NCT01249404|101386104|FG001|STARTED|Overall Study||129||
48429091|NCT01249404|101386105|FG002|STARTED|Overall Study||132||
48429092|NCT01249404|101386103|FG000|COMPLETED|Overall Study||120||
48429093|NCT01249404|101386104|FG001|COMPLETED|Overall Study||121||
48429094|NCT01249404|101386105|FG002|COMPLETED|Overall Study||125||
48429095|NCT01249404|101386103|FG000|NOT COMPLETED|Overall Study||7||
48429096|NCT01249404|101386104|FG001|NOT COMPLETED|Overall Study||8||
48429097|NCT01249404|101386105|FG002|NOT COMPLETED|Overall Study||7||
48429098|NCT00577382|101386106|FG000|STARTED|Overall Study||21||
48429099|NCT00577382|101386107|FG001|STARTED|Overall Study||31||
48429100|NCT00577382|101386106|FG000|COMPLETED|Overall Study||0||
48429101|NCT00577382|101386107|FG001|COMPLETED|Overall Study||0||
48429102|NCT00577382|101386106|FG000|NOT COMPLETED|Overall Study||21||
48429103|NCT00577382|101386107|FG001|NOT COMPLETED|Overall Study||31||
48429104|NCT03471507|101386108|FG000|STARTED|Overall Study||81||
48429105|NCT03471507|101386109|FG001|STARTED|Overall Study||83||
48429106|NCT03471507|101386108|FG000|COMPLETED|Overall Study||78||
48429107|NCT03471507|101386109|FG001|COMPLETED|Overall Study||78||
48429108|NCT03471507|101386108|FG000|NOT COMPLETED|Overall Study||3||
48429109|NCT03471507|101386109|FG001|NOT COMPLETED|Overall Study||5||
48429110|NCT04930562|101386110|FG000|STARTED|Overall Study||30||
48429111|NCT04930562|101386110|FG000|COMPLETED|Overall Study||30||
48429112|NCT04930562|101386110|FG000|NOT COMPLETED|Overall Study||0||
48429113|NCT03451630|101386111|FG000|STARTED|Overall Study||562||
48429114|NCT03451630|101386112|FG001|STARTED|Overall Study||552||
48429115|NCT03451630|101386113|FG002|STARTED|Overall Study||286||
48429116|NCT03451630|101386111|FG000|COMPLETED|Overall Study||535||
48429117|NCT03451630|101386112|FG001|COMPLETED|Overall Study||529||
48429118|NCT03451630|101386113|FG002|COMPLETED|Overall Study||268||
48429119|NCT03451630|101386111|FG000|NOT COMPLETED|Overall Study||27||
48429120|NCT03451630|101386112|FG001|NOT COMPLETED|Overall Study||23||
48429121|NCT03451630|101386113|FG002|NOT COMPLETED|Overall Study||18||
48429122|NCT02210559|101386114|FG000|STARTED|Overall Study||24||
48429123|NCT02210559|101386115|FG001|STARTED|Overall Study||13||
48429124|NCT02210559|101386114|FG000|Received at Least 1 Dose of Study Drug|Overall Study||24||
48429125|NCT02210559|101386115|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13||
48429126|NCT02210559|101386114|FG000|COMPLETED|Overall Study||18||
48429127|NCT02210559|101386115|FG001|COMPLETED|Overall Study||7||
48429128|NCT02210559|101386114|FG000|NOT COMPLETED|Overall Study||6||
48429129|NCT02210559|101386115|FG001|NOT COMPLETED|Overall Study||6||
48429130|NCT03308799|101386116|FG000|STARTED|Overall Study||342||
48429131|NCT03308799|101386117|FG001|STARTED|Overall Study||337||
48429132|NCT03308799|101386118|FG002|STARTED|Overall Study||115||
48429133|NCT03308799|101386116|FG000|COMPLETED|Overall Study||320||
48429134|NCT03308799|101386117|FG001|COMPLETED|Overall Study||309||
48429135|NCT03308799|101386118|FG002|COMPLETED|Overall Study||94||
48429136|NCT03308799|101386116|FG000|NOT COMPLETED|Overall Study||22||
48429137|NCT03308799|101386117|FG001|NOT COMPLETED|Overall Study||28||
48429138|NCT03308799|101386118|FG002|NOT COMPLETED|Overall Study||21||
48429139|NCT02208466|101386119|FG000|STARTED|Overall Study||9||
48429140|NCT02208466|101386120|FG001|STARTED|Overall Study||10||
48429141|NCT02208466|101386121|FG002|STARTED|Overall Study||8||
48429142|NCT02208466|101386119|FG000|COMPLETED|Overall Study||9||
48429143|NCT02208466|101386120|FG001|COMPLETED|Overall Study||10||
48638965|NCT04426656|101901541|FG001|NOT COMPLETED|Overall Study||3||
48638966|NCT03738215|101901542|FG000|STARTED|Double-blind Treatment Period (6 Weeks)||253||
48638967|NCT03738215|101901543|FG001|STARTED|Double-blind Treatment Period (6 Weeks)||252||
48763994|NCT01887327|102211844|FG000|COMPLETED|Overall Study||29||
48763995|NCT01887327|102211845|FG001|COMPLETED|Overall Study||27||
48763996|NCT01887327|102211846|FG002|COMPLETED|Overall Study||27||
48763997|NCT01887327|102211844|FG000|NOT COMPLETED|Overall Study||1||
48763998|NCT01887327|102211845|FG001|NOT COMPLETED|Overall Study||4||
48763999|NCT01887327|102211846|FG002|NOT COMPLETED|Overall Study||3||
48764000|NCT02589938|102211847|FG000|STARTED|Overall Study||86||
48764001|NCT02589938|102211848|FG001|STARTED|Overall Study||86||
48764002|NCT02589938|102211849|FG002|STARTED|Overall Study||86||
48764003|NCT02589938|102211847|FG000|COMPLETED|Overall Study||62||
48764004|NCT02589938|102211848|FG001|COMPLETED|Overall Study||73||
48764005|NCT02589938|102211849|FG002|COMPLETED|Overall Study||69||
48764006|NCT02589938|102211847|FG000|NOT COMPLETED|Overall Study||24||
48764007|NCT02589938|102211848|FG001|NOT COMPLETED|Overall Study||13||
48764008|NCT02589938|102211849|FG002|NOT COMPLETED|Overall Study||17||
48764009|NCT05530252|102211850|FG000|STARTED|Overall Study||17||
48764010|NCT05530252|102211851|FG001|STARTED|Overall Study||17||
48764011|NCT05530252|102211852|FG002|STARTED|Overall Study||17||
48764012|NCT05530252|102211850|FG000|COMPLETED|Overall Study||16||
48764013|NCT05530252|102211851|FG001|COMPLETED|Overall Study||16||
48764014|NCT05530252|102211852|FG002|COMPLETED|Overall Study||16||
48764015|NCT05530252|102211850|FG000|NOT COMPLETED|Overall Study||1||
48764016|NCT05530252|102211851|FG001|NOT COMPLETED|Overall Study||1||
48764017|NCT05530252|102211852|FG002|NOT COMPLETED|Overall Study||1||
48764018|NCT00536744|102211853|FG000|STARTED|Overall Study||107||
48764019|NCT00536744|102211854|FG001|STARTED|Overall Study||99||
48764020|NCT00536744|102211853|FG000|COMPLETED|Overall Study||78||
48764021|NCT00536744|102211854|FG001|COMPLETED|Overall Study||71||
48429144|NCT02208466|101386121|FG002|COMPLETED|Overall Study||8||
48429145|NCT02208466|101386119|FG000|NOT COMPLETED|Overall Study||0||
48429146|NCT02208466|101386120|FG001|NOT COMPLETED|Overall Study||0||
48429147|NCT02208466|101386121|FG002|NOT COMPLETED|Overall Study||0||
48638968|NCT03738215|101901544|FG002|STARTED|Double-blind Treatment Period (6 Weeks)||252||
48638969|NCT03738215|101901542|FG000|COMPLETED|Double-blind Treatment Period (6 Weeks)||229||
48638970|NCT03738215|101901543|FG001|COMPLETED|Double-blind Treatment Period (6 Weeks)||231||
48638971|NCT03738215|101901544|FG002|COMPLETED|Double-blind Treatment Period (6 Weeks)||219||
48638972|NCT03738215|101901542|FG000|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||24||
48638973|NCT03738215|101901543|FG001|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||21||
48638974|NCT03738215|101901544|FG002|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||33||
48638975|NCT03738215|101901542|FG000|STARTED|Safety Follow Up Period (4 Weeks)||240||
48638976|NCT03738215|101901543|FG001|STARTED|Safety Follow Up Period (4 Weeks)||239||
48638977|NCT03738215|101901544|FG002|STARTED|Safety Follow Up Period (4 Weeks)||238||
48638978|NCT03738215|101901542|FG000|COMPLETED|Safety Follow Up Period (4 Weeks)||237||
48764022|NCT00536744|102211853|FG000|NOT COMPLETED|Overall Study||29||
48764023|NCT00536744|102211854|FG001|NOT COMPLETED|Overall Study||28||
48764024|NCT03674411|102211855|FG000|STARTED|Overall Study||22||
48764025|NCT03674411|102211855|FG000|COMPLETED|Overall Study||18||
48764026|NCT03674411|102211855|FG000|NOT COMPLETED|Overall Study||4||
48764027|NCT00906204|102211856|FG000|STARTED|Primary Endpoint (Early Safety)||45||
48187397|NCT02950545|100780040|FG002|STARTED|Washout 1 (5 Minutes)||7||
48429148|NCT01707667|101386122|FG000|STARTED|Period 1||7||
48638979|NCT03738215|101901543|FG001|COMPLETED|Safety Follow Up Period (4 Weeks)||234||
48638980|NCT03738215|101901544|FG002|COMPLETED|Safety Follow Up Period (4 Weeks)||230||
48638981|NCT03738215|101901542|FG000|NOT COMPLETED|Safety Follow Up Period (4 Weeks)||3||
48638982|NCT03738215|101901543|FG001|NOT COMPLETED|Safety Follow Up Period (4 Weeks)||5||
48429149|NCT01707667|101386123|FG001|STARTED|Period 1||6||
48429150|NCT01707667|101386122|FG000|COMPLETED|Period 1||6||
48429151|NCT01707667|101386123|FG001|COMPLETED|Period 1||6||
48429152|NCT01707667|101386122|FG000|NOT COMPLETED|Period 1||1||
48429153|NCT01707667|101386123|FG001|NOT COMPLETED|Period 1||0||
48638983|NCT03738215|101901544|FG002|NOT COMPLETED|Safety Follow Up Period (4 Weeks)||8||
48638984|NCT03585543|101901545|FG000|STARTED|Overall Study||30||
48764028|NCT00906204|102211857|FG001|STARTED|Primary Endpoint (Early Safety)||52||
48429154|NCT01707667|101386122|FG000|STARTED|Period 2||6||
48764029|NCT00906204|102211856|FG000|COMPLETED|Primary Endpoint (Early Safety)||43||
48764030|NCT00906204|102211857|FG001|COMPLETED|Primary Endpoint (Early Safety)||51||
48764031|NCT00906204|102211856|FG000|NOT COMPLETED|Primary Endpoint (Early Safety)||2||
48764032|NCT00906204|102211857|FG001|NOT COMPLETED|Primary Endpoint (Early Safety)||1||
48764033|NCT00906204|102211856|FG000|STARTED|Secondary Endpoints (Long-term Safety)||43||
48764034|NCT00906204|102211857|FG001|STARTED|Secondary Endpoints (Long-term Safety)||51||
48764035|NCT00906204|102211856|FG000|COMPLETED|Secondary Endpoints (Long-term Safety)||41||
48764036|NCT00906204|102211857|FG001|COMPLETED|Secondary Endpoints (Long-term Safety)||48||
48764037|NCT00906204|102211856|FG000|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||2||
48764038|NCT00906204|102211857|FG001|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||3||
48764039|NCT04323124|102211858|FG000|STARTED|Overall Study||3||
48764040|NCT04323124|102211859|FG001|STARTED|Overall Study||3||
48764041|NCT04323124|102211860|FG002|STARTED|Overall Study||3||
48764042|NCT04323124|102211861|FG003|STARTED|Overall Study||3||
48764043|NCT04323124|102211862|FG004|STARTED|Overall Study||5||
48764044|NCT04323124|102211863|FG005|STARTED|Overall Study||4||
48764045|NCT04323124|102211864|FG006|STARTED|Overall Study||8||
48764046|NCT04323124|102211865|FG007|STARTED|Overall Study||8||
48764047|NCT04323124|102211866|FG008|STARTED|Overall Study||7||
48764048|NCT04323124|102211867|FG009|STARTED|Overall Study||6||
48764049|NCT04323124|102211868|FG010|STARTED|Overall Study||6||
48764050|NCT04323124|102211869|FG011|STARTED|Overall Study||2||
48764051|NCT04323124|102211870|FG012|STARTED|Overall Study||1||
48764052|NCT04323124|102211871|FG013|STARTED|Overall Study||1||
48764053|NCT04323124|102211872|FG014|STARTED|Overall Study||1||
48764054|NCT04323124|102211858|FG000|COMPLETED|Overall Study||3||
48764055|NCT04323124|102211859|FG001|COMPLETED|Overall Study||3||
48764056|NCT04323124|102211860|FG002|COMPLETED|Overall Study||3||
48764057|NCT04323124|102211861|FG003|COMPLETED|Overall Study||3||
48764058|NCT04323124|102211862|FG004|COMPLETED|Overall Study||3||
48764059|NCT04323124|102211863|FG005|COMPLETED|Overall Study||2||
48764060|NCT04323124|102211864|FG006|COMPLETED|Overall Study||8||
48764061|NCT04323124|102211865|FG007|COMPLETED|Overall Study||6||
48764062|NCT04323124|102211866|FG008|COMPLETED|Overall Study||5||
48764063|NCT04323124|102211867|FG009|COMPLETED|Overall Study||6||
48764064|NCT04323124|102211868|FG010|COMPLETED|Overall Study||6||
48764065|NCT04323124|102211869|FG011|COMPLETED|Overall Study||0||
48764066|NCT04323124|102211870|FG012|COMPLETED|Overall Study||0||
48764067|NCT04323124|102211871|FG013|COMPLETED|Overall Study||0||
48764068|NCT04323124|102211872|FG014|COMPLETED|Overall Study||0||
48764069|NCT04323124|102211858|FG000|NOT COMPLETED|Overall Study||0||
48764070|NCT04323124|102211859|FG001|NOT COMPLETED|Overall Study||0||
48764071|NCT04323124|102211860|FG002|NOT COMPLETED|Overall Study||0||
48764072|NCT04323124|102211861|FG003|NOT COMPLETED|Overall Study||0||
48764073|NCT04323124|102211862|FG004|NOT COMPLETED|Overall Study||2||
48764074|NCT04323124|102211863|FG005|NOT COMPLETED|Overall Study||2||
48764075|NCT04323124|102211864|FG006|NOT COMPLETED|Overall Study||0||
48764076|NCT04323124|102211865|FG007|NOT COMPLETED|Overall Study||2||
48764077|NCT04323124|102211866|FG008|NOT COMPLETED|Overall Study||2||
48764078|NCT04323124|102211867|FG009|NOT COMPLETED|Overall Study||0||
48764079|NCT04323124|102211868|FG010|NOT COMPLETED|Overall Study||0||
48764080|NCT04323124|102211869|FG011|NOT COMPLETED|Overall Study||2||
48764081|NCT04323124|102211870|FG012|NOT COMPLETED|Overall Study||1||
48764082|NCT04323124|102211871|FG013|NOT COMPLETED|Overall Study||1||
48764083|NCT04323124|102211872|FG014|NOT COMPLETED|Overall Study||1||
48764084|NCT03173248|102211873|FG000|STARTED|Overall Study||72||
48764085|NCT03173248|102211874|FG001|STARTED|Overall Study||74||
48764086|NCT03173248|102211873|FG000|Safety Analysis Set|Overall Study||71|Safety Analysis Set (SAS) included all participants who received at least 1 dose of the study treatment.|
48764087|NCT03173248|102211874|FG001|Safety Analysis Set|Overall Study||73|Safety Analysis Set (SAS) included all participants who received at least 1 dose of the study treatment.|
48764088|NCT03173248|102211873|FG000|COMPLETED|Overall Study||0||
48764089|NCT03173248|102211874|FG001|COMPLETED|Overall Study||0||
48429155|NCT01707667|101386123|FG001|STARTED|Period 2||6||
48429156|NCT01707667|101386122|FG000|COMPLETED|Period 2||6||
48429157|NCT01707667|101386123|FG001|COMPLETED|Period 2||6||
48764090|NCT03173248|102211873|FG000|NOT COMPLETED|Overall Study||72||
48764091|NCT03173248|102211874|FG001|NOT COMPLETED|Overall Study||74||
48764092|NCT02529072|102211875|FG000|STARTED|Overall Study||3||
48764093|NCT02529072|102211876|FG001|STARTED|Overall Study||3||
48764094|NCT02529072|102211875|FG000|COMPLETED|Overall Study||3||
48764095|NCT02529072|102211876|FG001|COMPLETED|Overall Study||3||
48764096|NCT02529072|102211875|FG000|NOT COMPLETED|Overall Study||0||
48764097|NCT02529072|102211876|FG001|NOT COMPLETED|Overall Study||0||
48764098|NCT02488915|102211877|FG000|STARTED|Overall Study||228||
48764099|NCT02488915|102211877|FG000|COMPLETED|Overall Study||202||
48764100|NCT02488915|102211877|FG000|NOT COMPLETED|Overall Study||26||
48764101|NCT02530515|102211878|FG000|STARTED|Overall Study||0||
48764102|NCT02530515|102211879|FG001|STARTED|Overall Study||0||
48764103|NCT02530515|102211880|FG002|STARTED|Overall Study||8||
48764104|NCT02530515|102211878|FG000|COMPLETED|Overall Study||0||
48764105|NCT02530515|102211879|FG001|COMPLETED|Overall Study||0||
48764106|NCT02530515|102211880|FG002|COMPLETED|Overall Study||8||
48764107|NCT02530515|102211878|FG000|NOT COMPLETED|Overall Study||0||
48764108|NCT02530515|102211879|FG001|NOT COMPLETED|Overall Study||0||
48764109|NCT02530515|102211880|FG002|NOT COMPLETED|Overall Study||0||
48429158|NCT01707667|101386122|FG000|NOT COMPLETED|Period 2||0||
48429159|NCT01707667|101386123|FG001|NOT COMPLETED|Period 2||0||
48429160|NCT01733758|101386124|FG000|STARTED|Overall Study||77||
48429161|NCT01733758|101386125|FG001|STARTED|Overall Study||160||
48429162|NCT01733758|101386126|FG002|STARTED|Overall Study||150||
48429163|NCT01733758|101386127|FG003|STARTED|Overall Study||103||
48429164|NCT01733758|101386124|FG000|COMPLETED|Overall Study||62||
48429165|NCT01733758|101386125|FG001|COMPLETED|Overall Study||148||
48429166|NCT01733758|101386126|FG002|COMPLETED|Overall Study||135||
48429167|NCT01733758|101386127|FG003|COMPLETED|Overall Study||95||
48429168|NCT01733758|101386124|FG000|NOT COMPLETED|Overall Study||15||
48429169|NCT01733758|101386125|FG001|NOT COMPLETED|Overall Study||12||
48429170|NCT01733758|101386126|FG002|NOT COMPLETED|Overall Study||15||
48429171|NCT01733758|101386127|FG003|NOT COMPLETED|Overall Study||8||
48429172|NCT00727246|101386128|FG000|STARTED|Overall Study||3||
48429173|NCT00727246|101386129|FG001|STARTED|Overall Study||3||
48429174|NCT00727246|101386130|FG002|STARTED|Overall Study||8||
48429175|NCT00727246|101386131|FG003|STARTED|Overall Study||5||
48429176|NCT00727246|101386128|FG000|COMPLETED|Overall Study||3||
48429177|NCT00727246|101386129|FG001|COMPLETED|Overall Study||2||
48429178|NCT00727246|101386130|FG002|COMPLETED|Overall Study||7||
48429179|NCT00727246|101386131|FG003|COMPLETED|Overall Study||3||
48429180|NCT00727246|101386128|FG000|NOT COMPLETED|Overall Study||0||
48429181|NCT00727246|101386129|FG001|NOT COMPLETED|Overall Study||1||
48429182|NCT00727246|101386130|FG002|NOT COMPLETED|Overall Study||1||
48429183|NCT00727246|101386131|FG003|NOT COMPLETED|Overall Study||2||
48429184|NCT03237325|101386132|FG000|STARTED|Overall Study||127||
48429185|NCT03237325|101386133|FG001|STARTED|Overall Study||139||
48429186|NCT03237325|101386132|FG000|COMPLETED|Overall Study||112||
48429187|NCT03237325|101386133|FG001|COMPLETED|Overall Study||114||
48429188|NCT03237325|101386132|FG000|NOT COMPLETED|Overall Study||15||
48429189|NCT03237325|101386133|FG001|NOT COMPLETED|Overall Study||25||
48429190|NCT06304064|101386134|FG000|STARTED|Overall Study||8||
48429191|NCT06304064|101386134|FG000|COMPLETED|Overall Study||8||
48429192|NCT06304064|101386134|FG000|NOT COMPLETED|Overall Study||0||
48429193|NCT04668066|101386135|FG000|STARTED|Part 1: Treatment Phase||2||
48429194|NCT04668066|101386136|FG001|STARTED|Part 1: Treatment Phase||2||
48429195|NCT04668066|101386137|FG002|STARTED|Part 1: Treatment Phase||2||
48429196|NCT04668066|101386138|FG003|STARTED|Part 1: Treatment Phase||6||
48429197|NCT04668066|101386139|FG004|STARTED|Part 1: Treatment Phase||6||
48429198|NCT04668066|101386140|FG005|STARTED|Part 1: Treatment Phase||6||
48429199|NCT04668066|101386141|FG006|STARTED|Part 1: Treatment Phase||6||
48429200|NCT04668066|101386142|FG007|STARTED|Part 1: Treatment Phase||6||
48429201|NCT04668066|101386143|FG008|STARTED|Part 1: Treatment Phase||4||
48429202|NCT04668066|101386144|FG009|STARTED|Part 1: Treatment Phase||6||
48429203|NCT04668066|101386145|FG010|STARTED|Part 1: Treatment Phase||6||
48429204|NCT04668066|101386146|FG011|STARTED|Part 1: Treatment Phase||6||
48429205|NCT04668066|101386147|FG012|STARTED|Part 1: Treatment Phase||6||
48429206|NCT04668066|101386148|FG013|STARTED|Part 1: Treatment Phase||6||
48429207|NCT04668066|101386149|FG014|STARTED|Part 1: Treatment Phase||17||
48429208|NCT04668066|101386150|FG015|STARTED|Part 1: Treatment Phase||8||
48429209|NCT04668066|101386151|FG016|STARTED|Part 1: Treatment Phase||2||
48429210|NCT04668066|101386152|FG017|STARTED|Part 1: Treatment Phase||0||
48429211|NCT04668066|101386153|FG018|STARTED|Part 1: Treatment Phase||0||
48429212|NCT04668066|101386135|FG000|COMPLETED|Part 1: Treatment Phase||2||
48429213|NCT04668066|101386136|FG001|COMPLETED|Part 1: Treatment Phase||2||
48429214|NCT04668066|101386137|FG002|COMPLETED|Part 1: Treatment Phase||1||
48429215|NCT04668066|101386138|FG003|COMPLETED|Part 1: Treatment Phase||6||
48429216|NCT04668066|101386139|FG004|COMPLETED|Part 1: Treatment Phase||6||
48429217|NCT04668066|101386140|FG005|COMPLETED|Part 1: Treatment Phase||6||
48429218|NCT04668066|101386141|FG006|COMPLETED|Part 1: Treatment Phase||6||
48429219|NCT04668066|101386142|FG007|COMPLETED|Part 1: Treatment Phase||6||
48429220|NCT04668066|101386143|FG008|COMPLETED|Part 1: Treatment Phase||4||
48429221|NCT04668066|101386144|FG009|COMPLETED|Part 1: Treatment Phase||6||
48429222|NCT04668066|101386145|FG010|COMPLETED|Part 1: Treatment Phase||6||
48429223|NCT04668066|101386146|FG011|COMPLETED|Part 1: Treatment Phase||4||
48429224|NCT04668066|101386147|FG012|COMPLETED|Part 1: Treatment Phase||4||
48429225|NCT04668066|101386148|FG013|COMPLETED|Part 1: Treatment Phase||6||
48429226|NCT04668066|101386149|FG014|COMPLETED|Part 1: Treatment Phase||17||
48429227|NCT04668066|101386150|FG015|COMPLETED|Part 1: Treatment Phase||6||
48429228|NCT04668066|101386151|FG016|COMPLETED|Part 1: Treatment Phase||2||
48429229|NCT04668066|101386152|FG017|COMPLETED|Part 1: Treatment Phase||0||
48429230|NCT04668066|101386153|FG018|COMPLETED|Part 1: Treatment Phase||0||
48429231|NCT04668066|101386135|FG000|NOT COMPLETED|Part 1: Treatment Phase||0||
48429232|NCT04668066|101386136|FG001|NOT COMPLETED|Part 1: Treatment Phase||0||
48429233|NCT04668066|101386137|FG002|NOT COMPLETED|Part 1: Treatment Phase||1||
48429234|NCT04668066|101386138|FG003|NOT COMPLETED|Part 1: Treatment Phase||0||
48429235|NCT04668066|101386139|FG004|NOT COMPLETED|Part 1: Treatment Phase||0||
48429236|NCT04668066|101386140|FG005|NOT COMPLETED|Part 1: Treatment Phase||0||
48429237|NCT04668066|101386141|FG006|NOT COMPLETED|Part 1: Treatment Phase||0||
48429238|NCT04668066|101386142|FG007|NOT COMPLETED|Part 1: Treatment Phase||0||
48429239|NCT04668066|101386143|FG008|NOT COMPLETED|Part 1: Treatment Phase||0||
48429240|NCT04668066|101386144|FG009|NOT COMPLETED|Part 1: Treatment Phase||0||
48429241|NCT04668066|101386145|FG010|NOT COMPLETED|Part 1: Treatment Phase||0||
48429242|NCT04668066|101386146|FG011|NOT COMPLETED|Part 1: Treatment Phase||2||
48429243|NCT04668066|101386147|FG012|NOT COMPLETED|Part 1: Treatment Phase||2||
48429244|NCT04668066|101386148|FG013|NOT COMPLETED|Part 1: Treatment Phase||0||
48429245|NCT04668066|101386149|FG014|NOT COMPLETED|Part 1: Treatment Phase||0||
48429246|NCT04668066|101386150|FG015|NOT COMPLETED|Part 1: Treatment Phase||2||
48429247|NCT04668066|101386151|FG016|NOT COMPLETED|Part 1: Treatment Phase||0||
48429248|NCT04668066|101386152|FG017|NOT COMPLETED|Part 1: Treatment Phase||0||
48429249|NCT04668066|101386153|FG018|NOT COMPLETED|Part 1: Treatment Phase||0||
48429250|NCT04668066|101386135|FG000|STARTED|Part 1: Follow-Up||2||
48429251|NCT04668066|101386136|FG001|STARTED|Part 1: Follow-Up||2||
48429252|NCT04668066|101386137|FG002|STARTED|Part 1: Follow-Up||1||
48429253|NCT04668066|101386138|FG003|STARTED|Part 1: Follow-Up||6||
48429254|NCT04668066|101386139|FG004|STARTED|Part 1: Follow-Up||6||
48429255|NCT04668066|101386140|FG005|STARTED|Part 1: Follow-Up||6||
48429256|NCT04668066|101386141|FG006|STARTED|Part 1: Follow-Up||6||
48429257|NCT04668066|101386142|FG007|STARTED|Part 1: Follow-Up||6||
48429258|NCT04668066|101386143|FG008|STARTED|Part 1: Follow-Up||4||
48429259|NCT04668066|101386144|FG009|STARTED|Part 1: Follow-Up||6||
48429260|NCT04668066|101386145|FG010|STARTED|Part 1: Follow-Up||6||
48429261|NCT04668066|101386146|FG011|STARTED|Part 1: Follow-Up||6||
48429262|NCT04668066|101386147|FG012|STARTED|Part 1: Follow-Up||6||
48429263|NCT04668066|101386148|FG013|STARTED|Part 1: Follow-Up||6||
48429264|NCT04668066|101386149|FG014|STARTED|Part 1: Follow-Up||17||
48429265|NCT04668066|101386150|FG015|STARTED|Part 1: Follow-Up||8||
48429266|NCT04668066|101386151|FG016|STARTED|Part 1: Follow-Up||2||
48429267|NCT04668066|101386152|FG017|STARTED|Part 1: Follow-Up||0||
48429268|NCT04668066|101386153|FG018|STARTED|Part 1: Follow-Up||0||
48429269|NCT04668066|101386135|FG000|COMPLETED|Part 1: Follow-Up||2||
48429270|NCT04668066|101386136|FG001|COMPLETED|Part 1: Follow-Up||2||
48429271|NCT04668066|101386137|FG002|COMPLETED|Part 1: Follow-Up||1||
48429272|NCT04668066|101386138|FG003|COMPLETED|Part 1: Follow-Up||6||
48429273|NCT04668066|101386139|FG004|COMPLETED|Part 1: Follow-Up||6||
48429274|NCT04668066|101386140|FG005|COMPLETED|Part 1: Follow-Up||6||
48429275|NCT04668066|101386141|FG006|COMPLETED|Part 1: Follow-Up||6||
48429276|NCT04668066|101386142|FG007|COMPLETED|Part 1: Follow-Up||6||
48429277|NCT04668066|101386143|FG008|COMPLETED|Part 1: Follow-Up||4||
48429278|NCT04668066|101386144|FG009|COMPLETED|Part 1: Follow-Up||6||
48429279|NCT04668066|101386145|FG010|COMPLETED|Part 1: Follow-Up||6||
48429280|NCT04668066|101386146|FG011|COMPLETED|Part 1: Follow-Up||4||
48429281|NCT04668066|101386147|FG012|COMPLETED|Part 1: Follow-Up||4||
48429282|NCT04668066|101386148|FG013|COMPLETED|Part 1: Follow-Up||6||
48429283|NCT04668066|101386149|FG014|COMPLETED|Part 1: Follow-Up||17||
48429284|NCT04668066|101386150|FG015|COMPLETED|Part 1: Follow-Up||6||
48429285|NCT04668066|101386151|FG016|COMPLETED|Part 1: Follow-Up||2||
48429286|NCT04668066|101386152|FG017|COMPLETED|Part 1: Follow-Up||0||
48429287|NCT04668066|101386153|FG018|COMPLETED|Part 1: Follow-Up||0||
48429288|NCT04668066|101386135|FG000|NOT COMPLETED|Part 1: Follow-Up||0||
48429289|NCT04668066|101386136|FG001|NOT COMPLETED|Part 1: Follow-Up||0||
48429290|NCT04668066|101386137|FG002|NOT COMPLETED|Part 1: Follow-Up||0||
48429291|NCT04668066|101386138|FG003|NOT COMPLETED|Part 1: Follow-Up||0||
48429292|NCT04668066|101386139|FG004|NOT COMPLETED|Part 1: Follow-Up||0||
48429293|NCT04668066|101386140|FG005|NOT COMPLETED|Part 1: Follow-Up||0||
48429294|NCT04668066|101386141|FG006|NOT COMPLETED|Part 1: Follow-Up||0||
48429295|NCT04668066|101386142|FG007|NOT COMPLETED|Part 1: Follow-Up||0||
48429296|NCT04668066|101386143|FG008|NOT COMPLETED|Part 1: Follow-Up||0||
48429297|NCT04668066|101386144|FG009|NOT COMPLETED|Part 1: Follow-Up||0||
48429298|NCT04668066|101386145|FG010|NOT COMPLETED|Part 1: Follow-Up||0||
48429299|NCT04668066|101386146|FG011|NOT COMPLETED|Part 1: Follow-Up||2||
48429300|NCT04668066|101386147|FG012|NOT COMPLETED|Part 1: Follow-Up||2||
48429301|NCT04668066|101386148|FG013|NOT COMPLETED|Part 1: Follow-Up||0||
48429302|NCT04668066|101386149|FG014|NOT COMPLETED|Part 1: Follow-Up||0||
48429303|NCT04668066|101386150|FG015|NOT COMPLETED|Part 1: Follow-Up||2||
48429304|NCT04668066|101386151|FG016|NOT COMPLETED|Part 1: Follow-Up||0||
48429305|NCT04668066|101386152|FG017|NOT COMPLETED|Part 1: Follow-Up||0||
48429306|NCT04668066|101386153|FG018|NOT COMPLETED|Part 1: Follow-Up||0||
48429307|NCT04668066|101386135|FG000|STARTED|Part 2: Treatment Phase||0||
48429308|NCT04668066|101386136|FG001|STARTED|Part 2: Treatment Phase||0||
48638985|NCT03585543|101901545|FG000|Mid-intervention Assessment (6-weeks)|Overall Study||25||
48429309|NCT04668066|101386137|FG002|STARTED|Part 2: Treatment Phase||0||
48429310|NCT04668066|101386138|FG003|STARTED|Part 2: Treatment Phase||0||
48429311|NCT04668066|101386139|FG004|STARTED|Part 2: Treatment Phase||0||
48429312|NCT04668066|101386140|FG005|STARTED|Part 2: Treatment Phase||0||
48429313|NCT04668066|101386141|FG006|STARTED|Part 2: Treatment Phase||0||
48429314|NCT04668066|101386142|FG007|STARTED|Part 2: Treatment Phase||0||
48429315|NCT04668066|101386143|FG008|STARTED|Part 2: Treatment Phase||0||
48429316|NCT04668066|101386144|FG009|STARTED|Part 2: Treatment Phase||0||
48429317|NCT04668066|101386145|FG010|STARTED|Part 2: Treatment Phase||0||
48429318|NCT04668066|101386146|FG011|STARTED|Part 2: Treatment Phase||0||
48429319|NCT04668066|101386147|FG012|STARTED|Part 2: Treatment Phase||0||
48429320|NCT04668066|101386148|FG013|STARTED|Part 2: Treatment Phase||0||
48429321|NCT04668066|101386149|FG014|STARTED|Part 2: Treatment Phase||0||
48429322|NCT04668066|101386150|FG015|STARTED|Part 2: Treatment Phase||0||
48429323|NCT04668066|101386151|FG016|STARTED|Part 2: Treatment Phase||0||
48429324|NCT04668066|101386152|FG017|STARTED|Part 2: Treatment Phase||16||
48429325|NCT04668066|101386153|FG018|STARTED|Part 2: Treatment Phase||9||
48429326|NCT04668066|101386135|FG000|COMPLETED|Part 2: Treatment Phase||0||
48429327|NCT04668066|101386136|FG001|COMPLETED|Part 2: Treatment Phase||0||
48429328|NCT04668066|101386137|FG002|COMPLETED|Part 2: Treatment Phase||0||
48429329|NCT04668066|101386138|FG003|COMPLETED|Part 2: Treatment Phase||0||
48429330|NCT04668066|101386139|FG004|COMPLETED|Part 2: Treatment Phase||0||
48429331|NCT04668066|101386140|FG005|COMPLETED|Part 2: Treatment Phase||0||
48429332|NCT04668066|101386141|FG006|COMPLETED|Part 2: Treatment Phase||0||
48429333|NCT04668066|101386142|FG007|COMPLETED|Part 2: Treatment Phase||0||
48429334|NCT04668066|101386143|FG008|COMPLETED|Part 2: Treatment Phase||0||
48429335|NCT04668066|101386144|FG009|COMPLETED|Part 2: Treatment Phase||0||
48429336|NCT04668066|101386145|FG010|COMPLETED|Part 2: Treatment Phase||0||
48429337|NCT04668066|101386146|FG011|COMPLETED|Part 2: Treatment Phase||0||
48429338|NCT04668066|101386147|FG012|COMPLETED|Part 2: Treatment Phase||0||
48429339|NCT04668066|101386148|FG013|COMPLETED|Part 2: Treatment Phase||0||
48429340|NCT04668066|101386149|FG014|COMPLETED|Part 2: Treatment Phase||0||
48429341|NCT04668066|101386150|FG015|COMPLETED|Part 2: Treatment Phase||0||
48429342|NCT04668066|101386151|FG016|COMPLETED|Part 2: Treatment Phase||0||
48429343|NCT04668066|101386152|FG017|COMPLETED|Part 2: Treatment Phase||16||
48429344|NCT04668066|101386153|FG018|COMPLETED|Part 2: Treatment Phase||6||
48429345|NCT04668066|101386135|FG000|NOT COMPLETED|Part 2: Treatment Phase||0||
48429346|NCT04668066|101386136|FG001|NOT COMPLETED|Part 2: Treatment Phase||0||
48429347|NCT04668066|101386137|FG002|NOT COMPLETED|Part 2: Treatment Phase||0||
48429348|NCT04668066|101386138|FG003|NOT COMPLETED|Part 2: Treatment Phase||0||
48429349|NCT04668066|101386139|FG004|NOT COMPLETED|Part 2: Treatment Phase||0||
48429350|NCT04668066|101386140|FG005|NOT COMPLETED|Part 2: Treatment Phase||0||
48429351|NCT04668066|101386141|FG006|NOT COMPLETED|Part 2: Treatment Phase||0||
48429352|NCT04668066|101386142|FG007|NOT COMPLETED|Part 2: Treatment Phase||0||
48429353|NCT04668066|101386143|FG008|NOT COMPLETED|Part 2: Treatment Phase||0||
48429354|NCT04668066|101386144|FG009|NOT COMPLETED|Part 2: Treatment Phase||0||
48429355|NCT04668066|101386145|FG010|NOT COMPLETED|Part 2: Treatment Phase||0||
48429356|NCT04668066|101386146|FG011|NOT COMPLETED|Part 2: Treatment Phase||0||
48429357|NCT04668066|101386147|FG012|NOT COMPLETED|Part 2: Treatment Phase||0||
48429358|NCT04668066|101386148|FG013|NOT COMPLETED|Part 2: Treatment Phase||0||
48429359|NCT04668066|101386149|FG014|NOT COMPLETED|Part 2: Treatment Phase||0||
48429360|NCT04668066|101386150|FG015|NOT COMPLETED|Part 2: Treatment Phase||0||
48429361|NCT04668066|101386151|FG016|NOT COMPLETED|Part 2: Treatment Phase||0||
48429362|NCT04668066|101386152|FG017|NOT COMPLETED|Part 2: Treatment Phase||0||
48429363|NCT04668066|101386153|FG018|NOT COMPLETED|Part 2: Treatment Phase||3||
48429364|NCT04668066|101386135|FG000|STARTED|Part 2: Follow-Up||0||
48429365|NCT04668066|101386136|FG001|STARTED|Part 2: Follow-Up||0||
48429366|NCT04668066|101386137|FG002|STARTED|Part 2: Follow-Up||0||
48429367|NCT04668066|101386138|FG003|STARTED|Part 2: Follow-Up||0||
48429368|NCT04668066|101386139|FG004|STARTED|Part 2: Follow-Up||0||
48429369|NCT04668066|101386140|FG005|STARTED|Part 2: Follow-Up||0||
48429370|NCT04668066|101386141|FG006|STARTED|Part 2: Follow-Up||0||
48429371|NCT04668066|101386142|FG007|STARTED|Part 2: Follow-Up||0||
48429372|NCT04668066|101386143|FG008|STARTED|Part 2: Follow-Up||0||
48429373|NCT04668066|101386144|FG009|STARTED|Part 2: Follow-Up||0||
48429374|NCT04668066|101386145|FG010|STARTED|Part 2: Follow-Up||0||
48429375|NCT04668066|101386146|FG011|STARTED|Part 2: Follow-Up||0||
48429376|NCT04668066|101386147|FG012|STARTED|Part 2: Follow-Up||0||
48429377|NCT04668066|101386148|FG013|STARTED|Part 2: Follow-Up||0||
48429378|NCT04668066|101386149|FG014|STARTED|Part 2: Follow-Up||0||
48429379|NCT04668066|101386150|FG015|STARTED|Part 2: Follow-Up||0||
48429380|NCT04668066|101386151|FG016|STARTED|Part 2: Follow-Up||0||
48429381|NCT04668066|101386152|FG017|STARTED|Part 2: Follow-Up||16||
48429382|NCT04668066|101386153|FG018|STARTED|Part 2: Follow-Up||8||
48429383|NCT04668066|101386135|FG000|COMPLETED|Part 2: Follow-Up||0||
48429384|NCT04668066|101386136|FG001|COMPLETED|Part 2: Follow-Up||0||
48429385|NCT04668066|101386137|FG002|COMPLETED|Part 2: Follow-Up||0||
48429386|NCT04668066|101386138|FG003|COMPLETED|Part 2: Follow-Up||0||
48429387|NCT04668066|101386139|FG004|COMPLETED|Part 2: Follow-Up||0||
48429388|NCT04668066|101386140|FG005|COMPLETED|Part 2: Follow-Up||0||
48429389|NCT04668066|101386141|FG006|COMPLETED|Part 2: Follow-Up||0||
48429390|NCT04668066|101386142|FG007|COMPLETED|Part 2: Follow-Up||0||
48429391|NCT04668066|101386143|FG008|COMPLETED|Part 2: Follow-Up||0||
48429392|NCT04668066|101386144|FG009|COMPLETED|Part 2: Follow-Up||0||
48429393|NCT04668066|101386145|FG010|COMPLETED|Part 2: Follow-Up||0||
48429394|NCT04668066|101386146|FG011|COMPLETED|Part 2: Follow-Up||0||
48429395|NCT04668066|101386147|FG012|COMPLETED|Part 2: Follow-Up||0||
48429396|NCT04668066|101386148|FG013|COMPLETED|Part 2: Follow-Up||0||
48429397|NCT04668066|101386149|FG014|COMPLETED|Part 2: Follow-Up||0||
48429398|NCT04668066|101386150|FG015|COMPLETED|Part 2: Follow-Up||0||
48429399|NCT04668066|101386151|FG016|COMPLETED|Part 2: Follow-Up||0||
48429400|NCT04668066|101386152|FG017|COMPLETED|Part 2: Follow-Up||16||
48429401|NCT04668066|101386153|FG018|COMPLETED|Part 2: Follow-Up||7||
48429402|NCT04668066|101386135|FG000|NOT COMPLETED|Part 2: Follow-Up||0||
48429403|NCT04668066|101386136|FG001|NOT COMPLETED|Part 2: Follow-Up||0||
48429404|NCT04668066|101386137|FG002|NOT COMPLETED|Part 2: Follow-Up||0||
48429405|NCT04668066|101386138|FG003|NOT COMPLETED|Part 2: Follow-Up||0||
48429406|NCT04668066|101386139|FG004|NOT COMPLETED|Part 2: Follow-Up||0||
48429407|NCT04668066|101386140|FG005|NOT COMPLETED|Part 2: Follow-Up||0||
48429408|NCT04668066|101386141|FG006|NOT COMPLETED|Part 2: Follow-Up||0||
48429409|NCT04668066|101386142|FG007|NOT COMPLETED|Part 2: Follow-Up||0||
48429410|NCT04668066|101386143|FG008|NOT COMPLETED|Part 2: Follow-Up||0||
48429411|NCT04668066|101386144|FG009|NOT COMPLETED|Part 2: Follow-Up||0||
48429412|NCT04668066|101386145|FG010|NOT COMPLETED|Part 2: Follow-Up||0||
48429413|NCT04668066|101386146|FG011|NOT COMPLETED|Part 2: Follow-Up||0||
48429414|NCT04668066|101386147|FG012|NOT COMPLETED|Part 2: Follow-Up||0||
48429415|NCT04668066|101386148|FG013|NOT COMPLETED|Part 2: Follow-Up||0||
48429416|NCT04668066|101386149|FG014|NOT COMPLETED|Part 2: Follow-Up||0||
48429417|NCT04668066|101386150|FG015|NOT COMPLETED|Part 2: Follow-Up||0||
48429418|NCT04668066|101386151|FG016|NOT COMPLETED|Part 2: Follow-Up||0||
48429419|NCT04668066|101386152|FG017|NOT COMPLETED|Part 2: Follow-Up||0||
48429420|NCT04668066|101386153|FG018|NOT COMPLETED|Part 2: Follow-Up||1||
48429421|NCT00070070|101386154|FG000|STARTED|Overall Study||1||
48429422|NCT00070070|101386155|FG001|STARTED|Overall Study||0||
48429423|NCT00070070|101386156|FG002|STARTED|Overall Study||0||
48429424|NCT00070070|101386157|FG003|STARTED|Overall Study||5||
48429425|NCT00070070|101386154|FG000|COMPLETED|Overall Study||1||
48429426|NCT00070070|101386155|FG001|COMPLETED|Overall Study||0||
48429427|NCT00070070|101386156|FG002|COMPLETED|Overall Study||0||
48429428|NCT00070070|101386157|FG003|COMPLETED|Overall Study||5||
48429429|NCT00070070|101386154|FG000|NOT COMPLETED|Overall Study||0||
48429430|NCT00070070|101386155|FG001|NOT COMPLETED|Overall Study||0||
48429431|NCT00070070|101386156|FG002|NOT COMPLETED|Overall Study||0||
48429432|NCT00070070|101386157|FG003|NOT COMPLETED|Overall Study||0||
48429433|NCT05267652|101386158|FG000|STARTED|Overall Study||645||
48429434|NCT05267652|101386159|FG001|STARTED|Overall Study||656||
48429435|NCT05267652|101386158|FG000|COMPLETED|Overall Study||645||
48429436|NCT05267652|101386159|FG001|COMPLETED|Overall Study||656||
48429437|NCT05267652|101386158|FG000|NOT COMPLETED|Overall Study||0||
48429438|NCT05267652|101386159|FG001|NOT COMPLETED|Overall Study||0||
48429439|NCT05227404|101386160|FG000|STARTED|Overall Study||330||
48429440|NCT05227404|101386160|FG000|COMPLETED|Overall Study||330||
48429441|NCT05227404|101386160|FG000|NOT COMPLETED|Overall Study||0||
48429442|NCT00399542|101386161|FG000|STARTED|Overall Study||387||
48429443|NCT00399542|101386162|FG001|STARTED|Overall Study||194||
48429444|NCT00399542|101386161|FG000|COMPLETED|Overall Study||303||
48429445|NCT00399542|101386162|FG001|COMPLETED|Overall Study||151||
48429446|NCT00399542|101386161|FG000|NOT COMPLETED|Overall Study||84||
48429447|NCT00399542|101386162|FG001|NOT COMPLETED|Overall Study||43||
48429448|NCT00334893|101386163|FG000|STARTED|Overall Study||37||
48429449|NCT00334893|101386164|FG001|STARTED|Overall Study||37||
48429450|NCT00334893|101386163|FG000|COMPLETED|Overall Study||36||
48429451|NCT00334893|101386164|FG001|COMPLETED|Overall Study||37||
48429452|NCT00334893|101386163|FG000|NOT COMPLETED|Overall Study||1||
48429453|NCT00334893|101386164|FG001|NOT COMPLETED|Overall Study||0||
48429454|NCT00429026|101386165|FG000|STARTED|Overall Study||40||
48764110|NCT03931941|102211881|FG000|STARTED|Overall Study||698||
48429455|NCT00429026|101386165|FG000|COMPLETED|Overall Study||0||
48429456|NCT00429026|101386165|FG000|NOT COMPLETED|Overall Study||40||
48429457|NCT02010359|101386166|FG000|STARTED|Overall Study||15||
48429458|NCT02010359|101386167|FG001|STARTED|Overall Study||14||
48429459|NCT02010359|101386166|FG000|COMPLETED|Overall Study||13||
48429460|NCT02010359|101386167|FG001|COMPLETED|Overall Study||12||
48429461|NCT02010359|101386166|FG000|NOT COMPLETED|Overall Study||2||
48429462|NCT02010359|101386167|FG001|NOT COMPLETED|Overall Study||2||
48429463|NCT02641691|101386168|FG000|STARTED|Overall Study||20||
48429464|NCT02641691|101386168|FG000|COMPLETED|Overall Study||20||
48429465|NCT02641691|101386168|FG000|NOT COMPLETED|Overall Study||0||
48764111|NCT03931941|102211881|FG000|COMPLETED|Overall Study||635||
48764112|NCT03931941|102211881|FG000|NOT COMPLETED|Overall Study||63||
48764113|NCT01099267|102211882|FG000|STARTED|MDS-003 Study||148||
48764114|NCT01099267|102211882|FG000|COMPLETED|MDS-003 Study||24||
48429466|NCT02190604|101386169|FG000|STARTED|Part 1 and 2 (Healthy Volunteers)||6||
48429467|NCT02190604|101386170|FG001|STARTED|Part 1 and 2 (Healthy Volunteers)||6||
48429468|NCT02190604|101386171|FG002|STARTED|Part 1 and 2 (Healthy Volunteers)||6||
48429469|NCT02190604|101386172|FG003|STARTED|Part 1 and 2 (Healthy Volunteers)||6||
48429470|NCT02190604|101386173|FG004|STARTED|Part 1 and 2 (Healthy Volunteers)||6||
48429471|NCT02190604|101386174|FG005|STARTED|Part 1 and 2 (Healthy Volunteers)||6||
48429472|NCT02190604|101386175|FG006|STARTED|Part 1 and 2 (Healthy Volunteers)||6||
48429473|NCT02190604|101386176|FG007|STARTED|Part 1 and 2 (Healthy Volunteers)||6||
48764115|NCT01099267|102211882|FG000|NOT COMPLETED|MDS-003 Study||124||
48429474|NCT02190604|101386177|FG008|STARTED|Part 1 and 2 (Healthy Volunteers)||16||
48429475|NCT02190604|101386178|FG009|STARTED|Part 1 and 2 (Healthy Volunteers)||6||
48429476|NCT02190604|101386179|FG010|STARTED|Part 1 and 2 (Healthy Volunteers)||6||
48429477|NCT02190604|101386180|FG011|STARTED|Part 1 and 2 (Healthy Volunteers)||6||
48764116|NCT01099267|102211882|FG000|STARTED|MDS-009 Extension Follow-up||54||
48764117|NCT01099267|102211882|FG000|Informed Consent Given|MDS-009 Extension Follow-up||33||
48187398|NCT02950545|100780041|FG003|STARTED|Washout 1 (5 Minutes)||8||
48187399|NCT02950545|100780042|FG004|STARTED|Washout 1 (5 Minutes)||8||
48187400|NCT02950545|100780043|FG005|STARTED|Washout 1 (5 Minutes)||9||
48187401|NCT02950545|100780038|FG000|COMPLETED|Washout 1 (5 Minutes)||8||
48187402|NCT02950545|100780039|FG001|COMPLETED|Washout 1 (5 Minutes)||9||
48187403|NCT02950545|100780040|FG002|COMPLETED|Washout 1 (5 Minutes)||7||
48187404|NCT02950545|100780041|FG003|COMPLETED|Washout 1 (5 Minutes)||7||
48187405|NCT02950545|100780042|FG004|COMPLETED|Washout 1 (5 Minutes)||8||
48187406|NCT02950545|100780043|FG005|COMPLETED|Washout 1 (5 Minutes)||8||
48187407|NCT02950545|100780038|FG000|NOT COMPLETED|Washout 1 (5 Minutes)||1||
48187408|NCT02950545|100780039|FG001|NOT COMPLETED|Washout 1 (5 Minutes)||0||
48187409|NCT02950545|100780040|FG002|NOT COMPLETED|Washout 1 (5 Minutes)||0||
48187410|NCT02950545|100780041|FG003|NOT COMPLETED|Washout 1 (5 Minutes)||1||
48187411|NCT02950545|100780042|FG004|NOT COMPLETED|Washout 1 (5 Minutes)||0||
48187412|NCT02950545|100780043|FG005|NOT COMPLETED|Washout 1 (5 Minutes)||1||
48187413|NCT02950545|100780038|FG000|STARTED|Session 2 (70 Minutes)||8||
48187414|NCT02950545|100780039|FG001|STARTED|Session 2 (70 Minutes)||9||
48187415|NCT02950545|100780040|FG002|STARTED|Session 2 (70 Minutes)||7||
48187416|NCT02950545|100780041|FG003|STARTED|Session 2 (70 Minutes)||7||
48187417|NCT02950545|100780042|FG004|STARTED|Session 2 (70 Minutes)||8||
48187418|NCT02950545|100780043|FG005|STARTED|Session 2 (70 Minutes)||8||
48187419|NCT02950545|100780038|FG000|COMPLETED|Session 2 (70 Minutes)||8||
48187420|NCT02950545|100780039|FG001|COMPLETED|Session 2 (70 Minutes)||9||
48187421|NCT02950545|100780040|FG002|COMPLETED|Session 2 (70 Minutes)||7||
48187422|NCT02950545|100780041|FG003|COMPLETED|Session 2 (70 Minutes)||7||
48187423|NCT02950545|100780042|FG004|COMPLETED|Session 2 (70 Minutes)||7||
48187424|NCT02950545|100780043|FG005|COMPLETED|Session 2 (70 Minutes)||8||
48187425|NCT02950545|100780038|FG000|NOT COMPLETED|Session 2 (70 Minutes)||0||
48187426|NCT02950545|100780039|FG001|NOT COMPLETED|Session 2 (70 Minutes)||0||
48187427|NCT02950545|100780040|FG002|NOT COMPLETED|Session 2 (70 Minutes)||0||
48187428|NCT02950545|100780041|FG003|NOT COMPLETED|Session 2 (70 Minutes)||0||
48187429|NCT02950545|100780042|FG004|NOT COMPLETED|Session 2 (70 Minutes)||1||
48187430|NCT02950545|100780043|FG005|NOT COMPLETED|Session 2 (70 Minutes)||0||
48187431|NCT02950545|100780038|FG000|STARTED|Washout 2 (5 Minutes)||8||
48187432|NCT02950545|100780039|FG001|STARTED|Washout 2 (5 Minutes)||9||
48187433|NCT02950545|100780040|FG002|STARTED|Washout 2 (5 Minutes)||7||
48187434|NCT02950545|100780041|FG003|STARTED|Washout 2 (5 Minutes)||7||
48187435|NCT02950545|100780042|FG004|STARTED|Washout 2 (5 Minutes)||7||
48187436|NCT02950545|100780043|FG005|STARTED|Washout 2 (5 Minutes)||8||
48187437|NCT02950545|100780038|FG000|COMPLETED|Washout 2 (5 Minutes)||7||
48187438|NCT02950545|100780039|FG001|COMPLETED|Washout 2 (5 Minutes)||9||
48360440|NCT01810991|101210880|FG000|NOT COMPLETED|Overall Study||2||
48360441|NCT02675517|101210881|FG000|STARTED|Overall Study||1737||
48360442|NCT02675517|101210881|FG000|COMPLETED|Overall Study||1578||
48360443|NCT02675517|101210881|FG000|NOT COMPLETED|Overall Study||159||
48360444|NCT04573777|101210882|FG000|STARTED|Overall Study||10||
48360445|NCT04573777|101210882|FG000|COMPLETED|Overall Study||0||
48360446|NCT04573777|101210882|FG000|NOT COMPLETED|Overall Study||10||
48360447|NCT02935738|101210883|FG000|STARTED|Overall Study||67||
48360448|NCT02935738|101210884|FG001|STARTED|Overall Study||74||
48360449|NCT02935738|101210885|FG002|STARTED|Overall Study||47||
48360450|NCT02935738|101210886|FG003|STARTED|Overall Study||53||
48360451|NCT02935738|101210883|FG000|COMPLETED|Overall Study||50||
48360452|NCT02935738|101210884|FG001|COMPLETED|Overall Study||53||
48360453|NCT02935738|101210885|FG002|COMPLETED|Overall Study||46||
48360454|NCT02935738|101210886|FG003|COMPLETED|Overall Study||48||
48360455|NCT02935738|101210883|FG000|NOT COMPLETED|Overall Study||17||
48360456|NCT02935738|101210884|FG001|NOT COMPLETED|Overall Study||21||
48360457|NCT02935738|101210885|FG002|NOT COMPLETED|Overall Study||1||
48360458|NCT02935738|101210886|FG003|NOT COMPLETED|Overall Study||5||
48360459|NCT01632878|101210887|FG000|STARTED|Screening||1531||
48360460|NCT01632878|101210887|FG000|COMPLETED|Screening||1263||
48360461|NCT01632878|101210887|FG000|NOT COMPLETED|Screening||268||
48360462|NCT01632878|101210887|FG000|STARTED|Treatment||1263||
48360463|NCT01632878|101210887|FG000|COMPLETED|Treatment||1105||
48360464|NCT01632878|101210887|FG000|NOT COMPLETED|Treatment||158||
48187439|NCT02950545|100780040|FG002|COMPLETED|Washout 2 (5 Minutes)||7||
48187440|NCT02950545|100780041|FG003|COMPLETED|Washout 2 (5 Minutes)||7||
48360465|NCT02351037|101210888|FG000|STARTED|Overall Study||7||
48360466|NCT02351037|101210889|FG001|STARTED|Overall Study||21||
48360467|NCT02351037|101210890|FG002|STARTED|Overall Study||8||
48360468|NCT02351037|101210888|FG000|COMPLETED|Overall Study||7||
48360469|NCT02351037|101210889|FG001|COMPLETED|Overall Study||21||
48360470|NCT02351037|101210890|FG002|COMPLETED|Overall Study||8||
48187441|NCT02950545|100780042|FG004|COMPLETED|Washout 2 (5 Minutes)||7||
48187442|NCT02950545|100780043|FG005|COMPLETED|Washout 2 (5 Minutes)||8||
48187443|NCT02950545|100780038|FG000|NOT COMPLETED|Washout 2 (5 Minutes)||1||
48360471|NCT02351037|101210888|FG000|NOT COMPLETED|Overall Study||0||
48360472|NCT02351037|101210889|FG001|NOT COMPLETED|Overall Study||0||
48360473|NCT02351037|101210890|FG002|NOT COMPLETED|Overall Study||0||
48360474|NCT00693719|101210891|FG000|STARTED|Overall Study||31||
48360475|NCT00693719|101210891|FG000|COMPLETED|Overall Study||31||
48429478|NCT02190604|101386181|FG012|STARTED|Part 1 and 2 (Healthy Volunteers)||6||
48429479|NCT02190604|101386182|FG013|STARTED|Part 1 and 2 (Healthy Volunteers)||6||
48429480|NCT02190604|101386183|FG014|STARTED|Part 1 and 2 (Healthy Volunteers)||10||
48429481|NCT02190604|101386184|FG015|STARTED|Part 1 and 2 (Healthy Volunteers)||0||
48429482|NCT02190604|101386185|FG016|STARTED|Part 1 and 2 (Healthy Volunteers)||0||
48429483|NCT02190604|101386186|FG017|STARTED|Part 1 and 2 (Healthy Volunteers)||0||
48429484|NCT02190604|101386187|FG018|STARTED|Part 1 and 2 (Healthy Volunteers)||0||
48429485|NCT02190604|101386169|FG000|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6||
48429486|NCT02190604|101386170|FG001|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6||
48429487|NCT02190604|101386171|FG002|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6||
48429488|NCT02190604|101386172|FG003|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6||
48429489|NCT02190604|101386173|FG004|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6||
48429490|NCT02190604|101386174|FG005|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6||
48429491|NCT02190604|101386175|FG006|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6||
48429492|NCT02190604|101386176|FG007|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6||
48429493|NCT02190604|101386177|FG008|COMPLETED|Part 1 and 2 (Healthy Volunteers)||16||
48429494|NCT02190604|101386178|FG009|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6||
48429495|NCT02190604|101386179|FG010|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6||
48429496|NCT02190604|101386180|FG011|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6||
48429497|NCT02190604|101386181|FG012|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6||
48429498|NCT02190604|101386182|FG013|COMPLETED|Part 1 and 2 (Healthy Volunteers)||5||
48429499|NCT02190604|101386183|FG014|COMPLETED|Part 1 and 2 (Healthy Volunteers)||8||
48429500|NCT02190604|101386184|FG015|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
48429501|NCT02190604|101386185|FG016|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
48429502|NCT02190604|101386186|FG017|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
48429503|NCT02190604|101386187|FG018|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
48429504|NCT02190604|101386169|FG000|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
48429505|NCT02190604|101386170|FG001|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
48429506|NCT02190604|101386171|FG002|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
48429507|NCT02190604|101386172|FG003|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
48429508|NCT02190604|101386173|FG004|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
48429509|NCT02190604|101386174|FG005|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
48429510|NCT02190604|101386175|FG006|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
48429511|NCT02190604|101386176|FG007|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
48429512|NCT02190604|101386177|FG008|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
48429513|NCT02190604|101386178|FG009|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
48429514|NCT02190604|101386179|FG010|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
48429515|NCT02190604|101386180|FG011|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
48429516|NCT02190604|101386181|FG012|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
48429517|NCT02190604|101386182|FG013|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||1||
48429518|NCT02190604|101386183|FG014|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||2||
48429519|NCT02190604|101386184|FG015|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
48429520|NCT02190604|101386185|FG016|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
48429521|NCT02190604|101386186|FG017|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
48429522|NCT02190604|101386187|FG018|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
48429523|NCT02190604|101386169|FG000|STARTED|Part 3 (Patients)||0||
48429524|NCT02190604|101386170|FG001|STARTED|Part 3 (Patients)||0||
48429525|NCT02190604|101386171|FG002|STARTED|Part 3 (Patients)||0||
48429526|NCT02190604|101386172|FG003|STARTED|Part 3 (Patients)||0||
48429527|NCT02190604|101386173|FG004|STARTED|Part 3 (Patients)||0||
48429528|NCT02190604|101386174|FG005|STARTED|Part 3 (Patients)||0||
48429529|NCT02190604|101386175|FG006|STARTED|Part 3 (Patients)||0||
48429530|NCT02190604|101386176|FG007|STARTED|Part 3 (Patients)||0||
48429531|NCT02190604|101386177|FG008|STARTED|Part 3 (Patients)||0||
48429532|NCT02190604|101386178|FG009|STARTED|Part 3 (Patients)||0||
48429533|NCT02190604|101386179|FG010|STARTED|Part 3 (Patients)||0||
48429534|NCT02190604|101386180|FG011|STARTED|Part 3 (Patients)||0||
48429535|NCT02190604|101386181|FG012|STARTED|Part 3 (Patients)||0||
48429536|NCT02190604|101386182|FG013|STARTED|Part 3 (Patients)||0||
48429537|NCT02190604|101386183|FG014|STARTED|Part 3 (Patients)||0||
48429538|NCT02190604|101386184|FG015|STARTED|Part 3 (Patients)||6||
48429539|NCT02190604|101386185|FG016|STARTED|Part 3 (Patients)||12||
48429540|NCT02190604|101386186|FG017|STARTED|Part 3 (Patients)||19||
48429541|NCT02190604|101386187|FG018|STARTED|Part 3 (Patients)||12||
48429542|NCT02190604|101386169|FG000|COMPLETED|Part 3 (Patients)||0||
48429543|NCT02190604|101386170|FG001|COMPLETED|Part 3 (Patients)||0||
48429544|NCT02190604|101386171|FG002|COMPLETED|Part 3 (Patients)||0||
48429545|NCT02190604|101386172|FG003|COMPLETED|Part 3 (Patients)||0||
48429546|NCT02190604|101386173|FG004|COMPLETED|Part 3 (Patients)||0||
48429547|NCT02190604|101386174|FG005|COMPLETED|Part 3 (Patients)||0||
48429548|NCT02190604|101386175|FG006|COMPLETED|Part 3 (Patients)||0||
48429549|NCT02190604|101386176|FG007|COMPLETED|Part 3 (Patients)||0||
48429550|NCT02190604|101386177|FG008|COMPLETED|Part 3 (Patients)||0||
48429551|NCT02190604|101386178|FG009|COMPLETED|Part 3 (Patients)||0||
48429552|NCT02190604|101386179|FG010|COMPLETED|Part 3 (Patients)||0||
48429553|NCT02190604|101386180|FG011|COMPLETED|Part 3 (Patients)||0||
48429554|NCT02190604|101386181|FG012|COMPLETED|Part 3 (Patients)||0||
48429555|NCT02190604|101386182|FG013|COMPLETED|Part 3 (Patients)||0||
48429556|NCT02190604|101386183|FG014|COMPLETED|Part 3 (Patients)||0||
48429557|NCT02190604|101386184|FG015|COMPLETED|Part 3 (Patients)||6||
48429558|NCT02190604|101386185|FG016|COMPLETED|Part 3 (Patients)||12||
48429559|NCT02190604|101386186|FG017|COMPLETED|Part 3 (Patients)||19||
48429560|NCT02190604|101386187|FG018|COMPLETED|Part 3 (Patients)||12||
48429561|NCT02190604|101386169|FG000|NOT COMPLETED|Part 3 (Patients)||0||
48429562|NCT02190604|101386170|FG001|NOT COMPLETED|Part 3 (Patients)||0||
48429563|NCT02190604|101386171|FG002|NOT COMPLETED|Part 3 (Patients)||0||
48429564|NCT02190604|101386172|FG003|NOT COMPLETED|Part 3 (Patients)||0||
48429565|NCT02190604|101386173|FG004|NOT COMPLETED|Part 3 (Patients)||0||
48429566|NCT02190604|101386174|FG005|NOT COMPLETED|Part 3 (Patients)||0||
48429567|NCT02190604|101386175|FG006|NOT COMPLETED|Part 3 (Patients)||0||
48429568|NCT02190604|101386176|FG007|NOT COMPLETED|Part 3 (Patients)||0||
48429569|NCT02190604|101386177|FG008|NOT COMPLETED|Part 3 (Patients)||0||
48429570|NCT02190604|101386178|FG009|NOT COMPLETED|Part 3 (Patients)||0||
48429571|NCT02190604|101386179|FG010|NOT COMPLETED|Part 3 (Patients)||0||
48429572|NCT02190604|101386180|FG011|NOT COMPLETED|Part 3 (Patients)||0||
48429573|NCT02190604|101386181|FG012|NOT COMPLETED|Part 3 (Patients)||0||
48429574|NCT02190604|101386182|FG013|NOT COMPLETED|Part 3 (Patients)||0||
48429575|NCT02190604|101386183|FG014|NOT COMPLETED|Part 3 (Patients)||0||
48429576|NCT02190604|101386184|FG015|NOT COMPLETED|Part 3 (Patients)||0||
48429577|NCT02190604|101386185|FG016|NOT COMPLETED|Part 3 (Patients)||0||
48429578|NCT02190604|101386186|FG017|NOT COMPLETED|Part 3 (Patients)||0||
48429579|NCT02190604|101386187|FG018|NOT COMPLETED|Part 3 (Patients)||0||
48429580|NCT03028324|101386188|FG000|STARTED|Overall Study||4||
48429581|NCT03028324|101386188|FG000|COMPLETED|Overall Study||4||
48429582|NCT03028324|101386188|FG000|NOT COMPLETED|Overall Study||0||
48429583|NCT00960869|101386189|FG000|STARTED|Overall Study||259||
48429584|NCT00960869|101386190|FG001|STARTED|Overall Study||260||
48429585|NCT00960869|101386189|FG000|Intent-to-Treat Population (ITT)|Overall Study||259||
48429586|NCT00960869|101386190|FG001|Intent-to-Treat Population (ITT)|Overall Study||260||
48429587|NCT00960869|101386189|FG000|Safety Popluation|Overall Study||257||
48429588|NCT00960869|101386190|FG001|Safety Popluation|Overall Study||259||
48429589|NCT00960869|101386189|FG000|COMPLETED|Overall Study||206||
48429590|NCT00960869|101386190|FG001|COMPLETED|Overall Study||198||
48429591|NCT00960869|101386189|FG000|NOT COMPLETED|Overall Study||53||
48429592|NCT00960869|101386190|FG001|NOT COMPLETED|Overall Study||62||
48429593|NCT02431559|101386191|FG000|STARTED|Overall Study||3||
48429594|NCT02431559|101386192|FG001|STARTED|Overall Study||4||
48429595|NCT02431559|101386193|FG002|STARTED|Overall Study||6||
48429596|NCT02431559|101386194|FG003|STARTED|Overall Study||40||
48429597|NCT02431559|101386191|FG000|COMPLETED|Overall Study||1|Completed 12 cycles of study treatment|
48429598|NCT02431559|101386192|FG001|COMPLETED|Overall Study||1|Completed 12 cycles of study treatment|
48429599|NCT02431559|101386193|FG002|COMPLETED|Overall Study||2|Completed 12 cycles of study treatment|
48429600|NCT02431559|101386194|FG003|COMPLETED|Overall Study||9|Completed 12 cycles of study treatment|
48429601|NCT02431559|101386191|FG000|NOT COMPLETED|Overall Study||2||
48429602|NCT02431559|101386192|FG001|NOT COMPLETED|Overall Study||3||
48429603|NCT02431559|101386193|FG002|NOT COMPLETED|Overall Study||4||
48764118|NCT01099267|102211882|FG000|Other Source of Follow-up Info Used|MDS-009 Extension Follow-up||21||
48764119|NCT01099267|102211882|FG000|COMPLETED|MDS-009 Extension Follow-up||54||
48764120|NCT01099267|102211882|FG000|NOT COMPLETED|MDS-009 Extension Follow-up||0||
48764121|NCT03198715|102211883|FG000|STARTED|Overall Study||6||
48764122|NCT03198715|102211884|FG001|STARTED|Overall Study||12||
48764123|NCT03198715|102211885|FG002|STARTED|Overall Study||12||
48764124|NCT03198715|102211886|FG003|STARTED|Overall Study||3||
48764125|NCT03198715|102211887|FG004|STARTED|Overall Study||9||
48764126|NCT03198715|102211883|FG000|COMPLETED|Overall Study||6||
48764127|NCT03198715|102211884|FG001|COMPLETED|Overall Study||11||
48764128|NCT03198715|102211885|FG002|COMPLETED|Overall Study||10||
48764129|NCT03198715|102211886|FG003|COMPLETED|Overall Study||3||
48429604|NCT02431559|101386194|FG003|NOT COMPLETED|Overall Study||31||
48429605|NCT01801475|101386195|FG000|STARTED|Overall Study||10||
48429606|NCT01801475|101386196|FG001|STARTED|Overall Study||30||
48429607|NCT01801475|101386197|FG002|STARTED|Overall Study||10||
48429608|NCT01801475|101386198|FG003|STARTED|Overall Study||10||
48429609|NCT01801475|101386199|FG004|STARTED|Overall Study||40||
48429610|NCT01801475|101386195|FG000|COMPLETED|Overall Study||10||
48429611|NCT01801475|101386196|FG001|COMPLETED|Overall Study||30||
48429612|NCT01801475|101386197|FG002|COMPLETED|Overall Study||10||
48429613|NCT01801475|101386198|FG003|COMPLETED|Overall Study||10||
48429614|NCT01801475|101386199|FG004|COMPLETED|Overall Study||39||
48429615|NCT01801475|101386195|FG000|NOT COMPLETED|Overall Study||0||
48429616|NCT01801475|101386196|FG001|NOT COMPLETED|Overall Study||0||
48429617|NCT01801475|101386197|FG002|NOT COMPLETED|Overall Study||0||
48429618|NCT01801475|101386198|FG003|NOT COMPLETED|Overall Study||0||
48429619|NCT01801475|101386199|FG004|NOT COMPLETED|Overall Study||1||
48429620|NCT05147311|101386200|FG000|STARTED|Overall Study||35||
48764130|NCT03198715|102211887|FG004|COMPLETED|Overall Study||7||
48764131|NCT03198715|102211883|FG000|NOT COMPLETED|Overall Study||0||
48764132|NCT03198715|102211884|FG001|NOT COMPLETED|Overall Study||1||
48764133|NCT03198715|102211885|FG002|NOT COMPLETED|Overall Study||2||
48764134|NCT03198715|102211886|FG003|NOT COMPLETED|Overall Study||0||
48764135|NCT03198715|102211887|FG004|NOT COMPLETED|Overall Study||2||
48429621|NCT05147311|101386201|FG001|STARTED|Overall Study||35||
48360476|NCT00693719|101210891|FG000|NOT COMPLETED|Overall Study||0||
48360477|NCT04538352|101210892|FG000|STARTED|Overall Study||40||
48360478|NCT04538352|101210893|FG001|STARTED|Overall Study||20||
48360479|NCT04538352|101210892|FG000|COMPLETED|Overall Study||40||
48360480|NCT04538352|101210893|FG001|COMPLETED|Overall Study||20||
48360481|NCT04538352|101210892|FG000|NOT COMPLETED|Overall Study||0||
48429622|NCT05147311|101386200|FG000|COMPLETED|Overall Study||31||
48429623|NCT05147311|101386201|FG001|COMPLETED|Overall Study||31||
48429624|NCT05147311|101386200|FG000|NOT COMPLETED|Overall Study||4||
48429625|NCT05147311|101386201|FG001|NOT COMPLETED|Overall Study||4||
48429626|NCT01884675|101386202|FG000|STARTED|Overall Study||16||
48429627|NCT01884675|101386203|FG001|STARTED|Overall Study||17||
48429628|NCT01884675|101386202|FG000|COMPLETED|Overall Study||13||
48429629|NCT01884675|101386203|FG001|COMPLETED|Overall Study||15||
48429630|NCT01884675|101386202|FG000|NOT COMPLETED|Overall Study||3||
48429631|NCT01884675|101386203|FG001|NOT COMPLETED|Overall Study||2||
48429632|NCT03556202|101386204|FG000|STARTED|Extension Treatment Period||527||
48429633|NCT03556202|101386205|FG001|STARTED|Extension Treatment Period||1020||
48429634|NCT03556202|101386206|FG002|STARTED|Extension Treatment Period||389||
48429635|NCT03556202|101386204|FG000|Received at Least One Dose of Study Drug|Extension Treatment Period||527||
48429636|NCT03556202|101386205|FG001|Received at Least One Dose of Study Drug|Extension Treatment Period||1020||
48429637|NCT03556202|101386206|FG002|Received at Least One Dose of Study Drug|Extension Treatment Period||389||
48429638|NCT03556202|101386204|FG000|From AMAF|Extension Treatment Period||35||
48429639|NCT03556202|101386205|FG001|From AMAF|Extension Treatment Period||132||
48429640|NCT03556202|101386206|FG002|From AMAF|Extension Treatment Period||0||
48429641|NCT03556202|101386204|FG000|From AMAK|Extension Treatment Period||83||
48429642|NCT03556202|101386205|FG001|From AMAK|Extension Treatment Period||390||
48764136|NCT01084655|102211888|FG000|STARTED|Overall Study||6||
48764137|NCT01084655|102211889|FG001|STARTED|Overall Study||8||
48764138|NCT01084655|102211890|FG002|STARTED|Overall Study||24||
48764139|NCT01084655|102211888|FG000|Treated|Overall Study||6||
48764140|NCT01084655|102211889|FG001|Treated|Overall Study||8||
48360482|NCT04538352|101210893|FG001|NOT COMPLETED|Overall Study||0||
48360483|NCT00984659|101210894|FG000|STARTED|2-week Run-in Period||418||
48360484|NCT00984659|101210895|FG001|STARTED|2-week Run-in Period||0||
48360485|NCT00984659|101210896|FG002|STARTED|2-week Run-in Period||0||
48360486|NCT00984659|101210897|FG003|STARTED|2-week Run-in Period||0||
48360487|NCT00984659|101210894|FG000|COMPLETED|2-week Run-in Period||366||
48360488|NCT00984659|101210895|FG001|COMPLETED|2-week Run-in Period||0||
48360489|NCT00984659|101210896|FG002|COMPLETED|2-week Run-in Period||0||
48360490|NCT00984659|101210897|FG003|COMPLETED|2-week Run-in Period||0||
48360491|NCT00984659|101210894|FG000|NOT COMPLETED|2-week Run-in Period||52||
48360492|NCT00984659|101210895|FG001|NOT COMPLETED|2-week Run-in Period||0||
48360493|NCT00984659|101210896|FG002|NOT COMPLETED|2-week Run-in Period||0||
48360494|NCT00984659|101210897|FG003|NOT COMPLETED|2-week Run-in Period||0||
48360495|NCT00984659|101210894|FG000|STARTED|6-week Double-blind Treatment Period||0||
48360496|NCT00984659|101210895|FG001|STARTED|6-week Double-blind Treatment Period||75||
48360497|NCT00984659|101210896|FG002|STARTED|6-week Double-blind Treatment Period||152||
48360498|NCT00984659|101210897|FG003|STARTED|6-week Double-blind Treatment Period||139||
48360499|NCT00984659|101210894|FG000|COMPLETED|6-week Double-blind Treatment Period||0||
48360500|NCT00984659|101210895|FG001|COMPLETED|6-week Double-blind Treatment Period||69||
48360501|NCT00984659|101210896|FG002|COMPLETED|6-week Double-blind Treatment Period||141||
48360502|NCT00984659|101210897|FG003|COMPLETED|6-week Double-blind Treatment Period||126||
48429643|NCT03556202|101386206|FG002|From AMAK|Extension Treatment Period||0||
48429644|NCT03556202|101386204|FG000|From AMAJ|Extension Treatment Period||409||
48429645|NCT03556202|101386205|FG001|From AMAJ|Extension Treatment Period||498||
48429646|NCT03556202|101386206|FG002|From AMAJ|Extension Treatment Period||389||
48429647|NCT03556202|101386204|FG000|COMPLETED|Extension Treatment Period||0||
48429648|NCT03556202|101386205|FG001|COMPLETED|Extension Treatment Period||0||
48429649|NCT03556202|101386206|FG002|COMPLETED|Extension Treatment Period||0||
48429650|NCT03556202|101386204|FG000|NOT COMPLETED|Extension Treatment Period||527||
48429651|NCT03556202|101386205|FG001|NOT COMPLETED|Extension Treatment Period||1020||
48429652|NCT03556202|101386206|FG002|NOT COMPLETED|Extension Treatment Period||389||
48429653|NCT03556202|101386204|FG000|STARTED|Follow-Up Period (12 Weeks)||453||
48429654|NCT03556202|101386205|FG001|STARTED|Follow-Up Period (12 Weeks)||861||
48429655|NCT03556202|101386206|FG002|STARTED|Follow-Up Period (12 Weeks)||333||
48429656|NCT03556202|101386204|FG000|COMPLETED|Follow-Up Period (12 Weeks)||0||
48429657|NCT03556202|101386205|FG001|COMPLETED|Follow-Up Period (12 Weeks)||0||
48764141|NCT01084655|102211890|FG002|Treated|Overall Study||23||
48360503|NCT00984659|101210894|FG000|NOT COMPLETED|6-week Double-blind Treatment Period||0||
48764142|NCT01084655|102211888|FG000|COMPLETED|Overall Study||0||
48360504|NCT00984659|101210895|FG001|NOT COMPLETED|6-week Double-blind Treatment Period||6||
48360505|NCT00984659|101210896|FG002|NOT COMPLETED|6-week Double-blind Treatment Period||11||
48429658|NCT03556202|101386206|FG002|COMPLETED|Follow-Up Period (12 Weeks)||0||
48429659|NCT03556202|101386204|FG000|NOT COMPLETED|Follow-Up Period (12 Weeks)||453||
48429660|NCT03556202|101386205|FG001|NOT COMPLETED|Follow-Up Period (12 Weeks)||861||
48429661|NCT03556202|101386206|FG002|NOT COMPLETED|Follow-Up Period (12 Weeks)||333||
48429662|NCT02257970|101386207|FG000|STARTED|Part 1||50||
48429663|NCT02257970|101386208|FG001|STARTED|Part 1||0||
48429664|NCT02257970|101386209|FG002|STARTED|Part 1||0||
48429665|NCT02257970|101386210|FG003|STARTED|Part 1||0||
48429666|NCT02257970|101386207|FG000|COMPLETED|Part 1||50||
48429667|NCT02257970|101386208|FG001|COMPLETED|Part 1||0||
48429668|NCT02257970|101386209|FG002|COMPLETED|Part 1||0||
48429669|NCT02257970|101386210|FG003|COMPLETED|Part 1||0||
48429670|NCT02257970|101386207|FG000|NOT COMPLETED|Part 1||0||
48429671|NCT02257970|101386208|FG001|NOT COMPLETED|Part 1||0||
48429672|NCT02257970|101386209|FG002|NOT COMPLETED|Part 1||0||
48429673|NCT02257970|101386210|FG003|NOT COMPLETED|Part 1||0||
48429674|NCT02257970|101386207|FG000|STARTED|Part 2||0||
48429675|NCT02257970|101386208|FG001|STARTED|Part 2||23||
48429676|NCT02257970|101386209|FG002|STARTED|Part 2||0||
48429677|NCT02257970|101386210|FG003|STARTED|Part 2||0||
48429678|NCT02257970|101386207|FG000|COMPLETED|Part 2||0||
48429679|NCT02257970|101386208|FG001|COMPLETED|Part 2||16||
48429680|NCT02257970|101386209|FG002|COMPLETED|Part 2||0||
48429681|NCT02257970|101386210|FG003|COMPLETED|Part 2||0||
48187444|NCT02950545|100780039|FG001|NOT COMPLETED|Washout 2 (5 Minutes)||0||
48187445|NCT02950545|100780040|FG002|NOT COMPLETED|Washout 2 (5 Minutes)||0||
48187446|NCT02950545|100780041|FG003|NOT COMPLETED|Washout 2 (5 Minutes)||0||
48187447|NCT02950545|100780042|FG004|NOT COMPLETED|Washout 2 (5 Minutes)||0||
48187448|NCT02950545|100780043|FG005|NOT COMPLETED|Washout 2 (5 Minutes)||0||
48187449|NCT02950545|100780038|FG000|STARTED|Session 3 (70 Minutes)||7||
48187450|NCT02950545|100780039|FG001|STARTED|Session 3 (70 Minutes)||9||
48187451|NCT02950545|100780040|FG002|STARTED|Session 3 (70 Minutes)||7||
48187452|NCT02950545|100780041|FG003|STARTED|Session 3 (70 Minutes)||7||
48187453|NCT02950545|100780042|FG004|STARTED|Session 3 (70 Minutes)||7||
48429682|NCT02257970|101386207|FG000|NOT COMPLETED|Part 2||0||
48429683|NCT02257970|101386208|FG001|NOT COMPLETED|Part 2||7||
48429684|NCT02257970|101386209|FG002|NOT COMPLETED|Part 2||0||
48429685|NCT02257970|101386210|FG003|NOT COMPLETED|Part 2||0||
48429686|NCT02257970|101386207|FG000|STARTED|Part 3||0||
48429687|NCT02257970|101386208|FG001|STARTED|Part 3||0||
48187454|NCT02950545|100780043|FG005|STARTED|Session 3 (70 Minutes)||8||
48187455|NCT02950545|100780038|FG000|COMPLETED|Session 3 (70 Minutes)||7||
48187456|NCT02950545|100780039|FG001|COMPLETED|Session 3 (70 Minutes)||9||
48187457|NCT02950545|100780040|FG002|COMPLETED|Session 3 (70 Minutes)||7||
48187458|NCT02950545|100780041|FG003|COMPLETED|Session 3 (70 Minutes)||7||
48187459|NCT02950545|100780042|FG004|COMPLETED|Session 3 (70 Minutes)||7||
48187460|NCT02950545|100780043|FG005|COMPLETED|Session 3 (70 Minutes)||7||
48187461|NCT02950545|100780038|FG000|NOT COMPLETED|Session 3 (70 Minutes)||0||
48187462|NCT02950545|100780039|FG001|NOT COMPLETED|Session 3 (70 Minutes)||0||
48187463|NCT02950545|100780040|FG002|NOT COMPLETED|Session 3 (70 Minutes)||0||
48187464|NCT02950545|100780041|FG003|NOT COMPLETED|Session 3 (70 Minutes)||0||
48187465|NCT02950545|100780042|FG004|NOT COMPLETED|Session 3 (70 Minutes)||0||
48429688|NCT02257970|101386209|FG002|STARTED|Part 3||23||
48429689|NCT02257970|101386210|FG003|STARTED|Part 3||21||
48429690|NCT02257970|101386207|FG000|COMPLETED|Part 3||0||
48187466|NCT02950545|100780043|FG005|NOT COMPLETED|Session 3 (70 Minutes)||1||
48360506|NCT00984659|101210897|FG003|NOT COMPLETED|6-week Double-blind Treatment Period||13||
48360507|NCT02873715|101210898|FG000|STARTED|Overall Study||504||226
48360508|NCT02873715|101210899|FG001|STARTED|Overall Study||506||226
48187467|NCT03738241|100780044|FG000|STARTED|Overall Study||38||
48360509|NCT02873715|101210898|FG000|6-month Follow-up|Overall Study||403||199
48360510|NCT02873715|101210899|FG001|6-month Follow-up|Overall Study||405||201
48360511|NCT02873715|101210898|FG000|12-month Follow-up|Overall Study||380||195
48360512|NCT02873715|101210899|FG001|12-month Follow-up|Overall Study||386||199
48360513|NCT02873715|101210898|FG000|18-month Follow-up|Overall Study||380||189
48360514|NCT02873715|101210899|FG001|18-month Follow-up|Overall Study||364||189
48360515|NCT02873715|101210898|FG000|24-month Follow-up|Overall Study||413||205
48360516|NCT02873715|101210899|FG001|24-month Follow-up|Overall Study||386||198
48429691|NCT02257970|101386208|FG001|COMPLETED|Part 3||0||
48429692|NCT02257970|101386209|FG002|COMPLETED|Part 3||16||
48429693|NCT02257970|101386210|FG003|COMPLETED|Part 3||14||
48429694|NCT02257970|101386207|FG000|NOT COMPLETED|Part 3||0||
48429695|NCT02257970|101386208|FG001|NOT COMPLETED|Part 3||0||
48429696|NCT02257970|101386209|FG002|NOT COMPLETED|Part 3||7||
48429697|NCT02257970|101386210|FG003|NOT COMPLETED|Part 3||7||
48429698|NCT00265382|101386211|FG000|STARTED|Overall Study||221||
48429699|NCT00265382|101386211|FG000|COMPLETED|Overall Study||76||
48429700|NCT00265382|101386211|FG000|NOT COMPLETED|Overall Study||145||
48429701|NCT00071006|101386212|FG000|STARTED|Overall Study||12||
48429702|NCT00071006|101386212|FG000|COMPLETED|Overall Study||0||
48429703|NCT00071006|101386212|FG000|NOT COMPLETED|Overall Study||12||
48429704|NCT01509638|101386213|FG000|STARTED|Overall Study||23||
48429705|NCT01509638|101386214|FG001|STARTED|Overall Study||26||
48429706|NCT01509638|101386213|FG000|COMPLETED|Overall Study||20||
48429707|NCT01509638|101386214|FG001|COMPLETED|Overall Study||24||
48429708|NCT01509638|101386213|FG000|NOT COMPLETED|Overall Study||3||
48429709|NCT01509638|101386214|FG001|NOT COMPLETED|Overall Study||2||
48429710|NCT01871870|101386215|FG000|STARTED|Overall Study||20||
48429711|NCT01871870|101386215|FG000|COMPLETED|Overall Study||11||
48429712|NCT01871870|101386215|FG000|NOT COMPLETED|Overall Study||9||
48429713|NCT01600677|101386216|FG000|STARTED|Overall Study||7||
48429714|NCT01600677|101386217|FG001|STARTED|Overall Study||4||
48429715|NCT01600677|101386216|FG000|COMPLETED|Overall Study||7||
48429716|NCT01600677|101386217|FG001|COMPLETED|Overall Study||4||
48360517|NCT02873715|101210898|FG000|COMPLETED|Overall Study||413||205
48360518|NCT02873715|101210899|FG001|COMPLETED|Overall Study||386||198
48360519|NCT02873715|101210898|FG000|NOT COMPLETED|Overall Study||91||21
48360520|NCT02873715|101210899|FG001|NOT COMPLETED|Overall Study||120||28
48360521|NCT03241173|101210900|FG000|STARTED|Overall Study||4||
48360522|NCT03241173|101210901|FG001|STARTED|Overall Study||4||
48360523|NCT03241173|101210902|FG002|STARTED|Overall Study||5||
48360524|NCT03241173|101210903|FG003|STARTED|Overall Study||5||
48360525|NCT03241173|101210904|FG004|STARTED|Overall Study||4||
48360526|NCT03241173|101210905|FG005|STARTED|Overall Study||5||
48360527|NCT03241173|101210906|FG006|STARTED|Overall Study||4||
48360528|NCT03241173|101210907|FG007|STARTED|Overall Study||3||
48360529|NCT03241173|101210908|FG008|STARTED|Overall Study||0||
48360530|NCT03241173|101210909|FG009|STARTED|Overall Study||6||
48360531|NCT03241173|101210910|FG010|STARTED|Overall Study||6||
48360532|NCT03241173|101210911|FG011|STARTED|Overall Study||6||
48429717|NCT01600677|101386216|FG000|NOT COMPLETED|Overall Study||0||
48429718|NCT01600677|101386217|FG001|NOT COMPLETED|Overall Study||0||
48429719|NCT00346476|101386218|FG000|STARTED|Overall Study||1250||
48429720|NCT00346476|101386218|FG000|COMPLETED|Overall Study||1250||
48429721|NCT00346476|101386218|FG000|NOT COMPLETED|Overall Study||0||
48429722|NCT03478982|101386219|FG000|STARTED|Overall Study||11||
48429723|NCT03478982|101386220|FG001|STARTED|Overall Study||50||
48429724|NCT03478982|101386221|FG002|STARTED|Overall Study||47||
48429725|NCT03478982|101386222|FG003|STARTED|Overall Study||48||
48429726|NCT03478982|101386219|FG000|Enrolled Participants But Not Treated|Overall Study||3||
48429727|NCT03478982|101386220|FG001|Enrolled Participants But Not Treated|Overall Study||10||
48429728|NCT03478982|101386221|FG002|Enrolled Participants But Not Treated|Overall Study||9||
48429729|NCT03478982|101386222|FG003|Enrolled Participants But Not Treated|Overall Study||10||
48429730|NCT03478982|101386219|FG000|Intent-to-treat (ITT) Population|Overall Study||8||
48429731|NCT03478982|101386220|FG001|Intent-to-treat (ITT) Population|Overall Study||40||
48429732|NCT03478982|101386221|FG002|Intent-to-treat (ITT) Population|Overall Study||38||
48429733|NCT03478982|101386222|FG003|Intent-to-treat (ITT) Population|Overall Study||38||
48429734|NCT03478982|101386219|FG000|COMPLETED|Overall Study||11||
48429735|NCT03478982|101386220|FG001|COMPLETED|Overall Study||50||
48429736|NCT03478982|101386221|FG002|COMPLETED|Overall Study||47||
48429737|NCT03478982|101386222|FG003|COMPLETED|Overall Study||48||
48429738|NCT03478982|101386219|FG000|NOT COMPLETED|Overall Study||0||
48429739|NCT03478982|101386220|FG001|NOT COMPLETED|Overall Study||0||
48429740|NCT03478982|101386221|FG002|NOT COMPLETED|Overall Study||0||
48429741|NCT03478982|101386222|FG003|NOT COMPLETED|Overall Study||0||
48429742|NCT01303159|101386223|FG000|STARTED|Overall Study||29||
48429743|NCT01303159|101386223|FG000|COMPLETED|Overall Study||6||
48360533|NCT03241173|101210912|FG012|STARTED|Overall Study||0||
48429744|NCT01303159|101386223|FG000|NOT COMPLETED|Overall Study||23||
48429745|NCT03628872|101386224|FG000|STARTED|Overall Study||26||52
48429746|NCT03628872|101386225|FG001|STARTED|Overall Study||26||52
48429747|NCT03628872|101386224|FG000|COMPLETED|Overall Study||26||52
48429748|NCT03628872|101386225|FG001|COMPLETED|Overall Study||26||52
48429749|NCT03628872|101386224|FG000|NOT COMPLETED|Overall Study||0||0
48429750|NCT03628872|101386225|FG001|NOT COMPLETED|Overall Study||0||0
48429751|NCT00814502|101386226|FG000|STARTED|Overall Study||8||
48429752|NCT00814502|101386227|FG001|STARTED|Overall Study||9||
48429753|NCT00814502|101386226|FG000|COMPLETED|Overall Study||7||
48360534|NCT03241173|101210913|FG013|STARTED|Overall Study||0||
48360535|NCT03241173|101210914|FG014|STARTED|Overall Study||0||
48360536|NCT03241173|101210900|FG000|COMPLETED|Overall Study||0||
48360537|NCT03241173|101210901|FG001|COMPLETED|Overall Study||0||
48360538|NCT03241173|101210902|FG002|COMPLETED|Overall Study||0||
48360539|NCT03241173|101210903|FG003|COMPLETED|Overall Study||0||
48429754|NCT00814502|101386227|FG001|COMPLETED|Overall Study||7||
48360540|NCT03241173|101210904|FG004|COMPLETED|Overall Study||0||
48429755|NCT00814502|101386226|FG000|NOT COMPLETED|Overall Study||1||
48429756|NCT00814502|101386227|FG001|NOT COMPLETED|Overall Study||2||
48429757|NCT04837807|101386228|FG000|STARTED|First Sequence (Week 1)||15|This was a crossover study, so all subject got both treatments.|
48429758|NCT04837807|101386229|FG001|STARTED|First Sequence (Week 1)||15|This was a crossover study, so all subject got both treatments.|
48429759|NCT04837807|101386228|FG000|Received Sequence|First Sequence (Week 1)||15||
48429760|NCT04837807|101386229|FG001|Received Sequence|First Sequence (Week 1)||15||
48429761|NCT04837807|101386228|FG000|COMPLETED|First Sequence (Week 1)||15||
48429762|NCT04837807|101386229|FG001|COMPLETED|First Sequence (Week 1)||14||
48429763|NCT04837807|101386228|FG000|NOT COMPLETED|First Sequence (Week 1)||0||
48429764|NCT04837807|101386229|FG001|NOT COMPLETED|First Sequence (Week 1)||1||
48429765|NCT04837807|101386228|FG000|STARTED|Washout 1 Day||15||
48429766|NCT04837807|101386229|FG001|STARTED|Washout 1 Day||14||
48429767|NCT04837807|101386228|FG000|COMPLETED|Washout 1 Day||14||
48429768|NCT04837807|101386229|FG001|COMPLETED|Washout 1 Day||14||
48429769|NCT04837807|101386228|FG000|NOT COMPLETED|Washout 1 Day||1||
48429770|NCT04837807|101386229|FG001|NOT COMPLETED|Washout 1 Day||0||
48429771|NCT04837807|101386228|FG000|STARTED|Second Sequence (Week 2)||14||
48429772|NCT04837807|101386229|FG001|STARTED|Second Sequence (Week 2)||14||
48429773|NCT04837807|101386228|FG000|COMPLETED|Second Sequence (Week 2)||14|Person dropped out prior to the crossover.|
48429774|NCT04837807|101386229|FG001|COMPLETED|Second Sequence (Week 2)||14|Person dropped out prior to the crossover.|
48429775|NCT04837807|101386228|FG000|NOT COMPLETED|Second Sequence (Week 2)||0||
48429776|NCT04837807|101386229|FG001|NOT COMPLETED|Second Sequence (Week 2)||0||
48429777|NCT01830621|101386230|FG000|STARTED|Overall Study||138||
48429778|NCT01830621|101386231|FG001|STARTED|Overall Study||144||
48429779|NCT01830621|101386230|FG000|COMPLETED|Overall Study||138||
48429780|NCT01830621|101386231|FG001|COMPLETED|Overall Study||144||
48429781|NCT01830621|101386230|FG000|NOT COMPLETED|Overall Study||0||
48429782|NCT01830621|101386231|FG001|NOT COMPLETED|Overall Study||0||
48429783|NCT01085331|101386232|FG000|STARTED|Overall Study||10||
48429784|NCT01085331|101386233|FG001|STARTED|Overall Study||6||
48429785|NCT01085331|101386232|FG000|COMPLETED|Overall Study||10||
48429786|NCT01085331|101386233|FG001|COMPLETED|Overall Study||6||
48429787|NCT01085331|101386232|FG000|NOT COMPLETED|Overall Study||0||
48429788|NCT01085331|101386233|FG001|NOT COMPLETED|Overall Study||0||
48429789|NCT00719706|101386234|FG000|STARTED|Overall Study||20||
48429790|NCT00719706|101386235|FG001|STARTED|Overall Study||20||
48429791|NCT00719706|101386234|FG000|COMPLETED|Overall Study||11||
48429792|NCT00719706|101386235|FG001|COMPLETED|Overall Study||14||
48429793|NCT00719706|101386234|FG000|NOT COMPLETED|Overall Study||9||
48429794|NCT00719706|101386235|FG001|NOT COMPLETED|Overall Study||6||
48429795|NCT01716221|101386236|FG000|STARTED|Overall Study||1||
48429796|NCT01716221|101386236|FG000|COMPLETED|Overall Study||1||
48429797|NCT01716221|101386236|FG000|NOT COMPLETED|Overall Study||0||
48429798|NCT00690612|101386237|FG000|STARTED|Overall Study||35||
48429799|NCT00690612|101386237|FG000|COMPLETED|Overall Study||32||
48429800|NCT00690612|101386237|FG000|NOT COMPLETED|Overall Study||3||
48429801|NCT01002573|101386238|FG000|STARTED|Overall Study||58||
48429802|NCT01002573|101386239|FG001|STARTED|Overall Study||60||
48429803|NCT01002573|101386238|FG000|COMPLETED|Overall Study||47||
48429804|NCT01002573|101386239|FG001|COMPLETED|Overall Study||53||
48429805|NCT01002573|101386238|FG000|NOT COMPLETED|Overall Study||11||
48429806|NCT01002573|101386239|FG001|NOT COMPLETED|Overall Study||7||
48429807|NCT00314262|101389165|FG000|STARTED|Overall Study||12||
48429808|NCT00314262|101389165|FG000|COMPLETED|Overall Study||7||
48429809|NCT00314262|101389165|FG000|NOT COMPLETED|Overall Study||5||
48429810|NCT03781167|101389166|FG000|STARTED|Overall Study||131||
48429811|NCT03781167|101389167|FG001|STARTED|Overall Study||113||
48429812|NCT03781167|101389166|FG000|COMPLETED|Overall Study||84||
48429813|NCT03781167|101389167|FG001|COMPLETED|Overall Study||65||
48429814|NCT03781167|101389166|FG000|NOT COMPLETED|Overall Study||47||
48429815|NCT03781167|101389167|FG001|NOT COMPLETED|Overall Study||48||
48429816|NCT02059265|101389168|FG000|STARTED|Overall Study||32||
48429817|NCT02059265|101389168|FG000|COMPLETED|Overall Study||28||
48429818|NCT02059265|101389168|FG000|NOT COMPLETED|Overall Study||4||
48429819|NCT00556972|101389169|FG000|STARTED|Overall Study||4||
48429820|NCT00556972|101389169|FG000|COMPLETED|Overall Study||4||
48429821|NCT00556972|101389169|FG000|NOT COMPLETED|Overall Study||0||
48429822|NCT01608321|101389170|FG000|STARTED|Overall Study||13||
48638986|NCT03585543|101901545|FG000|End-of-intervention Assessment (12 Weeks|Overall Study||22||
48429823|NCT01608321|101389171|FG001|STARTED|Overall Study||4||
48429824|NCT01608321|101389170|FG000|COMPLETED|Overall Study||12||
48429825|NCT01608321|101389171|FG001|COMPLETED|Overall Study||4||
48429826|NCT01608321|101389170|FG000|NOT COMPLETED|Overall Study||1||
48429827|NCT01608321|101389171|FG001|NOT COMPLETED|Overall Study||0||
48429828|NCT01215968|101389172|FG000|STARTED|Overall Study||13||
48429829|NCT01215968|101389173|FG001|STARTED|Overall Study||25||
48429830|NCT01215968|101389172|FG000|Received at Least 1 Dose of Study Drug|Overall Study||13||
48638987|NCT03585543|101901545|FG000|3-month Post-intervention Follow-up (6 m|Overall Study||15||
48429831|NCT01215968|101389173|FG001|Received at Least 1 Dose of Study Drug|Overall Study||24||
48429832|NCT01215968|101389172|FG000|COMPLETED|Overall Study||11||
48429833|NCT01215968|101389173|FG001|COMPLETED|Overall Study||18||
48429834|NCT01215968|101389172|FG000|NOT COMPLETED|Overall Study||2||
48429835|NCT01215968|101389173|FG001|NOT COMPLETED|Overall Study||7||
48429836|NCT00066573|101389174|FG000|STARTED|Overall Study||3789||
48429837|NCT00066573|101389175|FG001|STARTED|Overall Study||3787||
48429838|NCT00066573|101389174|FG000|COMPLETED|Overall Study||3761||
48429839|NCT00066573|101389175|FG001|COMPLETED|Overall Study||3759||
48429840|NCT00066573|101389174|FG000|NOT COMPLETED|Overall Study||28||
48429841|NCT00066573|101389175|FG001|NOT COMPLETED|Overall Study||28||
48429842|NCT00892710|101389176|FG000|STARTED|Overall Study||48||
48429843|NCT00892710|101389177|FG001|STARTED|Overall Study||59||
48429844|NCT00892710|101389178|FG002|STARTED|Overall Study||55||
48429845|NCT00892710|101389176|FG000|COMPLETED|Overall Study||0||
48429846|NCT00892710|101389177|FG001|COMPLETED|Overall Study||0||
48429847|NCT00892710|101389178|FG002|COMPLETED|Overall Study||0||
48429848|NCT00892710|101389176|FG000|NOT COMPLETED|Overall Study||48||
48429849|NCT00892710|101389177|FG001|NOT COMPLETED|Overall Study||59||
48429850|NCT00892710|101389178|FG002|NOT COMPLETED|Overall Study||55||
48429851|NCT02582216|101389179|FG000|STARTED|Overall Study||22||
48429852|NCT02582216|101389179|FG000|COMPLETED|Overall Study||22||
48429853|NCT02582216|101389179|FG000|NOT COMPLETED|Overall Study||0||
48429854|NCT00895817|101389180|FG000|STARTED|Overall Study||21||
48429855|NCT00895817|101389181|FG001|STARTED|Overall Study||21||
48429856|NCT00895817|101389180|FG000|COMPLETED|Overall Study||21||
48429857|NCT00895817|101389181|FG001|COMPLETED|Overall Study||21||
48429858|NCT00895817|101389180|FG000|NOT COMPLETED|Overall Study||0||
48429859|NCT00895817|101389181|FG001|NOT COMPLETED|Overall Study||0||
48429860|NCT01258803|101389182|FG000|STARTED|Treatment Period 1 (1 Dose)||15||
48429861|NCT01258803|101389183|FG001|STARTED|Treatment Period 1 (1 Dose)||16||
48429862|NCT01258803|101389184|FG002|STARTED|Treatment Period 1 (1 Dose)||15||
48429863|NCT01258803|101389185|FG003|STARTED|Treatment Period 1 (1 Dose)||15||
48429864|NCT01258803|101389186|FG004|STARTED|Treatment Period 1 (1 Dose)||15||
48429865|NCT01258803|101389187|FG005|STARTED|Treatment Period 1 (1 Dose)||16||
48429866|NCT01258803|101389182|FG000|COMPLETED|Treatment Period 1 (1 Dose)||15||
48429867|NCT01258803|101389183|FG001|COMPLETED|Treatment Period 1 (1 Dose)||16||
48429868|NCT01258803|101389184|FG002|COMPLETED|Treatment Period 1 (1 Dose)||15||
48429869|NCT01258803|101389185|FG003|COMPLETED|Treatment Period 1 (1 Dose)||15||
48429870|NCT01258803|101389186|FG004|COMPLETED|Treatment Period 1 (1 Dose)||15||
48429871|NCT01258803|101389187|FG005|COMPLETED|Treatment Period 1 (1 Dose)||16||
48429872|NCT01258803|101389182|FG000|NOT COMPLETED|Treatment Period 1 (1 Dose)||0||
48429873|NCT01258803|101389183|FG001|NOT COMPLETED|Treatment Period 1 (1 Dose)||0||
48429874|NCT01258803|101389184|FG002|NOT COMPLETED|Treatment Period 1 (1 Dose)||0||
48429875|NCT01258803|101389185|FG003|NOT COMPLETED|Treatment Period 1 (1 Dose)||0||
48429876|NCT01258803|101389186|FG004|NOT COMPLETED|Treatment Period 1 (1 Dose)||0||
48429877|NCT01258803|101389187|FG005|NOT COMPLETED|Treatment Period 1 (1 Dose)||0||
48429878|NCT01258803|101389182|FG000|STARTED|Treatment Period 2 (1 Dose)||15||
48429879|NCT01258803|101389183|FG001|STARTED|Treatment Period 2 (1 Dose)||16||
48429880|NCT01258803|101389184|FG002|STARTED|Treatment Period 2 (1 Dose)||15||
48429881|NCT01258803|101389185|FG003|STARTED|Treatment Period 2 (1 Dose)||15||
48429882|NCT01258803|101389186|FG004|STARTED|Treatment Period 2 (1 Dose)||15||
48429883|NCT01258803|101389187|FG005|STARTED|Treatment Period 2 (1 Dose)||16||
48429884|NCT01258803|101389182|FG000|COMPLETED|Treatment Period 2 (1 Dose)||14||
48429885|NCT01258803|101389183|FG001|COMPLETED|Treatment Period 2 (1 Dose)||14||
48429886|NCT01258803|101389184|FG002|COMPLETED|Treatment Period 2 (1 Dose)||15||
48429887|NCT01258803|101389185|FG003|COMPLETED|Treatment Period 2 (1 Dose)||15||
48429888|NCT01258803|101389186|FG004|COMPLETED|Treatment Period 2 (1 Dose)||15||
48429889|NCT01258803|101389187|FG005|COMPLETED|Treatment Period 2 (1 Dose)||15||
48429890|NCT01258803|101389182|FG000|NOT COMPLETED|Treatment Period 2 (1 Dose)||1||
48429891|NCT01258803|101389183|FG001|NOT COMPLETED|Treatment Period 2 (1 Dose)||2||
48429892|NCT01258803|101389184|FG002|NOT COMPLETED|Treatment Period 2 (1 Dose)||0||
48429893|NCT01258803|101389185|FG003|NOT COMPLETED|Treatment Period 2 (1 Dose)||0||
48429894|NCT01258803|101389186|FG004|NOT COMPLETED|Treatment Period 2 (1 Dose)||0||
48429895|NCT01258803|101389187|FG005|NOT COMPLETED|Treatment Period 2 (1 Dose)||1||
48429896|NCT01258803|101389182|FG000|STARTED|Treatment Period 3 (1 Dose)||14||
48429897|NCT01258803|101389183|FG001|STARTED|Treatment Period 3 (1 Dose)||14||
48429898|NCT01258803|101389184|FG002|STARTED|Treatment Period 3 (1 Dose)||15||
48429899|NCT01258803|101389185|FG003|STARTED|Treatment Period 3 (1 Dose)||15||
48429900|NCT01258803|101389186|FG004|STARTED|Treatment Period 3 (1 Dose)||15||
48429901|NCT01258803|101389187|FG005|STARTED|Treatment Period 3 (1 Dose)||15||
48429902|NCT01258803|101389182|FG000|COMPLETED|Treatment Period 3 (1 Dose)||14||
48429903|NCT01258803|101389183|FG001|COMPLETED|Treatment Period 3 (1 Dose)||14||
48429904|NCT01258803|101389184|FG002|COMPLETED|Treatment Period 3 (1 Dose)||14||
48429905|NCT01258803|101389185|FG003|COMPLETED|Treatment Period 3 (1 Dose)||15||
48429906|NCT01258803|101389186|FG004|COMPLETED|Treatment Period 3 (1 Dose)||15||
48429907|NCT01258803|101389187|FG005|COMPLETED|Treatment Period 3 (1 Dose)||15||
48429908|NCT01258803|101389182|FG000|NOT COMPLETED|Treatment Period 3 (1 Dose)||0||
48429909|NCT01258803|101389183|FG001|NOT COMPLETED|Treatment Period 3 (1 Dose)||0||
48429910|NCT01258803|101389184|FG002|NOT COMPLETED|Treatment Period 3 (1 Dose)||1||
48429911|NCT01258803|101389185|FG003|NOT COMPLETED|Treatment Period 3 (1 Dose)||0||
48429912|NCT01258803|101389186|FG004|NOT COMPLETED|Treatment Period 3 (1 Dose)||0||
48429913|NCT01258803|101389187|FG005|NOT COMPLETED|Treatment Period 3 (1 Dose)||0||
48429914|NCT01258803|101389182|FG000|STARTED|Treatment Period 4 (1 Dose)||14||
48429915|NCT01258803|101389183|FG001|STARTED|Treatment Period 4 (1 Dose)||14||
48429916|NCT01258803|101389184|FG002|STARTED|Treatment Period 4 (1 Dose)||14||
48429917|NCT01258803|101389185|FG003|STARTED|Treatment Period 4 (1 Dose)||15||
48429918|NCT01258803|101389186|FG004|STARTED|Treatment Period 4 (1 Dose)||15||
48429919|NCT01258803|101389187|FG005|STARTED|Treatment Period 4 (1 Dose)||15||
48429920|NCT01258803|101389182|FG000|COMPLETED|Treatment Period 4 (1 Dose)||14||
48429921|NCT01258803|101389183|FG001|COMPLETED|Treatment Period 4 (1 Dose)||14||
48429922|NCT01258803|101389184|FG002|COMPLETED|Treatment Period 4 (1 Dose)||14||
48429923|NCT01258803|101389185|FG003|COMPLETED|Treatment Period 4 (1 Dose)||15||
48429924|NCT01258803|101389186|FG004|COMPLETED|Treatment Period 4 (1 Dose)||15||
48429925|NCT01258803|101389187|FG005|COMPLETED|Treatment Period 4 (1 Dose)||15||
48429926|NCT01258803|101389182|FG000|NOT COMPLETED|Treatment Period 4 (1 Dose)||0||
48429927|NCT01258803|101389183|FG001|NOT COMPLETED|Treatment Period 4 (1 Dose)||0||
48429928|NCT01258803|101389184|FG002|NOT COMPLETED|Treatment Period 4 (1 Dose)||0||
48429929|NCT01258803|101389185|FG003|NOT COMPLETED|Treatment Period 4 (1 Dose)||0||
48429930|NCT01258803|101389186|FG004|NOT COMPLETED|Treatment Period 4 (1 Dose)||0||
48429931|NCT01258803|101389187|FG005|NOT COMPLETED|Treatment Period 4 (1 Dose)||0||
48429932|NCT02706327|101389188|FG000|STARTED|Overall Study||22||
48429933|NCT02706327|101389189|FG001|STARTED|Overall Study||22||
48429934|NCT02706327|101389190|FG002|STARTED|Overall Study||23||
48429935|NCT02706327|101389188|FG000|COMPLETED|Overall Study||21||
48429936|NCT02706327|101389189|FG001|COMPLETED|Overall Study||21||
48429937|NCT02706327|101389190|FG002|COMPLETED|Overall Study||21||
48429938|NCT02706327|101389188|FG000|NOT COMPLETED|Overall Study||1||
48429939|NCT02706327|101389189|FG001|NOT COMPLETED|Overall Study||1||
48429940|NCT02706327|101389190|FG002|NOT COMPLETED|Overall Study||2||
48429941|NCT01510704|101389191|FG000|STARTED|Overall Study||54||
48429942|NCT01510704|101389192|FG001|STARTED|Overall Study||58||
48429943|NCT01510704|101389193|FG002|STARTED|Overall Study||50||
48429944|NCT01510704|101389194|FG003|STARTED|Overall Study||53||
48429945|NCT01510704|101389191|FG000|COMPLETED|Overall Study||54||
48429946|NCT01510704|101389192|FG001|COMPLETED|Overall Study||58||
48429947|NCT01510704|101389193|FG002|COMPLETED|Overall Study||50||
48429948|NCT01510704|101389194|FG003|COMPLETED|Overall Study||53||
48429949|NCT01510704|101389191|FG000|NOT COMPLETED|Overall Study||0||
48429950|NCT01510704|101389192|FG001|NOT COMPLETED|Overall Study||0||
48429951|NCT01510704|101389193|FG002|NOT COMPLETED|Overall Study||0||
48429952|NCT01510704|101389194|FG003|NOT COMPLETED|Overall Study||0||
48429953|NCT04828993|101389195|FG000|STARTED|Disposition Phase: TREATMENT||15||
48429954|NCT04828993|101389195|FG000|COMPLETED|Disposition Phase: TREATMENT||15||
48429955|NCT04828993|101389195|FG000|NOT COMPLETED|Disposition Phase: TREATMENT||0||
48429956|NCT04828993|101389195|FG000|STARTED|Disposition Phase: FOLLOW-UP||15||
48429957|NCT04828993|101389195|FG000|COMPLETED|Disposition Phase: FOLLOW-UP||15||
48429958|NCT04828993|101389195|FG000|NOT COMPLETED|Disposition Phase: FOLLOW-UP||0||
48764143|NCT01084655|102211889|FG001|COMPLETED|Overall Study||2||
48764144|NCT01084655|102211890|FG002|COMPLETED|Overall Study||5||
48187468|NCT03738241|100780045|FG001|STARTED|Overall Study||40||
48187469|NCT03738241|100780046|FG002|STARTED|Overall Study||24||
48429959|NCT00638820|101389196|FG000|STARTED|Overall Study||3||
48429960|NCT00638820|101389196|FG000|COMPLETED|Overall Study||3||
48429961|NCT00638820|101389196|FG000|NOT COMPLETED|Overall Study||0||
48429962|NCT04337827|101389197|FG000|STARTED|Overall Study||6||
48429963|NCT04337827|101389197|FG000|COMPLETED|Overall Study||6||
48429964|NCT04337827|101389197|FG000|NOT COMPLETED|Overall Study||0||
48429965|NCT01041027|101389198|FG000|STARTED|Overall Study||31||
48429966|NCT01041027|101389198|FG000|COMPLETED|Overall Study||23||
48429967|NCT01041027|101389198|FG000|NOT COMPLETED|Overall Study||8||
48429968|NCT01761565|101389199|FG000|STARTED|Single Dose of SUF NT 15 mcg||40||
48429969|NCT01761565|101389199|FG000|COMPLETED|Single Dose of SUF NT 15 mcg||40||
48429970|NCT01761565|101389199|FG000|NOT COMPLETED|Single Dose of SUF NT 15 mcg||0||
48429971|NCT01761565|101389199|FG000|STARTED|40 Consecutive Doses of SUF 15 mcg||39||
48429972|NCT01761565|101389199|FG000|COMPLETED|40 Consecutive Doses of SUF 15 mcg||38||
48429973|NCT01761565|101389199|FG000|NOT COMPLETED|40 Consecutive Doses of SUF 15 mcg||1||
48429974|NCT02377674|101389200|FG000|STARTED|Overall Study||5||
48429975|NCT02377674|101389200|FG000|COMPLETED|Overall Study||5||
48429976|NCT02377674|101389200|FG000|NOT COMPLETED|Overall Study||0||
48429977|NCT00990782|101389201|FG000|STARTED|Overall Study||93||
48429978|NCT00990782|101389201|FG000|COMPLETED|Overall Study||88||
48429979|NCT00990782|101389201|FG000|NOT COMPLETED|Overall Study||5||
48187470|NCT03738241|100780047|FG003|STARTED|Overall Study||18||
48187471|NCT03738241|100780048|FG004|STARTED|Overall Study||40||
48429980|NCT00663208|101389202|FG000|STARTED|Treatment Period||4||
48429981|NCT00663208|101389203|FG001|STARTED|Treatment Period||4||
48429982|NCT00663208|101389204|FG002|STARTED|Treatment Period||4||
48429983|NCT00663208|101389205|FG003|STARTED|Treatment Period||4||
48429984|NCT00663208|101389206|FG004|STARTED|Treatment Period||4||
48187472|NCT03738241|100780049|FG005|STARTED|Overall Study||44||
48429985|NCT00663208|101389207|FG005|STARTED|Treatment Period||4||
48429986|NCT00663208|101389208|FG006|STARTED|Treatment Period||6||
48429987|NCT00663208|101389202|FG000|COMPLETED|Treatment Period||4||
48429988|NCT00663208|101389203|FG001|COMPLETED|Treatment Period||3||
48429989|NCT00663208|101389204|FG002|COMPLETED|Treatment Period||4||
48429990|NCT00663208|101389205|FG003|COMPLETED|Treatment Period||4||
48429991|NCT00663208|101389206|FG004|COMPLETED|Treatment Period||4||
48429992|NCT00663208|101389207|FG005|COMPLETED|Treatment Period||4||
48429993|NCT00663208|101389208|FG006|COMPLETED|Treatment Period||6||
48429994|NCT00663208|101389202|FG000|NOT COMPLETED|Treatment Period||0||
48429995|NCT00663208|101389203|FG001|NOT COMPLETED|Treatment Period||1||
48429996|NCT00663208|101389204|FG002|NOT COMPLETED|Treatment Period||0||
48429997|NCT00663208|101389205|FG003|NOT COMPLETED|Treatment Period||0||
48429998|NCT00663208|101389206|FG004|NOT COMPLETED|Treatment Period||0||
48429999|NCT00663208|101389207|FG005|NOT COMPLETED|Treatment Period||0||
48430000|NCT00663208|101389208|FG006|NOT COMPLETED|Treatment Period||0||
48430001|NCT00663208|101389202|FG000|STARTED|Follow-up Period||4||
48430002|NCT00663208|101389203|FG001|STARTED|Follow-up Period||3||
48430003|NCT00663208|101389204|FG002|STARTED|Follow-up Period||4||
48430004|NCT00663208|101389205|FG003|STARTED|Follow-up Period||4||
48430005|NCT00663208|101389206|FG004|STARTED|Follow-up Period||4||
48430006|NCT00663208|101389207|FG005|STARTED|Follow-up Period||4||
48430007|NCT00663208|101389208|FG006|STARTED|Follow-up Period||6||
48430008|NCT00663208|101389202|FG000|COMPLETED|Follow-up Period||1||
48430009|NCT00663208|101389203|FG001|COMPLETED|Follow-up Period||3||
48430010|NCT00663208|101389204|FG002|COMPLETED|Follow-up Period||1||
48430011|NCT00663208|101389205|FG003|COMPLETED|Follow-up Period||2||
48430012|NCT00663208|101389206|FG004|COMPLETED|Follow-up Period||4||
48430013|NCT00663208|101389207|FG005|COMPLETED|Follow-up Period||4||
48430014|NCT00663208|101389208|FG006|COMPLETED|Follow-up Period||5||
48430015|NCT00663208|101389202|FG000|NOT COMPLETED|Follow-up Period||3||
48430016|NCT00663208|101389203|FG001|NOT COMPLETED|Follow-up Period||0||
48430017|NCT00663208|101389204|FG002|NOT COMPLETED|Follow-up Period||3||
48430018|NCT00663208|101389205|FG003|NOT COMPLETED|Follow-up Period||2||
48430019|NCT00663208|101389206|FG004|NOT COMPLETED|Follow-up Period||0||
48430020|NCT00663208|101389207|FG005|NOT COMPLETED|Follow-up Period||0||
48430021|NCT00663208|101389208|FG006|NOT COMPLETED|Follow-up Period||1||
48430022|NCT00451191|101389209|FG000|STARTED|Overall Study||68||
48430023|NCT00451191|101389210|FG001|STARTED|Overall Study||66||
48430024|NCT00451191|101389209|FG000|COMPLETED|Overall Study||53||
48430025|NCT00451191|101389210|FG001|COMPLETED|Overall Study||55||
48430026|NCT00451191|101389209|FG000|NOT COMPLETED|Overall Study||15||
48430027|NCT00451191|101389210|FG001|NOT COMPLETED|Overall Study||11||
48430028|NCT03193996|101389211|FG000|STARTED|Overall Study||29||
48430029|NCT03193996|101389211|FG000|COMPLETED|Overall Study||16||
48430030|NCT03193996|101389211|FG000|NOT COMPLETED|Overall Study||13||
48430031|NCT02528331|101389212|FG000|STARTED|Overall Study||2||
48430032|NCT02528331|101389212|FG000|COMPLETED|Overall Study||0||
48430033|NCT02528331|101389212|FG000|NOT COMPLETED|Overall Study||2||
48430034|NCT02163759|101389213|FG000|STARTED|Overall Study||72||
48430035|NCT02163759|101389214|FG001|STARTED|Overall Study||142||
48430036|NCT02163759|101389215|FG002|STARTED|Overall Study||144||
48430037|NCT02163759|101389213|FG000|Completed Week 10|Overall Study||71||
48430038|NCT02163759|101389214|FG001|Completed Week 10|Overall Study||141||
48430039|NCT02163759|101389215|FG002|Completed Week 10|Overall Study||143||
48430040|NCT02163759|101389213|FG000|COMPLETED|Overall Study||71|Participants who rolled into open-label extension study or completed 12 weeks safety follow-up following treatment completion or discontinuation.|
48430041|NCT02163759|101389214|FG001|COMPLETED|Overall Study||137|Participants who rolled into open-label extension study or completed 12 weeks safety follow-up following treatment completion or discontinuation.|
48430042|NCT02163759|101389215|FG002|COMPLETED|Overall Study||141|Participants who rolled into open-label extension study or completed 12 weeks safety follow-up following treatment completion or discontinuation.|
48430043|NCT02163759|101389213|FG000|NOT COMPLETED|Overall Study||1||
48430044|NCT02163759|101389214|FG001|NOT COMPLETED|Overall Study||5||
48430045|NCT02163759|101389215|FG002|NOT COMPLETED|Overall Study||3||
48430046|NCT04196023|101389216|FG000|STARTED|Overall Study||62||
48430047|NCT04196023|101389217|FG001|STARTED|Overall Study||67||
48430048|NCT04196023|101389216|FG000|COMPLETED|Overall Study||59||
48430049|NCT04196023|101389217|FG001|COMPLETED|Overall Study||64||
48430050|NCT04196023|101389216|FG000|NOT COMPLETED|Overall Study||3||
48430051|NCT04196023|101389217|FG001|NOT COMPLETED|Overall Study||3||
48430052|NCT03709342|101389218|FG000|STARTED|Overall Study||7||
48430053|NCT03709342|101389218|FG000|COMPLETED|Overall Study||7||
48430054|NCT03709342|101389218|FG000|NOT COMPLETED|Overall Study||0||
48430055|NCT00511706|101389219|FG000|STARTED|Overall Study||123||
48430056|NCT00511706|101389220|FG001|STARTED|Overall Study||120||
48430057|NCT00511706|101389219|FG000|COMPLETED|Overall Study||115||
48430058|NCT00511706|101389220|FG001|COMPLETED|Overall Study||115||
48430059|NCT00511706|101389219|FG000|NOT COMPLETED|Overall Study||8||
48430060|NCT00511706|101389220|FG001|NOT COMPLETED|Overall Study||5||
48430061|NCT02159872|101389221|FG000|STARTED|Overall Study||48||
48430062|NCT02159872|101389221|FG000|COMPLETED|Overall Study||48||
48430063|NCT02159872|101389221|FG000|NOT COMPLETED|Overall Study||0||
48430064|NCT01015170|101389222|FG000|STARTED|Overall Study||454||
48430065|NCT01015170|101389222|FG000|COMPLETED|Overall Study||215||
48430066|NCT01015170|101389222|FG000|NOT COMPLETED|Overall Study||239||
48430067|NCT01283282|101389223|FG000|STARTED|First Intervention (6 Weeks)||25||
48430068|NCT01283282|101389224|FG001|STARTED|First Intervention (6 Weeks)||23||
48430069|NCT01283282|101389223|FG000|COMPLETED|First Intervention (6 Weeks)||22||
48430070|NCT01283282|101389224|FG001|COMPLETED|First Intervention (6 Weeks)||19||
48430071|NCT01283282|101389223|FG000|NOT COMPLETED|First Intervention (6 Weeks)||3||
48430072|NCT01283282|101389224|FG001|NOT COMPLETED|First Intervention (6 Weeks)||4||
48430073|NCT01283282|101389223|FG000|STARTED|Second Intervention (6 Weeks)||22||
48430074|NCT01283282|101389224|FG001|STARTED|Second Intervention (6 Weeks)||19||
48430075|NCT01283282|101389223|FG000|COMPLETED|Second Intervention (6 Weeks)||22||
48430076|NCT01283282|101389224|FG001|COMPLETED|Second Intervention (6 Weeks)||19||
48430077|NCT01283282|101389223|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0||
48430078|NCT01283282|101389224|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0||
48430079|NCT02213666|101389225|FG000|STARTED|Overall Study||72||
48430080|NCT02213666|101389225|FG000|COMPLETED|Overall Study||71||
48430081|NCT02213666|101389225|FG000|NOT COMPLETED|Overall Study||1||
48430082|NCT03500302|101389226|FG000|STARTED|Overall Study||19||
48430083|NCT03500302|101389226|FG000|COMPLETED|Overall Study||19||
48430084|NCT03500302|101389226|FG000|NOT COMPLETED|Overall Study||0||
48430085|NCT01972282|101389227|FG000|STARTED|Overall Study||1020||
48430086|NCT01972282|101389227|FG000|COMPLETED|Overall Study||1005||
48430087|NCT01972282|101389227|FG000|NOT COMPLETED|Overall Study||15||
48430088|NCT04398030|101389228|FG000|STARTED|Treatment Period 1 (1 Week)||3||
48430089|NCT04398030|101389229|FG001|STARTED|Treatment Period 1 (1 Week)||4||
48430090|NCT04398030|101389228|FG000|COMPLETED|Treatment Period 1 (1 Week)||3||
48430091|NCT04398030|101389229|FG001|COMPLETED|Treatment Period 1 (1 Week)||3||
48430092|NCT04398030|101389228|FG000|NOT COMPLETED|Treatment Period 1 (1 Week)||0||
48430093|NCT04398030|101389229|FG001|NOT COMPLETED|Treatment Period 1 (1 Week)||1||
48430094|NCT04398030|101389228|FG000|STARTED|Washout (2 Weeks)||3||
48430095|NCT04398030|101389229|FG001|STARTED|Washout (2 Weeks)||3||
48430096|NCT04398030|101389228|FG000|COMPLETED|Washout (2 Weeks)||3||
48430097|NCT04398030|101389229|FG001|COMPLETED|Washout (2 Weeks)||3||
48430098|NCT04398030|101389228|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
48430099|NCT04398030|101389229|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
48430100|NCT04398030|101389228|FG000|STARTED|Treatment Period 2 (1 Week)||3||
48430101|NCT04398030|101389229|FG001|STARTED|Treatment Period 2 (1 Week)||3||
48430102|NCT04398030|101389228|FG000|COMPLETED|Treatment Period 2 (1 Week)||2||
48430103|NCT04398030|101389229|FG001|COMPLETED|Treatment Period 2 (1 Week)||3||
48430104|NCT04398030|101389228|FG000|NOT COMPLETED|Treatment Period 2 (1 Week)||1||
48430105|NCT04398030|101389229|FG001|NOT COMPLETED|Treatment Period 2 (1 Week)||0||
48430106|NCT01945866|101389230|FG000|STARTED|Overall Study||65|Units in Eyes|65
48430107|NCT01945866|101389231|FG001|STARTED|Overall Study||64|Units in Eyes|64
48430108|NCT01945866|101389230|FG000|COMPLETED|Overall Study||63||63
48430109|NCT01945866|101389231|FG001|COMPLETED|Overall Study||64||64
48430110|NCT01945866|101389230|FG000|NOT COMPLETED|Overall Study||2||2
48430111|NCT01945866|101389231|FG001|NOT COMPLETED|Overall Study||0||0
48430112|NCT01013207|101389232|FG000|STARTED|CPAP Pre Nexus (S9)||50||
48430113|NCT01013207|101389232|FG000|COMPLETED|CPAP Pre Nexus (S9)||50||
48430114|NCT01013207|101389232|FG000|NOT COMPLETED|CPAP Pre Nexus (S9)||0||
48430115|NCT01013207|101389232|FG000|STARTED|Nexus (S9)||50||
48430116|NCT01013207|101389232|FG000|COMPLETED|Nexus (S9)||50||
48430117|NCT01013207|101389232|FG000|NOT COMPLETED|Nexus (S9)||0||
48430118|NCT01013207|101389232|FG000|STARTED|CPAP Post Nexus (S9)||50||
48430119|NCT01013207|101389232|FG000|COMPLETED|CPAP Post Nexus (S9)||44||
48430120|NCT01013207|101389232|FG000|NOT COMPLETED|CPAP Post Nexus (S9)||6||
48430121|NCT02078557|101389233|FG000|STARTED|Overall Study||4||
48430122|NCT02078557|101389233|FG000|COMPLETED|Overall Study||4||
48430123|NCT02078557|101389233|FG000|NOT COMPLETED|Overall Study||0||
48430124|NCT03112720|101389234|FG000|STARTED|Overall Study||5||
48430125|NCT03112720|101389235|FG001|STARTED|Overall Study||3||
48430126|NCT03112720|101389234|FG000|COMPLETED|Overall Study||5||
48430127|NCT03112720|101389235|FG001|COMPLETED|Overall Study||3||
48430128|NCT03112720|101389234|FG000|NOT COMPLETED|Overall Study||0||
48430129|NCT03112720|101389235|FG001|NOT COMPLETED|Overall Study||0||
48430130|NCT00475657|101389236|FG000|STARTED|Overall Study||5||
48430131|NCT00475657|101389236|FG000|COMPLETED|Overall Study||1||
48430132|NCT00475657|101389236|FG000|NOT COMPLETED|Overall Study||4||
48430133|NCT01008059|101389237|FG000|STARTED|Control Sequential Alfentanil||6||
48430134|NCT01008059|101389238|FG001|STARTED|Control Sequential Alfentanil||0||
48430135|NCT01008059|101389239|FG002|STARTED|Control Sequential Alfentanil||0||
48430136|NCT01008059|101389240|FG003|STARTED|Control Sequential Alfentanil||0||
48430137|NCT01008059|101389241|FG004|STARTED|Control Sequential Alfentanil||0||
48430138|NCT01008059|101389242|FG005|STARTED|Control Sequential Alfentanil||0||
48430139|NCT01008059|101389243|FG006|STARTED|Control Sequential Alfentanil||0||
48430140|NCT01008059|101389244|FG007|STARTED|Control Sequential Alfentanil||0||
48430141|NCT01008059|101389237|FG000|COMPLETED|Control Sequential Alfentanil||6||
48430142|NCT01008059|101389238|FG001|COMPLETED|Control Sequential Alfentanil||0||
48430143|NCT01008059|101389239|FG002|COMPLETED|Control Sequential Alfentanil||0||
48430144|NCT01008059|101389240|FG003|COMPLETED|Control Sequential Alfentanil||0||
48430145|NCT01008059|101389241|FG004|COMPLETED|Control Sequential Alfentanil||0||
48430146|NCT01008059|101389242|FG005|COMPLETED|Control Sequential Alfentanil||0||
48430147|NCT01008059|101389243|FG006|COMPLETED|Control Sequential Alfentanil||0||
48430148|NCT01008059|101389244|FG007|COMPLETED|Control Sequential Alfentanil||0||
48430149|NCT01008059|101389237|FG000|NOT COMPLETED|Control Sequential Alfentanil||0||
48430150|NCT01008059|101389238|FG001|NOT COMPLETED|Control Sequential Alfentanil||0||
48430151|NCT01008059|101389239|FG002|NOT COMPLETED|Control Sequential Alfentanil||0||
48764145|NCT01084655|102211888|FG000|NOT COMPLETED|Overall Study||6||
48764146|NCT01084655|102211889|FG001|NOT COMPLETED|Overall Study||6||
48764147|NCT01084655|102211890|FG002|NOT COMPLETED|Overall Study||19||
48764148|NCT01724346|102211891|FG000|STARTED|Overall Study||136||
48360541|NCT03241173|101210905|FG005|COMPLETED|Overall Study||0||
48360542|NCT03241173|101210906|FG006|COMPLETED|Overall Study||0||
48360543|NCT03241173|101210907|FG007|COMPLETED|Overall Study||0||
48360544|NCT03241173|101210908|FG008|COMPLETED|Overall Study||0||
48360545|NCT03241173|101210909|FG009|COMPLETED|Overall Study||0||
48360546|NCT03241173|101210910|FG010|COMPLETED|Overall Study||0||
48360547|NCT03241173|101210911|FG011|COMPLETED|Overall Study||0||
48764149|NCT01724346|102211892|FG001|STARTED|Overall Study||133||
48764150|NCT01724346|102211891|FG000|Received Next-Line Ibrutinib After PD|Overall Study||0||
48764151|NCT01724346|102211892|FG001|Received Next-Line Ibrutinib After PD|Overall Study||78||
48764152|NCT01724346|102211891|FG000|COMPLETED|Overall Study||57||
48764153|NCT01724346|102211892|FG001|COMPLETED|Overall Study||63||
48360548|NCT03241173|101210912|FG012|COMPLETED|Overall Study||0||
48360549|NCT03241173|101210913|FG013|COMPLETED|Overall Study||0||
48430152|NCT01008059|101389240|FG003|NOT COMPLETED|Control Sequential Alfentanil||0||
48430153|NCT01008059|101389241|FG004|NOT COMPLETED|Control Sequential Alfentanil||0||
48430154|NCT01008059|101389242|FG005|NOT COMPLETED|Control Sequential Alfentanil||0||
48764154|NCT01724346|102211891|FG000|NOT COMPLETED|Overall Study||79||
48764155|NCT01724346|102211892|FG001|NOT COMPLETED|Overall Study||70||
48764156|NCT01615484|102211893|FG000|STARTED|Overall Study||0||
48764157|NCT01615484|102211894|FG001|STARTED|Overall Study||24||
48764158|NCT01615484|102211893|FG000|COMPLETED|Overall Study||0||
48764159|NCT01615484|102211894|FG001|COMPLETED|Overall Study||24||
48764160|NCT01615484|102211893|FG000|NOT COMPLETED|Overall Study||0||
48764161|NCT01615484|102211894|FG001|NOT COMPLETED|Overall Study||0||
48764162|NCT04730804|102211895|FG000|STARTED|Overall Study||6||
48764163|NCT04730804|102211896|FG001|STARTED|Overall Study||1||
48764164|NCT04730804|102211897|FG002|STARTED|Overall Study||6||
48764165|NCT04730804|102211898|FG003|STARTED|Overall Study||6||
48764166|NCT04730804|102211899|FG004|STARTED|Overall Study||6||
48764167|NCT04730804|102211900|FG005|STARTED|Overall Study||9||
48764168|NCT04730804|102211895|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
48764169|NCT04730804|102211896|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1||
48764170|NCT04730804|102211897|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
48764171|NCT04730804|102211898|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6||
48764172|NCT04730804|102211899|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6||
48764173|NCT04730804|102211900|FG005|Received at Least 1 Dose of Study Drug|Overall Study||9||
48764174|NCT04730804|102211895|FG000|COMPLETED|Overall Study||6||
48764175|NCT04730804|102211896|FG001|COMPLETED|Overall Study||1||
48764176|NCT04730804|102211897|FG002|COMPLETED|Overall Study||6||
48764177|NCT04730804|102211898|FG003|COMPLETED|Overall Study||6||
48764178|NCT04730804|102211899|FG004|COMPLETED|Overall Study||5||
48360550|NCT03241173|101210914|FG014|COMPLETED|Overall Study||0||
48360551|NCT03241173|101210900|FG000|NOT COMPLETED|Overall Study||4||
48430155|NCT01008059|101389243|FG006|NOT COMPLETED|Control Sequential Alfentanil||0||
48430156|NCT01008059|101389244|FG007|NOT COMPLETED|Control Sequential Alfentanil||0||
48430157|NCT01008059|101389237|FG000|STARTED|Rifampin Sequential Alfentanil||0||
48430158|NCT01008059|101389238|FG001|STARTED|Rifampin Sequential Alfentanil||6||
48430159|NCT01008059|101389239|FG002|STARTED|Rifampin Sequential Alfentanil||0||
48764179|NCT04730804|102211900|FG005|COMPLETED|Overall Study||6||
48764180|NCT04730804|102211895|FG000|NOT COMPLETED|Overall Study||0||
48764181|NCT04730804|102211896|FG001|NOT COMPLETED|Overall Study||0||
48764182|NCT04730804|102211897|FG002|NOT COMPLETED|Overall Study||0||
48764183|NCT04730804|102211898|FG003|NOT COMPLETED|Overall Study||0||
48764184|NCT04730804|102211899|FG004|NOT COMPLETED|Overall Study||1||
48764185|NCT04730804|102211900|FG005|NOT COMPLETED|Overall Study||3||
48764186|NCT04983680|102211901|FG000|STARTED|Overall Study||19||
48764187|NCT04983680|102211901|FG000|COMPLETED|Overall Study||12||
48764188|NCT04983680|102211901|FG000|NOT COMPLETED|Overall Study||7||
48764189|NCT01131507|102211902|FG000|STARTED|Overall Study||15||
48764190|NCT01131507|102211902|FG000|COMPLETED|Overall Study||12||
48764191|NCT01131507|102211902|FG000|NOT COMPLETED|Overall Study||3||
48764192|NCT00003475|102211903|FG000|STARTED|Overall Study||40||
48764193|NCT00003475|102211903|FG000|COMPLETED|Overall Study||27||
48360552|NCT03241173|101210901|FG001|NOT COMPLETED|Overall Study||4||
48360553|NCT03241173|101210902|FG002|NOT COMPLETED|Overall Study||5||
48360554|NCT03241173|101210903|FG003|NOT COMPLETED|Overall Study||5||
48430160|NCT01008059|101389240|FG003|STARTED|Rifampin Sequential Alfentanil||0||
48430161|NCT01008059|101389241|FG004|STARTED|Rifampin Sequential Alfentanil||0||
48430162|NCT01008059|101389242|FG005|STARTED|Rifampin Sequential Alfentanil||0||
48430163|NCT01008059|101389243|FG006|STARTED|Rifampin Sequential Alfentanil||0||
48430164|NCT01008059|101389244|FG007|STARTED|Rifampin Sequential Alfentanil||0||
48430165|NCT01008059|101389237|FG000|COMPLETED|Rifampin Sequential Alfentanil||0||
48430166|NCT01008059|101389238|FG001|COMPLETED|Rifampin Sequential Alfentanil||6||
48430167|NCT01008059|101389239|FG002|COMPLETED|Rifampin Sequential Alfentanil||0||
48430168|NCT01008059|101389240|FG003|COMPLETED|Rifampin Sequential Alfentanil||0||
48430169|NCT01008059|101389241|FG004|COMPLETED|Rifampin Sequential Alfentanil||0||
48430170|NCT01008059|101389242|FG005|COMPLETED|Rifampin Sequential Alfentanil||0||
48430171|NCT01008059|101389243|FG006|COMPLETED|Rifampin Sequential Alfentanil||0||
48430172|NCT01008059|101389244|FG007|COMPLETED|Rifampin Sequential Alfentanil||0||
48430173|NCT01008059|101389237|FG000|NOT COMPLETED|Rifampin Sequential Alfentanil||0||
48430174|NCT01008059|101389238|FG001|NOT COMPLETED|Rifampin Sequential Alfentanil||0||
48430175|NCT01008059|101389239|FG002|NOT COMPLETED|Rifampin Sequential Alfentanil||0||
48430176|NCT01008059|101389240|FG003|NOT COMPLETED|Rifampin Sequential Alfentanil||0||
48430177|NCT01008059|101389241|FG004|NOT COMPLETED|Rifampin Sequential Alfentanil||0||
48430178|NCT01008059|101389242|FG005|NOT COMPLETED|Rifampin Sequential Alfentanil||0||
48430179|NCT01008059|101389243|FG006|NOT COMPLETED|Rifampin Sequential Alfentanil||0||
48430180|NCT01008059|101389244|FG007|NOT COMPLETED|Rifampin Sequential Alfentanil||0||
48430181|NCT01008059|101389237|FG000|STARTED|Grapefruit Juice Sequential Alfentanil||0||
48430182|NCT01008059|101389238|FG001|STARTED|Grapefruit Juice Sequential Alfentanil||0||
48430183|NCT01008059|101389239|FG002|STARTED|Grapefruit Juice Sequential Alfentanil||6||
48430184|NCT01008059|101389240|FG003|STARTED|Grapefruit Juice Sequential Alfentanil||0||
48430185|NCT01008059|101389241|FG004|STARTED|Grapefruit Juice Sequential Alfentanil||0||
48430186|NCT01008059|101389242|FG005|STARTED|Grapefruit Juice Sequential Alfentanil||0||
48430187|NCT01008059|101389243|FG006|STARTED|Grapefruit Juice Sequential Alfentanil||0||
48430188|NCT01008059|101389244|FG007|STARTED|Grapefruit Juice Sequential Alfentanil||0||
48430189|NCT01008059|101389237|FG000|COMPLETED|Grapefruit Juice Sequential Alfentanil||0||
48430190|NCT01008059|101389238|FG001|COMPLETED|Grapefruit Juice Sequential Alfentanil||0||
48360555|NCT03241173|101210904|FG004|NOT COMPLETED|Overall Study||4||
48360556|NCT03241173|101210905|FG005|NOT COMPLETED|Overall Study||5||
48360557|NCT03241173|101210906|FG006|NOT COMPLETED|Overall Study||4||
48360558|NCT03241173|101210907|FG007|NOT COMPLETED|Overall Study||3||
48360559|NCT03241173|101210908|FG008|NOT COMPLETED|Overall Study||0||
48360560|NCT03241173|101210909|FG009|NOT COMPLETED|Overall Study||6||
48360561|NCT03241173|101210910|FG010|NOT COMPLETED|Overall Study||6||
48360562|NCT03241173|101210911|FG011|NOT COMPLETED|Overall Study||6||
48360563|NCT03241173|101210912|FG012|NOT COMPLETED|Overall Study||0||
48360564|NCT03241173|101210913|FG013|NOT COMPLETED|Overall Study||0||
48360565|NCT03241173|101210914|FG014|NOT COMPLETED|Overall Study||0||
48360566|NCT02345161|101210915|FG000|STARTED|Overall Study||911||
48360567|NCT02345161|101210916|FG001|STARTED|Overall Study||899||
48360568|NCT02345161|101210915|FG000|COMPLETED|Overall Study||866||
48360569|NCT02345161|101210916|FG001|COMPLETED|Overall Study||842||
48360570|NCT02345161|101210915|FG000|NOT COMPLETED|Overall Study||45||
48360571|NCT02345161|101210916|FG001|NOT COMPLETED|Overall Study||57||
48360572|NCT01334125|101210917|FG000|STARTED|Overall Study||15||
48360573|NCT01334125|101210918|FG001|STARTED|Overall Study||13||
48360574|NCT01334125|101210917|FG000|COMPLETED|Overall Study||12||
48360575|NCT01334125|101210918|FG001|COMPLETED|Overall Study||10||
48360576|NCT01334125|101210917|FG000|NOT COMPLETED|Overall Study||3||
48360577|NCT01334125|101210918|FG001|NOT COMPLETED|Overall Study||3||
48360578|NCT00312377|101210919|FG000|STARTED|Overall Study||694||
48360579|NCT00312377|101210920|FG001|STARTED|Overall Study||697||
48430191|NCT01008059|101389239|FG002|COMPLETED|Grapefruit Juice Sequential Alfentanil||6||
48430192|NCT01008059|101389240|FG003|COMPLETED|Grapefruit Juice Sequential Alfentanil||0||
48360580|NCT00312377|101210919|FG000|COMPLETED|Overall Study||50||
48430193|NCT01008059|101389241|FG004|COMPLETED|Grapefruit Juice Sequential Alfentanil||0||
48430194|NCT01008059|101389242|FG005|COMPLETED|Grapefruit Juice Sequential Alfentanil||0||
48430195|NCT01008059|101389243|FG006|COMPLETED|Grapefruit Juice Sequential Alfentanil||0||
48430196|NCT01008059|101389244|FG007|COMPLETED|Grapefruit Juice Sequential Alfentanil||0||
48430197|NCT01008059|101389237|FG000|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0||
48430198|NCT01008059|101389238|FG001|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0||
48430199|NCT01008059|101389239|FG002|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0||
48430200|NCT01008059|101389240|FG003|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0||
48430201|NCT01008059|101389241|FG004|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0||
48430202|NCT01008059|101389242|FG005|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0||
48430203|NCT01008059|101389243|FG006|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0||
48430204|NCT01008059|101389244|FG007|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0||
48430205|NCT01008059|101389237|FG000|STARTED|Ketoconazole Sequential Alfentanil||0||
48430206|NCT01008059|101389238|FG001|STARTED|Ketoconazole Sequential Alfentanil||0||
48430207|NCT01008059|101389239|FG002|STARTED|Ketoconazole Sequential Alfentanil||0||
48430208|NCT01008059|101389240|FG003|STARTED|Ketoconazole Sequential Alfentanil||6||
48430209|NCT01008059|101389241|FG004|STARTED|Ketoconazole Sequential Alfentanil||0||
48430210|NCT01008059|101389242|FG005|STARTED|Ketoconazole Sequential Alfentanil||0||
48430211|NCT01008059|101389243|FG006|STARTED|Ketoconazole Sequential Alfentanil||0||
48430212|NCT01008059|101389244|FG007|STARTED|Ketoconazole Sequential Alfentanil||0||
48430213|NCT01008059|101389237|FG000|COMPLETED|Ketoconazole Sequential Alfentanil||0||
48430214|NCT01008059|101389238|FG001|COMPLETED|Ketoconazole Sequential Alfentanil||0||
48430215|NCT01008059|101389239|FG002|COMPLETED|Ketoconazole Sequential Alfentanil||0||
48430216|NCT01008059|101389240|FG003|COMPLETED|Ketoconazole Sequential Alfentanil||6||
48430217|NCT01008059|101389241|FG004|COMPLETED|Ketoconazole Sequential Alfentanil||0||
48430218|NCT01008059|101389242|FG005|COMPLETED|Ketoconazole Sequential Alfentanil||0||
48430219|NCT01008059|101389243|FG006|COMPLETED|Ketoconazole Sequential Alfentanil||0||
48430220|NCT01008059|101389244|FG007|COMPLETED|Ketoconazole Sequential Alfentanil||0||
48430221|NCT01008059|101389237|FG000|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0||
48430222|NCT01008059|101389238|FG001|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0||
48430223|NCT01008059|101389239|FG002|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0||
48430224|NCT01008059|101389240|FG003|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0||
48430225|NCT01008059|101389241|FG004|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0||
48430226|NCT01008059|101389242|FG005|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0||
48430227|NCT01008059|101389243|FG006|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0||
48430228|NCT01008059|101389244|FG007|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0||
48430229|NCT01008059|101389237|FG000|STARTED|Control Simultaneous Alfentanil||0||
48430230|NCT01008059|101389238|FG001|STARTED|Control Simultaneous Alfentanil||0||
48430231|NCT01008059|101389239|FG002|STARTED|Control Simultaneous Alfentanil||0||
48430232|NCT01008059|101389240|FG003|STARTED|Control Simultaneous Alfentanil||0||
48430233|NCT01008059|101389241|FG004|STARTED|Control Simultaneous Alfentanil||6||
48430234|NCT01008059|101389242|FG005|STARTED|Control Simultaneous Alfentanil||0||
48430235|NCT01008059|101389243|FG006|STARTED|Control Simultaneous Alfentanil||0||
48430236|NCT01008059|101389244|FG007|STARTED|Control Simultaneous Alfentanil||0||
48430237|NCT01008059|101389237|FG000|COMPLETED|Control Simultaneous Alfentanil||0||
48430238|NCT01008059|101389238|FG001|COMPLETED|Control Simultaneous Alfentanil||0||
48430239|NCT01008059|101389239|FG002|COMPLETED|Control Simultaneous Alfentanil||0||
48430240|NCT01008059|101389240|FG003|COMPLETED|Control Simultaneous Alfentanil||0||
48430241|NCT01008059|101389241|FG004|COMPLETED|Control Simultaneous Alfentanil||6||
48430242|NCT01008059|101389242|FG005|COMPLETED|Control Simultaneous Alfentanil||0||
48430243|NCT01008059|101389243|FG006|COMPLETED|Control Simultaneous Alfentanil||0||
48430244|NCT01008059|101389244|FG007|COMPLETED|Control Simultaneous Alfentanil||0||
48430245|NCT01008059|101389237|FG000|NOT COMPLETED|Control Simultaneous Alfentanil||0||
48430246|NCT01008059|101389238|FG001|NOT COMPLETED|Control Simultaneous Alfentanil||0||
48430247|NCT01008059|101389239|FG002|NOT COMPLETED|Control Simultaneous Alfentanil||0||
48430248|NCT01008059|101389240|FG003|NOT COMPLETED|Control Simultaneous Alfentanil||0||
48430249|NCT01008059|101389241|FG004|NOT COMPLETED|Control Simultaneous Alfentanil||0||
48430250|NCT01008059|101389242|FG005|NOT COMPLETED|Control Simultaneous Alfentanil||0||
48430251|NCT01008059|101389243|FG006|NOT COMPLETED|Control Simultaneous Alfentanil||0||
48187473|NCT03738241|100780050|FG006|STARTED|Overall Study||20||
48430252|NCT01008059|101389244|FG007|NOT COMPLETED|Control Simultaneous Alfentanil||0||
48430253|NCT01008059|101389237|FG000|STARTED|Rifampin Simultaneous Alfentanil||0||
48430254|NCT01008059|101389238|FG001|STARTED|Rifampin Simultaneous Alfentanil||0||
48430255|NCT01008059|101389239|FG002|STARTED|Rifampin Simultaneous Alfentanil||0||
48430256|NCT01008059|101389240|FG003|STARTED|Rifampin Simultaneous Alfentanil||0||
48430257|NCT01008059|101389241|FG004|STARTED|Rifampin Simultaneous Alfentanil||0||
48430258|NCT01008059|101389242|FG005|STARTED|Rifampin Simultaneous Alfentanil||6||
48187474|NCT03738241|100780051|FG007|STARTED|Overall Study||16||
48187475|NCT03738241|100780052|FG008|STARTED|Overall Study||29||
48187476|NCT03738241|100780053|FG009|STARTED|Overall Study||35||
48187477|NCT03738241|100780044|FG000|COMPLETED|Overall Study||37||
48187478|NCT03738241|100780045|FG001|COMPLETED|Overall Study||40||
48187479|NCT03738241|100780046|FG002|COMPLETED|Overall Study||24||
48187480|NCT03738241|100780047|FG003|COMPLETED|Overall Study||18||
48187481|NCT03738241|100780048|FG004|COMPLETED|Overall Study||40||
48187482|NCT03738241|100780049|FG005|COMPLETED|Overall Study||44||
48187483|NCT03738241|100780050|FG006|COMPLETED|Overall Study||20||
48187484|NCT03738241|100780051|FG007|COMPLETED|Overall Study||16||
48187485|NCT03738241|100780052|FG008|COMPLETED|Overall Study||28||
48187486|NCT03738241|100780053|FG009|COMPLETED|Overall Study||34||
48187487|NCT03738241|100780044|FG000|NOT COMPLETED|Overall Study||1||
48187488|NCT03738241|100780045|FG001|NOT COMPLETED|Overall Study||0||
48187489|NCT03738241|100780046|FG002|NOT COMPLETED|Overall Study||0||
48187490|NCT03738241|100780047|FG003|NOT COMPLETED|Overall Study||0||
48187491|NCT03738241|100780048|FG004|NOT COMPLETED|Overall Study||0||
48187492|NCT03738241|100780049|FG005|NOT COMPLETED|Overall Study||0||
48187493|NCT03738241|100780050|FG006|NOT COMPLETED|Overall Study||0||
48187494|NCT03738241|100780051|FG007|NOT COMPLETED|Overall Study||0||
48187495|NCT03738241|100780052|FG008|NOT COMPLETED|Overall Study||1||
48187496|NCT03738241|100780053|FG009|NOT COMPLETED|Overall Study||1||
48187497|NCT00412867|100780054|FG000|STARTED|Overall Study||58||
48187498|NCT00412867|100780054|FG000|COMPLETED|Overall Study||58||
48187499|NCT00412867|100780054|FG000|NOT COMPLETED|Overall Study||0||
48187500|NCT00057811|100780055|FG000|STARTED|Overall Study||51||
48187501|NCT00057811|100780056|FG001|STARTED|Overall Study||46||
48187502|NCT00057811|100780055|FG000|COMPLETED|Overall Study||41||
48187503|NCT00057811|100780056|FG001|COMPLETED|Overall Study||34||
48187504|NCT00057811|100780055|FG000|NOT COMPLETED|Overall Study||10||
48187505|NCT00057811|100780056|FG001|NOT COMPLETED|Overall Study||12||
48187506|NCT04183192|100780057|FG000|STARTED|Overall Study||8||
48187507|NCT04183192|100780058|FG001|STARTED|Overall Study||8||
48187508|NCT04183192|100780059|FG002|STARTED|Overall Study||8||
48187509|NCT04183192|100780060|FG003|STARTED|Overall Study||8||
48187510|NCT04183192|100780061|FG004|STARTED|Overall Study||8||
48187511|NCT04183192|100780062|FG005|STARTED|Overall Study||8||
48187512|NCT04183192|100780063|FG006|STARTED|Overall Study||8||
48187513|NCT04183192|100780064|FG007|STARTED|Overall Study||8||
48187514|NCT04183192|100780065|FG008|STARTED|Overall Study||8||
48187515|NCT04183192|100780057|FG000|COMPLETED|Overall Study||7||
48187516|NCT04183192|100780058|FG001|COMPLETED|Overall Study||8||
48187517|NCT04183192|100780059|FG002|COMPLETED|Overall Study||7||
48187518|NCT04183192|100780060|FG003|COMPLETED|Overall Study||8||
48187519|NCT04183192|100780061|FG004|COMPLETED|Overall Study||8||
48187520|NCT04183192|100780062|FG005|COMPLETED|Overall Study||8||
48187521|NCT04183192|100780063|FG006|COMPLETED|Overall Study||8||
48187522|NCT04183192|100780064|FG007|COMPLETED|Overall Study||8||
48187523|NCT04183192|100780065|FG008|COMPLETED|Overall Study||8||
48187524|NCT04183192|100780057|FG000|NOT COMPLETED|Overall Study||1||
48187525|NCT04183192|100780058|FG001|NOT COMPLETED|Overall Study||0||
48187526|NCT04183192|100780059|FG002|NOT COMPLETED|Overall Study||1||
48187527|NCT04183192|100780060|FG003|NOT COMPLETED|Overall Study||0||
48187528|NCT04183192|100780061|FG004|NOT COMPLETED|Overall Study||0||
48187529|NCT04183192|100780062|FG005|NOT COMPLETED|Overall Study||0||
48187530|NCT04183192|100780063|FG006|NOT COMPLETED|Overall Study||0||
48187531|NCT04183192|100780064|FG007|NOT COMPLETED|Overall Study||0||
48187532|NCT04183192|100780065|FG008|NOT COMPLETED|Overall Study||0||
48187533|NCT03860077|100780066|FG000|STARTED|Overall Study||25||
48360581|NCT00312377|101210920|FG001|COMPLETED|Overall Study||29||
48187534|NCT03860077|100780067|FG001|STARTED|Overall Study||24||
48187535|NCT03860077|100780066|FG000|COMPLETED|Overall Study||21||
48187536|NCT03860077|100780067|FG001|COMPLETED|Overall Study||17||
48187537|NCT03860077|100780066|FG000|NOT COMPLETED|Overall Study||4||
48187538|NCT03860077|100780067|FG001|NOT COMPLETED|Overall Study||7||
48187539|NCT03369951|100780068|FG000|STARTED|Overall Study||58||
48187540|NCT03369951|100780068|FG000|Received Study Drug|Overall Study||57||
48187541|NCT03369951|100780068|FG000|COMPLETED|Overall Study||52||
48187542|NCT03369951|100780068|FG000|NOT COMPLETED|Overall Study||6||
48187543|NCT01438229|100780069|FG000|STARTED|Overall Study||47||
48187544|NCT01438229|100780069|FG000|Excluded Due to Renal Artery Anatomy|Overall Study||1||
48187545|NCT01438229|100780069|FG000|Underwent Procedure|Overall Study||46||
48187546|NCT01438229|100780069|FG000|COMPLETED|Overall Study||44||
48187547|NCT01438229|100780069|FG000|NOT COMPLETED|Overall Study||3||
48187548|NCT00114959|100780070|FG000|STARTED|Overall Study||15||
48430259|NCT01008059|101389243|FG006|STARTED|Rifampin Simultaneous Alfentanil||0||
48430260|NCT01008059|101389244|FG007|STARTED|Rifampin Simultaneous Alfentanil||0||
48430261|NCT01008059|101389237|FG000|COMPLETED|Rifampin Simultaneous Alfentanil||0||
48430262|NCT01008059|101389238|FG001|COMPLETED|Rifampin Simultaneous Alfentanil||0||
48430263|NCT01008059|101389239|FG002|COMPLETED|Rifampin Simultaneous Alfentanil||0||
48430264|NCT01008059|101389240|FG003|COMPLETED|Rifampin Simultaneous Alfentanil||0||
48430265|NCT01008059|101389241|FG004|COMPLETED|Rifampin Simultaneous Alfentanil||0||
48430266|NCT01008059|101389242|FG005|COMPLETED|Rifampin Simultaneous Alfentanil||6||
48430267|NCT01008059|101389243|FG006|COMPLETED|Rifampin Simultaneous Alfentanil||0||
48430268|NCT01008059|101389244|FG007|COMPLETED|Rifampin Simultaneous Alfentanil||0||
48430269|NCT01008059|101389237|FG000|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0||
48430270|NCT01008059|101389238|FG001|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0||
48430271|NCT01008059|101389239|FG002|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0||
48430272|NCT01008059|101389240|FG003|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0||
48430273|NCT01008059|101389241|FG004|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0||
48430274|NCT01008059|101389242|FG005|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0||
48430275|NCT01008059|101389243|FG006|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0||
48430276|NCT01008059|101389244|FG007|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0||
48430277|NCT01008059|101389237|FG000|STARTED|Grapefruit Juice Simultaneous Alfentanil||0||
48430278|NCT01008059|101389238|FG001|STARTED|Grapefruit Juice Simultaneous Alfentanil||0||
48430279|NCT01008059|101389239|FG002|STARTED|Grapefruit Juice Simultaneous Alfentanil||0||
48430280|NCT01008059|101389240|FG003|STARTED|Grapefruit Juice Simultaneous Alfentanil||0||
48430281|NCT01008059|101389241|FG004|STARTED|Grapefruit Juice Simultaneous Alfentanil||0||
48430282|NCT01008059|101389242|FG005|STARTED|Grapefruit Juice Simultaneous Alfentanil||0||
48430283|NCT01008059|101389243|FG006|STARTED|Grapefruit Juice Simultaneous Alfentanil||6||
48430284|NCT01008059|101389244|FG007|STARTED|Grapefruit Juice Simultaneous Alfentanil||0||
48430285|NCT01008059|101389237|FG000|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0||
48430286|NCT01008059|101389238|FG001|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0||
48430287|NCT01008059|101389239|FG002|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0||
48430288|NCT01008059|101389240|FG003|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0||
48430289|NCT01008059|101389241|FG004|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0||
48430290|NCT01008059|101389242|FG005|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0||
48430291|NCT01008059|101389243|FG006|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||6||
48430292|NCT01008059|101389244|FG007|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0||
48430293|NCT01008059|101389237|FG000|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0||
48430294|NCT01008059|101389238|FG001|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0||
48430295|NCT01008059|101389239|FG002|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0||
48430296|NCT01008059|101389240|FG003|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0||
48430297|NCT01008059|101389241|FG004|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0||
48430298|NCT01008059|101389242|FG005|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0||
48430299|NCT01008059|101389243|FG006|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0||
48430300|NCT01008059|101389244|FG007|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0||
48430301|NCT01008059|101389237|FG000|STARTED|Ketoconazole Simultaneous Alfentanil||0||
48430302|NCT01008059|101389238|FG001|STARTED|Ketoconazole Simultaneous Alfentanil||0||
48430303|NCT01008059|101389239|FG002|STARTED|Ketoconazole Simultaneous Alfentanil||0||
48430304|NCT01008059|101389240|FG003|STARTED|Ketoconazole Simultaneous Alfentanil||0||
48430305|NCT01008059|101389241|FG004|STARTED|Ketoconazole Simultaneous Alfentanil||0||
48430306|NCT01008059|101389242|FG005|STARTED|Ketoconazole Simultaneous Alfentanil||0||
48430307|NCT01008059|101389243|FG006|STARTED|Ketoconazole Simultaneous Alfentanil||0||
48430308|NCT01008059|101389244|FG007|STARTED|Ketoconazole Simultaneous Alfentanil||6||
48430309|NCT01008059|101389237|FG000|COMPLETED|Ketoconazole Simultaneous Alfentanil||0||
48638988|NCT03585543|101901545|FG000|COMPLETED|Overall Study||15||
48638989|NCT03585543|101901545|FG000|NOT COMPLETED|Overall Study||15||
48638990|NCT02714153|101901546|FG000|STARTED|Overall Study||23||
48638991|NCT02714153|101901546|FG000|COMPLETED|Overall Study||22||
48638992|NCT02714153|101901546|FG000|NOT COMPLETED|Overall Study||1||
48638993|NCT01022580|101901547|FG000|STARTED|Overall Study||252||
48430310|NCT01008059|101389238|FG001|COMPLETED|Ketoconazole Simultaneous Alfentanil||0||
48430311|NCT01008059|101389239|FG002|COMPLETED|Ketoconazole Simultaneous Alfentanil||0||
48430312|NCT01008059|101389240|FG003|COMPLETED|Ketoconazole Simultaneous Alfentanil||0||
48430313|NCT01008059|101389241|FG004|COMPLETED|Ketoconazole Simultaneous Alfentanil||0||
48430314|NCT01008059|101389242|FG005|COMPLETED|Ketoconazole Simultaneous Alfentanil||0||
48430315|NCT01008059|101389243|FG006|COMPLETED|Ketoconazole Simultaneous Alfentanil||0||
48430316|NCT01008059|101389244|FG007|COMPLETED|Ketoconazole Simultaneous Alfentanil||6||
48430317|NCT01008059|101389237|FG000|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0||
48430318|NCT01008059|101389238|FG001|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0||
48430319|NCT01008059|101389239|FG002|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0||
48638994|NCT01022580|101901548|FG001|STARTED|Overall Study||259||
48638995|NCT01022580|101901547|FG000|COMPLETED|Overall Study||234||
48764194|NCT00003475|102211903|FG000|NOT COMPLETED|Overall Study||13||
48638996|NCT01022580|101901548|FG001|COMPLETED|Overall Study||237||
48430320|NCT01008059|101389240|FG003|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0||
48430321|NCT01008059|101389241|FG004|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0||
48430322|NCT01008059|101389242|FG005|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0||
48430323|NCT01008059|101389243|FG006|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0||
48430324|NCT01008059|101389244|FG007|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0||
48430325|NCT03044691|101389245|FG000|STARTED|Overall Study||0||
48430326|NCT03044691|101389246|FG001|STARTED|Overall Study||84||
48430327|NCT03044691|101389245|FG000|COMPLETED|Overall Study||0||
48430328|NCT03044691|101389246|FG001|COMPLETED|Overall Study||84||
48430329|NCT03044691|101389245|FG000|NOT COMPLETED|Overall Study||0||
48430330|NCT03044691|101389246|FG001|NOT COMPLETED|Overall Study||0||
48430331|NCT01605370|101389247|FG000|STARTED|Overall Study||1||
48430332|NCT01605370|101389248|FG001|STARTED|Overall Study||0||
48430333|NCT01605370|101389247|FG000|COMPLETED|Overall Study||0||
48430334|NCT01605370|101389248|FG001|COMPLETED|Overall Study||0||
48430335|NCT01605370|101389247|FG000|NOT COMPLETED|Overall Study||1||
48430336|NCT01605370|101389248|FG001|NOT COMPLETED|Overall Study||0||
48430337|NCT02185131|101389249|FG000|STARTED|Overall Study||7||
48430338|NCT02185131|101389250|FG001|STARTED|Overall Study||9||
48430339|NCT02185131|101389249|FG000|COMPLETED|Overall Study||6||
48430340|NCT02185131|101389250|FG001|COMPLETED|Overall Study||8||
48430341|NCT02185131|101389249|FG000|NOT COMPLETED|Overall Study||1||
48430342|NCT02185131|101389250|FG001|NOT COMPLETED|Overall Study||1||
48430343|NCT00598442|101389251|FG000|STARTED|Overall Study||167||
48430344|NCT00598442|101389252|FG001|STARTED|Overall Study||163||
48430345|NCT00598442|101389253|FG002|STARTED|Overall Study||163||
48187549|NCT00114959|100780070|FG000|COMPLETED|Overall Study||7||
48187550|NCT00114959|100780070|FG000|NOT COMPLETED|Overall Study||8||
48187551|NCT00409240|100780071|FG000|STARTED|Overall Study||53||
48187552|NCT00409240|100780072|FG001|STARTED|Overall Study||50||
48187553|NCT00409240|100780071|FG000|COMPLETED|Overall Study||50||
48187554|NCT00409240|100780072|FG001|COMPLETED|Overall Study||49||
48187555|NCT00409240|100780071|FG000|NOT COMPLETED|Overall Study||3||
48187556|NCT00409240|100780072|FG001|NOT COMPLETED|Overall Study||1||
48187557|NCT01559090|100780073|FG000|STARTED|Stage I||6||
48360582|NCT00312377|101210919|FG000|NOT COMPLETED|Overall Study||644||
48360583|NCT00312377|101210920|FG001|NOT COMPLETED|Overall Study||668||
48360584|NCT05105243|101210921|FG000|STARTED|SAD Cohort 1: 5 mg (14 Days)||6||
48360585|NCT05105243|101210922|FG001|STARTED|SAD Cohort 1: 5 mg (14 Days)||0||
48360586|NCT05105243|101210923|FG002|STARTED|SAD Cohort 1: 5 mg (14 Days)||0||
48360587|NCT05105243|101210924|FG003|STARTED|SAD Cohort 1: 5 mg (14 Days)||0||
48360588|NCT05105243|101210925|FG004|STARTED|SAD Cohort 1: 5 mg (14 Days)||0||
48360589|NCT05105243|101210926|FG005|STARTED|SAD Cohort 1: 5 mg (14 Days)||2||
48360590|NCT05105243|101210927|FG006|STARTED|SAD Cohort 1: 5 mg (14 Days)||0||
48360591|NCT05105243|101210928|FG007|STARTED|SAD Cohort 1: 5 mg (14 Days)||0||
48360592|NCT05105243|101210929|FG008|STARTED|SAD Cohort 1: 5 mg (14 Days)||0||
48360593|NCT05105243|101210930|FG009|STARTED|SAD Cohort 1: 5 mg (14 Days)||0||
48360594|NCT05105243|101210921|FG000|COMPLETED|SAD Cohort 1: 5 mg (14 Days)||6||
48360595|NCT05105243|101210922|FG001|COMPLETED|SAD Cohort 1: 5 mg (14 Days)||0||
48360596|NCT05105243|101210923|FG002|COMPLETED|SAD Cohort 1: 5 mg (14 Days)||0||
48360597|NCT05105243|101210924|FG003|COMPLETED|SAD Cohort 1: 5 mg (14 Days)||0||
48360598|NCT05105243|101210925|FG004|COMPLETED|SAD Cohort 1: 5 mg (14 Days)||0||
48360599|NCT05105243|101210926|FG005|COMPLETED|SAD Cohort 1: 5 mg (14 Days)||2||
48360600|NCT05105243|101210927|FG006|COMPLETED|SAD Cohort 1: 5 mg (14 Days)||0||
48360601|NCT05105243|101210928|FG007|COMPLETED|SAD Cohort 1: 5 mg (14 Days)||0||
48360602|NCT05105243|101210929|FG008|COMPLETED|SAD Cohort 1: 5 mg (14 Days)||0||
48360603|NCT05105243|101210930|FG009|COMPLETED|SAD Cohort 1: 5 mg (14 Days)||0||
48360604|NCT05105243|101210921|FG000|NOT COMPLETED|SAD Cohort 1: 5 mg (14 Days)||0||
48360605|NCT05105243|101210922|FG001|NOT COMPLETED|SAD Cohort 1: 5 mg (14 Days)||0||
48360606|NCT05105243|101210923|FG002|NOT COMPLETED|SAD Cohort 1: 5 mg (14 Days)||0||
48360607|NCT05105243|101210924|FG003|NOT COMPLETED|SAD Cohort 1: 5 mg (14 Days)||0||
48360608|NCT05105243|101210925|FG004|NOT COMPLETED|SAD Cohort 1: 5 mg (14 Days)||0||
48360609|NCT05105243|101210926|FG005|NOT COMPLETED|SAD Cohort 1: 5 mg (14 Days)||0||
48360610|NCT05105243|101210927|FG006|NOT COMPLETED|SAD Cohort 1: 5 mg (14 Days)||0||
48360611|NCT05105243|101210928|FG007|NOT COMPLETED|SAD Cohort 1: 5 mg (14 Days)||0||
48360612|NCT05105243|101210929|FG008|NOT COMPLETED|SAD Cohort 1: 5 mg (14 Days)||0||
48360613|NCT05105243|101210930|FG009|NOT COMPLETED|SAD Cohort 1: 5 mg (14 Days)||0||
48360614|NCT05105243|101210921|FG000|STARTED|SAD Cohort 2: 15 mg (14 Days)||0||
48360615|NCT05105243|101210922|FG001|STARTED|SAD Cohort 2: 15 mg (14 Days)||6||
48430346|NCT00598442|101389251|FG000|COMPLETED|Overall Study||124||
48430347|NCT00598442|101389252|FG001|COMPLETED|Overall Study||124||
48430348|NCT00598442|101389253|FG002|COMPLETED|Overall Study||139||
48430349|NCT00598442|101389251|FG000|NOT COMPLETED|Overall Study||43||
48430350|NCT00598442|101389252|FG001|NOT COMPLETED|Overall Study||39||
48430351|NCT00598442|101389253|FG002|NOT COMPLETED|Overall Study||24||
48430352|NCT02764229|101389254|FG000|STARTED|Overall Study||112||
48430353|NCT02764229|101389254|FG000|COMPLETED|Overall Study||10||
48430354|NCT02764229|101389254|FG000|NOT COMPLETED|Overall Study||102||
48187558|NCT01559090|100780074|FG001|STARTED|Stage I||5||
48430355|NCT00253747|101389255|FG000|STARTED|Overall Study||127||
48430356|NCT00253747|101389256|FG001|STARTED|Overall Study||128||
48430357|NCT00253747|101389255|FG000|COMPLETED|Overall Study||103||
48430358|NCT00253747|101389256|FG001|COMPLETED|Overall Study||101||
48430359|NCT00253747|101389255|FG000|NOT COMPLETED|Overall Study||24||
48430360|NCT00253747|101389256|FG001|NOT COMPLETED|Overall Study||27||
48430361|NCT02743117|101389257|FG000|STARTED|Overall Study||60||
48430362|NCT02743117|101389258|FG001|STARTED|Overall Study||241||
48430363|NCT02743117|101389257|FG000|Treated|Overall Study||59||
48430364|NCT02743117|101389258|FG001|Treated|Overall Study||241||
48430365|NCT02743117|101389257|FG000|COMPLETED|Overall Study||59||
48430366|NCT02743117|101389258|FG001|COMPLETED|Overall Study||240||
48430367|NCT02743117|101389257|FG000|NOT COMPLETED|Overall Study||1||
48430368|NCT02743117|101389258|FG001|NOT COMPLETED|Overall Study||1||
48430369|NCT01465958|101389259|FG000|STARTED|Run-in Phase||11||
48430370|NCT01465958|101389260|FG001|STARTED|Run-in Phase||0||
48430371|NCT01465958|101389259|FG000|COMPLETED|Run-in Phase||10||
48430372|NCT01465958|101389260|FG001|COMPLETED|Run-in Phase||0||
48430373|NCT01465958|101389259|FG000|NOT COMPLETED|Run-in Phase||1||
48430374|NCT01465958|101389260|FG001|NOT COMPLETED|Run-in Phase||0||
48430375|NCT01465958|101389259|FG000|STARTED|Intravenous (IV) Phase||11||
48430376|NCT01465958|101389260|FG001|STARTED|Intravenous (IV) Phase||0||
48430377|NCT01465958|101389259|FG000|COMPLETED|Intravenous (IV) Phase||11||
48430378|NCT01465958|101389260|FG001|COMPLETED|Intravenous (IV) Phase||0||
48430379|NCT01465958|101389259|FG000|NOT COMPLETED|Intravenous (IV) Phase||0||
48430380|NCT01465958|101389260|FG001|NOT COMPLETED|Intravenous (IV) Phase||0||
48430381|NCT01465958|101389259|FG000|STARTED|Subcutaneous (SC) Phase||0||
48430382|NCT01465958|101389260|FG001|STARTED|Subcutaneous (SC) Phase||11||
48430383|NCT01465958|101389259|FG000|COMPLETED|Subcutaneous (SC) Phase||0||
48430384|NCT01465958|101389260|FG001|COMPLETED|Subcutaneous (SC) Phase||10||
48430385|NCT01465958|101389259|FG000|NOT COMPLETED|Subcutaneous (SC) Phase||0||
48430386|NCT01465958|101389260|FG001|NOT COMPLETED|Subcutaneous (SC) Phase||1||
48430387|NCT00535262|101389261|FG000|STARTED|Overall Study||3||
48430388|NCT00535262|101389261|FG000|COMPLETED|Overall Study||0||
48430389|NCT00535262|101389261|FG000|NOT COMPLETED|Overall Study||3||
48430390|NCT03710824|101389262|FG000|STARTED|Overall Study||180||
48430391|NCT03710824|101389262|FG000|COMPLETED|Overall Study||149||
48430392|NCT03710824|101389262|FG000|NOT COMPLETED|Overall Study||31||
48430393|NCT00594958|101389263|FG000|STARTED|Overall Study||214||
48430394|NCT00594958|101389264|FG001|STARTED|Overall Study||213||
48430395|NCT00594958|101389265|FG002|STARTED|Overall Study||212||
48430396|NCT00594958|101389263|FG000|Randomized and at Least 1 Vaccination|Overall Study||212||
48430397|NCT00594958|101389264|FG001|Randomized and at Least 1 Vaccination|Overall Study||213||
48430398|NCT00594958|101389265|FG002|Randomized and at Least 1 Vaccination|Overall Study||211||
48430399|NCT00594958|101389263|FG000|COMPLETED|Overall Study||200||
48430400|NCT00594958|101389264|FG001|COMPLETED|Overall Study||210||
48430401|NCT00594958|101389265|FG002|COMPLETED|Overall Study||202||
48430402|NCT00594958|101389263|FG000|NOT COMPLETED|Overall Study||14||
48430403|NCT00594958|101389264|FG001|NOT COMPLETED|Overall Study||3||
48430404|NCT00594958|101389265|FG002|NOT COMPLETED|Overall Study||10||
48430405|NCT00914940|101389266|FG000|STARTED|D0 to D100 Post-transplant||41||
48430406|NCT00914940|101389266|FG000|COMPLETED|D0 to D100 Post-transplant||39||
48430407|NCT00914940|101389266|FG000|NOT COMPLETED|D0 to D100 Post-transplant||2||
48430408|NCT00914940|101389266|FG000|STARTED|D101 to 2 Years Post-transplant||39||
48430409|NCT00914940|101389266|FG000|COMPLETED|D101 to 2 Years Post-transplant||31||
48430410|NCT00914940|101389266|FG000|NOT COMPLETED|D101 to 2 Years Post-transplant||8||
48430411|NCT00914940|101389266|FG000|STARTED|2 Years to 5 Years Post-transplant||31||
48430412|NCT00914940|101389266|FG000|COMPLETED|2 Years to 5 Years Post-transplant||28||
48430413|NCT00914940|101389266|FG000|NOT COMPLETED|2 Years to 5 Years Post-transplant||3||
48430414|NCT00752895|101389267|FG000|STARTED|Overall Study||147||
48430415|NCT00752895|101389268|FG001|STARTED|Overall Study||146||
48430416|NCT00752895|101389267|FG000|COMPLETED|Overall Study||139||
48430417|NCT00752895|101389268|FG001|COMPLETED|Overall Study||143||
48430418|NCT00752895|101389267|FG000|NOT COMPLETED|Overall Study||8||
48430419|NCT00752895|101389268|FG001|NOT COMPLETED|Overall Study||3||
48430420|NCT03509766|101389269|FG000|STARTED|Overall Study||24||
48430421|NCT03509766|101389269|FG000|COMPLETED|Overall Study||24||
48430422|NCT03509766|101389269|FG000|NOT COMPLETED|Overall Study||0||
48430423|NCT01409382|101389270|FG000|STARTED|Overall Study||240||
48430424|NCT01409382|101389271|FG001|STARTED|Overall Study||240||
48638997|NCT01022580|101901547|FG000|NOT COMPLETED|Overall Study||18||
48430425|NCT01409382|101389270|FG000|COMPLETED|Overall Study||159||
48430426|NCT01409382|101389271|FG001|COMPLETED|Overall Study||160||
48430427|NCT01409382|101389270|FG000|NOT COMPLETED|Overall Study||81||
48430428|NCT01409382|101389271|FG001|NOT COMPLETED|Overall Study||80||
48430429|NCT00953576|101389272|FG000|STARTED|Overall Study||6||
48430430|NCT00953576|101389273|FG001|STARTED|Overall Study||5||
48430431|NCT00953576|101389272|FG000|DLT Evaluable|Overall Study||3|Participants were DLT evaluable if they received 1 cycle of KHLAD and full dose ketoconazole (KHAD).|
48430432|NCT00953576|101389273|FG001|DLT Evaluable|Overall Study||5|Participants were DLT evaluable if they received 1 cycle of KHLAD and full dose ketoconazole (KHAD).|
48430433|NCT00953576|101389272|FG000|Treated|Overall Study||4||
48430434|NCT00953576|101389273|FG001|Treated|Overall Study||5||
48430435|NCT00953576|101389272|FG000|Pharmacokinetic (PK) Evaluable|Overall Study||4|Participants with pre- and post KHLAD day 28 samples.|
48430436|NCT00953576|101389273|FG001|Pharmacokinetic (PK) Evaluable|Overall Study||3|Participants with pre- and post KHLAD day 28 samples.|
48430437|NCT00953576|101389272|FG000|COMPLETED|Overall Study||4||
48430438|NCT00953576|101389273|FG001|COMPLETED|Overall Study||4||
48430439|NCT00953576|101389272|FG000|NOT COMPLETED|Overall Study||2||
48430440|NCT00953576|101389273|FG001|NOT COMPLETED|Overall Study||1||
48430441|NCT01459016|101389274|FG000|STARTED|Overall Study||56||
48430442|NCT01459016|101389274|FG000|COMPLETED|Overall Study||41||
48430443|NCT01459016|101389274|FG000|NOT COMPLETED|Overall Study||15||
48430444|NCT04145531|101389275|FG000|STARTED|Part A||33||
48430445|NCT04145531|101389276|FG001|STARTED|Part A||83||
48430446|NCT04145531|101389277|FG002|STARTED|Part A||51||
48430447|NCT04145531|101389278|FG003|STARTED|Part A||0||
48430448|NCT04145531|101389275|FG000|Safety Analysis Set|Part A||33||
48430449|NCT04145531|101389276|FG001|Safety Analysis Set|Part A||83||
48430450|NCT04145531|101389277|FG002|Safety Analysis Set|Part A||51||
48430451|NCT04145531|101389278|FG003|Safety Analysis Set|Part A||0||
48430452|NCT04145531|101389275|FG000|Efficacy Analysis Set|Part A||32||
48430453|NCT04145531|101389276|FG001|Efficacy Analysis Set|Part A||83||
48430454|NCT04145531|101389277|FG002|Efficacy Analysis Set|Part A||50||
48430455|NCT04145531|101389278|FG003|Efficacy Analysis Set|Part A||0||
48430456|NCT04145531|101389275|FG000|COMPLETED|Part A||27||
48430457|NCT04145531|101389276|FG001|COMPLETED|Part A||62||
48430458|NCT04145531|101389277|FG002|COMPLETED|Part A||39||
48430459|NCT04145531|101389278|FG003|COMPLETED|Part A||0||
48430460|NCT04145531|101389275|FG000|NOT COMPLETED|Part A||6||
48430461|NCT04145531|101389276|FG001|NOT COMPLETED|Part A||21||
48430462|NCT04145531|101389277|FG002|NOT COMPLETED|Part A||12||
48430463|NCT04145531|101389278|FG003|NOT COMPLETED|Part A||0||
48430464|NCT04145531|101389275|FG000|STARTED|Part B||0||
48430465|NCT04145531|101389276|FG001|STARTED|Part B||0||
48430466|NCT04145531|101389277|FG002|STARTED|Part B||0||
48430467|NCT04145531|101389278|FG003|STARTED|Part B||62||
48430468|NCT04145531|101389275|FG000|Safety Analysis Set|Part B||0||
48430469|NCT04145531|101389276|FG001|Safety Analysis Set|Part B||0||
48430470|NCT04145531|101389277|FG002|Safety Analysis Set|Part B||0||
48430471|NCT04145531|101389278|FG003|Safety Analysis Set|Part B||61||
48430472|NCT04145531|101389275|FG000|Efficacy Analysis Set|Part B||0||
48430473|NCT04145531|101389276|FG001|Efficacy Analysis Set|Part B||0||
48430474|NCT04145531|101389277|FG002|Efficacy Analysis Set|Part B||0||
48430475|NCT04145531|101389278|FG003|Efficacy Analysis Set|Part B||59||
48430476|NCT04145531|101389275|FG000|COMPLETED|Part B||0||
48430477|NCT04145531|101389276|FG001|COMPLETED|Part B||0||
48430478|NCT04145531|101389277|FG002|COMPLETED|Part B||0||
48430479|NCT04145531|101389278|FG003|COMPLETED|Part B||27||
48430480|NCT04145531|101389275|FG000|NOT COMPLETED|Part B||0||
48430481|NCT04145531|101389276|FG001|NOT COMPLETED|Part B||0||
48430482|NCT04145531|101389277|FG002|NOT COMPLETED|Part B||0||
48430483|NCT04145531|101389278|FG003|NOT COMPLETED|Part B||35||
48430484|NCT04221373|101389279|FG000|STARTED|Overall Study||20||
48430485|NCT04221373|101389280|FG001|STARTED|Overall Study||12||
48430486|NCT04221373|101389279|FG000|COMPLETED|Overall Study||16||
48430487|NCT04221373|101389280|FG001|COMPLETED|Overall Study||12||
48430488|NCT04221373|101389279|FG000|NOT COMPLETED|Overall Study||4||
48430489|NCT04221373|101389280|FG001|NOT COMPLETED|Overall Study||0||
48430490|NCT02477319|101389281|FG000|STARTED|Overall Study||55||
48430491|NCT02477319|101389282|FG001|STARTED|Overall Study||40||
48430492|NCT02477319|101389283|FG002|STARTED|Overall Study||164||
48430493|NCT02477319|101389284|FG003|STARTED|Overall Study||193||
48430494|NCT02477319|101389281|FG000|COMPLETED|Overall Study||55||
48430495|NCT02477319|101389282|FG001|COMPLETED|Overall Study||37||
48430496|NCT02477319|101389283|FG002|COMPLETED|Overall Study||149||
48430497|NCT02477319|101389284|FG003|COMPLETED|Overall Study||171||
48430498|NCT02477319|101389281|FG000|NOT COMPLETED|Overall Study||0||
48430499|NCT02477319|101389282|FG001|NOT COMPLETED|Overall Study||3||
48430500|NCT02477319|101389283|FG002|NOT COMPLETED|Overall Study||15||
48430501|NCT02477319|101389284|FG003|NOT COMPLETED|Overall Study||22||
48430502|NCT01545375|101389285|FG000|STARTED|Overall Study||900||
48430503|NCT01545375|101389286|FG001|STARTED|Overall Study||903||
48430504|NCT01545375|101389285|FG000|COMPLETED|Overall Study||803||
48430505|NCT01545375|101389286|FG001|COMPLETED|Overall Study||813||
48430506|NCT01545375|101389285|FG000|NOT COMPLETED|Overall Study||97||
48430507|NCT01545375|101389286|FG001|NOT COMPLETED|Overall Study||90||
48430508|NCT04822701|101389287|FG000|STARTED|Overall Study||4||
48430509|NCT04822701|101389288|FG001|STARTED|Overall Study||1||
48430510|NCT04822701|101389287|FG000|Treated|Overall Study||2||
48430511|NCT04822701|101389288|FG001|Treated|Overall Study||1||
48430512|NCT04822701|101389287|FG000|COMPLETED|Overall Study||0|Completed planned observation time|
48430513|NCT04822701|101389288|FG001|COMPLETED|Overall Study||1|Completed planned observation time|
48430514|NCT04822701|101389287|FG000|NOT COMPLETED|Overall Study||4||
48430515|NCT04822701|101389288|FG001|NOT COMPLETED|Overall Study||0||
48430516|NCT02992743|101389289|FG000|STARTED|Overall Study||13||
48430517|NCT02992743|101389290|FG001|STARTED|Overall Study||10||
48430518|NCT02992743|101389289|FG000|Received T-cell Infusion|Overall Study||10||
48430519|NCT02992743|101389290|FG001|Received T-cell Infusion|Overall Study||10||
48430520|NCT02992743|101389289|FG000|COMPLETED|Overall Study||9|Participants who received T-cell infusion and were followed up in this study until death, 15 years post infusion or until transfer to the separate long term follow-up study are considered to have completed.|
48430521|NCT02992743|101389290|FG001|COMPLETED|Overall Study||8|Participants who received T-cell infusion and were followed up in this study until death, 15 years post infusion or until transfer to the separate long term follow-up study are considered to have completed.|
48430522|NCT02992743|101389289|FG000|NOT COMPLETED|Overall Study||4||
48430523|NCT02992743|101389290|FG001|NOT COMPLETED|Overall Study||2||
48430524|NCT03997383|101389291|FG000|STARTED|Double-blind Treatment Period||179||
48430525|NCT03997383|101389292|FG001|STARTED|Double-blind Treatment Period||181||
48430526|NCT03997383|101389291|FG000|Treated|Double-blind Treatment Period||178||
48430527|NCT03997383|101389292|FG001|Treated|Double-blind Treatment Period||181||
48430528|NCT03997383|101389291|FG000|COMPLETED|Double-blind Treatment Period||166||
48430529|NCT03997383|101389292|FG001|COMPLETED|Double-blind Treatment Period||168||
48430530|NCT03997383|101389291|FG000|NOT COMPLETED|Double-blind Treatment Period||13||
48430531|NCT03997383|101389292|FG001|NOT COMPLETED|Double-blind Treatment Period||13||
48430532|NCT03997383|101389291|FG000|STARTED|Open-label Extension Period||166||
48430533|NCT03997383|101389292|FG001|STARTED|Open-label Extension Period||168||
48430534|NCT03997383|101389291|FG000|COMPLETED|Open-label Extension Period||0||
48430535|NCT03997383|101389292|FG001|COMPLETED|Open-label Extension Period||0||
48430536|NCT03997383|101389291|FG000|NOT COMPLETED|Open-label Extension Period||166||
48430537|NCT03997383|101389292|FG001|NOT COMPLETED|Open-label Extension Period||168||
48430538|NCT02501642|101389293|FG000|STARTED|Overall Study||238||
48430539|NCT02501642|101389294|FG001|STARTED|Overall Study||241||
48430540|NCT02501642|101389293|FG000|COMPLETED|Overall Study||231||
48430541|NCT02501642|101389294|FG001|COMPLETED|Overall Study||230||
48430542|NCT02501642|101389293|FG000|NOT COMPLETED|Overall Study||7||
48430543|NCT02501642|101389294|FG001|NOT COMPLETED|Overall Study||11||
48430544|NCT03093480|101389295|FG000|STARTED|Overall Study||16|Immune Tolerance Induction (ITI) Full Analysis Set (ITIFAS): includes all participants who received at least 1 infusion of rFVIIIFc.|
48430545|NCT03093480|101389295|FG000|Tapering Period|Overall Study||10|Tapering Period Full Analysis Set (TPFAS): includes participants entering the tapering phase of the study|
48430546|NCT03093480|101389295|FG000|Follow-up Period|Overall Study||10|Follow-Up Period Full Analysis Set: includes all participants entering the follow-up phase in the study.|
48430547|NCT03093480|101389295|FG000|COMPLETED|Overall Study||16||
48430548|NCT03093480|101389295|FG000|NOT COMPLETED|Overall Study||0||
48430549|NCT02319642|101389296|FG000|STARTED|Overall Study||95||
48430550|NCT02319642|101389297|FG001|STARTED|Overall Study||251||
48430551|NCT02319642|101389296|FG000|COMPLETED|Overall Study||91||
48430552|NCT02319642|101389297|FG001|COMPLETED|Overall Study||245||
48430553|NCT02319642|101389296|FG000|NOT COMPLETED|Overall Study||4||
48430554|NCT02319642|101389297|FG001|NOT COMPLETED|Overall Study||6||
48430555|NCT03339999|101389298|FG000|STARTED|Overall Study||7||
48430556|NCT03339999|101389299|FG001|STARTED|Overall Study||6||
48430557|NCT03339999|101389300|FG002|STARTED|Overall Study||6||
48430558|NCT03339999|101389301|FG003|STARTED|Overall Study||5||
48430559|NCT03339999|101389298|FG000|Modified Intent-to-Treat Population|Overall Study||7||
48430560|NCT03339999|101389299|FG001|Modified Intent-to-Treat Population|Overall Study||6||
48430561|NCT03339999|101389300|FG002|Modified Intent-to-Treat Population|Overall Study||5||
48430562|NCT03339999|101389301|FG003|Modified Intent-to-Treat Population|Overall Study||4||
48430563|NCT03339999|101389298|FG000|Safety Population: Received Treatment|Overall Study||7||
48430564|NCT03339999|101389299|FG001|Safety Population: Received Treatment|Overall Study||6||
48430565|NCT03339999|101389300|FG002|Safety Population: Received Treatment|Overall Study||6||
48430566|NCT03339999|101389301|FG003|Safety Population: Received Treatment|Overall Study||4||
48430567|NCT03339999|101389298|FG000|COMPLETED|Overall Study||0||
48430568|NCT03339999|101389299|FG001|COMPLETED|Overall Study||0||
48430569|NCT03339999|101389300|FG002|COMPLETED|Overall Study||0||
48430570|NCT03339999|101389301|FG003|COMPLETED|Overall Study||0||
48430571|NCT03339999|101389298|FG000|NOT COMPLETED|Overall Study||7||
48430572|NCT03339999|101389299|FG001|NOT COMPLETED|Overall Study||6||
48430573|NCT03339999|101389300|FG002|NOT COMPLETED|Overall Study||6||
48430574|NCT03339999|101389301|FG003|NOT COMPLETED|Overall Study||5||
48430575|NCT01864746|101389302|FG000|STARTED|Overall Study||631|Randomly assigned to each arm|
48430576|NCT01864746|101389303|FG001|STARTED|Overall Study||619|Randomly assigned to each arm|
48430577|NCT01864746|101389302|FG000|Started Treatment|Overall Study||628|Started treatment in each arm|
48430578|NCT01864746|101389303|FG001|Started Treatment|Overall Study||616|Started treatment in each arm|
48430579|NCT01864746|101389302|FG000|Safety Population|Overall Study||633|N=5 patients who started treatment with placebo received palbociclib once; hence, they were analyzed for safety in the palbociclib arm.|
48430580|NCT01864746|101389303|FG001|Safety Population|Overall Study||611|N=5 patients who started treatment with placebo received palbociclib once; hence, they were analyzed for safety in the palbociclib arm.|
48430581|NCT01864746|101389302|FG000|COMPLETED|Overall Study||508||
48430582|NCT01864746|101389303|FG001|COMPLETED|Overall Study||523||
48638998|NCT01022580|101901548|FG001|NOT COMPLETED|Overall Study||22||
48638999|NCT01245751|101901549|FG000|STARTED|Part 1: Day 1 to Week 52 (1 Year)||201||
48430583|NCT01864746|101389302|FG000|NOT COMPLETED|Overall Study||123||
48430584|NCT01864746|101389303|FG001|NOT COMPLETED|Overall Study||96||
48430585|NCT01682876|101389304|FG000|STARTED|Overall Study||176||
48430586|NCT01682876|101389305|FG001|STARTED|Overall Study||183||
48430587|NCT01682876|101389306|FG002|STARTED|Overall Study||180||
48430588|NCT01682876|101389307|FG003|STARTED|Overall Study||176||
48430589|NCT01682876|101389304|FG000|COMPLETED|Overall Study||155||
48430590|NCT01682876|101389305|FG001|COMPLETED|Overall Study||163||
48430591|NCT01682876|101389306|FG002|COMPLETED|Overall Study||169||
48430592|NCT01682876|101389307|FG003|COMPLETED|Overall Study||157||
48430593|NCT01682876|101389304|FG000|NOT COMPLETED|Overall Study||21||
48430594|NCT01682876|101389305|FG001|NOT COMPLETED|Overall Study||20||
48430595|NCT01682876|101389306|FG002|NOT COMPLETED|Overall Study||11||
48430596|NCT01682876|101389307|FG003|NOT COMPLETED|Overall Study||19||
48430597|NCT02196025|101389308|FG000|STARTED|Overall Study||23||
48430598|NCT02196025|101389308|FG000|COMPLETED|Overall Study||19||
48430599|NCT02196025|101389308|FG000|NOT COMPLETED|Overall Study||4||
48430600|NCT01308476|101389309|FG000|STARTED|Overall Study||48||
48430601|NCT01308476|101389310|FG001|STARTED|Overall Study||47||
48430602|NCT01308476|101389309|FG000|COMPLETED|Overall Study||45||
48430603|NCT01308476|101389310|FG001|COMPLETED|Overall Study||45||
48430604|NCT01308476|101389309|FG000|NOT COMPLETED|Overall Study||3||
48430605|NCT01308476|101389310|FG001|NOT COMPLETED|Overall Study||2||
48430606|NCT01869959|101389311|FG000|STARTED|Randomization Period||0||
48430607|NCT01869959|101389312|FG001|STARTED|Randomization Period||0||
48430608|NCT01869959|101389313|FG002|STARTED|Randomization Period||0||
48430609|NCT01869959|101389314|FG003|STARTED|Randomization Period||0||
48430610|NCT01869959|101389315|FG004|STARTED|Randomization Period||47||
48430611|NCT01869959|101389311|FG000|COMPLETED|Randomization Period||0||
48430612|NCT01869959|101389312|FG001|COMPLETED|Randomization Period||0||
48430613|NCT01869959|101389313|FG002|COMPLETED|Randomization Period||0||
48430614|NCT01869959|101389314|FG003|COMPLETED|Randomization Period||0||
48430615|NCT01869959|101389315|FG004|COMPLETED|Randomization Period||46||
48430616|NCT01869959|101389311|FG000|NOT COMPLETED|Randomization Period||0||
48430617|NCT01869959|101389312|FG001|NOT COMPLETED|Randomization Period||0||
48430618|NCT01869959|101389313|FG002|NOT COMPLETED|Randomization Period||0||
48430619|NCT01869959|101389314|FG003|NOT COMPLETED|Randomization Period||0||
48430620|NCT01869959|101389315|FG004|NOT COMPLETED|Randomization Period||1||
48430621|NCT01869959|101389311|FG000|STARTED|Treatment Period||11||
48430622|NCT01869959|101389312|FG001|STARTED|Treatment Period||10||
48430623|NCT01869959|101389313|FG002|STARTED|Treatment Period||15||
48430624|NCT01869959|101389314|FG003|STARTED|Treatment Period||10||
48430625|NCT01869959|101389315|FG004|STARTED|Treatment Period||0||
48430626|NCT01869959|101389311|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||11||
48430627|NCT01869959|101389312|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||10||
48430628|NCT01869959|101389313|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||15||
48430629|NCT01869959|101389314|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||10||
48430630|NCT01869959|101389315|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||0||
48430631|NCT01869959|101389311|FG000|COMPLETED|Treatment Period||10||
48430632|NCT01869959|101389312|FG001|COMPLETED|Treatment Period||8||
48430633|NCT01869959|101389313|FG002|COMPLETED|Treatment Period||12||
48430634|NCT01869959|101389314|FG003|COMPLETED|Treatment Period||8||
48430635|NCT01869959|101389315|FG004|COMPLETED|Treatment Period||0||
48430636|NCT01869959|101389311|FG000|NOT COMPLETED|Treatment Period||1||
48430637|NCT01869959|101389312|FG001|NOT COMPLETED|Treatment Period||2||
48430638|NCT01869959|101389313|FG002|NOT COMPLETED|Treatment Period||3||
48430639|NCT01869959|101389314|FG003|NOT COMPLETED|Treatment Period||2||
48430640|NCT01869959|101389315|FG004|NOT COMPLETED|Treatment Period||0||
48430641|NCT00766727|101389316|FG000|STARTED|Overall Study||12||
48430642|NCT00766727|101389316|FG000|COMPLETED|Overall Study||9||
48430643|NCT00766727|101389316|FG000|NOT COMPLETED|Overall Study||3||
48430644|NCT01980056|101389317|FG000|STARTED|Overall Study||4||
48430645|NCT01980056|101389318|FG001|STARTED|Overall Study||4||
48764195|NCT00992108|102211904|FG000|STARTED|Overall Study||7||
48764196|NCT00992108|102211905|FG001|STARTED|Overall Study||10||
48430646|NCT01980056|101389319|FG002|STARTED|Overall Study||2||
48430647|NCT01980056|101389317|FG000|COMPLETED|Overall Study||3||
48764197|NCT00992108|102211904|FG000|COMPLETED|Overall Study||7||
48764198|NCT00992108|102211905|FG001|COMPLETED|Overall Study||9||
48764199|NCT00992108|102211904|FG000|NOT COMPLETED|Overall Study||0||
48430648|NCT01980056|101389318|FG001|COMPLETED|Overall Study||3||
48430649|NCT01980056|101389319|FG002|COMPLETED|Overall Study||2||
48430650|NCT01980056|101389317|FG000|NOT COMPLETED|Overall Study||1||
48430651|NCT01980056|101389318|FG001|NOT COMPLETED|Overall Study||1||
48430652|NCT01980056|101389319|FG002|NOT COMPLETED|Overall Study||0||
48430653|NCT01333501|101389320|FG000|STARTED|Overall Study||106||
48430654|NCT01333501|101389321|FG001|STARTED|Overall Study||51||
48430655|NCT01333501|101389320|FG000|Full Analysis Set (FAS)|Overall Study||80||
48430656|NCT01333501|101389321|FG001|Full Analysis Set (FAS)|Overall Study||28||
48430657|NCT01333501|101389320|FG000|Safety Population|Overall Study||104||
48430658|NCT01333501|101389321|FG001|Safety Population|Overall Study||47||
48430659|NCT01333501|101389320|FG000|COMPLETED|Overall Study||97||
48430660|NCT01333501|101389321|FG001|COMPLETED|Overall Study||30||
48430661|NCT01333501|101389320|FG000|NOT COMPLETED|Overall Study||9||
48430662|NCT01333501|101389321|FG001|NOT COMPLETED|Overall Study||21||
48430663|NCT00779857|101389322|FG000|STARTED|Overall Study||70||
48430664|NCT00779857|101389322|FG000|30 Day Post Procedure|Overall Study||68||
48430665|NCT00779857|101389322|FG000|3 Month Post Procedure|Overall Study||65||
48430666|NCT00779857|101389322|FG000|COMPLETED|Overall Study||64||
48430667|NCT00779857|101389322|FG000|NOT COMPLETED|Overall Study||6||
48430668|NCT03704194|101389323|FG000|STARTED|Overall Study||8||
48430669|NCT03704194|101389324|FG001|STARTED|Overall Study||9||
48430670|NCT03704194|101389323|FG000|COMPLETED|Overall Study||8||
48430671|NCT03704194|101389324|FG001|COMPLETED|Overall Study||8||
48430672|NCT03704194|101389323|FG000|NOT COMPLETED|Overall Study||0||
48430673|NCT03704194|101389324|FG001|NOT COMPLETED|Overall Study||1||
48430674|NCT00761462|101389325|FG000|STARTED|Treatment||510||
48430675|NCT00761462|101389326|FG001|STARTED|Treatment||519||
48430676|NCT00761462|101389325|FG000|COMPLETED|Treatment||487||
48430677|NCT00761462|101389326|FG001|COMPLETED|Treatment||507||
48430678|NCT00761462|101389325|FG000|NOT COMPLETED|Treatment||23||
48430679|NCT00761462|101389326|FG001|NOT COMPLETED|Treatment||12||
48430680|NCT00761462|101389325|FG000|STARTED|2 or 5 Years Long-term Safety Follow-up||487||
48430681|NCT00761462|101389326|FG001|STARTED|2 or 5 Years Long-term Safety Follow-up||507||
48430682|NCT00761462|101389325|FG000|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||487||
48430683|NCT00761462|101389326|FG001|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||507||
48430684|NCT00761462|101389325|FG000|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||485||
48430685|NCT00761462|101389326|FG001|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||507||
48430686|NCT00761462|101389325|FG000|COMPLETED|2 or 5 Years Long-term Safety Follow-up||333||
48430687|NCT00761462|101389326|FG001|COMPLETED|2 or 5 Years Long-term Safety Follow-up||456||
48430688|NCT00761462|101389325|FG000|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||154||
48430689|NCT00761462|101389326|FG001|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||51||
48430690|NCT00229931|101389327|FG000|STARTED|Overall Study||6||
48430691|NCT00229931|101389328|FG001|STARTED|Overall Study||5||
48430692|NCT00229931|101389327|FG000|COMPLETED|Overall Study||2||
48430693|NCT00229931|101389328|FG001|COMPLETED|Overall Study||3||
48430694|NCT00229931|101389327|FG000|NOT COMPLETED|Overall Study||4||
48430695|NCT00229931|101389328|FG001|NOT COMPLETED|Overall Study||2||
48430696|NCT01911546|101389329|FG000|STARTED|Overall Study||20||
48430697|NCT01911546|101389329|FG000|COMPLETED|Overall Study||14||
48430698|NCT01911546|101389329|FG000|NOT COMPLETED|Overall Study||6||
48430699|NCT03783026|101389330|FG000|STARTED|Treatment Phase||123||
48430700|NCT03783026|101389330|FG000|Received Apremilast|Treatment Phase||122||
48430701|NCT03783026|101389330|FG000|COMPLETED|Treatment Phase||80|Completed Treatment Phase|
48430702|NCT03783026|101389330|FG000|NOT COMPLETED|Treatment Phase||43||
48430703|NCT03783026|101389330|FG000|STARTED|Observational Follow-up Phase||111|Per protocol, all participants who terminated early or completed the study treatment were asked to continue the 4-week post-treatment observational follow-up. Eleven participants did not enter the follow-up phase.|
48430704|NCT03783026|101389330|FG000|COMPLETED|Observational Follow-up Phase||108||
48430705|NCT03783026|101389330|FG000|NOT COMPLETED|Observational Follow-up Phase||3||
48430706|NCT01241591|101389331|FG000|STARTED|Overall Study||329||
48430707|NCT01241591|101389332|FG001|STARTED|Overall Study||330||
48430708|NCT01241591|101389333|FG002|STARTED|Overall Study||335||
48430709|NCT01241591|101389334|FG003|STARTED|Overall Study||107||
48430710|NCT01241591|101389331|FG000|COMPLETED|Overall Study||306||
48430711|NCT01241591|101389332|FG001|COMPLETED|Overall Study||306||
48430712|NCT01241591|101389333|FG002|COMPLETED|Overall Study||313||
48430713|NCT01241591|101389334|FG003|COMPLETED|Overall Study||95||
48430714|NCT01241591|101389331|FG000|NOT COMPLETED|Overall Study||23||
48430715|NCT01241591|101389332|FG001|NOT COMPLETED|Overall Study||24||
48430716|NCT01241591|101389333|FG002|NOT COMPLETED|Overall Study||22||
48430717|NCT01241591|101389334|FG003|NOT COMPLETED|Overall Study||12||
48430718|NCT01098266|101389335|FG000|STARTED|Overall Study||200||
48430719|NCT01098266|101389336|FG001|STARTED|Overall Study||200||
48430720|NCT01098266|101389335|FG000|COMPLETED|Overall Study||193||
48430721|NCT01098266|101389336|FG001|COMPLETED|Overall Study||193||
48430722|NCT01098266|101389335|FG000|NOT COMPLETED|Overall Study||7||
48430723|NCT01098266|101389336|FG001|NOT COMPLETED|Overall Study||7||
48430724|NCT04155567|101389337|FG000|STARTED|Overall Study||10||
48430725|NCT04155567|101389337|FG000|COMPLETED|Overall Study||10||
48430726|NCT04155567|101389337|FG000|NOT COMPLETED|Overall Study||0||
48430727|NCT02120456|101389338|FG000|STARTED|Part 1 Open-label, Dose-escalation Phase||12||
48430728|NCT02120456|101389339|FG001|STARTED|Part 1 Open-label, Dose-escalation Phase||12||
48430729|NCT02120456|101389340|FG002|STARTED|Part 1 Open-label, Dose-escalation Phase||12||
48430730|NCT02120456|101389341|FG003|STARTED|Part 1 Open-label, Dose-escalation Phase||12||
48430731|NCT02120456|101389342|FG004|STARTED|Part 1 Open-label, Dose-escalation Phase||12||
48430732|NCT02120456|101389343|FG005|STARTED|Part 1 Open-label, Dose-escalation Phase||9||
48430733|NCT02120456|101389344|FG006|STARTED|Part 1 Open-label, Dose-escalation Phase||0||
48430734|NCT02120456|101389345|FG007|STARTED|Part 1 Open-label, Dose-escalation Phase||0||
48430735|NCT02120456|101389346|FG008|STARTED|Part 1 Open-label, Dose-escalation Phase||0||
48430736|NCT02120456|101389338|FG000|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12||
48430737|NCT02120456|101389339|FG001|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12||
48430738|NCT02120456|101389340|FG002|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12||
48430739|NCT02120456|101389341|FG003|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12||
48430740|NCT02120456|101389342|FG004|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12||
48430741|NCT02120456|101389343|FG005|COMPLETED|Part 1 Open-label, Dose-escalation Phase||9||
48430742|NCT02120456|101389344|FG006|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
48430743|NCT02120456|101389345|FG007|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
48430744|NCT02120456|101389346|FG008|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
48430745|NCT02120456|101389338|FG000|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
48430746|NCT02120456|101389339|FG001|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
48430747|NCT02120456|101389340|FG002|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
48430748|NCT02120456|101389341|FG003|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
48430749|NCT02120456|101389342|FG004|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
48430750|NCT02120456|101389343|FG005|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
48430751|NCT02120456|101389344|FG006|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
48430752|NCT02120456|101389345|FG007|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
48430753|NCT02120456|101389346|FG008|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
48430754|NCT02120456|101389338|FG000|STARTED|Part 2 Double-blind Phase||0||
48430755|NCT02120456|101389339|FG001|STARTED|Part 2 Double-blind Phase||0||
48430756|NCT02120456|101389340|FG002|STARTED|Part 2 Double-blind Phase||0||
48430757|NCT02120456|101389341|FG003|STARTED|Part 2 Double-blind Phase||0||
48430758|NCT02120456|101389342|FG004|STARTED|Part 2 Double-blind Phase||0||
48430759|NCT02120456|101389343|FG005|STARTED|Part 2 Double-blind Phase||0||
48430760|NCT02120456|101389344|FG006|STARTED|Part 2 Double-blind Phase||32||
48430761|NCT02120456|101389345|FG007|STARTED|Part 2 Double-blind Phase||60||
48430762|NCT02120456|101389346|FG008|STARTED|Part 2 Double-blind Phase||63||
48430763|NCT02120456|101389338|FG000|COMPLETED|Part 2 Double-blind Phase||0||
48430764|NCT02120456|101389339|FG001|COMPLETED|Part 2 Double-blind Phase||0||
48430765|NCT02120456|101389340|FG002|COMPLETED|Part 2 Double-blind Phase||0||
48430766|NCT02120456|101389341|FG003|COMPLETED|Part 2 Double-blind Phase||0||
48430767|NCT02120456|101389342|FG004|COMPLETED|Part 2 Double-blind Phase||0||
48430768|NCT02120456|101389343|FG005|COMPLETED|Part 2 Double-blind Phase||0||
48430769|NCT02120456|101389344|FG006|COMPLETED|Part 2 Double-blind Phase||30||
48430770|NCT02120456|101389345|FG007|COMPLETED|Part 2 Double-blind Phase||60||
48430771|NCT02120456|101389346|FG008|COMPLETED|Part 2 Double-blind Phase||62||
48430772|NCT02120456|101389338|FG000|NOT COMPLETED|Part 2 Double-blind Phase||0||
48430773|NCT02120456|101389339|FG001|NOT COMPLETED|Part 2 Double-blind Phase||0||
48430774|NCT02120456|101389340|FG002|NOT COMPLETED|Part 2 Double-blind Phase||0||
48430775|NCT02120456|101389341|FG003|NOT COMPLETED|Part 2 Double-blind Phase||0||
48430776|NCT02120456|101389342|FG004|NOT COMPLETED|Part 2 Double-blind Phase||0||
48430777|NCT02120456|101389343|FG005|NOT COMPLETED|Part 2 Double-blind Phase||0||
48430778|NCT02120456|101389344|FG006|NOT COMPLETED|Part 2 Double-blind Phase||2||
48430779|NCT02120456|101389345|FG007|NOT COMPLETED|Part 2 Double-blind Phase||0||
48430780|NCT02120456|101389346|FG008|NOT COMPLETED|Part 2 Double-blind Phase||1||
48430781|NCT01347931|101389347|FG000|STARTED|Standard Oxygen Therapy||30||
48430782|NCT01347931|101389347|FG000|COMPLETED|Standard Oxygen Therapy||29||
48430783|NCT01347931|101389347|FG000|NOT COMPLETED|Standard Oxygen Therapy||1||
48430784|NCT01347931|101389347|FG000|STARTED|NIOV System||29||
48430785|NCT01347931|101389347|FG000|COMPLETED|NIOV System||29||
48430786|NCT01347931|101389347|FG000|NOT COMPLETED|NIOV System||0||
48430787|NCT01881867|101389348|FG000|STARTED|Overall Study||26||
48430788|NCT01881867|101389349|FG001|STARTED|Overall Study||28||
48430789|NCT01881867|101389348|FG000|COMPLETED|Overall Study||14||
48430790|NCT01881867|101389349|FG001|COMPLETED|Overall Study||15||
48430791|NCT01881867|101389348|FG000|NOT COMPLETED|Overall Study||12||
48360616|NCT05105243|101210923|FG002|STARTED|SAD Cohort 2: 15 mg (14 Days)||0||
48360617|NCT05105243|101210924|FG003|STARTED|SAD Cohort 2: 15 mg (14 Days)||0||
48360618|NCT05105243|101210925|FG004|STARTED|SAD Cohort 2: 15 mg (14 Days)||0||
48360619|NCT05105243|101210926|FG005|STARTED|SAD Cohort 2: 15 mg (14 Days)||2||
48360620|NCT05105243|101210927|FG006|STARTED|SAD Cohort 2: 15 mg (14 Days)||0||
48360621|NCT05105243|101210928|FG007|STARTED|SAD Cohort 2: 15 mg (14 Days)||0||
48430792|NCT01881867|101389349|FG001|NOT COMPLETED|Overall Study||13||
48430793|NCT01302366|101389350|FG000|STARTED|Overall Study||20||
48430794|NCT01302366|101389350|FG000|COMPLETED|Overall Study||15||
48430795|NCT01302366|101389350|FG000|NOT COMPLETED|Overall Study||5||
48430796|NCT01206296|101389351|FG000|STARTED|Overall Study||0|"The study was terminated and the PI has left the institution. Efforts were made to contact the PI/study team members, but were unsuccessful.~Additional efforts were made to obtain study data via publications, IRB and RedCap systems.~No study data are available."|
48430797|NCT01206296|101389351|FG000|COMPLETED|Overall Study||0|"The study was terminated and the PI has left the institution. Efforts were made to contact the PI/study team members, but were unsuccessful.~Additional efforts were made to obtain study data via publications, IRB and RedCap systems.~No study data are available."|
48360622|NCT05105243|101210929|FG008|STARTED|SAD Cohort 2: 15 mg (14 Days)||0||
48360623|NCT05105243|101210930|FG009|STARTED|SAD Cohort 2: 15 mg (14 Days)||0||
48360624|NCT05105243|101210921|FG000|COMPLETED|SAD Cohort 2: 15 mg (14 Days)||0||
48430798|NCT01206296|101389351|FG000|NOT COMPLETED|Overall Study||0||
48430799|NCT02791906|101389352|FG000|STARTED|Overall Study||4||
48430800|NCT02791906|101389353|FG001|STARTED|Overall Study||3||
48430801|NCT02791906|101389352|FG000|COMPLETED|Overall Study||2||
48430802|NCT02791906|101389353|FG001|COMPLETED|Overall Study||2||
48430803|NCT02791906|101389352|FG000|NOT COMPLETED|Overall Study||2||
48430804|NCT02791906|101389353|FG001|NOT COMPLETED|Overall Study||1||
48430805|NCT01821391|101389354|FG000|STARTED|Overall Study||108||
48430806|NCT01821391|101389355|FG001|STARTED|Overall Study||23||
48430807|NCT01821391|101389354|FG000|COMPLETED|Overall Study||107||
48430808|NCT01821391|101389355|FG001|COMPLETED|Overall Study||23||
48430809|NCT01821391|101389354|FG000|NOT COMPLETED|Overall Study||1||
48430810|NCT01821391|101389355|FG001|NOT COMPLETED|Overall Study||0||
48430811|NCT02734290|101389356|FG000|STARTED|Overall Study||15||
48430812|NCT02734290|101389357|FG001|STARTED|Overall Study||14||
48430813|NCT02734290|101389356|FG000|COMPLETED|Overall Study||13||
48430814|NCT02734290|101389357|FG001|COMPLETED|Overall Study||14||
48430815|NCT02734290|101389356|FG000|NOT COMPLETED|Overall Study||2||
48430816|NCT02734290|101389357|FG001|NOT COMPLETED|Overall Study||0||
48430817|NCT01243762|101389358|FG000|STARTED|Part 1 (Dose Escalation/MTD)||4||
48430818|NCT01243762|101389359|FG001|STARTED|Part 1 (Dose Escalation/MTD)||13||
48430819|NCT01243762|101389360|FG002|STARTED|Part 1 (Dose Escalation/MTD)||3||
48430820|NCT01243762|101389361|FG003|STARTED|Part 1 (Dose Escalation/MTD)||8||
48430821|NCT01243762|101389362|FG004|STARTED|Part 1 (Dose Escalation/MTD)||10||
48430822|NCT01243762|101389363|FG005|STARTED|Part 1 (Dose Escalation/MTD)||3||
48430823|NCT01243762|101389364|FG006|STARTED|Part 1 (Dose Escalation/MTD)||0||
48430824|NCT01243762|101389358|FG000|COMPLETED|Part 1 (Dose Escalation/MTD)||1||
48430825|NCT01243762|101389359|FG001|COMPLETED|Part 1 (Dose Escalation/MTD)||5||
48430826|NCT01243762|101389360|FG002|COMPLETED|Part 1 (Dose Escalation/MTD)||0||
48430827|NCT01243762|101389361|FG003|COMPLETED|Part 1 (Dose Escalation/MTD)||2||
48430828|NCT01243762|101389362|FG004|COMPLETED|Part 1 (Dose Escalation/MTD)||4||
48430829|NCT01243762|101389363|FG005|COMPLETED|Part 1 (Dose Escalation/MTD)||0||
48430830|NCT01243762|101389364|FG006|COMPLETED|Part 1 (Dose Escalation/MTD)||0||
48430831|NCT01243762|101389358|FG000|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3||
48430832|NCT01243762|101389359|FG001|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||8||
48430833|NCT01243762|101389360|FG002|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3||
48430834|NCT01243762|101389361|FG003|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6||
48430835|NCT01243762|101389362|FG004|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6||
48430836|NCT01243762|101389363|FG005|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3||
48430837|NCT01243762|101389364|FG006|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||0||
48430838|NCT01243762|101389358|FG000|STARTED|Part 2 (Dose Confirmation/Efficacy)||1||
48639000|NCT01245751|101901550|FG001|STARTED|Part 1: Day 1 to Week 52 (1 Year)||199||
48639001|NCT01245751|101901551|FG002|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100||
48639002|NCT01245751|101901552|FG003|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100||
48639003|NCT01245751|101901549|FG000|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||201||
48639004|NCT01245751|101901550|FG001|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||199||
48639005|NCT01245751|101901551|FG002|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100||
48639006|NCT01245751|101901552|FG003|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100||
48639007|NCT01245751|101901549|FG000|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||199||
48639008|NCT01245751|101901550|FG001|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||194||
48639009|NCT01245751|101901551|FG002|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||100||
48639010|NCT01245751|101901552|FG003|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||98||
48639011|NCT01245751|101901549|FG000|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2||
48639012|NCT01245751|101901550|FG001|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||5||
48639013|NCT01245751|101901551|FG002|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||0||
48639014|NCT01245751|101901552|FG003|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2||
48639015|NCT01245751|101901549|FG000|STARTED|Part 2: Week 156 (3 Year) Visit||161||
48639016|NCT01245751|101901550|FG001|STARTED|Part 2: Week 156 (3 Year) Visit||139||
48639017|NCT01245751|101901551|FG002|STARTED|Part 2: Week 156 (3 Year) Visit||0||
48639018|NCT01245751|101901552|FG003|STARTED|Part 2: Week 156 (3 Year) Visit||0||
48430839|NCT01243762|101389359|FG001|STARTED|Part 2 (Dose Confirmation/Efficacy)||5||
48430840|NCT01243762|101389360|FG002|STARTED|Part 2 (Dose Confirmation/Efficacy)||0||
48430841|NCT01243762|101389361|FG003|STARTED|Part 2 (Dose Confirmation/Efficacy)||2||
48430842|NCT01243762|101389362|FG004|STARTED|Part 2 (Dose Confirmation/Efficacy)||4||
48430843|NCT01243762|101389363|FG005|STARTED|Part 2 (Dose Confirmation/Efficacy)||0||
48430844|NCT01243762|101389364|FG006|STARTED|Part 2 (Dose Confirmation/Efficacy)||6||
48430845|NCT01243762|101389358|FG000|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0||
48430846|NCT01243762|101389359|FG001|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0||
48430847|NCT01243762|101389360|FG002|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0||
48430848|NCT01243762|101389361|FG003|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0||
48430849|NCT01243762|101389362|FG004|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0||
48430850|NCT01243762|101389363|FG005|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0||
48430851|NCT01243762|101389364|FG006|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0||
48430852|NCT01243762|101389358|FG000|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||1||
48430853|NCT01243762|101389359|FG001|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||5||
48430854|NCT01243762|101389360|FG002|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0||
48430855|NCT01243762|101389361|FG003|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||2||
48430856|NCT01243762|101389362|FG004|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||4||
48430857|NCT01243762|101389363|FG005|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0||
48430858|NCT01243762|101389364|FG006|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||6||
48430859|NCT00779142|101389365|FG000|STARTED|Overall Study||5||
48430860|NCT00779142|101389365|FG000|COMPLETED|Overall Study||2||
48430861|NCT00779142|101389365|FG000|NOT COMPLETED|Overall Study||3||
48430862|NCT00938366|101389366|FG000|STARTED|Overall Study||9||
48430863|NCT00938366|101389367|FG001|STARTED|Overall Study||9||
48430864|NCT00938366|101389366|FG000|COMPLETED|Overall Study||8||
48430865|NCT00938366|101389367|FG001|COMPLETED|Overall Study||9||
48430866|NCT00938366|101389366|FG000|NOT COMPLETED|Overall Study||1||
48430867|NCT00938366|101389367|FG001|NOT COMPLETED|Overall Study||0||
48430868|NCT02087865|101389368|FG000|STARTED|Overall Study||28||
48430869|NCT02087865|101389369|FG001|STARTED|Overall Study||29||
48430870|NCT02087865|101389370|FG002|STARTED|Overall Study||32||
48430871|NCT02087865|101389368|FG000|COMPLETED|Overall Study||22||
48430872|NCT02087865|101389369|FG001|COMPLETED|Overall Study||26||
48430873|NCT02087865|101389370|FG002|COMPLETED|Overall Study||29||
48430874|NCT02087865|101389368|FG000|NOT COMPLETED|Overall Study||6||
48430875|NCT02087865|101389369|FG001|NOT COMPLETED|Overall Study||3||
48430876|NCT02087865|101389370|FG002|NOT COMPLETED|Overall Study||3||
48430877|NCT01004822|101389371|FG000|STARTED|Overall Study||3||
48430878|NCT01004822|101389372|FG001|STARTED|Overall Study||3||
48430879|NCT01004822|101389373|FG002|STARTED|Overall Study||4||
48430880|NCT01004822|101389374|FG003|STARTED|Overall Study||4||
48430881|NCT01004822|101389375|FG004|STARTED|Overall Study||4||
48430882|NCT01004822|101389376|FG005|STARTED|Overall Study||4||
48430883|NCT01004822|101389377|FG006|STARTED|Overall Study||4||
48430884|NCT01004822|101389378|FG007|STARTED|Overall Study||5||
48430885|NCT01004822|101389371|FG000|Treated|Overall Study||3||
48430886|NCT01004822|101389372|FG001|Treated|Overall Study||3||
48430887|NCT01004822|101389373|FG002|Treated|Overall Study||3||
48430888|NCT01004822|101389374|FG003|Treated|Overall Study||4||
48430889|NCT01004822|101389375|FG004|Treated|Overall Study||4||
48430890|NCT01004822|101389376|FG005|Treated|Overall Study||4||
48430891|NCT01004822|101389377|FG006|Treated|Overall Study||4||
48430892|NCT01004822|101389378|FG007|Treated|Overall Study||5||
48430893|NCT01004822|101389371|FG000|COMPLETED|Overall Study||0||
48430894|NCT01004822|101389372|FG001|COMPLETED|Overall Study||0||
48430895|NCT01004822|101389373|FG002|COMPLETED|Overall Study||0||
48430896|NCT01004822|101389374|FG003|COMPLETED|Overall Study||0||
48430897|NCT01004822|101389375|FG004|COMPLETED|Overall Study||0||
48430898|NCT01004822|101389376|FG005|COMPLETED|Overall Study||0||
48430899|NCT01004822|101389377|FG006|COMPLETED|Overall Study||0||
48430900|NCT01004822|101389378|FG007|COMPLETED|Overall Study||0||
48430901|NCT01004822|101389371|FG000|NOT COMPLETED|Overall Study||3||
48430902|NCT01004822|101389372|FG001|NOT COMPLETED|Overall Study||3||
48430903|NCT01004822|101389373|FG002|NOT COMPLETED|Overall Study||4||
48430904|NCT01004822|101389374|FG003|NOT COMPLETED|Overall Study||4||
48430905|NCT01004822|101389375|FG004|NOT COMPLETED|Overall Study||4||
48430906|NCT01004822|101389376|FG005|NOT COMPLETED|Overall Study||4||
48430907|NCT01004822|101389377|FG006|NOT COMPLETED|Overall Study||4||
48430908|NCT01004822|101389378|FG007|NOT COMPLETED|Overall Study||5||
48430909|NCT00525499|101389379|FG000|STARTED|Overall Study||47||
48430910|NCT00525499|101389380|FG001|STARTED|Overall Study||46||
48430911|NCT00525499|101389381|FG002|STARTED|Overall Study||47||
48430912|NCT00525499|101389382|FG003|STARTED|Overall Study||46||
48430913|NCT00525499|101389379|FG000|COMPLETED|Overall Study||40||
48430914|NCT00525499|101389380|FG001|COMPLETED|Overall Study||39||
48430915|NCT00525499|101389381|FG002|COMPLETED|Overall Study||40||
48430916|NCT00525499|101389382|FG003|COMPLETED|Overall Study||39||
48430917|NCT00525499|101389379|FG000|NOT COMPLETED|Overall Study||7||
48430918|NCT00525499|101389380|FG001|NOT COMPLETED|Overall Study||7||
48430919|NCT00525499|101389381|FG002|NOT COMPLETED|Overall Study||7||
48430920|NCT00525499|101389382|FG003|NOT COMPLETED|Overall Study||7||
48430921|NCT01795534|101389383|FG000|STARTED|First Intervention (First Shot)||5||
48430922|NCT01795534|101389384|FG001|STARTED|First Intervention (First Shot)||5||
48430923|NCT01795534|101389383|FG000|COMPLETED|First Intervention (First Shot)||5||
48430924|NCT01795534|101389384|FG001|COMPLETED|First Intervention (First Shot)||5||
48430925|NCT01795534|101389383|FG000|NOT COMPLETED|First Intervention (First Shot)||0||
48430926|NCT01795534|101389384|FG001|NOT COMPLETED|First Intervention (First Shot)||0||
48430927|NCT01795534|101389383|FG000|STARTED|Wash Out Period (4 Days)||5||
48430928|NCT01795534|101389384|FG001|STARTED|Wash Out Period (4 Days)||5||
48430929|NCT01795534|101389383|FG000|COMPLETED|Wash Out Period (4 Days)||5||
48430930|NCT01795534|101389384|FG001|COMPLETED|Wash Out Period (4 Days)||5||
48430931|NCT01795534|101389383|FG000|NOT COMPLETED|Wash Out Period (4 Days)||0||
48430932|NCT01795534|101389384|FG001|NOT COMPLETED|Wash Out Period (4 Days)||0||
48430933|NCT01795534|101389383|FG000|STARTED|Second Intervention (Second Shot)||5||
48430934|NCT01795534|101389384|FG001|STARTED|Second Intervention (Second Shot)||5||
48430935|NCT01795534|101389383|FG000|COMPLETED|Second Intervention (Second Shot)||5||
48430936|NCT01795534|101389384|FG001|COMPLETED|Second Intervention (Second Shot)||5||
48430937|NCT01795534|101389383|FG000|NOT COMPLETED|Second Intervention (Second Shot)||0||
48430938|NCT01795534|101389384|FG001|NOT COMPLETED|Second Intervention (Second Shot)||0||
48430939|NCT03426995|101389385|FG000|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
48430940|NCT03426995|101389386|FG001|STARTED|Part A: Cohort 1-Period 1 (Day1)||2||
48430941|NCT03426995|101389387|FG002|STARTED|Part A: Cohort 1-Period 1 (Day1)||1||
48430942|NCT03426995|101389388|FG003|STARTED|Part A: Cohort 1-Period 1 (Day1)||2||
48430943|NCT03426995|101389389|FG004|STARTED|Part A: Cohort 1-Period 1 (Day1)||1||
48430944|NCT03426995|101389390|FG005|STARTED|Part A: Cohort 1-Period 1 (Day1)||1||
48430945|NCT03426995|101389391|FG006|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
48430946|NCT03426995|101389392|FG007|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
48430947|NCT03426995|101389393|FG008|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
48430948|NCT03426995|101389394|FG009|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
48430949|NCT03426995|101389395|FG010|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
48430950|NCT03426995|101389396|FG011|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
48430951|NCT03426995|101389397|FG012|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
48430952|NCT03426995|101389398|FG013|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
48430953|NCT03426995|101389399|FG014|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
48430954|NCT03426995|101389400|FG015|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
48430955|NCT03426995|101389401|FG016|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
48430956|NCT03426995|101389402|FG017|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
48430957|NCT03426995|101389403|FG018|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
48430958|NCT03426995|101389385|FG000|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48430959|NCT03426995|101389386|FG001|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||2||
48430960|NCT03426995|101389387|FG002|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48430961|NCT03426995|101389388|FG003|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||2||
48430962|NCT03426995|101389389|FG004|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1||
48430963|NCT03426995|101389390|FG005|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1||
48430964|NCT03426995|101389391|FG006|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48430965|NCT03426995|101389392|FG007|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48430966|NCT03426995|101389393|FG008|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48430967|NCT03426995|101389394|FG009|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48430968|NCT03426995|101389395|FG010|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48430969|NCT03426995|101389396|FG011|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48430970|NCT03426995|101389397|FG012|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48430971|NCT03426995|101389398|FG013|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48430972|NCT03426995|101389399|FG014|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48430973|NCT03426995|101389400|FG015|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48430974|NCT03426995|101389401|FG016|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48430975|NCT03426995|101389402|FG017|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48430976|NCT03426995|101389403|FG018|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48430977|NCT03426995|101389385|FG000|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48430978|NCT03426995|101389386|FG001|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48430979|NCT03426995|101389387|FG002|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1||
48430980|NCT03426995|101389388|FG003|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48430981|NCT03426995|101389389|FG004|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48430982|NCT03426995|101389390|FG005|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48430983|NCT03426995|101389391|FG006|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48430984|NCT03426995|101389392|FG007|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48430985|NCT03426995|101389393|FG008|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48430986|NCT03426995|101389394|FG009|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48430987|NCT03426995|101389395|FG010|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48430988|NCT03426995|101389396|FG011|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48430989|NCT03426995|101389397|FG012|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48430990|NCT03426995|101389398|FG013|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48430991|NCT03426995|101389399|FG014|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48430992|NCT03426995|101389400|FG015|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48430993|NCT03426995|101389401|FG016|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48430994|NCT03426995|101389402|FG017|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48430995|NCT03426995|101389403|FG018|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
48430996|NCT03426995|101389385|FG000|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48430997|NCT03426995|101389386|FG001|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2||
48430998|NCT03426995|101389387|FG002|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48430999|NCT03426995|101389388|FG003|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2||
48431000|NCT03426995|101389389|FG004|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1||
48431001|NCT03426995|101389390|FG005|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1||
48431002|NCT03426995|101389391|FG006|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431003|NCT03426995|101389392|FG007|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48439989|NCT03176953|101410001|FG000|NOT COMPLETED|Overall Study||9||
48431004|NCT03426995|101389393|FG008|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431005|NCT03426995|101389394|FG009|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431006|NCT03426995|101389395|FG010|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431007|NCT03426995|101389396|FG011|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431008|NCT03426995|101389397|FG012|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431009|NCT03426995|101389398|FG013|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431010|NCT03426995|101389399|FG014|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431011|NCT03426995|101389400|FG015|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431012|NCT03426995|101389401|FG016|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431013|NCT03426995|101389402|FG017|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431014|NCT03426995|101389403|FG018|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431015|NCT03426995|101389385|FG000|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431016|NCT03426995|101389386|FG001|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2||
48431017|NCT03426995|101389387|FG002|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431018|NCT03426995|101389388|FG003|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2||
48431019|NCT03426995|101389389|FG004|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1||
48431020|NCT03426995|101389390|FG005|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1||
48431021|NCT03426995|101389391|FG006|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431022|NCT03426995|101389392|FG007|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431023|NCT03426995|101389393|FG008|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431024|NCT03426995|101389394|FG009|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431025|NCT03426995|101389395|FG010|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431026|NCT03426995|101389396|FG011|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431027|NCT03426995|101389397|FG012|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431028|NCT03426995|101389398|FG013|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431029|NCT03426995|101389399|FG014|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431030|NCT03426995|101389400|FG015|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431031|NCT03426995|101389401|FG016|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431032|NCT03426995|101389402|FG017|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431033|NCT03426995|101389403|FG018|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431034|NCT03426995|101389385|FG000|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431035|NCT03426995|101389386|FG001|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431036|NCT03426995|101389387|FG002|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431037|NCT03426995|101389388|FG003|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431038|NCT03426995|101389389|FG004|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431039|NCT03426995|101389390|FG005|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431040|NCT03426995|101389391|FG006|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431041|NCT03426995|101389392|FG007|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431042|NCT03426995|101389393|FG008|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431043|NCT03426995|101389394|FG009|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431044|NCT03426995|101389395|FG010|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431045|NCT03426995|101389396|FG011|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431046|NCT03426995|101389397|FG012|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431047|NCT03426995|101389398|FG013|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431048|NCT03426995|101389399|FG014|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431049|NCT03426995|101389400|FG015|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431050|NCT03426995|101389401|FG016|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431051|NCT03426995|101389402|FG017|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431052|NCT03426995|101389403|FG018|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
48431053|NCT03426995|101389385|FG000|STARTED|Part A: Cohort 1-Period 2 (Day1)||1||
48431054|NCT03426995|101389386|FG001|STARTED|Part A: Cohort 1-Period 2 (Day1)||2||
48431055|NCT03426995|101389387|FG002|STARTED|Part A: Cohort 1-Period 2 (Day1)||1||
48431056|NCT03426995|101389388|FG003|STARTED|Part A: Cohort 1-Period 2 (Day1)||2||
48431057|NCT03426995|101389389|FG004|STARTED|Part A: Cohort 1-Period 2 (Day1)||1||
48431058|NCT03426995|101389390|FG005|STARTED|Part A: Cohort 1-Period 2 (Day1)||3||
48431059|NCT03426995|101389391|FG006|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
48431060|NCT03426995|101389392|FG007|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
48431061|NCT03426995|101389393|FG008|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
48431062|NCT03426995|101389394|FG009|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
48431063|NCT03426995|101389395|FG010|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
48431064|NCT03426995|101389396|FG011|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
48431065|NCT03426995|101389397|FG012|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
48431066|NCT03426995|101389398|FG013|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
48431067|NCT03426995|101389399|FG014|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
48431068|NCT03426995|101389400|FG015|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
48431069|NCT03426995|101389401|FG016|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
48431070|NCT03426995|101389402|FG017|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
48431071|NCT03426995|101389403|FG018|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
48431072|NCT03426995|101389385|FG000|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1||
48431073|NCT03426995|101389386|FG001|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2||
48431074|NCT03426995|101389387|FG002|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1||
48431075|NCT03426995|101389388|FG003|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2||
48431076|NCT03426995|101389389|FG004|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48431077|NCT03426995|101389390|FG005|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1||
48431078|NCT03426995|101389391|FG006|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48431079|NCT03426995|101389392|FG007|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48431080|NCT03426995|101389393|FG008|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48431081|NCT03426995|101389394|FG009|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48431082|NCT03426995|101389395|FG010|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48431083|NCT03426995|101389396|FG011|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48431084|NCT03426995|101389397|FG012|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48431085|NCT03426995|101389398|FG013|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48431086|NCT03426995|101389399|FG014|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48431087|NCT03426995|101389400|FG015|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48431088|NCT03426995|101389401|FG016|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48431089|NCT03426995|101389402|FG017|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48431090|NCT03426995|101389403|FG018|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48431091|NCT03426995|101389385|FG000|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48431092|NCT03426995|101389386|FG001|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48431093|NCT03426995|101389387|FG002|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48431094|NCT03426995|101389388|FG003|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48431095|NCT03426995|101389389|FG004|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1||
48431096|NCT03426995|101389390|FG005|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2||
48431097|NCT03426995|101389391|FG006|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48431098|NCT03426995|101389392|FG007|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48431099|NCT03426995|101389393|FG008|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48431100|NCT03426995|101389394|FG009|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48431101|NCT03426995|101389395|FG010|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48431102|NCT03426995|101389396|FG011|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48431103|NCT03426995|101389397|FG012|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48431104|NCT03426995|101389398|FG013|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48431105|NCT03426995|101389399|FG014|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48431106|NCT03426995|101389400|FG015|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48431107|NCT03426995|101389401|FG016|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48431108|NCT03426995|101389402|FG017|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48431109|NCT03426995|101389403|FG018|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
48431110|NCT03426995|101389385|FG000|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1||
48431111|NCT03426995|101389386|FG001|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2||
48431112|NCT03426995|101389387|FG002|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1||
48431113|NCT03426995|101389388|FG003|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2||
48431114|NCT03426995|101389389|FG004|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431115|NCT03426995|101389390|FG005|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1||
48431116|NCT03426995|101389391|FG006|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431117|NCT03426995|101389392|FG007|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431118|NCT03426995|101389393|FG008|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431119|NCT03426995|101389394|FG009|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431120|NCT03426995|101389395|FG010|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431121|NCT03426995|101389396|FG011|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431122|NCT03426995|101389397|FG012|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431123|NCT03426995|101389398|FG013|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431124|NCT03426995|101389399|FG014|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431125|NCT03426995|101389400|FG015|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431126|NCT03426995|101389401|FG016|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431127|NCT03426995|101389402|FG017|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431128|NCT03426995|101389403|FG018|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431129|NCT03426995|101389385|FG000|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1||
48431130|NCT03426995|101389386|FG001|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2||
48431131|NCT03426995|101389387|FG002|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1||
48431132|NCT03426995|101389388|FG003|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2||
48431133|NCT03426995|101389389|FG004|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431134|NCT03426995|101389390|FG005|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1||
48431135|NCT03426995|101389391|FG006|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431136|NCT03426995|101389392|FG007|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431137|NCT03426995|101389393|FG008|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431138|NCT03426995|101389394|FG009|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431139|NCT03426995|101389395|FG010|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431140|NCT03426995|101389396|FG011|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431141|NCT03426995|101389397|FG012|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431142|NCT03426995|101389398|FG013|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431143|NCT03426995|101389399|FG014|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431144|NCT03426995|101389400|FG015|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431145|NCT03426995|101389401|FG016|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431146|NCT03426995|101389402|FG017|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431147|NCT03426995|101389403|FG018|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431148|NCT03426995|101389385|FG000|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431149|NCT03426995|101389386|FG001|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431150|NCT03426995|101389387|FG002|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431151|NCT03426995|101389388|FG003|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431152|NCT03426995|101389389|FG004|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431153|NCT03426995|101389390|FG005|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431154|NCT03426995|101389391|FG006|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431155|NCT03426995|101389392|FG007|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431156|NCT03426995|101389393|FG008|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431157|NCT03426995|101389394|FG009|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431158|NCT03426995|101389395|FG010|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431159|NCT03426995|101389396|FG011|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48187559|NCT01559090|100780075|FG002|STARTED|Stage I||6||
48187560|NCT01559090|100780073|FG000|COMPLETED|Stage I||4||
48187561|NCT01559090|100780074|FG001|COMPLETED|Stage I||3||
48187562|NCT01559090|100780075|FG002|COMPLETED|Stage I||3||
48187563|NCT01559090|100780073|FG000|NOT COMPLETED|Stage I||2||
48187564|NCT01559090|100780074|FG001|NOT COMPLETED|Stage I||2||
48187565|NCT01559090|100780075|FG002|NOT COMPLETED|Stage I||3||
48431160|NCT03426995|101389397|FG012|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431161|NCT03426995|101389398|FG013|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431162|NCT03426995|101389399|FG014|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431163|NCT03426995|101389400|FG015|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431164|NCT03426995|101389401|FG016|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431165|NCT03426995|101389402|FG017|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431166|NCT03426995|101389403|FG018|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
48431167|NCT03426995|101389385|FG000|STARTED|Part A: Cohort 1-Period 3 (Day1)||1||
48431168|NCT03426995|101389386|FG001|STARTED|Part A: Cohort 1-Period 3 (Day1)||2||
48431169|NCT03426995|101389387|FG002|STARTED|Part A: Cohort 1-Period 3 (Day1)||1||
48431170|NCT03426995|101389388|FG003|STARTED|Part A: Cohort 1-Period 3 (Day1)||2||
48431171|NCT03426995|101389389|FG004|STARTED|Part A: Cohort 1-Period 3 (Day1)||1||
48431172|NCT03426995|101389390|FG005|STARTED|Part A: Cohort 1-Period 3 (Day1)||2||
48431173|NCT03426995|101389391|FG006|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
48431174|NCT03426995|101389392|FG007|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
48431175|NCT03426995|101389393|FG008|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
48431176|NCT03426995|101389394|FG009|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
48431177|NCT03426995|101389395|FG010|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
48431178|NCT03426995|101389396|FG011|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
48431179|NCT03426995|101389397|FG012|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
48431180|NCT03426995|101389398|FG013|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
48431181|NCT03426995|101389399|FG014|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
48431182|NCT03426995|101389400|FG015|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
48431183|NCT03426995|101389401|FG016|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
48431184|NCT03426995|101389402|FG017|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
48431185|NCT03426995|101389403|FG018|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
48431186|NCT03426995|101389385|FG000|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1||
48431187|NCT03426995|101389386|FG001|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2||
48431188|NCT03426995|101389387|FG002|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1||
48431189|NCT03426995|101389388|FG003|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2||
48431190|NCT03426995|101389389|FG004|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1||
48431191|NCT03426995|101389390|FG005|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2||
48431192|NCT03426995|101389391|FG006|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48431193|NCT03426995|101389392|FG007|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48431194|NCT03426995|101389393|FG008|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48431195|NCT03426995|101389394|FG009|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48431196|NCT03426995|101389395|FG010|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48431197|NCT03426995|101389396|FG011|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48431198|NCT03426995|101389397|FG012|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48431199|NCT03426995|101389398|FG013|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48431200|NCT03426995|101389399|FG014|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48187566|NCT01559090|100780073|FG000|STARTED|Stage II||4||
48187567|NCT01559090|100780074|FG001|STARTED|Stage II||3||
48187568|NCT01559090|100780075|FG002|STARTED|Stage II||2||
48187569|NCT01559090|100780073|FG000|COMPLETED|Stage II||3||
48187570|NCT01559090|100780074|FG001|COMPLETED|Stage II||3||
48187571|NCT01559090|100780075|FG002|COMPLETED|Stage II||2||
48431201|NCT03426995|101389400|FG015|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48431202|NCT03426995|101389401|FG016|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48431203|NCT03426995|101389402|FG017|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48431204|NCT03426995|101389403|FG018|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48431205|NCT03426995|101389385|FG000|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48431206|NCT03426995|101389386|FG001|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48431207|NCT03426995|101389387|FG002|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48431208|NCT03426995|101389388|FG003|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48431209|NCT03426995|101389389|FG004|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48431210|NCT03426995|101389390|FG005|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48431211|NCT03426995|101389391|FG006|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48431212|NCT03426995|101389392|FG007|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48431213|NCT03426995|101389393|FG008|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48431214|NCT03426995|101389394|FG009|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48431215|NCT03426995|101389395|FG010|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48431216|NCT03426995|101389396|FG011|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48431217|NCT03426995|101389397|FG012|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48431218|NCT03426995|101389398|FG013|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48431219|NCT03426995|101389399|FG014|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48431220|NCT03426995|101389400|FG015|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48431221|NCT03426995|101389401|FG016|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48431222|NCT03426995|101389402|FG017|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48431223|NCT03426995|101389403|FG018|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
48431224|NCT03426995|101389385|FG000|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1||
48431225|NCT03426995|101389386|FG001|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2||
48431226|NCT03426995|101389387|FG002|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1||
48431227|NCT03426995|101389388|FG003|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2||
48431228|NCT03426995|101389389|FG004|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1||
48431229|NCT03426995|101389390|FG005|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2||
48431230|NCT03426995|101389391|FG006|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431231|NCT03426995|101389392|FG007|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431232|NCT03426995|101389393|FG008|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431233|NCT03426995|101389394|FG009|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48764200|NCT00992108|102211905|FG001|NOT COMPLETED|Overall Study||1||
48764201|NCT01995708|102211906|FG000|STARTED|Overall Study||13||
48764202|NCT01995708|102211907|FG001|STARTED|Overall Study||15||
48764203|NCT01995708|102211906|FG000|COMPLETED|Overall Study||13||
48764204|NCT01995708|102211907|FG001|COMPLETED|Overall Study||15||
48431234|NCT03426995|101389395|FG010|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431235|NCT03426995|101389396|FG011|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431236|NCT03426995|101389397|FG012|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431237|NCT03426995|101389398|FG013|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431238|NCT03426995|101389399|FG014|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431239|NCT03426995|101389400|FG015|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431240|NCT03426995|101389401|FG016|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431241|NCT03426995|101389402|FG017|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431242|NCT03426995|101389403|FG018|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431243|NCT03426995|101389385|FG000|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1||
48431244|NCT03426995|101389386|FG001|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2||
48431245|NCT03426995|101389387|FG002|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1||
48431246|NCT03426995|101389388|FG003|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2||
48431247|NCT03426995|101389389|FG004|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1||
48431248|NCT03426995|101389390|FG005|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2||
48431249|NCT03426995|101389391|FG006|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431250|NCT03426995|101389392|FG007|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431251|NCT03426995|101389393|FG008|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431252|NCT03426995|101389394|FG009|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431253|NCT03426995|101389395|FG010|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48764205|NCT01995708|102211906|FG000|NOT COMPLETED|Overall Study||0||
48764206|NCT01995708|102211907|FG001|NOT COMPLETED|Overall Study||0||
48764207|NCT00283296|102211908|FG000|STARTED|Overall Study||14||
48764208|NCT00283296|102211908|FG000|COMPLETED|Overall Study||9||
48764209|NCT00283296|102211908|FG000|NOT COMPLETED|Overall Study||5||
48764210|NCT00551642|102211909|FG000|STARTED|Treatment Period||399||
48431254|NCT03426995|101389396|FG011|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431255|NCT03426995|101389397|FG012|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431256|NCT03426995|101389398|FG013|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431257|NCT03426995|101389399|FG014|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48764211|NCT00551642|102211910|FG001|STARTED|Treatment Period||401||
48764212|NCT00551642|102211909|FG000|Safety Population|Treatment Period||395||
48764213|NCT00551642|102211910|FG001|Safety Population|Treatment Period||397||
48431258|NCT03426995|101389400|FG015|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431259|NCT03426995|101389401|FG016|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431260|NCT03426995|101389402|FG017|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431261|NCT03426995|101389403|FG018|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431262|NCT03426995|101389385|FG000|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431263|NCT03426995|101389386|FG001|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431264|NCT03426995|101389387|FG002|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431265|NCT03426995|101389388|FG003|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431266|NCT03426995|101389389|FG004|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431267|NCT03426995|101389390|FG005|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431268|NCT03426995|101389391|FG006|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431269|NCT03426995|101389392|FG007|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431270|NCT03426995|101389393|FG008|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431271|NCT03426995|101389394|FG009|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431272|NCT03426995|101389395|FG010|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431273|NCT03426995|101389396|FG011|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431274|NCT03426995|101389397|FG012|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431275|NCT03426995|101389398|FG013|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431276|NCT03426995|101389399|FG014|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431277|NCT03426995|101389400|FG015|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431278|NCT03426995|101389401|FG016|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431279|NCT03426995|101389402|FG017|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431280|NCT03426995|101389403|FG018|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
48431281|NCT03426995|101389385|FG000|STARTED|Part A: Cohort 1-Period 4 (Day1)||1||
48431282|NCT03426995|101389386|FG001|STARTED|Part A: Cohort 1-Period 4 (Day1)||2||
48431283|NCT03426995|101389387|FG002|STARTED|Part A: Cohort 1-Period 4 (Day1)||1||
48431284|NCT03426995|101389388|FG003|STARTED|Part A: Cohort 1-Period 4 (Day1)||2||
48431285|NCT03426995|101389389|FG004|STARTED|Part A: Cohort 1-Period 4 (Day1)||1||
48431286|NCT03426995|101389390|FG005|STARTED|Part A: Cohort 1-Period 4 (Day1)||2||
48431287|NCT03426995|101389391|FG006|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
48431288|NCT03426995|101389392|FG007|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
48431289|NCT03426995|101389393|FG008|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
48431290|NCT03426995|101389394|FG009|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
48431291|NCT03426995|101389395|FG010|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
48431292|NCT03426995|101389396|FG011|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
48431293|NCT03426995|101389397|FG012|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
48431294|NCT03426995|101389398|FG013|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
48431295|NCT03426995|101389399|FG014|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
48431296|NCT03426995|101389400|FG015|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
48431297|NCT03426995|101389401|FG016|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
48431298|NCT03426995|101389402|FG017|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
48431299|NCT03426995|101389403|FG018|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
48431300|NCT03426995|101389385|FG000|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1||
48431301|NCT03426995|101389386|FG001|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2||
48431302|NCT03426995|101389387|FG002|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1||
48431303|NCT03426995|101389388|FG003|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2||
48431304|NCT03426995|101389389|FG004|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1||
48431305|NCT03426995|101389390|FG005|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2||
48431306|NCT03426995|101389391|FG006|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48431307|NCT03426995|101389392|FG007|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48431308|NCT03426995|101389393|FG008|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48431309|NCT03426995|101389394|FG009|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48360625|NCT05105243|101210922|FG001|COMPLETED|SAD Cohort 2: 15 mg (14 Days)||6||
48360626|NCT05105243|101210923|FG002|COMPLETED|SAD Cohort 2: 15 mg (14 Days)||0||
48360627|NCT05105243|101210924|FG003|COMPLETED|SAD Cohort 2: 15 mg (14 Days)||0||
48360628|NCT05105243|101210925|FG004|COMPLETED|SAD Cohort 2: 15 mg (14 Days)||0||
48360629|NCT05105243|101210926|FG005|COMPLETED|SAD Cohort 2: 15 mg (14 Days)||2||
48360630|NCT05105243|101210927|FG006|COMPLETED|SAD Cohort 2: 15 mg (14 Days)||0||
48360631|NCT05105243|101210928|FG007|COMPLETED|SAD Cohort 2: 15 mg (14 Days)||0||
48360632|NCT05105243|101210929|FG008|COMPLETED|SAD Cohort 2: 15 mg (14 Days)||0||
48360633|NCT05105243|101210930|FG009|COMPLETED|SAD Cohort 2: 15 mg (14 Days)||0||
48360634|NCT05105243|101210921|FG000|NOT COMPLETED|SAD Cohort 2: 15 mg (14 Days)||0||
48360635|NCT05105243|101210922|FG001|NOT COMPLETED|SAD Cohort 2: 15 mg (14 Days)||0||
48360636|NCT05105243|101210923|FG002|NOT COMPLETED|SAD Cohort 2: 15 mg (14 Days)||0||
48360637|NCT05105243|101210924|FG003|NOT COMPLETED|SAD Cohort 2: 15 mg (14 Days)||0||
48360638|NCT05105243|101210925|FG004|NOT COMPLETED|SAD Cohort 2: 15 mg (14 Days)||0||
48360639|NCT05105243|101210926|FG005|NOT COMPLETED|SAD Cohort 2: 15 mg (14 Days)||0||
48360640|NCT05105243|101210927|FG006|NOT COMPLETED|SAD Cohort 2: 15 mg (14 Days)||0||
48360641|NCT05105243|101210928|FG007|NOT COMPLETED|SAD Cohort 2: 15 mg (14 Days)||0||
48360642|NCT05105243|101210929|FG008|NOT COMPLETED|SAD Cohort 2: 15 mg (14 Days)||0||
48439990|NCT03176953|101410002|FG001|NOT COMPLETED|Overall Study||10||
48360643|NCT05105243|101210930|FG009|NOT COMPLETED|SAD Cohort 2: 15 mg (14 Days)||0||
48360644|NCT05105243|101210921|FG000|STARTED|SAD Cohort 3: 45 mg (14 Days)||0||
48360645|NCT05105243|101210922|FG001|STARTED|SAD Cohort 3: 45 mg (14 Days)||0||
48360646|NCT05105243|101210923|FG002|STARTED|SAD Cohort 3: 45 mg (14 Days)||6||
48360647|NCT05105243|101210924|FG003|STARTED|SAD Cohort 3: 45 mg (14 Days)||0||
48360648|NCT05105243|101210925|FG004|STARTED|SAD Cohort 3: 45 mg (14 Days)||0||
48360649|NCT05105243|101210926|FG005|STARTED|SAD Cohort 3: 45 mg (14 Days)||2||
48360650|NCT05105243|101210927|FG006|STARTED|SAD Cohort 3: 45 mg (14 Days)||0||
48360651|NCT05105243|101210928|FG007|STARTED|SAD Cohort 3: 45 mg (14 Days)||0||
48360652|NCT05105243|101210929|FG008|STARTED|SAD Cohort 3: 45 mg (14 Days)||0||
48360653|NCT05105243|101210930|FG009|STARTED|SAD Cohort 3: 45 mg (14 Days)||0||
48360654|NCT05105243|101210921|FG000|COMPLETED|SAD Cohort 3: 45 mg (14 Days)||0||
48360655|NCT05105243|101210922|FG001|COMPLETED|SAD Cohort 3: 45 mg (14 Days)||0||
48360656|NCT05105243|101210923|FG002|COMPLETED|SAD Cohort 3: 45 mg (14 Days)||6||
48360657|NCT05105243|101210924|FG003|COMPLETED|SAD Cohort 3: 45 mg (14 Days)||0||
48360658|NCT05105243|101210925|FG004|COMPLETED|SAD Cohort 3: 45 mg (14 Days)||0||
48360659|NCT05105243|101210926|FG005|COMPLETED|SAD Cohort 3: 45 mg (14 Days)||2||
48360660|NCT05105243|101210927|FG006|COMPLETED|SAD Cohort 3: 45 mg (14 Days)||0||
48360661|NCT05105243|101210928|FG007|COMPLETED|SAD Cohort 3: 45 mg (14 Days)||0||
48360662|NCT05105243|101210929|FG008|COMPLETED|SAD Cohort 3: 45 mg (14 Days)||0||
48360663|NCT05105243|101210930|FG009|COMPLETED|SAD Cohort 3: 45 mg (14 Days)||0||
48360664|NCT05105243|101210921|FG000|NOT COMPLETED|SAD Cohort 3: 45 mg (14 Days)||0||
48360665|NCT05105243|101210922|FG001|NOT COMPLETED|SAD Cohort 3: 45 mg (14 Days)||0||
48360666|NCT05105243|101210923|FG002|NOT COMPLETED|SAD Cohort 3: 45 mg (14 Days)||0||
48360667|NCT05105243|101210924|FG003|NOT COMPLETED|SAD Cohort 3: 45 mg (14 Days)||0||
48360668|NCT05105243|101210925|FG004|NOT COMPLETED|SAD Cohort 3: 45 mg (14 Days)||0||
48360669|NCT05105243|101210926|FG005|NOT COMPLETED|SAD Cohort 3: 45 mg (14 Days)||0||
48360670|NCT05105243|101210927|FG006|NOT COMPLETED|SAD Cohort 3: 45 mg (14 Days)||0||
48360671|NCT05105243|101210928|FG007|NOT COMPLETED|SAD Cohort 3: 45 mg (14 Days)||0||
48360672|NCT05105243|101210929|FG008|NOT COMPLETED|SAD Cohort 3: 45 mg (14 Days)||0||
48360673|NCT05105243|101210930|FG009|NOT COMPLETED|SAD Cohort 3: 45 mg (14 Days)||0||
48360674|NCT05105243|101210921|FG000|STARTED|SAD Cohort 4: 125 mg (14 Days)||0||
48360675|NCT05105243|101210922|FG001|STARTED|SAD Cohort 4: 125 mg (14 Days)||0||
48360676|NCT05105243|101210923|FG002|STARTED|SAD Cohort 4: 125 mg (14 Days)||0||
48360677|NCT05105243|101210924|FG003|STARTED|SAD Cohort 4: 125 mg (14 Days)||6||
48360678|NCT05105243|101210925|FG004|STARTED|SAD Cohort 4: 125 mg (14 Days)||0||
48360679|NCT05105243|101210926|FG005|STARTED|SAD Cohort 4: 125 mg (14 Days)||2||
48360680|NCT05105243|101210927|FG006|STARTED|SAD Cohort 4: 125 mg (14 Days)||0||
48360681|NCT05105243|101210928|FG007|STARTED|SAD Cohort 4: 125 mg (14 Days)||0||
48360682|NCT05105243|101210929|FG008|STARTED|SAD Cohort 4: 125 mg (14 Days)||0||
48360683|NCT05105243|101210930|FG009|STARTED|SAD Cohort 4: 125 mg (14 Days)||0||
48360684|NCT05105243|101210921|FG000|COMPLETED|SAD Cohort 4: 125 mg (14 Days)||0||
48360685|NCT05105243|101210922|FG001|COMPLETED|SAD Cohort 4: 125 mg (14 Days)||0||
48360686|NCT05105243|101210923|FG002|COMPLETED|SAD Cohort 4: 125 mg (14 Days)||0||
48360687|NCT05105243|101210924|FG003|COMPLETED|SAD Cohort 4: 125 mg (14 Days)||6||
48360688|NCT05105243|101210925|FG004|COMPLETED|SAD Cohort 4: 125 mg (14 Days)||0||
48360689|NCT05105243|101210926|FG005|COMPLETED|SAD Cohort 4: 125 mg (14 Days)||2||
48360690|NCT05105243|101210927|FG006|COMPLETED|SAD Cohort 4: 125 mg (14 Days)||0||
48360691|NCT05105243|101210928|FG007|COMPLETED|SAD Cohort 4: 125 mg (14 Days)||0||
48360692|NCT05105243|101210929|FG008|COMPLETED|SAD Cohort 4: 125 mg (14 Days)||0||
48360693|NCT05105243|101210930|FG009|COMPLETED|SAD Cohort 4: 125 mg (14 Days)||0||
48360694|NCT05105243|101210921|FG000|NOT COMPLETED|SAD Cohort 4: 125 mg (14 Days)||0||
48360695|NCT05105243|101210922|FG001|NOT COMPLETED|SAD Cohort 4: 125 mg (14 Days)||0||
48360696|NCT05105243|101210923|FG002|NOT COMPLETED|SAD Cohort 4: 125 mg (14 Days)||0||
48360697|NCT05105243|101210924|FG003|NOT COMPLETED|SAD Cohort 4: 125 mg (14 Days)||0||
48360698|NCT05105243|101210925|FG004|NOT COMPLETED|SAD Cohort 4: 125 mg (14 Days)||0||
48360699|NCT05105243|101210926|FG005|NOT COMPLETED|SAD Cohort 4: 125 mg (14 Days)||0||
48360700|NCT05105243|101210927|FG006|NOT COMPLETED|SAD Cohort 4: 125 mg (14 Days)||0||
48360701|NCT05105243|101210928|FG007|NOT COMPLETED|SAD Cohort 4: 125 mg (14 Days)||0||
48360702|NCT05105243|101210929|FG008|NOT COMPLETED|SAD Cohort 4: 125 mg (14 Days)||0||
48360703|NCT05105243|101210930|FG009|NOT COMPLETED|SAD Cohort 4: 125 mg (14 Days)||0||
48360704|NCT05105243|101210921|FG000|STARTED|SAD Cohort 5: 250 mg (14 Days)||0||
48360705|NCT05105243|101210922|FG001|STARTED|SAD Cohort 5: 250 mg (14 Days)||0||
48360706|NCT05105243|101210923|FG002|STARTED|SAD Cohort 5: 250 mg (14 Days)||0||
48360707|NCT05105243|101210924|FG003|STARTED|SAD Cohort 5: 250 mg (14 Days)||0||
48360708|NCT05105243|101210925|FG004|STARTED|SAD Cohort 5: 250 mg (14 Days)||6||
48360709|NCT05105243|101210926|FG005|STARTED|SAD Cohort 5: 250 mg (14 Days)||2||
48360710|NCT05105243|101210927|FG006|STARTED|SAD Cohort 5: 250 mg (14 Days)||0||
48360711|NCT05105243|101210928|FG007|STARTED|SAD Cohort 5: 250 mg (14 Days)||0||
48360712|NCT05105243|101210929|FG008|STARTED|SAD Cohort 5: 250 mg (14 Days)||0||
48360713|NCT05105243|101210930|FG009|STARTED|SAD Cohort 5: 250 mg (14 Days)||0||
48360714|NCT05105243|101210921|FG000|COMPLETED|SAD Cohort 5: 250 mg (14 Days)||0||
48360715|NCT05105243|101210922|FG001|COMPLETED|SAD Cohort 5: 250 mg (14 Days)||0||
48431310|NCT03426995|101389395|FG010|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48431311|NCT03426995|101389396|FG011|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48431312|NCT03426995|101389397|FG012|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48431313|NCT03426995|101389398|FG013|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48431314|NCT03426995|101389399|FG014|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48431315|NCT03426995|101389400|FG015|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48431316|NCT03426995|101389401|FG016|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48431317|NCT03426995|101389402|FG017|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48431318|NCT03426995|101389403|FG018|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48431319|NCT03426995|101389385|FG000|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48431320|NCT03426995|101389386|FG001|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48431321|NCT03426995|101389387|FG002|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48431322|NCT03426995|101389388|FG003|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48431323|NCT03426995|101389389|FG004|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48431324|NCT03426995|101389390|FG005|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48431325|NCT03426995|101389391|FG006|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48431326|NCT03426995|101389392|FG007|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48431327|NCT03426995|101389393|FG008|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48431328|NCT03426995|101389394|FG009|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48431329|NCT03426995|101389395|FG010|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48431330|NCT03426995|101389396|FG011|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48431331|NCT03426995|101389397|FG012|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48431332|NCT03426995|101389398|FG013|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48431333|NCT03426995|101389399|FG014|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48431334|NCT03426995|101389400|FG015|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48431335|NCT03426995|101389401|FG016|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48431336|NCT03426995|101389402|FG017|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48431337|NCT03426995|101389403|FG018|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
48431338|NCT03426995|101389385|FG000|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
48431339|NCT03426995|101389386|FG001|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
48431340|NCT03426995|101389387|FG002|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
48431341|NCT03426995|101389388|FG003|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
48431342|NCT03426995|101389389|FG004|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
48431343|NCT03426995|101389390|FG005|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
48431344|NCT03426995|101389391|FG006|STARTED|Part A: Cohort 2-Period 1 (Day1)||1||
48431345|NCT03426995|101389392|FG007|STARTED|Part A: Cohort 2-Period 1 (Day1)||2||
48431346|NCT03426995|101389393|FG008|STARTED|Part A: Cohort 2-Period 1 (Day1)||1||
48431347|NCT03426995|101389394|FG009|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
48431348|NCT03426995|101389395|FG010|STARTED|Part A: Cohort 2-Period 1 (Day1)||1||
48431349|NCT03426995|101389396|FG011|STARTED|Part A: Cohort 2-Period 1 (Day1)||1||
48431350|NCT03426995|101389397|FG012|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
48431351|NCT03426995|101389398|FG013|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
48431352|NCT03426995|101389399|FG014|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
48431353|NCT03426995|101389400|FG015|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
48431354|NCT03426995|101389401|FG016|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
48431355|NCT03426995|101389402|FG017|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
48431356|NCT03426995|101389403|FG018|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
48431357|NCT03426995|101389385|FG000|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48431358|NCT03426995|101389386|FG001|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48431359|NCT03426995|101389387|FG002|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48431360|NCT03426995|101389388|FG003|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48431361|NCT03426995|101389389|FG004|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48431362|NCT03426995|101389390|FG005|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48431363|NCT03426995|101389391|FG006|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1||
48431364|NCT03426995|101389392|FG007|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||2||
48431365|NCT03426995|101389393|FG008|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1||
48431366|NCT03426995|101389394|FG009|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48431367|NCT03426995|101389395|FG010|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1||
48431368|NCT03426995|101389396|FG011|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1||
48431369|NCT03426995|101389397|FG012|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48431370|NCT03426995|101389398|FG013|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48431371|NCT03426995|101389399|FG014|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48431372|NCT03426995|101389400|FG015|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48431373|NCT03426995|101389401|FG016|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48431374|NCT03426995|101389402|FG017|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48431375|NCT03426995|101389403|FG018|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48431376|NCT03426995|101389385|FG000|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48431377|NCT03426995|101389386|FG001|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48431378|NCT03426995|101389387|FG002|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48431379|NCT03426995|101389388|FG003|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48431380|NCT03426995|101389389|FG004|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48431381|NCT03426995|101389390|FG005|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48431382|NCT03426995|101389391|FG006|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48431383|NCT03426995|101389392|FG007|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48431384|NCT03426995|101389393|FG008|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48431385|NCT03426995|101389394|FG009|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48431386|NCT03426995|101389395|FG010|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48431387|NCT03426995|101389396|FG011|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48431388|NCT03426995|101389397|FG012|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48431389|NCT03426995|101389398|FG013|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48431390|NCT03426995|101389399|FG014|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48431391|NCT03426995|101389400|FG015|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48431392|NCT03426995|101389401|FG016|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48431393|NCT03426995|101389402|FG017|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48431394|NCT03426995|101389403|FG018|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
48431395|NCT03426995|101389385|FG000|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431396|NCT03426995|101389386|FG001|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431397|NCT03426995|101389387|FG002|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431398|NCT03426995|101389388|FG003|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431399|NCT03426995|101389389|FG004|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431400|NCT03426995|101389390|FG005|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431401|NCT03426995|101389391|FG006|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1||
48431402|NCT03426995|101389392|FG007|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||2||
48431403|NCT03426995|101389393|FG008|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1||
48431404|NCT03426995|101389394|FG009|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431405|NCT03426995|101389395|FG010|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1||
48431406|NCT03426995|101389396|FG011|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1||
48431407|NCT03426995|101389397|FG012|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431408|NCT03426995|101389398|FG013|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431409|NCT03426995|101389399|FG014|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431410|NCT03426995|101389400|FG015|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431411|NCT03426995|101389401|FG016|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431412|NCT03426995|101389402|FG017|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431413|NCT03426995|101389403|FG018|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431414|NCT03426995|101389385|FG000|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431415|NCT03426995|101389386|FG001|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431416|NCT03426995|101389387|FG002|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431417|NCT03426995|101389388|FG003|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431418|NCT03426995|101389389|FG004|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431419|NCT03426995|101389390|FG005|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431420|NCT03426995|101389391|FG006|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1||
48431421|NCT03426995|101389392|FG007|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||2||
48431422|NCT03426995|101389393|FG008|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1||
48431423|NCT03426995|101389394|FG009|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431424|NCT03426995|101389395|FG010|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1||
48431425|NCT03426995|101389396|FG011|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1||
48431426|NCT03426995|101389397|FG012|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431427|NCT03426995|101389398|FG013|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431428|NCT03426995|101389399|FG014|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431429|NCT03426995|101389400|FG015|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431430|NCT03426995|101389401|FG016|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431431|NCT03426995|101389402|FG017|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431432|NCT03426995|101389403|FG018|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431433|NCT03426995|101389385|FG000|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431434|NCT03426995|101389386|FG001|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431435|NCT03426995|101389387|FG002|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431436|NCT03426995|101389388|FG003|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431437|NCT03426995|101389389|FG004|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431438|NCT03426995|101389390|FG005|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431439|NCT03426995|101389391|FG006|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431440|NCT03426995|101389392|FG007|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431441|NCT03426995|101389393|FG008|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431442|NCT03426995|101389394|FG009|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431443|NCT03426995|101389395|FG010|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431444|NCT03426995|101389396|FG011|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48764214|NCT00551642|102211909|FG000|COMPLETED|Treatment Period||338||
48431445|NCT03426995|101389397|FG012|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431446|NCT03426995|101389398|FG013|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431447|NCT03426995|101389399|FG014|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48360716|NCT05105243|101210923|FG002|COMPLETED|SAD Cohort 5: 250 mg (14 Days)||0||
48360717|NCT05105243|101210924|FG003|COMPLETED|SAD Cohort 5: 250 mg (14 Days)||0||
48360718|NCT05105243|101210925|FG004|COMPLETED|SAD Cohort 5: 250 mg (14 Days)||6||
48360719|NCT05105243|101210926|FG005|COMPLETED|SAD Cohort 5: 250 mg (14 Days)||2||
48360720|NCT05105243|101210927|FG006|COMPLETED|SAD Cohort 5: 250 mg (14 Days)||0||
48360721|NCT05105243|101210928|FG007|COMPLETED|SAD Cohort 5: 250 mg (14 Days)||0||
48360722|NCT05105243|101210929|FG008|COMPLETED|SAD Cohort 5: 250 mg (14 Days)||0||
48360723|NCT05105243|101210930|FG009|COMPLETED|SAD Cohort 5: 250 mg (14 Days)||0||
48360724|NCT05105243|101210921|FG000|NOT COMPLETED|SAD Cohort 5: 250 mg (14 Days)||0||
48360725|NCT05105243|101210922|FG001|NOT COMPLETED|SAD Cohort 5: 250 mg (14 Days)||0||
48360726|NCT05105243|101210923|FG002|NOT COMPLETED|SAD Cohort 5: 250 mg (14 Days)||0||
48360727|NCT05105243|101210924|FG003|NOT COMPLETED|SAD Cohort 5: 250 mg (14 Days)||0||
48360728|NCT05105243|101210925|FG004|NOT COMPLETED|SAD Cohort 5: 250 mg (14 Days)||0||
48360729|NCT05105243|101210926|FG005|NOT COMPLETED|SAD Cohort 5: 250 mg (14 Days)||0||
48360730|NCT05105243|101210927|FG006|NOT COMPLETED|SAD Cohort 5: 250 mg (14 Days)||0||
48360731|NCT05105243|101210928|FG007|NOT COMPLETED|SAD Cohort 5: 250 mg (14 Days)||0||
48360732|NCT05105243|101210929|FG008|NOT COMPLETED|SAD Cohort 5: 250 mg (14 Days)||0||
48360733|NCT05105243|101210930|FG009|NOT COMPLETED|SAD Cohort 5: 250 mg (14 Days)||0||
48360734|NCT05105243|101210921|FG000|STARTED|MAD Cohort 1: 45 mg (21 Days)||0||
48360735|NCT05105243|101210922|FG001|STARTED|MAD Cohort 1: 45 mg (21 Days)||0||
48360736|NCT05105243|101210923|FG002|STARTED|MAD Cohort 1: 45 mg (21 Days)||0||
48360737|NCT05105243|101210924|FG003|STARTED|MAD Cohort 1: 45 mg (21 Days)||0||
48360738|NCT05105243|101210925|FG004|STARTED|MAD Cohort 1: 45 mg (21 Days)||0||
48360739|NCT05105243|101210926|FG005|STARTED|MAD Cohort 1: 45 mg (21 Days)||0||
48360740|NCT05105243|101210927|FG006|STARTED|MAD Cohort 1: 45 mg (21 Days)||6||
48360741|NCT05105243|101210928|FG007|STARTED|MAD Cohort 1: 45 mg (21 Days)||0||
48360742|NCT05105243|101210929|FG008|STARTED|MAD Cohort 1: 45 mg (21 Days)||0||
48360743|NCT05105243|101210930|FG009|STARTED|MAD Cohort 1: 45 mg (21 Days)||2||
48360744|NCT05105243|101210921|FG000|COMPLETED|MAD Cohort 1: 45 mg (21 Days)||0||
48360745|NCT05105243|101210922|FG001|COMPLETED|MAD Cohort 1: 45 mg (21 Days)||0||
48360746|NCT05105243|101210923|FG002|COMPLETED|MAD Cohort 1: 45 mg (21 Days)||0||
48360747|NCT05105243|101210924|FG003|COMPLETED|MAD Cohort 1: 45 mg (21 Days)||0||
48360748|NCT05105243|101210925|FG004|COMPLETED|MAD Cohort 1: 45 mg (21 Days)||0||
48360749|NCT05105243|101210926|FG005|COMPLETED|MAD Cohort 1: 45 mg (21 Days)||0||
48360750|NCT05105243|101210927|FG006|COMPLETED|MAD Cohort 1: 45 mg (21 Days)||6||
48360751|NCT05105243|101210928|FG007|COMPLETED|MAD Cohort 1: 45 mg (21 Days)||0||
48360752|NCT05105243|101210929|FG008|COMPLETED|MAD Cohort 1: 45 mg (21 Days)||0||
48360753|NCT05105243|101210930|FG009|COMPLETED|MAD Cohort 1: 45 mg (21 Days)||2||
48360754|NCT05105243|101210921|FG000|NOT COMPLETED|MAD Cohort 1: 45 mg (21 Days)||0||
48360755|NCT05105243|101210922|FG001|NOT COMPLETED|MAD Cohort 1: 45 mg (21 Days)||0||
48360756|NCT05105243|101210923|FG002|NOT COMPLETED|MAD Cohort 1: 45 mg (21 Days)||0||
48360757|NCT05105243|101210924|FG003|NOT COMPLETED|MAD Cohort 1: 45 mg (21 Days)||0||
48360758|NCT05105243|101210925|FG004|NOT COMPLETED|MAD Cohort 1: 45 mg (21 Days)||0||
48360759|NCT05105243|101210926|FG005|NOT COMPLETED|MAD Cohort 1: 45 mg (21 Days)||0||
48360760|NCT05105243|101210927|FG006|NOT COMPLETED|MAD Cohort 1: 45 mg (21 Days)||0||
48360761|NCT05105243|101210928|FG007|NOT COMPLETED|MAD Cohort 1: 45 mg (21 Days)||0||
48360762|NCT05105243|101210929|FG008|NOT COMPLETED|MAD Cohort 1: 45 mg (21 Days)||0||
48360763|NCT05105243|101210930|FG009|NOT COMPLETED|MAD Cohort 1: 45 mg (21 Days)||0||
48360764|NCT05105243|101210921|FG000|STARTED|MAD Cohort 2: 125 mg (21 Days)||0||
48360765|NCT05105243|101210922|FG001|STARTED|MAD Cohort 2: 125 mg (21 Days)||0||
48360766|NCT05105243|101210923|FG002|STARTED|MAD Cohort 2: 125 mg (21 Days)||0||
48360767|NCT05105243|101210924|FG003|STARTED|MAD Cohort 2: 125 mg (21 Days)||0||
48360768|NCT05105243|101210925|FG004|STARTED|MAD Cohort 2: 125 mg (21 Days)||0||
48360769|NCT05105243|101210926|FG005|STARTED|MAD Cohort 2: 125 mg (21 Days)||0||
48360770|NCT05105243|101210927|FG006|STARTED|MAD Cohort 2: 125 mg (21 Days)||0||
48360771|NCT05105243|101210928|FG007|STARTED|MAD Cohort 2: 125 mg (21 Days)||6||
48360772|NCT05105243|101210929|FG008|STARTED|MAD Cohort 2: 125 mg (21 Days)||0||
48360773|NCT05105243|101210930|FG009|STARTED|MAD Cohort 2: 125 mg (21 Days)||2||
48360774|NCT05105243|101210921|FG000|COMPLETED|MAD Cohort 2: 125 mg (21 Days)||0||
48360775|NCT05105243|101210922|FG001|COMPLETED|MAD Cohort 2: 125 mg (21 Days)||0||
48360776|NCT05105243|101210923|FG002|COMPLETED|MAD Cohort 2: 125 mg (21 Days)||0||
48360777|NCT05105243|101210924|FG003|COMPLETED|MAD Cohort 2: 125 mg (21 Days)||0||
48360778|NCT05105243|101210925|FG004|COMPLETED|MAD Cohort 2: 125 mg (21 Days)||0||
48360779|NCT05105243|101210926|FG005|COMPLETED|MAD Cohort 2: 125 mg (21 Days)||0||
48360780|NCT05105243|101210927|FG006|COMPLETED|MAD Cohort 2: 125 mg (21 Days)||0||
48360781|NCT05105243|101210928|FG007|COMPLETED|MAD Cohort 2: 125 mg (21 Days)||6||
48360782|NCT05105243|101210929|FG008|COMPLETED|MAD Cohort 2: 125 mg (21 Days)||0||
48360783|NCT05105243|101210930|FG009|COMPLETED|MAD Cohort 2: 125 mg (21 Days)||2||
48360784|NCT05105243|101210921|FG000|NOT COMPLETED|MAD Cohort 2: 125 mg (21 Days)||0||
48360785|NCT05105243|101210922|FG001|NOT COMPLETED|MAD Cohort 2: 125 mg (21 Days)||0||
48360786|NCT05105243|101210923|FG002|NOT COMPLETED|MAD Cohort 2: 125 mg (21 Days)||0||
48360787|NCT05105243|101210924|FG003|NOT COMPLETED|MAD Cohort 2: 125 mg (21 Days)||0||
48360788|NCT05105243|101210925|FG004|NOT COMPLETED|MAD Cohort 2: 125 mg (21 Days)||0||
48431448|NCT03426995|101389400|FG015|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431449|NCT03426995|101389401|FG016|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431450|NCT03426995|101389402|FG017|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48764215|NCT00551642|102211910|FG001|COMPLETED|Treatment Period||338||
48764216|NCT00551642|102211909|FG000|NOT COMPLETED|Treatment Period||61||
48764217|NCT00551642|102211910|FG001|NOT COMPLETED|Treatment Period||63||
48764218|NCT00551642|102211909|FG000|STARTED|7-Year Follow-up||152|Participants with data available at 7-year Follow-up|
48764219|NCT00551642|102211910|FG001|STARTED|7-Year Follow-up||153|Participants with data available at 7-year Follow-up|
48764220|NCT00551642|102211909|FG000|COMPLETED|7-Year Follow-up||152||
48764221|NCT00551642|102211910|FG001|COMPLETED|7-Year Follow-up||153||
48764222|NCT00551642|102211909|FG000|NOT COMPLETED|7-Year Follow-up||0||
48764223|NCT00551642|102211910|FG001|NOT COMPLETED|7-Year Follow-up||0||
48431451|NCT03426995|101389403|FG018|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
48431452|NCT03426995|101389385|FG000|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
48431453|NCT03426995|101389386|FG001|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
48431454|NCT03426995|101389387|FG002|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
48431455|NCT03426995|101389388|FG003|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
48431456|NCT03426995|101389389|FG004|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
48431457|NCT03426995|101389390|FG005|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
48431458|NCT03426995|101389391|FG006|STARTED|Part A: Cohort 2-Period 2 (Day1)||1||
48431459|NCT03426995|101389392|FG007|STARTED|Part A: Cohort 2-Period 2 (Day1)||2||
48431460|NCT03426995|101389393|FG008|STARTED|Part A: Cohort 2-Period 2 (Day1)||1||
48431461|NCT03426995|101389394|FG009|STARTED|Part A: Cohort 2-Period 2 (Day1)||2||
48431462|NCT03426995|101389395|FG010|STARTED|Part A: Cohort 2-Period 2 (Day1)||1||
48431463|NCT03426995|101389396|FG011|STARTED|Part A: Cohort 2-Period 2 (Day1)||2||
48431464|NCT03426995|101389397|FG012|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
48431465|NCT03426995|101389398|FG013|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
48431466|NCT03426995|101389399|FG014|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
48431467|NCT03426995|101389400|FG015|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
48431468|NCT03426995|101389401|FG016|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
48431469|NCT03426995|101389402|FG017|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
48431470|NCT03426995|101389403|FG018|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
48431471|NCT03426995|101389385|FG000|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48431472|NCT03426995|101389386|FG001|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48431473|NCT03426995|101389387|FG002|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48431474|NCT03426995|101389388|FG003|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48431475|NCT03426995|101389389|FG004|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48431476|NCT03426995|101389390|FG005|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48431477|NCT03426995|101389391|FG006|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1||
48431478|NCT03426995|101389392|FG007|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2||
48431479|NCT03426995|101389393|FG008|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1||
48431480|NCT03426995|101389394|FG009|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2||
48431481|NCT03426995|101389395|FG010|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1||
48431482|NCT03426995|101389396|FG011|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2||
48431483|NCT03426995|101389397|FG012|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48431484|NCT03426995|101389398|FG013|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48431485|NCT03426995|101389399|FG014|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48764224|NCT00524511|102211911|FG000|STARTED|Overall Study||68||
48431486|NCT03426995|101389400|FG015|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48431487|NCT03426995|101389401|FG016|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48431488|NCT03426995|101389402|FG017|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48431489|NCT03426995|101389403|FG018|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48431490|NCT03426995|101389385|FG000|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48431491|NCT03426995|101389386|FG001|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48431492|NCT03426995|101389387|FG002|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48431493|NCT03426995|101389388|FG003|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48431494|NCT03426995|101389389|FG004|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48431495|NCT03426995|101389390|FG005|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48431496|NCT03426995|101389391|FG006|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48431497|NCT03426995|101389392|FG007|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48431498|NCT03426995|101389393|FG008|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48431499|NCT03426995|101389394|FG009|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48431500|NCT03426995|101389395|FG010|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48431501|NCT03426995|101389396|FG011|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48431502|NCT03426995|101389397|FG012|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48431503|NCT03426995|101389398|FG013|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48764225|NCT00524511|102211912|FG001|STARTED|Overall Study||68||
48764226|NCT00524511|102211911|FG000|COMPLETED|Overall Study||64||
48764227|NCT00524511|102211912|FG001|COMPLETED|Overall Study||61||
48764228|NCT00524511|102211911|FG000|NOT COMPLETED|Overall Study||4||
48764229|NCT00524511|102211912|FG001|NOT COMPLETED|Overall Study||7||
48431504|NCT03426995|101389399|FG014|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48431505|NCT03426995|101389400|FG015|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48431506|NCT03426995|101389401|FG016|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48431507|NCT03426995|101389402|FG017|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48431508|NCT03426995|101389403|FG018|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
48431509|NCT03426995|101389385|FG000|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431510|NCT03426995|101389386|FG001|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431511|NCT03426995|101389387|FG002|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431512|NCT03426995|101389388|FG003|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431513|NCT03426995|101389389|FG004|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431514|NCT03426995|101389390|FG005|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431515|NCT03426995|101389391|FG006|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1||
48431516|NCT03426995|101389392|FG007|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2||
48431517|NCT03426995|101389393|FG008|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1||
48431518|NCT03426995|101389394|FG009|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2||
48431519|NCT03426995|101389395|FG010|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1||
48431520|NCT03426995|101389396|FG011|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2||
48431521|NCT03426995|101389397|FG012|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431522|NCT03426995|101389398|FG013|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431523|NCT03426995|101389399|FG014|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431524|NCT03426995|101389400|FG015|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431525|NCT03426995|101389401|FG016|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431526|NCT03426995|101389402|FG017|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431527|NCT03426995|101389403|FG018|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431528|NCT03426995|101389385|FG000|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431529|NCT03426995|101389386|FG001|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431530|NCT03426995|101389387|FG002|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431531|NCT03426995|101389388|FG003|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431532|NCT03426995|101389389|FG004|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431533|NCT03426995|101389390|FG005|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431534|NCT03426995|101389391|FG006|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1||
48431535|NCT03426995|101389392|FG007|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2||
48431536|NCT03426995|101389393|FG008|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1||
48431537|NCT03426995|101389394|FG009|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2||
48431538|NCT03426995|101389395|FG010|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1||
48431539|NCT03426995|101389396|FG011|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2||
48431540|NCT03426995|101389397|FG012|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431541|NCT03426995|101389398|FG013|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431542|NCT03426995|101389399|FG014|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431543|NCT03426995|101389400|FG015|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431544|NCT03426995|101389401|FG016|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431545|NCT03426995|101389402|FG017|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431546|NCT03426995|101389403|FG018|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431547|NCT03426995|101389385|FG000|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431548|NCT03426995|101389386|FG001|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431549|NCT03426995|101389387|FG002|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431550|NCT03426995|101389388|FG003|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431551|NCT03426995|101389389|FG004|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431552|NCT03426995|101389390|FG005|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431553|NCT03426995|101389391|FG006|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431554|NCT03426995|101389392|FG007|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431555|NCT03426995|101389393|FG008|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431556|NCT03426995|101389394|FG009|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431557|NCT03426995|101389395|FG010|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431558|NCT03426995|101389396|FG011|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431559|NCT03426995|101389397|FG012|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431560|NCT03426995|101389398|FG013|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431561|NCT03426995|101389399|FG014|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431562|NCT03426995|101389400|FG015|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431563|NCT03426995|101389401|FG016|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431564|NCT03426995|101389402|FG017|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431565|NCT03426995|101389403|FG018|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
48431566|NCT03426995|101389385|FG000|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
48431567|NCT03426995|101389386|FG001|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
48431568|NCT03426995|101389387|FG002|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
48431569|NCT03426995|101389388|FG003|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
48431570|NCT03426995|101389389|FG004|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
48431571|NCT03426995|101389390|FG005|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
48431572|NCT03426995|101389391|FG006|STARTED|Part A: Cohort 2-Period 3 (Day1)||1||
48431573|NCT03426995|101389392|FG007|STARTED|Part A: Cohort 2-Period 3 (Day1)||2||
48431574|NCT03426995|101389393|FG008|STARTED|Part A: Cohort 2-Period 3 (Day1)||1||
48431575|NCT03426995|101389394|FG009|STARTED|Part A: Cohort 2-Period 3 (Day1)||2||
48431576|NCT03426995|101389395|FG010|STARTED|Part A: Cohort 2-Period 3 (Day1)||1||
48431577|NCT03426995|101389396|FG011|STARTED|Part A: Cohort 2-Period 3 (Day1)||2||
48431578|NCT03426995|101389397|FG012|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
48431579|NCT03426995|101389398|FG013|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
48431580|NCT03426995|101389399|FG014|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
48431581|NCT03426995|101389400|FG015|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
48431582|NCT03426995|101389401|FG016|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
48431583|NCT03426995|101389402|FG017|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
48431584|NCT03426995|101389403|FG018|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
48431585|NCT03426995|101389385|FG000|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48431586|NCT03426995|101389386|FG001|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48431587|NCT03426995|101389387|FG002|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48431588|NCT03426995|101389388|FG003|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48431589|NCT03426995|101389389|FG004|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48431590|NCT03426995|101389390|FG005|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48431591|NCT03426995|101389391|FG006|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1||
48431592|NCT03426995|101389392|FG007|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2||
48431593|NCT03426995|101389393|FG008|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1||
48431594|NCT03426995|101389394|FG009|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2||
48431595|NCT03426995|101389395|FG010|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1||
48431596|NCT03426995|101389396|FG011|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2||
48431597|NCT03426995|101389397|FG012|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48431598|NCT03426995|101389398|FG013|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48431599|NCT03426995|101389399|FG014|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48431600|NCT03426995|101389400|FG015|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48431601|NCT03426995|101389401|FG016|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48431602|NCT03426995|101389402|FG017|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48431603|NCT03426995|101389403|FG018|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48431604|NCT03426995|101389385|FG000|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48431605|NCT03426995|101389386|FG001|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48360789|NCT05105243|101210926|FG005|NOT COMPLETED|MAD Cohort 2: 125 mg (21 Days)||0||
48360790|NCT05105243|101210927|FG006|NOT COMPLETED|MAD Cohort 2: 125 mg (21 Days)||0||
48360791|NCT05105243|101210928|FG007|NOT COMPLETED|MAD Cohort 2: 125 mg (21 Days)||0||
48360792|NCT05105243|101210929|FG008|NOT COMPLETED|MAD Cohort 2: 125 mg (21 Days)||0||
48360793|NCT05105243|101210930|FG009|NOT COMPLETED|MAD Cohort 2: 125 mg (21 Days)||0||
48360794|NCT05105243|101210921|FG000|STARTED|MAD Cohort 1: 250 mg (21 Days)||0||
48360795|NCT05105243|101210922|FG001|STARTED|MAD Cohort 1: 250 mg (21 Days)||0||
48360796|NCT05105243|101210923|FG002|STARTED|MAD Cohort 1: 250 mg (21 Days)||0||
48431606|NCT03426995|101389387|FG002|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48187572|NCT01559090|100780073|FG000|NOT COMPLETED|Stage II||1||
48187573|NCT01559090|100780074|FG001|NOT COMPLETED|Stage II||0||
48187574|NCT01559090|100780075|FG002|NOT COMPLETED|Stage II||0||
48187575|NCT02403674|100780076|FG000|STARTED|Base Study||368|Randomized|
48431607|NCT03426995|101389388|FG003|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48431608|NCT03426995|101389389|FG004|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48431609|NCT03426995|101389390|FG005|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48431610|NCT03426995|101389391|FG006|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48431611|NCT03426995|101389392|FG007|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48187576|NCT02403674|100780077|FG001|STARTED|Base Study||366|Randomized|
48187577|NCT02403674|100780076|FG000|Treated|Base Study||364|Received ≥1 dose of study medication.|
48187578|NCT02403674|100780077|FG001|Treated|Base Study||364|Received ≥1 dose of study medication.|
48187579|NCT02403674|100780076|FG000|COMPLETED|Base Study||296|Completed through Week 96|
48431612|NCT03426995|101389393|FG008|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48431613|NCT03426995|101389394|FG009|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48431614|NCT03426995|101389395|FG010|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48431615|NCT03426995|101389396|FG011|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48431616|NCT03426995|101389397|FG012|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48431617|NCT03426995|101389398|FG013|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48431618|NCT03426995|101389399|FG014|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48431619|NCT03426995|101389400|FG015|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48431620|NCT03426995|101389401|FG016|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48431621|NCT03426995|101389402|FG017|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48187580|NCT02403674|100780077|FG001|COMPLETED|Base Study||276|Completed through Week 96|
48431622|NCT03426995|101389403|FG018|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
48431623|NCT03426995|101389385|FG000|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431624|NCT03426995|101389386|FG001|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431625|NCT03426995|101389387|FG002|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431626|NCT03426995|101389388|FG003|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431627|NCT03426995|101389389|FG004|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431628|NCT03426995|101389390|FG005|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48187581|NCT02403674|100780076|FG000|NOT COMPLETED|Base Study||72||
48187582|NCT02403674|100780077|FG001|NOT COMPLETED|Base Study||90||
48187583|NCT02403674|100780076|FG000|STARTED|Study Extension 1 (Open-Label)||291|Not all study participants continued into optional study extension 1|
48187584|NCT02403674|100780077|FG001|STARTED|Study Extension 1 (Open-Label)||269|Not all study participants continued into optional study extension 1|
48187585|NCT02403674|100780076|FG000|COMPLETED|Study Extension 1 (Open-Label)||230||
48187586|NCT02403674|100780077|FG001|COMPLETED|Study Extension 1 (Open-Label)||205||
48431629|NCT03426995|101389391|FG006|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1||
48431630|NCT03426995|101389392|FG007|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2||
48431631|NCT03426995|101389393|FG008|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1||
48431632|NCT03426995|101389394|FG009|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2||
48431633|NCT03426995|101389395|FG010|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1||
48431634|NCT03426995|101389396|FG011|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2||
48431635|NCT03426995|101389397|FG012|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431636|NCT03426995|101389398|FG013|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431637|NCT03426995|101389399|FG014|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431638|NCT03426995|101389400|FG015|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431639|NCT03426995|101389401|FG016|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431640|NCT03426995|101389402|FG017|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431641|NCT03426995|101389403|FG018|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431642|NCT03426995|101389385|FG000|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431643|NCT03426995|101389386|FG001|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431644|NCT03426995|101389387|FG002|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431645|NCT03426995|101389388|FG003|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431646|NCT03426995|101389389|FG004|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431647|NCT03426995|101389390|FG005|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431648|NCT03426995|101389391|FG006|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1||
48431649|NCT03426995|101389392|FG007|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2||
48431650|NCT03426995|101389393|FG008|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1||
48431651|NCT03426995|101389394|FG009|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2||
48764230|NCT01318577|102211913|FG000|STARTED|Overall Study||224||
48764231|NCT01318577|102211914|FG001|STARTED|Overall Study||220||
48764232|NCT01318577|102211913|FG000|COMPLETED|Overall Study||211||
48764233|NCT01318577|102211914|FG001|COMPLETED|Overall Study||212||
48764234|NCT01318577|102211913|FG000|NOT COMPLETED|Overall Study||13||
48187587|NCT02403674|100780076|FG000|NOT COMPLETED|Study Extension 1 (Open-Label)||61||
48187588|NCT02403674|100780077|FG001|NOT COMPLETED|Study Extension 1 (Open-Label)||64||
48187589|NCT02403674|100780076|FG000|STARTED|Study Extension 2 (Open-Label)||192|Not all study participants continued into optional study extension 2|
48187590|NCT02403674|100780077|FG001|STARTED|Study Extension 2 (Open-Label)||173|Not all study participants continued into optional study extension 2|
48187591|NCT02403674|100780076|FG000|COMPLETED|Study Extension 2 (Open-Label)||150||
48764235|NCT01318577|102211914|FG001|NOT COMPLETED|Overall Study||8||
48187592|NCT02403674|100780077|FG001|COMPLETED|Study Extension 2 (Open-Label)||132||
48187593|NCT02403674|100780076|FG000|NOT COMPLETED|Study Extension 2 (Open-Label)||42||
48187594|NCT02403674|100780077|FG001|NOT COMPLETED|Study Extension 2 (Open-Label)||41||
48431652|NCT03426995|101389395|FG010|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1||
48431653|NCT03426995|101389396|FG011|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2||
48431654|NCT03426995|101389397|FG012|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431655|NCT03426995|101389398|FG013|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431656|NCT03426995|101389399|FG014|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431657|NCT03426995|101389400|FG015|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431658|NCT03426995|101389401|FG016|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431659|NCT03426995|101389402|FG017|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431660|NCT03426995|101389403|FG018|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431661|NCT03426995|101389385|FG000|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431662|NCT03426995|101389386|FG001|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431663|NCT03426995|101389387|FG002|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431664|NCT03426995|101389388|FG003|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431665|NCT03426995|101389389|FG004|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48764236|NCT04567628|102211915|FG000|STARTED|Overall Study||436||
48764237|NCT04567628|102211916|FG001|STARTED|Overall Study||4758||
48764238|NCT04567628|102211915|FG000|COMPLETED|Overall Study||436||
48764239|NCT04567628|102211916|FG001|COMPLETED|Overall Study||4758||
48764240|NCT04567628|102211915|FG000|NOT COMPLETED|Overall Study||0||
48764241|NCT04567628|102211916|FG001|NOT COMPLETED|Overall Study||0||
48764242|NCT03043872|102211917|FG000|STARTED|Overall Study||329|Randomized in overall study|
48764243|NCT03043872|102211918|FG001|STARTED|Overall Study||328|Randomized in overall study|
48764244|NCT03043872|102211919|FG002|STARTED|Overall Study||330|Randomized in overall study|
48764245|NCT03043872|102211917|FG000|Randomized and Included in Global Cohort Analysis|Overall Study||268||
48764246|NCT03043872|102211918|FG001|Randomized and Included in Global Cohort Analysis|Overall Study||268||
48764247|NCT03043872|102211919|FG002|Randomized and Included in Global Cohort Analysis|Overall Study||269||
48764248|NCT03043872|102211917|FG000|Received Treatment in Global Cohort|Overall Study||266||
48764249|NCT03043872|102211918|FG001|Received Treatment in Global Cohort|Overall Study||265||
48764250|NCT03043872|102211919|FG002|Received Treatment in Global Cohort|Overall Study||266||
48764251|NCT03043872|102211917|FG000|Randomized and Included in China Cohort Analysis|Overall Study||65||
48764252|NCT03043872|102211918|FG001|Randomized and Included in China Cohort Analysis|Overall Study||61||
48764253|NCT03043872|102211919|FG002|Randomized and Included in China Cohort Analysis|Overall Study||62||
48764254|NCT03043872|102211917|FG000|Received Treatment in China Cohort|Overall Study||65||
48764255|NCT03043872|102211918|FG001|Received Treatment in China Cohort|Overall Study||61||
48764256|NCT03043872|102211919|FG002|Received Treatment in China Cohort|Overall Study||62||
48764257|NCT03043872|102211917|FG000|Included in Both Cohorts (Global + China)|Overall Study||4||
48431666|NCT03426995|101389390|FG005|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431667|NCT03426995|101389391|FG006|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431668|NCT03426995|101389392|FG007|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431669|NCT03426995|101389393|FG008|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431670|NCT03426995|101389394|FG009|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431671|NCT03426995|101389395|FG010|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431672|NCT03426995|101389396|FG011|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431673|NCT03426995|101389397|FG012|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431674|NCT03426995|101389398|FG013|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431675|NCT03426995|101389399|FG014|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431676|NCT03426995|101389400|FG015|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431677|NCT03426995|101389401|FG016|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431678|NCT03426995|101389402|FG017|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431679|NCT03426995|101389403|FG018|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
48431680|NCT03426995|101389385|FG000|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
48431681|NCT03426995|101389386|FG001|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
48431682|NCT03426995|101389387|FG002|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
48431683|NCT03426995|101389388|FG003|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
48431684|NCT03426995|101389389|FG004|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
48431685|NCT03426995|101389390|FG005|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
48431686|NCT03426995|101389391|FG006|STARTED|Part A: Cohort 2-Period 4 (Day1)||1||
48431687|NCT03426995|101389392|FG007|STARTED|Part A: Cohort 2-Period 4 (Day1)||3||
48431688|NCT03426995|101389393|FG008|STARTED|Part A: Cohort 2-Period 4 (Day1)||1||
48431689|NCT03426995|101389394|FG009|STARTED|Part A: Cohort 2-Period 4 (Day1)||2||
48431690|NCT03426995|101389395|FG010|STARTED|Part A: Cohort 2-Period 4 (Day1)||1||
48431691|NCT03426995|101389396|FG011|STARTED|Part A: Cohort 2-Period 4 (Day1)||2||
48431692|NCT03426995|101389397|FG012|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
48431693|NCT03426995|101389398|FG013|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
48431694|NCT03426995|101389399|FG014|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
48431695|NCT03426995|101389400|FG015|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
48431696|NCT03426995|101389401|FG016|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
48431697|NCT03426995|101389402|FG017|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
48431698|NCT03426995|101389403|FG018|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
48431699|NCT03426995|101389385|FG000|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48431700|NCT03426995|101389386|FG001|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48431701|NCT03426995|101389387|FG002|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48431702|NCT03426995|101389388|FG003|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48431703|NCT03426995|101389389|FG004|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48431704|NCT03426995|101389390|FG005|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48431705|NCT03426995|101389391|FG006|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1||
48431706|NCT03426995|101389392|FG007|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2||
48431707|NCT03426995|101389393|FG008|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1||
48431708|NCT03426995|101389394|FG009|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2||
48431709|NCT03426995|101389395|FG010|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48431710|NCT03426995|101389396|FG011|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2||
48431711|NCT03426995|101389397|FG012|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48431712|NCT03426995|101389398|FG013|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48764258|NCT03043872|102211918|FG001|Included in Both Cohorts (Global + China)|Overall Study||1||
48764259|NCT03043872|102211919|FG002|Included in Both Cohorts (Global + China)|Overall Study||1||
48764260|NCT03043872|102211917|FG000|Ongoing Study at Global Cohort Final Analysis Data Cut-off (DCO)|Overall Study||56||
48431713|NCT03426995|101389399|FG014|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48439991|NCT04176354|101410003|FG000|STARTED|Overall Study||813||
48431714|NCT03426995|101389400|FG015|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48431715|NCT03426995|101389401|FG016|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48431716|NCT03426995|101389402|FG017|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48431717|NCT03426995|101389403|FG018|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48431718|NCT03426995|101389385|FG000|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48431719|NCT03426995|101389386|FG001|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48431720|NCT03426995|101389387|FG002|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48431721|NCT03426995|101389388|FG003|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48431722|NCT03426995|101389389|FG004|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48431723|NCT03426995|101389390|FG005|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48431724|NCT03426995|101389391|FG006|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48431725|NCT03426995|101389392|FG007|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1||
48431726|NCT03426995|101389393|FG008|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48431727|NCT03426995|101389394|FG009|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48431728|NCT03426995|101389395|FG010|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1||
48431729|NCT03426995|101389396|FG011|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48431730|NCT03426995|101389397|FG012|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48431731|NCT03426995|101389398|FG013|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48431732|NCT03426995|101389399|FG014|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48431733|NCT03426995|101389400|FG015|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48431734|NCT03426995|101389401|FG016|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48431735|NCT03426995|101389402|FG017|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48431736|NCT03426995|101389403|FG018|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
48431737|NCT03426995|101389385|FG000|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431738|NCT03426995|101389386|FG001|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431739|NCT03426995|101389387|FG002|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431740|NCT03426995|101389388|FG003|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431741|NCT03426995|101389389|FG004|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431742|NCT03426995|101389390|FG005|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431743|NCT03426995|101389391|FG006|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431744|NCT03426995|101389392|FG007|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431745|NCT03426995|101389393|FG008|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431746|NCT03426995|101389394|FG009|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431747|NCT03426995|101389395|FG010|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431748|NCT03426995|101389396|FG011|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431749|NCT03426995|101389397|FG012|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431750|NCT03426995|101389398|FG013|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431751|NCT03426995|101389399|FG014|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431752|NCT03426995|101389400|FG015|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431753|NCT03426995|101389401|FG016|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431754|NCT03426995|101389402|FG017|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431755|NCT03426995|101389403|FG018|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431756|NCT03426995|101389385|FG000|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431757|NCT03426995|101389386|FG001|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431758|NCT03426995|101389387|FG002|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431759|NCT03426995|101389388|FG003|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431760|NCT03426995|101389389|FG004|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431761|NCT03426995|101389390|FG005|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431762|NCT03426995|101389391|FG006|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431763|NCT03426995|101389392|FG007|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431764|NCT03426995|101389393|FG008|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431765|NCT03426995|101389394|FG009|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431766|NCT03426995|101389395|FG010|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431767|NCT03426995|101389396|FG011|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431768|NCT03426995|101389397|FG012|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431769|NCT03426995|101389398|FG013|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431770|NCT03426995|101389399|FG014|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431771|NCT03426995|101389400|FG015|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431772|NCT03426995|101389401|FG016|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431773|NCT03426995|101389402|FG017|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431774|NCT03426995|101389403|FG018|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431775|NCT03426995|101389385|FG000|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431776|NCT03426995|101389386|FG001|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431777|NCT03426995|101389387|FG002|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431778|NCT03426995|101389388|FG003|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431779|NCT03426995|101389389|FG004|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431780|NCT03426995|101389390|FG005|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431781|NCT03426995|101389391|FG006|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431782|NCT03426995|101389392|FG007|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431783|NCT03426995|101389393|FG008|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431784|NCT03426995|101389394|FG009|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431785|NCT03426995|101389395|FG010|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431786|NCT03426995|101389396|FG011|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431787|NCT03426995|101389397|FG012|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431788|NCT03426995|101389398|FG013|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431789|NCT03426995|101389399|FG014|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431790|NCT03426995|101389400|FG015|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431791|NCT03426995|101389401|FG016|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431792|NCT03426995|101389402|FG017|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431793|NCT03426995|101389403|FG018|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
48431794|NCT03426995|101389385|FG000|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431795|NCT03426995|101389386|FG001|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431796|NCT03426995|101389387|FG002|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431797|NCT03426995|101389388|FG003|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431798|NCT03426995|101389389|FG004|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431799|NCT03426995|101389390|FG005|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431800|NCT03426995|101389391|FG006|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431801|NCT03426995|101389392|FG007|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431802|NCT03426995|101389393|FG008|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431803|NCT03426995|101389394|FG009|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431804|NCT03426995|101389395|FG010|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431805|NCT03426995|101389396|FG011|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431806|NCT03426995|101389397|FG012|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431807|NCT03426995|101389398|FG013|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431808|NCT03426995|101389399|FG014|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431809|NCT03426995|101389400|FG015|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431810|NCT03426995|101389401|FG016|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431811|NCT03426995|101389402|FG017|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431812|NCT03426995|101389403|FG018|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431813|NCT03426995|101389385|FG000|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431814|NCT03426995|101389386|FG001|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431815|NCT03426995|101389387|FG002|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431816|NCT03426995|101389388|FG003|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431817|NCT03426995|101389389|FG004|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431818|NCT03426995|101389390|FG005|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431819|NCT03426995|101389391|FG006|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431820|NCT03426995|101389392|FG007|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431821|NCT03426995|101389393|FG008|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431822|NCT03426995|101389394|FG009|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431823|NCT03426995|101389395|FG010|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431824|NCT03426995|101389396|FG011|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431825|NCT03426995|101389397|FG012|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431826|NCT03426995|101389398|FG013|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431827|NCT03426995|101389399|FG014|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431828|NCT03426995|101389400|FG015|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431829|NCT03426995|101389401|FG016|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431830|NCT03426995|101389402|FG017|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431831|NCT03426995|101389403|FG018|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431832|NCT03426995|101389385|FG000|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431833|NCT03426995|101389386|FG001|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431834|NCT03426995|101389387|FG002|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431835|NCT03426995|101389388|FG003|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431836|NCT03426995|101389389|FG004|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431837|NCT03426995|101389390|FG005|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431838|NCT03426995|101389391|FG006|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431839|NCT03426995|101389392|FG007|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431840|NCT03426995|101389393|FG008|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431841|NCT03426995|101389394|FG009|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431842|NCT03426995|101389395|FG010|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431843|NCT03426995|101389396|FG011|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431844|NCT03426995|101389397|FG012|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431845|NCT03426995|101389398|FG013|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431846|NCT03426995|101389399|FG014|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431847|NCT03426995|101389400|FG015|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431848|NCT03426995|101389401|FG016|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431849|NCT03426995|101389402|FG017|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48439992|NCT04176354|101410003|FG000|COMPLETED|Overall Study||813||
48431850|NCT03426995|101389403|FG018|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
48431851|NCT03426995|101389385|FG000|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431852|NCT03426995|101389386|FG001|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431853|NCT03426995|101389387|FG002|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431854|NCT03426995|101389388|FG003|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431855|NCT03426995|101389389|FG004|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431856|NCT03426995|101389390|FG005|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431857|NCT03426995|101389391|FG006|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431858|NCT03426995|101389392|FG007|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431859|NCT03426995|101389393|FG008|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431860|NCT03426995|101389394|FG009|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431861|NCT03426995|101389395|FG010|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431862|NCT03426995|101389396|FG011|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431863|NCT03426995|101389397|FG012|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431864|NCT03426995|101389398|FG013|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431865|NCT03426995|101389399|FG014|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431866|NCT03426995|101389400|FG015|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431867|NCT03426995|101389401|FG016|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431868|NCT03426995|101389402|FG017|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431869|NCT03426995|101389403|FG018|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431870|NCT03426995|101389385|FG000|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431871|NCT03426995|101389386|FG001|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431872|NCT03426995|101389387|FG002|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431873|NCT03426995|101389388|FG003|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431874|NCT03426995|101389389|FG004|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431875|NCT03426995|101389390|FG005|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431876|NCT03426995|101389391|FG006|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431877|NCT03426995|101389392|FG007|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431878|NCT03426995|101389393|FG008|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431879|NCT03426995|101389394|FG009|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431880|NCT03426995|101389395|FG010|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431881|NCT03426995|101389396|FG011|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431882|NCT03426995|101389397|FG012|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431883|NCT03426995|101389398|FG013|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431884|NCT03426995|101389399|FG014|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431885|NCT03426995|101389400|FG015|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431886|NCT03426995|101389401|FG016|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431887|NCT03426995|101389402|FG017|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431888|NCT03426995|101389403|FG018|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431889|NCT03426995|101389385|FG000|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431890|NCT03426995|101389386|FG001|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431891|NCT03426995|101389387|FG002|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431892|NCT03426995|101389388|FG003|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431893|NCT03426995|101389389|FG004|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431894|NCT03426995|101389390|FG005|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431895|NCT03426995|101389391|FG006|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431896|NCT03426995|101389392|FG007|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431897|NCT03426995|101389393|FG008|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431898|NCT03426995|101389394|FG009|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431899|NCT03426995|101389395|FG010|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431900|NCT03426995|101389396|FG011|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431901|NCT03426995|101389397|FG012|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431902|NCT03426995|101389398|FG013|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431903|NCT03426995|101389399|FG014|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431904|NCT03426995|101389400|FG015|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431905|NCT03426995|101389401|FG016|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431906|NCT03426995|101389402|FG017|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431907|NCT03426995|101389403|FG018|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
48431908|NCT03426995|101389385|FG000|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431909|NCT03426995|101389386|FG001|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431910|NCT03426995|101389387|FG002|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431911|NCT03426995|101389388|FG003|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431912|NCT03426995|101389389|FG004|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431913|NCT03426995|101389390|FG005|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431914|NCT03426995|101389391|FG006|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431915|NCT03426995|101389392|FG007|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431916|NCT03426995|101389393|FG008|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431917|NCT03426995|101389394|FG009|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431918|NCT03426995|101389395|FG010|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431919|NCT03426995|101389396|FG011|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431920|NCT03426995|101389397|FG012|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431921|NCT03426995|101389398|FG013|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431922|NCT03426995|101389399|FG014|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||11||
48431923|NCT03426995|101389400|FG015|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||14||
48431924|NCT03426995|101389401|FG016|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431925|NCT03426995|101389402|FG017|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431926|NCT03426995|101389403|FG018|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431927|NCT03426995|101389385|FG000|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431928|NCT03426995|101389386|FG001|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431929|NCT03426995|101389387|FG002|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431930|NCT03426995|101389388|FG003|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431931|NCT03426995|101389389|FG004|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431932|NCT03426995|101389390|FG005|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431933|NCT03426995|101389391|FG006|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431934|NCT03426995|101389392|FG007|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431935|NCT03426995|101389393|FG008|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431936|NCT03426995|101389394|FG009|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431937|NCT03426995|101389395|FG010|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431938|NCT03426995|101389396|FG011|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431939|NCT03426995|101389397|FG012|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431940|NCT03426995|101389398|FG013|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431941|NCT03426995|101389399|FG014|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||2||
48431942|NCT03426995|101389400|FG015|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||2||
48431943|NCT03426995|101389401|FG016|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431944|NCT03426995|101389402|FG017|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431945|NCT03426995|101389403|FG018|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431946|NCT03426995|101389385|FG000|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431947|NCT03426995|101389386|FG001|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431948|NCT03426995|101389387|FG002|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431949|NCT03426995|101389388|FG003|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431950|NCT03426995|101389389|FG004|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431951|NCT03426995|101389390|FG005|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431952|NCT03426995|101389391|FG006|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431953|NCT03426995|101389392|FG007|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431954|NCT03426995|101389393|FG008|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431955|NCT03426995|101389394|FG009|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431956|NCT03426995|101389395|FG010|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431957|NCT03426995|101389396|FG011|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431958|NCT03426995|101389397|FG012|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431959|NCT03426995|101389398|FG013|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431960|NCT03426995|101389399|FG014|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||9||
48431961|NCT03426995|101389400|FG015|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||12||
48431962|NCT03426995|101389401|FG016|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431963|NCT03426995|101389402|FG017|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431964|NCT03426995|101389403|FG018|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
48431965|NCT03377803|101389404|FG000|STARTED|Overall Study||150||
48431966|NCT03377803|101389405|FG001|STARTED|Overall Study||112||
48431967|NCT03377803|101389404|FG000|COMPLETED|Overall Study||139||
48431968|NCT03377803|101389405|FG001|COMPLETED|Overall Study||108||
48431969|NCT03377803|101389404|FG000|NOT COMPLETED|Overall Study||11||
48431970|NCT03377803|101389405|FG001|NOT COMPLETED|Overall Study||4||
48431971|NCT00538434|101389406|FG000|STARTED|Overall Study||56||
48639019|NCT01245751|101901549|FG000|COMPLETED|Part 2: Week 156 (3 Year) Visit||161||
48639020|NCT01245751|101901550|FG001|COMPLETED|Part 2: Week 156 (3 Year) Visit||139||
48639021|NCT01245751|101901551|FG002|COMPLETED|Part 2: Week 156 (3 Year) Visit||0||
48639022|NCT01245751|101901552|FG003|COMPLETED|Part 2: Week 156 (3 Year) Visit||0||
48639023|NCT01245751|101901549|FG000|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0||
48431972|NCT00538434|101389407|FG001|STARTED|Overall Study||57||
48431973|NCT00538434|101389408|FG002|STARTED|Overall Study||57||
48431974|NCT00538434|101389409|FG003|STARTED|Overall Study||57||
48431975|NCT00538434|101389406|FG000|Intent-to-treat (ITT) Population|Overall Study||55||
48431976|NCT00538434|101389407|FG001|Intent-to-treat (ITT) Population|Overall Study||57||
48431977|NCT00538434|101389408|FG002|Intent-to-treat (ITT) Population|Overall Study||57||
48431978|NCT00538434|101389409|FG003|Intent-to-treat (ITT) Population|Overall Study||57||
48431979|NCT00538434|101389406|FG000|COMPLETED|Overall Study||47||
48431980|NCT00538434|101389407|FG001|COMPLETED|Overall Study||46||
48639024|NCT01245751|101901550|FG001|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0||
48431981|NCT00538434|101389408|FG002|COMPLETED|Overall Study||50||
48431982|NCT00538434|101389409|FG003|COMPLETED|Overall Study||51||
48431983|NCT00538434|101389406|FG000|NOT COMPLETED|Overall Study||9||
48431984|NCT00538434|101389407|FG001|NOT COMPLETED|Overall Study||11||
48431985|NCT00538434|101389408|FG002|NOT COMPLETED|Overall Study||7||
48187595|NCT02403674|100780076|FG000|STARTED|Study Extension 3 (Open-Label)||121|Not all study participants continued into optional study extension 3|
48187596|NCT02403674|100780077|FG001|STARTED|Study Extension 3 (Open-Label)||111|Not all study participants continued into optional study extension 3|
48187597|NCT02403674|100780076|FG000|COMPLETED|Study Extension 3 (Open-Label)||100||
48187598|NCT02403674|100780077|FG001|COMPLETED|Study Extension 3 (Open-Label)||85||
48187599|NCT02403674|100780076|FG000|NOT COMPLETED|Study Extension 3 (Open-Label)||21||
48187600|NCT02403674|100780077|FG001|NOT COMPLETED|Study Extension 3 (Open-Label)||26||
48187601|NCT01543685|100783061|FG000|STARTED|Overall Study||93||
48187602|NCT01543685|100783062|FG001|STARTED|Overall Study||91||
48187603|NCT01543685|100783063|FG002|STARTED|Overall Study||91||
48187604|NCT01543685|100783064|FG003|STARTED|Overall Study||93||
48187605|NCT01543685|100783065|FG004|STARTED|Overall Study||94||
48187606|NCT01543685|100783061|FG000|COMPLETED|Overall Study||90||
48187607|NCT01543685|100783062|FG001|COMPLETED|Overall Study||88||
48187608|NCT01543685|100783063|FG002|COMPLETED|Overall Study||89||
48187609|NCT01543685|100783064|FG003|COMPLETED|Overall Study||93||
48187610|NCT01543685|100783065|FG004|COMPLETED|Overall Study||90||
48187611|NCT01543685|100783061|FG000|NOT COMPLETED|Overall Study||3||
48187612|NCT01543685|100783062|FG001|NOT COMPLETED|Overall Study||3||
48187613|NCT01543685|100783063|FG002|NOT COMPLETED|Overall Study||2||
48187614|NCT01543685|100783064|FG003|NOT COMPLETED|Overall Study||0||
48187615|NCT01543685|100783065|FG004|NOT COMPLETED|Overall Study||4||
48187616|NCT01657682|100783066|FG000|STARTED|Overall Study||13||
48187617|NCT01657682|100783067|FG001|STARTED|Overall Study||30||
48187618|NCT01657682|100783068|FG002|STARTED|Overall Study||13||
48187619|NCT01657682|100783066|FG000|COMPLETED|Overall Study||12||
48187620|NCT01657682|100783067|FG001|COMPLETED|Overall Study||28||
48187621|NCT01657682|100783068|FG002|COMPLETED|Overall Study||12||
48187622|NCT01657682|100783066|FG000|NOT COMPLETED|Overall Study||1||
48187623|NCT01657682|100783067|FG001|NOT COMPLETED|Overall Study||2||
48187624|NCT01657682|100783068|FG002|NOT COMPLETED|Overall Study||1||
48187625|NCT02084082|100783069|FG000|STARTED|Treatment Period 1 (4 Days)||26||
48187626|NCT02084082|100783070|FG001|STARTED|Treatment Period 1 (4 Days)||26||
48187627|NCT02084082|100783071|FG002|STARTED|Treatment Period 1 (4 Days)||8||
48187628|NCT02084082|100783072|FG003|STARTED|Treatment Period 1 (4 Days)||8||
48187629|NCT02084082|100783069|FG000|COMPLETED|Treatment Period 1 (4 Days)||26||
48187630|NCT02084082|100783070|FG001|COMPLETED|Treatment Period 1 (4 Days)||26||
48187631|NCT02084082|100783071|FG002|COMPLETED|Treatment Period 1 (4 Days)||8||
48187632|NCT02084082|100783072|FG003|COMPLETED|Treatment Period 1 (4 Days)||8||
48187633|NCT02084082|100783069|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
48187634|NCT02084082|100783070|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
48187635|NCT02084082|100783071|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
48187636|NCT02084082|100783072|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
48187637|NCT02084082|100783069|FG000|STARTED|Washout Period 1 (35 Days)||26||
48187638|NCT02084082|100783070|FG001|STARTED|Washout Period 1 (35 Days)||26||
48187639|NCT02084082|100783071|FG002|STARTED|Washout Period 1 (35 Days)||8||
48187640|NCT02084082|100783072|FG003|STARTED|Washout Period 1 (35 Days)||8||
48187641|NCT02084082|100783069|FG000|COMPLETED|Washout Period 1 (35 Days)||26||
48187642|NCT02084082|100783070|FG001|COMPLETED|Washout Period 1 (35 Days)||26||
48187643|NCT02084082|100783071|FG002|COMPLETED|Washout Period 1 (35 Days)||7||
48187644|NCT02084082|100783072|FG003|COMPLETED|Washout Period 1 (35 Days)||6||
48187645|NCT02084082|100783069|FG000|NOT COMPLETED|Washout Period 1 (35 Days)||0||
48187646|NCT02084082|100783070|FG001|NOT COMPLETED|Washout Period 1 (35 Days)||0||
48187647|NCT02084082|100783071|FG002|NOT COMPLETED|Washout Period 1 (35 Days)||1||
48187648|NCT02084082|100783072|FG003|NOT COMPLETED|Washout Period 1 (35 Days)||2||
48187649|NCT02084082|100783069|FG000|STARTED|Treatment Period 2 (4 Days)||26||
48187650|NCT02084082|100783070|FG001|STARTED|Treatment Period 2 (4 Days)||26||
48187651|NCT02084082|100783071|FG002|STARTED|Treatment Period 2 (4 Days)||7||
48187652|NCT02084082|100783072|FG003|STARTED|Treatment Period 2 (4 Days)||6||
48187653|NCT02084082|100783069|FG000|COMPLETED|Treatment Period 2 (4 Days)||26||
48187654|NCT02084082|100783070|FG001|COMPLETED|Treatment Period 2 (4 Days)||26||
48187655|NCT02084082|100783071|FG002|COMPLETED|Treatment Period 2 (4 Days)||7||
48187656|NCT02084082|100783072|FG003|COMPLETED|Treatment Period 2 (4 Days)||6||
48187657|NCT02084082|100783069|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
48187658|NCT02084082|100783070|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
48187659|NCT02084082|100783071|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
48187660|NCT02084082|100783072|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
48187661|NCT01244828|100783073|FG000|STARTED|Overall Study||157||
48187662|NCT01244828|100783073|FG000|COMPLETED|Overall Study||79||
48187663|NCT01244828|100783073|FG000|NOT COMPLETED|Overall Study||78||
48187664|NCT01688102|100783074|FG000|STARTED|Overall Study||60||
48187665|NCT01688102|100783075|FG001|STARTED|Overall Study||58||
48187666|NCT01688102|100783074|FG000|COMPLETED|Overall Study||44||
48187667|NCT01688102|100783075|FG001|COMPLETED|Overall Study||40||
48187668|NCT01688102|100783074|FG000|NOT COMPLETED|Overall Study||16||
48187669|NCT01688102|100783075|FG001|NOT COMPLETED|Overall Study||18||
48187670|NCT02703532|100783076|FG000|STARTED|Overall Study||21||
48187671|NCT02703532|100783077|FG001|STARTED|Overall Study||11||
48187672|NCT02703532|100783078|FG002|STARTED|Overall Study||21||
48360797|NCT05105243|101210924|FG003|STARTED|MAD Cohort 1: 250 mg (21 Days)||0||
48360798|NCT05105243|101210925|FG004|STARTED|MAD Cohort 1: 250 mg (21 Days)||0||
48360799|NCT05105243|101210926|FG005|STARTED|MAD Cohort 1: 250 mg (21 Days)||0||
48360800|NCT05105243|101210927|FG006|STARTED|MAD Cohort 1: 250 mg (21 Days)||0||
48360801|NCT05105243|101210928|FG007|STARTED|MAD Cohort 1: 250 mg (21 Days)||0||
48360802|NCT05105243|101210929|FG008|STARTED|MAD Cohort 1: 250 mg (21 Days)||6||
48360803|NCT05105243|101210930|FG009|STARTED|MAD Cohort 1: 250 mg (21 Days)||2||
48360804|NCT05105243|101210921|FG000|COMPLETED|MAD Cohort 1: 250 mg (21 Days)||0||
48360805|NCT05105243|101210922|FG001|COMPLETED|MAD Cohort 1: 250 mg (21 Days)||0||
48360806|NCT05105243|101210923|FG002|COMPLETED|MAD Cohort 1: 250 mg (21 Days)||0||
48360807|NCT05105243|101210924|FG003|COMPLETED|MAD Cohort 1: 250 mg (21 Days)||0||
48360808|NCT05105243|101210925|FG004|COMPLETED|MAD Cohort 1: 250 mg (21 Days)||0||
48360809|NCT05105243|101210926|FG005|COMPLETED|MAD Cohort 1: 250 mg (21 Days)||0||
48360810|NCT05105243|101210927|FG006|COMPLETED|MAD Cohort 1: 250 mg (21 Days)||0||
48360811|NCT05105243|101210928|FG007|COMPLETED|MAD Cohort 1: 250 mg (21 Days)||0||
48360812|NCT05105243|101210929|FG008|COMPLETED|MAD Cohort 1: 250 mg (21 Days)||6||
48360813|NCT05105243|101210930|FG009|COMPLETED|MAD Cohort 1: 250 mg (21 Days)||2||
48360814|NCT05105243|101210921|FG000|NOT COMPLETED|MAD Cohort 1: 250 mg (21 Days)||0||
48360815|NCT05105243|101210922|FG001|NOT COMPLETED|MAD Cohort 1: 250 mg (21 Days)||0||
48360816|NCT05105243|101210923|FG002|NOT COMPLETED|MAD Cohort 1: 250 mg (21 Days)||0||
48360817|NCT05105243|101210924|FG003|NOT COMPLETED|MAD Cohort 1: 250 mg (21 Days)||0||
48360818|NCT05105243|101210925|FG004|NOT COMPLETED|MAD Cohort 1: 250 mg (21 Days)||0||
48360819|NCT05105243|101210926|FG005|NOT COMPLETED|MAD Cohort 1: 250 mg (21 Days)||0||
48360820|NCT05105243|101210927|FG006|NOT COMPLETED|MAD Cohort 1: 250 mg (21 Days)||0||
48360821|NCT05105243|101210928|FG007|NOT COMPLETED|MAD Cohort 1: 250 mg (21 Days)||0||
48360822|NCT05105243|101210929|FG008|NOT COMPLETED|MAD Cohort 1: 250 mg (21 Days)||0||
48360823|NCT05105243|101210930|FG009|NOT COMPLETED|MAD Cohort 1: 250 mg (21 Days)||0||
48360824|NCT03461965|101210931|FG000|STARTED|Overall Study||42||
48360825|NCT03461965|101210932|FG001|STARTED|Overall Study||40||
48360826|NCT03461965|101210931|FG000|COMPLETED|Overall Study||42||
48360827|NCT03461965|101210932|FG001|COMPLETED|Overall Study||40||
48360828|NCT03461965|101210931|FG000|NOT COMPLETED|Overall Study||0||
48360829|NCT03461965|101210932|FG001|NOT COMPLETED|Overall Study||0||
48360830|NCT00265941|101210933|FG000|STARTED|Overall Study||470||
48360831|NCT00265941|101210934|FG001|STARTED|Overall Study||470||
48360832|NCT00265941|101210933|FG000|COMPLETED|Overall Study||447||
48360833|NCT00265941|101210934|FG001|COMPLETED|Overall Study||444||
48360834|NCT00265941|101210933|FG000|NOT COMPLETED|Overall Study||23||
48360835|NCT00265941|101210934|FG001|NOT COMPLETED|Overall Study||26||
48360836|NCT04624932|101210935|FG000|STARTED|Overall Study||282||
48360837|NCT04624932|101210936|FG001|STARTED|Overall Study||281||
48360838|NCT04624932|101210935|FG000|1-week Post-intervention|Overall Study||209||
48360839|NCT04624932|101210936|FG001|1-week Post-intervention|Overall Study||126||
48360840|NCT04624932|101210935|FG000|COMPLETED|Overall Study||195||
48360841|NCT04624932|101210936|FG001|COMPLETED|Overall Study||119||
48360842|NCT04624932|101210935|FG000|NOT COMPLETED|Overall Study||87||
48360843|NCT04624932|101210936|FG001|NOT COMPLETED|Overall Study||162||
48360844|NCT02544984|101210937|FG000|STARTED|Overall Study||30||
48360845|NCT02544984|101210938|FG001|STARTED|Overall Study||30||
48360846|NCT02544984|101210937|FG000|COMPLETED|Overall Study||28||
48360847|NCT02544984|101210938|FG001|COMPLETED|Overall Study||28||
48360848|NCT02544984|101210937|FG000|NOT COMPLETED|Overall Study||2||
48360849|NCT02544984|101210938|FG001|NOT COMPLETED|Overall Study||2||
48360850|NCT02517515|101210939|FG000|STARTED|Overall Study||325||
48360851|NCT02517515|101210940|FG001|STARTED|Overall Study||325||
48360852|NCT02517515|101210939|FG000|COMPLETED|Overall Study||323||
48360853|NCT02517515|101210940|FG001|COMPLETED|Overall Study||323||
48360854|NCT02517515|101210939|FG000|NOT COMPLETED|Overall Study||2||
48360855|NCT02517515|101210940|FG001|NOT COMPLETED|Overall Study||2||
48360856|NCT02927223|101210941|FG000|STARTED|Overall Study||6||
48360857|NCT02927223|101210941|FG000|COMPLETED|Overall Study||6||
48360858|NCT02927223|101210941|FG000|NOT COMPLETED|Overall Study||0||
48360859|NCT03809546|101210942|FG000|STARTED|Overall Study||20||
48360860|NCT03809546|101210943|FG001|STARTED|Overall Study||20||
48360861|NCT03809546|101210944|FG002|STARTED|Overall Study||20||
48360862|NCT03809546|101210942|FG000|COMPLETED|Overall Study||20||
48360863|NCT03809546|101210943|FG001|COMPLETED|Overall Study||20||
48360864|NCT03809546|101210944|FG002|COMPLETED|Overall Study||20||
48360865|NCT03809546|101210942|FG000|NOT COMPLETED|Overall Study||0||
48360866|NCT03809546|101210943|FG001|NOT COMPLETED|Overall Study||0||
48360867|NCT03809546|101210944|FG002|NOT COMPLETED|Overall Study||0||
48360868|NCT00471380|101210945|FG000|STARTED|First Intervention||22||
48360869|NCT00471380|101210946|FG001|STARTED|First Intervention||24||
48360870|NCT00471380|101210945|FG000|COMPLETED|First Intervention||18||
48360871|NCT00471380|101210946|FG001|COMPLETED|First Intervention||20||
48360872|NCT00471380|101210945|FG000|NOT COMPLETED|First Intervention||4||
48360873|NCT00471380|101210946|FG001|NOT COMPLETED|First Intervention||4||
48360874|NCT00471380|101210945|FG000|STARTED|Second Intervention||18||
48360875|NCT00471380|101210946|FG001|STARTED|Second Intervention||20||
48360876|NCT00471380|101210945|FG000|COMPLETED|Second Intervention||18||
48431986|NCT00538434|101389409|FG003|NOT COMPLETED|Overall Study||6||
48431987|NCT03557775|101389410|FG000|STARTED|Overall Study||5||
48431988|NCT03557775|101389411|FG001|STARTED|Overall Study||7||
48431989|NCT03557775|101389412|FG002|STARTED|Overall Study||8||
48431990|NCT03557775|101389410|FG000|COMPLETED|Overall Study||4||
48431991|NCT03557775|101389411|FG001|COMPLETED|Overall Study||4||
48431992|NCT03557775|101389412|FG002|COMPLETED|Overall Study||4||
48431993|NCT03557775|101389410|FG000|NOT COMPLETED|Overall Study||1||
48431994|NCT03557775|101389411|FG001|NOT COMPLETED|Overall Study||3||
48431995|NCT03557775|101389412|FG002|NOT COMPLETED|Overall Study||4||
48431996|NCT00509223|101389413|FG000|STARTED|Overall Study||207||
48431997|NCT00509223|101389414|FG001|STARTED|Overall Study||209||
48431998|NCT00509223|101389413|FG000|COMPLETED|Overall Study||119||
48431999|NCT00509223|101389414|FG001|COMPLETED|Overall Study||137||
48432000|NCT00509223|101389413|FG000|NOT COMPLETED|Overall Study||88||
48432001|NCT00509223|101389414|FG001|NOT COMPLETED|Overall Study||72||
48432002|NCT02331680|101389415|FG000|STARTED|Overall Study||40||
48432003|NCT02331680|101389416|FG001|STARTED|Overall Study||40||
48432004|NCT02331680|101389417|FG002|STARTED|Overall Study||44||
48432005|NCT02331680|101389415|FG000|COMPLETED|Overall Study||34||
48432006|NCT02331680|101389416|FG001|COMPLETED|Overall Study||36||
48432007|NCT02331680|101389417|FG002|COMPLETED|Overall Study||29||
48432008|NCT02331680|101389415|FG000|NOT COMPLETED|Overall Study||6||
48432009|NCT02331680|101389416|FG001|NOT COMPLETED|Overall Study||4||
48432010|NCT02331680|101389417|FG002|NOT COMPLETED|Overall Study||15||
48432011|NCT01855607|101389418|FG000|STARTED|Overall Study||12||
48432012|NCT01855607|101389418|FG000|COMPLETED|Overall Study||0||
48432013|NCT01855607|101389418|FG000|NOT COMPLETED|Overall Study||12||
48432014|NCT00650806|101389419|FG000|STARTED|Overall Study||89||
48432015|NCT00650806|101389420|FG001|STARTED|Overall Study||98||
48432016|NCT00650806|101389421|FG002|STARTED|Overall Study||93||
48432017|NCT00650806|101389422|FG003|STARTED|Overall Study||96||
48432018|NCT00650806|101389419|FG000|COMPLETED|Overall Study||71||
48432019|NCT00650806|101389420|FG001|COMPLETED|Overall Study||77||
48432020|NCT00650806|101389421|FG002|COMPLETED|Overall Study||64||
48432021|NCT00650806|101389422|FG003|COMPLETED|Overall Study||70||
48432022|NCT00650806|101389419|FG000|NOT COMPLETED|Overall Study||18||
48432023|NCT00650806|101389420|FG001|NOT COMPLETED|Overall Study||21||
48432024|NCT00650806|101389421|FG002|NOT COMPLETED|Overall Study||29||
48432025|NCT00650806|101389422|FG003|NOT COMPLETED|Overall Study||26||
48432026|NCT02067728|101389423|FG000|STARTED|Baseline - 1 Month Follow up Survey||220||
48432027|NCT02067728|101389424|FG001|STARTED|Baseline - 1 Month Follow up Survey||210||
48432028|NCT02067728|101389423|FG000|COMPLETED|Baseline - 1 Month Follow up Survey||213||
48432029|NCT02067728|101389424|FG001|COMPLETED|Baseline - 1 Month Follow up Survey||182||
48432030|NCT02067728|101389423|FG000|NOT COMPLETED|Baseline - 1 Month Follow up Survey||7||
48432031|NCT02067728|101389424|FG001|NOT COMPLETED|Baseline - 1 Month Follow up Survey||28||
48432032|NCT02067728|101389423|FG000|STARTED|6 Month Follow up Survey||220||
48432033|NCT02067728|101389424|FG001|STARTED|6 Month Follow up Survey||210||
48432034|NCT02067728|101389423|FG000|COMPLETED|6 Month Follow up Survey||172||
48432035|NCT02067728|101389424|FG001|COMPLETED|6 Month Follow up Survey||150||
48432036|NCT02067728|101389423|FG000|NOT COMPLETED|6 Month Follow up Survey||48||
48432037|NCT02067728|101389424|FG001|NOT COMPLETED|6 Month Follow up Survey||60||
48432038|NCT02067728|101389423|FG000|STARTED|6 Month Measurements||220||
48432039|NCT02067728|101389424|FG001|STARTED|6 Month Measurements||210||
48432040|NCT02067728|101389423|FG000|COMPLETED|6 Month Measurements||106||
48432041|NCT02067728|101389424|FG001|COMPLETED|6 Month Measurements||113||
48432042|NCT02067728|101389423|FG000|NOT COMPLETED|6 Month Measurements||114||
48432043|NCT02067728|101389424|FG001|NOT COMPLETED|6 Month Measurements||97||
48432044|NCT00096031|101389425|FG000|STARTED|Overall Study||63||
48432045|NCT00096031|101389425|FG000|Eligible|Overall Study||57||
48432046|NCT00096031|101389425|FG000|Eligible and Began Protocol Therapy|Overall Study||55||
48432047|NCT00096031|101389425|FG000|COMPLETED|Overall Study||0||
48432048|NCT00096031|101389425|FG000|NOT COMPLETED|Overall Study||63||
48432049|NCT02525575|101389426|FG000|STARTED|Overall Study||37||
48432050|NCT02525575|101389426|FG000|COMPLETED|Overall Study||22||
48432051|NCT02525575|101389426|FG000|NOT COMPLETED|Overall Study||15||
48432052|NCT03831282|101389427|FG000|STARTED|Overall Study||12||
48432053|NCT03831282|101389427|FG000|COMPLETED|Overall Study||11||
48432054|NCT03831282|101389427|FG000|NOT COMPLETED|Overall Study||1||
48432055|NCT03868059|101389428|FG000|STARTED|Overall Study||138||
48432056|NCT03868059|101389428|FG000|COMPLETED|Overall Study||126||
48432057|NCT03868059|101389428|FG000|NOT COMPLETED|Overall Study||12||
48432058|NCT02032433|101389429|FG000|STARTED|Overall Study||283||
48432059|NCT02032433|101389430|FG001|STARTED|Overall Study||287||
48432060|NCT02032433|101389429|FG000|COMPLETED|Overall Study||205||
48432061|NCT02032433|101389430|FG001|COMPLETED|Overall Study||225||
48432062|NCT02032433|101389429|FG000|NOT COMPLETED|Overall Study||78||
48432063|NCT02032433|101389430|FG001|NOT COMPLETED|Overall Study||62||
48432064|NCT00816062|101389431|FG000|STARTED|Overall Study||260||
48432065|NCT00816062|101389431|FG000|COMPLETED|Overall Study||133||
48432066|NCT00816062|101389431|FG000|NOT COMPLETED|Overall Study||127||
48432067|NCT01710839|101389432|FG000|STARTED|Overall Study||24||
48432068|NCT01710839|101389433|FG001|STARTED|Overall Study||6||
48432069|NCT01710839|101389432|FG000|COMPLETED|Overall Study||23||
48432070|NCT01710839|101389433|FG001|COMPLETED|Overall Study||0||
48432071|NCT01710839|101389432|FG000|NOT COMPLETED|Overall Study||1||
48432072|NCT01710839|101389433|FG001|NOT COMPLETED|Overall Study||6||
48432073|NCT01797458|101389434|FG000|STARTED|Overall Study||52||
48432074|NCT01797458|101389435|FG001|STARTED|Overall Study||52||
48432075|NCT01797458|101389436|FG002|STARTED|Overall Study||65||
48432076|NCT01797458|101389434|FG000|COMPLETED|Overall Study||40||
48432077|NCT01797458|101389435|FG001|COMPLETED|Overall Study||43||
48432078|NCT01797458|101389436|FG002|COMPLETED|Overall Study||58||
48432079|NCT01797458|101389434|FG000|NOT COMPLETED|Overall Study||12||
48432080|NCT01797458|101389435|FG001|NOT COMPLETED|Overall Study||9||
48432081|NCT01797458|101389436|FG002|NOT COMPLETED|Overall Study||7||
48432082|NCT01326312|101389437|FG000|STARTED|Overall Study||53||
48432083|NCT01326312|101389438|FG001|STARTED|Overall Study||55||
48432084|NCT01326312|101389439|FG002|STARTED|Overall Study||51||
48432085|NCT01326312|101389437|FG000|COMPLETED|Overall Study||0||
48432086|NCT01326312|101389438|FG001|COMPLETED|Overall Study||0||
48432087|NCT01326312|101389439|FG002|COMPLETED|Overall Study||0||
48432088|NCT01326312|101389437|FG000|NOT COMPLETED|Overall Study||53||
48432089|NCT01326312|101389438|FG001|NOT COMPLETED|Overall Study||55||
48432090|NCT01326312|101389439|FG002|NOT COMPLETED|Overall Study||51||
48432091|NCT03045926|101389440|FG000|STARTED|Overall Study||35||
48432092|NCT03045926|101389440|FG000|COMPLETED|Overall Study||35||
48432093|NCT03045926|101389440|FG000|NOT COMPLETED|Overall Study||0||
48432094|NCT00593385|101389441|FG000|STARTED|Overall Study||165||
48432095|NCT00593385|101389441|FG000|Intention to Treat (ITT) Population|Overall Study||152|Subjects who signed written informed consent, enrolled in the study and met study entry criteria.|
48432096|NCT00593385|101389441|FG000|COMPLETED|Overall Study||125||
48432097|NCT00593385|101389441|FG000|NOT COMPLETED|Overall Study||40||
48432098|NCT00313716|101389442|FG000|STARTED|Overall Study||18||
48432099|NCT00313716|101389443|FG001|STARTED|Overall Study||31||
48432100|NCT00313716|101389444|FG002|STARTED|Overall Study||50||
48432101|NCT00313716|101389445|FG003|STARTED|Overall Study||20||
48432102|NCT00313716|101389446|FG004|STARTED|Overall Study||33||
48432103|NCT00313716|101389447|FG005|STARTED|Overall Study||48||
48432104|NCT00313716|101389442|FG000|COMPLETED|Overall Study||13||
48432105|NCT00313716|101389443|FG001|COMPLETED|Overall Study||23||
48432106|NCT00313716|101389444|FG002|COMPLETED|Overall Study||38||
48432107|NCT00313716|101389445|FG003|COMPLETED|Overall Study||16||
48432108|NCT00313716|101389446|FG004|COMPLETED|Overall Study||27||
48432109|NCT00313716|101389447|FG005|COMPLETED|Overall Study||35||
48432110|NCT00313716|101389442|FG000|NOT COMPLETED|Overall Study||5||
48432111|NCT00313716|101389443|FG001|NOT COMPLETED|Overall Study||8||
48432112|NCT00313716|101389444|FG002|NOT COMPLETED|Overall Study||12||
48432113|NCT00313716|101389445|FG003|NOT COMPLETED|Overall Study||4||
48432114|NCT00313716|101389446|FG004|NOT COMPLETED|Overall Study||6||
48432115|NCT00313716|101389447|FG005|NOT COMPLETED|Overall Study||13||
48432116|NCT01520038|101389448|FG000|STARTED|Overall Study||2||
48432117|NCT01520038|101389448|FG000|COMPLETED|Overall Study||1||
48432118|NCT01520038|101389448|FG000|NOT COMPLETED|Overall Study||1||
48432119|NCT02103608|101392604|FG000|STARTED|Overall Study||17||
48432120|NCT02103608|101392604|FG000|COMPLETED|Overall Study||15||
48432121|NCT02103608|101392604|FG000|NOT COMPLETED|Overall Study||2||
48432122|NCT02352831|101392605|FG000|STARTED|Overall Study||6||
48432123|NCT02352831|101392606|FG001|STARTED|Overall Study||10||
48432124|NCT02352831|101392605|FG000|COMPLETED|Overall Study||6||
48432125|NCT02352831|101392606|FG001|COMPLETED|Overall Study||10||
48432126|NCT02352831|101392605|FG000|NOT COMPLETED|Overall Study||0||
48432127|NCT02352831|101392606|FG001|NOT COMPLETED|Overall Study||0||
48432128|NCT02181075|101392607|FG000|STARTED|Overall Study||6||
48432129|NCT02181075|101392608|FG001|STARTED|Overall Study||4||
48432130|NCT02181075|101392607|FG000|COMPLETED|Overall Study||6||
48432131|NCT02181075|101392608|FG001|COMPLETED|Overall Study||4||
48432132|NCT02181075|101392607|FG000|NOT COMPLETED|Overall Study||0||
48432133|NCT02181075|101392608|FG001|NOT COMPLETED|Overall Study||0||
48432134|NCT00777920|101392609|FG000|STARTED|Overall Study||140||
48432135|NCT00777920|101392609|FG000|COMPLETED|Overall Study||90||
48432136|NCT00777920|101392609|FG000|NOT COMPLETED|Overall Study||50||
48432137|NCT03532048|101392610|FG000|STARTED|Overall Study||68||19
48432138|NCT03532048|101392611|FG001|STARTED|Overall Study||67||17
48432139|NCT03532048|101392610|FG000|COMPLETED|Overall Study||49||14
48432140|NCT03532048|101392611|FG001|COMPLETED|Overall Study||50||13
48432141|NCT03532048|101392610|FG000|NOT COMPLETED|Overall Study||19||5
48432142|NCT03532048|101392611|FG001|NOT COMPLETED|Overall Study||17||4
48432143|NCT05059366|101392612|FG000|STARTED|Overall Study||8||
48432144|NCT05059366|101392613|FG001|STARTED|Overall Study||8||
48432145|NCT05059366|101392614|FG002|STARTED|Overall Study||8||
48432146|NCT05059366|101392615|FG003|STARTED|Overall Study||8||
48432147|NCT05059366|101392612|FG000|COMPLETED|Overall Study||8||
48432148|NCT05059366|101392613|FG001|COMPLETED|Overall Study||8||
48432149|NCT05059366|101392614|FG002|COMPLETED|Overall Study||8||
48432150|NCT05059366|101392615|FG003|COMPLETED|Overall Study||8||
48432151|NCT05059366|101392612|FG000|NOT COMPLETED|Overall Study||0||
48432152|NCT05059366|101392613|FG001|NOT COMPLETED|Overall Study||0||
48432153|NCT05059366|101392614|FG002|NOT COMPLETED|Overall Study||0||
48432154|NCT05059366|101392615|FG003|NOT COMPLETED|Overall Study||0||
48432155|NCT02503215|101392616|FG000|STARTED|Overall Study||17||
48432156|NCT02503215|101392616|FG000|COMPLETED|Overall Study||14||
48432157|NCT02503215|101392616|FG000|NOT COMPLETED|Overall Study||3||
48432158|NCT04988035|101392617|FG000|STARTED|Overall Study||98||
48432159|NCT04988035|101392618|FG001|STARTED|Overall Study||103||
48432160|NCT04988035|101392617|FG000|COMPLETED|Overall Study||63||
48432161|NCT04988035|101392618|FG001|COMPLETED|Overall Study||77||
48432162|NCT04988035|101392617|FG000|NOT COMPLETED|Overall Study||35||
48432163|NCT04988035|101392618|FG001|NOT COMPLETED|Overall Study||26||
48432164|NCT04516291|101392619|FG000|STARTED|Treatment Period (24 Weeks)||44||
48432165|NCT04516291|101392620|FG001|STARTED|Treatment Period (24 Weeks)||23||
48432166|NCT04516291|101392621|FG002|STARTED|Treatment Period (24 Weeks)||24||
48432167|NCT04516291|101392622|FG003|STARTED|Treatment Period (24 Weeks)||23||
48432168|NCT04516291|101392623|FG004|STARTED|Treatment Period (24 Weeks)||45||
48432169|NCT04516291|101392624|FG005|STARTED|Treatment Period (24 Weeks)||45||
48432170|NCT04516291|101392625|FG006|STARTED|Treatment Period (24 Weeks)||46||
48432171|NCT04516291|101392626|FG007|STARTED|Treatment Period (24 Weeks)||36||
48432172|NCT04516291|101392619|FG000|COMPLETED|Treatment Period (24 Weeks)||42||
48432173|NCT04516291|101392620|FG001|COMPLETED|Treatment Period (24 Weeks)||18||
48432174|NCT04516291|101392621|FG002|COMPLETED|Treatment Period (24 Weeks)||20||
48432175|NCT04516291|101392622|FG003|COMPLETED|Treatment Period (24 Weeks)||17||
48432176|NCT04516291|101392623|FG004|COMPLETED|Treatment Period (24 Weeks)||33||
48432177|NCT04516291|101392624|FG005|COMPLETED|Treatment Period (24 Weeks)||37||
48432178|NCT04516291|101392625|FG006|COMPLETED|Treatment Period (24 Weeks)||37||
48432179|NCT04516291|101392626|FG007|COMPLETED|Treatment Period (24 Weeks)||22||
48432180|NCT04516291|101392619|FG000|NOT COMPLETED|Treatment Period (24 Weeks)||2||
48432181|NCT04516291|101392620|FG001|NOT COMPLETED|Treatment Period (24 Weeks)||5||
48432182|NCT04516291|101392621|FG002|NOT COMPLETED|Treatment Period (24 Weeks)||4||
48432183|NCT04516291|101392622|FG003|NOT COMPLETED|Treatment Period (24 Weeks)||6||
48432184|NCT04516291|101392623|FG004|NOT COMPLETED|Treatment Period (24 Weeks)||12||
48432185|NCT04516291|101392624|FG005|NOT COMPLETED|Treatment Period (24 Weeks)||8||
48432186|NCT04516291|101392625|FG006|NOT COMPLETED|Treatment Period (24 Weeks)||9||
48432187|NCT04516291|101392626|FG007|NOT COMPLETED|Treatment Period (24 Weeks)||14||
48432188|NCT04516291|101392619|FG000|STARTED|Follow-up Period (12 Weeks)||44||
48432189|NCT04516291|101392620|FG001|STARTED|Follow-up Period (12 Weeks)||23||
48432190|NCT04516291|101392621|FG002|STARTED|Follow-up Period (12 Weeks)||24||
48432191|NCT04516291|101392622|FG003|STARTED|Follow-up Period (12 Weeks)||23||
48432192|NCT04516291|101392623|FG004|STARTED|Follow-up Period (12 Weeks)||45||
48432193|NCT04516291|101392624|FG005|STARTED|Follow-up Period (12 Weeks)||45||
48432194|NCT04516291|101392625|FG006|STARTED|Follow-up Period (12 Weeks)||46||
48432195|NCT04516291|101392626|FG007|STARTED|Follow-up Period (12 Weeks)||36||
48432196|NCT04516291|101392619|FG000|COMPLETED|Follow-up Period (12 Weeks)||44||
48432197|NCT04516291|101392620|FG001|COMPLETED|Follow-up Period (12 Weeks)||22||
48432198|NCT04516291|101392621|FG002|COMPLETED|Follow-up Period (12 Weeks)||23||
48432199|NCT04516291|101392622|FG003|COMPLETED|Follow-up Period (12 Weeks)||21||
48432200|NCT04516291|101392623|FG004|COMPLETED|Follow-up Period (12 Weeks)||43||
48432201|NCT04516291|101392624|FG005|COMPLETED|Follow-up Period (12 Weeks)||45||
48432202|NCT04516291|101392625|FG006|COMPLETED|Follow-up Period (12 Weeks)||46||
48432203|NCT04516291|101392626|FG007|COMPLETED|Follow-up Period (12 Weeks)||36||
48432204|NCT04516291|101392619|FG000|NOT COMPLETED|Follow-up Period (12 Weeks)||0||
48432205|NCT04516291|101392620|FG001|NOT COMPLETED|Follow-up Period (12 Weeks)||1||
48432206|NCT04516291|101392621|FG002|NOT COMPLETED|Follow-up Period (12 Weeks)||1||
48432207|NCT04516291|101392622|FG003|NOT COMPLETED|Follow-up Period (12 Weeks)||2||
48432208|NCT04516291|101392623|FG004|NOT COMPLETED|Follow-up Period (12 Weeks)||2||
48432209|NCT04516291|101392624|FG005|NOT COMPLETED|Follow-up Period (12 Weeks)||0||
48432210|NCT04516291|101392625|FG006|NOT COMPLETED|Follow-up Period (12 Weeks)||0||
48432211|NCT04516291|101392626|FG007|NOT COMPLETED|Follow-up Period (12 Weeks)||0||
48432212|NCT01945034|101392627|FG000|STARTED|Overall Study||67||
48432213|NCT01945034|101392628|FG001|STARTED|Overall Study||85||
48432214|NCT01945034|101392629|FG002|STARTED|Overall Study||152||
48432215|NCT01945034|101392627|FG000|COMPLETED|Overall Study||66||
48432216|NCT01945034|101392628|FG001|COMPLETED|Overall Study||80||
48432217|NCT01945034|101392629|FG002|COMPLETED|Overall Study||145||
48432218|NCT01945034|101392627|FG000|NOT COMPLETED|Overall Study||1||
48432219|NCT01945034|101392628|FG001|NOT COMPLETED|Overall Study||5||
48432220|NCT01945034|101392629|FG002|NOT COMPLETED|Overall Study||7||
48432221|NCT00379821|101392630|FG000|STARTED|Overall Study||160||
48432222|NCT00379821|101392631|FG001|STARTED|Overall Study||160||
48767780|NCT03863080|102222825|FG000|STARTED|Double-Blind Treatment Period (6 Weeks)||6||
48432223|NCT00379821|101392632|FG002|STARTED|Overall Study||160||
48432224|NCT00379821|101392633|FG003|STARTED|Overall Study||160||
48432225|NCT00379821|101392630|FG000|COMPLETED|Overall Study||87||
48432226|NCT00379821|101392631|FG001|COMPLETED|Overall Study||71||
48432227|NCT00379821|101392632|FG002|COMPLETED|Overall Study||93||
48432228|NCT00379821|101392633|FG003|COMPLETED|Overall Study||81||
48432229|NCT00379821|101392630|FG000|NOT COMPLETED|Overall Study||73||
48432230|NCT00379821|101392631|FG001|NOT COMPLETED|Overall Study||89||
48432231|NCT00379821|101392632|FG002|NOT COMPLETED|Overall Study||67||
48432232|NCT00379821|101392633|FG003|NOT COMPLETED|Overall Study||79||
48432233|NCT02787655|101392634|FG000|STARTED|Overall Study||40||
48432234|NCT02787655|101392635|FG001|STARTED|Overall Study||38||
48432235|NCT02787655|101392634|FG000|COMPLETED|Overall Study||29||
48432236|NCT02787655|101392635|FG001|COMPLETED|Overall Study||26||
48432237|NCT02787655|101392634|FG000|NOT COMPLETED|Overall Study||11||
48432238|NCT02787655|101392635|FG001|NOT COMPLETED|Overall Study||12||
48432239|NCT02504099|101392636|FG000|STARTED|Overall Study||3||
48432240|NCT02504099|101392636|FG000|COMPLETED|Overall Study||3||
48432241|NCT02504099|101392636|FG000|NOT COMPLETED|Overall Study||0||
48432242|NCT00777790|101392637|FG000|STARTED|Overall Study||76||
48432243|NCT00777790|101392638|FG001|STARTED|Overall Study||77||
48432244|NCT00777790|101392639|FG002|STARTED|Overall Study||88||
48432245|NCT00777790|101392637|FG000|COMPLETED|Overall Study||76||
48432246|NCT00777790|101392638|FG001|COMPLETED|Overall Study||77||
48432247|NCT00777790|101392639|FG002|COMPLETED|Overall Study||88||
48432248|NCT00777790|101392637|FG000|NOT COMPLETED|Overall Study||0||
48432249|NCT00777790|101392638|FG001|NOT COMPLETED|Overall Study||0||
48432250|NCT00777790|101392639|FG002|NOT COMPLETED|Overall Study||0||
48432251|NCT02191033|101392640|FG000|STARTED|Overall Study||20||
48432252|NCT02191033|101392641|FG001|STARTED|Overall Study||20||
48432253|NCT02191033|101392640|FG000|COMPLETED|Overall Study||18||
48432254|NCT02191033|101392641|FG001|COMPLETED|Overall Study||19||
48432255|NCT02191033|101392640|FG000|NOT COMPLETED|Overall Study||2||
48432256|NCT02191033|101392641|FG001|NOT COMPLETED|Overall Study||1||
48432257|NCT02341482|101392642|FG000|STARTED|Overall Study||13||
48432258|NCT02341482|101392642|FG000|COMPLETED|Overall Study||12||
48432259|NCT02341482|101392642|FG000|NOT COMPLETED|Overall Study||1||
48432260|NCT01519700|101392643|FG000|STARTED|Overall Study||54||
48432261|NCT01519700|101392644|FG001|STARTED|Overall Study||55||
48432262|NCT01519700|101392645|FG002|STARTED|Overall Study||55||
48432263|NCT01519700|101392646|FG003|STARTED|Overall Study||54||
48432264|NCT01519700|101392643|FG000|Treated Cycle 1 EP2006|Overall Study||53||
48432265|NCT01519700|101392644|FG001|Treated Cycle 1 EP2006|Overall Study||54||
48432266|NCT01519700|101392645|FG002|Treated Cycle 1 EP2006|Overall Study||0||
48432267|NCT01519700|101392646|FG003|Treated Cycle 1 EP2006|Overall Study||0||
48432268|NCT01519700|101392643|FG000|Treated Cycle 1 Neupogen|Overall Study||0||
48432269|NCT01519700|101392644|FG001|Treated Cycle 1 Neupogen|Overall Study||0||
48432270|NCT01519700|101392645|FG002|Treated Cycle 1 Neupogen|Overall Study||55||
48432271|NCT01519700|101392646|FG003|Treated Cycle 1 Neupogen|Overall Study||52||
48432272|NCT01519700|101392643|FG000|Treated Cycle 2 EP2006|Overall Study||52||
48432273|NCT01519700|101392644|FG001|Treated Cycle 2 EP2006|Overall Study||0||
48432274|NCT01519700|101392645|FG002|Treated Cycle 2 EP2006|Overall Study||55||
48432275|NCT01519700|101392646|FG003|Treated Cycle 2 EP2006|Overall Study||0||
48432276|NCT01519700|101392643|FG000|Treated Cycle 2 Neupogen|Overall Study||0||
48432277|NCT01519700|101392644|FG001|Treated Cycle 2 Neupogen|Overall Study||52||
48432278|NCT01519700|101392645|FG002|Treated Cycle 2 Neupogen|Overall Study||0||
48432279|NCT01519700|101392646|FG003|Treated Cycle 2 Neupogen|Overall Study||51||
48432280|NCT01519700|101392643|FG000|Treated Cycle 3 EP2006|Overall Study||51||
48432281|NCT01519700|101392644|FG001|Treated Cycle 3 EP2006|Overall Study||51||
48432282|NCT01519700|101392645|FG002|Treated Cycle 3 EP2006|Overall Study||0||
48432283|NCT01519700|101392646|FG003|Treated Cycle 3 EP2006|Overall Study||0||
48432284|NCT01519700|101392643|FG000|Treated Cycle 3 Neupogen|Overall Study||0||
48432285|NCT01519700|101392644|FG001|Treated Cycle 3 Neupogen|Overall Study||0||
48432286|NCT01519700|101392645|FG002|Treated Cycle 3 Neupogen|Overall Study||54||
48432287|NCT01519700|101392646|FG003|Treated Cycle 3 Neupogen|Overall Study||51||
48432288|NCT01519700|101392643|FG000|Treated Cycle 4 EP2006|Overall Study||51||
48432289|NCT01519700|101392644|FG001|Treated Cycle 4 EP2006|Overall Study||0||
48432290|NCT01519700|101392645|FG002|Treated Cycle 4 EP2006|Overall Study||50||
48432291|NCT01519700|101392646|FG003|Treated Cycle 4 EP2006|Overall Study||0||
48432292|NCT01519700|101392643|FG000|Treated Cycle 4 Neupogen|Overall Study||0||
48432293|NCT01519700|101392644|FG001|Treated Cycle 4 Neupogen|Overall Study||51||
48432294|NCT01519700|101392645|FG002|Treated Cycle 4 Neupogen|Overall Study||0||
48432295|NCT01519700|101392646|FG003|Treated Cycle 4 Neupogen|Overall Study||50||
48432296|NCT01519700|101392643|FG000|Treated Cycle 5 EP2006|Overall Study||46||
48432297|NCT01519700|101392644|FG001|Treated Cycle 5 EP2006|Overall Study||49||
48432298|NCT01519700|101392645|FG002|Treated Cycle 5 EP2006|Overall Study||0||
48432299|NCT01519700|101392646|FG003|Treated Cycle 5 EP2006|Overall Study||0||
48432300|NCT01519700|101392643|FG000|Treated Cycle 5 Neupogen|Overall Study||0||
48432301|NCT01519700|101392644|FG001|Treated Cycle 5 Neupogen|Overall Study||0||
48432302|NCT01519700|101392645|FG002|Treated Cycle 5 Neupogen|Overall Study||48||
48432303|NCT01519700|101392646|FG003|Treated Cycle 5 Neupogen|Overall Study||50||
48432304|NCT01519700|101392643|FG000|Treated Cycle 6 EP2006|Overall Study||45||
48432305|NCT01519700|101392644|FG001|Treated Cycle 6 EP2006|Overall Study||0||
48432306|NCT01519700|101392645|FG002|Treated Cycle 6 EP2006|Overall Study||48||
48432307|NCT01519700|101392646|FG003|Treated Cycle 6 EP2006|Overall Study||0||
48432308|NCT01519700|101392643|FG000|Treated Cycle 6 Neupogen|Overall Study||0||
48432309|NCT01519700|101392644|FG001|Treated Cycle 6 Neupogen|Overall Study||49||
48432310|NCT01519700|101392645|FG002|Treated Cycle 6 Neupogen|Overall Study||0||
48432311|NCT01519700|101392646|FG003|Treated Cycle 6 Neupogen|Overall Study||49||
48432312|NCT01519700|101392643|FG000|COMPLETED|Overall Study||45||
48432313|NCT01519700|101392644|FG001|COMPLETED|Overall Study||49||
48432314|NCT01519700|101392645|FG002|COMPLETED|Overall Study||48||
48432315|NCT01519700|101392646|FG003|COMPLETED|Overall Study||47||
48432316|NCT01519700|101392643|FG000|NOT COMPLETED|Overall Study||9||
48432317|NCT01519700|101392644|FG001|NOT COMPLETED|Overall Study||6||
48432318|NCT01519700|101392645|FG002|NOT COMPLETED|Overall Study||7||
48432319|NCT01519700|101392646|FG003|NOT COMPLETED|Overall Study||7||
48432320|NCT03712462|101392647|FG000|STARTED|Overall Study||63||
48432321|NCT03712462|101392648|FG001|STARTED|Overall Study||63||
48432322|NCT03712462|101392647|FG000|COMPLETED|Overall Study||43||
48432323|NCT03712462|101392648|FG001|COMPLETED|Overall Study||43||
48432324|NCT03712462|101392647|FG000|NOT COMPLETED|Overall Study||20||
48432325|NCT03712462|101392648|FG001|NOT COMPLETED|Overall Study||20||
48432326|NCT03778021|101392649|FG000|STARTED|Overall Study||100|Schools were the unit of randomization. School was the unit of intervention. Evaluation used data from students in each participating school. Details about baseline characteristics and results of evaluation all rely on student data.|2
48432327|NCT03778021|101392650|FG001|STARTED|Overall Study||194|Schools were the unit of randomization. School was the unit of intervention. Evaluation used data from students in each participating school. Details about baseline characteristics and results of evaluation all rely on student data.|4
48432328|NCT03778021|101392649|FG000|COMPLETED|Overall Study||72|"At the student level, completion refers to providing follow-up data.~At the school level, completion refers to completion of intervention or comparison condition, and of permission to collect follow up data from the students.~All students in grade 3 or 4 in the schools were exposed to the intervention condition to which their school was assigned."|2
48432329|NCT03778021|101392650|FG001|COMPLETED|Overall Study||141|"At the student level, completion refers to providing follow-up data.~At the school level, completion refers to completion of intervention or comparison condition, and of permission to collect follow up data from the students.~All students in grade 3 or 4 in the schools were exposed to the intervention condition to which their school was assigned."|4
48432330|NCT03778021|101392649|FG000|NOT COMPLETED|Overall Study||28||0
48432331|NCT03778021|101392650|FG001|NOT COMPLETED|Overall Study||53||0
48767781|NCT03863080|102222826|FG001|STARTED|Double-Blind Treatment Period (6 Weeks)||5||
48360877|NCT00471380|101210946|FG001|COMPLETED|Second Intervention||16||
48360878|NCT00471380|101210945|FG000|NOT COMPLETED|Second Intervention||0||
48360879|NCT00471380|101210946|FG001|NOT COMPLETED|Second Intervention||4||
48360880|NCT00471380|101210945|FG000|STARTED|Third Intervention||18||
48360881|NCT00471380|101210946|FG001|STARTED|Third Intervention||16||
48360882|NCT00471380|101210945|FG000|COMPLETED|Third Intervention||17||
48360883|NCT00471380|101210946|FG001|COMPLETED|Third Intervention||14||
48360884|NCT00471380|101210945|FG000|NOT COMPLETED|Third Intervention||1||
48360885|NCT00471380|101210946|FG001|NOT COMPLETED|Third Intervention||2||
48360886|NCT03063385|101210947|FG000|STARTED|Overall Study||330||
48360887|NCT03063385|101210948|FG001|STARTED|Overall Study||330||
48360888|NCT03063385|101210947|FG000|3-month Follow-up|Overall Study||257||
48360889|NCT03063385|101210948|FG001|3-month Follow-up|Overall Study||259||
48360890|NCT03063385|101210947|FG000|6-month Follow-up|Overall Study||265||
48360891|NCT03063385|101210948|FG001|6-month Follow-up|Overall Study||259||
48360892|NCT03063385|101210947|FG000|12-month Follow-up|Overall Study||243||
48360893|NCT03063385|101210948|FG001|12-month Follow-up|Overall Study||254||
48360894|NCT03063385|101210947|FG000|COMPLETED|Overall Study||243||
48360895|NCT03063385|101210948|FG001|COMPLETED|Overall Study||254||
48360896|NCT03063385|101210947|FG000|NOT COMPLETED|Overall Study||87||
48360897|NCT03063385|101210948|FG001|NOT COMPLETED|Overall Study||76||
48360898|NCT04530825|101210949|FG000|STARTED|Overall Study||7||
48360899|NCT04530825|101210950|FG001|STARTED|Overall Study||29||
48360900|NCT04530825|101210951|FG002|STARTED|Overall Study||16||
48360901|NCT04530825|101210952|FG003|STARTED|Overall Study||13||
48360902|NCT04530825|101210949|FG000|COMPLETED|Overall Study||4||
48360903|NCT04530825|101210950|FG001|COMPLETED|Overall Study||28||
48360904|NCT04530825|101210951|FG002|COMPLETED|Overall Study||16||
48360905|NCT04530825|101210952|FG003|COMPLETED|Overall Study||12||
48360906|NCT04530825|101210949|FG000|NOT COMPLETED|Overall Study||3||
48360907|NCT04530825|101210950|FG001|NOT COMPLETED|Overall Study||1||
48360908|NCT04530825|101210951|FG002|NOT COMPLETED|Overall Study||0||
48360909|NCT04530825|101210952|FG003|NOT COMPLETED|Overall Study||1||
48360910|NCT01773395|101210953|FG000|STARTED|Overall Study||64||
48360911|NCT01773395|101210954|FG001|STARTED|Overall Study||59||
48360912|NCT01773395|101210953|FG000|COMPLETED|Overall Study||30||
48360913|NCT01773395|101210954|FG001|COMPLETED|Overall Study||27||
48360914|NCT01773395|101210953|FG000|NOT COMPLETED|Overall Study||34||
48360915|NCT01773395|101210954|FG001|NOT COMPLETED|Overall Study||32||
48360916|NCT01330381|101214228|FG000|STARTED|Double-blind Treatment Period (8 Weeks)||107||
48360917|NCT01330381|101214229|FG001|STARTED|Double-blind Treatment Period (8 Weeks)||108||
48360918|NCT01330381|101214230|FG002|STARTED|Double-blind Treatment Period (8 Weeks)||0||
48432332|NCT01589185|101392651|FG000|STARTED|Overall Study||6||
48432333|NCT01589185|101392652|FG001|STARTED|Overall Study||8||
48432334|NCT01589185|101392653|FG002|STARTED|Overall Study||10||
48432335|NCT01589185|101392654|FG003|STARTED|Overall Study||8||
48432336|NCT01589185|101392655|FG004|STARTED|Overall Study||16||
48432337|NCT01589185|101392651|FG000|COMPLETED|Overall Study||4||
48432338|NCT01589185|101392652|FG001|COMPLETED|Overall Study||6||
48432339|NCT01589185|101392653|FG002|COMPLETED|Overall Study||6||
48432340|NCT01589185|101392654|FG003|COMPLETED|Overall Study||5||
48432341|NCT01589185|101392655|FG004|COMPLETED|Overall Study||15||
48432342|NCT01589185|101392651|FG000|NOT COMPLETED|Overall Study||2||
48432343|NCT01589185|101392652|FG001|NOT COMPLETED|Overall Study||2||
48432344|NCT01589185|101392653|FG002|NOT COMPLETED|Overall Study||4||
48432345|NCT01589185|101392654|FG003|NOT COMPLETED|Overall Study||3||
48432346|NCT01589185|101392655|FG004|NOT COMPLETED|Overall Study||1||
48432347|NCT00240331|101392656|FG000|STARTED|Overall Study||1389||
48432348|NCT00240331|101392657|FG001|STARTED|Overall Study||1384||
48432349|NCT00240331|101392656|FG000|COMPLETED|Overall Study||1263||
48432350|NCT00240331|101392657|FG001|COMPLETED|Overall Study||1250||
48432351|NCT00240331|101392656|FG000|NOT COMPLETED|Overall Study||126||
48432352|NCT00240331|101392657|FG001|NOT COMPLETED|Overall Study||134||
48432353|NCT01353209|101392658|FG000|STARTED|Overall Study||9||
48432354|NCT01353209|101392659|FG001|STARTED|Overall Study||8||
48432355|NCT01353209|101392658|FG000|COMPLETED|Overall Study||8||
48432356|NCT01353209|101392659|FG001|COMPLETED|Overall Study||7||
48432357|NCT01353209|101392658|FG000|NOT COMPLETED|Overall Study||1||
48432358|NCT01353209|101392659|FG001|NOT COMPLETED|Overall Study||1||
48432359|NCT03315780|101392660|FG000|STARTED|Period 1||6||
48432360|NCT03315780|101392661|FG001|STARTED|Period 1||6||
48432361|NCT03315780|101392660|FG000|Received One Dose of Study Drug|Period 1||6||
48432362|NCT03315780|101392661|FG001|Received One Dose of Study Drug|Period 1||6||
48432363|NCT03315780|101392660|FG000|COMPLETED|Period 1||6||
48432364|NCT03315780|101392661|FG001|COMPLETED|Period 1||6||
48432365|NCT03315780|101392660|FG000|NOT COMPLETED|Period 1||0||
48432366|NCT03315780|101392661|FG001|NOT COMPLETED|Period 1||0||
48432367|NCT03315780|101392660|FG000|STARTED|Period 2||6||
48432368|NCT03315780|101392661|FG001|STARTED|Period 2||6||
48432369|NCT03315780|101392660|FG000|COMPLETED|Period 2||6||
48432370|NCT03315780|101392661|FG001|COMPLETED|Period 2||6||
48432371|NCT03315780|101392660|FG000|NOT COMPLETED|Period 2||0||
48432372|NCT03315780|101392661|FG001|NOT COMPLETED|Period 2||0||
48432373|NCT00690573|101392662|FG000|STARTED|Overall Study||25||
48432374|NCT00690573|101392662|FG000|COMPLETED|Overall Study||16||
48432375|NCT00690573|101392662|FG000|NOT COMPLETED|Overall Study||9||
48432376|NCT01319994|101392663|FG000|STARTED|Overall Study||26||
48432377|NCT01319994|101392664|FG001|STARTED|Overall Study||27||
48432378|NCT01319994|101392663|FG000|Abto Keep Appoinment Shedule|Overall Study||23||
48432379|NCT01319994|101392664|FG001|Abto Keep Appoinment Shedule|Overall Study||24||
48432380|NCT01319994|101392663|FG000|Tolerated at Least 1.7g/Day Dose|Overall Study||19||
48432381|NCT01319994|101392664|FG001|Tolerated at Least 1.7g/Day Dose|Overall Study||24||
48432382|NCT01319994|101392663|FG000|Glucocorticoid Dose as Inc Cri|Overall Study||19||
48432383|NCT01319994|101392664|FG001|Glucocorticoid Dose as Inc Cri|Overall Study||22||
48432384|NCT01319994|101392663|FG000|Did Not Develop Overt Diabetes|Overall Study||19||
48432385|NCT01319994|101392664|FG001|Did Not Develop Overt Diabetes|Overall Study||21||
48432386|NCT01319994|101392663|FG000|COMPLETED|Overall Study||19||
48432387|NCT01319994|101392664|FG001|COMPLETED|Overall Study||21||
48432388|NCT01319994|101392663|FG000|NOT COMPLETED|Overall Study||7||
48432389|NCT01319994|101392664|FG001|NOT COMPLETED|Overall Study||6||
48432390|NCT00700115|101392665|FG000|STARTED|Overall Study||40||
48432391|NCT00700115|101392666|FG001|STARTED|Overall Study||20||
48432392|NCT00700115|101392665|FG000|COMPLETED|Overall Study||39||
48432393|NCT00700115|101392666|FG001|COMPLETED|Overall Study||19||
48432394|NCT00700115|101392665|FG000|NOT COMPLETED|Overall Study||1||
48432395|NCT00700115|101392666|FG001|NOT COMPLETED|Overall Study||1||
48432396|NCT02925650|101392667|FG000|STARTED|Overall Study||5||
48432397|NCT02925650|101392668|FG001|STARTED|Overall Study||5||
48432398|NCT02925650|101392669|FG002|STARTED|Overall Study||1||
48432399|NCT02925650|101392670|FG003|STARTED|Overall Study||7||
48432400|NCT02925650|101392667|FG000|COMPLETED|Overall Study||4||
48432401|NCT02925650|101392668|FG001|COMPLETED|Overall Study||5||
48432402|NCT02925650|101392669|FG002|COMPLETED|Overall Study||1||
48432403|NCT02925650|101392670|FG003|COMPLETED|Overall Study||5||
48432404|NCT02925650|101392667|FG000|NOT COMPLETED|Overall Study||1||
48432405|NCT02925650|101392668|FG001|NOT COMPLETED|Overall Study||0||
48432406|NCT02925650|101392669|FG002|NOT COMPLETED|Overall Study||0||
48432407|NCT02925650|101392670|FG003|NOT COMPLETED|Overall Study||2||
48432408|NCT02219477|101392671|FG000|STARTED|Overall Study||9||
48432409|NCT02219477|101392672|FG001|STARTED|Overall Study||24||
48432410|NCT02219477|101392673|FG002|STARTED|Overall Study||3||
48432411|NCT02219477|101392671|FG000|COMPLETED|Overall Study||9||
48432412|NCT02219477|101392672|FG001|COMPLETED|Overall Study||22||
48432413|NCT02219477|101392673|FG002|COMPLETED|Overall Study||2||
48764261|NCT03043872|102211918|FG001|Ongoing Study at Global Cohort Final Analysis Data Cut-off (DCO)|Overall Study||56||
48432414|NCT02219477|101392671|FG000|NOT COMPLETED|Overall Study||0||
48432415|NCT02219477|101392672|FG001|NOT COMPLETED|Overall Study||2||
48432416|NCT02219477|101392673|FG002|NOT COMPLETED|Overall Study||1||
48432417|NCT01593761|101392674|FG000|STARTED|Overall Study||20||
48360919|NCT01330381|101214228|FG000|Received Treatment|Double-blind Treatment Period (8 Weeks)||106||
48360920|NCT01330381|101214229|FG001|Received Treatment|Double-blind Treatment Period (8 Weeks)||107||
48360921|NCT01330381|101214230|FG002|Received Treatment|Double-blind Treatment Period (8 Weeks)||0||
48360922|NCT01330381|101214228|FG000|COMPLETED|Double-blind Treatment Period (8 Weeks)||96||
48360923|NCT01330381|101214229|FG001|COMPLETED|Double-blind Treatment Period (8 Weeks)||101||
48360924|NCT01330381|101214230|FG002|COMPLETED|Double-blind Treatment Period (8 Weeks)||0||
48360925|NCT01330381|101214228|FG000|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||11||
48360926|NCT01330381|101214229|FG001|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||7||
48432418|NCT01593761|101392674|FG000|COMPLETED|Overall Study||12||
48432419|NCT01593761|101392674|FG000|NOT COMPLETED|Overall Study||8||
48187673|NCT02703532|100783079|FG003|STARTED|Overall Study||11||
48187674|NCT02703532|100783076|FG000|COMPLETED|Overall Study||19||
48187675|NCT02703532|100783077|FG001|COMPLETED|Overall Study||10||
48187676|NCT02703532|100783078|FG002|COMPLETED|Overall Study||19||
48187677|NCT02703532|100783079|FG003|COMPLETED|Overall Study||10||
48187678|NCT02703532|100783076|FG000|NOT COMPLETED|Overall Study||2||
48187679|NCT02703532|100783077|FG001|NOT COMPLETED|Overall Study||1||
48187680|NCT02703532|100783078|FG002|NOT COMPLETED|Overall Study||2||
48187681|NCT02703532|100783079|FG003|NOT COMPLETED|Overall Study||1||
48187682|NCT03717194|100783080|FG000|STARTED|Overall Study||51||
48187683|NCT03717194|100783081|FG001|STARTED|Overall Study||51||
48187684|NCT03717194|100783080|FG000|COMPLETED|Overall Study||48||
48187685|NCT03717194|100783081|FG001|COMPLETED|Overall Study||46||
48764262|NCT03043872|102211919|FG002|Ongoing Study at Global Cohort Final Analysis Data Cut-off (DCO)|Overall Study||31||
48360927|NCT01330381|101214230|FG002|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||0||
48360928|NCT01330381|101214228|FG000|STARTED|Open-label Treatment Period (16 Weeks)||98||
48360929|NCT01330381|101214229|FG001|STARTED|Open-label Treatment Period (16 Weeks)||0||
48360930|NCT01330381|101214230|FG002|STARTED|Open-label Treatment Period (16 Weeks)||99||
48360931|NCT01330381|101214228|FG000|COMPLETED|Open-label Treatment Period (16 Weeks)||88||
48360932|NCT01330381|101214229|FG001|COMPLETED|Open-label Treatment Period (16 Weeks)||0||
48360933|NCT01330381|101214230|FG002|COMPLETED|Open-label Treatment Period (16 Weeks)||81||
48360934|NCT01330381|101214228|FG000|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||10||
48360935|NCT01330381|101214229|FG001|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||0||
48360936|NCT01330381|101214230|FG002|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||18||
48360937|NCT03739983|101214231|FG000|STARTED|Overall Study||2||
48360938|NCT03739983|101214231|FG000|COMPLETED|Overall Study||2||
48360939|NCT03739983|101214231|FG000|NOT COMPLETED|Overall Study||0||
48360940|NCT02004990|101214232|FG000|STARTED|Overall Study||12||
48360941|NCT02004990|101214232|FG000|COMPLETED|Overall Study||12||
48432420|NCT00470301|101392675|FG000|STARTED|Overall Study||60||
48432421|NCT00470301|101392675|FG000|COMPLETED|Overall Study||55||
48432422|NCT00470301|101392675|FG000|NOT COMPLETED|Overall Study||5||
48432423|NCT01195662|101392676|FG000|STARTED|Double Blind Treatment Period||224||
48639025|NCT01245751|101901551|FG002|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0||
48639026|NCT01245751|101901552|FG003|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0||
48639027|NCT03424304|101901553|FG000|STARTED|Overall Study||20||
48639028|NCT03424304|101901553|FG000|COMPLETED|Overall Study||19||
48639029|NCT03424304|101901553|FG000|NOT COMPLETED|Overall Study||1||
48639030|NCT03704688|101901554|FG000|STARTED|Overall Study||0||
48187686|NCT03717194|100783080|FG000|NOT COMPLETED|Overall Study||3||
48432424|NCT01195662|101392677|FG001|STARTED|Double Blind Treatment Period||225||
48432425|NCT01195662|101392678|FG002|STARTED|Double Blind Treatment Period||133||
48432426|NCT01195662|101392676|FG000|COMPLETED|Double Blind Treatment Period||202||
48639031|NCT03704688|101901555|FG001|STARTED|Overall Study||0||
48639032|NCT03704688|101901556|FG002|STARTED|Overall Study||0||
48639033|NCT03704688|101901557|FG003|STARTED|Overall Study||7||
48639034|NCT03704688|101901558|FG004|STARTED|Overall Study||5||
48639035|NCT03704688|101901559|FG005|STARTED|Overall Study||0||
48639036|NCT03704688|101901554|FG000|COMPLETED|Overall Study||0||
48639037|NCT03704688|101901555|FG001|COMPLETED|Overall Study||0||
48639038|NCT03704688|101901556|FG002|COMPLETED|Overall Study||0||
48639039|NCT03704688|101901557|FG003|COMPLETED|Overall Study||0||
48639040|NCT03704688|101901558|FG004|COMPLETED|Overall Study||0||
48639041|NCT03704688|101901559|FG005|COMPLETED|Overall Study||0||
48639042|NCT03704688|101901554|FG000|NOT COMPLETED|Overall Study||0||
48639043|NCT03704688|101901555|FG001|NOT COMPLETED|Overall Study||0||
48639044|NCT03704688|101901556|FG002|NOT COMPLETED|Overall Study||0||
48639045|NCT03704688|101901557|FG003|NOT COMPLETED|Overall Study||7||
48639046|NCT03704688|101901558|FG004|NOT COMPLETED|Overall Study||5||
48639047|NCT03704688|101901559|FG005|NOT COMPLETED|Overall Study||0||
48639048|NCT02949934|101901560|FG000|STARTED|Natural Drinking Period||16||
48639049|NCT02949934|101901561|FG001|STARTED|Natural Drinking Period||12||
48639050|NCT02949934|101901562|FG002|STARTED|Natural Drinking Period||17||
48639051|NCT02949934|101901563|FG003|STARTED|Natural Drinking Period||16||
48639052|NCT02949934|101901564|FG004|STARTED|Natural Drinking Period||15||
48432427|NCT01195662|101392677|FG001|COMPLETED|Double Blind Treatment Period||211||
48432428|NCT01195662|101392678|FG002|COMPLETED|Double Blind Treatment Period||119||
48432429|NCT01195662|101392676|FG000|NOT COMPLETED|Double Blind Treatment Period||22||
48432430|NCT01195662|101392677|FG001|NOT COMPLETED|Double Blind Treatment Period||14||
48432431|NCT01195662|101392678|FG002|NOT COMPLETED|Double Blind Treatment Period||14||
48432432|NCT01195662|101392676|FG000|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)||203||
48432433|NCT01195662|101392677|FG001|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)||209||
48432434|NCT01195662|101392678|FG002|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)||120||
48432435|NCT01195662|101392676|FG000|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||200||
48432436|NCT01195662|101392677|FG001|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||209||
48432437|NCT01195662|101392678|FG002|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||119||
48432438|NCT01195662|101392676|FG000|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||3||
48432439|NCT01195662|101392677|FG001|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||0||
48432440|NCT01195662|101392678|FG002|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||1||
48432441|NCT00822185|101392679|FG000|STARTED|Overall Study||6||
48432442|NCT00822185|101392680|FG001|STARTED|Overall Study||6||
48432443|NCT00822185|101392681|FG002|STARTED|Overall Study||6||
48432444|NCT00822185|101392682|FG003|STARTED|Overall Study||6||
48432445|NCT00822185|101392683|FG004|STARTED|Overall Study||8||
48432446|NCT00822185|101392679|FG000|COMPLETED|Overall Study||6||
48432447|NCT00822185|101392680|FG001|COMPLETED|Overall Study||6||
48432448|NCT00822185|101392681|FG002|COMPLETED|Overall Study||6||
48432449|NCT00822185|101392682|FG003|COMPLETED|Overall Study||6||
48432450|NCT00822185|101392683|FG004|COMPLETED|Overall Study||8||
48432451|NCT00822185|101392679|FG000|NOT COMPLETED|Overall Study||0||
48432452|NCT00822185|101392680|FG001|NOT COMPLETED|Overall Study||0||
48432453|NCT00822185|101392681|FG002|NOT COMPLETED|Overall Study||0||
48432454|NCT00822185|101392682|FG003|NOT COMPLETED|Overall Study||0||
48432455|NCT00822185|101392683|FG004|NOT COMPLETED|Overall Study||0||
48432456|NCT00903357|101392684|FG000|STARTED|First Intervention||27||
48432457|NCT00903357|101392685|FG001|STARTED|First Intervention||27||
48432458|NCT00903357|101392684|FG000|COMPLETED|First Intervention||22||
48432459|NCT00903357|101392685|FG001|COMPLETED|First Intervention||23||
48432460|NCT00903357|101392684|FG000|NOT COMPLETED|First Intervention||5||
48432461|NCT00903357|101392685|FG001|NOT COMPLETED|First Intervention||4||
48432462|NCT00903357|101392684|FG000|STARTED|Wash Out Period of 2 Weeks||22||
48432463|NCT00903357|101392685|FG001|STARTED|Wash Out Period of 2 Weeks||23||
48432464|NCT00903357|101392684|FG000|COMPLETED|Wash Out Period of 2 Weeks||22||
48432465|NCT00903357|101392685|FG001|COMPLETED|Wash Out Period of 2 Weeks||22||
48432466|NCT00903357|101392684|FG000|NOT COMPLETED|Wash Out Period of 2 Weeks||0||
48432467|NCT00903357|101392685|FG001|NOT COMPLETED|Wash Out Period of 2 Weeks||1||
48432468|NCT00903357|101392684|FG000|STARTED|Second Intervention||22||
48432469|NCT00903357|101392685|FG001|STARTED|Second Intervention||22||
48432470|NCT00903357|101392684|FG000|COMPLETED|Second Intervention||21||
48432471|NCT00903357|101392685|FG001|COMPLETED|Second Intervention||22||
48432472|NCT00903357|101392684|FG000|NOT COMPLETED|Second Intervention||1||
48432473|NCT00903357|101392685|FG001|NOT COMPLETED|Second Intervention||0||
48432474|NCT05146999|101392686|FG000|STARTED|Overall Study||99||
48432475|NCT05146999|101392687|FG001|STARTED|Overall Study||33||
48432476|NCT05146999|101392686|FG000|COMPLETED|Overall Study||89||
48432477|NCT05146999|101392687|FG001|COMPLETED|Overall Study||27||
48432478|NCT05146999|101392686|FG000|NOT COMPLETED|Overall Study||10||
48432479|NCT05146999|101392687|FG001|NOT COMPLETED|Overall Study||6||
48432480|NCT05732610|101392688|FG000|STARTED|Overall Study||19||
48432481|NCT05732610|101392689|FG001|STARTED|Overall Study||15||
48432482|NCT05732610|101392688|FG000|COMPLETED|Overall Study||19||
48432483|NCT05732610|101392689|FG001|COMPLETED|Overall Study||15||
48432484|NCT05732610|101392688|FG000|NOT COMPLETED|Overall Study||0||
48432485|NCT05732610|101392689|FG001|NOT COMPLETED|Overall Study||0||
48432486|NCT01115166|101392690|FG000|STARTED|Overall Study||10||
48432487|NCT01115166|101392690|FG000|COMPLETED|Overall Study||10||
48432488|NCT01115166|101392690|FG000|NOT COMPLETED|Overall Study||0||
48432489|NCT03000075|101392691|FG000|STARTED|Part A||58||
48432490|NCT03000075|101392692|FG001|STARTED|Part A||58||
48432491|NCT03000075|101392693|FG002|STARTED|Part A||55||
48432492|NCT03000075|101392694|FG003|STARTED|Part A||0||
48432493|NCT03000075|101392695|FG004|STARTED|Part A||0||
48432494|NCT03000075|101392696|FG005|STARTED|Part A||0||
48432495|NCT03000075|101392697|FG006|STARTED|Part A||0||
48432496|NCT03000075|101392691|FG000|COMPLETED|Part A||54||
48432497|NCT03000075|101392692|FG001|COMPLETED|Part A||58||
48432498|NCT03000075|101392693|FG002|COMPLETED|Part A||55||
48432499|NCT03000075|101392694|FG003|COMPLETED|Part A||0||
48432500|NCT03000075|101392695|FG004|COMPLETED|Part A||0||
48432501|NCT03000075|101392696|FG005|COMPLETED|Part A||0||
48432502|NCT03000075|101392697|FG006|COMPLETED|Part A||0||
48432503|NCT03000075|101392691|FG000|NOT COMPLETED|Part A||4||
48432504|NCT03000075|101392692|FG001|NOT COMPLETED|Part A||0||
48432505|NCT03000075|101392693|FG002|NOT COMPLETED|Part A||0||
48432506|NCT03000075|101392694|FG003|NOT COMPLETED|Part A||0||
48432507|NCT03000075|101392695|FG004|NOT COMPLETED|Part A||0||
48432508|NCT03000075|101392696|FG005|NOT COMPLETED|Part A||0||
48432509|NCT03000075|101392697|FG006|NOT COMPLETED|Part A||0||
48432510|NCT03000075|101392691|FG000|STARTED|Part B||0||
48432511|NCT03000075|101392692|FG001|STARTED|Part B||0||
48432512|NCT03000075|101392693|FG002|STARTED|Part B||0||
48432513|NCT03000075|101392694|FG003|STARTED|Part B||27||
48432514|NCT03000075|101392695|FG004|STARTED|Part B||27||
48432515|NCT03000075|101392696|FG005|STARTED|Part B||58||
48432516|NCT03000075|101392697|FG006|STARTED|Part B||55||
48432517|NCT03000075|101392691|FG000|COMPLETED|Part B||0||
48432518|NCT03000075|101392692|FG001|COMPLETED|Part B||0||
48432519|NCT03000075|101392693|FG002|COMPLETED|Part B||0||
48432520|NCT03000075|101392694|FG003|COMPLETED|Part B||27||
48432521|NCT03000075|101392695|FG004|COMPLETED|Part B||26||
48432522|NCT03000075|101392696|FG005|COMPLETED|Part B||56||
48432523|NCT03000075|101392697|FG006|COMPLETED|Part B||54||
48360942|NCT02004990|101214232|FG000|NOT COMPLETED|Overall Study||0||
48360943|NCT01269125|101214233|FG000|STARTED|Overall Study||60||
48360944|NCT01269125|101214234|FG001|STARTED|Overall Study||60||
48360945|NCT01269125|101214235|FG002|STARTED|Overall Study||60||
48360946|NCT01269125|101214233|FG000|COMPLETED|Overall Study||53||
48360947|NCT01269125|101214234|FG001|COMPLETED|Overall Study||55||
48360948|NCT01269125|101214235|FG002|COMPLETED|Overall Study||60||
48360949|NCT01269125|101214233|FG000|NOT COMPLETED|Overall Study||7||
48360950|NCT01269125|101214234|FG001|NOT COMPLETED|Overall Study||5||
48360951|NCT01269125|101214235|FG002|NOT COMPLETED|Overall Study||0||
48360952|NCT00318708|101214236|FG000|STARTED|Overall Study||47||
48360953|NCT00318708|101214237|FG001|STARTED|Overall Study||45||
48360954|NCT00318708|101214236|FG000|8-week Milestone|Overall Study||42||
48360955|NCT00318708|101214237|FG001|8-week Milestone|Overall Study||42||
48360956|NCT00318708|101214236|FG000|COMPLETED|Overall Study||39||
48360957|NCT00318708|101214237|FG001|COMPLETED|Overall Study||40||
48360958|NCT00318708|101214236|FG000|NOT COMPLETED|Overall Study||8||
48432524|NCT03000075|101392691|FG000|NOT COMPLETED|Part B||0||
48432525|NCT03000075|101392692|FG001|NOT COMPLETED|Part B||0||
48432526|NCT03000075|101392693|FG002|NOT COMPLETED|Part B||0||
48432527|NCT03000075|101392694|FG003|NOT COMPLETED|Part B||0||
48432528|NCT03000075|101392695|FG004|NOT COMPLETED|Part B||1||
48432529|NCT03000075|101392696|FG005|NOT COMPLETED|Part B||2||
48432530|NCT03000075|101392697|FG006|NOT COMPLETED|Part B||1||
48432531|NCT03661346|101392698|FG000|STARTED|Overall Study||13||
48432532|NCT03661346|101392699|FG001|STARTED|Overall Study||15||
48432533|NCT03661346|101392698|FG000|COMPLETED|Overall Study||13||
48432534|NCT03661346|101392699|FG001|COMPLETED|Overall Study||15||
48432535|NCT03661346|101392698|FG000|NOT COMPLETED|Overall Study||0||
48432536|NCT03661346|101392699|FG001|NOT COMPLETED|Overall Study||0||
48432537|NCT02917421|101392700|FG000|STARTED|Overall Study||47||
48432538|NCT02917421|101392701|FG001|STARTED|Overall Study||41||
48432539|NCT02917421|101392700|FG000|COMPLETED|Overall Study||47||
48432540|NCT02917421|101392701|FG001|COMPLETED|Overall Study||41||
48432541|NCT02917421|101392700|FG000|NOT COMPLETED|Overall Study||0||
48432542|NCT02917421|101392701|FG001|NOT COMPLETED|Overall Study||0||
48432543|NCT01876901|101392702|FG000|STARTED|Overall Study||65||
48432544|NCT01876901|101392703|FG001|STARTED|Overall Study||59||
48432545|NCT01876901|101392702|FG000|COMPLETED|Overall Study||48||
48432546|NCT01876901|101392703|FG001|COMPLETED|Overall Study||52||
48432547|NCT01876901|101392702|FG000|NOT COMPLETED|Overall Study||17||
48432548|NCT01876901|101392703|FG001|NOT COMPLETED|Overall Study||7||
48432549|NCT00379639|101392704|FG000|STARTED|Overall Study||7||
48432550|NCT00379639|101392705|FG001|STARTED|Overall Study||7||
48432551|NCT00379639|101392706|FG002|STARTED|Overall Study||10||
48432552|NCT00379639|101392707|FG003|STARTED|Overall Study||6||
48432553|NCT00379639|101392708|FG004|STARTED|Overall Study||6||
48432554|NCT00379639|101392704|FG000|Efficacy Evaluable Population|Overall Study||6||
48432555|NCT00379639|101392705|FG001|Efficacy Evaluable Population|Overall Study||7||
48432556|NCT00379639|101392706|FG002|Efficacy Evaluable Population|Overall Study||7||
48432557|NCT00379639|101392707|FG003|Efficacy Evaluable Population|Overall Study||4||
48432558|NCT00379639|101392708|FG004|Efficacy Evaluable Population|Overall Study||3||
48432559|NCT00379639|101392704|FG000|Completed 6 Cycles of Therapy|Overall Study||4||
48432560|NCT00379639|101392705|FG001|Completed 6 Cycles of Therapy|Overall Study||2||
48432561|NCT00379639|101392706|FG002|Completed 6 Cycles of Therapy|Overall Study||1||
48432562|NCT00379639|101392707|FG003|Completed 6 Cycles of Therapy|Overall Study||0||
48360959|NCT00318708|101214237|FG001|NOT COMPLETED|Overall Study||5||
48360960|NCT01009463|101214238|FG000|STARTED|4-week, Open-label Run-In Period||2071||
48360961|NCT01009463|101214239|FG001|STARTED|4-week, Open-label Run-In Period||0||
48360962|NCT01009463|101214240|FG002|STARTED|4-week, Open-label Run-In Period||0||
48360963|NCT01009463|101214241|FG003|STARTED|4-week, Open-label Run-In Period||0||
48360964|NCT01009463|101214242|FG004|STARTED|4-week, Open-label Run-In Period||0||
48360965|NCT01009463|101214238|FG000|COMPLETED|4-week, Open-label Run-In Period||1622||
48360966|NCT01009463|101214239|FG001|COMPLETED|4-week, Open-label Run-In Period||0||
48360967|NCT01009463|101214240|FG002|COMPLETED|4-week, Open-label Run-In Period||0||
48432563|NCT00379639|101392708|FG004|Completed 6 Cycles of Therapy|Overall Study||0||
48432564|NCT00379639|101392704|FG000|COMPLETED|Overall Study||4||
48432565|NCT00379639|101392705|FG001|COMPLETED|Overall Study||2||
48432566|NCT00379639|101392706|FG002|COMPLETED|Overall Study||1||
48432567|NCT00379639|101392707|FG003|COMPLETED|Overall Study||0||
48432568|NCT00379639|101392708|FG004|COMPLETED|Overall Study||0||
48432569|NCT00379639|101392704|FG000|NOT COMPLETED|Overall Study||3||
48360968|NCT01009463|101214241|FG003|COMPLETED|4-week, Open-label Run-In Period||0||
48360969|NCT01009463|101214242|FG004|COMPLETED|4-week, Open-label Run-In Period||0||
48360970|NCT01009463|101214238|FG000|NOT COMPLETED|4-week, Open-label Run-In Period||449||
48360971|NCT01009463|101214239|FG001|NOT COMPLETED|4-week, Open-label Run-In Period||0||
48360972|NCT01009463|101214240|FG002|NOT COMPLETED|4-week, Open-label Run-In Period||0||
48360973|NCT01009463|101214241|FG003|NOT COMPLETED|4-week, Open-label Run-In Period||0||
48360974|NCT01009463|101214242|FG004|NOT COMPLETED|4-week, Open-label Run-In Period||0||
48360975|NCT01009463|101214238|FG000|STARTED|52-week, Double-blind Treatment Period||0||
48360976|NCT01009463|101214239|FG001|STARTED|52-week, Double-blind Treatment Period||409||
48360977|NCT01009463|101214240|FG002|STARTED|52-week, Double-blind Treatment Period||408||
48360978|NCT01009463|101214241|FG003|STARTED|52-week, Double-blind Treatment Period||403||
48360979|NCT01009463|101214242|FG004|STARTED|52-week, Double-blind Treatment Period||402||
48360980|NCT01009463|101214238|FG000|Completed the Treatment Period|52-week, Double-blind Treatment Period||0||
48360981|NCT01009463|101214239|FG001|Completed the Treatment Period|52-week, Double-blind Treatment Period||295||
48360982|NCT01009463|101214240|FG002|Completed the Treatment Period|52-week, Double-blind Treatment Period||318||
48360983|NCT01009463|101214241|FG003|Completed the Treatment Period|52-week, Double-blind Treatment Period||314||
48360984|NCT01009463|101214242|FG004|Completed the Treatment Period|52-week, Double-blind Treatment Period||303||
48360985|NCT01009463|101214238|FG000|COMPLETED|52-week, Double-blind Treatment Period||0||
48360986|NCT01009463|101214239|FG001|COMPLETED|52-week, Double-blind Treatment Period||294||
48360987|NCT01009463|101214240|FG002|COMPLETED|52-week, Double-blind Treatment Period||315||
48360988|NCT01009463|101214241|FG003|COMPLETED|52-week, Double-blind Treatment Period||312||
48360989|NCT01009463|101214242|FG004|COMPLETED|52-week, Double-blind Treatment Period||301||
48360990|NCT01009463|101214238|FG000|NOT COMPLETED|52-week, Double-blind Treatment Period||0||
48360991|NCT01009463|101214239|FG001|NOT COMPLETED|52-week, Double-blind Treatment Period||115||
48360992|NCT01009463|101214240|FG002|NOT COMPLETED|52-week, Double-blind Treatment Period||93||
48360993|NCT01009463|101214241|FG003|NOT COMPLETED|52-week, Double-blind Treatment Period||91||
48360994|NCT01009463|101214242|FG004|NOT COMPLETED|52-week, Double-blind Treatment Period||101||
48360995|NCT01618656|101214243|FG000|STARTED|Overall Study||46||
48360996|NCT01618656|101214244|FG001|STARTED|Overall Study||24||
48360997|NCT01618656|101214243|FG000|COMPLETED|Overall Study||38||
48360998|NCT01618656|101214244|FG001|COMPLETED|Overall Study||20||
48360999|NCT01618656|101214243|FG000|NOT COMPLETED|Overall Study||8||
48361000|NCT01618656|101214244|FG001|NOT COMPLETED|Overall Study||4||
48361001|NCT02042131|101214245|FG000|STARTED|Overall Study||32||
48361002|NCT02042131|101214246|FG001|STARTED|Overall Study||32||
48361003|NCT02042131|101214247|FG002|STARTED|Overall Study||33||
48361004|NCT02042131|101214245|FG000|COMPLETED|Overall Study||32||
48361005|NCT02042131|101214246|FG001|COMPLETED|Overall Study||32||
48361006|NCT02042131|101214247|FG002|COMPLETED|Overall Study||33||
48361007|NCT02042131|101214245|FG000|NOT COMPLETED|Overall Study||0||
48361008|NCT02042131|101214246|FG001|NOT COMPLETED|Overall Study||0||
48361009|NCT02042131|101214247|FG002|NOT COMPLETED|Overall Study||0||
48361010|NCT01855789|101214248|FG000|STARTED|1) Baseline up to Week 24||718||
48361011|NCT01855789|101214249|FG001|STARTED|1) Baseline up to Week 24||0||
48361012|NCT01855789|101214250|FG002|STARTED|1) Baseline up to Week 24||0||
48361013|NCT01855789|101214251|FG003|STARTED|1) Baseline up to Week 24||0||
48361014|NCT01855789|101214248|FG000|COMPLETED|1) Baseline up to Week 24||602||
48361015|NCT01855789|101214249|FG001|COMPLETED|1) Baseline up to Week 24||0||
48432570|NCT00379639|101392705|FG001|NOT COMPLETED|Overall Study||5||
48432571|NCT00379639|101392706|FG002|NOT COMPLETED|Overall Study||9||
48432572|NCT00379639|101392707|FG003|NOT COMPLETED|Overall Study||6||
48432573|NCT00379639|101392708|FG004|NOT COMPLETED|Overall Study||6||
48432574|NCT02686437|101392709|FG000|STARTED|Overall Study||16||
48432575|NCT02686437|101392710|FG001|STARTED|Overall Study||20||
48639053|NCT02949934|101901565|FG005|STARTED|Natural Drinking Period||14||
48361016|NCT01855789|101214250|FG002|COMPLETED|1) Baseline up to Week 24||0||
48361017|NCT01855789|101214251|FG003|COMPLETED|1) Baseline up to Week 24||0||
48361018|NCT01855789|101214248|FG000|NOT COMPLETED|1) Baseline up to Week 24||116||
48361019|NCT01855789|101214249|FG001|NOT COMPLETED|1) Baseline up to Week 24||0||
48361020|NCT01855789|101214250|FG002|NOT COMPLETED|1) Baseline up to Week 24||0||
48361021|NCT01855789|101214251|FG003|NOT COMPLETED|1) Baseline up to Week 24||0||
48361022|NCT01855789|101214248|FG000|STARTED|2) Week 24 up to End of Study||0||
48361023|NCT01855789|101214249|FG001|STARTED|2) Week 24 up to End of Study||147||
48361024|NCT01855789|101214250|FG002|STARTED|2) Week 24 up to End of Study||147||
48361025|NCT01855789|101214251|FG003|STARTED|2) Week 24 up to End of Study||308||
48361026|NCT01855789|101214248|FG000|COMPLETED|2) Week 24 up to End of Study||0||
48361027|NCT01855789|101214249|FG001|COMPLETED|2) Week 24 up to End of Study||132||
48361028|NCT01855789|101214250|FG002|COMPLETED|2) Week 24 up to End of Study||129||
48361029|NCT01855789|101214251|FG003|COMPLETED|2) Week 24 up to End of Study||250||
48361030|NCT01855789|101214248|FG000|NOT COMPLETED|2) Week 24 up to End of Study||0||
48432576|NCT02686437|101392709|FG000|COMPLETED|Overall Study||13||
48432577|NCT02686437|101392710|FG001|COMPLETED|Overall Study||12||
48432578|NCT02686437|101392709|FG000|NOT COMPLETED|Overall Study||3||
48432579|NCT02686437|101392710|FG001|NOT COMPLETED|Overall Study||8||
48432580|NCT04366258|101392711|FG000|STARTED|Baseline Assessments||55||
48432581|NCT04366258|101392711|FG000|COMPLETED|Baseline Assessments||31||
48432582|NCT04366258|101392711|FG000|NOT COMPLETED|Baseline Assessments||24||
48432583|NCT04366258|101392711|FG000|STARTED|Randomized Cross-Over||31||
48432584|NCT04366258|101392711|FG000|Received t-PBM at High Irradiance|Randomized Cross-Over||27||
48432585|NCT04366258|101392711|FG000|Received t-PBM at Medium Irradiance|Randomized Cross-Over||29||
48432586|NCT04366258|101392711|FG000|Received t-PBM at Low Irradiance|Randomized Cross-Over||29||
48432587|NCT04366258|101392711|FG000|Received t-PBM at Sham Irradiance|Randomized Cross-Over||29||
48432588|NCT04366258|101392711|FG000|COMPLETED|Randomized Cross-Over||31||
48432589|NCT04366258|101392711|FG000|NOT COMPLETED|Randomized Cross-Over||0||
48432590|NCT01005810|101392712|FG000|STARTED|Overall Study||58||
48432591|NCT01005810|101392713|FG001|STARTED|Overall Study||58||
48432592|NCT01005810|101392712|FG000|COMPLETED|Overall Study||37||
48432593|NCT01005810|101392713|FG001|COMPLETED|Overall Study||33||
48432594|NCT01005810|101392712|FG000|NOT COMPLETED|Overall Study||21||
48432595|NCT01005810|101392713|FG001|NOT COMPLETED|Overall Study||25||
48432596|NCT00501969|101392714|FG000|STARTED|Overall Study||395||
48432597|NCT00501969|101392714|FG000|COMPLETED|Overall Study||189||
48432598|NCT00501969|101392714|FG000|NOT COMPLETED|Overall Study||206||
48432599|NCT03586427|101392715|FG000|STARTED|Overall Study||48||
48432600|NCT03586427|101392716|FG001|STARTED|Overall Study||50||
48432601|NCT03586427|101392717|FG002|STARTED|Overall Study||52||
48432602|NCT03586427|101392718|FG003|STARTED|Overall Study||50||
48432603|NCT03586427|101392719|FG004|STARTED|Overall Study||51||
48432604|NCT03586427|101392715|FG000|COMPLETED|Overall Study||48||
48432605|NCT03586427|101392716|FG001|COMPLETED|Overall Study||46||
48432606|NCT03586427|101392717|FG002|COMPLETED|Overall Study||46||
48432607|NCT03586427|101392718|FG003|COMPLETED|Overall Study||46||
48432608|NCT03586427|101392719|FG004|COMPLETED|Overall Study||46||
48432609|NCT03586427|101392715|FG000|NOT COMPLETED|Overall Study||0||
48432610|NCT03586427|101392716|FG001|NOT COMPLETED|Overall Study||4||
48432611|NCT03586427|101392717|FG002|NOT COMPLETED|Overall Study||6||
48432612|NCT03586427|101392718|FG003|NOT COMPLETED|Overall Study||4||
48432613|NCT03586427|101392719|FG004|NOT COMPLETED|Overall Study||5||
48432614|NCT02967055|101392720|FG000|STARTED|Overall Study||54||
48432615|NCT02967055|101392720|FG000|In-person Screening|Overall Study||14|Presented for In-person screening|
48432616|NCT02967055|101392720|FG000|Enrolled|Overall Study||9||
48432617|NCT02967055|101392720|FG000|Completed 4 Week Follow-up Visit|Overall Study||8||
48432618|NCT02967055|101392720|FG000|COMPLETED|Overall Study||5||
48432619|NCT02967055|101392720|FG000|NOT COMPLETED|Overall Study||49||
48432620|NCT00846573|101392721|FG000|STARTED|Overall Study||5||
48432621|NCT00846573|101392722|FG001|STARTED|Overall Study||2||
48432622|NCT00846573|101392723|FG002|STARTED|Overall Study||7||
48432623|NCT00846573|101392724|FG003|STARTED|Overall Study||0||
48432624|NCT00846573|101392721|FG000|COMPLETED|Overall Study||5||
48432625|NCT00846573|101392722|FG001|COMPLETED|Overall Study||2||
48432626|NCT00846573|101392723|FG002|COMPLETED|Overall Study||7||
48432627|NCT00846573|101392724|FG003|COMPLETED|Overall Study||0||
48432628|NCT00846573|101392721|FG000|NOT COMPLETED|Overall Study||0||
48432629|NCT00846573|101392722|FG001|NOT COMPLETED|Overall Study||0||
48432630|NCT00846573|101392723|FG002|NOT COMPLETED|Overall Study||0||
48432631|NCT00846573|101392724|FG003|NOT COMPLETED|Overall Study||0||
48432632|NCT00234533|101392725|FG000|STARTED|Overall Study||251||
48432633|NCT00234533|101392725|FG000|COMPLETED|Overall Study||240||
48432634|NCT00234533|101392725|FG000|NOT COMPLETED|Overall Study||11||
48432635|NCT00570492|101392726|FG000|STARTED|16-week Single-blind Baseline Period||910||
48432636|NCT00570492|101392727|FG001|STARTED|16-week Single-blind Baseline Period||0||
48432637|NCT00570492|101392728|FG002|STARTED|16-week Single-blind Baseline Period||0||
48432638|NCT00570492|101392726|FG000|COMPLETED|16-week Single-blind Baseline Period||474||
48432639|NCT00570492|101392727|FG001|COMPLETED|16-week Single-blind Baseline Period||0||
48432640|NCT00570492|101392728|FG002|COMPLETED|16-week Single-blind Baseline Period||0||
48432641|NCT00570492|101392726|FG000|NOT COMPLETED|16-week Single-blind Baseline Period||436||
48432642|NCT00570492|101392727|FG001|NOT COMPLETED|16-week Single-blind Baseline Period||0||
48432643|NCT00570492|101392728|FG002|NOT COMPLETED|16-week Single-blind Baseline Period||0||
48432644|NCT00570492|101392726|FG000|STARTED|52-week Double-blind Treatment Period||0||
48432645|NCT00570492|101392727|FG001|STARTED|52-week Double-blind Treatment Period||237||
48432646|NCT00570492|101392728|FG002|STARTED|52-week Double-blind Treatment Period||237||
48432647|NCT00570492|101392726|FG000|COMPLETED|52-week Double-blind Treatment Period||0||
48432648|NCT00570492|101392727|FG001|COMPLETED|52-week Double-blind Treatment Period||187||
48432649|NCT00570492|101392728|FG002|COMPLETED|52-week Double-blind Treatment Period||186||
48432650|NCT00570492|101392726|FG000|NOT COMPLETED|52-week Double-blind Treatment Period||0||
48432651|NCT00570492|101392727|FG001|NOT COMPLETED|52-week Double-blind Treatment Period||50||
48432652|NCT00570492|101392728|FG002|NOT COMPLETED|52-week Double-blind Treatment Period||51||
48432653|NCT02058940|101392729|FG000|STARTED|Overall Study||8||
48432654|NCT02058940|101392729|FG000|COMPLETED|Overall Study||7||
48432655|NCT02058940|101392729|FG000|NOT COMPLETED|Overall Study||1||
48432656|NCT00465101|101392730|FG000|STARTED|Overall Study||150||
48432657|NCT00465101|101392730|FG000|COMPLETED|Overall Study||91||
48432658|NCT00465101|101392730|FG000|NOT COMPLETED|Overall Study||59||
48432659|NCT00710840|101392731|FG000|STARTED|Overall Study||22||
48432660|NCT00710840|101392732|FG001|STARTED|Overall Study||22||
48432661|NCT00710840|101392731|FG000|COMPLETED|Overall Study||22||
48432662|NCT00710840|101392732|FG001|COMPLETED|Overall Study||19||
48432663|NCT00710840|101392731|FG000|NOT COMPLETED|Overall Study||0||
48432664|NCT00710840|101392732|FG001|NOT COMPLETED|Overall Study||3||
48432665|NCT02646566|101392733|FG000|STARTED|Overall Study||237||
48432666|NCT02646566|101392734|FG001|STARTED|Overall Study||230||
48432667|NCT02646566|101392735|FG002|STARTED|Overall Study||235||
48432668|NCT02646566|101392733|FG000|COMPLETED|Overall Study||231||
48432669|NCT02646566|101392734|FG001|COMPLETED|Overall Study||226||
48432670|NCT02646566|101392735|FG002|COMPLETED|Overall Study||230||
48432671|NCT02646566|101392733|FG000|NOT COMPLETED|Overall Study||6||
48432672|NCT02646566|101392734|FG001|NOT COMPLETED|Overall Study||4||
48432673|NCT02646566|101392735|FG002|NOT COMPLETED|Overall Study||5||
48432674|NCT02696382|101392736|FG000|STARTED|Overall Study||75||
48432675|NCT02696382|101392737|FG001|STARTED|Overall Study||75||
48432676|NCT02696382|101392736|FG000|30-Day Assessment|Overall Study||65||
48432677|NCT02696382|101392737|FG001|30-Day Assessment|Overall Study||69||
48432678|NCT02696382|101392736|FG000|60-Day Assessment|Overall Study||64||
48432679|NCT02696382|101392737|FG001|60-Day Assessment|Overall Study||66||
48432680|NCT02696382|101392736|FG000|90-Day Assessment|Overall Study||63||
48432681|NCT02696382|101392737|FG001|90-Day Assessment|Overall Study||64||
48432682|NCT02696382|101392736|FG000|COMPLETED|Overall Study||59||
48432683|NCT02696382|101392737|FG001|COMPLETED|Overall Study||54||
48432684|NCT02696382|101392736|FG000|NOT COMPLETED|Overall Study||16||
48432685|NCT02696382|101392737|FG001|NOT COMPLETED|Overall Study||21||
48432686|NCT02277665|101392738|FG000|STARTED|Overall Study||33||
48432687|NCT02277665|101392739|FG001|STARTED|Overall Study||34||
48432688|NCT02277665|101392738|FG000|COMPLETED|Overall Study||33||
48432689|NCT02277665|101392739|FG001|COMPLETED|Overall Study||34||
48432690|NCT02277665|101392738|FG000|NOT COMPLETED|Overall Study||0||
48432691|NCT02277665|101392739|FG001|NOT COMPLETED|Overall Study||0||
48432692|NCT01846039|101392740|FG000|STARTED|Overall Study||29||
48432693|NCT01846039|101392740|FG000|COMPLETED|Overall Study||27||
48432694|NCT01846039|101392740|FG000|NOT COMPLETED|Overall Study||2||
48432695|NCT02545270|101392741|FG000|STARTED|Overall Study||6||
48432696|NCT02545270|101392742|FG001|STARTED|Overall Study||5||
48432697|NCT02545270|101392743|FG002|STARTED|Overall Study||5||
48432698|NCT02545270|101392741|FG000|COMPLETED|Overall Study||6||
48432699|NCT02545270|101392742|FG001|COMPLETED|Overall Study||4||
48432700|NCT02545270|101392743|FG002|COMPLETED|Overall Study||3||
48764263|NCT03043872|102211917|FG000|Ongoing Study at China Cohort Second (Final) Analysis DCO|Overall Study||16||
48764264|NCT03043872|102211918|FG001|Ongoing Study at China Cohort Second (Final) Analysis DCO|Overall Study||11||
48764265|NCT03043872|102211919|FG002|Ongoing Study at China Cohort Second (Final) Analysis DCO|Overall Study||7||
48764266|NCT03043872|102211917|FG000|COMPLETED|Overall Study||51|Ongoing in overall study at long-term follow-up (LTFU) analysis DCO|
48764267|NCT03043872|102211918|FG001|COMPLETED|Overall Study||52|Ongoing in overall study at long-term follow-up (LTFU) analysis DCO|
48764268|NCT03043872|102211919|FG002|COMPLETED|Overall Study||18|Ongoing in overall study at long-term follow-up (LTFU) analysis DCO|
48764269|NCT03043872|102211917|FG000|NOT COMPLETED|Overall Study||278||
48764270|NCT03043872|102211918|FG001|NOT COMPLETED|Overall Study||276||
48764271|NCT03043872|102211919|FG002|NOT COMPLETED|Overall Study||312||
48764272|NCT01550003|102211920|FG000|STARTED|Overall Study||18||
48764273|NCT01550003|102211921|FG001|STARTED|Overall Study||63||
48432701|NCT02545270|101392741|FG000|NOT COMPLETED|Overall Study||0||
48432702|NCT02545270|101392742|FG001|NOT COMPLETED|Overall Study||1||
48432703|NCT02545270|101392743|FG002|NOT COMPLETED|Overall Study||2||
48432704|NCT01553708|101392744|FG000|STARTED|Overall Study||17||
48432705|NCT01553708|101392745|FG001|STARTED|Overall Study||17||
48432706|NCT01553708|101392744|FG000|COMPLETED|Overall Study||17||
48432707|NCT01553708|101392745|FG001|COMPLETED|Overall Study||17||
48432708|NCT01553708|101392744|FG000|NOT COMPLETED|Overall Study||0||
48432709|NCT01553708|101392745|FG001|NOT COMPLETED|Overall Study||0||
48432710|NCT02748096|101392746|FG000|STARTED|Overall Study||23||
48432711|NCT02748096|101392747|FG001|STARTED|Overall Study||22||
48432712|NCT02748096|101392746|FG000|COMPLETED|Overall Study||23||
48432713|NCT02748096|101392747|FG001|COMPLETED|Overall Study||22||
48432714|NCT02748096|101392746|FG000|NOT COMPLETED|Overall Study||0||
48432715|NCT02748096|101392747|FG001|NOT COMPLETED|Overall Study||0||
48432716|NCT02850159|101392748|FG000|STARTED|Overall Study||16||
48432717|NCT02850159|101392749|FG001|STARTED|Overall Study||16||
48432718|NCT02850159|101392748|FG000|COMPLETED|Overall Study||16||
48432719|NCT02850159|101392749|FG001|COMPLETED|Overall Study||16||
48432720|NCT02850159|101392748|FG000|NOT COMPLETED|Overall Study||0||
48432721|NCT02850159|101392749|FG001|NOT COMPLETED|Overall Study||0||
48432722|NCT01121224|101392750|FG000|STARTED|Overall Study||305||
48432723|NCT01121224|101392751|FG001|STARTED|Overall Study||292||
48432724|NCT01121224|101392750|FG000|COMPLETED|Overall Study||280||
48432725|NCT01121224|101392751|FG001|COMPLETED|Overall Study||275||
48432726|NCT01121224|101392750|FG000|NOT COMPLETED|Overall Study||25||
48432727|NCT01121224|101392751|FG001|NOT COMPLETED|Overall Study||17||
48432728|NCT02071823|101392752|FG000|STARTED|Overall Study||6||
48432729|NCT02071823|101392753|FG001|STARTED|Overall Study||6||
48432730|NCT02071823|101392752|FG000|COMPLETED|Overall Study||5||
48432731|NCT02071823|101392753|FG001|COMPLETED|Overall Study||6||
48432732|NCT02071823|101392752|FG000|NOT COMPLETED|Overall Study||1||
48432733|NCT02071823|101392753|FG001|NOT COMPLETED|Overall Study||0||
48432734|NCT00483119|101392754|FG000|STARTED|Overall Study||5||
48432735|NCT00483119|101392755|FG001|STARTED|Overall Study||4||
48432736|NCT00483119|101392754|FG000|COMPLETED|Overall Study||4||
48432737|NCT00483119|101392755|FG001|COMPLETED|Overall Study||3||
48432738|NCT00483119|101392754|FG000|NOT COMPLETED|Overall Study||1||
48432739|NCT00483119|101392755|FG001|NOT COMPLETED|Overall Study||1||
48432740|NCT02147132|101392756|FG000|STARTED|Overall Study||2||
48432741|NCT02147132|101392757|FG001|STARTED|Overall Study||2||
48432742|NCT02147132|101392758|FG002|STARTED|Overall Study||1||
48432743|NCT02147132|101392759|FG003|STARTED|Overall Study||2||
48432744|NCT02147132|101392756|FG000|COMPLETED|Overall Study||1||
48432745|NCT02147132|101392757|FG001|COMPLETED|Overall Study||2||
48432746|NCT02147132|101392758|FG002|COMPLETED|Overall Study||1||
48432747|NCT02147132|101392759|FG003|COMPLETED|Overall Study||2||
48432748|NCT02147132|101392756|FG000|NOT COMPLETED|Overall Study||1||
48432749|NCT02147132|101392757|FG001|NOT COMPLETED|Overall Study||0||
48432750|NCT02147132|101392758|FG002|NOT COMPLETED|Overall Study||0||
48432751|NCT02147132|101392759|FG003|NOT COMPLETED|Overall Study||0||
48432752|NCT00812968|101392760|FG000|STARTED|Overall Study||11||
48432753|NCT00812968|101392760|FG000|COMPLETED|Overall Study||0||
48432754|NCT00812968|101392760|FG000|NOT COMPLETED|Overall Study||11||
48432755|NCT02873598|101392761|FG000|STARTED|Overall Study||5||
48432756|NCT02873598|101392762|FG001|STARTED|Overall Study||5||
48432757|NCT02873598|101392763|FG002|STARTED|Overall Study||4||
48432758|NCT02873598|101392761|FG000|COMPLETED|Overall Study||5||
48432759|NCT02873598|101392762|FG001|COMPLETED|Overall Study||5||
48432760|NCT02873598|101392763|FG002|COMPLETED|Overall Study||4||
48432761|NCT02873598|101392761|FG000|NOT COMPLETED|Overall Study||0||
48432762|NCT02873598|101392762|FG001|NOT COMPLETED|Overall Study||0||
48432763|NCT02873598|101392763|FG002|NOT COMPLETED|Overall Study||0||
48432764|NCT00731094|101392764|FG000|STARTED|Overall Study||116||
48432765|NCT00731094|101392765|FG001|STARTED|Overall Study||116||
48432766|NCT00731094|101392764|FG000|Month 6|Overall Study||101||
48432767|NCT00731094|101392765|FG001|Month 6|Overall Study||107||
48432768|NCT00731094|101392764|FG000|COMPLETED|Overall Study||98||
48432769|NCT00731094|101392765|FG001|COMPLETED|Overall Study||105||
48432770|NCT00731094|101392764|FG000|NOT COMPLETED|Overall Study||18||
48432771|NCT00731094|101392765|FG001|NOT COMPLETED|Overall Study||11||
48432772|NCT04156802|101392766|FG000|STARTED|Overall Study||13||
48432773|NCT04156802|101392767|FG001|STARTED|Overall Study||6||
48432774|NCT04156802|101392768|FG002|STARTED|Overall Study||13||
48432775|NCT04156802|101392769|FG003|STARTED|Overall Study||6||
48432776|NCT04156802|101392766|FG000|COMPLETED|Overall Study||9||
48432777|NCT04156802|101392767|FG001|COMPLETED|Overall Study||5||
48432778|NCT04156802|101392768|FG002|COMPLETED|Overall Study||10||
48432779|NCT04156802|101392769|FG003|COMPLETED|Overall Study||5||
48432780|NCT04156802|101392766|FG000|NOT COMPLETED|Overall Study||4||
48432781|NCT04156802|101392767|FG001|NOT COMPLETED|Overall Study||1||
48432782|NCT04156802|101392768|FG002|NOT COMPLETED|Overall Study||3||
48432783|NCT04156802|101392769|FG003|NOT COMPLETED|Overall Study||1||
48432784|NCT00828009|101392770|FG000|STARTED|Step 1 - Chemo RT/Consolidation Chemo||70||
48432785|NCT00828009|101392770|FG000|Started Treatment|Step 1 - Chemo RT/Consolidation Chemo||68||
48432786|NCT00828009|101392770|FG000|COMPLETED|Step 1 - Chemo RT/Consolidation Chemo||39||
48432787|NCT00828009|101392770|FG000|NOT COMPLETED|Step 1 - Chemo RT/Consolidation Chemo||31||
48432788|NCT00828009|101392770|FG000|STARTED|Step 2 - Maintenance Therapy||33||
48432789|NCT00828009|101392770|FG000|COMPLETED|Step 2 - Maintenance Therapy||0||
48432790|NCT00828009|101392770|FG000|NOT COMPLETED|Step 2 - Maintenance Therapy||33||
48432791|NCT00965458|101392771|FG000|STARTED|Overall Study||33||
48432792|NCT00965458|101392772|FG001|STARTED|Overall Study||16||
48639054|NCT02949934|101901560|FG000|COMPLETED|Natural Drinking Period||15||
48432793|NCT00965458|101392771|FG000|COMPLETED|Overall Study||31||
48432794|NCT00965458|101392772|FG001|COMPLETED|Overall Study||12||
48432795|NCT00965458|101392771|FG000|NOT COMPLETED|Overall Study||2||
48432796|NCT00965458|101392772|FG001|NOT COMPLETED|Overall Study||4||
48432797|NCT00920582|101392773|FG000|STARTED|Overall Study||63||
48432798|NCT00920582|101392774|FG001|STARTED|Overall Study||66||
48432799|NCT00920582|101392775|FG002|STARTED|Overall Study||63||
48432800|NCT00920582|101392776|FG003|STARTED|Overall Study||62||
48432801|NCT00920582|101392773|FG000|COMPLETED|Overall Study||50||
48432802|NCT00920582|101392774|FG001|COMPLETED|Overall Study||60||
48432803|NCT00920582|101392775|FG002|COMPLETED|Overall Study||52||
48432804|NCT00920582|101392776|FG003|COMPLETED|Overall Study||57||
48432805|NCT00920582|101392773|FG000|NOT COMPLETED|Overall Study||13||
48432806|NCT00920582|101392774|FG001|NOT COMPLETED|Overall Study||6||
48432807|NCT00920582|101392775|FG002|NOT COMPLETED|Overall Study||11||
48432808|NCT00920582|101392776|FG003|NOT COMPLETED|Overall Study||5||
48432809|NCT01453296|101392777|FG000|STARTED|Treatment Period 1||14||
48432810|NCT01453296|101392778|FG001|STARTED|Treatment Period 1||14||
48432811|NCT01453296|101392777|FG000|COMPLETED|Treatment Period 1||13||
48432812|NCT01453296|101392778|FG001|COMPLETED|Treatment Period 1||13||
48432813|NCT01453296|101392777|FG000|NOT COMPLETED|Treatment Period 1||1||
48432814|NCT01453296|101392778|FG001|NOT COMPLETED|Treatment Period 1||1||
48432815|NCT01453296|101392777|FG000|STARTED|Washout Period||13||
48432816|NCT01453296|101392778|FG001|STARTED|Washout Period||13||
48432817|NCT01453296|101392777|FG000|COMPLETED|Washout Period||13||
48432818|NCT01453296|101392778|FG001|COMPLETED|Washout Period||13||
48432819|NCT01453296|101392777|FG000|NOT COMPLETED|Washout Period||0||
48432820|NCT01453296|101392778|FG001|NOT COMPLETED|Washout Period||0||
48432821|NCT01453296|101392777|FG000|STARTED|Treatment Period 2||13||
48432822|NCT01453296|101392778|FG001|STARTED|Treatment Period 2||13||
48432823|NCT01453296|101392777|FG000|COMPLETED|Treatment Period 2||11||
48432824|NCT01453296|101392778|FG001|COMPLETED|Treatment Period 2||13||
48432825|NCT01453296|101392777|FG000|NOT COMPLETED|Treatment Period 2||2||
48432826|NCT01453296|101392778|FG001|NOT COMPLETED|Treatment Period 2||0||
48432827|NCT04804579|101392779|FG000|STARTED|Overall Study||12||
48432828|NCT04804579|101392780|FG001|STARTED|Overall Study||11||
48432829|NCT04804579|101392779|FG000|COMPLETED|Overall Study||11||
48432830|NCT04804579|101392780|FG001|COMPLETED|Overall Study||11||
48432831|NCT04804579|101392779|FG000|NOT COMPLETED|Overall Study||1||
48432832|NCT04804579|101392780|FG001|NOT COMPLETED|Overall Study||0||
48432833|NCT00692198|101392781|FG000|STARTED|Overall Study||368||
48432834|NCT00692198|101392782|FG001|STARTED|Overall Study||370||
48432835|NCT00692198|101392781|FG000|COMPLETED|Overall Study||368||
48432836|NCT00692198|101392782|FG001|COMPLETED|Overall Study||370||
48432837|NCT00692198|101392781|FG000|NOT COMPLETED|Overall Study||0||
48432838|NCT00692198|101392782|FG001|NOT COMPLETED|Overall Study||0||
48432839|NCT02044094|101392783|FG000|STARTED|RBP-6000 Injection 1 (Day 1 to Day 28)||39||
48432840|NCT02044094|101392783|FG000|Intent to Treat Population|RBP-6000 Injection 1 (Day 1 to Day 28)||38||
48432841|NCT02044094|101392783|FG000|Completers Population|RBP-6000 Injection 1 (Day 1 to Day 28)||30||
48432842|NCT02044094|101392783|FG000|COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||30||
48432843|NCT02044094|101392783|FG000|NOT COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||9||
48432844|NCT02044094|101392783|FG000|STARTED|RBP-6000 Injection 2 (Day 29 to Week 12)||30||
48432845|NCT02044094|101392783|FG000|COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||17||
48432846|NCT02044094|101392783|FG000|NOT COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||13||
48432847|NCT04115488|101392784|FG000|STARTED|Overall Study||131||
48432848|NCT04115488|101392785|FG001|STARTED|Overall Study||133||
48432849|NCT04115488|101392784|FG000|Patients Re-randomized and Switched From Tysabri to PB006 at Week 24.|Overall Study||0||
48432850|NCT04115488|101392785|FG001|Patients Re-randomized and Switched From Tysabri to PB006 at Week 24.|Overall Study||30||
48432851|NCT04115488|101392784|FG000|Patients Continuing on Tysabri Following the Re-randomization at Week 24.|Overall Study||0||
48432852|NCT04115488|101392785|FG001|Patients Continuing on Tysabri Following the Re-randomization at Week 24.|Overall Study||95||
48432853|NCT04115488|101392784|FG000|COMPLETED|Overall Study||117||
48432854|NCT04115488|101392785|FG001|COMPLETED|Overall Study||122||
48432855|NCT04115488|101392784|FG000|NOT COMPLETED|Overall Study||14||
48432856|NCT04115488|101392785|FG001|NOT COMPLETED|Overall Study||11||
48432857|NCT00726882|101392786|FG000|STARTED|Overall Study||35||
48432858|NCT00726882|101392786|FG000|Received ABT-333 in Study M10-380|Overall Study||22||
48432859|NCT00726882|101392786|FG000|Received ABT-333 in Study M10-351|Overall Study||6||
48432860|NCT00726882|101392786|FG000|COMPLETED|Overall Study||13||
48432861|NCT00726882|101392786|FG000|NOT COMPLETED|Overall Study||22||
48432862|NCT01040624|101392787|FG000|STARTED|Overall Study||58||
48432863|NCT01040624|101392788|FG001|STARTED|Overall Study||19||
48432864|NCT01040624|101392787|FG000|COMPLETED|Overall Study||58||
48432865|NCT01040624|101392788|FG001|COMPLETED|Overall Study||19||
48432866|NCT01040624|101392787|FG000|NOT COMPLETED|Overall Study||0||
48432867|NCT01040624|101392788|FG001|NOT COMPLETED|Overall Study||0||
48432868|NCT02268214|101392789|FG000|STARTED|Overall Study||277||
48432869|NCT02268214|101392790|FG001|STARTED|Overall Study||296||
48432870|NCT02268214|101392791|FG002|STARTED|Overall Study||260||
48432871|NCT02268214|101392789|FG000|COMPLETED 24 WEEK PERIOD|Overall Study||252||
48432872|NCT02268214|101392790|FG001|COMPLETED 24 WEEK PERIOD|Overall Study||273||
48432873|NCT02268214|101392791|FG002|COMPLETED 24 WEEK PERIOD|Overall Study||232||
48432874|NCT02268214|101392789|FG000|COMPLETED|Overall Study||235||
48432875|NCT02268214|101392790|FG001|COMPLETED|Overall Study||255||
48432876|NCT02268214|101392791|FG002|COMPLETED|Overall Study||218||
48432877|NCT02268214|101392789|FG000|NOT COMPLETED|Overall Study||42||
48432878|NCT02268214|101392790|FG001|NOT COMPLETED|Overall Study||41||
48432879|NCT02268214|101392791|FG002|NOT COMPLETED|Overall Study||42||
48432880|NCT02883400|101392792|FG000|STARTED|Overall Study||22||
48432881|NCT02883400|101392793|FG001|STARTED|Overall Study||8||
48432882|NCT02883400|101392792|FG000|COMPLETED|Overall Study||22||
48432883|NCT02883400|101392793|FG001|COMPLETED|Overall Study||8||
48432884|NCT02883400|101392792|FG000|NOT COMPLETED|Overall Study||0||
48432885|NCT02883400|101392793|FG001|NOT COMPLETED|Overall Study||0||
48432886|NCT00889928|101392794|FG000|STARTED|Overall Study||7||
48432887|NCT00889928|101392794|FG000|COMPLETED|Overall Study||7||
48432888|NCT00889928|101392794|FG000|NOT COMPLETED|Overall Study||0||
48432889|NCT01361308|101392795|FG000|STARTED|Overall Study||306||
48432890|NCT01361308|101392796|FG001|STARTED|Overall Study||308||
48432891|NCT01361308|101392795|FG000|COMPLETED|Overall Study||271||
48432892|NCT01361308|101392796|FG001|COMPLETED|Overall Study||278||
48432893|NCT01361308|101392795|FG000|NOT COMPLETED|Overall Study||35||
48432894|NCT01361308|101392796|FG001|NOT COMPLETED|Overall Study||30||
48432895|NCT00906776|101392797|FG000|STARTED|Overall Study||11||
48432896|NCT00906776|101392798|FG001|STARTED|Overall Study||8||
48432897|NCT00906776|101392797|FG000|COMPLETED|Overall Study||11||
48432898|NCT00906776|101392798|FG001|COMPLETED|Overall Study||8||
48432899|NCT00906776|101392797|FG000|NOT COMPLETED|Overall Study||0||
48432900|NCT00906776|101392798|FG001|NOT COMPLETED|Overall Study||0||
48432901|NCT02648646|101392799|FG000|STARTED|Overall Study||10||
48432902|NCT02648646|101392799|FG000|COMPLETED|Overall Study||8||
48432903|NCT02648646|101392799|FG000|NOT COMPLETED|Overall Study||2||
48432904|NCT05461742|101392800|FG000|STARTED|Overall Study||35||
48432905|NCT05461742|101392800|FG000|COMPLETED|Overall Study||33||
48432906|NCT05461742|101392800|FG000|NOT COMPLETED|Overall Study||2||
48432907|NCT00118209|101392801|FG000|STARTED|Overall Study||262||
48432908|NCT00118209|101392802|FG001|STARTED|Overall Study||262||
48432909|NCT00118209|101392801|FG000|Evaluable for Primary Endpoint|Overall Study||250||
48432910|NCT00118209|101392802|FG001|Evaluable for Primary Endpoint|Overall Study||241||
48432911|NCT00118209|101392801|FG000|Evaluable for Safety Analysis|Overall Study||243|Evaluable for adverse events|
48432912|NCT00118209|101392802|FG001|Evaluable for Safety Analysis|Overall Study||237|Evaluable for adverse events|
48432913|NCT00118209|101392801|FG000|COMPLETED|Overall Study||250||
48432914|NCT00118209|101392802|FG001|COMPLETED|Overall Study||241||
48432915|NCT00118209|101392801|FG000|NOT COMPLETED|Overall Study||12||
48432916|NCT00118209|101392802|FG001|NOT COMPLETED|Overall Study||21||
48432917|NCT00594009|101392803|FG000|STARTED|Overall Study||1||
48432918|NCT00594009|101392803|FG000|COMPLETED|Overall Study||1||
48432919|NCT00594009|101392803|FG000|NOT COMPLETED|Overall Study||0||
48432920|NCT04177862|101392804|FG000|STARTED|Overall Study||35|Allocated to intervention|
48361031|NCT01855789|101214249|FG001|NOT COMPLETED|2) Week 24 up to End of Study||15||
48361032|NCT01855789|101214250|FG002|NOT COMPLETED|2) Week 24 up to End of Study||18||
48361033|NCT01855789|101214251|FG003|NOT COMPLETED|2) Week 24 up to End of Study||58||
48361034|NCT01385696|101214252|FG000|STARTED|Overall Study||66||
48361035|NCT01385696|101214253|FG001|STARTED|Overall Study||64||
48361036|NCT01385696|101214252|FG000|COMPLETED|Overall Study||66||
48361037|NCT01385696|101214253|FG001|COMPLETED|Overall Study||64||
48361038|NCT01385696|101214252|FG000|NOT COMPLETED|Overall Study||0||
48361039|NCT01385696|101214253|FG001|NOT COMPLETED|Overall Study||0||
48361040|NCT00955110|101214254|FG000|STARTED|Qualification Phase||78||
48361041|NCT00955110|101214254|FG000|COMPLETED|Qualification Phase||54||
48361042|NCT00955110|101214254|FG000|NOT COMPLETED|Qualification Phase||24||
48361043|NCT00955110|101214254|FG000|STARTED|Treatment Phase||41||
48361044|NCT00955110|101214254|FG000|Placebo|Treatment Phase||38||
48361045|NCT00955110|101214254|FG000|Oxymorphone ER 15 mg|Treatment Phase||37||
48361046|NCT00955110|101214254|FG000|Oxymorphone ER 30 mg|Treatment Phase||38||
48361047|NCT00955110|101214254|FG000|Oxycodone CR 30 mg|Treatment Phase||40||
48432921|NCT04177862|101392805|FG001|STARTED|Overall Study||40|Allocated to intervention|
48432922|NCT04177862|101392804|FG000|COMPLETED|Overall Study||33||
48432923|NCT04177862|101392805|FG001|COMPLETED|Overall Study||33||
48432924|NCT04177862|101392804|FG000|NOT COMPLETED|Overall Study||2||
48432925|NCT04177862|101392805|FG001|NOT COMPLETED|Overall Study||7||
48432926|NCT05040295|101392806|FG000|STARTED|Period 1||6||
48432927|NCT05040295|101392807|FG001|STARTED|Period 1||6||
48432928|NCT05040295|101392806|FG000|COMPLETED|Period 1||6||
48432929|NCT05040295|101392807|FG001|COMPLETED|Period 1||6||
48432930|NCT05040295|101392806|FG000|NOT COMPLETED|Period 1||0||
48432931|NCT05040295|101392807|FG001|NOT COMPLETED|Period 1||0||
48432932|NCT05040295|101392806|FG000|STARTED|Period 2||6||
48361048|NCT00955110|101214254|FG000|Oxycodone CR 60 mg|Treatment Phase||40||
48361049|NCT00955110|101214254|FG000|COMPLETED|Treatment Phase||35||
48361050|NCT00955110|101214254|FG000|NOT COMPLETED|Treatment Phase||6||
48432933|NCT05040295|101392807|FG001|STARTED|Period 2||6||
48361051|NCT04799782|101214255|FG000|STARTED|First Intervention||8||
48361052|NCT04799782|101214256|FG001|STARTED|First Intervention||7||
48361053|NCT04799782|101214255|FG000|COMPLETED|First Intervention||8||
48432934|NCT05040295|101392806|FG000|COMPLETED|Period 2||6||
48432935|NCT05040295|101392807|FG001|COMPLETED|Period 2||6||
48361054|NCT04799782|101214256|FG001|COMPLETED|First Intervention||7||
48361055|NCT04799782|101214255|FG000|NOT COMPLETED|First Intervention||0||
48361056|NCT04799782|101214256|FG001|NOT COMPLETED|First Intervention||0||
48432936|NCT05040295|101392806|FG000|NOT COMPLETED|Period 2||0||
48432937|NCT05040295|101392807|FG001|NOT COMPLETED|Period 2||0||
48432938|NCT05040295|101392806|FG000|STARTED|Period 3||6||
48432939|NCT05040295|101392807|FG001|STARTED|Period 3||6||
48432940|NCT05040295|101392806|FG000|COMPLETED|Period 3||6||
48432941|NCT05040295|101392807|FG001|COMPLETED|Period 3||6||
48432942|NCT05040295|101392806|FG000|NOT COMPLETED|Period 3||0||
48432943|NCT05040295|101392807|FG001|NOT COMPLETED|Period 3||0||
48432944|NCT00131937|101392808|FG000|STARTED|Overall Study||14||
48432945|NCT00131937|101392808|FG000|COMPLETED|Overall Study||0||
48432946|NCT00131937|101392808|FG000|NOT COMPLETED|Overall Study||14||
48432947|NCT02547064|101392809|FG000|STARTED|Overall Study||81||
48432948|NCT02547064|101392810|FG001|STARTED|Overall Study||81||
48432949|NCT02547064|101392809|FG000|COMPLETED|Overall Study||78||
48432950|NCT02547064|101392810|FG001|COMPLETED|Overall Study||79||
48432951|NCT02547064|101392809|FG000|NOT COMPLETED|Overall Study||3||
48432952|NCT02547064|101392810|FG001|NOT COMPLETED|Overall Study||2||
48432953|NCT05056311|101392811|FG000|STARTED|Overall Study||65||
48432954|NCT05056311|101392811|FG000|Received Intervention|Overall Study||64||
48432955|NCT05056311|101392811|FG000|COMPLETED|Overall Study||27||
48432956|NCT05056311|101392811|FG000|NOT COMPLETED|Overall Study||38||
48432957|NCT00859313|101392812|FG000|STARTED|Overall Study||30||
48432958|NCT00859313|101392812|FG000|COMPLETED|Overall Study||26||
48432959|NCT00859313|101392812|FG000|NOT COMPLETED|Overall Study||4||
48432960|NCT00471237|101392813|FG000|STARTED|Overall Study||90||
48432961|NCT00471237|101392814|FG001|STARTED|Overall Study||87||
48432962|NCT00471237|101392815|FG002|STARTED|Overall Study||82||
48432963|NCT00471237|101392816|FG003|STARTED|Overall Study||88||
48432964|NCT00471237|101392817|FG004|STARTED|Overall Study||87||
48432965|NCT00471237|101392818|FG005|STARTED|Overall Study||89||
48432966|NCT00471237|101392819|FG006|STARTED|Overall Study||41||
48432967|NCT00471237|101392813|FG000|COMPLETED|Overall Study||49||
48432968|NCT00471237|101392814|FG001|COMPLETED|Overall Study||45||
48432969|NCT00471237|101392815|FG002|COMPLETED|Overall Study||48||
48432970|NCT00471237|101392816|FG003|COMPLETED|Overall Study||43||
48432971|NCT00471237|101392817|FG004|COMPLETED|Overall Study||46||
48432972|NCT00471237|101392818|FG005|COMPLETED|Overall Study||50||
48432973|NCT00471237|101392819|FG006|COMPLETED|Overall Study||38||
48432974|NCT00471237|101392813|FG000|NOT COMPLETED|Overall Study||41||
48432975|NCT00471237|101392814|FG001|NOT COMPLETED|Overall Study||42||
48432976|NCT00471237|101392815|FG002|NOT COMPLETED|Overall Study||34||
48432977|NCT00471237|101392816|FG003|NOT COMPLETED|Overall Study||45||
48432978|NCT00471237|101392817|FG004|NOT COMPLETED|Overall Study||41||
48432979|NCT00471237|101392818|FG005|NOT COMPLETED|Overall Study||39||
48432980|NCT00471237|101392819|FG006|NOT COMPLETED|Overall Study||3||
48432981|NCT02551874|101392820|FG000|STARTED|Overall Study||324||
48432982|NCT02551874|101392821|FG001|STARTED|Overall Study||326||
48432983|NCT02551874|101392820|FG000|Received Treatment in Short-term Study|Overall Study||324||
48432984|NCT02551874|101392821|FG001|Received Treatment in Short-term Study|Overall Study||319||
48432985|NCT02551874|101392820|FG000|Entered Long-term Study|Overall Study||306||
48432986|NCT02551874|101392821|FG001|Entered Long-term Study|Overall Study||294||
48432987|NCT02551874|101392820|FG000|Received Treatment in Long-term Study|Overall Study||295||
48432988|NCT02551874|101392821|FG001|Received Treatment in Long-term Study|Overall Study||284||
48432989|NCT02551874|101392820|FG000|COMPLETED|Overall Study||296||
48432990|NCT02551874|101392821|FG001|COMPLETED|Overall Study||287||
48432991|NCT02551874|101392820|FG000|NOT COMPLETED|Overall Study||28||
48432992|NCT02551874|101392821|FG001|NOT COMPLETED|Overall Study||39||
48432993|NCT00633217|101392822|FG000|STARTED|Overall Study||121||
48432994|NCT00633217|101392823|FG001|STARTED|Overall Study||126||
48432995|NCT00633217|101392822|FG000|COMPLETED|Overall Study||106||
48432996|NCT00633217|101392823|FG001|COMPLETED|Overall Study||103||
48432997|NCT00633217|101392822|FG000|NOT COMPLETED|Overall Study||15||
48432998|NCT00633217|101392823|FG001|NOT COMPLETED|Overall Study||23||
48432999|NCT03808298|101392824|FG000|STARTED|Overall Study||57||
48433000|NCT03808298|101392824|FG000|COMPLETED|Overall Study||49||
48433001|NCT03808298|101392824|FG000|NOT COMPLETED|Overall Study||8||
48433002|NCT00796367|101392825|FG000|STARTED|Overall Study||227||
48433003|NCT00796367|101392826|FG001|STARTED|Overall Study||154||
48433004|NCT00796367|101392827|FG002|STARTED|Overall Study||295||
48433005|NCT00796367|101392825|FG000|COMPLETED|Overall Study||197||
48433006|NCT00796367|101392826|FG001|COMPLETED|Overall Study||129||
48433007|NCT00796367|101392827|FG002|COMPLETED|Overall Study||248||
48433008|NCT00796367|101392825|FG000|NOT COMPLETED|Overall Study||30||
48433009|NCT00796367|101392826|FG001|NOT COMPLETED|Overall Study||25||
48433010|NCT00796367|101392827|FG002|NOT COMPLETED|Overall Study||47||
48433011|NCT04768881|101392828|FG000|STARTED|Overall Study||9||
48433012|NCT04768881|101392829|FG001|STARTED|Overall Study||6||
48433013|NCT04768881|101392828|FG000|COMPLETED|Overall Study||0||
48433014|NCT04768881|101392829|FG001|COMPLETED|Overall Study||0||
48433015|NCT04768881|101392828|FG000|NOT COMPLETED|Overall Study||9||
48433016|NCT04768881|101392829|FG001|NOT COMPLETED|Overall Study||6||
48433017|NCT04435431|101392830|FG000|STARTED|Overall Study||40||
48433018|NCT04435431|101392831|FG001|STARTED|Overall Study||38||
48433019|NCT04435431|101392832|FG002|STARTED|Overall Study||38||
48433020|NCT04435431|101392833|FG003|STARTED|Overall Study||39||
48433021|NCT04435431|101392830|FG000|COMPLETED|Overall Study||32||
48433022|NCT04435431|101392831|FG001|COMPLETED|Overall Study||31||
48433023|NCT04435431|101392832|FG002|COMPLETED|Overall Study||29||
48433024|NCT04435431|101392833|FG003|COMPLETED|Overall Study||33||
48433025|NCT04435431|101392830|FG000|NOT COMPLETED|Overall Study||8||
48433026|NCT04435431|101392831|FG001|NOT COMPLETED|Overall Study||7||
48433027|NCT04435431|101392832|FG002|NOT COMPLETED|Overall Study||9||
48433028|NCT04435431|101392833|FG003|NOT COMPLETED|Overall Study||6||
48187687|NCT03717194|100783081|FG001|NOT COMPLETED|Overall Study||5||
48433029|NCT01441882|101392834|FG000|STARTED|Overall Study||19||
48433030|NCT01441882|101392834|FG000|COMPLETED|Overall Study||13||
48433031|NCT01441882|101392834|FG000|NOT COMPLETED|Overall Study||6||
48433032|NCT00227591|101392835|FG000|STARTED|Overall Study||48||
48433033|NCT00227591|101392835|FG000|Began Treatment|Overall Study||47||
48433034|NCT00227591|101392835|FG000|COMPLETED|Overall Study||47||
48433035|NCT00227591|101392835|FG000|NOT COMPLETED|Overall Study||1||
48433036|NCT01729559|101392836|FG000|STARTED|Overall Study||251||
48433037|NCT01729559|101392837|FG001|STARTED|Overall Study||244||
48433038|NCT01729559|101392836|FG000|COMPLETED|Overall Study||220||
48433039|NCT01729559|101392837|FG001|COMPLETED|Overall Study||216||
48433040|NCT01729559|101392836|FG000|NOT COMPLETED|Overall Study||31||
48433041|NCT01729559|101392837|FG001|NOT COMPLETED|Overall Study||28||
48433042|NCT00664066|101392838|FG000|STARTED|Overall Study||3||
48433043|NCT00664066|101392838|FG000|COMPLETED|Overall Study||0||
48433044|NCT00664066|101392838|FG000|NOT COMPLETED|Overall Study||3||
48361057|NCT04799782|101214255|FG000|STARTED|Washout||8||
48361058|NCT04799782|101214256|FG001|STARTED|Washout||7||
48361059|NCT04799782|101214255|FG000|COMPLETED|Washout||6||
48361060|NCT04799782|101214256|FG001|COMPLETED|Washout||4||
48361061|NCT04799782|101214255|FG000|NOT COMPLETED|Washout||2||
48361062|NCT04799782|101214256|FG001|NOT COMPLETED|Washout||3||
48361063|NCT04799782|101214255|FG000|STARTED|Second Intervention||6||
48361064|NCT04799782|101214256|FG001|STARTED|Second Intervention||4||
48361065|NCT04799782|101214255|FG000|COMPLETED|Second Intervention||6||
48361066|NCT04799782|101214256|FG001|COMPLETED|Second Intervention||4||
48361067|NCT04799782|101214255|FG000|NOT COMPLETED|Second Intervention||0||
48361068|NCT04799782|101214256|FG001|NOT COMPLETED|Second Intervention||0||
48187688|NCT02213900|100783082|FG000|STARTED|Overall Study||68||
48187689|NCT02213900|100783083|FG001|STARTED|Overall Study||67||
48187690|NCT02213900|100783082|FG000|COMPLETED|Overall Study||68||
48361069|NCT00425438|101214257|FG000|STARTED|Overall Study||25||
48361070|NCT00425438|101214258|FG001|STARTED|Overall Study||27||
48361071|NCT00425438|101214257|FG000|COMPLETED|Overall Study||0||
48361072|NCT00425438|101214258|FG001|COMPLETED|Overall Study||0||
48433045|NCT00790270|101392839|FG000|STARTED|Overall Study||21||
48433046|NCT00790270|101392840|FG001|STARTED|Overall Study||20||
48433047|NCT00790270|101392841|FG002|STARTED|Overall Study||20||
48433048|NCT00790270|101392839|FG000|COMPLETED|Overall Study||21||
48639055|NCT02949934|101901561|FG001|COMPLETED|Natural Drinking Period||12||
48639056|NCT02949934|101901562|FG002|COMPLETED|Natural Drinking Period||17||
48639057|NCT02949934|101901563|FG003|COMPLETED|Natural Drinking Period||15||
48639058|NCT02949934|101901564|FG004|COMPLETED|Natural Drinking Period||14||
48639059|NCT02949934|101901565|FG005|COMPLETED|Natural Drinking Period||14||
48639060|NCT02949934|101901560|FG000|NOT COMPLETED|Natural Drinking Period||1||
48639061|NCT02949934|101901561|FG001|NOT COMPLETED|Natural Drinking Period||0||
48639062|NCT02949934|101901562|FG002|NOT COMPLETED|Natural Drinking Period||0||
48639063|NCT02949934|101901563|FG003|NOT COMPLETED|Natural Drinking Period||1||
48639064|NCT02949934|101901564|FG004|NOT COMPLETED|Natural Drinking Period||1||
48639065|NCT02949934|101901565|FG005|NOT COMPLETED|Natural Drinking Period||0||
48639066|NCT02949934|101901560|FG000|STARTED|Neuroimaging||15||
48639067|NCT02949934|101901561|FG001|STARTED|Neuroimaging||12||
48187691|NCT02213900|100783083|FG001|COMPLETED|Overall Study||67||
48361073|NCT00425438|101214257|FG000|NOT COMPLETED|Overall Study||25||
48361074|NCT00425438|101214258|FG001|NOT COMPLETED|Overall Study||27||
48361075|NCT01823653|101214259|FG000|STARTED|Overall Study||60||
48433049|NCT00790270|101392840|FG001|COMPLETED|Overall Study||20||
48433050|NCT00790270|101392841|FG002|COMPLETED|Overall Study||20||
48433051|NCT00790270|101392839|FG000|NOT COMPLETED|Overall Study||0||
48639068|NCT02949934|101901562|FG002|STARTED|Neuroimaging||17||
48639069|NCT02949934|101901563|FG003|STARTED|Neuroimaging||15||
48361076|NCT01823653|101214259|FG000|COMPLETED|Overall Study||60||
48187692|NCT02213900|100783082|FG000|NOT COMPLETED|Overall Study||0||
48187693|NCT02213900|100783083|FG001|NOT COMPLETED|Overall Study||0||
48187694|NCT05550337|100783084|FG000|STARTED|Overall Study||269||
48187695|NCT05550337|100783085|FG001|STARTED|Overall Study||269||
48187696|NCT05550337|100783086|FG002|STARTED|Overall Study||269||
48187697|NCT05550337|100783084|FG000|COMPLETED|Overall Study||241||
48187698|NCT05550337|100783085|FG001|COMPLETED|Overall Study||235||
48187699|NCT05550337|100783086|FG002|COMPLETED|Overall Study||241||
48187700|NCT05550337|100783084|FG000|NOT COMPLETED|Overall Study||28||
48361077|NCT01823653|101214259|FG000|NOT COMPLETED|Overall Study||0||
48433052|NCT00790270|101392840|FG001|NOT COMPLETED|Overall Study||0||
48433053|NCT00790270|101392841|FG002|NOT COMPLETED|Overall Study||0||
48433054|NCT01965600|101392842|FG000|STARTED|First Intervention||6||
48433055|NCT01965600|101392843|FG001|STARTED|First Intervention||8||
48433056|NCT01965600|101392844|FG002|STARTED|First Intervention||5||
48433057|NCT01965600|101392845|FG003|STARTED|First Intervention||4||
48433058|NCT01965600|101392842|FG000|Received at Least One Dose of Drug|First Intervention||6||
48433059|NCT01965600|101392843|FG001|Received at Least One Dose of Drug|First Intervention||8||
48433060|NCT01965600|101392844|FG002|Received at Least One Dose of Drug|First Intervention||5||
48433061|NCT01965600|101392845|FG003|Received at Least One Dose of Drug|First Intervention||4||
48433062|NCT01965600|101392842|FG000|COMPLETED|First Intervention||6||
48433063|NCT01965600|101392843|FG001|COMPLETED|First Intervention||8||
48433064|NCT01965600|101392844|FG002|COMPLETED|First Intervention||5||
48433065|NCT01965600|101392845|FG003|COMPLETED|First Intervention||4||
48433066|NCT01965600|101392842|FG000|NOT COMPLETED|First Intervention||0||
48433067|NCT01965600|101392843|FG001|NOT COMPLETED|First Intervention||0||
48433068|NCT01965600|101392844|FG002|NOT COMPLETED|First Intervention||0||
48433069|NCT01965600|101392845|FG003|NOT COMPLETED|First Intervention||0||
48433070|NCT01965600|101392842|FG000|STARTED|Washout Period of Approximately 15 Days||6||
48433071|NCT01965600|101392843|FG001|STARTED|Washout Period of Approximately 15 Days||8||
48433072|NCT01965600|101392844|FG002|STARTED|Washout Period of Approximately 15 Days||5||
48639070|NCT02949934|101901564|FG004|STARTED|Neuroimaging||14||
48639071|NCT02949934|101901565|FG005|STARTED|Neuroimaging||14||
48639072|NCT02949934|101901560|FG000|COMPLETED|Neuroimaging||12||
48187701|NCT05550337|100783085|FG001|NOT COMPLETED|Overall Study||34||
48187702|NCT05550337|100783086|FG002|NOT COMPLETED|Overall Study||28||
48187703|NCT02056119|100783087|FG000|STARTED|Overall Study||58||
48187704|NCT02056119|100783088|FG001|STARTED|Overall Study||62||
48187705|NCT02056119|100783087|FG000|COMPLETED|Overall Study||48||
48187706|NCT02056119|100783088|FG001|COMPLETED|Overall Study||42||
48187707|NCT02056119|100783087|FG000|NOT COMPLETED|Overall Study||10||
48187708|NCT02056119|100783088|FG001|NOT COMPLETED|Overall Study||20||
48361078|NCT03494725|101214260|FG000|STARTED|Overall Study||60||
48361079|NCT03494725|101214261|FG001|STARTED|Overall Study||60||
48361080|NCT03494725|101214260|FG000|Intervention (Post 2 Weeks run-in)|Overall Study||59|N=2 did not receive any treatment. Reasons: antibiotic therapy and consent withdrawn during run-in.|
48361081|NCT03494725|101214261|FG001|Intervention (Post 2 Weeks run-in)|Overall Study||59|N=2 did not receive any treatment. Reasons: antibiotic therapy and consent withdrawn during run-in.|
48361082|NCT03494725|101214260|FG000|COMPLETED|Overall Study||59||
48361083|NCT03494725|101214261|FG001|COMPLETED|Overall Study||58||
48361084|NCT03494725|101214260|FG000|NOT COMPLETED|Overall Study||1||
48361085|NCT03494725|101214261|FG001|NOT COMPLETED|Overall Study||2||
48361086|NCT03323307|101214262|FG000|STARTED|Overall Study||70||
48361087|NCT03323307|101214262|FG000|COMPLETED|Overall Study||70||
48361088|NCT03323307|101214262|FG000|NOT COMPLETED|Overall Study||0||
48361089|NCT03396471|101214263|FG000|STARTED|Study Treatment - Up to 22 Months||14||
48361090|NCT03396471|101214263|FG000|COMPLETED|Study Treatment - Up to 22 Months||0||
48361091|NCT03396471|101214263|FG000|NOT COMPLETED|Study Treatment - Up to 22 Months||14||
48361092|NCT03396471|101214263|FG000|STARTED|Follow up - Up to 2 Years||14|Treatment and Follow-up are sequential time periods. All subjects from the Treatment time period continue to the follow-up time period, regardless of their completion status.|
48361093|NCT03396471|101214263|FG000|COMPLETED|Follow up - Up to 2 Years||0||
48361094|NCT03396471|101214263|FG000|NOT COMPLETED|Follow up - Up to 2 Years||14||
48361095|NCT01849848|101214264|FG000|STARTED|Overall Study||17||
48361096|NCT01849848|101214264|FG000|COMPLETED|Overall Study||13||
48361097|NCT01849848|101214264|FG000|NOT COMPLETED|Overall Study||4||
48361098|NCT00570739|101214265|FG000|STARTED|Overall Study||141||
48361099|NCT00570739|101214266|FG001|STARTED|Overall Study||145||
48361100|NCT00570739|101214267|FG002|STARTED|Overall Study||108||
48361101|NCT00570739|101214268|FG003|STARTED|Overall Study||108||
48361102|NCT00570739|101214265|FG000|COMPLETED|Overall Study||120||
48361103|NCT00570739|101214266|FG001|COMPLETED|Overall Study||124||
48361104|NCT00570739|101214267|FG002|COMPLETED|Overall Study||92||
48361105|NCT00570739|101214268|FG003|COMPLETED|Overall Study||96||
48361106|NCT00570739|101214265|FG000|NOT COMPLETED|Overall Study||21||
48361107|NCT00570739|101214266|FG001|NOT COMPLETED|Overall Study||21||
48361108|NCT00570739|101214267|FG002|NOT COMPLETED|Overall Study||16||
48361109|NCT00570739|101214268|FG003|NOT COMPLETED|Overall Study||12||
48361110|NCT02057237|101214269|FG000|STARTED|Overall Study||1||
48361111|NCT02057237|101214269|FG000|COMPLETED|Overall Study||1||
48433073|NCT01965600|101392845|FG003|STARTED|Washout Period of Approximately 15 Days||4||
48433074|NCT01965600|101392842|FG000|COMPLETED|Washout Period of Approximately 15 Days||4||
48433075|NCT01965600|101392843|FG001|COMPLETED|Washout Period of Approximately 15 Days||4||
48433076|NCT01965600|101392844|FG002|COMPLETED|Washout Period of Approximately 15 Days||3||
48433077|NCT01965600|101392845|FG003|COMPLETED|Washout Period of Approximately 15 Days||2||
48433078|NCT01965600|101392842|FG000|NOT COMPLETED|Washout Period of Approximately 15 Days||2||
48433079|NCT01965600|101392843|FG001|NOT COMPLETED|Washout Period of Approximately 15 Days||4||
48433080|NCT01965600|101392844|FG002|NOT COMPLETED|Washout Period of Approximately 15 Days||2||
48433081|NCT01965600|101392845|FG003|NOT COMPLETED|Washout Period of Approximately 15 Days||2||
48433082|NCT01965600|101392842|FG000|STARTED|Second Intervention||4||
48433083|NCT01965600|101392843|FG001|STARTED|Second Intervention||4||
48433084|NCT01965600|101392844|FG002|STARTED|Second Intervention||3||
48433085|NCT01965600|101392845|FG003|STARTED|Second Intervention||2||
48433086|NCT01965600|101392842|FG000|COMPLETED|Second Intervention||4||
48433087|NCT01965600|101392843|FG001|COMPLETED|Second Intervention||4||
48433088|NCT01965600|101392844|FG002|COMPLETED|Second Intervention||1||
48433089|NCT01965600|101392845|FG003|COMPLETED|Second Intervention||0||
48433090|NCT01965600|101392842|FG000|NOT COMPLETED|Second Intervention||0||
48433091|NCT01965600|101392843|FG001|NOT COMPLETED|Second Intervention||0||
48433092|NCT01965600|101392844|FG002|NOT COMPLETED|Second Intervention||2||
48433093|NCT01965600|101392845|FG003|NOT COMPLETED|Second Intervention||2||
48433094|NCT03878108|101392846|FG000|STARTED|Overall Study||11||
48433095|NCT03878108|101392847|FG001|STARTED|Overall Study||10||
48433096|NCT03878108|101392846|FG000|Completed First Phase|Overall Study||10||
48433097|NCT03878108|101392847|FG001|Completed First Phase|Overall Study||10||
48433098|NCT03878108|101392846|FG000|COMPLETED|Overall Study||10||
48433099|NCT03878108|101392847|FG001|COMPLETED|Overall Study||10||
48433100|NCT03878108|101392846|FG000|NOT COMPLETED|Overall Study||1||
48433101|NCT03878108|101392847|FG001|NOT COMPLETED|Overall Study||0||
48433102|NCT03233009|101392848|FG000|STARTED|Overall Study||40||
48433103|NCT03233009|101392848|FG000|Test Product 1|Overall Study||39||
48433104|NCT03233009|101392848|FG000|Test Product 2|Overall Study||39||
48433105|NCT03233009|101392848|FG000|Test Product 3|Overall Study||39||
48433106|NCT03233009|101392848|FG000|Test Product 4|Overall Study||39||
48433107|NCT03233009|101392848|FG000|Reference Product|Overall Study||39||
48433108|NCT03233009|101392848|FG000|COMPLETED|Overall Study||39|1 participant lost to follow-up was removed from all the treatment arms.|
48433109|NCT03233009|101392848|FG000|NOT COMPLETED|Overall Study||1||
48433110|NCT03890731|101392849|FG000|STARTED|Overall Study||6||
48433111|NCT03890731|101392849|FG000|COMPLETED|Overall Study||0||
48433112|NCT03890731|101392849|FG000|NOT COMPLETED|Overall Study||6||
48433113|NCT01399619|101392850|FG000|STARTED|Overall Study||123||
48433114|NCT01399619|101392851|FG001|STARTED|Overall Study||84||
48433115|NCT01399619|101392852|FG002|STARTED|Overall Study||86||
48433116|NCT01399619|101392853|FG003|STARTED|Overall Study||17||
48433117|NCT01399619|101392850|FG000|COMPLETED|Overall Study||98||
48433118|NCT01399619|101392851|FG001|COMPLETED|Overall Study||84||
48433119|NCT01399619|101392852|FG002|COMPLETED|Overall Study||74||
48433120|NCT01399619|101392853|FG003|COMPLETED|Overall Study||0||
48433121|NCT01399619|101392850|FG000|NOT COMPLETED|Overall Study||25||
48433122|NCT01399619|101392851|FG001|NOT COMPLETED|Overall Study||0||
48433123|NCT01399619|101392852|FG002|NOT COMPLETED|Overall Study||12||
48433124|NCT01399619|101392853|FG003|NOT COMPLETED|Overall Study||17||
48433125|NCT03292731|101392854|FG000|STARTED|Overall Study||67||
48433126|NCT03292731|101392855|FG001|STARTED|Overall Study||76||
48433127|NCT03292731|101392856|FG002|STARTED|Overall Study||16||
48433128|NCT03292731|101392854|FG000|COMPLETED|Overall Study||63||
48433129|NCT03292731|101392855|FG001|COMPLETED|Overall Study||65||
48433130|NCT03292731|101392856|FG002|COMPLETED|Overall Study||15||
48433131|NCT03292731|101392854|FG000|NOT COMPLETED|Overall Study||4||
48433132|NCT03292731|101392855|FG001|NOT COMPLETED|Overall Study||11||
48433133|NCT03292731|101392856|FG002|NOT COMPLETED|Overall Study||1||
48433134|NCT00167414|101392857|FG000|STARTED|Overall Study||49||
48433135|NCT00167414|101392857|FG000|COMPLETED|Overall Study||39||
48433136|NCT00167414|101392857|FG000|NOT COMPLETED|Overall Study||10||
48433137|NCT04436497|101392858|FG000|STARTED|Overall Study||122||
48433138|NCT04436497|101392859|FG001|STARTED|Overall Study||40||
48433139|NCT04436497|101392858|FG000|COMPLETED|Overall Study||88||
48433140|NCT04436497|101392859|FG001|COMPLETED|Overall Study||29||
48433141|NCT04436497|101392858|FG000|NOT COMPLETED|Overall Study||34||
48433142|NCT04436497|101392859|FG001|NOT COMPLETED|Overall Study||11||
48433143|NCT00883129|101392860|FG000|STARTED|Overall Study||69||
48433144|NCT00883129|101392861|FG001|STARTED|Overall Study||73||
48433145|NCT00883129|101392860|FG000|COMPLETED|Overall Study||49||
48433146|NCT00883129|101392861|FG001|COMPLETED|Overall Study||37||
48433147|NCT00883129|101392860|FG000|NOT COMPLETED|Overall Study||20||
48433148|NCT00883129|101392861|FG001|NOT COMPLETED|Overall Study||36||
48433149|NCT02848781|101392862|FG000|STARTED|Overall Study||67||
48433150|NCT02848781|101392863|FG001|STARTED|Overall Study||66||
48433151|NCT02848781|101392864|FG002|STARTED|Overall Study||47||
48433152|NCT02848781|101392862|FG000|COMPLETED|Overall Study||60||
48433153|NCT02848781|101392863|FG001|COMPLETED|Overall Study||61||
48433154|NCT02848781|101392864|FG002|COMPLETED|Overall Study||47||
48433155|NCT02848781|101392862|FG000|NOT COMPLETED|Overall Study||7||
48361112|NCT02057237|101214269|FG000|NOT COMPLETED|Overall Study||0||
48361113|NCT00933335|101214270|FG000|STARTED|Overall Study||2||
48361114|NCT00933335|101214271|FG001|STARTED|Overall Study||36||
48361115|NCT00933335|101214270|FG000|COMPLETED|Overall Study||0||
48361116|NCT00933335|101214271|FG001|COMPLETED|Overall Study||20||
48361117|NCT00933335|101214270|FG000|NOT COMPLETED|Overall Study||2||
48361118|NCT00933335|101214271|FG001|NOT COMPLETED|Overall Study||16||
48361119|NCT02114203|101214272|FG000|STARTED|Overall Study||7||
48361120|NCT02114203|101214273|FG001|STARTED|Overall Study||16||
48361121|NCT02114203|101214274|FG002|STARTED|Overall Study||7||
48361122|NCT02114203|101214272|FG000|COMPLETED|Overall Study||7||
48361123|NCT02114203|101214273|FG001|COMPLETED|Overall Study||14||
48361124|NCT02114203|101214274|FG002|COMPLETED|Overall Study||7||
48361125|NCT02114203|101214272|FG000|NOT COMPLETED|Overall Study||0||
48361126|NCT02114203|101214273|FG001|NOT COMPLETED|Overall Study||2||
48361127|NCT02114203|101214274|FG002|NOT COMPLETED|Overall Study||0||
48361128|NCT02903511|101214275|FG000|STARTED|Overall Study||26||
48361129|NCT02903511|101214276|FG001|STARTED|Overall Study||25||
48361130|NCT02903511|101214275|FG000|Received Intervention|Overall Study||25||
48361131|NCT02903511|101214276|FG001|Received Intervention|Overall Study||25||
48361132|NCT02903511|101214275|FG000|COMPLETED|Overall Study||22||
48361133|NCT02903511|101214276|FG001|COMPLETED|Overall Study||23||
48361134|NCT02903511|101214275|FG000|NOT COMPLETED|Overall Study||4||
48361135|NCT02903511|101214276|FG001|NOT COMPLETED|Overall Study||2||
48361136|NCT02946229|101214277|FG000|STARTED|Overall Study||142||
48361137|NCT02946229|101214277|FG000|COMPLETED|Overall Study||142||
48361138|NCT02946229|101214277|FG000|NOT COMPLETED|Overall Study||0||
48361139|NCT01354691|101214278|FG000|STARTED|Overall Study||101||
48361140|NCT01354691|101214279|FG001|STARTED|Overall Study||99||
48361141|NCT01354691|101214278|FG000|ITT|Overall Study||99||
48361142|NCT01354691|101214279|FG001|ITT|Overall Study||96||
48361143|NCT01354691|101214278|FG000|PP|Overall Study||79||
48361144|NCT01354691|101214279|FG001|PP|Overall Study||75||
48361145|NCT01354691|101214278|FG000|COMPLETED|Overall Study||80||
48361146|NCT01354691|101214279|FG001|COMPLETED|Overall Study||77||
48361147|NCT01354691|101214278|FG000|NOT COMPLETED|Overall Study||21||
48361148|NCT01354691|101214279|FG001|NOT COMPLETED|Overall Study||22||
48361149|NCT00942708|101214280|FG000|STARTED|Overall Study||6||
48361150|NCT00942708|101214280|FG000|COMPLETED|Overall Study||5||
48361151|NCT00942708|101214280|FG000|NOT COMPLETED|Overall Study||1||
48361152|NCT00501852|101214281|FG000|STARTED|Overall Study||83||
48361153|NCT00501852|101214281|FG000|NVA237 12.5µg|Overall Study||55||
48361154|NCT00501852|101214281|FG000|NVA237 25µg|Overall Study||51||
48361155|NCT00501852|101214281|FG000|NVA237 50µg|Overall Study||53||
48361156|NCT00501852|101214281|FG000|NVA237 100µg|Overall Study||54||
48361157|NCT00501852|101214281|FG000|Placebo|Overall Study||55||
48361158|NCT00501852|101214281|FG000|Tiotropium|Overall Study||55||
48361159|NCT00501852|101214281|FG000|COMPLETED|Overall Study||78||
48361160|NCT00501852|101214281|FG000|NOT COMPLETED|Overall Study||5||
48361161|NCT02089737|101214282|FG000|STARTED|Overall Study||3091||
48361162|NCT02089737|101214282|FG000|COMPLETED|Overall Study||3085||
48361163|NCT02089737|101214282|FG000|NOT COMPLETED|Overall Study||6||
48361164|NCT03823768|101214283|FG000|STARTED|Overall Study||15||
48361165|NCT03823768|101214284|FG001|STARTED|Overall Study||15||
48361166|NCT03823768|101214283|FG000|COMPLETED|Overall Study||15||
48361167|NCT03823768|101214284|FG001|COMPLETED|Overall Study||15||
48361168|NCT03823768|101214283|FG000|NOT COMPLETED|Overall Study||0||
48361169|NCT03823768|101214284|FG001|NOT COMPLETED|Overall Study||0||
48361170|NCT01089725|101214285|FG000|STARTED|Overall Study||72||
48361171|NCT01089725|101214286|FG001|STARTED|Overall Study||75||
48361172|NCT01089725|101214287|FG002|STARTED|Overall Study||65||
48361173|NCT01089725|101214288|FG003|STARTED|Overall Study||87||
48361174|NCT01089725|101214289|FG004|STARTED|Overall Study||86||
48361175|NCT01089725|101214285|FG000|Treated|Overall Study||72||
48361176|NCT01089725|101214286|FG001|Treated|Overall Study||74||
48361177|NCT01089725|101214287|FG002|Treated|Overall Study||63||
48361178|NCT01089725|101214288|FG003|Treated|Overall Study||86||
48361179|NCT01089725|101214289|FG004|Treated|Overall Study||84||
48361180|NCT01089725|101214285|FG000|COMPLETED|Overall Study||6||
48361181|NCT01089725|101214286|FG001|COMPLETED|Overall Study||7||
48361182|NCT01089725|101214287|FG002|COMPLETED|Overall Study||4||
48361183|NCT01089725|101214288|FG003|COMPLETED|Overall Study||8||
48361184|NCT01089725|101214289|FG004|COMPLETED|Overall Study||6||
48361185|NCT01089725|101214285|FG000|NOT COMPLETED|Overall Study||66||
48361186|NCT01089725|101214286|FG001|NOT COMPLETED|Overall Study||68||
48361187|NCT01089725|101214287|FG002|NOT COMPLETED|Overall Study||61||
48361188|NCT01089725|101214288|FG003|NOT COMPLETED|Overall Study||79||
48361189|NCT01089725|101214289|FG004|NOT COMPLETED|Overall Study||80||
48361190|NCT00450463|101214290|FG000|STARTED|Initial Drug Administration||33||
48361191|NCT00450463|101214291|FG001|STARTED|Initial Drug Administration||31||
48361192|NCT00450463|101214290|FG000|COMPLETED|Initial Drug Administration||33||
48361193|NCT00450463|101214291|FG001|COMPLETED|Initial Drug Administration||31||
48361194|NCT00450463|101214290|FG000|NOT COMPLETED|Initial Drug Administration||0||
48361195|NCT00450463|101214291|FG001|NOT COMPLETED|Initial Drug Administration||0||
48361196|NCT00450463|101214290|FG000|STARTED|Progressed to Receive Vaccine Alone||11||
48433156|NCT02848781|101392863|FG001|NOT COMPLETED|Overall Study||5||
48433157|NCT02848781|101392864|FG002|NOT COMPLETED|Overall Study||0||
48433158|NCT03410693|101392865|FG000|STARTED|Overall Study||87||
48433159|NCT03410693|101392866|FG001|STARTED|Overall Study||88||
48433160|NCT03410693|101392865|FG000|Started Treatment|Overall Study||86||
48433161|NCT03410693|101392866|FG001|Started Treatment|Overall Study||82||
48433162|NCT03410693|101392865|FG000|Active Follow-up Performed|Overall Study||61||
48433163|NCT03410693|101392866|FG001|Active Follow-up Performed|Overall Study||56||
48433164|NCT03410693|101392865|FG000|Entered Long Term Follow-up|Overall Study||56||
48433165|NCT03410693|101392866|FG001|Entered Long Term Follow-up|Overall Study||69||
48433166|NCT03410693|101392865|FG000|COMPLETED|Overall Study||0|Completed treatment, participants who discontinued treatment could enter follow-up.|
48433167|NCT03410693|101392866|FG001|COMPLETED|Overall Study||0|Completed treatment, participants who discontinued treatment could enter follow-up.|
48433168|NCT03410693|101392865|FG000|NOT COMPLETED|Overall Study||87||
48433169|NCT03410693|101392866|FG001|NOT COMPLETED|Overall Study||88||
48433170|NCT00145795|101392867|FG000|STARTED|Overall Study||10||
48433171|NCT00145795|101392868|FG001|STARTED|Overall Study||10||
48433172|NCT00145795|101392867|FG000|COMPLETED|Overall Study||9||
48433173|NCT00145795|101392868|FG001|COMPLETED|Overall Study||10||
48433174|NCT00145795|101392867|FG000|NOT COMPLETED|Overall Study||1||
48433175|NCT00145795|101392868|FG001|NOT COMPLETED|Overall Study||0||
48433176|NCT04144140|101392869|FG000|STARTED|Overall Study||2||
48433177|NCT04144140|101392870|FG001|STARTED|Overall Study||2||
48433178|NCT04144140|101392871|FG002|STARTED|Overall Study||2||
48433179|NCT04144140|101392872|FG003|STARTED|Overall Study||11||
48433180|NCT04144140|101392873|FG004|STARTED|Overall Study||6||
48433181|NCT04144140|101392874|FG005|STARTED|Overall Study||1||
48433182|NCT04144140|101392875|FG006|STARTED|Overall Study||0||
48433183|NCT04144140|101392869|FG000|COMPLETED|Overall Study||2||
48433184|NCT04144140|101392870|FG001|COMPLETED|Overall Study||2||
48433185|NCT04144140|101392871|FG002|COMPLETED|Overall Study||2||
48433186|NCT04144140|101392872|FG003|COMPLETED|Overall Study||11||
48433187|NCT04144140|101392873|FG004|COMPLETED|Overall Study||6||
48433188|NCT04144140|101392874|FG005|COMPLETED|Overall Study||0||
48433189|NCT04144140|101392875|FG006|COMPLETED|Overall Study||0||
48433190|NCT04144140|101392869|FG000|NOT COMPLETED|Overall Study||0||
48433191|NCT04144140|101392870|FG001|NOT COMPLETED|Overall Study||0||
48433192|NCT04144140|101392871|FG002|NOT COMPLETED|Overall Study||0||
48433193|NCT04144140|101392872|FG003|NOT COMPLETED|Overall Study||0||
48433194|NCT04144140|101392873|FG004|NOT COMPLETED|Overall Study||0||
48433195|NCT04144140|101392874|FG005|NOT COMPLETED|Overall Study||1||
48433196|NCT04144140|101392875|FG006|NOT COMPLETED|Overall Study||0||
48433197|NCT01674010|101392876|FG000|STARTED|Open Treatment Phase 1||309||
48433198|NCT01674010|101392877|FG001|STARTED|Open Treatment Phase 1||0||
48433199|NCT01674010|101392878|FG002|STARTED|Open Treatment Phase 1||0||
48433200|NCT01674010|101392876|FG000|COMPLETED|Open Treatment Phase 1||129||
48433201|NCT01674010|101392877|FG001|COMPLETED|Open Treatment Phase 1||0||
48433202|NCT01674010|101392878|FG002|COMPLETED|Open Treatment Phase 1||0||
48433203|NCT01674010|101392876|FG000|NOT COMPLETED|Open Treatment Phase 1||180||
48433204|NCT01674010|101392877|FG001|NOT COMPLETED|Open Treatment Phase 1||0||
48433205|NCT01674010|101392878|FG002|NOT COMPLETED|Open Treatment Phase 1||0||
48433206|NCT01674010|101392876|FG000|STARTED|Randomization Phase 2||0||
48433207|NCT01674010|101392877|FG001|STARTED|Randomization Phase 2||65||
48433208|NCT01674010|101392878|FG002|STARTED|Randomization Phase 2||64||
48433209|NCT01674010|101392876|FG000|COMPLETED|Randomization Phase 2||0||
48433210|NCT01674010|101392877|FG001|COMPLETED|Randomization Phase 2||3||
48433211|NCT01674010|101392878|FG002|COMPLETED|Randomization Phase 2||3||
48433212|NCT01674010|101392876|FG000|NOT COMPLETED|Randomization Phase 2||0||
48433213|NCT01674010|101392877|FG001|NOT COMPLETED|Randomization Phase 2||62||
48433214|NCT01674010|101392878|FG002|NOT COMPLETED|Randomization Phase 2||61||
48433215|NCT05182840|101397013|FG000|STARTED|Run-in Period||356|Randomised to Run-in period|
48433216|NCT05182840|101397014|FG001|STARTED|Run-in Period||358|Randomised to Run-in period|
48433217|NCT05182840|101397015|FG002|STARTED|Run-in Period||0|Randomised to Run-in period|
48433218|NCT05182840|101397016|FG003|STARTED|Run-in Period||0|Randomised to Run-in period|
48433219|NCT05182840|101397017|FG004|STARTED|Run-in Period||0|Randomised to Run-in period|
48433220|NCT05182840|101397018|FG005|STARTED|Run-in Period||0|Randomised to Run-in period|
48433221|NCT05182840|101397019|FG006|STARTED|Run-in Period||0|Randomised to Run-in period|
48433222|NCT05182840|101397020|FG007|STARTED|Run-in Period||0|Randomised to Run-in period|
48433223|NCT05182840|101397021|FG008|STARTED|Run-in Period||0|Randomised to Run-in period|
48433224|NCT05182840|101397022|FG009|STARTED|Run-in Period||0|Randomised to Run-in period|
48433225|NCT05182840|101397013|FG000|Treated With Empagliflozin 10 mg or Placebo Matching Empagliflozin 10 mg|Run-in Period||356||
48433226|NCT05182840|101397014|FG001|Treated With Empagliflozin 10 mg or Placebo Matching Empagliflozin 10 mg|Run-in Period||357||
48433227|NCT05182840|101397015|FG002|Treated With Empagliflozin 10 mg or Placebo Matching Empagliflozin 10 mg|Run-in Period||0||
48433228|NCT05182840|101397016|FG003|Treated With Empagliflozin 10 mg or Placebo Matching Empagliflozin 10 mg|Run-in Period||0||
48433229|NCT05182840|101397017|FG004|Treated With Empagliflozin 10 mg or Placebo Matching Empagliflozin 10 mg|Run-in Period||0||
48433230|NCT05182840|101397018|FG005|Treated With Empagliflozin 10 mg or Placebo Matching Empagliflozin 10 mg|Run-in Period||0||
48433231|NCT05182840|101397019|FG006|Treated With Empagliflozin 10 mg or Placebo Matching Empagliflozin 10 mg|Run-in Period||0||
48433232|NCT05182840|101397020|FG007|Treated With Empagliflozin 10 mg or Placebo Matching Empagliflozin 10 mg|Run-in Period||0||
48433233|NCT05182840|101397021|FG008|Treated With Empagliflozin 10 mg or Placebo Matching Empagliflozin 10 mg|Run-in Period||0||
48433234|NCT05182840|101397022|FG009|Treated With Empagliflozin 10 mg or Placebo Matching Empagliflozin 10 mg|Run-in Period||0||
48433235|NCT05182840|101397013|FG000|COMPLETED|Run-in Period||332||
48433236|NCT05182840|101397014|FG001|COMPLETED|Run-in Period||330||
48433237|NCT05182840|101397015|FG002|COMPLETED|Run-in Period||0||
48433238|NCT05182840|101397016|FG003|COMPLETED|Run-in Period||0||
48433239|NCT05182840|101397017|FG004|COMPLETED|Run-in Period||0||
48433240|NCT05182840|101397018|FG005|COMPLETED|Run-in Period||0||
48433241|NCT05182840|101397019|FG006|COMPLETED|Run-in Period||0||
48433242|NCT05182840|101397020|FG007|COMPLETED|Run-in Period||0||
48433243|NCT05182840|101397021|FG008|COMPLETED|Run-in Period||0||
48433244|NCT05182840|101397022|FG009|COMPLETED|Run-in Period||0||
48433245|NCT05182840|101397013|FG000|NOT COMPLETED|Run-in Period||24||
48433246|NCT05182840|101397014|FG001|NOT COMPLETED|Run-in Period||28||
48433247|NCT05182840|101397015|FG002|NOT COMPLETED|Run-in Period||0||
48433248|NCT05182840|101397016|FG003|NOT COMPLETED|Run-in Period||0||
48433249|NCT05182840|101397017|FG004|NOT COMPLETED|Run-in Period||0||
48433250|NCT05182840|101397018|FG005|NOT COMPLETED|Run-in Period||0||
48433251|NCT05182840|101397019|FG006|NOT COMPLETED|Run-in Period||0||
48433252|NCT05182840|101397020|FG007|NOT COMPLETED|Run-in Period||0||
48433253|NCT05182840|101397021|FG008|NOT COMPLETED|Run-in Period||0||
48433254|NCT05182840|101397022|FG009|NOT COMPLETED|Run-in Period||0||
48433255|NCT05182840|101397013|FG000|STARTED|Completed RP and Randomized to TP||332|Completed planned Run-in period|
48433256|NCT05182840|101397014|FG001|STARTED|Completed RP and Randomized to TP||330|Completed planned Run-in period|
48433257|NCT05182840|101397015|FG002|STARTED|Completed RP and Randomized to TP||0|Completed planned Run-in period|
48433258|NCT05182840|101397016|FG003|STARTED|Completed RP and Randomized to TP||0|Completed planned Run-in period|
48433259|NCT05182840|101397017|FG004|STARTED|Completed RP and Randomized to TP||0|Completed planned Run-in period|
48433260|NCT05182840|101397018|FG005|STARTED|Completed RP and Randomized to TP||0|Completed planned Run-in period|
48433261|NCT05182840|101397019|FG006|STARTED|Completed RP and Randomized to TP||0|Completed planned Run-in period|
48433262|NCT05182840|101397020|FG007|STARTED|Completed RP and Randomized to TP||0|Completed planned Run-in period|
48433263|NCT05182840|101397021|FG008|STARTED|Completed RP and Randomized to TP||0|Completed planned Run-in period|
48433264|NCT05182840|101397022|FG009|STARTED|Completed RP and Randomized to TP||0|Completed planned Run-in period|
48433265|NCT05182840|101397013|FG000|COMPLETED|Completed RP and Randomized to TP||298|Randomised to Treatment period|
48433266|NCT05182840|101397014|FG001|COMPLETED|Completed RP and Randomized to TP||286|Randomised to Treatment period|
48433267|NCT05182840|101397015|FG002|COMPLETED|Completed RP and Randomized to TP||0|Randomised to Treatment period|
48433268|NCT05182840|101397016|FG003|COMPLETED|Completed RP and Randomized to TP||0|Randomised to Treatment period|
48433269|NCT05182840|101397017|FG004|COMPLETED|Completed RP and Randomized to TP||0|Randomised to Treatment period|
48433270|NCT05182840|101397018|FG005|COMPLETED|Completed RP and Randomized to TP||0|Randomised to Treatment period|
48433271|NCT05182840|101397019|FG006|COMPLETED|Completed RP and Randomized to TP||0|Randomised to Treatment period|
48433272|NCT05182840|101397020|FG007|COMPLETED|Completed RP and Randomized to TP||0|Randomised to Treatment period|
48433273|NCT05182840|101397021|FG008|COMPLETED|Completed RP and Randomized to TP||0|Randomised to Treatment period|
48433274|NCT05182840|101397022|FG009|COMPLETED|Completed RP and Randomized to TP||0|Randomised to Treatment period|
48433275|NCT05182840|101397013|FG000|NOT COMPLETED|Completed RP and Randomized to TP||34||
48433276|NCT05182840|101397014|FG001|NOT COMPLETED|Completed RP and Randomized to TP||44||
48433277|NCT05182840|101397015|FG002|NOT COMPLETED|Completed RP and Randomized to TP||0||
48433278|NCT05182840|101397016|FG003|NOT COMPLETED|Completed RP and Randomized to TP||0||
48433279|NCT05182840|101397017|FG004|NOT COMPLETED|Completed RP and Randomized to TP||0||
48433280|NCT05182840|101397018|FG005|NOT COMPLETED|Completed RP and Randomized to TP||0||
48433281|NCT05182840|101397019|FG006|NOT COMPLETED|Completed RP and Randomized to TP||0||
48433282|NCT05182840|101397020|FG007|NOT COMPLETED|Completed RP and Randomized to TP||0||
48433283|NCT05182840|101397021|FG008|NOT COMPLETED|Completed RP and Randomized to TP||0||
48433284|NCT05182840|101397022|FG009|NOT COMPLETED|Completed RP and Randomized to TP||0||
48433285|NCT05182840|101397013|FG000|STARTED|Patients Starting the Treatment Period||298||
48433286|NCT05182840|101397014|FG001|STARTED|Patients Starting the Treatment Period||288||
48433287|NCT05182840|101397015|FG002|STARTED|Patients Starting the Treatment Period||0||
48433288|NCT05182840|101397016|FG003|STARTED|Patients Starting the Treatment Period||0||
48433289|NCT05182840|101397017|FG004|STARTED|Patients Starting the Treatment Period||0||
48433290|NCT05182840|101397018|FG005|STARTED|Patients Starting the Treatment Period||0||
48433291|NCT05182840|101397019|FG006|STARTED|Patients Starting the Treatment Period||0||
48433292|NCT05182840|101397020|FG007|STARTED|Patients Starting the Treatment Period||0||
48433293|NCT05182840|101397021|FG008|STARTED|Patients Starting the Treatment Period||0||
48433294|NCT05182840|101397022|FG009|STARTED|Patients Starting the Treatment Period||0||
48433295|NCT05182840|101397013|FG000|Did Not Complete the run-in Period and Was Randomized to Treatment Period|Patients Starting the Treatment Period||0||
48433296|NCT05182840|101397014|FG001|Did Not Complete the run-in Period and Was Randomized to Treatment Period|Patients Starting the Treatment Period||2||
48433297|NCT05182840|101397015|FG002|Did Not Complete the run-in Period and Was Randomized to Treatment Period|Patients Starting the Treatment Period||0||
48433298|NCT05182840|101397016|FG003|Did Not Complete the run-in Period and Was Randomized to Treatment Period|Patients Starting the Treatment Period||0||
48433299|NCT05182840|101397017|FG004|Did Not Complete the run-in Period and Was Randomized to Treatment Period|Patients Starting the Treatment Period||0||
48433300|NCT05182840|101397018|FG005|Did Not Complete the run-in Period and Was Randomized to Treatment Period|Patients Starting the Treatment Period||0||
48433301|NCT05182840|101397019|FG006|Did Not Complete the run-in Period and Was Randomized to Treatment Period|Patients Starting the Treatment Period||0||
48433302|NCT05182840|101397020|FG007|Did Not Complete the run-in Period and Was Randomized to Treatment Period|Patients Starting the Treatment Period||0||
48433303|NCT05182840|101397021|FG008|Did Not Complete the run-in Period and Was Randomized to Treatment Period|Patients Starting the Treatment Period||0||
48433304|NCT05182840|101397022|FG009|Did Not Complete the run-in Period and Was Randomized to Treatment Period|Patients Starting the Treatment Period||0||
48433305|NCT05182840|101397013|FG000|Completed run-in Period and Randomized to Treatment Period|Patients Starting the Treatment Period||298||
48433306|NCT05182840|101397014|FG001|Completed run-in Period and Randomized to Treatment Period|Patients Starting the Treatment Period||286||
48433307|NCT05182840|101397015|FG002|Completed run-in Period and Randomized to Treatment Period|Patients Starting the Treatment Period||0||
48433308|NCT05182840|101397016|FG003|Completed run-in Period and Randomized to Treatment Period|Patients Starting the Treatment Period||0||
48433309|NCT05182840|101397017|FG004|Completed run-in Period and Randomized to Treatment Period|Patients Starting the Treatment Period||0||
48433310|NCT05182840|101397018|FG005|Completed run-in Period and Randomized to Treatment Period|Patients Starting the Treatment Period||0||
48433311|NCT05182840|101397019|FG006|Completed run-in Period and Randomized to Treatment Period|Patients Starting the Treatment Period||0||
48433312|NCT05182840|101397020|FG007|Completed run-in Period and Randomized to Treatment Period|Patients Starting the Treatment Period||0||
48433313|NCT05182840|101397021|FG008|Completed run-in Period and Randomized to Treatment Period|Patients Starting the Treatment Period||0||
48433314|NCT05182840|101397022|FG009|Completed run-in Period and Randomized to Treatment Period|Patients Starting the Treatment Period||0||
48433315|NCT05182840|101397013|FG000|COMPLETED|Patients Starting the Treatment Period||298||
48433316|NCT05182840|101397014|FG001|COMPLETED|Patients Starting the Treatment Period||288||
48433317|NCT05182840|101397015|FG002|COMPLETED|Patients Starting the Treatment Period||0||
48433318|NCT05182840|101397016|FG003|COMPLETED|Patients Starting the Treatment Period||0||
48433319|NCT05182840|101397017|FG004|COMPLETED|Patients Starting the Treatment Period||0||
48433320|NCT05182840|101397018|FG005|COMPLETED|Patients Starting the Treatment Period||0||
48433321|NCT05182840|101397019|FG006|COMPLETED|Patients Starting the Treatment Period||0||
48433322|NCT05182840|101397020|FG007|COMPLETED|Patients Starting the Treatment Period||0||
48433323|NCT05182840|101397021|FG008|COMPLETED|Patients Starting the Treatment Period||0||
48433324|NCT05182840|101397022|FG009|COMPLETED|Patients Starting the Treatment Period||0||
48433325|NCT05182840|101397013|FG000|NOT COMPLETED|Patients Starting the Treatment Period||0||
48433326|NCT05182840|101397014|FG001|NOT COMPLETED|Patients Starting the Treatment Period||0||
48361197|NCT00450463|101214291|FG001|STARTED|Progressed to Receive Vaccine Alone||0||
48361198|NCT00450463|101214290|FG000|COMPLETED|Progressed to Receive Vaccine Alone||11||
48361199|NCT00450463|101214291|FG001|COMPLETED|Progressed to Receive Vaccine Alone||0||
48361200|NCT00450463|101214290|FG000|NOT COMPLETED|Progressed to Receive Vaccine Alone||0||
48361201|NCT00450463|101214291|FG001|NOT COMPLETED|Progressed to Receive Vaccine Alone||0||
48361202|NCT00708877|101214292|FG000|STARTED|Overall Study||5||
48361203|NCT00708877|101214292|FG000|COMPLETED|Overall Study||5||
48361204|NCT00708877|101214292|FG000|NOT COMPLETED|Overall Study||0||
48361205|NCT01709799|101214293|FG000|STARTED|Overall Study||25||
48361206|NCT01709799|101214294|FG001|STARTED|Overall Study||21||
48361207|NCT01709799|101214295|FG002|STARTED|Overall Study||18||
48361208|NCT01709799|101214293|FG000|COMPLETED|Overall Study||22||
48361209|NCT01709799|101214294|FG001|COMPLETED|Overall Study||18||
48361210|NCT01709799|101214295|FG002|COMPLETED|Overall Study||15||
48361211|NCT01709799|101214293|FG000|NOT COMPLETED|Overall Study||3||
48361212|NCT01709799|101214294|FG001|NOT COMPLETED|Overall Study||3||
48361213|NCT01709799|101214295|FG002|NOT COMPLETED|Overall Study||3||
48361214|NCT01903434|101214296|FG000|STARTED|Treatment Period 1||30||
48361215|NCT01903434|101214297|FG001|STARTED|Treatment Period 1||30||
48361216|NCT01903434|101214296|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||30||
48361217|NCT01903434|101214297|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||30||
48433327|NCT05182840|101397015|FG002|NOT COMPLETED|Patients Starting the Treatment Period||0||
48433328|NCT05182840|101397016|FG003|NOT COMPLETED|Patients Starting the Treatment Period||0||
48433329|NCT05182840|101397017|FG004|NOT COMPLETED|Patients Starting the Treatment Period||0||
48433330|NCT05182840|101397018|FG005|NOT COMPLETED|Patients Starting the Treatment Period||0||
48433331|NCT05182840|101397019|FG006|NOT COMPLETED|Patients Starting the Treatment Period||0||
48433332|NCT05182840|101397020|FG007|NOT COMPLETED|Patients Starting the Treatment Period||0||
48433333|NCT05182840|101397021|FG008|NOT COMPLETED|Patients Starting the Treatment Period||0||
48433334|NCT05182840|101397022|FG009|NOT COMPLETED|Patients Starting the Treatment Period||0||
48433335|NCT05182840|101397013|FG000|STARTED|Treatment Period||0|Randomised to Treatment period|
48361218|NCT01903434|101214296|FG000|COMPLETED|Treatment Period 1||30||
48361219|NCT01903434|101214297|FG001|COMPLETED|Treatment Period 1||30||
48361220|NCT01903434|101214296|FG000|NOT COMPLETED|Treatment Period 1||0||
48433336|NCT05182840|101397014|FG001|STARTED|Treatment Period||0|Randomised to Treatment period|
48433337|NCT05182840|101397015|FG002|STARTED|Treatment Period||76|Randomised to Treatment period|
48433338|NCT05182840|101397016|FG003|STARTED|Treatment Period||74|Randomised to Treatment period|
48433339|NCT05182840|101397017|FG004|STARTED|Treatment Period||74|Randomised to Treatment period|
48433340|NCT05182840|101397018|FG005|STARTED|Treatment Period||74|Randomised to Treatment period|
48433341|NCT05182840|101397019|FG006|STARTED|Treatment Period||71|Randomised to Treatment period|
48433342|NCT05182840|101397020|FG007|STARTED|Treatment Period||72|Randomised to Treatment period|
48433343|NCT05182840|101397021|FG008|STARTED|Treatment Period||72|Randomised to Treatment period|
48433344|NCT05182840|101397022|FG009|STARTED|Treatment Period||73|Randomised to Treatment period|
48433345|NCT05182840|101397013|FG000|Treated With BI 690517 or Placebo Matching BI 690517|Treatment Period||0||
48433346|NCT05182840|101397014|FG001|Treated With BI 690517 or Placebo Matching BI 690517|Treatment Period||0||
48433347|NCT05182840|101397015|FG002|Treated With BI 690517 or Placebo Matching BI 690517|Treatment Period||76||
48433348|NCT05182840|101397016|FG003|Treated With BI 690517 or Placebo Matching BI 690517|Treatment Period||73||
48433349|NCT05182840|101397017|FG004|Treated With BI 690517 or Placebo Matching BI 690517|Treatment Period||74||
48433350|NCT05182840|101397018|FG005|Treated With BI 690517 or Placebo Matching BI 690517|Treatment Period||74||
48433351|NCT05182840|101397019|FG006|Treated With BI 690517 or Placebo Matching BI 690517|Treatment Period||70||
48433352|NCT05182840|101397020|FG007|Treated With BI 690517 or Placebo Matching BI 690517|Treatment Period||71||
48433353|NCT05182840|101397021|FG008|Treated With BI 690517 or Placebo Matching BI 690517|Treatment Period||72||
48433354|NCT05182840|101397022|FG009|Treated With BI 690517 or Placebo Matching BI 690517|Treatment Period||73||
48433355|NCT05182840|101397013|FG000|COMPLETED|Treatment Period||0|Completed planned treatment with BI 690517 or placebo matching BI 690517|
48433356|NCT05182840|101397014|FG001|COMPLETED|Treatment Period||0|Completed planned treatment with BI 690517 or placebo matching BI 690517|
48433357|NCT05182840|101397015|FG002|COMPLETED|Treatment Period||63|Completed planned treatment with BI 690517 or placebo matching BI 690517|
48433358|NCT05182840|101397016|FG003|COMPLETED|Treatment Period||50|Completed planned treatment with BI 690517 or placebo matching BI 690517|
48433359|NCT05182840|101397017|FG004|COMPLETED|Treatment Period||55|Completed planned treatment with BI 690517 or placebo matching BI 690517|
48433360|NCT05182840|101397018|FG005|COMPLETED|Treatment Period||58|Completed planned treatment with BI 690517 or placebo matching BI 690517|
48433361|NCT05182840|101397019|FG006|COMPLETED|Treatment Period||61|Completed planned treatment with BI 690517 or placebo matching BI 690517|
48433362|NCT05182840|101397020|FG007|COMPLETED|Treatment Period||54|Completed planned treatment with BI 690517 or placebo matching BI 690517|
48433363|NCT05182840|101397021|FG008|COMPLETED|Treatment Period||48|Completed planned treatment with BI 690517 or placebo matching BI 690517|
48433364|NCT05182840|101397022|FG009|COMPLETED|Treatment Period||66|Completed planned treatment with BI 690517 or placebo matching BI 690517|
48433365|NCT05182840|101397013|FG000|NOT COMPLETED|Treatment Period||0||
48433366|NCT05182840|101397014|FG001|NOT COMPLETED|Treatment Period||0||
48433367|NCT05182840|101397015|FG002|NOT COMPLETED|Treatment Period||13||
48433368|NCT05182840|101397016|FG003|NOT COMPLETED|Treatment Period||24||
48433369|NCT05182840|101397017|FG004|NOT COMPLETED|Treatment Period||19||
48433370|NCT05182840|101397018|FG005|NOT COMPLETED|Treatment Period||16||
48433371|NCT05182840|101397019|FG006|NOT COMPLETED|Treatment Period||10||
48433372|NCT05182840|101397020|FG007|NOT COMPLETED|Treatment Period||18||
48433373|NCT05182840|101397021|FG008|NOT COMPLETED|Treatment Period||24||
48433374|NCT05182840|101397022|FG009|NOT COMPLETED|Treatment Period||7||
48433375|NCT00111007|101397023|FG000|STARTED|Double-blind (DB) Treatment||135||
48433376|NCT00111007|101397024|FG001|STARTED|Double-blind (DB) Treatment||135||
48433377|NCT00111007|101397023|FG000|Received Treatment|Double-blind (DB) Treatment||134||
48433378|NCT00111007|101397024|FG001|Received Treatment|Double-blind (DB) Treatment||134||
48433379|NCT00111007|101397023|FG000|COMPLETED|Double-blind (DB) Treatment||27||
48433380|NCT00111007|101397024|FG001|COMPLETED|Double-blind (DB) Treatment||24||
48433381|NCT00111007|101397023|FG000|NOT COMPLETED|Double-blind (DB) Treatment||108||
48433382|NCT00111007|101397024|FG001|NOT COMPLETED|Double-blind (DB) Treatment||111||
48433383|NCT00111007|101397023|FG000|STARTED|Active Follow-up||6||
48433384|NCT00111007|101397024|FG001|STARTED|Active Follow-up||4||
48433385|NCT00111007|101397023|FG000|COMPLETED|Active Follow-up||0||
48433386|NCT00111007|101397024|FG001|COMPLETED|Active Follow-up||2||
48433387|NCT00111007|101397023|FG000|NOT COMPLETED|Active Follow-up||6||
48433388|NCT00111007|101397024|FG001|NOT COMPLETED|Active Follow-up||2||
48433389|NCT00111007|101397023|FG000|STARTED|Long Term Follow-up||101||
48433390|NCT00111007|101397024|FG001|STARTED|Long Term Follow-up||107||
48433391|NCT00111007|101397023|FG000|COMPLETED|Long Term Follow-up||54||
48433392|NCT00111007|101397024|FG001|COMPLETED|Long Term Follow-up||62||
48433393|NCT00111007|101397023|FG000|NOT COMPLETED|Long Term Follow-up||47||
48433394|NCT00111007|101397024|FG001|NOT COMPLETED|Long Term Follow-up||45||
48433395|NCT00347776|101397025|FG000|STARTED|1.5 Month Follow-up||484||
48433396|NCT00347776|101397026|FG001|STARTED|1.5 Month Follow-up||483||
48433397|NCT00347776|101397027|FG002|STARTED|1.5 Month Follow-up||485||
48433398|NCT00347776|101397025|FG000|COMPLETED|1.5 Month Follow-up||470||
48433399|NCT00347776|101397026|FG001|COMPLETED|1.5 Month Follow-up||475||
48433400|NCT00347776|101397027|FG002|COMPLETED|1.5 Month Follow-up||473||
48433401|NCT00347776|101397025|FG000|NOT COMPLETED|1.5 Month Follow-up||14||
48433402|NCT00347776|101397026|FG001|NOT COMPLETED|1.5 Month Follow-up||8||
48433403|NCT00347776|101397027|FG002|NOT COMPLETED|1.5 Month Follow-up||12||
48433404|NCT00347776|101397025|FG000|STARTED|6 Month Follow-up||470||
48433405|NCT00347776|101397026|FG001|STARTED|6 Month Follow-up||475||
48433406|NCT00347776|101397027|FG002|STARTED|6 Month Follow-up||473||
48433407|NCT00347776|101397025|FG000|COMPLETED|6 Month Follow-up||448||
48433408|NCT00347776|101397026|FG001|COMPLETED|6 Month Follow-up||462||
48433409|NCT00347776|101397027|FG002|COMPLETED|6 Month Follow-up||455||
48433410|NCT00347776|101397025|FG000|NOT COMPLETED|6 Month Follow-up||22||
48433411|NCT00347776|101397026|FG001|NOT COMPLETED|6 Month Follow-up||13||
48433412|NCT00347776|101397027|FG002|NOT COMPLETED|6 Month Follow-up||18||
48433413|NCT00347776|101397025|FG000|STARTED|12 Month Follow-up||448||
48433414|NCT00347776|101397026|FG001|STARTED|12 Month Follow-up||462||
48433415|NCT00347776|101397027|FG002|STARTED|12 Month Follow-up||455||
48433416|NCT00347776|101397025|FG000|COMPLETED|12 Month Follow-up||425||
48433417|NCT00347776|101397026|FG001|COMPLETED|12 Month Follow-up||446||
48433418|NCT00347776|101397027|FG002|COMPLETED|12 Month Follow-up||436||
48433419|NCT00347776|101397025|FG000|NOT COMPLETED|12 Month Follow-up||23||
48433420|NCT00347776|101397026|FG001|NOT COMPLETED|12 Month Follow-up||16||
48433421|NCT00347776|101397027|FG002|NOT COMPLETED|12 Month Follow-up||19||
48433422|NCT00674440|101397028|FG000|STARTED|Overall Study||106||
48433423|NCT00674440|101397028|FG000|COMPLETED|Overall Study||95||
48433424|NCT00674440|101397028|FG000|NOT COMPLETED|Overall Study||11||
48433425|NCT02279082|101397029|FG000|STARTED|Overall Study||167||
48433426|NCT02279082|101397029|FG000|COMPLETED|Overall Study||134||
48433427|NCT02279082|101397029|FG000|NOT COMPLETED|Overall Study||33||
48433428|NCT01301625|101397030|FG000|STARTED|Overall Study||78||
48433429|NCT01301625|101397030|FG000|COMPLETED|Overall Study||43||
48433430|NCT01301625|101397030|FG000|NOT COMPLETED|Overall Study||35||
48433431|NCT00908375|101397031|FG000|STARTED|Overall Study||20||
48433432|NCT00908375|101397032|FG001|STARTED|Overall Study||19||
48433433|NCT00908375|101397031|FG000|COMPLETED|Overall Study||10||
48433434|NCT00908375|101397032|FG001|COMPLETED|Overall Study||9||
48433435|NCT00908375|101397031|FG000|NOT COMPLETED|Overall Study||10||
48433436|NCT00908375|101397032|FG001|NOT COMPLETED|Overall Study||10||
48433437|NCT00594568|101397033|FG000|STARTED|Initial Treatment||501||
48433438|NCT00594568|101397034|FG001|STARTED|Initial Treatment||507||
48433439|NCT00594568|101397035|FG002|STARTED|Initial Treatment||529||
48433440|NCT00594568|101397033|FG000|Intent-to-treat (ITT)|Initial Treatment||501||
48433441|NCT00594568|101397034|FG001|Intent-to-treat (ITT)|Initial Treatment||506||
48433442|NCT00594568|101397035|FG002|Intent-to-treat (ITT)|Initial Treatment||527||
48433443|NCT00594568|101397033|FG000|COMPLETED|Initial Treatment||189||
48433444|NCT00594568|101397034|FG001|COMPLETED|Initial Treatment||153||
48433445|NCT00594568|101397035|FG002|COMPLETED|Initial Treatment||121||
48433446|NCT00594568|101397033|FG000|NOT COMPLETED|Initial Treatment||312||
48433447|NCT00594568|101397034|FG001|NOT COMPLETED|Initial Treatment||354||
48433448|NCT00594568|101397035|FG002|NOT COMPLETED|Initial Treatment||408||
48433449|NCT00594568|101397033|FG000|STARTED|Delayed Start||189||
48433450|NCT00594568|101397034|FG001|STARTED|Delayed Start||153||
48433451|NCT00594568|101397035|FG002|STARTED|Delayed Start||121||
48433452|NCT00594568|101397033|FG000|COMPLETED|Delayed Start||91||
48433453|NCT00594568|101397034|FG001|COMPLETED|Delayed Start||76||
48433454|NCT00594568|101397035|FG002|COMPLETED|Delayed Start||55||
48433455|NCT00594568|101397033|FG000|NOT COMPLETED|Delayed Start||98||
48433456|NCT00594568|101397034|FG001|NOT COMPLETED|Delayed Start||77||
48433457|NCT00594568|101397035|FG002|NOT COMPLETED|Delayed Start||66||
48433458|NCT00594568|101397033|FG000|STARTED|Safety Follow Up (SFU)-Optional||290||
48433459|NCT00594568|101397034|FG001|STARTED|Safety Follow Up (SFU)-Optional||223||
48433460|NCT00594568|101397035|FG002|STARTED|Safety Follow Up (SFU)-Optional||214||
48433461|NCT00594568|101397033|FG000|COMPLETED|Safety Follow Up (SFU)-Optional||229||
48433462|NCT00594568|101397034|FG001|COMPLETED|Safety Follow Up (SFU)-Optional||168||
48433463|NCT00594568|101397035|FG002|COMPLETED|Safety Follow Up (SFU)-Optional||172||
48433464|NCT00594568|101397033|FG000|NOT COMPLETED|Safety Follow Up (SFU)-Optional||61||
48433465|NCT00594568|101397034|FG001|NOT COMPLETED|Safety Follow Up (SFU)-Optional||55||
48433466|NCT00594568|101397035|FG002|NOT COMPLETED|Safety Follow Up (SFU)-Optional||42||
48433467|NCT04640168|101397036|FG000|STARTED|Overall Study||516||
48433468|NCT04640168|101397037|FG001|STARTED|Overall Study||494||
48433469|NCT04640168|101397036|FG000|Treated|Overall Study||503||
48433470|NCT04640168|101397037|FG001|Treated|Overall Study||482||
48433471|NCT04640168|101397036|FG000|ITT and Modified ITT Population|Overall Study||516||
48433472|NCT04640168|101397037|FG001|ITT and Modified ITT Population|Overall Study||494||
48433473|NCT04640168|101397036|FG000|As Treated Population|Overall Study||503||
48433474|NCT04640168|101397037|FG001|As Treated Population|Overall Study||482||
48433475|NCT04640168|101397036|FG000|COMPLETED|Overall Study||495||
48433476|NCT04640168|101397037|FG001|COMPLETED|Overall Study||475||
48433477|NCT04640168|101397036|FG000|NOT COMPLETED|Overall Study||21||
48433478|NCT04640168|101397037|FG001|NOT COMPLETED|Overall Study||19||
48433479|NCT03246152|101397038|FG000|STARTED|Overall Study||31||
48433480|NCT03246152|101397038|FG000|COMPLETED|Overall Study||28||
48433481|NCT03246152|101397038|FG000|NOT COMPLETED|Overall Study||3||
48433482|NCT04983589|101397039|FG000|STARTED|Overall Study||116||
48433483|NCT04983589|101397040|FG001|STARTED|Overall Study||114||
48433484|NCT04983589|101397039|FG000|COMPLETED|Overall Study||113||
48433485|NCT04983589|101397040|FG001|COMPLETED|Overall Study||111||
48433486|NCT04983589|101397039|FG000|NOT COMPLETED|Overall Study||3||
48433487|NCT04983589|101397040|FG001|NOT COMPLETED|Overall Study||3||
48433488|NCT03722459|101397041|FG000|STARTED|Overall Study||22||
48433489|NCT03722459|101397041|FG000|COMPLETED|Overall Study||22||
48433490|NCT03722459|101397041|FG000|NOT COMPLETED|Overall Study||0||
48433491|NCT00834366|101397042|FG000|STARTED|Treatment Period 1||13||
48433492|NCT00834366|101397043|FG001|STARTED|Treatment Period 1||13||
48433493|NCT00834366|101397042|FG000|COMPLETED|Treatment Period 1||12||
48433494|NCT00834366|101397043|FG001|COMPLETED|Treatment Period 1||12||
48433495|NCT00834366|101397042|FG000|NOT COMPLETED|Treatment Period 1||1||
48433496|NCT00834366|101397043|FG001|NOT COMPLETED|Treatment Period 1||1||
48433497|NCT00834366|101397042|FG000|STARTED|Treatment Period 2||12||
48433498|NCT00834366|101397043|FG001|STARTED|Treatment Period 2||12||
48433499|NCT00834366|101397042|FG000|COMPLETED|Treatment Period 2||12||
48433500|NCT00834366|101397043|FG001|COMPLETED|Treatment Period 2||12||
48433501|NCT00834366|101397042|FG000|NOT COMPLETED|Treatment Period 2||0||
48433502|NCT00834366|101397043|FG001|NOT COMPLETED|Treatment Period 2||0||
48433503|NCT02022566|101397044|FG000|STARTED|Overall Study||227||
48433504|NCT02022566|101397045|FG001|STARTED|Overall Study||90||
48433505|NCT02022566|101397044|FG000|COMPLETED|Overall Study||169||
48433506|NCT02022566|101397045|FG001|COMPLETED|Overall Study||49||
48433507|NCT02022566|101397044|FG000|NOT COMPLETED|Overall Study||58||
48433508|NCT02022566|101397045|FG001|NOT COMPLETED|Overall Study||41||
48433509|NCT02222246|101397046|FG000|STARTED|Overall Study||53||
48433510|NCT02222246|101397047|FG001|STARTED|Overall Study||53||
48433511|NCT02222246|101397046|FG000|COMPLETED|Overall Study||26||
48433512|NCT02222246|101397047|FG001|COMPLETED|Overall Study||26||
48433513|NCT02222246|101397046|FG000|NOT COMPLETED|Overall Study||27||
48764274|NCT01550003|102211922|FG002|STARTED|Overall Study||112||
48764275|NCT01550003|102211920|FG000|Original CZP Dose|Overall Study||7||
48764276|NCT01550003|102211921|FG001|Original CZP Dose|Overall Study||34||
48764277|NCT01550003|102211922|FG002|Original CZP Dose|Overall Study||64||
48764278|NCT01550003|102211920|FG000|Reduced CZP Dose|Overall Study||11||
48764279|NCT01550003|102211921|FG001|Reduced CZP Dose|Overall Study||29||
48764280|NCT01550003|102211922|FG002|Reduced CZP Dose|Overall Study||48||
48764281|NCT01550003|102211920|FG000|COMPLETED|Overall Study||0||
48764282|NCT01550003|102211921|FG001|COMPLETED|Overall Study||0||
48764283|NCT01550003|102211922|FG002|COMPLETED|Overall Study||0||
48764284|NCT01550003|102211920|FG000|NOT COMPLETED|Overall Study||18||
48764285|NCT01550003|102211921|FG001|NOT COMPLETED|Overall Study||63||
48764286|NCT01550003|102211922|FG002|NOT COMPLETED|Overall Study||112||
48764287|NCT02092610|102211923|FG000|STARTED|Overall Study||25||
48764288|NCT02092610|102211924|FG001|STARTED|Overall Study||52||
48764289|NCT02092610|102211923|FG000|COMPLETED|Overall Study||17||
48764290|NCT02092610|102211924|FG001|COMPLETED|Overall Study||40||
48764291|NCT02092610|102211923|FG000|NOT COMPLETED|Overall Study||8||
48764292|NCT02092610|102211924|FG001|NOT COMPLETED|Overall Study||12||
48764293|NCT03011099|102211925|FG000|STARTED|Overall Study||6||
48764294|NCT03011099|102211926|FG001|STARTED|Overall Study||5||
48764295|NCT03011099|102211925|FG000|COMPLETED|Overall Study||6||
48764296|NCT03011099|102211926|FG001|COMPLETED|Overall Study||3||
48764297|NCT03011099|102211925|FG000|NOT COMPLETED|Overall Study||0||
48764298|NCT03011099|102211926|FG001|NOT COMPLETED|Overall Study||2||
48764299|NCT02195518|102211927|FG000|STARTED|Overall Study||213||
48764300|NCT02195518|102211927|FG000|COMPLETED|Overall Study||204||
48764301|NCT02195518|102211927|FG000|NOT COMPLETED|Overall Study||9||
48764302|NCT00728689|102211928|FG000|STARTED|First Intervention (Days 1 - 3)||6||
48764303|NCT00728689|102211929|FG001|STARTED|First Intervention (Days 1 - 3)||6||
48764304|NCT00728689|102211928|FG000|COMPLETED|First Intervention (Days 1 - 3)||6||
48764305|NCT00728689|102211929|FG001|COMPLETED|First Intervention (Days 1 - 3)||6||
48764306|NCT00728689|102211928|FG000|NOT COMPLETED|First Intervention (Days 1 - 3)||0||
48764307|NCT00728689|102211929|FG001|NOT COMPLETED|First Intervention (Days 1 - 3)||0||
48764308|NCT00728689|102211928|FG000|STARTED|Washout Period (Days 4 - 10)||6||
48764309|NCT00728689|102211929|FG001|STARTED|Washout Period (Days 4 - 10)||6||
48433514|NCT02222246|101397047|FG001|NOT COMPLETED|Overall Study||27||
48433515|NCT03186794|101397048|FG000|STARTED|Overall Study||20||
48433516|NCT03186794|101397048|FG000|COMPLETED|Overall Study||16||
48433517|NCT03186794|101397048|FG000|NOT COMPLETED|Overall Study||4||
48433518|NCT02046993|101397049|FG000|STARTED|Overall Study||105||
48433519|NCT02046993|101397050|FG001|STARTED|Overall Study||105||
48433520|NCT02046993|101397049|FG000|3rd Month|Overall Study||104||
48433521|NCT02046993|101397050|FG001|3rd Month|Overall Study||97||
48433522|NCT02046993|101397049|FG000|6th Month|Overall Study||102||
48764310|NCT00728689|102211928|FG000|COMPLETED|Washout Period (Days 4 - 10)||5||
48764311|NCT00728689|102211929|FG001|COMPLETED|Washout Period (Days 4 - 10)||6||
48764312|NCT00728689|102211928|FG000|NOT COMPLETED|Washout Period (Days 4 - 10)||1||
48764313|NCT00728689|102211929|FG001|NOT COMPLETED|Washout Period (Days 4 - 10)||0||
48764314|NCT00728689|102211928|FG000|STARTED|Second Intervention (Days 11 - 13)||5||
48764315|NCT00728689|102211929|FG001|STARTED|Second Intervention (Days 11 - 13)||6||
48764316|NCT00728689|102211928|FG000|COMPLETED|Second Intervention (Days 11 - 13)||5||
48764317|NCT00728689|102211929|FG001|COMPLETED|Second Intervention (Days 11 - 13)||6||
48433523|NCT02046993|101397050|FG001|6th Month|Overall Study||94||
48433524|NCT02046993|101397049|FG000|COMPLETED|Overall Study||102||
48433525|NCT02046993|101397050|FG001|COMPLETED|Overall Study||94||
48433526|NCT02046993|101397049|FG000|NOT COMPLETED|Overall Study||3||
48433527|NCT02046993|101397050|FG001|NOT COMPLETED|Overall Study||11||
48433528|NCT02335229|101397051|FG000|STARTED|Overall Study||30||
48433529|NCT02335229|101397051|FG000|Received Trial System|Overall Study||10||
48433530|NCT02335229|101397051|FG000|Received Permanent System|Overall Study||26||
48433531|NCT02335229|101397051|FG000|COMPLETED|Overall Study||23||
48433532|NCT02335229|101397051|FG000|NOT COMPLETED|Overall Study||7||
48433533|NCT00656669|101397052|FG000|STARTED|Single Agent Sunitinib (Cycle 1)||23||
48433534|NCT00656669|101397052|FG000|COMPLETED|Single Agent Sunitinib (Cycle 1)||23||
48433535|NCT00656669|101397052|FG000|NOT COMPLETED|Single Agent Sunitinib (Cycle 1)||0||
48433536|NCT00656669|101397052|FG000|STARTED|Paclitaxel/Sunitinib (Cycles 2-5)||23||
48433537|NCT00656669|101397052|FG000|COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||17||
48433538|NCT00656669|101397052|FG000|NOT COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||6||
48433539|NCT00656669|101397052|FG000|STARTED|AC (Cycles 6-9)||17||
48433540|NCT00656669|101397052|FG000|COMPLETED|AC (Cycles 6-9)||15||
48433541|NCT00656669|101397052|FG000|NOT COMPLETED|AC (Cycles 6-9)||2||
48433542|NCT00694070|101397053|FG000|STARTED|Overall Study||51||
48433543|NCT00694070|101397053|FG000|COMPLETED|Overall Study||51||
48433544|NCT00694070|101397053|FG000|NOT COMPLETED|Overall Study||0||
48433545|NCT02464176|101397054|FG000|STARTED|Overall Study||50||
48433546|NCT02464176|101397055|FG001|STARTED|Overall Study||50||
48433547|NCT02464176|101397056|FG002|STARTED|Overall Study||15||
48433548|NCT02464176|101397054|FG000|COMPLETED|Overall Study||50||
48433549|NCT02464176|101397055|FG001|COMPLETED|Overall Study||50||
48433550|NCT02464176|101397056|FG002|COMPLETED|Overall Study||15||
48433551|NCT02464176|101397054|FG000|NOT COMPLETED|Overall Study||0||
48433552|NCT02464176|101397055|FG001|NOT COMPLETED|Overall Study||0||
48433553|NCT02464176|101397056|FG002|NOT COMPLETED|Overall Study||0||
48433554|NCT00494234|101397057|FG000|STARTED|Overall Study||27||
48433555|NCT00494234|101397058|FG001|STARTED|Overall Study||27||
48433556|NCT00494234|101397057|FG000|COMPLETED|Overall Study||13||
48433557|NCT00494234|101397058|FG001|COMPLETED|Overall Study||18||
48433558|NCT00494234|101397057|FG000|NOT COMPLETED|Overall Study||14||
48433559|NCT00494234|101397058|FG001|NOT COMPLETED|Overall Study||9||
48433560|NCT00965562|101397059|FG000|STARTED|Overall Study||16||
48433561|NCT00965562|101397060|FG001|STARTED|Overall Study||17||
48433562|NCT00965562|101397061|FG002|STARTED|Overall Study||16||
48433563|NCT00965562|101397059|FG000|Women With at Least 2 Follow up Visits|Overall Study||13||
48433564|NCT00965562|101397060|FG001|Women With at Least 2 Follow up Visits|Overall Study||13||
48433565|NCT00965562|101397061|FG002|Women With at Least 2 Follow up Visits|Overall Study||13||
48433566|NCT00965562|101397059|FG000|Women Who Participated Full Follow up|Overall Study||6||
48433567|NCT00965562|101397060|FG001|Women Who Participated Full Follow up|Overall Study||10||
48433568|NCT00965562|101397061|FG002|Women Who Participated Full Follow up|Overall Study||11||
48433569|NCT00965562|101397059|FG000|COMPLETED|Overall Study||13||
48433570|NCT00965562|101397060|FG001|COMPLETED|Overall Study||13||
48433571|NCT00965562|101397061|FG002|COMPLETED|Overall Study||13||
48433572|NCT00965562|101397059|FG000|NOT COMPLETED|Overall Study||3||
48433573|NCT00965562|101397060|FG001|NOT COMPLETED|Overall Study||4||
48433574|NCT00965562|101397061|FG002|NOT COMPLETED|Overall Study||3||
48433575|NCT05375942|101397062|FG000|STARTED|Overall Study||255||
48433576|NCT05375942|101397062|FG000|Participants With 6 Month Follow-up (Cohort 2)|Overall Study||176||
48433577|NCT05375942|101397062|FG000|COMPLETED|Overall Study||255||
48433578|NCT05375942|101397062|FG000|NOT COMPLETED|Overall Study||0||
48433579|NCT02396849|101397063|FG000|STARTED|Overall Study||29||
48433580|NCT02396849|101397064|FG001|STARTED|Overall Study||30||
48433581|NCT02396849|101397063|FG000|COMPLETED|Overall Study||27||
48433582|NCT02396849|101397064|FG001|COMPLETED|Overall Study||28||
48433583|NCT02396849|101397063|FG000|NOT COMPLETED|Overall Study||2||
48433584|NCT02396849|101397064|FG001|NOT COMPLETED|Overall Study||2||
48433585|NCT01711424|101397065|FG000|STARTED|Overall Study||1209||
48433586|NCT01711424|101397065|FG000|COMPLETED|Overall Study||1209||
48433587|NCT01711424|101397065|FG000|NOT COMPLETED|Overall Study||0||
48433588|NCT00461591|101397066|FG000|STARTED|Overall Study||406||
48433589|NCT00461591|101397067|FG001|STARTED|Overall Study||396||
48433590|NCT00461591|101397066|FG000|COMPLETED|Overall Study||317||
48433591|NCT00461591|101397067|FG001|COMPLETED|Overall Study||311||
48433592|NCT00461591|101397066|FG000|NOT COMPLETED|Overall Study||89||
48433593|NCT00461591|101397067|FG001|NOT COMPLETED|Overall Study||85||
48433594|NCT01958619|101397068|FG000|STARTED|Overall Study||15||
48433595|NCT01958619|101397069|FG001|STARTED|Overall Study||14||
48433596|NCT01958619|101397070|FG002|STARTED|Overall Study||14||
48433597|NCT01958619|101397071|FG003|STARTED|Overall Study||12||
48433598|NCT01958619|101397068|FG000|COMPLETED|Overall Study||13||
48433599|NCT01958619|101397069|FG001|COMPLETED|Overall Study||14||
48433600|NCT01958619|101397070|FG002|COMPLETED|Overall Study||13||
48433601|NCT01958619|101397071|FG003|COMPLETED|Overall Study||12||
48433602|NCT01958619|101397068|FG000|NOT COMPLETED|Overall Study||2||
48433603|NCT01958619|101397069|FG001|NOT COMPLETED|Overall Study||0||
48433604|NCT01958619|101397070|FG002|NOT COMPLETED|Overall Study||1||
48433605|NCT01958619|101397071|FG003|NOT COMPLETED|Overall Study||0||
48433606|NCT01519635|101397072|FG000|STARTED|Overall Study||12||
48433607|NCT01519635|101397073|FG001|STARTED|Overall Study||12||
48433608|NCT01519635|101397072|FG000|COMPLETED|Overall Study||11||
48433609|NCT01519635|101397073|FG001|COMPLETED|Overall Study||9||
48639073|NCT02949934|101901561|FG001|COMPLETED|Neuroimaging||12||
48639074|NCT02949934|101901562|FG002|COMPLETED|Neuroimaging||15||
48639075|NCT02949934|101901563|FG003|COMPLETED|Neuroimaging||15||
48639076|NCT02949934|101901564|FG004|COMPLETED|Neuroimaging||12||
48639077|NCT02949934|101901565|FG005|COMPLETED|Neuroimaging||12||
48639078|NCT02949934|101901560|FG000|NOT COMPLETED|Neuroimaging||3||
48639079|NCT02949934|101901561|FG001|NOT COMPLETED|Neuroimaging||0||
48639080|NCT02949934|101901562|FG002|NOT COMPLETED|Neuroimaging||2||
48639081|NCT02949934|101901563|FG003|NOT COMPLETED|Neuroimaging||0||
48639082|NCT02949934|101901564|FG004|NOT COMPLETED|Neuroimaging||2||
48639083|NCT02949934|101901565|FG005|NOT COMPLETED|Neuroimaging||2||
48639084|NCT02949934|101901560|FG000|STARTED|Bar Laboratory||13|The number of participants who started the bar laboratory on Day 8 is in some cases greater than the number who completed neuroimaging on Day 7. Some participants were not scanned on Day 7 and some had unusable neuroimaging data due to motion, but still started the bar laboratory.|
48639085|NCT02949934|101901561|FG001|STARTED|Bar Laboratory||12|The number of participants who started the bar laboratory on Day 8 is in some cases greater than the number who completed neuroimaging on Day 7. Some participants were not scanned on Day 7 and some had unusable neuroimaging data due to motion, but still started the bar laboratory.|
48639086|NCT02949934|101901562|FG002|STARTED|Bar Laboratory||17|The number of participants who started the bar laboratory on Day 8 is in some cases greater than the number who completed neuroimaging on Day 7. Some participants were not scanned on Day 7 and some had unusable neuroimaging data due to motion, but still started the bar laboratory.|
48639087|NCT02949934|101901563|FG003|STARTED|Bar Laboratory||15|The number of participants who started the bar laboratory on Day 8 is in some cases greater than the number who completed neuroimaging on Day 7. Some participants were not scanned on Day 7 and some had unusable neuroimaging data due to motion, but still started the bar laboratory.|
48639088|NCT02949934|101901564|FG004|STARTED|Bar Laboratory||13|The number of participants who started the bar laboratory on Day 8 is in some cases greater than the number who completed neuroimaging on Day 7. Some participants were not scanned on Day 7 and some had unusable neuroimaging data due to motion, but still started the bar laboratory.|
48639089|NCT02949934|101901565|FG005|STARTED|Bar Laboratory||14|The number of participants who started the bar laboratory on Day 8 is in some cases greater than the number who completed neuroimaging on Day 7. Some participants were not scanned on Day 7 and some had unusable neuroimaging data due to motion, but still started the bar laboratory.|
48639090|NCT02949934|101901560|FG000|COMPLETED|Bar Laboratory||12||
48639091|NCT02949934|101901561|FG001|COMPLETED|Bar Laboratory||7||
48639092|NCT02949934|101901562|FG002|COMPLETED|Bar Laboratory||10||
48639093|NCT02949934|101901563|FG003|COMPLETED|Bar Laboratory||11||
48639094|NCT02949934|101901564|FG004|COMPLETED|Bar Laboratory||7||
48639095|NCT02949934|101901565|FG005|COMPLETED|Bar Laboratory||13||
48639096|NCT02949934|101901560|FG000|NOT COMPLETED|Bar Laboratory||1||
48639097|NCT02949934|101901561|FG001|NOT COMPLETED|Bar Laboratory||5||
48639098|NCT02949934|101901562|FG002|NOT COMPLETED|Bar Laboratory||7||
48764318|NCT00728689|102211928|FG000|NOT COMPLETED|Second Intervention (Days 11 - 13)||0||
48433610|NCT01519635|101397072|FG000|NOT COMPLETED|Overall Study||1||
48433611|NCT01519635|101397073|FG001|NOT COMPLETED|Overall Study||3||
48639099|NCT02949934|101901563|FG003|NOT COMPLETED|Bar Laboratory||4||
48639100|NCT02949934|101901564|FG004|NOT COMPLETED|Bar Laboratory||6||
48639101|NCT02949934|101901565|FG005|NOT COMPLETED|Bar Laboratory||1||
48764319|NCT00728689|102211929|FG001|NOT COMPLETED|Second Intervention (Days 11 - 13)||0||
48764320|NCT03085095|102211930|FG000|STARTED|Overall Study||624||
48764321|NCT03085095|102211931|FG001|STARTED|Overall Study||310||
48764322|NCT03085095|102211930|FG000|Received at Least 1 Dose of Study Drug|Overall Study||622|Four participants (2 in each treatment group) were randomized but did not receive study drug.|
48433612|NCT03965754|101397074|FG000|STARTED|Overall Study||1422|No email bounce information was available, so this number includes all people emailed.|
48639102|NCT03880565|101901566|FG000|STARTED|Overall Study||15||
48639103|NCT03880565|101901567|FG001|STARTED|Overall Study||15||
48639104|NCT03880565|101901566|FG000|COMPLETED|Overall Study||14||
48639105|NCT03880565|101901567|FG001|COMPLETED|Overall Study||15||
48639106|NCT03880565|101901566|FG000|NOT COMPLETED|Overall Study||1||
48639107|NCT03880565|101901567|FG001|NOT COMPLETED|Overall Study||0||
48639108|NCT01063907|101901568|FG000|STARTED|Overall Study||15||
48639109|NCT01063907|101901569|FG001|STARTED|Overall Study||80||
48639110|NCT01063907|101901568|FG000|COMPLETED|Overall Study||15||
48639111|NCT01063907|101901569|FG001|COMPLETED|Overall Study||80||
48639112|NCT01063907|101901568|FG000|NOT COMPLETED|Overall Study||0||
48639113|NCT01063907|101901569|FG001|NOT COMPLETED|Overall Study||0||
48639114|NCT01137786|101901570|FG000|STARTED|Overall Study||25||
48639115|NCT01137786|101901571|FG001|STARTED|Overall Study||24||
48639116|NCT01137786|101901570|FG000|COMPLETED|Overall Study||24||
48639117|NCT01137786|101901571|FG001|COMPLETED|Overall Study||21||
48639118|NCT01137786|101901570|FG000|NOT COMPLETED|Overall Study||1||
48639119|NCT01137786|101901571|FG001|NOT COMPLETED|Overall Study||3||
48639120|NCT03690544|101901572|FG000|STARTED|Overall Study||15||
48639121|NCT03690544|101901572|FG000|COMPLETED|Overall Study||15||
48433613|NCT03965754|101397075|FG001|STARTED|Overall Study||1425|No email bounce information was available, so this number includes all people emailed.|
48187709|NCT04649359|100783089|FG000|STARTED|Overall Study||123||
48187710|NCT04649359|100783090|FG001|STARTED|Overall Study||64||
48187711|NCT04649359|100783089|FG000|COMPLETED|Overall Study||0||
48187712|NCT04649359|100783090|FG001|COMPLETED|Overall Study||0||
48187713|NCT04649359|100783089|FG000|NOT COMPLETED|Overall Study||123||
48187714|NCT04649359|100783090|FG001|NOT COMPLETED|Overall Study||64||
48187715|NCT04060680|100783091|FG000|STARTED|Overall Study||316||
48187716|NCT04060680|100783092|FG001|STARTED|Overall Study||33||
48187717|NCT04060680|100783091|FG000|COMPLETED|Overall Study||292||
48187718|NCT04060680|100783092|FG001|COMPLETED|Overall Study||31||
48187719|NCT04060680|100783091|FG000|NOT COMPLETED|Overall Study||24||
48187720|NCT04060680|100783092|FG001|NOT COMPLETED|Overall Study||2||
48187721|NCT00795132|100783093|FG000|STARTED|Overall Study||47||
48187722|NCT00795132|100783093|FG000|COMPLETED|Overall Study||44||
48187723|NCT00795132|100783093|FG000|NOT COMPLETED|Overall Study||3||
48187724|NCT01125202|100783094|FG000|STARTED|Overall Study||93||
48187725|NCT01125202|100783095|FG001|STARTED|Overall Study||86||
48187726|NCT01125202|100783094|FG000|COMPLETED|Overall Study||81||
48187727|NCT01125202|100783095|FG001|COMPLETED|Overall Study||79||
48187728|NCT01125202|100783094|FG000|NOT COMPLETED|Overall Study||12||
48187729|NCT01125202|100783095|FG001|NOT COMPLETED|Overall Study||7||
48187730|NCT00003377|100783096|FG000|STARTED|Period I||3||
48187731|NCT00003377|100783097|FG001|STARTED|Period I||3||
48361221|NCT01903434|101214297|FG001|NOT COMPLETED|Treatment Period 1||0||
48361222|NCT01903434|101214296|FG000|STARTED|Washout Period 1 (at Least 14 Days)||30||
48361223|NCT01903434|101214297|FG001|STARTED|Washout Period 1 (at Least 14 Days)||30||
48764323|NCT03085095|102211931|FG001|Received at Least 1 Dose of Study Drug|Overall Study||308|Four participants (2 in each treatment group) were randomized but did not receive study drug.|
48764324|NCT03085095|102211930|FG000|COMPLETED|Overall Study||563|Completed 48 weeks of treatment.|
48764325|NCT03085095|102211931|FG001|COMPLETED|Overall Study||276|Completed 48 weeks of treatment.|
48764326|NCT03085095|102211930|FG000|NOT COMPLETED|Overall Study||61||
48764327|NCT03085095|102211931|FG001|NOT COMPLETED|Overall Study||34||
48764328|NCT02220920|102211932|FG000|STARTED|Overall Study||76||
48764329|NCT02220920|102211933|FG001|STARTED|Overall Study||70||
48764330|NCT02220920|102211932|FG000|COMPLETED|Overall Study||73||
48764331|NCT02220920|102211933|FG001|COMPLETED|Overall Study||67||
48361224|NCT01903434|101214296|FG000|COMPLETED|Washout Period 1 (at Least 14 Days)||29||
48361225|NCT01903434|101214297|FG001|COMPLETED|Washout Period 1 (at Least 14 Days)||28||
48361226|NCT01903434|101214296|FG000|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||1||
48361227|NCT01903434|101214297|FG001|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||2||
48361228|NCT01903434|101214296|FG000|STARTED|Treatment Period 2||29||
48433614|NCT03965754|101397076|FG002|STARTED|Overall Study||1425|No email bounce information was available, so this number includes all people emailed.|
48433615|NCT03965754|101397077|FG003|STARTED|Overall Study||1425|No email bounce information was available, so this number includes all people emailed.|
48433616|NCT03965754|101397074|FG000|COMPLETED|Overall Study||1422|Given no bounce information, all emails were considered received, which we counted as completion.|
48361229|NCT01903434|101214297|FG001|STARTED|Treatment Period 2||28||
48361230|NCT01903434|101214296|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||29||
48361231|NCT01903434|101214297|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2||28||
48361232|NCT01903434|101214296|FG000|COMPLETED|Treatment Period 2||29||
48361233|NCT01903434|101214297|FG001|COMPLETED|Treatment Period 2||28||
48361234|NCT01903434|101214296|FG000|NOT COMPLETED|Treatment Period 2||0||
48433617|NCT03965754|101397075|FG001|COMPLETED|Overall Study||1425|Given no bounce information, all emails were considered received, which we counted as completion.|
48433618|NCT03965754|101397076|FG002|COMPLETED|Overall Study||1425|Given no bounce information, all emails were considered received, which we counted as completion.|
48433619|NCT03965754|101397077|FG003|COMPLETED|Overall Study||1425|Given no bounce information, all emails were considered received, which we counted as completion.|
48433620|NCT03965754|101397074|FG000|NOT COMPLETED|Overall Study||0||
48764332|NCT02220920|102211932|FG000|NOT COMPLETED|Overall Study||3||
48764333|NCT02220920|102211933|FG001|NOT COMPLETED|Overall Study||3||
48764334|NCT02151058|102211934|FG000|STARTED|Overall Study||45||
48187732|NCT00003377|100783098|FG002|STARTED|Period I||3||
48187733|NCT00003377|100783099|FG003|STARTED|Period I||3||
48187734|NCT00003377|100783100|FG004|STARTED|Period I||0||
48187735|NCT00003377|100783096|FG000|COMPLETED|Period I||3||
48187736|NCT00003377|100783097|FG001|COMPLETED|Period I||3||
48187737|NCT00003377|100783098|FG002|COMPLETED|Period I||2||
48187738|NCT00003377|100783099|FG003|COMPLETED|Period I||2||
48187739|NCT00003377|100783100|FG004|COMPLETED|Period I||0||
48361235|NCT01903434|101214297|FG001|NOT COMPLETED|Treatment Period 2||0||
48361236|NCT01903434|101214296|FG000|STARTED|Washout Period 1 (at Least 14 Days)||29||
48361237|NCT01903434|101214297|FG001|STARTED|Washout Period 1 (at Least 14 Days)||28||
48361238|NCT01903434|101214296|FG000|COMPLETED|Washout Period 1 (at Least 14 Days)||29||
48361239|NCT01903434|101214297|FG001|COMPLETED|Washout Period 1 (at Least 14 Days)||28||
48187740|NCT00003377|100783096|FG000|NOT COMPLETED|Period I||0||
48187741|NCT00003377|100783097|FG001|NOT COMPLETED|Period I||0||
48187742|NCT00003377|100783098|FG002|NOT COMPLETED|Period I||1||
48187743|NCT00003377|100783099|FG003|NOT COMPLETED|Period I||1||
48187744|NCT00003377|100783100|FG004|NOT COMPLETED|Period I||0||
48187745|NCT00003377|100783096|FG000|STARTED|Period II||0||
48187746|NCT00003377|100783097|FG001|STARTED|Period II||0||
48187747|NCT00003377|100783098|FG002|STARTED|Period II||0||
48187748|NCT00003377|100783099|FG003|STARTED|Period II||0||
48187749|NCT00003377|100783100|FG004|STARTED|Period II||17||
48187750|NCT00003377|100783096|FG000|COMPLETED|Period II||0||
48187751|NCT00003377|100783097|FG001|COMPLETED|Period II||0||
48187752|NCT00003377|100783098|FG002|COMPLETED|Period II||0||
48187753|NCT00003377|100783099|FG003|COMPLETED|Period II||0||
48187754|NCT00003377|100783100|FG004|COMPLETED|Period II||16||
48187755|NCT00003377|100783096|FG000|NOT COMPLETED|Period II||0||
48187756|NCT00003377|100783097|FG001|NOT COMPLETED|Period II||0||
48187757|NCT00003377|100783098|FG002|NOT COMPLETED|Period II||0||
48187758|NCT00003377|100783099|FG003|NOT COMPLETED|Period II||0||
48187759|NCT00003377|100783100|FG004|NOT COMPLETED|Period II||1||
48187760|NCT01427907|100783101|FG000|STARTED|Overall Study||20||
48187761|NCT01427907|100783102|FG001|STARTED|Overall Study||18||
48187762|NCT01427907|100783101|FG000|COMPLETED|Overall Study||17||
48187763|NCT01427907|100783102|FG001|COMPLETED|Overall Study||14||
48187764|NCT01427907|100783101|FG000|NOT COMPLETED|Overall Study||3||
48187765|NCT01427907|100783102|FG001|NOT COMPLETED|Overall Study||4||
48187766|NCT00430677|100783103|FG000|STARTED|Short-term Period||99||
48187767|NCT00430677|100783104|FG001|STARTED|Short-term Period||99||
48187768|NCT00430677|100783105|FG002|STARTED|Short-term Period||100||
48187769|NCT00430677|100783103|FG000|COMPLETED|Short-term Period||76||
48187770|NCT00430677|100783104|FG001|COMPLETED|Short-term Period||74||
48187771|NCT00430677|100783105|FG002|COMPLETED|Short-term Period||78||
48187772|NCT00430677|100783103|FG000|NOT COMPLETED|Short-term Period||23||
48187773|NCT00430677|100783104|FG001|NOT COMPLETED|Short-term Period||25||
48187774|NCT00430677|100783105|FG002|NOT COMPLETED|Short-term Period||22||
48187775|NCT00430677|100783103|FG000|STARTED|Long-term Extension Period||70||
48187776|NCT00430677|100783104|FG001|STARTED|Long-term Extension Period||67||
48187777|NCT00430677|100783105|FG002|STARTED|Long-term Extension Period||74||
48187778|NCT00430677|100783103|FG000|COMPLETED|Long-term Extension Period||10||
48187779|NCT00430677|100783104|FG001|COMPLETED|Long-term Extension Period||9||
48187780|NCT00430677|100783105|FG002|COMPLETED|Long-term Extension Period||11||
48361240|NCT01903434|101214296|FG000|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0||
48361241|NCT01903434|101214297|FG001|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0||
48361242|NCT01903434|101214296|FG000|STARTED|Treatment Period 3||29||
48361243|NCT01903434|101214297|FG001|STARTED|Treatment Period 3||28||
48361244|NCT01903434|101214296|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 3||29||
48361245|NCT01903434|101214297|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 3||28||
48187781|NCT00430677|100783103|FG000|NOT COMPLETED|Long-term Extension Period||60||
48187782|NCT00430677|100783104|FG001|NOT COMPLETED|Long-term Extension Period||58||
48187783|NCT00430677|100783105|FG002|NOT COMPLETED|Long-term Extension Period||63||
48187784|NCT01253200|100783106|FG000|STARTED|Overall Study||125||
48187785|NCT01253200|100783107|FG001|STARTED|Overall Study||125||
48187786|NCT01253200|100783108|FG002|STARTED|Overall Study||30||
48187787|NCT01253200|100783109|FG003|STARTED|Overall Study||17||
48433621|NCT03965754|101397075|FG001|NOT COMPLETED|Overall Study||0||
48639122|NCT03690544|101901572|FG000|NOT COMPLETED|Overall Study||0||
48187788|NCT01253200|100783110|FG004|STARTED|Overall Study||5||
48187789|NCT01253200|100783106|FG000|Procedure|Overall Study||109||
48187790|NCT01253200|100783107|FG001|Procedure|Overall Study||111||
48187791|NCT01253200|100783108|FG002|Procedure|Overall Study||28||
48361246|NCT01903434|101214296|FG000|COMPLETED|Treatment Period 3||29||
48187792|NCT01253200|100783109|FG003|Procedure|Overall Study||12||
48187793|NCT01253200|100783110|FG004|Procedure|Overall Study||0||
48187794|NCT01253200|100783106|FG000|10 Day Follow-up|Overall Study||106||
48187795|NCT01253200|100783107|FG001|10 Day Follow-up|Overall Study||111||
48187796|NCT01253200|100783108|FG002|10 Day Follow-up|Overall Study||28||
48187797|NCT01253200|100783109|FG003|10 Day Follow-up|Overall Study||12||
48187798|NCT01253200|100783110|FG004|10 Day Follow-up|Overall Study||0||
48187799|NCT01253200|100783106|FG000|3 Month Follow-up|Overall Study||104||
48187800|NCT01253200|100783107|FG001|3 Month Follow-up|Overall Study||106||
48187801|NCT01253200|100783108|FG002|3 Month Follow-up|Overall Study||28||
48187802|NCT01253200|100783109|FG003|3 Month Follow-up|Overall Study||12||
48187803|NCT01253200|100783110|FG004|3 Month Follow-up|Overall Study||0||
48187804|NCT01253200|100783106|FG000|COMPLETED|Overall Study||104||
48361247|NCT01903434|101214297|FG001|COMPLETED|Treatment Period 3||28||
48361248|NCT01903434|101214296|FG000|NOT COMPLETED|Treatment Period 3||0||
48361249|NCT01903434|101214297|FG001|NOT COMPLETED|Treatment Period 3||0||
48361250|NCT00306891|101214298|FG000|STARTED|Part A||23||
48187805|NCT01253200|100783107|FG001|COMPLETED|Overall Study||106||
48187806|NCT01253200|100783108|FG002|COMPLETED|Overall Study||28||
48187807|NCT01253200|100783109|FG003|COMPLETED|Overall Study||12||
48187808|NCT01253200|100783110|FG004|COMPLETED|Overall Study||0||
48187809|NCT01253200|100783106|FG000|NOT COMPLETED|Overall Study||21||
48187810|NCT01253200|100783107|FG001|NOT COMPLETED|Overall Study||19||
48187811|NCT01253200|100783108|FG002|NOT COMPLETED|Overall Study||2||
48187812|NCT01253200|100783109|FG003|NOT COMPLETED|Overall Study||5||
48187813|NCT01253200|100783110|FG004|NOT COMPLETED|Overall Study||5||
48187814|NCT01939938|100783111|FG000|STARTED|Overall Study||10||
48361251|NCT00306891|101214299|FG001|STARTED|Part A||22||
48187815|NCT01939938|100783111|FG000|COMPLETED|Overall Study||10||
48187816|NCT01939938|100783111|FG000|NOT COMPLETED|Overall Study||0||
48187817|NCT02783482|100783112|FG000|STARTED|Overall Study||29||
48187818|NCT02783482|100783113|FG001|STARTED|Overall Study||20||
48187819|NCT02783482|100783112|FG000|COMPLETED|Overall Study||24||
48187820|NCT02783482|100783113|FG001|COMPLETED|Overall Study||19||
48187821|NCT02783482|100783112|FG000|NOT COMPLETED|Overall Study||5||
48187822|NCT02783482|100783113|FG001|NOT COMPLETED|Overall Study||1||
48187823|NCT02338609|100783114|FG000|STARTED|Overall Study||15||
48187824|NCT02338609|100783114|FG000|Safety Analysis Set|Overall Study||14|All pediatric participants enrolled in this study who had at least one-post baseline safety assessment.|
48187825|NCT02338609|100783114|FG000|COMPLETED|Overall Study||13||
48187826|NCT02338609|100783114|FG000|NOT COMPLETED|Overall Study||2||
48187827|NCT02243007|100783115|FG000|STARTED|Overall Study||4||
48187828|NCT02243007|100783116|FG001|STARTED|Overall Study||3||
48187829|NCT02243007|100783115|FG000|COMPLETED|Overall Study||4||
48187830|NCT02243007|100783116|FG001|COMPLETED|Overall Study||3||
48187831|NCT02243007|100783115|FG000|NOT COMPLETED|Overall Study||0||
48187832|NCT02243007|100783116|FG001|NOT COMPLETED|Overall Study||0||
48187833|NCT01275053|100783117|FG000|STARTED|Overall Study||12||
48187834|NCT01275053|100783117|FG000|COMPLETED|Overall Study||12||
48187835|NCT01275053|100783117|FG000|NOT COMPLETED|Overall Study||0||
48187836|NCT04129580|100783118|FG000|STARTED|Overall Study||48||
48187837|NCT04129580|100783119|FG001|STARTED|Overall Study||52||
48187838|NCT04129580|100783118|FG000|COMPLETED|Overall Study||34||
48187839|NCT04129580|100783119|FG001|COMPLETED|Overall Study||27||
48187840|NCT04129580|100783118|FG000|NOT COMPLETED|Overall Study||14||
48187841|NCT04129580|100783119|FG001|NOT COMPLETED|Overall Study||25||
48187842|NCT00480441|100783120|FG000|STARTED|Screening||61||
48187843|NCT00480441|100783121|FG001|STARTED|Screening||0||
48187844|NCT00480441|100783122|FG002|STARTED|Screening||0||
48187845|NCT00480441|100783120|FG000|COMPLETED|Screening||24||
48187846|NCT00480441|100783121|FG001|COMPLETED|Screening||0||
48187847|NCT00480441|100783122|FG002|COMPLETED|Screening||0||
48187848|NCT00480441|100783120|FG000|NOT COMPLETED|Screening||37||
48187849|NCT00480441|100783121|FG001|NOT COMPLETED|Screening||0||
48187850|NCT00480441|100783122|FG002|NOT COMPLETED|Screening||0||
48187851|NCT00480441|100783120|FG000|STARTED|Baseline Functional MRI||24||
48187852|NCT00480441|100783121|FG001|STARTED|Baseline Functional MRI||0||
48187853|NCT00480441|100783122|FG002|STARTED|Baseline Functional MRI||0||
48361252|NCT00306891|101214300|FG002|STARTED|Part A||0||
48361253|NCT00306891|101214301|FG003|STARTED|Part A||0||
48361254|NCT00306891|101214298|FG000|COMPLETED|Part A||18||
48361255|NCT00306891|101214299|FG001|COMPLETED|Part A||16||
48361256|NCT00306891|101214300|FG002|COMPLETED|Part A||0||
48361257|NCT00306891|101214301|FG003|COMPLETED|Part A||0||
48361258|NCT00306891|101214298|FG000|NOT COMPLETED|Part A||5||
48361259|NCT00306891|101214299|FG001|NOT COMPLETED|Part A||6||
48187854|NCT00480441|100783120|FG000|COMPLETED|Baseline Functional MRI||12||
48187855|NCT00480441|100783121|FG001|COMPLETED|Baseline Functional MRI||0||
48187856|NCT00480441|100783122|FG002|COMPLETED|Baseline Functional MRI||0||
48764335|NCT02151058|102211935|FG001|STARTED|Overall Study||91||
48764336|NCT02151058|102211936|FG002|STARTED|Overall Study||91||
48764337|NCT02151058|102211934|FG000|COMPLETED|Overall Study||43||
48764338|NCT02151058|102211935|FG001|COMPLETED|Overall Study||90||
48764339|NCT02151058|102211936|FG002|COMPLETED|Overall Study||86||
48764340|NCT02151058|102211934|FG000|NOT COMPLETED|Overall Study||2||
48764341|NCT02151058|102211935|FG001|NOT COMPLETED|Overall Study||1||
48764342|NCT02151058|102211936|FG002|NOT COMPLETED|Overall Study||5||
48764343|NCT04223479|102211937|FG000|STARTED|Overall Study||16||
48187857|NCT00480441|100783120|FG000|NOT COMPLETED|Baseline Functional MRI||12||
48187858|NCT00480441|100783121|FG001|NOT COMPLETED|Baseline Functional MRI||0||
48187859|NCT00480441|100783122|FG002|NOT COMPLETED|Baseline Functional MRI||0||
48187860|NCT00480441|100783120|FG000|STARTED|Randomization||0||
48187861|NCT00480441|100783121|FG001|STARTED|Randomization||13||
48187862|NCT00480441|100783122|FG002|STARTED|Randomization||11||
48187863|NCT00480441|100783120|FG000|COMPLETED|Randomization||0||
48187864|NCT00480441|100783121|FG001|COMPLETED|Randomization||6||
48187865|NCT00480441|100783122|FG002|COMPLETED|Randomization||9||
48187866|NCT00480441|100783120|FG000|NOT COMPLETED|Randomization||0||
48187867|NCT00480441|100783121|FG001|NOT COMPLETED|Randomization||7||
48187868|NCT00480441|100783122|FG002|NOT COMPLETED|Randomization||2||
48187869|NCT01253980|100783123|FG000|STARTED|Overall Study||35||
48187870|NCT01253980|100783124|FG001|STARTED|Overall Study||39||
48187871|NCT01253980|100783123|FG000|COMPLETED|Overall Study||35||
48361260|NCT00306891|101214300|FG002|NOT COMPLETED|Part A||0||
48361261|NCT00306891|101214301|FG003|NOT COMPLETED|Part A||0||
48361262|NCT00306891|101214298|FG000|STARTED|Part B||0||
48361263|NCT00306891|101214299|FG001|STARTED|Part B||0||
48361264|NCT00306891|101214300|FG002|STARTED|Part B||16||
48361265|NCT00306891|101214301|FG003|STARTED|Part B||31||
48433622|NCT03965754|101397076|FG002|NOT COMPLETED|Overall Study||0||
48361266|NCT00306891|101214298|FG000|COMPLETED|Part B||0||
48361267|NCT00306891|101214299|FG001|COMPLETED|Part B||0||
48361268|NCT00306891|101214300|FG002|COMPLETED|Part B||5||
48764344|NCT04223479|102211938|FG001|STARTED|Overall Study||14||
48764345|NCT04223479|102211937|FG000|COMPLETED|Overall Study||12||
48764346|NCT04223479|102211938|FG001|COMPLETED|Overall Study||12||
48639123|NCT01056536|101901573|FG000|STARTED|Overall Study||596||
48639124|NCT01056536|101901574|FG001|STARTED|Overall Study||356||
48639125|NCT01056536|101901575|FG002|STARTED|Overall Study||729||
48639126|NCT01056536|101901573|FG000|COMPLETED|Overall Study||394||
48639127|NCT01056536|101901574|FG001|COMPLETED|Overall Study||240||
48639128|NCT01056536|101901575|FG002|COMPLETED|Overall Study||481||
48639129|NCT01056536|101901573|FG000|NOT COMPLETED|Overall Study||202||
48639130|NCT01056536|101901574|FG001|NOT COMPLETED|Overall Study||116||
48639131|NCT01056536|101901575|FG002|NOT COMPLETED|Overall Study||248||
48639132|NCT02508389|101901576|FG000|STARTED|Overall Study||73||
48639133|NCT02508389|101901577|FG001|STARTED|Overall Study||76||
48639134|NCT02508389|101901578|FG002|STARTED|Overall Study||74||
48433623|NCT03965754|101397077|FG003|NOT COMPLETED|Overall Study||0||
48433624|NCT02687815|101397078|FG000|STARTED|Overall Study||96||
48433625|NCT02687815|101397079|FG001|STARTED|Overall Study||96||
48433626|NCT02687815|101397078|FG000|COMPLETED|Overall Study||92||
48433627|NCT02687815|101397079|FG001|COMPLETED|Overall Study||88||
48433628|NCT02687815|101397078|FG000|NOT COMPLETED|Overall Study||4||
48433629|NCT02687815|101397079|FG001|NOT COMPLETED|Overall Study||8||
48433630|NCT01778296|101397080|FG000|STARTED|Overall Study||12||
48433631|NCT01778296|101397080|FG000|COMPLETED|Overall Study||12||
48433632|NCT01778296|101397080|FG000|NOT COMPLETED|Overall Study||0||
48433633|NCT02392377|101397081|FG000|STARTED|Overall Study||0||
48433634|NCT02392377|101397082|FG001|STARTED|Overall Study||1||
48433635|NCT02392377|101397081|FG000|COMPLETED|Overall Study||0||
48433636|NCT02392377|101397082|FG001|COMPLETED|Overall Study||0||
48433637|NCT02392377|101397081|FG000|NOT COMPLETED|Overall Study||0||
48433638|NCT02392377|101397082|FG001|NOT COMPLETED|Overall Study||1||
48433639|NCT02379442|101397083|FG000|STARTED|Overall Study||1||
48433640|NCT02379442|101397083|FG000|COMPLETED|Overall Study||1||
48433641|NCT02379442|101397083|FG000|NOT COMPLETED|Overall Study||0||
48433642|NCT03732534|101397084|FG000|STARTED|Overall Study||6||
48433643|NCT03732534|101397084|FG000|COMPLETED|Overall Study||0||
48433644|NCT03732534|101397084|FG000|NOT COMPLETED|Overall Study||6||
48433645|NCT01683565|101397085|FG000|STARTED|Overall Study||15||
48433646|NCT01683565|101397086|FG001|STARTED|Overall Study||16||
48433647|NCT01683565|101397085|FG000|COMPLETED|Overall Study||12||
48433648|NCT01683565|101397086|FG001|COMPLETED|Overall Study||15||
48433649|NCT01683565|101397085|FG000|NOT COMPLETED|Overall Study||3||
48433650|NCT01683565|101397086|FG001|NOT COMPLETED|Overall Study||1||
48639135|NCT02508389|101901576|FG000|COMPLETED|Overall Study||45||
48639136|NCT02508389|101901577|FG001|COMPLETED|Overall Study||45||
48764347|NCT04223479|102211937|FG000|NOT COMPLETED|Overall Study||4||
48764348|NCT04223479|102211938|FG001|NOT COMPLETED|Overall Study||2||
48764349|NCT00914849|102211939|FG000|STARTED|Overall Study||34||
48764350|NCT00914849|102211940|FG001|STARTED|Overall Study||34||
48764351|NCT00914849|102211939|FG000|COMPLETED|Overall Study||33||
48764352|NCT00914849|102211940|FG001|COMPLETED|Overall Study||33||
48639137|NCT02508389|101901578|FG002|COMPLETED|Overall Study||42||
48639138|NCT02508389|101901576|FG000|NOT COMPLETED|Overall Study||28||
48639139|NCT02508389|101901577|FG001|NOT COMPLETED|Overall Study||31||
48639140|NCT02508389|101901578|FG002|NOT COMPLETED|Overall Study||32||
48639141|NCT00303953|101901579|FG000|STARTED|Overall Study||22||
48639142|NCT00303953|101901579|FG000|Eligible|Overall Study||21||
48639143|NCT00303953|101901579|FG000|Eligible and Treated|Overall Study||20||
48639144|NCT00303953|101901579|FG000|COMPLETED|Overall Study||3||
48639145|NCT00303953|101901579|FG000|NOT COMPLETED|Overall Study||19||
48639146|NCT01980888|101901580|FG000|STARTED|Overall Study||157||
48639147|NCT01980888|101901581|FG001|STARTED|Overall Study||154||
48639148|NCT01980888|101901580|FG000|COMPLETED|Overall Study||13||
48639149|NCT01980888|101901581|FG001|COMPLETED|Overall Study||21||
48764353|NCT00914849|102211939|FG000|NOT COMPLETED|Overall Study||1||
48433651|NCT02689973|101397087|FG000|STARTED|Overall Study||311||
48639150|NCT01980888|101901580|FG000|NOT COMPLETED|Overall Study||144||
48433652|NCT02689973|101397088|FG001|STARTED|Overall Study||270||
48433653|NCT02689973|101397089|FG002|STARTED|Overall Study||351||
48433654|NCT02689973|101397090|FG003|STARTED|Overall Study||285||
48433655|NCT02689973|101397087|FG000|COMPLETED|Overall Study||257||
48433656|NCT02689973|101397088|FG001|COMPLETED|Overall Study||221||
48433657|NCT02689973|101397089|FG002|COMPLETED|Overall Study||279||
48433658|NCT02689973|101397090|FG003|COMPLETED|Overall Study||232||
48433659|NCT02689973|101397087|FG000|NOT COMPLETED|Overall Study||54||
48639151|NCT01980888|101901581|FG001|NOT COMPLETED|Overall Study||133||
48639152|NCT01807455|101901582|FG000|STARTED|Overall Study||12||
48639153|NCT01807455|101901582|FG000|COMPLETED|Overall Study||12||
48639154|NCT01807455|101901582|FG000|NOT COMPLETED|Overall Study||0||
48639155|NCT01767415|101901583|FG000|STARTED|Overall Study||10||
48639156|NCT01767415|101901583|FG000|COMPLETED|Overall Study||10||
48639157|NCT01767415|101901583|FG000|NOT COMPLETED|Overall Study||0||
48639158|NCT00915525|101901584|FG000|STARTED|Overall Study||543||
48764354|NCT00914849|102211940|FG001|NOT COMPLETED|Overall Study||1||
48764355|NCT00723736|102211941|FG000|STARTED|Overall Study||100||
48764356|NCT00723736|102211941|FG000|COMPLETED|Overall Study||99||
48639159|NCT00915525|101901585|FG001|STARTED|Overall Study||286||
48639160|NCT00915525|101901584|FG000|COMPLETED|Overall Study||278||
48639161|NCT00915525|101901585|FG001|COMPLETED|Overall Study||151||
48639162|NCT00915525|101901584|FG000|NOT COMPLETED|Overall Study||265||
48639163|NCT00915525|101901585|FG001|NOT COMPLETED|Overall Study||135||
48639164|NCT00818272|101901586|FG000|STARTED|Overall Study||148||
48639165|NCT00818272|101901586|FG000|COMPLETED|Overall Study||74||
48639166|NCT00818272|101901586|FG000|NOT COMPLETED|Overall Study||74||
48639167|NCT00975923|101901587|FG000|STARTED|Overall Study||30||
48639168|NCT00975923|101901588|FG001|STARTED|Overall Study||30||
48639169|NCT00975923|101901587|FG000|COMPLETED|Overall Study||30||
48639170|NCT00975923|101901588|FG001|COMPLETED|Overall Study||29||
48639171|NCT00975923|101901587|FG000|NOT COMPLETED|Overall Study||0||
48639172|NCT00975923|101901588|FG001|NOT COMPLETED|Overall Study||1||
48639173|NCT00250484|101901589|FG000|STARTED|Overall Study||9||
48639174|NCT00250484|101901590|FG001|STARTED|Overall Study||8||
48639175|NCT00250484|101901589|FG000|COMPLETED|Overall Study||9||
48639176|NCT00250484|101901590|FG001|COMPLETED|Overall Study||8||
48639177|NCT00250484|101901589|FG000|NOT COMPLETED|Overall Study||0||
48639178|NCT00250484|101901590|FG001|NOT COMPLETED|Overall Study||0||
48639179|NCT01044498|101901591|FG000|STARTED|Overall Study||23||
48639180|NCT01044498|101901592|FG001|STARTED|Overall Study||23||
48639181|NCT01044498|101901591|FG000|COMPLETED|Overall Study||20||
48639182|NCT01044498|101901592|FG001|COMPLETED|Overall Study||21||
48639183|NCT01044498|101901591|FG000|NOT COMPLETED|Overall Study||3||
48639184|NCT01044498|101901592|FG001|NOT COMPLETED|Overall Study||2||
48639185|NCT04298853|101901593|FG000|STARTED|Overall Study||9||
48639186|NCT04298853|101901594|FG001|STARTED|Overall Study||8||
48639187|NCT04298853|101901593|FG000|COMPLETED|Overall Study||9||
48639188|NCT04298853|101901594|FG001|COMPLETED|Overall Study||8||
48639189|NCT04298853|101901593|FG000|NOT COMPLETED|Overall Study||0||
48639190|NCT04298853|101901594|FG001|NOT COMPLETED|Overall Study||0||
48639191|NCT02471183|101901595|FG000|STARTED|Main Treatment Period||34||
48639192|NCT02471183|101901595|FG000|COMPLETED|Main Treatment Period||32||
48639193|NCT02471183|101901595|FG000|NOT COMPLETED|Main Treatment Period||2||
48639194|NCT02471183|101901595|FG000|STARTED|Extended Treatment Period||32||
48639195|NCT02471183|101901595|FG000|COMPLETED|Extended Treatment Period||31||
48639196|NCT02471183|101901595|FG000|NOT COMPLETED|Extended Treatment Period||1||
48639197|NCT01500083|101901596|FG000|STARTED|Overall Study||16||
48639198|NCT01500083|101901597|FG001|STARTED|Overall Study||74||
48639199|NCT01500083|101901596|FG000|COMPLETED|Overall Study||4||
48639200|NCT01500083|101901597|FG001|COMPLETED|Overall Study||31||
48639201|NCT01500083|101901596|FG000|NOT COMPLETED|Overall Study||12||
48639202|NCT01500083|101901597|FG001|NOT COMPLETED|Overall Study||43||
48639203|NCT02115386|101901598|FG000|STARTED|Overall Study||7||
48639204|NCT02115386|101901598|FG000|COMPLETED|Overall Study||0||
48639205|NCT02115386|101901598|FG000|NOT COMPLETED|Overall Study||7||
48639206|NCT00090103|101901599|FG000|STARTED|Four-Year Double-Blind Treatment Period||1610||
48639207|NCT00090103|101901600|FG001|STARTED|Four-Year Double-Blind Treatment Period||1623||
48639208|NCT00090103|101901601|FG002|STARTED|Four-Year Double-Blind Treatment Period||1611||
48639209|NCT00090103|101901599|FG000|COMPLETED|Four-Year Double-Blind Treatment Period||1113||
48639210|NCT00090103|101901600|FG001|COMPLETED|Four-Year Double-Blind Treatment Period||1093||
48639211|NCT00090103|101901601|FG002|COMPLETED|Four-Year Double-Blind Treatment Period||989||
48639212|NCT00090103|101901599|FG000|NOT COMPLETED|Four-Year Double-Blind Treatment Period||497||
48639213|NCT00090103|101901600|FG001|NOT COMPLETED|Four-Year Double-Blind Treatment Period||530||
48639214|NCT00090103|101901601|FG002|NOT COMPLETED|Four-Year Double-Blind Treatment Period||622||
48639215|NCT00090103|101901599|FG000|STARTED|16-Week Safety Follow-up Period||1598||
48639216|NCT00090103|101901600|FG001|STARTED|16-Week Safety Follow-up Period||1615||
48639217|NCT00090103|101901601|FG002|STARTED|16-Week Safety Follow-up Period||1600||
48639218|NCT00090103|101901599|FG000|COMPLETED|16-Week Safety Follow-up Period||1224||
48639219|NCT00090103|101901600|FG001|COMPLETED|16-Week Safety Follow-up Period||1205||
48639220|NCT00090103|101901601|FG002|COMPLETED|16-Week Safety Follow-up Period||1143||
48639221|NCT00090103|101901599|FG000|NOT COMPLETED|16-Week Safety Follow-up Period||374||
48639222|NCT00090103|101901600|FG001|NOT COMPLETED|16-Week Safety Follow-up Period||410||
48639223|NCT00090103|101901601|FG002|NOT COMPLETED|16-Week Safety Follow-up Period||457||
48639224|NCT05067270|101901602|FG000|STARTED|Period 1||8||
48639225|NCT05067270|101901603|FG001|STARTED|Period 1||8||
48639226|NCT05067270|101901604|FG002|STARTED|Period 1||8||
48639227|NCT05067270|101901605|FG003|STARTED|Period 1||8||
48639228|NCT05067270|101901606|FG004|STARTED|Period 1||8||
48639229|NCT05067270|101901602|FG000|Received At Least One Infusion|Period 1||8||
48639230|NCT05067270|101901603|FG001|Received At Least One Infusion|Period 1||8||
48639231|NCT05067270|101901604|FG002|Received At Least One Infusion|Period 1||8||
48639232|NCT05067270|101901605|FG003|Received At Least One Infusion|Period 1||8||
48639233|NCT05067270|101901606|FG004|Received At Least One Infusion|Period 1||8||
48639234|NCT05067270|101901602|FG000|COMPLETED|Period 1||8||
48639235|NCT05067270|101901603|FG001|COMPLETED|Period 1||8||
48639236|NCT05067270|101901604|FG002|COMPLETED|Period 1||8||
48639237|NCT05067270|101901605|FG003|COMPLETED|Period 1||8||
48639238|NCT05067270|101901606|FG004|COMPLETED|Period 1||8||
48639239|NCT05067270|101901602|FG000|NOT COMPLETED|Period 1||0||
48639240|NCT05067270|101901603|FG001|NOT COMPLETED|Period 1||0||
48639241|NCT05067270|101901604|FG002|NOT COMPLETED|Period 1||0||
48639242|NCT05067270|101901605|FG003|NOT COMPLETED|Period 1||0||
48639243|NCT05067270|101901606|FG004|NOT COMPLETED|Period 1||0||
48639244|NCT05067270|101901602|FG000|STARTED|Period 2||8||
48639245|NCT05067270|101901603|FG001|STARTED|Period 2||8||
48639246|NCT05067270|101901604|FG002|STARTED|Period 2||8||
48639247|NCT05067270|101901605|FG003|STARTED|Period 2||8||
48639248|NCT05067270|101901606|FG004|STARTED|Period 2||8||
48639249|NCT05067270|101901602|FG000|Received At Least One Infusion|Period 2||8||
48639250|NCT05067270|101901603|FG001|Received At Least One Infusion|Period 2||8||
48639251|NCT05067270|101901604|FG002|Received At Least One Infusion|Period 2||8||
48639252|NCT05067270|101901605|FG003|Received At Least One Infusion|Period 2||8||
48639253|NCT05067270|101901606|FG004|Received At Least One Infusion|Period 2||8||
48639254|NCT05067270|101901602|FG000|COMPLETED|Period 2||8||
48639255|NCT05067270|101901603|FG001|COMPLETED|Period 2||8||
48639256|NCT05067270|101901604|FG002|COMPLETED|Period 2||8||
48639257|NCT05067270|101901605|FG003|COMPLETED|Period 2||8||
48639258|NCT05067270|101901606|FG004|COMPLETED|Period 2||8||
48639259|NCT05067270|101901602|FG000|NOT COMPLETED|Period 2||0||
48639260|NCT05067270|101901603|FG001|NOT COMPLETED|Period 2||0||
48639261|NCT05067270|101901604|FG002|NOT COMPLETED|Period 2||0||
48639262|NCT05067270|101901605|FG003|NOT COMPLETED|Period 2||0||
48639263|NCT05067270|101901606|FG004|NOT COMPLETED|Period 2||0||
48639264|NCT05067270|101901602|FG000|STARTED|Period 3||8||
48639265|NCT05067270|101901603|FG001|STARTED|Period 3||8||
48639266|NCT05067270|101901604|FG002|STARTED|Period 3||8||
48639267|NCT05067270|101901605|FG003|STARTED|Period 3||8||
48639268|NCT05067270|101901606|FG004|STARTED|Period 3||8||
48639269|NCT05067270|101901602|FG000|Received At Least One Infusion|Period 3||8||
48639270|NCT05067270|101901603|FG001|Received At Least One Infusion|Period 3||8||
48639271|NCT05067270|101901604|FG002|Received At Least One Infusion|Period 3||8||
48639272|NCT05067270|101901605|FG003|Received At Least One Infusion|Period 3||8||
48639273|NCT05067270|101901606|FG004|Received At Least One Infusion|Period 3||8||
48639274|NCT05067270|101901602|FG000|COMPLETED|Period 3||8||
48639275|NCT05067270|101901603|FG001|COMPLETED|Period 3||8||
48639276|NCT05067270|101901604|FG002|COMPLETED|Period 3||8||
48639277|NCT05067270|101901605|FG003|COMPLETED|Period 3||8||
48639278|NCT05067270|101901606|FG004|COMPLETED|Period 3||8||
48639279|NCT05067270|101901602|FG000|NOT COMPLETED|Period 3||0||
48639280|NCT05067270|101901603|FG001|NOT COMPLETED|Period 3||0||
48639281|NCT05067270|101901604|FG002|NOT COMPLETED|Period 3||0||
48639282|NCT05067270|101901605|FG003|NOT COMPLETED|Period 3||0||
48639283|NCT05067270|101901606|FG004|NOT COMPLETED|Period 3||0||
48639284|NCT05067270|101901602|FG000|STARTED|Period 4||8||
48639285|NCT05067270|101901603|FG001|STARTED|Period 4||8||
48639286|NCT05067270|101901604|FG002|STARTED|Period 4||8||
48639287|NCT05067270|101901605|FG003|STARTED|Period 4||8||
48639288|NCT05067270|101901606|FG004|STARTED|Period 4||8||
48639289|NCT05067270|101901602|FG000|Received At Least One Infusion|Period 4||8||
48639290|NCT05067270|101901603|FG001|Received At Least One Infusion|Period 4||8||
48639291|NCT05067270|101901604|FG002|Received At Least One Infusion|Period 4||8||
48639292|NCT05067270|101901605|FG003|Received At Least One Infusion|Period 4||8||
48639293|NCT05067270|101901606|FG004|Received At Least One Infusion|Period 4||8||
48639294|NCT05067270|101901602|FG000|COMPLETED|Period 4||8||
48639295|NCT05067270|101901603|FG001|COMPLETED|Period 4||8||
48639296|NCT05067270|101901604|FG002|COMPLETED|Period 4||8||
48639297|NCT05067270|101901605|FG003|COMPLETED|Period 4||8||
48639298|NCT05067270|101901606|FG004|COMPLETED|Period 4||8||
48639299|NCT05067270|101901602|FG000|NOT COMPLETED|Period 4||0||
48639300|NCT05067270|101901603|FG001|NOT COMPLETED|Period 4||0||
48639301|NCT05067270|101901604|FG002|NOT COMPLETED|Period 4||0||
48639302|NCT05067270|101901605|FG003|NOT COMPLETED|Period 4||0||
48639303|NCT05067270|101901606|FG004|NOT COMPLETED|Period 4||0||
48639304|NCT05067270|101901602|FG000|STARTED|Period 5||8||
48639305|NCT05067270|101901603|FG001|STARTED|Period 5||8||
48639306|NCT05067270|101901604|FG002|STARTED|Period 5||8||
48639307|NCT05067270|101901605|FG003|STARTED|Period 5||8||
48639308|NCT05067270|101901606|FG004|STARTED|Period 5||8||
48639309|NCT05067270|101901602|FG000|Received At Least One Infusion|Period 5||8||
48639310|NCT05067270|101901603|FG001|Received At Least One Infusion|Period 5||8||
48639311|NCT05067270|101901604|FG002|Received At Least One Infusion|Period 5||8||
48639312|NCT05067270|101901605|FG003|Received At Least One Infusion|Period 5||8||
48639313|NCT05067270|101901606|FG004|Received At Least One Infusion|Period 5||8||
48639314|NCT05067270|101901602|FG000|COMPLETED|Period 5||8||
48639315|NCT05067270|101901603|FG001|COMPLETED|Period 5||8||
48639316|NCT05067270|101901604|FG002|COMPLETED|Period 5||8||
48639317|NCT05067270|101901605|FG003|COMPLETED|Period 5||8||
48639318|NCT05067270|101901606|FG004|COMPLETED|Period 5||8||
48639319|NCT05067270|101901602|FG000|NOT COMPLETED|Period 5||0||
48639320|NCT05067270|101901603|FG001|NOT COMPLETED|Period 5||0||
48639321|NCT05067270|101901604|FG002|NOT COMPLETED|Period 5||0||
48639322|NCT05067270|101901605|FG003|NOT COMPLETED|Period 5||0||
48639323|NCT05067270|101901606|FG004|NOT COMPLETED|Period 5||0||
48639324|NCT01006629|101901607|FG000|STARTED|Overall Study||100||
48639325|NCT01006629|101901607|FG000|COMPLETED|Overall Study||94||
48639326|NCT01006629|101901607|FG000|NOT COMPLETED|Overall Study||6||
48639327|NCT02239328|101901608|FG000|STARTED|Overall Study||182||
48639328|NCT02239328|101901608|FG000|COMPLETED|Overall Study||174||
48639329|NCT02239328|101901608|FG000|NOT COMPLETED|Overall Study||8||
48639330|NCT01151436|101901609|FG000|STARTED|Overall Study||77||
48639331|NCT01151436|101901609|FG000|COMPLETED|Overall Study||76||
48639332|NCT01151436|101901609|FG000|NOT COMPLETED|Overall Study||1||
48639333|NCT00367458|101901610|FG000|STARTED|First Intervention - 8 Weeks||12||
48639334|NCT00367458|101901611|FG001|STARTED|First Intervention - 8 Weeks||12||
48639335|NCT00367458|101901610|FG000|COMPLETED|First Intervention - 8 Weeks||10||
48639336|NCT00367458|101901611|FG001|COMPLETED|First Intervention - 8 Weeks||12||
48639337|NCT00367458|101901610|FG000|NOT COMPLETED|First Intervention - 8 Weeks||2||
48639338|NCT00367458|101901611|FG001|NOT COMPLETED|First Intervention - 8 Weeks||0||
48639339|NCT00367458|101901610|FG000|STARTED|Washout Period - 4-6 Weeks||10||
48639340|NCT00367458|101901611|FG001|STARTED|Washout Period - 4-6 Weeks||12||
48639341|NCT00367458|101901610|FG000|COMPLETED|Washout Period - 4-6 Weeks||10||
48639342|NCT00367458|101901611|FG001|COMPLETED|Washout Period - 4-6 Weeks||12||
48639343|NCT00367458|101901610|FG000|NOT COMPLETED|Washout Period - 4-6 Weeks||0||
48639344|NCT00367458|101901611|FG001|NOT COMPLETED|Washout Period - 4-6 Weeks||0||
48639345|NCT00367458|101901610|FG000|STARTED|Second Intervention - 8 Weeks||10||
48639346|NCT00367458|101901611|FG001|STARTED|Second Intervention - 8 Weeks||12||
48639347|NCT00367458|101901610|FG000|COMPLETED|Second Intervention - 8 Weeks||10||
48639348|NCT00367458|101901611|FG001|COMPLETED|Second Intervention - 8 Weeks||12||
48639349|NCT00367458|101901610|FG000|NOT COMPLETED|Second Intervention - 8 Weeks||0||
48639350|NCT00367458|101901611|FG001|NOT COMPLETED|Second Intervention - 8 Weeks||0||
48639351|NCT01928849|101901612|FG000|STARTED|Overall Study||66||
48639352|NCT01928849|101901613|FG001|STARTED|Overall Study||62||
48639353|NCT01928849|101901612|FG000|COMPLETED|Overall Study||52||
48639354|NCT01928849|101901613|FG001|COMPLETED|Overall Study||55||
48639355|NCT01928849|101901612|FG000|NOT COMPLETED|Overall Study||14||
48361269|NCT00306891|101214301|FG003|COMPLETED|Part B||14||
48361270|NCT00306891|101214298|FG000|NOT COMPLETED|Part B||0||
48361271|NCT00306891|101214299|FG001|NOT COMPLETED|Part B||0||
48639356|NCT01928849|101901613|FG001|NOT COMPLETED|Overall Study||7||
48639357|NCT04249778|101901614|FG000|STARTED|Overall Study||50|Participants who were randomized to a study arm|
48639358|NCT04249778|101901615|FG001|STARTED|Overall Study||55|Participants who were randomized to a study arm|
48639359|NCT04249778|101901614|FG000|Started Study Medication|Overall Study||46||
48639360|NCT04249778|101901615|FG001|Started Study Medication|Overall Study||53||
48639361|NCT04249778|101901614|FG000|Attended Week 12 Visit|Overall Study||16||
48639362|NCT04249778|101901615|FG001|Attended Week 12 Visit|Overall Study||19||
48639363|NCT04249778|101901614|FG000|COMPLETED|Overall Study||15|Completed the Week 26 visit|
48639364|NCT04249778|101901615|FG001|COMPLETED|Overall Study||12|Completed the Week 26 visit|
48639365|NCT04249778|101901614|FG000|NOT COMPLETED|Overall Study||35||
48639366|NCT04249778|101901615|FG001|NOT COMPLETED|Overall Study||43||
48639367|NCT02546570|101901616|FG000|STARTED|Overall Study||9||
48639368|NCT02546570|101901617|FG001|STARTED|Overall Study||2||
48639369|NCT02546570|101901616|FG000|Crossover Order: Oxytocin, Placebo|Overall Study||6||
48639370|NCT02546570|101901617|FG001|Crossover Order: Oxytocin, Placebo|Overall Study||2||
48639371|NCT02546570|101901616|FG000|Crossover Order: Placebo, Oxytocin|Overall Study||3||
48639372|NCT02546570|101901617|FG001|Crossover Order: Placebo, Oxytocin|Overall Study||0||
48639373|NCT02546570|101901616|FG000|COMPLETED|Overall Study||9||
48639374|NCT02546570|101901617|FG001|COMPLETED|Overall Study||2||
48639375|NCT02546570|101901616|FG000|NOT COMPLETED|Overall Study||0||
48639376|NCT02546570|101901617|FG001|NOT COMPLETED|Overall Study||0||
48639377|NCT00729586|101901618|FG000|STARTED|Overall Study||51||
48639378|NCT00729586|101901619|FG001|STARTED|Overall Study||22||
48639379|NCT00729586|101901618|FG000|COMPLETED|Overall Study||50||
48639380|NCT00729586|101901619|FG001|COMPLETED|Overall Study||21||
48639381|NCT00729586|101901618|FG000|NOT COMPLETED|Overall Study||1||
48639382|NCT00729586|101901619|FG001|NOT COMPLETED|Overall Study||1||
48639383|NCT02317549|101901620|FG000|STARTED|Overall Study||5||
48361272|NCT00306891|101214300|FG002|NOT COMPLETED|Part B||11||
48639384|NCT02317549|101901621|FG001|STARTED|Overall Study||3||
48639385|NCT02317549|101901620|FG000|COMPLETED|Overall Study||5||
48639386|NCT02317549|101901621|FG001|COMPLETED|Overall Study||3||
48639387|NCT02317549|101901620|FG000|NOT COMPLETED|Overall Study||0||
48361273|NCT00306891|101214301|FG003|NOT COMPLETED|Part B||17||
48639388|NCT02317549|101901621|FG001|NOT COMPLETED|Overall Study||0||
48639389|NCT02378181|101901622|FG000|STARTED|Overall Study||21||
48639390|NCT02378181|101901623|FG001|STARTED|Overall Study||28||
48764357|NCT00723736|102211941|FG000|NOT COMPLETED|Overall Study||1||
48639391|NCT02378181|101901622|FG000|6 Week Assessment|Overall Study||18||
48639392|NCT02378181|101901623|FG001|6 Week Assessment|Overall Study||16||
48639393|NCT02378181|101901622|FG000|3 Month Assessment|Overall Study||18||
48639394|NCT02378181|101901623|FG001|3 Month Assessment|Overall Study||21||
48639395|NCT02378181|101901622|FG000|COMPLETED|Overall Study||18||
48639396|NCT02378181|101901623|FG001|COMPLETED|Overall Study||21||
48361274|NCT01522651|101214302|FG000|STARTED|Overall Study||26||
48639397|NCT02378181|101901622|FG000|NOT COMPLETED|Overall Study||3||
48639398|NCT02378181|101901623|FG001|NOT COMPLETED|Overall Study||7||
48639399|NCT02202616|101901624|FG000|STARTED|Overall Study||401||
48639400|NCT02202616|101901624|FG000|Intent to Treat Set (ITT)|Overall Study||338||
48639401|NCT02202616|101901624|FG000|COMPLETED|Overall Study||301||
48639402|NCT02202616|101901624|FG000|NOT COMPLETED|Overall Study||100||
48639403|NCT04124965|101901625|FG000|STARTED|Overall Study||35||
48639404|NCT04124965|101901626|FG001|STARTED|Overall Study||36||
48639405|NCT04124965|101901625|FG000|Safety Set|Overall Study||35|Received at least 1 dose of investigational medicinal product|
48639406|NCT04124965|101901626|FG001|Safety Set|Overall Study||35|Received at least 1 dose of investigational medicinal product|
48639407|NCT04124965|101901625|FG000|COMPLETED|Overall Study||5||
48639408|NCT04124965|101901626|FG001|COMPLETED|Overall Study||3||
48639409|NCT04124965|101901625|FG000|NOT COMPLETED|Overall Study||30||
48639410|NCT04124965|101901626|FG001|NOT COMPLETED|Overall Study||33||
48639411|NCT05417113|101901627|FG000|STARTED|Overall Study||7||
48639412|NCT05417113|101901628|FG001|STARTED|Overall Study||6||
48639413|NCT05417113|101901627|FG000|COMPLETED|Overall Study||5||
48639414|NCT05417113|101901628|FG001|COMPLETED|Overall Study||4||
48639415|NCT05417113|101901627|FG000|NOT COMPLETED|Overall Study||2||
48639416|NCT05417113|101901628|FG001|NOT COMPLETED|Overall Study||2||
48639417|NCT01136915|101901629|FG000|STARTED|Overall Study||8||
48639418|NCT01136915|101901630|FG001|STARTED|Overall Study||7||
48639419|NCT01136915|101901629|FG000|COMPLETED|Overall Study||6||
48639420|NCT01136915|101901630|FG001|COMPLETED|Overall Study||6||
48639421|NCT01136915|101901629|FG000|NOT COMPLETED|Overall Study||2||
48639422|NCT01136915|101901630|FG001|NOT COMPLETED|Overall Study||1||
48639423|NCT01695746|101901631|FG000|STARTED|Overall Study||108||
48639424|NCT01695746|101901631|FG000|COMPLETED|Overall Study||96||
48639425|NCT01695746|101901631|FG000|NOT COMPLETED|Overall Study||12||
48639426|NCT01708603|101901632|FG000|STARTED|Overall Study||612||
48639427|NCT01708603|101901633|FG001|STARTED|Overall Study||610||
48639428|NCT01708603|101901634|FG002|STARTED|Overall Study||300||
48639429|NCT01708603|101901635|FG003|STARTED|Overall Study||309||
48639430|NCT01708603|101901632|FG000|COMPLETED|Overall Study||597||
48639431|NCT01708603|101901633|FG001|COMPLETED|Overall Study||588||
48639432|NCT01708603|101901634|FG002|COMPLETED|Overall Study||291||
48639433|NCT01708603|101901635|FG003|COMPLETED|Overall Study||300||
48639434|NCT01708603|101901632|FG000|NOT COMPLETED|Overall Study||15||
48639435|NCT01708603|101901633|FG001|NOT COMPLETED|Overall Study||22||
48639436|NCT01708603|101901634|FG002|NOT COMPLETED|Overall Study||9||
48639437|NCT01708603|101901635|FG003|NOT COMPLETED|Overall Study||9||
48639438|NCT01014091|101901636|FG000|STARTED|Overall Study||7||
48639439|NCT01014091|101901637|FG001|STARTED|Overall Study||13||
48639440|NCT01014091|101901638|FG002|STARTED|Overall Study||5||
48639441|NCT01014091|101901639|FG003|STARTED|Overall Study||15||
48639442|NCT01014091|101901640|FG004|STARTED|Overall Study||6||
48639443|NCT01014091|101901641|FG005|STARTED|Overall Study||12||
48639444|NCT01014091|101901636|FG000|COMPLETED|Overall Study||7||
48639445|NCT01014091|101901637|FG001|COMPLETED|Overall Study||13||
48639446|NCT01014091|101901638|FG002|COMPLETED|Overall Study||5||
48639447|NCT01014091|101901639|FG003|COMPLETED|Overall Study||15||
48639448|NCT01014091|101901640|FG004|COMPLETED|Overall Study||6||
48639449|NCT01014091|101901641|FG005|COMPLETED|Overall Study||12||
48639450|NCT01014091|101901636|FG000|NOT COMPLETED|Overall Study||0||
48361275|NCT01522651|101214303|FG001|STARTED|Overall Study||27||
48639451|NCT01014091|101901637|FG001|NOT COMPLETED|Overall Study||0||
48639452|NCT01014091|101901638|FG002|NOT COMPLETED|Overall Study||0||
48639453|NCT01014091|101901639|FG003|NOT COMPLETED|Overall Study||0||
48639454|NCT01014091|101901640|FG004|NOT COMPLETED|Overall Study||0||
48639455|NCT01014091|101901641|FG005|NOT COMPLETED|Overall Study||0||
48639456|NCT02787291|101901642|FG000|STARTED|Overall Study||227||
48639457|NCT02787291|101901642|FG000|COMPLETED|Overall Study||227||
48639458|NCT02787291|101901642|FG000|NOT COMPLETED|Overall Study||0||
48639459|NCT00368550|101901643|FG000|STARTED|Overall Study||63||
48639460|NCT00368550|101901644|FG001|STARTED|Overall Study||71||
48639461|NCT00368550|101901643|FG000|COMPLETED|Overall Study||35||
48639462|NCT00368550|101901644|FG001|COMPLETED|Overall Study||48||
48639463|NCT00368550|101901643|FG000|NOT COMPLETED|Overall Study||28||
48639464|NCT00368550|101901644|FG001|NOT COMPLETED|Overall Study||23||
48639465|NCT01115231|101901645|FG000|STARTED|Overall Study||133||
48639466|NCT01115231|101901646|FG001|STARTED|Overall Study||90||
48639467|NCT01115231|101901645|FG000|COMPLETED|Overall Study||133||
48764358|NCT00217399|102211942|FG000|STARTED|Overall Study||35||
48361276|NCT01522651|101214304|FG002|STARTED|Overall Study||26||
48639468|NCT01115231|101901646|FG001|COMPLETED|Overall Study||90||
48639469|NCT01115231|101901645|FG000|NOT COMPLETED|Overall Study||0||
48639470|NCT01115231|101901646|FG001|NOT COMPLETED|Overall Study||0||
48639471|NCT00844519|101901647|FG000|STARTED|Overall Study||26||
48639472|NCT00844519|101901648|FG001|STARTED|Overall Study||26||
48639473|NCT00844519|101901647|FG000|COMPLETED|Overall Study||24||
48361277|NCT01522651|101214305|FG003|STARTED|Overall Study||28||
48639474|NCT00844519|101901648|FG001|COMPLETED|Overall Study||25||
48639475|NCT00844519|101901647|FG000|NOT COMPLETED|Overall Study||2||
48639476|NCT00844519|101901648|FG001|NOT COMPLETED|Overall Study||1||
48639477|NCT02394275|101901649|FG000|STARTED|Overall Study||140||
48639478|NCT02394275|101901649|FG000|Safety Population|Overall Study||133||
48639479|NCT02394275|101901649|FG000|Evaluable at 13 Weeks|Overall Study||133||
48639480|NCT02394275|101901649|FG000|COMPLETED|Overall Study||111||
48639481|NCT02394275|101901649|FG000|NOT COMPLETED|Overall Study||29||
48639482|NCT03301714|101901650|FG000|STARTED|Overall Study||60||
48639483|NCT03301714|101901651|FG001|STARTED|Overall Study||60||
48639484|NCT03301714|101901652|FG002|STARTED|Overall Study||60||
48639485|NCT03301714|101901650|FG000|COMPLETED|Overall Study||50||
48639486|NCT03301714|101901651|FG001|COMPLETED|Overall Study||54||
48639487|NCT03301714|101901652|FG002|COMPLETED|Overall Study||53||
48639488|NCT03301714|101901650|FG000|NOT COMPLETED|Overall Study||10||
48639489|NCT03301714|101901651|FG001|NOT COMPLETED|Overall Study||6||
48639490|NCT03301714|101901652|FG002|NOT COMPLETED|Overall Study||7||
48639491|NCT00805532|101901653|FG000|STARTED|Overall Study||42||
48639492|NCT00805532|101901654|FG001|STARTED|Overall Study||39||
48639493|NCT00805532|101901653|FG000|COMPLETED|Overall Study||42||
48639494|NCT00805532|101901654|FG001|COMPLETED|Overall Study||38||
48639495|NCT00805532|101901653|FG000|NOT COMPLETED|Overall Study||0||
48639496|NCT00805532|101901654|FG001|NOT COMPLETED|Overall Study||1||
48639497|NCT01059851|101901655|FG000|STARTED|Overall Study||8||
48639498|NCT01059851|101901656|FG001|STARTED|Overall Study||8||
48639499|NCT01059851|101901657|FG002|STARTED|Overall Study||0||
48433660|NCT02689973|101397088|FG001|NOT COMPLETED|Overall Study||49||
48433661|NCT02689973|101397089|FG002|NOT COMPLETED|Overall Study||72||
48433662|NCT02689973|101397090|FG003|NOT COMPLETED|Overall Study||53||
48433663|NCT01255865|101397091|FG000|STARTED|Overall Study||1||
48433664|NCT01255865|101397092|FG001|STARTED|Overall Study||10||
48433665|NCT01255865|101397093|FG002|STARTED|Overall Study||10||
48433666|NCT01255865|101397094|FG003|STARTED|Overall Study||30||
48433667|NCT01255865|101397095|FG004|STARTED|Overall Study||20||
48433668|NCT01255865|101397096|FG005|STARTED|Overall Study||20||
48433669|NCT01255865|101397097|FG006|STARTED|Overall Study||20||
48433670|NCT01255865|101397091|FG000|COMPLETED|Overall Study||1||
48433671|NCT01255865|101397092|FG001|COMPLETED|Overall Study||10||
48433672|NCT01255865|101397093|FG002|COMPLETED|Overall Study||10||
48433673|NCT01255865|101397094|FG003|COMPLETED|Overall Study||30||
48433674|NCT01255865|101397095|FG004|COMPLETED|Overall Study||20||
48433675|NCT01255865|101397096|FG005|COMPLETED|Overall Study||20||
48433676|NCT01255865|101397097|FG006|COMPLETED|Overall Study||20||
48433677|NCT01255865|101397091|FG000|NOT COMPLETED|Overall Study||0||
48433678|NCT01255865|101397092|FG001|NOT COMPLETED|Overall Study||0||
48433679|NCT01255865|101397093|FG002|NOT COMPLETED|Overall Study||0||
48433680|NCT01255865|101397094|FG003|NOT COMPLETED|Overall Study||0||
48433681|NCT01255865|101397095|FG004|NOT COMPLETED|Overall Study||0||
48433682|NCT01255865|101397096|FG005|NOT COMPLETED|Overall Study||0||
48433683|NCT01255865|101397097|FG006|NOT COMPLETED|Overall Study||0||
48433684|NCT00077766|101397098|FG000|STARTED|Overall Study||157||
48433685|NCT00077766|101397099|FG001|STARTED|Overall Study||156||
48433686|NCT00077766|101397098|FG000|COMPLETED|Overall Study||118||
48433687|NCT00077766|101397099|FG001|COMPLETED|Overall Study||131||
48433688|NCT00077766|101397098|FG000|NOT COMPLETED|Overall Study||39||
48433689|NCT00077766|101397099|FG001|NOT COMPLETED|Overall Study||25||
48433690|NCT02951182|101397100|FG000|STARTED|Overall Study||11||
48433691|NCT02951182|101397101|FG001|STARTED|Overall Study||9||
48433692|NCT02951182|101397102|FG002|STARTED|Overall Study||9||
48433693|NCT02951182|101397103|FG003|STARTED|Overall Study||18||
48433694|NCT02951182|101397104|FG004|STARTED|Overall Study||6||
48433695|NCT02951182|101397105|FG005|STARTED|Overall Study||20||
48433696|NCT02951182|101397100|FG000|COMPLETED|Overall Study||11||
48433697|NCT02951182|101397101|FG001|COMPLETED|Overall Study||9||
48433698|NCT02951182|101397102|FG002|COMPLETED|Overall Study||9||
48433699|NCT02951182|101397103|FG003|COMPLETED|Overall Study||18||
48433700|NCT02951182|101397104|FG004|COMPLETED|Overall Study||6||
48433701|NCT02951182|101397105|FG005|COMPLETED|Overall Study||20||
48433702|NCT02951182|101397100|FG000|NOT COMPLETED|Overall Study||0||
48433703|NCT02951182|101397101|FG001|NOT COMPLETED|Overall Study||0||
48433704|NCT02951182|101397102|FG002|NOT COMPLETED|Overall Study||0||
48433705|NCT02951182|101397103|FG003|NOT COMPLETED|Overall Study||0||
48433706|NCT02951182|101397104|FG004|NOT COMPLETED|Overall Study||0||
48433707|NCT02951182|101397105|FG005|NOT COMPLETED|Overall Study||0||
48639500|NCT01059851|101901658|FG003|STARTED|Overall Study||0||
48639501|NCT01059851|101901659|FG004|STARTED|Overall Study||0||
48639502|NCT01059851|101901660|FG005|STARTED|Overall Study||0||
48639503|NCT01059851|101901655|FG000|COMPLETED|Overall Study||8||
48639504|NCT01059851|101901656|FG001|COMPLETED|Overall Study||8||
48639505|NCT01059851|101901657|FG002|COMPLETED|Overall Study||0||
48433708|NCT00540982|101397106|FG000|STARTED|Overall Study||47||
48433709|NCT00540982|101397106|FG000|Normal Liver Function|Overall Study||11||
48433710|NCT00540982|101397106|FG000|Mild Liver Dysfunction|Overall Study||6||
48433711|NCT00540982|101397106|FG000|Moderate Liver Dysfunction|Overall Study||18||
48433712|NCT00540982|101397106|FG000|Severe Liver Dysfunction|Overall Study||12||
48433713|NCT00540982|101397106|FG000|COMPLETED|Overall Study||47||
48433714|NCT00540982|101397106|FG000|NOT COMPLETED|Overall Study||0||
48439993|NCT04176354|101410003|FG000|NOT COMPLETED|Overall Study||0||
48639506|NCT01059851|101901658|FG003|COMPLETED|Overall Study||0||
48639507|NCT01059851|101901659|FG004|COMPLETED|Overall Study||0||
48639508|NCT01059851|101901660|FG005|COMPLETED|Overall Study||0||
48639509|NCT01059851|101901655|FG000|NOT COMPLETED|Overall Study||0||
48639510|NCT01059851|101901656|FG001|NOT COMPLETED|Overall Study||0||
48639511|NCT01059851|101901657|FG002|NOT COMPLETED|Overall Study||0||
48639512|NCT01059851|101901658|FG003|NOT COMPLETED|Overall Study||0||
48639513|NCT01059851|101901659|FG004|NOT COMPLETED|Overall Study||0||
48639514|NCT01059851|101901660|FG005|NOT COMPLETED|Overall Study||0||
48639515|NCT00226655|101901661|FG000|STARTED|Overall Study||112||
48639516|NCT00226655|101901661|FG000|COMPLETED|Overall Study||33||
48639517|NCT00226655|101901661|FG000|NOT COMPLETED|Overall Study||79||
48639518|NCT00147238|101901662|FG000|STARTED|Overall Study||10||
48639519|NCT00147238|101901662|FG000|COMPLETED|Overall Study||2||
48639520|NCT00147238|101901662|FG000|NOT COMPLETED|Overall Study||8||
48639521|NCT00392041|101901663|FG000|STARTED|First 4 Weeks||19||
48639522|NCT00392041|101901664|FG001|STARTED|First 4 Weeks||17||
48639523|NCT00392041|101901663|FG000|COMPLETED|First 4 Weeks||11||
48639524|NCT00392041|101901664|FG001|COMPLETED|First 4 Weeks||14||
48639525|NCT00392041|101901663|FG000|NOT COMPLETED|First 4 Weeks||8||
48639526|NCT00392041|101901664|FG001|NOT COMPLETED|First 4 Weeks||3||
48639527|NCT00392041|101901663|FG000|STARTED|Weeks 5 - 12||11||
48639528|NCT00392041|101901664|FG001|STARTED|Weeks 5 - 12||14||
48639529|NCT00392041|101901663|FG000|COMPLETED|Weeks 5 - 12||7||
48639530|NCT00392041|101901664|FG001|COMPLETED|Weeks 5 - 12||9||
48639531|NCT00392041|101901663|FG000|NOT COMPLETED|Weeks 5 - 12||4||
48639532|NCT00392041|101901664|FG001|NOT COMPLETED|Weeks 5 - 12||5||
48639533|NCT02013414|101901665|FG000|STARTED|Overall Study||9||
48639534|NCT02013414|101901665|FG000|COMPLETED|Overall Study||9||
48639535|NCT02013414|101901665|FG000|NOT COMPLETED|Overall Study||0||
48639536|NCT00230737|101901666|FG000|STARTED|Overall Study||9||
48639537|NCT00230737|101901667|FG001|STARTED|Overall Study||10||
48639538|NCT00230737|101901668|FG002|STARTED|Overall Study||8||
48639539|NCT00230737|101901666|FG000|COMPLETED|Overall Study||9||
48639540|NCT00230737|101901667|FG001|COMPLETED|Overall Study||10||
48639541|NCT00230737|101901668|FG002|COMPLETED|Overall Study||8||
48639542|NCT00230737|101901666|FG000|NOT COMPLETED|Overall Study||0||
48639543|NCT00230737|101901667|FG001|NOT COMPLETED|Overall Study||0||
48639544|NCT00230737|101901668|FG002|NOT COMPLETED|Overall Study||0||
48639545|NCT01670006|101901669|FG000|STARTED|Overall Study||10||
48639546|NCT01670006|101901669|FG000|COMPLETED|Overall Study||10||
48639547|NCT01670006|101901669|FG000|NOT COMPLETED|Overall Study||0||
48639548|NCT00898807|101901670|FG000|STARTED|Overall Study||94||
48639549|NCT00898807|101901671|FG001|STARTED|Overall Study||92||
48639550|NCT00898807|101901670|FG000|COMPLETED|Overall Study||86||
48639551|NCT00898807|101901671|FG001|COMPLETED|Overall Study||83||
48639552|NCT00898807|101901670|FG000|NOT COMPLETED|Overall Study||8||
48639553|NCT00898807|101901671|FG001|NOT COMPLETED|Overall Study||9||
48639554|NCT01017250|101901672|FG000|STARTED|Overall Study||15||
48639555|NCT01017250|101901672|FG000|2-month MRI|Overall Study||14||
48639556|NCT01017250|101901672|FG000|COMPLETED|Overall Study||15||
48639557|NCT01017250|101901672|FG000|NOT COMPLETED|Overall Study||0||
48639558|NCT00274456|101901673|FG000|STARTED|Overall Study||76||
48639559|NCT00274456|101901674|FG001|STARTED|Overall Study||76||
48639560|NCT00274456|101901675|FG002|STARTED|Overall Study||74||
48639561|NCT00274456|101901676|FG003|STARTED|Overall Study||74||
48639562|NCT00274456|101901673|FG000|At Least One Response Assessment|Overall Study||73||
48639563|NCT00274456|101901674|FG001|At Least One Response Assessment|Overall Study||76||
48639564|NCT00274456|101901675|FG002|At Least One Response Assessment|Overall Study||73||
48639565|NCT00274456|101901676|FG003|At Least One Response Assessment|Overall Study||70||
48639566|NCT00274456|101901673|FG000|COMPLETED|Overall Study||39||
48639567|NCT00274456|101901674|FG001|COMPLETED|Overall Study||49||
48639568|NCT00274456|101901675|FG002|COMPLETED|Overall Study||39||
48639569|NCT00274456|101901676|FG003|COMPLETED|Overall Study||29||
48639570|NCT00274456|101901673|FG000|NOT COMPLETED|Overall Study||37||
48639571|NCT00274456|101901674|FG001|NOT COMPLETED|Overall Study||27||
48639572|NCT00274456|101901675|FG002|NOT COMPLETED|Overall Study||35||
48639573|NCT00274456|101901676|FG003|NOT COMPLETED|Overall Study||45||
48639574|NCT04601506|101901677|FG000|STARTED|Overall Study||79||11
48639575|NCT04601506|101901678|FG001|STARTED|Overall Study||69||11
48639576|NCT04601506|101901679|FG002|STARTED|Overall Study||74||10
48639577|NCT04601506|101901680|FG003|STARTED|Overall Study||87||11
48639578|NCT04601506|101901677|FG000|COMPLETED|Overall Study||79||11
48639579|NCT04601506|101901678|FG001|COMPLETED|Overall Study||69||11
48639580|NCT04601506|101901679|FG002|COMPLETED|Overall Study||74||10
48639581|NCT04601506|101901680|FG003|COMPLETED|Overall Study||87||11
48639582|NCT04601506|101901677|FG000|NOT COMPLETED|Overall Study||0||0
48639583|NCT04601506|101901678|FG001|NOT COMPLETED|Overall Study||0||0
48639584|NCT04601506|101901679|FG002|NOT COMPLETED|Overall Study||0||0
48639585|NCT04601506|101901680|FG003|NOT COMPLETED|Overall Study||0||0
48639586|NCT00632359|101901681|FG000|STARTED|Overall Study||33||
48639587|NCT00632359|101901681|FG000|COMPLETED|Overall Study||31||
48639588|NCT00632359|101901681|FG000|NOT COMPLETED|Overall Study||2||
48639589|NCT01498549|101901682|FG000|STARTED|Overall Study||39||
48639590|NCT01498549|101901682|FG000|Atomoxetine 40 mg|Overall Study||39||
48639591|NCT01498549|101901682|FG000|Atomoxetine 80 mg|Overall Study||37||
48639592|NCT01498549|101901682|FG000|Sugar Pill 0 mg|Overall Study||36||
48639593|NCT01498549|101901682|FG000|COMPLETED|Overall Study||35|Completed all 3 days for each arm in the crossover design.|
48639594|NCT01498549|101901682|FG000|NOT COMPLETED|Overall Study||4||
48639595|NCT02278354|101901683|FG000|STARTED|Overall Study||12||
48639596|NCT02278354|101901684|FG001|STARTED|Overall Study||23||
48639597|NCT02278354|101901683|FG000|Flortaucipir PET Scan|Overall Study||10||
48639598|NCT02278354|101901684|FG001|Flortaucipir PET Scan|Overall Study||20||
48639599|NCT02278354|101901683|FG000|COMPLETED|Overall Study||8||
48639600|NCT02278354|101901684|FG001|COMPLETED|Overall Study||20||
48639601|NCT02278354|101901683|FG000|NOT COMPLETED|Overall Study||4||
48639602|NCT02278354|101901684|FG001|NOT COMPLETED|Overall Study||3||
48639603|NCT04766333|101901685|FG000|STARTED|Overall Study||63||
48639604|NCT04766333|101901686|FG001|STARTED|Overall Study||1037||
48639605|NCT04766333|101901685|FG000|COMPLETED|Overall Study||23||
48639606|NCT04766333|101901686|FG001|COMPLETED|Overall Study||211||
48639607|NCT04766333|101901685|FG000|NOT COMPLETED|Overall Study||40||
48639608|NCT04766333|101901686|FG001|NOT COMPLETED|Overall Study||826||
48639609|NCT01199614|101901687|FG000|STARTED|Overall Study||62||
48639610|NCT01199614|101901687|FG000|Completed|Overall Study||27|At 4 years|
48639611|NCT01199614|101901687|FG000|COMPLETED|Overall Study||13|At study conclusion|
48639612|NCT01199614|101901687|FG000|NOT COMPLETED|Overall Study||49||
48639613|NCT01968317|101901688|FG000|STARTED|Overall Study||76||
48639614|NCT01968317|101901689|FG001|STARTED|Overall Study||74||
48639615|NCT01968317|101901688|FG000|COMPLETED|Overall Study||76||
48639616|NCT01968317|101901689|FG001|COMPLETED|Overall Study||74||
48639617|NCT01968317|101901688|FG000|NOT COMPLETED|Overall Study||0||
48639618|NCT01968317|101901689|FG001|NOT COMPLETED|Overall Study||0||
48639619|NCT00704353|101901690|FG000|STARTED|Overall Study||366||
48639620|NCT00704353|101901691|FG001|STARTED|Overall Study||369||
48639621|NCT00704353|101901690|FG000|COMPLETED|Overall Study||268||
48639622|NCT00704353|101901691|FG001|COMPLETED|Overall Study||255||
48639623|NCT00704353|101901690|FG000|NOT COMPLETED|Overall Study||98||
48639624|NCT00704353|101901691|FG001|NOT COMPLETED|Overall Study||114||
48639625|NCT02595749|101901692|FG000|STARTED|Overall Study||45||
48639626|NCT02595749|101901693|FG001|STARTED|Overall Study||38||
48639627|NCT02595749|101901692|FG000|COMPLETED|Overall Study||33||
48639628|NCT02595749|101901693|FG001|COMPLETED|Overall Study||31||
48639629|NCT02595749|101901692|FG000|NOT COMPLETED|Overall Study||12||
48639630|NCT02595749|101901693|FG001|NOT COMPLETED|Overall Study||7||
48639631|NCT01898078|101901694|FG000|STARTED|Overall Study||13||
48639632|NCT01898078|101901695|FG001|STARTED|Overall Study||13||
48639633|NCT01898078|101901694|FG000|COMPLETED|Overall Study||7||
48639634|NCT01898078|101901695|FG001|COMPLETED|Overall Study||5||
48639635|NCT01898078|101901694|FG000|NOT COMPLETED|Overall Study||6||
48639636|NCT01898078|101901695|FG001|NOT COMPLETED|Overall Study||8||
48639637|NCT02421211|101901696|FG000|STARTED|Overall Study||20||
48639638|NCT02421211|101901697|FG001|STARTED|Overall Study||20||
48639639|NCT02421211|101901696|FG000|COMPLETED|Overall Study||20||
48639640|NCT02421211|101901697|FG001|COMPLETED|Overall Study||20||
48639641|NCT02421211|101901696|FG000|NOT COMPLETED|Overall Study||0||
48639642|NCT02421211|101901697|FG001|NOT COMPLETED|Overall Study||0||
48639643|NCT00153842|101901698|FG000|STARTED|Overall Study||26||
48639644|NCT00153842|101901699|FG001|STARTED|Overall Study||7||
48639645|NCT00153842|101901698|FG000|COMPLETED|Overall Study||26||
48639646|NCT00153842|101901699|FG001|COMPLETED|Overall Study||7||
48639647|NCT00153842|101901698|FG000|NOT COMPLETED|Overall Study||0||
48639648|NCT00153842|101901699|FG001|NOT COMPLETED|Overall Study||0||
48639649|NCT00876395|101901700|FG000|STARTED|Overall Study||480||
48639650|NCT00876395|101901701|FG001|STARTED|Overall Study||239||
48639651|NCT00876395|101901700|FG000|Untreated|Overall Study||8||
48639652|NCT00876395|101901701|FG001|Untreated|Overall Study||1||
48639653|NCT00876395|101901700|FG000|COMPLETED|Overall Study||0||
48639654|NCT00876395|101901701|FG001|COMPLETED|Overall Study||0||
48639655|NCT00876395|101901700|FG000|NOT COMPLETED|Overall Study||480||
48639656|NCT00876395|101901701|FG001|NOT COMPLETED|Overall Study||239||
48639657|NCT03785028|101901702|FG000|STARTED|Overall Study||5||
48639658|NCT03785028|101901702|FG000|COMPLETED|Overall Study||5||
48639659|NCT03785028|101901702|FG000|NOT COMPLETED|Overall Study||0||
48639660|NCT02522845|101901703|FG000|STARTED|Overall Study||100||
48639661|NCT02522845|101901704|FG001|STARTED|Overall Study||104||
48639662|NCT02522845|101901703|FG000|COMPLETED|Overall Study||63||
48639663|NCT02522845|101901704|FG001|COMPLETED|Overall Study||69||
48639664|NCT02522845|101901703|FG000|NOT COMPLETED|Overall Study||37||
48639665|NCT02522845|101901704|FG001|NOT COMPLETED|Overall Study||35||
48639666|NCT03144232|101901705|FG000|STARTED|Overall Study||37||
48639667|NCT03144232|101901706|FG001|STARTED|Overall Study||35||
48639668|NCT03144232|101901705|FG000|COMPLETED|Overall Study||28||
48639669|NCT03144232|101901706|FG001|COMPLETED|Overall Study||23||
48639670|NCT03144232|101901705|FG000|NOT COMPLETED|Overall Study||9||
48639671|NCT03144232|101901706|FG001|NOT COMPLETED|Overall Study||12||
48639672|NCT02065557|101901707|FG000|STARTED|Induction Period||32||
48187872|NCT01253980|100783124|FG001|COMPLETED|Overall Study||39||
48639673|NCT02065557|101901708|FG001|STARTED|Induction Period||51||
48639674|NCT02065557|101901709|FG002|STARTED|Induction Period||18||
48639675|NCT02065557|101901710|FG003|STARTED|Induction Period||0||
48639676|NCT02065557|101901711|FG004|STARTED|Induction Period||0||
48639677|NCT02065557|101901712|FG005|STARTED|Induction Period||0||
48639678|NCT02065557|101901707|FG000|Enrolled in Main Study|Induction Period||30||
48639679|NCT02065557|101901708|FG001|Enrolled in Main Study|Induction Period||47||
48639680|NCT02065557|101901709|FG002|Enrolled in Main Study|Induction Period||16||
48639681|NCT02065557|101901710|FG003|Enrolled in Main Study|Induction Period||0||
48639682|NCT02065557|101901711|FG004|Enrolled in Main Study|Induction Period||0||
48639683|NCT02065557|101901712|FG005|Enrolled in Main Study|Induction Period||0||
48639684|NCT02065557|101901707|FG000|Enrolled in Japan Sub-study|Induction Period||2||
48639685|NCT02065557|101901708|FG001|Enrolled in Japan Sub-study|Induction Period||4||
48639686|NCT02065557|101901709|FG002|Enrolled in Japan Sub-study|Induction Period||2||
48639687|NCT02065557|101901710|FG003|Enrolled in Japan Sub-study|Induction Period||0||
48639688|NCT02065557|101901711|FG004|Enrolled in Japan Sub-study|Induction Period||0||
48639689|NCT02065557|101901712|FG005|Enrolled in Japan Sub-study|Induction Period||0||
48639690|NCT02065557|101901707|FG000|COMPLETED|Induction Period||22||
48639691|NCT02065557|101901708|FG001|COMPLETED|Induction Period||43||
48639692|NCT02065557|101901709|FG002|COMPLETED|Induction Period||16||
48639693|NCT02065557|101901710|FG003|COMPLETED|Induction Period||0||
48639694|NCT02065557|101901711|FG004|COMPLETED|Induction Period||0||
48639695|NCT02065557|101901712|FG005|COMPLETED|Induction Period||0||
48639696|NCT02065557|101901707|FG000|NOT COMPLETED|Induction Period||10||
48639697|NCT02065557|101901708|FG001|NOT COMPLETED|Induction Period||8||
48639698|NCT02065557|101901709|FG002|NOT COMPLETED|Induction Period||2||
48639699|NCT02065557|101901710|FG003|NOT COMPLETED|Induction Period||0||
48639700|NCT02065557|101901711|FG004|NOT COMPLETED|Induction Period||0||
48639701|NCT02065557|101901712|FG005|NOT COMPLETED|Induction Period||0||
48639702|NCT02065557|101901707|FG000|STARTED|Maintenance Period||0||
48639703|NCT02065557|101901708|FG001|STARTED|Maintenance Period||0||
48639704|NCT02065557|101901709|FG002|STARTED|Maintenance Period||0||
48639705|NCT02065557|101901710|FG003|STARTED|Maintenance Period||12||
48639706|NCT02065557|101901711|FG004|STARTED|Maintenance Period||33||
48639707|NCT02065557|101901712|FG005|STARTED|Maintenance Period||36||
48639708|NCT02065557|101901707|FG000|COMPLETED|Maintenance Period||0|Completed Week 52|
48639709|NCT02065557|101901708|FG001|COMPLETED|Maintenance Period||0|Completed Week 52|
48639710|NCT02065557|101901709|FG002|COMPLETED|Maintenance Period||0|Completed Week 52|
48639711|NCT02065557|101901710|FG003|COMPLETED|Maintenance Period||11|Completed Week 52|
48639712|NCT02065557|101901711|FG004|COMPLETED|Maintenance Period||25|Completed Week 52|
48639713|NCT02065557|101901712|FG005|COMPLETED|Maintenance Period||32|Completed Week 52|
48639714|NCT02065557|101901707|FG000|NOT COMPLETED|Maintenance Period||0||
48639715|NCT02065557|101901708|FG001|NOT COMPLETED|Maintenance Period||0||
48639716|NCT02065557|101901709|FG002|NOT COMPLETED|Maintenance Period||0||
48639717|NCT02065557|101901710|FG003|NOT COMPLETED|Maintenance Period||1||
48639718|NCT02065557|101901711|FG004|NOT COMPLETED|Maintenance Period||8||
48639719|NCT02065557|101901712|FG005|NOT COMPLETED|Maintenance Period||4||
48639720|NCT01113749|101901713|FG000|STARTED|Overall Study||127||
48639721|NCT01113749|101901714|FG001|STARTED|Overall Study||129||
48639722|NCT01113749|101901713|FG000|COMPLETED|Overall Study||126||
48639723|NCT01113749|101901714|FG001|COMPLETED|Overall Study||127||
48639724|NCT01113749|101901713|FG000|NOT COMPLETED|Overall Study||1||
48639725|NCT01113749|101901714|FG001|NOT COMPLETED|Overall Study||2||
48639726|NCT01432327|101901715|FG000|STARTED|Baseline||56||
48639727|NCT01432327|101901716|FG001|STARTED|Baseline||57||
48639728|NCT01432327|101901717|FG002|STARTED|Baseline||57||
48639729|NCT01432327|101901718|FG003|STARTED|Baseline||57||
48639730|NCT01432327|101901715|FG000|COMPLETED|Baseline||56||
48639731|NCT01432327|101901716|FG001|COMPLETED|Baseline||57||
48639732|NCT01432327|101901717|FG002|COMPLETED|Baseline||57||
48639733|NCT01432327|101901718|FG003|COMPLETED|Baseline||57||
48639734|NCT01432327|101901715|FG000|NOT COMPLETED|Baseline||0||
48639735|NCT01432327|101901716|FG001|NOT COMPLETED|Baseline||0||
48639736|NCT01432327|101901717|FG002|NOT COMPLETED|Baseline||0||
48639737|NCT01432327|101901718|FG003|NOT COMPLETED|Baseline||0||
48639738|NCT01432327|101901715|FG000|STARTED|Posttest 3 Months||56||
48639739|NCT01432327|101901716|FG001|STARTED|Posttest 3 Months||57||
48639740|NCT01432327|101901717|FG002|STARTED|Posttest 3 Months||57||
48639741|NCT01432327|101901718|FG003|STARTED|Posttest 3 Months||57||
48639742|NCT01432327|101901715|FG000|COMPLETED|Posttest 3 Months||52||
48639743|NCT01432327|101901716|FG001|COMPLETED|Posttest 3 Months||55||
48639744|NCT01432327|101901717|FG002|COMPLETED|Posttest 3 Months||55||
48639745|NCT01432327|101901718|FG003|COMPLETED|Posttest 3 Months||56||
48639746|NCT01432327|101901715|FG000|NOT COMPLETED|Posttest 3 Months||4||
48639747|NCT01432327|101901716|FG001|NOT COMPLETED|Posttest 3 Months||2||
48639748|NCT01432327|101901717|FG002|NOT COMPLETED|Posttest 3 Months||2||
48639749|NCT01432327|101901718|FG003|NOT COMPLETED|Posttest 3 Months||1||
48639750|NCT01432327|101901715|FG000|STARTED|Posttest 6 Months||52||
48639751|NCT01432327|101901716|FG001|STARTED|Posttest 6 Months||55||
48639752|NCT01432327|101901717|FG002|STARTED|Posttest 6 Months||55||
48639753|NCT01432327|101901718|FG003|STARTED|Posttest 6 Months||56||
48639754|NCT01432327|101901715|FG000|COMPLETED|Posttest 6 Months||52||
48639755|NCT01432327|101901716|FG001|COMPLETED|Posttest 6 Months||55||
48639756|NCT01432327|101901717|FG002|COMPLETED|Posttest 6 Months||50||
48639757|NCT01432327|101901718|FG003|COMPLETED|Posttest 6 Months||54||
48639758|NCT01432327|101901715|FG000|NOT COMPLETED|Posttest 6 Months||0||
48639759|NCT01432327|101901716|FG001|NOT COMPLETED|Posttest 6 Months||0||
48639760|NCT01432327|101901717|FG002|NOT COMPLETED|Posttest 6 Months||5||
48639761|NCT01432327|101901718|FG003|NOT COMPLETED|Posttest 6 Months||2||
48639762|NCT01432327|101901715|FG000|STARTED|Posttest 1 Year||52||
48639763|NCT01432327|101901716|FG001|STARTED|Posttest 1 Year||55||
48639764|NCT01432327|101901717|FG002|STARTED|Posttest 1 Year||50||
48639765|NCT01432327|101901718|FG003|STARTED|Posttest 1 Year||54||
48639766|NCT01432327|101901715|FG000|COMPLETED|Posttest 1 Year||28||
48639767|NCT01432327|101901716|FG001|COMPLETED|Posttest 1 Year||27||
48639768|NCT01432327|101901717|FG002|COMPLETED|Posttest 1 Year||30||
48639769|NCT01432327|101901718|FG003|COMPLETED|Posttest 1 Year||31||
48639770|NCT01432327|101901715|FG000|NOT COMPLETED|Posttest 1 Year||24||
48639771|NCT01432327|101901716|FG001|NOT COMPLETED|Posttest 1 Year||28||
48639772|NCT01432327|101901717|FG002|NOT COMPLETED|Posttest 1 Year||20||
48639773|NCT01432327|101901718|FG003|NOT COMPLETED|Posttest 1 Year||23||
48639774|NCT01047501|101901719|FG000|STARTED|Overall Study||233||
48639775|NCT01047501|101901720|FG001|STARTED|Overall Study||236||
48639776|NCT01047501|101901721|FG002|STARTED|Overall Study||233||
48639777|NCT01047501|101901719|FG000|COMPLETED|Overall Study||217||
48639778|NCT01047501|101901720|FG001|COMPLETED|Overall Study||225||
48639779|NCT01047501|101901721|FG002|COMPLETED|Overall Study||221||
48639780|NCT01047501|101901719|FG000|NOT COMPLETED|Overall Study||16||
48639781|NCT01047501|101901720|FG001|NOT COMPLETED|Overall Study||11||
48639782|NCT01047501|101901721|FG002|NOT COMPLETED|Overall Study||12||
48639783|NCT01288430|101901722|FG000|STARTED|Part 1||2|Only participants enrolled in Pt 1 are reported in this section.|
48639784|NCT01288430|101901723|FG001|STARTED|Part 1||3|Only participants enrolled in Pt 1 are reported in this section.|
48639785|NCT01288430|101901724|FG002|STARTED|Part 1||5|Only participants enrolled in Pt 1 are reported in this section.|
48639786|NCT01288430|101901725|FG003|STARTED|Part 1||7|Only participants enrolled in Pt 1 are reported in this section.|
48639787|NCT01288430|101901726|FG004|STARTED|Part 1||3|Only participants enrolled in Pt 1 are reported in this section.|
48639788|NCT01288430|101901727|FG005|STARTED|Part 1||6|Only participants enrolled in Pt 1 are reported in this section.|
48639789|NCT01288430|101901728|FG006|STARTED|Part 1||7|Only participants enrolled in Pt 1 are reported in this section.|
48639790|NCT01288430|101901729|FG007|STARTED|Part 1||0|Only participants enrolled in Pt 1 are reported in this section.|
48639791|NCT01288430|101901730|FG008|STARTED|Part 1||0|Only participants enrolled in Pt 1 are reported in this section.|
48639792|NCT01288430|101901731|FG009|STARTED|Part 1||0|Only participants enrolled in Pt 1 are reported in this section.|
48639793|NCT01288430|101901722|FG000|COMPLETED|Part 1||0||
48639794|NCT01288430|101901723|FG001|COMPLETED|Part 1||0||
48639795|NCT01288430|101901724|FG002|COMPLETED|Part 1||0||
48639796|NCT01288430|101901725|FG003|COMPLETED|Part 1||0||
48639797|NCT01288430|101901726|FG004|COMPLETED|Part 1||0||
48639798|NCT01288430|101901727|FG005|COMPLETED|Part 1||0||
48639799|NCT01288430|101901728|FG006|COMPLETED|Part 1||0||
48639800|NCT01288430|101901729|FG007|COMPLETED|Part 1||0||
48639801|NCT01288430|101901730|FG008|COMPLETED|Part 1||0||
48639802|NCT01288430|101901731|FG009|COMPLETED|Part 1||0||
48639803|NCT01288430|101901722|FG000|NOT COMPLETED|Part 1||2||
48639804|NCT01288430|101901723|FG001|NOT COMPLETED|Part 1||3||
48639805|NCT01288430|101901724|FG002|NOT COMPLETED|Part 1||5||
48639806|NCT01288430|101901725|FG003|NOT COMPLETED|Part 1||7||
48639807|NCT01288430|101901726|FG004|NOT COMPLETED|Part 1||3||
48639808|NCT01288430|101901727|FG005|NOT COMPLETED|Part 1||6||
48639809|NCT01288430|101901728|FG006|NOT COMPLETED|Part 1||7||
48639810|NCT01288430|101901729|FG007|NOT COMPLETED|Part 1||0||
48639811|NCT01288430|101901730|FG008|NOT COMPLETED|Part 1||0||
48639812|NCT01288430|101901731|FG009|NOT COMPLETED|Part 1||0||
48639813|NCT01288430|101901722|FG000|STARTED|Part 2||0|Only participants enrolled in Pt 2 are reported in this section.|
48639814|NCT01288430|101901723|FG001|STARTED|Part 2||0|Only participants enrolled in Pt 2 are reported in this section.|
48639815|NCT01288430|101901724|FG002|STARTED|Part 2||0|Only participants enrolled in Pt 2 are reported in this section.|
48639816|NCT01288430|101901725|FG003|STARTED|Part 2||0|Only participants enrolled in Pt 2 are reported in this section.|
48639817|NCT01288430|101901726|FG004|STARTED|Part 2||0|Only participants enrolled in Pt 2 are reported in this section.|
48639818|NCT01288430|101901727|FG005|STARTED|Part 2||0|Only participants enrolled in Pt 2 are reported in this section.|
48639819|NCT01288430|101901728|FG006|STARTED|Part 2||0|Only participants enrolled in Pt 2 are reported in this section.|
48639820|NCT01288430|101901729|FG007|STARTED|Part 2||12|Only participants enrolled in Pt 2 are reported in this section.|
48639821|NCT01288430|101901730|FG008|STARTED|Part 2||12|Only participants enrolled in Pt 2 are reported in this section.|
48639822|NCT01288430|101901731|FG009|STARTED|Part 2||3|Only participants enrolled in Pt 2 are reported in this section.|
48639823|NCT01288430|101901722|FG000|COMPLETED|Part 2||0||
48639824|NCT01288430|101901723|FG001|COMPLETED|Part 2||0||
48639825|NCT01288430|101901724|FG002|COMPLETED|Part 2||0||
48639826|NCT01288430|101901725|FG003|COMPLETED|Part 2||0||
48639827|NCT01288430|101901726|FG004|COMPLETED|Part 2||0||
48639828|NCT01288430|101901727|FG005|COMPLETED|Part 2||0||
48639829|NCT01288430|101901728|FG006|COMPLETED|Part 2||0||
48639830|NCT01288430|101901729|FG007|COMPLETED|Part 2||0||
48639831|NCT01288430|101901730|FG008|COMPLETED|Part 2||0||
48639832|NCT01288430|101901731|FG009|COMPLETED|Part 2||0||
48639833|NCT01288430|101901722|FG000|NOT COMPLETED|Part 2||0||
48639834|NCT01288430|101901723|FG001|NOT COMPLETED|Part 2||0||
48639835|NCT01288430|101901724|FG002|NOT COMPLETED|Part 2||0||
48639836|NCT01288430|101901725|FG003|NOT COMPLETED|Part 2||0||
48639837|NCT01288430|101901726|FG004|NOT COMPLETED|Part 2||0||
48639838|NCT01288430|101901727|FG005|NOT COMPLETED|Part 2||0||
48639839|NCT01288430|101901728|FG006|NOT COMPLETED|Part 2||0||
48639840|NCT01288430|101901729|FG007|NOT COMPLETED|Part 2||12||
48639841|NCT01288430|101901730|FG008|NOT COMPLETED|Part 2||12||
48639842|NCT01288430|101901731|FG009|NOT COMPLETED|Part 2||3||
48639843|NCT03801252|101901732|FG000|STARTED|Overall Study||93||
48639844|NCT03801252|101901733|FG001|STARTED|Overall Study||93||
48639845|NCT03801252|101901732|FG000|COMPLETED|Overall Study||92||
48639846|NCT03801252|101901733|FG001|COMPLETED|Overall Study||91||
48639847|NCT03801252|101901732|FG000|NOT COMPLETED|Overall Study||1||
48639848|NCT03801252|101901733|FG001|NOT COMPLETED|Overall Study||2||
48639849|NCT00485303|101901734|FG000|STARTED|Overall Study||58||
48639850|NCT00485303|101901734|FG000|COMPLETED|Overall Study||2||
48639851|NCT00485303|101901734|FG000|NOT COMPLETED|Overall Study||56||
48639852|NCT03100747|101901735|FG000|STARTED|Overall Study||1631||2299
48639853|NCT03100747|101901736|FG001|STARTED|Overall Study||1648||2337
48639854|NCT03100747|101901737|FG002|STARTED|Overall Study||1635||2304
48639855|NCT03100747|101901735|FG000|Completed Week 6|Overall Study||1514||2132
48639856|NCT03100747|101901736|FG001|Completed Week 6|Overall Study||1498||2136
48639857|NCT03100747|101901737|FG002|Completed Week 6|Overall Study||1518||2148
48639858|NCT03100747|101901735|FG000|Completed Month 12|Overall Study||1467||2052
48639859|NCT03100747|101901736|FG001|Completed Month 12|Overall Study||1478||2097
48639860|NCT03100747|101901737|FG002|Completed Month 12|Overall Study||1468||2081
48639861|NCT03100747|101901735|FG000|Completed Week 6 and/or Month 12|Overall Study||1600|End of data collection for the primary outcome.|2257
48639862|NCT03100747|101901736|FG001|Completed Week 6 and/or Month 12|Overall Study||1609|End of data collection for the primary outcome.|2290
48639863|NCT03100747|101901737|FG002|Completed Week 6 and/or Month 12|Overall Study||1610|End of data collection for the primary outcome.|2268
48639864|NCT03100747|101901735|FG000|Completed Year 3|Overall Study||1253||1760
48639865|NCT03100747|101901736|FG001|Completed Year 3|Overall Study||1238||1757
48639866|NCT03100747|101901737|FG002|Completed Year 3|Overall Study||1261||1781
48639867|NCT03100747|101901735|FG000|COMPLETED|Overall Study||1253||1760
48639868|NCT03100747|101901736|FG001|COMPLETED|Overall Study||1238||1757
48639869|NCT03100747|101901737|FG002|COMPLETED|Overall Study||1261||1781
48639870|NCT03100747|101901735|FG000|NOT COMPLETED|Overall Study||378||539
48639871|NCT03100747|101901736|FG001|NOT COMPLETED|Overall Study||410||580
48639872|NCT03100747|101901737|FG002|NOT COMPLETED|Overall Study||374||523
48639873|NCT03003468|101901738|FG000|STARTED|Overall Study||3||
48639874|NCT03003468|101901739|FG001|STARTED|Overall Study||6||
48639875|NCT03003468|101901740|FG002|STARTED|Overall Study||26||
48639876|NCT03003468|101901738|FG000|COMPLETED|Overall Study||3||
48639877|NCT03003468|101901739|FG001|COMPLETED|Overall Study||6||
48639878|NCT03003468|101901740|FG002|COMPLETED|Overall Study||24||
48639879|NCT03003468|101901738|FG000|NOT COMPLETED|Overall Study||0||
48639880|NCT03003468|101901739|FG001|NOT COMPLETED|Overall Study||0||
48639881|NCT03003468|101901740|FG002|NOT COMPLETED|Overall Study||2||
48639882|NCT02110693|101901741|FG000|STARTED|Overall Study||1026||
48639883|NCT02110693|101901742|FG001|STARTED|Overall Study||1031||
48639884|NCT02110693|101901741|FG000|COMPLETED|Overall Study||998||
48639885|NCT02110693|101901742|FG001|COMPLETED|Overall Study||1002||
48639886|NCT02110693|101901741|FG000|NOT COMPLETED|Overall Study||28||
48639887|NCT02110693|101901742|FG001|NOT COMPLETED|Overall Study||29||
48639888|NCT04612400|101901743|FG000|STARTED|Overall Study||4||
48639889|NCT04612400|101901744|FG001|STARTED|Overall Study||4||
48639890|NCT04612400|101901743|FG000|COMPLETED|Overall Study||4||
48639891|NCT04612400|101901744|FG001|COMPLETED|Overall Study||4||
48639892|NCT04612400|101901743|FG000|NOT COMPLETED|Overall Study||0||
48639893|NCT04612400|101901744|FG001|NOT COMPLETED|Overall Study||0||
48639894|NCT05399771|101901745|FG000|STARTED|Overall Study||20||40
48639895|NCT05399771|101901745|FG000|Radiofrequency Heating System|Overall Study||20||20
48639896|NCT05399771|101901745|FG000|No Heating|Overall Study||20||20
48639897|NCT05399771|101901745|FG000|COMPLETED|Overall Study||16||32
48639898|NCT05399771|101901745|FG000|NOT COMPLETED|Overall Study||4||8
48639899|NCT01155141|101901746|FG000|STARTED|Overall Study||16||
48639900|NCT01155141|101901746|FG000|COMPLETED|Overall Study||14||
48639901|NCT01155141|101901746|FG000|NOT COMPLETED|Overall Study||2||
48639902|NCT01186406|101901747|FG000|STARTED|Overall Study||41||
48639903|NCT01186406|101901747|FG000|COMPLETED|Overall Study||41||
48639904|NCT01186406|101901747|FG000|NOT COMPLETED|Overall Study||0||
48639905|NCT00927472|101901748|FG000|STARTED|Overall Study||126||
48639906|NCT00927472|101901749|FG001|STARTED|Overall Study||128||
48639907|NCT00927472|101901748|FG000|COMPLETED|Overall Study||115||
48639908|NCT00927472|101901749|FG001|COMPLETED|Overall Study||106||
48639909|NCT00927472|101901748|FG000|NOT COMPLETED|Overall Study||11||
48639910|NCT00927472|101901749|FG001|NOT COMPLETED|Overall Study||22||
48639911|NCT01750502|101901750|FG000|STARTED|Overall Study||70||
48639912|NCT01750502|101901751|FG001|STARTED|Overall Study||186||
48639913|NCT01750502|101901750|FG000|COMPLETED|Overall Study||70||
48639914|NCT01750502|101901751|FG001|COMPLETED|Overall Study||186||
48639915|NCT01750502|101901750|FG000|NOT COMPLETED|Overall Study||0||
48639916|NCT01750502|101901751|FG001|NOT COMPLETED|Overall Study||0||
48639917|NCT00118287|101901752|FG000|STARTED|Overall Study||32||
48639918|NCT00118287|101901752|FG000|COMPLETED|Overall Study||30||
48639919|NCT00118287|101901752|FG000|NOT COMPLETED|Overall Study||2||
48639920|NCT01750346|101901753|FG000|STARTED|Overall Study||3||
48639921|NCT01750346|101901754|FG001|STARTED|Overall Study||2||
48639922|NCT01750346|101901755|FG002|STARTED|Overall Study||3||
48639923|NCT01750346|101901753|FG000|COMPLETED|Overall Study||2||
48639924|NCT01750346|101901754|FG001|COMPLETED|Overall Study||2||
48639925|NCT01750346|101901755|FG002|COMPLETED|Overall Study||3||
48639926|NCT01750346|101901753|FG000|NOT COMPLETED|Overall Study||1||
48639927|NCT01750346|101901754|FG001|NOT COMPLETED|Overall Study||0||
48639928|NCT01750346|101901755|FG002|NOT COMPLETED|Overall Study||0||
48639929|NCT02311478|101901756|FG000|STARTED|Overall Study||79||
48639930|NCT02311478|101901756|FG000|IUD Insertion|Overall Study||78||
48639931|NCT02311478|101901756|FG000|COMPLETED|Overall Study||72||
48639932|NCT02311478|101901756|FG000|NOT COMPLETED|Overall Study||7||
48639933|NCT00759096|101901757|FG000|STARTED|Overall Study||30||
48639934|NCT00759096|101901757|FG000|COMPLETED|Overall Study||30||
48639935|NCT00759096|101901757|FG000|NOT COMPLETED|Overall Study||0||
48639936|NCT01039675|101901758|FG000|STARTED|Overall Study||9||
48639937|NCT01039675|101901759|FG001|STARTED|Overall Study||42||
48639938|NCT01039675|101901758|FG000|COMPLETED|Overall Study||9||
48639939|NCT01039675|101901759|FG001|COMPLETED|Overall Study||35||
48639940|NCT01039675|101901758|FG000|NOT COMPLETED|Overall Study||0||
48639941|NCT01039675|101901759|FG001|NOT COMPLETED|Overall Study||7||
48639942|NCT01180777|101901760|FG000|STARTED|Overall Study||92||
48639943|NCT01180777|101901760|FG000|COMPLETED|Overall Study||80||
48639944|NCT01180777|101901760|FG000|NOT COMPLETED|Overall Study||12||
48639945|NCT01181479|101905061|FG000|STARTED|Subjects Receive AG200-15 or Lessina||1129|Includes all subjects that were randomized.|
48639946|NCT01181479|101905062|FG001|STARTED|Subjects Receive AG200-15 or Lessina||375|Includes all subjects that were randomized.|
48639947|NCT01181479|101905063|FG002|STARTED|Subjects Receive AG200-15 or Lessina||0|Includes all subjects that were randomized.|
48639948|NCT01181479|101905061|FG000|COMPLETED|Subjects Receive AG200-15 or Lessina||485||
48639949|NCT01181479|101905062|FG001|COMPLETED|Subjects Receive AG200-15 or Lessina||249||
48639950|NCT01181479|101905063|FG002|COMPLETED|Subjects Receive AG200-15 or Lessina||0||
48639951|NCT01181479|101905061|FG000|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||644||
48639952|NCT01181479|101905062|FG001|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||126||
48639953|NCT01181479|101905063|FG002|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||0||
48639954|NCT01181479|101905061|FG000|STARTED|Crossover Subjects Recieve AG200-15||0||
48639955|NCT01181479|101905062|FG001|STARTED|Crossover Subjects Recieve AG200-15||0||
48639956|NCT01181479|101905063|FG002|STARTED|Crossover Subjects Recieve AG200-15||249||
48639957|NCT01181479|101905061|FG000|COMPLETED|Crossover Subjects Recieve AG200-15||0||
48639958|NCT01181479|101905062|FG001|COMPLETED|Crossover Subjects Recieve AG200-15||0||
48639959|NCT01181479|101905063|FG002|COMPLETED|Crossover Subjects Recieve AG200-15||150||
48764359|NCT00217399|102211942|FG000|COMPLETED|Overall Study||35||
48764360|NCT00217399|102211942|FG000|NOT COMPLETED|Overall Study||0||
48764361|NCT00630838|102211943|FG000|STARTED|Overall Study||32||
48764362|NCT00630838|102211944|FG001|STARTED|Overall Study||30||
48764363|NCT00630838|102211943|FG000|COMPLETED|Overall Study||32||
48764364|NCT00630838|102211944|FG001|COMPLETED|Overall Study||28||
48764365|NCT00630838|102211943|FG000|NOT COMPLETED|Overall Study||0||
48764366|NCT00630838|102211944|FG001|NOT COMPLETED|Overall Study||2||
48764367|NCT00389610|102211945|FG000|STARTED|Overall Study||11||
48639960|NCT01181479|101905061|FG000|NOT COMPLETED|Crossover Subjects Recieve AG200-15||0||
48639961|NCT01181479|101905062|FG001|NOT COMPLETED|Crossover Subjects Recieve AG200-15||0||
48639962|NCT01181479|101905063|FG002|NOT COMPLETED|Crossover Subjects Recieve AG200-15||99||
48639963|NCT04115059|101905064|FG000|STARTED|Overall Study||3||
48639964|NCT04115059|101905064|FG000|COMPLETED|Overall Study||0||
48639965|NCT04115059|101905064|FG000|NOT COMPLETED|Overall Study||3||
48639966|NCT04424901|101905065|FG000|STARTED|Overall Study||21||
48639967|NCT04424901|101905066|FG001|STARTED|Overall Study||20||
48639968|NCT04424901|101905065|FG000|COMPLETED|Overall Study||4||
48639969|NCT04424901|101905066|FG001|COMPLETED|Overall Study||4||
48639970|NCT04424901|101905065|FG000|NOT COMPLETED|Overall Study||17||
48639971|NCT04424901|101905066|FG001|NOT COMPLETED|Overall Study||16||
48764368|NCT00389610|102211946|FG001|STARTED|Overall Study||45||
48639972|NCT01922011|101905067|FG000|STARTED|Overall Study||75||
48639973|NCT01922011|101905068|FG001|STARTED|Overall Study||74||
48639974|NCT01922011|101905067|FG000|Treated|Overall Study||73||
48639975|NCT01922011|101905068|FG001|Treated|Overall Study||73||
48639976|NCT01922011|101905067|FG000|Treatment Actually Received|Overall Study||74||
48764369|NCT00389610|102211945|FG000|COMPLETED|Overall Study||11||
48764370|NCT00389610|102211946|FG001|COMPLETED|Overall Study||23||
48639977|NCT01922011|101905068|FG001|Treatment Actually Received|Overall Study||72||
48639978|NCT01922011|101905067|FG000|COMPLETED|Overall Study||69||
48639979|NCT01922011|101905068|FG001|COMPLETED|Overall Study||69||
48639980|NCT01922011|101905067|FG000|NOT COMPLETED|Overall Study||6||
48639981|NCT01922011|101905068|FG001|NOT COMPLETED|Overall Study||5||
48639982|NCT01341470|101905069|FG000|STARTED|Overall Study||6||
48639983|NCT01341470|101905070|FG001|STARTED|Overall Study||9||
48639984|NCT01341470|101905071|FG002|STARTED|Overall Study||10||
48639985|NCT01341470|101905072|FG003|STARTED|Overall Study||10||
48639986|NCT01341470|101905073|FG004|STARTED|Overall Study||2||
48639987|NCT01341470|101905074|FG005|STARTED|Overall Study||10||
48639988|NCT01341470|101905069|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
48639989|NCT01341470|101905070|FG001|Received at Least 1 Dose of Study Drug|Overall Study||9||
48639990|NCT01341470|101905071|FG002|Received at Least 1 Dose of Study Drug|Overall Study||10||
48639991|NCT01341470|101905072|FG003|Received at Least 1 Dose of Study Drug|Overall Study||10||
48639992|NCT01341470|101905073|FG004|Received at Least 1 Dose of Study Drug|Overall Study||2||
48639993|NCT01341470|101905074|FG005|Received at Least 1 Dose of Study Drug|Overall Study||10||
48639994|NCT01341470|101905069|FG000|COMPLETED|Overall Study||6||
48639995|NCT01341470|101905070|FG001|COMPLETED|Overall Study||9||
48639996|NCT01341470|101905071|FG002|COMPLETED|Overall Study||9||
48639997|NCT01341470|101905072|FG003|COMPLETED|Overall Study||9||
48639998|NCT01341470|101905073|FG004|COMPLETED|Overall Study||2||
48639999|NCT01341470|101905074|FG005|COMPLETED|Overall Study||9||
48640000|NCT01341470|101905069|FG000|NOT COMPLETED|Overall Study||0||
48640001|NCT01341470|101905070|FG001|NOT COMPLETED|Overall Study||0||
48640002|NCT01341470|101905071|FG002|NOT COMPLETED|Overall Study||1||
48640003|NCT01341470|101905072|FG003|NOT COMPLETED|Overall Study||1||
48640004|NCT01341470|101905073|FG004|NOT COMPLETED|Overall Study||0||
48640005|NCT01341470|101905074|FG005|NOT COMPLETED|Overall Study||1||
48640006|NCT01432951|101905075|FG000|STARTED|Treatment Phase (Day 1 to 30)||26||
48640007|NCT01432951|101905075|FG000|Received at Least One Dose of Study Drug|Treatment Phase (Day 1 to 30)||25||
48640008|NCT01432951|101905075|FG000|PK Sampling (no Dosing) Days 15-17|Treatment Phase (Day 1 to 30)||23||
48640009|NCT01432951|101905075|FG000|Progressive Disease|Treatment Phase (Day 1 to 30)||10||
48640010|NCT01432951|101905075|FG000|COMPLETED|Treatment Phase (Day 1 to 30)||25||
48640011|NCT01432951|101905075|FG000|NOT COMPLETED|Treatment Phase (Day 1 to 30)||1||
48640012|NCT01432951|101905075|FG000|STARTED|Safety Extension Day 30 to End of Study||15||
48640013|NCT01432951|101905075|FG000|COMPLETED|Safety Extension Day 30 to End of Study||15||
48640014|NCT01432951|101905075|FG000|NOT COMPLETED|Safety Extension Day 30 to End of Study||0||
48640015|NCT01373229|101905076|FG000|STARTED|Overall Study||15||
48640016|NCT01373229|101905076|FG000|COMPLETED|Overall Study||9||
48640017|NCT01373229|101905076|FG000|NOT COMPLETED|Overall Study||6||
48640018|NCT00689936|101905077|FG000|STARTED|Active Treatment Phase||535||
48640019|NCT00689936|101905078|FG001|STARTED|Active Treatment Phase||541||
48640020|NCT00689936|101905079|FG002|STARTED|Active Treatment Phase||547||
48640021|NCT00689936|101905077|FG000|Safety Population|Active Treatment Phase||532||
48640022|NCT00689936|101905078|FG001|Safety Population|Active Treatment Phase||540||
48640023|NCT00689936|101905079|FG002|Safety Population|Active Treatment Phase||541||
48640024|NCT00689936|101905077|FG000|Untreated|Active Treatment Phase||3||
48640025|NCT00689936|101905078|FG001|Untreated|Active Treatment Phase||1||
48640026|NCT00689936|101905079|FG002|Untreated|Active Treatment Phase||6||
48640027|NCT00689936|101905077|FG000|COMPLETED|Active Treatment Phase||0||
48640028|NCT00689936|101905078|FG001|COMPLETED|Active Treatment Phase||0||
48640029|NCT00689936|101905079|FG002|COMPLETED|Active Treatment Phase||0||
48640030|NCT00689936|101905077|FG000|NOT COMPLETED|Active Treatment Phase||535||
48640031|NCT00689936|101905078|FG001|NOT COMPLETED|Active Treatment Phase||541||
48640032|NCT00689936|101905079|FG002|NOT COMPLETED|Active Treatment Phase||547||
48640033|NCT00689936|101905077|FG000|STARTED|Progression Free Survival-PFS-Follow-Up||87||
48640034|NCT00689936|101905078|FG001|STARTED|Progression Free Survival-PFS-Follow-Up||300||
48640035|NCT00689936|101905079|FG002|STARTED|Progression Free Survival-PFS-Follow-Up||273||
48640036|NCT00689936|101905077|FG000|COMPLETED|Progression Free Survival-PFS-Follow-Up||87||
48640037|NCT00689936|101905078|FG001|COMPLETED|Progression Free Survival-PFS-Follow-Up||300||
48640038|NCT00689936|101905079|FG002|COMPLETED|Progression Free Survival-PFS-Follow-Up||273||
48640039|NCT00689936|101905077|FG000|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0||
48640040|NCT00689936|101905078|FG001|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0||
48640041|NCT00689936|101905079|FG002|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0||
48640042|NCT00689936|101905077|FG000|STARTED|Long-Term Follow Up Phase||382||
48640043|NCT00689936|101905078|FG001|STARTED|Long-Term Follow Up Phase||463||
48640044|NCT00689936|101905079|FG002|STARTED|Long-Term Follow Up Phase||459||
48640045|NCT00689936|101905077|FG000|COMPLETED|Long-Term Follow Up Phase||255||
48640046|NCT00689936|101905078|FG001|COMPLETED|Long-Term Follow Up Phase||275||
48640047|NCT00689936|101905079|FG002|COMPLETED|Long-Term Follow Up Phase||315||
48640048|NCT00689936|101905077|FG000|NOT COMPLETED|Long-Term Follow Up Phase||127||
48640049|NCT00689936|101905078|FG001|NOT COMPLETED|Long-Term Follow Up Phase||188||
48640050|NCT00689936|101905079|FG002|NOT COMPLETED|Long-Term Follow Up Phase||144||
48640051|NCT05075772|101905080|FG000|STARTED|Overall Study||14||
48640052|NCT05075772|101905081|FG001|STARTED|Overall Study||14||
48640053|NCT05075772|101905080|FG000|COMPLETED|Overall Study||14||
48640054|NCT05075772|101905081|FG001|COMPLETED|Overall Study||14||
48640055|NCT05075772|101905080|FG000|NOT COMPLETED|Overall Study||0||
48640056|NCT05075772|101905081|FG001|NOT COMPLETED|Overall Study||0||
48640057|NCT05436288|101905082|FG000|STARTED|Overall Study||10||
48640058|NCT05436288|101905082|FG000|COMPLETED|Overall Study||8||
48640059|NCT05436288|101905082|FG000|NOT COMPLETED|Overall Study||2||
48640060|NCT00622518|101905083|FG000|STARTED|Overall Study||59||
48640061|NCT00622518|101905084|FG001|STARTED|Overall Study||60||
48640062|NCT00622518|101905083|FG000|COMPLETED|Overall Study||59||
48640063|NCT00622518|101905084|FG001|COMPLETED|Overall Study||60||
48640064|NCT00622518|101905083|FG000|NOT COMPLETED|Overall Study||0||
48640065|NCT00622518|101905084|FG001|NOT COMPLETED|Overall Study||0||
48640066|NCT01900314|101905085|FG000|STARTED|Overall Study||20||
48640067|NCT01900314|101905086|FG001|STARTED|Overall Study||20||
48640068|NCT01900314|101905085|FG000|Completed MRI#1|Overall Study||17|MRI required BEFORE first treatment|
48640069|NCT01900314|101905086|FG001|Completed MRI#1|Overall Study||17|MRI required BEFORE first treatment|
48640070|NCT01900314|101905085|FG000|COMPLETED|Overall Study||16||
48640071|NCT01900314|101905086|FG001|COMPLETED|Overall Study||16||
48640072|NCT01900314|101905085|FG000|NOT COMPLETED|Overall Study||4||
48640073|NCT01900314|101905086|FG001|NOT COMPLETED|Overall Study||4||
48640074|NCT01125748|101905087|FG000|STARTED|Overall Study||88||
48187873|NCT01253980|100783123|FG000|NOT COMPLETED|Overall Study||0||
48187874|NCT01253980|100783124|FG001|NOT COMPLETED|Overall Study||0||
48187875|NCT01824082|100783125|FG000|STARTED|Initial Treatment||71||
48187876|NCT01824082|100783126|FG001|STARTED|Initial Treatment||73||
48640075|NCT01125748|101905088|FG001|STARTED|Overall Study||88||
48640076|NCT01125748|101905087|FG000|COMPLETED|Overall Study||78||
48640077|NCT01125748|101905088|FG001|COMPLETED|Overall Study||74||
48640078|NCT01125748|101905087|FG000|NOT COMPLETED|Overall Study||10||
48640079|NCT01125748|101905088|FG001|NOT COMPLETED|Overall Study||14||
48640080|NCT01454284|101905089|FG000|STARTED|Overall Study||664||
48640081|NCT01454284|101905090|FG001|STARTED|Overall Study||450||
48640082|NCT01454284|101905089|FG000|Received at Least 1 Dose of Study Drug|Overall Study||663||
48640083|NCT01454284|101905090|FG001|Received at Least 1 Dose of Study Drug|Overall Study||449||
48640084|NCT01454284|101905089|FG000|COMPLETED|Overall Study||548||
48640085|NCT01454284|101905090|FG001|COMPLETED|Overall Study||377||
48640086|NCT01454284|101905089|FG000|NOT COMPLETED|Overall Study||116||
48640087|NCT01454284|101905090|FG001|NOT COMPLETED|Overall Study||73||
48640088|NCT01695772|101905091|FG000|STARTED|Overall Study||50||
48640089|NCT01695772|101905091|FG000|COMPLETED|Overall Study||12||
48640090|NCT01695772|101905091|FG000|NOT COMPLETED|Overall Study||38||
48640091|NCT02336503|101905092|FG000|STARTED|Overall Study||47||
48640092|NCT02336503|101905093|FG001|STARTED|Overall Study||48||
48764371|NCT00389610|102211945|FG000|NOT COMPLETED|Overall Study||0||
48764372|NCT00389610|102211946|FG001|NOT COMPLETED|Overall Study||22||
48764373|NCT02376998|102211947|FG000|STARTED|Overall Study||20||
48764374|NCT02376998|102211947|FG000|COMPLETED|Overall Study||11||
48764375|NCT02376998|102211947|FG000|NOT COMPLETED|Overall Study||9||
48764376|NCT04693767|102211948|FG000|STARTED|Overall Study||388||
48764377|NCT04693767|102211949|FG001|STARTED|Overall Study||12||
48187877|NCT01824082|100783125|FG000|COMPLETED|Initial Treatment||71||
48187878|NCT01824082|100783126|FG001|COMPLETED|Initial Treatment||73||
48187879|NCT01824082|100783125|FG000|NOT COMPLETED|Initial Treatment||0||
48187880|NCT01824082|100783126|FG001|NOT COMPLETED|Initial Treatment||0||
48187881|NCT01824082|100783125|FG000|STARTED|Optional Crossover Treatment||40||
48640093|NCT02336503|101905094|FG002|STARTED|Overall Study||48||
48640094|NCT02336503|101905095|FG003|STARTED|Overall Study||46||
48640095|NCT02336503|101905092|FG000|COMPLETED|Overall Study||45||
48640096|NCT02336503|101905093|FG001|COMPLETED|Overall Study||45||
48640097|NCT02336503|101905094|FG002|COMPLETED|Overall Study||47||
48640098|NCT02336503|101905095|FG003|COMPLETED|Overall Study||40||
48640099|NCT02336503|101905092|FG000|NOT COMPLETED|Overall Study||2||
48640100|NCT02336503|101905093|FG001|NOT COMPLETED|Overall Study||3||
48640101|NCT02336503|101905094|FG002|NOT COMPLETED|Overall Study||1||
48640102|NCT02336503|101905095|FG003|NOT COMPLETED|Overall Study||6||
48640103|NCT02210195|101905096|FG000|STARTED|Overall Study||10||
48640104|NCT02210195|101905097|FG001|STARTED|Overall Study||10||
48640105|NCT02210195|101905096|FG000|COMPLETED|Overall Study||6||
48640106|NCT02210195|101905097|FG001|COMPLETED|Overall Study||10||
48640107|NCT02210195|101905096|FG000|NOT COMPLETED|Overall Study||4||
48640108|NCT02210195|101905097|FG001|NOT COMPLETED|Overall Study||0||
48640109|NCT02734667|101905098|FG000|STARTED|Overall Study||84||
48640110|NCT02734667|101905099|FG001|STARTED|Overall Study||36||
48640111|NCT02734667|101905098|FG000|Youth|Overall Study||42||
48640112|NCT02734667|101905099|FG001|Youth|Overall Study||18||
48640113|NCT02734667|101905098|FG000|Parent|Overall Study||42||
48187882|NCT01824082|100783126|FG001|STARTED|Optional Crossover Treatment||25||
48640114|NCT02734667|101905099|FG001|Parent|Overall Study||18||
48640115|NCT02734667|101905098|FG000|COMPLETED|Overall Study||82||
48640116|NCT02734667|101905099|FG001|COMPLETED|Overall Study||30||
48640117|NCT02734667|101905098|FG000|NOT COMPLETED|Overall Study||2||
48764378|NCT04693767|102211948|FG000|COMPLETED|Overall Study||388||
48764379|NCT04693767|102211949|FG001|COMPLETED|Overall Study||12||
48764380|NCT04693767|102211948|FG000|NOT COMPLETED|Overall Study||0||
48764381|NCT04693767|102211949|FG001|NOT COMPLETED|Overall Study||0||
48764382|NCT00561925|102211950|FG000|STARTED|14 Day Lead-In Period||1068||
48764383|NCT00561925|102211951|FG001|STARTED|14 Day Lead-In Period||0||
48764384|NCT00561925|102211952|FG002|STARTED|14 Day Lead-In Period||0||
48764385|NCT00561925|102211953|FG003|STARTED|14 Day Lead-In Period||0||
48764386|NCT00561925|102211954|FG004|STARTED|14 Day Lead-In Period||0||
48764387|NCT00561925|102211950|FG000|COMPLETED|14 Day Lead-In Period||1013||
48764388|NCT00561925|102211951|FG001|COMPLETED|14 Day Lead-In Period||0||
48764389|NCT00561925|102211952|FG002|COMPLETED|14 Day Lead-In Period||0||
48764390|NCT00561925|102211953|FG003|COMPLETED|14 Day Lead-In Period||0||
48764391|NCT00561925|102211954|FG004|COMPLETED|14 Day Lead-In Period||0||
48764392|NCT00561925|102211950|FG000|NOT COMPLETED|14 Day Lead-In Period||55||
48764393|NCT00561925|102211951|FG001|NOT COMPLETED|14 Day Lead-In Period||0||
48640118|NCT02734667|101905099|FG001|NOT COMPLETED|Overall Study||6||
48640119|NCT02734147|101905100|FG000|STARTED|Overall Study||12||
48640120|NCT02734147|101905101|FG001|STARTED|Overall Study||12||
48640121|NCT02734147|101905100|FG000|COMPLETED|Overall Study||9||
48640122|NCT02734147|101905101|FG001|COMPLETED|Overall Study||11||
48640123|NCT02734147|101905100|FG000|NOT COMPLETED|Overall Study||3||
48640124|NCT02734147|101905101|FG001|NOT COMPLETED|Overall Study||1||
48640125|NCT04307394|101905102|FG000|STARTED|Overall Study||10||
48640126|NCT04307394|101905102|FG000|COMPLETED|Overall Study||5||
48640127|NCT04307394|101905102|FG000|NOT COMPLETED|Overall Study||5||
48640128|NCT00460798|101905103|FG000|STARTED|Overall Study||448||
48640129|NCT00460798|101905103|FG000|Treated|Overall Study||421||
48640130|NCT00460798|101905103|FG000|COMPLETED|Overall Study||108||
48640131|NCT00460798|101905103|FG000|NOT COMPLETED|Overall Study||340||
48640132|NCT01890577|101905104|FG000|STARTED|Overall Study||28||
48640133|NCT01890577|101905104|FG000|COMPLETED|Overall Study||0||
48640134|NCT01890577|101905104|FG000|NOT COMPLETED|Overall Study||28||
48640135|NCT01932606|101905105|FG000|STARTED|Overall Study||14||
48640136|NCT01932606|101905106|FG001|STARTED|Overall Study||14||
48640137|NCT01932606|101905105|FG000|COMPLETED|Overall Study||14||
48640138|NCT01932606|101905106|FG001|COMPLETED|Overall Study||14||
48640139|NCT01932606|101905105|FG000|NOT COMPLETED|Overall Study||0||
48640140|NCT01932606|101905106|FG001|NOT COMPLETED|Overall Study||0||
48640141|NCT01983930|101905107|FG000|STARTED|Overall Study||41||
48640142|NCT01983930|101905108|FG001|STARTED|Overall Study||38||
48640143|NCT01983930|101905107|FG000|COMPLETED|Overall Study||32||
48640144|NCT01983930|101905108|FG001|COMPLETED|Overall Study||29||
48640145|NCT01983930|101905107|FG000|NOT COMPLETED|Overall Study||9||
48640146|NCT01983930|101905108|FG001|NOT COMPLETED|Overall Study||9||
48640147|NCT01860404|101905109|FG000|STARTED|Overall Study||8||
48764394|NCT00561925|102211952|FG002|NOT COMPLETED|14 Day Lead-In Period||0||
48764395|NCT00561925|102211953|FG003|NOT COMPLETED|14 Day Lead-In Period||0||
48640148|NCT01860404|101905110|FG001|STARTED|Overall Study||8||
48640149|NCT01860404|101905111|FG002|STARTED|Overall Study||9||
48640150|NCT01860404|101905112|FG003|STARTED|Overall Study||9||
48640151|NCT01860404|101905113|FG004|STARTED|Overall Study||8||
48640152|NCT01860404|101905109|FG000|COMPLETED|Overall Study||5||
48640153|NCT01860404|101905110|FG001|COMPLETED|Overall Study||4||
48640154|NCT01860404|101905111|FG002|COMPLETED|Overall Study||4||
48640155|NCT01860404|101905112|FG003|COMPLETED|Overall Study||3||
48640156|NCT01860404|101905113|FG004|COMPLETED|Overall Study||4||
48640157|NCT01860404|101905109|FG000|NOT COMPLETED|Overall Study||3||
48640158|NCT01860404|101905110|FG001|NOT COMPLETED|Overall Study||4||
48640159|NCT01860404|101905111|FG002|NOT COMPLETED|Overall Study||5||
48640160|NCT01860404|101905112|FG003|NOT COMPLETED|Overall Study||6||
48640161|NCT01860404|101905113|FG004|NOT COMPLETED|Overall Study||4||
48640162|NCT01988415|101905114|FG000|STARTED|Overall Study||26||
48640163|NCT01988415|101905114|FG000|COMPLETED|Overall Study||26||
48640164|NCT01988415|101905114|FG000|NOT COMPLETED|Overall Study||0||
48640165|NCT04826731|101905115|FG000|STARTED|Overall Study||10||
48640166|NCT04826731|101905116|FG001|STARTED|Overall Study||4||
48640167|NCT04826731|101905115|FG000|COMPLETED|Overall Study||10||
48640168|NCT04826731|101905116|FG001|COMPLETED|Overall Study||4||
48640169|NCT04826731|101905115|FG000|NOT COMPLETED|Overall Study||0||
48640170|NCT04826731|101905116|FG001|NOT COMPLETED|Overall Study||0||
48640171|NCT03329001|101905117|FG000|STARTED|Stage 1: PK Phase- Period 1 (Day 1)||15||
48640172|NCT03329001|101905118|FG001|STARTED|Stage 1: PK Phase- Period 1 (Day 1)||14||
48640173|NCT03329001|101905119|FG002|STARTED|Stage 1: PK Phase- Period 1 (Day 1)||0||
48640174|NCT03329001|101905120|FG003|STARTED|Stage 1: PK Phase- Period 1 (Day 1)||0||
48640175|NCT03329001|101905121|FG004|STARTED|Stage 1: PK Phase- Period 1 (Day 1)||0||
48640176|NCT03329001|101905122|FG005|STARTED|Stage 1: PK Phase- Period 1 (Day 1)||0||
48640177|NCT03329001|101905123|FG006|STARTED|Stage 1: PK Phase- Period 1 (Day 1)||0||
48640178|NCT03329001|101905124|FG007|STARTED|Stage 1: PK Phase- Period 1 (Day 1)||0||
48640179|NCT03329001|101905117|FG000|COMPLETED|Stage 1: PK Phase- Period 1 (Day 1)||15||
48640180|NCT03329001|101905118|FG001|COMPLETED|Stage 1: PK Phase- Period 1 (Day 1)||14||
48764396|NCT00561925|102211954|FG004|NOT COMPLETED|14 Day Lead-In Period||0||
48764397|NCT00561925|102211950|FG000|STARTED|144-week Double-blind, Double-dummy||0||
48764398|NCT00561925|102211951|FG001|STARTED|144-week Double-blind, Double-dummy||508||
48764399|NCT00561925|102211952|FG002|STARTED|144-week Double-blind, Double-dummy||505||
48640181|NCT03329001|101905119|FG002|COMPLETED|Stage 1: PK Phase- Period 1 (Day 1)||0||
48640182|NCT03329001|101905120|FG003|COMPLETED|Stage 1: PK Phase- Period 1 (Day 1)||0||
48640183|NCT03329001|101905121|FG004|COMPLETED|Stage 1: PK Phase- Period 1 (Day 1)||0||
48640184|NCT03329001|101905122|FG005|COMPLETED|Stage 1: PK Phase- Period 1 (Day 1)||0||
48640185|NCT03329001|101905123|FG006|COMPLETED|Stage 1: PK Phase- Period 1 (Day 1)||0||
48640186|NCT03329001|101905124|FG007|COMPLETED|Stage 1: PK Phase- Period 1 (Day 1)||0||
48640187|NCT03329001|101905117|FG000|NOT COMPLETED|Stage 1: PK Phase- Period 1 (Day 1)||0||
48640188|NCT03329001|101905118|FG001|NOT COMPLETED|Stage 1: PK Phase- Period 1 (Day 1)||0||
48640189|NCT03329001|101905119|FG002|NOT COMPLETED|Stage 1: PK Phase- Period 1 (Day 1)||0||
48640190|NCT03329001|101905120|FG003|NOT COMPLETED|Stage 1: PK Phase- Period 1 (Day 1)||0||
48640191|NCT03329001|101905121|FG004|NOT COMPLETED|Stage 1: PK Phase- Period 1 (Day 1)||0||
48640192|NCT03329001|101905122|FG005|NOT COMPLETED|Stage 1: PK Phase- Period 1 (Day 1)||0||
48640193|NCT03329001|101905123|FG006|NOT COMPLETED|Stage 1: PK Phase- Period 1 (Day 1)||0||
48640194|NCT03329001|101905124|FG007|NOT COMPLETED|Stage 1: PK Phase- Period 1 (Day 1)||0||
48640195|NCT03329001|101905117|FG000|STARTED|Stage1:PK Phase Washout1(W)(Up to Day 7)||15||
48640196|NCT03329001|101905118|FG001|STARTED|Stage1:PK Phase Washout1(W)(Up to Day 7)||14||
48640197|NCT03329001|101905119|FG002|STARTED|Stage1:PK Phase Washout1(W)(Up to Day 7)||0||
48640198|NCT03329001|101905120|FG003|STARTED|Stage1:PK Phase Washout1(W)(Up to Day 7)||0||
48640199|NCT03329001|101905121|FG004|STARTED|Stage1:PK Phase Washout1(W)(Up to Day 7)||0||
48640200|NCT03329001|101905122|FG005|STARTED|Stage1:PK Phase Washout1(W)(Up to Day 7)||0||
48640201|NCT03329001|101905123|FG006|STARTED|Stage1:PK Phase Washout1(W)(Up to Day 7)||0||
48640202|NCT03329001|101905124|FG007|STARTED|Stage1:PK Phase Washout1(W)(Up to Day 7)||0||
48640203|NCT03329001|101905117|FG000|COMPLETED|Stage1:PK Phase Washout1(W)(Up to Day 7)||15||
48640204|NCT03329001|101905118|FG001|COMPLETED|Stage1:PK Phase Washout1(W)(Up to Day 7)||14||
48640205|NCT03329001|101905119|FG002|COMPLETED|Stage1:PK Phase Washout1(W)(Up to Day 7)||0||
48640206|NCT03329001|101905120|FG003|COMPLETED|Stage1:PK Phase Washout1(W)(Up to Day 7)||0||
48640207|NCT03329001|101905121|FG004|COMPLETED|Stage1:PK Phase Washout1(W)(Up to Day 7)||0||
48640208|NCT03329001|101905122|FG005|COMPLETED|Stage1:PK Phase Washout1(W)(Up to Day 7)||0||
48640209|NCT03329001|101905123|FG006|COMPLETED|Stage1:PK Phase Washout1(W)(Up to Day 7)||0||
48640210|NCT03329001|101905124|FG007|COMPLETED|Stage1:PK Phase Washout1(W)(Up to Day 7)||0||
48640211|NCT03329001|101905117|FG000|NOT COMPLETED|Stage1:PK Phase Washout1(W)(Up to Day 7)||0||
48640212|NCT03329001|101905118|FG001|NOT COMPLETED|Stage1:PK Phase Washout1(W)(Up to Day 7)||0||
48640213|NCT03329001|101905119|FG002|NOT COMPLETED|Stage1:PK Phase Washout1(W)(Up to Day 7)||0||
48640214|NCT03329001|101905120|FG003|NOT COMPLETED|Stage1:PK Phase Washout1(W)(Up to Day 7)||0||
48640215|NCT03329001|101905121|FG004|NOT COMPLETED|Stage1:PK Phase Washout1(W)(Up to Day 7)||0||
48640216|NCT03329001|101905122|FG005|NOT COMPLETED|Stage1:PK Phase Washout1(W)(Up to Day 7)||0||
48640217|NCT03329001|101905123|FG006|NOT COMPLETED|Stage1:PK Phase Washout1(W)(Up to Day 7)||0||
48640218|NCT03329001|101905124|FG007|NOT COMPLETED|Stage1:PK Phase Washout1(W)(Up to Day 7)||0||
48640219|NCT03329001|101905117|FG000|STARTED|Stage 1: PK Phase- Period 2 (Day 1)||15||
48640220|NCT03329001|101905118|FG001|STARTED|Stage 1: PK Phase- Period 2 (Day 1)||14||
48640221|NCT03329001|101905119|FG002|STARTED|Stage 1: PK Phase- Period 2 (Day 1)||0||
48640222|NCT03329001|101905120|FG003|STARTED|Stage 1: PK Phase- Period 2 (Day 1)||0||
48640223|NCT03329001|101905121|FG004|STARTED|Stage 1: PK Phase- Period 2 (Day 1)||0||
48640224|NCT03329001|101905122|FG005|STARTED|Stage 1: PK Phase- Period 2 (Day 1)||0||
48640225|NCT03329001|101905123|FG006|STARTED|Stage 1: PK Phase- Period 2 (Day 1)||0||
48640226|NCT03329001|101905124|FG007|STARTED|Stage 1: PK Phase- Period 2 (Day 1)||0||
48640227|NCT03329001|101905117|FG000|COMPLETED|Stage 1: PK Phase- Period 2 (Day 1)||15||
48640228|NCT03329001|101905118|FG001|COMPLETED|Stage 1: PK Phase- Period 2 (Day 1)||14||
48640229|NCT03329001|101905119|FG002|COMPLETED|Stage 1: PK Phase- Period 2 (Day 1)||0||
48640230|NCT03329001|101905120|FG003|COMPLETED|Stage 1: PK Phase- Period 2 (Day 1)||0||
48640231|NCT03329001|101905121|FG004|COMPLETED|Stage 1: PK Phase- Period 2 (Day 1)||0||
48640232|NCT03329001|101905122|FG005|COMPLETED|Stage 1: PK Phase- Period 2 (Day 1)||0||
48640233|NCT03329001|101905123|FG006|COMPLETED|Stage 1: PK Phase- Period 2 (Day 1)||0||
48640234|NCT03329001|101905124|FG007|COMPLETED|Stage 1: PK Phase- Period 2 (Day 1)||0||
48640235|NCT03329001|101905117|FG000|NOT COMPLETED|Stage 1: PK Phase- Period 2 (Day 1)||0||
48640236|NCT03329001|101905118|FG001|NOT COMPLETED|Stage 1: PK Phase- Period 2 (Day 1)||0||
48188689|NCT05590910|100783310|FG000|STARTED|Overall Study||49||
48640237|NCT03329001|101905119|FG002|NOT COMPLETED|Stage 1: PK Phase- Period 2 (Day 1)||0||
48640238|NCT03329001|101905120|FG003|NOT COMPLETED|Stage 1: PK Phase- Period 2 (Day 1)||0||
48640239|NCT03329001|101905121|FG004|NOT COMPLETED|Stage 1: PK Phase- Period 2 (Day 1)||0||
48640240|NCT03329001|101905122|FG005|NOT COMPLETED|Stage 1: PK Phase- Period 2 (Day 1)||0||
48640241|NCT03329001|101905123|FG006|NOT COMPLETED|Stage 1: PK Phase- Period 2 (Day 1)||0||
48640242|NCT03329001|101905124|FG007|NOT COMPLETED|Stage 1: PK Phase- Period 2 (Day 1)||0||
48640243|NCT03329001|101905117|FG000|STARTED|Stage1:PK Phase W2 (Up to Day 7)||15||
48640244|NCT03329001|101905118|FG001|STARTED|Stage1:PK Phase W2 (Up to Day 7)||14||
48640245|NCT03329001|101905119|FG002|STARTED|Stage1:PK Phase W2 (Up to Day 7)||0||
48640246|NCT03329001|101905120|FG003|STARTED|Stage1:PK Phase W2 (Up to Day 7)||0||
48640247|NCT03329001|101905121|FG004|STARTED|Stage1:PK Phase W2 (Up to Day 7)||0||
48640248|NCT03329001|101905122|FG005|STARTED|Stage1:PK Phase W2 (Up to Day 7)||0||
48640249|NCT03329001|101905123|FG006|STARTED|Stage1:PK Phase W2 (Up to Day 7)||0||
48640250|NCT03329001|101905124|FG007|STARTED|Stage1:PK Phase W2 (Up to Day 7)||0||
48640251|NCT03329001|101905117|FG000|COMPLETED|Stage1:PK Phase W2 (Up to Day 7)||15||
48640252|NCT03329001|101905118|FG001|COMPLETED|Stage1:PK Phase W2 (Up to Day 7)||14||
48640253|NCT03329001|101905119|FG002|COMPLETED|Stage1:PK Phase W2 (Up to Day 7)||0||
48640254|NCT03329001|101905120|FG003|COMPLETED|Stage1:PK Phase W2 (Up to Day 7)||0||
48640255|NCT03329001|101905121|FG004|COMPLETED|Stage1:PK Phase W2 (Up to Day 7)||0||
48640256|NCT03329001|101905122|FG005|COMPLETED|Stage1:PK Phase W2 (Up to Day 7)||0||
48640257|NCT03329001|101905123|FG006|COMPLETED|Stage1:PK Phase W2 (Up to Day 7)||0||
48640258|NCT03329001|101905124|FG007|COMPLETED|Stage1:PK Phase W2 (Up to Day 7)||0||
48640259|NCT03329001|101905117|FG000|NOT COMPLETED|Stage1:PK Phase W2 (Up to Day 7)||0||
48640260|NCT03329001|101905118|FG001|NOT COMPLETED|Stage1:PK Phase W2 (Up to Day 7)||0||
48640261|NCT03329001|101905119|FG002|NOT COMPLETED|Stage1:PK Phase W2 (Up to Day 7)||0||
48640262|NCT03329001|101905120|FG003|NOT COMPLETED|Stage1:PK Phase W2 (Up to Day 7)||0||
48640263|NCT03329001|101905121|FG004|NOT COMPLETED|Stage1:PK Phase W2 (Up to Day 7)||0||
48640264|NCT03329001|101905122|FG005|NOT COMPLETED|Stage1:PK Phase W2 (Up to Day 7)||0||
48640265|NCT03329001|101905123|FG006|NOT COMPLETED|Stage1:PK Phase W2 (Up to Day 7)||0||
48640266|NCT03329001|101905124|FG007|NOT COMPLETED|Stage1:PK Phase W2 (Up to Day 7)||0||
48640267|NCT03329001|101905117|FG000|STARTED|Stage 2: PK Phase-Period 1 (Day 1)||0||
48640268|NCT03329001|101905118|FG001|STARTED|Stage 2: PK Phase-Period 1 (Day 1)||0||
48640269|NCT03329001|101905119|FG002|STARTED|Stage 2: PK Phase-Period 1 (Day 1)||90||
48640270|NCT03329001|101905120|FG003|STARTED|Stage 2: PK Phase-Period 1 (Day 1)||89||
48640271|NCT03329001|101905121|FG004|STARTED|Stage 2: PK Phase-Period 1 (Day 1)||0||
48640272|NCT03329001|101905122|FG005|STARTED|Stage 2: PK Phase-Period 1 (Day 1)||0||
48640273|NCT03329001|101905123|FG006|STARTED|Stage 2: PK Phase-Period 1 (Day 1)||0||
48640274|NCT03329001|101905124|FG007|STARTED|Stage 2: PK Phase-Period 1 (Day 1)||0||
48640275|NCT03329001|101905117|FG000|Treatment Received|Stage 2: PK Phase-Period 1 (Day 1)||0||
48640276|NCT03329001|101905118|FG001|Treatment Received|Stage 2: PK Phase-Period 1 (Day 1)||0||
48640277|NCT03329001|101905119|FG002|Treatment Received|Stage 2: PK Phase-Period 1 (Day 1)||85||
48640278|NCT03329001|101905120|FG003|Treatment Received|Stage 2: PK Phase-Period 1 (Day 1)||83||
48640279|NCT03329001|101905121|FG004|Treatment Received|Stage 2: PK Phase-Period 1 (Day 1)||0||
48640280|NCT03329001|101905122|FG005|Treatment Received|Stage 2: PK Phase-Period 1 (Day 1)||0||
48640281|NCT03329001|101905123|FG006|Treatment Received|Stage 2: PK Phase-Period 1 (Day 1)||0||
48640282|NCT03329001|101905124|FG007|Treatment Received|Stage 2: PK Phase-Period 1 (Day 1)||0||
48640283|NCT03329001|101905117|FG000|COMPLETED|Stage 2: PK Phase-Period 1 (Day 1)||0||
48640284|NCT03329001|101905118|FG001|COMPLETED|Stage 2: PK Phase-Period 1 (Day 1)||0||
48640285|NCT03329001|101905119|FG002|COMPLETED|Stage 2: PK Phase-Period 1 (Day 1)||85||
48640286|NCT03329001|101905120|FG003|COMPLETED|Stage 2: PK Phase-Period 1 (Day 1)||83||
48640287|NCT03329001|101905121|FG004|COMPLETED|Stage 2: PK Phase-Period 1 (Day 1)||0||
48640288|NCT03329001|101905122|FG005|COMPLETED|Stage 2: PK Phase-Period 1 (Day 1)||0||
48640289|NCT03329001|101905123|FG006|COMPLETED|Stage 2: PK Phase-Period 1 (Day 1)||0||
48640290|NCT03329001|101905124|FG007|COMPLETED|Stage 2: PK Phase-Period 1 (Day 1)||0||
48640291|NCT03329001|101905117|FG000|NOT COMPLETED|Stage 2: PK Phase-Period 1 (Day 1)||0||
48640292|NCT03329001|101905118|FG001|NOT COMPLETED|Stage 2: PK Phase-Period 1 (Day 1)||0||
48640293|NCT03329001|101905119|FG002|NOT COMPLETED|Stage 2: PK Phase-Period 1 (Day 1)||5||
48640294|NCT03329001|101905120|FG003|NOT COMPLETED|Stage 2: PK Phase-Period 1 (Day 1)||6||
48640295|NCT03329001|101905121|FG004|NOT COMPLETED|Stage 2: PK Phase-Period 1 (Day 1)||0||
48640296|NCT03329001|101905122|FG005|NOT COMPLETED|Stage 2: PK Phase-Period 1 (Day 1)||0||
48640297|NCT03329001|101905123|FG006|NOT COMPLETED|Stage 2: PK Phase-Period 1 (Day 1)||0||
48640298|NCT03329001|101905124|FG007|NOT COMPLETED|Stage 2: PK Phase-Period 1 (Day 1)||0||
48640299|NCT03329001|101905117|FG000|STARTED|Stage 2: PK Phase-W1 (Up to Day 14)||0||
48640300|NCT03329001|101905118|FG001|STARTED|Stage 2: PK Phase-W1 (Up to Day 14)||0||
48640301|NCT03329001|101905119|FG002|STARTED|Stage 2: PK Phase-W1 (Up to Day 14)||85||
48640302|NCT03329001|101905120|FG003|STARTED|Stage 2: PK Phase-W1 (Up to Day 14)||83||
48640303|NCT03329001|101905121|FG004|STARTED|Stage 2: PK Phase-W1 (Up to Day 14)||0||
48640304|NCT03329001|101905122|FG005|STARTED|Stage 2: PK Phase-W1 (Up to Day 14)||0||
48640305|NCT03329001|101905123|FG006|STARTED|Stage 2: PK Phase-W1 (Up to Day 14)||0||
48640306|NCT03329001|101905124|FG007|STARTED|Stage 2: PK Phase-W1 (Up to Day 14)||0||
48764400|NCT00561925|102211953|FG003|STARTED|144-week Double-blind, Double-dummy||0||
48640307|NCT03329001|101905117|FG000|COMPLETED|Stage 2: PK Phase-W1 (Up to Day 14)||0||
48640308|NCT03329001|101905118|FG001|COMPLETED|Stage 2: PK Phase-W1 (Up to Day 14)||0||
48361278|NCT01522651|101214306|FG004|STARTED|Overall Study||27||
48361279|NCT01522651|101214302|FG000|COMPLETED|Overall Study||17||
48640309|NCT03329001|101905119|FG002|COMPLETED|Stage 2: PK Phase-W1 (Up to Day 14)||69||
48640310|NCT03329001|101905120|FG003|COMPLETED|Stage 2: PK Phase-W1 (Up to Day 14)||71||
48640311|NCT03329001|101905121|FG004|COMPLETED|Stage 2: PK Phase-W1 (Up to Day 14)||0||
48640312|NCT03329001|101905122|FG005|COMPLETED|Stage 2: PK Phase-W1 (Up to Day 14)||0||
48640313|NCT03329001|101905123|FG006|COMPLETED|Stage 2: PK Phase-W1 (Up to Day 14)||0||
48640314|NCT03329001|101905124|FG007|COMPLETED|Stage 2: PK Phase-W1 (Up to Day 14)||0||
48640315|NCT03329001|101905117|FG000|NOT COMPLETED|Stage 2: PK Phase-W1 (Up to Day 14)||0||
48640316|NCT03329001|101905118|FG001|NOT COMPLETED|Stage 2: PK Phase-W1 (Up to Day 14)||0||
48640317|NCT03329001|101905119|FG002|NOT COMPLETED|Stage 2: PK Phase-W1 (Up to Day 14)||16||
48640318|NCT03329001|101905120|FG003|NOT COMPLETED|Stage 2: PK Phase-W1 (Up to Day 14)||12||
48640319|NCT03329001|101905121|FG004|NOT COMPLETED|Stage 2: PK Phase-W1 (Up to Day 14)||0||
48640320|NCT03329001|101905122|FG005|NOT COMPLETED|Stage 2: PK Phase-W1 (Up to Day 14)||0||
48640321|NCT03329001|101905123|FG006|NOT COMPLETED|Stage 2: PK Phase-W1 (Up to Day 14)||0||
48640322|NCT03329001|101905124|FG007|NOT COMPLETED|Stage 2: PK Phase-W1 (Up to Day 14)||0||
48640323|NCT03329001|101905117|FG000|STARTED|Stage 2: PK Phase- Period 2 (Day 15)||0||
48640324|NCT03329001|101905118|FG001|STARTED|Stage 2: PK Phase- Period 2 (Day 15)||0||
48640325|NCT03329001|101905119|FG002|STARTED|Stage 2: PK Phase- Period 2 (Day 15)||69||
48640326|NCT03329001|101905120|FG003|STARTED|Stage 2: PK Phase- Period 2 (Day 15)||71||
48640327|NCT03329001|101905121|FG004|STARTED|Stage 2: PK Phase- Period 2 (Day 15)||0||
48640328|NCT03329001|101905122|FG005|STARTED|Stage 2: PK Phase- Period 2 (Day 15)||0||
48640329|NCT03329001|101905123|FG006|STARTED|Stage 2: PK Phase- Period 2 (Day 15)||0||
48640330|NCT03329001|101905124|FG007|STARTED|Stage 2: PK Phase- Period 2 (Day 15)||0||
48640331|NCT03329001|101905117|FG000|COMPLETED|Stage 2: PK Phase- Period 2 (Day 15)||0||
48640332|NCT03329001|101905118|FG001|COMPLETED|Stage 2: PK Phase- Period 2 (Day 15)||0||
48640333|NCT03329001|101905119|FG002|COMPLETED|Stage 2: PK Phase- Period 2 (Day 15)||69||
48640334|NCT03329001|101905120|FG003|COMPLETED|Stage 2: PK Phase- Period 2 (Day 15)||71||
48640335|NCT03329001|101905121|FG004|COMPLETED|Stage 2: PK Phase- Period 2 (Day 15)||0||
48640336|NCT03329001|101905122|FG005|COMPLETED|Stage 2: PK Phase- Period 2 (Day 15)||0||
48640337|NCT03329001|101905123|FG006|COMPLETED|Stage 2: PK Phase- Period 2 (Day 15)||0||
48640338|NCT03329001|101905124|FG007|COMPLETED|Stage 2: PK Phase- Period 2 (Day 15)||0||
48640339|NCT03329001|101905117|FG000|NOT COMPLETED|Stage 2: PK Phase- Period 2 (Day 15)||0||
48640340|NCT03329001|101905118|FG001|NOT COMPLETED|Stage 2: PK Phase- Period 2 (Day 15)||0||
48640341|NCT03329001|101905119|FG002|NOT COMPLETED|Stage 2: PK Phase- Period 2 (Day 15)||0||
48640342|NCT03329001|101905120|FG003|NOT COMPLETED|Stage 2: PK Phase- Period 2 (Day 15)||0||
48640343|NCT03329001|101905121|FG004|NOT COMPLETED|Stage 2: PK Phase- Period 2 (Day 15)||0||
48640344|NCT03329001|101905122|FG005|NOT COMPLETED|Stage 2: PK Phase- Period 2 (Day 15)||0||
48640345|NCT03329001|101905123|FG006|NOT COMPLETED|Stage 2: PK Phase- Period 2 (Day 15)||0||
48640346|NCT03329001|101905124|FG007|NOT COMPLETED|Stage 2: PK Phase- Period 2 (Day 15)||0||
48640347|NCT03329001|101905117|FG000|STARTED|Stage2:PK Phase W2 (Up to Day 7)||0||
48640348|NCT03329001|101905118|FG001|STARTED|Stage2:PK Phase W2 (Up to Day 7)||0||
48640349|NCT03329001|101905119|FG002|STARTED|Stage2:PK Phase W2 (Up to Day 7)||69||
48640350|NCT03329001|101905120|FG003|STARTED|Stage2:PK Phase W2 (Up to Day 7)||71||
48640351|NCT03329001|101905121|FG004|STARTED|Stage2:PK Phase W2 (Up to Day 7)||0||
48640352|NCT03329001|101905122|FG005|STARTED|Stage2:PK Phase W2 (Up to Day 7)||0||
48640353|NCT03329001|101905123|FG006|STARTED|Stage2:PK Phase W2 (Up to Day 7)||0||
48640354|NCT03329001|101905124|FG007|STARTED|Stage2:PK Phase W2 (Up to Day 7)||0||
48640355|NCT03329001|101905117|FG000|COMPLETED|Stage2:PK Phase W2 (Up to Day 7)||0||
48640356|NCT03329001|101905118|FG001|COMPLETED|Stage2:PK Phase W2 (Up to Day 7)||0||
48640357|NCT03329001|101905119|FG002|COMPLETED|Stage2:PK Phase W2 (Up to Day 7)||64||
48640358|NCT03329001|101905120|FG003|COMPLETED|Stage2:PK Phase W2 (Up to Day 7)||66||
48640359|NCT03329001|101905121|FG004|COMPLETED|Stage2:PK Phase W2 (Up to Day 7)||0||
48640360|NCT03329001|101905122|FG005|COMPLETED|Stage2:PK Phase W2 (Up to Day 7)||0||
48640361|NCT03329001|101905123|FG006|COMPLETED|Stage2:PK Phase W2 (Up to Day 7)||0||
48640362|NCT03329001|101905124|FG007|COMPLETED|Stage2:PK Phase W2 (Up to Day 7)||0||
48640363|NCT03329001|101905117|FG000|NOT COMPLETED|Stage2:PK Phase W2 (Up to Day 7)||0||
48640364|NCT03329001|101905118|FG001|NOT COMPLETED|Stage2:PK Phase W2 (Up to Day 7)||0||
48361280|NCT01522651|101214303|FG001|COMPLETED|Overall Study||19||
48640365|NCT03329001|101905119|FG002|NOT COMPLETED|Stage2:PK Phase W2 (Up to Day 7)||5||
48640366|NCT03329001|101905120|FG003|NOT COMPLETED|Stage2:PK Phase W2 (Up to Day 7)||5||
48640367|NCT03329001|101905121|FG004|NOT COMPLETED|Stage2:PK Phase W2 (Up to Day 7)||0||
48640368|NCT03329001|101905122|FG005|NOT COMPLETED|Stage2:PK Phase W2 (Up to Day 7)||0||
48640369|NCT03329001|101905123|FG006|NOT COMPLETED|Stage2:PK Phase W2 (Up to Day 7)||0||
48361281|NCT01522651|101214304|FG002|COMPLETED|Overall Study||22||
48361282|NCT01522651|101214305|FG003|COMPLETED|Overall Study||20||
48361283|NCT01522651|101214306|FG004|COMPLETED|Overall Study||21||
48361284|NCT01522651|101214302|FG000|NOT COMPLETED|Overall Study||9||
48361285|NCT01522651|101214303|FG001|NOT COMPLETED|Overall Study||8||
48657034|NCT02018809|101943753|FG000|NOT COMPLETED|Overall Study||0||
48640370|NCT03329001|101905124|FG007|NOT COMPLETED|Stage2:PK Phase W2 (Up to Day 7)||0||
48640371|NCT03329001|101905117|FG000|STARTED|Stage 3: PK Phase- Period 1 (Day 1)||0||
48640372|NCT03329001|101905118|FG001|STARTED|Stage 3: PK Phase- Period 1 (Day 1)||0||
48640373|NCT03329001|101905119|FG002|STARTED|Stage 3: PK Phase- Period 1 (Day 1)||0||
48640374|NCT03329001|101905120|FG003|STARTED|Stage 3: PK Phase- Period 1 (Day 1)||0||
48640375|NCT03329001|101905121|FG004|STARTED|Stage 3: PK Phase- Period 1 (Day 1)||14||
48640376|NCT03329001|101905122|FG005|STARTED|Stage 3: PK Phase- Period 1 (Day 1)||14||
48640377|NCT03329001|101905123|FG006|STARTED|Stage 3: PK Phase- Period 1 (Day 1)||0||
48640378|NCT03329001|101905124|FG007|STARTED|Stage 3: PK Phase- Period 1 (Day 1)||0||
48640379|NCT03329001|101905117|FG000|COMPLETED|Stage 3: PK Phase- Period 1 (Day 1)||0||
48640380|NCT03329001|101905118|FG001|COMPLETED|Stage 3: PK Phase- Period 1 (Day 1)||0||
48640381|NCT03329001|101905119|FG002|COMPLETED|Stage 3: PK Phase- Period 1 (Day 1)||0||
48640382|NCT03329001|101905120|FG003|COMPLETED|Stage 3: PK Phase- Period 1 (Day 1)||0||
48640383|NCT03329001|101905121|FG004|COMPLETED|Stage 3: PK Phase- Period 1 (Day 1)||11||
48640384|NCT03329001|101905122|FG005|COMPLETED|Stage 3: PK Phase- Period 1 (Day 1)||12||
48640385|NCT03329001|101905123|FG006|COMPLETED|Stage 3: PK Phase- Period 1 (Day 1)||0||
48640386|NCT03329001|101905124|FG007|COMPLETED|Stage 3: PK Phase- Period 1 (Day 1)||0||
48640387|NCT03329001|101905117|FG000|NOT COMPLETED|Stage 3: PK Phase- Period 1 (Day 1)||0||
48640388|NCT03329001|101905118|FG001|NOT COMPLETED|Stage 3: PK Phase- Period 1 (Day 1)||0||
48640389|NCT03329001|101905119|FG002|NOT COMPLETED|Stage 3: PK Phase- Period 1 (Day 1)||0||
48640390|NCT03329001|101905120|FG003|NOT COMPLETED|Stage 3: PK Phase- Period 1 (Day 1)||0||
48640391|NCT03329001|101905121|FG004|NOT COMPLETED|Stage 3: PK Phase- Period 1 (Day 1)||3||
48640392|NCT03329001|101905122|FG005|NOT COMPLETED|Stage 3: PK Phase- Period 1 (Day 1)||2||
48640393|NCT03329001|101905123|FG006|NOT COMPLETED|Stage 3: PK Phase- Period 1 (Day 1)||0||
48640394|NCT03329001|101905124|FG007|NOT COMPLETED|Stage 3: PK Phase- Period 1 (Day 1)||0||
48640395|NCT03329001|101905117|FG000|STARTED|Stage 3: PK Phase-W1 (Up to Day 14)||0||
48640396|NCT03329001|101905118|FG001|STARTED|Stage 3: PK Phase-W1 (Up to Day 14)||0||
48640397|NCT03329001|101905119|FG002|STARTED|Stage 3: PK Phase-W1 (Up to Day 14)||0||
48640398|NCT03329001|101905120|FG003|STARTED|Stage 3: PK Phase-W1 (Up to Day 14)||0||
48640399|NCT03329001|101905121|FG004|STARTED|Stage 3: PK Phase-W1 (Up to Day 14)||11||
48640400|NCT03329001|101905122|FG005|STARTED|Stage 3: PK Phase-W1 (Up to Day 14)||12||
48640401|NCT03329001|101905123|FG006|STARTED|Stage 3: PK Phase-W1 (Up to Day 14)||0||
48640402|NCT03329001|101905124|FG007|STARTED|Stage 3: PK Phase-W1 (Up to Day 14)||0||
48640403|NCT03329001|101905117|FG000|COMPLETED|Stage 3: PK Phase-W1 (Up to Day 14)||0||
48640404|NCT03329001|101905118|FG001|COMPLETED|Stage 3: PK Phase-W1 (Up to Day 14)||0||
48640405|NCT03329001|101905119|FG002|COMPLETED|Stage 3: PK Phase-W1 (Up to Day 14)||0||
48640406|NCT03329001|101905120|FG003|COMPLETED|Stage 3: PK Phase-W1 (Up to Day 14)||0||
48640407|NCT03329001|101905121|FG004|COMPLETED|Stage 3: PK Phase-W1 (Up to Day 14)||11||
48640408|NCT03329001|101905122|FG005|COMPLETED|Stage 3: PK Phase-W1 (Up to Day 14)||12||
48640409|NCT03329001|101905123|FG006|COMPLETED|Stage 3: PK Phase-W1 (Up to Day 14)||0||
48640410|NCT03329001|101905124|FG007|COMPLETED|Stage 3: PK Phase-W1 (Up to Day 14)||0||
48640411|NCT03329001|101905117|FG000|NOT COMPLETED|Stage 3: PK Phase-W1 (Up to Day 14)||0||
48640412|NCT03329001|101905118|FG001|NOT COMPLETED|Stage 3: PK Phase-W1 (Up to Day 14)||0||
48640413|NCT03329001|101905119|FG002|NOT COMPLETED|Stage 3: PK Phase-W1 (Up to Day 14)||0||
48640414|NCT03329001|101905120|FG003|NOT COMPLETED|Stage 3: PK Phase-W1 (Up to Day 14)||0||
48640415|NCT03329001|101905121|FG004|NOT COMPLETED|Stage 3: PK Phase-W1 (Up to Day 14)||0||
48640416|NCT03329001|101905122|FG005|NOT COMPLETED|Stage 3: PK Phase-W1 (Up to Day 14)||0||
48640417|NCT03329001|101905123|FG006|NOT COMPLETED|Stage 3: PK Phase-W1 (Up to Day 14)||0||
48640418|NCT03329001|101905124|FG007|NOT COMPLETED|Stage 3: PK Phase-W1 (Up to Day 14)||0||
48640419|NCT03329001|101905117|FG000|STARTED|Stage 3: PK Phase- Period 2 (Day 15)||0||
48640420|NCT03329001|101905118|FG001|STARTED|Stage 3: PK Phase- Period 2 (Day 15)||0||
48640421|NCT03329001|101905119|FG002|STARTED|Stage 3: PK Phase- Period 2 (Day 15)||0||
48640422|NCT03329001|101905120|FG003|STARTED|Stage 3: PK Phase- Period 2 (Day 15)||0||
48640423|NCT03329001|101905121|FG004|STARTED|Stage 3: PK Phase- Period 2 (Day 15)||11||
48640424|NCT03329001|101905122|FG005|STARTED|Stage 3: PK Phase- Period 2 (Day 15)||12||
48640425|NCT03329001|101905123|FG006|STARTED|Stage 3: PK Phase- Period 2 (Day 15)||0||
48640426|NCT03329001|101905124|FG007|STARTED|Stage 3: PK Phase- Period 2 (Day 15)||0||
48640427|NCT03329001|101905117|FG000|COMPLETED|Stage 3: PK Phase- Period 2 (Day 15)||0||
48640428|NCT03329001|101905118|FG001|COMPLETED|Stage 3: PK Phase- Period 2 (Day 15)||0||
48640429|NCT03329001|101905119|FG002|COMPLETED|Stage 3: PK Phase- Period 2 (Day 15)||0||
48640430|NCT03329001|101905120|FG003|COMPLETED|Stage 3: PK Phase- Period 2 (Day 15)||0||
48640431|NCT03329001|101905121|FG004|COMPLETED|Stage 3: PK Phase- Period 2 (Day 15)||10||
48640432|NCT03329001|101905122|FG005|COMPLETED|Stage 3: PK Phase- Period 2 (Day 15)||11||
48640433|NCT03329001|101905123|FG006|COMPLETED|Stage 3: PK Phase- Period 2 (Day 15)||0||
48764401|NCT00561925|102211954|FG004|STARTED|144-week Double-blind, Double-dummy||0||
48764402|NCT00561925|102211950|FG000|COMPLETED|144-week Double-blind, Double-dummy||0||
48764403|NCT00561925|102211951|FG001|COMPLETED|144-week Double-blind, Double-dummy||358||
48640434|NCT03329001|101905124|FG007|COMPLETED|Stage 3: PK Phase- Period 2 (Day 15)||0||
48640435|NCT03329001|101905117|FG000|NOT COMPLETED|Stage 3: PK Phase- Period 2 (Day 15)||0||
48640436|NCT03329001|101905118|FG001|NOT COMPLETED|Stage 3: PK Phase- Period 2 (Day 15)||0||
48640437|NCT03329001|101905119|FG002|NOT COMPLETED|Stage 3: PK Phase- Period 2 (Day 15)||0||
48640438|NCT03329001|101905120|FG003|NOT COMPLETED|Stage 3: PK Phase- Period 2 (Day 15)||0||
48640439|NCT03329001|101905121|FG004|NOT COMPLETED|Stage 3: PK Phase- Period 2 (Day 15)||1||
48640440|NCT03329001|101905122|FG005|NOT COMPLETED|Stage 3: PK Phase- Period 2 (Day 15)||1||
48640441|NCT03329001|101905123|FG006|NOT COMPLETED|Stage 3: PK Phase- Period 2 (Day 15)||0||
48640442|NCT03329001|101905124|FG007|NOT COMPLETED|Stage 3: PK Phase- Period 2 (Day 15)||0||
48640443|NCT03329001|101905117|FG000|STARTED|Stage3:PK Phase W2 (Up to Day 7)||0||
48640444|NCT03329001|101905118|FG001|STARTED|Stage3:PK Phase W2 (Up to Day 7)||0||
48640445|NCT03329001|101905119|FG002|STARTED|Stage3:PK Phase W2 (Up to Day 7)||0||
48640446|NCT03329001|101905120|FG003|STARTED|Stage3:PK Phase W2 (Up to Day 7)||0||
48640447|NCT03329001|101905121|FG004|STARTED|Stage3:PK Phase W2 (Up to Day 7)||10||
48640448|NCT03329001|101905122|FG005|STARTED|Stage3:PK Phase W2 (Up to Day 7)||11||
48640449|NCT03329001|101905123|FG006|STARTED|Stage3:PK Phase W2 (Up to Day 7)||0||
48640450|NCT03329001|101905124|FG007|STARTED|Stage3:PK Phase W2 (Up to Day 7)||0||
48640451|NCT03329001|101905117|FG000|COMPLETED|Stage3:PK Phase W2 (Up to Day 7)||0||
48640452|NCT03329001|101905118|FG001|COMPLETED|Stage3:PK Phase W2 (Up to Day 7)||0||
48640453|NCT03329001|101905119|FG002|COMPLETED|Stage3:PK Phase W2 (Up to Day 7)||0||
48640454|NCT03329001|101905120|FG003|COMPLETED|Stage3:PK Phase W2 (Up to Day 7)||0||
48640455|NCT03329001|101905121|FG004|COMPLETED|Stage3:PK Phase W2 (Up to Day 7)||10||
48640456|NCT03329001|101905122|FG005|COMPLETED|Stage3:PK Phase W2 (Up to Day 7)||11||
48640457|NCT03329001|101905123|FG006|COMPLETED|Stage3:PK Phase W2 (Up to Day 7)||0||
48640458|NCT03329001|101905124|FG007|COMPLETED|Stage3:PK Phase W2 (Up to Day 7)||0||
48640459|NCT03329001|101905117|FG000|NOT COMPLETED|Stage3:PK Phase W2 (Up to Day 7)||0||
48640460|NCT03329001|101905118|FG001|NOT COMPLETED|Stage3:PK Phase W2 (Up to Day 7)||0||
48640461|NCT03329001|101905119|FG002|NOT COMPLETED|Stage3:PK Phase W2 (Up to Day 7)||0||
48640462|NCT03329001|101905120|FG003|NOT COMPLETED|Stage3:PK Phase W2 (Up to Day 7)||0||
48640463|NCT03329001|101905121|FG004|NOT COMPLETED|Stage3:PK Phase W2 (Up to Day 7)||0||
48640464|NCT03329001|101905122|FG005|NOT COMPLETED|Stage3:PK Phase W2 (Up to Day 7)||0||
48433715|NCT05794126|101397107|FG000|STARTED|Period 1: Lens 1, 15 Minutes||47||
48433716|NCT05794126|101397108|FG001|STARTED|Period 1: Lens 1, 15 Minutes||0||
48640465|NCT03329001|101905123|FG006|NOT COMPLETED|Stage3:PK Phase W2 (Up to Day 7)||0||
48640466|NCT03329001|101905124|FG007|NOT COMPLETED|Stage3:PK Phase W2 (Up to Day 7)||0||
48640467|NCT03329001|101905117|FG000|STARTED|Extension Phase(Approx 5 Years 5 Months)||0||
48640468|NCT03329001|101905118|FG001|STARTED|Extension Phase(Approx 5 Years 5 Months)||0||
48640469|NCT03329001|101905119|FG002|STARTED|Extension Phase(Approx 5 Years 5 Months)||0||
48640470|NCT03329001|101905120|FG003|STARTED|Extension Phase(Approx 5 Years 5 Months)||0||
48640471|NCT03329001|101905121|FG004|STARTED|Extension Phase(Approx 5 Years 5 Months)||0||
48640472|NCT03329001|101905122|FG005|STARTED|Extension Phase(Approx 5 Years 5 Months)||0||
48640473|NCT03329001|101905123|FG006|STARTED|Extension Phase(Approx 5 Years 5 Months)||124||
48640474|NCT03329001|101905124|FG007|STARTED|Extension Phase(Approx 5 Years 5 Months)||66||
48640475|NCT03329001|101905117|FG000|COMPLETED|Extension Phase(Approx 5 Years 5 Months)||0||
48640476|NCT03329001|101905118|FG001|COMPLETED|Extension Phase(Approx 5 Years 5 Months)||0||
48640477|NCT03329001|101905119|FG002|COMPLETED|Extension Phase(Approx 5 Years 5 Months)||0||
48640478|NCT03329001|101905120|FG003|COMPLETED|Extension Phase(Approx 5 Years 5 Months)||0||
48640479|NCT03329001|101905121|FG004|COMPLETED|Extension Phase(Approx 5 Years 5 Months)||0||
48640480|NCT03329001|101905122|FG005|COMPLETED|Extension Phase(Approx 5 Years 5 Months)||0||
48640481|NCT03329001|101905123|FG006|COMPLETED|Extension Phase(Approx 5 Years 5 Months)||53||
48640482|NCT03329001|101905124|FG007|COMPLETED|Extension Phase(Approx 5 Years 5 Months)||36||
48640483|NCT03329001|101905117|FG000|NOT COMPLETED|Extension Phase(Approx 5 Years 5 Months)||0||
48640484|NCT03329001|101905118|FG001|NOT COMPLETED|Extension Phase(Approx 5 Years 5 Months)||0||
48640485|NCT03329001|101905119|FG002|NOT COMPLETED|Extension Phase(Approx 5 Years 5 Months)||0||
48640486|NCT03329001|101905120|FG003|NOT COMPLETED|Extension Phase(Approx 5 Years 5 Months)||0||
48640487|NCT03329001|101905121|FG004|NOT COMPLETED|Extension Phase(Approx 5 Years 5 Months)||0||
48640488|NCT03329001|101905122|FG005|NOT COMPLETED|Extension Phase(Approx 5 Years 5 Months)||0||
48640489|NCT03329001|101905123|FG006|NOT COMPLETED|Extension Phase(Approx 5 Years 5 Months)||71||
48640490|NCT03329001|101905124|FG007|NOT COMPLETED|Extension Phase(Approx 5 Years 5 Months)||30||
48640491|NCT04398134|101905125|FG000|STARTED|Overall Study||32||
48640492|NCT04398134|101905126|FG001|STARTED|Overall Study||11||
48640493|NCT04398134|101905127|FG002|STARTED|Overall Study||33||
48640494|NCT04398134|101905128|FG003|STARTED|Overall Study||12||
48640495|NCT04398134|101905125|FG000|COMPLETED|Overall Study||0||
48640496|NCT04398134|101905126|FG001|COMPLETED|Overall Study||0||
48640497|NCT04398134|101905127|FG002|COMPLETED|Overall Study||0||
48640498|NCT04398134|101905128|FG003|COMPLETED|Overall Study||0||
48640499|NCT04398134|101905125|FG000|NOT COMPLETED|Overall Study||32||
48640500|NCT04398134|101905126|FG001|NOT COMPLETED|Overall Study||11||
48640501|NCT04398134|101905127|FG002|NOT COMPLETED|Overall Study||33||
48640502|NCT04398134|101905128|FG003|NOT COMPLETED|Overall Study||12||
48640503|NCT00933933|101905129|FG000|STARTED|General Population From 16 to 89 Years||6164||
48640504|NCT00933933|101905130|FG001|STARTED|General Population From 16 to 89 Years||1287||
48640505|NCT00933933|101905131|FG002|STARTED|General Population From 16 to 89 Years||1206||
48640506|NCT00933933|101905129|FG000|COMPLETED|General Population From 16 to 89 Years||6164||
48640507|NCT00933933|101905130|FG001|COMPLETED|General Population From 16 to 89 Years||1267||
48640508|NCT00933933|101905131|FG002|COMPLETED|General Population From 16 to 89 Years||1206||
48640509|NCT00933933|101905129|FG000|NOT COMPLETED|General Population From 16 to 89 Years||0||
48640510|NCT00933933|101905130|FG001|NOT COMPLETED|General Population From 16 to 89 Years||20||
48640511|NCT00933933|101905131|FG002|NOT COMPLETED|General Population From 16 to 89 Years||0||
48640512|NCT00933933|101905129|FG000|STARTED|Pregnant Females Between 16-44 Years||448||
48640513|NCT00933933|101905130|FG001|STARTED|Pregnant Females Between 16-44 Years||67||
48640514|NCT00933933|101905131|FG002|STARTED|Pregnant Females Between 16-44 Years||203||
48640515|NCT00933933|101905129|FG000|COMPLETED|Pregnant Females Between 16-44 Years||448||
48640516|NCT00933933|101905130|FG001|COMPLETED|Pregnant Females Between 16-44 Years||65||
48640517|NCT00933933|101905131|FG002|COMPLETED|Pregnant Females Between 16-44 Years||203||
48640518|NCT00933933|101905129|FG000|NOT COMPLETED|Pregnant Females Between 16-44 Years||0||
48640519|NCT00933933|101905130|FG001|NOT COMPLETED|Pregnant Females Between 16-44 Years||2||
48640520|NCT00933933|101905131|FG002|NOT COMPLETED|Pregnant Females Between 16-44 Years||0||
48640521|NCT00933933|101905129|FG000|STARTED|Pediatric From 2 to 21 Years||588||
48640522|NCT00933933|101905130|FG001|STARTED|Pediatric From 2 to 21 Years||64||
48640523|NCT00933933|101905131|FG002|STARTED|Pediatric From 2 to 21 Years||0||
48640524|NCT00933933|101905129|FG000|COMPLETED|Pediatric From 2 to 21 Years||588||
48640525|NCT00933933|101905130|FG001|COMPLETED|Pediatric From 2 to 21 Years||64||
48640526|NCT00933933|101905131|FG002|COMPLETED|Pediatric From 2 to 21 Years||0||
48640527|NCT00933933|101905129|FG000|NOT COMPLETED|Pediatric From 2 to 21 Years||0||
48640528|NCT00933933|101905130|FG001|NOT COMPLETED|Pediatric From 2 to 21 Years||0||
48640529|NCT00933933|101905131|FG002|NOT COMPLETED|Pediatric From 2 to 21 Years||0||
48640530|NCT03759184|101905132|FG000|STARTED|Overall Study||1||
48640531|NCT03759184|101905132|FG000|COMPLETED|Overall Study||1||
48640532|NCT03759184|101905132|FG000|NOT COMPLETED|Overall Study||0||
48640533|NCT03589703|101905133|FG000|STARTED|Overall Study||92||
48640534|NCT03589703|101905134|FG001|STARTED|Overall Study||91||
48640535|NCT03589703|101905135|FG002|STARTED|Overall Study||89||
48640536|NCT03589703|101905133|FG000|Completed Follow up 1 Month Post-intervention|Overall Study||81||
48640537|NCT03589703|101905134|FG001|Completed Follow up 1 Month Post-intervention|Overall Study||68||
48640538|NCT03589703|101905135|FG002|Completed Follow up 1 Month Post-intervention|Overall Study||71||
48640539|NCT03589703|101905133|FG000|COMPLETED|Overall Study||81||
48640540|NCT03589703|101905134|FG001|COMPLETED|Overall Study||68||
48640541|NCT03589703|101905135|FG002|COMPLETED|Overall Study||71||
48640542|NCT03589703|101905133|FG000|NOT COMPLETED|Overall Study||11||
48640543|NCT03589703|101905134|FG001|NOT COMPLETED|Overall Study||23||
48640544|NCT03589703|101905135|FG002|NOT COMPLETED|Overall Study||18||
48640545|NCT00585182|101905136|FG000|STARTED|Overall Study||28||
48640546|NCT00585182|101905136|FG000|COMPLETED|Overall Study||28||
48640547|NCT00585182|101905136|FG000|NOT COMPLETED|Overall Study||0||
48640548|NCT00063622|101905137|FG000|STARTED|Overall Study||80||
48640549|NCT00063622|101905138|FG001|STARTED|Overall Study||84||
48640550|NCT00063622|101905139|FG002|STARTED|Overall Study||83||
48640551|NCT00063622|101905137|FG000|COMPLETED|Overall Study||70||
48640552|NCT00063622|101905138|FG001|COMPLETED|Overall Study||80||
48640553|NCT00063622|101905139|FG002|COMPLETED|Overall Study||72||
48640554|NCT00063622|101905137|FG000|NOT COMPLETED|Overall Study||10||
48640555|NCT00063622|101905138|FG001|NOT COMPLETED|Overall Study||4||
48640556|NCT00063622|101905139|FG002|NOT COMPLETED|Overall Study||11||
48640557|NCT01334515|101905140|FG000|STARTED|Overall Study||16||
48640558|NCT01334515|101905141|FG001|STARTED|Overall Study||36||
48640559|NCT01334515|101905140|FG000|COMPLETED|Overall Study||4||
48640560|NCT01334515|101905141|FG001|COMPLETED|Overall Study||7||
48640561|NCT01334515|101905140|FG000|NOT COMPLETED|Overall Study||12||
48640562|NCT01334515|101905141|FG001|NOT COMPLETED|Overall Study||29||
48640563|NCT02593864|101905142|FG000|STARTED|Overall Study||25||
48640564|NCT02593864|101905142|FG000|COMPLETED|Overall Study||19||
48640565|NCT02593864|101905142|FG000|NOT COMPLETED|Overall Study||6||
48640566|NCT04810962|101905143|FG000|STARTED|Overall Study||185||
48640567|NCT04810962|101905144|FG001|STARTED|Overall Study||185||
48640568|NCT04810962|101905143|FG000|COMPLETED|Overall Study||179||
48640569|NCT04810962|101905144|FG001|COMPLETED|Overall Study||179||
48640570|NCT04810962|101905143|FG000|NOT COMPLETED|Overall Study||6||
48640571|NCT04810962|101905144|FG001|NOT COMPLETED|Overall Study||6||
48640572|NCT00800540|101905145|FG000|STARTED|Period One: 6 Weeks||17||
48640573|NCT00800540|101905146|FG001|STARTED|Period One: 6 Weeks||18||
48640574|NCT00800540|101905145|FG000|COMPLETED|Period One: 6 Weeks||16||
48640575|NCT00800540|101905146|FG001|COMPLETED|Period One: 6 Weeks||17||
48640576|NCT00800540|101905145|FG000|NOT COMPLETED|Period One: 6 Weeks||1||
48640577|NCT00800540|101905146|FG001|NOT COMPLETED|Period One: 6 Weeks||1||
48640578|NCT00800540|101905145|FG000|STARTED|Washout: 4 Weeks||16||
48640579|NCT00800540|101905146|FG001|STARTED|Washout: 4 Weeks||17||
48640580|NCT00800540|101905145|FG000|COMPLETED|Washout: 4 Weeks||16||
48640581|NCT00800540|101905146|FG001|COMPLETED|Washout: 4 Weeks||17||
48640582|NCT00800540|101905145|FG000|NOT COMPLETED|Washout: 4 Weeks||0||
48640583|NCT00800540|101905146|FG001|NOT COMPLETED|Washout: 4 Weeks||0||
48640584|NCT00800540|101905145|FG000|STARTED|Period 2: 6 Weeks||16||
48640585|NCT00800540|101905146|FG001|STARTED|Period 2: 6 Weeks||17||
48640586|NCT00800540|101905145|FG000|COMPLETED|Period 2: 6 Weeks||16||
48640587|NCT00800540|101905146|FG001|COMPLETED|Period 2: 6 Weeks||16||
48640588|NCT00800540|101905145|FG000|NOT COMPLETED|Period 2: 6 Weeks||0||
48640589|NCT00800540|101905146|FG001|NOT COMPLETED|Period 2: 6 Weeks||1||
48640590|NCT01089595|101905147|FG000|STARTED|Overall Study||2||
48640591|NCT01089595|101905148|FG001|STARTED|Overall Study||3||
48640592|NCT01089595|101905147|FG000|COMPLETED|Overall Study||2||
48640593|NCT01089595|101905148|FG001|COMPLETED|Overall Study||3||
48640594|NCT01089595|101905147|FG000|NOT COMPLETED|Overall Study||0||
48640595|NCT01089595|101905148|FG001|NOT COMPLETED|Overall Study||0||
48640596|NCT02530242|101905149|FG000|STARTED|Overall Study||16||
48640597|NCT02530242|101905150|FG001|STARTED|Overall Study||16||
48640598|NCT02530242|101905149|FG000|COMPLETED|Overall Study||16||
48640599|NCT02530242|101905150|FG001|COMPLETED|Overall Study||15||
48640600|NCT02530242|101905149|FG000|NOT COMPLETED|Overall Study||0||
48640601|NCT02530242|101905150|FG001|NOT COMPLETED|Overall Study||1||
48640602|NCT01301092|101905151|FG000|STARTED|Overall Study||6||
48640603|NCT01301092|101905152|FG001|STARTED|Overall Study||16||
48640604|NCT01301092|101905153|FG002|STARTED|Overall Study||8||
48640605|NCT01301092|101905151|FG000|COMPLETED|Overall Study||6||
48640606|NCT01301092|101905152|FG001|COMPLETED|Overall Study||16||
48640607|NCT01301092|101905153|FG002|COMPLETED|Overall Study||7||
48640608|NCT01301092|101905151|FG000|NOT COMPLETED|Overall Study||0||
48640609|NCT01301092|101905152|FG001|NOT COMPLETED|Overall Study||0||
48640610|NCT01301092|101905153|FG002|NOT COMPLETED|Overall Study||1||
48640611|NCT00886236|101905154|FG000|STARTED|Overall Study||20||
48640612|NCT00886236|101905155|FG001|STARTED|Overall Study||21||
48640613|NCT00886236|101905156|FG002|STARTED|Overall Study||21||
48640614|NCT00886236|101905154|FG000|COMPLETED|Overall Study||18||
48640615|NCT00886236|101905155|FG001|COMPLETED|Overall Study||17||
48640616|NCT00886236|101905156|FG002|COMPLETED|Overall Study||17||
48640617|NCT00886236|101905154|FG000|NOT COMPLETED|Overall Study||2||
48640618|NCT00886236|101905155|FG001|NOT COMPLETED|Overall Study||4||
48640619|NCT00886236|101905156|FG002|NOT COMPLETED|Overall Study||4||
48640620|NCT00498550|101905157|FG000|STARTED|Overall Study||15||
48640621|NCT00498550|101905158|FG001|STARTED|Overall Study||16||
48640622|NCT00498550|101905157|FG000|COMPLETED|Overall Study||15||
48640623|NCT00498550|101905158|FG001|COMPLETED|Overall Study||15||
48640624|NCT00498550|101905157|FG000|NOT COMPLETED|Overall Study||0||
48640625|NCT00498550|101905158|FG001|NOT COMPLETED|Overall Study||1||
48640626|NCT03286504|101905159|FG000|STARTED|Overall Study||60||
48640627|NCT03286504|101905160|FG001|STARTED|Overall Study||60||
48640628|NCT03286504|101905159|FG000|COMPLETED|Overall Study||41||
48640629|NCT03286504|101905160|FG001|COMPLETED|Overall Study||44||
48640630|NCT03286504|101905159|FG000|NOT COMPLETED|Overall Study||19||
48640631|NCT03286504|101905160|FG001|NOT COMPLETED|Overall Study||16||
48640632|NCT01967277|101905161|FG000|STARTED|Overall Study||22||
48640633|NCT01967277|101905162|FG001|STARTED|Overall Study||22||
48640634|NCT01967277|101905161|FG000|COMPLETED|Overall Study||21||
48640635|NCT01967277|101905162|FG001|COMPLETED|Overall Study||19||
48640636|NCT01967277|101905161|FG000|NOT COMPLETED|Overall Study||1||
48640637|NCT01967277|101905162|FG001|NOT COMPLETED|Overall Study||3||
48640638|NCT02638493|101905163|FG000|STARTED|Overall Study||10||
48640639|NCT02638493|101905164|FG001|STARTED|Overall Study||8||
48640640|NCT02638493|101905165|FG002|STARTED|Overall Study||8||
48640641|NCT02638493|101905163|FG000|COMPLETED|Overall Study||8||
48640642|NCT02638493|101905164|FG001|COMPLETED|Overall Study||8||
48640643|NCT02638493|101905165|FG002|COMPLETED|Overall Study||8||
48640644|NCT02638493|101905163|FG000|NOT COMPLETED|Overall Study||2||
48640645|NCT02638493|101905164|FG001|NOT COMPLETED|Overall Study||0||
48640646|NCT02638493|101905165|FG002|NOT COMPLETED|Overall Study||0||
48640647|NCT01107015|101905166|FG000|STARTED|Overall Study||62||
48640648|NCT01107015|101905167|FG001|STARTED|Overall Study||38||
48640649|NCT01107015|101905168|FG002|STARTED|Overall Study||33||
48640650|NCT01107015|101905169|FG003|STARTED|Overall Study||80||
48640651|NCT01107015|101905166|FG000|COMPLETED|Overall Study||56||
48640652|NCT01107015|101905167|FG001|COMPLETED|Overall Study||23||
48640653|NCT01107015|101905168|FG002|COMPLETED|Overall Study||22||
48640654|NCT01107015|101905169|FG003|COMPLETED|Overall Study||62||
48640655|NCT01107015|101905166|FG000|NOT COMPLETED|Overall Study||6||
48640656|NCT01107015|101905167|FG001|NOT COMPLETED|Overall Study||15||
48640657|NCT01107015|101905168|FG002|NOT COMPLETED|Overall Study||11||
48640658|NCT01107015|101905169|FG003|NOT COMPLETED|Overall Study||18||
48640659|NCT00168298|101905170|FG000|STARTED|Double-Blind Period||226||
48640660|NCT00168298|101905171|FG001|STARTED|Double-Blind Period||218||
48640661|NCT00168298|101905172|FG002|STARTED|Double-Blind Period||224||
48640662|NCT00168298|101905170|FG000|COMPLETED|Double-Blind Period||214||
48640663|NCT00168298|101905171|FG001|COMPLETED|Double-Blind Period||206||
48640664|NCT00168298|101905172|FG002|COMPLETED|Double-Blind Period||209||
48640665|NCT00168298|101905170|FG000|NOT COMPLETED|Double-Blind Period||12||
48640666|NCT00168298|101905171|FG001|NOT COMPLETED|Double-Blind Period||12||
48640667|NCT00168298|101905172|FG002|NOT COMPLETED|Double-Blind Period||15||
48640668|NCT00168298|101905170|FG000|STARTED|Open-Label Period||179||
48640669|NCT00168298|101905171|FG001|STARTED|Open-Label Period||173||
48640670|NCT00168298|101905172|FG002|STARTED|Open-Label Period||168||
48640671|NCT00168298|101905170|FG000|COMPLETED|Open-Label Period||172||
48640672|NCT00168298|101905171|FG001|COMPLETED|Open-Label Period||168||
48640673|NCT00168298|101905172|FG002|COMPLETED|Open-Label Period||160||
48640674|NCT00168298|101905170|FG000|NOT COMPLETED|Open-Label Period||7||
48640675|NCT00168298|101905171|FG001|NOT COMPLETED|Open-Label Period||5||
48640676|NCT00168298|101905172|FG002|NOT COMPLETED|Open-Label Period||8||
48640677|NCT04666298|101905173|FG000|STARTED|Overall Study||57||
48640678|NCT04666298|101905174|FG001|STARTED|Overall Study||55||
48640679|NCT04666298|101905175|FG002|STARTED|Overall Study||101||
48640680|NCT04666298|101905176|FG003|STARTED|Overall Study||99||
48640681|NCT04666298|101905173|FG000|COMPLETED|Overall Study||55||
48640682|NCT04666298|101905174|FG001|COMPLETED|Overall Study||55||
48640683|NCT04666298|101905175|FG002|COMPLETED|Overall Study||100||
48640684|NCT04666298|101905176|FG003|COMPLETED|Overall Study||95||
48640685|NCT04666298|101905173|FG000|NOT COMPLETED|Overall Study||2||
48640686|NCT04666298|101905174|FG001|NOT COMPLETED|Overall Study||0||
48640687|NCT04666298|101905175|FG002|NOT COMPLETED|Overall Study||1||
48640688|NCT04666298|101905176|FG003|NOT COMPLETED|Overall Study||4||
48640689|NCT02421510|101905177|FG000|STARTED|Overall Study||258||
48640690|NCT02421510|101905178|FG001|STARTED|Overall Study||261||
48640691|NCT02421510|101905179|FG002|STARTED|Overall Study||263||
48640692|NCT02421510|101905177|FG000|Completed the 24 Week Treatment Period|Overall Study||236||
48640693|NCT02421510|101905178|FG001|Completed the 24 Week Treatment Period|Overall Study||239||
48640694|NCT02421510|101905179|FG002|Completed the 24 Week Treatment Period|Overall Study||240||
48640695|NCT02421510|101905177|FG000|COMPLETED|Overall Study||225|Participants who completed 52 week treatment (24 weeks + 28 extension weeks) period.|
48640696|NCT02421510|101905178|FG001|COMPLETED|Overall Study||226|Participants who completed 52 week treatment (24 weeks + 28 extension weeks) period.|
48640697|NCT02421510|101905179|FG002|COMPLETED|Overall Study||227|Participants who completed 52 week treatment (24 weeks + 28 extension weeks) period.|
48640698|NCT02421510|101905177|FG000|NOT COMPLETED|Overall Study||33||
48640699|NCT02421510|101905178|FG001|NOT COMPLETED|Overall Study||35||
48640700|NCT02421510|101905179|FG002|NOT COMPLETED|Overall Study||36||
48640701|NCT02184156|101905180|FG000|STARTED|Phase 1 Safety||7||
48640702|NCT02184156|101905181|FG001|STARTED|Phase 1 Safety||0||
48640703|NCT02184156|101905180|FG000|COMPLETED|Phase 1 Safety||7||
48640704|NCT02184156|101905181|FG001|COMPLETED|Phase 1 Safety||0||
48640705|NCT02184156|101905180|FG000|NOT COMPLETED|Phase 1 Safety||0||
48640706|NCT02184156|101905181|FG001|NOT COMPLETED|Phase 1 Safety||0||
48640707|NCT02184156|101905180|FG000|STARTED|Phase 2 20 Week Efficacy||20||
48640708|NCT02184156|101905181|FG001|STARTED|Phase 2 20 Week Efficacy||20||
48640709|NCT02184156|101905180|FG000|COMPLETED|Phase 2 20 Week Efficacy||19||
48640710|NCT02184156|101905181|FG001|COMPLETED|Phase 2 20 Week Efficacy||19||
48640711|NCT02184156|101905180|FG000|NOT COMPLETED|Phase 2 20 Week Efficacy||1||
48640712|NCT02184156|101905181|FG001|NOT COMPLETED|Phase 2 20 Week Efficacy||1||
48640713|NCT00393367|101905182|FG000|STARTED|Overall Study||91||
48640714|NCT00393367|101905183|FG001|STARTED|Overall Study||88||
48640715|NCT00393367|101905182|FG000|COMPLETED|Overall Study||89||
48640716|NCT00393367|101905183|FG001|COMPLETED|Overall Study||81||
48640717|NCT00393367|101905182|FG000|NOT COMPLETED|Overall Study||2||
48640718|NCT00393367|101905183|FG001|NOT COMPLETED|Overall Study||7||
48640719|NCT01245062|101905184|FG000|STARTED|Randomization and Crossover Phase||214|Par. randomized onto study.|
48640720|NCT01245062|101905185|FG001|STARTED|Randomization and Crossover Phase||108|Par. randomized onto study.|
48640721|NCT01245062|101905186|FG002|STARTED|Randomization and Crossover Phase||0|Par. randomized onto study.|
48640722|NCT01245062|101905184|FG000|COMPLETED|Randomization and Crossover Phase||173|Par. completed the study as they died during the conduct of the study.|
48640723|NCT01245062|101905185|FG001|COMPLETED|Randomization and Crossover Phase||77|Par. completed the study as they died during the conduct of the study.|
48640724|NCT01245062|101905186|FG002|COMPLETED|Randomization and Crossover Phase||0|Par. completed the study as they died during the conduct of the study.|
48640725|NCT01245062|101905184|FG000|NOT COMPLETED|Randomization and Crossover Phase||41||
48640726|NCT01245062|101905185|FG001|NOT COMPLETED|Randomization and Crossover Phase||31||
48640727|NCT01245062|101905186|FG002|NOT COMPLETED|Randomization and Crossover Phase||0||
48640728|NCT01245062|101905184|FG000|STARTED|Cross-over Phase||0||
48640729|NCT01245062|101905185|FG001|STARTED|Cross-over Phase||0||
48640730|NCT01245062|101905186|FG002|STARTED|Cross-over Phase||70||
48640731|NCT01245062|101905184|FG000|COMPLETED|Cross-over Phase||0|Par. completed the study as they died during the conduct of the study.|
48764404|NCT00561925|102211952|FG002|COMPLETED|144-week Double-blind, Double-dummy||378||
48764405|NCT00561925|102211953|FG003|COMPLETED|144-week Double-blind, Double-dummy||0||
48640732|NCT01245062|101905185|FG001|COMPLETED|Cross-over Phase||0|Par. completed the study as they died during the conduct of the study.|
48640733|NCT01245062|101905186|FG002|COMPLETED|Cross-over Phase||53|Par. completed the study as they died during the conduct of the study.|
48640734|NCT01245062|101905184|FG000|NOT COMPLETED|Cross-over Phase||0||
48640735|NCT01245062|101905185|FG001|NOT COMPLETED|Cross-over Phase||0||
48640736|NCT01245062|101905186|FG002|NOT COMPLETED|Cross-over Phase||17||
48640737|NCT00464464|101905187|FG000|STARTED|Overall Study||41||
48764406|NCT00561925|102211954|FG004|COMPLETED|144-week Double-blind, Double-dummy||0||
48764407|NCT00561925|102211950|FG000|NOT COMPLETED|144-week Double-blind, Double-dummy||0||
48640738|NCT00464464|101905188|FG001|STARTED|Overall Study||39||
48640739|NCT00464464|101905187|FG000|COMPLETED|Overall Study||36||
48640740|NCT00464464|101905188|FG001|COMPLETED|Overall Study||36||
48640741|NCT00464464|101905187|FG000|NOT COMPLETED|Overall Study||5||
48640742|NCT00464464|101905188|FG001|NOT COMPLETED|Overall Study||3||
48640743|NCT03983109|101905189|FG000|STARTED|Overall Study||30||
48640744|NCT03983109|101905190|FG001|STARTED|Overall Study||30||
48640745|NCT03983109|101905189|FG000|COMPLETED|Overall Study||18||
48640746|NCT03983109|101905190|FG001|COMPLETED|Overall Study||30||
48640747|NCT03983109|101905189|FG000|NOT COMPLETED|Overall Study||12||
48764408|NCT00561925|102211951|FG001|NOT COMPLETED|144-week Double-blind, Double-dummy||150||
48764409|NCT00561925|102211952|FG002|NOT COMPLETED|144-week Double-blind, Double-dummy||127||
48764410|NCT00561925|102211953|FG003|NOT COMPLETED|144-week Double-blind, Double-dummy||0||
48764411|NCT00561925|102211954|FG004|NOT COMPLETED|144-week Double-blind, Double-dummy||0||
48764412|NCT00561925|102211950|FG000|STARTED|Open-Label Extension Period||0||
48764413|NCT00561925|102211951|FG001|STARTED|Open-Label Extension Period||1||
48764414|NCT00561925|102211952|FG002|STARTED|Open-Label Extension Period||0||
48764415|NCT00561925|102211953|FG003|STARTED|Open-Label Extension Period||358||
48764416|NCT00561925|102211954|FG004|STARTED|Open-Label Extension Period||378||
48764417|NCT00561925|102211950|FG000|COMPLETED|Open-Label Extension Period||0||
48764418|NCT00561925|102211951|FG001|COMPLETED|Open-Label Extension Period||1||
48764419|NCT00561925|102211952|FG002|COMPLETED|Open-Label Extension Period||0||
48764420|NCT00561925|102211953|FG003|COMPLETED|Open-Label Extension Period||315||
48764421|NCT00561925|102211954|FG004|COMPLETED|Open-Label Extension Period||328||
48764422|NCT00561925|102211950|FG000|NOT COMPLETED|Open-Label Extension Period||0||
48764423|NCT00561925|102211951|FG001|NOT COMPLETED|Open-Label Extension Period||0||
48764424|NCT00561925|102211952|FG002|NOT COMPLETED|Open-Label Extension Period||0||
48764425|NCT00561925|102211953|FG003|NOT COMPLETED|Open-Label Extension Period||43||
48764426|NCT00561925|102211954|FG004|NOT COMPLETED|Open-Label Extension Period||50||
48764427|NCT00578539|102211955|FG000|STARTED|Overall Study||24||
48764428|NCT00578539|102211955|FG000|COMPLETED|Overall Study||24||
48764429|NCT00578539|102211955|FG000|NOT COMPLETED|Overall Study||0||
48764430|NCT04596267|102211956|FG000|STARTED|Medication Dispense/Exposure Period 1||4||
48764431|NCT04596267|102211957|FG001|STARTED|Medication Dispense/Exposure Period 1||5||
48764432|NCT04596267|102211956|FG000|COMPLETED|Medication Dispense/Exposure Period 1||3||
48764433|NCT04596267|102211957|FG001|COMPLETED|Medication Dispense/Exposure Period 1||4||
48764434|NCT04596267|102211956|FG000|NOT COMPLETED|Medication Dispense/Exposure Period 1||1||
48764435|NCT04596267|102211957|FG001|NOT COMPLETED|Medication Dispense/Exposure Period 1||1||
48764436|NCT04596267|102211956|FG000|STARTED|Alcohol Self-Administration Trial 1||3||
48764437|NCT04596267|102211957|FG001|STARTED|Alcohol Self-Administration Trial 1||4||
48764438|NCT04596267|102211956|FG000|COMPLETED|Alcohol Self-Administration Trial 1||3||
48764439|NCT04596267|102211957|FG001|COMPLETED|Alcohol Self-Administration Trial 1||4||
48764440|NCT04596267|102211956|FG000|NOT COMPLETED|Alcohol Self-Administration Trial 1||0||
48764441|NCT04596267|102211957|FG001|NOT COMPLETED|Alcohol Self-Administration Trial 1||0||
48764442|NCT04596267|102211956|FG000|STARTED|Medication Dispense/Exposure Period 2||3||
48764443|NCT04596267|102211957|FG001|STARTED|Medication Dispense/Exposure Period 2||4||
48764444|NCT04596267|102211956|FG000|COMPLETED|Medication Dispense/Exposure Period 2||3||
48764445|NCT04596267|102211957|FG001|COMPLETED|Medication Dispense/Exposure Period 2||4||
48764446|NCT04596267|102211956|FG000|NOT COMPLETED|Medication Dispense/Exposure Period 2||0||
48764447|NCT04596267|102211957|FG001|NOT COMPLETED|Medication Dispense/Exposure Period 2||0||
48764448|NCT04596267|102211956|FG000|STARTED|Alcohol Self-Administration Trial 2||3||
48764449|NCT04596267|102211957|FG001|STARTED|Alcohol Self-Administration Trial 2||4||
48764450|NCT04596267|102211956|FG000|COMPLETED|Alcohol Self-Administration Trial 2||3||
48764451|NCT04596267|102211957|FG001|COMPLETED|Alcohol Self-Administration Trial 2||4||
48764452|NCT04596267|102211956|FG000|NOT COMPLETED|Alcohol Self-Administration Trial 2||0||
48764453|NCT04596267|102211957|FG001|NOT COMPLETED|Alcohol Self-Administration Trial 2||0||
48764454|NCT01207414|102211958|FG000|STARTED|Overall Study||241||
48764455|NCT01207414|102211959|FG001|STARTED|Overall Study||260||
48764456|NCT01207414|102211958|FG000|Safety Population: Received Study Drug|Overall Study||240||
48640748|NCT03983109|101905190|FG001|NOT COMPLETED|Overall Study||0||
48640749|NCT02507284|101905191|FG000|STARTED|Overall Study||36||
48640750|NCT02507284|101905192|FG001|STARTED|Overall Study||34||
48640751|NCT02507284|101905193|FG002|STARTED|Overall Study||36||
48640752|NCT02507284|101905191|FG000|COMPLETED|Overall Study||25||
48640753|NCT02507284|101905192|FG001|COMPLETED|Overall Study||27||
48640754|NCT02507284|101905193|FG002|COMPLETED|Overall Study||30||
48640755|NCT02507284|101905191|FG000|NOT COMPLETED|Overall Study||11||
48640756|NCT02507284|101905192|FG001|NOT COMPLETED|Overall Study||7||
48764457|NCT01207414|102211959|FG001|Safety Population: Received Study Drug|Overall Study||260||
48764458|NCT01207414|102211958|FG000|COMPLETED|Overall Study||168||
48764459|NCT01207414|102211959|FG001|COMPLETED|Overall Study||178||
48764460|NCT01207414|102211958|FG000|NOT COMPLETED|Overall Study||73||
48764461|NCT01207414|102211959|FG001|NOT COMPLETED|Overall Study||82||
48764462|NCT03138369|102211960|FG000|STARTED|Overall Study||11||
48640757|NCT02507284|101905193|FG002|NOT COMPLETED|Overall Study||6||
48640758|NCT02612155|101905194|FG000|STARTED|Overall Study||17||
48764463|NCT03138369|102211961|FG001|STARTED|Overall Study||11||
48764464|NCT03138369|102211960|FG000|COMPLETED|Overall Study||8||
48764465|NCT03138369|102211961|FG001|COMPLETED|Overall Study||3||
48764466|NCT03138369|102211960|FG000|NOT COMPLETED|Overall Study||3||
48764467|NCT03138369|102211961|FG001|NOT COMPLETED|Overall Study||8||
48764468|NCT04939714|102211962|FG000|STARTED|Overall Study||50||
48764469|NCT04939714|102211963|FG001|STARTED|Overall Study||50||
48764470|NCT04939714|102211962|FG000|Completed Week 8 Assessment|Overall Study||38||
48764471|NCT04939714|102211963|FG001|Completed Week 8 Assessment|Overall Study||38||
48764472|NCT04939714|102211962|FG000|COMPLETED|Overall Study||33|Completed Week 16 Assessment|
48764473|NCT04939714|102211963|FG001|COMPLETED|Overall Study||30|Completed Week 16 Assessment|
48764474|NCT04939714|102211962|FG000|NOT COMPLETED|Overall Study||17||
48764475|NCT04939714|102211963|FG001|NOT COMPLETED|Overall Study||20||
48764476|NCT01046396|102211964|FG000|STARTED|Overall Study||69||
48764477|NCT01046396|102211964|FG000|COMPLETED|Overall Study||64||
48764478|NCT01046396|102211964|FG000|NOT COMPLETED|Overall Study||5||
48764479|NCT02594124|102211965|FG000|STARTED|Overall Study||13||
48764480|NCT02594124|102211966|FG001|STARTED|Overall Study||24||
48764481|NCT02594124|102211967|FG002|STARTED|Overall Study||65||
48764482|NCT02594124|102211968|FG003|STARTED|Overall Study||12||
48764483|NCT02594124|102211969|FG004|STARTED|Overall Study||20||
48764484|NCT02594124|102211970|FG005|STARTED|Overall Study||25||
48764485|NCT02594124|102211971|FG006|STARTED|Overall Study||42||
48764486|NCT02594124|102211972|FG007|STARTED|Overall Study||83||
48764487|NCT02594124|102211973|FG008|STARTED|Overall Study||8||
48764488|NCT02594124|102211965|FG000|COMPLETED|Overall Study||10||
48764489|NCT02594124|102211966|FG001|COMPLETED|Overall Study||10||
48764490|NCT02594124|102211967|FG002|COMPLETED|Overall Study||42||
48764491|NCT02594124|102211968|FG003|COMPLETED|Overall Study||7||
48764492|NCT02594124|102211969|FG004|COMPLETED|Overall Study||12||
48764493|NCT02594124|102211970|FG005|COMPLETED|Overall Study||20||
48764494|NCT02594124|102211971|FG006|COMPLETED|Overall Study||19||
48764495|NCT02594124|102211972|FG007|COMPLETED|Overall Study||44||
48764496|NCT02594124|102211973|FG008|COMPLETED|Overall Study||5||
48764497|NCT02594124|102211965|FG000|NOT COMPLETED|Overall Study||3||
48764498|NCT02594124|102211966|FG001|NOT COMPLETED|Overall Study||14||
48764499|NCT02594124|102211967|FG002|NOT COMPLETED|Overall Study||23||
48764500|NCT02594124|102211968|FG003|NOT COMPLETED|Overall Study||5||
48764501|NCT02594124|102211969|FG004|NOT COMPLETED|Overall Study||8||
48764502|NCT02594124|102211970|FG005|NOT COMPLETED|Overall Study||5||
48764503|NCT02594124|102211971|FG006|NOT COMPLETED|Overall Study||23||
48764504|NCT02594124|102211972|FG007|NOT COMPLETED|Overall Study||39||
48764505|NCT02594124|102211973|FG008|NOT COMPLETED|Overall Study||3||
48764506|NCT02596867|102211974|FG000|STARTED|Overall Study||2||
48764507|NCT02596867|102211974|FG000|2 Patients Prospectively Recruited|Overall Study||2||
48764508|NCT02596867|102211974|FG000|COMPLETED|Overall Study||2||
48764509|NCT02596867|102211974|FG000|NOT COMPLETED|Overall Study||0||
48764510|NCT03877510|102211975|FG000|STARTED|Overall Study||419||
48764511|NCT03877510|102211975|FG000|COMPLETED|Overall Study||352||
48764512|NCT03877510|102211975|FG000|NOT COMPLETED|Overall Study||67||
48764513|NCT00411684|102211976|FG000|STARTED|Overall Study||1533||
48764514|NCT00411684|102211976|FG000|COMPLETED|Overall Study||1241||
48764515|NCT00411684|102211976|FG000|NOT COMPLETED|Overall Study||292||
48764516|NCT00928408|102211977|FG000|STARTED|Overall Study||305||
48764517|NCT00928408|102211977|FG000|Full Analysis Set|Overall Study||303||
48764518|NCT00928408|102211977|FG000|COMPLETED|Overall Study||282||
48764519|NCT00928408|102211977|FG000|NOT COMPLETED|Overall Study||23||
48764520|NCT01972217|102211978|FG000|STARTED|Part A: Open-label Safety Run-in Period||3||
48764521|NCT01972217|102211979|FG001|STARTED|Part A: Open-label Safety Run-in Period||13||
48764522|NCT01972217|102211980|FG002|STARTED|Part A: Open-label Safety Run-in Period||0||
48764523|NCT01972217|102211981|FG003|STARTED|Part A: Open-label Safety Run-in Period||0||
48764524|NCT01972217|102211978|FG000|COMPLETED|Part A: Open-label Safety Run-in Period||2||
48764525|NCT01972217|102211979|FG001|COMPLETED|Part A: Open-label Safety Run-in Period||1||
48764526|NCT01972217|102211980|FG002|COMPLETED|Part A: Open-label Safety Run-in Period||0||
48764527|NCT01972217|102211981|FG003|COMPLETED|Part A: Open-label Safety Run-in Period||0||
48764528|NCT01972217|102211978|FG000|NOT COMPLETED|Part A: Open-label Safety Run-in Period||1||
48764529|NCT01972217|102211979|FG001|NOT COMPLETED|Part A: Open-label Safety Run-in Period||12||
48764530|NCT01972217|102211980|FG002|NOT COMPLETED|Part A: Open-label Safety Run-in Period||0||
48764531|NCT01972217|102211981|FG003|NOT COMPLETED|Part A: Open-label Safety Run-in Period||0||
48764532|NCT01972217|102211978|FG000|STARTED|Part B Double-blind, Randomised Period||0||
48764533|NCT01972217|102211979|FG001|STARTED|Part B Double-blind, Randomised Period||0||
48764534|NCT01972217|102211980|FG002|STARTED|Part B Double-blind, Randomised Period||71||
48764535|NCT01972217|102211981|FG003|STARTED|Part B Double-blind, Randomised Period||71||
48764536|NCT01972217|102211978|FG000|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||0||
48764537|NCT01972217|102211979|FG001|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||0||
48764538|NCT01972217|102211980|FG002|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||71||
48764539|NCT01972217|102211981|FG003|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||71||
48764540|NCT01972217|102211978|FG000|Received Abiraterone|Part B Double-blind, Randomised Period||0||
48764541|NCT01972217|102211979|FG001|Received Abiraterone|Part B Double-blind, Randomised Period||0||
48764542|NCT01972217|102211980|FG002|Received Abiraterone|Part B Double-blind, Randomised Period||71||
48764543|NCT01972217|102211981|FG003|Received Abiraterone|Part B Double-blind, Randomised Period||71||
48764544|NCT01972217|102211978|FG000|COMPLETED|Part B Double-blind, Randomised Period||0||
48764545|NCT01972217|102211979|FG001|COMPLETED|Part B Double-blind, Randomised Period||0||
48764546|NCT01972217|102211980|FG002|COMPLETED|Part B Double-blind, Randomised Period||25||
48764547|NCT01972217|102211981|FG003|COMPLETED|Part B Double-blind, Randomised Period||24||
48764548|NCT01972217|102211978|FG000|NOT COMPLETED|Part B Double-blind, Randomised Period||0||
48764549|NCT01972217|102211979|FG001|NOT COMPLETED|Part B Double-blind, Randomised Period||0||
48764550|NCT01972217|102211980|FG002|NOT COMPLETED|Part B Double-blind, Randomised Period||46||
48764551|NCT01972217|102211981|FG003|NOT COMPLETED|Part B Double-blind, Randomised Period||47||
48764552|NCT02536976|102211982|FG000|STARTED|Overall Study||3||
48764553|NCT02536976|102211983|FG001|STARTED|Overall Study||2||
48764554|NCT02536976|102211982|FG000|Randomization|Overall Study||3||
48764555|NCT02536976|102211983|FG001|Randomization|Overall Study||1||
48764556|NCT02536976|102211982|FG000|Dose Escalation and Maintenance|Overall Study||3||
48764557|NCT02536976|102211983|FG001|Dose Escalation and Maintenance|Overall Study||1||
48764558|NCT02536976|102211982|FG000|Washout|Overall Study||3||
48764559|NCT02536976|102211983|FG001|Washout|Overall Study||1||
48764560|NCT02536976|102211982|FG000|COMPLETED|Overall Study||3||
48764561|NCT02536976|102211983|FG001|COMPLETED|Overall Study||1||
48764562|NCT02536976|102211982|FG000|NOT COMPLETED|Overall Study||0||
48764563|NCT02536976|102211983|FG001|NOT COMPLETED|Overall Study||1||
48764564|NCT03480048|102211984|FG000|STARTED|Overall Study||28||
48764565|NCT03480048|102211985|FG001|STARTED|Overall Study||25||
48764566|NCT03480048|102211984|FG000|COMPLETED|Overall Study||18||
48764567|NCT03480048|102211985|FG001|COMPLETED|Overall Study||17||
48764568|NCT03480048|102211984|FG000|NOT COMPLETED|Overall Study||10||
48764569|NCT03480048|102211985|FG001|NOT COMPLETED|Overall Study||8||
48764570|NCT03493464|102211986|FG000|STARTED|Overall Study||14||
48764571|NCT03493464|102211986|FG000|COMPLETED|Overall Study||13||
48764572|NCT03493464|102211986|FG000|NOT COMPLETED|Overall Study||1||
48764573|NCT04267380|102211987|FG000|STARTED|Overall Study||149||
48764574|NCT04267380|102211988|FG001|STARTED|Overall Study||149||
48764575|NCT04267380|102211987|FG000|COMPLETED|Overall Study||149||
48764576|NCT04267380|102211988|FG001|COMPLETED|Overall Study||149||
48764577|NCT04267380|102211987|FG000|NOT COMPLETED|Overall Study||0||
48764578|NCT04267380|102211988|FG001|NOT COMPLETED|Overall Study||0||
48764579|NCT01569191|102211989|FG000|STARTED|Overall Study||11||
48764580|NCT01569191|102211990|FG001|STARTED|Overall Study||7||
48764581|NCT01569191|102211989|FG000|COMPLETED|Overall Study||11||
48764582|NCT01569191|102211990|FG001|COMPLETED|Overall Study||7||
48764583|NCT01569191|102211989|FG000|NOT COMPLETED|Overall Study||0||
48764584|NCT01569191|102211990|FG001|NOT COMPLETED|Overall Study||0||
48764585|NCT02761330|102211991|FG000|STARTED|Treatment Week 1||2||
48764586|NCT02761330|102211992|FG001|STARTED|Treatment Week 1||3||
48764587|NCT02761330|102211993|FG002|STARTED|Treatment Week 1||2||
48764588|NCT02761330|102211994|FG003|STARTED|Treatment Week 1||3||
48764589|NCT02761330|102211995|FG004|STARTED|Treatment Week 1||1||
48764590|NCT02761330|102211996|FG005|STARTED|Treatment Week 1||3||
48764591|NCT02761330|102211991|FG000|COMPLETED|Treatment Week 1||2||
48764592|NCT02761330|102211992|FG001|COMPLETED|Treatment Week 1||3||
48764593|NCT02761330|102211993|FG002|COMPLETED|Treatment Week 1||2||
48764594|NCT02761330|102211994|FG003|COMPLETED|Treatment Week 1||2||
48764595|NCT02761330|102211995|FG004|COMPLETED|Treatment Week 1||1||
48764596|NCT02761330|102211996|FG005|COMPLETED|Treatment Week 1||2||
48764597|NCT02761330|102211991|FG000|NOT COMPLETED|Treatment Week 1||0||
48764598|NCT02761330|102211992|FG001|NOT COMPLETED|Treatment Week 1||0||
48764599|NCT02761330|102211993|FG002|NOT COMPLETED|Treatment Week 1||0||
48764600|NCT02761330|102211994|FG003|NOT COMPLETED|Treatment Week 1||1||
48764601|NCT02761330|102211995|FG004|NOT COMPLETED|Treatment Week 1||0||
48764602|NCT02761330|102211996|FG005|NOT COMPLETED|Treatment Week 1||1||
48764603|NCT02761330|102211991|FG000|STARTED|Treatment Week 2||2||
48764604|NCT02761330|102211992|FG001|STARTED|Treatment Week 2||3||
48764605|NCT02761330|102211993|FG002|STARTED|Treatment Week 2||2||
48764606|NCT02761330|102211994|FG003|STARTED|Treatment Week 2||1||
48764607|NCT02761330|102211995|FG004|STARTED|Treatment Week 2||1||
48764608|NCT02761330|102211996|FG005|STARTED|Treatment Week 2||1||
48764609|NCT02761330|102211991|FG000|COMPLETED|Treatment Week 2||2||
48764610|NCT02761330|102211992|FG001|COMPLETED|Treatment Week 2||3||
48764611|NCT02761330|102211993|FG002|COMPLETED|Treatment Week 2||2||
48764612|NCT02761330|102211994|FG003|COMPLETED|Treatment Week 2||1||
48764613|NCT02761330|102211995|FG004|COMPLETED|Treatment Week 2||1||
48764614|NCT02761330|102211996|FG005|COMPLETED|Treatment Week 2||1||
48764615|NCT02761330|102211991|FG000|NOT COMPLETED|Treatment Week 2||0||
48764616|NCT02761330|102211992|FG001|NOT COMPLETED|Treatment Week 2||0||
48764617|NCT02761330|102211993|FG002|NOT COMPLETED|Treatment Week 2||0||
48764618|NCT02761330|102211994|FG003|NOT COMPLETED|Treatment Week 2||0||
48764619|NCT02761330|102211995|FG004|NOT COMPLETED|Treatment Week 2||0||
48764620|NCT02761330|102211996|FG005|NOT COMPLETED|Treatment Week 2||0||
48764621|NCT01074502|102211997|FG000|STARTED|Overall Study||3||
48764622|NCT01074502|102211997|FG000|COMPLETED|Overall Study||2||
48764623|NCT01074502|102211997|FG000|NOT COMPLETED|Overall Study||1||
48764624|NCT03292926|102211998|FG000|STARTED|Overall Study||39||
48764625|NCT03292926|102211999|FG001|STARTED|Overall Study||39||
48764626|NCT03292926|102211998|FG000|COMPLETED|Overall Study||39||
48764627|NCT03292926|102211999|FG001|COMPLETED|Overall Study||39||
48764628|NCT03292926|102211998|FG000|NOT COMPLETED|Overall Study||0||
48764629|NCT03292926|102211999|FG001|NOT COMPLETED|Overall Study||0||
48764630|NCT01317472|102212000|FG000|STARTED|Overall Study||9||
48764631|NCT01317472|102212001|FG001|STARTED|Overall Study||2||
48764632|NCT01317472|102212000|FG000|COMPLETED|Overall Study||7||
48764633|NCT01317472|102212001|FG001|COMPLETED|Overall Study||2||
48764634|NCT01317472|102212000|FG000|NOT COMPLETED|Overall Study||2||
48764635|NCT01317472|102212001|FG001|NOT COMPLETED|Overall Study||0||
48764636|NCT01553084|102212002|FG000|STARTED|Overall Study||241||
48764637|NCT01553084|102212003|FG001|STARTED|Overall Study||421||
48764638|NCT01553084|102212004|FG002|STARTED|Overall Study||424||
48764639|NCT01553084|102212002|FG000|COMPLETED|Overall Study||226||
48764640|NCT01553084|102212003|FG001|COMPLETED|Overall Study||408||
48764641|NCT01553084|102212004|FG002|COMPLETED|Overall Study||389||
48764642|NCT01553084|102212002|FG000|NOT COMPLETED|Overall Study||15||
48764643|NCT01553084|102212003|FG001|NOT COMPLETED|Overall Study||13||
48764644|NCT01553084|102212004|FG002|NOT COMPLETED|Overall Study||35||
48764645|NCT03895203|102212005|FG000|STARTED|Double-Blind Treatment Period: 16 Weeks||281||
48764646|NCT03895203|102212006|FG001|STARTED|Double-Blind Treatment Period: 16 Weeks||431||
48764647|NCT03895203|102212007|FG002|STARTED|Double-Blind Treatment Period: 16 Weeks||140||
48764648|NCT03895203|102212008|FG003|STARTED|Double-Blind Treatment Period: 16 Weeks||0||
48764649|NCT03895203|102212009|FG004|STARTED|Double-Blind Treatment Period: 16 Weeks||0||
48764650|NCT03895203|102212010|FG005|STARTED|Double-Blind Treatment Period: 16 Weeks||0||
48764651|NCT03895203|102212005|FG000|Enthesitis at Baseline: PA0010/PA0011 Pooled Population|Double-Blind Treatment Period: 16 Weeks||106||
48764652|NCT03895203|102212006|FG001|Enthesitis at Baseline: PA0010/PA0011 Pooled Population|Double-Blind Treatment Period: 16 Weeks||249||
48764653|NCT03895203|102212007|FG002|Enthesitis at Baseline: PA0010/PA0011 Pooled Population|Double-Blind Treatment Period: 16 Weeks||0||
48764654|NCT03895203|102212008|FG003|Enthesitis at Baseline: PA0010/PA0011 Pooled Population|Double-Blind Treatment Period: 16 Weeks||0||
48764655|NCT03895203|102212009|FG004|Enthesitis at Baseline: PA0010/PA0011 Pooled Population|Double-Blind Treatment Period: 16 Weeks||0||
48764656|NCT03895203|102212010|FG005|Enthesitis at Baseline: PA0010/PA0011 Pooled Population|Double-Blind Treatment Period: 16 Weeks||0||
48764657|NCT03895203|102212005|FG000|Dactylitis at Baseline: PA0010/PA0011 Pooled Population|Double-Blind Treatment Period: 16 Weeks||47||
48764658|NCT03895203|102212006|FG001|Dactylitis at Baseline: PA0010/PA0011 Pooled Population|Double-Blind Treatment Period: 16 Weeks||90||
48764659|NCT03895203|102212007|FG002|Dactylitis at Baseline: PA0010/PA0011 Pooled Population|Double-Blind Treatment Period: 16 Weeks||0||
48764660|NCT03895203|102212008|FG003|Dactylitis at Baseline: PA0010/PA0011 Pooled Population|Double-Blind Treatment Period: 16 Weeks||0||
48764661|NCT03895203|102212009|FG004|Dactylitis at Baseline: PA0010/PA0011 Pooled Population|Double-Blind Treatment Period: 16 Weeks||0||
48764662|NCT03895203|102212010|FG005|Dactylitis at Baseline: PA0010/PA0011 Pooled Population|Double-Blind Treatment Period: 16 Weeks||0||
48764663|NCT03895203|102212005|FG000|COMPLETED|Double-Blind Treatment Period: 16 Weeks||271||
48764664|NCT03895203|102212006|FG001|COMPLETED|Double-Blind Treatment Period: 16 Weeks||415||
48764665|NCT03895203|102212007|FG002|COMPLETED|Double-Blind Treatment Period: 16 Weeks||137||
48764666|NCT03895203|102212008|FG003|COMPLETED|Double-Blind Treatment Period: 16 Weeks||0||
48764667|NCT03895203|102212009|FG004|COMPLETED|Double-Blind Treatment Period: 16 Weeks||0||
48764668|NCT03895203|102212010|FG005|COMPLETED|Double-Blind Treatment Period: 16 Weeks||0||
48764669|NCT03895203|102212005|FG000|NOT COMPLETED|Double-Blind Treatment Period: 16 Weeks||10||
48764670|NCT03895203|102212006|FG001|NOT COMPLETED|Double-Blind Treatment Period: 16 Weeks||16||
48764671|NCT03895203|102212007|FG002|NOT COMPLETED|Double-Blind Treatment Period: 16 Weeks||3||
48764672|NCT03895203|102212008|FG003|NOT COMPLETED|Double-Blind Treatment Period: 16 Weeks||0||
48764673|NCT03895203|102212009|FG004|NOT COMPLETED|Double-Blind Treatment Period: 16 Weeks||0||
48764674|NCT03895203|102212010|FG005|NOT COMPLETED|Double-Blind Treatment Period: 16 Weeks||0||
48764675|NCT03895203|102212005|FG000|STARTED|Active Treatment-Blind Period: 36 Weeks||0||
48764676|NCT03895203|102212006|FG001|STARTED|Active Treatment-Blind Period: 36 Weeks||0||
48764677|NCT03895203|102212007|FG002|STARTED|Active Treatment-Blind Period: 36 Weeks||0||
48764678|NCT03895203|102212008|FG003|STARTED|Active Treatment-Blind Period: 36 Weeks||271||
48764679|NCT03895203|102212009|FG004|STARTED|Active Treatment-Blind Period: 36 Weeks||414||
48764680|NCT03895203|102212010|FG005|STARTED|Active Treatment-Blind Period: 36 Weeks||136||
48764681|NCT03895203|102212005|FG000|COMPLETED|Active Treatment-Blind Period: 36 Weeks||0||
48764682|NCT03895203|102212006|FG001|COMPLETED|Active Treatment-Blind Period: 36 Weeks||0||
48764683|NCT03895203|102212007|FG002|COMPLETED|Active Treatment-Blind Period: 36 Weeks||0||
48764684|NCT03895203|102212008|FG003|COMPLETED|Active Treatment-Blind Period: 36 Weeks||257||
48764685|NCT03895203|102212009|FG004|COMPLETED|Active Treatment-Blind Period: 36 Weeks||387||
48764686|NCT03895203|102212010|FG005|COMPLETED|Active Treatment-Blind Period: 36 Weeks||125||
48764687|NCT03895203|102212005|FG000|NOT COMPLETED|Active Treatment-Blind Period: 36 Weeks||0||
48764688|NCT03895203|102212006|FG001|NOT COMPLETED|Active Treatment-Blind Period: 36 Weeks||0||
48764689|NCT03895203|102212007|FG002|NOT COMPLETED|Active Treatment-Blind Period: 36 Weeks||0||
48764690|NCT03895203|102212008|FG003|NOT COMPLETED|Active Treatment-Blind Period: 36 Weeks||14||
48764691|NCT03895203|102212009|FG004|NOT COMPLETED|Active Treatment-Blind Period: 36 Weeks||27||
48764692|NCT03895203|102212010|FG005|NOT COMPLETED|Active Treatment-Blind Period: 36 Weeks||11||
48764693|NCT04992312|102212011|FG000|STARTED|Overall Study||7||
48764694|NCT04992312|102212011|FG000|Received at Least One Dose of Study Drug|Overall Study||7||
48640759|NCT02612155|101905195|FG001|STARTED|Overall Study||18||
48640760|NCT02612155|101905194|FG000|COMPLETED|Overall Study||14||
48640761|NCT02612155|101905195|FG001|COMPLETED|Overall Study||15||
48640762|NCT02612155|101905194|FG000|NOT COMPLETED|Overall Study||3||
48640763|NCT02612155|101905195|FG001|NOT COMPLETED|Overall Study||3||
48640764|NCT01648959|101905196|FG000|STARTED|Overall Study||5||
48640765|NCT01648959|101905196|FG000|COMPLETED|Overall Study||5||
48640766|NCT01648959|101905196|FG000|NOT COMPLETED|Overall Study||0||
48640767|NCT03572218|101905197|FG000|STARTED|Overall Study||36||
48640768|NCT03572218|101905198|FG001|STARTED|Overall Study||36||
48640769|NCT03572218|101905197|FG000|Week 12|Overall Study||30||
48640770|NCT03572218|101905198|FG001|Week 12|Overall Study||31||
48640771|NCT03572218|101905197|FG000|Week 26|Overall Study||30||
48640772|NCT03572218|101905198|FG001|Week 26|Overall Study||31||
48640773|NCT03572218|101905197|FG000|COMPLETED|Overall Study||30||
48640774|NCT03572218|101905198|FG001|COMPLETED|Overall Study||31||
48640775|NCT03572218|101905197|FG000|NOT COMPLETED|Overall Study||6||
48640776|NCT03572218|101905198|FG001|NOT COMPLETED|Overall Study||5||
48640777|NCT00694161|101905199|FG000|STARTED|Part 1 (up to Week 6)||35||
48640778|NCT00694161|101905199|FG000|COMPLETED|Part 1 (up to Week 6)||35||
48640779|NCT00694161|101905199|FG000|NOT COMPLETED|Part 1 (up to Week 6)||0||
48640780|NCT00694161|101905199|FG000|STARTED|Part 2 (After Week 6 up to Month 12)||35||
48640781|NCT00694161|101905199|FG000|COMPLETED|Part 2 (After Week 6 up to Month 12)||32||
48640782|NCT00694161|101905199|FG000|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||3||
48640783|NCT04018001|101905200|FG000|STARTED|Overall Study||678||
48640784|NCT04018001|101905201|FG001|STARTED|Overall Study||379||
48640785|NCT04018001|101905200|FG000|COMPLETED|Overall Study||678||
48640786|NCT04018001|101905201|FG001|COMPLETED|Overall Study||379||
48640787|NCT04018001|101905200|FG000|NOT COMPLETED|Overall Study||0||
48640788|NCT04018001|101905201|FG001|NOT COMPLETED|Overall Study||0||
48640789|NCT03611062|101905202|FG000|STARTED|Overall Study||14||
48640790|NCT03611062|101905203|FG001|STARTED|Overall Study||13||
48640791|NCT03611062|101905202|FG000|COMPLETED|Overall Study||13||
48640792|NCT03611062|101905203|FG001|COMPLETED|Overall Study||12||
48640793|NCT03611062|101905202|FG000|NOT COMPLETED|Overall Study||1||
48640794|NCT03611062|101905203|FG001|NOT COMPLETED|Overall Study||1||
48640795|NCT02006654|101905204|FG000|STARTED|Overall Study||369||
48640796|NCT02006654|101905205|FG001|STARTED|Overall Study||365||
48640797|NCT02006654|101905204|FG000|Treated|Overall Study||365||
48640798|NCT02006654|101905205|FG001|Treated|Overall Study||363||
48640799|NCT02006654|101905204|FG000|COMPLETED|Overall Study||324||
48640800|NCT02006654|101905205|FG001|COMPLETED|Overall Study||321||
48640801|NCT02006654|101905204|FG000|NOT COMPLETED|Overall Study||45||
48640802|NCT02006654|101905205|FG001|NOT COMPLETED|Overall Study||44||
48764695|NCT04992312|102212011|FG000|COMPLETED|Overall Study||7||
48764696|NCT04992312|102212011|FG000|NOT COMPLETED|Overall Study||0||
48764697|NCT03520998|102212012|FG000|STARTED|Overall Study||24||
48764698|NCT03520998|102212013|FG001|STARTED|Overall Study||23||
48764699|NCT03520998|102212012|FG000|COMPLETED|Overall Study||18||
48764700|NCT03520998|102212013|FG001|COMPLETED|Overall Study||21||
48764701|NCT03520998|102212012|FG000|NOT COMPLETED|Overall Study||6||
48764702|NCT03520998|102212013|FG001|NOT COMPLETED|Overall Study||2||
48764703|NCT00325897|102212014|FG000|STARTED|Overall Study||570||
48764704|NCT00325897|102212015|FG001|STARTED|Overall Study||572||
48764705|NCT00325897|102212014|FG000|COMPLETED|Overall Study||558||
48640803|NCT02393755|101905206|FG000|STARTED|Overall Study||3||
48640804|NCT02393755|101905207|FG001|STARTED|Overall Study||39||
48640805|NCT02393755|101905206|FG000|COMPLETED|Overall Study||3||
48640806|NCT02393755|101905207|FG001|COMPLETED|Overall Study||32||
48640807|NCT02393755|101905206|FG000|NOT COMPLETED|Overall Study||0||
48640808|NCT02393755|101905207|FG001|NOT COMPLETED|Overall Study||7||
48640809|NCT02194465|101905208|FG000|STARTED|Overall Study||51||
48764706|NCT00325897|102212015|FG001|COMPLETED|Overall Study||559||
48764707|NCT00325897|102212014|FG000|NOT COMPLETED|Overall Study||12||
48764708|NCT00325897|102212015|FG001|NOT COMPLETED|Overall Study||13||
48764709|NCT01586364|102212016|FG000|STARTED|Overall Study||301||
48764710|NCT01586364|102212016|FG000|COMPLETED|Overall Study||184||
48640810|NCT02194465|101905209|FG001|STARTED|Overall Study||50||
48640811|NCT02194465|101905210|FG002|STARTED|Overall Study||52||
48640812|NCT02194465|101905211|FG003|STARTED|Overall Study||49||
48640813|NCT02194465|101905212|FG004|STARTED|Overall Study||51||
48640814|NCT02194465|101905213|FG005|STARTED|Overall Study||25||
48640815|NCT02194465|101905214|FG006|STARTED|Overall Study||26||
48764711|NCT01586364|102212016|FG000|NOT COMPLETED|Overall Study||117||
48640816|NCT02194465|101905208|FG000|Received at Least 1 Dose of Study Drug|Overall Study||51||
48640817|NCT02194465|101905209|FG001|Received at Least 1 Dose of Study Drug|Overall Study||50||
48640818|NCT02194465|101905210|FG002|Received at Least 1 Dose of Study Drug|Overall Study||51||
48640819|NCT02194465|101905211|FG003|Received at Least 1 Dose of Study Drug|Overall Study||49||
48640820|NCT02194465|101905212|FG004|Received at Least 1 Dose of Study Drug|Overall Study||51||
48640821|NCT02194465|101905213|FG005|Received at Least 1 Dose of Study Drug|Overall Study||25||
48640822|NCT02194465|101905214|FG006|Received at Least 1 Dose of Study Drug|Overall Study||26||
48640823|NCT02194465|101905208|FG000|COMPLETED|Overall Study||42||
48640824|NCT02194465|101905209|FG001|COMPLETED|Overall Study||43||
48640825|NCT02194465|101905210|FG002|COMPLETED|Overall Study||44||
48640826|NCT02194465|101905211|FG003|COMPLETED|Overall Study||41||
48640827|NCT02194465|101905212|FG004|COMPLETED|Overall Study||42||
48640828|NCT02194465|101905213|FG005|COMPLETED|Overall Study||21||
48640829|NCT02194465|101905214|FG006|COMPLETED|Overall Study||24||
48640830|NCT02194465|101905208|FG000|NOT COMPLETED|Overall Study||9||
48640831|NCT02194465|101905209|FG001|NOT COMPLETED|Overall Study||7||
48640832|NCT02194465|101905210|FG002|NOT COMPLETED|Overall Study||8||
48640833|NCT02194465|101905211|FG003|NOT COMPLETED|Overall Study||8||
48640834|NCT02194465|101905212|FG004|NOT COMPLETED|Overall Study||9||
48640835|NCT02194465|101905213|FG005|NOT COMPLETED|Overall Study||4||
48640836|NCT02194465|101905214|FG006|NOT COMPLETED|Overall Study||2||
48640837|NCT01653418|101905215|FG000|STARTED|Overall Study||10||
48640838|NCT01653418|101905215|FG000|COMPLETED|Overall Study||10||
48640839|NCT01653418|101905215|FG000|NOT COMPLETED|Overall Study||0||
48640840|NCT02403271|101905216|FG000|STARTED|Period 1||7||
48640841|NCT02403271|101905217|FG001|STARTED|Period 1||0||
48640842|NCT02403271|101905216|FG000|COMPLETED|Period 1||6||
48640843|NCT02403271|101905217|FG001|COMPLETED|Period 1||0||
48640844|NCT02403271|101905216|FG000|NOT COMPLETED|Period 1||1||
48640845|NCT02403271|101905217|FG001|NOT COMPLETED|Period 1||0||
48640846|NCT02403271|101905216|FG000|STARTED|Period 2||0||
48640847|NCT02403271|101905217|FG001|STARTED|Period 2||124||
48640848|NCT02403271|101905216|FG000|COMPLETED|Period 2||0||
48640849|NCT02403271|101905217|FG001|COMPLETED|Period 2||0||
48640850|NCT02403271|101905216|FG000|NOT COMPLETED|Period 2||0||
48640851|NCT02403271|101905217|FG001|NOT COMPLETED|Period 2||124||
48640852|NCT01143324|101905218|FG000|STARTED|Overall Study||252||
48640853|NCT01143324|101905218|FG000|COMPLETED|Overall Study||233||
48640854|NCT01143324|101905218|FG000|NOT COMPLETED|Overall Study||19||
48640855|NCT03439839|101905219|FG000|STARTED|Overall Study||10||
48640856|NCT03439839|101905220|FG001|STARTED|Overall Study||6||
48640857|NCT03439839|101905219|FG000|COMPLETED|Overall Study||7||
48640858|NCT03439839|101905220|FG001|COMPLETED|Overall Study||6||
48640859|NCT03439839|101905219|FG000|NOT COMPLETED|Overall Study||3||
48640860|NCT03439839|101905220|FG001|NOT COMPLETED|Overall Study||0||
48640861|NCT00149643|101905221|FG000|STARTED|Overall Study||34||
48640862|NCT00149643|101905222|FG001|STARTED|Overall Study||36||
48640863|NCT00149643|101905221|FG000|COMPLETED|Overall Study||0||
48640864|NCT00149643|101905222|FG001|COMPLETED|Overall Study||0||
48640865|NCT00149643|101905221|FG000|NOT COMPLETED|Overall Study||34||
48640866|NCT00149643|101905222|FG001|NOT COMPLETED|Overall Study||36||
48640867|NCT04940221|101905223|FG000|STARTED|Overall Study||80||
48640868|NCT04940221|101905223|FG000|COMPLETED|Overall Study||80||
48640869|NCT04940221|101905223|FG000|NOT COMPLETED|Overall Study||0||
48640870|NCT00261040|101905224|FG000|STARTED|Overall Study||20||
48640871|NCT00261040|101905225|FG001|STARTED|Overall Study||20||
48640872|NCT00261040|101905224|FG000|COMPLETED|Overall Study||19||
48640873|NCT00261040|101905225|FG001|COMPLETED|Overall Study||20||
48640874|NCT00261040|101905224|FG000|NOT COMPLETED|Overall Study||1||
48640875|NCT00261040|101905225|FG001|NOT COMPLETED|Overall Study||0||
48640876|NCT03483103|101905226|FG000|STARTED|Pre-Treatment Phase||74|Participants who underwent leukapheresis|
48640877|NCT03483103|101905226|FG000|COMPLETED|Pre-Treatment Phase||63|Participants who completed leukapheresis and continued to lymphodepleting chemotherapy (LDC) treatment period|
48640878|NCT03483103|101905226|FG000|NOT COMPLETED|Pre-Treatment Phase||11||
48640879|NCT03483103|101905226|FG000|STARTED|Treatment Phase||63|Participants who underwent lymphodepleting chemotherapy (LDC) treatment|
48640880|NCT03483103|101905226|FG000|Received JCAR017|Treatment Phase||61||
48640881|NCT03483103|101905226|FG000|Received Nonconforming Product|Treatment Phase||1||
48640882|NCT03483103|101905226|FG000|Did Not Receive Either JAR017 or Nonconforming Product|Treatment Phase||1||
48640883|NCT03483103|101905226|FG000|COMPLETED|Treatment Phase||30|Completed study|
48640884|NCT03483103|101905226|FG000|NOT COMPLETED|Treatment Phase||33||
48640885|NCT01875237|101905227|FG000|STARTED|Overall Study||2||
48640886|NCT01875237|101905228|FG001|STARTED|Overall Study||1||
48640887|NCT01875237|101905227|FG000|COMPLETED|Overall Study||0||
48640888|NCT01875237|101905228|FG001|COMPLETED|Overall Study||1||
48433717|NCT05794126|101397107|FG000|COMPLETED|Period 1: Lens 1, 15 Minutes||47||
48433718|NCT05794126|101397108|FG001|COMPLETED|Period 1: Lens 1, 15 Minutes||0||
48433719|NCT05794126|101397107|FG000|NOT COMPLETED|Period 1: Lens 1, 15 Minutes||0||
48640889|NCT01875237|101905227|FG000|NOT COMPLETED|Overall Study||2||
48640890|NCT01875237|101905228|FG001|NOT COMPLETED|Overall Study||0||
48640891|NCT05169905|101905229|FG000|STARTED|Overall Study||1||
48640892|NCT05169905|101905230|FG001|STARTED|Overall Study||3||
48433720|NCT05794126|101397108|FG001|NOT COMPLETED|Period 1: Lens 1, 15 Minutes||0||
48433721|NCT05794126|101397107|FG000|STARTED|Period 2: Lens 2, 15 Minutes||0||
48433722|NCT05794126|101397108|FG001|STARTED|Period 2: Lens 2, 15 Minutes||47||
48433723|NCT05794126|101397107|FG000|COMPLETED|Period 2: Lens 2, 15 Minutes||0||
48640893|NCT05169905|101905231|FG002|STARTED|Overall Study||4||
48640894|NCT05169905|101905229|FG000|COMPLETED|Overall Study||1||
48640895|NCT05169905|101905230|FG001|COMPLETED|Overall Study||3||
48640896|NCT05169905|101905231|FG002|COMPLETED|Overall Study||4||
48640897|NCT05169905|101905229|FG000|NOT COMPLETED|Overall Study||0||
48640898|NCT05169905|101905230|FG001|NOT COMPLETED|Overall Study||0||
48640899|NCT05169905|101905231|FG002|NOT COMPLETED|Overall Study||0||
48640900|NCT00867932|101905232|FG000|STARTED|Overall Study||7||
48640901|NCT00867932|101905232|FG000|Induction Phase|Overall Study||7||
48640902|NCT00867932|101905232|FG000|Maintenance Phase|Overall Study||7||
48640903|NCT00867932|101905232|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7||
48640904|NCT00867932|101905232|FG000|Intent-to-Treat (ITT) Population|Overall Study||7|Participants who received at least 1 dose of study drug.|
48640905|NCT00867932|101905232|FG000|COMPLETED|Overall Study||7||
48640906|NCT00867932|101905232|FG000|NOT COMPLETED|Overall Study||0||
48640907|NCT00784875|101905233|FG000|STARTED|Period A - Baseline||0||
48640908|NCT00784875|101905234|FG001|STARTED|Period A - Baseline||0||
48640909|NCT00784875|101905235|FG002|STARTED|Period A - Baseline||0||
48640910|NCT00784875|101905236|FG003|STARTED|Period A - Baseline||643||
48640911|NCT00784875|101905233|FG000|COMPLETED|Period A - Baseline||0||
48640912|NCT00784875|101905234|FG001|COMPLETED|Period A - Baseline||0||
48640913|NCT00784875|101905235|FG002|COMPLETED|Period A - Baseline||0||
48640914|NCT00784875|101905236|FG003|COMPLETED|Period A - Baseline||461||
48640915|NCT00784875|101905233|FG000|NOT COMPLETED|Period A - Baseline||0||
48640916|NCT00784875|101905234|FG001|NOT COMPLETED|Period A - Baseline||0||
48640917|NCT00784875|101905235|FG002|NOT COMPLETED|Period A - Baseline||0||
48640918|NCT00784875|101905236|FG003|NOT COMPLETED|Period A - Baseline||182||
48640919|NCT00784875|101905233|FG000|STARTED|Period B - Efficacy Endpoint||114||
48640920|NCT00784875|101905234|FG001|STARTED|Period B - Efficacy Endpoint||113||
48640921|NCT00784875|101905235|FG002|STARTED|Period B - Efficacy Endpoint||117||
48640922|NCT00784875|101905236|FG003|STARTED|Period B - Efficacy Endpoint||117||
48640923|NCT00784875|101905233|FG000|Cohort 2|Period B - Efficacy Endpoint||102||
48640924|NCT00784875|101905234|FG001|Cohort 2|Period B - Efficacy Endpoint||102||
48640925|NCT00784875|101905235|FG002|Cohort 2|Period B - Efficacy Endpoint||102||
48640926|NCT00784875|101905236|FG003|Cohort 2|Period B - Efficacy Endpoint||101||
48640927|NCT00784875|101905233|FG000|COMPLETED|Period B - Efficacy Endpoint||100||
48640928|NCT00784875|101905234|FG001|COMPLETED|Period B - Efficacy Endpoint||101||
48640929|NCT00784875|101905235|FG002|COMPLETED|Period B - Efficacy Endpoint||96||
48640930|NCT00784875|101905236|FG003|COMPLETED|Period B - Efficacy Endpoint||98||
48640931|NCT00784875|101905233|FG000|NOT COMPLETED|Period B - Efficacy Endpoint||14||
48640932|NCT00784875|101905234|FG001|NOT COMPLETED|Period B - Efficacy Endpoint||12||
48640933|NCT00784875|101905235|FG002|NOT COMPLETED|Period B - Efficacy Endpoint||21||
48640934|NCT00784875|101905236|FG003|NOT COMPLETED|Period B - Efficacy Endpoint||19||
48640935|NCT00784875|101905233|FG000|STARTED|Period C||103||
48640936|NCT00784875|101905234|FG001|STARTED|Period C||97||
48640937|NCT00784875|101905235|FG002|STARTED|Period C||97||
48640938|NCT00784875|101905236|FG003|STARTED|Period C||98||
48640939|NCT00784875|101905233|FG000|COMPLETED|Period C||96||
48640940|NCT00784875|101905234|FG001|COMPLETED|Period C||91||
48640941|NCT00784875|101905235|FG002|COMPLETED|Period C||84||
48640942|NCT00784875|101905236|FG003|COMPLETED|Period C||91||
48433724|NCT05794126|101397108|FG001|COMPLETED|Period 2: Lens 2, 15 Minutes||47||
48433725|NCT05794126|101397107|FG000|NOT COMPLETED|Period 2: Lens 2, 15 Minutes||0||
48433726|NCT05794126|101397108|FG001|NOT COMPLETED|Period 2: Lens 2, 15 Minutes||0||
48433727|NCT00083226|101397109|FG000|STARTED|Overall Study||42||
48433728|NCT00083226|101397109|FG000|COMPLETED|Overall Study||0||
48433729|NCT00083226|101397109|FG000|NOT COMPLETED|Overall Study||42||
48433730|NCT03743571|101397110|FG000|STARTED|Overall Study||17||
48433731|NCT03743571|101397111|FG001|STARTED|Overall Study||16||
48640943|NCT00784875|101905233|FG000|NOT COMPLETED|Period C||7||
48640944|NCT00784875|101905234|FG001|NOT COMPLETED|Period C||6||
48640945|NCT00784875|101905235|FG002|NOT COMPLETED|Period C||13||
48640946|NCT00784875|101905236|FG003|NOT COMPLETED|Period C||7||
48640947|NCT00784875|101905233|FG000|STARTED|Period D||91||
48433732|NCT03743571|101397110|FG000|COMPLETED|Overall Study||15||
48433733|NCT03743571|101397111|FG001|COMPLETED|Overall Study||13||
48433734|NCT03743571|101397110|FG000|NOT COMPLETED|Overall Study||2||
48433735|NCT03743571|101397111|FG001|NOT COMPLETED|Overall Study||3||
48433736|NCT00752206|101397112|FG000|STARTED|Overall Study||19||
48433737|NCT00752206|101397113|FG001|STARTED|Overall Study||19||
48640948|NCT00784875|101905234|FG001|STARTED|Period D||89||
48640949|NCT00784875|101905235|FG002|STARTED|Period D||94||
48640950|NCT00784875|101905236|FG003|STARTED|Period D||88||
48433738|NCT00752206|101397112|FG000|COMPLETED|Overall Study||10||
48433739|NCT00752206|101397113|FG001|COMPLETED|Overall Study||8||
48640951|NCT00784875|101905233|FG000|COMPLETED|Period D||86||
48640952|NCT00784875|101905234|FG001|COMPLETED|Period D||85||
48640953|NCT00784875|101905235|FG002|COMPLETED|Period D||88||
48433740|NCT00752206|101397112|FG000|NOT COMPLETED|Overall Study||9||
48433741|NCT00752206|101397113|FG001|NOT COMPLETED|Overall Study||11||
48433742|NCT03446157|101397114|FG000|STARTED|Overall Study||13||
48433743|NCT03446157|101397115|FG001|STARTED|Overall Study||11||
48433744|NCT03446157|101397114|FG000|COMPLETED|Overall Study||0||
48640954|NCT00784875|101905236|FG003|COMPLETED|Period D||87||
48640955|NCT00784875|101905233|FG000|NOT COMPLETED|Period D||5||
48640956|NCT00784875|101905234|FG001|NOT COMPLETED|Period D||4||
48640957|NCT00784875|101905235|FG002|NOT COMPLETED|Period D||6||
48640958|NCT00784875|101905236|FG003|NOT COMPLETED|Period D||1||
48640959|NCT02401230|101905237|FG000|STARTED|Overall Study||26||
48640960|NCT02401230|101905238|FG001|STARTED|Overall Study||25||
48640961|NCT02401230|101905239|FG002|STARTED|Overall Study||25||
48640962|NCT02401230|101905237|FG000|COMPLETED|Overall Study||20||
48640963|NCT02401230|101905238|FG001|COMPLETED|Overall Study||19||
48640964|NCT02401230|101905239|FG002|COMPLETED|Overall Study||21||
48640965|NCT02401230|101905237|FG000|NOT COMPLETED|Overall Study||6||
48640966|NCT02401230|101905238|FG001|NOT COMPLETED|Overall Study||6||
48640967|NCT02401230|101905239|FG002|NOT COMPLETED|Overall Study||4||
48640968|NCT01017497|101905240|FG000|STARTED|Overall Study||49||
48640969|NCT01017497|101905240|FG000|COMPLETED|Overall Study||49||
48640970|NCT01017497|101905240|FG000|NOT COMPLETED|Overall Study||0||
48640971|NCT03720847|101905241|FG000|STARTED|Condition 1||15||
48640972|NCT03720847|101905242|FG001|STARTED|Condition 1||15||
48640973|NCT03720847|101905241|FG000|COMPLETED|Condition 1||15||
48640974|NCT03720847|101905242|FG001|COMPLETED|Condition 1||15||
48640975|NCT03720847|101905241|FG000|NOT COMPLETED|Condition 1||0||
48640976|NCT03720847|101905242|FG001|NOT COMPLETED|Condition 1||0||
48640977|NCT03720847|101905241|FG000|STARTED|Washout||15||
48640978|NCT03720847|101905242|FG001|STARTED|Washout||15||
48640979|NCT03720847|101905241|FG000|COMPLETED|Washout||14||
48640980|NCT03720847|101905242|FG001|COMPLETED|Washout||13||
48640981|NCT03720847|101905241|FG000|NOT COMPLETED|Washout||1||
48640982|NCT03720847|101905242|FG001|NOT COMPLETED|Washout||2||
48640983|NCT03720847|101905241|FG000|STARTED|Condition 2||14||
48640984|NCT03720847|101905242|FG001|STARTED|Condition 2||13||
48640985|NCT03720847|101905241|FG000|COMPLETED|Condition 2||14||
48640986|NCT03720847|101905242|FG001|COMPLETED|Condition 2||13||
48640987|NCT03720847|101905241|FG000|NOT COMPLETED|Condition 2||0||
48640988|NCT03720847|101905242|FG001|NOT COMPLETED|Condition 2||0||
48640989|NCT02232698|101905243|FG000|STARTED|Overall Study||120||
48640990|NCT02232698|101905244|FG001|STARTED|Overall Study||121||
48640991|NCT02232698|101905243|FG000|COMPLETED|Overall Study||110||
48640992|NCT02232698|101905244|FG001|COMPLETED|Overall Study||101||
48640993|NCT02232698|101905243|FG000|NOT COMPLETED|Overall Study||10||
48640994|NCT02232698|101905244|FG001|NOT COMPLETED|Overall Study||20||
48640995|NCT02568423|101905245|FG000|STARTED|Overall Study||2||
48640996|NCT02568423|101905246|FG001|STARTED|Overall Study||10||
48640997|NCT02568423|101905247|FG002|STARTED|Overall Study||6||
48640998|NCT02568423|101905248|FG003|STARTED|Overall Study||6||
48640999|NCT02568423|101905249|FG004|STARTED|Overall Study||6||
48641000|NCT02568423|101905250|FG005|STARTED|Overall Study||9||
48641001|NCT02568423|101905251|FG006|STARTED|Overall Study||6||
48641002|NCT02568423|101905252|FG007|STARTED|Overall Study||6||
48641003|NCT02568423|101905245|FG000|Received at Least One Dose of Study Drug|Overall Study||2||
48641004|NCT02568423|101905246|FG001|Received at Least One Dose of Study Drug|Overall Study||10||
48641005|NCT02568423|101905247|FG002|Received at Least One Dose of Study Drug|Overall Study||6||
48641006|NCT02568423|101905248|FG003|Received at Least One Dose of Study Drug|Overall Study||6||
48641007|NCT02568423|101905249|FG004|Received at Least One Dose of Study Drug|Overall Study||6||
48641008|NCT02568423|101905250|FG005|Received at Least One Dose of Study Drug|Overall Study||9||
48641009|NCT02568423|101905251|FG006|Received at Least One Dose of Study Drug|Overall Study||6||
48641010|NCT02568423|101905252|FG007|Received at Least One Dose of Study Drug|Overall Study||6||
48641011|NCT02568423|101905245|FG000|COMPLETED|Overall Study||2||
48641012|NCT02568423|101905246|FG001|COMPLETED|Overall Study||8||
48641013|NCT02568423|101905247|FG002|COMPLETED|Overall Study||6||
48641014|NCT02568423|101905248|FG003|COMPLETED|Overall Study||6||
48641015|NCT02568423|101905249|FG004|COMPLETED|Overall Study||6||
48641016|NCT02568423|101905250|FG005|COMPLETED|Overall Study||8||
48641017|NCT02568423|101905251|FG006|COMPLETED|Overall Study||6||
48641018|NCT02568423|101905252|FG007|COMPLETED|Overall Study||6||
48433745|NCT03446157|101397115|FG001|COMPLETED|Overall Study||0||
48433746|NCT03446157|101397114|FG000|NOT COMPLETED|Overall Study||13||
48641019|NCT02568423|101905245|FG000|NOT COMPLETED|Overall Study||0||
48641020|NCT02568423|101905246|FG001|NOT COMPLETED|Overall Study||2||
48641021|NCT02568423|101905247|FG002|NOT COMPLETED|Overall Study||0||
48641022|NCT02568423|101905248|FG003|NOT COMPLETED|Overall Study||0||
48641023|NCT02568423|101905249|FG004|NOT COMPLETED|Overall Study||0||
48641024|NCT02568423|101905250|FG005|NOT COMPLETED|Overall Study||1||
48641025|NCT02568423|101905251|FG006|NOT COMPLETED|Overall Study||0||
48641026|NCT02568423|101905252|FG007|NOT COMPLETED|Overall Study||0||
48641027|NCT02326883|101905253|FG000|STARTED|Overall Study||6314||
48641028|NCT02326883|101905254|FG001|STARTED|Overall Study||6312||
48641029|NCT02326883|101905255|FG002|STARTED|Overall Study||6256||
48433747|NCT03446157|101397115|FG001|NOT COMPLETED|Overall Study||11||
48641030|NCT02326883|101905253|FG000|COMPLETED|Overall Study||6230||
48641031|NCT02326883|101905254|FG001|COMPLETED|Overall Study||6227||
48641032|NCT02326883|101905255|FG002|COMPLETED|Overall Study||6187||
48641033|NCT02326883|101905253|FG000|NOT COMPLETED|Overall Study||84||
48641034|NCT02326883|101905254|FG001|NOT COMPLETED|Overall Study||85||
48641035|NCT02326883|101905255|FG002|NOT COMPLETED|Overall Study||69||
48641036|NCT02323334|101905256|FG000|STARTED|Period 1||4||
48641037|NCT02323334|101905257|FG001|STARTED|Period 1||4||
48641038|NCT02323334|101905258|FG002|STARTED|Period 1||4||
48641039|NCT02323334|101905259|FG003|STARTED|Period 1||4||
48641040|NCT02323334|101905260|FG004|STARTED|Period 1||4||
48641041|NCT02323334|101905261|FG005|STARTED|Period 1||4||
48641042|NCT02323334|101905262|FG006|STARTED|Period 1||6||
48641043|NCT02323334|101905263|FG007|STARTED|Period 1||6||
48641044|NCT02323334|101905264|FG008|STARTED|Period 1||5||
48641045|NCT02323334|101905265|FG009|STARTED|Period 1||7||
48641046|NCT02323334|101905266|FG010|STARTED|Period 1||5||
48641047|NCT02323334|101905267|FG011|STARTED|Period 1||3||
48641048|NCT02323334|101905268|FG012|STARTED|Period 1||9||
48641049|NCT02323334|101905269|FG013|STARTED|Period 1||9||
48641050|NCT02323334|101905270|FG014|STARTED|Period 1||9||
48641051|NCT02323334|101905271|FG015|STARTED|Period 1||9||
48641052|NCT02323334|101905272|FG016|STARTED|Period 1||2||
48641053|NCT02323334|101905256|FG000|Received at Least One Dose of Study Drug|Period 1||4||
48641054|NCT02323334|101905257|FG001|Received at Least One Dose of Study Drug|Period 1||4||
48641055|NCT02323334|101905258|FG002|Received at Least One Dose of Study Drug|Period 1||4||
48641056|NCT02323334|101905259|FG003|Received at Least One Dose of Study Drug|Period 1||4||
48641057|NCT02323334|101905260|FG004|Received at Least One Dose of Study Drug|Period 1||4||
48641058|NCT02323334|101905261|FG005|Received at Least One Dose of Study Drug|Period 1||4||
48641059|NCT02323334|101905262|FG006|Received at Least One Dose of Study Drug|Period 1||6||
48641060|NCT02323334|101905263|FG007|Received at Least One Dose of Study Drug|Period 1||6||
48641061|NCT02323334|101905264|FG008|Received at Least One Dose of Study Drug|Period 1||5||
48641062|NCT02323334|101905265|FG009|Received at Least One Dose of Study Drug|Period 1||7||
48641063|NCT02323334|101905266|FG010|Received at Least One Dose of Study Drug|Period 1||5||
48641064|NCT02323334|101905267|FG011|Received at Least One Dose of Study Drug|Period 1||3||
48641065|NCT02323334|101905268|FG012|Received at Least One Dose of Study Drug|Period 1||9||
48641066|NCT02323334|101905269|FG013|Received at Least One Dose of Study Drug|Period 1||9||
48641067|NCT02323334|101905270|FG014|Received at Least One Dose of Study Drug|Period 1||9||
48641068|NCT02323334|101905271|FG015|Received at Least One Dose of Study Drug|Period 1||9||
48641069|NCT02323334|101905272|FG016|Received at Least One Dose of Study Drug|Period 1||2||
48641070|NCT02323334|101905256|FG000|COMPLETED|Period 1||4||
48641071|NCT02323334|101905257|FG001|COMPLETED|Period 1||4||
48641072|NCT02323334|101905258|FG002|COMPLETED|Period 1||4||
48641073|NCT02323334|101905259|FG003|COMPLETED|Period 1||4||
48641074|NCT02323334|101905260|FG004|COMPLETED|Period 1||4||
48641075|NCT02323334|101905261|FG005|COMPLETED|Period 1||4||
48641076|NCT02323334|101905262|FG006|COMPLETED|Period 1||6||
48641077|NCT02323334|101905263|FG007|COMPLETED|Period 1||6||
48641078|NCT02323334|101905264|FG008|COMPLETED|Period 1||5||
48641079|NCT02323334|101905265|FG009|COMPLETED|Period 1||7||
48641080|NCT02323334|101905266|FG010|COMPLETED|Period 1||5||
48641081|NCT02323334|101905267|FG011|COMPLETED|Period 1||3||
48641082|NCT02323334|101905268|FG012|COMPLETED|Period 1||9||
48641083|NCT02323334|101905269|FG013|COMPLETED|Period 1||9||
48641084|NCT02323334|101905270|FG014|COMPLETED|Period 1||9||
48641085|NCT02323334|101905271|FG015|COMPLETED|Period 1||9||
48641086|NCT02323334|101905272|FG016|COMPLETED|Period 1||2||
48641087|NCT02323334|101905256|FG000|NOT COMPLETED|Period 1||0||
48641088|NCT02323334|101905257|FG001|NOT COMPLETED|Period 1||0||
48641089|NCT02323334|101905258|FG002|NOT COMPLETED|Period 1||0||
48641090|NCT02323334|101905259|FG003|NOT COMPLETED|Period 1||0||
48641091|NCT02323334|101905260|FG004|NOT COMPLETED|Period 1||0||
48641092|NCT02323334|101905261|FG005|NOT COMPLETED|Period 1||0||
48641093|NCT02323334|101905262|FG006|NOT COMPLETED|Period 1||0||
48641094|NCT02323334|101905263|FG007|NOT COMPLETED|Period 1||0||
48641095|NCT02323334|101905264|FG008|NOT COMPLETED|Period 1||0||
48641096|NCT02323334|101905265|FG009|NOT COMPLETED|Period 1||0||
48641097|NCT02323334|101905266|FG010|NOT COMPLETED|Period 1||0||
48641098|NCT02323334|101905267|FG011|NOT COMPLETED|Period 1||0||
48641099|NCT02323334|101905268|FG012|NOT COMPLETED|Period 1||0||
48641100|NCT02323334|101905269|FG013|NOT COMPLETED|Period 1||0||
48641101|NCT02323334|101905270|FG014|NOT COMPLETED|Period 1||0||
48641102|NCT02323334|101905271|FG015|NOT COMPLETED|Period 1||0||
48641103|NCT02323334|101905272|FG016|NOT COMPLETED|Period 1||0||
48641104|NCT02323334|101905256|FG000|STARTED|Period 2||4||
48641105|NCT02323334|101905257|FG001|STARTED|Period 2||4||
48641106|NCT02323334|101905258|FG002|STARTED|Period 2||4||
48641107|NCT02323334|101905259|FG003|STARTED|Period 2||4||
48641108|NCT02323334|101905260|FG004|STARTED|Period 2||4||
48641109|NCT02323334|101905261|FG005|STARTED|Period 2||4||
48641110|NCT02323334|101905262|FG006|STARTED|Period 2||6||
48641111|NCT02323334|101905263|FG007|STARTED|Period 2||6||
48641112|NCT02323334|101905264|FG008|STARTED|Period 2||0||
48641113|NCT02323334|101905265|FG009|STARTED|Period 2||0||
48641114|NCT02323334|101905266|FG010|STARTED|Period 2||0||
48641115|NCT02323334|101905267|FG011|STARTED|Period 2||0||
48641116|NCT02323334|101905268|FG012|STARTED|Period 2||0||
48641117|NCT02323334|101905269|FG013|STARTED|Period 2||0||
48641118|NCT02323334|101905270|FG014|STARTED|Period 2||0||
48641119|NCT02323334|101905271|FG015|STARTED|Period 2||0||
48641120|NCT02323334|101905272|FG016|STARTED|Period 2||0||
48641121|NCT02323334|101905256|FG000|COMPLETED|Period 2||4||
48764712|NCT04314284|102212017|FG000|STARTED|Overall Study||69||
48764713|NCT04314284|102212018|FG001|STARTED|Overall Study||81||
48764714|NCT04314284|102212017|FG000|COMPLETED|Overall Study||65||
48764715|NCT04314284|102212018|FG001|COMPLETED|Overall Study||68||
48361286|NCT01522651|101214304|FG002|NOT COMPLETED|Overall Study||4||
48361287|NCT01522651|101214305|FG003|NOT COMPLETED|Overall Study||8||
48361288|NCT01522651|101214306|FG004|NOT COMPLETED|Overall Study||6||
48361289|NCT04901026|101214307|FG000|STARTED|Overall Study||19||
48361290|NCT04901026|101214308|FG001|STARTED|Overall Study||18||
48641122|NCT02323334|101905257|FG001|COMPLETED|Period 2||4||
48641123|NCT02323334|101905258|FG002|COMPLETED|Period 2||4||
48641124|NCT02323334|101905259|FG003|COMPLETED|Period 2||4||
48641125|NCT02323334|101905260|FG004|COMPLETED|Period 2||4||
48641126|NCT02323334|101905261|FG005|COMPLETED|Period 2||4||
48641127|NCT02323334|101905262|FG006|COMPLETED|Period 2||6||
48641128|NCT02323334|101905263|FG007|COMPLETED|Period 2||6||
48641129|NCT02323334|101905264|FG008|COMPLETED|Period 2||0||
48641130|NCT02323334|101905265|FG009|COMPLETED|Period 2||0||
48641131|NCT02323334|101905266|FG010|COMPLETED|Period 2||0||
48641132|NCT02323334|101905267|FG011|COMPLETED|Period 2||0||
48641133|NCT02323334|101905268|FG012|COMPLETED|Period 2||0||
48641134|NCT02323334|101905269|FG013|COMPLETED|Period 2||0||
48641135|NCT02323334|101905270|FG014|COMPLETED|Period 2||0||
48641136|NCT02323334|101905271|FG015|COMPLETED|Period 2||0||
48641137|NCT02323334|101905272|FG016|COMPLETED|Period 2||0||
48641138|NCT02323334|101905256|FG000|NOT COMPLETED|Period 2||0||
48641139|NCT02323334|101905257|FG001|NOT COMPLETED|Period 2||0||
48641140|NCT02323334|101905258|FG002|NOT COMPLETED|Period 2||0||
48641141|NCT02323334|101905259|FG003|NOT COMPLETED|Period 2||0||
48641142|NCT02323334|101905260|FG004|NOT COMPLETED|Period 2||0||
48641143|NCT02323334|101905261|FG005|NOT COMPLETED|Period 2||0||
48641144|NCT02323334|101905262|FG006|NOT COMPLETED|Period 2||0||
48641145|NCT02323334|101905263|FG007|NOT COMPLETED|Period 2||0||
48641146|NCT02323334|101905264|FG008|NOT COMPLETED|Period 2||0||
48641147|NCT02323334|101905265|FG009|NOT COMPLETED|Period 2||0||
48641148|NCT02323334|101905266|FG010|NOT COMPLETED|Period 2||0||
48641149|NCT02323334|101905267|FG011|NOT COMPLETED|Period 2||0||
48641150|NCT02323334|101905268|FG012|NOT COMPLETED|Period 2||0||
48641151|NCT02323334|101905269|FG013|NOT COMPLETED|Period 2||0||
48641152|NCT02323334|101905270|FG014|NOT COMPLETED|Period 2||0||
48641153|NCT02323334|101905271|FG015|NOT COMPLETED|Period 2||0||
48641154|NCT02323334|101905272|FG016|NOT COMPLETED|Period 2||0||
48641155|NCT02323334|101905256|FG000|STARTED|Period 3||4||
48641156|NCT02323334|101905257|FG001|STARTED|Period 3||4||
48641157|NCT02323334|101905258|FG002|STARTED|Period 3||4||
48641158|NCT02323334|101905259|FG003|STARTED|Period 3||4||
48641159|NCT02323334|101905260|FG004|STARTED|Period 3||4||
48641160|NCT02323334|101905261|FG005|STARTED|Period 3||4||
48764716|NCT04314284|102212017|FG000|NOT COMPLETED|Overall Study||4||
48764717|NCT04314284|102212018|FG001|NOT COMPLETED|Overall Study||13||
48764718|NCT04760782|102212019|FG000|STARTED|Overall Study||5||
48764719|NCT04760782|102212020|FG001|STARTED|Overall Study||17||
48641161|NCT02323334|101905262|FG006|STARTED|Period 3||0||
48641162|NCT02323334|101905263|FG007|STARTED|Period 3||0||
48641163|NCT02323334|101905264|FG008|STARTED|Period 3||0||
48641164|NCT02323334|101905265|FG009|STARTED|Period 3||0||
48641165|NCT02323334|101905266|FG010|STARTED|Period 3||0||
48641166|NCT02323334|101905267|FG011|STARTED|Period 3||0||
48641167|NCT02323334|101905268|FG012|STARTED|Period 3||0||
48641168|NCT02323334|101905269|FG013|STARTED|Period 3||0||
48641169|NCT02323334|101905270|FG014|STARTED|Period 3||0||
48641170|NCT02323334|101905271|FG015|STARTED|Period 3||0||
48764720|NCT04760782|102212019|FG000|COMPLETED|Overall Study||1||
48641171|NCT02323334|101905272|FG016|STARTED|Period 3||0||
48764721|NCT04760782|102212020|FG001|COMPLETED|Overall Study||17||
48764722|NCT04760782|102212019|FG000|NOT COMPLETED|Overall Study||4||
48361291|NCT04901026|101214307|FG000|COMPLETED|Overall Study||19||
48361292|NCT04901026|101214308|FG001|COMPLETED|Overall Study||18||
48361293|NCT04901026|101214307|FG000|NOT COMPLETED|Overall Study||0||
48361294|NCT04901026|101214308|FG001|NOT COMPLETED|Overall Study||0||
48641172|NCT02323334|101905256|FG000|COMPLETED|Period 3||3||
48641173|NCT02323334|101905257|FG001|COMPLETED|Period 3||4||
48641174|NCT02323334|101905258|FG002|COMPLETED|Period 3||3||
48641175|NCT02323334|101905259|FG003|COMPLETED|Period 3||4||
48641176|NCT02323334|101905260|FG004|COMPLETED|Period 3||4||
48641177|NCT02323334|101905261|FG005|COMPLETED|Period 3||4||
48764723|NCT04760782|102212020|FG001|NOT COMPLETED|Overall Study||0||
48641178|NCT02323334|101905262|FG006|COMPLETED|Period 3||0||
48641179|NCT02323334|101905263|FG007|COMPLETED|Period 3||0||
48641180|NCT02323334|101905264|FG008|COMPLETED|Period 3||0||
48641181|NCT02323334|101905265|FG009|COMPLETED|Period 3||0||
48641182|NCT02323334|101905266|FG010|COMPLETED|Period 3||0||
48641183|NCT02323334|101905267|FG011|COMPLETED|Period 3||0||
48641184|NCT02323334|101905268|FG012|COMPLETED|Period 3||0||
48641185|NCT02323334|101905269|FG013|COMPLETED|Period 3||0||
48641186|NCT02323334|101905270|FG014|COMPLETED|Period 3||0||
48641187|NCT02323334|101905271|FG015|COMPLETED|Period 3||0||
48641188|NCT02323334|101905272|FG016|COMPLETED|Period 3||0||
48641189|NCT02323334|101905256|FG000|NOT COMPLETED|Period 3||1||
48641190|NCT02323334|101905257|FG001|NOT COMPLETED|Period 3||0||
48641191|NCT02323334|101905258|FG002|NOT COMPLETED|Period 3||1||
48641192|NCT02323334|101905259|FG003|NOT COMPLETED|Period 3||0||
48641193|NCT02323334|101905260|FG004|NOT COMPLETED|Period 3||0||
48641194|NCT02323334|101905261|FG005|NOT COMPLETED|Period 3||0||
48641195|NCT02323334|101905262|FG006|NOT COMPLETED|Period 3||0||
48641196|NCT02323334|101905263|FG007|NOT COMPLETED|Period 3||0||
48641197|NCT02323334|101905264|FG008|NOT COMPLETED|Period 3||0||
48641198|NCT02323334|101905265|FG009|NOT COMPLETED|Period 3||0||
48641199|NCT02323334|101905266|FG010|NOT COMPLETED|Period 3||0||
48641200|NCT02323334|101905267|FG011|NOT COMPLETED|Period 3||0||
48641201|NCT02323334|101905268|FG012|NOT COMPLETED|Period 3||0||
48641202|NCT02323334|101905269|FG013|NOT COMPLETED|Period 3||0||
48641203|NCT02323334|101905270|FG014|NOT COMPLETED|Period 3||0||
48641204|NCT02323334|101905271|FG015|NOT COMPLETED|Period 3||0||
48641205|NCT02323334|101905272|FG016|NOT COMPLETED|Period 3||0||
48641206|NCT02323334|101905256|FG000|STARTED|Period 4||3||
48641207|NCT02323334|101905257|FG001|STARTED|Period 4||4||
48641208|NCT02323334|101905258|FG002|STARTED|Period 4||3||
48641209|NCT02323334|101905259|FG003|STARTED|Period 4||4||
48641210|NCT02323334|101905260|FG004|STARTED|Period 4||4||
48641211|NCT02323334|101905261|FG005|STARTED|Period 4||4||
48641212|NCT02323334|101905262|FG006|STARTED|Period 4||0||
48641213|NCT02323334|101905263|FG007|STARTED|Period 4||0||
48641214|NCT02323334|101905264|FG008|STARTED|Period 4||0||
48641215|NCT02323334|101905265|FG009|STARTED|Period 4||0||
48641216|NCT02323334|101905266|FG010|STARTED|Period 4||0||
48641217|NCT02323334|101905267|FG011|STARTED|Period 4||0||
48641218|NCT02323334|101905268|FG012|STARTED|Period 4||0||
48641219|NCT02323334|101905269|FG013|STARTED|Period 4||0||
48641220|NCT02323334|101905270|FG014|STARTED|Period 4||0||
48641221|NCT02323334|101905271|FG015|STARTED|Period 4||0||
48641222|NCT02323334|101905272|FG016|STARTED|Period 4||0||
48641223|NCT02323334|101905256|FG000|COMPLETED|Period 4||3||
48641224|NCT02323334|101905257|FG001|COMPLETED|Period 4||4||
48641225|NCT02323334|101905258|FG002|COMPLETED|Period 4||3||
48641226|NCT02323334|101905259|FG003|COMPLETED|Period 4||4||
48641227|NCT02323334|101905260|FG004|COMPLETED|Period 4||4||
48641228|NCT02323334|101905261|FG005|COMPLETED|Period 4||4||
48641229|NCT02323334|101905262|FG006|COMPLETED|Period 4||0||
48641230|NCT02323334|101905263|FG007|COMPLETED|Period 4||0||
48641231|NCT02323334|101905264|FG008|COMPLETED|Period 4||0||
48641232|NCT02323334|101905265|FG009|COMPLETED|Period 4||0||
48641233|NCT02323334|101905266|FG010|COMPLETED|Period 4||0||
48641234|NCT02323334|101905267|FG011|COMPLETED|Period 4||0||
48641235|NCT02323334|101905268|FG012|COMPLETED|Period 4||0||
48641236|NCT02323334|101905269|FG013|COMPLETED|Period 4||0||
48641237|NCT02323334|101905270|FG014|COMPLETED|Period 4||0||
48641238|NCT02323334|101905271|FG015|COMPLETED|Period 4||0||
48641239|NCT02323334|101905272|FG016|COMPLETED|Period 4||0||
48641240|NCT02323334|101905256|FG000|NOT COMPLETED|Period 4||0||
48641241|NCT02323334|101905257|FG001|NOT COMPLETED|Period 4||0||
48641242|NCT02323334|101905258|FG002|NOT COMPLETED|Period 4||0||
48641243|NCT02323334|101905259|FG003|NOT COMPLETED|Period 4||0||
48641244|NCT02323334|101905260|FG004|NOT COMPLETED|Period 4||0||
48641245|NCT02323334|101905261|FG005|NOT COMPLETED|Period 4||0||
48641246|NCT02323334|101905262|FG006|NOT COMPLETED|Period 4||0||
48641247|NCT02323334|101905263|FG007|NOT COMPLETED|Period 4||0||
48641248|NCT02323334|101905264|FG008|NOT COMPLETED|Period 4||0||
48641249|NCT02323334|101905265|FG009|NOT COMPLETED|Period 4||0||
48641250|NCT02323334|101905266|FG010|NOT COMPLETED|Period 4||0||
48641251|NCT02323334|101905267|FG011|NOT COMPLETED|Period 4||0||
48641252|NCT02323334|101905268|FG012|NOT COMPLETED|Period 4||0||
48641253|NCT02323334|101905269|FG013|NOT COMPLETED|Period 4||0||
48641254|NCT02323334|101905270|FG014|NOT COMPLETED|Period 4||0||
48641255|NCT02323334|101905271|FG015|NOT COMPLETED|Period 4||0||
48641256|NCT02323334|101905272|FG016|NOT COMPLETED|Period 4||0||
48641257|NCT00764517|101905273|FG000|STARTED|Overall Study||39||
48641258|NCT00764517|101905274|FG001|STARTED|Overall Study||18||
48641259|NCT00764517|101905273|FG000|COMPLETED|Overall Study||24||
48641260|NCT00764517|101905274|FG001|COMPLETED|Overall Study||4||
48641261|NCT00764517|101905273|FG000|NOT COMPLETED|Overall Study||15||
48641262|NCT00764517|101905274|FG001|NOT COMPLETED|Overall Study||14||
48641263|NCT00627978|101905275|FG000|STARTED|Overall Study||10||
48641264|NCT00627978|101905276|FG001|STARTED|Overall Study||5||
48641265|NCT00627978|101905275|FG000|COMPLETED|Overall Study||10||
48641266|NCT00627978|101905276|FG001|COMPLETED|Overall Study||5||
48641267|NCT00627978|101905275|FG000|NOT COMPLETED|Overall Study||0||
48641268|NCT00627978|101905276|FG001|NOT COMPLETED|Overall Study||0||
48641269|NCT02187055|101905277|FG000|STARTED|Overall Study||384||
48641270|NCT02187055|101905278|FG001|STARTED|Overall Study||376||
48641271|NCT02187055|101905279|FG002|STARTED|Overall Study||386||
48641272|NCT02187055|101905277|FG000|COMPLETED|Overall Study||315||
48641273|NCT02187055|101905278|FG001|COMPLETED|Overall Study||303||
48641274|NCT02187055|101905279|FG002|COMPLETED|Overall Study||312||
48641275|NCT02187055|101905277|FG000|NOT COMPLETED|Overall Study||69||
48641276|NCT02187055|101905278|FG001|NOT COMPLETED|Overall Study||73||
48641277|NCT02187055|101905279|FG002|NOT COMPLETED|Overall Study||74||
48641278|NCT04871113|101905280|FG000|STARTED|Part1:Monotherapy Phase(up to Day 84)||8|1 participant was randomized to Part 1: GSK3810109A 280 mg IV, but received GSK3810109A 40mg/kg IV intervention. Hence the participant was included in Part 1:GSK3810109A 40milligram(mg)/kilogram intravenously (IV) in the safety and pharmacokinetic set, and in Part 1: GSK3810109A 280 mg IV group in Full ANalysis Set, resulting in different sizes of these populations.|
48641279|NCT04871113|101905281|FG001|STARTED|Part1:Monotherapy Phase(up to Day 84)||6|1 participant was randomized to Part 1: GSK3810109A 280 mg IV, but received GSK3810109A 40mg/kg IV intervention. Hence the participant was included in Part 1:GSK3810109A 40milligram(mg)/kilogram intravenously (IV) in the safety and pharmacokinetic set, and in Part 1: GSK3810109A 280 mg IV group in Full ANalysis Set, resulting in different sizes of these populations.|
48641280|NCT04871113|101905282|FG002|STARTED|Part1:Monotherapy Phase(up to Day 84)||0|1 participant was randomized to Part 1: GSK3810109A 280 mg IV, but received GSK3810109A 40mg/kg IV intervention. Hence the participant was included in Part 1:GSK3810109A 40milligram(mg)/kilogram intravenously (IV) in the safety and pharmacokinetic set, and in Part 1: GSK3810109A 280 mg IV group in Full ANalysis Set, resulting in different sizes of these populations.|
48641281|NCT04871113|101905283|FG003|STARTED|Part1:Monotherapy Phase(up to Day 84)||0|1 participant was randomized to Part 1: GSK3810109A 280 mg IV, but received GSK3810109A 40mg/kg IV intervention. Hence the participant was included in Part 1:GSK3810109A 40milligram(mg)/kilogram intravenously (IV) in the safety and pharmacokinetic set, and in Part 1: GSK3810109A 280 mg IV group in Full ANalysis Set, resulting in different sizes of these populations.|
48641282|NCT04871113|101905284|FG004|STARTED|Part1:Monotherapy Phase(up to Day 84)||0|1 participant was randomized to Part 1: GSK3810109A 280 mg IV, but received GSK3810109A 40mg/kg IV intervention. Hence the participant was included in Part 1:GSK3810109A 40milligram(mg)/kilogram intravenously (IV) in the safety and pharmacokinetic set, and in Part 1: GSK3810109A 280 mg IV group in Full ANalysis Set, resulting in different sizes of these populations.|
48641283|NCT04871113|101905285|FG005|STARTED|Part1:Monotherapy Phase(up to Day 84)||0|1 participant was randomized to Part 1: GSK3810109A 280 mg IV, but received GSK3810109A 40mg/kg IV intervention. Hence the participant was included in Part 1:GSK3810109A 40milligram(mg)/kilogram intravenously (IV) in the safety and pharmacokinetic set, and in Part 1: GSK3810109A 280 mg IV group in Full ANalysis Set, resulting in different sizes of these populations.|
48641284|NCT04871113|101905286|FG006|STARTED|Part1:Monotherapy Phase(up to Day 84)||0|1 participant was randomized to Part 1: GSK3810109A 280 mg IV, but received GSK3810109A 40mg/kg IV intervention. Hence the participant was included in Part 1:GSK3810109A 40milligram(mg)/kilogram intravenously (IV) in the safety and pharmacokinetic set, and in Part 1: GSK3810109A 280 mg IV group in Full ANalysis Set, resulting in different sizes of these populations.|
48641285|NCT04871113|101905287|FG007|STARTED|Part1:Monotherapy Phase(up to Day 84)||0|1 participant was randomized to Part 1: GSK3810109A 280 mg IV, but received GSK3810109A 40mg/kg IV intervention. Hence the participant was included in Part 1:GSK3810109A 40milligram(mg)/kilogram intravenously (IV) in the safety and pharmacokinetic set, and in Part 1: GSK3810109A 280 mg IV group in Full ANalysis Set, resulting in different sizes of these populations.|
48641286|NCT04871113|101905288|FG008|STARTED|Part1:Monotherapy Phase(up to Day 84)||0|1 participant was randomized to Part 1: GSK3810109A 280 mg IV, but received GSK3810109A 40mg/kg IV intervention. Hence the participant was included in Part 1:GSK3810109A 40milligram(mg)/kilogram intravenously (IV) in the safety and pharmacokinetic set, and in Part 1: GSK3810109A 280 mg IV group in Full ANalysis Set, resulting in different sizes of these populations.|
48641287|NCT04871113|101905289|FG009|STARTED|Part1:Monotherapy Phase(up to Day 84)||0|1 participant was randomized to Part 1: GSK3810109A 280 mg IV, but received GSK3810109A 40mg/kg IV intervention. Hence the participant was included in Part 1:GSK3810109A 40milligram(mg)/kilogram intravenously (IV) in the safety and pharmacokinetic set, and in Part 1: GSK3810109A 280 mg IV group in Full ANalysis Set, resulting in different sizes of these populations.|
48641288|NCT04871113|101905280|FG000|COMPLETED|Part1:Monotherapy Phase(up to Day 84)||8||
48641289|NCT04871113|101905281|FG001|COMPLETED|Part1:Monotherapy Phase(up to Day 84)||6||
48641290|NCT04871113|101905282|FG002|COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
48641291|NCT04871113|101905283|FG003|COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
48641292|NCT04871113|101905284|FG004|COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
48641293|NCT04871113|101905285|FG005|COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
48641294|NCT04871113|101905286|FG006|COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
48641295|NCT04871113|101905287|FG007|COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
48641296|NCT04871113|101905288|FG008|COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
48641297|NCT04871113|101905289|FG009|COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
48641298|NCT04871113|101905280|FG000|NOT COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
48641299|NCT04871113|101905281|FG001|NOT COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
48641300|NCT04871113|101905282|FG002|NOT COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
48641301|NCT04871113|101905283|FG003|NOT COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
48641302|NCT04871113|101905284|FG004|NOT COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
48641303|NCT04871113|101905285|FG005|NOT COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
48641304|NCT04871113|101905286|FG006|NOT COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
48641305|NCT04871113|101905287|FG007|NOT COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
48641306|NCT04871113|101905288|FG008|NOT COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
48641307|NCT04871113|101905289|FG009|NOT COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
48641308|NCT04871113|101905280|FG000|STARTED|Part2:Monotherapy Phase(up to Day 84)||0||
48641309|NCT04871113|101905281|FG001|STARTED|Part2:Monotherapy Phase(up to Day 84)||0||
48641310|NCT04871113|101905282|FG002|STARTED|Part2:Monotherapy Phase(up to Day 84)||16||
48641311|NCT04871113|101905283|FG003|STARTED|Part2:Monotherapy Phase(up to Day 84)||16||
48641312|NCT04871113|101905284|FG004|STARTED|Part2:Monotherapy Phase(up to Day 84)||16||
48641313|NCT04871113|101905285|FG005|STARTED|Part2:Monotherapy Phase(up to Day 84)||0||
48641314|NCT04871113|101905286|FG006|STARTED|Part2:Monotherapy Phase(up to Day 84)||0||
48641315|NCT04871113|101905287|FG007|STARTED|Part2:Monotherapy Phase(up to Day 84)||0||
48641316|NCT04871113|101905288|FG008|STARTED|Part2:Monotherapy Phase(up to Day 84)||0||
48641317|NCT04871113|101905289|FG009|STARTED|Part2:Monotherapy Phase(up to Day 84)||0||
48641318|NCT04871113|101905280|FG000|COMPLETED|Part2:Monotherapy Phase(up to Day 84)||0||
48641319|NCT04871113|101905281|FG001|COMPLETED|Part2:Monotherapy Phase(up to Day 84)||0||
48641320|NCT04871113|101905282|FG002|COMPLETED|Part2:Monotherapy Phase(up to Day 84)||16||
48641321|NCT04871113|101905283|FG003|COMPLETED|Part2:Monotherapy Phase(up to Day 84)||16||
48641322|NCT04871113|101905284|FG004|COMPLETED|Part2:Monotherapy Phase(up to Day 84)||16||
48641323|NCT04871113|101905285|FG005|COMPLETED|Part2:Monotherapy Phase(up to Day 84)||0||
48641324|NCT04871113|101905286|FG006|COMPLETED|Part2:Monotherapy Phase(up to Day 84)||0||
48641325|NCT04871113|101905287|FG007|COMPLETED|Part2:Monotherapy Phase(up to Day 84)||0||
48641326|NCT04871113|101905288|FG008|COMPLETED|Part2:Monotherapy Phase(up to Day 84)||0||
48641327|NCT04871113|101905289|FG009|COMPLETED|Part2:Monotherapy Phase(up to Day 84)||0||
48641328|NCT04871113|101905280|FG000|NOT COMPLETED|Part2:Monotherapy Phase(up to Day 84)||0||
48641329|NCT04871113|101905281|FG001|NOT COMPLETED|Part2:Monotherapy Phase(up to Day 84)||0||
48641330|NCT04871113|101905282|FG002|NOT COMPLETED|Part2:Monotherapy Phase(up to Day 84)||0||
48641331|NCT04871113|101905283|FG003|NOT COMPLETED|Part2:Monotherapy Phase(up to Day 84)||0||
48641332|NCT04871113|101905284|FG004|NOT COMPLETED|Part2:Monotherapy Phase(up to Day 84)||0||
48641333|NCT04871113|101905285|FG005|NOT COMPLETED|Part2:Monotherapy Phase(up to Day 84)||0||
48641334|NCT04871113|101905286|FG006|NOT COMPLETED|Part2:Monotherapy Phase(up to Day 84)||0||
48641335|NCT04871113|101905287|FG007|NOT COMPLETED|Part2:Monotherapy Phase(up to Day 84)||0||
48641336|NCT04871113|101905288|FG008|NOT COMPLETED|Part2:Monotherapy Phase(up to Day 84)||0||
48641337|NCT04871113|101905289|FG009|NOT COMPLETED|Part2:Monotherapy Phase(up to Day 84)||0||
48641338|NCT04871113|101905280|FG000|STARTED|SOC Follow-up (SOC Day 1 to 48 Weeks)||0||
48641339|NCT04871113|101905281|FG001|STARTED|SOC Follow-up (SOC Day 1 to 48 Weeks)||0||
48641340|NCT04871113|101905282|FG002|STARTED|SOC Follow-up (SOC Day 1 to 48 Weeks)||0||
48641341|NCT04871113|101905283|FG003|STARTED|SOC Follow-up (SOC Day 1 to 48 Weeks)||0||
48641342|NCT04871113|101905284|FG004|STARTED|SOC Follow-up (SOC Day 1 to 48 Weeks)||0||
48641343|NCT04871113|101905285|FG005|STARTED|SOC Follow-up (SOC Day 1 to 48 Weeks)||8||
48641344|NCT04871113|101905286|FG006|STARTED|SOC Follow-up (SOC Day 1 to 48 Weeks)||6||
48641345|NCT04871113|101905287|FG007|STARTED|SOC Follow-up (SOC Day 1 to 48 Weeks)||16||
48641346|NCT04871113|101905288|FG008|STARTED|SOC Follow-up (SOC Day 1 to 48 Weeks)||16||
48641347|NCT04871113|101905289|FG009|STARTED|SOC Follow-up (SOC Day 1 to 48 Weeks)||16||
48641348|NCT04871113|101905280|FG000|COMPLETED|SOC Follow-up (SOC Day 1 to 48 Weeks)||0||
48641349|NCT04871113|101905281|FG001|COMPLETED|SOC Follow-up (SOC Day 1 to 48 Weeks)||0||
48641350|NCT04871113|101905282|FG002|COMPLETED|SOC Follow-up (SOC Day 1 to 48 Weeks)||0||
48641351|NCT04871113|101905283|FG003|COMPLETED|SOC Follow-up (SOC Day 1 to 48 Weeks)||0||
48641352|NCT04871113|101905284|FG004|COMPLETED|SOC Follow-up (SOC Day 1 to 48 Weeks)||0||
48641353|NCT04871113|101905285|FG005|COMPLETED|SOC Follow-up (SOC Day 1 to 48 Weeks)||7||
48641354|NCT04871113|101905286|FG006|COMPLETED|SOC Follow-up (SOC Day 1 to 48 Weeks)||5||
48641355|NCT04871113|101905287|FG007|COMPLETED|SOC Follow-up (SOC Day 1 to 48 Weeks)||14||
48641356|NCT04871113|101905288|FG008|COMPLETED|SOC Follow-up (SOC Day 1 to 48 Weeks)||16||
48641357|NCT04871113|101905289|FG009|COMPLETED|SOC Follow-up (SOC Day 1 to 48 Weeks)||16||
48641358|NCT04871113|101905280|FG000|NOT COMPLETED|SOC Follow-up (SOC Day 1 to 48 Weeks)||0||
48641359|NCT04871113|101905281|FG001|NOT COMPLETED|SOC Follow-up (SOC Day 1 to 48 Weeks)||0||
48641360|NCT04871113|101905282|FG002|NOT COMPLETED|SOC Follow-up (SOC Day 1 to 48 Weeks)||0||
48641361|NCT04871113|101905283|FG003|NOT COMPLETED|SOC Follow-up (SOC Day 1 to 48 Weeks)||0||
48641362|NCT04871113|101905284|FG004|NOT COMPLETED|SOC Follow-up (SOC Day 1 to 48 Weeks)||0||
48641363|NCT04871113|101905285|FG005|NOT COMPLETED|SOC Follow-up (SOC Day 1 to 48 Weeks)||1||
48641364|NCT04871113|101905286|FG006|NOT COMPLETED|SOC Follow-up (SOC Day 1 to 48 Weeks)||1||
48641365|NCT04871113|101905287|FG007|NOT COMPLETED|SOC Follow-up (SOC Day 1 to 48 Weeks)||2||
48641366|NCT04871113|101905288|FG008|NOT COMPLETED|SOC Follow-up (SOC Day 1 to 48 Weeks)||0||
48641367|NCT04871113|101905289|FG009|NOT COMPLETED|SOC Follow-up (SOC Day 1 to 48 Weeks)||0||
48641368|NCT01002105|101905290|FG000|STARTED|Overall Study||32||
48641369|NCT01002105|101905291|FG001|STARTED|Overall Study||32||
48641370|NCT01002105|101905290|FG000|COMPLETED|Overall Study||13||
48641371|NCT01002105|101905291|FG001|COMPLETED|Overall Study||11||
48641372|NCT01002105|101905290|FG000|NOT COMPLETED|Overall Study||19||
48641373|NCT01002105|101905291|FG001|NOT COMPLETED|Overall Study||21||
48641374|NCT00296335|101905292|FG000|STARTED|Overall Study||424||
48641375|NCT00296335|101905293|FG001|STARTED|Overall Study||431||
48641376|NCT00296335|101905292|FG000|COMPLETED|Overall Study||394||
48641377|NCT00296335|101905293|FG001|COMPLETED|Overall Study||309||
48641378|NCT00296335|101905292|FG000|NOT COMPLETED|Overall Study||30||
48641379|NCT00296335|101905293|FG001|NOT COMPLETED|Overall Study||122||
48641380|NCT02107898|101905294|FG000|STARTED|Overall Study||72||
48641381|NCT02107898|101905295|FG001|STARTED|Overall Study||144||
48641382|NCT02107898|101905294|FG000|Treated|Overall Study||72||
48641383|NCT02107898|101905295|FG001|Treated|Overall Study||143||
48641384|NCT02107898|101905294|FG000|COMPLETED|Overall Study||66||
48641385|NCT02107898|101905295|FG001|COMPLETED|Overall Study||132||
48641386|NCT02107898|101905294|FG000|NOT COMPLETED|Overall Study||6||
48641387|NCT02107898|101905295|FG001|NOT COMPLETED|Overall Study||12||
48641388|NCT01177410|101905296|FG000|STARTED|Overall Study||51||
48641389|NCT01177410|101905297|FG001|STARTED|Overall Study||47||
48641390|NCT01177410|101905298|FG002|STARTED|Overall Study||50||
48641391|NCT01177410|101905296|FG000|COMPLETED|Overall Study||50||
48641392|NCT01177410|101905297|FG001|COMPLETED|Overall Study||40||
48641393|NCT01177410|101905298|FG002|COMPLETED|Overall Study||45||
48641394|NCT01177410|101905296|FG000|NOT COMPLETED|Overall Study||1||
48641395|NCT01177410|101905297|FG001|NOT COMPLETED|Overall Study||7||
48641396|NCT01177410|101905298|FG002|NOT COMPLETED|Overall Study||5||
48641397|NCT03404375|101905299|FG000|STARTED|Overall Study||70||
48641398|NCT03404375|101905300|FG001|STARTED|Overall Study||172||
48641399|NCT03404375|101905299|FG000|COMPLETED|Overall Study||70||
48641400|NCT03404375|101905300|FG001|COMPLETED|Overall Study||172||
48641401|NCT03404375|101905299|FG000|NOT COMPLETED|Overall Study||0||
48641402|NCT03404375|101905300|FG001|NOT COMPLETED|Overall Study||0||
48641403|NCT04790201|101905301|FG000|STARTED|Overall Study||26||
48641404|NCT04790201|101905302|FG001|STARTED|Overall Study||25||
48641405|NCT04790201|101905303|FG002|STARTED|Overall Study||26||
48641406|NCT04790201|101905301|FG000|COMPLETED|Overall Study||25||
48641407|NCT04790201|101905302|FG001|COMPLETED|Overall Study||24||
48641408|NCT04790201|101905303|FG002|COMPLETED|Overall Study||23||
48641409|NCT04790201|101905301|FG000|NOT COMPLETED|Overall Study||1||
48641410|NCT04790201|101905302|FG001|NOT COMPLETED|Overall Study||1||
48641411|NCT04790201|101905303|FG002|NOT COMPLETED|Overall Study||3||
48641412|NCT03034928|101905304|FG000|STARTED|Period 1, First 2 Hours of Wear||8|Started = Randomized|
48641413|NCT03034928|101905305|FG001|STARTED|Period 1, First 2 Hours of Wear||8|Started = Randomized|
48641414|NCT03034928|101905306|FG002|STARTED|Period 1, First 2 Hours of Wear||9|Started = Randomized|
48641415|NCT03034928|101905307|FG003|STARTED|Period 1, First 2 Hours of Wear||8|Started = Randomized|
48641416|NCT03034928|101905304|FG000|COMPLETED|Period 1, First 2 Hours of Wear||8||
48641417|NCT03034928|101905305|FG001|COMPLETED|Period 1, First 2 Hours of Wear||8||
48641418|NCT03034928|101905306|FG002|COMPLETED|Period 1, First 2 Hours of Wear||9||
48641419|NCT03034928|101905307|FG003|COMPLETED|Period 1, First 2 Hours of Wear||8||
48641420|NCT03034928|101905304|FG000|NOT COMPLETED|Period 1, First 2 Hours of Wear||0||
48641421|NCT03034928|101905305|FG001|NOT COMPLETED|Period 1, First 2 Hours of Wear||0||
48641422|NCT03034928|101905306|FG002|NOT COMPLETED|Period 1, First 2 Hours of Wear||0||
48641423|NCT03034928|101905307|FG003|NOT COMPLETED|Period 1, First 2 Hours of Wear||0||
48641424|NCT03034928|101905304|FG000|STARTED|Washout Period Between Lens Wear||8||
48641425|NCT03034928|101905305|FG001|STARTED|Washout Period Between Lens Wear||8||
48641426|NCT03034928|101905306|FG002|STARTED|Washout Period Between Lens Wear||9||
48641427|NCT03034928|101905307|FG003|STARTED|Washout Period Between Lens Wear||8||
48641428|NCT03034928|101905304|FG000|COMPLETED|Washout Period Between Lens Wear||8||
48641429|NCT03034928|101905305|FG001|COMPLETED|Washout Period Between Lens Wear||8||
48641430|NCT03034928|101905306|FG002|COMPLETED|Washout Period Between Lens Wear||9||
48641431|NCT03034928|101905307|FG003|COMPLETED|Washout Period Between Lens Wear||8||
48641432|NCT03034928|101905304|FG000|NOT COMPLETED|Washout Period Between Lens Wear||0||
48641433|NCT03034928|101905305|FG001|NOT COMPLETED|Washout Period Between Lens Wear||0||
48641434|NCT03034928|101905306|FG002|NOT COMPLETED|Washout Period Between Lens Wear||0||
48641435|NCT03034928|101905307|FG003|NOT COMPLETED|Washout Period Between Lens Wear||0||
48641436|NCT03034928|101905304|FG000|STARTED|Period 2, Second 2 Hours of Wear||8||
48641437|NCT03034928|101905305|FG001|STARTED|Period 2, Second 2 Hours of Wear||8||
48641438|NCT03034928|101905306|FG002|STARTED|Period 2, Second 2 Hours of Wear||9||
48641439|NCT03034928|101905307|FG003|STARTED|Period 2, Second 2 Hours of Wear||8||
48641440|NCT03034928|101905304|FG000|COMPLETED|Period 2, Second 2 Hours of Wear||8||
48641441|NCT03034928|101905305|FG001|COMPLETED|Period 2, Second 2 Hours of Wear||8||
48641442|NCT03034928|101905306|FG002|COMPLETED|Period 2, Second 2 Hours of Wear||9||
48641443|NCT03034928|101905307|FG003|COMPLETED|Period 2, Second 2 Hours of Wear||8||
48641444|NCT03034928|101905304|FG000|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0||
48641445|NCT03034928|101905305|FG001|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0||
48641446|NCT03034928|101905306|FG002|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0||
48641447|NCT03034928|101905307|FG003|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0||
48641448|NCT01482221|101905308|FG000|STARTED|Overall Study||101||
48641449|NCT01482221|101905309|FG001|STARTED|Overall Study||101||
48641450|NCT01482221|101905310|FG002|STARTED|Overall Study||100||
48641451|NCT01482221|101905308|FG000|COMPLETED|Overall Study||80||
48641452|NCT01482221|101905309|FG001|COMPLETED|Overall Study||81||
48641453|NCT01482221|101905310|FG002|COMPLETED|Overall Study||77||
48641454|NCT01482221|101905308|FG000|NOT COMPLETED|Overall Study||21||
48641455|NCT01482221|101905309|FG001|NOT COMPLETED|Overall Study||20||
48641456|NCT01482221|101905310|FG002|NOT COMPLETED|Overall Study||23||
48641457|NCT03593629|101905311|FG000|STARTED|Overall Study||166||
48641458|NCT03593629|101905312|FG001|STARTED|Overall Study||166||
48641459|NCT03593629|101905313|FG002|STARTED|Overall Study||291||
48641460|NCT03593629|101905314|FG003|STARTED|Overall Study||163||
48641461|NCT03593629|101905311|FG000|COMPLETED|Overall Study||166||
48641462|NCT03593629|101905312|FG001|COMPLETED|Overall Study||166||
48641463|NCT03593629|101905313|FG002|COMPLETED|Overall Study||291||
48641464|NCT03593629|101905314|FG003|COMPLETED|Overall Study||163||
48641465|NCT03593629|101905311|FG000|NOT COMPLETED|Overall Study||0||
48641466|NCT03593629|101905312|FG001|NOT COMPLETED|Overall Study||0||
48641467|NCT03593629|101905313|FG002|NOT COMPLETED|Overall Study||0||
48641468|NCT03593629|101905314|FG003|NOT COMPLETED|Overall Study||0||
48641469|NCT01397747|101905315|FG000|STARTED|Overall Study||11016||
48641470|NCT01397747|101905315|FG000|COMPLETED|Overall Study||9989||
48641471|NCT01397747|101905315|FG000|NOT COMPLETED|Overall Study||1027||
48641472|NCT00248547|101905316|FG000|STARTED|Overall Study||20||
48641473|NCT00248547|101905317|FG001|STARTED|Overall Study||20||
48641474|NCT00248547|101905316|FG000|COMPLETED|Overall Study||20||
48641475|NCT00248547|101905317|FG001|COMPLETED|Overall Study||20||
48641476|NCT00248547|101905316|FG000|NOT COMPLETED|Overall Study||0||
48641477|NCT00248547|101905317|FG001|NOT COMPLETED|Overall Study||0||
48641478|NCT01499511|101905318|FG000|STARTED|Overall Study||885||
48641479|NCT01499511|101905319|FG001|STARTED|Overall Study||833||
48641480|NCT01499511|101905318|FG000|COMPLETED|Overall Study||884||
48641481|NCT01499511|101905319|FG001|COMPLETED|Overall Study||833||
48641482|NCT01499511|101905318|FG000|NOT COMPLETED|Overall Study||1||
48641483|NCT01499511|101905319|FG001|NOT COMPLETED|Overall Study||0||
48641484|NCT01564407|101905320|FG000|STARTED|Overall Study||4||
48641485|NCT01564407|101905321|FG001|STARTED|Overall Study||5||
48641486|NCT01564407|101905322|FG002|STARTED|Overall Study||4||
48641487|NCT01564407|101905323|FG003|STARTED|Overall Study||2||
48641488|NCT01564407|101905324|FG004|STARTED|Overall Study||0||
48641489|NCT01564407|101905320|FG000|COMPLETED|Overall Study||4||
48641490|NCT01564407|101905321|FG001|COMPLETED|Overall Study||3||
48641491|NCT01564407|101905322|FG002|COMPLETED|Overall Study||4||
48641492|NCT01564407|101905323|FG003|COMPLETED|Overall Study||1||
48641493|NCT01564407|101905324|FG004|COMPLETED|Overall Study||0||
48641494|NCT01564407|101905320|FG000|NOT COMPLETED|Overall Study||0||
48641495|NCT01564407|101905321|FG001|NOT COMPLETED|Overall Study||2||
48641496|NCT01564407|101905322|FG002|NOT COMPLETED|Overall Study||0||
48641497|NCT01564407|101905323|FG003|NOT COMPLETED|Overall Study||1||
48641498|NCT01564407|101905324|FG004|NOT COMPLETED|Overall Study||0||
48641499|NCT04575324|101905325|FG000|STARTED|Overall Study||138||
48641500|NCT04575324|101905326|FG001|STARTED|Overall Study||137||
48641501|NCT04575324|101905325|FG000|COMPLETED|Overall Study||108||
48641502|NCT04575324|101905326|FG001|COMPLETED|Overall Study||109||
48641503|NCT04575324|101905325|FG000|NOT COMPLETED|Overall Study||30||
48641504|NCT04575324|101905326|FG001|NOT COMPLETED|Overall Study||28||
48641505|NCT02316613|101905327|FG000|STARTED|Overall Study||260||
48641506|NCT02316613|101905327|FG000|Safety Population|Overall Study||255||
48641507|NCT02316613|101905327|FG000|Overall Population|Overall Study||241||
48641508|NCT02316613|101905327|FG000|COMPLETED|Overall Study||156||
48641509|NCT02316613|101905327|FG000|NOT COMPLETED|Overall Study||104||
48641510|NCT00577408|101905328|FG000|STARTED|Overall Study||28||
48641511|NCT00577408|101905329|FG001|STARTED|Overall Study||32||
48641512|NCT00577408|101905328|FG000|COMPLETED|Overall Study||16||
48641513|NCT00577408|101905329|FG001|COMPLETED|Overall Study||9||
48641514|NCT00577408|101905328|FG000|NOT COMPLETED|Overall Study||12||
48641515|NCT00577408|101905329|FG001|NOT COMPLETED|Overall Study||23||
48641516|NCT00478036|101905330|FG000|STARTED|Overall Study||10||
48641517|NCT00478036|101905331|FG001|STARTED|Overall Study||7||
48641518|NCT00478036|101905332|FG002|STARTED|Overall Study||14||
48641519|NCT00478036|101905330|FG000|COMPLETED|Overall Study||10||
48641520|NCT00478036|101905331|FG001|COMPLETED|Overall Study||7||
48641521|NCT00478036|101905332|FG002|COMPLETED|Overall Study||14||
48641522|NCT00478036|101905330|FG000|NOT COMPLETED|Overall Study||0||
48641523|NCT00478036|101905331|FG001|NOT COMPLETED|Overall Study||0||
48641524|NCT00478036|101905332|FG002|NOT COMPLETED|Overall Study||0||
48641525|NCT00845000|101905333|FG000|STARTED|Period 1||2||
48641526|NCT00845000|101905334|FG001|STARTED|Period 1||2||
48641527|NCT00845000|101905335|FG002|STARTED|Period 1||2||
48641528|NCT00845000|101905336|FG003|STARTED|Period 1||2||
48641529|NCT00845000|101905337|FG004|STARTED|Period 1||2||
48641530|NCT00845000|101905338|FG005|STARTED|Period 1||2||
48641531|NCT00845000|101905333|FG000|COMPLETED|Period 1||2||
48641532|NCT00845000|101905334|FG001|COMPLETED|Period 1||2||
48641533|NCT00845000|101905335|FG002|COMPLETED|Period 1||2||
48641534|NCT00845000|101905336|FG003|COMPLETED|Period 1||2||
48641535|NCT00845000|101905337|FG004|COMPLETED|Period 1||2||
48641536|NCT00845000|101905338|FG005|COMPLETED|Period 1||2||
48641537|NCT00845000|101905333|FG000|NOT COMPLETED|Period 1||0||
48641538|NCT00845000|101905334|FG001|NOT COMPLETED|Period 1||0||
48641539|NCT00845000|101905335|FG002|NOT COMPLETED|Period 1||0||
48641540|NCT00845000|101905336|FG003|NOT COMPLETED|Period 1||0||
48641541|NCT00845000|101905337|FG004|NOT COMPLETED|Period 1||0||
48641542|NCT00845000|101905338|FG005|NOT COMPLETED|Period 1||0||
48641543|NCT00845000|101905333|FG000|STARTED|Period 2||2||
48641544|NCT00845000|101905334|FG001|STARTED|Period 2||2||
48641545|NCT00845000|101905335|FG002|STARTED|Period 2||2||
48641546|NCT00845000|101905336|FG003|STARTED|Period 2||2||
48641547|NCT00845000|101905337|FG004|STARTED|Period 2||2||
48641548|NCT00845000|101905338|FG005|STARTED|Period 2||2||
48641549|NCT00845000|101905333|FG000|COMPLETED|Period 2||2||
48641550|NCT00845000|101905334|FG001|COMPLETED|Period 2||2||
48641551|NCT00845000|101905335|FG002|COMPLETED|Period 2||2||
48641552|NCT00845000|101905336|FG003|COMPLETED|Period 2||2||
48641553|NCT00845000|101905337|FG004|COMPLETED|Period 2||2||
48641554|NCT00845000|101905338|FG005|COMPLETED|Period 2||2||
48641555|NCT00845000|101905333|FG000|NOT COMPLETED|Period 2||0||
48641556|NCT00845000|101905334|FG001|NOT COMPLETED|Period 2||0||
48641557|NCT00845000|101905335|FG002|NOT COMPLETED|Period 2||0||
48641558|NCT00845000|101905336|FG003|NOT COMPLETED|Period 2||0||
48641559|NCT00845000|101905337|FG004|NOT COMPLETED|Period 2||0||
48641560|NCT00845000|101905338|FG005|NOT COMPLETED|Period 2||0||
48641561|NCT00845000|101905333|FG000|STARTED|Period 3||2||
48641562|NCT00845000|101905334|FG001|STARTED|Period 3||2||
48641563|NCT00845000|101905335|FG002|STARTED|Period 3||2||
48641564|NCT00845000|101905336|FG003|STARTED|Period 3||2||
48641565|NCT00845000|101905337|FG004|STARTED|Period 3||2||
48641566|NCT00845000|101905338|FG005|STARTED|Period 3||2||
48641567|NCT00845000|101905333|FG000|COMPLETED|Period 3||2||
48641568|NCT00845000|101905334|FG001|COMPLETED|Period 3||2||
48641569|NCT00845000|101905335|FG002|COMPLETED|Period 3||2||
48641570|NCT00845000|101905336|FG003|COMPLETED|Period 3||2||
48641571|NCT00845000|101905337|FG004|COMPLETED|Period 3||2||
48641572|NCT00845000|101905338|FG005|COMPLETED|Period 3||2||
48641573|NCT00845000|101905333|FG000|NOT COMPLETED|Period 3||0||
48641574|NCT00845000|101905334|FG001|NOT COMPLETED|Period 3||0||
48641575|NCT00845000|101905335|FG002|NOT COMPLETED|Period 3||0||
48641576|NCT00845000|101905336|FG003|NOT COMPLETED|Period 3||0||
48641577|NCT00845000|101905337|FG004|NOT COMPLETED|Period 3||0||
48764724|NCT01347112|102212021|FG000|STARTED|Overall Study||16||
48641578|NCT00845000|101905338|FG005|NOT COMPLETED|Period 3||0||
48641579|NCT00177671|101905339|FG000|STARTED|Overall Study||67||
48641580|NCT00177671|101905340|FG001|STARTED|Overall Study||63||
48641581|NCT00177671|101905339|FG000|Month 12|Overall Study||45||
48641582|NCT00177671|101905340|FG001|Month 12|Overall Study||57||
48641583|NCT00177671|101905339|FG000|Month 24|Overall Study||42||
48641584|NCT00177671|101905340|FG001|Month 24|Overall Study||49||
48641585|NCT00177671|101905339|FG000|COMPLETED|Overall Study||42||
48641586|NCT00177671|101905340|FG001|COMPLETED|Overall Study||49||
48641587|NCT00177671|101905339|FG000|NOT COMPLETED|Overall Study||25||
48641588|NCT00177671|101905340|FG001|NOT COMPLETED|Overall Study||14||
48641589|NCT04232137|101905341|FG000|STARTED|Overall Study||254||
48641590|NCT04232137|101905342|FG001|STARTED|Overall Study||185||
48641591|NCT04232137|101905341|FG000|COMPLETED|Overall Study||254||
48641592|NCT04232137|101905342|FG001|COMPLETED|Overall Study||185||
48641593|NCT04232137|101905341|FG000|NOT COMPLETED|Overall Study||0||
48641594|NCT04232137|101905342|FG001|NOT COMPLETED|Overall Study||0||
48641595|NCT02693418|101905343|FG000|STARTED|Overall Study||22||
48764725|NCT01347112|102212022|FG001|STARTED|Overall Study||17||
48764726|NCT01347112|102212021|FG000|COMPLETED|Overall Study||12||
48641596|NCT02693418|101905344|FG001|STARTED|Overall Study||21||
48641597|NCT02693418|101905345|FG002|STARTED|Overall Study||21||
48641598|NCT02693418|101905346|FG003|STARTED|Overall Study||20||
48641599|NCT02693418|101905347|FG004|STARTED|Overall Study||21||
48641600|NCT02693418|101905343|FG000|COMPLETED|Overall Study||21||
48641601|NCT02693418|101905344|FG001|COMPLETED|Overall Study||19||
48764727|NCT01347112|102212022|FG001|COMPLETED|Overall Study||5||
48641602|NCT02693418|101905345|FG002|COMPLETED|Overall Study||19||
48641603|NCT02693418|101905346|FG003|COMPLETED|Overall Study||20||
48641604|NCT02693418|101905347|FG004|COMPLETED|Overall Study||21||
48641605|NCT02693418|101905343|FG000|NOT COMPLETED|Overall Study||1||
48641606|NCT02693418|101905344|FG001|NOT COMPLETED|Overall Study||2||
48641607|NCT02693418|101905345|FG002|NOT COMPLETED|Overall Study||2||
48641608|NCT02693418|101905346|FG003|NOT COMPLETED|Overall Study||0||
48641609|NCT02693418|101905347|FG004|NOT COMPLETED|Overall Study||0||
48641610|NCT04615507|101905348|FG000|STARTED|Period 1||34||
48641611|NCT04615507|101905349|FG001|STARTED|Period 1||34||
48641612|NCT04615507|101905348|FG000|COMPLETED|Period 1||32||
48641613|NCT04615507|101905349|FG001|COMPLETED|Period 1||33||
48641614|NCT04615507|101905348|FG000|NOT COMPLETED|Period 1||2||
48641615|NCT04615507|101905349|FG001|NOT COMPLETED|Period 1||1||
48641616|NCT04615507|101905348|FG000|STARTED|Period 2||32||
48641617|NCT04615507|101905349|FG001|STARTED|Period 2||33||
48641618|NCT04615507|101905348|FG000|COMPLETED|Period 2||30||
48764728|NCT01347112|102212021|FG000|NOT COMPLETED|Overall Study||4||
48641619|NCT04615507|101905349|FG001|COMPLETED|Period 2||31||
48641620|NCT04615507|101905348|FG000|NOT COMPLETED|Period 2||2||
48641621|NCT04615507|101905349|FG001|NOT COMPLETED|Period 2||2||
48641622|NCT04615507|101905348|FG000|STARTED|Period 3||30||
48641623|NCT04615507|101905349|FG001|STARTED|Period 3||31||
48641624|NCT04615507|101905348|FG000|COMPLETED|Period 3||30||
48641625|NCT04615507|101905349|FG001|COMPLETED|Period 3||30||
48641626|NCT04615507|101905348|FG000|NOT COMPLETED|Period 3||0||
48641627|NCT04615507|101905349|FG001|NOT COMPLETED|Period 3||1||
48641628|NCT00990288|101905350|FG000|STARTED|Overall Study||97||
48641629|NCT00990288|101905351|FG001|STARTED|Overall Study||99||
48641630|NCT00990288|101905350|FG000|COMPLETED|Overall Study||97||
48641631|NCT00990288|101905351|FG001|COMPLETED|Overall Study||99||
48641632|NCT00990288|101905350|FG000|NOT COMPLETED|Overall Study||0||
48641633|NCT00990288|101905351|FG001|NOT COMPLETED|Overall Study||0||
48641634|NCT00410488|101905352|FG000|STARTED|Overall Study||16||
48641635|NCT00410488|101905353|FG001|STARTED|Overall Study||34||
48641636|NCT00410488|101905352|FG000|COMPLETED|Overall Study||16||
48641637|NCT00410488|101905353|FG001|COMPLETED|Overall Study||34||
48641638|NCT00410488|101905352|FG000|NOT COMPLETED|Overall Study||0||
48641639|NCT00410488|101905353|FG001|NOT COMPLETED|Overall Study||0||
48641640|NCT04327271|101905354|FG000|STARTED|Overall Study||553||
48641641|NCT04327271|101905355|FG001|STARTED|Overall Study||540||
48641642|NCT04327271|101905354|FG000|COMPLETED|Overall Study||547||
48641643|NCT04327271|101905355|FG001|COMPLETED|Overall Study||537||
48641644|NCT04327271|101905354|FG000|NOT COMPLETED|Overall Study||6||
48641645|NCT04327271|101905355|FG001|NOT COMPLETED|Overall Study||3||
48641646|NCT01744821|101905356|FG000|STARTED|Overall Study||1||
48641647|NCT01744821|101905357|FG001|STARTED|Overall Study||3||
48641648|NCT01744821|101905358|FG002|STARTED|Overall Study||2||
48641649|NCT01744821|101905359|FG003|STARTED|Overall Study||1||
48641650|NCT01744821|101905356|FG000|COMPLETED|Overall Study||1||
48641651|NCT01744821|101905357|FG001|COMPLETED|Overall Study||3||
48641652|NCT01744821|101905358|FG002|COMPLETED|Overall Study||2||
48641653|NCT01744821|101905359|FG003|COMPLETED|Overall Study||1||
48641654|NCT01744821|101905356|FG000|NOT COMPLETED|Overall Study||0||
48641655|NCT01744821|101905357|FG001|NOT COMPLETED|Overall Study||0||
48641656|NCT01744821|101905358|FG002|NOT COMPLETED|Overall Study||0||
48641657|NCT01744821|101905359|FG003|NOT COMPLETED|Overall Study||0||
48641658|NCT00541229|101905360|FG000|STARTED|Treatment Period I (Week 1)||17||
48641659|NCT00541229|101905361|FG001|STARTED|Treatment Period I (Week 1)||16||
48641660|NCT00541229|101905362|FG002|STARTED|Treatment Period I (Week 1)||20||
48641661|NCT00541229|101905363|FG003|STARTED|Treatment Period I (Week 1)||18||
48641662|NCT00541229|101905364|FG004|STARTED|Treatment Period I (Week 1)||14||
48641663|NCT00541229|101905365|FG005|STARTED|Treatment Period I (Week 1)||18||
48641664|NCT00541229|101905360|FG000|COMPLETED|Treatment Period I (Week 1)||17||
48641665|NCT00541229|101905361|FG001|COMPLETED|Treatment Period I (Week 1)||15||
48764729|NCT01347112|102212022|FG001|NOT COMPLETED|Overall Study||12||
48764730|NCT01032538|102212023|FG000|STARTED|Overall Study||99||
48764731|NCT01032538|102212023|FG000|COMPLETED|Overall Study||99||
48764732|NCT01032538|102212023|FG000|NOT COMPLETED|Overall Study||0||
48764733|NCT02072668|102212024|FG000|STARTED|First Intervention||7||
48764734|NCT02072668|102212025|FG001|STARTED|First Intervention||7||
48764735|NCT02072668|102212024|FG000|COMPLETED|First Intervention||7||
48764736|NCT02072668|102212025|FG001|COMPLETED|First Intervention||7||
48764737|NCT02072668|102212024|FG000|NOT COMPLETED|First Intervention||0||
48764738|NCT02072668|102212025|FG001|NOT COMPLETED|First Intervention||0||
48764739|NCT02072668|102212024|FG000|STARTED|Washout (2 Weeks)||7||
48764740|NCT02072668|102212025|FG001|STARTED|Washout (2 Weeks)||7||
48641666|NCT00541229|101905362|FG002|COMPLETED|Treatment Period I (Week 1)||17||
48641667|NCT00541229|101905363|FG003|COMPLETED|Treatment Period I (Week 1)||17||
48641668|NCT00541229|101905364|FG004|COMPLETED|Treatment Period I (Week 1)||14||
48641669|NCT00541229|101905365|FG005|COMPLETED|Treatment Period I (Week 1)||16||
48641670|NCT00541229|101905360|FG000|NOT COMPLETED|Treatment Period I (Week 1)||0||
48641671|NCT00541229|101905361|FG001|NOT COMPLETED|Treatment Period I (Week 1)||1||
48764741|NCT02072668|102212024|FG000|COMPLETED|Washout (2 Weeks)||7||
48764742|NCT02072668|102212025|FG001|COMPLETED|Washout (2 Weeks)||7||
48764743|NCT02072668|102212024|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
48641672|NCT00541229|101905362|FG002|NOT COMPLETED|Treatment Period I (Week 1)||3||
48641673|NCT00541229|101905363|FG003|NOT COMPLETED|Treatment Period I (Week 1)||1||
48641674|NCT00541229|101905364|FG004|NOT COMPLETED|Treatment Period I (Week 1)||0||
48641675|NCT00541229|101905365|FG005|NOT COMPLETED|Treatment Period I (Week 1)||2||
48641676|NCT00541229|101905360|FG000|STARTED|Washout Period I (Week 2-5)||17||
48641677|NCT00541229|101905361|FG001|STARTED|Washout Period I (Week 2-5)||15||
48764744|NCT02072668|102212025|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
48764745|NCT02072668|102212024|FG000|STARTED|Second Intervention||7||
48641678|NCT00541229|101905362|FG002|STARTED|Washout Period I (Week 2-5)||17||
48641679|NCT00541229|101905363|FG003|STARTED|Washout Period I (Week 2-5)||17||
48641680|NCT00541229|101905364|FG004|STARTED|Washout Period I (Week 2-5)||14||
48641681|NCT00541229|101905365|FG005|STARTED|Washout Period I (Week 2-5)||16||
48641682|NCT00541229|101905360|FG000|COMPLETED|Washout Period I (Week 2-5)||13||
48187883|NCT01824082|100783125|FG000|COMPLETED|Optional Crossover Treatment||40||
48433748|NCT00346775|101397116|FG000|STARTED|Period 1: Intervention Period 1||49||
48433749|NCT00346775|101397117|FG001|STARTED|Period 1: Intervention Period 1||48||
48433750|NCT00346775|101397116|FG000|COMPLETED|Period 1: Intervention Period 1||44||
48433751|NCT00346775|101397117|FG001|COMPLETED|Period 1: Intervention Period 1||45||
48433752|NCT00346775|101397116|FG000|NOT COMPLETED|Period 1: Intervention Period 1||5||
48433753|NCT00346775|101397117|FG001|NOT COMPLETED|Period 1: Intervention Period 1||3||
48433754|NCT00346775|101397116|FG000|STARTED|Period 2: Washout Period (7 Days)||44||
48433755|NCT00346775|101397117|FG001|STARTED|Period 2: Washout Period (7 Days)||45||
48433756|NCT00346775|101397116|FG000|COMPLETED|Period 2: Washout Period (7 Days)||44||
48433757|NCT00346775|101397117|FG001|COMPLETED|Period 2: Washout Period (7 Days)||45||
48433758|NCT00346775|101397116|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0||
48433759|NCT00346775|101397117|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||0||
48433760|NCT00346775|101397116|FG000|STARTED|Period 3: Intervention Period 2||44||
48433761|NCT00346775|101397117|FG001|STARTED|Period 3: Intervention Period 2||45||
48641683|NCT00541229|101905361|FG001|COMPLETED|Washout Period I (Week 2-5)||13||
48641684|NCT00541229|101905362|FG002|COMPLETED|Washout Period I (Week 2-5)||13||
48641685|NCT00541229|101905363|FG003|COMPLETED|Washout Period I (Week 2-5)||13||
48641686|NCT00541229|101905364|FG004|COMPLETED|Washout Period I (Week 2-5)||13||
48641687|NCT00541229|101905365|FG005|COMPLETED|Washout Period I (Week 2-5)||11||
48641688|NCT00541229|101905360|FG000|NOT COMPLETED|Washout Period I (Week 2-5)||4||
48641689|NCT00541229|101905361|FG001|NOT COMPLETED|Washout Period I (Week 2-5)||2||
48641690|NCT00541229|101905362|FG002|NOT COMPLETED|Washout Period I (Week 2-5)||4||
48641691|NCT00541229|101905363|FG003|NOT COMPLETED|Washout Period I (Week 2-5)||4||
48641692|NCT00541229|101905364|FG004|NOT COMPLETED|Washout Period I (Week 2-5)||1||
48641693|NCT00541229|101905365|FG005|NOT COMPLETED|Washout Period I (Week 2-5)||5||
48641694|NCT00541229|101905360|FG000|STARTED|Treatment Period II (Week 6)||13||
48641695|NCT00541229|101905361|FG001|STARTED|Treatment Period II (Week 6)||13||
48641696|NCT00541229|101905362|FG002|STARTED|Treatment Period II (Week 6)||13||
48641697|NCT00541229|101905363|FG003|STARTED|Treatment Period II (Week 6)||13||
48641698|NCT00541229|101905364|FG004|STARTED|Treatment Period II (Week 6)||13||
48641699|NCT00541229|101905365|FG005|STARTED|Treatment Period II (Week 6)||11||
48641700|NCT00541229|101905360|FG000|COMPLETED|Treatment Period II (Week 6)||11||
48641701|NCT00541229|101905361|FG001|COMPLETED|Treatment Period II (Week 6)||12||
48641702|NCT00541229|101905362|FG002|COMPLETED|Treatment Period II (Week 6)||12||
48641703|NCT00541229|101905363|FG003|COMPLETED|Treatment Period II (Week 6)||12||
48641704|NCT00541229|101905364|FG004|COMPLETED|Treatment Period II (Week 6)||11||
48641705|NCT00541229|101905365|FG005|COMPLETED|Treatment Period II (Week 6)||8||
48641706|NCT00541229|101905360|FG000|NOT COMPLETED|Treatment Period II (Week 6)||2||
48641707|NCT00541229|101905361|FG001|NOT COMPLETED|Treatment Period II (Week 6)||1||
48641708|NCT00541229|101905362|FG002|NOT COMPLETED|Treatment Period II (Week 6)||1||
48641709|NCT00541229|101905363|FG003|NOT COMPLETED|Treatment Period II (Week 6)||1||
48641710|NCT00541229|101905364|FG004|NOT COMPLETED|Treatment Period II (Week 6)||2||
48641711|NCT00541229|101905365|FG005|NOT COMPLETED|Treatment Period II (Week 6)||3||
48641712|NCT00541229|101905360|FG000|STARTED|Washout Period II (Week 7-10)||11||
48641713|NCT00541229|101905361|FG001|STARTED|Washout Period II (Week 7-10)||12||
48641714|NCT00541229|101905362|FG002|STARTED|Washout Period II (Week 7-10)||12||
48641715|NCT00541229|101905363|FG003|STARTED|Washout Period II (Week 7-10)||12||
48641716|NCT00541229|101905364|FG004|STARTED|Washout Period II (Week 7-10)||11||
48641717|NCT00541229|101905365|FG005|STARTED|Washout Period II (Week 7-10)||8||
48641718|NCT00541229|101905360|FG000|COMPLETED|Washout Period II (Week 7-10)||7||
48641719|NCT00541229|101905361|FG001|COMPLETED|Washout Period II (Week 7-10)||8||
48641720|NCT00541229|101905362|FG002|COMPLETED|Washout Period II (Week 7-10)||10||
48641721|NCT00541229|101905363|FG003|COMPLETED|Washout Period II (Week 7-10)||8||
48641722|NCT00541229|101905364|FG004|COMPLETED|Washout Period II (Week 7-10)||7||
48641723|NCT00541229|101905365|FG005|COMPLETED|Washout Period II (Week 7-10)||5||
48641724|NCT00541229|101905360|FG000|NOT COMPLETED|Washout Period II (Week 7-10)||4||
48433762|NCT00346775|101397116|FG000|COMPLETED|Period 3: Intervention Period 2||44||
48433763|NCT00346775|101397117|FG001|COMPLETED|Period 3: Intervention Period 2||45||
48433764|NCT00346775|101397116|FG000|NOT COMPLETED|Period 3: Intervention Period 2||0||
48433765|NCT00346775|101397117|FG001|NOT COMPLETED|Period 3: Intervention Period 2||0||
48433766|NCT01298362|101397118|FG000|STARTED|Overall Study||124||
48641725|NCT00541229|101905361|FG001|NOT COMPLETED|Washout Period II (Week 7-10)||4||
48641726|NCT00541229|101905362|FG002|NOT COMPLETED|Washout Period II (Week 7-10)||2||
48641727|NCT00541229|101905363|FG003|NOT COMPLETED|Washout Period II (Week 7-10)||4||
48641728|NCT00541229|101905364|FG004|NOT COMPLETED|Washout Period II (Week 7-10)||4||
48641729|NCT00541229|101905365|FG005|NOT COMPLETED|Washout Period II (Week 7-10)||3||
48187884|NCT01824082|100783126|FG001|COMPLETED|Optional Crossover Treatment||25||
48433767|NCT01298362|101397119|FG001|STARTED|Overall Study||166||
48641730|NCT00541229|101905360|FG000|STARTED|Treatment Period III (Week 11)||7||
48641731|NCT00541229|101905361|FG001|STARTED|Treatment Period III (Week 11)||8||
48641732|NCT00541229|101905362|FG002|STARTED|Treatment Period III (Week 11)||10||
48641733|NCT00541229|101905363|FG003|STARTED|Treatment Period III (Week 11)||8||
48187885|NCT01824082|100783125|FG000|NOT COMPLETED|Optional Crossover Treatment||0||
48641734|NCT00541229|101905364|FG004|STARTED|Treatment Period III (Week 11)||7||
48641735|NCT00541229|101905365|FG005|STARTED|Treatment Period III (Week 11)||5||
48641736|NCT00541229|101905360|FG000|COMPLETED|Treatment Period III (Week 11)||7||
48641737|NCT00541229|101905361|FG001|COMPLETED|Treatment Period III (Week 11)||8||
48641738|NCT00541229|101905362|FG002|COMPLETED|Treatment Period III (Week 11)||9||
48433768|NCT01298362|101397118|FG000|COMPLETED|Overall Study||86||
48433769|NCT01298362|101397119|FG001|COMPLETED|Overall Study||123||
48433770|NCT01298362|101397118|FG000|NOT COMPLETED|Overall Study||38||
48641739|NCT00541229|101905363|FG003|COMPLETED|Treatment Period III (Week 11)||8||
48641740|NCT00541229|101905364|FG004|COMPLETED|Treatment Period III (Week 11)||6||
48641741|NCT00541229|101905365|FG005|COMPLETED|Treatment Period III (Week 11)||4||
48641742|NCT00541229|101905360|FG000|NOT COMPLETED|Treatment Period III (Week 11)||0||
48641743|NCT00541229|101905361|FG001|NOT COMPLETED|Treatment Period III (Week 11)||0||
48641744|NCT00541229|101905362|FG002|NOT COMPLETED|Treatment Period III (Week 11)||1||
48641745|NCT00541229|101905363|FG003|NOT COMPLETED|Treatment Period III (Week 11)||0||
48641746|NCT00541229|101905364|FG004|NOT COMPLETED|Treatment Period III (Week 11)||1||
48641747|NCT00541229|101905365|FG005|NOT COMPLETED|Treatment Period III (Week 11)||1||
48641748|NCT04203056|101905366|FG000|STARTED|Overall Study||6||
48641749|NCT04203056|101905367|FG001|STARTED|Overall Study||9||
48641750|NCT04203056|101905366|FG000|COMPLETED|Overall Study||3||
48641751|NCT04203056|101905367|FG001|COMPLETED|Overall Study||5||
48641752|NCT04203056|101905366|FG000|NOT COMPLETED|Overall Study||3||
48641753|NCT04203056|101905367|FG001|NOT COMPLETED|Overall Study||4||
48641754|NCT02332707|101905368|FG000|STARTED|Overall Study||23||
48641755|NCT02332707|101905369|FG001|STARTED|Overall Study||24||
48641756|NCT02332707|101905370|FG002|STARTED|Overall Study||16||
48641757|NCT02332707|101905371|FG003|STARTED|Overall Study||14||
48641758|NCT02332707|101905372|FG004|STARTED|Overall Study||23||
48641759|NCT02332707|101905373|FG005|STARTED|Overall Study||23||
48641760|NCT02332707|101905374|FG006|STARTED|Overall Study||15||
48641761|NCT02332707|101905375|FG007|STARTED|Overall Study||16||
48641762|NCT02332707|101905376|FG008|STARTED|Overall Study||48||
48641763|NCT02332707|101905377|FG009|STARTED|Overall Study||31||
48641764|NCT02332707|101905378|FG010|STARTED|Overall Study||31||
48641765|NCT02332707|101905379|FG011|STARTED|Overall Study||35||
48641766|NCT02332707|101905380|FG012|STARTED|Overall Study||40||
48641767|NCT02332707|101905381|FG013|STARTED|Overall Study||15||
48641768|NCT02332707|101905382|FG014|STARTED|Overall Study||16||
48641769|NCT02332707|101905383|FG015|STARTED|Overall Study||26||
48641770|NCT02332707|101905384|FG016|STARTED|Overall Study||30||
48641771|NCT02332707|101905385|FG017|STARTED|Overall Study||16||
48641772|NCT02332707|101905368|FG000|COMPLETED|Overall Study||23||
48641773|NCT02332707|101905369|FG001|COMPLETED|Overall Study||24||
48641774|NCT02332707|101905370|FG002|COMPLETED|Overall Study||15||
48641775|NCT02332707|101905371|FG003|COMPLETED|Overall Study||13||
48641776|NCT02332707|101905372|FG004|COMPLETED|Overall Study||23||
48641777|NCT02332707|101905373|FG005|COMPLETED|Overall Study||22||
48641778|NCT02332707|101905374|FG006|COMPLETED|Overall Study||15||
48641779|NCT02332707|101905375|FG007|COMPLETED|Overall Study||16||
48641780|NCT02332707|101905376|FG008|COMPLETED|Overall Study||48||
48641781|NCT02332707|101905377|FG009|COMPLETED|Overall Study||28||
48433771|NCT01298362|101397119|FG001|NOT COMPLETED|Overall Study||43||
48433772|NCT05111548|101397120|FG000|STARTED|Overall Study||8||
48433773|NCT05111548|101397121|FG001|STARTED|Overall Study||7||
48433774|NCT05111548|101397120|FG000|COMPLETED|Overall Study||5||
48433775|NCT05111548|101397121|FG001|COMPLETED|Overall Study||6||
48433776|NCT05111548|101397120|FG000|NOT COMPLETED|Overall Study||3||
48433777|NCT05111548|101397121|FG001|NOT COMPLETED|Overall Study||1||
48433778|NCT02389621|101397122|FG000|STARTED|Treatment Period||108||
48641782|NCT02332707|101905378|FG010|COMPLETED|Overall Study||29||
48641783|NCT02332707|101905379|FG011|COMPLETED|Overall Study||35||
48641784|NCT02332707|101905380|FG012|COMPLETED|Overall Study||35||
48641785|NCT02332707|101905381|FG013|COMPLETED|Overall Study||15||
48641786|NCT02332707|101905382|FG014|COMPLETED|Overall Study||16||
48641787|NCT02332707|101905383|FG015|COMPLETED|Overall Study||26||
48641788|NCT02332707|101905384|FG016|COMPLETED|Overall Study||30||
48641789|NCT02332707|101905385|FG017|COMPLETED|Overall Study||16||
48641790|NCT02332707|101905368|FG000|NOT COMPLETED|Overall Study||0||
48641791|NCT02332707|101905369|FG001|NOT COMPLETED|Overall Study||0||
48641792|NCT02332707|101905370|FG002|NOT COMPLETED|Overall Study||1||
48641793|NCT02332707|101905371|FG003|NOT COMPLETED|Overall Study||1||
48641794|NCT02332707|101905372|FG004|NOT COMPLETED|Overall Study||0||
48641795|NCT02332707|101905373|FG005|NOT COMPLETED|Overall Study||1||
48641796|NCT02332707|101905374|FG006|NOT COMPLETED|Overall Study||0||
48641797|NCT02332707|101905375|FG007|NOT COMPLETED|Overall Study||0||
48641798|NCT02332707|101905376|FG008|NOT COMPLETED|Overall Study||0||
48641799|NCT02332707|101905377|FG009|NOT COMPLETED|Overall Study||3||
48641800|NCT02332707|101905378|FG010|NOT COMPLETED|Overall Study||2||
48641801|NCT02332707|101905379|FG011|NOT COMPLETED|Overall Study||0||
48433779|NCT02389621|101397123|FG001|STARTED|Treatment Period||107||
48641802|NCT02332707|101905380|FG012|NOT COMPLETED|Overall Study||5||
48641803|NCT02332707|101905381|FG013|NOT COMPLETED|Overall Study||0||
48641804|NCT02332707|101905382|FG014|NOT COMPLETED|Overall Study||0||
48641805|NCT02332707|101905383|FG015|NOT COMPLETED|Overall Study||0||
48641806|NCT02332707|101905384|FG016|NOT COMPLETED|Overall Study||0||
48641807|NCT02332707|101905385|FG017|NOT COMPLETED|Overall Study||0||
48641808|NCT00314106|101905386|FG000|STARTED|Overall Study||18||
48641809|NCT00314106|101905387|FG001|STARTED|Overall Study||8||
48641810|NCT00314106|101905386|FG000|COMPLETED|Overall Study||18||
48641811|NCT00314106|101905387|FG001|COMPLETED|Overall Study||8||
48641812|NCT00314106|101905386|FG000|NOT COMPLETED|Overall Study||0||
48641813|NCT00314106|101905387|FG001|NOT COMPLETED|Overall Study||0||
48641814|NCT03969420|101905388|FG000|STARTED|Overall Study||3||
48641815|NCT03969420|101905389|FG001|STARTED|Overall Study||4||
48641816|NCT03969420|101905390|FG002|STARTED|Overall Study||2||
48641817|NCT03969420|101905391|FG003|STARTED|Overall Study||2||
48641818|NCT03969420|101905388|FG000|COMPLETED|Overall Study||3||
48641819|NCT03969420|101905389|FG001|COMPLETED|Overall Study||4||
48641820|NCT03969420|101905390|FG002|COMPLETED|Overall Study||2||
48641821|NCT03969420|101905391|FG003|COMPLETED|Overall Study||2||
48641822|NCT03969420|101905388|FG000|NOT COMPLETED|Overall Study||0||
48641823|NCT03969420|101905389|FG001|NOT COMPLETED|Overall Study||0||
48641824|NCT03969420|101905390|FG002|NOT COMPLETED|Overall Study||0||
48641825|NCT03969420|101905391|FG003|NOT COMPLETED|Overall Study||0||
48641826|NCT01428245|101905392|FG000|STARTED|Overall Study||1||
48641827|NCT01428245|101905392|FG000|COMPLETED|Overall Study||1||
48641828|NCT01428245|101905392|FG000|NOT COMPLETED|Overall Study||0||
48361295|NCT02553915|101214309|FG000|STARTED|Overall Study||15||
48361296|NCT02553915|101214310|FG001|STARTED|Overall Study||15||
48641829|NCT03325439|101905393|FG000|STARTED|Overall Study||9||
48641830|NCT03325439|101905393|FG000|Treated|Overall Study||6|Only 6 of 9 participants were treated with BRV.|
48641831|NCT03325439|101905393|FG000|COMPLETED|Overall Study||6||
48641832|NCT03325439|101905393|FG000|NOT COMPLETED|Overall Study||3||
48641833|NCT03807843|101905394|FG000|STARTED|Overall Study||21||
48641834|NCT03807843|101905395|FG001|STARTED|Overall Study||20||
48641835|NCT03807843|101905394|FG000|COMPLETED|Overall Study||20||
48641836|NCT03807843|101905395|FG001|COMPLETED|Overall Study||20||
48641837|NCT03807843|101905394|FG000|NOT COMPLETED|Overall Study||1||
48641838|NCT03807843|101905395|FG001|NOT COMPLETED|Overall Study||0||
48641839|NCT02512419|101905396|FG000|STARTED|Overall Study||24||
48641840|NCT02512419|101905397|FG001|STARTED|Overall Study||24||
48641841|NCT02512419|101905396|FG000|COMPLETED|Overall Study||22||
48641842|NCT02512419|101905397|FG001|COMPLETED|Overall Study||24||
48641843|NCT02512419|101905396|FG000|NOT COMPLETED|Overall Study||2||
48641844|NCT02512419|101905397|FG001|NOT COMPLETED|Overall Study||0||
48641845|NCT03228914|101905398|FG000|STARTED|Overall Study||20||20
48641846|NCT03228914|101905399|FG001|STARTED|Overall Study||20||20
48641847|NCT03228914|101905398|FG000|COMPLETED|Overall Study||20||20
48641848|NCT03228914|101905399|FG001|COMPLETED|Overall Study||20||20
48641849|NCT03228914|101905398|FG000|NOT COMPLETED|Overall Study||0||0
48641850|NCT03228914|101905399|FG001|NOT COMPLETED|Overall Study||0||0
48641851|NCT03860753|101905400|FG000|STARTED|Overall Study||4||
48641852|NCT03860753|101905401|FG001|STARTED|Overall Study||0||
48641853|NCT03860753|101905400|FG000|COMPLETED|Overall Study||4||
48641854|NCT03860753|101905401|FG001|COMPLETED|Overall Study||0||
48641855|NCT03860753|101905400|FG000|NOT COMPLETED|Overall Study||0||
48641856|NCT03860753|101905401|FG001|NOT COMPLETED|Overall Study||0||
48641857|NCT00857389|101905402|FG000|STARTED|Overall Study||60||
48641858|NCT00857389|101905402|FG000|COMPLETED|Overall Study||58||
48641859|NCT00857389|101905402|FG000|NOT COMPLETED|Overall Study||2||
48641860|NCT01704079|101905403|FG000|STARTED|Overall Study||72||
48641861|NCT01704079|101905404|FG001|STARTED|Overall Study||144||
48641862|NCT01704079|101905403|FG000|Entered Extension Study|Overall Study||53||
48641863|NCT01704079|101905404|FG001|Entered Extension Study|Overall Study||102||
48641864|NCT01704079|101905403|FG000|COMPLETED|Overall Study||58||
48641865|NCT01704079|101905404|FG001|COMPLETED|Overall Study||121||
48641866|NCT01704079|101905403|FG000|NOT COMPLETED|Overall Study||14||
48361297|NCT02553915|101214311|FG002|STARTED|Overall Study||15||
48361298|NCT02553915|101214312|FG003|STARTED|Overall Study||16||
48361299|NCT02553915|101214309|FG000|COMPLETED|Overall Study||11||
48361300|NCT02553915|101214310|FG001|COMPLETED|Overall Study||14||
48641867|NCT01704079|101905404|FG001|NOT COMPLETED|Overall Study||23||
48641868|NCT02547935|101905405|FG000|STARTED|Overall Study||155|Patients randomised to 24-week double-blind treatment period.|
48641869|NCT02547935|101905406|FG001|STARTED|Overall Study||145|Patients randomised to 24-week double-blind treatment period.|
48641870|NCT02547935|101905407|FG002|STARTED|Overall Study||148|Patients randomised to 24-week double-blind treatment period.|
48641871|NCT02547935|101905405|FG000|Received Treatment|Overall Study||152||
48641872|NCT02547935|101905406|FG001|Received Treatment|Overall Study||145||
48641873|NCT02547935|101905407|FG002|Received Treatment|Overall Study||148||
48641874|NCT02547935|101905405|FG000|Full Analysis Set|Overall Study||152||
48641875|NCT02547935|101905406|FG001|Full Analysis Set|Overall Study||144||
48641876|NCT02547935|101905407|FG002|Full Analysis Set|Overall Study||148||
48641877|NCT02547935|101905405|FG000|Safety Analysis Set|Overall Study||152||
48641878|NCT02547935|101905406|FG001|Safety Analysis Set|Overall Study||145||
48641879|NCT02547935|101905407|FG002|Safety Analysis Set|Overall Study||148||
48641880|NCT02547935|101905405|FG000|COMPLETED|Overall Study||150||
48641881|NCT02547935|101905406|FG001|COMPLETED|Overall Study||137||
48641882|NCT02547935|101905407|FG002|COMPLETED|Overall Study||143||
48641883|NCT02547935|101905405|FG000|NOT COMPLETED|Overall Study||5||
48641884|NCT02547935|101905406|FG001|NOT COMPLETED|Overall Study||8||
48641885|NCT02547935|101905407|FG002|NOT COMPLETED|Overall Study||5||
48641886|NCT05177094|101905408|FG000|STARTED|Overall Study||103||
48641887|NCT05177094|101905409|FG001|STARTED|Overall Study||52||
48641888|NCT05177094|101905408|FG000|Received at Least One Dose of Study Drug (Safety Population Week 1-4)|Overall Study||102||
48641889|NCT05177094|101905409|FG001|Received at Least One Dose of Study Drug (Safety Population Week 1-4)|Overall Study||52||
48641890|NCT05177094|101905408|FG000|Safety Population Week 5-8|Overall Study||95|All participants who took at least 1 dose of study drug and who did not discontinue at or prior to week 4.|
48641891|NCT05177094|101905409|FG001|Safety Population Week 5-8|Overall Study||46|All participants who took at least 1 dose of study drug and who did not discontinue at or prior to week 4.|
48641892|NCT05177094|101905408|FG000|COMPLETED|Overall Study||88||
48641893|NCT05177094|101905409|FG001|COMPLETED|Overall Study||43||
48641894|NCT05177094|101905408|FG000|NOT COMPLETED|Overall Study||15||
48641895|NCT05177094|101905409|FG001|NOT COMPLETED|Overall Study||9||
48641896|NCT02018107|101905410|FG000|STARTED|Overall Study||27||
48641897|NCT02018107|101905410|FG000|COMPLETED|Overall Study||27||
48433780|NCT02389621|101397122|FG000|Received Study Drug|Treatment Period||107||
48433781|NCT02389621|101397123|FG001|Received Study Drug|Treatment Period||107||
48433782|NCT02389621|101397122|FG000|COMPLETED|Treatment Period||107||
48433783|NCT02389621|101397123|FG001|COMPLETED|Treatment Period||106||
48433784|NCT02389621|101397122|FG000|NOT COMPLETED|Treatment Period||1||
48433785|NCT02389621|101397123|FG001|NOT COMPLETED|Treatment Period||1||
48641898|NCT02018107|101905410|FG000|NOT COMPLETED|Overall Study||0||
48641899|NCT01847209|101908391|FG000|STARTED|Overall Study||25||
48641900|NCT01847209|101908391|FG000|COMPLETED|Overall Study||23||
48641901|NCT01847209|101908391|FG000|NOT COMPLETED|Overall Study||2||
48641902|NCT03677401|101908392|FG000|STARTED|Overall Study||148||
48641903|NCT03677401|101908393|FG001|STARTED|Overall Study||147||
48641904|NCT03677401|101908392|FG000|COMPLETED|Overall Study||138||
48641905|NCT03677401|101908393|FG001|COMPLETED|Overall Study||129||
48641906|NCT03677401|101908392|FG000|NOT COMPLETED|Overall Study||10||
48641907|NCT03677401|101908393|FG001|NOT COMPLETED|Overall Study||18||
48641908|NCT00774748|101908394|FG000|STARTED|Overall Study||21||
48641909|NCT00774748|101908394|FG000|COMPLETED|Overall Study||18||
48641910|NCT00774748|101908394|FG000|NOT COMPLETED|Overall Study||3||
48641911|NCT02782104|101908395|FG000|STARTED|Overall Study||1148||
48641912|NCT02782104|101908395|FG000|IND Phase|Overall Study||458|Participants From Study NCT02417064:132; NCT02418585: 51; NCT02493868: 245; NCT02497287: 12; NCT02422186: 3; ESKETINTRD3006: 15|
48641913|NCT02782104|101908395|FG000|OP/MA Phase|Overall Study||1110|690 Participants From Study (NCT02417064:0; NCT02418585: 0; NCT02493868: 224; NCT02497287: 455; NCT02422186: 1; ESKETINTRD3006: 10) and 420 Participants from IND Phase|
48641914|NCT02782104|101908395|FG000|COMPLETED|Overall Study||680||
48641915|NCT02782104|101908395|FG000|NOT COMPLETED|Overall Study||468||
48641916|NCT01279200|101908396|FG000|STARTED|Overall Study||10||
48641917|NCT01279200|101908397|FG001|STARTED|Overall Study||11||
48641918|NCT01279200|101908396|FG000|COMPLETED|Overall Study||8||
48641919|NCT01279200|101908397|FG001|COMPLETED|Overall Study||4||
48641920|NCT01279200|101908396|FG000|NOT COMPLETED|Overall Study||2||
48641921|NCT01279200|101908397|FG001|NOT COMPLETED|Overall Study||7||
48641922|NCT04591015|101908398|FG000|STARTED|Overall Study||86||
48641923|NCT04591015|101908399|FG001|STARTED|Overall Study||86||
48641924|NCT04591015|101908398|FG000|COMPLETED|Overall Study||58||
48641925|NCT04591015|101908399|FG001|COMPLETED|Overall Study||68||
48641926|NCT04591015|101908398|FG000|NOT COMPLETED|Overall Study||28||
48641927|NCT04591015|101908399|FG001|NOT COMPLETED|Overall Study||18||
48641928|NCT01910441|101908400|FG000|STARTED|Overall Study||48||
48641929|NCT01910441|101908401|FG001|STARTED|Overall Study||47||
48641930|NCT01910441|101908400|FG000|COMPLETED|Overall Study||41||
48641931|NCT01910441|101908401|FG001|COMPLETED|Overall Study||37||
48641932|NCT01910441|101908400|FG000|NOT COMPLETED|Overall Study||7||
48641933|NCT01910441|101908401|FG001|NOT COMPLETED|Overall Study||10||
48641934|NCT01350973|101908402|FG000|STARTED|Overall Study||206||
48641935|NCT01350973|101908403|FG001|STARTED|Overall Study||210||
48641936|NCT01350973|101908404|FG002|STARTED|Overall Study||195||
48641937|NCT01350973|101908402|FG000|Received Treatment|Overall Study||205||
48641938|NCT01350973|101908403|FG001|Received Treatment|Overall Study||210||
48641939|NCT01350973|101908404|FG002|Received Treatment|Overall Study||195||
48641940|NCT01350973|101908402|FG000|COMPLETED|Overall Study||200||
48641941|NCT01350973|101908403|FG001|COMPLETED|Overall Study||202||
48641942|NCT01350973|101908404|FG002|COMPLETED|Overall Study||187||
48641943|NCT01350973|101908402|FG000|NOT COMPLETED|Overall Study||6||
48641944|NCT01350973|101908403|FG001|NOT COMPLETED|Overall Study||8||
48641945|NCT01350973|101908404|FG002|NOT COMPLETED|Overall Study||8||
48641946|NCT01989975|101908405|FG000|STARTED|Overall Study||40||
48433786|NCT02389621|101397122|FG000|STARTED|Posttreatment Period||107||
48433787|NCT02389621|101397123|FG001|STARTED|Posttreatment Period||106||
48433788|NCT02389621|101397122|FG000|COMPLETED|Posttreatment Period||98||
48433789|NCT02389621|101397123|FG001|COMPLETED|Posttreatment Period||102||
48433790|NCT02389621|101397122|FG000|NOT COMPLETED|Posttreatment Period||9||
48641947|NCT01989975|101908405|FG000|COMPLETED|Overall Study||40||
48641948|NCT01989975|101908405|FG000|NOT COMPLETED|Overall Study||0||
48641949|NCT02132468|101908406|FG000|STARTED|Overall Study||18||
48641950|NCT02132468|101908406|FG000|COMPLETED|Overall Study||11||
48641951|NCT02132468|101908406|FG000|NOT COMPLETED|Overall Study||7||
48641952|NCT02069184|101908407|FG000|STARTED|Overall Study||33||
48641953|NCT02069184|101908408|FG001|STARTED|Overall Study||33||
48641954|NCT02069184|101908407|FG000|COMPLETED|Overall Study||27||
48641955|NCT02069184|101908408|FG001|COMPLETED|Overall Study||31||
48641956|NCT02069184|101908407|FG000|NOT COMPLETED|Overall Study||6||
48641957|NCT02069184|101908408|FG001|NOT COMPLETED|Overall Study||2||
48641958|NCT04882800|101908409|FG000|STARTED|Device A Right Ear/Device B Left Ear||15||
48641959|NCT04882800|101908409|FG000|COMPLETED|Device A Right Ear/Device B Left Ear||15||
48641960|NCT04882800|101908409|FG000|NOT COMPLETED|Device A Right Ear/Device B Left Ear||0||
48641961|NCT04882800|101908409|FG000|STARTED|Device B Right Ear/Device A Left Ear||15||
48641962|NCT04882800|101908409|FG000|COMPLETED|Device B Right Ear/Device A Left Ear||15||
48641963|NCT04882800|101908409|FG000|NOT COMPLETED|Device B Right Ear/Device A Left Ear||0||
48641964|NCT02178956|101908410|FG000|STARTED|Overall Study||357||
48641965|NCT02178956|101908411|FG001|STARTED|Overall Study||357||
48641966|NCT02178956|101908410|FG000|COMPLETED|Overall Study||286||
48641967|NCT02178956|101908411|FG001|COMPLETED|Overall Study||279||
48641968|NCT02178956|101908410|FG000|NOT COMPLETED|Overall Study||71||
48641969|NCT02178956|101908411|FG001|NOT COMPLETED|Overall Study||78||
48641970|NCT01970371|101908412|FG000|STARTED|Overall Study||18||
48641971|NCT01970371|101908413|FG001|STARTED|Overall Study||21||
48641972|NCT01970371|101908414|FG002|STARTED|Overall Study||30||
48641973|NCT01970371|101908412|FG000|COMPLETED|Overall Study||10||
48641974|NCT01970371|101908413|FG001|COMPLETED|Overall Study||8||
48641975|NCT01970371|101908414|FG002|COMPLETED|Overall Study||17||
48641976|NCT01970371|101908412|FG000|NOT COMPLETED|Overall Study||8||
48641977|NCT01970371|101908413|FG001|NOT COMPLETED|Overall Study||13||
48641978|NCT01970371|101908414|FG002|NOT COMPLETED|Overall Study||13||
48641979|NCT01325441|101908415|FG000|STARTED|Overall Study||2||
48641980|NCT01325441|101908416|FG001|STARTED|Overall Study||185||
48641981|NCT01325441|101908417|FG002|STARTED|Overall Study||4||
48641982|NCT01325441|101908418|FG003|STARTED|Overall Study||317||
48641983|NCT01325441|101908419|FG004|STARTED|Overall Study||57||
48641984|NCT01325441|101908415|FG000|COMPLETED|Overall Study||2||
48641985|NCT01325441|101908416|FG001|COMPLETED|Overall Study||185||
48641986|NCT01325441|101908417|FG002|COMPLETED|Overall Study||4||
48641987|NCT01325441|101908418|FG003|COMPLETED|Overall Study||317||
48641988|NCT01325441|101908419|FG004|COMPLETED|Overall Study||57||
48641989|NCT01325441|101908415|FG000|NOT COMPLETED|Overall Study||0||
48641990|NCT01325441|101908416|FG001|NOT COMPLETED|Overall Study||0||
48641991|NCT01325441|101908417|FG002|NOT COMPLETED|Overall Study||0||
48641992|NCT01325441|101908418|FG003|NOT COMPLETED|Overall Study||0||
48641993|NCT01325441|101908419|FG004|NOT COMPLETED|Overall Study||0||
48641994|NCT01901562|101908420|FG000|STARTED|Overall Study||9||
48641995|NCT01901562|101908420|FG000|COMPLETED|Overall Study||0||
48641996|NCT01901562|101908420|FG000|NOT COMPLETED|Overall Study||9||
48641997|NCT00876343|101908421|FG000|STARTED|Overall Study||194||
48641998|NCT00876343|101908422|FG001|STARTED|Overall Study||197||
48641999|NCT00876343|101908423|FG002|STARTED|Overall Study||195||
48642000|NCT00876343|101908421|FG000|COMPLETED|Overall Study||177||
48642001|NCT00876343|101908422|FG001|COMPLETED|Overall Study||180||
48642002|NCT00876343|101908423|FG002|COMPLETED|Overall Study||183||
48642003|NCT00876343|101908421|FG000|NOT COMPLETED|Overall Study||17||
48642004|NCT00876343|101908422|FG001|NOT COMPLETED|Overall Study||17||
48642005|NCT00876343|101908423|FG002|NOT COMPLETED|Overall Study||12||
48642006|NCT01222351|101908424|FG000|STARTED|Overall Study||160||
48642007|NCT01222351|101908424|FG000|COMPLETED|Overall Study||160||
48642008|NCT01222351|101908424|FG000|NOT COMPLETED|Overall Study||0||
48642009|NCT02737618|101908425|FG000|STARTED|Overall Study||43||
48642010|NCT02737618|101908425|FG000|COMPLETED|Overall Study||34||
48642011|NCT02737618|101908425|FG000|NOT COMPLETED|Overall Study||9||
48642012|NCT01407367|101908426|FG000|STARTED|Overall Study||108||
48642013|NCT01407367|101908427|FG001|STARTED|Overall Study||242||
48642014|NCT01407367|101908426|FG000|COMPLETED|Overall Study||68||
48642015|NCT01407367|101908427|FG001|COMPLETED|Overall Study||164||
48642016|NCT01407367|101908426|FG000|NOT COMPLETED|Overall Study||40||
48642017|NCT01407367|101908427|FG001|NOT COMPLETED|Overall Study||78||
48642018|NCT02774278|101908428|FG000|STARTED|Overall Study||264||
48642019|NCT02774278|101908428|FG000|Safety Analysis Population (SAP)|Overall Study||261||
48642020|NCT02774278|101908428|FG000|COMPLETED|Overall Study||0||
48642021|NCT02774278|101908428|FG000|NOT COMPLETED|Overall Study||264||
48642022|NCT04028960|101908429|FG000|STARTED|Overall Study||2||
48642023|NCT04028960|101908430|FG001|STARTED|Overall Study||2||
48642024|NCT04028960|101908429|FG000|COMPLETED|Overall Study||2||
48642025|NCT04028960|101908430|FG001|COMPLETED|Overall Study||2||
48642026|NCT04028960|101908429|FG000|NOT COMPLETED|Overall Study||0||
48642027|NCT04028960|101908430|FG001|NOT COMPLETED|Overall Study||0||
48642028|NCT03770455|101908431|FG000|STARTED|Overall Study||8||
48642029|NCT03770455|101908431|FG000|COMPLETED|Overall Study||5||
48642030|NCT03770455|101908431|FG000|NOT COMPLETED|Overall Study||3||
48642031|NCT00433290|101908432|FG000|STARTED|Overall Study||128||
48642032|NCT00433290|101908433|FG001|STARTED|Overall Study||128||
48642033|NCT00433290|101908432|FG000|COMPLETED|Overall Study||93||
48642034|NCT00433290|101908433|FG001|COMPLETED|Overall Study||111||
48642035|NCT00433290|101908432|FG000|NOT COMPLETED|Overall Study||35||
48642036|NCT00433290|101908433|FG001|NOT COMPLETED|Overall Study||17||
48642037|NCT02594111|101908434|FG000|STARTED|Overall Study||366||
48642038|NCT02594111|101908435|FG001|STARTED|Overall Study||348||
48642039|NCT02594111|101908434|FG000|COMPLETED|Overall Study||366||
48642040|NCT02594111|101908435|FG001|COMPLETED|Overall Study||348||
48642041|NCT02594111|101908434|FG000|NOT COMPLETED|Overall Study||0||
48642042|NCT02594111|101908435|FG001|NOT COMPLETED|Overall Study||0||
48642043|NCT02008370|101908436|FG000|STARTED|Overall Study||7||
48642044|NCT02008370|101908436|FG000|COMPLETED|Overall Study||0||
48642045|NCT02008370|101908436|FG000|NOT COMPLETED|Overall Study||7||
48642046|NCT00743093|101908437|FG000|STARTED|Base Study Period||224||
48642047|NCT00743093|101908438|FG001|STARTED|Base Study Period||52||
48642048|NCT00743093|101908437|FG000|COMPLETED|Base Study Period||205||
48642049|NCT00743093|101908438|FG001|COMPLETED|Base Study Period||47||
48642050|NCT00743093|101908437|FG000|NOT COMPLETED|Base Study Period||19||
48642051|NCT00743093|101908438|FG001|NOT COMPLETED|Base Study Period||5||
48642052|NCT00743093|101908437|FG000|STARTED|Extended Dosing Period||51||
48642053|NCT00743093|101908438|FG001|STARTED|Extended Dosing Period||1||
48642054|NCT00743093|101908437|FG000|COMPLETED|Extended Dosing Period||48||
48642055|NCT00743093|101908438|FG001|COMPLETED|Extended Dosing Period||1||
48642056|NCT00743093|101908437|FG000|NOT COMPLETED|Extended Dosing Period||3||
48642057|NCT00743093|101908438|FG001|NOT COMPLETED|Extended Dosing Period||0||
48361301|NCT02553915|101214311|FG002|COMPLETED|Overall Study||12||
48361302|NCT02553915|101214312|FG003|COMPLETED|Overall Study||13||
48361303|NCT02553915|101214309|FG000|NOT COMPLETED|Overall Study||4||
48361304|NCT02553915|101214310|FG001|NOT COMPLETED|Overall Study||1||
48642058|NCT00754923|101908439|FG000|STARTED|Overall Study||11||
48642059|NCT00754923|101908439|FG000|COMPLETED|Overall Study||11||
48642060|NCT00754923|101908439|FG000|NOT COMPLETED|Overall Study||0||
48642061|NCT00357162|101908440|FG000|STARTED|Overall Study||21||
48642062|NCT00357162|101908440|FG000|COMPLETED|Overall Study||21||
48642063|NCT00357162|101908440|FG000|NOT COMPLETED|Overall Study||0||
48642064|NCT03624036|101908441|FG000|STARTED|Overall Study||7||
48642065|NCT03624036|101908442|FG001|STARTED|Overall Study||3||
48642066|NCT03624036|101908443|FG002|STARTED|Overall Study||3||
48764746|NCT02072668|102212025|FG001|STARTED|Second Intervention||7||
48764747|NCT02072668|102212024|FG000|COMPLETED|Second Intervention||6||
48764748|NCT02072668|102212025|FG001|COMPLETED|Second Intervention||7||
48764749|NCT02072668|102212024|FG000|NOT COMPLETED|Second Intervention||1||
48764750|NCT02072668|102212025|FG001|NOT COMPLETED|Second Intervention||0||
48361305|NCT02553915|101214311|FG002|NOT COMPLETED|Overall Study||3||
48642067|NCT03624036|101908444|FG003|STARTED|Overall Study||3||
48642068|NCT03624036|101908441|FG000|COMPLETED|Overall Study||0||
48642069|NCT03624036|101908442|FG001|COMPLETED|Overall Study||0||
48764751|NCT03027609|102212026|FG000|STARTED|Overall Study||79||
48764752|NCT03027609|102212027|FG001|STARTED|Overall Study||79||
48764753|NCT03027609|102212026|FG000|COMPLETED|Overall Study||49||
48764754|NCT03027609|102212027|FG001|COMPLETED|Overall Study||62||
48764755|NCT03027609|102212026|FG000|NOT COMPLETED|Overall Study||30||
48361306|NCT02553915|101214312|FG003|NOT COMPLETED|Overall Study||3||
48187886|NCT01824082|100783126|FG001|NOT COMPLETED|Optional Crossover Treatment||0||
48187887|NCT01374490|100783127|FG000|STARTED|Overall Study||250||
48187888|NCT01374490|100783127|FG000|COMPLETED|Overall Study||190||
48642070|NCT03624036|101908443|FG002|COMPLETED|Overall Study||0||
48642071|NCT03624036|101908444|FG003|COMPLETED|Overall Study||0||
48642072|NCT03624036|101908441|FG000|NOT COMPLETED|Overall Study||7||
48642073|NCT03624036|101908442|FG001|NOT COMPLETED|Overall Study||3||
48642074|NCT03624036|101908443|FG002|NOT COMPLETED|Overall Study||3||
48642075|NCT03624036|101908444|FG003|NOT COMPLETED|Overall Study||3||
48642076|NCT04925934|101908445|FG000|STARTED|Overall Study||71||
48642077|NCT04925934|101908446|FG001|STARTED|Overall Study||72||
48642078|NCT04925934|101908447|FG002|STARTED|Overall Study||71||
48642079|NCT04925934|101908445|FG000|COMPLETED|Overall Study||51||
48642080|NCT04925934|101908446|FG001|COMPLETED|Overall Study||61||
48642081|NCT04925934|101908447|FG002|COMPLETED|Overall Study||57||
48642082|NCT04925934|101908445|FG000|NOT COMPLETED|Overall Study||20||
48764756|NCT03027609|102212027|FG001|NOT COMPLETED|Overall Study||17||
48764757|NCT01283139|102212028|FG000|STARTED|Overall Study||108||
48361307|NCT03511638|101214313|FG000|STARTED|Overall Study||184||
48764758|NCT01283139|102212029|FG001|STARTED|Overall Study||108||
48361308|NCT03511638|101214314|FG001|STARTED|Overall Study||188||
48361309|NCT03511638|101214313|FG000|COMPLETED|Overall Study||182||
48361310|NCT03511638|101214314|FG001|COMPLETED|Overall Study||187||
48361311|NCT03511638|101214313|FG000|NOT COMPLETED|Overall Study||2||
48361312|NCT03511638|101214314|FG001|NOT COMPLETED|Overall Study||1||
48642083|NCT04925934|101908446|FG001|NOT COMPLETED|Overall Study||11||
48642084|NCT04925934|101908447|FG002|NOT COMPLETED|Overall Study||14||
48642085|NCT02331407|101908448|FG000|STARTED|Overall Study||9||
48642086|NCT02331407|101908448|FG000|COMPLETED|Overall Study||9||
48642087|NCT02331407|101908448|FG000|NOT COMPLETED|Overall Study||0||
48642088|NCT02582632|101908449|FG000|STARTED|Overall Study||166||
48642089|NCT02582632|101908449|FG000|COMPLETED|Overall Study||165||
48642090|NCT02582632|101908449|FG000|NOT COMPLETED|Overall Study||1||
48642091|NCT05688657|101908450|FG000|STARTED|Period 1: Lens A (15 Minutes)||42||
48642092|NCT05688657|101908451|FG001|STARTED|Period 1: Lens A (15 Minutes)||0||
48642093|NCT05688657|101908450|FG000|COMPLETED|Period 1: Lens A (15 Minutes)||42||
48642094|NCT05688657|101908451|FG001|COMPLETED|Period 1: Lens A (15 Minutes)||0||
48642095|NCT05688657|101908450|FG000|NOT COMPLETED|Period 1: Lens A (15 Minutes)||0||
48642096|NCT05688657|101908451|FG001|NOT COMPLETED|Period 1: Lens A (15 Minutes)||0||
48642097|NCT05688657|101908450|FG000|STARTED|Period 2: Lens B (15 Minutes)||0||
48642098|NCT05688657|101908451|FG001|STARTED|Period 2: Lens B (15 Minutes)||42||
48642099|NCT05688657|101908450|FG000|COMPLETED|Period 2: Lens B (15 Minutes)||0||
48642100|NCT05688657|101908451|FG001|COMPLETED|Period 2: Lens B (15 Minutes)||42||
48642101|NCT05688657|101908450|FG000|NOT COMPLETED|Period 2: Lens B (15 Minutes)||0||
48642102|NCT05688657|101908451|FG001|NOT COMPLETED|Period 2: Lens B (15 Minutes)||0||
48642103|NCT01810952|101908452|FG000|STARTED|Overall Study||20||
48642104|NCT01810952|101908453|FG001|STARTED|Overall Study||17||
48642105|NCT01810952|101908452|FG000|COMPLETED|Overall Study||20||
48642106|NCT01810952|101908453|FG001|COMPLETED|Overall Study||17||
48642107|NCT01810952|101908452|FG000|NOT COMPLETED|Overall Study||0||
48642108|NCT01810952|101908453|FG001|NOT COMPLETED|Overall Study||0||
48642109|NCT00850642|101908454|FG000|STARTED|Overall Study||3||
48642110|NCT00850642|101908455|FG001|STARTED|Overall Study||4||
48642111|NCT00850642|101908454|FG000|COMPLETED|Overall Study||3||
48642112|NCT00850642|101908455|FG001|COMPLETED|Overall Study||4||
48642113|NCT00850642|101908454|FG000|NOT COMPLETED|Overall Study||0||
48642114|NCT00850642|101908455|FG001|NOT COMPLETED|Overall Study||0||
48433791|NCT02389621|101397123|FG001|NOT COMPLETED|Posttreatment Period||4||
48433792|NCT02851069|101397124|FG000|STARTED|Overall Study||65|Received at least 1 dose of study drug.|
48642115|NCT01405911|101908456|FG000|STARTED|Overall Study||83||
48642116|NCT01405911|101908457|FG001|STARTED|Overall Study||82||
48642117|NCT01405911|101908458|FG002|STARTED|Overall Study||77||
48642118|NCT01405911|101908456|FG000|Treated|Overall Study||82||
48642119|NCT01405911|101908457|FG001|Treated|Overall Study||82||
48642120|NCT01405911|101908458|FG002|Treated|Overall Study||77||
48642121|NCT01405911|101908456|FG000|COMPLETED|Overall Study||79||
48642122|NCT01405911|101908457|FG001|COMPLETED|Overall Study||79||
48642123|NCT01405911|101908458|FG002|COMPLETED|Overall Study||76||
48642124|NCT01405911|101908456|FG000|NOT COMPLETED|Overall Study||4||
48642125|NCT01405911|101908457|FG001|NOT COMPLETED|Overall Study||3||
48642126|NCT01405911|101908458|FG002|NOT COMPLETED|Overall Study||1||
48642127|NCT04926233|101908459|FG000|STARTED|Overall Study||1280486||
48642128|NCT04926233|101908460|FG001|STARTED|Overall Study||90660||
48642129|NCT04926233|101908459|FG000|COMPLETED|Overall Study||1280486||
48642130|NCT04926233|101908460|FG001|COMPLETED|Overall Study||90660||
48642131|NCT04926233|101908459|FG000|NOT COMPLETED|Overall Study||0||
48764759|NCT01283139|102212030|FG002|STARTED|Overall Study||109||
48764760|NCT01283139|102212031|FG003|STARTED|Overall Study||107||
48764761|NCT01283139|102212028|FG000|COMPLETED|Overall Study||91||
48764762|NCT01283139|102212029|FG001|COMPLETED|Overall Study||90||
48764763|NCT01283139|102212030|FG002|COMPLETED|Overall Study||91||
48764764|NCT01283139|102212031|FG003|COMPLETED|Overall Study||92||
48764765|NCT01283139|102212028|FG000|NOT COMPLETED|Overall Study||17||
48764766|NCT01283139|102212029|FG001|NOT COMPLETED|Overall Study||18||
48764767|NCT01283139|102212030|FG002|NOT COMPLETED|Overall Study||18||
48764768|NCT01283139|102212031|FG003|NOT COMPLETED|Overall Study||15||
48764769|NCT00307801|102212032|FG000|STARTED|Overall Study||149||
48764770|NCT00307801|102212033|FG001|STARTED|Overall Study||82||
48764771|NCT00307801|102212032|FG000|Subjects Received Treatment|Overall Study||145||
48764772|NCT00307801|102212033|FG001|Subjects Received Treatment|Overall Study||81||
48764773|NCT00307801|102212032|FG000|Cycle 1, Visit 5, Baseline|Overall Study||145||
48642132|NCT04926233|101908460|FG001|NOT COMPLETED|Overall Study||0||
48642133|NCT01995201|101908461|FG000|STARTED|From Baseline Until Week 24||74||
48642134|NCT01995201|101908462|FG001|STARTED|From Baseline Until Week 24||327||
48642135|NCT01995201|101908463|FG002|STARTED|From Baseline Until Week 24||0||
48433793|NCT02851069|101397124|FG000|COMPLETED|Overall Study||59||
48642136|NCT01995201|101908464|FG003|STARTED|From Baseline Until Week 24||0||
48642137|NCT01995201|101908465|FG004|STARTED|From Baseline Until Week 24||0||
48642138|NCT01995201|101908466|FG005|STARTED|From Baseline Until Week 24||0||
48642139|NCT01995201|101908467|FG006|STARTED|From Baseline Until Week 24||0||
48642140|NCT01995201|101908461|FG000|COMPLETED|From Baseline Until Week 24||64||
48642141|NCT01995201|101908462|FG001|COMPLETED|From Baseline Until Week 24||281||
48642142|NCT01995201|101908463|FG002|COMPLETED|From Baseline Until Week 24||0||
48642143|NCT01995201|101908464|FG003|COMPLETED|From Baseline Until Week 24||0||
48642144|NCT01995201|101908465|FG004|COMPLETED|From Baseline Until Week 24||0||
48764774|NCT00307801|102212033|FG001|Cycle 1, Visit 5, Baseline|Overall Study||81||
48764775|NCT00307801|102212032|FG000|Cycle 3, Visit 7, Treatment Day 84|Overall Study||130||
48764776|NCT00307801|102212033|FG001|Cycle 3, Visit 7, Treatment Day 84|Overall Study||71||
48764777|NCT00307801|102212032|FG000|Cycle 7, Treatment Day 196|Overall Study||141||
48764778|NCT00307801|102212033|FG001|Cycle 7, Treatment Day 196|Overall Study||77||
48764779|NCT00307801|102212032|FG000|COMPLETED|Overall Study||117||
48764780|NCT00307801|102212033|FG001|COMPLETED|Overall Study||65||
48764781|NCT00307801|102212032|FG000|NOT COMPLETED|Overall Study||32||
48764782|NCT00307801|102212033|FG001|NOT COMPLETED|Overall Study||17||
48764783|NCT03278249|102212034|FG000|STARTED|Overall Study||12||
48764784|NCT03278249|102212034|FG000|COMPLETED|Overall Study||9||
48764785|NCT03278249|102212034|FG000|NOT COMPLETED|Overall Study||3||
48764786|NCT00888173|102212035|FG000|STARTED|Overall Study||45||
48764787|NCT00888173|102212035|FG000|COMPLETED|Overall Study||43||
48764788|NCT00888173|102212035|FG000|NOT COMPLETED|Overall Study||2||
48642145|NCT01995201|101908466|FG005|COMPLETED|From Baseline Until Week 24||0||
48642146|NCT01995201|101908467|FG006|COMPLETED|From Baseline Until Week 24||0||
48642147|NCT01995201|101908461|FG000|NOT COMPLETED|From Baseline Until Week 24||10||
48764789|NCT01188343|102212036|FG000|STARTED|Overall Study||102||
48764790|NCT01188343|102212037|FG001|STARTED|Overall Study||219||
48764791|NCT01188343|102212038|FG002|STARTED|Overall Study||221||
48764792|NCT01188343|102212036|FG000|COMPLETED|Overall Study||101||
48764793|NCT01188343|102212037|FG001|COMPLETED|Overall Study||193||
48764794|NCT01188343|102212038|FG002|COMPLETED|Overall Study||220||
48764795|NCT01188343|102212036|FG000|NOT COMPLETED|Overall Study||1||
48764796|NCT01188343|102212037|FG001|NOT COMPLETED|Overall Study||26||
48764797|NCT01188343|102212038|FG002|NOT COMPLETED|Overall Study||1||
48764798|NCT00817843|102212039|FG000|STARTED|First Period (6 Weeks)||50||
48764799|NCT00817843|102212040|FG001|STARTED|First Period (6 Weeks)||50||
48764800|NCT00817843|102212039|FG000|COMPLETED|First Period (6 Weeks)||42||
48764801|NCT00817843|102212040|FG001|COMPLETED|First Period (6 Weeks)||46||
48764802|NCT00817843|102212039|FG000|NOT COMPLETED|First Period (6 Weeks)||8||
48764803|NCT00817843|102212040|FG001|NOT COMPLETED|First Period (6 Weeks)||4||
48642148|NCT01995201|101908462|FG001|NOT COMPLETED|From Baseline Until Week 24||46||
48642149|NCT01995201|101908463|FG002|NOT COMPLETED|From Baseline Until Week 24||0||
48764804|NCT00817843|102212039|FG000|STARTED|Washout Period (6 Weeks)||42||
48764805|NCT00817843|102212040|FG001|STARTED|Washout Period (6 Weeks)||46||
48764806|NCT00817843|102212039|FG000|COMPLETED|Washout Period (6 Weeks)||41||
48764807|NCT00817843|102212040|FG001|COMPLETED|Washout Period (6 Weeks)||45||
48764808|NCT00817843|102212039|FG000|NOT COMPLETED|Washout Period (6 Weeks)||1||
48764809|NCT00817843|102212040|FG001|NOT COMPLETED|Washout Period (6 Weeks)||1||
48764810|NCT00817843|102212039|FG000|STARTED|Second Period (6 Weeks)||41||
48764811|NCT00817843|102212040|FG001|STARTED|Second Period (6 Weeks)||45||
48764812|NCT00817843|102212039|FG000|COMPLETED|Second Period (6 Weeks)||41||
48764813|NCT00817843|102212040|FG001|COMPLETED|Second Period (6 Weeks)||44||
48764814|NCT00817843|102212039|FG000|NOT COMPLETED|Second Period (6 Weeks)||0||
48764815|NCT00817843|102212040|FG001|NOT COMPLETED|Second Period (6 Weeks)||1||
48764816|NCT00092417|102212041|FG000|STARTED|Overall Study||464||
48764817|NCT00092417|102212042|FG001|STARTED|Overall Study||234||
48764818|NCT00092417|102212041|FG000|Vaccinated|Overall Study||461||
48764819|NCT00092417|102212042|FG001|Vaccinated|Overall Study||234||
48764820|NCT00092417|102212041|FG000|COMPLETED|Overall Study||459||
48764821|NCT00092417|102212042|FG001|COMPLETED|Overall Study||233||
48764822|NCT00092417|102212041|FG000|NOT COMPLETED|Overall Study||5||
48764823|NCT00092417|102212042|FG001|NOT COMPLETED|Overall Study||1||
48764824|NCT02968758|102212043|FG000|STARTED|Overall Study||797||
48764825|NCT02968758|102212044|FG001|STARTED|Overall Study||1664||
48764826|NCT02968758|102212043|FG000|COMPLETED|Overall Study||797||
48764827|NCT02968758|102212044|FG001|COMPLETED|Overall Study||1664||
48642150|NCT01995201|101908464|FG003|NOT COMPLETED|From Baseline Until Week 24||0||
48642151|NCT01995201|101908465|FG004|NOT COMPLETED|From Baseline Until Week 24||0||
48642152|NCT01995201|101908466|FG005|NOT COMPLETED|From Baseline Until Week 24||0||
48642153|NCT01995201|101908467|FG006|NOT COMPLETED|From Baseline Until Week 24||0||
48642154|NCT01995201|101908461|FG000|STARTED|From Week 24 Until Week 48||0||
48642155|NCT01995201|101908462|FG001|STARTED|From Week 24 Until Week 48||0||
48764828|NCT02968758|102212043|FG000|NOT COMPLETED|Overall Study||0||
48764829|NCT02968758|102212044|FG001|NOT COMPLETED|Overall Study||0||
48764830|NCT00595088|102212045|FG000|STARTED|Overall Study||47||
48764831|NCT00595088|102212045|FG000|COMPLETED|Overall Study||7||
48764832|NCT00595088|102212045|FG000|NOT COMPLETED|Overall Study||40||
48764833|NCT03331315|102212046|FG000|STARTED|Overall Study||88||
48764834|NCT03331315|102212047|FG001|STARTED|Overall Study||82||
48764835|NCT03331315|102212046|FG000|COMPLETED|Overall Study||70||
48764836|NCT03331315|102212047|FG001|COMPLETED|Overall Study||68||
48764837|NCT03331315|102212046|FG000|NOT COMPLETED|Overall Study||18||
48764838|NCT03331315|102212047|FG001|NOT COMPLETED|Overall Study||14||
48764839|NCT00853307|102212048|FG000|STARTED|Overall Study||6||
48764840|NCT00853307|102212049|FG001|STARTED|Overall Study||25||
48764841|NCT00853307|102212048|FG000|COMPLETED|Overall Study||4||
48764842|NCT00853307|102212049|FG001|COMPLETED|Overall Study||20||
48764843|NCT00853307|102212048|FG000|NOT COMPLETED|Overall Study||2||
48764844|NCT00853307|102212049|FG001|NOT COMPLETED|Overall Study||5||
48764845|NCT04030143|102212050|FG000|STARTED|Overall Study||132||
48642156|NCT01995201|101908463|FG002|STARTED|From Week 24 Until Week 48||89||
48642157|NCT01995201|101908464|FG003|STARTED|From Week 24 Until Week 48||90||
48642158|NCT01995201|101908465|FG004|STARTED|From Week 24 Until Week 48||95||
48642159|NCT01995201|101908466|FG005|STARTED|From Week 24 Until Week 48||67||
48433794|NCT02851069|101397124|FG000|NOT COMPLETED|Overall Study||6||
48433795|NCT04888377|101397125|FG000|STARTED|Overall Study||343||
48433796|NCT04888377|101397126|FG001|STARTED|Overall Study||323||
48433797|NCT04888377|101397125|FG000|Completed BSID-III Assessment|Overall Study||330||
48433798|NCT04888377|101397126|FG001|Completed BSID-III Assessment|Overall Study||312||
48433799|NCT04888377|101397125|FG000|COMPLETED|Overall Study||329|Complete data for BSID-III Cognitive Composite Score|
48433800|NCT04888377|101397126|FG001|COMPLETED|Overall Study||311|Complete data for BSID-III Cognitive Composite Score|
48433801|NCT04888377|101397125|FG000|NOT COMPLETED|Overall Study||14||
48433802|NCT04888377|101397126|FG001|NOT COMPLETED|Overall Study||12||
48433803|NCT04066894|101397127|FG000|STARTED|Overall Study||3||
48642160|NCT01995201|101908467|FG006|STARTED|From Week 24 Until Week 48||2||
48642161|NCT01995201|101908461|FG000|COMPLETED|From Week 24 Until Week 48||0||
48642162|NCT01995201|101908462|FG001|COMPLETED|From Week 24 Until Week 48||0||
48642163|NCT01995201|101908463|FG002|COMPLETED|From Week 24 Until Week 48||84||
48642164|NCT01995201|101908464|FG003|COMPLETED|From Week 24 Until Week 48||89||
48642165|NCT01995201|101908465|FG004|COMPLETED|From Week 24 Until Week 48||89||
48642166|NCT01995201|101908466|FG005|COMPLETED|From Week 24 Until Week 48||59||
48642167|NCT01995201|101908467|FG006|COMPLETED|From Week 24 Until Week 48||0||
48642168|NCT01995201|101908461|FG000|NOT COMPLETED|From Week 24 Until Week 48||0||
48642169|NCT01995201|101908462|FG001|NOT COMPLETED|From Week 24 Until Week 48||0||
48642170|NCT01995201|101908463|FG002|NOT COMPLETED|From Week 24 Until Week 48||5||
48642171|NCT01995201|101908464|FG003|NOT COMPLETED|From Week 24 Until Week 48||1||
48642172|NCT01995201|101908465|FG004|NOT COMPLETED|From Week 24 Until Week 48||6||
48642173|NCT01995201|101908466|FG005|NOT COMPLETED|From Week 24 Until Week 48||8||
48642174|NCT01995201|101908467|FG006|NOT COMPLETED|From Week 24 Until Week 48||2||
48642175|NCT00601627|101908468|FG000|STARTED|Overall Study||51||
48642176|NCT00601627|101908468|FG000|COMPLETED|Overall Study||51||
48642177|NCT00601627|101908468|FG000|NOT COMPLETED|Overall Study||0||
48642178|NCT01767285|101908469|FG000|STARTED|Overall Study||29||
48642179|NCT01767285|101908470|FG001|STARTED|Overall Study||30||
48642180|NCT01767285|101908469|FG000|COMPLETED|Overall Study||22||
48642181|NCT01767285|101908470|FG001|COMPLETED|Overall Study||24||
48642182|NCT01767285|101908469|FG000|NOT COMPLETED|Overall Study||7||
48642183|NCT01767285|101908470|FG001|NOT COMPLETED|Overall Study||6||
48642184|NCT02515253|101908471|FG000|STARTED|Overall Study||17||
48642185|NCT02515253|101908472|FG001|STARTED|Overall Study||16||
48642186|NCT02515253|101908471|FG000|COMPLETED|Overall Study||10||
48361313|NCT02289755|101214315|FG000|STARTED|Baseline Period [No Treatment, 3 Days]||16||
48361314|NCT02289755|101214315|FG000|COMPLETED|Baseline Period [No Treatment, 3 Days]||16||
48361315|NCT02289755|101214315|FG000|NOT COMPLETED|Baseline Period [No Treatment, 3 Days]||0||
48361316|NCT02289755|101214315|FG000|STARTED|ALLN-177 Treatment Period [4 Days]||16||
48361317|NCT02289755|101214315|FG000|COMPLETED|ALLN-177 Treatment Period [4 Days]||16||
48361318|NCT02289755|101214315|FG000|NOT COMPLETED|ALLN-177 Treatment Period [4 Days]||0||
48361319|NCT02289755|101214315|FG000|STARTED|Follow up Period [4 Days]||16||
48361320|NCT02289755|101214315|FG000|COMPLETED|Follow up Period [4 Days]||16||
48361321|NCT02289755|101214315|FG000|NOT COMPLETED|Follow up Period [4 Days]||0||
48361322|NCT01253460|101214316|FG000|STARTED|Overall Study||18||
48361323|NCT01253460|101214316|FG000|COMPLETED|Overall Study||18||
48361324|NCT01253460|101214316|FG000|NOT COMPLETED|Overall Study||0||
48361325|NCT00810797|101214317|FG000|STARTED|Overall Study||36||
48361326|NCT00810797|101214317|FG000|COMPLETED|Overall Study||36||
48361327|NCT00810797|101214317|FG000|NOT COMPLETED|Overall Study||0||
48361328|NCT01001494|101214318|FG000|STARTED|Overall Study||277||
48361329|NCT01001494|101214319|FG001|STARTED|Overall Study||269||
48361330|NCT01001494|101214320|FG002|STARTED|Overall Study||273||
48361331|NCT01001494|101214318|FG000|COMPLETED|Overall Study||253||
48361332|NCT01001494|101214319|FG001|COMPLETED|Overall Study||252||
48361333|NCT01001494|101214320|FG002|COMPLETED|Overall Study||232||
48361334|NCT01001494|101214318|FG000|NOT COMPLETED|Overall Study||24||
48642187|NCT02515253|101908472|FG001|COMPLETED|Overall Study||8||
48642188|NCT02515253|101908471|FG000|NOT COMPLETED|Overall Study||7||
48642189|NCT02515253|101908472|FG001|NOT COMPLETED|Overall Study||8||
48642190|NCT01132755|101908473|FG000|STARTED|Overall Study||112||
48642191|NCT01132755|101908473|FG000|COMPLETED|Overall Study||70||
48642192|NCT01132755|101908473|FG000|NOT COMPLETED|Overall Study||42||
48642193|NCT01107457|101908474|FG000|STARTED|Part A||27||
48361335|NCT01001494|101214319|FG001|NOT COMPLETED|Overall Study||17||
48361336|NCT01001494|101214320|FG002|NOT COMPLETED|Overall Study||41||
48361337|NCT02413255|101214321|FG000|STARTED|Overall Study||18||
48361338|NCT02413255|101214322|FG001|STARTED|Overall Study||6||
48361339|NCT02413255|101214323|FG002|STARTED|Overall Study||6||
48361340|NCT02413255|101214324|FG003|STARTED|Overall Study||6||
48361341|NCT02413255|101214325|FG004|STARTED|Overall Study||6||
48361342|NCT02413255|101214326|FG005|STARTED|Overall Study||6||
48361343|NCT02413255|101214327|FG006|STARTED|Overall Study||6||
48361344|NCT02413255|101214328|FG007|STARTED|Overall Study||6||
48433804|NCT04066894|101397127|FG000|COMPLETED|Overall Study||1||
48433805|NCT04066894|101397127|FG000|NOT COMPLETED|Overall Study||2||
48433806|NCT00302068|101397128|FG000|STARTED|Overall Study||37||
48433807|NCT00302068|101397129|FG001|STARTED|Overall Study||40||
48433808|NCT00302068|101397130|FG002|STARTED|Overall Study||24||
48433809|NCT00302068|101397128|FG000|COMPLETED|Overall Study||36||
48642194|NCT01107457|101908475|FG001|STARTED|Part A||28||
48642195|NCT01107457|101908476|FG002|STARTED|Part A||30||
48642196|NCT01107457|101908477|FG003|STARTED|Part A||29||
48642197|NCT01107457|101908478|FG004|STARTED|Part A||28||
48642198|NCT01107457|101908479|FG005|STARTED|Part A||0||
48642199|NCT01107457|101908474|FG000|Received at Least 1 Dose of Study Drug|Part A||27||
48642200|NCT01107457|101908475|FG001|Received at Least 1 Dose of Study Drug|Part A||28||
48642201|NCT01107457|101908476|FG002|Received at Least 1 Dose of Study Drug|Part A||30||
48433810|NCT00302068|101397129|FG001|COMPLETED|Overall Study||36||
48433811|NCT00302068|101397130|FG002|COMPLETED|Overall Study||23||
48433812|NCT00302068|101397128|FG000|NOT COMPLETED|Overall Study||1||
48433813|NCT00302068|101397129|FG001|NOT COMPLETED|Overall Study||4||
48433814|NCT00302068|101397130|FG002|NOT COMPLETED|Overall Study||1||
48433815|NCT03446846|101397131|FG000|STARTED|Overall Study||90||
48642202|NCT01107457|101908477|FG003|Received at Least 1 Dose of Study Drug|Part A||29||
48642203|NCT01107457|101908478|FG004|Received at Least 1 Dose of Study Drug|Part A||28||
48642204|NCT01107457|101908479|FG005|Received at Least 1 Dose of Study Drug|Part A||0||
48642205|NCT01107457|101908474|FG000|COMPLETED|Part A||22||
48642206|NCT01107457|101908475|FG001|COMPLETED|Part A||21||
48642207|NCT01107457|101908476|FG002|COMPLETED|Part A||29||
48642208|NCT01107457|101908477|FG003|COMPLETED|Part A||26||
48642209|NCT01107457|101908478|FG004|COMPLETED|Part A||27||
48642210|NCT01107457|101908479|FG005|COMPLETED|Part A||0||
48642211|NCT01107457|101908474|FG000|NOT COMPLETED|Part A||5||
48642212|NCT01107457|101908475|FG001|NOT COMPLETED|Part A||7||
48642213|NCT01107457|101908476|FG002|NOT COMPLETED|Part A||1||
48642214|NCT01107457|101908477|FG003|NOT COMPLETED|Part A||3||
48642215|NCT01107457|101908478|FG004|NOT COMPLETED|Part A||1||
48642216|NCT01107457|101908479|FG005|NOT COMPLETED|Part A||0||
48642217|NCT01107457|101908474|FG000|STARTED|Part B and C||0||
48642218|NCT01107457|101908475|FG001|STARTED|Part B and C||0||
48642219|NCT01107457|101908476|FG002|STARTED|Part B and C||0||
48642220|NCT01107457|101908477|FG003|STARTED|Part B and C||0||
48642221|NCT01107457|101908478|FG004|STARTED|Part B and C||0||
48361345|NCT02413255|101214329|FG008|STARTED|Overall Study||6||
48361346|NCT02413255|101214330|FG009|STARTED|Overall Study||6||
48361347|NCT02413255|101214331|FG010|STARTED|Overall Study||12||
48361348|NCT02413255|101214332|FG011|STARTED|Overall Study||6||
48361349|NCT02413255|101214333|FG012|STARTED|Overall Study||6||
48433816|NCT03446846|101397132|FG001|STARTED|Overall Study||92||
48433817|NCT03446846|101397133|FG002|STARTED|Overall Study||178||
48433818|NCT03446846|101397131|FG000|COMPLETED|Overall Study||83||
48433819|NCT03446846|101397132|FG001|COMPLETED|Overall Study||87||
48433820|NCT03446846|101397133|FG002|COMPLETED|Overall Study||162||
48433821|NCT03446846|101397131|FG000|NOT COMPLETED|Overall Study||7||
48433822|NCT03446846|101397132|FG001|NOT COMPLETED|Overall Study||5||
48433823|NCT03446846|101397133|FG002|NOT COMPLETED|Overall Study||16||
48433824|NCT00921934|101397134|FG000|STARTED|Overall Study||68||
48433825|NCT00921934|101397134|FG000|COMPLETED|Overall Study||68||
48433826|NCT00921934|101397134|FG000|NOT COMPLETED|Overall Study||0||
48642222|NCT01107457|101908479|FG005|STARTED|Part B and C||120||
48642223|NCT01107457|101908474|FG000|Completed Part B (Week 240)|Part B and C||0||
48642224|NCT01107457|101908475|FG001|Completed Part B (Week 240)|Part B and C||0||
48642225|NCT01107457|101908476|FG002|Completed Part B (Week 240)|Part B and C||0||
48361350|NCT02413255|101214334|FG013|STARTED|Overall Study||6||
48433827|NCT02422186|101397135|FG000|STARTED|Double-blind Induction Phase (4 Weeks)||72||
48433828|NCT02422186|101397136|FG001|STARTED|Double-blind Induction Phase (4 Weeks)||66||
48433829|NCT02422186|101397135|FG000|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||72||
48433830|NCT02422186|101397136|FG001|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||65||
48642226|NCT01107457|101908477|FG003|Completed Part B (Week 240)|Part B and C||0||
48642227|NCT01107457|101908478|FG004|Completed Part B (Week 240)|Part B and C||0||
48642228|NCT01107457|101908479|FG005|Completed Part B (Week 240)|Part B and C||74||
48361351|NCT02413255|101214335|FG014|STARTED|Overall Study||6||
48361352|NCT02413255|101214336|FG015|STARTED|Overall Study||6||
48433831|NCT02422186|101397135|FG000|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||72||
48433832|NCT02422186|101397136|FG001|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||65||
48433833|NCT02422186|101397135|FG000|COMPLETED|Double-blind Induction Phase (4 Weeks)||62||
48433834|NCT02422186|101397136|FG001|COMPLETED|Double-blind Induction Phase (4 Weeks)||60||
48433835|NCT02422186|101397135|FG000|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||10||
48642229|NCT01107457|101908474|FG000|Completed Part C|Part B and C||0||
48642230|NCT01107457|101908475|FG001|Completed Part C|Part B and C||0||
48642231|NCT01107457|101908476|FG002|Completed Part C|Part B and C||0||
48642232|NCT01107457|101908477|FG003|Completed Part C|Part B and C||0||
48642233|NCT01107457|101908478|FG004|Completed Part C|Part B and C||0||
48642234|NCT01107457|101908479|FG005|Completed Part C|Part B and C||0||
48361353|NCT02413255|101214337|FG016|STARTED|Overall Study||6||
48433836|NCT02422186|101397136|FG001|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6||
48433837|NCT02422186|101397135|FG000|STARTED|Follow-up Phase (2 Weeks)||12||
48433838|NCT02422186|101397136|FG001|STARTED|Follow-up Phase (2 Weeks)||3||
48433839|NCT02422186|101397135|FG000|COMPLETED|Follow-up Phase (2 Weeks)||8||
48433840|NCT02422186|101397136|FG001|COMPLETED|Follow-up Phase (2 Weeks)||3||
48433841|NCT02422186|101397135|FG000|NOT COMPLETED|Follow-up Phase (2 Weeks)||4||
48433842|NCT02422186|101397136|FG001|NOT COMPLETED|Follow-up Phase (2 Weeks)||0||
48433843|NCT01846442|101397137|FG000|STARTED|Overall Study||54||
48433844|NCT01846442|101397138|FG001|STARTED|Overall Study||54||
48433845|NCT01846442|101397139|FG002|STARTED|Overall Study||56||
48433846|NCT01846442|101397140|FG003|STARTED|Overall Study||54||
48433847|NCT01846442|101397137|FG000|Safety Population|Overall Study||54||
48433848|NCT01846442|101397138|FG001|Safety Population|Overall Study||53||
48433849|NCT01846442|101397139|FG002|Safety Population|Overall Study||56||
48433850|NCT01846442|101397140|FG003|Safety Population|Overall Study||54||
48433851|NCT01846442|101397137|FG000|ITT Population|Overall Study||53||
48433852|NCT01846442|101397138|FG001|ITT Population|Overall Study||53||
48433853|NCT01846442|101397139|FG002|ITT Population|Overall Study||56||
48433854|NCT01846442|101397140|FG003|ITT Population|Overall Study||54||
48433855|NCT01846442|101397137|FG000|COMPLETED|Overall Study||48||
48433856|NCT01846442|101397138|FG001|COMPLETED|Overall Study||48||
48433857|NCT01846442|101397139|FG002|COMPLETED|Overall Study||52||
48433858|NCT01846442|101397140|FG003|COMPLETED|Overall Study||51||
48433859|NCT01846442|101397137|FG000|NOT COMPLETED|Overall Study||6||
48433860|NCT01846442|101397138|FG001|NOT COMPLETED|Overall Study||6||
48433861|NCT01846442|101397139|FG002|NOT COMPLETED|Overall Study||4||
48433862|NCT01846442|101397140|FG003|NOT COMPLETED|Overall Study||3||
48433863|NCT02223520|101397141|FG000|STARTED|Overall Study||147||
48433864|NCT02223520|101397142|FG001|STARTED|Overall Study||160||
48433865|NCT02223520|101397141|FG000|COMPLETED|Overall Study||147||
48433866|NCT02223520|101397142|FG001|COMPLETED|Overall Study||160||
48433867|NCT02223520|101397141|FG000|NOT COMPLETED|Overall Study||0||
48433868|NCT02223520|101397142|FG001|NOT COMPLETED|Overall Study||0||
48433869|NCT00198107|101397143|FG000|STARTED|Double-Blind Period||41||
48433870|NCT00198107|101397144|FG001|STARTED|Double-Blind Period||40||
48433871|NCT00198107|101397145|FG002|STARTED|Double-Blind Period||0||
48433872|NCT00198107|101397143|FG000|1 or More Follow-up Visits|Double-Blind Period||40||
48433873|NCT00198107|101397144|FG001|1 or More Follow-up Visits|Double-Blind Period||38||
48433874|NCT00198107|101397145|FG002|1 or More Follow-up Visits|Double-Blind Period||0||
48433875|NCT00198107|101397143|FG000|COMPLETED|Double-Blind Period||35||
48433876|NCT00198107|101397144|FG001|COMPLETED|Double-Blind Period||37||
48433877|NCT00198107|101397145|FG002|COMPLETED|Double-Blind Period||0||
48433878|NCT00198107|101397143|FG000|NOT COMPLETED|Double-Blind Period||6||
48433879|NCT00198107|101397144|FG001|NOT COMPLETED|Double-Blind Period||3||
48433880|NCT00198107|101397145|FG002|NOT COMPLETED|Double-Blind Period||0||
48433881|NCT00198107|101397143|FG000|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||0||
48433882|NCT00198107|101397144|FG001|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||0||
48433883|NCT00198107|101397145|FG002|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||10||
48433884|NCT00198107|101397143|FG000|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0||
48433885|NCT00198107|101397144|FG001|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0||
48433886|NCT00198107|101397145|FG002|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||8||
48433887|NCT00198107|101397143|FG000|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0||
48433888|NCT00198107|101397144|FG001|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0||
48642235|NCT01107457|101908474|FG000|Post Treatment Safety Visits|Part B and C||0||
48642236|NCT01107457|101908475|FG001|Post Treatment Safety Visits|Part B and C||0||
48642237|NCT01107457|101908476|FG002|Post Treatment Safety Visits|Part B and C||0||
48642238|NCT01107457|101908477|FG003|Post Treatment Safety Visits|Part B and C||0||
48642239|NCT01107457|101908478|FG004|Post Treatment Safety Visits|Part B and C||0||
48642240|NCT01107457|101908479|FG005|Post Treatment Safety Visits|Part B and C||6||
48642241|NCT01107457|101908474|FG000|COMPLETED|Part B and C||0||
48433889|NCT00198107|101397145|FG002|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||2||
48433890|NCT00151775|101397146|FG000|STARTED|Period 2 - Double-Blind Dose Response||95||
48433891|NCT00151775|101397147|FG001|STARTED|Period 2 - Double-Blind Dose Response||95||
48433892|NCT00151775|101397148|FG002|STARTED|Period 2 - Double-Blind Dose Response||0||
48433893|NCT00151775|101397149|FG003|STARTED|Period 2 - Double-Blind Dose Response||0||
48433894|NCT00151775|101397150|FG004|STARTED|Period 2 - Double-Blind Dose Response||0||
48433895|NCT00151775|101397151|FG005|STARTED|Period 2 - Double-Blind Dose Response||56||
48433896|NCT00151775|101397152|FG006|STARTED|Period 2 - Double-Blind Dose Response||56||
48433897|NCT00151775|101397153|FG007|STARTED|Period 2 - Double-Blind Dose Response||0||
48433898|NCT00151775|101397154|FG008|STARTED|Period 2 - Double-Blind Dose Response||0||
48433899|NCT00151775|101397155|FG009|STARTED|Period 2 - Double-Blind Dose Response||0||
48433900|NCT00151775|101397156|FG010|STARTED|Period 2 - Double-Blind Dose Response||60||
48433901|NCT00151775|101397157|FG011|STARTED|Period 2 - Double-Blind Dose Response||0||
48433902|NCT00151775|101397146|FG000|COMPLETED|Period 2 - Double-Blind Dose Response||93||
48439994|NCT00792142|101410004|FG000|STARTED|Overall Study||45||
48642242|NCT01107457|101908475|FG001|COMPLETED|Part B and C||0||
48642243|NCT01107457|101908476|FG002|COMPLETED|Part B and C||0||
48433903|NCT00151775|101397147|FG001|COMPLETED|Period 2 - Double-Blind Dose Response||89||
48433904|NCT00151775|101397148|FG002|COMPLETED|Period 2 - Double-Blind Dose Response||0||
48433905|NCT00151775|101397149|FG003|COMPLETED|Period 2 - Double-Blind Dose Response||0||
48433906|NCT00151775|101397150|FG004|COMPLETED|Period 2 - Double-Blind Dose Response||0||
48433907|NCT00151775|101397151|FG005|COMPLETED|Period 2 - Double-Blind Dose Response||54||
48433908|NCT00151775|101397152|FG006|COMPLETED|Period 2 - Double-Blind Dose Response||53||
48433909|NCT00151775|101397153|FG007|COMPLETED|Period 2 - Double-Blind Dose Response||0||
48433910|NCT00151775|101397154|FG008|COMPLETED|Period 2 - Double-Blind Dose Response||0||
48433911|NCT00151775|101397155|FG009|COMPLETED|Period 2 - Double-Blind Dose Response||0||
48433912|NCT00151775|101397156|FG010|COMPLETED|Period 2 - Double-Blind Dose Response||59||
48433913|NCT00151775|101397157|FG011|COMPLETED|Period 2 - Double-Blind Dose Response||0||
48433914|NCT00151775|101397146|FG000|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2||
48433915|NCT00151775|101397147|FG001|NOT COMPLETED|Period 2 - Double-Blind Dose Response||6||
48433916|NCT00151775|101397148|FG002|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0||
48433917|NCT00151775|101397149|FG003|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0||
48433918|NCT00151775|101397150|FG004|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0||
48433919|NCT00151775|101397151|FG005|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2||
48433920|NCT00151775|101397152|FG006|NOT COMPLETED|Period 2 - Double-Blind Dose Response||3||
48433921|NCT00151775|101397153|FG007|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0||
48433922|NCT00151775|101397154|FG008|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0||
48433923|NCT00151775|101397155|FG009|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0||
48433924|NCT00151775|101397156|FG010|NOT COMPLETED|Period 2 - Double-Blind Dose Response||1||
48433925|NCT00151775|101397157|FG011|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0||
48433926|NCT00151775|101397146|FG000|STARTED|Period 3: Double-blind, Withdrawal||48||
48433927|NCT00151775|101397147|FG001|STARTED|Period 3: Double-blind, Withdrawal||45||
48433928|NCT00151775|101397148|FG002|STARTED|Period 3: Double-blind, Withdrawal||45||
48433929|NCT00151775|101397149|FG003|STARTED|Period 3: Double-blind, Withdrawal||44||
48433930|NCT00151775|101397150|FG004|STARTED|Period 3: Double-blind, Withdrawal||0||
48433931|NCT00151775|101397151|FG005|STARTED|Period 3: Double-blind, Withdrawal||26||
48433932|NCT00151775|101397152|FG006|STARTED|Period 3: Double-blind, Withdrawal||27||
48433933|NCT00151775|101397153|FG007|STARTED|Period 3: Double-blind, Withdrawal||28||
48433934|NCT00151775|101397154|FG008|STARTED|Period 3: Double-blind, Withdrawal||26||
48433935|NCT00151775|101397155|FG009|STARTED|Period 3: Double-blind, Withdrawal||0||
48433936|NCT00151775|101397156|FG010|STARTED|Period 3: Double-blind, Withdrawal||29||
48433937|NCT00151775|101397157|FG011|STARTED|Period 3: Double-blind, Withdrawal||29||
48433938|NCT00151775|101397146|FG000|COMPLETED|Period 3: Double-blind, Withdrawal||48||
48433939|NCT00151775|101397147|FG001|COMPLETED|Period 3: Double-blind, Withdrawal||45||
48433940|NCT00151775|101397148|FG002|COMPLETED|Period 3: Double-blind, Withdrawal||42||
48433941|NCT00151775|101397149|FG003|COMPLETED|Period 3: Double-blind, Withdrawal||44||
48433942|NCT00151775|101397150|FG004|COMPLETED|Period 3: Double-blind, Withdrawal||0||
48433943|NCT00151775|101397151|FG005|COMPLETED|Period 3: Double-blind, Withdrawal||25||
48433944|NCT00151775|101397152|FG006|COMPLETED|Period 3: Double-blind, Withdrawal||26||
48433945|NCT00151775|101397153|FG007|COMPLETED|Period 3: Double-blind, Withdrawal||27||
48433946|NCT00151775|101397154|FG008|COMPLETED|Period 3: Double-blind, Withdrawal||26||
48433947|NCT00151775|101397155|FG009|COMPLETED|Period 3: Double-blind, Withdrawal||0||
48433948|NCT00151775|101397156|FG010|COMPLETED|Period 3: Double-blind, Withdrawal||29||
48433949|NCT00151775|101397157|FG011|COMPLETED|Period 3: Double-blind, Withdrawal||28||
48433950|NCT00151775|101397146|FG000|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0||
48433951|NCT00151775|101397147|FG001|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0||
48433952|NCT00151775|101397148|FG002|NOT COMPLETED|Period 3: Double-blind, Withdrawal||3||
48433953|NCT00151775|101397149|FG003|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0||
48433954|NCT00151775|101397150|FG004|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0||
48433955|NCT00151775|101397151|FG005|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1||
48433956|NCT00151775|101397152|FG006|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1||
48433957|NCT00151775|101397153|FG007|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1||
48433958|NCT00151775|101397154|FG008|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0||
48433959|NCT00151775|101397155|FG009|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0||
48433960|NCT00151775|101397156|FG010|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0||
48433961|NCT00151775|101397157|FG011|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1||
48433962|NCT00151775|101397146|FG000|STARTED|Period 4: Open Label||0||
48433963|NCT00151775|101397147|FG001|STARTED|Period 4: Open Label||0||
48764846|NCT04030143|102212051|FG001|STARTED|Overall Study||134||
48764847|NCT04030143|102212050|FG000|Safety Sample|Overall Study||132|Safety sample included all randomized participants who received at least 1 dose of aripiprazole injection, regardless of any protocol violation.|
48433964|NCT00151775|101397148|FG002|STARTED|Period 4: Open Label||0||
48433965|NCT00151775|101397149|FG003|STARTED|Period 4: Open Label||0||
48433966|NCT00151775|101397150|FG004|STARTED|Period 4: Open Label||179||
48433967|NCT00151775|101397151|FG005|STARTED|Period 4: Open Label||0||
48433968|NCT00151775|101397152|FG006|STARTED|Period 4: Open Label||0||
48433969|NCT00151775|101397153|FG007|STARTED|Period 4: Open Label||0||
48433970|NCT00151775|101397154|FG008|STARTED|Period 4: Open Label||0||
48433971|NCT00151775|101397155|FG009|STARTED|Period 4: Open Label||104||
48433972|NCT00151775|101397156|FG010|STARTED|Period 4: Open Label||57||
48433973|NCT00151775|101397157|FG011|STARTED|Period 4: Open Label||0||
48433974|NCT00151775|101397146|FG000|COMPLETED|Period 4: Open Label||0||
48433975|NCT00151775|101397147|FG001|COMPLETED|Period 4: Open Label||0||
48433976|NCT00151775|101397148|FG002|COMPLETED|Period 4: Open Label||0||
48433977|NCT00151775|101397149|FG003|COMPLETED|Period 4: Open Label||0||
48433978|NCT00151775|101397150|FG004|COMPLETED|Period 4: Open Label||149||
48433979|NCT00151775|101397151|FG005|COMPLETED|Period 4: Open Label||0||
48433980|NCT00151775|101397152|FG006|COMPLETED|Period 4: Open Label||0||
48433981|NCT00151775|101397153|FG007|COMPLETED|Period 4: Open Label||0||
48433982|NCT00151775|101397154|FG008|COMPLETED|Period 4: Open Label||0||
48433983|NCT00151775|101397155|FG009|COMPLETED|Period 4: Open Label||83||
48433984|NCT00151775|101397156|FG010|COMPLETED|Period 4: Open Label||57||
48433985|NCT00151775|101397157|FG011|COMPLETED|Period 4: Open Label||0||
48433986|NCT00151775|101397146|FG000|NOT COMPLETED|Period 4: Open Label||0||
48433987|NCT00151775|101397147|FG001|NOT COMPLETED|Period 4: Open Label||0||
48433988|NCT00151775|101397148|FG002|NOT COMPLETED|Period 4: Open Label||0||
48433989|NCT00151775|101397149|FG003|NOT COMPLETED|Period 4: Open Label||0||
48433990|NCT00151775|101397150|FG004|NOT COMPLETED|Period 4: Open Label||30||
48433991|NCT00151775|101397151|FG005|NOT COMPLETED|Period 4: Open Label||0||
48433992|NCT00151775|101397152|FG006|NOT COMPLETED|Period 4: Open Label||0||
48433993|NCT00151775|101397153|FG007|NOT COMPLETED|Period 4: Open Label||0||
48642244|NCT01107457|101908477|FG003|COMPLETED|Part B and C||0||
48642245|NCT01107457|101908478|FG004|COMPLETED|Part B and C||0||
48642246|NCT01107457|101908479|FG005|COMPLETED|Part B and C||0||
48642247|NCT01107457|101908474|FG000|NOT COMPLETED|Part B and C||0||
48433994|NCT00151775|101397154|FG008|NOT COMPLETED|Period 4: Open Label||0||
48433995|NCT00151775|101397155|FG009|NOT COMPLETED|Period 4: Open Label||21||
48433996|NCT00151775|101397156|FG010|NOT COMPLETED|Period 4: Open Label||0||
48433997|NCT00151775|101397157|FG011|NOT COMPLETED|Period 4: Open Label||0||
48433998|NCT04120116|101397158|FG000|STARTED|Overall Study||23||
48433999|NCT04120116|101397159|FG001|STARTED|Overall Study||25||
48434000|NCT04120116|101397160|FG002|STARTED|Overall Study||24||
48434001|NCT04120116|101397161|FG003|STARTED|Overall Study||23||
48434002|NCT04120116|101397158|FG000|COMPLETED|Overall Study||22||
48434003|NCT04120116|101397159|FG001|COMPLETED|Overall Study||24||
48434004|NCT04120116|101397160|FG002|COMPLETED|Overall Study||22||
48434005|NCT04120116|101397161|FG003|COMPLETED|Overall Study||20||
48434006|NCT04120116|101397158|FG000|NOT COMPLETED|Overall Study||1||
48434007|NCT04120116|101397159|FG001|NOT COMPLETED|Overall Study||1||
48434008|NCT04120116|101397160|FG002|NOT COMPLETED|Overall Study||2||
48434009|NCT04120116|101397161|FG003|NOT COMPLETED|Overall Study||3||
48434010|NCT02983305|101397162|FG000|STARTED|Overall Study||12||
48434011|NCT02983305|101397163|FG001|STARTED|Overall Study||10||
48434012|NCT02983305|101397162|FG000|COMPLETED|Overall Study||10|Participants were deemed to have not completed the study if they contributed incomplete data.|
48434013|NCT02983305|101397163|FG001|COMPLETED|Overall Study||10|Participants were deemed to have not completed the study if they contributed incomplete data.|
48434014|NCT02983305|101397162|FG000|NOT COMPLETED|Overall Study||2||
48434015|NCT02983305|101397163|FG001|NOT COMPLETED|Overall Study||0||
48434016|NCT03358407|101397164|FG000|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434017|NCT03358407|101397165|FG001|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434018|NCT03358407|101397166|FG002|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434019|NCT03358407|101397167|FG003|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434020|NCT03358407|101397168|FG004|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434021|NCT03358407|101397169|FG005|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48439995|NCT00792142|101410004|FG000|COMPLETED|Overall Study||45||
48642248|NCT01107457|101908475|FG001|NOT COMPLETED|Part B and C||0||
48642249|NCT01107457|101908476|FG002|NOT COMPLETED|Part B and C||0||
48642250|NCT01107457|101908477|FG003|NOT COMPLETED|Part B and C||0||
48642251|NCT01107457|101908478|FG004|NOT COMPLETED|Part B and C||0||
48642252|NCT01107457|101908479|FG005|NOT COMPLETED|Part B and C||120||
48642253|NCT01859741|101908480|FG000|STARTED|Overall Study||3||
48642254|NCT01859741|101908481|FG001|STARTED|Overall Study||3||
48642255|NCT01859741|101908482|FG002|STARTED|Overall Study||6||
48642256|NCT01859741|101908483|FG003|STARTED|Overall Study||3||
48642257|NCT01859741|101908484|FG004|STARTED|Overall Study||6||
48642258|NCT01859741|101908485|FG005|STARTED|Overall Study||6||
48642259|NCT01859741|101908486|FG006|STARTED|Overall Study||72||
48642260|NCT01859741|101908487|FG007|STARTED|Overall Study||73||
48434022|NCT03358407|101397170|FG006|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434023|NCT03358407|101397171|FG007|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434024|NCT03358407|101397172|FG008|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434025|NCT03358407|101397173|FG009|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434026|NCT03358407|101397164|FG000|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2||
48434027|NCT03358407|101397165|FG001|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2||
48434028|NCT03358407|101397166|FG002|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2||
48434029|NCT03358407|101397167|FG003|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2||
48434030|NCT03358407|101397168|FG004|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2||
48434031|NCT03358407|101397169|FG005|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0||
48434032|NCT03358407|101397170|FG006|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0||
48434033|NCT03358407|101397171|FG007|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0||
48434034|NCT03358407|101397172|FG008|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0||
48434035|NCT03358407|101397173|FG009|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0||
48434036|NCT03358407|101397164|FG000|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0||
48434037|NCT03358407|101397165|FG001|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0||
48434038|NCT03358407|101397166|FG002|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0||
48434039|NCT03358407|101397167|FG003|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0||
48434040|NCT03358407|101397168|FG004|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0||
48434041|NCT03358407|101397169|FG005|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0||
48434042|NCT03358407|101397170|FG006|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0||
48434043|NCT03358407|101397171|FG007|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0||
48434044|NCT03358407|101397172|FG008|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0||
48434045|NCT03358407|101397173|FG009|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0||
48434046|NCT03358407|101397164|FG000|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434047|NCT03358407|101397165|FG001|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434048|NCT03358407|101397166|FG002|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434049|NCT03358407|101397167|FG003|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434050|NCT03358407|101397168|FG004|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434051|NCT03358407|101397169|FG005|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434052|NCT03358407|101397170|FG006|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434053|NCT03358407|101397171|FG007|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434054|NCT03358407|101397172|FG008|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434055|NCT03358407|101397173|FG009|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434056|NCT03358407|101397164|FG000|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2||
48434057|NCT03358407|101397165|FG001|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2||
48434058|NCT03358407|101397166|FG002|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||1||
48434059|NCT03358407|101397167|FG003|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2||
48434060|NCT03358407|101397168|FG004|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2||
48434061|NCT03358407|101397169|FG005|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0||
48434062|NCT03358407|101397170|FG006|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0||
48434063|NCT03358407|101397171|FG007|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0||
48434064|NCT03358407|101397172|FG008|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0||
48434065|NCT03358407|101397173|FG009|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0||
48434066|NCT03358407|101397164|FG000|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0||
48434067|NCT03358407|101397165|FG001|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0||
48434068|NCT03358407|101397166|FG002|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||1||
48434069|NCT03358407|101397167|FG003|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0||
48434070|NCT03358407|101397168|FG004|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0||
48434071|NCT03358407|101397169|FG005|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0||
48434072|NCT03358407|101397170|FG006|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0||
48434073|NCT03358407|101397171|FG007|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0||
48434074|NCT03358407|101397172|FG008|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0||
48434075|NCT03358407|101397173|FG009|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0||
48439996|NCT00792142|101410004|FG000|NOT COMPLETED|Overall Study||0||
48434076|NCT03358407|101397164|FG000|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434077|NCT03358407|101397165|FG001|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434078|NCT03358407|101397166|FG002|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434079|NCT03358407|101397167|FG003|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434080|NCT03358407|101397168|FG004|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434081|NCT03358407|101397169|FG005|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434082|NCT03358407|101397170|FG006|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434083|NCT03358407|101397171|FG007|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434084|NCT03358407|101397172|FG008|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434085|NCT03358407|101397173|FG009|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434086|NCT03358407|101397164|FG000|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2||
48434087|NCT03358407|101397165|FG001|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2||
48434088|NCT03358407|101397166|FG002|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2||
48434089|NCT03358407|101397167|FG003|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2||
48434090|NCT03358407|101397168|FG004|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2||
48434091|NCT03358407|101397169|FG005|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0||
48434092|NCT03358407|101397170|FG006|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0||
48434093|NCT03358407|101397171|FG007|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0||
48434094|NCT03358407|101397172|FG008|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0||
48434095|NCT03358407|101397173|FG009|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0||
48434096|NCT03358407|101397164|FG000|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0||
48434097|NCT03358407|101397165|FG001|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0||
48434098|NCT03358407|101397166|FG002|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0||
48434099|NCT03358407|101397167|FG003|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0||
48434100|NCT03358407|101397168|FG004|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0||
48434101|NCT03358407|101397169|FG005|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0||
48434102|NCT03358407|101397170|FG006|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0||
48434103|NCT03358407|101397171|FG007|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0||
48434104|NCT03358407|101397172|FG008|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0||
48434105|NCT03358407|101397173|FG009|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0||
48434106|NCT03358407|101397164|FG000|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434107|NCT03358407|101397165|FG001|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434108|NCT03358407|101397166|FG002|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434109|NCT03358407|101397167|FG003|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434110|NCT03358407|101397168|FG004|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434111|NCT03358407|101397169|FG005|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434112|NCT03358407|101397170|FG006|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434113|NCT03358407|101397171|FG007|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434114|NCT03358407|101397172|FG008|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434115|NCT03358407|101397173|FG009|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48439997|NCT01143610|101410005|FG000|STARTED|Overall Study||7||
48764848|NCT04030143|102212051|FG001|Safety Sample|Overall Study||134|Safety sample included all randomized participants who received at least 1 dose of aripiprazole injection, regardless of any protocol violation.|
48764849|NCT04030143|102212050|FG000|Efficacy Sample|Overall Study||132|Efficacy sample included all randomized participants who received at least 1 dose of aripiprazole injection and had at least 1 efficacy assessment.|
48764850|NCT04030143|102212051|FG001|Efficacy Sample|Overall Study||134|Efficacy sample included all randomized participants who received at least 1 dose of aripiprazole injection and had at least 1 efficacy assessment.|
48764851|NCT04030143|102212050|FG000|COMPLETED|Overall Study||102||
48764852|NCT04030143|102212051|FG001|COMPLETED|Overall Study||92||
48764853|NCT04030143|102212050|FG000|NOT COMPLETED|Overall Study||30||
48764854|NCT04030143|102212051|FG001|NOT COMPLETED|Overall Study||42||
48434116|NCT03358407|101397164|FG000|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2||
48434117|NCT03358407|101397165|FG001|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2||
48434118|NCT03358407|101397166|FG002|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2||
48434119|NCT03358407|101397167|FG003|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2||
48434120|NCT03358407|101397168|FG004|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||1||
48434121|NCT03358407|101397169|FG005|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0||
48434122|NCT03358407|101397170|FG006|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0||
48434123|NCT03358407|101397171|FG007|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0||
48434124|NCT03358407|101397172|FG008|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0||
48434125|NCT03358407|101397173|FG009|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0||
48434126|NCT03358407|101397164|FG000|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0||
48434127|NCT03358407|101397165|FG001|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0||
48434128|NCT03358407|101397166|FG002|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0||
48434129|NCT03358407|101397167|FG003|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0||
48434130|NCT03358407|101397168|FG004|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||1||
48434131|NCT03358407|101397169|FG005|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0||
48434132|NCT03358407|101397170|FG006|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0||
48434133|NCT03358407|101397171|FG007|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0||
48434134|NCT03358407|101397172|FG008|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0||
48434135|NCT03358407|101397173|FG009|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0||
48434136|NCT03358407|101397164|FG000|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434137|NCT03358407|101397165|FG001|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434138|NCT03358407|101397166|FG002|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434139|NCT03358407|101397167|FG003|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434140|NCT03358407|101397168|FG004|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434141|NCT03358407|101397169|FG005|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434142|NCT03358407|101397170|FG006|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434143|NCT03358407|101397171|FG007|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434144|NCT03358407|101397172|FG008|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434145|NCT03358407|101397173|FG009|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434146|NCT03358407|101397164|FG000|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2||
48434147|NCT03358407|101397165|FG001|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2||
48434148|NCT03358407|101397166|FG002|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2||
48434149|NCT03358407|101397167|FG003|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2||
48434150|NCT03358407|101397168|FG004|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2||
48434151|NCT03358407|101397169|FG005|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0||
48434152|NCT03358407|101397170|FG006|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0||
48434153|NCT03358407|101397171|FG007|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0||
48434154|NCT03358407|101397172|FG008|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0||
48434155|NCT03358407|101397173|FG009|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0||
48434156|NCT03358407|101397164|FG000|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0||
48434157|NCT03358407|101397165|FG001|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0||
48434158|NCT03358407|101397166|FG002|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0||
48434159|NCT03358407|101397167|FG003|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0||
48434160|NCT03358407|101397168|FG004|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0||
48434161|NCT03358407|101397169|FG005|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0||
48434162|NCT03358407|101397170|FG006|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0||
48434163|NCT03358407|101397171|FG007|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0||
48434164|NCT03358407|101397172|FG008|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0||
48642261|NCT01859741|101908480|FG000|COMPLETED|Overall Study||0||
48642262|NCT01859741|101908481|FG001|COMPLETED|Overall Study||0||
48642263|NCT01859741|101908482|FG002|COMPLETED|Overall Study||0||
48642264|NCT01859741|101908483|FG003|COMPLETED|Overall Study||0||
48642265|NCT01859741|101908484|FG004|COMPLETED|Overall Study||0||
48642266|NCT01859741|101908485|FG005|COMPLETED|Overall Study||0||
48642267|NCT01859741|101908486|FG006|COMPLETED|Overall Study||2||
48642268|NCT01859741|101908487|FG007|COMPLETED|Overall Study||3||
48642269|NCT01859741|101908480|FG000|NOT COMPLETED|Overall Study||3||
48642270|NCT01859741|101908481|FG001|NOT COMPLETED|Overall Study||3||
48642271|NCT01859741|101908482|FG002|NOT COMPLETED|Overall Study||6||
48434165|NCT03358407|101397173|FG009|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0||
48434166|NCT03358407|101397164|FG000|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434167|NCT03358407|101397165|FG001|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434168|NCT03358407|101397166|FG002|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434169|NCT03358407|101397167|FG003|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434170|NCT03358407|101397168|FG004|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434171|NCT03358407|101397169|FG005|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||3|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434172|NCT03358407|101397170|FG006|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||3|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434173|NCT03358407|101397171|FG007|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||6|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434174|NCT03358407|101397172|FG008|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434175|NCT03358407|101397173|FG009|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434176|NCT03358407|101397164|FG000|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0||
48434177|NCT03358407|101397165|FG001|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0||
48434178|NCT03358407|101397166|FG002|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0||
48434179|NCT03358407|101397167|FG003|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0||
48434180|NCT03358407|101397168|FG004|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0||
48434181|NCT03358407|101397169|FG005|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0||
48434182|NCT03358407|101397170|FG006|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||2||
48434183|NCT03358407|101397171|FG007|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3||
48434184|NCT03358407|101397172|FG008|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0||
48434185|NCT03358407|101397173|FG009|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0||
48434186|NCT03358407|101397164|FG000|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0||
48434187|NCT03358407|101397165|FG001|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0||
48434188|NCT03358407|101397166|FG002|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0||
48434189|NCT03358407|101397167|FG003|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0||
48434190|NCT03358407|101397168|FG004|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0||
48434191|NCT03358407|101397169|FG005|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3||
48434192|NCT03358407|101397170|FG006|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||1||
48434193|NCT03358407|101397171|FG007|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3||
48434194|NCT03358407|101397172|FG008|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0||
48434195|NCT03358407|101397173|FG009|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0||
48434196|NCT03358407|101397164|FG000|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434197|NCT03358407|101397165|FG001|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434198|NCT03358407|101397166|FG002|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434199|NCT03358407|101397167|FG003|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434200|NCT03358407|101397168|FG004|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434201|NCT03358407|101397169|FG005|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||3|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434202|NCT03358407|101397170|FG006|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||3|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434203|NCT03358407|101397171|FG007|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||6|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434204|NCT03358407|101397172|FG008|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434205|NCT03358407|101397173|FG009|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment \& washout periods are combined|
48434206|NCT03358407|101397164|FG000|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0||
48434207|NCT03358407|101397165|FG001|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0||
48434208|NCT03358407|101397166|FG002|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0||
48434209|NCT03358407|101397167|FG003|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0||
48434210|NCT03358407|101397168|FG004|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0||
48434211|NCT03358407|101397169|FG005|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0||
48434212|NCT03358407|101397170|FG006|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0||
48434213|NCT03358407|101397171|FG007|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0||
48434214|NCT03358407|101397172|FG008|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0||
48434215|NCT03358407|101397173|FG009|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0||
48434216|NCT03358407|101397164|FG000|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0||
48434217|NCT03358407|101397165|FG001|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0||
48434218|NCT03358407|101397166|FG002|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0||
48434219|NCT03358407|101397167|FG003|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0||
48434220|NCT03358407|101397168|FG004|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0||
48434221|NCT03358407|101397169|FG005|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||3||
48434222|NCT03358407|101397170|FG006|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||3||
48434223|NCT03358407|101397171|FG007|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||6||
48434224|NCT03358407|101397172|FG008|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0||
48434225|NCT03358407|101397173|FG009|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0||
48434226|NCT03358407|101397164|FG000|STARTED|Part B: Overall Period (11 Weeks)||0|No participants were enrolled in Part B as the study was terminated during Part A.|
48434227|NCT03358407|101397165|FG001|STARTED|Part B: Overall Period (11 Weeks)||0|No participants were enrolled in Part B as the study was terminated during Part A.|
48434228|NCT03358407|101397166|FG002|STARTED|Part B: Overall Period (11 Weeks)||0|No participants were enrolled in Part B as the study was terminated during Part A.|
48434229|NCT03358407|101397167|FG003|STARTED|Part B: Overall Period (11 Weeks)||0|No participants were enrolled in Part B as the study was terminated during Part A.|
48434230|NCT03358407|101397168|FG004|STARTED|Part B: Overall Period (11 Weeks)||0|No participants were enrolled in Part B as the study was terminated during Part A.|
48187889|NCT01374490|100783127|FG000|NOT COMPLETED|Overall Study||60||
48187890|NCT00994279|100783128|FG000|STARTED|Overall Study||22||
48187891|NCT00994279|100783129|FG001|STARTED|Overall Study||18||
48361354|NCT02413255|101214321|FG000|COMPLETED|Overall Study||18||
48434231|NCT03358407|101397169|FG005|STARTED|Part B: Overall Period (11 Weeks)||0|No participants were enrolled in Part B as the study was terminated during Part A.|
48434232|NCT03358407|101397170|FG006|STARTED|Part B: Overall Period (11 Weeks)||0|No participants were enrolled in Part B as the study was terminated during Part A.|
48434233|NCT03358407|101397171|FG007|STARTED|Part B: Overall Period (11 Weeks)||0|No participants were enrolled in Part B as the study was terminated during Part A.|
48434234|NCT03358407|101397172|FG008|STARTED|Part B: Overall Period (11 Weeks)||0|No participants were enrolled in Part B as the study was terminated during Part A.|
48434235|NCT03358407|101397173|FG009|STARTED|Part B: Overall Period (11 Weeks)||0|No participants were enrolled in Part B as the study was terminated during Part A.|
48439998|NCT01143610|101410006|FG001|STARTED|Overall Study||8||
48361355|NCT02413255|101214322|FG001|COMPLETED|Overall Study||6||
48361356|NCT02413255|101214323|FG002|COMPLETED|Overall Study||6||
48361357|NCT02413255|101214324|FG003|COMPLETED|Overall Study||6||
48361358|NCT02413255|101214325|FG004|COMPLETED|Overall Study||6||
48361359|NCT02413255|101214326|FG005|COMPLETED|Overall Study||6||
48361360|NCT02413255|101214327|FG006|COMPLETED|Overall Study||6||
48361361|NCT02413255|101214328|FG007|COMPLETED|Overall Study||6||
48361362|NCT02413255|101214329|FG008|COMPLETED|Overall Study||6||
48361363|NCT02413255|101214330|FG009|COMPLETED|Overall Study||6||
48361364|NCT02413255|101214331|FG010|COMPLETED|Overall Study||12||
48361365|NCT02413255|101214332|FG011|COMPLETED|Overall Study||6||
48361366|NCT02413255|101214333|FG012|COMPLETED|Overall Study||6||
48361367|NCT02413255|101214334|FG013|COMPLETED|Overall Study||6||
48361368|NCT02413255|101214335|FG014|COMPLETED|Overall Study||5||
48361369|NCT02413255|101214336|FG015|COMPLETED|Overall Study||6||
48361370|NCT02413255|101214337|FG016|COMPLETED|Overall Study||6||
48361371|NCT02413255|101214321|FG000|NOT COMPLETED|Overall Study||0||
48361372|NCT02413255|101214322|FG001|NOT COMPLETED|Overall Study||0||
48361373|NCT02413255|101214323|FG002|NOT COMPLETED|Overall Study||0||
48361374|NCT02413255|101214324|FG003|NOT COMPLETED|Overall Study||0||
48361375|NCT02413255|101214325|FG004|NOT COMPLETED|Overall Study||0||
48361376|NCT02413255|101214326|FG005|NOT COMPLETED|Overall Study||0||
48361377|NCT02413255|101214327|FG006|NOT COMPLETED|Overall Study||0||
48361378|NCT02413255|101214328|FG007|NOT COMPLETED|Overall Study||0||
48361379|NCT02413255|101214329|FG008|NOT COMPLETED|Overall Study||0||
48361380|NCT02413255|101214330|FG009|NOT COMPLETED|Overall Study||0||
48361381|NCT02413255|101214331|FG010|NOT COMPLETED|Overall Study||0||
48361382|NCT02413255|101214332|FG011|NOT COMPLETED|Overall Study||0||
48361383|NCT02413255|101214333|FG012|NOT COMPLETED|Overall Study||0||
48361384|NCT02413255|101214334|FG013|NOT COMPLETED|Overall Study||0||
48361385|NCT02413255|101214335|FG014|NOT COMPLETED|Overall Study||1||
48361386|NCT02413255|101214336|FG015|NOT COMPLETED|Overall Study||0||
48361387|NCT02413255|101214337|FG016|NOT COMPLETED|Overall Study||0||
48361388|NCT03756012|101214338|FG000|STARTED|Overall Study||15||
48361389|NCT03756012|101214338|FG000|COMPLETED|Overall Study||15||
48361390|NCT03756012|101214338|FG000|NOT COMPLETED|Overall Study||0||
48361391|NCT02342171|101214339|FG000|STARTED|Overall Study||99||
48361392|NCT02342171|101214340|FG001|STARTED|Overall Study||507||
48361393|NCT02342171|101214339|FG000|COMPLETED|Overall Study||84||
48361394|NCT02342171|101214340|FG001|COMPLETED|Overall Study||418||
48361395|NCT02342171|101214339|FG000|NOT COMPLETED|Overall Study||15||
48361396|NCT02342171|101214340|FG001|NOT COMPLETED|Overall Study||89||
48434236|NCT03358407|101397164|FG000|COMPLETED|Part B: Overall Period (11 Weeks)||0||
48434237|NCT03358407|101397165|FG001|COMPLETED|Part B: Overall Period (11 Weeks)||0||
48434238|NCT03358407|101397166|FG002|COMPLETED|Part B: Overall Period (11 Weeks)||0||
48434239|NCT03358407|101397167|FG003|COMPLETED|Part B: Overall Period (11 Weeks)||0||
48434240|NCT03358407|101397168|FG004|COMPLETED|Part B: Overall Period (11 Weeks)||0||
48434241|NCT03358407|101397169|FG005|COMPLETED|Part B: Overall Period (11 Weeks)||0||
48434242|NCT03358407|101397170|FG006|COMPLETED|Part B: Overall Period (11 Weeks)||0||
48434243|NCT03358407|101397171|FG007|COMPLETED|Part B: Overall Period (11 Weeks)||0||
48434244|NCT03358407|101397172|FG008|COMPLETED|Part B: Overall Period (11 Weeks)||0||
48434245|NCT03358407|101397173|FG009|COMPLETED|Part B: Overall Period (11 Weeks)||0||
48434246|NCT03358407|101397164|FG000|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0||
48434247|NCT03358407|101397165|FG001|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0||
48434248|NCT03358407|101397166|FG002|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0||
48434249|NCT03358407|101397167|FG003|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0||
48434250|NCT03358407|101397168|FG004|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0||
48434251|NCT03358407|101397169|FG005|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0||
48434252|NCT03358407|101397170|FG006|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0||
48434253|NCT03358407|101397171|FG007|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0||
48434254|NCT03358407|101397172|FG008|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0||
48434255|NCT03358407|101397173|FG009|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0||
48434256|NCT00835861|101397174|FG000|STARTED|Overall Study||15||
48434257|NCT00835861|101397175|FG001|STARTED|Overall Study||16||
48434258|NCT00835861|101397174|FG000|COMPLETED|Overall Study||14||
48434259|NCT00835861|101397175|FG001|COMPLETED|Overall Study||14||
48434260|NCT00835861|101397174|FG000|NOT COMPLETED|Overall Study||1||
48434261|NCT00835861|101397175|FG001|NOT COMPLETED|Overall Study||2||
48434262|NCT02696980|101397176|FG000|STARTED|Overall Study||18||
48434263|NCT02696980|101397176|FG000|COMPLETED|Overall Study||18||
48434264|NCT02696980|101397176|FG000|NOT COMPLETED|Overall Study||0||
48434265|NCT03832907|101397177|FG000|STARTED|Overall Study||101||
48434266|NCT03832907|101397177|FG000|COMPLETED|Overall Study||91||
48434267|NCT03832907|101397177|FG000|NOT COMPLETED|Overall Study||10||
48434268|NCT03075826|101397178|FG000|STARTED|Overall Study||22||
48434269|NCT03075826|101397178|FG000|COMPLETED|Overall Study||16||
48434270|NCT03075826|101397178|FG000|NOT COMPLETED|Overall Study||6||
48434271|NCT01001195|101397179|FG000|STARTED|Overall Study||39||
48434272|NCT01001195|101397180|FG001|STARTED|Overall Study||41||
48434273|NCT01001195|101397181|FG002|STARTED|Overall Study||44||
48434274|NCT01001195|101397182|FG003|STARTED|Overall Study||41||
48434275|NCT01001195|101397179|FG000|COMPLETED|Overall Study||37||
48434276|NCT01001195|101397180|FG001|COMPLETED|Overall Study||39||
48434277|NCT01001195|101397181|FG002|COMPLETED|Overall Study||44||
48434278|NCT01001195|101397182|FG003|COMPLETED|Overall Study||41||
48434279|NCT01001195|101397179|FG000|NOT COMPLETED|Overall Study||2||
48434280|NCT01001195|101397180|FG001|NOT COMPLETED|Overall Study||2||
48434281|NCT01001195|101397181|FG002|NOT COMPLETED|Overall Study||0||
48434282|NCT01001195|101397182|FG003|NOT COMPLETED|Overall Study||0||
48434283|NCT04524351|101397183|FG000|STARTED|Overall Study||10||
48434284|NCT04524351|101397184|FG001|STARTED|Overall Study||10||
48434285|NCT04524351|101397185|FG002|STARTED|Overall Study||11||
48434286|NCT04524351|101397186|FG003|STARTED|Overall Study||10||
48434287|NCT04524351|101397187|FG004|STARTED|Overall Study||12||
48434288|NCT04524351|101397188|FG005|STARTED|Overall Study||5||
48434289|NCT04524351|101397189|FG006|STARTED|Overall Study||6||
48434290|NCT04524351|101397190|FG007|STARTED|Overall Study||10||
48434291|NCT04524351|101397183|FG000|COMPLETED|Overall Study||9||
48434292|NCT04524351|101397184|FG001|COMPLETED|Overall Study||9||
48434293|NCT04524351|101397185|FG002|COMPLETED|Overall Study||11||
48434294|NCT04524351|101397186|FG003|COMPLETED|Overall Study||9||
48434295|NCT04524351|101397187|FG004|COMPLETED|Overall Study||11||
48434296|NCT04524351|101397188|FG005|COMPLETED|Overall Study||5||
48434297|NCT04524351|101397189|FG006|COMPLETED|Overall Study||5||
48434298|NCT04524351|101397190|FG007|COMPLETED|Overall Study||10||
48434299|NCT04524351|101397183|FG000|NOT COMPLETED|Overall Study||1||
48434300|NCT04524351|101397184|FG001|NOT COMPLETED|Overall Study||1||
48434301|NCT04524351|101397185|FG002|NOT COMPLETED|Overall Study||0||
48434302|NCT04524351|101397186|FG003|NOT COMPLETED|Overall Study||1||
48434303|NCT04524351|101397187|FG004|NOT COMPLETED|Overall Study||1||
48434304|NCT04524351|101397188|FG005|NOT COMPLETED|Overall Study||0||
48434305|NCT04524351|101397189|FG006|NOT COMPLETED|Overall Study||1||
48434306|NCT04524351|101397190|FG007|NOT COMPLETED|Overall Study||0||
48434307|NCT01339273|101397191|FG000|STARTED|Overall Study||36||
48434308|NCT01339273|101397192|FG001|STARTED|Overall Study||36||
48434309|NCT01339273|101397191|FG000|COMPLETED|Overall Study||28||
48434310|NCT01339273|101397192|FG001|COMPLETED|Overall Study||28||
48434311|NCT01339273|101397191|FG000|NOT COMPLETED|Overall Study||8||
48434312|NCT01339273|101397192|FG001|NOT COMPLETED|Overall Study||8||
48434313|NCT01993238|101397193|FG000|STARTED|Overall Study||11||
48434314|NCT01993238|101397193|FG000|COMPLETED|Overall Study||11||
48434315|NCT01993238|101397193|FG000|NOT COMPLETED|Overall Study||0||
48434316|NCT03329404|101397194|FG000|STARTED|Overall Study||4||
48434317|NCT03329404|101397195|FG001|STARTED|Overall Study||5||
48434318|NCT03329404|101397194|FG000|COMPLETED|Overall Study||3|"4 subjects were randomized to the MIR/REF RBC treatment sequence, 3 of the 4 subjects completed the first arm of the study and 1 subject did not complete the first arm of the study.~5 subjects were randomized to the REF/MIR RBC treatment sequence, 1 of the 5 subjects completed the first arm of the study and 4 subjects did not complete the first arm of the study.~In summary- no subjects completed the entire study and 4 subjects completed one arm of the study."|
48434319|NCT03329404|101397195|FG001|COMPLETED|Overall Study||1|"4 subjects were randomized to the MIR/REF RBC treatment sequence, 3 of the 4 subjects completed the first arm of the study and 1 subject did not complete the first arm of the study.~5 subjects were randomized to the REF/MIR RBC treatment sequence, 1 of the 5 subjects completed the first arm of the study and 4 subjects did not complete the first arm of the study.~In summary- no subjects completed the entire study and 4 subjects completed one arm of the study."|
48434320|NCT03329404|101397194|FG000|NOT COMPLETED|Overall Study||1||
48434321|NCT03329404|101397195|FG001|NOT COMPLETED|Overall Study||4||
48434322|NCT02184988|101397196|FG000|STARTED|Overall Study||352||
48434323|NCT02184988|101397196|FG000|COMPLETED|Overall Study||297||
48434324|NCT02184988|101397196|FG000|NOT COMPLETED|Overall Study||55||
48434325|NCT00344968|101397197|FG000|STARTED|Overall Study||185||
48434326|NCT00344968|101397198|FG001|STARTED|Overall Study||376||
48434327|NCT00344968|101397199|FG002|STARTED|Overall Study||395||
48434328|NCT00344968|101397197|FG000|COMPLETED|Overall Study||126||
48434329|NCT00344968|101397198|FG001|COMPLETED|Overall Study||274||
48434330|NCT00344968|101397199|FG002|COMPLETED|Overall Study||279||
48434331|NCT00344968|101397197|FG000|NOT COMPLETED|Overall Study||59||
48434332|NCT00344968|101397198|FG001|NOT COMPLETED|Overall Study||102||
48434333|NCT00344968|101397199|FG002|NOT COMPLETED|Overall Study||116||
48434334|NCT01473602|101397200|FG000|STARTED|Overall Study||18||
48434335|NCT01473602|101397201|FG001|STARTED|Overall Study||21||
48434336|NCT01473602|101397200|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18||
48434337|NCT01473602|101397201|FG001|Received at Least 1 Dose of Study Drug|Overall Study||20||
48434338|NCT01473602|101397200|FG000|Completed 6 Months|Overall Study||12||
48434339|NCT01473602|101397201|FG001|Completed 6 Months|Overall Study||15||
48434340|NCT01473602|101397200|FG000|Completed 12 Months|Overall Study||10||
48434341|NCT01473602|101397201|FG001|Completed 12 Months|Overall Study||13||
48434342|NCT01473602|101397200|FG000|COMPLETED|Overall Study||10||
48434343|NCT01473602|101397201|FG001|COMPLETED|Overall Study||13||
48434344|NCT01473602|101397200|FG000|NOT COMPLETED|Overall Study||8||
48434345|NCT01473602|101397201|FG001|NOT COMPLETED|Overall Study||8||
48434346|NCT01771172|101397202|FG000|STARTED|Overall Study||48||
48434347|NCT01771172|101397202|FG000|COMPLETED|Overall Study||46||
48434348|NCT01771172|101397202|FG000|NOT COMPLETED|Overall Study||2||
48434349|NCT00944528|101397203|FG000|STARTED|Overall Study||9||
48434350|NCT00944528|101397204|FG001|STARTED|Overall Study||10||
48434351|NCT00944528|101397205|FG002|STARTED|Overall Study||16||
48434352|NCT00944528|101397203|FG000|COMPLETED|Overall Study||8||
48434353|NCT00944528|101397204|FG001|COMPLETED|Overall Study||8||
48434354|NCT00944528|101397205|FG002|COMPLETED|Overall Study||16||
48434355|NCT00944528|101397203|FG000|NOT COMPLETED|Overall Study||1||
48434356|NCT00944528|101397204|FG001|NOT COMPLETED|Overall Study||2||
48434357|NCT00944528|101397205|FG002|NOT COMPLETED|Overall Study||0||
48434358|NCT05022121|101397206|FG000|STARTED|Overall Study||20||
48434359|NCT05022121|101397207|FG001|STARTED|Overall Study||22||
48434360|NCT05022121|101397206|FG000|COMPLETED|Overall Study||19||
48434361|NCT05022121|101397207|FG001|COMPLETED|Overall Study||20||
48434362|NCT05022121|101397206|FG000|NOT COMPLETED|Overall Study||1||
48434363|NCT05022121|101397207|FG001|NOT COMPLETED|Overall Study||2||
48434364|NCT04409509|101397208|FG000|STARTED|Overall Study||61||
48434365|NCT04409509|101397209|FG001|STARTED|Overall Study||63||
48434366|NCT04409509|101397208|FG000|COMPLETED|Overall Study||48||
48434367|NCT04409509|101397209|FG001|COMPLETED|Overall Study||43||
48434368|NCT04409509|101397208|FG000|NOT COMPLETED|Overall Study||13||
48434369|NCT04409509|101397209|FG001|NOT COMPLETED|Overall Study||20||
48434370|NCT02951143|101397210|FG000|STARTED|Overall Study||97||
48434371|NCT02951143|101397211|FG001|STARTED|Overall Study||41||
48434372|NCT02951143|101397212|FG002|STARTED|Overall Study||47||
48434373|NCT02951143|101397213|FG003|STARTED|Overall Study||39||
48434374|NCT02951143|101397214|FG004|STARTED|Overall Study||37||
48434375|NCT02951143|101397215|FG005|STARTED|Overall Study||44||
48434376|NCT02951143|101397210|FG000|COMPLETED|Overall Study||36||
48434377|NCT02951143|101397211|FG001|COMPLETED|Overall Study||32||
48434378|NCT02951143|101397212|FG002|COMPLETED|Overall Study||29||
48434379|NCT02951143|101397213|FG003|COMPLETED|Overall Study||30||
48434380|NCT02951143|101397214|FG004|COMPLETED|Overall Study||31||
48434381|NCT02951143|101397215|FG005|COMPLETED|Overall Study||29||
48434382|NCT02951143|101397210|FG000|NOT COMPLETED|Overall Study||61||
48434383|NCT02951143|101397211|FG001|NOT COMPLETED|Overall Study||9||
48434384|NCT02951143|101397212|FG002|NOT COMPLETED|Overall Study||18||
48434385|NCT02951143|101397213|FG003|NOT COMPLETED|Overall Study||9||
48434386|NCT02951143|101397214|FG004|NOT COMPLETED|Overall Study||6||
48434387|NCT02951143|101397215|FG005|NOT COMPLETED|Overall Study||15||
48434388|NCT01652040|101397216|FG000|STARTED|Overall Study||13||
48434389|NCT01652040|101397217|FG001|STARTED|Overall Study||13||
48434390|NCT01652040|101397216|FG000|COMPLETED|Overall Study||11||
48434391|NCT01652040|101397217|FG001|COMPLETED|Overall Study||11||
48434392|NCT01652040|101397216|FG000|NOT COMPLETED|Overall Study||2||
48434393|NCT01652040|101397217|FG001|NOT COMPLETED|Overall Study||2||
48434394|NCT00578448|101397218|FG000|STARTED|Day 1 up to 3 Years of Planned Study||12||
48434395|NCT00578448|101397218|FG000|COMPLETED|Day 1 up to 3 Years of Planned Study||9||
48434396|NCT00578448|101397218|FG000|NOT COMPLETED|Day 1 up to 3 Years of Planned Study||3||
48434397|NCT00578448|101397218|FG000|STARTED|1 Year Long Term Extension (LTE)||9||
48434398|NCT00578448|101397218|FG000|COMPLETED|1 Year Long Term Extension (LTE)||8||
48434399|NCT00578448|101397218|FG000|NOT COMPLETED|1 Year Long Term Extension (LTE)||1||
48434400|NCT04446182|101397219|FG000|STARTED|Overall Study||3||
48434401|NCT04446182|101397219|FG000|COMPLETED|Overall Study||3||
48434402|NCT04446182|101397219|FG000|NOT COMPLETED|Overall Study||0||
48434403|NCT04487886|101397220|FG000|STARTED|Overall Study||25||
48434404|NCT04487886|101397221|FG001|STARTED|Overall Study||22||
48434405|NCT04487886|101397220|FG000|COMPLETED|Overall Study||25||
48434406|NCT04487886|101397221|FG001|COMPLETED|Overall Study||22||
48434407|NCT04487886|101397220|FG000|NOT COMPLETED|Overall Study||0||
48434408|NCT04487886|101397221|FG001|NOT COMPLETED|Overall Study||0||
48434409|NCT02329834|101397222|FG000|STARTED|Overall Study||8||
48434410|NCT02329834|101397223|FG001|STARTED|Overall Study||9||
48434411|NCT02329834|101397222|FG000|COMPLETED|Overall Study||7||
48434412|NCT02329834|101397223|FG001|COMPLETED|Overall Study||9||
48434413|NCT02329834|101397222|FG000|NOT COMPLETED|Overall Study||1||
48434414|NCT02329834|101397223|FG001|NOT COMPLETED|Overall Study||0||
48434415|NCT01225029|101397224|FG000|STARTED|Overall Study||32||
48434416|NCT01225029|101397225|FG001|STARTED|Overall Study||32||
48434417|NCT01225029|101397224|FG000|COMPLETED|Overall Study||32||
48434418|NCT01225029|101397225|FG001|COMPLETED|Overall Study||32||
48434419|NCT01225029|101397224|FG000|NOT COMPLETED|Overall Study||0||
48434420|NCT01225029|101397225|FG001|NOT COMPLETED|Overall Study||0||
48434421|NCT01798056|101397226|FG000|STARTED|Overall Study||117||
48434422|NCT01798056|101397227|FG001|STARTED|Overall Study||115||
48434423|NCT01798056|101397226|FG000|COMPLETED|Overall Study||90||
48434424|NCT01798056|101397227|FG001|COMPLETED|Overall Study||90||
48434425|NCT01798056|101397226|FG000|NOT COMPLETED|Overall Study||27||
48361397|NCT02760602|101214341|FG000|STARTED|Overall Study||13||
48361398|NCT02760602|101214342|FG001|STARTED|Overall Study||13||
48361399|NCT02760602|101214341|FG000|COMPLETED|Overall Study||0||
48361400|NCT02760602|101214342|FG001|COMPLETED|Overall Study||0||
48361401|NCT02760602|101214341|FG000|NOT COMPLETED|Overall Study||13||
48361402|NCT02760602|101214342|FG001|NOT COMPLETED|Overall Study||13||
48434426|NCT01798056|101397227|FG001|NOT COMPLETED|Overall Study||25||
48434427|NCT00975000|101397228|FG000|STARTED|Overall Study||57||
48434428|NCT00975000|101397229|FG001|STARTED|Overall Study||57||
48434429|NCT00975000|101397228|FG000|Completed Titration Phase|Overall Study||54||
48434430|NCT00975000|101397229|FG001|Completed Titration Phase|Overall Study||55||
48434431|NCT00975000|101397228|FG000|Completed Efficacy Assessment Phase|Overall Study||54||
48434432|NCT00975000|101397229|FG001|Completed Efficacy Assessment Phase|Overall Study||54||
48434433|NCT00975000|101397228|FG000|Completed Maintenance Phase|Overall Study||52||
48434434|NCT00975000|101397229|FG001|Completed Maintenance Phase|Overall Study||52||
48434435|NCT00975000|101397228|FG000|COMPLETED|Overall Study||52||
48434436|NCT00975000|101397229|FG001|COMPLETED|Overall Study||52||
48434437|NCT00975000|101397228|FG000|NOT COMPLETED|Overall Study||5||
48434438|NCT00975000|101397229|FG001|NOT COMPLETED|Overall Study||5||
48434439|NCT00886626|101397230|FG000|STARTED|Period 1 (90 Days)||6||
48434440|NCT00886626|101397231|FG001|STARTED|Period 1 (90 Days)||6||
48434441|NCT00886626|101397230|FG000|COMPLETED|Period 1 (90 Days)||5||
48361403|NCT01041573|101214343|FG000|STARTED|Overall Study||540||
48361404|NCT01041573|101214344|FG001|STARTED|Overall Study||871||
48361405|NCT01041573|101214345|FG002|STARTED|Overall Study||394||
48361406|NCT01041573|101214346|FG003|STARTED|Overall Study||64||
48361407|NCT01041573|101214343|FG000|COMPLETED|Overall Study||535||
48434442|NCT00886626|101397231|FG001|COMPLETED|Period 1 (90 Days)||6||
48434443|NCT00886626|101397230|FG000|NOT COMPLETED|Period 1 (90 Days)||1||
48434444|NCT00886626|101397231|FG001|NOT COMPLETED|Period 1 (90 Days)||0||
48434445|NCT00886626|101397230|FG000|STARTED|Period 2 (90 Days)||5||
48434446|NCT00886626|101397231|FG001|STARTED|Period 2 (90 Days)||6||
48434447|NCT00886626|101397230|FG000|COMPLETED|Period 2 (90 Days)||5||
48434448|NCT00886626|101397231|FG001|COMPLETED|Period 2 (90 Days)||6||
48434449|NCT00886626|101397230|FG000|NOT COMPLETED|Period 2 (90 Days)||0||
48434450|NCT00886626|101397231|FG001|NOT COMPLETED|Period 2 (90 Days)||0||
48434451|NCT02047929|101397232|FG000|STARTED|Overall Study||1503||10
48434452|NCT02047929|101397233|FG001|STARTED|Overall Study||2523||10
48434453|NCT02047929|101397234|FG002|STARTED|Overall Study||2248||10
48434454|NCT02047929|101397232|FG000|Practice Rollout|Overall Study||1503||10
48434455|NCT02047929|101397233|FG001|Practice Rollout|Overall Study||2523||10
48434456|NCT02047929|101397234|FG002|Practice Rollout|Overall Study||0||0
48434457|NCT02047929|101397232|FG000|Practice Refresher|Overall Study||1503||10
48434458|NCT02047929|101397233|FG001|Practice Refresher|Overall Study||2523||10
48434459|NCT02047929|101397234|FG002|Practice Refresher|Overall Study||0||0
48434460|NCT02047929|101397232|FG000|Surveys Collected|Overall Study||1503||10
48434461|NCT02047929|101397233|FG001|Surveys Collected|Overall Study||2523||10
48361408|NCT01041573|101214344|FG001|COMPLETED|Overall Study||858||
48434462|NCT02047929|101397234|FG002|Surveys Collected|Overall Study||0||0
48434463|NCT02047929|101397232|FG000|COMPLETED|Overall Study||1503||10
48434464|NCT02047929|101397233|FG001|COMPLETED|Overall Study||2523||10
48434465|NCT02047929|101397234|FG002|COMPLETED|Overall Study||2248||10
48434466|NCT02047929|101397232|FG000|NOT COMPLETED|Overall Study||0||0
48434467|NCT02047929|101397233|FG001|NOT COMPLETED|Overall Study||0||0
48434468|NCT02047929|101397234|FG002|NOT COMPLETED|Overall Study||0||0
48434469|NCT00910000|101397235|FG000|STARTED|Overall Study||3||
48434470|NCT00910000|101397236|FG001|STARTED|Overall Study||3||
48434471|NCT00910000|101397237|FG002|STARTED|Overall Study||3||
48434472|NCT00910000|101397238|FG003|STARTED|Overall Study||2||
48434473|NCT00910000|101397239|FG004|STARTED|Overall Study||3||
48434474|NCT00910000|101397240|FG005|STARTED|Overall Study||1||
48434475|NCT00910000|101397235|FG000|COMPLETED|Overall Study||3||
48434476|NCT00910000|101397236|FG001|COMPLETED|Overall Study||0||
48434477|NCT00910000|101397237|FG002|COMPLETED|Overall Study||0||
48434478|NCT00910000|101397238|FG003|COMPLETED|Overall Study||0||
48434479|NCT00910000|101397239|FG004|COMPLETED|Overall Study||2||
48434480|NCT00910000|101397240|FG005|COMPLETED|Overall Study||0||
48434481|NCT00910000|101397235|FG000|NOT COMPLETED|Overall Study||0||
48434482|NCT00910000|101397236|FG001|NOT COMPLETED|Overall Study||3||
48434483|NCT00910000|101397237|FG002|NOT COMPLETED|Overall Study||3||
48434484|NCT00910000|101397238|FG003|NOT COMPLETED|Overall Study||2||
48434485|NCT00910000|101397239|FG004|NOT COMPLETED|Overall Study||1||
48434486|NCT00910000|101397240|FG005|NOT COMPLETED|Overall Study||1||
48434487|NCT01317199|101397241|FG000|STARTED|Dose-escalation Phase 1||14||
48434488|NCT01317199|101397242|FG001|STARTED|Dose-escalation Phase 1||0||
48434489|NCT01317199|101397243|FG002|STARTED|Dose-escalation Phase 1||0||
48434490|NCT01317199|101397244|FG003|STARTED|Dose-escalation Phase 1||0||
48434491|NCT01317199|101397241|FG000|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||2||
48434492|NCT01317199|101397242|FG001|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0||
48434493|NCT01317199|101397243|FG002|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0||
48434494|NCT01317199|101397244|FG003|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0||
48434495|NCT01317199|101397241|FG000|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2||
48434496|NCT01317199|101397242|FG001|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0||
48434497|NCT01317199|101397243|FG002|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0||
48434498|NCT01317199|101397244|FG003|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0||
48434499|NCT01317199|101397241|FG000|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2||
48434500|NCT01317199|101397242|FG001|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0||
48434501|NCT01317199|101397243|FG002|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0||
48434502|NCT01317199|101397244|FG003|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0||
48434503|NCT01317199|101397241|FG000|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2||
48434504|NCT01317199|101397242|FG001|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0||
48434505|NCT01317199|101397243|FG002|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0||
48434506|NCT01317199|101397244|FG003|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0||
48434507|NCT01317199|101397241|FG000|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||6||
48434508|NCT01317199|101397242|FG001|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0||
48434509|NCT01317199|101397243|FG002|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0||
48434510|NCT01317199|101397244|FG003|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0||
48434511|NCT01317199|101397241|FG000|COMPLETED|Dose-escalation Phase 1||7||
48434512|NCT01317199|101397242|FG001|COMPLETED|Dose-escalation Phase 1||0||
48434513|NCT01317199|101397243|FG002|COMPLETED|Dose-escalation Phase 1||0||
48434514|NCT01317199|101397244|FG003|COMPLETED|Dose-escalation Phase 1||0||
48434515|NCT01317199|101397241|FG000|NOT COMPLETED|Dose-escalation Phase 1||7||
48434516|NCT01317199|101397242|FG001|NOT COMPLETED|Dose-escalation Phase 1||0||
48434517|NCT01317199|101397243|FG002|NOT COMPLETED|Dose-escalation Phase 1||0||
48434518|NCT01317199|101397244|FG003|NOT COMPLETED|Dose-escalation Phase 1||0||
48434519|NCT01317199|101397241|FG000|STARTED|Randomized Phase 2||0||
48434520|NCT01317199|101397242|FG001|STARTED|Randomized Phase 2||24||
48434521|NCT01317199|101397243|FG002|STARTED|Randomized Phase 2||56||
48434522|NCT01317199|101397244|FG003|STARTED|Randomized Phase 2||49||
48434523|NCT01317199|101397241|FG000|COMPLETED|Randomized Phase 2||0||
48434524|NCT01317199|101397242|FG001|COMPLETED|Randomized Phase 2||13||
48434525|NCT01317199|101397243|FG002|COMPLETED|Randomized Phase 2||35||
48434526|NCT01317199|101397244|FG003|COMPLETED|Randomized Phase 2||32||
48434527|NCT01317199|101397241|FG000|NOT COMPLETED|Randomized Phase 2||0||
48434528|NCT01317199|101397242|FG001|NOT COMPLETED|Randomized Phase 2||11||
48434529|NCT01317199|101397243|FG002|NOT COMPLETED|Randomized Phase 2||21||
48434530|NCT01317199|101397244|FG003|NOT COMPLETED|Randomized Phase 2||17||
48434531|NCT02543918|101397245|FG000|STARTED|Overall Study||41||
48434532|NCT02543918|101397246|FG001|STARTED|Overall Study||43||
48434533|NCT02543918|101397245|FG000|Received at Least 1 Dose of Study Drug|Overall Study||41||
48434534|NCT02543918|101397246|FG001|Received at Least 1 Dose of Study Drug|Overall Study||42||
48434535|NCT02543918|101397245|FG000|COMPLETED|Overall Study||38||
48434536|NCT02543918|101397246|FG001|COMPLETED|Overall Study||39||
48434537|NCT02543918|101397245|FG000|NOT COMPLETED|Overall Study||3||
48434538|NCT02543918|101397246|FG001|NOT COMPLETED|Overall Study||4||
48434539|NCT00761969|101397247|FG000|STARTED|Overall Study||742||
48434540|NCT00761969|101397248|FG001|STARTED|Overall Study||713||
48434541|NCT00761969|101397247|FG000|COMPLETED|Overall Study||542||
48434542|NCT00761969|101397248|FG001|COMPLETED|Overall Study||573||
48434543|NCT00761969|101397247|FG000|NOT COMPLETED|Overall Study||200||
48434544|NCT00761969|101397248|FG001|NOT COMPLETED|Overall Study||140||
48434545|NCT02866721|101397249|FG000|STARTED|Overall Study||3||
48434546|NCT02866721|101397250|FG001|STARTED|Overall Study||3||
48434547|NCT02866721|101397251|FG002|STARTED|Overall Study||8||
48434548|NCT02866721|101397249|FG000|COMPLETED|Overall Study||3||
48434549|NCT02866721|101397250|FG001|COMPLETED|Overall Study||3||
48434550|NCT02866721|101397251|FG002|COMPLETED|Overall Study||8||
48434551|NCT02866721|101397249|FG000|NOT COMPLETED|Overall Study||0||
48434552|NCT02866721|101397250|FG001|NOT COMPLETED|Overall Study||0||
48434553|NCT02866721|101397251|FG002|NOT COMPLETED|Overall Study||0||
48434554|NCT00381680|101397252|FG000|STARTED|Overall Study||206||
48434555|NCT00381680|101397253|FG001|STARTED|Overall Study||69||
48434556|NCT00381680|101397252|FG000|COMPLETED|Overall Study||81||
48434557|NCT00381680|101397253|FG001|COMPLETED|Overall Study||19||
48434558|NCT00381680|101397252|FG000|NOT COMPLETED|Overall Study||125||
48434559|NCT00381680|101397253|FG001|NOT COMPLETED|Overall Study||50||
48434560|NCT03433482|101397254|FG000|STARTED|Overall Study||420||
48434561|NCT03433482|101397255|FG001|STARTED|Overall Study||424||
48434562|NCT03433482|101397256|FG002|STARTED|Overall Study||427||
48434563|NCT03433482|101397257|FG003|STARTED|Overall Study||419||
48434564|NCT03433482|101397254|FG000|COMPLETED|Overall Study||419||
48434565|NCT03433482|101397255|FG001|COMPLETED|Overall Study||424||
48434566|NCT03433482|101397256|FG002|COMPLETED|Overall Study||423||
48434567|NCT03433482|101397257|FG003|COMPLETED|Overall Study||418||
48434568|NCT03433482|101397254|FG000|NOT COMPLETED|Overall Study||1||
48434569|NCT03433482|101397255|FG001|NOT COMPLETED|Overall Study||0||
48434570|NCT03433482|101397256|FG002|NOT COMPLETED|Overall Study||4||
48434571|NCT03433482|101397257|FG003|NOT COMPLETED|Overall Study||1||
48434572|NCT01966458|101397258|FG000|STARTED|Overall Study||308||
48434573|NCT01966458|101397259|FG001|STARTED|Overall Study||157||
48434574|NCT01966458|101397258|FG000|COMPLETED|Overall Study||304||
48434575|NCT01966458|101397259|FG001|COMPLETED|Overall Study||155||
48434576|NCT01966458|101397258|FG000|NOT COMPLETED|Overall Study||4||
48434577|NCT01966458|101397259|FG001|NOT COMPLETED|Overall Study||2||
48434578|NCT00795886|101397260|FG000|STARTED|Overall Study||63||
48434579|NCT00795886|101397260|FG000|COMPLETED|Overall Study||53||
48434580|NCT00795886|101397260|FG000|NOT COMPLETED|Overall Study||10||
48434581|NCT00938015|101397261|FG000|STARTED|Overall Study||303||
48434582|NCT00938015|101397261|FG000|COMPLETED|Overall Study||156||
48434583|NCT00938015|101397261|FG000|NOT COMPLETED|Overall Study||147||
48434584|NCT01711736|101397262|FG000|STARTED|Overall Study||299||
48434585|NCT01711736|101397263|FG001|STARTED|Overall Study||302||
48434586|NCT01711736|101397262|FG000|COMPLETED|Overall Study||287||
48434587|NCT01711736|101397263|FG001|COMPLETED|Overall Study||294||
48434588|NCT01711736|101397262|FG000|NOT COMPLETED|Overall Study||12||
48434589|NCT01711736|101397263|FG001|NOT COMPLETED|Overall Study||8||
48434590|NCT01740297|101397264|FG000|STARTED|Overall Study||19||
48434591|NCT01740297|101397265|FG001|STARTED|Overall Study||100||
48434592|NCT01740297|101397266|FG002|STARTED|Overall Study||98||
48434593|NCT01740297|101397264|FG000|Received Talimogene Laherparepvec|Overall Study||19||
48434594|NCT01740297|101397265|FG001|Received Talimogene Laherparepvec|Overall Study||0||
48434595|NCT01740297|101397266|FG002|Received Talimogene Laherparepvec|Overall Study||95||
48434596|NCT01740297|101397264|FG000|Received Ipilimumab|Overall Study||18||
48434597|NCT01740297|101397265|FG001|Received Ipilimumab|Overall Study||95||
48434598|NCT01740297|101397266|FG002|Received Ipilimumab|Overall Study||92||
48434599|NCT01740297|101397264|FG000|COMPLETED|Overall Study||6|Completed study|
48434600|NCT01740297|101397265|FG001|COMPLETED|Overall Study||36|Completed study|
48434601|NCT01740297|101397266|FG002|COMPLETED|Overall Study||37|Completed study|
48434602|NCT01740297|101397264|FG000|NOT COMPLETED|Overall Study||13||
48434603|NCT01740297|101397265|FG001|NOT COMPLETED|Overall Study||64||
48434604|NCT01740297|101397266|FG002|NOT COMPLETED|Overall Study||61||
48434605|NCT02513732|101397267|FG000|STARTED|Overall Study||100||
48434606|NCT02513732|101397267|FG000|COMPLETED|Overall Study||78||
48434607|NCT02513732|101397267|FG000|NOT COMPLETED|Overall Study||22||
48434608|NCT00478218|101397268|FG000|STARTED|Overall Study||34||
48434609|NCT00478218|101397269|FG001|STARTED|Overall Study||19||
48434610|NCT00478218|101397268|FG000|COMPLETED|Overall Study||34||
48434611|NCT00478218|101397269|FG001|COMPLETED|Overall Study||19||
48434612|NCT00478218|101397268|FG000|NOT COMPLETED|Overall Study||0||
48434613|NCT00478218|101397269|FG001|NOT COMPLETED|Overall Study||0||
48434614|NCT04020822|101397270|FG000|STARTED|Overall Study||19||
48434615|NCT04020822|101397270|FG000|COMPLETED|Overall Study||19||
48434616|NCT04020822|101397270|FG000|NOT COMPLETED|Overall Study||0||
48434617|NCT03417245|101397271|FG000|STARTED|Overall Study||40||
48434618|NCT03417245|101397272|FG001|STARTED|Overall Study||80||
48434619|NCT03417245|101397271|FG000|Treated|Overall Study||40||
48434620|NCT03417245|101397272|FG001|Treated|Overall Study||79||
48434621|NCT03417245|101397271|FG000|COMPLETED|Overall Study||37||
48434622|NCT03417245|101397272|FG001|COMPLETED|Overall Study||79||
48434623|NCT03417245|101397271|FG000|NOT COMPLETED|Overall Study||3||
48434624|NCT03417245|101397272|FG001|NOT COMPLETED|Overall Study||1||
48434625|NCT00659945|101397273|FG000|STARTED|Overall Study||75||
48434626|NCT00659945|101397274|FG001|STARTED|Overall Study||75||
48187892|NCT00994279|100783128|FG000|COMPLETED|Overall Study||18||
48187893|NCT00994279|100783129|FG001|COMPLETED|Overall Study||13||
48187894|NCT00994279|100783128|FG000|NOT COMPLETED|Overall Study||4||
48187895|NCT00994279|100783129|FG001|NOT COMPLETED|Overall Study||5||
48187896|NCT02851511|100783130|FG000|STARTED|Overall (Phase I + Phase II)||168||
48187897|NCT02851511|100783131|FG001|STARTED|Overall (Phase I + Phase II)||166||
48187898|NCT02851511|100783132|FG002|STARTED|Overall (Phase I + Phase II)||23||
48187899|NCT02851511|100783133|FG003|STARTED|Overall (Phase I + Phase II)||22||
48187900|NCT02851511|100783130|FG000|COMPLETED|Overall (Phase I + Phase II)||126||
48187901|NCT02851511|100783131|FG001|COMPLETED|Overall (Phase I + Phase II)||127||
48187902|NCT02851511|100783132|FG002|COMPLETED|Overall (Phase I + Phase II)||23||
48187903|NCT02851511|100783133|FG003|COMPLETED|Overall (Phase I + Phase II)||18||
48187904|NCT02851511|100783130|FG000|NOT COMPLETED|Overall (Phase I + Phase II)||42||
48187905|NCT02851511|100783131|FG001|NOT COMPLETED|Overall (Phase I + Phase II)||39||
48187906|NCT02851511|100783132|FG002|NOT COMPLETED|Overall (Phase I + Phase II)||0||
48187907|NCT02851511|100783133|FG003|NOT COMPLETED|Overall (Phase I + Phase II)||4||
48187908|NCT02851511|100783130|FG000|STARTED|Phase I||21||
48187909|NCT02851511|100783131|FG001|STARTED|Phase I||21||
48187910|NCT02851511|100783132|FG002|STARTED|Phase I||23||
48187911|NCT02851511|100783133|FG003|STARTED|Phase I||22||
48187912|NCT02851511|100783130|FG000|COMPLETED|Phase I||19||
48187913|NCT02851511|100783131|FG001|COMPLETED|Phase I||20||
48187914|NCT02851511|100783132|FG002|COMPLETED|Phase I||23||
48187915|NCT02851511|100783133|FG003|COMPLETED|Phase I||18||
48187916|NCT02851511|100783130|FG000|NOT COMPLETED|Phase I||2||
48187917|NCT02851511|100783131|FG001|NOT COMPLETED|Phase I||1||
48187918|NCT02851511|100783132|FG002|NOT COMPLETED|Phase I||0||
48187919|NCT02851511|100783133|FG003|NOT COMPLETED|Phase I||4||
48187920|NCT02851511|100783130|FG000|STARTED|Phase II||147||
48187921|NCT02851511|100783131|FG001|STARTED|Phase II||145||
48187922|NCT02851511|100783132|FG002|STARTED|Phase II||0||
48187923|NCT02851511|100783133|FG003|STARTED|Phase II||0||
48187924|NCT02851511|100783130|FG000|COMPLETED|Phase II||107||
48187925|NCT02851511|100783131|FG001|COMPLETED|Phase II||107||
48187926|NCT02851511|100783132|FG002|COMPLETED|Phase II||0||
48187927|NCT02851511|100783133|FG003|COMPLETED|Phase II||0||
48187928|NCT02851511|100783130|FG000|NOT COMPLETED|Phase II||40||
48187929|NCT02851511|100783131|FG001|NOT COMPLETED|Phase II||38||
48187930|NCT02851511|100783132|FG002|NOT COMPLETED|Phase II||0||
48187931|NCT02851511|100783133|FG003|NOT COMPLETED|Phase II||0||
48187932|NCT03302910|100783134|FG000|STARTED|Overall Study||94||
48187933|NCT03302910|100783135|FG001|STARTED|Overall Study||100||
48187934|NCT03302910|100783134|FG000|COMPLETED|Overall Study||93||
48187935|NCT03302910|100783135|FG001|COMPLETED|Overall Study||100||
48187936|NCT03302910|100783134|FG000|NOT COMPLETED|Overall Study||1||
48187937|NCT03302910|100783135|FG001|NOT COMPLETED|Overall Study||0||
48187938|NCT02123966|100783136|FG000|STARTED|Overall Study||10||
48187939|NCT02123966|100783136|FG000|COMPLETED|Overall Study||9||
48187940|NCT02123966|100783136|FG000|NOT COMPLETED|Overall Study||1||
48187941|NCT01866475|100783137|FG000|STARTED|Overall Study||0||
48187942|NCT01866475|100783138|FG001|STARTED|Overall Study||40||
48187943|NCT01866475|100783139|FG002|STARTED|Overall Study||3||
48187944|NCT01866475|100783140|FG003|STARTED|Overall Study||84||
48187945|NCT01866475|100783137|FG000|COMPLETED|Overall Study||0|Completed through day 3 procedures|
48187946|NCT01866475|100783138|FG001|COMPLETED|Overall Study||39|Completed through day 3 procedures|
48187947|NCT01866475|100783139|FG002|COMPLETED|Overall Study||3|Completed through day 3 procedures|
48187948|NCT01866475|100783140|FG003|COMPLETED|Overall Study||79|Completed through day 3 procedures|
48187949|NCT01866475|100783137|FG000|NOT COMPLETED|Overall Study||0||
48434627|NCT00659945|101397273|FG000|COMPLETED|Overall Study||75||
48434628|NCT00659945|101397274|FG001|COMPLETED|Overall Study||75||
48434629|NCT00659945|101397273|FG000|NOT COMPLETED|Overall Study||0||
48434630|NCT00659945|101397274|FG001|NOT COMPLETED|Overall Study||0||
48434631|NCT01171794|101397275|FG000|STARTED|Overall Study||47||
48434632|NCT01171794|101397276|FG001|STARTED|Overall Study||42||
48434633|NCT01171794|101397275|FG000|COMPLETED|Overall Study||44||
48434634|NCT01171794|101397276|FG001|COMPLETED|Overall Study||42||
48434635|NCT01171794|101397275|FG000|NOT COMPLETED|Overall Study||3||
48434636|NCT01171794|101397276|FG001|NOT COMPLETED|Overall Study||0||
48187950|NCT01866475|100783138|FG001|NOT COMPLETED|Overall Study||1||
48187951|NCT01866475|100783139|FG002|NOT COMPLETED|Overall Study||0||
48187952|NCT01866475|100783140|FG003|NOT COMPLETED|Overall Study||5||
48187953|NCT05349084|100783141|FG000|STARTED|Overall Study||21||
48187954|NCT05349084|100783141|FG000|COMPLETED|Overall Study||20||
48187955|NCT05349084|100783141|FG000|NOT COMPLETED|Overall Study||1||
48187956|NCT02662244|100783142|FG000|STARTED|Overall Study||33||
48434637|NCT00483717|101397277|FG000|STARTED|Overall Study||87||
48434638|NCT00483717|101397278|FG001|STARTED|Overall Study||86||
48434639|NCT00483717|101397277|FG000|COMPLETED|Overall Study||63||
48187957|NCT02662244|100783142|FG000|COMPLETED|Overall Study||31||
48187958|NCT02662244|100783142|FG000|NOT COMPLETED|Overall Study||2||
48187959|NCT01615809|100783143|FG000|STARTED|Overall Study||32||
48187960|NCT01615809|100783143|FG000|COMPLETED|Overall Study||22||
48187961|NCT01615809|100783143|FG000|NOT COMPLETED|Overall Study||10||
48187962|NCT03782727|100783144|FG000|STARTED|Overall Study||148||
48187963|NCT03782727|100783144|FG000|COMPLETED|Overall Study||116||
48187964|NCT03782727|100783144|FG000|NOT COMPLETED|Overall Study||32||
48187965|NCT00770211|100783145|FG000|STARTED|Overall Study||182||
48187966|NCT00770211|100783146|FG001|STARTED|Overall Study||89||
48187967|NCT00770211|100783145|FG000|COMPLETED|Overall Study||181||
48187968|NCT00770211|100783146|FG001|COMPLETED|Overall Study||87||
48187969|NCT00770211|100783145|FG000|NOT COMPLETED|Overall Study||1||
48187970|NCT00770211|100783146|FG001|NOT COMPLETED|Overall Study||2||
48187971|NCT04949399|100783147|FG000|STARTED|Overall Study||209|ITT Population|
48187972|NCT04949399|100783148|FG001|STARTED|Overall Study||199|ITT Population|
48187973|NCT04949399|100783147|FG000|COMPLETED|Overall Study||196||
48187974|NCT04949399|100783148|FG001|COMPLETED|Overall Study||190||
48187975|NCT04949399|100783147|FG000|NOT COMPLETED|Overall Study||13||
48187976|NCT04949399|100783148|FG001|NOT COMPLETED|Overall Study||9||
48187977|NCT04285229|100783149|FG000|STARTED|Double-Blind Treatment Period||73||
48187978|NCT04285229|100783150|FG001|STARTED|Double-Blind Treatment Period||74||
48187979|NCT04285229|100783151|FG002|STARTED|Double-Blind Treatment Period||0||
48187980|NCT04285229|100783152|FG003|STARTED|Double-Blind Treatment Period||0||
48187981|NCT04285229|100783153|FG004|STARTED|Double-Blind Treatment Period||0||
48187982|NCT04285229|100783154|FG005|STARTED|Double-Blind Treatment Period||0||
48187983|NCT04285229|100783149|FG000|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||73||
48187984|NCT04285229|100783150|FG001|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||74||
48187985|NCT04285229|100783151|FG002|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||0||
48187986|NCT04285229|100783152|FG003|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||0||
48187987|NCT04285229|100783153|FG004|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||0||
48187988|NCT04285229|100783154|FG005|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||0||
48187989|NCT04285229|100783149|FG000|COMPLETED|Double-Blind Treatment Period||71||
48187990|NCT04285229|100783150|FG001|COMPLETED|Double-Blind Treatment Period||74||
48187991|NCT04285229|100783151|FG002|COMPLETED|Double-Blind Treatment Period||0||
48187992|NCT04285229|100783152|FG003|COMPLETED|Double-Blind Treatment Period||0||
48187993|NCT04285229|100783153|FG004|COMPLETED|Double-Blind Treatment Period||0||
48187994|NCT04285229|100783154|FG005|COMPLETED|Double-Blind Treatment Period||0||
48187995|NCT04285229|100783149|FG000|NOT COMPLETED|Double-Blind Treatment Period||2||
48187996|NCT04285229|100783150|FG001|NOT COMPLETED|Double-Blind Treatment Period||0||
48187997|NCT04285229|100783151|FG002|NOT COMPLETED|Double-Blind Treatment Period||0||
48187998|NCT04285229|100783152|FG003|NOT COMPLETED|Double-Blind Treatment Period||0||
48187999|NCT04285229|100783153|FG004|NOT COMPLETED|Double-Blind Treatment Period||0||
48188000|NCT04285229|100783154|FG005|NOT COMPLETED|Double-Blind Treatment Period||0||
48361409|NCT01041573|101214345|FG002|COMPLETED|Overall Study||387||
48361410|NCT01041573|101214346|FG003|COMPLETED|Overall Study||62||
48188001|NCT04285229|100783149|FG000|STARTED|Extended Treatment Period||0||
48188002|NCT04285229|100783150|FG001|STARTED|Extended Treatment Period||0||
48188003|NCT04285229|100783151|FG002|STARTED|Extended Treatment Period||70||
48188004|NCT04285229|100783152|FG003|STARTED|Extended Treatment Period||72||
48188005|NCT04285229|100783153|FG004|STARTED|Extended Treatment Period||0||
48188006|NCT04285229|100783154|FG005|STARTED|Extended Treatment Period||0||
48188007|NCT04285229|100783149|FG000|COMPLETED|Extended Treatment Period||0||
48188008|NCT04285229|100783150|FG001|COMPLETED|Extended Treatment Period||0||
48188009|NCT04285229|100783151|FG002|COMPLETED|Extended Treatment Period||69||
48188010|NCT04285229|100783152|FG003|COMPLETED|Extended Treatment Period||64||
48188011|NCT04285229|100783153|FG004|COMPLETED|Extended Treatment Period||0||
48188012|NCT04285229|100783154|FG005|COMPLETED|Extended Treatment Period||0||
48188013|NCT04285229|100783149|FG000|NOT COMPLETED|Extended Treatment Period||0||
48188014|NCT04285229|100783150|FG001|NOT COMPLETED|Extended Treatment Period||0||
48188015|NCT04285229|100783151|FG002|NOT COMPLETED|Extended Treatment Period||1||
48188016|NCT04285229|100783152|FG003|NOT COMPLETED|Extended Treatment Period||8||
48188017|NCT04285229|100783153|FG004|NOT COMPLETED|Extended Treatment Period||0||
48188018|NCT04285229|100783154|FG005|NOT COMPLETED|Extended Treatment Period||0||
48188019|NCT04285229|100783149|FG000|STARTED|Follow-up Period||0||
48188020|NCT04285229|100783150|FG001|STARTED|Follow-up Period||0||
48188021|NCT04285229|100783151|FG002|STARTED|Follow-up Period||0||
48188022|NCT04285229|100783152|FG003|STARTED|Follow-up Period||0||
48188023|NCT04285229|100783153|FG004|STARTED|Follow-up Period||1||
48188024|NCT04285229|100783154|FG005|STARTED|Follow-up Period||135||
48188025|NCT04285229|100783149|FG000|COMPLETED|Follow-up Period||0||
48188026|NCT04285229|100783150|FG001|COMPLETED|Follow-up Period||0||
48188027|NCT04285229|100783151|FG002|COMPLETED|Follow-up Period||0||
48188028|NCT04285229|100783152|FG003|COMPLETED|Follow-up Period||0||
48361411|NCT01041573|101214343|FG000|NOT COMPLETED|Overall Study||5||
48361412|NCT01041573|101214344|FG001|NOT COMPLETED|Overall Study||13||
48361413|NCT01041573|101214345|FG002|NOT COMPLETED|Overall Study||7||
48188029|NCT04285229|100783153|FG004|COMPLETED|Follow-up Period||0||
48188030|NCT04285229|100783154|FG005|COMPLETED|Follow-up Period||123||
48188031|NCT04285229|100783149|FG000|NOT COMPLETED|Follow-up Period||0||
48188032|NCT04285229|100783150|FG001|NOT COMPLETED|Follow-up Period||0||
48188033|NCT04285229|100783151|FG002|NOT COMPLETED|Follow-up Period||0||
48188034|NCT04285229|100783152|FG003|NOT COMPLETED|Follow-up Period||0||
48188035|NCT04285229|100783153|FG004|NOT COMPLETED|Follow-up Period||1||
48188036|NCT04285229|100783154|FG005|NOT COMPLETED|Follow-up Period||12||
48188037|NCT03537014|100783155|FG000|STARTED|Overall Study||46||
48188038|NCT03537014|100783156|FG001|STARTED|Overall Study||45||
48188039|NCT03537014|100783155|FG000|COMPLETED|Overall Study||42|Completed all study visits|
48188040|NCT03537014|100783156|FG001|COMPLETED|Overall Study||37|Completed all study visits|
48188041|NCT03537014|100783155|FG000|NOT COMPLETED|Overall Study||4||
48188042|NCT03537014|100783156|FG001|NOT COMPLETED|Overall Study||8||
48188043|NCT03976362|100783157|FG000|STARTED|Induction Phase||851||
48188044|NCT03976362|100783158|FG001|STARTED|Induction Phase||0||
48188045|NCT03976362|100783159|FG002|STARTED|Induction Phase||0||
48188046|NCT03976362|100783157|FG000|COMPLETED|Induction Phase||591||
48188047|NCT03976362|100783158|FG001|COMPLETED|Induction Phase||0||
48188048|NCT03976362|100783159|FG002|COMPLETED|Induction Phase||0||
48188049|NCT03976362|100783157|FG000|NOT COMPLETED|Induction Phase||260||
48188050|NCT03976362|100783158|FG001|NOT COMPLETED|Induction Phase||0||
48188051|NCT03976362|100783159|FG002|NOT COMPLETED|Induction Phase||0||
48188052|NCT03976362|100783157|FG000|STARTED|Maintenance Phase||0||
48188053|NCT03976362|100783158|FG001|STARTED|Maintenance Phase||296||
48188054|NCT03976362|100783159|FG002|STARTED|Maintenance Phase||295||
48188055|NCT03976362|100783157|FG000|Pembro + Olaparib/Placebo (Second Course Pembro Only)|Maintenance Phase||0||
48188056|NCT03976362|100783158|FG001|Pembro + Olaparib/Placebo (Second Course Pembro Only)|Maintenance Phase||7||
48188057|NCT03976362|100783159|FG002|Pembro + Olaparib/Placebo (Second Course Pembro Only)|Maintenance Phase||9||
48188058|NCT03976362|100783157|FG000|COMPLETED|Maintenance Phase||0||
48188059|NCT03976362|100783158|FG001|COMPLETED|Maintenance Phase||0||
48188060|NCT03976362|100783159|FG002|COMPLETED|Maintenance Phase||0||
48188061|NCT03976362|100783157|FG000|NOT COMPLETED|Maintenance Phase||0||
48188062|NCT03976362|100783158|FG001|NOT COMPLETED|Maintenance Phase||296||
48188063|NCT03976362|100783159|FG002|NOT COMPLETED|Maintenance Phase||295||
48188064|NCT03606460|100783160|FG000|STARTED|Overall Study||95||
48361414|NCT01041573|101214346|FG003|NOT COMPLETED|Overall Study||2||
48361415|NCT00945191|101214347|FG000|STARTED|Overall Study||24||
48361416|NCT00945191|101214347|FG000|COMPLETED|Overall Study||0||
48361417|NCT00945191|101214347|FG000|NOT COMPLETED|Overall Study||24||
48361418|NCT01749735|101214348|FG000|STARTED|Overall Study||2||
48361419|NCT01749735|101214349|FG001|STARTED|Overall Study||0||
48361420|NCT01749735|101214348|FG000|COMPLETED|Overall Study||1||
48361421|NCT01749735|101214349|FG001|COMPLETED|Overall Study||0||
48361422|NCT01749735|101214348|FG000|NOT COMPLETED|Overall Study||1||
48361423|NCT01749735|101214349|FG001|NOT COMPLETED|Overall Study||0||
48361424|NCT00759473|101214350|FG000|STARTED|Overall Study||10||
48361425|NCT00759473|101214351|FG001|STARTED|Overall Study||10||
48361426|NCT00759473|101214352|FG002|STARTED|Overall Study||12||
48361427|NCT00759473|101214353|FG003|STARTED|Overall Study||23||
48361428|NCT00759473|101214354|FG004|STARTED|Overall Study||24||
48361429|NCT00759473|101214350|FG000|COMPLETED|Overall Study||10||
48361430|NCT00759473|101214351|FG001|COMPLETED|Overall Study||10||
48361431|NCT00759473|101214352|FG002|COMPLETED|Overall Study||12||
48361432|NCT00759473|101214353|FG003|COMPLETED|Overall Study||23||
48361433|NCT00759473|101214354|FG004|COMPLETED|Overall Study||24||
48361434|NCT00759473|101214350|FG000|NOT COMPLETED|Overall Study||0||
48361435|NCT00759473|101214351|FG001|NOT COMPLETED|Overall Study||0||
48361436|NCT00759473|101214352|FG002|NOT COMPLETED|Overall Study||0||
48361437|NCT00759473|101214353|FG003|NOT COMPLETED|Overall Study||0||
48361438|NCT00759473|101214354|FG004|NOT COMPLETED|Overall Study||0||
48188065|NCT03606460|100783161|FG001|STARTED|Overall Study||46||
48188066|NCT03606460|100783160|FG000|COMPLETED|Overall Study||94||
48188067|NCT03606460|100783161|FG001|COMPLETED|Overall Study||38||
48188068|NCT03606460|100783160|FG000|NOT COMPLETED|Overall Study||1||
48188069|NCT03606460|100783161|FG001|NOT COMPLETED|Overall Study||8||
48188070|NCT03670602|100783162|FG000|STARTED|Overall Study||31||
48188071|NCT03670602|100783163|FG001|STARTED|Overall Study||33||
48188072|NCT03670602|100783162|FG000|Received Intervention Treatment|Overall Study||30||
48188073|NCT03670602|100783163|FG001|Received Intervention Treatment|Overall Study||30||
48188074|NCT03670602|100783162|FG000|Completed Session 2 (Week 12)|Overall Study||29|Completed Session 2 refers to participants who completed the follow up assessment measures for week 12|
48361439|NCT02747628|101214355|FG000|STARTED|Overall Study||20||
48361440|NCT02747628|101214356|FG001|STARTED|Overall Study||20||
48361441|NCT02747628|101214357|FG002|STARTED|Overall Study||20||
48361442|NCT02747628|101214355|FG000|COMPLETED|Overall Study||20||
48361443|NCT02747628|101214356|FG001|COMPLETED|Overall Study||20||
48361444|NCT02747628|101214357|FG002|COMPLETED|Overall Study||20||
48361445|NCT02747628|101214355|FG000|NOT COMPLETED|Overall Study||0||
48361446|NCT02747628|101214356|FG001|NOT COMPLETED|Overall Study||0||
48361447|NCT02747628|101214357|FG002|NOT COMPLETED|Overall Study||0||
48361448|NCT02679066|101214358|FG000|STARTED|Overall Study||100||
48361449|NCT02679066|101214359|FG001|STARTED|Overall Study||100||
48361450|NCT02679066|101214358|FG000|COMPLETED|Overall Study||100||
48361451|NCT02679066|101214359|FG001|COMPLETED|Overall Study||100||
48361452|NCT02679066|101214358|FG000|NOT COMPLETED|Overall Study||0||
48361453|NCT02679066|101214359|FG001|NOT COMPLETED|Overall Study||0||
48361454|NCT05372315|101214360|FG000|STARTED|Overall Study||40||
48361455|NCT05372315|101214361|FG001|STARTED|Overall Study||40||
48361456|NCT05372315|101214360|FG000|COMPLETED|Overall Study||39||
48361457|NCT05372315|101214361|FG001|COMPLETED|Overall Study||40||
48361458|NCT05372315|101214360|FG000|NOT COMPLETED|Overall Study||1||
48361459|NCT05372315|101214361|FG001|NOT COMPLETED|Overall Study||0||
48361460|NCT01769404|101214362|FG000|STARTED|Treatment Period 1||12||
48361461|NCT01769404|101214363|FG001|STARTED|Treatment Period 1||13||
48361462|NCT01769404|101214362|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||9||
48361463|NCT01769404|101214363|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||13||
48361464|NCT01769404|101214362|FG000|COMPLETED|Treatment Period 1||7||
48361465|NCT01769404|101214363|FG001|COMPLETED|Treatment Period 1||13||
48361466|NCT01769404|101214362|FG000|NOT COMPLETED|Treatment Period 1||5||
48361467|NCT01769404|101214363|FG001|NOT COMPLETED|Treatment Period 1||0||
48361468|NCT01769404|101214362|FG000|STARTED|Treatment Period 2||7||
48361469|NCT01769404|101214363|FG001|STARTED|Treatment Period 2||13||
48361470|NCT01769404|101214362|FG000|COMPLETED|Treatment Period 2||0||
48361471|NCT01769404|101214363|FG001|COMPLETED|Treatment Period 2||13||
48361472|NCT01769404|101214362|FG000|NOT COMPLETED|Treatment Period 2||7||
48361473|NCT01769404|101214363|FG001|NOT COMPLETED|Treatment Period 2||0||
48361474|NCT05635838|101214364|FG000|STARTED|16-Week DBVC Period||34||
48361475|NCT05635838|101214365|FG001|STARTED|16-Week DBVC Period||35||
48361476|NCT05635838|101214366|FG002|STARTED|16-Week DBVC Period||0||
48361477|NCT05635838|101214367|FG003|STARTED|16-Week DBVC Period||0||
48361478|NCT05635838|101214364|FG000|COMPLETED|16-Week DBVC Period||24||
48361479|NCT05635838|101214365|FG001|COMPLETED|16-Week DBVC Period||32||
48361480|NCT05635838|101214366|FG002|COMPLETED|16-Week DBVC Period||0||
48361481|NCT05635838|101214367|FG003|COMPLETED|16-Week DBVC Period||0||
48361482|NCT05635838|101214364|FG000|NOT COMPLETED|16-Week DBVC Period||10||
48361483|NCT05635838|101214365|FG001|NOT COMPLETED|16-Week DBVC Period||3||
48361484|NCT05635838|101214366|FG002|NOT COMPLETED|16-Week DBVC Period||0||
48361485|NCT05635838|101214367|FG003|NOT COMPLETED|16-Week DBVC Period||0||
48361486|NCT05635838|101214364|FG000|STARTED|16-Week OLE Period||0||
48361487|NCT05635838|101214365|FG001|STARTED|16-Week OLE Period||0||
48361488|NCT05635838|101214366|FG002|STARTED|16-Week OLE Period||24||
48361489|NCT05635838|101214367|FG003|STARTED|16-Week OLE Period||32||
48361490|NCT05635838|101214364|FG000|COMPLETED|16-Week OLE Period||0||
48361491|NCT05635838|101214365|FG001|COMPLETED|16-Week OLE Period||0||
48361492|NCT05635838|101214366|FG002|COMPLETED|16-Week OLE Period||21||
48361493|NCT05635838|101214367|FG003|COMPLETED|16-Week OLE Period||24||
48361494|NCT05635838|101214364|FG000|NOT COMPLETED|16-Week OLE Period||0||
48361495|NCT05635838|101214365|FG001|NOT COMPLETED|16-Week OLE Period||0||
48361496|NCT05635838|101214366|FG002|NOT COMPLETED|16-Week OLE Period||3||
48361497|NCT05635838|101214367|FG003|NOT COMPLETED|16-Week OLE Period||8||
48361498|NCT01853228|101214368|FG000|STARTED|Phase 1||9||
48361499|NCT01853228|101214369|FG001|STARTED|Phase 1||7||
48361500|NCT01853228|101214368|FG000|COMPLETED|Phase 1||0||
48361501|NCT01853228|101214369|FG001|COMPLETED|Phase 1||7||
48361502|NCT01853228|101214368|FG000|NOT COMPLETED|Phase 1||9||
48361503|NCT01853228|101214369|FG001|NOT COMPLETED|Phase 1||0||
48361504|NCT01853228|101214368|FG000|STARTED|Phase 2||0||
48361505|NCT01853228|101214369|FG001|STARTED|Phase 2||8||
48361506|NCT01853228|101214368|FG000|COMPLETED|Phase 2||0||
48361507|NCT01853228|101214369|FG001|COMPLETED|Phase 2||0||
48361508|NCT01853228|101214368|FG000|NOT COMPLETED|Phase 2||0||
48361509|NCT01853228|101214369|FG001|NOT COMPLETED|Phase 2||8||
48361510|NCT02513940|101214370|FG000|STARTED|Overall Study||2||
48361511|NCT02513940|101214371|FG001|STARTED|Overall Study||3||
48361512|NCT02513940|101214372|FG002|STARTED|Overall Study||2||
48361513|NCT02513940|101214373|FG003|STARTED|Overall Study||2||
48764855|NCT00664443|102212052|FG000|STARTED|Overall Study||2260||
48764856|NCT00664443|102212052|FG000|COMPLETED|Overall Study||2260||
48764857|NCT00664443|102212052|FG000|NOT COMPLETED|Overall Study||0||
48764858|NCT01843621|102212053|FG000|STARTED|Overall Study||7||
48361514|NCT02513940|101214374|FG004|STARTED|Overall Study||2||
48361515|NCT02513940|101214375|FG005|STARTED|Overall Study||3||
48361516|NCT02513940|101214370|FG000|COMPLETED|Overall Study||2||
48361517|NCT02513940|101214371|FG001|COMPLETED|Overall Study||3||
48361518|NCT02513940|101214372|FG002|COMPLETED|Overall Study||2||
48361519|NCT02513940|101214373|FG003|COMPLETED|Overall Study||2||
48361520|NCT02513940|101214374|FG004|COMPLETED|Overall Study||2||
48361521|NCT02513940|101214375|FG005|COMPLETED|Overall Study||3||
48361522|NCT02513940|101214370|FG000|NOT COMPLETED|Overall Study||0||
48361523|NCT02513940|101214371|FG001|NOT COMPLETED|Overall Study||0||
48361524|NCT02513940|101214372|FG002|NOT COMPLETED|Overall Study||0||
48361525|NCT02513940|101214373|FG003|NOT COMPLETED|Overall Study||0||
48361526|NCT02513940|101214374|FG004|NOT COMPLETED|Overall Study||0||
48361527|NCT02513940|101214375|FG005|NOT COMPLETED|Overall Study||0||
48361528|NCT03090737|101214376|FG000|STARTED|Overall Study||129|Started=Treated|
48361529|NCT03090737|101214376|FG000|COMPLETED|Overall Study||0||
48361530|NCT03090737|101214376|FG000|NOT COMPLETED|Overall Study||129||
48361531|NCT02224846|101214377|FG000|STARTED|Period 1 (Month 3)||211||
48361532|NCT02224846|101214378|FG001|STARTED|Period 1 (Month 3)||424||
48361533|NCT02224846|101214377|FG000|Received at Least One Dose of Study Drug|Period 1 (Month 3)||210||
48361534|NCT02224846|101214378|FG001|Received at Least One Dose of Study Drug|Period 1 (Month 3)||421||
48361535|NCT02224846|101214377|FG000|COMPLETED|Period 1 (Month 3)||192||
48361536|NCT02224846|101214378|FG001|COMPLETED|Period 1 (Month 3)||388||
48361537|NCT02224846|101214377|FG000|NOT COMPLETED|Period 1 (Month 3)||19||
48361538|NCT02224846|101214378|FG001|NOT COMPLETED|Period 1 (Month 3)||36||
48361539|NCT02224846|101214377|FG000|STARTED|Period 2 (Month 3 to Month 12)||192||
48361540|NCT02224846|101214378|FG001|STARTED|Period 2 (Month 3 to Month 12)||388||
48361541|NCT02224846|101214377|FG000|COMPLETED|Period 2 (Month 3 to Month 12)||173||
48361542|NCT02224846|101214378|FG001|COMPLETED|Period 2 (Month 3 to Month 12)||357||
48361543|NCT02224846|101214377|FG000|NOT COMPLETED|Period 2 (Month 3 to Month 12)||19||
48361544|NCT02224846|101214378|FG001|NOT COMPLETED|Period 2 (Month 3 to Month 12)||31||
48361545|NCT02224846|101214377|FG000|STARTED|Period 2 (Month 12 to Month 24)||173||
48361546|NCT02224846|101214378|FG001|STARTED|Period 2 (Month 12 to Month 24)||357||
48361547|NCT02224846|101214377|FG000|COMPLETED|Period 2 (Month 12 to Month 24)||131||
48361548|NCT02224846|101214378|FG001|COMPLETED|Period 2 (Month 12 to Month 24)||283||
48361549|NCT02224846|101214377|FG000|NOT COMPLETED|Period 2 (Month 12 to Month 24)||42||
48361550|NCT02224846|101214378|FG001|NOT COMPLETED|Period 2 (Month 12 to Month 24)||74||
48361551|NCT04498910|101214379|FG000|STARTED|Overall Study||19||
48361552|NCT04498910|101214380|FG001|STARTED|Overall Study||19||
48361553|NCT04498910|101214379|FG000|Received at Least One Dose of Study Drug|Overall Study||19||
48361554|NCT04498910|101214380|FG001|Received at Least One Dose of Study Drug|Overall Study||19||
48361555|NCT04498910|101214379|FG000|COMPLETED|Overall Study||16||
48361556|NCT04498910|101214380|FG001|COMPLETED|Overall Study||17||
48361557|NCT04498910|101214379|FG000|NOT COMPLETED|Overall Study||3||
48361558|NCT04498910|101214380|FG001|NOT COMPLETED|Overall Study||2||
48361559|NCT02267577|101214381|FG000|STARTED|Overall Study||85||
48361560|NCT02267577|101214381|FG000|COMPLETED|Overall Study||81||
48361561|NCT02267577|101214381|FG000|NOT COMPLETED|Overall Study||4||
48361562|NCT04579393|101214382|FG000|STARTED|Overall Study||30||
48361563|NCT04579393|101214383|FG001|STARTED|Overall Study||29||
48361564|NCT04579393|101214382|FG000|COMPLETED|Overall Study||27||
48361565|NCT04579393|101214383|FG001|COMPLETED|Overall Study||24||
48361566|NCT04579393|101214382|FG000|NOT COMPLETED|Overall Study||3||
48361567|NCT04579393|101214383|FG001|NOT COMPLETED|Overall Study||5||
48361568|NCT02021812|101214384|FG000|STARTED|Overall Study||31||
48361569|NCT02021812|101214384|FG000|COMPLETED|Overall Study||16||
48361570|NCT02021812|101214384|FG000|NOT COMPLETED|Overall Study||15||
48361571|NCT04083222|101214385|FG000|STARTED|Overall Study||8||
48361572|NCT04083222|101214386|FG001|STARTED|Overall Study||18||
48361573|NCT04083222|101214385|FG000|COMPLETED|Overall Study||8||
48361574|NCT04083222|101214386|FG001|COMPLETED|Overall Study||16||
48361575|NCT04083222|101214385|FG000|NOT COMPLETED|Overall Study||0||
48361576|NCT04083222|101214386|FG001|NOT COMPLETED|Overall Study||2||
48361577|NCT04435769|101214387|FG000|STARTED|Overall Study||42||
48361578|NCT04435769|101214388|FG001|STARTED|Overall Study||67||
48361579|NCT04435769|101214387|FG000|Full Analysis Set (FAS)|Overall Study||42||
48361580|NCT04435769|101214388|FG001|Full Analysis Set (FAS)|Overall Study||67||
48361581|NCT04435769|101214387|FG000|Per Protocol (PP) Population|Overall Study||40||
48361582|NCT04435769|101214388|FG001|Per Protocol (PP) Population|Overall Study||63||
48361583|NCT04435769|101214387|FG000|COMPLETED|Overall Study||42||
48361584|NCT04435769|101214388|FG001|COMPLETED|Overall Study||67||
48361585|NCT04435769|101214387|FG000|NOT COMPLETED|Overall Study||0||
48361586|NCT04435769|101214388|FG001|NOT COMPLETED|Overall Study||0||
48361587|NCT04021862|101214389|FG000|STARTED|Placebo Controlled Period (Week 0-16)||29||
48361588|NCT04021862|101214390|FG001|STARTED|Placebo Controlled Period (Week 0-16)||29||
48361589|NCT04021862|101214391|FG002|STARTED|Placebo Controlled Period (Week 0-16)||29||
48361590|NCT04021862|101214392|FG003|STARTED|Placebo Controlled Period (Week 0-16)||0||
48361591|NCT04021862|101214393|FG004|STARTED|Placebo Controlled Period (Week 0-16)||0||
48361592|NCT04021862|101214394|FG005|STARTED|Placebo Controlled Period (Week 0-16)||0||
48361593|NCT04021862|101214389|FG000|COMPLETED|Placebo Controlled Period (Week 0-16)||27||
48361594|NCT04021862|101214390|FG001|COMPLETED|Placebo Controlled Period (Week 0-16)||28||
48361595|NCT04021862|101214391|FG002|COMPLETED|Placebo Controlled Period (Week 0-16)||27||
48361596|NCT04021862|101214392|FG003|COMPLETED|Placebo Controlled Period (Week 0-16)||0||
48361597|NCT04021862|101214393|FG004|COMPLETED|Placebo Controlled Period (Week 0-16)||0||
48361598|NCT04021862|101214394|FG005|COMPLETED|Placebo Controlled Period (Week 0-16)||0||
48361599|NCT04021862|101214389|FG000|NOT COMPLETED|Placebo Controlled Period (Week 0-16)||2||
48361600|NCT04021862|101214390|FG001|NOT COMPLETED|Placebo Controlled Period (Week 0-16)||1||
48361601|NCT04021862|101214391|FG002|NOT COMPLETED|Placebo Controlled Period (Week 0-16)||2||
48361602|NCT04021862|101214392|FG003|NOT COMPLETED|Placebo Controlled Period (Week 0-16)||0||
48361603|NCT04021862|101214393|FG004|NOT COMPLETED|Placebo Controlled Period (Week 0-16)||0||
48361604|NCT04021862|101214394|FG005|NOT COMPLETED|Placebo Controlled Period (Week 0-16)||0||
48368128|NCT01555463|101230111|FG000|STARTED|Follow up||447||
48361605|NCT04021862|101214389|FG000|STARTED|Active Treatment Period (Week 16-32)||0||
48361606|NCT04021862|101214390|FG001|STARTED|Active Treatment Period (Week 16-32)||0||
48361607|NCT04021862|101214391|FG002|STARTED|Active Treatment Period (Week 16-32)||0||
48361608|NCT04021862|101214392|FG003|STARTED|Active Treatment Period (Week 16-32)||27||
48361609|NCT04021862|101214393|FG004|STARTED|Active Treatment Period (Week 16-32)||28||
48361610|NCT04021862|101214394|FG005|STARTED|Active Treatment Period (Week 16-32)||27||
48361611|NCT04021862|101214389|FG000|COMPLETED|Active Treatment Period (Week 16-32)||0||
48361612|NCT04021862|101214390|FG001|COMPLETED|Active Treatment Period (Week 16-32)||0||
48361613|NCT04021862|101214391|FG002|COMPLETED|Active Treatment Period (Week 16-32)||0||
48361614|NCT04021862|101214392|FG003|COMPLETED|Active Treatment Period (Week 16-32)||26||
48361615|NCT04021862|101214393|FG004|COMPLETED|Active Treatment Period (Week 16-32)||28||
48361616|NCT04021862|101214394|FG005|COMPLETED|Active Treatment Period (Week 16-32)||27||
48361617|NCT04021862|101214389|FG000|NOT COMPLETED|Active Treatment Period (Week 16-32)||0||
48361618|NCT04021862|101214390|FG001|NOT COMPLETED|Active Treatment Period (Week 16-32)||0||
48361619|NCT04021862|101214391|FG002|NOT COMPLETED|Active Treatment Period (Week 16-32)||0||
48361620|NCT04021862|101214392|FG003|NOT COMPLETED|Active Treatment Period (Week 16-32)||1||
48361621|NCT04021862|101214393|FG004|NOT COMPLETED|Active Treatment Period (Week 16-32)||0||
48361622|NCT04021862|101214394|FG005|NOT COMPLETED|Active Treatment Period (Week 16-32)||0||
48361623|NCT02117050|101214395|FG000|STARTED|Overall Study||1||
48361624|NCT02117050|101214395|FG000|COMPLETED|Overall Study||0||
48361625|NCT02117050|101214395|FG000|NOT COMPLETED|Overall Study||1||
48361626|NCT01377467|101214396|FG000|STARTED|Overall Study||46||
48361627|NCT01377467|101214397|FG001|STARTED|Overall Study||44||
48361628|NCT01377467|101214396|FG000|COMPLETED|Overall Study||46||
48361629|NCT01377467|101214397|FG001|COMPLETED|Overall Study||44||
48361630|NCT01377467|101214396|FG000|NOT COMPLETED|Overall Study||0||
48361631|NCT01377467|101214397|FG001|NOT COMPLETED|Overall Study||0||
48361632|NCT03700892|101214398|FG000|STARTED|Baseline||15||
48361633|NCT03700892|101214399|FG001|STARTED|Baseline||0||
48361634|NCT03700892|101214400|FG002|STARTED|Baseline||4||
48361635|NCT03700892|101214398|FG000|COMPLETED|Baseline||15||
48361636|NCT03700892|101214399|FG001|COMPLETED|Baseline||0||
48361637|NCT03700892|101214400|FG002|COMPLETED|Baseline||4||
48361638|NCT03700892|101214398|FG000|NOT COMPLETED|Baseline||0||
48361639|NCT03700892|101214399|FG001|NOT COMPLETED|Baseline||0||
48434640|NCT00483717|101397278|FG001|COMPLETED|Overall Study||65||
48434641|NCT00483717|101397277|FG000|NOT COMPLETED|Overall Study||24||
48434642|NCT00483717|101397278|FG001|NOT COMPLETED|Overall Study||21||
48434643|NCT00909857|101397279|FG000|STARTED|Overall Study||253||
48434644|NCT00909857|101397280|FG001|STARTED|Overall Study||254||
48434645|NCT00909857|101397279|FG000|Treated|Overall Study||234||
48434646|NCT00909857|101397280|FG001|Treated|Overall Study||230||
48434647|NCT00909857|101397279|FG000|COMPLETED|Overall Study||217||
48434648|NCT00909857|101397280|FG001|COMPLETED|Overall Study||209||
48434649|NCT00909857|101397279|FG000|NOT COMPLETED|Overall Study||36||
48434650|NCT00909857|101397280|FG001|NOT COMPLETED|Overall Study||45||
48434651|NCT01166126|101397281|FG000|STARTED|Overall Study||4||
48361640|NCT03700892|101214400|FG002|NOT COMPLETED|Baseline||0||
48361641|NCT03700892|101214398|FG000|STARTED|First Intervention (Single 1-Day Visit)||1||
48361642|NCT03700892|101214399|FG001|STARTED|First Intervention (Single 1-Day Visit)||4||
48361643|NCT03700892|101214400|FG002|STARTED|First Intervention (Single 1-Day Visit)||0||
48361644|NCT03700892|101214398|FG000|COMPLETED|First Intervention (Single 1-Day Visit)||1||
48361645|NCT03700892|101214399|FG001|COMPLETED|First Intervention (Single 1-Day Visit)||4||
48361646|NCT03700892|101214400|FG002|COMPLETED|First Intervention (Single 1-Day Visit)||0||
48434652|NCT01166126|101397281|FG000|COMPLETED|Overall Study||4||
48434653|NCT01166126|101397281|FG000|NOT COMPLETED|Overall Study||0||
48434654|NCT00978120|101397282|FG000|STARTED|Overall Study||110||
48434655|NCT00978120|101397283|FG001|STARTED|Overall Study||107||
48434656|NCT00978120|101397284|FG002|STARTED|Overall Study||87||
48434657|NCT00978120|101397285|FG003|STARTED|Overall Study||86||
48434658|NCT00978120|101397282|FG000|COMPLETED|Overall Study||108||
48434659|NCT00978120|101397283|FG001|COMPLETED|Overall Study||107||
48434660|NCT00978120|101397284|FG002|COMPLETED|Overall Study||84||
48434661|NCT00978120|101397285|FG003|COMPLETED|Overall Study||84||
48434662|NCT00978120|101397282|FG000|NOT COMPLETED|Overall Study||2||
48434663|NCT00978120|101397283|FG001|NOT COMPLETED|Overall Study||0||
48434664|NCT00978120|101397284|FG002|NOT COMPLETED|Overall Study||3||
48434665|NCT00978120|101397285|FG003|NOT COMPLETED|Overall Study||2||
48434666|NCT02322866|101397286|FG000|STARTED|Overall Study||515||
48434667|NCT02322866|101397287|FG001|STARTED|Overall Study||519||
48434668|NCT02322866|101397286|FG000|COMPLETED|Overall Study||444||
48434669|NCT02322866|101397287|FG001|COMPLETED|Overall Study||433||
48434670|NCT02322866|101397286|FG000|NOT COMPLETED|Overall Study||71||
48434671|NCT02322866|101397287|FG001|NOT COMPLETED|Overall Study||86||
48361647|NCT03700892|101214398|FG000|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0||
48361648|NCT03700892|101214399|FG001|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0||
48361649|NCT03700892|101214400|FG002|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0||
48434672|NCT01312948|101397288|FG000|STARTED|Overall Study||6||
48434673|NCT01312948|101397288|FG000|COMPLETED|Overall Study||6||
48434674|NCT01312948|101397288|FG000|NOT COMPLETED|Overall Study||0||
48434675|NCT02980666|101397289|FG000|STARTED|Overall Study||8||
48434676|NCT02980666|101397290|FG001|STARTED|Overall Study||2||
48434677|NCT02980666|101397289|FG000|COMPLETED|Overall Study||8||
48434678|NCT02980666|101397290|FG001|COMPLETED|Overall Study||2||
48434679|NCT02980666|101397289|FG000|NOT COMPLETED|Overall Study||0||
48434680|NCT02980666|101397290|FG001|NOT COMPLETED|Overall Study||0||
48434681|NCT03413618|101397291|FG000|STARTED|Overall Study||45||
48434682|NCT03413618|101397292|FG001|STARTED|Overall Study||45||
48434683|NCT03413618|101397291|FG000|COMPLETED|Overall Study||45||
48434684|NCT03413618|101397292|FG001|COMPLETED|Overall Study||45||
48434685|NCT03413618|101397291|FG000|NOT COMPLETED|Overall Study||0||
48434686|NCT03413618|101397292|FG001|NOT COMPLETED|Overall Study||0||
48434687|NCT02325739|101397293|FG000|STARTED|Phase I Part||11||
48434688|NCT02325739|101397294|FG001|STARTED|Phase I Part||6||
48434689|NCT02325739|101397295|FG002|STARTED|Phase I Part||5||
48434690|NCT02325739|101397296|FG003|STARTED|Phase I Part||26||
48434691|NCT02325739|101397297|FG004|STARTED|Phase I Part||19||
48434692|NCT02325739|101397298|FG005|STARTED|Phase I Part||7||
48434693|NCT02325739|101397299|FG006|STARTED|Phase I Part||6||
48434694|NCT02325739|101397300|FG007|STARTED|Phase I Part||6||
48434695|NCT02325739|101397301|FG008|STARTED|Phase I Part||0||
48434696|NCT02325739|101397302|FG009|STARTED|Phase I Part||0||
48434697|NCT02325739|101397303|FG010|STARTED|Phase I Part||0||
48434698|NCT02325739|101397293|FG000|COMPLETED|Phase I Part||0||
48434699|NCT02325739|101397294|FG001|COMPLETED|Phase I Part||0||
48434700|NCT02325739|101397295|FG002|COMPLETED|Phase I Part||0||
48434701|NCT02325739|101397296|FG003|COMPLETED|Phase I Part||0||
48434702|NCT02325739|101397297|FG004|COMPLETED|Phase I Part||0||
48434703|NCT02325739|101397298|FG005|COMPLETED|Phase I Part||0||
48434704|NCT02325739|101397299|FG006|COMPLETED|Phase I Part||0||
48434705|NCT02325739|101397300|FG007|COMPLETED|Phase I Part||0||
48434706|NCT02325739|101397301|FG008|COMPLETED|Phase I Part||0||
48434707|NCT02325739|101397302|FG009|COMPLETED|Phase I Part||0||
48434708|NCT02325739|101397303|FG010|COMPLETED|Phase I Part||0||
48434709|NCT02325739|101397293|FG000|NOT COMPLETED|Phase I Part||11||
48434710|NCT02325739|101397294|FG001|NOT COMPLETED|Phase I Part||6||
48434711|NCT02325739|101397295|FG002|NOT COMPLETED|Phase I Part||5||
48434712|NCT02325739|101397296|FG003|NOT COMPLETED|Phase I Part||26||
48434713|NCT02325739|101397297|FG004|NOT COMPLETED|Phase I Part||19||
48434714|NCT02325739|101397298|FG005|NOT COMPLETED|Phase I Part||7||
48434715|NCT02325739|101397299|FG006|NOT COMPLETED|Phase I Part||6||
48434716|NCT02325739|101397300|FG007|NOT COMPLETED|Phase I Part||6||
48434717|NCT02325739|101397301|FG008|NOT COMPLETED|Phase I Part||0||
48434718|NCT02325739|101397302|FG009|NOT COMPLETED|Phase I Part||0||
48434719|NCT02325739|101397303|FG010|NOT COMPLETED|Phase I Part||0||
48434720|NCT02325739|101397293|FG000|STARTED|Phase II Part||0||
48434721|NCT02325739|101397294|FG001|STARTED|Phase II Part||0||
48434722|NCT02325739|101397295|FG002|STARTED|Phase II Part||0||
48434723|NCT02325739|101397296|FG003|STARTED|Phase II Part||0||
48434724|NCT02325739|101397297|FG004|STARTED|Phase II Part||0||
48434725|NCT02325739|101397298|FG005|STARTED|Phase II Part||0||
48434726|NCT02325739|101397299|FG006|STARTED|Phase II Part||0||
48434727|NCT02325739|101397300|FG007|STARTED|Phase II Part||0||
48434728|NCT02325739|101397301|FG008|STARTED|Phase II Part||30||
48434729|NCT02325739|101397302|FG009|STARTED|Phase II Part||36||
48434730|NCT02325739|101397303|FG010|STARTED|Phase II Part||20||
48434731|NCT02325739|101397293|FG000|COMPLETED|Phase II Part||0||
48434732|NCT02325739|101397294|FG001|COMPLETED|Phase II Part||0||
48434733|NCT02325739|101397295|FG002|COMPLETED|Phase II Part||0||
48434734|NCT02325739|101397296|FG003|COMPLETED|Phase II Part||0||
48434735|NCT02325739|101397297|FG004|COMPLETED|Phase II Part||0||
48434736|NCT02325739|101397298|FG005|COMPLETED|Phase II Part||0||
48434737|NCT02325739|101397299|FG006|COMPLETED|Phase II Part||0||
48434738|NCT02325739|101397300|FG007|COMPLETED|Phase II Part||0||
48188075|NCT03670602|100783163|FG001|Completed Session 2 (Week 12)|Overall Study||30|Completed Session 2 refers to participants who completed the follow up assessment measures for week 12|
48188690|NCT05590910|100783311|FG001|STARTED|Overall Study||40||
48188691|NCT05590910|100783310|FG000|COMPLETED|Overall Study||49||
48434739|NCT02325739|101397301|FG008|COMPLETED|Phase II Part||0||
48434740|NCT02325739|101397302|FG009|COMPLETED|Phase II Part||0||
48434741|NCT02325739|101397303|FG010|COMPLETED|Phase II Part||0||
48434742|NCT02325739|101397293|FG000|NOT COMPLETED|Phase II Part||0||
48434743|NCT02325739|101397294|FG001|NOT COMPLETED|Phase II Part||0||
48434744|NCT02325739|101397295|FG002|NOT COMPLETED|Phase II Part||0||
48434745|NCT02325739|101397296|FG003|NOT COMPLETED|Phase II Part||0||
48434746|NCT02325739|101397297|FG004|NOT COMPLETED|Phase II Part||0||
48434747|NCT02325739|101397298|FG005|NOT COMPLETED|Phase II Part||0||
48434748|NCT02325739|101397299|FG006|NOT COMPLETED|Phase II Part||0||
48434749|NCT02325739|101397300|FG007|NOT COMPLETED|Phase II Part||0||
48434750|NCT02325739|101397301|FG008|NOT COMPLETED|Phase II Part||30||
48434751|NCT02325739|101397302|FG009|NOT COMPLETED|Phase II Part||36||
48434752|NCT02325739|101397303|FG010|NOT COMPLETED|Phase II Part||20||
48434753|NCT02544607|101397304|FG000|STARTED|Overall Study||16||
48434754|NCT02544607|101397304|FG000|COMPLETED|Overall Study||16||
48188076|NCT03670602|100783162|FG000|Completed Session 3 (Week 24)|Overall Study||28|Completed Session 3 refers to participants who were able to complete follow-up assessment measures at week 24|
48188077|NCT03670602|100783163|FG001|Completed Session 3 (Week 24)|Overall Study||31|Completed Session 3 refers to participants who were able to complete follow-up assessment measures at week 24|
48188078|NCT03670602|100783162|FG000|COMPLETED|Overall Study||30||
48188079|NCT03670602|100783163|FG001|COMPLETED|Overall Study||30||
48188080|NCT03670602|100783162|FG000|NOT COMPLETED|Overall Study||1||
48188081|NCT03670602|100783163|FG001|NOT COMPLETED|Overall Study||3||
48188082|NCT00278564|100783164|FG000|STARTED|Overall Study||7||
48188083|NCT00278564|100783164|FG000|COMPLETED|Overall Study||3||
48188084|NCT00278564|100783164|FG000|NOT COMPLETED|Overall Study||4||
48188085|NCT04873817|100783165|FG000|STARTED|Overall Study||184||
48188086|NCT04873817|100783165|FG000|COMPLETED|Overall Study||165||
48188087|NCT04873817|100783165|FG000|NOT COMPLETED|Overall Study||19||
48188088|NCT01911221|100783166|FG000|STARTED|Overall Study||13||
48188089|NCT01911221|100783166|FG000|COMPLETED|Overall Study||13||
48188090|NCT01911221|100783166|FG000|NOT COMPLETED|Overall Study||0||
48188091|NCT03781960|100783167|FG000|STARTED|Overall Study||7||
48188092|NCT03781960|100783167|FG000|COMPLETED|Overall Study||7||
48188093|NCT03781960|100783167|FG000|NOT COMPLETED|Overall Study||0||
48188094|NCT01582243|100783168|FG000|STARTED|Overall Study||40||
48188095|NCT01582243|100783168|FG000|COMPLETED|Overall Study||37||
48188096|NCT01582243|100783168|FG000|NOT COMPLETED|Overall Study||3||
48188097|NCT03459729|100783169|FG000|STARTED|Overall Study||6||
48188098|NCT03459729|100783169|FG000|Received Therapy|Overall Study||4||
48188099|NCT03459729|100783169|FG000|COMPLETED|Overall Study||4||
48188100|NCT03459729|100783169|FG000|NOT COMPLETED|Overall Study||2||
48188101|NCT02018861|100783170|FG000|STARTED|Parsaclisib Monotherapy: 21-day Cycles||1||
48361650|NCT03700892|101214398|FG000|STARTED|Washout (2-3 Weeks)||1||
48434755|NCT02544607|101397304|FG000|NOT COMPLETED|Overall Study||0||
48434756|NCT00351611|101397305|FG000|STARTED|Overall Study||89||
48434757|NCT00351611|101397306|FG001|STARTED|Overall Study||98||
48434758|NCT00351611|101397305|FG000|Treated|Overall Study||89||
48434759|NCT00351611|101397306|FG001|Treated|Overall Study||98||
48434760|NCT00351611|101397305|FG000|COMPLETED|Overall Study||75||
48434761|NCT00351611|101397306|FG001|COMPLETED|Overall Study||88||
48434762|NCT00351611|101397305|FG000|NOT COMPLETED|Overall Study||14||
48434763|NCT00351611|101397306|FG001|NOT COMPLETED|Overall Study||10||
48434764|NCT01358266|101397307|FG000|STARTED|Double-Masked Period||208||
48434765|NCT01358266|101397308|FG001|STARTED|Double-Masked Period||208||
48188102|NCT02018861|100783171|FG001|STARTED|Parsaclisib Monotherapy: 21-day Cycles||3||
48361651|NCT03700892|101214399|FG001|STARTED|Washout (2-3 Weeks)||4||
48361652|NCT03700892|101214400|FG002|STARTED|Washout (2-3 Weeks)||0||
48361653|NCT03700892|101214398|FG000|COMPLETED|Washout (2-3 Weeks)||1||
48361654|NCT03700892|101214399|FG001|COMPLETED|Washout (2-3 Weeks)||4||
48361655|NCT03700892|101214400|FG002|COMPLETED|Washout (2-3 Weeks)||0||
48361656|NCT03700892|101214398|FG000|NOT COMPLETED|Washout (2-3 Weeks)||0||
48361657|NCT03700892|101214399|FG001|NOT COMPLETED|Washout (2-3 Weeks)||0||
48361658|NCT03700892|101214400|FG002|NOT COMPLETED|Washout (2-3 Weeks)||0||
48361659|NCT03700892|101214398|FG000|STARTED|Second Intervention (Single 1-Day Visit)||1||
48361660|NCT03700892|101214399|FG001|STARTED|Second Intervention (Single 1-Day Visit)||4||
48361661|NCT03700892|101214400|FG002|STARTED|Second Intervention (Single 1-Day Visit)||0||
48361662|NCT03700892|101214398|FG000|Received Intervention|Second Intervention (Single 1-Day Visit)||1||
48361663|NCT03700892|101214399|FG001|Received Intervention|Second Intervention (Single 1-Day Visit)||3||
48361664|NCT03700892|101214400|FG002|Received Intervention|Second Intervention (Single 1-Day Visit)||0||
48361665|NCT03700892|101214398|FG000|COMPLETED|Second Intervention (Single 1-Day Visit)||1||
48361666|NCT03700892|101214399|FG001|COMPLETED|Second Intervention (Single 1-Day Visit)||3||
48361667|NCT03700892|101214400|FG002|COMPLETED|Second Intervention (Single 1-Day Visit)||0||
48361668|NCT03700892|101214398|FG000|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0||
48361669|NCT03700892|101214399|FG001|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||1||
48361670|NCT03700892|101214400|FG002|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0||
48361671|NCT03000452|101214401|FG000|STARTED|Treatment Period||18||
48361672|NCT03000452|101214401|FG000|COMPLETED|Treatment Period||0||
48361673|NCT03000452|101214401|FG000|NOT COMPLETED|Treatment Period||18||
48361674|NCT03000452|101214401|FG000|STARTED|Follow-Up Period||17||
48361675|NCT03000452|101214401|FG000|COMPLETED|Follow-Up Period||10||
48434766|NCT01358266|101397309|FG002|STARTED|Double-Masked Period||176||
48188103|NCT02018861|100783172|FG002|STARTED|Parsaclisib Monotherapy: 21-day Cycles||3||
48188104|NCT02018861|100783173|FG003|STARTED|Parsaclisib Monotherapy: 21-day Cycles||34||
48188105|NCT02018861|100783174|FG004|STARTED|Parsaclisib Monotherapy: 21-day Cycles||27||
48361676|NCT03000452|101214401|FG000|NOT COMPLETED|Follow-Up Period||7||
48361677|NCT02269319|101214402|FG000|STARTED|Overall Study||80||
48361678|NCT02269319|101214403|FG001|STARTED|Overall Study||40||
48361679|NCT02269319|101214402|FG000|COMPLETED|Overall Study||75||
48361680|NCT02269319|101214403|FG001|COMPLETED|Overall Study||36||
48361681|NCT02269319|101214402|FG000|NOT COMPLETED|Overall Study||5||
48361682|NCT02269319|101214403|FG001|NOT COMPLETED|Overall Study||4||
48361683|NCT00970294|101214404|FG000|STARTED|Overall Study||11||
48434767|NCT01358266|101397307|FG000|COMPLETED|Double-Masked Period||175||
48434768|NCT01358266|101397308|FG001|COMPLETED|Double-Masked Period||162||
48434769|NCT01358266|101397309|FG002|COMPLETED|Double-Masked Period||137||
48434770|NCT01358266|101397307|FG000|NOT COMPLETED|Double-Masked Period||33||
48434771|NCT01358266|101397308|FG001|NOT COMPLETED|Double-Masked Period||46||
48434772|NCT01358266|101397309|FG002|NOT COMPLETED|Double-Masked Period||39||
48434773|NCT01358266|101397307|FG000|STARTED|Open-Label Period||119||
48434774|NCT01358266|101397308|FG001|STARTED|Open-Label Period||102||
48434775|NCT01358266|101397309|FG002|STARTED|Open-Label Period||114||
48434776|NCT01358266|101397307|FG000|COMPLETED|Open-Label Period||63||
48434777|NCT01358266|101397308|FG001|COMPLETED|Open-Label Period||58||
48434778|NCT01358266|101397309|FG002|COMPLETED|Open-Label Period||44||
48434779|NCT01358266|101397307|FG000|NOT COMPLETED|Open-Label Period||56||
48434780|NCT01358266|101397308|FG001|NOT COMPLETED|Open-Label Period||44||
48434781|NCT01358266|101397309|FG002|NOT COMPLETED|Open-Label Period||70||
48434782|NCT04629534|101397310|FG000|STARTED|Overall Study||4||
48434783|NCT04629534|101397311|FG001|STARTED|Overall Study||4||
48434784|NCT04629534|101397310|FG000|COMPLETED|Overall Study||3||
48434785|NCT04629534|101397311|FG001|COMPLETED|Overall Study||2||
48434786|NCT04629534|101397310|FG000|NOT COMPLETED|Overall Study||1||
48434787|NCT04629534|101397311|FG001|NOT COMPLETED|Overall Study||2||
48434788|NCT00422058|101397312|FG000|STARTED|Double-Blind, Week 0-20||98||
48434789|NCT00422058|101397313|FG001|STARTED|Double-Blind, Week 0-20||95||
48434790|NCT00422058|101397314|FG002|STARTED|Double-Blind, Week 0-20||90||
48434791|NCT00422058|101397315|FG003|STARTED|Double-Blind, Week 0-20||93||
48434792|NCT00422058|101397316|FG004|STARTED|Double-Blind, Week 0-20||93||
48434793|NCT00422058|101397317|FG005|STARTED|Double-Blind, Week 0-20||95||
48434794|NCT00422058|101397312|FG000|COMPLETED|Double-Blind, Week 0-20||79||
48434795|NCT00422058|101397313|FG001|COMPLETED|Double-Blind, Week 0-20||85||
48764859|NCT01843621|102212053|FG000|COMPLETED|Overall Study||7||
48764860|NCT01843621|102212053|FG000|NOT COMPLETED|Overall Study||0||
48764861|NCT01001221|102212054|FG000|STARTED|Overall Study||5||
48764862|NCT01001221|102212055|FG001|STARTED|Overall Study||5||
48764863|NCT01001221|102212056|FG002|STARTED|Overall Study||3||
48764864|NCT01001221|102212057|FG003|STARTED|Overall Study||6||
48764865|NCT01001221|102212058|FG004|STARTED|Overall Study||0||
48764866|NCT01001221|102212054|FG000|Treated|Overall Study||5||
48764867|NCT01001221|102212055|FG001|Treated|Overall Study||5||
48764868|NCT01001221|102212056|FG002|Treated|Overall Study||2||
48764869|NCT01001221|102212057|FG003|Treated|Overall Study||6||
48764870|NCT01001221|102212058|FG004|Treated|Overall Study||0||
48764871|NCT01001221|102212054|FG000|Completed 1st Treatment Cycle|Overall Study||5||
48764872|NCT01001221|102212055|FG001|Completed 1st Treatment Cycle|Overall Study||5||
48764873|NCT01001221|102212056|FG002|Completed 1st Treatment Cycle|Overall Study||2||
48764874|NCT01001221|102212057|FG003|Completed 1st Treatment Cycle|Overall Study||6||
48764875|NCT01001221|102212058|FG004|Completed 1st Treatment Cycle|Overall Study||0||
48764876|NCT01001221|102212054|FG000|COMPLETED|Overall Study||0||
48764877|NCT01001221|102212055|FG001|COMPLETED|Overall Study||0||
48764878|NCT01001221|102212056|FG002|COMPLETED|Overall Study||0||
48764879|NCT01001221|102212057|FG003|COMPLETED|Overall Study||0||
48764880|NCT01001221|102212058|FG004|COMPLETED|Overall Study||0||
48764881|NCT01001221|102212054|FG000|NOT COMPLETED|Overall Study||5||
48764882|NCT01001221|102212055|FG001|NOT COMPLETED|Overall Study||5||
48764883|NCT01001221|102212056|FG002|NOT COMPLETED|Overall Study||3||
48764884|NCT01001221|102212057|FG003|NOT COMPLETED|Overall Study||6||
48764885|NCT01001221|102212058|FG004|NOT COMPLETED|Overall Study||0||
48764886|NCT03299166|102212059|FG000|STARTED|Overall Study||124|Participants who were randomized.|
48764887|NCT03299166|102212060|FG001|STARTED|Overall Study||124|Participants who were randomized.|
48764888|NCT03299166|102212059|FG000|Treated|Overall Study||122||
48434796|NCT00422058|101397314|FG002|COMPLETED|Double-Blind, Week 0-20||74||
48434797|NCT00422058|101397315|FG003|COMPLETED|Double-Blind, Week 0-20||73||
48434798|NCT00422058|101397316|FG004|COMPLETED|Double-Blind, Week 0-20||82||
48434799|NCT00422058|101397317|FG005|COMPLETED|Double-Blind, Week 0-20||79||
48434800|NCT00422058|101397312|FG000|NOT COMPLETED|Double-Blind, Week 0-20||19||
48434801|NCT00422058|101397313|FG001|NOT COMPLETED|Double-Blind, Week 0-20||10||
48764889|NCT03299166|102212060|FG001|Treated|Overall Study||122||
48764890|NCT03299166|102212059|FG000|Modified Intent-to- Treat (mITT) Participants|Overall Study||115|Modified intent-to-treat (mITT) participants in the randomization phase included randomized participants who received at least 1 dose of blinded study drug and provided a non-missing baseline assessment and at least 1 non-missing post-baseline efficacy assessment.|
48764891|NCT03299166|102212060|FG001|Modified Intent-to- Treat (mITT) Participants|Overall Study||117|Modified intent-to-treat (mITT) participants in the randomization phase included randomized participants who received at least 1 dose of blinded study drug and provided a non-missing baseline assessment and at least 1 non-missing post-baseline efficacy assessment.|
48764892|NCT03299166|102212059|FG000|COMPLETED|Overall Study||101||
48764893|NCT03299166|102212060|FG001|COMPLETED|Overall Study||109||
48764894|NCT03299166|102212059|FG000|NOT COMPLETED|Overall Study||23||
48764895|NCT03299166|102212060|FG001|NOT COMPLETED|Overall Study||15||
48434802|NCT00422058|101397314|FG002|NOT COMPLETED|Double-Blind, Week 0-20||16||
48434803|NCT00422058|101397315|FG003|NOT COMPLETED|Double-Blind, Week 0-20||20||
48434804|NCT00422058|101397316|FG004|NOT COMPLETED|Double-Blind, Week 0-20||11||
48434805|NCT00422058|101397317|FG005|NOT COMPLETED|Double-Blind, Week 0-20||16||
48764896|NCT00696072|102212061|FG000|STARTED|Overall Study||57||
48764897|NCT00696072|102212062|FG001|STARTED|Overall Study||63||
48764898|NCT00696072|102212061|FG000|COMPLETED|Overall Study||0||
48764899|NCT00696072|102212062|FG001|COMPLETED|Overall Study||0||
48764900|NCT00696072|102212061|FG000|NOT COMPLETED|Overall Study||57||
48764901|NCT00696072|102212062|FG001|NOT COMPLETED|Overall Study||63||
48764902|NCT02017405|102212063|FG000|STARTED|Two-day, Double-blind, Crossover Phase||9|Dosing errors occurred in six subjects during the double-blind, crossover phase. Four subjects assigned to 10g of SBI received 5g of SBI and two subjects assigned to 20g of SBI received 10g of SBI. An additional six subjects were added to the 2-day, double-blind, crossover phase to ensure \~12 subjects per SBI gram dosage group.|
48764903|NCT02017405|102212064|FG001|STARTED|Two-day, Double-blind, Crossover Phase||9|Dosing errors occurred in six subjects during the double-blind, crossover phase. Four subjects assigned to 10g of SBI received 5g of SBI and two subjects assigned to 20g of SBI received 10g of SBI. An additional six subjects were added to the 2-day, double-blind, crossover phase to ensure \~12 subjects per SBI gram dosage group.|
48764904|NCT02017405|102212065|FG002|STARTED|Two-day, Double-blind, Crossover Phase||7|Dosing errors occurred in six subjects during the double-blind, crossover phase. Four subjects assigned to 10g of SBI received 5g of SBI and two subjects assigned to 20g of SBI received 10g of SBI. An additional six subjects were added to the 2-day, double-blind, crossover phase to ensure \~12 subjects per SBI gram dosage group.|
48764905|NCT02017405|102212066|FG003|STARTED|Two-day, Double-blind, Crossover Phase||5|Dosing errors occurred in six subjects during the double-blind, crossover phase. Four subjects assigned to 10g of SBI received 5g of SBI and two subjects assigned to 20g of SBI received 10g of SBI. An additional six subjects were added to the 2-day, double-blind, crossover phase to ensure \~12 subjects per SBI gram dosage group.|
48764906|NCT02017405|102212067|FG004|STARTED|Two-day, Double-blind, Crossover Phase||5|Dosing errors occurred in six subjects during the double-blind, crossover phase. Four subjects assigned to 10g of SBI received 5g of SBI and two subjects assigned to 20g of SBI received 10g of SBI. An additional six subjects were added to the 2-day, double-blind, crossover phase to ensure \~12 subjects per SBI gram dosage group.|
48764907|NCT02017405|102212068|FG005|STARTED|Two-day, Double-blind, Crossover Phase||7|Dosing errors occurred in six subjects during the double-blind, crossover phase. Four subjects assigned to 10g of SBI received 5g of SBI and two subjects assigned to 20g of SBI received 10g of SBI. An additional six subjects were added to the 2-day, double-blind, crossover phase to ensure \~12 subjects per SBI gram dosage group.|
48764908|NCT02017405|102212063|FG000|COMPLETED|Two-day, Double-blind, Crossover Phase||9||
48764909|NCT02017405|102212064|FG001|COMPLETED|Two-day, Double-blind, Crossover Phase||9||
48764910|NCT02017405|102212065|FG002|COMPLETED|Two-day, Double-blind, Crossover Phase||7||
48764911|NCT02017405|102212066|FG003|COMPLETED|Two-day, Double-blind, Crossover Phase||5||
48764912|NCT02017405|102212067|FG004|COMPLETED|Two-day, Double-blind, Crossover Phase||5||
48764913|NCT02017405|102212068|FG005|COMPLETED|Two-day, Double-blind, Crossover Phase||6||
48764914|NCT02017405|102212063|FG000|NOT COMPLETED|Two-day, Double-blind, Crossover Phase||0||
48764915|NCT02017405|102212064|FG001|NOT COMPLETED|Two-day, Double-blind, Crossover Phase||0||
48764916|NCT02017405|102212065|FG002|NOT COMPLETED|Two-day, Double-blind, Crossover Phase||0||
48764917|NCT02017405|102212066|FG003|NOT COMPLETED|Two-day, Double-blind, Crossover Phase||0||
48764918|NCT02017405|102212067|FG004|NOT COMPLETED|Two-day, Double-blind, Crossover Phase||0||
48764919|NCT02017405|102212068|FG005|NOT COMPLETED|Two-day, Double-blind, Crossover Phase||1||
48764920|NCT02017405|102212063|FG000|STARTED|Open-label Phase||7|Dosing errors occurred in six subjects during the double-blind, crossover phase. These six subjects continued with the originally assigned dose of SBI for the 14-day, open-label phase of the study. This led to a difference in number of participants who completed phase 1 and started phase 2.|
48767782|NCT03863080|102222827|FG002|STARTED|Double-Blind Treatment Period (6 Weeks)||6||
48361684|NCT00970294|101214404|FG000|COMPLETED|Overall Study||6||
48361685|NCT00970294|101214404|FG000|NOT COMPLETED|Overall Study||5||
48361686|NCT00231062|101214405|FG000|STARTED|Overall Study||115||
48361687|NCT00231062|101214405|FG000|COMPLETED|Overall Study||109||
48361688|NCT00231062|101214405|FG000|NOT COMPLETED|Overall Study||6||
48361689|NCT02383719|101214406|FG000|STARTED|Overall Study||18||
48361690|NCT02383719|101214406|FG000|COMPLETED|Overall Study||18||
48361691|NCT02383719|101214406|FG000|NOT COMPLETED|Overall Study||0||
48361692|NCT00573131|101214407|FG000|STARTED|Overall Study||72||
48361693|NCT00573131|101214408|FG001|STARTED|Overall Study||65||
48361694|NCT00573131|101214407|FG000|COMPLETED|Overall Study||62||
48361695|NCT00573131|101214408|FG001|COMPLETED|Overall Study||57||
48361696|NCT00573131|101214407|FG000|NOT COMPLETED|Overall Study||10||
48361697|NCT00573131|101214408|FG001|NOT COMPLETED|Overall Study||8||
48642272|NCT01859741|101908483|FG003|NOT COMPLETED|Overall Study||3||
48361698|NCT00492921|101214409|FG000|STARTED|Overall Study||5||
48361699|NCT00492921|101214410|FG001|STARTED|Overall Study||4||
48361700|NCT00492921|101214411|FG002|STARTED|Overall Study||3||
48361701|NCT00492921|101214409|FG000|COMPLETED|Overall Study||4||
48361702|NCT00492921|101214410|FG001|COMPLETED|Overall Study||4||
48642273|NCT01859741|101908484|FG004|NOT COMPLETED|Overall Study||6||
48642274|NCT01859741|101908485|FG005|NOT COMPLETED|Overall Study||6||
48642275|NCT01859741|101908486|FG006|NOT COMPLETED|Overall Study||70||
48642276|NCT01859741|101908487|FG007|NOT COMPLETED|Overall Study||70||
48642277|NCT01257438|101908488|FG000|STARTED|Overall Study||132||
48642278|NCT01257438|101908489|FG001|STARTED|Overall Study||143||
48642279|NCT01257438|101908488|FG000|COMPLETED|Overall Study||102||
48642280|NCT01257438|101908489|FG001|COMPLETED|Overall Study||97||
48642281|NCT01257438|101908488|FG000|NOT COMPLETED|Overall Study||30||
48434806|NCT00422058|101397312|FG000|STARTED|Open-Label Extension, Week 20-104||79||
48434807|NCT00422058|101397313|FG001|STARTED|Open-Label Extension, Week 20-104||85||
48434808|NCT00422058|101397314|FG002|STARTED|Open-Label Extension, Week 20-104||74||
48434809|NCT00422058|101397315|FG003|STARTED|Open-Label Extension, Week 20-104||73||
48434810|NCT00422058|101397316|FG004|STARTED|Open-Label Extension, Week 20-104||82||
48434811|NCT00422058|101397317|FG005|STARTED|Open-Label Extension, Week 20-104||79||
48434812|NCT00422058|101397312|FG000|Enrolled in Extension|Open-Label Extension, Week 20-104||67||
48434813|NCT00422058|101397313|FG001|Enrolled in Extension|Open-Label Extension, Week 20-104||68||
48434814|NCT00422058|101397314|FG002|Enrolled in Extension|Open-Label Extension, Week 20-104||59||
48434815|NCT00422058|101397315|FG003|Enrolled in Extension|Open-Label Extension, Week 20-104||65||
48434816|NCT00422058|101397316|FG004|Enrolled in Extension|Open-Label Extension, Week 20-104||72||
48434817|NCT00422058|101397317|FG005|Enrolled in Extension|Open-Label Extension, Week 20-104||67||
48434818|NCT00422058|101397312|FG000|COMPLETED|Open-Label Extension, Week 20-104||47||
48434819|NCT00422058|101397313|FG001|COMPLETED|Open-Label Extension, Week 20-104||46||
48434820|NCT00422058|101397314|FG002|COMPLETED|Open-Label Extension, Week 20-104||38||
48434821|NCT00422058|101397315|FG003|COMPLETED|Open-Label Extension, Week 20-104||45||
48434822|NCT00422058|101397316|FG004|COMPLETED|Open-Label Extension, Week 20-104||47||
48434823|NCT00422058|101397317|FG005|COMPLETED|Open-Label Extension, Week 20-104||45||
48434824|NCT00422058|101397312|FG000|NOT COMPLETED|Open-Label Extension, Week 20-104||32||
48434825|NCT00422058|101397313|FG001|NOT COMPLETED|Open-Label Extension, Week 20-104||39||
48434826|NCT00422058|101397314|FG002|NOT COMPLETED|Open-Label Extension, Week 20-104||36||
48434827|NCT00422058|101397315|FG003|NOT COMPLETED|Open-Label Extension, Week 20-104||28||
48434828|NCT00422058|101397316|FG004|NOT COMPLETED|Open-Label Extension, Week 20-104||35||
48434829|NCT00422058|101397317|FG005|NOT COMPLETED|Open-Label Extension, Week 20-104||34||
48434830|NCT02842736|101397318|FG000|STARTED|Overall Study||242||
48434831|NCT02842736|101397318|FG000|Known Month 12 Outcome|Overall Study||230||
48434832|NCT02842736|101397318|FG000|24 Month Visit Performed|Overall Study||210||
48434833|NCT02842736|101397318|FG000|COMPLETED|Overall Study||201||
48434834|NCT02842736|101397318|FG000|NOT COMPLETED|Overall Study||41||
48434835|NCT04871451|101397319|FG000|STARTED|Overall Study||25||
48434836|NCT04871451|101397320|FG001|STARTED|Overall Study||17||
48434837|NCT04871451|101397321|FG002|STARTED|Overall Study||9||
48434838|NCT04871451|101397319|FG000|COMPLETED|Overall Study||18||
48434839|NCT04871451|101397320|FG001|COMPLETED|Overall Study||15||
48434840|NCT04871451|101397321|FG002|COMPLETED|Overall Study||7||
48434841|NCT04871451|101397319|FG000|NOT COMPLETED|Overall Study||7||
48434842|NCT04871451|101397320|FG001|NOT COMPLETED|Overall Study||2||
48434843|NCT04871451|101397321|FG002|NOT COMPLETED|Overall Study||2||
48434844|NCT03575806|101397322|FG000|STARTED|Overall Study||25||
48434845|NCT03575806|101397323|FG001|STARTED|Overall Study||27||
48434846|NCT03575806|101397322|FG000|COMPLETED|Overall Study||25||
48434847|NCT03575806|101397323|FG001|COMPLETED|Overall Study||23||
48434848|NCT03575806|101397322|FG000|NOT COMPLETED|Overall Study||0||
48434849|NCT03575806|101397323|FG001|NOT COMPLETED|Overall Study||4||
48434850|NCT04717323|101397324|FG000|STARTED|Overall Study||0||
48434851|NCT04717323|101397325|FG001|STARTED|Overall Study||10||
48434852|NCT04717323|101397324|FG000|COMPLETED|Overall Study||0||
48434853|NCT04717323|101397325|FG001|COMPLETED|Overall Study||10||
48434854|NCT04717323|101397324|FG000|NOT COMPLETED|Overall Study||0||
48434855|NCT04717323|101397325|FG001|NOT COMPLETED|Overall Study||0||
48434856|NCT02558634|101397326|FG000|STARTED|Blinded: First Intervention (3 Months)||4||
48434857|NCT02558634|101397327|FG001|STARTED|Blinded: First Intervention (3 Months)||2||
48434858|NCT02558634|101397326|FG000|COMPLETED|Blinded: First Intervention (3 Months)||4||
48434859|NCT02558634|101397327|FG001|COMPLETED|Blinded: First Intervention (3 Months)||2||
48434860|NCT02558634|101397326|FG000|NOT COMPLETED|Blinded: First Intervention (3 Months)||0||
48434861|NCT02558634|101397327|FG001|NOT COMPLETED|Blinded: First Intervention (3 Months)||0||
48434862|NCT02558634|101397326|FG000|STARTED|Blinded: Second Intervention (3 Months)||4||
48434863|NCT02558634|101397327|FG001|STARTED|Blinded: Second Intervention (3 Months)||2||
48434864|NCT02558634|101397326|FG000|COMPLETED|Blinded: Second Intervention (3 Months)||3||
48434865|NCT02558634|101397327|FG001|COMPLETED|Blinded: Second Intervention (3 Months)||2||
48434866|NCT02558634|101397326|FG000|NOT COMPLETED|Blinded: Second Intervention (3 Months)||1||
48434867|NCT02558634|101397327|FG001|NOT COMPLETED|Blinded: Second Intervention (3 Months)||0||
48434868|NCT02558634|101397326|FG000|STARTED|Unblinded: DBS on (6 Months)||4||
48434869|NCT02558634|101397327|FG001|STARTED|Unblinded: DBS on (6 Months)||2||
48434870|NCT02558634|101397326|FG000|COMPLETED|Unblinded: DBS on (6 Months)||4||
48434871|NCT02558634|101397327|FG001|COMPLETED|Unblinded: DBS on (6 Months)||2||
48434872|NCT02558634|101397326|FG000|NOT COMPLETED|Unblinded: DBS on (6 Months)||0||
48434873|NCT02558634|101397327|FG001|NOT COMPLETED|Unblinded: DBS on (6 Months)||0||
48434874|NCT01541644|101397328|FG000|STARTED|Overall Study||27||
48434875|NCT01541644|101397328|FG000|COMPLETED|Overall Study||24||
48434876|NCT01541644|101397328|FG000|NOT COMPLETED|Overall Study||3||
48434877|NCT03952377|101397329|FG000|STARTED|Overall Study||18||
48434878|NCT03952377|101397330|FG001|STARTED|Overall Study||21||
48434879|NCT03952377|101397331|FG002|STARTED|Overall Study||17||
48434880|NCT03952377|101397329|FG000|COMPLETED|Overall Study||16||
48434881|NCT03952377|101397330|FG001|COMPLETED|Overall Study||19||
48434882|NCT03952377|101397331|FG002|COMPLETED|Overall Study||16||
48434883|NCT03952377|101397329|FG000|NOT COMPLETED|Overall Study||2||
48434884|NCT03952377|101397330|FG001|NOT COMPLETED|Overall Study||2||
48434885|NCT03952377|101397331|FG002|NOT COMPLETED|Overall Study||1||
48434886|NCT03843775|101397332|FG000|STARTED|Overall Study||4||
48434887|NCT03843775|101397333|FG001|STARTED|Overall Study||13||
48434888|NCT03843775|101397332|FG000|COMPLETED|Overall Study||1||
48434889|NCT03843775|101397333|FG001|COMPLETED|Overall Study||5||
48434890|NCT03843775|101397332|FG000|NOT COMPLETED|Overall Study||3||
48434891|NCT03843775|101397333|FG001|NOT COMPLETED|Overall Study||8||
48434892|NCT02818582|101397334|FG000|STARTED|Overall Study||20||
48434893|NCT02818582|101397335|FG001|STARTED|Overall Study||18||
48434894|NCT02818582|101397334|FG000|COMPLETED|Overall Study||20||
48434895|NCT02818582|101397335|FG001|COMPLETED|Overall Study||18||
48434896|NCT02818582|101397334|FG000|NOT COMPLETED|Overall Study||0||
48434897|NCT02818582|101397335|FG001|NOT COMPLETED|Overall Study||0||
48434898|NCT00483574|101397336|FG000|STARTED|Overall Study||1053||
48434899|NCT00483574|101397337|FG001|STARTED|Overall Study||321||
48434900|NCT00483574|101397336|FG000|COMPLETED|Overall Study||951||
48434901|NCT00483574|101397337|FG001|COMPLETED|Overall Study||308||
48434902|NCT00483574|101397336|FG000|NOT COMPLETED|Overall Study||102||
48434903|NCT00483574|101397337|FG001|NOT COMPLETED|Overall Study||13||
48434904|NCT00544778|101397338|FG000|STARTED|Overall Study||7||
48434905|NCT00544778|101397338|FG000|COMPLETED|Overall Study||7||
48434906|NCT00544778|101397338|FG000|NOT COMPLETED|Overall Study||0||
48434907|NCT02920866|101397339|FG000|STARTED|Overall Study||45||
48434908|NCT02920866|101397340|FG001|STARTED|Overall Study||50||
48434909|NCT02920866|101397339|FG000|COMPLETED|Overall Study||41||
48434910|NCT02920866|101397340|FG001|COMPLETED|Overall Study||45||
48434911|NCT02920866|101397339|FG000|NOT COMPLETED|Overall Study||4||
48434912|NCT02920866|101397340|FG001|NOT COMPLETED|Overall Study||5||
48434913|NCT02057549|101397341|FG000|STARTED|Overall Study||18||
48434914|NCT02057549|101397342|FG001|STARTED|Overall Study||18||
48434915|NCT02057549|101397341|FG000|COMPLETED|Overall Study||15||
48434916|NCT02057549|101397342|FG001|COMPLETED|Overall Study||18||
48434917|NCT02057549|101397341|FG000|NOT COMPLETED|Overall Study||3||
48434918|NCT02057549|101397342|FG001|NOT COMPLETED|Overall Study||0||
48434919|NCT02777554|101397343|FG000|STARTED|Overall Study||62||
48434920|NCT02777554|101397344|FG001|STARTED|Overall Study||62||
48434921|NCT02777554|101397345|FG002|STARTED|Overall Study||5||
48434922|NCT02777554|101397346|FG003|STARTED|Overall Study||5||
48434923|NCT02777554|101397347|FG004|STARTED|Overall Study||5||
48434924|NCT02777554|101397348|FG005|STARTED|Overall Study||5||
48434925|NCT02777554|101397343|FG000|COMPLETED|Overall Study||32||
48434926|NCT02777554|101397344|FG001|COMPLETED|Overall Study||37||
48434927|NCT02777554|101397345|FG002|COMPLETED|Overall Study||4||
48434928|NCT02777554|101397346|FG003|COMPLETED|Overall Study||4||
48434929|NCT02777554|101397347|FG004|COMPLETED|Overall Study||5||
48434930|NCT02777554|101397348|FG005|COMPLETED|Overall Study||5||
48434931|NCT02777554|101397343|FG000|NOT COMPLETED|Overall Study||30||
48434932|NCT02777554|101397344|FG001|NOT COMPLETED|Overall Study||25||
48434933|NCT02777554|101397345|FG002|NOT COMPLETED|Overall Study||1||
48434934|NCT02777554|101397346|FG003|NOT COMPLETED|Overall Study||1||
48434935|NCT02777554|101397347|FG004|NOT COMPLETED|Overall Study||0||
48434936|NCT02777554|101397348|FG005|NOT COMPLETED|Overall Study||0||
48434937|NCT01714726|101399901|FG000|STARTED|Double-Blinded Induction Period||60||
48434938|NCT01714726|101399902|FG001|STARTED|Double-Blinded Induction Period||59||
48434939|NCT01714726|101399903|FG002|STARTED|Double-Blinded Induction Period||0||
48434940|NCT01714726|101399904|FG003|STARTED|Double-Blinded Induction Period||0||
48434941|NCT01714726|101399901|FG000|COMPLETED|Double-Blinded Induction Period||52||
48434942|NCT01714726|101399902|FG001|COMPLETED|Double-Blinded Induction Period||52||
48434943|NCT01714726|101399903|FG002|COMPLETED|Double-Blinded Induction Period||0||
48434944|NCT01714726|101399904|FG003|COMPLETED|Double-Blinded Induction Period||0||
48434945|NCT01714726|101399901|FG000|NOT COMPLETED|Double-Blinded Induction Period||8||
48434946|NCT01714726|101399902|FG001|NOT COMPLETED|Double-Blinded Induction Period||7||
48767783|NCT03863080|102222828|FG003|STARTED|Double-Blind Treatment Period (6 Weeks)||0||
48767784|NCT03863080|102222825|FG000|COMPLETED|Double-Blind Treatment Period (6 Weeks)||6||
48767785|NCT03863080|102222826|FG001|COMPLETED|Double-Blind Treatment Period (6 Weeks)||5||
48434947|NCT01714726|101399903|FG002|NOT COMPLETED|Double-Blinded Induction Period||0||
48434948|NCT01714726|101399904|FG003|NOT COMPLETED|Double-Blinded Induction Period||0||
48434949|NCT01714726|101399901|FG000|STARTED|Open-Label Period||0||
48434950|NCT01714726|101399902|FG001|STARTED|Open-Label Period||0||
48434951|NCT01714726|101399903|FG002|STARTED|Open-Label Period||52||
48434952|NCT01714726|101399904|FG003|STARTED|Open-Label Period||52||
48434953|NCT01714726|101399901|FG000|COMPLETED|Open-Label Period||0||
48434954|NCT01714726|101399902|FG001|COMPLETED|Open-Label Period||0||
48434955|NCT01714726|101399903|FG002|COMPLETED|Open-Label Period||33||
48434956|NCT01714726|101399904|FG003|COMPLETED|Open-Label Period||24||
48434957|NCT01714726|101399901|FG000|NOT COMPLETED|Open-Label Period||0||
48434958|NCT01714726|101399902|FG001|NOT COMPLETED|Open-Label Period||0||
48434959|NCT01714726|101399903|FG002|NOT COMPLETED|Open-Label Period||19||
48434960|NCT01714726|101399904|FG003|NOT COMPLETED|Open-Label Period||28||
48434961|NCT02946515|101399905|FG000|STARTED|Overall Study||22||
48434962|NCT02946515|101399906|FG001|STARTED|Overall Study||22||
48434963|NCT02946515|101399905|FG000|COMPLETED|Overall Study||20||
48434964|NCT02946515|101399906|FG001|COMPLETED|Overall Study||21||
48434965|NCT02946515|101399905|FG000|NOT COMPLETED|Overall Study||2||
48434966|NCT02946515|101399906|FG001|NOT COMPLETED|Overall Study||1||
48434967|NCT00661037|101399907|FG000|STARTED|Overall Study||836||
48434968|NCT00661037|101399908|FG001|STARTED|Overall Study||1284||
48434969|NCT00661037|101399907|FG000|Witdrawn|Overall Study||47||
48434970|NCT00661037|101399908|FG001|Witdrawn|Overall Study||68||
48434971|NCT00661037|101399907|FG000|Deaths|Overall Study||108||
48434972|NCT00661037|101399908|FG001|Deaths|Overall Study||188||
48434973|NCT00661037|101399907|FG000|COMPLETED|Overall Study||682||
48434974|NCT00661037|101399908|FG001|COMPLETED|Overall Study||1027||
48434975|NCT00661037|101399907|FG000|NOT COMPLETED|Overall Study||154||
48434976|NCT00661037|101399908|FG001|NOT COMPLETED|Overall Study||257||
48434977|NCT02203604|101399909|FG000|STARTED|Overall Study||9||
48434978|NCT02203604|101399909|FG000|COMPLETED|Overall Study||9||
48434979|NCT02203604|101399909|FG000|NOT COMPLETED|Overall Study||0||
48434980|NCT03226366|101399910|FG000|STARTED|Overall Study||911||
48434981|NCT03226366|101399911|FG001|STARTED|Overall Study||495||
48434982|NCT03226366|101399912|FG002|STARTED|Overall Study||1183||
48434983|NCT03226366|101399913|FG003|STARTED|Overall Study||641||
48434984|NCT03226366|101399910|FG000|COMPLETED|Overall Study||911||
48434985|NCT03226366|101399911|FG001|COMPLETED|Overall Study||495||
48434986|NCT03226366|101399912|FG002|COMPLETED|Overall Study||1183||
48434987|NCT03226366|101399913|FG003|COMPLETED|Overall Study||641||
48434988|NCT03226366|101399910|FG000|NOT COMPLETED|Overall Study||0||
48434989|NCT03226366|101399911|FG001|NOT COMPLETED|Overall Study||0||
48434990|NCT03226366|101399912|FG002|NOT COMPLETED|Overall Study||0||
48434991|NCT03226366|101399913|FG003|NOT COMPLETED|Overall Study||0||
48434992|NCT00994123|101399914|FG000|STARTED|Overall Study||33||
48434993|NCT00994123|101399915|FG001|STARTED|Overall Study||85||
48434994|NCT00994123|101399916|FG002|STARTED|Overall Study||44||
48434995|NCT00994123|101399914|FG000|COMPLETED|Overall Study||33||
48434996|NCT00994123|101399915|FG001|COMPLETED|Overall Study||85||
48434997|NCT00994123|101399916|FG002|COMPLETED|Overall Study||44||
48434998|NCT00994123|101399914|FG000|NOT COMPLETED|Overall Study||0||
48434999|NCT00994123|101399915|FG001|NOT COMPLETED|Overall Study||0||
48435000|NCT00994123|101399916|FG002|NOT COMPLETED|Overall Study||0||
48435001|NCT00094900|101399917|FG000|STARTED|Overall Study||11||
48435002|NCT00094900|101399917|FG000|COMPLETED|Overall Study||10||
48435003|NCT00094900|101399917|FG000|NOT COMPLETED|Overall Study||1||
48435004|NCT00122954|101399918|FG000|STARTED|Overall Study||18||
48435005|NCT00122954|101399919|FG001|STARTED|Overall Study||21||
48435006|NCT00122954|101399918|FG000|COMPLETED|Overall Study||16||
48435007|NCT00122954|101399919|FG001|COMPLETED|Overall Study||18||
48435008|NCT00122954|101399918|FG000|NOT COMPLETED|Overall Study||2||
48435009|NCT00122954|101399919|FG001|NOT COMPLETED|Overall Study||3||
48435010|NCT00308555|101399920|FG000|STARTED|Overall Study||13||
48435011|NCT00308555|101399921|FG001|STARTED|Overall Study||11||
48435012|NCT00308555|101399920|FG000|COMPLETED|Overall Study||10||
48435013|NCT00308555|101399921|FG001|COMPLETED|Overall Study||11||
48435014|NCT00308555|101399920|FG000|NOT COMPLETED|Overall Study||3||
48435015|NCT00308555|101399921|FG001|NOT COMPLETED|Overall Study||0||
48435016|NCT00625846|101399922|FG000|STARTED|Overall Study||39||
48435017|NCT00625846|101399923|FG001|STARTED|Overall Study||35||
48435018|NCT00625846|101399924|FG002|STARTED|Overall Study||16||
48435019|NCT00625846|101399925|FG003|STARTED|Overall Study||62||
48435020|NCT00625846|101399922|FG000|COMPLETED|Overall Study||37||
48435021|NCT00625846|101399923|FG001|COMPLETED|Overall Study||35||
48435022|NCT00625846|101399924|FG002|COMPLETED|Overall Study||15||
48764921|NCT02017405|102212064|FG001|STARTED|Open-label Phase||7|Dosing errors occurred in six subjects during the double-blind, crossover phase. These six subjects continued with the originally assigned dose of SBI for the 14-day, open-label phase of the study. This led to a difference in number of participants who completed phase 1 and started phase 2.|
48767786|NCT03863080|102222827|FG002|COMPLETED|Double-Blind Treatment Period (6 Weeks)||5||
48435023|NCT00625846|101399925|FG003|COMPLETED|Overall Study||60||
48435024|NCT00625846|101399922|FG000|NOT COMPLETED|Overall Study||2||
48435025|NCT00625846|101399923|FG001|NOT COMPLETED|Overall Study||0||
48435026|NCT00625846|101399924|FG002|NOT COMPLETED|Overall Study||1||
48435027|NCT00625846|101399925|FG003|NOT COMPLETED|Overall Study||2||
48435028|NCT01250418|101399926|FG000|STARTED|Overall Study||9||
48435029|NCT01250418|101399927|FG001|STARTED|Overall Study||16||
48435030|NCT01250418|101399926|FG000|COMPLETED|Overall Study||8||
48435031|NCT01250418|101399927|FG001|COMPLETED|Overall Study||15||
48435032|NCT01250418|101399926|FG000|NOT COMPLETED|Overall Study||1||
48435033|NCT01250418|101399927|FG001|NOT COMPLETED|Overall Study||1||
48435034|NCT01018680|101399928|FG000|STARTED|Overall Study||260||
48435035|NCT01018680|101399929|FG001|STARTED|Overall Study||264||
48435036|NCT01018680|101399928|FG000|COMPLETED|Overall Study||199||
48435037|NCT01018680|101399929|FG001|COMPLETED|Overall Study||189||
48435038|NCT01018680|101399928|FG000|NOT COMPLETED|Overall Study||61||
48435039|NCT01018680|101399929|FG001|NOT COMPLETED|Overall Study||75||
48435040|NCT00869362|101399930|FG000|STARTED|Overall Study||15||
48764922|NCT02017405|102212065|FG002|STARTED|Open-label Phase||7|Dosing errors occurred in six subjects during the double-blind, crossover phase. These six subjects continued with the originally assigned dose of SBI for the 14-day, open-label phase of the study. This led to a difference in number of participants who completed phase 1 and started phase 2.|
48764923|NCT02017405|102212066|FG003|STARTED|Open-label Phase||7|Dosing errors occurred in six subjects during the double-blind, crossover phase. These six subjects continued with the originally assigned dose of SBI for the 14-day, open-label phase of the study. This led to a difference in number of participants who completed phase 1 and started phase 2.|
48764924|NCT02017405|102212067|FG004|STARTED|Open-label Phase||7|Dosing errors occurred in six subjects during the double-blind, crossover phase. These six subjects continued with the originally assigned dose of SBI for the 14-day, open-label phase of the study. This led to a difference in number of participants who completed phase 1 and started phase 2.|
48764925|NCT02017405|102212068|FG005|STARTED|Open-label Phase||6|Dosing errors occurred in six subjects during the double-blind, crossover phase. These six subjects continued with the originally assigned dose of SBI for the 14-day, open-label phase of the study. This led to a difference in number of participants who completed phase 1 and started phase 2.|
48764926|NCT02017405|102212063|FG000|COMPLETED|Open-label Phase||6||
48764927|NCT02017405|102212064|FG001|COMPLETED|Open-label Phase||6||
48764928|NCT02017405|102212065|FG002|COMPLETED|Open-label Phase||7||
48764929|NCT02017405|102212066|FG003|COMPLETED|Open-label Phase||7||
48764930|NCT02017405|102212067|FG004|COMPLETED|Open-label Phase||7||
48764931|NCT02017405|102212068|FG005|COMPLETED|Open-label Phase||6||
48764932|NCT02017405|102212063|FG000|NOT COMPLETED|Open-label Phase||1||
48764933|NCT02017405|102212064|FG001|NOT COMPLETED|Open-label Phase||1||
48764934|NCT02017405|102212065|FG002|NOT COMPLETED|Open-label Phase||0||
48764935|NCT02017405|102212066|FG003|NOT COMPLETED|Open-label Phase||0||
48764936|NCT02017405|102212067|FG004|NOT COMPLETED|Open-label Phase||0||
48361703|NCT00492921|101214411|FG002|COMPLETED|Overall Study||2||
48361704|NCT00492921|101214409|FG000|NOT COMPLETED|Overall Study||1||
48361705|NCT00492921|101214410|FG001|NOT COMPLETED|Overall Study||0||
48361706|NCT00492921|101214411|FG002|NOT COMPLETED|Overall Study||1||
48361707|NCT01765647|101214412|FG000|STARTED|Overall Study||10||
48361708|NCT01765647|101214412|FG000|COMPLETED|Overall Study||10||
48361709|NCT01765647|101214412|FG000|NOT COMPLETED|Overall Study||0||
48361710|NCT00779038|101214413|FG000|STARTED|Overall Study||13||
48361711|NCT00779038|101214413|FG000|COMPLETED|Overall Study||0||
48361712|NCT00779038|101214413|FG000|NOT COMPLETED|Overall Study||13||
48361713|NCT03366844|101214414|FG000|STARTED|Overall Study||66||
48361714|NCT03366844|101214414|FG000|Phase 1b|Overall Study||10||
48361715|NCT03366844|101214414|FG000|Phase II|Overall Study||50||
48361716|NCT03366844|101214414|FG000|COMPLETED|Overall Study||60||
48361717|NCT03366844|101214414|FG000|NOT COMPLETED|Overall Study||6||
48361718|NCT00537940|101214415|FG000|STARTED|Overall Study||241||
48361719|NCT00537940|101214416|FG001|STARTED|Overall Study||241||
48361720|NCT00537940|101214415|FG000|Completed Titration Phase|Overall Study||213||
48361721|NCT00537940|101214416|FG001|Completed Titration Phase|Overall Study||210||
48361722|NCT00537940|101214415|FG000|Completed Maintenance Phase|Overall Study||187||
48361723|NCT00537940|101214416|FG001|Completed Maintenance Phase|Overall Study||172||
48361724|NCT00537940|101214415|FG000|Entered Opt Blinded Continuation Phase|Overall Study||140||
48361725|NCT00537940|101214416|FG001|Entered Opt Blinded Continuation Phase|Overall Study||139||
48642282|NCT01257438|101908489|FG001|NOT COMPLETED|Overall Study||46||
48642283|NCT00421993|101908490|FG000|STARTED|Overall Study||419||
48642284|NCT00421993|101908491|FG001|STARTED|Overall Study||418||
48642285|NCT00421993|101908492|FG002|STARTED|Overall Study||415||
48642286|NCT00421993|101908493|FG003|STARTED|Overall Study||418||
48642287|NCT00421993|101908490|FG000|COMPLETED|Overall Study||366||
48642288|NCT00421993|101908491|FG001|COMPLETED|Overall Study||369||
48642289|NCT00421993|101908492|FG002|COMPLETED|Overall Study||363||
48642290|NCT00421993|101908493|FG003|COMPLETED|Overall Study||361||
48642291|NCT00421993|101908490|FG000|NOT COMPLETED|Overall Study||53||
48642292|NCT00421993|101908491|FG001|NOT COMPLETED|Overall Study||49||
48642293|NCT00421993|101908492|FG002|NOT COMPLETED|Overall Study||52||
48642294|NCT00421993|101908493|FG003|NOT COMPLETED|Overall Study||57||
48642295|NCT04022694|101908494|FG000|STARTED|Overall Study||167||
48642296|NCT04022694|101908495|FG001|STARTED|Overall Study||145||
48361726|NCT00537940|101214415|FG000|COMPLETED|Overall Study||58||
48361727|NCT00537940|101214416|FG001|COMPLETED|Overall Study||62||
48361728|NCT00537940|101214415|FG000|NOT COMPLETED|Overall Study||183||
48361729|NCT00537940|101214416|FG001|NOT COMPLETED|Overall Study||179||
48361730|NCT00537745|101214417|FG000|STARTED|Overall Study||14||
48361731|NCT00537745|101214417|FG000|Began Intervention|Overall Study||11||
48361732|NCT00537745|101214417|FG000|COMPLETED|Overall Study||9||
48361733|NCT00537745|101214417|FG000|NOT COMPLETED|Overall Study||5||
48361734|NCT02973815|101214418|FG000|STARTED|Post Intervention||116||
48361735|NCT02973815|101214419|FG001|STARTED|Post Intervention||112||
48361736|NCT02973815|101214418|FG000|COMPLETED|Post Intervention||108||
48361737|NCT02973815|101214419|FG001|COMPLETED|Post Intervention||88||
48361738|NCT02973815|101214418|FG000|NOT COMPLETED|Post Intervention||8||
48361739|NCT02973815|101214419|FG001|NOT COMPLETED|Post Intervention||24||
48361740|NCT02973815|101214418|FG000|STARTED|Follow-up||108||
48361741|NCT02973815|101214419|FG001|STARTED|Follow-up||88||
48361742|NCT02973815|101214418|FG000|COMPLETED|Follow-up||106||
48642297|NCT04022694|101908496|FG002|STARTED|Overall Study||143||
48435041|NCT00869362|101399931|FG001|STARTED|Overall Study||16||
48435042|NCT00869362|101399930|FG000|COMPLETED|Overall Study||14||
48435043|NCT00869362|101399931|FG001|COMPLETED|Overall Study||11||
48435044|NCT00869362|101399930|FG000|NOT COMPLETED|Overall Study||1||
48435045|NCT00869362|101399931|FG001|NOT COMPLETED|Overall Study||5||
48435046|NCT03919669|101399932|FG000|STARTED|Overall Study||6||
48435047|NCT03919669|101399933|FG001|STARTED|Overall Study||8||
48435048|NCT03919669|101399934|FG002|STARTED|Overall Study||13||
48435049|NCT03919669|101399932|FG000|COMPLETED|Overall Study||5||
48435050|NCT03919669|101399933|FG001|COMPLETED|Overall Study||8||
48435051|NCT03919669|101399934|FG002|COMPLETED|Overall Study||13||
48435052|NCT03919669|101399932|FG000|NOT COMPLETED|Overall Study||1||
48435053|NCT03919669|101399933|FG001|NOT COMPLETED|Overall Study||0||
48435054|NCT03919669|101399934|FG002|NOT COMPLETED|Overall Study||0||
48435055|NCT01281475|101399935|FG000|STARTED|Overall Study||33||
48435056|NCT01281475|101399936|FG001|STARTED|Overall Study||34||
48435057|NCT01281475|101399935|FG000|COMPLETED|Overall Study||29||
48435058|NCT01281475|101399936|FG001|COMPLETED|Overall Study||26||
48435059|NCT01281475|101399935|FG000|NOT COMPLETED|Overall Study||4||
48435060|NCT01281475|101399936|FG001|NOT COMPLETED|Overall Study||8||
48435061|NCT01055184|101399937|FG000|STARTED|Overall Study||34||
48435062|NCT01055184|101399937|FG000|COMPLETED|Overall Study||34||
48435063|NCT01055184|101399937|FG000|NOT COMPLETED|Overall Study||0||
48435064|NCT03986216|101399938|FG000|STARTED|Overall Study||3||
48435065|NCT03986216|101399938|FG000|COMPLETED|Overall Study||3||
48435066|NCT03986216|101399938|FG000|NOT COMPLETED|Overall Study||0||
48435067|NCT00937859|101399939|FG000|STARTED|Overall Study||148||
48435068|NCT00937859|101399940|FG001|STARTED|Overall Study||153||
48435069|NCT00937859|101399939|FG000|COMPLETED|Overall Study||129||
48435070|NCT00937859|101399940|FG001|COMPLETED|Overall Study||134||
48435071|NCT00937859|101399939|FG000|NOT COMPLETED|Overall Study||19||
48435072|NCT00937859|101399940|FG001|NOT COMPLETED|Overall Study||19||
48435073|NCT00564876|101399941|FG000|STARTED|Overall Study||2||
48435074|NCT00564876|101399941|FG000|COMPLETED|Overall Study||2||
48435075|NCT00564876|101399941|FG000|NOT COMPLETED|Overall Study||0||
48435076|NCT00219349|101399942|FG000|STARTED|Cognitive Behavioral Therapy Phase||25||
48435077|NCT00219349|101399942|FG000|COMPLETED|Cognitive Behavioral Therapy Phase||15||
48435078|NCT00219349|101399942|FG000|NOT COMPLETED|Cognitive Behavioral Therapy Phase||10||
48435079|NCT00219349|101399942|FG000|STARTED|Escitalopram Phase||7||
48435080|NCT00219349|101399942|FG000|COMPLETED|Escitalopram Phase||4||
48435081|NCT00219349|101399942|FG000|NOT COMPLETED|Escitalopram Phase||3||
48435082|NCT01465048|101399943|FG000|STARTED|Overall Study||6||
48435083|NCT01465048|101399944|FG001|STARTED|Overall Study||6||
48435084|NCT01465048|101399945|FG002|STARTED|Overall Study||6||
48435085|NCT01465048|101399943|FG000|COMPLETED|Overall Study||6||
48435086|NCT01465048|101399944|FG001|COMPLETED|Overall Study||6||
48435087|NCT01465048|101399945|FG002|COMPLETED|Overall Study||6||
48435088|NCT01465048|101399943|FG000|NOT COMPLETED|Overall Study||0||
48435089|NCT01465048|101399944|FG001|NOT COMPLETED|Overall Study||0||
48435090|NCT01465048|101399945|FG002|NOT COMPLETED|Overall Study||0||
48435091|NCT00398476|101399946|FG000|STARTED|Treatment Period 1||63||
48435092|NCT00398476|101399947|FG001|STARTED|Treatment Period 1||64||
48435093|NCT00398476|101399946|FG000|COMPLETED|Treatment Period 1||63||
48435094|NCT00398476|101399947|FG001|COMPLETED|Treatment Period 1||64||
48435095|NCT00398476|101399946|FG000|NOT COMPLETED|Treatment Period 1||0||
48435096|NCT00398476|101399947|FG001|NOT COMPLETED|Treatment Period 1||0||
48435097|NCT00398476|101399946|FG000|STARTED|Washout Period (20 Minutes)||63||
48435098|NCT00398476|101399947|FG001|STARTED|Washout Period (20 Minutes)||64||
48435099|NCT00398476|101399946|FG000|COMPLETED|Washout Period (20 Minutes)||63||
48435100|NCT00398476|101399947|FG001|COMPLETED|Washout Period (20 Minutes)||64||
48435101|NCT00398476|101399946|FG000|NOT COMPLETED|Washout Period (20 Minutes)||0||
48435102|NCT00398476|101399947|FG001|NOT COMPLETED|Washout Period (20 Minutes)||0||
48435103|NCT00398476|101399946|FG000|STARTED|Treatment Period 2||63||
48435104|NCT00398476|101399947|FG001|STARTED|Treatment Period 2||64||
48435105|NCT00398476|101399946|FG000|COMPLETED|Treatment Period 2||63||
48435106|NCT00398476|101399947|FG001|COMPLETED|Treatment Period 2||64||
48435107|NCT00398476|101399946|FG000|NOT COMPLETED|Treatment Period 2||0||
48435108|NCT00398476|101399947|FG001|NOT COMPLETED|Treatment Period 2||0||
48435109|NCT01852669|101399948|FG000|STARTED|Overall Study||71||
48435110|NCT01852669|101399949|FG001|STARTED|Overall Study||69||
48435111|NCT01852669|101399948|FG000|COMPLETED|Overall Study||71||
48642298|NCT04022694|101908497|FG003|STARTED|Overall Study||173||
48435112|NCT01852669|101399949|FG001|COMPLETED|Overall Study||68||
48435113|NCT01852669|101399948|FG000|NOT COMPLETED|Overall Study||0||
48435114|NCT01852669|101399949|FG001|NOT COMPLETED|Overall Study||1||
48435115|NCT01685320|101399950|FG000|STARTED|Overall Study||15||
48435116|NCT01685320|101399951|FG001|STARTED|Overall Study||15||
48435117|NCT01685320|101399950|FG000|COMPLETED|Overall Study||15||
48435118|NCT01685320|101399951|FG001|COMPLETED|Overall Study||15||
48435119|NCT01685320|101399950|FG000|NOT COMPLETED|Overall Study||0||
48642299|NCT04022694|101908494|FG000|COMPLETED|Overall Study||167||
48435120|NCT01685320|101399951|FG001|NOT COMPLETED|Overall Study||0||
48435121|NCT01976104|101399952|FG000|STARTED|Overall Study||43||
48435122|NCT01976104|101399953|FG001|STARTED|Overall Study||70||
48435123|NCT01976104|101399954|FG002|STARTED|Overall Study||33||
48435124|NCT01976104|101399955|FG003|STARTED|Overall Study||58||
48435125|NCT01976104|101399952|FG000|COMPLETED|Overall Study||37||
48435126|NCT01976104|101399953|FG001|COMPLETED|Overall Study||68||
48435127|NCT01976104|101399954|FG002|COMPLETED|Overall Study||31||
48435128|NCT01976104|101399955|FG003|COMPLETED|Overall Study||55||
48435129|NCT01976104|101399952|FG000|NOT COMPLETED|Overall Study||6||
48435130|NCT01976104|101399953|FG001|NOT COMPLETED|Overall Study||2||
48435131|NCT01976104|101399954|FG002|NOT COMPLETED|Overall Study||2||
48435132|NCT01976104|101399955|FG003|NOT COMPLETED|Overall Study||3||
48435133|NCT03155269|101399956|FG000|STARTED|Overall Study||57||
48435134|NCT03155269|101399957|FG001|STARTED|Overall Study||57||
48435135|NCT03155269|101399956|FG000|COMPLETED|Overall Study||52||
48361743|NCT02973815|101214419|FG001|COMPLETED|Follow-up||88||
48361744|NCT02973815|101214418|FG000|NOT COMPLETED|Follow-up||2||
48361745|NCT02973815|101214419|FG001|NOT COMPLETED|Follow-up||0||
48361746|NCT02698423|101214420|FG000|STARTED|Overall Study||336||
48642300|NCT04022694|101908495|FG001|COMPLETED|Overall Study||145||
48642301|NCT04022694|101908496|FG002|COMPLETED|Overall Study||143||
48642302|NCT04022694|101908497|FG003|COMPLETED|Overall Study||173||
48361747|NCT02698423|101214421|FG001|STARTED|Overall Study||331||
48361748|NCT02698423|101214420|FG000|COMPLETED|Overall Study||317||
48361749|NCT02698423|101214421|FG001|COMPLETED|Overall Study||307||
48361750|NCT02698423|101214420|FG000|NOT COMPLETED|Overall Study||19||
48361751|NCT02698423|101214421|FG001|NOT COMPLETED|Overall Study||24||
48435136|NCT03155269|101399957|FG001|COMPLETED|Overall Study||50||
48435137|NCT03155269|101399956|FG000|NOT COMPLETED|Overall Study||5||
48435138|NCT03155269|101399957|FG001|NOT COMPLETED|Overall Study||7||
48435139|NCT03733301|101399958|FG000|STARTED|Overall Study||109||
48435140|NCT03733301|101399959|FG001|STARTED|Overall Study||109||
48361752|NCT01408537|101214422|FG000|STARTED|Overall Study||152||
48361753|NCT01408537|101214422|FG000|COMPLETED|Overall Study||144||
48361754|NCT01408537|101214422|FG000|NOT COMPLETED|Overall Study||8||
48361755|NCT04957498|101214423|FG000|STARTED|Overall Study||20||
48361756|NCT04957498|101214424|FG001|STARTED|Overall Study||20||
48361757|NCT04957498|101214423|FG000|COMPLETED|Overall Study||19||
48361758|NCT04957498|101214424|FG001|COMPLETED|Overall Study||18||
48361759|NCT04957498|101214423|FG000|NOT COMPLETED|Overall Study||1||
48361760|NCT04957498|101214424|FG001|NOT COMPLETED|Overall Study||2||
48361761|NCT01645280|101214425|FG000|STARTED|Overall Study||55||
48361762|NCT01645280|101214426|FG001|STARTED|Overall Study||54||
48361763|NCT01645280|101214427|FG002|STARTED|Overall Study||55||
48361764|NCT01645280|101214428|FG003|STARTED|Overall Study||54||
48361765|NCT01645280|101214429|FG004|STARTED|Overall Study||55||
48361766|NCT01645280|101214425|FG000|COMPLETED|Overall Study||49||
48361767|NCT01645280|101214426|FG001|COMPLETED|Overall Study||51||
48361768|NCT01645280|101214427|FG002|COMPLETED|Overall Study||49||
48361769|NCT01645280|101214428|FG003|COMPLETED|Overall Study||48||
48361770|NCT01645280|101214429|FG004|COMPLETED|Overall Study||47||
48361771|NCT01645280|101214425|FG000|NOT COMPLETED|Overall Study||6||
48361772|NCT01645280|101214426|FG001|NOT COMPLETED|Overall Study||3||
48361773|NCT01645280|101214427|FG002|NOT COMPLETED|Overall Study||6||
48361774|NCT01645280|101214428|FG003|NOT COMPLETED|Overall Study||6||
48435141|NCT03733301|101399960|FG002|STARTED|Overall Study||111||
48435142|NCT03733301|101399958|FG000|Received One Dose of Study Drug|Overall Study||108||
48435143|NCT03733301|101399959|FG001|Received One Dose of Study Drug|Overall Study||109||
48642303|NCT04022694|101908494|FG000|NOT COMPLETED|Overall Study||0||
48642304|NCT04022694|101908495|FG001|NOT COMPLETED|Overall Study||0||
48642305|NCT04022694|101908496|FG002|NOT COMPLETED|Overall Study||0||
48642306|NCT04022694|101908497|FG003|NOT COMPLETED|Overall Study||0||
48642307|NCT05370326|101908498|FG000|STARTED|Overall Study||36||
48642308|NCT05370326|101908499|FG001|STARTED|Overall Study||16||
48642309|NCT05370326|101908498|FG000|Complete Clinical Data|Overall Study||36||
48642310|NCT05370326|101908499|FG001|Complete Clinical Data|Overall Study||16||
48642311|NCT05370326|101908498|FG000|Complete Self Report Data|Overall Study||31||
48642312|NCT05370326|101908499|FG001|Complete Self Report Data|Overall Study||14||
48642313|NCT05370326|101908498|FG000|COMPLETED|Overall Study||36||
48642314|NCT05370326|101908499|FG001|COMPLETED|Overall Study||16||
48642315|NCT05370326|101908498|FG000|NOT COMPLETED|Overall Study||0||
48642316|NCT05370326|101908499|FG001|NOT COMPLETED|Overall Study||0||
48642317|NCT02626611|101908500|FG000|STARTED|Overall Study||20||
48642318|NCT02626611|101908501|FG001|STARTED|Overall Study||21||
48642319|NCT02626611|101908502|FG002|STARTED|Overall Study||19||
48361775|NCT01645280|101214429|FG004|NOT COMPLETED|Overall Study||8||
48361776|NCT03870022|101214430|FG000|STARTED|Overall Study||70||
48361777|NCT03870022|101214430|FG000|COMPLETED|Overall Study||70||
48361778|NCT03870022|101214430|FG000|NOT COMPLETED|Overall Study||0||
48361779|NCT02961764|101214431|FG000|STARTED|Overall Study||160||
48361780|NCT02961764|101214432|FG001|STARTED|Overall Study||153||
48361781|NCT02961764|101214431|FG000|COMPLETED|Overall Study||121||
48435144|NCT03733301|101399960|FG002|Received One Dose of Study Drug|Overall Study||111||
48642320|NCT02626611|101908500|FG000|COMPLETED|Overall Study||16||
48435145|NCT03733301|101399958|FG000|COMPLETED|Overall Study||102||
48435146|NCT03733301|101399959|FG001|COMPLETED|Overall Study||100||
48435147|NCT03733301|101399960|FG002|COMPLETED|Overall Study||107||
48435148|NCT03733301|101399958|FG000|NOT COMPLETED|Overall Study||7||
48435149|NCT03733301|101399959|FG001|NOT COMPLETED|Overall Study||9||
48435150|NCT03733301|101399960|FG002|NOT COMPLETED|Overall Study||4||
48435151|NCT02249065|101399961|FG000|STARTED|Overall Study||205||
48435152|NCT02249065|101399961|FG000|Treated|Overall Study||181||
48435153|NCT02249065|101399961|FG000|COMPLETED|Overall Study||176||
48435154|NCT02249065|101399961|FG000|NOT COMPLETED|Overall Study||29||
48435155|NCT00104858|101399962|FG000|STARTED|Overall Study||52||
48435156|NCT00104858|101399962|FG000|COMPLETED|Overall Study||52||
48435157|NCT00104858|101399962|FG000|NOT COMPLETED|Overall Study||0||
48435158|NCT01646268|101399963|FG000|STARTED|Overall Study||124||
48435159|NCT01646268|101399964|FG001|STARTED|Overall Study||123||
48435160|NCT01646268|101399963|FG000|COMPLETED|Overall Study||113||
48435161|NCT01646268|101399964|FG001|COMPLETED|Overall Study||107||
48435162|NCT01646268|101399963|FG000|NOT COMPLETED|Overall Study||11||
48435163|NCT01646268|101399964|FG001|NOT COMPLETED|Overall Study||16||
48435164|NCT03866811|101399965|FG000|STARTED|Overall Study||72||
48435165|NCT03866811|101399966|FG001|STARTED|Overall Study||74||
48435166|NCT03866811|101399965|FG000|COMPLETED|Overall Study||59||
48435167|NCT03866811|101399966|FG001|COMPLETED|Overall Study||64||
48435168|NCT03866811|101399965|FG000|NOT COMPLETED|Overall Study||13||
48435169|NCT03866811|101399966|FG001|NOT COMPLETED|Overall Study||10||
48435170|NCT04882085|101399967|FG000|STARTED|Overall Study||31||
48435171|NCT04882085|101399968|FG001|STARTED|Overall Study||29||
48435172|NCT04882085|101399967|FG000|Safety Analysis Set|Overall Study||30||
48435173|NCT04882085|101399968|FG001|Safety Analysis Set|Overall Study||29||
48435174|NCT04882085|101399967|FG000|COMPLETED|Overall Study||24||
48435175|NCT04882085|101399968|FG001|COMPLETED|Overall Study||17||
48435176|NCT04882085|101399967|FG000|NOT COMPLETED|Overall Study||7||
48435177|NCT04882085|101399968|FG001|NOT COMPLETED|Overall Study||12||
48435178|NCT03503565|101399969|FG000|STARTED|Overall Study||59||
48435179|NCT03503565|101399970|FG001|STARTED|Overall Study||58||
48435180|NCT03503565|101399969|FG000|COMPLETED|Overall Study||59||
48435181|NCT03503565|101399970|FG001|COMPLETED|Overall Study||58||
48435182|NCT03503565|101399969|FG000|NOT COMPLETED|Overall Study||0||
48435183|NCT03503565|101399970|FG001|NOT COMPLETED|Overall Study||0||
48435184|NCT01283009|101399971|FG000|STARTED|Overall Study||287||
48435185|NCT01283009|101399972|FG001|STARTED|Overall Study||297||
48435186|NCT01283009|101399971|FG000|COMPLETED|Overall Study||169||
48435187|NCT01283009|101399972|FG001|COMPLETED|Overall Study||180||
48435188|NCT01283009|101399971|FG000|NOT COMPLETED|Overall Study||118||
48435189|NCT01283009|101399972|FG001|NOT COMPLETED|Overall Study||117||
48435190|NCT02223637|101399973|FG000|STARTED|Overall Study||82||
48435191|NCT02223637|101399973|FG000|COMPLETED|Overall Study||82||
48435192|NCT02223637|101399973|FG000|NOT COMPLETED|Overall Study||0||
48435193|NCT03648073|101399974|FG000|STARTED|Overall Study||12||
48435194|NCT03648073|101399974|FG000|COMPLETED|Overall Study||12||
48435195|NCT03648073|101399974|FG000|NOT COMPLETED|Overall Study||0||
48435196|NCT04876482|101399975|FG000|STARTED|Overall Study||20||
48435197|NCT04876482|101399976|FG001|STARTED|Overall Study||42||
48435198|NCT04876482|101399977|FG002|STARTED|Overall Study||19||
48642321|NCT02626611|101908501|FG001|COMPLETED|Overall Study||20||
48642322|NCT02626611|101908502|FG002|COMPLETED|Overall Study||16||
48642323|NCT02626611|101908500|FG000|NOT COMPLETED|Overall Study||4||
48642324|NCT02626611|101908501|FG001|NOT COMPLETED|Overall Study||1||
48642325|NCT02626611|101908502|FG002|NOT COMPLETED|Overall Study||3||
48642326|NCT00562328|101908503|FG000|STARTED|Overall Study||33||
48642327|NCT00562328|101908503|FG000|COMPLETED|Overall Study||33||
48642328|NCT00562328|101908503|FG000|NOT COMPLETED|Overall Study||0||
48435199|NCT04876482|101399975|FG000|COMPLETED|Overall Study||17||
48435200|NCT04876482|101399976|FG001|COMPLETED|Overall Study||38||
48435201|NCT04876482|101399977|FG002|COMPLETED|Overall Study||19||
48435202|NCT04876482|101399975|FG000|NOT COMPLETED|Overall Study||3||
48435203|NCT04876482|101399976|FG001|NOT COMPLETED|Overall Study||4||
48642329|NCT00785629|101908504|FG000|STARTED|Overall Study||30||
48642330|NCT00785629|101908505|FG001|STARTED|Overall Study||30||
48435204|NCT04876482|101399977|FG002|NOT COMPLETED|Overall Study||0||
48435205|NCT00905437|101399978|FG000|STARTED|Overall Study||35||
48435206|NCT00905437|101399979|FG001|STARTED|Overall Study||37||
48435207|NCT00905437|101399978|FG000|COMPLETED|Overall Study||27||
48435208|NCT00905437|101399979|FG001|COMPLETED|Overall Study||27||
48435209|NCT00905437|101399978|FG000|NOT COMPLETED|Overall Study||8||
48435210|NCT00905437|101399979|FG001|NOT COMPLETED|Overall Study||10||
48435211|NCT02145949|101399980|FG000|STARTED|Overall Study||31||
48435212|NCT02145949|101399981|FG001|STARTED|Overall Study||36||
48435213|NCT02145949|101399980|FG000|COMPLETED|Overall Study||19||
48642331|NCT00785629|101908506|FG002|STARTED|Overall Study||28||
48642332|NCT00785629|101908507|FG003|STARTED|Overall Study||57||
48435214|NCT02145949|101399981|FG001|COMPLETED|Overall Study||20||
48435215|NCT02145949|101399980|FG000|NOT COMPLETED|Overall Study||12||
48435216|NCT02145949|101399981|FG001|NOT COMPLETED|Overall Study||16||
48435217|NCT00621309|101399982|FG000|STARTED|Overall Study||6||
48435218|NCT00621309|101399983|FG001|STARTED|Overall Study||4||
48188106|NCT02018861|100783175|FG005|STARTED|Parsaclisib Monotherapy: 21-day Cycles||4||
48188107|NCT02018861|100783176|FG006|STARTED|Parsaclisib Monotherapy: 21-day Cycles||0||
48188108|NCT02018861|100783177|FG007|STARTED|Parsaclisib Monotherapy: 21-day Cycles||0||
48188109|NCT02018861|100783178|FG008|STARTED|Parsaclisib Monotherapy: 21-day Cycles||0||
48188110|NCT02018861|100783179|FG009|STARTED|Parsaclisib Monotherapy: 21-day Cycles||0||
48188111|NCT02018861|100783170|FG000|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0||
48188112|NCT02018861|100783171|FG001|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0||
48188113|NCT02018861|100783172|FG002|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0||
48188114|NCT02018861|100783173|FG003|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||4||
48188115|NCT02018861|100783174|FG004|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0||
48188116|NCT02018861|100783175|FG005|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0||
48188117|NCT02018861|100783176|FG006|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0||
48188118|NCT02018861|100783177|FG007|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0||
48188119|NCT02018861|100783178|FG008|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0||
48188120|NCT02018861|100783179|FG009|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0||
48188121|NCT02018861|100783170|FG000|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||1||
48435219|NCT00621309|101399984|FG002|STARTED|Overall Study||5||
48435220|NCT00621309|101399985|FG003|STARTED|Overall Study||6||
48435221|NCT00621309|101399986|FG004|STARTED|Overall Study||4||
48435222|NCT00621309|101399987|FG005|STARTED|Overall Study||4||
48435223|NCT00621309|101399982|FG000|COMPLETED|Overall Study||4||
48435224|NCT00621309|101399983|FG001|COMPLETED|Overall Study||4||
48435225|NCT00621309|101399984|FG002|COMPLETED|Overall Study||4||
48435226|NCT00621309|101399985|FG003|COMPLETED|Overall Study||5||
48435227|NCT00621309|101399986|FG004|COMPLETED|Overall Study||3||
48435228|NCT00621309|101399987|FG005|COMPLETED|Overall Study||3||
48435229|NCT00621309|101399982|FG000|NOT COMPLETED|Overall Study||2||
48435230|NCT00621309|101399983|FG001|NOT COMPLETED|Overall Study||0||
48435231|NCT00621309|101399984|FG002|NOT COMPLETED|Overall Study||1||
48435232|NCT00621309|101399985|FG003|NOT COMPLETED|Overall Study||1||
48435233|NCT00621309|101399986|FG004|NOT COMPLETED|Overall Study||1||
48435234|NCT00621309|101399987|FG005|NOT COMPLETED|Overall Study||1||
48435235|NCT01275170|101399988|FG000|STARTED|Part 1: Period 1||7|Randomized|
48435236|NCT01275170|101399989|FG001|STARTED|Part 1: Period 1||6|Randomized|
48435237|NCT01275170|101399990|FG002|STARTED|Part 1: Period 1||6|Randomized|
48435238|NCT01275170|101399991|FG003|STARTED|Part 1: Period 1||6|Randomized|
48435239|NCT01275170|101399992|FG004|STARTED|Part 1: Period 1||6|Randomized|
48435240|NCT01275170|101399993|FG005|STARTED|Part 1: Period 1||6|Randomized|
48435241|NCT01275170|101399994|FG006|STARTED|Part 1: Period 1||6|Randomized|
48435242|NCT01275170|101399995|FG007|STARTED|Part 1: Period 1||6|Randomized|
48435243|NCT01275170|101399988|FG000|Treated|Part 1: Period 1||6||
48435244|NCT01275170|101399989|FG001|Treated|Part 1: Period 1||6||
48435245|NCT01275170|101399990|FG002|Treated|Part 1: Period 1||6||
48435246|NCT01275170|101399991|FG003|Treated|Part 1: Period 1||6||
48435247|NCT01275170|101399992|FG004|Treated|Part 1: Period 1||6||
48435248|NCT01275170|101399993|FG005|Treated|Part 1: Period 1||6||
48435249|NCT01275170|101399994|FG006|Treated|Part 1: Period 1||6||
48435250|NCT01275170|101399995|FG007|Treated|Part 1: Period 1||6||
48435251|NCT01275170|101399988|FG000|COMPLETED|Part 1: Period 1||6||
48435252|NCT01275170|101399989|FG001|COMPLETED|Part 1: Period 1||6||
48435253|NCT01275170|101399990|FG002|COMPLETED|Part 1: Period 1||6||
48435254|NCT01275170|101399991|FG003|COMPLETED|Part 1: Period 1||6||
48435255|NCT01275170|101399992|FG004|COMPLETED|Part 1: Period 1||6||
48435256|NCT01275170|101399993|FG005|COMPLETED|Part 1: Period 1||6||
48435257|NCT01275170|101399994|FG006|COMPLETED|Part 1: Period 1||6||
48435258|NCT01275170|101399995|FG007|COMPLETED|Part 1: Period 1||6||
48435259|NCT01275170|101399988|FG000|NOT COMPLETED|Part 1: Period 1||1||
48435260|NCT01275170|101399989|FG001|NOT COMPLETED|Part 1: Period 1||0||
48435261|NCT01275170|101399990|FG002|NOT COMPLETED|Part 1: Period 1||0||
48435262|NCT01275170|101399991|FG003|NOT COMPLETED|Part 1: Period 1||0||
48435263|NCT01275170|101399992|FG004|NOT COMPLETED|Part 1: Period 1||0||
48435264|NCT01275170|101399993|FG005|NOT COMPLETED|Part 1: Period 1||0||
48435265|NCT01275170|101399994|FG006|NOT COMPLETED|Part 1: Period 1||0||
48188122|NCT02018861|100783171|FG001|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||3||
48188123|NCT02018861|100783172|FG002|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||3||
48188124|NCT02018861|100783173|FG003|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||30||
48188125|NCT02018861|100783174|FG004|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||27||
48188126|NCT02018861|100783175|FG005|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||4||
48188127|NCT02018861|100783176|FG006|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0||
48188128|NCT02018861|100783177|FG007|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0||
48188129|NCT02018861|100783178|FG008|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0||
48435266|NCT01275170|101399995|FG007|NOT COMPLETED|Part 1: Period 1||0||
48435267|NCT01275170|101399988|FG000|STARTED|Part 1: Period 2||0||
48435268|NCT01275170|101399989|FG001|STARTED|Part 1: Period 2||0||
48435269|NCT01275170|101399990|FG002|STARTED|Part 1: Period 2||0||
48435270|NCT01275170|101399991|FG003|STARTED|Part 1: Period 2||0||
48435271|NCT01275170|101399992|FG004|STARTED|Part 1: Period 2||0||
48435272|NCT01275170|101399993|FG005|STARTED|Part 1: Period 2||0||
48435273|NCT01275170|101399994|FG006|STARTED|Part 1: Period 2||6||
48435274|NCT01275170|101399995|FG007|STARTED|Part 1: Period 2||6||
48435275|NCT01275170|101399988|FG000|COMPLETED|Part 1: Period 2||0||
48435276|NCT01275170|101399989|FG001|COMPLETED|Part 1: Period 2||0||
48435277|NCT01275170|101399990|FG002|COMPLETED|Part 1: Period 2||0||
48435278|NCT01275170|101399991|FG003|COMPLETED|Part 1: Period 2||0||
48435279|NCT01275170|101399992|FG004|COMPLETED|Part 1: Period 2||0||
48435280|NCT01275170|101399993|FG005|COMPLETED|Part 1: Period 2||0||
48435281|NCT01275170|101399994|FG006|COMPLETED|Part 1: Period 2||6||
48435282|NCT01275170|101399995|FG007|COMPLETED|Part 1: Period 2||6||
48435283|NCT01275170|101399988|FG000|NOT COMPLETED|Part 1: Period 2||0||
48435284|NCT01275170|101399989|FG001|NOT COMPLETED|Part 1: Period 2||0||
48435285|NCT01275170|101399990|FG002|NOT COMPLETED|Part 1: Period 2||0||
48435286|NCT01275170|101399991|FG003|NOT COMPLETED|Part 1: Period 2||0||
48435287|NCT01275170|101399992|FG004|NOT COMPLETED|Part 1: Period 2||0||
48435288|NCT01275170|101399993|FG005|NOT COMPLETED|Part 1: Period 2||0||
48435289|NCT01275170|101399994|FG006|NOT COMPLETED|Part 1: Period 2||0||
48435290|NCT01275170|101399995|FG007|NOT COMPLETED|Part 1: Period 2||0||
48435291|NCT01275170|101399988|FG000|STARTED|Part 2: Period 1||0||
48435292|NCT01275170|101399989|FG001|STARTED|Part 2: Period 1||0||
48435293|NCT01275170|101399990|FG002|STARTED|Part 2: Period 1||0||
48435294|NCT01275170|101399991|FG003|STARTED|Part 2: Period 1||0||
48435295|NCT01275170|101399992|FG004|STARTED|Part 2: Period 1||6||
48435296|NCT01275170|101399993|FG005|STARTED|Part 2: Period 1||6||
48435297|NCT01275170|101399994|FG006|STARTED|Part 2: Period 1||6||
48435298|NCT01275170|101399995|FG007|STARTED|Part 2: Period 1||6||
48435299|NCT01275170|101399988|FG000|COMPLETED|Part 2: Period 1||0||
48435300|NCT01275170|101399989|FG001|COMPLETED|Part 2: Period 1||0||
48435301|NCT01275170|101399990|FG002|COMPLETED|Part 2: Period 1||0||
48435302|NCT01275170|101399991|FG003|COMPLETED|Part 2: Period 1||0||
48435303|NCT01275170|101399992|FG004|COMPLETED|Part 2: Period 1||6||
48435304|NCT01275170|101399993|FG005|COMPLETED|Part 2: Period 1||6||
48435305|NCT01275170|101399994|FG006|COMPLETED|Part 2: Period 1||6||
48435306|NCT01275170|101399995|FG007|COMPLETED|Part 2: Period 1||6||
48435307|NCT01275170|101399988|FG000|NOT COMPLETED|Part 2: Period 1||0||
48435308|NCT01275170|101399989|FG001|NOT COMPLETED|Part 2: Period 1||0||
48435309|NCT01275170|101399990|FG002|NOT COMPLETED|Part 2: Period 1||0||
48435310|NCT01275170|101399991|FG003|NOT COMPLETED|Part 2: Period 1||0||
48435311|NCT01275170|101399992|FG004|NOT COMPLETED|Part 2: Period 1||0||
48435312|NCT01275170|101399993|FG005|NOT COMPLETED|Part 2: Period 1||0||
48435313|NCT01275170|101399994|FG006|NOT COMPLETED|Part 2: Period 1||0||
48435314|NCT01275170|101399995|FG007|NOT COMPLETED|Part 2: Period 1||0||
48435315|NCT01275170|101399988|FG000|STARTED|Part 2: Period 2||0||
48435316|NCT01275170|101399989|FG001|STARTED|Part 2: Period 2||0||
48435317|NCT01275170|101399990|FG002|STARTED|Part 2: Period 2||0||
48435318|NCT01275170|101399991|FG003|STARTED|Part 2: Period 2||0||
48435319|NCT01275170|101399992|FG004|STARTED|Part 2: Period 2||0||
48435320|NCT01275170|101399993|FG005|STARTED|Part 2: Period 2||0||
48435321|NCT01275170|101399994|FG006|STARTED|Part 2: Period 2||6||
48435322|NCT01275170|101399995|FG007|STARTED|Part 2: Period 2||6||
48435323|NCT01275170|101399988|FG000|COMPLETED|Part 2: Period 2||0||
48435324|NCT01275170|101399989|FG001|COMPLETED|Part 2: Period 2||0||
48435325|NCT01275170|101399990|FG002|COMPLETED|Part 2: Period 2||0||
48435326|NCT01275170|101399991|FG003|COMPLETED|Part 2: Period 2||0||
48435327|NCT01275170|101399992|FG004|COMPLETED|Part 2: Period 2||0||
48435328|NCT01275170|101399993|FG005|COMPLETED|Part 2: Period 2||0||
48435329|NCT01275170|101399994|FG006|COMPLETED|Part 2: Period 2||6||
48435330|NCT01275170|101399995|FG007|COMPLETED|Part 2: Period 2||6||
48435331|NCT01275170|101399988|FG000|NOT COMPLETED|Part 2: Period 2||0||
48642333|NCT00785629|101908504|FG000|COMPLETED|Overall Study||22||
48642334|NCT00785629|101908505|FG001|COMPLETED|Overall Study||25||
48642335|NCT00785629|101908506|FG002|COMPLETED|Overall Study||18||
48642336|NCT00785629|101908507|FG003|COMPLETED|Overall Study||41||
48642337|NCT00785629|101908504|FG000|NOT COMPLETED|Overall Study||8||
48642338|NCT00785629|101908505|FG001|NOT COMPLETED|Overall Study||5||
48435332|NCT01275170|101399989|FG001|NOT COMPLETED|Part 2: Period 2||0||
48435333|NCT01275170|101399990|FG002|NOT COMPLETED|Part 2: Period 2||0||
48435334|NCT01275170|101399991|FG003|NOT COMPLETED|Part 2: Period 2||0||
48435335|NCT01275170|101399992|FG004|NOT COMPLETED|Part 2: Period 2||0||
48435336|NCT01275170|101399993|FG005|NOT COMPLETED|Part 2: Period 2||0||
48435337|NCT01275170|101399994|FG006|NOT COMPLETED|Part 2: Period 2||0||
48435338|NCT01275170|101399995|FG007|NOT COMPLETED|Part 2: Period 2||0||
48435339|NCT00548340|101399996|FG000|STARTED|Overall Study||109||
48435340|NCT00548340|101399997|FG001|STARTED|Overall Study||109||
48642339|NCT00785629|101908506|FG002|NOT COMPLETED|Overall Study||10||
48435341|NCT00548340|101399998|FG002|STARTED|Overall Study||104||
48435342|NCT00548340|101399996|FG000|COMPLETED|Overall Study||101||
48435343|NCT00548340|101399997|FG001|COMPLETED|Overall Study||98||
48435344|NCT00548340|101399998|FG002|COMPLETED|Overall Study||95||
48435345|NCT00548340|101399996|FG000|NOT COMPLETED|Overall Study||8||
48435346|NCT00548340|101399997|FG001|NOT COMPLETED|Overall Study||11||
48435347|NCT00548340|101399998|FG002|NOT COMPLETED|Overall Study||9||
48435348|NCT00698009|101399999|FG000|STARTED|Overall Study||1||
48642340|NCT00785629|101908507|FG003|NOT COMPLETED|Overall Study||16||
48435349|NCT00698009|101399999|FG000|COMPLETED|Overall Study||0||
48435350|NCT00698009|101399999|FG000|NOT COMPLETED|Overall Study||1||
48435351|NCT05292248|101400000|FG000|STARTED|Overall Study||20||
48435352|NCT05292248|101400000|FG000|Completed Intervention|Overall Study||18||
48435353|NCT05292248|101400000|FG000|Follow Up Survey|Overall Study||14||
48435354|NCT05292248|101400000|FG000|COMPLETED|Overall Study||14||
48435355|NCT05292248|101400000|FG000|NOT COMPLETED|Overall Study||6||
48435356|NCT01678586|101400001|FG000|STARTED|Overall Study||15||
48435357|NCT01678586|101400002|FG001|STARTED|Overall Study||16||
48435358|NCT01678586|101400003|FG002|STARTED|Overall Study||11||
48435359|NCT01678586|101400004|FG003|STARTED|Overall Study||14||
48188130|NCT02018861|100783179|FG009|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0||
48188131|NCT02018861|100783170|FG000|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0||
48188132|NCT02018861|100783171|FG001|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0||
48188133|NCT02018861|100783172|FG002|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0||
48188134|NCT02018861|100783173|FG003|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0||
48188135|NCT02018861|100783174|FG004|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0||
48435360|NCT01678586|101400001|FG000|COMPLETED|Overall Study||14||
48435361|NCT01678586|101400002|FG001|COMPLETED|Overall Study||15||
48435362|NCT01678586|101400003|FG002|COMPLETED|Overall Study||9||
48435363|NCT01678586|101400004|FG003|COMPLETED|Overall Study||12||
48435364|NCT01678586|101400001|FG000|NOT COMPLETED|Overall Study||1||
48435365|NCT01678586|101400002|FG001|NOT COMPLETED|Overall Study||1||
48435366|NCT01678586|101400003|FG002|NOT COMPLETED|Overall Study||2||
48435367|NCT01678586|101400004|FG003|NOT COMPLETED|Overall Study||2||
48435368|NCT01012609|101400005|FG000|STARTED|Overall Study||21||
48435369|NCT01012609|101400006|FG001|STARTED|Overall Study||26||
48435370|NCT01012609|101400005|FG000|COMPLETED|Overall Study||20||
48435371|NCT01012609|101400006|FG001|COMPLETED|Overall Study||25||
48435372|NCT01012609|101400005|FG000|NOT COMPLETED|Overall Study||1||
48435373|NCT01012609|101400006|FG001|NOT COMPLETED|Overall Study||1||
48435374|NCT01096017|101400007|FG000|STARTED|Treatment Period 1||12||
48435375|NCT01096017|101400008|FG001|STARTED|Treatment Period 1||12||
48435376|NCT01096017|101400007|FG000|COMPLETED|Treatment Period 1||12||
48435377|NCT01096017|101400008|FG001|COMPLETED|Treatment Period 1||12||
48435378|NCT01096017|101400007|FG000|NOT COMPLETED|Treatment Period 1||0||
48435379|NCT01096017|101400008|FG001|NOT COMPLETED|Treatment Period 1||0||
48435380|NCT01096017|101400007|FG000|STARTED|Washout 1 - 14 Days||12||
48435381|NCT01096017|101400008|FG001|STARTED|Washout 1 - 14 Days||12||
48435382|NCT01096017|101400007|FG000|COMPLETED|Washout 1 - 14 Days||12||
48435383|NCT01096017|101400008|FG001|COMPLETED|Washout 1 - 14 Days||12||
48435384|NCT01096017|101400007|FG000|NOT COMPLETED|Washout 1 - 14 Days||0||
48435385|NCT01096017|101400008|FG001|NOT COMPLETED|Washout 1 - 14 Days||0||
48435386|NCT01096017|101400007|FG000|STARTED|Treatment Period 2||12||
48435387|NCT01096017|101400008|FG001|STARTED|Treatment Period 2||12||
48435388|NCT01096017|101400007|FG000|COMPLETED|Treatment Period 2||11||
48435389|NCT01096017|101400008|FG001|COMPLETED|Treatment Period 2||11||
48435390|NCT01096017|101400007|FG000|NOT COMPLETED|Treatment Period 2||1||
48435391|NCT01096017|101400008|FG001|NOT COMPLETED|Treatment Period 2||1||
48435392|NCT05102162|101400009|FG000|STARTED|Overall Study||19||
48435393|NCT05102162|101400010|FG001|STARTED|Overall Study||16||
48435394|NCT05102162|101400009|FG000|COMPLETED|Overall Study||5||
48435395|NCT05102162|101400010|FG001|COMPLETED|Overall Study||13||
48435396|NCT05102162|101400009|FG000|NOT COMPLETED|Overall Study||14||
48435397|NCT05102162|101400010|FG001|NOT COMPLETED|Overall Study||3||
48435398|NCT04113746|101400011|FG000|STARTED|Overall Study||13||
48435399|NCT04113746|101400012|FG001|STARTED|Overall Study||14||
48435400|NCT04113746|101400011|FG000|COMPLETED|Overall Study||9||
48435401|NCT04113746|101400012|FG001|COMPLETED|Overall Study||10||
48435402|NCT04113746|101400011|FG000|NOT COMPLETED|Overall Study||4||
48435403|NCT04113746|101400012|FG001|NOT COMPLETED|Overall Study||4||
48435404|NCT03014570|101400013|FG000|STARTED|Overall Study||248||
48435405|NCT03014570|101400014|FG001|STARTED|Overall Study||305||
48435406|NCT03014570|101400013|FG000|COMPLETED|Overall Study||123||
48435407|NCT03014570|101400014|FG001|COMPLETED|Overall Study||174||
48435408|NCT03014570|101400013|FG000|NOT COMPLETED|Overall Study||125||
48435409|NCT03014570|101400014|FG001|NOT COMPLETED|Overall Study||131||
48435410|NCT03583931|101400015|FG000|STARTED|Overall Study||5||
48435411|NCT03583931|101400016|FG001|STARTED|Overall Study||5||
48435412|NCT03583931|101400015|FG000|COMPLETED|Overall Study||5||
48435413|NCT03583931|101400016|FG001|COMPLETED|Overall Study||5||
48435414|NCT03583931|101400015|FG000|NOT COMPLETED|Overall Study||0||
48435415|NCT03583931|101400016|FG001|NOT COMPLETED|Overall Study||0||
48435416|NCT03546270|101400017|FG000|STARTED|Overall Study||52||
48188136|NCT02018861|100783175|FG005|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0||
48435417|NCT03546270|101400018|FG001|STARTED|Overall Study||48||
48435418|NCT03546270|101400017|FG000|COMPLETED|Overall Study||52||
48435419|NCT03546270|101400018|FG001|COMPLETED|Overall Study||48||
48435420|NCT03546270|101400017|FG000|NOT COMPLETED|Overall Study||0||
48435421|NCT03546270|101400018|FG001|NOT COMPLETED|Overall Study||0||
48435422|NCT00124709|101400019|FG000|STARTED|Overall Study||546||
48435423|NCT00124709|101400020|FG001|STARTED|Overall Study||545||
48435424|NCT00124709|101400019|FG000|Patients Who Received Study Medication|Overall Study||543||
48435425|NCT00124709|101400020|FG001|Patients Who Received Study Medication|Overall Study||544||
48435426|NCT00124709|101400019|FG000|COMPLETED|Overall Study||291||
48435427|NCT00124709|101400020|FG001|COMPLETED|Overall Study||273||
48435428|NCT00124709|101400019|FG000|NOT COMPLETED|Overall Study||255||
48435429|NCT00124709|101400020|FG001|NOT COMPLETED|Overall Study||272||
48435430|NCT01969201|101400021|FG000|STARTED|Overall Study||352||
48435431|NCT01969201|101400022|FG001|STARTED|Overall Study||358||
48435432|NCT01969201|101400021|FG000|COMPLETED|Overall Study||307||
48435433|NCT01969201|101400022|FG001|COMPLETED|Overall Study||313||
48435434|NCT01969201|101400021|FG000|NOT COMPLETED|Overall Study||45||
48435435|NCT01969201|101400022|FG001|NOT COMPLETED|Overall Study||45||
48435436|NCT01340794|101400023|FG000|STARTED|Overall Study||2||
48435437|NCT01340794|101400024|FG001|STARTED|Overall Study||5||
48435438|NCT01340794|101400023|FG000|COMPLETED|Overall Study||2||
48435439|NCT01340794|101400024|FG001|COMPLETED|Overall Study||4||
48361782|NCT02961764|101214432|FG001|COMPLETED|Overall Study||128||
48361783|NCT02961764|101214431|FG000|NOT COMPLETED|Overall Study||39||
48361784|NCT02961764|101214432|FG001|NOT COMPLETED|Overall Study||25||
48361785|NCT00487279|101214433|FG000|STARTED|Overall Study||44||
48361786|NCT00487279|101214434|FG001|STARTED|Overall Study||37||
48361787|NCT00487279|101214433|FG000|COMPLETED|Overall Study||43||
48435440|NCT01340794|101400023|FG000|NOT COMPLETED|Overall Study||0||
48435441|NCT01340794|101400024|FG001|NOT COMPLETED|Overall Study||1||
48435442|NCT00604175|101400025|FG000|STARTED|Entry Through Week 28||130||
48435443|NCT00604175|101400026|FG001|STARTED|Entry Through Week 28||95||
48435444|NCT00604175|101400027|FG002|STARTED|Entry Through Week 28||94||
48435445|NCT00604175|101400025|FG000|COMPLETED|Entry Through Week 28||120||
48642341|NCT03320369|101908508|FG000|STARTED|Overall Study||18||
48642342|NCT03320369|101908508|FG000|COMPLETED|Overall Study||15||
48642343|NCT03320369|101908508|FG000|NOT COMPLETED|Overall Study||3||
48642344|NCT04167670|101908509|FG000|STARTED|Overall Study||349||
48361788|NCT00487279|101214434|FG001|COMPLETED|Overall Study||35||
48361789|NCT00487279|101214433|FG000|NOT COMPLETED|Overall Study||1||
48361790|NCT00487279|101214434|FG001|NOT COMPLETED|Overall Study||2||
48361791|NCT04095416|101214435|FG000|STARTED|Overall Study||13||
48361792|NCT04095416|101214436|FG001|STARTED|Overall Study||19||
48361793|NCT04095416|101214435|FG000|COMPLETED|Overall Study||10||
48361794|NCT04095416|101214436|FG001|COMPLETED|Overall Study||19||
48361795|NCT04095416|101214435|FG000|NOT COMPLETED|Overall Study||3||
48361796|NCT04095416|101214436|FG001|NOT COMPLETED|Overall Study||0||
48361797|NCT01399827|101214437|FG000|STARTED|Overall Study||1||
48361798|NCT01399827|101214438|FG001|STARTED|Overall Study||1||
48361799|NCT01399827|101214437|FG000|COMPLETED|Overall Study||1||
48361800|NCT01399827|101214438|FG001|COMPLETED|Overall Study||1||
48361801|NCT01399827|101214437|FG000|NOT COMPLETED|Overall Study||0||
48361802|NCT01399827|101214438|FG001|NOT COMPLETED|Overall Study||0||
48361803|NCT00857246|101214439|FG000|STARTED|Induction Regimen||30||
48361804|NCT00857246|101214439|FG000|COMPLETED|Induction Regimen||27||
48361805|NCT00857246|101214439|FG000|NOT COMPLETED|Induction Regimen||3||
48361806|NCT00857246|101214439|FG000|STARTED|Surgery (Curative)||27||
48361807|NCT00857246|101214439|FG000|COMPLETED|Surgery (Curative)||21||
48361808|NCT00857246|101214439|FG000|NOT COMPLETED|Surgery (Curative)||6||
48361809|NCT00857246|101214439|FG000|STARTED|ChemoRT||15||
48361810|NCT00857246|101214439|FG000|COMPLETED|ChemoRT||12||
48361811|NCT00857246|101214439|FG000|NOT COMPLETED|ChemoRT||3||
48361812|NCT00466752|101214440|FG000|STARTED|Overall Study||5||
48361813|NCT00466752|101214441|FG001|STARTED|Overall Study||0||
48361814|NCT00466752|101214440|FG000|COMPLETED|Overall Study||5||
48361815|NCT00466752|101214441|FG001|COMPLETED|Overall Study||0||
48361816|NCT00466752|101214440|FG000|NOT COMPLETED|Overall Study||0||
48361817|NCT00466752|101214441|FG001|NOT COMPLETED|Overall Study||0||
48361818|NCT01342640|101214442|FG000|STARTED|Overall Study||70||
48361819|NCT01342640|101214442|FG000|COMPLETED|Overall Study||29||
48361820|NCT01342640|101214442|FG000|NOT COMPLETED|Overall Study||41||
48361821|NCT01276847|101214443|FG000|STARTED|Overall Study||10||
48361822|NCT01276847|101214444|FG001|STARTED|Overall Study||10||
48361823|NCT01276847|101214445|FG002|STARTED|Overall Study||20||
48361824|NCT01276847|101214443|FG000|COMPLETED|Overall Study||9||
48361825|NCT01276847|101214444|FG001|COMPLETED|Overall Study||10||
48361826|NCT01276847|101214445|FG002|COMPLETED|Overall Study||20||
48361827|NCT01276847|101214443|FG000|NOT COMPLETED|Overall Study||1||
48361828|NCT01276847|101214444|FG001|NOT COMPLETED|Overall Study||0||
48361829|NCT01276847|101214445|FG002|NOT COMPLETED|Overall Study||0||
48361830|NCT01084252|101214446|FG000|STARTED|Phase 1 (120 Weeks)||16||
48361831|NCT01084252|101214447|FG001|STARTED|Phase 1 (120 Weeks)||6||
48361832|NCT01084252|101214448|FG002|STARTED|Phase 1 (120 Weeks)||3||
48361833|NCT01084252|101214449|FG003|STARTED|Phase 1 (120 Weeks)||26||
48361834|NCT01084252|101214450|FG004|STARTED|Phase 1 (120 Weeks)||18||
48361835|NCT01084252|101214451|FG005|STARTED|Phase 1 (120 Weeks)||6||
48435446|NCT00604175|101400026|FG001|COMPLETED|Entry Through Week 28||92||
48435447|NCT00604175|101400027|FG002|COMPLETED|Entry Through Week 28||93||
48435448|NCT00604175|101400025|FG000|NOT COMPLETED|Entry Through Week 28||10||
48435449|NCT00604175|101400026|FG001|NOT COMPLETED|Entry Through Week 28||3||
48435450|NCT00604175|101400027|FG002|NOT COMPLETED|Entry Through Week 28||1||
48435451|NCT00604175|101400025|FG000|STARTED|Week 29 Through Week 72||120||
48435452|NCT00604175|101400026|FG001|STARTED|Week 29 Through Week 72||92||
48435453|NCT00604175|101400027|FG002|STARTED|Week 29 Through Week 72||93||
48435454|NCT00604175|101400025|FG000|COMPLETED|Week 29 Through Week 72||108||
48435455|NCT00604175|101400026|FG001|COMPLETED|Week 29 Through Week 72||85||
48435456|NCT00604175|101400027|FG002|COMPLETED|Week 29 Through Week 72||89||
48435457|NCT00604175|101400025|FG000|NOT COMPLETED|Week 29 Through Week 72||12||
48435458|NCT00604175|101400026|FG001|NOT COMPLETED|Week 29 Through Week 72||7||
48435459|NCT00604175|101400027|FG002|NOT COMPLETED|Week 29 Through Week 72||4||
48435460|NCT01381068|101400028|FG000|STARTED|Overall Study||25|one infant had an unassigned randomization and was not included|
48435461|NCT01381068|101400029|FG001|STARTED|Overall Study||24|one infant had an unassigned randomization and was not included|
48435462|NCT01381068|101400028|FG000|COMPLETED|Overall Study||24||
48435463|NCT01381068|101400029|FG001|COMPLETED|Overall Study||24||
48435464|NCT01381068|101400028|FG000|NOT COMPLETED|Overall Study||1||
48435465|NCT01381068|101400029|FG001|NOT COMPLETED|Overall Study||0||
48435466|NCT02064231|101400030|FG000|STARTED|First Test Period (Test A or Test C)||14||
48435467|NCT02064231|101400031|FG001|STARTED|First Test Period (Test A or Test C)||12||
48435468|NCT02064231|101400032|FG002|STARTED|First Test Period (Test A or Test C)||1||
48435469|NCT02064231|101400033|FG003|STARTED|First Test Period (Test A or Test C)||1||
48435470|NCT02064231|101400030|FG000|COMPLETED|First Test Period (Test A or Test C)||7||
48435471|NCT02064231|101400031|FG001|COMPLETED|First Test Period (Test A or Test C)||8||
48435472|NCT02064231|101400032|FG002|COMPLETED|First Test Period (Test A or Test C)||0||
48435473|NCT02064231|101400033|FG003|COMPLETED|First Test Period (Test A or Test C)||1||
48435474|NCT02064231|101400030|FG000|NOT COMPLETED|First Test Period (Test A or Test C)||7||
48435475|NCT02064231|101400031|FG001|NOT COMPLETED|First Test Period (Test A or Test C)||4||
48435476|NCT02064231|101400032|FG002|NOT COMPLETED|First Test Period (Test A or Test C)||1||
48435477|NCT02064231|101400033|FG003|NOT COMPLETED|First Test Period (Test A or Test C)||0||
48435478|NCT02064231|101400030|FG000|STARTED|Second Test Period (Test B or Test D)||7||
48435479|NCT02064231|101400031|FG001|STARTED|Second Test Period (Test B or Test D)||8||
48435480|NCT02064231|101400032|FG002|STARTED|Second Test Period (Test B or Test D)||0||
48435481|NCT02064231|101400033|FG003|STARTED|Second Test Period (Test B or Test D)||1||
48435482|NCT02064231|101400030|FG000|COMPLETED|Second Test Period (Test B or Test D)||6||
48435483|NCT02064231|101400031|FG001|COMPLETED|Second Test Period (Test B or Test D)||7||
48435484|NCT02064231|101400032|FG002|COMPLETED|Second Test Period (Test B or Test D)||0||
48435485|NCT02064231|101400033|FG003|COMPLETED|Second Test Period (Test B or Test D)||1||
48435486|NCT02064231|101400030|FG000|NOT COMPLETED|Second Test Period (Test B or Test D)||1||
48435487|NCT02064231|101400031|FG001|NOT COMPLETED|Second Test Period (Test B or Test D)||1||
48435488|NCT02064231|101400032|FG002|NOT COMPLETED|Second Test Period (Test B or Test D)||0||
48642345|NCT04167670|101908510|FG001|STARTED|Overall Study||349||
48642346|NCT04167670|101908511|FG002|STARTED|Overall Study||348||
48642347|NCT04167670|101908509|FG000|Received Study Drugs|Overall Study||348||
48642348|NCT04167670|101908510|FG001|Received Study Drugs|Overall Study||346||
48642349|NCT04167670|101908511|FG002|Received Study Drugs|Overall Study||345||
48435489|NCT02064231|101400033|FG003|NOT COMPLETED|Second Test Period (Test B or Test D)||0||
48435490|NCT02064231|101400030|FG000|STARTED|Third Test Period (Own Product)||8||
48435491|NCT02064231|101400031|FG001|STARTED|Third Test Period (Own Product)||8||
48435492|NCT02064231|101400032|FG002|STARTED|Third Test Period (Own Product)||0||
48435493|NCT02064231|101400033|FG003|STARTED|Third Test Period (Own Product)||1||
48435494|NCT02064231|101400030|FG000|COMPLETED|Third Test Period (Own Product)||8||
48435495|NCT02064231|101400031|FG001|COMPLETED|Third Test Period (Own Product)||8||
48435496|NCT02064231|101400032|FG002|COMPLETED|Third Test Period (Own Product)||0||
48435497|NCT02064231|101400033|FG003|COMPLETED|Third Test Period (Own Product)||1||
48435498|NCT02064231|101400030|FG000|NOT COMPLETED|Third Test Period (Own Product)||0||
48435499|NCT02064231|101400031|FG001|NOT COMPLETED|Third Test Period (Own Product)||0||
48435500|NCT02064231|101400032|FG002|NOT COMPLETED|Third Test Period (Own Product)||0||
48435501|NCT02064231|101400033|FG003|NOT COMPLETED|Third Test Period (Own Product)||0||
48435502|NCT01042288|101400034|FG000|STARTED|Overall Study||69||
48435503|NCT01042288|101400034|FG000|Maintenance|Overall Study||27||
48435504|NCT01042288|101400034|FG000|COMPLETED|Overall Study||0||
48435505|NCT01042288|101400034|FG000|NOT COMPLETED|Overall Study||69||
48435506|NCT00627094|101400035|FG000|STARTED|Overall Study||60||
48642350|NCT04167670|101908509|FG000|COMPLETED|Overall Study||334||
48642351|NCT04167670|101908510|FG001|COMPLETED|Overall Study||331||
48642352|NCT04167670|101908511|FG002|COMPLETED|Overall Study||334||
48642353|NCT04167670|101908509|FG000|NOT COMPLETED|Overall Study||15||
48435507|NCT00627094|101400036|FG001|STARTED|Overall Study||60||
48435508|NCT00627094|101400035|FG000|COMPLETED|Overall Study||48||
48435509|NCT00627094|101400036|FG001|COMPLETED|Overall Study||45||
48435510|NCT00627094|101400035|FG000|NOT COMPLETED|Overall Study||12||
48435511|NCT00627094|101400036|FG001|NOT COMPLETED|Overall Study||15||
48642354|NCT04167670|101908510|FG001|NOT COMPLETED|Overall Study||18||
48642355|NCT04167670|101908511|FG002|NOT COMPLETED|Overall Study||14||
48642356|NCT01101100|101908512|FG000|STARTED|Overall Study||181||
48642357|NCT01101100|101908512|FG000|COMPLETED|Overall Study||126||
48435512|NCT04822467|101400037|FG000|STARTED|Overall Study||29||
48435513|NCT04822467|101400038|FG001|STARTED|Overall Study||30||
48435514|NCT04822467|101400037|FG000|COMPLETED|Overall Study||29||
48435515|NCT04822467|101400038|FG001|COMPLETED|Overall Study||30||
48435516|NCT04822467|101400037|FG000|NOT COMPLETED|Overall Study||0||
48435517|NCT04822467|101400038|FG001|NOT COMPLETED|Overall Study||0||
48435518|NCT00457795|101400039|FG000|STARTED|Overall Study||15||
48435519|NCT00457795|101400039|FG000|COMPLETED|Overall Study||15||
48435520|NCT00457795|101400039|FG000|NOT COMPLETED|Overall Study||0||
48435521|NCT05299359|101400040|FG000|STARTED|Main Part: Day 1 up to Day 366||150||
48435522|NCT05299359|101400041|FG001|STARTED|Main Part: Day 1 up to Day 366||0||
48435523|NCT05299359|101400040|FG000|COMPLETED|Main Part: Day 1 up to Day 366||17||
48435524|NCT05299359|101400041|FG001|COMPLETED|Main Part: Day 1 up to Day 366||0||
48435525|NCT05299359|101400040|FG000|NOT COMPLETED|Main Part: Day 1 up to Day 366||133||
48435526|NCT05299359|101400041|FG001|NOT COMPLETED|Main Part: Day 1 up to Day 366||0||
48435527|NCT05299359|101400040|FG000|STARTED|Extension Part: Day 1 to Day 366||0||
48435528|NCT05299359|101400041|FG001|STARTED|Extension Part: Day 1 to Day 366||129||
48435529|NCT05299359|101400040|FG000|COMPLETED|Extension Part: Day 1 to Day 366||0||
48435530|NCT05299359|101400041|FG001|COMPLETED|Extension Part: Day 1 to Day 366||121||
48435531|NCT05299359|101400040|FG000|NOT COMPLETED|Extension Part: Day 1 to Day 366||0||
48435532|NCT05299359|101400041|FG001|NOT COMPLETED|Extension Part: Day 1 to Day 366||8||
48435533|NCT04281030|101400042|FG000|STARTED|Overall Study||56||
48435534|NCT04281030|101400043|FG001|STARTED|Overall Study||56||
48435535|NCT04281030|101400042|FG000|Participants Allocated to Intervention|Overall Study||54||
48435536|NCT04281030|101400043|FG001|Participants Allocated to Intervention|Overall Study||54||
48435537|NCT04281030|101400042|FG000|COMPLETED|Overall Study||46||
48435538|NCT04281030|101400043|FG001|COMPLETED|Overall Study||48||
48435539|NCT04281030|101400042|FG000|NOT COMPLETED|Overall Study||10||
48435540|NCT04281030|101400043|FG001|NOT COMPLETED|Overall Study||8||
48435541|NCT00673712|101400044|FG000|STARTED|Overall Study||321||
48435542|NCT00673712|101400045|FG001|STARTED|Overall Study||326||
48435543|NCT00673712|101400044|FG000|COMPLETED|Overall Study||321||
48435544|NCT00673712|101400045|FG001|COMPLETED|Overall Study||326||
48435545|NCT00673712|101400044|FG000|NOT COMPLETED|Overall Study||0||
48435546|NCT00673712|101400045|FG001|NOT COMPLETED|Overall Study||0||
48435547|NCT03526549|101400046|FG000|STARTED|180 Days Observational Phase||243||
48435548|NCT03526549|101400047|FG001|STARTED|180 Days Observational Phase||240||
48435549|NCT03526549|101400046|FG000|Completed Day 180|180 Days Observational Phase||243||
48435550|NCT03526549|101400047|FG001|Completed Day 180|180 Days Observational Phase||240||
48435551|NCT03526549|101400046|FG000|COMPLETED|180 Days Observational Phase||202|Completed 180 days of observation and consented to continue in the Open-label Phase.|
48435552|NCT03526549|101400047|FG001|COMPLETED|180 Days Observational Phase||0|Completed 180 days of observation and consented to continue in the Open-label Phase.|
48435553|NCT03526549|101400046|FG000|NOT COMPLETED|180 Days Observational Phase||41||
48435554|NCT03526549|101400047|FG001|NOT COMPLETED|180 Days Observational Phase||240||
48435555|NCT03526549|101400046|FG000|STARTED|Open-label Phase||202||
48435556|NCT03526549|101400047|FG001|STARTED|Open-label Phase||0||
48435557|NCT03526549|101400046|FG000|CCH-aaes Retreatment|Open-label Phase||55|Participants who qualified and opted for CCH-aaes retreatment in the Open-label Phase.|
48435558|NCT03526549|101400047|FG001|CCH-aaes Retreatment|Open-label Phase||0|Participants who qualified and opted for CCH-aaes retreatment in the Open-label Phase.|
48435559|NCT03526549|101400046|FG000|COMPLETED|Open-label Phase||104||
48435560|NCT03526549|101400047|FG001|COMPLETED|Open-label Phase||0||
48435561|NCT03526549|101400046|FG000|NOT COMPLETED|Open-label Phase||98||
48435562|NCT03526549|101400047|FG001|NOT COMPLETED|Open-label Phase||0||
48435563|NCT00270205|101400048|FG000|STARTED|Overall Study||6||
48435564|NCT00270205|101400049|FG001|STARTED|Overall Study||6||
48435565|NCT00270205|101400050|FG002|STARTED|Overall Study||6||
48435566|NCT00270205|101400051|FG003|STARTED|Overall Study||7||
48435567|NCT00270205|101400048|FG000|COMPLETED|Overall Study||5||
48435568|NCT00270205|101400049|FG001|COMPLETED|Overall Study||6||
48435569|NCT00270205|101400050|FG002|COMPLETED|Overall Study||6||
48764937|NCT02017405|102212068|FG005|NOT COMPLETED|Open-label Phase||0||
48435570|NCT00270205|101400051|FG003|COMPLETED|Overall Study||6||
48435571|NCT00270205|101400048|FG000|NOT COMPLETED|Overall Study||1||
48435572|NCT00270205|101400049|FG001|NOT COMPLETED|Overall Study||0||
48435573|NCT00270205|101400050|FG002|NOT COMPLETED|Overall Study||0||
48435574|NCT00270205|101400051|FG003|NOT COMPLETED|Overall Study||1||
48435575|NCT03290131|101400052|FG000|STARTED|Overall Study||179||
48435576|NCT03290131|101400053|FG001|STARTED|Overall Study||179||
48435577|NCT03290131|101400054|FG002|STARTED|Overall Study||178||
48435578|NCT03290131|101400052|FG000|COMPLETED|Overall Study||137||
48435579|NCT03290131|101400053|FG001|COMPLETED|Overall Study||107||
48435580|NCT03290131|101400054|FG002|COMPLETED|Overall Study||159||
48435581|NCT03290131|101400052|FG000|NOT COMPLETED|Overall Study||42||
48435582|NCT03290131|101400053|FG001|NOT COMPLETED|Overall Study||72||
48435583|NCT03290131|101400054|FG002|NOT COMPLETED|Overall Study||19||
48435584|NCT04165824|101400055|FG000|STARTED|Overall Study||185||
48435585|NCT04165824|101400055|FG000|COMPLETED|Overall Study||139||
48435586|NCT04165824|101400055|FG000|NOT COMPLETED|Overall Study||46||
48435587|NCT00357734|101400056|FG000|STARTED|Overall Study||14||
48642358|NCT01101100|101908512|FG000|NOT COMPLETED|Overall Study||55||
48435588|NCT00357734|101400056|FG000|Patients Received 250 mg of ZD1839|Overall Study||13||
48435589|NCT00357734|101400056|FG000|Patient Received 500 mg of ZD1839|Overall Study||1||
48435590|NCT00357734|101400056|FG000|COMPLETED|Overall Study||10||
48642359|NCT02233413|101908513|FG000|STARTED|Overall Study||35||
48642360|NCT02233413|101908514|FG001|STARTED|Overall Study||33||
48642361|NCT02233413|101908513|FG000|COMPLETED|Overall Study||24||
48642362|NCT02233413|101908514|FG001|COMPLETED|Overall Study||19||
48642363|NCT02233413|101908513|FG000|NOT COMPLETED|Overall Study||11||
48642364|NCT02233413|101908514|FG001|NOT COMPLETED|Overall Study||14||
48642365|NCT00154466|101908515|FG000|STARTED|Overall Study||20||
48642366|NCT00154466|101908516|FG001|STARTED|Overall Study||19||
48642367|NCT00154466|101908517|FG002|STARTED|Overall Study||19||
48642368|NCT00154466|101908515|FG000|COMPLETED|Overall Study||20||
48642369|NCT00154466|101908516|FG001|COMPLETED|Overall Study||19||
48642370|NCT00154466|101908517|FG002|COMPLETED|Overall Study||19||
48642371|NCT00154466|101908515|FG000|NOT COMPLETED|Overall Study||0||
48642372|NCT00154466|101908516|FG001|NOT COMPLETED|Overall Study||0||
48642373|NCT00154466|101908517|FG002|NOT COMPLETED|Overall Study||0||
48642374|NCT00447278|101908518|FG000|STARTED|Period II (6 Month Open-Label)||199||
48642375|NCT00447278|101908519|FG001|STARTED|Period II (6 Month Open-Label)||200||
48642376|NCT00447278|101908518|FG000|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)||199||
48642377|NCT00447278|101908519|FG001|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)||199||
48642378|NCT00447278|101908518|FG000|COMPLETED|Period II (6 Month Open-Label)||157||
48642379|NCT00447278|101908519|FG001|COMPLETED|Period II (6 Month Open-Label)||171||
48642380|NCT00447278|101908518|FG000|NOT COMPLETED|Period II (6 Month Open-Label)||42||
48642381|NCT00447278|101908519|FG001|NOT COMPLETED|Period II (6 Month Open-Label)||29||
48642382|NCT00447278|101908518|FG000|STARTED|Period III (Optional 6 Month Extension)||139||
48642383|NCT00447278|101908519|FG001|STARTED|Period III (Optional 6 Month Extension)||155||
48642384|NCT00447278|101908518|FG000|COMPLETED|Period III (Optional 6 Month Extension)||109||
48642385|NCT00447278|101908519|FG001|COMPLETED|Period III (Optional 6 Month Extension)||140||
48642386|NCT00447278|101908518|FG000|NOT COMPLETED|Period III (Optional 6 Month Extension)||30||
48642387|NCT00447278|101908519|FG001|NOT COMPLETED|Period III (Optional 6 Month Extension)||15||
48642388|NCT01584388|101908520|FG000|STARTED|Overall Study||30||
48642389|NCT01584388|101908520|FG000|COMPLETED|Overall Study||30||
48642390|NCT01584388|101908520|FG000|NOT COMPLETED|Overall Study||0||
48642391|NCT00827242|101908521|FG000|STARTED|Overall Study||161||
48764938|NCT00004563|102212069|FG000|STARTED|Overall Study||79||
48764939|NCT00004563|102212070|FG001|STARTED|Overall Study||79||
48764940|NCT00004563|102212069|FG000|COMPLETED|Overall Study||54||
48764941|NCT00004563|102212070|FG001|COMPLETED|Overall Study||55||
48764942|NCT00004563|102212069|FG000|NOT COMPLETED|Overall Study||25||
48764943|NCT00004563|102212070|FG001|NOT COMPLETED|Overall Study||24||
48435591|NCT00357734|101400056|FG000|NOT COMPLETED|Overall Study||4||
48642392|NCT00827242|101908522|FG001|STARTED|Overall Study||164||
48642393|NCT00827242|101908521|FG000|COMPLETED|Overall Study||148||
48642394|NCT00827242|101908522|FG001|COMPLETED|Overall Study||152||
48642395|NCT00827242|101908521|FG000|NOT COMPLETED|Overall Study||13||
48642396|NCT00827242|101908522|FG001|NOT COMPLETED|Overall Study||12||
48642397|NCT00728923|101908523|FG000|STARTED|Overall Study||9||
48642398|NCT00728923|101908523|FG000|COMPLETED|Overall Study||9||
48642399|NCT00728923|101908523|FG000|NOT COMPLETED|Overall Study||0||
48642400|NCT00992836|101908524|FG000|STARTED|Overall Study||155||
48642401|NCT00992836|101908524|FG000|Received Both Study Vaccinations|Overall Study||150||
48642402|NCT00992836|101908524|FG000|COMPLETED|Overall Study||150||
48642403|NCT00992836|101908524|FG000|NOT COMPLETED|Overall Study||5||
48642404|NCT01327703|101908525|FG000|STARTED|First Treatment Period||42||
48642405|NCT01327703|101908526|FG001|STARTED|First Treatment Period||45||
48642406|NCT01327703|101908525|FG000|COMPLETED|First Treatment Period||42||
48642407|NCT01327703|101908526|FG001|COMPLETED|First Treatment Period||45||
48764944|NCT04123470|102212071|FG000|STARTED|Group 1: LOAd703 Dose Level 1x10e11 VP||7||
48764945|NCT04123470|102212072|FG001|STARTED|Group 1: LOAd703 Dose Level 1x10e11 VP||0||
48435592|NCT01238861|101400057|FG000|STARTED|Overall Study||80||
48642408|NCT01327703|101908525|FG000|NOT COMPLETED|First Treatment Period||0||
48642409|NCT01327703|101908526|FG001|NOT COMPLETED|First Treatment Period||0||
48642410|NCT01327703|101908525|FG000|STARTED|Second Treatment Period||40||
48642411|NCT01327703|101908526|FG001|STARTED|Second Treatment Period||44||
48642412|NCT01327703|101908525|FG000|COMPLETED|Second Treatment Period||39||
48642413|NCT01327703|101908526|FG001|COMPLETED|Second Treatment Period||42||
48642414|NCT01327703|101908525|FG000|NOT COMPLETED|Second Treatment Period||1||
48642415|NCT01327703|101908526|FG001|NOT COMPLETED|Second Treatment Period||2||
48642416|NCT02260622|101908527|FG000|STARTED|Overall Study||11||
48642417|NCT02260622|101908528|FG001|STARTED|Overall Study||9||
48435593|NCT01238861|101400058|FG001|STARTED|Overall Study||81||
48642418|NCT02260622|101908527|FG000|COMPLETED|Overall Study||11||
48642419|NCT02260622|101908528|FG001|COMPLETED|Overall Study||9||
48642420|NCT02260622|101908527|FG000|NOT COMPLETED|Overall Study||0||
48642421|NCT02260622|101908528|FG001|NOT COMPLETED|Overall Study||0||
48642422|NCT01671059|101908529|FG000|STARTED|Overall Study||80||
48764946|NCT04123470|102212071|FG000|COMPLETED|Group 1: LOAd703 Dose Level 1x10e11 VP||3||
48764947|NCT04123470|102212072|FG001|COMPLETED|Group 1: LOAd703 Dose Level 1x10e11 VP||0||
48764948|NCT04123470|102212071|FG000|NOT COMPLETED|Group 1: LOAd703 Dose Level 1x10e11 VP||4||
48764949|NCT04123470|102212072|FG001|NOT COMPLETED|Group 1: LOAd703 Dose Level 1x10e11 VP||0||
48764950|NCT04123470|102212071|FG000|STARTED|Group 2: LOAd703 Dose Level 5x10e11 VP||0||
48764951|NCT04123470|102212072|FG001|STARTED|Group 2: LOAd703 Dose Level 5x10e11 VP||17||
48764952|NCT04123470|102212071|FG000|COMPLETED|Group 2: LOAd703 Dose Level 5x10e11 VP||0||
48764953|NCT04123470|102212072|FG001|COMPLETED|Group 2: LOAd703 Dose Level 5x10e11 VP||8||
48764954|NCT04123470|102212071|FG000|NOT COMPLETED|Group 2: LOAd703 Dose Level 5x10e11 VP||0||
48764955|NCT04123470|102212072|FG001|NOT COMPLETED|Group 2: LOAd703 Dose Level 5x10e11 VP||9||
48764956|NCT02807402|102212073|FG000|STARTED|Overall Study||522||
48764957|NCT02807402|102212073|FG000|COMPLETED|Overall Study||516|HCV ribonucleic acid (RNA) treatment assessment performed at least 10 weeks post-treatment|
48764958|NCT02807402|102212073|FG000|NOT COMPLETED|Overall Study||6||
48764959|NCT01374438|102214555|FG000|STARTED|Overall Study||16||
48764960|NCT01374438|102214556|FG001|STARTED|Overall Study||13||
48764961|NCT01374438|102214555|FG000|COMPLETED|Overall Study||16||
48764962|NCT01374438|102214556|FG001|COMPLETED|Overall Study||13||
48764963|NCT01374438|102214555|FG000|NOT COMPLETED|Overall Study||0||
48764964|NCT01374438|102214556|FG001|NOT COMPLETED|Overall Study||0||
48764965|NCT02431637|102214557|FG000|STARTED|Overall Study||6||
48764966|NCT02431637|102214557|FG000|COMPLETED|Overall Study||6||
48764967|NCT02431637|102214557|FG000|NOT COMPLETED|Overall Study||0||
48764968|NCT03051178|102214558|FG000|STARTED|Overall Study||17||
48764969|NCT03051178|102214558|FG000|Implementation of Responsive DBS Based on Wearable Sensors|Overall Study||12||
48764970|NCT03051178|102214558|FG000|COMPLETED|Overall Study||12||
48764971|NCT03051178|102214558|FG000|NOT COMPLETED|Overall Study||5||
48764972|NCT02749422|102214559|FG000|STARTED|Overall Study||0||
48764973|NCT02749422|102214560|FG001|STARTED|Overall Study||8||
48764974|NCT02749422|102214559|FG000|COMPLETED|Overall Study||0||
48764975|NCT02749422|102214560|FG001|COMPLETED|Overall Study||5||
48764976|NCT02749422|102214559|FG000|NOT COMPLETED|Overall Study||0||
48764977|NCT02749422|102214560|FG001|NOT COMPLETED|Overall Study||3||
48764978|NCT03100149|102214561|FG000|STARTED|Overall Study||105||
48764979|NCT03100149|102214562|FG001|STARTED|Overall Study||105||
48764980|NCT03100149|102214563|FG002|STARTED|Overall Study||106||
48764981|NCT03100149|102214561|FG000|COMPLETED|Overall Study||105|Completed Part 1|
48764982|NCT03100149|102214562|FG001|COMPLETED|Overall Study||101|Completed Part 1|
48764983|NCT03100149|102214563|FG002|COMPLETED|Overall Study||104|Completed Part 1|
48764984|NCT03100149|102214561|FG000|NOT COMPLETED|Overall Study||0||
48764985|NCT03100149|102214562|FG001|NOT COMPLETED|Overall Study||4||
48764986|NCT03100149|102214563|FG002|NOT COMPLETED|Overall Study||2||
48764987|NCT03067077|102214564|FG000|STARTED|Overall Study||44||44
48764988|NCT03067077|102214565|FG001|STARTED|Overall Study||44||44
48764989|NCT03067077|102214564|FG000|Received Surgery|Overall Study||40||40
48764990|NCT03067077|102214565|FG001|Received Surgery|Overall Study||39||39
48764991|NCT03067077|102214564|FG000|COMPLETED|Overall Study||37||37
48764992|NCT03067077|102214565|FG001|COMPLETED|Overall Study||37||37
48764993|NCT03067077|102214564|FG000|NOT COMPLETED|Overall Study||7||7
48764994|NCT03067077|102214565|FG001|NOT COMPLETED|Overall Study||7||7
48764995|NCT01456039|102214566|FG000|STARTED|Phase 1 (First Step)||3||
48764996|NCT01456039|102214567|FG001|STARTED|Phase 1 (First Step)||8||
48764997|NCT01456039|102214568|FG002|STARTED|Phase 1 (First Step)||0||
48764998|NCT01456039|102214566|FG000|COMPLETED|Phase 1 (First Step)||1||
48764999|NCT01456039|102214567|FG001|COMPLETED|Phase 1 (First Step)||1||
48765000|NCT01456039|102214568|FG002|COMPLETED|Phase 1 (First Step)||0||
48765001|NCT01456039|102214566|FG000|NOT COMPLETED|Phase 1 (First Step)||2||
48765002|NCT01456039|102214567|FG001|NOT COMPLETED|Phase 1 (First Step)||7||
48765003|NCT01456039|102214568|FG002|NOT COMPLETED|Phase 1 (First Step)||0||
48765004|NCT01456039|102214566|FG000|STARTED|Phase 2 (Second Step)||0||
48765005|NCT01456039|102214567|FG001|STARTED|Phase 2 (Second Step)||0||
48765006|NCT01456039|102214568|FG002|STARTED|Phase 2 (Second Step)||40||
48765007|NCT01456039|102214566|FG000|COMPLETED|Phase 2 (Second Step)||0||
48765008|NCT01456039|102214567|FG001|COMPLETED|Phase 2 (Second Step)||0||
48765009|NCT01456039|102214568|FG002|COMPLETED|Phase 2 (Second Step)||7||
48765010|NCT01456039|102214566|FG000|NOT COMPLETED|Phase 2 (Second Step)||0||
48765011|NCT01456039|102214567|FG001|NOT COMPLETED|Phase 2 (Second Step)||0||
48765012|NCT01456039|102214568|FG002|NOT COMPLETED|Phase 2 (Second Step)||33||
48765013|NCT01217229|102214569|FG000|STARTED|Overall Study||20||
48765014|NCT01217229|102214569|FG000|COMPLETED|Overall Study||0||
48765015|NCT01217229|102214569|FG000|NOT COMPLETED|Overall Study||20||
48765016|NCT02961894|102214570|FG000|STARTED|Overall Study||121||
48765017|NCT02961894|102214570|FG000|COMPLETED|Overall Study||121||
48765018|NCT02961894|102214570|FG000|NOT COMPLETED|Overall Study||0||
48765019|NCT01748292|102214571|FG000|STARTED|Overall Study||20||
48765020|NCT01748292|102214572|FG001|STARTED|Overall Study||40||
48765021|NCT01748292|102214571|FG000|COMPLETED|Overall Study||18||
48765022|NCT01748292|102214572|FG001|COMPLETED|Overall Study||28||
48765023|NCT01748292|102214571|FG000|NOT COMPLETED|Overall Study||2||
48765024|NCT01748292|102214572|FG001|NOT COMPLETED|Overall Study||12||
48765025|NCT04080505|102214573|FG000|STARTED|Overall Study||16||
48765026|NCT04080505|102214574|FG001|STARTED|Overall Study||11||
48765027|NCT04080505|102214573|FG000|COMPLETED|Overall Study||16||
48765028|NCT04080505|102214574|FG001|COMPLETED|Overall Study||11||
48765029|NCT04080505|102214573|FG000|NOT COMPLETED|Overall Study||0||
48765030|NCT04080505|102214574|FG001|NOT COMPLETED|Overall Study||0||
48765031|NCT05283031|102214575|FG000|STARTED|Overall Study||46||
48765032|NCT05283031|102214575|FG000|COMPLETED|Overall Study||42||
48765033|NCT05283031|102214575|FG000|NOT COMPLETED|Overall Study||4||
48765034|NCT05135767|102214576|FG000|STARTED|Baseline||29||
48765035|NCT05135767|102214577|FG001|STARTED|Baseline||8||
48765036|NCT05135767|102214576|FG000|COMPLETED|Baseline||28||
48765037|NCT05135767|102214577|FG001|COMPLETED|Baseline||5||
48765038|NCT05135767|102214576|FG000|NOT COMPLETED|Baseline||1||
48765039|NCT05135767|102214577|FG001|NOT COMPLETED|Baseline||3||
48765040|NCT05135767|102214576|FG000|STARTED|Active Study Phase||28||
48765041|NCT05135767|102214577|FG001|STARTED|Active Study Phase||5||
48765042|NCT05135767|102214576|FG000|Week 1|Active Study Phase||27||
48765043|NCT05135767|102214577|FG001|Week 1|Active Study Phase||5||
48765044|NCT05135767|102214576|FG000|Week 2|Active Study Phase||27||
48765045|NCT05135767|102214577|FG001|Week 2|Active Study Phase||5||
48765046|NCT05135767|102214576|FG000|COMPLETED|Active Study Phase||26|Week 3|
48765047|NCT05135767|102214577|FG001|COMPLETED|Active Study Phase||5|Week 3|
48765048|NCT05135767|102214576|FG000|NOT COMPLETED|Active Study Phase||2||
48765049|NCT05135767|102214577|FG001|NOT COMPLETED|Active Study Phase||0||
48765050|NCT04944992|102214578|FG000|STARTED|Overall Study||72||
48435594|NCT01238861|101400059|FG002|STARTED|Overall Study||81||
48435595|NCT01238861|101400060|FG003|STARTED|Overall Study||82||
48435596|NCT01238861|101400061|FG004|STARTED|Overall Study||142||
48435597|NCT01238861|101400062|FG005|STARTED|Overall Study||140||
48435598|NCT01238861|101400057|FG000|COMPLETED|Overall Study||69||
48435599|NCT01238861|101400058|FG001|COMPLETED|Overall Study||73||
48435600|NCT01238861|101400059|FG002|COMPLETED|Overall Study||70||
48435601|NCT01238861|101400060|FG003|COMPLETED|Overall Study||69||
48435602|NCT01238861|101400061|FG004|COMPLETED|Overall Study||129||
48435603|NCT01238861|101400062|FG005|COMPLETED|Overall Study||125||
48435604|NCT01238861|101400057|FG000|NOT COMPLETED|Overall Study||11||
48435605|NCT01238861|101400058|FG001|NOT COMPLETED|Overall Study||8||
48435606|NCT01238861|101400059|FG002|NOT COMPLETED|Overall Study||11||
48435607|NCT01238861|101400060|FG003|NOT COMPLETED|Overall Study||13||
48435608|NCT01238861|101400061|FG004|NOT COMPLETED|Overall Study||13||
48435609|NCT01238861|101400062|FG005|NOT COMPLETED|Overall Study||15||
48435610|NCT01484691|101400063|FG000|STARTED|Overall Study||21||
48435611|NCT01484691|101400064|FG001|STARTED|Overall Study||22||
48435612|NCT01484691|101400065|FG002|STARTED|Overall Study||12||
48435613|NCT01484691|101400063|FG000|COMPLETED|Overall Study||20||
48435614|NCT01484691|101400064|FG001|COMPLETED|Overall Study||19||
48435615|NCT01484691|101400065|FG002|COMPLETED|Overall Study||10||
48435616|NCT01484691|101400063|FG000|NOT COMPLETED|Overall Study||1||
48435617|NCT01484691|101400064|FG001|NOT COMPLETED|Overall Study||3||
48435618|NCT01484691|101400065|FG002|NOT COMPLETED|Overall Study||2||
48435619|NCT01756586|101400066|FG000|STARTED|Overall Study||2||
48435620|NCT01756586|101400067|FG001|STARTED|Overall Study||2||
48435621|NCT01756586|101400066|FG000|COMPLETED|Overall Study||0||
48435622|NCT01756586|101400067|FG001|COMPLETED|Overall Study||0||
48435623|NCT01756586|101400066|FG000|NOT COMPLETED|Overall Study||2||
48435624|NCT01756586|101400067|FG001|NOT COMPLETED|Overall Study||2||
48435625|NCT01118949|101400068|FG000|STARTED|Overall Study||49||
48435626|NCT01118949|101400068|FG000|COMPLETED|Overall Study||40||
48435627|NCT01118949|101400068|FG000|NOT COMPLETED|Overall Study||9||
48435628|NCT00998166|101400069|FG000|STARTED|Overall Study||8||
48435629|NCT00998166|101400069|FG000|COMPLETED|Overall Study||0||
48435630|NCT00998166|101400069|FG000|NOT COMPLETED|Overall Study||8||
48435631|NCT03022526|101400070|FG000|STARTED|Overall Study||31||
48435632|NCT03022526|101400071|FG001|STARTED|Overall Study||30||
48435633|NCT03022526|101400070|FG000|COMPLETED|Overall Study||21||
48435634|NCT03022526|101400071|FG001|COMPLETED|Overall Study||25||
48435635|NCT03022526|101400070|FG000|NOT COMPLETED|Overall Study||10||
48765051|NCT04944992|102214579|FG001|STARTED|Overall Study||73||
48765052|NCT04944992|102214578|FG000|COMPLETED|Overall Study||64||
48765053|NCT04944992|102214579|FG001|COMPLETED|Overall Study||71||
48765054|NCT04944992|102214578|FG000|NOT COMPLETED|Overall Study||8||
48765055|NCT04944992|102214579|FG001|NOT COMPLETED|Overall Study||2||
48765056|NCT00361296|102214580|FG000|STARTED|Overall Study||5||
48765057|NCT00361296|102214580|FG000|COMPLETED|Overall Study||2||
48765058|NCT00361296|102214580|FG000|NOT COMPLETED|Overall Study||3||
48765059|NCT01393821|102214581|FG000|STARTED|Overall Study||14|eligible participants|
48765060|NCT01393821|102214582|FG001|STARTED|Overall Study||13|eligible participants|
48765061|NCT01393821|102214581|FG000|COMPLETED|Overall Study||9|evaluable for primary endpoint|
48765062|NCT01393821|102214582|FG001|COMPLETED|Overall Study||10|evaluable for primary endpoint|
48765063|NCT01393821|102214581|FG000|NOT COMPLETED|Overall Study||5||
48765064|NCT01393821|102214582|FG001|NOT COMPLETED|Overall Study||3||
48765065|NCT02113982|102214583|FG000|STARTED|Stage 1: Dose Escalation||3||
48765066|NCT02113982|102214584|FG001|STARTED|Stage 1: Dose Escalation||3||
48765067|NCT02113982|102214585|FG002|STARTED|Stage 1: Dose Escalation||2||
48765068|NCT02113982|102214586|FG003|STARTED|Stage 1: Dose Escalation||6||
48765069|NCT02113982|102214587|FG004|STARTED|Stage 1: Dose Escalation||3||
48435636|NCT03022526|101400071|FG001|NOT COMPLETED|Overall Study||5||
48435637|NCT01383759|101400072|FG000|STARTED|Overall Study||19||
48435638|NCT01383759|101400073|FG001|STARTED|Overall Study||1||
48435639|NCT01383759|101400072|FG000|COMPLETED|Overall Study||19||
48435640|NCT01383759|101400073|FG001|COMPLETED|Overall Study||1||
48435641|NCT01383759|101400072|FG000|NOT COMPLETED|Overall Study||0||
48435642|NCT01383759|101400073|FG001|NOT COMPLETED|Overall Study||0||
48435643|NCT04505592|101400074|FG000|STARTED|Overall Study||8||
48435644|NCT04505592|101400075|FG001|STARTED|Overall Study||5||
48435645|NCT04505592|101400074|FG000|COMPLETED|Overall Study||6||
48435646|NCT04505592|101400075|FG001|COMPLETED|Overall Study||4||
48435647|NCT04505592|101400074|FG000|NOT COMPLETED|Overall Study||2||
48435648|NCT04505592|101400075|FG001|NOT COMPLETED|Overall Study||1||
48435649|NCT04887922|101400076|FG000|STARTED|1st Randomization||1||
48435650|NCT04887922|101400077|FG001|STARTED|1st Randomization||1||
48435651|NCT04887922|101400078|FG002|STARTED|1st Randomization||0||
48435652|NCT04887922|101400079|FG003|STARTED|1st Randomization||0||
48435653|NCT04887922|101400080|FG004|STARTED|1st Randomization||0||
48435654|NCT04887922|101400076|FG000|COMPLETED|1st Randomization||1||
48435655|NCT04887922|101400077|FG001|COMPLETED|1st Randomization||0||
48435656|NCT04887922|101400078|FG002|COMPLETED|1st Randomization||0||
48435657|NCT04887922|101400079|FG003|COMPLETED|1st Randomization||0||
48435658|NCT04887922|101400080|FG004|COMPLETED|1st Randomization||0||
48435659|NCT04887922|101400076|FG000|NOT COMPLETED|1st Randomization||0||
48435660|NCT04887922|101400077|FG001|NOT COMPLETED|1st Randomization||1||
48435661|NCT04887922|101400078|FG002|NOT COMPLETED|1st Randomization||0||
48435662|NCT04887922|101400079|FG003|NOT COMPLETED|1st Randomization||0||
48435663|NCT04887922|101400080|FG004|NOT COMPLETED|1st Randomization||0||
48435664|NCT04887922|101400076|FG000|STARTED|2nd Randomization||0||
48435665|NCT04887922|101400077|FG001|STARTED|2nd Randomization||0||
48435666|NCT04887922|101400078|FG002|STARTED|2nd Randomization||0||
48435667|NCT04887922|101400079|FG003|STARTED|2nd Randomization||0||
48435668|NCT04887922|101400080|FG004|STARTED|2nd Randomization||1||
48435669|NCT04887922|101400076|FG000|COMPLETED|2nd Randomization||0||
48435670|NCT04887922|101400077|FG001|COMPLETED|2nd Randomization||0||
48435671|NCT04887922|101400078|FG002|COMPLETED|2nd Randomization||0||
48435672|NCT04887922|101400079|FG003|COMPLETED|2nd Randomization||0||
48435673|NCT04887922|101400080|FG004|COMPLETED|2nd Randomization||1||
48435674|NCT04887922|101400076|FG000|NOT COMPLETED|2nd Randomization||0||
48435675|NCT04887922|101400077|FG001|NOT COMPLETED|2nd Randomization||0||
48435676|NCT04887922|101400078|FG002|NOT COMPLETED|2nd Randomization||0||
48435677|NCT04887922|101400079|FG003|NOT COMPLETED|2nd Randomization||0||
48435678|NCT04887922|101400080|FG004|NOT COMPLETED|2nd Randomization||0||
48435679|NCT00620191|101400081|FG000|STARTED|Overall Study||40||
48435680|NCT00620191|101400082|FG001|STARTED|Overall Study||40||
48435681|NCT00620191|101400081|FG000|3 Month Follow-up|Overall Study||39||
48435682|NCT00620191|101400082|FG001|3 Month Follow-up|Overall Study||39||
48435683|NCT00620191|101400081|FG000|6 Month Follow-up|Overall Study||38||
48435684|NCT00620191|101400082|FG001|6 Month Follow-up|Overall Study||36||
48435685|NCT00620191|101400081|FG000|9 Month Follow-up|Overall Study||37||
48435686|NCT00620191|101400082|FG001|9 Month Follow-up|Overall Study||34||
48435687|NCT00620191|101400081|FG000|COMPLETED|Overall Study||33||
48435688|NCT00620191|101400082|FG001|COMPLETED|Overall Study||32||
48435689|NCT00620191|101400081|FG000|NOT COMPLETED|Overall Study||7||
48435690|NCT00620191|101400082|FG001|NOT COMPLETED|Overall Study||8||
48435691|NCT03056456|101400083|FG000|STARTED|Period 1||6||
48435692|NCT03056456|101400084|FG001|STARTED|Period 1||6||
48765070|NCT02113982|102214588|FG005|STARTED|Stage 1: Dose Escalation||3||
48765071|NCT02113982|102214589|FG006|STARTED|Stage 1: Dose Escalation||3||
48765072|NCT02113982|102214590|FG007|STARTED|Stage 1: Dose Escalation||0||
48765073|NCT02113982|102214591|FG008|STARTED|Stage 1: Dose Escalation||0||
48765074|NCT02113982|102214592|FG009|STARTED|Stage 1: Dose Escalation||0||
48435693|NCT03056456|101400085|FG002|STARTED|Period 1||6||
48435694|NCT03056456|101400086|FG003|STARTED|Period 1||6||
48435695|NCT03056456|101400083|FG000|Received One Dose of Study Drug|Period 1||6||
48435696|NCT03056456|101400084|FG001|Received One Dose of Study Drug|Period 1||6||
48435697|NCT03056456|101400085|FG002|Received One Dose of Study Drug|Period 1||6||
48435698|NCT03056456|101400086|FG003|Received One Dose of Study Drug|Period 1||6||
48435699|NCT03056456|101400083|FG000|COMPLETED|Period 1||6||
48435700|NCT03056456|101400084|FG001|COMPLETED|Period 1||6||
48435701|NCT03056456|101400085|FG002|COMPLETED|Period 1||6||
48435702|NCT03056456|101400086|FG003|COMPLETED|Period 1||6||
48435703|NCT03056456|101400083|FG000|NOT COMPLETED|Period 1||0||
48435704|NCT03056456|101400084|FG001|NOT COMPLETED|Period 1||0||
48435705|NCT03056456|101400085|FG002|NOT COMPLETED|Period 1||0||
48435706|NCT03056456|101400086|FG003|NOT COMPLETED|Period 1||0||
48435707|NCT03056456|101400083|FG000|STARTED|Period 2||6||
48435708|NCT03056456|101400084|FG001|STARTED|Period 2||6||
48435709|NCT03056456|101400085|FG002|STARTED|Period 2||6||
48765075|NCT02113982|102214593|FG010|STARTED|Stage 1: Dose Escalation||0||
48765076|NCT02113982|102214594|FG011|STARTED|Stage 1: Dose Escalation||0||
48765077|NCT02113982|102214595|FG012|STARTED|Stage 1: Dose Escalation||0||
48765078|NCT02113982|102214596|FG013|STARTED|Stage 1: Dose Escalation||0||
48765079|NCT02113982|102214583|FG000|COMPLETED|Stage 1: Dose Escalation||0||
48435710|NCT03056456|101400086|FG003|STARTED|Period 2||6||
48435711|NCT03056456|101400083|FG000|COMPLETED|Period 2||6||
48435712|NCT03056456|101400084|FG001|COMPLETED|Period 2||6||
48435713|NCT03056456|101400085|FG002|COMPLETED|Period 2||6||
48435714|NCT03056456|101400086|FG003|COMPLETED|Period 2||6||
48435715|NCT03056456|101400083|FG000|NOT COMPLETED|Period 2||0||
48435716|NCT03056456|101400084|FG001|NOT COMPLETED|Period 2||0||
48435717|NCT03056456|101400085|FG002|NOT COMPLETED|Period 2||0||
48435718|NCT03056456|101400086|FG003|NOT COMPLETED|Period 2||0||
48435719|NCT03056456|101400083|FG000|STARTED|Period 3||6||
48435720|NCT03056456|101400084|FG001|STARTED|Period 3||6||
48435721|NCT03056456|101400085|FG002|STARTED|Period 3||6||
48435722|NCT03056456|101400086|FG003|STARTED|Period 3||6||
48435723|NCT03056456|101400083|FG000|COMPLETED|Period 3||6||
48642423|NCT01671059|101908529|FG000|COMPLETED|Overall Study||75||
48642424|NCT01671059|101908529|FG000|NOT COMPLETED|Overall Study||5||
48642425|NCT02406612|101908530|FG000|STARTED|Overall Study||26||
48642426|NCT02406612|101908531|FG001|STARTED|Overall Study||21||
48642427|NCT02406612|101908530|FG000|COMPLETED|Overall Study||22||
48642428|NCT02406612|101908531|FG001|COMPLETED|Overall Study||17||
48642429|NCT02406612|101908530|FG000|NOT COMPLETED|Overall Study||4||
48642430|NCT02406612|101908531|FG001|NOT COMPLETED|Overall Study||4||
48642431|NCT02788045|101908532|FG000|STARTED|Main Study (Up to Week 72)||110||
48642432|NCT02788045|101908533|FG001|STARTED|Main Study (Up to Week 72)||55||
48642433|NCT02788045|101908534|FG002|STARTED|Main Study (Up to Week 72)||33||
48642434|NCT02788045|101908532|FG000|COMPLETED|Main Study (Up to Week 72)||94||
48642435|NCT02788045|101908533|FG001|COMPLETED|Main Study (Up to Week 72)||45||
48642436|NCT02788045|101908534|FG002|COMPLETED|Main Study (Up to Week 72)||28||
48642437|NCT02788045|101908532|FG000|NOT COMPLETED|Main Study (Up to Week 72)||16||
48642438|NCT02788045|101908533|FG001|NOT COMPLETED|Main Study (Up to Week 72)||10||
48642439|NCT02788045|101908534|FG002|NOT COMPLETED|Main Study (Up to Week 72)||5||
48642440|NCT02788045|101908532|FG000|STARTED|Long Term Extension (From Wk 72 to 264)||77||
48642441|NCT02788045|101908533|FG001|STARTED|Long Term Extension (From Wk 72 to 264)||0||
48642442|NCT02788045|101908534|FG002|STARTED|Long Term Extension (From Wk 72 to 264)||0||
48642443|NCT02788045|101908532|FG000|COMPLETED|Long Term Extension (From Wk 72 to 264)||60||
48642444|NCT02788045|101908533|FG001|COMPLETED|Long Term Extension (From Wk 72 to 264)||0||
48642445|NCT02788045|101908534|FG002|COMPLETED|Long Term Extension (From Wk 72 to 264)||0||
48642446|NCT02788045|101908532|FG000|NOT COMPLETED|Long Term Extension (From Wk 72 to 264)||17||
48642447|NCT02788045|101908533|FG001|NOT COMPLETED|Long Term Extension (From Wk 72 to 264)||0||
48642448|NCT02788045|101908534|FG002|NOT COMPLETED|Long Term Extension (From Wk 72 to 264)||0||
48642449|NCT01214720|101908535|FG000|STARTED|Overall Study||306||
48642450|NCT01214720|101908536|FG001|STARTED|Overall Study||301||
48642451|NCT01214720|101908535|FG000|COMPLETED|Overall Study||221||
48642452|NCT01214720|101908536|FG001|COMPLETED|Overall Study||233||
48642453|NCT01214720|101908535|FG000|NOT COMPLETED|Overall Study||85||
48642454|NCT01214720|101908536|FG001|NOT COMPLETED|Overall Study||68||
48642455|NCT02709369|101908537|FG000|STARTED|Overall Study||300||
48435724|NCT03056456|101400084|FG001|COMPLETED|Period 3||6||
48435725|NCT03056456|101400085|FG002|COMPLETED|Period 3||6||
48435726|NCT03056456|101400086|FG003|COMPLETED|Period 3||6||
48435727|NCT03056456|101400083|FG000|NOT COMPLETED|Period 3||0||
48435728|NCT03056456|101400084|FG001|NOT COMPLETED|Period 3||0||
48435729|NCT03056456|101400085|FG002|NOT COMPLETED|Period 3||0||
48435730|NCT03056456|101400086|FG003|NOT COMPLETED|Period 3||0||
48435731|NCT03056456|101400083|FG000|STARTED|Period 4||6||
48435732|NCT03056456|101400084|FG001|STARTED|Period 4||6||
48435733|NCT03056456|101400085|FG002|STARTED|Period 4||6||
48435734|NCT03056456|101400086|FG003|STARTED|Period 4||5||
48435735|NCT03056456|101400083|FG000|COMPLETED|Period 4||6||
48435736|NCT03056456|101400084|FG001|COMPLETED|Period 4||6||
48435737|NCT03056456|101400085|FG002|COMPLETED|Period 4||6||
48435738|NCT03056456|101400086|FG003|COMPLETED|Period 4||5||
48642456|NCT02709369|101908537|FG000|COMPLETED|Overall Study||273||
48642457|NCT02709369|101908537|FG000|NOT COMPLETED|Overall Study||27||
48642458|NCT01751685|101908538|FG000|STARTED|6-mo Followup||51||
48642459|NCT01751685|101908539|FG001|STARTED|6-mo Followup||48||
48642460|NCT01751685|101908538|FG000|COMPLETED|6-mo Followup||48||
48765080|NCT02113982|102214584|FG001|COMPLETED|Stage 1: Dose Escalation||0||
48765081|NCT02113982|102214585|FG002|COMPLETED|Stage 1: Dose Escalation||0||
48765082|NCT02113982|102214586|FG003|COMPLETED|Stage 1: Dose Escalation||0||
48642461|NCT01751685|101908539|FG001|COMPLETED|6-mo Followup||45||
48765083|NCT02113982|102214587|FG004|COMPLETED|Stage 1: Dose Escalation||0||
48765084|NCT02113982|102214588|FG005|COMPLETED|Stage 1: Dose Escalation||0||
48765085|NCT02113982|102214589|FG006|COMPLETED|Stage 1: Dose Escalation||0||
48435739|NCT03056456|101400083|FG000|NOT COMPLETED|Period 4||0||
48435740|NCT03056456|101400084|FG001|NOT COMPLETED|Period 4||0||
48435741|NCT03056456|101400085|FG002|NOT COMPLETED|Period 4||0||
48435742|NCT03056456|101400086|FG003|NOT COMPLETED|Period 4||0||
48435743|NCT03814824|101400087|FG000|STARTED|Overall Study||67||
48435744|NCT03814824|101400088|FG001|STARTED|Overall Study||66||
48435745|NCT03814824|101400087|FG000|COMPLETED|Overall Study||67||
48435746|NCT03814824|101400088|FG001|COMPLETED|Overall Study||66||
48435747|NCT03814824|101400087|FG000|NOT COMPLETED|Overall Study||0||
48642462|NCT01751685|101908538|FG000|NOT COMPLETED|6-mo Followup||3||
48642463|NCT01751685|101908539|FG001|NOT COMPLETED|6-mo Followup||3||
48642464|NCT01751685|101908538|FG000|STARTED|12-mo Followup||48||
48642465|NCT01751685|101908539|FG001|STARTED|12-mo Followup||45||
48642466|NCT01751685|101908538|FG000|COMPLETED|12-mo Followup||43||
48642467|NCT01751685|101908539|FG001|COMPLETED|12-mo Followup||45||
48642468|NCT01751685|101908538|FG000|NOT COMPLETED|12-mo Followup||5||
48642469|NCT01751685|101908539|FG001|NOT COMPLETED|12-mo Followup||0||
48642470|NCT02441283|101908540|FG000|STARTED|Overall Study||377||
48642471|NCT02441283|101908540|FG000|COMPLETED|Overall Study||287||
48642472|NCT02441283|101908540|FG000|NOT COMPLETED|Overall Study||90||
48642473|NCT03822416|101908541|FG000|STARTED|Overall Study||19||
48642474|NCT03822416|101908542|FG001|STARTED|Overall Study||19||
48642475|NCT03822416|101908541|FG000|COMPLETED|Overall Study||18||
48642476|NCT03822416|101908542|FG001|COMPLETED|Overall Study||18||
48642477|NCT03822416|101908541|FG000|NOT COMPLETED|Overall Study||1||
48642478|NCT03822416|101908542|FG001|NOT COMPLETED|Overall Study||1||
48642479|NCT03823131|101908543|FG000|STARTED|Overall Study||14||
48642480|NCT03823131|101908544|FG001|STARTED|Overall Study||0||
48642481|NCT03823131|101908545|FG002|STARTED|Overall Study||0||
48642482|NCT03823131|101908543|FG000|COMPLETED|Overall Study||14||
48642483|NCT03823131|101908544|FG001|COMPLETED|Overall Study||0||
48642484|NCT03823131|101908545|FG002|COMPLETED|Overall Study||0||
48642485|NCT03823131|101908543|FG000|NOT COMPLETED|Overall Study||0||
48642486|NCT03823131|101908544|FG001|NOT COMPLETED|Overall Study||0||
48642487|NCT03823131|101908545|FG002|NOT COMPLETED|Overall Study||0||
48642488|NCT02181738|101908546|FG000|STARTED|Overall Study||63||
48642489|NCT02181738|101908547|FG001|STARTED|Overall Study||80||
48642490|NCT02181738|101908548|FG002|STARTED|Overall Study||100||
48642491|NCT02181738|101908549|FG003|STARTED|Overall Study||51||
48642492|NCT02181738|101908546|FG000|N-AVD Combination Therapy Phase|Overall Study||0|Received N-AVD|
48642493|NCT02181738|101908547|FG001|N-AVD Combination Therapy Phase|Overall Study||0|Received N-AVD|
48642494|NCT02181738|101908548|FG002|N-AVD Combination Therapy Phase|Overall Study||0|Received N-AVD|
48642495|NCT02181738|101908549|FG003|N-AVD Combination Therapy Phase|Overall Study||49|Received N-AVD|
48642496|NCT02181738|101908546|FG000|N-AVD Combination Therapy Phase|Overall Study||0|Received only AVD|
48642497|NCT02181738|101908547|FG001|N-AVD Combination Therapy Phase|Overall Study||0|Received only AVD|
48642498|NCT02181738|101908548|FG002|N-AVD Combination Therapy Phase|Overall Study||0|Received only AVD|
48642499|NCT02181738|101908549|FG003|N-AVD Combination Therapy Phase|Overall Study||1|Received only AVD|
48642500|NCT02181738|101908546|FG000|COMPLETED|Overall Study||0|Completed = completed treatment as per protocol|
48642501|NCT02181738|101908547|FG001|COMPLETED|Overall Study||0|Completed = completed treatment as per protocol|
48642502|NCT02181738|101908548|FG002|COMPLETED|Overall Study||13|Completed = completed treatment as per protocol|
48642503|NCT02181738|101908549|FG003|COMPLETED|Overall Study||45|Completed = completed treatment as per protocol|
48642504|NCT02181738|101908546|FG000|NOT COMPLETED|Overall Study||63||
48642505|NCT02181738|101908547|FG001|NOT COMPLETED|Overall Study||80||
48642506|NCT02181738|101908548|FG002|NOT COMPLETED|Overall Study||87||
48642507|NCT02181738|101908549|FG003|NOT COMPLETED|Overall Study||6||
48642508|NCT03259308|101908550|FG000|STARTED|Overall Study||56||
48642509|NCT03259308|101908551|FG001|STARTED|Overall Study||111||
48642510|NCT03259308|101908552|FG002|STARTED|Overall Study||112||
48642511|NCT03259308|101908550|FG000|COMPLETED|Overall Study||49||
48642512|NCT03259308|101908551|FG001|COMPLETED|Overall Study||103||
48642513|NCT03259308|101908552|FG002|COMPLETED|Overall Study||105||
48642514|NCT03259308|101908550|FG000|NOT COMPLETED|Overall Study||7||
48642515|NCT03259308|101908551|FG001|NOT COMPLETED|Overall Study||8||
48642516|NCT03259308|101908552|FG002|NOT COMPLETED|Overall Study||7||
48642517|NCT02013427|101908553|FG000|STARTED|Overall Study||25||
48642518|NCT02013427|101908554|FG001|STARTED|Overall Study||5||
48642519|NCT02013427|101908555|FG002|STARTED|Overall Study||52||
48642520|NCT02013427|101908553|FG000|COMPLETED|Overall Study||20||
48642521|NCT02013427|101908554|FG001|COMPLETED|Overall Study||4||
48642522|NCT02013427|101908555|FG002|COMPLETED|Overall Study||43||
48642523|NCT02013427|101908553|FG000|NOT COMPLETED|Overall Study||5||
48642524|NCT02013427|101908554|FG001|NOT COMPLETED|Overall Study||1||
48642525|NCT02013427|101908555|FG002|NOT COMPLETED|Overall Study||9||
48642526|NCT01771913|101908556|FG000|STARTED|Overall Study||9||
48642527|NCT01771913|101908557|FG001|STARTED|Overall Study||11||
48642528|NCT01771913|101908556|FG000|COMPLETED|Overall Study||8||
48642529|NCT01771913|101908557|FG001|COMPLETED|Overall Study||11||
48642530|NCT01771913|101908556|FG000|NOT COMPLETED|Overall Study||1||
48642531|NCT01771913|101908557|FG001|NOT COMPLETED|Overall Study||0||
48642532|NCT01590875|101908558|FG000|STARTED|Overall Study||10||
48642533|NCT01590875|101908559|FG001|STARTED|Overall Study||10||
48642534|NCT01590875|101908558|FG000|COMPLETED|Overall Study||10||
48642535|NCT01590875|101908559|FG001|COMPLETED|Overall Study||10||
48642536|NCT01590875|101908558|FG000|NOT COMPLETED|Overall Study||0||
48642537|NCT01590875|101908559|FG001|NOT COMPLETED|Overall Study||0||
48642538|NCT00103506|101908560|FG000|STARTED|Overall Study||322||
48642539|NCT00103506|101908561|FG001|STARTED|Overall Study||324||
48642540|NCT00103506|101908560|FG000|COMPLETED|Overall Study||0||
48642541|NCT00103506|101908561|FG001|COMPLETED|Overall Study||0||
48642542|NCT00103506|101908560|FG000|NOT COMPLETED|Overall Study||322||
48642543|NCT00103506|101908561|FG001|NOT COMPLETED|Overall Study||324||
48642544|NCT00884949|101908562|FG000|STARTED|Weeks 1-12: 0.1 mg/kg/Week||20||
48642545|NCT00884949|101908562|FG000|COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||18||
48642546|NCT00884949|101908562|FG000|NOT COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||2||
48642547|NCT00884949|101908562|FG000|STARTED|Weeks 13-24: 1.0 mg/kg/Week||18||
48642548|NCT00884949|101908562|FG000|COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||18||
48435748|NCT03814824|101400088|FG001|NOT COMPLETED|Overall Study||0||
48435749|NCT02511587|101400089|FG000|STARTED|Overall Study||58||
48435750|NCT02511587|101400090|FG001|STARTED|Overall Study||58||
48435751|NCT02511587|101400089|FG000|COMPLETED|Overall Study||58||
48435752|NCT02511587|101400090|FG001|COMPLETED|Overall Study||58||
48435753|NCT02511587|101400089|FG000|NOT COMPLETED|Overall Study||0||
48435754|NCT02511587|101400090|FG001|NOT COMPLETED|Overall Study||0||
48435755|NCT01458535|101400091|FG000|STARTED|Overall Study||10||
48435756|NCT01458535|101400092|FG001|STARTED|Overall Study||10||
48435757|NCT01458535|101400093|FG002|STARTED|Overall Study||10||
48435758|NCT01458535|101400094|FG003|STARTED|Overall Study||10||
48435759|NCT01458535|101400095|FG004|STARTED|Overall Study||10||
48435760|NCT01458535|101400096|FG005|STARTED|Overall Study||11||
48435761|NCT01458535|101400091|FG000|COMPLETED|Overall Study||10||
48435762|NCT01458535|101400092|FG001|COMPLETED|Overall Study||8||
48642549|NCT00884949|101908562|FG000|NOT COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||0||
48642550|NCT00884949|101908562|FG000|STARTED|Weeks 25-36: 2.0 mg/kg/Week||18||
48642551|NCT00884949|101908562|FG000|COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||18||
48642552|NCT00884949|101908562|FG000|NOT COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||0||
48642553|NCT00884949|101908562|FG000|STARTED|Continuation Period||18||
48642554|NCT00884949|101908562|FG000|COMPLETED|Continuation Period||18||
48642555|NCT00884949|101908562|FG000|NOT COMPLETED|Continuation Period||0||
48642556|NCT02347787|101908563|FG000|STARTED|6 Month Follow-Up||288||
48642557|NCT02347787|101908564|FG001|STARTED|6 Month Follow-Up||304||
48642558|NCT02347787|101908563|FG000|COMPLETED|6 Month Follow-Up||222||
48642559|NCT02347787|101908564|FG001|COMPLETED|6 Month Follow-Up||248||
48642560|NCT02347787|101908563|FG000|NOT COMPLETED|6 Month Follow-Up||66||
48642561|NCT02347787|101908564|FG001|NOT COMPLETED|6 Month Follow-Up||56||
48642562|NCT02347787|101908563|FG000|STARTED|9 Month Follow-Up||288||
48642563|NCT02347787|101908564|FG001|STARTED|9 Month Follow-Up||304||
48435763|NCT01458535|101400093|FG002|COMPLETED|Overall Study||8||
48435764|NCT01458535|101400094|FG003|COMPLETED|Overall Study||6||
48435765|NCT01458535|101400095|FG004|COMPLETED|Overall Study||6||
48642564|NCT02347787|101908563|FG000|COMPLETED|9 Month Follow-Up||227||
48642565|NCT02347787|101908564|FG001|COMPLETED|9 Month Follow-Up||233||
48642566|NCT02347787|101908563|FG000|NOT COMPLETED|9 Month Follow-Up||61||
48642567|NCT02347787|101908564|FG001|NOT COMPLETED|9 Month Follow-Up||71||
48642568|NCT01181128|101908565|FG000|STARTED|Overall Study||118||
48642569|NCT01181128|101908566|FG001|STARTED|Overall Study||24||
48642570|NCT01181128|101908567|FG002|STARTED|Overall Study||23||
48642571|NCT01181128|101908565|FG000|Pharmacokinetic (PK) Subgroup|Overall Study||30||
48642572|NCT01181128|101908566|FG001|Pharmacokinetic (PK) Subgroup|Overall Study||0||
48642573|NCT01181128|101908567|FG002|Pharmacokinetic (PK) Subgroup|Overall Study||0||
48642574|NCT01181128|101908565|FG000|Perioperative Management Subgroup|Overall Study||8||
48642575|NCT01181128|101908566|FG001|Perioperative Management Subgroup|Overall Study||1||
48642576|NCT01181128|101908567|FG002|Perioperative Management Subgroup|Overall Study||0||
48642577|NCT01181128|101908565|FG000|COMPLETED|Overall Study||112||
48642578|NCT01181128|101908566|FG001|COMPLETED|Overall Study||19||
48642579|NCT01181128|101908567|FG002|COMPLETED|Overall Study||22||
48642580|NCT01181128|101908565|FG000|NOT COMPLETED|Overall Study||6||
48642581|NCT01181128|101908566|FG001|NOT COMPLETED|Overall Study||5||
48642582|NCT01181128|101908567|FG002|NOT COMPLETED|Overall Study||1||
48642583|NCT00032487|101908568|FG000|STARTED|Overall Study||899||
48435766|NCT01458535|101400096|FG005|COMPLETED|Overall Study||7||
48435767|NCT01458535|101400091|FG000|NOT COMPLETED|Overall Study||0||
48435768|NCT01458535|101400092|FG001|NOT COMPLETED|Overall Study||2||
48435769|NCT01458535|101400093|FG002|NOT COMPLETED|Overall Study||2||
48435770|NCT01458535|101400094|FG003|NOT COMPLETED|Overall Study||4||
48435771|NCT01458535|101400095|FG004|NOT COMPLETED|Overall Study||4||
48435772|NCT01458535|101400096|FG005|NOT COMPLETED|Overall Study||4||
48435773|NCT00552422|101400097|FG000|STARTED|Overall Study||6||
48435774|NCT00552422|101400097|FG000|COMPLETED|Overall Study||6||
48435775|NCT00552422|101400097|FG000|NOT COMPLETED|Overall Study||0||
48435776|NCT00678652|101400098|FG000|STARTED|Overall Study||9||
48435777|NCT00678652|101400099|FG001|STARTED|Overall Study||9||
48435778|NCT00678652|101400100|FG002|STARTED|Overall Study||9||
48435779|NCT00678652|101400101|FG003|STARTED|Overall Study||9||
48435780|NCT00678652|101400098|FG000|COMPLETED|Overall Study||6||
48435781|NCT00678652|101400099|FG001|COMPLETED|Overall Study||9||
48435782|NCT00678652|101400100|FG002|COMPLETED|Overall Study||8||
48642584|NCT00032487|101908569|FG001|STARTED|Overall Study||892||
48642585|NCT00032487|101908568|FG000|COMPLETED|Overall Study||760||
48642586|NCT00032487|101908569|FG001|COMPLETED|Overall Study||772||
48642587|NCT00032487|101908568|FG000|NOT COMPLETED|Overall Study||139||
48642588|NCT00032487|101908569|FG001|NOT COMPLETED|Overall Study||120||
48642589|NCT00614393|101908570|FG000|STARTED|Overall Study||180||
48642590|NCT00614393|101908571|FG001|STARTED|Overall Study||8||
48642591|NCT00614393|101908572|FG002|STARTED|Overall Study||10||
48642592|NCT00614393|101908573|FG003|STARTED|Overall Study||180||
48642593|NCT00614393|101908574|FG004|STARTED|Overall Study||180||
48642594|NCT00614393|101908570|FG000|Treated|Overall Study||180||
48642595|NCT00614393|101908571|FG001|Treated|Overall Study||8||
48642596|NCT00614393|101908572|FG002|Treated|Overall Study||10||
48642597|NCT00614393|101908573|FG003|Treated|Overall Study||180||
48642598|NCT00614393|101908574|FG004|Treated|Overall Study||178||
48642599|NCT00614393|101908570|FG000|COMPLETED|Overall Study||0||
48642600|NCT00614393|101908571|FG001|COMPLETED|Overall Study||0||
48642601|NCT00614393|101908572|FG002|COMPLETED|Overall Study||0||
48642602|NCT00614393|101908573|FG003|COMPLETED|Overall Study||0||
48642603|NCT00614393|101908574|FG004|COMPLETED|Overall Study||0||
48642604|NCT00614393|101908570|FG000|NOT COMPLETED|Overall Study||180||
48642605|NCT00614393|101908571|FG001|NOT COMPLETED|Overall Study||8||
48642606|NCT00614393|101908572|FG002|NOT COMPLETED|Overall Study||10||
48642607|NCT00614393|101908573|FG003|NOT COMPLETED|Overall Study||180||
48642608|NCT00614393|101908574|FG004|NOT COMPLETED|Overall Study||180||
48642609|NCT03988647|101908575|FG000|STARTED|Overall Study||1||
48642610|NCT03988647|101908575|FG000|COMPLETED|Overall Study||1||
48642611|NCT03988647|101908575|FG000|NOT COMPLETED|Overall Study||0||
48642612|NCT02448043|101908576|FG000|STARTED|Overall Study||23||
48642613|NCT02448043|101908577|FG001|STARTED|Overall Study||22||
48642614|NCT02448043|101908576|FG000|COMPLETED|Overall Study||20||
48642615|NCT02448043|101908577|FG001|COMPLETED|Overall Study||18||
48642616|NCT02448043|101908576|FG000|NOT COMPLETED|Overall Study||3||
48642617|NCT02448043|101908577|FG001|NOT COMPLETED|Overall Study||4||
48642618|NCT04333498|101908578|FG000|STARTED|Overall Study||30||
48642619|NCT04333498|101908579|FG001|STARTED|Overall Study||30||
48642620|NCT04333498|101908578|FG000|COMPLETED|Overall Study||29||
48642621|NCT04333498|101908579|FG001|COMPLETED|Overall Study||29||
48642622|NCT04333498|101908578|FG000|NOT COMPLETED|Overall Study||1||
48642623|NCT04333498|101908579|FG001|NOT COMPLETED|Overall Study||1||
48642624|NCT02932943|101908580|FG000|STARTED|Overall Study||227||
48642625|NCT02932943|101908581|FG001|STARTED|Overall Study||231||
48642626|NCT02932943|101908580|FG000|COMPLETED|Overall Study||222||
48642627|NCT02932943|101908581|FG001|COMPLETED|Overall Study||224||
48642628|NCT02932943|101908580|FG000|NOT COMPLETED|Overall Study||5||
48642629|NCT02932943|101908581|FG001|NOT COMPLETED|Overall Study||7||
48642630|NCT02082288|101908582|FG000|STARTED|Overall Study||243||
48642631|NCT02082288|101908582|FG000|COMPLETED|Overall Study||243||
48642632|NCT02082288|101908582|FG000|NOT COMPLETED|Overall Study||0||
48642633|NCT01588509|101908583|FG000|STARTED|Overall Study||30||
48642634|NCT01588509|101908584|FG001|STARTED|Overall Study||30||
48642635|NCT01588509|101908583|FG000|Received Treatment|Overall Study||30||
48642636|NCT01588509|101908584|FG001|Received Treatment|Overall Study||30||
48642637|NCT01588509|101908583|FG000|COMPLETED|Overall Study||29||
48642638|NCT01588509|101908584|FG001|COMPLETED|Overall Study||30||
48642639|NCT01588509|101908583|FG000|NOT COMPLETED|Overall Study||1||
48642640|NCT01588509|101908584|FG001|NOT COMPLETED|Overall Study||0||
48642641|NCT02320396|101908585|FG000|STARTED|Overall Study||224||
48642642|NCT02320396|101908586|FG001|STARTED|Overall Study||225||
48642643|NCT02320396|101908585|FG000|Treated (Full Analysis Set)|Overall Study||223||
48642644|NCT02320396|101908586|FG001|Treated (Full Analysis Set)|Overall Study||225||
48642645|NCT02320396|101908585|FG000|COMPLETED|Overall Study||220||
48642646|NCT02320396|101908586|FG001|COMPLETED|Overall Study||221||
48642647|NCT02320396|101908585|FG000|NOT COMPLETED|Overall Study||4||
48642648|NCT02320396|101908586|FG001|NOT COMPLETED|Overall Study||4||
48642649|NCT00462462|101908587|FG000|STARTED|Overall Study||17||
48642650|NCT00462462|101908588|FG001|STARTED|Overall Study||14||
48642651|NCT00462462|101908587|FG000|COMPLETED|Overall Study||17||
48435783|NCT00678652|101400101|FG003|COMPLETED|Overall Study||9||
48435784|NCT00678652|101400098|FG000|NOT COMPLETED|Overall Study||3||
48435785|NCT00678652|101400099|FG001|NOT COMPLETED|Overall Study||0||
48642652|NCT00462462|101908588|FG001|COMPLETED|Overall Study||13||
48642653|NCT00462462|101908587|FG000|NOT COMPLETED|Overall Study||0||
48642654|NCT00462462|101908588|FG001|NOT COMPLETED|Overall Study||1||
48642655|NCT02315625|101908589|FG000|STARTED|First Intervention||14||
48642656|NCT02315625|101908590|FG001|STARTED|First Intervention||2||
48642657|NCT02315625|101908589|FG000|COMPLETED|First Intervention||13||
48642658|NCT02315625|101908590|FG001|COMPLETED|First Intervention||2||
48642659|NCT02315625|101908589|FG000|NOT COMPLETED|First Intervention||1||
48642660|NCT02315625|101908590|FG001|NOT COMPLETED|First Intervention||0||
48642661|NCT02315625|101908589|FG000|STARTED|Second Intervention||13||
48642662|NCT02315625|101908590|FG001|STARTED|Second Intervention||2||
48642663|NCT02315625|101908589|FG000|COMPLETED|Second Intervention||9||
48435786|NCT00678652|101400100|FG002|NOT COMPLETED|Overall Study||1||
48435787|NCT00678652|101400101|FG003|NOT COMPLETED|Overall Study||0||
48435788|NCT00731640|101400102|FG000|STARTED|Overall Study||20||
48642664|NCT02315625|101908590|FG001|COMPLETED|Second Intervention||1||
48642665|NCT02315625|101908589|FG000|NOT COMPLETED|Second Intervention||4||
48642666|NCT02315625|101908590|FG001|NOT COMPLETED|Second Intervention||1||
48435789|NCT00731640|101400103|FG001|STARTED|Overall Study||32||
48642667|NCT03491917|101908591|FG000|STARTED|First Reading Session||50||
48642668|NCT03491917|101908592|FG001|STARTED|First Reading Session||50||
48642669|NCT03491917|101908591|FG000|COMPLETED|First Reading Session||50||
48642670|NCT03491917|101908592|FG001|COMPLETED|First Reading Session||50||
48642671|NCT03491917|101908591|FG000|NOT COMPLETED|First Reading Session||0||
48642672|NCT03491917|101908592|FG001|NOT COMPLETED|First Reading Session||0||
48765086|NCT02113982|102214590|FG007|COMPLETED|Stage 1: Dose Escalation||0||
48765087|NCT02113982|102214591|FG008|COMPLETED|Stage 1: Dose Escalation||0||
48642673|NCT03491917|101908591|FG000|STARTED|4 Week Memory Washout Period||50||
48642674|NCT03491917|101908592|FG001|STARTED|4 Week Memory Washout Period||50||
48642675|NCT03491917|101908591|FG000|COMPLETED|4 Week Memory Washout Period||50||
48642676|NCT03491917|101908592|FG001|COMPLETED|4 Week Memory Washout Period||50||
48642677|NCT03491917|101908591|FG000|NOT COMPLETED|4 Week Memory Washout Period||0||
48642678|NCT03491917|101908592|FG001|NOT COMPLETED|4 Week Memory Washout Period||0||
48642679|NCT03491917|101908591|FG000|STARTED|Second Reading Session||50||
48642680|NCT03491917|101908592|FG001|STARTED|Second Reading Session||50||
48642681|NCT03491917|101908591|FG000|COMPLETED|Second Reading Session||50||
48642682|NCT03491917|101908592|FG001|COMPLETED|Second Reading Session||50||
48642683|NCT03491917|101908591|FG000|NOT COMPLETED|Second Reading Session||0||
48642684|NCT03491917|101908592|FG001|NOT COMPLETED|Second Reading Session||0||
48642685|NCT01402700|101908593|FG000|STARTED|Overall Study||75||
48642686|NCT01402700|101908593|FG000|COMPLETED|Overall Study||68||
48642687|NCT01402700|101908593|FG000|NOT COMPLETED|Overall Study||7||
48642688|NCT03380572|101908594|FG000|STARTED|Overall Study||20||
48642689|NCT03380572|101908595|FG001|STARTED|Overall Study||20||
48642690|NCT03380572|101908594|FG000|COMPLETED|Overall Study||20||
48642691|NCT03380572|101908595|FG001|COMPLETED|Overall Study||20||
48642692|NCT03380572|101908594|FG000|NOT COMPLETED|Overall Study||0||
48642693|NCT03380572|101908595|FG001|NOT COMPLETED|Overall Study||0||
48642694|NCT00002874|101908596|FG000|STARTED|Overall Study||421||
48642695|NCT00002874|101908597|FG001|STARTED|Overall Study||419||
48642696|NCT00002874|101908596|FG000|COMPLETED|Overall Study||376|Subjects with data available for the primary analysis are considered to have completed the study.|
48642697|NCT00002874|101908597|FG001|COMPLETED|Overall Study||384|Subjects with data available for the primary analysis are considered to have completed the study.|
48642698|NCT00002874|101908596|FG000|NOT COMPLETED|Overall Study||45||
48642699|NCT00002874|101908597|FG001|NOT COMPLETED|Overall Study||35||
48642700|NCT03298061|101908598|FG000|STARTED|Overall Study||100||
48642701|NCT03298061|101908598|FG000|COMPLETED|Overall Study||73||
48642702|NCT03298061|101908598|FG000|NOT COMPLETED|Overall Study||27||
48642703|NCT01191749|101908599|FG000|STARTED|Overall Study||7||
48642704|NCT01191749|101908599|FG000|COMPLETED|Overall Study||7||
48642705|NCT01191749|101908599|FG000|NOT COMPLETED|Overall Study||0||
48642706|NCT01346683|101908600|FG000|STARTED|Overall Study||45||107
48642707|NCT01346683|101908600|FG000|COMPLETED|Overall Study||45||107
48642708|NCT01346683|101908600|FG000|NOT COMPLETED|Overall Study||0||0
48642709|NCT02145676|101908601|FG000|STARTED|Overall Study||17||
48642710|NCT02145676|101908602|FG001|STARTED|Overall Study||18||
48642711|NCT02145676|101908603|FG002|STARTED|Overall Study||18||
48642712|NCT02145676|101908601|FG000|COMPLETED|Overall Study||17||
48642713|NCT02145676|101908602|FG001|COMPLETED|Overall Study||18||
48642714|NCT02145676|101908603|FG002|COMPLETED|Overall Study||18||
48642715|NCT02145676|101908601|FG000|NOT COMPLETED|Overall Study||0||
48642716|NCT02145676|101908602|FG001|NOT COMPLETED|Overall Study||0||
48642717|NCT02145676|101908603|FG002|NOT COMPLETED|Overall Study||0||
48642718|NCT00363168|101908604|FG000|STARTED|Overall Study||5||
48642719|NCT00363168|101908605|FG001|STARTED|Overall Study||2||
48642720|NCT00363168|101908604|FG000|COMPLETED|Overall Study||5||
48642721|NCT00363168|101908605|FG001|COMPLETED|Overall Study||2||
48642722|NCT00363168|101908604|FG000|NOT COMPLETED|Overall Study||0||
48642723|NCT00363168|101908605|FG001|NOT COMPLETED|Overall Study||0||
48642724|NCT02397837|101908606|FG000|STARTED|Overall Study||33||
48642725|NCT02397837|101908607|FG001|STARTED|Overall Study||30||
48642726|NCT02397837|101908606|FG000|COMPLETED|Overall Study||26||
48642727|NCT02397837|101908607|FG001|COMPLETED|Overall Study||24||
48642728|NCT02397837|101908606|FG000|NOT COMPLETED|Overall Study||7||
48642729|NCT02397837|101908607|FG001|NOT COMPLETED|Overall Study||6||
48642730|NCT00954538|101908608|FG000|STARTED|Part I||3||
48642731|NCT00954538|101908609|FG001|STARTED|Part I||0||
48642732|NCT00954538|101908610|FG002|STARTED|Part I||0||
48642733|NCT00954538|101908611|FG003|STARTED|Part I||0||
48642734|NCT00954538|101908612|FG004|STARTED|Part I||0||
48642735|NCT00954538|101908613|FG005|STARTED|Part I||0||
48642736|NCT00954538|101908608|FG000|COMPLETED|Part I||3||
48642737|NCT00954538|101908609|FG001|COMPLETED|Part I||0||
48642738|NCT00954538|101908610|FG002|COMPLETED|Part I||0||
48642739|NCT00954538|101908611|FG003|COMPLETED|Part I||0||
48642740|NCT00954538|101908612|FG004|COMPLETED|Part I||0||
48642741|NCT00954538|101908613|FG005|COMPLETED|Part I||0||
48642742|NCT00954538|101908608|FG000|NOT COMPLETED|Part I||0||
48642743|NCT00954538|101908609|FG001|NOT COMPLETED|Part I||0||
48642744|NCT00954538|101908610|FG002|NOT COMPLETED|Part I||0||
48642745|NCT00954538|101908611|FG003|NOT COMPLETED|Part I||0||
48642746|NCT00954538|101908612|FG004|NOT COMPLETED|Part I||0||
48642747|NCT00954538|101908613|FG005|NOT COMPLETED|Part I||0||
48765088|NCT02113982|102214592|FG009|COMPLETED|Stage 1: Dose Escalation||0||
48642748|NCT00954538|101908608|FG000|STARTED|Part II||0||
48642749|NCT00954538|101908609|FG001|STARTED|Part II||1||
48642750|NCT00954538|101908610|FG002|STARTED|Part II||3||
48642751|NCT00954538|101908611|FG003|STARTED|Part II||0||
48642752|NCT00954538|101908612|FG004|STARTED|Part II||0||
48642753|NCT00954538|101908613|FG005|STARTED|Part II||2||
48642754|NCT00954538|101908608|FG000|COMPLETED|Part II||0||
48642755|NCT00954538|101908609|FG001|COMPLETED|Part II||1||
48642756|NCT00954538|101908610|FG002|COMPLETED|Part II||3||
48642757|NCT00954538|101908611|FG003|COMPLETED|Part II||0||
48642758|NCT00954538|101908612|FG004|COMPLETED|Part II||0||
48642759|NCT00954538|101908613|FG005|COMPLETED|Part II||2||
48642760|NCT00954538|101908608|FG000|NOT COMPLETED|Part II||0||
48642761|NCT00954538|101908609|FG001|NOT COMPLETED|Part II||0||
48642762|NCT00954538|101908610|FG002|NOT COMPLETED|Part II||0||
48642763|NCT00954538|101908611|FG003|NOT COMPLETED|Part II||0||
48642764|NCT00954538|101908612|FG004|NOT COMPLETED|Part II||0||
48642765|NCT00954538|101908613|FG005|NOT COMPLETED|Part II||0||
48642766|NCT00954538|101908608|FG000|STARTED|Part III||0||
48642767|NCT00954538|101908609|FG001|STARTED|Part III||0||
48642768|NCT00954538|101908610|FG002|STARTED|Part III||0||
48642769|NCT00954538|101908611|FG003|STARTED|Part III||4||
48642770|NCT00954538|101908612|FG004|STARTED|Part III||6||
48642771|NCT00954538|101908613|FG005|STARTED|Part III||2||
48642772|NCT00954538|101908608|FG000|COMPLETED|Part III||0||
48642773|NCT00954538|101908609|FG001|COMPLETED|Part III||0||
48642774|NCT00954538|101908610|FG002|COMPLETED|Part III||0||
48642775|NCT00954538|101908611|FG003|COMPLETED|Part III||4||
48642776|NCT00954538|101908612|FG004|COMPLETED|Part III||5||
48642777|NCT00954538|101908613|FG005|COMPLETED|Part III||2||
48642778|NCT00954538|101908608|FG000|NOT COMPLETED|Part III||0||
48642779|NCT00954538|101908609|FG001|NOT COMPLETED|Part III||0||
48642780|NCT00954538|101908610|FG002|NOT COMPLETED|Part III||0||
48642781|NCT00954538|101908611|FG003|NOT COMPLETED|Part III||0||
48642782|NCT00954538|101908612|FG004|NOT COMPLETED|Part III||1||
48642783|NCT00954538|101908613|FG005|NOT COMPLETED|Part III||0||
48642784|NCT02965833|101908614|FG000|STARTED|Period 1, First 30 Days of Wear||67||
48642785|NCT02965833|101908615|FG001|STARTED|Period 1, First 30 Days of Wear||54||
48642786|NCT02965833|101908614|FG000|COMPLETED|Period 1, First 30 Days of Wear||64||
48642787|NCT02965833|101908615|FG001|COMPLETED|Period 1, First 30 Days of Wear||52||
48642788|NCT02965833|101908614|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||3||
48642789|NCT02965833|101908615|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||2||
48642790|NCT02965833|101908614|FG000|STARTED|Period 2, Second 30 Days of Wear||64||
48642791|NCT02965833|101908615|FG001|STARTED|Period 2, Second 30 Days of Wear||52||
48642792|NCT02965833|101908614|FG000|COMPLETED|Period 2, Second 30 Days of Wear||62||
48642793|NCT02965833|101908615|FG001|COMPLETED|Period 2, Second 30 Days of Wear||52||
48642794|NCT02965833|101908614|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||2||
48642795|NCT02965833|101908615|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||0||
48642796|NCT04502524|101908616|FG000|STARTED|Overall Study||25||
48642797|NCT04502524|101908617|FG001|STARTED|Overall Study||24||
48642798|NCT04502524|101908616|FG000|COMPLETED|Overall Study||18||
48642799|NCT04502524|101908617|FG001|COMPLETED|Overall Study||20||
48642800|NCT04502524|101908616|FG000|NOT COMPLETED|Overall Study||7||
48642801|NCT04502524|101908617|FG001|NOT COMPLETED|Overall Study||4||
48642802|NCT00849472|101908618|FG000|STARTED|Doxorubicin and Cyclophosphamide (AC)||101||
48642803|NCT00849472|101908618|FG000|COMPLETED|Doxorubicin and Cyclophosphamide (AC)||95||
48642804|NCT00849472|101908618|FG000|NOT COMPLETED|Doxorubicin and Cyclophosphamide (AC)||6||
48642805|NCT00849472|101908618|FG000|STARTED|Weekly Paclitaxel||94||
48642806|NCT00849472|101908618|FG000|COMPLETED|Weekly Paclitaxel||78||
48642807|NCT00849472|101908618|FG000|NOT COMPLETED|Weekly Paclitaxel||16||
48642808|NCT00849472|101908618|FG000|STARTED|Pazopanib Presurgery Treatment (PPT)||94||
48642809|NCT00849472|101908618|FG000|COMPLETED|Pazopanib Presurgery Treatment (PPT)||36||
48642810|NCT00849472|101908618|FG000|NOT COMPLETED|Pazopanib Presurgery Treatment (PPT)||58||
48642811|NCT00849472|101908618|FG000|STARTED|Pazopanib Postsurgery Treatment||42||
48642812|NCT00849472|101908618|FG000|COMPLETED|Pazopanib Postsurgery Treatment||16||
48642813|NCT00849472|101908618|FG000|NOT COMPLETED|Pazopanib Postsurgery Treatment||26||
48642814|NCT02665117|101908619|FG000|STARTED|Overall Study||30||
48642815|NCT02665117|101908620|FG001|STARTED|Overall Study||31||
48642816|NCT02665117|101908619|FG000|COMPLETED|Overall Study||29||
48642817|NCT02665117|101908620|FG001|COMPLETED|Overall Study||31||
48642818|NCT02665117|101908619|FG000|NOT COMPLETED|Overall Study||1||
48642819|NCT02665117|101908620|FG001|NOT COMPLETED|Overall Study||0||
48642820|NCT00580398|101908621|FG000|STARTED|Overall Study||17||
48642821|NCT00580398|101908622|FG001|STARTED|Overall Study||32||
48642822|NCT00580398|101908621|FG000|COMPLETED|Overall Study||17||
48642823|NCT00580398|101908622|FG001|COMPLETED|Overall Study||32||
48642824|NCT00580398|101908621|FG000|NOT COMPLETED|Overall Study||0||
48642825|NCT00580398|101908622|FG001|NOT COMPLETED|Overall Study||0||
48642826|NCT03113955|101908623|FG000|STARTED|Overall Study||109||
48642827|NCT03113955|101908623|FG000|COMPLETED|Overall Study||92||
48642828|NCT03113955|101908623|FG000|NOT COMPLETED|Overall Study||17||
48642829|NCT02805998|101908624|FG000|STARTED|Overall Study||105||
48642830|NCT02805998|101908625|FG001|STARTED|Overall Study||103||
48657035|NCT02018809|101943754|FG001|NOT COMPLETED|Overall Study||0||
48642831|NCT02805998|101908624|FG000|COMPLETED|Overall Study||91|Completed is defined as completing the primary outcome measure at the post-intervention timepoint.|
48642832|NCT02805998|101908625|FG001|COMPLETED|Overall Study||94|Completed is defined as completing the primary outcome measure at the post-intervention timepoint.|
48642833|NCT02805998|101908624|FG000|NOT COMPLETED|Overall Study||14||
48642834|NCT02805998|101908625|FG001|NOT COMPLETED|Overall Study||9||
48642835|NCT00504309|101908626|FG000|STARTED|Overall Study||7||
48642836|NCT00504309|101908627|FG001|STARTED|Overall Study||5||
48642837|NCT00504309|101908628|FG002|STARTED|Overall Study||2||
48642838|NCT00504309|101908629|FG003|STARTED|Overall Study||3||
48642839|NCT00504309|101908630|FG004|STARTED|Overall Study||8||
48642840|NCT00504309|101908631|FG005|STARTED|Overall Study||3||
48642841|NCT00504309|101908626|FG000|COMPLETED|Overall Study||7||
48642842|NCT00504309|101908627|FG001|COMPLETED|Overall Study||5||
48642843|NCT00504309|101908628|FG002|COMPLETED|Overall Study||1||
48642844|NCT00504309|101908629|FG003|COMPLETED|Overall Study||3||
48642845|NCT00504309|101908630|FG004|COMPLETED|Overall Study||7||
48642846|NCT00504309|101908631|FG005|COMPLETED|Overall Study||3||
48642847|NCT00504309|101908626|FG000|NOT COMPLETED|Overall Study||0||
48642848|NCT00504309|101908627|FG001|NOT COMPLETED|Overall Study||0||
48642849|NCT00504309|101908628|FG002|NOT COMPLETED|Overall Study||1||
48642850|NCT00504309|101908629|FG003|NOT COMPLETED|Overall Study||0||
48642851|NCT00504309|101908630|FG004|NOT COMPLETED|Overall Study||1||
48642852|NCT00504309|101908631|FG005|NOT COMPLETED|Overall Study||0||
48642853|NCT00920816|101908632|FG000|STARTED|Overall Study||192||
48642854|NCT00920816|101908633|FG001|STARTED|Overall Study||96||
48642855|NCT00920816|101908634|FG002|STARTED|Overall Study||135||
48642856|NCT00920816|101908635|FG003|STARTED|Overall Study||69||
48642857|NCT00920816|101908632|FG000|Treated|Overall Study||189||
48642858|NCT00920816|101908633|FG001|Treated|Overall Study||96||
48642859|NCT00920816|101908634|FG002|Treated|Overall Study||135||
48642860|NCT00920816|101908635|FG003|Treated|Overall Study||69||
48642861|NCT00920816|101908632|FG000|Participants From China (Excluded From Safety Analysis)|Overall Study||16||
48642862|NCT00920816|101908633|FG001|Participants From China (Excluded From Safety Analysis)|Overall Study||8||
48642863|NCT00920816|101908634|FG002|Participants From China (Excluded From Safety Analysis)|Overall Study||124||
48642864|NCT00920816|101908635|FG003|Participants From China (Excluded From Safety Analysis)|Overall Study||64||
48642865|NCT00920816|101908632|FG000|COMPLETED|Overall Study||0||
48642866|NCT00920816|101908633|FG001|COMPLETED|Overall Study||0||
48642867|NCT00920816|101908634|FG002|COMPLETED|Overall Study||0||
48642868|NCT00920816|101908635|FG003|COMPLETED|Overall Study||0||
48642869|NCT00920816|101908632|FG000|NOT COMPLETED|Overall Study||192||
48642870|NCT00920816|101908633|FG001|NOT COMPLETED|Overall Study||96||
48642871|NCT00920816|101908634|FG002|NOT COMPLETED|Overall Study||135||
48642872|NCT00920816|101908635|FG003|NOT COMPLETED|Overall Study||69||
48642873|NCT02100631|101908636|FG000|STARTED|Overall Study||299||
48642874|NCT02100631|101908637|FG001|STARTED|Overall Study||99||
48642875|NCT02100631|101908638|FG002|STARTED|Overall Study||2688||
48642876|NCT02100631|101908636|FG000|COMPLETED|Overall Study||292||
48642877|NCT02100631|101908637|FG001|COMPLETED|Overall Study||95||
48642878|NCT02100631|101908638|FG002|COMPLETED|Overall Study||2688||
48642879|NCT02100631|101908636|FG000|NOT COMPLETED|Overall Study||7||
48642880|NCT02100631|101908637|FG001|NOT COMPLETED|Overall Study||4||
48642881|NCT02100631|101908638|FG002|NOT COMPLETED|Overall Study||0||
48642882|NCT01001104|101908639|FG000|STARTED|Overall Study||35||
48642883|NCT01001104|101908640|FG001|STARTED|Overall Study||37||
48642884|NCT01001104|101908641|FG002|STARTED|Overall Study||36||
48642885|NCT01001104|101908642|FG003|STARTED|Overall Study||37||
48642886|NCT01001104|101908639|FG000|COMPLETED|Overall Study||33||
48642887|NCT01001104|101908640|FG001|COMPLETED|Overall Study||36||
48642888|NCT01001104|101908641|FG002|COMPLETED|Overall Study||35||
48642889|NCT01001104|101908642|FG003|COMPLETED|Overall Study||34||
48642890|NCT01001104|101908639|FG000|NOT COMPLETED|Overall Study||2||
48642891|NCT01001104|101908640|FG001|NOT COMPLETED|Overall Study||1||
48642892|NCT01001104|101908641|FG002|NOT COMPLETED|Overall Study||1||
48642893|NCT01001104|101908642|FG003|NOT COMPLETED|Overall Study||3||
48642894|NCT02412657|101908643|FG000|STARTED|Overall Study||25||
48642895|NCT02412657|101908644|FG001|STARTED|Overall Study||25||
48642896|NCT02412657|101908645|FG002|STARTED|Overall Study||25||
48642897|NCT02412657|101908643|FG000|COMPLETED|Overall Study||24||
48642898|NCT02412657|101908644|FG001|COMPLETED|Overall Study||23||
48642899|NCT02412657|101908645|FG002|COMPLETED|Overall Study||22||
48642900|NCT02412657|101908643|FG000|NOT COMPLETED|Overall Study||1||
48642901|NCT02412657|101908644|FG001|NOT COMPLETED|Overall Study||2||
48642902|NCT02412657|101908645|FG002|NOT COMPLETED|Overall Study||3||
48642903|NCT04529980|101908646|FG000|STARTED|Overall Study||57||
48642904|NCT04529980|101908647|FG001|STARTED|Overall Study||41||
48642905|NCT04529980|101908646|FG000|COMPLETED|Overall Study||53||
48642906|NCT04529980|101908647|FG001|COMPLETED|Overall Study||40||
48642907|NCT04529980|101908646|FG000|NOT COMPLETED|Overall Study||4||
48642908|NCT04529980|101908647|FG001|NOT COMPLETED|Overall Study||1||
48642909|NCT01433913|101908648|FG000|STARTED|Overall Study||10||
48642910|NCT01433913|101908649|FG001|STARTED|Overall Study||10||
48642911|NCT01433913|101908648|FG000|COMPLETED|Overall Study||9||
48642912|NCT01433913|101908649|FG001|COMPLETED|Overall Study||10||
48642913|NCT01433913|101908648|FG000|NOT COMPLETED|Overall Study||1||
48642914|NCT01433913|101908649|FG001|NOT COMPLETED|Overall Study||0||
48642915|NCT01757847|101908650|FG000|STARTED|Overall Study||44||
48642916|NCT01757847|101908651|FG001|STARTED|Overall Study||46||
48642917|NCT01757847|101908650|FG000|COMPLETED|Overall Study||41||
48642918|NCT01757847|101908651|FG001|COMPLETED|Overall Study||42||
48642919|NCT01757847|101908650|FG000|NOT COMPLETED|Overall Study||3||
48642920|NCT01757847|101908651|FG001|NOT COMPLETED|Overall Study||4||
48642921|NCT03339453|101908652|FG000|STARTED|First Visit of Glucagon Treatment||35||
48642922|NCT03339453|101908653|FG001|STARTED|First Visit of Glucagon Treatment||35||
48642923|NCT03339453|101908652|FG000|Received at Least 1 Dose of Study Drug|First Visit of Glucagon Treatment||35||
48642924|NCT03339453|101908653|FG001|Received at Least 1 Dose of Study Drug|First Visit of Glucagon Treatment||35||
48642925|NCT03339453|101908652|FG000|COMPLETED|First Visit of Glucagon Treatment||35||
48642926|NCT03339453|101908653|FG001|COMPLETED|First Visit of Glucagon Treatment||34||
48642927|NCT03339453|101908652|FG000|NOT COMPLETED|First Visit of Glucagon Treatment||0||
48642928|NCT03339453|101908653|FG001|NOT COMPLETED|First Visit of Glucagon Treatment||1||
48642929|NCT03339453|101908652|FG000|STARTED|Second Visit for Alternate Glucagon||35||
48642930|NCT03339453|101908653|FG001|STARTED|Second Visit for Alternate Glucagon||34||
48642931|NCT03339453|101908652|FG000|COMPLETED|Second Visit for Alternate Glucagon||35|Completed both inpatient study visits.|
48642932|NCT03339453|101908653|FG001|COMPLETED|Second Visit for Alternate Glucagon||34|Completed both inpatient study visits.|
48642933|NCT03339453|101908652|FG000|NOT COMPLETED|Second Visit for Alternate Glucagon||0||
48642934|NCT03339453|101908653|FG001|NOT COMPLETED|Second Visit for Alternate Glucagon||0||
48642935|NCT02034591|101908654|FG000|STARTED|Overall Study||4||
48642936|NCT02034591|101908655|FG001|STARTED|Overall Study||3||
48642937|NCT02034591|101908656|FG002|STARTED|Overall Study||4||
48642938|NCT02034591|101908657|FG003|STARTED|Overall Study||3||
48642939|NCT02034591|101908658|FG004|STARTED|Overall Study||4||
48642940|NCT02034591|101908659|FG005|STARTED|Overall Study||3||
48642941|NCT02034591|101908654|FG000|COMPLETED|Overall Study||4||
48642942|NCT02034591|101908655|FG001|COMPLETED|Overall Study||3||
48642943|NCT02034591|101908656|FG002|COMPLETED|Overall Study||4||
48642944|NCT02034591|101908657|FG003|COMPLETED|Overall Study||3||
48642945|NCT02034591|101908658|FG004|COMPLETED|Overall Study||3||
48642946|NCT02034591|101908659|FG005|COMPLETED|Overall Study||3||
48642947|NCT02034591|101908654|FG000|NOT COMPLETED|Overall Study||0||
48642948|NCT02034591|101908655|FG001|NOT COMPLETED|Overall Study||0||
48361836|NCT01084252|101214452|FG006|STARTED|Phase 1 (120 Weeks)||7||
48361837|NCT01084252|101214453|FG007|STARTED|Phase 1 (120 Weeks)||7||
48361838|NCT01084252|101214454|FG008|STARTED|Phase 1 (120 Weeks)||0||
48361839|NCT01084252|101214455|FG009|STARTED|Phase 1 (120 Weeks)||0||
48361840|NCT01084252|101214456|FG010|STARTED|Phase 1 (120 Weeks)||0||
48361841|NCT01084252|101214457|FG011|STARTED|Phase 1 (120 Weeks)||0||
48361842|NCT01084252|101214458|FG012|STARTED|Phase 1 (120 Weeks)||0||
48361843|NCT01084252|101214459|FG013|STARTED|Phase 1 (120 Weeks)||0||
48361844|NCT01084252|101214446|FG000|All Treated (AT) Population|Phase 1 (120 Weeks)||16|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361845|NCT01084252|101214447|FG001|All Treated (AT) Population|Phase 1 (120 Weeks)||6|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361846|NCT01084252|101214448|FG002|All Treated (AT) Population|Phase 1 (120 Weeks)||3|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361847|NCT01084252|101214449|FG003|All Treated (AT) Population|Phase 1 (120 Weeks)||26|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361848|NCT01084252|101214450|FG004|All Treated (AT) Population|Phase 1 (120 Weeks)||18|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361849|NCT01084252|101214451|FG005|All Treated (AT) Population|Phase 1 (120 Weeks)||6|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361850|NCT01084252|101214452|FG006|All Treated (AT) Population|Phase 1 (120 Weeks)||7|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361851|NCT01084252|101214453|FG007|All Treated (AT) Population|Phase 1 (120 Weeks)||7|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48368129|NCT01555463|101230112|FG001|STARTED|Follow up||439||
48368130|NCT01555463|101230111|FG000|COMPLETED|Follow up||409||
48642949|NCT02034591|101908656|FG002|NOT COMPLETED|Overall Study||0||
48642950|NCT02034591|101908657|FG003|NOT COMPLETED|Overall Study||0||
48642951|NCT02034591|101908658|FG004|NOT COMPLETED|Overall Study||1||
48642952|NCT02034591|101908659|FG005|NOT COMPLETED|Overall Study||0||
48642953|NCT03086343|101908660|FG000|STARTED|Period 1||303||
48642954|NCT03086343|101908661|FG001|STARTED|Period 1||309||
48642955|NCT03086343|101908662|FG002|STARTED|Period 1||21||
48642956|NCT03086343|101908663|FG003|STARTED|Period 1||23||
48642957|NCT03086343|101908660|FG000|COMPLETED|Period 1||278||
48642958|NCT03086343|101908661|FG001|COMPLETED|Period 1||277||
48642959|NCT03086343|101908662|FG002|COMPLETED|Period 1||18||
48642960|NCT03086343|101908663|FG003|COMPLETED|Period 1||21||
48642961|NCT03086343|101908660|FG000|NOT COMPLETED|Period 1||25||
48642962|NCT03086343|101908661|FG001|NOT COMPLETED|Period 1||32||
48642963|NCT03086343|101908662|FG002|NOT COMPLETED|Period 1||3||
48361852|NCT01084252|101214454|FG008|All Treated (AT) Population|Phase 1 (120 Weeks)||0|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361853|NCT01084252|101214455|FG009|All Treated (AT) Population|Phase 1 (120 Weeks)||0|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361854|NCT01084252|101214456|FG010|All Treated (AT) Population|Phase 1 (120 Weeks)||0|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361855|NCT01084252|101214457|FG011|All Treated (AT) Population|Phase 1 (120 Weeks)||0|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361856|NCT01084252|101214458|FG012|All Treated (AT) Population|Phase 1 (120 Weeks)||0|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361857|NCT01084252|101214459|FG013|All Treated (AT) Population|Phase 1 (120 Weeks)||0|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361858|NCT01084252|101214446|FG000|COMPLETED|Phase 1 (120 Weeks)||16|Participants with end of treatment or death from any cause forms completed.|
48361859|NCT01084252|101214447|FG001|COMPLETED|Phase 1 (120 Weeks)||6|Participants with end of treatment or death from any cause forms completed.|
48368131|NCT01555463|101230112|FG001|COMPLETED|Follow up||394||
48435790|NCT00731640|101400102|FG000|COMPLETED|Overall Study||20||
48435791|NCT00731640|101400103|FG001|COMPLETED|Overall Study||32||
48435792|NCT00731640|101400102|FG000|NOT COMPLETED|Overall Study||0||
48642964|NCT03086343|101908663|FG003|NOT COMPLETED|Period 1||2||
48642965|NCT03086343|101908660|FG000|STARTED|Period 2||277||
48642966|NCT03086343|101908661|FG001|STARTED|Period 2||277||
48642967|NCT03086343|101908662|FG002|STARTED|Period 2||17||
48642968|NCT03086343|101908663|FG003|STARTED|Period 2||20||
48642969|NCT03086343|101908660|FG000|Entered Period 2 on Study Drug|Period 2||271||
48188137|NCT02018861|100783176|FG006|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||8||
48642970|NCT03086343|101908661|FG001|Entered Period 2 on Study Drug|Period 2||276||
48642971|NCT03086343|101908662|FG002|Entered Period 2 on Study Drug|Period 2||17||
48642972|NCT03086343|101908663|FG003|Entered Period 2 on Study Drug|Period 2||19||
48642973|NCT03086343|101908660|FG000|Upadacitinib Dose Switch From 30 mg QD to 15 mg QD During Part 2|Period 2||0||
48642974|NCT03086343|101908661|FG001|Upadacitinib Dose Switch From 30 mg QD to 15 mg QD During Part 2|Period 2||0||
48642975|NCT03086343|101908662|FG002|Upadacitinib Dose Switch From 30 mg QD to 15 mg QD During Part 2|Period 2||12||
48642976|NCT03086343|101908663|FG003|Upadacitinib Dose Switch From 30 mg QD to 15 mg QD During Part 2|Period 2||12||
48642977|NCT03086343|101908660|FG000|No Upadacitinib Dose Switch During Part 2|Period 2||0||
48642978|NCT03086343|101908661|FG001|No Upadacitinib Dose Switch During Part 2|Period 2||0||
48642979|NCT03086343|101908662|FG002|No Upadacitinib Dose Switch During Part 2|Period 2||5||
48642980|NCT03086343|101908663|FG003|No Upadacitinib Dose Switch During Part 2|Period 2||7||
48642981|NCT03086343|101908660|FG000|COMPLETED|Period 2||207||
48642982|NCT03086343|101908661|FG001|COMPLETED|Period 2||208||
48642983|NCT03086343|101908662|FG002|COMPLETED|Period 2||11||
48642984|NCT03086343|101908663|FG003|COMPLETED|Period 2||12||
48642985|NCT03086343|101908660|FG000|NOT COMPLETED|Period 2||70||
48642986|NCT03086343|101908661|FG001|NOT COMPLETED|Period 2||69||
48642987|NCT03086343|101908662|FG002|NOT COMPLETED|Period 2||6||
48642988|NCT03086343|101908663|FG003|NOT COMPLETED|Period 2||8||
48642989|NCT01104766|101908664|FG000|STARTED|Overall Study||153||
48642990|NCT01104766|101908665|FG001|STARTED|Overall Study||155||
48642991|NCT01104766|101908666|FG002|STARTED|Overall Study||157||
48642992|NCT01104766|101908667|FG003|STARTED|Overall Study||152||
48642993|NCT01104766|101908664|FG000|COMPLETED|Overall Study||95||
48642994|NCT01104766|101908665|FG001|COMPLETED|Overall Study||104||
48642995|NCT01104766|101908666|FG002|COMPLETED|Overall Study||97||
48642996|NCT01104766|101908667|FG003|COMPLETED|Overall Study||114||
48188138|NCT02018861|100783177|FG007|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||3||
48435793|NCT00731640|101400103|FG001|NOT COMPLETED|Overall Study||0||
48435794|NCT00615927|101400104|FG000|STARTED|Overall Study||32||
48435795|NCT00615927|101400105|FG001|STARTED|Overall Study||32||
48642997|NCT01104766|101908664|FG000|NOT COMPLETED|Overall Study||58||
48642998|NCT01104766|101908665|FG001|NOT COMPLETED|Overall Study||51||
48642999|NCT01104766|101908666|FG002|NOT COMPLETED|Overall Study||60||
48643000|NCT01104766|101908667|FG003|NOT COMPLETED|Overall Study||38||
48643001|NCT02193152|101908668|FG000|STARTED|Overall Study||16||
48643002|NCT02193152|101908668|FG000|COMPLETED|Overall Study||16||
48643003|NCT02193152|101908668|FG000|NOT COMPLETED|Overall Study||0||
48643004|NCT04115228|101908669|FG000|STARTED|Overall Study||10||
48643005|NCT04115228|101908669|FG000|COMPLETED|Overall Study||10||
48643006|NCT04115228|101908669|FG000|NOT COMPLETED|Overall Study||0||
48643007|NCT02298491|101908670|FG000|STARTED|Overall Study||4||
48643008|NCT02298491|101908670|FG000|COMPLETED|Overall Study||3||
48643009|NCT02298491|101908670|FG000|NOT COMPLETED|Overall Study||1||
48643010|NCT00088153|101908671|FG000|STARTED|Overall Study||55||
48643011|NCT00088153|101908672|FG001|STARTED|Overall Study||55||
48643012|NCT00088153|101908671|FG000|COMPLETED|Overall Study||31||
48361860|NCT01084252|101214448|FG002|COMPLETED|Phase 1 (120 Weeks)||3|Participants with end of treatment or death from any cause forms completed.|
48361861|NCT01084252|101214449|FG003|COMPLETED|Phase 1 (120 Weeks)||26|Participants with end of treatment or death from any cause forms completed.|
48361862|NCT01084252|101214450|FG004|COMPLETED|Phase 1 (120 Weeks)||18|Participants with end of treatment or death from any cause forms completed.|
48361863|NCT01084252|101214451|FG005|COMPLETED|Phase 1 (120 Weeks)||6|Participants with end of treatment or death from any cause forms completed.|
48361864|NCT01084252|101214452|FG006|COMPLETED|Phase 1 (120 Weeks)||7|Participants with end of treatment or death from any cause forms completed.|
48361865|NCT01084252|101214453|FG007|COMPLETED|Phase 1 (120 Weeks)||7|Participants with end of treatment or death from any cause forms completed.|
48361866|NCT01084252|101214454|FG008|COMPLETED|Phase 1 (120 Weeks)||0|Participants with end of treatment or death from any cause forms completed.|
48361867|NCT01084252|101214455|FG009|COMPLETED|Phase 1 (120 Weeks)||0|Participants with end of treatment or death from any cause forms completed.|
48361868|NCT01084252|101214456|FG010|COMPLETED|Phase 1 (120 Weeks)||0|Participants with end of treatment or death from any cause forms completed.|
48361869|NCT01084252|101214457|FG011|COMPLETED|Phase 1 (120 Weeks)||0|Participants with end of treatment or death from any cause forms completed.|
48361870|NCT01084252|101214458|FG012|COMPLETED|Phase 1 (120 Weeks)||0|Participants with end of treatment or death from any cause forms completed.|
48361871|NCT01084252|101214459|FG013|COMPLETED|Phase 1 (120 Weeks)||0|Participants with end of treatment or death from any cause forms completed.|
48361872|NCT01084252|101214446|FG000|NOT COMPLETED|Phase 1 (120 Weeks)||0||
48361873|NCT01084252|101214447|FG001|NOT COMPLETED|Phase 1 (120 Weeks)||0||
48361874|NCT01084252|101214448|FG002|NOT COMPLETED|Phase 1 (120 Weeks)||0||
48361875|NCT01084252|101214449|FG003|NOT COMPLETED|Phase 1 (120 Weeks)||0||
48361876|NCT01084252|101214450|FG004|NOT COMPLETED|Phase 1 (120 Weeks)||0||
48361877|NCT01084252|101214451|FG005|NOT COMPLETED|Phase 1 (120 Weeks)||0||
48361878|NCT01084252|101214452|FG006|NOT COMPLETED|Phase 1 (120 Weeks)||0||
48361879|NCT01084252|101214453|FG007|NOT COMPLETED|Phase 1 (120 Weeks)||0||
48361880|NCT01084252|101214454|FG008|NOT COMPLETED|Phase 1 (120 Weeks)||0||
48361881|NCT01084252|101214455|FG009|NOT COMPLETED|Phase 1 (120 Weeks)||0||
48361882|NCT01084252|101214456|FG010|NOT COMPLETED|Phase 1 (120 Weeks)||0||
48361883|NCT01084252|101214457|FG011|NOT COMPLETED|Phase 1 (120 Weeks)||0||
48361884|NCT01084252|101214458|FG012|NOT COMPLETED|Phase 1 (120 Weeks)||0||
48361885|NCT01084252|101214459|FG013|NOT COMPLETED|Phase 1 (120 Weeks)||0||
48361886|NCT01084252|101214446|FG000|STARTED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0||
48435796|NCT00615927|101400104|FG000|COMPLETED|Overall Study||32||
48435797|NCT00615927|101400105|FG001|COMPLETED|Overall Study||32||
48435798|NCT00615927|101400104|FG000|NOT COMPLETED|Overall Study||0||
48435799|NCT00615927|101400105|FG001|NOT COMPLETED|Overall Study||0||
48435800|NCT01808508|101400106|FG000|STARTED|Overall Study||11||
48435801|NCT01808508|101400107|FG001|STARTED|Overall Study||9||
48435802|NCT01808508|101400108|FG002|STARTED|Overall Study||3||
48435803|NCT01808508|101400106|FG000|COMPLETED|Overall Study||10||
48435804|NCT01808508|101400107|FG001|COMPLETED|Overall Study||9||
48435805|NCT01808508|101400108|FG002|COMPLETED|Overall Study||3||
48435806|NCT01808508|101400106|FG000|NOT COMPLETED|Overall Study||1||
48435807|NCT01808508|101400107|FG001|NOT COMPLETED|Overall Study||0||
48435808|NCT01808508|101400108|FG002|NOT COMPLETED|Overall Study||0||
48435809|NCT00453336|101400109|FG000|STARTED|Overall Study||45||
48435810|NCT00453336|101400109|FG000|COMPLETED|Overall Study||45||
48435811|NCT00453336|101400109|FG000|NOT COMPLETED|Overall Study||0||
48435812|NCT01335620|101400110|FG000|STARTED|Overall Study||19||
48435813|NCT01335620|101400110|FG000|COMPLETED|Overall Study||19||
48435814|NCT01335620|101400110|FG000|NOT COMPLETED|Overall Study||0||
48435815|NCT03971422|101400111|FG000|STARTED|Overall Study||67||
48435816|NCT03971422|101400112|FG001|STARTED|Overall Study||66||
48435817|NCT03971422|101400113|FG002|STARTED|Overall Study||67||
48643013|NCT00088153|101908672|FG001|COMPLETED|Overall Study||30||
48643014|NCT00088153|101908671|FG000|NOT COMPLETED|Overall Study||24||
48643015|NCT00088153|101908672|FG001|NOT COMPLETED|Overall Study||25||
48643016|NCT01129128|101908673|FG000|STARTED|Overall Study||22||
48643017|NCT01129128|101908674|FG001|STARTED|Overall Study||22||
48643018|NCT01129128|101908675|FG002|STARTED|Overall Study||23||
48643019|NCT01129128|101908673|FG000|COMPLETED|Overall Study||19||
48643020|NCT01129128|101908674|FG001|COMPLETED|Overall Study||18||
48643021|NCT01129128|101908675|FG002|COMPLETED|Overall Study||19||
48643022|NCT01129128|101908673|FG000|NOT COMPLETED|Overall Study||3||
48643023|NCT01129128|101908674|FG001|NOT COMPLETED|Overall Study||4||
48361887|NCT01084252|101214447|FG001|STARTED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0||
48361888|NCT01084252|101214448|FG002|STARTED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0||
48361889|NCT01084252|101214449|FG003|STARTED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0||
48361890|NCT01084252|101214450|FG004|STARTED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0||
48361891|NCT01084252|101214451|FG005|STARTED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0||
48435818|NCT03971422|101400111|FG000|COMPLETED|Overall Study||42||
48435819|NCT03971422|101400112|FG001|COMPLETED|Overall Study||43||
48435820|NCT03971422|101400113|FG002|COMPLETED|Overall Study||43||
48435821|NCT03971422|101400111|FG000|NOT COMPLETED|Overall Study||25||
48435822|NCT03971422|101400112|FG001|NOT COMPLETED|Overall Study||23||
48643024|NCT01129128|101908675|FG002|NOT COMPLETED|Overall Study||4||
48643025|NCT02930941|101908676|FG000|STARTED|Overall Study||17||
48643026|NCT02930941|101908677|FG001|STARTED|Overall Study||18||
48643027|NCT02930941|101908676|FG000|COMPLETED|Overall Study||16||
48643028|NCT02930941|101908677|FG001|COMPLETED|Overall Study||16||
48643029|NCT02930941|101908676|FG000|NOT COMPLETED|Overall Study||1||
48643030|NCT02930941|101908677|FG001|NOT COMPLETED|Overall Study||2||
48643031|NCT04167462|101908678|FG000|STARTED|Overall Study||146|Started=treated|
48643032|NCT04167462|101908679|FG001|STARTED|Overall Study||74|Started=treated|
48643033|NCT04167462|101908678|FG000|COMPLETED|Overall Study||132||
48643034|NCT04167462|101908679|FG001|COMPLETED|Overall Study||64||
48361892|NCT01084252|101214452|FG006|STARTED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0||
48643035|NCT04167462|101908678|FG000|NOT COMPLETED|Overall Study||14||
48643036|NCT04167462|101908679|FG001|NOT COMPLETED|Overall Study||10||
48643037|NCT00191100|101908680|FG000|STARTED|Overall Study||259||
48643038|NCT00191100|101908681|FG001|STARTED|Overall Study||256||
48643039|NCT00191100|101908680|FG000|COMPLETED|Overall Study||217||
48643040|NCT00191100|101908681|FG001|COMPLETED|Overall Study||244||
48643041|NCT00191100|101908680|FG000|NOT COMPLETED|Overall Study||42||
48643042|NCT00191100|101908681|FG001|NOT COMPLETED|Overall Study||12||
48643043|NCT03670628|101908682|FG000|STARTED|Baseline Visit||13||
48643044|NCT03670628|101908683|FG001|STARTED|Baseline Visit||10||
48643045|NCT03670628|101908682|FG000|COMPLETED|Baseline Visit||13||
48643046|NCT03670628|101908683|FG001|COMPLETED|Baseline Visit||10||
48643047|NCT03670628|101908682|FG000|NOT COMPLETED|Baseline Visit||0||
48643048|NCT03670628|101908683|FG001|NOT COMPLETED|Baseline Visit||0||
48643049|NCT03670628|101908682|FG000|STARTED|Weekly Therapy Sessions||13||
48643050|NCT03670628|101908683|FG001|STARTED|Weekly Therapy Sessions||10||
48643051|NCT03670628|101908682|FG000|COMPLETED|Weekly Therapy Sessions||5||
48643052|NCT03670628|101908683|FG001|COMPLETED|Weekly Therapy Sessions||7||
48643053|NCT03670628|101908682|FG000|NOT COMPLETED|Weekly Therapy Sessions||8||
48643054|NCT03670628|101908683|FG001|NOT COMPLETED|Weekly Therapy Sessions||3||
48643055|NCT03670628|101908682|FG000|STARTED|Month 1 Visit||5||
48643056|NCT03670628|101908683|FG001|STARTED|Month 1 Visit||7||
48643057|NCT03670628|101908682|FG000|COMPLETED|Month 1 Visit||5||
48643058|NCT03670628|101908683|FG001|COMPLETED|Month 1 Visit||7||
48643059|NCT03670628|101908682|FG000|NOT COMPLETED|Month 1 Visit||0||
48643060|NCT03670628|101908683|FG001|NOT COMPLETED|Month 1 Visit||0||
48643061|NCT03670628|101908682|FG000|STARTED|Waiting Period||5||
48643062|NCT03670628|101908683|FG001|STARTED|Waiting Period||7||
48643063|NCT03670628|101908682|FG000|COMPLETED|Waiting Period||1||
48643064|NCT03670628|101908683|FG001|COMPLETED|Waiting Period||1||
48643065|NCT03670628|101908682|FG000|NOT COMPLETED|Waiting Period||4||
48643066|NCT03670628|101908683|FG001|NOT COMPLETED|Waiting Period||6||
48643067|NCT03670628|101908682|FG000|STARTED|Month 3 Visit||1||
48643068|NCT03670628|101908683|FG001|STARTED|Month 3 Visit||1||
48643069|NCT03670628|101908682|FG000|COMPLETED|Month 3 Visit||1||
48643070|NCT03670628|101908683|FG001|COMPLETED|Month 3 Visit||1||
48643071|NCT03670628|101908682|FG000|NOT COMPLETED|Month 3 Visit||0||
48643072|NCT03670628|101908683|FG001|NOT COMPLETED|Month 3 Visit||0||
48643073|NCT00972738|101908684|FG000|STARTED|Overall Study||522||
48643074|NCT00972738|101908685|FG001|STARTED|Overall Study||171||
48643075|NCT00972738|101908686|FG002|STARTED|Overall Study||521||
48643076|NCT00972738|101908684|FG000|COMPLETED|Overall Study||501||
48643077|NCT00972738|101908685|FG001|COMPLETED|Overall Study||165||
48643078|NCT00972738|101908686|FG002|COMPLETED|Overall Study||492||
48643079|NCT00972738|101908684|FG000|NOT COMPLETED|Overall Study||21||
48643080|NCT00972738|101908685|FG001|NOT COMPLETED|Overall Study||6||
48643081|NCT00972738|101908686|FG002|NOT COMPLETED|Overall Study||29||
48643082|NCT01026038|101908687|FG000|STARTED|Overall Study||130||
48643083|NCT01026038|101908688|FG001|STARTED|Overall Study||65||
48643084|NCT01026038|101908689|FG002|STARTED|Overall Study||67||
48643085|NCT01026038|101908687|FG000|COMPLETED|Overall Study||129||
48643086|NCT01026038|101908688|FG001|COMPLETED|Overall Study||64||
48643087|NCT01026038|101908689|FG002|COMPLETED|Overall Study||67||
48643088|NCT01026038|101908687|FG000|NOT COMPLETED|Overall Study||1||
48643089|NCT01026038|101908688|FG001|NOT COMPLETED|Overall Study||1||
48643090|NCT01026038|101908689|FG002|NOT COMPLETED|Overall Study||0||
48643091|NCT05607043|101908690|FG000|STARTED|Overall Study||11||
48643092|NCT05607043|101908690|FG000|COMPLETED|Overall Study||9||
48643093|NCT05607043|101908690|FG000|NOT COMPLETED|Overall Study||2||
48643094|NCT04057235|101908691|FG000|STARTED|Overall Study||129||
48643095|NCT04057235|101908691|FG000|Had Radiographic Data|Overall Study||58||
48643096|NCT04057235|101908691|FG000|Had ODI Data|Overall Study||43||
48643097|NCT04057235|101908691|FG000|Had VAS Back Data|Overall Study||45||
48643098|NCT04057235|101908691|FG000|Had VAS Leg Data|Overall Study||45||
48643099|NCT04057235|101908691|FG000|COMPLETED|Overall Study||129||
48643100|NCT04057235|101908691|FG000|NOT COMPLETED|Overall Study||0||
48643101|NCT01239680|101908692|FG000|STARTED|Overall Study||3||
48643102|NCT01239680|101908693|FG001|STARTED|Overall Study||2||
48643103|NCT01239680|101908692|FG000|COMPLETED|Overall Study||1||
48361893|NCT01084252|101214453|FG007|STARTED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0||
48643104|NCT01239680|101908693|FG001|COMPLETED|Overall Study||2||
48643105|NCT01239680|101908692|FG000|NOT COMPLETED|Overall Study||2||
48643106|NCT01239680|101908693|FG001|NOT COMPLETED|Overall Study||0||
48643107|NCT01756235|101908694|FG000|STARTED|Overall Study||462||
48643108|NCT01756235|101908694|FG000|COMPLETED|Overall Study||460||
48643109|NCT01756235|101908694|FG000|NOT COMPLETED|Overall Study||2||
48643110|NCT00790036|101913450|FG000|STARTED|Overall Study||372||
48643111|NCT00790036|101913451|FG001|STARTED|Overall Study||370||
48643112|NCT00790036|101913450|FG000|Untreated Participants|Overall Study||4||
48643113|NCT00790036|101913451|FG001|Untreated Participants|Overall Study||6||
48643114|NCT00790036|101913450|FG000|COMPLETED|Overall Study||177||
48643115|NCT00790036|101913451|FG001|COMPLETED|Overall Study||249||
48643116|NCT00790036|101913450|FG000|NOT COMPLETED|Overall Study||195||
48643117|NCT00790036|101913451|FG001|NOT COMPLETED|Overall Study||121||
48643118|NCT01718691|101913452|FG000|STARTED|Overall Study||60||
48643119|NCT01718691|101913453|FG001|STARTED|Overall Study||10||
48643120|NCT01718691|101913452|FG000|COMPLETED|Overall Study||42||
48643121|NCT01718691|101913453|FG001|COMPLETED|Overall Study||9||
48643122|NCT01718691|101913452|FG000|NOT COMPLETED|Overall Study||18||
48643123|NCT01718691|101913453|FG001|NOT COMPLETED|Overall Study||1||
48643124|NCT00879359|101913454|FG000|STARTED|Overall Study||15||
48643125|NCT00879359|101913454|FG000|COMPLETED|Overall Study||15||
48643126|NCT00879359|101913454|FG000|NOT COMPLETED|Overall Study||0||
48643127|NCT05350423|101913455|FG000|STARTED|Overall Study||54||
48643128|NCT05350423|101913456|FG001|STARTED|Overall Study||54||
48643129|NCT05350423|101913455|FG000|COMPLETED|Overall Study||46||
48643130|NCT05350423|101913456|FG001|COMPLETED|Overall Study||45||
48643131|NCT05350423|101913455|FG000|NOT COMPLETED|Overall Study||8||
48643132|NCT05350423|101913456|FG001|NOT COMPLETED|Overall Study||9||
48643133|NCT03421561|101913457|FG000|STARTED|Overall Study||200||
48643134|NCT03421561|101913458|FG001|STARTED|Overall Study||100||
48643135|NCT03421561|101913457|FG000|COMPLETED|Overall Study||135||
48643136|NCT03421561|101913458|FG001|COMPLETED|Overall Study||70||
48643137|NCT03421561|101913457|FG000|NOT COMPLETED|Overall Study||65||
48643138|NCT03421561|101913458|FG001|NOT COMPLETED|Overall Study||30||
48643139|NCT03014362|101913459|FG000|STARTED|Overall Study||59||
48643140|NCT03014362|101913460|FG001|STARTED|Overall Study||61||
48643141|NCT03014362|101913459|FG000|COMPLETED|Overall Study||41|completed|
48643142|NCT03014362|101913460|FG001|COMPLETED|Overall Study||51|completed|
48643143|NCT03014362|101913459|FG000|NOT COMPLETED|Overall Study||18||
48643144|NCT03014362|101913460|FG001|NOT COMPLETED|Overall Study||10||
48643145|NCT04398966|101913461|FG000|STARTED|Overall Study||12||
48643146|NCT04398966|101913461|FG000|COMPLETED|Overall Study||10||
48643147|NCT04398966|101913461|FG000|NOT COMPLETED|Overall Study||2||
48643148|NCT00382070|101913462|FG000|STARTED|Overall Study||1983||
48643149|NCT00382070|101913463|FG001|STARTED|Overall Study||1983||
48643150|NCT00382070|101913462|FG000|COMPLETED|Overall Study||1950||
48643151|NCT00382070|101913463|FG001|COMPLETED|Overall Study||1953||
48643152|NCT00382070|101913462|FG000|NOT COMPLETED|Overall Study||33||
48643153|NCT00382070|101913463|FG001|NOT COMPLETED|Overall Study||30||
48643154|NCT04149353|101913464|FG000|STARTED|Overall Study||1||
48643155|NCT04149353|101913464|FG000|COMPLETED|Overall Study||0||
48643156|NCT04149353|101913464|FG000|NOT COMPLETED|Overall Study||1||
48643157|NCT02707744|101913465|FG000|STARTED|Overall Study||50||
48643158|NCT02707744|101913466|FG001|STARTED|Overall Study||50||
48643159|NCT02707744|101913465|FG000|COMPLETED|Overall Study||47||
48643160|NCT02707744|101913466|FG001|COMPLETED|Overall Study||50||
48643161|NCT02707744|101913465|FG000|NOT COMPLETED|Overall Study||3||
48643162|NCT02707744|101913466|FG001|NOT COMPLETED|Overall Study||0||
48643163|NCT03888274|101913467|FG000|STARTED|Overall Study||30||
48643164|NCT03888274|101913467|FG000|COMPLETED|Overall Study||30||
48643165|NCT03888274|101913467|FG000|NOT COMPLETED|Overall Study||0||
48643166|NCT06173648|101913468|FG000|STARTED|Overall Study||10||12
48643167|NCT06173648|101913468|FG000|COMPLETED|Overall Study||10||12
48643168|NCT06173648|101913468|FG000|NOT COMPLETED|Overall Study||0||0
48643169|NCT01276652|101913469|FG000|STARTED|Period 1: Randomization||9||
48643170|NCT01276652|101913470|FG001|STARTED|Period 1: Randomization||8||
48643171|NCT01276652|101913471|FG002|STARTED|Period 1: Randomization||0||
48643172|NCT01276652|101913469|FG000|COMPLETED|Period 1: Randomization||9||
48643173|NCT01276652|101913470|FG001|COMPLETED|Period 1: Randomization||8||
48643174|NCT01276652|101913471|FG002|COMPLETED|Period 1: Randomization||0||
48765089|NCT02113982|102214593|FG010|COMPLETED|Stage 1: Dose Escalation||0||
48643175|NCT01276652|101913469|FG000|NOT COMPLETED|Period 1: Randomization||0||
48643176|NCT01276652|101913470|FG001|NOT COMPLETED|Period 1: Randomization||0||
48643177|NCT01276652|101913471|FG002|NOT COMPLETED|Period 1: Randomization||0||
48643178|NCT01276652|101913469|FG000|STARTED|Period 2: Observational||9||
48643179|NCT01276652|101913470|FG001|STARTED|Period 2: Observational||8||
48765090|NCT02113982|102214594|FG011|COMPLETED|Stage 1: Dose Escalation||0||
48643180|NCT01276652|101913471|FG002|STARTED|Period 2: Observational||5||
48643181|NCT01276652|101913469|FG000|COMPLETED|Period 2: Observational||9||
48643182|NCT01276652|101913470|FG001|COMPLETED|Period 2: Observational||8||
48643183|NCT01276652|101913471|FG002|COMPLETED|Period 2: Observational||5||
48643184|NCT01276652|101913469|FG000|NOT COMPLETED|Period 2: Observational||0||
48643185|NCT01276652|101913470|FG001|NOT COMPLETED|Period 2: Observational||0||
48643186|NCT01276652|101913471|FG002|NOT COMPLETED|Period 2: Observational||0||
48643187|NCT01311661|101913472|FG000|STARTED|Overall Study||206||
48643188|NCT01311661|101913472|FG000|Received Placebo|Overall Study||201||
48643189|NCT01311661|101913472|FG000|Received Olo 2.5 mcg Bid|Overall Study||101||
48643190|NCT01311661|101913472|FG000|Received Olo 5 mcg qd|Overall Study||101||
48643191|NCT01311661|101913472|FG000|Received Olo 5 mcg Bid|Overall Study||101||
48643192|NCT01311661|101913472|FG000|Received Olo 10 mcg qd|Overall Study||102||
48643193|NCT01311661|101913472|FG000|COMPLETED|Overall Study||199||
48643194|NCT01311661|101913472|FG000|NOT COMPLETED|Overall Study||7||
48643195|NCT02724644|101913473|FG000|STARTED|Overall Study||189||
48643196|NCT02724644|101913474|FG001|STARTED|Overall Study||186||
48643197|NCT02724644|101913473|FG000|COMPLETED|Overall Study||168||
48643198|NCT02724644|101913474|FG001|COMPLETED|Overall Study||182||
48643199|NCT02724644|101913473|FG000|NOT COMPLETED|Overall Study||21||
48643200|NCT02724644|101913474|FG001|NOT COMPLETED|Overall Study||4||
48643201|NCT02265744|101913475|FG000|STARTED|Overall Study||69||
48643202|NCT02265744|101913476|FG001|STARTED|Overall Study||68||
48643203|NCT02265744|101913477|FG002|STARTED|Overall Study||68||
48643204|NCT02265744|101913478|FG003|STARTED|Overall Study||70||
48643205|NCT02265744|101913479|FG004|STARTED|Overall Study||71||
48643206|NCT02265744|101913475|FG000|COMPLETED|Overall Study||49||
48643207|NCT02265744|101913476|FG001|COMPLETED|Overall Study||53||
48643208|NCT02265744|101913477|FG002|COMPLETED|Overall Study||51||
48643209|NCT02265744|101913478|FG003|COMPLETED|Overall Study||47||
48643210|NCT02265744|101913479|FG004|COMPLETED|Overall Study||58||
48643211|NCT02265744|101913475|FG000|NOT COMPLETED|Overall Study||20||
48643212|NCT02265744|101913476|FG001|NOT COMPLETED|Overall Study||15||
48643213|NCT02265744|101913477|FG002|NOT COMPLETED|Overall Study||17||
48643214|NCT02265744|101913478|FG003|NOT COMPLETED|Overall Study||23||
48643215|NCT02265744|101913479|FG004|NOT COMPLETED|Overall Study||13||
48643216|NCT01331005|101913480|FG000|STARTED|Overall Study||64||
48643217|NCT01331005|101913481|FG001|STARTED|Overall Study||61||
48643218|NCT01331005|101913480|FG000|COMPLETED|Overall Study||60||
48643219|NCT01331005|101913481|FG001|COMPLETED|Overall Study||57||
48643220|NCT01331005|101913480|FG000|NOT COMPLETED|Overall Study||4||
48643221|NCT01331005|101913481|FG001|NOT COMPLETED|Overall Study||4||
48643222|NCT00731198|101913482|FG000|STARTED|Overall Study||325||
48643223|NCT00731198|101913483|FG001|STARTED|Overall Study||325||
48643224|NCT00731198|101913482|FG000|COMPLETED|Overall Study||319||
48643225|NCT00731198|101913483|FG001|COMPLETED|Overall Study||319||
48643226|NCT00731198|101913482|FG000|NOT COMPLETED|Overall Study||6||
48643227|NCT00731198|101913483|FG001|NOT COMPLETED|Overall Study||6||
48643228|NCT02550210|101913484|FG000|STARTED|Overall Study||23||
48643229|NCT02550210|101913484|FG000|COMPLETED|Overall Study||19||
48643230|NCT02550210|101913484|FG000|NOT COMPLETED|Overall Study||4||
48643231|NCT01779362|101913485|FG000|STARTED|Overall Study||65||
48643232|NCT01779362|101913486|FG001|STARTED|Overall Study||67||
48643233|NCT01779362|101913487|FG002|STARTED|Overall Study||67||
48643234|NCT01779362|101913488|FG003|STARTED|Overall Study||68||
48643235|NCT01779362|101913485|FG000|COMPLETED|Overall Study||56||
48643236|NCT01779362|101913486|FG001|COMPLETED|Overall Study||65||
48643237|NCT01779362|101913487|FG002|COMPLETED|Overall Study||58||
48643238|NCT01779362|101913488|FG003|COMPLETED|Overall Study||53||
48643239|NCT01779362|101913485|FG000|NOT COMPLETED|Overall Study||9||
48643240|NCT01779362|101913486|FG001|NOT COMPLETED|Overall Study||2||
48643241|NCT01779362|101913487|FG002|NOT COMPLETED|Overall Study||9||
48643242|NCT01779362|101913488|FG003|NOT COMPLETED|Overall Study||15||
48643243|NCT00620542|101913489|FG000|STARTED|Part A (Run-in - 2 Weeks)||1167||
48643244|NCT00620542|101913490|FG001|STARTED|Part A (Run-in - 2 Weeks)||1166||
48643245|NCT00620542|101913491|FG002|STARTED|Part A (Run-in - 2 Weeks)||0||
48643246|NCT00620542|101913492|FG003|STARTED|Part A (Run-in - 2 Weeks)||0||
48643247|NCT00620542|101913489|FG000|Received Treatment|Part A (Run-in - 2 Weeks)||783||
48643248|NCT00620542|101913490|FG001|Received Treatment|Part A (Run-in - 2 Weeks)||795||
48643249|NCT00620542|101913491|FG002|Received Treatment|Part A (Run-in - 2 Weeks)||0||
48643250|NCT00620542|101913492|FG003|Received Treatment|Part A (Run-in - 2 Weeks)||0||
48643251|NCT00620542|101913489|FG000|COMPLETED|Part A (Run-in - 2 Weeks)||695||
48643252|NCT00620542|101913490|FG001|COMPLETED|Part A (Run-in - 2 Weeks)||690||
48643253|NCT00620542|101913491|FG002|COMPLETED|Part A (Run-in - 2 Weeks)||0||
48643254|NCT00620542|101913492|FG003|COMPLETED|Part A (Run-in - 2 Weeks)||0||
48643255|NCT00620542|101913489|FG000|NOT COMPLETED|Part A (Run-in - 2 Weeks)||472||
48643256|NCT00620542|101913490|FG001|NOT COMPLETED|Part A (Run-in - 2 Weeks)||476||
48643257|NCT00620542|101913491|FG002|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0||
48643258|NCT00620542|101913492|FG003|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0||
48643259|NCT00620542|101913489|FG000|STARTED|Part B (2 Year Core Study)||0||
48643260|NCT00620542|101913490|FG001|STARTED|Part B (2 Year Core Study)||0||
48643261|NCT00620542|101913491|FG002|STARTED|Part B (2 Year Core Study)||694||
48643262|NCT00620542|101913492|FG003|STARTED|Part B (2 Year Core Study)||691||
48643263|NCT00620542|101913489|FG000|Received Treatment|Part B (2 Year Core Study)||0||
48643264|NCT00620542|101913490|FG001|Received Treatment|Part B (2 Year Core Study)||0||
48643265|NCT00620542|101913491|FG002|Received Treatment|Part B (2 Year Core Study)||691||
48643266|NCT00620542|101913492|FG003|Received Treatment|Part B (2 Year Core Study)||689||
48643267|NCT00620542|101913489|FG000|Intent-to-treat Population|Part B (2 Year Core Study)||0||
48643268|NCT00620542|101913490|FG001|Intent-to-treat Population|Part B (2 Year Core Study)||0||
48643269|NCT00620542|101913491|FG002|Intent-to-treat Population|Part B (2 Year Core Study)||520||
48643270|NCT00620542|101913492|FG003|Intent-to-treat Population|Part B (2 Year Core Study)||519||
48643271|NCT00620542|101913489|FG000|COMPLETED|Part B (2 Year Core Study)||0||
48643272|NCT00620542|101913490|FG001|COMPLETED|Part B (2 Year Core Study)||0||
48643273|NCT00620542|101913491|FG002|COMPLETED|Part B (2 Year Core Study)||546||
48643274|NCT00620542|101913492|FG003|COMPLETED|Part B (2 Year Core Study)||547||
48643275|NCT00620542|101913489|FG000|NOT COMPLETED|Part B (2 Year Core Study)||0||
48643276|NCT00620542|101913490|FG001|NOT COMPLETED|Part B (2 Year Core Study)||0||
48643277|NCT00620542|101913491|FG002|NOT COMPLETED|Part B (2 Year Core Study)||148||
48643278|NCT00620542|101913492|FG003|NOT COMPLETED|Part B (2 Year Core Study)||144||
48643279|NCT03601052|101913493|FG000|STARTED|Overall Study||14||
48643280|NCT03601052|101913493|FG000|COMPLETED|Overall Study||12||
48643281|NCT03601052|101913493|FG000|NOT COMPLETED|Overall Study||2||
48643282|NCT01013753|101913494|FG000|STARTED|Overall Study||198||
48643283|NCT01013753|101913494|FG000|Received Placebo|Overall Study||125||
48643284|NCT01013753|101913494|FG000|Received Olo 2 mcg qd|Overall Study||121||
48643285|NCT01013753|101913494|FG000|Received Olo 5 mcg qd|Overall Study||130||
48643286|NCT01013753|101913494|FG000|Received Olo 10 mcg qd|Overall Study||127||
48643287|NCT01013753|101913494|FG000|Received Olo 20 mcg qd|Overall Study||124||
48643288|NCT01013753|101913494|FG000|Received Form 12 mcg Bid|Overall Study||125||
48643289|NCT01013753|101913494|FG000|COMPLETED|Overall Study||182||
48643290|NCT01013753|101913494|FG000|NOT COMPLETED|Overall Study||16||
48643291|NCT01410604|101913495|FG000|STARTED|Overall Study||15||
48643292|NCT01410604|101913496|FG001|STARTED|Overall Study||16||
48643293|NCT01410604|101913495|FG000|COMPLETED|Overall Study||12||
48643294|NCT01410604|101913496|FG001|COMPLETED|Overall Study||14||
48643295|NCT01410604|101913495|FG000|NOT COMPLETED|Overall Study||3||
48643296|NCT01410604|101913496|FG001|NOT COMPLETED|Overall Study||2||
48643297|NCT01348698|101913497|FG000|STARTED|Overall Study||74||
48643298|NCT01348698|101913497|FG000|COMPLETED|Overall Study||2||
48643299|NCT01348698|101913497|FG000|NOT COMPLETED|Overall Study||72||
48643300|NCT01078545|101913498|FG000|STARTED|Overall Study||729||
48643301|NCT01078545|101913498|FG000|Intent-to-treat Population|Overall Study||729||
48643302|NCT01078545|101913498|FG000|Per Protocol Population|Overall Study||661||
48643303|NCT01078545|101913498|FG000|COMPLETED|Overall Study||703||
48643304|NCT01078545|101913498|FG000|NOT COMPLETED|Overall Study||26||
48643305|NCT02927145|101913499|FG000|STARTED|Initial Recruitment||12||
48643306|NCT02927145|101913500|FG001|STARTED|Initial Recruitment||12||
48643307|NCT02927145|101913501|FG002|STARTED|Initial Recruitment||12||
48643308|NCT02927145|101913502|FG003|STARTED|Initial Recruitment||14||
48643309|NCT02927145|101913503|FG004|STARTED|Initial Recruitment||17||
48643310|NCT02927145|101913504|FG005|STARTED|Initial Recruitment||15||
48643311|NCT02927145|101913505|FG006|STARTED|Initial Recruitment||0||
48643312|NCT02927145|101913506|FG007|STARTED|Initial Recruitment||0||
48643313|NCT02927145|101913507|FG008|STARTED|Initial Recruitment||6||
48643314|NCT02927145|101913499|FG000|COMPLETED|Initial Recruitment||12||
48643315|NCT02927145|101913500|FG001|COMPLETED|Initial Recruitment||11||
48643316|NCT02927145|101913501|FG002|COMPLETED|Initial Recruitment||11||
48643317|NCT02927145|101913502|FG003|COMPLETED|Initial Recruitment||10||
48643318|NCT02927145|101913503|FG004|COMPLETED|Initial Recruitment||14||
48643319|NCT02927145|101913504|FG005|COMPLETED|Initial Recruitment||14||
48643320|NCT02927145|101913505|FG006|COMPLETED|Initial Recruitment||0||
48643321|NCT02927145|101913506|FG007|COMPLETED|Initial Recruitment||0||
48643322|NCT02927145|101913507|FG008|COMPLETED|Initial Recruitment||4||
48643323|NCT02927145|101913499|FG000|NOT COMPLETED|Initial Recruitment||0||
48643324|NCT02927145|101913500|FG001|NOT COMPLETED|Initial Recruitment||1||
48643325|NCT02927145|101913501|FG002|NOT COMPLETED|Initial Recruitment||1||
48643326|NCT02927145|101913502|FG003|NOT COMPLETED|Initial Recruitment||4||
48643327|NCT02927145|101913503|FG004|NOT COMPLETED|Initial Recruitment||3||
48643328|NCT02927145|101913504|FG005|NOT COMPLETED|Initial Recruitment||1||
48643329|NCT02927145|101913505|FG006|NOT COMPLETED|Initial Recruitment||0||
48643330|NCT02927145|101913506|FG007|NOT COMPLETED|Initial Recruitment||0||
48643331|NCT02927145|101913507|FG008|NOT COMPLETED|Initial Recruitment||2||
48643332|NCT02927145|101913499|FG000|STARTED|Invitation for Additional Challenge||0||
48643333|NCT02927145|101913500|FG001|STARTED|Invitation for Additional Challenge||0||
48643334|NCT02927145|101913501|FG002|STARTED|Invitation for Additional Challenge||0||
48643335|NCT02927145|101913502|FG003|STARTED|Invitation for Additional Challenge||0||
48643336|NCT02927145|101913503|FG004|STARTED|Invitation for Additional Challenge||0||
48643337|NCT02927145|101913504|FG005|STARTED|Invitation for Additional Challenge||0||
48643338|NCT02927145|101913505|FG006|STARTED|Invitation for Additional Challenge||9||
48643339|NCT02927145|101913506|FG007|STARTED|Invitation for Additional Challenge||8||
48643340|NCT02927145|101913507|FG008|STARTED|Invitation for Additional Challenge||0||
48643341|NCT02927145|101913499|FG000|COMPLETED|Invitation for Additional Challenge||0||
48643342|NCT02927145|101913500|FG001|COMPLETED|Invitation for Additional Challenge||0||
48643343|NCT02927145|101913501|FG002|COMPLETED|Invitation for Additional Challenge||0||
48643344|NCT02927145|101913502|FG003|COMPLETED|Invitation for Additional Challenge||0||
48643345|NCT02927145|101913503|FG004|COMPLETED|Invitation for Additional Challenge||0||
48643346|NCT02927145|101913504|FG005|COMPLETED|Invitation for Additional Challenge||0||
48643347|NCT02927145|101913505|FG006|COMPLETED|Invitation for Additional Challenge||8||
48643348|NCT02927145|101913506|FG007|COMPLETED|Invitation for Additional Challenge||8||
48643349|NCT02927145|101913507|FG008|COMPLETED|Invitation for Additional Challenge||0||
48643350|NCT02927145|101913499|FG000|NOT COMPLETED|Invitation for Additional Challenge||0||
48643351|NCT02927145|101913500|FG001|NOT COMPLETED|Invitation for Additional Challenge||0||
48643352|NCT02927145|101913501|FG002|NOT COMPLETED|Invitation for Additional Challenge||0||
48643353|NCT02927145|101913502|FG003|NOT COMPLETED|Invitation for Additional Challenge||0||
48643354|NCT02927145|101913503|FG004|NOT COMPLETED|Invitation for Additional Challenge||0||
48643355|NCT02927145|101913504|FG005|NOT COMPLETED|Invitation for Additional Challenge||0||
48643356|NCT02927145|101913505|FG006|NOT COMPLETED|Invitation for Additional Challenge||1||
48643357|NCT02927145|101913506|FG007|NOT COMPLETED|Invitation for Additional Challenge||0||
48643358|NCT02927145|101913507|FG008|NOT COMPLETED|Invitation for Additional Challenge||0||
48643359|NCT04339972|101913508|FG000|STARTED|Overall Study||15||
48643360|NCT04339972|101913509|FG001|STARTED|Overall Study||14||
48643361|NCT04339972|101913508|FG000|COMPLETED|Overall Study||10||
48643362|NCT04339972|101913509|FG001|COMPLETED|Overall Study||9||
48643363|NCT04339972|101913508|FG000|NOT COMPLETED|Overall Study||5||
48643364|NCT04339972|101913509|FG001|NOT COMPLETED|Overall Study||5||
48643365|NCT03387046|101913510|FG000|STARTED|Overall Study||5||
48643366|NCT03387046|101913511|FG001|STARTED|Overall Study||2||
48643367|NCT03387046|101913510|FG000|COMPLETED|Overall Study||4||
48643368|NCT03387046|101913511|FG001|COMPLETED|Overall Study||1||
48643369|NCT03387046|101913510|FG000|NOT COMPLETED|Overall Study||1||
48643370|NCT03387046|101913511|FG001|NOT COMPLETED|Overall Study||1||
48643371|NCT00429299|101913512|FG000|STARTED|Overall Study||36||
48643372|NCT00429299|101913513|FG001|STARTED|Overall Study||39||
48643373|NCT00429299|101913514|FG002|STARTED|Overall Study||46||
48643374|NCT00429299|101913512|FG000|COMPLETED|Overall Study||32||
48643375|NCT00429299|101913513|FG001|COMPLETED|Overall Study||32||
48643376|NCT00429299|101913514|FG002|COMPLETED|Overall Study||42||
48643377|NCT00429299|101913512|FG000|NOT COMPLETED|Overall Study||4||
48643378|NCT00429299|101913513|FG001|NOT COMPLETED|Overall Study||7||
48643379|NCT00429299|101913514|FG002|NOT COMPLETED|Overall Study||4||
48643380|NCT00848185|101913515|FG000|STARTED|Overall Study||32||
48643381|NCT00848185|101913516|FG001|STARTED|Overall Study||32||
48643382|NCT00848185|101913517|FG002|STARTED|Overall Study||32||
48643383|NCT00848185|101913515|FG000|COMPLETED|Overall Study||32||
48643384|NCT00848185|101913516|FG001|COMPLETED|Overall Study||32||
48643385|NCT00848185|101913517|FG002|COMPLETED|Overall Study||32||
48643386|NCT00848185|101913515|FG000|NOT COMPLETED|Overall Study||0||
48643387|NCT00848185|101913516|FG001|NOT COMPLETED|Overall Study||0||
48643388|NCT00848185|101913517|FG002|NOT COMPLETED|Overall Study||0||
48643389|NCT01483651|101913518|FG000|STARTED|Overall Study||1||
48643390|NCT01483651|101913519|FG001|STARTED|Overall Study||3||
48643391|NCT01483651|101913520|FG002|STARTED|Overall Study||2||
48643392|NCT01483651|101913521|FG003|STARTED|Overall Study||1||
48643393|NCT01483651|101913522|FG004|STARTED|Overall Study||2||
48643394|NCT01483651|101913523|FG005|STARTED|Overall Study||2||
48643395|NCT01483651|101913518|FG000|COMPLETED|Overall Study||1||
48643396|NCT01483651|101913519|FG001|COMPLETED|Overall Study||2||
48435823|NCT03971422|101400113|FG002|NOT COMPLETED|Overall Study||24||
48435824|NCT02279888|101400114|FG000|STARTED|Overall Study||1214||
48435825|NCT02279888|101400114|FG000|Successful Implant|Overall Study||1200||
48435826|NCT02279888|101400114|FG000|6 Months Follow Up Completed|Overall Study||1013||
48435827|NCT02279888|101400114|FG000|1 Year Follow Up Completed|Overall Study||875||
48435828|NCT02279888|101400114|FG000|18 Months Follow Up Completed|Overall Study||770||
48643397|NCT01483651|101913520|FG002|COMPLETED|Overall Study||1||
48643398|NCT01483651|101913521|FG003|COMPLETED|Overall Study||1||
48643399|NCT01483651|101913522|FG004|COMPLETED|Overall Study||2||
48643400|NCT01483651|101913523|FG005|COMPLETED|Overall Study||1||
48643401|NCT01483651|101913518|FG000|NOT COMPLETED|Overall Study||0||
48435829|NCT02279888|101400114|FG000|COMPLETED|Overall Study||684||
48435830|NCT02279888|101400114|FG000|NOT COMPLETED|Overall Study||530||
48643402|NCT01483651|101913519|FG001|NOT COMPLETED|Overall Study||1||
48643403|NCT01483651|101913520|FG002|NOT COMPLETED|Overall Study||1||
48643404|NCT01483651|101913521|FG003|NOT COMPLETED|Overall Study||0||
48643405|NCT01483651|101913522|FG004|NOT COMPLETED|Overall Study||0||
48643406|NCT01483651|101913523|FG005|NOT COMPLETED|Overall Study||1||
48643407|NCT00455455|101913524|FG000|STARTED|Washout||25||
48435831|NCT01269346|101400115|FG000|STARTED|Treatment Phase||52||
48435832|NCT01269346|101400115|FG000|Completed 6 Cycles|Treatment Phase||45||
48643408|NCT00455455|101913525|FG001|STARTED|Washout||25||
48643409|NCT00455455|101913524|FG000|COMPLETED|Washout||25||
48643410|NCT00455455|101913525|FG001|COMPLETED|Washout||24||
48643411|NCT00455455|101913524|FG000|NOT COMPLETED|Washout||0||
48643412|NCT00455455|101913525|FG001|NOT COMPLETED|Washout||1||
48643413|NCT00455455|101913524|FG000|STARTED|First Intervention||25||
48643414|NCT00455455|101913525|FG001|STARTED|First Intervention||24||
48643415|NCT00455455|101913524|FG000|COMPLETED|First Intervention||25||
48643416|NCT00455455|101913525|FG001|COMPLETED|First Intervention||24||
48643417|NCT00455455|101913524|FG000|NOT COMPLETED|First Intervention||0||
48643418|NCT00455455|101913525|FG001|NOT COMPLETED|First Intervention||0||
48643419|NCT00455455|101913524|FG000|STARTED|Washout||25||
48435833|NCT01269346|101400115|FG000|COMPLETED|Treatment Phase||43||
48643420|NCT00455455|101913525|FG001|STARTED|Washout||24||
48435834|NCT01269346|101400115|FG000|NOT COMPLETED|Treatment Phase||9||
48435835|NCT01269346|101400115|FG000|STARTED|Extension Phase||43||
48435836|NCT01269346|101400115|FG000|COMPLETED|Extension Phase||0||
48435837|NCT01269346|101400115|FG000|NOT COMPLETED|Extension Phase||43||
48765091|NCT02113982|102214595|FG012|COMPLETED|Stage 1: Dose Escalation||0||
48765092|NCT02113982|102214596|FG013|COMPLETED|Stage 1: Dose Escalation||0||
48765093|NCT02113982|102214583|FG000|NOT COMPLETED|Stage 1: Dose Escalation||3||
48435838|NCT03628781|101400116|FG000|STARTED|Overall Study||85||
48435839|NCT03628781|101400117|FG001|STARTED|Overall Study||84||
48435840|NCT03628781|101400116|FG000|6-month Timepoint|Overall Study||63||
48435841|NCT03628781|101400117|FG001|6-month Timepoint|Overall Study||79||
48435842|NCT03628781|101400116|FG000|12-month Timepoint|Overall Study||53||
48435843|NCT03628781|101400117|FG001|12-month Timepoint|Overall Study||75||
48435844|NCT03628781|101400116|FG000|COMPLETED|Overall Study||53||
48435845|NCT03628781|101400117|FG001|COMPLETED|Overall Study||75||
48435846|NCT03628781|101400116|FG000|NOT COMPLETED|Overall Study||32||
48435847|NCT03628781|101400117|FG001|NOT COMPLETED|Overall Study||9||
48435848|NCT04342130|101400118|FG000|STARTED|Overall Study||10||
48435849|NCT04342130|101400118|FG000|COMPLETED|Overall Study||10||
48435850|NCT04342130|101400118|FG000|NOT COMPLETED|Overall Study||0||
48435851|NCT00103376|101400119|FG000|STARTED|Overall Study||8||
48435852|NCT00103376|101400120|FG001|STARTED|Overall Study||7||
48435853|NCT00103376|101400121|FG002|STARTED|Overall Study||8||
48435854|NCT00103376|101400119|FG000|COMPLETED|Overall Study||8||
48435855|NCT00103376|101400120|FG001|COMPLETED|Overall Study||7||
48435856|NCT00103376|101400121|FG002|COMPLETED|Overall Study||8||
48435857|NCT00103376|101400119|FG000|NOT COMPLETED|Overall Study||0||
48435858|NCT00103376|101400120|FG001|NOT COMPLETED|Overall Study||0||
48435859|NCT00103376|101400121|FG002|NOT COMPLETED|Overall Study||0||
48435860|NCT00536991|101400122|FG000|STARTED|Overall Study||51||
48435861|NCT00536991|101400122|FG000|COMPLETED|Overall Study||38||
48435862|NCT00536991|101400122|FG000|NOT COMPLETED|Overall Study||13||
48435863|NCT03930524|101400123|FG000|STARTED|Stage 1||300||
48435864|NCT03930524|101400124|FG001|STARTED|Stage 1||295||
48435865|NCT03930524|101400125|FG002|STARTED|Stage 1||0||
48435866|NCT03930524|101400126|FG003|STARTED|Stage 1||0||
48435867|NCT03930524|101400127|FG004|STARTED|Stage 1||296||
48435868|NCT03930524|101400128|FG005|STARTED|Stage 1||0||
48435869|NCT03930524|101400129|FG006|STARTED|Stage 1||0||
48643421|NCT00455455|101913524|FG000|COMPLETED|Washout||24||
48643422|NCT00455455|101913525|FG001|COMPLETED|Washout||24||
48643423|NCT00455455|101913524|FG000|NOT COMPLETED|Washout||1||
48643424|NCT00455455|101913525|FG001|NOT COMPLETED|Washout||0||
48643425|NCT00455455|101913524|FG000|STARTED|Second Intervention||24||
48643426|NCT00455455|101913525|FG001|STARTED|Second Intervention||24||
48643427|NCT00455455|101913524|FG000|COMPLETED|Second Intervention||24||
48643428|NCT00455455|101913525|FG001|COMPLETED|Second Intervention||24||
48643429|NCT00455455|101913524|FG000|NOT COMPLETED|Second Intervention||0||
48643430|NCT00455455|101913525|FG001|NOT COMPLETED|Second Intervention||0||
48643431|NCT02153827|101913526|FG000|STARTED|Overall Study||25||
48643432|NCT02153827|101913527|FG001|STARTED|Overall Study||23||
48643433|NCT02153827|101913526|FG000|COMPLETED|Overall Study||22||
48643434|NCT02153827|101913527|FG001|COMPLETED|Overall Study||14||
48643435|NCT02153827|101913526|FG000|NOT COMPLETED|Overall Study||3||
48643436|NCT02153827|101913527|FG001|NOT COMPLETED|Overall Study||9||
48643437|NCT00853385|101913528|FG000|STARTED|Overall Study||204||
48643438|NCT00853385|101913529|FG001|STARTED|Overall Study||201||
48643439|NCT00853385|101913530|FG002|STARTED|Overall Study||56||
48643440|NCT00853385|101913531|FG003|STARTED|Overall Study||52||
48643441|NCT00853385|101913532|FG004|STARTED|Overall Study||204||
48643442|NCT00853385|101913528|FG000|COMPLETED|Overall Study||150||
48643443|NCT00853385|101913529|FG001|COMPLETED|Overall Study||158||
48643444|NCT00853385|101913530|FG002|COMPLETED|Overall Study||47||
48643445|NCT00853385|101913531|FG003|COMPLETED|Overall Study||39||
48765094|NCT02113982|102214584|FG001|NOT COMPLETED|Stage 1: Dose Escalation||3||
48765095|NCT02113982|102214585|FG002|NOT COMPLETED|Stage 1: Dose Escalation||2||
48765096|NCT02113982|102214586|FG003|NOT COMPLETED|Stage 1: Dose Escalation||6||
48765097|NCT02113982|102214587|FG004|NOT COMPLETED|Stage 1: Dose Escalation||3||
48765098|NCT02113982|102214588|FG005|NOT COMPLETED|Stage 1: Dose Escalation||3||
48765099|NCT02113982|102214589|FG006|NOT COMPLETED|Stage 1: Dose Escalation||3||
48765100|NCT02113982|102214590|FG007|NOT COMPLETED|Stage 1: Dose Escalation||0||
48643446|NCT00853385|101913532|FG004|COMPLETED|Overall Study||162||
48643447|NCT00853385|101913528|FG000|NOT COMPLETED|Overall Study||54||
48765101|NCT02113982|102214591|FG008|NOT COMPLETED|Stage 1: Dose Escalation||0||
48765102|NCT02113982|102214592|FG009|NOT COMPLETED|Stage 1: Dose Escalation||0||
48435870|NCT03930524|101400123|FG000|COMPLETED|Stage 1||274||
48435871|NCT03930524|101400124|FG001|COMPLETED|Stage 1||254||
48435872|NCT03930524|101400125|FG002|COMPLETED|Stage 1||0||
48435873|NCT03930524|101400126|FG003|COMPLETED|Stage 1||0||
48435874|NCT03930524|101400127|FG004|COMPLETED|Stage 1||253||
48435875|NCT03930524|101400128|FG005|COMPLETED|Stage 1||0||
48435876|NCT03930524|101400129|FG006|COMPLETED|Stage 1||0||
48643448|NCT00853385|101913529|FG001|NOT COMPLETED|Overall Study||43||
48435877|NCT03930524|101400123|FG000|NOT COMPLETED|Stage 1||26||
48435878|NCT03930524|101400124|FG001|NOT COMPLETED|Stage 1||41||
48643449|NCT00853385|101913530|FG002|NOT COMPLETED|Overall Study||9||
48643450|NCT00853385|101913531|FG003|NOT COMPLETED|Overall Study||13||
48643451|NCT00853385|101913532|FG004|NOT COMPLETED|Overall Study||42||
48643452|NCT01807520|101913533|FG000|STARTED|Treatment Period 1 (0-16 Weeks)||67||
48643453|NCT01807520|101913534|FG001|STARTED|Treatment Period 1 (0-16 Weeks)||66||
48643454|NCT01807520|101913535|FG002|STARTED|Treatment Period 1 (0-16 Weeks)||65||
48643455|NCT01807520|101913536|FG003|STARTED|Treatment Period 1 (0-16 Weeks)||0||
48643456|NCT01807520|101913537|FG004|STARTED|Treatment Period 1 (0-16 Weeks)||0||
48643457|NCT01807520|101913538|FG005|STARTED|Treatment Period 1 (0-16 Weeks)||0||
48643458|NCT01807520|101913539|FG006|STARTED|Treatment Period 1 (0-16 Weeks)||0||
48643459|NCT01807520|101913533|FG000|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||67||
48643460|NCT01807520|101913534|FG001|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||66||
48643461|NCT01807520|101913535|FG002|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||65||
48643462|NCT01807520|101913536|FG003|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0||
48643463|NCT01807520|101913537|FG004|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0||
48643464|NCT01807520|101913538|FG005|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0||
48643465|NCT01807520|101913539|FG006|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0||
48643466|NCT01807520|101913533|FG000|Safety Set|Treatment Period 1 (0-16 Weeks)||67||
48643467|NCT01807520|101913534|FG001|Safety Set|Treatment Period 1 (0-16 Weeks)||65||
48643468|NCT01807520|101913535|FG002|Safety Set|Treatment Period 1 (0-16 Weeks)||65||
48643469|NCT01807520|101913536|FG003|Safety Set|Treatment Period 1 (0-16 Weeks)||0||
48643470|NCT01807520|101913537|FG004|Safety Set|Treatment Period 1 (0-16 Weeks)||0||
48643471|NCT01807520|101913538|FG005|Safety Set|Treatment Period 1 (0-16 Weeks)||0||
48643472|NCT01807520|101913539|FG006|Safety Set|Treatment Period 1 (0-16 Weeks)||0||
48643473|NCT01807520|101913533|FG000|COMPLETED|Treatment Period 1 (0-16 Weeks)||63||
48643474|NCT01807520|101913534|FG001|COMPLETED|Treatment Period 1 (0-16 Weeks)||65||
48643475|NCT01807520|101913535|FG002|COMPLETED|Treatment Period 1 (0-16 Weeks)||58||
48643476|NCT01807520|101913536|FG003|COMPLETED|Treatment Period 1 (0-16 Weeks)||0||
48643477|NCT01807520|101913537|FG004|COMPLETED|Treatment Period 1 (0-16 Weeks)||0||
48643478|NCT01807520|101913538|FG005|COMPLETED|Treatment Period 1 (0-16 Weeks)||0||
48643479|NCT01807520|101913539|FG006|COMPLETED|Treatment Period 1 (0-16 Weeks)||0||
48643480|NCT01807520|101913533|FG000|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||4||
48643481|NCT01807520|101913534|FG001|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||1||
48643482|NCT01807520|101913535|FG002|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||7||
48643483|NCT01807520|101913536|FG003|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0||
48643484|NCT01807520|101913537|FG004|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0||
48643485|NCT01807520|101913538|FG005|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0||
48643486|NCT01807520|101913539|FG006|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0||
48643487|NCT01807520|101913533|FG000|STARTED|Treatment Period 2 (16-132 Weeks)||63||
48643488|NCT01807520|101913534|FG001|STARTED|Treatment Period 2 (16-132 Weeks)||65||
48643489|NCT01807520|101913535|FG002|STARTED|Treatment Period 2 (16-132 Weeks)||0||
48643490|NCT01807520|101913536|FG003|STARTED|Treatment Period 2 (16-132 Weeks)||29||
48643491|NCT01807520|101913537|FG004|STARTED|Treatment Period 2 (16-132 Weeks)||29||
48643492|NCT01807520|101913538|FG005|STARTED|Treatment Period 2 (16-132 Weeks)||0||
48643493|NCT01807520|101913539|FG006|STARTED|Treatment Period 2 (16-132 Weeks)||0||
48643494|NCT01807520|101913533|FG000|Safety Set|Treatment Period 2 (16-132 Weeks)||63||
48643495|NCT01807520|101913534|FG001|Safety Set|Treatment Period 2 (16-132 Weeks)||65||
48643496|NCT01807520|101913535|FG002|Safety Set|Treatment Period 2 (16-132 Weeks)||0||
48643497|NCT01807520|101913536|FG003|Safety Set|Treatment Period 2 (16-132 Weeks)||29||
48643498|NCT01807520|101913537|FG004|Safety Set|Treatment Period 2 (16-132 Weeks)||29||
48643499|NCT01807520|101913538|FG005|Safety Set|Treatment Period 2 (16-132 Weeks)||0||
48643500|NCT01807520|101913539|FG006|Safety Set|Treatment Period 2 (16-132 Weeks)||0||
48643501|NCT01807520|101913533|FG000|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||67||
48643502|NCT01807520|101913534|FG001|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||66||
48643503|NCT01807520|101913535|FG002|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0||
48643504|NCT01807520|101913536|FG003|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29||
48643505|NCT01807520|101913537|FG004|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29||
48643506|NCT01807520|101913538|FG005|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0||
48643507|NCT01807520|101913539|FG006|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0||
48643508|NCT01807520|101913533|FG000|COMPLETED|Treatment Period 2 (16-132 Weeks)||38||
48643509|NCT01807520|101913534|FG001|COMPLETED|Treatment Period 2 (16-132 Weeks)||47||
48643510|NCT01807520|101913535|FG002|COMPLETED|Treatment Period 2 (16-132 Weeks)||0||
48643511|NCT01807520|101913536|FG003|COMPLETED|Treatment Period 2 (16-132 Weeks)||22||
48765103|NCT02113982|102214593|FG010|NOT COMPLETED|Stage 1: Dose Escalation||0||
48643512|NCT01807520|101913537|FG004|COMPLETED|Treatment Period 2 (16-132 Weeks)||24||
48643513|NCT01807520|101913538|FG005|COMPLETED|Treatment Period 2 (16-132 Weeks)||0||
48643514|NCT01807520|101913539|FG006|COMPLETED|Treatment Period 2 (16-132 Weeks)||0||
48643515|NCT01807520|101913533|FG000|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||25||
48643516|NCT01807520|101913534|FG001|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||18||
48643517|NCT01807520|101913535|FG002|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0||
48643518|NCT01807520|101913536|FG003|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||7||
48643519|NCT01807520|101913537|FG004|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||5||
48643520|NCT01807520|101913538|FG005|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0||
48643521|NCT01807520|101913539|FG006|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0||
48643522|NCT01807520|101913533|FG000|STARTED|Follow-up Period (132-140 Weeks)||0||
48643523|NCT01807520|101913534|FG001|STARTED|Follow-up Period (132-140 Weeks)||0||
48643524|NCT01807520|101913535|FG002|STARTED|Follow-up Period (132-140 Weeks)||2||
48643525|NCT01807520|101913536|FG003|STARTED|Follow-up Period (132-140 Weeks)||0||
48643526|NCT01807520|101913537|FG004|STARTED|Follow-up Period (132-140 Weeks)||0||
48643527|NCT01807520|101913538|FG005|STARTED|Follow-up Period (132-140 Weeks)||81||
48643528|NCT01807520|101913539|FG006|STARTED|Follow-up Period (132-140 Weeks)||76||
48643529|NCT01807520|101913533|FG000|COMPLETED|Follow-up Period (132-140 Weeks)||0||
48643530|NCT01807520|101913534|FG001|COMPLETED|Follow-up Period (132-140 Weeks)||0||
48643531|NCT01807520|101913535|FG002|COMPLETED|Follow-up Period (132-140 Weeks)||2||
48643532|NCT01807520|101913536|FG003|COMPLETED|Follow-up Period (132-140 Weeks)||0||
48643533|NCT01807520|101913537|FG004|COMPLETED|Follow-up Period (132-140 Weeks)||0||
48643534|NCT01807520|101913538|FG005|COMPLETED|Follow-up Period (132-140 Weeks)||77||
48643535|NCT01807520|101913539|FG006|COMPLETED|Follow-up Period (132-140 Weeks)||75||
48643536|NCT01807520|101913533|FG000|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0||
48643537|NCT01807520|101913534|FG001|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0||
48643538|NCT01807520|101913535|FG002|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0||
48643539|NCT01807520|101913536|FG003|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0||
48643540|NCT01807520|101913537|FG004|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0||
48643541|NCT01807520|101913538|FG005|NOT COMPLETED|Follow-up Period (132-140 Weeks)||4||
48643542|NCT01807520|101913539|FG006|NOT COMPLETED|Follow-up Period (132-140 Weeks)||1||
48643543|NCT01908842|101913540|FG000|STARTED|Induction||383||
48643544|NCT01908842|101913541|FG001|STARTED|Induction||375||
48643545|NCT01908842|101913540|FG000|COMPLETED|Induction||357||
48643546|NCT01908842|101913541|FG001|COMPLETED|Induction||344||
48643547|NCT01908842|101913540|FG000|NOT COMPLETED|Induction||26||
48643548|NCT01908842|101913541|FG001|NOT COMPLETED|Induction||31||
48643549|NCT01908842|101913540|FG000|STARTED|Switch to Other BNX Formulation (Day 15)||357||
48643550|NCT01908842|101913541|FG001|STARTED|Switch to Other BNX Formulation (Day 15)||344||
48643551|NCT01908842|101913540|FG000|COMPLETED|Switch to Other BNX Formulation (Day 15)||287||
48643552|NCT01908842|101913541|FG001|COMPLETED|Switch to Other BNX Formulation (Day 15)||279||
48765104|NCT02113982|102214594|FG011|NOT COMPLETED|Stage 1: Dose Escalation||0||
48765105|NCT02113982|102214595|FG012|NOT COMPLETED|Stage 1: Dose Escalation||0||
48765106|NCT02113982|102214596|FG013|NOT COMPLETED|Stage 1: Dose Escalation||0||
48361894|NCT01084252|101214454|FG008|STARTED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||23||
48361895|NCT01084252|101214455|FG009|STARTED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||24||
48361896|NCT01084252|101214456|FG010|STARTED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||25||
48361897|NCT01084252|101214457|FG011|STARTED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||25||
48435879|NCT03930524|101400125|FG002|NOT COMPLETED|Stage 1||0||
48435880|NCT03930524|101400126|FG003|NOT COMPLETED|Stage 1||0||
48435881|NCT03930524|101400127|FG004|NOT COMPLETED|Stage 1||43||
48643553|NCT01908842|101913540|FG000|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||70||
48643554|NCT01908842|101913541|FG001|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||65||
48643555|NCT01908842|101913540|FG000|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||287||
48643556|NCT01908842|101913541|FG001|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||279||
48643557|NCT01908842|101913540|FG000|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262||
48643558|NCT01908842|101913541|FG001|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262||
48643559|NCT01908842|101913540|FG000|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||25||
48643560|NCT01908842|101913541|FG001|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||17||
48643561|NCT01625182|101913542|FG000|STARTED|Overall Study||54||
48643562|NCT01625182|101913543|FG001|STARTED|Overall Study||52||
48643563|NCT01625182|101913542|FG000|COMPLETED|Overall Study||34||
48643564|NCT01625182|101913543|FG001|COMPLETED|Overall Study||41||
48643565|NCT01625182|101913542|FG000|NOT COMPLETED|Overall Study||20||
48643566|NCT01625182|101913543|FG001|NOT COMPLETED|Overall Study||11||
48643567|NCT00081458|101913544|FG000|STARTED|Overall Study||16||
48643568|NCT00081458|101913545|FG001|STARTED|Overall Study||35||
48643569|NCT00081458|101913546|FG002|STARTED|Overall Study||33||
48643570|NCT00081458|101913544|FG000|Received Treatment|Overall Study||16||
48643571|NCT00081458|101913545|FG001|Received Treatment|Overall Study||35||
48643572|NCT00081458|101913546|FG002|Received Treatment|Overall Study||32||
48643573|NCT00081458|101913544|FG000|COMPLETED|Overall Study||15||
48643574|NCT00081458|101913545|FG001|COMPLETED|Overall Study||27||
48643575|NCT00081458|101913546|FG002|COMPLETED|Overall Study||29||
48643576|NCT00081458|101913544|FG000|NOT COMPLETED|Overall Study||1||
48643577|NCT00081458|101913545|FG001|NOT COMPLETED|Overall Study||8||
48643578|NCT00081458|101913546|FG002|NOT COMPLETED|Overall Study||4||
48643579|NCT00500890|101913547|FG000|STARTED|Overall Study||1||
48643580|NCT00500890|101913548|FG001|STARTED|Overall Study||1||
48643581|NCT00500890|101913547|FG000|COMPLETED|Overall Study||1||
48643582|NCT00500890|101913548|FG001|COMPLETED|Overall Study||1||
48643583|NCT00500890|101913547|FG000|NOT COMPLETED|Overall Study||0||
48361898|NCT01084252|101214458|FG012|STARTED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0||
48643584|NCT00500890|101913548|FG001|NOT COMPLETED|Overall Study||0||
48643585|NCT03142750|101913549|FG000|STARTED|Overall Study||14||
48643586|NCT03142750|101913550|FG001|STARTED|Overall Study||10||
48643587|NCT03142750|101913549|FG000|COMPLETED|Overall Study||10||
48643588|NCT03142750|101913550|FG001|COMPLETED|Overall Study||9||
48643589|NCT03142750|101913549|FG000|NOT COMPLETED|Overall Study||4||
48643590|NCT03142750|101913550|FG001|NOT COMPLETED|Overall Study||1||
48643591|NCT00243061|101913551|FG000|STARTED|Overall Study||24||
48643592|NCT00243061|101913551|FG000|COMPLETED|Overall Study||24||
48643593|NCT00243061|101913551|FG000|NOT COMPLETED|Overall Study||0||
48643594|NCT00286455|101913552|FG000|STARTED|Overall Study||65||
48643595|NCT00286455|101913553|FG001|STARTED|Overall Study||133||
48643596|NCT00286455|101913554|FG002|STARTED|Overall Study||131||
48643597|NCT00286455|101913552|FG000|COMPLETED|Overall Study||40||
48643598|NCT00286455|101913553|FG001|COMPLETED|Overall Study||105||
48643599|NCT00286455|101913554|FG002|COMPLETED|Overall Study||107||
48643600|NCT00286455|101913552|FG000|NOT COMPLETED|Overall Study||25||
48643601|NCT00286455|101913553|FG001|NOT COMPLETED|Overall Study||28||
48643602|NCT00286455|101913554|FG002|NOT COMPLETED|Overall Study||24||
48643603|NCT02826551|101913555|FG000|STARTED|Overall Study||11||
48643604|NCT02826551|101913556|FG001|STARTED|Overall Study||12||
48643605|NCT02826551|101913555|FG000|COMPLETED|Overall Study||11||
48643606|NCT02826551|101913556|FG001|COMPLETED|Overall Study||12||
48643607|NCT02826551|101913555|FG000|NOT COMPLETED|Overall Study||0||
48643608|NCT02826551|101913556|FG001|NOT COMPLETED|Overall Study||0||
48643609|NCT00976898|101913557|FG000|STARTED|Overall Study||83||
48643610|NCT00976898|101913557|FG000|COMPLETED|Overall Study||78||
48643611|NCT00976898|101913557|FG000|NOT COMPLETED|Overall Study||5||
48643612|NCT00546273|101913558|FG000|STARTED|I||4||
48643613|NCT00546273|101913559|FG001|STARTED|I||0||
48643614|NCT00546273|101913560|FG002|STARTED|I||0||
48643615|NCT00546273|101913561|FG003|STARTED|I||0||
48643616|NCT00546273|101913562|FG004|STARTED|I||2||
48643617|NCT00546273|101913558|FG000|COMPLETED|I||4||
48643618|NCT00546273|101913559|FG001|COMPLETED|I||0||
48643619|NCT00546273|101913560|FG002|COMPLETED|I||0||
48643620|NCT00546273|101913561|FG003|COMPLETED|I||0||
48643621|NCT00546273|101913562|FG004|COMPLETED|I||2||
48643622|NCT00546273|101913558|FG000|NOT COMPLETED|I||0||
48643623|NCT00546273|101913559|FG001|NOT COMPLETED|I||0||
48643624|NCT00546273|101913560|FG002|NOT COMPLETED|I||0||
48643625|NCT00546273|101913561|FG003|NOT COMPLETED|I||0||
48643626|NCT00546273|101913562|FG004|NOT COMPLETED|I||0||
48643627|NCT00546273|101913558|FG000|STARTED|II||0||
48643628|NCT00546273|101913559|FG001|STARTED|II||4||
48643629|NCT00546273|101913560|FG002|STARTED|II||0||
48643630|NCT00546273|101913561|FG003|STARTED|II||0||
48643631|NCT00546273|101913562|FG004|STARTED|II||2||
48643632|NCT00546273|101913558|FG000|COMPLETED|II||0||
48643633|NCT00546273|101913559|FG001|COMPLETED|II||4||
48643634|NCT00546273|101913560|FG002|COMPLETED|II||0||
48643635|NCT00546273|101913561|FG003|COMPLETED|II||0||
48435882|NCT03930524|101400128|FG005|NOT COMPLETED|Stage 1||0||
48435883|NCT03930524|101400129|FG006|NOT COMPLETED|Stage 1||0||
48435884|NCT03930524|101400123|FG000|STARTED|"Stage 2 (Heavy Drinkers)"||0||
48435885|NCT03930524|101400124|FG001|STARTED|"Stage 2 (Heavy Drinkers)"||0||
48435886|NCT03930524|101400125|FG002|STARTED|"Stage 2 (Heavy Drinkers)"||38||
48435887|NCT03930524|101400126|FG003|STARTED|"Stage 2 (Heavy Drinkers)"||37||
48435888|NCT03930524|101400127|FG004|STARTED|"Stage 2 (Heavy Drinkers)"||0||
48435889|NCT03930524|101400128|FG005|STARTED|"Stage 2 (Heavy Drinkers)"||40||
48435890|NCT03930524|101400129|FG006|STARTED|"Stage 2 (Heavy Drinkers)"||43||
48435891|NCT03930524|101400123|FG000|COMPLETED|"Stage 2 (Heavy Drinkers)"||0||
48435892|NCT03930524|101400124|FG001|COMPLETED|"Stage 2 (Heavy Drinkers)"||0||
48435893|NCT03930524|101400125|FG002|COMPLETED|"Stage 2 (Heavy Drinkers)"||36||
48435894|NCT03930524|101400126|FG003|COMPLETED|"Stage 2 (Heavy Drinkers)"||34||
48435895|NCT03930524|101400127|FG004|COMPLETED|"Stage 2 (Heavy Drinkers)"||0||
48435896|NCT03930524|101400128|FG005|COMPLETED|"Stage 2 (Heavy Drinkers)"||33||
48435897|NCT03930524|101400129|FG006|COMPLETED|"Stage 2 (Heavy Drinkers)"||40||
48643636|NCT00546273|101913562|FG004|COMPLETED|II||2||
48643637|NCT00546273|101913558|FG000|NOT COMPLETED|II||0||
48643638|NCT00546273|101913559|FG001|NOT COMPLETED|II||0||
48643639|NCT00546273|101913560|FG002|NOT COMPLETED|II||0||
48643640|NCT00546273|101913561|FG003|NOT COMPLETED|II||0||
48643641|NCT00546273|101913562|FG004|NOT COMPLETED|II||0||
48435898|NCT03930524|101400123|FG000|NOT COMPLETED|"Stage 2 (Heavy Drinkers)"||0||
48643642|NCT00546273|101913558|FG000|STARTED|III||0||
48643643|NCT00546273|101913559|FG001|STARTED|III||0||
48643644|NCT00546273|101913560|FG002|STARTED|III||4||
48643645|NCT00546273|101913561|FG003|STARTED|III||0||
48643646|NCT00546273|101913562|FG004|STARTED|III||2||
48643647|NCT00546273|101913558|FG000|COMPLETED|III||0||
48643648|NCT00546273|101913559|FG001|COMPLETED|III||0||
48643649|NCT00546273|101913560|FG002|COMPLETED|III||4||
48643650|NCT00546273|101913561|FG003|COMPLETED|III||0||
48643651|NCT00546273|101913562|FG004|COMPLETED|III||2||
48643652|NCT00546273|101913558|FG000|NOT COMPLETED|III||0||
48643653|NCT00546273|101913559|FG001|NOT COMPLETED|III||0||
48643654|NCT00546273|101913560|FG002|NOT COMPLETED|III||0||
48643655|NCT00546273|101913561|FG003|NOT COMPLETED|III||0||
48435899|NCT03930524|101400124|FG001|NOT COMPLETED|"Stage 2 (Heavy Drinkers)"||0||
48435900|NCT03930524|101400125|FG002|NOT COMPLETED|"Stage 2 (Heavy Drinkers)"||2||
48435901|NCT03930524|101400126|FG003|NOT COMPLETED|"Stage 2 (Heavy Drinkers)"||3||
48435902|NCT03930524|101400127|FG004|NOT COMPLETED|"Stage 2 (Heavy Drinkers)"||0||
48435903|NCT03930524|101400128|FG005|NOT COMPLETED|"Stage 2 (Heavy Drinkers)"||7||
48435904|NCT03930524|101400129|FG006|NOT COMPLETED|"Stage 2 (Heavy Drinkers)"||3||
48435905|NCT03309072|101400130|FG000|STARTED|Overall Study||15||
48435906|NCT03309072|101400131|FG001|STARTED|Overall Study||15||
48435907|NCT03309072|101400130|FG000|COMPLETED|Overall Study||15||
48435908|NCT03309072|101400131|FG001|COMPLETED|Overall Study||15||
48435909|NCT03309072|101400130|FG000|NOT COMPLETED|Overall Study||0||
48435910|NCT03309072|101400131|FG001|NOT COMPLETED|Overall Study||0||
48435911|NCT00437294|101400132|FG000|STARTED|Overall Study||43||
48435912|NCT00437294|101400133|FG001|STARTED|Overall Study||43||
48435913|NCT00437294|101400132|FG000|Received at Least 1 Dose of Study Drug|Overall Study||42||
48435914|NCT00437294|101400133|FG001|Received at Least 1 Dose of Study Drug|Overall Study||43||
48435915|NCT00437294|101400132|FG000|COMPLETED|Overall Study||0||
48435916|NCT00437294|101400133|FG001|COMPLETED|Overall Study||0||
48435917|NCT00437294|101400132|FG000|NOT COMPLETED|Overall Study||43||
48435918|NCT00437294|101400133|FG001|NOT COMPLETED|Overall Study||43||
48435919|NCT01418365|101400134|FG000|STARTED|First Intervention||15||
48435920|NCT01418365|101400135|FG001|STARTED|First Intervention||15||
48435921|NCT01418365|101400134|FG000|COMPLETED|First Intervention||14||
48435922|NCT01418365|101400135|FG001|COMPLETED|First Intervention||14||
48435923|NCT01418365|101400134|FG000|NOT COMPLETED|First Intervention||1||
48435924|NCT01418365|101400135|FG001|NOT COMPLETED|First Intervention||1||
48435925|NCT01418365|101400134|FG000|STARTED|Second Intervention||14||
48435926|NCT01418365|101400135|FG001|STARTED|Second Intervention||14||
48435927|NCT01418365|101400134|FG000|COMPLETED|Second Intervention||14||
48435928|NCT01418365|101400135|FG001|COMPLETED|Second Intervention||13||
48435929|NCT01418365|101400134|FG000|NOT COMPLETED|Second Intervention||0||
48435930|NCT01418365|101400135|FG001|NOT COMPLETED|Second Intervention||1||
48435931|NCT00740129|101400136|FG000|STARTED|Overall Study||6||
48435932|NCT00740129|101400136|FG000|COMPLETED|Overall Study||6||
48435933|NCT00740129|101400136|FG000|NOT COMPLETED|Overall Study||0||
48435934|NCT02116309|101400137|FG000|STARTED|Overall Study||482||
48435935|NCT02116309|101400138|FG001|STARTED|Overall Study||478||
48435936|NCT02116309|101400137|FG000|COMPLETED|Overall Study||482||
48435937|NCT02116309|101400138|FG001|COMPLETED|Overall Study||477||
48435938|NCT02116309|101400137|FG000|NOT COMPLETED|Overall Study||0||
48435939|NCT02116309|101400138|FG001|NOT COMPLETED|Overall Study||1||
48435940|NCT04899362|101400139|FG000|STARTED|Overall Study||36||
48435941|NCT04899362|101400139|FG000|COMPLETED|Overall Study||22||
48435942|NCT04899362|101400139|FG000|NOT COMPLETED|Overall Study||14||
48435943|NCT00572910|101400140|FG000|STARTED|Overall Study||19||
48435944|NCT00572910|101400141|FG001|STARTED|Overall Study||18||
48435945|NCT00572910|101400142|FG002|STARTED|Overall Study||19||
48435946|NCT00572910|101400143|FG003|STARTED|Overall Study||18||
48435947|NCT00572910|101400144|FG004|STARTED|Overall Study||19||
48435948|NCT00572910|101400145|FG005|STARTED|Overall Study||19||
48765107|NCT02113982|102214583|FG000|STARTED|Stage 2: Cohort Expansion||0||
48435949|NCT00572910|101400146|FG006|STARTED|Overall Study||19||
48435950|NCT00572910|101400147|FG007|STARTED|Overall Study||19||
48435951|NCT00572910|101400148|FG008|STARTED|Overall Study||19||
48435952|NCT00572910|101400149|FG009|STARTED|Overall Study||19||
48435953|NCT00572910|101400150|FG010|STARTED|Overall Study||18||
48435954|NCT00572910|101400140|FG000|COMPLETED|Overall Study||15||
48435955|NCT00572910|101400141|FG001|COMPLETED|Overall Study||15||
48435956|NCT00572910|101400142|FG002|COMPLETED|Overall Study||17||
48435957|NCT00572910|101400143|FG003|COMPLETED|Overall Study||14||
48435958|NCT00572910|101400144|FG004|COMPLETED|Overall Study||17||
48435959|NCT00572910|101400145|FG005|COMPLETED|Overall Study||16||
48435960|NCT00572910|101400146|FG006|COMPLETED|Overall Study||15||
48435961|NCT00572910|101400147|FG007|COMPLETED|Overall Study||15||
48435962|NCT00572910|101400148|FG008|COMPLETED|Overall Study||16||
48435963|NCT00572910|101400149|FG009|COMPLETED|Overall Study||13||
48435964|NCT00572910|101400150|FG010|COMPLETED|Overall Study||15||
48435965|NCT00572910|101400140|FG000|NOT COMPLETED|Overall Study||4||
48435966|NCT00572910|101400141|FG001|NOT COMPLETED|Overall Study||3||
48435967|NCT00572910|101400142|FG002|NOT COMPLETED|Overall Study||2||
48765108|NCT02113982|102214584|FG001|STARTED|Stage 2: Cohort Expansion||0||
48435968|NCT00572910|101400143|FG003|NOT COMPLETED|Overall Study||4||
48435969|NCT00572910|101400144|FG004|NOT COMPLETED|Overall Study||2||
48435970|NCT00572910|101400145|FG005|NOT COMPLETED|Overall Study||3||
48765109|NCT02113982|102214585|FG002|STARTED|Stage 2: Cohort Expansion||0||
48435971|NCT00572910|101400146|FG006|NOT COMPLETED|Overall Study||4||
48435972|NCT00572910|101400147|FG007|NOT COMPLETED|Overall Study||4||
48435973|NCT00572910|101400148|FG008|NOT COMPLETED|Overall Study||3||
48435974|NCT00572910|101400149|FG009|NOT COMPLETED|Overall Study||6||
48435975|NCT00572910|101400150|FG010|NOT COMPLETED|Overall Study||3||
48435976|NCT04478994|101400151|FG000|STARTED|Overall Study||1||
48435977|NCT04478994|101400152|FG001|STARTED|Overall Study||2||
48435978|NCT04478994|101400151|FG000|COMPLETED|Overall Study||0||
48435979|NCT04478994|101400152|FG001|COMPLETED|Overall Study||1||
48435980|NCT04478994|101400151|FG000|NOT COMPLETED|Overall Study||1||
48435981|NCT04478994|101400152|FG001|NOT COMPLETED|Overall Study||1||
48435982|NCT00186875|101400153|FG000|STARTED|Overall Study||26||
48435983|NCT00186875|101400154|FG001|STARTED|Overall Study||14||
48435984|NCT00186875|101400153|FG000|COMPLETED|Overall Study||26||
48435985|NCT00186875|101400154|FG001|COMPLETED|Overall Study||14||
48435986|NCT00186875|101400153|FG000|NOT COMPLETED|Overall Study||0||
48435987|NCT00186875|101400154|FG001|NOT COMPLETED|Overall Study||0||
48435988|NCT01153971|101400155|FG000|STARTED|Induction Phase (Months 1 to 7 of Study)||47||
48435989|NCT01153971|101400155|FG000|COMPLETED|Induction Phase (Months 1 to 7 of Study)||44||
48435990|NCT01153971|101400155|FG000|NOT COMPLETED|Induction Phase (Months 1 to 7 of Study)||3||
48435991|NCT01153971|101400155|FG000|STARTED|Maintenance Phase (Months 8-16 of Study)||44||
48435992|NCT01153971|101400155|FG000|COMPLETED|Maintenance Phase (Months 8-16 of Study)||41||
48435993|NCT01153971|101400155|FG000|NOT COMPLETED|Maintenance Phase (Months 8-16 of Study)||3||
48435994|NCT01153971|101400155|FG000|STARTED|Follow-up (Months 17-40 of Study)||41||
48435995|NCT01153971|101400155|FG000|COMPLETED|Follow-up (Months 17-40 of Study)||37||
48435996|NCT01153971|101400155|FG000|NOT COMPLETED|Follow-up (Months 17-40 of Study)||4||
48435997|NCT03053102|101400156|FG000|STARTED|Study Part 1: 28-Day Treatment||10||
48435998|NCT03053102|101400156|FG000|Received at Least 1 Dose of Study Drug|Study Part 1: 28-Day Treatment||10||
48435999|NCT03053102|101400156|FG000|COMPLETED|Study Part 1: 28-Day Treatment||10||
48436000|NCT03053102|101400156|FG000|NOT COMPLETED|Study Part 1: 28-Day Treatment||0||
48436001|NCT03053102|101400156|FG000|STARTED|Study Part 2: 84-Day Treatment||10||
48436002|NCT03053102|101400156|FG000|COMPLETED|Study Part 2: 84-Day Treatment||8||
48436003|NCT03053102|101400156|FG000|NOT COMPLETED|Study Part 2: 84-Day Treatment||2||
48436004|NCT00467051|101400157|FG000|STARTED|Overall Study||20||
48436005|NCT00467051|101400157|FG000|COMPLETED|Overall Study||18||
48436006|NCT00467051|101400157|FG000|NOT COMPLETED|Overall Study||2||
48436007|NCT00585468|101400158|FG000|STARTED|First Intervention||10||
48436008|NCT00585468|101400159|FG001|STARTED|First Intervention||11||
48436009|NCT00585468|101400158|FG000|COMPLETED|First Intervention||9||
48436010|NCT00585468|101400159|FG001|COMPLETED|First Intervention||10||
48436011|NCT00585468|101400158|FG000|NOT COMPLETED|First Intervention||1||
48436012|NCT00585468|101400159|FG001|NOT COMPLETED|First Intervention||1||
48436013|NCT00585468|101400158|FG000|STARTED|Second Intervention||9||
48436014|NCT00585468|101400159|FG001|STARTED|Second Intervention||10||
48436015|NCT00585468|101400158|FG000|COMPLETED|Second Intervention||9||
48436016|NCT00585468|101400159|FG001|COMPLETED|Second Intervention||10||
48436017|NCT00585468|101400158|FG000|NOT COMPLETED|Second Intervention||0||
48436018|NCT00585468|101400159|FG001|NOT COMPLETED|Second Intervention||0||
48436019|NCT02158949|101400160|FG000|STARTED|Overall Study||24||
48643656|NCT00546273|101913562|FG004|NOT COMPLETED|III||0||
48643657|NCT00546273|101913558|FG000|STARTED|IV||0||
48643658|NCT00546273|101913559|FG001|STARTED|IV||0||
48643659|NCT00546273|101913560|FG002|STARTED|IV||0||
48643660|NCT00546273|101913561|FG003|STARTED|IV||4||
48643661|NCT00546273|101913562|FG004|STARTED|IV||2||
48643662|NCT00546273|101913558|FG000|COMPLETED|IV||0||
48643663|NCT00546273|101913559|FG001|COMPLETED|IV||0||
48643664|NCT00546273|101913560|FG002|COMPLETED|IV||0||
48643665|NCT00546273|101913561|FG003|COMPLETED|IV||4||
48643666|NCT00546273|101913562|FG004|COMPLETED|IV||2||
48643667|NCT00546273|101913558|FG000|NOT COMPLETED|IV||0||
48643668|NCT00546273|101913559|FG001|NOT COMPLETED|IV||0||
48436020|NCT02158949|101400161|FG001|STARTED|Overall Study||24||
48436021|NCT02158949|101400160|FG000|COMPLETED|Overall Study||18||
48436022|NCT02158949|101400161|FG001|COMPLETED|Overall Study||13||
48436023|NCT02158949|101400160|FG000|NOT COMPLETED|Overall Study||6||
48436024|NCT02158949|101400161|FG001|NOT COMPLETED|Overall Study||11||
48436025|NCT02209272|101400162|FG000|STARTED|Overall Study||32||
48436026|NCT02209272|101400163|FG001|STARTED|Overall Study||36||
48436027|NCT02209272|101400162|FG000|COMPLETED|Overall Study||32||
48436028|NCT02209272|101400163|FG001|COMPLETED|Overall Study||36||
48436029|NCT02209272|101400162|FG000|NOT COMPLETED|Overall Study||0||
48436030|NCT02209272|101400163|FG001|NOT COMPLETED|Overall Study||0||
48643669|NCT00546273|101913560|FG002|NOT COMPLETED|IV||0||
48436031|NCT03323034|101400164|FG000|STARTED|Overall Study||6||
48436032|NCT03323034|101400165|FG001|STARTED|Overall Study||6||
48436033|NCT03323034|101400166|FG002|STARTED|Overall Study||6||
48436034|NCT03323034|101400167|FG003|STARTED|Overall Study||6||
48436035|NCT03323034|101400168|FG004|STARTED|Overall Study||6||
48643670|NCT00546273|101913561|FG003|NOT COMPLETED|IV||0||
48436036|NCT03323034|101400164|FG000|COMPLETED|Overall Study||0||
48436037|NCT03323034|101400165|FG001|COMPLETED|Overall Study||0||
48436038|NCT03323034|101400166|FG002|COMPLETED|Overall Study||0||
48436039|NCT03323034|101400167|FG003|COMPLETED|Overall Study||0||
48643671|NCT00546273|101913562|FG004|NOT COMPLETED|IV||0||
48643672|NCT03349515|101913563|FG000|STARTED|Overall Study||55||
48643673|NCT03349515|101913564|FG001|STARTED|Overall Study||51||
48643674|NCT03349515|101913563|FG000|COMPLETED|Overall Study||50||
48643675|NCT03349515|101913564|FG001|COMPLETED|Overall Study||50||
48643676|NCT03349515|101913563|FG000|NOT COMPLETED|Overall Study||5||
48643677|NCT03349515|101913564|FG001|NOT COMPLETED|Overall Study||1||
48643678|NCT00433537|101913565|FG000|STARTED|Step 1 - VcR-CVAD Induction||45||
48643679|NCT00433537|101913566|FG001|STARTED|Step 1 - VcR-CVAD Induction||22||
48643680|NCT00433537|101913567|FG002|STARTED|Step 1 - VcR-CVAD Induction||10||
48643681|NCT00433537|101913565|FG000|Eligible and Treated|Step 1 - VcR-CVAD Induction||44||
48643682|NCT00433537|101913566|FG001|Eligible and Treated|Step 1 - VcR-CVAD Induction||22||
48643683|NCT00433537|101913567|FG002|Eligible and Treated|Step 1 - VcR-CVAD Induction||9||
48643684|NCT00433537|101913565|FG000|COMPLETED|Step 1 - VcR-CVAD Induction||44||
48643685|NCT00433537|101913566|FG001|COMPLETED|Step 1 - VcR-CVAD Induction||22||
48643686|NCT00433537|101913567|FG002|COMPLETED|Step 1 - VcR-CVAD Induction||1||
48643687|NCT00433537|101913565|FG000|NOT COMPLETED|Step 1 - VcR-CVAD Induction||1||
48643688|NCT00433537|101913566|FG001|NOT COMPLETED|Step 1 - VcR-CVAD Induction||0||
48643689|NCT00433537|101913567|FG002|NOT COMPLETED|Step 1 - VcR-CVAD Induction||9||
48643690|NCT00433537|101913565|FG000|STARTED|Step 2 - Maintenance Rituximab or ASCT||45||
48643691|NCT00433537|101913566|FG001|STARTED|Step 2 - Maintenance Rituximab or ASCT||22||
48643692|NCT00433537|101913567|FG002|STARTED|Step 2 - Maintenance Rituximab or ASCT||0||
48643693|NCT00433537|101913565|FG000|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||44||
48643694|NCT00433537|101913566|FG001|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||22||
48643695|NCT00433537|101913567|FG002|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||0||
48643696|NCT00433537|101913565|FG000|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||29||
48643697|NCT00433537|101913566|FG001|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||22||
48643698|NCT00433537|101913567|FG002|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0||
48643699|NCT00433537|101913565|FG000|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||16||
48643700|NCT00433537|101913566|FG001|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0||
48643701|NCT00433537|101913567|FG002|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0||
48643702|NCT00221104|101913568|FG000|STARTED|Overall Study||793||
48643703|NCT00221104|101913569|FG001|STARTED|Overall Study||785||
48643704|NCT00221104|101913568|FG000|COMPLETED|Overall Study||710||
48643705|NCT00221104|101913569|FG001|COMPLETED|Overall Study||709||
48643706|NCT00221104|101913568|FG000|NOT COMPLETED|Overall Study||83||
48643707|NCT00221104|101913569|FG001|NOT COMPLETED|Overall Study||76||
48643708|NCT01755637|101913570|FG000|STARTED|Period 1||28||
48643709|NCT01755637|101913571|FG001|STARTED|Period 1||28||
48643710|NCT01755637|101913570|FG000|COMPLETED|Period 1||28||
48643711|NCT01755637|101913571|FG001|COMPLETED|Period 1||27||
48643712|NCT01755637|101913570|FG000|NOT COMPLETED|Period 1||0||
48643713|NCT01755637|101913571|FG001|NOT COMPLETED|Period 1||1||
48643714|NCT01755637|101913570|FG000|STARTED|Period 2||28||
48643715|NCT01755637|101913571|FG001|STARTED|Period 2||27||
48643716|NCT01755637|101913570|FG000|COMPLETED|Period 2||28||
48643717|NCT01755637|101913571|FG001|COMPLETED|Period 2||27||
48643718|NCT01755637|101913570|FG000|NOT COMPLETED|Period 2||0||
48643719|NCT01755637|101913571|FG001|NOT COMPLETED|Period 2||0||
48643720|NCT00267670|101913572|FG000|STARTED|Overall Study||19||
48643721|NCT00267670|101913573|FG001|STARTED|Overall Study||7||
48643722|NCT00267670|101913572|FG000|COMPLETED|Overall Study||15||
48643723|NCT00267670|101913573|FG001|COMPLETED|Overall Study||7||
48643724|NCT00267670|101913572|FG000|NOT COMPLETED|Overall Study||4||
48643725|NCT00267670|101913573|FG001|NOT COMPLETED|Overall Study||0||
48643726|NCT02939781|101913574|FG000|STARTED|Overall Study||12||
48643727|NCT02939781|101913574|FG000|COMPLETED|Overall Study||3||
48643728|NCT02939781|101913574|FG000|NOT COMPLETED|Overall Study||9||
48643729|NCT03478878|101913575|FG000|STARTED|Overall Study||7||
48643730|NCT03478878|101913576|FG001|STARTED|Overall Study||2||
48643731|NCT03478878|101913575|FG000|Completed Treatment Completion Visit|Overall Study||7||
48643732|NCT03478878|101913576|FG001|Completed Treatment Completion Visit|Overall Study||2||
48643733|NCT03478878|101913575|FG000|COMPLETED|Overall Study||7||
48643734|NCT03478878|101913576|FG001|COMPLETED|Overall Study||2||
48643735|NCT03478878|101913575|FG000|NOT COMPLETED|Overall Study||0||
48643736|NCT03478878|101913576|FG001|NOT COMPLETED|Overall Study||0||
48643737|NCT00450749|101913577|FG000|STARTED|Overall Study||3||
48643738|NCT00450749|101913578|FG001|STARTED|Overall Study||3||
48643739|NCT00450749|101913579|FG002|STARTED|Overall Study||4||
48643740|NCT00450749|101913577|FG000|COMPLETED|Overall Study||3||
48643741|NCT00450749|101913578|FG001|COMPLETED|Overall Study||2||
48643742|NCT00450749|101913579|FG002|COMPLETED|Overall Study||2||
48643743|NCT00450749|101913577|FG000|NOT COMPLETED|Overall Study||0||
48643744|NCT00450749|101913578|FG001|NOT COMPLETED|Overall Study||1||
48643745|NCT00450749|101913579|FG002|NOT COMPLETED|Overall Study||2||
48643746|NCT02260986|101913580|FG000|STARTED|Overall Study||315||
48643747|NCT02260986|101913581|FG001|STARTED|Overall Study||106||
48643748|NCT02260986|101913582|FG002|STARTED|Overall Study||319||
48643749|NCT02260986|101913580|FG000|Safety Population|Overall Study||315||
48643750|NCT02260986|101913581|FG001|Safety Population|Overall Study||110||
48643751|NCT02260986|101913582|FG002|Safety Population|Overall Study||315||
48643752|NCT02260986|101913580|FG000|COMPLETED|Overall Study||225||
48643753|NCT02260986|101913581|FG001|COMPLETED|Overall Study||93||
48643754|NCT02260986|101913582|FG002|COMPLETED|Overall Study||278||
48765110|NCT02113982|102214586|FG003|STARTED|Stage 2: Cohort Expansion||0||
48643755|NCT02260986|101913580|FG000|NOT COMPLETED|Overall Study||90||
48643756|NCT02260986|101913581|FG001|NOT COMPLETED|Overall Study||13||
48643757|NCT02260986|101913582|FG002|NOT COMPLETED|Overall Study||41||
48643758|NCT03562507|101913583|FG000|STARTED|Overall Study||8||
48643759|NCT03562507|101913584|FG001|STARTED|Overall Study||0||
48643760|NCT03562507|101913583|FG000|COMPLETED|Overall Study||8||
48643761|NCT03562507|101913584|FG001|COMPLETED|Overall Study||0||
48643762|NCT03562507|101913583|FG000|NOT COMPLETED|Overall Study||0||
48643763|NCT03562507|101913584|FG001|NOT COMPLETED|Overall Study||0||
48643764|NCT01149538|101913585|FG000|STARTED|Overall Study||31||
48643765|NCT01149538|101913586|FG001|STARTED|Overall Study||29||
48643766|NCT01149538|101913585|FG000|COMPLETED|Overall Study||26||
48643767|NCT01149538|101913586|FG001|COMPLETED|Overall Study||25||
48643768|NCT01149538|101913585|FG000|NOT COMPLETED|Overall Study||5||
48643769|NCT01149538|101913586|FG001|NOT COMPLETED|Overall Study||4||
48643770|NCT01692015|101913587|FG000|STARTED|Overall Study||50||
48643771|NCT01692015|101913587|FG000|COMPLETED|Overall Study||50||
48643772|NCT01692015|101913587|FG000|NOT COMPLETED|Overall Study||0||
48643773|NCT04491994|101913588|FG000|STARTED|Overall Study||180|15 withdrew consent 5 became symptomatic 13 patients non compliant 7 were lost to follow up|
48643774|NCT04491994|101913589|FG001|STARTED|Overall Study||360|15 withdrew consent 5 became symptomatic 13 patients non compliant 7 were lost to follow up|
48643775|NCT04491994|101913588|FG000|COMPLETED|Overall Study||151||
48643776|NCT04491994|101913589|FG001|COMPLETED|Overall Study||349||
48643777|NCT04491994|101913588|FG000|NOT COMPLETED|Overall Study||29||
48643778|NCT04491994|101913589|FG001|NOT COMPLETED|Overall Study||11||
48643779|NCT02405962|101913590|FG000|STARTED|Overall Study||84||
48643780|NCT02405962|101913591|FG001|STARTED|Overall Study||84||
48643781|NCT02405962|101913590|FG000|Post-intervention|Overall Study||80||
48643782|NCT02405962|101913591|FG001|Post-intervention|Overall Study||81||
48643783|NCT02405962|101913590|FG000|3 Months After the Intervention|Overall Study||80||
48643784|NCT02405962|101913591|FG001|3 Months After the Intervention|Overall Study||79||
48643785|NCT02405962|101913590|FG000|COMPLETED|Overall Study||83||
48643786|NCT02405962|101913591|FG001|COMPLETED|Overall Study||79||
48643787|NCT02405962|101913590|FG000|NOT COMPLETED|Overall Study||1||
48643788|NCT02405962|101913591|FG001|NOT COMPLETED|Overall Study||5||
48643789|NCT02299167|101913592|FG000|STARTED|Overall Study||35||
48643790|NCT02299167|101913592|FG000|Dural Puncture|Overall Study||24|Dural puncture to inject the study drug|
48643791|NCT02299167|101913592|FG000|Success Rate|Overall Study||24|10 min after Dural puncture (to test the success of the block)|
48643792|NCT02299167|101913592|FG000|Adverse Effects|Overall Study||24|24 after surgery to record any complication|
48643793|NCT02299167|101913592|FG000|COMPLETED|Overall Study||24||
48643794|NCT02299167|101913592|FG000|NOT COMPLETED|Overall Study||11||
48643795|NCT00471354|101913593|FG000|STARTED|Overall Study||228||
48643796|NCT00471354|101913593|FG000|COMPLETED|Overall Study||176||
48643797|NCT00471354|101913593|FG000|NOT COMPLETED|Overall Study||52||
48643798|NCT01290731|101913594|FG000|STARTED|Overall Study||49||
48643799|NCT01290731|101913594|FG000|COMPLETED|Overall Study||48||
48643800|NCT01290731|101913594|FG000|NOT COMPLETED|Overall Study||1||
48643801|NCT01800058|101913595|FG000|STARTED|Overall Study||66||
48643802|NCT01800058|101913595|FG000|COMPLETED|Overall Study||65||
48643803|NCT01800058|101913595|FG000|NOT COMPLETED|Overall Study||1||
48643804|NCT01566162|101913596|FG000|STARTED|Overall Study||191||
48643805|NCT01566162|101913596|FG000|COMPLETED|Overall Study||155||
48643806|NCT01566162|101913596|FG000|NOT COMPLETED|Overall Study||36||
48643807|NCT00308685|101913597|FG000|STARTED|Overall Study||50||
48643808|NCT00308685|101913598|FG001|STARTED|Overall Study||45||
48643809|NCT00308685|101913597|FG000|Received at Least 1 Dose of Study Drug|Overall Study||50||
48643810|NCT00308685|101913598|FG001|Received at Least 1 Dose of Study Drug|Overall Study||45||
48643811|NCT00308685|101913597|FG000|COMPLETED|Overall Study||47||
48643812|NCT00308685|101913598|FG001|COMPLETED|Overall Study||40||
48643813|NCT00308685|101913597|FG000|NOT COMPLETED|Overall Study||3||
48643814|NCT00308685|101913598|FG001|NOT COMPLETED|Overall Study||5||
48643815|NCT04308694|101913599|FG000|STARTED|Overall Study||20||
48643816|NCT04308694|101913599|FG000|COMPLETED|Overall Study||16||
48643817|NCT04308694|101913599|FG000|NOT COMPLETED|Overall Study||4||
48643818|NCT01227395|101913600|FG000|STARTED|Overall Study||391||
48643819|NCT01227395|101913601|FG001|STARTED|Overall Study||85||
48643820|NCT01227395|101913600|FG000|COMPLETED|Overall Study||391||
48643821|NCT01227395|101913601|FG001|COMPLETED|Overall Study||84||
48643822|NCT01227395|101913600|FG000|NOT COMPLETED|Overall Study||0||
48643823|NCT01227395|101913601|FG001|NOT COMPLETED|Overall Study||1||
48643824|NCT01138046|101913602|FG000|STARTED|Overall Study||12||
48643825|NCT01138046|101913602|FG000|COMPLETED|Overall Study||6||
48643826|NCT01138046|101913602|FG000|NOT COMPLETED|Overall Study||6||
48643827|NCT00308282|101913603|FG000|STARTED|Overall Study||34||
48643828|NCT00308282|101913604|FG001|STARTED|Overall Study||34||
48643829|NCT00308282|101913605|FG002|STARTED|Overall Study||34||
48643830|NCT00308282|101913606|FG003|STARTED|Overall Study||34||
48643831|NCT00308282|101913603|FG000|Received at Least One Dose of Study Drug|Overall Study||34||
48643832|NCT00308282|101913604|FG001|Received at Least One Dose of Study Drug|Overall Study||34||
48643833|NCT00308282|101913605|FG002|Received at Least One Dose of Study Drug|Overall Study||34||
48643834|NCT00308282|101913606|FG003|Received at Least One Dose of Study Drug|Overall Study||34||
48643835|NCT00308282|101913603|FG000|COMPLETED|Overall Study||31||
48643836|NCT00308282|101913604|FG001|COMPLETED|Overall Study||30||
48643837|NCT00308282|101913605|FG002|COMPLETED|Overall Study||33||
48643838|NCT00308282|101913606|FG003|COMPLETED|Overall Study||32||
48643839|NCT00308282|101913603|FG000|NOT COMPLETED|Overall Study||3||
48643840|NCT00308282|101913604|FG001|NOT COMPLETED|Overall Study||4||
48643841|NCT00308282|101913605|FG002|NOT COMPLETED|Overall Study||1||
48643842|NCT00308282|101913606|FG003|NOT COMPLETED|Overall Study||2||
48643843|NCT00416949|101913607|FG000|STARTED|Overall Study||9||
48643844|NCT00416949|101913607|FG000|COMPLETED|Overall Study||4||
48643845|NCT00416949|101913607|FG000|NOT COMPLETED|Overall Study||5||
48643846|NCT02691663|101913608|FG000|STARTED|Overall Study||41||
48643847|NCT02691663|101913609|FG001|STARTED|Overall Study||42||
48643848|NCT02691663|101913608|FG000|COMPLETED|Overall Study||33||
48643849|NCT02691663|101913609|FG001|COMPLETED|Overall Study||35||
48643850|NCT02691663|101913608|FG000|NOT COMPLETED|Overall Study||8||
48643851|NCT02691663|101913609|FG001|NOT COMPLETED|Overall Study||7||
48643852|NCT03395990|101913610|FG000|STARTED|Overall Study||8||
48643853|NCT03395990|101913611|FG001|STARTED|Overall Study||8||
48643854|NCT03395990|101913610|FG000|COMPLETED|Overall Study||8||
48643855|NCT03395990|101913611|FG001|COMPLETED|Overall Study||8||
48643856|NCT03395990|101913610|FG000|NOT COMPLETED|Overall Study||0||
48643857|NCT03395990|101913611|FG001|NOT COMPLETED|Overall Study||0||
48643858|NCT01033942|101913612|FG000|STARTED|Overall Study||20||
48643859|NCT01033942|101913613|FG001|STARTED|Overall Study||19||
48643860|NCT01033942|101913614|FG002|STARTED|Overall Study||19||
48643861|NCT01033942|101913612|FG000|COMPLETED|Overall Study||18||
48643862|NCT01033942|101913613|FG001|COMPLETED|Overall Study||15||
48643863|NCT01033942|101913614|FG002|COMPLETED|Overall Study||18||
48643864|NCT01033942|101913612|FG000|NOT COMPLETED|Overall Study||2||
48643865|NCT01033942|101913613|FG001|NOT COMPLETED|Overall Study||4||
48643866|NCT01033942|101913614|FG002|NOT COMPLETED|Overall Study||1||
48643867|NCT04073407|101913615|FG000|STARTED|Part 1||6||
48643868|NCT04073407|101913616|FG001|STARTED|Part 1||3||
48643869|NCT04073407|101913615|FG000|COMPLETED|Part 1||1||
48643870|NCT04073407|101913616|FG001|COMPLETED|Part 1||2||
48643871|NCT04073407|101913615|FG000|NOT COMPLETED|Part 1||5||
48643872|NCT04073407|101913616|FG001|NOT COMPLETED|Part 1||1||
48643873|NCT04073407|101913615|FG000|STARTED|Part 2||0||
48643874|NCT04073407|101913616|FG001|STARTED|Part 2||1||
48643875|NCT04073407|101913615|FG000|COMPLETED|Part 2||0||
48436040|NCT03323034|101400168|FG004|COMPLETED|Overall Study||0||
48436041|NCT03323034|101400164|FG000|NOT COMPLETED|Overall Study||6||
48436042|NCT03323034|101400165|FG001|NOT COMPLETED|Overall Study||6||
48436043|NCT03323034|101400166|FG002|NOT COMPLETED|Overall Study||6||
48643876|NCT04073407|101913616|FG001|COMPLETED|Part 2||0||
48643877|NCT04073407|101913615|FG000|NOT COMPLETED|Part 2||0||
48643878|NCT04073407|101913616|FG001|NOT COMPLETED|Part 2||1||
48643879|NCT01106950|101913617|FG000|STARTED|Overall Study||15||
48643880|NCT01106950|101913617|FG000|COMPLETED|Overall Study||15||
48643881|NCT01106950|101913617|FG000|NOT COMPLETED|Overall Study||0||
48643882|NCT00875329|101913618|FG000|STARTED|Overall Study||97||
48643883|NCT00875329|101913618|FG000|COMPLETED|Overall Study||97||
48643884|NCT00875329|101913618|FG000|NOT COMPLETED|Overall Study||0||
48643885|NCT02011464|101913619|FG000|STARTED|Overall Study||10||
48643886|NCT02011464|101913620|FG001|STARTED|Overall Study||10||
48643887|NCT02011464|101913619|FG000|COMPLETED|Overall Study||10||
48643888|NCT02011464|101913620|FG001|COMPLETED|Overall Study||10||
48643889|NCT02011464|101913619|FG000|NOT COMPLETED|Overall Study||0||
48643890|NCT02011464|101913620|FG001|NOT COMPLETED|Overall Study||0||
48643891|NCT00621530|101913621|FG000|STARTED|Overall Study||30||
48643892|NCT00621530|101913622|FG001|STARTED|Overall Study||32||
48643893|NCT00621530|101913621|FG000|COMPLETED|Overall Study||28||
48643894|NCT00621530|101913622|FG001|COMPLETED|Overall Study||29||
48643895|NCT00621530|101913621|FG000|NOT COMPLETED|Overall Study||2||
48643896|NCT00621530|101913622|FG001|NOT COMPLETED|Overall Study||3||
48643897|NCT01198548|101913623|FG000|STARTED|Overall Study||10||
48643898|NCT01198548|101913623|FG000|COMPLETED|Overall Study||0||
48643899|NCT01198548|101913623|FG000|NOT COMPLETED|Overall Study||10||
48436044|NCT03323034|101400167|FG003|NOT COMPLETED|Overall Study||6||
48436045|NCT03323034|101400168|FG004|NOT COMPLETED|Overall Study||6||
48643900|NCT03147287|101913624|FG000|STARTED|Overall Study||55||
48643901|NCT03147287|101913625|FG001|STARTED|Overall Study||111||
48643902|NCT03147287|101913626|FG002|STARTED|Overall Study||54||
48643903|NCT03147287|101913624|FG000|COMPLETED|Overall Study||0||
48643904|NCT03147287|101913625|FG001|COMPLETED|Overall Study||0||
48643905|NCT03147287|101913626|FG002|COMPLETED|Overall Study||0||
48643906|NCT03147287|101913624|FG000|NOT COMPLETED|Overall Study||55||
48643907|NCT03147287|101913625|FG001|NOT COMPLETED|Overall Study||111||
48643908|NCT03147287|101913626|FG002|NOT COMPLETED|Overall Study||54||
48643909|NCT00294398|101913627|FG000|STARTED|Overall Study||78||
48436046|NCT00741026|101403468|FG000|STARTED|Overall Study||15||
48643910|NCT00294398|101913628|FG001|STARTED|Overall Study||74||
48643911|NCT00294398|101913627|FG000|COMPLETED|Overall Study||57||
48643912|NCT00294398|101913628|FG001|COMPLETED|Overall Study||48||
48643913|NCT00294398|101913627|FG000|NOT COMPLETED|Overall Study||21||
48643914|NCT00294398|101913628|FG001|NOT COMPLETED|Overall Study||26||
48643915|NCT02097277|101913629|FG000|STARTED|Overall Study||24||
48643916|NCT02097277|101913630|FG001|STARTED|Overall Study||24||
48643917|NCT02097277|101913631|FG002|STARTED|Overall Study||24||
48643918|NCT02097277|101913632|FG003|STARTED|Overall Study||24||
48643919|NCT02097277|101913633|FG004|STARTED|Overall Study||24||
48643920|NCT02097277|101913629|FG000|COMPLETED|Overall Study||22||
48643921|NCT02097277|101913630|FG001|COMPLETED|Overall Study||21||
48643922|NCT02097277|101913631|FG002|COMPLETED|Overall Study||22||
48643923|NCT02097277|101913632|FG003|COMPLETED|Overall Study||20||
48643924|NCT02097277|101913633|FG004|COMPLETED|Overall Study||23||
48643925|NCT02097277|101913629|FG000|NOT COMPLETED|Overall Study||2||
48643926|NCT02097277|101913630|FG001|NOT COMPLETED|Overall Study||3||
48643927|NCT02097277|101913631|FG002|NOT COMPLETED|Overall Study||2||
48643928|NCT02097277|101913632|FG003|NOT COMPLETED|Overall Study||4||
48643929|NCT02097277|101913633|FG004|NOT COMPLETED|Overall Study||1||
48643930|NCT00105508|101913634|FG000|STARTED|Overall Study||253||
48643931|NCT00105508|101913635|FG001|STARTED|Overall Study||253||
48643932|NCT00105508|101913634|FG000|COMPLETED|Overall Study||213||
48643933|NCT00105508|101913635|FG001|COMPLETED|Overall Study||217||
48643934|NCT00105508|101913634|FG000|NOT COMPLETED|Overall Study||40||
48643935|NCT00105508|101913635|FG001|NOT COMPLETED|Overall Study||36||
48643936|NCT00004859|101913636|FG000|STARTED|Overall Study||295||
48643937|NCT00004859|101913637|FG001|STARTED|Overall Study||294||
48643938|NCT00004859|101913636|FG000|Eligible|Overall Study||275||
48643939|NCT00004859|101913637|FG001|Eligible|Overall Study||271||
48643940|NCT00004859|101913636|FG000|Treated|Overall Study||289||
48643941|NCT00004859|101913637|FG001|Treated|Overall Study||289||
48643942|NCT00004859|101913636|FG000|Treated and Having Toxicity Data|Overall Study||289||
48643943|NCT00004859|101913637|FG001|Treated and Having Toxicity Data|Overall Study||288||
48643944|NCT00004859|101913636|FG000|COMPLETED|Overall Study||177||
48643945|NCT00004859|101913637|FG001|COMPLETED|Overall Study||12||
48643946|NCT00004859|101913636|FG000|NOT COMPLETED|Overall Study||118||
48643947|NCT00004859|101913637|FG001|NOT COMPLETED|Overall Study||282||
48643948|NCT01105130|101913638|FG000|STARTED|Overall Study||48||
48643949|NCT01105130|101913639|FG001|STARTED|Overall Study||45||
48643950|NCT01105130|101913640|FG002|STARTED|Overall Study||47||
48643951|NCT01105130|101913638|FG000|COMPLETED|Overall Study||38||
48643952|NCT01105130|101913639|FG001|COMPLETED|Overall Study||34||
48643953|NCT01105130|101913640|FG002|COMPLETED|Overall Study||37||
48643954|NCT01105130|101913638|FG000|NOT COMPLETED|Overall Study||10||
48643955|NCT01105130|101913639|FG001|NOT COMPLETED|Overall Study||11||
48643956|NCT01105130|101913640|FG002|NOT COMPLETED|Overall Study||10||
48643957|NCT02989389|101913641|FG000|STARTED|Period 1||3||
48643958|NCT02989389|101913642|FG001|STARTED|Period 1||4||
48643959|NCT02989389|101913643|FG002|STARTED|Period 1||3||
48643960|NCT02989389|101913644|FG003|STARTED|Period 1||3||
48643961|NCT02989389|101913645|FG004|STARTED|Period 1||3||
48643962|NCT02989389|101913646|FG005|STARTED|Period 1||3||
48643963|NCT02989389|101913647|FG006|STARTED|Period 1||6||
48643964|NCT02989389|101913648|FG007|STARTED|Period 1||5||
48643965|NCT02989389|101913649|FG008|STARTED|Period 1||6||
48643966|NCT02989389|101913650|FG009|STARTED|Period 1||6||
48643967|NCT02989389|101913641|FG000|Received at Least 1 Dose of Study Drug|Period 1||3||
48643968|NCT02989389|101913642|FG001|Received at Least 1 Dose of Study Drug|Period 1||4||
48643969|NCT02989389|101913643|FG002|Received at Least 1 Dose of Study Drug|Period 1||3||
48643970|NCT02989389|101913644|FG003|Received at Least 1 Dose of Study Drug|Period 1||3||
48643971|NCT02989389|101913645|FG004|Received at Least 1 Dose of Study Drug|Period 1||3||
48643972|NCT02989389|101913646|FG005|Received at Least 1 Dose of Study Drug|Period 1||3||
48643973|NCT02989389|101913647|FG006|Received at Least 1 Dose of Study Drug|Period 1||6||
48643974|NCT02989389|101913648|FG007|Received at Least 1 Dose of Study Drug|Period 1||5||
48643975|NCT02989389|101913649|FG008|Received at Least 1 Dose of Study Drug|Period 1||6||
48643976|NCT02989389|101913650|FG009|Received at Least 1 Dose of Study Drug|Period 1||6||
48643977|NCT02989389|101913641|FG000|COMPLETED|Period 1||3||
48643978|NCT02989389|101913642|FG001|COMPLETED|Period 1||3||
48643979|NCT02989389|101913643|FG002|COMPLETED|Period 1||3||
48643980|NCT02989389|101913644|FG003|COMPLETED|Period 1||3||
48643981|NCT02989389|101913645|FG004|COMPLETED|Period 1||3||
48643982|NCT02989389|101913646|FG005|COMPLETED|Period 1||3||
48643983|NCT02989389|101913647|FG006|COMPLETED|Period 1||6||
48643984|NCT02989389|101913648|FG007|COMPLETED|Period 1||5||
48643985|NCT02989389|101913649|FG008|COMPLETED|Period 1||5||
48643986|NCT02989389|101913650|FG009|COMPLETED|Period 1||6||
48643987|NCT02989389|101913641|FG000|NOT COMPLETED|Period 1||0||
48643988|NCT02989389|101913642|FG001|NOT COMPLETED|Period 1||1||
48643989|NCT02989389|101913643|FG002|NOT COMPLETED|Period 1||0||
48643990|NCT02989389|101913644|FG003|NOT COMPLETED|Period 1||0||
48643991|NCT02989389|101913645|FG004|NOT COMPLETED|Period 1||0||
48643992|NCT02989389|101913646|FG005|NOT COMPLETED|Period 1||0||
48643993|NCT02989389|101913647|FG006|NOT COMPLETED|Period 1||0||
48643994|NCT02989389|101913648|FG007|NOT COMPLETED|Period 1||0||
48643995|NCT02989389|101913649|FG008|NOT COMPLETED|Period 1||1||
48643996|NCT02989389|101913650|FG009|NOT COMPLETED|Period 1||0||
48643997|NCT02989389|101913641|FG000|STARTED|Period 2||3||
48643998|NCT02989389|101913642|FG001|STARTED|Period 2||3||
48643999|NCT02989389|101913643|FG002|STARTED|Period 2||3||
48644000|NCT02989389|101913644|FG003|STARTED|Period 2||3||
48644001|NCT02989389|101913645|FG004|STARTED|Period 2||3||
48644002|NCT02989389|101913646|FG005|STARTED|Period 2||3||
48644003|NCT02989389|101913647|FG006|STARTED|Period 2||0||
48644004|NCT02989389|101913648|FG007|STARTED|Period 2||0||
48644005|NCT02989389|101913649|FG008|STARTED|Period 2||0||
48644006|NCT02989389|101913650|FG009|STARTED|Period 2||0||
48644007|NCT02989389|101913641|FG000|COMPLETED|Period 2||3||
48644008|NCT02989389|101913642|FG001|COMPLETED|Period 2||3||
48644009|NCT02989389|101913643|FG002|COMPLETED|Period 2||3||
48644010|NCT02989389|101913644|FG003|COMPLETED|Period 2||3||
48644011|NCT02989389|101913645|FG004|COMPLETED|Period 2||3||
48644012|NCT02989389|101913646|FG005|COMPLETED|Period 2||3||
48644013|NCT02989389|101913647|FG006|COMPLETED|Period 2||0||
48644014|NCT02989389|101913648|FG007|COMPLETED|Period 2||0||
48644015|NCT02989389|101913649|FG008|COMPLETED|Period 2||0||
48644016|NCT02989389|101913650|FG009|COMPLETED|Period 2||0||
48644017|NCT02989389|101913641|FG000|NOT COMPLETED|Period 2||0||
48644018|NCT02989389|101913642|FG001|NOT COMPLETED|Period 2||0||
48644019|NCT02989389|101913643|FG002|NOT COMPLETED|Period 2||0||
48644020|NCT02989389|101913644|FG003|NOT COMPLETED|Period 2||0||
48644021|NCT02989389|101913645|FG004|NOT COMPLETED|Period 2||0||
48644022|NCT02989389|101913646|FG005|NOT COMPLETED|Period 2||0||
48644023|NCT02989389|101913647|FG006|NOT COMPLETED|Period 2||0||
48644024|NCT02989389|101913648|FG007|NOT COMPLETED|Period 2||0||
48644025|NCT02989389|101913649|FG008|NOT COMPLETED|Period 2||0||
48644026|NCT02989389|101913650|FG009|NOT COMPLETED|Period 2||0||
48644027|NCT02989389|101913641|FG000|STARTED|Period 3||3||
48644028|NCT02989389|101913642|FG001|STARTED|Period 3||3||
48644029|NCT02989389|101913643|FG002|STARTED|Period 3||3||
48644030|NCT02989389|101913644|FG003|STARTED|Period 3||3||
48644031|NCT02989389|101913645|FG004|STARTED|Period 3||3||
48644032|NCT02989389|101913646|FG005|STARTED|Period 3||3||
48644033|NCT02989389|101913647|FG006|STARTED|Period 3||0||
48644034|NCT02989389|101913648|FG007|STARTED|Period 3||0||
48644035|NCT02989389|101913649|FG008|STARTED|Period 3||0||
48644036|NCT02989389|101913650|FG009|STARTED|Period 3||0||
48644037|NCT02989389|101913641|FG000|COMPLETED|Period 3||3||
48644038|NCT02989389|101913642|FG001|COMPLETED|Period 3||3||
48644039|NCT02989389|101913643|FG002|COMPLETED|Period 3||3||
48644040|NCT02989389|101913644|FG003|COMPLETED|Period 3||3||
48644041|NCT02989389|101913645|FG004|COMPLETED|Period 3||3||
48644042|NCT02989389|101913646|FG005|COMPLETED|Period 3||3||
48644043|NCT02989389|101913647|FG006|COMPLETED|Period 3||0||
48644044|NCT02989389|101913648|FG007|COMPLETED|Period 3||0||
48644045|NCT02989389|101913649|FG008|COMPLETED|Period 3||0||
48644046|NCT02989389|101913650|FG009|COMPLETED|Period 3||0||
48644047|NCT02989389|101913641|FG000|NOT COMPLETED|Period 3||0||
48644048|NCT02989389|101913642|FG001|NOT COMPLETED|Period 3||0||
48644049|NCT02989389|101913643|FG002|NOT COMPLETED|Period 3||0||
48644050|NCT02989389|101913644|FG003|NOT COMPLETED|Period 3||0||
48644051|NCT02989389|101913645|FG004|NOT COMPLETED|Period 3||0||
48644052|NCT02989389|101913646|FG005|NOT COMPLETED|Period 3||0||
48644053|NCT02989389|101913647|FG006|NOT COMPLETED|Period 3||0||
48644054|NCT02989389|101913648|FG007|NOT COMPLETED|Period 3||0||
48644055|NCT02989389|101913649|FG008|NOT COMPLETED|Period 3||0||
48644056|NCT02989389|101913650|FG009|NOT COMPLETED|Period 3||0||
48644057|NCT00771602|101913651|FG000|STARTED|Overall Study||1||
48644058|NCT00771602|101913652|FG001|STARTED|Overall Study||0||
48644059|NCT00771602|101913653|FG002|STARTED|Overall Study||0||
48644060|NCT00771602|101913651|FG000|COMPLETED|Overall Study||1||
48644061|NCT00771602|101913652|FG001|COMPLETED|Overall Study||0||
48644062|NCT00771602|101913653|FG002|COMPLETED|Overall Study||0||
48644063|NCT00771602|101913651|FG000|NOT COMPLETED|Overall Study||0||
48644064|NCT00771602|101913652|FG001|NOT COMPLETED|Overall Study||0||
48644065|NCT00771602|101913653|FG002|NOT COMPLETED|Overall Study||0||
48644066|NCT03406975|101913654|FG000|STARTED|Level 1: Lifestyle Modification vs ESG||123||
48644067|NCT03406975|101913655|FG001|STARTED|Level 1: Lifestyle Modification vs ESG||85||
48644068|NCT03406975|101913656|FG002|STARTED|Level 1: Lifestyle Modification vs ESG||0||
48644069|NCT03406975|101913654|FG000|COMPLETED|Level 1: Lifestyle Modification vs ESG||75||
48644070|NCT03406975|101913655|FG001|COMPLETED|Level 1: Lifestyle Modification vs ESG||62||
48644071|NCT03406975|101913656|FG002|COMPLETED|Level 1: Lifestyle Modification vs ESG||0||
48644072|NCT03406975|101913654|FG000|NOT COMPLETED|Level 1: Lifestyle Modification vs ESG||48||
48644073|NCT03406975|101913655|FG001|NOT COMPLETED|Level 1: Lifestyle Modification vs ESG||23||
48644074|NCT03406975|101913656|FG002|NOT COMPLETED|Level 1: Lifestyle Modification vs ESG||0||
48644075|NCT03406975|101913654|FG000|STARTED|Level 2: Crossover Lifestyle to ESG||0||
48644076|NCT03406975|101913655|FG001|STARTED|Level 2: Crossover Lifestyle to ESG||0||
48644077|NCT03406975|101913656|FG002|STARTED|Level 2: Crossover Lifestyle to ESG||73||
48644078|NCT03406975|101913654|FG000|COMPLETED|Level 2: Crossover Lifestyle to ESG||0||
48644079|NCT03406975|101913655|FG001|COMPLETED|Level 2: Crossover Lifestyle to ESG||0||
48644080|NCT03406975|101913656|FG002|COMPLETED|Level 2: Crossover Lifestyle to ESG||72||
48644081|NCT03406975|101913654|FG000|NOT COMPLETED|Level 2: Crossover Lifestyle to ESG||0||
48644082|NCT03406975|101913655|FG001|NOT COMPLETED|Level 2: Crossover Lifestyle to ESG||0||
48644083|NCT03406975|101913656|FG002|NOT COMPLETED|Level 2: Crossover Lifestyle to ESG||1||
48361899|NCT01084252|101214459|FG013|STARTED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0||
48361900|NCT01084252|101214446|FG000|AT Population|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361901|NCT01084252|101214447|FG001|AT Population|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361902|NCT01084252|101214448|FG002|AT Population|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361903|NCT01084252|101214449|FG003|AT Population|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361904|NCT01084252|101214450|FG004|AT Population|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48436047|NCT00741026|101403468|FG000|COMPLETED|Overall Study||15||
48436048|NCT00741026|101403468|FG000|NOT COMPLETED|Overall Study||0||
48436049|NCT00003726|101403469|FG000|STARTED|Overall Study||1||
48361905|NCT01084252|101214451|FG005|AT Population|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361906|NCT01084252|101214452|FG006|AT Population|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361907|NCT01084252|101214453|FG007|AT Population|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361908|NCT01084252|101214454|FG008|AT Population|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||23|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361909|NCT01084252|101214455|FG009|AT Population|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||24|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361910|NCT01084252|101214456|FG010|AT Population|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||25|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361911|NCT01084252|101214457|FG011|AT Population|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||25|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361912|NCT01084252|101214458|FG012|AT Population|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361913|NCT01084252|101214459|FG013|AT Population|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361914|NCT01084252|101214446|FG000|COMPLETED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0|Participants with end of treatment or death from any cause forms completed.|
48361915|NCT01084252|101214447|FG001|COMPLETED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0|Participants with end of treatment or death from any cause forms completed.|
48361916|NCT01084252|101214448|FG002|COMPLETED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0|Participants with end of treatment or death from any cause forms completed.|
48361917|NCT01084252|101214449|FG003|COMPLETED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0|Participants with end of treatment or death from any cause forms completed.|
48361918|NCT01084252|101214450|FG004|COMPLETED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0|Participants with end of treatment or death from any cause forms completed.|
48361919|NCT01084252|101214451|FG005|COMPLETED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0|Participants with end of treatment or death from any cause forms completed.|
48361920|NCT01084252|101214452|FG006|COMPLETED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0|Participants with end of treatment or death from any cause forms completed.|
48361921|NCT01084252|101214453|FG007|COMPLETED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0|Participants with end of treatment or death from any cause forms completed.|
48361922|NCT01084252|101214454|FG008|COMPLETED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||23|Participants with end of treatment or death from any cause forms completed.|
48368132|NCT01555463|101230111|FG000|NOT COMPLETED|Follow up||38||
48436050|NCT00003726|101403469|FG000|COMPLETED|Overall Study||0||
48436051|NCT00003726|101403469|FG000|NOT COMPLETED|Overall Study||1||
48436052|NCT00762073|101403470|FG000|STARTED|Overall Study||21||
48436053|NCT00762073|101403471|FG001|STARTED|Overall Study||21||
48436054|NCT00762073|101403472|FG002|STARTED|Overall Study||20||
48436055|NCT00762073|101403473|FG003|STARTED|Overall Study||20||
48436056|NCT00762073|101403470|FG000|COMPLETED|Overall Study||17||
48436057|NCT00762073|101403471|FG001|COMPLETED|Overall Study||17||
48436058|NCT00762073|101403472|FG002|COMPLETED|Overall Study||18||
48436059|NCT00762073|101403473|FG003|COMPLETED|Overall Study||17||
48436060|NCT00762073|101403470|FG000|NOT COMPLETED|Overall Study||4||
48436061|NCT00762073|101403471|FG001|NOT COMPLETED|Overall Study||4||
48436062|NCT00762073|101403472|FG002|NOT COMPLETED|Overall Study||2||
48436063|NCT00762073|101403473|FG003|NOT COMPLETED|Overall Study||3||
48436064|NCT01495793|101403474|FG000|STARTED|Overall Study||24||
48436065|NCT01495793|101403474|FG000|COMPLETED|Overall Study||22||
48436066|NCT01495793|101403474|FG000|NOT COMPLETED|Overall Study||2||
48644084|NCT00266812|101913657|FG000|STARTED|Overall Study||22||
48644085|NCT00266812|101913658|FG001|STARTED|Overall Study||13||
48644086|NCT00266812|101913657|FG000|COMPLETED|Overall Study||1||
48644087|NCT00266812|101913658|FG001|COMPLETED|Overall Study||2||
48644088|NCT00266812|101913657|FG000|NOT COMPLETED|Overall Study||21||
48644089|NCT00266812|101913658|FG001|NOT COMPLETED|Overall Study||11||
48644090|NCT01555931|101913659|FG000|STARTED|Overall Study||17||
48644091|NCT01555931|101913660|FG001|STARTED|Overall Study||18||
48644092|NCT01555931|101913659|FG000|COMPLETED|Overall Study||15||
48644093|NCT01555931|101913660|FG001|COMPLETED|Overall Study||13||
48644094|NCT01555931|101913659|FG000|NOT COMPLETED|Overall Study||2||
48644095|NCT01555931|101913660|FG001|NOT COMPLETED|Overall Study||5||
48361923|NCT01084252|101214455|FG009|COMPLETED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||24|Participants with end of treatment or death from any cause forms completed.|
48361924|NCT01084252|101214456|FG010|COMPLETED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||25|Participants with end of treatment or death from any cause forms completed.|
48361925|NCT01084252|101214457|FG011|COMPLETED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||25|Participants with end of treatment or death from any cause forms completed.|
48361926|NCT01084252|101214458|FG012|COMPLETED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0|Participants with end of treatment or death from any cause forms completed.|
48644096|NCT02318979|101913661|FG000|STARTED|Overall Study||15||
48644097|NCT02318979|101913662|FG001|STARTED|Overall Study||15||
48644098|NCT02318979|101913661|FG000|COMPLETED|Overall Study||15||
48644099|NCT02318979|101913662|FG001|COMPLETED|Overall Study||15||
48644100|NCT02318979|101913661|FG000|NOT COMPLETED|Overall Study||0||
48644101|NCT02318979|101913662|FG001|NOT COMPLETED|Overall Study||0||
48644102|NCT00668564|101913663|FG000|STARTED|Overall Study||18||
48765111|NCT02113982|102214587|FG004|STARTED|Stage 2: Cohort Expansion||0||
48765112|NCT02113982|102214588|FG005|STARTED|Stage 2: Cohort Expansion||0||
48765113|NCT02113982|102214589|FG006|STARTED|Stage 2: Cohort Expansion||0||
48765114|NCT02113982|102214590|FG007|STARTED|Stage 2: Cohort Expansion||34||
48644103|NCT00668564|101913663|FG000|COMPLETED|Overall Study||18||
48644104|NCT00668564|101913663|FG000|NOT COMPLETED|Overall Study||0||
48644105|NCT00489268|101913664|FG000|STARTED|Overall Study||1||
48644106|NCT00489268|101913665|FG001|STARTED|Overall Study||10||
48765115|NCT02113982|102214591|FG008|STARTED|Stage 2: Cohort Expansion||1||
48765116|NCT02113982|102214592|FG009|STARTED|Stage 2: Cohort Expansion||13||
48765117|NCT02113982|102214593|FG010|STARTED|Stage 2: Cohort Expansion||10||
48765118|NCT02113982|102214594|FG011|STARTED|Stage 2: Cohort Expansion||0||
48765119|NCT02113982|102214595|FG012|STARTED|Stage 2: Cohort Expansion||0||
48765120|NCT02113982|102214596|FG013|STARTED|Stage 2: Cohort Expansion||0||
48765121|NCT02113982|102214583|FG000|COMPLETED|Stage 2: Cohort Expansion||0||
48361927|NCT01084252|101214459|FG013|COMPLETED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0|Participants with end of treatment or death from any cause forms completed.|
48361928|NCT01084252|101214446|FG000|NOT COMPLETED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0||
48361929|NCT01084252|101214447|FG001|NOT COMPLETED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0||
48361930|NCT01084252|101214448|FG002|NOT COMPLETED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0||
48361931|NCT01084252|101214449|FG003|NOT COMPLETED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0||
48361932|NCT01084252|101214450|FG004|NOT COMPLETED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0||
48361933|NCT01084252|101214451|FG005|NOT COMPLETED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0||
48361934|NCT01084252|101214452|FG006|NOT COMPLETED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0||
48361935|NCT01084252|101214453|FG007|NOT COMPLETED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0||
48361936|NCT01084252|101214454|FG008|NOT COMPLETED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0||
48361937|NCT01084252|101214455|FG009|NOT COMPLETED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0||
48361938|NCT01084252|101214456|FG010|NOT COMPLETED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0||
48361939|NCT01084252|101214457|FG011|NOT COMPLETED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0||
48361940|NCT01084252|101214458|FG012|NOT COMPLETED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0||
48361941|NCT01084252|101214459|FG013|NOT COMPLETED|Phase 2 Stage 1(1a-414Weeks;1b-92Weeks)||0||
48361942|NCT01084252|101214446|FG000|STARTED|Phase 2 Stage 2 (301 Weeks)||0||
48361943|NCT01084252|101214447|FG001|STARTED|Phase 2 Stage 2 (301 Weeks)||0||
48361944|NCT01084252|101214448|FG002|STARTED|Phase 2 Stage 2 (301 Weeks)||0||
48361945|NCT01084252|101214449|FG003|STARTED|Phase 2 Stage 2 (301 Weeks)||0||
48361946|NCT01084252|101214450|FG004|STARTED|Phase 2 Stage 2 (301 Weeks)||0||
48644107|NCT00489268|101913666|FG002|STARTED|Overall Study||10||
48644108|NCT00489268|101913667|FG003|STARTED|Overall Study||11||
48644109|NCT00489268|101913668|FG004|STARTED|Overall Study||70||
48644110|NCT00489268|101913664|FG000|COMPLETED|Overall Study||1||
48644111|NCT00489268|101913665|FG001|COMPLETED|Overall Study||10||
48644112|NCT00489268|101913666|FG002|COMPLETED|Overall Study||9||
48644113|NCT00489268|101913667|FG003|COMPLETED|Overall Study||11||
48644114|NCT00489268|101913668|FG004|COMPLETED|Overall Study||50||
48644115|NCT00489268|101913664|FG000|NOT COMPLETED|Overall Study||0||
48644116|NCT00489268|101913665|FG001|NOT COMPLETED|Overall Study||0||
48644117|NCT00489268|101913666|FG002|NOT COMPLETED|Overall Study||1||
48644118|NCT00489268|101913667|FG003|NOT COMPLETED|Overall Study||0||
48644119|NCT00489268|101913668|FG004|NOT COMPLETED|Overall Study||20||
48644120|NCT00790933|101913669|FG000|STARTED|Overall Study||675||
48644121|NCT00790933|101913670|FG001|STARTED|Overall Study||726||
48644122|NCT00790933|101913671|FG002|STARTED|Overall Study||384||
48644123|NCT00790933|101913672|FG003|STARTED|Overall Study||37||
48644124|NCT00790933|101913673|FG004|STARTED|Overall Study||421||
48644125|NCT00790933|101913669|FG000|COMPLETED|Overall Study||237||
48644126|NCT00790933|101913670|FG001|COMPLETED|Overall Study||246||
48644127|NCT00790933|101913671|FG002|COMPLETED|Overall Study||115||
48644128|NCT00790933|101913672|FG003|COMPLETED|Overall Study||23||
48644129|NCT00790933|101913673|FG004|COMPLETED|Overall Study||145||
48644130|NCT00790933|101913669|FG000|NOT COMPLETED|Overall Study||438||
48644131|NCT00790933|101913670|FG001|NOT COMPLETED|Overall Study||480||
48765122|NCT02113982|102214584|FG001|COMPLETED|Stage 2: Cohort Expansion||0||
48765123|NCT02113982|102214585|FG002|COMPLETED|Stage 2: Cohort Expansion||0||
48644132|NCT00790933|101913671|FG002|NOT COMPLETED|Overall Study||269||
48644133|NCT00790933|101913672|FG003|NOT COMPLETED|Overall Study||14||
48644134|NCT00790933|101913673|FG004|NOT COMPLETED|Overall Study||276||
48644135|NCT01789775|101913674|FG000|STARTED|Overall Study||55||
48644136|NCT01789775|101913675|FG001|STARTED|Overall Study||57||
48644137|NCT01789775|101913674|FG000|COMPLETED|Overall Study||53||
48644138|NCT01789775|101913675|FG001|COMPLETED|Overall Study||50||
48644139|NCT01789775|101913674|FG000|NOT COMPLETED|Overall Study||2||
48644140|NCT01789775|101913675|FG001|NOT COMPLETED|Overall Study||7||
48644141|NCT01509807|101913676|FG000|STARTED|Overall Study||16||
48644142|NCT01509807|101913677|FG001|STARTED|Overall Study||17||
48644143|NCT01509807|101913676|FG000|COMPLETED|Overall Study||15||
48644144|NCT01509807|101913677|FG001|COMPLETED|Overall Study||16||
48644145|NCT01509807|101913676|FG000|NOT COMPLETED|Overall Study||1||
48644146|NCT01509807|101913677|FG001|NOT COMPLETED|Overall Study||1||
48644147|NCT01370538|101913678|FG000|STARTED|Overall Study||170||
48644148|NCT01370538|101913679|FG001|STARTED|Overall Study||171||
48644149|NCT01370538|101913678|FG000|Patients Who Received Treatment|Overall Study||165||
48644150|NCT01370538|101913679|FG001|Patients Who Received Treatment|Overall Study||161||
48644151|NCT01370538|101913678|FG000|Patients Who Completed Treatment|Overall Study||151||
48644152|NCT01370538|101913679|FG001|Patients Who Completed Treatment|Overall Study||152||
48644153|NCT01370538|101913678|FG000|COMPLETED|Overall Study||151||
48644154|NCT01370538|101913679|FG001|COMPLETED|Overall Study||152||
48644155|NCT01370538|101913678|FG000|NOT COMPLETED|Overall Study||19||
48644156|NCT01370538|101913679|FG001|NOT COMPLETED|Overall Study||19||
48644157|NCT01174459|101913680|FG000|STARTED|Overall Study||571||
48644158|NCT01174459|101913680|FG000|COMPLETED|Overall Study||566||
48644159|NCT01174459|101913680|FG000|NOT COMPLETED|Overall Study||5||
48644160|NCT03033901|101913681|FG000|STARTED|Overall Study||345||
48644161|NCT03033901|101913681|FG000|COMPLETED|Overall Study||248||
48188139|NCT02018861|100783178|FG008|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0||
48188140|NCT02018861|100783179|FG009|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0||
48188141|NCT02018861|100783170|FG000|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
48361947|NCT01084252|101214451|FG005|STARTED|Phase 2 Stage 2 (301 Weeks)||0||
48361948|NCT01084252|101214452|FG006|STARTED|Phase 2 Stage 2 (301 Weeks)||0||
48644162|NCT03033901|101913681|FG000|NOT COMPLETED|Overall Study||97||
48644163|NCT02122952|101913682|FG000|STARTED|Overall Study||3||
48644164|NCT02122952|101913683|FG001|STARTED|Overall Study||12||
48644165|NCT02122952|101913682|FG000|COMPLETED|Overall Study||3||
48644166|NCT02122952|101913683|FG001|COMPLETED|Overall Study||12||
48644167|NCT02122952|101913682|FG000|NOT COMPLETED|Overall Study||0||
48644168|NCT02122952|101913683|FG001|NOT COMPLETED|Overall Study||0||
48644169|NCT02487199|101913684|FG000|STARTED|Overall Study||13||
48644170|NCT02487199|101913685|FG001|STARTED|Overall Study||5||
48644171|NCT02487199|101913684|FG000|COMPLETED|Overall Study||13||
48644172|NCT02487199|101913685|FG001|COMPLETED|Overall Study||4||
48644173|NCT02487199|101913684|FG000|NOT COMPLETED|Overall Study||0||
48644174|NCT02487199|101913685|FG001|NOT COMPLETED|Overall Study||1||
48644175|NCT03615534|101913686|FG000|STARTED|Overall Study||14||
48644176|NCT03615534|101913687|FG001|STARTED|Overall Study||15||
48644177|NCT03615534|101913688|FG002|STARTED|Overall Study||14||
48644178|NCT03615534|101913689|FG003|STARTED|Overall Study||14||
48644179|NCT03615534|101913686|FG000|COMPLETED|Overall Study||12||
48644180|NCT03615534|101913687|FG001|COMPLETED|Overall Study||15||
48644181|NCT03615534|101913688|FG002|COMPLETED|Overall Study||14||
48644182|NCT03615534|101913689|FG003|COMPLETED|Overall Study||13||
48644183|NCT03615534|101913686|FG000|NOT COMPLETED|Overall Study||2||
48644184|NCT03615534|101913687|FG001|NOT COMPLETED|Overall Study||0||
48644185|NCT03615534|101913688|FG002|NOT COMPLETED|Overall Study||0||
48644186|NCT03615534|101913689|FG003|NOT COMPLETED|Overall Study||1||
48644187|NCT01479530|101913690|FG000|STARTED|Overall Study||158||
48644188|NCT01479530|101913691|FG001|STARTED|Overall Study||163||
48644189|NCT01479530|101913690|FG000|COMPLETED|Overall Study||148||
48644190|NCT01479530|101913691|FG001|COMPLETED|Overall Study||151||
48644191|NCT01479530|101913690|FG000|NOT COMPLETED|Overall Study||10||
48644192|NCT01479530|101913691|FG001|NOT COMPLETED|Overall Study||12||
48644193|NCT00762788|101913692|FG000|STARTED|Overall Study||55||
48644194|NCT00762788|101913693|FG001|STARTED|Overall Study||58||
48644195|NCT00762788|101913694|FG002|STARTED|Overall Study||42||
48644196|NCT00762788|101913695|FG003|STARTED|Overall Study||64||
48644197|NCT00762788|101913696|FG004|STARTED|Overall Study||43||
48644198|NCT00762788|101913697|FG005|STARTED|Overall Study||52||
48644199|NCT00762788|101913692|FG000|COMPLETED|Overall Study||29||
48188142|NCT02018861|100783171|FG001|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
48361949|NCT01084252|101214453|FG007|STARTED|Phase 2 Stage 2 (301 Weeks)||0||
48644200|NCT00762788|101913693|FG001|COMPLETED|Overall Study||21||
48644201|NCT00762788|101913694|FG002|COMPLETED|Overall Study||21||
48644202|NCT00762788|101913695|FG003|COMPLETED|Overall Study||38||
48644203|NCT00762788|101913696|FG004|COMPLETED|Overall Study||30||
48644204|NCT00762788|101913697|FG005|COMPLETED|Overall Study||31||
48644205|NCT00762788|101913692|FG000|NOT COMPLETED|Overall Study||26||
48644206|NCT00762788|101913693|FG001|NOT COMPLETED|Overall Study||37||
48644207|NCT00762788|101913694|FG002|NOT COMPLETED|Overall Study||21||
48644208|NCT00762788|101913695|FG003|NOT COMPLETED|Overall Study||26||
48644209|NCT00762788|101913696|FG004|NOT COMPLETED|Overall Study||13||
48644210|NCT00762788|101913697|FG005|NOT COMPLETED|Overall Study||21||
48644211|NCT00694122|101913698|FG000|STARTED|First Intervention (3-4 Weeks)||20||
48644212|NCT00694122|101913699|FG001|STARTED|First Intervention (3-4 Weeks)||7||
48644213|NCT00694122|101913698|FG000|COMPLETED|First Intervention (3-4 Weeks)||10||
48644214|NCT00694122|101913699|FG001|COMPLETED|First Intervention (3-4 Weeks)||5||
48644215|NCT00694122|101913698|FG000|NOT COMPLETED|First Intervention (3-4 Weeks)||10||
48644216|NCT00694122|101913699|FG001|NOT COMPLETED|First Intervention (3-4 Weeks)||2||
48644217|NCT00694122|101913698|FG000|STARTED|Washout (1 Day)||10||
48644218|NCT00694122|101913699|FG001|STARTED|Washout (1 Day)||5||
48644219|NCT00694122|101913698|FG000|COMPLETED|Washout (1 Day)||10||
48644220|NCT00694122|101913699|FG001|COMPLETED|Washout (1 Day)||5||
48644221|NCT00694122|101913698|FG000|NOT COMPLETED|Washout (1 Day)||0||
48644222|NCT00694122|101913699|FG001|NOT COMPLETED|Washout (1 Day)||0||
48644223|NCT00694122|101913698|FG000|STARTED|Second Intervention (3-4 Weeks)||10||
48644224|NCT00694122|101913699|FG001|STARTED|Second Intervention (3-4 Weeks)||5||
48644225|NCT00694122|101913698|FG000|COMPLETED|Second Intervention (3-4 Weeks)||10||
48644226|NCT00694122|101913699|FG001|COMPLETED|Second Intervention (3-4 Weeks)||5||
48644227|NCT00694122|101913698|FG000|NOT COMPLETED|Second Intervention (3-4 Weeks)||0||
48644228|NCT00694122|101913699|FG001|NOT COMPLETED|Second Intervention (3-4 Weeks)||0||
48644229|NCT03718000|101913700|FG000|STARTED|Overall Study||55||
48644230|NCT03718000|101913701|FG001|STARTED|Overall Study||56||
48644231|NCT03718000|101913700|FG000|COMPLETED|Overall Study||53||
48644232|NCT03718000|101913701|FG001|COMPLETED|Overall Study||51||
48644233|NCT03718000|101913700|FG000|NOT COMPLETED|Overall Study||2||
48644234|NCT03718000|101913701|FG001|NOT COMPLETED|Overall Study||5||
48644235|NCT02730130|101913702|FG000|STARTED|Overall Study||17||
48644236|NCT02730130|101913702|FG000|COMPLETED|Overall Study||17||
48644237|NCT02730130|101913702|FG000|NOT COMPLETED|Overall Study||0||
48644238|NCT02641353|101913703|FG000|STARTED|Overall Study||5||
48644239|NCT02641353|101913704|FG001|STARTED|Overall Study||5||
48644240|NCT02641353|101913705|FG002|STARTED|Overall Study||6||
48644241|NCT02641353|101913706|FG003|STARTED|Overall Study||6||
48644242|NCT02641353|101913707|FG004|STARTED|Overall Study||6||
48644243|NCT02641353|101913708|FG005|STARTED|Overall Study||6||
48644244|NCT02641353|101913703|FG000|COMPLETED|Overall Study||5||
48644245|NCT02641353|101913704|FG001|COMPLETED|Overall Study||5||
48644246|NCT02641353|101913705|FG002|COMPLETED|Overall Study||6||
48644247|NCT02641353|101913706|FG003|COMPLETED|Overall Study||6||
48644248|NCT02641353|101913707|FG004|COMPLETED|Overall Study||6||
48644249|NCT02641353|101913708|FG005|COMPLETED|Overall Study||6||
48644250|NCT02641353|101913703|FG000|NOT COMPLETED|Overall Study||0||
48644251|NCT02641353|101913704|FG001|NOT COMPLETED|Overall Study||0||
48644252|NCT02641353|101913705|FG002|NOT COMPLETED|Overall Study||0||
48644253|NCT02641353|101913706|FG003|NOT COMPLETED|Overall Study||0||
48644254|NCT02641353|101913707|FG004|NOT COMPLETED|Overall Study||0||
48644255|NCT02641353|101913708|FG005|NOT COMPLETED|Overall Study||0||
48644256|NCT01200355|101913709|FG000|STARTED|Overall Study||58||
48644257|NCT01200355|101913710|FG001|STARTED|Overall Study||55||
48644258|NCT01200355|101913709|FG000|COMPLETED|Overall Study||51||
48644259|NCT01200355|101913710|FG001|COMPLETED|Overall Study||53||
48644260|NCT01200355|101913709|FG000|NOT COMPLETED|Overall Study||7||
48644261|NCT01200355|101913710|FG001|NOT COMPLETED|Overall Study||2||
48644262|NCT00520468|101913711|FG000|STARTED|Overall Study||14||
48644263|NCT00520468|101913711|FG000|COMPLETED|Overall Study||14||
48644264|NCT00520468|101913711|FG000|NOT COMPLETED|Overall Study||0||
48644265|NCT03802110|101913712|FG000|STARTED|Overall Study||42||
48644266|NCT03802110|101913712|FG000|Started Testing|Overall Study||35||
48644267|NCT03802110|101913712|FG000|COMPLETED|Overall Study||28||
48644268|NCT03802110|101913712|FG000|NOT COMPLETED|Overall Study||14||
48644269|NCT02120079|101913713|FG000|STARTED|Baseline||17||28
48644270|NCT02120079|101913714|FG001|STARTED|Baseline||20||34
48644271|NCT02120079|101913713|FG000|COMPLETED|Baseline||17||28
48644272|NCT02120079|101913714|FG001|COMPLETED|Baseline||20||34
48644273|NCT02120079|101913713|FG000|NOT COMPLETED|Baseline||0||0
48644274|NCT02120079|101913714|FG001|NOT COMPLETED|Baseline||0||0
48644275|NCT02120079|101913713|FG000|STARTED|2 Weeks||17||28
48644276|NCT02120079|101913714|FG001|STARTED|2 Weeks||20||34
48644277|NCT02120079|101913713|FG000|COMPLETED|2 Weeks||17||28
48644278|NCT02120079|101913714|FG001|COMPLETED|2 Weeks||20||34
48644279|NCT02120079|101913713|FG000|NOT COMPLETED|2 Weeks||0||0
48644280|NCT02120079|101913714|FG001|NOT COMPLETED|2 Weeks||0||0
48644281|NCT02120079|101913713|FG000|STARTED|6 Weeks||17||28
48644282|NCT02120079|101913714|FG001|STARTED|6 Weeks||20||34
48644283|NCT02120079|101913713|FG000|COMPLETED|6 Weeks||17||28
48644284|NCT02120079|101913714|FG001|COMPLETED|6 Weeks||20||34
48644285|NCT02120079|101913713|FG000|NOT COMPLETED|6 Weeks||0||0
48644286|NCT02120079|101913714|FG001|NOT COMPLETED|6 Weeks||0||0
48644287|NCT04055519|101913715|FG000|STARTED|First Wear Period (30 Days)||16||32
48644288|NCT04055519|101913716|FG001|STARTED|First Wear Period (30 Days)||20||40
48644289|NCT04055519|101913715|FG000|COMPLETED|First Wear Period (30 Days)||16||32
48644290|NCT04055519|101913716|FG001|COMPLETED|First Wear Period (30 Days)||20||40
48765124|NCT02113982|102214586|FG003|COMPLETED|Stage 2: Cohort Expansion||0||
48765125|NCT02113982|102214587|FG004|COMPLETED|Stage 2: Cohort Expansion||0||
48765126|NCT02113982|102214588|FG005|COMPLETED|Stage 2: Cohort Expansion||0||
48436067|NCT01628159|101403475|FG000|STARTED|Overall Study||657||
48436068|NCT01628159|101403475|FG000|COMPLETED|Overall Study||493||
48436069|NCT01628159|101403475|FG000|NOT COMPLETED|Overall Study||164||
48436070|NCT03901339|101403476|FG000|STARTED|Overall Study||272||
48436071|NCT03901339|101403477|FG001|STARTED|Overall Study||271||
48436072|NCT03901339|101403476|FG000|Received at Least 1 Dose of Study Drug|Overall Study||268||
48436073|NCT03901339|101403477|FG001|Received at Least 1 Dose of Study Drug|Overall Study||249||
48436074|NCT03901339|101403476|FG000|COMPLETED|Overall Study||0||
48436075|NCT03901339|101403477|FG001|COMPLETED|Overall Study||0||
48436076|NCT03901339|101403476|FG000|NOT COMPLETED|Overall Study||272||
48436077|NCT03901339|101403477|FG001|NOT COMPLETED|Overall Study||271||
48436078|NCT03839693|101403478|FG000|STARTED|Overall Study||25||
48436079|NCT03839693|101403479|FG001|STARTED|Overall Study||30||
48436080|NCT03839693|101403480|FG002|STARTED|Overall Study||20||
48436081|NCT03839693|101403478|FG000|COMPLETED|Overall Study||23||
48436082|NCT03839693|101403479|FG001|COMPLETED|Overall Study||28||
48436083|NCT03839693|101403480|FG002|COMPLETED|Overall Study||16||
48436084|NCT03839693|101403478|FG000|NOT COMPLETED|Overall Study||2||
48436085|NCT03839693|101403479|FG001|NOT COMPLETED|Overall Study||2||
48436086|NCT03839693|101403480|FG002|NOT COMPLETED|Overall Study||4||
48436087|NCT01748162|101403481|FG000|STARTED|Overall Study||5||
48188143|NCT02018861|100783172|FG002|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
48188144|NCT02018861|100783173|FG003|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
48436088|NCT01748162|101403482|FG001|STARTED|Overall Study||5||
48436089|NCT01748162|101403481|FG000|Started 6 Month Initial Treatment Plan|Overall Study||2||
48436090|NCT01748162|101403482|FG001|Started 6 Month Initial Treatment Plan|Overall Study||2||
48436091|NCT01748162|101403481|FG000|Completed 6 Month Initial Treatment|Overall Study||0||
48436092|NCT01748162|101403482|FG001|Completed 6 Month Initial Treatment|Overall Study||0||
48436093|NCT01748162|101403481|FG000|Started 6 Month Followup|Overall Study||0||
48436094|NCT01748162|101403482|FG001|Started 6 Month Followup|Overall Study||0||
48436095|NCT01748162|101403481|FG000|COMPLETED|Overall Study||0||
48436096|NCT01748162|101403482|FG001|COMPLETED|Overall Study||0||
48436097|NCT01748162|101403481|FG000|NOT COMPLETED|Overall Study||5||
48436098|NCT01748162|101403482|FG001|NOT COMPLETED|Overall Study||5||
48436099|NCT03988049|101403483|FG000|STARTED|Overall Study||22||22
48436100|NCT03988049|101403484|FG001|STARTED|Overall Study||22||22
48436101|NCT03988049|101403483|FG000|COMPLETED|Overall Study||22||22
48436102|NCT03988049|101403484|FG001|COMPLETED|Overall Study||22||22
48436103|NCT03988049|101403483|FG000|NOT COMPLETED|Overall Study||0||0
48436104|NCT03988049|101403484|FG001|NOT COMPLETED|Overall Study||0||0
48436105|NCT00824993|101403485|FG000|STARTED|Overall Study||39||
48436106|NCT00824993|101403486|FG001|STARTED|Overall Study||39||
48765127|NCT02113982|102214589|FG006|COMPLETED|Stage 2: Cohort Expansion||0||
48765128|NCT02113982|102214590|FG007|COMPLETED|Stage 2: Cohort Expansion||0||
48765129|NCT02113982|102214591|FG008|COMPLETED|Stage 2: Cohort Expansion||0||
48188145|NCT02018861|100783174|FG004|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
48188146|NCT02018861|100783175|FG005|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
48188147|NCT02018861|100783176|FG006|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
48188148|NCT02018861|100783177|FG007|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
48188149|NCT02018861|100783178|FG008|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
48188150|NCT02018861|100783179|FG009|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
48188151|NCT02018861|100783170|FG000|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
48188152|NCT02018861|100783171|FG001|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
48188153|NCT02018861|100783172|FG002|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
48436107|NCT00824993|101403485|FG000|6 Month Follow up|Overall Study||33||
48436108|NCT00824993|101403486|FG001|6 Month Follow up|Overall Study||27||
48765130|NCT02113982|102214592|FG009|COMPLETED|Stage 2: Cohort Expansion||0||
48436109|NCT00824993|101403485|FG000|COMPLETED|Overall Study||25||
48436110|NCT00824993|101403486|FG001|COMPLETED|Overall Study||22||
48436111|NCT00824993|101403485|FG000|NOT COMPLETED|Overall Study||14||
48436112|NCT00824993|101403486|FG001|NOT COMPLETED|Overall Study||17||
48436113|NCT02424357|101403487|FG000|STARTED|Overall Study||35||
48436114|NCT02424357|101403488|FG001|STARTED|Overall Study||30||
48436115|NCT02424357|101403487|FG000|COMPLETED|Overall Study||35||
48436116|NCT02424357|101403488|FG001|COMPLETED|Overall Study||30||
48436117|NCT02424357|101403487|FG000|NOT COMPLETED|Overall Study||0||
48436118|NCT02424357|101403488|FG001|NOT COMPLETED|Overall Study||0||
48436119|NCT01905631|101403489|FG000|STARTED|Overall Study||10||
48436120|NCT01905631|101403490|FG001|STARTED|Overall Study||20||
48436121|NCT01905631|101403489|FG000|COMPLETED|Overall Study||10||
48436122|NCT01905631|101403490|FG001|COMPLETED|Overall Study||20||
48436123|NCT01905631|101403489|FG000|NOT COMPLETED|Overall Study||0||
48436124|NCT01905631|101403490|FG001|NOT COMPLETED|Overall Study||0||
48644291|NCT04055519|101913715|FG000|NOT COMPLETED|First Wear Period (30 Days)||0||0
48644292|NCT04055519|101913716|FG001|NOT COMPLETED|First Wear Period (30 Days)||0||0
48644293|NCT04055519|101913715|FG000|STARTED|Second Wear Period (30 Days)||16||32
48644294|NCT04055519|101913716|FG001|STARTED|Second Wear Period (30 Days)||20||40
48644295|NCT04055519|101913715|FG000|COMPLETED|Second Wear Period (30 Days)||16||32
48644296|NCT04055519|101913716|FG001|COMPLETED|Second Wear Period (30 Days)||20||40
48644297|NCT04055519|101913715|FG000|NOT COMPLETED|Second Wear Period (30 Days)||0||0
48644298|NCT04055519|101913716|FG001|NOT COMPLETED|Second Wear Period (30 Days)||0||0
48644299|NCT04518410|101913717|FG000|STARTED|Overall Study||48|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A\*= Subjects Treated and then not completed for reported reason and not excluded from analyses = 0 + 325 + 204 + 36 + 31 + 38 + 1 = 635~Not completed=A\*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses+Dual Enrolled Subject = 635 + 0 + 54 + 2 + 252 +1"|
48644300|NCT04518410|101913718|FG001|STARTED|Overall Study||46|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A\*= Subjects Treated and then not completed for reported reason and not excluded from analyses = 0 + 325 + 204 + 36 + 31 + 38 + 1 = 635~Not completed=A\*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses+Dual Enrolled Subject = 635 + 0 + 54 + 2 + 252 +1"|
48644301|NCT04518410|101913719|FG002|STARTED|Overall Study||111|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A\*= Subjects Treated and then not completed for reported reason and not excluded from analyses = 0 + 325 + 204 + 36 + 31 + 38 + 1 = 635~Not completed=A\*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses+Dual Enrolled Subject = 635 + 0 + 54 + 2 + 252 +1"|
48644302|NCT04518410|101913720|FG003|STARTED|Overall Study||114|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A\*= Subjects Treated and then not completed for reported reason and not excluded from analyses = 0 + 325 + 204 + 36 + 31 + 38 + 1 = 635~Not completed=A\*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses+Dual Enrolled Subject = 635 + 0 + 54 + 2 + 252 +1"|
48644303|NCT04518410|101913721|FG004|STARTED|Overall Study||1079|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A\*= Subjects Treated and then not completed for reported reason and not excluded from analyses = 0 + 325 + 204 + 36 + 31 + 38 + 1 = 635~Not completed=A\*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses+Dual Enrolled Subject = 635 + 0 + 54 + 2 + 252 +1"|
48644304|NCT04518410|101913722|FG005|STARTED|Overall Study||424|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A\*= Subjects Treated and then not completed for reported reason and not excluded from analyses = 0 + 325 + 204 + 36 + 31 + 38 + 1 = 635~Not completed=A\*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses+Dual Enrolled Subject = 635 + 0 + 54 + 2 + 252 +1"|
48644305|NCT04518410|101913723|FG006|STARTED|Overall Study||422|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A\*= Subjects Treated and then not completed for reported reason and not excluded from analyses = 0 + 325 + 204 + 36 + 31 + 38 + 1 = 635~Not completed=A\*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses+Dual Enrolled Subject = 635 + 0 + 54 + 2 + 252 +1"|
48644306|NCT04518410|101913724|FG007|STARTED|Overall Study||61|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A\*= Subjects Treated and then not completed for reported reason and not excluded from analyses = 0 + 325 + 204 + 36 + 31 + 38 + 1 = 635~Not completed=A\*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses+Dual Enrolled Subject = 635 + 0 + 54 + 2 + 252 +1"|
48644307|NCT04518410|101913725|FG008|STARTED|Overall Study||33|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A\*= Subjects Treated and then not completed for reported reason and not excluded from analyses = 0 + 325 + 204 + 36 + 31 + 38 + 1 = 635~Not completed=A\*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses+Dual Enrolled Subject = 635 + 0 + 54 + 2 + 252 +1"|
48644308|NCT04518410|101913726|FG009|STARTED|Overall Study||110|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A\*= Subjects Treated and then not completed for reported reason and not excluded from analyses = 0 + 325 + 204 + 36 + 31 + 38 + 1 = 635~Not completed=A\*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses+Dual Enrolled Subject = 635 + 0 + 54 + 2 + 252 +1"|
48644309|NCT04518410|101913727|FG010|STARTED|Overall Study||54|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A\*= Subjects Treated and then not completed for reported reason and not excluded from analyses = 0 + 325 + 204 + 36 + 31 + 38 + 1 = 635~Not completed=A\*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses+Dual Enrolled Subject = 635 + 0 + 54 + 2 + 252 +1"|
48644310|NCT04518410|101913728|FG011|STARTED|Overall Study||110|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A\*= Subjects Treated and then not completed for reported reason and not excluded from analyses = 0 + 325 + 204 + 36 + 31 + 38 + 1 = 635~Not completed=A\*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses+Dual Enrolled Subject = 635 + 0 + 54 + 2 + 252 +1"|
48657036|NCT02018809|101943755|FG002|NOT COMPLETED|Overall Study||0||
48657037|NCT02018809|101943756|FG003|NOT COMPLETED|Overall Study||0||
48657038|NCT03648372|101943757|FG000|STARTED|Overall Study||5||
48657039|NCT03648372|101943758|FG001|STARTED|Overall Study||3||
48644311|NCT04518410|101913729|FG012|STARTED|Overall Study||53|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A\*= Subjects Treated and then not completed for reported reason and not excluded from analyses = 0 + 325 + 204 + 36 + 31 + 38 + 1 = 635~Not completed=A\*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses+Dual Enrolled Subject = 635 + 0 + 54 + 2 + 252 +1"|
48644312|NCT04518410|101913730|FG013|STARTED|Overall Study||113|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A\*= Subjects Treated and then not completed for reported reason and not excluded from analyses = 0 + 325 + 204 + 36 + 31 + 38 + 1 = 635~Not completed=A\*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses+Dual Enrolled Subject = 635 + 0 + 54 + 2 + 252 +1"|
48644313|NCT04518410|101913731|FG014|STARTED|Overall Study||54|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A\*= Subjects Treated and then not completed for reported reason and not excluded from analyses = 0 + 325 + 204 + 36 + 31 + 38 + 1 = 635~Not completed=A\*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses+Dual Enrolled Subject = 635 + 0 + 54 + 2 + 252 +1"|
48644314|NCT04518410|101913732|FG015|STARTED|Overall Study||110|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A\*= Subjects Treated and then not completed for reported reason and not excluded from analyses = 0 + 325 + 204 + 36 + 31 + 38 + 1 = 635~Not completed=A\*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses+Dual Enrolled Subject = 635 + 0 + 54 + 2 + 252 +1"|
48644315|NCT04518410|101913733|FG016|STARTED|Overall Study||39|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A\*= Subjects Treated and then not completed for reported reason and not excluded from analyses = 0 + 325 + 204 + 36 + 31 + 38 + 1 = 635~Not completed=A\*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses+Dual Enrolled Subject = 635 + 0 + 54 + 2 + 252 +1"|
48644316|NCT04518410|101913734|FG017|STARTED|Overall Study||225|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A\*= Subjects Treated and then not completed for reported reason and not excluded from analyses = 0 + 325 + 204 + 36 + 31 + 38 + 1 = 635~Not completed=A\*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses+Dual Enrolled Subject = 635 + 0 + 54 + 2 + 252 +1"|
48644317|NCT04518410|101913735|FG018|STARTED|Overall Study||214|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A\*= Subjects Treated and then not completed for reported reason and not excluded from analyses = 0 + 325 + 204 + 36 + 31 + 38 + 1 = 635~Not completed=A\*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses+Dual Enrolled Subject = 635 + 0 + 54 + 2 + 252 +1"|
48644318|NCT04518410|101913736|FG019|STARTED|Overall Study||142|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A\*= Subjects Treated and then not completed for reported reason and not excluded from analyses = 0 + 325 + 204 + 36 + 31 + 38 + 1 = 635~Not completed=A\*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses+Dual Enrolled Subject = 635 + 0 + 54 + 2 + 252 +1"|
48644319|NCT04518410|101913737|FG020|STARTED|Overall Study||153|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A\*= Subjects Treated and then not completed for reported reason and not excluded from analyses = 0 + 325 + 204 + 36 + 31 + 38 + 1 = 635~Not completed=A\*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses+Dual Enrolled Subject = 635 + 0 + 54 + 2 + 252 +1"|
48644320|NCT04518410|101913738|FG021|STARTED|Overall Study||115|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A\*= Subjects Treated and then not completed for reported reason and not excluded from analyses = 0 + 325 + 204 + 36 + 31 + 38 + 1 = 635~Not completed=A\*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses+Dual Enrolled Subject = 635 + 0 + 54 + 2 + 252 +1"|
48644321|NCT04518410|101913739|FG022|STARTED|Overall Study||41|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A\*= Subjects Treated and then not completed for reported reason and not excluded from analyses = 0 + 325 + 204 + 36 + 31 + 38 + 1 = 635~Not completed=A\*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses+Dual Enrolled Subject = 635 + 0 + 54 + 2 + 252 +1"|
48644322|NCT04518410|101913740|FG023|STARTED|Overall Study||112|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A\*= Subjects Treated and then not completed for reported reason and not excluded from analyses = 0 + 325 + 204 + 36 + 31 + 38 + 1 = 635~Not completed=A\*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses+Dual Enrolled Subject = 635 + 0 + 54 + 2 + 252 +1"|
48657040|NCT03648372|101943759|FG002|STARTED|Overall Study||4||
48657041|NCT03648372|101943760|FG003|STARTED|Overall Study||3||
48765131|NCT02113982|102214593|FG010|COMPLETED|Stage 2: Cohort Expansion||0||
48765132|NCT02113982|102214594|FG011|COMPLETED|Stage 2: Cohort Expansion||0||
48765133|NCT02113982|102214595|FG012|COMPLETED|Stage 2: Cohort Expansion||0||
48765134|NCT02113982|102214596|FG013|COMPLETED|Stage 2: Cohort Expansion||0||
48644323|NCT04518410|101913741|FG024|STARTED|Overall Study||61|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A\*= Subjects Treated and then not completed for reported reason and not excluded from analyses = 0 + 325 + 204 + 36 + 31 + 38 + 1 = 635~Not completed=A\*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses+Dual Enrolled Subject = 635 + 0 + 54 + 2 + 252 +1"|
48644324|NCT04518410|101913717|FG000|COMPLETED|Overall Study||45||
48644325|NCT04518410|101913718|FG001|COMPLETED|Overall Study||43||
48644326|NCT04518410|101913719|FG002|COMPLETED|Overall Study||100||
48644327|NCT04518410|101913720|FG003|COMPLETED|Overall Study||101||
48644328|NCT04518410|101913721|FG004|COMPLETED|Overall Study||843||
48644329|NCT04518410|101913722|FG005|COMPLETED|Overall Study||329||
48644330|NCT04518410|101913723|FG006|COMPLETED|Overall Study||328||
48644331|NCT04518410|101913724|FG007|COMPLETED|Overall Study||42||
48644332|NCT04518410|101913725|FG008|COMPLETED|Overall Study||23||
48644333|NCT04518410|101913726|FG009|COMPLETED|Overall Study||77||
48644334|NCT04518410|101913727|FG010|COMPLETED|Overall Study||36||
48644335|NCT04518410|101913728|FG011|COMPLETED|Overall Study||88||
48644336|NCT04518410|101913729|FG012|COMPLETED|Overall Study||41||
48644337|NCT04518410|101913730|FG013|COMPLETED|Overall Study||79||
48644338|NCT04518410|101913731|FG014|COMPLETED|Overall Study||38||
48644339|NCT04518410|101913732|FG015|COMPLETED|Overall Study||84||
48644340|NCT04518410|101913733|FG016|COMPLETED|Overall Study||26||
48644341|NCT04518410|101913734|FG017|COMPLETED|Overall Study||167||
48644342|NCT04518410|101913735|FG018|COMPLETED|Overall Study||156||
48361950|NCT01084252|101214454|FG008|STARTED|Phase 2 Stage 2 (301 Weeks)||0||
48361951|NCT01084252|101214455|FG009|STARTED|Phase 2 Stage 2 (301 Weeks)||0||
48361952|NCT01084252|101214456|FG010|STARTED|Phase 2 Stage 2 (301 Weeks)||0||
48361953|NCT01084252|101214457|FG011|STARTED|Phase 2 Stage 2 (301 Weeks)||0||
48361954|NCT01084252|101214458|FG012|STARTED|Phase 2 Stage 2 (301 Weeks)||110||
48361955|NCT01084252|101214459|FG013|STARTED|Phase 2 Stage 2 (301 Weeks)||55||
48361956|NCT01084252|101214446|FG000|AT Population|Phase 2 Stage 2 (301 Weeks)||0|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361957|NCT01084252|101214447|FG001|AT Population|Phase 2 Stage 2 (301 Weeks)||0|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361958|NCT01084252|101214448|FG002|AT Population|Phase 2 Stage 2 (301 Weeks)||0|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361959|NCT01084252|101214449|FG003|AT Population|Phase 2 Stage 2 (301 Weeks)||0|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48644343|NCT04518410|101913736|FG019|COMPLETED|Overall Study||102||
48644344|NCT04518410|101913737|FG020|COMPLETED|Overall Study||110||
48644345|NCT04518410|101913738|FG021|COMPLETED|Overall Study||81||
48644346|NCT04518410|101913739|FG022|COMPLETED|Overall Study||35||
48644347|NCT04518410|101913740|FG023|COMPLETED|Overall Study||84||
48644348|NCT04518410|101913741|FG024|COMPLETED|Overall Study||42||
48644349|NCT04518410|101913717|FG000|NOT COMPLETED|Overall Study||3||
48644350|NCT04518410|101913718|FG001|NOT COMPLETED|Overall Study||3||
48644351|NCT04518410|101913719|FG002|NOT COMPLETED|Overall Study||11||
48644352|NCT04518410|101913720|FG003|NOT COMPLETED|Overall Study||13||
48644353|NCT04518410|101913721|FG004|NOT COMPLETED|Overall Study||236||
48644354|NCT04518410|101913722|FG005|NOT COMPLETED|Overall Study||95||
48644355|NCT04518410|101913723|FG006|NOT COMPLETED|Overall Study||94||
48644356|NCT04518410|101913724|FG007|NOT COMPLETED|Overall Study||19||
48644357|NCT04518410|101913725|FG008|NOT COMPLETED|Overall Study||10||
48644358|NCT04518410|101913726|FG009|NOT COMPLETED|Overall Study||33||
48644359|NCT04518410|101913727|FG010|NOT COMPLETED|Overall Study||18||
48644360|NCT04518410|101913728|FG011|NOT COMPLETED|Overall Study||22||
48644361|NCT04518410|101913729|FG012|NOT COMPLETED|Overall Study||12||
48644362|NCT04518410|101913730|FG013|NOT COMPLETED|Overall Study||34||
48644363|NCT04518410|101913731|FG014|NOT COMPLETED|Overall Study||16||
48644364|NCT04518410|101913732|FG015|NOT COMPLETED|Overall Study||26||
48644365|NCT04518410|101913733|FG016|NOT COMPLETED|Overall Study||13||
48644366|NCT04518410|101913734|FG017|NOT COMPLETED|Overall Study||58||
48644367|NCT04518410|101913735|FG018|NOT COMPLETED|Overall Study||58||
48644368|NCT04518410|101913736|FG019|NOT COMPLETED|Overall Study||40||
48644369|NCT04518410|101913737|FG020|NOT COMPLETED|Overall Study||43||
48644370|NCT04518410|101913738|FG021|NOT COMPLETED|Overall Study||34||
48644371|NCT04518410|101913739|FG022|NOT COMPLETED|Overall Study||6||
48644372|NCT04518410|101913740|FG023|NOT COMPLETED|Overall Study||28||
48644373|NCT04518410|101913741|FG024|NOT COMPLETED|Overall Study||19||
48644374|NCT00890162|101913742|FG000|STARTED|Overall Study||8||
48644375|NCT00890162|101913743|FG001|STARTED|Overall Study||8||
48644376|NCT00890162|101913742|FG000|COMPLETED|Overall Study||6||
48644377|NCT00890162|101913743|FG001|COMPLETED|Overall Study||7||
48644378|NCT00890162|101913742|FG000|NOT COMPLETED|Overall Study||2||
48644379|NCT00890162|101913743|FG001|NOT COMPLETED|Overall Study||1||
48644380|NCT00250718|101913744|FG000|STARTED|Overall Study||17||
48644381|NCT00250718|101913744|FG000|Received Treatment|Overall Study||16||
48644382|NCT00250718|101913744|FG000|COMPLETED|Overall Study||14||
48644383|NCT00250718|101913744|FG000|NOT COMPLETED|Overall Study||3||
48644384|NCT04706221|101913745|FG000|STARTED|Overall Study||91||
48644385|NCT04706221|101913746|FG001|STARTED|Overall Study||109||
48644386|NCT04706221|101913745|FG000|COMPLETED|Overall Study||75||
48644387|NCT04706221|101913746|FG001|COMPLETED|Overall Study||98||
48644388|NCT04706221|101913745|FG000|NOT COMPLETED|Overall Study||16||
48644389|NCT04706221|101913746|FG001|NOT COMPLETED|Overall Study||11||
48644390|NCT00809146|101913747|FG000|STARTED|Overall Study||448||
48644391|NCT00809146|101913748|FG001|STARTED|Overall Study||445||
48644392|NCT00809146|101913747|FG000|COMPLETED|Overall Study||448||
48644393|NCT00809146|101913748|FG001|COMPLETED|Overall Study||445||
48644394|NCT00809146|101913747|FG000|NOT COMPLETED|Overall Study||0||
48644395|NCT00809146|101913748|FG001|NOT COMPLETED|Overall Study||0||
48644396|NCT01680172|101913749|FG000|STARTED|Overall Study||3||
48644397|NCT01680172|101913750|FG001|STARTED|Overall Study||2||
48644398|NCT01680172|101913749|FG000|COMPLETED|Overall Study||3||
48644399|NCT01680172|101913750|FG001|COMPLETED|Overall Study||2||
48644400|NCT01680172|101913749|FG000|NOT COMPLETED|Overall Study||0||
48644401|NCT01680172|101913750|FG001|NOT COMPLETED|Overall Study||0||
48644402|NCT04964388|101913751|FG000|STARTED|Overall Study||3||
48644403|NCT04964388|101913752|FG001|STARTED|Overall Study||2||
48644404|NCT04964388|101913751|FG000|COMPLETED|Overall Study||0||
48644405|NCT04964388|101913752|FG001|COMPLETED|Overall Study||0||
48644406|NCT04964388|101913751|FG000|NOT COMPLETED|Overall Study||3||
48644407|NCT04964388|101913752|FG001|NOT COMPLETED|Overall Study||2||
48644408|NCT02536794|101913753|FG000|STARTED|Reached 1st Response Assessment||30||
48644409|NCT02536794|101913753|FG000|Started Treatment|Reached 1st Response Assessment||30||
48644410|NCT02536794|101913753|FG000|Attempted First Cycle|Reached 1st Response Assessment||30||
48644411|NCT02536794|101913753|FG000|Attempted Second Cycle|Reached 1st Response Assessment||24||
48644412|NCT02536794|101913753|FG000|Reached First Response|Reached 1st Response Assessment||24||
48644413|NCT02536794|101913753|FG000|COMPLETED|Reached 1st Response Assessment||24||
48644414|NCT02536794|101913753|FG000|NOT COMPLETED|Reached 1st Response Assessment||6||
48644415|NCT02536794|101913753|FG000|STARTED|Continued Treatment After 1st Response||24||
48644416|NCT02536794|101913753|FG000|Went on to Start Cycle 3|Continued Treatment After 1st Response||16||
48644417|NCT02536794|101913753|FG000|COMPLETED|Continued Treatment After 1st Response||16||
48644418|NCT02536794|101913753|FG000|NOT COMPLETED|Continued Treatment After 1st Response||8||
48644419|NCT02536794|101913753|FG000|STARTED|Follow up for 3 Years or Death||29|All patients who are treated on study go into the follow up phase|
48644420|NCT02536794|101913753|FG000|COMPLETED|Follow up for 3 Years or Death||29||
48644421|NCT02536794|101913753|FG000|NOT COMPLETED|Follow up for 3 Years or Death||0||
48644422|NCT03222128|101913754|FG000|STARTED|Overall Study||1074||
48644423|NCT03222128|101913754|FG000|Valve-Implanted|Overall Study||1069||
48644424|NCT03222128|101913754|FG000|COMPLETED|Overall Study||968|One year follow-up|
48644425|NCT03222128|101913754|FG000|NOT COMPLETED|Overall Study||106||
48644426|NCT02129556|101913755|FG000|STARTED|Overall Study||3||
48644427|NCT02129556|101913756|FG001|STARTED|Overall Study||3||
48644428|NCT02129556|101913757|FG002|STARTED|Overall Study||40||
48644429|NCT02129556|101913758|FG003|STARTED|Overall Study||12||
48644430|NCT02129556|101913755|FG000|COMPLETED|Overall Study||3||
48644431|NCT02129556|101913756|FG001|COMPLETED|Overall Study||3||
48644432|NCT02129556|101913757|FG002|COMPLETED|Overall Study||37||
48644433|NCT02129556|101913758|FG003|COMPLETED|Overall Study||12||
48644434|NCT02129556|101913755|FG000|NOT COMPLETED|Overall Study||0||
48644435|NCT02129556|101913756|FG001|NOT COMPLETED|Overall Study||0||
48644436|NCT02129556|101913757|FG002|NOT COMPLETED|Overall Study||3||
48644437|NCT02129556|101913758|FG003|NOT COMPLETED|Overall Study||0||
48644438|NCT03837938|101913759|FG000|STARTED|Overall Study||92||
48644439|NCT03837938|101913760|FG001|STARTED|Overall Study||92||
48644440|NCT03837938|101913759|FG000|ITT Population|Overall Study||92||
48644441|NCT03837938|101913760|FG001|ITT Population|Overall Study||92||
48644442|NCT03837938|101913759|FG000|PP Population|Overall Study||88||
48644443|NCT03837938|101913760|FG001|PP Population|Overall Study||91||
48644444|NCT03837938|101913759|FG000|Safety Population|Overall Study||92||
48644445|NCT03837938|101913760|FG001|Safety Population|Overall Study||92||
48644446|NCT03837938|101913759|FG000|COMPLETED|Overall Study||92||
48644447|NCT03837938|101913760|FG001|COMPLETED|Overall Study||92||
48644448|NCT03837938|101913759|FG000|NOT COMPLETED|Overall Study||0||
48644449|NCT03837938|101913760|FG001|NOT COMPLETED|Overall Study||0||
48644450|NCT01834261|101913761|FG000|STARTED|MIT fMRI and MEG Resting State Study||11||
48644451|NCT01834261|101913762|FG001|STARTED|MIT fMRI and MEG Resting State Study||10||
48644452|NCT01834261|101913761|FG000|COMPLETED|MIT fMRI and MEG Resting State Study||10||
48644453|NCT01834261|101913762|FG001|COMPLETED|MIT fMRI and MEG Resting State Study||9||
48644454|NCT01834261|101913761|FG000|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1||
48644455|NCT01834261|101913762|FG001|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1||
48644456|NCT01834261|101913761|FG000|STARTED|MGH Rest + Nueroeconomic Task fMRI||10||
48644457|NCT01834261|101913762|FG001|STARTED|MGH Rest + Nueroeconomic Task fMRI||10||
48644458|NCT01834261|101913761|FG000|COMPLETED|MGH Rest + Nueroeconomic Task fMRI||10||
48644459|NCT01834261|101913762|FG001|COMPLETED|MGH Rest + Nueroeconomic Task fMRI||10||
48644460|NCT01834261|101913761|FG000|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0||
48644461|NCT01834261|101913762|FG001|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0||
48644462|NCT03071744|101913763|FG000|STARTED|Overall Study||6||
48644463|NCT03071744|101913763|FG000|COMPLETED|Overall Study||4||
48644464|NCT03071744|101913763|FG000|NOT COMPLETED|Overall Study||2||
48644465|NCT01049828|101913764|FG000|STARTED|Overall Study||20||
48644466|NCT01049828|101913764|FG000|COMPLETED|Overall Study||18||
48644467|NCT01049828|101913764|FG000|NOT COMPLETED|Overall Study||2||
48644468|NCT00997126|101913765|FG000|STARTED|Overall Study||63||
48644469|NCT00997126|101913766|FG001|STARTED|Overall Study||63||
48644470|NCT00997126|101913765|FG000|COMPLETED|Overall Study||56||
48644471|NCT00997126|101913766|FG001|COMPLETED|Overall Study||52||
48644472|NCT00997126|101913765|FG000|NOT COMPLETED|Overall Study||7||
48644473|NCT00997126|101913766|FG001|NOT COMPLETED|Overall Study||11||
48644474|NCT01481779|101913767|FG000|STARTED|Overall Study||295||
48644475|NCT01481779|101913768|FG001|STARTED|Overall Study||160||
48644476|NCT01481779|101913767|FG000|Received at Least 1 Dose of Study Drug|Overall Study||294||
48644477|NCT01481779|101913768|FG001|Received at Least 1 Dose of Study Drug|Overall Study||159||
48644478|NCT01481779|101913767|FG000|COMPLETED|Overall Study||225||
48644479|NCT01481779|101913768|FG001|COMPLETED|Overall Study||132||
48644480|NCT01481779|101913767|FG000|NOT COMPLETED|Overall Study||70||
48644481|NCT01481779|101913768|FG001|NOT COMPLETED|Overall Study||28||
48644482|NCT01565551|101913769|FG000|STARTED|Overall Study||586||
48644483|NCT01565551|101913770|FG001|STARTED|Overall Study||51||
48644484|NCT01565551|101913769|FG000|Clinical/Demographics|Overall Study||586||
48644485|NCT01565551|101913770|FG001|Clinical/Demographics|Overall Study||51||
48644486|NCT01565551|101913769|FG000|Biospecimens/Biomarkers|Overall Study||479||
48644487|NCT01565551|101913770|FG001|Biospecimens/Biomarkers|Overall Study||22||
48644488|NCT01565551|101913769|FG000|Neuroimaging|Overall Study||233||
48644489|NCT01565551|101913770|FG001|Neuroimaging|Overall Study||25||
48644490|NCT01565551|101913769|FG000|6-Month Outcomes|Overall Study||412||
48644491|NCT01565551|101913770|FG001|6-Month Outcomes|Overall Study||30||
48644492|NCT01565551|101913769|FG000|COMPLETED|Overall Study||586||
48644493|NCT01565551|101913770|FG001|COMPLETED|Overall Study||51||
48644494|NCT01565551|101913769|FG000|NOT COMPLETED|Overall Study||0||
48644495|NCT01565551|101913770|FG001|NOT COMPLETED|Overall Study||0||
48644496|NCT01732783|101913771|FG000|STARTED|Overall Study||164||
48644497|NCT01732783|101913772|FG001|STARTED|Overall Study||37||
48644498|NCT01732783|101913773|FG002|STARTED|Overall Study||12||
48644499|NCT01732783|101913771|FG000|COMPLETED|Overall Study||29||
48644500|NCT01732783|101913772|FG001|COMPLETED|Overall Study||5||
48644501|NCT01732783|101913773|FG002|COMPLETED|Overall Study||2||
48644502|NCT01732783|101913771|FG000|NOT COMPLETED|Overall Study||135||
48644503|NCT01732783|101913772|FG001|NOT COMPLETED|Overall Study||32||
48644504|NCT01732783|101913773|FG002|NOT COMPLETED|Overall Study||10||
48644505|NCT00727064|101913774|FG000|STARTED|Overall Study||7||
48644506|NCT00727064|101913775|FG001|STARTED|Overall Study||7||
48644507|NCT00727064|101913774|FG000|COMPLETED|Overall Study||7||
48644508|NCT00727064|101913775|FG001|COMPLETED|Overall Study||7||
48644509|NCT00727064|101913774|FG000|NOT COMPLETED|Overall Study||0||
48644510|NCT00727064|101913775|FG001|NOT COMPLETED|Overall Study||0||
48644511|NCT04913675|101913776|FG000|STARTED|Main Study (Up to Week 36)||393||
48644512|NCT04913675|101913777|FG001|STARTED|Main Study (Up to Week 36)||385||
48644513|NCT04913675|101913778|FG002|STARTED|Main Study (Up to Week 36)||195||
48644514|NCT04913675|101913779|FG003|STARTED|Main Study (Up to Week 36)||0||
48644515|NCT04913675|101913776|FG000|COMPLETED|Main Study (Up to Week 36)||356||
48644516|NCT04913675|101913777|FG001|COMPLETED|Main Study (Up to Week 36)||341||
48644517|NCT04913675|101913778|FG002|COMPLETED|Main Study (Up to Week 36)||176||
48644518|NCT04913675|101913779|FG003|COMPLETED|Main Study (Up to Week 36)||0||
48644519|NCT04913675|101913776|FG000|NOT COMPLETED|Main Study (Up to Week 36)||37||
48644520|NCT04913675|101913777|FG001|NOT COMPLETED|Main Study (Up to Week 36)||44||
48644521|NCT04913675|101913778|FG002|NOT COMPLETED|Main Study (Up to Week 36)||19||
48644522|NCT04913675|101913779|FG003|NOT COMPLETED|Main Study (Up to Week 36)||0||
48644523|NCT04913675|101913776|FG000|STARTED|Safety Sub-study (Up to Week 36)||0||
48644524|NCT04913675|101913777|FG001|STARTED|Safety Sub-study (Up to Week 36)||0||
48644525|NCT04913675|101913778|FG002|STARTED|Safety Sub-study (Up to Week 36)||0||
48644526|NCT04913675|101913779|FG003|STARTED|Safety Sub-study (Up to Week 36)||81||
48644527|NCT04913675|101913776|FG000|COMPLETED|Safety Sub-study (Up to Week 36)||0||
48644528|NCT04913675|101913777|FG001|COMPLETED|Safety Sub-study (Up to Week 36)||0||
48644529|NCT04913675|101913778|FG002|COMPLETED|Safety Sub-study (Up to Week 36)||0||
48644530|NCT04913675|101913779|FG003|COMPLETED|Safety Sub-study (Up to Week 36)||80||
48644531|NCT04913675|101913776|FG000|NOT COMPLETED|Safety Sub-study (Up to Week 36)||0||
48644532|NCT04913675|101913777|FG001|NOT COMPLETED|Safety Sub-study (Up to Week 36)||0||
48644533|NCT04913675|101913778|FG002|NOT COMPLETED|Safety Sub-study (Up to Week 36)||0||
48644534|NCT04913675|101913779|FG003|NOT COMPLETED|Safety Sub-study (Up to Week 36)||1||
48644535|NCT03312907|101913780|FG000|STARTED|Overall Study||72||
48644536|NCT03312907|101913781|FG001|STARTED|Overall Study||144||
48644537|NCT03312907|101913782|FG002|STARTED|Overall Study||76||
48644538|NCT03312907|101913780|FG000|COMPLETED|Overall Study||55||
48644539|NCT03312907|101913781|FG001|COMPLETED|Overall Study||114||
48644540|NCT03312907|101913782|FG002|COMPLETED|Overall Study||57||
48644541|NCT03312907|101913780|FG000|NOT COMPLETED|Overall Study||17||
48644542|NCT03312907|101913781|FG001|NOT COMPLETED|Overall Study||30||
48644543|NCT03312907|101913782|FG002|NOT COMPLETED|Overall Study||19||
48644544|NCT04727749|101913783|FG000|STARTED|Overall Study||107||
48644545|NCT04727749|101913784|FG001|STARTED|Overall Study||104||
48644546|NCT04727749|101913783|FG000|COMPLETED|Overall Study||97||
48644547|NCT04727749|101913784|FG001|COMPLETED|Overall Study||101||
48644548|NCT04727749|101913783|FG000|NOT COMPLETED|Overall Study||10||
48644549|NCT04727749|101913784|FG001|NOT COMPLETED|Overall Study||3||
48644550|NCT03404167|101913785|FG000|STARTED|Overall Study||8||
48644551|NCT03404167|101913785|FG000|COMPLETED|Overall Study||8||
48644552|NCT03404167|101913785|FG000|NOT COMPLETED|Overall Study||0||
48644553|NCT02478671|101913786|FG000|STARTED|Overall Study||4||
48644554|NCT02478671|101913786|FG000|COMPLETED|Overall Study||4||
48644555|NCT02478671|101913786|FG000|NOT COMPLETED|Overall Study||0||
48644556|NCT01363440|101913787|FG000|STARTED|Overall Study||156||
48644557|NCT01363440|101913788|FG001|STARTED|Overall Study||156||
48644558|NCT01363440|101913789|FG002|STARTED|Overall Study||154||
48644559|NCT01363440|101913787|FG000|Participants Received Treatment|Overall Study||154||
48644560|NCT01363440|101913788|FG001|Participants Received Treatment|Overall Study||155||
48644561|NCT01363440|101913789|FG002|Participants Received Treatment|Overall Study||152||
48644562|NCT01363440|101913787|FG000|Completed Week 52|Overall Study||145||
48644563|NCT01363440|101913788|FG001|Completed Week 52|Overall Study||146||
48644564|NCT01363440|101913789|FG002|Completed Week 52|Overall Study||144||
48644565|NCT01363440|101913787|FG000|Completed Week 100|Overall Study||133||
48644566|NCT01363440|101913788|FG001|Completed Week 100|Overall Study||125||
48644567|NCT01363440|101913789|FG002|Completed Week 100|Overall Study||127||
48644568|NCT01363440|101913787|FG000|COMPLETED|Overall Study||133||
48644569|NCT01363440|101913788|FG001|COMPLETED|Overall Study||125||
48644570|NCT01363440|101913789|FG002|COMPLETED|Overall Study||127||
48644571|NCT01363440|101913787|FG000|NOT COMPLETED|Overall Study||23||
48644572|NCT01363440|101913788|FG001|NOT COMPLETED|Overall Study||31||
48644573|NCT01363440|101913789|FG002|NOT COMPLETED|Overall Study||27||
48644574|NCT00585650|101913790|FG000|STARTED|Overall Study||8||
48644575|NCT00585650|101913791|FG001|STARTED|Overall Study||12||
48644576|NCT00585650|101913790|FG000|COMPLETED|Overall Study||8||
48644577|NCT00585650|101913791|FG001|COMPLETED|Overall Study||12||
48644578|NCT00585650|101913790|FG000|NOT COMPLETED|Overall Study||0||
48644579|NCT00585650|101913791|FG001|NOT COMPLETED|Overall Study||0||
48644580|NCT00690898|101913792|FG000|STARTED|SCREENING||108||
48644581|NCT00690898|101913792|FG000|COMPLETED|SCREENING||90||
48644582|NCT00690898|101913792|FG000|NOT COMPLETED|SCREENING||18||
48644583|NCT00690898|101913792|FG000|STARTED|TREATMENT||90||
48644584|NCT00690898|101913792|FG000|COMPLETED|TREATMENT||64||
48644585|NCT00690898|101913792|FG000|NOT COMPLETED|TREATMENT||26||
48644586|NCT00299221|101913793|FG000|STARTED|Overall Study||79||
48644587|NCT00299221|101913794|FG001|STARTED|Overall Study||71||
48644588|NCT00299221|101913793|FG000|COMPLETED|Overall Study||79||
48644589|NCT00299221|101913794|FG001|COMPLETED|Overall Study||71||
48644590|NCT00299221|101913793|FG000|NOT COMPLETED|Overall Study||0||
48644591|NCT00299221|101913794|FG001|NOT COMPLETED|Overall Study||0||
48644592|NCT02293499|101916788|FG000|STARTED|Baseline - Enrollment||152||
48644593|NCT02293499|101916789|FG001|STARTED|Baseline - Enrollment||168||
48644594|NCT02293499|101916790|FG002|STARTED|Baseline - Enrollment||51||
48644595|NCT02293499|101916788|FG000|COMPLETED|Baseline - Enrollment||152||
48644596|NCT02293499|101916789|FG001|COMPLETED|Baseline - Enrollment||168||
48644597|NCT02293499|101916790|FG002|COMPLETED|Baseline - Enrollment||51||
48644598|NCT02293499|101916788|FG000|NOT COMPLETED|Baseline - Enrollment||0||
48644599|NCT02293499|101916789|FG001|NOT COMPLETED|Baseline - Enrollment||0||
48644600|NCT02293499|101916790|FG002|NOT COMPLETED|Baseline - Enrollment||0||
48644601|NCT02293499|101916788|FG000|STARTED|Training - Peer Leaders Only||0|Only the Peer leader arm of this study participated in this time point by study design.|
48644602|NCT02293499|101916789|FG001|STARTED|Training - Peer Leaders Only||0|Only the Peer leader arm of this study participated in this time point by study design.|
48644603|NCT02293499|101916790|FG002|STARTED|Training - Peer Leaders Only||51|Only the Peer leader arm of this study participated in this time point by study design.|
48644604|NCT02293499|101916788|FG000|COMPLETED|Training - Peer Leaders Only||0||
48644605|NCT02293499|101916789|FG001|COMPLETED|Training - Peer Leaders Only||0||
48644606|NCT02293499|101916790|FG002|COMPLETED|Training - Peer Leaders Only||41||
48644607|NCT02293499|101916788|FG000|NOT COMPLETED|Training - Peer Leaders Only||0||
48644608|NCT02293499|101916789|FG001|NOT COMPLETED|Training - Peer Leaders Only||0||
48644609|NCT02293499|101916790|FG002|NOT COMPLETED|Training - Peer Leaders Only||10||
48644610|NCT02293499|101916788|FG000|STARTED|Intervention - Camp||152||
48644611|NCT02293499|101916789|FG001|STARTED|Intervention - Camp||168||
48644612|NCT02293499|101916790|FG002|STARTED|Intervention - Camp||41||
48644613|NCT02293499|101916788|FG000|COMPLETED|Intervention - Camp||125||
48644614|NCT02293499|101916789|FG001|COMPLETED|Intervention - Camp||134||
48644615|NCT02293499|101916790|FG002|COMPLETED|Intervention - Camp||35||
48765135|NCT02113982|102214583|FG000|NOT COMPLETED|Stage 2: Cohort Expansion||0||
48765136|NCT02113982|102214584|FG001|NOT COMPLETED|Stage 2: Cohort Expansion||0||
48644616|NCT02293499|101916788|FG000|NOT COMPLETED|Intervention - Camp||27||
48644617|NCT02293499|101916789|FG001|NOT COMPLETED|Intervention - Camp||34||
48644618|NCT02293499|101916790|FG002|NOT COMPLETED|Intervention - Camp||6||
48644619|NCT02293499|101916788|FG000|STARTED|3 Month Follow Up||149||
48644620|NCT02293499|101916789|FG001|STARTED|3 Month Follow Up||162||
48644621|NCT02293499|101916790|FG002|STARTED|3 Month Follow Up||39||
48644622|NCT02293499|101916788|FG000|COMPLETED|3 Month Follow Up||134||
48644623|NCT02293499|101916789|FG001|COMPLETED|3 Month Follow Up||147||
48644624|NCT02293499|101916790|FG002|COMPLETED|3 Month Follow Up||29||
48644625|NCT02293499|101916788|FG000|NOT COMPLETED|3 Month Follow Up||15||
48644626|NCT02293499|101916789|FG001|NOT COMPLETED|3 Month Follow Up||15||
48644627|NCT02293499|101916790|FG002|NOT COMPLETED|3 Month Follow Up||10||
48644628|NCT02293499|101916788|FG000|STARTED|6 Month Follow Up||148||
48644629|NCT02293499|101916789|FG001|STARTED|6 Month Follow Up||162||
48644630|NCT02293499|101916790|FG002|STARTED|6 Month Follow Up||35||
48644631|NCT02293499|101916788|FG000|COMPLETED|6 Month Follow Up||131||
48644632|NCT02293499|101916789|FG001|COMPLETED|6 Month Follow Up||135||
48644633|NCT02293499|101916790|FG002|COMPLETED|6 Month Follow Up||28||
48644634|NCT02293499|101916788|FG000|NOT COMPLETED|6 Month Follow Up||17||
48644635|NCT02293499|101916789|FG001|NOT COMPLETED|6 Month Follow Up||27||
48644636|NCT02293499|101916790|FG002|NOT COMPLETED|6 Month Follow Up||7||
48644637|NCT02293499|101916788|FG000|STARTED|9 Month Follow Up||148||
48644638|NCT02293499|101916789|FG001|STARTED|9 Month Follow Up||162||
48644639|NCT02293499|101916790|FG002|STARTED|9 Month Follow Up||34||
48644640|NCT02293499|101916788|FG000|COMPLETED|9 Month Follow Up||122||
48644641|NCT02293499|101916789|FG001|COMPLETED|9 Month Follow Up||134||
48644642|NCT02293499|101916790|FG002|COMPLETED|9 Month Follow Up||30||
48644643|NCT02293499|101916788|FG000|NOT COMPLETED|9 Month Follow Up||26||
48644644|NCT02293499|101916789|FG001|NOT COMPLETED|9 Month Follow Up||28||
48644645|NCT02293499|101916790|FG002|NOT COMPLETED|9 Month Follow Up||4||
48644646|NCT02293499|101916788|FG000|STARTED|12 Month Follow Up||146||
48644647|NCT02293499|101916789|FG001|STARTED|12 Month Follow Up||162||
48644648|NCT02293499|101916790|FG002|STARTED|12 Month Follow Up||34||
48644649|NCT02293499|101916788|FG000|COMPLETED|12 Month Follow Up||120||
48644650|NCT02293499|101916789|FG001|COMPLETED|12 Month Follow Up||136||
48644651|NCT02293499|101916790|FG002|COMPLETED|12 Month Follow Up||28||
48644652|NCT02293499|101916788|FG000|NOT COMPLETED|12 Month Follow Up||26||
48644653|NCT02293499|101916789|FG001|NOT COMPLETED|12 Month Follow Up||26||
48644654|NCT02293499|101916790|FG002|NOT COMPLETED|12 Month Follow Up||6||
48644655|NCT02293499|101916788|FG000|STARTED|15 Month Follow Up||146||
48644656|NCT02293499|101916789|FG001|STARTED|15 Month Follow Up||161||
48644657|NCT02293499|101916790|FG002|STARTED|15 Month Follow Up||34||
48644658|NCT02293499|101916788|FG000|COMPLETED|15 Month Follow Up||124||
48644659|NCT02293499|101916789|FG001|COMPLETED|15 Month Follow Up||139||
48644660|NCT02293499|101916790|FG002|COMPLETED|15 Month Follow Up||27||
48644661|NCT02293499|101916788|FG000|NOT COMPLETED|15 Month Follow Up||22||
48644662|NCT02293499|101916789|FG001|NOT COMPLETED|15 Month Follow Up||22||
48644663|NCT02293499|101916790|FG002|NOT COMPLETED|15 Month Follow Up||7||
48644664|NCT00990769|101916791|FG000|STARTED|Overall Study||22||
48644665|NCT00990769|101916792|FG001|STARTED|Overall Study||18||
48644666|NCT00990769|101916791|FG000|COMPLETED|Overall Study||22||
48644667|NCT00990769|101916792|FG001|COMPLETED|Overall Study||18||
48644668|NCT00990769|101916791|FG000|NOT COMPLETED|Overall Study||0||
48644669|NCT00990769|101916792|FG001|NOT COMPLETED|Overall Study||0||
48644670|NCT04795323|101916793|FG000|STARTED|Overall Study||4|Entered set (ES)|
48644671|NCT04795323|101916794|FG001|STARTED|Overall Study||1|Entered set (ES)|
48644672|NCT04795323|101916793|FG000|COMPLETED|Overall Study||3||
48644673|NCT04795323|101916794|FG001|COMPLETED|Overall Study||1||
48644674|NCT04795323|101916793|FG000|NOT COMPLETED|Overall Study||1||
48644675|NCT04795323|101916794|FG001|NOT COMPLETED|Overall Study||0||
48644676|NCT01292538|101916795|FG000|STARTED|Overall Study||35||
48644677|NCT01292538|101916796|FG001|STARTED|Overall Study||32||
48644678|NCT01292538|101916795|FG000|COMPLETED|Overall Study||35||
48644679|NCT01292538|101916796|FG001|COMPLETED|Overall Study||32||
48644680|NCT01292538|101916795|FG000|NOT COMPLETED|Overall Study||0||
48644681|NCT01292538|101916796|FG001|NOT COMPLETED|Overall Study||0||
48765137|NCT02113982|102214585|FG002|NOT COMPLETED|Stage 2: Cohort Expansion||0||
48765138|NCT02113982|102214586|FG003|NOT COMPLETED|Stage 2: Cohort Expansion||0||
48644682|NCT01940146|101916797|FG000|STARTED|Overall Study||56||
48644683|NCT01940146|101916798|FG001|STARTED|Overall Study||55||
48765139|NCT02113982|102214587|FG004|NOT COMPLETED|Stage 2: Cohort Expansion||0||
48765140|NCT02113982|102214588|FG005|NOT COMPLETED|Stage 2: Cohort Expansion||0||
48644684|NCT01940146|101916799|FG002|STARTED|Overall Study||56||
48644685|NCT01940146|101916800|FG003|STARTED|Overall Study||55||
48644686|NCT01940146|101916797|FG000|COMPLETED|Overall Study||55||
48644687|NCT01940146|101916798|FG001|COMPLETED|Overall Study||55||
48644688|NCT01940146|101916799|FG002|COMPLETED|Overall Study||55||
48644689|NCT01940146|101916800|FG003|COMPLETED|Overall Study||53||
48644690|NCT01940146|101916797|FG000|NOT COMPLETED|Overall Study||1||
48644691|NCT01940146|101916798|FG001|NOT COMPLETED|Overall Study||0||
48644692|NCT01940146|101916799|FG002|NOT COMPLETED|Overall Study||1||
48644693|NCT01940146|101916800|FG003|NOT COMPLETED|Overall Study||2||
48644694|NCT04069520|101916801|FG000|STARTED|Overall Study||48||
48644695|NCT04069520|101916802|FG001|STARTED|Overall Study||45||
48644696|NCT04069520|101916801|FG000|COMPLETED|Overall Study||46||
48361960|NCT01084252|101214450|FG004|AT Population|Phase 2 Stage 2 (301 Weeks)||0|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361961|NCT01084252|101214451|FG005|AT Population|Phase 2 Stage 2 (301 Weeks)||0|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361962|NCT01084252|101214452|FG006|AT Population|Phase 2 Stage 2 (301 Weeks)||0|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361963|NCT01084252|101214453|FG007|AT Population|Phase 2 Stage 2 (301 Weeks)||0|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361964|NCT01084252|101214454|FG008|AT Population|Phase 2 Stage 2 (301 Weeks)||0|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361965|NCT01084252|101214455|FG009|AT Population|Phase 2 Stage 2 (301 Weeks)||0|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361966|NCT01084252|101214456|FG010|AT Population|Phase 2 Stage 2 (301 Weeks)||0|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361967|NCT01084252|101214457|FG011|AT Population|Phase 2 Stage 2 (301 Weeks)||0|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361968|NCT01084252|101214458|FG012|AT Population|Phase 2 Stage 2 (301 Weeks)||109|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361969|NCT01084252|101214459|FG013|AT Population|Phase 2 Stage 2 (301 Weeks)||55|Participants who signed informed consent \& received at least 1 dose/even incomplete of isatuximab.|
48361970|NCT01084252|101214446|FG000|COMPLETED|Phase 2 Stage 2 (301 Weeks)||0|Participants with end of treatment or death from any cause forms completed.|
48361971|NCT01084252|101214447|FG001|COMPLETED|Phase 2 Stage 2 (301 Weeks)||0|Participants with end of treatment or death from any cause forms completed.|
48361972|NCT01084252|101214448|FG002|COMPLETED|Phase 2 Stage 2 (301 Weeks)||0|Participants with end of treatment or death from any cause forms completed.|
48361973|NCT01084252|101214449|FG003|COMPLETED|Phase 2 Stage 2 (301 Weeks)||0|Participants with end of treatment or death from any cause forms completed.|
48361974|NCT01084252|101214450|FG004|COMPLETED|Phase 2 Stage 2 (301 Weeks)||0|Participants with end of treatment or death from any cause forms completed.|
48361975|NCT01084252|101214451|FG005|COMPLETED|Phase 2 Stage 2 (301 Weeks)||0|Participants with end of treatment or death from any cause forms completed.|
48361976|NCT01084252|101214452|FG006|COMPLETED|Phase 2 Stage 2 (301 Weeks)||0|Participants with end of treatment or death from any cause forms completed.|
48361977|NCT01084252|101214453|FG007|COMPLETED|Phase 2 Stage 2 (301 Weeks)||0|Participants with end of treatment or death from any cause forms completed.|
48361978|NCT01084252|101214454|FG008|COMPLETED|Phase 2 Stage 2 (301 Weeks)||0|Participants with end of treatment or death from any cause forms completed.|
48361979|NCT01084252|101214455|FG009|COMPLETED|Phase 2 Stage 2 (301 Weeks)||0|Participants with end of treatment or death from any cause forms completed.|
48361980|NCT01084252|101214456|FG010|COMPLETED|Phase 2 Stage 2 (301 Weeks)||0|Participants with end of treatment or death from any cause forms completed.|
48361981|NCT01084252|101214457|FG011|COMPLETED|Phase 2 Stage 2 (301 Weeks)||0|Participants with end of treatment or death from any cause forms completed.|
48361982|NCT01084252|101214458|FG012|COMPLETED|Phase 2 Stage 2 (301 Weeks)||109|Participants with end of treatment or death from any cause forms completed.|
48361983|NCT01084252|101214459|FG013|COMPLETED|Phase 2 Stage 2 (301 Weeks)||55|Participants with end of treatment or death from any cause forms completed.|
48361984|NCT01084252|101214446|FG000|NOT COMPLETED|Phase 2 Stage 2 (301 Weeks)||0||
48361985|NCT01084252|101214447|FG001|NOT COMPLETED|Phase 2 Stage 2 (301 Weeks)||0||
48361986|NCT01084252|101214448|FG002|NOT COMPLETED|Phase 2 Stage 2 (301 Weeks)||0||
48361987|NCT01084252|101214449|FG003|NOT COMPLETED|Phase 2 Stage 2 (301 Weeks)||0||
48361988|NCT01084252|101214450|FG004|NOT COMPLETED|Phase 2 Stage 2 (301 Weeks)||0||
48361989|NCT01084252|101214451|FG005|NOT COMPLETED|Phase 2 Stage 2 (301 Weeks)||0||
48361990|NCT01084252|101214452|FG006|NOT COMPLETED|Phase 2 Stage 2 (301 Weeks)||0||
48361991|NCT01084252|101214453|FG007|NOT COMPLETED|Phase 2 Stage 2 (301 Weeks)||0||
48361992|NCT01084252|101214454|FG008|NOT COMPLETED|Phase 2 Stage 2 (301 Weeks)||0||
48436125|NCT04828551|101403491|FG000|STARTED|Overall Study||40||
48436126|NCT04828551|101403491|FG000|COMPLETED|Overall Study||40||
48436127|NCT04828551|101403491|FG000|NOT COMPLETED|Overall Study||0||
48436128|NCT00561600|101403492|FG000|STARTED|Overall Study||130||
48436129|NCT00561600|101403493|FG001|STARTED|Overall Study||135||
48436130|NCT00561600|101403492|FG000|COMPLETED|Overall Study||112||
48436131|NCT00561600|101403493|FG001|COMPLETED|Overall Study||119||
48436132|NCT00561600|101403492|FG000|NOT COMPLETED|Overall Study||18||
48765141|NCT02113982|102214589|FG006|NOT COMPLETED|Stage 2: Cohort Expansion||0||
48765142|NCT02113982|102214590|FG007|NOT COMPLETED|Stage 2: Cohort Expansion||34||
48765143|NCT02113982|102214591|FG008|NOT COMPLETED|Stage 2: Cohort Expansion||1||
48765144|NCT02113982|102214592|FG009|NOT COMPLETED|Stage 2: Cohort Expansion||13||
48765145|NCT02113982|102214593|FG010|NOT COMPLETED|Stage 2: Cohort Expansion||10||
48765146|NCT02113982|102214594|FG011|NOT COMPLETED|Stage 2: Cohort Expansion||0||
48765147|NCT02113982|102214595|FG012|NOT COMPLETED|Stage 2: Cohort Expansion||0||
48765148|NCT02113982|102214596|FG013|NOT COMPLETED|Stage 2: Cohort Expansion||0||
48765149|NCT02113982|102214583|FG000|STARTED|Stage 3: Efficacy Cohort||0||
48765150|NCT02113982|102214584|FG001|STARTED|Stage 3: Efficacy Cohort||0||
48765151|NCT02113982|102214585|FG002|STARTED|Stage 3: Efficacy Cohort||0||
48765152|NCT02113982|102214586|FG003|STARTED|Stage 3: Efficacy Cohort||0||
48765153|NCT02113982|102214587|FG004|STARTED|Stage 3: Efficacy Cohort||0||
48765154|NCT02113982|102214588|FG005|STARTED|Stage 3: Efficacy Cohort||0||
48765155|NCT02113982|102214589|FG006|STARTED|Stage 3: Efficacy Cohort||0||
48765156|NCT02113982|102214590|FG007|STARTED|Stage 3: Efficacy Cohort||0||
48765157|NCT02113982|102214591|FG008|STARTED|Stage 3: Efficacy Cohort||0||
48644697|NCT04069520|101916802|FG001|COMPLETED|Overall Study||40||
48644698|NCT04069520|101916801|FG000|NOT COMPLETED|Overall Study||2||
48644699|NCT04069520|101916802|FG001|NOT COMPLETED|Overall Study||5||
48644700|NCT02447029|101916803|FG000|STARTED|Overall Study||72||
48644701|NCT02447029|101916804|FG001|STARTED|Overall Study||70||
48644702|NCT02447029|101916803|FG000|Treated|Overall Study||69||
48644703|NCT02447029|101916804|FG001|Treated|Overall Study||68||
48644704|NCT02447029|101916803|FG000|COMPLETED|Overall Study||69||
48644705|NCT02447029|101916804|FG001|COMPLETED|Overall Study||68||
48644706|NCT02447029|101916803|FG000|NOT COMPLETED|Overall Study||3||
48644707|NCT02447029|101916804|FG001|NOT COMPLETED|Overall Study||2||
48644708|NCT03595748|101916805|FG000|STARTED|Overall Study||101||
48644709|NCT03595748|101916806|FG001|STARTED|Overall Study||98||
48644710|NCT03595748|101916805|FG000|COMPLETED|Overall Study||62||
48644711|NCT03595748|101916806|FG001|COMPLETED|Overall Study||56||
48644712|NCT03595748|101916805|FG000|NOT COMPLETED|Overall Study||39||
48644713|NCT03595748|101916806|FG001|NOT COMPLETED|Overall Study||42||
48644714|NCT00021255|101916807|FG000|STARTED|Overall Study||1073||
48644715|NCT00021255|101916808|FG001|STARTED|Overall Study||1074||
48644716|NCT00021255|101916809|FG002|STARTED|Overall Study||1075||
48644717|NCT00021255|101916807|FG000|Treated|Overall Study||1045||
48644718|NCT00021255|101916808|FG001|Treated|Overall Study||1072||
48644719|NCT00021255|101916809|FG002|Treated|Overall Study||1057||
48644720|NCT00021255|101916807|FG000|Safety Population|Overall Study||1018||
48644721|NCT00021255|101916808|FG001|Safety Population|Overall Study||1100||
48644722|NCT00021255|101916809|FG002|Safety Population|Overall Study||1056||
48644723|NCT00021255|101916807|FG000|COMPLETED|Overall Study||952||
48644724|NCT00021255|101916808|FG001|COMPLETED|Overall Study||804||
48644725|NCT00021255|101916809|FG002|COMPLETED|Overall Study||926||
48644726|NCT00021255|101916807|FG000|NOT COMPLETED|Overall Study||121||
48644727|NCT00021255|101916808|FG001|NOT COMPLETED|Overall Study||270||
48644728|NCT00021255|101916809|FG002|NOT COMPLETED|Overall Study||149||
48644729|NCT00114777|101916810|FG000|STARTED|Randomization to Month 36||184||
48644730|NCT00114777|101916811|FG001|STARTED|Randomization to Month 36||175||
48644731|NCT00114777|101916812|FG002|STARTED|Randomization to Month 36||184||
48644732|NCT00114777|101916810|FG000|COMPLETED|Randomization to Month 36||109||
48644733|NCT00114777|101916811|FG001|COMPLETED|Randomization to Month 36||114||
48644734|NCT00114777|101916812|FG002|COMPLETED|Randomization to Month 36||100||
48644735|NCT00114777|101916810|FG000|NOT COMPLETED|Randomization to Month 36||75||
48644736|NCT00114777|101916811|FG001|NOT COMPLETED|Randomization to Month 36||61||
48644737|NCT00114777|101916812|FG002|NOT COMPLETED|Randomization to Month 36||84||
48644738|NCT00114777|101916810|FG000|STARTED|Long-Term Extension to Month 84||104||
48644739|NCT00114777|101916811|FG001|STARTED|Long-Term Extension to Month 84||113||
48644740|NCT00114777|101916812|FG002|STARTED|Long-Term Extension to Month 84||87||
48361993|NCT01084252|101214455|FG009|NOT COMPLETED|Phase 2 Stage 2 (301 Weeks)||0||
48361994|NCT01084252|101214456|FG010|NOT COMPLETED|Phase 2 Stage 2 (301 Weeks)||0||
48361995|NCT01084252|101214457|FG011|NOT COMPLETED|Phase 2 Stage 2 (301 Weeks)||0||
48644741|NCT00114777|101916810|FG000|COMPLETED|Long-Term Extension to Month 84||74||
48644742|NCT00114777|101916811|FG001|COMPLETED|Long-Term Extension to Month 84||84||
48644743|NCT00114777|101916812|FG002|COMPLETED|Long-Term Extension to Month 84||57||
48644744|NCT00114777|101916810|FG000|NOT COMPLETED|Long-Term Extension to Month 84||30||
48644745|NCT00114777|101916811|FG001|NOT COMPLETED|Long-Term Extension to Month 84||29||
48644746|NCT00114777|101916812|FG002|NOT COMPLETED|Long-Term Extension to Month 84||30||
48644747|NCT01118091|101916813|FG000|STARTED|Overall Study||7||
48644748|NCT01118091|101916814|FG001|STARTED|Overall Study||5||
48644749|NCT01118091|101916813|FG000|COMPLETED|Overall Study||7||
48644750|NCT01118091|101916814|FG001|COMPLETED|Overall Study||5||
48644751|NCT01118091|101916813|FG000|NOT COMPLETED|Overall Study||0||
48644752|NCT01118091|101916814|FG001|NOT COMPLETED|Overall Study||0||
48644753|NCT01500096|101916815|FG000|STARTED|Overall Study||32||
48644754|NCT01500096|101916816|FG001|STARTED|Overall Study||17||
48644755|NCT01500096|101916817|FG002|STARTED|Overall Study||31||
48644756|NCT01500096|101916818|FG003|STARTED|Overall Study||16||
48361996|NCT01084252|101214458|FG012|NOT COMPLETED|Phase 2 Stage 2 (301 Weeks)||1||
48361997|NCT01084252|101214459|FG013|NOT COMPLETED|Phase 2 Stage 2 (301 Weeks)||0||
48361998|NCT00336492|101214460|FG000|STARTED|Overall Study||15||
48644757|NCT01500096|101916815|FG000|COMPLETED|Overall Study||31||
48644758|NCT01500096|101916816|FG001|COMPLETED|Overall Study||17||
48644759|NCT01500096|101916817|FG002|COMPLETED|Overall Study||31||
48644760|NCT01500096|101916818|FG003|COMPLETED|Overall Study||14||
48644761|NCT01500096|101916815|FG000|NOT COMPLETED|Overall Study||1||
48644762|NCT01500096|101916816|FG001|NOT COMPLETED|Overall Study||0||
48644763|NCT01500096|101916817|FG002|NOT COMPLETED|Overall Study||0||
48644764|NCT01500096|101916818|FG003|NOT COMPLETED|Overall Study||2||
48644765|NCT02513199|101916819|FG000|STARTED|Treatment||32||
48644766|NCT02513199|101916819|FG000|COMPLETED|Treatment||30||
48644767|NCT02513199|101916819|FG000|NOT COMPLETED|Treatment||2||
48644768|NCT02513199|101916819|FG000|STARTED|Follow-Up||30||
48644769|NCT02513199|101916819|FG000|COMPLETED|Follow-Up||19||
48644770|NCT02513199|101916819|FG000|NOT COMPLETED|Follow-Up||11||
48644771|NCT01732692|101916820|FG000|STARTED|Overall Study||70||
48644772|NCT01732692|101916821|FG001|STARTED|Overall Study||70||
48644773|NCT01732692|101916820|FG000|COMPLETED|Overall Study||70||
48644774|NCT01732692|101916821|FG001|COMPLETED|Overall Study||69||
48644775|NCT01732692|101916820|FG000|NOT COMPLETED|Overall Study||0||
48644776|NCT01732692|101916821|FG001|NOT COMPLETED|Overall Study||1||
48644777|NCT00441896|101916822|FG000|STARTED|Overall Study||6||
48644778|NCT00441896|101916823|FG001|STARTED|Overall Study||3||
48644779|NCT00441896|101916824|FG002|STARTED|Overall Study||7||
48644780|NCT00441896|101916825|FG003|STARTED|Overall Study||4||
48644781|NCT00441896|101916826|FG004|STARTED|Overall Study||12||
48644782|NCT00441896|101916827|FG005|STARTED|Overall Study||3||
48644783|NCT00441896|101916828|FG006|STARTED|Overall Study||7||
48644784|NCT00441896|101916829|FG007|STARTED|Overall Study||5||
48644785|NCT00441896|101916830|FG008|STARTED|Overall Study||6||
48644786|NCT00441896|101916831|FG009|STARTED|Overall Study||4||
48644787|NCT00441896|101916822|FG000|COMPLETED|Overall Study||6||
48644788|NCT00441896|101916823|FG001|COMPLETED|Overall Study||3||
48644789|NCT00441896|101916824|FG002|COMPLETED|Overall Study||7||
48644790|NCT00441896|101916825|FG003|COMPLETED|Overall Study||3||
48644791|NCT00441896|101916826|FG004|COMPLETED|Overall Study||11||
48644792|NCT00441896|101916827|FG005|COMPLETED|Overall Study||3||
48644793|NCT00441896|101916828|FG006|COMPLETED|Overall Study||7||
48644794|NCT00441896|101916829|FG007|COMPLETED|Overall Study||5||
48644795|NCT00441896|101916830|FG008|COMPLETED|Overall Study||6||
48644796|NCT00441896|101916831|FG009|COMPLETED|Overall Study||4||
48644797|NCT00441896|101916822|FG000|NOT COMPLETED|Overall Study||0||
48644798|NCT00441896|101916823|FG001|NOT COMPLETED|Overall Study||0||
48644799|NCT00441896|101916824|FG002|NOT COMPLETED|Overall Study||0||
48644800|NCT00441896|101916825|FG003|NOT COMPLETED|Overall Study||1||
48644801|NCT00441896|101916826|FG004|NOT COMPLETED|Overall Study||1||
48644802|NCT00441896|101916827|FG005|NOT COMPLETED|Overall Study||0||
48644803|NCT00441896|101916828|FG006|NOT COMPLETED|Overall Study||0||
48644804|NCT00441896|101916829|FG007|NOT COMPLETED|Overall Study||0||
48644805|NCT00441896|101916830|FG008|NOT COMPLETED|Overall Study||0||
48644806|NCT00441896|101916831|FG009|NOT COMPLETED|Overall Study||0||
48644807|NCT01866592|101916832|FG000|STARTED|Overall Study||81||
48644808|NCT01866592|101916832|FG000|COMPLETED|Overall Study||58||
48644809|NCT01866592|101916832|FG000|NOT COMPLETED|Overall Study||23||
48644810|NCT00986232|101916833|FG000|STARTED|Overall Study||387||
48644811|NCT00986232|101916834|FG001|STARTED|Overall Study||393||
48644812|NCT00986232|101916835|FG002|STARTED|Overall Study||381||
48644813|NCT00986232|101916836|FG003|STARTED|Overall Study||390||
48644814|NCT00986232|101916833|FG000|Vaccination Visit 1|Overall Study||387||
48644815|NCT00986232|101916834|FG001|Vaccination Visit 1|Overall Study||393||
48644816|NCT00986232|101916835|FG002|Vaccination Visit 1|Overall Study||381||
48644817|NCT00986232|101916836|FG003|Vaccination Visit 1|Overall Study||390||
48644818|NCT00986232|101916833|FG000|Vaccination Visit 2|Overall Study||360||
48644819|NCT00986232|101916834|FG001|Vaccination Visit 2|Overall Study||365||
48644820|NCT00986232|101916835|FG002|Vaccination Visit 2|Overall Study||360||
48644821|NCT00986232|101916836|FG003|Vaccination Visit 2|Overall Study||0||
48644822|NCT00986232|101916833|FG000|COMPLETED|Overall Study||336||
48644823|NCT00986232|101916834|FG001|COMPLETED|Overall Study||343||
48644824|NCT00986232|101916835|FG002|COMPLETED|Overall Study||346||
48644825|NCT00986232|101916836|FG003|COMPLETED|Overall Study||370||
48644826|NCT00986232|101916833|FG000|NOT COMPLETED|Overall Study||51||
48644827|NCT00986232|101916834|FG001|NOT COMPLETED|Overall Study||50||
48644828|NCT00986232|101916835|FG002|NOT COMPLETED|Overall Study||35||
48644829|NCT00986232|101916836|FG003|NOT COMPLETED|Overall Study||20||
48644830|NCT01851369|101916837|FG000|STARTED|Phase I Dose Escalation||0||
48644831|NCT01851369|101916838|FG001|STARTED|Phase I Dose Escalation||0||
48644832|NCT01851369|101916839|FG002|STARTED|Phase I Dose Escalation||3||
48644833|NCT01851369|101916840|FG003|STARTED|Phase I Dose Escalation||6||
48644834|NCT01851369|101916841|FG004|STARTED|Phase I Dose Escalation||4||
48644835|NCT01851369|101916842|FG005|STARTED|Phase I Dose Escalation||8||
48644836|NCT01851369|101916843|FG006|STARTED|Phase I Dose Escalation||3||
48644837|NCT01851369|101916844|FG007|STARTED|Phase I Dose Escalation||3||
48644838|NCT01851369|101916845|FG008|STARTED|Phase I Dose Escalation||5||
48644839|NCT01851369|101916846|FG009|STARTED|Phase I Dose Escalation||3||
48644840|NCT01851369|101916847|FG010|STARTED|Phase I Dose Escalation||0||
48644841|NCT01851369|101916848|FG011|STARTED|Phase I Dose Escalation||0||
48644842|NCT01851369|101916849|FG012|STARTED|Phase I Dose Escalation||0||
48644843|NCT01851369|101916837|FG000|COMPLETED|Phase I Dose Escalation||0||
48644844|NCT01851369|101916838|FG001|COMPLETED|Phase I Dose Escalation||0||
48644845|NCT01851369|101916839|FG002|COMPLETED|Phase I Dose Escalation||3||
48644846|NCT01851369|101916840|FG003|COMPLETED|Phase I Dose Escalation||6||
48644847|NCT01851369|101916841|FG004|COMPLETED|Phase I Dose Escalation||4||
48644848|NCT01851369|101916842|FG005|COMPLETED|Phase I Dose Escalation||7||
48644849|NCT01851369|101916843|FG006|COMPLETED|Phase I Dose Escalation||3||
48644850|NCT01851369|101916844|FG007|COMPLETED|Phase I Dose Escalation||3||
48644851|NCT01851369|101916845|FG008|COMPLETED|Phase I Dose Escalation||5||
48644852|NCT01851369|101916846|FG009|COMPLETED|Phase I Dose Escalation||3||
48644853|NCT01851369|101916847|FG010|COMPLETED|Phase I Dose Escalation||0||
48644854|NCT01851369|101916848|FG011|COMPLETED|Phase I Dose Escalation||0||
48644855|NCT01851369|101916849|FG012|COMPLETED|Phase I Dose Escalation||0||
48644856|NCT01851369|101916837|FG000|NOT COMPLETED|Phase I Dose Escalation||0||
48644857|NCT01851369|101916838|FG001|NOT COMPLETED|Phase I Dose Escalation||0||
48644858|NCT01851369|101916839|FG002|NOT COMPLETED|Phase I Dose Escalation||0||
48644859|NCT01851369|101916840|FG003|NOT COMPLETED|Phase I Dose Escalation||0||
48644860|NCT01851369|101916841|FG004|NOT COMPLETED|Phase I Dose Escalation||0||
48644861|NCT01851369|101916842|FG005|NOT COMPLETED|Phase I Dose Escalation||1||
48644862|NCT01851369|101916843|FG006|NOT COMPLETED|Phase I Dose Escalation||0||
48644863|NCT01851369|101916844|FG007|NOT COMPLETED|Phase I Dose Escalation||0||
48644864|NCT01851369|101916845|FG008|NOT COMPLETED|Phase I Dose Escalation||0||
48644865|NCT01851369|101916846|FG009|NOT COMPLETED|Phase I Dose Escalation||0||
48644866|NCT01851369|101916847|FG010|NOT COMPLETED|Phase I Dose Escalation||0||
48644867|NCT01851369|101916848|FG011|NOT COMPLETED|Phase I Dose Escalation||0||
48644868|NCT01851369|101916849|FG012|NOT COMPLETED|Phase I Dose Escalation||0||
48644869|NCT01851369|101916837|FG000|STARTED|Phase I Maximum Tolerated Dose Expansion||0||
48644870|NCT01851369|101916838|FG001|STARTED|Phase I Maximum Tolerated Dose Expansion||0||
48644871|NCT01851369|101916839|FG002|STARTED|Phase I Maximum Tolerated Dose Expansion||0||
48644872|NCT01851369|101916840|FG003|STARTED|Phase I Maximum Tolerated Dose Expansion||0||
48644873|NCT01851369|101916841|FG004|STARTED|Phase I Maximum Tolerated Dose Expansion||0||
48644874|NCT01851369|101916842|FG005|STARTED|Phase I Maximum Tolerated Dose Expansion||0||
48644875|NCT01851369|101916843|FG006|STARTED|Phase I Maximum Tolerated Dose Expansion||0||
48644876|NCT01851369|101916844|FG007|STARTED|Phase I Maximum Tolerated Dose Expansion||7||
48644877|NCT01851369|101916845|FG008|STARTED|Phase I Maximum Tolerated Dose Expansion||10||
48644878|NCT01851369|101916846|FG009|STARTED|Phase I Maximum Tolerated Dose Expansion||0||
48644879|NCT01851369|101916847|FG010|STARTED|Phase I Maximum Tolerated Dose Expansion||0||
48644880|NCT01851369|101916848|FG011|STARTED|Phase I Maximum Tolerated Dose Expansion||0||
48644881|NCT01851369|101916849|FG012|STARTED|Phase I Maximum Tolerated Dose Expansion||0||
48644882|NCT01851369|101916837|FG000|COMPLETED|Phase I Maximum Tolerated Dose Expansion||0||
48644883|NCT01851369|101916838|FG001|COMPLETED|Phase I Maximum Tolerated Dose Expansion||0||
48644884|NCT01851369|101916839|FG002|COMPLETED|Phase I Maximum Tolerated Dose Expansion||0||
48644885|NCT01851369|101916840|FG003|COMPLETED|Phase I Maximum Tolerated Dose Expansion||0||
48644886|NCT01851369|101916841|FG004|COMPLETED|Phase I Maximum Tolerated Dose Expansion||0||
48644887|NCT01851369|101916842|FG005|COMPLETED|Phase I Maximum Tolerated Dose Expansion||0||
48644888|NCT01851369|101916843|FG006|COMPLETED|Phase I Maximum Tolerated Dose Expansion||0||
48644889|NCT01851369|101916844|FG007|COMPLETED|Phase I Maximum Tolerated Dose Expansion||7||
48644890|NCT01851369|101916845|FG008|COMPLETED|Phase I Maximum Tolerated Dose Expansion||10||
48644891|NCT01851369|101916846|FG009|COMPLETED|Phase I Maximum Tolerated Dose Expansion||0||
48644892|NCT01851369|101916847|FG010|COMPLETED|Phase I Maximum Tolerated Dose Expansion||0||
48644893|NCT01851369|101916848|FG011|COMPLETED|Phase I Maximum Tolerated Dose Expansion||0||
48644894|NCT01851369|101916849|FG012|COMPLETED|Phase I Maximum Tolerated Dose Expansion||0||
48644895|NCT01851369|101916837|FG000|NOT COMPLETED|Phase I Maximum Tolerated Dose Expansion||0||
48644896|NCT01851369|101916838|FG001|NOT COMPLETED|Phase I Maximum Tolerated Dose Expansion||0||
48644897|NCT01851369|101916839|FG002|NOT COMPLETED|Phase I Maximum Tolerated Dose Expansion||0||
48644898|NCT01851369|101916840|FG003|NOT COMPLETED|Phase I Maximum Tolerated Dose Expansion||0||
48644899|NCT01851369|101916841|FG004|NOT COMPLETED|Phase I Maximum Tolerated Dose Expansion||0||
48644900|NCT01851369|101916842|FG005|NOT COMPLETED|Phase I Maximum Tolerated Dose Expansion||0||
48644901|NCT01851369|101916843|FG006|NOT COMPLETED|Phase I Maximum Tolerated Dose Expansion||0||
48644902|NCT01851369|101916844|FG007|NOT COMPLETED|Phase I Maximum Tolerated Dose Expansion||0||
48644903|NCT01851369|101916845|FG008|NOT COMPLETED|Phase I Maximum Tolerated Dose Expansion||0||
48644904|NCT01851369|101916846|FG009|NOT COMPLETED|Phase I Maximum Tolerated Dose Expansion||0||
48644905|NCT01851369|101916847|FG010|NOT COMPLETED|Phase I Maximum Tolerated Dose Expansion||0||
48765158|NCT02113982|102214592|FG009|STARTED|Stage 3: Efficacy Cohort||0||
48765159|NCT02113982|102214593|FG010|STARTED|Stage 3: Efficacy Cohort||0||
48765160|NCT02113982|102214594|FG011|STARTED|Stage 3: Efficacy Cohort||13||
48765161|NCT02113982|102214595|FG012|STARTED|Stage 3: Efficacy Cohort||0||
48765162|NCT02113982|102214596|FG013|STARTED|Stage 3: Efficacy Cohort||0||
48765163|NCT02113982|102214583|FG000|COMPLETED|Stage 3: Efficacy Cohort||0||
48765164|NCT02113982|102214584|FG001|COMPLETED|Stage 3: Efficacy Cohort||0||
48765165|NCT02113982|102214585|FG002|COMPLETED|Stage 3: Efficacy Cohort||0||
48765166|NCT02113982|102214586|FG003|COMPLETED|Stage 3: Efficacy Cohort||0||
48765167|NCT02113982|102214587|FG004|COMPLETED|Stage 3: Efficacy Cohort||0||
48765168|NCT02113982|102214588|FG005|COMPLETED|Stage 3: Efficacy Cohort||0||
48765169|NCT02113982|102214589|FG006|COMPLETED|Stage 3: Efficacy Cohort||0||
48765170|NCT02113982|102214590|FG007|COMPLETED|Stage 3: Efficacy Cohort||0||
48765171|NCT02113982|102214591|FG008|COMPLETED|Stage 3: Efficacy Cohort||0||
48644906|NCT01851369|101916848|FG011|NOT COMPLETED|Phase I Maximum Tolerated Dose Expansion||0||
48644907|NCT01851369|101916849|FG012|NOT COMPLETED|Phase I Maximum Tolerated Dose Expansion||0||
48644908|NCT01851369|101916837|FG000|STARTED|Phase II||0||
48644909|NCT01851369|101916838|FG001|STARTED|Phase II||0||
48644910|NCT01851369|101916839|FG002|STARTED|Phase II||0||
48644911|NCT01851369|101916840|FG003|STARTED|Phase II||0||
48644912|NCT01851369|101916841|FG004|STARTED|Phase II||0||
48644913|NCT01851369|101916842|FG005|STARTED|Phase II||0||
48644914|NCT01851369|101916843|FG006|STARTED|Phase II||0||
48644915|NCT01851369|101916844|FG007|STARTED|Phase II||0||
48644916|NCT01851369|101916845|FG008|STARTED|Phase II||0||
48644917|NCT01851369|101916846|FG009|STARTED|Phase II||0||
48644918|NCT01851369|101916847|FG010|STARTED|Phase II||16||
48644919|NCT01851369|101916848|FG011|STARTED|Phase II||16||
48644920|NCT01851369|101916849|FG012|STARTED|Phase II||9||
48644921|NCT01851369|101916837|FG000|COMPLETED|Phase II||0||
48644922|NCT01851369|101916838|FG001|COMPLETED|Phase II||0||
48644923|NCT01851369|101916839|FG002|COMPLETED|Phase II||0||
48644924|NCT01851369|101916840|FG003|COMPLETED|Phase II||0||
48644925|NCT01851369|101916841|FG004|COMPLETED|Phase II||0||
48644926|NCT01851369|101916842|FG005|COMPLETED|Phase II||0||
48644927|NCT01851369|101916843|FG006|COMPLETED|Phase II||0||
48644928|NCT01851369|101916844|FG007|COMPLETED|Phase II||0||
48644929|NCT01851369|101916845|FG008|COMPLETED|Phase II||0||
48644930|NCT01851369|101916846|FG009|COMPLETED|Phase II||0||
48644931|NCT01851369|101916847|FG010|COMPLETED|Phase II||16||
48644932|NCT01851369|101916848|FG011|COMPLETED|Phase II||16||
48644933|NCT01851369|101916849|FG012|COMPLETED|Phase II||9||
48644934|NCT01851369|101916837|FG000|NOT COMPLETED|Phase II||0||
48644935|NCT01851369|101916838|FG001|NOT COMPLETED|Phase II||0||
48644936|NCT01851369|101916839|FG002|NOT COMPLETED|Phase II||0||
48644937|NCT01851369|101916840|FG003|NOT COMPLETED|Phase II||0||
48644938|NCT01851369|101916841|FG004|NOT COMPLETED|Phase II||0||
48644939|NCT01851369|101916842|FG005|NOT COMPLETED|Phase II||0||
48644940|NCT01851369|101916843|FG006|NOT COMPLETED|Phase II||0||
48644941|NCT01851369|101916844|FG007|NOT COMPLETED|Phase II||0||
48644942|NCT01851369|101916845|FG008|NOT COMPLETED|Phase II||0||
48644943|NCT01851369|101916846|FG009|NOT COMPLETED|Phase II||0||
48644944|NCT01851369|101916847|FG010|NOT COMPLETED|Phase II||0||
48644945|NCT01851369|101916848|FG011|NOT COMPLETED|Phase II||0||
48644946|NCT01851369|101916849|FG012|NOT COMPLETED|Phase II||0||
48644947|NCT02606253|101916850|FG000|STARTED|Overall Study||20||
48644948|NCT02606253|101916851|FG001|STARTED|Overall Study||20||
48644949|NCT02606253|101916852|FG002|STARTED|Overall Study||20||
48644950|NCT02606253|101916850|FG000|COMPLETED|Overall Study||15||
48644951|NCT02606253|101916851|FG001|COMPLETED|Overall Study||18||
48644952|NCT02606253|101916852|FG002|COMPLETED|Overall Study||20||
48644953|NCT02606253|101916850|FG000|NOT COMPLETED|Overall Study||5||
48644954|NCT02606253|101916851|FG001|NOT COMPLETED|Overall Study||2||
48644955|NCT02606253|101916852|FG002|NOT COMPLETED|Overall Study||0||
48644956|NCT01933425|101916853|FG000|STARTED|Overall Study||7||
48644957|NCT01933425|101916854|FG001|STARTED|Overall Study||7||
48644958|NCT01933425|101916853|FG000|COMPLETED|Overall Study||7||
48644959|NCT01933425|101916854|FG001|COMPLETED|Overall Study||7||
48644960|NCT01933425|101916853|FG000|NOT COMPLETED|Overall Study||0||
48644961|NCT01933425|101916854|FG001|NOT COMPLETED|Overall Study||0||
48644962|NCT03520387|101916855|FG000|STARTED|Pre-Randomization||16||
48644963|NCT03520387|101916856|FG001|STARTED|Pre-Randomization||0||
48644964|NCT03520387|101916857|FG002|STARTED|Pre-Randomization||0||
48644965|NCT03520387|101916858|FG003|STARTED|Pre-Randomization||0||
48644966|NCT03520387|101916859|FG004|STARTED|Pre-Randomization||0||
48644967|NCT03520387|101916855|FG000|COMPLETED|Pre-Randomization||13||
48644968|NCT03520387|101916856|FG001|COMPLETED|Pre-Randomization||0||
48644969|NCT03520387|101916857|FG002|COMPLETED|Pre-Randomization||0||
48644970|NCT03520387|101916858|FG003|COMPLETED|Pre-Randomization||0||
48644971|NCT03520387|101916859|FG004|COMPLETED|Pre-Randomization||0||
48644972|NCT03520387|101916855|FG000|NOT COMPLETED|Pre-Randomization||3||
48644973|NCT03520387|101916856|FG001|NOT COMPLETED|Pre-Randomization||0||
48644974|NCT03520387|101916857|FG002|NOT COMPLETED|Pre-Randomization||0||
48644975|NCT03520387|101916858|FG003|NOT COMPLETED|Pre-Randomization||0||
48644976|NCT03520387|101916859|FG004|NOT COMPLETED|Pre-Randomization||0||
48644977|NCT03520387|101916855|FG000|STARTED|Randomized||0||
48644978|NCT03520387|101916856|FG001|STARTED|Randomized||4||
48644979|NCT03520387|101916857|FG002|STARTED|Randomized||3||
48644980|NCT03520387|101916858|FG003|STARTED|Randomized||3||
48644981|NCT03520387|101916859|FG004|STARTED|Randomized||3||
48644982|NCT03520387|101916855|FG000|COMPLETED|Randomized||0||
48644983|NCT03520387|101916856|FG001|COMPLETED|Randomized||4||
48644984|NCT03520387|101916857|FG002|COMPLETED|Randomized||3||
48644985|NCT03520387|101916858|FG003|COMPLETED|Randomized||3||
48644986|NCT03520387|101916859|FG004|COMPLETED|Randomized||3||
48644987|NCT03520387|101916855|FG000|NOT COMPLETED|Randomized||0||
48644988|NCT03520387|101916856|FG001|NOT COMPLETED|Randomized||0||
48644989|NCT03520387|101916857|FG002|NOT COMPLETED|Randomized||0||
48644990|NCT03520387|101916858|FG003|NOT COMPLETED|Randomized||0||
48644991|NCT03520387|101916859|FG004|NOT COMPLETED|Randomized||0||
48644992|NCT01033071|101916860|FG000|STARTED|Overall Study||355||
48644993|NCT01033071|101916861|FG001|STARTED|Overall Study||352||
48644994|NCT01033071|101916862|FG002|STARTED|Overall Study||364||
48644995|NCT01033071|101916860|FG000|COMPLETED|Overall Study||300||
48644996|NCT01033071|101916861|FG001|COMPLETED|Overall Study||275||
48644997|NCT01033071|101916862|FG002|COMPLETED|Overall Study||317||
48644998|NCT01033071|101916860|FG000|NOT COMPLETED|Overall Study||55||
48644999|NCT01033071|101916861|FG001|NOT COMPLETED|Overall Study||77||
48645000|NCT01033071|101916862|FG002|NOT COMPLETED|Overall Study||47||
48645001|NCT02068599|101916863|FG000|STARTED|Overall Study||130||
48645002|NCT02068599|101916864|FG001|STARTED|Overall Study||129||
48645003|NCT02068599|101916865|FG002|STARTED|Overall Study||130||
48645004|NCT02068599|101916863|FG000|Safety Analysis Set|Overall Study||129||
48645005|NCT02068599|101916864|FG001|Safety Analysis Set|Overall Study||128||
48645006|NCT02068599|101916865|FG002|Safety Analysis Set|Overall Study||130||
48645007|NCT02068599|101916863|FG000|Full Analysis Set|Overall Study||129||
48645008|NCT02068599|101916864|FG001|Full Analysis Set|Overall Study||128||
48645009|NCT02068599|101916865|FG002|Full Analysis Set|Overall Study||130||
48645010|NCT02068599|101916863|FG000|COMPLETED|Overall Study||119||
48645011|NCT02068599|101916864|FG001|COMPLETED|Overall Study||119||
48645012|NCT02068599|101916865|FG002|COMPLETED|Overall Study||117||
48645013|NCT02068599|101916863|FG000|NOT COMPLETED|Overall Study||11||
48645014|NCT02068599|101916864|FG001|NOT COMPLETED|Overall Study||10||
48645015|NCT02068599|101916865|FG002|NOT COMPLETED|Overall Study||13||
48645016|NCT00726557|101916866|FG000|STARTED|Overall Study||246||
48645017|NCT00726557|101916866|FG000|COMPLETED|Overall Study||118||
48645018|NCT00726557|101916866|FG000|NOT COMPLETED|Overall Study||128||
48645019|NCT03723070|101916867|FG000|STARTED|Overall Study||88||
48645020|NCT03723070|101916867|FG000|COMPLETED|Overall Study||79||
48645021|NCT03723070|101916867|FG000|NOT COMPLETED|Overall Study||9||
48645022|NCT04368910|101916868|FG000|STARTED|Overall Study||15||
48645023|NCT04368910|101916869|FG001|STARTED|Overall Study||15||
48645024|NCT04368910|101916868|FG000|COMPLETED|Overall Study||15||
48645025|NCT04368910|101916869|FG001|COMPLETED|Overall Study||15||
48645026|NCT04368910|101916868|FG000|NOT COMPLETED|Overall Study||0||
48645027|NCT04368910|101916869|FG001|NOT COMPLETED|Overall Study||0||
48645028|NCT03274661|101916870|FG000|STARTED|Overall Study||52||
48645029|NCT03274661|101916870|FG000|COMPLETED|Overall Study||52||
48645030|NCT03274661|101916870|FG000|NOT COMPLETED|Overall Study||0||
48645031|NCT00927082|101916871|FG000|STARTED|Overall Study||91||
48645032|NCT00927082|101916872|FG001|STARTED|Overall Study||87||
48645033|NCT00927082|101916873|FG002|STARTED|Overall Study||108||
48645034|NCT00927082|101916874|FG003|STARTED|Overall Study||97||
48645035|NCT00927082|101916871|FG000|COMPLETED|Overall Study||79||
48645036|NCT00927082|101916872|FG001|COMPLETED|Overall Study||77||
48645037|NCT00927082|101916873|FG002|COMPLETED|Overall Study||86||
48645038|NCT00927082|101916874|FG003|COMPLETED|Overall Study||78||
48645039|NCT00927082|101916871|FG000|NOT COMPLETED|Overall Study||12||
48645040|NCT00927082|101916872|FG001|NOT COMPLETED|Overall Study||10||
48645041|NCT00927082|101916873|FG002|NOT COMPLETED|Overall Study||22||
48645042|NCT00927082|101916874|FG003|NOT COMPLETED|Overall Study||19||
48645043|NCT04602000|101916875|FG000|STARTED|Overall Study||105||
48645044|NCT04602000|101916876|FG001|STARTED|Overall Study||111||
48645045|NCT04602000|101916877|FG002|STARTED|Overall Study||111||
48645046|NCT04602000|101916878|FG003|STARTED|Overall Study||656||
48645047|NCT04602000|101916879|FG004|STARTED|Overall Study||659||
48645048|NCT04602000|101916875|FG000|COMPLETED|Overall Study||97||
48645049|NCT04602000|101916876|FG001|COMPLETED|Overall Study||103||
48645050|NCT04602000|101916877|FG002|COMPLETED|Overall Study||105||
48645051|NCT04602000|101916878|FG003|COMPLETED|Overall Study||618||
48645052|NCT04602000|101916879|FG004|COMPLETED|Overall Study||608||
48645053|NCT04602000|101916875|FG000|NOT COMPLETED|Overall Study||8||
48645054|NCT04602000|101916876|FG001|NOT COMPLETED|Overall Study||8||
48645055|NCT04602000|101916877|FG002|NOT COMPLETED|Overall Study||6||
48645056|NCT04602000|101916878|FG003|NOT COMPLETED|Overall Study||38||
48645057|NCT04602000|101916879|FG004|NOT COMPLETED|Overall Study||51||
48645058|NCT04913636|101916880|FG000|STARTED|Overall Study||18||
48645059|NCT04913636|101916881|FG001|STARTED|Overall Study||20||
48645060|NCT04913636|101916880|FG000|COMPLETED|Overall Study||18||
48645061|NCT04913636|101916881|FG001|COMPLETED|Overall Study||20||
48645062|NCT04913636|101916880|FG000|NOT COMPLETED|Overall Study||0||
48645063|NCT04913636|101916881|FG001|NOT COMPLETED|Overall Study||0||
48645064|NCT00368849|101916882|FG000|STARTED|Overall Study||10||
48645065|NCT00368849|101916883|FG001|STARTED|Overall Study||10||
48765172|NCT02113982|102214592|FG009|COMPLETED|Stage 3: Efficacy Cohort||0||
48645066|NCT00368849|101916882|FG000|COMPLETED|Overall Study||10||
48645067|NCT00368849|101916883|FG001|COMPLETED|Overall Study||8||
48645068|NCT00368849|101916882|FG000|NOT COMPLETED|Overall Study||0||
48645069|NCT00368849|101916883|FG001|NOT COMPLETED|Overall Study||2||
48645070|NCT00442689|101916884|FG000|STARTED|Overall Study||21||
48645071|NCT00442689|101916885|FG001|STARTED|Overall Study||24||
48645072|NCT00442689|101916886|FG002|STARTED|Overall Study||22||
48645073|NCT00442689|101916884|FG000|COMPLETED|Overall Study||11||
48645074|NCT00442689|101916885|FG001|COMPLETED|Overall Study||13||
48645075|NCT00442689|101916886|FG002|COMPLETED|Overall Study||13||
48645076|NCT00442689|101916884|FG000|NOT COMPLETED|Overall Study||10||
48645077|NCT00442689|101916885|FG001|NOT COMPLETED|Overall Study||11||
48645078|NCT00442689|101916886|FG002|NOT COMPLETED|Overall Study||9||
48645079|NCT05161936|101916887|FG000|STARTED|Overall Study||1||
48645080|NCT05161936|101916888|FG001|STARTED|Overall Study||0||
48645081|NCT05161936|101916889|FG002|STARTED|Overall Study||1||
48645082|NCT05161936|101916887|FG000|COMPLETED|Overall Study||0||
48645083|NCT05161936|101916888|FG001|COMPLETED|Overall Study||0||
48645084|NCT05161936|101916889|FG002|COMPLETED|Overall Study||0||
48645085|NCT05161936|101916887|FG000|NOT COMPLETED|Overall Study||1||
48645086|NCT05161936|101916888|FG001|NOT COMPLETED|Overall Study||0||
48645087|NCT05161936|101916889|FG002|NOT COMPLETED|Overall Study||1||
48645088|NCT02497755|101916890|FG000|STARTED|Overall Study||18||
48645089|NCT02497755|101916891|FG001|STARTED|Overall Study||1||
48645090|NCT02497755|101916890|FG000|COMPLETED|Overall Study||17||
48645091|NCT02497755|101916891|FG001|COMPLETED|Overall Study||1||
48645092|NCT02497755|101916890|FG000|NOT COMPLETED|Overall Study||1||
48645093|NCT02497755|101916891|FG001|NOT COMPLETED|Overall Study||0||
48645094|NCT01436500|101916892|FG000|STARTED|Overall Study||12||
48645095|NCT01436500|101916893|FG001|STARTED|Overall Study||12||
48645096|NCT01436500|101916894|FG002|STARTED|Overall Study||12||
48645097|NCT01436500|101916895|FG003|STARTED|Overall Study||6||
48645098|NCT01436500|101916896|FG004|STARTED|Overall Study||13||
48645099|NCT01436500|101916892|FG000|COMPLETED|Overall Study||9||
48645100|NCT01436500|101916893|FG001|COMPLETED|Overall Study||9||
48645101|NCT01436500|101916894|FG002|COMPLETED|Overall Study||7||
48645102|NCT01436500|101916895|FG003|COMPLETED|Overall Study||5||
48645103|NCT01436500|101916896|FG004|COMPLETED|Overall Study||9||
48645104|NCT01436500|101916892|FG000|NOT COMPLETED|Overall Study||3||
48645105|NCT01436500|101916893|FG001|NOT COMPLETED|Overall Study||3||
48645106|NCT01436500|101916894|FG002|NOT COMPLETED|Overall Study||5||
48645107|NCT01436500|101916895|FG003|NOT COMPLETED|Overall Study||1||
48645108|NCT01436500|101916896|FG004|NOT COMPLETED|Overall Study||4||
48645109|NCT02280499|101916897|FG000|STARTED|Overall Study||87||
48645110|NCT02280499|101916897|FG000|COMPLETED|Overall Study||26||
48645111|NCT02280499|101916897|FG000|NOT COMPLETED|Overall Study||61||
48645112|NCT02212977|101916898|FG000|STARTED|Overall Study||55||
48645113|NCT02212977|101916899|FG001|STARTED|Overall Study||54||
48645114|NCT02212977|101916898|FG000|COMPLETED|Overall Study||50||
48645115|NCT02212977|101916899|FG001|COMPLETED|Overall Study||48||
48645116|NCT02212977|101916898|FG000|NOT COMPLETED|Overall Study||5||
48645117|NCT02212977|101916899|FG001|NOT COMPLETED|Overall Study||6||
48645118|NCT00853047|101916900|FG000|STARTED|Core Phase||5||
48645119|NCT00853047|101916901|FG001|STARTED|Core Phase||3||
48645120|NCT00853047|101916902|FG002|STARTED|Core Phase||3||
48645121|NCT00853047|101916903|FG003|STARTED|Core Phase||3||
48645122|NCT00853047|101916904|FG004|STARTED|Core Phase||9||
48645123|NCT00853047|101916905|FG005|STARTED|Core Phase||0||
48645124|NCT00853047|101916900|FG000|COMPLETED|Core Phase||5||
48645125|NCT00853047|101916901|FG001|COMPLETED|Core Phase||3||
48645126|NCT00853047|101916902|FG002|COMPLETED|Core Phase||3||
48645127|NCT00853047|101916903|FG003|COMPLETED|Core Phase||2||
48645128|NCT00853047|101916904|FG004|COMPLETED|Core Phase||9||
48645129|NCT00853047|101916905|FG005|COMPLETED|Core Phase||0||
48645130|NCT00853047|101916900|FG000|NOT COMPLETED|Core Phase||0||
48645131|NCT00853047|101916901|FG001|NOT COMPLETED|Core Phase||0||
48645132|NCT00853047|101916902|FG002|NOT COMPLETED|Core Phase||0||
48645133|NCT00853047|101916903|FG003|NOT COMPLETED|Core Phase||1||
48645134|NCT00853047|101916904|FG004|NOT COMPLETED|Core Phase||0||
48645135|NCT00853047|101916905|FG005|NOT COMPLETED|Core Phase||0||
48645136|NCT00853047|101916900|FG000|STARTED|Open-Label Extension Phase||0||
48645137|NCT00853047|101916901|FG001|STARTED|Open-Label Extension Phase||0||
48645138|NCT00853047|101916902|FG002|STARTED|Open-Label Extension Phase||0||
48645139|NCT00853047|101916903|FG003|STARTED|Open-Label Extension Phase||0||
48645140|NCT00853047|101916904|FG004|STARTED|Open-Label Extension Phase||0||
48645141|NCT00853047|101916905|FG005|STARTED|Open-Label Extension Phase||19||
48645142|NCT00853047|101916900|FG000|Completed 8-week Extension Period|Open-Label Extension Phase||0||
48645143|NCT00853047|101916901|FG001|Completed 8-week Extension Period|Open-Label Extension Phase||0||
48645144|NCT00853047|101916902|FG002|Completed 8-week Extension Period|Open-Label Extension Phase||0||
48645145|NCT00853047|101916903|FG003|Completed 8-week Extension Period|Open-Label Extension Phase||0||
48645146|NCT00853047|101916904|FG004|Completed 8-week Extension Period|Open-Label Extension Phase||0||
48645147|NCT00853047|101916905|FG005|Completed 8-week Extension Period|Open-Label Extension Phase||16||
48645148|NCT00853047|101916900|FG000|COMPLETED|Open-Label Extension Phase||0||
48645149|NCT00853047|101916901|FG001|COMPLETED|Open-Label Extension Phase||0||
48645150|NCT00853047|101916902|FG002|COMPLETED|Open-Label Extension Phase||0||
48645151|NCT00853047|101916903|FG003|COMPLETED|Open-Label Extension Phase||0||
48645152|NCT00853047|101916904|FG004|COMPLETED|Open-Label Extension Phase||0||
48645153|NCT00853047|101916905|FG005|COMPLETED|Open-Label Extension Phase||2||
48645154|NCT00853047|101916900|FG000|NOT COMPLETED|Open-Label Extension Phase||0||
48645155|NCT00853047|101916901|FG001|NOT COMPLETED|Open-Label Extension Phase||0||
48645156|NCT00853047|101916902|FG002|NOT COMPLETED|Open-Label Extension Phase||0||
48645157|NCT00853047|101916903|FG003|NOT COMPLETED|Open-Label Extension Phase||0||
48657042|NCT03648372|101943761|FG004|STARTED|Overall Study||4||
48645158|NCT00853047|101916904|FG004|NOT COMPLETED|Open-Label Extension Phase||0||
48645159|NCT00853047|101916905|FG005|NOT COMPLETED|Open-Label Extension Phase||17||
48645160|NCT01917773|101916906|FG000|STARTED|Overall Study||13||
48645161|NCT01917773|101916906|FG000|COMPLETED|Overall Study||13||
48645162|NCT01917773|101916906|FG000|NOT COMPLETED|Overall Study||0||
48645163|NCT00683384|101916907|FG000|STARTED|Overall Study||93||
48645164|NCT00683384|101916907|FG000|COMPLETED|Overall Study||91||
48645165|NCT00683384|101916907|FG000|NOT COMPLETED|Overall Study||2||
48645166|NCT01567085|101916908|FG000|STARTED|Overall Study||80||
48645167|NCT01567085|101916908|FG000|Received at Least 1 Dose of Study Drug|Overall Study||80||
48645168|NCT01567085|101916908|FG000|COMPLETED|Overall Study||60||
48645169|NCT01567085|101916908|FG000|NOT COMPLETED|Overall Study||20||
48645170|NCT01131585|101916909|FG000|STARTED|Overall Study||85||
48645171|NCT01131585|101916910|FG001|STARTED|Overall Study||43||
48645172|NCT01131585|101916909|FG000|COMPLETED|Overall Study||0||
48645173|NCT01131585|101916910|FG001|COMPLETED|Overall Study||0||
48645174|NCT01131585|101916909|FG000|NOT COMPLETED|Overall Study||85||
48645175|NCT01131585|101916910|FG001|NOT COMPLETED|Overall Study||43||
48645176|NCT05027282|101916911|FG000|STARTED|Overall Study||28||
48645177|NCT05027282|101916911|FG000|COMPLETED|Overall Study||28||
48645178|NCT05027282|101916911|FG000|NOT COMPLETED|Overall Study||0||
48645179|NCT02061592|101916912|FG000|STARTED|Period 1||66||
48645180|NCT02061592|101916913|FG001|STARTED|Period 1||62||
48645181|NCT02061592|101916912|FG000|COMPLETED|Period 1||64||
48645182|NCT02061592|101916913|FG001|COMPLETED|Period 1||62||
48645183|NCT02061592|101916912|FG000|NOT COMPLETED|Period 1||2||
48645184|NCT02061592|101916913|FG001|NOT COMPLETED|Period 1||0||
48645185|NCT02061592|101916912|FG000|STARTED|Period 2||64||
48645186|NCT02061592|101916913|FG001|STARTED|Period 2||62||
48645187|NCT02061592|101916912|FG000|COMPLETED|Period 2||64||
48645188|NCT02061592|101916913|FG001|COMPLETED|Period 2||61||
48645189|NCT02061592|101916912|FG000|NOT COMPLETED|Period 2||0||
48645190|NCT02061592|101916913|FG001|NOT COMPLETED|Period 2||1||
48645191|NCT00724503|101916914|FG000|STARTED|Overall Study||267||
48645192|NCT00724503|101916915|FG001|STARTED|Overall Study||263||
48645193|NCT00724503|101916914|FG000|COMPLETED|Overall Study||57||
48645194|NCT00724503|101916915|FG001|COMPLETED|Overall Study||43||
48645195|NCT00724503|101916914|FG000|NOT COMPLETED|Overall Study||210||
48645196|NCT00724503|101916915|FG001|NOT COMPLETED|Overall Study||220||
48645197|NCT01365611|101916916|FG000|STARTED|Overall Study||36||
48645198|NCT01365611|101916916|FG000|COMPLETED|Overall Study||36||
48645199|NCT01365611|101916916|FG000|NOT COMPLETED|Overall Study||0||
48645200|NCT01028391|101916917|FG000|STARTED|Overall Study||164||
48645201|NCT01028391|101916918|FG001|STARTED|Overall Study||153||
48645202|NCT01028391|101916917|FG000|COMPLETED|Overall Study||150||
48645203|NCT01028391|101916918|FG001|COMPLETED|Overall Study||142||
48645204|NCT01028391|101916917|FG000|NOT COMPLETED|Overall Study||14||
48645205|NCT01028391|101916918|FG001|NOT COMPLETED|Overall Study||11||
48645206|NCT02162433|101916919|FG000|STARTED|Overall Study||23||
48645207|NCT02162433|101916920|FG001|STARTED|Overall Study||23||
48645208|NCT02162433|101916921|FG002|STARTED|Overall Study||23||
48645209|NCT02162433|101916922|FG003|STARTED|Overall Study||23||
48645210|NCT02162433|101916919|FG000|COMPLETED|Overall Study||22||
48645211|NCT02162433|101916920|FG001|COMPLETED|Overall Study||21||
48645212|NCT02162433|101916921|FG002|COMPLETED|Overall Study||21||
48645213|NCT02162433|101916922|FG003|COMPLETED|Overall Study||22||
48645214|NCT02162433|101916919|FG000|NOT COMPLETED|Overall Study||1||
48645215|NCT02162433|101916920|FG001|NOT COMPLETED|Overall Study||2||
48645216|NCT02162433|101916921|FG002|NOT COMPLETED|Overall Study||2||
48645217|NCT02162433|101916922|FG003|NOT COMPLETED|Overall Study||1||
48645218|NCT00315822|101916923|FG000|STARTED|Overall Study||198||
48645219|NCT00315822|101916924|FG001|STARTED|Overall Study||202||
48645220|NCT00315822|101916923|FG000|COMPLETED|Overall Study||198||
48645221|NCT00315822|101916924|FG001|COMPLETED|Overall Study||202||
48645222|NCT00315822|101916923|FG000|NOT COMPLETED|Overall Study||0||
48645223|NCT00315822|101916924|FG001|NOT COMPLETED|Overall Study||0||
48645224|NCT01258855|101916925|FG000|STARTED|Overall Study||55||
48645225|NCT01258855|101916926|FG001|STARTED|Overall Study||29||
48645226|NCT01258855|101916925|FG000|COMPLETED|Overall Study||55||
48645227|NCT01258855|101916926|FG001|COMPLETED|Overall Study||29||
48645228|NCT01258855|101916925|FG000|NOT COMPLETED|Overall Study||0||
48645229|NCT01258855|101916926|FG001|NOT COMPLETED|Overall Study||0||
48645230|NCT01769443|101916927|FG000|STARTED|Overall Study||1||
48645231|NCT01769443|101916928|FG001|STARTED|Overall Study||1||
48645232|NCT01769443|101916927|FG000|COMPLETED|Overall Study||0||
48645233|NCT01769443|101916928|FG001|COMPLETED|Overall Study||1||
48645234|NCT01769443|101916927|FG000|NOT COMPLETED|Overall Study||1||
48645235|NCT01769443|101916928|FG001|NOT COMPLETED|Overall Study||0||
48645236|NCT01783938|101916929|FG000|STARTED|Overall Study||68||
48645237|NCT01783938|101916930|FG001|STARTED|Overall Study||70||
48645238|NCT01783938|101916929|FG000|COMPLETED|Overall Study||11||
48645239|NCT01783938|101916930|FG001|COMPLETED|Overall Study||9||
48645240|NCT01783938|101916929|FG000|NOT COMPLETED|Overall Study||57||
48645241|NCT01783938|101916930|FG001|NOT COMPLETED|Overall Study||61||
48645242|NCT00770484|101916931|FG000|STARTED|Overall Study||8||
48645243|NCT00770484|101916932|FG001|STARTED|Overall Study||4||
48645244|NCT00770484|101916931|FG000|COMPLETED|Overall Study||7||
48765173|NCT02113982|102214593|FG010|COMPLETED|Stage 3: Efficacy Cohort||0||
48765174|NCT02113982|102214594|FG011|COMPLETED|Stage 3: Efficacy Cohort||0||
48436133|NCT00561600|101403493|FG001|NOT COMPLETED|Overall Study||16||
48436134|NCT02230332|101403494|FG000|STARTED|Overall Study||38||
48436135|NCT02230332|101403495|FG001|STARTED|Overall Study||40||
48436136|NCT02230332|101403494|FG000|COMPLETED|Overall Study||34||
48436137|NCT02230332|101403495|FG001|COMPLETED|Overall Study||39||
48436138|NCT02230332|101403494|FG000|NOT COMPLETED|Overall Study||4||
48436139|NCT02230332|101403495|FG001|NOT COMPLETED|Overall Study||1||
48436140|NCT01015118|101403496|FG000|STARTED|Overall Study||911||
48436141|NCT01015118|101403497|FG001|STARTED|Overall Study||455||
48436142|NCT01015118|101403496|FG000|COMPLETED|Overall Study||242||
48436143|NCT01015118|101403497|FG001|COMPLETED|Overall Study||128||
48436144|NCT01015118|101403496|FG000|NOT COMPLETED|Overall Study||669||
48436145|NCT01015118|101403497|FG001|NOT COMPLETED|Overall Study||327||
48436146|NCT01092676|101403498|FG000|STARTED|Overall Study||50||
48436147|NCT01092676|101403499|FG001|STARTED|Overall Study||49||
48436148|NCT01092676|101403498|FG000|COMPLETED|Overall Study||50||
48436149|NCT01092676|101403499|FG001|COMPLETED|Overall Study||49||
48436150|NCT01092676|101403498|FG000|NOT COMPLETED|Overall Study||0||
48436151|NCT01092676|101403499|FG001|NOT COMPLETED|Overall Study||0||
48436152|NCT00061568|101403500|FG000|STARTED|Overall Study||62||
48436153|NCT00061568|101403501|FG001|STARTED|Overall Study||68||
48436154|NCT00061568|101403500|FG000|COMPLETED|Overall Study||43||
48436155|NCT00061568|101403501|FG001|COMPLETED|Overall Study||68||
48436156|NCT00061568|101403500|FG000|NOT COMPLETED|Overall Study||19||
48436157|NCT00061568|101403501|FG001|NOT COMPLETED|Overall Study||0||
48436158|NCT00090259|101403502|FG000|STARTED|Overall Study||1913||
48436159|NCT00090259|101403503|FG001|STARTED|Overall Study||1921||
48436160|NCT00090259|101403502|FG000|COMPLETED|Overall Study||1851||
48645245|NCT00770484|101916932|FG001|COMPLETED|Overall Study||4||
48645246|NCT00770484|101916931|FG000|NOT COMPLETED|Overall Study||1||
48645247|NCT00770484|101916932|FG001|NOT COMPLETED|Overall Study||0||
48645248|NCT00639379|101916933|FG000|STARTED|Period 1 - 2 Weeks||44||
48645249|NCT00639379|101916934|FG001|STARTED|Period 1 - 2 Weeks||45||
48645250|NCT00639379|101916933|FG000|COMPLETED|Period 1 - 2 Weeks||39||
48645251|NCT00639379|101916934|FG001|COMPLETED|Period 1 - 2 Weeks||45||
48645252|NCT00639379|101916933|FG000|NOT COMPLETED|Period 1 - 2 Weeks||5||
48645253|NCT00639379|101916934|FG001|NOT COMPLETED|Period 1 - 2 Weeks||0||
48765175|NCT02113982|102214595|FG012|COMPLETED|Stage 3: Efficacy Cohort||0||
48765176|NCT02113982|102214596|FG013|COMPLETED|Stage 3: Efficacy Cohort||0||
48765177|NCT02113982|102214583|FG000|NOT COMPLETED|Stage 3: Efficacy Cohort||0||
48765178|NCT02113982|102214584|FG001|NOT COMPLETED|Stage 3: Efficacy Cohort||0||
48765179|NCT02113982|102214585|FG002|NOT COMPLETED|Stage 3: Efficacy Cohort||0||
48436161|NCT00090259|101403503|FG001|COMPLETED|Overall Study||1873||
48436162|NCT00090259|101403502|FG000|NOT COMPLETED|Overall Study||62||
48436163|NCT00090259|101403503|FG001|NOT COMPLETED|Overall Study||48||
48436164|NCT04070157|101403504|FG000|STARTED|Overall Study||1||
48436165|NCT04070157|101403505|FG001|STARTED|Overall Study||3||
48436166|NCT04070157|101403504|FG000|COMPLETED|Overall Study||0||
48436167|NCT04070157|101403505|FG001|COMPLETED|Overall Study||2||
48436168|NCT04070157|101403504|FG000|NOT COMPLETED|Overall Study||1||
48436169|NCT04070157|101403505|FG001|NOT COMPLETED|Overall Study||1||
48436170|NCT02556112|101403506|FG000|STARTED|Overall Study||40||
48436171|NCT02556112|101403507|FG001|STARTED|Overall Study||40||
48436172|NCT02556112|101403508|FG002|STARTED|Overall Study||42||
48436173|NCT02556112|101403506|FG000|COMPLETED|Overall Study||30||
48436174|NCT02556112|101403507|FG001|COMPLETED|Overall Study||23||
48436175|NCT02556112|101403508|FG002|COMPLETED|Overall Study||30||
48436176|NCT02556112|101403506|FG000|NOT COMPLETED|Overall Study||10||
48436177|NCT02556112|101403507|FG001|NOT COMPLETED|Overall Study||17||
48436178|NCT02556112|101403508|FG002|NOT COMPLETED|Overall Study||12||
48436179|NCT00750373|101403509|FG000|STARTED|Overall Study||39||
48436180|NCT00750373|101403510|FG001|STARTED|Overall Study||37||
48436181|NCT00750373|101403509|FG000|COMPLETED|Overall Study||39||
48436182|NCT00750373|101403510|FG001|COMPLETED|Overall Study||37||
48436183|NCT00750373|101403509|FG000|NOT COMPLETED|Overall Study||0||
48436184|NCT00750373|101403510|FG001|NOT COMPLETED|Overall Study||0||
48436185|NCT00054639|101403511|FG000|STARTED|Overall Study||48||
48436186|NCT00054639|101403511|FG000|COMPLETED|Overall Study||46||
48436187|NCT00054639|101403511|FG000|NOT COMPLETED|Overall Study||2||
48436188|NCT02424851|101403512|FG000|STARTED|Overall Study||16||
48436189|NCT02424851|101403513|FG001|STARTED|Overall Study||15||
48436190|NCT02424851|101403512|FG000|COMPLETED|Overall Study||14||
48436191|NCT02424851|101403513|FG001|COMPLETED|Overall Study||12||
48436192|NCT02424851|101403512|FG000|NOT COMPLETED|Overall Study||2||
48645254|NCT00639379|101916933|FG000|STARTED|Period 2 - 2 Weeks||39||
48436193|NCT02424851|101403513|FG001|NOT COMPLETED|Overall Study||3||
48436194|NCT03522506|101403514|FG000|STARTED|Treatment Period 1 (2 Days)||5||
48436195|NCT03522506|101403515|FG001|STARTED|Treatment Period 1 (2 Days)||5||
48436196|NCT03522506|101403516|FG002|STARTED|Treatment Period 1 (2 Days)||5||
48436197|NCT03522506|101403517|FG003|STARTED|Treatment Period 1 (2 Days)||5||
48436198|NCT03522506|101403514|FG000|COMPLETED|Treatment Period 1 (2 Days)||5||
48645255|NCT00639379|101916934|FG001|STARTED|Period 2 - 2 Weeks||45||
48645256|NCT00639379|101916933|FG000|COMPLETED|Period 2 - 2 Weeks||39||
48645257|NCT00639379|101916934|FG001|COMPLETED|Period 2 - 2 Weeks||45||
48645258|NCT00639379|101916933|FG000|NOT COMPLETED|Period 2 - 2 Weeks||0||
48645259|NCT00639379|101916934|FG001|NOT COMPLETED|Period 2 - 2 Weeks||0||
48645260|NCT00387127|101916935|FG000|STARTED|Overall Study||33||
48645261|NCT00387127|101916936|FG001|STARTED|Overall Study||34||
48645262|NCT00387127|101916935|FG000|COMPLETED|Overall Study||0||
48645263|NCT00387127|101916936|FG001|COMPLETED|Overall Study||0||
48645264|NCT00387127|101916935|FG000|NOT COMPLETED|Overall Study||33||
48645265|NCT00387127|101916936|FG001|NOT COMPLETED|Overall Study||34||
48645266|NCT02475837|101916937|FG000|STARTED|Overall Study||6||
48645267|NCT02475837|101916938|FG001|STARTED|Overall Study||7||
48645268|NCT02475837|101916937|FG000|COMPLETED|Overall Study||6||
48645269|NCT02475837|101916938|FG001|COMPLETED|Overall Study||7||
48645270|NCT02475837|101916937|FG000|NOT COMPLETED|Overall Study||0||
48645271|NCT02475837|101916938|FG001|NOT COMPLETED|Overall Study||0||
48645272|NCT01312129|101916939|FG000|STARTED|First Intervention (24 Hours)||6||
48645273|NCT01312129|101916940|FG001|STARTED|First Intervention (24 Hours)||7||
48645274|NCT01312129|101916939|FG000|Control Cue|First Intervention (24 Hours)||6||
48645275|NCT01312129|101916940|FG001|Control Cue|First Intervention (24 Hours)||7||
48645276|NCT01312129|101916939|FG000|Alcohol Cue|First Intervention (24 Hours)||6||
48645277|NCT01312129|101916940|FG001|Alcohol Cue|First Intervention (24 Hours)||7||
48645278|NCT01312129|101916939|FG000|COMPLETED|First Intervention (24 Hours)||6||
48645279|NCT01312129|101916940|FG001|COMPLETED|First Intervention (24 Hours)||7||
48645280|NCT01312129|101916939|FG000|NOT COMPLETED|First Intervention (24 Hours)||0||
48645281|NCT01312129|101916940|FG001|NOT COMPLETED|First Intervention (24 Hours)||0||
48645282|NCT01312129|101916939|FG000|STARTED|Washout (1 Week)||6||
48645283|NCT01312129|101916940|FG001|STARTED|Washout (1 Week)||7||
48645284|NCT01312129|101916939|FG000|COMPLETED|Washout (1 Week)||6||
48645285|NCT01312129|101916940|FG001|COMPLETED|Washout (1 Week)||7||
48645286|NCT01312129|101916939|FG000|NOT COMPLETED|Washout (1 Week)||0||
48645287|NCT01312129|101916940|FG001|NOT COMPLETED|Washout (1 Week)||0||
48645288|NCT01312129|101916939|FG000|STARTED|Second Intervention (24 Hours)||6||
48645289|NCT01312129|101916940|FG001|STARTED|Second Intervention (24 Hours)||7||
48645290|NCT01312129|101916939|FG000|Control Cue|Second Intervention (24 Hours)||6||
48645291|NCT01312129|101916940|FG001|Control Cue|Second Intervention (24 Hours)||6||
48645292|NCT01312129|101916939|FG000|Alcohol Cue|Second Intervention (24 Hours)||6||
48645293|NCT01312129|101916940|FG001|Alcohol Cue|Second Intervention (24 Hours)||6||
48645294|NCT01312129|101916939|FG000|COMPLETED|Second Intervention (24 Hours)||6||
48645295|NCT01312129|101916940|FG001|COMPLETED|Second Intervention (24 Hours)||6||
48645296|NCT01312129|101916939|FG000|NOT COMPLETED|Second Intervention (24 Hours)||0||
48645297|NCT01312129|101916940|FG001|NOT COMPLETED|Second Intervention (24 Hours)||1||
48645298|NCT01121926|101916941|FG000|STARTED|First Intervention Period||15||
48645299|NCT01121926|101916942|FG001|STARTED|First Intervention Period||15||
48645300|NCT01121926|101916941|FG000|COMPLETED|First Intervention Period||14||
48645301|NCT01121926|101916942|FG001|COMPLETED|First Intervention Period||15||
48645302|NCT01121926|101916941|FG000|NOT COMPLETED|First Intervention Period||1||
48645303|NCT01121926|101916942|FG001|NOT COMPLETED|First Intervention Period||0||
48645304|NCT01121926|101916941|FG000|STARTED|Washout Period||14||
48645305|NCT01121926|101916942|FG001|STARTED|Washout Period||15||
48645306|NCT01121926|101916941|FG000|COMPLETED|Washout Period||14||
48645307|NCT01121926|101916942|FG001|COMPLETED|Washout Period||13||
48645308|NCT01121926|101916941|FG000|NOT COMPLETED|Washout Period||0||
48645309|NCT01121926|101916942|FG001|NOT COMPLETED|Washout Period||2||
48645310|NCT01121926|101916941|FG000|STARTED|Second Intervention Period||14||
48645311|NCT01121926|101916942|FG001|STARTED|Second Intervention Period||13||
48645312|NCT01121926|101916941|FG000|COMPLETED|Second Intervention Period||14||
48645313|NCT01121926|101916942|FG001|COMPLETED|Second Intervention Period||13||
48645314|NCT01121926|101916941|FG000|NOT COMPLETED|Second Intervention Period||0||
48645315|NCT01121926|101916942|FG001|NOT COMPLETED|Second Intervention Period||0||
48645316|NCT03812328|101916943|FG000|STARTED|Overall Study||55||
48645317|NCT03812328|101916944|FG001|STARTED|Overall Study||63||
48645318|NCT03812328|101916945|FG002|STARTED|Overall Study||89||
48645319|NCT03812328|101916943|FG000|Modified Intent-to-Treat (mITT) Population|Overall Study||48||
48645320|NCT03812328|101916944|FG001|Modified Intent-to-Treat (mITT) Population|Overall Study||61||
48645321|NCT03812328|101916945|FG002|Modified Intent-to-Treat (mITT) Population|Overall Study||84||
48645322|NCT03812328|101916943|FG000|Safety Population|Overall Study||55||
48645323|NCT03812328|101916944|FG001|Safety Population|Overall Study||63||
48645324|NCT03812328|101916945|FG002|Safety Population|Overall Study||88||
48645325|NCT03812328|101916943|FG000|COMPLETED|Overall Study||55||
48645326|NCT03812328|101916944|FG001|COMPLETED|Overall Study||60||
48645327|NCT03812328|101916945|FG002|COMPLETED|Overall Study||88||
48645328|NCT03812328|101916943|FG000|NOT COMPLETED|Overall Study||0||
48645329|NCT03812328|101916944|FG001|NOT COMPLETED|Overall Study||3||
48645330|NCT03812328|101916945|FG002|NOT COMPLETED|Overall Study||1||
48645331|NCT02609633|101916946|FG000|STARTED|Overall Study||42||
48645332|NCT02609633|101916947|FG001|STARTED|Overall Study||56||
48645333|NCT02609633|101916946|FG000|Full Analysis Set (FAS)|Overall Study||32||
48645334|NCT02609633|101916947|FG001|Full Analysis Set (FAS)|Overall Study||46||
48645335|NCT02609633|101916946|FG000|COMPLETED|Overall Study||37||
48645336|NCT02609633|101916947|FG001|COMPLETED|Overall Study||54||
48645337|NCT02609633|101916946|FG000|NOT COMPLETED|Overall Study||5||
48645338|NCT02609633|101916947|FG001|NOT COMPLETED|Overall Study||2||
48645339|NCT03501277|101916948|FG000|STARTED|Intervention Period 1 (4 Days)||18||
48645340|NCT03501277|101916949|FG001|STARTED|Intervention Period 1 (4 Days)||18||
48645341|NCT03501277|101916950|FG002|STARTED|Intervention Period 1 (4 Days)||18||
48645342|NCT03501277|101916951|FG003|STARTED|Intervention Period 1 (4 Days)||18||
48645343|NCT03501277|101916948|FG000|Safety Analysis Set|Intervention Period 1 (4 Days)||18||
48645344|NCT03501277|101916949|FG001|Safety Analysis Set|Intervention Period 1 (4 Days)||18||
48645345|NCT03501277|101916950|FG002|Safety Analysis Set|Intervention Period 1 (4 Days)||17||
48645346|NCT03501277|101916951|FG003|Safety Analysis Set|Intervention Period 1 (4 Days)||17||
48645347|NCT03501277|101916948|FG000|COMPLETED|Intervention Period 1 (4 Days)||18||
48645348|NCT03501277|101916949|FG001|COMPLETED|Intervention Period 1 (4 Days)||18||
48645349|NCT03501277|101916950|FG002|COMPLETED|Intervention Period 1 (4 Days)||17||
48645350|NCT03501277|101916951|FG003|COMPLETED|Intervention Period 1 (4 Days)||17||
48645351|NCT03501277|101916948|FG000|NOT COMPLETED|Intervention Period 1 (4 Days)||0||
48645352|NCT03501277|101916949|FG001|NOT COMPLETED|Intervention Period 1 (4 Days)||0||
48645353|NCT03501277|101916950|FG002|NOT COMPLETED|Intervention Period 1 (4 Days)||1||
48645354|NCT03501277|101916951|FG003|NOT COMPLETED|Intervention Period 1 (4 Days)||1||
48645355|NCT03501277|101916948|FG000|STARTED|Washout Period 1 (7 Days)||18||
48645356|NCT03501277|101916949|FG001|STARTED|Washout Period 1 (7 Days)||18||
48645357|NCT03501277|101916950|FG002|STARTED|Washout Period 1 (7 Days)||17||
48645358|NCT03501277|101916951|FG003|STARTED|Washout Period 1 (7 Days)||17||
48645359|NCT03501277|101916948|FG000|COMPLETED|Washout Period 1 (7 Days)||18||
48645360|NCT03501277|101916949|FG001|COMPLETED|Washout Period 1 (7 Days)||18||
48645361|NCT03501277|101916950|FG002|COMPLETED|Washout Period 1 (7 Days)||17||
48645362|NCT03501277|101916951|FG003|COMPLETED|Washout Period 1 (7 Days)||17||
48645363|NCT03501277|101916948|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48645364|NCT03501277|101916949|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48645365|NCT03501277|101916950|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48645366|NCT03501277|101916951|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48645367|NCT03501277|101916948|FG000|STARTED|Intervention Period 2 (4 Days)||18||
48645368|NCT03501277|101916949|FG001|STARTED|Intervention Period 2 (4 Days)||18||
48645369|NCT03501277|101916950|FG002|STARTED|Intervention Period 2 (4 Days)||17||
48645370|NCT03501277|101916951|FG003|STARTED|Intervention Period 2 (4 Days)||17||
48645371|NCT03501277|101916948|FG000|COMPLETED|Intervention Period 2 (4 Days)||18||
48645372|NCT03501277|101916949|FG001|COMPLETED|Intervention Period 2 (4 Days)||18||
48645373|NCT03501277|101916950|FG002|COMPLETED|Intervention Period 2 (4 Days)||17||
48645374|NCT03501277|101916951|FG003|COMPLETED|Intervention Period 2 (4 Days)||16||
48645375|NCT03501277|101916948|FG000|NOT COMPLETED|Intervention Period 2 (4 Days)||0||
48645376|NCT03501277|101916949|FG001|NOT COMPLETED|Intervention Period 2 (4 Days)||0||
48645377|NCT03501277|101916950|FG002|NOT COMPLETED|Intervention Period 2 (4 Days)||0||
48645378|NCT03501277|101916951|FG003|NOT COMPLETED|Intervention Period 2 (4 Days)||1||
48645379|NCT03501277|101916948|FG000|STARTED|Washout Period 2 (7 Days)||18||
48645380|NCT03501277|101916949|FG001|STARTED|Washout Period 2 (7 Days)||18||
48645381|NCT03501277|101916950|FG002|STARTED|Washout Period 2 (7 Days)||17||
48645382|NCT03501277|101916951|FG003|STARTED|Washout Period 2 (7 Days)||16||
48645383|NCT03501277|101916948|FG000|COMPLETED|Washout Period 2 (7 Days)||18||
48645384|NCT03501277|101916949|FG001|COMPLETED|Washout Period 2 (7 Days)||18||
48645385|NCT03501277|101916950|FG002|COMPLETED|Washout Period 2 (7 Days)||17||
48645386|NCT03501277|101916951|FG003|COMPLETED|Washout Period 2 (7 Days)||16||
48645387|NCT03501277|101916948|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48645388|NCT03501277|101916949|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48645389|NCT03501277|101916950|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48645390|NCT03501277|101916951|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48645391|NCT03501277|101916948|FG000|STARTED|Intervention Period 3 (4 Days)||18||
48645392|NCT03501277|101916949|FG001|STARTED|Intervention Period 3 (4 Days)||18||
48645393|NCT03501277|101916950|FG002|STARTED|Intervention Period 3 (4 Days)||17||
48645394|NCT03501277|101916951|FG003|STARTED|Intervention Period 3 (4 Days)||16||
48645395|NCT03501277|101916948|FG000|COMPLETED|Intervention Period 3 (4 Days)||18||
48645396|NCT03501277|101916949|FG001|COMPLETED|Intervention Period 3 (4 Days)||18||
48645397|NCT03501277|101916950|FG002|COMPLETED|Intervention Period 3 (4 Days)||17||
48645398|NCT03501277|101916951|FG003|COMPLETED|Intervention Period 3 (4 Days)||15||
48645399|NCT03501277|101916948|FG000|NOT COMPLETED|Intervention Period 3 (4 Days)||0||
48188692|NCT05590910|100783311|FG001|COMPLETED|Overall Study||40||
48645400|NCT03501277|101916949|FG001|NOT COMPLETED|Intervention Period 3 (4 Days)||0||
48645401|NCT03501277|101916950|FG002|NOT COMPLETED|Intervention Period 3 (4 Days)||0||
48645402|NCT03501277|101916951|FG003|NOT COMPLETED|Intervention Period 3 (4 Days)||1||
48645403|NCT03501277|101916948|FG000|STARTED|Washout Period 3 (7 Days)||18||
48645404|NCT03501277|101916949|FG001|STARTED|Washout Period 3 (7 Days)||18||
48645405|NCT03501277|101916950|FG002|STARTED|Washout Period 3 (7 Days)||17||
48645406|NCT03501277|101916951|FG003|STARTED|Washout Period 3 (7 Days)||15||
48645407|NCT03501277|101916948|FG000|COMPLETED|Washout Period 3 (7 Days)||18||
48645408|NCT03501277|101916949|FG001|COMPLETED|Washout Period 3 (7 Days)||18||
48645409|NCT03501277|101916950|FG002|COMPLETED|Washout Period 3 (7 Days)||17||
48645410|NCT03501277|101916951|FG003|COMPLETED|Washout Period 3 (7 Days)||15||
48645411|NCT03501277|101916948|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48645412|NCT03501277|101916949|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48645413|NCT03501277|101916950|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48645414|NCT03501277|101916951|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48645415|NCT03501277|101916948|FG000|STARTED|Intervention Period 4 (4 Days)||18||
48645416|NCT03501277|101916949|FG001|STARTED|Intervention Period 4 (4 Days)||18||
48645417|NCT03501277|101916950|FG002|STARTED|Intervention Period 4 (4 Days)||17||
48645418|NCT03501277|101916951|FG003|STARTED|Intervention Period 4 (4 Days)||15||
48645419|NCT03501277|101916948|FG000|COMPLETED|Intervention Period 4 (4 Days)||18||
48645420|NCT03501277|101916949|FG001|COMPLETED|Intervention Period 4 (4 Days)||18||
48645421|NCT03501277|101916950|FG002|COMPLETED|Intervention Period 4 (4 Days)||17||
48645422|NCT03501277|101916951|FG003|COMPLETED|Intervention Period 4 (4 Days)||15||
48645423|NCT03501277|101916948|FG000|NOT COMPLETED|Intervention Period 4 (4 Days)||0||
48645424|NCT03501277|101916949|FG001|NOT COMPLETED|Intervention Period 4 (4 Days)||0||
48645425|NCT03501277|101916950|FG002|NOT COMPLETED|Intervention Period 4 (4 Days)||0||
48645426|NCT03501277|101916951|FG003|NOT COMPLETED|Intervention Period 4 (4 Days)||0||
48645427|NCT00710970|101916952|FG000|STARTED|Overall Study||28||
48645428|NCT00710970|101916952|FG000|COMPLETED|Overall Study||25||
48645429|NCT00710970|101916952|FG000|NOT COMPLETED|Overall Study||3||
48645430|NCT02933476|101916953|FG000|STARTED|Overall Study||5||
48645431|NCT02933476|101916953|FG000|COMPLETED|Overall Study||5||
48645432|NCT02933476|101916953|FG000|NOT COMPLETED|Overall Study||0||
48645433|NCT00066170|101916954|FG000|STARTED|Overall Study||56||
48645434|NCT00066170|101916955|FG001|STARTED|Overall Study||55||
48645435|NCT00066170|101916956|FG002|STARTED|Overall Study||63||
48645436|NCT00066170|101916957|FG003|STARTED|Overall Study||57||
48645437|NCT00066170|101916954|FG000|Intent to Treat|Overall Study||55||
48645438|NCT00066170|101916955|FG001|Intent to Treat|Overall Study||50||
48645439|NCT00066170|101916956|FG002|Intent to Treat|Overall Study||63||
48645440|NCT00066170|101916957|FG003|Intent to Treat|Overall Study||54||
48645441|NCT00066170|101916954|FG000|COMPLETED|Overall Study||49||
48645442|NCT00066170|101916955|FG001|COMPLETED|Overall Study||45||
48645443|NCT00066170|101916956|FG002|COMPLETED|Overall Study||59||
48645444|NCT00066170|101916957|FG003|COMPLETED|Overall Study||48||
48645445|NCT00066170|101916954|FG000|NOT COMPLETED|Overall Study||7||
48645446|NCT00066170|101916955|FG001|NOT COMPLETED|Overall Study||10||
48645447|NCT00066170|101916956|FG002|NOT COMPLETED|Overall Study||4||
48645448|NCT00066170|101916957|FG003|NOT COMPLETED|Overall Study||9||
48645449|NCT00086307|101916958|FG000|STARTED|Overall Study||13||
48645450|NCT00086307|101916959|FG001|STARTED|Overall Study||13||
48645451|NCT00086307|101916960|FG002|STARTED|Overall Study||13||
48645452|NCT00086307|101916958|FG000|COMPLETED|Overall Study||11||
48645453|NCT00086307|101916959|FG001|COMPLETED|Overall Study||12||
48645454|NCT00086307|101916960|FG002|COMPLETED|Overall Study||5||
48645455|NCT00086307|101916958|FG000|NOT COMPLETED|Overall Study||2||
48645456|NCT00086307|101916959|FG001|NOT COMPLETED|Overall Study||1||
48645457|NCT00086307|101916960|FG002|NOT COMPLETED|Overall Study||8||
48645458|NCT01257542|101916961|FG000|STARTED|Overall Study||55||
48645459|NCT01257542|101916962|FG001|STARTED|Overall Study||52||
48645460|NCT01257542|101916961|FG000|COMPLETED|Overall Study||52||
48645461|NCT01257542|101916962|FG001|COMPLETED|Overall Study||45||
48645462|NCT01257542|101916961|FG000|NOT COMPLETED|Overall Study||3||
48645463|NCT01257542|101916962|FG001|NOT COMPLETED|Overall Study||7||
48645464|NCT03017261|101916963|FG000|STARTED|6 Week Follow up||115||
48645465|NCT03017261|101916963|FG000|COMPLETED|6 Week Follow up||115|8 did not complete the procedure with the device leaving 107 in the per protocol cohort.|
48645466|NCT03017261|101916963|FG000|NOT COMPLETED|6 Week Follow up||0||
48645467|NCT03017261|101916963|FG000|STARTED|3 Month Follow up||115||
48645468|NCT03017261|101916963|FG000|COMPLETED|3 Month Follow up||115||
48645469|NCT03017261|101916963|FG000|NOT COMPLETED|3 Month Follow up||0||
48765180|NCT02113982|102214586|FG003|NOT COMPLETED|Stage 3: Efficacy Cohort||0||
48765181|NCT02113982|102214587|FG004|NOT COMPLETED|Stage 3: Efficacy Cohort||0||
48765182|NCT02113982|102214588|FG005|NOT COMPLETED|Stage 3: Efficacy Cohort||0||
48645470|NCT03017261|101916963|FG000|STARTED|6 Month Follow up||115||
48645471|NCT03017261|101916963|FG000|COMPLETED|6 Month Follow up||106|2 failed to compete 6M imaging so only 104 have 6M data for KSS Objective Score.|
48645472|NCT03017261|101916963|FG000|NOT COMPLETED|6 Month Follow up||9||
48645473|NCT03017261|101916963|FG000|STARTED|12 Month Follow up||106||
48645474|NCT03017261|101916963|FG000|COMPLETED|12 Month Follow up||59||
48645475|NCT03017261|101916963|FG000|NOT COMPLETED|12 Month Follow up||47||
48645476|NCT01501513|101916964|FG000|STARTED|Overall Study||184||
48645477|NCT01501513|101916965|FG001|STARTED|Overall Study||180||
48645478|NCT01501513|101916966|FG002|STARTED|Overall Study||177||
48645479|NCT01501513|101916964|FG000|COMPLETED|Overall Study||168||
48645480|NCT01501513|101916965|FG001|COMPLETED|Overall Study||165||
48645481|NCT01501513|101916966|FG002|COMPLETED|Overall Study||164||
48645482|NCT01501513|101916964|FG000|NOT COMPLETED|Overall Study||16||
48645483|NCT01501513|101916965|FG001|NOT COMPLETED|Overall Study||15||
48645484|NCT01501513|101916966|FG002|NOT COMPLETED|Overall Study||13||
48645485|NCT01428128|101916967|FG000|STARTED|Overall Study||50||
48645486|NCT01428128|101916967|FG000|COMPLETED|Overall Study||33||
48645487|NCT01428128|101916967|FG000|NOT COMPLETED|Overall Study||17||
48645488|NCT02043860|101916968|FG000|STARTED|Overall Study||2||
48645489|NCT02043860|101916968|FG000|COMPLETED|Overall Study||2||
48645490|NCT02043860|101916968|FG000|NOT COMPLETED|Overall Study||0||
48645491|NCT00456612|101916969|FG000|STARTED|Overall Study||4||
48645492|NCT00456612|101916969|FG000|COMPLETED|Overall Study||1||
48645493|NCT00456612|101916969|FG000|NOT COMPLETED|Overall Study||3||
48645494|NCT00864513|101916970|FG000|STARTED|Overall Study||15||
48645495|NCT00864513|101916970|FG000|COMPLETED|Overall Study||12||
48645496|NCT00864513|101916970|FG000|NOT COMPLETED|Overall Study||3||
48645497|NCT00376506|101916971|FG000|STARTED|Overall Study||4||
48645498|NCT00376506|101916972|FG001|STARTED|Overall Study||6||
48645499|NCT00376506|101916971|FG000|COMPLETED|Overall Study||4||
48645500|NCT00376506|101916972|FG001|COMPLETED|Overall Study||4||
48645501|NCT00376506|101916971|FG000|NOT COMPLETED|Overall Study||0||
48645502|NCT00376506|101916972|FG001|NOT COMPLETED|Overall Study||2||
48645503|NCT00604383|101916973|FG000|STARTED|Overall Study||345||
48645504|NCT00604383|101916974|FG001|STARTED|Overall Study||340||
48645505|NCT00604383|101916973|FG000|Received at Least 1 Dose of Study Drug|Overall Study||345||
48645506|NCT00604383|101916974|FG001|Received at Least 1 Dose of Study Drug|Overall Study||340||
48645507|NCT00604383|101916973|FG000|Received Extended Treatment|Overall Study||136||
48645508|NCT00604383|101916974|FG001|Received Extended Treatment|Overall Study||141||
48645509|NCT00604383|101916973|FG000|COMPLETED|Overall Study||258||
48645510|NCT00604383|101916974|FG001|COMPLETED|Overall Study||256||
48645511|NCT00604383|101916973|FG000|NOT COMPLETED|Overall Study||87||
48645512|NCT00604383|101916974|FG001|NOT COMPLETED|Overall Study||84||
48645513|NCT00549328|101916975|FG000|STARTED|Overall Study||14||
48645514|NCT00549328|101916975|FG000|COMPLETED|Overall Study||0||
48645515|NCT00549328|101916975|FG000|NOT COMPLETED|Overall Study||14||
48645516|NCT01668537|101916976|FG000|STARTED|Overall Study||327|randomized and vaccinated|
48645517|NCT01668537|101916977|FG001|STARTED|Overall Study||324|randomized and vaccinated|
48645518|NCT01668537|101916976|FG000|COMPLETED|Overall Study||305|active trial phase|
48645519|NCT01668537|101916977|FG001|COMPLETED|Overall Study||314|active trial phase|
48645520|NCT01668537|101916976|FG000|NOT COMPLETED|Overall Study||22||
48645521|NCT01668537|101916977|FG001|NOT COMPLETED|Overall Study||10||
48645522|NCT01108055|101916978|FG000|STARTED|Overall Study||43||
48645523|NCT01108055|101916978|FG000|Eligible and Started Treatment|Overall Study||32||
48645524|NCT01108055|101916978|FG000|COMPLETED|Overall Study||28||
48645525|NCT01108055|101916978|FG000|NOT COMPLETED|Overall Study||15||
48645526|NCT03188705|101916979|FG000|STARTED|Clopidogrel Treatment||6||
48645527|NCT03188705|101916979|FG000|COMPLETED|Clopidogrel Treatment||5||
48645528|NCT03188705|101916979|FG000|NOT COMPLETED|Clopidogrel Treatment||1||
48645529|NCT03188705|101916979|FG000|STARTED|Clopidogrel Plus Aspirin Treatment||6||
48645530|NCT03188705|101916979|FG000|COMPLETED|Clopidogrel Plus Aspirin Treatment||5||
48645531|NCT03188705|101916979|FG000|NOT COMPLETED|Clopidogrel Plus Aspirin Treatment||1||
48645532|NCT01098578|101916980|FG000|STARTED|Overall Study||20||
48645533|NCT01098578|101916980|FG000|COMPLETED|Overall Study||20||
48645534|NCT01098578|101916980|FG000|NOT COMPLETED|Overall Study||0||
48645535|NCT01896986|101916981|FG000|STARTED|Overall Study||14||
48645536|NCT01896986|101916982|FG001|STARTED|Overall Study||23||
48645537|NCT01896986|101916981|FG000|COMPLETED|Overall Study||0||
48645538|NCT01896986|101916982|FG001|COMPLETED|Overall Study||0||
48645539|NCT01896986|101916981|FG000|NOT COMPLETED|Overall Study||14||
48645540|NCT01896986|101916982|FG001|NOT COMPLETED|Overall Study||23||
48645541|NCT01797185|101916983|FG000|STARTED|Overall Study||162||
48645542|NCT01797185|101916984|FG001|STARTED|Overall Study||163||
48645543|NCT01797185|101916985|FG002|STARTED|Overall Study||50||
48645544|NCT01797185|101916983|FG000|COMPLETED|Overall Study||134||
48645545|NCT01797185|101916984|FG001|COMPLETED|Overall Study||125||
48645546|NCT01797185|101916985|FG002|COMPLETED|Overall Study||38||
48645547|NCT01797185|101916983|FG000|NOT COMPLETED|Overall Study||28||
48645548|NCT01797185|101916984|FG001|NOT COMPLETED|Overall Study||38||
48645549|NCT01797185|101916985|FG002|NOT COMPLETED|Overall Study||12||
48645550|NCT04764539|101916986|FG000|STARTED|Overall Study||3||
48645551|NCT04764539|101916987|FG001|STARTED|Overall Study||3||
48645552|NCT04764539|101916986|FG000|COMPLETED|Overall Study||3||
48645553|NCT04764539|101916987|FG001|COMPLETED|Overall Study||3||
48645554|NCT04764539|101916986|FG000|NOT COMPLETED|Overall Study||0||
48645555|NCT04764539|101916987|FG001|NOT COMPLETED|Overall Study||0||
48645556|NCT01163656|101916988|FG000|STARTED|Overall Study||33||
48645557|NCT01163656|101916989|FG001|STARTED|Overall Study||33||
48645558|NCT01163656|101916988|FG000|COMPLETED|Overall Study||30||
48645559|NCT01163656|101916989|FG001|COMPLETED|Overall Study||30||
48645560|NCT01163656|101916988|FG000|NOT COMPLETED|Overall Study||3||
48645561|NCT01163656|101916989|FG001|NOT COMPLETED|Overall Study||3||
48645562|NCT00120874|101916990|FG000|STARTED|Overall Study||10||
48645563|NCT00120874|101916991|FG001|STARTED|Overall Study||10||
48657043|NCT03648372|101943762|FG005|STARTED|Overall Study||4||
48645564|NCT00120874|101916990|FG000|Completed Study; Started Extension Study|Overall Study||10||
48645565|NCT00120874|101916991|FG001|Completed Study; Started Extension Study|Overall Study||10||
48645566|NCT00120874|101916990|FG000|COMPLETED|Overall Study||10||
48645567|NCT00120874|101916991|FG001|COMPLETED|Overall Study||9||
48645568|NCT00120874|101916990|FG000|NOT COMPLETED|Overall Study||0||
48645569|NCT00120874|101916991|FG001|NOT COMPLETED|Overall Study||1||
48645570|NCT01623752|101916992|FG000|STARTED|Phase 1 (78 Weeks)||1378||
48645571|NCT01623752|101916993|FG001|STARTED|Phase 1 (78 Weeks)||440||
48645572|NCT01623752|101916994|FG002|STARTED|Phase 1 (78 Weeks)||3||
48645573|NCT01623752|101916992|FG000|COMPLETED|Phase 1 (78 Weeks)||747||
48645574|NCT01623752|101916993|FG001|COMPLETED|Phase 1 (78 Weeks)||233||
48645575|NCT01623752|101916994|FG002|COMPLETED|Phase 1 (78 Weeks)||1||
48645576|NCT01623752|101916992|FG000|NOT COMPLETED|Phase 1 (78 Weeks)||631||
48645577|NCT01623752|101916993|FG001|NOT COMPLETED|Phase 1 (78 Weeks)||207||
48645578|NCT01623752|101916994|FG002|NOT COMPLETED|Phase 1 (78 Weeks)||2||
48645579|NCT01623752|101916992|FG000|STARTED|Phase 2 (78 Weeks)||291||
48645580|NCT01623752|101916993|FG001|STARTED|Phase 2 (78 Weeks)||116||
48645581|NCT01623752|101916994|FG002|STARTED|Phase 2 (78 Weeks)||0||
48645582|NCT01623752|101916992|FG000|COMPLETED|Phase 2 (78 Weeks)||225||
48645583|NCT01623752|101916993|FG001|COMPLETED|Phase 2 (78 Weeks)||98||
48645584|NCT01623752|101916994|FG002|COMPLETED|Phase 2 (78 Weeks)||0||
48645585|NCT01623752|101916992|FG000|NOT COMPLETED|Phase 2 (78 Weeks)||66||
48645586|NCT01623752|101916993|FG001|NOT COMPLETED|Phase 2 (78 Weeks)||18||
48645587|NCT01623752|101916994|FG002|NOT COMPLETED|Phase 2 (78 Weeks)||0||
48645588|NCT00597675|101916995|FG000|STARTED|Blinded Phase||4||
48645589|NCT00597675|101916996|FG001|STARTED|Blinded Phase||6||
48645590|NCT00597675|101916995|FG000|COMPLETED|Blinded Phase||2||
48645591|NCT00597675|101916996|FG001|COMPLETED|Blinded Phase||5||
48645592|NCT00597675|101916995|FG000|NOT COMPLETED|Blinded Phase||2||
48645593|NCT00597675|101916996|FG001|NOT COMPLETED|Blinded Phase||1||
48645594|NCT00597675|101916995|FG000|STARTED|Open Label Phase||2||
48645595|NCT00597675|101916996|FG001|STARTED|Open Label Phase||5||
48645596|NCT00597675|101916995|FG000|COMPLETED|Open Label Phase||2||
48645597|NCT00597675|101916996|FG001|COMPLETED|Open Label Phase||5||
48645598|NCT00597675|101916995|FG000|NOT COMPLETED|Open Label Phase||0||
48645599|NCT00597675|101916996|FG001|NOT COMPLETED|Open Label Phase||0||
48645600|NCT00837330|101916997|FG000|STARTED|Overall Study||10||
48645601|NCT00837330|101916998|FG001|STARTED|Overall Study||10||
48645602|NCT00837330|101916997|FG000|COMPLETED|Overall Study||9||
48645603|NCT00837330|101916998|FG001|COMPLETED|Overall Study||7||
48645604|NCT00837330|101916997|FG000|NOT COMPLETED|Overall Study||1||
48645605|NCT00837330|101916998|FG001|NOT COMPLETED|Overall Study||3||
48645606|NCT00508300|101916999|FG000|STARTED|Overall Study||67||
48645607|NCT00508300|101917000|FG001|STARTED|Overall Study||61||
48645608|NCT00508300|101916999|FG000|COMPLETED|Overall Study||65||
48645609|NCT00508300|101917000|FG001|COMPLETED|Overall Study||57||
48645610|NCT00508300|101916999|FG000|NOT COMPLETED|Overall Study||2||
48645611|NCT00508300|101917000|FG001|NOT COMPLETED|Overall Study||4||
48645612|NCT03083379|101917001|FG000|STARTED|Overall Study||15||
48765183|NCT02113982|102214589|FG006|NOT COMPLETED|Stage 3: Efficacy Cohort||0||
48765184|NCT02113982|102214590|FG007|NOT COMPLETED|Stage 3: Efficacy Cohort||0||
48645613|NCT03083379|101917002|FG001|STARTED|Overall Study||15||
48645614|NCT03083379|101917001|FG000|COMPLETED|Overall Study||15||
48645615|NCT03083379|101917002|FG001|COMPLETED|Overall Study||15||
48645616|NCT03083379|101917001|FG000|NOT COMPLETED|Overall Study||0||
48645617|NCT03083379|101917002|FG001|NOT COMPLETED|Overall Study||0||
48645618|NCT00601107|101917003|FG000|STARTED|Overall Study||27||
48645619|NCT00601107|101917004|FG001|STARTED|Overall Study||31||
48645620|NCT00601107|101917005|FG002|STARTED|Overall Study||28||
48645621|NCT00601107|101917006|FG003|STARTED|Overall Study||25||
48645622|NCT00601107|101917003|FG000|Treated|Overall Study||27||
48645623|NCT00601107|101917004|FG001|Treated|Overall Study||31||
48645624|NCT00601107|101917005|FG002|Treated|Overall Study||28||
48645625|NCT00601107|101917006|FG003|Treated|Overall Study||25||
48645626|NCT00601107|101917003|FG000|COMPLETED|Overall Study||14||
48765185|NCT02113982|102214591|FG008|NOT COMPLETED|Stage 3: Efficacy Cohort||0||
48765186|NCT02113982|102214592|FG009|NOT COMPLETED|Stage 3: Efficacy Cohort||0||
48765187|NCT02113982|102214593|FG010|NOT COMPLETED|Stage 3: Efficacy Cohort||0||
48645627|NCT00601107|101917004|FG001|COMPLETED|Overall Study||22||
48645628|NCT00601107|101917005|FG002|COMPLETED|Overall Study||16||
48645629|NCT00601107|101917006|FG003|COMPLETED|Overall Study||13||
48645630|NCT00601107|101917003|FG000|NOT COMPLETED|Overall Study||13||
48645631|NCT00601107|101917004|FG001|NOT COMPLETED|Overall Study||9||
48645632|NCT00601107|101917005|FG002|NOT COMPLETED|Overall Study||12||
48645633|NCT00601107|101917006|FG003|NOT COMPLETED|Overall Study||12||
48645634|NCT04401293|101917007|FG000|STARTED|Overall Study||130||
48645635|NCT04401293|101917008|FG001|STARTED|Overall Study||127||
48645636|NCT04401293|101917007|FG000|COMPLETED|Overall Study||129||
48645637|NCT04401293|101917008|FG001|COMPLETED|Overall Study||124||
48645638|NCT04401293|101917007|FG000|NOT COMPLETED|Overall Study||1||
48645639|NCT04401293|101917008|FG001|NOT COMPLETED|Overall Study||3||
48645640|NCT04097223|101917009|FG000|STARTED|Overall Study||17464||
48645641|NCT04097223|101917009|FG000|COMPLETED|Overall Study||17464||
48645642|NCT04097223|101917009|FG000|NOT COMPLETED|Overall Study||0||
48645643|NCT02337946|101917010|FG000|STARTED|Protocol Treatment 1 Period||164||
48645644|NCT02337946|101917011|FG001|STARTED|Protocol Treatment 1 Period||0||
48645645|NCT02337946|101917012|FG002|STARTED|Protocol Treatment 1 Period||0||
48645646|NCT02337946|101917010|FG000|COMPLETED|Protocol Treatment 1 Period||114||
48645647|NCT02337946|101917011|FG001|COMPLETED|Protocol Treatment 1 Period||0||
48645648|NCT02337946|101917012|FG002|COMPLETED|Protocol Treatment 1 Period||0||
48645649|NCT02337946|101917010|FG000|NOT COMPLETED|Protocol Treatment 1 Period||50||
48645650|NCT02337946|101917011|FG001|NOT COMPLETED|Protocol Treatment 1 Period||0||
48645651|NCT02337946|101917012|FG002|NOT COMPLETED|Protocol Treatment 1 Period||0||
48645652|NCT02337946|101917010|FG000|STARTED|In-between Period||114||
48645653|NCT02337946|101917011|FG001|STARTED|In-between Period||0||
48645654|NCT02337946|101917012|FG002|STARTED|In-between Period||0||
48645655|NCT02337946|101917010|FG000|COMPLETED|In-between Period||113||
48645656|NCT02337946|101917011|FG001|COMPLETED|In-between Period||0||
48645657|NCT02337946|101917012|FG002|COMPLETED|In-between Period||0||
48645658|NCT02337946|101917010|FG000|NOT COMPLETED|In-between Period||1||
48645659|NCT02337946|101917011|FG001|NOT COMPLETED|In-between Period||0||
48645660|NCT02337946|101917012|FG002|NOT COMPLETED|In-between Period||0||
48645661|NCT02337946|101917010|FG000|STARTED|Protocol Treatment 2 Period||0||
48645662|NCT02337946|101917011|FG001|STARTED|Protocol Treatment 2 Period||56||
48645663|NCT02337946|101917012|FG002|STARTED|Protocol Treatment 2 Period||57||
48645664|NCT02337946|101917010|FG000|Safety Population|Protocol Treatment 2 Period||0||
48188154|NCT02018861|100783173|FG003|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
48188155|NCT02018861|100783174|FG004|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
48188156|NCT02018861|100783175|FG005|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
48188157|NCT02018861|100783176|FG006|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||8||
48188158|NCT02018861|100783177|FG007|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||3||
48188159|NCT02018861|100783178|FG008|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
48188160|NCT02018861|100783179|FG009|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
48188161|NCT02018861|100783170|FG000|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0||
48188162|NCT02018861|100783171|FG001|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0||
48188163|NCT02018861|100783172|FG002|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0||
48188164|NCT02018861|100783173|FG003|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0||
48361999|NCT00336492|101214461|FG001|STARTED|Overall Study||22||
48436199|NCT03522506|101403515|FG001|COMPLETED|Treatment Period 1 (2 Days)||5||
48645665|NCT02337946|101917011|FG001|Safety Population|Protocol Treatment 2 Period||56||
48645666|NCT02337946|101917012|FG002|Safety Population|Protocol Treatment 2 Period||54||
48645667|NCT02337946|101917010|FG000|COMPLETED|Protocol Treatment 2 Period||0||
48645668|NCT02337946|101917011|FG001|COMPLETED|Protocol Treatment 2 Period||5||
48188165|NCT02018861|100783174|FG004|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0||
48188166|NCT02018861|100783175|FG005|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0||
48188167|NCT02018861|100783176|FG006|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0||
48188168|NCT02018861|100783177|FG007|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0||
48362000|NCT00336492|101214462|FG002|STARTED|Overall Study||23||
48362001|NCT00336492|101214460|FG000|COMPLETED|Overall Study||0||
48362002|NCT00336492|101214461|FG001|COMPLETED|Overall Study||18||
48362003|NCT00336492|101214462|FG002|COMPLETED|Overall Study||12||
48362004|NCT00336492|101214460|FG000|NOT COMPLETED|Overall Study||15||
48362005|NCT00336492|101214461|FG001|NOT COMPLETED|Overall Study||4||
48362006|NCT00336492|101214462|FG002|NOT COMPLETED|Overall Study||11||
48362007|NCT00756977|101214463|FG000|STARTED|Overall Study||196||
48362008|NCT00756977|101214464|FG001|STARTED|Overall Study||198||
48362009|NCT00756977|101214463|FG000|COMPLETED|Overall Study||175||
48362010|NCT00756977|101214464|FG001|COMPLETED|Overall Study||187||
48362011|NCT00756977|101214463|FG000|NOT COMPLETED|Overall Study||21||
48362012|NCT00756977|101214464|FG001|NOT COMPLETED|Overall Study||11||
48362013|NCT00325572|101214465|FG000|STARTED|PHASE I||45||
48362014|NCT00325572|101214466|FG001|STARTED|PHASE I||44||
48362015|NCT00325572|101214465|FG000|COMPLETED|PHASE I||45||
48362016|NCT00325572|101214466|FG001|COMPLETED|PHASE I||44||
48362017|NCT00325572|101214465|FG000|NOT COMPLETED|PHASE I||0||
48362018|NCT00325572|101214466|FG001|NOT COMPLETED|PHASE I||0||
48362019|NCT00325572|101214465|FG000|STARTED|PHASE ii||0||
48362020|NCT00325572|101214466|FG001|STARTED|PHASE ii||0||
48362021|NCT00325572|101214465|FG000|COMPLETED|PHASE ii||0||
48362022|NCT00325572|101214466|FG001|COMPLETED|PHASE ii||0||
48362023|NCT00325572|101214465|FG000|NOT COMPLETED|PHASE ii||0||
48362024|NCT00325572|101214466|FG001|NOT COMPLETED|PHASE ii||0||
48362025|NCT00117338|101214467|FG000|STARTED|Overall Study||145||
48362026|NCT00117338|101214468|FG001|STARTED|Overall Study||131||
48362027|NCT00117338|101214467|FG000|COMPLETED|Overall Study||140||
48362028|NCT00117338|101214468|FG001|COMPLETED|Overall Study||127||
48362029|NCT00117338|101214467|FG000|NOT COMPLETED|Overall Study||5||
48362030|NCT00117338|101214468|FG001|NOT COMPLETED|Overall Study||4||
48362031|NCT00128206|101214469|FG000|STARTED|Overall Study||184||
48362032|NCT00128206|101214470|FG001|STARTED|Overall Study||180||
48362033|NCT00128206|101214469|FG000|COMPLETED|Overall Study||47||
48362034|NCT00128206|101214470|FG001|COMPLETED|Overall Study||60||
48362035|NCT00128206|101214469|FG000|NOT COMPLETED|Overall Study||137||
48362036|NCT00128206|101214470|FG001|NOT COMPLETED|Overall Study||120||
48362037|NCT00728416|101214471|FG000|STARTED|Overall Study||168||
48362038|NCT00728416|101214472|FG001|STARTED|Overall Study||165||
48362039|NCT00728416|101214471|FG000|COMPLETED|Overall Study||166||
48362040|NCT00728416|101214472|FG001|COMPLETED|Overall Study||163||
48362041|NCT00728416|101214471|FG000|NOT COMPLETED|Overall Study||2||
48362042|NCT00728416|101214472|FG001|NOT COMPLETED|Overall Study||2||
48362043|NCT00758862|101214473|FG000|STARTED|Overall Study||20||
48362044|NCT00758862|101214473|FG000|COMPLETED|Overall Study||19||
48362045|NCT00758862|101214473|FG000|NOT COMPLETED|Overall Study||1||
48362046|NCT01852344|101214474|FG000|STARTED|Overall Study||27||
48362047|NCT01852344|101214475|FG001|STARTED|Overall Study||27||
48362048|NCT01852344|101214476|FG002|STARTED|Overall Study||27||
48362049|NCT01852344|101214477|FG003|STARTED|Overall Study||27||
48362050|NCT01852344|101214474|FG000|Actual Participation in First Assignment|Overall Study||27||
48645669|NCT02337946|101917012|FG002|COMPLETED|Protocol Treatment 2 Period||7||
48645670|NCT02337946|101917010|FG000|NOT COMPLETED|Protocol Treatment 2 Period||0||
48645671|NCT02337946|101917011|FG001|NOT COMPLETED|Protocol Treatment 2 Period||51||
48645672|NCT02337946|101917012|FG002|NOT COMPLETED|Protocol Treatment 2 Period||50||
48188169|NCT02018861|100783178|FG008|STARTED|Parsaclisib + R-ICE; 21-day Cycles||4||
48188170|NCT02018861|100783179|FG009|STARTED|Parsaclisib + R-ICE; 21-day Cycles||1||
48188171|NCT02018861|100783170|FG000|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0||
48188172|NCT02018861|100783171|FG001|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0||
48188173|NCT02018861|100783172|FG002|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0||
48436200|NCT03522506|101403516|FG002|COMPLETED|Treatment Period 1 (2 Days)||5||
48436201|NCT03522506|101403517|FG003|COMPLETED|Treatment Period 1 (2 Days)||5||
48436202|NCT03522506|101403514|FG000|NOT COMPLETED|Treatment Period 1 (2 Days)||0||
48436203|NCT03522506|101403515|FG001|NOT COMPLETED|Treatment Period 1 (2 Days)||0||
48436204|NCT03522506|101403516|FG002|NOT COMPLETED|Treatment Period 1 (2 Days)||0||
48436205|NCT03522506|101403517|FG003|NOT COMPLETED|Treatment Period 1 (2 Days)||0||
48436206|NCT03522506|101403514|FG000|STARTED|Washout Period 1 (7 Days)||5||
48436207|NCT03522506|101403515|FG001|STARTED|Washout Period 1 (7 Days)||5||
48436208|NCT03522506|101403516|FG002|STARTED|Washout Period 1 (7 Days)||5||
48436209|NCT03522506|101403517|FG003|STARTED|Washout Period 1 (7 Days)||5||
48436210|NCT03522506|101403514|FG000|COMPLETED|Washout Period 1 (7 Days)||5||
48436211|NCT03522506|101403515|FG001|COMPLETED|Washout Period 1 (7 Days)||5||
48436212|NCT03522506|101403516|FG002|COMPLETED|Washout Period 1 (7 Days)||5||
48436213|NCT03522506|101403517|FG003|COMPLETED|Washout Period 1 (7 Days)||4||
48436214|NCT03522506|101403514|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48436215|NCT03522506|101403515|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48436216|NCT03522506|101403516|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48436217|NCT03522506|101403517|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1||
48436218|NCT03522506|101403514|FG000|STARTED|Treatment Period 2 (2 Days)||5||
48436219|NCT03522506|101403515|FG001|STARTED|Treatment Period 2 (2 Days)||5||
48436220|NCT03522506|101403516|FG002|STARTED|Treatment Period 2 (2 Days)||5||
48436221|NCT03522506|101403517|FG003|STARTED|Treatment Period 2 (2 Days)||4||
48436222|NCT03522506|101403514|FG000|COMPLETED|Treatment Period 2 (2 Days)||5||
48436223|NCT03522506|101403515|FG001|COMPLETED|Treatment Period 2 (2 Days)||5||
48436224|NCT03522506|101403516|FG002|COMPLETED|Treatment Period 2 (2 Days)||5||
48436225|NCT03522506|101403517|FG003|COMPLETED|Treatment Period 2 (2 Days)||4||
48436226|NCT03522506|101403514|FG000|NOT COMPLETED|Treatment Period 2 (2 Days)||0||
48436227|NCT03522506|101403515|FG001|NOT COMPLETED|Treatment Period 2 (2 Days)||0||
48436228|NCT03522506|101403516|FG002|NOT COMPLETED|Treatment Period 2 (2 Days)||0||
48436229|NCT03522506|101403517|FG003|NOT COMPLETED|Treatment Period 2 (2 Days)||0||
48436230|NCT03522506|101403514|FG000|STARTED|Washout Period 2 (7 Days)||5||
48436231|NCT03522506|101403515|FG001|STARTED|Washout Period 2 (7 Days)||5||
48436232|NCT03522506|101403516|FG002|STARTED|Washout Period 2 (7 Days)||5||
48436233|NCT03522506|101403517|FG003|STARTED|Washout Period 2 (7 Days)||4||
48436234|NCT03522506|101403514|FG000|COMPLETED|Washout Period 2 (7 Days)||5||
48436235|NCT03522506|101403515|FG001|COMPLETED|Washout Period 2 (7 Days)||5||
48436236|NCT03522506|101403516|FG002|COMPLETED|Washout Period 2 (7 Days)||5||
48436237|NCT03522506|101403517|FG003|COMPLETED|Washout Period 2 (7 Days)||3||
48436238|NCT03522506|101403514|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48436239|NCT03522506|101403515|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48436240|NCT03522506|101403516|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48436241|NCT03522506|101403517|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||1||
48436242|NCT03522506|101403514|FG000|STARTED|Treatment Period 3 (2 Days)||5||
48436243|NCT03522506|101403515|FG001|STARTED|Treatment Period 3 (2 Days)||5||
48436244|NCT03522506|101403516|FG002|STARTED|Treatment Period 3 (2 Days)||5||
48436245|NCT03522506|101403517|FG003|STARTED|Treatment Period 3 (2 Days)||3||
48436246|NCT03522506|101403514|FG000|COMPLETED|Treatment Period 3 (2 Days)||5||
48436247|NCT03522506|101403515|FG001|COMPLETED|Treatment Period 3 (2 Days)||5||
48436248|NCT03522506|101403516|FG002|COMPLETED|Treatment Period 3 (2 Days)||5||
48436249|NCT03522506|101403517|FG003|COMPLETED|Treatment Period 3 (2 Days)||3||
48436250|NCT03522506|101403514|FG000|NOT COMPLETED|Treatment Period 3 (2 Days)||0||
48436251|NCT03522506|101403515|FG001|NOT COMPLETED|Treatment Period 3 (2 Days)||0||
48436252|NCT03522506|101403516|FG002|NOT COMPLETED|Treatment Period 3 (2 Days)||0||
48436253|NCT03522506|101403517|FG003|NOT COMPLETED|Treatment Period 3 (2 Days)||0||
48436254|NCT03522506|101403514|FG000|STARTED|Washout Period 3 (7 Days)||5||
48436255|NCT03522506|101403515|FG001|STARTED|Washout Period 3 (7 Days)||5||
48436256|NCT03522506|101403516|FG002|STARTED|Washout Period 3 (7 Days)||5||
48436257|NCT03522506|101403517|FG003|STARTED|Washout Period 3 (7 Days)||3||
48436258|NCT03522506|101403514|FG000|COMPLETED|Washout Period 3 (7 Days)||5||
48436259|NCT03522506|101403515|FG001|COMPLETED|Washout Period 3 (7 Days)||5||
48436260|NCT03522506|101403516|FG002|COMPLETED|Washout Period 3 (7 Days)||5||
48436261|NCT03522506|101403517|FG003|COMPLETED|Washout Period 3 (7 Days)||3||
48439999|NCT01143610|101410005|FG000|COMPLETED|Overall Study||7||
48645673|NCT02487485|101917013|FG000|STARTED|Overall Study||12||
48645674|NCT02487485|101917014|FG001|STARTED|Overall Study||11||
48436262|NCT03522506|101403514|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48645675|NCT02487485|101917013|FG000|COMPLETED|Overall Study||9||
48645676|NCT02487485|101917014|FG001|COMPLETED|Overall Study||8||
48645677|NCT02487485|101917013|FG000|NOT COMPLETED|Overall Study||3||
48645678|NCT02487485|101917014|FG001|NOT COMPLETED|Overall Study||3||
48645679|NCT01192698|101917015|FG000|STARTED|Overall Study||10||
48645680|NCT01192698|101917016|FG001|STARTED|Overall Study||5||
48645681|NCT01192698|101917015|FG000|COMPLETED|Overall Study||10||
48645682|NCT01192698|101917016|FG001|COMPLETED|Overall Study||5||
48645683|NCT01192698|101917015|FG000|NOT COMPLETED|Overall Study||0||
48645684|NCT01192698|101917016|FG001|NOT COMPLETED|Overall Study||0||
48645685|NCT00968968|101917017|FG000|STARTED|Overall Study||20||
48645686|NCT00968968|101917018|FG001|STARTED|Overall Study||17||
48645687|NCT00968968|101917017|FG000|COMPLETED|Overall Study||4||
48645688|NCT00968968|101917018|FG001|COMPLETED|Overall Study||3||
48645689|NCT00968968|101917017|FG000|NOT COMPLETED|Overall Study||16||
48645690|NCT00968968|101917018|FG001|NOT COMPLETED|Overall Study||14||
48645691|NCT03097315|101917019|FG000|STARTED|Overall Study||38||
48645692|NCT03097315|101917019|FG000|Intention-to-Treat Population|Overall Study||38|Defined as all patients eligible to be treated with CLS-TA (i.e., patients who did not fail screening and entered the study).|
48645693|NCT03097315|101917019|FG000|Safety Population|Overall Study||38|Defined as all patients who entered the study and were administered at least one dose of CLS-TA.|
48645694|NCT03097315|101917019|FG000|COMPLETED|Overall Study||37||
48645695|NCT03097315|101917019|FG000|NOT COMPLETED|Overall Study||1||
48645696|NCT00311168|101917020|FG000|STARTED|First Intervention||66||
48645697|NCT00311168|101917021|FG001|STARTED|First Intervention||68||
48645698|NCT00311168|101917020|FG000|COMPLETED|First Intervention||59||
48645699|NCT00311168|101917021|FG001|COMPLETED|First Intervention||62||
48645700|NCT00311168|101917020|FG000|NOT COMPLETED|First Intervention||7||
48645701|NCT00311168|101917021|FG001|NOT COMPLETED|First Intervention||6||
48645702|NCT00311168|101917020|FG000|STARTED|Second Intervention||59||
48645703|NCT00311168|101917021|FG001|STARTED|Second Intervention||62||
48645704|NCT00311168|101917020|FG000|COMPLETED|Second Intervention||49||
48645705|NCT00311168|101917021|FG001|COMPLETED|Second Intervention||58||
48645706|NCT00311168|101917020|FG000|NOT COMPLETED|Second Intervention||10||
48645707|NCT00311168|101917021|FG001|NOT COMPLETED|Second Intervention||4||
48645708|NCT01137812|101917022|FG000|STARTED|Overall Study||377||
48645709|NCT01137812|101917023|FG001|STARTED|Overall Study||378||
48645710|NCT01137812|101917022|FG000|COMPLETED|Overall Study||254||
48645711|NCT01137812|101917023|FG001|COMPLETED|Overall Study||210||
48645712|NCT01137812|101917022|FG000|NOT COMPLETED|Overall Study||123||
48645713|NCT01137812|101917023|FG001|NOT COMPLETED|Overall Study||168||
48645714|NCT01774370|101917024|FG000|STARTED|Overall Study||3182||
48645715|NCT01774370|101917024|FG000|COMPLETED|Overall Study||3053||
48645716|NCT01774370|101917024|FG000|NOT COMPLETED|Overall Study||129||
48645717|NCT02346916|101917025|FG000|STARTED|Overall Study||20||
48645718|NCT02346916|101917025|FG000|COMPLETED|Overall Study||20||
48645719|NCT02346916|101917025|FG000|NOT COMPLETED|Overall Study||0||
48645720|NCT03096353|101917026|FG000|STARTED|Period 1||15||
48645721|NCT03096353|101917027|FG001|STARTED|Period 1||13||
48645722|NCT03096353|101917026|FG000|COMPLETED|Period 1||12||
48645723|NCT03096353|101917027|FG001|COMPLETED|Period 1||12||
48645724|NCT03096353|101917026|FG000|NOT COMPLETED|Period 1||3||
48645725|NCT03096353|101917027|FG001|NOT COMPLETED|Period 1||1||
48645726|NCT03096353|101917026|FG000|STARTED|Period 2||12||
48645727|NCT03096353|101917027|FG001|STARTED|Period 2||12||
48645728|NCT03096353|101917026|FG000|COMPLETED|Period 2||12||
48645729|NCT03096353|101917027|FG001|COMPLETED|Period 2||12||
48645730|NCT03096353|101917026|FG000|NOT COMPLETED|Period 2||0||
48645731|NCT03096353|101917027|FG001|NOT COMPLETED|Period 2||0||
48645732|NCT02810327|101917028|FG000|STARTED|Overall Study||76||
48645733|NCT02810327|101917029|FG001|STARTED|Overall Study||41||
48645734|NCT02810327|101917028|FG000|COMPLETED|Overall Study||69||
48645735|NCT02810327|101917029|FG001|COMPLETED|Overall Study||34||
48645736|NCT02810327|101917028|FG000|NOT COMPLETED|Overall Study||7||
48765188|NCT02113982|102214594|FG011|NOT COMPLETED|Stage 3: Efficacy Cohort||13||
48765189|NCT02113982|102214595|FG012|NOT COMPLETED|Stage 3: Efficacy Cohort||0||
48436263|NCT03522506|101403515|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48645737|NCT02810327|101917029|FG001|NOT COMPLETED|Overall Study||7||
48645738|NCT01953237|101917030|FG000|STARTED|Overall Study||10||
48645739|NCT01953237|101917031|FG001|STARTED|Overall Study||21||
48645740|NCT01953237|101917030|FG000|COMPLETED|Overall Study||10||
48645741|NCT01953237|101917031|FG001|COMPLETED|Overall Study||21||
48645742|NCT01953237|101917030|FG000|NOT COMPLETED|Overall Study||0||
48645743|NCT01953237|101917031|FG001|NOT COMPLETED|Overall Study||0||
48645744|NCT01109381|101917032|FG000|STARTED|Overall Study||33||
48645745|NCT01109381|101917032|FG000|COMPLETED|Overall Study||31||
48645746|NCT01109381|101917032|FG000|NOT COMPLETED|Overall Study||2||
48645747|NCT00875667|101917033|FG000|STARTED|Overall Study||170||
48645748|NCT00875667|101917034|FG001|STARTED|Overall Study||84||
48645749|NCT00875667|101917033|FG000|Crossover From IC to Lenalidomide|Overall Study||0|Upon disease progression, participants crossed over to lenalidomide|
48657044|NCT03648372|101943763|FG006|STARTED|Overall Study||7||
48645750|NCT00875667|101917034|FG001|Crossover From IC to Lenalidomide|Overall Study||40|Upon disease progression, participants crossed over to lenalidomide|
48645751|NCT00875667|101917033|FG000|Participants Treated|Overall Study||167||
48645752|NCT00875667|101917034|FG001|Participants Treated|Overall Study||83||
48645753|NCT00875667|101917033|FG000|COMPLETED|Overall Study||0||
48645754|NCT00875667|101917034|FG001|COMPLETED|Overall Study||11||
48645755|NCT00875667|101917033|FG000|NOT COMPLETED|Overall Study||170||
48645756|NCT00875667|101917034|FG001|NOT COMPLETED|Overall Study||73||
48645757|NCT04171999|101917035|FG000|STARTED|Overall Study||320||
48645758|NCT04171999|101917036|FG001|STARTED|Overall Study||320||
48645759|NCT04171999|101917035|FG000|COMPLETED|Overall Study||318||
48645760|NCT04171999|101917036|FG001|COMPLETED|Overall Study||319||
48645761|NCT04171999|101917035|FG000|NOT COMPLETED|Overall Study||2||
48645762|NCT04171999|101917036|FG001|NOT COMPLETED|Overall Study||1||
48645763|NCT02236767|101917037|FG000|STARTED|Overall Study||1||
48645764|NCT02236767|101917037|FG000|COMPLETED|Overall Study||1||
48645765|NCT02236767|101917037|FG000|NOT COMPLETED|Overall Study||0||
48645766|NCT00498485|101917038|FG000|STARTED|Overall Study||7||
48645767|NCT00498485|101917039|FG001|STARTED|Overall Study||10||
48645768|NCT00498485|101917038|FG000|COMPLETED|Overall Study||6||
48645769|NCT00498485|101917039|FG001|COMPLETED|Overall Study||5||
48645770|NCT00498485|101917038|FG000|NOT COMPLETED|Overall Study||1||
48645771|NCT00498485|101917039|FG001|NOT COMPLETED|Overall Study||5||
48645772|NCT02234180|101917040|FG000|STARTED|Overall Study||2||
48645773|NCT02234180|101917041|FG001|STARTED|Overall Study||1||
48645774|NCT02234180|101917040|FG000|COMPLETED|Overall Study||2||
48645775|NCT02234180|101917041|FG001|COMPLETED|Overall Study||1||
48645776|NCT02234180|101917040|FG000|NOT COMPLETED|Overall Study||0||
48645777|NCT02234180|101917041|FG001|NOT COMPLETED|Overall Study||0||
48645778|NCT00962650|101917042|FG000|STARTED|Overall Study||10||
48645779|NCT00962650|101917042|FG000|COMPLETED|Overall Study||8||
48645780|NCT00962650|101917042|FG000|NOT COMPLETED|Overall Study||2||
48645781|NCT03558672|101917043|FG000|STARTED|Overall Study||18||
48645782|NCT03558672|101917043|FG000|COMPLETED|Overall Study||8||
48645783|NCT03558672|101917043|FG000|NOT COMPLETED|Overall Study||10||
48645784|NCT02508207|101917044|FG000|STARTED|Overall Study||7||
48645785|NCT02508207|101917045|FG001|STARTED|Overall Study||27||
48645786|NCT02508207|101917044|FG000|COMPLETED|Overall Study||7||
48645787|NCT02508207|101917045|FG001|COMPLETED|Overall Study||27||
48645788|NCT02508207|101917044|FG000|NOT COMPLETED|Overall Study||0||
48645789|NCT02508207|101917045|FG001|NOT COMPLETED|Overall Study||0||
48645790|NCT00599313|101917046|FG000|STARTED|Overall Study||36||
48645791|NCT00599313|101917046|FG000|COMPLETED|Overall Study||0||
48645792|NCT00599313|101917046|FG000|NOT COMPLETED|Overall Study||36||
48645793|NCT00371449|101917047|FG000|STARTED|Overall Study||120||
48645794|NCT00371449|101917047|FG000|COMPLETED|Overall Study||120||
48645795|NCT00371449|101917047|FG000|NOT COMPLETED|Overall Study||0||
48645796|NCT01281306|101917048|FG000|STARTED|Overall Study||144||
48645797|NCT01281306|101917049|FG001|STARTED|Overall Study||145||
48645798|NCT01281306|101917050|FG002|STARTED|Overall Study||141||
48645799|NCT01281306|101917051|FG003|STARTED|Overall Study||134||
48645800|NCT01281306|101917052|FG004|STARTED|Overall Study||143||
48645801|NCT01281306|101917053|FG005|STARTED|Overall Study||142||
48645802|NCT01281306|101917054|FG006|STARTED|Overall Study||58||
48645803|NCT01281306|101917048|FG000|Full Analysis Set|Overall Study||143||
48645804|NCT01281306|101917049|FG001|Full Analysis Set|Overall Study||145||
48645805|NCT01281306|101917050|FG002|Full Analysis Set|Overall Study||141||
48362051|NCT01852344|101214475|FG001|Actual Participation in First Assignment|Overall Study||27||
48362052|NCT01852344|101214476|FG002|Actual Participation in First Assignment|Overall Study||27||
48362053|NCT01852344|101214477|FG003|Actual Participation in First Assignment|Overall Study||27||
48362054|NCT01852344|101214474|FG000|COMPLETED|Overall Study||27||
48362055|NCT01852344|101214475|FG001|COMPLETED|Overall Study||27||
48645806|NCT01281306|101917051|FG003|Full Analysis Set|Overall Study||133||
48645807|NCT01281306|101917052|FG004|Full Analysis Set|Overall Study||143||
48645808|NCT01281306|101917053|FG005|Full Analysis Set|Overall Study||142||
48645809|NCT01281306|101917054|FG006|Full Analysis Set|Overall Study||58||
48645810|NCT01281306|101917048|FG000|Safety Set|Overall Study||143||
48645811|NCT01281306|101917049|FG001|Safety Set|Overall Study||145||
48645812|NCT01281306|101917050|FG002|Safety Set|Overall Study||141||
48645813|NCT01281306|101917051|FG003|Safety Set|Overall Study||133||
48645814|NCT01281306|101917052|FG004|Safety Set|Overall Study||143||
48645815|NCT01281306|101917053|FG005|Safety Set|Overall Study||142||
48645816|NCT01281306|101917054|FG006|Safety Set|Overall Study||58||
48645817|NCT01281306|101917048|FG000|Ambulatory Blood Pressure Monitoring Set|Overall Study||95||
48645818|NCT01281306|101917049|FG001|Ambulatory Blood Pressure Monitoring Set|Overall Study||99||
48645819|NCT01281306|101917050|FG002|Ambulatory Blood Pressure Monitoring Set|Overall Study||92||
48645820|NCT01281306|101917051|FG003|Ambulatory Blood Pressure Monitoring Set|Overall Study||95||
48645821|NCT01281306|101917052|FG004|Ambulatory Blood Pressure Monitoring Set|Overall Study||93||
48645822|NCT01281306|101917053|FG005|Ambulatory Blood Pressure Monitoring Set|Overall Study||91||
48645823|NCT01281306|101917054|FG006|Ambulatory Blood Pressure Monitoring Set|Overall Study||35||
48645824|NCT01281306|101917048|FG000|COMPLETED|Overall Study||136||
48645825|NCT01281306|101917049|FG001|COMPLETED|Overall Study||141||
48645826|NCT01281306|101917050|FG002|COMPLETED|Overall Study||133||
48188174|NCT02018861|100783173|FG003|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0||
48188175|NCT02018861|100783174|FG004|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0||
48188176|NCT02018861|100783175|FG005|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0||
48188177|NCT02018861|100783176|FG006|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0||
48188178|NCT02018861|100783177|FG007|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0||
48436264|NCT03522506|101403516|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48436265|NCT03522506|101403517|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48436266|NCT03522506|101403514|FG000|STARTED|Treatment Period 4 (2 Days)||5||
48436267|NCT03522506|101403515|FG001|STARTED|Treatment Period 4 (2 Days)||5||
48436268|NCT03522506|101403516|FG002|STARTED|Treatment Period 4 (2 Days)||5||
48436269|NCT03522506|101403517|FG003|STARTED|Treatment Period 4 (2 Days)||3||
48436270|NCT03522506|101403514|FG000|COMPLETED|Treatment Period 4 (2 Days)||5||
48436271|NCT03522506|101403515|FG001|COMPLETED|Treatment Period 4 (2 Days)||5||
48436272|NCT03522506|101403516|FG002|COMPLETED|Treatment Period 4 (2 Days)||5||
48436273|NCT03522506|101403517|FG003|COMPLETED|Treatment Period 4 (2 Days)||3||
48436274|NCT03522506|101403514|FG000|NOT COMPLETED|Treatment Period 4 (2 Days)||0||
48436275|NCT03522506|101403515|FG001|NOT COMPLETED|Treatment Period 4 (2 Days)||0||
48436276|NCT03522506|101403516|FG002|NOT COMPLETED|Treatment Period 4 (2 Days)||0||
48645827|NCT01281306|101917051|FG003|COMPLETED|Overall Study||123||
48645828|NCT01281306|101917052|FG004|COMPLETED|Overall Study||134||
48645829|NCT01281306|101917053|FG005|COMPLETED|Overall Study||135||
48645830|NCT01281306|101917054|FG006|COMPLETED|Overall Study||51||
48645831|NCT01281306|101917048|FG000|NOT COMPLETED|Overall Study||8||
48645832|NCT01281306|101917049|FG001|NOT COMPLETED|Overall Study||4||
48645833|NCT01281306|101917050|FG002|NOT COMPLETED|Overall Study||8||
48645834|NCT01281306|101917051|FG003|NOT COMPLETED|Overall Study||11||
48645835|NCT01281306|101917052|FG004|NOT COMPLETED|Overall Study||9||
48645836|NCT01281306|101917053|FG005|NOT COMPLETED|Overall Study||7||
48645837|NCT01281306|101917054|FG006|NOT COMPLETED|Overall Study||7||
48765190|NCT02113982|102214596|FG013|NOT COMPLETED|Stage 3: Efficacy Cohort||0||
48188179|NCT02018861|100783178|FG008|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||1||
48362056|NCT01852344|101214476|FG002|COMPLETED|Overall Study||27||
48362057|NCT01852344|101214477|FG003|COMPLETED|Overall Study||27||
48362058|NCT01852344|101214474|FG000|NOT COMPLETED|Overall Study||0||
48362059|NCT01852344|101214475|FG001|NOT COMPLETED|Overall Study||0||
48362060|NCT01852344|101214476|FG002|NOT COMPLETED|Overall Study||0||
48362061|NCT01852344|101214477|FG003|NOT COMPLETED|Overall Study||0||
48362062|NCT01145391|101214478|FG000|STARTED|Overall Study||293||
48362063|NCT01145391|101214479|FG001|STARTED|Overall Study||298||
48362064|NCT01145391|101214478|FG000|9 Months Post-randomization|Overall Study||293||
48362065|NCT01145391|101214479|FG001|9 Months Post-randomization|Overall Study||298||
48362066|NCT01145391|101214478|FG000|COMPLETED|Overall Study||293||
48362067|NCT01145391|101214479|FG001|COMPLETED|Overall Study||298||
48362068|NCT01145391|101214478|FG000|NOT COMPLETED|Overall Study||0||
48645838|NCT03418675|101917055|FG000|STARTED|Overall Study||40||
48645839|NCT03418675|101917056|FG001|STARTED|Overall Study||40||
48765191|NCT02113982|102214583|FG000|STARTED|Stage 4: First-line and R/R BPDCN||0||
48362069|NCT01145391|101214479|FG001|NOT COMPLETED|Overall Study||0||
48362070|NCT01330446|101214480|FG000|STARTED|Overall Study||13||
48362071|NCT01330446|101214481|FG001|STARTED|Overall Study||13||
48362072|NCT01330446|101214480|FG000|COMPLETED|Overall Study||8||
48362073|NCT01330446|101214481|FG001|COMPLETED|Overall Study||9||
48362074|NCT01330446|101214480|FG000|NOT COMPLETED|Overall Study||5||
48362075|NCT01330446|101214481|FG001|NOT COMPLETED|Overall Study||4||
48362076|NCT01899144|101214482|FG000|STARTED|Treatment Period 1||61||
48362077|NCT01899144|101214482|FG000|COMPLETED|Treatment Period 1||61||
48362078|NCT01899144|101214482|FG000|NOT COMPLETED|Treatment Period 1||0||
48362079|NCT01899144|101214482|FG000|STARTED|Treatment Period 2||61||
48362080|NCT01899144|101214482|FG000|COMPLETED|Treatment Period 2||60||
48362081|NCT01899144|101214482|FG000|NOT COMPLETED|Treatment Period 2||1||
48362082|NCT01899144|101214482|FG000|STARTED|Treatment Period 3||60||
48362083|NCT01899144|101214482|FG000|COMPLETED|Treatment Period 3||58||
48362084|NCT01899144|101214482|FG000|NOT COMPLETED|Treatment Period 3||2||
48362085|NCT01899144|101214482|FG000|STARTED|Treatment Period 4||58||
48362086|NCT01899144|101214482|FG000|COMPLETED|Treatment Period 4||58||
48362087|NCT01899144|101214482|FG000|NOT COMPLETED|Treatment Period 4||0||
48362088|NCT01899144|101214482|FG000|STARTED|Treatment Period 5||58||
48362089|NCT01899144|101214482|FG000|COMPLETED|Treatment Period 5||57||
48362090|NCT01899144|101214482|FG000|NOT COMPLETED|Treatment Period 5||1||
48362091|NCT04983901|101214483|FG000|STARTED|Overall Study||50||
48362092|NCT04983901|101214484|FG001|STARTED|Overall Study||50||
48362093|NCT04983901|101214483|FG000|COMPLETED|Overall Study||44||
48362094|NCT04983901|101214484|FG001|COMPLETED|Overall Study||44||
48362095|NCT04983901|101214483|FG000|NOT COMPLETED|Overall Study||6||
48362096|NCT04983901|101214484|FG001|NOT COMPLETED|Overall Study||6||
48362097|NCT00564629|101214485|FG000|STARTED|Overall Study||51||
48362098|NCT00564629|101214486|FG001|STARTED|Overall Study||54||
48436277|NCT03522506|101403517|FG003|NOT COMPLETED|Treatment Period 4 (2 Days)||0||
48645840|NCT03418675|101917055|FG000|Completed All Baseline Measures|Overall Study||37||
48645841|NCT03418675|101917056|FG001|Completed All Baseline Measures|Overall Study||40||
48645842|NCT03418675|101917055|FG000|Completed One-post Randomization Visit|Overall Study||34||
48645843|NCT03418675|101917056|FG001|Completed One-post Randomization Visit|Overall Study||35||
48645844|NCT03418675|101917055|FG000|COMPLETED|Overall Study||25||
48645845|NCT03418675|101917056|FG001|COMPLETED|Overall Study||30||
48645846|NCT03418675|101917055|FG000|NOT COMPLETED|Overall Study||15||
48645847|NCT03418675|101917056|FG001|NOT COMPLETED|Overall Study||10||
48645848|NCT02945046|101917057|FG000|STARTED|Overall Study||59|Intent-to-treat (ITT) analysis set: all randomized participants.|
48645849|NCT02945046|101917058|FG001|STARTED|Overall Study||55|Intent-to-treat (ITT) analysis set: all randomized participants.|
48645850|NCT02945046|101917059|FG002|STARTED|Overall Study||55|Intent-to-treat (ITT) analysis set: all randomized participants.|
48645851|NCT02945046|101917057|FG000|Safety Analysis Set|Overall Study||59|All randomized participants who received at least 1 dose of investigational medicinal product (IMP).|
48645852|NCT02945046|101917058|FG001|Safety Analysis Set|Overall Study||55|All randomized participants who received at least 1 dose of investigational medicinal product (IMP).|
48645853|NCT02945046|101917059|FG002|Safety Analysis Set|Overall Study||55|All randomized participants who received at least 1 dose of investigational medicinal product (IMP).|
48645854|NCT02945046|101917057|FG000|Full Analysis Set|Overall Study||57|Received ≥1 dose of IMP; had ≥10 days of postbaseline efficacy assessment on primary endpoint.|
48645855|NCT02945046|101917058|FG001|Full Analysis Set|Overall Study||53|Received ≥1 dose of IMP; had ≥10 days of postbaseline efficacy assessment on primary endpoint.|
48645856|NCT02945046|101917059|FG002|Full Analysis Set|Overall Study||55|Received ≥1 dose of IMP; had ≥10 days of postbaseline efficacy assessment on primary endpoint.|
48645857|NCT02945046|101917057|FG000|COMPLETED|Overall Study||46||
48645858|NCT02945046|101917058|FG001|COMPLETED|Overall Study||42||
48645859|NCT02945046|101917059|FG002|COMPLETED|Overall Study||40||
48645860|NCT02945046|101917057|FG000|NOT COMPLETED|Overall Study||13||
48645861|NCT02945046|101917058|FG001|NOT COMPLETED|Overall Study||13||
48645862|NCT02945046|101917059|FG002|NOT COMPLETED|Overall Study||15||
48645863|NCT04027946|101917060|FG000|STARTED|Overall Study||6||
48645864|NCT04027946|101917060|FG000|COMPLETED|Overall Study||3||
48645865|NCT04027946|101917060|FG000|NOT COMPLETED|Overall Study||3||
48645866|NCT01793935|101917061|FG000|STARTED|Overall Study||34||
48645867|NCT01793935|101917062|FG001|STARTED|Overall Study||34||
48645868|NCT01793935|101917061|FG000|COMPLETED|Overall Study||28||
48645869|NCT01793935|101917062|FG001|COMPLETED|Overall Study||31||
48645870|NCT01793935|101917061|FG000|NOT COMPLETED|Overall Study||6||
48645871|NCT01793935|101917062|FG001|NOT COMPLETED|Overall Study||3||
48645872|NCT00428077|101917063|FG000|STARTED|Overall Study||4||
48645873|NCT00428077|101917063|FG000|COMPLETED|Overall Study||4||
48645874|NCT00428077|101917063|FG000|NOT COMPLETED|Overall Study||0||
48645875|NCT01068912|101917064|FG000|STARTED|Overall Study||134||
48645876|NCT01068912|101917065|FG001|STARTED|Overall Study||195||
48645877|NCT01068912|101917066|FG002|STARTED|Overall Study||201||
48645878|NCT01068912|101917064|FG000|COMPLETED|Overall Study||123||
48645879|NCT01068912|101917065|FG001|COMPLETED|Overall Study||173||
48645880|NCT01068912|101917066|FG002|COMPLETED|Overall Study||186||
48645881|NCT01068912|101917064|FG000|NOT COMPLETED|Overall Study||11||
48645882|NCT01068912|101917065|FG001|NOT COMPLETED|Overall Study||22||
48645883|NCT01068912|101917066|FG002|NOT COMPLETED|Overall Study||15||
48645884|NCT00407030|101917067|FG000|STARTED|Main Period - 8 to 20 Weeks||81||
48645885|NCT00407030|101917068|FG001|STARTED|Main Period - 8 to 20 Weeks||78||
48645886|NCT00407030|101917069|FG002|STARTED|Main Period - 8 to 20 Weeks||74||
48645887|NCT00407030|101917067|FG000|COMPLETED|Main Period - 8 to 20 Weeks||76||
48645888|NCT00407030|101917068|FG001|COMPLETED|Main Period - 8 to 20 Weeks||75||
48645889|NCT00407030|101917069|FG002|COMPLETED|Main Period - 8 to 20 Weeks||68||
48645890|NCT00407030|101917067|FG000|NOT COMPLETED|Main Period - 8 to 20 Weeks||5||
48645891|NCT00407030|101917068|FG001|NOT COMPLETED|Main Period - 8 to 20 Weeks||3||
48645892|NCT00407030|101917069|FG002|NOT COMPLETED|Main Period - 8 to 20 Weeks||6||
48645893|NCT00407030|101917067|FG000|STARTED|Extension Period - up to 68 Weeks||111||
48765192|NCT02113982|102214584|FG001|STARTED|Stage 4: First-line and R/R BPDCN||0||
48765193|NCT02113982|102214585|FG002|STARTED|Stage 4: First-line and R/R BPDCN||0||
48765194|NCT02113982|102214586|FG003|STARTED|Stage 4: First-line and R/R BPDCN||0||
48765195|NCT02113982|102214587|FG004|STARTED|Stage 4: First-line and R/R BPDCN||0||
48765196|NCT02113982|102214588|FG005|STARTED|Stage 4: First-line and R/R BPDCN||0||
48188180|NCT02018861|100783179|FG009|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||1||
48765197|NCT02113982|102214589|FG006|STARTED|Stage 4: First-line and R/R BPDCN||0||
48765198|NCT02113982|102214590|FG007|STARTED|Stage 4: First-line and R/R BPDCN||0||
48645894|NCT00407030|101917068|FG001|STARTED|Extension Period - up to 68 Weeks||103||
48645895|NCT00407030|101917069|FG002|STARTED|Extension Period - up to 68 Weeks||0||
48645896|NCT00407030|101917067|FG000|COMPLETED|Extension Period - up to 68 Weeks||84||
48645897|NCT00407030|101917068|FG001|COMPLETED|Extension Period - up to 68 Weeks||74||
48645898|NCT00407030|101917069|FG002|COMPLETED|Extension Period - up to 68 Weeks||0||
48645899|NCT00407030|101917067|FG000|NOT COMPLETED|Extension Period - up to 68 Weeks||27||
48645900|NCT00407030|101917068|FG001|NOT COMPLETED|Extension Period - up to 68 Weeks||29||
48645901|NCT00407030|101917069|FG002|NOT COMPLETED|Extension Period - up to 68 Weeks||0||
48645902|NCT01111292|101917070|FG000|STARTED|Randomization||3||
48645903|NCT01111292|101917071|FG001|STARTED|Randomization||2||
48645904|NCT01111292|101917070|FG000|COMPLETED|Randomization||3||
48645905|NCT01111292|101917071|FG001|COMPLETED|Randomization||2||
48765199|NCT02113982|102214591|FG008|STARTED|Stage 4: First-line and R/R BPDCN||0||
48765200|NCT02113982|102214592|FG009|STARTED|Stage 4: First-line and R/R BPDCN||0||
48765201|NCT02113982|102214593|FG010|STARTED|Stage 4: First-line and R/R BPDCN||0||
48765202|NCT02113982|102214594|FG011|STARTED|Stage 4: First-line and R/R BPDCN||0||
48765203|NCT02113982|102214595|FG012|STARTED|Stage 4: First-line and R/R BPDCN||37||
48765204|NCT02113982|102214596|FG013|STARTED|Stage 4: First-line and R/R BPDCN||7||
48765205|NCT02113982|102214583|FG000|COMPLETED|Stage 4: First-line and R/R BPDCN||0||
48765206|NCT02113982|102214584|FG001|COMPLETED|Stage 4: First-line and R/R BPDCN||0||
48765207|NCT02113982|102214585|FG002|COMPLETED|Stage 4: First-line and R/R BPDCN||0||
48765208|NCT02113982|102214586|FG003|COMPLETED|Stage 4: First-line and R/R BPDCN||0||
48765209|NCT02113982|102214587|FG004|COMPLETED|Stage 4: First-line and R/R BPDCN||0||
48765210|NCT02113982|102214588|FG005|COMPLETED|Stage 4: First-line and R/R BPDCN||0||
48765211|NCT02113982|102214589|FG006|COMPLETED|Stage 4: First-line and R/R BPDCN||0||
48765212|NCT02113982|102214590|FG007|COMPLETED|Stage 4: First-line and R/R BPDCN||0||
48765213|NCT02113982|102214591|FG008|COMPLETED|Stage 4: First-line and R/R BPDCN||0||
48765214|NCT02113982|102214592|FG009|COMPLETED|Stage 4: First-line and R/R BPDCN||0||
48765215|NCT02113982|102214593|FG010|COMPLETED|Stage 4: First-line and R/R BPDCN||0||
48765216|NCT02113982|102214594|FG011|COMPLETED|Stage 4: First-line and R/R BPDCN||0||
48765217|NCT02113982|102214595|FG012|COMPLETED|Stage 4: First-line and R/R BPDCN||0||
48436278|NCT02074982|101403518|FG000|STARTED|Overall Study||337||
48436279|NCT02074982|101403519|FG001|STARTED|Overall Study||339||
48436280|NCT02074982|101403518|FG000|Full Analysis Set (FAS)|Overall Study||336||
48436281|NCT02074982|101403519|FG001|Full Analysis Set (FAS)|Overall Study||339||
48645906|NCT01111292|101917070|FG000|NOT COMPLETED|Randomization||0||
48645907|NCT01111292|101917071|FG001|NOT COMPLETED|Randomization||0||
48645908|NCT01111292|101917070|FG000|STARTED|Treatment||3||
48645909|NCT01111292|101917071|FG001|STARTED|Treatment||2||
48645910|NCT01111292|101917070|FG000|COMPLETED|Treatment||2||
48645911|NCT01111292|101917071|FG001|COMPLETED|Treatment||1||
48645912|NCT01111292|101917070|FG000|NOT COMPLETED|Treatment||1||
48645913|NCT01111292|101917071|FG001|NOT COMPLETED|Treatment||1||
48645914|NCT01111292|101917070|FG000|STARTED|Post Treatment Biopsy||2||
48645915|NCT01111292|101917071|FG001|STARTED|Post Treatment Biopsy||1||
48645916|NCT01111292|101917070|FG000|COMPLETED|Post Treatment Biopsy||2||
48645917|NCT01111292|101917071|FG001|COMPLETED|Post Treatment Biopsy||1||
48645918|NCT01111292|101917070|FG000|NOT COMPLETED|Post Treatment Biopsy||0||
48645919|NCT01111292|101917071|FG001|NOT COMPLETED|Post Treatment Biopsy||0||
48645920|NCT01111292|101917070|FG000|STARTED|Follow-Up||2||
48645921|NCT01111292|101917071|FG001|STARTED|Follow-Up||1||
48645922|NCT01111292|101917070|FG000|COMPLETED|Follow-Up||2||
48645923|NCT01111292|101917071|FG001|COMPLETED|Follow-Up||1||
48645924|NCT01111292|101917070|FG000|NOT COMPLETED|Follow-Up||0||
48645925|NCT01111292|101917071|FG001|NOT COMPLETED|Follow-Up||0||
48645926|NCT01951066|101917072|FG000|STARTED|First Intervention (Baseline to Week 16)||10||
48645927|NCT01951066|101917073|FG001|STARTED|First Intervention (Baseline to Week 16)||10||
48645928|NCT01951066|101917072|FG000|COMPLETED|First Intervention (Baseline to Week 16)||10||
48645929|NCT01951066|101917073|FG001|COMPLETED|First Intervention (Baseline to Week 16)||10||
48645930|NCT01951066|101917072|FG000|NOT COMPLETED|First Intervention (Baseline to Week 16)||0||
48645931|NCT01951066|101917073|FG001|NOT COMPLETED|First Intervention (Baseline to Week 16)||0||
48645932|NCT01951066|101917072|FG000|STARTED|Second Intervention (Week 16 to Week 32)||10||
48645933|NCT01951066|101917073|FG001|STARTED|Second Intervention (Week 16 to Week 32)||10||
48645934|NCT01951066|101917072|FG000|COMPLETED|Second Intervention (Week 16 to Week 32)||10||
48645935|NCT01951066|101917073|FG001|COMPLETED|Second Intervention (Week 16 to Week 32)||10||
48645936|NCT01951066|101917072|FG000|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0||
48645937|NCT01951066|101917073|FG001|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0||
48645938|NCT02852434|101917074|FG000|STARTED|Overall Study||36||
48645939|NCT02852434|101917075|FG001|STARTED|Overall Study||36||
48645940|NCT02852434|101917074|FG000|COMPLETED|Overall Study||34||
48765218|NCT02113982|102214596|FG013|COMPLETED|Stage 4: First-line and R/R BPDCN||0||
48765219|NCT02113982|102214583|FG000|NOT COMPLETED|Stage 4: First-line and R/R BPDCN||0||
48765220|NCT02113982|102214584|FG001|NOT COMPLETED|Stage 4: First-line and R/R BPDCN||0||
48765221|NCT02113982|102214585|FG002|NOT COMPLETED|Stage 4: First-line and R/R BPDCN||0||
48765222|NCT02113982|102214586|FG003|NOT COMPLETED|Stage 4: First-line and R/R BPDCN||0||
48765223|NCT02113982|102214587|FG004|NOT COMPLETED|Stage 4: First-line and R/R BPDCN||0||
48765224|NCT02113982|102214588|FG005|NOT COMPLETED|Stage 4: First-line and R/R BPDCN||0||
48765225|NCT02113982|102214589|FG006|NOT COMPLETED|Stage 4: First-line and R/R BPDCN||0||
48436282|NCT02074982|101403518|FG000|Safety Set (SF)|Overall Study||335||
48436283|NCT02074982|101403519|FG001|Safety Set (SF)|Overall Study||336||
48436284|NCT02074982|101403518|FG000|COMPLETED|Overall Study||286||
48645941|NCT02852434|101917075|FG001|COMPLETED|Overall Study||35||
48765226|NCT02113982|102214590|FG007|NOT COMPLETED|Stage 4: First-line and R/R BPDCN||0||
48765227|NCT02113982|102214591|FG008|NOT COMPLETED|Stage 4: First-line and R/R BPDCN||0||
48645942|NCT02852434|101917074|FG000|NOT COMPLETED|Overall Study||2||
48645943|NCT02852434|101917075|FG001|NOT COMPLETED|Overall Study||1||
48645944|NCT01363076|101917076|FG000|STARTED|Overall Study||7||
48645945|NCT01363076|101917077|FG001|STARTED|Overall Study||13||
48645946|NCT01363076|101917076|FG000|COMPLETED|Overall Study||7||
48645947|NCT01363076|101917077|FG001|COMPLETED|Overall Study||12||
48645948|NCT01363076|101917076|FG000|NOT COMPLETED|Overall Study||0||
48645949|NCT01363076|101917077|FG001|NOT COMPLETED|Overall Study||1||
48645950|NCT02384460|101917078|FG000|STARTED|Overall Study||82||
48645951|NCT02384460|101917079|FG001|STARTED|Overall Study||87||
48645952|NCT02384460|101917078|FG000|Received at Least 1 Dose of Study Drug|Overall Study||82||
48645953|NCT02384460|101917079|FG001|Received at Least 1 Dose of Study Drug|Overall Study||87||
48645954|NCT02384460|101917078|FG000|COMPLETED|Overall Study||75||
48645955|NCT02384460|101917079|FG001|COMPLETED|Overall Study||80||
48645956|NCT02384460|101917078|FG000|NOT COMPLETED|Overall Study||7||
48645957|NCT02384460|101917079|FG001|NOT COMPLETED|Overall Study||7||
48645958|NCT03345004|101917080|FG000|STARTED|Overall Study||57||
48645959|NCT03345004|101917081|FG001|STARTED|Overall Study||52||
48645960|NCT03345004|101917080|FG000|Haplotype DR3-DQ2 Population Month 15|Overall Study||29||
48645961|NCT03345004|101917081|FG001|Haplotype DR3-DQ2 Population Month 15|Overall Study||19||
48645962|NCT03345004|101917080|FG000|COMPLETED|Overall Study||56||
48645963|NCT03345004|101917081|FG001|COMPLETED|Overall Study||51||
48645964|NCT03345004|101917080|FG000|NOT COMPLETED|Overall Study||1||
48645965|NCT03345004|101917081|FG001|NOT COMPLETED|Overall Study||1||
48645966|NCT03695094|101917082|FG000|STARTED|Overall Study||16||
48645967|NCT03695094|101917083|FG001|STARTED|Overall Study||15||
48645968|NCT03695094|101917082|FG000|COMPLETED|Overall Study||14||
48645969|NCT03695094|101917083|FG001|COMPLETED|Overall Study||14||
48645970|NCT03695094|101917082|FG000|NOT COMPLETED|Overall Study||2||
48645971|NCT03695094|101917083|FG001|NOT COMPLETED|Overall Study||1||
48645972|NCT03928327|101917084|FG000|STARTED|Period 1||12||
48645973|NCT03928327|101917085|FG001|STARTED|Period 1||12||
48645974|NCT03928327|101917084|FG000|COMPLETED|Period 1||12||
48645975|NCT03928327|101917085|FG001|COMPLETED|Period 1||12||
48645976|NCT03928327|101917084|FG000|NOT COMPLETED|Period 1||0||
48645977|NCT03928327|101917085|FG001|NOT COMPLETED|Period 1||0||
48645978|NCT03928327|101917084|FG000|STARTED|Washout Period||12||
48645979|NCT03928327|101917085|FG001|STARTED|Washout Period||12||
48645980|NCT03928327|101917084|FG000|COMPLETED|Washout Period||12||
48645981|NCT03928327|101917085|FG001|COMPLETED|Washout Period||12||
48645982|NCT03928327|101917084|FG000|NOT COMPLETED|Washout Period||0||
48645983|NCT03928327|101917085|FG001|NOT COMPLETED|Washout Period||0||
48645984|NCT03928327|101917084|FG000|STARTED|Period 2||12||
48645985|NCT03928327|101917085|FG001|STARTED|Period 2||12||
48645986|NCT03928327|101917084|FG000|COMPLETED|Period 2||12||
48645987|NCT03928327|101917085|FG001|COMPLETED|Period 2||12||
48645988|NCT03928327|101917084|FG000|NOT COMPLETED|Period 2||0||
48645989|NCT03928327|101917085|FG001|NOT COMPLETED|Period 2||0||
48645990|NCT01716156|101920079|FG000|STARTED|Overall Study||9||
48645991|NCT01716156|101920080|FG001|STARTED|Overall Study||4||
48645992|NCT01716156|101920081|FG002|STARTED|Overall Study||13||
48645993|NCT01716156|101920079|FG000|COMPLETED|Overall Study||7||
48645994|NCT01716156|101920080|FG001|COMPLETED|Overall Study||3||
48645995|NCT01716156|101920081|FG002|COMPLETED|Overall Study||11||
48645996|NCT01716156|101920079|FG000|NOT COMPLETED|Overall Study||2||
48765228|NCT02113982|102214592|FG009|NOT COMPLETED|Stage 4: First-line and R/R BPDCN||0||
48765229|NCT02113982|102214593|FG010|NOT COMPLETED|Stage 4: First-line and R/R BPDCN||0||
48765230|NCT02113982|102214594|FG011|NOT COMPLETED|Stage 4: First-line and R/R BPDCN||0||
48765231|NCT02113982|102214595|FG012|NOT COMPLETED|Stage 4: First-line and R/R BPDCN||37||
48765232|NCT02113982|102214596|FG013|NOT COMPLETED|Stage 4: First-line and R/R BPDCN||7||
48765233|NCT01069003|102214597|FG000|STARTED|Overall Study||399||
48765234|NCT01069003|102214598|FG001|STARTED|Overall Study||412||
48765235|NCT01069003|102214599|FG002|STARTED|Overall Study||1451||
48765236|NCT01069003|102214597|FG000|COMPLETED|Overall Study||353||
48645997|NCT01716156|101920080|FG001|NOT COMPLETED|Overall Study||1||
48645998|NCT01716156|101920081|FG002|NOT COMPLETED|Overall Study||2||
48645999|NCT01431846|101920082|FG000|STARTED|Overall Study||8||
48646000|NCT01431846|101920083|FG001|STARTED|Overall Study||3||
48646001|NCT01431846|101920084|FG002|STARTED|Overall Study||8||
48646002|NCT01431846|101920082|FG000|COMPLETED|Overall Study||8||
48646003|NCT01431846|101920083|FG001|COMPLETED|Overall Study||3||
48646004|NCT01431846|101920084|FG002|COMPLETED|Overall Study||8||
48646005|NCT01431846|101920082|FG000|NOT COMPLETED|Overall Study||0||
48646006|NCT01431846|101920083|FG001|NOT COMPLETED|Overall Study||0||
48646007|NCT01431846|101920084|FG002|NOT COMPLETED|Overall Study||0||
48646008|NCT00127933|101920085|FG000|STARTED|Overall Study||123||
48646009|NCT00127933|101920086|FG001|STARTED|Overall Study||34||
48646010|NCT00127933|101920085|FG000|Pathological Response|Overall Study||101||
48646011|NCT00127933|101920086|FG001|Pathological Response|Overall Study||28||
48646012|NCT00127933|101920085|FG000|Clinical Response|Overall Study||122||
48646013|NCT00127933|101920086|FG001|Clinical Response|Overall Study||34||
48646014|NCT00127933|101920085|FG000|Safety Population|Overall Study||122||
48646015|NCT00127933|101920086|FG001|Safety Population|Overall Study||34||
48646016|NCT00127933|101920085|FG000|Quality of Life Population|Overall Study||118||
48646017|NCT00127933|101920086|FG001|Quality of Life Population|Overall Study||33||
48646018|NCT00127933|101920085|FG000|Postoperative|Overall Study||98||
48765237|NCT01069003|102214598|FG001|COMPLETED|Overall Study||358||
48646019|NCT00127933|101920086|FG001|Postoperative|Overall Study||27||
48646020|NCT00127933|101920085|FG000|COMPLETED|Overall Study||122||
48646021|NCT00127933|101920086|FG001|COMPLETED|Overall Study||34||
48646022|NCT00127933|101920085|FG000|NOT COMPLETED|Overall Study||1||
48646023|NCT00127933|101920086|FG001|NOT COMPLETED|Overall Study||0||
48646024|NCT00943202|101920087|FG000|STARTED|Overall Study||133||
48646025|NCT00943202|101920088|FG001|STARTED|Overall Study||133||
48646026|NCT00943202|101920089|FG002|STARTED|Overall Study||133||
48646027|NCT00943202|101920090|FG003|STARTED|Overall Study||132||
48646028|NCT00943202|101920087|FG000|COMPLETED|Overall Study||132||
48646029|NCT00943202|101920088|FG001|COMPLETED|Overall Study||131||
48646030|NCT00943202|101920089|FG002|COMPLETED|Overall Study||133||
48646031|NCT00943202|101920090|FG003|COMPLETED|Overall Study||131||
48646032|NCT00943202|101920087|FG000|NOT COMPLETED|Overall Study||1||
48646033|NCT00943202|101920088|FG001|NOT COMPLETED|Overall Study||2||
48646034|NCT00943202|101920089|FG002|NOT COMPLETED|Overall Study||0||
48646035|NCT00943202|101920090|FG003|NOT COMPLETED|Overall Study||1||
48646036|NCT04764604|101920091|FG000|STARTED|Overall Study||16||
48646037|NCT04764604|101920092|FG001|STARTED|Overall Study||14||
48646038|NCT04764604|101920091|FG000|Acapella Choice Task|Overall Study||16||
48646039|NCT04764604|101920092|FG001|Acapella Choice Task|Overall Study||14||
48646040|NCT04764604|101920091|FG000|Tube-in-Water Task|Overall Study||16||
48646041|NCT04764604|101920092|FG001|Tube-in-Water Task|Overall Study||14||
48646042|NCT04764604|101920091|FG000|COMPLETED|Overall Study||16||
48646043|NCT04764604|101920092|FG001|COMPLETED|Overall Study||14||
48646044|NCT04764604|101920091|FG000|NOT COMPLETED|Overall Study||0||
48646045|NCT04764604|101920092|FG001|NOT COMPLETED|Overall Study||0||
48646046|NCT01696968|101920093|FG000|STARTED|Overall Study||77456||
48646047|NCT01696968|101920094|FG001|STARTED|Overall Study||77445||
48646048|NCT01696968|101920093|FG000|COMPLETED|Overall Study||76255||
48646049|NCT01696968|101920094|FG001|COMPLETED|Overall Study||70633||
48646050|NCT01696968|101920093|FG000|NOT COMPLETED|Overall Study||1201||
48646051|NCT01696968|101920094|FG001|NOT COMPLETED|Overall Study||6812||
48646052|NCT02993302|101920095|FG000|STARTED|Overall Study||13||
48646053|NCT02993302|101920096|FG001|STARTED|Overall Study||12||
48646054|NCT02993302|101920095|FG000|COMPLETED|Overall Study||13||
48646055|NCT02993302|101920096|FG001|COMPLETED|Overall Study||12||
48646056|NCT02993302|101920095|FG000|NOT COMPLETED|Overall Study||0||
48646057|NCT02993302|101920096|FG001|NOT COMPLETED|Overall Study||0||
48646058|NCT02112552|101920097|FG000|STARTED|Overall Study||3||
48646059|NCT02112552|101920097|FG000|COMPLETED|Overall Study||1||
48646060|NCT02112552|101920097|FG000|NOT COMPLETED|Overall Study||2||
48646061|NCT00896233|101920098|FG000|STARTED|Overall Study||10||
48646062|NCT00896233|101920098|FG000|COMPLETED|Overall Study||9||
48646063|NCT00896233|101920098|FG000|NOT COMPLETED|Overall Study||1||
48646064|NCT03927716|101920099|FG000|STARTED|Overall Study||236||
48646065|NCT03927716|101920100|FG001|STARTED|Overall Study||116||
48646066|NCT03927716|101920099|FG000|COMPLETED|Overall Study||192||
48646067|NCT03927716|101920100|FG001|COMPLETED|Overall Study||106||
48646068|NCT03927716|101920099|FG000|NOT COMPLETED|Overall Study||44||
48646069|NCT03927716|101920100|FG001|NOT COMPLETED|Overall Study||10||
48646070|NCT03123588|101920101|FG000|STARTED|Overall Study||6||
48646071|NCT03123588|101920102|FG001|STARTED|Overall Study||6||
48765238|NCT01069003|102214599|FG002|COMPLETED|Overall Study||976||
48765239|NCT01069003|102214597|FG000|NOT COMPLETED|Overall Study||46||
48765240|NCT01069003|102214598|FG001|NOT COMPLETED|Overall Study||54||
48765241|NCT01069003|102214599|FG002|NOT COMPLETED|Overall Study||475||
48188181|NCT02018861|100783170|FG000|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0||
48188182|NCT02018861|100783171|FG001|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0||
48188183|NCT02018861|100783172|FG002|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0||
48646072|NCT03123588|101920101|FG000|COMPLETED|Overall Study||0||
48646073|NCT03123588|101920102|FG001|COMPLETED|Overall Study||0||
48646074|NCT03123588|101920101|FG000|NOT COMPLETED|Overall Study||6||
48646075|NCT03123588|101920102|FG001|NOT COMPLETED|Overall Study||6||
48646076|NCT02887586|101920103|FG000|STARTED|Overall Study||30||
48646077|NCT02887586|101920104|FG001|STARTED|Overall Study||30||
48646078|NCT02887586|101920103|FG000|COMPLETED|Overall Study||27||
48646079|NCT02887586|101920104|FG001|COMPLETED|Overall Study||28||
48646080|NCT02887586|101920103|FG000|NOT COMPLETED|Overall Study||3||
48646081|NCT02887586|101920104|FG001|NOT COMPLETED|Overall Study||2||
48646082|NCT01750281|101920105|FG000|STARTED|Overall Study||43||
48646083|NCT01750281|101920106|FG001|STARTED|Overall Study||85||
48646084|NCT01750281|101920107|FG002|STARTED|Overall Study||84||
48646085|NCT01750281|101920105|FG000|Received Treatment|Overall Study||43||
48646086|NCT01750281|101920106|FG001|Received Treatment|Overall Study||84||
48646087|NCT01750281|101920107|FG002|Received Treatment|Overall Study||84||
48646088|NCT01750281|101920105|FG000|Did Not Receive Treatment|Overall Study||0||
48646089|NCT01750281|101920106|FG001|Did Not Receive Treatment|Overall Study||1||
48646090|NCT01750281|101920107|FG002|Did Not Receive Treatment|Overall Study||0||
48646091|NCT01750281|101920105|FG000|COMPLETED|Overall Study||0||
48646092|NCT01750281|101920106|FG001|COMPLETED|Overall Study||0||
48646093|NCT01750281|101920107|FG002|COMPLETED|Overall Study||0||
48646094|NCT01750281|101920105|FG000|NOT COMPLETED|Overall Study||43||
48646095|NCT01750281|101920106|FG001|NOT COMPLETED|Overall Study||85||
48646096|NCT01750281|101920107|FG002|NOT COMPLETED|Overall Study||84||
48646097|NCT00607594|101920108|FG000|STARTED|Overall Study||21||
48646098|NCT00607594|101920108|FG000|COMPLETED|Overall Study||21||
48646099|NCT00607594|101920108|FG000|NOT COMPLETED|Overall Study||0||
48646100|NCT04625972|101920109|FG000|STARTED|Overall Study||756||
48646101|NCT04625972|101920110|FG001|STARTED|Overall Study||375||
48646102|NCT04625972|101920109|FG000|Dosed (Full Analysis Set)|Overall Study||749||
48646103|NCT04625972|101920110|FG001|Dosed (Full Analysis Set)|Overall Study||372||
48646104|NCT04625972|101920109|FG000|COMPLETED|Overall Study||624||
48646105|NCT04625972|101920110|FG001|COMPLETED|Overall Study||304||
48646106|NCT04625972|101920109|FG000|NOT COMPLETED|Overall Study||132||
48646107|NCT04625972|101920110|FG001|NOT COMPLETED|Overall Study||71||
48646108|NCT03019588|101920111|FG000|STARTED|Overall Study||47||
48646109|NCT03019588|101920112|FG001|STARTED|Overall Study||47||
48646110|NCT03019588|101920111|FG000|Treated|Overall Study||47||
48646111|NCT03019588|101920112|FG001|Treated|Overall Study||44||
48646112|NCT03019588|101920111|FG000|COMPLETED|Overall Study||0||
48646113|NCT03019588|101920112|FG001|COMPLETED|Overall Study||0||
48646114|NCT03019588|101920111|FG000|NOT COMPLETED|Overall Study||47||
48646115|NCT03019588|101920112|FG001|NOT COMPLETED|Overall Study||47||
48646116|NCT00182637|101920113|FG000|STARTED|Overall Study||5||
48646117|NCT00182637|101920113|FG000|COMPLETED|Overall Study||2||
48646118|NCT00182637|101920113|FG000|NOT COMPLETED|Overall Study||3||
48646119|NCT01799278|101920114|FG000|STARTED|Overall Study||60||
48646120|NCT01799278|101920114|FG000|COMPLETED|Overall Study||60||
48646121|NCT01799278|101920114|FG000|NOT COMPLETED|Overall Study||0||
48646122|NCT01120197|101920115|FG000|STARTED|Overall Study||47||
48646123|NCT01120197|101920116|FG001|STARTED|Overall Study||42||
48646124|NCT01120197|101920115|FG000|COMPLETED|Overall Study||38||
48646125|NCT01120197|101920116|FG001|COMPLETED|Overall Study||32||
48646126|NCT01120197|101920115|FG000|NOT COMPLETED|Overall Study||9||
48646127|NCT01120197|101920116|FG001|NOT COMPLETED|Overall Study||10||
48646128|NCT01011283|101920117|FG000|STARTED|Overall Study||13||
48646129|NCT01011283|101920118|FG001|STARTED|Overall Study||13||
48646130|NCT01011283|101920117|FG000|COMPLETED|Overall Study||2||
48646131|NCT01011283|101920118|FG001|COMPLETED|Overall Study||2||
48646132|NCT01011283|101920117|FG000|NOT COMPLETED|Overall Study||11||
48646133|NCT01011283|101920118|FG001|NOT COMPLETED|Overall Study||11||
48646134|NCT02643199|101920119|FG000|STARTED|Overall Study||90||
48646135|NCT02643199|101920119|FG000|COMPLETED|Overall Study||90||
48646136|NCT02643199|101920119|FG000|NOT COMPLETED|Overall Study||0||
48646137|NCT03828383|101920120|FG000|STARTED|Overall Study||41||
48646138|NCT03828383|101920121|FG001|STARTED|Overall Study||37||
48646139|NCT03828383|101920120|FG000|COMPLETED|Overall Study||34||
48646140|NCT03828383|101920121|FG001|COMPLETED|Overall Study||30||
48646141|NCT03828383|101920120|FG000|NOT COMPLETED|Overall Study||7||
48646142|NCT03828383|101920121|FG001|NOT COMPLETED|Overall Study||7||
48646143|NCT02313597|101920122|FG000|STARTED|Overall Study||40||
48646144|NCT02313597|101920123|FG001|STARTED|Overall Study||40||
48646145|NCT02313597|101920122|FG000|COMPLETED|Overall Study||40||
48646146|NCT02313597|101920123|FG001|COMPLETED|Overall Study||40||
48646147|NCT02313597|101920122|FG000|NOT COMPLETED|Overall Study||0||
48646148|NCT02313597|101920123|FG001|NOT COMPLETED|Overall Study||0||
48646149|NCT03300336|101920124|FG000|STARTED|Overall Study||7134||
48646150|NCT03300336|101920125|FG001|STARTED|Overall Study||6723||
48646151|NCT03300336|101920124|FG000|COMPLETED|Overall Study||7134||
48646152|NCT03300336|101920125|FG001|COMPLETED|Overall Study||6723||
48646153|NCT03300336|101920124|FG000|NOT COMPLETED|Overall Study||0||
48646154|NCT03300336|101920125|FG001|NOT COMPLETED|Overall Study||0||
48646155|NCT01905683|101920126|FG000|STARTED|Overall Study||370||
48646156|NCT01905683|101920126|FG000|COMPLETED|Overall Study||319||
48646157|NCT01905683|101920126|FG000|NOT COMPLETED|Overall Study||51||
48646158|NCT00714272|101920127|FG000|STARTED|Overall Study||2||
48646159|NCT00714272|101920128|FG001|STARTED|Overall Study||2||
48646160|NCT00714272|101920127|FG000|COMPLETED|Overall Study||2||
48646161|NCT00714272|101920128|FG001|COMPLETED|Overall Study||2||
48188184|NCT02018861|100783173|FG003|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0||
48646162|NCT00714272|101920127|FG000|NOT COMPLETED|Overall Study||0||
48646163|NCT00714272|101920128|FG001|NOT COMPLETED|Overall Study||0||
48646164|NCT00923702|101920129|FG000|STARTED|Overall Study||4348||
48646165|NCT00923702|101920130|FG001|STARTED|Overall Study||4979||
48646166|NCT00923702|101920131|FG002|STARTED|Overall Study||3452||
48646167|NCT00923702|101920132|FG003|STARTED|Overall Study||4950||
48646168|NCT00923702|101920133|FG004|STARTED|Overall Study||5000||
48646169|NCT00923702|101920129|FG000|COMPLETED|Overall Study||4348||
48646170|NCT00923702|101920130|FG001|COMPLETED|Overall Study||4979||
48646171|NCT00923702|101920131|FG002|COMPLETED|Overall Study||3452||
48646172|NCT00923702|101920132|FG003|COMPLETED|Overall Study||4950||
48646173|NCT00923702|101920133|FG004|COMPLETED|Overall Study||4646||
48646174|NCT00923702|101920129|FG000|NOT COMPLETED|Overall Study||0||
48646175|NCT00923702|101920130|FG001|NOT COMPLETED|Overall Study||0||
48646176|NCT00923702|101920131|FG002|NOT COMPLETED|Overall Study||0||
48646177|NCT00923702|101920132|FG003|NOT COMPLETED|Overall Study||0||
48646178|NCT00923702|101920133|FG004|NOT COMPLETED|Overall Study||354||
48646179|NCT03948386|101920134|FG000|STARTED|Overall Study||52||
48188185|NCT02018861|100783174|FG004|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0||
48188186|NCT02018861|100783175|FG005|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0||
48188187|NCT02018861|100783176|FG006|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0||
48646180|NCT03948386|101920135|FG001|STARTED|Overall Study||54||
48646181|NCT03948386|101920136|FG002|STARTED|Overall Study||53||
48646182|NCT03948386|101920134|FG000|COMPLETED|Overall Study||51||
48646183|NCT03948386|101920135|FG001|COMPLETED|Overall Study||53||
48646184|NCT03948386|101920136|FG002|COMPLETED|Overall Study||50||
48646185|NCT03948386|101920134|FG000|NOT COMPLETED|Overall Study||1||
48646186|NCT03948386|101920135|FG001|NOT COMPLETED|Overall Study||1||
48646187|NCT03948386|101920136|FG002|NOT COMPLETED|Overall Study||3||
48646188|NCT03637374|101920137|FG000|STARTED|Overall Study||2||
48646189|NCT03637374|101920138|FG001|STARTED|Overall Study||0||
48646190|NCT03637374|101920137|FG000|COMPLETED|Overall Study||0||
48646191|NCT03637374|101920138|FG001|COMPLETED|Overall Study||0||
48646192|NCT03637374|101920137|FG000|NOT COMPLETED|Overall Study||2||
48646193|NCT03637374|101920138|FG001|NOT COMPLETED|Overall Study||0||
48646194|NCT00977561|101920139|FG000|STARTED|Overall Study||5||
48646195|NCT00977561|101920140|FG001|STARTED|Overall Study||4||
48646196|NCT00977561|101920139|FG000|COMPLETED|Overall Study||0||
48646197|NCT00977561|101920140|FG001|COMPLETED|Overall Study||0||
48646198|NCT00977561|101920139|FG000|NOT COMPLETED|Overall Study||5||
48646199|NCT00977561|101920140|FG001|NOT COMPLETED|Overall Study||4||
48646200|NCT04757584|101920141|FG000|STARTED|On or Off Beta Blockers Up to 6 Wks||5||
48646201|NCT04757584|101920142|FG001|STARTED|On or Off Beta Blockers Up to 6 Wks||4||
48646202|NCT04757584|101920141|FG000|COMPLETED|On or Off Beta Blockers Up to 6 Wks||5||
48646203|NCT04757584|101920142|FG001|COMPLETED|On or Off Beta Blockers Up to 6 Wks||4||
48646204|NCT04757584|101920141|FG000|NOT COMPLETED|On or Off Beta Blockers Up to 6 Wks||0||
48646205|NCT04757584|101920142|FG001|NOT COMPLETED|On or Off Beta Blockers Up to 6 Wks||0||
48646206|NCT04757584|101920141|FG000|STARTED|Down-titration/Up-titration Up to 6 Wks||5||
48646207|NCT04757584|101920142|FG001|STARTED|Down-titration/Up-titration Up to 6 Wks||4||
48646208|NCT04757584|101920141|FG000|COMPLETED|Down-titration/Up-titration Up to 6 Wks||5||
48646209|NCT04757584|101920142|FG001|COMPLETED|Down-titration/Up-titration Up to 6 Wks||4||
48646210|NCT04757584|101920141|FG000|NOT COMPLETED|Down-titration/Up-titration Up to 6 Wks||0||
48646211|NCT04757584|101920142|FG001|NOT COMPLETED|Down-titration/Up-titration Up to 6 Wks||0||
48646212|NCT04757584|101920141|FG000|STARTED|Up-titration/Down-titration Up to 6 Wks||0||
48646213|NCT04757584|101920142|FG001|STARTED|Up-titration/Down-titration Up to 6 Wks||2||
48646214|NCT04757584|101920141|FG000|COMPLETED|Up-titration/Down-titration Up to 6 Wks||0||
48646215|NCT04757584|101920142|FG001|COMPLETED|Up-titration/Down-titration Up to 6 Wks||2||
48646216|NCT04757584|101920141|FG000|NOT COMPLETED|Up-titration/Down-titration Up to 6 Wks||0||
48646217|NCT04757584|101920142|FG001|NOT COMPLETED|Up-titration/Down-titration Up to 6 Wks||0||
48646218|NCT04757584|101920141|FG000|STARTED|Down-titration/Up-Titration Up to 6 Wks||0||
48646219|NCT04757584|101920142|FG001|STARTED|Down-titration/Up-Titration Up to 6 Wks||0||
48646220|NCT04757584|101920141|FG000|COMPLETED|Down-titration/Up-Titration Up to 6 Wks||0||
48646221|NCT04757584|101920142|FG001|COMPLETED|Down-titration/Up-Titration Up to 6 Wks||0||
48646222|NCT04757584|101920141|FG000|NOT COMPLETED|Down-titration/Up-Titration Up to 6 Wks||0||
48646223|NCT04757584|101920142|FG001|NOT COMPLETED|Down-titration/Up-Titration Up to 6 Wks||0||
48646224|NCT04757584|101920141|FG000|STARTED|Follow-up||5|After each of the subjects complete their intervention phase, they proceed to a follow-up phase, which lasts for 12 months.|
48646225|NCT04757584|101920142|FG001|STARTED|Follow-up||4|After each of the subjects complete their intervention phase, they proceed to a follow-up phase, which lasts for 12 months.|
48646226|NCT04757584|101920141|FG000|COMPLETED|Follow-up||5||
48646227|NCT04757584|101920142|FG001|COMPLETED|Follow-up||4||
48646228|NCT04757584|101920141|FG000|NOT COMPLETED|Follow-up||0||
48646229|NCT04757584|101920142|FG001|NOT COMPLETED|Follow-up||0||
48646230|NCT01018953|101920143|FG000|STARTED|Overall Study||8||
48646231|NCT01018953|101920143|FG000|BIM 23A760 1 mg|Overall Study||3||
48646232|NCT01018953|101920143|FG000|BIM 23A760 2 mg|Overall Study||2||
48765242|NCT02326155|102214600|FG000|STARTED|Overall Study||407||
48765243|NCT02326155|102214601|FG001|STARTED|Overall Study||63||
48188188|NCT02018861|100783177|FG007|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0||
48188189|NCT02018861|100783178|FG008|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||3||
48188190|NCT02018861|100783179|FG009|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0||
48646233|NCT01018953|101920143|FG000|BIM 23A760 4 mg|Overall Study||3||
48646234|NCT01018953|101920143|FG000|COMPLETED|Overall Study||0||
48646235|NCT01018953|101920143|FG000|NOT COMPLETED|Overall Study||8||
48646236|NCT02755090|101920144|FG000|STARTED|Overall Study||19||
48646237|NCT02755090|101920145|FG001|STARTED|Overall Study||20||
48646238|NCT02755090|101920144|FG000|COMPLETED|Overall Study||18||
48646239|NCT02755090|101920145|FG001|COMPLETED|Overall Study||20||
48646240|NCT02755090|101920144|FG000|NOT COMPLETED|Overall Study||1||
48646241|NCT02755090|101920145|FG001|NOT COMPLETED|Overall Study||0||
48646242|NCT03461861|101920146|FG000|STARTED|Overall Study||13||
48646243|NCT03461861|101920147|FG001|STARTED|Overall Study||13||
48646244|NCT03461861|101920146|FG000|COMPLETED|Overall Study||13||
48646245|NCT03461861|101920147|FG001|COMPLETED|Overall Study||13||
48646246|NCT03461861|101920146|FG000|NOT COMPLETED|Overall Study||0||
48646247|NCT03461861|101920147|FG001|NOT COMPLETED|Overall Study||0||
48646248|NCT00327171|101920148|FG000|STARTED|Overall Study||109||
48646249|NCT00327171|101920149|FG001|STARTED|Overall Study||109||
48646250|NCT00327171|101920148|FG000|COMPLETED|Overall Study||1||
48646251|NCT00327171|101920149|FG001|COMPLETED|Overall Study||0||
48646252|NCT00327171|101920148|FG000|NOT COMPLETED|Overall Study||108||
48646253|NCT00327171|101920149|FG001|NOT COMPLETED|Overall Study||109||
48646254|NCT03403517|101920150|FG000|STARTED|Overall Study||88||
48646255|NCT03403517|101920151|FG001|STARTED|Overall Study||86||
48646256|NCT03403517|101920150|FG000|COMPLETED|Overall Study||88||
48646257|NCT03403517|101920151|FG001|COMPLETED|Overall Study||86||
48646258|NCT03403517|101920150|FG000|NOT COMPLETED|Overall Study||0||
48646259|NCT03403517|101920151|FG001|NOT COMPLETED|Overall Study||0||
48646260|NCT01155323|101920152|FG000|STARTED|First Intervention||60||
48646261|NCT01155323|101920153|FG001|STARTED|First Intervention||58||
48646262|NCT01155323|101920152|FG000|COMPLETED|First Intervention||59||
48646263|NCT01155323|101920153|FG001|COMPLETED|First Intervention||57||
48646264|NCT01155323|101920152|FG000|NOT COMPLETED|First Intervention||1||
48646265|NCT01155323|101920153|FG001|NOT COMPLETED|First Intervention||1||
48646266|NCT01155323|101920152|FG000|STARTED|Second Intervention||59||
48646267|NCT01155323|101920153|FG001|STARTED|Second Intervention||57||
48646268|NCT01155323|101920152|FG000|COMPLETED|Second Intervention||58||
48646269|NCT01155323|101920153|FG001|COMPLETED|Second Intervention||56||
48646270|NCT01155323|101920152|FG000|NOT COMPLETED|Second Intervention||1||
48646271|NCT01155323|101920153|FG001|NOT COMPLETED|Second Intervention||1||
48646272|NCT01846871|101920154|FG000|STARTED|Overall Study||10||
48646273|NCT01846871|101920154|FG000|COMPLETED|Overall Study||10||
48646274|NCT01846871|101920154|FG000|NOT COMPLETED|Overall Study||0||
48646275|NCT03111732|101920155|FG000|STARTED|Overall Study||11||
48646276|NCT03111732|101920155|FG000|COMPLETED|Overall Study||6||
48646277|NCT03111732|101920155|FG000|NOT COMPLETED|Overall Study||5||
48646278|NCT02134028|101920156|FG000|STARTED|Overall Study||111|Participants who completed studies DRI12544, PDY14192, EFC13579, and EFC13691.|
48646279|NCT02134028|101920157|FG001|STARTED|Overall Study||421|Participants who completed studies DRI12544, PDY14192, EFC13579, and EFC13691.|
48646280|NCT02134028|101920158|FG002|STARTED|Overall Study||517|Participants who completed studies DRI12544, PDY14192, EFC13579, and EFC13691.|
48646281|NCT02134028|101920159|FG003|STARTED|Overall Study||1013|Participants who completed studies DRI12544, PDY14192, EFC13579, and EFC13691.|
48362099|NCT00564629|101214485|FG000|COMPLETED|Overall Study||36||
48362100|NCT00564629|101214486|FG001|COMPLETED|Overall Study||45||
48646282|NCT02134028|101920160|FG004|STARTED|Overall Study||97|Participants who completed studies DRI12544, PDY14192, EFC13579, and EFC13691.|
48646283|NCT02134028|101920161|FG005|STARTED|Overall Study||90|Participants who completed studies DRI12544, PDY14192, EFC13579, and EFC13691.|
48646284|NCT02134028|101920162|FG006|STARTED|Overall Study||19|Participants who completed studies DRI12544, PDY14192, EFC13579, and EFC13691.|
48646285|NCT02134028|101920163|FG007|STARTED|Overall Study||14|Participants who completed studies DRI12544, PDY14192, EFC13579, and EFC13691.|
48646286|NCT02134028|101920156|FG000|COMPLETED|Overall Study||102||
48646287|NCT02134028|101920157|FG001|COMPLETED|Overall Study||379||
48646288|NCT02134028|101920158|FG002|COMPLETED|Overall Study||465||
48646289|NCT02134028|101920159|FG003|COMPLETED|Overall Study||908||
48646290|NCT02134028|101920160|FG004|COMPLETED|Overall Study||83||
48646291|NCT02134028|101920161|FG005|COMPLETED|Overall Study||76||
48646292|NCT02134028|101920162|FG006|COMPLETED|Overall Study||15||
48646293|NCT02134028|101920163|FG007|COMPLETED|Overall Study||11||
48646294|NCT02134028|101920156|FG000|NOT COMPLETED|Overall Study||9||
48646295|NCT02134028|101920157|FG001|NOT COMPLETED|Overall Study||42||
48646296|NCT02134028|101920158|FG002|NOT COMPLETED|Overall Study||52||
48646297|NCT02134028|101920159|FG003|NOT COMPLETED|Overall Study||105||
48646298|NCT02134028|101920160|FG004|NOT COMPLETED|Overall Study||14||
48646299|NCT02134028|101920161|FG005|NOT COMPLETED|Overall Study||14||
48646300|NCT02134028|101920162|FG006|NOT COMPLETED|Overall Study||4||
48646301|NCT02134028|101920163|FG007|NOT COMPLETED|Overall Study||3||
48646302|NCT00629239|101920164|FG000|STARTED|Overall Study||34||
48646303|NCT00629239|101920165|FG001|STARTED|Overall Study||32||
48646304|NCT00629239|101920164|FG000|COMPLETED|Overall Study||26||
48646305|NCT00629239|101920165|FG001|COMPLETED|Overall Study||28||
48646306|NCT00629239|101920164|FG000|NOT COMPLETED|Overall Study||8||
48646307|NCT00629239|101920165|FG001|NOT COMPLETED|Overall Study||4||
48646308|NCT05181657|101920166|FG000|STARTED|Overall Study||75||5
48646309|NCT05181657|101920167|FG001|STARTED|Overall Study||75||7
48646310|NCT05181657|101920166|FG000|Enrollment at the End of Week 1|Overall Study||0||0
48646311|NCT05181657|101920167|FG001|Enrollment at the End of Week 1|Overall Study||7||1
48646312|NCT05181657|101920166|FG000|Enrollment at the End of Week 2|Overall Study||4||1
48362101|NCT00564629|101214485|FG000|NOT COMPLETED|Overall Study||15||
48362102|NCT00564629|101214486|FG001|NOT COMPLETED|Overall Study||9||
48362103|NCT00923091|101214487|FG000|STARTED|PeriodI-II (Randomized, Double-Blind)||335||
48646313|NCT05181657|101920167|FG001|Enrollment at the End of Week 2|Overall Study||7||1
48646314|NCT05181657|101920166|FG000|Enrollment at the End of Week 3|Overall Study||4||1
48646315|NCT05181657|101920167|FG001|Enrollment at the End of Week 3|Overall Study||11||2
48646316|NCT05181657|101920166|FG000|Enrollment at the End of Week 4|Overall Study||22||2
48646317|NCT05181657|101920167|FG001|Enrollment at the End of Week 4|Overall Study||11||2
48646318|NCT05181657|101920166|FG000|Enrollment at the End of Week 5|Overall Study||22||2
48646319|NCT05181657|101920167|FG001|Enrollment at the End of Week 5|Overall Study||23||3
48646320|NCT05181657|101920166|FG000|Enrollment at the End of Week 6|Overall Study||39||3
48646321|NCT05181657|101920167|FG001|Enrollment at the End of Week 6|Overall Study||23||3
48646322|NCT05181657|101920166|FG000|Enrollment at the End of Week 7|Overall Study||39||3
48646323|NCT05181657|101920167|FG001|Enrollment at the End of Week 7|Overall Study||39||4
48646324|NCT05181657|101920166|FG000|Enrollment at the End of Week 8|Overall Study||50||4
48646325|NCT05181657|101920167|FG001|Enrollment at the End of Week 8|Overall Study||39||4
48646326|NCT05181657|101920166|FG000|Enrollment at the End of Week 9|Overall Study||50||4
48646327|NCT05181657|101920167|FG001|Enrollment at the End of Week 9|Overall Study||60||5
48646328|NCT05181657|101920166|FG000|Enrollment at the End of Week 10|Overall Study||75||5
48646329|NCT05181657|101920167|FG001|Enrollment at the End of Week 10|Overall Study||60||5
48646330|NCT05181657|101920166|FG000|Enrollment at the End of Week 11|Overall Study||75||5
48646331|NCT05181657|101920167|FG001|Enrollment at the End of Week 11|Overall Study||72||6
48646332|NCT05181657|101920166|FG000|Enrollment at the End of Week 12|Overall Study||75||5
48646333|NCT05181657|101920167|FG001|Enrollment at the End of Week 12|Overall Study||75||7
48646334|NCT05181657|101920166|FG000|COMPLETED|Overall Study||75||5
48646335|NCT05181657|101920167|FG001|COMPLETED|Overall Study||75||7
48646336|NCT05181657|101920166|FG000|NOT COMPLETED|Overall Study||0||0
48646337|NCT05181657|101920167|FG001|NOT COMPLETED|Overall Study||0||0
48646338|NCT01509105|101920168|FG000|STARTED|Overall Study||649||
48646339|NCT01509105|101920168|FG000|COMPLETED|Overall Study||649||
48646340|NCT01509105|101920168|FG000|NOT COMPLETED|Overall Study||0||
48646341|NCT00476788|101920169|FG000|STARTED|Overall Study||14||
48646342|NCT00476788|101920169|FG000|COMPLETED|Overall Study||11||
48646343|NCT00476788|101920169|FG000|NOT COMPLETED|Overall Study||3||
48646344|NCT01339013|101920170|FG000|STARTED|Overall Study||6||
48646345|NCT01339013|101920170|FG000|COMPLETED|Overall Study||6||
48646346|NCT01339013|101920170|FG000|NOT COMPLETED|Overall Study||0||
48646347|NCT00397930|101920171|FG000|STARTED|Overall Study||206||
48646348|NCT00397930|101920172|FG001|STARTED|Overall Study||204||
48646349|NCT00397930|101920171|FG000|COMPLETED|Overall Study||168||
48646350|NCT00397930|101920172|FG001|COMPLETED|Overall Study||153||
48646351|NCT00397930|101920171|FG000|NOT COMPLETED|Overall Study||38||
48646352|NCT00397930|101920172|FG001|NOT COMPLETED|Overall Study||51||
48646353|NCT02762604|101920173|FG000|STARTED|Overall Study||25||
48646354|NCT02762604|101920174|FG001|STARTED|Overall Study||24||
48646355|NCT02762604|101920173|FG000|COMPLETED|Overall Study||22||
48646356|NCT02762604|101920174|FG001|COMPLETED|Overall Study||14||
48646357|NCT02762604|101920173|FG000|NOT COMPLETED|Overall Study||3||
48646358|NCT02762604|101920174|FG001|NOT COMPLETED|Overall Study||10||
48646359|NCT00762177|101920175|FG000|STARTED|1st Treatment Period||8||
48646360|NCT00762177|101920176|FG001|STARTED|1st Treatment Period||8||
48646361|NCT00762177|101920177|FG002|STARTED|1st Treatment Period||8||
48646362|NCT00762177|101920175|FG000|COMPLETED|1st Treatment Period||8||
48646363|NCT00762177|101920176|FG001|COMPLETED|1st Treatment Period||8||
48646364|NCT00762177|101920177|FG002|COMPLETED|1st Treatment Period||8||
48646365|NCT00762177|101920175|FG000|NOT COMPLETED|1st Treatment Period||0||
48646366|NCT00762177|101920176|FG001|NOT COMPLETED|1st Treatment Period||0||
48646367|NCT00762177|101920177|FG002|NOT COMPLETED|1st Treatment Period||0||
48646368|NCT00762177|101920175|FG000|STARTED|Washout After 1st Treatment||8||
48646369|NCT00762177|101920176|FG001|STARTED|Washout After 1st Treatment||8||
48646370|NCT00762177|101920177|FG002|STARTED|Washout After 1st Treatment||8||
48646371|NCT00762177|101920175|FG000|COMPLETED|Washout After 1st Treatment||8||
48362104|NCT00923091|101214488|FG001|STARTED|PeriodI-II (Randomized, Double-Blind)||336||
48362105|NCT00923091|101214489|FG002|STARTED|PeriodI-II (Randomized, Double-Blind)||336||
48362106|NCT00923091|101214490|FG003|STARTED|PeriodI-II (Randomized, Double-Blind)||336||
48362107|NCT00923091|101214491|FG004|STARTED|PeriodI-II (Randomized, Double-Blind)||336||
48362108|NCT00923091|101214492|FG005|STARTED|PeriodI-II (Randomized, Double-Blind)||337||
48646372|NCT00762177|101920176|FG001|COMPLETED|Washout After 1st Treatment||8||
48646373|NCT00762177|101920177|FG002|COMPLETED|Washout After 1st Treatment||8||
48646374|NCT00762177|101920175|FG000|NOT COMPLETED|Washout After 1st Treatment||0||
48646375|NCT00762177|101920176|FG001|NOT COMPLETED|Washout After 1st Treatment||0||
48646376|NCT00762177|101920177|FG002|NOT COMPLETED|Washout After 1st Treatment||0||
48646377|NCT00762177|101920175|FG000|STARTED|2nd Treatment Period||8||
48646378|NCT00762177|101920176|FG001|STARTED|2nd Treatment Period||8||
48362109|NCT00923091|101214493|FG006|STARTED|PeriodI-II (Randomized, Double-Blind)||337||
48362110|NCT00923091|101214494|FG007|STARTED|PeriodI-II (Randomized, Double-Blind)||336||
48362111|NCT00923091|101214495|FG008|STARTED|PeriodI-II (Randomized, Double-Blind)||0||
48362112|NCT00923091|101214496|FG009|STARTED|PeriodI-II (Randomized, Double-Blind)||0||
48362113|NCT00923091|101214497|FG010|STARTED|PeriodI-II (Randomized, Double-Blind)||0||
48646379|NCT00762177|101920177|FG002|STARTED|2nd Treatment Period||8||
48646380|NCT00762177|101920175|FG000|COMPLETED|2nd Treatment Period||8||
48646381|NCT00762177|101920176|FG001|COMPLETED|2nd Treatment Period||8||
48646382|NCT00762177|101920177|FG002|COMPLETED|2nd Treatment Period||8||
48646383|NCT00762177|101920175|FG000|NOT COMPLETED|2nd Treatment Period||0||
48646384|NCT00762177|101920176|FG001|NOT COMPLETED|2nd Treatment Period||0||
48646385|NCT00762177|101920177|FG002|NOT COMPLETED|2nd Treatment Period||0||
48646386|NCT00762177|101920175|FG000|STARTED|Washout After 2nd Treatment||8||
48646387|NCT00762177|101920176|FG001|STARTED|Washout After 2nd Treatment||8||
48646388|NCT00762177|101920177|FG002|STARTED|Washout After 2nd Treatment||8||
48646389|NCT00762177|101920175|FG000|COMPLETED|Washout After 2nd Treatment||8||
48646390|NCT00762177|101920176|FG001|COMPLETED|Washout After 2nd Treatment||8||
48646391|NCT00762177|101920177|FG002|COMPLETED|Washout After 2nd Treatment||8||
48646392|NCT00762177|101920175|FG000|NOT COMPLETED|Washout After 2nd Treatment||0||
48646393|NCT00762177|101920176|FG001|NOT COMPLETED|Washout After 2nd Treatment||0||
48646394|NCT00762177|101920177|FG002|NOT COMPLETED|Washout After 2nd Treatment||0||
48646395|NCT00762177|101920175|FG000|STARTED|3rd Treatment Period||8||
48646396|NCT00762177|101920176|FG001|STARTED|3rd Treatment Period||8||
48646397|NCT00762177|101920177|FG002|STARTED|3rd Treatment Period||8||
48646398|NCT00762177|101920175|FG000|COMPLETED|3rd Treatment Period||8||
48646399|NCT00762177|101920176|FG001|COMPLETED|3rd Treatment Period||8||
48646400|NCT00762177|101920177|FG002|COMPLETED|3rd Treatment Period||8||
48646401|NCT00762177|101920175|FG000|NOT COMPLETED|3rd Treatment Period||0||
48646402|NCT00762177|101920176|FG001|NOT COMPLETED|3rd Treatment Period||0||
48646403|NCT00762177|101920177|FG002|NOT COMPLETED|3rd Treatment Period||0||
48646404|NCT01952678|101920178|FG000|STARTED|Overall Study||102||
48646405|NCT01952678|101920179|FG001|STARTED|Overall Study||102||
48646406|NCT01952678|101920178|FG000|COMPLETED|Overall Study||102||
48646407|NCT01952678|101920179|FG001|COMPLETED|Overall Study||102||
48646408|NCT01952678|101920178|FG000|NOT COMPLETED|Overall Study||0||
48646409|NCT01952678|101920179|FG001|NOT COMPLETED|Overall Study||0||
48646410|NCT03679884|101920180|FG000|STARTED|Overall Study||142|DB treatment period|
48646411|NCT03679884|101920181|FG001|STARTED|Overall Study||268|DB treatment period|
48646412|NCT03679884|101920182|FG002|STARTED|Overall Study||137|DB treatment period|
48646413|NCT03679884|101920183|FG003|STARTED|Overall Study||128|DB treatment period|
48646414|NCT03679884|101920184|FG004|STARTED|Overall Study||126|DB treatment period|
48646415|NCT03679884|101920180|FG000|COMPLETED|Overall Study||99|DB treatment period|
48646416|NCT03679884|101920181|FG001|COMPLETED|Overall Study||190|DB treatment period|
48646417|NCT03679884|101920182|FG002|COMPLETED|Overall Study||93|DB treatment period|
48646418|NCT03679884|101920183|FG003|COMPLETED|Overall Study||78|DB treatment period|
48646419|NCT03679884|101920184|FG004|COMPLETED|Overall Study||90|DB treatment period|
48646420|NCT03679884|101920180|FG000|NOT COMPLETED|Overall Study||43||
48646421|NCT03679884|101920181|FG001|NOT COMPLETED|Overall Study||78||
48646422|NCT03679884|101920182|FG002|NOT COMPLETED|Overall Study||44||
48646423|NCT03679884|101920183|FG003|NOT COMPLETED|Overall Study||50||
48646424|NCT03679884|101920184|FG004|NOT COMPLETED|Overall Study||36||
48646425|NCT02541903|101920185|FG000|STARTED|Overall Study||8||
48646426|NCT02541903|101920185|FG000|COMPLETED|Overall Study||7||
48646427|NCT02541903|101920185|FG000|NOT COMPLETED|Overall Study||1||
48646428|NCT04914000|101920186|FG000|STARTED|Overall Study||53||
48646429|NCT04914000|101920186|FG000|COMPLETED|Overall Study||44||
48646430|NCT04914000|101920186|FG000|NOT COMPLETED|Overall Study||9||
48646431|NCT01531153|101920187|FG000|STARTED|Overall Study||32||
48646432|NCT01531153|101920188|FG001|STARTED|Overall Study||31||
48646433|NCT01531153|101920189|FG002|STARTED|Overall Study||30||
48646434|NCT01531153|101920187|FG000|COMPLETED|Overall Study||22||
48646435|NCT01531153|101920188|FG001|COMPLETED|Overall Study||22||
48646436|NCT01531153|101920189|FG002|COMPLETED|Overall Study||15||
48646437|NCT01531153|101920187|FG000|NOT COMPLETED|Overall Study||10||
48646438|NCT01531153|101920188|FG001|NOT COMPLETED|Overall Study||9||
48646439|NCT01531153|101920189|FG002|NOT COMPLETED|Overall Study||15||
48646440|NCT01895647|101920190|FG000|STARTED|Overall Study||8||
48646441|NCT01895647|101920191|FG001|STARTED|Overall Study||10||
48646442|NCT01895647|101920192|FG002|STARTED|Overall Study||7||
48646443|NCT01895647|101920190|FG000|COMPLETED|Overall Study||8||
48646444|NCT01895647|101920191|FG001|COMPLETED|Overall Study||10||
48646445|NCT01895647|101920192|FG002|COMPLETED|Overall Study||7||
48646446|NCT01895647|101920190|FG000|NOT COMPLETED|Overall Study||0||
48646447|NCT01895647|101920191|FG001|NOT COMPLETED|Overall Study||0||
48362114|NCT00923091|101214498|FG011|STARTED|PeriodI-II (Randomized, Double-Blind)||0||
48362115|NCT00923091|101214499|FG012|STARTED|PeriodI-II (Randomized, Double-Blind)||0||
48362116|NCT00923091|101214487|FG000|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319||
48362117|NCT00923091|101214488|FG001|COMPLETED|PeriodI-II (Randomized, Double-Blind)||325||
48362118|NCT00923091|101214489|FG002|COMPLETED|PeriodI-II (Randomized, Double-Blind)||323||
48362119|NCT00923091|101214490|FG003|COMPLETED|PeriodI-II (Randomized, Double-Blind)||309||
48362120|NCT00923091|101214491|FG004|COMPLETED|PeriodI-II (Randomized, Double-Blind)||315||
48646448|NCT01895647|101920192|FG002|NOT COMPLETED|Overall Study||0||
48646449|NCT03467945|101920193|FG000|STARTED|Treatment Period 1||10||
48646450|NCT03467945|101920194|FG001|STARTED|Treatment Period 1||10||
48646451|NCT03467945|101920195|FG002|STARTED|Treatment Period 1||10||
48646452|NCT03467945|101920196|FG003|STARTED|Treatment Period 1||10||
48646453|NCT03467945|101920193|FG000|COMPLETED|Treatment Period 1||10||
48646454|NCT03467945|101920194|FG001|COMPLETED|Treatment Period 1||10||
48646455|NCT03467945|101920195|FG002|COMPLETED|Treatment Period 1||10||
48646456|NCT03467945|101920196|FG003|COMPLETED|Treatment Period 1||10||
48646457|NCT03467945|101920193|FG000|NOT COMPLETED|Treatment Period 1||0||
48646458|NCT03467945|101920194|FG001|NOT COMPLETED|Treatment Period 1||0||
48646459|NCT03467945|101920195|FG002|NOT COMPLETED|Treatment Period 1||0||
48646460|NCT03467945|101920196|FG003|NOT COMPLETED|Treatment Period 1||0||
48646461|NCT03467945|101920193|FG000|STARTED|Treatment Period 2||10||
48646462|NCT03467945|101920194|FG001|STARTED|Treatment Period 2||10||
48646463|NCT03467945|101920195|FG002|STARTED|Treatment Period 2||10||
48646464|NCT03467945|101920196|FG003|STARTED|Treatment Period 2||10||
48646465|NCT03467945|101920193|FG000|COMPLETED|Treatment Period 2||10||
48646466|NCT03467945|101920194|FG001|COMPLETED|Treatment Period 2||9||
48646467|NCT03467945|101920195|FG002|COMPLETED|Treatment Period 2||10||
48646468|NCT03467945|101920196|FG003|COMPLETED|Treatment Period 2||10||
48646469|NCT03467945|101920193|FG000|NOT COMPLETED|Treatment Period 2||0||
48646470|NCT03467945|101920194|FG001|NOT COMPLETED|Treatment Period 2||1||
48646471|NCT03467945|101920195|FG002|NOT COMPLETED|Treatment Period 2||0||
48646472|NCT03467945|101920196|FG003|NOT COMPLETED|Treatment Period 2||0||
48646473|NCT03467945|101920193|FG000|STARTED|Treatment Period 3||10||
48646474|NCT03467945|101920194|FG001|STARTED|Treatment Period 3||9||
48646475|NCT03467945|101920195|FG002|STARTED|Treatment Period 3||10||
48646476|NCT03467945|101920196|FG003|STARTED|Treatment Period 3||10||
48646477|NCT03467945|101920193|FG000|COMPLETED|Treatment Period 3||9||
48646478|NCT03467945|101920194|FG001|COMPLETED|Treatment Period 3||9||
48646479|NCT03467945|101920195|FG002|COMPLETED|Treatment Period 3||8||
48646480|NCT03467945|101920196|FG003|COMPLETED|Treatment Period 3||9||
48646481|NCT03467945|101920193|FG000|NOT COMPLETED|Treatment Period 3||1||
48646482|NCT03467945|101920194|FG001|NOT COMPLETED|Treatment Period 3||0||
48646483|NCT03467945|101920195|FG002|NOT COMPLETED|Treatment Period 3||2||
48646484|NCT03467945|101920196|FG003|NOT COMPLETED|Treatment Period 3||1||
48646485|NCT03467945|101920193|FG000|STARTED|Treatment Period 4||9||
48646486|NCT03467945|101920194|FG001|STARTED|Treatment Period 4||9||
48646487|NCT03467945|101920195|FG002|STARTED|Treatment Period 4||8||
48646488|NCT03467945|101920196|FG003|STARTED|Treatment Period 4||9||
48646489|NCT03467945|101920193|FG000|COMPLETED|Treatment Period 4||9||
48646490|NCT03467945|101920194|FG001|COMPLETED|Treatment Period 4||9||
48646491|NCT03467945|101920195|FG002|COMPLETED|Treatment Period 4||8||
48646492|NCT03467945|101920196|FG003|COMPLETED|Treatment Period 4||9||
48646493|NCT03467945|101920193|FG000|NOT COMPLETED|Treatment Period 4||0||
48646494|NCT03467945|101920194|FG001|NOT COMPLETED|Treatment Period 4||0||
48646495|NCT03467945|101920195|FG002|NOT COMPLETED|Treatment Period 4||0||
48646496|NCT03467945|101920196|FG003|NOT COMPLETED|Treatment Period 4||0||
48646497|NCT03158311|101920197|FG000|STARTED|Overall Study||474|All participants who were assigned a randomization number|
48646498|NCT03158311|101920198|FG001|STARTED|Overall Study||476|All participants who were assigned a randomization number|
48646499|NCT03158311|101920199|FG002|STARTED|Overall Study||476|All participants who were assigned a randomization number|
48646500|NCT03158311|101920197|FG000|Full Analysis Set (FAS)|Overall Study||474|All the participants in the randomization set who received at least one dose of the study medication|
48646501|NCT03158311|101920198|FG001|Full Analysis Set (FAS)|Overall Study||476|All the participants in the randomization set who received at least one dose of the study medication|
48646502|NCT03158311|101920199|FG002|Full Analysis Set (FAS)|Overall Study||475|All the participants in the randomization set who received at least one dose of the study medication|
48646503|NCT03158311|101920197|FG000|Safety Set (SAF)|Overall Study||474|All the participants who received at least one dose of the study medication|
48646504|NCT03158311|101920198|FG001|Safety Set (SAF)|Overall Study||476|All the participants who received at least one dose of the study medication|
48646505|NCT03158311|101920199|FG002|Safety Set (SAF)|Overall Study||475|All the participants who received at least one dose of the study medication|
48646506|NCT03158311|101920197|FG000|COMPLETED|Overall Study||452||
48646507|NCT03158311|101920198|FG001|COMPLETED|Overall Study||460||
48646508|NCT03158311|101920199|FG002|COMPLETED|Overall Study||448||
48646509|NCT03158311|101920197|FG000|NOT COMPLETED|Overall Study||22||
48646510|NCT03158311|101920198|FG001|NOT COMPLETED|Overall Study||16||
48646511|NCT03158311|101920199|FG002|NOT COMPLETED|Overall Study||28||
48646512|NCT01873833|101920200|FG000|STARTED|Overall Study||10||
48646513|NCT01873833|101920200|FG000|COMPLETED|Overall Study||9||
48646514|NCT01873833|101920200|FG000|NOT COMPLETED|Overall Study||1||
48646515|NCT02357485|101920201|FG000|STARTED|Overall Study||6||
48646516|NCT02357485|101920201|FG000|COMPLETED|Overall Study||6||
48646517|NCT02357485|101920201|FG000|NOT COMPLETED|Overall Study||0||
48646518|NCT01708525|101920202|FG000|STARTED|Overall Study||2||
48646519|NCT01708525|101920202|FG000|COMPLETED|Overall Study||2||
48646520|NCT01708525|101920202|FG000|NOT COMPLETED|Overall Study||0||
48646521|NCT03072875|101920203|FG000|STARTED|Overall Study||26||
48646522|NCT03072875|101920203|FG000|COMPLETED|Overall Study||25||
48646523|NCT03072875|101920203|FG000|NOT COMPLETED|Overall Study||1||
48646524|NCT04706403|101920204|FG000|STARTED|Overall Study||172||
48646525|NCT04706403|101920205|FG001|STARTED|Overall Study||121||
48646526|NCT04706403|101920206|FG002|STARTED|Overall Study||165||
48646527|NCT04706403|101920207|FG003|STARTED|Overall Study||146||
48765244|NCT02326155|102214600|FG000|COMPLETED|Overall Study||13||
48646528|NCT04706403|101920208|FG004|STARTED|Overall Study||152||
48646529|NCT04706403|101920204|FG000|COMPLETED|Overall Study||172||
48646530|NCT04706403|101920205|FG001|COMPLETED|Overall Study||121||
48646531|NCT04706403|101920206|FG002|COMPLETED|Overall Study||164||
48646532|NCT04706403|101920207|FG003|COMPLETED|Overall Study||145||
48646533|NCT04706403|101920208|FG004|COMPLETED|Overall Study||150||
48646534|NCT04706403|101920204|FG000|NOT COMPLETED|Overall Study||0||
48646535|NCT04706403|101920205|FG001|NOT COMPLETED|Overall Study||0||
48646536|NCT04706403|101920206|FG002|NOT COMPLETED|Overall Study||1||
48646537|NCT04706403|101920207|FG003|NOT COMPLETED|Overall Study||1||
48646538|NCT04706403|101920208|FG004|NOT COMPLETED|Overall Study||2||
48646539|NCT01086475|101920209|FG000|STARTED|Overall Study||34||
48646540|NCT01086475|101920210|FG001|STARTED|Overall Study||33||
48646541|NCT01086475|101920209|FG000|COMPLETED|Overall Study||34||
48646542|NCT01086475|101920210|FG001|COMPLETED|Overall Study||33||
48646543|NCT01086475|101920209|FG000|NOT COMPLETED|Overall Study||0||
48646544|NCT01086475|101920210|FG001|NOT COMPLETED|Overall Study||0||
48646545|NCT04243837|101920211|FG000|STARTED|Overall Study||28||
48646546|NCT04243837|101920212|FG001|STARTED|Overall Study||22||
48646547|NCT04243837|101920211|FG000|COMPLETED|Overall Study||10||
48646548|NCT04243837|101920212|FG001|COMPLETED|Overall Study||7||
48646549|NCT04243837|101920211|FG000|NOT COMPLETED|Overall Study||18||
48646550|NCT04243837|101920212|FG001|NOT COMPLETED|Overall Study||15||
48646551|NCT02547987|101920213|FG000|STARTED|Overall Study||25||
48646552|NCT02547987|101920213|FG000|COMPLETED|Overall Study||22||
48646553|NCT02547987|101920213|FG000|NOT COMPLETED|Overall Study||3||
48646554|NCT00800384|101920214|FG000|STARTED|Overall Study||1247||
48646555|NCT00800384|101920215|FG001|STARTED|Overall Study||1253||
48646556|NCT00800384|101920214|FG000|COMPLETED|Overall Study||1206||
48646557|NCT00800384|101920215|FG001|COMPLETED|Overall Study||1210||
48646558|NCT00800384|101920214|FG000|NOT COMPLETED|Overall Study||41||
48646559|NCT00800384|101920215|FG001|NOT COMPLETED|Overall Study||43||
48646560|NCT01898130|101920216|FG000|STARTED|Treatment||27||
48646561|NCT01898130|101920216|FG000|Reached 1st Response/2 Cycles|Treatment||24||
48646562|NCT01898130|101920216|FG000|Went on to Start Cycle 3|Treatment||21||
48646563|NCT01898130|101920216|FG000|COMPLETED|Treatment||21||
48646564|NCT01898130|101920216|FG000|NOT COMPLETED|Treatment||6||
48646565|NCT01898130|101920216|FG000|STARTED|Follow up Until PD or Death||27||
48646566|NCT01898130|101920216|FG000|COMPLETED|Follow up Until PD or Death||26||
48646567|NCT01898130|101920216|FG000|NOT COMPLETED|Follow up Until PD or Death||1||
48646568|NCT03235414|101920217|FG000|STARTED|Overall Study||101||
48646569|NCT03235414|101920217|FG000|COMPLETED|Overall Study||101||
48646570|NCT03235414|101920217|FG000|NOT COMPLETED|Overall Study||0||
48646571|NCT01946802|101920218|FG000|STARTED|Overall Study||44||
48646572|NCT01946802|101920218|FG000|COMPLETED|Overall Study||39||
48646573|NCT01946802|101920218|FG000|NOT COMPLETED|Overall Study||5||
48646574|NCT00884065|101920219|FG000|STARTED|Overall Study||25||
48646575|NCT00884065|101920220|FG001|STARTED|Overall Study||25||
48646576|NCT00884065|101920219|FG000|COMPLETED|Overall Study||25||
48646577|NCT00884065|101920220|FG001|COMPLETED|Overall Study||25||
48646578|NCT00884065|101920219|FG000|NOT COMPLETED|Overall Study||0||
48646579|NCT00884065|101920220|FG001|NOT COMPLETED|Overall Study||0||
48646580|NCT02555098|101920221|FG000|STARTED|First Intervention||12||
48646581|NCT02555098|101920222|FG001|STARTED|First Intervention||11||
48646582|NCT02555098|101920221|FG000|COMPLETED|First Intervention||12||
48646583|NCT02555098|101920222|FG001|COMPLETED|First Intervention||11||
48646584|NCT02555098|101920221|FG000|NOT COMPLETED|First Intervention||0||
48646585|NCT02555098|101920222|FG001|NOT COMPLETED|First Intervention||0||
48646586|NCT02555098|101920221|FG000|STARTED|Second Intervention||12||
48646587|NCT02555098|101920222|FG001|STARTED|Second Intervention||11||
48646588|NCT02555098|101920221|FG000|COMPLETED|Second Intervention||12||
48646589|NCT02555098|101920222|FG001|COMPLETED|Second Intervention||11||
48646590|NCT02555098|101920221|FG000|NOT COMPLETED|Second Intervention||0||
48646591|NCT02555098|101920222|FG001|NOT COMPLETED|Second Intervention||0||
48646592|NCT00326495|101920223|FG000|STARTED|Overall Study||51||
48646593|NCT00326495|101920223|FG000|COMPLETED|Overall Study||46||
48646594|NCT00326495|101920223|FG000|NOT COMPLETED|Overall Study||5||
48646595|NCT00583804|101920224|FG000|STARTED|Overall Study||10||
48646596|NCT00583804|101920224|FG000|COMPLETED|Overall Study||10||
48646597|NCT00583804|101920224|FG000|NOT COMPLETED|Overall Study||0||
48646598|NCT00793611|101920225|FG000|STARTED|Overall Study||10||
48646599|NCT00793611|101920226|FG001|STARTED|Overall Study||10||
48646600|NCT00793611|101920225|FG000|COMPLETED|Overall Study||10||
48646601|NCT00793611|101920226|FG001|COMPLETED|Overall Study||10||
48646602|NCT00793611|101920225|FG000|NOT COMPLETED|Overall Study||0||
48646603|NCT00793611|101920226|FG001|NOT COMPLETED|Overall Study||0||
48646604|NCT01145222|101920227|FG000|STARTED|Overall Study||40||
48646605|NCT01145222|101920228|FG001|STARTED|Overall Study||40||
48646606|NCT01145222|101920229|FG002|STARTED|Overall Study||41||
48646607|NCT01145222|101920230|FG003|STARTED|Overall Study||41||
48646608|NCT01145222|101920227|FG000|Safety Population|Overall Study||40|Safety population included all randomized patients who received any amount of study drug|
48646609|NCT01145222|101920228|FG001|Safety Population|Overall Study||40|Safety population included all randomized patients who received any amount of study drug|
48646610|NCT01145222|101920229|FG002|Safety Population|Overall Study||40|Safety population included all randomized patients who received any amount of study drug|
48646611|NCT01145222|101920230|FG003|Safety Population|Overall Study||41|Safety population included all randomized patients who received any amount of study drug|
48646612|NCT01145222|101920227|FG000|Intention to Treat (ITT) Population|Overall Study||40|Received any amount of study drug, started the procedure, and had at least 1 efficacy assessment|
48646613|NCT01145222|101920228|FG001|Intention to Treat (ITT) Population|Overall Study||40|Received any amount of study drug, started the procedure, and had at least 1 efficacy assessment|
48646614|NCT01145222|101920229|FG002|Intention to Treat (ITT) Population|Overall Study||40|Received any amount of study drug, started the procedure, and had at least 1 efficacy assessment|
48646615|NCT01145222|101920230|FG003|Intention to Treat (ITT) Population|Overall Study||40|Received any amount of study drug, started the procedure, and had at least 1 efficacy assessment|
48646616|NCT01145222|101920227|FG000|COMPLETED|Overall Study||40||
48646617|NCT01145222|101920228|FG001|COMPLETED|Overall Study||40||
48646618|NCT01145222|101920229|FG002|COMPLETED|Overall Study||40||
48646619|NCT01145222|101920230|FG003|COMPLETED|Overall Study||40||
48646620|NCT01145222|101920227|FG000|NOT COMPLETED|Overall Study||0||
48646621|NCT01145222|101920228|FG001|NOT COMPLETED|Overall Study||0||
48646622|NCT01145222|101920229|FG002|NOT COMPLETED|Overall Study||1||
48646623|NCT01145222|101920230|FG003|NOT COMPLETED|Overall Study||1||
48646624|NCT02370394|101920231|FG000|STARTED|Overall Study||28||
48646625|NCT02370394|101920232|FG001|STARTED|Overall Study||25||
48646626|NCT02370394|101920231|FG000|COMPLETED|Overall Study||26||
48646627|NCT02370394|101920232|FG001|COMPLETED|Overall Study||23||
48646628|NCT02370394|101920231|FG000|NOT COMPLETED|Overall Study||2||
48646629|NCT02370394|101920232|FG001|NOT COMPLETED|Overall Study||2||
48646630|NCT03712852|101920233|FG000|STARTED|Overall Study||20||
48646631|NCT03712852|101920234|FG001|STARTED|Overall Study||20||
48646632|NCT03712852|101920235|FG002|STARTED|Overall Study||20||
48646633|NCT03712852|101920233|FG000|COMPLETED|Overall Study||20||
48646634|NCT03712852|101920234|FG001|COMPLETED|Overall Study||20||
48646635|NCT03712852|101920235|FG002|COMPLETED|Overall Study||20||
48646636|NCT03712852|101920233|FG000|NOT COMPLETED|Overall Study||0||
48646637|NCT03712852|101920234|FG001|NOT COMPLETED|Overall Study||0||
48646638|NCT03712852|101920235|FG002|NOT COMPLETED|Overall Study||0||
48646639|NCT03331562|101920236|FG000|STARTED|Overall Study||12|Randomized to study arm, received allocated study treatment|
48646640|NCT03331562|101920237|FG001|STARTED|Overall Study||12|Randomized to study arm, received allocated study treatment|
48646641|NCT03331562|101920236|FG000|COMPLETED|Overall Study||9|Patients continued on study treatment until disease progression|
48646642|NCT03331562|101920237|FG001|COMPLETED|Overall Study||12|Patients continued on study treatment until disease progression|
48646643|NCT03331562|101920236|FG000|NOT COMPLETED|Overall Study||3||
48646644|NCT03331562|101920237|FG001|NOT COMPLETED|Overall Study||0||
48646645|NCT00676052|101920238|FG000|STARTED|Overall Study||96||
48646646|NCT00676052|101920239|FG001|STARTED|Overall Study||95||
48646647|NCT00676052|101920240|FG002|STARTED|Overall Study||96||
48646648|NCT00676052|101920241|FG003|STARTED|Overall Study||97||
48646649|NCT00676052|101920242|FG004|STARTED|Overall Study||95||
48646650|NCT00676052|101920243|FG005|STARTED|Overall Study||97||
48646651|NCT00676052|101920238|FG000|COMPLETED|Overall Study||87||
48646652|NCT00676052|101920239|FG001|COMPLETED|Overall Study||88||
48646653|NCT00676052|101920240|FG002|COMPLETED|Overall Study||90||
48646654|NCT00676052|101920241|FG003|COMPLETED|Overall Study||92||
48646655|NCT00676052|101920242|FG004|COMPLETED|Overall Study||89||
48646656|NCT00676052|101920243|FG005|COMPLETED|Overall Study||91||
48646657|NCT00676052|101920238|FG000|NOT COMPLETED|Overall Study||9||
48646658|NCT00676052|101920239|FG001|NOT COMPLETED|Overall Study||7||
48646659|NCT00676052|101920240|FG002|NOT COMPLETED|Overall Study||6||
48646660|NCT00676052|101920241|FG003|NOT COMPLETED|Overall Study||5||
48646661|NCT00676052|101920242|FG004|NOT COMPLETED|Overall Study||6||
48646662|NCT00676052|101920243|FG005|NOT COMPLETED|Overall Study||6||
48646663|NCT02958527|101920244|FG000|STARTED|Overall Study||1408||
48646664|NCT02958527|101920244|FG000|COMPLETED|Overall Study||1396||
48646665|NCT02958527|101920244|FG000|NOT COMPLETED|Overall Study||12||
48646666|NCT00727337|101920245|FG000|STARTED|Overall Study||68||
48646667|NCT00727337|101920246|FG001|STARTED|Overall Study||65||
48646668|NCT00727337|101920247|FG002|STARTED|Overall Study||73||
48646669|NCT00727337|101920248|FG003|STARTED|Overall Study||73||
48646670|NCT00727337|101920245|FG000|COMPLETED|Overall Study||61||
48646671|NCT00727337|101920246|FG001|COMPLETED|Overall Study||55||
48646672|NCT00727337|101920247|FG002|COMPLETED|Overall Study||63||
48646673|NCT00727337|101920248|FG003|COMPLETED|Overall Study||64||
48646674|NCT00727337|101920245|FG000|NOT COMPLETED|Overall Study||7||
48646675|NCT00727337|101920246|FG001|NOT COMPLETED|Overall Study||10||
48646676|NCT00727337|101920247|FG002|NOT COMPLETED|Overall Study||10||
48646677|NCT00727337|101920248|FG003|NOT COMPLETED|Overall Study||9||
48646678|NCT00309244|101920249|FG000|STARTED|Overall Study||334||
48646679|NCT00309244|101920250|FG001|STARTED|Overall Study||343||
48646680|NCT00309244|101920249|FG000|COMPLETED|Overall Study||216||
48646681|NCT00309244|101920250|FG001|COMPLETED|Overall Study||246||
48646682|NCT00309244|101920249|FG000|NOT COMPLETED|Overall Study||118||
48646683|NCT00309244|101920250|FG001|NOT COMPLETED|Overall Study||97||
48646684|NCT01945242|101920251|FG000|STARTED|Overall Study||1251||
48646685|NCT01945242|101920252|FG001|STARTED|Overall Study||123||
48646686|NCT01945242|101920251|FG000|COMPLETED|Overall Study||1248||
48646687|NCT01945242|101920252|FG001|COMPLETED|Overall Study||120||
48646688|NCT01945242|101920251|FG000|NOT COMPLETED|Overall Study||3||
48646689|NCT01945242|101920252|FG001|NOT COMPLETED|Overall Study||3||
48646690|NCT00541775|101920253|FG000|STARTED|Overall Study||94||
48646691|NCT00541775|101920254|FG001|STARTED|Overall Study||87||
48646692|NCT00541775|101920255|FG002|STARTED|Overall Study||92||
48646693|NCT00541775|101920253|FG000|COMPLETED|Overall Study||85||
48646694|NCT00541775|101920254|FG001|COMPLETED|Overall Study||85||
48646695|NCT00541775|101920255|FG002|COMPLETED|Overall Study||84||
48646696|NCT00541775|101920253|FG000|NOT COMPLETED|Overall Study||9||
48646697|NCT00541775|101920254|FG001|NOT COMPLETED|Overall Study||2||
48646698|NCT00541775|101920255|FG002|NOT COMPLETED|Overall Study||8||
48646699|NCT00837447|101920256|FG000|STARTED|Overall Study||54||
48646700|NCT00837447|101920256|FG000|COMPLETED|Overall Study||54||
48646701|NCT00837447|101920256|FG000|NOT COMPLETED|Overall Study||0||
48646702|NCT00448357|101920257|FG000|STARTED|Overall Study||54||
48646703|NCT00448357|101920257|FG000|COMPLETED|Overall Study||54||
48646704|NCT00448357|101920257|FG000|NOT COMPLETED|Overall Study||0||
48646705|NCT00663351|101920258|FG000|STARTED|Initial Study (Year 1 up to Year 6)||308||372
48646706|NCT00663351|101920259|FG001|STARTED|Initial Study (Year 1 up to Year 6)||148||163
48646707|NCT00663351|101920258|FG000|COMPLETED|Initial Study (Year 1 up to Year 6)||298||364
48646708|NCT00663351|101920259|FG001|COMPLETED|Initial Study (Year 1 up to Year 6)||129||144
48646709|NCT00663351|101920258|FG000|NOT COMPLETED|Initial Study (Year 1 up to Year 6)||10||8
48646710|NCT00663351|101920259|FG001|NOT COMPLETED|Initial Study (Year 1 up to Year 6)||19||19
48646711|NCT00663351|101920258|FG000|STARTED|Post-Approval Study (Year 6 to Year 10)||298||364
48646712|NCT00663351|101920259|FG001|STARTED|Post-Approval Study (Year 6 to Year 10)||129||144
48646713|NCT00663351|101920258|FG000|COMPLETED|Post-Approval Study (Year 6 to Year 10)||186||252
48646714|NCT00663351|101920259|FG001|COMPLETED|Post-Approval Study (Year 6 to Year 10)||58||73
48646715|NCT00663351|101920258|FG000|NOT COMPLETED|Post-Approval Study (Year 6 to Year 10)||112||112
48646716|NCT00663351|101920259|FG001|NOT COMPLETED|Post-Approval Study (Year 6 to Year 10)||71||71
48646717|NCT00471107|101920260|FG000|STARTED|Overall Study||15||
48646718|NCT00471107|101920261|FG001|STARTED|Overall Study||15||
48646719|NCT00471107|101920262|FG002|STARTED|Overall Study||15||
48646720|NCT00471107|101920260|FG000|COMPLETED|Overall Study||12||
48646721|NCT00471107|101920261|FG001|COMPLETED|Overall Study||14||
48646722|NCT00471107|101920262|FG002|COMPLETED|Overall Study||12||
48646723|NCT00471107|101920260|FG000|NOT COMPLETED|Overall Study||3||
48646724|NCT00471107|101920261|FG001|NOT COMPLETED|Overall Study||1||
48646725|NCT00471107|101920262|FG002|NOT COMPLETED|Overall Study||3||
48646726|NCT03277274|101920263|FG000|STARTED|Overall Study||8||
48646727|NCT03277274|101920264|FG001|STARTED|Overall Study||10||
48646728|NCT03277274|101920265|FG002|STARTED|Overall Study||7||
48646729|NCT03277274|101920263|FG000|COMPLETED|Overall Study||8||
48646730|NCT03277274|101920264|FG001|COMPLETED|Overall Study||10||
48646731|NCT03277274|101920265|FG002|COMPLETED|Overall Study||7||
48646732|NCT03277274|101920263|FG000|NOT COMPLETED|Overall Study||0||
48646733|NCT03277274|101920264|FG001|NOT COMPLETED|Overall Study||0||
48646734|NCT03277274|101920265|FG002|NOT COMPLETED|Overall Study||0||
48646735|NCT00363467|101920266|FG000|STARTED|Overall Study||3||
48646736|NCT00363467|101920266|FG000|COMPLETED|Overall Study||2||
48646737|NCT00363467|101920266|FG000|NOT COMPLETED|Overall Study||1||
48646738|NCT03989570|101920267|FG000|STARTED|Overall Study||31||
48646739|NCT03989570|101920268|FG001|STARTED|Overall Study||31||
48646740|NCT03989570|101920269|FG002|STARTED|Overall Study||31||
48646741|NCT03989570|101920267|FG000|COMPLETED|Overall Study||31||
48646742|NCT03989570|101920268|FG001|COMPLETED|Overall Study||31||
48646743|NCT03989570|101920269|FG002|COMPLETED|Overall Study||31||
48646744|NCT03989570|101920267|FG000|NOT COMPLETED|Overall Study||0||
48646745|NCT03989570|101920268|FG001|NOT COMPLETED|Overall Study||0||
48646746|NCT03989570|101920269|FG002|NOT COMPLETED|Overall Study||0||
48646747|NCT00356590|101920270|FG000|STARTED|Overall Study||468||
48646748|NCT00356590|101920270|FG000|COMPLETED|Overall Study||194||
48646749|NCT00356590|101920270|FG000|NOT COMPLETED|Overall Study||274||
48646750|NCT00625378|101920271|FG000|STARTED|Overall Study||205||
48646751|NCT00625378|101920272|FG001|STARTED|Overall Study||1||
48646752|NCT00625378|101920271|FG000|Treated in STEP|Overall Study||203||
48765245|NCT02326155|102214601|FG001|COMPLETED|Overall Study||1||
48765246|NCT02326155|102214600|FG000|NOT COMPLETED|Overall Study||394||
48765247|NCT02326155|102214601|FG001|NOT COMPLETED|Overall Study||62||
48765248|NCT05174416|102214602|FG000|STARTED|Overall Study||54||
48646753|NCT00625378|101920272|FG001|Treated in STEP|Overall Study||1||
48646754|NCT00625378|101920271|FG000|COMPLETED|Overall Study||0||
48646755|NCT00625378|101920272|FG001|COMPLETED|Overall Study||0||
48646756|NCT00625378|101920271|FG000|NOT COMPLETED|Overall Study||205||
48646757|NCT00625378|101920272|FG001|NOT COMPLETED|Overall Study||1||
48646758|NCT01312675|101920273|FG000|STARTED|Overall Study||9||
48646759|NCT01312675|101920274|FG001|STARTED|Overall Study||7||
48646760|NCT01312675|101920273|FG000|COMPLETED|Overall Study||9||
48646761|NCT01312675|101920274|FG001|COMPLETED|Overall Study||7||
48646762|NCT01312675|101920273|FG000|NOT COMPLETED|Overall Study||0||
48646763|NCT01312675|101920274|FG001|NOT COMPLETED|Overall Study||0||
48646764|NCT02904356|101920275|FG000|STARTED|Overall Study||2||
48646765|NCT02904356|101920275|FG000|COMPLETED|Overall Study||2||
48646766|NCT02904356|101920275|FG000|NOT COMPLETED|Overall Study||0||
48362121|NCT00923091|101214492|FG005|COMPLETED|PeriodI-II (Randomized, Double-Blind)||322||
48362122|NCT00923091|101214493|FG006|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319||
48646767|NCT02568254|101920276|FG000|STARTED|Period 1||13||
48646768|NCT02568254|101920277|FG001|STARTED|Period 1||12||
48646769|NCT02568254|101920278|FG002|STARTED|Period 1||13||
48646770|NCT02568254|101920279|FG003|STARTED|Period 1||12||
48646771|NCT02568254|101920280|FG004|STARTED|Period 1||12||
48646772|NCT02568254|101920281|FG005|STARTED|Period 1||12||
48646773|NCT02568254|101920276|FG000|COMPLETED|Period 1||13||
48646774|NCT02568254|101920277|FG001|COMPLETED|Period 1||12||
48646775|NCT02568254|101920278|FG002|COMPLETED|Period 1||13||
48646776|NCT02568254|101920279|FG003|COMPLETED|Period 1||12||
48646777|NCT02568254|101920280|FG004|COMPLETED|Period 1||12||
48646778|NCT02568254|101920281|FG005|COMPLETED|Period 1||12||
48646779|NCT02568254|101920276|FG000|NOT COMPLETED|Period 1||0||
48646780|NCT02568254|101920277|FG001|NOT COMPLETED|Period 1||0||
48646781|NCT02568254|101920278|FG002|NOT COMPLETED|Period 1||0||
48646782|NCT02568254|101920279|FG003|NOT COMPLETED|Period 1||0||
48646783|NCT02568254|101920280|FG004|NOT COMPLETED|Period 1||0||
48646784|NCT02568254|101920281|FG005|NOT COMPLETED|Period 1||0||
48646785|NCT02568254|101920276|FG000|STARTED|Period 2||13||
48646786|NCT02568254|101920277|FG001|STARTED|Period 2||12||
48646787|NCT02568254|101920278|FG002|STARTED|Period 2||13||
48646788|NCT02568254|101920279|FG003|STARTED|Period 2||12||
48646789|NCT02568254|101920280|FG004|STARTED|Period 2||12||
48646790|NCT02568254|101920281|FG005|STARTED|Period 2||12||
48646791|NCT02568254|101920276|FG000|COMPLETED|Period 2||13||
48646792|NCT02568254|101920277|FG001|COMPLETED|Period 2||12||
48646793|NCT02568254|101920278|FG002|COMPLETED|Period 2||12||
48646794|NCT02568254|101920279|FG003|COMPLETED|Period 2||12||
48646795|NCT02568254|101920280|FG004|COMPLETED|Period 2||12||
48646796|NCT02568254|101920281|FG005|COMPLETED|Period 2||12||
48646797|NCT02568254|101920276|FG000|NOT COMPLETED|Period 2||0||
48646798|NCT02568254|101920277|FG001|NOT COMPLETED|Period 2||0||
48646799|NCT02568254|101920278|FG002|NOT COMPLETED|Period 2||1||
48646800|NCT02568254|101920279|FG003|NOT COMPLETED|Period 2||0||
48646801|NCT02568254|101920280|FG004|NOT COMPLETED|Period 2||0||
48646802|NCT02568254|101920281|FG005|NOT COMPLETED|Period 2||0||
48646803|NCT02568254|101920276|FG000|STARTED|Period 3||13||
48646804|NCT02568254|101920277|FG001|STARTED|Period 3||12||
48646805|NCT02568254|101920278|FG002|STARTED|Period 3||12||
48646806|NCT02568254|101920279|FG003|STARTED|Period 3||12||
48646807|NCT02568254|101920280|FG004|STARTED|Period 3||12||
48646808|NCT02568254|101920281|FG005|STARTED|Period 3||12||
48646809|NCT02568254|101920276|FG000|COMPLETED|Period 3||13||
48646810|NCT02568254|101920277|FG001|COMPLETED|Period 3||12||
48646811|NCT02568254|101920278|FG002|COMPLETED|Period 3||12||
48646812|NCT02568254|101920279|FG003|COMPLETED|Period 3||12||
48646813|NCT02568254|101920280|FG004|COMPLETED|Period 3||11||
48765249|NCT05174416|102214603|FG001|STARTED|Overall Study||27||
48765250|NCT05174416|102214602|FG000|COMPLETED|Overall Study||54||
48765251|NCT05174416|102214603|FG001|COMPLETED|Overall Study||27||
48765252|NCT05174416|102214602|FG000|NOT COMPLETED|Overall Study||0||
48765253|NCT05174416|102214603|FG001|NOT COMPLETED|Overall Study||0||
48765254|NCT02584686|102214604|FG000|STARTED|Overall Study||12||
48765255|NCT02584686|102214605|FG001|STARTED|Overall Study||12||
48765256|NCT02584686|102214604|FG000|COMPLETED|Overall Study||12||
48765257|NCT02584686|102214605|FG001|COMPLETED|Overall Study||12||
48188191|NCT02711995|100783180|FG000|STARTED|First Intervention (30 Days)||8||
48646814|NCT02568254|101920281|FG005|COMPLETED|Period 3||12||
48646815|NCT02568254|101920276|FG000|NOT COMPLETED|Period 3||0||
48646816|NCT02568254|101920277|FG001|NOT COMPLETED|Period 3||0||
48646817|NCT02568254|101920278|FG002|NOT COMPLETED|Period 3||0||
48646818|NCT02568254|101920279|FG003|NOT COMPLETED|Period 3||0||
48646819|NCT02568254|101920280|FG004|NOT COMPLETED|Period 3||1||
48646820|NCT02568254|101920281|FG005|NOT COMPLETED|Period 3||0||
48765258|NCT02584686|102214604|FG000|NOT COMPLETED|Overall Study||0||
48765259|NCT02584686|102214605|FG001|NOT COMPLETED|Overall Study||0||
48765260|NCT01222689|102214606|FG000|STARTED|Overall Study||46||
48765261|NCT01222689|102214606|FG000|COMPLETED|Overall Study||46||
48765262|NCT01222689|102214606|FG000|NOT COMPLETED|Overall Study||0||
48765263|NCT01256788|102214607|FG000|STARTED|Overall Study||12||
48362123|NCT00923091|101214494|FG007|COMPLETED|PeriodI-II (Randomized, Double-Blind)||311||
48765264|NCT01256788|102214608|FG001|STARTED|Overall Study||14||
48646821|NCT00682838|101920282|FG000|STARTED|Overall Study||65||
48646822|NCT00682838|101920283|FG001|STARTED|Overall Study||67||
48646823|NCT00682838|101920284|FG002|STARTED|Overall Study||75||
48646824|NCT00682838|101920285|FG003|STARTED|Overall Study||73||
48646825|NCT00682838|101920282|FG000|COMPLETED|Overall Study||65||
48646826|NCT00682838|101920283|FG001|COMPLETED|Overall Study||67||
48646827|NCT00682838|101920284|FG002|COMPLETED|Overall Study||75||
48646828|NCT00682838|101920285|FG003|COMPLETED|Overall Study||73||
48646829|NCT00682838|101920282|FG000|NOT COMPLETED|Overall Study||0||
48646830|NCT00682838|101920283|FG001|NOT COMPLETED|Overall Study||0||
48646831|NCT00682838|101920284|FG002|NOT COMPLETED|Overall Study||0||
48646832|NCT00682838|101920285|FG003|NOT COMPLETED|Overall Study||0||
48765265|NCT01256788|102214609|FG002|STARTED|Overall Study||8||
48765266|NCT01256788|102214607|FG000|COMPLETED|Overall Study||7||
48646833|NCT02218268|101920286|FG000|STARTED|First Phase (2 Hours)||30||
48646834|NCT02218268|101920287|FG001|STARTED|First Phase (2 Hours)||30||
48646835|NCT02218268|101920286|FG000|COMPLETED|First Phase (2 Hours)||30||
48646836|NCT02218268|101920287|FG001|COMPLETED|First Phase (2 Hours)||30||
48646837|NCT02218268|101920286|FG000|NOT COMPLETED|First Phase (2 Hours)||0||
48646838|NCT02218268|101920287|FG001|NOT COMPLETED|First Phase (2 Hours)||0||
48646839|NCT02218268|101920286|FG000|STARTED|24 Hour Washout||30||
48646840|NCT02218268|101920287|FG001|STARTED|24 Hour Washout||30||
48646841|NCT02218268|101920286|FG000|COMPLETED|24 Hour Washout||19||
48646842|NCT02218268|101920287|FG001|COMPLETED|24 Hour Washout||21||
48646843|NCT02218268|101920286|FG000|NOT COMPLETED|24 Hour Washout||11||
48646844|NCT02218268|101920287|FG001|NOT COMPLETED|24 Hour Washout||9||
48646845|NCT02218268|101920286|FG000|STARTED|Final Phase (2 Hours)||19||
48646846|NCT02218268|101920287|FG001|STARTED|Final Phase (2 Hours)||21||
48646847|NCT02218268|101920286|FG000|COMPLETED|Final Phase (2 Hours)||19||
48646848|NCT02218268|101920287|FG001|COMPLETED|Final Phase (2 Hours)||21||
48646849|NCT02218268|101920286|FG000|NOT COMPLETED|Final Phase (2 Hours)||0||
48646850|NCT02218268|101920287|FG001|NOT COMPLETED|Final Phase (2 Hours)||0||
48646851|NCT00907088|101920288|FG000|STARTED|Overall Study||122||
48646852|NCT00907088|101920289|FG001|STARTED|Overall Study||129||
48646853|NCT00907088|101920288|FG000|COMPLETED|Overall Study||102||
48646854|NCT00907088|101920289|FG001|COMPLETED|Overall Study||99||
48646855|NCT00907088|101920288|FG000|NOT COMPLETED|Overall Study||20||
48646856|NCT00907088|101920289|FG001|NOT COMPLETED|Overall Study||30||
48646857|NCT01657500|101920290|FG000|STARTED|Overall Study||32||
48646858|NCT01657500|101920291|FG001|STARTED|Overall Study||32||
48646859|NCT01657500|101920290|FG000|COMPLETED|Overall Study||27||
48646860|NCT01657500|101920291|FG001|COMPLETED|Overall Study||27||
48646861|NCT01657500|101920290|FG000|NOT COMPLETED|Overall Study||5||
48646862|NCT01657500|101920291|FG001|NOT COMPLETED|Overall Study||5||
48646863|NCT02470377|101920292|FG000|STARTED|Overall Study||10||
48646864|NCT02470377|101920293|FG001|STARTED|Overall Study||9||
48646865|NCT02470377|101920294|FG002|STARTED|Overall Study||5||
48646866|NCT02470377|101920292|FG000|COMPLETED|Overall Study||10||
48646867|NCT02470377|101920293|FG001|COMPLETED|Overall Study||9||
48646868|NCT02470377|101920294|FG002|COMPLETED|Overall Study||5||
48646869|NCT02470377|101920292|FG000|NOT COMPLETED|Overall Study||0||
48646870|NCT02470377|101920293|FG001|NOT COMPLETED|Overall Study||0||
48646871|NCT02470377|101920294|FG002|NOT COMPLETED|Overall Study||0||
48646872|NCT02697422|101920295|FG000|STARTED|Overall Study||134||
48646873|NCT02697422|101920296|FG001|STARTED|Overall Study||130||
48646874|NCT02697422|101920295|FG000|COMPLETED|Overall Study||108||
48646875|NCT02697422|101920296|FG001|COMPLETED|Overall Study||117||
48646876|NCT02697422|101920295|FG000|NOT COMPLETED|Overall Study||26||
48646877|NCT02697422|101920296|FG001|NOT COMPLETED|Overall Study||13||
48646878|NCT01684592|101920297|FG000|STARTED|Overall Study||64|No intake data for two participants, thus only 128 were randomized.|
48646879|NCT01684592|101920298|FG001|STARTED|Overall Study||64|No intake data for two participants, thus only 128 were randomized.|
48646880|NCT01684592|101920297|FG000|COMPLETED|Overall Study||38||
48646881|NCT01684592|101920298|FG001|COMPLETED|Overall Study||40||
48646882|NCT01684592|101920297|FG000|NOT COMPLETED|Overall Study||26||
48646883|NCT01684592|101920298|FG001|NOT COMPLETED|Overall Study||24||
48646884|NCT02468700|101920299|FG000|STARTED|Overall Study||22||
48646885|NCT02468700|101920300|FG001|STARTED|Overall Study||21||
48646886|NCT02468700|101920299|FG000|COMPLETED|Overall Study||20||
48646887|NCT02468700|101920300|FG001|COMPLETED|Overall Study||19||
48646888|NCT02468700|101920299|FG000|NOT COMPLETED|Overall Study||2||
48765267|NCT01256788|102214608|FG001|COMPLETED|Overall Study||6||
48765268|NCT01256788|102214609|FG002|COMPLETED|Overall Study||5||
48646889|NCT02468700|101920300|FG001|NOT COMPLETED|Overall Study||2||
48646890|NCT03794323|101920301|FG000|STARTED|Treatment Period 1 (SRD and FE Parts)||16||
48646891|NCT03794323|101920302|FG001|STARTED|Treatment Period 1 (SRD and FE Parts)||6||
48646892|NCT03794323|101920303|FG002|STARTED|Treatment Period 1 (SRD and FE Parts)||6||
48765269|NCT01256788|102214607|FG000|NOT COMPLETED|Overall Study||5||
48646893|NCT03794323|101920304|FG003|STARTED|Treatment Period 1 (SRD and FE Parts)||6||
48646894|NCT03794323|101920305|FG004|STARTED|Treatment Period 1 (SRD and FE Parts)||6||
48646895|NCT03794323|101920306|FG005|STARTED|Treatment Period 1 (SRD and FE Parts)||6||
48646896|NCT03794323|101920307|FG006|STARTED|Treatment Period 1 (SRD and FE Parts)||6||
48646897|NCT03794323|101920308|FG007|STARTED|Treatment Period 1 (SRD and FE Parts)||6||
48646898|NCT03794323|101920309|FG008|STARTED|Treatment Period 1 (SRD and FE Parts)||6||
48646899|NCT03794323|101920310|FG009|STARTED|Treatment Period 1 (SRD and FE Parts)||6||
48646900|NCT03794323|101920311|FG010|STARTED|Treatment Period 1 (SRD and FE Parts)||6||
48646901|NCT03794323|101920301|FG000|COMPLETED|Treatment Period 1 (SRD and FE Parts)||16||
48646902|NCT03794323|101920302|FG001|COMPLETED|Treatment Period 1 (SRD and FE Parts)||6||
48646903|NCT03794323|101920303|FG002|COMPLETED|Treatment Period 1 (SRD and FE Parts)||6||
48646904|NCT03794323|101920304|FG003|COMPLETED|Treatment Period 1 (SRD and FE Parts)||6||
48646905|NCT03794323|101920305|FG004|COMPLETED|Treatment Period 1 (SRD and FE Parts)||6||
48646906|NCT03794323|101920306|FG005|COMPLETED|Treatment Period 1 (SRD and FE Parts)||6||
48646907|NCT03794323|101920307|FG006|COMPLETED|Treatment Period 1 (SRD and FE Parts)||6||
48646908|NCT03794323|101920308|FG007|COMPLETED|Treatment Period 1 (SRD and FE Parts)||6||
48646909|NCT03794323|101920309|FG008|COMPLETED|Treatment Period 1 (SRD and FE Parts)||6||
48646910|NCT03794323|101920310|FG009|COMPLETED|Treatment Period 1 (SRD and FE Parts)||6||
48646911|NCT03794323|101920311|FG010|COMPLETED|Treatment Period 1 (SRD and FE Parts)||6||
48646912|NCT03794323|101920301|FG000|NOT COMPLETED|Treatment Period 1 (SRD and FE Parts)||0||
48646913|NCT03794323|101920302|FG001|NOT COMPLETED|Treatment Period 1 (SRD and FE Parts)||0||
48646914|NCT03794323|101920303|FG002|NOT COMPLETED|Treatment Period 1 (SRD and FE Parts)||0||
48646915|NCT03794323|101920304|FG003|NOT COMPLETED|Treatment Period 1 (SRD and FE Parts)||0||
48646916|NCT03794323|101920305|FG004|NOT COMPLETED|Treatment Period 1 (SRD and FE Parts)||0||
48646917|NCT03794323|101920306|FG005|NOT COMPLETED|Treatment Period 1 (SRD and FE Parts)||0||
48646918|NCT03794323|101920307|FG006|NOT COMPLETED|Treatment Period 1 (SRD and FE Parts)||0||
48646919|NCT03794323|101920308|FG007|NOT COMPLETED|Treatment Period 1 (SRD and FE Parts)||0||
48646920|NCT03794323|101920309|FG008|NOT COMPLETED|Treatment Period 1 (SRD and FE Parts)||0||
48646921|NCT03794323|101920310|FG009|NOT COMPLETED|Treatment Period 1 (SRD and FE Parts)||0||
48646922|NCT03794323|101920311|FG010|NOT COMPLETED|Treatment Period 1 (SRD and FE Parts)||0||
48646923|NCT03794323|101920301|FG000|STARTED|Wash-out Period (FE Part Only)||0||
48646924|NCT03794323|101920302|FG001|STARTED|Wash-out Period (FE Part Only)||0||
48646925|NCT03794323|101920303|FG002|STARTED|Wash-out Period (FE Part Only)||0||
48646926|NCT03794323|101920304|FG003|STARTED|Wash-out Period (FE Part Only)||0||
48646927|NCT03794323|101920305|FG004|STARTED|Wash-out Period (FE Part Only)||0||
48646928|NCT03794323|101920306|FG005|STARTED|Wash-out Period (FE Part Only)||0||
48646929|NCT03794323|101920307|FG006|STARTED|Wash-out Period (FE Part Only)||0||
48646930|NCT03794323|101920308|FG007|STARTED|Wash-out Period (FE Part Only)||0||
48646931|NCT03794323|101920309|FG008|STARTED|Wash-out Period (FE Part Only)||0||
48646932|NCT03794323|101920310|FG009|STARTED|Wash-out Period (FE Part Only)||6||
48646933|NCT03794323|101920311|FG010|STARTED|Wash-out Period (FE Part Only)||6||
48646934|NCT03794323|101920301|FG000|COMPLETED|Wash-out Period (FE Part Only)||0||
48646935|NCT03794323|101920302|FG001|COMPLETED|Wash-out Period (FE Part Only)||0||
48646936|NCT03794323|101920303|FG002|COMPLETED|Wash-out Period (FE Part Only)||0||
48646937|NCT03794323|101920304|FG003|COMPLETED|Wash-out Period (FE Part Only)||0||
48646938|NCT03794323|101920305|FG004|COMPLETED|Wash-out Period (FE Part Only)||0||
48646939|NCT03794323|101920306|FG005|COMPLETED|Wash-out Period (FE Part Only)||0||
48646940|NCT03794323|101920307|FG006|COMPLETED|Wash-out Period (FE Part Only)||0||
48646941|NCT03794323|101920308|FG007|COMPLETED|Wash-out Period (FE Part Only)||0||
48646942|NCT03794323|101920309|FG008|COMPLETED|Wash-out Period (FE Part Only)||0||
48646943|NCT03794323|101920310|FG009|COMPLETED|Wash-out Period (FE Part Only)||6||
48646944|NCT03794323|101920311|FG010|COMPLETED|Wash-out Period (FE Part Only)||6||
48646945|NCT03794323|101920301|FG000|NOT COMPLETED|Wash-out Period (FE Part Only)||0||
48646946|NCT03794323|101920302|FG001|NOT COMPLETED|Wash-out Period (FE Part Only)||0||
48646947|NCT03794323|101920303|FG002|NOT COMPLETED|Wash-out Period (FE Part Only)||0||
48646948|NCT03794323|101920304|FG003|NOT COMPLETED|Wash-out Period (FE Part Only)||0||
48646949|NCT03794323|101920305|FG004|NOT COMPLETED|Wash-out Period (FE Part Only)||0||
48646950|NCT03794323|101920306|FG005|NOT COMPLETED|Wash-out Period (FE Part Only)||0||
48646951|NCT03794323|101920307|FG006|NOT COMPLETED|Wash-out Period (FE Part Only)||0||
48646952|NCT03794323|101920308|FG007|NOT COMPLETED|Wash-out Period (FE Part Only)||0||
48646953|NCT03794323|101920309|FG008|NOT COMPLETED|Wash-out Period (FE Part Only)||0||
48646954|NCT03794323|101920310|FG009|NOT COMPLETED|Wash-out Period (FE Part Only)||0||
48646955|NCT03794323|101920311|FG010|NOT COMPLETED|Wash-out Period (FE Part Only)||0||
48646956|NCT03794323|101920301|FG000|STARTED|Treatment Period 2 (FE Part Only)||0||
48646957|NCT03794323|101920302|FG001|STARTED|Treatment Period 2 (FE Part Only)||0||
48646958|NCT03794323|101920303|FG002|STARTED|Treatment Period 2 (FE Part Only)||0||
48646959|NCT03794323|101920304|FG003|STARTED|Treatment Period 2 (FE Part Only)||0||
48646960|NCT03794323|101920305|FG004|STARTED|Treatment Period 2 (FE Part Only)||0||
48646961|NCT03794323|101920306|FG005|STARTED|Treatment Period 2 (FE Part Only)||0||
48646962|NCT03794323|101920307|FG006|STARTED|Treatment Period 2 (FE Part Only)||0||
48646963|NCT03794323|101920308|FG007|STARTED|Treatment Period 2 (FE Part Only)||0||
48646964|NCT03794323|101920309|FG008|STARTED|Treatment Period 2 (FE Part Only)||0||
48646965|NCT03794323|101920310|FG009|STARTED|Treatment Period 2 (FE Part Only)||6||
48646966|NCT03794323|101920311|FG010|STARTED|Treatment Period 2 (FE Part Only)||6||
48646967|NCT03794323|101920301|FG000|COMPLETED|Treatment Period 2 (FE Part Only)||0||
48646968|NCT03794323|101920302|FG001|COMPLETED|Treatment Period 2 (FE Part Only)||0||
48646969|NCT03794323|101920303|FG002|COMPLETED|Treatment Period 2 (FE Part Only)||0||
48646970|NCT03794323|101920304|FG003|COMPLETED|Treatment Period 2 (FE Part Only)||0||
48646971|NCT03794323|101920305|FG004|COMPLETED|Treatment Period 2 (FE Part Only)||0||
48646972|NCT03794323|101920306|FG005|COMPLETED|Treatment Period 2 (FE Part Only)||0||
48646973|NCT03794323|101920307|FG006|COMPLETED|Treatment Period 2 (FE Part Only)||0||
48646974|NCT03794323|101920308|FG007|COMPLETED|Treatment Period 2 (FE Part Only)||0||
48646975|NCT03794323|101920309|FG008|COMPLETED|Treatment Period 2 (FE Part Only)||0||
48646976|NCT03794323|101920310|FG009|COMPLETED|Treatment Period 2 (FE Part Only)||6||
48646977|NCT03794323|101920311|FG010|COMPLETED|Treatment Period 2 (FE Part Only)||6||
48646978|NCT03794323|101920301|FG000|NOT COMPLETED|Treatment Period 2 (FE Part Only)||0||
48657045|NCT03648372|101943764|FG007|STARTED|Overall Study||6||
48646979|NCT03794323|101920302|FG001|NOT COMPLETED|Treatment Period 2 (FE Part Only)||0||
48646980|NCT03794323|101920303|FG002|NOT COMPLETED|Treatment Period 2 (FE Part Only)||0||
48646981|NCT03794323|101920304|FG003|NOT COMPLETED|Treatment Period 2 (FE Part Only)||0||
48646982|NCT03794323|101920305|FG004|NOT COMPLETED|Treatment Period 2 (FE Part Only)||0||
48646983|NCT03794323|101920306|FG005|NOT COMPLETED|Treatment Period 2 (FE Part Only)||0||
48646984|NCT03794323|101920307|FG006|NOT COMPLETED|Treatment Period 2 (FE Part Only)||0||
48646985|NCT03794323|101920308|FG007|NOT COMPLETED|Treatment Period 2 (FE Part Only)||0||
48646986|NCT03794323|101920309|FG008|NOT COMPLETED|Treatment Period 2 (FE Part Only)||0||
48646987|NCT03794323|101920310|FG009|NOT COMPLETED|Treatment Period 2 (FE Part Only)||0||
48646988|NCT03794323|101920311|FG010|NOT COMPLETED|Treatment Period 2 (FE Part Only)||0||
48646989|NCT04132466|101920312|FG000|STARTED|Overall Study||13||
48646990|NCT04132466|101920312|FG000|COMPLETED|Overall Study||13||
48646991|NCT04132466|101920312|FG000|NOT COMPLETED|Overall Study||0||
48646992|NCT02391584|101920313|FG000|STARTED|Primary Endpoint (6-weeks)||31||
48646993|NCT02391584|101920314|FG001|STARTED|Primary Endpoint (6-weeks)||29||
48646994|NCT02391584|101920313|FG000|COMPLETED|Primary Endpoint (6-weeks)||29||
48646995|NCT02391584|101920314|FG001|COMPLETED|Primary Endpoint (6-weeks)||27||
48646996|NCT02391584|101920313|FG000|NOT COMPLETED|Primary Endpoint (6-weeks)||2||
48646997|NCT02391584|101920314|FG001|NOT COMPLETED|Primary Endpoint (6-weeks)||2||
48646998|NCT02391584|101920313|FG000|STARTED|3 Month||53|Control participants crossed over to balloon dilation or exited the study after the 6-week visit.|
48646999|NCT02391584|101920314|FG001|STARTED|3 Month||0|Control participants crossed over to balloon dilation or exited the study after the 6-week visit.|
48647000|NCT02391584|101920313|FG000|COMPLETED|3 Month||52||
48647001|NCT02391584|101920314|FG001|COMPLETED|3 Month||0||
48647002|NCT02391584|101920313|FG000|NOT COMPLETED|3 Month||1||
48647003|NCT02391584|101920314|FG001|NOT COMPLETED|3 Month||0||
48647004|NCT02391584|101920313|FG000|STARTED|6 Month||52||
48647005|NCT02391584|101920314|FG001|STARTED|6 Month||0||
48647006|NCT02391584|101920313|FG000|COMPLETED|6 Month||51||
48647007|NCT02391584|101920314|FG001|COMPLETED|6 Month||0||
48647008|NCT02391584|101920313|FG000|NOT COMPLETED|6 Month||1||
48647009|NCT02391584|101920314|FG001|NOT COMPLETED|6 Month||0||
48647010|NCT02391584|101920313|FG000|STARTED|12 Month (End of Study)||51||
48647011|NCT02391584|101920314|FG001|STARTED|12 Month (End of Study)||0||
48647012|NCT02391584|101920313|FG000|COMPLETED|12 Month (End of Study)||49||
48647013|NCT02391584|101920314|FG001|COMPLETED|12 Month (End of Study)||0||
48647014|NCT02391584|101920313|FG000|NOT COMPLETED|12 Month (End of Study)||2||
48647015|NCT02391584|101920314|FG001|NOT COMPLETED|12 Month (End of Study)||0||
48647016|NCT04137887|101920315|FG000|STARTED|Overall Study||16549||
48647017|NCT04137887|101920316|FG001|STARTED|Overall Study||16546||
48647018|NCT04137887|101920315|FG000|Vaccinated|Overall Study||16549||
48647019|NCT04137887|101920316|FG001|Vaccinated|Overall Study||16544||
48647020|NCT04137887|101920315|FG000|COMPLETED|Overall Study||16445||
48647021|NCT04137887|101920316|FG001|COMPLETED|Overall Study||16450||
48647022|NCT04137887|101920315|FG000|NOT COMPLETED|Overall Study||104||
48647023|NCT04137887|101920316|FG001|NOT COMPLETED|Overall Study||96||
48647024|NCT01699685|101920317|FG000|STARTED|Period 1||39||
48647025|NCT01699685|101920318|FG001|STARTED|Period 1||39||
48647026|NCT01699685|101920317|FG000|Safety Population|Period 1||39||
48647027|NCT01699685|101920318|FG001|Safety Population|Period 1||38||
48647028|NCT01699685|101920317|FG000|Full Analysis Population (FAS)|Period 1||38||
48647029|NCT01699685|101920318|FG001|Full Analysis Population (FAS)|Period 1||38||
48647030|NCT01699685|101920317|FG000|COMPLETED|Period 1||36||
48647031|NCT01699685|101920318|FG001|COMPLETED|Period 1||36||
48647032|NCT01699685|101920317|FG000|NOT COMPLETED|Period 1||3||
48647033|NCT01699685|101920318|FG001|NOT COMPLETED|Period 1||3||
48647034|NCT01699685|101920317|FG000|STARTED|Period 2||36||
48647035|NCT01699685|101920318|FG001|STARTED|Period 2||36||
48647036|NCT01699685|101920317|FG000|COMPLETED|Period 2||35||
48647037|NCT01699685|101920318|FG001|COMPLETED|Period 2||36||
48647038|NCT01699685|101920317|FG000|NOT COMPLETED|Period 2||1||
48647039|NCT01699685|101920318|FG001|NOT COMPLETED|Period 2||0||
48647040|NCT01617967|101920319|FG000|STARTED|Overall Study||4||
48647041|NCT01617967|101920320|FG001|STARTED|Overall Study||3||
48647042|NCT01617967|101920321|FG002|STARTED|Overall Study||3||
48647043|NCT01617967|101920322|FG003|STARTED|Overall Study||7||
48647044|NCT01617967|101920323|FG004|STARTED|Overall Study||3||
48647045|NCT01617967|101920324|FG005|STARTED|Overall Study||9||
48647046|NCT01617967|101920319|FG000|COMPLETED|Overall Study||3||
48647047|NCT01617967|101920320|FG001|COMPLETED|Overall Study||3||
48647048|NCT01617967|101920321|FG002|COMPLETED|Overall Study||3||
48647049|NCT01617967|101920322|FG003|COMPLETED|Overall Study||6||
48647050|NCT01617967|101920323|FG004|COMPLETED|Overall Study||3||
48647051|NCT01617967|101920324|FG005|COMPLETED|Overall Study||8||
48647052|NCT01617967|101920319|FG000|NOT COMPLETED|Overall Study||1||
48647053|NCT01617967|101920320|FG001|NOT COMPLETED|Overall Study||0||
48647054|NCT01617967|101920321|FG002|NOT COMPLETED|Overall Study||0||
48647055|NCT01617967|101920322|FG003|NOT COMPLETED|Overall Study||1||
48647056|NCT01617967|101920323|FG004|NOT COMPLETED|Overall Study||0||
48647057|NCT01617967|101920324|FG005|NOT COMPLETED|Overall Study||1||
48647058|NCT01717859|101920325|FG000|STARTED|Overall Study||54||
48647059|NCT01717859|101920325|FG000|3 Month|Overall Study||50||
48647060|NCT01717859|101920325|FG000|COMPLETED|Overall Study||44||
48647061|NCT01717859|101920325|FG000|NOT COMPLETED|Overall Study||10||
48647062|NCT01316900|101920326|FG000|STARTED|Overall Study||209||
48647063|NCT01316900|101920327|FG001|STARTED|Overall Study||212||
48647064|NCT01316900|101920328|FG002|STARTED|Overall Study||214||
48647065|NCT01316900|101920329|FG003|STARTED|Overall Study||208||
48647066|NCT01316900|101920326|FG000|COMPLETED|Overall Study||165||
48647067|NCT01316900|101920327|FG001|COMPLETED|Overall Study||181||
48647068|NCT01316900|101920328|FG002|COMPLETED|Overall Study||173||
48647069|NCT01316900|101920329|FG003|COMPLETED|Overall Study||177||
48647070|NCT01316900|101920326|FG000|NOT COMPLETED|Overall Study||44||
48647071|NCT01316900|101920327|FG001|NOT COMPLETED|Overall Study||31||
48647072|NCT01316900|101920328|FG002|NOT COMPLETED|Overall Study||41||
48647073|NCT01316900|101920329|FG003|NOT COMPLETED|Overall Study||31||
48647074|NCT02296801|101920330|FG000|STARTED|Overall Study||103||
48647075|NCT02296801|101920331|FG001|STARTED|Overall Study||68||
48647076|NCT02296801|101920332|FG002|STARTED|Overall Study||69||
48647077|NCT02296801|101920333|FG003|STARTED|Overall Study||67||
48647078|NCT02296801|101920330|FG000|COMPLETED|Overall Study||83||
48647079|NCT02296801|101920331|FG001|COMPLETED|Overall Study||53||
48647080|NCT02296801|101920332|FG002|COMPLETED|Overall Study||50||
48647081|NCT02296801|101920333|FG003|COMPLETED|Overall Study||58||
48647082|NCT02296801|101920330|FG000|NOT COMPLETED|Overall Study||20||
48647083|NCT02296801|101920331|FG001|NOT COMPLETED|Overall Study||15||
48647084|NCT02296801|101920332|FG002|NOT COMPLETED|Overall Study||19||
48647085|NCT02296801|101920333|FG003|NOT COMPLETED|Overall Study||9||
48647086|NCT01030575|101920334|FG000|STARTED|Overall Study||29|3 infants were randomized but did not receive treatment; 2 died and 1 was determined ineligible.|
48647087|NCT01030575|101920335|FG001|STARTED|Overall Study||30|3 infants were randomized but did not receive treatment; 2 died and 1 was determined ineligible.|
48647088|NCT01030575|101920336|FG002|STARTED|Overall Study||28|3 infants were randomized but did not receive treatment; 2 died and 1 was determined ineligible.|
48362124|NCT00923091|101214495|FG008|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0||
48362125|NCT00923091|101214496|FG009|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0||
48647089|NCT01030575|101920337|FG003|STARTED|Overall Study||35|3 infants were randomized but did not receive treatment; 2 died and 1 was determined ineligible.|
48647090|NCT01030575|101920334|FG000|COMPLETED|Overall Study||29||
48647091|NCT01030575|101920335|FG001|COMPLETED|Overall Study||30||
48647092|NCT01030575|101920336|FG002|COMPLETED|Overall Study||28||
48647093|NCT01030575|101920337|FG003|COMPLETED|Overall Study||35||
48647094|NCT01030575|101920334|FG000|NOT COMPLETED|Overall Study||0||
48647095|NCT01030575|101920335|FG001|NOT COMPLETED|Overall Study||0||
48647096|NCT01030575|101920336|FG002|NOT COMPLETED|Overall Study||0||
48647097|NCT01030575|101920337|FG003|NOT COMPLETED|Overall Study||0||
48647098|NCT03018938|101920338|FG000|STARTED|Overall Study||404||
48647099|NCT03018938|101920339|FG001|STARTED|Overall Study||410||
48647100|NCT03018938|101920338|FG000|Received at Least 1 Dose of Study Drug|Overall Study||404||
48647101|NCT03018938|101920339|FG001|Received at Least 1 Dose of Study Drug|Overall Study||410||
48647102|NCT03018938|101920338|FG000|COMPLETED|Overall Study||338||
48647103|NCT03018938|101920339|FG001|COMPLETED|Overall Study||325||
48647104|NCT03018938|101920338|FG000|NOT COMPLETED|Overall Study||66||
48647105|NCT03018938|101920339|FG001|NOT COMPLETED|Overall Study||85||
48647106|NCT02782468|101920340|FG000|STARTED|Overall Study||3||
48647107|NCT02782468|101920341|FG001|STARTED|Overall Study||7||
48647108|NCT02782468|101920342|FG002|STARTED|Overall Study||3||
48647109|NCT02782468|101920343|FG003|STARTED|Overall Study||10||
48647110|NCT02782468|101920340|FG000|COMPLETED|Overall Study||0||
48647111|NCT02782468|101920341|FG001|COMPLETED|Overall Study||0||
48647112|NCT02782468|101920342|FG002|COMPLETED|Overall Study||0||
48647113|NCT02782468|101920343|FG003|COMPLETED|Overall Study||0||
48647114|NCT02782468|101920340|FG000|NOT COMPLETED|Overall Study||3||
48647115|NCT02782468|101920341|FG001|NOT COMPLETED|Overall Study||7||
48647116|NCT02782468|101920342|FG002|NOT COMPLETED|Overall Study||3||
48647117|NCT02782468|101920343|FG003|NOT COMPLETED|Overall Study||10||
48647118|NCT01210443|101920344|FG000|STARTED|Overall Study||2||
48647119|NCT01210443|101920344|FG000|COMPLETED|Overall Study||0||
48647120|NCT01210443|101920344|FG000|NOT COMPLETED|Overall Study||2||
48647121|NCT02002208|101920345|FG000|STARTED|Overall Study||69||
48647122|NCT02002208|101920346|FG001|STARTED|Overall Study||70||
48647123|NCT02002208|101920345|FG000|COMPLETED|Overall Study||32||
48647124|NCT02002208|101920346|FG001|COMPLETED|Overall Study||30||
48647125|NCT02002208|101920345|FG000|NOT COMPLETED|Overall Study||37||
48647126|NCT02002208|101920346|FG001|NOT COMPLETED|Overall Study||40||
48647127|NCT03338686|101920347|FG000|STARTED|Overall Study||2||2
48647128|NCT03338686|101920348|FG001|STARTED|Overall Study||5||5
48647129|NCT03338686|101920349|FG002|STARTED|Overall Study||7||19
48647130|NCT03338686|101920347|FG000|COMPLETED|Overall Study||2||2
48362126|NCT00923091|101214497|FG010|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0||
48362127|NCT00923091|101214498|FG011|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0||
48362128|NCT00923091|101214499|FG012|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0||
48362129|NCT00923091|101214487|FG000|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||16||
48362130|NCT00923091|101214488|FG001|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||11||
48647131|NCT03338686|101920348|FG001|COMPLETED|Overall Study||5||5
48647132|NCT03338686|101920349|FG002|COMPLETED|Overall Study||7||19
48647133|NCT03338686|101920347|FG000|NOT COMPLETED|Overall Study||0||0
48647134|NCT03338686|101920348|FG001|NOT COMPLETED|Overall Study||0||0
48647135|NCT03338686|101920349|FG002|NOT COMPLETED|Overall Study||0||0
48647136|NCT00669331|101920350|FG000|STARTED|Randomisation to First Dose||244||
48647137|NCT00669331|101920351|FG001|STARTED|Randomisation to First Dose||241||
48647138|NCT00669331|101920350|FG000|COMPLETED|Randomisation to First Dose||233||
48647139|NCT00669331|101920351|FG001|COMPLETED|Randomisation to First Dose||228||
48647140|NCT00669331|101920350|FG000|NOT COMPLETED|Randomisation to First Dose||11||
48647141|NCT00669331|101920351|FG001|NOT COMPLETED|Randomisation to First Dose||13||
48647142|NCT00669331|101920350|FG000|STARTED|Blinded Treatment Period||233||
48647143|NCT00669331|101920351|FG001|STARTED|Blinded Treatment Period||228||
48647144|NCT00669331|101920350|FG000|COMPLETED|Blinded Treatment Period||191||
48647145|NCT00669331|101920351|FG001|COMPLETED|Blinded Treatment Period||189||
48647146|NCT00669331|101920350|FG000|NOT COMPLETED|Blinded Treatment Period||42||
48647147|NCT00669331|101920351|FG001|NOT COMPLETED|Blinded Treatment Period||39||
48647148|NCT02506036|101920352|FG000|STARTED|First Intervention (4-6 Weeks)||3||
48647149|NCT02506036|101920353|FG001|STARTED|First Intervention (4-6 Weeks)||3||
48647150|NCT02506036|101920352|FG000|COMPLETED|First Intervention (4-6 Weeks)||2||
48647151|NCT02506036|101920353|FG001|COMPLETED|First Intervention (4-6 Weeks)||1||
48647152|NCT02506036|101920352|FG000|NOT COMPLETED|First Intervention (4-6 Weeks)||1||
48647153|NCT02506036|101920353|FG001|NOT COMPLETED|First Intervention (4-6 Weeks)||2||
48647154|NCT02506036|101920352|FG000|STARTED|Washout (1-2 Weeks)||2||
48647155|NCT02506036|101920353|FG001|STARTED|Washout (1-2 Weeks)||1||
48647156|NCT02506036|101920352|FG000|COMPLETED|Washout (1-2 Weeks)||2||
48647157|NCT02506036|101920353|FG001|COMPLETED|Washout (1-2 Weeks)||1||
48647158|NCT02506036|101920352|FG000|NOT COMPLETED|Washout (1-2 Weeks)||0||
48647159|NCT02506036|101920353|FG001|NOT COMPLETED|Washout (1-2 Weeks)||0||
48647160|NCT02506036|101920352|FG000|STARTED|Second Intervention (4-6 Weeks)||2||
48647161|NCT02506036|101920353|FG001|STARTED|Second Intervention (4-6 Weeks)||1||
48647162|NCT02506036|101920352|FG000|COMPLETED|Second Intervention (4-6 Weeks)||2||
48647163|NCT02506036|101920353|FG001|COMPLETED|Second Intervention (4-6 Weeks)||1||
48647164|NCT02506036|101920352|FG000|NOT COMPLETED|Second Intervention (4-6 Weeks)||0||
48647165|NCT02506036|101920353|FG001|NOT COMPLETED|Second Intervention (4-6 Weeks)||0||
48647166|NCT00973973|101920354|FG000|STARTED|Double-blind Treatment Phase (Weeks 1-8)||69||
48647167|NCT00973973|101920355|FG001|STARTED|Double-blind Treatment Phase (Weeks 1-8)||68||
48647168|NCT00973973|101920354|FG000|Received Study Drug|Double-blind Treatment Phase (Weeks 1-8)||69||
48647169|NCT00973973|101920355|FG001|Received Study Drug|Double-blind Treatment Phase (Weeks 1-8)||68||
48647170|NCT00973973|101920354|FG000|COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||63||
48647171|NCT00973973|101920355|FG001|COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||60||
48647172|NCT00973973|101920354|FG000|NOT COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||6||
48647173|NCT00973973|101920355|FG001|NOT COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||8||
48647174|NCT00973973|101920354|FG000|STARTED|Open-label Treatment Phase (Weeks 8-24)||63||
48647175|NCT00973973|101920355|FG001|STARTED|Open-label Treatment Phase (Weeks 8-24)||60||
48647176|NCT00973973|101920354|FG000|COMPLETED|Open-label Treatment Phase (Weeks 8-24)||57||
48647177|NCT00973973|101920355|FG001|COMPLETED|Open-label Treatment Phase (Weeks 8-24)||55||
48647178|NCT00973973|101920354|FG000|NOT COMPLETED|Open-label Treatment Phase (Weeks 8-24)||6||
48647179|NCT00973973|101920355|FG001|NOT COMPLETED|Open-label Treatment Phase (Weeks 8-24)||5||
48647180|NCT00584285|101920356|FG000|STARTED|Overall Study||18||
48647181|NCT00584285|101920356|FG000|COMPLETED|Overall Study||18||
48647182|NCT00584285|101920356|FG000|NOT COMPLETED|Overall Study||0||
48647183|NCT02278237|101920357|FG000|STARTED|Overall Study||90||
48647184|NCT02278237|101920357|FG000|COMPLETED|Overall Study||83||
48647185|NCT02278237|101920357|FG000|NOT COMPLETED|Overall Study||7||
48647186|NCT00888849|101920358|FG000|STARTED|Overall Study||142||
48647187|NCT00888849|101920359|FG001|STARTED|Overall Study||138||
48647188|NCT00888849|101920358|FG000|COMPLETED|Overall Study||137||
48647189|NCT00888849|101920359|FG001|COMPLETED|Overall Study||129||
48647190|NCT00888849|101920358|FG000|NOT COMPLETED|Overall Study||5||
48647191|NCT00888849|101920359|FG001|NOT COMPLETED|Overall Study||9||
48647192|NCT01149785|101920360|FG000|STARTED|First Intervention||15||
48647193|NCT01149785|101920361|FG001|STARTED|First Intervention||0||
48647194|NCT01149785|101920360|FG000|COMPLETED|First Intervention||15||
48647195|NCT01149785|101920361|FG001|COMPLETED|First Intervention||0||
48647196|NCT01149785|101920360|FG000|NOT COMPLETED|First Intervention||0||
48647197|NCT01149785|101920361|FG001|NOT COMPLETED|First Intervention||0||
48647198|NCT01149785|101920360|FG000|STARTED|Washout Period of at Least 14 Days||15||
48647199|NCT01149785|101920361|FG001|STARTED|Washout Period of at Least 14 Days||0||
48647200|NCT01149785|101920360|FG000|COMPLETED|Washout Period of at Least 14 Days||15||
48647201|NCT01149785|101920361|FG001|COMPLETED|Washout Period of at Least 14 Days||0||
48647202|NCT01149785|101920360|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||0||
48647203|NCT01149785|101920361|FG001|NOT COMPLETED|Washout Period of at Least 14 Days||0||
48647204|NCT01149785|101920360|FG000|STARTED|Second Intervention||0||
48647205|NCT01149785|101920361|FG001|STARTED|Second Intervention||15||
48647206|NCT01149785|101920360|FG000|COMPLETED|Second Intervention||0||
48647207|NCT01149785|101920361|FG001|COMPLETED|Second Intervention||15||
48188192|NCT02711995|100783180|FG000|COMPLETED|First Intervention (30 Days)||8||
48188193|NCT02711995|100783180|FG000|NOT COMPLETED|First Intervention (30 Days)||0||
48188194|NCT02711995|100783180|FG000|STARTED|Washout (90 Days)||8||
48188195|NCT02711995|100783180|FG000|COMPLETED|Washout (90 Days)||7||
48188196|NCT02711995|100783180|FG000|NOT COMPLETED|Washout (90 Days)||1||
48188197|NCT02711995|100783180|FG000|STARTED|Second Intervention (30 Days)||7||
48188198|NCT02711995|100783180|FG000|COMPLETED|Second Intervention (30 Days)||7||
48188199|NCT02711995|100783180|FG000|NOT COMPLETED|Second Intervention (30 Days)||0||
48188200|NCT03884231|100783181|FG000|STARTED|Overall Study||74||
48188201|NCT03884231|100783181|FG000|COMPLETED|Overall Study||71||
48188202|NCT03884231|100783181|FG000|NOT COMPLETED|Overall Study||3||
48188203|NCT01852162|100783182|FG000|STARTED|Overall Study||18||
48188204|NCT01852162|100783183|FG001|STARTED|Overall Study||17||
48188205|NCT01852162|100783182|FG000|COMPLETED|Overall Study||14||
48188206|NCT01852162|100783183|FG001|COMPLETED|Overall Study||16||
48188207|NCT01852162|100783182|FG000|NOT COMPLETED|Overall Study||4||
48188208|NCT01852162|100783183|FG001|NOT COMPLETED|Overall Study||1||
48188209|NCT03783533|100783184|FG000|STARTED|Overall Study||11||
48188210|NCT03783533|100783184|FG000|COMPLETED|Overall Study||7||
48188211|NCT03783533|100783184|FG000|NOT COMPLETED|Overall Study||4||
48188212|NCT00839982|100783185|FG000|STARTED|Overall Study||4||
48188213|NCT00839982|100783186|FG001|STARTED|Overall Study||26||
48188214|NCT00839982|100783187|FG002|STARTED|Overall Study||2||
48188215|NCT00839982|100783188|FG003|STARTED|Overall Study||3||
48188216|NCT00839982|100783185|FG000|COMPLETED|Overall Study||4||
48188217|NCT00839982|100783186|FG001|COMPLETED|Overall Study||26||
48188218|NCT00839982|100783187|FG002|COMPLETED|Overall Study||2||
48188219|NCT00839982|100783188|FG003|COMPLETED|Overall Study||3||
48188220|NCT00839982|100783185|FG000|NOT COMPLETED|Overall Study||0||
48188221|NCT00839982|100783186|FG001|NOT COMPLETED|Overall Study||0||
48188222|NCT00839982|100783187|FG002|NOT COMPLETED|Overall Study||0||
48188223|NCT00839982|100783188|FG003|NOT COMPLETED|Overall Study||0||
48188224|NCT04985383|100783189|FG000|STARTED|Overall Study||10||
48188225|NCT04985383|100783189|FG000|Week 1 AKST1210 S-15 at 250 mL/Min|Overall Study||9||
48188226|NCT04985383|100783189|FG000|Week 2 AKST1210 S-15 at up to 450 mL/Min|Overall Study||9||
48188227|NCT04985383|100783189|FG000|Week 3 AKST1210 S-25 at 250 mL/Min|Overall Study||9||
48188228|NCT04985383|100783189|FG000|Week 4 AKST1210 S-25 at up to 450 mL/Min|Overall Study||9||
48188229|NCT04985383|100783189|FG000|Week 5 AKST1210 S-35 at 250 mL/Min|Overall Study||9||
48188230|NCT04985383|100783189|FG000|Week 6 AKST1210 S-35 at up to 450 mL/Min|Overall Study||9||
48188231|NCT04985383|100783189|FG000|COMPLETED|Overall Study||9||
48188232|NCT04985383|100783189|FG000|NOT COMPLETED|Overall Study||1||
48188233|NCT03424239|100783190|FG000|STARTED|Overall Study||6||
48188234|NCT03424239|100783190|FG000|Baseline/Zoledronic Acid Administration|Overall Study||4||
48188235|NCT03424239|100783190|FG000|2 Week Post-op|Overall Study||4||
48188236|NCT03424239|100783190|FG000|12 Week Post-op|Overall Study||4||
48188237|NCT03424239|100783190|FG000|24 Week Post-op|Overall Study||4||
48188238|NCT03424239|100783190|FG000|COMPLETED|Overall Study||4||
48188239|NCT03424239|100783190|FG000|NOT COMPLETED|Overall Study||2||
48188240|NCT01822821|100783191|FG000|STARTED|Overall Study||75||
48188241|NCT01822821|100783192|FG001|STARTED|Overall Study||75||
48188242|NCT01822821|100783191|FG000|COMPLETED|Overall Study||73||
48188243|NCT01822821|100783192|FG001|COMPLETED|Overall Study||74||
48188244|NCT01822821|100783191|FG000|NOT COMPLETED|Overall Study||2||
48188245|NCT01822821|100783192|FG001|NOT COMPLETED|Overall Study||1||
48188246|NCT03610633|100783193|FG000|STARTED|Overall Study||5||
48647208|NCT01149785|101920360|FG000|NOT COMPLETED|Second Intervention||0||
48647209|NCT01149785|101920361|FG001|NOT COMPLETED|Second Intervention||0||
48647210|NCT01968785|101920362|FG000|STARTED|Overall Study||2||
48647211|NCT01968785|101920363|FG001|STARTED|Overall Study||0||
48188247|NCT03610633|100783194|FG001|STARTED|Overall Study||6||
48188248|NCT03610633|100783193|FG000|COMPLETED|Overall Study||5||
48188249|NCT03610633|100783194|FG001|COMPLETED|Overall Study||5||
48188250|NCT03610633|100783193|FG000|NOT COMPLETED|Overall Study||0||
48188251|NCT03610633|100783194|FG001|NOT COMPLETED|Overall Study||1||
48188252|NCT02271594|100783195|FG000|STARTED|Overall Study||19||
48188253|NCT02271594|100783196|FG001|STARTED|Overall Study||12||
48188254|NCT02271594|100783195|FG000|COMPLETED|Overall Study||0||
48188255|NCT02271594|100783196|FG001|COMPLETED|Overall Study||0||
48362131|NCT00923091|101214489|FG002|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||13||
48362132|NCT00923091|101214490|FG003|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||27||
48362133|NCT00923091|101214491|FG004|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||21||
48188256|NCT02271594|100783195|FG000|NOT COMPLETED|Overall Study||19||
48188257|NCT02271594|100783196|FG001|NOT COMPLETED|Overall Study||12||
48188258|NCT03748264|100783197|FG000|STARTED|Overall Study||21||
48362134|NCT00923091|101214492|FG005|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||15||
48362135|NCT00923091|101214493|FG006|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||18||
48362136|NCT00923091|101214494|FG007|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||25||
48362137|NCT00923091|101214495|FG008|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0||
48647212|NCT01968785|101920362|FG000|COMPLETED|Overall Study||1||
48647213|NCT01968785|101920363|FG001|COMPLETED|Overall Study||0||
48647214|NCT01968785|101920362|FG000|NOT COMPLETED|Overall Study||1||
48647215|NCT01968785|101920363|FG001|NOT COMPLETED|Overall Study||0||
48647216|NCT01028053|101920364|FG000|STARTED|Overall Study||365||
48647217|NCT01028053|101920364|FG000|COMPLETED|Overall Study||232||
48647218|NCT01028053|101920364|FG000|NOT COMPLETED|Overall Study||133||
48647219|NCT01727154|101920365|FG000|STARTED|Overall Study||139||
48647220|NCT01727154|101920365|FG000|COMPLETED|Overall Study||80||
48647221|NCT01727154|101920365|FG000|NOT COMPLETED|Overall Study||59||
48647222|NCT02413346|101920366|FG000|STARTED|Overall Study||236||
48647223|NCT02413346|101920367|FG001|STARTED|Overall Study||247||
48647224|NCT02413346|101920366|FG000|COMPLETED|Overall Study||177||
48647225|NCT02413346|101920367|FG001|COMPLETED|Overall Study||177||
48647226|NCT02413346|101920366|FG000|NOT COMPLETED|Overall Study||59||
48647227|NCT02413346|101920367|FG001|NOT COMPLETED|Overall Study||70||
48647228|NCT00303628|101920368|FG000|STARTED|Overall Study||176||
48647229|NCT00303628|101920369|FG001|STARTED|Overall Study||179||
48647230|NCT00303628|101920368|FG000|Eligible|Overall Study||171||
48647231|NCT00303628|101920369|FG001|Eligible|Overall Study||177||
48647232|NCT00303628|101920368|FG000|Treated|Overall Study||173||
48647233|NCT00303628|101920369|FG001|Treated|Overall Study||174||
48647234|NCT00303628|101920368|FG000|COMPLETED|Overall Study||126||
48647235|NCT00303628|101920369|FG001|COMPLETED|Overall Study||106||
48647236|NCT00303628|101920368|FG000|NOT COMPLETED|Overall Study||50||
48647237|NCT00303628|101920369|FG001|NOT COMPLETED|Overall Study||73||
48647238|NCT01646216|101920370|FG000|STARTED|Overall Study||17||
48647239|NCT01646216|101920371|FG001|STARTED|Overall Study||17||
48647240|NCT01646216|101920370|FG000|COMPLETED|Overall Study||6||
48647241|NCT01646216|101920371|FG001|COMPLETED|Overall Study||4||
48647242|NCT01646216|101920370|FG000|NOT COMPLETED|Overall Study||11||
48647243|NCT01646216|101920371|FG001|NOT COMPLETED|Overall Study||13||
48647244|NCT03338023|101920372|FG000|STARTED|Overall Study||137||
48647245|NCT03338023|101920373|FG001|STARTED|Overall Study||135||
48647246|NCT03338023|101920372|FG000|Received at Least One Dose of Study Drug|Overall Study||137||
48647247|NCT03338023|101920373|FG001|Received at Least One Dose of Study Drug|Overall Study||135||
48647248|NCT03338023|101920372|FG000|COMPLETED|Overall Study||128||
48647249|NCT03338023|101920373|FG001|COMPLETED|Overall Study||125||
48647250|NCT03338023|101920372|FG000|NOT COMPLETED|Overall Study||9||
48647251|NCT03338023|101920373|FG001|NOT COMPLETED|Overall Study||10||
48647252|NCT04002557|101920374|FG000|STARTED|Overall Study||9||
48647253|NCT04002557|101920374|FG000|COMPLETED|Overall Study||9||
48647254|NCT04002557|101920374|FG000|NOT COMPLETED|Overall Study||0||
48647255|NCT01556100|101920375|FG000|STARTED|Overall Study||40||
48647256|NCT01556100|101920375|FG000|COMPLETED|Overall Study||34||
48647257|NCT01556100|101920375|FG000|NOT COMPLETED|Overall Study||6||
48647258|NCT00806026|101920376|FG000|STARTED|Overall Study||185||
48647259|NCT00806026|101920377|FG001|STARTED|Overall Study||183||
48647260|NCT00806026|101920378|FG002|STARTED|Overall Study||182||
48647261|NCT00806026|101920379|FG003|STARTED|Overall Study||61||
48647262|NCT00806026|101920380|FG004|STARTED|Overall Study||59||
48647263|NCT00806026|101920381|FG005|STARTED|Overall Study||61||
48647264|NCT00806026|101920376|FG000|Treated|Overall Study||182||
48647265|NCT00806026|101920377|FG001|Treated|Overall Study||178||
48647266|NCT00806026|101920378|FG002|Treated|Overall Study||180||
48647267|NCT00806026|101920379|FG003|Treated|Overall Study||59||
48647268|NCT00806026|101920380|FG004|Treated|Overall Study||59||
48647269|NCT00806026|101920381|FG005|Treated|Overall Study||61||
48647270|NCT00806026|101920376|FG000|COMPLETED|Overall Study||93||
48647271|NCT00806026|101920377|FG001|COMPLETED|Overall Study||82||
48647272|NCT00806026|101920378|FG002|COMPLETED|Overall Study||89||
48647273|NCT00806026|101920379|FG003|COMPLETED|Overall Study||32||
48647274|NCT00806026|101920380|FG004|COMPLETED|Overall Study||29||
48647275|NCT00806026|101920381|FG005|COMPLETED|Overall Study||29||
48647276|NCT00806026|101920376|FG000|NOT COMPLETED|Overall Study||92||
48647277|NCT00806026|101920377|FG001|NOT COMPLETED|Overall Study||101||
48647278|NCT00806026|101920378|FG002|NOT COMPLETED|Overall Study||93||
48647279|NCT00806026|101920379|FG003|NOT COMPLETED|Overall Study||29||
48647280|NCT00806026|101920380|FG004|NOT COMPLETED|Overall Study||30||
48647281|NCT00806026|101920381|FG005|NOT COMPLETED|Overall Study||32||
48647282|NCT01127061|101920382|FG000|STARTED|Overall Study||67||
48647283|NCT01127061|101920383|FG001|STARTED|Overall Study||69||
48647284|NCT01127061|101920382|FG000|COMPLETED|Overall Study||57||
48647285|NCT01127061|101920383|FG001|COMPLETED|Overall Study||56||
48647286|NCT01127061|101920382|FG000|NOT COMPLETED|Overall Study||10||
48647287|NCT01127061|101920383|FG001|NOT COMPLETED|Overall Study||13||
48647288|NCT02569242|101920384|FG000|STARTED|Overall Study||210|Enrolled and randomly assigned|
48647289|NCT02569242|101920385|FG001|STARTED|Overall Study||209|Enrolled and randomly assigned|
48647290|NCT02569242|101920384|FG000|COMPLETED|Overall Study||209|Received assigned treatment of IMP|
48647291|NCT02569242|101920385|FG001|COMPLETED|Overall Study||208|Received assigned treatment of IMP|
48647292|NCT02569242|101920384|FG000|NOT COMPLETED|Overall Study||1||
48647293|NCT02569242|101920385|FG001|NOT COMPLETED|Overall Study||1||
48647294|NCT02923180|101920386|FG000|STARTED|Overall Study||32||
48647295|NCT02923180|101920386|FG000|COMPLETED|Overall Study||6||
48647296|NCT02923180|101920386|FG000|NOT COMPLETED|Overall Study||26||
48647297|NCT05399355|101920387|FG000|STARTED|Overall Study||59||
48647298|NCT05399355|101920388|FG001|STARTED|Overall Study||60||
48647299|NCT05399355|101920387|FG000|COMPLETED|Overall Study||59||
48647300|NCT05399355|101920388|FG001|COMPLETED|Overall Study||60||
48647301|NCT05399355|101920387|FG000|NOT COMPLETED|Overall Study||0||
48647302|NCT05399355|101920388|FG001|NOT COMPLETED|Overall Study||0||
48647303|NCT01263379|101920389|FG000|STARTED|Overall Study||7||
48647304|NCT01263379|101920389|FG000|COMPLETED|Overall Study||7||
48647305|NCT01263379|101920389|FG000|NOT COMPLETED|Overall Study||0||
48647306|NCT01827943|101923504|FG000|STARTED|Overall Study||54||
48647307|NCT01827943|101923504|FG000|Safety Population|Overall Study||53|Safety population included patients with at least one administration of treatment|
48647308|NCT01827943|101923504|FG000|COMPLETED|Overall Study||45||
48647309|NCT01827943|101923504|FG000|NOT COMPLETED|Overall Study||9||
48647310|NCT03150797|101923505|FG000|STARTED|Single-blind Placebo Run in Phase||0|In the single-blind phase, all participants started on placebo for 8 weeks. At the end of the 8 weeks, only those who had not dropped out and who met randomization criteria went on to the double-blind phase. Of the 59 who completed phase 1, only 44 met randomization criteria, of whom 42 were randomized (2 were not randomized due to error).|
48647311|NCT03150797|101923506|FG001|STARTED|Single-blind Placebo Run in Phase||0|In the single-blind phase, all participants started on placebo for 8 weeks. At the end of the 8 weeks, only those who had not dropped out and who met randomization criteria went on to the double-blind phase. Of the 59 who completed phase 1, only 44 met randomization criteria, of whom 42 were randomized (2 were not randomized due to error).|
48647312|NCT03150797|101923507|FG002|STARTED|Single-blind Placebo Run in Phase||72|In the single-blind phase, all participants started on placebo for 8 weeks. At the end of the 8 weeks, only those who had not dropped out and who met randomization criteria went on to the double-blind phase. Of the 59 who completed phase 1, only 44 met randomization criteria, of whom 42 were randomized (2 were not randomized due to error).|
48647313|NCT03150797|101923505|FG000|COMPLETED|Single-blind Placebo Run in Phase||0||
48647314|NCT03150797|101923506|FG001|COMPLETED|Single-blind Placebo Run in Phase||0||
48647315|NCT03150797|101923507|FG002|COMPLETED|Single-blind Placebo Run in Phase||59||
48647316|NCT03150797|101923505|FG000|NOT COMPLETED|Single-blind Placebo Run in Phase||0||
48647317|NCT03150797|101923506|FG001|NOT COMPLETED|Single-blind Placebo Run in Phase||0||
48647318|NCT03150797|101923507|FG002|NOT COMPLETED|Single-blind Placebo Run in Phase||13||
48647319|NCT03150797|101923505|FG000|STARTED|Double Blind Phase||14|The reason this number does not match the number above is that in the single blind phase ALL participants received placebo.|
48647320|NCT03150797|101923506|FG001|STARTED|Double Blind Phase||14|The reason this number does not match the number above is that in the single blind phase ALL participants received placebo.|
48647321|NCT03150797|101923507|FG002|STARTED|Double Blind Phase||14|The reason this number does not match the number above is that in the single blind phase ALL participants received placebo.|
48647322|NCT03150797|101923505|FG000|COMPLETED|Double Blind Phase||10|i.e., provided at least 21/28 headache diary days during final four weeks of double-blind treatment (weeks 13-16 overall).|
48647323|NCT03150797|101923506|FG001|COMPLETED|Double Blind Phase||10|i.e., provided at least 21/28 headache diary days during final four weeks of double-blind treatment (weeks 13-16 overall).|
48647324|NCT03150797|101923507|FG002|COMPLETED|Double Blind Phase||7|i.e., provided at least 21/28 headache diary days during final four weeks of double-blind treatment (weeks 13-16 overall).|
48647325|NCT03150797|101923505|FG000|NOT COMPLETED|Double Blind Phase||4||
48647326|NCT03150797|101923506|FG001|NOT COMPLETED|Double Blind Phase||4||
48647327|NCT03150797|101923507|FG002|NOT COMPLETED|Double Blind Phase||7||
48647328|NCT00509600|101923508|FG000|STARTED|Overall Study||1||
48647329|NCT00509600|101923508|FG000|COMPLETED|Overall Study||0||
48647330|NCT00509600|101923508|FG000|NOT COMPLETED|Overall Study||1||
48647331|NCT01653262|101923509|FG000|STARTED|Overall Study||29||
48647332|NCT01653262|101923509|FG000|COMPLETED|Overall Study||26||
48647333|NCT01653262|101923509|FG000|NOT COMPLETED|Overall Study||3||
48647334|NCT01362270|101923510|FG000|STARTED|Overall Study||7||
48647335|NCT01362270|101923511|FG001|STARTED|Overall Study||8||
48647336|NCT01362270|101923510|FG000|COMPLETED|Overall Study||5||
48647337|NCT01362270|101923511|FG001|COMPLETED|Overall Study||6||
48647338|NCT01362270|101923510|FG000|NOT COMPLETED|Overall Study||2||
48647339|NCT01362270|101923511|FG001|NOT COMPLETED|Overall Study||2||
48647340|NCT00394472|101923512|FG000|STARTED|Overall Study||122||
48647341|NCT00394472|101923513|FG001|STARTED|Overall Study||122||
48647342|NCT00394472|101923512|FG000|COMPLETED|Overall Study||113||
48647343|NCT00394472|101923513|FG001|COMPLETED|Overall Study||111||
48647344|NCT00394472|101923512|FG000|NOT COMPLETED|Overall Study||9||
48647345|NCT00394472|101923513|FG001|NOT COMPLETED|Overall Study||11||
48647346|NCT05427916|101923514|FG000|STARTED|Overall Study||12||
48647347|NCT05427916|101923515|FG001|STARTED|Overall Study||8||
48647348|NCT05427916|101923514|FG000|COMPLETED|Overall Study||0||
48647349|NCT05427916|101923515|FG001|COMPLETED|Overall Study||0||
48647350|NCT05427916|101923514|FG000|NOT COMPLETED|Overall Study||12||
48647351|NCT05427916|101923515|FG001|NOT COMPLETED|Overall Study||8||
48647352|NCT00693303|101923516|FG000|STARTED|Overall Study||21||
48647353|NCT00693303|101923516|FG000|COMPLETED|Overall Study||21||
48647354|NCT00693303|101923516|FG000|NOT COMPLETED|Overall Study||0||
48647355|NCT01956942|101923517|FG000|STARTED|Overall Study||38||
48647356|NCT01956942|101923518|FG001|STARTED|Overall Study||31||
48647357|NCT01956942|101923517|FG000|COMPLETED|Overall Study||38||
48647358|NCT01956942|101923518|FG001|COMPLETED|Overall Study||31||
48647359|NCT01956942|101923517|FG000|NOT COMPLETED|Overall Study||0||
48647360|NCT01956942|101923518|FG001|NOT COMPLETED|Overall Study||0||
48647361|NCT00776997|101923519|FG000|STARTED|Overall Study||100||
48647362|NCT00776997|101923519|FG000|COMPLETED|Overall Study||98||
48647363|NCT00776997|101923519|FG000|NOT COMPLETED|Overall Study||2||
48647364|NCT00290238|101923520|FG000|STARTED|Overall Study||57||
48647365|NCT00290238|101923521|FG001|STARTED|Overall Study||65||
48647366|NCT00290238|101923520|FG000|COMPLETED|Overall Study||15||
48647367|NCT00290238|101923521|FG001|COMPLETED|Overall Study||24||
48647368|NCT00290238|101923520|FG000|NOT COMPLETED|Overall Study||42||
48647369|NCT00290238|101923521|FG001|NOT COMPLETED|Overall Study||41||
48647370|NCT02636283|101923522|FG000|STARTED|Overall Study||3||
48647371|NCT02636283|101923523|FG001|STARTED|Overall Study||3||
48647372|NCT02636283|101923522|FG000|COMPLETED|Overall Study||1||
48647373|NCT02636283|101923523|FG001|COMPLETED|Overall Study||0||
48647374|NCT02636283|101923522|FG000|NOT COMPLETED|Overall Study||2||
48647375|NCT02636283|101923523|FG001|NOT COMPLETED|Overall Study||3||
48647376|NCT00812097|101923524|FG000|STARTED|Overall Study||572||
48647377|NCT00812097|101923525|FG001|STARTED|Overall Study||190||
48647378|NCT00812097|101923526|FG002|STARTED|Overall Study||124||
48647379|NCT00812097|101923527|FG003|STARTED|Overall Study||69||
48647380|NCT00812097|101923524|FG000|COMPLETED|Overall Study||327||
48647381|NCT00812097|101923525|FG001|COMPLETED|Overall Study||101||
48647382|NCT00812097|101923526|FG002|COMPLETED|Overall Study||67||
48647383|NCT00812097|101923527|FG003|COMPLETED|Overall Study||34||
48647384|NCT00812097|101923524|FG000|NOT COMPLETED|Overall Study||245||
48647385|NCT00812097|101923525|FG001|NOT COMPLETED|Overall Study||89||
48647386|NCT00812097|101923526|FG002|NOT COMPLETED|Overall Study||57||
48647387|NCT00812097|101923527|FG003|NOT COMPLETED|Overall Study||35||
48647388|NCT04863807|101923528|FG000|STARTED|Overall Study||325||
48647389|NCT04863807|101923529|FG001|STARTED|Overall Study||26||
48647390|NCT04863807|101923530|FG002|STARTED|Overall Study||38||
48647391|NCT04863807|101923528|FG000|COMPLETED|Overall Study||325||
48647392|NCT04863807|101923529|FG001|COMPLETED|Overall Study||26||
48647393|NCT04863807|101923530|FG002|COMPLETED|Overall Study||38||
48647394|NCT04863807|101923528|FG000|NOT COMPLETED|Overall Study||0||
48647395|NCT04863807|101923529|FG001|NOT COMPLETED|Overall Study||0||
48647396|NCT04863807|101923530|FG002|NOT COMPLETED|Overall Study||0||
48647397|NCT00350220|101923531|FG000|STARTED|Overall Study||30||
48647398|NCT00350220|101923532|FG001|STARTED|Overall Study||30||
48647399|NCT00350220|101923531|FG000|COMPLETED|Overall Study||30||
48647400|NCT00350220|101923532|FG001|COMPLETED|Overall Study||30||
48647401|NCT00350220|101923531|FG000|NOT COMPLETED|Overall Study||0||
48647402|NCT00350220|101923532|FG001|NOT COMPLETED|Overall Study||0||
48647403|NCT02489773|101923533|FG000|STARTED|Overall Study||98||
48647404|NCT02489773|101923534|FG001|STARTED|Overall Study||52||
48647405|NCT02489773|101923533|FG000|COMPLETED|Overall Study||91||
48647406|NCT02489773|101923534|FG001|COMPLETED|Overall Study||50||
48647407|NCT02489773|101923533|FG000|NOT COMPLETED|Overall Study||7||
48647408|NCT02489773|101923534|FG001|NOT COMPLETED|Overall Study||2||
48647409|NCT03211832|101923535|FG000|STARTED|Overall Study||78|Baseline Survey. All participants were employees at participating local health departments.|4
48647410|NCT03211832|101923536|FG001|STARTED|Overall Study||85|Baseline Survey. All participants were employees at participating local health departments.|4
48647411|NCT03211832|101923537|FG002|STARTED|Overall Study||66|Baseline Survey. All participants were employees at participating local health departments.|4
48647412|NCT03211832|101923535|FG000|Survey Time 2|Overall Study||83|At Survey Time 2, 37 health department employees were added to replace those no longer working at the agency.|4
48647413|NCT03211832|101923536|FG001|Survey Time 2|Overall Study||87|At Survey Time 2, 37 health department employees were added to replace those no longer working at the agency.|4
48647414|NCT03211832|101923537|FG002|Survey Time 2|Overall Study||63|At Survey Time 2, 37 health department employees were added to replace those no longer working at the agency.|4
48647415|NCT03211832|101923535|FG000|Survey Time 3|Overall Study||70|More unique health department employee participants were again added (27 due to employee turnover and 15 to better reflect Group 2 health department units involved in the intervention).|4
48647416|NCT03211832|101923536|FG001|Survey Time 3|Overall Study||112|More unique health department employee participants were again added (27 due to employee turnover and 15 to better reflect Group 2 health department units involved in the intervention).|4
48647417|NCT03211832|101923537|FG002|Survey Time 3|Overall Study||55|More unique health department employee participants were again added (27 due to employee turnover and 15 to better reflect Group 2 health department units involved in the intervention).|4
48647418|NCT03211832|101923535|FG000|Survey Time 4|Overall Study||70|At Survey Time 4, all groups were in Intervention status. At Survey Time 4, 23 health department employees were added to replace those no longer working at the health departments.|4
48647419|NCT03211832|101923536|FG001|Survey Time 4|Overall Study||97|At Survey Time 4, all groups were in Intervention status. At Survey Time 4, 23 health department employees were added to replace those no longer working at the health departments.|4
48647420|NCT03211832|101923537|FG002|Survey Time 4|Overall Study||60|At Survey Time 4, all groups were in Intervention status. At Survey Time 4, 23 health department employees were added to replace those no longer working at the health departments.|4
48647421|NCT03211832|101923535|FG000|COMPLETED|Overall Study||42||4
48647422|NCT03211832|101923536|FG001|COMPLETED|Overall Study||33||4
48647423|NCT03211832|101923537|FG002|COMPLETED|Overall Study||32||4
48647424|NCT03211832|101923535|FG000|NOT COMPLETED|Overall Study||36||0
48647425|NCT03211832|101923536|FG001|NOT COMPLETED|Overall Study||52||0
48647426|NCT03211832|101923537|FG002|NOT COMPLETED|Overall Study||34||0
48647427|NCT01971593|101923538|FG000|STARTED|Overall Study||14||
48647428|NCT01971593|101923539|FG001|STARTED|Overall Study||12||
48647429|NCT01971593|101923538|FG000|COMPLETED|Overall Study||9||
48647430|NCT01971593|101923539|FG001|COMPLETED|Overall Study||8||
48647431|NCT01971593|101923538|FG000|NOT COMPLETED|Overall Study||5||
48647432|NCT01971593|101923539|FG001|NOT COMPLETED|Overall Study||4||
48647433|NCT01716195|101923540|FG000|STARTED|Overall Study||18||
48647434|NCT01716195|101923540|FG000|COMPLETED|Overall Study||17||
48647435|NCT01716195|101923540|FG000|NOT COMPLETED|Overall Study||1||
48647436|NCT00527878|101923541|FG000|STARTED|Intervention 1||7||
48647437|NCT00527878|101923542|FG001|STARTED|Intervention 1||7||
48647438|NCT00527878|101923541|FG000|COMPLETED|Intervention 1||5||
48647439|NCT00527878|101923542|FG001|COMPLETED|Intervention 1||4||
48647440|NCT00527878|101923541|FG000|NOT COMPLETED|Intervention 1||2||
48647441|NCT00527878|101923542|FG001|NOT COMPLETED|Intervention 1||3||
48647442|NCT00527878|101923541|FG000|STARTED|Intervention 2||5||
48647443|NCT00527878|101923542|FG001|STARTED|Intervention 2||4||
48647444|NCT00527878|101923541|FG000|COMPLETED|Intervention 2||5||
48647445|NCT00527878|101923542|FG001|COMPLETED|Intervention 2||4||
48362138|NCT00923091|101214496|FG009|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0||
48362139|NCT00923091|101214497|FG010|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0||
48647446|NCT00527878|101923541|FG000|NOT COMPLETED|Intervention 2||0||
48647447|NCT00527878|101923542|FG001|NOT COMPLETED|Intervention 2||0||
48647448|NCT03074643|101923543|FG000|STARTED|Overall Study||62||
48647449|NCT03074643|101923544|FG001|STARTED|Overall Study||62||
48647450|NCT03074643|101923545|FG002|STARTED|Overall Study||63||
48647451|NCT03074643|101923543|FG000|COMPLETED|Overall Study||51||
48647452|NCT03074643|101923544|FG001|COMPLETED|Overall Study||50||
48647453|NCT03074643|101923545|FG002|COMPLETED|Overall Study||52||
48647454|NCT03074643|101923543|FG000|NOT COMPLETED|Overall Study||11||
48647455|NCT03074643|101923544|FG001|NOT COMPLETED|Overall Study||12||
48647456|NCT03074643|101923545|FG002|NOT COMPLETED|Overall Study||11||
48647457|NCT00289900|101923546|FG000|STARTED|Overall Study||297||
48647458|NCT00289900|101923547|FG001|STARTED|Overall Study||436||
48647459|NCT00289900|101923548|FG002|STARTED|Overall Study||298||
48647460|NCT00289900|101923549|FG003|STARTED|Overall Study||439||
48647461|NCT00289900|101923550|FG004|STARTED|Overall Study||437||
48647462|NCT00289900|101923551|FG005|STARTED|Overall Study||433||
48647463|NCT00289900|101923546|FG000|Treated|Overall Study||297||
48647464|NCT00289900|101923547|FG001|Treated|Overall Study||435||
48647465|NCT00289900|101923548|FG002|Treated|Overall Study||298||
48647466|NCT00289900|101923549|FG003|Treated|Overall Study||439||
48647467|NCT00289900|101923550|FG004|Treated|Overall Study||437||
48647468|NCT00289900|101923551|FG005|Treated|Overall Study||433||
48647469|NCT00289900|101923546|FG000|COMPLETED|Overall Study||229||
48647470|NCT00289900|101923547|FG001|COMPLETED|Overall Study||316||
48647471|NCT00289900|101923548|FG002|COMPLETED|Overall Study||265||
48647472|NCT00289900|101923549|FG003|COMPLETED|Overall Study||380||
48647473|NCT00289900|101923550|FG004|COMPLETED|Overall Study||392||
48647474|NCT00289900|101923551|FG005|COMPLETED|Overall Study||372||
48647475|NCT00289900|101923546|FG000|NOT COMPLETED|Overall Study||68||
48647476|NCT00289900|101923547|FG001|NOT COMPLETED|Overall Study||120||
48647477|NCT00289900|101923548|FG002|NOT COMPLETED|Overall Study||33||
48647478|NCT00289900|101923549|FG003|NOT COMPLETED|Overall Study||59||
48647479|NCT00289900|101923550|FG004|NOT COMPLETED|Overall Study||45||
48647480|NCT00289900|101923551|FG005|NOT COMPLETED|Overall Study||61||
48647481|NCT01732211|101923552|FG000|STARTED|Overall Study||1||
48647482|NCT01732211|101923552|FG000|COMPLETED|Overall Study||1||
48647483|NCT01732211|101923552|FG000|NOT COMPLETED|Overall Study||0||
48647484|NCT01898091|101923553|FG000|STARTED|Overall Study||25||
48647485|NCT01898091|101923554|FG001|STARTED|Overall Study||25||
48647486|NCT01898091|101923553|FG000|COMPLETED|Overall Study||23||
48647487|NCT01898091|101923554|FG001|COMPLETED|Overall Study||19||
48647488|NCT01898091|101923553|FG000|NOT COMPLETED|Overall Study||2||
48647489|NCT01898091|101923554|FG001|NOT COMPLETED|Overall Study||6||
48647490|NCT00478140|101923555|FG000|STARTED|Overall Study||4||
48647491|NCT00478140|101923555|FG000|COMPLETED|Overall Study||3||
48647492|NCT00478140|101923555|FG000|NOT COMPLETED|Overall Study||1||
48647493|NCT02441114|101923556|FG000|STARTED|Period1||10||
48647494|NCT02441114|101923556|FG000|COMPLETED|Period1||10||
48647495|NCT02441114|101923556|FG000|NOT COMPLETED|Period1||0||
48647496|NCT02441114|101923556|FG000|STARTED|Washout1||10||
48647497|NCT02441114|101923556|FG000|COMPLETED|Washout1||10||
48647498|NCT02441114|101923556|FG000|NOT COMPLETED|Washout1||0||
48647499|NCT02441114|101923556|FG000|STARTED|Period2||10||
48647500|NCT02441114|101923556|FG000|COMPLETED|Period2||10||
48647501|NCT02441114|101923556|FG000|NOT COMPLETED|Period2||0||
48647502|NCT02441114|101923556|FG000|STARTED|Washout2||10||
48647503|NCT02441114|101923556|FG000|COMPLETED|Washout2||6||
48368133|NCT01555463|101230112|FG001|NOT COMPLETED|Follow up||45||
48647504|NCT02441114|101923556|FG000|NOT COMPLETED|Washout2||4||
48647505|NCT02441114|101923556|FG000|STARTED|Period3||6||
48647506|NCT02441114|101923556|FG000|COMPLETED|Period3||6||
48647507|NCT02441114|101923556|FG000|NOT COMPLETED|Period3||0||
48647508|NCT00871000|101923557|FG000|STARTED|Overall Study||151||
48647509|NCT00871000|101923558|FG001|STARTED|Overall Study||152||
48647510|NCT00871000|101923557|FG000|COMPLETED|Overall Study||150||
48647511|NCT00871000|101923558|FG001|COMPLETED|Overall Study||152||
48647512|NCT00871000|101923557|FG000|NOT COMPLETED|Overall Study||1||
48647513|NCT00871000|101923558|FG001|NOT COMPLETED|Overall Study||0||
48647514|NCT03439514|101923559|FG000|STARTED|Double-Blind Treatment Period||40||
48647515|NCT03439514|101923560|FG001|STARTED|Double-Blind Treatment Period||37||
48647516|NCT03439514|101923559|FG000|COMPLETED|Double-Blind Treatment Period||0||
48647517|NCT03439514|101923560|FG001|COMPLETED|Double-Blind Treatment Period||0||
48647518|NCT03439514|101923559|FG000|NOT COMPLETED|Double-Blind Treatment Period||40||
48647519|NCT03439514|101923560|FG001|NOT COMPLETED|Double-Blind Treatment Period||37||
48647520|NCT03439514|101923559|FG000|STARTED|Open-Label Treatment Period||0||
48647521|NCT03439514|101923560|FG001|STARTED|Open-Label Treatment Period||0||
48647522|NCT03439514|101923559|FG000|COMPLETED|Open-Label Treatment Period||0||
48647523|NCT03439514|101923560|FG001|COMPLETED|Open-Label Treatment Period||0||
48647524|NCT03439514|101923559|FG000|NOT COMPLETED|Open-Label Treatment Period||0||
48647525|NCT03439514|101923560|FG001|NOT COMPLETED|Open-Label Treatment Period||0||
48647526|NCT03912805|101923561|FG000|STARTED|Overall Study||19||
48647527|NCT03912805|101923562|FG001|STARTED|Overall Study||19||
48647528|NCT03912805|101923561|FG000|COMPLETED|Overall Study||19||
48647529|NCT03912805|101923562|FG001|COMPLETED|Overall Study||19||
48647530|NCT03912805|101923561|FG000|NOT COMPLETED|Overall Study||0||
48647531|NCT03912805|101923562|FG001|NOT COMPLETED|Overall Study||0||
48647532|NCT00371631|101923563|FG000|STARTED|Overall Study||13||
48647533|NCT00371631|101923563|FG000|COMPLETED|Overall Study||13||
48647534|NCT00371631|101923563|FG000|NOT COMPLETED|Overall Study||0||
48647535|NCT00454142|101923564|FG000|STARTED|Overall Study||33||
48647536|NCT00454142|101923564|FG000|COMPLETED|Overall Study||32||
48647537|NCT00454142|101923564|FG000|NOT COMPLETED|Overall Study||1||
48647538|NCT00501085|101923565|FG000|STARTED|Overall Study||515||
48647539|NCT00501085|101923565|FG000|COMPLETED|Overall Study||83||
48647540|NCT00501085|101923565|FG000|NOT COMPLETED|Overall Study||432||
48647541|NCT03767894|101923566|FG000|STARTED|Overall Study||12||
48647542|NCT03767894|101923566|FG000|COMPLETED|Overall Study||11||
48647543|NCT03767894|101923566|FG000|NOT COMPLETED|Overall Study||1||
48647544|NCT00710554|101923567|FG000|STARTED|Overall Study||128||
48647545|NCT00710554|101923568|FG001|STARTED|Overall Study||118||
48647546|NCT00710554|101923567|FG000|COMPLETED|Overall Study||79||
48647547|NCT00710554|101923568|FG001|COMPLETED|Overall Study||94||
48647548|NCT00710554|101923567|FG000|NOT COMPLETED|Overall Study||49||
48647549|NCT00710554|101923568|FG001|NOT COMPLETED|Overall Study||24||
48647550|NCT01986751|101923569|FG000|STARTED|Overall Study||10||
48647551|NCT01986751|101923570|FG001|STARTED|Overall Study||4||
48647552|NCT01986751|101923569|FG000|COMPLETED|Overall Study||0||
48647553|NCT01986751|101923570|FG001|COMPLETED|Overall Study||2||
48647554|NCT01986751|101923569|FG000|NOT COMPLETED|Overall Study||10||
48647555|NCT01986751|101923570|FG001|NOT COMPLETED|Overall Study||2||
48647556|NCT01703221|101923571|FG000|STARTED|Phase A (Up to 24 Weeks)||166||
48647557|NCT01703221|101923572|FG001|STARTED|Phase A (Up to 24 Weeks)||165||
48647558|NCT01703221|101923573|FG002|STARTED|Phase A (Up to 24 Weeks)||83||
48647559|NCT01703221|101923571|FG000|COMPLETED|Phase A (Up to 24 Weeks)||159||
48647560|NCT01703221|101923572|FG001|COMPLETED|Phase A (Up to 24 Weeks)||161||
48647561|NCT01703221|101923573|FG002|COMPLETED|Phase A (Up to 24 Weeks)||80||
48647562|NCT01703221|101923571|FG000|NOT COMPLETED|Phase A (Up to 24 Weeks)||7||
48647563|NCT01703221|101923572|FG001|NOT COMPLETED|Phase A (Up to 24 Weeks)||4||
48647564|NCT01703221|101923573|FG002|NOT COMPLETED|Phase A (Up to 24 Weeks)||3||
48765270|NCT01256788|102214608|FG001|NOT COMPLETED|Overall Study||8||
48647565|NCT01703221|101923571|FG000|STARTED|Phase B - (Week 25 to 52)||159||
48647566|NCT01703221|101923572|FG001|STARTED|Phase B - (Week 25 to 52)||161||
48647567|NCT01703221|101923573|FG002|STARTED|Phase B - (Week 25 to 52)||80||
48647568|NCT01703221|101923571|FG000|COMPLETED|Phase B - (Week 25 to 52)||143||
48647569|NCT01703221|101923572|FG001|COMPLETED|Phase B - (Week 25 to 52)||147||
48647570|NCT01703221|101923573|FG002|COMPLETED|Phase B - (Week 25 to 52)||75||
48647571|NCT01703221|101923571|FG000|NOT COMPLETED|Phase B - (Week 25 to 52)||16||
48647572|NCT01703221|101923572|FG001|NOT COMPLETED|Phase B - (Week 25 to 52)||14||
48647573|NCT01703221|101923573|FG002|NOT COMPLETED|Phase B - (Week 25 to 52)||5||
48765271|NCT01256788|102214609|FG002|NOT COMPLETED|Overall Study||3||
48647574|NCT03676725|101923574|FG000|STARTED|Overall Study||23||
48647575|NCT03676725|101923575|FG001|STARTED|Overall Study||14||
48765272|NCT02201953|102214610|FG000|STARTED|Overall Study||278||
48765273|NCT02201953|102214611|FG001|STARTED|Overall Study||280||
48765274|NCT02201953|102214610|FG000|COMPLETED|Overall Study||258||
48647576|NCT03676725|101923576|FG002|STARTED|Overall Study||22||
48647577|NCT03676725|101923577|FG003|STARTED|Overall Study||5||
48647578|NCT03676725|101923578|FG004|STARTED|Overall Study||15||
48647579|NCT03676725|101923579|FG005|STARTED|Overall Study||11||
48647580|NCT03676725|101923574|FG000|COMPLETED|Overall Study||23||
48647581|NCT03676725|101923575|FG001|COMPLETED|Overall Study||14||
48647582|NCT03676725|101923576|FG002|COMPLETED|Overall Study||22||
48647583|NCT03676725|101923577|FG003|COMPLETED|Overall Study||5||
48647584|NCT03676725|101923578|FG004|COMPLETED|Overall Study||15||
48647585|NCT03676725|101923579|FG005|COMPLETED|Overall Study||11||
48647586|NCT03676725|101923574|FG000|NOT COMPLETED|Overall Study||0||
48647587|NCT03676725|101923575|FG001|NOT COMPLETED|Overall Study||0||
48647588|NCT03676725|101923576|FG002|NOT COMPLETED|Overall Study||0||
48647589|NCT03676725|101923577|FG003|NOT COMPLETED|Overall Study||0||
48647590|NCT03676725|101923578|FG004|NOT COMPLETED|Overall Study||0||
48647591|NCT03676725|101923579|FG005|NOT COMPLETED|Overall Study||0||
48647592|NCT04902144|101923580|FG000|STARTED|Overall Study||6||
48647593|NCT04902144|101923580|FG000|COMPLETED|Overall Study||6||
48647594|NCT04902144|101923580|FG000|NOT COMPLETED|Overall Study||0||
48647595|NCT02018887|101923581|FG000|STARTED|Part A: Cohorts 1-2: Period 1||9||
48647596|NCT02018887|101923582|FG001|STARTED|Part A: Cohorts 1-2: Period 1||9||
48647597|NCT02018887|101923583|FG002|STARTED|Part A: Cohorts 1-2: Period 1||0||
48647598|NCT02018887|101923584|FG003|STARTED|Part A: Cohorts 1-2: Period 1||0||
48647599|NCT02018887|101923585|FG004|STARTED|Part A: Cohorts 1-2: Period 1||0||
48647600|NCT02018887|101923586|FG005|STARTED|Part A: Cohorts 1-2: Period 1||0||
48647601|NCT02018887|101923587|FG006|STARTED|Part A: Cohorts 1-2: Period 1||0||
48647602|NCT02018887|101923588|FG007|STARTED|Part A: Cohorts 1-2: Period 1||0||
48647603|NCT02018887|101923589|FG008|STARTED|Part A: Cohorts 1-2: Period 1||0||
48647604|NCT02018887|101923590|FG009|STARTED|Part A: Cohorts 1-2: Period 1||0||
48647605|NCT02018887|101923591|FG010|STARTED|Part A: Cohorts 1-2: Period 1||0||
48647606|NCT02018887|101923581|FG000|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||9||
48647607|NCT02018887|101923582|FG001|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||9||
48647608|NCT02018887|101923583|FG002|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0||
48647609|NCT02018887|101923584|FG003|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0||
48647610|NCT02018887|101923585|FG004|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0||
48647611|NCT02018887|101923586|FG005|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0||
48647612|NCT02018887|101923587|FG006|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0||
48647613|NCT02018887|101923588|FG007|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0||
48647614|NCT02018887|101923589|FG008|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0||
48647615|NCT02018887|101923590|FG009|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0||
48647616|NCT02018887|101923591|FG010|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0||
48647617|NCT02018887|101923581|FG000|COMPLETED|Part A: Cohorts 1-2: Period 1||9||
48647618|NCT02018887|101923582|FG001|COMPLETED|Part A: Cohorts 1-2: Period 1||9||
48647619|NCT02018887|101923583|FG002|COMPLETED|Part A: Cohorts 1-2: Period 1||0||
48647620|NCT02018887|101923584|FG003|COMPLETED|Part A: Cohorts 1-2: Period 1||0||
48647621|NCT02018887|101923585|FG004|COMPLETED|Part A: Cohorts 1-2: Period 1||0||
48647622|NCT02018887|101923586|FG005|COMPLETED|Part A: Cohorts 1-2: Period 1||0||
48647623|NCT02018887|101923587|FG006|COMPLETED|Part A: Cohorts 1-2: Period 1||0||
48647624|NCT02018887|101923588|FG007|COMPLETED|Part A: Cohorts 1-2: Period 1||0||
48647625|NCT02018887|101923589|FG008|COMPLETED|Part A: Cohorts 1-2: Period 1||0||
48647626|NCT02018887|101923590|FG009|COMPLETED|Part A: Cohorts 1-2: Period 1||0||
48647627|NCT02018887|101923591|FG010|COMPLETED|Part A: Cohorts 1-2: Period 1||0||
48647628|NCT02018887|101923581|FG000|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0||
48647629|NCT02018887|101923582|FG001|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0||
48647630|NCT02018887|101923583|FG002|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0||
48647631|NCT02018887|101923584|FG003|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0||
48647632|NCT02018887|101923585|FG004|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0||
48647633|NCT02018887|101923586|FG005|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0||
48647634|NCT02018887|101923587|FG006|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0||
48647635|NCT02018887|101923588|FG007|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0||
48647636|NCT02018887|101923589|FG008|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0||
48647637|NCT02018887|101923590|FG009|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0||
48647638|NCT02018887|101923591|FG010|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0||
48647639|NCT02018887|101923581|FG000|STARTED|Part A: Cohorts 1-2: Period 2||9||
48647640|NCT02018887|101923582|FG001|STARTED|Part A: Cohorts 1-2: Period 2||9||
48647641|NCT02018887|101923583|FG002|STARTED|Part A: Cohorts 1-2: Period 2||0||
48647642|NCT02018887|101923584|FG003|STARTED|Part A: Cohorts 1-2: Period 2||0||
48647643|NCT02018887|101923585|FG004|STARTED|Part A: Cohorts 1-2: Period 2||0||
48647644|NCT02018887|101923586|FG005|STARTED|Part A: Cohorts 1-2: Period 2||0||
48647645|NCT02018887|101923587|FG006|STARTED|Part A: Cohorts 1-2: Period 2||0||
48647646|NCT02018887|101923588|FG007|STARTED|Part A: Cohorts 1-2: Period 2||0||
48647647|NCT02018887|101923589|FG008|STARTED|Part A: Cohorts 1-2: Period 2||0||
48647648|NCT02018887|101923590|FG009|STARTED|Part A: Cohorts 1-2: Period 2||0||
48647649|NCT02018887|101923591|FG010|STARTED|Part A: Cohorts 1-2: Period 2||0||
48647650|NCT02018887|101923581|FG000|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||9||
48647651|NCT02018887|101923582|FG001|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||9||
48647652|NCT02018887|101923583|FG002|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0||
48647653|NCT02018887|101923584|FG003|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0||
48647654|NCT02018887|101923585|FG004|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0||
48647655|NCT02018887|101923586|FG005|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0||
48647656|NCT02018887|101923587|FG006|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0||
48647657|NCT02018887|101923588|FG007|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0||
48657046|NCT03648372|101943765|FG008|STARTED|Overall Study||6||
48765275|NCT02201953|102214611|FG001|COMPLETED|Overall Study||224||
48765276|NCT02201953|102214610|FG000|NOT COMPLETED|Overall Study||20||
48647658|NCT02018887|101923589|FG008|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0||
48647659|NCT02018887|101923590|FG009|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0||
48647660|NCT02018887|101923591|FG010|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0||
48647661|NCT02018887|101923581|FG000|COMPLETED|Part A: Cohorts 1-2: Period 2||9||
48647662|NCT02018887|101923582|FG001|COMPLETED|Part A: Cohorts 1-2: Period 2||9||
48647663|NCT02018887|101923583|FG002|COMPLETED|Part A: Cohorts 1-2: Period 2||0||
48647664|NCT02018887|101923584|FG003|COMPLETED|Part A: Cohorts 1-2: Period 2||0||
48647665|NCT02018887|101923585|FG004|COMPLETED|Part A: Cohorts 1-2: Period 2||0||
48647666|NCT02018887|101923586|FG005|COMPLETED|Part A: Cohorts 1-2: Period 2||0||
48647667|NCT02018887|101923587|FG006|COMPLETED|Part A: Cohorts 1-2: Period 2||0||
48647668|NCT02018887|101923588|FG007|COMPLETED|Part A: Cohorts 1-2: Period 2||0||
48647669|NCT02018887|101923589|FG008|COMPLETED|Part A: Cohorts 1-2: Period 2||0||
48647670|NCT02018887|101923590|FG009|COMPLETED|Part A: Cohorts 1-2: Period 2||0||
48647671|NCT02018887|101923591|FG010|COMPLETED|Part A: Cohorts 1-2: Period 2||0||
48647672|NCT02018887|101923581|FG000|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0||
48647673|NCT02018887|101923582|FG001|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0||
48647674|NCT02018887|101923583|FG002|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0||
48647675|NCT02018887|101923584|FG003|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0||
48647676|NCT02018887|101923585|FG004|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0||
48647677|NCT02018887|101923586|FG005|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0||
48647678|NCT02018887|101923587|FG006|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0||
48647679|NCT02018887|101923588|FG007|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0||
48647680|NCT02018887|101923589|FG008|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0||
48647681|NCT02018887|101923590|FG009|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0||
48647682|NCT02018887|101923591|FG010|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0||
48647683|NCT02018887|101923581|FG000|STARTED|Part A: Cohorts 1-2: Period 3||9||
48647684|NCT02018887|101923582|FG001|STARTED|Part A: Cohorts 1-2: Period 3||9||
48647685|NCT02018887|101923583|FG002|STARTED|Part A: Cohorts 1-2: Period 3||0||
48647686|NCT02018887|101923584|FG003|STARTED|Part A: Cohorts 1-2: Period 3||0||
48647687|NCT02018887|101923585|FG004|STARTED|Part A: Cohorts 1-2: Period 3||0||
48647688|NCT02018887|101923586|FG005|STARTED|Part A: Cohorts 1-2: Period 3||0||
48647689|NCT02018887|101923587|FG006|STARTED|Part A: Cohorts 1-2: Period 3||0||
48647690|NCT02018887|101923588|FG007|STARTED|Part A: Cohorts 1-2: Period 3||0||
48647691|NCT02018887|101923589|FG008|STARTED|Part A: Cohorts 1-2: Period 3||0||
48647692|NCT02018887|101923590|FG009|STARTED|Part A: Cohorts 1-2: Period 3||0||
48647693|NCT02018887|101923591|FG010|STARTED|Part A: Cohorts 1-2: Period 3||0||
48647694|NCT02018887|101923581|FG000|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||8||
48647695|NCT02018887|101923582|FG001|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||9||
48647696|NCT02018887|101923583|FG002|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0||
48647697|NCT02018887|101923584|FG003|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0||
48647698|NCT02018887|101923585|FG004|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0||
48647699|NCT02018887|101923586|FG005|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0||
48647700|NCT02018887|101923587|FG006|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0||
48647701|NCT02018887|101923588|FG007|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0||
48647702|NCT02018887|101923589|FG008|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0||
48647703|NCT02018887|101923590|FG009|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0||
48647704|NCT02018887|101923591|FG010|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0||
48647705|NCT02018887|101923581|FG000|COMPLETED|Part A: Cohorts 1-2: Period 3||8||
48647706|NCT02018887|101923582|FG001|COMPLETED|Part A: Cohorts 1-2: Period 3||9||
48647707|NCT02018887|101923583|FG002|COMPLETED|Part A: Cohorts 1-2: Period 3||0||
48647708|NCT02018887|101923584|FG003|COMPLETED|Part A: Cohorts 1-2: Period 3||0||
48647709|NCT02018887|101923585|FG004|COMPLETED|Part A: Cohorts 1-2: Period 3||0||
48647710|NCT02018887|101923586|FG005|COMPLETED|Part A: Cohorts 1-2: Period 3||0||
48647711|NCT02018887|101923587|FG006|COMPLETED|Part A: Cohorts 1-2: Period 3||0||
48647712|NCT02018887|101923588|FG007|COMPLETED|Part A: Cohorts 1-2: Period 3||0||
48647713|NCT02018887|101923589|FG008|COMPLETED|Part A: Cohorts 1-2: Period 3||0||
48647714|NCT02018887|101923590|FG009|COMPLETED|Part A: Cohorts 1-2: Period 3||0||
48647715|NCT02018887|101923591|FG010|COMPLETED|Part A: Cohorts 1-2: Period 3||0||
48647716|NCT02018887|101923581|FG000|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||1||
48647717|NCT02018887|101923582|FG001|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0||
48647718|NCT02018887|101923583|FG002|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0||
48647719|NCT02018887|101923584|FG003|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0||
48647720|NCT02018887|101923585|FG004|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0||
48647721|NCT02018887|101923586|FG005|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0||
48647722|NCT02018887|101923587|FG006|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0||
48647723|NCT02018887|101923588|FG007|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0||
48647724|NCT02018887|101923589|FG008|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0||
48647725|NCT02018887|101923590|FG009|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0||
48647726|NCT02018887|101923591|FG010|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0||
48647727|NCT02018887|101923581|FG000|STARTED|Part B: Cohorts 3-7 Overall||0||
48647728|NCT02018887|101923582|FG001|STARTED|Part B: Cohorts 3-7 Overall||0||
48647729|NCT02018887|101923583|FG002|STARTED|Part B: Cohorts 3-7 Overall||15||
48647730|NCT02018887|101923584|FG003|STARTED|Part B: Cohorts 3-7 Overall||9||
48647731|NCT02018887|101923585|FG004|STARTED|Part B: Cohorts 3-7 Overall||9||
48647732|NCT02018887|101923586|FG005|STARTED|Part B: Cohorts 3-7 Overall||9||
48647733|NCT02018887|101923587|FG006|STARTED|Part B: Cohorts 3-7 Overall||9||
48647734|NCT02018887|101923588|FG007|STARTED|Part B: Cohorts 3-7 Overall||9||
48647735|NCT02018887|101923589|FG008|STARTED|Part B: Cohorts 3-7 Overall||0||
48647736|NCT02018887|101923590|FG009|STARTED|Part B: Cohorts 3-7 Overall||0||
48647737|NCT02018887|101923591|FG010|STARTED|Part B: Cohorts 3-7 Overall||0||
48647738|NCT02018887|101923581|FG000|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0||
48647739|NCT02018887|101923582|FG001|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0||
48647740|NCT02018887|101923583|FG002|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||15||
48647741|NCT02018887|101923584|FG003|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9||
48647742|NCT02018887|101923585|FG004|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9||
48647743|NCT02018887|101923586|FG005|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9||
48647744|NCT02018887|101923587|FG006|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9||
48647745|NCT02018887|101923588|FG007|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9||
48647746|NCT02018887|101923589|FG008|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0||
48647747|NCT02018887|101923590|FG009|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0||
48647748|NCT02018887|101923591|FG010|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0||
48647749|NCT02018887|101923581|FG000|COMPLETED|Part B: Cohorts 3-7 Overall||0||
48647750|NCT02018887|101923582|FG001|COMPLETED|Part B: Cohorts 3-7 Overall||0||
48647751|NCT02018887|101923583|FG002|COMPLETED|Part B: Cohorts 3-7 Overall||15||
48647752|NCT02018887|101923584|FG003|COMPLETED|Part B: Cohorts 3-7 Overall||9||
48647753|NCT02018887|101923585|FG004|COMPLETED|Part B: Cohorts 3-7 Overall||8||
48647754|NCT02018887|101923586|FG005|COMPLETED|Part B: Cohorts 3-7 Overall||9||
48647755|NCT02018887|101923587|FG006|COMPLETED|Part B: Cohorts 3-7 Overall||8||
48647756|NCT02018887|101923588|FG007|COMPLETED|Part B: Cohorts 3-7 Overall||5||
48647757|NCT02018887|101923589|FG008|COMPLETED|Part B: Cohorts 3-7 Overall||0||
48647758|NCT02018887|101923590|FG009|COMPLETED|Part B: Cohorts 3-7 Overall||0||
48647759|NCT02018887|101923591|FG010|COMPLETED|Part B: Cohorts 3-7 Overall||0||
48647760|NCT02018887|101923581|FG000|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0||
48647761|NCT02018887|101923582|FG001|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0||
48647762|NCT02018887|101923583|FG002|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0||
48647763|NCT02018887|101923584|FG003|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0||
48647764|NCT02018887|101923585|FG004|NOT COMPLETED|Part B: Cohorts 3-7 Overall||1||
48647765|NCT02018887|101923586|FG005|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0||
48647766|NCT02018887|101923587|FG006|NOT COMPLETED|Part B: Cohorts 3-7 Overall||1||
48647767|NCT02018887|101923588|FG007|NOT COMPLETED|Part B: Cohorts 3-7 Overall||4||
48647768|NCT02018887|101923589|FG008|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0||
48647769|NCT02018887|101923590|FG009|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0||
48647770|NCT02018887|101923591|FG010|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0||
48647771|NCT02018887|101923581|FG000|STARTED|Part C: Cohort 8 Overall||0||
48647772|NCT02018887|101923582|FG001|STARTED|Part C: Cohort 8 Overall||0||
48647773|NCT02018887|101923583|FG002|STARTED|Part C: Cohort 8 Overall||0||
48647774|NCT02018887|101923584|FG003|STARTED|Part C: Cohort 8 Overall||0||
48647775|NCT02018887|101923585|FG004|STARTED|Part C: Cohort 8 Overall||0||
48647776|NCT02018887|101923586|FG005|STARTED|Part C: Cohort 8 Overall||0||
48647777|NCT02018887|101923587|FG006|STARTED|Part C: Cohort 8 Overall||0||
48647778|NCT02018887|101923588|FG007|STARTED|Part C: Cohort 8 Overall||0||
48647779|NCT02018887|101923589|FG008|STARTED|Part C: Cohort 8 Overall||10||
48647780|NCT02018887|101923590|FG009|STARTED|Part C: Cohort 8 Overall||4||
48647781|NCT02018887|101923591|FG010|STARTED|Part C: Cohort 8 Overall||7||
48647782|NCT02018887|101923581|FG000|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0||
48647783|NCT02018887|101923582|FG001|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0||
48647784|NCT02018887|101923583|FG002|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0||
48647785|NCT02018887|101923584|FG003|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0||
48647786|NCT02018887|101923585|FG004|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0||
48647787|NCT02018887|101923586|FG005|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0||
48647788|NCT02018887|101923587|FG006|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0||
48647789|NCT02018887|101923588|FG007|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0||
48647790|NCT02018887|101923589|FG008|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||10||
48647791|NCT02018887|101923590|FG009|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||4||
48647792|NCT02018887|101923591|FG010|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||7||
48647793|NCT02018887|101923581|FG000|COMPLETED|Part C: Cohort 8 Overall||0||
48647794|NCT02018887|101923582|FG001|COMPLETED|Part C: Cohort 8 Overall||0||
48647795|NCT02018887|101923583|FG002|COMPLETED|Part C: Cohort 8 Overall||0||
48647796|NCT02018887|101923584|FG003|COMPLETED|Part C: Cohort 8 Overall||0||
48647797|NCT02018887|101923585|FG004|COMPLETED|Part C: Cohort 8 Overall||0||
48647798|NCT02018887|101923586|FG005|COMPLETED|Part C: Cohort 8 Overall||0||
48647799|NCT02018887|101923587|FG006|COMPLETED|Part C: Cohort 8 Overall||0||
48647800|NCT02018887|101923588|FG007|COMPLETED|Part C: Cohort 8 Overall||0||
48647801|NCT02018887|101923589|FG008|COMPLETED|Part C: Cohort 8 Overall||7||
48647802|NCT02018887|101923590|FG009|COMPLETED|Part C: Cohort 8 Overall||1||
48647803|NCT02018887|101923591|FG010|COMPLETED|Part C: Cohort 8 Overall||6||
48647804|NCT02018887|101923581|FG000|NOT COMPLETED|Part C: Cohort 8 Overall||0||
48647805|NCT02018887|101923582|FG001|NOT COMPLETED|Part C: Cohort 8 Overall||0||
48647806|NCT02018887|101923583|FG002|NOT COMPLETED|Part C: Cohort 8 Overall||0||
48647807|NCT02018887|101923584|FG003|NOT COMPLETED|Part C: Cohort 8 Overall||0||
48647808|NCT02018887|101923585|FG004|NOT COMPLETED|Part C: Cohort 8 Overall||0||
48647809|NCT02018887|101923586|FG005|NOT COMPLETED|Part C: Cohort 8 Overall||0||
48647810|NCT02018887|101923587|FG006|NOT COMPLETED|Part C: Cohort 8 Overall||0||
48647811|NCT02018887|101923588|FG007|NOT COMPLETED|Part C: Cohort 8 Overall||0||
48647812|NCT02018887|101923589|FG008|NOT COMPLETED|Part C: Cohort 8 Overall||3||
48647813|NCT02018887|101923590|FG009|NOT COMPLETED|Part C: Cohort 8 Overall||3||
48647814|NCT02018887|101923591|FG010|NOT COMPLETED|Part C: Cohort 8 Overall||1||
48647815|NCT01215240|101923592|FG000|STARTED|Overall Study||10||
48647816|NCT01215240|101923593|FG001|STARTED|Overall Study||12||
48647817|NCT01215240|101923592|FG000|COMPLETED|Overall Study||10||
48647818|NCT01215240|101923593|FG001|COMPLETED|Overall Study||12||
48647819|NCT01215240|101923592|FG000|NOT COMPLETED|Overall Study||0||
48647820|NCT01215240|101923593|FG001|NOT COMPLETED|Overall Study||0||
48647821|NCT01659541|101923594|FG000|STARTED|Overall Study||12||
48647822|NCT01659541|101923594|FG000|COMPLETED|Overall Study||11||
48647823|NCT01659541|101923594|FG000|NOT COMPLETED|Overall Study||1||
48647824|NCT00981175|101923595|FG000|STARTED|Primary Dose Vaccination||101||
48647825|NCT00981175|101923596|FG001|STARTED|Primary Dose Vaccination||101||
48647826|NCT00981175|101923595|FG000|COMPLETED|Primary Dose Vaccination||98||
48647827|NCT00981175|101923596|FG001|COMPLETED|Primary Dose Vaccination||99||
48647828|NCT00981175|101923595|FG000|NOT COMPLETED|Primary Dose Vaccination||3||
48647829|NCT00981175|101923596|FG001|NOT COMPLETED|Primary Dose Vaccination||2||
48647830|NCT00981175|101923595|FG000|STARTED|Booster Dose Vaccination||55||
48647831|NCT00981175|101923596|FG001|STARTED|Booster Dose Vaccination||43||
48647832|NCT00981175|101923595|FG000|COMPLETED|Booster Dose Vaccination||53||
48647833|NCT00981175|101923596|FG001|COMPLETED|Booster Dose Vaccination||40||
48647834|NCT00981175|101923595|FG000|NOT COMPLETED|Booster Dose Vaccination||2||
48647835|NCT00981175|101923596|FG001|NOT COMPLETED|Booster Dose Vaccination||3||
48647836|NCT01016015|101923597|FG000|STARTED|Overall Study||178||
48647837|NCT01016015|101923597|FG000|COMPLETED|Overall Study||159||
48647838|NCT01016015|101923597|FG000|NOT COMPLETED|Overall Study||19||
48647839|NCT01552889|101923598|FG000|STARTED|Overall Study||101||
48647840|NCT01552889|101923599|FG001|STARTED|Overall Study||100||
48647841|NCT01552889|101923598|FG000|COMPLETED|Overall Study||90||
48647842|NCT01552889|101923599|FG001|COMPLETED|Overall Study||95||
48647843|NCT01552889|101923598|FG000|NOT COMPLETED|Overall Study||11||
48647844|NCT01552889|101923599|FG001|NOT COMPLETED|Overall Study||5||
48647845|NCT03362957|101923600|FG000|STARTED|Overall Study||14||
48647846|NCT03362957|101923601|FG001|STARTED|Overall Study||7||
48647847|NCT03362957|101923600|FG000|Crossover to Receive GAE Procedure|Overall Study||0||
48647848|NCT03362957|101923601|FG001|Crossover to Receive GAE Procedure|Overall Study||7||
48647849|NCT03362957|101923600|FG000|COMPLETED|Overall Study||14||
48647850|NCT03362957|101923601|FG001|COMPLETED|Overall Study||7||
48647851|NCT03362957|101923600|FG000|NOT COMPLETED|Overall Study||0||
48647852|NCT03362957|101923601|FG001|NOT COMPLETED|Overall Study||0||
48647853|NCT02400580|101923602|FG000|STARTED|Overall Study||91||
48647854|NCT02400580|101923603|FG001|STARTED|Overall Study||92||
48647855|NCT02400580|101923602|FG000|COMPLETED|Overall Study||89||
48647856|NCT02400580|101923603|FG001|COMPLETED|Overall Study||91||
48647857|NCT02400580|101923602|FG000|NOT COMPLETED|Overall Study||2||
48647858|NCT02400580|101923603|FG001|NOT COMPLETED|Overall Study||1||
48647859|NCT00977184|101923604|FG000|STARTED|Overall Study||13||
48647860|NCT00977184|101923605|FG001|STARTED|Overall Study||13||
48647861|NCT00977184|101923604|FG000|COMPLETED|Overall Study||13||
48647862|NCT00977184|101923605|FG001|COMPLETED|Overall Study||13||
48647863|NCT00977184|101923604|FG000|NOT COMPLETED|Overall Study||0||
48647864|NCT00977184|101923605|FG001|NOT COMPLETED|Overall Study||0||
48647865|NCT04772547|101923606|FG000|STARTED|Overall Study||6||
48647866|NCT04772547|101923606|FG000|COMPLETED|Overall Study||6||
48647867|NCT04772547|101923606|FG000|NOT COMPLETED|Overall Study||0||
48647868|NCT00976391|101923607|FG000|STARTED|Treatment Period (52 Weeks)||285||
48647869|NCT00976391|101923608|FG001|STARTED|Treatment Period (52 Weeks)||281||
48647870|NCT00976391|101923607|FG000|COMPLETED|Treatment Period (52 Weeks)||243||
48647871|NCT00976391|101923608|FG001|COMPLETED|Treatment Period (52 Weeks)||242||
48647872|NCT00976391|101923607|FG000|NOT COMPLETED|Treatment Period (52 Weeks)||42||
48647873|NCT00976391|101923608|FG001|NOT COMPLETED|Treatment Period (52 Weeks)||39||
48647874|NCT00976391|101923607|FG000|STARTED|Follow-up Period (8 Weeks)||285||
48647875|NCT00976391|101923608|FG001|STARTED|Follow-up Period (8 Weeks)||281||
48647876|NCT00976391|101923607|FG000|COMPLETED|Follow-up Period (8 Weeks)||256||
48647877|NCT00976391|101923608|FG001|COMPLETED|Follow-up Period (8 Weeks)||247||
48647878|NCT00976391|101923607|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||29||
48647879|NCT00976391|101923608|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||34||
48647880|NCT01058005|101923609|FG000|STARTED|Overall Study||38||
48647881|NCT01058005|101923610|FG001|STARTED|Overall Study||25||
48647882|NCT01058005|101923611|FG002|STARTED|Overall Study||21||
48647883|NCT01058005|101923609|FG000|Dosed With Study Treatment|Overall Study||36||
48647884|NCT01058005|101923610|FG001|Dosed With Study Treatment|Overall Study||22||
48647885|NCT01058005|101923611|FG002|Dosed With Study Treatment|Overall Study||17||
48647886|NCT01058005|101923609|FG000|COMPLETED|Overall Study||0||
48647887|NCT01058005|101923610|FG001|COMPLETED|Overall Study||0||
48647888|NCT01058005|101923611|FG002|COMPLETED|Overall Study||1||
48647889|NCT01058005|101923609|FG000|NOT COMPLETED|Overall Study||38||
48647890|NCT01058005|101923610|FG001|NOT COMPLETED|Overall Study||25||
48647891|NCT01058005|101923611|FG002|NOT COMPLETED|Overall Study||20||
48647892|NCT03780387|101923612|FG000|STARTED|Overall Study||1||
48647893|NCT03780387|101923612|FG000|COMPLETED|Overall Study||1||
48647894|NCT03780387|101923612|FG000|NOT COMPLETED|Overall Study||0||
48647895|NCT01696214|101923613|FG000|STARTED|Overall Study||5||
48647896|NCT01696214|101923614|FG001|STARTED|Overall Study||5||
48647897|NCT01696214|101923615|FG002|STARTED|Overall Study||5||
48647898|NCT01696214|101923616|FG003|STARTED|Overall Study||5||
48647899|NCT01696214|101923613|FG000|COMPLETED|Overall Study||4||
48647900|NCT01696214|101923614|FG001|COMPLETED|Overall Study||5||
48647901|NCT01696214|101923615|FG002|COMPLETED|Overall Study||5||
48647902|NCT01696214|101923616|FG003|COMPLETED|Overall Study||5||
48647903|NCT01696214|101923613|FG000|NOT COMPLETED|Overall Study||1||
48647904|NCT01696214|101923614|FG001|NOT COMPLETED|Overall Study||0||
48647905|NCT01696214|101923615|FG002|NOT COMPLETED|Overall Study||0||
48647906|NCT01696214|101923616|FG003|NOT COMPLETED|Overall Study||0||
48647907|NCT00142597|101923617|FG000|STARTED|Overall Study||23||
48647908|NCT00142597|101923618|FG001|STARTED|Overall Study||23||
48647909|NCT00142597|101923617|FG000|COMPLETED|Overall Study||20||
48647910|NCT00142597|101923618|FG001|COMPLETED|Overall Study||22||
48647911|NCT00142597|101923617|FG000|NOT COMPLETED|Overall Study||3||
48647912|NCT00142597|101923618|FG001|NOT COMPLETED|Overall Study||1||
48647913|NCT01724190|101923619|FG000|STARTED|Overall Study||19||
48647914|NCT01724190|101923620|FG001|STARTED|Overall Study||18||
48647915|NCT01724190|101923619|FG000|COMPLETED|Overall Study||15||
48647916|NCT01724190|101923620|FG001|COMPLETED|Overall Study||14||
48647917|NCT01724190|101923619|FG000|NOT COMPLETED|Overall Study||4||
48647918|NCT01724190|101923620|FG001|NOT COMPLETED|Overall Study||4||
48647919|NCT01769365|101923621|FG000|STARTED|Overall Study||102||
48647920|NCT01769365|101923622|FG001|STARTED|Overall Study||102||
48647921|NCT01769365|101923623|FG002|STARTED|Overall Study||103||
48647922|NCT01769365|101923621|FG000|COMPLETED|Overall Study||102||
48647923|NCT01769365|101923622|FG001|COMPLETED|Overall Study||100||
48647924|NCT01769365|101923623|FG002|COMPLETED|Overall Study||101||
48647925|NCT01769365|101923621|FG000|NOT COMPLETED|Overall Study||0||
48647926|NCT01769365|101923622|FG001|NOT COMPLETED|Overall Study||2||
48647927|NCT01769365|101923623|FG002|NOT COMPLETED|Overall Study||2||
48647928|NCT01835756|101923624|FG000|STARTED|Overall Study||31||
48647929|NCT01835756|101923625|FG001|STARTED|Overall Study||31||
48647930|NCT01835756|101923624|FG000|COMPLETED|Overall Study||31||
48647931|NCT01835756|101923625|FG001|COMPLETED|Overall Study||31||
48647932|NCT01835756|101923624|FG000|NOT COMPLETED|Overall Study||0||
48647933|NCT01835756|101923625|FG001|NOT COMPLETED|Overall Study||0||
48647934|NCT03336866|101923626|FG000|STARTED|Overall Study||20||
48647935|NCT03336866|101923627|FG001|STARTED|Overall Study||18||
48647936|NCT03336866|101923628|FG002|STARTED|Overall Study||18||
48647937|NCT03336866|101923626|FG000|COMPLETED|Overall Study||17||
48647938|NCT03336866|101923627|FG001|COMPLETED|Overall Study||17||
48647939|NCT03336866|101923628|FG002|COMPLETED|Overall Study||14||
48647940|NCT03336866|101923626|FG000|NOT COMPLETED|Overall Study||3||
48647941|NCT03336866|101923627|FG001|NOT COMPLETED|Overall Study||1||
48647942|NCT03336866|101923628|FG002|NOT COMPLETED|Overall Study||4||
48647943|NCT03203512|101923629|FG000|STARTED|First Intervention (12 Weeks)||20||
48647944|NCT03203512|101923630|FG001|STARTED|First Intervention (12 Weeks)||20||
48647945|NCT03203512|101923629|FG000|COMPLETED|First Intervention (12 Weeks)||20||
48647946|NCT03203512|101923630|FG001|COMPLETED|First Intervention (12 Weeks)||20||
48647947|NCT03203512|101923629|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0||
48647948|NCT03203512|101923630|FG001|NOT COMPLETED|First Intervention (12 Weeks)||0||
48647949|NCT03203512|101923629|FG000|STARTED|Washout (12 Weeks)||20||
48647950|NCT03203512|101923630|FG001|STARTED|Washout (12 Weeks)||20||
48647951|NCT03203512|101923629|FG000|COMPLETED|Washout (12 Weeks)||20||
48647952|NCT03203512|101923630|FG001|COMPLETED|Washout (12 Weeks)||20||
48647953|NCT03203512|101923629|FG000|NOT COMPLETED|Washout (12 Weeks)||0||
48647954|NCT03203512|101923630|FG001|NOT COMPLETED|Washout (12 Weeks)||0||
48647955|NCT03203512|101923629|FG000|STARTED|Second Intervention (12 Weeks)||20||
48647956|NCT03203512|101923630|FG001|STARTED|Second Intervention (12 Weeks)||20||
48647957|NCT03203512|101923629|FG000|COMPLETED|Second Intervention (12 Weeks)||20||
48647958|NCT03203512|101923630|FG001|COMPLETED|Second Intervention (12 Weeks)||20||
48647959|NCT03203512|101923629|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0||
48647960|NCT03203512|101923630|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0||
48647961|NCT00530075|101923631|FG000|STARTED|Overall Study||45||
48647962|NCT00530075|101923631|FG000|COMPLETED|Overall Study||38||
48647963|NCT00530075|101923631|FG000|NOT COMPLETED|Overall Study||7||
48647964|NCT03174275|101923632|FG000|STARTED|Overall Study (Until End of Surgery)||39||
48647965|NCT03174275|101923632|FG000|COMPLETED|Overall Study (Until End of Surgery)||25||
48647966|NCT03174275|101923632|FG000|NOT COMPLETED|Overall Study (Until End of Surgery)||14||
48647967|NCT03174275|101923632|FG000|STARTED|Adjuvant Chemotherapy||21||
48647968|NCT03174275|101923632|FG000|COMPLETED|Adjuvant Chemotherapy||13||
48647969|NCT03174275|101923632|FG000|NOT COMPLETED|Adjuvant Chemotherapy||8||
48647970|NCT03174275|101923632|FG000|STARTED|Adjuvant Durvalumab||35||
48647971|NCT03174275|101923632|FG000|COMPLETED|Adjuvant Durvalumab||25||
48647972|NCT03174275|101923632|FG000|NOT COMPLETED|Adjuvant Durvalumab||10||
48647973|NCT03174275|101923632|FG000|STARTED|Adjuvant Radiotherapy||21||
48647974|NCT03174275|101923632|FG000|COMPLETED|Adjuvant Radiotherapy||14||
48647975|NCT03174275|101923632|FG000|NOT COMPLETED|Adjuvant Radiotherapy||7||
48647976|NCT01913470|101923633|FG000|STARTED|Overall Study||5||
48647977|NCT01913470|101923634|FG001|STARTED|Overall Study||7||
48647978|NCT01913470|101923633|FG000|COMPLETED|Overall Study||5||
48647979|NCT01913470|101923634|FG001|COMPLETED|Overall Study||4||
48647980|NCT01913470|101923633|FG000|NOT COMPLETED|Overall Study||0||
48647981|NCT01913470|101923634|FG001|NOT COMPLETED|Overall Study||3||
48647982|NCT03753542|101923635|FG000|STARTED|Overall Study||50||
48647983|NCT03753542|101923636|FG001|STARTED|Overall Study||50||
48647984|NCT03753542|101923635|FG000|COMPLETED|Overall Study||41||
48647985|NCT03753542|101923636|FG001|COMPLETED|Overall Study||36||
48647986|NCT03753542|101923635|FG000|NOT COMPLETED|Overall Study||9||
48647987|NCT03753542|101923636|FG001|NOT COMPLETED|Overall Study||14||
48647988|NCT03389750|101923637|FG000|STARTED|Overall Study||16||
48647989|NCT03389750|101923637|FG000|Oxycodone|Overall Study||8||
48647990|NCT03389750|101923637|FG000|Oxymorphone|Overall Study||8||
48647991|NCT03389750|101923637|FG000|Hydromorphone|Overall Study||8||
48647992|NCT03389750|101923637|FG000|Placebo|Overall Study||8||
48647993|NCT03389750|101923637|FG000|COMPLETED|Overall Study||8||
48647994|NCT03389750|101923637|FG000|NOT COMPLETED|Overall Study||8||
48647995|NCT03684057|101923638|FG000|STARTED|Overall Study||40||
48647996|NCT03684057|101923639|FG001|STARTED|Overall Study||40||
48647997|NCT03684057|101923638|FG000|COMPLETED|Overall Study||36||
48647998|NCT03684057|101923639|FG001|COMPLETED|Overall Study||35||
48647999|NCT03684057|101923638|FG000|NOT COMPLETED|Overall Study||4||
48648000|NCT03684057|101923639|FG001|NOT COMPLETED|Overall Study||5||
48648001|NCT00412451|101923640|FG000|STARTED|Overall Study||8||
48648002|NCT00412451|101923641|FG001|STARTED|Overall Study||15||
48648003|NCT00412451|101923642|FG002|STARTED|Overall Study||15||
48648004|NCT00412451|101923643|FG003|STARTED|Overall Study||13||
48648005|NCT00412451|101923640|FG000|COMPLETED|Overall Study||8||
48648006|NCT00412451|101923641|FG001|COMPLETED|Overall Study||15||
48648007|NCT00412451|101923642|FG002|COMPLETED|Overall Study||14||
48648008|NCT00412451|101923643|FG003|COMPLETED|Overall Study||11||
48648009|NCT00412451|101923640|FG000|NOT COMPLETED|Overall Study||0||
48648010|NCT00412451|101923641|FG001|NOT COMPLETED|Overall Study||0||
48648011|NCT00412451|101923642|FG002|NOT COMPLETED|Overall Study||1||
48648012|NCT00412451|101923643|FG003|NOT COMPLETED|Overall Study||2||
48648013|NCT02827708|101923644|FG000|STARTED|Overall Study||163||
48648014|NCT02827708|101923645|FG001|STARTED|Overall Study||161||
48648015|NCT02827708|101923644|FG000|Full Analysis Set (FAS)|Overall Study||163||
48648016|NCT02827708|101923645|FG001|Full Analysis Set (FAS)|Overall Study||161||
48648017|NCT02827708|101923644|FG000|Safety Analysis Set (SAS)|Overall Study||163||
48648018|NCT02827708|101923645|FG001|Safety Analysis Set (SAS)|Overall Study||161||
48648019|NCT02827708|101923644|FG000|COMPLETED|Overall Study||158||
48648020|NCT02827708|101923645|FG001|COMPLETED|Overall Study||156||
48648021|NCT02827708|101923644|FG000|NOT COMPLETED|Overall Study||5||
48648022|NCT02827708|101923645|FG001|NOT COMPLETED|Overall Study||5||
48648023|NCT01370642|101923646|FG000|STARTED|Overall Study||98||
48648024|NCT01370642|101923647|FG001|STARTED|Overall Study||98||
48648025|NCT01370642|101923648|FG002|STARTED|Overall Study||98||
48648026|NCT01370642|101923646|FG000|FAS Population|Overall Study||98||
48648027|NCT01370642|101923647|FG001|FAS Population|Overall Study||97||
48648028|NCT01370642|101923648|FG002|FAS Population|Overall Study||98||
48648029|NCT01370642|101923646|FG000|COMPLETED|Overall Study||90||
48648030|NCT01370642|101923647|FG001|COMPLETED|Overall Study||92||
48648031|NCT01370642|101923648|FG002|COMPLETED|Overall Study||69||
48648032|NCT01370642|101923646|FG000|NOT COMPLETED|Overall Study||8||
48648033|NCT01370642|101923647|FG001|NOT COMPLETED|Overall Study||6||
48648034|NCT01370642|101923648|FG002|NOT COMPLETED|Overall Study||29||
48648035|NCT00835978|101923649|FG000|STARTED|Overall Study||56||
48648036|NCT00835978|101923650|FG001|STARTED|Overall Study||56||
48648037|NCT00835978|101923651|FG002|STARTED|Overall Study||91||
48648038|NCT00835978|101923652|FG003|STARTED|Overall Study||10||
48648039|NCT00835978|101923649|FG000|Treated|Overall Study||56||
48648040|NCT00835978|101923650|FG001|Treated|Overall Study||56||
48648041|NCT00835978|101923651|FG002|Treated|Overall Study||91||
48648042|NCT00835978|101923652|FG003|Treated|Overall Study||10||
48648043|NCT00835978|101923649|FG000|COMPLETED|Overall Study||0||
48648044|NCT00835978|101923650|FG001|COMPLETED|Overall Study||0||
48648045|NCT00835978|101923651|FG002|COMPLETED|Overall Study||0||
48648046|NCT00835978|101923652|FG003|COMPLETED|Overall Study||0||
48648047|NCT00835978|101923649|FG000|NOT COMPLETED|Overall Study||56||
48648048|NCT00835978|101923650|FG001|NOT COMPLETED|Overall Study||56||
48648049|NCT00835978|101923651|FG002|NOT COMPLETED|Overall Study||91||
48648050|NCT00835978|101923652|FG003|NOT COMPLETED|Overall Study||10||
48648051|NCT02287025|101923653|FG000|STARTED|Overall Study||12||6
48648052|NCT02287025|101923654|FG001|STARTED|Overall Study||11||4
48648053|NCT02287025|101923653|FG000|COMPLETED|Overall Study||2||6
48648054|NCT02287025|101923654|FG001|COMPLETED|Overall Study||2||4
48648055|NCT02287025|101923653|FG000|NOT COMPLETED|Overall Study||10||0
48648056|NCT02287025|101923654|FG001|NOT COMPLETED|Overall Study||9||0
48648057|NCT00126737|101923655|FG000|STARTED|Overall Study||28||
48648058|NCT00126737|101923656|FG001|STARTED|Overall Study||27||
48648059|NCT00126737|101923657|FG002|STARTED|Overall Study||30||
48648060|NCT00126737|101923658|FG003|STARTED|Overall Study||25||
48648061|NCT00126737|101923655|FG000|COMPLETED|Overall Study||22||
48648062|NCT00126737|101923656|FG001|COMPLETED|Overall Study||24||
48648063|NCT00126737|101923657|FG002|COMPLETED|Overall Study||24||
48648064|NCT00126737|101923658|FG003|COMPLETED|Overall Study||18||
48648065|NCT00126737|101923655|FG000|NOT COMPLETED|Overall Study||6||
48648066|NCT00126737|101923656|FG001|NOT COMPLETED|Overall Study||3||
48648067|NCT00126737|101923657|FG002|NOT COMPLETED|Overall Study||6||
48648068|NCT00126737|101923658|FG003|NOT COMPLETED|Overall Study||7||
48648069|NCT00924482|101923659|FG000|STARTED|Overall Study||261||
48648070|NCT00924482|101923659|FG000|COMPLETED|Overall Study||261||
48648071|NCT00924482|101923659|FG000|NOT COMPLETED|Overall Study||0||
48648072|NCT01601977|101923660|FG000|STARTED|Overall Study||10||
48648073|NCT01601977|101923660|FG000|COMPLETED|Overall Study||10||
48648074|NCT01601977|101923660|FG000|NOT COMPLETED|Overall Study||0||
48648075|NCT00985790|101923661|FG000|STARTED|Overall Study||298||
48648076|NCT00985790|101923662|FG001|STARTED|Overall Study||301||
48648077|NCT00985790|101923661|FG000|COMPLETED|Overall Study||291||
48648078|NCT00985790|101923662|FG001|COMPLETED|Overall Study||293||
48648079|NCT00985790|101923661|FG000|NOT COMPLETED|Overall Study||7||
48648080|NCT00985790|101923662|FG001|NOT COMPLETED|Overall Study||8||
48648081|NCT02383173|101923663|FG000|STARTED|Overall Study||88||23
48648082|NCT02383173|101923664|FG001|STARTED|Overall Study||46||24
48648083|NCT02383173|101923663|FG000|COMPLETED|Overall Study||88||23
48648084|NCT02383173|101923664|FG001|COMPLETED|Overall Study||44||23
48648085|NCT02383173|101923663|FG000|NOT COMPLETED|Overall Study||0||0
48648086|NCT02383173|101923664|FG001|NOT COMPLETED|Overall Study||2||1
48648087|NCT01283386|101923665|FG000|STARTED|Overall Study||10||
48648088|NCT01283386|101923666|FG001|STARTED|Overall Study||16||
48648089|NCT01283386|101923665|FG000|COMPLETED|Overall Study||2||
48648090|NCT01283386|101923666|FG001|COMPLETED|Overall Study||4||
48648091|NCT01283386|101923665|FG000|NOT COMPLETED|Overall Study||8||
48648092|NCT01283386|101923666|FG001|NOT COMPLETED|Overall Study||12||
48648093|NCT01623154|101923667|FG000|STARTED|Overall Study||99||
48648094|NCT01623154|101923667|FG000|Available for Analysis|Overall Study||95||
48648095|NCT01623154|101923667|FG000|COMPLETED|Overall Study||95||
48648096|NCT01623154|101923667|FG000|NOT COMPLETED|Overall Study||4||
48648097|NCT01027416|101923668|FG000|STARTED|Overall Study||31||
48648098|NCT01027416|101923669|FG001|STARTED|Overall Study||28||
48648099|NCT01027416|101923668|FG000|COMPLETED|Overall Study||30||
48648100|NCT01027416|101923669|FG001|COMPLETED|Overall Study||23||
48648101|NCT01027416|101923668|FG000|NOT COMPLETED|Overall Study||1||
48648102|NCT01027416|101923669|FG001|NOT COMPLETED|Overall Study||5||
48648103|NCT02313272|101923670|FG000|STARTED|Overall Study||3||
48648104|NCT02313272|101923671|FG001|STARTED|Overall Study||16||
48648105|NCT02313272|101923672|FG002|STARTED|Overall Study||13||
48648106|NCT02313272|101923670|FG000|COMPLETED|Overall Study||3||
48648107|NCT02313272|101923671|FG001|COMPLETED|Overall Study||16||
48765277|NCT02201953|102214611|FG001|NOT COMPLETED|Overall Study||56||
48765278|NCT04369404|102214612|FG000|STARTED|Overall Study||33||
48765279|NCT04369404|102214613|FG001|STARTED|Overall Study||33||
48648108|NCT02313272|101923672|FG002|COMPLETED|Overall Study||13||
48648109|NCT02313272|101923670|FG000|NOT COMPLETED|Overall Study||0||
48648110|NCT02313272|101923671|FG001|NOT COMPLETED|Overall Study||0||
48648111|NCT02313272|101923672|FG002|NOT COMPLETED|Overall Study||0||
48648112|NCT01960842|101923673|FG000|STARTED|Overall Study||31||
48648113|NCT01960842|101923673|FG000|COMPLETED|Overall Study||28||
48648114|NCT01960842|101923673|FG000|NOT COMPLETED|Overall Study||3||
48648115|NCT02371252|101923674|FG000|STARTED|Overall Study||70||
48648116|NCT02371252|101923675|FG001|STARTED|Overall Study||70||
48648117|NCT02371252|101923674|FG000|COMPLETED|Overall Study||70||
48648118|NCT02371252|101923675|FG001|COMPLETED|Overall Study||70||
48648119|NCT02371252|101923674|FG000|NOT COMPLETED|Overall Study||0||
48648120|NCT02371252|101923675|FG001|NOT COMPLETED|Overall Study||0||
48648121|NCT00090402|101923676|FG000|STARTED|Overall Study||13||
48648122|NCT00090402|101923677|FG001|STARTED|Overall Study||13||
48648123|NCT00090402|101923678|FG002|STARTED|Overall Study||13||
48648124|NCT00090402|101923676|FG000|COMPLETED|Overall Study||11||
48648125|NCT00090402|101923677|FG001|COMPLETED|Overall Study||11||
48648126|NCT00090402|101923678|FG002|COMPLETED|Overall Study||12||
48648127|NCT00090402|101923676|FG000|NOT COMPLETED|Overall Study||2||
48648128|NCT00090402|101923677|FG001|NOT COMPLETED|Overall Study||2||
48648129|NCT00090402|101923678|FG002|NOT COMPLETED|Overall Study||1||
48648130|NCT01083472|101923679|FG000|STARTED|Overall Study||18||
48648131|NCT01083472|101923680|FG001|STARTED|Overall Study||19||
48648132|NCT01083472|101923679|FG000|COMPLETED|Overall Study||18||
48648133|NCT01083472|101923680|FG001|COMPLETED|Overall Study||19||
48765280|NCT04369404|102214612|FG000|COMPLETED|Overall Study||33||
48765281|NCT04369404|102214613|FG001|COMPLETED|Overall Study||33||
48765282|NCT04369404|102214612|FG000|NOT COMPLETED|Overall Study||0||
48648134|NCT01083472|101923679|FG000|NOT COMPLETED|Overall Study||0||
48648135|NCT01083472|101923680|FG001|NOT COMPLETED|Overall Study||0||
48648136|NCT01186419|101923681|FG000|STARTED|Overall Study||24||
48648137|NCT01186419|101923682|FG001|STARTED|Overall Study||27||
48648138|NCT01186419|101923681|FG000|COMPLETED|Overall Study||17||
48648139|NCT01186419|101923682|FG001|COMPLETED|Overall Study||18||
48436285|NCT02074982|101403519|FG001|COMPLETED|Overall Study||285||
48436286|NCT02074982|101403518|FG000|NOT COMPLETED|Overall Study||51||
48436287|NCT02074982|101403519|FG001|NOT COMPLETED|Overall Study||54||
48436288|NCT04074109|101403520|FG000|STARTED|Overall Study||18||
48436289|NCT04074109|101403521|FG001|STARTED|Overall Study||16||
48436290|NCT04074109|101403520|FG000|COMPLETED|Overall Study||13||
48436291|NCT04074109|101403521|FG001|COMPLETED|Overall Study||8||
48436292|NCT04074109|101403520|FG000|NOT COMPLETED|Overall Study||5||
48436293|NCT04074109|101403521|FG001|NOT COMPLETED|Overall Study||8||
48436294|NCT00721513|101403522|FG000|STARTED|Overall Study||20||
48436295|NCT00721513|101403522|FG000|COMPLETED|Overall Study||20||
48436296|NCT00721513|101403522|FG000|NOT COMPLETED|Overall Study||0||
48436297|NCT03480243|101403523|FG000|STARTED|Padsevonil (Period 1)||28||
48436298|NCT03480243|101403523|FG000|COMPLETED|Padsevonil (Period 1)||28||
48436299|NCT03480243|101403523|FG000|NOT COMPLETED|Padsevonil (Period 1)||0||
48436300|NCT03480243|101403523|FG000|STARTED|Padsevonil (Period 2)||28||
48436301|NCT03480243|101403523|FG000|COMPLETED|Padsevonil (Period 2)||27||
48436302|NCT03480243|101403523|FG000|NOT COMPLETED|Padsevonil (Period 2)||1||
48436303|NCT03480243|101403523|FG000|STARTED|Erythromycin (Period 3a)||27||
48436304|NCT03480243|101403523|FG000|COMPLETED|Erythromycin (Period 3a)||27||
48436305|NCT03480243|101403523|FG000|NOT COMPLETED|Erythromycin (Period 3a)||0||
48436306|NCT03480243|101403523|FG000|STARTED|Padsevonil and Erythromycin (Period 3b)||27||
48436307|NCT03480243|101403523|FG000|COMPLETED|Padsevonil and Erythromycin (Period 3b)||26||
48436308|NCT03480243|101403523|FG000|NOT COMPLETED|Padsevonil and Erythromycin (Period 3b)||1||
48648140|NCT01186419|101923681|FG000|NOT COMPLETED|Overall Study||7||
48648141|NCT01186419|101923682|FG001|NOT COMPLETED|Overall Study||9||
48648142|NCT01121575|101923683|FG000|STARTED|Overall Study||14||
48648143|NCT01121575|101923684|FG001|STARTED|Overall Study||6||
48648144|NCT01121575|101923685|FG002|STARTED|Overall Study||7||
48648145|NCT01121575|101923686|FG003|STARTED|Overall Study||6||
48648146|NCT01121575|101923687|FG004|STARTED|Overall Study||25||
48765283|NCT04369404|102214613|FG001|NOT COMPLETED|Overall Study||0||
48765284|NCT00423579|102214614|FG000|STARTED|Overall Study||60||
48765285|NCT00423579|102214615|FG001|STARTED|Overall Study||60||
48765286|NCT00423579|102214614|FG000|COMPLETED|Overall Study||56||
48765287|NCT00423579|102214615|FG001|COMPLETED|Overall Study||56||
48765288|NCT00423579|102214614|FG000|NOT COMPLETED|Overall Study||4||
48765289|NCT00423579|102214615|FG001|NOT COMPLETED|Overall Study||4||
48765290|NCT00656448|102214616|FG000|STARTED|Overall Study||25||
48436309|NCT03480243|101403523|FG000|STARTED|Erythromycin (Period 3c)||26||
48436310|NCT03480243|101403523|FG000|COMPLETED|Erythromycin (Period 3c)||26||
48436311|NCT03480243|101403523|FG000|NOT COMPLETED|Erythromycin (Period 3c)||0||
48436312|NCT03605758|101403524|FG000|STARTED|Overall Study||22||
48436313|NCT03605758|101403525|FG001|STARTED|Overall Study||26||
48436314|NCT03605758|101403524|FG000|COMPLETED|Overall Study||0||
48436315|NCT03605758|101403525|FG001|COMPLETED|Overall Study||2||
48436316|NCT03605758|101403524|FG000|NOT COMPLETED|Overall Study||22||
48436317|NCT03605758|101403525|FG001|NOT COMPLETED|Overall Study||24||
48436318|NCT00620776|101403526|FG000|STARTED|Overall Study||29||
48436319|NCT00620776|101403527|FG001|STARTED|Overall Study||40||
48436320|NCT00620776|101403526|FG000|Received at Least One Session/Dose|Overall Study||26||
48436321|NCT00620776|101403527|FG001|Received at Least One Session/Dose|Overall Study||35||
48436322|NCT00620776|101403526|FG000|COMPLETED|Overall Study||17||
48436323|NCT00620776|101403527|FG001|COMPLETED|Overall Study||24||
48436324|NCT00620776|101403526|FG000|NOT COMPLETED|Overall Study||12||
48436325|NCT00620776|101403527|FG001|NOT COMPLETED|Overall Study||16||
48436326|NCT01374516|101403528|FG000|STARTED|Vaccination Phase (Up to 25 Months)||13920||
48436327|NCT01374516|101403529|FG001|STARTED|Vaccination Phase (Up to 25 Months)||6949||
48436328|NCT01374516|101403528|FG000|COMPLETED|Vaccination Phase (Up to 25 Months)||13281||
48648147|NCT01121575|101923688|FG005|STARTED|Overall Study||12||
48648148|NCT01121575|101923683|FG000|Treated|Overall Study||14||
48648149|NCT01121575|101923684|FG001|Treated|Overall Study||6||
48648150|NCT01121575|101923685|FG002|Treated|Overall Study||7||
48648151|NCT01121575|101923686|FG003|Treated|Overall Study||6||
48765291|NCT00656448|102214617|FG001|STARTED|Overall Study||25||
48765292|NCT00656448|102214616|FG000|COMPLETED|Overall Study||25||
48648152|NCT01121575|101923687|FG004|Treated|Overall Study||25||
48648153|NCT01121575|101923688|FG005|Treated|Overall Study||12||
48648154|NCT01121575|101923683|FG000|COMPLETED|Overall Study||0||
48648155|NCT01121575|101923684|FG001|COMPLETED|Overall Study||0||
48648156|NCT01121575|101923685|FG002|COMPLETED|Overall Study||0||
48648157|NCT01121575|101923686|FG003|COMPLETED|Overall Study||0||
48648158|NCT01121575|101923687|FG004|COMPLETED|Overall Study||0||
48648159|NCT01121575|101923688|FG005|COMPLETED|Overall Study||0||
48648160|NCT01121575|101923683|FG000|NOT COMPLETED|Overall Study||14||
48648161|NCT01121575|101923684|FG001|NOT COMPLETED|Overall Study||6||
48648162|NCT01121575|101923685|FG002|NOT COMPLETED|Overall Study||7||
48648163|NCT01121575|101923686|FG003|NOT COMPLETED|Overall Study||6||
48648164|NCT01121575|101923687|FG004|NOT COMPLETED|Overall Study||25||
48648165|NCT01121575|101923688|FG005|NOT COMPLETED|Overall Study||12||
48648166|NCT00066937|101923689|FG000|STARTED|Treatment Phase||41||
48648167|NCT00066937|101923690|FG001|STARTED|Treatment Phase||38||
48648168|NCT00066937|101923691|FG002|STARTED|Treatment Phase||37||
48648169|NCT00066937|101923692|FG003|STARTED|Treatment Phase||24||
48648170|NCT00066937|101923689|FG000|COMPLETED|Treatment Phase||38||
48648171|NCT00066937|101923690|FG001|COMPLETED|Treatment Phase||33||
48648172|NCT00066937|101923691|FG002|COMPLETED|Treatment Phase||26||
48648173|NCT00066937|101923692|FG003|COMPLETED|Treatment Phase||19||
48648174|NCT00066937|101923689|FG000|NOT COMPLETED|Treatment Phase||3||
48648175|NCT00066937|101923690|FG001|NOT COMPLETED|Treatment Phase||5||
48648176|NCT00066937|101923691|FG002|NOT COMPLETED|Treatment Phase||11||
48648177|NCT00066937|101923692|FG003|NOT COMPLETED|Treatment Phase||5||
48648178|NCT00066937|101923689|FG000|STARTED|3 Month Follow-up||38||
48648179|NCT00066937|101923690|FG001|STARTED|3 Month Follow-up||33||
48648180|NCT00066937|101923691|FG002|STARTED|3 Month Follow-up||26||
48648181|NCT00066937|101923692|FG003|STARTED|3 Month Follow-up||19||
48648182|NCT00066937|101923689|FG000|COMPLETED|3 Month Follow-up||33||
48648183|NCT00066937|101923690|FG001|COMPLETED|3 Month Follow-up||32||
48648184|NCT00066937|101923691|FG002|COMPLETED|3 Month Follow-up||25||
48648185|NCT00066937|101923692|FG003|COMPLETED|3 Month Follow-up||15||
48648186|NCT00066937|101923689|FG000|NOT COMPLETED|3 Month Follow-up||5||
48648187|NCT00066937|101923690|FG001|NOT COMPLETED|3 Month Follow-up||1||
48648188|NCT00066937|101923691|FG002|NOT COMPLETED|3 Month Follow-up||1||
48648189|NCT00066937|101923692|FG003|NOT COMPLETED|3 Month Follow-up||4||
48648190|NCT00066937|101923689|FG000|STARTED|6 Month Follow-up||33||
48648191|NCT00066937|101923690|FG001|STARTED|6 Month Follow-up||32||
48648192|NCT00066937|101923691|FG002|STARTED|6 Month Follow-up||25||
48648193|NCT00066937|101923692|FG003|STARTED|6 Month Follow-up||15||
48648194|NCT00066937|101923689|FG000|COMPLETED|6 Month Follow-up||26||
48648195|NCT00066937|101923690|FG001|COMPLETED|6 Month Follow-up||29||
48648196|NCT00066937|101923691|FG002|COMPLETED|6 Month Follow-up||22||
48648197|NCT00066937|101923692|FG003|COMPLETED|6 Month Follow-up||14||
48648198|NCT00066937|101923689|FG000|NOT COMPLETED|6 Month Follow-up||7||
48648199|NCT00066937|101923690|FG001|NOT COMPLETED|6 Month Follow-up||3||
48648200|NCT00066937|101923691|FG002|NOT COMPLETED|6 Month Follow-up||3||
48648201|NCT00066937|101923692|FG003|NOT COMPLETED|6 Month Follow-up||1||
48648202|NCT02460380|101923693|FG000|STARTED|Overall Study||45||
48648203|NCT02460380|101923694|FG001|STARTED|Overall Study||23||
48648204|NCT02460380|101923693|FG000|COMPLETED|Overall Study||35||
48648205|NCT02460380|101923694|FG001|COMPLETED|Overall Study||18||
48648206|NCT02460380|101923693|FG000|NOT COMPLETED|Overall Study||10||
48648207|NCT02460380|101923694|FG001|NOT COMPLETED|Overall Study||5||
48648208|NCT01457430|101923695|FG000|STARTED|Overall Study||19||
48648209|NCT01457430|101923695|FG000|COMPLETED|Overall Study||19||
48648210|NCT01457430|101923695|FG000|NOT COMPLETED|Overall Study||0||
48648211|NCT03055195|101923696|FG000|STARTED|Overall Study||16||
48648212|NCT03055195|101923697|FG001|STARTED|Overall Study||18||
48648213|NCT03055195|101923696|FG000|COMPLETED|Overall Study||4||
48648214|NCT03055195|101923697|FG001|COMPLETED|Overall Study||4||
48648215|NCT03055195|101923696|FG000|NOT COMPLETED|Overall Study||12||
48648216|NCT03055195|101923697|FG001|NOT COMPLETED|Overall Study||14||
48648217|NCT01452789|101923698|FG000|STARTED|Overall Study||33||
48648218|NCT01452789|101923699|FG001|STARTED|Overall Study||30||
48648219|NCT01452789|101923698|FG000|COMPLETED|Overall Study||30||
48648220|NCT01452789|101923699|FG001|COMPLETED|Overall Study||28||
48648221|NCT01452789|101923698|FG000|NOT COMPLETED|Overall Study||3||
48648222|NCT01452789|101923699|FG001|NOT COMPLETED|Overall Study||2||
48648223|NCT01936974|101923700|FG000|STARTED|Overall Study||2||
48648224|NCT01936974|101923701|FG001|STARTED|Overall Study||5||
48648225|NCT01936974|101923700|FG000|COMPLETED|Overall Study||0||
48648226|NCT01936974|101923701|FG001|COMPLETED|Overall Study||0||
48648227|NCT01936974|101923700|FG000|NOT COMPLETED|Overall Study||2||
48648228|NCT01936974|101923701|FG001|NOT COMPLETED|Overall Study||5||
48648229|NCT00483509|101923702|FG000|STARTED|Overall Study||28||
48648230|NCT00483509|101923702|FG000|COMPLETED|Overall Study||28||
48648231|NCT00483509|101923702|FG000|NOT COMPLETED|Overall Study||0||
48648232|NCT01684033|101923703|FG000|STARTED|Period 1, First 30 Days||99||
48648233|NCT01684033|101923704|FG001|STARTED|Period 1, First 30 Days||99||
48648234|NCT01684033|101923703|FG000|COMPLETED|Period 1, First 30 Days||95||
48648235|NCT01684033|101923704|FG001|COMPLETED|Period 1, First 30 Days||98||
48648236|NCT01684033|101923703|FG000|NOT COMPLETED|Period 1, First 30 Days||4||
48648237|NCT01684033|101923704|FG001|NOT COMPLETED|Period 1, First 30 Days||1||
48648238|NCT01684033|101923703|FG000|STARTED|Period 2, Second 30 Days||95||
48648239|NCT01684033|101923704|FG001|STARTED|Period 2, Second 30 Days||98||
48648240|NCT01684033|101923703|FG000|COMPLETED|Period 2, Second 30 Days||94||
48648241|NCT01684033|101923704|FG001|COMPLETED|Period 2, Second 30 Days||98||
48648242|NCT01684033|101923703|FG000|NOT COMPLETED|Period 2, Second 30 Days||1||
48648243|NCT01684033|101923704|FG001|NOT COMPLETED|Period 2, Second 30 Days||0||
48648244|NCT03315559|101923705|FG000|STARTED|Treatment Period 1 (8 Days)||6||
48648245|NCT03315559|101923705|FG000|COMPLETED|Treatment Period 1 (8 Days)||6||
48648246|NCT03315559|101923705|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
48648247|NCT03315559|101923705|FG000|STARTED|Washout Period (14 Days)||6||
48648248|NCT03315559|101923705|FG000|COMPLETED|Washout Period (14 Days)||6||
48648249|NCT03315559|101923705|FG000|NOT COMPLETED|Washout Period (14 Days)||0||
48648250|NCT03315559|101923705|FG000|STARTED|Treatment Period 2 (15 Days)||6||
48648251|NCT03315559|101923705|FG000|COMPLETED|Treatment Period 2 (15 Days)||6||
48648252|NCT03315559|101923705|FG000|NOT COMPLETED|Treatment Period 2 (15 Days)||0||
48648253|NCT00943904|101923706|FG000|STARTED|Overall Study||31||
48648254|NCT00943904|101923706|FG000|COMPLETED|Overall Study||31||
48648255|NCT00943904|101923706|FG000|NOT COMPLETED|Overall Study||0||
48648256|NCT00120250|101923707|FG000|STARTED|Overall Study||13||
48648257|NCT00120250|101923708|FG001|STARTED|Overall Study||14||
48648258|NCT00120250|101923707|FG000|COMPLETED|Overall Study||12||
48648259|NCT00120250|101923708|FG001|COMPLETED|Overall Study||12||
48648260|NCT00120250|101923707|FG000|NOT COMPLETED|Overall Study||1||
48648261|NCT00120250|101923708|FG001|NOT COMPLETED|Overall Study||2||
48648262|NCT01928576|101923709|FG000|STARTED|Overall Study||32||
48648263|NCT01928576|101923710|FG001|STARTED|Overall Study||7||
48648264|NCT01928576|101923711|FG002|STARTED|Overall Study||21||
48648265|NCT01928576|101923712|FG003|STARTED|Overall Study||14||
48648266|NCT01928576|101923713|FG004|STARTED|Overall Study||7||
48648267|NCT01928576|101923714|FG005|STARTED|Overall Study||19||
48648268|NCT01928576|101923709|FG000|COMPLETED|Overall Study||32||
48648269|NCT01928576|101923710|FG001|COMPLETED|Overall Study||7||
48648270|NCT01928576|101923711|FG002|COMPLETED|Overall Study||21||
48648271|NCT01928576|101923712|FG003|COMPLETED|Overall Study||14||
48648272|NCT01928576|101923713|FG004|COMPLETED|Overall Study||7||
48648273|NCT01928576|101923714|FG005|COMPLETED|Overall Study||19||
48648274|NCT01928576|101923709|FG000|NOT COMPLETED|Overall Study||0||
48648275|NCT01928576|101923710|FG001|NOT COMPLETED|Overall Study||0||
48648276|NCT01928576|101923711|FG002|NOT COMPLETED|Overall Study||0||
48648277|NCT01928576|101923712|FG003|NOT COMPLETED|Overall Study||0||
48648278|NCT01928576|101923713|FG004|NOT COMPLETED|Overall Study||0||
48648279|NCT01928576|101923714|FG005|NOT COMPLETED|Overall Study||0||
48648280|NCT01243424|101923715|FG000|STARTED|Discontinuation From Study (Treated Set)||3028|Started are entered/ randomised|
48648281|NCT01243424|101923716|FG001|STARTED|Discontinuation From Study (Treated Set)||3014|Started are entered/ randomised|
48648282|NCT01243424|101923715|FG000|Patient Died (Other Cause Than CV Death)|Discontinuation From Study (Treated Set)||123||
48648283|NCT01243424|101923716|FG001|Patient Died (Other Cause Than CV Death)|Discontinuation From Study (Treated Set)||146||
48648284|NCT01243424|101923715|FG000|Treated|Discontinuation From Study (Treated Set)||3023||
48648285|NCT01243424|101923716|FG001|Treated|Discontinuation From Study (Treated Set)||3010||
48648286|NCT01243424|101923715|FG000|COMPLETED|Discontinuation From Study (Treated Set)||2899|Completed regarding MACE status or died|
48188259|NCT03748264|100783198|FG001|STARTED|Overall Study||21||
48188260|NCT03748264|100783199|FG002|STARTED|Overall Study||20||
48362140|NCT00923091|101214498|FG011|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0||
48362141|NCT00923091|101214499|FG012|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0||
48362142|NCT00923091|101214487|FG000|STARTED|Period III (Single-Blind)||2540||
48362143|NCT00923091|101214488|FG001|STARTED|Period III (Single-Blind)||0||
48362144|NCT00923091|101214489|FG002|STARTED|Period III (Single-Blind)||0||
48362145|NCT00923091|101214490|FG003|STARTED|Period III (Single-Blind)||0||
48362146|NCT00923091|101214491|FG004|STARTED|Period III (Single-Blind)||0||
48362147|NCT00923091|101214492|FG005|STARTED|Period III (Single-Blind)||0||
48362148|NCT00923091|101214493|FG006|STARTED|Period III (Single-Blind)||0||
48362149|NCT00923091|101214494|FG007|STARTED|Period III (Single-Blind)||0||
48362150|NCT00923091|101214495|FG008|STARTED|Period III (Single-Blind)||0||
48362151|NCT00923091|101214496|FG009|STARTED|Period III (Single-Blind)||0||
48362152|NCT00923091|101214497|FG010|STARTED|Period III (Single-Blind)||0||
48648287|NCT01243424|101923716|FG001|COMPLETED|Discontinuation From Study (Treated Set)||2895|Completed regarding MACE status or died|
48648288|NCT01243424|101923715|FG000|NOT COMPLETED|Discontinuation From Study (Treated Set)||129||
48648289|NCT01243424|101923716|FG001|NOT COMPLETED|Discontinuation From Study (Treated Set)||119||
48648290|NCT01243424|101923715|FG000|STARTED|Discontinuation From Treatment||3028|Started are entered/ randomised|
48648291|NCT01243424|101923716|FG001|STARTED|Discontinuation From Treatment||3014|Started are entered/ randomised|
48188261|NCT03748264|100783197|FG000|COMPLETED|Overall Study||21||
48362153|NCT00923091|101214498|FG011|STARTED|Period III (Single-Blind)||0||
48362154|NCT00923091|101214499|FG012|STARTED|Period III (Single-Blind)||0||
48362155|NCT00923091|101214487|FG000|COMPLETED|Period III (Single-Blind)||2520||
48648292|NCT01243424|101923715|FG000|Treated|Discontinuation From Treatment||3023||
48648293|NCT01243424|101923716|FG001|Treated|Discontinuation From Treatment||3010||
48362156|NCT00923091|101214488|FG001|COMPLETED|Period III (Single-Blind)||0||
48362157|NCT00923091|101214489|FG002|COMPLETED|Period III (Single-Blind)||0||
48362158|NCT00923091|101214490|FG003|COMPLETED|Period III (Single-Blind)||0||
48362159|NCT00923091|101214491|FG004|COMPLETED|Period III (Single-Blind)||0||
48362160|NCT00923091|101214492|FG005|COMPLETED|Period III (Single-Blind)||0||
48362161|NCT00923091|101214493|FG006|COMPLETED|Period III (Single-Blind)||0||
48362162|NCT00923091|101214494|FG007|COMPLETED|Period III (Single-Blind)||0||
48362163|NCT00923091|101214495|FG008|COMPLETED|Period III (Single-Blind)||0||
48362164|NCT00923091|101214496|FG009|COMPLETED|Period III (Single-Blind)||0||
48362165|NCT00923091|101214497|FG010|COMPLETED|Period III (Single-Blind)||0||
48362166|NCT00923091|101214498|FG011|COMPLETED|Period III (Single-Blind)||0||
48362167|NCT00923091|101214499|FG012|COMPLETED|Period III (Single-Blind)||0||
48362168|NCT00923091|101214487|FG000|NOT COMPLETED|Period III (Single-Blind)||20||
48362169|NCT00923091|101214488|FG001|NOT COMPLETED|Period III (Single-Blind)||0||
48362170|NCT00923091|101214489|FG002|NOT COMPLETED|Period III (Single-Blind)||0||
48362171|NCT00923091|101214490|FG003|NOT COMPLETED|Period III (Single-Blind)||0||
48362172|NCT00923091|101214491|FG004|NOT COMPLETED|Period III (Single-Blind)||0||
48362173|NCT00923091|101214492|FG005|NOT COMPLETED|Period III (Single-Blind)||0||
48362174|NCT00923091|101214493|FG006|NOT COMPLETED|Period III (Single-Blind)||0||
48362175|NCT00923091|101214494|FG007|NOT COMPLETED|Period III (Single-Blind)||0||
48362176|NCT00923091|101214495|FG008|NOT COMPLETED|Period III (Single-Blind)||0||
48362177|NCT00923091|101214496|FG009|NOT COMPLETED|Period III (Single-Blind)||0||
48362178|NCT00923091|101214497|FG010|NOT COMPLETED|Period III (Single-Blind)||0||
48362179|NCT00923091|101214498|FG011|NOT COMPLETED|Period III (Single-Blind)||0||
48362180|NCT00923091|101214499|FG012|NOT COMPLETED|Period III (Single-Blind)||0||
48362181|NCT00923091|101214487|FG000|STARTED|Period IV (Double-Blind)||228||
48362182|NCT00923091|101214488|FG001|STARTED|Period IV (Double-Blind)||453||
48648294|NCT01243424|101923715|FG000|COMPLETED|Discontinuation From Treatment||1896|Not prematurely discontinued from trial medication|
48648295|NCT01243424|101923716|FG001|COMPLETED|Discontinuation From Treatment||1832|Not prematurely discontinued from trial medication|
48648296|NCT01243424|101923715|FG000|NOT COMPLETED|Discontinuation From Treatment||1132||
48648297|NCT01243424|101923716|FG001|NOT COMPLETED|Discontinuation From Treatment||1182||
48648298|NCT01953354|101923717|FG000|STARTED|Overall Study||9||
48648299|NCT01953354|101923718|FG001|STARTED|Overall Study||7||
48648300|NCT01953354|101923717|FG000|COMPLETED|Overall Study||8||
48648301|NCT01953354|101923718|FG001|COMPLETED|Overall Study||5||
48648302|NCT01953354|101923717|FG000|NOT COMPLETED|Overall Study||1||
48648303|NCT01953354|101923718|FG001|NOT COMPLETED|Overall Study||2||
48648304|NCT00890721|101923719|FG000|STARTED|Overall Study||95||
48648305|NCT00890721|101923720|FG001|STARTED|Overall Study||94||
48362183|NCT00923091|101214489|FG002|STARTED|Period IV (Double-Blind)||0||
48362184|NCT00923091|101214490|FG003|STARTED|Period IV (Double-Blind)||0||
48362185|NCT00923091|101214491|FG004|STARTED|Period IV (Double-Blind)||0||
48362186|NCT00923091|101214492|FG005|STARTED|Period IV (Double-Blind)||0||
48362187|NCT00923091|101214493|FG006|STARTED|Period IV (Double-Blind)||0||
48362188|NCT00923091|101214494|FG007|STARTED|Period IV (Double-Blind)||0||
48362189|NCT00923091|101214495|FG008|STARTED|Period IV (Double-Blind)||0||
48362190|NCT00923091|101214496|FG009|STARTED|Period IV (Double-Blind)||0||
48362191|NCT00923091|101214497|FG010|STARTED|Period IV (Double-Blind)||0||
48362192|NCT00923091|101214498|FG011|STARTED|Period IV (Double-Blind)||0||
48362193|NCT00923091|101214499|FG012|STARTED|Period IV (Double-Blind)||0||
48362194|NCT00923091|101214487|FG000|COMPLETED|Period IV (Double-Blind)||226||
48362195|NCT00923091|101214488|FG001|COMPLETED|Period IV (Double-Blind)||451||
48648306|NCT00890721|101923719|FG000|COMPLETED|Overall Study||94||
48648307|NCT00890721|101923720|FG001|COMPLETED|Overall Study||93||
48648308|NCT00890721|101923719|FG000|NOT COMPLETED|Overall Study||1||
48362196|NCT00923091|101214489|FG002|COMPLETED|Period IV (Double-Blind)||0||
48362197|NCT00923091|101214490|FG003|COMPLETED|Period IV (Double-Blind)||0||
48362198|NCT00923091|101214491|FG004|COMPLETED|Period IV (Double-Blind)||0||
48362199|NCT00923091|101214492|FG005|COMPLETED|Period IV (Double-Blind)||0||
48362200|NCT00923091|101214493|FG006|COMPLETED|Period IV (Double-Blind)||0||
48362201|NCT00923091|101214494|FG007|COMPLETED|Period IV (Double-Blind)||0||
48362202|NCT00923091|101214495|FG008|COMPLETED|Period IV (Double-Blind)||0||
48362203|NCT00923091|101214496|FG009|COMPLETED|Period IV (Double-Blind)||0||
48362204|NCT00923091|101214497|FG010|COMPLETED|Period IV (Double-Blind)||0||
48362205|NCT00923091|101214498|FG011|COMPLETED|Period IV (Double-Blind)||0||
48362206|NCT00923091|101214499|FG012|COMPLETED|Period IV (Double-Blind)||0||
48362207|NCT00923091|101214487|FG000|NOT COMPLETED|Period IV (Double-Blind)||2||
48362208|NCT00923091|101214488|FG001|NOT COMPLETED|Period IV (Double-Blind)||2||
48362209|NCT00923091|101214489|FG002|NOT COMPLETED|Period IV (Double-Blind)||0||
48362210|NCT00923091|101214490|FG003|NOT COMPLETED|Period IV (Double-Blind)||0||
48362211|NCT00923091|101214491|FG004|NOT COMPLETED|Period IV (Double-Blind)||0||
48362212|NCT00923091|101214492|FG005|NOT COMPLETED|Period IV (Double-Blind)||0||
48648309|NCT00890721|101923720|FG001|NOT COMPLETED|Overall Study||1||
48648310|NCT03694652|101923721|FG000|STARTED|Overall Study||13||
48648311|NCT03694652|101923722|FG001|STARTED|Overall Study||16||
48648312|NCT03694652|101923721|FG000|COMPLETED|Overall Study||11||
48648313|NCT03694652|101923722|FG001|COMPLETED|Overall Study||14||
48648314|NCT03694652|101923721|FG000|NOT COMPLETED|Overall Study||2||
48648315|NCT03694652|101923722|FG001|NOT COMPLETED|Overall Study||2||
48648316|NCT01901588|101923723|FG000|STARTED|Overall Study||32||
48648317|NCT01901588|101923724|FG001|STARTED|Overall Study||31||
48648318|NCT01901588|101923723|FG000|COMPLETED|Overall Study||32||
48648319|NCT01901588|101923724|FG001|COMPLETED|Overall Study||31||
48648320|NCT01901588|101923723|FG000|NOT COMPLETED|Overall Study||0||
48648321|NCT01901588|101923724|FG001|NOT COMPLETED|Overall Study||0||
48648322|NCT01676350|101923725|FG000|STARTED|Overall Study||11||
48648323|NCT01676350|101923726|FG001|STARTED|Overall Study||11||
48648324|NCT01676350|101923725|FG000|COMPLETED|Overall Study||11||
48648325|NCT01676350|101923726|FG001|COMPLETED|Overall Study||11||
48648326|NCT01676350|101923725|FG000|NOT COMPLETED|Overall Study||0||
48648327|NCT01676350|101923726|FG001|NOT COMPLETED|Overall Study||0||
48648328|NCT01034527|101923727|FG000|STARTED|Overall Study||307||
48648329|NCT01034527|101923728|FG001|STARTED|Overall Study||216||
48648330|NCT01034527|101923727|FG000|COMPLETED|Overall Study||307||
48648331|NCT01034527|101923728|FG001|COMPLETED|Overall Study||216||
48648332|NCT01034527|101923727|FG000|NOT COMPLETED|Overall Study||0||
48648333|NCT01034527|101923728|FG001|NOT COMPLETED|Overall Study||0||
48648334|NCT01307618|101923729|FG000|STARTED|Overall Study||5||
48648335|NCT01307618|101923730|FG001|STARTED|Overall Study||5||
48648336|NCT01307618|101923729|FG000|COMPLETED|Overall Study||5||
48648337|NCT01307618|101923730|FG001|COMPLETED|Overall Study||5||
48648338|NCT01307618|101923729|FG000|NOT COMPLETED|Overall Study||0||
48648339|NCT01307618|101923730|FG001|NOT COMPLETED|Overall Study||0||
48648340|NCT01482286|101923731|FG000|STARTED|Overall Study||7||
48648341|NCT01482286|101923732|FG001|STARTED|Overall Study||7||
48648342|NCT01482286|101923733|FG002|STARTED|Overall Study||8||
48648343|NCT01482286|101923734|FG003|STARTED|Overall Study||10||
48648344|NCT01482286|101923731|FG000|COMPLETED|Overall Study||4||
48648345|NCT01482286|101923732|FG001|COMPLETED|Overall Study||4||
48648346|NCT01482286|101923733|FG002|COMPLETED|Overall Study||4||
48648347|NCT01482286|101923734|FG003|COMPLETED|Overall Study||5||
48648348|NCT01482286|101923731|FG000|NOT COMPLETED|Overall Study||3||
48648349|NCT01482286|101923732|FG001|NOT COMPLETED|Overall Study||3||
48648350|NCT01482286|101923733|FG002|NOT COMPLETED|Overall Study||4||
48648351|NCT01482286|101923734|FG003|NOT COMPLETED|Overall Study||5||
48648352|NCT02545127|101923735|FG000|STARTED|Overall Study||2||
48648353|NCT02545127|101923736|FG001|STARTED|Overall Study||2||
48648354|NCT02545127|101923735|FG000|COMPLETED|Overall Study||1||
48648355|NCT02545127|101923736|FG001|COMPLETED|Overall Study||2||
48648356|NCT02545127|101923735|FG000|NOT COMPLETED|Overall Study||1||
48648357|NCT02545127|101923736|FG001|NOT COMPLETED|Overall Study||0||
48648358|NCT01119222|101923737|FG000|STARTED|Overall Study||5||
48648359|NCT01119222|101923738|FG001|STARTED|Overall Study||5||
48648360|NCT01119222|101923739|FG002|STARTED|Overall Study||5||
48648361|NCT01119222|101923740|FG003|STARTED|Overall Study||4||
48648362|NCT01119222|101923737|FG000|COMPLETED|Overall Study||5||
48648363|NCT01119222|101923738|FG001|COMPLETED|Overall Study||5||
48648364|NCT01119222|101923739|FG002|COMPLETED|Overall Study||5||
48648365|NCT01119222|101923740|FG003|COMPLETED|Overall Study||4||
48648366|NCT01119222|101923737|FG000|NOT COMPLETED|Overall Study||0||
48648367|NCT01119222|101923738|FG001|NOT COMPLETED|Overall Study||0||
48648368|NCT01119222|101923739|FG002|NOT COMPLETED|Overall Study||0||
48648369|NCT01119222|101923740|FG003|NOT COMPLETED|Overall Study||0||
48648370|NCT04621786|101923741|FG000|STARTED|Overall Study||41||
48648371|NCT04621786|101923741|FG000|COMPLETED|Overall Study||29||
48648372|NCT04621786|101923741|FG000|NOT COMPLETED|Overall Study||12||
48648373|NCT03022630|101923742|FG000|STARTED|Overall Study||31||
48648374|NCT03022630|101923743|FG001|STARTED|Overall Study||32||
48648375|NCT03022630|101923742|FG000|COMPLETED|Overall Study||22||
48648376|NCT03022630|101923743|FG001|COMPLETED|Overall Study||20||
48648377|NCT03022630|101923742|FG000|NOT COMPLETED|Overall Study||9||
48648378|NCT03022630|101923743|FG001|NOT COMPLETED|Overall Study||12||
48648379|NCT02942407|101923744|FG000|STARTED|Overall Study||82||
48648380|NCT02942407|101923745|FG001|STARTED|Overall Study||72||
48648381|NCT02942407|101923744|FG000|COMPLETED|Overall Study||56||
48648382|NCT02942407|101923745|FG001|COMPLETED|Overall Study||48||
48648383|NCT02942407|101923744|FG000|NOT COMPLETED|Overall Study||26||
48648384|NCT02942407|101923745|FG001|NOT COMPLETED|Overall Study||24||
48648385|NCT04267328|101923746|FG000|STARTED|Overall Study||47||
48648386|NCT04267328|101923746|FG000|COMPLETED|Overall Study||47||
48648387|NCT04267328|101923746|FG000|NOT COMPLETED|Overall Study||0||
48648388|NCT00924651|101923747|FG000|STARTED|Overall Study||356||
48648389|NCT00924651|101923748|FG001|STARTED|Overall Study||337||
48648390|NCT00924651|101923747|FG000|COMPLETED|Overall Study||331||
48648391|NCT00924651|101923748|FG001|COMPLETED|Overall Study||312||
48648392|NCT00924651|101923747|FG000|NOT COMPLETED|Overall Study||25||
48648393|NCT00924651|101923748|FG001|NOT COMPLETED|Overall Study||25||
48648394|NCT00899847|101923749|FG000|STARTED|Overall Study||9||
48648395|NCT00899847|101923749|FG000|COMPLETED|Overall Study||7||
48648396|NCT00899847|101923749|FG000|NOT COMPLETED|Overall Study||2||
48648397|NCT03994120|101923750|FG000|STARTED|Overall Study||7||
48648398|NCT03994120|101923751|FG001|STARTED|Overall Study||6||
48648399|NCT03994120|101923750|FG000|COMPLETED|Overall Study||4||
48648400|NCT03994120|101923751|FG001|COMPLETED|Overall Study||5||
48648401|NCT03994120|101923750|FG000|NOT COMPLETED|Overall Study||3||
48362213|NCT00923091|101214493|FG006|NOT COMPLETED|Period IV (Double-Blind)||0||
48648402|NCT03994120|101923751|FG001|NOT COMPLETED|Overall Study||1||
48648403|NCT00948935|101923752|FG000|STARTED|Overall Study||35||
48648404|NCT00948935|101923752|FG000|COMPLETED|Overall Study||35||
48648405|NCT00948935|101923752|FG000|NOT COMPLETED|Overall Study||0||
48648406|NCT00393380|101923753|FG000|STARTED|Overall Study||13||
48648407|NCT00393380|101923753|FG000|COMPLETED|Overall Study||13||
48648408|NCT00393380|101923753|FG000|NOT COMPLETED|Overall Study||0||
48648409|NCT01178411|101923754|FG000|STARTED|Overall Study||60||
48648410|NCT01178411|101923754|FG000|COMPLETED|Overall Study||0||
48648411|NCT01178411|101923754|FG000|NOT COMPLETED|Overall Study||60||
48648412|NCT00564070|101923755|FG000|STARTED|Overall Study||42||
48648413|NCT00564070|101923756|FG001|STARTED|Overall Study||45||
48648414|NCT00564070|101923755|FG000|COMPLETED|Overall Study||30||
48648415|NCT00564070|101923756|FG001|COMPLETED|Overall Study||38||
48648416|NCT00564070|101923755|FG000|NOT COMPLETED|Overall Study||12||
48648417|NCT00564070|101923756|FG001|NOT COMPLETED|Overall Study||7||
48648418|NCT01184118|101923757|FG000|STARTED|Overall Study||36||
48648419|NCT01184118|101923757|FG000|FP MDI 1,760 mcg/Day (16 Weeks)|Overall Study||18||
48648420|NCT01184118|101923757|FG000|FP MDI 880 mcg/Day (2 Weeks)|Overall Study||18||
48648421|NCT01184118|101923757|FG000|FP MDI as Indicated (2 Weeks)|Overall Study||18||
48648422|NCT01184118|101923757|FG000|COMPLETED|Overall Study||18||
48648423|NCT01184118|101923757|FG000|NOT COMPLETED|Overall Study||18||
48648424|NCT02573467|101923758|FG000|STARTED|Double-blind Treatment Epoch||53|Mean duration of exposure during the extension double-blind treatment period was 197.2 to 212.3 days|
48648425|NCT02573467|101923759|FG001|STARTED|Double-blind Treatment Epoch||52|Mean duration of exposure during the extension double-blind treatment period was 197.2 to 212.3 days|
48648426|NCT02573467|101923760|FG002|STARTED|Double-blind Treatment Epoch||51|Mean duration of exposure during the extension double-blind treatment period was 197.2 to 212.3 days|
48648427|NCT02573467|101923761|FG003|STARTED|Double-blind Treatment Epoch||55|Mean duration of exposure during the extension double-blind treatment period was 197.2 to 212.3 days|
48648428|NCT02573467|101923758|FG000|Full Analysis Set|Double-blind Treatment Epoch||53||
48648429|NCT02573467|101923759|FG001|Full Analysis Set|Double-blind Treatment Epoch||52||
48648430|NCT02573467|101923760|FG002|Full Analysis Set|Double-blind Treatment Epoch||51||
48648431|NCT02573467|101923761|FG003|Full Analysis Set|Double-blind Treatment Epoch||55||
48648432|NCT02573467|101923758|FG000|COMPLETED|Double-blind Treatment Epoch||0||
48648433|NCT02573467|101923759|FG001|COMPLETED|Double-blind Treatment Epoch||0||
48648434|NCT02573467|101923760|FG002|COMPLETED|Double-blind Treatment Epoch||0||
48362214|NCT00923091|101214494|FG007|NOT COMPLETED|Period IV (Double-Blind)||0||
48362215|NCT00923091|101214495|FG008|NOT COMPLETED|Period IV (Double-Blind)||0||
48362216|NCT00923091|101214496|FG009|NOT COMPLETED|Period IV (Double-Blind)||0||
48362217|NCT00923091|101214497|FG010|NOT COMPLETED|Period IV (Double-Blind)||0||
48362218|NCT00923091|101214498|FG011|NOT COMPLETED|Period IV (Double-Blind)||0||
48362219|NCT00923091|101214499|FG012|NOT COMPLETED|Period IV (Double-Blind)||0||
48362220|NCT00923091|101214487|FG000|STARTED|Period V (Double -Blind)||0||
48362221|NCT00923091|101214488|FG001|STARTED|Period V (Double -Blind)||0||
48362222|NCT00923091|101214489|FG002|STARTED|Period V (Double -Blind)||0||
48362223|NCT00923091|101214490|FG003|STARTED|Period V (Double -Blind)||0||
48362224|NCT00923091|101214491|FG004|STARTED|Period V (Double -Blind)||0||
48362225|NCT00923091|101214492|FG005|STARTED|Period V (Double -Blind)||0||
48362226|NCT00923091|101214493|FG006|STARTED|Period V (Double -Blind)||0||
48362227|NCT00923091|101214494|FG007|STARTED|Period V (Double -Blind)||0||
48362228|NCT00923091|101214495|FG008|STARTED|Period V (Double -Blind)||135||
48362229|NCT00923091|101214496|FG009|STARTED|Period V (Double -Blind)||119||
48362230|NCT00923091|101214497|FG010|STARTED|Period V (Double -Blind)||194||
48362231|NCT00923091|101214498|FG011|STARTED|Period V (Double -Blind)||151||
48362232|NCT00923091|101214499|FG012|STARTED|Period V (Double -Blind)||75||
48648435|NCT02573467|101923761|FG003|COMPLETED|Double-blind Treatment Epoch||0||
48362233|NCT00923091|101214487|FG000|COMPLETED|Period V (Double -Blind)||0||
48362234|NCT00923091|101214488|FG001|COMPLETED|Period V (Double -Blind)||0||
48648436|NCT02573467|101923758|FG000|NOT COMPLETED|Double-blind Treatment Epoch||53||
48648437|NCT02573467|101923759|FG001|NOT COMPLETED|Double-blind Treatment Epoch||52||
48648438|NCT02573467|101923760|FG002|NOT COMPLETED|Double-blind Treatment Epoch||51||
48648439|NCT02573467|101923761|FG003|NOT COMPLETED|Double-blind Treatment Epoch||55||
48648440|NCT02573467|101923758|FG000|STARTED|Post-treatment Follow up Epoch||41||
48648441|NCT02573467|101923759|FG001|STARTED|Post-treatment Follow up Epoch||46||
48648442|NCT02573467|101923760|FG002|STARTED|Post-treatment Follow up Epoch||44||
48648443|NCT02573467|101923761|FG003|STARTED|Post-treatment Follow up Epoch||47||
48648444|NCT02573467|101923758|FG000|COMPLETED|Post-treatment Follow up Epoch||35||
48648445|NCT02573467|101923759|FG001|COMPLETED|Post-treatment Follow up Epoch||41||
48362235|NCT00923091|101214489|FG002|COMPLETED|Period V (Double -Blind)||0||
48362236|NCT00923091|101214490|FG003|COMPLETED|Period V (Double -Blind)||0||
48362237|NCT00923091|101214491|FG004|COMPLETED|Period V (Double -Blind)||0||
48362238|NCT00923091|101214492|FG005|COMPLETED|Period V (Double -Blind)||0||
48362239|NCT00923091|101214493|FG006|COMPLETED|Period V (Double -Blind)||0||
48362240|NCT00923091|101214494|FG007|COMPLETED|Period V (Double -Blind)||0||
48648446|NCT02573467|101923760|FG002|COMPLETED|Post-treatment Follow up Epoch||34||
48648447|NCT02573467|101923761|FG003|COMPLETED|Post-treatment Follow up Epoch||44||
48648448|NCT02573467|101923758|FG000|NOT COMPLETED|Post-treatment Follow up Epoch||6||
48648449|NCT02573467|101923759|FG001|NOT COMPLETED|Post-treatment Follow up Epoch||5||
48648450|NCT02573467|101923760|FG002|NOT COMPLETED|Post-treatment Follow up Epoch||10||
48648451|NCT02573467|101923761|FG003|NOT COMPLETED|Post-treatment Follow up Epoch||3||
48648452|NCT03478787|101923762|FG000|STARTED|Overall Study||163||
48648453|NCT03478787|101923763|FG001|STARTED|Overall Study||164||
48648454|NCT03478787|101923762|FG000|COMPLETED|Overall Study||134||
48648455|NCT03478787|101923763|FG001|COMPLETED|Overall Study||151||
48648456|NCT03478787|101923762|FG000|NOT COMPLETED|Overall Study||29||
48648457|NCT03478787|101923763|FG001|NOT COMPLETED|Overall Study||13||
48648458|NCT00215553|101923764|FG000|STARTED|Overall Study||5||
48648459|NCT00215553|101923765|FG001|STARTED|Overall Study||6||
48648460|NCT00215553|101923766|FG002|STARTED|Overall Study||6||
48648461|NCT00215553|101923767|FG003|STARTED|Overall Study||5||
48648462|NCT00215553|101923768|FG004|STARTED|Overall Study||28||
48648463|NCT00215553|101923769|FG005|STARTED|Overall Study||38||
48648464|NCT00215553|101923770|FG006|STARTED|Overall Study||36||
48648465|NCT00215553|101923764|FG000|COMPLETED|Overall Study||5||
48648466|NCT00215553|101923765|FG001|COMPLETED|Overall Study||5||
48648467|NCT00215553|101923766|FG002|COMPLETED|Overall Study||4||
48648468|NCT00215553|101923767|FG003|COMPLETED|Overall Study||4||
48648469|NCT00215553|101923768|FG004|COMPLETED|Overall Study||26||
48648470|NCT00215553|101923769|FG005|COMPLETED|Overall Study||32||
48648471|NCT00215553|101923770|FG006|COMPLETED|Overall Study||36||
48648472|NCT00215553|101923764|FG000|NOT COMPLETED|Overall Study||0||
48648473|NCT00215553|101923765|FG001|NOT COMPLETED|Overall Study||1||
48648474|NCT00215553|101923766|FG002|NOT COMPLETED|Overall Study||2||
48648475|NCT00215553|101923767|FG003|NOT COMPLETED|Overall Study||1||
48648476|NCT00215553|101923768|FG004|NOT COMPLETED|Overall Study||2||
48648477|NCT00215553|101923769|FG005|NOT COMPLETED|Overall Study||6||
48648478|NCT00215553|101923770|FG006|NOT COMPLETED|Overall Study||0||
48648479|NCT03520569|101923771|FG000|STARTED|Overall Study||15||
48648480|NCT03520569|101923771|FG000|Octreotide-Euglycemia|Overall Study||13||
48648481|NCT03520569|101923771|FG000|Octreotide-Euglycemia-Insulin Clamp|Overall Study||14||
48648482|NCT03520569|101923771|FG000|Octreotide-Hyperglycemia|Overall Study||10||
48648483|NCT03520569|101923771|FG000|Octreotide-Hyperglycemia-Insulin Clamp|Overall Study||12||
48648484|NCT03520569|101923771|FG000|COMPLETED|Overall Study||14||
48648485|NCT03520569|101923771|FG000|NOT COMPLETED|Overall Study||1||
48648486|NCT01543503|101923772|FG000|STARTED|Overall Study||426||
48648487|NCT01543503|101923773|FG001|STARTED|Overall Study||798||
48648488|NCT01543503|101923772|FG000|COMPLETED|Overall Study||350||
48648489|NCT01543503|101923773|FG001|COMPLETED|Overall Study||711||
48648490|NCT01543503|101923772|FG000|NOT COMPLETED|Overall Study||76||
48648491|NCT01543503|101923773|FG001|NOT COMPLETED|Overall Study||87||
48648492|NCT01441414|101923774|FG000|STARTED|Overall Study||18||
48648493|NCT01441414|101923774|FG000|COMPLETED|Overall Study||3||
48648494|NCT01441414|101923774|FG000|NOT COMPLETED|Overall Study||15||
48648495|NCT04648241|101923775|FG000|STARTED|Overall Study||100||
48648496|NCT04648241|101923776|FG001|STARTED|Overall Study||65||
48648497|NCT04648241|101923775|FG000|COMPLETED|Overall Study||99||
48648498|NCT04648241|101923776|FG001|COMPLETED|Overall Study||65||
48648499|NCT04648241|101923775|FG000|NOT COMPLETED|Overall Study||1||
48648500|NCT04648241|101923776|FG001|NOT COMPLETED|Overall Study||0||
48648501|NCT01691092|101923777|FG000|STARTED|Overall Study||79||
48648502|NCT01691092|101923777|FG000|COMPLETED|Overall Study||38||
48648503|NCT01691092|101923777|FG000|NOT COMPLETED|Overall Study||41||
48648504|NCT01160744|101923778|FG000|STARTED|Overall Study||71||
48648505|NCT01160744|101923779|FG001|STARTED|Overall Study||69||
48648506|NCT01160744|101923780|FG002|STARTED|Overall Study||69||
48648507|NCT01160744|101923781|FG003|STARTED|Overall Study||71||
48648508|NCT01160744|101923778|FG000|Received Study Drug|Overall Study||69||
48648509|NCT01160744|101923779|FG001|Received Study Drug|Overall Study||67||
48648510|NCT01160744|101923780|FG002|Received Study Drug|Overall Study||63||
48765293|NCT00656448|102214617|FG001|COMPLETED|Overall Study||25||
48648511|NCT01160744|101923781|FG003|Received Study Drug|Overall Study||71||
48648512|NCT01160744|101923778|FG000|COMPLETED|Overall Study||60||
48648513|NCT01160744|101923779|FG001|COMPLETED|Overall Study||64||
48648514|NCT01160744|101923780|FG002|COMPLETED|Overall Study||62||
48648515|NCT01160744|101923781|FG003|COMPLETED|Overall Study||67||
48362241|NCT00923091|101214495|FG008|COMPLETED|Period V (Double -Blind)||134||
48440000|NCT01143610|101410006|FG001|COMPLETED|Overall Study||8||
48648516|NCT01160744|101923778|FG000|NOT COMPLETED|Overall Study||11||
48648517|NCT01160744|101923779|FG001|NOT COMPLETED|Overall Study||5||
48648518|NCT01160744|101923780|FG002|NOT COMPLETED|Overall Study||7||
48648519|NCT01160744|101923781|FG003|NOT COMPLETED|Overall Study||4||
48648520|NCT00834587|101923782|FG000|STARTED|First Intervention||20||
48648521|NCT00834587|101923783|FG001|STARTED|First Intervention||20||
48648522|NCT00834587|101923782|FG000|COMPLETED|First Intervention||20||
48648523|NCT00834587|101923783|FG001|COMPLETED|First Intervention||20||
48648524|NCT00834587|101923782|FG000|NOT COMPLETED|First Intervention||0||
48648525|NCT00834587|101923783|FG001|NOT COMPLETED|First Intervention||0||
48648526|NCT00834587|101923782|FG000|STARTED|Washout: 7 Days||20||
48648527|NCT00834587|101923783|FG001|STARTED|Washout: 7 Days||20||
48648528|NCT00834587|101923782|FG000|COMPLETED|Washout: 7 Days||19||
48648529|NCT00834587|101923783|FG001|COMPLETED|Washout: 7 Days||20||
48648530|NCT00834587|101923782|FG000|NOT COMPLETED|Washout: 7 Days||1||
48648531|NCT00834587|101923783|FG001|NOT COMPLETED|Washout: 7 Days||0||
48648532|NCT00834587|101923782|FG000|STARTED|Second Intervention||19||
48648533|NCT00834587|101923783|FG001|STARTED|Second Intervention||20||
48648534|NCT00834587|101923782|FG000|COMPLETED|Second Intervention||19||
48648535|NCT00834587|101923783|FG001|COMPLETED|Second Intervention||20||
48648536|NCT00834587|101923782|FG000|NOT COMPLETED|Second Intervention||0||
48648537|NCT00834587|101923783|FG001|NOT COMPLETED|Second Intervention||0||
48648538|NCT03343886|101923784|FG000|STARTED|Overall Study||4753||
48648539|NCT03343886|101923785|FG001|STARTED|Overall Study||3002||
48648540|NCT03343886|101923784|FG000|Second Wave|Overall Study||2528||
48648541|NCT03343886|101923785|FG001|Second Wave|Overall Study||0||
48648542|NCT03343886|101923784|FG000|Third Wave|Overall Study||1577||
48648543|NCT03343886|101923785|FG001|Third Wave|Overall Study||0||
48648544|NCT03343886|101923784|FG000|Fourth Wave|Overall Study||963||
48648545|NCT03343886|101923785|FG001|Fourth Wave|Overall Study||0||
48648546|NCT03343886|101923784|FG000|COMPLETED|Overall Study||963||
48648547|NCT03343886|101923785|FG001|COMPLETED|Overall Study||0||
48648548|NCT03343886|101923784|FG000|NOT COMPLETED|Overall Study||3790||
48648549|NCT03343886|101923785|FG001|NOT COMPLETED|Overall Study||3002||
48648550|NCT01879852|101923786|FG000|STARTED|Overall Study||14||
48648551|NCT01879852|101923787|FG001|STARTED|Overall Study||13||
48648552|NCT01879852|101923786|FG000|COMPLETED|Overall Study||12||
48648553|NCT01879852|101923787|FG001|COMPLETED|Overall Study||13||
48648554|NCT01879852|101923786|FG000|NOT COMPLETED|Overall Study||2||
48648555|NCT01879852|101923787|FG001|NOT COMPLETED|Overall Study||0||
48648556|NCT00673114|101923788|FG000|STARTED|Overall Study||3||
48648557|NCT00673114|101923788|FG000|COMPLETED|Overall Study||3||
48648558|NCT00673114|101923788|FG000|NOT COMPLETED|Overall Study||0||
48648559|NCT02822287|101923789|FG000|STARTED|Overall Study||57||
48648560|NCT02822287|101923789|FG000|COMPLETED|Overall Study||57||
48648561|NCT02822287|101923789|FG000|NOT COMPLETED|Overall Study||0||
48648562|NCT01395537|101923790|FG000|STARTED|Phase I||13||
48648563|NCT01395537|101923790|FG000|COMPLETED|Phase I||13||
48648564|NCT01395537|101923790|FG000|NOT COMPLETED|Phase I||0||
48648565|NCT01395537|101923790|FG000|STARTED|Phase II||1|Only one participant was eligible to move to the phase II part of the study.|
48648566|NCT01395537|101923790|FG000|COMPLETED|Phase II||1||
48648567|NCT01395537|101923790|FG000|NOT COMPLETED|Phase II||0||
48648568|NCT00964678|101923791|FG000|STARTED|Overall Study||10||
48648569|NCT00964678|101923791|FG000|COMPLETED|Overall Study||6||
48648570|NCT00964678|101923791|FG000|NOT COMPLETED|Overall Study||4||
48648571|NCT03422718|101923792|FG000|STARTED|12 Month Interventional Trial Period||62||
48648572|NCT03422718|101923793|FG001|STARTED|12 Month Interventional Trial Period||60||
48648573|NCT03422718|101923794|FG002|STARTED|12 Month Interventional Trial Period||63||
48648574|NCT03422718|101923795|FG003|STARTED|12 Month Interventional Trial Period||61||
48648575|NCT03422718|101923796|FG004|STARTED|12 Month Interventional Trial Period||58||
48648576|NCT03422718|101923797|FG005|STARTED|12 Month Interventional Trial Period||61||
48648577|NCT03422718|101923798|FG006|STARTED|12 Month Interventional Trial Period||64||
48648578|NCT03422718|101923799|FG007|STARTED|12 Month Interventional Trial Period||59||
48648579|NCT03422718|101923792|FG000|6 Month Outcome|12 Month Interventional Trial Period||26||
48648580|NCT03422718|101923793|FG001|6 Month Outcome|12 Month Interventional Trial Period||35||
48648581|NCT03422718|101923794|FG002|6 Month Outcome|12 Month Interventional Trial Period||30||
48648582|NCT03422718|101923795|FG003|6 Month Outcome|12 Month Interventional Trial Period||29||
48648583|NCT03422718|101923796|FG004|6 Month Outcome|12 Month Interventional Trial Period||31||
48648584|NCT03422718|101923797|FG005|6 Month Outcome|12 Month Interventional Trial Period||32||
48648585|NCT03422718|101923798|FG006|6 Month Outcome|12 Month Interventional Trial Period||29||
48648586|NCT03422718|101923799|FG007|6 Month Outcome|12 Month Interventional Trial Period||28||
48648587|NCT03422718|101923792|FG000|COMPLETED|12 Month Interventional Trial Period||25|Completed here means completed 12 month outcomes|
48648588|NCT03422718|101923793|FG001|COMPLETED|12 Month Interventional Trial Period||31|Completed here means completed 12 month outcomes|
48648589|NCT03422718|101923794|FG002|COMPLETED|12 Month Interventional Trial Period||25|Completed here means completed 12 month outcomes|
48648590|NCT03422718|101923795|FG003|COMPLETED|12 Month Interventional Trial Period||22|Completed here means completed 12 month outcomes|
48648591|NCT03422718|101923796|FG004|COMPLETED|12 Month Interventional Trial Period||30|Completed here means completed 12 month outcomes|
48648592|NCT03422718|101923797|FG005|COMPLETED|12 Month Interventional Trial Period||31|Completed here means completed 12 month outcomes|
48648593|NCT03422718|101923798|FG006|COMPLETED|12 Month Interventional Trial Period||24|Completed here means completed 12 month outcomes|
48648594|NCT03422718|101923799|FG007|COMPLETED|12 Month Interventional Trial Period||23|Completed here means completed 12 month outcomes|
48648595|NCT03422718|101923792|FG000|NOT COMPLETED|12 Month Interventional Trial Period||37||
48648596|NCT03422718|101923793|FG001|NOT COMPLETED|12 Month Interventional Trial Period||29||
48657047|NCT03648372|101943766|FG009|STARTED|Overall Study||6||
48648597|NCT03422718|101923794|FG002|NOT COMPLETED|12 Month Interventional Trial Period||38||
48648598|NCT03422718|101923795|FG003|NOT COMPLETED|12 Month Interventional Trial Period||39||
48648599|NCT03422718|101923796|FG004|NOT COMPLETED|12 Month Interventional Trial Period||28||
48648600|NCT03422718|101923797|FG005|NOT COMPLETED|12 Month Interventional Trial Period||30||
48648601|NCT03422718|101923798|FG006|NOT COMPLETED|12 Month Interventional Trial Period||40||
48648602|NCT03422718|101923799|FG007|NOT COMPLETED|12 Month Interventional Trial Period||36||
48648603|NCT03422718|101923792|FG000|STARTED|Optional Six Month Follow-Up Period||25|This simply represents all those who completed the 12 month and had the option to continue; some chose not to exercise it|
48648604|NCT03422718|101923793|FG001|STARTED|Optional Six Month Follow-Up Period||31|This simply represents all those who completed the 12 month and had the option to continue; some chose not to exercise it|
48648605|NCT03422718|101923794|FG002|STARTED|Optional Six Month Follow-Up Period||25|This simply represents all those who completed the 12 month and had the option to continue; some chose not to exercise it|
48648606|NCT03422718|101923795|FG003|STARTED|Optional Six Month Follow-Up Period||22|This simply represents all those who completed the 12 month and had the option to continue; some chose not to exercise it|
48648607|NCT03422718|101923796|FG004|STARTED|Optional Six Month Follow-Up Period||30|This simply represents all those who completed the 12 month and had the option to continue; some chose not to exercise it|
48648608|NCT03422718|101923797|FG005|STARTED|Optional Six Month Follow-Up Period||31|This simply represents all those who completed the 12 month and had the option to continue; some chose not to exercise it|
48648609|NCT03422718|101923798|FG006|STARTED|Optional Six Month Follow-Up Period||24|This simply represents all those who completed the 12 month and had the option to continue; some chose not to exercise it|
48648610|NCT03422718|101923799|FG007|STARTED|Optional Six Month Follow-Up Period||23|This simply represents all those who completed the 12 month and had the option to continue; some chose not to exercise it|
48648611|NCT03422718|101923792|FG000|Opted in to Optional Follow Up Phase|Optional Six Month Follow-Up Period||17|Note: Although participants are shown here based on the arm in which they participated during the main 12 month study, there was|
48648612|NCT03422718|101923793|FG001|Opted in to Optional Follow Up Phase|Optional Six Month Follow-Up Period||20|Note: Although participants are shown here based on the arm in which they participated during the main 12 month study, there was|
48648613|NCT03422718|101923794|FG002|Opted in to Optional Follow Up Phase|Optional Six Month Follow-Up Period||9|Note: Although participants are shown here based on the arm in which they participated during the main 12 month study, there was|
48648614|NCT03422718|101923795|FG003|Opted in to Optional Follow Up Phase|Optional Six Month Follow-Up Period||8|Note: Although participants are shown here based on the arm in which they participated during the main 12 month study, there was|
48648615|NCT03422718|101923796|FG004|Opted in to Optional Follow Up Phase|Optional Six Month Follow-Up Period||13|Note: Although participants are shown here based on the arm in which they participated during the main 12 month study, there was|
48648616|NCT03422718|101923797|FG005|Opted in to Optional Follow Up Phase|Optional Six Month Follow-Up Period||17|Note: Although participants are shown here based on the arm in which they participated during the main 12 month study, there was|
48648617|NCT03422718|101923798|FG006|Opted in to Optional Follow Up Phase|Optional Six Month Follow-Up Period||10|Note: Although participants are shown here based on the arm in which they participated during the main 12 month study, there was|
48648618|NCT03422718|101923799|FG007|Opted in to Optional Follow Up Phase|Optional Six Month Follow-Up Period||13|Note: Although participants are shown here based on the arm in which they participated during the main 12 month study, there was|
48648619|NCT03422718|101923792|FG000|COMPLETED|Optional Six Month Follow-Up Period||1||
48648620|NCT03422718|101923793|FG001|COMPLETED|Optional Six Month Follow-Up Period||1||
48648621|NCT03422718|101923794|FG002|COMPLETED|Optional Six Month Follow-Up Period||1||
48648622|NCT03422718|101923795|FG003|COMPLETED|Optional Six Month Follow-Up Period||2||
48648623|NCT03422718|101923796|FG004|COMPLETED|Optional Six Month Follow-Up Period||2||
48648624|NCT03422718|101923797|FG005|COMPLETED|Optional Six Month Follow-Up Period||2||
48648625|NCT03422718|101923798|FG006|COMPLETED|Optional Six Month Follow-Up Period||5||
48648626|NCT03422718|101923799|FG007|COMPLETED|Optional Six Month Follow-Up Period||3||
48648627|NCT03422718|101923792|FG000|NOT COMPLETED|Optional Six Month Follow-Up Period||24||
48648628|NCT03422718|101923793|FG001|NOT COMPLETED|Optional Six Month Follow-Up Period||30||
48648629|NCT03422718|101923794|FG002|NOT COMPLETED|Optional Six Month Follow-Up Period||24||
48648630|NCT03422718|101923795|FG003|NOT COMPLETED|Optional Six Month Follow-Up Period||20||
48648631|NCT03422718|101923796|FG004|NOT COMPLETED|Optional Six Month Follow-Up Period||28||
48648632|NCT03422718|101923797|FG005|NOT COMPLETED|Optional Six Month Follow-Up Period||29||
48648633|NCT03422718|101923798|FG006|NOT COMPLETED|Optional Six Month Follow-Up Period||19||
48648634|NCT03422718|101923799|FG007|NOT COMPLETED|Optional Six Month Follow-Up Period||20||
48648635|NCT01889563|101923800|FG000|STARTED|Overall Study||17||
48648636|NCT01889563|101923801|FG001|STARTED|Overall Study||15||
48648637|NCT01889563|101923800|FG000|COMPLETED|Overall Study||10||
48648638|NCT01889563|101923801|FG001|COMPLETED|Overall Study||10||
48648639|NCT01889563|101923800|FG000|NOT COMPLETED|Overall Study||7||
48648640|NCT01889563|101923801|FG001|NOT COMPLETED|Overall Study||5||
48648641|NCT01111370|101923802|FG000|STARTED|Overall Study||60||
48648642|NCT01111370|101923802|FG000|COMPLETED|Overall Study||58||
48648643|NCT01111370|101923802|FG000|NOT COMPLETED|Overall Study||2||
48648644|NCT02082483|101923803|FG000|STARTED|Overall Study||71||
48648645|NCT02082483|101923804|FG001|STARTED|Overall Study||73||
48648646|NCT02082483|101923803|FG000|COMPLETED|Overall Study||65||
48648647|NCT02082483|101923804|FG001|COMPLETED|Overall Study||67||
48648648|NCT02082483|101923803|FG000|NOT COMPLETED|Overall Study||6||
48648649|NCT02082483|101923804|FG001|NOT COMPLETED|Overall Study||6||
48648650|NCT02665455|101923805|FG000|STARTED|Overall Study||83||
48648651|NCT02665455|101923805|FG000|COMPLETED|Overall Study||74||
48648652|NCT02665455|101923805|FG000|NOT COMPLETED|Overall Study||9||
48648653|NCT00855582|101923806|FG000|STARTED|Overall Study||198||
48648654|NCT00855582|101923807|FG001|STARTED|Overall Study||208||
48648655|NCT00855582|101923808|FG002|STARTED|Overall Study||200||
48648656|NCT00855582|101923806|FG000|COMPLETED|Overall Study||172||
48648657|NCT00855582|101923807|FG001|COMPLETED|Overall Study||184||
48648658|NCT00855582|101923808|FG002|COMPLETED|Overall Study||170||
48648659|NCT00855582|101923806|FG000|NOT COMPLETED|Overall Study||26||
48648660|NCT00855582|101923807|FG001|NOT COMPLETED|Overall Study||24||
48648661|NCT00855582|101923808|FG002|NOT COMPLETED|Overall Study||30||
48648662|NCT02346370|101923809|FG000|STARTED|Overall Study||8||
48648663|NCT02346370|101923810|FG001|STARTED|Overall Study||4||
48648664|NCT02346370|101923811|FG002|STARTED|Overall Study||4||
48648665|NCT02346370|101923809|FG000|COMPLETED|Overall Study||0||
48648666|NCT02346370|101923810|FG001|COMPLETED|Overall Study||0||
48648667|NCT02346370|101923811|FG002|COMPLETED|Overall Study||0||
48648668|NCT02346370|101923809|FG000|NOT COMPLETED|Overall Study||8||
48648669|NCT02346370|101923810|FG001|NOT COMPLETED|Overall Study||4||
48648670|NCT02346370|101923811|FG002|NOT COMPLETED|Overall Study||4||
48648671|NCT01814332|101923812|FG000|STARTED|Overall Study||63||
48648672|NCT01814332|101923813|FG001|STARTED|Overall Study||65||
48648673|NCT01814332|101923812|FG000|COMPLETED|Overall Study||47||
48648674|NCT01814332|101923813|FG001|COMPLETED|Overall Study||49||
48648675|NCT01814332|101923812|FG000|NOT COMPLETED|Overall Study||16||
48648676|NCT01814332|101923813|FG001|NOT COMPLETED|Overall Study||16||
48648677|NCT00552058|101923814|FG000|STARTED|Overall Study||223||
48648678|NCT00552058|101923815|FG001|STARTED|Overall Study||216||
48648679|NCT00552058|101923814|FG000|COMPLETED|Overall Study||207||
48648680|NCT00552058|101923815|FG001|COMPLETED|Overall Study||192||
48648681|NCT00552058|101923814|FG000|NOT COMPLETED|Overall Study||16||
48648682|NCT00552058|101923815|FG001|NOT COMPLETED|Overall Study||24||
48648683|NCT02636322|101923816|FG000|STARTED|Overall Study||58||
48648684|NCT02636322|101923816|FG000|Complete Response|Overall Study||21||
48648685|NCT02636322|101923816|FG000|Partial Response|Overall Study||29||
48648686|NCT02636322|101923816|FG000|Non Responsive|Overall Study||8||
48648687|NCT02636322|101923816|FG000|COMPLETED|Overall Study||58||
48648688|NCT02636322|101923816|FG000|NOT COMPLETED|Overall Study||0||
48648689|NCT01472835|101923817|FG000|STARTED|Overall Study||37||
48648690|NCT01472835|101923818|FG001|STARTED|Overall Study||36||
48648691|NCT01472835|101923817|FG000|COMPLETED|Overall Study||35||
48648692|NCT01472835|101923818|FG001|COMPLETED|Overall Study||36||
48648693|NCT01472835|101923817|FG000|NOT COMPLETED|Overall Study||2||
48648694|NCT01472835|101923818|FG001|NOT COMPLETED|Overall Study||0||
48648695|NCT01060111|101923819|FG000|STARTED|Overall Study||81||
48648696|NCT01060111|101923820|FG001|STARTED|Overall Study||84||
48648697|NCT01060111|101923821|FG002|STARTED|Overall Study||80||
48648698|NCT01060111|101923819|FG000|Treated|Overall Study||81||
48648699|NCT01060111|101923820|FG001|Treated|Overall Study||83||
48648700|NCT01060111|101923821|FG002|Treated|Overall Study||79||
48648701|NCT01060111|101923819|FG000|COMPLETED|Overall Study||54||
48648702|NCT01060111|101923820|FG001|COMPLETED|Overall Study||61||
48648703|NCT01060111|101923821|FG002|COMPLETED|Overall Study||45||
48648704|NCT01060111|101923819|FG000|NOT COMPLETED|Overall Study||27||
48648705|NCT01060111|101923820|FG001|NOT COMPLETED|Overall Study||23||
48648706|NCT01060111|101923821|FG002|NOT COMPLETED|Overall Study||35||
48648707|NCT02502071|101923822|FG000|STARTED|Overall Study||45||
48648708|NCT02502071|101923822|FG000|COMPLETED|Overall Study||45||
48648709|NCT02502071|101923822|FG000|NOT COMPLETED|Overall Study||0||
48648710|NCT03055507|101923823|FG000|STARTED|Overall Study||16||
48648711|NCT03055507|101923824|FG001|STARTED|Overall Study||26||
48436329|NCT01374516|101403529|FG001|COMPLETED|Vaccination Phase (Up to 25 Months)||6640||
48648712|NCT03055507|101923823|FG000|COMPLETED|Overall Study||16||
48648713|NCT03055507|101923824|FG001|COMPLETED|Overall Study||26||
48648714|NCT03055507|101923823|FG000|NOT COMPLETED|Overall Study||0||
48648715|NCT03055507|101923824|FG001|NOT COMPLETED|Overall Study||0||
48648716|NCT02830087|101923825|FG000|STARTED|Overall Study||4||
48648717|NCT02830087|101923826|FG001|STARTED|Overall Study||4||
48648718|NCT02830087|101923827|FG002|STARTED|Overall Study||4||
48648719|NCT02830087|101923828|FG003|STARTED|Overall Study||3||
48648720|NCT02830087|101923829|FG004|STARTED|Overall Study||3||
48648721|NCT02830087|101923830|FG005|STARTED|Overall Study||3||
48648722|NCT02830087|101923825|FG000|COMPLETED|Overall Study||0||
48436330|NCT01374516|101403528|FG000|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||639||
48436331|NCT01374516|101403529|FG001|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||309||
48436332|NCT01374516|101403528|FG000|STARTED|Surveillance Expansion Period||13281||
48436333|NCT01374516|101403529|FG001|STARTED|Surveillance Expansion Period||6640||
48648723|NCT02830087|101923826|FG001|COMPLETED|Overall Study||0||
48648724|NCT02830087|101923827|FG002|COMPLETED|Overall Study||0||
48648725|NCT02830087|101923828|FG003|COMPLETED|Overall Study||0||
48648726|NCT02830087|101923829|FG004|COMPLETED|Overall Study||0||
48648727|NCT02830087|101923830|FG005|COMPLETED|Overall Study||0||
48648728|NCT02830087|101923825|FG000|NOT COMPLETED|Overall Study||4||
48648729|NCT02830087|101923826|FG001|NOT COMPLETED|Overall Study||4||
48648730|NCT02830087|101923827|FG002|NOT COMPLETED|Overall Study||4||
48648731|NCT02830087|101923828|FG003|NOT COMPLETED|Overall Study||3||
48648732|NCT02830087|101923829|FG004|NOT COMPLETED|Overall Study||3||
48648733|NCT02830087|101923830|FG005|NOT COMPLETED|Overall Study||3||
48648734|NCT00245570|101923831|FG000|STARTED|Treatment Period II||7||
48648735|NCT00245570|101923832|FG001|STARTED|Treatment Period II||8||
48648736|NCT00245570|101923833|FG002|STARTED|Treatment Period II||8||
48648737|NCT00245570|101923834|FG003|STARTED|Treatment Period II||8||
48648738|NCT00245570|101923835|FG004|STARTED|Treatment Period II||8||
48648739|NCT00245570|101923836|FG005|STARTED|Treatment Period II||8||
48648740|NCT00245570|101923831|FG000|COMPLETED|Treatment Period II||7||
48648741|NCT00245570|101923832|FG001|COMPLETED|Treatment Period II||8||
48648742|NCT00245570|101923833|FG002|COMPLETED|Treatment Period II||8||
48648743|NCT00245570|101923834|FG003|COMPLETED|Treatment Period II||8||
48648744|NCT00245570|101923835|FG004|COMPLETED|Treatment Period II||8||
48648745|NCT00245570|101923836|FG005|COMPLETED|Treatment Period II||8||
48648746|NCT00245570|101923831|FG000|NOT COMPLETED|Treatment Period II||0||
48648747|NCT00245570|101923832|FG001|NOT COMPLETED|Treatment Period II||0||
48648748|NCT00245570|101923833|FG002|NOT COMPLETED|Treatment Period II||0||
48648749|NCT00245570|101923834|FG003|NOT COMPLETED|Treatment Period II||0||
48648750|NCT00245570|101923835|FG004|NOT COMPLETED|Treatment Period II||0||
48648751|NCT00245570|101923836|FG005|NOT COMPLETED|Treatment Period II||0||
48648752|NCT00245570|101923831|FG000|STARTED|Washout Between Periods II and III||7||
48648753|NCT00245570|101923832|FG001|STARTED|Washout Between Periods II and III||8||
48648754|NCT00245570|101923833|FG002|STARTED|Washout Between Periods II and III||8||
48648755|NCT00245570|101923834|FG003|STARTED|Washout Between Periods II and III||8||
48648756|NCT00245570|101923835|FG004|STARTED|Washout Between Periods II and III||8||
48648757|NCT00245570|101923836|FG005|STARTED|Washout Between Periods II and III||8||
48648758|NCT00245570|101923831|FG000|COMPLETED|Washout Between Periods II and III||7||
48648759|NCT00245570|101923832|FG001|COMPLETED|Washout Between Periods II and III||8||
48648760|NCT00245570|101923833|FG002|COMPLETED|Washout Between Periods II and III||8||
48648761|NCT00245570|101923834|FG003|COMPLETED|Washout Between Periods II and III||8||
48648762|NCT00245570|101923835|FG004|COMPLETED|Washout Between Periods II and III||8||
48648763|NCT00245570|101923836|FG005|COMPLETED|Washout Between Periods II and III||8||
48648764|NCT00245570|101923831|FG000|NOT COMPLETED|Washout Between Periods II and III||0||
48648765|NCT00245570|101923832|FG001|NOT COMPLETED|Washout Between Periods II and III||0||
48648766|NCT00245570|101923833|FG002|NOT COMPLETED|Washout Between Periods II and III||0||
48648767|NCT00245570|101923834|FG003|NOT COMPLETED|Washout Between Periods II and III||0||
48648768|NCT00245570|101923835|FG004|NOT COMPLETED|Washout Between Periods II and III||0||
48648769|NCT00245570|101923836|FG005|NOT COMPLETED|Washout Between Periods II and III||0||
48648770|NCT00245570|101923831|FG000|STARTED|Treatment Period III||7||
48648771|NCT00245570|101923832|FG001|STARTED|Treatment Period III||8||
48648772|NCT00245570|101923833|FG002|STARTED|Treatment Period III||8||
48648773|NCT00245570|101923834|FG003|STARTED|Treatment Period III||8||
48648774|NCT00245570|101923835|FG004|STARTED|Treatment Period III||8||
48648775|NCT00245570|101923836|FG005|STARTED|Treatment Period III||8||
48648776|NCT00245570|101923831|FG000|COMPLETED|Treatment Period III||7||
48648777|NCT00245570|101923832|FG001|COMPLETED|Treatment Period III||8||
48648778|NCT00245570|101923833|FG002|COMPLETED|Treatment Period III||8||
48648779|NCT00245570|101923834|FG003|COMPLETED|Treatment Period III||8||
48648780|NCT00245570|101923835|FG004|COMPLETED|Treatment Period III||8||
48648781|NCT00245570|101923836|FG005|COMPLETED|Treatment Period III||8||
48648782|NCT00245570|101923831|FG000|NOT COMPLETED|Treatment Period III||0||
48648783|NCT00245570|101923832|FG001|NOT COMPLETED|Treatment Period III||0||
48648784|NCT00245570|101923833|FG002|NOT COMPLETED|Treatment Period III||0||
48648785|NCT00245570|101923834|FG003|NOT COMPLETED|Treatment Period III||0||
48648786|NCT00245570|101923835|FG004|NOT COMPLETED|Treatment Period III||0||
48648787|NCT00245570|101923836|FG005|NOT COMPLETED|Treatment Period III||0||
48648788|NCT00245570|101923831|FG000|STARTED|Washout Between Periods III and IV||7||
48648789|NCT00245570|101923832|FG001|STARTED|Washout Between Periods III and IV||8||
48648790|NCT00245570|101923833|FG002|STARTED|Washout Between Periods III and IV||8||
48648791|NCT00245570|101923834|FG003|STARTED|Washout Between Periods III and IV||8||
48648792|NCT00245570|101923835|FG004|STARTED|Washout Between Periods III and IV||8||
48648793|NCT00245570|101923836|FG005|STARTED|Washout Between Periods III and IV||8||
48648794|NCT00245570|101923831|FG000|COMPLETED|Washout Between Periods III and IV||7||
48648795|NCT00245570|101923832|FG001|COMPLETED|Washout Between Periods III and IV||7||
48648796|NCT00245570|101923833|FG002|COMPLETED|Washout Between Periods III and IV||8||
48648797|NCT00245570|101923834|FG003|COMPLETED|Washout Between Periods III and IV||8||
48648798|NCT00245570|101923835|FG004|COMPLETED|Washout Between Periods III and IV||8||
48648799|NCT00245570|101923836|FG005|COMPLETED|Washout Between Periods III and IV||8||
48648800|NCT00245570|101923831|FG000|NOT COMPLETED|Washout Between Periods III and IV||0||
48648801|NCT00245570|101923832|FG001|NOT COMPLETED|Washout Between Periods III and IV||1||
48648802|NCT00245570|101923833|FG002|NOT COMPLETED|Washout Between Periods III and IV||0||
48648803|NCT00245570|101923834|FG003|NOT COMPLETED|Washout Between Periods III and IV||0||
48648804|NCT00245570|101923835|FG004|NOT COMPLETED|Washout Between Periods III and IV||0||
48648805|NCT00245570|101923836|FG005|NOT COMPLETED|Washout Between Periods III and IV||0||
48648806|NCT00245570|101923831|FG000|STARTED|Treatment Period IV||7||
48648807|NCT00245570|101923832|FG001|STARTED|Treatment Period IV||7||
48648808|NCT00245570|101923833|FG002|STARTED|Treatment Period IV||8||
48648809|NCT00245570|101923834|FG003|STARTED|Treatment Period IV||8||
48648810|NCT00245570|101923835|FG004|STARTED|Treatment Period IV||8||
48648811|NCT00245570|101923836|FG005|STARTED|Treatment Period IV||8||
48648812|NCT00245570|101923831|FG000|COMPLETED|Treatment Period IV||7||
48648813|NCT00245570|101923832|FG001|COMPLETED|Treatment Period IV||7||
48648814|NCT00245570|101923833|FG002|COMPLETED|Treatment Period IV||8||
48648815|NCT00245570|101923834|FG003|COMPLETED|Treatment Period IV||8||
48648816|NCT00245570|101923835|FG004|COMPLETED|Treatment Period IV||8||
48648817|NCT00245570|101923836|FG005|COMPLETED|Treatment Period IV||8||
48648818|NCT00245570|101923831|FG000|NOT COMPLETED|Treatment Period IV||0||
48648819|NCT00245570|101923832|FG001|NOT COMPLETED|Treatment Period IV||0||
48648820|NCT00245570|101923833|FG002|NOT COMPLETED|Treatment Period IV||0||
48648821|NCT00245570|101923834|FG003|NOT COMPLETED|Treatment Period IV||0||
48648822|NCT00245570|101923835|FG004|NOT COMPLETED|Treatment Period IV||0||
48648823|NCT00245570|101923836|FG005|NOT COMPLETED|Treatment Period IV||0||
48648824|NCT01786109|101923837|FG000|STARTED|Overall Study||24||
48648825|NCT01786109|101923838|FG001|STARTED|Overall Study||24||
48648826|NCT01786109|101923839|FG002|STARTED|Overall Study||27||
48648827|NCT01786109|101923837|FG000|COMPLETED|Overall Study||23||
48648828|NCT01786109|101923838|FG001|COMPLETED|Overall Study||24||
48648829|NCT01786109|101923839|FG002|COMPLETED|Overall Study||25||
48648830|NCT01786109|101923837|FG000|NOT COMPLETED|Overall Study||1||
48648831|NCT01786109|101923838|FG001|NOT COMPLETED|Overall Study||0||
48648832|NCT01786109|101923839|FG002|NOT COMPLETED|Overall Study||2||
48648833|NCT05696158|101923840|FG000|STARTED|Overall Study||97||
48648834|NCT05696158|101923840|FG000|COMPLETED|Overall Study||57||
48648835|NCT05696158|101923840|FG000|NOT COMPLETED|Overall Study||40||
48648836|NCT01618708|101927683|FG000|STARTED|Overall Study||175||
48648837|NCT01618708|101927684|FG001|STARTED|Overall Study||182||
48648838|NCT01618708|101927683|FG000|Treated|Overall Study||172||
48648839|NCT01618708|101927684|FG001|Treated|Overall Study||180||
48648840|NCT01618708|101927683|FG000|COMPLETED|Overall Study||131||
48648841|NCT01618708|101927684|FG001|COMPLETED|Overall Study||136||
48648842|NCT01618708|101927683|FG000|NOT COMPLETED|Overall Study||44||
48648843|NCT01618708|101927684|FG001|NOT COMPLETED|Overall Study||46||
48648844|NCT01666314|101927685|FG000|STARTED|Overall Study||33||
48648845|NCT01666314|101927686|FG001|STARTED|Overall Study||32||
48648846|NCT01666314|101927687|FG002|STARTED|Overall Study||36||
48648847|NCT01666314|101927688|FG003|STARTED|Overall Study||36||
48648848|NCT01666314|101927685|FG000|COMPLETED|Overall Study||0||
48648849|NCT01666314|101927686|FG001|COMPLETED|Overall Study||0||
48648850|NCT01666314|101927687|FG002|COMPLETED|Overall Study||0||
48648851|NCT01666314|101927688|FG003|COMPLETED|Overall Study||0||
48648852|NCT01666314|101927685|FG000|NOT COMPLETED|Overall Study||33||
48648853|NCT01666314|101927686|FG001|NOT COMPLETED|Overall Study||32||
48648854|NCT01666314|101927687|FG002|NOT COMPLETED|Overall Study||36||
48648855|NCT01666314|101927688|FG003|NOT COMPLETED|Overall Study||36||
48648856|NCT03777176|101927689|FG000|STARTED|Treatment Period 1||16||
48648857|NCT03777176|101927690|FG001|STARTED|Treatment Period 1||16||
48648858|NCT03777176|101927691|FG002|STARTED|Treatment Period 1||0||
48648859|NCT03777176|101927689|FG000|COMPLETED|Treatment Period 1||16||
48648860|NCT03777176|101927690|FG001|COMPLETED|Treatment Period 1||16||
48648861|NCT03777176|101927691|FG002|COMPLETED|Treatment Period 1||0||
48648862|NCT03777176|101927689|FG000|NOT COMPLETED|Treatment Period 1||0||
48648863|NCT03777176|101927690|FG001|NOT COMPLETED|Treatment Period 1||0||
48648864|NCT03777176|101927691|FG002|NOT COMPLETED|Treatment Period 1||0||
48648865|NCT03777176|101927689|FG000|STARTED|Treatment Period 2||0||
48648866|NCT03777176|101927690|FG001|STARTED|Treatment Period 2||0||
48648867|NCT03777176|101927691|FG002|STARTED|Treatment Period 2||32||
48648868|NCT03777176|101927689|FG000|Completed Study But Discontinued Treatment Due to an AE|Treatment Period 2||0||
48648869|NCT03777176|101927690|FG001|Completed Study But Discontinued Treatment Due to an AE|Treatment Period 2||0||
48648870|NCT03777176|101927691|FG002|Completed Study But Discontinued Treatment Due to an AE|Treatment Period 2||1||
48648871|NCT03777176|101927689|FG000|COMPLETED|Treatment Period 2||0||
48648872|NCT03777176|101927690|FG001|COMPLETED|Treatment Period 2||0||
48648873|NCT03777176|101927691|FG002|COMPLETED|Treatment Period 2||32||
48648874|NCT03777176|101927689|FG000|NOT COMPLETED|Treatment Period 2||0||
48648875|NCT03777176|101927690|FG001|NOT COMPLETED|Treatment Period 2||0||
48648876|NCT03777176|101927691|FG002|NOT COMPLETED|Treatment Period 2||0||
48648877|NCT02453191|101927692|FG000|STARTED|Overall Study||30||
48648878|NCT02453191|101927692|FG000|COMPLETED|Overall Study||29||
48648879|NCT02453191|101927692|FG000|NOT COMPLETED|Overall Study||1||
48648880|NCT01093885|101927693|FG000|STARTED|Overall Study||15||
48648881|NCT01093885|101927693|FG000|COMPLETED|Overall Study||10||
48648882|NCT01093885|101927693|FG000|NOT COMPLETED|Overall Study||5||
48648883|NCT02732145|101927694|FG000|STARTED|Overall Study||82||
48648884|NCT02732145|101927695|FG001|STARTED|Overall Study||82||
48648885|NCT02732145|101927696|FG002|STARTED|Overall Study||82||
48648886|NCT02732145|101927697|FG003|STARTED|Overall Study||82||
48648887|NCT02732145|101927694|FG000|COMPLETED|Overall Study||82||
48648888|NCT02732145|101927695|FG001|COMPLETED|Overall Study||82||
48648889|NCT02732145|101927696|FG002|COMPLETED|Overall Study||82||
48648890|NCT02732145|101927697|FG003|COMPLETED|Overall Study||82||
48648891|NCT02732145|101927694|FG000|NOT COMPLETED|Overall Study||0||
48648892|NCT02732145|101927695|FG001|NOT COMPLETED|Overall Study||0||
48648893|NCT02732145|101927696|FG002|NOT COMPLETED|Overall Study||0||
48648894|NCT02732145|101927697|FG003|NOT COMPLETED|Overall Study||0||
48648895|NCT00337194|101927698|FG000|STARTED|Overall Study||23||
48648896|NCT00337194|101927699|FG001|STARTED|Overall Study||7||
48648897|NCT00337194|101927698|FG000|COMPLETED|Overall Study||11||
48648898|NCT00337194|101927699|FG001|COMPLETED|Overall Study||3||
48648899|NCT00337194|101927698|FG000|NOT COMPLETED|Overall Study||12||
48648900|NCT00337194|101927699|FG001|NOT COMPLETED|Overall Study||4||
48648901|NCT02056288|101927700|FG000|STARTED|In-Hospital Data||40|Randomized|
48648902|NCT02056288|101927701|FG001|STARTED|In-Hospital Data||38|Randomized|
48648903|NCT02056288|101927700|FG000|COMPLETED|In-Hospital Data||35||
48648904|NCT02056288|101927701|FG001|COMPLETED|In-Hospital Data||38||
48648905|NCT02056288|101927700|FG000|NOT COMPLETED|In-Hospital Data||5||
48648906|NCT02056288|101927701|FG001|NOT COMPLETED|In-Hospital Data||0||
48648907|NCT02056288|101927700|FG000|STARTED|48-Hour Post-Discharge Data||35||
48648908|NCT02056288|101927701|FG001|STARTED|48-Hour Post-Discharge Data||38||
48648909|NCT02056288|101927700|FG000|COMPLETED|48-Hour Post-Discharge Data||21||
48648910|NCT02056288|101927701|FG001|COMPLETED|48-Hour Post-Discharge Data||18||
48648911|NCT02056288|101927700|FG000|NOT COMPLETED|48-Hour Post-Discharge Data||14||
48648912|NCT02056288|101927701|FG001|NOT COMPLETED|48-Hour Post-Discharge Data||20||
48648913|NCT00574951|101927702|FG000|STARTED|Overall Study||23||
48648914|NCT00574951|101927702|FG000|COMPLETED|Overall Study||22|Eligible and treated patients.|
48648915|NCT00574951|101927702|FG000|NOT COMPLETED|Overall Study||1||
48648916|NCT02614768|101927703|FG000|STARTED|Overall Study||12||
48648917|NCT02614768|101927703|FG000|COMPLETED|Overall Study||12||
48648918|NCT02614768|101927703|FG000|NOT COMPLETED|Overall Study||0||
48648919|NCT02053584|101927704|FG000|STARTED|Overall Study||230||
48648920|NCT02053584|101927704|FG000|COMPLETED|Overall Study||230||
48648921|NCT02053584|101927704|FG000|NOT COMPLETED|Overall Study||0||
48648922|NCT00153920|101927705|FG000|STARTED|Overall Study||66||
48648923|NCT00153920|101927705|FG000|Eligible and Treated|Overall Study||64||
48648924|NCT00153920|101927705|FG000|COMPLETED|Overall Study||36||
48648925|NCT00153920|101927705|FG000|NOT COMPLETED|Overall Study||30||
48648926|NCT01663987|101927706|FG000|STARTED|Overall Study||39||
48648927|NCT01663987|101927707|FG001|STARTED|Overall Study||40||
48648928|NCT01663987|101927706|FG000|COMPLETED|Overall Study||26||
48648929|NCT01663987|101927707|FG001|COMPLETED|Overall Study||34||
48648930|NCT01663987|101927706|FG000|NOT COMPLETED|Overall Study||13||
48648931|NCT01663987|101927707|FG001|NOT COMPLETED|Overall Study||6||
48765294|NCT00656448|102214616|FG000|NOT COMPLETED|Overall Study||0||
48765295|NCT00656448|102214617|FG001|NOT COMPLETED|Overall Study||0||
48765296|NCT02703597|102214618|FG000|STARTED|Assignment to Baseline||153||7
48765297|NCT02703597|102214619|FG001|STARTED|Assignment to Baseline||240||8
48765298|NCT02703597|102214618|FG000|COMPLETED|Assignment to Baseline||136||7
48765299|NCT02703597|102214619|FG001|COMPLETED|Assignment to Baseline||224||8
48362242|NCT00923091|101214496|FG009|COMPLETED|Period V (Double -Blind)||119||
48362243|NCT00923091|101214497|FG010|COMPLETED|Period V (Double -Blind)||193||
48362244|NCT00923091|101214498|FG011|COMPLETED|Period V (Double -Blind)||151||
48648932|NCT01834651|101927708|FG000|STARTED|Overall Study||17||
48648933|NCT01834651|101927708|FG000|COMPLETED|Overall Study||16||
48648934|NCT01834651|101927708|FG000|NOT COMPLETED|Overall Study||1||
48648935|NCT01975285|101927709|FG000|STARTED|Overall Study||30||
48648936|NCT01975285|101927710|FG001|STARTED|Overall Study||30||
48648937|NCT01975285|101927709|FG000|COMPLETED|Overall Study||28||
48648938|NCT01975285|101927710|FG001|COMPLETED|Overall Study||28||
48648939|NCT01975285|101927709|FG000|NOT COMPLETED|Overall Study||2||
48765300|NCT02703597|102214618|FG000|NOT COMPLETED|Assignment to Baseline||17||0
48765301|NCT02703597|102214619|FG001|NOT COMPLETED|Assignment to Baseline||16||0
48765302|NCT02703597|102214618|FG000|STARTED|Baseline to First Post-test||136||7
48765303|NCT02703597|102214619|FG001|STARTED|Baseline to First Post-test||224||8
48765304|NCT02703597|102214618|FG000|COMPLETED|Baseline to First Post-test||75||7
48765305|NCT02703597|102214619|FG001|COMPLETED|Baseline to First Post-test||132||8
48765306|NCT02703597|102214618|FG000|NOT COMPLETED|Baseline to First Post-test||61||0
48765307|NCT02703597|102214619|FG001|NOT COMPLETED|Baseline to First Post-test||92||0
48765308|NCT02703597|102214618|FG000|STARTED|First Post-test to First Follow-up||75||7
48648940|NCT01975285|101927710|FG001|NOT COMPLETED|Overall Study||2||
48648941|NCT04289298|101927711|FG000|STARTED|Overall Study||22||
48648942|NCT04289298|101927712|FG001|STARTED|Overall Study||4||
48648943|NCT04289298|101927711|FG000|COMPLETED|Overall Study||15||
48648944|NCT04289298|101927712|FG001|COMPLETED|Overall Study||4||
48648945|NCT04289298|101927711|FG000|NOT COMPLETED|Overall Study||7||
48648946|NCT04289298|101927712|FG001|NOT COMPLETED|Overall Study||0||
48648947|NCT00728182|101927713|FG000|STARTED|Overall Study||92||
48648948|NCT00728182|101927714|FG001|STARTED|Overall Study||93||
48648949|NCT00728182|101927713|FG000|COMPLETED|Overall Study||89||
48648950|NCT00728182|101927714|FG001|COMPLETED|Overall Study||90||
48648951|NCT00728182|101927713|FG000|NOT COMPLETED|Overall Study||3||
48648952|NCT00728182|101927714|FG001|NOT COMPLETED|Overall Study||3||
48648953|NCT04679818|101927715|FG000|STARTED|Overall Study||35||
48648954|NCT04679818|101927716|FG001|STARTED|Overall Study||37||
48648955|NCT04679818|101927715|FG000|COMPLETED|Overall Study||34||
48648956|NCT04679818|101927716|FG001|COMPLETED|Overall Study||37||
48648957|NCT04679818|101927715|FG000|NOT COMPLETED|Overall Study||1||
48648958|NCT04679818|101927716|FG001|NOT COMPLETED|Overall Study||0||
48648959|NCT03888482|101927717|FG000|STARTED|First Wear Period (8 -1/+2 Days)||76||
48648960|NCT03888482|101927718|FG001|STARTED|First Wear Period (8 -1/+2 Days)||75||
48648961|NCT03888482|101927717|FG000|COMPLETED|First Wear Period (8 -1/+2 Days)||76||
48648962|NCT03888482|101927718|FG001|COMPLETED|First Wear Period (8 -1/+2 Days)||75||
48648963|NCT03888482|101927717|FG000|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0||
48648964|NCT03888482|101927718|FG001|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0||
48648965|NCT03888482|101927717|FG000|STARTED|Second Wear (8 -1/+2 Days)||74||
48648966|NCT03888482|101927718|FG001|STARTED|Second Wear (8 -1/+2 Days)||75||
48648967|NCT03888482|101927717|FG000|COMPLETED|Second Wear (8 -1/+2 Days)||73||
48648968|NCT03888482|101927718|FG001|COMPLETED|Second Wear (8 -1/+2 Days)||74||
48648969|NCT03888482|101927717|FG000|NOT COMPLETED|Second Wear (8 -1/+2 Days)||1||
48648970|NCT03888482|101927718|FG001|NOT COMPLETED|Second Wear (8 -1/+2 Days)||1||
48648971|NCT00300495|101927719|FG000|STARTED|Overall Study||10||
48648972|NCT00300495|101927720|FG001|STARTED|Overall Study||9||
48648973|NCT00300495|101927719|FG000|COMPLETED|Overall Study||6||
48648974|NCT00300495|101927720|FG001|COMPLETED|Overall Study||8||
48648975|NCT00300495|101927719|FG000|NOT COMPLETED|Overall Study||4||
48648976|NCT00300495|101927720|FG001|NOT COMPLETED|Overall Study||1||
48648977|NCT01666652|101927721|FG000|STARTED|Overall Study||20||
48648978|NCT01666652|101927722|FG001|STARTED|Overall Study||20||
48648979|NCT01666652|101927723|FG002|STARTED|Overall Study||20||
48765309|NCT02703597|102214619|FG001|STARTED|First Post-test to First Follow-up||132||8
48765310|NCT02703597|102214618|FG000|COMPLETED|First Post-test to First Follow-up||70||7
48765311|NCT02703597|102214619|FG001|COMPLETED|First Post-test to First Follow-up||71||7
48765312|NCT02703597|102214618|FG000|NOT COMPLETED|First Post-test to First Follow-up||5||0
48765313|NCT02703597|102214619|FG001|NOT COMPLETED|First Post-test to First Follow-up||61||1
48765314|NCT02703597|102214618|FG000|STARTED|Recruitment Period for Assessment 5||70||7
48648980|NCT01666652|101927724|FG003|STARTED|Overall Study||20||
48648981|NCT01666652|101927725|FG004|STARTED|Overall Study||20||
48648982|NCT01666652|101927721|FG000|COMPLETED|Overall Study||18||
48648983|NCT01666652|101927722|FG001|COMPLETED|Overall Study||19||
48648984|NCT01666652|101927723|FG002|COMPLETED|Overall Study||19||
48648985|NCT01666652|101927724|FG003|COMPLETED|Overall Study||16||
48648986|NCT01666652|101927725|FG004|COMPLETED|Overall Study||19||
48648987|NCT01666652|101927721|FG000|NOT COMPLETED|Overall Study||2||
48648988|NCT01666652|101927722|FG001|NOT COMPLETED|Overall Study||1||
48648989|NCT01666652|101927723|FG002|NOT COMPLETED|Overall Study||1||
48648990|NCT01666652|101927724|FG003|NOT COMPLETED|Overall Study||4||
48648991|NCT01666652|101927725|FG004|NOT COMPLETED|Overall Study||1||
48648992|NCT03600428|101927726|FG000|STARTED|Overall Study||79||
48648993|NCT03600428|101927727|FG001|STARTED|Overall Study||73||
48648994|NCT03600428|101927726|FG000|15-day Follow-up|Overall Study||76||
48648995|NCT03600428|101927727|FG001|15-day Follow-up|Overall Study||70||
48648996|NCT03600428|101927726|FG000|43-day Follow-up|Overall Study||74||
48648997|NCT03600428|101927727|FG001|43-day Follow-up|Overall Study||68||
48648998|NCT03600428|101927726|FG000|COMPLETED|Overall Study||74||
48648999|NCT03600428|101927727|FG001|COMPLETED|Overall Study||68||
48649000|NCT03600428|101927726|FG000|NOT COMPLETED|Overall Study||5||
48649001|NCT03600428|101927727|FG001|NOT COMPLETED|Overall Study||5||
48649002|NCT01208051|101927728|FG000|STARTED|Total Enrollment||4||
48649003|NCT01208051|101927729|FG001|STARTED|Total Enrollment||7||
48649004|NCT01208051|101927730|FG002|STARTED|Total Enrollment||6||
48649005|NCT01208051|101927731|FG003|STARTED|Total Enrollment||39||
48649006|NCT01208051|101927732|FG004|STARTED|Total Enrollment||71||
48765315|NCT02703597|102214619|FG001|STARTED|Recruitment Period for Assessment 5||71||7
48765316|NCT02703597|102214618|FG000|COMPLETED|Recruitment Period for Assessment 5||54||4
48765317|NCT02703597|102214619|FG001|COMPLETED|Recruitment Period for Assessment 5||0||0
48649007|NCT01208051|101927728|FG000|COMPLETED|Total Enrollment||4||
48765318|NCT02703597|102214618|FG000|NOT COMPLETED|Recruitment Period for Assessment 5||16||3
48765319|NCT02703597|102214619|FG001|NOT COMPLETED|Recruitment Period for Assessment 5||71||7
48765320|NCT02703597|102214618|FG000|STARTED|Recruitment to Assessment 5||54||4
48649008|NCT01208051|101927729|FG001|COMPLETED|Total Enrollment||6||
48649009|NCT01208051|101927730|FG002|COMPLETED|Total Enrollment||5||
48649010|NCT01208051|101927731|FG003|COMPLETED|Total Enrollment||39||
48649011|NCT01208051|101927732|FG004|COMPLETED|Total Enrollment||69||
48649012|NCT01208051|101927728|FG000|NOT COMPLETED|Total Enrollment||0||
48649013|NCT01208051|101927729|FG001|NOT COMPLETED|Total Enrollment||1||
48649014|NCT01208051|101927730|FG002|NOT COMPLETED|Total Enrollment||1||
48649015|NCT01208051|101927731|FG003|NOT COMPLETED|Total Enrollment||0||
48649016|NCT01208051|101927732|FG004|NOT COMPLETED|Total Enrollment||2||
48649017|NCT01208051|101927728|FG000|STARTED|Interim Futility Analysis||0||
48649018|NCT01208051|101927729|FG001|STARTED|Interim Futility Analysis||0||
48649019|NCT01208051|101927730|FG002|STARTED|Interim Futility Analysis||0||
48649020|NCT01208051|101927731|FG003|STARTED|Interim Futility Analysis||39||
48649021|NCT01208051|101927732|FG004|STARTED|Interim Futility Analysis||68||
48649022|NCT01208051|101927728|FG000|COMPLETED|Interim Futility Analysis||0||
48649023|NCT01208051|101927729|FG001|COMPLETED|Interim Futility Analysis||0||
48649024|NCT01208051|101927730|FG002|COMPLETED|Interim Futility Analysis||0||
48649025|NCT01208051|101927731|FG003|COMPLETED|Interim Futility Analysis||39||
48649026|NCT01208051|101927732|FG004|COMPLETED|Interim Futility Analysis||68||
48649027|NCT01208051|101927728|FG000|NOT COMPLETED|Interim Futility Analysis||0||
48649028|NCT01208051|101927729|FG001|NOT COMPLETED|Interim Futility Analysis||0||
48649029|NCT01208051|101927730|FG002|NOT COMPLETED|Interim Futility Analysis||0||
48649030|NCT01208051|101927731|FG003|NOT COMPLETED|Interim Futility Analysis||0||
48649031|NCT01208051|101927732|FG004|NOT COMPLETED|Interim Futility Analysis||0||
48649032|NCT01208051|101927728|FG000|STARTED|After Crossover to Cediranib Only||0||
48649033|NCT01208051|101927729|FG001|STARTED|After Crossover to Cediranib Only||0||
48649034|NCT01208051|101927730|FG002|STARTED|After Crossover to Cediranib Only||0||
48649035|NCT01208051|101927731|FG003|STARTED|After Crossover to Cediranib Only||39||
48649036|NCT01208051|101927732|FG004|STARTED|After Crossover to Cediranib Only||69||
48649037|NCT01208051|101927728|FG000|COMPLETED|After Crossover to Cediranib Only||0||
48649038|NCT01208051|101927729|FG001|COMPLETED|After Crossover to Cediranib Only||0||
48649039|NCT01208051|101927730|FG002|COMPLETED|After Crossover to Cediranib Only||0||
48649040|NCT01208051|101927731|FG003|COMPLETED|After Crossover to Cediranib Only||39||
48649041|NCT01208051|101927732|FG004|COMPLETED|After Crossover to Cediranib Only||69||
48649042|NCT01208051|101927728|FG000|NOT COMPLETED|After Crossover to Cediranib Only||0||
48649043|NCT01208051|101927729|FG001|NOT COMPLETED|After Crossover to Cediranib Only||0||
48649044|NCT01208051|101927730|FG002|NOT COMPLETED|After Crossover to Cediranib Only||0||
48649045|NCT01208051|101927731|FG003|NOT COMPLETED|After Crossover to Cediranib Only||0||
48649046|NCT01208051|101927732|FG004|NOT COMPLETED|After Crossover to Cediranib Only||0||
48649047|NCT02164721|101927733|FG000|STARTED|Overall Study||30||
48649048|NCT02164721|101927733|FG000|COMPLETED|Overall Study||30||
48649049|NCT02164721|101927733|FG000|NOT COMPLETED|Overall Study||0||
48649050|NCT03436420|101927734|FG000|STARTED|Overall Study||6||
48649051|NCT03436420|101927734|FG000|COMPLETED|Overall Study||3||
48649052|NCT03436420|101927734|FG000|NOT COMPLETED|Overall Study||3||
48649053|NCT01691313|101927735|FG000|STARTED|Overall Study||22||
48649054|NCT01691313|101927736|FG001|STARTED|Overall Study||32||
48649055|NCT01691313|101927737|FG002|STARTED|Overall Study||25||
48649056|NCT01691313|101927738|FG003|STARTED|Overall Study||25||
48649057|NCT01691313|101927735|FG000|COMPLETED|Overall Study||22||
48649058|NCT01691313|101927736|FG001|COMPLETED|Overall Study||32||
48649059|NCT01691313|101927737|FG002|COMPLETED|Overall Study||25||
48649060|NCT01691313|101927738|FG003|COMPLETED|Overall Study||25||
48649061|NCT01691313|101927735|FG000|NOT COMPLETED|Overall Study||0||
48649062|NCT01691313|101927736|FG001|NOT COMPLETED|Overall Study||0||
48649063|NCT01691313|101927737|FG002|NOT COMPLETED|Overall Study||0||
48649064|NCT01691313|101927738|FG003|NOT COMPLETED|Overall Study||0||
48649065|NCT03281538|101927739|FG000|STARTED|Overall Study||288||
48649066|NCT03281538|101927739|FG000|COMPLETED|Overall Study||133||
48649067|NCT03281538|101927739|FG000|NOT COMPLETED|Overall Study||155||
48649068|NCT00620035|101927740|FG000|STARTED|Overall Study||301||
48649069|NCT00620035|101927740|FG000|COMPLETED|Overall Study||156||
48649070|NCT00620035|101927740|FG000|NOT COMPLETED|Overall Study||145||
48649071|NCT00474968|101927741|FG000|STARTED|Overall Study||366||
48649072|NCT00474968|101927742|FG001|STARTED|Overall Study||371||
48649073|NCT00474968|101927741|FG000|COMPLETED|Overall Study||348||
48649074|NCT00474968|101927742|FG001|COMPLETED|Overall Study||355||
48649075|NCT00474968|101927741|FG000|NOT COMPLETED|Overall Study||18||
48649076|NCT00474968|101927742|FG001|NOT COMPLETED|Overall Study||16||
48649077|NCT02965976|101927743|FG000|STARTED|Overall Study||15||
48649078|NCT02965976|101927744|FG001|STARTED|Overall Study||17||
48649079|NCT02965976|101927743|FG000|COMPLETED|Overall Study||13||
48649080|NCT02965976|101927744|FG001|COMPLETED|Overall Study||17||
48649081|NCT02965976|101927743|FG000|NOT COMPLETED|Overall Study||2||
48649082|NCT02965976|101927744|FG001|NOT COMPLETED|Overall Study||0||
48649083|NCT02269488|101927745|FG000|STARTED|Overall Study||100||
48649084|NCT02269488|101927745|FG000|COMPLETED|Overall Study||100||
48649085|NCT02269488|101927745|FG000|NOT COMPLETED|Overall Study||0||
48649086|NCT00291226|101927746|FG000|STARTED|Overall Study||4||
48649087|NCT00291226|101927747|FG001|STARTED|Overall Study||4||
48649088|NCT00291226|101927746|FG000|COMPLETED|Overall Study||3||
48649089|NCT00291226|101927747|FG001|COMPLETED|Overall Study||3||
48649090|NCT00291226|101927746|FG000|NOT COMPLETED|Overall Study||1||
48649091|NCT00291226|101927747|FG001|NOT COMPLETED|Overall Study||1||
48649092|NCT00612768|101927748|FG000|STARTED|Overall Study||50||
48649093|NCT00612768|101927748|FG000|COMPLETED|Overall Study||50||
48649094|NCT00612768|101927748|FG000|NOT COMPLETED|Overall Study||0||
48649095|NCT00580294|101927749|FG000|STARTED|Overall Study||12||
48649096|NCT00580294|101927749|FG000|COMPLETED|Overall Study||12||
48649097|NCT00580294|101927749|FG000|NOT COMPLETED|Overall Study||0||
48649098|NCT00138294|101927750|FG000|STARTED|Overall Study||29255||
48649099|NCT00138294|101927750|FG000|COMPLETED|Overall Study||29255||
48649100|NCT00138294|101927750|FG000|NOT COMPLETED|Overall Study||0||
48649101|NCT04366583|101927751|FG000|STARTED|Overall Study||82||
48649102|NCT04366583|101927752|FG001|STARTED|Overall Study||84||
48649103|NCT04366583|101927751|FG000|COMPLETED|Overall Study||82||
48649104|NCT04366583|101927752|FG001|COMPLETED|Overall Study||84||
48649105|NCT04366583|101927751|FG000|NOT COMPLETED|Overall Study||0||
48649106|NCT04366583|101927752|FG001|NOT COMPLETED|Overall Study||0||
48649107|NCT01259024|101927753|FG000|STARTED|Overall Study||1||
48649108|NCT01259024|101927753|FG000|COMPLETED|Overall Study||0||
48649109|NCT01259024|101927753|FG000|NOT COMPLETED|Overall Study||1||
48649110|NCT02493855|101927754|FG000|STARTED|Overall Study||21||
48649111|NCT02493855|101927755|FG001|STARTED|Overall Study||19||
48649112|NCT02493855|101927756|FG002|STARTED|Overall Study||6||
48649113|NCT02493855|101927754|FG000|COMPLETED|Overall Study||19||
48649114|NCT02493855|101927755|FG001|COMPLETED|Overall Study||18||
48649115|NCT02493855|101927756|FG002|COMPLETED|Overall Study||6||
48649116|NCT02493855|101927754|FG000|NOT COMPLETED|Overall Study||2||
48649117|NCT02493855|101927755|FG001|NOT COMPLETED|Overall Study||1||
48649118|NCT02493855|101927756|FG002|NOT COMPLETED|Overall Study||0||
48649119|NCT00025233|101927757|FG000|STARTED|Overall Study||50||
48649120|NCT00025233|101927757|FG000|COMPLETED|Overall Study||46||
48649121|NCT00025233|101927757|FG000|NOT COMPLETED|Overall Study||4||
48649122|NCT02985710|101927758|FG000|STARTED|Overall Study||69||
48649123|NCT02985710|101927759|FG001|STARTED|Overall Study||33||
48649124|NCT02985710|101927758|FG000|COMPLETED|Overall Study||65||
48649125|NCT02985710|101927759|FG001|COMPLETED|Overall Study||33||
48649126|NCT02985710|101927758|FG000|NOT COMPLETED|Overall Study||4||
48649127|NCT02985710|101927759|FG001|NOT COMPLETED|Overall Study||0||
48649128|NCT00504231|101927760|FG000|STARTED|Overall Study||65||
48649129|NCT00504231|101927761|FG001|STARTED|Overall Study||64||
48649130|NCT00504231|101927762|FG002|STARTED|Overall Study||64||
48649131|NCT00504231|101927763|FG003|STARTED|Overall Study||65||
48649132|NCT00504231|101927760|FG000|COMPLETED|Overall Study||65||
48649133|NCT00504231|101927761|FG001|COMPLETED|Overall Study||64||
48649134|NCT00504231|101927762|FG002|COMPLETED|Overall Study||63||
48649135|NCT00504231|101927763|FG003|COMPLETED|Overall Study||65||
48649136|NCT00504231|101927760|FG000|NOT COMPLETED|Overall Study||0||
48649137|NCT00504231|101927761|FG001|NOT COMPLETED|Overall Study||0||
48649138|NCT00504231|101927762|FG002|NOT COMPLETED|Overall Study||1||
48649139|NCT00504231|101927763|FG003|NOT COMPLETED|Overall Study||0||
48649140|NCT03189433|101927764|FG000|STARTED|Overall Study||2||
48649141|NCT03189433|101927765|FG001|STARTED|Overall Study||0||
48649142|NCT03189433|101927764|FG000|COMPLETED|Overall Study||0||
48649143|NCT03189433|101927765|FG001|COMPLETED|Overall Study||0||
48649144|NCT03189433|101927764|FG000|NOT COMPLETED|Overall Study||2||
48765321|NCT02703597|102214619|FG001|STARTED|Recruitment to Assessment 5||0||0
48649145|NCT03189433|101927765|FG001|NOT COMPLETED|Overall Study||0||
48649146|NCT00185900|101927766|FG000|STARTED|Overall Study||92||
48649147|NCT00185900|101927767|FG001|STARTED|Overall Study||100||
48649148|NCT00185900|101927766|FG000|COMPLETED|Overall Study||92||
48649149|NCT00185900|101927767|FG001|COMPLETED|Overall Study||100||
48649150|NCT00185900|101927766|FG000|NOT COMPLETED|Overall Study||0||
48649151|NCT00185900|101927767|FG001|NOT COMPLETED|Overall Study||0||
48649152|NCT01530256|101927768|FG000|STARTED|Overall Study||3||
48649153|NCT01530256|101927768|FG000|COMPLETED|Overall Study||1||
48649154|NCT01530256|101927768|FG000|NOT COMPLETED|Overall Study||2||
48649155|NCT00500110|101927769|FG000|STARTED|Overall Study||39||
48649156|NCT00500110|101927769|FG000|COMPLETED|Overall Study||36||
48649157|NCT00500110|101927769|FG000|NOT COMPLETED|Overall Study||3||
48649158|NCT01245049|101927770|FG000|STARTED|Overall Study||255||
48649159|NCT01245049|101927771|FG001|STARTED|Overall Study||130||
48649160|NCT01245049|101927770|FG000|COMPLETED|Overall Study||254||
48649161|NCT01245049|101927771|FG001|COMPLETED|Overall Study||126||
48649162|NCT01245049|101927770|FG000|NOT COMPLETED|Overall Study||1||
48649163|NCT01245049|101927771|FG001|NOT COMPLETED|Overall Study||4||
48649164|NCT03532490|101927772|FG000|STARTED|Overall Study||16||
48765322|NCT02703597|102214618|FG000|COMPLETED|Recruitment to Assessment 5||54||4
48765323|NCT02703597|102214619|FG001|COMPLETED|Recruitment to Assessment 5||0||0
48649165|NCT03532490|101927773|FG001|STARTED|Overall Study||22||
48649166|NCT03532490|101927772|FG000|COMPLETED|Overall Study||16||
48649167|NCT03532490|101927773|FG001|COMPLETED|Overall Study||22||
48649168|NCT03532490|101927772|FG000|NOT COMPLETED|Overall Study||0||
48649169|NCT03532490|101927773|FG001|NOT COMPLETED|Overall Study||0||
48649170|NCT03607695|101927774|FG000|STARTED|2 Week||19||
48649171|NCT03607695|101927774|FG000|COMPLETED|2 Week||19||
48649172|NCT03607695|101927774|FG000|NOT COMPLETED|2 Week||0||
48649173|NCT03607695|101927774|FG000|STARTED|10 Week||19||
48649174|NCT03607695|101927774|FG000|COMPLETED|10 Week||18||
48649175|NCT03607695|101927774|FG000|NOT COMPLETED|10 Week||1||
48649176|NCT03607695|101927774|FG000|STARTED|16 Week||18||
48649177|NCT03607695|101927774|FG000|COMPLETED|16 Week||16||
48649178|NCT03607695|101927774|FG000|NOT COMPLETED|16 Week||2||
48649179|NCT00887588|101927775|FG000|STARTED|Core Period||149||
48649180|NCT00887588|101927776|FG001|STARTED|Core Period||152||
48649181|NCT00887588|101927775|FG000|Extension Efficacy Set|Core Period||127||
48649182|NCT00887588|101927776|FG001|Extension Efficacy Set|Core Period||125||
48649183|NCT00887588|101927775|FG000|Full Analysis Set|Core Period||148||
48649184|NCT00887588|101927776|FG001|Full Analysis Set|Core Period||146||
48649185|NCT00887588|101927775|FG000|Arterial Stiffness Set|Core Period||86||
48649186|NCT00887588|101927776|FG001|Arterial Stiffness Set|Core Period||94||
48649187|NCT00887588|101927775|FG000|COMPLETED|Core Period||130||
48649188|NCT00887588|101927776|FG001|COMPLETED|Core Period||131||
48649189|NCT00887588|101927775|FG000|NOT COMPLETED|Core Period||19||
48649190|NCT00887588|101927776|FG001|NOT COMPLETED|Core Period||21||
48649191|NCT00887588|101927775|FG000|STARTED|Extension Period||127||
48649192|NCT00887588|101927776|FG001|STARTED|Extension Period||125||
48649193|NCT00887588|101927775|FG000|Arterial Stiffness Set|Extension Period||86||
48649194|NCT00887588|101927776|FG001|Arterial Stiffness Set|Extension Period||94||
48649195|NCT00887588|101927775|FG000|COMPLETED|Extension Period||121||
48649196|NCT00887588|101927776|FG001|COMPLETED|Extension Period||120||
48649197|NCT00887588|101927775|FG000|NOT COMPLETED|Extension Period||6||
48649198|NCT00887588|101927776|FG001|NOT COMPLETED|Extension Period||5||
48649199|NCT04621760|101927777|FG000|STARTED|Overall Study||95||
48649200|NCT04621760|101927778|FG001|STARTED|Overall Study||94||
48649201|NCT04621760|101927777|FG000|COMPLETED|Overall Study||92||
48649202|NCT04621760|101927778|FG001|COMPLETED|Overall Study||90||
48649203|NCT04621760|101927777|FG000|NOT COMPLETED|Overall Study||3||
48649204|NCT04621760|101927778|FG001|NOT COMPLETED|Overall Study||4||
48649205|NCT01691482|101927779|FG000|STARTED|Treatment Period 1||28||
48649206|NCT01691482|101927780|FG001|STARTED|Treatment Period 1||28||
48649207|NCT01691482|101927779|FG000|COMPLETED|Treatment Period 1||28||
48649208|NCT01691482|101927780|FG001|COMPLETED|Treatment Period 1||28||
48649209|NCT01691482|101927779|FG000|NOT COMPLETED|Treatment Period 1||0||
48765324|NCT02703597|102214618|FG000|NOT COMPLETED|Recruitment to Assessment 5||0||0
48765325|NCT02703597|102214619|FG001|NOT COMPLETED|Recruitment to Assessment 5||0||0
48765326|NCT02703597|102214618|FG000|STARTED|Assessment 5 to Second Post-test||54||4
48765327|NCT02703597|102214619|FG001|STARTED|Assessment 5 to Second Post-test||0||0
48765328|NCT02703597|102214618|FG000|COMPLETED|Assessment 5 to Second Post-test||27||4
48765329|NCT02703597|102214619|FG001|COMPLETED|Assessment 5 to Second Post-test||0||0
48765330|NCT02703597|102214618|FG000|NOT COMPLETED|Assessment 5 to Second Post-test||27||0
48765331|NCT02703597|102214619|FG001|NOT COMPLETED|Assessment 5 to Second Post-test||0||0
48765332|NCT00573508|102214620|FG000|STARTED|Overall Study||382||
48765333|NCT00573508|102214621|FG001|STARTED|Overall Study||386||
48765334|NCT00573508|102214620|FG000|Full Analysis Set (FAS)|Overall Study||374||
48765335|NCT00573508|102214621|FG001|Full Analysis Set (FAS)|Overall Study||377||
48765336|NCT00573508|102214620|FG000|COMPLETED|Overall Study||318||
48765337|NCT00573508|102214621|FG001|COMPLETED|Overall Study||345||
48765338|NCT00573508|102214620|FG000|NOT COMPLETED|Overall Study||64||
48765339|NCT00573508|102214621|FG001|NOT COMPLETED|Overall Study||41||
48765340|NCT01907854|102214622|FG000|STARTED|Overall Study||203||
48765341|NCT01907854|102214623|FG001|STARTED|Overall Study||204||
48765342|NCT01907854|102214622|FG000|Exposed|Overall Study||202||
48765343|NCT01907854|102214623|FG001|Exposed|Overall Study||204||
48765344|NCT01907854|102214622|FG000|COMPLETED|Overall Study||187||
48765345|NCT01907854|102214623|FG001|COMPLETED|Overall Study||191||
48765346|NCT01907854|102214622|FG000|NOT COMPLETED|Overall Study||16||
48765347|NCT01907854|102214623|FG001|NOT COMPLETED|Overall Study||13||
48765348|NCT01151189|102214624|FG000|STARTED|Overall Study||326||
48765349|NCT01151189|102214625|FG001|STARTED|Overall Study||324||
48765350|NCT01151189|102214624|FG000|Received Vaccine|Overall Study||325||
48765351|NCT01151189|102214625|FG001|Received Vaccine|Overall Study||324||
48765352|NCT01151189|102214624|FG000|COMPLETED|Overall Study||311||
48649210|NCT01691482|101927780|FG001|NOT COMPLETED|Treatment Period 1||0||
48649211|NCT01691482|101927779|FG000|STARTED|Treatment Period 2||28||
48649212|NCT01691482|101927780|FG001|STARTED|Treatment Period 2||28||
48649213|NCT01691482|101927779|FG000|COMPLETED|Treatment Period 2||27||
48649214|NCT01691482|101927780|FG001|COMPLETED|Treatment Period 2||26||
48649215|NCT01691482|101927779|FG000|NOT COMPLETED|Treatment Period 2||1||
48649216|NCT01691482|101927780|FG001|NOT COMPLETED|Treatment Period 2||2||
48649217|NCT01390584|101927781|FG000|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||4||
48765353|NCT01151189|102214625|FG001|COMPLETED|Overall Study||314||
48765354|NCT01151189|102214624|FG000|NOT COMPLETED|Overall Study||15||
48765355|NCT01151189|102214625|FG001|NOT COMPLETED|Overall Study||10||
48649218|NCT01390584|101927782|FG001|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||1||
48649219|NCT01390584|101927783|FG002|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||1||
48649220|NCT01390584|101927781|FG000|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||4||
48649221|NCT01390584|101927782|FG001|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||1||
48649222|NCT01390584|101927783|FG002|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0||
48657048|NCT03648372|101943767|FG010|STARTED|Overall Study||8||
48765356|NCT05258721|102214626|FG000|STARTED|Overall Study||60||
48765357|NCT05258721|102214626|FG000|COMPLETED|Overall Study||52||
48765358|NCT05258721|102214626|FG000|NOT COMPLETED|Overall Study||8||
48765359|NCT05286749|102214627|FG000|STARTED|Overall Study||75||
48765360|NCT05286749|102214628|FG001|STARTED|Overall Study||78||
48765361|NCT05286749|102214627|FG000|COMPLETED|Overall Study||75||
48765362|NCT05286749|102214628|FG001|COMPLETED|Overall Study||78||
48765363|NCT05286749|102214627|FG000|NOT COMPLETED|Overall Study||0||
48649223|NCT01390584|101927781|FG000|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0||
48649224|NCT01390584|101927782|FG001|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0||
48649225|NCT01390584|101927783|FG002|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||1||
48649226|NCT01390584|101927781|FG000|STARTED|Step 2: ABVD or BEACOPP Then INRT||4||
48649227|NCT01390584|101927782|FG001|STARTED|Step 2: ABVD or BEACOPP Then INRT||1||
48649228|NCT01390584|101927783|FG002|STARTED|Step 2: ABVD or BEACOPP Then INRT||0||
48649229|NCT01390584|101927781|FG000|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||4||
48649230|NCT01390584|101927782|FG001|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||1||
48649231|NCT01390584|101927783|FG002|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0||
48649232|NCT01390584|101927781|FG000|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0||
48649233|NCT01390584|101927782|FG001|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0||
48649234|NCT01390584|101927783|FG002|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0||
48649235|NCT01902303|101927784|FG000|STARTED|Overall Study||77||
48649236|NCT01902303|101927785|FG001|STARTED|Overall Study||81||
48649237|NCT01902303|101927784|FG000|Number of Participants|Overall Study||56||
48649238|NCT01902303|101927785|FG001|Number of Participants|Overall Study||62||
48649239|NCT01902303|101927784|FG000|COMPLETED|Overall Study||54||
48649240|NCT01902303|101927785|FG001|COMPLETED|Overall Study||57||
48649241|NCT01902303|101927784|FG000|NOT COMPLETED|Overall Study||23||
48649242|NCT01902303|101927785|FG001|NOT COMPLETED|Overall Study||24||
48649243|NCT02216851|101927786|FG000|STARTED|Overall Study||98||
48649244|NCT02216851|101927787|FG001|STARTED|Overall Study||33||
48649245|NCT02216851|101927786|FG000|COMPLETED|Overall Study||96||
48649246|NCT02216851|101927787|FG001|COMPLETED|Overall Study||32||
48649247|NCT02216851|101927786|FG000|NOT COMPLETED|Overall Study||2||
48649248|NCT02216851|101927787|FG001|NOT COMPLETED|Overall Study||1||
48649249|NCT00992394|101927788|FG000|STARTED|Overall Study||88||
48649250|NCT00992394|101927789|FG001|STARTED|Overall Study||86||
48649251|NCT00992394|101927788|FG000|Safety Population|Overall Study||87||
48649252|NCT00992394|101927789|FG001|Safety Population|Overall Study||84||
48649253|NCT00992394|101927788|FG000|mITT Population|Overall Study||86||
48649254|NCT00992394|101927789|FG001|mITT Population|Overall Study||84||
48649255|NCT00992394|101927788|FG000|COMPLETED|Overall Study||64||
48649256|NCT00992394|101927789|FG001|COMPLETED|Overall Study||72||
48649257|NCT00992394|101927788|FG000|NOT COMPLETED|Overall Study||24||
48649258|NCT00992394|101927789|FG001|NOT COMPLETED|Overall Study||14||
48649259|NCT00472641|101927790|FG000|STARTED|Overall Study||25||
48649260|NCT00472641|101927790|FG000|COMPLETED|Overall Study||18||
48649261|NCT00472641|101927790|FG000|NOT COMPLETED|Overall Study||7||
48649262|NCT01778985|101927791|FG000|STARTED|Overall Study||15||
48649263|NCT01778985|101927792|FG001|STARTED|Overall Study||15||
48649264|NCT01778985|101927791|FG000|COMPLETED|Overall Study||8||
48649265|NCT01778985|101927792|FG001|COMPLETED|Overall Study||12||
48649266|NCT01778985|101927791|FG000|NOT COMPLETED|Overall Study||7||
48649267|NCT01778985|101927792|FG001|NOT COMPLETED|Overall Study||3||
48649268|NCT01309880|101927793|FG000|STARTED|Overall Study||33||
48649269|NCT01309880|101927794|FG001|STARTED|Overall Study||33||
48649270|NCT01309880|101927793|FG000|COMPLETED|Overall Study||33||
48649271|NCT01309880|101927794|FG001|COMPLETED|Overall Study||33||
48649272|NCT01309880|101927793|FG000|NOT COMPLETED|Overall Study||0||
48649273|NCT01309880|101927794|FG001|NOT COMPLETED|Overall Study||0||
48649274|NCT02205359|101927795|FG000|STARTED|Overall Study||1810|Number of subjects following successful implant and randomization|
48649275|NCT02205359|101927796|FG001|STARTED|Overall Study||1807|Number of subjects following successful implant and randomization|
48649276|NCT02205359|101927795|FG000|COMPLETED|Overall Study||1117||
48649277|NCT02205359|101927796|FG001|COMPLETED|Overall Study||1096||
48649278|NCT02205359|101927795|FG000|NOT COMPLETED|Overall Study||693||
48649279|NCT02205359|101927796|FG001|NOT COMPLETED|Overall Study||711||
48649280|NCT01089543|101927797|FG000|STARTED|Overall Study||84||
48649281|NCT01089543|101927798|FG001|STARTED|Overall Study||85||
48649282|NCT01089543|101927799|FG002|STARTED|Overall Study||84||
48649283|NCT01089543|101927800|FG003|STARTED|Overall Study||85||
48649284|NCT01089543|101927797|FG000|COMPLETED|Overall Study||81||
48649285|NCT01089543|101927798|FG001|COMPLETED|Overall Study||81||
48649286|NCT01089543|101927799|FG002|COMPLETED|Overall Study||81||
48649287|NCT01089543|101927800|FG003|COMPLETED|Overall Study||83||
48765364|NCT05286749|102214628|FG001|NOT COMPLETED|Overall Study||0||
48765365|NCT03591406|102214629|FG000|STARTED|Overall Study||188||
48765366|NCT03591406|102214630|FG001|STARTED|Overall Study||183||
48765367|NCT03591406|102214629|FG000|COMPLETED|Overall Study||181||
48765368|NCT03591406|102214630|FG001|COMPLETED|Overall Study||174||
48765369|NCT03591406|102214629|FG000|NOT COMPLETED|Overall Study||7||
48649288|NCT01089543|101927797|FG000|NOT COMPLETED|Overall Study||3||
48649289|NCT01089543|101927798|FG001|NOT COMPLETED|Overall Study||4||
48649290|NCT01089543|101927799|FG002|NOT COMPLETED|Overall Study||3||
48765370|NCT03591406|102214630|FG001|NOT COMPLETED|Overall Study||9||
48649291|NCT01089543|101927800|FG003|NOT COMPLETED|Overall Study||2||
48649292|NCT00069329|101927801|FG000|STARTED|Overall Study||43||
48649293|NCT00069329|101927801|FG000|COMPLETED|Overall Study||41||
48649294|NCT00069329|101927801|FG000|NOT COMPLETED|Overall Study||2||
48649295|NCT01521364|101927802|FG000|STARTED|Linezolid Without Clarithromycin (1 wk)||7||
48649296|NCT01521364|101927802|FG000|COMPLETED|Linezolid Without Clarithromycin (1 wk)||7||
48649297|NCT01521364|101927802|FG000|NOT COMPLETED|Linezolid Without Clarithromycin (1 wk)||0||
48649298|NCT01521364|101927802|FG000|STARTED|Linezolid + 250mg Claritromycin (wk 2&3)||7||
48649299|NCT01521364|101927802|FG000|COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||6||
48649300|NCT01521364|101927802|FG000|NOT COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||1||
48649301|NCT01521364|101927802|FG000|STARTED|Linezolid + 500mg Claritromycin (wk 4&5)||6||
48649302|NCT01521364|101927802|FG000|COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||5||
48649303|NCT01521364|101927802|FG000|NOT COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||1||
48649304|NCT00400205|101927803|FG000|STARTED|Overall Study||14||
48649305|NCT00400205|101927803|FG000|COMPLETED|Overall Study||9||
48649306|NCT00400205|101927803|FG000|NOT COMPLETED|Overall Study||5||
48649307|NCT04102111|101927804|FG000|STARTED|Overall Study||18||
48649308|NCT04102111|101927805|FG001|STARTED|Overall Study||30||
48649309|NCT04102111|101927804|FG000|COMPLETED|Overall Study||14||
48649310|NCT04102111|101927805|FG001|COMPLETED|Overall Study||23||
48649311|NCT04102111|101927804|FG000|NOT COMPLETED|Overall Study||4||
48649312|NCT04102111|101927805|FG001|NOT COMPLETED|Overall Study||7||
48649313|NCT02979054|101927806|FG000|STARTED|Overall Study||71||
48649314|NCT02979054|101927807|FG001|STARTED|Overall Study||64||
48649315|NCT02979054|101927806|FG000|COMPLETED|Overall Study||71||
48649316|NCT02979054|101927807|FG001|COMPLETED|Overall Study||64||
48649317|NCT02979054|101927806|FG000|NOT COMPLETED|Overall Study||0||
48649318|NCT02979054|101927807|FG001|NOT COMPLETED|Overall Study||0||
48649319|NCT00003456|101927808|FG000|STARTED|Overall Study||40||
48649320|NCT00003456|101927808|FG000|COMPLETED|Overall Study||32||
48649321|NCT00003456|101927808|FG000|NOT COMPLETED|Overall Study||8||
48649322|NCT02070991|101927809|FG000|STARTED|Overall Study||31||
48649323|NCT02070991|101927810|FG001|STARTED|Overall Study||32||
48649324|NCT02070991|101927809|FG000|COMPLETED|Overall Study||28||
48649325|NCT02070991|101927810|FG001|COMPLETED|Overall Study||32||
48649326|NCT02070991|101927809|FG000|NOT COMPLETED|Overall Study||3||
48649327|NCT02070991|101927810|FG001|NOT COMPLETED|Overall Study||0||
48649328|NCT00425854|101927811|FG000|STARTED|Overall Study||29||
48649329|NCT00425854|101927812|FG001|STARTED|Overall Study||21||
48649330|NCT00425854|101927811|FG000|COMPLETED|Overall Study||0||
48649331|NCT00425854|101927812|FG001|COMPLETED|Overall Study||0||
48649332|NCT00425854|101927811|FG000|NOT COMPLETED|Overall Study||29||
48649333|NCT00425854|101927812|FG001|NOT COMPLETED|Overall Study||21||
48649334|NCT00927186|101927813|FG000|STARTED|12 Months Primary Study||34||
48649335|NCT00927186|101927814|FG001|STARTED|12 Months Primary Study||35||
48649336|NCT00927186|101927813|FG000|Completed 6 Months Double Blind Phase|12 Months Primary Study||28||
48649337|NCT00927186|101927814|FG001|Completed 6 Months Double Blind Phase|12 Months Primary Study||31||
48649338|NCT00927186|101927813|FG000|COMPLETED|12 Months Primary Study||27||
48649339|NCT00927186|101927814|FG001|COMPLETED|12 Months Primary Study||31||
48649340|NCT00927186|101927813|FG000|NOT COMPLETED|12 Months Primary Study||7||
48649341|NCT00927186|101927814|FG001|NOT COMPLETED|12 Months Primary Study||4||
48649342|NCT00927186|101927813|FG000|STARTED|12 - 24 Months Extension Treatment||10||
48649343|NCT00927186|101927814|FG001|STARTED|12 - 24 Months Extension Treatment||11||
48649344|NCT00927186|101927813|FG000|COMPLETED|12 - 24 Months Extension Treatment||10||
48649345|NCT00927186|101927814|FG001|COMPLETED|12 - 24 Months Extension Treatment||11||
48649346|NCT00927186|101927813|FG000|NOT COMPLETED|12 - 24 Months Extension Treatment||0||
48649347|NCT00927186|101927814|FG001|NOT COMPLETED|12 - 24 Months Extension Treatment||0||
48649348|NCT01301001|101927815|FG000|STARTED|First Intervention||44||
48649349|NCT01301001|101927816|FG001|STARTED|First Intervention||45||
48649350|NCT01301001|101927815|FG000|COMPLETED|First Intervention||34||
48649351|NCT01301001|101927816|FG001|COMPLETED|First Intervention||36||
48649352|NCT01301001|101927815|FG000|NOT COMPLETED|First Intervention||10||
48649353|NCT01301001|101927816|FG001|NOT COMPLETED|First Intervention||9||
48649354|NCT01301001|101927815|FG000|STARTED|Washout (2 Weeks)||34||
48649355|NCT01301001|101927816|FG001|STARTED|Washout (2 Weeks)||36||
48649356|NCT01301001|101927815|FG000|COMPLETED|Washout (2 Weeks)||34||
48649357|NCT01301001|101927816|FG001|COMPLETED|Washout (2 Weeks)||36||
48649358|NCT01301001|101927815|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
48649359|NCT01301001|101927816|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
48649360|NCT01301001|101927815|FG000|STARTED|Second Intervention||34||
48649361|NCT01301001|101927816|FG001|STARTED|Second Intervention||36||
48649362|NCT01301001|101927815|FG000|COMPLETED|Second Intervention||30||
48649363|NCT01301001|101927816|FG001|COMPLETED|Second Intervention||36||
48649364|NCT01301001|101927815|FG000|NOT COMPLETED|Second Intervention||4||
48649365|NCT01301001|101927816|FG001|NOT COMPLETED|Second Intervention||0||
48649366|NCT01429623|101927817|FG000|STARTED|Overall Study||102||
48649367|NCT01429623|101927818|FG001|STARTED|Overall Study||107||
48649368|NCT01429623|101927817|FG000|Converted to Alzheimer's|Overall Study||14|Upon conversion to Alzheimer's disease, the primary endpoint, subjects removed from study|
48657049|NCT03648372|101943768|FG011|STARTED|Overall Study||7||
48649369|NCT01429623|101927818|FG001|Converted to Alzheimer's|Overall Study||21|Upon conversion to Alzheimer's disease, the primary endpoint, subjects removed from study|
48649370|NCT01429623|101927817|FG000|COMPLETED|Overall Study||51||
48649371|NCT01429623|101927818|FG001|COMPLETED|Overall Study||48||
48649372|NCT01429623|101927817|FG000|NOT COMPLETED|Overall Study||51||
48649373|NCT01429623|101927818|FG001|NOT COMPLETED|Overall Study||59||
48649374|NCT00819832|101927819|FG000|STARTED|Overall Study||3||
48649375|NCT00819832|101927820|FG001|STARTED|Overall Study||0||
48649376|NCT00819832|101927821|FG002|STARTED|Overall Study||0||
48649377|NCT00819832|101927822|FG003|STARTED|Overall Study||0||
48649378|NCT00819832|101927823|FG004|STARTED|Overall Study||0||
48649379|NCT00819832|101927824|FG005|STARTED|Overall Study||0||
48649380|NCT00819832|101927819|FG000|COMPLETED|Overall Study||0||
48649381|NCT00819832|101927820|FG001|COMPLETED|Overall Study||0||
48649382|NCT00819832|101927821|FG002|COMPLETED|Overall Study||0||
48649383|NCT00819832|101927822|FG003|COMPLETED|Overall Study||0||
48649384|NCT00819832|101927823|FG004|COMPLETED|Overall Study||0||
48649385|NCT00819832|101927824|FG005|COMPLETED|Overall Study||0||
48649386|NCT00819832|101927819|FG000|NOT COMPLETED|Overall Study||3||
48649387|NCT00819832|101927820|FG001|NOT COMPLETED|Overall Study||0||
48649388|NCT00819832|101927821|FG002|NOT COMPLETED|Overall Study||0||
48649389|NCT00819832|101927822|FG003|NOT COMPLETED|Overall Study||0||
48649390|NCT00819832|101927823|FG004|NOT COMPLETED|Overall Study||0||
48649391|NCT00819832|101927824|FG005|NOT COMPLETED|Overall Study||0||
48649392|NCT02503865|101927825|FG000|STARTED|Overall Study||70||
48649393|NCT02503865|101927826|FG001|STARTED|Overall Study||269||
48649394|NCT02503865|101927827|FG002|STARTED|Overall Study||66||
48649395|NCT02503865|101927825|FG000|COMPLETED|Overall Study||65||
48649396|NCT02503865|101927826|FG001|COMPLETED|Overall Study||222||
48649397|NCT02503865|101927827|FG002|COMPLETED|Overall Study||64||
48649398|NCT02503865|101927825|FG000|NOT COMPLETED|Overall Study||5||
48649399|NCT02503865|101927826|FG001|NOT COMPLETED|Overall Study||47||
48649400|NCT02503865|101927827|FG002|NOT COMPLETED|Overall Study||2||
48649401|NCT01560988|101927828|FG000|STARTED|First Intervention (Six Weeks)||32||
48649402|NCT01560988|101927829|FG001|STARTED|First Intervention (Six Weeks)||30||
48649403|NCT01560988|101927828|FG000|COMPLETED|First Intervention (Six Weeks)||22||
48649404|NCT01560988|101927829|FG001|COMPLETED|First Intervention (Six Weeks)||26||
48649405|NCT01560988|101927828|FG000|NOT COMPLETED|First Intervention (Six Weeks)||10||
48649406|NCT01560988|101927829|FG001|NOT COMPLETED|First Intervention (Six Weeks)||4||
48649407|NCT01560988|101927828|FG000|STARTED|Washout (Six Weeks)||22||
48649408|NCT01560988|101927829|FG001|STARTED|Washout (Six Weeks)||26||
48649409|NCT01560988|101927828|FG000|COMPLETED|Washout (Six Weeks)||20||
48649410|NCT01560988|101927829|FG001|COMPLETED|Washout (Six Weeks)||24||
48649411|NCT01560988|101927828|FG000|NOT COMPLETED|Washout (Six Weeks)||2||
48649412|NCT01560988|101927829|FG001|NOT COMPLETED|Washout (Six Weeks)||2||
48649413|NCT01560988|101927828|FG000|STARTED|Second Intervention (Six Weeks)||20||
48649414|NCT01560988|101927829|FG001|STARTED|Second Intervention (Six Weeks)||24||
48649415|NCT01560988|101927828|FG000|COMPLETED|Second Intervention (Six Weeks)||18||
48649416|NCT01560988|101927829|FG001|COMPLETED|Second Intervention (Six Weeks)||22||
48649417|NCT01560988|101927828|FG000|NOT COMPLETED|Second Intervention (Six Weeks)||2||
48649418|NCT01560988|101927829|FG001|NOT COMPLETED|Second Intervention (Six Weeks)||2||
48649419|NCT00593645|101927830|FG000|STARTED|Overall Study||7||
48649420|NCT00593645|101927830|FG000|COMPLETED|Overall Study||7||
48649421|NCT00593645|101927830|FG000|NOT COMPLETED|Overall Study||0||
48649422|NCT01292473|101927831|FG000|STARTED|Overall Study||79||
48649423|NCT01292473|101927832|FG001|STARTED|Overall Study||82||
48649424|NCT01292473|101927833|FG002|STARTED|Overall Study||83||
48649425|NCT01292473|101927834|FG003|STARTED|Overall Study||79||
48649426|NCT01292473|101927831|FG000|COMPLETED|Overall Study||74||
48649427|NCT01292473|101927832|FG001|COMPLETED|Overall Study||75||
48649428|NCT01292473|101927833|FG002|COMPLETED|Overall Study||74||
48649429|NCT01292473|101927834|FG003|COMPLETED|Overall Study||67||
48649430|NCT01292473|101927831|FG000|NOT COMPLETED|Overall Study||5||
48649431|NCT01292473|101927832|FG001|NOT COMPLETED|Overall Study||7||
48649432|NCT01292473|101927833|FG002|NOT COMPLETED|Overall Study||9||
48649433|NCT01292473|101927834|FG003|NOT COMPLETED|Overall Study||12||
48649434|NCT00621322|101927835|FG000|STARTED|Overall Study||10||
48649435|NCT00621322|101927836|FG001|STARTED|Overall Study||10||
48649436|NCT00621322|101927837|FG002|STARTED|Overall Study||40||
48649437|NCT00621322|101927838|FG003|STARTED|Overall Study||40||
48649438|NCT00621322|101927839|FG004|STARTED|Overall Study||40||
48649439|NCT00621322|101927840|FG005|STARTED|Overall Study||40||
48649440|NCT00621322|101927835|FG000|COMPLETED|Overall Study||9||
48649441|NCT00621322|101927836|FG001|COMPLETED|Overall Study||10||
48649442|NCT00621322|101927837|FG002|COMPLETED|Overall Study||38||
48649443|NCT00621322|101927838|FG003|COMPLETED|Overall Study||37||
48649444|NCT00621322|101927839|FG004|COMPLETED|Overall Study||39||
48649445|NCT00621322|101927840|FG005|COMPLETED|Overall Study||36||
48649446|NCT00621322|101927835|FG000|NOT COMPLETED|Overall Study||1||
48649447|NCT00621322|101927836|FG001|NOT COMPLETED|Overall Study||0||
48649448|NCT00621322|101927837|FG002|NOT COMPLETED|Overall Study||2||
48649449|NCT00621322|101927838|FG003|NOT COMPLETED|Overall Study||3||
48649450|NCT00621322|101927839|FG004|NOT COMPLETED|Overall Study||1||
48649451|NCT00621322|101927840|FG005|NOT COMPLETED|Overall Study||4||
48649452|NCT00452400|101927841|FG000|STARTED|Overall Study||79||
48649453|NCT00452400|101927842|FG001|STARTED|Overall Study||81||
48649454|NCT00452400|101927843|FG002|STARTED|Overall Study||80||
48649455|NCT00452400|101927844|FG003|STARTED|Overall Study||86||
48649456|NCT00452400|101927845|FG004|STARTED|Overall Study||79||
48649457|NCT00452400|101927841|FG000|COMPLETED|Overall Study||74||
48649458|NCT00452400|101927842|FG001|COMPLETED|Overall Study||80||
48649459|NCT00452400|101927843|FG002|COMPLETED|Overall Study||73||
48649460|NCT00452400|101927844|FG003|COMPLETED|Overall Study||85||
48649461|NCT00452400|101927845|FG004|COMPLETED|Overall Study||76||
48649462|NCT00452400|101927841|FG000|NOT COMPLETED|Overall Study||5||
48649463|NCT00452400|101927842|FG001|NOT COMPLETED|Overall Study||1||
48649464|NCT00452400|101927843|FG002|NOT COMPLETED|Overall Study||7||
48649465|NCT00452400|101927844|FG003|NOT COMPLETED|Overall Study||1||
48649466|NCT00452400|101927845|FG004|NOT COMPLETED|Overall Study||3||
48649467|NCT02403778|101927846|FG000|STARTED|Overall Study||6||
48649468|NCT02403778|101927847|FG001|STARTED|Overall Study||4||
48649469|NCT02403778|101927846|FG000|COMPLETED|Overall Study||6||
48649470|NCT02403778|101927847|FG001|COMPLETED|Overall Study||4||
48649471|NCT02403778|101927846|FG000|NOT COMPLETED|Overall Study||0||
48649472|NCT02403778|101927847|FG001|NOT COMPLETED|Overall Study||0||
48649473|NCT01346709|101927848|FG000|STARTED|Overall Study||5450||
48649474|NCT01346709|101927848|FG000|COMPLETED|Overall Study||5099||
48649475|NCT01346709|101927848|FG000|NOT COMPLETED|Overall Study||351||
48649476|NCT03683901|101927849|FG000|STARTED|Overall Study||10||
48649477|NCT03683901|101927849|FG000|COMPLETED|Overall Study||10||
48649478|NCT03683901|101927849|FG000|NOT COMPLETED|Overall Study||0||
48649479|NCT00682435|101927850|FG000|STARTED|Overall Study||230||
48649480|NCT00682435|101927850|FG000|Ensured Enrolled Only Once|Overall Study||228||
48649481|NCT00682435|101927850|FG000|Sufficient Data to Carry Out Analysis|Overall Study||223||
48649482|NCT00682435|101927850|FG000|COMPLETED|Overall Study||223||
48649483|NCT00682435|101927850|FG000|NOT COMPLETED|Overall Study||7||
48649484|NCT01939275|101927851|FG000|STARTED|Overall Study||8||
48649485|NCT01939275|101927851|FG000|COMPLETED|Overall Study||8||
48649486|NCT01939275|101927851|FG000|NOT COMPLETED|Overall Study||0||
48649487|NCT03055221|101927852|FG000|STARTED|Overall Study||20||
48649488|NCT03055221|101927852|FG000|COMPLETED|Overall Study||0||
48649489|NCT03055221|101927852|FG000|NOT COMPLETED|Overall Study||20||
48649490|NCT03270241|101927853|FG000|STARTED|Overall Study||10||
48649491|NCT03270241|101927853|FG000|COMPLETED|Overall Study||10||
48649492|NCT03270241|101927853|FG000|NOT COMPLETED|Overall Study||0||
48649493|NCT03073109|101927854|FG000|STARTED|Overall Study||100||
48649494|NCT03073109|101927855|FG001|STARTED|Overall Study||70||
48649495|NCT03073109|101927854|FG000|COMPLETED|Overall Study||90||
48649496|NCT03073109|101927855|FG001|COMPLETED|Overall Study||68||
48649497|NCT03073109|101927854|FG000|NOT COMPLETED|Overall Study||10||
48649498|NCT03073109|101927855|FG001|NOT COMPLETED|Overall Study||2||
48649499|NCT03446573|101927856|FG000|STARTED|Early Switch Phase (Day 1 to Week 148)||371|Randomised|
48649500|NCT03446573|101927857|FG001|STARTED|Early Switch Phase (Day 1 to Week 148)||372|Randomised|
48649501|NCT03446573|101927856|FG000|ITT-E Population|Early Switch Phase (Day 1 to Week 148)||369||
48649502|NCT03446573|101927857|FG001|ITT-E Population|Early Switch Phase (Day 1 to Week 148)||372||
48649503|NCT03446573|101927856|FG000|COMPLETED|Early Switch Phase (Day 1 to Week 148)||319||
48649504|NCT03446573|101927857|FG001|COMPLETED|Early Switch Phase (Day 1 to Week 148)||299||
48649505|NCT03446573|101927856|FG000|NOT COMPLETED|Early Switch Phase (Day 1 to Week 148)||52||
48649506|NCT03446573|101927857|FG001|NOT COMPLETED|Early Switch Phase (Day 1 to Week 148)||73||
48649507|NCT03446573|101927856|FG000|STARTED|Late Switch Phase (Week 148 to Week 196)||319||
48649508|NCT03446573|101927857|FG001|STARTED|Late Switch Phase (Week 148 to Week 196)||298||
48649509|NCT03446573|101927856|FG000|COMPLETED|Late Switch Phase (Week 148 to Week 196)||307||
48649510|NCT03446573|101927857|FG001|COMPLETED|Late Switch Phase (Week 148 to Week 196)||274||
48649511|NCT03446573|101927856|FG000|NOT COMPLETED|Late Switch Phase (Week 148 to Week 196)||12||
48649512|NCT03446573|101927857|FG001|NOT COMPLETED|Late Switch Phase (Week 148 to Week 196)||24||
48649513|NCT03528577|101927858|FG000|STARTED|Sequence 1||128|128 subjects with persistent bronchial asthma were randomized during the study.|
48649514|NCT03528577|101927858|FG000|COMPLETED|Sequence 1||126||
48649515|NCT03528577|101927858|FG000|NOT COMPLETED|Sequence 1||2||
48765371|NCT00089297|102214631|FG000|STARTED|Overall Study||74||
48765372|NCT00089297|102214631|FG000|Treated|Overall Study||70||
48649516|NCT03528577|101927858|FG000|STARTED|Sequence 2||128||
48649517|NCT03528577|101927858|FG000|COMPLETED|Sequence 2||125||
48649518|NCT03528577|101927858|FG000|NOT COMPLETED|Sequence 2||3||
48649519|NCT03528577|101927858|FG000|STARTED|Sequence 3||128||
48649520|NCT03528577|101927858|FG000|COMPLETED|Sequence 3||127||
48649521|NCT03528577|101927858|FG000|NOT COMPLETED|Sequence 3||1||
48649522|NCT03528577|101927858|FG000|STARTED|Sequence 4||128||
48649523|NCT03528577|101927858|FG000|COMPLETED|Sequence 4||125||
48649524|NCT03528577|101927858|FG000|NOT COMPLETED|Sequence 4||3||
48649525|NCT01421134|101927859|FG000|STARTED|Overall Study||109||
48649526|NCT01421134|101927860|FG001|STARTED|Overall Study||102||
48649527|NCT01421134|101927859|FG000|COMPLETED|Overall Study||102||
48649528|NCT01421134|101927860|FG001|COMPLETED|Overall Study||87||
48649529|NCT01421134|101927859|FG000|NOT COMPLETED|Overall Study||7||
48649530|NCT01421134|101927860|FG001|NOT COMPLETED|Overall Study||15||
48649531|NCT00191152|101927861|FG000|STARTED|Initial Treatment||239||
48649532|NCT00191152|101927862|FG001|STARTED|Initial Treatment||236||
48649533|NCT00191152|101927861|FG000|Received Initial Treatment|Initial Treatment||236||
48649534|NCT00191152|101927862|FG001|Received Initial Treatment|Initial Treatment||227||
48649535|NCT00191152|101927861|FG000|COMPLETED|Initial Treatment||98||
48649536|NCT00191152|101927862|FG001|COMPLETED|Initial Treatment||83||
48649537|NCT00191152|101927861|FG000|NOT COMPLETED|Initial Treatment||141||
48649538|NCT00191152|101927862|FG001|NOT COMPLETED|Initial Treatment||153||
48649539|NCT00191152|101927861|FG000|STARTED|Crossover Treatment||77||
48649540|NCT00191152|101927862|FG001|STARTED|Crossover Treatment||81||
48649541|NCT00191152|101927861|FG000|Received Treatment|Crossover Treatment||76||
48649542|NCT00191152|101927862|FG001|Received Treatment|Crossover Treatment||80||
48649543|NCT00191152|101927861|FG000|COMPLETED|Crossover Treatment||50||
48649544|NCT00191152|101927862|FG001|COMPLETED|Crossover Treatment||53||
48649545|NCT00191152|101927861|FG000|NOT COMPLETED|Crossover Treatment||27||
48649546|NCT00191152|101927862|FG001|NOT COMPLETED|Crossover Treatment||28||
48649547|NCT02409901|101927863|FG000|STARTED|Overall Study||93||
48649548|NCT02409901|101927864|FG001|STARTED|Overall Study||42||
48649549|NCT02409901|101927863|FG000|Completed Baseline Assessment|Overall Study||80|Those number of patients have baseline characteristics collected|
48649550|NCT02409901|101927864|FG001|Completed Baseline Assessment|Overall Study||33|Those number of patients have baseline characteristics collected|
48649551|NCT02409901|101927863|FG000|COMPLETED|Overall Study||52|Completed data analysis|
48649552|NCT02409901|101927864|FG001|COMPLETED|Overall Study||28|Completed data analysis|
48649553|NCT02409901|101927863|FG000|NOT COMPLETED|Overall Study||41||
48649554|NCT02409901|101927864|FG001|NOT COMPLETED|Overall Study||14||
48649555|NCT00449007|101927865|FG000|STARTED|Overall Study||2||
48649556|NCT00449007|101927866|FG001|STARTED|Overall Study||3||
48649557|NCT00449007|101927865|FG000|COMPLETED|Overall Study||2||
48649558|NCT00449007|101927866|FG001|COMPLETED|Overall Study||3||
48649559|NCT00449007|101927865|FG000|NOT COMPLETED|Overall Study||0||
48649560|NCT00449007|101927866|FG001|NOT COMPLETED|Overall Study||0||
48649561|NCT02687165|101927867|FG000|STARTED|Overall Study||0||
48649562|NCT02687165|101927868|FG001|STARTED|Overall Study||0||
48649563|NCT02687165|101927867|FG000|COMPLETED|Overall Study||0||
48649564|NCT02687165|101927868|FG001|COMPLETED|Overall Study||0||
48649565|NCT02687165|101927867|FG000|NOT COMPLETED|Overall Study||0||
48649566|NCT02687165|101927868|FG001|NOT COMPLETED|Overall Study||0||
48649567|NCT01404260|101927869|FG000|STARTED|Overall Study||109||
48649568|NCT01404260|101927870|FG001|STARTED|Overall Study||110||
48649569|NCT01404260|101927869|FG000|COMPLETED|Overall Study||106||
48649570|NCT01404260|101927870|FG001|COMPLETED|Overall Study||101||
48649571|NCT01404260|101927869|FG000|NOT COMPLETED|Overall Study||3||
48649572|NCT01404260|101927870|FG001|NOT COMPLETED|Overall Study||9||
48649573|NCT01297244|101927871|FG000|STARTED|Overall Study||90||
48649574|NCT01297244|101927872|FG001|STARTED|Overall Study||15||
48649575|NCT01297244|101927871|FG000|COMPLETED|Overall Study||55||
48649576|NCT01297244|101927872|FG001|COMPLETED|Overall Study||9||
48649577|NCT01297244|101927871|FG000|NOT COMPLETED|Overall Study||35||
48649578|NCT01297244|101927872|FG001|NOT COMPLETED|Overall Study||6||
48649579|NCT01158404|101927873|FG000|STARTED|Overall Study||3||
48649580|NCT01158404|101927874|FG001|STARTED|Overall Study||4||
48649581|NCT01158404|101927875|FG002|STARTED|Overall Study||3||
48649582|NCT01158404|101927876|FG003|STARTED|Overall Study||3||
48649583|NCT01158404|101927877|FG004|STARTED|Overall Study||6||
48649584|NCT01158404|101927878|FG005|STARTED|Overall Study||5||
48649585|NCT01158404|101927879|FG006|STARTED|Overall Study||3||
48649586|NCT01158404|101927880|FG007|STARTED|Overall Study||8||
48649587|NCT01158404|101927873|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
48649588|NCT01158404|101927874|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4||
48649589|NCT01158404|101927875|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
48649590|NCT01158404|101927876|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3||
48649591|NCT01158404|101927877|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6||
48649592|NCT01158404|101927878|FG005|Received at Least 1 Dose of Study Drug|Overall Study||5||
48649593|NCT01158404|101927879|FG006|Received at Least 1 Dose of Study Drug|Overall Study||3||
48649594|NCT01158404|101927880|FG007|Received at Least 1 Dose of Study Drug|Overall Study||8||
48649595|NCT01158404|101927873|FG000|COMPLETED|Overall Study||3||
48649596|NCT01158404|101927874|FG001|COMPLETED|Overall Study||3||
48649597|NCT01158404|101927875|FG002|COMPLETED|Overall Study||3||
48649598|NCT01158404|101927876|FG003|COMPLETED|Overall Study||3||
48649599|NCT01158404|101927877|FG004|COMPLETED|Overall Study||3||
48649600|NCT01158404|101927878|FG005|COMPLETED|Overall Study||4||
48649601|NCT01158404|101927879|FG006|COMPLETED|Overall Study||2||
48649602|NCT01158404|101927880|FG007|COMPLETED|Overall Study||6||
48649603|NCT01158404|101927873|FG000|NOT COMPLETED|Overall Study||0||
48649604|NCT01158404|101927874|FG001|NOT COMPLETED|Overall Study||1||
48649605|NCT01158404|101927875|FG002|NOT COMPLETED|Overall Study||0||
48649606|NCT01158404|101927876|FG003|NOT COMPLETED|Overall Study||0||
48649607|NCT01158404|101927877|FG004|NOT COMPLETED|Overall Study||3||
48649608|NCT01158404|101927878|FG005|NOT COMPLETED|Overall Study||1||
48649609|NCT01158404|101927879|FG006|NOT COMPLETED|Overall Study||1||
48649610|NCT01158404|101927880|FG007|NOT COMPLETED|Overall Study||2||
48649611|NCT03657407|101927881|FG000|STARTED|Overall Study||29||
48649612|NCT03657407|101927882|FG001|STARTED|Overall Study||27||
48649613|NCT03657407|101927881|FG000|COMPLETED|Overall Study||29||
48649614|NCT03657407|101927882|FG001|COMPLETED|Overall Study||27||
48649615|NCT03657407|101927881|FG000|NOT COMPLETED|Overall Study||0||
48649616|NCT03657407|101927882|FG001|NOT COMPLETED|Overall Study||0||
48649617|NCT02249793|101927883|FG000|STARTED|Session 1, 48-hours Healthy Volunteers||6||
48649618|NCT02249793|101927883|FG000|COMPLETED|Session 1, 48-hours Healthy Volunteers||6||
48649619|NCT02249793|101927883|FG000|NOT COMPLETED|Session 1, 48-hours Healthy Volunteers||0||
48649620|NCT02249793|101927883|FG000|STARTED|Session 2, 48-Hours Healthy Volunteers||6||
48649621|NCT02249793|101927883|FG000|COMPLETED|Session 2, 48-Hours Healthy Volunteers||6||
48649622|NCT02249793|101927883|FG000|NOT COMPLETED|Session 2, 48-Hours Healthy Volunteers||0||
48649623|NCT02931539|101927884|FG000|STARTED|Period 1: Treatment Phase||117||
48649624|NCT02931539|101927885|FG001|STARTED|Period 1: Treatment Phase||235||
48649625|NCT02931539|101927886|FG002|STARTED|Period 1: Treatment Phase||0||
48649626|NCT02931539|101927884|FG000|Treated Participants|Period 1: Treatment Phase||116||
48649627|NCT02931539|101927885|FG001|Treated Participants|Period 1: Treatment Phase||234||
48649628|NCT02931539|101927886|FG002|Treated Participants|Period 1: Treatment Phase||0||
48649629|NCT02931539|101927884|FG000|IAT (Ganciclovir/ Valganciclovir)|Period 1: Treatment Phase||56||
48649630|NCT02931539|101927885|FG001|IAT (Ganciclovir/ Valganciclovir)|Period 1: Treatment Phase||0||
48649631|NCT02931539|101927886|FG002|IAT (Ganciclovir/ Valganciclovir)|Period 1: Treatment Phase||0||
48649632|NCT02931539|101927884|FG000|IAT (Foscarnet)|Period 1: Treatment Phase||47||
48649633|NCT02931539|101927885|FG001|IAT (Foscarnet)|Period 1: Treatment Phase||0||
48649634|NCT02931539|101927886|FG002|IAT (Foscarnet)|Period 1: Treatment Phase||0||
48649635|NCT02931539|101927884|FG000|IAT (Cidofovir)|Period 1: Treatment Phase||6||
48649636|NCT02931539|101927885|FG001|IAT (Cidofovir)|Period 1: Treatment Phase||0||
48649637|NCT02931539|101927886|FG002|IAT (Cidofovir)|Period 1: Treatment Phase||0||
48649638|NCT02931539|101927884|FG000|IAT (Foscarnet + Valganciclovir/Ganciclovir)|Period 1: Treatment Phase||7||
48649639|NCT02931539|101927885|FG001|IAT (Foscarnet + Valganciclovir/Ganciclovir)|Period 1: Treatment Phase||0||
48649640|NCT02931539|101927886|FG002|IAT (Foscarnet + Valganciclovir/Ganciclovir)|Period 1: Treatment Phase||0||
48649641|NCT02931539|101927884|FG000|COMPLETED|Period 1: Treatment Phase||58||
48649642|NCT02931539|101927885|FG001|COMPLETED|Period 1: Treatment Phase||199||
48649643|NCT02931539|101927886|FG002|COMPLETED|Period 1: Treatment Phase||0||
48649644|NCT02931539|101927884|FG000|NOT COMPLETED|Period 1: Treatment Phase||59||
48649645|NCT02931539|101927885|FG001|NOT COMPLETED|Period 1: Treatment Phase||36||
48649646|NCT02931539|101927886|FG002|NOT COMPLETED|Period 1: Treatment Phase||0||
48649647|NCT02931539|101927884|FG000|STARTED|Period 2: Maribavir Rescue Therapy||0||
48649648|NCT02931539|101927885|FG001|STARTED|Period 2: Maribavir Rescue Therapy||0||
48649649|NCT02931539|101927886|FG002|STARTED|Period 2: Maribavir Rescue Therapy||22||
48649650|NCT02931539|101927884|FG000|COMPLETED|Period 2: Maribavir Rescue Therapy||0||
48649651|NCT02931539|101927885|FG001|COMPLETED|Period 2: Maribavir Rescue Therapy||0||
48649652|NCT02931539|101927886|FG002|COMPLETED|Period 2: Maribavir Rescue Therapy||20||
48649653|NCT02931539|101927884|FG000|NOT COMPLETED|Period 2: Maribavir Rescue Therapy||0||
48649654|NCT02931539|101927885|FG001|NOT COMPLETED|Period 2: Maribavir Rescue Therapy||0||
48649655|NCT02931539|101927886|FG002|NOT COMPLETED|Period 2: Maribavir Rescue Therapy||2||
48649656|NCT01112267|101927887|FG000|STARTED|Overall Study||126||
48649657|NCT01112267|101927888|FG001|STARTED|Overall Study||122||
48649658|NCT01112267|101927887|FG000|Treated|Overall Study||125||
48649659|NCT01112267|101927888|FG001|Treated|Overall Study||120||
48649660|NCT01112267|101927887|FG000|COMPLETED|Overall Study||92||
48649661|NCT01112267|101927888|FG001|COMPLETED|Overall Study||104||
48649662|NCT01112267|101927887|FG000|NOT COMPLETED|Overall Study||34||
48649663|NCT01112267|101927888|FG001|NOT COMPLETED|Overall Study||18||
48649664|NCT03000751|101927889|FG000|STARTED|Overall Study||251607||327,462
48649665|NCT03000751|101927890|FG001|STARTED|Overall Study||229022||306,825
48649666|NCT03000751|101927891|FG002|STARTED|Overall Study||383451||522,370
48649667|NCT03000751|101927889|FG000|COMPLETED|Overall Study||251607|All subjects started and completed each track. Note, however, that patients were enrolled passively. The unit of analysis was CT scans (not individual subjects), and all eligible CT scans performed during each study period were included.|327,462
48649668|NCT03000751|101927890|FG001|COMPLETED|Overall Study||229022|All subjects started and completed each track. Note, however, that patients were enrolled passively. The unit of analysis was CT scans (not individual subjects), and all eligible CT scans performed during each study period were included.|306,825
48649669|NCT03000751|101927891|FG002|COMPLETED|Overall Study||383451|All subjects started and completed each track. Note, however, that patients were enrolled passively. The unit of analysis was CT scans (not individual subjects), and all eligible CT scans performed during each study period were included.|522,370
48649670|NCT03000751|101927889|FG000|NOT COMPLETED|Overall Study||0||NA
48649671|NCT03000751|101927890|FG001|NOT COMPLETED|Overall Study||0||NA
48649672|NCT03000751|101927891|FG002|NOT COMPLETED|Overall Study||0||NA
48649673|NCT05890586|101927892|FG000|STARTED|Overall Study||686||
48649674|NCT05890586|101927893|FG001|STARTED|Overall Study||645||
48649675|NCT05890586|101927892|FG000|COMPLETED|Overall Study||676||
48649676|NCT05890586|101927893|FG001|COMPLETED|Overall Study||615||
48649677|NCT05890586|101927892|FG000|NOT COMPLETED|Overall Study||10||
48649678|NCT05890586|101927893|FG001|NOT COMPLETED|Overall Study||30||
48649679|NCT00366535|101927894|FG000|STARTED|First Phase: 12 Weeks||27||
48649680|NCT00366535|101927895|FG001|STARTED|First Phase: 12 Weeks||29||
48649681|NCT00366535|101927894|FG000|COMPLETED|First Phase: 12 Weeks||24||
48649682|NCT00366535|101927895|FG001|COMPLETED|First Phase: 12 Weeks||21||
48649683|NCT00366535|101927894|FG000|NOT COMPLETED|First Phase: 12 Weeks||3||
48649684|NCT00366535|101927895|FG001|NOT COMPLETED|First Phase: 12 Weeks||8||
48649685|NCT00366535|101927894|FG000|STARTED|Washout Period (at Least a Week)||24||
48649686|NCT00366535|101927895|FG001|STARTED|Washout Period (at Least a Week)||21||
48649687|NCT00366535|101927894|FG000|COMPLETED|Washout Period (at Least a Week)||24||
48649688|NCT00366535|101927895|FG001|COMPLETED|Washout Period (at Least a Week)||21||
48649689|NCT00366535|101927894|FG000|NOT COMPLETED|Washout Period (at Least a Week)||0||
48649690|NCT00366535|101927895|FG001|NOT COMPLETED|Washout Period (at Least a Week)||0||
48649691|NCT00366535|101927894|FG000|STARTED|Second Phase: 12 Weeks||24||
48649692|NCT00366535|101927895|FG001|STARTED|Second Phase: 12 Weeks||21||
48649693|NCT00366535|101927894|FG000|COMPLETED|Second Phase: 12 Weeks||21||
48649694|NCT00366535|101927895|FG001|COMPLETED|Second Phase: 12 Weeks||18||
48649695|NCT00366535|101927894|FG000|NOT COMPLETED|Second Phase: 12 Weeks||3||
48649696|NCT00366535|101927895|FG001|NOT COMPLETED|Second Phase: 12 Weeks||3||
48649697|NCT04250363|101927896|FG000|STARTED|Overall Study||6||
48649698|NCT04250363|101927897|FG001|STARTED|Overall Study||3||
48649699|NCT04250363|101927898|FG002|STARTED|Overall Study||6||
48649700|NCT04250363|101927899|FG003|STARTED|Overall Study||6||
48649701|NCT04250363|101927900|FG004|STARTED|Overall Study||3||
48649702|NCT04250363|101927901|FG005|STARTED|Overall Study||3||
48649703|NCT04250363|101927902|FG006|STARTED|Overall Study||3||
48649704|NCT04250363|101927903|FG007|STARTED|Overall Study||3||
48649705|NCT04250363|101927904|FG008|STARTED|Overall Study||3||
48649706|NCT04250363|101927905|FG009|STARTED|Overall Study||3||
48649707|NCT04250363|101927896|FG000|COMPLETED|Overall Study||6||
48649708|NCT04250363|101927897|FG001|COMPLETED|Overall Study||3||
48649709|NCT04250363|101927898|FG002|COMPLETED|Overall Study||6||
48649710|NCT04250363|101927899|FG003|COMPLETED|Overall Study||6||
48649711|NCT04250363|101927900|FG004|COMPLETED|Overall Study||3||
48649712|NCT04250363|101927901|FG005|COMPLETED|Overall Study||3||
48649713|NCT04250363|101927902|FG006|COMPLETED|Overall Study||3||
48649714|NCT04250363|101927903|FG007|COMPLETED|Overall Study||3||
48649715|NCT04250363|101927904|FG008|COMPLETED|Overall Study||3||
48649716|NCT04250363|101927905|FG009|COMPLETED|Overall Study||3||
48649717|NCT04250363|101927896|FG000|NOT COMPLETED|Overall Study||0||
48649718|NCT04250363|101927897|FG001|NOT COMPLETED|Overall Study||0||
48649719|NCT04250363|101927898|FG002|NOT COMPLETED|Overall Study||0||
48649720|NCT04250363|101927899|FG003|NOT COMPLETED|Overall Study||0||
48649721|NCT04250363|101927900|FG004|NOT COMPLETED|Overall Study||0||
48649722|NCT04250363|101927901|FG005|NOT COMPLETED|Overall Study||0||
48649723|NCT04250363|101927902|FG006|NOT COMPLETED|Overall Study||0||
48649724|NCT04250363|101927903|FG007|NOT COMPLETED|Overall Study||0||
48649725|NCT04250363|101927904|FG008|NOT COMPLETED|Overall Study||0||
48649726|NCT04250363|101927905|FG009|NOT COMPLETED|Overall Study||0||
48649727|NCT02821000|101927906|FG000|STARTED|Overall Study||103||
48649728|NCT02821000|101927906|FG000|Treated|Overall Study||103||
48649729|NCT02821000|101927906|FG000|COMPLETED|Overall Study||0||
48649730|NCT02821000|101927906|FG000|NOT COMPLETED|Overall Study||103||
48649731|NCT03462563|101927907|FG000|STARTED|Overall Study||94||
48649732|NCT03462563|101927908|FG001|STARTED|Overall Study||81||
48649733|NCT03462563|101927907|FG000|COMPLETED|Overall Study||79||
48649734|NCT03462563|101927908|FG001|COMPLETED|Overall Study||64||
48649735|NCT03462563|101927907|FG000|NOT COMPLETED|Overall Study||15||
48649736|NCT03462563|101927908|FG001|NOT COMPLETED|Overall Study||17||
48649737|NCT03016403|101927909|FG000|STARTED|Baseline||139||
48649738|NCT03016403|101927910|FG001|STARTED|Baseline||147||
48649739|NCT03016403|101927911|FG002|STARTED|Baseline||118||
48649740|NCT03016403|101927912|FG003|STARTED|Baseline||131||
48649741|NCT03016403|101927909|FG000|COMPLETED|Baseline||123||
48649742|NCT03016403|101927910|FG001|COMPLETED|Baseline||120||
48649743|NCT03016403|101927911|FG002|COMPLETED|Baseline||107||
48649744|NCT03016403|101927912|FG003|COMPLETED|Baseline||97||
48649745|NCT03016403|101927909|FG000|NOT COMPLETED|Baseline||16||
48649746|NCT03016403|101927910|FG001|NOT COMPLETED|Baseline||27||
48649747|NCT03016403|101927911|FG002|NOT COMPLETED|Baseline||11||
48649748|NCT03016403|101927912|FG003|NOT COMPLETED|Baseline||34||
48649749|NCT03016403|101927909|FG000|STARTED|6-week Follow-up||123||
48649750|NCT03016403|101927910|FG001|STARTED|6-week Follow-up||120||
48649751|NCT03016403|101927911|FG002|STARTED|6-week Follow-up||107||
48649752|NCT03016403|101927912|FG003|STARTED|6-week Follow-up||97||
48649753|NCT03016403|101927909|FG000|COMPLETED|6-week Follow-up||120||
48649754|NCT03016403|101927910|FG001|COMPLETED|6-week Follow-up||107||
48649755|NCT03016403|101927911|FG002|COMPLETED|6-week Follow-up||103||
48649756|NCT03016403|101927912|FG003|COMPLETED|6-week Follow-up||88||
48649757|NCT03016403|101927909|FG000|NOT COMPLETED|6-week Follow-up||3||
48649758|NCT03016403|101927910|FG001|NOT COMPLETED|6-week Follow-up||13||
48649759|NCT03016403|101927911|FG002|NOT COMPLETED|6-week Follow-up||4||
48649760|NCT03016403|101927912|FG003|NOT COMPLETED|6-week Follow-up||9||
48649761|NCT03016403|101927909|FG000|STARTED|3-month Follow-up and 6-month Follow-up||120||
48649762|NCT03016403|101927910|FG001|STARTED|3-month Follow-up and 6-month Follow-up||107||
48649763|NCT03016403|101927911|FG002|STARTED|3-month Follow-up and 6-month Follow-up||103||
48649764|NCT03016403|101927912|FG003|STARTED|3-month Follow-up and 6-month Follow-up||88||
48649765|NCT03016403|101927909|FG000|COMPLETED|3-month Follow-up and 6-month Follow-up||108||
48649766|NCT03016403|101927910|FG001|COMPLETED|3-month Follow-up and 6-month Follow-up||96||
48649767|NCT03016403|101927911|FG002|COMPLETED|3-month Follow-up and 6-month Follow-up||95||
48649768|NCT03016403|101927912|FG003|COMPLETED|3-month Follow-up and 6-month Follow-up||81||
48649769|NCT03016403|101927909|FG000|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||12||
48649770|NCT03016403|101927910|FG001|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||11||
48649771|NCT03016403|101927911|FG002|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||8||
48649772|NCT03016403|101927912|FG003|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||7||
48649773|NCT00290758|101927913|FG000|STARTED|Pre-Intervention rFNA Through Follow-Up||62||
48649774|NCT00290758|101927914|FG001|STARTED|Pre-Intervention rFNA Through Follow-Up||64||
48649775|NCT00290758|101927913|FG000|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||62||
48649776|NCT00290758|101927914|FG001|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||64||
48649777|NCT00290758|101927913|FG000|Randomization|Pre-Intervention rFNA Through Follow-Up||62||
48649778|NCT00290758|101927914|FG001|Randomization|Pre-Intervention rFNA Through Follow-Up||62||
48649779|NCT00290758|101927913|FG000|Treatment|Pre-Intervention rFNA Through Follow-Up||61||
48649780|NCT00290758|101927914|FG001|Treatment|Pre-Intervention rFNA Through Follow-Up||64||
48649781|NCT00290758|101927913|FG000|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||55||
48649782|NCT00290758|101927914|FG001|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||54||
48649783|NCT00290758|101927913|FG000|COMPLETED|Pre-Intervention rFNA Through Follow-Up||55||
48649784|NCT00290758|101927914|FG001|COMPLETED|Pre-Intervention rFNA Through Follow-Up||54||
48649785|NCT00290758|101927913|FG000|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||7||
48649786|NCT00290758|101927914|FG001|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||10||
48649787|NCT00290758|101927913|FG000|STARTED|Post Intervention rFNA||55||
48649788|NCT00290758|101927914|FG001|STARTED|Post Intervention rFNA||54||
48649789|NCT00290758|101927913|FG000|COMPLETED|Post Intervention rFNA||49||
48649790|NCT00290758|101927914|FG001|COMPLETED|Post Intervention rFNA||49||
48649791|NCT00290758|101927913|FG000|NOT COMPLETED|Post Intervention rFNA||6||
48649792|NCT00290758|101927914|FG001|NOT COMPLETED|Post Intervention rFNA||5||
48649793|NCT03181009|101927915|FG000|STARTED|Overall Study||30||
48649794|NCT03181009|101927916|FG001|STARTED|Overall Study||30||
48649795|NCT03181009|101927915|FG000|COMPLETED|Overall Study||30||
48649796|NCT03181009|101927916|FG001|COMPLETED|Overall Study||28||
48649797|NCT03181009|101927915|FG000|NOT COMPLETED|Overall Study||0||
48649798|NCT03181009|101927916|FG001|NOT COMPLETED|Overall Study||2||
48649799|NCT01096186|101927917|FG000|STARTED|Overall Study||617||
48649800|NCT01096186|101927917|FG000|COMPLETED|Overall Study||567||
48649801|NCT01096186|101927917|FG000|NOT COMPLETED|Overall Study||50||
48649802|NCT03926598|101927918|FG000|STARTED|Overall Study||1||
48649803|NCT03926598|101927919|FG001|STARTED|Overall Study||1||
48649804|NCT03926598|101927920|FG002|STARTED|Overall Study||0||
48649805|NCT03926598|101927921|FG003|STARTED|Overall Study||2||
48649806|NCT03926598|101927922|FG004|STARTED|Overall Study||2||
48649807|NCT03926598|101927918|FG000|COMPLETED|Overall Study||1||
48649808|NCT03926598|101927919|FG001|COMPLETED|Overall Study||1||
48649809|NCT03926598|101927920|FG002|COMPLETED|Overall Study||0||
48649810|NCT03926598|101927921|FG003|COMPLETED|Overall Study||2||
48649811|NCT03926598|101927922|FG004|COMPLETED|Overall Study||2||
48649812|NCT03926598|101927918|FG000|NOT COMPLETED|Overall Study||0||
48649813|NCT03926598|101927919|FG001|NOT COMPLETED|Overall Study||0||
48649814|NCT03926598|101927920|FG002|NOT COMPLETED|Overall Study||0||
48649815|NCT03926598|101927921|FG003|NOT COMPLETED|Overall Study||0||
48649816|NCT03926598|101927922|FG004|NOT COMPLETED|Overall Study||0||
48649817|NCT03722030|101927923|FG000|STARTED|Overall Study||20||
48649818|NCT03722030|101927924|FG001|STARTED|Overall Study||20||
48649819|NCT03722030|101927923|FG000|COMPLETED|Overall Study||19||
48649820|NCT03722030|101927924|FG001|COMPLETED|Overall Study||20||
48649821|NCT03722030|101927923|FG000|NOT COMPLETED|Overall Study||1||
48649822|NCT03722030|101927924|FG001|NOT COMPLETED|Overall Study||0||
48649823|NCT03193307|101927925|FG000|STARTED|Period 1 - Microgynon® 30 + BI 409306||16|Entered|
48649824|NCT03193307|101927925|FG000|COMPLETED|Period 1 - Microgynon® 30 + BI 409306||16|Treated and completed|
48649825|NCT03193307|101927925|FG000|NOT COMPLETED|Period 1 - Microgynon® 30 + BI 409306||0||
48649826|NCT03193307|101927925|FG000|STARTED|Period 2 - BI 409306 Alone||16||
48649827|NCT03193307|101927925|FG000|COMPLETED|Period 2 - BI 409306 Alone||16||
48649828|NCT03193307|101927925|FG000|NOT COMPLETED|Period 2 - BI 409306 Alone||0||
48649829|NCT03178942|101927926|FG000|STARTED|Overall Study||129||
48649830|NCT03178942|101927927|FG001|STARTED|Overall Study||125||
48649831|NCT03178942|101927926|FG000|COMPLETED|Overall Study||126||
48649832|NCT03178942|101927927|FG001|COMPLETED|Overall Study||123||
48649833|NCT03178942|101927926|FG000|NOT COMPLETED|Overall Study||3||
48649834|NCT03178942|101927927|FG001|NOT COMPLETED|Overall Study||2||
48649835|NCT00908687|101927928|FG000|STARTED|Overall Study||50||
48649836|NCT00908687|101927929|FG001|STARTED|Overall Study||100||
48649837|NCT00908687|101927930|FG002|STARTED|Overall Study||102||
48649838|NCT00908687|101927931|FG003|STARTED|Overall Study||50||
48649839|NCT00908687|101927932|FG004|STARTED|Overall Study||98||
48649840|NCT00908687|101927933|FG005|STARTED|Overall Study||100||
48649841|NCT00908687|101927928|FG000|COMPLETED|Overall Study||49||
48649842|NCT00908687|101927929|FG001|COMPLETED|Overall Study||99||
48649843|NCT00908687|101927930|FG002|COMPLETED|Overall Study||99||
48649844|NCT00908687|101927931|FG003|COMPLETED|Overall Study||47||
48649845|NCT00908687|101927932|FG004|COMPLETED|Overall Study||94||
48649846|NCT00908687|101927933|FG005|COMPLETED|Overall Study||94||
48649847|NCT00908687|101927928|FG000|NOT COMPLETED|Overall Study||1||
48649848|NCT00908687|101927929|FG001|NOT COMPLETED|Overall Study||1||
48649849|NCT00908687|101927930|FG002|NOT COMPLETED|Overall Study||3||
48649850|NCT00908687|101927931|FG003|NOT COMPLETED|Overall Study||3||
48649851|NCT00908687|101927932|FG004|NOT COMPLETED|Overall Study||4||
48649852|NCT00908687|101927933|FG005|NOT COMPLETED|Overall Study||6||
48649853|NCT00736476|101927934|FG000|STARTED|Overall Study||36||
48649854|NCT00736476|101927935|FG001|STARTED|Overall Study||27||
48649855|NCT00736476|101927934|FG000|COMPLETED|Overall Study||35||
48649856|NCT00736476|101927935|FG001|COMPLETED|Overall Study||27||
48649857|NCT00736476|101927934|FG000|NOT COMPLETED|Overall Study||1||
48649858|NCT00736476|101927935|FG001|NOT COMPLETED|Overall Study||0||
48649859|NCT02318277|101927936|FG000|STARTED|Overall Study||6||
48649860|NCT02318277|101927937|FG001|STARTED|Overall Study||3||
48649861|NCT02318277|101927938|FG002|STARTED|Overall Study||4||
48649862|NCT02318277|101927939|FG003|STARTED|Overall Study||4||
48649863|NCT02318277|101927940|FG004|STARTED|Overall Study||8||
48649864|NCT02318277|101927941|FG005|STARTED|Overall Study||9||
48649865|NCT02318277|101927942|FG006|STARTED|Overall Study||49||
48649866|NCT02318277|101927943|FG007|STARTED|Overall Study||93||
48649867|NCT02318277|101927936|FG000|COMPLETED|Overall Study||0||
48649868|NCT02318277|101927937|FG001|COMPLETED|Overall Study||0||
48649869|NCT02318277|101927938|FG002|COMPLETED|Overall Study||0||
48649870|NCT02318277|101927939|FG003|COMPLETED|Overall Study||0||
48649871|NCT02318277|101927940|FG004|COMPLETED|Overall Study||0||
48649872|NCT02318277|101927941|FG005|COMPLETED|Overall Study||0||
48649873|NCT02318277|101927942|FG006|COMPLETED|Overall Study||0||
48649874|NCT02318277|101927943|FG007|COMPLETED|Overall Study||0||
48649875|NCT02318277|101927936|FG000|NOT COMPLETED|Overall Study||6||
48649876|NCT02318277|101927937|FG001|NOT COMPLETED|Overall Study||3||
48649877|NCT02318277|101927938|FG002|NOT COMPLETED|Overall Study||4||
48649878|NCT02318277|101927939|FG003|NOT COMPLETED|Overall Study||4||
48649879|NCT02318277|101927940|FG004|NOT COMPLETED|Overall Study||8||
48649880|NCT02318277|101927941|FG005|NOT COMPLETED|Overall Study||9||
48649881|NCT02318277|101927942|FG006|NOT COMPLETED|Overall Study||49||
48649882|NCT02318277|101927943|FG007|NOT COMPLETED|Overall Study||93||
48649883|NCT03197935|101927944|FG000|STARTED|Overall Study||168||
48649884|NCT03197935|101927945|FG001|STARTED|Overall Study||165||
48649885|NCT03197935|101927944|FG000|COMPLETED|Overall Study||121||
48649886|NCT03197935|101927945|FG001|COMPLETED|Overall Study||136||
48649887|NCT03197935|101927944|FG000|NOT COMPLETED|Overall Study||47||
48649888|NCT03197935|101927945|FG001|NOT COMPLETED|Overall Study||29||
48649889|NCT00201773|101927946|FG000|STARTED|Overall Study||22||
48649890|NCT00201773|101927946|FG000|Completed 8 Weeks of Planned Therapy|Overall Study||16||
48649891|NCT00201773|101927946|FG000|Received All Exemestane Therapy|Overall Study||5||
48649892|NCT00201773|101927946|FG000|Stopped Exemestane After 4 Weeks|Overall Study||1||
48649893|NCT00201773|101927946|FG000|COMPLETED|Overall Study||16||
48649894|NCT00201773|101927946|FG000|NOT COMPLETED|Overall Study||6||
48649895|NCT05254210|101927947|FG000|STARTED|Overall Study||10||
48649896|NCT05254210|101927947|FG000|COMPLETED|Overall Study||8||
48649897|NCT05254210|101927947|FG000|NOT COMPLETED|Overall Study||2||
48649898|NCT00537082|101927948|FG000|STARTED|Overall Study||57||
48649899|NCT00537082|101927949|FG001|STARTED|Overall Study||57||
48649900|NCT00537082|101927950|FG002|STARTED|Overall Study||57||
48649901|NCT00537082|101927948|FG000|COMPLETED|Overall Study||48||
48649902|NCT00537082|101927949|FG001|COMPLETED|Overall Study||48||
48649903|NCT00537082|101927950|FG002|COMPLETED|Overall Study||51||
48649904|NCT00537082|101927948|FG000|NOT COMPLETED|Overall Study||9||
48649905|NCT00537082|101927949|FG001|NOT COMPLETED|Overall Study||9||
48649906|NCT00537082|101927950|FG002|NOT COMPLETED|Overall Study||6||
48649907|NCT03309605|101927951|FG000|STARTED|Overall Study||6||
48649908|NCT03309605|101927952|FG001|STARTED|Overall Study||5||
48649909|NCT03309605|101927953|FG002|STARTED|Overall Study||6||
48649910|NCT03309605|101927954|FG003|STARTED|Overall Study||6||
48649911|NCT03309605|101927955|FG004|STARTED|Overall Study||6||
48649912|NCT03309605|101927956|FG005|STARTED|Overall Study||6||
48649913|NCT03309605|101927957|FG006|STARTED|Overall Study||6||
48649914|NCT03309605|101927958|FG007|STARTED|Overall Study||21||
48649915|NCT03309605|101927951|FG000|COMPLETED|Overall Study||6||
48649916|NCT03309605|101927952|FG001|COMPLETED|Overall Study||5||
48649917|NCT03309605|101927953|FG002|COMPLETED|Overall Study||6||
48649918|NCT03309605|101927954|FG003|COMPLETED|Overall Study||5||
48649919|NCT03309605|101927955|FG004|COMPLETED|Overall Study||5||
48649920|NCT03309605|101927956|FG005|COMPLETED|Overall Study||6||
48649921|NCT03309605|101927957|FG006|COMPLETED|Overall Study||3||
48649922|NCT03309605|101927958|FG007|COMPLETED|Overall Study||19||
48649923|NCT03309605|101927951|FG000|NOT COMPLETED|Overall Study||0||
48649924|NCT03309605|101927952|FG001|NOT COMPLETED|Overall Study||0||
48649925|NCT03309605|101927953|FG002|NOT COMPLETED|Overall Study||0||
48649926|NCT03309605|101927954|FG003|NOT COMPLETED|Overall Study||1||
48649927|NCT03309605|101927955|FG004|NOT COMPLETED|Overall Study||1||
48649928|NCT03309605|101927956|FG005|NOT COMPLETED|Overall Study||0||
48649929|NCT03309605|101927957|FG006|NOT COMPLETED|Overall Study||3||
48649930|NCT03309605|101927958|FG007|NOT COMPLETED|Overall Study||2||
48649931|NCT02474901|101927959|FG000|STARTED|Overall Study||45||
48649932|NCT02474901|101927960|FG001|STARTED|Overall Study||56||
48649933|NCT02474901|101927959|FG000|COMPLETED|Overall Study||44||
48649934|NCT02474901|101927960|FG001|COMPLETED|Overall Study||56||
48649935|NCT02474901|101927959|FG000|NOT COMPLETED|Overall Study||1||
48649936|NCT02474901|101927960|FG001|NOT COMPLETED|Overall Study||0||
48649937|NCT04389671|101927961|FG000|STARTED|Overall Study||20||
48649938|NCT04389671|101927961|FG000|COMPLETED|Overall Study||13||
48649939|NCT04389671|101927961|FG000|NOT COMPLETED|Overall Study||7||
48649940|NCT00356421|101927962|FG000|STARTED|Overall Study||38||
48649941|NCT00356421|101927963|FG001|STARTED|Overall Study||20||
48649942|NCT00356421|101927962|FG000|COMPLETED|Overall Study||6||
48649943|NCT00356421|101927963|FG001|COMPLETED|Overall Study||3||
48649944|NCT00356421|101927962|FG000|NOT COMPLETED|Overall Study||32||
48649945|NCT00356421|101927963|FG001|NOT COMPLETED|Overall Study||17||
48649946|NCT05064800|101927964|FG000|STARTED|Period 1||4||
48649947|NCT05064800|101927965|FG001|STARTED|Period 1||4||
48649948|NCT05064800|101927966|FG002|STARTED|Period 1||4||
48649949|NCT05064800|101927967|FG003|STARTED|Period 1||4||
48649950|NCT05064800|101927968|FG004|STARTED|Period 1||4||
48649951|NCT05064800|101927969|FG005|STARTED|Period 1||4||
48649952|NCT05064800|101927964|FG000|COMPLETED|Period 1||4||
48649953|NCT05064800|101927965|FG001|COMPLETED|Period 1||4||
48649954|NCT05064800|101927966|FG002|COMPLETED|Period 1||4||
48649955|NCT05064800|101927967|FG003|COMPLETED|Period 1||4||
48649956|NCT05064800|101927968|FG004|COMPLETED|Period 1||4||
48649957|NCT05064800|101927969|FG005|COMPLETED|Period 1||4||
48649958|NCT05064800|101927964|FG000|NOT COMPLETED|Period 1||0||
48649959|NCT05064800|101927965|FG001|NOT COMPLETED|Period 1||0||
48649960|NCT05064800|101927966|FG002|NOT COMPLETED|Period 1||0||
48649961|NCT05064800|101927967|FG003|NOT COMPLETED|Period 1||0||
48649962|NCT05064800|101927968|FG004|NOT COMPLETED|Period 1||0||
48649963|NCT05064800|101927969|FG005|NOT COMPLETED|Period 1||0||
48649964|NCT05064800|101927964|FG000|STARTED|Period 2||4||
48649965|NCT05064800|101927965|FG001|STARTED|Period 2||4||
48362245|NCT00923091|101214499|FG012|COMPLETED|Period V (Double -Blind)||73||
48362246|NCT00923091|101214487|FG000|NOT COMPLETED|Period V (Double -Blind)||0||
48362247|NCT00923091|101214488|FG001|NOT COMPLETED|Period V (Double -Blind)||0||
48362248|NCT00923091|101214489|FG002|NOT COMPLETED|Period V (Double -Blind)||0||
48362249|NCT00923091|101214490|FG003|NOT COMPLETED|Period V (Double -Blind)||0||
48362250|NCT00923091|101214491|FG004|NOT COMPLETED|Period V (Double -Blind)||0||
48765373|NCT00089297|102214631|FG000|Eligible|Overall Study||63||
48765374|NCT00089297|102214631|FG000|COMPLETED|Overall Study||36||
48649966|NCT05064800|101927966|FG002|STARTED|Period 2||4||
48649967|NCT05064800|101927967|FG003|STARTED|Period 2||4||
48649968|NCT05064800|101927968|FG004|STARTED|Period 2||4||
48649969|NCT05064800|101927969|FG005|STARTED|Period 2||4||
48649970|NCT05064800|101927964|FG000|COMPLETED|Period 2||4||
48649971|NCT05064800|101927965|FG001|COMPLETED|Period 2||4||
48649972|NCT05064800|101927966|FG002|COMPLETED|Period 2||4||
48649973|NCT05064800|101927967|FG003|COMPLETED|Period 2||4||
48649974|NCT05064800|101927968|FG004|COMPLETED|Period 2||4||
48649975|NCT05064800|101927969|FG005|COMPLETED|Period 2||4||
48649976|NCT05064800|101927964|FG000|NOT COMPLETED|Period 2||0||
48649977|NCT05064800|101927965|FG001|NOT COMPLETED|Period 2||0||
48649978|NCT05064800|101927966|FG002|NOT COMPLETED|Period 2||0||
48649979|NCT05064800|101927967|FG003|NOT COMPLETED|Period 2||0||
48649980|NCT05064800|101927968|FG004|NOT COMPLETED|Period 2||0||
48649981|NCT05064800|101927969|FG005|NOT COMPLETED|Period 2||0||
48649982|NCT05064800|101927964|FG000|STARTED|Period 3||4||
48649983|NCT05064800|101927965|FG001|STARTED|Period 3||4||
48649984|NCT05064800|101927966|FG002|STARTED|Period 3||4||
48649985|NCT05064800|101927967|FG003|STARTED|Period 3||4||
48649986|NCT05064800|101927968|FG004|STARTED|Period 3||4||
48649987|NCT05064800|101927969|FG005|STARTED|Period 3||4||
48649988|NCT05064800|101927964|FG000|COMPLETED|Period 3||4||
48649989|NCT05064800|101927965|FG001|COMPLETED|Period 3||4||
48649990|NCT05064800|101927966|FG002|COMPLETED|Period 3||4||
48649991|NCT05064800|101927967|FG003|COMPLETED|Period 3||4||
48649992|NCT05064800|101927968|FG004|COMPLETED|Period 3||3||
48649993|NCT05064800|101927969|FG005|COMPLETED|Period 3||4||
48649994|NCT05064800|101927964|FG000|NOT COMPLETED|Period 3||0||
48649995|NCT05064800|101927965|FG001|NOT COMPLETED|Period 3||0||
48649996|NCT05064800|101927966|FG002|NOT COMPLETED|Period 3||0||
48649997|NCT05064800|101927967|FG003|NOT COMPLETED|Period 3||0||
48649998|NCT05064800|101927968|FG004|NOT COMPLETED|Period 3||1||
48649999|NCT05064800|101927969|FG005|NOT COMPLETED|Period 3||0||
48650000|NCT00632970|101927970|FG000|STARTED|Overall Study||3||
48650001|NCT00632970|101927971|FG001|STARTED|Overall Study||3||
48650002|NCT00632970|101927970|FG000|COMPLETED|Overall Study||3||
48650003|NCT00632970|101927971|FG001|COMPLETED|Overall Study||3||
48650004|NCT00632970|101927970|FG000|NOT COMPLETED|Overall Study||0||
48650005|NCT00632970|101927971|FG001|NOT COMPLETED|Overall Study||0||
48650006|NCT04233580|101927972|FG000|STARTED|Overall Study||20||
48650007|NCT04233580|101927973|FG001|STARTED|Overall Study||20||
48650008|NCT04233580|101927972|FG000|COMPLETED|Overall Study||15||
48650009|NCT04233580|101927973|FG001|COMPLETED|Overall Study||16||
48650010|NCT04233580|101927972|FG000|NOT COMPLETED|Overall Study||5||
48650011|NCT04233580|101927973|FG001|NOT COMPLETED|Overall Study||4||
48650012|NCT02032212|101927974|FG000|STARTED|Overall Study||3||
48650013|NCT02032212|101927975|FG001|STARTED|Overall Study||3||
48650014|NCT02032212|101927976|FG002|STARTED|Overall Study||3||
48650015|NCT02032212|101927977|FG003|STARTED|Overall Study||3||
48650016|NCT02032212|101927974|FG000|COMPLETED|Overall Study||3||
48650017|NCT02032212|101927975|FG001|COMPLETED|Overall Study||3||
48650018|NCT02032212|101927976|FG002|COMPLETED|Overall Study||3||
48650019|NCT02032212|101927977|FG003|COMPLETED|Overall Study||3||
48650020|NCT02032212|101927974|FG000|NOT COMPLETED|Overall Study||0||
48650021|NCT02032212|101927975|FG001|NOT COMPLETED|Overall Study||0||
48650022|NCT02032212|101927976|FG002|NOT COMPLETED|Overall Study||0||
48650023|NCT02032212|101927977|FG003|NOT COMPLETED|Overall Study||0||
48650024|NCT00567112|101927978|FG000|STARTED|Treatment Period 1 (3 Days)||7||
48650025|NCT00567112|101927979|FG001|STARTED|Treatment Period 1 (3 Days)||8||
48650026|NCT00567112|101927980|FG002|STARTED|Treatment Period 1 (3 Days)||0||
48650027|NCT00567112|101927978|FG000|COMPLETED|Treatment Period 1 (3 Days)||7||
48650028|NCT00567112|101927979|FG001|COMPLETED|Treatment Period 1 (3 Days)||8||
48650029|NCT00567112|101927980|FG002|COMPLETED|Treatment Period 1 (3 Days)||0||
48650030|NCT00567112|101927978|FG000|NOT COMPLETED|Treatment Period 1 (3 Days)||0||
48650031|NCT00567112|101927979|FG001|NOT COMPLETED|Treatment Period 1 (3 Days)||0||
48650032|NCT00567112|101927980|FG002|NOT COMPLETED|Treatment Period 1 (3 Days)||0||
48650033|NCT00567112|101927978|FG000|STARTED|Washout Period 1 (3 Days)||7||
48650034|NCT00567112|101927979|FG001|STARTED|Washout Period 1 (3 Days)||8||
48650035|NCT00567112|101927980|FG002|STARTED|Washout Period 1 (3 Days)||0||
48650036|NCT00567112|101927978|FG000|COMPLETED|Washout Period 1 (3 Days)||7||
48650037|NCT00567112|101927979|FG001|COMPLETED|Washout Period 1 (3 Days)||8||
48650038|NCT00567112|101927980|FG002|COMPLETED|Washout Period 1 (3 Days)||0||
48650039|NCT00567112|101927978|FG000|NOT COMPLETED|Washout Period 1 (3 Days)||0||
48650040|NCT00567112|101927979|FG001|NOT COMPLETED|Washout Period 1 (3 Days)||0||
48650041|NCT00567112|101927980|FG002|NOT COMPLETED|Washout Period 1 (3 Days)||0||
48650042|NCT00567112|101927978|FG000|STARTED|Treatment Period 2 (3 Days)||7||
48650043|NCT00567112|101927979|FG001|STARTED|Treatment Period 2 (3 Days)||8||
48650044|NCT00567112|101927980|FG002|STARTED|Treatment Period 2 (3 Days)||3||
48650045|NCT00567112|101927978|FG000|COMPLETED|Treatment Period 2 (3 Days)||7||
48650046|NCT00567112|101927979|FG001|COMPLETED|Treatment Period 2 (3 Days)||7||
48650047|NCT00567112|101927980|FG002|COMPLETED|Treatment Period 2 (3 Days)||3||
48650048|NCT00567112|101927978|FG000|NOT COMPLETED|Treatment Period 2 (3 Days)||0||
48650049|NCT00567112|101927979|FG001|NOT COMPLETED|Treatment Period 2 (3 Days)||1||
48650050|NCT00567112|101927980|FG002|NOT COMPLETED|Treatment Period 2 (3 Days)||0||
48650051|NCT00567112|101927978|FG000|STARTED|Washout Period 2 (3 Days)||7||
48650052|NCT00567112|101927979|FG001|STARTED|Washout Period 2 (3 Days)||7||
48650053|NCT00567112|101927980|FG002|STARTED|Washout Period 2 (3 Days)||3||
48650054|NCT00567112|101927978|FG000|COMPLETED|Washout Period 2 (3 Days)||7||
48650055|NCT00567112|101927979|FG001|COMPLETED|Washout Period 2 (3 Days)||7||
48650056|NCT00567112|101927980|FG002|COMPLETED|Washout Period 2 (3 Days)||3||
48650057|NCT00567112|101927978|FG000|NOT COMPLETED|Washout Period 2 (3 Days)||0||
48650058|NCT00567112|101927979|FG001|NOT COMPLETED|Washout Period 2 (3 Days)||0||
48650059|NCT00567112|101927980|FG002|NOT COMPLETED|Washout Period 2 (3 Days)||0||
48362251|NCT00923091|101214492|FG005|NOT COMPLETED|Period V (Double -Blind)||0||
48362252|NCT00923091|101214493|FG006|NOT COMPLETED|Period V (Double -Blind)||0||
48362253|NCT00923091|101214494|FG007|NOT COMPLETED|Period V (Double -Blind)||0||
48650060|NCT00567112|101927978|FG000|STARTED|Treatment Period 3 (3 Days)||7||
48650061|NCT00567112|101927979|FG001|STARTED|Treatment Period 3 (3 Days)||7||
48650062|NCT00567112|101927980|FG002|STARTED|Treatment Period 3 (3 Days)||3||
48650063|NCT00567112|101927978|FG000|COMPLETED|Treatment Period 3 (3 Days)||7||
48650064|NCT00567112|101927979|FG001|COMPLETED|Treatment Period 3 (3 Days)||7||
48650065|NCT00567112|101927980|FG002|COMPLETED|Treatment Period 3 (3 Days)||3||
48650066|NCT00567112|101927978|FG000|NOT COMPLETED|Treatment Period 3 (3 Days)||0||
48650067|NCT00567112|101927979|FG001|NOT COMPLETED|Treatment Period 3 (3 Days)||0||
48650068|NCT00567112|101927980|FG002|NOT COMPLETED|Treatment Period 3 (3 Days)||0||
48650069|NCT00567112|101927978|FG000|STARTED|Washout Period 3 (3 Days)||7||
48650070|NCT00567112|101927979|FG001|STARTED|Washout Period 3 (3 Days)||7||
48650071|NCT00567112|101927980|FG002|STARTED|Washout Period 3 (3 Days)||3||
48650072|NCT00567112|101927978|FG000|COMPLETED|Washout Period 3 (3 Days)||4||
48650073|NCT00567112|101927979|FG001|COMPLETED|Washout Period 3 (3 Days)||7||
48650074|NCT00567112|101927980|FG002|COMPLETED|Washout Period 3 (3 Days)||3||
48650075|NCT00567112|101927978|FG000|NOT COMPLETED|Washout Period 3 (3 Days)||3||
48650076|NCT00567112|101927979|FG001|NOT COMPLETED|Washout Period 3 (3 Days)||0||
48650077|NCT00567112|101927980|FG002|NOT COMPLETED|Washout Period 3 (3 Days)||0||
48650078|NCT00567112|101927978|FG000|STARTED|Treatment Period 4 (3 Days)||4||
48650079|NCT00567112|101927979|FG001|STARTED|Treatment Period 4 (3 Days)||7||
48650080|NCT00567112|101927980|FG002|STARTED|Treatment Period 4 (3 Days)||3||
48650081|NCT00567112|101927978|FG000|COMPLETED|Treatment Period 4 (3 Days)||4||
48650082|NCT00567112|101927979|FG001|COMPLETED|Treatment Period 4 (3 Days)||7||
48650083|NCT00567112|101927980|FG002|COMPLETED|Treatment Period 4 (3 Days)||3||
48650084|NCT00567112|101927978|FG000|NOT COMPLETED|Treatment Period 4 (3 Days)||0||
48650085|NCT00567112|101927979|FG001|NOT COMPLETED|Treatment Period 4 (3 Days)||0||
48650086|NCT00567112|101927980|FG002|NOT COMPLETED|Treatment Period 4 (3 Days)||0||
48650087|NCT00560404|101927981|FG000|STARTED|Overall Study||112||
48650088|NCT00560404|101927982|FG001|STARTED|Overall Study||121||
48650089|NCT00560404|101927981|FG000|COMPLETED|Overall Study||76||
48650090|NCT00560404|101927982|FG001|COMPLETED|Overall Study||100||
48650091|NCT00560404|101927981|FG000|NOT COMPLETED|Overall Study||36||
48650092|NCT00560404|101927982|FG001|NOT COMPLETED|Overall Study||21||
48650093|NCT00585585|101927983|FG000|STARTED|Overall Study||1||
48650094|NCT00585585|101927983|FG000|Patients Receiving Drug|Overall Study||1||
48650095|NCT00585585|101927983|FG000|COMPLETED|Overall Study||0||
48650096|NCT00585585|101927983|FG000|NOT COMPLETED|Overall Study||1||
48650097|NCT03548415|101927984|FG000|STARTED|Overall Study||12||
48650098|NCT03548415|101927985|FG001|STARTED|Overall Study||12||
48650099|NCT03548415|101927986|FG002|STARTED|Overall Study||11||
48650100|NCT03548415|101927987|FG003|STARTED|Overall Study||2||
48650101|NCT03548415|101927988|FG004|STARTED|Overall Study||6||
48650102|NCT03548415|101927984|FG000|Per-Protocol Set|Overall Study||12|The Per-Protocol Set included all randomized participants who received at least 5 of the 6 doses of Study Drug and had at least one post-baseline efficacy or pharmacodynamic assessment, with the first 3 doses administered on schedule, and had no significant protocol deviations that would have been expected to affect efficacy.|
48650103|NCT03548415|101927985|FG001|Per-Protocol Set|Overall Study||11|The Per-Protocol Set included all randomized participants who received at least 5 of the 6 doses of Study Drug and had at least one post-baseline efficacy or pharmacodynamic assessment, with the first 3 doses administered on schedule, and had no significant protocol deviations that would have been expected to affect efficacy.|
48650104|NCT03548415|101927986|FG002|Per-Protocol Set|Overall Study||11|The Per-Protocol Set included all randomized participants who received at least 5 of the 6 doses of Study Drug and had at least one post-baseline efficacy or pharmacodynamic assessment, with the first 3 doses administered on schedule, and had no significant protocol deviations that would have been expected to affect efficacy.|
48650105|NCT03548415|101927987|FG003|Per-Protocol Set|Overall Study||2|The Per-Protocol Set included all randomized participants who received at least 5 of the 6 doses of Study Drug and had at least one post-baseline efficacy or pharmacodynamic assessment, with the first 3 doses administered on schedule, and had no significant protocol deviations that would have been expected to affect efficacy.|
48650106|NCT03548415|101927988|FG004|Per-Protocol Set|Overall Study||5|The Per-Protocol Set included all randomized participants who received at least 5 of the 6 doses of Study Drug and had at least one post-baseline efficacy or pharmacodynamic assessment, with the first 3 doses administered on schedule, and had no significant protocol deviations that would have been expected to affect efficacy.|
48650107|NCT03548415|101927984|FG000|COMPLETED|Overall Study||12||
48650108|NCT03548415|101927985|FG001|COMPLETED|Overall Study||11||
48650109|NCT03548415|101927986|FG002|COMPLETED|Overall Study||11||
48650110|NCT03548415|101927987|FG003|COMPLETED|Overall Study||2||
48650111|NCT03548415|101927988|FG004|COMPLETED|Overall Study||5||
48650112|NCT03548415|101927984|FG000|NOT COMPLETED|Overall Study||0||
48650113|NCT03548415|101927985|FG001|NOT COMPLETED|Overall Study||1||
48650114|NCT03548415|101927986|FG002|NOT COMPLETED|Overall Study||0||
48650115|NCT03548415|101927987|FG003|NOT COMPLETED|Overall Study||0||
48650116|NCT03548415|101927988|FG004|NOT COMPLETED|Overall Study||1||
48650117|NCT00723944|101927989|FG000|STARTED|Implant Placement Surgery||52||
48650118|NCT00723944|101927990|FG001|STARTED|Implant Placement Surgery||50||
48650119|NCT00723944|101927989|FG000|COMPLETED|Implant Placement Surgery||52||
48650120|NCT00723944|101927990|FG001|COMPLETED|Implant Placement Surgery||50||
48650121|NCT00723944|101927989|FG000|NOT COMPLETED|Implant Placement Surgery||0||
48650122|NCT00723944|101927990|FG001|NOT COMPLETED|Implant Placement Surgery||0||
48650123|NCT00723944|101927989|FG000|STARTED|Permanent Prosthesis Placement||52||
48650124|NCT00723944|101927990|FG001|STARTED|Permanent Prosthesis Placement||50||
48650125|NCT00723944|101927989|FG000|COMPLETED|Permanent Prosthesis Placement||49||
48650126|NCT00723944|101927990|FG001|COMPLETED|Permanent Prosthesis Placement||41||
48650127|NCT00723944|101927989|FG000|NOT COMPLETED|Permanent Prosthesis Placement||3||
48650128|NCT00723944|101927990|FG001|NOT COMPLETED|Permanent Prosthesis Placement||9||
48650129|NCT00723944|101927989|FG000|STARTED|One Year Post Placement Follow-up||49||
48650130|NCT00723944|101927990|FG001|STARTED|One Year Post Placement Follow-up||41||
48650131|NCT00723944|101927989|FG000|COMPLETED|One Year Post Placement Follow-up||48||
48650132|NCT00723944|101927990|FG001|COMPLETED|One Year Post Placement Follow-up||37||
48650133|NCT00723944|101927989|FG000|NOT COMPLETED|One Year Post Placement Follow-up||1||
48650134|NCT00723944|101927990|FG001|NOT COMPLETED|One Year Post Placement Follow-up||4||
48650135|NCT00723944|101927989|FG000|STARTED|Two Year Post Placement Follow-up||48||
48650136|NCT00723944|101927990|FG001|STARTED|Two Year Post Placement Follow-up||37||
48650137|NCT00723944|101927989|FG000|COMPLETED|Two Year Post Placement Follow-up||48||
48650138|NCT00723944|101927990|FG001|COMPLETED|Two Year Post Placement Follow-up||37||
48650139|NCT00723944|101927989|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||0||
48650140|NCT00723944|101927990|FG001|NOT COMPLETED|Two Year Post Placement Follow-up||0||
48650141|NCT01658735|101927991|FG000|STARTED|Overall Study||39||
48650142|NCT01658735|101927992|FG001|STARTED|Overall Study||36||
48650143|NCT01658735|101927993|FG002|STARTED|Overall Study||38||
48650144|NCT01658735|101927991|FG000|COMPLETED|Overall Study||34||
48650145|NCT01658735|101927992|FG001|COMPLETED|Overall Study||29||
48650146|NCT01658735|101927993|FG002|COMPLETED|Overall Study||34||
48650147|NCT01658735|101927991|FG000|NOT COMPLETED|Overall Study||5||
48650148|NCT01658735|101927992|FG001|NOT COMPLETED|Overall Study||7||
48650149|NCT01658735|101927993|FG002|NOT COMPLETED|Overall Study||4||
48650150|NCT03708770|101927994|FG000|STARTED|Overall Study||32||
48650151|NCT03708770|101927994|FG000|COMPLETED|Overall Study||22||
48650152|NCT03708770|101927994|FG000|NOT COMPLETED|Overall Study||10||
48650153|NCT02175758|101927995|FG000|STARTED|PK Lead-in Phase||4||
48650154|NCT02175758|101927996|FG001|STARTED|PK Lead-in Phase||6||
48650155|NCT02175758|101927997|FG002|STARTED|PK Lead-in Phase||2||
48650156|NCT02175758|101927998|FG003|STARTED|PK Lead-in Phase||10||
48650157|NCT02175758|101927999|FG004|STARTED|PK Lead-in Phase||4||
48650158|NCT02175758|101928000|FG005|STARTED|PK Lead-in Phase||8||
48650159|NCT02175758|101927995|FG000|COMPLETED|PK Lead-in Phase||4||
48650160|NCT02175758|101927996|FG001|COMPLETED|PK Lead-in Phase||6||
48650161|NCT02175758|101927997|FG002|COMPLETED|PK Lead-in Phase||2||
48650162|NCT02175758|101927998|FG003|COMPLETED|PK Lead-in Phase||10||
48650163|NCT02175758|101927999|FG004|COMPLETED|PK Lead-in Phase||4||
48650164|NCT02175758|101928000|FG005|COMPLETED|PK Lead-in Phase||8||
48650165|NCT02175758|101927995|FG000|NOT COMPLETED|PK Lead-in Phase||0||
48650166|NCT02175758|101927996|FG001|NOT COMPLETED|PK Lead-in Phase||0||
48650167|NCT02175758|101927997|FG002|NOT COMPLETED|PK Lead-in Phase||0||
48650168|NCT02175758|101927998|FG003|NOT COMPLETED|PK Lead-in Phase||0||
48650169|NCT02175758|101927999|FG004|NOT COMPLETED|PK Lead-in Phase||0||
48650170|NCT02175758|101928000|FG005|NOT COMPLETED|PK Lead-in Phase||0||
48650171|NCT02175758|101927995|FG000|STARTED|Treatment Phase||13||
48765375|NCT00089297|102214631|FG000|NOT COMPLETED|Overall Study||38||
48765376|NCT01409707|102214632|FG000|STARTED|Overall Study||41||
48765377|NCT01409707|102214633|FG001|STARTED|Overall Study||45||
48765378|NCT01409707|102214634|FG002|STARTED|Overall Study||40||
48650172|NCT02175758|101927996|FG001|STARTED|Treatment Phase||39||
48650173|NCT02175758|101927997|FG002|STARTED|Treatment Phase||13||
48650174|NCT02175758|101927998|FG003|STARTED|Treatment Phase||28||
48650175|NCT02175758|101927999|FG004|STARTED|Treatment Phase||5||
48650176|NCT02175758|101928000|FG005|STARTED|Treatment Phase||8||
48650177|NCT02175758|101927995|FG000|COMPLETED|Treatment Phase||13||
48650178|NCT02175758|101927996|FG001|COMPLETED|Treatment Phase||38||
48650179|NCT02175758|101927997|FG002|COMPLETED|Treatment Phase||13||
48650180|NCT02175758|101927998|FG003|COMPLETED|Treatment Phase||28||
48650181|NCT02175758|101927999|FG004|COMPLETED|Treatment Phase||4||
48650182|NCT02175758|101928000|FG005|COMPLETED|Treatment Phase||8||
48650183|NCT02175758|101927995|FG000|NOT COMPLETED|Treatment Phase||0||
48650184|NCT02175758|101927996|FG001|NOT COMPLETED|Treatment Phase||1||
48650185|NCT02175758|101927997|FG002|NOT COMPLETED|Treatment Phase||0||
48650186|NCT02175758|101927998|FG003|NOT COMPLETED|Treatment Phase||0||
48650187|NCT02175758|101927999|FG004|NOT COMPLETED|Treatment Phase||1||
48650188|NCT02175758|101928000|FG005|NOT COMPLETED|Treatment Phase||0||
48650189|NCT00753142|101928001|FG000|STARTED|Overall Study||8||
48650190|NCT00753142|101928002|FG001|STARTED|Overall Study||7||
48650191|NCT00753142|101928003|FG002|STARTED|Overall Study||13||
48650192|NCT00753142|101928001|FG000|COMPLETED|Overall Study||8||
48650193|NCT00753142|101928002|FG001|COMPLETED|Overall Study||7||
48650194|NCT00753142|101928003|FG002|COMPLETED|Overall Study||13||
48650195|NCT00753142|101928001|FG000|NOT COMPLETED|Overall Study||0||
48650196|NCT00753142|101928002|FG001|NOT COMPLETED|Overall Study||0||
48650197|NCT00753142|101928003|FG002|NOT COMPLETED|Overall Study||0||
48650198|NCT03144635|101928004|FG000|STARTED|Overall Study||80||
48650199|NCT03144635|101928004|FG000|COMPLETED|Overall Study||0||
48650200|NCT03144635|101928004|FG000|NOT COMPLETED|Overall Study||80||
48650201|NCT01117350|101928005|FG000|STARTED|Comparative Period||489||
48650202|NCT01117350|101928006|FG001|STARTED|Comparative Period||489||
48650203|NCT01117350|101928005|FG000|TREATED = Safety Population|Comparative Period||484||
48765379|NCT01409707|102214632|FG000|COMPLETED|Overall Study||36||
48436334|NCT01374516|101403528|FG000|COMPLETED|Surveillance Expansion Period||10932||
48650204|NCT01117350|101928006|FG001|TREATED = Safety Population|Comparative Period||481||
48650205|NCT01117350|101928005|FG000|mITT Population|Comparative Period||474||
48650206|NCT01117350|101928006|FG001|mITT Population|Comparative Period||470||
48650207|NCT01117350|101928005|FG000|COMPLETED|Comparative Period||447||
48650208|NCT01117350|101928006|FG001|COMPLETED|Comparative Period||414||
48765380|NCT01409707|102214633|FG001|COMPLETED|Overall Study||28||
48765381|NCT01409707|102214634|FG002|COMPLETED|Overall Study||24||
48765382|NCT01409707|102214632|FG000|NOT COMPLETED|Overall Study||5||
48650209|NCT01117350|101928005|FG000|NOT COMPLETED|Comparative Period||42||
48650210|NCT01117350|101928006|FG001|NOT COMPLETED|Comparative Period||75||
48650211|NCT01117350|101928005|FG000|STARTED|Extension Period||0||
48650212|NCT01117350|101928006|FG001|STARTED|Extension Period||210||
48650213|NCT01117350|101928005|FG000|TREATED = Safety Population (Extension)|Extension Period||0||
48650214|NCT01117350|101928006|FG001|TREATED = Safety Population (Extension)|Extension Period||160||
48650215|NCT01117350|101928005|FG000|mITT Population (Extension)|Extension Period||0||
48650216|NCT01117350|101928006|FG001|mITT Population (Extension)|Extension Period||154||
48650217|NCT01117350|101928005|FG000|COMPLETED|Extension Period||0||
48650218|NCT01117350|101928006|FG001|COMPLETED|Extension Period||147||
48650219|NCT01117350|101928005|FG000|NOT COMPLETED|Extension Period||0||
48650220|NCT01117350|101928006|FG001|NOT COMPLETED|Extension Period||63||
48650221|NCT03518203|101928007|FG000|STARTED|Overall Study||23||
48650222|NCT03518203|101928007|FG000|COMPLETED|Overall Study||21||
48650223|NCT03518203|101928007|FG000|NOT COMPLETED|Overall Study||2||
48650224|NCT02222181|101928008|FG000|STARTED|Overall Study||163||
48650225|NCT02222181|101928008|FG000|COMPLETED|Overall Study||55||
48650226|NCT02222181|101928008|FG000|NOT COMPLETED|Overall Study||108||
48650227|NCT00585169|101928009|FG000|STARTED|Overall Study||29||
48650228|NCT00585169|101928009|FG000|COMPLETED|Overall Study||28||
48650229|NCT00585169|101928009|FG000|NOT COMPLETED|Overall Study||1||
48650230|NCT01270867|101928010|FG000|STARTED|Overall Study||90||
48650231|NCT01270867|101928011|FG001|STARTED|Overall Study||88||
48650232|NCT01270867|101928010|FG000|COMPLETED|Overall Study||89||
48650233|NCT01270867|101928011|FG001|COMPLETED|Overall Study||88||
48650234|NCT01270867|101928010|FG000|NOT COMPLETED|Overall Study||1||
48650235|NCT01270867|101928011|FG001|NOT COMPLETED|Overall Study||0||
48650236|NCT00729807|101928012|FG000|STARTED|Overall Study||6||
48650237|NCT00729807|101928012|FG000|COMPLETED|Overall Study||6||
48650238|NCT00729807|101928012|FG000|NOT COMPLETED|Overall Study||0||
48650239|NCT00514917|101928013|FG000|STARTED|Overall Study||207||
48650240|NCT00514917|101928014|FG001|STARTED|Overall Study||206||
48650241|NCT00514917|101928013|FG000|Treated|Overall Study||196||
48650242|NCT00514917|101928014|FG001|Treated|Overall Study||204||
48650243|NCT00514917|101928013|FG000|Completed Study Treatment|Overall Study||170||
48650244|NCT00514917|101928014|FG001|Completed Study Treatment|Overall Study||182||
48650245|NCT00514917|101928013|FG000|Testosterone-Specific Evaluable|Overall Study||122||
48650246|NCT00514917|101928014|FG001|Testosterone-Specific Evaluable|Overall Study||124||
48650247|NCT00514917|101928013|FG000|COMPLETED|Overall Study||81||
48650248|NCT00514917|101928014|FG001|COMPLETED|Overall Study||91||
48650249|NCT00514917|101928013|FG000|NOT COMPLETED|Overall Study||126||
48650250|NCT00514917|101928014|FG001|NOT COMPLETED|Overall Study||115||
48650251|NCT03646188|101928015|FG000|STARTED|Overall Study||3||
48650252|NCT03646188|101928016|FG001|STARTED|Overall Study||3||
48650253|NCT03646188|101928017|FG002|STARTED|Overall Study||3||
48650254|NCT03646188|101928018|FG003|STARTED|Overall Study||3||
48650255|NCT03646188|101928019|FG004|STARTED|Overall Study||1||
48650256|NCT03646188|101928015|FG000|COMPLETED|Overall Study||3||
48650257|NCT03646188|101928016|FG001|COMPLETED|Overall Study||3||
48650258|NCT03646188|101928017|FG002|COMPLETED|Overall Study||3||
48650259|NCT03646188|101928018|FG003|COMPLETED|Overall Study||3||
48650260|NCT03646188|101928019|FG004|COMPLETED|Overall Study||1||
48650261|NCT03646188|101928015|FG000|NOT COMPLETED|Overall Study||0||
48650262|NCT03646188|101928016|FG001|NOT COMPLETED|Overall Study||0||
48650263|NCT03646188|101928017|FG002|NOT COMPLETED|Overall Study||0||
48650264|NCT03646188|101928018|FG003|NOT COMPLETED|Overall Study||0||
48650265|NCT03646188|101928019|FG004|NOT COMPLETED|Overall Study||0||
48650266|NCT02571244|101928020|FG000|STARTED|Overall Study||44||
48650267|NCT02571244|101928021|FG001|STARTED|Overall Study||22||
48650268|NCT02571244|101928020|FG000|COMPLETED|Overall Study||41||
48650269|NCT02571244|101928021|FG001|COMPLETED|Overall Study||21||
48650270|NCT02571244|101928020|FG000|NOT COMPLETED|Overall Study||3||
48650271|NCT02571244|101928021|FG001|NOT COMPLETED|Overall Study||1||
48650272|NCT04250675|101928022|FG000|STARTED|Overall Study||5||
48650273|NCT04250675|101928023|FG001|STARTED|Overall Study||4||
48650274|NCT04250675|101928022|FG000|COMPLETED|Overall Study||4||
48650275|NCT04250675|101928023|FG001|COMPLETED|Overall Study||4||
48650276|NCT04250675|101928022|FG000|NOT COMPLETED|Overall Study||1||
48650277|NCT04250675|101928023|FG001|NOT COMPLETED|Overall Study||0||
48650278|NCT00505362|101928024|FG000|STARTED|Overall Study||35||
48650279|NCT00505362|101928025|FG001|STARTED|Overall Study||28||
48650280|NCT00505362|101928024|FG000|COMPLETED|Overall Study||35||
48650281|NCT00505362|101928025|FG001|COMPLETED|Overall Study||28||
48650282|NCT00505362|101928024|FG000|NOT COMPLETED|Overall Study||0||
48650283|NCT00505362|101928025|FG001|NOT COMPLETED|Overall Study||0||
48650284|NCT01454063|101928026|FG000|STARTED|Randomized||202||
48650285|NCT01454063|101928027|FG001|STARTED|Randomized||203||
48650286|NCT01454063|101928026|FG000|COMPLETED|Randomized||201||
48650287|NCT01454063|101928027|FG001|COMPLETED|Randomized||201||
48650288|NCT01454063|101928026|FG000|NOT COMPLETED|Randomized||1||
48650289|NCT01454063|101928027|FG001|NOT COMPLETED|Randomized||2||
48650290|NCT01454063|101928026|FG000|STARTED|Treated||201||
48650291|NCT01454063|101928027|FG001|STARTED|Treated||201||
48650292|NCT01454063|101928026|FG000|COMPLETED|Treated||199||
48650293|NCT01454063|101928027|FG001|COMPLETED|Treated||201||
48650294|NCT01454063|101928026|FG000|NOT COMPLETED|Treated||2||
48650295|NCT01454063|101928027|FG001|NOT COMPLETED|Treated||0||
48650296|NCT00122187|101928028|FG000|STARTED|Overall Study||4||
48650297|NCT00122187|101928029|FG001|STARTED|Overall Study||4||
48650298|NCT00122187|101928028|FG000|Matched by Colonoscopy Volume|Overall Study||4||
48650299|NCT00122187|101928029|FG001|Matched by Colonoscopy Volume|Overall Study||4||
48650300|NCT00122187|101928028|FG000|Randomized to Intervention or Usual Care|Overall Study||4||
48650301|NCT00122187|101928029|FG001|Randomized to Intervention or Usual Care|Overall Study||4||
48650302|NCT00122187|101928028|FG000|Intervention Implemented|Overall Study||3||
48650303|NCT00122187|101928029|FG001|Intervention Implemented|Overall Study||4||
48650304|NCT00122187|101928028|FG000|Post-intervention Data Collection|Overall Study||2||
48650305|NCT00122187|101928029|FG001|Post-intervention Data Collection|Overall Study||2||
48650306|NCT00122187|101928028|FG000|COMPLETED|Overall Study||2||
48650307|NCT00122187|101928029|FG001|COMPLETED|Overall Study||2||
48650308|NCT00122187|101928028|FG000|NOT COMPLETED|Overall Study||2||
48650309|NCT00122187|101928029|FG001|NOT COMPLETED|Overall Study||2||
48650310|NCT03296345|101928030|FG000|STARTED|Overall Study||62||
48765383|NCT01409707|102214633|FG001|NOT COMPLETED|Overall Study||17||
48650311|NCT03296345|101928030|FG000|COMPLETED|Overall Study||62||
48650312|NCT03296345|101928030|FG000|NOT COMPLETED|Overall Study||0||
48650313|NCT03335566|101928031|FG000|STARTED|Overall Study||218||
48650314|NCT03335566|101928032|FG001|STARTED|Overall Study||206||
48650315|NCT03335566|101928031|FG000|COMPLETED|Overall Study||214||
48650316|NCT03335566|101928032|FG001|COMPLETED|Overall Study||203||
48650317|NCT03335566|101928031|FG000|NOT COMPLETED|Overall Study||4||
48650318|NCT03335566|101928032|FG001|NOT COMPLETED|Overall Study||3||
48650319|NCT01169337|101931748|FG000|STARTED|Overall Study||44||
48650320|NCT01169337|101931749|FG001|STARTED|Overall Study||90||
48650321|NCT01169337|101931750|FG002|STARTED|Overall Study||92||
48650322|NCT01169337|101931748|FG000|Received Treatment/Observation|Overall Study||44||
48650323|NCT01169337|101931749|FG001|Received Treatment/Observation|Overall Study||88||
48650324|NCT01169337|101931750|FG002|Received Treatment/Observation|Overall Study||86||
48650325|NCT01169337|101931748|FG000|COMPLETED|Overall Study||0||
48650326|NCT01169337|101931749|FG001|COMPLETED|Overall Study||0||
48650327|NCT01169337|101931750|FG002|COMPLETED|Overall Study||86||
48650328|NCT01169337|101931748|FG000|NOT COMPLETED|Overall Study||44||
48650329|NCT01169337|101931749|FG001|NOT COMPLETED|Overall Study||90||
48650330|NCT01169337|101931750|FG002|NOT COMPLETED|Overall Study||6||
48650331|NCT01734928|101931751|FG000|STARTED|Randomization||281||
48650332|NCT01734928|101931752|FG001|STARTED|Randomization||278||
48650333|NCT01734928|101931751|FG000|COMPLETED|Randomization||278||
48650334|NCT01734928|101931752|FG001|COMPLETED|Randomization||270||
48650335|NCT01734928|101931751|FG000|NOT COMPLETED|Randomization||3||
48650336|NCT01734928|101931752|FG001|NOT COMPLETED|Randomization||8||
48650337|NCT01734928|101931751|FG000|STARTED|Treatment Period||278||
48650338|NCT01734928|101931752|FG001|STARTED|Treatment Period||270||
48650339|NCT01734928|101931751|FG000|COMPLETED|Treatment Period||0||
48650340|NCT01734928|101931752|FG001|COMPLETED|Treatment Period||0||
48650341|NCT01734928|101931751|FG000|NOT COMPLETED|Treatment Period||278||
48650342|NCT01734928|101931752|FG001|NOT COMPLETED|Treatment Period||270||
48650343|NCT00799864|101931753|FG000|STARTED|Overall Study||36||
48650344|NCT00799864|101931754|FG001|STARTED|Overall Study||9||
48650345|NCT00799864|101931755|FG002|STARTED|Overall Study||5||
48650346|NCT00799864|101931756|FG003|STARTED|Overall Study||2||
48650347|NCT00799864|101931757|FG004|STARTED|Overall Study||2||
48650348|NCT00799864|101931753|FG000|COMPLETED|Overall Study||25||
48650349|NCT00799864|101931754|FG001|COMPLETED|Overall Study||6||
48650350|NCT00799864|101931755|FG002|COMPLETED|Overall Study||3||
48650351|NCT00799864|101931756|FG003|COMPLETED|Overall Study||2||
48650352|NCT00799864|101931757|FG004|COMPLETED|Overall Study||2||
48650353|NCT00799864|101931753|FG000|NOT COMPLETED|Overall Study||11||
48650354|NCT00799864|101931754|FG001|NOT COMPLETED|Overall Study||3||
48650355|NCT00799864|101931755|FG002|NOT COMPLETED|Overall Study||2||
48650356|NCT00799864|101931756|FG003|NOT COMPLETED|Overall Study||0||
48650357|NCT00799864|101931757|FG004|NOT COMPLETED|Overall Study||0||
48650358|NCT01629862|101931758|FG000|STARTED|Overall Study||28||
48650359|NCT01629862|101931759|FG001|STARTED|Overall Study||25||
48650360|NCT01629862|101931758|FG000|COMPLETED|Overall Study||26||
48650361|NCT01629862|101931759|FG001|COMPLETED|Overall Study||23||
48650362|NCT01629862|101931758|FG000|NOT COMPLETED|Overall Study||2||
48650363|NCT01629862|101931759|FG001|NOT COMPLETED|Overall Study||2||
48650364|NCT01795937|101931760|FG000|STARTED|Overall Study||18||
48650365|NCT01795937|101931761|FG001|STARTED|Overall Study||16||
48650366|NCT01795937|101931762|FG002|STARTED|Overall Study||17||
48650367|NCT01795937|101931760|FG000|COMPLETED|Overall Study||17||
48650368|NCT01795937|101931761|FG001|COMPLETED|Overall Study||15||
48650369|NCT01795937|101931762|FG002|COMPLETED|Overall Study||17||
48650370|NCT01795937|101931760|FG000|NOT COMPLETED|Overall Study||1||
48650371|NCT01795937|101931761|FG001|NOT COMPLETED|Overall Study||1||
48650372|NCT01795937|101931762|FG002|NOT COMPLETED|Overall Study||0||
48650373|NCT01829165|101931763|FG000|STARTED|Overall Study||20||
48765384|NCT01409707|102214634|FG002|NOT COMPLETED|Overall Study||16||
48765385|NCT00535496|102214635|FG000|STARTED|Overall Study||15||
48650374|NCT01829165|101931764|FG001|STARTED|Overall Study||13||
48650375|NCT01829165|101931763|FG000|COMPLETED|Overall Study||18||
48650376|NCT01829165|101931764|FG001|COMPLETED|Overall Study||13||
48650377|NCT01829165|101931763|FG000|NOT COMPLETED|Overall Study||2||
48650378|NCT01829165|101931764|FG001|NOT COMPLETED|Overall Study||0||
48650379|NCT00003474|101931765|FG000|STARTED|Overall Study||40||
48650380|NCT00003474|101931765|FG000|COMPLETED|Overall Study||26||
48650381|NCT00003474|101931765|FG000|NOT COMPLETED|Overall Study||14||
48650382|NCT04090749|101931766|FG000|STARTED|Open Label Pilot||3||
48765386|NCT00535496|102214636|FG001|STARTED|Overall Study||15||
48765387|NCT00535496|102214637|FG002|STARTED|Overall Study||30||
48765388|NCT00535496|102214638|FG003|STARTED|Overall Study||31||
48765389|NCT00535496|102214635|FG000|All-Subjects-Treated (AST) Group|Overall Study||15||
48765390|NCT00535496|102214636|FG001|All-Subjects-Treated (AST) Group|Overall Study||14||
48765391|NCT00535496|102214637|FG002|All-Subjects-Treated (AST) Group|Overall Study||30||
48765392|NCT00535496|102214638|FG003|All-Subjects-Treated (AST) Group|Overall Study||31||
48765393|NCT00535496|102214635|FG000|COMPLETED|Overall Study||15||
48650383|NCT04090749|101931767|FG001|STARTED|Open Label Pilot||0||
48650384|NCT04090749|101931768|FG002|STARTED|Open Label Pilot||0||
48650385|NCT04090749|101931766|FG000|COMPLETED|Open Label Pilot||2||
48650386|NCT04090749|101931767|FG001|COMPLETED|Open Label Pilot||0||
48650387|NCT04090749|101931768|FG002|COMPLETED|Open Label Pilot||0||
48650388|NCT04090749|101931766|FG000|NOT COMPLETED|Open Label Pilot||1||
48650389|NCT04090749|101931767|FG001|NOT COMPLETED|Open Label Pilot||0||
48650390|NCT04090749|101931768|FG002|NOT COMPLETED|Open Label Pilot||0||
48650391|NCT04090749|101931766|FG000|STARTED|Pilot Trial||0||
48650392|NCT04090749|101931767|FG001|STARTED|Pilot Trial||12||
48650393|NCT04090749|101931768|FG002|STARTED|Pilot Trial||12||
48650394|NCT04090749|101931766|FG000|COMPLETED|Pilot Trial||0||
48650395|NCT04090749|101931767|FG001|COMPLETED|Pilot Trial||10||
48765394|NCT00535496|102214636|FG001|COMPLETED|Overall Study||13||
48765395|NCT00535496|102214637|FG002|COMPLETED|Overall Study||30||
48765396|NCT00535496|102214638|FG003|COMPLETED|Overall Study||31||
48765397|NCT00535496|102214635|FG000|NOT COMPLETED|Overall Study||0||
48765398|NCT00535496|102214636|FG001|NOT COMPLETED|Overall Study||2||
48765399|NCT00535496|102214637|FG002|NOT COMPLETED|Overall Study||0||
48765400|NCT00535496|102214638|FG003|NOT COMPLETED|Overall Study||0||
48765401|NCT02582775|102214639|FG000|STARTED|Overall Study||7||
48765402|NCT02582775|102214640|FG001|STARTED|Overall Study||9||
48765403|NCT02582775|102214641|FG002|STARTED|Overall Study||1||
48765404|NCT02582775|102214642|FG003|STARTED|Overall Study||0||
48765405|NCT02582775|102214643|FG004|STARTED|Overall Study||0||
48765406|NCT02582775|102214644|FG005|STARTED|Overall Study||0||
48765407|NCT02582775|102214645|FG006|STARTED|Overall Study||0||
48765408|NCT02582775|102214646|FG007|STARTED|Overall Study||0||
48765409|NCT02582775|102214639|FG000|COMPLETED|Overall Study||7||
48765410|NCT02582775|102214640|FG001|COMPLETED|Overall Study||9||
48765411|NCT02582775|102214641|FG002|COMPLETED|Overall Study||1||
48765412|NCT02582775|102214642|FG003|COMPLETED|Overall Study||0||
48650396|NCT04090749|101931768|FG002|COMPLETED|Pilot Trial||11||
48650397|NCT04090749|101931766|FG000|NOT COMPLETED|Pilot Trial||0||
48650398|NCT04090749|101931767|FG001|NOT COMPLETED|Pilot Trial||2||
48650399|NCT04090749|101931768|FG002|NOT COMPLETED|Pilot Trial||1||
48650400|NCT00655746|101931769|FG000|STARTED|Overall Study||14||
48650401|NCT00655746|101931769|FG000|COMPLETED|Overall Study||13||
48650402|NCT00655746|101931769|FG000|NOT COMPLETED|Overall Study||1||
48650403|NCT00754559|101931770|FG000|STARTED|Overall Study||286||
48650404|NCT00754559|101931770|FG000|COMPLETED|Overall Study||239||
48650405|NCT00754559|101931770|FG000|NOT COMPLETED|Overall Study||47||
48650406|NCT01132690|101931771|FG000|STARTED|Overall Study||6||
48650407|NCT01132690|101931772|FG001|STARTED|Overall Study||5||
48650408|NCT01132690|101931771|FG000|COMPLETED|Overall Study||6||
48650409|NCT01132690|101931772|FG001|COMPLETED|Overall Study||5||
48650410|NCT01132690|101931771|FG000|NOT COMPLETED|Overall Study||0||
48650411|NCT01132690|101931772|FG001|NOT COMPLETED|Overall Study||0||
48650412|NCT04359680|101931773|FG000|STARTED|Overall Study||711||
48650413|NCT04359680|101931774|FG001|STARTED|Overall Study||696||
48650414|NCT04359680|101931773|FG000|COMPLETED|Overall Study||616||
48650415|NCT04359680|101931774|FG001|COMPLETED|Overall Study||604||
48650416|NCT04359680|101931773|FG000|NOT COMPLETED|Overall Study||95||
48650417|NCT04359680|101931774|FG001|NOT COMPLETED|Overall Study||92||
48650418|NCT01631929|101931775|FG000|STARTED|Overall Study||6||
48650419|NCT01631929|101931776|FG001|STARTED|Overall Study||6||
48650420|NCT01631929|101931775|FG000|COMPLETED|Overall Study||6||
48650421|NCT01631929|101931776|FG001|COMPLETED|Overall Study||6||
48765413|NCT02582775|102214643|FG004|COMPLETED|Overall Study||0||
48650422|NCT01631929|101931775|FG000|NOT COMPLETED|Overall Study||0||
48650423|NCT01631929|101931776|FG001|NOT COMPLETED|Overall Study||0||
48650424|NCT03632720|101931777|FG000|STARTED|Overall Study||314||
48650425|NCT03632720|101931778|FG001|STARTED|Overall Study||316||
48650426|NCT03632720|101931779|FG002|STARTED|Overall Study||158||
48650427|NCT03632720|101931777|FG000|Safety Analysis Set|Overall Study||314|Safety analysis set included all participants who had received at least 1 dose of study vaccines and had any safety data available. All participants had their safety analyzed after each dose according to the vaccine they actually received at each visit, and after any dose according to the vaccine received.|
48657050|NCT03648372|101943769|FG012|STARTED|Overall Study||7||
48657051|NCT03648372|101943770|FG013|STARTED|Overall Study||8||
48765414|NCT02582775|102214644|FG005|COMPLETED|Overall Study||0||
48765415|NCT02582775|102214645|FG006|COMPLETED|Overall Study||0||
48765416|NCT02582775|102214646|FG007|COMPLETED|Overall Study||0||
48765417|NCT02582775|102214639|FG000|NOT COMPLETED|Overall Study||0||
48765418|NCT02582775|102214640|FG001|NOT COMPLETED|Overall Study||0||
48765419|NCT02582775|102214641|FG002|NOT COMPLETED|Overall Study||0||
48650428|NCT03632720|101931778|FG001|Safety Analysis Set|Overall Study||314|Safety analysis set included all participants who had received at least 1 dose of study vaccines and had any safety data available. All participants had their safety analyzed after each dose according to the vaccine they actually received at each visit, and after any dose according to the vaccine received.|
48650429|NCT03632720|101931779|FG002|Safety Analysis Set|Overall Study||157|Safety analysis set included all participants who had received at least 1 dose of study vaccines and had any safety data available. All participants had their safety analyzed after each dose according to the vaccine they actually received at each visit, and after any dose according to the vaccine received.|
48650430|NCT03632720|101931777|FG000|COMPLETED|Overall Study||301||
48650431|NCT03632720|101931778|FG001|COMPLETED|Overall Study||305||
48650432|NCT03632720|101931779|FG002|COMPLETED|Overall Study||150||
48650433|NCT03632720|101931777|FG000|NOT COMPLETED|Overall Study||13||
48650434|NCT03632720|101931778|FG001|NOT COMPLETED|Overall Study||11||
48650435|NCT03632720|101931779|FG002|NOT COMPLETED|Overall Study||8||
48650436|NCT01531803|101931780|FG000|STARTED|Overall Study||1||
48650437|NCT01531803|101931781|FG001|STARTED|Overall Study||2||
48650438|NCT01531803|101931780|FG000|COMPLETED|Overall Study||1||
48650439|NCT01531803|101931781|FG001|COMPLETED|Overall Study||2||
48650440|NCT01531803|101931780|FG000|NOT COMPLETED|Overall Study||0||
48650441|NCT01531803|101931781|FG001|NOT COMPLETED|Overall Study||0||
48650442|NCT02366130|101931782|FG000|STARTED|Overall Study||45||
48650443|NCT02366130|101931782|FG000|COMPLETED|Overall Study||36||
48650444|NCT02366130|101931782|FG000|NOT COMPLETED|Overall Study||9||
48650445|NCT03202550|101931783|FG000|STARTED|Overall Study||13||
48650446|NCT03202550|101931784|FG001|STARTED|Overall Study||11||
48650447|NCT03202550|101931783|FG000|COMPLETED|Overall Study||13||
48650448|NCT03202550|101931784|FG001|COMPLETED|Overall Study||11||
48650449|NCT03202550|101931783|FG000|NOT COMPLETED|Overall Study||0||
48650450|NCT03202550|101931784|FG001|NOT COMPLETED|Overall Study||0||
48650451|NCT05938010|101931785|FG000|STARTED|Overall Study||42||
48650452|NCT05938010|101931785|FG000|COMPLETED|Overall Study||40||
48650453|NCT05938010|101931785|FG000|NOT COMPLETED|Overall Study||2||
48650454|NCT02728726|101931786|FG000|STARTED|Overall Study||127||
48650455|NCT02728726|101931787|FG001|STARTED|Overall Study||133||
48650456|NCT02728726|101931786|FG000|COMPLETED|Overall Study||127||
48650457|NCT02728726|101931787|FG001|COMPLETED|Overall Study||133||
48650458|NCT02728726|101931786|FG000|NOT COMPLETED|Overall Study||0||
48650459|NCT02728726|101931787|FG001|NOT COMPLETED|Overall Study||0||
48650460|NCT04017910|101931788|FG000|STARTED|Overall Study||17||
48650461|NCT04017910|101931788|FG000|COMPLETED|Overall Study||17||
48650462|NCT04017910|101931788|FG000|NOT COMPLETED|Overall Study||0||
48650463|NCT05610267|101931789|FG000|STARTED|Overall Study||28||
48650464|NCT05610267|101931789|FG000|COMPLETED|Overall Study||28||
48650465|NCT05610267|101931789|FG000|NOT COMPLETED|Overall Study||0||
48650466|NCT02528305|101931790|FG000|STARTED|Overall Study||12||
48650467|NCT02528305|101931790|FG000|End of Control Period Assessment|Overall Study||11||
48650468|NCT02528305|101931790|FG000|End of Intervention Period Assessment|Overall Study||9||
48650469|NCT02528305|101931790|FG000|COMPLETED|Overall Study||9||
48650470|NCT02528305|101931790|FG000|NOT COMPLETED|Overall Study||3||
48362254|NCT00923091|101214495|FG008|NOT COMPLETED|Period V (Double -Blind)||1||
48650471|NCT00821821|101931791|FG000|STARTED|Overall Study||12||
48650472|NCT00821821|101931792|FG001|STARTED|Overall Study||13||
48650473|NCT00821821|101931793|FG002|STARTED|Overall Study||11||
48650474|NCT00821821|101931791|FG000|COMPLETED|Overall Study||12||
48650475|NCT00821821|101931792|FG001|COMPLETED|Overall Study||13||
48650476|NCT00821821|101931793|FG002|COMPLETED|Overall Study||11||
48650477|NCT00821821|101931791|FG000|NOT COMPLETED|Overall Study||0||
48765420|NCT02582775|102214642|FG003|NOT COMPLETED|Overall Study||0||
48362255|NCT00923091|101214496|FG009|NOT COMPLETED|Period V (Double -Blind)||0||
48362256|NCT00923091|101214497|FG010|NOT COMPLETED|Period V (Double -Blind)||1||
48650478|NCT00821821|101931792|FG001|NOT COMPLETED|Overall Study||0||
48650479|NCT00821821|101931793|FG002|NOT COMPLETED|Overall Study||0||
48650480|NCT04119336|101931794|FG000|STARTED|Overall Study||2||
48650481|NCT04119336|101931794|FG000|COMPLETED|Overall Study||2||
48650482|NCT04119336|101931794|FG000|NOT COMPLETED|Overall Study||0||
48650483|NCT01489358|101931795|FG000|STARTED|Overall Study||5||
48650484|NCT01489358|101931796|FG001|STARTED|Overall Study||10||
48650485|NCT01489358|101931797|FG002|STARTED|Overall Study||10||
48650486|NCT01489358|101931795|FG000|COMPLETED|Overall Study||5||
48650487|NCT01489358|101931796|FG001|COMPLETED|Overall Study||10||
48765421|NCT02582775|102214643|FG004|NOT COMPLETED|Overall Study||0||
48650488|NCT01489358|101931797|FG002|COMPLETED|Overall Study||8||
48650489|NCT01489358|101931795|FG000|NOT COMPLETED|Overall Study||0||
48650490|NCT01489358|101931796|FG001|NOT COMPLETED|Overall Study||0||
48650491|NCT01489358|101931797|FG002|NOT COMPLETED|Overall Study||2||
48650492|NCT03164356|101931798|FG000|STARTED|Overall Study||19||
48650493|NCT03164356|101931799|FG001|STARTED|Overall Study||15||
48650494|NCT03164356|101931800|FG002|STARTED|Overall Study||17||
48650495|NCT03164356|101931801|FG003|STARTED|Overall Study||17||
48650496|NCT03164356|101931798|FG000|COMPLETED|Overall Study||14||
48362257|NCT00923091|101214498|FG011|NOT COMPLETED|Period V (Double -Blind)||0||
48362258|NCT00923091|101214499|FG012|NOT COMPLETED|Period V (Double -Blind)||2||
48650497|NCT03164356|101931799|FG001|COMPLETED|Overall Study||10||
48650498|NCT03164356|101931800|FG002|COMPLETED|Overall Study||11||
48650499|NCT03164356|101931801|FG003|COMPLETED|Overall Study||15||
48650500|NCT03164356|101931798|FG000|NOT COMPLETED|Overall Study||5||
48650501|NCT03164356|101931799|FG001|NOT COMPLETED|Overall Study||5||
48650502|NCT03164356|101931800|FG002|NOT COMPLETED|Overall Study||6||
48650503|NCT03164356|101931801|FG003|NOT COMPLETED|Overall Study||2||
48650504|NCT00908388|101931802|FG000|STARTED|Overall Study||50||
48650505|NCT00908388|101931802|FG000|COMPLETED|Overall Study||40||
48650506|NCT00908388|101931802|FG000|NOT COMPLETED|Overall Study||10||
48650507|NCT00212355|101931803|FG000|STARTED|Overall Study||37||
48650508|NCT00212355|101931803|FG000|COMPLETED|Overall Study||34||
48650509|NCT00212355|101931803|FG000|NOT COMPLETED|Overall Study||3||
48650510|NCT00684138|101931804|FG000|STARTED|Overall Study||141||
48650511|NCT00684138|101931805|FG001|STARTED|Overall Study||139||
48650512|NCT00684138|101931804|FG000|COMPLETED|Overall Study||138||
48650513|NCT00684138|101931805|FG001|COMPLETED|Overall Study||131||
48650514|NCT00684138|101931804|FG000|NOT COMPLETED|Overall Study||3||
48650515|NCT00684138|101931805|FG001|NOT COMPLETED|Overall Study||8||
48650516|NCT03020888|101931806|FG000|STARTED|Overall Study||120||
48650517|NCT03020888|101931806|FG000|COMPLETED|Overall Study||107||
48650518|NCT03020888|101931806|FG000|NOT COMPLETED|Overall Study||13||
48650519|NCT01033227|101931807|FG000|STARTED|Overall Study||3||
48650520|NCT01033227|101931808|FG001|STARTED|Overall Study||2||
48650521|NCT01033227|101931807|FG000|COMPLETED|Overall Study||3||
48650522|NCT01033227|101931808|FG001|COMPLETED|Overall Study||2||
48650523|NCT01033227|101931807|FG000|NOT COMPLETED|Overall Study||0||
48650524|NCT01033227|101931808|FG001|NOT COMPLETED|Overall Study||0||
48650525|NCT01263028|101931809|FG000|STARTED|Overall Study||6||
48650526|NCT01263028|101931809|FG000|COMPLETED|Overall Study||0||
48650527|NCT01263028|101931809|FG000|NOT COMPLETED|Overall Study||6||
48650528|NCT00422461|101931810|FG000|STARTED|Overall Study||35||
48650529|NCT00422461|101931811|FG001|STARTED|Overall Study||35||
48765422|NCT02582775|102214644|FG005|NOT COMPLETED|Overall Study||0||
48765423|NCT02582775|102214645|FG006|NOT COMPLETED|Overall Study||0||
48765424|NCT02582775|102214646|FG007|NOT COMPLETED|Overall Study||0||
48765425|NCT00129246|102214647|FG000|STARTED|Overall Study||20||
48765426|NCT00129246|102214648|FG001|STARTED|Overall Study||20||
48765427|NCT00129246|102214647|FG000|COMPLETED|Overall Study||20||
48765428|NCT00129246|102214648|FG001|COMPLETED|Overall Study||20||
48765429|NCT00129246|102214647|FG000|NOT COMPLETED|Overall Study||0||
48765430|NCT00129246|102214648|FG001|NOT COMPLETED|Overall Study||0||
48765431|NCT00303069|102214649|FG000|STARTED|Overall Study||31||
48650530|NCT00422461|101931812|FG002|STARTED|Overall Study||32||
48650531|NCT00422461|101931813|FG003|STARTED|Overall Study||33||
48650532|NCT00422461|101931810|FG000|Treated|Overall Study||34||
48650533|NCT00422461|101931811|FG001|Treated|Overall Study||34||
48650534|NCT00422461|101931812|FG002|Treated|Overall Study||32||
48650535|NCT00422461|101931813|FG003|Treated|Overall Study||33||
48650536|NCT00422461|101931810|FG000|Full Analysis Set|Overall Study||34||
48650537|NCT00422461|101931811|FG001|Full Analysis Set|Overall Study||34||
48650538|NCT00422461|101931812|FG002|Full Analysis Set|Overall Study||31||
48650539|NCT00422461|101931813|FG003|Full Analysis Set|Overall Study||33||
48650540|NCT00422461|101931810|FG000|COMPLETED|Overall Study||32||
48650541|NCT00422461|101931811|FG001|COMPLETED|Overall Study||32||
48650542|NCT00422461|101931812|FG002|COMPLETED|Overall Study||31||
48650543|NCT00422461|101931813|FG003|COMPLETED|Overall Study||30||
48650544|NCT00422461|101931810|FG000|NOT COMPLETED|Overall Study||3||
48650545|NCT00422461|101931811|FG001|NOT COMPLETED|Overall Study||3||
48650546|NCT00422461|101931812|FG002|NOT COMPLETED|Overall Study||1||
48765432|NCT00303069|102214650|FG001|STARTED|Overall Study||28||
48765433|NCT00303069|102214651|FG002|STARTED|Overall Study||34||
48765434|NCT00303069|102214652|FG003|STARTED|Overall Study||31||
48765435|NCT00303069|102214649|FG000|COMPLETED|Overall Study||29||
48765436|NCT00303069|102214650|FG001|COMPLETED|Overall Study||28||
48765437|NCT00303069|102214651|FG002|COMPLETED|Overall Study||33||
48765438|NCT00303069|102214652|FG003|COMPLETED|Overall Study||29||
48765439|NCT00303069|102214649|FG000|NOT COMPLETED|Overall Study||2||
48765440|NCT00303069|102214650|FG001|NOT COMPLETED|Overall Study||0||
48765441|NCT00303069|102214651|FG002|NOT COMPLETED|Overall Study||1||
48765442|NCT00303069|102214652|FG003|NOT COMPLETED|Overall Study||2||
48650547|NCT00422461|101931813|FG003|NOT COMPLETED|Overall Study||3||
48650548|NCT00395512|101931814|FG000|STARTED|Overall Study||164||
48650549|NCT00395512|101931815|FG001|STARTED|Overall Study||163||
48650550|NCT00395512|101931816|FG002|STARTED|Overall Study||164||
48650551|NCT00395512|101931817|FG003|STARTED|Overall Study||164||
48650552|NCT00395512|101931814|FG000|Safety Set|Overall Study||164||
48650553|NCT00395512|101931815|FG001|Safety Set|Overall Study||163||
48650554|NCT00395512|101931816|FG002|Safety Set|Overall Study||164||
48650555|NCT00395512|101931817|FG003|Safety Set|Overall Study||163||
48650556|NCT00395512|101931814|FG000|COMPLETED|Overall Study||126||
48650557|NCT00395512|101931815|FG001|COMPLETED|Overall Study||126||
48650558|NCT00395512|101931816|FG002|COMPLETED|Overall Study||136||
48765443|NCT03304626|102214653|FG000|STARTED|Overall Study||20||
48765444|NCT03304626|102214654|FG001|STARTED|Overall Study||20||
48765445|NCT03304626|102214653|FG000|COMPLETED|Overall Study||18||
48650559|NCT00395512|101931817|FG003|COMPLETED|Overall Study||126||
48650560|NCT00395512|101931814|FG000|NOT COMPLETED|Overall Study||38||
48650561|NCT00395512|101931815|FG001|NOT COMPLETED|Overall Study||37||
48650562|NCT00395512|101931816|FG002|NOT COMPLETED|Overall Study||28||
48650563|NCT00395512|101931817|FG003|NOT COMPLETED|Overall Study||38||
48650564|NCT01570192|101931818|FG000|STARTED|Overall Study||13||
48650565|NCT01570192|101931819|FG001|STARTED|Overall Study||30||
48650566|NCT01570192|101931818|FG000|COMPLETED|Overall Study||6||
48650567|NCT01570192|101931819|FG001|COMPLETED|Overall Study||17||
48650568|NCT01570192|101931818|FG000|NOT COMPLETED|Overall Study||7||
48650569|NCT01570192|101931819|FG001|NOT COMPLETED|Overall Study||13||
48650570|NCT02829957|101931820|FG000|STARTED|Overall Study||8||
48650571|NCT02829957|101931821|FG001|STARTED|Overall Study||11||
48650572|NCT02829957|101931820|FG000|COMPLETED|Overall Study||6||
48650573|NCT02829957|101931821|FG001|COMPLETED|Overall Study||10||
48650574|NCT02829957|101931820|FG000|NOT COMPLETED|Overall Study||2||
48650575|NCT02829957|101931821|FG001|NOT COMPLETED|Overall Study||1||
48650576|NCT04432298|101931822|FG000|STARTED|Overall Study||11||
48650577|NCT04432298|101931823|FG001|STARTED|Overall Study||11||
48650578|NCT04432298|101931822|FG000|Intent-to-Treat (ITT) Population|Overall Study||11|All randomized participants|
48650579|NCT04432298|101931823|FG001|Intent-to-Treat (ITT) Population|Overall Study||11|All randomized participants|
48650580|NCT04432298|101931822|FG000|Safety Population|Overall Study||9|Received at least 1 dose of study drug|
48650581|NCT04432298|101931823|FG001|Safety Population|Overall Study||11|Received at least 1 dose of study drug|
48650582|NCT04432298|101931822|FG000|COMPLETED|Overall Study||5||
48650583|NCT04432298|101931823|FG001|COMPLETED|Overall Study||8||
48650584|NCT04432298|101931822|FG000|NOT COMPLETED|Overall Study||6||
48650585|NCT04432298|101931823|FG001|NOT COMPLETED|Overall Study||3||
48650586|NCT01783015|101931824|FG000|STARTED|Blinded Treatment||11||
48650587|NCT01783015|101931825|FG001|STARTED|Blinded Treatment||5||
48650588|NCT01783015|101931826|FG002|STARTED|Blinded Treatment||0||
48650589|NCT01783015|101931824|FG000|Treated|Blinded Treatment||11||
48650590|NCT01783015|101931825|FG001|Treated|Blinded Treatment||5||
48650591|NCT01783015|101931826|FG002|Treated|Blinded Treatment||0||
48650592|NCT01783015|101931824|FG000|COMPLETED|Blinded Treatment||9||
48650593|NCT01783015|101931825|FG001|COMPLETED|Blinded Treatment||2||
48650594|NCT01783015|101931826|FG002|COMPLETED|Blinded Treatment||0||
48650595|NCT01783015|101931824|FG000|NOT COMPLETED|Blinded Treatment||2||
48650596|NCT01783015|101931825|FG001|NOT COMPLETED|Blinded Treatment||3||
48650597|NCT01783015|101931826|FG002|NOT COMPLETED|Blinded Treatment||0||
48650598|NCT01783015|101931824|FG000|STARTED|Open Label Treatment||0||
48650599|NCT01783015|101931825|FG001|STARTED|Open Label Treatment||0||
48650600|NCT01783015|101931826|FG002|STARTED|Open Label Treatment||11||
48650601|NCT01783015|101931824|FG000|COMPLETED|Open Label Treatment||0||
48650602|NCT01783015|101931825|FG001|COMPLETED|Open Label Treatment||0||
48650603|NCT01783015|101931826|FG002|COMPLETED|Open Label Treatment||5||
48650604|NCT01783015|101931824|FG000|NOT COMPLETED|Open Label Treatment||0||
48650605|NCT01783015|101931825|FG001|NOT COMPLETED|Open Label Treatment||0||
48650606|NCT01783015|101931826|FG002|NOT COMPLETED|Open Label Treatment||6||
48650607|NCT01630811|101931827|FG000|STARTED|First Intervention (8 Weeks)||7||
48650608|NCT01630811|101931828|FG001|STARTED|First Intervention (8 Weeks)||6||
48650609|NCT01630811|101931827|FG000|COMPLETED|First Intervention (8 Weeks)||7||
48650610|NCT01630811|101931828|FG001|COMPLETED|First Intervention (8 Weeks)||6||
48650611|NCT01630811|101931827|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0||
48650612|NCT01630811|101931828|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0||
48650613|NCT01630811|101931827|FG000|STARTED|Washout (4 Weeks)||7||
48650614|NCT01630811|101931828|FG001|STARTED|Washout (4 Weeks)||6||
48650615|NCT01630811|101931827|FG000|COMPLETED|Washout (4 Weeks)||7||
48650616|NCT01630811|101931828|FG001|COMPLETED|Washout (4 Weeks)||6||
48650617|NCT01630811|101931827|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
48650618|NCT01630811|101931828|FG001|NOT COMPLETED|Washout (4 Weeks)||0||
48650619|NCT01630811|101931827|FG000|STARTED|Second Intervention (8 Weeks)||7||
48650620|NCT01630811|101931828|FG001|STARTED|Second Intervention (8 Weeks)||6||
48650621|NCT01630811|101931827|FG000|COMPLETED|Second Intervention (8 Weeks)||6||
48650622|NCT01630811|101931828|FG001|COMPLETED|Second Intervention (8 Weeks)||6||
48650623|NCT01630811|101931827|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||1||
48650624|NCT01630811|101931828|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0||
48650625|NCT01630811|101931827|FG000|STARTED|Second Washout (4 Weeks)||6||
48650626|NCT01630811|101931828|FG001|STARTED|Second Washout (4 Weeks)||6||
48650627|NCT01630811|101931827|FG000|COMPLETED|Second Washout (4 Weeks)||6||
48650628|NCT01630811|101931828|FG001|COMPLETED|Second Washout (4 Weeks)||6||
48650629|NCT01630811|101931827|FG000|NOT COMPLETED|Second Washout (4 Weeks)||0||
48650630|NCT01630811|101931828|FG001|NOT COMPLETED|Second Washout (4 Weeks)||0||
48650631|NCT01412983|101931829|FG000|STARTED|1st Period||50||
48650632|NCT01412983|101931830|FG001|STARTED|1st Period||50||
48650633|NCT01412983|101931829|FG000|COMPLETED|1st Period||50||
48650634|NCT01412983|101931830|FG001|COMPLETED|1st Period||46||
48650635|NCT01412983|101931829|FG000|NOT COMPLETED|1st Period||0||
48650636|NCT01412983|101931830|FG001|NOT COMPLETED|1st Period||4||
48650637|NCT01412983|101931829|FG000|STARTED|2nd Period||50||
48650638|NCT01412983|101931830|FG001|STARTED|2nd Period||46||
48650639|NCT01412983|101931829|FG000|COMPLETED|2nd Period||50||
48650640|NCT01412983|101931830|FG001|COMPLETED|2nd Period||46||
48650641|NCT01412983|101931829|FG000|NOT COMPLETED|2nd Period||0||
48650642|NCT01412983|101931830|FG001|NOT COMPLETED|2nd Period||0||
48650643|NCT01197898|101931831|FG000|STARTED|Overall Study||5||
48650644|NCT01197898|101931832|FG001|STARTED|Overall Study||5||
48650645|NCT01197898|101931831|FG000|COMPLETED|Overall Study||5||
48650646|NCT01197898|101931832|FG001|COMPLETED|Overall Study||5||
48650647|NCT01197898|101931831|FG000|NOT COMPLETED|Overall Study||0||
48436335|NCT01374516|101403529|FG001|COMPLETED|Surveillance Expansion Period||5387||
48436336|NCT01374516|101403528|FG000|NOT COMPLETED|Surveillance Expansion Period||2349||
48436337|NCT01374516|101403529|FG001|NOT COMPLETED|Surveillance Expansion Period||1253||
48436338|NCT05637515|101403530|FG000|STARTED|Overall Study||193||
48436339|NCT05637515|101403531|FG001|STARTED|Overall Study||181||
48436340|NCT05637515|101403530|FG000|COMPLETED|Overall Study||176||
48436341|NCT05637515|101403531|FG001|COMPLETED|Overall Study||164||
48436342|NCT05637515|101403530|FG000|NOT COMPLETED|Overall Study||17||
48650648|NCT01197898|101931832|FG001|NOT COMPLETED|Overall Study||0||
48650649|NCT00965094|101931833|FG000|STARTED|Overall Study||19||
48650650|NCT00965094|101931834|FG001|STARTED|Overall Study||17||
48650651|NCT00965094|101931833|FG000|COMPLETED|Overall Study||14||
48650652|NCT00965094|101931834|FG001|COMPLETED|Overall Study||16||
48650653|NCT00965094|101931833|FG000|NOT COMPLETED|Overall Study||5||
48650654|NCT00965094|101931834|FG001|NOT COMPLETED|Overall Study||1||
48650655|NCT03377127|101931835|FG000|STARTED|Overall Study||42||
48650656|NCT03377127|101931836|FG001|STARTED|Overall Study||44||
48650657|NCT03377127|101931835|FG000|COMPLETED|Overall Study||42||
48650658|NCT03377127|101931836|FG001|COMPLETED|Overall Study||44||
48650659|NCT03377127|101931835|FG000|NOT COMPLETED|Overall Study||0||
48650660|NCT03377127|101931836|FG001|NOT COMPLETED|Overall Study||0||
48650661|NCT04193527|101931837|FG000|STARTED|Overall Study||75||
48650662|NCT04193527|101931838|FG001|STARTED|Overall Study||75||
48650663|NCT04193527|101931839|FG002|STARTED|Overall Study||22||
48650664|NCT04193527|101931837|FG000|COMPLETED|Overall Study||74||
48650665|NCT04193527|101931838|FG001|COMPLETED|Overall Study||74||
48650666|NCT04193527|101931839|FG002|COMPLETED|Overall Study||22||
48650667|NCT04193527|101931837|FG000|NOT COMPLETED|Overall Study||1||
48650668|NCT04193527|101931838|FG001|NOT COMPLETED|Overall Study||1||
48650669|NCT04193527|101931839|FG002|NOT COMPLETED|Overall Study||0||
48650670|NCT04576949|101931840|FG000|STARTED|Overall Study||271|randomized|
48650671|NCT04576949|101931841|FG001|STARTED|Overall Study||269|randomized|
48650672|NCT04576949|101931842|FG002|STARTED|Overall Study||270|randomized|
48650673|NCT04576949|101931840|FG000|COMPLETED|Overall Study||194||
48650674|NCT04576949|101931841|FG001|COMPLETED|Overall Study||199||
48650675|NCT04576949|101931842|FG002|COMPLETED|Overall Study||225||
48650676|NCT04576949|101931840|FG000|NOT COMPLETED|Overall Study||77||
48650677|NCT04576949|101931841|FG001|NOT COMPLETED|Overall Study||70||
48650678|NCT04576949|101931842|FG002|NOT COMPLETED|Overall Study||45||
48650679|NCT01524705|101931843|FG000|STARTED|Overall Study||52||
48650680|NCT01524705|101931844|FG001|STARTED|Overall Study||50||
48650681|NCT01524705|101931843|FG000|COMPLETED|Overall Study||49||
48650682|NCT01524705|101931844|FG001|COMPLETED|Overall Study||47||
48650683|NCT01524705|101931843|FG000|NOT COMPLETED|Overall Study||3||
48650684|NCT01524705|101931844|FG001|NOT COMPLETED|Overall Study||3||
48650685|NCT01161121|101931845|FG000|STARTED|Overall Study||46||
48650686|NCT01161121|101931845|FG000|COMPLETED|Overall Study||46||
48650687|NCT01161121|101931845|FG000|NOT COMPLETED|Overall Study||0||
48650688|NCT02619812|101931846|FG000|STARTED|Overall Study||0||
48650689|NCT02619812|101931847|FG001|STARTED|Overall Study||0||
48650690|NCT02619812|101931848|FG002|STARTED|Overall Study||1||
48650691|NCT02619812|101931849|FG003|STARTED|Overall Study||2||
48650692|NCT02619812|101931846|FG000|COMPLETED|Overall Study||0||
48650693|NCT02619812|101931847|FG001|COMPLETED|Overall Study||0||
48650694|NCT02619812|101931848|FG002|COMPLETED|Overall Study||0||
48650695|NCT02619812|101931849|FG003|COMPLETED|Overall Study||0||
48650696|NCT02619812|101931846|FG000|NOT COMPLETED|Overall Study||0||
48650697|NCT02619812|101931847|FG001|NOT COMPLETED|Overall Study||0||
48650698|NCT02619812|101931848|FG002|NOT COMPLETED|Overall Study||1||
48650699|NCT02619812|101931849|FG003|NOT COMPLETED|Overall Study||2||
48650700|NCT01654250|101931850|FG000|STARTED|Overall Study||44||
48436343|NCT05637515|101403531|FG001|NOT COMPLETED|Overall Study||17||
48436344|NCT01256086|101403532|FG000|STARTED|Treatment Day 1||11||
48436345|NCT01256086|101403533|FG001|STARTED|Treatment Day 1||11||
48436346|NCT01256086|101403534|FG002|STARTED|Treatment Day 1||11||
48650701|NCT01654250|101931851|FG001|STARTED|Overall Study||42||
48650702|NCT01654250|101931850|FG000|COMPLETED|Overall Study||43||
48650703|NCT01654250|101931851|FG001|COMPLETED|Overall Study||42||
48650704|NCT01654250|101931850|FG000|NOT COMPLETED|Overall Study||1||
48436347|NCT01256086|101403535|FG003|STARTED|Treatment Day 1||11||
48650705|NCT01654250|101931851|FG001|NOT COMPLETED|Overall Study||0||
48650706|NCT01217515|101931852|FG000|STARTED|Overall Study||154||
48436348|NCT01256086|101403532|FG000|COMPLETED|Treatment Day 1||11||
48650707|NCT01217515|101931853|FG001|STARTED|Overall Study||156||
48650708|NCT01217515|101931854|FG002|STARTED|Overall Study||155||
48650709|NCT01217515|101931852|FG000|COMPLETED|Overall Study||147||
48650710|NCT01217515|101931853|FG001|COMPLETED|Overall Study||148||
48650711|NCT01217515|101931854|FG002|COMPLETED|Overall Study||145||
48650712|NCT01217515|101931852|FG000|NOT COMPLETED|Overall Study||7||
48650713|NCT01217515|101931853|FG001|NOT COMPLETED|Overall Study||8||
48650714|NCT01217515|101931854|FG002|NOT COMPLETED|Overall Study||10||
48650715|NCT01185366|101931855|FG000|STARTED|First Line Therapy||38||
48650716|NCT01185366|101931856|FG001|STARTED|First Line Therapy||34||
48650717|NCT01185366|101931855|FG000|Received 1st Drug|First Line Therapy||36||
48650718|NCT01185366|101931856|FG001|Received 1st Drug|First Line Therapy||33||
48650719|NCT01185366|101931855|FG000|COMPLETED|First Line Therapy||35||
48650720|NCT01185366|101931856|FG001|COMPLETED|First Line Therapy||33||
48650721|NCT01185366|101931855|FG000|NOT COMPLETED|First Line Therapy||3||
48650722|NCT01185366|101931856|FG001|NOT COMPLETED|First Line Therapy||1||
48650723|NCT01185366|101931855|FG000|STARTED|Crossover to Second Line Therapy||35||
48650724|NCT01185366|101931856|FG001|STARTED|Crossover to Second Line Therapy||33||
48650725|NCT01185366|101931855|FG000|Received Crossover Drug|Crossover to Second Line Therapy||21||
48650726|NCT01185366|101931856|FG001|Received Crossover Drug|Crossover to Second Line Therapy||23||
48650727|NCT01185366|101931855|FG000|COMPLETED|Crossover to Second Line Therapy||21||
48650728|NCT01185366|101931856|FG001|COMPLETED|Crossover to Second Line Therapy||23||
48650729|NCT01185366|101931855|FG000|NOT COMPLETED|Crossover to Second Line Therapy||14||
48650730|NCT01185366|101931856|FG001|NOT COMPLETED|Crossover to Second Line Therapy||10||
48650731|NCT01567020|101931857|FG000|STARTED|Overall Study||28||
48650732|NCT01567020|101931858|FG001|STARTED|Overall Study||46||
48650733|NCT01567020|101931859|FG002|STARTED|Overall Study||20||
48650734|NCT01567020|101931860|FG003|STARTED|Overall Study||11||
48650735|NCT01567020|101931857|FG000|COMPLETED|Overall Study||21||
48650736|NCT01567020|101931858|FG001|COMPLETED|Overall Study||41||
48650737|NCT01567020|101931859|FG002|COMPLETED|Overall Study||18||
48650738|NCT01567020|101931860|FG003|COMPLETED|Overall Study||10||
48650739|NCT01567020|101931857|FG000|NOT COMPLETED|Overall Study||7||
48650740|NCT01567020|101931858|FG001|NOT COMPLETED|Overall Study||5||
48650741|NCT01567020|101931859|FG002|NOT COMPLETED|Overall Study||2||
48650742|NCT01567020|101931860|FG003|NOT COMPLETED|Overall Study||1||
48650743|NCT04285684|101931861|FG000|STARTED|Overall Study||4||
48650744|NCT04285684|101931861|FG000|COMPLETED|Overall Study||4||
48650745|NCT04285684|101931861|FG000|NOT COMPLETED|Overall Study||0||
48650746|NCT02798952|101931862|FG000|STARTED|Overall Study||302||
48650747|NCT02798952|101931862|FG000|COMPLETED|Overall Study||302||
48650748|NCT02798952|101931862|FG000|NOT COMPLETED|Overall Study||0||
48650749|NCT00160615|101931863|FG000|STARTED|Overall Study||50||
48650750|NCT00160615|101931864|FG001|STARTED|Overall Study||101||
48650751|NCT00160615|101931863|FG000|COMPLETED|Overall Study||32||
48650752|NCT00160615|101931864|FG001|COMPLETED|Overall Study||56||
48650753|NCT00160615|101931863|FG000|NOT COMPLETED|Overall Study||18||
48650754|NCT00160615|101931864|FG001|NOT COMPLETED|Overall Study||45||
48650755|NCT02740582|101931865|FG000|STARTED|First Intervention||29||
48650756|NCT02740582|101931866|FG001|STARTED|First Intervention||33||
48650757|NCT02740582|101931865|FG000|COMPLETED|First Intervention||24||
48650758|NCT02740582|101931866|FG001|COMPLETED|First Intervention||31||
48650759|NCT02740582|101931865|FG000|NOT COMPLETED|First Intervention||5||
48650760|NCT02740582|101931866|FG001|NOT COMPLETED|First Intervention||2||
48650761|NCT02740582|101931865|FG000|STARTED|Washout||24||
48650762|NCT02740582|101931866|FG001|STARTED|Washout||31||
48765446|NCT03304626|102214654|FG001|COMPLETED|Overall Study||19||
48765447|NCT03304626|102214653|FG000|NOT COMPLETED|Overall Study||2||
48765448|NCT03304626|102214654|FG001|NOT COMPLETED|Overall Study||1||
48765449|NCT02158546|102214655|FG000|STARTED|Overall Study||152|3 subjects were randomized but did not receive study drug.|
48765450|NCT02158546|102214656|FG001|STARTED|Overall Study||153|3 subjects were randomized but did not receive study drug.|
48650763|NCT02740582|101931865|FG000|COMPLETED|Washout||24||
48650764|NCT02740582|101931866|FG001|COMPLETED|Washout||31||
48650765|NCT02740582|101931865|FG000|NOT COMPLETED|Washout||0||
48650766|NCT02740582|101931866|FG001|NOT COMPLETED|Washout||0||
48650767|NCT02740582|101931865|FG000|STARTED|Second Intervention||24||
48650768|NCT02740582|101931866|FG001|STARTED|Second Intervention||31||
48650769|NCT02740582|101931865|FG000|COMPLETED|Second Intervention||23||
48650770|NCT02740582|101931866|FG001|COMPLETED|Second Intervention||28||
48650771|NCT02740582|101931865|FG000|NOT COMPLETED|Second Intervention||1||
48650772|NCT02740582|101931866|FG001|NOT COMPLETED|Second Intervention||3||
48650773|NCT00284934|101931867|FG000|STARTED|Overall Study||48||
48650774|NCT00284934|101931868|FG001|STARTED|Overall Study||46||
48650775|NCT00284934|101931867|FG000|Intent-to-treat Population (ITT)|Overall Study||47||
48650776|NCT00284934|101931868|FG001|Intent-to-treat Population (ITT)|Overall Study||45||
48650777|NCT00284934|101931867|FG000|COMPLETED|Overall Study||44||
48650778|NCT00284934|101931868|FG001|COMPLETED|Overall Study||43||
48650779|NCT00284934|101931867|FG000|NOT COMPLETED|Overall Study||4||
48650780|NCT00284934|101931868|FG001|NOT COMPLETED|Overall Study||3||
48650781|NCT02882178|101931869|FG000|STARTED|Overall Study||18||
48650782|NCT02882178|101931869|FG000|COMPLETED|Overall Study||18||
48650783|NCT02882178|101931869|FG000|NOT COMPLETED|Overall Study||0||
48650784|NCT05085405|101931870|FG000|STARTED|Overall Study||13||
48650785|NCT05085405|101931871|FG001|STARTED|Overall Study||13||
48650786|NCT05085405|101931872|FG002|STARTED|Overall Study||12||
48650787|NCT05085405|101931873|FG003|STARTED|Overall Study||13||
48650788|NCT05085405|101931874|FG004|STARTED|Overall Study||6||
48650789|NCT05085405|101931875|FG005|STARTED|Overall Study||6||
48650790|NCT05085405|101931870|FG000|COMPLETED|Overall Study||13|"Patients were considered to have completed the overall study if they continued to meet all eligibility criteria at the time of study entry (e.g., not screen failures), and if they were still enrolled in the Anticoagulation Monitoring Service 5 weeks after study entry and eligible for the week 5 patient phone assessment per study protocol.~Clinicians were considered to have completed the overall study if they received the clinician-level intervention for any of their eligible patients."|
48650791|NCT05085405|101931871|FG001|COMPLETED|Overall Study||13|"Patients were considered to have completed the overall study if they continued to meet all eligibility criteria at the time of study entry (e.g., not screen failures), and if they were still enrolled in the Anticoagulation Monitoring Service 5 weeks after study entry and eligible for the week 5 patient phone assessment per study protocol.~Clinicians were considered to have completed the overall study if they received the clinician-level intervention for any of their eligible patients."|
48650792|NCT05085405|101931872|FG002|COMPLETED|Overall Study||11|"Patients were considered to have completed the overall study if they continued to meet all eligibility criteria at the time of study entry (e.g., not screen failures), and if they were still enrolled in the Anticoagulation Monitoring Service 5 weeks after study entry and eligible for the week 5 patient phone assessment per study protocol.~Clinicians were considered to have completed the overall study if they received the clinician-level intervention for any of their eligible patients."|
48650793|NCT05085405|101931873|FG003|COMPLETED|Overall Study||10|"Patients were considered to have completed the overall study if they continued to meet all eligibility criteria at the time of study entry (e.g., not screen failures), and if they were still enrolled in the Anticoagulation Monitoring Service 5 weeks after study entry and eligible for the week 5 patient phone assessment per study protocol.~Clinicians were considered to have completed the overall study if they received the clinician-level intervention for any of their eligible patients."|
48650794|NCT05085405|101931874|FG004|COMPLETED|Overall Study||6|"Patients were considered to have completed the overall study if they continued to meet all eligibility criteria at the time of study entry (e.g., not screen failures), and if they were still enrolled in the Anticoagulation Monitoring Service 5 weeks after study entry and eligible for the week 5 patient phone assessment per study protocol.~Clinicians were considered to have completed the overall study if they received the clinician-level intervention for any of their eligible patients."|
48650795|NCT05085405|101931875|FG005|COMPLETED|Overall Study||6|"Patients were considered to have completed the overall study if they continued to meet all eligibility criteria at the time of study entry (e.g., not screen failures), and if they were still enrolled in the Anticoagulation Monitoring Service 5 weeks after study entry and eligible for the week 5 patient phone assessment per study protocol.~Clinicians were considered to have completed the overall study if they received the clinician-level intervention for any of their eligible patients."|
48650796|NCT05085405|101931870|FG000|NOT COMPLETED|Overall Study||0||
48650797|NCT05085405|101931871|FG001|NOT COMPLETED|Overall Study||0||
48650798|NCT05085405|101931872|FG002|NOT COMPLETED|Overall Study||1||
48650799|NCT05085405|101931873|FG003|NOT COMPLETED|Overall Study||3||
48650800|NCT05085405|101931874|FG004|NOT COMPLETED|Overall Study||0||
48650801|NCT05085405|101931875|FG005|NOT COMPLETED|Overall Study||0||
48650802|NCT00378560|101931876|FG000|STARTED|Overall Study||509||
48650803|NCT00378560|101931877|FG001|STARTED|Overall Study||512||
48650804|NCT00378560|101931876|FG000|Vaccinated|Overall Study||509||
48650805|NCT00378560|101931877|FG001|Vaccinated|Overall Study||512||
48650806|NCT00378560|101931876|FG000|COMPLETED|Overall Study||453||
48650807|NCT00378560|101931877|FG001|COMPLETED|Overall Study||454||
48650808|NCT00378560|101931876|FG000|NOT COMPLETED|Overall Study||56||
48650809|NCT00378560|101931877|FG001|NOT COMPLETED|Overall Study||58||
48650810|NCT01166945|101931878|FG000|STARTED|Randomized||51||
48650811|NCT01166945|101931879|FG001|STARTED|Randomized||47||
48650812|NCT01166945|101931878|FG000|COMPLETED|Randomized||47||
48650813|NCT01166945|101931879|FG001|COMPLETED|Randomized||43||
48650814|NCT01166945|101931878|FG000|NOT COMPLETED|Randomized||4||
48650815|NCT01166945|101931879|FG001|NOT COMPLETED|Randomized||4||
48650816|NCT01166945|101931878|FG000|STARTED|Day 5||47||
48650817|NCT01166945|101931879|FG001|STARTED|Day 5||43||
48650818|NCT01166945|101931878|FG000|COMPLETED|Day 5||47||
48650819|NCT01166945|101931879|FG001|COMPLETED|Day 5||43||
48650820|NCT01166945|101931878|FG000|NOT COMPLETED|Day 5||0||
48650821|NCT01166945|101931879|FG001|NOT COMPLETED|Day 5||0||
48650822|NCT01166945|101931878|FG000|STARTED|Day 10||47||
48650823|NCT01166945|101931879|FG001|STARTED|Day 10||43||
48650824|NCT01166945|101931878|FG000|COMPLETED|Day 10||44||
48650825|NCT01166945|101931879|FG001|COMPLETED|Day 10||41||
48650826|NCT01166945|101931878|FG000|NOT COMPLETED|Day 10||3||
48650827|NCT01166945|101931879|FG001|NOT COMPLETED|Day 10||2||
48650828|NCT01166945|101931878|FG000|STARTED|Day 15||44||
48650829|NCT01166945|101931879|FG001|STARTED|Day 15||41||
48650830|NCT01166945|101931878|FG000|COMPLETED|Day 15||42||
48650831|NCT01166945|101931879|FG001|COMPLETED|Day 15||40||
48650832|NCT01166945|101931878|FG000|NOT COMPLETED|Day 15||2||
48650833|NCT01166945|101931879|FG001|NOT COMPLETED|Day 15||1||
48650834|NCT01166945|101931878|FG000|STARTED|Day 20||42||
48650835|NCT01166945|101931879|FG001|STARTED|Day 20||40||
48650836|NCT01166945|101931878|FG000|COMPLETED|Day 20||42||
48650837|NCT01166945|101931879|FG001|COMPLETED|Day 20||40||
48650838|NCT01166945|101931878|FG000|NOT COMPLETED|Day 20||0||
48650839|NCT01166945|101931879|FG001|NOT COMPLETED|Day 20||0||
48650840|NCT01166945|101931878|FG000|STARTED|Day 30||42||
48650841|NCT01166945|101931879|FG001|STARTED|Day 30||40||
48650842|NCT01166945|101931878|FG000|COMPLETED|Day 30||38||
48650843|NCT01166945|101931879|FG001|COMPLETED|Day 30||37||
48650844|NCT01166945|101931878|FG000|NOT COMPLETED|Day 30||4||
48650845|NCT01166945|101931879|FG001|NOT COMPLETED|Day 30||3||
48650846|NCT03335267|101931880|FG000|STARTED|Overall Study||30||
48650847|NCT03335267|101931880|FG000|COMPLETED|Overall Study||30||
48650848|NCT03335267|101931880|FG000|NOT COMPLETED|Overall Study||0||
48650849|NCT00743262|101931881|FG000|STARTED|Overall Study||15||
48650850|NCT00743262|101931881|FG000|COMPLETED|Overall Study||15||
48362259|NCT00923091|101214487|FG000|STARTED|Period VI (Open-Label)||1447||
48362260|NCT00923091|101214488|FG001|STARTED|Period VI (Open-Label)||272||
48362261|NCT00923091|101214489|FG002|STARTED|Period VI (Open-Label)||480||
48362262|NCT00923091|101214490|FG003|STARTED|Period VI (Open-Label)||146||
48362263|NCT00923091|101214491|FG004|STARTED|Period VI (Open-Label)||164||
48362264|NCT00923091|101214492|FG005|STARTED|Period VI (Open-Label)||0||
48362265|NCT00923091|101214493|FG006|STARTED|Period VI (Open-Label)||0||
48362266|NCT00923091|101214494|FG007|STARTED|Period VI (Open-Label)||0||
48362267|NCT00923091|101214495|FG008|STARTED|Period VI (Open-Label)||0||
48362268|NCT00923091|101214496|FG009|STARTED|Period VI (Open-Label)||0||
48362269|NCT00923091|101214497|FG010|STARTED|Period VI (Open-Label)||0||
48362270|NCT00923091|101214498|FG011|STARTED|Period VI (Open-Label)||0||
48362271|NCT00923091|101214499|FG012|STARTED|Period VI (Open-Label)||0||
48436349|NCT01256086|101403533|FG001|COMPLETED|Treatment Day 1||11||
48436350|NCT01256086|101403534|FG002|COMPLETED|Treatment Day 1||11||
48436351|NCT01256086|101403535|FG003|COMPLETED|Treatment Day 1||11||
48436352|NCT01256086|101403532|FG000|NOT COMPLETED|Treatment Day 1||0||
48436353|NCT01256086|101403533|FG001|NOT COMPLETED|Treatment Day 1||0||
48436354|NCT01256086|101403534|FG002|NOT COMPLETED|Treatment Day 1||0||
48436355|NCT01256086|101403535|FG003|NOT COMPLETED|Treatment Day 1||0||
48436356|NCT01256086|101403532|FG000|STARTED|Treatment Day 2||11||
48436357|NCT01256086|101403533|FG001|STARTED|Treatment Day 2||10||
48436358|NCT01256086|101403534|FG002|STARTED|Treatment Day 2||9||
48436359|NCT01256086|101403535|FG003|STARTED|Treatment Day 2||11||
48436360|NCT01256086|101403532|FG000|COMPLETED|Treatment Day 2||11||
48436361|NCT01256086|101403533|FG001|COMPLETED|Treatment Day 2||10||
48436362|NCT01256086|101403534|FG002|COMPLETED|Treatment Day 2||9||
48436363|NCT01256086|101403535|FG003|COMPLETED|Treatment Day 2||11||
48436364|NCT01256086|101403532|FG000|NOT COMPLETED|Treatment Day 2||0||
48436365|NCT01256086|101403533|FG001|NOT COMPLETED|Treatment Day 2||0||
48436366|NCT01256086|101403534|FG002|NOT COMPLETED|Treatment Day 2||0||
48650851|NCT00743262|101931881|FG000|NOT COMPLETED|Overall Study||0||
48650852|NCT01108796|101931882|FG000|STARTED|Overall Study||774||
48650853|NCT01108796|101931883|FG001|STARTED|Overall Study||1067||
48650854|NCT01108796|101931882|FG000|COMPLETED|Overall Study||767||
48650855|NCT01108796|101931883|FG001|COMPLETED|Overall Study||1060||
48650856|NCT01108796|101931882|FG000|NOT COMPLETED|Overall Study||7||
48650857|NCT01108796|101931883|FG001|NOT COMPLETED|Overall Study||7||
48650858|NCT00147537|101931884|FG000|STARTED|Phase 1b||3||
48650859|NCT00147537|101931885|FG001|STARTED|Phase 1b||2||
48650860|NCT00147537|101931886|FG002|STARTED|Phase 1b||4||
48650861|NCT00147537|101931887|FG003|STARTED|Phase 1b||3||
48650862|NCT00147537|101931888|FG004|STARTED|Phase 1b||3||
48650863|NCT00147537|101931889|FG005|STARTED|Phase 1b||3||
48650864|NCT00147537|101931890|FG006|STARTED|Phase 1b||18||
48650865|NCT00147537|101931891|FG007|STARTED|Phase 1b||7||
48650866|NCT00147537|101931892|FG008|STARTED|Phase 1b||18||
48650867|NCT00147537|101931893|FG009|STARTED|Phase 1b||0||
48650868|NCT00147537|101931894|FG010|STARTED|Phase 1b||0||
48650869|NCT00147537|101931884|FG000|COMPLETED|Phase 1b||1||
48650870|NCT00147537|101931885|FG001|COMPLETED|Phase 1b||0||
48650871|NCT00147537|101931886|FG002|COMPLETED|Phase 1b||0||
48650872|NCT00147537|101931887|FG003|COMPLETED|Phase 1b||1||
48650873|NCT00147537|101931888|FG004|COMPLETED|Phase 1b||0||
48650874|NCT00147537|101931889|FG005|COMPLETED|Phase 1b||0||
48767787|NCT03863080|102222828|FG003|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0||
48362272|NCT00923091|101214487|FG000|COMPLETED|Period VI (Open-Label)||1408||
48362273|NCT00923091|101214488|FG001|COMPLETED|Period VI (Open-Label)||264||
48362274|NCT00923091|101214489|FG002|COMPLETED|Period VI (Open-Label)||467||
48362275|NCT00923091|101214490|FG003|COMPLETED|Period VI (Open-Label)||143||
48362276|NCT00923091|101214491|FG004|COMPLETED|Period VI (Open-Label)||157||
48362277|NCT00923091|101214492|FG005|COMPLETED|Period VI (Open-Label)||0||
48362278|NCT00923091|101214493|FG006|COMPLETED|Period VI (Open-Label)||0||
48362279|NCT00923091|101214494|FG007|COMPLETED|Period VI (Open-Label)||0||
48362280|NCT00923091|101214495|FG008|COMPLETED|Period VI (Open-Label)||0||
48362281|NCT00923091|101214496|FG009|COMPLETED|Period VI (Open-Label)||0||
48362282|NCT00923091|101214497|FG010|COMPLETED|Period VI (Open-Label)||0||
48362283|NCT00923091|101214498|FG011|COMPLETED|Period VI (Open-Label)||0||
48362284|NCT00923091|101214499|FG012|COMPLETED|Period VI (Open-Label)||0||
48362285|NCT00923091|101214487|FG000|NOT COMPLETED|Period VI (Open-Label)||39||
48362286|NCT00923091|101214488|FG001|NOT COMPLETED|Period VI (Open-Label)||8||
48362287|NCT00923091|101214489|FG002|NOT COMPLETED|Period VI (Open-Label)||13||
48362288|NCT00923091|101214490|FG003|NOT COMPLETED|Period VI (Open-Label)||3||
48362289|NCT00923091|101214491|FG004|NOT COMPLETED|Period VI (Open-Label)||7||
48362290|NCT00923091|101214492|FG005|NOT COMPLETED|Period VI (Open-Label)||0||
48650875|NCT00147537|101931890|FG006|COMPLETED|Phase 1b||0||
48650876|NCT00147537|101931891|FG007|COMPLETED|Phase 1b||0||
48650877|NCT00147537|101931892|FG008|COMPLETED|Phase 1b||1||
48650878|NCT00147537|101931893|FG009|COMPLETED|Phase 1b||0||
48650879|NCT00147537|101931894|FG010|COMPLETED|Phase 1b||0||
48650880|NCT00147537|101931884|FG000|NOT COMPLETED|Phase 1b||2||
48650881|NCT00147537|101931885|FG001|NOT COMPLETED|Phase 1b||2||
48650882|NCT00147537|101931886|FG002|NOT COMPLETED|Phase 1b||4||
48650883|NCT00147537|101931887|FG003|NOT COMPLETED|Phase 1b||2||
48650884|NCT00147537|101931888|FG004|NOT COMPLETED|Phase 1b||3||
48650885|NCT00147537|101931889|FG005|NOT COMPLETED|Phase 1b||3||
48650886|NCT00147537|101931890|FG006|NOT COMPLETED|Phase 1b||18||
48650887|NCT00147537|101931891|FG007|NOT COMPLETED|Phase 1b||7||
48650888|NCT00147537|101931892|FG008|NOT COMPLETED|Phase 1b||17||
48650889|NCT00147537|101931893|FG009|NOT COMPLETED|Phase 1b||0||
48650890|NCT00147537|101931894|FG010|NOT COMPLETED|Phase 1b||0||
48650891|NCT00147537|101931884|FG000|STARTED|Phase 2||0||
48650892|NCT00147537|101931885|FG001|STARTED|Phase 2||0||
48650893|NCT00147537|101931886|FG002|STARTED|Phase 2||0||
48650894|NCT00147537|101931887|FG003|STARTED|Phase 2||0||
48650895|NCT00147537|101931888|FG004|STARTED|Phase 2||0||
48650896|NCT00147537|101931889|FG005|STARTED|Phase 2||0||
48650897|NCT00147537|101931890|FG006|STARTED|Phase 2||0||
48650898|NCT00147537|101931891|FG007|STARTED|Phase 2||0||
48650899|NCT00147537|101931892|FG008|STARTED|Phase 2||0||
48650900|NCT00147537|101931893|FG009|STARTED|Phase 2||166||
48650901|NCT00147537|101931894|FG010|STARTED|Phase 2||55||
48650902|NCT00147537|101931884|FG000|COMPLETED|Phase 2||0||
48650903|NCT00147537|101931885|FG001|COMPLETED|Phase 2||0||
48650904|NCT00147537|101931886|FG002|COMPLETED|Phase 2||0||
48650905|NCT00147537|101931887|FG003|COMPLETED|Phase 2||0||
48650906|NCT00147537|101931888|FG004|COMPLETED|Phase 2||0||
48650907|NCT00147537|101931889|FG005|COMPLETED|Phase 2||0||
48650908|NCT00147537|101931890|FG006|COMPLETED|Phase 2||0||
48188262|NCT03748264|100783198|FG001|COMPLETED|Overall Study||21||
48188263|NCT03748264|100783199|FG002|COMPLETED|Overall Study||20||
48436367|NCT01256086|101403535|FG003|NOT COMPLETED|Treatment Day 2||0||
48650909|NCT00147537|101931891|FG007|COMPLETED|Phase 2||0||
48650910|NCT00147537|101931892|FG008|COMPLETED|Phase 2||0||
48650911|NCT00147537|101931893|FG009|COMPLETED|Phase 2||5||
48650912|NCT00147537|101931894|FG010|COMPLETED|Phase 2||3||
48650913|NCT00147537|101931884|FG000|NOT COMPLETED|Phase 2||0||
48650914|NCT00147537|101931885|FG001|NOT COMPLETED|Phase 2||0||
48650915|NCT00147537|101931886|FG002|NOT COMPLETED|Phase 2||0||
48650916|NCT00147537|101931887|FG003|NOT COMPLETED|Phase 2||0||
48650917|NCT00147537|101931888|FG004|NOT COMPLETED|Phase 2||0||
48650918|NCT00147537|101931889|FG005|NOT COMPLETED|Phase 2||0||
48650919|NCT00147537|101931890|FG006|NOT COMPLETED|Phase 2||0||
48650920|NCT00147537|101931891|FG007|NOT COMPLETED|Phase 2||0||
48650921|NCT00147537|101931892|FG008|NOT COMPLETED|Phase 2||0||
48650922|NCT00147537|101931893|FG009|NOT COMPLETED|Phase 2||161||
48650923|NCT00147537|101931894|FG010|NOT COMPLETED|Phase 2||52||
48650924|NCT00281580|101931895|FG000|STARTED|Overall Study||46||
48650925|NCT00281580|101931896|FG001|STARTED|Overall Study||42||
48650926|NCT00281580|101931897|FG002|STARTED|Overall Study||130||
48650927|NCT00281580|101931898|FG003|STARTED|Overall Study||135||
48650928|NCT00281580|101931899|FG004|STARTED|Overall Study||44||
48650929|NCT00281580|101931900|FG005|STARTED|Overall Study||46||
48650930|NCT00281580|101931901|FG006|STARTED|Overall Study||44||
48650931|NCT00281580|101931902|FG007|STARTED|Overall Study||47||
48650932|NCT00281580|101931903|FG008|STARTED|Overall Study||143||
48650933|NCT00281580|101931904|FG009|STARTED|Overall Study||129||
48650934|NCT00281580|101931905|FG010|STARTED|Overall Study||48||
48650935|NCT00281580|101931906|FG011|STARTED|Overall Study||146||
48650936|NCT00281580|101931907|FG012|STARTED|Overall Study||142||
48650937|NCT00281580|101931908|FG013|STARTED|Overall Study||50||
48650938|NCT00281580|101931909|FG014|STARTED|Overall Study||140||
48650939|NCT00281580|101931910|FG015|STARTED|Overall Study||129||
48650940|NCT00281580|101931895|FG000|COMPLETED|Overall Study||39||
48650941|NCT00281580|101931896|FG001|COMPLETED|Overall Study||41||
48650942|NCT00281580|101931897|FG002|COMPLETED|Overall Study||125||
48650943|NCT00281580|101931898|FG003|COMPLETED|Overall Study||118||
48650944|NCT00281580|101931899|FG004|COMPLETED|Overall Study||40||
48650945|NCT00281580|101931900|FG005|COMPLETED|Overall Study||43||
48650946|NCT00281580|101931901|FG006|COMPLETED|Overall Study||39||
48650947|NCT00281580|101931902|FG007|COMPLETED|Overall Study||46||
48650948|NCT00281580|101931903|FG008|COMPLETED|Overall Study||135||
48650949|NCT00281580|101931904|FG009|COMPLETED|Overall Study||117||
48650950|NCT00281580|101931905|FG010|COMPLETED|Overall Study||44||
48650951|NCT00281580|101931906|FG011|COMPLETED|Overall Study||136||
48188264|NCT03748264|100783197|FG000|NOT COMPLETED|Overall Study||0||
48188265|NCT03748264|100783198|FG001|NOT COMPLETED|Overall Study||0||
48188266|NCT03748264|100783199|FG002|NOT COMPLETED|Overall Study||0||
48650952|NCT00281580|101931907|FG012|COMPLETED|Overall Study||129||
48650953|NCT00281580|101931908|FG013|COMPLETED|Overall Study||43||
48650954|NCT00281580|101931909|FG014|COMPLETED|Overall Study||133||
48650955|NCT00281580|101931910|FG015|COMPLETED|Overall Study||116||
48650956|NCT00281580|101931895|FG000|NOT COMPLETED|Overall Study||7||
48650957|NCT00281580|101931896|FG001|NOT COMPLETED|Overall Study||1||
48650958|NCT00281580|101931897|FG002|NOT COMPLETED|Overall Study||5||
48650959|NCT00281580|101931898|FG003|NOT COMPLETED|Overall Study||17||
48650960|NCT00281580|101931899|FG004|NOT COMPLETED|Overall Study||4||
48650961|NCT00281580|101931900|FG005|NOT COMPLETED|Overall Study||3||
48650962|NCT00281580|101931901|FG006|NOT COMPLETED|Overall Study||5||
48650963|NCT00281580|101931902|FG007|NOT COMPLETED|Overall Study||1||
48650964|NCT00281580|101931903|FG008|NOT COMPLETED|Overall Study||8||
48650965|NCT00281580|101931904|FG009|NOT COMPLETED|Overall Study||12||
48650966|NCT00281580|101931905|FG010|NOT COMPLETED|Overall Study||4||
48650967|NCT00281580|101931906|FG011|NOT COMPLETED|Overall Study||10||
48650968|NCT00281580|101931907|FG012|NOT COMPLETED|Overall Study||13||
48650969|NCT00281580|101931908|FG013|NOT COMPLETED|Overall Study||7||
48650970|NCT00281580|101931909|FG014|NOT COMPLETED|Overall Study||7||
48650971|NCT00281580|101931910|FG015|NOT COMPLETED|Overall Study||13||
48650972|NCT03254147|101931911|FG000|STARTED|Overall Study||53969||
48650973|NCT03254147|101931911|FG000|COMPLETED|Overall Study||53969||
48650974|NCT03254147|101931911|FG000|NOT COMPLETED|Overall Study||0||
48650975|NCT05029362|101931912|FG000|STARTED|Overall Study||18||
48650976|NCT05029362|101931912|FG000|COMPLETED|Overall Study||9||
48650977|NCT05029362|101931912|FG000|NOT COMPLETED|Overall Study||9||
48650978|NCT04135443|101931913|FG000|STARTED|Overall Study||89||
48650979|NCT04135443|101931914|FG001|STARTED|Overall Study||89||
48650980|NCT04135443|101931913|FG000|COMPLETED|Overall Study||74||
48650981|NCT04135443|101931914|FG001|COMPLETED|Overall Study||74||
48650982|NCT04135443|101931913|FG000|NOT COMPLETED|Overall Study||15||
48650983|NCT04135443|101931914|FG001|NOT COMPLETED|Overall Study||15||
48650984|NCT00756444|101931915|FG000|STARTED|Overall Study||33||
48650985|NCT00756444|101931916|FG001|STARTED|Overall Study||34||
48650986|NCT00756444|101931915|FG000|COMPLETED|Overall Study||18||
48650987|NCT00756444|101931916|FG001|COMPLETED|Overall Study||13||
48650988|NCT00756444|101931915|FG000|NOT COMPLETED|Overall Study||15||
48650989|NCT00756444|101931916|FG001|NOT COMPLETED|Overall Study||21||
48650990|NCT03315689|101931917|FG000|STARTED|Double-blind Period = 28 Days||4||
48650991|NCT03315689|101931918|FG001|STARTED|Double-blind Period = 28 Days||7||
48650992|NCT03315689|101931917|FG000|COMPLETED|Double-blind Period = 28 Days||3||
48650993|NCT03315689|101931918|FG001|COMPLETED|Double-blind Period = 28 Days||7||
48650994|NCT03315689|101931917|FG000|NOT COMPLETED|Double-blind Period = 28 Days||1||
48650995|NCT03315689|101931918|FG001|NOT COMPLETED|Double-blind Period = 28 Days||0||
48650996|NCT03315689|101931917|FG000|STARTED|Open Label Extension = 52 Weeks||0|All participants entering the Open Label Extension were provided ATI-50002 0.46% Topical Solution.|
48765451|NCT02158546|102214657|FG002|STARTED|Overall Study||18|3 subjects were randomized but did not receive study drug.|
48765452|NCT02158546|102214658|FG003|STARTED|Overall Study||19|3 subjects were randomized but did not receive study drug.|
48650997|NCT03315689|101931918|FG001|STARTED|Open Label Extension = 52 Weeks||10|All participants entering the Open Label Extension were provided ATI-50002 0.46% Topical Solution.|
48650998|NCT03315689|101931917|FG000|COMPLETED|Open Label Extension = 52 Weeks||0||
48650999|NCT03315689|101931918|FG001|COMPLETED|Open Label Extension = 52 Weeks||7||
48651000|NCT03315689|101931917|FG000|NOT COMPLETED|Open Label Extension = 52 Weeks||0||
48651001|NCT03315689|101931918|FG001|NOT COMPLETED|Open Label Extension = 52 Weeks||3||
48651002|NCT04217057|101931919|FG000|STARTED|Overall Study||11||
48651003|NCT04217057|101931919|FG000|COMPLETED|Overall Study||11||
48651004|NCT04217057|101931919|FG000|NOT COMPLETED|Overall Study||0||
48651005|NCT04792970|101931920|FG000|STARTED|Overall Study||2||
48651006|NCT04792970|101931921|FG001|STARTED|Overall Study||2||
48651007|NCT04792970|101931920|FG000|COMPLETED|Overall Study||1||
48651008|NCT04792970|101931921|FG001|COMPLETED|Overall Study||1||
48651009|NCT04792970|101931920|FG000|NOT COMPLETED|Overall Study||1||
48651010|NCT04792970|101931921|FG001|NOT COMPLETED|Overall Study||1||
48651011|NCT04865978|101931922|FG000|STARTED|Overall Study||16||
48651012|NCT04865978|101931923|FG001|STARTED|Overall Study||14||
48651013|NCT04865978|101931922|FG000|COMPLETED|Overall Study||15||
48651014|NCT04865978|101931923|FG001|COMPLETED|Overall Study||14||
48651015|NCT04865978|101931922|FG000|NOT COMPLETED|Overall Study||1||
48651016|NCT04865978|101931923|FG001|NOT COMPLETED|Overall Study||0||
48651017|NCT00057577|101931924|FG000|STARTED|Overall Study||227||
48651018|NCT00057577|101931925|FG001|STARTED|Overall Study||225||
48651019|NCT00057577|101931924|FG000|COMPLETED|Overall Study||227||
48651020|NCT00057577|101931925|FG001|COMPLETED|Overall Study||225||
48651021|NCT00057577|101931924|FG000|NOT COMPLETED|Overall Study||0||
48651022|NCT00057577|101931925|FG001|NOT COMPLETED|Overall Study||0||
48651023|NCT03364686|101931926|FG000|STARTED|Overall Study||6||
48651024|NCT03364686|101931926|FG000|COMPLETED|Overall Study||4||
48651025|NCT03364686|101931926|FG000|NOT COMPLETED|Overall Study||2||
48651026|NCT01134614|101931927|FG000|STARTED|Overall Study||123||
48651027|NCT01134614|101931928|FG001|STARTED|Overall Study||122||
48651028|NCT01134614|101931927|FG000|Treated|Overall Study||119||
48651029|NCT01134614|101931928|FG001|Treated|Overall Study||121||
48651030|NCT01134614|101931927|FG000|Treated and Toxicity Assessed|Overall Study||118||
48651031|NCT01134614|101931928|FG001|Treated and Toxicity Assessed|Overall Study||120||
48651032|NCT01134614|101931927|FG000|COMPLETED|Overall Study||0||
48651033|NCT01134614|101931928|FG001|COMPLETED|Overall Study||0||
48651034|NCT01134614|101931927|FG000|NOT COMPLETED|Overall Study||123||
48651035|NCT01134614|101931928|FG001|NOT COMPLETED|Overall Study||122||
48765453|NCT02158546|102214655|FG000|COMPLETED|Overall Study||133||
48651036|NCT00712075|101931929|FG000|STARTED|Overall Study||22||
48651037|NCT00712075|101931930|FG001|STARTED|Overall Study||30||
48651038|NCT00712075|101931931|FG002|STARTED|Overall Study||25||
48651039|NCT00712075|101931929|FG000|COMPLETED|Overall Study||17||
48651040|NCT00712075|101931930|FG001|COMPLETED|Overall Study||26||
48651041|NCT00712075|101931931|FG002|COMPLETED|Overall Study||14||
48651042|NCT00712075|101931929|FG000|NOT COMPLETED|Overall Study||5||
48651043|NCT00712075|101931930|FG001|NOT COMPLETED|Overall Study||4||
48651044|NCT00712075|101931931|FG002|NOT COMPLETED|Overall Study||11||
48651045|NCT00784927|101931932|FG000|STARTED|Overall Study||36||
48651046|NCT00784927|101931932|FG000|COMPLETED|Overall Study||33||
48651047|NCT00784927|101931932|FG000|NOT COMPLETED|Overall Study||3||
48651048|NCT01829503|101931933|FG000|STARTED|Overall Study||44||
48651049|NCT01829503|101931933|FG000|COMPLETED|Overall Study||44||
48651050|NCT01829503|101931933|FG000|NOT COMPLETED|Overall Study||0||
48651051|NCT00617903|101931934|FG000|STARTED|Overall Study||41||
48651052|NCT00617903|101931935|FG001|STARTED|Overall Study||42||
48651053|NCT00617903|101931934|FG000|COMPLETED|Overall Study||38||
48651054|NCT00617903|101931935|FG001|COMPLETED|Overall Study||35||
48651055|NCT00617903|101931934|FG000|NOT COMPLETED|Overall Study||3||
48362291|NCT00923091|101214493|FG006|NOT COMPLETED|Period VI (Open-Label)||0||
48362292|NCT00923091|101214494|FG007|NOT COMPLETED|Period VI (Open-Label)||0||
48362293|NCT00923091|101214495|FG008|NOT COMPLETED|Period VI (Open-Label)||0||
48362294|NCT00923091|101214496|FG009|NOT COMPLETED|Period VI (Open-Label)||0||
48362295|NCT00923091|101214497|FG010|NOT COMPLETED|Period VI (Open-Label)||0||
48436368|NCT01256086|101403532|FG000|STARTED|Treatment Day 3||11||
48651056|NCT00617903|101931935|FG001|NOT COMPLETED|Overall Study||7||
48651057|NCT02083263|101931936|FG000|STARTED|Overall Study||16||
48651058|NCT02083263|101931937|FG001|STARTED|Overall Study||16||
48651059|NCT02083263|101931936|FG000|COMPLETED|Overall Study||16||
48651060|NCT02083263|101931937|FG001|COMPLETED|Overall Study||16||
48651061|NCT02083263|101931936|FG000|NOT COMPLETED|Overall Study||0||
48651062|NCT02083263|101931937|FG001|NOT COMPLETED|Overall Study||0||
48651063|NCT00756314|101931938|FG000|STARTED|Overall Study||123||
48651064|NCT00756314|101931939|FG001|STARTED|Overall Study||123||
48651065|NCT00756314|101931938|FG000|COMPLETED|Overall Study||121||
48651066|NCT00756314|101931939|FG001|COMPLETED|Overall Study||64||
48651067|NCT00756314|101931938|FG000|NOT COMPLETED|Overall Study||2||
48651068|NCT00756314|101931939|FG001|NOT COMPLETED|Overall Study||59||
48651069|NCT01862029|101931940|FG000|STARTED|Overall Study||9||
48651070|NCT01862029|101931940|FG000|COMPLETED|Overall Study||8||
48651071|NCT01862029|101931940|FG000|NOT COMPLETED|Overall Study||1||
48651072|NCT03020082|101931941|FG000|STARTED|Overall Study||141||
48651073|NCT03020082|101931941|FG000|COMPLETED|Overall Study||138||
48651074|NCT03020082|101931941|FG000|NOT COMPLETED|Overall Study||3||
48651075|NCT02975700|101931942|FG000|STARTED|Overall Study||6||
48651076|NCT02975700|101931942|FG000|COMPLETED|Overall Study||0||
48651077|NCT02975700|101931942|FG000|NOT COMPLETED|Overall Study||6||
48651078|NCT00263562|101931943|FG000|STARTED|Overall Study||9|This study was terminated early and not completed.|
48651079|NCT00263562|101931944|FG001|STARTED|Overall Study||9|This study was terminated early and not completed.|
48651080|NCT00263562|101931943|FG000|COMPLETED|Overall Study||6||
48651081|NCT00263562|101931944|FG001|COMPLETED|Overall Study||9||
48651082|NCT00263562|101931943|FG000|NOT COMPLETED|Overall Study||3||
48651083|NCT00263562|101931944|FG001|NOT COMPLETED|Overall Study||0||
48362296|NCT00923091|101214498|FG011|NOT COMPLETED|Period VI (Open-Label)||0||
48362297|NCT00923091|101214499|FG012|NOT COMPLETED|Period VI (Open-Label)||0||
48362298|NCT04745832|101214500|FG000|STARTED|Overall Study||41||
48362299|NCT04745832|101214501|FG001|STARTED|Overall Study||41||
48362300|NCT04745832|101214500|FG000|COMPLETED|Overall Study||41||
48362301|NCT04745832|101214501|FG001|COMPLETED|Overall Study||41||
48362302|NCT04745832|101214500|FG000|NOT COMPLETED|Overall Study||0||
48651084|NCT02255279|101931945|FG000|STARTED|Overall Study||144||
48651085|NCT02255279|101931946|FG001|STARTED|Overall Study||143||
48651086|NCT02255279|101931945|FG000|COMPLETED|Overall Study||139||
48651087|NCT02255279|101931946|FG001|COMPLETED|Overall Study||134||
48651088|NCT02255279|101931945|FG000|NOT COMPLETED|Overall Study||5||
48651089|NCT02255279|101931946|FG001|NOT COMPLETED|Overall Study||9||
48651090|NCT03437733|101931947|FG000|STARTED|Overall Study||8||
48651091|NCT03437733|101931948|FG001|STARTED|Overall Study||90||
48651092|NCT03437733|101931947|FG000|Safety|Overall Study||8||
48651093|NCT03437733|101931948|FG001|Safety|Overall Study||87||
48651094|NCT03437733|101931947|FG000|COMPLETED|Overall Study||8||
48651095|NCT03437733|101931948|FG001|COMPLETED|Overall Study||87||
48651096|NCT03437733|101931947|FG000|NOT COMPLETED|Overall Study||0||
48651097|NCT03437733|101931948|FG001|NOT COMPLETED|Overall Study||3||
48651098|NCT02369159|101931949|FG000|STARTED|Overall Study||114||
48651099|NCT02369159|101931950|FG001|STARTED|Overall Study||23||
48651100|NCT02369159|101931949|FG000|ITT Population|Overall Study||114|Intend-to-treat (ITT) population included all randomized subjects|
48651101|NCT02369159|101931950|FG001|ITT Population|Overall Study||23|Intend-to-treat (ITT) population included all randomized subjects|
48651102|NCT02369159|101931949|FG000|Safety Population|Overall Study||107|Safety Population included all randomized subjects who received ≥ 1 partial dose of peramivir or oseltamivir.|
48657052|NCT03648372|101943771|FG014|STARTED|Overall Study||6||
48651103|NCT02369159|101931950|FG001|Safety Population|Overall Study||23|Safety Population included all randomized subjects who received ≥ 1 partial dose of peramivir or oseltamivir.|
48651104|NCT02369159|101931949|FG000|ITTI Population|Overall Study||81|Intent-to-treat-infected (ITTI) population included all subjects who were enrolled, treated, and had influenza confirmed by RT-PCR.|
48651105|NCT02369159|101931950|FG001|ITTI Population|Overall Study||16|Intent-to-treat-infected (ITTI) population included all subjects who were enrolled, treated, and had influenza confirmed by RT-PCR.|
48651106|NCT02369159|101931949|FG000|E-R Population|Overall Study||80|Exposure-response (E-R) Population included all subjects in the ITTI population who had a quantifiable peramivir concentration on Day 1 and had ≥ 1 post-baseline effectiveness assessment.|
48651107|NCT02369159|101931950|FG001|E-R Population|Overall Study||0|Exposure-response (E-R) Population included all subjects in the ITTI population who had a quantifiable peramivir concentration on Day 1 and had ≥ 1 post-baseline effectiveness assessment.|
48651108|NCT02369159|101931949|FG000|COMPLETED|Overall Study||106||
48651109|NCT02369159|101931950|FG001|COMPLETED|Overall Study||21||
48651110|NCT02369159|101931949|FG000|NOT COMPLETED|Overall Study||8||
48651111|NCT02369159|101931950|FG001|NOT COMPLETED|Overall Study||2||
48651112|NCT00195429|101931951|FG000|STARTED|Overall Study||24||
48651113|NCT00195429|101931952|FG001|STARTED|Overall Study||23||
48651114|NCT00195429|101931951|FG000|COMPLETED|Overall Study||19||
48651115|NCT00195429|101931952|FG001|COMPLETED|Overall Study||18||
48651116|NCT00195429|101931951|FG000|NOT COMPLETED|Overall Study||5||
48651117|NCT00195429|101931952|FG001|NOT COMPLETED|Overall Study||5||
48651118|NCT05059080|101931953|FG000|STARTED|Overall Study||72||
48651119|NCT05059080|101931953|FG000|COMPLETED|Overall Study||5||
48651120|NCT05059080|101931953|FG000|NOT COMPLETED|Overall Study||67||
48651121|NCT02046200|101931954|FG000|STARTED|First Intervention (1 Day)||5||
48651122|NCT02046200|101931955|FG001|STARTED|First Intervention (1 Day)||6||
48651123|NCT02046200|101931954|FG000|COMPLETED|First Intervention (1 Day)||5||
48651124|NCT02046200|101931955|FG001|COMPLETED|First Intervention (1 Day)||6||
48651125|NCT02046200|101931954|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48651126|NCT02046200|101931955|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48651127|NCT02046200|101931954|FG000|STARTED|Second Intervention (1 Day)||5||
48651128|NCT02046200|101931955|FG001|STARTED|Second Intervention (1 Day)||6||
48651129|NCT02046200|101931954|FG000|COMPLETED|Second Intervention (1 Day)||5||
48651130|NCT02046200|101931955|FG001|COMPLETED|Second Intervention (1 Day)||6||
48651131|NCT02046200|101931954|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48651132|NCT02046200|101931955|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48651133|NCT01348490|101931956|FG000|STARTED|Overall Study||66||
48651134|NCT01348490|101931956|FG000|COMPLETED|Overall Study||42||
48651135|NCT01348490|101931956|FG000|NOT COMPLETED|Overall Study||24||
48651136|NCT04632030|101931957|FG000|STARTED|Overall Study||96||
48651137|NCT04632030|101931958|FG001|STARTED|Overall Study||86||
48651138|NCT04632030|101931959|FG002|STARTED|Overall Study||93||
48651139|NCT04632030|101931957|FG000|COMPLETED|Overall Study||96||
48651140|NCT04632030|101931958|FG001|COMPLETED|Overall Study||86||
48651141|NCT04632030|101931959|FG002|COMPLETED|Overall Study||93||
48651142|NCT04632030|101931957|FG000|NOT COMPLETED|Overall Study||0||
48651143|NCT04632030|101931958|FG001|NOT COMPLETED|Overall Study||0||
48651144|NCT04632030|101931959|FG002|NOT COMPLETED|Overall Study||0||
48651145|NCT01803737|101931960|FG000|STARTED|Overall Study||13||
48651146|NCT01803737|101931961|FG001|STARTED|Overall Study||13||
48651147|NCT01803737|101931960|FG000|COMPLETED|Overall Study||12||
48651148|NCT01803737|101931961|FG001|COMPLETED|Overall Study||10||
48651149|NCT01803737|101931960|FG000|NOT COMPLETED|Overall Study||1||
48651150|NCT01803737|101931961|FG001|NOT COMPLETED|Overall Study||3||
48651151|NCT03050489|101931962|FG000|STARTED|Overall Study||128||
48651152|NCT03050489|101931963|FG001|STARTED|Overall Study||181||
48651153|NCT03050489|101931964|FG002|STARTED|Overall Study||27||
48651154|NCT03050489|101931962|FG000|COMPLETED|Overall Study||128||
48651155|NCT03050489|101931963|FG001|COMPLETED|Overall Study||175||
48651156|NCT03050489|101931964|FG002|COMPLETED|Overall Study||27||
48651157|NCT03050489|101931962|FG000|NOT COMPLETED|Overall Study||0||
48651158|NCT03050489|101931963|FG001|NOT COMPLETED|Overall Study||6||
48651159|NCT03050489|101931964|FG002|NOT COMPLETED|Overall Study||0||
48651160|NCT02186171|101931965|FG000|STARTED|Overall Study||82||
48651161|NCT02186171|101931966|FG001|STARTED|Overall Study||163||
48651162|NCT02186171|101931965|FG000|Received Treatment|Overall Study||81||
48651163|NCT02186171|101931966|FG001|Received Treatment|Overall Study||163||
48651164|NCT02186171|101931965|FG000|COMPLETED|Overall Study||78||
48651165|NCT02186171|101931966|FG001|COMPLETED|Overall Study||148||
48651166|NCT02186171|101931965|FG000|NOT COMPLETED|Overall Study||4||
48651167|NCT02186171|101931966|FG001|NOT COMPLETED|Overall Study||15||
48651168|NCT01529112|101931967|FG000|STARTED|Overall Study||89||
48651169|NCT01529112|101931968|FG001|STARTED|Overall Study||46||
48651170|NCT01529112|101931967|FG000|COMPLETED|Overall Study||20||
48651171|NCT01529112|101931968|FG001|COMPLETED|Overall Study||5||
48651172|NCT01529112|101931967|FG000|NOT COMPLETED|Overall Study||69||
48651173|NCT01529112|101931968|FG001|NOT COMPLETED|Overall Study||41||
48651174|NCT02916433|101931969|FG000|STARTED|Overall Study||3||
48651175|NCT02916433|101931970|FG001|STARTED|Overall Study||2||
48651176|NCT02916433|101931969|FG000|COMPLETED|Overall Study||1||
48651177|NCT02916433|101931970|FG001|COMPLETED|Overall Study||2||
48651178|NCT02916433|101931969|FG000|NOT COMPLETED|Overall Study||2||
48651179|NCT02916433|101931970|FG001|NOT COMPLETED|Overall Study||0||
48651180|NCT03954938|101931971|FG000|STARTED|Overall Study||5||
48651181|NCT03954938|101931971|FG000|Positive-80 mg Cocaine|Overall Study||5||
48651182|NCT03954938|101931971|FG000|Look-80 mg Cocaine|Overall Study||5||
48651183|NCT03954938|101931971|FG000|Positive-40 mg Cocaine|Overall Study||4||
48651184|NCT03954938|101931971|FG000|Look-0 mg Cocaine|Overall Study||4||
48651185|NCT03954938|101931971|FG000|Positive-0 mg Cocaine|Overall Study||3||
48651186|NCT03954938|101931971|FG000|Look-40 mg Cocaine|Overall Study||3||
48651187|NCT03954938|101931971|FG000|Negative-0 mg Cocaine|Overall Study||3||
48651188|NCT03954938|101931971|FG000|Negative-40 mg Cocaine|Overall Study||3||
48651189|NCT03954938|101931971|FG000|Negative-80 mg Cocaine|Overall Study||2||
48651190|NCT03954938|101931971|FG000|COMPLETED|Overall Study||2||
48651191|NCT03954938|101931971|FG000|NOT COMPLETED|Overall Study||3||
48651192|NCT03061214|101931972|FG000|STARTED|Overall Study||288||
48651193|NCT03061214|101931973|FG001|STARTED|Overall Study||290||
48651194|NCT03061214|101931974|FG002|STARTED|Overall Study||290||
48651195|NCT03061214|101931972|FG000|Exposed|Overall Study||287||
48651196|NCT03061214|101931973|FG001|Exposed|Overall Study||290||
48651197|NCT03061214|101931974|FG002|Exposed|Overall Study||290||
48651198|NCT03061214|101931972|FG000|Full Analysis Set (FAS)|Overall Study||288||
48651199|NCT03061214|101931973|FG001|Full Analysis Set (FAS)|Overall Study||290||
48651200|NCT03061214|101931974|FG002|Full Analysis Set (FAS)|Overall Study||290||
48651201|NCT03061214|101931972|FG000|Safety Analysis Set (SAS)|Overall Study||287||
48651202|NCT03061214|101931973|FG001|Safety Analysis Set (SAS)|Overall Study||290||
48651203|NCT03061214|101931974|FG002|Safety Analysis Set (SAS)|Overall Study||290||
48651204|NCT03061214|101931972|FG000|COMPLETED|Overall Study||263||
48651205|NCT03061214|101931973|FG001|COMPLETED|Overall Study||262||
48651206|NCT03061214|101931974|FG002|COMPLETED|Overall Study||280||
48651207|NCT03061214|101931972|FG000|NOT COMPLETED|Overall Study||25||
48651208|NCT03061214|101931973|FG001|NOT COMPLETED|Overall Study||28||
48651209|NCT03061214|101931974|FG002|NOT COMPLETED|Overall Study||10||
48651210|NCT03095976|101931975|FG000|STARTED|Overall Study||4||
48651211|NCT03095976|101931975|FG000|COMPLETED|Overall Study||4||
48651212|NCT03095976|101931975|FG000|NOT COMPLETED|Overall Study||0||
48651213|NCT03142451|101931976|FG000|STARTED|Overall Study||495||
48651214|NCT03142451|101931977|FG001|STARTED|Overall Study||256||
48651215|NCT03142451|101931976|FG000|COMPLETED|Overall Study||437||
48651216|NCT03142451|101931977|FG001|COMPLETED|Overall Study||232||
48651217|NCT03142451|101931976|FG000|NOT COMPLETED|Overall Study||58||
48651218|NCT03142451|101931977|FG001|NOT COMPLETED|Overall Study||24||
48651219|NCT00894647|101931978|FG000|STARTED|Overall Study||121||
48651220|NCT00894647|101931979|FG001|STARTED|Overall Study||126||
48651221|NCT00894647|101931978|FG000|COMPLETED|Overall Study||111||
48651222|NCT00894647|101931979|FG001|COMPLETED|Overall Study||112||
48651223|NCT00894647|101931978|FG000|NOT COMPLETED|Overall Study||10||
48651224|NCT00894647|101931979|FG001|NOT COMPLETED|Overall Study||14||
48651225|NCT00949078|101931980|FG000|STARTED|Overall Study||5||
48651226|NCT00949078|101931981|FG001|STARTED|Overall Study||9||
48651227|NCT00949078|101931980|FG000|COMPLETED|Overall Study||5||
48651228|NCT00949078|101931981|FG001|COMPLETED|Overall Study||9||
48651229|NCT00949078|101931980|FG000|NOT COMPLETED|Overall Study||0||
48651230|NCT00949078|101931981|FG001|NOT COMPLETED|Overall Study||0||
48651231|NCT01698008|101931982|FG000|STARTED|Overall Study||3||
48651232|NCT01698008|101931983|FG001|STARTED|Overall Study||2||
48651233|NCT01698008|101931982|FG000|COMPLETED|Overall Study||2||
48651234|NCT01698008|101931983|FG001|COMPLETED|Overall Study||0||
48651235|NCT01698008|101931982|FG000|NOT COMPLETED|Overall Study||1||
48651236|NCT01698008|101931983|FG001|NOT COMPLETED|Overall Study||2||
48651237|NCT02194088|101931984|FG000|STARTED|Overall Study||75||
48651238|NCT02194088|101931985|FG001|STARTED|Overall Study||25||
48651239|NCT02194088|101931984|FG000|COMPLETED|Overall Study||75||
48651240|NCT02194088|101931985|FG001|COMPLETED|Overall Study||25||
48651241|NCT02194088|101931984|FG000|NOT COMPLETED|Overall Study||0||
48651242|NCT02194088|101931985|FG001|NOT COMPLETED|Overall Study||0||
48651243|NCT01522976|101931986|FG000|STARTED|Overall Study||97||
48651244|NCT01522976|101931987|FG001|STARTED|Overall Study||92||
48651245|NCT01522976|101931988|FG002|STARTED|Overall Study||93||
48651246|NCT01522976|101931986|FG000|COMPLETED|Overall Study||0||
48651247|NCT01522976|101931987|FG001|COMPLETED|Overall Study||0||
48651248|NCT01522976|101931988|FG002|COMPLETED|Overall Study||0||
48651249|NCT01522976|101931986|FG000|NOT COMPLETED|Overall Study||97||
48651250|NCT01522976|101931987|FG001|NOT COMPLETED|Overall Study||92||
48651251|NCT01522976|101931988|FG002|NOT COMPLETED|Overall Study||93||
48651252|NCT01733888|101931989|FG000|STARTED|Overall Study||20||
48651253|NCT01733888|101931990|FG001|STARTED|Overall Study||20||
48651254|NCT01733888|101931991|FG002|STARTED|Overall Study||20||
48651255|NCT01733888|101931992|FG003|STARTED|Overall Study||20||
48651256|NCT01733888|101931989|FG000|COMPLETED|Overall Study||20||
48651257|NCT01733888|101931990|FG001|COMPLETED|Overall Study||20||
48651258|NCT01733888|101931991|FG002|COMPLETED|Overall Study||20||
48651259|NCT01733888|101931992|FG003|COMPLETED|Overall Study||20||
48651260|NCT01733888|101931989|FG000|NOT COMPLETED|Overall Study||0||
48651261|NCT01733888|101931990|FG001|NOT COMPLETED|Overall Study||0||
48651262|NCT01733888|101931991|FG002|NOT COMPLETED|Overall Study||0||
48765454|NCT02158546|102214656|FG001|COMPLETED|Overall Study||136||
48765455|NCT02158546|102214657|FG002|COMPLETED|Overall Study||14||
48765456|NCT02158546|102214658|FG003|COMPLETED|Overall Study||13||
48765457|NCT02158546|102214655|FG000|NOT COMPLETED|Overall Study||19||
48362303|NCT04745832|101214501|FG001|NOT COMPLETED|Overall Study||0||
48362304|NCT00492622|101214502|FG000|STARTED|Overall Study||12||
48362305|NCT00492622|101214502|FG000|COMPLETED|Overall Study||12||
48362306|NCT00492622|101214502|FG000|NOT COMPLETED|Overall Study||0||
48362307|NCT00729430|101214503|FG000|STARTED|Overall Study||180||
48362308|NCT00729430|101214504|FG001|STARTED|Overall Study||178||
48362309|NCT00729430|101214503|FG000|COMPLETED|Overall Study||133||
48362310|NCT00729430|101214504|FG001|COMPLETED|Overall Study||128||
48362311|NCT00729430|101214503|FG000|NOT COMPLETED|Overall Study||47||
48765458|NCT02158546|102214656|FG001|NOT COMPLETED|Overall Study||17||
48765459|NCT02158546|102214657|FG002|NOT COMPLETED|Overall Study||4||
48765460|NCT02158546|102214658|FG003|NOT COMPLETED|Overall Study||6||
48362312|NCT00729430|101214504|FG001|NOT COMPLETED|Overall Study||50||
48362313|NCT01507545|101214505|FG000|STARTED|Overall Study||84||
48436369|NCT01256086|101403533|FG001|STARTED|Treatment Day 3||10||
48436370|NCT01256086|101403534|FG002|STARTED|Treatment Day 3||9||
48436371|NCT01256086|101403535|FG003|STARTED|Treatment Day 3||11||
48436372|NCT01256086|101403532|FG000|COMPLETED|Treatment Day 3||11||
48436373|NCT01256086|101403533|FG001|COMPLETED|Treatment Day 3||10||
48436374|NCT01256086|101403534|FG002|COMPLETED|Treatment Day 3||9||
48436375|NCT01256086|101403535|FG003|COMPLETED|Treatment Day 3||11||
48436376|NCT01256086|101403532|FG000|NOT COMPLETED|Treatment Day 3||0||
48436377|NCT01256086|101403533|FG001|NOT COMPLETED|Treatment Day 3||0||
48436378|NCT01256086|101403534|FG002|NOT COMPLETED|Treatment Day 3||0||
48436379|NCT01256086|101403535|FG003|NOT COMPLETED|Treatment Day 3||0||
48436380|NCT01256086|101403532|FG000|STARTED|Treatment Day 4||11||
48436381|NCT01256086|101403533|FG001|STARTED|Treatment Day 4||10||
48436382|NCT01256086|101403534|FG002|STARTED|Treatment Day 4||9||
48436383|NCT01256086|101403535|FG003|STARTED|Treatment Day 4||11||
48436384|NCT01256086|101403532|FG000|COMPLETED|Treatment Day 4||11||
48436385|NCT01256086|101403533|FG001|COMPLETED|Treatment Day 4||10||
48436386|NCT01256086|101403534|FG002|COMPLETED|Treatment Day 4||9||
48436387|NCT01256086|101403535|FG003|COMPLETED|Treatment Day 4||11||
48436388|NCT01256086|101403532|FG000|NOT COMPLETED|Treatment Day 4||0||
48436389|NCT01256086|101403533|FG001|NOT COMPLETED|Treatment Day 4||0||
48436390|NCT01256086|101403534|FG002|NOT COMPLETED|Treatment Day 4||0||
48436391|NCT01256086|101403535|FG003|NOT COMPLETED|Treatment Day 4||0||
48436392|NCT03690375|101403536|FG000|STARTED|Overall Study||10|While 10 subjects were enrolled, only 5 subjects were analyzed for senile purpura while the other 5 subjects were used as controls in some secondary measures|10
48362314|NCT01507545|101214506|FG001|STARTED|Overall Study||42||
48362315|NCT01507545|101214505|FG000|Treated/Safety Set|Overall Study||82||
48362316|NCT01507545|101214506|FG001|Treated/Safety Set|Overall Study||40||
48362317|NCT01507545|101214505|FG000|COMPLETED|Overall Study||0||
48362318|NCT01507545|101214506|FG001|COMPLETED|Overall Study||0||
48362319|NCT01507545|101214505|FG000|NOT COMPLETED|Overall Study||84||
48362320|NCT01507545|101214506|FG001|NOT COMPLETED|Overall Study||42||
48362321|NCT02235285|101214507|FG000|STARTED|Overall Study||162||
48436393|NCT03690375|101403537|FG001|STARTED|Overall Study||10|While 10 subjects were enrolled, only 5 subjects were analyzed for senile purpura while the other 5 subjects were used as controls in some secondary measures|10
48765461|NCT00999102|102214659|FG000|STARTED|4 Weeks at Lower Dose of First Drug||16||
48765462|NCT00999102|102214660|FG001|STARTED|4 Weeks at Lower Dose of First Drug||17||
48362322|NCT02235285|101214507|FG000|COMPLETED|Overall Study||149||
48362323|NCT02235285|101214507|FG000|NOT COMPLETED|Overall Study||13||
48362324|NCT00872898|101214508|FG000|STARTED|Part One - Open Label, Pharmacokinetics||0||
48362325|NCT00872898|101214509|FG001|STARTED|Part One - Open Label, Pharmacokinetics||4||
48436394|NCT03690375|101403536|FG000|COMPLETED|Overall Study||10||10
48436395|NCT03690375|101403537|FG001|COMPLETED|Overall Study||10||10
48436396|NCT03690375|101403536|FG000|NOT COMPLETED|Overall Study||0||0
48436397|NCT03690375|101403537|FG001|NOT COMPLETED|Overall Study||0||0
48436398|NCT01982539|101403538|FG000|STARTED|Overall Study||25||
48436399|NCT01982539|101403538|FG000|COMPLETED|Overall Study||25||
48765463|NCT00999102|102214659|FG000|COMPLETED|4 Weeks at Lower Dose of First Drug||15||
48651263|NCT01733888|101931992|FG003|NOT COMPLETED|Overall Study||0||
48651264|NCT01633112|101931993|FG000|STARTED|Overall Study||352||
48651265|NCT01633112|101931994|FG001|STARTED|Overall Study||370||
48651266|NCT01633112|101931995|FG002|STARTED|Overall Study||342||
48651267|NCT01633112|101931993|FG000|COMPLETED|Overall Study||299||
48651268|NCT01633112|101931994|FG001|COMPLETED|Overall Study||310||
48651269|NCT01633112|101931995|FG002|COMPLETED|Overall Study||250||
48651270|NCT01633112|101931993|FG000|NOT COMPLETED|Overall Study||53||
48651271|NCT01633112|101931994|FG001|NOT COMPLETED|Overall Study||60||
48651272|NCT01633112|101931995|FG002|NOT COMPLETED|Overall Study||92||
48651273|NCT00933166|101931996|FG000|STARTED|Overall Study||169||
48651274|NCT00933166|101931996|FG000|COMPLETED|Overall Study||151||
48651275|NCT00933166|101931996|FG000|NOT COMPLETED|Overall Study||18||
48651276|NCT03128086|101931997|FG000|STARTED|Overall Study||50||
48651277|NCT03128086|101931998|FG001|STARTED|Overall Study||44||
48651278|NCT03128086|101931997|FG000|COMPLETED|Overall Study||50||
48651279|NCT03128086|101931998|FG001|COMPLETED|Overall Study||44||
48651280|NCT03128086|101931997|FG000|NOT COMPLETED|Overall Study||0||
48651281|NCT03128086|101931998|FG001|NOT COMPLETED|Overall Study||0||
48651282|NCT04341662|101931999|FG000|STARTED|Overall Study||49101||
48651283|NCT04341662|101932000|FG001|STARTED|Overall Study||50558||
48651284|NCT04341662|101931999|FG000|COMPLETED|Overall Study||48678||
48651285|NCT04341662|101932000|FG001|COMPLETED|Overall Study||50044||
48651286|NCT04341662|101931999|FG000|NOT COMPLETED|Overall Study||423||
48651287|NCT04341662|101932000|FG001|NOT COMPLETED|Overall Study||514||
48651288|NCT03782103|101932001|FG000|STARTED|Overall Study||156||72
48651289|NCT03782103|101932001|FG000|ZP|Overall Study||156||72
48651290|NCT03782103|101932001|FG000|CP|Overall Study||156||72
48651291|NCT03782103|101932001|FG000|Vehicle|Overall Study||156||72
48651292|NCT03782103|101932001|FG000|COMPLETED|Overall Study||156||72
48651293|NCT03782103|101932001|FG000|NOT COMPLETED|Overall Study||0||0
48651294|NCT00098293|101932002|FG000|STARTED|Double-blind (DB) Phase||177||
48651295|NCT00098293|101932003|FG001|STARTED|Double-blind (DB) Phase||368||
48651296|NCT00098293|101932004|FG002|STARTED|Double-blind (DB) Phase||372||
48651297|NCT00098293|101932005|FG003|STARTED|Double-blind (DB) Phase||0||
48651298|NCT00098293|101932006|FG004|STARTED|Double-blind (DB) Phase||0||
48651299|NCT00098293|101932002|FG000|Treated|Double-blind (DB) Phase||174||
48651300|NCT00098293|101932003|FG001|Treated|Double-blind (DB) Phase||360||
48651301|NCT00098293|101932004|FG002|Treated|Double-blind (DB) Phase||361||
48651302|NCT00098293|101932005|FG003|Treated|Double-blind (DB) Phase||0||
48651303|NCT00098293|101932006|FG004|Treated|Double-blind (DB) Phase||0||
48651304|NCT00098293|101932002|FG000|COMPLETED|Double-blind (DB) Phase||0||
48651305|NCT00098293|101932003|FG001|COMPLETED|Double-blind (DB) Phase||202||
48651306|NCT00098293|101932004|FG002|COMPLETED|Double-blind (DB) Phase||202||
48651307|NCT00098293|101932005|FG003|COMPLETED|Double-blind (DB) Phase||0||
48651308|NCT00098293|101932006|FG004|COMPLETED|Double-blind (DB) Phase||0||
48651309|NCT00098293|101932002|FG000|NOT COMPLETED|Double-blind (DB) Phase||177||
48651310|NCT00098293|101932003|FG001|NOT COMPLETED|Double-blind (DB) Phase||166||
48651311|NCT00098293|101932004|FG002|NOT COMPLETED|Double-blind (DB) Phase||170||
48651312|NCT00098293|101932005|FG003|NOT COMPLETED|Double-blind (DB) Phase||0||
48651313|NCT00098293|101932006|FG004|NOT COMPLETED|Double-blind (DB) Phase||0||
48651314|NCT00098293|101932002|FG000|STARTED|Between DB and OL Phase||0||
48651315|NCT00098293|101932003|FG001|STARTED|Between DB and OL Phase||202||
48651316|NCT00098293|101932004|FG002|STARTED|Between DB and OL Phase||202||
48651317|NCT00098293|101932005|FG003|STARTED|Between DB and OL Phase||0||
48651318|NCT00098293|101932006|FG004|STARTED|Between DB and OL Phase||0||
48651319|NCT00098293|101932002|FG000|COMPLETED|Between DB and OL Phase||0||
48651320|NCT00098293|101932003|FG001|COMPLETED|Between DB and OL Phase||202||
48651321|NCT00098293|101932004|FG002|COMPLETED|Between DB and OL Phase||199||
48651322|NCT00098293|101932005|FG003|COMPLETED|Between DB and OL Phase||0||
48651323|NCT00098293|101932006|FG004|COMPLETED|Between DB and OL Phase||0||
48651324|NCT00098293|101932002|FG000|NOT COMPLETED|Between DB and OL Phase||0||
48765464|NCT00999102|102214660|FG001|COMPLETED|4 Weeks at Lower Dose of First Drug||16||
48765465|NCT00999102|102214659|FG000|NOT COMPLETED|4 Weeks at Lower Dose of First Drug||1||
48765466|NCT00999102|102214660|FG001|NOT COMPLETED|4 Weeks at Lower Dose of First Drug||1||
48765467|NCT00999102|102214659|FG000|STARTED|4 Weeks at Higher Dose of First Drug||15||
48651325|NCT00098293|101932003|FG001|NOT COMPLETED|Between DB and OL Phase||0||
48651326|NCT00098293|101932004|FG002|NOT COMPLETED|Between DB and OL Phase||3||
48651327|NCT00098293|101932005|FG003|NOT COMPLETED|Between DB and OL Phase||0||
48651328|NCT00098293|101932006|FG004|NOT COMPLETED|Between DB and OL Phase||0||
48651329|NCT00098293|101932002|FG000|STARTED|Open-label (OL) Phase||0||
48651330|NCT00098293|101932003|FG001|STARTED|Open-label (OL) Phase||202||
48651331|NCT00098293|101932004|FG002|STARTED|Open-label (OL) Phase||199||
48765468|NCT00999102|102214660|FG001|STARTED|4 Weeks at Higher Dose of First Drug||16||
48765469|NCT00999102|102214659|FG000|COMPLETED|4 Weeks at Higher Dose of First Drug||15||
48765470|NCT00999102|102214660|FG001|COMPLETED|4 Weeks at Higher Dose of First Drug||16||
48765471|NCT00999102|102214659|FG000|NOT COMPLETED|4 Weeks at Higher Dose of First Drug||0||
48651332|NCT00098293|101932005|FG003|STARTED|Open-label (OL) Phase||130||
48651333|NCT00098293|101932006|FG004|STARTED|Open-label (OL) Phase||0||
48651334|NCT00098293|101932002|FG000|COMPLETED|Open-label (OL) Phase||0||
48651335|NCT00098293|101932003|FG001|COMPLETED|Open-label (OL) Phase||177||
48651336|NCT00098293|101932004|FG002|COMPLETED|Open-label (OL) Phase||158||
48651337|NCT00098293|101932005|FG003|COMPLETED|Open-label (OL) Phase||65||
48651338|NCT00098293|101932006|FG004|COMPLETED|Open-label (OL) Phase||0||
48651339|NCT00098293|101932002|FG000|NOT COMPLETED|Open-label (OL) Phase||0||
48651340|NCT00098293|101932003|FG001|NOT COMPLETED|Open-label (OL) Phase||25||
48651341|NCT00098293|101932004|FG002|NOT COMPLETED|Open-label (OL) Phase||41||
48651342|NCT00098293|101932005|FG003|NOT COMPLETED|Open-label (OL) Phase||65||
48651343|NCT00098293|101932006|FG004|NOT COMPLETED|Open-label (OL) Phase||0||
48651344|NCT00098293|101932002|FG000|STARTED|Supplemental Phase (SP)||0||
48651345|NCT00098293|101932003|FG001|STARTED|Supplemental Phase (SP)||0||
48651346|NCT00098293|101932004|FG002|STARTED|Supplemental Phase (SP)||0||
48651347|NCT00098293|101932005|FG003|STARTED|Supplemental Phase (SP)||0||
48651348|NCT00098293|101932006|FG004|STARTED|Supplemental Phase (SP)||127||
48651349|NCT00098293|101932002|FG000|COMPLETED|Supplemental Phase (SP)||0||
48651350|NCT00098293|101932003|FG001|COMPLETED|Supplemental Phase (SP)||0||
48651351|NCT00098293|101932004|FG002|COMPLETED|Supplemental Phase (SP)||0||
48651352|NCT00098293|101932005|FG003|COMPLETED|Supplemental Phase (SP)||0||
48651353|NCT00098293|101932006|FG004|COMPLETED|Supplemental Phase (SP)||94||
48651354|NCT00098293|101932002|FG000|NOT COMPLETED|Supplemental Phase (SP)||0||
48651355|NCT00098293|101932003|FG001|NOT COMPLETED|Supplemental Phase (SP)||0||
48651356|NCT00098293|101932004|FG002|NOT COMPLETED|Supplemental Phase (SP)||0||
48651357|NCT00098293|101932005|FG003|NOT COMPLETED|Supplemental Phase (SP)||0||
48651358|NCT00098293|101932006|FG004|NOT COMPLETED|Supplemental Phase (SP)||33||
48651359|NCT01712074|101932007|FG000|STARTED|Placebo Run-in Period||195||
48651360|NCT01712074|101932008|FG001|STARTED|Placebo Run-in Period||0||
48651361|NCT01712074|101932009|FG002|STARTED|Placebo Run-in Period||0||
48651362|NCT01712074|101932007|FG000|COMPLETED|Placebo Run-in Period||185||
48651363|NCT01712074|101932008|FG001|COMPLETED|Placebo Run-in Period||0||
48651364|NCT01712074|101932009|FG002|COMPLETED|Placebo Run-in Period||0||
48651365|NCT01712074|101932007|FG000|NOT COMPLETED|Placebo Run-in Period||10||
48651366|NCT01712074|101932008|FG001|NOT COMPLETED|Placebo Run-in Period||0||
48651367|NCT01712074|101932009|FG002|NOT COMPLETED|Placebo Run-in Period||0||
48651368|NCT01712074|101932007|FG000|STARTED|Double Blind Period||0||
48651369|NCT01712074|101932008|FG001|STARTED|Double Blind Period||91||
48651370|NCT01712074|101932009|FG002|STARTED|Double Blind Period||94||
48651371|NCT01712074|101932007|FG000|COMPLETED|Double Blind Period||0||
48651372|NCT01712074|101932008|FG001|COMPLETED|Double Blind Period||77||
48651373|NCT01712074|101932009|FG002|COMPLETED|Double Blind Period||86||
48651374|NCT01712074|101932007|FG000|NOT COMPLETED|Double Blind Period||0||
48651375|NCT01712074|101932008|FG001|NOT COMPLETED|Double Blind Period||14||
48651376|NCT01712074|101932009|FG002|NOT COMPLETED|Double Blind Period||8||
48651377|NCT04584554|101932010|FG000|STARTED|Overall Study||15||
48651378|NCT04584554|101932011|FG001|STARTED|Overall Study||16||
48362326|NCT00872898|101214508|FG000|COMPLETED|Part One - Open Label, Pharmacokinetics||0||
48362327|NCT00872898|101214509|FG001|COMPLETED|Part One - Open Label, Pharmacokinetics||4||
48362328|NCT00872898|101214508|FG000|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0||
48362329|NCT00872898|101214509|FG001|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0||
48651379|NCT04584554|101932010|FG000|COMPLETED|Overall Study||13||
48651380|NCT04584554|101932011|FG001|COMPLETED|Overall Study||14||
48651381|NCT04584554|101932010|FG000|NOT COMPLETED|Overall Study||2||
48651382|NCT04584554|101932011|FG001|NOT COMPLETED|Overall Study||2||
48651383|NCT02400736|101932012|FG000|STARTED|Overall Study||58||
48651384|NCT02400736|101932013|FG001|STARTED|Overall Study||61||
48651385|NCT02400736|101932012|FG000|COMPLETED|Overall Study||47||
48651386|NCT02400736|101932013|FG001|COMPLETED|Overall Study||53||
48651387|NCT02400736|101932012|FG000|NOT COMPLETED|Overall Study||11||
48651388|NCT02400736|101932013|FG001|NOT COMPLETED|Overall Study||8||
48651389|NCT01389284|101932014|FG000|STARTED|Overall Study||120||
48651390|NCT01389284|101932015|FG001|STARTED|Overall Study||120||
48651391|NCT01389284|101932016|FG002|STARTED|Overall Study||60||
48651392|NCT01389284|101932014|FG000|COMPLETED|Overall Study||120||
48651393|NCT01389284|101932015|FG001|COMPLETED|Overall Study||120||
48651394|NCT01389284|101932016|FG002|COMPLETED|Overall Study||60||
48651395|NCT01389284|101932014|FG000|NOT COMPLETED|Overall Study||0||
48651396|NCT01389284|101932015|FG001|NOT COMPLETED|Overall Study||0||
48651397|NCT01389284|101932016|FG002|NOT COMPLETED|Overall Study||0||
48651398|NCT00145327|101932017|FG000|STARTED|Overall Study||616||
48651399|NCT00145327|101932018|FG001|STARTED|Overall Study||617||
48651400|NCT00145327|101932019|FG002|STARTED|Overall Study||1223||
48651401|NCT00145327|101932017|FG000|COMPLETED|Overall Study||474||
48651402|NCT00145327|101932018|FG001|COMPLETED|Overall Study||493||
48651403|NCT00145327|101932019|FG002|COMPLETED|Overall Study||975||
48651404|NCT00145327|101932017|FG000|NOT COMPLETED|Overall Study||142||
48651405|NCT00145327|101932018|FG001|NOT COMPLETED|Overall Study||124||
48651406|NCT00145327|101932019|FG002|NOT COMPLETED|Overall Study||248||
48651407|NCT01740427|101932020|FG000|STARTED|Overall Study||444||
48362330|NCT00872898|101214508|FG000|STARTED|Part Two - Double Blind||61||
48651408|NCT01740427|101932021|FG001|STARTED|Overall Study||222||
48651409|NCT01740427|101932020|FG000|COMPLETED|Overall Study||0||
48651410|NCT01740427|101932021|FG001|COMPLETED|Overall Study||0||
48651411|NCT01740427|101932020|FG000|NOT COMPLETED|Overall Study||444||
48651412|NCT01740427|101932021|FG001|NOT COMPLETED|Overall Study||222||
48651413|NCT02551809|101932022|FG000|STARTED|Overall Study||14||
48651414|NCT02551809|101932023|FG001|STARTED|Overall Study||15||
48651415|NCT02551809|101932024|FG002|STARTED|Overall Study||14||
48651416|NCT02551809|101932022|FG000|COMPLETED|Overall Study||14||
48651417|NCT02551809|101932023|FG001|COMPLETED|Overall Study||14||
48651418|NCT02551809|101932024|FG002|COMPLETED|Overall Study||13||
48651419|NCT02551809|101932022|FG000|NOT COMPLETED|Overall Study||0||
48651420|NCT02551809|101932023|FG001|NOT COMPLETED|Overall Study||1||
48651421|NCT02551809|101932024|FG002|NOT COMPLETED|Overall Study||1||
48651422|NCT00176254|101932025|FG000|STARTED|Overall Study||40||
48651423|NCT00176254|101932025|FG000|COMPLETED|Overall Study||39||
48651424|NCT00176254|101932025|FG000|NOT COMPLETED|Overall Study||1||
48651425|NCT02151604|101932026|FG000|STARTED|Overall Study||22||
48651426|NCT02151604|101932026|FG000|COMPLETED|Overall Study||13||
48651427|NCT02151604|101932026|FG000|NOT COMPLETED|Overall Study||9||
48651428|NCT00063999|101932027|FG000|STARTED|Overall Study||692||
48651429|NCT00063999|101932028|FG001|STARTED|Overall Study||689||
48651430|NCT00063999|101932027|FG000|COMPLETED|Overall Study||647||
48651431|NCT00063999|101932028|FG001|COMPLETED|Overall Study||665||
48651432|NCT00063999|101932027|FG000|NOT COMPLETED|Overall Study||45||
48651433|NCT00063999|101932028|FG001|NOT COMPLETED|Overall Study||24||
48651434|NCT00986583|101932029|FG000|STARTED|Overall Study||38||
48651435|NCT00986583|101932030|FG001|STARTED|Overall Study||32||
48651436|NCT00986583|101932029|FG000|COMPLETED|Overall Study||38||
48651437|NCT00986583|101932030|FG001|COMPLETED|Overall Study||32||
48651438|NCT00986583|101932029|FG000|NOT COMPLETED|Overall Study||0||
48651439|NCT00986583|101932030|FG001|NOT COMPLETED|Overall Study||0||
48651440|NCT02978508|101932031|FG000|STARTED|Overall Study||70||
48651441|NCT02978508|101932032|FG001|STARTED|Overall Study||70||
48651442|NCT02978508|101932031|FG000|COMPLETED|Overall Study||70||
48651443|NCT02978508|101932032|FG001|COMPLETED|Overall Study||70||
48651444|NCT02978508|101932031|FG000|NOT COMPLETED|Overall Study||0||
48651445|NCT02978508|101932032|FG001|NOT COMPLETED|Overall Study||0||
48651446|NCT00553475|101932033|FG000|STARTED|Overall Study||135||
48651447|NCT00553475|101932034|FG001|STARTED|Overall Study||134||
48651448|NCT00553475|101932035|FG002|STARTED|Overall Study||45||
48651449|NCT00553475|101932033|FG000|COMPLETED|Overall Study||119||
48651450|NCT00553475|101932034|FG001|COMPLETED|Overall Study||114||
48651451|NCT00553475|101932035|FG002|COMPLETED|Overall Study||32||
48651452|NCT00553475|101932033|FG000|NOT COMPLETED|Overall Study||16||
48651453|NCT00553475|101932034|FG001|NOT COMPLETED|Overall Study||20||
48651454|NCT00553475|101932035|FG002|NOT COMPLETED|Overall Study||13||
48651455|NCT01502072|101932036|FG000|STARTED|Overall Study||14||
48651456|NCT01502072|101932037|FG001|STARTED|Overall Study||10||
48651457|NCT01502072|101932038|FG002|STARTED|Overall Study||20||
48651458|NCT01502072|101932036|FG000|COMPLETED|Overall Study||13||
48651459|NCT01502072|101932037|FG001|COMPLETED|Overall Study||9||
48651460|NCT01502072|101932038|FG002|COMPLETED|Overall Study||20||
48651461|NCT01502072|101932036|FG000|NOT COMPLETED|Overall Study||1||
48651462|NCT01502072|101932037|FG001|NOT COMPLETED|Overall Study||1||
48651463|NCT01502072|101932038|FG002|NOT COMPLETED|Overall Study||0||
48651464|NCT00602641|101932039|FG000|STARTED|Overall Study||154||
48651465|NCT00602641|101932040|FG001|STARTED|Overall Study||152||
48651466|NCT00602641|101932039|FG000|Started Protocol Therapy|Overall Study||148||
48651467|NCT00602641|101932040|FG001|Started Protocol Therapy|Overall Study||150||
48651468|NCT00602641|101932039|FG000|COMPLETED|Overall Study||0||
48765472|NCT00999102|102214660|FG001|NOT COMPLETED|4 Weeks at Higher Dose of First Drug||0||
48765473|NCT00999102|102214659|FG000|STARTED|4 Weeks at Lower Dose of Second Drug||15||
48765474|NCT00999102|102214660|FG001|STARTED|4 Weeks at Lower Dose of Second Drug||16||
48651469|NCT00602641|101932040|FG001|COMPLETED|Overall Study||0||
48651470|NCT00602641|101932039|FG000|NOT COMPLETED|Overall Study||154||
48651471|NCT00602641|101932040|FG001|NOT COMPLETED|Overall Study||152||
48651472|NCT02320825|101932041|FG000|STARTED|Overall Study||8||
48765475|NCT00999102|102214659|FG000|COMPLETED|4 Weeks at Lower Dose of Second Drug||15||
48765476|NCT00999102|102214660|FG001|COMPLETED|4 Weeks at Lower Dose of Second Drug||16||
48651473|NCT02320825|101932042|FG001|STARTED|Overall Study||8||
48651474|NCT02320825|101932041|FG000|COMPLETED|Overall Study||8||
48651475|NCT02320825|101932042|FG001|COMPLETED|Overall Study||8||
48651476|NCT02320825|101932041|FG000|NOT COMPLETED|Overall Study||0||
48651477|NCT02320825|101932042|FG001|NOT COMPLETED|Overall Study||0||
48651478|NCT00052715|101932043|FG000|STARTED|Overall Study||31||
48651479|NCT00052715|101932043|FG000|COMPLETED|Overall Study||30||
48651480|NCT00052715|101932043|FG000|NOT COMPLETED|Overall Study||1||
48651481|NCT01004393|101932044|FG000|STARTED|Overall Study||12||
48651482|NCT01004393|101932044|FG000|COMPLETED|Overall Study||12||
48651483|NCT01004393|101932044|FG000|NOT COMPLETED|Overall Study||0||
48651484|NCT04032327|101932045|FG000|STARTED|Overall Study||60||
48651485|NCT04032327|101932046|FG001|STARTED|Overall Study||60||
48651486|NCT04032327|101932045|FG000|COMPLETED|Overall Study||60||
48651487|NCT04032327|101932046|FG001|COMPLETED|Overall Study||60||
48651488|NCT04032327|101932045|FG000|NOT COMPLETED|Overall Study||0||
48651489|NCT04032327|101932046|FG001|NOT COMPLETED|Overall Study||0||
48651490|NCT04495478|101932047|FG000|STARTED|Overall Study||3||
48651491|NCT04495478|101932048|FG001|STARTED|Overall Study||7||
48651492|NCT04495478|101932049|FG002|STARTED|Overall Study||12||
48651493|NCT04495478|101932050|FG003|STARTED|Overall Study||7||
48651494|NCT04495478|101932051|FG004|STARTED|Overall Study||7||
48651495|NCT04495478|101932052|FG005|STARTED|Overall Study||7||
48651496|NCT04495478|101932053|FG006|STARTED|Overall Study||7||
48651497|NCT04495478|101932047|FG000|Received at Least One Dose of Study Drug|Overall Study||3||
48651498|NCT04495478|101932048|FG001|Received at Least One Dose of Study Drug|Overall Study||7||
48651499|NCT04495478|101932049|FG002|Received at Least One Dose of Study Drug|Overall Study||12||
48651500|NCT04495478|101932050|FG003|Received at Least One Dose of Study Drug|Overall Study||7||
48651501|NCT04495478|101932051|FG004|Received at Least One Dose of Study Drug|Overall Study||7||
48651502|NCT04495478|101932052|FG005|Received at Least One Dose of Study Drug|Overall Study||7||
48651503|NCT04495478|101932053|FG006|Received at Least One Dose of Study Drug|Overall Study||7||
48651504|NCT04495478|101932047|FG000|COMPLETED|Overall Study||3||
48651505|NCT04495478|101932048|FG001|COMPLETED|Overall Study||6||
48651506|NCT04495478|101932049|FG002|COMPLETED|Overall Study||12||
48651507|NCT04495478|101932050|FG003|COMPLETED|Overall Study||6||
48651508|NCT04495478|101932051|FG004|COMPLETED|Overall Study||6||
48651509|NCT04495478|101932052|FG005|COMPLETED|Overall Study||7||
48651510|NCT04495478|101932053|FG006|COMPLETED|Overall Study||7||
48651511|NCT04495478|101932047|FG000|NOT COMPLETED|Overall Study||0||
48765477|NCT00999102|102214659|FG000|NOT COMPLETED|4 Weeks at Lower Dose of Second Drug||0||
48765478|NCT00999102|102214660|FG001|NOT COMPLETED|4 Weeks at Lower Dose of Second Drug||0||
48765479|NCT00999102|102214659|FG000|STARTED|4 Weeks at Higher Dose of Second Drug||15||
48765480|NCT00999102|102214660|FG001|STARTED|4 Weeks at Higher Dose of Second Drug||16||
48765481|NCT00999102|102214659|FG000|COMPLETED|4 Weeks at Higher Dose of Second Drug||15||
48765482|NCT00999102|102214660|FG001|COMPLETED|4 Weeks at Higher Dose of Second Drug||16||
48765483|NCT00999102|102214659|FG000|NOT COMPLETED|4 Weeks at Higher Dose of Second Drug||0||
48765484|NCT00999102|102214660|FG001|NOT COMPLETED|4 Weeks at Higher Dose of Second Drug||0||
48765485|NCT04400643|102214661|FG000|STARTED|Overall Study||31||
48765486|NCT04400643|102214662|FG001|STARTED|Overall Study||31||
48765487|NCT04400643|102214661|FG000|COMPLETED|Overall Study||31||
48765488|NCT04400643|102214662|FG001|COMPLETED|Overall Study||31||
48765489|NCT04400643|102214661|FG000|NOT COMPLETED|Overall Study||0||
48765490|NCT04400643|102214662|FG001|NOT COMPLETED|Overall Study||0||
48765491|NCT00907335|102214663|FG000|STARTED|Overall Study||55||
48765492|NCT00907335|102214664|FG001|STARTED|Overall Study||55||
48765493|NCT00907335|102214663|FG000|COMPLETED|Overall Study||47||
48765494|NCT00907335|102214664|FG001|COMPLETED|Overall Study||54||
48765495|NCT00907335|102214663|FG000|NOT COMPLETED|Overall Study||8||
48765496|NCT00907335|102214664|FG001|NOT COMPLETED|Overall Study||1||
48651512|NCT04495478|101932048|FG001|NOT COMPLETED|Overall Study||1||
48651513|NCT04495478|101932049|FG002|NOT COMPLETED|Overall Study||0||
48651514|NCT04495478|101932050|FG003|NOT COMPLETED|Overall Study||1||
48765497|NCT03137381|102214665|FG000|STARTED|Overall Study||44||
48765498|NCT03137381|102214666|FG001|STARTED|Overall Study||30||
48765499|NCT03137381|102214667|FG002|STARTED|Overall Study||38||
48765500|NCT03137381|102214668|FG003|STARTED|Overall Study||37||
48765501|NCT03137381|102214665|FG000|Safety Population|Overall Study||44|Safety Population included all participants who received study drug during the treatment period. Participants were analyzed according to the actual treatment received during the study.|
48765502|NCT03137381|102214666|FG001|Safety Population|Overall Study||29|Safety Population included all participants who received study drug during the treatment period. Participants were analyzed according to the actual treatment received during the study.|
48765503|NCT03137381|102214667|FG002|Safety Population|Overall Study||38|Safety Population included all participants who received study drug during the treatment period. Participants were analyzed according to the actual treatment received during the study.|
48765504|NCT03137381|102214668|FG003|Safety Population|Overall Study||36|Safety Population included all participants who received study drug during the treatment period. Participants were analyzed according to the actual treatment received during the study.|
48765505|NCT03137381|102214665|FG000|COMPLETED|Overall Study||35||
48765506|NCT03137381|102214666|FG001|COMPLETED|Overall Study||23||
48765507|NCT03137381|102214667|FG002|COMPLETED|Overall Study||30||
48765508|NCT03137381|102214668|FG003|COMPLETED|Overall Study||36||
48765509|NCT03137381|102214665|FG000|NOT COMPLETED|Overall Study||9||
48651515|NCT04495478|101932051|FG004|NOT COMPLETED|Overall Study||1||
48651516|NCT04495478|101932052|FG005|NOT COMPLETED|Overall Study||0||
48651517|NCT04495478|101932053|FG006|NOT COMPLETED|Overall Study||0||
48651518|NCT04605588|101934833|FG000|STARTED|Overall Study||2||
48651519|NCT04605588|101934834|FG001|STARTED|Overall Study||5||
48651520|NCT04605588|101934833|FG000|COMPLETED|Overall Study||1||
48651521|NCT04605588|101934834|FG001|COMPLETED|Overall Study||5||
48651522|NCT04605588|101934833|FG000|NOT COMPLETED|Overall Study||1||
48651523|NCT04605588|101934834|FG001|NOT COMPLETED|Overall Study||0||
48651524|NCT00825175|101934835|FG000|STARTED|Overall Study||10||
48651525|NCT00825175|101934836|FG001|STARTED|Overall Study||12||
48651526|NCT00825175|101934835|FG000|COMPLETED|Overall Study||10||
48651527|NCT00825175|101934836|FG001|COMPLETED|Overall Study||7||
48651528|NCT00825175|101934835|FG000|NOT COMPLETED|Overall Study||0||
48651529|NCT00825175|101934836|FG001|NOT COMPLETED|Overall Study||5||
48651530|NCT02583477|101934837|FG000|STARTED|Overall Study||3||
48651531|NCT02583477|101934838|FG001|STARTED|Overall Study||20||
48651532|NCT02583477|101934837|FG000|Received Treatment|Overall Study||3||
48651533|NCT02583477|101934838|FG001|Received Treatment|Overall Study||20||
48651534|NCT02583477|101934837|FG000|Completed Treatment|Overall Study||0||
48651535|NCT02583477|101934838|FG001|Completed Treatment|Overall Study||0||
48651536|NCT02583477|101934837|FG000|COMPLETED|Overall Study||0|Completed study|
48651537|NCT02583477|101934838|FG001|COMPLETED|Overall Study||0|Completed study|
48651538|NCT02583477|101934837|FG000|NOT COMPLETED|Overall Study||3||
48651539|NCT02583477|101934838|FG001|NOT COMPLETED|Overall Study||20||
48651540|NCT01300065|101934839|FG000|STARTED|Overall Study||221||
48651541|NCT01300065|101934840|FG001|STARTED|Overall Study||220||
48651542|NCT01300065|101934839|FG000|COMPLETED|Overall Study||215||
48651543|NCT01300065|101934840|FG001|COMPLETED|Overall Study||217||
48651544|NCT01300065|101934839|FG000|NOT COMPLETED|Overall Study||6||
48651545|NCT01300065|101934840|FG001|NOT COMPLETED|Overall Study||3||
48651546|NCT01602666|101934841|FG000|STARTED|Induction Chemotherapy||107||
48651547|NCT01602666|101934842|FG001|STARTED|Induction Chemotherapy||137||
48651548|NCT01602666|101934841|FG000|COMPLETED|Induction Chemotherapy||70||
48651549|NCT01602666|101934842|FG001|COMPLETED|Induction Chemotherapy||113||
48651550|NCT01602666|101934841|FG000|NOT COMPLETED|Induction Chemotherapy||37||
48651551|NCT01602666|101934842|FG001|NOT COMPLETED|Induction Chemotherapy||24||
48651552|NCT01602666|101934841|FG000|STARTED|Radiation Therapy on Protocol||70||
48651553|NCT01602666|101934842|FG001|STARTED|Radiation Therapy on Protocol||113||
48651554|NCT01602666|101934841|FG000|Evaluable for Reduced Dose (30Gy)|Radiation Therapy on Protocol||66||
48651555|NCT01602666|101934842|FG001|Evaluable for Reduced Dose (30Gy)|Radiation Therapy on Protocol||0||
48651556|NCT01602666|101934841|FG000|Evaluable for Reduced Dose (18 Gy)|Radiation Therapy on Protocol||0||
48651557|NCT01602666|101934842|FG001|Evaluable for Reduced Dose (18 Gy)|Radiation Therapy on Protocol||74||
48651558|NCT01602666|101934841|FG000|Evaluable for RT Dose (24Gy)|Radiation Therapy on Protocol||0||
48651559|NCT01602666|101934842|FG001|Evaluable for RT Dose (24Gy)|Radiation Therapy on Protocol||16||
48651560|NCT01602666|101934841|FG000|COMPLETED|Radiation Therapy on Protocol||60||
48651561|NCT01602666|101934842|FG001|COMPLETED|Radiation Therapy on Protocol||82||
48651562|NCT01602666|101934841|FG000|NOT COMPLETED|Radiation Therapy on Protocol||10||
48651563|NCT01602666|101934842|FG001|NOT COMPLETED|Radiation Therapy on Protocol||31||
48651564|NCT02176525|101934843|FG000|STARTED|Overall Study||15||
48651565|NCT02176525|101934844|FG001|STARTED|Overall Study||9||
48651566|NCT02176525|101934845|FG002|STARTED|Overall Study||9||
48651567|NCT02176525|101934846|FG003|STARTED|Overall Study||9||
48651568|NCT02176525|101934847|FG004|STARTED|Overall Study||8||
48651569|NCT02176525|101934848|FG005|STARTED|Overall Study||6||
48651570|NCT02176525|101934849|FG006|STARTED|Overall Study||9||
48651571|NCT02176525|101934850|FG007|STARTED|Overall Study||10||
48651572|NCT02176525|101934843|FG000|COMPLETED|Overall Study||14||
48651573|NCT02176525|101934844|FG001|COMPLETED|Overall Study||9||
48651574|NCT02176525|101934845|FG002|COMPLETED|Overall Study||9||
48651575|NCT02176525|101934846|FG003|COMPLETED|Overall Study||8||
48651576|NCT02176525|101934847|FG004|COMPLETED|Overall Study||7||
48651577|NCT02176525|101934848|FG005|COMPLETED|Overall Study||5||
48651578|NCT02176525|101934849|FG006|COMPLETED|Overall Study||8||
48651579|NCT02176525|101934850|FG007|COMPLETED|Overall Study||10||
48651580|NCT02176525|101934843|FG000|NOT COMPLETED|Overall Study||1||
48651581|NCT02176525|101934844|FG001|NOT COMPLETED|Overall Study||0||
48651582|NCT02176525|101934845|FG002|NOT COMPLETED|Overall Study||0||
48651583|NCT02176525|101934846|FG003|NOT COMPLETED|Overall Study||1||
48651584|NCT02176525|101934847|FG004|NOT COMPLETED|Overall Study||1||
48651585|NCT02176525|101934848|FG005|NOT COMPLETED|Overall Study||1||
48651586|NCT02176525|101934849|FG006|NOT COMPLETED|Overall Study||1||
48651587|NCT02176525|101934850|FG007|NOT COMPLETED|Overall Study||0||
48651588|NCT01064284|101934851|FG000|STARTED|Overall Study||125||
48651589|NCT01064284|101934852|FG001|STARTED|Overall Study||126||
48651590|NCT01064284|101934851|FG000|COMPLETED|Overall Study||107||
48651591|NCT01064284|101934852|FG001|COMPLETED|Overall Study||109||
48651592|NCT01064284|101934851|FG000|NOT COMPLETED|Overall Study||18||
48651593|NCT01064284|101934852|FG001|NOT COMPLETED|Overall Study||17||
48651594|NCT02903381|101934853|FG000|STARTED|Overall Study||8||
48651595|NCT02903381|101934853|FG000|COMPLETED|Overall Study||8||
48651596|NCT02903381|101934853|FG000|NOT COMPLETED|Overall Study||0||
48651597|NCT01579305|101934854|FG000|STARTED|Overall Study||139||
48651598|NCT01579305|101934855|FG001|STARTED|Overall Study||142||
48651599|NCT01579305|101934854|FG000|Discontinued Before Treatment|Overall Study||0||
48765510|NCT03137381|102214666|FG001|NOT COMPLETED|Overall Study||7||
48651600|NCT01579305|101934855|FG001|Discontinued Before Treatment|Overall Study||1||
48651601|NCT01579305|101934854|FG000|Continued After Treatment|Overall Study||139||
48651602|NCT01579305|101934855|FG001|Continued After Treatment|Overall Study||141||
48651603|NCT01579305|101934854|FG000|COMPLETED|Overall Study||118||
48651604|NCT01579305|101934855|FG001|COMPLETED|Overall Study||115||
48651605|NCT01579305|101934854|FG000|NOT COMPLETED|Overall Study||21||
48651606|NCT01579305|101934855|FG001|NOT COMPLETED|Overall Study||27||
48651607|NCT02314247|101934856|FG000|STARTED|Overall Study||9||
48651608|NCT02314247|101934857|FG001|STARTED|Overall Study||6||
48651609|NCT02314247|101934858|FG002|STARTED|Overall Study||1||
48651610|NCT02314247|101934856|FG000|COMPLETED|Overall Study||0||
48651611|NCT02314247|101934857|FG001|COMPLETED|Overall Study||0||
48651612|NCT02314247|101934858|FG002|COMPLETED|Overall Study||0||
48651613|NCT02314247|101934856|FG000|NOT COMPLETED|Overall Study||9||
48651614|NCT02314247|101934857|FG001|NOT COMPLETED|Overall Study||6||
48651615|NCT02314247|101934858|FG002|NOT COMPLETED|Overall Study||1||
48651616|NCT00689052|101934859|FG000|STARTED|Overall Study||31||
48651617|NCT00689052|101934860|FG001|STARTED|Overall Study||30||
48651618|NCT00689052|101934859|FG000|COMPLETED|Overall Study||0||
48651619|NCT00689052|101934860|FG001|COMPLETED|Overall Study||0||
48651620|NCT00689052|101934859|FG000|NOT COMPLETED|Overall Study||31||
48651621|NCT00689052|101934860|FG001|NOT COMPLETED|Overall Study||30||
48651622|NCT03302936|101934861|FG000|STARTED|Overall Study||49||
48651623|NCT03302936|101934862|FG001|STARTED|Overall Study||49||
48651624|NCT03302936|101934861|FG000|COMPLETED|Overall Study||46||
48651625|NCT03302936|101934862|FG001|COMPLETED|Overall Study||45||
48651626|NCT03302936|101934861|FG000|NOT COMPLETED|Overall Study||3||
48651627|NCT03302936|101934862|FG001|NOT COMPLETED|Overall Study||4||
48651628|NCT00362609|101934863|FG000|STARTED|Overall Study||19||
48651629|NCT00362609|101934864|FG001|STARTED|Overall Study||40||
48651630|NCT00362609|101934863|FG000|COMPLETED|Overall Study||19||
48651631|NCT00362609|101934864|FG001|COMPLETED|Overall Study||38||
48651632|NCT00362609|101934863|FG000|NOT COMPLETED|Overall Study||0||
48651633|NCT00362609|101934864|FG001|NOT COMPLETED|Overall Study||2||
48651634|NCT02872142|101934865|FG000|STARTED|Overall Study||12||
48651635|NCT02872142|101934865|FG000|COMPLETED|Overall Study||6||
48651636|NCT02872142|101934865|FG000|NOT COMPLETED|Overall Study||6||
48651637|NCT02197104|101934866|FG000|STARTED|Overall Study||10||
48651638|NCT02197104|101934866|FG000|COMPLETED|Overall Study||9||
48651639|NCT02197104|101934866|FG000|NOT COMPLETED|Overall Study||1||
48651640|NCT00667589|101934867|FG000|STARTED|Overall Study||1||
48651641|NCT00667589|101934868|FG001|STARTED|Overall Study||0||
48651642|NCT00667589|101934869|FG002|STARTED|Overall Study||3||
48651643|NCT00667589|101934870|FG003|STARTED|Overall Study||2||
48651644|NCT00667589|101934867|FG000|COMPLETED|Overall Study||0||
48651645|NCT00667589|101934868|FG001|COMPLETED|Overall Study||0||
48651646|NCT00667589|101934869|FG002|COMPLETED|Overall Study||0||
48651647|NCT00667589|101934870|FG003|COMPLETED|Overall Study||1||
48651648|NCT00667589|101934867|FG000|NOT COMPLETED|Overall Study||1||
48651649|NCT00667589|101934868|FG001|NOT COMPLETED|Overall Study||0||
48651650|NCT00667589|101934869|FG002|NOT COMPLETED|Overall Study||3||
48651651|NCT00667589|101934870|FG003|NOT COMPLETED|Overall Study||1||
48651652|NCT01943825|101934871|FG000|STARTED|Overall Study||25||
48651653|NCT01943825|101934872|FG001|STARTED|Overall Study||15||
48651654|NCT01943825|101934873|FG002|STARTED|Overall Study||25||
48651655|NCT01943825|101934874|FG003|STARTED|Overall Study||25||
48651656|NCT01943825|101934871|FG000|COMPLETED|Overall Study||15||
48651657|NCT01943825|101934872|FG001|COMPLETED|Overall Study||11||
48651658|NCT01943825|101934873|FG002|COMPLETED|Overall Study||10||
48651659|NCT01943825|101934874|FG003|COMPLETED|Overall Study||14||
48651660|NCT01943825|101934871|FG000|NOT COMPLETED|Overall Study||10||
48651661|NCT01943825|101934872|FG001|NOT COMPLETED|Overall Study||4||
48651662|NCT01943825|101934873|FG002|NOT COMPLETED|Overall Study||15||
48651663|NCT01943825|101934874|FG003|NOT COMPLETED|Overall Study||11||
48651664|NCT01018056|101934875|FG000|STARTED|Overall Study||12||
48651665|NCT01018056|101934876|FG001|STARTED|Overall Study||12||
48651666|NCT01018056|101934877|FG002|STARTED|Overall Study||6||
48651667|NCT01018056|101934875|FG000|COMPLETED|Overall Study||9||
48651668|NCT01018056|101934876|FG001|COMPLETED|Overall Study||10||
48651669|NCT01018056|101934877|FG002|COMPLETED|Overall Study||5||
48651670|NCT01018056|101934875|FG000|NOT COMPLETED|Overall Study||3||
48651671|NCT01018056|101934876|FG001|NOT COMPLETED|Overall Study||2||
48651672|NCT01018056|101934877|FG002|NOT COMPLETED|Overall Study||1||
48651673|NCT01426555|101934878|FG000|STARTED|Overall Study||35||
48651674|NCT01426555|101934879|FG001|STARTED|Overall Study||35||
48651675|NCT01426555|101934878|FG000|COMPLETED|Overall Study||17||
48651676|NCT01426555|101934879|FG001|COMPLETED|Overall Study||20||
48651677|NCT01426555|101934878|FG000|NOT COMPLETED|Overall Study||18||
48651678|NCT01426555|101934879|FG001|NOT COMPLETED|Overall Study||15||
48651679|NCT05215847|101934880|FG000|STARTED|Overall Study||12||
48651680|NCT05215847|101934880|FG000|COMPLETED|Overall Study||11||
48651681|NCT05215847|101934880|FG000|NOT COMPLETED|Overall Study||1||
48651682|NCT00137280|101934881|FG000|STARTED|Overall Study||389||
48651683|NCT00137280|101934882|FG001|STARTED|Overall Study||412||
48651684|NCT00137280|101934881|FG000|COMPLETED|Overall Study||305||
48651685|NCT00137280|101934882|FG001|COMPLETED|Overall Study||357||
48651686|NCT00137280|101934881|FG000|NOT COMPLETED|Overall Study||84||
48651687|NCT00137280|101934882|FG001|NOT COMPLETED|Overall Study||55||
48651688|NCT03412890|101934883|FG000|STARTED|Overall Study||163||
48651689|NCT03412890|101934884|FG001|STARTED|Overall Study||150||
48651690|NCT03412890|101934885|FG002|STARTED|Overall Study||164||
48651691|NCT03412890|101934883|FG000|Received at Least 1 Dose of Study Drug|Overall Study||163||
48651692|NCT03412890|101934884|FG001|Received at Least 1 Dose of Study Drug|Overall Study||149||
48651693|NCT03412890|101934885|FG002|Received at Least 1 Dose of Study Drug|Overall Study||164||
48651694|NCT03412890|101934883|FG000|COMPLETED|Overall Study||133||
48651695|NCT03412890|101934884|FG001|COMPLETED|Overall Study||108||
48651696|NCT03412890|101934885|FG002|COMPLETED|Overall Study||122||
48651697|NCT03412890|101934883|FG000|NOT COMPLETED|Overall Study||30||
48651698|NCT03412890|101934884|FG001|NOT COMPLETED|Overall Study||42||
48651699|NCT03412890|101934885|FG002|NOT COMPLETED|Overall Study||42||
48651700|NCT01471574|101934886|FG000|STARTED|Treatment Period||132||
48651701|NCT01471574|101934887|FG001|STARTED|Treatment Period||39||
48651702|NCT01471574|101934888|FG002|STARTED|Treatment Period||106||
48651703|NCT01471574|101934889|FG003|STARTED|Treatment Period||24||
48651704|NCT01471574|101934886|FG000|COMPLETED|Treatment Period||101||
48651705|NCT01471574|101934887|FG001|COMPLETED|Treatment Period||29||
48651706|NCT01471574|101934888|FG002|COMPLETED|Treatment Period||82||
48651707|NCT01471574|101934889|FG003|COMPLETED|Treatment Period||21||
48651708|NCT01471574|101934886|FG000|NOT COMPLETED|Treatment Period||31||
48651709|NCT01471574|101934887|FG001|NOT COMPLETED|Treatment Period||10||
48651710|NCT01471574|101934888|FG002|NOT COMPLETED|Treatment Period||24||
48651711|NCT01471574|101934889|FG003|NOT COMPLETED|Treatment Period||3||
48651712|NCT01471574|101934886|FG000|STARTED|Follow-up Period||121||
48651713|NCT01471574|101934887|FG001|STARTED|Follow-up Period||34||
48651714|NCT01471574|101934888|FG002|STARTED|Follow-up Period||102||
48651715|NCT01471574|101934889|FG003|STARTED|Follow-up Period||24||
48651716|NCT01471574|101934886|FG000|COMPLETED|Follow-up Period||114||
48651717|NCT01471574|101934887|FG001|COMPLETED|Follow-up Period||32||
48651718|NCT01471574|101934888|FG002|COMPLETED|Follow-up Period||95||
48651719|NCT01471574|101934889|FG003|COMPLETED|Follow-up Period||21||
48651720|NCT01471574|101934886|FG000|NOT COMPLETED|Follow-up Period||7||
48651721|NCT01471574|101934887|FG001|NOT COMPLETED|Follow-up Period||2||
48651722|NCT01471574|101934888|FG002|NOT COMPLETED|Follow-up Period||7||
48651723|NCT01471574|101934889|FG003|NOT COMPLETED|Follow-up Period||3||
48651724|NCT01398475|101934890|FG000|STARTED|Overall Study||4||
48651725|NCT01398475|101934891|FG001|STARTED|Overall Study||3||
48651726|NCT01398475|101934892|FG002|STARTED|Overall Study||4||
48651727|NCT01398475|101934893|FG003|STARTED|Overall Study||4||
48651728|NCT01398475|101934890|FG000|Received First Intervention|Overall Study||4||
48651729|NCT01398475|101934891|FG001|Received First Intervention|Overall Study||3||
48651730|NCT01398475|101934892|FG002|Received First Intervention|Overall Study||4||
48651731|NCT01398475|101934893|FG003|Received First Intervention|Overall Study||4||
48651732|NCT01398475|101934890|FG000|Received Second Intervention|Overall Study||4||
48651733|NCT01398475|101934891|FG001|Received Second Intervention|Overall Study||3||
48651734|NCT01398475|101934892|FG002|Received Second Intervention|Overall Study||4||
48651735|NCT01398475|101934893|FG003|Received Second Intervention|Overall Study||4||
48651736|NCT01398475|101934890|FG000|Received Third Intervention|Overall Study||4||
48651737|NCT01398475|101934891|FG001|Received Third Intervention|Overall Study||3||
48651738|NCT01398475|101934892|FG002|Received Third Intervention|Overall Study||4||
48651739|NCT01398475|101934893|FG003|Received Third Intervention|Overall Study||4||
48765511|NCT03137381|102214667|FG002|NOT COMPLETED|Overall Study||8||
48765512|NCT03137381|102214668|FG003|NOT COMPLETED|Overall Study||1||
48765513|NCT00656513|102214669|FG000|STARTED|Overall Study||48||
48765514|NCT00656513|102214670|FG001|STARTED|Overall Study||73||
48765515|NCT00656513|102214671|FG002|STARTED|Overall Study||75||
48651740|NCT01398475|101934890|FG000|Received Fourth Intervention|Overall Study||4||
48651741|NCT01398475|101934891|FG001|Received Fourth Intervention|Overall Study||3||
48651742|NCT01398475|101934892|FG002|Received Fourth Intervention|Overall Study||4||
48651743|NCT01398475|101934893|FG003|Received Fourth Intervention|Overall Study||4||
48765516|NCT00656513|102214669|FG000|COMPLETED|Overall Study||44||
48765517|NCT00656513|102214670|FG001|COMPLETED|Overall Study||43||
48765518|NCT00656513|102214671|FG002|COMPLETED|Overall Study||53||
48765519|NCT00656513|102214669|FG000|NOT COMPLETED|Overall Study||4||
48765520|NCT00656513|102214670|FG001|NOT COMPLETED|Overall Study||30||
48765521|NCT00656513|102214671|FG002|NOT COMPLETED|Overall Study||22||
48651744|NCT01398475|101934890|FG000|COMPLETED|Overall Study||4||
48651745|NCT01398475|101934891|FG001|COMPLETED|Overall Study||3||
48651746|NCT01398475|101934892|FG002|COMPLETED|Overall Study||4||
48651747|NCT01398475|101934893|FG003|COMPLETED|Overall Study||4||
48651748|NCT01398475|101934890|FG000|NOT COMPLETED|Overall Study||0||
48651749|NCT01398475|101934891|FG001|NOT COMPLETED|Overall Study||0||
48651750|NCT01398475|101934892|FG002|NOT COMPLETED|Overall Study||0||
48765522|NCT03000608|102214672|FG000|STARTED|Overall Study||46||
48765523|NCT03000608|102214673|FG001|STARTED|Overall Study||23||
48651751|NCT01398475|101934893|FG003|NOT COMPLETED|Overall Study||0||
48651752|NCT03156621|101934894|FG000|STARTED|Double-Blind Treatment Period (DBTP)||24||
48651753|NCT03156621|101934895|FG001|STARTED|Double-Blind Treatment Period (DBTP)||45||
48651754|NCT03156621|101934894|FG000|COMPLETED|Double-Blind Treatment Period (DBTP)||24||
48651755|NCT03156621|101934895|FG001|COMPLETED|Double-Blind Treatment Period (DBTP)||45||
48651756|NCT03156621|101934894|FG000|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||0||
48651757|NCT03156621|101934895|FG001|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||0||
48651758|NCT03156621|101934894|FG000|STARTED|Open-Label Treatment Period (OLTP)||24||
48651759|NCT03156621|101934895|FG001|STARTED|Open-Label Treatment Period (OLTP)||45||
48651760|NCT03156621|101934894|FG000|COMPLETED|Open-Label Treatment Period (OLTP)||24||
48651761|NCT03156621|101934895|FG001|COMPLETED|Open-Label Treatment Period (OLTP)||42||
48651762|NCT03156621|101934894|FG000|NOT COMPLETED|Open-Label Treatment Period (OLTP)||0||
48651763|NCT03156621|101934895|FG001|NOT COMPLETED|Open-Label Treatment Period (OLTP)||3||
48651764|NCT00676689|101934896|FG000|STARTED|Overall Study||81||
48651765|NCT00676689|101934896|FG000|Procedure|Overall Study||79||
48651766|NCT00676689|101934896|FG000|30 Day Follow-up|Overall Study||78||
48651767|NCT00676689|101934896|FG000|1 Year Follow-up|Overall Study||64||
48651768|NCT00676689|101934896|FG000|COMPLETED|Overall Study||20||
48651769|NCT00676689|101934896|FG000|NOT COMPLETED|Overall Study||61||
48651770|NCT00609973|101934897|FG000|STARTED|Overall Study||17||
48651771|NCT00609973|101934898|FG001|STARTED|Overall Study||16||
48651772|NCT00609973|101934897|FG000|COMPLETED|Overall Study||9||
48651773|NCT00609973|101934898|FG001|COMPLETED|Overall Study||10||
48651774|NCT00609973|101934897|FG000|NOT COMPLETED|Overall Study||8||
48651775|NCT00609973|101934898|FG001|NOT COMPLETED|Overall Study||6||
48651776|NCT01052428|101934899|FG000|STARTED|Overall Study||19||
48651777|NCT01052428|101934900|FG001|STARTED|Overall Study||19||
48651778|NCT01052428|101934899|FG000|COMPLETED|Overall Study||18||
48651779|NCT01052428|101934900|FG001|COMPLETED|Overall Study||18||
48651780|NCT01052428|101934899|FG000|NOT COMPLETED|Overall Study||1||
48651781|NCT01052428|101934900|FG001|NOT COMPLETED|Overall Study||1||
48651782|NCT00983957|101934901|FG000|STARTED|Overall Study||20||
48651783|NCT00983957|101934901|FG000|Treatment A|Overall Study||20||
48651784|NCT00983957|101934901|FG000|Treatment B|Overall Study||20||
48651785|NCT00983957|101934901|FG000|Treatment C|Overall Study||18||
48651786|NCT00983957|101934901|FG000|COMPLETED|Overall Study||18||
48651787|NCT00983957|101934901|FG000|NOT COMPLETED|Overall Study||2||
48651788|NCT01720602|101934902|FG000|STARTED|Overall Study||15||
48651789|NCT01720602|101934902|FG000|COMPLETED|Overall Study||10||
48651790|NCT01720602|101934902|FG000|NOT COMPLETED|Overall Study||5||
48651791|NCT01167712|101934903|FG000|STARTED|Overall Study||346||
48651792|NCT01167712|101934904|FG001|STARTED|Overall Study||346||
48651793|NCT01167712|101934903|FG000|COMPLETED|Overall Study||346||
48651794|NCT01167712|101934904|FG001|COMPLETED|Overall Study||346||
48651795|NCT01167712|101934903|FG000|NOT COMPLETED|Overall Study||0||
48651796|NCT01167712|101934904|FG001|NOT COMPLETED|Overall Study||0||
48651797|NCT00106535|101934905|FG000|STARTED|2-year Placebo Controlled Period||394||
48651798|NCT00106535|101934906|FG001|STARTED|2-year Placebo Controlled Period||401||
48651799|NCT00106535|101934907|FG002|STARTED|2-year Placebo Controlled Period||401||
48651800|NCT00106535|101934908|FG003|STARTED|2-year Placebo Controlled Period||0||
48651801|NCT00106535|101934905|FG000|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||393||
48651802|NCT00106535|101934906|FG001|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||399||
48651803|NCT00106535|101934907|FG002|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||398||
48651804|NCT00106535|101934908|FG003|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||0||
48651805|NCT00106535|101934905|FG000|Safety: Actual Treatment Received|2-year Placebo Controlled Period||392||
48651806|NCT00106535|101934906|FG001|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399||
48651807|NCT00106535|101934907|FG002|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399||
48651808|NCT00106535|101934908|FG003|Safety: Actual Treatment Received|2-year Placebo Controlled Period||0||
48651809|NCT00106535|101934905|FG000|Completed Week 24|2-year Placebo Controlled Period||356||
48651810|NCT00106535|101934906|FG001|Completed Week 24|2-year Placebo Controlled Period||373||
48651811|NCT00106535|101934907|FG002|Completed Week 24|2-year Placebo Controlled Period||366||
48651812|NCT00106535|101934908|FG003|Completed Week 24|2-year Placebo Controlled Period||0||
48651813|NCT00106535|101934905|FG000|Completed Week 52|2-year Placebo Controlled Period||326||
48651814|NCT00106535|101934906|FG001|Completed Week 52|2-year Placebo Controlled Period||342||
48651815|NCT00106535|101934907|FG002|Completed Week 52|2-year Placebo Controlled Period||338||
48651816|NCT00106535|101934908|FG003|Completed Week 52|2-year Placebo Controlled Period||0||
48651817|NCT00106535|101934905|FG000|COMPLETED|2-year Placebo Controlled Period||287||
48651818|NCT00106535|101934906|FG001|COMPLETED|2-year Placebo Controlled Period||309||
48651819|NCT00106535|101934907|FG002|COMPLETED|2-year Placebo Controlled Period||310||
48651820|NCT00106535|101934908|FG003|COMPLETED|2-year Placebo Controlled Period||0||
48651821|NCT00106535|101934905|FG000|NOT COMPLETED|2-year Placebo Controlled Period||107||
48651822|NCT00106535|101934906|FG001|NOT COMPLETED|2-year Placebo Controlled Period||92||
48651823|NCT00106535|101934907|FG002|NOT COMPLETED|2-year Placebo Controlled Period||91||
48651824|NCT00106535|101934908|FG003|NOT COMPLETED|2-year Placebo Controlled Period||0||
48651825|NCT00106535|101934905|FG000|STARTED|Long-term Extension Period (Year 3 to 5)||0||
48651826|NCT00106535|101934906|FG001|STARTED|Long-term Extension Period (Year 3 to 5)||0||
48651827|NCT00106535|101934907|FG002|STARTED|Long-term Extension Period (Year 3 to 5)||0||
48651828|NCT00106535|101934908|FG003|STARTED|Long-term Extension Period (Year 3 to 5)||894||
48651829|NCT00106535|101934905|FG000|COMPLETED|Long-term Extension Period (Year 3 to 5)||0||
48651830|NCT00106535|101934906|FG001|COMPLETED|Long-term Extension Period (Year 3 to 5)||0||
48651831|NCT00106535|101934907|FG002|COMPLETED|Long-term Extension Period (Year 3 to 5)||0||
48651832|NCT00106535|101934908|FG003|COMPLETED|Long-term Extension Period (Year 3 to 5)||704||
48651833|NCT00106535|101934905|FG000|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0||
48651834|NCT00106535|101934906|FG001|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0||
48651835|NCT00106535|101934907|FG002|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0||
48651836|NCT00106535|101934908|FG003|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||190||
48651837|NCT02294019|101934909|FG000|STARTED|Overall Study||738||
48651838|NCT02294019|101934909|FG000|COMPLETED|Overall Study||635||
48651839|NCT02294019|101934909|FG000|NOT COMPLETED|Overall Study||103||
48651840|NCT00974233|101934910|FG000|STARTED|Induction Chemoimmunotherapy||34||
48651841|NCT00974233|101934910|FG000|COMPLETED|Induction Chemoimmunotherapy||19||
48651842|NCT00974233|101934910|FG000|NOT COMPLETED|Induction Chemoimmunotherapy||15||
48651843|NCT00974233|101934910|FG000|STARTED|Maintenance Lenalidomide||19||
48651844|NCT00974233|101934910|FG000|COMPLETED|Maintenance Lenalidomide||6||
48651845|NCT00974233|101934910|FG000|NOT COMPLETED|Maintenance Lenalidomide||13||
48651846|NCT02111980|101934911|FG000|STARTED|Overall Study||50||
48651847|NCT02111980|101934911|FG000|COMPLETED|Overall Study||50||
48651848|NCT02111980|101934911|FG000|NOT COMPLETED|Overall Study||0||
48651849|NCT01336972|101934912|FG000|STARTED|Overall Study||10||
48651850|NCT01336972|101934913|FG001|STARTED|Overall Study||10||
48651851|NCT01336972|101934914|FG002|STARTED|Overall Study||9||
48651852|NCT01336972|101934912|FG000|COMPLETED|Overall Study||9||
48651853|NCT01336972|101934913|FG001|COMPLETED|Overall Study||9||
48651854|NCT01336972|101934914|FG002|COMPLETED|Overall Study||9||
48651855|NCT01336972|101934912|FG000|NOT COMPLETED|Overall Study||1||
48651856|NCT01336972|101934913|FG001|NOT COMPLETED|Overall Study||1||
48651857|NCT01336972|101934914|FG002|NOT COMPLETED|Overall Study||0||
48651858|NCT00930176|101934915|FG000|STARTED|Overall Study||16||
48651859|NCT00930176|101934915|FG000|COMPLETED|Overall Study||15||
48651860|NCT00930176|101934915|FG000|NOT COMPLETED|Overall Study||1||
48651861|NCT01807104|101934916|FG000|STARTED|Overall Study||43||
48651862|NCT01807104|101934917|FG001|STARTED|Overall Study||44||
48651863|NCT01807104|101934916|FG000|COMPLETED|Overall Study||39||
48651864|NCT01807104|101934917|FG001|COMPLETED|Overall Study||40||
48651865|NCT01807104|101934916|FG000|NOT COMPLETED|Overall Study||4||
48651866|NCT01807104|101934917|FG001|NOT COMPLETED|Overall Study||4||
48651867|NCT03636269|101934918|FG000|STARTED|Period 1: Double-blind Phase||235||
48651868|NCT03636269|101934919|FG001|STARTED|Period 1: Double-blind Phase||236||
48651869|NCT03636269|101934920|FG002|STARTED|Period 1: Double-blind Phase||0||
48651870|NCT03636269|101934918|FG000|COMPLETED|Period 1: Double-blind Phase||206||
48651871|NCT03636269|101934919|FG001|COMPLETED|Period 1: Double-blind Phase||223||
48651872|NCT03636269|101934920|FG002|COMPLETED|Period 1: Double-blind Phase||0||
48651873|NCT03636269|101934918|FG000|NOT COMPLETED|Period 1: Double-blind Phase||29||
48651874|NCT03636269|101934919|FG001|NOT COMPLETED|Period 1: Double-blind Phase||13||
48651875|NCT03636269|101934920|FG002|NOT COMPLETED|Period 1: Double-blind Phase||0||
48651876|NCT03636269|101934918|FG000|STARTED|Period 2: Open-label Phase||0||
48651877|NCT03636269|101934919|FG001|STARTED|Period 2: Open-label Phase||0||
48651878|NCT03636269|101934920|FG002|STARTED|Period 2: Open-label Phase||399||
48651879|NCT03636269|101934918|FG000|COMPLETED|Period 2: Open-label Phase||0||
48651880|NCT03636269|101934919|FG001|COMPLETED|Period 2: Open-label Phase||0||
48651881|NCT03636269|101934920|FG002|COMPLETED|Period 2: Open-label Phase||5||
48651882|NCT03636269|101934918|FG000|NOT COMPLETED|Period 2: Open-label Phase||0||
48651883|NCT03636269|101934919|FG001|NOT COMPLETED|Period 2: Open-label Phase||0||
48651884|NCT03636269|101934920|FG002|NOT COMPLETED|Period 2: Open-label Phase||394||
48651885|NCT01852214|101934921|FG000|STARTED|Period 1||26||
48651886|NCT01852214|101934922|FG001|STARTED|Period 1||24||
48651887|NCT01852214|101934921|FG000|COMPLETED|Period 1||25||
48651888|NCT01852214|101934922|FG001|COMPLETED|Period 1||21||
48651889|NCT01852214|101934921|FG000|NOT COMPLETED|Period 1||1||
48651890|NCT01852214|101934922|FG001|NOT COMPLETED|Period 1||3||
48651891|NCT01852214|101934921|FG000|STARTED|Washout Period||25||
48651892|NCT01852214|101934922|FG001|STARTED|Washout Period||21||
48651893|NCT01852214|101934921|FG000|COMPLETED|Washout Period||25||
48651894|NCT01852214|101934922|FG001|COMPLETED|Washout Period||20||
48651895|NCT01852214|101934921|FG000|NOT COMPLETED|Washout Period||0||
48651896|NCT01852214|101934922|FG001|NOT COMPLETED|Washout Period||1||
48651897|NCT01852214|101934921|FG000|STARTED|Period 2||25||
48651898|NCT01852214|101934922|FG001|STARTED|Period 2||20||
48651899|NCT01852214|101934921|FG000|COMPLETED|Period 2||25||
48651900|NCT01852214|101934922|FG001|COMPLETED|Period 2||20||
48651901|NCT01852214|101934921|FG000|NOT COMPLETED|Period 2||0||
48651902|NCT01852214|101934922|FG001|NOT COMPLETED|Period 2||0||
48651903|NCT01148420|101934923|FG000|STARTED|Overall Study||48||
48651904|NCT01148420|101934923|FG000|COMPLETED|Overall Study||48||
48651905|NCT01148420|101934923|FG000|NOT COMPLETED|Overall Study||0||
48651906|NCT01905267|101934924|FG000|STARTED|Overall Study||17||
48651907|NCT01905267|101934925|FG001|STARTED|Overall Study||16||
48651908|NCT01905267|101934924|FG000|COMPLETED|Overall Study||15||
48651909|NCT01905267|101934925|FG001|COMPLETED|Overall Study||14||
48651910|NCT01905267|101934924|FG000|NOT COMPLETED|Overall Study||2||
48651911|NCT01905267|101934925|FG001|NOT COMPLETED|Overall Study||2||
48651912|NCT03093870|101934926|FG000|STARTED|Overall Study||24||
48651913|NCT03093870|101934927|FG001|STARTED|Overall Study||64||
48651914|NCT03093870|101934928|FG002|STARTED|Overall Study||63||
48651915|NCT03093870|101934926|FG000|COMPLETED|Overall Study||0||
48651916|NCT03093870|101934927|FG001|COMPLETED|Overall Study||23||
48651917|NCT03093870|101934928|FG002|COMPLETED|Overall Study||22||
48651918|NCT03093870|101934926|FG000|NOT COMPLETED|Overall Study||24||
48651919|NCT03093870|101934927|FG001|NOT COMPLETED|Overall Study||41||
48651920|NCT03093870|101934928|FG002|NOT COMPLETED|Overall Study||41||
48651921|NCT03808909|101934929|FG000|STARTED|Overall Study||12||
48651922|NCT03808909|101934930|FG001|STARTED|Overall Study||1||
48651923|NCT03808909|101934929|FG000|COMPLETED|Overall Study||9||
48651924|NCT03808909|101934930|FG001|COMPLETED|Overall Study||1||
48651925|NCT03808909|101934929|FG000|NOT COMPLETED|Overall Study||3||
48651926|NCT03808909|101934930|FG001|NOT COMPLETED|Overall Study||0||
48651927|NCT01362530|101934931|FG000|STARTED|Base Study (Cycle 1)||155||
48651928|NCT01362530|101934932|FG001|STARTED|Base Study (Cycle 1)||152||
48651929|NCT01362530|101934931|FG000|Received Study Treatment|Base Study (Cycle 1)||152||
48651930|NCT01362530|101934932|FG001|Received Study Treatment|Base Study (Cycle 1)||150||
48651931|NCT01362530|101934931|FG000|COMPLETED|Base Study (Cycle 1)||150||
48651932|NCT01362530|101934932|FG001|COMPLETED|Base Study (Cycle 1)||149||
48651933|NCT01362530|101934931|FG000|NOT COMPLETED|Base Study (Cycle 1)||5||
48651934|NCT01362530|101934932|FG001|NOT COMPLETED|Base Study (Cycle 1)||3||
48651935|NCT01362530|101934931|FG000|STARTED|Optional Extension (Cycles 2-6)||171||
48651936|NCT01362530|101934932|FG001|STARTED|Optional Extension (Cycles 2-6)||0||
48651937|NCT01362530|101934931|FG000|COMPLETED|Optional Extension (Cycles 2-6)||46||
48651938|NCT01362530|101934932|FG001|COMPLETED|Optional Extension (Cycles 2-6)||0||
48651939|NCT01362530|101934931|FG000|NOT COMPLETED|Optional Extension (Cycles 2-6)||125||
48651940|NCT01362530|101934932|FG001|NOT COMPLETED|Optional Extension (Cycles 2-6)||0||
48651941|NCT03733483|101934933|FG000|STARTED|Overall Study||12||
48651942|NCT03733483|101934933|FG000|COMPLETED|Overall Study||12||
48651943|NCT03733483|101934933|FG000|NOT COMPLETED|Overall Study||0||
48651944|NCT00625729|101934934|FG000|STARTED|Overall Study||6||
48651945|NCT00625729|101934934|FG000|COMPLETED|Overall Study||6||
48765524|NCT03000608|102214672|FG000|COMPLETED|Overall Study||40||
48765525|NCT03000608|102214673|FG001|COMPLETED|Overall Study||19||
48765526|NCT03000608|102214672|FG000|NOT COMPLETED|Overall Study||6||
48765527|NCT03000608|102214673|FG001|NOT COMPLETED|Overall Study||4||
48765528|NCT04885998|102214674|FG000|STARTED|Overall Study||7||
48765529|NCT04885998|102214675|FG001|STARTED|Overall Study||5||
48765530|NCT04885998|102214676|FG002|STARTED|Overall Study||4||
48765531|NCT04885998|102214677|FG003|STARTED|Overall Study||7||
48765532|NCT04885998|102214674|FG000|Safety Analysis Set|Overall Study||7||
48765533|NCT04885998|102214675|FG001|Safety Analysis Set|Overall Study||5||
48765534|NCT04885998|102214676|FG002|Safety Analysis Set|Overall Study||4||
48765535|NCT04885998|102214677|FG003|Safety Analysis Set|Overall Study||7||
48765536|NCT04885998|102214674|FG000|Entered Extended Safety Period (EP)|Overall Study||5||
48765537|NCT04885998|102214675|FG001|Entered Extended Safety Period (EP)|Overall Study||2||
48765538|NCT04885998|102214676|FG002|Entered Extended Safety Period (EP)|Overall Study||2||
48765539|NCT04885998|102214677|FG003|Entered Extended Safety Period (EP)|Overall Study||3||
48765540|NCT04885998|102214674|FG000|COMPLETED|Overall Study||1||
48765541|NCT04885998|102214675|FG001|COMPLETED|Overall Study||0||
48765542|NCT04885998|102214676|FG002|COMPLETED|Overall Study||0||
48765543|NCT04885998|102214677|FG003|COMPLETED|Overall Study||0||
48651946|NCT00625729|101934934|FG000|NOT COMPLETED|Overall Study||0||
48651947|NCT03511066|101934935|FG000|STARTED|Overall Study||88||
48651948|NCT03511066|101934936|FG001|STARTED|Overall Study||90||
48651949|NCT03511066|101934937|FG002|STARTED|Overall Study||50||
48651950|NCT03511066|101934935|FG000|COMPLETED|Overall Study||85||
48651951|NCT03511066|101934936|FG001|COMPLETED|Overall Study||85||
48765544|NCT04885998|102214674|FG000|NOT COMPLETED|Overall Study||6||
48765545|NCT04885998|102214675|FG001|NOT COMPLETED|Overall Study||5||
48765546|NCT04885998|102214676|FG002|NOT COMPLETED|Overall Study||4||
48765547|NCT04885998|102214677|FG003|NOT COMPLETED|Overall Study||7||
48765548|NCT03873116|102214678|FG000|STARTED|Part 1||3||
48765549|NCT03873116|102214679|FG001|STARTED|Part 1||3||
48651952|NCT03511066|101934937|FG002|COMPLETED|Overall Study||47||
48651953|NCT03511066|101934935|FG000|NOT COMPLETED|Overall Study||3||
48651954|NCT03511066|101934936|FG001|NOT COMPLETED|Overall Study||5||
48765550|NCT03873116|102214680|FG002|STARTED|Part 1||2||
48765551|NCT03873116|102214681|FG003|STARTED|Part 1||1||
48651955|NCT03511066|101934937|FG002|NOT COMPLETED|Overall Study||3||
48765552|NCT03873116|102214682|FG004|STARTED|Part 1||7||
48765553|NCT03873116|102214683|FG005|STARTED|Part 1||3||
48765554|NCT03873116|102214678|FG000|COMPLETED|Part 1||3||
48765555|NCT03873116|102214679|FG001|COMPLETED|Part 1||3||
48765556|NCT03873116|102214680|FG002|COMPLETED|Part 1||2||
48651956|NCT03473301|101934938|FG000|STARTED|Overall Study||31||
48651957|NCT03473301|101934939|FG001|STARTED|Overall Study||29||
48651958|NCT03473301|101934940|FG002|STARTED|Overall Study||31||
48651959|NCT03473301|101934938|FG000|COMPLETED|Overall Study||20||
48651960|NCT03473301|101934939|FG001|COMPLETED|Overall Study||23||
48651961|NCT03473301|101934940|FG002|COMPLETED|Overall Study||25||
48651962|NCT03473301|101934938|FG000|NOT COMPLETED|Overall Study||11||
48651963|NCT03473301|101934939|FG001|NOT COMPLETED|Overall Study||6||
48651964|NCT03473301|101934940|FG002|NOT COMPLETED|Overall Study||6||
48651965|NCT03892915|101934941|FG000|STARTED|Overall Study||191||4
48651966|NCT03892915|101934942|FG001|STARTED|Overall Study||200||4
48651967|NCT03892915|101934941|FG000|COMPLETED|Overall Study||171||4
48651968|NCT03892915|101934942|FG001|COMPLETED|Overall Study||167||4
48651969|NCT03892915|101934941|FG000|NOT COMPLETED|Overall Study||20||0
48651970|NCT03892915|101934942|FG001|NOT COMPLETED|Overall Study||33||0
48651971|NCT02614066|101934943|FG000|STARTED|Overall Study||6||
48651972|NCT02614066|101934944|FG001|STARTED|Overall Study||28||
48651973|NCT02614066|101934945|FG002|STARTED|Overall Study||20||
48651974|NCT02614066|101934946|FG003|STARTED|Overall Study||71||
48651975|NCT02614066|101934943|FG000|COMPLETED|Overall Study||0||
48651976|NCT02614066|101934944|FG001|COMPLETED|Overall Study||0||
48651977|NCT02614066|101934945|FG002|COMPLETED|Overall Study||0||
48651978|NCT02614066|101934946|FG003|COMPLETED|Overall Study||0||
48651979|NCT02614066|101934943|FG000|NOT COMPLETED|Overall Study||6||
48651980|NCT02614066|101934944|FG001|NOT COMPLETED|Overall Study||28||
48651981|NCT02614066|101934945|FG002|NOT COMPLETED|Overall Study||20||
48651982|NCT02614066|101934946|FG003|NOT COMPLETED|Overall Study||71||
48651983|NCT00985192|101934947|FG000|STARTED|Overall Study||49||
48651984|NCT00985192|101934947|FG000|COMPLETED|Overall Study||45||
48651985|NCT00985192|101934947|FG000|NOT COMPLETED|Overall Study||4||
48651986|NCT04076579|101934948|FG000|STARTED|Overall Study||16||
48651987|NCT04076579|101934949|FG001|STARTED|Overall Study||13||
48651988|NCT04076579|101934948|FG000|COMPLETED|Overall Study||12||
48651989|NCT04076579|101934949|FG001|COMPLETED|Overall Study||9||
48651990|NCT04076579|101934948|FG000|NOT COMPLETED|Overall Study||4||
48651991|NCT04076579|101934949|FG001|NOT COMPLETED|Overall Study||4||
48651992|NCT01793909|101934950|FG000|STARTED|Overall Study||30||
48651993|NCT01793909|101934951|FG001|STARTED|Overall Study||25||
48651994|NCT01793909|101934950|FG000|COMPLETED|Overall Study||20||
48651995|NCT01793909|101934951|FG001|COMPLETED|Overall Study||20||
48651996|NCT01793909|101934950|FG000|NOT COMPLETED|Overall Study||10||
48651997|NCT01793909|101934951|FG001|NOT COMPLETED|Overall Study||5||
48651998|NCT01530997|101934952|FG000|STARTED|Overall Study||45||
48651999|NCT01530997|101934952|FG000|COMPLETED|Overall Study||43||
48652000|NCT01530997|101934952|FG000|NOT COMPLETED|Overall Study||2||
48652001|NCT01189227|101934953|FG000|STARTED|Overall Study||6||
48652002|NCT01189227|101934954|FG001|STARTED|Overall Study||3||
48652003|NCT01189227|101934953|FG000|COMPLETED|Overall Study||0||
48652004|NCT01189227|101934954|FG001|COMPLETED|Overall Study||0||
48652005|NCT01189227|101934953|FG000|NOT COMPLETED|Overall Study||6||
48652006|NCT01189227|101934954|FG001|NOT COMPLETED|Overall Study||3||
48652007|NCT01260324|101934955|FG000|STARTED|Overall Study||1283||
48652008|NCT01260324|101934956|FG001|STARTED|Overall Study||20000||
48652009|NCT01260324|101934955|FG000|COMPLETED|Overall Study||1283||
48652010|NCT01260324|101934956|FG001|COMPLETED|Overall Study||20000||
48652011|NCT01260324|101934955|FG000|NOT COMPLETED|Overall Study||0||
48652012|NCT01260324|101934956|FG001|NOT COMPLETED|Overall Study||0||
48652013|NCT01990352|101934957|FG000|STARTED|Overall Study||24||
48652014|NCT01990352|101934957|FG000|COMPLETED|Overall Study||24||
48652015|NCT01990352|101934957|FG000|NOT COMPLETED|Overall Study||0||
48652016|NCT01266083|101934958|FG000|STARTED|Overall Study||22||
48652017|NCT01266083|101934958|FG000|Eligible for Additional Monthly Vaccinations After Initial 6 Vaccinations (Q2W)|Overall Study||13||
48652018|NCT01266083|101934958|FG000|COMPLETED|Overall Study||22||
48652019|NCT01266083|101934958|FG000|NOT COMPLETED|Overall Study||0||
48652020|NCT06074523|101934959|FG000|STARTED|Overall Study||75||
48652021|NCT06074523|101934959|FG000|COMPLETED|Overall Study||65||
48652022|NCT06074523|101934959|FG000|NOT COMPLETED|Overall Study||10||
48652023|NCT03784300|101934960|FG000|STARTED|Overall Study||6||
48652024|NCT03784300|101934961|FG001|STARTED|Overall Study||2||
48652025|NCT03784300|101934962|FG002|STARTED|Overall Study||6||
48652026|NCT03784300|101934963|FG003|STARTED|Overall Study||2||
48652027|NCT03784300|101934964|FG004|STARTED|Overall Study||6||
48652028|NCT03784300|101934965|FG005|STARTED|Overall Study||2||
48652029|NCT03784300|101934960|FG000|COMPLETED|Overall Study||6||
48652030|NCT03784300|101934961|FG001|COMPLETED|Overall Study||2||
48652031|NCT03784300|101934962|FG002|COMPLETED|Overall Study||6||
48652032|NCT03784300|101934963|FG003|COMPLETED|Overall Study||2||
48652033|NCT03784300|101934964|FG004|COMPLETED|Overall Study||6||
48652034|NCT03784300|101934965|FG005|COMPLETED|Overall Study||2||
48652035|NCT03784300|101934960|FG000|NOT COMPLETED|Overall Study||0||
48652036|NCT03784300|101934961|FG001|NOT COMPLETED|Overall Study||0||
48652037|NCT03784300|101934962|FG002|NOT COMPLETED|Overall Study||0||
48652038|NCT03784300|101934963|FG003|NOT COMPLETED|Overall Study||0||
48652039|NCT03784300|101934964|FG004|NOT COMPLETED|Overall Study||0||
48652040|NCT03784300|101934965|FG005|NOT COMPLETED|Overall Study||0||
48652041|NCT00944021|101934966|FG000|STARTED|Overall Study||15||
48652042|NCT00944021|101934967|FG001|STARTED|Overall Study||15||
48652043|NCT00944021|101934968|FG002|STARTED|Overall Study||15||
48652044|NCT00944021|101934969|FG003|STARTED|Overall Study||16||
48652045|NCT00944021|101934970|FG004|STARTED|Overall Study||8||
48652046|NCT00944021|101934966|FG000|COMPLETED|Overall Study||14||
48652047|NCT00944021|101934967|FG001|COMPLETED|Overall Study||15||
48652048|NCT00944021|101934968|FG002|COMPLETED|Overall Study||15||
48652049|NCT00944021|101934969|FG003|COMPLETED|Overall Study||16||
48652050|NCT00944021|101934970|FG004|COMPLETED|Overall Study||8||
48652051|NCT00944021|101934966|FG000|NOT COMPLETED|Overall Study||1||
48652052|NCT00944021|101934967|FG001|NOT COMPLETED|Overall Study||0||
48652053|NCT00944021|101934968|FG002|NOT COMPLETED|Overall Study||0||
48652054|NCT00944021|101934969|FG003|NOT COMPLETED|Overall Study||0||
48652055|NCT00944021|101934970|FG004|NOT COMPLETED|Overall Study||0||
48652056|NCT02802865|101934971|FG000|STARTED|Overall Study||35||
48652057|NCT02802865|101934972|FG001|STARTED|Overall Study||35||
48652058|NCT02802865|101934971|FG000|COMPLETED|Overall Study||34||
48652059|NCT02802865|101934972|FG001|COMPLETED|Overall Study||33||
48652060|NCT02802865|101934971|FG000|NOT COMPLETED|Overall Study||1||
48652061|NCT02802865|101934972|FG001|NOT COMPLETED|Overall Study||2||
48652062|NCT00414609|101934973|FG000|STARTED|Core Study||397||
48652063|NCT00414609|101934974|FG001|STARTED|Core Study||423||
48652064|NCT00414609|101934975|FG002|STARTED|Core Study||0||
48652065|NCT00414609|101934973|FG000|Received Study Drug|Core Study||397||
48652066|NCT00414609|101934974|FG001|Received Study Drug|Core Study||422||
48652067|NCT00414609|101934975|FG002|Received Study Drug|Core Study||0||
48652068|NCT00414609|101934973|FG000|Echocardiogram Evaluable Set|Core Study||330||
48652069|NCT00414609|101934974|FG001|Echocardiogram Evaluable Set|Core Study||343||
48652070|NCT00414609|101934975|FG002|Echocardiogram Evaluable Set|Core Study||0||
48652071|NCT00414609|101934973|FG000|COMPLETED|Core Study||363||
48652072|NCT00414609|101934974|FG001|COMPLETED|Core Study||378||
48652073|NCT00414609|101934975|FG002|COMPLETED|Core Study||0||
48652074|NCT00414609|101934973|FG000|NOT COMPLETED|Core Study||34||
48652075|NCT00414609|101934974|FG001|NOT COMPLETED|Core Study||45||
48652076|NCT00414609|101934975|FG002|NOT COMPLETED|Core Study||0||
48652077|NCT00414609|101934973|FG000|STARTED|Extension Study||0||
48652078|NCT00414609|101934974|FG001|STARTED|Extension Study||0||
48652079|NCT00414609|101934975|FG002|STARTED|Extension Study||422||
48652080|NCT00414609|101934973|FG000|Echocardiogram (ECHO) Analysis Set|Extension Study||0||
48652081|NCT00414609|101934974|FG001|Echocardiogram (ECHO) Analysis Set|Extension Study||0||
48652082|NCT00414609|101934975|FG002|Echocardiogram (ECHO) Analysis Set|Extension Study||400||
48652083|NCT00414609|101934973|FG000|COMPLETED|Extension Study||0||
48652084|NCT00414609|101934974|FG001|COMPLETED|Extension Study||0||
48652085|NCT00414609|101934975|FG002|COMPLETED|Extension Study||365||
48652086|NCT00414609|101934973|FG000|NOT COMPLETED|Extension Study||0||
48652087|NCT00414609|101934974|FG001|NOT COMPLETED|Extension Study||0||
48652088|NCT00414609|101934975|FG002|NOT COMPLETED|Extension Study||57||
48652089|NCT00276380|101934976|FG000|STARTED|Overall Study||102||
48652090|NCT00276380|101934977|FG001|STARTED|Overall Study||102||
48652091|NCT00276380|101934976|FG000|COMPLETED|Overall Study||88||
48652092|NCT00276380|101934977|FG001|COMPLETED|Overall Study||88||
48652093|NCT00276380|101934976|FG000|NOT COMPLETED|Overall Study||14||
48652094|NCT00276380|101934977|FG001|NOT COMPLETED|Overall Study||14||
48652095|NCT01716559|101934978|FG000|STARTED|Overall Study||160||
48652096|NCT01716559|101934978|FG000|COMPLETED|Overall Study||49||
48652097|NCT01716559|101934978|FG000|NOT COMPLETED|Overall Study||111||
48652098|NCT02639559|101934979|FG000|STARTED|Overall Study||25||
48652099|NCT02639559|101934980|FG001|STARTED|Overall Study||25||
48652100|NCT02639559|101934979|FG000|COMPLETED|Overall Study||24||
48652101|NCT02639559|101934980|FG001|COMPLETED|Overall Study||22||
48652102|NCT02639559|101934979|FG000|NOT COMPLETED|Overall Study||1||
48652103|NCT02639559|101934980|FG001|NOT COMPLETED|Overall Study||3||
48652104|NCT02048813|101934981|FG000|STARTED|Overall Study||354||
48652105|NCT02048813|101934982|FG001|STARTED|Overall Study||175||
48652106|NCT02048813|101934981|FG000|COMPLETED|Overall Study||0||
48652107|NCT02048813|101934982|FG001|COMPLETED|Overall Study||105||
48652108|NCT02048813|101934981|FG000|NOT COMPLETED|Overall Study||354||
48652109|NCT02048813|101934982|FG001|NOT COMPLETED|Overall Study||70||
48652110|NCT02739828|101934983|FG000|STARTED|Overall Study||24||
48652111|NCT02739828|101934983|FG000|COMPLETED|Overall Study||19||
48652112|NCT02739828|101934983|FG000|NOT COMPLETED|Overall Study||5||
48652113|NCT03142334|101934984|FG000|STARTED|Overall Study||496||
48652114|NCT03142334|101934985|FG001|STARTED|Overall Study||498||
48652115|NCT03142334|101934984|FG000|Treated|Overall Study||488||
48652116|NCT03142334|101934985|FG001|Treated|Overall Study||496||
48652117|NCT03142334|101934984|FG000|Continuing Study Treatment|Overall Study||0||
48652118|NCT03142334|101934985|FG001|Continuing Study Treatment|Overall Study||1||
48652119|NCT03142334|101934984|FG000|Completed Study Treatment|Overall Study||298||
48652120|NCT03142334|101934985|FG001|Completed Study Treatment|Overall Study||365||
48652121|NCT03142334|101934984|FG000|Discontinued Study Treatment|Overall Study||190||
48765557|NCT03873116|102214681|FG003|COMPLETED|Part 1||1||
48652122|NCT03142334|101934985|FG001|Discontinued Study Treatment|Overall Study||130||
48765558|NCT03873116|102214682|FG004|COMPLETED|Part 1||7||
48652123|NCT03142334|101934984|FG000|COMPLETED|Overall Study||0|Completed Trial|
48652124|NCT03142334|101934985|FG001|COMPLETED|Overall Study||0|Completed Trial|
48652125|NCT03142334|101934984|FG000|NOT COMPLETED|Overall Study||496||
48652126|NCT03142334|101934985|FG001|NOT COMPLETED|Overall Study||498||
48652127|NCT02261532|101934986|FG000|STARTED|Overall Study||15||
48652128|NCT02261532|101934986|FG000|COMPLETED|Overall Study||15||
48652129|NCT02261532|101934986|FG000|NOT COMPLETED|Overall Study||0||
48652130|NCT01282138|101934987|FG000|STARTED|EEC||6||
48652131|NCT01282138|101934988|FG001|STARTED|EEC||7||
48652132|NCT01282138|101934987|FG000|COMPLETED|EEC||6||
48652133|NCT01282138|101934988|FG001|COMPLETED|EEC||7||
48652134|NCT01282138|101934987|FG000|NOT COMPLETED|EEC||0||
48652135|NCT01282138|101934988|FG001|NOT COMPLETED|EEC||0||
48652136|NCT01282138|101934987|FG000|STARTED|CAPT||6||
48765559|NCT03873116|102214683|FG005|COMPLETED|Part 1||2||
48362331|NCT00872898|101214509|FG001|STARTED|Part Two - Double Blind||60||
48362332|NCT00872898|101214508|FG000|COMPLETED|Part Two - Double Blind||50||
48362333|NCT00872898|101214509|FG001|COMPLETED|Part Two - Double Blind||54||
48362334|NCT00872898|101214508|FG000|NOT COMPLETED|Part Two - Double Blind||11||
48362335|NCT00872898|101214509|FG001|NOT COMPLETED|Part Two - Double Blind||6||
48652137|NCT01282138|101934988|FG001|STARTED|CAPT||7||
48652138|NCT01282138|101934987|FG000|COMPLETED|CAPT||6||
48652139|NCT01282138|101934988|FG001|COMPLETED|CAPT||7||
48652140|NCT01282138|101934987|FG000|NOT COMPLETED|CAPT||0||
48652141|NCT01282138|101934988|FG001|NOT COMPLETED|CAPT||0||
48652142|NCT00433511|101934989|FG000|STARTED|Step 1||1000||
48652143|NCT00433511|101934990|FG001|STARTED|Step 1||1986||
48652144|NCT00433511|101934991|FG002|STARTED|Step 1||2008||
48652145|NCT00433511|101934989|FG000|Patients Who Received Treatment|Step 1||972||
48652146|NCT00433511|101934990|FG001|Patients Who Received Treatment|Step 1||1922||
48652147|NCT00433511|101934991|FG002|Patients Who Received Treatment|Step 1||1942||
48652148|NCT00433511|101934989|FG000|Patients in Genetic Ancestry Analysis|Step 1||575||
48652149|NCT00433511|101934990|FG001|Patients in Genetic Ancestry Analysis|Step 1||1126||
48652150|NCT00433511|101934991|FG002|Patients in Genetic Ancestry Analysis|Step 1||1158||
48652151|NCT00433511|101934989|FG000|COMPLETED|Step 1||864||
48652152|NCT00433511|101934990|FG001|COMPLETED|Step 1||1601||
48652153|NCT00433511|101934991|FG002|COMPLETED|Step 1||1618||
48652154|NCT00433511|101934989|FG000|NOT COMPLETED|Step 1||136||
48652155|NCT00433511|101934990|FG001|NOT COMPLETED|Step 1||385||
48652156|NCT00433511|101934991|FG002|NOT COMPLETED|Step 1||390||
48652157|NCT00433511|101934989|FG000|STARTED|Step 2 (Arm D)||0||
48652158|NCT00433511|101934990|FG001|STARTED|Step 2 (Arm D)||0||
48652159|NCT00433511|101934991|FG002|STARTED|Step 2 (Arm D)||1316||
48652160|NCT00433511|101934989|FG000|Patients Who Received Treatment|Step 2 (Arm D)||0||
48362336|NCT02167204|101214510|FG000|STARTED|Overall Study||9||
48362337|NCT02167204|101214510|FG000|COMPLETED|Overall Study||9||
48362338|NCT02167204|101214510|FG000|NOT COMPLETED|Overall Study||0||
48362339|NCT00970203|101214511|FG000|STARTED|Overall Study||7||
48652161|NCT00433511|101934990|FG001|Patients Who Received Treatment|Step 2 (Arm D)||0||
48652162|NCT00433511|101934991|FG002|Patients Who Received Treatment|Step 2 (Arm D)||1168||
48652163|NCT00433511|101934989|FG000|COMPLETED|Step 2 (Arm D)||0||
48652164|NCT00433511|101934990|FG001|COMPLETED|Step 2 (Arm D)||0||
48652165|NCT00433511|101934991|FG002|COMPLETED|Step 2 (Arm D)||825||
48652166|NCT00433511|101934989|FG000|NOT COMPLETED|Step 2 (Arm D)||0||
48652167|NCT00433511|101934990|FG001|NOT COMPLETED|Step 2 (Arm D)||0||
48652168|NCT00433511|101934991|FG002|NOT COMPLETED|Step 2 (Arm D)||491||
48652169|NCT03099863|101934992|FG000|STARTED|Overall Study||121||
48652170|NCT03099863|101934993|FG001|STARTED|Overall Study||121||
48652171|NCT03099863|101934992|FG000|COMPLETED|Overall Study||111||
48652172|NCT03099863|101934993|FG001|COMPLETED|Overall Study||105||
48652173|NCT03099863|101934992|FG000|NOT COMPLETED|Overall Study||10||
48652174|NCT03099863|101934993|FG001|NOT COMPLETED|Overall Study||16||
48652175|NCT02191397|101934994|FG000|STARTED|Overall Study||266||
48652176|NCT02191397|101934995|FG001|STARTED|Overall Study||268||
48652177|NCT02191397|101934994|FG000|COMPLETED|Overall Study||183||
48652178|NCT02191397|101934995|FG001|COMPLETED|Overall Study||198||
48652179|NCT02191397|101934994|FG000|NOT COMPLETED|Overall Study||83||
48652180|NCT02191397|101934995|FG001|NOT COMPLETED|Overall Study||70||
48652181|NCT02957123|101934996|FG000|STARTED|Overall Study||30||
48652182|NCT02957123|101934996|FG000|COMPLETED|Overall Study||30||
48652183|NCT02957123|101934996|FG000|NOT COMPLETED|Overall Study||0||
48652184|NCT01129284|101934997|FG000|STARTED|Overall Study||5||
48652185|NCT01129284|101934998|FG001|STARTED|Overall Study||5||
48652186|NCT01129284|101934999|FG002|STARTED|Overall Study||5||
48652187|NCT01129284|101934997|FG000|COMPLETED|Overall Study||3||
48652188|NCT01129284|101934998|FG001|COMPLETED|Overall Study||5||
48652189|NCT01129284|101934999|FG002|COMPLETED|Overall Study||4||
48652190|NCT01129284|101934997|FG000|NOT COMPLETED|Overall Study||2||
48652191|NCT01129284|101934998|FG001|NOT COMPLETED|Overall Study||0||
48652192|NCT01129284|101934999|FG002|NOT COMPLETED|Overall Study||1||
48652193|NCT04501445|101935000|FG000|STARTED|Overall Study||90||
48652194|NCT04501445|101935000|FG000|COMPLETED|Overall Study||90||
48652195|NCT04501445|101935000|FG000|NOT COMPLETED|Overall Study||0||
48652196|NCT02213107|101935001|FG000|STARTED|Overall Study||43||
48652197|NCT02213107|101935001|FG000|COMPLETED|Overall Study||43||
48652198|NCT02213107|101935001|FG000|NOT COMPLETED|Overall Study||0||
48652199|NCT02427672|101935002|FG000|STARTED|Overall Study||40||
48652200|NCT02427672|101935003|FG001|STARTED|Overall Study||44||
48652201|NCT02427672|101935002|FG000|COMPLETED|Overall Study||39||
48652202|NCT02427672|101935003|FG001|COMPLETED|Overall Study||42||
48652203|NCT02427672|101935002|FG000|NOT COMPLETED|Overall Study||1||
48652204|NCT02427672|101935003|FG001|NOT COMPLETED|Overall Study||2||
48652205|NCT00070499|101935004|FG000|STARTED|Overall Study||75||
48652206|NCT00070499|101935005|FG001|STARTED|Overall Study||78||
48652207|NCT00070499|101935006|FG002|STARTED|Overall Study||126||
48652208|NCT00070499|101935007|FG003|STARTED|Overall Study||127||
48652209|NCT00070499|101935004|FG000|Eligible|Overall Study||73||
48652210|NCT00070499|101935005|FG001|Eligible|Overall Study||73||
48652211|NCT00070499|101935006|FG002|Eligible|Overall Study||123||
48652212|NCT00070499|101935007|FG003|Eligible|Overall Study||125||
48652213|NCT00070499|101935004|FG000|Eligible and Treated|Overall Study||72||
48652214|NCT00070499|101935005|FG001|Eligible and Treated|Overall Study||73||
48652215|NCT00070499|101935006|FG002|Eligible and Treated|Overall Study||123||
48652216|NCT00070499|101935007|FG003|Eligible and Treated|Overall Study||123||
48652217|NCT00070499|101935004|FG000|COMPLETED|Overall Study||37||
48652218|NCT00070499|101935005|FG001|COMPLETED|Overall Study||52||
48652219|NCT00070499|101935006|FG002|COMPLETED|Overall Study||6||
48652220|NCT00070499|101935007|FG003|COMPLETED|Overall Study||17||
48652221|NCT00070499|101935004|FG000|NOT COMPLETED|Overall Study||38||
48652222|NCT00070499|101935005|FG001|NOT COMPLETED|Overall Study||26||
48652223|NCT00070499|101935006|FG002|NOT COMPLETED|Overall Study||120||
48652224|NCT00070499|101935007|FG003|NOT COMPLETED|Overall Study||110||
48652225|NCT01279187|101935008|FG000|STARTED|Overall Study||14||
48652226|NCT01279187|101935009|FG001|STARTED|Overall Study||13||
48652227|NCT01279187|101935008|FG000|COMPLETED|Overall Study||14||
48652228|NCT01279187|101935009|FG001|COMPLETED|Overall Study||13||
48652229|NCT01279187|101935008|FG000|NOT COMPLETED|Overall Study||0||
48652230|NCT01279187|101935009|FG001|NOT COMPLETED|Overall Study||0||
48652231|NCT02070380|101935010|FG000|STARTED|First Injection||31||
48652232|NCT02070380|101935011|FG001|STARTED|First Injection||39||
48652233|NCT02070380|101935012|FG002|STARTED|First Injection||53||
48652234|NCT02070380|101935013|FG003|STARTED|First Injection||54||
48652235|NCT02070380|101935010|FG000|COMPLETED|First Injection||31||
48652236|NCT02070380|101935011|FG001|COMPLETED|First Injection||39||
48652237|NCT02070380|101935012|FG002|COMPLETED|First Injection||53||
48652238|NCT02070380|101935013|FG003|COMPLETED|First Injection||54||
48652239|NCT02070380|101935010|FG000|NOT COMPLETED|First Injection||0||
48652240|NCT02070380|101935011|FG001|NOT COMPLETED|First Injection||0||
48652241|NCT02070380|101935012|FG002|NOT COMPLETED|First Injection||0||
48652242|NCT02070380|101935013|FG003|NOT COMPLETED|First Injection||0||
48652243|NCT02070380|101935010|FG000|STARTED|Washout (no Second Injection/MRI)||31||
48652244|NCT02070380|101935011|FG001|STARTED|Washout (no Second Injection/MRI)||39||
48652245|NCT02070380|101935012|FG002|STARTED|Washout (no Second Injection/MRI)||53||
48652246|NCT02070380|101935013|FG003|STARTED|Washout (no Second Injection/MRI)||54||
48652247|NCT02070380|101935010|FG000|COMPLETED|Washout (no Second Injection/MRI)||31||
48652248|NCT02070380|101935011|FG001|COMPLETED|Washout (no Second Injection/MRI)||34||
48652249|NCT02070380|101935012|FG002|COMPLETED|Washout (no Second Injection/MRI)||51||
48652250|NCT02070380|101935013|FG003|COMPLETED|Washout (no Second Injection/MRI)||51||
48652251|NCT02070380|101935010|FG000|NOT COMPLETED|Washout (no Second Injection/MRI)||0||
48652252|NCT02070380|101935011|FG001|NOT COMPLETED|Washout (no Second Injection/MRI)||5||
48652253|NCT02070380|101935012|FG002|NOT COMPLETED|Washout (no Second Injection/MRI)||2||
48652254|NCT02070380|101935013|FG003|NOT COMPLETED|Washout (no Second Injection/MRI)||3||
48652255|NCT02070380|101935010|FG000|STARTED|Second Injection||31||
48652256|NCT02070380|101935011|FG001|STARTED|Second Injection||34||
48652257|NCT02070380|101935012|FG002|STARTED|Second Injection||51||
48652258|NCT02070380|101935013|FG003|STARTED|Second Injection||51||
48652259|NCT02070380|101935010|FG000|COMPLETED|Second Injection||31||
48652260|NCT02070380|101935011|FG001|COMPLETED|Second Injection||32||
48652261|NCT02070380|101935012|FG002|COMPLETED|Second Injection||50||
48652262|NCT02070380|101935013|FG003|COMPLETED|Second Injection||46||
48652263|NCT02070380|101935010|FG000|NOT COMPLETED|Second Injection||0||
48652264|NCT02070380|101935011|FG001|NOT COMPLETED|Second Injection||2||
48652265|NCT02070380|101935012|FG002|NOT COMPLETED|Second Injection||1||
48652266|NCT02070380|101935013|FG003|NOT COMPLETED|Second Injection||5||
48652267|NCT02565186|101935014|FG000|STARTED|Overall Study||1046||
48652268|NCT02565186|101935015|FG001|STARTED|Overall Study||1125||
48652269|NCT02565186|101935014|FG000|Received at Least One Dose of Study Drug|Overall Study||991||
48652270|NCT02565186|101935015|FG001|Received at Least One Dose of Study Drug|Overall Study||1039||
48652271|NCT02565186|101935014|FG000|COMPLETED|Overall Study||466||
48652272|NCT02565186|101935015|FG001|COMPLETED|Overall Study||504||
48652273|NCT02565186|101935014|FG000|NOT COMPLETED|Overall Study||580||
48652274|NCT02565186|101935015|FG001|NOT COMPLETED|Overall Study||621||
48652275|NCT02540434|101935016|FG000|STARTED|Overall Study||1|Out of the total 19 subjects that underwent surgery (-3 WD before surgery), only 1 was randomized.|
48652276|NCT02540434|101935017|FG001|STARTED|Overall Study||1|Out of the total 19 subjects that underwent surgery (-3 WD before surgery), only 1 was randomized.|
48652277|NCT02540434|101935016|FG000|COMPLETED|Overall Study||1||
48652278|NCT02540434|101935017|FG001|COMPLETED|Overall Study||1||
48652279|NCT02540434|101935016|FG000|NOT COMPLETED|Overall Study||0||
48652280|NCT02540434|101935017|FG001|NOT COMPLETED|Overall Study||0||
48652281|NCT02539394|101935018|FG000|STARTED|Overall Study||64||
48652282|NCT02539394|101935019|FG001|STARTED|Overall Study||64||
48652283|NCT02539394|101935018|FG000|COMPLETED|Overall Study||56||
48652284|NCT02539394|101935019|FG001|COMPLETED|Overall Study||53||
48652285|NCT02539394|101935018|FG000|NOT COMPLETED|Overall Study||8||
48652286|NCT02539394|101935019|FG001|NOT COMPLETED|Overall Study||11||
48652287|NCT00576407|101935020|FG000|STARTED|Overall Study||26||
48652288|NCT00576407|101935020|FG000|COMPLETED|Overall Study||18||
48652289|NCT00576407|101935020|FG000|NOT COMPLETED|Overall Study||8||
48652290|NCT01694771|101935021|FG000|STARTED|Overall Study||567||
48652291|NCT01694771|101935022|FG001|STARTED|Overall Study||565||
48652292|NCT01694771|101935021|FG000|COMPLETED|Overall Study||527||
48652293|NCT01694771|101935022|FG001|COMPLETED|Overall Study||525||
48652294|NCT01694771|101935021|FG000|NOT COMPLETED|Overall Study||40||
48652295|NCT01694771|101935022|FG001|NOT COMPLETED|Overall Study||40||
48652296|NCT03952520|101935023|FG000|STARTED|HIV Test Site Directors and Staff||136|HIV Test Site Directors and Staff is a distinctly different group than the People Who Inject Drugs (PWID).|21
48652297|NCT03952520|101935024|FG001|STARTED|HIV Test Site Directors and Staff||141|HIV Test Site Directors and Staff is a distinctly different group than the People Who Inject Drugs (PWID).|21
48652298|NCT03952520|101935023|FG000|Completed 24-month Survey|HIV Test Site Directors and Staff||119||21
48652299|NCT03952520|101935024|FG001|Completed 24-month Survey|HIV Test Site Directors and Staff||123||21
48652300|NCT03952520|101935023|FG000|COMPLETED|HIV Test Site Directors and Staff||119||21
48652301|NCT03952520|101935024|FG001|COMPLETED|HIV Test Site Directors and Staff||123||21
48436400|NCT01982539|101403538|FG000|NOT COMPLETED|Overall Study||0||
48436401|NCT02526017|101403539|FG000|STARTED|Overall Study||3||
48436402|NCT02526017|101403540|FG001|STARTED|Overall Study||10||
48436403|NCT02526017|101403541|FG002|STARTED|Overall Study||11||
48652302|NCT03952520|101935023|FG000|NOT COMPLETED|HIV Test Site Directors and Staff||17||0
48652303|NCT03952520|101935024|FG001|NOT COMPLETED|HIV Test Site Directors and Staff||18||0
48652304|NCT03952520|101935023|FG000|STARTED|People Who Inject Drugs (PWID)||359||21
48652305|NCT03952520|101935024|FG001|STARTED|People Who Inject Drugs (PWID)||364||21
48652306|NCT03952520|101935023|FG000|Longitudinal Subsample Cohort|People Who Inject Drugs (PWID)||338||21
48652307|NCT03952520|101935024|FG001|Longitudinal Subsample Cohort|People Who Inject Drugs (PWID)||347||20
48652308|NCT03952520|101935023|FG000|Eligible for First Survey|People Who Inject Drugs (PWID)||321||21
48652309|NCT03952520|101935024|FG001|Eligible for First Survey|People Who Inject Drugs (PWID)||312||20
48652310|NCT03952520|101935023|FG000|Completed First Survey|People Who Inject Drugs (PWID)||249||20
48436404|NCT02526017|101403542|FG003|STARTED|Overall Study||4||
48436405|NCT02526017|101403543|FG004|STARTED|Overall Study||4||
48652311|NCT03952520|101935024|FG001|Completed First Survey|People Who Inject Drugs (PWID)||266||20
48652312|NCT03952520|101935023|FG000|COMPLETED|People Who Inject Drugs (PWID)||359||21
48652313|NCT03952520|101935024|FG001|COMPLETED|People Who Inject Drugs (PWID)||364||21
48652314|NCT03952520|101935023|FG000|NOT COMPLETED|People Who Inject Drugs (PWID)||0||0
48652315|NCT03952520|101935024|FG001|NOT COMPLETED|People Who Inject Drugs (PWID)||0||0
48652316|NCT04630626|101935025|FG000|STARTED|Overall Study||142||
48652317|NCT04630626|101935026|FG001|STARTED|Overall Study||106||
48652318|NCT04630626|101935025|FG000|COMPLETED|Overall Study||125||
48652319|NCT04630626|101935026|FG001|COMPLETED|Overall Study||65||
48652320|NCT04630626|101935025|FG000|NOT COMPLETED|Overall Study||17||
48652321|NCT04630626|101935026|FG001|NOT COMPLETED|Overall Study||41||
48652322|NCT01853085|101935027|FG000|STARTED|Overall Study||1830||
48652323|NCT01853085|101935027|FG000|COMPLETED|Overall Study||1595||
48652324|NCT01853085|101935027|FG000|NOT COMPLETED|Overall Study||235||
48652325|NCT02533674|101935028|FG000|STARTED|Dose Level I||5||
48652326|NCT02533674|101935029|FG001|STARTED|Dose Level I||0||
48652327|NCT02533674|101935030|FG002|STARTED|Dose Level I||0||
48652328|NCT02533674|101935031|FG003|STARTED|Dose Level I||0||
48652329|NCT02533674|101935032|FG004|STARTED|Dose Level I||0||
48652330|NCT02533674|101935033|FG005|STARTED|Dose Level I||0||
48652331|NCT02533674|101935034|FG006|STARTED|Dose Level I||0||
48652332|NCT02533674|101935035|FG007|STARTED|Dose Level I||0||
48652333|NCT02533674|101935028|FG000|COMPLETED|Dose Level I||0||
48652334|NCT02533674|101935029|FG001|COMPLETED|Dose Level I||0||
48652335|NCT02533674|101935030|FG002|COMPLETED|Dose Level I||0||
48652336|NCT02533674|101935031|FG003|COMPLETED|Dose Level I||0||
48652337|NCT02533674|101935032|FG004|COMPLETED|Dose Level I||0||
48652338|NCT02533674|101935033|FG005|COMPLETED|Dose Level I||0||
48652339|NCT02533674|101935034|FG006|COMPLETED|Dose Level I||0||
48436406|NCT02526017|101403544|FG005|STARTED|Overall Study||3||
48652340|NCT02533674|101935035|FG007|COMPLETED|Dose Level I||0||
48652341|NCT02533674|101935028|FG000|NOT COMPLETED|Dose Level I||5||
48652342|NCT02533674|101935029|FG001|NOT COMPLETED|Dose Level I||0||
48652343|NCT02533674|101935030|FG002|NOT COMPLETED|Dose Level I||0||
48652344|NCT02533674|101935031|FG003|NOT COMPLETED|Dose Level I||0||
48436407|NCT02526017|101403545|FG006|STARTED|Overall Study||6||
48436408|NCT02526017|101403546|FG007|STARTED|Overall Study||10||
48436409|NCT02526017|101403547|FG008|STARTED|Overall Study||262||
48652345|NCT02533674|101935032|FG004|NOT COMPLETED|Dose Level I||0||
48652346|NCT02533674|101935033|FG005|NOT COMPLETED|Dose Level I||0||
48652347|NCT02533674|101935034|FG006|NOT COMPLETED|Dose Level I||0||
48652348|NCT02533674|101935035|FG007|NOT COMPLETED|Dose Level I||0||
48652349|NCT02533674|101935028|FG000|STARTED|Dose Level II||0||
48652350|NCT02533674|101935029|FG001|STARTED|Dose Level II||7||
48652351|NCT02533674|101935030|FG002|STARTED|Dose Level II||0||
48652352|NCT02533674|101935031|FG003|STARTED|Dose Level II||0||
48652353|NCT02533674|101935032|FG004|STARTED|Dose Level II||0||
48652354|NCT02533674|101935033|FG005|STARTED|Dose Level II||0||
48652355|NCT02533674|101935034|FG006|STARTED|Dose Level II||0||
48652356|NCT02533674|101935035|FG007|STARTED|Dose Level II||0||
48652357|NCT02533674|101935028|FG000|COMPLETED|Dose Level II||0||
48652358|NCT02533674|101935029|FG001|COMPLETED|Dose Level II||0||
48652359|NCT02533674|101935030|FG002|COMPLETED|Dose Level II||0||
48652360|NCT02533674|101935031|FG003|COMPLETED|Dose Level II||0||
48652361|NCT02533674|101935032|FG004|COMPLETED|Dose Level II||0||
48652362|NCT02533674|101935033|FG005|COMPLETED|Dose Level II||0||
48652363|NCT02533674|101935034|FG006|COMPLETED|Dose Level II||0||
48652364|NCT02533674|101935035|FG007|COMPLETED|Dose Level II||0||
48652365|NCT02533674|101935028|FG000|NOT COMPLETED|Dose Level II||0||
48652366|NCT02533674|101935029|FG001|NOT COMPLETED|Dose Level II||7||
48652367|NCT02533674|101935030|FG002|NOT COMPLETED|Dose Level II||0||
48652368|NCT02533674|101935031|FG003|NOT COMPLETED|Dose Level II||0||
48652369|NCT02533674|101935032|FG004|NOT COMPLETED|Dose Level II||0||
48652370|NCT02533674|101935033|FG005|NOT COMPLETED|Dose Level II||0||
48652371|NCT02533674|101935034|FG006|NOT COMPLETED|Dose Level II||0||
48652372|NCT02533674|101935035|FG007|NOT COMPLETED|Dose Level II||0||
48652373|NCT02533674|101935028|FG000|STARTED|Dose Level III||0||
48652374|NCT02533674|101935029|FG001|STARTED|Dose Level III||0||
48652375|NCT02533674|101935030|FG002|STARTED|Dose Level III||4||
48652376|NCT02533674|101935031|FG003|STARTED|Dose Level III||0||
48652377|NCT02533674|101935032|FG004|STARTED|Dose Level III||0||
48652378|NCT02533674|101935033|FG005|STARTED|Dose Level III||0||
48652379|NCT02533674|101935034|FG006|STARTED|Dose Level III||0||
48652380|NCT02533674|101935035|FG007|STARTED|Dose Level III||0||
48652381|NCT02533674|101935028|FG000|COMPLETED|Dose Level III||0||
48652382|NCT02533674|101935029|FG001|COMPLETED|Dose Level III||0||
48652383|NCT02533674|101935030|FG002|COMPLETED|Dose Level III||0||
48652384|NCT02533674|101935031|FG003|COMPLETED|Dose Level III||0||
48652385|NCT02533674|101935032|FG004|COMPLETED|Dose Level III||0||
48652386|NCT02533674|101935033|FG005|COMPLETED|Dose Level III||0||
48652387|NCT02533674|101935034|FG006|COMPLETED|Dose Level III||0||
48652388|NCT02533674|101935035|FG007|COMPLETED|Dose Level III||0||
48652389|NCT02533674|101935028|FG000|NOT COMPLETED|Dose Level III||0||
48652390|NCT02533674|101935029|FG001|NOT COMPLETED|Dose Level III||0||
48652391|NCT02533674|101935030|FG002|NOT COMPLETED|Dose Level III||4||
48652392|NCT02533674|101935031|FG003|NOT COMPLETED|Dose Level III||0||
48652393|NCT02533674|101935032|FG004|NOT COMPLETED|Dose Level III||0||
48652394|NCT02533674|101935033|FG005|NOT COMPLETED|Dose Level III||0||
48652395|NCT02533674|101935034|FG006|NOT COMPLETED|Dose Level III||0||
48652396|NCT02533674|101935035|FG007|NOT COMPLETED|Dose Level III||0||
48652397|NCT02533674|101935028|FG000|STARTED|Dose Level IV||0||
48652398|NCT02533674|101935029|FG001|STARTED|Dose Level IV||0||
48652399|NCT02533674|101935030|FG002|STARTED|Dose Level IV||0||
48652400|NCT02533674|101935031|FG003|STARTED|Dose Level IV||5||
48652401|NCT02533674|101935032|FG004|STARTED|Dose Level IV||0||
48652402|NCT02533674|101935033|FG005|STARTED|Dose Level IV||0||
48652403|NCT02533674|101935034|FG006|STARTED|Dose Level IV||0||
48652404|NCT02533674|101935035|FG007|STARTED|Dose Level IV||0||
48652405|NCT02533674|101935028|FG000|COMPLETED|Dose Level IV||0||
48652406|NCT02533674|101935029|FG001|COMPLETED|Dose Level IV||0||
48652407|NCT02533674|101935030|FG002|COMPLETED|Dose Level IV||0||
48652408|NCT02533674|101935031|FG003|COMPLETED|Dose Level IV||0||
48652409|NCT02533674|101935032|FG004|COMPLETED|Dose Level IV||0||
48652410|NCT02533674|101935033|FG005|COMPLETED|Dose Level IV||0||
48652411|NCT02533674|101935034|FG006|COMPLETED|Dose Level IV||0||
48652412|NCT02533674|101935035|FG007|COMPLETED|Dose Level IV||0||
48652413|NCT02533674|101935028|FG000|NOT COMPLETED|Dose Level IV||0||
48652414|NCT02533674|101935029|FG001|NOT COMPLETED|Dose Level IV||0||
48652415|NCT02533674|101935030|FG002|NOT COMPLETED|Dose Level IV||0||
48652416|NCT02533674|101935031|FG003|NOT COMPLETED|Dose Level IV||5||
48652417|NCT02533674|101935032|FG004|NOT COMPLETED|Dose Level IV||0||
48652418|NCT02533674|101935033|FG005|NOT COMPLETED|Dose Level IV||0||
48652419|NCT02533674|101935034|FG006|NOT COMPLETED|Dose Level IV||0||
48652420|NCT02533674|101935035|FG007|NOT COMPLETED|Dose Level IV||0||
48652421|NCT02533674|101935028|FG000|STARTED|Dose Level V||0||
48652422|NCT02533674|101935029|FG001|STARTED|Dose Level V||0||
48652423|NCT02533674|101935030|FG002|STARTED|Dose Level V||0||
48652424|NCT02533674|101935031|FG003|STARTED|Dose Level V||0||
48652425|NCT02533674|101935032|FG004|STARTED|Dose Level V||5||
48652426|NCT02533674|101935033|FG005|STARTED|Dose Level V||0||
48652427|NCT02533674|101935034|FG006|STARTED|Dose Level V||0||
48652428|NCT02533674|101935035|FG007|STARTED|Dose Level V||0||
48652429|NCT02533674|101935028|FG000|COMPLETED|Dose Level V||0||
48652430|NCT02533674|101935029|FG001|COMPLETED|Dose Level V||0||
48652431|NCT02533674|101935030|FG002|COMPLETED|Dose Level V||0||
48652432|NCT02533674|101935031|FG003|COMPLETED|Dose Level V||0||
48652433|NCT02533674|101935032|FG004|COMPLETED|Dose Level V||0||
48652434|NCT02533674|101935033|FG005|COMPLETED|Dose Level V||0||
48652435|NCT02533674|101935034|FG006|COMPLETED|Dose Level V||0||
48652436|NCT02533674|101935035|FG007|COMPLETED|Dose Level V||0||
48652437|NCT02533674|101935028|FG000|NOT COMPLETED|Dose Level V||0||
48652438|NCT02533674|101935029|FG001|NOT COMPLETED|Dose Level V||0||
48652439|NCT02533674|101935030|FG002|NOT COMPLETED|Dose Level V||0||
48652440|NCT02533674|101935031|FG003|NOT COMPLETED|Dose Level V||0||
48652441|NCT02533674|101935032|FG004|NOT COMPLETED|Dose Level V||5||
48652442|NCT02533674|101935033|FG005|NOT COMPLETED|Dose Level V||0||
48652443|NCT02533674|101935034|FG006|NOT COMPLETED|Dose Level V||0||
48652444|NCT02533674|101935035|FG007|NOT COMPLETED|Dose Level V||0||
48652445|NCT02533674|101935028|FG000|STARTED|Dose Level VI||0||
48652446|NCT02533674|101935029|FG001|STARTED|Dose Level VI||0||
48652447|NCT02533674|101935030|FG002|STARTED|Dose Level VI||0||
48652448|NCT02533674|101935031|FG003|STARTED|Dose Level VI||0||
48652449|NCT02533674|101935032|FG004|STARTED|Dose Level VI||0||
48652450|NCT02533674|101935033|FG005|STARTED|Dose Level VI||9||
48652451|NCT02533674|101935034|FG006|STARTED|Dose Level VI||0||
48652452|NCT02533674|101935035|FG007|STARTED|Dose Level VI||0||
48652453|NCT02533674|101935028|FG000|COMPLETED|Dose Level VI||0||
48652454|NCT02533674|101935029|FG001|COMPLETED|Dose Level VI||0||
48652455|NCT02533674|101935030|FG002|COMPLETED|Dose Level VI||0||
48652456|NCT02533674|101935031|FG003|COMPLETED|Dose Level VI||0||
48652457|NCT02533674|101935032|FG004|COMPLETED|Dose Level VI||0||
48652458|NCT02533674|101935033|FG005|COMPLETED|Dose Level VI||0||
48652459|NCT02533674|101935034|FG006|COMPLETED|Dose Level VI||0||
48652460|NCT02533674|101935035|FG007|COMPLETED|Dose Level VI||0||
48652461|NCT02533674|101935028|FG000|NOT COMPLETED|Dose Level VI||0||
48652462|NCT02533674|101935029|FG001|NOT COMPLETED|Dose Level VI||0||
48652463|NCT02533674|101935030|FG002|NOT COMPLETED|Dose Level VI||0||
48652464|NCT02533674|101935031|FG003|NOT COMPLETED|Dose Level VI||0||
48652465|NCT02533674|101935032|FG004|NOT COMPLETED|Dose Level VI||0||
48652466|NCT02533674|101935033|FG005|NOT COMPLETED|Dose Level VI||9||
48652467|NCT02533674|101935034|FG006|NOT COMPLETED|Dose Level VI||0||
48652468|NCT02533674|101935035|FG007|NOT COMPLETED|Dose Level VI||0||
48652469|NCT02533674|101935028|FG000|STARTED|Dose Level VII||0||
48652470|NCT02533674|101935029|FG001|STARTED|Dose Level VII||0||
48652471|NCT02533674|101935030|FG002|STARTED|Dose Level VII||0||
48652472|NCT02533674|101935031|FG003|STARTED|Dose Level VII||0||
48652473|NCT02533674|101935032|FG004|STARTED|Dose Level VII||0||
48652474|NCT02533674|101935033|FG005|STARTED|Dose Level VII||0||
48652475|NCT02533674|101935034|FG006|STARTED|Dose Level VII||16||
48652476|NCT02533674|101935035|FG007|STARTED|Dose Level VII||0||
48652477|NCT02533674|101935028|FG000|COMPLETED|Dose Level VII||0||
48652478|NCT02533674|101935029|FG001|COMPLETED|Dose Level VII||0||
48652479|NCT02533674|101935030|FG002|COMPLETED|Dose Level VII||0||
48652480|NCT02533674|101935031|FG003|COMPLETED|Dose Level VII||0||
48652481|NCT02533674|101935032|FG004|COMPLETED|Dose Level VII||0||
48652482|NCT02533674|101935033|FG005|COMPLETED|Dose Level VII||0||
48652483|NCT02533674|101935034|FG006|COMPLETED|Dose Level VII||0||
48652484|NCT02533674|101935035|FG007|COMPLETED|Dose Level VII||0||
48652485|NCT02533674|101935028|FG000|NOT COMPLETED|Dose Level VII||0||
48652486|NCT02533674|101935029|FG001|NOT COMPLETED|Dose Level VII||0||
48652487|NCT02533674|101935030|FG002|NOT COMPLETED|Dose Level VII||0||
48652488|NCT02533674|101935031|FG003|NOT COMPLETED|Dose Level VII||0||
48652489|NCT02533674|101935032|FG004|NOT COMPLETED|Dose Level VII||0||
48652490|NCT02533674|101935033|FG005|NOT COMPLETED|Dose Level VII||0||
48652491|NCT02533674|101935034|FG006|NOT COMPLETED|Dose Level VII||16||
48652492|NCT02533674|101935035|FG007|NOT COMPLETED|Dose Level VII||0||
48652493|NCT02533674|101935028|FG000|STARTED|Dose Level VIII||0||
48652494|NCT02533674|101935029|FG001|STARTED|Dose Level VIII||0||
48652495|NCT02533674|101935030|FG002|STARTED|Dose Level VIII||0||
48652496|NCT02533674|101935031|FG003|STARTED|Dose Level VIII||0||
48652497|NCT02533674|101935032|FG004|STARTED|Dose Level VIII||0||
48652498|NCT02533674|101935033|FG005|STARTED|Dose Level VIII||0||
48652499|NCT02533674|101935034|FG006|STARTED|Dose Level VIII||0||
48652500|NCT02533674|101935035|FG007|STARTED|Dose Level VIII||6||
48652501|NCT02533674|101935028|FG000|COMPLETED|Dose Level VIII||0||
48652502|NCT02533674|101935029|FG001|COMPLETED|Dose Level VIII||0||
48652503|NCT02533674|101935030|FG002|COMPLETED|Dose Level VIII||0||
48652504|NCT02533674|101935031|FG003|COMPLETED|Dose Level VIII||0||
48652505|NCT02533674|101935032|FG004|COMPLETED|Dose Level VIII||0||
48652506|NCT02533674|101935033|FG005|COMPLETED|Dose Level VIII||0||
48652507|NCT02533674|101935034|FG006|COMPLETED|Dose Level VIII||0||
48652508|NCT02533674|101935035|FG007|COMPLETED|Dose Level VIII||0||
48652509|NCT02533674|101935028|FG000|NOT COMPLETED|Dose Level VIII||0||
48652510|NCT02533674|101935029|FG001|NOT COMPLETED|Dose Level VIII||0||
48652511|NCT02533674|101935030|FG002|NOT COMPLETED|Dose Level VIII||0||
48652512|NCT02533674|101935031|FG003|NOT COMPLETED|Dose Level VIII||0||
48652513|NCT02533674|101935032|FG004|NOT COMPLETED|Dose Level VIII||0||
48652514|NCT02533674|101935033|FG005|NOT COMPLETED|Dose Level VIII||0||
48652515|NCT02533674|101935034|FG006|NOT COMPLETED|Dose Level VIII||0||
48652516|NCT02533674|101935035|FG007|NOT COMPLETED|Dose Level VIII||6||
48652517|NCT02203786|101935036|FG000|STARTED|Overall Study||15||
48652518|NCT02203786|101935037|FG001|STARTED|Overall Study||15||
48652519|NCT02203786|101935038|FG002|STARTED|Overall Study||17||
48652520|NCT02203786|101935039|FG003|STARTED|Overall Study||15||
48652521|NCT02203786|101935036|FG000|COMPLETED|Overall Study||15||
48652522|NCT02203786|101935037|FG001|COMPLETED|Overall Study||15||
48652523|NCT02203786|101935038|FG002|COMPLETED|Overall Study||15||
48652524|NCT02203786|101935039|FG003|COMPLETED|Overall Study||15||
48652525|NCT02203786|101935036|FG000|NOT COMPLETED|Overall Study||0||
48652526|NCT02203786|101935037|FG001|NOT COMPLETED|Overall Study||0||
48652527|NCT02203786|101935038|FG002|NOT COMPLETED|Overall Study||2||
48652528|NCT02203786|101935039|FG003|NOT COMPLETED|Overall Study||0||
48652529|NCT04299425|101935040|FG000|STARTED|Overall Study||80||
48652530|NCT04299425|101935041|FG001|STARTED|Overall Study||80||
48652531|NCT04299425|101935040|FG000|COMPLETED|Overall Study||80||
48652532|NCT04299425|101935041|FG001|COMPLETED|Overall Study||80||
48652533|NCT04299425|101935040|FG000|NOT COMPLETED|Overall Study||0||
48652534|NCT04299425|101935041|FG001|NOT COMPLETED|Overall Study||0||
48652535|NCT00421733|101935042|FG000|STARTED|Overall Study||93||
48652536|NCT00421733|101935043|FG001|STARTED|Overall Study||95||
48652537|NCT00421733|101935044|FG002|STARTED|Overall Study||93||
48652538|NCT00421733|101935042|FG000|COMPLETED|Overall Study||78||
48652539|NCT00421733|101935043|FG001|COMPLETED|Overall Study||69||
48652540|NCT00421733|101935044|FG002|COMPLETED|Overall Study||73||
48652541|NCT00421733|101935042|FG000|NOT COMPLETED|Overall Study||15||
48652542|NCT00421733|101935043|FG001|NOT COMPLETED|Overall Study||26||
48652543|NCT00421733|101935044|FG002|NOT COMPLETED|Overall Study||20||
48652544|NCT04091438|101935045|FG000|STARTED|Treatment Period 1 (1 Day)||14||
48652545|NCT04091438|101935046|FG001|STARTED|Treatment Period 1 (1 Day)||14||
48652546|NCT04091438|101935045|FG000|Treated|Treatment Period 1 (1 Day)||13||
48652547|NCT04091438|101935046|FG001|Treated|Treatment Period 1 (1 Day)||14||
48652548|NCT04091438|101935045|FG000|COMPLETED|Treatment Period 1 (1 Day)||13||
48652549|NCT04091438|101935046|FG001|COMPLETED|Treatment Period 1 (1 Day)||14||
48652550|NCT04091438|101935045|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||1||
48652551|NCT04091438|101935046|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
48652552|NCT04091438|101935045|FG000|STARTED|Washout Period (1 Day)||13||
48652553|NCT04091438|101935046|FG001|STARTED|Washout Period (1 Day)||14||
48652554|NCT04091438|101935045|FG000|COMPLETED|Washout Period (1 Day)||13||
48652555|NCT04091438|101935046|FG001|COMPLETED|Washout Period (1 Day)||12||
48652556|NCT04091438|101935045|FG000|NOT COMPLETED|Washout Period (1 Day)||0||
48652557|NCT04091438|101935046|FG001|NOT COMPLETED|Washout Period (1 Day)||2||
48652558|NCT04091438|101935045|FG000|STARTED|Treatment Period 2 (1 Day)||13||
48652559|NCT04091438|101935046|FG001|STARTED|Treatment Period 2 (1 Day)||12||
48652560|NCT04091438|101935045|FG000|COMPLETED|Treatment Period 2 (1 Day)||13||
48652561|NCT04091438|101935046|FG001|COMPLETED|Treatment Period 2 (1 Day)||12||
48652562|NCT04091438|101935045|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
48652563|NCT04091438|101935046|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
48652564|NCT00964444|101935047|FG000|STARTED|Overall Study||10||
48652565|NCT00964444|101935047|FG000|COMPLETED|Overall Study||10||
48652566|NCT00964444|101935047|FG000|NOT COMPLETED|Overall Study||0||
48652567|NCT05156125|101935048|FG000|STARTED|Overall Study||70||
48652568|NCT05156125|101935049|FG001|STARTED|Overall Study||73||
48652569|NCT05156125|101935050|FG002|STARTED|Overall Study||70||
48652570|NCT05156125|101935048|FG000|Entered Long-Term Extension Following Induction|Overall Study||29||
48652571|NCT05156125|101935049|FG001|Entered Long-Term Extension Following Induction|Overall Study||34||
48652572|NCT05156125|101935050|FG002|Entered Long-Term Extension Following Induction|Overall Study||22||
48652573|NCT05156125|101935048|FG000|Entered Open-Label Extension Following Induction|Overall Study||37||
48652574|NCT05156125|101935049|FG001|Entered Open-Label Extension Following Induction|Overall Study||36||
48652575|NCT05156125|101935050|FG002|Entered Open-Label Extension Following Induction|Overall Study||42||
48652576|NCT05156125|101935048|FG000|Did Not Enter Long-Term or Open-Label Extension Following Induction|Overall Study||1||
48652577|NCT05156125|101935049|FG001|Did Not Enter Long-Term or Open-Label Extension Following Induction|Overall Study||0||
48652578|NCT05156125|101935050|FG002|Did Not Enter Long-Term or Open-Label Extension Following Induction|Overall Study||2||
48652579|NCT05156125|101935048|FG000|COMPLETED|Overall Study||67|Completed Induction Treatment Period; participants who completed this study period could have entered the Long-Term Extension or Open-Label Extension Periods|
48652580|NCT05156125|101935049|FG001|COMPLETED|Overall Study||70|Completed Induction Treatment Period; participants who completed this study period could have entered the Long-Term Extension or Open-Label Extension Periods|
48652581|NCT05156125|101935050|FG002|COMPLETED|Overall Study||66|Completed Induction Treatment Period; participants who completed this study period could have entered the Long-Term Extension or Open-Label Extension Periods|
48652582|NCT05156125|101935048|FG000|NOT COMPLETED|Overall Study||3||
48652583|NCT05156125|101935049|FG001|NOT COMPLETED|Overall Study||3||
48652584|NCT05156125|101935050|FG002|NOT COMPLETED|Overall Study||4||
48652585|NCT03438656|101935051|FG000|STARTED|Overall Study||32||
48652586|NCT03438656|101935051|FG000|COMPLETED|Overall Study||30||
48652587|NCT03438656|101935051|FG000|NOT COMPLETED|Overall Study||2||
48652588|NCT00401830|101935052|FG000|STARTED|Overall Study||81||
48652589|NCT00401830|101935053|FG001|STARTED|Overall Study||78||
48652590|NCT00401830|101935052|FG000|COMPLETED|Overall Study||50||
48652591|NCT00401830|101935053|FG001|COMPLETED|Overall Study||46||
48652592|NCT00401830|101935052|FG000|NOT COMPLETED|Overall Study||31||
48652593|NCT00401830|101935053|FG001|NOT COMPLETED|Overall Study||32||
48652594|NCT01034657|101935054|FG000|STARTED|Core Phase||34||
48652595|NCT01034657|101935055|FG001|STARTED|Core Phase||0||
48652596|NCT01034657|101935056|FG002|STARTED|Core Phase||0||
48652597|NCT01034657|101935054|FG000|COMPLETED|Core Phase||20||
48652598|NCT01034657|101935055|FG001|COMPLETED|Core Phase||0||
48652599|NCT01034657|101935056|FG002|COMPLETED|Core Phase||0||
48652600|NCT01034657|101935054|FG000|NOT COMPLETED|Core Phase||14||
48652601|NCT01034657|101935055|FG001|NOT COMPLETED|Core Phase||0||
48652602|NCT01034657|101935056|FG002|NOT COMPLETED|Core Phase||0||
48652603|NCT01034657|101935054|FG000|STARTED|Randomized Phase||6||
48652604|NCT01034657|101935055|FG001|STARTED|Randomized Phase||6||
48652605|NCT01034657|101935056|FG002|STARTED|Randomized Phase||1||
48652606|NCT01034657|101935054|FG000|COMPLETED|Randomized Phase||1||
48652607|NCT01034657|101935055|FG001|COMPLETED|Randomized Phase||0||
48652608|NCT01034657|101935056|FG002|COMPLETED|Randomized Phase||0||
48652609|NCT01034657|101935054|FG000|NOT COMPLETED|Randomized Phase||5||
48652610|NCT01034657|101935055|FG001|NOT COMPLETED|Randomized Phase||6||
48652611|NCT01034657|101935056|FG002|NOT COMPLETED|Randomized Phase||1||
48652612|NCT03225989|101935057|FG000|STARTED|Group 1: LOAd703 Dose Level 5x10e10VP||3||
48652613|NCT03225989|101935058|FG001|STARTED|Group 1: LOAd703 Dose Level 5x10e10VP||0||
48652614|NCT03225989|101935059|FG002|STARTED|Group 1: LOAd703 Dose Level 5x10e10VP||0||
48652615|NCT03225989|101935057|FG000|COMPLETED|Group 1: LOAd703 Dose Level 5x10e10VP||1||
48652616|NCT03225989|101935058|FG001|COMPLETED|Group 1: LOAd703 Dose Level 5x10e10VP||0||
48652617|NCT03225989|101935059|FG002|COMPLETED|Group 1: LOAd703 Dose Level 5x10e10VP||0||
48652618|NCT03225989|101935057|FG000|NOT COMPLETED|Group 1: LOAd703 Dose Level 5x10e10VP||2||
48652619|NCT03225989|101935058|FG001|NOT COMPLETED|Group 1: LOAd703 Dose Level 5x10e10VP||0||
48652620|NCT03225989|101935059|FG002|NOT COMPLETED|Group 1: LOAd703 Dose Level 5x10e10VP||0||
48652621|NCT03225989|101935057|FG000|STARTED|Group 2: LOAd703 Dose Level 1x10e11 VP||0||
48652622|NCT03225989|101935058|FG001|STARTED|Group 2: LOAd703 Dose Level 1x10e11 VP||12||
48652623|NCT03225989|101935059|FG002|STARTED|Group 2: LOAd703 Dose Level 1x10e11 VP||0||
48652624|NCT03225989|101935057|FG000|COMPLETED|Group 2: LOAd703 Dose Level 1x10e11 VP||0||
48652625|NCT03225989|101935058|FG001|COMPLETED|Group 2: LOAd703 Dose Level 1x10e11 VP||2||
48652626|NCT03225989|101935059|FG002|COMPLETED|Group 2: LOAd703 Dose Level 1x10e11 VP||0||
48652627|NCT03225989|101935057|FG000|NOT COMPLETED|Group 2: LOAd703 Dose Level 1x10e11 VP||0||
48652628|NCT03225989|101935058|FG001|NOT COMPLETED|Group 2: LOAd703 Dose Level 1x10e11 VP||10||
48652629|NCT03225989|101935059|FG002|NOT COMPLETED|Group 2: LOAd703 Dose Level 1x10e11 VP||0||
48652630|NCT03225989|101935057|FG000|STARTED|Group 3: LOAd703 Dose Level 5x10e11VP||0||
48652631|NCT03225989|101935058|FG001|STARTED|Group 3: LOAd703 Dose Level 5x10e11VP||0||
48652632|NCT03225989|101935059|FG002|STARTED|Group 3: LOAd703 Dose Level 5x10e11VP||27||
48652633|NCT03225989|101935057|FG000|COMPLETED|Group 3: LOAd703 Dose Level 5x10e11VP||0||
48652634|NCT03225989|101935058|FG001|COMPLETED|Group 3: LOAd703 Dose Level 5x10e11VP||0||
48652635|NCT03225989|101935059|FG002|COMPLETED|Group 3: LOAd703 Dose Level 5x10e11VP||1||
48652636|NCT03225989|101935057|FG000|NOT COMPLETED|Group 3: LOAd703 Dose Level 5x10e11VP||0||
48652637|NCT03225989|101935058|FG001|NOT COMPLETED|Group 3: LOAd703 Dose Level 5x10e11VP||0||
48652638|NCT03225989|101935059|FG002|NOT COMPLETED|Group 3: LOAd703 Dose Level 5x10e11VP||26||
48652639|NCT05569954|101935060|FG000|STARTED|Overall Study||741|All Randomized Participants|
48652640|NCT05569954|101935061|FG001|STARTED|Overall Study||743|All Randomized Participants|
48652641|NCT05569954|101935060|FG000|Vaccinated|Overall Study||739|All Participants as Treated (APaT)|
48652642|NCT05569954|101935061|FG001|Vaccinated|Overall Study||741|All Participants as Treated (APaT)|
48652643|NCT05569954|101935060|FG000|COMPLETED|Overall Study||733||
48652644|NCT05569954|101935061|FG001|COMPLETED|Overall Study||735||
48652645|NCT05569954|101935060|FG000|NOT COMPLETED|Overall Study||8||
48362340|NCT00970203|101214512|FG001|STARTED|Overall Study||6||
48362341|NCT00970203|101214511|FG000|COMPLETED|Overall Study||7||
48362342|NCT00970203|101214512|FG001|COMPLETED|Overall Study||6||
48652646|NCT05569954|101935061|FG001|NOT COMPLETED|Overall Study||8||
48652647|NCT00231465|101935062|FG000|STARTED|Overall Study||44||
48652648|NCT00231465|101935062|FG000|COMPLETED|Overall Study||42||
48652649|NCT00231465|101935062|FG000|NOT COMPLETED|Overall Study||2||
48652650|NCT01399099|101935063|FG000|STARTED|Overall Study||67||
48652651|NCT01399099|101935063|FG000|6 Months|Overall Study||47||
48652652|NCT01399099|101935063|FG000|COMPLETED|Overall Study||33||
48362343|NCT00970203|101214511|FG000|NOT COMPLETED|Overall Study||0||
48652653|NCT01399099|101935063|FG000|NOT COMPLETED|Overall Study||34||
48652654|NCT03928704|101935064|FG000|STARTED|Double-Blind Treatment Period:Week 1-16||126||
48652655|NCT03928704|101935065|FG001|STARTED|Double-Blind Treatment Period:Week 1-16||128||
48652656|NCT03928704|101935066|FG002|STARTED|Double-Blind Treatment Period:Week 1-16||0||
48657053|NCT03648372|101943772|FG015|STARTED|Overall Study||7||
48362344|NCT00970203|101214512|FG001|NOT COMPLETED|Overall Study||0||
48652657|NCT03928704|101935067|FG003|STARTED|Double-Blind Treatment Period:Week 1-16||11||
48652658|NCT03928704|101935068|FG004|STARTED|Double-Blind Treatment Period:Week 1-16||9||
48652659|NCT03928704|101935069|FG005|STARTED|Double-Blind Treatment Period:Week 1-16||0||
48652660|NCT03928704|101935064|FG000|Started Chinese Participants|Double-Blind Treatment Period:Week 1-16||7||
48652661|NCT03928704|101935065|FG001|Started Chinese Participants|Double-Blind Treatment Period:Week 1-16||9||
48652662|NCT03928704|101935066|FG002|Started Chinese Participants|Double-Blind Treatment Period:Week 1-16||0||
48652663|NCT03928704|101935067|FG003|Started Chinese Participants|Double-Blind Treatment Period:Week 1-16||11||
48362345|NCT00455858|101214513|FG000|STARTED|Overall Study||87||
48362346|NCT00455858|101214513|FG000|COMPLETED|Overall Study||81||
48362347|NCT00455858|101214513|FG000|NOT COMPLETED|Overall Study||6||
48362348|NCT00375934|101214514|FG000|STARTED|Overall Study||99||
48362349|NCT00375934|101214515|FG001|STARTED|Overall Study||101||
48652664|NCT03928704|101935068|FG004|Started Chinese Participants|Double-Blind Treatment Period:Week 1-16||9||
48652665|NCT03928704|101935069|FG005|Started Chinese Participants|Double-Blind Treatment Period:Week 1-16||0||
48652666|NCT03928704|101935064|FG000|COMPLETED|Double-Blind Treatment Period:Week 1-16||118||
48652667|NCT03928704|101935065|FG001|COMPLETED|Double-Blind Treatment Period:Week 1-16||126||
48652668|NCT03928704|101935066|FG002|COMPLETED|Double-Blind Treatment Period:Week 1-16||0||
48652669|NCT03928704|101935067|FG003|COMPLETED|Double-Blind Treatment Period:Week 1-16||11||
48652670|NCT03928704|101935068|FG004|COMPLETED|Double-Blind Treatment Period:Week 1-16||9||
48652671|NCT03928704|101935069|FG005|COMPLETED|Double-Blind Treatment Period:Week 1-16||0||
48652672|NCT03928704|101935064|FG000|NOT COMPLETED|Double-Blind Treatment Period:Week 1-16||8||
48652673|NCT03928704|101935065|FG001|NOT COMPLETED|Double-Blind Treatment Period:Week 1-16||2||
48652674|NCT03928704|101935066|FG002|NOT COMPLETED|Double-Blind Treatment Period:Week 1-16||0||
48652675|NCT03928704|101935067|FG003|NOT COMPLETED|Double-Blind Treatment Period:Week 1-16||0||
48652676|NCT03928704|101935068|FG004|NOT COMPLETED|Double-Blind Treatment Period:Week 1-16||0||
48652677|NCT03928704|101935069|FG005|NOT COMPLETED|Double-Blind Treatment Period:Week 1-16||0||
48652678|NCT03928704|101935064|FG000|STARTED|Maintenance Period: Week 16-52||0||
48652679|NCT03928704|101935065|FG001|STARTED|Maintenance Period: Week 16-52||0||
48652680|NCT03928704|101935066|FG002|STARTED|Maintenance Period: Week 16-52||242||
48362350|NCT00375934|101214514|FG000|COMPLETED|Overall Study||96||
48362351|NCT00375934|101214515|FG001|COMPLETED|Overall Study||95||
48652681|NCT03928704|101935067|FG003|STARTED|Maintenance Period: Week 16-52||0||
48652682|NCT03928704|101935068|FG004|STARTED|Maintenance Period: Week 16-52||0||
48652683|NCT03928704|101935069|FG005|STARTED|Maintenance Period: Week 16-52||20||
48652684|NCT03928704|101935064|FG000|COMPLETED|Maintenance Period: Week 16-52||0||
48652685|NCT03928704|101935065|FG001|COMPLETED|Maintenance Period: Week 16-52||0||
48652686|NCT03928704|101935066|FG002|COMPLETED|Maintenance Period: Week 16-52||220||
48652687|NCT03928704|101935067|FG003|COMPLETED|Maintenance Period: Week 16-52||0||
48652688|NCT03928704|101935068|FG004|COMPLETED|Maintenance Period: Week 16-52||0||
48652689|NCT03928704|101935069|FG005|COMPLETED|Maintenance Period: Week 16-52||17||
48436410|NCT02526017|101403539|FG000|Received Study Treatment|Overall Study||3||
48436411|NCT02526017|101403540|FG001|Received Study Treatment|Overall Study||10||
48436412|NCT02526017|101403541|FG002|Received Study Treatment|Overall Study||11||
48436413|NCT02526017|101403542|FG003|Received Study Treatment|Overall Study||4||
48436414|NCT02526017|101403543|FG004|Received Study Treatment|Overall Study||3||
48436415|NCT02526017|101403544|FG005|Received Study Treatment|Overall Study||3||
48436416|NCT02526017|101403545|FG006|Received Study Treatment|Overall Study||6||
48436417|NCT02526017|101403546|FG007|Received Study Treatment|Overall Study||10||
48436418|NCT02526017|101403547|FG008|Received Study Treatment|Overall Study||262||
48436419|NCT02526017|101403539|FG000|COMPLETED|Overall Study||3||
48436420|NCT02526017|101403540|FG001|COMPLETED|Overall Study||10||
48436421|NCT02526017|101403541|FG002|COMPLETED|Overall Study||11||
48436422|NCT02526017|101403542|FG003|COMPLETED|Overall Study||4||
48436423|NCT02526017|101403543|FG004|COMPLETED|Overall Study||3||
48436424|NCT02526017|101403544|FG005|COMPLETED|Overall Study||3||
48436425|NCT02526017|101403545|FG006|COMPLETED|Overall Study||6||
48436426|NCT02526017|101403546|FG007|COMPLETED|Overall Study||10||
48436427|NCT02526017|101403547|FG008|COMPLETED|Overall Study||262||
48436428|NCT02526017|101403539|FG000|NOT COMPLETED|Overall Study||0||
48436429|NCT02526017|101403540|FG001|NOT COMPLETED|Overall Study||0||
48652690|NCT03928704|101935064|FG000|NOT COMPLETED|Maintenance Period: Week 16-52||0||
48652691|NCT03928704|101935065|FG001|NOT COMPLETED|Maintenance Period: Week 16-52||0||
48652692|NCT03928704|101935066|FG002|NOT COMPLETED|Maintenance Period: Week 16-52||22||
48652693|NCT03928704|101935067|FG003|NOT COMPLETED|Maintenance Period: Week 16-52||0||
48362352|NCT00375934|101214514|FG000|NOT COMPLETED|Overall Study||3||
48362353|NCT00375934|101214515|FG001|NOT COMPLETED|Overall Study||6||
48362354|NCT04283461|101214516|FG000|STARTED|Overall Study||0||
48362355|NCT04283461|101214517|FG001|STARTED|Overall Study||15||
48436430|NCT02526017|101403541|FG002|NOT COMPLETED|Overall Study||0||
48362356|NCT04283461|101214518|FG002|STARTED|Overall Study||15||
48362357|NCT04283461|101214519|FG003|STARTED|Overall Study||15||
48436431|NCT02526017|101403542|FG003|NOT COMPLETED|Overall Study||0||
48436432|NCT02526017|101403543|FG004|NOT COMPLETED|Overall Study||1||
48436433|NCT02526017|101403544|FG005|NOT COMPLETED|Overall Study||0||
48436434|NCT02526017|101403545|FG006|NOT COMPLETED|Overall Study||0||
48652694|NCT03928704|101935068|FG004|NOT COMPLETED|Maintenance Period: Week 16-52||0||
48652695|NCT03928704|101935069|FG005|NOT COMPLETED|Maintenance Period: Week 16-52||3||
48652696|NCT04146909|101935070|FG000|STARTED|Overall Study||7||
48652697|NCT04146909|101935070|FG000|Screened, Consented and Qualified|Overall Study||6||
48652698|NCT04146909|101935070|FG000|Received Intervention|Overall Study||3||
48652699|NCT04146909|101935070|FG000|COMPLETED|Overall Study||3||
48652700|NCT04146909|101935070|FG000|NOT COMPLETED|Overall Study||4||
48652701|NCT03850431|101935071|FG000|STARTED|Overall Study||10929|Some patients had appointments in multiple arms of the study, so the sum of participants in each arm will not equal the number of unique participants in the trial.|50
48652702|NCT03850431|101935072|FG001|STARTED|Overall Study||13465|Some patients had appointments in multiple arms of the study, so the sum of participants in each arm will not equal the number of unique participants in the trial.|51
48652703|NCT03850431|101935073|FG002|STARTED|Overall Study||13525|Some patients had appointments in multiple arms of the study, so the sum of participants in each arm will not equal the number of unique participants in the trial.|50
48652704|NCT03850431|101935074|FG003|STARTED|Overall Study||9223|Some patients had appointments in multiple arms of the study, so the sum of participants in each arm will not equal the number of unique participants in the trial.|52
48652705|NCT03850431|101935075|FG004|STARTED|Overall Study||12556|Some patients had appointments in multiple arms of the study, so the sum of participants in each arm will not equal the number of unique participants in the trial.|51
48652706|NCT03850431|101935076|FG005|STARTED|Overall Study||3737|Some patients had appointments in multiple arms of the study, so the sum of participants in each arm will not equal the number of unique participants in the trial.|51
48652707|NCT03850431|101935077|FG006|STARTED|Overall Study||3996|Some patients had appointments in multiple arms of the study, so the sum of participants in each arm will not equal the number of unique participants in the trial.|44
48652708|NCT03850431|101935078|FG007|STARTED|Overall Study||4844|Some patients had appointments in multiple arms of the study, so the sum of participants in each arm will not equal the number of unique participants in the trial.|48
48652709|NCT03850431|101935079|FG008|STARTED|Overall Study||4760|Some patients had appointments in multiple arms of the study, so the sum of participants in each arm will not equal the number of unique participants in the trial.|46
48652710|NCT03850431|101935080|FG009|STARTED|Overall Study||3354|Some patients had appointments in multiple arms of the study, so the sum of participants in each arm will not equal the number of unique participants in the trial.|45
48652711|NCT03850431|101935071|FG000|COMPLETED|Overall Study||5584|Some patients had appointments in multiple arms of the study, so the sum of participants in each arm will not equal the number of unique participants in the trial.|47
48652712|NCT03850431|101935072|FG001|COMPLETED|Overall Study||7287|Some patients had appointments in multiple arms of the study, so the sum of participants in each arm will not equal the number of unique participants in the trial.|48
48652713|NCT03850431|101935073|FG002|COMPLETED|Overall Study||6196|Some patients had appointments in multiple arms of the study, so the sum of participants in each arm will not equal the number of unique participants in the trial.|43
48652714|NCT03850431|101935074|FG003|COMPLETED|Overall Study||5056|Some patients had appointments in multiple arms of the study, so the sum of participants in each arm will not equal the number of unique participants in the trial.|44
48652715|NCT03850431|101935075|FG004|COMPLETED|Overall Study||6543|Some patients had appointments in multiple arms of the study, so the sum of participants in each arm will not equal the number of unique participants in the trial.|49
48652716|NCT03850431|101935076|FG005|COMPLETED|Overall Study||2184|Some patients had appointments in multiple arms of the study, so the sum of participants in each arm will not equal the number of unique participants in the trial.|46
48652717|NCT03850431|101935077|FG006|COMPLETED|Overall Study||2167|Some patients had appointments in multiple arms of the study, so the sum of participants in each arm will not equal the number of unique participants in the trial.|39
48652718|NCT03850431|101935078|FG007|COMPLETED|Overall Study||2863|Some patients had appointments in multiple arms of the study, so the sum of participants in each arm will not equal the number of unique participants in the trial.|45
48652719|NCT03850431|101935079|FG008|COMPLETED|Overall Study||2860|Some patients had appointments in multiple arms of the study, so the sum of participants in each arm will not equal the number of unique participants in the trial.|43
48652720|NCT03850431|101935080|FG009|COMPLETED|Overall Study||2142|Some patients had appointments in multiple arms of the study, so the sum of participants in each arm will not equal the number of unique participants in the trial.|42
48652721|NCT03850431|101935071|FG000|NOT COMPLETED|Overall Study||5345||3
48652722|NCT03850431|101935072|FG001|NOT COMPLETED|Overall Study||6178||3
48652723|NCT03850431|101935073|FG002|NOT COMPLETED|Overall Study||7329||7
48652724|NCT03850431|101935074|FG003|NOT COMPLETED|Overall Study||4167||8
48652725|NCT03850431|101935075|FG004|NOT COMPLETED|Overall Study||6013||2
48652726|NCT03850431|101935076|FG005|NOT COMPLETED|Overall Study||1553||5
48652727|NCT03850431|101935077|FG006|NOT COMPLETED|Overall Study||1829||5
48652728|NCT03850431|101935078|FG007|NOT COMPLETED|Overall Study||1981||3
48652729|NCT03850431|101935079|FG008|NOT COMPLETED|Overall Study||1900||3
48652730|NCT03850431|101935080|FG009|NOT COMPLETED|Overall Study||1212||3
48652731|NCT01239745|101935081|FG000|STARTED|Overall Study||46||
48652732|NCT01239745|101935081|FG000|COMPLETED|Overall Study||0||
48652733|NCT01239745|101935081|FG000|NOT COMPLETED|Overall Study||46||
48652734|NCT02123511|101935082|FG000|STARTED|Overall Study||18||
48652735|NCT02123511|101935083|FG001|STARTED|Overall Study||16||
48652736|NCT02123511|101935082|FG000|Eligible Patients|Overall Study||17||
48652737|NCT02123511|101935083|FG001|Eligible Patients|Overall Study||15||
48652738|NCT02123511|101935082|FG000|COMPLETED|Overall Study||16|evaluable for Primary Endpoint (AUC for GRIX Sticky Saliva Total Score)|
48657054|NCT03648372|101943773|FG016|STARTED|Overall Study||3||
48652739|NCT02123511|101935083|FG001|COMPLETED|Overall Study||12|evaluable for Primary Endpoint (AUC for GRIX Sticky Saliva Total Score)|
48652740|NCT02123511|101935082|FG000|NOT COMPLETED|Overall Study||2||
48652741|NCT02123511|101935083|FG001|NOT COMPLETED|Overall Study||4||
48652742|NCT01061710|101935084|FG000|STARTED|Overall Study||20||
48652743|NCT01061710|101935084|FG000|COMPLETED|Overall Study||6||
48652744|NCT01061710|101935084|FG000|NOT COMPLETED|Overall Study||14||
48652745|NCT00507507|101935085|FG000|STARTED|Treatment Period||64||
48652746|NCT00507507|101935086|FG001|STARTED|Treatment Period||62||
48652747|NCT00507507|101935085|FG000|Completed 192 Weeks of Treatment|Treatment Period||52||
48652748|NCT00507507|101935086|FG001|Completed 192 Weeks of Treatment|Treatment Period||52||
48652749|NCT00507507|101935085|FG000|COMPLETED|Treatment Period||12||
48652750|NCT00507507|101935086|FG001|COMPLETED|Treatment Period||9||
48652751|NCT00507507|101935085|FG000|NOT COMPLETED|Treatment Period||52||
48652752|NCT00507507|101935086|FG001|NOT COMPLETED|Treatment Period||53||
48652753|NCT00507507|101935085|FG000|STARTED|24-week Treatment-free Follow-up Period||26||
48652754|NCT00507507|101935086|FG001|STARTED|24-week Treatment-free Follow-up Period||29||
48652755|NCT00507507|101935085|FG000|COMPLETED|24-week Treatment-free Follow-up Period||16||
48652756|NCT00507507|101935086|FG001|COMPLETED|24-week Treatment-free Follow-up Period||12||
48652757|NCT00507507|101935085|FG000|NOT COMPLETED|24-week Treatment-free Follow-up Period||10||
48652758|NCT00507507|101935086|FG001|NOT COMPLETED|24-week Treatment-free Follow-up Period||17||
48652759|NCT00562861|101935087|FG000|STARTED|Overall Study||60||
48652760|NCT00562861|101935088|FG001|STARTED|Overall Study||59||
48652761|NCT00562861|101935087|FG000|COMPLETED|Overall Study||40||
48652762|NCT00562861|101935088|FG001|COMPLETED|Overall Study||48||
48652763|NCT00562861|101935087|FG000|NOT COMPLETED|Overall Study||20||
48652764|NCT00562861|101935088|FG001|NOT COMPLETED|Overall Study||11||
48652765|NCT02959892|101935089|FG000|STARTED|Overall Study||6||
48652766|NCT02959892|101935090|FG001|STARTED|Overall Study||6||
48652767|NCT02959892|101935089|FG000|COMPLETED|Overall Study||5||
48652768|NCT02959892|101935090|FG001|COMPLETED|Overall Study||5||
48652769|NCT02959892|101935089|FG000|NOT COMPLETED|Overall Study||1||
48652770|NCT02959892|101935090|FG001|NOT COMPLETED|Overall Study||1||
48652771|NCT02562040|101935091|FG000|STARTED|Overall Study||228||
48652772|NCT02562040|101935092|FG001|STARTED|Overall Study||231||
48652773|NCT02562040|101935091|FG000|6-month Visit|Overall Study||189||
48652774|NCT02562040|101935092|FG001|6-month Visit|Overall Study||188||
48652775|NCT02562040|101935091|FG000|COMPLETED|Overall Study||199||
48652776|NCT02562040|101935092|FG001|COMPLETED|Overall Study||196||
48652777|NCT02562040|101935091|FG000|NOT COMPLETED|Overall Study||29||
48652778|NCT02562040|101935092|FG001|NOT COMPLETED|Overall Study||35||
48652779|NCT01229111|101937833|FG000|STARTED|Overall Study||14||
48652780|NCT01229111|101937833|FG000|COMPLETED|Overall Study||13||
48652781|NCT01229111|101937833|FG000|NOT COMPLETED|Overall Study||1||
48652782|NCT02944461|101937834|FG000|STARTED|Overall Study||20||
48652783|NCT02944461|101937834|FG000|COMPLETED|Overall Study||15||
48652784|NCT02944461|101937834|FG000|NOT COMPLETED|Overall Study||5||
48652785|NCT01152385|101937835|FG000|STARTED|Overall Study||55||
48652786|NCT01152385|101937836|FG001|STARTED|Overall Study||58||
48652787|NCT01152385|101937837|FG002|STARTED|Overall Study||56||
48652788|NCT01152385|101937838|FG003|STARTED|Overall Study||55||
48652789|NCT01152385|101937835|FG000|COMPLETED|Overall Study||46||
48652790|NCT01152385|101937836|FG001|COMPLETED|Overall Study||52||
48652791|NCT01152385|101937837|FG002|COMPLETED|Overall Study||51||
48652792|NCT01152385|101937838|FG003|COMPLETED|Overall Study||50||
48652793|NCT01152385|101937835|FG000|NOT COMPLETED|Overall Study||9||
48652794|NCT01152385|101937836|FG001|NOT COMPLETED|Overall Study||6||
48652795|NCT01152385|101937837|FG002|NOT COMPLETED|Overall Study||5||
48652796|NCT01152385|101937838|FG003|NOT COMPLETED|Overall Study||5||
48652797|NCT00225758|101937839|FG000|STARTED|Overall Study||27||
48652798|NCT00225758|101937839|FG000|COMPLETED|Overall Study||23||
48652799|NCT00225758|101937839|FG000|NOT COMPLETED|Overall Study||4||
48652800|NCT04396860|101937840|FG000|STARTED|Overall Study||80||
48652801|NCT04396860|101937841|FG001|STARTED|Overall Study||79||
48652802|NCT04396860|101937840|FG000|Randomized|Overall Study||80||
48652803|NCT04396860|101937841|FG001|Randomized|Overall Study||79||
48652804|NCT04396860|101937840|FG000|Adverse Event Population|Overall Study||74|Randomized, started protocol treatment, and assessed for adverse events|
48652805|NCT04396860|101937841|FG001|Adverse Event Population|Overall Study||78|Randomized, started protocol treatment, and assessed for adverse events|
48652806|NCT04396860|101937840|FG000|COMPLETED|Overall Study||80|Participants contributing data to results are considered to have completed the study.|
48652807|NCT04396860|101937841|FG001|COMPLETED|Overall Study||79|Participants contributing data to results are considered to have completed the study.|
48652808|NCT04396860|101937840|FG000|NOT COMPLETED|Overall Study||0||
48652809|NCT04396860|101937841|FG001|NOT COMPLETED|Overall Study||0||
48652810|NCT03760068|101937842|FG000|STARTED|Overall Study||238||
48652811|NCT03760068|101937843|FG001|STARTED|Overall Study||240||
48652812|NCT03760068|101937842|FG000|COMPLETED|Overall Study||224||
48652813|NCT03760068|101937843|FG001|COMPLETED|Overall Study||217||
48652814|NCT03760068|101937842|FG000|NOT COMPLETED|Overall Study||14||
48652815|NCT03760068|101937843|FG001|NOT COMPLETED|Overall Study||23||
48652816|NCT00271570|101937844|FG000|STARTED|Overall Study||12||
48652817|NCT00271570|101937845|FG001|STARTED|Overall Study||12||
48652818|NCT00271570|101937844|FG000|COMPLETED|Overall Study||12||
48652819|NCT00271570|101937845|FG001|COMPLETED|Overall Study||12||
48652820|NCT00271570|101937844|FG000|NOT COMPLETED|Overall Study||0||
48652821|NCT00271570|101937845|FG001|NOT COMPLETED|Overall Study||0||
48652822|NCT02037984|101937846|FG000|STARTED|Overall Study||20|Randomized|
48652823|NCT02037984|101937847|FG001|STARTED|Overall Study||20|Randomized|
48652824|NCT02037984|101937848|FG002|STARTED|Overall Study||50|Randomized|
48652825|NCT02037984|101937849|FG003|STARTED|Overall Study||51|Randomized|
48652826|NCT02037984|101937850|FG004|STARTED|Overall Study||50|Randomized|
48652827|NCT02037984|101937851|FG005|STARTED|Overall Study||49|Randomized|
48652828|NCT02037984|101937852|FG006|STARTED|Overall Study||50|Randomized|
48652829|NCT02037984|101937853|FG007|STARTED|Overall Study||51|Randomized|
48652830|NCT02037984|101937846|FG000|COMPLETED|Overall Study||19||
48652831|NCT02037984|101937847|FG001|COMPLETED|Overall Study||20||
48652832|NCT02037984|101937848|FG002|COMPLETED|Overall Study||38||
48362358|NCT04283461|101214520|FG004|STARTED|Overall Study||15||
48362359|NCT04283461|101214521|FG005|STARTED|Overall Study||10||
48362360|NCT04283461|101214522|FG006|STARTED|Overall Study||10||
48362361|NCT04283461|101214523|FG007|STARTED|Overall Study||10||
48652833|NCT02037984|101937849|FG003|COMPLETED|Overall Study||30||
48652834|NCT02037984|101937850|FG004|COMPLETED|Overall Study||38||
48652835|NCT02037984|101937851|FG005|COMPLETED|Overall Study||37||
48652836|NCT02037984|101937852|FG006|COMPLETED|Overall Study||33||
48652837|NCT02037984|101937853|FG007|COMPLETED|Overall Study||39||
48652838|NCT02037984|101937846|FG000|NOT COMPLETED|Overall Study||1||
48652839|NCT02037984|101937847|FG001|NOT COMPLETED|Overall Study||0||
48652840|NCT02037984|101937848|FG002|NOT COMPLETED|Overall Study||12||
48652841|NCT02037984|101937849|FG003|NOT COMPLETED|Overall Study||21||
48652842|NCT02037984|101937850|FG004|NOT COMPLETED|Overall Study||12||
48652843|NCT02037984|101937851|FG005|NOT COMPLETED|Overall Study||12||
48652844|NCT02037984|101937852|FG006|NOT COMPLETED|Overall Study||17||
48652845|NCT02037984|101937853|FG007|NOT COMPLETED|Overall Study||12||
48652846|NCT03931785|101937854|FG000|STARTED|Overall Study||97||
48652847|NCT03931785|101937855|FG001|STARTED|Overall Study||97||
48652848|NCT03931785|101937856|FG002|STARTED|Overall Study||97||
48652849|NCT03931785|101937857|FG003|STARTED|Overall Study||97||
48652850|NCT03931785|101937854|FG000|COMPLETED|Overall Study||92||
48652851|NCT03931785|101937855|FG001|COMPLETED|Overall Study||90||
48652852|NCT03931785|101937856|FG002|COMPLETED|Overall Study||84||
48652853|NCT03931785|101937857|FG003|COMPLETED|Overall Study||86||
48652854|NCT03931785|101937854|FG000|NOT COMPLETED|Overall Study||5||
48652855|NCT03931785|101937855|FG001|NOT COMPLETED|Overall Study||7||
48652856|NCT03931785|101937856|FG002|NOT COMPLETED|Overall Study||13||
48652857|NCT03931785|101937857|FG003|NOT COMPLETED|Overall Study||11||
48652858|NCT02003209|101937858|FG000|STARTED|Overall Study||158||
48652859|NCT02003209|101937859|FG001|STARTED|Overall Study||157||
48652860|NCT02003209|101937858|FG000|COMPLETED|Overall Study||153||
48652861|NCT02003209|101937859|FG001|COMPLETED|Overall Study||155||
48652862|NCT02003209|101937858|FG000|NOT COMPLETED|Overall Study||5||
48652863|NCT02003209|101937859|FG001|NOT COMPLETED|Overall Study||2||
48652864|NCT02201628|101937860|FG000|STARTED|Overall Study||50||
48652865|NCT02201628|101937860|FG000|COMPLETED|Overall Study||50||
48652866|NCT02201628|101937860|FG000|NOT COMPLETED|Overall Study||0||
48652867|NCT02301429|101937861|FG000|STARTED|Overall Study||16||
48652868|NCT02301429|101937861|FG000|COMPLETED|Overall Study||13||
48652869|NCT02301429|101937861|FG000|NOT COMPLETED|Overall Study||3||
48652870|NCT01655069|101937862|FG000|STARTED|Overall Study||61||
48652871|NCT01655069|101937863|FG001|STARTED|Overall Study||58||
48652872|NCT01655069|101937864|FG002|STARTED|Overall Study||14||
48652873|NCT01655069|101937865|FG003|STARTED|Overall Study||15||
48652874|NCT01655069|101937862|FG000|Safety Analysis Set (SAF)|Overall Study||61|SAF consisted of all participants with at least 1 dose of open-label solifenacin and safety data.|
48652875|NCT01655069|101937863|FG001|Safety Analysis Set (SAF)|Overall Study||57|SAF consisted of all participants with at least 1 dose of open-label solifenacin and safety data.|
48652876|NCT01655069|101937864|FG002|Safety Analysis Set (SAF)|Overall Study||14|SAF consisted of all participants with at least 1 dose of open-label solifenacin and safety data.|
48652877|NCT01655069|101937865|FG003|Safety Analysis Set (SAF)|Overall Study||15|SAF consisted of all participants with at least 1 dose of open-label solifenacin and safety data.|
48652878|NCT01655069|101937862|FG000|Full Analysis Set (FAS)|Overall Study||60|FAS consisted of all participants with at least 1 dose of open-label solifenacin and efficacy data.|
48652879|NCT01655069|101937863|FG001|Full Analysis Set (FAS)|Overall Study||57|FAS consisted of all participants with at least 1 dose of open-label solifenacin and efficacy data.|
48652880|NCT01655069|101937864|FG002|Full Analysis Set (FAS)|Overall Study||14|FAS consisted of all participants with at least 1 dose of open-label solifenacin and efficacy data.|
48652881|NCT01655069|101937865|FG003|Full Analysis Set (FAS)|Overall Study||15|FAS consisted of all participants with at least 1 dose of open-label solifenacin and efficacy data.|
48652882|NCT01655069|101937862|FG000|COMPLETED|Overall Study||53||
48652883|NCT01655069|101937863|FG001|COMPLETED|Overall Study||46||
48652884|NCT01655069|101937864|FG002|COMPLETED|Overall Study||12||
48652885|NCT01655069|101937865|FG003|COMPLETED|Overall Study||11||
48652886|NCT01655069|101937862|FG000|NOT COMPLETED|Overall Study||8||
48652887|NCT01655069|101937863|FG001|NOT COMPLETED|Overall Study||12||
48362362|NCT04283461|101214524|FG008|STARTED|Overall Study||0||
48652888|NCT01655069|101937864|FG002|NOT COMPLETED|Overall Study||2||
48652889|NCT01655069|101937865|FG003|NOT COMPLETED|Overall Study||4||
48652890|NCT03737032|101937866|FG000|STARTED|Overall Study||5||
48652891|NCT03737032|101937867|FG001|STARTED|Overall Study||4||
48652892|NCT03737032|101937868|FG002|STARTED|Overall Study||4||
48652893|NCT03737032|101937869|FG003|STARTED|Overall Study||5||
48652894|NCT03737032|101937870|FG004|STARTED|Overall Study||4||
48652895|NCT03737032|101937871|FG005|STARTED|Overall Study||3||
48652896|NCT03737032|101937866|FG000|COMPLETED|Overall Study||5||
48652897|NCT03737032|101937867|FG001|COMPLETED|Overall Study||4||
48652898|NCT03737032|101937868|FG002|COMPLETED|Overall Study||4||
48652899|NCT03737032|101937869|FG003|COMPLETED|Overall Study||5||
48652900|NCT03737032|101937870|FG004|COMPLETED|Overall Study||4||
48652901|NCT03737032|101937871|FG005|COMPLETED|Overall Study||3||
48652902|NCT03737032|101937866|FG000|NOT COMPLETED|Overall Study||0||
48652903|NCT03737032|101937867|FG001|NOT COMPLETED|Overall Study||0||
48652904|NCT03737032|101937868|FG002|NOT COMPLETED|Overall Study||0||
48652905|NCT03737032|101937869|FG003|NOT COMPLETED|Overall Study||0||
48652906|NCT03737032|101937870|FG004|NOT COMPLETED|Overall Study||0||
48652907|NCT03737032|101937871|FG005|NOT COMPLETED|Overall Study||0||
48652908|NCT01065766|101937872|FG000|STARTED|Overall Study||4065||
48652909|NCT01065766|101937872|FG000|COMPLETED|Overall Study||4033||
48652910|NCT01065766|101937872|FG000|NOT COMPLETED|Overall Study||32||
48652911|NCT02059642|101937873|FG000|STARTED|Overall Study||148||
48652912|NCT02059642|101937874|FG001|STARTED|Overall Study||152||
48652913|NCT02059642|101937873|FG000|COMPLETED|Overall Study||121||
48652914|NCT02059642|101937874|FG001|COMPLETED|Overall Study||128||
48652915|NCT02059642|101937873|FG000|NOT COMPLETED|Overall Study||27||
48652916|NCT02059642|101937874|FG001|NOT COMPLETED|Overall Study||24||
48652917|NCT00183391|101937875|FG000|STARTED|Block 1 - 5 Weeks||108||
48652918|NCT00183391|101937876|FG001|STARTED|Block 1 - 5 Weeks||124||
48652919|NCT00183391|101937875|FG000|COMPLETED|Block 1 - 5 Weeks||95||
48652920|NCT00183391|101937876|FG001|COMPLETED|Block 1 - 5 Weeks||110||
48652921|NCT00183391|101937875|FG000|NOT COMPLETED|Block 1 - 5 Weeks||13||
48652922|NCT00183391|101937876|FG001|NOT COMPLETED|Block 1 - 5 Weeks||14||
48652923|NCT00183391|101937875|FG000|STARTED|Crossover Placebo - 2 Weeks||95||
48652924|NCT00183391|101937876|FG001|STARTED|Crossover Placebo - 2 Weeks||110||
48652925|NCT00183391|101937875|FG000|COMPLETED|Crossover Placebo - 2 Weeks||95||
48652926|NCT00183391|101937876|FG001|COMPLETED|Crossover Placebo - 2 Weeks||110||
48652927|NCT00183391|101937875|FG000|NOT COMPLETED|Crossover Placebo - 2 Weeks||0||
48652928|NCT00183391|101937876|FG001|NOT COMPLETED|Crossover Placebo - 2 Weeks||0||
48652929|NCT00183391|101937875|FG000|STARTED|Block 2 - 5 Weeks||95||
48652930|NCT00183391|101937876|FG001|STARTED|Block 2 - 5 Weeks||110||
48652931|NCT00183391|101937875|FG000|COMPLETED|Block 2 - 5 Weeks||91||
48652932|NCT00183391|101937876|FG001|COMPLETED|Block 2 - 5 Weeks||108||
48652933|NCT00183391|101937875|FG000|NOT COMPLETED|Block 2 - 5 Weeks||4||
48652934|NCT00183391|101937876|FG001|NOT COMPLETED|Block 2 - 5 Weeks||2||
48652935|NCT01063881|101937877|FG000|STARTED|Overall Study||147||
48652936|NCT01063881|101937878|FG001|STARTED|Overall Study||125||
48652937|NCT01063881|101937879|FG002|STARTED|Overall Study||13||
48652938|NCT01063881|101937877|FG000|COMPLETED|Overall Study||92||
48652939|NCT01063881|101937878|FG001|COMPLETED|Overall Study||114||
48652940|NCT01063881|101937879|FG002|COMPLETED|Overall Study||12||
48652941|NCT01063881|101937877|FG000|NOT COMPLETED|Overall Study||55||
48652942|NCT01063881|101937878|FG001|NOT COMPLETED|Overall Study||11||
48652943|NCT01063881|101937879|FG002|NOT COMPLETED|Overall Study||1||
48652944|NCT01775410|101937880|FG000|STARTED|Overall Study||4||
48652945|NCT01775410|101937880|FG000|COMPLETED|Overall Study||4||
48652946|NCT01775410|101937880|FG000|NOT COMPLETED|Overall Study||0||
48652947|NCT00890097|101937881|FG000|STARTED|Overall Study||252||
48652948|NCT00890097|101937882|FG001|STARTED|Overall Study||259||
48652949|NCT00890097|101937883|FG002|STARTED|Overall Study||261||
48652950|NCT00890097|101937881|FG000|COMPLETED|Overall Study||184||
48652951|NCT00890097|101937882|FG001|COMPLETED|Overall Study||173||
48652952|NCT00890097|101937883|FG002|COMPLETED|Overall Study||184||
48652953|NCT00890097|101937881|FG000|NOT COMPLETED|Overall Study||68||
48652954|NCT00890097|101937882|FG001|NOT COMPLETED|Overall Study||86||
48652955|NCT00890097|101937883|FG002|NOT COMPLETED|Overall Study||77||
48652956|NCT05084885|101937884|FG000|STARTED|Baseline||3||
48652957|NCT05084885|101937885|FG001|STARTED|Baseline||13||
48652958|NCT05084885|101937884|FG000|Treated|Baseline||2||
48652959|NCT05084885|101937885|FG001|Treated|Baseline||0||
48652960|NCT05084885|101937884|FG000|Not Treated|Baseline||1||
48652961|NCT05084885|101937885|FG001|Not Treated|Baseline||13||
48652962|NCT05084885|101937884|FG000|COMPLETED|Baseline||2||
48652963|NCT05084885|101937885|FG001|COMPLETED|Baseline||13||
48652964|NCT05084885|101937884|FG000|NOT COMPLETED|Baseline||1||
48652965|NCT05084885|101937885|FG001|NOT COMPLETED|Baseline||0||
48652966|NCT05084885|101937884|FG000|STARTED|Post Treatment||2||
48652967|NCT05084885|101937885|FG001|STARTED|Post Treatment||13||
48652968|NCT05084885|101937884|FG000|COMPLETED|Post Treatment||2||
48652969|NCT05084885|101937885|FG001|COMPLETED|Post Treatment||13||
48652970|NCT05084885|101937884|FG000|NOT COMPLETED|Post Treatment||0||
48652971|NCT05084885|101937885|FG001|NOT COMPLETED|Post Treatment||0||
48652972|NCT05084885|101937884|FG000|STARTED|Follow-up||2||
48652973|NCT05084885|101937885|FG001|STARTED|Follow-up||13||
48652974|NCT05084885|101937884|FG000|Treated|Follow-up||2||
48652975|NCT05084885|101937885|FG001|Treated|Follow-up||0||
48652976|NCT05084885|101937884|FG000|Not Treated|Follow-up||0||
48652977|NCT05084885|101937885|FG001|Not Treated|Follow-up||13||
48652978|NCT05084885|101937884|FG000|COMPLETED|Follow-up||2||
48652979|NCT05084885|101937885|FG001|COMPLETED|Follow-up||8||
48652980|NCT05084885|101937884|FG000|NOT COMPLETED|Follow-up||0||
48652981|NCT05084885|101937885|FG001|NOT COMPLETED|Follow-up||5||
48652982|NCT04191733|101937886|FG000|STARTED|Overall Study||122|Enrolled participants|
48652983|NCT04191733|101937887|FG001|STARTED|Overall Study||121|Enrolled participants|
48652984|NCT04191733|101937886|FG000|Enrolled But Not Treated|Overall Study||5||
48652985|NCT04191733|101937887|FG001|Enrolled But Not Treated|Overall Study||10||
48652986|NCT04191733|101937886|FG000|Safety Population|Overall Study||117|The safety population set consisted of all enrolled participants who signed the informed consent document and attempted treatment according to the actual treatment received.|
48652987|NCT04191733|101937887|FG001|Safety Population|Overall Study||111|The safety population set consisted of all enrolled participants who signed the informed consent document and attempted treatment according to the actual treatment received.|
48652988|NCT04191733|101937886|FG000|COMPLETED|Overall Study||101||
48652989|NCT04191733|101937887|FG001|COMPLETED|Overall Study||95||
48652990|NCT04191733|101937886|FG000|NOT COMPLETED|Overall Study||21||
48652991|NCT04191733|101937887|FG001|NOT COMPLETED|Overall Study||26||
48652992|NCT03681093|101937888|FG000|STARTED|Overall Study||32|All subjects who were randomized|
48652993|NCT03681093|101937889|FG001|STARTED|Overall Study||34|All subjects who were randomized|
48652994|NCT03681093|101937890|FG002|STARTED|Overall Study||32|All subjects who were randomized|
48652995|NCT03681093|101937888|FG000|Full Analysis Set (FAS)|Overall Study||31|All randomized subjects who received at least one dose of study treatment AND had baseline NPS score \>=4|
48652996|NCT03681093|101937889|FG001|Full Analysis Set (FAS)|Overall Study||32|All randomized subjects who received at least one dose of study treatment AND had baseline NPS score \>=4|
48652997|NCT03681093|101937890|FG002|Full Analysis Set (FAS)|Overall Study||28|All randomized subjects who received at least one dose of study treatment AND had baseline NPS score \>=4|
48652998|NCT03681093|101937888|FG000|Safety Analysis Set (SAF)|Overall Study||32|All subjects who received at least one dose of study treatment|
48652999|NCT03681093|101937889|FG001|Safety Analysis Set (SAF)|Overall Study||34|All subjects who received at least one dose of study treatment|
48653000|NCT03681093|101937890|FG002|Safety Analysis Set (SAF)|Overall Study||32|All subjects who received at least one dose of study treatment|
48653001|NCT03681093|101937888|FG000|COMPLETED|Overall Study||32||
48653002|NCT03681093|101937889|FG001|COMPLETED|Overall Study||32||
48653003|NCT03681093|101937890|FG002|COMPLETED|Overall Study||31||
48653004|NCT03681093|101937888|FG000|NOT COMPLETED|Overall Study||0||
48653005|NCT03681093|101937889|FG001|NOT COMPLETED|Overall Study||2||
48653006|NCT03681093|101937890|FG002|NOT COMPLETED|Overall Study||1||
48653007|NCT01230814|101937891|FG000|STARTED|Overall Study||118||
48653008|NCT01230814|101937892|FG001|STARTED|Overall Study||116||
48653009|NCT01230814|101937891|FG000|COMPLETED|Overall Study||105||
48653010|NCT01230814|101937892|FG001|COMPLETED|Overall Study||112||
48653011|NCT01230814|101937891|FG000|NOT COMPLETED|Overall Study||13||
48653012|NCT01230814|101937892|FG001|NOT COMPLETED|Overall Study||4||
48653013|NCT04463914|101937893|FG000|STARTED|Overall Study||212||
48653014|NCT04463914|101937894|FG001|STARTED|Overall Study||216||
48653015|NCT04463914|101937895|FG002|STARTED|Overall Study||221||
48653016|NCT04463914|101937893|FG000|COMPLETED|Overall Study||212||
48653017|NCT04463914|101937894|FG001|COMPLETED|Overall Study||216||
48653018|NCT04463914|101937895|FG002|COMPLETED|Overall Study||221||
48653019|NCT04463914|101937893|FG000|NOT COMPLETED|Overall Study||0||
48653020|NCT04463914|101937894|FG001|NOT COMPLETED|Overall Study||0||
48653021|NCT04463914|101937895|FG002|NOT COMPLETED|Overall Study||0||
48653022|NCT02143778|101937896|FG000|STARTED|Overall Study||246||
48653023|NCT02143778|101937896|FG000|COMPLETED|Overall Study||243||
48653024|NCT02143778|101937896|FG000|NOT COMPLETED|Overall Study||3||
48653025|NCT02775851|101937897|FG000|STARTED|Overall Study||30||
48653026|NCT02775851|101937898|FG001|STARTED|Overall Study||27||
48653027|NCT02775851|101937897|FG000|COMPLETED|Overall Study||28||
48653028|NCT02775851|101937898|FG001|COMPLETED|Overall Study||5||
48653029|NCT02775851|101937897|FG000|NOT COMPLETED|Overall Study||2||
48653030|NCT02775851|101937898|FG001|NOT COMPLETED|Overall Study||22||
48653031|NCT00520572|101937899|FG000|STARTED|Overall Study||64||
48653032|NCT00520572|101937900|FG001|STARTED|Overall Study||64||
48653033|NCT00520572|101937901|FG002|STARTED|Overall Study||64||
48653034|NCT00520572|101937902|FG003|STARTED|Overall Study||64||
48653035|NCT00520572|101937903|FG004|STARTED|Overall Study||65||
48653036|NCT00520572|101937904|FG005|STARTED|Overall Study||64||
48653037|NCT00520572|101937899|FG000|COMPLETED|Overall Study||52||
48653038|NCT00520572|101937900|FG001|COMPLETED|Overall Study||50||
48653039|NCT00520572|101937901|FG002|COMPLETED|Overall Study||49||
48653040|NCT00520572|101937902|FG003|COMPLETED|Overall Study||50||
48653041|NCT00520572|101937903|FG004|COMPLETED|Overall Study||53||
48653042|NCT00520572|101937904|FG005|COMPLETED|Overall Study||62||
48653043|NCT00520572|101937899|FG000|NOT COMPLETED|Overall Study||12||
48653044|NCT00520572|101937900|FG001|NOT COMPLETED|Overall Study||14||
48653045|NCT00520572|101937901|FG002|NOT COMPLETED|Overall Study||15||
48653046|NCT00520572|101937902|FG003|NOT COMPLETED|Overall Study||14||
48653047|NCT00520572|101937903|FG004|NOT COMPLETED|Overall Study||12||
48653048|NCT00520572|101937904|FG005|NOT COMPLETED|Overall Study||2||
48653049|NCT01133977|101937905|FG000|STARTED|Overall Study||3||
48653050|NCT01133977|101937906|FG001|STARTED|Overall Study||7||
48653051|NCT01133977|101937907|FG002|STARTED|Overall Study||6||
48653052|NCT01133977|101937908|FG003|STARTED|Overall Study||42||
48653053|NCT01133977|101937909|FG004|STARTED|Overall Study||39||
48653054|NCT01133977|101937905|FG000|COMPLETED|Overall Study||0||
48653055|NCT01133977|101937906|FG001|COMPLETED|Overall Study||0||
48653056|NCT01133977|101937907|FG002|COMPLETED|Overall Study||0||
48653057|NCT01133977|101937908|FG003|COMPLETED|Overall Study||3||
48653058|NCT01133977|101937909|FG004|COMPLETED|Overall Study||1||
48653059|NCT01133977|101937905|FG000|NOT COMPLETED|Overall Study||3||
48653060|NCT01133977|101937906|FG001|NOT COMPLETED|Overall Study||7||
48653061|NCT01133977|101937907|FG002|NOT COMPLETED|Overall Study||6||
48653062|NCT01133977|101937908|FG003|NOT COMPLETED|Overall Study||39||
48653063|NCT01133977|101937909|FG004|NOT COMPLETED|Overall Study||38||
48653064|NCT03076164|101937910|FG000|STARTED|Overall Study||24||
48653065|NCT03076164|101937910|FG000|COMPLETED|Overall Study||24||
48653066|NCT03076164|101937910|FG000|NOT COMPLETED|Overall Study||0||
48653067|NCT01392495|101937911|FG000|STARTED|Overall Study||17||
48653068|NCT01392495|101937911|FG000|Received 200 mg|Overall Study||4||
48653069|NCT01392495|101937911|FG000|Received 400 mg|Overall Study||13||
48653070|NCT01392495|101937911|FG000|COMPLETED|Overall Study||1||
48653071|NCT01392495|101937911|FG000|NOT COMPLETED|Overall Study||16||
48653072|NCT02469961|101937912|FG000|STARTED|Overall Study||25||
48653073|NCT02469961|101937913|FG001|STARTED|Overall Study||25||
48653074|NCT02469961|101937912|FG000|COMPLETED|Overall Study||21||
48653075|NCT02469961|101937913|FG001|COMPLETED|Overall Study||24||
48653076|NCT02469961|101937912|FG000|NOT COMPLETED|Overall Study||4||
48653077|NCT02469961|101937913|FG001|NOT COMPLETED|Overall Study||1||
48653078|NCT03180138|101937914|FG000|STARTED|Overall Study||204||
48653079|NCT03180138|101937915|FG001|STARTED|Overall Study||201||
48653080|NCT03180138|101937916|FG002|STARTED|Overall Study||203||
48653081|NCT03180138|101937914|FG000|COMPLETED|Overall Study||182||
48653082|NCT03180138|101937915|FG001|COMPLETED|Overall Study||188||
48653083|NCT03180138|101937916|FG002|COMPLETED|Overall Study||179||
48653084|NCT03180138|101937914|FG000|NOT COMPLETED|Overall Study||22||
48653085|NCT03180138|101937915|FG001|NOT COMPLETED|Overall Study||13||
48653086|NCT03180138|101937916|FG002|NOT COMPLETED|Overall Study||24||
48653087|NCT00432991|101937917|FG000|STARTED|Overall Study||22||
48653088|NCT00432991|101937918|FG001|STARTED|Overall Study||31||
48653089|NCT00432991|101937917|FG000|COMPLETED|Overall Study||15||
48653090|NCT00432991|101937918|FG001|COMPLETED|Overall Study||19||
48653091|NCT00432991|101937917|FG000|NOT COMPLETED|Overall Study||7||
48653092|NCT00432991|101937918|FG001|NOT COMPLETED|Overall Study||12||
48653093|NCT02168439|101937919|FG000|STARTED|Overall Study||20||
48653094|NCT02168439|101937920|FG001|STARTED|Overall Study||20||
48653095|NCT02168439|101937919|FG000|COMPLETED|Overall Study||20||
48653096|NCT02168439|101937920|FG001|COMPLETED|Overall Study||18||
48653097|NCT02168439|101937919|FG000|NOT COMPLETED|Overall Study||0||
48653098|NCT02168439|101937920|FG001|NOT COMPLETED|Overall Study||2||
48653099|NCT04525183|101937921|FG000|STARTED|Overall Study||4||
48765560|NCT03873116|102214678|FG000|NOT COMPLETED|Part 1||0||
48653100|NCT04525183|101937922|FG001|STARTED|Overall Study||23||
48653101|NCT04525183|101937923|FG002|STARTED|Overall Study||21||
48653102|NCT04525183|101937921|FG000|COMPLETED|Overall Study||4||
48653103|NCT04525183|101937922|FG001|COMPLETED|Overall Study||23||
48653104|NCT04525183|101937923|FG002|COMPLETED|Overall Study||16||
48653105|NCT04525183|101937921|FG000|NOT COMPLETED|Overall Study||0||
48653106|NCT04525183|101937922|FG001|NOT COMPLETED|Overall Study||0||
48653107|NCT04525183|101937923|FG002|NOT COMPLETED|Overall Study||5||
48653108|NCT00452530|101937924|FG000|STARTED|Overall Study||1528||
48653109|NCT00452530|101937925|FG001|STARTED|Overall Study||1529||
48653110|NCT00452530|101937924|FG000|Received Treatment|Overall Study||1501||
48653111|NCT00452530|101937925|FG001|Received Treatment|Overall Study||1508||
48653112|NCT00452530|101937924|FG000|Evaluable Participants|Overall Study||907||
48653113|NCT00452530|101937925|FG001|Evaluable Participants|Overall Study||921||
48653114|NCT00452530|101937924|FG000|Primary Participants|Overall Study||976||
48653115|NCT00452530|101937925|FG001|Primary Participants|Overall Study||997||
48653116|NCT00452530|101937924|FG000|COMPLETED|Overall Study||1392||
48653117|NCT00452530|101937925|FG001|COMPLETED|Overall Study||1393||
48653118|NCT00452530|101937924|FG000|NOT COMPLETED|Overall Study||136||
48653119|NCT00452530|101937925|FG001|NOT COMPLETED|Overall Study||136||
48653120|NCT01431573|101937926|FG000|STARTED|Overall Study||8||
48653121|NCT01431573|101937926|FG000|COMPLETED|Overall Study||8||
48653122|NCT01431573|101937926|FG000|NOT COMPLETED|Overall Study||0||
48653123|NCT00965991|101937927|FG000|STARTED|Overall Study||75||
48653124|NCT00965991|101937928|FG001|STARTED|Overall Study||74||
48653125|NCT00965991|101937927|FG000|COMPLETED|Overall Study||75||
48653126|NCT00965991|101937928|FG001|COMPLETED|Overall Study||74||
48653127|NCT00965991|101937927|FG000|NOT COMPLETED|Overall Study||0||
48653128|NCT00965991|101937928|FG001|NOT COMPLETED|Overall Study||0||
48653129|NCT01950390|101937929|FG000|STARTED|Overall Study||85||
48765561|NCT03873116|102214679|FG001|NOT COMPLETED|Part 1||0||
48653130|NCT01950390|101937930|FG001|STARTED|Overall Study||84||
48653131|NCT01950390|101937929|FG000|Started Treatment|Overall Study||82||
48653132|NCT01950390|101937930|FG001|Started Treatment|Overall Study||82||
48653133|NCT01950390|101937929|FG000|COMPLETED|Overall Study||1||
48653134|NCT01950390|101937930|FG001|COMPLETED|Overall Study||0||
48653135|NCT01950390|101937929|FG000|NOT COMPLETED|Overall Study||84||
48653136|NCT01950390|101937930|FG001|NOT COMPLETED|Overall Study||84||
48653137|NCT02370693|101937931|FG000|STARTED|Overall Study||3||
48653138|NCT02370693|101937932|FG001|STARTED|Overall Study||4||
48653139|NCT02370693|101937931|FG000|COMPLETED|Overall Study||2||
48653140|NCT02370693|101937932|FG001|COMPLETED|Overall Study||3||
48653141|NCT02370693|101937931|FG000|NOT COMPLETED|Overall Study||1||
48653142|NCT02370693|101937932|FG001|NOT COMPLETED|Overall Study||1||
48653143|NCT04634903|101937933|FG000|STARTED|Overall Study||818||
48653144|NCT04634903|101937934|FG001|STARTED|Overall Study||821||
48653145|NCT04634903|101937935|FG002|STARTED|Overall Study||813||
48653146|NCT04634903|101937933|FG000|COMPLETED|Overall Study||669||
48653147|NCT04634903|101937934|FG001|COMPLETED|Overall Study||732||
48653148|NCT04634903|101937935|FG002|COMPLETED|Overall Study||653||
48653149|NCT04634903|101937933|FG000|NOT COMPLETED|Overall Study||149||
48653150|NCT04634903|101937934|FG001|NOT COMPLETED|Overall Study||89||
48653151|NCT04634903|101937935|FG002|NOT COMPLETED|Overall Study||160||
48653152|NCT03566550|101937936|FG000|STARTED|Overall Study||12||
48653153|NCT03566550|101937937|FG001|STARTED|Overall Study||13||
48653154|NCT03566550|101937936|FG000|COMPLETED|Overall Study||12||
48653155|NCT03566550|101937937|FG001|COMPLETED|Overall Study||12||
48653156|NCT03566550|101937936|FG000|NOT COMPLETED|Overall Study||0||
48653157|NCT03566550|101937937|FG001|NOT COMPLETED|Overall Study||1||
48653158|NCT00758043|101937938|FG000|STARTED|Overall Study||162||
48653159|NCT00758043|101937939|FG001|STARTED|Overall Study||160||
48653160|NCT00758043|101937940|FG002|STARTED|Overall Study||118||
48653161|NCT00758043|101937941|FG003|STARTED|Overall Study||100||
48653162|NCT00758043|101937938|FG000|COMPLETED|Overall Study||161||
48653163|NCT00758043|101937939|FG001|COMPLETED|Overall Study||119||
48653164|NCT00758043|101937940|FG002|COMPLETED|Overall Study||79||
48653165|NCT00758043|101937941|FG003|COMPLETED|Overall Study||0||
48653166|NCT00758043|101937938|FG000|NOT COMPLETED|Overall Study||1||
48653167|NCT00758043|101937939|FG001|NOT COMPLETED|Overall Study||41||
48653168|NCT00758043|101937940|FG002|NOT COMPLETED|Overall Study||39||
48653169|NCT00758043|101937941|FG003|NOT COMPLETED|Overall Study||100||
48653170|NCT00862277|101937942|FG000|STARTED|Overall Study||561||
48653171|NCT00862277|101937943|FG001|STARTED|Overall Study||96||
48653172|NCT00862277|101937944|FG002|STARTED|Overall Study||105||
48653173|NCT00862277|101937942|FG000|COMPLETED|Overall Study||560||
48653174|NCT00862277|101937943|FG001|COMPLETED|Overall Study||94||
48653175|NCT00862277|101937944|FG002|COMPLETED|Overall Study||100||
48653176|NCT00862277|101937942|FG000|NOT COMPLETED|Overall Study||1||
48653177|NCT00862277|101937943|FG001|NOT COMPLETED|Overall Study||2||
48653178|NCT00862277|101937944|FG002|NOT COMPLETED|Overall Study||5||
48653179|NCT01722734|101937945|FG000|STARTED|Overall Study||554||
48653180|NCT01722734|101937946|FG001|STARTED|Overall Study||277||
48653181|NCT01722734|101937947|FG002|STARTED|Overall Study||309||
48653182|NCT01722734|101937945|FG000|COMPLETED|Overall Study||552||
48653183|NCT01722734|101937946|FG001|COMPLETED|Overall Study||276||
48653184|NCT01722734|101937947|FG002|COMPLETED|Overall Study||307||
48653185|NCT01722734|101937945|FG000|NOT COMPLETED|Overall Study||2||
48653186|NCT01722734|101937946|FG001|NOT COMPLETED|Overall Study||1||
48653187|NCT01722734|101937947|FG002|NOT COMPLETED|Overall Study||2||
48653188|NCT01415453|101937948|FG000|STARTED|Overall Study||1||
48653189|NCT01415453|101937948|FG000|Imaging Study|Overall Study||1||
48653190|NCT01415453|101937948|FG000|COMPLETED|Overall Study||1||
48653191|NCT01415453|101937948|FG000|NOT COMPLETED|Overall Study||0||
48653192|NCT04882215|101937949|FG000|STARTED|Overall Study||14||
48653193|NCT04882215|101937950|FG001|STARTED|Overall Study||0||
48653194|NCT04882215|101937949|FG000|COMPLETED|Overall Study||9||
48653195|NCT04882215|101937950|FG001|COMPLETED|Overall Study||0||
48653196|NCT04882215|101937949|FG000|NOT COMPLETED|Overall Study||5||
48653197|NCT04882215|101937950|FG001|NOT COMPLETED|Overall Study||0||
48653198|NCT00063232|101937951|FG000|STARTED|Overall Study||26||
48653199|NCT00063232|101937951|FG000|COMPLETED|Overall Study||26||
48653200|NCT00063232|101937951|FG000|NOT COMPLETED|Overall Study||0||
48653201|NCT03721965|101937952|FG000|STARTED|Overall Study||2||
48653202|NCT03721965|101937952|FG000|COMPLETED|Overall Study||0||
48653203|NCT03721965|101937952|FG000|NOT COMPLETED|Overall Study||2||
48653204|NCT03918031|101937953|FG000|STARTED|Overall Study||57||
48653205|NCT03918031|101937954|FG001|STARTED|Overall Study||64||
48653206|NCT03918031|101937953|FG000|Post-Intervention|Overall Study||57||
48653207|NCT03918031|101937954|FG001|Post-Intervention|Overall Study||64||
48653208|NCT03918031|101937953|FG000|2-Week Follow-up|Overall Study||57||
48653209|NCT03918031|101937954|FG001|2-Week Follow-up|Overall Study||60||
48653210|NCT03918031|101937953|FG000|1-Month Follow-up|Overall Study||56||
48653211|NCT03918031|101937954|FG001|1-Month Follow-up|Overall Study||62||
48653212|NCT03918031|101937953|FG000|COMPLETED|Overall Study||57||
48653213|NCT03918031|101937954|FG001|COMPLETED|Overall Study||64||
48653214|NCT03918031|101937953|FG000|NOT COMPLETED|Overall Study||0||
48653215|NCT03918031|101937954|FG001|NOT COMPLETED|Overall Study||0||
48653216|NCT04191096|101937955|FG000|STARTED|Overall Study||626||
48653217|NCT04191096|101937956|FG001|STARTED|Overall Study||625||
48653218|NCT04191096|101937955|FG000|COMPLETED|Overall Study||0||
48653219|NCT04191096|101937956|FG001|COMPLETED|Overall Study||0||
48653220|NCT04191096|101937955|FG000|NOT COMPLETED|Overall Study||626||
48653221|NCT04191096|101937956|FG001|NOT COMPLETED|Overall Study||625||
48653222|NCT04566510|101937957|FG000|STARTED|12 Month Cross Sectional Survey||7940|All residents from selected households that provided informed consent were enrolled.|32
48653223|NCT04566510|101937958|FG001|STARTED|12 Month Cross Sectional Survey||8249|All residents from selected households that provided informed consent were enrolled.|32
48653224|NCT04566510|101937957|FG000|COMPLETED|12 Month Cross Sectional Survey||7940||32
48653225|NCT04566510|101937958|FG001|COMPLETED|12 Month Cross Sectional Survey||8249||32
48653226|NCT04566510|101937957|FG000|NOT COMPLETED|12 Month Cross Sectional Survey||0||0
48653227|NCT04566510|101937958|FG001|NOT COMPLETED|12 Month Cross Sectional Survey||0||0
48653228|NCT04566510|101937957|FG000|STARTED|24 Month Cross Sectional Period||8306|All residents from selected households that provided informed consent were enrolled.|32
48653229|NCT04566510|101937958|FG001|STARTED|24 Month Cross Sectional Period||8400|All residents from selected households that provided informed consent were enrolled.|32
48653230|NCT04566510|101937957|FG000|COMPLETED|24 Month Cross Sectional Period||8306||32
48653231|NCT04566510|101937958|FG001|COMPLETED|24 Month Cross Sectional Period||8400||32
48653232|NCT04566510|101937957|FG000|NOT COMPLETED|24 Month Cross Sectional Period||0||0
48653233|NCT04566510|101937958|FG001|NOT COMPLETED|24 Month Cross Sectional Period||0||0
48653234|NCT04928339|101937959|FG000|STARTED|Overall Study||50||
48653235|NCT04928339|101937960|FG001|STARTED|Overall Study||50||
48653236|NCT04928339|101937959|FG000|COMPLETED|Overall Study||50||
48653237|NCT04928339|101937960|FG001|COMPLETED|Overall Study||50||
48653238|NCT04928339|101937959|FG000|NOT COMPLETED|Overall Study||0||
48653239|NCT04928339|101937960|FG001|NOT COMPLETED|Overall Study||0||
48653240|NCT02618187|101937961|FG000|STARTED|Overall Study||15||
48653241|NCT02618187|101937962|FG001|STARTED|Overall Study||11||
48653242|NCT02618187|101937963|FG002|STARTED|Overall Study||15||
48653243|NCT02618187|101937964|FG003|STARTED|Overall Study||17||
48653244|NCT02618187|101937961|FG000|Completed|Overall Study||13|Subjects Completed Visit 12 Endoscopy (8-week treatment)|
48653245|NCT02618187|101937962|FG001|Completed|Overall Study||10|Subjects Completed Visit 12 Endoscopy (8-week treatment)|
48653246|NCT02618187|101937963|FG002|Completed|Overall Study||13|Subjects Completed Visit 12 Endoscopy (8-week treatment)|
48653247|NCT02618187|101937964|FG003|Completed|Overall Study||13|Subjects Completed Visit 12 Endoscopy (8-week treatment)|
48653248|NCT02618187|101937961|FG000|COMPLETED|Overall Study||13|Subjects Completed Visit 13 (short-term safety follow-up)|
48653249|NCT02618187|101937962|FG001|COMPLETED|Overall Study||9|Subjects Completed Visit 13 (short-term safety follow-up)|
48653250|NCT02618187|101937963|FG002|COMPLETED|Overall Study||11|Subjects Completed Visit 13 (short-term safety follow-up)|
48653251|NCT02618187|101937964|FG003|COMPLETED|Overall Study||12|Subjects Completed Visit 13 (short-term safety follow-up)|
48653252|NCT02618187|101937961|FG000|NOT COMPLETED|Overall Study||2||
48653253|NCT02618187|101937962|FG001|NOT COMPLETED|Overall Study||2||
48653254|NCT02618187|101937963|FG002|NOT COMPLETED|Overall Study||4||
48653255|NCT02618187|101937964|FG003|NOT COMPLETED|Overall Study||5||
48653256|NCT02773537|101937965|FG000|STARTED|Overall Study||25||
48653257|NCT02773537|101937966|FG001|STARTED|Overall Study||25||
48653258|NCT02773537|101937967|FG002|STARTED|Overall Study||25||
48653259|NCT02773537|101937965|FG000|COMPLETED|Overall Study||25||
48653260|NCT02773537|101937966|FG001|COMPLETED|Overall Study||24||
48653261|NCT02773537|101937967|FG002|COMPLETED|Overall Study||21||
48653262|NCT02773537|101937965|FG000|NOT COMPLETED|Overall Study||0||
48653263|NCT02773537|101937966|FG001|NOT COMPLETED|Overall Study||1||
48653264|NCT02773537|101937967|FG002|NOT COMPLETED|Overall Study||4||
48653265|NCT01064622|101937968|FG000|STARTED|Lead-in Phase I||0||
48653266|NCT01064622|101937969|FG001|STARTED|Lead-in Phase I||7||
48653267|NCT01064622|101937968|FG000|COMPLETED|Lead-in Phase I||0||
48653268|NCT01064622|101937969|FG001|COMPLETED|Lead-in Phase I||7||
48653269|NCT01064622|101937968|FG000|NOT COMPLETED|Lead-in Phase I||0||
48765562|NCT03873116|102214680|FG002|NOT COMPLETED|Part 1||0||
48765563|NCT03873116|102214681|FG003|NOT COMPLETED|Part 1||0||
48765564|NCT03873116|102214682|FG004|NOT COMPLETED|Part 1||0||
48765565|NCT03873116|102214683|FG005|NOT COMPLETED|Part 1||1||
48765566|NCT03873116|102214678|FG000|STARTED|Part 2||3||
48765567|NCT03873116|102214679|FG001|STARTED|Part 2||3||
48765568|NCT03873116|102214680|FG002|STARTED|Part 2||1||
48765569|NCT03873116|102214681|FG003|STARTED|Part 2||1||
48188267|NCT05457842|100783200|FG000|STARTED|Overall Study||1||
48653270|NCT01064622|101937969|FG001|NOT COMPLETED|Lead-in Phase I||0||
48765570|NCT03873116|102214682|FG004|STARTED|Part 2||7||
48765571|NCT03873116|102214683|FG005|STARTED|Part 2||2||
48653271|NCT01064622|101937968|FG000|STARTED|Randomized Phase II||55||
48653272|NCT01064622|101937969|FG001|STARTED|Randomized Phase II||56||
48653273|NCT01064622|101937968|FG000|COMPLETED|Randomized Phase II||53||
48653274|NCT01064622|101937969|FG001|COMPLETED|Randomized Phase II||53||
48765572|NCT03873116|102214678|FG000|COMPLETED|Part 2||3||
48765573|NCT03873116|102214679|FG001|COMPLETED|Part 2||3||
48765574|NCT03873116|102214680|FG002|COMPLETED|Part 2||0||
48188268|NCT05457842|100783200|FG000|COMPLETED|Overall Study||1||
48653275|NCT01064622|101937968|FG000|NOT COMPLETED|Randomized Phase II||2||
48653276|NCT01064622|101937969|FG001|NOT COMPLETED|Randomized Phase II||3||
48653277|NCT01064622|101937968|FG000|STARTED|Crossover of Arm I||22||
48653278|NCT01064622|101937969|FG001|STARTED|Crossover of Arm I||0||
48653279|NCT01064622|101937968|FG000|COMPLETED|Crossover of Arm I||22||
48653280|NCT01064622|101937969|FG001|COMPLETED|Crossover of Arm I||0||
48653281|NCT01064622|101937968|FG000|NOT COMPLETED|Crossover of Arm I||0||
48653282|NCT01064622|101937969|FG001|NOT COMPLETED|Crossover of Arm I||0||
48653283|NCT00358579|101937970|FG000|STARTED|Overall Study||353||
48653284|NCT00358579|101937971|FG001|STARTED|Overall Study||374||
48653285|NCT00358579|101937970|FG000|COMPLETED|Overall Study||353||
48653286|NCT00358579|101937971|FG001|COMPLETED|Overall Study||374||
48653287|NCT00358579|101937970|FG000|NOT COMPLETED|Overall Study||0||
48653288|NCT00358579|101937971|FG001|NOT COMPLETED|Overall Study||0||
48653289|NCT04595370|101937972|FG000|STARTED|Overall Study||35||
48653290|NCT04595370|101937973|FG001|STARTED|Overall Study||33||
48653291|NCT04595370|101937974|FG002|STARTED|Overall Study||36||
48653292|NCT04595370|101937975|FG003|STARTED|Overall Study||7||
48653293|NCT04595370|101937976|FG004|STARTED|Overall Study||35||
48653294|NCT04595370|101937977|FG005|STARTED|Overall Study||7||
48653295|NCT04595370|101937972|FG000|COMPLETED|Overall Study||33||
48653296|NCT04595370|101937973|FG001|COMPLETED|Overall Study||25||
48653297|NCT04595370|101937974|FG002|COMPLETED|Overall Study||27||
48653298|NCT04595370|101937975|FG003|COMPLETED|Overall Study||6||
48653299|NCT04595370|101937976|FG004|COMPLETED|Overall Study||29||
48653300|NCT04595370|101937977|FG005|COMPLETED|Overall Study||6||
48653301|NCT04595370|101937972|FG000|NOT COMPLETED|Overall Study||2||
48653302|NCT04595370|101937973|FG001|NOT COMPLETED|Overall Study||8||
48653303|NCT04595370|101937974|FG002|NOT COMPLETED|Overall Study||9||
48653304|NCT04595370|101937975|FG003|NOT COMPLETED|Overall Study||1||
48653305|NCT04595370|101937976|FG004|NOT COMPLETED|Overall Study||6||
48653306|NCT04595370|101937977|FG005|NOT COMPLETED|Overall Study||1||
48653307|NCT01157429|101937978|FG000|STARTED|Overall Study||12||
48653308|NCT01157429|101937979|FG001|STARTED|Overall Study||12||
48653309|NCT01157429|101937978|FG000|COMPLETED|Overall Study||8||
48653310|NCT01157429|101937979|FG001|COMPLETED|Overall Study||8||
48653311|NCT01157429|101937978|FG000|NOT COMPLETED|Overall Study||4||
48653312|NCT01157429|101937979|FG001|NOT COMPLETED|Overall Study||4||
48653313|NCT03856177|101937980|FG000|STARTED|Overall Study||50||
48653314|NCT03856177|101937981|FG001|STARTED|Overall Study||50||
48653315|NCT03856177|101937980|FG000|COMPLETED|Overall Study||50||
48653316|NCT03856177|101937981|FG001|COMPLETED|Overall Study||50||
48653317|NCT03856177|101937980|FG000|NOT COMPLETED|Overall Study||0||
48653318|NCT03856177|101937981|FG001|NOT COMPLETED|Overall Study||0||
48653319|NCT03656562|101937982|FG000|STARTED|Overall Study||34|All patients randomized were included in the Safety Set|
48653320|NCT03656562|101937983|FG001|STARTED|Overall Study||33|All patients randomized were included in the Safety Set|
48653321|NCT03656562|101937984|FG002|STARTED|Overall Study||20|All patients randomized were included in the Safety Set|
48653322|NCT03656562|101937985|FG003|STARTED|Overall Study||20|All patients randomized were included in the Safety Set|
48653323|NCT03656562|101937982|FG000|Pharmacodynamic Analysis Set|Overall Study||34||
48653324|NCT03656562|101937983|FG001|Pharmacodynamic Analysis Set|Overall Study||33||
48653325|NCT03656562|101937984|FG002|Pharmacodynamic Analysis Set|Overall Study||20||
48653326|NCT03656562|101937985|FG003|Pharmacodynamic Analysis Set|Overall Study||20||
48653327|NCT03656562|101937982|FG000|COMPLETED|Overall Study||11||
48653328|NCT03656562|101937983|FG001|COMPLETED|Overall Study||13||
48653329|NCT03656562|101937984|FG002|COMPLETED|Overall Study||15||
48653330|NCT03656562|101937985|FG003|COMPLETED|Overall Study||14||
48653331|NCT03656562|101937982|FG000|NOT COMPLETED|Overall Study||23||
48653332|NCT03656562|101937983|FG001|NOT COMPLETED|Overall Study||20||
48653333|NCT03656562|101937984|FG002|NOT COMPLETED|Overall Study||5||
48653334|NCT03656562|101937985|FG003|NOT COMPLETED|Overall Study||6||
48653335|NCT04829214|101937986|FG000|STARTED|Randomization||77||
48653336|NCT04829214|101937987|FG001|STARTED|Randomization||76||
48653337|NCT04829214|101937986|FG000|COMPLETED|Randomization||77||
48653338|NCT04829214|101937987|FG001|COMPLETED|Randomization||76||
48653339|NCT04829214|101937986|FG000|NOT COMPLETED|Randomization||0||
48653340|NCT04829214|101937987|FG001|NOT COMPLETED|Randomization||0||
48653341|NCT04829214|101937986|FG000|STARTED|Follow-up and Efficacy Analysis||77||
48653342|NCT04829214|101937987|FG001|STARTED|Follow-up and Efficacy Analysis||76||
48653343|NCT04829214|101937986|FG000|COMPLETED|Follow-up and Efficacy Analysis||70||
48653344|NCT04829214|101937987|FG001|COMPLETED|Follow-up and Efficacy Analysis||72||
48653345|NCT04829214|101937986|FG000|NOT COMPLETED|Follow-up and Efficacy Analysis||7||
48653346|NCT04829214|101937987|FG001|NOT COMPLETED|Follow-up and Efficacy Analysis||4||
48653347|NCT00420056|101937988|FG000|STARTED|Overall Study||17||
48653348|NCT00420056|101937988|FG000|COMPLETED|Overall Study||0||
48653349|NCT00420056|101937988|FG000|NOT COMPLETED|Overall Study||17||
48653350|NCT02520154|101937989|FG000|STARTED|Overall Study||31||
48653351|NCT02520154|101937989|FG000|COMPLETED|Overall Study||26||
48653352|NCT02520154|101937989|FG000|NOT COMPLETED|Overall Study||5||
48653353|NCT03760666|101937990|FG000|STARTED|Overall Study||5||
48653354|NCT03760666|101937991|FG001|STARTED|Overall Study||11||
48653355|NCT03760666|101937992|FG002|STARTED|Overall Study||1||
48653356|NCT03760666|101937990|FG000|COMPLETED|Overall Study||0||
48653357|NCT03760666|101937991|FG001|COMPLETED|Overall Study||0||
48653358|NCT03760666|101937992|FG002|COMPLETED|Overall Study||0||
48653359|NCT03760666|101937990|FG000|NOT COMPLETED|Overall Study||5||
48653360|NCT03760666|101937991|FG001|NOT COMPLETED|Overall Study||11||
48653361|NCT03760666|101937992|FG002|NOT COMPLETED|Overall Study||1||
48653362|NCT02004275|101937993|FG000|STARTED|Phase 1||0||
48653363|NCT02004275|101937994|FG001|STARTED|Phase 1||0||
48653364|NCT02004275|101937995|FG002|STARTED|Phase 1||3||
48653365|NCT02004275|101937996|FG003|STARTED|Phase 1||5||
48653366|NCT02004275|101937997|FG004|STARTED|Phase 1||7||
48653367|NCT02004275|101937998|FG005|STARTED|Phase 1||11||
48653368|NCT02004275|101937993|FG000|COMPLETED|Phase 1||0||
48653369|NCT02004275|101937994|FG001|COMPLETED|Phase 1||0||
48653370|NCT02004275|101937995|FG002|COMPLETED|Phase 1||3||
48653371|NCT02004275|101937996|FG003|COMPLETED|Phase 1||3||
48653372|NCT02004275|101937997|FG004|COMPLETED|Phase 1||6||
48653373|NCT02004275|101937998|FG005|COMPLETED|Phase 1||6||
48653374|NCT02004275|101937993|FG000|NOT COMPLETED|Phase 1||0||
48653375|NCT02004275|101937994|FG001|NOT COMPLETED|Phase 1||0||
48653376|NCT02004275|101937995|FG002|NOT COMPLETED|Phase 1||0||
48653377|NCT02004275|101937996|FG003|NOT COMPLETED|Phase 1||2||
48653378|NCT02004275|101937997|FG004|NOT COMPLETED|Phase 1||1||
48653379|NCT02004275|101937998|FG005|NOT COMPLETED|Phase 1||5||
48653380|NCT02004275|101937993|FG000|STARTED|Phase 2 Part 1||45||
48436435|NCT02526017|101403546|FG007|NOT COMPLETED|Overall Study||0||
48436436|NCT02526017|101403547|FG008|NOT COMPLETED|Overall Study||0||
48653381|NCT02004275|101937994|FG001|STARTED|Phase 2 Part 1||47||
48653382|NCT02004275|101937995|FG002|STARTED|Phase 2 Part 1||0||
48653383|NCT02004275|101937996|FG003|STARTED|Phase 2 Part 1||0||
48653384|NCT02004275|101937997|FG004|STARTED|Phase 2 Part 1||0||
48653385|NCT02004275|101937998|FG005|STARTED|Phase 2 Part 1||0||
48653386|NCT02004275|101937993|FG000|COMPLETED|Phase 2 Part 1||39||
48653387|NCT02004275|101937994|FG001|COMPLETED|Phase 2 Part 1||38||
48653388|NCT02004275|101937995|FG002|COMPLETED|Phase 2 Part 1||0||
48653389|NCT02004275|101937996|FG003|COMPLETED|Phase 2 Part 1||0||
48653390|NCT02004275|101937997|FG004|COMPLETED|Phase 2 Part 1||0||
48653391|NCT02004275|101937998|FG005|COMPLETED|Phase 2 Part 1||0||
48653392|NCT02004275|101937993|FG000|NOT COMPLETED|Phase 2 Part 1||6||
48653393|NCT02004275|101937994|FG001|NOT COMPLETED|Phase 2 Part 1||9||
48653394|NCT02004275|101937995|FG002|NOT COMPLETED|Phase 2 Part 1||0||
48653395|NCT02004275|101937996|FG003|NOT COMPLETED|Phase 2 Part 1||0||
48653396|NCT02004275|101937997|FG004|NOT COMPLETED|Phase 2 Part 1||0||
48653397|NCT02004275|101937998|FG005|NOT COMPLETED|Phase 2 Part 1||0||
48653398|NCT02004275|101937993|FG000|STARTED|Phase 2 Part 2||30||
48653399|NCT02004275|101937994|FG001|STARTED|Phase 2 Part 2||0||
48653400|NCT02004275|101937995|FG002|STARTED|Phase 2 Part 2||0||
48653401|NCT02004275|101937996|FG003|STARTED|Phase 2 Part 2||0||
48653402|NCT02004275|101937997|FG004|STARTED|Phase 2 Part 2||0||
48653403|NCT02004275|101937998|FG005|STARTED|Phase 2 Part 2||0||
48653404|NCT02004275|101937993|FG000|COMPLETED|Phase 2 Part 2||26||
48653405|NCT02004275|101937994|FG001|COMPLETED|Phase 2 Part 2||0||
48653406|NCT02004275|101937995|FG002|COMPLETED|Phase 2 Part 2||0||
48653407|NCT02004275|101937996|FG003|COMPLETED|Phase 2 Part 2||0||
48653408|NCT02004275|101937997|FG004|COMPLETED|Phase 2 Part 2||0||
48653409|NCT02004275|101937998|FG005|COMPLETED|Phase 2 Part 2||0||
48653410|NCT02004275|101937993|FG000|NOT COMPLETED|Phase 2 Part 2||4||
48653411|NCT02004275|101937994|FG001|NOT COMPLETED|Phase 2 Part 2||0||
48653412|NCT02004275|101937995|FG002|NOT COMPLETED|Phase 2 Part 2||0||
48653413|NCT02004275|101937996|FG003|NOT COMPLETED|Phase 2 Part 2||0||
48653414|NCT02004275|101937997|FG004|NOT COMPLETED|Phase 2 Part 2||0||
48653415|NCT02004275|101937998|FG005|NOT COMPLETED|Phase 2 Part 2||0||
48653416|NCT04634331|101937999|FG000|STARTED|Overall Study||24||
48653417|NCT04634331|101938000|FG001|STARTED|Overall Study||27||
48653418|NCT04634331|101937999|FG000|COMPLETED|Overall Study||22||
48653419|NCT04634331|101938000|FG001|COMPLETED|Overall Study||25||
48653420|NCT04634331|101937999|FG000|NOT COMPLETED|Overall Study||2||
48653421|NCT04634331|101938000|FG001|NOT COMPLETED|Overall Study||2||
48653422|NCT03055013|101938001|FG000|STARTED|Overall Study||404||
48653423|NCT03055013|101938002|FG001|STARTED|Overall Study||415||
48436437|NCT02262507|101403548|FG000|STARTED|Overall Study||410||
48436438|NCT02262507|101403548|FG000|COMPLETED|Overall Study||410||
48436439|NCT02262507|101403548|FG000|NOT COMPLETED|Overall Study||0||
48436440|NCT01891669|101403549|FG000|STARTED|Overall Study||2||
48436441|NCT01891669|101403550|FG001|STARTED|Overall Study||2||
48436442|NCT01891669|101403551|FG002|STARTED|Overall Study||2||
48436443|NCT01891669|101403552|FG003|STARTED|Overall Study||2||
48653424|NCT03055013|101938001|FG000|RCC Patients|Overall Study||381||
48653425|NCT03055013|101938002|FG001|RCC Patients|Overall Study||399||
48653426|NCT03055013|101938001|FG000|Patients Who Received Treatment and Were Assessed for Adverse Events|Overall Study||357||
48653427|NCT03055013|101938002|FG001|Patients Who Received Treatment and Were Assessed for Adverse Events|Overall Study||377||
48653428|NCT03055013|101938001|FG000|COMPLETED|Overall Study||197||
48653429|NCT03055013|101938002|FG001|COMPLETED|Overall Study||387||
48436444|NCT01891669|101403553|FG004|STARTED|Overall Study||2||
48653430|NCT03055013|101938001|FG000|NOT COMPLETED|Overall Study||207||
48653431|NCT03055013|101938002|FG001|NOT COMPLETED|Overall Study||28||
48653432|NCT02057666|101938003|FG000|STARTED|Double Blind Treatment Period||96||
48653433|NCT02057666|101938004|FG001|STARTED|Double Blind Treatment Period||50||
48653434|NCT02057666|101938003|FG000|COMPLETED|Double Blind Treatment Period||0||
48653435|NCT02057666|101938004|FG001|COMPLETED|Double Blind Treatment Period||6||
48653436|NCT02057666|101938003|FG000|NOT COMPLETED|Double Blind Treatment Period||96||
48653437|NCT02057666|101938004|FG001|NOT COMPLETED|Double Blind Treatment Period||44||
48653438|NCT02057666|101938003|FG000|STARTED|Open-Label Treatment Period||0||
48653439|NCT02057666|101938004|FG001|STARTED|Open-Label Treatment Period||6||
48653440|NCT02057666|101938003|FG000|COMPLETED|Open-Label Treatment Period||0||
48653441|NCT02057666|101938004|FG001|COMPLETED|Open-Label Treatment Period||0||
48653442|NCT02057666|101938003|FG000|NOT COMPLETED|Open-Label Treatment Period||0||
48653443|NCT02057666|101938004|FG001|NOT COMPLETED|Open-Label Treatment Period||6||
48653444|NCT03511209|101938005|FG000|STARTED|Overall Study||66||
48653445|NCT03511209|101938006|FG001|STARTED|Overall Study||66||
48653446|NCT03511209|101938005|FG000|COMPLETED|Overall Study||63||
48653447|NCT03511209|101938006|FG001|COMPLETED|Overall Study||60||
48653448|NCT03511209|101938005|FG000|NOT COMPLETED|Overall Study||3||
48653449|NCT03511209|101938006|FG001|NOT COMPLETED|Overall Study||6||
48653450|NCT03876808|101938007|FG000|STARTED|Overall Study||6||
48653451|NCT03876808|101938008|FG001|STARTED|Overall Study||4||
48653452|NCT03876808|101938007|FG000|COMPLETED|Overall Study||6||
48653453|NCT03876808|101938008|FG001|COMPLETED|Overall Study||4||
48653454|NCT03876808|101938007|FG000|NOT COMPLETED|Overall Study||0||
48653455|NCT03876808|101938008|FG001|NOT COMPLETED|Overall Study||0||
48653456|NCT04560309|101938009|FG000|STARTED|Overall Study||30||
48653457|NCT04560309|101938010|FG001|STARTED|Overall Study||30||
48653458|NCT04560309|101938009|FG000|COMPLETED|Overall Study||29||
48653459|NCT04560309|101938010|FG001|COMPLETED|Overall Study||29||
48653460|NCT04560309|101938009|FG000|NOT COMPLETED|Overall Study||1||
48653461|NCT04560309|101938010|FG001|NOT COMPLETED|Overall Study||1||
48653462|NCT00501943|101938011|FG000|STARTED|Overall Study||22||
48653463|NCT00501943|101938012|FG001|STARTED|Overall Study||21||
48653464|NCT00501943|101938011|FG000|COMPLETED|Overall Study||20||
48765575|NCT03873116|102214681|FG003|COMPLETED|Part 2||1||
48765576|NCT03873116|102214682|FG004|COMPLETED|Part 2||6||
48765577|NCT03873116|102214683|FG005|COMPLETED|Part 2||2||
48653465|NCT00501943|101938012|FG001|COMPLETED|Overall Study||18||
48653466|NCT00501943|101938011|FG000|NOT COMPLETED|Overall Study||2||
48653467|NCT00501943|101938012|FG001|NOT COMPLETED|Overall Study||3||
48653468|NCT03787212|101938013|FG000|STARTED|Period 1||2||
48653469|NCT03787212|101938014|FG001|STARTED|Period 1||2||
48653470|NCT03787212|101938013|FG000|COMPLETED|Period 1||2||
48653471|NCT03787212|101938014|FG001|COMPLETED|Period 1||2||
48653472|NCT03787212|101938013|FG000|NOT COMPLETED|Period 1||0||
48653473|NCT03787212|101938014|FG001|NOT COMPLETED|Period 1||0||
48653474|NCT03787212|101938013|FG000|STARTED|Period 1||2||
48653475|NCT03787212|101938014|FG001|STARTED|Period 1||2||
48653476|NCT03787212|101938013|FG000|COMPLETED|Period 1||0||
48653477|NCT03787212|101938014|FG001|COMPLETED|Period 1||0||
48653478|NCT03787212|101938013|FG000|NOT COMPLETED|Period 1||2||
48653479|NCT03787212|101938014|FG001|NOT COMPLETED|Period 1||2||
48653480|NCT01520714|101938015|FG000|STARTED|Overall Study||0||
48653481|NCT01520714|101938016|FG001|STARTED|Overall Study||11||
48653482|NCT01520714|101938015|FG000|COMPLETED|Overall Study||0||
48653483|NCT01520714|101938016|FG001|COMPLETED|Overall Study||5||
48653484|NCT01520714|101938015|FG000|NOT COMPLETED|Overall Study||0||
48653485|NCT01520714|101938016|FG001|NOT COMPLETED|Overall Study||6||
48653486|NCT04581629|101938017|FG000|STARTED|Period 1 (5 Days)||6||
48653487|NCT04581629|101938018|FG001|STARTED|Period 1 (5 Days)||0||
48653488|NCT04581629|101938019|FG002|STARTED|Period 1 (5 Days)||0||
48653489|NCT04581629|101938017|FG000|Received at Least One Dose of Study Treatment|Period 1 (5 Days)||6||
48653490|NCT04581629|101938018|FG001|Received at Least One Dose of Study Treatment|Period 1 (5 Days)||0||
48653491|NCT04581629|101938019|FG002|Received at Least One Dose of Study Treatment|Period 1 (5 Days)||0||
48653492|NCT04581629|101938017|FG000|COMPLETED|Period 1 (5 Days)||6||
48653493|NCT04581629|101938018|FG001|COMPLETED|Period 1 (5 Days)||0||
48653494|NCT04581629|101938019|FG002|COMPLETED|Period 1 (5 Days)||0||
48653495|NCT04581629|101938017|FG000|NOT COMPLETED|Period 1 (5 Days)||0||
48653496|NCT04581629|101938018|FG001|NOT COMPLETED|Period 1 (5 Days)||0||
48653497|NCT04581629|101938019|FG002|NOT COMPLETED|Period 1 (5 Days)||0||
48653498|NCT04581629|101938017|FG000|STARTED|Period 2 (5 Days)||0||
48653499|NCT04581629|101938018|FG001|STARTED|Period 2 (5 Days)||13||
48653500|NCT04581629|101938019|FG002|STARTED|Period 2 (5 Days)||0||
48653501|NCT04581629|101938017|FG000|Received at Least One Dose of Study Treatment|Period 2 (5 Days)||0||
48653502|NCT04581629|101938018|FG001|Received at Least One Dose of Study Treatment|Period 2 (5 Days)||13||
48653503|NCT04581629|101938019|FG002|Received at Least One Dose of Study Treatment|Period 2 (5 Days)||0||
48653504|NCT04581629|101938017|FG000|COMPLETED|Period 2 (5 Days)||0||
48653505|NCT04581629|101938018|FG001|COMPLETED|Period 2 (5 Days)||13||
48653506|NCT04581629|101938019|FG002|COMPLETED|Period 2 (5 Days)||0||
48653507|NCT04581629|101938017|FG000|NOT COMPLETED|Period 2 (5 Days)||0||
48653508|NCT04581629|101938018|FG001|NOT COMPLETED|Period 2 (5 Days)||0||
48653509|NCT04581629|101938019|FG002|NOT COMPLETED|Period 2 (5 Days)||0||
48765578|NCT03873116|102214678|FG000|NOT COMPLETED|Part 2||0||
48653510|NCT04581629|101938017|FG000|STARTED|Period 3 (24 Weeks)||0||
48653511|NCT04581629|101938018|FG001|STARTED|Period 3 (24 Weeks)||0||
48653512|NCT04581629|101938019|FG002|STARTED|Period 3 (24 Weeks)||13||
48653513|NCT04581629|101938017|FG000|Received at Least One Dose of Study Treatment|Period 3 (24 Weeks)||0||
48653514|NCT04581629|101938018|FG001|Received at Least One Dose of Study Treatment|Period 3 (24 Weeks)||0||
48653515|NCT04581629|101938019|FG002|Received at Least One Dose of Study Treatment|Period 3 (24 Weeks)||13||
48653516|NCT04581629|101938017|FG000|COMPLETED|Period 3 (24 Weeks)||0||
48653517|NCT04581629|101938018|FG001|COMPLETED|Period 3 (24 Weeks)||0||
48653518|NCT04581629|101938019|FG002|COMPLETED|Period 3 (24 Weeks)||13||
48653519|NCT04581629|101938017|FG000|NOT COMPLETED|Period 3 (24 Weeks)||0||
48653520|NCT04581629|101938018|FG001|NOT COMPLETED|Period 3 (24 Weeks)||0||
48653521|NCT04581629|101938019|FG002|NOT COMPLETED|Period 3 (24 Weeks)||0||
48653522|NCT02852005|101938020|FG000|STARTED|Overall Study||4||
48653523|NCT02852005|101938021|FG001|STARTED|Overall Study||4||
48653524|NCT02852005|101938022|FG002|STARTED|Overall Study||6||
48653525|NCT02852005|101938023|FG003|STARTED|Overall Study||6||
48653526|NCT02852005|101938024|FG004|STARTED|Overall Study||7||
48653527|NCT02852005|101938020|FG000|Month 0.5|Overall Study||3||
48653528|NCT02852005|101938021|FG001|Month 0.5|Overall Study||4||
48653529|NCT02852005|101938022|FG002|Month 0.5|Overall Study||6||
48653530|NCT02852005|101938023|FG003|Month 0.5|Overall Study||6||
48653531|NCT02852005|101938024|FG004|Month 0.5|Overall Study||7||
48653532|NCT02852005|101938020|FG000|Month 4.5|Overall Study||3||
48653533|NCT02852005|101938021|FG001|Month 4.5|Overall Study||4||
48653534|NCT02852005|101938022|FG002|Month 4.5|Overall Study||6||
48653535|NCT02852005|101938023|FG003|Month 4.5|Overall Study||6||
48653536|NCT02852005|101938024|FG004|Month 4.5|Overall Study||7||
48653537|NCT02852005|101938020|FG000|Month 10|Overall Study||3||
48653538|NCT02852005|101938021|FG001|Month 10|Overall Study||3||
48653539|NCT02852005|101938022|FG002|Month 10|Overall Study||6||
48653540|NCT02852005|101938023|FG003|Month 10|Overall Study||5||
48653541|NCT02852005|101938024|FG004|Month 10|Overall Study||7||
48653542|NCT02852005|101938020|FG000|COMPLETED|Overall Study||3||
48653543|NCT02852005|101938021|FG001|COMPLETED|Overall Study||4||
48653544|NCT02852005|101938022|FG002|COMPLETED|Overall Study||6||
48653545|NCT02852005|101938023|FG003|COMPLETED|Overall Study||6||
48653546|NCT02852005|101938024|FG004|COMPLETED|Overall Study||6||
48653547|NCT02852005|101938020|FG000|NOT COMPLETED|Overall Study||1||
48653548|NCT02852005|101938021|FG001|NOT COMPLETED|Overall Study||0||
48653549|NCT02852005|101938022|FG002|NOT COMPLETED|Overall Study||0||
48653550|NCT02852005|101938023|FG003|NOT COMPLETED|Overall Study||0||
48653551|NCT02852005|101938024|FG004|NOT COMPLETED|Overall Study||1||
48653552|NCT01783236|101938025|FG000|STARTED|Overall Study||8||
48653553|NCT01783236|101938026|FG001|STARTED|Overall Study||8||
48653554|NCT01783236|101938025|FG000|COMPLETED|Overall Study||6||
48653555|NCT01783236|101938026|FG001|COMPLETED|Overall Study||8||
48653556|NCT01783236|101938025|FG000|NOT COMPLETED|Overall Study||2||
48653557|NCT01783236|101938026|FG001|NOT COMPLETED|Overall Study||0||
48653558|NCT02642679|101938027|FG000|STARTED|Overall Study||19||
48653559|NCT02642679|101938027|FG000|COMPLETED|Overall Study||16|Three patients were withdrawn for personal reasons, and surgeon request.|
48653560|NCT02642679|101938027|FG000|NOT COMPLETED|Overall Study||3||
48653561|NCT01433081|101938028|FG000|STARTED|Overall Study||25||
48653562|NCT01433081|101938029|FG001|STARTED|Overall Study||25||
48653563|NCT01433081|101938028|FG000|COMPLETED|Overall Study||23||
48653564|NCT01433081|101938029|FG001|COMPLETED|Overall Study||23||
48653565|NCT01433081|101938028|FG000|NOT COMPLETED|Overall Study||2||
48653566|NCT01433081|101938029|FG001|NOT COMPLETED|Overall Study||2||
48653567|NCT01835431|101938030|FG000|STARTED|Overall Study||182||
48653568|NCT01835431|101938031|FG001|STARTED|Overall Study||180||
48653569|NCT01835431|101938030|FG000|Exposed|Overall Study||181||
48653570|NCT01835431|101938031|FG001|Exposed|Overall Study||179||
48653571|NCT01835431|101938030|FG000|COMPLETED|Overall Study||174||
48653572|NCT01835431|101938031|FG001|COMPLETED|Overall Study||168||
48653573|NCT01835431|101938030|FG000|NOT COMPLETED|Overall Study||8||
48653574|NCT01835431|101938031|FG001|NOT COMPLETED|Overall Study||12||
48653575|NCT01044693|101938032|FG000|STARTED|Overall Study||3||
48653576|NCT01044693|101938033|FG001|STARTED|Overall Study||1||
48653577|NCT01044693|101938034|FG002|STARTED|Overall Study||1||
48653578|NCT01044693|101938035|FG003|STARTED|Overall Study||1||
48653579|NCT01044693|101938036|FG004|STARTED|Overall Study||1||
48653580|NCT01044693|101938037|FG005|STARTED|Overall Study||2||
48653581|NCT01044693|101938038|FG006|STARTED|Overall Study||1||
48653582|NCT01044693|101938039|FG007|STARTED|Overall Study||1||
48653583|NCT01044693|101938040|FG008|STARTED|Overall Study||1||
48653584|NCT01044693|101938041|FG009|STARTED|Overall Study||1||
48653585|NCT01044693|101938042|FG010|STARTED|Overall Study||1||
48653586|NCT01044693|101938043|FG011|STARTED|Overall Study||1||
48653587|NCT01044693|101938044|FG012|STARTED|Overall Study||2||
48653588|NCT01044693|101938045|FG013|STARTED|Overall Study||1||
48653589|NCT01044693|101938046|FG014|STARTED|Overall Study||1||
48653590|NCT01044693|101938047|FG015|STARTED|Overall Study||1||
48653591|NCT01044693|101938032|FG000|COMPLETED|Overall Study||3||
48653592|NCT01044693|101938033|FG001|COMPLETED|Overall Study||1||
48653593|NCT01044693|101938034|FG002|COMPLETED|Overall Study||1||
48653594|NCT01044693|101938035|FG003|COMPLETED|Overall Study||1||
48653595|NCT01044693|101938036|FG004|COMPLETED|Overall Study||1||
48653596|NCT01044693|101938037|FG005|COMPLETED|Overall Study||2||
48653597|NCT01044693|101938038|FG006|COMPLETED|Overall Study||1||
48653598|NCT01044693|101938039|FG007|COMPLETED|Overall Study||1||
48653599|NCT01044693|101938040|FG008|COMPLETED|Overall Study||1||
48653600|NCT01044693|101938041|FG009|COMPLETED|Overall Study||1||
48653601|NCT01044693|101938042|FG010|COMPLETED|Overall Study||1||
48653602|NCT01044693|101938043|FG011|COMPLETED|Overall Study||1||
48653603|NCT01044693|101938044|FG012|COMPLETED|Overall Study||2||
48653604|NCT01044693|101938045|FG013|COMPLETED|Overall Study||1||
48653605|NCT01044693|101938046|FG014|COMPLETED|Overall Study||1||
48653606|NCT01044693|101938047|FG015|COMPLETED|Overall Study||1||
48653607|NCT01044693|101938032|FG000|NOT COMPLETED|Overall Study||0||
48653608|NCT01044693|101938033|FG001|NOT COMPLETED|Overall Study||0||
48653609|NCT01044693|101938034|FG002|NOT COMPLETED|Overall Study||0||
48653610|NCT01044693|101938035|FG003|NOT COMPLETED|Overall Study||0||
48653611|NCT01044693|101938036|FG004|NOT COMPLETED|Overall Study||0||
48653612|NCT01044693|101938037|FG005|NOT COMPLETED|Overall Study||0||
48653613|NCT01044693|101938038|FG006|NOT COMPLETED|Overall Study||0||
48653614|NCT01044693|101938039|FG007|NOT COMPLETED|Overall Study||0||
48653615|NCT01044693|101938040|FG008|NOT COMPLETED|Overall Study||0||
48653616|NCT01044693|101938041|FG009|NOT COMPLETED|Overall Study||0||
48653617|NCT01044693|101938042|FG010|NOT COMPLETED|Overall Study||0||
48653618|NCT01044693|101938043|FG011|NOT COMPLETED|Overall Study||0||
48653619|NCT01044693|101938044|FG012|NOT COMPLETED|Overall Study||0||
48653620|NCT01044693|101938045|FG013|NOT COMPLETED|Overall Study||0||
48653621|NCT01044693|101938046|FG014|NOT COMPLETED|Overall Study||0||
48653622|NCT01044693|101938047|FG015|NOT COMPLETED|Overall Study||0||
48653623|NCT00159874|101938048|FG000|STARTED|Overall Study||42||
48653624|NCT00159874|101938049|FG001|STARTED|Overall Study||55||
48653625|NCT00159874|101938050|FG002|STARTED|Overall Study||77||
48653626|NCT00159874|101938051|FG003|STARTED|Overall Study||13||
48653627|NCT00159874|101938052|FG004|STARTED|Overall Study||19||
48653628|NCT00159874|101938053|FG005|STARTED|Overall Study||23||
48653629|NCT00159874|101938054|FG006|STARTED|Overall Study||5||
48653630|NCT00159874|101938048|FG000|Treated|Overall Study||42||
48653631|NCT00159874|101938049|FG001|Treated|Overall Study||55||
48653632|NCT00159874|101938050|FG002|Treated|Overall Study||77||
48653633|NCT00159874|101938051|FG003|Treated|Overall Study||13||
48653634|NCT00159874|101938052|FG004|Treated|Overall Study||19||
48653635|NCT00159874|101938053|FG005|Treated|Overall Study||23||
48653636|NCT00159874|101938054|FG006|Treated|Overall Study||5||
48653637|NCT00159874|101938048|FG000|COMPLETED|Overall Study||22||
48653638|NCT00159874|101938049|FG001|COMPLETED|Overall Study||25||
48653639|NCT00159874|101938050|FG002|COMPLETED|Overall Study||34||
48653640|NCT00159874|101938051|FG003|COMPLETED|Overall Study||7||
48653641|NCT00159874|101938052|FG004|COMPLETED|Overall Study||11||
48653642|NCT00159874|101938053|FG005|COMPLETED|Overall Study||11||
48653643|NCT00159874|101938054|FG006|COMPLETED|Overall Study||0||
48653644|NCT00159874|101938048|FG000|NOT COMPLETED|Overall Study||20||
48653645|NCT00159874|101938049|FG001|NOT COMPLETED|Overall Study||30||
48653646|NCT00159874|101938050|FG002|NOT COMPLETED|Overall Study||43||
48653647|NCT00159874|101938051|FG003|NOT COMPLETED|Overall Study||6||
48653648|NCT00159874|101938052|FG004|NOT COMPLETED|Overall Study||8||
48653649|NCT00159874|101938053|FG005|NOT COMPLETED|Overall Study||12||
48653650|NCT00159874|101938054|FG006|NOT COMPLETED|Overall Study||5||
48653651|NCT04191616|101938055|FG000|STARTED|Overall Study||54||
48653652|NCT04191616|101938055|FG000|Received Carfilzomib|Overall Study||52||
48653653|NCT04191616|101938055|FG000|Received Pomalidomide|Overall Study||52||
48653654|NCT04191616|101938055|FG000|Received Dexamethasone|Overall Study||52||
48653655|NCT04191616|101938055|FG000|COMPLETED|Overall Study||0||
48653656|NCT04191616|101938055|FG000|NOT COMPLETED|Overall Study||54||
48653657|NCT05675020|101938056|FG000|STARTED|Overall Study||86||
48653658|NCT05675020|101938056|FG000|COMPLETED|Overall Study||9||
48765579|NCT03873116|102214679|FG001|NOT COMPLETED|Part 2||0||
48188269|NCT05457842|100783200|FG000|NOT COMPLETED|Overall Study||0||
48653659|NCT05675020|101938056|FG000|NOT COMPLETED|Overall Study||77||
48653660|NCT03506633|101938057|FG000|STARTED|First Intervention (1 Day)||8||
48653661|NCT03506633|101938058|FG001|STARTED|First Intervention (1 Day)||6||
48653662|NCT03506633|101938057|FG000|COMPLETED|First Intervention (1 Day)||8||
48653663|NCT03506633|101938058|FG001|COMPLETED|First Intervention (1 Day)||6||
48653664|NCT03506633|101938057|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48653665|NCT03506633|101938058|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48653666|NCT03506633|101938057|FG000|STARTED|Washout (14 Days)||8||
48653667|NCT03506633|101938058|FG001|STARTED|Washout (14 Days)||6||
48653668|NCT03506633|101938057|FG000|COMPLETED|Washout (14 Days)||7||
48653669|NCT03506633|101938058|FG001|COMPLETED|Washout (14 Days)||6||
48653670|NCT03506633|101938057|FG000|NOT COMPLETED|Washout (14 Days)||1||
48653671|NCT03506633|101938058|FG001|NOT COMPLETED|Washout (14 Days)||0||
48653672|NCT03506633|101938057|FG000|STARTED|Second Intervention (1 Day)||7||
48653673|NCT03506633|101938058|FG001|STARTED|Second Intervention (1 Day)||6||
48653674|NCT03506633|101938057|FG000|COMPLETED|Second Intervention (1 Day)||7||
48653675|NCT03506633|101938058|FG001|COMPLETED|Second Intervention (1 Day)||6||
48653676|NCT03506633|101938057|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48653677|NCT03506633|101938058|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48653678|NCT03166631|101938059|FG000|STARTED|Overall Study||3||
48653679|NCT03166631|101938060|FG001|STARTED|Overall Study||1||
48653680|NCT03166631|101938061|FG002|STARTED|Overall Study||3||
48653681|NCT03166631|101938062|FG003|STARTED|Overall Study||4||
48653682|NCT03166631|101938063|FG004|STARTED|Overall Study||3||
48653683|NCT03166631|101938064|FG005|STARTED|Overall Study||3||
48653684|NCT03166631|101938065|FG006|STARTED|Overall Study||8||
48653685|NCT03166631|101938066|FG007|STARTED|Overall Study||6||
48653686|NCT03166631|101938067|FG008|STARTED|Overall Study||14||
48653687|NCT03166631|101938068|FG009|STARTED|Overall Study||8||
48653688|NCT03166631|101938069|FG010|STARTED|Overall Study||9||
48653689|NCT03166631|101938059|FG000|COMPLETED|Overall Study||0|Completers: Patients who did not discontinue from trial medication (e.g. due to progressive disease)|
48653690|NCT03166631|101938060|FG001|COMPLETED|Overall Study||0|Completers: Patients who did not discontinue from trial medication (e.g. due to progressive disease)|
48653691|NCT03166631|101938061|FG002|COMPLETED|Overall Study||0|Completers: Patients who did not discontinue from trial medication (e.g. due to progressive disease)|
48653692|NCT03166631|101938062|FG003|COMPLETED|Overall Study||0|Completers: Patients who did not discontinue from trial medication (e.g. due to progressive disease)|
48653693|NCT03166631|101938063|FG004|COMPLETED|Overall Study||0|Completers: Patients who did not discontinue from trial medication (e.g. due to progressive disease)|
48653694|NCT03166631|101938064|FG005|COMPLETED|Overall Study||0|Completers: Patients who did not discontinue from trial medication (e.g. due to progressive disease)|
48653695|NCT03166631|101938065|FG006|COMPLETED|Overall Study||0|Completers: Patients who did not discontinue from trial medication (e.g. due to progressive disease)|
48653696|NCT03166631|101938066|FG007|COMPLETED|Overall Study||0|Completers: Patients who did not discontinue from trial medication (e.g. due to progressive disease)|
48653697|NCT03166631|101938067|FG008|COMPLETED|Overall Study||0|Completers: Patients who did not discontinue from trial medication (e.g. due to progressive disease)|
48653698|NCT03166631|101938068|FG009|COMPLETED|Overall Study||0|Completers: Patients who did not discontinue from trial medication (e.g. due to progressive disease)|
48653699|NCT03166631|101938069|FG010|COMPLETED|Overall Study||0|Completers: Patients who did not discontinue from trial medication (e.g. due to progressive disease)|
48653700|NCT03166631|101938059|FG000|NOT COMPLETED|Overall Study||3||
48653701|NCT03166631|101938060|FG001|NOT COMPLETED|Overall Study||1||
48653702|NCT03166631|101938061|FG002|NOT COMPLETED|Overall Study||3||
48653703|NCT03166631|101938062|FG003|NOT COMPLETED|Overall Study||4||
48653704|NCT03166631|101938063|FG004|NOT COMPLETED|Overall Study||3||
48653705|NCT03166631|101938064|FG005|NOT COMPLETED|Overall Study||3||
48653706|NCT03166631|101938065|FG006|NOT COMPLETED|Overall Study||8||
48653707|NCT03166631|101938066|FG007|NOT COMPLETED|Overall Study||6||
48653708|NCT03166631|101938067|FG008|NOT COMPLETED|Overall Study||14||
48653709|NCT03166631|101938068|FG009|NOT COMPLETED|Overall Study||8||
48653710|NCT03166631|101938069|FG010|NOT COMPLETED|Overall Study||9||
48653711|NCT01478087|101938070|FG000|STARTED|Overall Study||3||
48653712|NCT01478087|101938070|FG000|COMPLETED|Overall Study||2||
48653713|NCT01478087|101938070|FG000|NOT COMPLETED|Overall Study||1||
48653714|NCT05463705|101938071|FG000|STARTED|Overall Study||459||
48653715|NCT05463705|101938072|FG001|STARTED|Overall Study||484||
48653716|NCT05463705|101938073|FG002|STARTED|Overall Study||446||
48653717|NCT05463705|101938074|FG003|STARTED|Overall Study||62||
48653718|NCT05463705|101938075|FG004|STARTED|Overall Study||66||
48765580|NCT03873116|102214680|FG002|NOT COMPLETED|Part 2||1||
48188270|NCT04491617|100783201|FG000|STARTED|Overall Study||64||
48765581|NCT03873116|102214681|FG003|NOT COMPLETED|Part 2||0||
48765582|NCT03873116|102214682|FG004|NOT COMPLETED|Part 2||1||
48765583|NCT03873116|102214683|FG005|NOT COMPLETED|Part 2||0||
48765584|NCT03873116|102214678|FG000|STARTED|Part 3||0||
48765585|NCT03873116|102214679|FG001|STARTED|Part 3||3||
48765586|NCT03873116|102214680|FG002|STARTED|Part 3||0||
48765587|NCT03873116|102214681|FG003|STARTED|Part 3||1||
48765588|NCT03873116|102214682|FG004|STARTED|Part 3||6||
48765589|NCT03873116|102214683|FG005|STARTED|Part 3||1||
48765590|NCT03873116|102214678|FG000|COMPLETED|Part 3||0||
48765591|NCT03873116|102214679|FG001|COMPLETED|Part 3||3||
48765592|NCT03873116|102214680|FG002|COMPLETED|Part 3||0||
48765593|NCT03873116|102214681|FG003|COMPLETED|Part 3||1||
48765594|NCT03873116|102214682|FG004|COMPLETED|Part 3||5||
48765595|NCT03873116|102214683|FG005|COMPLETED|Part 3||1||
48765596|NCT03873116|102214678|FG000|NOT COMPLETED|Part 3||0||
48765597|NCT03873116|102214679|FG001|NOT COMPLETED|Part 3||0||
48765598|NCT03873116|102214680|FG002|NOT COMPLETED|Part 3||0||
48765599|NCT03873116|102214681|FG003|NOT COMPLETED|Part 3||0||
48765600|NCT03873116|102214682|FG004|NOT COMPLETED|Part 3||1||
48653719|NCT05463705|101938076|FG005|STARTED|Overall Study||63||
48653720|NCT05463705|101938071|FG000|COMPLETED|Overall Study||356|Only eligible patients who attended a visit with their PCP during the intervention period are included in the primary outcome. Providers were also required to have had at least one visit completed with an eligible patient for inclusion in the primary outcome.|
48653721|NCT05463705|101938072|FG001|COMPLETED|Overall Study||377|Only eligible patients who attended a visit with their PCP during the intervention period are included in the primary outcome. Providers were also required to have had at least one visit completed with an eligible patient for inclusion in the primary outcome.|
48653722|NCT05463705|101938073|FG002|COMPLETED|Overall Study||346|Only eligible patients who attended a visit with their PCP during the intervention period are included in the primary outcome. Providers were also required to have had at least one visit completed with an eligible patient for inclusion in the primary outcome.|
48653723|NCT05463705|101938074|FG003|COMPLETED|Overall Study||58|Only eligible patients who attended a visit with their PCP during the intervention period are included in the primary outcome. Providers were also required to have had at least one visit completed with an eligible patient for inclusion in the primary outcome.|
48653724|NCT05463705|101938075|FG004|COMPLETED|Overall Study||58|Only eligible patients who attended a visit with their PCP during the intervention period are included in the primary outcome. Providers were also required to have had at least one visit completed with an eligible patient for inclusion in the primary outcome.|
48653725|NCT05463705|101938076|FG005|COMPLETED|Overall Study||59|Only eligible patients who attended a visit with their PCP during the intervention period are included in the primary outcome. Providers were also required to have had at least one visit completed with an eligible patient for inclusion in the primary outcome.|
48653726|NCT05463705|101938071|FG000|NOT COMPLETED|Overall Study||103||
48653727|NCT05463705|101938072|FG001|NOT COMPLETED|Overall Study||107||
48653728|NCT05463705|101938073|FG002|NOT COMPLETED|Overall Study||100||
48653729|NCT05463705|101938074|FG003|NOT COMPLETED|Overall Study||4||
48653730|NCT05463705|101938075|FG004|NOT COMPLETED|Overall Study||8||
48653731|NCT05463705|101938076|FG005|NOT COMPLETED|Overall Study||4||
48653732|NCT01657942|101938077|FG000|STARTED|Overall Study||101||
48653733|NCT01657942|101938077|FG000|Post Treatment Assignment Group 1) Involvement of Neurovascular Bundles and/or Urethra|Overall Study||57||
48653734|NCT01657942|101938077|FG000|Post Treatment Assignment Group 2) no Involvement of Neurovascular Bundles and/or Urethra|Overall Study||44||
48653735|NCT01657942|101938077|FG000|COMPLETED|Overall Study||93||
48653736|NCT01657942|101938077|FG000|NOT COMPLETED|Overall Study||8||
48653737|NCT02991859|101938078|FG000|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2||
48653738|NCT02991859|101938079|FG001|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3||
48653739|NCT02991859|101938080|FG002|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2||
48653740|NCT02991859|101938081|FG003|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2||
48653741|NCT02991859|101938082|FG004|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3||
48653742|NCT02991859|101938083|FG005|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3||
48653743|NCT02991859|101938084|FG006|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2||
48653744|NCT02991859|101938085|FG007|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2||
48653745|NCT02991859|101938086|FG008|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2||
48653746|NCT02991859|101938087|FG009|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2||
48653747|NCT02991859|101938088|FG010|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2||
48653748|NCT02991859|101938089|FG011|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2||
48653749|NCT02991859|101938090|FG012|STARTED|Period 1,Escalation Phase 1,Upto Day 7||7||
48653750|NCT02991859|101938091|FG013|STARTED|Period 1,Escalation Phase 1,Upto Day 7||7||
48653751|NCT02991859|101938092|FG014|STARTED|Period 1,Escalation Phase 1,Upto Day 7||6||
48653752|NCT02991859|101938093|FG015|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3||
48653753|NCT02991859|101938094|FG016|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3||
48653754|NCT02991859|101938078|FG000|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2||
48653755|NCT02991859|101938079|FG001|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2||
48653756|NCT02991859|101938080|FG002|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2||
48653757|NCT02991859|101938081|FG003|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2||
48653758|NCT02991859|101938082|FG004|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2||
48653759|NCT02991859|101938083|FG005|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3||
48653760|NCT02991859|101938084|FG006|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2||
48653761|NCT02991859|101938085|FG007|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2||
48653762|NCT02991859|101938086|FG008|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2||
48653763|NCT02991859|101938087|FG009|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2||
48653764|NCT02991859|101938088|FG010|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2||
48653765|NCT02991859|101938089|FG011|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2||
48653766|NCT02991859|101938090|FG012|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||7||
48653767|NCT02991859|101938091|FG013|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||7||
48653768|NCT02991859|101938092|FG014|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||6||
48653769|NCT02991859|101938093|FG015|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3||
48653770|NCT02991859|101938094|FG016|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3||
48653771|NCT02991859|101938078|FG000|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0||
48653772|NCT02991859|101938079|FG001|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||1||
48653773|NCT02991859|101938080|FG002|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0||
48362363|NCT04283461|101214525|FG009|STARTED|Overall Study||10||
48362364|NCT04283461|101214526|FG010|STARTED|Overall Study||10||
48653774|NCT02991859|101938081|FG003|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0||
48653775|NCT02991859|101938082|FG004|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||1||
48653776|NCT02991859|101938083|FG005|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0||
48653777|NCT02991859|101938084|FG006|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0||
48653778|NCT02991859|101938085|FG007|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0||
48653779|NCT02991859|101938086|FG008|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0||
48653780|NCT02991859|101938087|FG009|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0||
48653781|NCT02991859|101938088|FG010|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0||
48653782|NCT02991859|101938089|FG011|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0||
48653783|NCT02991859|101938090|FG012|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0||
48653784|NCT02991859|101938091|FG013|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0||
48653785|NCT02991859|101938092|FG014|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0||
48653786|NCT02991859|101938093|FG015|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0||
48653787|NCT02991859|101938094|FG016|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0||
48653788|NCT02991859|101938078|FG000|STARTED|Period 1,Escalation Phase2,Upto Day 14||2||
48653789|NCT02991859|101938079|FG001|STARTED|Period 1,Escalation Phase2,Upto Day 14||2||
48653790|NCT02991859|101938080|FG002|STARTED|Period 1,Escalation Phase2,Upto Day 14||2||
48653791|NCT02991859|101938081|FG003|STARTED|Period 1,Escalation Phase2,Upto Day 14||2||
48653792|NCT02991859|101938082|FG004|STARTED|Period 1,Escalation Phase2,Upto Day 14||2||
48653793|NCT02991859|101938083|FG005|STARTED|Period 1,Escalation Phase2,Upto Day 14||3||
48653794|NCT02991859|101938084|FG006|STARTED|Period 1,Escalation Phase2,Upto Day 14||2||
48653795|NCT02991859|101938085|FG007|STARTED|Period 1,Escalation Phase2,Upto Day 14||2||
48653796|NCT02991859|101938086|FG008|STARTED|Period 1,Escalation Phase2,Upto Day 14||2||
48653797|NCT02991859|101938087|FG009|STARTED|Period 1,Escalation Phase2,Upto Day 14||2||
48653798|NCT02991859|101938088|FG010|STARTED|Period 1,Escalation Phase2,Upto Day 14||2||
48653799|NCT02991859|101938089|FG011|STARTED|Period 1,Escalation Phase2,Upto Day 14||2||
48653800|NCT02991859|101938090|FG012|STARTED|Period 1,Escalation Phase2,Upto Day 14||7||
48653801|NCT02991859|101938091|FG013|STARTED|Period 1,Escalation Phase2,Upto Day 14||7||
48653802|NCT02991859|101938092|FG014|STARTED|Period 1,Escalation Phase2,Upto Day 14||6||
48653803|NCT02991859|101938093|FG015|STARTED|Period 1,Escalation Phase2,Upto Day 14||3||
48653804|NCT02991859|101938094|FG016|STARTED|Period 1,Escalation Phase2,Upto Day 14||3||
48653805|NCT02991859|101938078|FG000|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2||
48653806|NCT02991859|101938079|FG001|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2||
48653807|NCT02991859|101938080|FG002|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2||
48653808|NCT02991859|101938081|FG003|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2||
48653809|NCT02991859|101938082|FG004|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2||
48653810|NCT02991859|101938083|FG005|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3||
48653811|NCT02991859|101938084|FG006|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2||
48653812|NCT02991859|101938085|FG007|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2||
48653813|NCT02991859|101938086|FG008|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2||
48653814|NCT02991859|101938087|FG009|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2||
48653815|NCT02991859|101938088|FG010|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2||
48653816|NCT02991859|101938089|FG011|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2||
48653817|NCT02991859|101938090|FG012|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||7||
48653818|NCT02991859|101938091|FG013|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||7||
48653819|NCT02991859|101938092|FG014|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||6||
48653820|NCT02991859|101938093|FG015|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3||
48653821|NCT02991859|101938094|FG016|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3||
48653822|NCT02991859|101938078|FG000|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0||
48653823|NCT02991859|101938079|FG001|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0||
48653824|NCT02991859|101938080|FG002|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0||
48653825|NCT02991859|101938081|FG003|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0||
48653826|NCT02991859|101938082|FG004|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0||
48653827|NCT02991859|101938083|FG005|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0||
48653828|NCT02991859|101938084|FG006|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0||
48653829|NCT02991859|101938085|FG007|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0||
48653830|NCT02991859|101938086|FG008|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0||
48653831|NCT02991859|101938087|FG009|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0||
48653832|NCT02991859|101938088|FG010|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0||
48653833|NCT02991859|101938089|FG011|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0||
48653834|NCT02991859|101938090|FG012|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0||
48653835|NCT02991859|101938091|FG013|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0||
48653836|NCT02991859|101938092|FG014|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0||
48653837|NCT02991859|101938093|FG015|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0||
48653838|NCT02991859|101938094|FG016|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0||
48653839|NCT02991859|101938078|FG000|STARTED|Period1, Escalation Phase3, Upto Day21||2||
48653840|NCT02991859|101938079|FG001|STARTED|Period1, Escalation Phase3, Upto Day21||2||
48653841|NCT02991859|101938080|FG002|STARTED|Period1, Escalation Phase3, Upto Day21||2||
48653842|NCT02991859|101938081|FG003|STARTED|Period1, Escalation Phase3, Upto Day21||2||
48653843|NCT02991859|101938082|FG004|STARTED|Period1, Escalation Phase3, Upto Day21||2||
48653844|NCT02991859|101938083|FG005|STARTED|Period1, Escalation Phase3, Upto Day21||3||
48653845|NCT02991859|101938084|FG006|STARTED|Period1, Escalation Phase3, Upto Day21||2||
48653846|NCT02991859|101938085|FG007|STARTED|Period1, Escalation Phase3, Upto Day21||2||
48653847|NCT02991859|101938086|FG008|STARTED|Period1, Escalation Phase3, Upto Day21||2||
48653848|NCT02991859|101938087|FG009|STARTED|Period1, Escalation Phase3, Upto Day21||2||
48653849|NCT02991859|101938088|FG010|STARTED|Period1, Escalation Phase3, Upto Day21||2||
48653850|NCT02991859|101938089|FG011|STARTED|Period1, Escalation Phase3, Upto Day21||2||
48653851|NCT02991859|101938090|FG012|STARTED|Period1, Escalation Phase3, Upto Day21||7||
48653852|NCT02991859|101938091|FG013|STARTED|Period1, Escalation Phase3, Upto Day21||7||
48653853|NCT02991859|101938092|FG014|STARTED|Period1, Escalation Phase3, Upto Day21||6||
48653854|NCT02991859|101938093|FG015|STARTED|Period1, Escalation Phase3, Upto Day21||3||
48653855|NCT02991859|101938094|FG016|STARTED|Period1, Escalation Phase3, Upto Day21||3||
48653856|NCT02991859|101938078|FG000|COMPLETED|Period1, Escalation Phase3, Upto Day21||2||
48653857|NCT02991859|101938079|FG001|COMPLETED|Period1, Escalation Phase3, Upto Day21||2||
48653858|NCT02991859|101938080|FG002|COMPLETED|Period1, Escalation Phase3, Upto Day21||2||
48653859|NCT02991859|101938081|FG003|COMPLETED|Period1, Escalation Phase3, Upto Day21||2||
48653860|NCT02991859|101938082|FG004|COMPLETED|Period1, Escalation Phase3, Upto Day21||2||
48653861|NCT02991859|101938083|FG005|COMPLETED|Period1, Escalation Phase3, Upto Day21||3||
48653862|NCT02991859|101938084|FG006|COMPLETED|Period1, Escalation Phase3, Upto Day21||2||
48653863|NCT02991859|101938085|FG007|COMPLETED|Period1, Escalation Phase3, Upto Day21||2||
48653864|NCT02991859|101938086|FG008|COMPLETED|Period1, Escalation Phase3, Upto Day21||2||
48653865|NCT02991859|101938087|FG009|COMPLETED|Period1, Escalation Phase3, Upto Day21||2||
48653866|NCT02991859|101938088|FG010|COMPLETED|Period1, Escalation Phase3, Upto Day21||2||
48653867|NCT02991859|101938089|FG011|COMPLETED|Period1, Escalation Phase3, Upto Day21||2||
48653868|NCT02991859|101938090|FG012|COMPLETED|Period1, Escalation Phase3, Upto Day21||6||
48653869|NCT02991859|101938091|FG013|COMPLETED|Period1, Escalation Phase3, Upto Day21||6||
48653870|NCT02991859|101938092|FG014|COMPLETED|Period1, Escalation Phase3, Upto Day21||6||
48653871|NCT02991859|101938093|FG015|COMPLETED|Period1, Escalation Phase3, Upto Day21||3||
48653872|NCT02991859|101938094|FG016|COMPLETED|Period1, Escalation Phase3, Upto Day21||3||
48653873|NCT02991859|101938078|FG000|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0||
48653874|NCT02991859|101938079|FG001|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0||
48653875|NCT02991859|101938080|FG002|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0||
48653876|NCT02991859|101938081|FG003|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0||
48653877|NCT02991859|101938082|FG004|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0||
48653878|NCT02991859|101938083|FG005|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0||
48653879|NCT02991859|101938084|FG006|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0||
48653880|NCT02991859|101938085|FG007|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0||
48653881|NCT02991859|101938086|FG008|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0||
48653882|NCT02991859|101938087|FG009|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0||
48653883|NCT02991859|101938088|FG010|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0||
48653884|NCT02991859|101938089|FG011|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0||
48653885|NCT02991859|101938090|FG012|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||1||
48653886|NCT02991859|101938091|FG013|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||1||
48653887|NCT02991859|101938092|FG014|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0||
48653888|NCT02991859|101938093|FG015|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0||
48653889|NCT02991859|101938094|FG016|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0||
48653890|NCT02991859|101938078|FG000|STARTED|Period1, Escalation Phase4, Upto Day28||2||
48653891|NCT02991859|101938079|FG001|STARTED|Period1, Escalation Phase4, Upto Day28||2||
48653892|NCT02991859|101938080|FG002|STARTED|Period1, Escalation Phase4, Upto Day28||2||
48653893|NCT02991859|101938081|FG003|STARTED|Period1, Escalation Phase4, Upto Day28||2||
48653894|NCT02991859|101938082|FG004|STARTED|Period1, Escalation Phase4, Upto Day28||2||
48653895|NCT02991859|101938083|FG005|STARTED|Period1, Escalation Phase4, Upto Day28||2||
48653896|NCT02991859|101938084|FG006|STARTED|Period1, Escalation Phase4, Upto Day28||2||
48653897|NCT02991859|101938085|FG007|STARTED|Period1, Escalation Phase4, Upto Day28||2||
48653898|NCT02991859|101938086|FG008|STARTED|Period1, Escalation Phase4, Upto Day28||2||
48653899|NCT02991859|101938087|FG009|STARTED|Period1, Escalation Phase4, Upto Day28||2||
48653900|NCT02991859|101938088|FG010|STARTED|Period1, Escalation Phase4, Upto Day28||2||
48653901|NCT02991859|101938089|FG011|STARTED|Period1, Escalation Phase4, Upto Day28||2||
48653902|NCT02991859|101938090|FG012|STARTED|Period1, Escalation Phase4, Upto Day28||6||
48653903|NCT02991859|101938091|FG013|STARTED|Period1, Escalation Phase4, Upto Day28||6||
48653904|NCT02991859|101938092|FG014|STARTED|Period1, Escalation Phase4, Upto Day28||6||
48653905|NCT02991859|101938093|FG015|STARTED|Period1, Escalation Phase4, Upto Day28||3||
48653906|NCT02991859|101938094|FG016|STARTED|Period1, Escalation Phase4, Upto Day28||3||
48653907|NCT02991859|101938078|FG000|COMPLETED|Period1, Escalation Phase4, Upto Day28||2||
48653908|NCT02991859|101938079|FG001|COMPLETED|Period1, Escalation Phase4, Upto Day28||2||
48653909|NCT02991859|101938080|FG002|COMPLETED|Period1, Escalation Phase4, Upto Day28||2||
48653910|NCT02991859|101938081|FG003|COMPLETED|Period1, Escalation Phase4, Upto Day28||2||
48653911|NCT02991859|101938082|FG004|COMPLETED|Period1, Escalation Phase4, Upto Day28||2||
48653912|NCT02991859|101938083|FG005|COMPLETED|Period1, Escalation Phase4, Upto Day28||2||
48653913|NCT02991859|101938084|FG006|COMPLETED|Period1, Escalation Phase4, Upto Day28||2||
48653914|NCT02991859|101938085|FG007|COMPLETED|Period1, Escalation Phase4, Upto Day28||2||
48653915|NCT02991859|101938086|FG008|COMPLETED|Period1, Escalation Phase4, Upto Day28||2||
48653916|NCT02991859|101938087|FG009|COMPLETED|Period1, Escalation Phase4, Upto Day28||2||
48653917|NCT02991859|101938088|FG010|COMPLETED|Period1, Escalation Phase4, Upto Day28||2||
48653918|NCT02991859|101938089|FG011|COMPLETED|Period1, Escalation Phase4, Upto Day28||2||
48653919|NCT02991859|101938090|FG012|COMPLETED|Period1, Escalation Phase4, Upto Day28||6||
48653920|NCT02991859|101938091|FG013|COMPLETED|Period1, Escalation Phase4, Upto Day28||6||
48653921|NCT02991859|101938092|FG014|COMPLETED|Period1, Escalation Phase4, Upto Day28||6||
48653922|NCT02991859|101938093|FG015|COMPLETED|Period1, Escalation Phase4, Upto Day28||3||
48653923|NCT02991859|101938094|FG016|COMPLETED|Period1, Escalation Phase4, Upto Day28||3||
48653924|NCT02991859|101938078|FG000|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0||
48653925|NCT02991859|101938079|FG001|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0||
48362365|NCT04283461|101214527|FG011|STARTED|Overall Study||10||
48362366|NCT04283461|101214528|FG012|STARTED|Overall Study||0||
48362367|NCT04283461|101214516|FG000|COMPLETED|Overall Study||0||
48362368|NCT04283461|101214517|FG001|COMPLETED|Overall Study||15||
48653926|NCT02991859|101938080|FG002|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0||
48653927|NCT02991859|101938081|FG003|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0||
48653928|NCT02991859|101938082|FG004|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0||
48653929|NCT02991859|101938083|FG005|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0||
48653930|NCT02991859|101938084|FG006|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0||
48653931|NCT02991859|101938085|FG007|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0||
48653932|NCT02991859|101938086|FG008|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0||
48653933|NCT02991859|101938087|FG009|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0||
48653934|NCT02991859|101938088|FG010|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0||
48653935|NCT02991859|101938089|FG011|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0||
48653936|NCT02991859|101938090|FG012|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0||
48653937|NCT02991859|101938091|FG013|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0||
48653938|NCT02991859|101938092|FG014|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0||
48653939|NCT02991859|101938093|FG015|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0||
48653940|NCT02991859|101938094|FG016|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0||
48653941|NCT02991859|101938078|FG000|STARTED|Period1, Escalation Phase5, Upto Day35||2||
48653942|NCT02991859|101938079|FG001|STARTED|Period1, Escalation Phase5, Upto Day35||2||
48653943|NCT02991859|101938080|FG002|STARTED|Period1, Escalation Phase5, Upto Day35||2||
48653944|NCT02991859|101938081|FG003|STARTED|Period1, Escalation Phase5, Upto Day35||2||
48653945|NCT02991859|101938082|FG004|STARTED|Period1, Escalation Phase5, Upto Day35||2||
48653946|NCT02991859|101938083|FG005|STARTED|Period1, Escalation Phase5, Upto Day35||2||
48653947|NCT02991859|101938084|FG006|STARTED|Period1, Escalation Phase5, Upto Day35||2||
48653948|NCT02991859|101938085|FG007|STARTED|Period1, Escalation Phase5, Upto Day35||2||
48653949|NCT02991859|101938086|FG008|STARTED|Period1, Escalation Phase5, Upto Day35||2||
48653950|NCT02991859|101938087|FG009|STARTED|Period1, Escalation Phase5, Upto Day35||2||
48653951|NCT02991859|101938088|FG010|STARTED|Period1, Escalation Phase5, Upto Day35||1||
48653952|NCT02991859|101938089|FG011|STARTED|Period1, Escalation Phase5, Upto Day35||2||
48653953|NCT02991859|101938090|FG012|STARTED|Period1, Escalation Phase5, Upto Day35||6||
48653954|NCT02991859|101938091|FG013|STARTED|Period1, Escalation Phase5, Upto Day35||6||
48653955|NCT02991859|101938092|FG014|STARTED|Period1, Escalation Phase5, Upto Day35||6||
48653956|NCT02991859|101938093|FG015|STARTED|Period1, Escalation Phase5, Upto Day35||3||
48653957|NCT02991859|101938094|FG016|STARTED|Period1, Escalation Phase5, Upto Day35||3||
48653958|NCT02991859|101938078|FG000|COMPLETED|Period1, Escalation Phase5, Upto Day35||2||
48653959|NCT02991859|101938079|FG001|COMPLETED|Period1, Escalation Phase5, Upto Day35||2||
48653960|NCT02991859|101938080|FG002|COMPLETED|Period1, Escalation Phase5, Upto Day35||2||
48653961|NCT02991859|101938081|FG003|COMPLETED|Period1, Escalation Phase5, Upto Day35||2||
48653962|NCT02991859|101938082|FG004|COMPLETED|Period1, Escalation Phase5, Upto Day35||2||
48653963|NCT02991859|101938083|FG005|COMPLETED|Period1, Escalation Phase5, Upto Day35||2||
48653964|NCT02991859|101938084|FG006|COMPLETED|Period1, Escalation Phase5, Upto Day35||2||
48653965|NCT02991859|101938085|FG007|COMPLETED|Period1, Escalation Phase5, Upto Day35||2||
48653966|NCT02991859|101938086|FG008|COMPLETED|Period1, Escalation Phase5, Upto Day35||2||
48653967|NCT02991859|101938087|FG009|COMPLETED|Period1, Escalation Phase5, Upto Day35||2||
48653968|NCT02991859|101938088|FG010|COMPLETED|Period1, Escalation Phase5, Upto Day35||1||
48653969|NCT02991859|101938089|FG011|COMPLETED|Period1, Escalation Phase5, Upto Day35||2||
48362369|NCT04283461|101214518|FG002|COMPLETED|Overall Study||7||
48362370|NCT04283461|101214519|FG003|COMPLETED|Overall Study||2||
48362371|NCT04283461|101214520|FG004|COMPLETED|Overall Study||3||
48362372|NCT04283461|101214521|FG005|COMPLETED|Overall Study||10||
48362373|NCT04283461|101214522|FG006|COMPLETED|Overall Study||10||
48362374|NCT04283461|101214523|FG007|COMPLETED|Overall Study||2||
48362375|NCT04283461|101214524|FG008|COMPLETED|Overall Study||0||
48362376|NCT04283461|101214525|FG009|COMPLETED|Overall Study||10||
48653970|NCT02991859|101938090|FG012|COMPLETED|Period1, Escalation Phase5, Upto Day35||6||
48653971|NCT02991859|101938091|FG013|COMPLETED|Period1, Escalation Phase5, Upto Day35||6||
48653972|NCT02991859|101938092|FG014|COMPLETED|Period1, Escalation Phase5, Upto Day35||6||
48653973|NCT02991859|101938093|FG015|COMPLETED|Period1, Escalation Phase5, Upto Day35||3||
48653974|NCT02991859|101938094|FG016|COMPLETED|Period1, Escalation Phase5, Upto Day35||3||
48653975|NCT02991859|101938078|FG000|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0||
48653976|NCT02991859|101938079|FG001|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0||
48653977|NCT02991859|101938080|FG002|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0||
48653978|NCT02991859|101938081|FG003|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0||
48653979|NCT02991859|101938082|FG004|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0||
48653980|NCT02991859|101938083|FG005|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0||
48653981|NCT02991859|101938084|FG006|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0||
48653982|NCT02991859|101938085|FG007|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0||
48653983|NCT02991859|101938086|FG008|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0||
48653984|NCT02991859|101938087|FG009|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0||
48653985|NCT02991859|101938088|FG010|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0||
48653986|NCT02991859|101938089|FG011|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0||
48653987|NCT02991859|101938090|FG012|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0||
48653988|NCT02991859|101938091|FG013|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0||
48653989|NCT02991859|101938092|FG014|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0||
48653990|NCT02991859|101938093|FG015|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0||
48653991|NCT02991859|101938094|FG016|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0||
48653992|NCT02991859|101938078|FG000|STARTED|Wash Out, Up to Day 77||2||
48653993|NCT02991859|101938079|FG001|STARTED|Wash Out, Up to Day 77||2||
48653994|NCT02991859|101938080|FG002|STARTED|Wash Out, Up to Day 77||2||
48653995|NCT02991859|101938081|FG003|STARTED|Wash Out, Up to Day 77||2||
48653996|NCT02991859|101938082|FG004|STARTED|Wash Out, Up to Day 77||2||
48653997|NCT02991859|101938083|FG005|STARTED|Wash Out, Up to Day 77||2||
48362377|NCT04283461|101214526|FG010|COMPLETED|Overall Study||10||
48362378|NCT04283461|101214527|FG011|COMPLETED|Overall Study||3||
48653998|NCT02991859|101938084|FG006|STARTED|Wash Out, Up to Day 77||2||
48653999|NCT02991859|101938085|FG007|STARTED|Wash Out, Up to Day 77||2||
48654000|NCT02991859|101938086|FG008|STARTED|Wash Out, Up to Day 77||2||
48654001|NCT02991859|101938087|FG009|STARTED|Wash Out, Up to Day 77||2||
48654002|NCT02991859|101938088|FG010|STARTED|Wash Out, Up to Day 77||1||
48654003|NCT02991859|101938089|FG011|STARTED|Wash Out, Up to Day 77||2||
48654004|NCT02991859|101938090|FG012|STARTED|Wash Out, Up to Day 77||0||
48654005|NCT02991859|101938091|FG013|STARTED|Wash Out, Up to Day 77||0||
48654006|NCT02991859|101938092|FG014|STARTED|Wash Out, Up to Day 77||0||
48654007|NCT02991859|101938093|FG015|STARTED|Wash Out, Up to Day 77||0||
48654008|NCT02991859|101938094|FG016|STARTED|Wash Out, Up to Day 77||0||
48654009|NCT02991859|101938078|FG000|COMPLETED|Wash Out, Up to Day 77||2||
48654010|NCT02991859|101938079|FG001|COMPLETED|Wash Out, Up to Day 77||2||
48654011|NCT02991859|101938080|FG002|COMPLETED|Wash Out, Up to Day 77||2||
48654012|NCT02991859|101938081|FG003|COMPLETED|Wash Out, Up to Day 77||2||
48654013|NCT02991859|101938082|FG004|COMPLETED|Wash Out, Up to Day 77||2||
48654014|NCT02991859|101938083|FG005|COMPLETED|Wash Out, Up to Day 77||1||
48654015|NCT02991859|101938084|FG006|COMPLETED|Wash Out, Up to Day 77||2||
48654016|NCT02991859|101938085|FG007|COMPLETED|Wash Out, Up to Day 77||2||
48765601|NCT03873116|102214683|FG005|NOT COMPLETED|Part 3||0||
48765602|NCT02166346|102214684|FG000|STARTED|Screening and Randomization||12||
48765603|NCT02166346|102214685|FG001|STARTED|Screening and Randomization||12||
48765604|NCT02166346|102214684|FG000|COMPLETED|Screening and Randomization||8||
48765605|NCT02166346|102214685|FG001|COMPLETED|Screening and Randomization||8||
48765606|NCT02166346|102214684|FG000|NOT COMPLETED|Screening and Randomization||4||
48765607|NCT02166346|102214685|FG001|NOT COMPLETED|Screening and Randomization||4||
48765608|NCT02166346|102214684|FG000|STARTED|Intervention - Phase 1||8||
48765609|NCT02166346|102214685|FG001|STARTED|Intervention - Phase 1||8||
48654017|NCT02991859|101938086|FG008|COMPLETED|Wash Out, Up to Day 77||2||
48654018|NCT02991859|101938087|FG009|COMPLETED|Wash Out, Up to Day 77||1||
48654019|NCT02991859|101938088|FG010|COMPLETED|Wash Out, Up to Day 77||1||
48654020|NCT02991859|101938089|FG011|COMPLETED|Wash Out, Up to Day 77||2||
48654021|NCT02991859|101938090|FG012|COMPLETED|Wash Out, Up to Day 77||0||
48654022|NCT02991859|101938091|FG013|COMPLETED|Wash Out, Up to Day 77||0||
48654023|NCT02991859|101938092|FG014|COMPLETED|Wash Out, Up to Day 77||0||
48654024|NCT02991859|101938093|FG015|COMPLETED|Wash Out, Up to Day 77||0||
48654025|NCT02991859|101938094|FG016|COMPLETED|Wash Out, Up to Day 77||0||
48765610|NCT02166346|102214684|FG000|COMPLETED|Intervention - Phase 1||8||
48765611|NCT02166346|102214685|FG001|COMPLETED|Intervention - Phase 1||6||
48765612|NCT02166346|102214684|FG000|NOT COMPLETED|Intervention - Phase 1||0||
48765613|NCT02166346|102214685|FG001|NOT COMPLETED|Intervention - Phase 1||2||
48765614|NCT02166346|102214684|FG000|STARTED|Intervention - Phase 2 (After Crossover)||8||
48765615|NCT02166346|102214685|FG001|STARTED|Intervention - Phase 2 (After Crossover)||6||
48765616|NCT02166346|102214684|FG000|COMPLETED|Intervention - Phase 2 (After Crossover)||7||
48765617|NCT02166346|102214685|FG001|COMPLETED|Intervention - Phase 2 (After Crossover)||6||
48654026|NCT02991859|101938078|FG000|NOT COMPLETED|Wash Out, Up to Day 77||0||
48654027|NCT02991859|101938079|FG001|NOT COMPLETED|Wash Out, Up to Day 77||0||
48654028|NCT02991859|101938080|FG002|NOT COMPLETED|Wash Out, Up to Day 77||0||
48654029|NCT02991859|101938081|FG003|NOT COMPLETED|Wash Out, Up to Day 77||0||
48654030|NCT02991859|101938082|FG004|NOT COMPLETED|Wash Out, Up to Day 77||0||
48654031|NCT02991859|101938083|FG005|NOT COMPLETED|Wash Out, Up to Day 77||1||
48654032|NCT02991859|101938084|FG006|NOT COMPLETED|Wash Out, Up to Day 77||0||
48654033|NCT02991859|101938085|FG007|NOT COMPLETED|Wash Out, Up to Day 77||0||
48654034|NCT02991859|101938086|FG008|NOT COMPLETED|Wash Out, Up to Day 77||0||
48654035|NCT02991859|101938087|FG009|NOT COMPLETED|Wash Out, Up to Day 77||1||
48654036|NCT02991859|101938088|FG010|NOT COMPLETED|Wash Out, Up to Day 77||0||
48654037|NCT02991859|101938089|FG011|NOT COMPLETED|Wash Out, Up to Day 77||0||
48654038|NCT02991859|101938090|FG012|NOT COMPLETED|Wash Out, Up to Day 77||0||
48654039|NCT02991859|101938091|FG013|NOT COMPLETED|Wash Out, Up to Day 77||0||
48654040|NCT02991859|101938092|FG014|NOT COMPLETED|Wash Out, Up to Day 77||0||
48654041|NCT02991859|101938093|FG015|NOT COMPLETED|Wash Out, Up to Day 77||0||
48654042|NCT02991859|101938094|FG016|NOT COMPLETED|Wash Out, Up to Day 77||0||
48654043|NCT02991859|101938078|FG000|STARTED|Period2, Escalation Phase1, Upto Day 84||2||
48654044|NCT02991859|101938079|FG001|STARTED|Period2, Escalation Phase1, Upto Day 84||2||
48654045|NCT02991859|101938080|FG002|STARTED|Period2, Escalation Phase1, Upto Day 84||2||
48654046|NCT02991859|101938081|FG003|STARTED|Period2, Escalation Phase1, Upto Day 84||2||
48654047|NCT02991859|101938082|FG004|STARTED|Period2, Escalation Phase1, Upto Day 84||2||
48654048|NCT02991859|101938083|FG005|STARTED|Period2, Escalation Phase1, Upto Day 84||1||
48654049|NCT02991859|101938084|FG006|STARTED|Period2, Escalation Phase1, Upto Day 84||2||
48654050|NCT02991859|101938085|FG007|STARTED|Period2, Escalation Phase1, Upto Day 84||2||
48654051|NCT02991859|101938086|FG008|STARTED|Period2, Escalation Phase1, Upto Day 84||2||
48654052|NCT02991859|101938087|FG009|STARTED|Period2, Escalation Phase1, Upto Day 84||2||
48654053|NCT02991859|101938088|FG010|STARTED|Period2, Escalation Phase1, Upto Day 84||2||
48654054|NCT02991859|101938089|FG011|STARTED|Period2, Escalation Phase1, Upto Day 84||2||
48654055|NCT02991859|101938090|FG012|STARTED|Period2, Escalation Phase1, Upto Day 84||0||
48654056|NCT02991859|101938091|FG013|STARTED|Period2, Escalation Phase1, Upto Day 84||0||
48654057|NCT02991859|101938092|FG014|STARTED|Period2, Escalation Phase1, Upto Day 84||0||
48654058|NCT02991859|101938093|FG015|STARTED|Period2, Escalation Phase1, Upto Day 84||0||
48654059|NCT02991859|101938094|FG016|STARTED|Period2, Escalation Phase1, Upto Day 84||0||
48654060|NCT02991859|101938078|FG000|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2||
48654061|NCT02991859|101938079|FG001|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2||
48654062|NCT02991859|101938080|FG002|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2||
48654063|NCT02991859|101938081|FG003|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2||
48654064|NCT02991859|101938082|FG004|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2||
48654065|NCT02991859|101938083|FG005|COMPLETED|Period2, Escalation Phase1, Upto Day 84||1||
48654066|NCT02991859|101938084|FG006|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2||
48654067|NCT02991859|101938085|FG007|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2||
48654068|NCT02991859|101938086|FG008|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2||
48654069|NCT02991859|101938087|FG009|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2||
48654070|NCT02991859|101938088|FG010|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2||
48654071|NCT02991859|101938089|FG011|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2||
48654072|NCT02991859|101938090|FG012|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
48654073|NCT02991859|101938091|FG013|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
48654074|NCT02991859|101938092|FG014|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
48654075|NCT02991859|101938093|FG015|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
48654076|NCT02991859|101938094|FG016|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
48654077|NCT02991859|101938078|FG000|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
48654078|NCT02991859|101938079|FG001|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
48654079|NCT02991859|101938080|FG002|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
48654080|NCT02991859|101938081|FG003|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
48654081|NCT02991859|101938082|FG004|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
48654082|NCT02991859|101938083|FG005|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
48654083|NCT02991859|101938084|FG006|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
48654084|NCT02991859|101938085|FG007|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
48654085|NCT02991859|101938086|FG008|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
48654086|NCT02991859|101938087|FG009|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
48654087|NCT02991859|101938088|FG010|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
48654088|NCT02991859|101938089|FG011|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
48654089|NCT02991859|101938090|FG012|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
48654090|NCT02991859|101938091|FG013|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
48654091|NCT02991859|101938092|FG014|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
48654092|NCT02991859|101938093|FG015|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
48654093|NCT02991859|101938094|FG016|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
48654094|NCT02991859|101938078|FG000|STARTED|Period2, Escalation Phase2, Upto Day 91||2||
48654095|NCT02991859|101938079|FG001|STARTED|Period2, Escalation Phase2, Upto Day 91||2||
48654096|NCT02991859|101938080|FG002|STARTED|Period2, Escalation Phase2, Upto Day 91||2||
48654097|NCT02991859|101938081|FG003|STARTED|Period2, Escalation Phase2, Upto Day 91||2||
48654098|NCT02991859|101938082|FG004|STARTED|Period2, Escalation Phase2, Upto Day 91||2||
48654099|NCT02991859|101938083|FG005|STARTED|Period2, Escalation Phase2, Upto Day 91||1||
48654100|NCT02991859|101938084|FG006|STARTED|Period2, Escalation Phase2, Upto Day 91||2||
48654101|NCT02991859|101938085|FG007|STARTED|Period2, Escalation Phase2, Upto Day 91||2||
48654102|NCT02991859|101938086|FG008|STARTED|Period2, Escalation Phase2, Upto Day 91||2||
48654103|NCT02991859|101938087|FG009|STARTED|Period2, Escalation Phase2, Upto Day 91||2||
48654104|NCT02991859|101938088|FG010|STARTED|Period2, Escalation Phase2, Upto Day 91||2||
48654105|NCT02991859|101938089|FG011|STARTED|Period2, Escalation Phase2, Upto Day 91||2||
48654106|NCT02991859|101938090|FG012|STARTED|Period2, Escalation Phase2, Upto Day 91||0||
48654107|NCT02991859|101938091|FG013|STARTED|Period2, Escalation Phase2, Upto Day 91||0||
48654108|NCT02991859|101938092|FG014|STARTED|Period2, Escalation Phase2, Upto Day 91||0||
48654109|NCT02991859|101938093|FG015|STARTED|Period2, Escalation Phase2, Upto Day 91||0||
48654110|NCT02991859|101938094|FG016|STARTED|Period2, Escalation Phase2, Upto Day 91||0||
48654111|NCT02991859|101938078|FG000|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2||
48654112|NCT02991859|101938079|FG001|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2||
48654113|NCT02991859|101938080|FG002|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2||
48654114|NCT02991859|101938081|FG003|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2||
48654115|NCT02991859|101938082|FG004|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2||
48654116|NCT02991859|101938083|FG005|COMPLETED|Period2, Escalation Phase2, Upto Day 91||1||
48654117|NCT02991859|101938084|FG006|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2||
48654118|NCT02991859|101938085|FG007|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2||
48654119|NCT02991859|101938086|FG008|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2||
48654120|NCT02991859|101938087|FG009|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2||
48654121|NCT02991859|101938088|FG010|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2||
48654122|NCT02991859|101938089|FG011|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2||
48654123|NCT02991859|101938090|FG012|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
48654124|NCT02991859|101938091|FG013|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
48654125|NCT02991859|101938092|FG014|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
48654126|NCT02991859|101938093|FG015|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
48654127|NCT02991859|101938094|FG016|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
48654128|NCT02991859|101938078|FG000|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
48654129|NCT02991859|101938079|FG001|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
48654130|NCT02991859|101938080|FG002|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
48654131|NCT02991859|101938081|FG003|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
48654132|NCT02991859|101938082|FG004|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
48654133|NCT02991859|101938083|FG005|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
48654134|NCT02991859|101938084|FG006|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
48654135|NCT02991859|101938085|FG007|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
48654136|NCT02991859|101938086|FG008|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
48654137|NCT02991859|101938087|FG009|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
48654138|NCT02991859|101938088|FG010|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
48654139|NCT02991859|101938089|FG011|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
48654140|NCT02991859|101938090|FG012|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
48654141|NCT02991859|101938091|FG013|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
48654142|NCT02991859|101938092|FG014|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
48654143|NCT02991859|101938093|FG015|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
48654144|NCT02991859|101938094|FG016|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
48654145|NCT02991859|101938078|FG000|STARTED|Period2, Escalation Phase3, Upto Day 98||2||
48654146|NCT02991859|101938079|FG001|STARTED|Period2, Escalation Phase3, Upto Day 98||2||
48654147|NCT02991859|101938080|FG002|STARTED|Period2, Escalation Phase3, Upto Day 98||2||
48654148|NCT02991859|101938081|FG003|STARTED|Period2, Escalation Phase3, Upto Day 98||2||
48654149|NCT02991859|101938082|FG004|STARTED|Period2, Escalation Phase3, Upto Day 98||2||
48654150|NCT02991859|101938083|FG005|STARTED|Period2, Escalation Phase3, Upto Day 98||1||
48654151|NCT02991859|101938084|FG006|STARTED|Period2, Escalation Phase3, Upto Day 98||2||
48654152|NCT02991859|101938085|FG007|STARTED|Period2, Escalation Phase3, Upto Day 98||2||
48654153|NCT02991859|101938086|FG008|STARTED|Period2, Escalation Phase3, Upto Day 98||2||
48654154|NCT02991859|101938087|FG009|STARTED|Period2, Escalation Phase3, Upto Day 98||2||
48654155|NCT02991859|101938088|FG010|STARTED|Period2, Escalation Phase3, Upto Day 98||2||
48654156|NCT02991859|101938089|FG011|STARTED|Period2, Escalation Phase3, Upto Day 98||2||
48654157|NCT02991859|101938090|FG012|STARTED|Period2, Escalation Phase3, Upto Day 98||0||
48654158|NCT02991859|101938091|FG013|STARTED|Period2, Escalation Phase3, Upto Day 98||0||
48654159|NCT02991859|101938092|FG014|STARTED|Period2, Escalation Phase3, Upto Day 98||0||
48654160|NCT02991859|101938093|FG015|STARTED|Period2, Escalation Phase3, Upto Day 98||0||
48654161|NCT02991859|101938094|FG016|STARTED|Period2, Escalation Phase3, Upto Day 98||0||
48654162|NCT02991859|101938078|FG000|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2||
48654163|NCT02991859|101938079|FG001|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2||
48654164|NCT02991859|101938080|FG002|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2||
48654165|NCT02991859|101938081|FG003|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2||
48654166|NCT02991859|101938082|FG004|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2||
48654167|NCT02991859|101938083|FG005|COMPLETED|Period2, Escalation Phase3, Upto Day 98||1||
48654168|NCT02991859|101938084|FG006|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2||
48654169|NCT02991859|101938085|FG007|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2||
48654170|NCT02991859|101938086|FG008|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2||
48654171|NCT02991859|101938087|FG009|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2||
48654172|NCT02991859|101938088|FG010|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2||
48654173|NCT02991859|101938089|FG011|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2||
48654174|NCT02991859|101938090|FG012|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
48654175|NCT02991859|101938091|FG013|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
48765618|NCT02166346|102214684|FG000|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||1||
48765619|NCT02166346|102214685|FG001|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||0||
48765620|NCT02798627|102214686|FG000|STARTED|Overall Study||27||
48765621|NCT02798627|102214687|FG001|STARTED|Overall Study||28||
48654176|NCT02991859|101938092|FG014|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
48654177|NCT02991859|101938093|FG015|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
48654178|NCT02991859|101938094|FG016|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
48654179|NCT02991859|101938078|FG000|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
48654180|NCT02991859|101938079|FG001|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
48654181|NCT02991859|101938080|FG002|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
48654182|NCT02991859|101938081|FG003|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
48654183|NCT02991859|101938082|FG004|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
48654184|NCT02991859|101938083|FG005|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
48654185|NCT02991859|101938084|FG006|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
48654186|NCT02991859|101938085|FG007|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
48654187|NCT02991859|101938086|FG008|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
48654188|NCT02991859|101938087|FG009|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
48654189|NCT02991859|101938088|FG010|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
48654190|NCT02991859|101938089|FG011|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
48654191|NCT02991859|101938090|FG012|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
48654192|NCT02991859|101938091|FG013|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
48654193|NCT02991859|101938092|FG014|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
48654194|NCT02991859|101938093|FG015|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
48654195|NCT02991859|101938094|FG016|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
48654196|NCT02991859|101938078|FG000|STARTED|Period2, Escalation Phase4, Upto Day 105||2||
48654197|NCT02991859|101938079|FG001|STARTED|Period2, Escalation Phase4, Upto Day 105||2||
48654198|NCT02991859|101938080|FG002|STARTED|Period2, Escalation Phase4, Upto Day 105||2||
48654199|NCT02991859|101938081|FG003|STARTED|Period2, Escalation Phase4, Upto Day 105||2||
48654200|NCT02991859|101938082|FG004|STARTED|Period2, Escalation Phase4, Upto Day 105||2||
48654201|NCT02991859|101938083|FG005|STARTED|Period2, Escalation Phase4, Upto Day 105||1||
48654202|NCT02991859|101938084|FG006|STARTED|Period2, Escalation Phase4, Upto Day 105||2||
48654203|NCT02991859|101938085|FG007|STARTED|Period2, Escalation Phase4, Upto Day 105||2||
48654204|NCT02991859|101938086|FG008|STARTED|Period2, Escalation Phase4, Upto Day 105||2||
48654205|NCT02991859|101938087|FG009|STARTED|Period2, Escalation Phase4, Upto Day 105||2||
48654206|NCT02991859|101938088|FG010|STARTED|Period2, Escalation Phase4, Upto Day 105||2||
48654207|NCT02991859|101938089|FG011|STARTED|Period2, Escalation Phase4, Upto Day 105||2||
48654208|NCT02991859|101938090|FG012|STARTED|Period2, Escalation Phase4, Upto Day 105||0||
48654209|NCT02991859|101938091|FG013|STARTED|Period2, Escalation Phase4, Upto Day 105||0||
48654210|NCT02991859|101938092|FG014|STARTED|Period2, Escalation Phase4, Upto Day 105||0||
48654211|NCT02991859|101938093|FG015|STARTED|Period2, Escalation Phase4, Upto Day 105||0||
48654212|NCT02991859|101938094|FG016|STARTED|Period2, Escalation Phase4, Upto Day 105||0||
48654213|NCT02991859|101938078|FG000|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2||
48654214|NCT02991859|101938079|FG001|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2||
48654215|NCT02991859|101938080|FG002|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2||
48654216|NCT02991859|101938081|FG003|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2||
48765622|NCT02798627|102214686|FG000|COMPLETED|Overall Study||27||
48765623|NCT02798627|102214687|FG001|COMPLETED|Overall Study||28||
48765624|NCT02798627|102214686|FG000|NOT COMPLETED|Overall Study||0||
48765625|NCT02798627|102214687|FG001|NOT COMPLETED|Overall Study||0||
48654217|NCT02991859|101938082|FG004|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2||
48765626|NCT01310777|102214688|FG000|STARTED|Overall Study||193||
48765627|NCT01310777|102214689|FG001|STARTED|Overall Study||192||
48765628|NCT01310777|102214690|FG002|STARTED|Overall Study||175||
48765629|NCT01310777|102214688|FG000|COMPLETED|Overall Study||160||
48765630|NCT01310777|102214689|FG001|COMPLETED|Overall Study||178||
48654218|NCT02991859|101938083|FG005|COMPLETED|Period2, Escalation Phase4, Upto Day 105||1||
48654219|NCT02991859|101938084|FG006|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2||
48654220|NCT02991859|101938085|FG007|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2||
48654221|NCT02991859|101938086|FG008|COMPLETED|Period2, Escalation Phase4, Upto Day 105||1||
48654222|NCT02991859|101938087|FG009|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2||
48654223|NCT02991859|101938088|FG010|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2||
48654224|NCT02991859|101938089|FG011|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2||
48654225|NCT02991859|101938090|FG012|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
48654226|NCT02991859|101938091|FG013|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
48654227|NCT02991859|101938092|FG014|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
48654228|NCT02991859|101938093|FG015|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
48654229|NCT02991859|101938094|FG016|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
48654230|NCT02991859|101938078|FG000|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
48654231|NCT02991859|101938079|FG001|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
48654232|NCT02991859|101938080|FG002|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
48654233|NCT02991859|101938081|FG003|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
48654234|NCT02991859|101938082|FG004|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
48654235|NCT02991859|101938083|FG005|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
48654236|NCT02991859|101938084|FG006|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
48654237|NCT02991859|101938085|FG007|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
48654238|NCT02991859|101938086|FG008|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||1||
48654239|NCT02991859|101938087|FG009|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
48654240|NCT02991859|101938088|FG010|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
48654241|NCT02991859|101938089|FG011|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
48654242|NCT02991859|101938090|FG012|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
48654243|NCT02991859|101938091|FG013|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
48654244|NCT02991859|101938092|FG014|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
48654245|NCT02991859|101938093|FG015|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
48654246|NCT02991859|101938094|FG016|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
48654247|NCT02991859|101938078|FG000|STARTED|Period2,Escalation Phase5,Upto Day 112||2||
48654248|NCT02991859|101938079|FG001|STARTED|Period2,Escalation Phase5,Upto Day 112||2||
48654249|NCT02991859|101938080|FG002|STARTED|Period2,Escalation Phase5,Upto Day 112||2||
48654250|NCT02991859|101938081|FG003|STARTED|Period2,Escalation Phase5,Upto Day 112||2||
48654251|NCT02991859|101938082|FG004|STARTED|Period2,Escalation Phase5,Upto Day 112||2||
48654252|NCT02991859|101938083|FG005|STARTED|Period2,Escalation Phase5,Upto Day 112||1||
48654253|NCT02991859|101938084|FG006|STARTED|Period2,Escalation Phase5,Upto Day 112||2||
48654254|NCT02991859|101938085|FG007|STARTED|Period2,Escalation Phase5,Upto Day 112||2||
48654255|NCT02991859|101938086|FG008|STARTED|Period2,Escalation Phase5,Upto Day 112||1||
48654256|NCT02991859|101938087|FG009|STARTED|Period2,Escalation Phase5,Upto Day 112||2||
48654257|NCT02991859|101938088|FG010|STARTED|Period2,Escalation Phase5,Upto Day 112||2||
48654258|NCT02991859|101938089|FG011|STARTED|Period2,Escalation Phase5,Upto Day 112||2||
48654259|NCT02991859|101938090|FG012|STARTED|Period2,Escalation Phase5,Upto Day 112||0||
48654260|NCT02991859|101938091|FG013|STARTED|Period2,Escalation Phase5,Upto Day 112||0||
48654261|NCT02991859|101938092|FG014|STARTED|Period2,Escalation Phase5,Upto Day 112||0||
48654262|NCT02991859|101938093|FG015|STARTED|Period2,Escalation Phase5,Upto Day 112||0||
48654263|NCT02991859|101938094|FG016|STARTED|Period2,Escalation Phase5,Upto Day 112||0||
48654264|NCT02991859|101938078|FG000|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2||
48654265|NCT02991859|101938079|FG001|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2||
48654266|NCT02991859|101938080|FG002|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2||
48654267|NCT02991859|101938081|FG003|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2||
48654268|NCT02991859|101938082|FG004|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2||
48654269|NCT02991859|101938083|FG005|COMPLETED|Period2,Escalation Phase5,Upto Day 112||1||
48654270|NCT02991859|101938084|FG006|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2||
48654271|NCT02991859|101938085|FG007|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2||
48654272|NCT02991859|101938086|FG008|COMPLETED|Period2,Escalation Phase5,Upto Day 112||1||
48654273|NCT02991859|101938087|FG009|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2||
48654274|NCT02991859|101938088|FG010|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2||
48654275|NCT02991859|101938089|FG011|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2||
48654276|NCT02991859|101938090|FG012|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
48654277|NCT02991859|101938091|FG013|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
48654278|NCT02991859|101938092|FG014|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
48654279|NCT02991859|101938093|FG015|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
48654280|NCT02991859|101938094|FG016|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
48654281|NCT02991859|101938078|FG000|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
48654282|NCT02991859|101938079|FG001|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
48654283|NCT02991859|101938080|FG002|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
48654284|NCT02991859|101938081|FG003|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
48654285|NCT02991859|101938082|FG004|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
48654286|NCT02991859|101938083|FG005|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
48654287|NCT02991859|101938084|FG006|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
48654288|NCT02991859|101938085|FG007|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
48654289|NCT02991859|101938086|FG008|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
48654290|NCT02991859|101938087|FG009|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
48654291|NCT02991859|101938088|FG010|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
48654292|NCT02991859|101938089|FG011|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
48654293|NCT02991859|101938090|FG012|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
48654294|NCT02991859|101938091|FG013|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
48654295|NCT02991859|101938092|FG014|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
48654296|NCT02991859|101938093|FG015|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
48654297|NCT02991859|101938094|FG016|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
48654298|NCT03382561|101938095|FG000|STARTED|Overall Study||80||
48654299|NCT03382561|101938096|FG001|STARTED|Overall Study||80||
48654300|NCT03382561|101938095|FG000|Received Treatment|Overall Study||77||
48654301|NCT03382561|101938096|FG001|Received Treatment|Overall Study||74||
48654302|NCT03382561|101938095|FG000|Eligible and Treated Patients|Overall Study||75||
48654303|NCT03382561|101938096|FG001|Eligible and Treated Patients|Overall Study||69||
48654304|NCT03382561|101938095|FG000|COMPLETED|Overall Study||4||
48654305|NCT03382561|101938096|FG001|COMPLETED|Overall Study||47||
48654306|NCT03382561|101938095|FG000|NOT COMPLETED|Overall Study||76||
48654307|NCT03382561|101938096|FG001|NOT COMPLETED|Overall Study||33||
48654308|NCT02340676|101938097|FG000|STARTED|Overall Study||25||
48654309|NCT02340676|101938097|FG000|COMPLETED|Overall Study||25||
48654310|NCT02340676|101938097|FG000|NOT COMPLETED|Overall Study||0||
48654311|NCT01234714|101938098|FG000|STARTED|Overall Study||84||
48654312|NCT01234714|101938098|FG000|COMPLETED|Overall Study||84||
48654313|NCT01234714|101938098|FG000|NOT COMPLETED|Overall Study||0||
48654314|NCT03387579|101938099|FG000|STARTED|Overall Study||12||
48654315|NCT03387579|101938100|FG001|STARTED|Overall Study||12||
48654316|NCT03387579|101938101|FG002|STARTED|Overall Study||24||
48654317|NCT03387579|101938099|FG000|COMPLETED|Overall Study||12||
48654318|NCT03387579|101938100|FG001|COMPLETED|Overall Study||12||
48654319|NCT03387579|101938101|FG002|COMPLETED|Overall Study||24||
48654320|NCT03387579|101938099|FG000|NOT COMPLETED|Overall Study||0||
48654321|NCT03387579|101938100|FG001|NOT COMPLETED|Overall Study||0||
48654322|NCT03387579|101938101|FG002|NOT COMPLETED|Overall Study||0||
48654323|NCT04778709|101938102|FG000|STARTED|Overall Study||2||4
48654324|NCT04778709|101938103|FG001|STARTED|Overall Study||2||4
48654325|NCT04778709|101938102|FG000|COMPLETED|Overall Study||0||0
48654326|NCT04778709|101938103|FG001|COMPLETED|Overall Study||0||0
48654327|NCT04778709|101938102|FG000|NOT COMPLETED|Overall Study||2||4
48654328|NCT04778709|101938103|FG001|NOT COMPLETED|Overall Study||2||4
48654329|NCT02799290|101938104|FG000|STARTED|Overall Study||24||28
48654330|NCT02799290|101938105|FG001|STARTED|Overall Study||13||15
48654331|NCT02799290|101938106|FG002|STARTED|Overall Study||11||13
48654332|NCT02799290|101938104|FG000|COMPLETED|Overall Study||24||28
48654333|NCT02799290|101938105|FG001|COMPLETED|Overall Study||13||15
48654334|NCT02799290|101938106|FG002|COMPLETED|Overall Study||11||13
48654335|NCT02799290|101938104|FG000|NOT COMPLETED|Overall Study||0||0
48654336|NCT02799290|101938105|FG001|NOT COMPLETED|Overall Study||0||0
48654337|NCT02799290|101938106|FG002|NOT COMPLETED|Overall Study||0||0
48654338|NCT01371565|101938107|FG000|STARTED|Overall Study||4||
48654339|NCT01371565|101938107|FG000|COMPLETED|Overall Study||1||
48654340|NCT01371565|101938107|FG000|NOT COMPLETED|Overall Study||3||
48654341|NCT03760640|101938108|FG000|STARTED|Period 1||20||
48654342|NCT03760640|101938109|FG001|STARTED|Period 1||22||
48654343|NCT03760640|101938108|FG000|Received at Least 1 Dose of Study Drug|Period 1||20||
48654344|NCT03760640|101938109|FG001|Received at Least 1 Dose of Study Drug|Period 1||22||
48654345|NCT03760640|101938108|FG000|COMPLETED|Period 1||20||
48654346|NCT03760640|101938109|FG001|COMPLETED|Period 1||22||
48654347|NCT03760640|101938108|FG000|NOT COMPLETED|Period 1||0||
48654348|NCT03760640|101938109|FG001|NOT COMPLETED|Period 1||0||
48654349|NCT03760640|101938108|FG000|STARTED|Period 2||20||
48654350|NCT03760640|101938109|FG001|STARTED|Period 2||22||
48654351|NCT03760640|101938108|FG000|COMPLETED|Period 2||20||
48654352|NCT03760640|101938109|FG001|COMPLETED|Period 2||22||
48654353|NCT03760640|101938108|FG000|NOT COMPLETED|Period 2||0||
48654354|NCT03760640|101938109|FG001|NOT COMPLETED|Period 2||0||
48654355|NCT04941898|101938110|FG000|STARTED|Overall Study||16||
48654356|NCT04941898|101938110|FG000|COMPLETED|Overall Study||15||
48654357|NCT04941898|101938110|FG000|NOT COMPLETED|Overall Study||1||
48654358|NCT00310180|101938111|FG000|STARTED|Overall Study||1629||
48654359|NCT00310180|101938112|FG001|STARTED|Overall Study||3458||
48654360|NCT00310180|101938113|FG002|STARTED|Overall Study||3449||
48654361|NCT00310180|101938114|FG003|STARTED|Overall Study||1737||
48654362|NCT00310180|101938111|FG000|No On-study Data|Overall Study||0||
48654363|NCT00310180|101938112|FG001|No On-study Data|Overall Study||2||
48654364|NCT00310180|101938113|FG002|No On-study Data|Overall Study||10||
48654365|NCT00310180|101938114|FG003|No On-study Data|Overall Study||172||
48654366|NCT00310180|101938111|FG000|Ineligible|Overall Study||3||
48654367|NCT00310180|101938112|FG001|Ineligible|Overall Study||4||
48654368|NCT00310180|101938113|FG002|Ineligible|Overall Study||6||
48654369|NCT00310180|101938114|FG003|Ineligible|Overall Study||7||
48654370|NCT00310180|101938111|FG000|No Follow-up Data|Overall Study||7||
48654371|NCT00310180|101938112|FG001|No Follow-up Data|Overall Study||55||
48654372|NCT00310180|101938113|FG002|No Follow-up Data|Overall Study||131||
48654373|NCT00310180|101938114|FG003|No Follow-up Data|Overall Study||245||
48654374|NCT00310180|101938111|FG000|COMPLETED|Overall Study||1619|Patients analyzed in the main analysis|
48654375|NCT00310180|101938112|FG001|COMPLETED|Overall Study||3399|Patients analyzed in the main analysis|
48654376|NCT00310180|101938113|FG002|COMPLETED|Overall Study||3312|Patients analyzed in the main analysis|
48654377|NCT00310180|101938114|FG003|COMPLETED|Overall Study||1389|Patients analyzed in the main analysis|
48654378|NCT00310180|101938111|FG000|NOT COMPLETED|Overall Study||10||
48654379|NCT00310180|101938112|FG001|NOT COMPLETED|Overall Study||59||
48654380|NCT00310180|101938113|FG002|NOT COMPLETED|Overall Study||137||
48654381|NCT00310180|101938114|FG003|NOT COMPLETED|Overall Study||348||
48654382|NCT01708954|101938115|FG000|STARTED|Step 1||42||
48654383|NCT01708954|101938116|FG001|STARTED|Step 1||40||
48654384|NCT01708954|101938117|FG002|STARTED|Step 1||43||
48654385|NCT01708954|101938115|FG000|Started Protocol Therapy|Step 1||40||
48654386|NCT01708954|101938116|FG001|Started Protocol Therapy|Step 1||40||
48654387|NCT01708954|101938117|FG002|Started Protocol Therapy|Step 1||39||
48654388|NCT01708954|101938115|FG000|Eligible and Treated|Step 1||38||
48654389|NCT01708954|101938116|FG001|Eligible and Treated|Step 1||38||
48654390|NCT01708954|101938117|FG002|Eligible and Treated|Step 1||35||
48654391|NCT01708954|101938115|FG000|Patients With MET Status Data Available|Step 1||30||
48654392|NCT01708954|101938116|FG001|Patients With MET Status Data Available|Step 1||32||
48654393|NCT01708954|101938117|FG002|Patients With MET Status Data Available|Step 1||24||
48654394|NCT01708954|101938115|FG000|COMPLETED|Step 1||0||
48654395|NCT01708954|101938116|FG001|COMPLETED|Step 1||0||
48654396|NCT01708954|101938117|FG002|COMPLETED|Step 1||0||
48654397|NCT01708954|101938115|FG000|NOT COMPLETED|Step 1||42||
48654398|NCT01708954|101938116|FG001|NOT COMPLETED|Step 1||40||
48654399|NCT01708954|101938117|FG002|NOT COMPLETED|Step 1||43||
48654400|NCT01708954|101938115|FG000|STARTED|Step 2||13||
48654401|NCT01708954|101938116|FG001|STARTED|Step 2||7||
48654402|NCT01708954|101938117|FG002|STARTED|Step 2||0||
48654403|NCT01708954|101938115|FG000|COMPLETED|Step 2||0||
48654404|NCT01708954|101938116|FG001|COMPLETED|Step 2||0||
48654405|NCT01708954|101938117|FG002|COMPLETED|Step 2||0||
48654406|NCT01708954|101938115|FG000|NOT COMPLETED|Step 2||13||
48654407|NCT01708954|101938116|FG001|NOT COMPLETED|Step 2||7||
48654408|NCT01708954|101938117|FG002|NOT COMPLETED|Step 2||0||
48654409|NCT00972478|101938118|FG000|STARTED|Overall Study||11||
48654410|NCT00972478|101938119|FG001|STARTED|Overall Study||72||
48654411|NCT00972478|101938118|FG000|Eligible and Began Protocol Therapy|Overall Study||9||
48654412|NCT00972478|101938119|FG001|Eligible and Began Protocol Therapy|Overall Study||63||
48654413|NCT00972478|101938118|FG000|COMPLETED|Overall Study||4||
48654414|NCT00972478|101938119|FG001|COMPLETED|Overall Study||34||
48654415|NCT00972478|101938118|FG000|NOT COMPLETED|Overall Study||7||
48654416|NCT00972478|101938119|FG001|NOT COMPLETED|Overall Study||38||
48654417|NCT00930787|101938120|FG000|STARTED|Overall Study||14||
48654418|NCT00930787|101938121|FG001|STARTED|Overall Study||9||
48654419|NCT00930787|101938120|FG000|COMPLETED|Overall Study||14||
48654420|NCT00930787|101938121|FG001|COMPLETED|Overall Study||9||
48654421|NCT00930787|101938120|FG000|NOT COMPLETED|Overall Study||0||
48654422|NCT00930787|101938121|FG001|NOT COMPLETED|Overall Study||0||
48654423|NCT00420407|101938122|FG000|STARTED|Overall Study||41||
48654424|NCT00420407|101938123|FG001|STARTED|Overall Study||40||
48654425|NCT00420407|101938122|FG000|COMPLETED|Overall Study||37||
48654426|NCT00420407|101938123|FG001|COMPLETED|Overall Study||34||
48654427|NCT00420407|101938122|FG000|NOT COMPLETED|Overall Study||4||
48654428|NCT00420407|101938123|FG001|NOT COMPLETED|Overall Study||6||
48654429|NCT03721107|101938124|FG000|STARTED|Overall Study||80||
48654430|NCT03721107|101938125|FG001|STARTED|Overall Study||84||
48654431|NCT03721107|101938126|FG002|STARTED|Overall Study||98||
48654432|NCT03721107|101938127|FG003|STARTED|Overall Study||104||
48654433|NCT03721107|101938124|FG000|Treated|Overall Study||80||
48654434|NCT03721107|101938125|FG001|Treated|Overall Study||84||
48654435|NCT03721107|101938126|FG002|Treated|Overall Study||97||
48654436|NCT03721107|101938127|FG003|Treated|Overall Study||104||
48654437|NCT03721107|101938124|FG000|COMPLETED|Overall Study||75||
48188271|NCT04491617|100783202|FG001|STARTED|Overall Study||65||
48654438|NCT03721107|101938125|FG001|COMPLETED|Overall Study||81||
48654439|NCT03721107|101938126|FG002|COMPLETED|Overall Study||83||
48654440|NCT03721107|101938127|FG003|COMPLETED|Overall Study||92||
48654441|NCT03721107|101938124|FG000|NOT COMPLETED|Overall Study||5||
48654442|NCT03721107|101938125|FG001|NOT COMPLETED|Overall Study||3||
48654443|NCT03721107|101938126|FG002|NOT COMPLETED|Overall Study||15||
48654444|NCT03721107|101938127|FG003|NOT COMPLETED|Overall Study||12||
48654445|NCT01755156|101938128|FG000|STARTED|Phase A (Weeks 0-24)||201||
48654446|NCT01755156|101938129|FG001|STARTED|Phase A (Weeks 0-24)||201||
48654447|NCT01755156|101938128|FG000|COMPLETED|Phase A (Weeks 0-24)||184||
48654448|NCT01755156|101938129|FG001|COMPLETED|Phase A (Weeks 0-24)||177||
48654449|NCT01755156|101938128|FG000|NOT COMPLETED|Phase A (Weeks 0-24)||17||
48654450|NCT01755156|101938129|FG001|NOT COMPLETED|Phase A (Weeks 0-24)||24||
48654451|NCT01755156|101938128|FG000|STARTED|Phase B (Weeks 24-104)||183||
48654452|NCT01755156|101938129|FG001|STARTED|Phase B (Weeks 24-104)||177||
48654453|NCT01755156|101938128|FG000|COMPLETED|Phase B (Weeks 24-104)||144||
48654454|NCT01755156|101938129|FG001|COMPLETED|Phase B (Weeks 24-104)||141||
48654455|NCT01755156|101938128|FG000|NOT COMPLETED|Phase B (Weeks 24-104)||39||
48654456|NCT01755156|101938129|FG001|NOT COMPLETED|Phase B (Weeks 24-104)||36||
48654457|NCT05463055|101938130|FG000|STARTED|Overall Study||47||
48654458|NCT05463055|101938130|FG000|COMPLETED|Overall Study||45||
48654459|NCT05463055|101938130|FG000|NOT COMPLETED|Overall Study||2||
48654460|NCT05587998|101938131|FG000|STARTED|Overall Study||29||
48654461|NCT05587998|101938132|FG001|STARTED|Overall Study||16||
48654462|NCT05587998|101938131|FG000|Treated|Overall Study||26||
48654463|NCT05587998|101938132|FG001|Treated|Overall Study||15||
48654464|NCT05587998|101938131|FG000|COMPLETED|Overall Study||25||
48654465|NCT05587998|101938132|FG001|COMPLETED|Overall Study||13||
48654466|NCT05587998|101938131|FG000|NOT COMPLETED|Overall Study||4||
48654467|NCT05587998|101938132|FG001|NOT COMPLETED|Overall Study||3||
48654468|NCT02883049|101941047|FG000|STARTED|Induction||4749||
48654469|NCT02883049|101941048|FG001|STARTED|Induction||224||
48654470|NCT02883049|101941049|FG002|STARTED|Induction||0||
48654471|NCT02883049|101941050|FG003|STARTED|Induction||0||
48654472|NCT02883049|101941051|FG004|STARTED|Induction||0||
48654473|NCT02883049|101941052|FG005|STARTED|Induction||0||
48654474|NCT02883049|101941053|FG006|STARTED|Induction||0||
48654475|NCT02883049|101941054|FG007|STARTED|Induction||0||
48765631|NCT01310777|102214690|FG002|COMPLETED|Overall Study||145||
48765632|NCT01310777|102214688|FG000|NOT COMPLETED|Overall Study||33||
48765633|NCT01310777|102214689|FG001|NOT COMPLETED|Overall Study||14||
48654476|NCT02883049|101941055|FG008|STARTED|Induction||0||
48654477|NCT02883049|101941056|FG009|STARTED|Induction||0||
48654478|NCT02883049|101941057|FG010|STARTED|Induction||0||
48654479|NCT02883049|101941058|FG011|STARTED|Induction||0||
48654480|NCT02883049|101941059|FG012|STARTED|Induction||0||
48654481|NCT02883049|101941060|FG013|STARTED|Induction||0||
48654482|NCT02883049|101941061|FG014|STARTED|Induction||0||
48654483|NCT02883049|101941062|FG015|STARTED|Induction||0||
48654484|NCT02883049|101941047|FG000|COMPLETED|Induction||1801||
48654485|NCT02883049|101941048|FG001|COMPLETED|Induction||199||
48654486|NCT02883049|101941049|FG002|COMPLETED|Induction||0||
48654487|NCT02883049|101941050|FG003|COMPLETED|Induction||0||
48654488|NCT02883049|101941051|FG004|COMPLETED|Induction||0||
48654489|NCT02883049|101941052|FG005|COMPLETED|Induction||0||
48654490|NCT02883049|101941053|FG006|COMPLETED|Induction||0||
48654491|NCT02883049|101941054|FG007|COMPLETED|Induction||0||
48654492|NCT02883049|101941055|FG008|COMPLETED|Induction||0||
48654493|NCT02883049|101941056|FG009|COMPLETED|Induction||0||
48654494|NCT02883049|101941057|FG010|COMPLETED|Induction||0||
48654495|NCT02883049|101941058|FG011|COMPLETED|Induction||0||
48654496|NCT02883049|101941059|FG012|COMPLETED|Induction||0||
48654497|NCT02883049|101941060|FG013|COMPLETED|Induction||0||
48654498|NCT02883049|101941061|FG014|COMPLETED|Induction||0||
48654499|NCT02883049|101941062|FG015|COMPLETED|Induction||0||
48654500|NCT02883049|101941047|FG000|NOT COMPLETED|Induction||2948||
48654501|NCT02883049|101941048|FG001|NOT COMPLETED|Induction||25||
48654502|NCT02883049|101941049|FG002|NOT COMPLETED|Induction||0||
48654503|NCT02883049|101941050|FG003|NOT COMPLETED|Induction||0||
48654504|NCT02883049|101941051|FG004|NOT COMPLETED|Induction||0||
48654505|NCT02883049|101941052|FG005|NOT COMPLETED|Induction||0||
48654506|NCT02883049|101941053|FG006|NOT COMPLETED|Induction||0||
48654507|NCT02883049|101941054|FG007|NOT COMPLETED|Induction||0||
48654508|NCT02883049|101941055|FG008|NOT COMPLETED|Induction||0||
48654509|NCT02883049|101941056|FG009|NOT COMPLETED|Induction||0||
48654510|NCT02883049|101941057|FG010|NOT COMPLETED|Induction||0||
48654511|NCT02883049|101941058|FG011|NOT COMPLETED|Induction||0||
48765634|NCT01310777|102214690|FG002|NOT COMPLETED|Overall Study||30||
48765635|NCT05030129|102214691|FG000|STARTED|Screening Period||15||
48765636|NCT05030129|102214691|FG000|COMPLETED|Screening Period||15||
48765637|NCT05030129|102214691|FG000|NOT COMPLETED|Screening Period||0||
48765638|NCT05030129|102214691|FG000|STARTED|Treatment Period 1: EM & Placebo||15||
48765639|NCT05030129|102214691|FG000|COMPLETED|Treatment Period 1: EM & Placebo||15||
48765640|NCT05030129|102214691|FG000|NOT COMPLETED|Treatment Period 1: EM & Placebo||0||
48765641|NCT05030129|102214691|FG000|STARTED|Treatment Period 2: EM & 5-HTP||15||
48765642|NCT05030129|102214691|FG000|COMPLETED|Treatment Period 2: EM & 5-HTP||15||
48654512|NCT02883049|101941059|FG012|NOT COMPLETED|Induction||0||
48654513|NCT02883049|101941060|FG013|NOT COMPLETED|Induction||0||
48654514|NCT02883049|101941061|FG014|NOT COMPLETED|Induction||0||
48654515|NCT02883049|101941062|FG015|NOT COMPLETED|Induction||0||
48654516|NCT02883049|101941047|FG000|STARTED|Post Induction||0||
48654517|NCT02883049|101941048|FG001|STARTED|Post Induction||0||
48654518|NCT02883049|101941049|FG002|STARTED|Post Induction||2||
48654519|NCT02883049|101941050|FG003|STARTED|Post Induction||526||
48654520|NCT02883049|101941051|FG004|STARTED|Post Induction||528||
48654521|NCT02883049|101941052|FG005|STARTED|Post Induction||348||
48654522|NCT02883049|101941053|FG006|STARTED|Post Induction||346||
48654523|NCT02883049|101941054|FG007|STARTED|Post Induction||282||
48654524|NCT02883049|101941055|FG008|STARTED|Post Induction||369||
48654525|NCT02883049|101941056|FG009|STARTED|Post Induction||73||
48654526|NCT02883049|101941057|FG010|STARTED|Post Induction||62||
48654527|NCT02883049|101941058|FG011|STARTED|Post Induction||131||
48654528|NCT02883049|101941059|FG012|STARTED|Post Induction||28||
48654529|NCT02883049|101941060|FG013|STARTED|Post Induction||23||
48765643|NCT05030129|102214691|FG000|NOT COMPLETED|Treatment Period 2: EM & 5-HTP||0||
48765644|NCT05030129|102214691|FG000|STARTED|Treatment Period 3: 5-HTP & Placebo||15||
48436445|NCT01891669|101403554|FG005|STARTED|Overall Study||2||
48436446|NCT01891669|101403555|FG006|STARTED|Overall Study||2||
48436447|NCT01891669|101403556|FG007|STARTED|Overall Study||6||
48436448|NCT01891669|101403557|FG008|STARTED|Overall Study||3||
48436449|NCT01891669|101403558|FG009|STARTED|Overall Study||3||
48436450|NCT01891669|101403549|FG000|COMPLETED|Overall Study||0||
48436451|NCT01891669|101403550|FG001|COMPLETED|Overall Study||1||
48436452|NCT01891669|101403551|FG002|COMPLETED|Overall Study||2||
48436453|NCT01891669|101403552|FG003|COMPLETED|Overall Study||2||
48436454|NCT01891669|101403553|FG004|COMPLETED|Overall Study||2||
48436455|NCT01891669|101403554|FG005|COMPLETED|Overall Study||2||
48436456|NCT01891669|101403555|FG006|COMPLETED|Overall Study||1||
48436457|NCT01891669|101403556|FG007|COMPLETED|Overall Study||2||
48436458|NCT01891669|101403557|FG008|COMPLETED|Overall Study||2||
48436459|NCT01891669|101403558|FG009|COMPLETED|Overall Study||1||
48436460|NCT01891669|101403549|FG000|NOT COMPLETED|Overall Study||2||
48436461|NCT01891669|101403550|FG001|NOT COMPLETED|Overall Study||1||
48436462|NCT01891669|101403551|FG002|NOT COMPLETED|Overall Study||0||
48436463|NCT01891669|101403552|FG003|NOT COMPLETED|Overall Study||0||
48436464|NCT01891669|101403553|FG004|NOT COMPLETED|Overall Study||0||
48436465|NCT01891669|101403554|FG005|NOT COMPLETED|Overall Study||0||
48436466|NCT01891669|101403555|FG006|NOT COMPLETED|Overall Study||1||
48436467|NCT01891669|101403556|FG007|NOT COMPLETED|Overall Study||4||
48436468|NCT01891669|101403557|FG008|NOT COMPLETED|Overall Study||1||
48436469|NCT01891669|101403558|FG009|NOT COMPLETED|Overall Study||2||
48436470|NCT02575807|101403559|FG000|STARTED|Overall Study||9||
48436471|NCT02575807|101403560|FG001|STARTED|Overall Study||4||
48436472|NCT02575807|101403561|FG002|STARTED|Overall Study||16||
48436473|NCT02575807|101403562|FG003|STARTED|Overall Study||2||
48436474|NCT02575807|101403563|FG004|STARTED|Overall Study||4||
48436475|NCT02575807|101403559|FG000|Treated|Overall Study||8|Subjects who received at least 1 dose of protocol-specified drug.|
48436476|NCT02575807|101403560|FG001|Treated|Overall Study||4|Subjects who received at least 1 dose of protocol-specified drug.|
48436477|NCT02575807|101403561|FG002|Treated|Overall Study||16|Subjects who received at least 1 dose of protocol-specified drug.|
48436478|NCT02575807|101403562|FG003|Treated|Overall Study||1|Subjects who received at least 1 dose of protocol-specified drug.|
48436479|NCT02575807|101403563|FG004|Treated|Overall Study||3|Subjects who received at least 1 dose of protocol-specified drug.|
48436480|NCT02575807|101403559|FG000|COMPLETED|Overall Study||0|No predetermined study completion date or study completion event specified in protocol.|
48436481|NCT02575807|101403560|FG001|COMPLETED|Overall Study||0|No predetermined study completion date or study completion event specified in protocol.|
48436482|NCT02575807|101403561|FG002|COMPLETED|Overall Study||0|No predetermined study completion date or study completion event specified in protocol.|
48436483|NCT02575807|101403562|FG003|COMPLETED|Overall Study||0|No predetermined study completion date or study completion event specified in protocol.|
48436484|NCT02575807|101403563|FG004|COMPLETED|Overall Study||0|No predetermined study completion date or study completion event specified in protocol.|
48436485|NCT02575807|101403559|FG000|NOT COMPLETED|Overall Study||9||
48436486|NCT02575807|101403560|FG001|NOT COMPLETED|Overall Study||4||
48436487|NCT02575807|101403561|FG002|NOT COMPLETED|Overall Study||16||
48436488|NCT02575807|101403562|FG003|NOT COMPLETED|Overall Study||2||
48436489|NCT02575807|101403563|FG004|NOT COMPLETED|Overall Study||4||
48436490|NCT04812548|101403564|FG000|STARTED|Overall Study||5||
48436491|NCT04812548|101403565|FG001|STARTED|Overall Study||15||
48436492|NCT04812548|101403564|FG000|Did Not Enter Post-treatment Follow-up|Overall Study||1||
48436493|NCT04812548|101403565|FG001|Did Not Enter Post-treatment Follow-up|Overall Study||5||
48436494|NCT04812548|101403564|FG000|Entered Post-treatment Follow-up|Overall Study||4||
48436495|NCT04812548|101403565|FG001|Entered Post-treatment Follow-up|Overall Study||10||
48436496|NCT04812548|101403564|FG000|COMPLETED|Overall Study||0|Completed = completed treatment Not completed = discontinued from treatment|
48436497|NCT04812548|101403565|FG001|COMPLETED|Overall Study||0|Completed = completed treatment Not completed = discontinued from treatment|
48765645|NCT05030129|102214691|FG000|COMPLETED|Treatment Period 3: 5-HTP & Placebo||15||
48765646|NCT05030129|102214691|FG000|NOT COMPLETED|Treatment Period 3: 5-HTP & Placebo||0||
48765647|NCT05030129|102214691|FG000|STARTED|Treatment Period 4: Placebo||15||
48436498|NCT04812548|101403564|FG000|NOT COMPLETED|Overall Study||5||
48436499|NCT04812548|101403565|FG001|NOT COMPLETED|Overall Study||15||
48436500|NCT04780776|101403566|FG000|STARTED|Titration Week 1-5||35||
48436501|NCT04780776|101403567|FG001|STARTED|Titration Week 1-5||34||
48654530|NCT02883049|101941061|FG014|STARTED|Post Induction||199||
48654531|NCT02883049|101941062|FG015|STARTED|Post Induction||59||
48654532|NCT02883049|101941047|FG000|COMPLETED|Post Induction||0||
48654533|NCT02883049|101941048|FG001|COMPLETED|Post Induction||0||
48654534|NCT02883049|101941049|FG002|COMPLETED|Post Induction||0||
48436502|NCT04780776|101403566|FG000|COMPLETED|Titration Week 1-5||33||
48654535|NCT02883049|101941050|FG003|COMPLETED|Post Induction||448||
48654536|NCT02883049|101941051|FG004|COMPLETED|Post Induction||451||
48654537|NCT02883049|101941052|FG005|COMPLETED|Post Induction||305||
48654538|NCT02883049|101941053|FG006|COMPLETED|Post Induction||288||
48654539|NCT02883049|101941054|FG007|COMPLETED|Post Induction||151||
48654540|NCT02883049|101941055|FG008|COMPLETED|Post Induction||212||
48654541|NCT02883049|101941056|FG009|COMPLETED|Post Induction||35||
48654542|NCT02883049|101941057|FG010|COMPLETED|Post Induction||46||
48654543|NCT02883049|101941058|FG011|COMPLETED|Post Induction||90||
48654544|NCT02883049|101941059|FG012|COMPLETED|Post Induction||20||
48654545|NCT02883049|101941060|FG013|COMPLETED|Post Induction||7||
48654546|NCT02883049|101941061|FG014|COMPLETED|Post Induction||150||
48654547|NCT02883049|101941062|FG015|COMPLETED|Post Induction||44||
48654548|NCT02883049|101941047|FG000|NOT COMPLETED|Post Induction||0||
48654549|NCT02883049|101941048|FG001|NOT COMPLETED|Post Induction||0||
48654550|NCT02883049|101941049|FG002|NOT COMPLETED|Post Induction||2||
48654551|NCT02883049|101941050|FG003|NOT COMPLETED|Post Induction||78||
48654552|NCT02883049|101941051|FG004|NOT COMPLETED|Post Induction||77||
48654553|NCT02883049|101941052|FG005|NOT COMPLETED|Post Induction||43||
48654554|NCT02883049|101941053|FG006|NOT COMPLETED|Post Induction||58||
48654555|NCT02883049|101941054|FG007|NOT COMPLETED|Post Induction||131||
48654556|NCT02883049|101941055|FG008|NOT COMPLETED|Post Induction||157||
48654557|NCT02883049|101941056|FG009|NOT COMPLETED|Post Induction||38||
48654558|NCT02883049|101941057|FG010|NOT COMPLETED|Post Induction||16||
48654559|NCT02883049|101941058|FG011|NOT COMPLETED|Post Induction||41||
48654560|NCT02883049|101941059|FG012|NOT COMPLETED|Post Induction||8||
48654561|NCT02883049|101941060|FG013|NOT COMPLETED|Post Induction||16||
48654562|NCT02883049|101941061|FG014|NOT COMPLETED|Post Induction||49||
48654563|NCT02883049|101941062|FG015|NOT COMPLETED|Post Induction||15||
48654564|NCT01941628|101941063|FG000|STARTED|Overall Study||46||
48654565|NCT01941628|101941064|FG001|STARTED|Overall Study||45||
48654566|NCT01941628|101941063|FG000|COMPLETED|Overall Study||45||
48654567|NCT01941628|101941064|FG001|COMPLETED|Overall Study||45||
48654568|NCT01941628|101941063|FG000|NOT COMPLETED|Overall Study||1||
48654569|NCT01941628|101941064|FG001|NOT COMPLETED|Overall Study||0||
48654570|NCT02605616|101941065|FG000|STARTED|Overall Study||46||
48654571|NCT02605616|101941066|FG001|STARTED|Overall Study||47||
48654572|NCT02605616|101941065|FG000|COMPLETED|Overall Study||42||
48654573|NCT02605616|101941066|FG001|COMPLETED|Overall Study||43||
48654574|NCT02605616|101941065|FG000|NOT COMPLETED|Overall Study||4||
48654575|NCT02605616|101941066|FG001|NOT COMPLETED|Overall Study||4||
48654576|NCT05524948|101941067|FG000|STARTED|Overall Study||52||
48654577|NCT05524948|101941068|FG001|STARTED|Overall Study||52||
48654578|NCT05524948|101941067|FG000|COMPLETED|Overall Study||50||
48362379|NCT04283461|101214528|FG012|COMPLETED|Overall Study||0||
48362380|NCT04283461|101214516|FG000|NOT COMPLETED|Overall Study||0||
48362381|NCT04283461|101214517|FG001|NOT COMPLETED|Overall Study||0||
48362382|NCT04283461|101214518|FG002|NOT COMPLETED|Overall Study||8||
48362383|NCT04283461|101214519|FG003|NOT COMPLETED|Overall Study||13||
48362384|NCT04283461|101214520|FG004|NOT COMPLETED|Overall Study||12||
48362385|NCT04283461|101214521|FG005|NOT COMPLETED|Overall Study||0||
48362386|NCT04283461|101214522|FG006|NOT COMPLETED|Overall Study||0||
48362387|NCT04283461|101214523|FG007|NOT COMPLETED|Overall Study||8||
48436503|NCT04780776|101403567|FG001|COMPLETED|Titration Week 1-5||26||
48436504|NCT04780776|101403566|FG000|NOT COMPLETED|Titration Week 1-5||2||
48436505|NCT04780776|101403567|FG001|NOT COMPLETED|Titration Week 1-5||8||
48436506|NCT04780776|101403566|FG000|STARTED|Treatment Week 6-21||33||
48436507|NCT04780776|101403567|FG001|STARTED|Treatment Week 6-21||26||
48654579|NCT05524948|101941068|FG001|COMPLETED|Overall Study||51||
48654580|NCT05524948|101941067|FG000|NOT COMPLETED|Overall Study||2||
48654581|NCT05524948|101941068|FG001|NOT COMPLETED|Overall Study||1||
48654582|NCT05702047|101941069|FG000|STARTED|Overall Study||10||
48654583|NCT05702047|101941070|FG001|STARTED|Overall Study||10||
48654584|NCT05702047|101941069|FG000|COMPLETED|Overall Study||10||
48654585|NCT05702047|101941070|FG001|COMPLETED|Overall Study||10||
48654586|NCT05702047|101941069|FG000|NOT COMPLETED|Overall Study||0||
48654587|NCT05702047|101941070|FG001|NOT COMPLETED|Overall Study||0||
48654588|NCT03927846|101941071|FG000|STARTED|Overall Study||30||
48654589|NCT03927846|101941072|FG001|STARTED|Overall Study||30||
48654590|NCT03927846|101941071|FG000|COMPLETED|Overall Study||20||
48654591|NCT03927846|101941072|FG001|COMPLETED|Overall Study||19||
48654592|NCT03927846|101941071|FG000|NOT COMPLETED|Overall Study||10||
48654593|NCT03927846|101941072|FG001|NOT COMPLETED|Overall Study||11||
48654594|NCT00348374|101941073|FG000|STARTED|Overall Study||88||
48654595|NCT00348374|101941074|FG001|STARTED|Overall Study||103||
48654596|NCT00348374|101941073|FG000|Received Study Treatment|Overall Study||88||
48654597|NCT00348374|101941074|FG001|Received Study Treatment|Overall Study||96||
48654598|NCT00348374|101941073|FG000|COMPLETED|Overall Study||69||
48654599|NCT00348374|101941074|FG001|COMPLETED|Overall Study||71||
48654600|NCT00348374|101941073|FG000|NOT COMPLETED|Overall Study||19||
48654601|NCT00348374|101941074|FG001|NOT COMPLETED|Overall Study||32||
48362388|NCT04283461|101214524|FG008|NOT COMPLETED|Overall Study||0||
48362389|NCT04283461|101214525|FG009|NOT COMPLETED|Overall Study||0||
48654602|NCT01748552|101941075|FG000|STARTED|Intervention Period 1 and Washout||3||
48654603|NCT01748552|101941076|FG001|STARTED|Intervention Period 1 and Washout||3||
48654604|NCT01748552|101941077|FG002|STARTED|Intervention Period 1 and Washout||3||
48654605|NCT01748552|101941078|FG003|STARTED|Intervention Period 1 and Washout||3||
48654606|NCT01748552|101941079|FG004|STARTED|Intervention Period 1 and Washout||3||
48654607|NCT01748552|101941080|FG005|STARTED|Intervention Period 1 and Washout||3||
48654608|NCT01748552|101941081|FG006|STARTED|Intervention Period 1 and Washout||3||
48654609|NCT01748552|101941082|FG007|STARTED|Intervention Period 1 and Washout||3||
48654610|NCT01748552|101941083|FG008|STARTED|Intervention Period 1 and Washout||3||
48654611|NCT01748552|101941084|FG009|STARTED|Intervention Period 1 and Washout||3||
48654612|NCT01748552|101941085|FG010|STARTED|Intervention Period 1 and Washout||3||
48654613|NCT01748552|101941086|FG011|STARTED|Intervention Period 1 and Washout||3||
48654614|NCT01748552|101941075|FG000|COMPLETED|Intervention Period 1 and Washout||3||
48654615|NCT01748552|101941076|FG001|COMPLETED|Intervention Period 1 and Washout||3||
48436508|NCT04780776|101403566|FG000|COMPLETED|Treatment Week 6-21||29||
48362390|NCT04283461|101214526|FG010|NOT COMPLETED|Overall Study||0||
48362391|NCT04283461|101214527|FG011|NOT COMPLETED|Overall Study||7||
48362392|NCT04283461|101214528|FG012|NOT COMPLETED|Overall Study||0||
48362393|NCT03849560|101214529|FG000|STARTED|Overall Study||205||
48362394|NCT03849560|101214530|FG001|STARTED|Overall Study||205||
48362395|NCT03849560|101214531|FG002|STARTED|Overall Study||202||
48362396|NCT03849560|101214529|FG000|COMPLETED|Overall Study||204||
48362397|NCT03849560|101214530|FG001|COMPLETED|Overall Study||205||
48362398|NCT03849560|101214531|FG002|COMPLETED|Overall Study||202||
48362399|NCT03849560|101214529|FG000|NOT COMPLETED|Overall Study||1||
48362400|NCT03849560|101214530|FG001|NOT COMPLETED|Overall Study||0||
48362401|NCT03849560|101214531|FG002|NOT COMPLETED|Overall Study||0||
48654616|NCT01748552|101941077|FG002|COMPLETED|Intervention Period 1 and Washout||3||
48654617|NCT01748552|101941078|FG003|COMPLETED|Intervention Period 1 and Washout||3||
48654618|NCT01748552|101941079|FG004|COMPLETED|Intervention Period 1 and Washout||3||
48654619|NCT01748552|101941080|FG005|COMPLETED|Intervention Period 1 and Washout||3||
48654620|NCT01748552|101941081|FG006|COMPLETED|Intervention Period 1 and Washout||3||
48654621|NCT01748552|101941082|FG007|COMPLETED|Intervention Period 1 and Washout||3||
48654622|NCT01748552|101941083|FG008|COMPLETED|Intervention Period 1 and Washout||3||
48654623|NCT01748552|101941084|FG009|COMPLETED|Intervention Period 1 and Washout||3||
48654624|NCT01748552|101941085|FG010|COMPLETED|Intervention Period 1 and Washout||3||
48654625|NCT01748552|101941086|FG011|COMPLETED|Intervention Period 1 and Washout||3||
48654626|NCT01748552|101941075|FG000|NOT COMPLETED|Intervention Period 1 and Washout||0||
48654627|NCT01748552|101941076|FG001|NOT COMPLETED|Intervention Period 1 and Washout||0||
48654628|NCT01748552|101941077|FG002|NOT COMPLETED|Intervention Period 1 and Washout||0||
48654629|NCT01748552|101941078|FG003|NOT COMPLETED|Intervention Period 1 and Washout||0||
48654630|NCT01748552|101941079|FG004|NOT COMPLETED|Intervention Period 1 and Washout||0||
48654631|NCT01748552|101941080|FG005|NOT COMPLETED|Intervention Period 1 and Washout||0||
48654632|NCT01748552|101941081|FG006|NOT COMPLETED|Intervention Period 1 and Washout||0||
48654633|NCT01748552|101941082|FG007|NOT COMPLETED|Intervention Period 1 and Washout||0||
48654634|NCT01748552|101941083|FG008|NOT COMPLETED|Intervention Period 1 and Washout||0||
48654635|NCT01748552|101941084|FG009|NOT COMPLETED|Intervention Period 1 and Washout||0||
48654636|NCT01748552|101941085|FG010|NOT COMPLETED|Intervention Period 1 and Washout||0||
48654637|NCT01748552|101941086|FG011|NOT COMPLETED|Intervention Period 1 and Washout||0||
48654638|NCT01748552|101941075|FG000|STARTED|Intervention Period 2 and Washout||3||
48654639|NCT01748552|101941076|FG001|STARTED|Intervention Period 2 and Washout||3||
48654640|NCT01748552|101941077|FG002|STARTED|Intervention Period 2 and Washout||3||
48765648|NCT05030129|102214691|FG000|COMPLETED|Treatment Period 4: Placebo||15||
48765649|NCT05030129|102214691|FG000|NOT COMPLETED|Treatment Period 4: Placebo||0||
48767788|NCT03863080|102222825|FG000|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0||
48362402|NCT02307526|101214532|FG000|STARTED|Day 1 - No Drug||10||
48362403|NCT02307526|101214532|FG000|COMPLETED|Day 1 - No Drug||10||
48362404|NCT02307526|101214532|FG000|NOT COMPLETED|Day 1 - No Drug||0||
48362405|NCT02307526|101214532|FG000|STARTED|Day 2 - 60 mg of Pyridostigmine||10||
48362406|NCT02307526|101214532|FG000|COMPLETED|Day 2 - 60 mg of Pyridostigmine||10||
48362407|NCT02307526|101214532|FG000|NOT COMPLETED|Day 2 - 60 mg of Pyridostigmine||0||
48362408|NCT02836886|101214533|FG000|STARTED|Overall Study||6||
48362409|NCT02836886|101214533|FG000|COMPLETED|Overall Study||6||
48362410|NCT02836886|101214533|FG000|NOT COMPLETED|Overall Study||0||
48362411|NCT02714205|101214534|FG000|STARTED|Overall Study||70||
48362412|NCT02714205|101214535|FG001|STARTED|Overall Study||71||
48362413|NCT02714205|101214534|FG000|COMPLETED|Overall Study||66||
48362414|NCT02714205|101214535|FG001|COMPLETED|Overall Study||70||
48362415|NCT02714205|101214534|FG000|NOT COMPLETED|Overall Study||4||
48362416|NCT02714205|101214535|FG001|NOT COMPLETED|Overall Study||1||
48362417|NCT03184701|101214536|FG000|STARTED|Overall Study||45||
48362418|NCT03184701|101214536|FG000|COMPLETED|Overall Study||28||
48362419|NCT03184701|101214536|FG000|NOT COMPLETED|Overall Study||17||
48362420|NCT01232946|101214537|FG000|STARTED|Overall Study||9||
48362421|NCT01232946|101214538|FG001|STARTED|Overall Study||10||
48362422|NCT01232946|101214539|FG002|STARTED|Overall Study||11||
48362423|NCT01232946|101214537|FG000|COMPLETED|Overall Study||9||
48362424|NCT01232946|101214538|FG001|COMPLETED|Overall Study||9||
48362425|NCT01232946|101214539|FG002|COMPLETED|Overall Study||9||
48362426|NCT01232946|101214537|FG000|NOT COMPLETED|Overall Study||0||
48362427|NCT01232946|101214538|FG001|NOT COMPLETED|Overall Study||1||
48362428|NCT01232946|101214539|FG002|NOT COMPLETED|Overall Study||2||
48362429|NCT04770155|101214540|FG000|STARTED|Overall Study||1|The only data collected were baseline measurements and no participants were ever given either intervention; the investigator was never able to obtain the treatments to use for the planned intervention arm of the study, resulting in its termination.|
48362430|NCT04770155|101214541|FG001|STARTED|Overall Study||1|The only data collected were baseline measurements and no participants were ever given either intervention; the investigator was never able to obtain the treatments to use for the planned intervention arm of the study, resulting in its termination.|
48362431|NCT04770155|101214542|FG002|STARTED|Overall Study||1|The only data collected were baseline measurements and no participants were ever given either intervention; the investigator was never able to obtain the treatments to use for the planned intervention arm of the study, resulting in its termination.|
48362432|NCT04770155|101214543|FG003|STARTED|Overall Study||1|The only data collected were baseline measurements and no participants were ever given either intervention; the investigator was never able to obtain the treatments to use for the planned intervention arm of the study, resulting in its termination.|
48362433|NCT04770155|101214544|FG004|STARTED|Overall Study||1|The only data collected were baseline measurements and no participants were ever given either intervention; the investigator was never able to obtain the treatments to use for the planned intervention arm of the study, resulting in its termination.|
48362434|NCT04770155|101214545|FG005|STARTED|Overall Study||1|The only data collected were baseline measurements and no participants were ever given either intervention; the investigator was never able to obtain the treatments to use for the planned intervention arm of the study, resulting in its termination.|
48362435|NCT04770155|101214546|FG006|STARTED|Overall Study||1|The only data collected were baseline measurements and no participants were ever given either intervention; the investigator was never able to obtain the treatments to use for the planned intervention arm of the study, resulting in its termination.|
48362436|NCT04770155|101214547|FG007|STARTED|Overall Study||1|The only data collected were baseline measurements and no participants were ever given either intervention; the investigator was never able to obtain the treatments to use for the planned intervention arm of the study, resulting in its termination.|
48362437|NCT04770155|101214540|FG000|COMPLETED|Overall Study||0|The only data collected were baseline measurements and no participants were ever given either intervention; the investigator was never able to obtain the treatments to use for the planned intervention arm of the study, resulting in its termination.|
48362438|NCT04770155|101214541|FG001|COMPLETED|Overall Study||0|The only data collected were baseline measurements and no participants were ever given either intervention; the investigator was never able to obtain the treatments to use for the planned intervention arm of the study, resulting in its termination.|
48362439|NCT04770155|101214542|FG002|COMPLETED|Overall Study||0|The only data collected were baseline measurements and no participants were ever given either intervention; the investigator was never able to obtain the treatments to use for the planned intervention arm of the study, resulting in its termination.|
48362440|NCT04770155|101214543|FG003|COMPLETED|Overall Study||0|The only data collected were baseline measurements and no participants were ever given either intervention; the investigator was never able to obtain the treatments to use for the planned intervention arm of the study, resulting in its termination.|
48362441|NCT04770155|101214544|FG004|COMPLETED|Overall Study||0|The only data collected were baseline measurements and no participants were ever given either intervention; the investigator was never able to obtain the treatments to use for the planned intervention arm of the study, resulting in its termination.|
48362442|NCT04770155|101214545|FG005|COMPLETED|Overall Study||0|The only data collected were baseline measurements and no participants were ever given either intervention; the investigator was never able to obtain the treatments to use for the planned intervention arm of the study, resulting in its termination.|
48362443|NCT04770155|101214546|FG006|COMPLETED|Overall Study||0|The only data collected were baseline measurements and no participants were ever given either intervention; the investigator was never able to obtain the treatments to use for the planned intervention arm of the study, resulting in its termination.|
48362444|NCT04770155|101214547|FG007|COMPLETED|Overall Study||0|The only data collected were baseline measurements and no participants were ever given either intervention; the investigator was never able to obtain the treatments to use for the planned intervention arm of the study, resulting in its termination.|
48362445|NCT04770155|101214540|FG000|NOT COMPLETED|Overall Study||1||
48362446|NCT04770155|101214541|FG001|NOT COMPLETED|Overall Study||1||
48362447|NCT04770155|101214542|FG002|NOT COMPLETED|Overall Study||1||
48362448|NCT04770155|101214543|FG003|NOT COMPLETED|Overall Study||1||
48362449|NCT04770155|101214544|FG004|NOT COMPLETED|Overall Study||1||
48362450|NCT04770155|101214545|FG005|NOT COMPLETED|Overall Study||1||
48362451|NCT04770155|101214546|FG006|NOT COMPLETED|Overall Study||1||
48362452|NCT04770155|101214547|FG007|NOT COMPLETED|Overall Study||1||
48654641|NCT01748552|101941078|FG003|STARTED|Intervention Period 2 and Washout||3||
48654642|NCT01748552|101941079|FG004|STARTED|Intervention Period 2 and Washout||3||
48654643|NCT01748552|101941080|FG005|STARTED|Intervention Period 2 and Washout||3||
48654644|NCT01748552|101941081|FG006|STARTED|Intervention Period 2 and Washout||3||
48654645|NCT01748552|101941082|FG007|STARTED|Intervention Period 2 and Washout||3||
48188272|NCT04491617|100783201|FG000|COMPLETED|Overall Study||64||
48188273|NCT04491617|100783202|FG001|COMPLETED|Overall Study||63||
48188274|NCT04491617|100783201|FG000|NOT COMPLETED|Overall Study||0||
48188275|NCT04491617|100783202|FG001|NOT COMPLETED|Overall Study||2||
48188276|NCT01767909|100783203|FG000|STARTED|Overall Study||121||
48188277|NCT01767909|100783204|FG001|STARTED|Overall Study||119||
48188278|NCT01767909|100783203|FG000|COMPLETED|Overall Study||108||
48188279|NCT01767909|100783204|FG001|COMPLETED|Overall Study||107||
48188280|NCT01767909|100783203|FG000|NOT COMPLETED|Overall Study||13||
48654646|NCT01748552|101941083|FG008|STARTED|Intervention Period 2 and Washout||3||
48654647|NCT01748552|101941084|FG009|STARTED|Intervention Period 2 and Washout||3||
48654648|NCT01748552|101941085|FG010|STARTED|Intervention Period 2 and Washout||3||
48654649|NCT01748552|101941086|FG011|STARTED|Intervention Period 2 and Washout||3||
48654650|NCT01748552|101941075|FG000|COMPLETED|Intervention Period 2 and Washout||3||
48188281|NCT01767909|100783204|FG001|NOT COMPLETED|Overall Study||12||
48362453|NCT00427661|101214548|FG000|STARTED|Overall Study||8||
48362454|NCT00427661|101214548|FG000|COMPLETED|Overall Study||8||
48362455|NCT00427661|101214548|FG000|NOT COMPLETED|Overall Study||0||
48765650|NCT01709721|102214692|FG000|STARTED|Open Label Phase||41|The purpose of the 12-week Open Label Phase of the trial is to titrate subjects to an optimal dose of hydromorphone hydrochloride and demonstrate the ability to maintain adequate pain relief in subjects requiring intrathecal opioid therapy.|
48765651|NCT01709721|102214693|FG001|STARTED|Open Label Phase||40|The purpose of the 12-week Open Label Phase of the trial is to titrate subjects to an optimal dose of hydromorphone hydrochloride and demonstrate the ability to maintain adequate pain relief in subjects requiring intrathecal opioid therapy.|
48362456|NCT00668525|101217305|FG000|STARTED|Overall Study||325||
48362457|NCT00668525|101217306|FG001|STARTED|Overall Study||332||
48362458|NCT00668525|101217307|FG002|STARTED|Overall Study||220||
48362459|NCT00668525|101217305|FG000|COMPLETED|Overall Study||248||
48362460|NCT00668525|101217306|FG001|COMPLETED|Overall Study||239||
48362461|NCT00668525|101217307|FG002|COMPLETED|Overall Study||167||
48362462|NCT00668525|101217305|FG000|NOT COMPLETED|Overall Study||77||
48362463|NCT00668525|101217306|FG001|NOT COMPLETED|Overall Study||93||
48362464|NCT00668525|101217307|FG002|NOT COMPLETED|Overall Study||53||
48362465|NCT02717546|101217308|FG000|STARTED|Overall Study||32||
48362466|NCT02717546|101217308|FG000|COMPLETED|Overall Study||20||
48362467|NCT02717546|101217308|FG000|NOT COMPLETED|Overall Study||12||
48362468|NCT01635933|101217309|FG000|STARTED|Overall Study||178||
48362469|NCT01635933|101217310|FG001|STARTED|Overall Study||185||
48362470|NCT01635933|101217309|FG000|COMPLETED|Overall Study||176||
48654651|NCT01748552|101941076|FG001|COMPLETED|Intervention Period 2 and Washout||3||
48654652|NCT01748552|101941077|FG002|COMPLETED|Intervention Period 2 and Washout||2||
48654653|NCT01748552|101941078|FG003|COMPLETED|Intervention Period 2 and Washout||3||
48654654|NCT01748552|101941079|FG004|COMPLETED|Intervention Period 2 and Washout||3||
48654655|NCT01748552|101941080|FG005|COMPLETED|Intervention Period 2 and Washout||3||
48654656|NCT01748552|101941081|FG006|COMPLETED|Intervention Period 2 and Washout||0||
48654657|NCT01748552|101941082|FG007|COMPLETED|Intervention Period 2 and Washout||0||
48654658|NCT01748552|101941083|FG008|COMPLETED|Intervention Period 2 and Washout||0||
48654659|NCT01748552|101941084|FG009|COMPLETED|Intervention Period 2 and Washout||3||
48654660|NCT01748552|101941085|FG010|COMPLETED|Intervention Period 2 and Washout||3||
48654661|NCT01748552|101941086|FG011|COMPLETED|Intervention Period 2 and Washout||3||
48654662|NCT01748552|101941075|FG000|NOT COMPLETED|Intervention Period 2 and Washout||0||
48654663|NCT01748552|101941076|FG001|NOT COMPLETED|Intervention Period 2 and Washout||0||
48654664|NCT01748552|101941077|FG002|NOT COMPLETED|Intervention Period 2 and Washout||1||
48654665|NCT01748552|101941078|FG003|NOT COMPLETED|Intervention Period 2 and Washout||0||
48657055|NCT03648372|101943774|FG017|STARTED|Overall Study||7||
48188282|NCT03163992|100783205|FG000|STARTED|Overall Study||60||
48188283|NCT03163992|100783205|FG000|COMPLETED|Overall Study||1||
48188284|NCT03163992|100783205|FG000|NOT COMPLETED|Overall Study||59||
48362471|NCT01635933|101217310|FG001|COMPLETED|Overall Study||177||
48362472|NCT01635933|101217309|FG000|NOT COMPLETED|Overall Study||2||
48362473|NCT01635933|101217310|FG001|NOT COMPLETED|Overall Study||8||
48362474|NCT03133481|101217311|FG000|STARTED|Overall Study||45||
48362475|NCT03133481|101217312|FG001|STARTED|Overall Study||49||
48362476|NCT03133481|101217311|FG000|COMPLETED|Overall Study||45||
48362477|NCT03133481|101217312|FG001|COMPLETED|Overall Study||45||
48362478|NCT03133481|101217311|FG000|NOT COMPLETED|Overall Study||0||
48362479|NCT03133481|101217312|FG001|NOT COMPLETED|Overall Study||4||
48362480|NCT00866294|101217313|FG000|STARTED|Overall Study||172||
48362481|NCT00866294|101217314|FG001|STARTED|Overall Study||161||
48362482|NCT00866294|101217315|FG002|STARTED|Overall Study||83||
48362483|NCT00866294|101217313|FG000|COMPLETED|Overall Study||139||
48362484|NCT00866294|101217314|FG001|COMPLETED|Overall Study||141||
48362485|NCT00866294|101217315|FG002|COMPLETED|Overall Study||72||
48362486|NCT00866294|101217313|FG000|NOT COMPLETED|Overall Study||33||
48362487|NCT00866294|101217314|FG001|NOT COMPLETED|Overall Study||20||
48362488|NCT00866294|101217315|FG002|NOT COMPLETED|Overall Study||11||
48362489|NCT02613572|101217316|FG000|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||15||
48362490|NCT02613572|101217317|FG001|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||0||
48362491|NCT02613572|101217318|FG002|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||0||
48362492|NCT02613572|101217316|FG000|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||15||
48362493|NCT02613572|101217317|FG001|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||0||
48362494|NCT02613572|101217318|FG002|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||0||
48362495|NCT02613572|101217316|FG000|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||15||
48362496|NCT02613572|101217317|FG001|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||0||
48362497|NCT02613572|101217318|FG002|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||0||
48362498|NCT02613572|101217316|FG000|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||14||
48765652|NCT01709721|102214694|FG002|STARTED|Open Label Phase||72|The purpose of the 12-week Open Label Phase of the trial is to titrate subjects to an optimal dose of hydromorphone hydrochloride and demonstrate the ability to maintain adequate pain relief in subjects requiring intrathecal opioid therapy.|
48765653|NCT01709721|102214692|FG000|COMPLETED|Open Label Phase||41||
48765654|NCT01709721|102214693|FG001|COMPLETED|Open Label Phase||40||
48765655|NCT01709721|102214694|FG002|COMPLETED|Open Label Phase||0||
48765656|NCT01709721|102214692|FG000|NOT COMPLETED|Open Label Phase||0||
48362499|NCT02613572|101217317|FG001|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||0||
48362500|NCT02613572|101217318|FG002|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||0||
48362501|NCT02613572|101217316|FG000|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||14||
48362502|NCT02613572|101217317|FG001|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0||
48362503|NCT02613572|101217318|FG002|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0||
48362504|NCT02613572|101217316|FG000|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||1||
48362505|NCT02613572|101217317|FG001|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0||
48362506|NCT02613572|101217318|FG002|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0||
48362507|NCT02613572|101217316|FG000|STARTED|Phase II: Double-Blind Rand Plac Control||0||
48362508|NCT02613572|101217317|FG001|STARTED|Phase II: Double-Blind Rand Plac Control||27||
48362509|NCT02613572|101217318|FG002|STARTED|Phase II: Double-Blind Rand Plac Control||26||
48362510|NCT02613572|101217316|FG000|COMPLETED|Phase II: Double-Blind Rand Plac Control||0||
48362511|NCT02613572|101217317|FG001|COMPLETED|Phase II: Double-Blind Rand Plac Control||26||
48362512|NCT02613572|101217318|FG002|COMPLETED|Phase II: Double-Blind Rand Plac Control||26||
48362513|NCT02613572|101217316|FG000|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||0||
48362514|NCT02613572|101217317|FG001|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||1||
48765657|NCT01709721|102214693|FG001|NOT COMPLETED|Open Label Phase||0||
48765658|NCT01709721|102214694|FG002|NOT COMPLETED|Open Label Phase||72||
48765659|NCT01709721|102214692|FG000|STARTED|Randomized Phase||41|At the end of the Open Label Phase (ie, the 12 week chronic dosing period), subjects who meet criteria for randomization will be assigned to either remain at their current dose of hydromorphone hydrochloride or to have their dose titrated downward (control group) in a blinded fashion.|
48765660|NCT01709721|102214693|FG001|STARTED|Randomized Phase||40|At the end of the Open Label Phase (ie, the 12 week chronic dosing period), subjects who meet criteria for randomization will be assigned to either remain at their current dose of hydromorphone hydrochloride or to have their dose titrated downward (control group) in a blinded fashion.|
48765661|NCT01709721|102214694|FG002|STARTED|Randomized Phase||0|At the end of the Open Label Phase (ie, the 12 week chronic dosing period), subjects who meet criteria for randomization will be assigned to either remain at their current dose of hydromorphone hydrochloride or to have their dose titrated downward (control group) in a blinded fashion.|
48765662|NCT01709721|102214692|FG000|COMPLETED|Randomized Phase||38||
48765663|NCT01709721|102214693|FG001|COMPLETED|Randomized Phase||34||
48765664|NCT01709721|102214694|FG002|COMPLETED|Randomized Phase||0||
48765665|NCT01709721|102214692|FG000|NOT COMPLETED|Randomized Phase||3||
48362515|NCT02613572|101217318|FG002|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||0||
48362516|NCT01494038|101217319|FG000|STARTED|Overall Study||477||
48362517|NCT01494038|101217320|FG001|STARTED|Overall Study||479||
48362518|NCT01494038|101217319|FG000|COMPLETED|Overall Study||389||
48362519|NCT01494038|101217320|FG001|COMPLETED|Overall Study||396||
48362520|NCT01494038|101217319|FG000|NOT COMPLETED|Overall Study||88||
48362521|NCT01494038|101217320|FG001|NOT COMPLETED|Overall Study||83||
48362522|NCT00435539|101217321|FG000|STARTED|Overall Study||12||
48362523|NCT00435539|101217322|FG001|STARTED|Overall Study||13||
48362524|NCT00435539|101217323|FG002|STARTED|Overall Study||11||
48362525|NCT00435539|101217324|FG003|STARTED|Overall Study||12||
48362526|NCT00435539|101217325|FG004|STARTED|Overall Study||12||
48362527|NCT00435539|101217321|FG000|COMPLETED|Overall Study||12||
48362528|NCT00435539|101217322|FG001|COMPLETED|Overall Study||13||
48362529|NCT00435539|101217323|FG002|COMPLETED|Overall Study||11||
48362530|NCT00435539|101217324|FG003|COMPLETED|Overall Study||12||
48362531|NCT00435539|101217325|FG004|COMPLETED|Overall Study||12||
48362532|NCT00435539|101217321|FG000|NOT COMPLETED|Overall Study||0||
48362533|NCT00435539|101217322|FG001|NOT COMPLETED|Overall Study||0||
48362534|NCT00435539|101217323|FG002|NOT COMPLETED|Overall Study||0||
48362535|NCT00435539|101217324|FG003|NOT COMPLETED|Overall Study||0||
48362536|NCT00435539|101217325|FG004|NOT COMPLETED|Overall Study||0||
48362537|NCT02749721|101217326|FG000|STARTED|Screening||31||
48362538|NCT02749721|101217326|FG000|COMPLETED|Screening||25||
48362539|NCT02749721|101217326|FG000|NOT COMPLETED|Screening||6||
48362540|NCT02749721|101217326|FG000|STARTED|8-week Open-Label Treatment Phase||25||
48362541|NCT02749721|101217326|FG000|COMPLETED|8-week Open-Label Treatment Phase||22||
48362542|NCT02749721|101217326|FG000|NOT COMPLETED|8-week Open-Label Treatment Phase||3||
48362543|NCT03461289|101217327|FG000|STARTED|Overall Study||33||
48362544|NCT03461289|101217327|FG000|COMPLETED|Overall Study||32||
48362545|NCT03461289|101217327|FG000|NOT COMPLETED|Overall Study||1||
48362546|NCT02116972|101217328|FG000|STARTED|Overall Study||102||
48362547|NCT02116972|101217329|FG001|STARTED|Overall Study||104||
48362548|NCT02116972|101217330|FG002|STARTED|Overall Study||104||
48362549|NCT02116972|101217328|FG000|COMPLETED|Overall Study||83||
48362550|NCT02116972|101217329|FG001|COMPLETED|Overall Study||87||
48362551|NCT02116972|101217330|FG002|COMPLETED|Overall Study||85||
48362552|NCT02116972|101217328|FG000|NOT COMPLETED|Overall Study||19||
48362553|NCT02116972|101217329|FG001|NOT COMPLETED|Overall Study||17||
48362554|NCT02116972|101217330|FG002|NOT COMPLETED|Overall Study||19||
48362555|NCT03635190|101217331|FG000|STARTED|Overall Study||112||154
48362556|NCT03635190|101217331|FG000|COMPLETED|Overall Study||103||152
48362557|NCT03635190|101217331|FG000|NOT COMPLETED|Overall Study||9||2
48362558|NCT03453060|101217332|FG000|STARTED|Overall Study||4||
48362559|NCT03453060|101217333|FG001|STARTED|Overall Study||4||
48362560|NCT03453060|101217334|FG002|STARTED|Overall Study||4||
48362561|NCT03453060|101217335|FG003|STARTED|Overall Study||4||
48362562|NCT03453060|101217336|FG004|STARTED|Overall Study||5||
48362563|NCT03453060|101217332|FG000|COMPLETED|Overall Study||4||
48362564|NCT03453060|101217333|FG001|COMPLETED|Overall Study||4||
48362565|NCT03453060|101217334|FG002|COMPLETED|Overall Study||4||
48362566|NCT03453060|101217335|FG003|COMPLETED|Overall Study||4||
48362567|NCT03453060|101217336|FG004|COMPLETED|Overall Study||5||
48362568|NCT03453060|101217332|FG000|NOT COMPLETED|Overall Study||0||
48362569|NCT03453060|101217333|FG001|NOT COMPLETED|Overall Study||0||
48362570|NCT03453060|101217334|FG002|NOT COMPLETED|Overall Study||0||
48362571|NCT03453060|101217335|FG003|NOT COMPLETED|Overall Study||0||
48188285|NCT01072929|100783206|FG000|STARTED|Overall Study||199||
48188286|NCT01072929|100783207|FG001|STARTED|Overall Study||201||
48188287|NCT01072929|100783208|FG002|STARTED|Overall Study||33||
48188288|NCT01072929|100783206|FG000|Safety Population|Overall Study||199||
48188289|NCT01072929|100783207|FG001|Safety Population|Overall Study||198||
48362572|NCT03453060|101217336|FG004|NOT COMPLETED|Overall Study||0||
48362573|NCT01118143|101217337|FG000|STARTED|Overall Study||64||
48362574|NCT01118143|101217338|FG001|STARTED|Overall Study||69||
48362575|NCT01118143|101217337|FG000|COMPLETED|Overall Study||62||
48362576|NCT01118143|101217338|FG001|COMPLETED|Overall Study||64||
48362577|NCT01118143|101217337|FG000|NOT COMPLETED|Overall Study||2||
48362578|NCT01118143|101217338|FG001|NOT COMPLETED|Overall Study||5||
48362579|NCT02465034|101217339|FG000|STARTED|Overall Study||19||
48362580|NCT02465034|101217340|FG001|STARTED|Overall Study||26||
48362581|NCT02465034|101217339|FG000|Started PAS|Overall Study||12||
48362582|NCT02465034|101217340|FG001|Started PAS|Overall Study||21||
48362583|NCT02465034|101217339|FG000|Completed PAS|Overall Study||9||
48362584|NCT02465034|101217340|FG001|Completed PAS|Overall Study||20||
48362585|NCT02465034|101217339|FG000|Started CC-PAS|Overall Study||16||
48362586|NCT02465034|101217340|FG001|Started CC-PAS|Overall Study||0||
48362587|NCT02465034|101217339|FG000|Completed CC-PAS|Overall Study||16||
48362588|NCT02465034|101217340|FG001|Completed CC-PAS|Overall Study||0||
48362589|NCT02465034|101217339|FG000|COMPLETED|Overall Study||16||
48362590|NCT02465034|101217340|FG001|COMPLETED|Overall Study||20||
48362591|NCT02465034|101217339|FG000|NOT COMPLETED|Overall Study||3||
48362592|NCT02465034|101217340|FG001|NOT COMPLETED|Overall Study||6||
48362593|NCT01183546|101217341|FG000|STARTED|Overall Study||53||
48362594|NCT01183546|101217341|FG000|COMPLETED|Overall Study||53||
48362595|NCT01183546|101217341|FG000|NOT COMPLETED|Overall Study||0||
48362596|NCT00891657|101217342|FG000|STARTED|Overall Study||9||
48362597|NCT00891657|101217343|FG001|STARTED|Overall Study||6||
48362598|NCT00891657|101217342|FG000|COMPLETED|Overall Study||8||
48362599|NCT00891657|101217343|FG001|COMPLETED|Overall Study||5||
48362600|NCT00891657|101217342|FG000|NOT COMPLETED|Overall Study||1||
48362601|NCT00891657|101217343|FG001|NOT COMPLETED|Overall Study||1||
48362602|NCT03134963|101217344|FG000|STARTED|Overall Study||12||
48362603|NCT03134963|101217345|FG001|STARTED|Overall Study||13||
48362604|NCT03134963|101217346|FG002|STARTED|Overall Study||3||
48362605|NCT03134963|101217347|FG003|STARTED|Overall Study||14||
48362606|NCT03134963|101217344|FG000|COMPLETED|Overall Study||12||
48362607|NCT03134963|101217345|FG001|COMPLETED|Overall Study||13||
48362608|NCT03134963|101217346|FG002|COMPLETED|Overall Study||3||
48362609|NCT03134963|101217347|FG003|COMPLETED|Overall Study||14||
48362610|NCT03134963|101217344|FG000|NOT COMPLETED|Overall Study||0||
48362611|NCT03134963|101217345|FG001|NOT COMPLETED|Overall Study||0||
48362612|NCT03134963|101217346|FG002|NOT COMPLETED|Overall Study||0||
48362613|NCT03134963|101217347|FG003|NOT COMPLETED|Overall Study||0||
48362614|NCT00537823|101217348|FG000|STARTED|Overall Study||7||
48362615|NCT00537823|101217349|FG001|STARTED|Overall Study||2||
48362616|NCT00537823|101217348|FG000|COMPLETED|Overall Study||5||
48362617|NCT00537823|101217349|FG001|COMPLETED|Overall Study||2||
48362618|NCT00537823|101217348|FG000|NOT COMPLETED|Overall Study||2||
48362619|NCT00537823|101217349|FG001|NOT COMPLETED|Overall Study||0||
48362620|NCT00607828|101217350|FG000|STARTED|Overall Study||3||
48362621|NCT00607828|101217351|FG001|STARTED|Overall Study||3||
48362622|NCT00607828|101217352|FG002|STARTED|Overall Study||1||
48362623|NCT00607828|101217350|FG000|COMPLETED|Overall Study||3||
48362624|NCT00607828|101217351|FG001|COMPLETED|Overall Study||3||
48362625|NCT00607828|101217352|FG002|COMPLETED|Overall Study||1||
48362626|NCT00607828|101217350|FG000|NOT COMPLETED|Overall Study||0||
48362627|NCT00607828|101217351|FG001|NOT COMPLETED|Overall Study||0||
48362628|NCT00607828|101217352|FG002|NOT COMPLETED|Overall Study||0||
48362629|NCT03176966|101217353|FG000|STARTED|Baseline to 3 Months (1st Intervention)||14||
48362630|NCT03176966|101217354|FG001|STARTED|Baseline to 3 Months (1st Intervention)||16||
48362631|NCT03176966|101217353|FG000|COMPLETED|Baseline to 3 Months (1st Intervention)||10||
48362632|NCT03176966|101217354|FG001|COMPLETED|Baseline to 3 Months (1st Intervention)||9||
48362633|NCT03176966|101217353|FG000|NOT COMPLETED|Baseline to 3 Months (1st Intervention)||4||
48362634|NCT03176966|101217354|FG001|NOT COMPLETED|Baseline to 3 Months (1st Intervention)||7||
48362635|NCT03176966|101217353|FG000|STARTED|3 Month to 6 Months (2nd Intervention)||10||
48362636|NCT03176966|101217354|FG001|STARTED|3 Month to 6 Months (2nd Intervention)||9||
48362637|NCT03176966|101217353|FG000|COMPLETED|3 Month to 6 Months (2nd Intervention)||4||
48362638|NCT03176966|101217354|FG001|COMPLETED|3 Month to 6 Months (2nd Intervention)||4||
48362639|NCT03176966|101217353|FG000|NOT COMPLETED|3 Month to 6 Months (2nd Intervention)||6||
48362640|NCT03176966|101217354|FG001|NOT COMPLETED|3 Month to 6 Months (2nd Intervention)||5||
48362641|NCT03208192|101217355|FG000|STARTED|Overall Study||32||
48362642|NCT03208192|101217356|FG001|STARTED|Overall Study||36||
48362643|NCT03208192|101217355|FG000|COMPLETED|Overall Study||32||
48362644|NCT03208192|101217356|FG001|COMPLETED|Overall Study||36||
48362645|NCT03208192|101217355|FG000|NOT COMPLETED|Overall Study||0||
48362646|NCT03208192|101217356|FG001|NOT COMPLETED|Overall Study||0||
48362647|NCT01452425|101217357|FG000|STARTED|Overall Study||10||
48765666|NCT01709721|102214693|FG001|NOT COMPLETED|Randomized Phase||6||
48765667|NCT01709721|102214694|FG002|NOT COMPLETED|Randomized Phase||0||
48765668|NCT02345070|102214695|FG000|STARTED|Overall Study||110|Randomized|
48765669|NCT02345070|102214696|FG001|STARTED|Overall Study||109|Randomized|
48765670|NCT02345070|102214697|FG002|STARTED|Overall Study||108|Randomized|
48765671|NCT02345070|102214695|FG000|Treated|Overall Study||109||
48362648|NCT01452425|101217357|FG000|COMPLETED|Overall Study||10||
48362649|NCT01452425|101217357|FG000|NOT COMPLETED|Overall Study||0||
48362650|NCT00685178|101217358|FG000|STARTED|Overall Study||40||
48362651|NCT00685178|101217359|FG001|STARTED|Overall Study||45||
48362652|NCT00685178|101217360|FG002|STARTED|Overall Study||39||
48362653|NCT00685178|101217361|FG003|STARTED|Overall Study||47||
48362654|NCT00685178|101217358|FG000|COMPLETED|Overall Study||27||
48362655|NCT00685178|101217359|FG001|COMPLETED|Overall Study||26||
48362656|NCT00685178|101217360|FG002|COMPLETED|Overall Study||27||
48362657|NCT00685178|101217361|FG003|COMPLETED|Overall Study||33||
48362658|NCT00685178|101217358|FG000|NOT COMPLETED|Overall Study||13||
48362659|NCT00685178|101217359|FG001|NOT COMPLETED|Overall Study||19||
48362660|NCT00685178|101217360|FG002|NOT COMPLETED|Overall Study||12||
48362661|NCT00685178|101217361|FG003|NOT COMPLETED|Overall Study||14||
48362662|NCT04773041|101217362|FG000|STARTED|Overall Study||19||
48362663|NCT04773041|101217363|FG001|STARTED|Overall Study||36||
48362664|NCT04773041|101217364|FG002|STARTED|Overall Study||36||
48362665|NCT04773041|101217362|FG000|COMPLETED|Overall Study||18||
48765672|NCT02345070|102214696|FG001|Treated|Overall Study||108||
48765673|NCT02345070|102214697|FG002|Treated|Overall Study||108||
48765674|NCT02345070|102214695|FG000|COMPLETED|Overall Study||90||
48765675|NCT02345070|102214696|FG001|COMPLETED|Overall Study||98||
48765676|NCT02345070|102214697|FG002|COMPLETED|Overall Study||85||
48765677|NCT02345070|102214695|FG000|NOT COMPLETED|Overall Study||20||
48765678|NCT02345070|102214696|FG001|NOT COMPLETED|Overall Study||11||
48765679|NCT02345070|102214697|FG002|NOT COMPLETED|Overall Study||23||
48765680|NCT04102098|102214698|FG000|STARTED|Main Study Period||334||
48765681|NCT04102098|102214699|FG001|STARTED|Main Study Period||334||
48765682|NCT04102098|102214698|FG000|COMPLETED|Main Study Period||0||
48362666|NCT04773041|101217363|FG001|COMPLETED|Overall Study||36||
48362667|NCT04773041|101217364|FG002|COMPLETED|Overall Study||36||
48362668|NCT04773041|101217362|FG000|NOT COMPLETED|Overall Study||1||
48362669|NCT04773041|101217363|FG001|NOT COMPLETED|Overall Study||0||
48362670|NCT04773041|101217364|FG002|NOT COMPLETED|Overall Study||0||
48362671|NCT03279237|101217365|FG000|STARTED|Overall Study||25||
48362672|NCT03279237|101217365|FG000|Chemo-radiation|Overall Study||23||
48362673|NCT03279237|101217365|FG000|Surgical Resection|Overall Study||20||
48362674|NCT03279237|101217365|FG000|COMPLETED|Overall Study||20||
48362675|NCT03279237|101217365|FG000|NOT COMPLETED|Overall Study||5||
48362676|NCT01088815|101217366|FG000|STARTED|Overall Study||72||
48362677|NCT01088815|101217366|FG000|COMPLETED|Overall Study||72||
48362678|NCT01088815|101217366|FG000|NOT COMPLETED|Overall Study||0||
48362679|NCT01713036|101217367|FG000|STARTED|Overall Study||6||
48362680|NCT01713036|101217367|FG000|COMPLETED|Overall Study||5||
48362681|NCT01713036|101217367|FG000|NOT COMPLETED|Overall Study||1||
48362682|NCT01332435|101217368|FG000|STARTED|Overall Study||1572||
48362683|NCT01332435|101217369|FG001|STARTED|Overall Study||1064||
48765683|NCT04102098|102214699|FG001|COMPLETED|Main Study Period||0||
48765684|NCT04102098|102214698|FG000|NOT COMPLETED|Main Study Period||334||
48765685|NCT04102098|102214699|FG001|NOT COMPLETED|Main Study Period||334||
48765686|NCT04102098|102214698|FG000|STARTED|Crossover: AS Who Crossed Over||81||
48765687|NCT04102098|102214699|FG001|STARTED|Crossover: AS Who Crossed Over||0||
48362684|NCT01332435|101217370|FG002|STARTED|Overall Study||2604||
48362685|NCT01332435|101217371|FG003|STARTED|Overall Study||1656||
48362686|NCT01332435|101217368|FG000|COMPLETED|Overall Study||1572||
48362687|NCT01332435|101217369|FG001|COMPLETED|Overall Study||1064||
48362688|NCT01332435|101217370|FG002|COMPLETED|Overall Study||2604||
48362689|NCT01332435|101217371|FG003|COMPLETED|Overall Study||1656||
48362690|NCT01332435|101217368|FG000|NOT COMPLETED|Overall Study||0||
48362691|NCT01332435|101217369|FG001|NOT COMPLETED|Overall Study||0||
48362692|NCT01332435|101217370|FG002|NOT COMPLETED|Overall Study||0||
48362693|NCT01332435|101217371|FG003|NOT COMPLETED|Overall Study||0||
48362694|NCT01206595|101217372|FG000|STARTED|Overall Study||38||
48362695|NCT01206595|101217373|FG001|STARTED|Overall Study||20||
48362696|NCT01206595|101217372|FG000|COMPLETED|Overall Study||38||
48362697|NCT01206595|101217373|FG001|COMPLETED|Overall Study||20||
48362698|NCT01206595|101217372|FG000|NOT COMPLETED|Overall Study||0||
48362699|NCT01206595|101217373|FG001|NOT COMPLETED|Overall Study||0||
48362700|NCT01134887|101217374|FG000|STARTED|Overall Study||9||
48362701|NCT01134887|101217375|FG001|STARTED|Overall Study||11||
48362702|NCT01134887|101217376|FG002|STARTED|Overall Study||5||
48362703|NCT01134887|101217377|FG003|STARTED|Overall Study||5||
48362704|NCT01134887|101217374|FG000|COMPLETED|Overall Study||9||
48362705|NCT01134887|101217375|FG001|COMPLETED|Overall Study||7||
48362706|NCT01134887|101217376|FG002|COMPLETED|Overall Study||5||
48362707|NCT01134887|101217377|FG003|COMPLETED|Overall Study||5||
48362708|NCT01134887|101217374|FG000|NOT COMPLETED|Overall Study||0||
48362709|NCT01134887|101217375|FG001|NOT COMPLETED|Overall Study||4||
48362710|NCT01134887|101217376|FG002|NOT COMPLETED|Overall Study||0||
48362711|NCT01134887|101217377|FG003|NOT COMPLETED|Overall Study||0||
48362712|NCT02901262|101217378|FG000|STARTED|Overall Study||30||86
48362713|NCT02901262|101217378|FG000|COMPLETED|Overall Study||30||86
48362714|NCT02901262|101217378|FG000|NOT COMPLETED|Overall Study||0||0
48362715|NCT00844298|101217379|FG000|STARTED|Overall Study||91||
48362716|NCT00844298|101217379|FG000|COMPLETED|Overall Study||91||
48362717|NCT00844298|101217379|FG000|NOT COMPLETED|Overall Study||0||
48362718|NCT03237845|101217380|FG000|STARTED|Overall Study||594|Randomized|
48362719|NCT03237845|101217381|FG001|STARTED|Overall Study||592|Randomized|
48362720|NCT03237845|101217380|FG000|Treated|Overall Study||543||
48362721|NCT03237845|101217381|FG001|Treated|Overall Study||543||
48362722|NCT03237845|101217380|FG000|COMPLETED|Overall Study||538||
48362723|NCT03237845|101217381|FG001|COMPLETED|Overall Study||542||
48362724|NCT03237845|101217380|FG000|NOT COMPLETED|Overall Study||56||
48362725|NCT03237845|101217381|FG001|NOT COMPLETED|Overall Study||50||
48362726|NCT01184989|101217382|FG000|STARTED|Overall Study||112||
48362727|NCT01184989|101217382|FG000|COMPLETED|Overall Study||100||
48362728|NCT01184989|101217382|FG000|NOT COMPLETED|Overall Study||12||
48362729|NCT03109951|101217383|FG000|STARTED|Overall Study||187||
48362730|NCT03109951|101217383|FG000|COMPLETED|Overall Study||187||
48362731|NCT03109951|101217383|FG000|NOT COMPLETED|Overall Study||0||
48362732|NCT01663740|101217384|FG000|STARTED|Overall Study||38||
48362733|NCT01663740|101217385|FG001|STARTED|Overall Study||21||
48362734|NCT01663740|101217384|FG000|COMPLETED|Overall Study||22||
48362735|NCT01663740|101217385|FG001|COMPLETED|Overall Study||13||
48362736|NCT01663740|101217384|FG000|NOT COMPLETED|Overall Study||16||
48362737|NCT01663740|101217385|FG001|NOT COMPLETED|Overall Study||8||
48362738|NCT01277289|101217386|FG000|STARTED|Overall Study||28||
48362739|NCT01277289|101217387|FG001|STARTED|Overall Study||23||
48362740|NCT01277289|101217386|FG000|COMPLETED|Overall Study||5||
48362741|NCT01277289|101217387|FG001|COMPLETED|Overall Study||2||
48362742|NCT01277289|101217386|FG000|NOT COMPLETED|Overall Study||23||
48362743|NCT01277289|101217387|FG001|NOT COMPLETED|Overall Study||21||
48362744|NCT02795767|101217388|FG000|STARTED|Overall Study||68||
48362745|NCT02795767|101217389|FG001|STARTED|Overall Study||10||
48654666|NCT01748552|101941079|FG004|NOT COMPLETED|Intervention Period 2 and Washout||0||
48362746|NCT02795767|101217390|FG002|STARTED|Overall Study||10||
48362747|NCT02795767|101217388|FG000|Received at Least One Dose of Emicizumab|Overall Study||68||
48362748|NCT02795767|101217389|FG001|Received at Least One Dose of Emicizumab|Overall Study||10||
48362749|NCT02795767|101217390|FG002|Received at Least One Dose of Emicizumab|Overall Study||10||
48362750|NCT02795767|101217388|FG000|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0||
48362751|NCT02795767|101217389|FG001|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0||
48362752|NCT02795767|101217390|FG002|Dose Up-Titrated to 3 mg/kg QW|Overall Study||3||
48362753|NCT02795767|101217388|FG000|Completed 52 Weeks in Study|Overall Study||67||
48362754|NCT02795767|101217389|FG001|Completed 52 Weeks in Study|Overall Study||10||
48362755|NCT02795767|101217390|FG002|Completed 52 Weeks in Study|Overall Study||9||
48362756|NCT02795767|101217388|FG000|COMPLETED|Overall Study||67||
48362757|NCT02795767|101217389|FG001|COMPLETED|Overall Study||10||
48362758|NCT02795767|101217390|FG002|COMPLETED|Overall Study||10||
48362759|NCT02795767|101217388|FG000|NOT COMPLETED|Overall Study||1||
48362760|NCT02795767|101217389|FG001|NOT COMPLETED|Overall Study||0||
48362761|NCT02795767|101217390|FG002|NOT COMPLETED|Overall Study||0||
48362762|NCT01188798|101217391|FG000|STARTED|Overall Study||2||
48362763|NCT01188798|101217392|FG001|STARTED|Overall Study||4||
48362764|NCT01188798|101217391|FG000|COMPLETED|Overall Study||0||
48362765|NCT01188798|101217392|FG001|COMPLETED|Overall Study||1||
48362766|NCT01188798|101217391|FG000|NOT COMPLETED|Overall Study||2||
48362767|NCT01188798|101217392|FG001|NOT COMPLETED|Overall Study||3||
48362768|NCT00399802|101217393|FG000|STARTED|Overall Study||14||
48362769|NCT00399802|101217394|FG001|STARTED|Overall Study||29||
48362770|NCT00399802|101217393|FG000|COMPLETED|Overall Study||14||
48362771|NCT00399802|101217394|FG001|COMPLETED|Overall Study||26||
48362772|NCT00399802|101217393|FG000|NOT COMPLETED|Overall Study||0||
48362773|NCT00399802|101217394|FG001|NOT COMPLETED|Overall Study||3||
48362774|NCT01952015|101217395|FG000|STARTED|Induction||12||
48362775|NCT01952015|101217395|FG000|COMPLETED|Induction||11||
48362776|NCT01952015|101217395|FG000|NOT COMPLETED|Induction||1||
48362777|NCT01952015|101217395|FG000|STARTED|Maintenance||11||
48362778|NCT01952015|101217395|FG000|COMPLETED|Maintenance||9||
48362779|NCT01952015|101217395|FG000|NOT COMPLETED|Maintenance||2||
48362780|NCT01952015|101217395|FG000|STARTED|Treatment Period 3||9||
48362781|NCT01952015|101217395|FG000|COMPLETED|Treatment Period 3||0||
48362782|NCT01952015|101217395|FG000|NOT COMPLETED|Treatment Period 3||9||
48362783|NCT04172831|101217396|FG000|STARTED|Overall Study||248||
48362784|NCT04172831|101217397|FG001|STARTED|Overall Study||255||
48362785|NCT04172831|101217396|FG000|COMPLETED|Overall Study||204||
48362786|NCT04172831|101217397|FG001|COMPLETED|Overall Study||213||
48765688|NCT04102098|102214698|FG000|COMPLETED|Crossover: AS Who Crossed Over||0||
48765689|NCT04102098|102214699|FG001|COMPLETED|Crossover: AS Who Crossed Over||0||
48362787|NCT04172831|101217396|FG000|NOT COMPLETED|Overall Study||44||
48362788|NCT04172831|101217397|FG001|NOT COMPLETED|Overall Study||42||
48362789|NCT01266148|101217398|FG000|STARTED|Overall Study||56||
48362790|NCT01266148|101217399|FG001|STARTED|Overall Study||59||
48362791|NCT01266148|101217398|FG000|COMPLETED|Overall Study||49||
48362792|NCT01266148|101217399|FG001|COMPLETED|Overall Study||56||
48362793|NCT01266148|101217398|FG000|NOT COMPLETED|Overall Study||7||
48362794|NCT01266148|101217399|FG001|NOT COMPLETED|Overall Study||3||
48362795|NCT00778999|101217400|FG000|STARTED|Overall Study||223||
48362796|NCT00778999|101217401|FG001|STARTED|Overall Study||219||
48362797|NCT00778999|101217400|FG000|COMPLETED|Overall Study||195||
48362798|NCT00778999|101217401|FG001|COMPLETED|Overall Study||185||
48362799|NCT00778999|101217400|FG000|NOT COMPLETED|Overall Study||28||
48362800|NCT00778999|101217401|FG001|NOT COMPLETED|Overall Study||34||
48362801|NCT03847337|101217402|FG000|STARTED|Overall Study||73||
48362802|NCT03847337|101217403|FG001|STARTED|Overall Study||71||
48362803|NCT03847337|101217402|FG000|COMPLETED|Overall Study||73||
48362804|NCT03847337|101217403|FG001|COMPLETED|Overall Study||71||
48362805|NCT03847337|101217402|FG000|NOT COMPLETED|Overall Study||0||
48362806|NCT03847337|101217403|FG001|NOT COMPLETED|Overall Study||0||
48362807|NCT04073823|101217404|FG000|STARTED|Overall Study||1||
48362808|NCT04073823|101217405|FG001|STARTED|Overall Study||1||
48362809|NCT04073823|101217404|FG000|COMPLETED|Overall Study||1||
48362810|NCT04073823|101217405|FG001|COMPLETED|Overall Study||1||
48362811|NCT04073823|101217404|FG000|NOT COMPLETED|Overall Study||0||
48362812|NCT04073823|101217405|FG001|NOT COMPLETED|Overall Study||0||
48362813|NCT00576693|101217406|FG000|STARTED|Overall Study||224||
48362814|NCT00576693|101217407|FG001|STARTED|Overall Study||227||
48362815|NCT00576693|101217406|FG000|COMPLETED|Overall Study||214||
48362816|NCT00576693|101217407|FG001|COMPLETED|Overall Study||203||
48362817|NCT00576693|101217406|FG000|NOT COMPLETED|Overall Study||10||
48362818|NCT00576693|101217407|FG001|NOT COMPLETED|Overall Study||24||
48362819|NCT00882713|101217408|FG000|STARTED|Overall Study||194||
48362820|NCT00882713|101217408|FG000|COMPLETED|Overall Study||172||
48362821|NCT00882713|101217408|FG000|NOT COMPLETED|Overall Study||22||
48362822|NCT02504892|101217409|FG000|STARTED|Overall Study||3||
48362823|NCT02504892|101217409|FG000|COMPLETED|Overall Study||1||
48362824|NCT02504892|101217409|FG000|NOT COMPLETED|Overall Study||2||
48362825|NCT01650779|101217410|FG000|STARTED|Overall Study||15||
48362826|NCT01650779|101217410|FG000|COMPLETED|Overall Study||14||
48362827|NCT01650779|101217410|FG000|NOT COMPLETED|Overall Study||1||
48362828|NCT01556633|101217411|FG000|STARTED|Overall Study||10||
48362829|NCT01556633|101217412|FG001|STARTED|Overall Study||6||
48362830|NCT01556633|101217411|FG000|COMPLETED|Overall Study||10||
48362831|NCT01556633|101217412|FG001|COMPLETED|Overall Study||6||
48765690|NCT04102098|102214698|FG000|NOT COMPLETED|Crossover: AS Who Crossed Over||81||
48362832|NCT01556633|101217411|FG000|NOT COMPLETED|Overall Study||0||
48362833|NCT01556633|101217412|FG001|NOT COMPLETED|Overall Study||0||
48362834|NCT04083144|101217413|FG000|STARTED|Overall Study||24||
48362835|NCT04083144|101217414|FG001|STARTED|Overall Study||18||
48362836|NCT04083144|101217413|FG000|COMPLETED|Overall Study||16||
48362837|NCT04083144|101217414|FG001|COMPLETED|Overall Study||15||
48362838|NCT04083144|101217413|FG000|NOT COMPLETED|Overall Study||8||
48362839|NCT04083144|101217414|FG001|NOT COMPLETED|Overall Study||3||
48362840|NCT00418886|101217415|FG000|STARTED|Overall Study||256||
48362841|NCT00418886|101217416|FG001|STARTED|Overall Study||278||
48362842|NCT00418886|101217415|FG000|COMPLETED|Overall Study||30||
48362843|NCT00418886|101217416|FG001|COMPLETED|Overall Study||23||
48362844|NCT00418886|101217415|FG000|NOT COMPLETED|Overall Study||226||
48362845|NCT00418886|101217416|FG001|NOT COMPLETED|Overall Study||255||
48362846|NCT03071406|101217417|FG000|STARTED|Overall Study||25||
48362847|NCT03071406|101217418|FG001|STARTED|Overall Study||25||
48362848|NCT03071406|101217417|FG000|COMPLETED|Overall Study||25||
48362849|NCT03071406|101217418|FG001|COMPLETED|Overall Study||24||
48362850|NCT03071406|101217417|FG000|NOT COMPLETED|Overall Study||0||
48362851|NCT03071406|101217418|FG001|NOT COMPLETED|Overall Study||1||
48362852|NCT04542291|101217419|FG000|STARTED|Overall Study||15||
48362853|NCT04542291|101217419|FG000|COMPLETED|Overall Study||12||
48362854|NCT04542291|101217419|FG000|NOT COMPLETED|Overall Study||3||
48362855|NCT01070303|101217420|FG000|STARTED|Overall Study||177||
48362856|NCT01070303|101217420|FG000|COMPLETED|Overall Study||88||
48362857|NCT01070303|101217420|FG000|NOT COMPLETED|Overall Study||89||
48362858|NCT00611130|101217421|FG000|STARTED|Overall Study||92||
48362859|NCT00611130|101217422|FG001|STARTED|Overall Study||94||
48362860|NCT00611130|101217421|FG000|Completed 12 Week Treatment Phase|Overall Study||61||
48362861|NCT00611130|101217422|FG001|Completed 12 Week Treatment Phase|Overall Study||64||
48362862|NCT00611130|101217421|FG000|COMPLETED|Overall Study||43||
48362863|NCT00611130|101217422|FG001|COMPLETED|Overall Study||47||
48362864|NCT00611130|101217421|FG000|NOT COMPLETED|Overall Study||49||
48362865|NCT00611130|101217422|FG001|NOT COMPLETED|Overall Study||47||
48362866|NCT00339079|101217423|FG000|STARTED|Overall Study||53||
48362867|NCT00339079|101217424|FG001|STARTED|Overall Study||44||
48362868|NCT00339079|101217425|FG002|STARTED|Overall Study||45||
48362869|NCT00339079|101217426|FG003|STARTED|Overall Study||53||
48362870|NCT00339079|101217423|FG000|COMPLETED|Overall Study||20||
48362871|NCT00339079|101217424|FG001|COMPLETED|Overall Study||21||
48362872|NCT00339079|101217425|FG002|COMPLETED|Overall Study||27||
48362873|NCT00339079|101217426|FG003|COMPLETED|Overall Study||29||
48362874|NCT00339079|101217423|FG000|NOT COMPLETED|Overall Study||33||
48362875|NCT00339079|101217424|FG001|NOT COMPLETED|Overall Study||23||
48362876|NCT00339079|101217425|FG002|NOT COMPLETED|Overall Study||18||
48362877|NCT00339079|101217426|FG003|NOT COMPLETED|Overall Study||24||
48362878|NCT04076072|101217427|FG000|STARTED|Overall Study||20||
48654667|NCT01748552|101941080|FG005|NOT COMPLETED|Intervention Period 2 and Washout||0||
48654668|NCT01748552|101941081|FG006|NOT COMPLETED|Intervention Period 2 and Washout||3||
48654669|NCT01748552|101941082|FG007|NOT COMPLETED|Intervention Period 2 and Washout||3||
48654670|NCT01748552|101941083|FG008|NOT COMPLETED|Intervention Period 2 and Washout||3||
48654671|NCT01748552|101941084|FG009|NOT COMPLETED|Intervention Period 2 and Washout||0||
48654672|NCT01748552|101941085|FG010|NOT COMPLETED|Intervention Period 2 and Washout||0||
48654673|NCT01748552|101941086|FG011|NOT COMPLETED|Intervention Period 2 and Washout||0||
48654674|NCT01748552|101941075|FG000|STARTED|Intervention Period 3 and Washout||3||
48654675|NCT01748552|101941076|FG001|STARTED|Intervention Period 3 and Washout||3||
48654676|NCT01748552|101941077|FG002|STARTED|Intervention Period 3 and Washout||2||
48654677|NCT01748552|101941078|FG003|STARTED|Intervention Period 3 and Washout||3||
48654678|NCT01748552|101941079|FG004|STARTED|Intervention Period 3 and Washout||3||
48654679|NCT01748552|101941080|FG005|STARTED|Intervention Period 3 and Washout||3||
48654680|NCT01748552|101941081|FG006|STARTED|Intervention Period 3 and Washout||0||
48654681|NCT01748552|101941082|FG007|STARTED|Intervention Period 3 and Washout||0||
48654682|NCT01748552|101941083|FG008|STARTED|Intervention Period 3 and Washout||0||
48654683|NCT01748552|101941084|FG009|STARTED|Intervention Period 3 and Washout||3||
48362879|NCT04076072|101217428|FG001|STARTED|Overall Study||20||
48362880|NCT04076072|101217427|FG000|COMPLETED|Overall Study||20||
48362881|NCT04076072|101217428|FG001|COMPLETED|Overall Study||20||
48362882|NCT04076072|101217427|FG000|NOT COMPLETED|Overall Study||0||
48362883|NCT04076072|101217428|FG001|NOT COMPLETED|Overall Study||0||
48362884|NCT00092547|101217429|FG000|STARTED|Base Vaccine Phase (Day 1 to Month 7)||1184||
48654684|NCT01748552|101941085|FG010|STARTED|Intervention Period 3 and Washout||3||
48654685|NCT01748552|101941086|FG011|STARTED|Intervention Period 3 and Washout||3||
48654686|NCT01748552|101941075|FG000|COMPLETED|Intervention Period 3 and Washout||3||
48654687|NCT01748552|101941076|FG001|COMPLETED|Intervention Period 3 and Washout||3||
48654688|NCT01748552|101941077|FG002|COMPLETED|Intervention Period 3 and Washout||2||
48362885|NCT00092547|101217430|FG001|STARTED|Base Vaccine Phase (Day 1 to Month 7)||597||
48362886|NCT00092547|101217431|FG002|STARTED|Base Vaccine Phase (Day 1 to Month 7)||0||
48654689|NCT01748552|101941078|FG003|COMPLETED|Intervention Period 3 and Washout||3||
48654690|NCT01748552|101941079|FG004|COMPLETED|Intervention Period 3 and Washout||3||
48654691|NCT01748552|101941080|FG005|COMPLETED|Intervention Period 3 and Washout||3||
48654692|NCT01748552|101941081|FG006|COMPLETED|Intervention Period 3 and Washout||0||
48654693|NCT01748552|101941082|FG007|COMPLETED|Intervention Period 3 and Washout||0||
48362887|NCT00092547|101217429|FG000|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||1179||
48362888|NCT00092547|101217430|FG001|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||596||
48362889|NCT00092547|101217431|FG002|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||0||
48362890|NCT00092547|101217429|FG000|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||1121||
48362891|NCT00092547|101217430|FG001|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||561||
48362892|NCT00092547|101217431|FG002|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0||
48362893|NCT00092547|101217429|FG000|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||63||
48362894|NCT00092547|101217430|FG001|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||36||
48362895|NCT00092547|101217431|FG002|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0||
48362896|NCT00092547|101217429|FG000|STARTED|Base Follow-up Phase (Month 7 to 18)||1128||
48362897|NCT00092547|101217430|FG001|STARTED|Base Follow-up Phase (Month 7 to 18)||565||
48362898|NCT00092547|101217431|FG002|STARTED|Base Follow-up Phase (Month 7 to 18)||0||
48362899|NCT00092547|101217429|FG000|COMPLETED|Base Follow-up Phase (Month 7 to 18)||1108||
48362900|NCT00092547|101217430|FG001|COMPLETED|Base Follow-up Phase (Month 7 to 18)||551||
48362901|NCT00092547|101217431|FG002|COMPLETED|Base Follow-up Phase (Month 7 to 18)||0||
48362902|NCT00092547|101217429|FG000|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||20||
48362903|NCT00092547|101217430|FG001|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||14||
48362904|NCT00092547|101217431|FG002|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||0||
48362905|NCT00092547|101217429|FG000|STARTED|Base Follow-up Phase (Month 18 to 30)||964||
48362906|NCT00092547|101217430|FG001|STARTED|Base Follow-up Phase (Month 18 to 30)||490||
48362907|NCT00092547|101217431|FG002|STARTED|Base Follow-up Phase (Month 18 to 30)||0||
48362908|NCT00092547|101217429|FG000|COMPLETED|Base Follow-up Phase (Month 18 to 30)||956||
48362909|NCT00092547|101217430|FG001|COMPLETED|Base Follow-up Phase (Month 18 to 30)||485||
48362910|NCT00092547|101217431|FG002|COMPLETED|Base Follow-up Phase (Month 18 to 30)||0||
48362911|NCT00092547|101217429|FG000|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||8||
48362912|NCT00092547|101217430|FG001|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||5||
48362913|NCT00092547|101217431|FG002|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||0||
48362914|NCT00092547|101217429|FG000|STARTED|Extension Vaccine Phase (Month 30 to 37)||956||
48362915|NCT00092547|101217430|FG001|STARTED|Extension Vaccine Phase (Month 30 to 37)||0||
48362916|NCT00092547|101217431|FG002|STARTED|Extension Vaccine Phase (Month 30 to 37)||485||
48362917|NCT00092547|101217429|FG000|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0||
48362918|NCT00092547|101217430|FG001|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0||
48362919|NCT00092547|101217431|FG002|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||482||
48362920|NCT00092547|101217429|FG000|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||933||
48362921|NCT00092547|101217430|FG001|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0||
48362922|NCT00092547|101217431|FG002|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||469||
48362923|NCT00092547|101217429|FG000|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||23||
48362924|NCT00092547|101217430|FG001|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0||
48362925|NCT00092547|101217431|FG002|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||16||
48362926|NCT00092547|101217429|FG000|STARTED|Long-term Follow-up (Month 42 Visit)||612||
48362927|NCT00092547|101217430|FG001|STARTED|Long-term Follow-up (Month 42 Visit)||0||
48362928|NCT00092547|101217431|FG002|STARTED|Long-term Follow-up (Month 42 Visit)||308||
48362929|NCT00092547|101217429|FG000|COMPLETED|Long-term Follow-up (Month 42 Visit)||611||
48362930|NCT00092547|101217430|FG001|COMPLETED|Long-term Follow-up (Month 42 Visit)||0||
48362931|NCT00092547|101217431|FG002|COMPLETED|Long-term Follow-up (Month 42 Visit)||308||
48362932|NCT00092547|101217429|FG000|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||1||
48362933|NCT00092547|101217430|FG001|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0||
48362934|NCT00092547|101217431|FG002|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0||
48362935|NCT00092547|101217429|FG000|STARTED|Long-term Follow-up (Month 72 Visit)||550||
48362936|NCT00092547|101217430|FG001|STARTED|Long-term Follow-up (Month 72 Visit)||0||
48362937|NCT00092547|101217431|FG002|STARTED|Long-term Follow-up (Month 72 Visit)||276||
48362938|NCT00092547|101217429|FG000|COMPLETED|Long-term Follow-up (Month 72 Visit)||550||
48362939|NCT00092547|101217430|FG001|COMPLETED|Long-term Follow-up (Month 72 Visit)||0||
48362940|NCT00092547|101217431|FG002|COMPLETED|Long-term Follow-up (Month 72 Visit)||276||
48362941|NCT00092547|101217429|FG000|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0||
48362942|NCT00092547|101217430|FG001|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0||
48362943|NCT00092547|101217431|FG002|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0||
48362944|NCT00092547|101217429|FG000|STARTED|Long-term Follow-up (Month 96 Visit)||508||
48362945|NCT00092547|101217430|FG001|STARTED|Long-term Follow-up (Month 96 Visit)||0||
48657056|NCT03648372|101943775|FG018|STARTED|Overall Study||4||
48362946|NCT00092547|101217431|FG002|STARTED|Long-term Follow-up (Month 96 Visit)||267||
48362947|NCT00092547|101217429|FG000|COMPLETED|Long-term Follow-up (Month 96 Visit)||508||
48362948|NCT00092547|101217430|FG001|COMPLETED|Long-term Follow-up (Month 96 Visit)||0||
48362949|NCT00092547|101217431|FG002|COMPLETED|Long-term Follow-up (Month 96 Visit)||267||
48362950|NCT00092547|101217429|FG000|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0||
48362951|NCT00092547|101217430|FG001|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0||
48362952|NCT00092547|101217431|FG002|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0||
48362953|NCT00092547|101217429|FG000|STARTED|Long-term Follow-up (Month 126 Visit)||454||
48362954|NCT00092547|101217430|FG001|STARTED|Long-term Follow-up (Month 126 Visit)||0||
48362955|NCT00092547|101217431|FG002|STARTED|Long-term Follow-up (Month 126 Visit)||211||
48362956|NCT00092547|101217429|FG000|COMPLETED|Long-term Follow-up (Month 126 Visit)||454||
48362957|NCT00092547|101217430|FG001|COMPLETED|Long-term Follow-up (Month 126 Visit)||0||
48362958|NCT00092547|101217431|FG002|COMPLETED|Long-term Follow-up (Month 126 Visit)||211||
48362959|NCT00092547|101217429|FG000|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0||
48362960|NCT00092547|101217430|FG001|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0||
48362961|NCT00092547|101217431|FG002|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0||
48362962|NCT02722577|101217432|FG000|STARTED|Overall Study||20||
48362963|NCT02722577|101217432|FG000|COMPLETED|Overall Study||20||
48362964|NCT02722577|101217432|FG000|NOT COMPLETED|Overall Study||0||
48362965|NCT03463265|101217433|FG000|STARTED|Overall Study||7||
48362966|NCT03463265|101217434|FG001|STARTED|Overall Study||6||
48362967|NCT03463265|101217435|FG002|STARTED|Overall Study||9||
48362968|NCT03463265|101217436|FG003|STARTED|Overall Study||4||
48362969|NCT03463265|101217437|FG004|STARTED|Overall Study||10||
48362970|NCT03463265|101217438|FG005|STARTED|Overall Study||26||
48362971|NCT03463265|101217433|FG000|COMPLETED|Overall Study||7||
48362972|NCT03463265|101217434|FG001|COMPLETED|Overall Study||6||
48362973|NCT03463265|101217435|FG002|COMPLETED|Overall Study||9||
48362974|NCT03463265|101217436|FG003|COMPLETED|Overall Study||4||
48362975|NCT03463265|101217437|FG004|COMPLETED|Overall Study||10||
48362976|NCT03463265|101217438|FG005|COMPLETED|Overall Study||26||
48362977|NCT03463265|101217433|FG000|NOT COMPLETED|Overall Study||0||
48362978|NCT03463265|101217434|FG001|NOT COMPLETED|Overall Study||0||
48362979|NCT03463265|101217435|FG002|NOT COMPLETED|Overall Study||0||
48362980|NCT03463265|101217436|FG003|NOT COMPLETED|Overall Study||0||
48362981|NCT03463265|101217437|FG004|NOT COMPLETED|Overall Study||0||
48362982|NCT03463265|101217438|FG005|NOT COMPLETED|Overall Study||0||
48362983|NCT02138110|101217439|FG000|STARTED|Enrolled in Study||20||
48362984|NCT02138110|101217439|FG000|COMPLETED|Enrolled in Study||20||
48362985|NCT02138110|101217439|FG000|NOT COMPLETED|Enrolled in Study||0||
48362986|NCT02138110|101217439|FG000|STARTED|Enrolled for Scaffold Implantation||20||
48362987|NCT02138110|101217439|FG000|COMPLETED|Enrolled for Scaffold Implantation||19||
48362988|NCT02138110|101217439|FG000|NOT COMPLETED|Enrolled for Scaffold Implantation||1||
48362989|NCT02138110|101217439|FG000|STARTED|Overall Scaffold Implantation||19||
48362990|NCT02138110|101217439|FG000|6-month Follow-Up|Overall Scaffold Implantation||16||
48362991|NCT02138110|101217439|FG000|COMPLETED|Overall Scaffold Implantation||16||
48362992|NCT02138110|101217439|FG000|NOT COMPLETED|Overall Scaffold Implantation||3||
48362993|NCT01597193|101217440|FG000|STARTED|Stage 1: Dose Escalation (141 Days)||7||
48362994|NCT01597193|101217441|FG001|STARTED|Stage 1: Dose Escalation (141 Days)||8||
48362995|NCT01597193|101217442|FG002|STARTED|Stage 1: Dose Escalation (141 Days)||0||
48362996|NCT01597193|101217443|FG003|STARTED|Stage 1: Dose Escalation (141 Days)||0||
48362997|NCT01597193|101217444|FG004|STARTED|Stage 1: Dose Escalation (141 Days)||0||
48362998|NCT01597193|101217445|FG005|STARTED|Stage 1: Dose Escalation (141 Days)||0||
48362999|NCT01597193|101217446|FG006|STARTED|Stage 1: Dose Escalation (141 Days)||0||
48363000|NCT01597193|101217440|FG000|COMPLETED|Stage 1: Dose Escalation (141 Days)||0||
48363001|NCT01597193|101217441|FG001|COMPLETED|Stage 1: Dose Escalation (141 Days)||0||
48363002|NCT01597193|101217442|FG002|COMPLETED|Stage 1: Dose Escalation (141 Days)||0||
48363003|NCT01597193|101217443|FG003|COMPLETED|Stage 1: Dose Escalation (141 Days)||0||
48363004|NCT01597193|101217444|FG004|COMPLETED|Stage 1: Dose Escalation (141 Days)||0||
48363005|NCT01597193|101217445|FG005|COMPLETED|Stage 1: Dose Escalation (141 Days)||0||
48363006|NCT01597193|101217446|FG006|COMPLETED|Stage 1: Dose Escalation (141 Days)||0||
48363007|NCT01597193|101217440|FG000|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||7||
48363008|NCT01597193|101217441|FG001|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||8||
48363009|NCT01597193|101217442|FG002|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0||
48363010|NCT01597193|101217443|FG003|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0||
48363011|NCT01597193|101217444|FG004|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0||
48363012|NCT01597193|101217445|FG005|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0||
48363013|NCT01597193|101217446|FG006|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0||
48363014|NCT01597193|101217440|FG000|STARTED|Stage 2: Dose Expansion (1067 Days)||0||
48363015|NCT01597193|101217441|FG001|STARTED|Stage 2: Dose Expansion (1067 Days)||0||
48363016|NCT01597193|101217442|FG002|STARTED|Stage 2: Dose Expansion (1067 Days)||14||
48363017|NCT01597193|101217443|FG003|STARTED|Stage 2: Dose Expansion (1067 Days)||20||
48363018|NCT01597193|101217444|FG004|STARTED|Stage 2: Dose Expansion (1067 Days)||16||
48363019|NCT01597193|101217445|FG005|STARTED|Stage 2: Dose Expansion (1067 Days)||23||
48363020|NCT01597193|101217446|FG006|STARTED|Stage 2: Dose Expansion (1067 Days)||11||
48363021|NCT01597193|101217440|FG000|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0||
48363022|NCT01597193|101217441|FG001|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0||
48363023|NCT01597193|101217442|FG002|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0||
48363024|NCT01597193|101217443|FG003|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0||
48363025|NCT01597193|101217444|FG004|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0||
48363026|NCT01597193|101217445|FG005|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0||
48363027|NCT01597193|101217446|FG006|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0||
48363028|NCT01597193|101217440|FG000|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||0||
48436509|NCT04780776|101403567|FG001|COMPLETED|Treatment Week 6-21||22||
48363029|NCT01597193|101217441|FG001|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||0||
48363030|NCT01597193|101217442|FG002|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||14||
48363031|NCT01597193|101217443|FG003|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||20||
48363032|NCT01597193|101217444|FG004|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||16||
48436510|NCT04780776|101403566|FG000|NOT COMPLETED|Treatment Week 6-21||4||
48363033|NCT01597193|101217445|FG005|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||23||
48363034|NCT01597193|101217446|FG006|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||11||
48363035|NCT00593112|101217447|FG000|STARTED|Overall Study||27||
48363036|NCT00593112|101217448|FG001|STARTED|Overall Study||12||
48363037|NCT00593112|101217447|FG000|COMPLETED|Overall Study||17||
48363038|NCT00593112|101217448|FG001|COMPLETED|Overall Study||12||
48363039|NCT00593112|101217447|FG000|NOT COMPLETED|Overall Study||10||
48363040|NCT00593112|101217448|FG001|NOT COMPLETED|Overall Study||0||
48363041|NCT03704051|101217449|FG000|STARTED|Overall Study||48||
48363042|NCT03704051|101217450|FG001|STARTED|Overall Study||46||
48363043|NCT03704051|101217449|FG000|COMPLETED|Overall Study||44||
48363044|NCT03704051|101217450|FG001|COMPLETED|Overall Study||46||
48363045|NCT03704051|101217449|FG000|NOT COMPLETED|Overall Study||4||
48363046|NCT03704051|101217450|FG001|NOT COMPLETED|Overall Study||0||
48363047|NCT02487745|101217451|FG000|STARTED|Overall Study||47||
48363048|NCT02487745|101217452|FG001|STARTED|Overall Study||44||
48188290|NCT01072929|100783208|FG002|Safety Population|Overall Study||32||
48363049|NCT02487745|101217451|FG000|COMPLETED|Overall Study||47||
48363050|NCT02487745|101217452|FG001|COMPLETED|Overall Study||44||
48363051|NCT02487745|101217451|FG000|NOT COMPLETED|Overall Study||0||
48363052|NCT02487745|101217452|FG001|NOT COMPLETED|Overall Study||0||
48363053|NCT00450866|101217453|FG000|STARTED|Overall Study||45||
48363054|NCT00450866|101217454|FG001|STARTED|Overall Study||10||
48363055|NCT00450866|101217453|FG000|COMPLETED|Overall Study||38||
48363056|NCT00450866|101217454|FG001|COMPLETED|Overall Study||7||
48363057|NCT00450866|101217453|FG000|NOT COMPLETED|Overall Study||7||
48363058|NCT00450866|101217454|FG001|NOT COMPLETED|Overall Study||3||
48363059|NCT00909090|101217455|FG000|STARTED|Overall Study||53||
48363060|NCT00909090|101217456|FG001|STARTED|Overall Study||56||
48363061|NCT00909090|101217455|FG000|COMPLETED|Overall Study||36||
48363062|NCT00909090|101217456|FG001|COMPLETED|Overall Study||39||
48363063|NCT00909090|101217455|FG000|NOT COMPLETED|Overall Study||17||
48363064|NCT00909090|101217456|FG001|NOT COMPLETED|Overall Study||17||
48363065|NCT00916721|101217457|FG000|STARTED|Overall Study||35||
48363066|NCT00916721|101217458|FG001|STARTED|Overall Study||39||
48363067|NCT00916721|101217457|FG000|COMPLETED|Overall Study||25||
48363068|NCT00916721|101217458|FG001|COMPLETED|Overall Study||29||
48363069|NCT00916721|101217457|FG000|NOT COMPLETED|Overall Study||10||
48363070|NCT00916721|101217458|FG001|NOT COMPLETED|Overall Study||10||
48363071|NCT03321929|101217459|FG000|STARTED|Overall Study||234||
48363072|NCT03321929|101217459|FG000|COMPLETED|Overall Study||230||
48363073|NCT03321929|101217459|FG000|NOT COMPLETED|Overall Study||4||
48363074|NCT01056523|101217460|FG000|STARTED|Overall Study||4||
48363075|NCT01056523|101217461|FG001|STARTED|Overall Study||3||
48363076|NCT01056523|101217462|FG002|STARTED|Overall Study||5||
48363077|NCT01056523|101217463|FG003|STARTED|Overall Study||6||
48363078|NCT01056523|101217464|FG004|STARTED|Overall Study||3||
48363079|NCT01056523|101217465|FG005|STARTED|Overall Study||3||
48363080|NCT01056523|101217466|FG006|STARTED|Overall Study||5||
48363081|NCT01056523|101217460|FG000|COMPLETED|Overall Study||3||
48363082|NCT01056523|101217461|FG001|COMPLETED|Overall Study||3||
48363083|NCT01056523|101217462|FG002|COMPLETED|Overall Study||3||
48363084|NCT01056523|101217463|FG003|COMPLETED|Overall Study||3||
48363085|NCT01056523|101217464|FG004|COMPLETED|Overall Study||3||
48363086|NCT01056523|101217465|FG005|COMPLETED|Overall Study||3||
48188291|NCT01072929|100783206|FG000|Full Analysis Population|Overall Study||196||
48188292|NCT01072929|100783207|FG001|Full Analysis Population|Overall Study||197||
48363087|NCT01056523|101217466|FG006|COMPLETED|Overall Study||4||
48436511|NCT04780776|101403567|FG001|NOT COMPLETED|Treatment Week 6-21||4||
48654694|NCT01748552|101941083|FG008|COMPLETED|Intervention Period 3 and Washout||0||
48654695|NCT01748552|101941084|FG009|COMPLETED|Intervention Period 3 and Washout||3||
48363088|NCT01056523|101217460|FG000|NOT COMPLETED|Overall Study||1||
48363089|NCT01056523|101217461|FG001|NOT COMPLETED|Overall Study||0||
48363090|NCT01056523|101217462|FG002|NOT COMPLETED|Overall Study||2||
48363091|NCT01056523|101217463|FG003|NOT COMPLETED|Overall Study||3||
48363092|NCT01056523|101217464|FG004|NOT COMPLETED|Overall Study||0||
48363093|NCT01056523|101217465|FG005|NOT COMPLETED|Overall Study||0||
48363094|NCT01056523|101217466|FG006|NOT COMPLETED|Overall Study||1||
48363095|NCT05111249|101217467|FG000|STARTED|Overall Study||5||
48363096|NCT05111249|101217468|FG001|STARTED|Overall Study||21||
48363097|NCT05111249|101217467|FG000|COMPLETED|Overall Study||4||
48363098|NCT05111249|101217468|FG001|COMPLETED|Overall Study||13||
48363099|NCT05111249|101217467|FG000|NOT COMPLETED|Overall Study||1||
48363100|NCT05111249|101217468|FG001|NOT COMPLETED|Overall Study||8||
48363101|NCT01712438|101217469|FG000|STARTED|Overall Study||110||
48363102|NCT01712438|101217469|FG000|SAF Population|Overall Study||108|SAF population = study population of patients in safety analysis|
48363103|NCT01712438|101217469|FG000|ITT Population|Overall Study||108|ITT population = intent-to-treat population|
48363104|NCT01712438|101217469|FG000|PP Population|Overall Study||95|PP Population = per-protocol population|
48363105|NCT01712438|101217469|FG000|PROPH Population|Overall Study||103|PROPH population = study population of patients receiving prophylaxis|
48363106|NCT01712438|101217469|FG000|BLEED Population|Overall Study||94|BLEED population = study population of Bleeding Events (BEs)|
48363107|NCT01712438|101217469|FG000|SURG Population|Overall Study||24|SURG population = study population of patients undergoing surgery treated with Human-cl rhFVIII|
48363108|NCT01712438|101217469|FG000|COMPLETED|Overall Study||73||
48363109|NCT01712438|101217469|FG000|NOT COMPLETED|Overall Study||37||
48363110|NCT01048125|101217470|FG000|STARTED|Overall Study||0||
48363111|NCT01048125|101217471|FG001|STARTED|Overall Study||0||
48363112|NCT01048125|101217470|FG000|COMPLETED|Overall Study||0||
48363113|NCT01048125|101217471|FG001|COMPLETED|Overall Study||0||
48363114|NCT01048125|101217470|FG000|NOT COMPLETED|Overall Study||0||
48363115|NCT01048125|101217471|FG001|NOT COMPLETED|Overall Study||0||
48363116|NCT03988751|101217472|FG000|STARTED|Overall Study||11||
48363117|NCT03988751|101217473|FG001|STARTED|Overall Study||11||
48363118|NCT03988751|101217472|FG000|COMPLETED|Overall Study||10||
48363119|NCT03988751|101217473|FG001|COMPLETED|Overall Study||10||
48363120|NCT03988751|101217472|FG000|NOT COMPLETED|Overall Study||1||
48363121|NCT03988751|101217473|FG001|NOT COMPLETED|Overall Study||1||
48363122|NCT01612793|101217474|FG000|STARTED|Overall Study||2||
48363123|NCT01612793|101217475|FG001|STARTED|Overall Study||2||
48363124|NCT01612793|101217474|FG000|COMPLETED|Overall Study||2||
48363125|NCT01612793|101217475|FG001|COMPLETED|Overall Study||2||
48363126|NCT01612793|101217474|FG000|NOT COMPLETED|Overall Study||0||
48363127|NCT01612793|101217475|FG001|NOT COMPLETED|Overall Study||0||
48363128|NCT02168946|101217476|FG000|STARTED|Overall Study||50||
48363129|NCT02168946|101217477|FG001|STARTED|Overall Study||25||
48363130|NCT02168946|101217476|FG000|COMPLETED|Overall Study||38||
48363131|NCT02168946|101217477|FG001|COMPLETED|Overall Study||20||
48363132|NCT02168946|101217476|FG000|NOT COMPLETED|Overall Study||12||
48363133|NCT02168946|101217477|FG001|NOT COMPLETED|Overall Study||5||
48363134|NCT04933812|101217478|FG000|STARTED|Overall Study||31||
48363135|NCT04933812|101217478|FG000|COMPLETED|Overall Study||29||
48363136|NCT04933812|101217478|FG000|NOT COMPLETED|Overall Study||2||
48363137|NCT03634072|101217479|FG000|STARTED|Overall Study||1||
48363138|NCT03634072|101217480|FG001|STARTED|Overall Study||0||
48363139|NCT03634072|101217479|FG000|COMPLETED|Overall Study||0||
48363140|NCT03634072|101217480|FG001|COMPLETED|Overall Study||0||
48363141|NCT03634072|101217479|FG000|NOT COMPLETED|Overall Study||1||
48363142|NCT03634072|101217480|FG001|NOT COMPLETED|Overall Study||0||
48363143|NCT00597558|101217481|FG000|STARTED|Overall Study||13||
48363144|NCT00597558|101217481|FG000|COMPLETED|Overall Study||9||
48363145|NCT00597558|101217481|FG000|NOT COMPLETED|Overall Study||4||
48363146|NCT02601001|101217482|FG000|STARTED|Dosing Period 1||10||
48363147|NCT02601001|101217483|FG001|STARTED|Dosing Period 1||20||
48654696|NCT01748552|101941085|FG010|COMPLETED|Intervention Period 3 and Washout||3||
48188693|NCT05590910|100783310|FG000|NOT COMPLETED|Overall Study||0||
48363148|NCT02601001|101217484|FG002|STARTED|Dosing Period 1||20||
48363149|NCT02601001|101217485|FG003|STARTED|Dosing Period 1||0||
48363150|NCT02601001|101217486|FG004|STARTED|Dosing Period 1||0||
48363151|NCT02601001|101217487|FG005|STARTED|Dosing Period 1||0||
48363152|NCT02601001|101217488|FG006|STARTED|Dosing Period 1||0||
48363153|NCT02601001|101217482|FG000|COMPLETED|Dosing Period 1||10|Completed dosing in period 1|
48363154|NCT02601001|101217483|FG001|COMPLETED|Dosing Period 1||20|Completed dosing in period 1|
48363155|NCT02601001|101217484|FG002|COMPLETED|Dosing Period 1||20|Completed dosing in period 1|
48363156|NCT02601001|101217485|FG003|COMPLETED|Dosing Period 1||0|Completed dosing in period 1|
48363157|NCT02601001|101217486|FG004|COMPLETED|Dosing Period 1||0|Completed dosing in period 1|
48363158|NCT02601001|101217487|FG005|COMPLETED|Dosing Period 1||0|Completed dosing in period 1|
48363159|NCT02601001|101217488|FG006|COMPLETED|Dosing Period 1||0|Completed dosing in period 1|
48363160|NCT02601001|101217482|FG000|NOT COMPLETED|Dosing Period 1||0||
48654697|NCT01748552|101941086|FG011|COMPLETED|Intervention Period 3 and Washout||3||
48654698|NCT01748552|101941075|FG000|NOT COMPLETED|Intervention Period 3 and Washout||0||
48654699|NCT01748552|101941076|FG001|NOT COMPLETED|Intervention Period 3 and Washout||0||
48654700|NCT01748552|101941077|FG002|NOT COMPLETED|Intervention Period 3 and Washout||0||
48654701|NCT01748552|101941078|FG003|NOT COMPLETED|Intervention Period 3 and Washout||0||
48654702|NCT01748552|101941079|FG004|NOT COMPLETED|Intervention Period 3 and Washout||0||
48654703|NCT01748552|101941080|FG005|NOT COMPLETED|Intervention Period 3 and Washout||0||
48363161|NCT02601001|101217483|FG001|NOT COMPLETED|Dosing Period 1||0||
48363162|NCT02601001|101217484|FG002|NOT COMPLETED|Dosing Period 1||0||
48363163|NCT02601001|101217485|FG003|NOT COMPLETED|Dosing Period 1||0||
48363164|NCT02601001|101217486|FG004|NOT COMPLETED|Dosing Period 1||0||
48363165|NCT02601001|101217487|FG005|NOT COMPLETED|Dosing Period 1||0||
48363166|NCT02601001|101217488|FG006|NOT COMPLETED|Dosing Period 1||0||
48363167|NCT02601001|101217482|FG000|STARTED|Dosing Period 2||10||
48363168|NCT02601001|101217483|FG001|STARTED|Dosing Period 2||0||
48363169|NCT02601001|101217484|FG002|STARTED|Dosing Period 2||0||
48363170|NCT02601001|101217485|FG003|STARTED|Dosing Period 2||7||
48363171|NCT02601001|101217486|FG004|STARTED|Dosing Period 2||13||
48363172|NCT02601001|101217487|FG005|STARTED|Dosing Period 2||7||
48363173|NCT02601001|101217488|FG006|STARTED|Dosing Period 2||13||
48363174|NCT02601001|101217482|FG000|COMPLETED|Dosing Period 2||10|Completed dosing in period 2|
48363175|NCT02601001|101217483|FG001|COMPLETED|Dosing Period 2||0|Completed dosing in period 2|
48363176|NCT02601001|101217484|FG002|COMPLETED|Dosing Period 2||0|Completed dosing in period 2|
48363177|NCT02601001|101217485|FG003|COMPLETED|Dosing Period 2||7|Completed dosing in period 2|
48363178|NCT02601001|101217486|FG004|COMPLETED|Dosing Period 2||13|Completed dosing in period 2|
48363179|NCT02601001|101217487|FG005|COMPLETED|Dosing Period 2||7|Completed dosing in period 2|
48363180|NCT02601001|101217488|FG006|COMPLETED|Dosing Period 2||12|Completed dosing in period 2|
48363181|NCT02601001|101217482|FG000|NOT COMPLETED|Dosing Period 2||0||
48363182|NCT02601001|101217483|FG001|NOT COMPLETED|Dosing Period 2||0||
48363183|NCT02601001|101217484|FG002|NOT COMPLETED|Dosing Period 2||0||
48363184|NCT02601001|101217485|FG003|NOT COMPLETED|Dosing Period 2||0||
48363185|NCT02601001|101217486|FG004|NOT COMPLETED|Dosing Period 2||0||
48363186|NCT02601001|101217487|FG005|NOT COMPLETED|Dosing Period 2||0||
48363187|NCT02601001|101217488|FG006|NOT COMPLETED|Dosing Period 2||1||
48363188|NCT03515538|101217489|FG000|STARTED|Overall Study||14||
48765691|NCT04102098|102214699|FG001|NOT COMPLETED|Crossover: AS Who Crossed Over||0||
48765692|NCT01011894|102214700|FG000|STARTED|Overall Study||26||
48765693|NCT01011894|102214700|FG000|COMPLETED|Overall Study||26||
48765694|NCT01011894|102214700|FG000|NOT COMPLETED|Overall Study||0||
48765695|NCT02351817|102214701|FG000|STARTED|Baseline Period||5||
48765696|NCT02351817|102214702|FG001|STARTED|Baseline Period||5||
48765697|NCT02351817|102214701|FG000|COMPLETED|Baseline Period||5||
48765698|NCT02351817|102214702|FG001|COMPLETED|Baseline Period||5||
48765699|NCT02351817|102214701|FG000|NOT COMPLETED|Baseline Period||0||
48765700|NCT02351817|102214702|FG001|NOT COMPLETED|Baseline Period||0||
48765701|NCT02351817|102214701|FG000|STARTED|Period 1||5||
48765702|NCT02351817|102214702|FG001|STARTED|Period 1||5||
48765703|NCT02351817|102214701|FG000|COMPLETED|Period 1||4||
48765704|NCT02351817|102214702|FG001|COMPLETED|Period 1||2||
48765705|NCT02351817|102214701|FG000|NOT COMPLETED|Period 1||1||
48188293|NCT01072929|100783208|FG002|Full Analysis Population|Overall Study||31||
48188294|NCT01072929|100783206|FG000|COMPLETED|Overall Study||155||
48363189|NCT03515538|101217490|FG001|STARTED|Overall Study||13||
48363190|NCT03515538|101217491|FG002|STARTED|Overall Study||13||
48363191|NCT03515538|101217492|FG003|STARTED|Overall Study||13||
48363192|NCT03515538|101217489|FG000|COMPLETED|Overall Study||9||
48363193|NCT03515538|101217490|FG001|COMPLETED|Overall Study||10||
48363194|NCT03515538|101217491|FG002|COMPLETED|Overall Study||9||
48363195|NCT03515538|101217492|FG003|COMPLETED|Overall Study||8||
48363196|NCT03515538|101217489|FG000|NOT COMPLETED|Overall Study||5||
48363197|NCT03515538|101217490|FG001|NOT COMPLETED|Overall Study||3||
48363198|NCT03515538|101217491|FG002|NOT COMPLETED|Overall Study||4||
48363199|NCT03515538|101217492|FG003|NOT COMPLETED|Overall Study||5||
48363200|NCT01747330|101217493|FG000|STARTED|Overall Study||40||
48363201|NCT01747330|101217493|FG000|COMPLETED|Overall Study||40||
48363202|NCT01747330|101217493|FG000|NOT COMPLETED|Overall Study||0||
48363203|NCT03595215|101217494|FG000|STARTED|Overall Study||18||
48363204|NCT03595215|101217494|FG000|COMPLETED|Overall Study||10||
48363205|NCT03595215|101217494|FG000|NOT COMPLETED|Overall Study||8||
48363206|NCT01013883|101217495|FG000|STARTED|Overall Study||270||
48363207|NCT01013883|101217496|FG001|STARTED|Overall Study||243||
48363208|NCT01013883|101217495|FG000|COMPLETED|Overall Study||268||
48363209|NCT01013883|101217496|FG001|COMPLETED|Overall Study||241||
48363210|NCT01013883|101217495|FG000|NOT COMPLETED|Overall Study||2||
48363211|NCT01013883|101217496|FG001|NOT COMPLETED|Overall Study||2||
48363212|NCT00374907|101217497|FG000|STARTED|12-Week Short-term Period||20||
48363213|NCT00374907|101217498|FG001|STARTED|12-Week Short-term Period||16||
48363214|NCT00374907|101217497|FG000|COMPLETED|12-Week Short-term Period||17||
48363215|NCT00374907|101217498|FG001|COMPLETED|12-Week Short-term Period||15||
48363216|NCT00374907|101217497|FG000|NOT COMPLETED|12-Week Short-term Period||3||
48765706|NCT02351817|102214702|FG001|NOT COMPLETED|Period 1||3||
48765707|NCT02351817|102214701|FG000|STARTED|Period 2||5||
48765708|NCT02351817|102214702|FG001|STARTED|Period 2||5||
48765709|NCT02351817|102214701|FG000|COMPLETED|Period 2||4||
48765710|NCT02351817|102214702|FG001|COMPLETED|Period 2||3||
48363217|NCT00374907|101217498|FG001|NOT COMPLETED|12-Week Short-term Period||1||
48363218|NCT00374907|101217497|FG000|STARTED|116-Week Short-term + Long-term Period||20||
48363219|NCT00374907|101217498|FG001|STARTED|116-Week Short-term + Long-term Period||16||
48363220|NCT00374907|101217497|FG000|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||17||
48363221|NCT00374907|101217498|FG001|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||15||
48363222|NCT00374907|101217497|FG000|COMPLETED|116-Week Short-term + Long-term Period||7||
48765711|NCT02351817|102214701|FG000|NOT COMPLETED|Period 2||1||
48765712|NCT02351817|102214702|FG001|NOT COMPLETED|Period 2||2||
48765713|NCT00702221|102214703|FG000|STARTED|Overall Study||10||
48765714|NCT00702221|102214704|FG001|STARTED|Overall Study||10||
48363223|NCT00374907|101217498|FG001|COMPLETED|116-Week Short-term + Long-term Period||2||
48363224|NCT00374907|101217497|FG000|NOT COMPLETED|116-Week Short-term + Long-term Period||13||
48363225|NCT00374907|101217498|FG001|NOT COMPLETED|116-Week Short-term + Long-term Period||14||
48363226|NCT00184054|101217499|FG000|STARTED|Overall Study||11||
48363227|NCT00184054|101217499|FG000|COMPLETED|Overall Study||10||
48363228|NCT00184054|101217499|FG000|NOT COMPLETED|Overall Study||1||
48363229|NCT00098345|101217500|FG000|STARTED|Overall Study||30||
48363230|NCT00098345|101217500|FG000|COMPLETED|Overall Study||17||
48363231|NCT00098345|101217500|FG000|NOT COMPLETED|Overall Study||13||
48363232|NCT00091390|101217501|FG000|STARTED|Overall Study||129||
48363233|NCT00091390|101217501|FG000|Eligible and Started Study Treatment|Overall Study||125||
48363234|NCT00091390|101217501|FG000|Eligible, Started Treatment, Has AE Data|Overall Study||115|Eligible, started study treatment, and has adverse event (AE) data|
48363235|NCT00091390|101217501|FG000|COMPLETED|Overall Study||125||
48363236|NCT00091390|101217501|FG000|NOT COMPLETED|Overall Study||4||
48363237|NCT02983292|101217502|FG000|STARTED|Overall Study||137||
48363238|NCT02983292|101217502|FG000|COMPLETED|Overall Study||85||
48363239|NCT02983292|101217502|FG000|NOT COMPLETED|Overall Study||52||
48363240|NCT02234115|101217503|FG000|STARTED|Overall Study||137||
48363241|NCT02234115|101217503|FG000|ITT|Overall Study||137||
48363242|NCT02234115|101217503|FG000|PP|Overall Study||124||
48363243|NCT02234115|101217503|FG000|PK Subgroup|Overall Study||31||
48363244|NCT02234115|101217503|FG000|COMPLETED|Overall Study||122||
48363245|NCT02234115|101217503|FG000|NOT COMPLETED|Overall Study||15||
48363246|NCT03964415|101217504|FG000|STARTED|Overall Study||1948||
48363247|NCT03964415|101217505|FG001|STARTED|Overall Study||1952||
48363248|NCT03964415|101217504|FG000|Treated: Full Analysis Set (FAS)|Overall Study||1942||
48363249|NCT03964415|101217505|FG001|Treated: Full Analysis Set (FAS)|Overall Study||1945||
48363250|NCT03964415|101217504|FG000|COMPLETED|Overall Study||95||
48363251|NCT03964415|101217505|FG001|COMPLETED|Overall Study||103||
48363252|NCT03964415|101217504|FG000|NOT COMPLETED|Overall Study||1853||
48363253|NCT03964415|101217505|FG001|NOT COMPLETED|Overall Study||1849||
48363254|NCT00227877|101217506|FG000|STARTED|Pre-visit Assessment||1075||
48363255|NCT00227877|101217507|FG001|STARTED|Pre-visit Assessment||1031||
48363256|NCT00227877|101217508|FG002|STARTED|Pre-visit Assessment||297||
48363257|NCT00227877|101217509|FG003|STARTED|Pre-visit Assessment||292||
48363258|NCT00227877|101217506|FG000|COMPLETED|Pre-visit Assessment||1068||
48363259|NCT00227877|101217507|FG001|COMPLETED|Pre-visit Assessment||1028||
48363260|NCT00227877|101217508|FG002|COMPLETED|Pre-visit Assessment||297||
48363261|NCT00227877|101217509|FG003|COMPLETED|Pre-visit Assessment||292||
48363262|NCT00227877|101217506|FG000|NOT COMPLETED|Pre-visit Assessment||7||
48363263|NCT00227877|101217507|FG001|NOT COMPLETED|Pre-visit Assessment||3||
48363264|NCT00227877|101217508|FG002|NOT COMPLETED|Pre-visit Assessment||0||
48363265|NCT00227877|101217509|FG003|NOT COMPLETED|Pre-visit Assessment||0||
48363266|NCT00227877|101217506|FG000|STARTED|Post-visit Checklist||1068||
48363267|NCT00227877|101217507|FG001|STARTED|Post-visit Checklist||1028||
48363268|NCT00227877|101217508|FG002|STARTED|Post-visit Checklist||297||
48363269|NCT00227877|101217509|FG003|STARTED|Post-visit Checklist||292||
48363270|NCT00227877|101217506|FG000|COMPLETED|Post-visit Checklist||1044||
48363271|NCT00227877|101217507|FG001|COMPLETED|Post-visit Checklist||1015||
48363272|NCT00227877|101217508|FG002|COMPLETED|Post-visit Checklist||296||
48363273|NCT00227877|101217509|FG003|COMPLETED|Post-visit Checklist||292||
48363274|NCT00227877|101217506|FG000|NOT COMPLETED|Post-visit Checklist||24||
48363275|NCT00227877|101217507|FG001|NOT COMPLETED|Post-visit Checklist||13||
48363276|NCT00227877|101217508|FG002|NOT COMPLETED|Post-visit Checklist||1||
48363277|NCT00227877|101217509|FG003|NOT COMPLETED|Post-visit Checklist||0||
48363278|NCT00227877|101217506|FG000|STARTED|3-months Follow-up||1068|"These Started numbers reflect those who completed the pre-visit assessment."|
48363279|NCT00227877|101217507|FG001|STARTED|3-months Follow-up||1028|"These Started numbers reflect those who completed the pre-visit assessment."|
48363280|NCT00227877|101217508|FG002|STARTED|3-months Follow-up||297|"These Started numbers reflect those who completed the pre-visit assessment."|
48363281|NCT00227877|101217509|FG003|STARTED|3-months Follow-up||292|"These Started numbers reflect those who completed the pre-visit assessment."|
48363282|NCT00227877|101217506|FG000|COMPLETED|3-months Follow-up||755||
48436512|NCT04780776|101403566|FG000|STARTED|Follow up Week 22-25||29||
48363283|NCT00227877|101217507|FG001|COMPLETED|3-months Follow-up||761||
48363284|NCT00227877|101217508|FG002|COMPLETED|3-months Follow-up||245||
48363285|NCT00227877|101217509|FG003|COMPLETED|3-months Follow-up||271||
48363286|NCT00227877|101217506|FG000|NOT COMPLETED|3-months Follow-up||313||
48363287|NCT00227877|101217507|FG001|NOT COMPLETED|3-months Follow-up||267||
48363288|NCT00227877|101217508|FG002|NOT COMPLETED|3-months Follow-up||52||
48363289|NCT00227877|101217509|FG003|NOT COMPLETED|3-months Follow-up||21||
48363290|NCT00227877|101217506|FG000|STARTED|12-months Follow-up||1068|"These Started numbers reflect those who completed the pre-visit assessment."|
48363291|NCT00227877|101217507|FG001|STARTED|12-months Follow-up||1028|"These Started numbers reflect those who completed the pre-visit assessment."|
48363292|NCT00227877|101217508|FG002|STARTED|12-months Follow-up||297|"These Started numbers reflect those who completed the pre-visit assessment."|
48363293|NCT00227877|101217509|FG003|STARTED|12-months Follow-up||292|"These Started numbers reflect those who completed the pre-visit assessment."|
48436513|NCT04780776|101403567|FG001|STARTED|Follow up Week 22-25||22||
48436514|NCT04780776|101403566|FG000|COMPLETED|Follow up Week 22-25||27||
48363294|NCT00227877|101217506|FG000|COMPLETED|12-months Follow-up||758||
48654704|NCT01748552|101941081|FG006|NOT COMPLETED|Intervention Period 3 and Washout||0||
48654705|NCT01748552|101941082|FG007|NOT COMPLETED|Intervention Period 3 and Washout||0||
48654706|NCT01748552|101941083|FG008|NOT COMPLETED|Intervention Period 3 and Washout||0||
48654707|NCT01748552|101941084|FG009|NOT COMPLETED|Intervention Period 3 and Washout||0||
48654708|NCT01748552|101941085|FG010|NOT COMPLETED|Intervention Period 3 and Washout||0||
48654709|NCT01748552|101941086|FG011|NOT COMPLETED|Intervention Period 3 and Washout||0||
48654710|NCT04744831|101941087|FG000|STARTED|Overall Study||40|This analysis population is based on the Full Analysis Set, which included 1 participant who was randomized/registered to T-DXd 6.4 mg/kg Q3W but actually received T-DXd 5.4 mg/kg Q3W.|
48654711|NCT04744831|101941088|FG001|STARTED|Overall Study||42|This analysis population is based on the Full Analysis Set, which included 1 participant who was randomized/registered to T-DXd 6.4 mg/kg Q3W but actually received T-DXd 5.4 mg/kg Q3W.|
48654712|NCT04744831|101941089|FG002|STARTED|Overall Study||40|This analysis population is based on the Full Analysis Set, which included 1 participant who was randomized/registered to T-DXd 6.4 mg/kg Q3W but actually received T-DXd 5.4 mg/kg Q3W.|
48654713|NCT04744831|101941087|FG000|COMPLETED|Overall Study||3|Completed = Participants who are on-going study treatment as of 01 November 2022, Not Completed = Participants who discontinued treatment and participants randomized/registered.|
48654714|NCT04744831|101941088|FG001|COMPLETED|Overall Study||6|Completed = Participants who are on-going study treatment as of 01 November 2022, Not Completed = Participants who discontinued treatment and participants randomized/registered.|
48654715|NCT04744831|101941089|FG002|COMPLETED|Overall Study||5|Completed = Participants who are on-going study treatment as of 01 November 2022, Not Completed = Participants who discontinued treatment and participants randomized/registered.|
48654716|NCT04744831|101941087|FG000|NOT COMPLETED|Overall Study||37||
48654717|NCT04744831|101941088|FG001|NOT COMPLETED|Overall Study||36||
48654718|NCT04744831|101941089|FG002|NOT COMPLETED|Overall Study||35||
48363295|NCT00227877|101217507|FG001|COMPLETED|12-months Follow-up||765||
48363296|NCT00227877|101217508|FG002|COMPLETED|12-months Follow-up||266||
48363297|NCT00227877|101217509|FG003|COMPLETED|12-months Follow-up||266||
48363298|NCT00227877|101217506|FG000|NOT COMPLETED|12-months Follow-up||310||
48363299|NCT00227877|101217507|FG001|NOT COMPLETED|12-months Follow-up||263||
48363300|NCT00227877|101217508|FG002|NOT COMPLETED|12-months Follow-up||31||
48363301|NCT00227877|101217509|FG003|NOT COMPLETED|12-months Follow-up||26||
48363302|NCT04355117|101217510|FG000|STARTED|Overall Study||71||
48363303|NCT04355117|101217510|FG000|COMPLETED|Overall Study||71||
48363304|NCT04355117|101217510|FG000|NOT COMPLETED|Overall Study||0||
48363305|NCT00623012|101217511|FG000|STARTED|Overall Study||2||
48363306|NCT00623012|101217511|FG000|COMPLETED|Overall Study||2||
48363307|NCT00623012|101217511|FG000|NOT COMPLETED|Overall Study||0||
48363308|NCT03216265|101217512|FG000|STARTED|Overall Study||22||
48363309|NCT03216265|101217513|FG001|STARTED|Overall Study||22||
48363310|NCT03216265|101217514|FG002|STARTED|Overall Study||22||
48363311|NCT03216265|101217512|FG000|COMPLETED|Overall Study||20||
48363312|NCT03216265|101217513|FG001|COMPLETED|Overall Study||21||
48363313|NCT03216265|101217514|FG002|COMPLETED|Overall Study||19||
48363314|NCT03216265|101217512|FG000|NOT COMPLETED|Overall Study||2||
48363315|NCT03216265|101217513|FG001|NOT COMPLETED|Overall Study||1||
48363316|NCT03216265|101217514|FG002|NOT COMPLETED|Overall Study||3||
48363317|NCT02138578|101217515|FG000|STARTED|Overall Study||1||
48363318|NCT02138578|101217516|FG001|STARTED|Overall Study||0||
48363319|NCT02138578|101217517|FG002|STARTED|Overall Study||3||
48363320|NCT02138578|101217515|FG000|COMPLETED|Overall Study||1||
48363321|NCT02138578|101217516|FG001|COMPLETED|Overall Study||0||
48363322|NCT02138578|101217517|FG002|COMPLETED|Overall Study||3||
48363323|NCT02138578|101217515|FG000|NOT COMPLETED|Overall Study||0||
48363324|NCT02138578|101217516|FG001|NOT COMPLETED|Overall Study||0||
48363325|NCT02138578|101217517|FG002|NOT COMPLETED|Overall Study||0||
48363326|NCT01221298|101217518|FG000|STARTED|Overall Study||11||
48363327|NCT01221298|101217518|FG000|COMPLETED|Overall Study||11||
48363328|NCT01221298|101217518|FG000|NOT COMPLETED|Overall Study||0||
48363329|NCT04275310|101217519|FG000|STARTED|Overall Study||4||
48363330|NCT04275310|101217520|FG001|STARTED|Overall Study||0||
48363331|NCT04275310|101217519|FG000|COMPLETED|Overall Study||0||
48363332|NCT04275310|101217520|FG001|COMPLETED|Overall Study||0||
48363333|NCT04275310|101217519|FG000|NOT COMPLETED|Overall Study||4||
48363334|NCT04275310|101217520|FG001|NOT COMPLETED|Overall Study||0||
48363335|NCT04222725|101217521|FG000|STARTED|Overall Study||8||
48363336|NCT04222725|101217522|FG001|STARTED|Overall Study||10||
48363337|NCT04222725|101217523|FG002|STARTED|Overall Study||9||
48363338|NCT04222725|101217524|FG003|STARTED|Overall Study||10||
48363339|NCT04222725|101217521|FG000|COMPLETED|Overall Study||8||
48363340|NCT04222725|101217522|FG001|COMPLETED|Overall Study||9||
48363341|NCT04222725|101217523|FG002|COMPLETED|Overall Study||9||
48363342|NCT04222725|101217524|FG003|COMPLETED|Overall Study||10||
48363343|NCT04222725|101217521|FG000|NOT COMPLETED|Overall Study||0||
48363344|NCT04222725|101217522|FG001|NOT COMPLETED|Overall Study||1||
48363345|NCT04222725|101217523|FG002|NOT COMPLETED|Overall Study||0||
48363346|NCT04222725|101217524|FG003|NOT COMPLETED|Overall Study||0||
48363347|NCT03321617|101217525|FG000|STARTED|Overall Study||3||
48363348|NCT03321617|101217526|FG001|STARTED|Overall Study||3||
48363349|NCT03321617|101217527|FG002|STARTED|Overall Study||2||
48363350|NCT03321617|101217528|FG003|STARTED|Overall Study||3||
48363351|NCT03321617|101217525|FG000|COMPLETED|Overall Study||2||
48363352|NCT03321617|101217526|FG001|COMPLETED|Overall Study||3||
48363353|NCT03321617|101217527|FG002|COMPLETED|Overall Study||2||
48363354|NCT03321617|101217528|FG003|COMPLETED|Overall Study||2||
48363355|NCT03321617|101217525|FG000|NOT COMPLETED|Overall Study||1||
48363356|NCT03321617|101217526|FG001|NOT COMPLETED|Overall Study||0||
48363357|NCT03321617|101217527|FG002|NOT COMPLETED|Overall Study||0||
48363358|NCT03321617|101217528|FG003|NOT COMPLETED|Overall Study||1||
48363359|NCT03238248|101217529|FG000|STARTED|Overall Study||71||
48363360|NCT03238248|101217529|FG000|COMPLETED|Overall Study||4||
48363361|NCT03238248|101217529|FG000|NOT COMPLETED|Overall Study||67||
48363362|NCT02677701|101217530|FG000|STARTED|Overall Study||62||
48363363|NCT02677701|101217531|FG001|STARTED|Overall Study||57||
48363364|NCT02677701|101217530|FG000|Treated|Overall Study||61|Participants receiving at least one dose of study drug|
48363365|NCT02677701|101217531|FG001|Treated|Overall Study||54|Participants receiving at least one dose of study drug|
48363366|NCT02677701|101217530|FG000|COMPLETED|Overall Study||56||
48363367|NCT02677701|101217531|FG001|COMPLETED|Overall Study||52||
48363368|NCT02677701|101217530|FG000|NOT COMPLETED|Overall Study||6||
48363369|NCT02677701|101217531|FG001|NOT COMPLETED|Overall Study||5||
48363370|NCT01797432|101217532|FG000|STARTED|Overall Study||14||
48363371|NCT01797432|101217532|FG000|COMPLETED|Overall Study||10||
48363372|NCT01797432|101217532|FG000|NOT COMPLETED|Overall Study||4||
48363373|NCT01863758|101217533|FG000|STARTED|Pharmacokinetic Assessment||66||
48363374|NCT01863758|101217533|FG000|COMPLETED|Pharmacokinetic Assessment||66||
48363375|NCT01863758|101217533|FG000|NOT COMPLETED|Pharmacokinetic Assessment||0||
48363376|NCT01863758|101217533|FG000|STARTED|Prophylactic Treatment-Phase I||66||
48363377|NCT01863758|101217533|FG000|COMPLETED|Prophylactic Treatment-Phase I||66||
48363378|NCT01863758|101217533|FG000|NOT COMPLETED|Prophylactic Treatment-Phase I||0||
48363379|NCT01863758|101217533|FG000|STARTED|Prophylactic Treatment-Phase II||66||
48363380|NCT01863758|101217533|FG000|COMPLETED|Prophylactic Treatment-Phase II||64||
48363381|NCT01863758|101217533|FG000|NOT COMPLETED|Prophylactic Treatment-Phase II||2||
48363382|NCT04634162|101217534|FG000|STARTED|Phase 1 Pre-cossover||10||
48363383|NCT04634162|101217535|FG001|STARTED|Phase 1 Pre-cossover||10||
48363384|NCT04634162|101217534|FG000|COMPLETED|Phase 1 Pre-cossover||10||
48363385|NCT04634162|101217535|FG001|COMPLETED|Phase 1 Pre-cossover||10||
48363386|NCT04634162|101217534|FG000|NOT COMPLETED|Phase 1 Pre-cossover||0||
48363387|NCT04634162|101217535|FG001|NOT COMPLETED|Phase 1 Pre-cossover||0||
48363388|NCT04634162|101217534|FG000|STARTED|Phase 2 Post-cossover||10||
48363389|NCT04634162|101217535|FG001|STARTED|Phase 2 Post-cossover||10||
48363390|NCT04634162|101217534|FG000|COMPLETED|Phase 2 Post-cossover||10||
48363391|NCT04634162|101217535|FG001|COMPLETED|Phase 2 Post-cossover||10||
48363392|NCT04634162|101217534|FG000|NOT COMPLETED|Phase 2 Post-cossover||0||
48363393|NCT04634162|101217535|FG001|NOT COMPLETED|Phase 2 Post-cossover||0||
48363394|NCT02203838|101217536|FG000|STARTED|Overall Study||408||
48363395|NCT02203838|101217537|FG001|STARTED|Overall Study||28||
48363396|NCT02203838|101217538|FG002|STARTED|Overall Study||31||
48363397|NCT02203838|101217539|FG003|STARTED|Overall Study||33||
48363398|NCT02203838|101217536|FG000|COMPLETED|Overall Study||198||
48363399|NCT02203838|101217537|FG001|COMPLETED|Overall Study||6||
48363400|NCT02203838|101217538|FG002|COMPLETED|Overall Study||15||
48363401|NCT02203838|101217539|FG003|COMPLETED|Overall Study||15||
48363402|NCT02203838|101217536|FG000|NOT COMPLETED|Overall Study||210||
48363403|NCT02203838|101217537|FG001|NOT COMPLETED|Overall Study||22||
48363404|NCT02203838|101217538|FG002|NOT COMPLETED|Overall Study||16||
48363405|NCT02203838|101217539|FG003|NOT COMPLETED|Overall Study||18||
48363406|NCT02616029|101217540|FG000|STARTED|Overall Study||38||
48363407|NCT02616029|101217541|FG001|STARTED|Overall Study||28||
48363408|NCT02616029|101217540|FG000|COMPLETED|Overall Study||34||
48363409|NCT02616029|101217541|FG001|COMPLETED|Overall Study||26||
48363410|NCT02616029|101217540|FG000|NOT COMPLETED|Overall Study||4||
48363411|NCT02616029|101217541|FG001|NOT COMPLETED|Overall Study||2||
48363412|NCT01696877|101217542|FG000|STARTED|Overall Study||15||
48363413|NCT01696877|101217543|FG001|STARTED|Overall Study||14||
48363414|NCT01696877|101217542|FG000|COMPLETED|Overall Study||15||
48363415|NCT01696877|101217543|FG001|COMPLETED|Overall Study||13||
48363416|NCT01696877|101217542|FG000|NOT COMPLETED|Overall Study||0||
48363417|NCT01696877|101217543|FG001|NOT COMPLETED|Overall Study||1||
48363418|NCT00443430|101217544|FG000|STARTED|Overall Study||43||
48363419|NCT00443430|101217545|FG001|STARTED|Overall Study||42||
48363420|NCT00443430|101217544|FG000|COMPLETED|Overall Study||39||
48363421|NCT00443430|101217545|FG001|COMPLETED|Overall Study||38||
48363422|NCT00443430|101217544|FG000|NOT COMPLETED|Overall Study||4||
48363423|NCT00443430|101217545|FG001|NOT COMPLETED|Overall Study||4||
48363424|NCT04036136|101217546|FG000|STARTED|Overall Study||61||
48363425|NCT04036136|101217547|FG001|STARTED|Overall Study||55||
48363426|NCT04036136|101217546|FG000|COMPLETED|Overall Study||46||
48363427|NCT04036136|101217547|FG001|COMPLETED|Overall Study||35||
48363428|NCT04036136|101217546|FG000|NOT COMPLETED|Overall Study||15||
48363429|NCT04036136|101217547|FG001|NOT COMPLETED|Overall Study||20||
48363430|NCT00320671|101217548|FG000|STARTED|Overall Study||102||
48363431|NCT00320671|101217549|FG001|STARTED|Overall Study||96||
48363432|NCT00320671|101217548|FG000|COMPLETED|Overall Study||69||
48363433|NCT00320671|101217549|FG001|COMPLETED|Overall Study||58||
48363434|NCT00320671|101217548|FG000|NOT COMPLETED|Overall Study||33||
48363435|NCT00320671|101217549|FG001|NOT COMPLETED|Overall Study||38||
48363436|NCT00719810|101217550|FG000|STARTED|Overall Study||49||
48363437|NCT00719810|101217551|FG001|STARTED|Overall Study||51||
48654719|NCT05463952|101941090|FG000|STARTED|Treatment||6||
48654720|NCT05463952|101941090|FG000|COMPLETED|Treatment||0||
48654721|NCT05463952|101941090|FG000|NOT COMPLETED|Treatment||6||
48654722|NCT05463952|101941090|FG000|STARTED|Follow-up||4||
48654723|NCT05463952|101941090|FG000|COMPLETED|Follow-up||4||
48654724|NCT05463952|101941090|FG000|NOT COMPLETED|Follow-up||0||
48654725|NCT00527748|101941091|FG000|STARTED|Overall Study||26||
48654726|NCT00527748|101941091|FG000|COMPLETED|Overall Study||23||
48654727|NCT00527748|101941091|FG000|NOT COMPLETED|Overall Study||3||
48654728|NCT01682603|101941092|FG000|STARTED|Overall Study||37||
48654729|NCT01682603|101941092|FG000|COMPLETED|Overall Study||34||
48654730|NCT01682603|101941092|FG000|NOT COMPLETED|Overall Study||3||
48654731|NCT02112916|101941093|FG000|STARTED|Overall Study||312||
48654732|NCT02112916|101941094|FG001|STARTED|Overall Study||315||
48654733|NCT02112916|101941095|FG002|STARTED|Overall Study||111||
48654734|NCT02112916|101941096|FG003|STARTED|Overall Study||109||
48654735|NCT02112916|101941093|FG000|COMPLETED|Overall Study||108||
48654736|NCT02112916|101941094|FG001|COMPLETED|Overall Study||123||
48654737|NCT02112916|101941095|FG002|COMPLETED|Overall Study||52||
48654738|NCT02112916|101941096|FG003|COMPLETED|Overall Study||62||
48654739|NCT02112916|101941093|FG000|NOT COMPLETED|Overall Study||204||
48654740|NCT02112916|101941094|FG001|NOT COMPLETED|Overall Study||192||
48654741|NCT02112916|101941095|FG002|NOT COMPLETED|Overall Study||59||
48654742|NCT02112916|101941096|FG003|NOT COMPLETED|Overall Study||47||
48654743|NCT01924065|101941097|FG000|STARTED|Overall Study||56||
48654744|NCT01924065|101941098|FG001|STARTED|Overall Study||56||
48654745|NCT01924065|101941097|FG000|COMPLETED|Overall Study||56||
48654746|NCT01924065|101941098|FG001|COMPLETED|Overall Study||56||
48654747|NCT01924065|101941097|FG000|NOT COMPLETED|Overall Study||0||
48654748|NCT01924065|101941098|FG001|NOT COMPLETED|Overall Study||0||
48654749|NCT02043847|101941099|FG000|STARTED|Overall Study||3||
48654750|NCT02043847|101941100|FG001|STARTED|Overall Study||3||
48654751|NCT02043847|101941101|FG002|STARTED|Overall Study||6||
48654752|NCT02043847|101941099|FG000|COMPLETED|Overall Study||1||
48654753|NCT02043847|101941100|FG001|COMPLETED|Overall Study||0||
48654754|NCT02043847|101941101|FG002|COMPLETED|Overall Study||0||
48654755|NCT02043847|101941099|FG000|NOT COMPLETED|Overall Study||2||
48654756|NCT02043847|101941100|FG001|NOT COMPLETED|Overall Study||3||
48654757|NCT02043847|101941101|FG002|NOT COMPLETED|Overall Study||6||
48654758|NCT04576481|101941102|FG000|STARTED|Rapid Cycle Interviews (Phase 1)||10|Note: For phase 1, 10 mothers of eligible children were enrolled.|
48654759|NCT04576481|101941103|FG001|STARTED|Rapid Cycle Interviews (Phase 1)||0|Note: For phase 1, 10 mothers of eligible children were enrolled.|
48654760|NCT04576481|101941104|FG002|STARTED|Rapid Cycle Interviews (Phase 1)||0|Note: For phase 1, 10 mothers of eligible children were enrolled.|
48363438|NCT00719810|101217552|FG002|STARTED|Overall Study||50||
48363439|NCT00719810|101217550|FG000|COMPLETED|Overall Study||46||
48363440|NCT00719810|101217551|FG001|COMPLETED|Overall Study||47||
48363441|NCT00719810|101217552|FG002|COMPLETED|Overall Study||42||
48363442|NCT00719810|101217550|FG000|NOT COMPLETED|Overall Study||3||
48363443|NCT00719810|101217551|FG001|NOT COMPLETED|Overall Study||4||
48363444|NCT00719810|101217552|FG002|NOT COMPLETED|Overall Study||8||
48363445|NCT02037919|101217553|FG000|STARTED|Overall Study||73||
48363446|NCT02037919|101217554|FG001|STARTED|Overall Study||75||
48363447|NCT02037919|101217553|FG000|Had Implant Inserted|Overall Study||73||
48436515|NCT04780776|101403567|FG001|COMPLETED|Follow up Week 22-25||20||
48654761|NCT04576481|101941105|FG003|STARTED|Rapid Cycle Interviews (Phase 1)||0|Note: For phase 1, 10 mothers of eligible children were enrolled.|
48654762|NCT04576481|101941102|FG000|COMPLETED|Rapid Cycle Interviews (Phase 1)||10|10 mothers completed Rapid Cycle Interviews|
48654763|NCT04576481|101941103|FG001|COMPLETED|Rapid Cycle Interviews (Phase 1)||0|10 mothers completed Rapid Cycle Interviews|
48654764|NCT04576481|101941104|FG002|COMPLETED|Rapid Cycle Interviews (Phase 1)||0|10 mothers completed Rapid Cycle Interviews|
48654765|NCT04576481|101941105|FG003|COMPLETED|Rapid Cycle Interviews (Phase 1)||0|10 mothers completed Rapid Cycle Interviews|
48654766|NCT04576481|101941102|FG000|NOT COMPLETED|Rapid Cycle Interviews (Phase 1)||0||
48654767|NCT04576481|101941103|FG001|NOT COMPLETED|Rapid Cycle Interviews (Phase 1)||0||
48654768|NCT04576481|101941104|FG002|NOT COMPLETED|Rapid Cycle Interviews (Phase 1)||0||
48654769|NCT04576481|101941105|FG003|NOT COMPLETED|Rapid Cycle Interviews (Phase 1)||0||
48654770|NCT04576481|101941102|FG000|STARTED|Randomized Controlled Trial (Phase 2)||0|For phase 2, dyads consisting of a single parent and eligible child were enrolled both virtually and in-person at 2 outpatient clinics.|
48363448|NCT02037919|101217554|FG001|Had Implant Inserted|Overall Study||32||
48363449|NCT02037919|101217553|FG000|Contacted at Six Months and Using Implant|Overall Study||40||
48654771|NCT04576481|101941103|FG001|STARTED|Randomized Controlled Trial (Phase 2)||15|For phase 2, dyads consisting of a single parent and eligible child were enrolled both virtually and in-person at 2 outpatient clinics.|
48654772|NCT04576481|101941104|FG002|STARTED|Randomized Controlled Trial (Phase 2)||15|For phase 2, dyads consisting of a single parent and eligible child were enrolled both virtually and in-person at 2 outpatient clinics.|
48657057|NCT03648372|101943776|FG019|STARTED|Overall Study||3||
48363450|NCT02037919|101217554|FG001|Contacted at Six Months and Using Implant|Overall Study||19||
48363451|NCT02037919|101217553|FG000|Contacted at 6 Months and Not Using Implant|Overall Study||3||
48363452|NCT02037919|101217554|FG001|Contacted at 6 Months and Not Using Implant|Overall Study||11||
48363453|NCT02037919|101217553|FG000|COMPLETED|Overall Study||43|Contacted at 6 months and completed telephone follow up|
48363454|NCT02037919|101217554|FG001|COMPLETED|Overall Study||30|Contacted at 6 months and completed telephone follow up|
48363455|NCT02037919|101217553|FG000|NOT COMPLETED|Overall Study||30||
48363456|NCT02037919|101217554|FG001|NOT COMPLETED|Overall Study||45||
48363457|NCT01022853|101217555|FG000|STARTED|Overall Study||3||
48363458|NCT01022853|101217556|FG001|STARTED|Overall Study||4||
48363459|NCT01022853|101217557|FG002|STARTED|Overall Study||13||
48363460|NCT01022853|101217558|FG003|STARTED|Overall Study||8||
48363461|NCT01022853|101217559|FG004|STARTED|Overall Study||2||
48363462|NCT01022853|101217555|FG000|COMPLETED|Overall Study||0||
48363463|NCT01022853|101217556|FG001|COMPLETED|Overall Study||0||
48363464|NCT01022853|101217557|FG002|COMPLETED|Overall Study||0||
48363465|NCT01022853|101217558|FG003|COMPLETED|Overall Study||0||
48363466|NCT01022853|101217559|FG004|COMPLETED|Overall Study||0||
48363467|NCT01022853|101217555|FG000|NOT COMPLETED|Overall Study||3||
48363468|NCT01022853|101217556|FG001|NOT COMPLETED|Overall Study||4||
48363469|NCT01022853|101217557|FG002|NOT COMPLETED|Overall Study||13||
48363470|NCT01022853|101217558|FG003|NOT COMPLETED|Overall Study||8||
48363471|NCT01022853|101217559|FG004|NOT COMPLETED|Overall Study||2||
48363472|NCT01780389|101217560|FG000|STARTED|Overall Study||5||
48363473|NCT01780389|101217560|FG000|COMPLETED|Overall Study||4||
48363474|NCT01780389|101217560|FG000|NOT COMPLETED|Overall Study||1||
48363475|NCT00170157|101217561|FG000|STARTED|Treatment Period 1 Initial Randomization||54||
48363476|NCT00170157|101217562|FG001|STARTED|Treatment Period 1 Initial Randomization||58||
48363477|NCT00170157|101217561|FG000|COMPLETED|Treatment Period 1 Initial Randomization||54||
48363478|NCT00170157|101217562|FG001|COMPLETED|Treatment Period 1 Initial Randomization||58||
48363479|NCT00170157|101217561|FG000|NOT COMPLETED|Treatment Period 1 Initial Randomization||0||
48363480|NCT00170157|101217562|FG001|NOT COMPLETED|Treatment Period 1 Initial Randomization||0||
48363481|NCT00170157|101217561|FG000|STARTED|Washout Period of 14 Days||0||
48363482|NCT00170157|101217562|FG001|STARTED|Washout Period of 14 Days||58||
48363483|NCT00170157|101217561|FG000|COMPLETED|Washout Period of 14 Days||0||
48363484|NCT00170157|101217562|FG001|COMPLETED|Washout Period of 14 Days||41||
48363485|NCT00170157|101217561|FG000|NOT COMPLETED|Washout Period of 14 Days||0||
48363486|NCT00170157|101217562|FG001|NOT COMPLETED|Washout Period of 14 Days||17||
48363487|NCT00170157|101217561|FG000|STARTED|Treatment Period 2 Crossover||0||
48363488|NCT00170157|101217562|FG001|STARTED|Treatment Period 2 Crossover||41||
48363489|NCT00170157|101217561|FG000|COMPLETED|Treatment Period 2 Crossover||0||
48363490|NCT00170157|101217562|FG001|COMPLETED|Treatment Period 2 Crossover||41||
48363491|NCT00170157|101217561|FG000|NOT COMPLETED|Treatment Period 2 Crossover||0||
48363492|NCT00170157|101217562|FG001|NOT COMPLETED|Treatment Period 2 Crossover||0||
48363493|NCT02749370|101217563|FG000|STARTED|Overall Study||80||
48363494|NCT02749370|101217563|FG000|COMPLETED|Overall Study||66||
48363495|NCT02749370|101217563|FG000|NOT COMPLETED|Overall Study||14||
48363496|NCT02273310|101217564|FG000|STARTED|Overall Study||42||
48363497|NCT02273310|101217565|FG001|STARTED|Overall Study||41||
48363498|NCT02273310|101217564|FG000|COMPLETED|Overall Study||24||
48363499|NCT02273310|101217565|FG001|COMPLETED|Overall Study||38||
48363500|NCT02273310|101217564|FG000|NOT COMPLETED|Overall Study||18||
48363501|NCT02273310|101217565|FG001|NOT COMPLETED|Overall Study||3||
48363502|NCT00734929|101217566|FG000|STARTED|Overall Study||57||
48363503|NCT00734929|101217567|FG001|STARTED|Overall Study||58||
48363504|NCT00734929|101217566|FG000|COMPLETED|Overall Study||51||
48363505|NCT00734929|101217567|FG001|COMPLETED|Overall Study||53||
48363506|NCT00734929|101217566|FG000|NOT COMPLETED|Overall Study||6||
48363507|NCT00734929|101217567|FG001|NOT COMPLETED|Overall Study||5||
48363508|NCT02369835|101217568|FG000|STARTED|Overall Study||64||
48363509|NCT02369835|101217569|FG001|STARTED|Overall Study||68||
48363510|NCT02369835|101217568|FG000|COMPLETED|Overall Study||53||
48363511|NCT02369835|101217569|FG001|COMPLETED|Overall Study||55||
48363512|NCT02369835|101217568|FG000|NOT COMPLETED|Overall Study||11||
48363513|NCT02369835|101217569|FG001|NOT COMPLETED|Overall Study||13||
48363514|NCT03280550|101217570|FG000|STARTED|Overall Study||66||
48363515|NCT03280550|101217571|FG001|STARTED|Overall Study||72||
48363516|NCT03280550|101217570|FG000|COMPLETED|Overall Study||64||
48363517|NCT03280550|101217571|FG001|COMPLETED|Overall Study||69||
48363518|NCT03280550|101217570|FG000|NOT COMPLETED|Overall Study||2||
48363519|NCT03280550|101217571|FG001|NOT COMPLETED|Overall Study||3||
48363520|NCT03199911|101217572|FG000|STARTED|Overall Study||208||
48363521|NCT03199911|101217573|FG001|STARTED|Overall Study||193||
48363522|NCT03199911|101217572|FG000|Did Not Proceed With Surgery|Overall Study||2||
48363523|NCT03199911|101217573|FG001|Did Not Proceed With Surgery|Overall Study||1||
48363524|NCT03199911|101217572|FG000|Received Allocated Treatment|Overall Study||206||
48363525|NCT03199911|101217573|FG001|Received Allocated Treatment|Overall Study||192||
48363526|NCT03199911|101217572|FG000|Lost to Follow-up|Overall Study||5||
48363527|NCT03199911|101217573|FG001|Lost to Follow-up|Overall Study||5||
48363528|NCT03199911|101217572|FG000|Primary Outcome Analyzed|Overall Study||201||
48363529|NCT03199911|101217573|FG001|Primary Outcome Analyzed|Overall Study||187||
48363530|NCT03199911|101217572|FG000|COMPLETED|Overall Study||201||
48363531|NCT03199911|101217573|FG001|COMPLETED|Overall Study||187||
48363532|NCT03199911|101217572|FG000|NOT COMPLETED|Overall Study||7||
48363533|NCT03199911|101217573|FG001|NOT COMPLETED|Overall Study||6||
48363534|NCT02397720|101217574|FG000|STARTED|Overall Study||6||
48363535|NCT02397720|101217575|FG001|STARTED|Overall Study||85||
48363536|NCT02397720|101217576|FG002|STARTED|Overall Study||6||
48363537|NCT02397720|101217577|FG003|STARTED|Overall Study||47||
48363538|NCT02397720|101217578|FG004|STARTED|Overall Study||6||
48363539|NCT02397720|101217579|FG005|STARTED|Overall Study||0||
48363540|NCT02397720|101217574|FG000|COMPLETED|Overall Study||6||
48363541|NCT02397720|101217575|FG001|COMPLETED|Overall Study||85||
48363542|NCT02397720|101217576|FG002|COMPLETED|Overall Study||6||
48363543|NCT02397720|101217577|FG003|COMPLETED|Overall Study||47||
48363544|NCT02397720|101217578|FG004|COMPLETED|Overall Study||6||
48363545|NCT02397720|101217579|FG005|COMPLETED|Overall Study||0||
48363546|NCT02397720|101217574|FG000|NOT COMPLETED|Overall Study||0||
48363547|NCT02397720|101217575|FG001|NOT COMPLETED|Overall Study||0||
48363548|NCT02397720|101217576|FG002|NOT COMPLETED|Overall Study||0||
48363549|NCT02397720|101217577|FG003|NOT COMPLETED|Overall Study||0||
48363550|NCT02397720|101217578|FG004|NOT COMPLETED|Overall Study||0||
48363551|NCT02397720|101217579|FG005|NOT COMPLETED|Overall Study||0||
48363552|NCT00790296|101217580|FG000|STARTED|Overall Study||5||
48363553|NCT00790296|101217581|FG001|STARTED|Overall Study||6||
48363554|NCT00790296|101217580|FG000|COMPLETED|Overall Study||4||
48363555|NCT00790296|101217581|FG001|COMPLETED|Overall Study||4||
48363556|NCT00790296|101217580|FG000|NOT COMPLETED|Overall Study||1||
48363557|NCT00790296|101217581|FG001|NOT COMPLETED|Overall Study||2||
48363558|NCT01834326|101217582|FG000|STARTED|Overall Study||10||
48363559|NCT01834326|101217583|FG001|STARTED|Overall Study||8||
48363560|NCT01834326|101217582|FG000|COMPLETED|Overall Study||8||
48363561|NCT01834326|101217583|FG001|COMPLETED|Overall Study||2||
48363562|NCT01834326|101217582|FG000|NOT COMPLETED|Overall Study||2||
48363563|NCT01834326|101217583|FG001|NOT COMPLETED|Overall Study||6||
48363564|NCT00062738|101220325|FG000|STARTED|Overall Study||17||
48363565|NCT00062738|101220326|FG001|STARTED|Overall Study||18||
48363566|NCT00062738|101220327|FG002|STARTED|Overall Study||17||
48363567|NCT00062738|101220325|FG000|COMPLETED|Overall Study||17||
48363568|NCT00062738|101220326|FG001|COMPLETED|Overall Study||18||
48363569|NCT00062738|101220327|FG002|COMPLETED|Overall Study||17||
48363570|NCT00062738|101220325|FG000|NOT COMPLETED|Overall Study||0||
48363571|NCT00062738|101220326|FG001|NOT COMPLETED|Overall Study||0||
48363572|NCT00062738|101220327|FG002|NOT COMPLETED|Overall Study||0||
48363573|NCT00394914|101220328|FG000|STARTED|Screening Period||311||
48363574|NCT00394914|101220329|FG001|STARTED|Screening Period||0||
48363575|NCT00394914|101220330|FG002|STARTED|Screening Period||0||
48363576|NCT00394914|101220328|FG000|COMPLETED|Screening Period||311||
48363577|NCT00394914|101220329|FG001|COMPLETED|Screening Period||0||
48363578|NCT00394914|101220330|FG002|COMPLETED|Screening Period||0||
48363579|NCT00394914|101220328|FG000|NOT COMPLETED|Screening Period||0||
48363580|NCT00394914|101220329|FG001|NOT COMPLETED|Screening Period||0||
48363581|NCT00394914|101220330|FG002|NOT COMPLETED|Screening Period||0||
48363582|NCT00394914|101220328|FG000|STARTED|Pre-exposure Period||311||
48363583|NCT00394914|101220329|FG001|STARTED|Pre-exposure Period||0||
48363584|NCT00394914|101220330|FG002|STARTED|Pre-exposure Period||0||
48363585|NCT00394914|101220328|FG000|COMPLETED|Pre-exposure Period||311||
48363586|NCT00394914|101220329|FG001|COMPLETED|Pre-exposure Period||0||
48363587|NCT00394914|101220330|FG002|COMPLETED|Pre-exposure Period||0||
48363588|NCT00394914|101220328|FG000|NOT COMPLETED|Pre-exposure Period||0||
48363589|NCT00394914|101220329|FG001|NOT COMPLETED|Pre-exposure Period||0||
48363590|NCT00394914|101220330|FG002|NOT COMPLETED|Pre-exposure Period||0||
48363591|NCT00394914|101220328|FG000|STARTED|Treatment Period||0||
48363592|NCT00394914|101220329|FG001|STARTED|Treatment Period||154||
48363593|NCT00394914|101220330|FG002|STARTED|Treatment Period||157||
48363594|NCT00394914|101220328|FG000|COMPLETED|Treatment Period||0||
48363595|NCT00394914|101220329|FG001|COMPLETED|Treatment Period||144||
48363596|NCT00394914|101220330|FG002|COMPLETED|Treatment Period||151||
48363597|NCT00394914|101220328|FG000|NOT COMPLETED|Treatment Period||0||
48363598|NCT00394914|101220329|FG001|NOT COMPLETED|Treatment Period||10||
48363599|NCT00394914|101220330|FG002|NOT COMPLETED|Treatment Period||6||
48363600|NCT00803244|101220331|FG000|STARTED|Overall Study||188||
48363601|NCT00803244|101220332|FG001|STARTED|Overall Study||193||
48363602|NCT00803244|101220331|FG000|COMPLETED|Overall Study||181||
48363603|NCT00803244|101220332|FG001|COMPLETED|Overall Study||178||
48363604|NCT00803244|101220331|FG000|NOT COMPLETED|Overall Study||7||
48363605|NCT00803244|101220332|FG001|NOT COMPLETED|Overall Study||15||
48363606|NCT03531957|101220333|FG000|STARTED|Overall Study||61|Initially 62 subjects randomized into ASN002 40 mg arm, but one subject did not received any dose, therefore the subject was excluded from all analysis sets, including mITT and safety sets. The 10 subjects who were not completed the study in ASN002 40 mg group did not include the subjects who did not received any dose.|
48368134|NCT01819922|101230113|FG000|STARTED|First Intervention Period (1 Day)||6||
48368135|NCT01819922|101230114|FG001|STARTED|First Intervention Period (1 Day)||6||
48368136|NCT01819922|101230113|FG000|COMPLETED|First Intervention Period (1 Day)||6||
48363607|NCT03531957|101220334|FG001|STARTED|Overall Study||59|Initially 62 subjects randomized into ASN002 40 mg arm, but one subject did not received any dose, therefore the subject was excluded from all analysis sets, including mITT and safety sets. The 10 subjects who were not completed the study in ASN002 40 mg group did not include the subjects who did not received any dose.|
48765715|NCT00702221|102214703|FG000|COMPLETED|Overall Study||6||
48765716|NCT00702221|102214704|FG001|COMPLETED|Overall Study||7||
48765717|NCT00702221|102214703|FG000|NOT COMPLETED|Overall Study||4||
48765718|NCT00702221|102214704|FG001|NOT COMPLETED|Overall Study||3||
48765719|NCT02144610|102214705|FG000|STARTED|Overall Study||23||
48765720|NCT02144610|102214706|FG001|STARTED|Overall Study||23||
48363608|NCT03531957|101220335|FG002|STARTED|Overall Study||63|Initially 62 subjects randomized into ASN002 40 mg arm, but one subject did not received any dose, therefore the subject was excluded from all analysis sets, including mITT and safety sets. The 10 subjects who were not completed the study in ASN002 40 mg group did not include the subjects who did not received any dose.|
48363609|NCT03531957|101220336|FG003|STARTED|Overall Study||60|Initially 62 subjects randomized into ASN002 40 mg arm, but one subject did not received any dose, therefore the subject was excluded from all analysis sets, including mITT and safety sets. The 10 subjects who were not completed the study in ASN002 40 mg group did not include the subjects who did not received any dose.|
48363610|NCT03531957|101220333|FG000|COMPLETED|Overall Study||51||
48363611|NCT03531957|101220334|FG001|COMPLETED|Overall Study||54||
48363612|NCT03531957|101220335|FG002|COMPLETED|Overall Study||49||
48363613|NCT03531957|101220336|FG003|COMPLETED|Overall Study||49||
48363614|NCT03531957|101220333|FG000|NOT COMPLETED|Overall Study||10||
48363615|NCT03531957|101220334|FG001|NOT COMPLETED|Overall Study||5||
48363616|NCT03531957|101220335|FG002|NOT COMPLETED|Overall Study||14||
48363617|NCT03531957|101220336|FG003|NOT COMPLETED|Overall Study||11||
48363618|NCT02119104|101220337|FG000|STARTED|Overall Study||1087||
48363619|NCT02119104|101220337|FG000|COMPLETED|Overall Study||1071||
48363620|NCT02119104|101220337|FG000|NOT COMPLETED|Overall Study||16||
48363621|NCT01595646|101220338|FG000|STARTED|Overall Study||13||
48363622|NCT01595646|101220339|FG001|STARTED|Overall Study||12||
48363623|NCT01595646|101220340|FG002|STARTED|Overall Study||12||
48363624|NCT01595646|101220338|FG000|COMPLETED|Overall Study||12||
48363625|NCT01595646|101220339|FG001|COMPLETED|Overall Study||12||
48363626|NCT01595646|101220340|FG002|COMPLETED|Overall Study||12||
48363627|NCT01595646|101220338|FG000|NOT COMPLETED|Overall Study||1||
48363628|NCT01595646|101220339|FG001|NOT COMPLETED|Overall Study||0||
48363629|NCT01595646|101220340|FG002|NOT COMPLETED|Overall Study||0||
48363630|NCT04902950|101220341|FG000|STARTED|Overall Study||4||
48363631|NCT04902950|101220342|FG001|STARTED|Overall Study||5||
48363632|NCT04902950|101220341|FG000|COMPLETED|Overall Study||4||
48363633|NCT04902950|101220342|FG001|COMPLETED|Overall Study||5||
48363634|NCT04902950|101220341|FG000|NOT COMPLETED|Overall Study||0||
48363635|NCT04902950|101220342|FG001|NOT COMPLETED|Overall Study||0||
48363636|NCT01133639|101220343|FG000|STARTED|Overall Study||0|See comments in Recruitment Details section above. Maximum length is too short to explain here.|
48363637|NCT01133639|101220344|FG001|STARTED|Overall Study||0|See comments in Recruitment Details section above. Maximum length is too short to explain here.|
48363638|NCT01133639|101220343|FG000|COMPLETED|Overall Study||0|See comments in Recruitment Details section above. Maximum length is too short to explain here.|
48363639|NCT01133639|101220344|FG001|COMPLETED|Overall Study||0|See comments in Recruitment Details section above. Maximum length is too short to explain here.|
48363640|NCT01133639|101220343|FG000|NOT COMPLETED|Overall Study||0||
48363641|NCT01133639|101220344|FG001|NOT COMPLETED|Overall Study||0||
48363642|NCT01016483|101220345|FG000|STARTED|Safety Run-in Part||27||
48363643|NCT01016483|101220346|FG001|STARTED|Safety Run-in Part||26||
48765721|NCT02144610|102214705|FG000|COMPLETED|Overall Study||0||
48765722|NCT02144610|102214706|FG001|COMPLETED|Overall Study||1||
48765723|NCT02144610|102214705|FG000|NOT COMPLETED|Overall Study||23||
48765724|NCT02144610|102214706|FG001|NOT COMPLETED|Overall Study||22||
48765725|NCT02819011|102214707|FG000|STARTED|Overall Study||22||
48765726|NCT02819011|102214708|FG001|STARTED|Overall Study||22||
48363644|NCT01016483|101220347|FG002|STARTED|Safety Run-in Part||0||
48363645|NCT01016483|101220348|FG003|STARTED|Safety Run-in Part||0||
48363646|NCT01016483|101220345|FG000|COMPLETED|Safety Run-in Part||27||
48363647|NCT01016483|101220346|FG001|COMPLETED|Safety Run-in Part||26||
48363648|NCT01016483|101220347|FG002|COMPLETED|Safety Run-in Part||0||
48363649|NCT01016483|101220348|FG003|COMPLETED|Safety Run-in Part||0||
48363650|NCT01016483|101220345|FG000|NOT COMPLETED|Safety Run-in Part||0||
48363651|NCT01016483|101220346|FG001|NOT COMPLETED|Safety Run-in Part||0||
48363652|NCT01016483|101220347|FG002|NOT COMPLETED|Safety Run-in Part||0||
48363653|NCT01016483|101220348|FG003|NOT COMPLETED|Safety Run-in Part||0||
48363654|NCT01016483|101220345|FG000|STARTED|Phase II||0||
48363655|NCT01016483|101220346|FG001|STARTED|Phase II||0||
48363656|NCT01016483|101220347|FG002|STARTED|Phase II||44||
48363657|NCT01016483|101220348|FG003|STARTED|Phase II||44||
48363658|NCT01016483|101220345|FG000|Treated (Safety Analysis Set [SAF])|Phase II||0||
48363659|NCT01016483|101220346|FG001|Treated (Safety Analysis Set [SAF])|Phase II||0||
48363660|NCT01016483|101220347|FG002|Treated (Safety Analysis Set [SAF])|Phase II||42||
48765727|NCT02819011|102214707|FG000|COMPLETED|Overall Study||15||
48765728|NCT02819011|102214708|FG001|COMPLETED|Overall Study||17||
48765729|NCT02819011|102214707|FG000|NOT COMPLETED|Overall Study||7||
48765730|NCT02819011|102214708|FG001|NOT COMPLETED|Overall Study||5||
48765731|NCT02059278|102214709|FG000|STARTED|Overall Study||165||
48363661|NCT01016483|101220348|FG003|Treated (Safety Analysis Set [SAF])|Phase II||45||
48363662|NCT01016483|101220345|FG000|COMPLETED|Phase II||0||
48363663|NCT01016483|101220346|FG001|COMPLETED|Phase II||0||
48363664|NCT01016483|101220347|FG002|COMPLETED|Phase II||44||
48363665|NCT01016483|101220348|FG003|COMPLETED|Phase II||44||
48363666|NCT01016483|101220345|FG000|NOT COMPLETED|Phase II||0||
48363667|NCT01016483|101220346|FG001|NOT COMPLETED|Phase II||0||
48363668|NCT01016483|101220347|FG002|NOT COMPLETED|Phase II||0||
48363669|NCT01016483|101220348|FG003|NOT COMPLETED|Phase II||0||
48363670|NCT02574312|101220349|FG000|STARTED|Pre-Operative||44||
48363671|NCT02574312|101220350|FG001|STARTED|Pre-Operative||44||
48654773|NCT04576481|101941105|FG003|STARTED|Randomized Controlled Trial (Phase 2)||15|For phase 2, dyads consisting of a single parent and eligible child were enrolled both virtually and in-person at 2 outpatient clinics.|
48654774|NCT04576481|101941102|FG000|Baseline Visit|Randomized Controlled Trial (Phase 2)||0|45 Parent-child dyads completed baseline measures prior to randomization assignment|
48654775|NCT04576481|101941103|FG001|Baseline Visit|Randomized Controlled Trial (Phase 2)||15|45 Parent-child dyads completed baseline measures prior to randomization assignment|
48654776|NCT04576481|101941104|FG002|Baseline Visit|Randomized Controlled Trial (Phase 2)||15|45 Parent-child dyads completed baseline measures prior to randomization assignment|
48654777|NCT04576481|101941105|FG003|Baseline Visit|Randomized Controlled Trial (Phase 2)||15|45 Parent-child dyads completed baseline measures prior to randomization assignment|
48654778|NCT04576481|101941102|FG000|COMPLETED|Randomized Controlled Trial (Phase 2)||0|40 Parent-child dyads completed 2 month follow-up surveys|
48654779|NCT04576481|101941103|FG001|COMPLETED|Randomized Controlled Trial (Phase 2)||14|40 Parent-child dyads completed 2 month follow-up surveys|
48654780|NCT04576481|101941104|FG002|COMPLETED|Randomized Controlled Trial (Phase 2)||12|40 Parent-child dyads completed 2 month follow-up surveys|
48654781|NCT04576481|101941105|FG003|COMPLETED|Randomized Controlled Trial (Phase 2)||14|40 Parent-child dyads completed 2 month follow-up surveys|
48654782|NCT04576481|101941102|FG000|NOT COMPLETED|Randomized Controlled Trial (Phase 2)||0||
48654783|NCT04576481|101941103|FG001|NOT COMPLETED|Randomized Controlled Trial (Phase 2)||1||
48654784|NCT04576481|101941104|FG002|NOT COMPLETED|Randomized Controlled Trial (Phase 2)||3||
48654785|NCT04576481|101941105|FG003|NOT COMPLETED|Randomized Controlled Trial (Phase 2)||1||
48363672|NCT02574312|101220349|FG000|COMPLETED|Pre-Operative||44||
48363673|NCT02574312|101220350|FG001|COMPLETED|Pre-Operative||44||
48363674|NCT02574312|101220349|FG000|NOT COMPLETED|Pre-Operative||0||
48363675|NCT02574312|101220350|FG001|NOT COMPLETED|Pre-Operative||0||
48363676|NCT02574312|101220349|FG000|STARTED|3 Months Follow-up||44||
48363677|NCT02574312|101220350|FG001|STARTED|3 Months Follow-up||44||
48363678|NCT02574312|101220349|FG000|COMPLETED|3 Months Follow-up||43||
48363679|NCT02574312|101220350|FG001|COMPLETED|3 Months Follow-up||44||
48363680|NCT02574312|101220349|FG000|NOT COMPLETED|3 Months Follow-up||1||
48363681|NCT02574312|101220350|FG001|NOT COMPLETED|3 Months Follow-up||0||
48363682|NCT02211495|101220351|FG000|STARTED|Overall Study||4||
48363683|NCT02211495|101220352|FG001|STARTED|Overall Study||4||
48363684|NCT02211495|101220351|FG000|COMPLETED|Overall Study||4||
48363685|NCT02211495|101220352|FG001|COMPLETED|Overall Study||4||
48363686|NCT02211495|101220351|FG000|NOT COMPLETED|Overall Study||0||
48363687|NCT02211495|101220352|FG001|NOT COMPLETED|Overall Study||0||
48363688|NCT01371838|101220353|FG000|STARTED|Overall Study||381||
48363689|NCT01371838|101220354|FG001|STARTED|Overall Study||383||
48363690|NCT01371838|101220353|FG000|COMPLETED|Overall Study||332||
48363691|NCT01371838|101220354|FG001|COMPLETED|Overall Study||317||
48363692|NCT01371838|101220353|FG000|NOT COMPLETED|Overall Study||49||
48363693|NCT01371838|101220354|FG001|NOT COMPLETED|Overall Study||66||
48363694|NCT01518699|101220355|FG000|STARTED|Period 1||10||
48363695|NCT01518699|101220356|FG001|STARTED|Period 1||9||
48363696|NCT01518699|101220357|FG002|STARTED|Period 1||9||
48363697|NCT01518699|101220358|FG003|STARTED|Period 1||10||
48363698|NCT01518699|101220359|FG004|STARTED|Period 1||10||
48363699|NCT01518699|101220360|FG005|STARTED|Period 1||9||
48363700|NCT01518699|101220355|FG000|COMPLETED|Period 1||10||
48363701|NCT01518699|101220356|FG001|COMPLETED|Period 1||9||
48363702|NCT01518699|101220357|FG002|COMPLETED|Period 1||9||
48363703|NCT01518699|101220358|FG003|COMPLETED|Period 1||10||
48363704|NCT01518699|101220359|FG004|COMPLETED|Period 1||10||
48363705|NCT01518699|101220360|FG005|COMPLETED|Period 1||9||
48363706|NCT01518699|101220355|FG000|NOT COMPLETED|Period 1||0||
48363707|NCT01518699|101220356|FG001|NOT COMPLETED|Period 1||0||
48363708|NCT01518699|101220357|FG002|NOT COMPLETED|Period 1||0||
48363709|NCT01518699|101220358|FG003|NOT COMPLETED|Period 1||0||
48363710|NCT01518699|101220359|FG004|NOT COMPLETED|Period 1||0||
48363711|NCT01518699|101220360|FG005|NOT COMPLETED|Period 1||0||
48363712|NCT01518699|101220355|FG000|STARTED|Period 2||10||
48363713|NCT01518699|101220356|FG001|STARTED|Period 2||9||
48363714|NCT01518699|101220357|FG002|STARTED|Period 2||9||
48363715|NCT01518699|101220358|FG003|STARTED|Period 2||10||
48363716|NCT01518699|101220359|FG004|STARTED|Period 2||10||
48363717|NCT01518699|101220360|FG005|STARTED|Period 2||9||
48363718|NCT01518699|101220355|FG000|COMPLETED|Period 2||8||
48363719|NCT01518699|101220356|FG001|COMPLETED|Period 2||7||
48363720|NCT01518699|101220357|FG002|COMPLETED|Period 2||9||
48363721|NCT01518699|101220358|FG003|COMPLETED|Period 2||10||
48363722|NCT01518699|101220359|FG004|COMPLETED|Period 2||10||
48363723|NCT01518699|101220360|FG005|COMPLETED|Period 2||9||
48363724|NCT01518699|101220355|FG000|NOT COMPLETED|Period 2||2||
48363725|NCT01518699|101220356|FG001|NOT COMPLETED|Period 2||2||
48363726|NCT01518699|101220357|FG002|NOT COMPLETED|Period 2||0||
48363727|NCT01518699|101220358|FG003|NOT COMPLETED|Period 2||0||
48363728|NCT01518699|101220359|FG004|NOT COMPLETED|Period 2||0||
48363729|NCT01518699|101220360|FG005|NOT COMPLETED|Period 2||0||
48363730|NCT01518699|101220355|FG000|STARTED|Period 3||8||
48363731|NCT01518699|101220356|FG001|STARTED|Period 3||7||
48363732|NCT01518699|101220357|FG002|STARTED|Period 3||9||
48363733|NCT01518699|101220358|FG003|STARTED|Period 3||10||
48363734|NCT01518699|101220359|FG004|STARTED|Period 3||10||
48363735|NCT01518699|101220360|FG005|STARTED|Period 3||9||
48363736|NCT01518699|101220355|FG000|COMPLETED|Period 3||8||
48363737|NCT01518699|101220356|FG001|COMPLETED|Period 3||7||
48363738|NCT01518699|101220357|FG002|COMPLETED|Period 3||9||
48363739|NCT01518699|101220358|FG003|COMPLETED|Period 3||10||
48363740|NCT01518699|101220359|FG004|COMPLETED|Period 3||10||
48363741|NCT01518699|101220360|FG005|COMPLETED|Period 3||9||
48363742|NCT01518699|101220355|FG000|NOT COMPLETED|Period 3||0||
48363743|NCT01518699|101220356|FG001|NOT COMPLETED|Period 3||0||
48363744|NCT01518699|101220357|FG002|NOT COMPLETED|Period 3||0||
48363745|NCT01518699|101220358|FG003|NOT COMPLETED|Period 3||0||
48363746|NCT01518699|101220359|FG004|NOT COMPLETED|Period 3||0||
48363747|NCT01518699|101220360|FG005|NOT COMPLETED|Period 3||0||
48363748|NCT00914628|101220361|FG000|STARTED|Overall Study||64||
48363749|NCT00914628|101220362|FG001|STARTED|Overall Study||28||
48363750|NCT00914628|101220361|FG000|COMPLETED|Overall Study||0||
48363751|NCT00914628|101220362|FG001|COMPLETED|Overall Study||0||
48363752|NCT00914628|101220361|FG000|NOT COMPLETED|Overall Study||64||
48363753|NCT00914628|101220362|FG001|NOT COMPLETED|Overall Study||28||
48363754|NCT01260181|101220363|FG000|STARTED|Overall Study||30||
48363755|NCT01260181|101220363|FG000|COMPLETED|Overall Study||29||
48363756|NCT01260181|101220363|FG000|NOT COMPLETED|Overall Study||1||
48363757|NCT00923910|101220364|FG000|STARTED|Period 1||5||
48363758|NCT00923910|101220365|FG001|STARTED|Period 1||5||
48363759|NCT00923910|101220364|FG000|COMPLETED|Period 1||5||
48363760|NCT00923910|101220365|FG001|COMPLETED|Period 1||5||
48363761|NCT00923910|101220364|FG000|NOT COMPLETED|Period 1||0||
48363762|NCT00923910|101220365|FG001|NOT COMPLETED|Period 1||0||
48363763|NCT00923910|101220364|FG000|STARTED|Period 2||5||
48363764|NCT00923910|101220365|FG001|STARTED|Period 2||5||
48363765|NCT00923910|101220364|FG000|COMPLETED|Period 2||5||
48363766|NCT00923910|101220365|FG001|COMPLETED|Period 2||5||
48363767|NCT00923910|101220364|FG000|NOT COMPLETED|Period 2||0||
48363768|NCT00923910|101220365|FG001|NOT COMPLETED|Period 2||0||
48363769|NCT00401973|101220366|FG000|STARTED|Overall Study||50||
48363770|NCT00401973|101220367|FG001|STARTED|Overall Study||76||
48363771|NCT00401973|101220368|FG002|STARTED|Overall Study||73||
48363772|NCT00401973|101220366|FG000|COMPLETED|Overall Study||39||
48363773|NCT00401973|101220367|FG001|COMPLETED|Overall Study||50||
48363774|NCT00401973|101220368|FG002|COMPLETED|Overall Study||50||
48363775|NCT00401973|101220366|FG000|NOT COMPLETED|Overall Study||11||
48363776|NCT00401973|101220367|FG001|NOT COMPLETED|Overall Study||26||
48363777|NCT00401973|101220368|FG002|NOT COMPLETED|Overall Study||23||
48363778|NCT01797029|101220369|FG000|STARTED|Overall Study||1174||
48363779|NCT01797029|101220370|FG001|STARTED|Overall Study||587||
48363780|NCT01797029|101220369|FG000|COMPLETED|Overall Study||1015||
48363781|NCT01797029|101220370|FG001|COMPLETED|Overall Study||526||
48363782|NCT01797029|101220369|FG000|NOT COMPLETED|Overall Study||159||
48363783|NCT01797029|101220370|FG001|NOT COMPLETED|Overall Study||61||
48363784|NCT00590681|101220371|FG000|STARTED|Overall Study||62||
48363785|NCT00590681|101220371|FG000|COMPLETED|Overall Study||42||
48363786|NCT00590681|101220371|FG000|NOT COMPLETED|Overall Study||20||
48363787|NCT00849693|101220372|FG000|STARTED|Acute Treatment Phase||108||
48363788|NCT00849693|101220373|FG001|STARTED|Acute Treatment Phase||116||
48363789|NCT00849693|101220374|FG002|STARTED|Acute Treatment Phase||117||
48363790|NCT00849693|101220375|FG003|STARTED|Acute Treatment Phase||122||
48363791|NCT00849693|101220372|FG000|COMPLETED|Acute Treatment Phase||75||
48363792|NCT00849693|101220373|FG001|COMPLETED|Acute Treatment Phase||81||
48363793|NCT00849693|101220374|FG002|COMPLETED|Acute Treatment Phase||84||
48363794|NCT00849693|101220375|FG003|COMPLETED|Acute Treatment Phase||85||
48363795|NCT00849693|101220372|FG000|NOT COMPLETED|Acute Treatment Phase||33||
48363796|NCT00849693|101220373|FG001|NOT COMPLETED|Acute Treatment Phase||35||
48363797|NCT00849693|101220374|FG002|NOT COMPLETED|Acute Treatment Phase||33||
48363798|NCT00849693|101220375|FG003|NOT COMPLETED|Acute Treatment Phase||37||
48363799|NCT00849693|101220372|FG000|STARTED|Extension Phase||73||
48363800|NCT00849693|101220373|FG001|STARTED|Extension Phase||80||
48363801|NCT00849693|101220374|FG002|STARTED|Extension Phase||84||
48363802|NCT00849693|101220375|FG003|STARTED|Extension Phase||82||
48363803|NCT00849693|101220372|FG000|COMPLETED|Extension Phase||43||
48363804|NCT00849693|101220373|FG001|COMPLETED|Extension Phase||50||
48363805|NCT00849693|101220374|FG002|COMPLETED|Extension Phase||49||
48363806|NCT00849693|101220375|FG003|COMPLETED|Extension Phase||44||
48363807|NCT00849693|101220372|FG000|NOT COMPLETED|Extension Phase||30||
48363808|NCT00849693|101220373|FG001|NOT COMPLETED|Extension Phase||30||
48363809|NCT00849693|101220374|FG002|NOT COMPLETED|Extension Phase||35||
48363810|NCT00849693|101220375|FG003|NOT COMPLETED|Extension Phase||38||
48363811|NCT00839098|101220376|FG000|STARTED|Overall Study||3||
48363812|NCT00839098|101220377|FG001|STARTED|Overall Study||12||
48363813|NCT00839098|101220378|FG002|STARTED|Overall Study||13||
48363814|NCT00839098|101220376|FG000|COMPLETED|Overall Study||1||
48363815|NCT00839098|101220377|FG001|COMPLETED|Overall Study||11||
48363816|NCT00839098|101220378|FG002|COMPLETED|Overall Study||6||
48363817|NCT00839098|101220376|FG000|NOT COMPLETED|Overall Study||2||
48363818|NCT00839098|101220377|FG001|NOT COMPLETED|Overall Study||1||
48363819|NCT00839098|101220378|FG002|NOT COMPLETED|Overall Study||7||
48363820|NCT03242759|101220379|FG000|STARTED|Overall Study||88||
48363821|NCT03242759|101220380|FG001|STARTED|Overall Study||13||
48363822|NCT03242759|101220379|FG000|COMPLETED|Overall Study||53||
48363823|NCT03242759|101220380|FG001|COMPLETED|Overall Study||6||
48363824|NCT03242759|101220379|FG000|NOT COMPLETED|Overall Study||35||
48363825|NCT03242759|101220380|FG001|NOT COMPLETED|Overall Study||7||
48363826|NCT01651260|101220381|FG000|STARTED|Overall Study||65||
48363827|NCT01651260|101220381|FG000|COMPLETED|Overall Study||62||
48363828|NCT01651260|101220381|FG000|NOT COMPLETED|Overall Study||3||
48363829|NCT04860713|101220382|FG000|STARTED|Overall Study||4||
48363830|NCT04860713|101220383|FG001|STARTED|Overall Study||1||
48363831|NCT04860713|101220382|FG000|COMPLETED|Overall Study||4||
48363832|NCT04860713|101220383|FG001|COMPLETED|Overall Study||1||
48363833|NCT04860713|101220382|FG000|NOT COMPLETED|Overall Study||0||
48363834|NCT04860713|101220383|FG001|NOT COMPLETED|Overall Study||0||
48363835|NCT02100657|101220384|FG000|STARTED|Cohort 1: Dose Level 1||8||
48363836|NCT02100657|101220385|FG001|STARTED|Cohort 1: Dose Level 1||0||
48363837|NCT02100657|101220386|FG002|STARTED|Cohort 1: Dose Level 1||0||
48363838|NCT02100657|101220384|FG000|COMPLETED|Cohort 1: Dose Level 1||0||
48363839|NCT02100657|101220385|FG001|COMPLETED|Cohort 1: Dose Level 1||0||
48363840|NCT02100657|101220386|FG002|COMPLETED|Cohort 1: Dose Level 1||0||
48363841|NCT02100657|101220384|FG000|NOT COMPLETED|Cohort 1: Dose Level 1||8||
48363842|NCT02100657|101220385|FG001|NOT COMPLETED|Cohort 1: Dose Level 1||0||
48363843|NCT02100657|101220386|FG002|NOT COMPLETED|Cohort 1: Dose Level 1||0||
48363844|NCT02100657|101220384|FG000|STARTED|Cohort 2: Dose Level 2||0||
48363845|NCT02100657|101220385|FG001|STARTED|Cohort 2: Dose Level 2||4||
48363846|NCT02100657|101220386|FG002|STARTED|Cohort 2: Dose Level 2||0||
48363847|NCT02100657|101220384|FG000|COMPLETED|Cohort 2: Dose Level 2||0||
48363848|NCT02100657|101220385|FG001|COMPLETED|Cohort 2: Dose Level 2||0||
48363849|NCT02100657|101220386|FG002|COMPLETED|Cohort 2: Dose Level 2||0||
48363850|NCT02100657|101220384|FG000|NOT COMPLETED|Cohort 2: Dose Level 2||0||
48363851|NCT02100657|101220385|FG001|NOT COMPLETED|Cohort 2: Dose Level 2||4||
48363852|NCT02100657|101220386|FG002|NOT COMPLETED|Cohort 2: Dose Level 2||0||
48363853|NCT02100657|101220384|FG000|STARTED|Cohort 3: Dose Level 3||0||
48363854|NCT02100657|101220385|FG001|STARTED|Cohort 3: Dose Level 3||0||
48363855|NCT02100657|101220386|FG002|STARTED|Cohort 3: Dose Level 3||27||
48363856|NCT02100657|101220384|FG000|COMPLETED|Cohort 3: Dose Level 3||0||
48363857|NCT02100657|101220385|FG001|COMPLETED|Cohort 3: Dose Level 3||0||
48363858|NCT02100657|101220386|FG002|COMPLETED|Cohort 3: Dose Level 3||0||
48363859|NCT02100657|101220384|FG000|NOT COMPLETED|Cohort 3: Dose Level 3||0||
48363860|NCT02100657|101220385|FG001|NOT COMPLETED|Cohort 3: Dose Level 3||0||
48363861|NCT02100657|101220386|FG002|NOT COMPLETED|Cohort 3: Dose Level 3||27||
48363862|NCT01748695|101220387|FG000|STARTED|First Intervention (4 Weeks)||14||
48363863|NCT01748695|101220388|FG001|STARTED|First Intervention (4 Weeks)||11||
48363864|NCT01748695|101220387|FG000|COMPLETED|First Intervention (4 Weeks)||14||
48363865|NCT01748695|101220388|FG001|COMPLETED|First Intervention (4 Weeks)||11||
48363866|NCT01748695|101220387|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0||
48363867|NCT01748695|101220388|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0||
48363868|NCT01748695|101220387|FG000|STARTED|Second Intervention (4 Weeks)||14||
48363869|NCT01748695|101220388|FG001|STARTED|Second Intervention (4 Weeks)||11||
48363870|NCT01748695|101220387|FG000|COMPLETED|Second Intervention (4 Weeks)||14||
48363871|NCT01748695|101220388|FG001|COMPLETED|Second Intervention (4 Weeks)||11||
48363872|NCT01748695|101220387|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0||
48363873|NCT01748695|101220388|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0||
48363874|NCT01469052|101220389|FG000|STARTED|Overall Study||6||
48363875|NCT01469052|101220390|FG001|STARTED|Overall Study||4||
48363876|NCT01469052|101220391|FG002|STARTED|Overall Study||6||
48654786|NCT03425188|101941106|FG000|STARTED|Overall Study||53||
48363877|NCT01469052|101220392|FG003|STARTED|Overall Study||6||
48363878|NCT01469052|101220393|FG004|STARTED|Overall Study||8||
48363879|NCT01469052|101220394|FG005|STARTED|Overall Study||6||
48363880|NCT01469052|101220389|FG000|COMPLETED|Overall Study||0||
48363881|NCT01469052|101220390|FG001|COMPLETED|Overall Study||0||
48363882|NCT01469052|101220391|FG002|COMPLETED|Overall Study||0||
48363883|NCT01469052|101220392|FG003|COMPLETED|Overall Study||1||
48363884|NCT01469052|101220393|FG004|COMPLETED|Overall Study||0||
48363885|NCT01469052|101220394|FG005|COMPLETED|Overall Study||0||
48363886|NCT01469052|101220389|FG000|NOT COMPLETED|Overall Study||6||
48363887|NCT01469052|101220390|FG001|NOT COMPLETED|Overall Study||4||
48363888|NCT01469052|101220391|FG002|NOT COMPLETED|Overall Study||6||
48363889|NCT01469052|101220392|FG003|NOT COMPLETED|Overall Study||5||
48363890|NCT01469052|101220393|FG004|NOT COMPLETED|Overall Study||8||
48363891|NCT01469052|101220394|FG005|NOT COMPLETED|Overall Study||6||
48363892|NCT01863563|101220395|FG000|STARTED|Overall Study||100||
48363893|NCT01863563|101220395|FG000|COMPLETED|Overall Study||100||
48363894|NCT01863563|101220395|FG000|NOT COMPLETED|Overall Study||0||
48363895|NCT02278185|101220396|FG000|STARTED|Overall Study||10||
48363896|NCT02278185|101220397|FG001|STARTED|Overall Study||9||
48363897|NCT02278185|101220396|FG000|COMPLETED|Overall Study||7||
48363898|NCT02278185|101220397|FG001|COMPLETED|Overall Study||7||
48363899|NCT02278185|101220396|FG000|NOT COMPLETED|Overall Study||3||
48363900|NCT02278185|101220397|FG001|NOT COMPLETED|Overall Study||2||
48363901|NCT00149825|101220398|FG000|STARTED|Overall Study||15||
48363902|NCT00149825|101220399|FG001|STARTED|Overall Study||15||
48363903|NCT00149825|101220398|FG000|COMPLETED|Overall Study||10||
48363904|NCT00149825|101220399|FG001|COMPLETED|Overall Study||12||
48363905|NCT00149825|101220398|FG000|NOT COMPLETED|Overall Study||5||
48363906|NCT00149825|101220399|FG001|NOT COMPLETED|Overall Study||3||
48363907|NCT02606877|101220400|FG000|STARTED|Overall Study||20||
48363908|NCT02606877|101220401|FG001|STARTED|Overall Study||17||
48363909|NCT02606877|101220400|FG000|COMPLETED|Overall Study||16||
48363910|NCT02606877|101220401|FG001|COMPLETED|Overall Study||16||
48363911|NCT02606877|101220400|FG000|NOT COMPLETED|Overall Study||4||
48363912|NCT02606877|101220401|FG001|NOT COMPLETED|Overall Study||1||
48363913|NCT02940886|101220402|FG000|STARTED|Overall Study||1009||
48363914|NCT02940886|101220403|FG001|STARTED|Overall Study||503||
48363915|NCT02940886|101220402|FG000|Safety Analysis Set|Overall Study||989||
48363916|NCT02940886|101220403|FG001|Safety Analysis Set|Overall Study||494||
48363917|NCT02940886|101220402|FG000|COMPLETED|Overall Study||907||
48363918|NCT02940886|101220403|FG001|COMPLETED|Overall Study||449||
48363919|NCT02940886|101220402|FG000|NOT COMPLETED|Overall Study||102||
48363920|NCT02940886|101220403|FG001|NOT COMPLETED|Overall Study||54||
48363921|NCT00418262|101220404|FG000|STARTED|Visits 1 (Baseline) Thru 5||27||
48363922|NCT00418262|101220404|FG000|COMPLETED|Visits 1 (Baseline) Thru 5||25||
48363923|NCT00418262|101220404|FG000|NOT COMPLETED|Visits 1 (Baseline) Thru 5||2||
48363924|NCT00418262|101220404|FG000|STARTED|Visits 5 Thru 8||25||
48363925|NCT00418262|101220404|FG000|COMPLETED|Visits 5 Thru 8||16||
48363926|NCT00418262|101220404|FG000|NOT COMPLETED|Visits 5 Thru 8||9||
48363927|NCT00418262|101220404|FG000|STARTED|Visits 8 Thru 10||16||
48363928|NCT00418262|101220404|FG000|COMPLETED|Visits 8 Thru 10||11||
48363929|NCT00418262|101220404|FG000|NOT COMPLETED|Visits 8 Thru 10||5||
48363930|NCT04003155|101220405|FG000|STARTED|Double-Blind (DB) Period (12 Weeks)||175||
48363931|NCT04003155|101220406|FG001|STARTED|Double-Blind (DB) Period (12 Weeks)||176||
48363932|NCT04003155|101220407|FG002|STARTED|Double-Blind (DB) Period (12 Weeks)||176||
48363933|NCT04003155|101220408|FG003|STARTED|Double-Blind (DB) Period (12 Weeks)||0||
48363934|NCT04003155|101220409|FG004|STARTED|Double-Blind (DB) Period (12 Weeks)||0||
48363935|NCT04003155|101220405|FG000|Full Analysis Set|Double-Blind (DB) Period (12 Weeks)||175||
48363936|NCT04003155|101220406|FG001|Full Analysis Set|Double-Blind (DB) Period (12 Weeks)||173||
48363937|NCT04003155|101220407|FG002|Full Analysis Set|Double-Blind (DB) Period (12 Weeks)||174||
48363938|NCT04003155|101220408|FG003|Full Analysis Set|Double-Blind (DB) Period (12 Weeks)||0||
48363939|NCT04003155|101220409|FG004|Full Analysis Set|Double-Blind (DB) Period (12 Weeks)||0||
48363940|NCT04003155|101220405|FG000|Safety Analysis Set|Double-Blind (DB) Period (12 Weeks)||175||
48363941|NCT04003155|101220406|FG001|Safety Analysis Set|Double-Blind (DB) Period (12 Weeks)||174||
48363942|NCT04003155|101220407|FG002|Safety Analysis Set|Double-Blind (DB) Period (12 Weeks)||173||
48363943|NCT04003155|101220408|FG003|Safety Analysis Set|Double-Blind (DB) Period (12 Weeks)||0||
48363944|NCT04003155|101220409|FG004|Safety Analysis Set|Double-Blind (DB) Period (12 Weeks)||0||
48363945|NCT04003155|101220405|FG000|Treated|Double-Blind (DB) Period (12 Weeks)||175||
48363946|NCT04003155|101220406|FG001|Treated|Double-Blind (DB) Period (12 Weeks)||173||
48363947|NCT04003155|101220407|FG002|Treated|Double-Blind (DB) Period (12 Weeks)||174||
48363948|NCT04003155|101220408|FG003|Treated|Double-Blind (DB) Period (12 Weeks)||0||
48363949|NCT04003155|101220409|FG004|Treated|Double-Blind (DB) Period (12 Weeks)||0||
48363950|NCT04003155|101220405|FG000|COMPLETED|Double-Blind (DB) Period (12 Weeks)||152||
48363951|NCT04003155|101220406|FG001|COMPLETED|Double-Blind (DB) Period (12 Weeks)||142||
48363952|NCT04003155|101220407|FG002|COMPLETED|Double-Blind (DB) Period (12 Weeks)||161||
48363953|NCT04003155|101220408|FG003|COMPLETED|Double-Blind (DB) Period (12 Weeks)||0||
48363954|NCT04003155|101220409|FG004|COMPLETED|Double-Blind (DB) Period (12 Weeks)||0||
48363955|NCT04003155|101220405|FG000|NOT COMPLETED|Double-Blind (DB) Period (12 Weeks)||23||
48363956|NCT04003155|101220406|FG001|NOT COMPLETED|Double-Blind (DB) Period (12 Weeks)||34||
48363957|NCT04003155|101220407|FG002|NOT COMPLETED|Double-Blind (DB) Period (12 Weeks)||15||
48363958|NCT04003155|101220408|FG003|NOT COMPLETED|Double-Blind (DB) Period (12 Weeks)||0||
48363959|NCT04003155|101220409|FG004|NOT COMPLETED|Double-Blind (DB) Period (12 Weeks)||0||
48363960|NCT04003155|101220405|FG000|STARTED|Extension Period (EP) (40 Weeks)||0||
48363961|NCT04003155|101220406|FG001|STARTED|Extension Period (EP) (40 Weeks)||142||
48363962|NCT04003155|101220407|FG002|STARTED|Extension Period (EP) (40 Weeks)||158||
48363963|NCT04003155|101220408|FG003|STARTED|Extension Period (EP) (40 Weeks)||76||
48363964|NCT04003155|101220409|FG004|STARTED|Extension Period (EP) (40 Weeks)||76||
48363965|NCT04003155|101220405|FG000|COMPLETED|Extension Period (EP) (40 Weeks)||0||
48363966|NCT04003155|101220406|FG001|COMPLETED|Extension Period (EP) (40 Weeks)||124||
48363967|NCT04003155|101220407|FG002|COMPLETED|Extension Period (EP) (40 Weeks)||143||
48363968|NCT04003155|101220408|FG003|COMPLETED|Extension Period (EP) (40 Weeks)||62||
48363969|NCT04003155|101220409|FG004|COMPLETED|Extension Period (EP) (40 Weeks)||67||
48363970|NCT04003155|101220405|FG000|NOT COMPLETED|Extension Period (EP) (40 Weeks)||0||
48363971|NCT04003155|101220406|FG001|NOT COMPLETED|Extension Period (EP) (40 Weeks)||18||
48363972|NCT04003155|101220407|FG002|NOT COMPLETED|Extension Period (EP) (40 Weeks)||15||
48363973|NCT04003155|101220408|FG003|NOT COMPLETED|Extension Period (EP) (40 Weeks)||14||
48363974|NCT04003155|101220409|FG004|NOT COMPLETED|Extension Period (EP) (40 Weeks)||9||
48363975|NCT00081289|101220410|FG000|STARTED|Overall Study||73||
48363976|NCT00081289|101220411|FG001|STARTED|Overall Study||73||
48363977|NCT00081289|101220410|FG000|Primary Endpoint Population|Overall Study||48|First 48 eligible patients accrued per arm after the protocol amendment|
48363978|NCT00081289|101220411|FG001|Primary Endpoint Population|Overall Study||48|First 48 eligible patients accrued per arm after the protocol amendment|
48363979|NCT00081289|101220410|FG000|General Analysis Population|Overall Study||52|Eligible participants enrolled after the protocol ammendment|
48363980|NCT00081289|101220411|FG001|General Analysis Population|Overall Study||52|Eligible participants enrolled after the protocol ammendment|
48363981|NCT00081289|101220410|FG000|Full AE Population|Overall Study||70|All eligible patients including those enrolled prior to protocol amendment|
48363982|NCT00081289|101220411|FG001|Full AE Population|Overall Study||68|All eligible patients including those enrolled prior to protocol amendment|
48363983|NCT00081289|101220410|FG000|Surgery|Overall Study||47|Eligible patients enrolled after the protocol amendment who had surgery|
48363984|NCT00081289|101220411|FG001|Surgery|Overall Study||51|Eligible patients enrolled after the protocol amendment who had surgery|
48363985|NCT00081289|101220410|FG000|Global Health Status Score at End of CR|Overall Study||34|EORTC QLQ-C30 Global Health Status (GHS) Score at baseline and end of chemoradiation (CR)|
48363986|NCT00081289|101220411|FG001|Global Health Status Score at End of CR|Overall Study||32|EORTC QLQ-C30 Global Health Status (GHS) Score at baseline and end of chemoradiation (CR)|
48363987|NCT00081289|101220410|FG000|GHS at End of Post-op CT|Overall Study||20|EORTC QLQ-C30 GHS Score at baseline and end of post-operative chemotherapy (CT)|
48363988|NCT00081289|101220411|FG001|GHS at End of Post-op CT|Overall Study||28|EORTC QLQ-C30 GHS Score at baseline and end of post-operative chemotherapy (CT)|
48363989|NCT00081289|101220410|FG000|GHS at Two Years|Overall Study||21|EORTC QLQ-C30 GHS Score at baseline and two years|
48363990|NCT00081289|101220411|FG001|GHS at Two Years|Overall Study||20|EORTC QLQ-C30 GHS Score at baseline and two years|
48363991|NCT00081289|101220410|FG000|GI Symptom Score at End of CR|Overall Study||34|EORTC QLQ-CR38 Gastro-Intestinal (GI) Symptom Score at baseline and end of chemoradiation|
48363992|NCT00081289|101220411|FG001|GI Symptom Score at End of CR|Overall Study||33|EORTC QLQ-CR38 Gastro-Intestinal (GI) Symptom Score at baseline and end of chemoradiation|
48363993|NCT00081289|101220410|FG000|GI Symptom Score at End of Post-op CT|Overall Study||22|EORTC QLQ-CR38 GI Symptom Score at baseline and end of post-operative chemotherapy|
48363994|NCT00081289|101220411|FG001|GI Symptom Score at End of Post-op CT|Overall Study||27|EORTC QLQ-CR38 GI Symptom Score at baseline and end of post-operative chemotherapy|
48363995|NCT00081289|101220410|FG000|GI Symptom Score at Two Years|Overall Study||21|EORTC QLQ-CR38 GI Symptom Score at baseline and two years|
48363996|NCT00081289|101220411|FG001|GI Symptom Score at Two Years|Overall Study||20|EORTC QLQ-CR38 GI Symptom Score at baseline and two years|
48363997|NCT00081289|101220410|FG000|Defecation Symptom Score at End of CR|Overall Study||32|EORTC QLQ-CR38 Defecation Symptom Score at baseline and end of chemoradiation|
48363998|NCT00081289|101220411|FG001|Defecation Symptom Score at End of CR|Overall Study||32|EORTC QLQ-CR38 Defecation Symptom Score at baseline and end of chemoradiation|
48363999|NCT00081289|101220410|FG000|DS Score at End of Post-op CT|Overall Study||12|EORTC QLQ-CR38 Defecation Symptom (DS) Score at baseline and end of post-operative chemotherapy|
48364000|NCT00081289|101220411|FG001|DS Score at End of Post-op CT|Overall Study||14|EORTC QLQ-CR38 Defecation Symptom (DS) Score at baseline and end of post-operative chemotherapy|
48364001|NCT00081289|101220410|FG000|Defecation Symptom Score at Two Years|Overall Study||13|EORTC QLQ-CR38 Defecation Symptom Score at baseline and two years|
48364002|NCT00081289|101220411|FG001|Defecation Symptom Score at Two Years|Overall Study||15|EORTC QLQ-CR38 Defecation Symptom Score at baseline and two years|
48364003|NCT00081289|101220410|FG000|COMPLETED|Overall Study||52|Subjects contributing any data to analysis are considered to have completed the study|
48364004|NCT00081289|101220411|FG001|COMPLETED|Overall Study||52|Subjects contributing any data to analysis are considered to have completed the study|
48364005|NCT00081289|101220410|FG000|NOT COMPLETED|Overall Study||21||
48364006|NCT00081289|101220411|FG001|NOT COMPLETED|Overall Study||21||
48364007|NCT00121810|101220412|FG000|STARTED|Overall Study||151||
48364008|NCT00121810|101220413|FG001|STARTED|Overall Study||154||
48364009|NCT00121810|101220412|FG000|Safety Population|Overall Study||148||
48364010|NCT00121810|101220413|FG001|Safety Population|Overall Study||153||
48364011|NCT00121810|101220412|FG000|Intent-to-Treat (ITT) Population|Overall Study||148||
48364012|NCT00121810|101220413|FG001|Intent-to-Treat (ITT) Population|Overall Study||151||
48364013|NCT00121810|101220412|FG000|COMPLETED|Overall Study||121||
48364014|NCT00121810|101220413|FG001|COMPLETED|Overall Study||115||
48364015|NCT00121810|101220412|FG000|NOT COMPLETED|Overall Study||30||
48364016|NCT00121810|101220413|FG001|NOT COMPLETED|Overall Study||39||
48364017|NCT00915967|101220414|FG000|STARTED|Overall Study||98||
48364018|NCT00915967|101220415|FG001|STARTED|Overall Study||100||
48364019|NCT00915967|101220414|FG000|COMPLETED|Overall Study||97||
48364020|NCT00915967|101220415|FG001|COMPLETED|Overall Study||98||
48364021|NCT00915967|101220414|FG000|NOT COMPLETED|Overall Study||1||
48364022|NCT00915967|101220415|FG001|NOT COMPLETED|Overall Study||2||
48364023|NCT03897712|101220416|FG000|STARTED|Overall Study||56||112
48364024|NCT03897712|101220417|FG001|STARTED|Overall Study||28||56
48364025|NCT03897712|101220416|FG000|COMPLETED|Overall Study||46||92
48364026|NCT03897712|101220417|FG001|COMPLETED|Overall Study||25||50
48364027|NCT03897712|101220416|FG000|NOT COMPLETED|Overall Study||10||20
48364028|NCT03897712|101220417|FG001|NOT COMPLETED|Overall Study||3||6
48364029|NCT01422304|101220418|FG000|STARTED|Overall Study||598||
48364030|NCT01422304|101220419|FG001|STARTED|Overall Study||600||
48364031|NCT01422304|101220418|FG000|Treated|Overall Study||595||
48364032|NCT01422304|101220419|FG001|Treated|Overall Study||589||
48364033|NCT01422304|101220418|FG000|COMPLETED|Overall Study||574||
48364034|NCT01422304|101220419|FG001|COMPLETED|Overall Study||563||
48364035|NCT01422304|101220418|FG000|NOT COMPLETED|Overall Study||24||
48364036|NCT01422304|101220419|FG001|NOT COMPLETED|Overall Study||37||
48364037|NCT00317941|101220420|FG000|STARTED|Overall Study||73||
48364038|NCT00317941|101220421|FG001|STARTED|Overall Study||79||
48364039|NCT00317941|101220422|FG002|STARTED|Overall Study||68||
48364040|NCT00317941|101220420|FG000|Participants Received Treatment|Overall Study||73||
48364041|NCT00317941|101220421|FG001|Participants Received Treatment|Overall Study||79||
48654787|NCT03425188|101941106|FG000|COMPLETED|Overall Study||52||
48654788|NCT03425188|101941106|FG000|NOT COMPLETED|Overall Study||1||
48654789|NCT05339659|101941107|FG000|STARTED|Overall Study||9||
48654790|NCT05339659|101941108|FG001|STARTED|Overall Study||13||
48654791|NCT05339659|101941107|FG000|Installed App|Overall Study||7||
48364042|NCT00317941|101220422|FG002|Participants Received Treatment|Overall Study||68||
48364043|NCT00317941|101220420|FG000|Fulfilled Requirement Safety Population|Overall Study||73||
48364044|NCT00317941|101220421|FG001|Fulfilled Requirement Safety Population|Overall Study||77||
48364045|NCT00317941|101220422|FG002|Fulfilled Requirement Safety Population|Overall Study||65||
48364046|NCT00317941|101220420|FG000|Fulfilled Requirements PP Population|Overall Study||66||
48364047|NCT00317941|101220421|FG001|Fulfilled Requirements PP Population|Overall Study||76||
48364048|NCT00317941|101220422|FG002|Fulfilled Requirements PP Population|Overall Study||63||
48364049|NCT00317941|101220420|FG000|COMPLETED|Overall Study||66||
48364050|NCT00317941|101220421|FG001|COMPLETED|Overall Study||74||
48364051|NCT00317941|101220422|FG002|COMPLETED|Overall Study||60||
48364052|NCT00317941|101220420|FG000|NOT COMPLETED|Overall Study||7||
48364053|NCT00317941|101220421|FG001|NOT COMPLETED|Overall Study||5||
48654792|NCT05339659|101941108|FG001|Installed App|Overall Study||12||
48654793|NCT05339659|101941107|FG000|Completed 1-month Self-report Survey|Overall Study||6||
48654794|NCT05339659|101941108|FG001|Completed 1-month Self-report Survey|Overall Study||9||
48654795|NCT05339659|101941107|FG000|Completed 3-month Self-report Survey|Overall Study||6||
48654796|NCT05339659|101941108|FG001|Completed 3-month Self-report Survey|Overall Study||8||
48364054|NCT00317941|101220422|FG002|NOT COMPLETED|Overall Study||8||
48364055|NCT02110108|101220423|FG000|STARTED|Overall Study||10||
48364056|NCT02110108|101220423|FG000|RevLite Single Wavelength|Overall Study||10||
48364057|NCT02110108|101220423|FG000|RevLite Combo Wavelength|Overall Study||10||
48364058|NCT02110108|101220423|FG000|COMPLETED|Overall Study||7||
48364059|NCT02110108|101220423|FG000|NOT COMPLETED|Overall Study||3||
48364060|NCT00053846|101220424|FG000|STARTED|Overall Study||213||
48364061|NCT00053846|101220425|FG001|STARTED|Overall Study||219||
48364062|NCT00053846|101220424|FG000|COMPLETED|Overall Study||187||
48364063|NCT00053846|101220425|FG001|COMPLETED|Overall Study||192||
48364064|NCT00053846|101220424|FG000|NOT COMPLETED|Overall Study||26||
48654797|NCT05339659|101941107|FG000|Completed App Utilization Period|Overall Study||7||
48654798|NCT05339659|101941108|FG001|Completed App Utilization Period|Overall Study||12||
48364065|NCT00053846|101220425|FG001|NOT COMPLETED|Overall Study||27||
48364066|NCT00744055|101220426|FG000|STARTED|Overall Study||50||
48364067|NCT00744055|101220427|FG001|STARTED|Overall Study||46||
48364068|NCT00744055|101220426|FG000|COMPLETED|Overall Study||43||
48364069|NCT00744055|101220427|FG001|COMPLETED|Overall Study||32||
48364070|NCT00744055|101220426|FG000|NOT COMPLETED|Overall Study||7||
48364071|NCT00744055|101220427|FG001|NOT COMPLETED|Overall Study||14||
48364072|NCT02680301|101220428|FG000|STARTED|Overall Study||22||
48364073|NCT02680301|101220429|FG001|STARTED|Overall Study||18||
48364074|NCT02680301|101220428|FG000|COMPLETED|Overall Study||22||
48364075|NCT02680301|101220429|FG001|COMPLETED|Overall Study||17||
48364076|NCT02680301|101220428|FG000|NOT COMPLETED|Overall Study||0||
48364077|NCT02680301|101220429|FG001|NOT COMPLETED|Overall Study||1||
48364078|NCT02746679|101220430|FG000|STARTED|Overall Study||80||
48364079|NCT02746679|101220431|FG001|STARTED|Overall Study||81||
48364080|NCT02746679|101220430|FG000|COMPLETED|Overall Study||76||
48364081|NCT02746679|101220431|FG001|COMPLETED|Overall Study||75||
48364082|NCT02746679|101220430|FG000|NOT COMPLETED|Overall Study||4||
48364083|NCT02746679|101220431|FG001|NOT COMPLETED|Overall Study||6||
48364084|NCT05372575|101220432|FG000|STARTED|Overall Study||101||
48364085|NCT05372575|101220433|FG001|STARTED|Overall Study||199||
48364086|NCT05372575|101220432|FG000|COMPLETED|Overall Study||94||
48364087|NCT05372575|101220433|FG001|COMPLETED|Overall Study||183||
48364088|NCT05372575|101220432|FG000|NOT COMPLETED|Overall Study||7||
48364089|NCT05372575|101220433|FG001|NOT COMPLETED|Overall Study||16||
48364090|NCT00052429|101220434|FG000|STARTED|Overall Study||25||
48364091|NCT00052429|101220434|FG000|COMPLETED|Overall Study||25||
48364092|NCT00052429|101220434|FG000|NOT COMPLETED|Overall Study||0||
48364093|NCT01202110|101220435|FG000|STARTED|Overall Study||10||
48364094|NCT01202110|101220436|FG001|STARTED|Overall Study||0||
48364095|NCT01202110|101220435|FG000|COMPLETED|Overall Study||10||
48364096|NCT01202110|101220436|FG001|COMPLETED|Overall Study||0||
48364097|NCT01202110|101220435|FG000|NOT COMPLETED|Overall Study||0||
48364098|NCT01202110|101220436|FG001|NOT COMPLETED|Overall Study||0||
48364099|NCT02133235|101220437|FG000|STARTED|Overall Study||55||
48364100|NCT02133235|101220438|FG001|STARTED|Overall Study||57||
48364101|NCT02133235|101220437|FG000|COMPLETED|Overall Study||55||
48364102|NCT02133235|101220438|FG001|COMPLETED|Overall Study||57||
48364103|NCT02133235|101220437|FG000|NOT COMPLETED|Overall Study||0||
48364104|NCT02133235|101220438|FG001|NOT COMPLETED|Overall Study||0||
48364105|NCT00234104|101220439|FG000|STARTED|Overall Study||30||
48364106|NCT00234104|101220440|FG001|STARTED|Overall Study||29||
48364107|NCT00234104|101220441|FG002|STARTED|Overall Study||34||
48364108|NCT00234104|101220442|FG003|STARTED|Overall Study||29||
48364109|NCT00234104|101220439|FG000|COMPLETED|Overall Study||26||
48364110|NCT00234104|101220440|FG001|COMPLETED|Overall Study||28||
48364111|NCT00234104|101220441|FG002|COMPLETED|Overall Study||29||
48364112|NCT00234104|101220442|FG003|COMPLETED|Overall Study||21||
48364113|NCT00234104|101220439|FG000|NOT COMPLETED|Overall Study||4||
48364114|NCT00234104|101220440|FG001|NOT COMPLETED|Overall Study||1||
48364115|NCT00234104|101220441|FG002|NOT COMPLETED|Overall Study||5||
48364116|NCT00234104|101220442|FG003|NOT COMPLETED|Overall Study||8||
48364117|NCT02399475|101220443|FG000|STARTED|Overall Study||7||
48364118|NCT02399475|101220444|FG001|STARTED|Overall Study||7||
48436516|NCT04780776|101403566|FG000|NOT COMPLETED|Follow up Week 22-25||2||
48436517|NCT04780776|101403567|FG001|NOT COMPLETED|Follow up Week 22-25||2||
48436518|NCT00808769|101403568|FG000|STARTED|First Intervention||15||
48436519|NCT00808769|101403569|FG001|STARTED|First Intervention||15||
48436520|NCT00808769|101403568|FG000|COMPLETED|First Intervention||15||
48436521|NCT00808769|101403569|FG001|COMPLETED|First Intervention||15||
48436522|NCT00808769|101403568|FG000|NOT COMPLETED|First Intervention||0||
48436523|NCT00808769|101403569|FG001|NOT COMPLETED|First Intervention||0||
48436524|NCT00808769|101403568|FG000|STARTED|Second Intervention||15||
48436525|NCT00808769|101403569|FG001|STARTED|Second Intervention||15||
48364119|NCT02399475|101220443|FG000|COMPLETED|Overall Study||6||
48364120|NCT02399475|101220444|FG001|COMPLETED|Overall Study||7||
48364121|NCT02399475|101220443|FG000|NOT COMPLETED|Overall Study||1||
48364122|NCT02399475|101220444|FG001|NOT COMPLETED|Overall Study||0||
48364123|NCT01322607|101220445|FG000|STARTED|Overall Study||11||
48364124|NCT01322607|101220446|FG001|STARTED|Overall Study||9||
48436526|NCT00808769|101403568|FG000|COMPLETED|Second Intervention||15||
48364125|NCT01322607|101220445|FG000|COMPLETED|Overall Study||10||
48364126|NCT01322607|101220446|FG001|COMPLETED|Overall Study||9||
48364127|NCT01322607|101220445|FG000|NOT COMPLETED|Overall Study||1||
48364128|NCT01322607|101220446|FG001|NOT COMPLETED|Overall Study||0||
48364129|NCT02739698|101220447|FG000|STARTED|Overall Study||22||
48364130|NCT02739698|101220448|FG001|STARTED|Overall Study||21||
48436527|NCT00808769|101403569|FG001|COMPLETED|Second Intervention||15||
48436528|NCT00808769|101403568|FG000|NOT COMPLETED|Second Intervention||0||
48436529|NCT00808769|101403569|FG001|NOT COMPLETED|Second Intervention||0||
48436530|NCT00029107|101403570|FG000|STARTED|Overall Study||12||
48436531|NCT00029107|101403571|FG001|STARTED|Overall Study||12||
48364131|NCT02739698|101220447|FG000|COMPLETED|Overall Study||16||
48364132|NCT02739698|101220448|FG001|COMPLETED|Overall Study||16||
48364133|NCT02739698|101220447|FG000|NOT COMPLETED|Overall Study||6||
48364134|NCT02739698|101220448|FG001|NOT COMPLETED|Overall Study||5||
48364135|NCT01052012|101220449|FG000|STARTED|Overall Study||32||
48364136|NCT01052012|101220450|FG001|STARTED|Overall Study||23||
48364137|NCT01052012|101220451|FG002|STARTED|Overall Study||30||
48364138|NCT01052012|101220452|FG003|STARTED|Overall Study||20||
48364139|NCT01052012|101220453|FG004|STARTED|Overall Study||140||
48364140|NCT01052012|101220454|FG005|STARTED|Overall Study||86||
48436532|NCT00029107|101403570|FG000|COMPLETED|Overall Study||12||
48436533|NCT00029107|101403571|FG001|COMPLETED|Overall Study||12||
48364141|NCT01052012|101220449|FG000|COMPLETED|Overall Study||28||
48364142|NCT01052012|101220450|FG001|COMPLETED|Overall Study||17||
48364143|NCT01052012|101220451|FG002|COMPLETED|Overall Study||30||
48364144|NCT01052012|101220452|FG003|COMPLETED|Overall Study||19||
48364145|NCT01052012|101220453|FG004|COMPLETED|Overall Study||124||
48364146|NCT01052012|101220454|FG005|COMPLETED|Overall Study||76||
48364147|NCT01052012|101220449|FG000|NOT COMPLETED|Overall Study||4||
48364148|NCT01052012|101220450|FG001|NOT COMPLETED|Overall Study||6||
48364149|NCT01052012|101220451|FG002|NOT COMPLETED|Overall Study||0||
48364150|NCT01052012|101220452|FG003|NOT COMPLETED|Overall Study||1||
48364151|NCT01052012|101220453|FG004|NOT COMPLETED|Overall Study||16||
48364152|NCT01052012|101220454|FG005|NOT COMPLETED|Overall Study||10||
48364153|NCT01272180|101220455|FG000|STARTED|Overall Study||120||
48364154|NCT01272180|101220456|FG001|STARTED|Overall Study||121||
48364155|NCT01272180|101220457|FG002|STARTED|Overall Study||122||
48364156|NCT01272180|101220458|FG003|STARTED|Overall Study||121||
48364157|NCT01272180|101220455|FG000|COMPLETED|Overall Study||103||
48364158|NCT01272180|101220456|FG001|COMPLETED|Overall Study||100||
48364159|NCT01272180|101220457|FG002|COMPLETED|Overall Study||109||
48364160|NCT01272180|101220458|FG003|COMPLETED|Overall Study||107||
48364161|NCT01272180|101220455|FG000|NOT COMPLETED|Overall Study||17||
48364162|NCT01272180|101220456|FG001|NOT COMPLETED|Overall Study||21||
48364163|NCT01272180|101220457|FG002|NOT COMPLETED|Overall Study||13||
48364164|NCT01272180|101220458|FG003|NOT COMPLETED|Overall Study||14||
48364165|NCT01126619|101220459|FG000|STARTED|Overall Study||103||
48364166|NCT01126619|101220459|FG000|COMPLETED|Overall Study||86||
48364167|NCT01126619|101220459|FG000|NOT COMPLETED|Overall Study||17||
48364168|NCT01004146|101220460|FG000|STARTED|Overall Study||25||
48364169|NCT01004146|101220461|FG001|STARTED|Overall Study||25||
48364170|NCT01004146|101220460|FG000|Have Incentive Spirometry Data|Overall Study||21||
48364171|NCT01004146|101220461|FG001|Have Incentive Spirometry Data|Overall Study||20||
48364172|NCT01004146|101220460|FG000|COMPLETED|Overall Study||21||
48364173|NCT01004146|101220461|FG001|COMPLETED|Overall Study||20||
48364174|NCT01004146|101220460|FG000|NOT COMPLETED|Overall Study||4||
48364175|NCT01004146|101220461|FG001|NOT COMPLETED|Overall Study||5||
48364176|NCT00514449|101220462|FG000|STARTED|Overall Study||12||
48364177|NCT00514449|101220463|FG001|STARTED|Overall Study||12||
48364178|NCT00514449|101220462|FG000|COMPLETED|Overall Study||9||
48364179|NCT00514449|101220463|FG001|COMPLETED|Overall Study||8||
48364180|NCT00514449|101220462|FG000|NOT COMPLETED|Overall Study||3||
48364181|NCT00514449|101220463|FG001|NOT COMPLETED|Overall Study||4||
48364182|NCT00554294|101220464|FG000|STARTED|Overall Study||1469||
48364183|NCT00554294|101220465|FG001|STARTED|Overall Study||1721||
48364184|NCT00554294|101220464|FG000|COMPLETED|Overall Study||1309||
48364185|NCT00554294|101220465|FG001|COMPLETED|Overall Study||1641||
48364186|NCT00554294|101220464|FG000|NOT COMPLETED|Overall Study||160||
48364187|NCT00554294|101220465|FG001|NOT COMPLETED|Overall Study||80||
48364188|NCT01781026|101220466|FG000|STARTED|Overall Study||2||
48364189|NCT01781026|101220466|FG000|COMPLETED|Overall Study||0||
48364190|NCT01781026|101220466|FG000|NOT COMPLETED|Overall Study||2||
48364191|NCT01062399|101220467|FG000|STARTED|Overall Study||8||
48364192|NCT01062399|101220468|FG001|STARTED|Overall Study||10||
48364193|NCT01062399|101220469|FG002|STARTED|Overall Study||8||
48364194|NCT01062399|101220470|FG003|STARTED|Overall Study||89||
48364195|NCT01062399|101220471|FG004|STARTED|Overall Study||92||
48364196|NCT01062399|101220467|FG000|COMPLETED|Overall Study||8||
48364197|NCT01062399|101220468|FG001|COMPLETED|Overall Study||9||
48364198|NCT01062399|101220469|FG002|COMPLETED|Overall Study||8||
48364199|NCT01062399|101220470|FG003|COMPLETED|Overall Study||83||
48364200|NCT01062399|101220471|FG004|COMPLETED|Overall Study||88||
48364201|NCT01062399|101220467|FG000|NOT COMPLETED|Overall Study||0||
48364202|NCT01062399|101220468|FG001|NOT COMPLETED|Overall Study||1||
48364203|NCT01062399|101220469|FG002|NOT COMPLETED|Overall Study||0||
48364204|NCT01062399|101220470|FG003|NOT COMPLETED|Overall Study||6||
48364205|NCT01062399|101220471|FG004|NOT COMPLETED|Overall Study||4||
48364206|NCT01302041|101220472|FG000|STARTED|Overall Study||67||
48364207|NCT01302041|101220472|FG000|Treatment Received|Overall Study||67||
48654799|NCT05339659|101941107|FG000|COMPLETED|Overall Study||7||
48654800|NCT05339659|101941108|FG001|COMPLETED|Overall Study||12||
48654801|NCT05339659|101941107|FG000|NOT COMPLETED|Overall Study||2||
48654802|NCT05339659|101941108|FG001|NOT COMPLETED|Overall Study||1||
48364208|NCT01302041|101220472|FG000|COMPLETED|Overall Study||27||
48364209|NCT01302041|101220472|FG000|NOT COMPLETED|Overall Study||40||
48364210|NCT04973228|101220473|FG000|STARTED|Overall Study||304||
48364211|NCT04973228|101220474|FG001|STARTED|Overall Study||153||
48364212|NCT04973228|101220473|FG000|COMPLETED|Overall Study||276||
48364213|NCT04973228|101220474|FG001|COMPLETED|Overall Study||138||
48364214|NCT04973228|101220473|FG000|NOT COMPLETED|Overall Study||28||
48364215|NCT04973228|101220474|FG001|NOT COMPLETED|Overall Study||15||
48364216|NCT03291197|101220475|FG000|STARTED|Overall Study||5||
48364217|NCT03291197|101220475|FG000|COMPLETED|Overall Study||5||
48364218|NCT03291197|101220475|FG000|NOT COMPLETED|Overall Study||0||
48364219|NCT01553539|101220476|FG000|STARTED|Overall Study||20||
48364220|NCT01553539|101220476|FG000|COMPLETED|Overall Study||20||
48364221|NCT01553539|101220476|FG000|NOT COMPLETED|Overall Study||0||
48364222|NCT00469014|101220477|FG000|STARTED|Initial Phase Randomization||5||
48364223|NCT00469014|101220478|FG001|STARTED|Initial Phase Randomization||4||
48364224|NCT00469014|101220479|FG002|STARTED|Initial Phase Randomization||5||
48364225|NCT00469014|101220480|FG003|STARTED|Initial Phase Randomization||6||
48364226|NCT00469014|101220477|FG000|COMPLETED|Initial Phase Randomization||4||
48364227|NCT00469014|101220478|FG001|COMPLETED|Initial Phase Randomization||3||
48364228|NCT00469014|101220479|FG002|COMPLETED|Initial Phase Randomization||4||
48364229|NCT00469014|101220480|FG003|COMPLETED|Initial Phase Randomization||5||
48364230|NCT00469014|101220477|FG000|NOT COMPLETED|Initial Phase Randomization||1||
48364231|NCT00469014|101220478|FG001|NOT COMPLETED|Initial Phase Randomization||1||
48364232|NCT00469014|101220479|FG002|NOT COMPLETED|Initial Phase Randomization||1||
48364233|NCT00469014|101220480|FG003|NOT COMPLETED|Initial Phase Randomization||1||
48364234|NCT00469014|101220477|FG000|STARTED|Adaptive Randomization||13||
48364235|NCT00469014|101220478|FG001|STARTED|Adaptive Randomization||3||
48364236|NCT00469014|101220479|FG002|STARTED|Adaptive Randomization||24||
48364237|NCT00469014|101220480|FG003|STARTED|Adaptive Randomization||11||
48364238|NCT00469014|101220477|FG000|COMPLETED|Adaptive Randomization||12||
48364239|NCT00469014|101220478|FG001|COMPLETED|Adaptive Randomization||2||
48364240|NCT00469014|101220479|FG002|COMPLETED|Adaptive Randomization||23||
48364241|NCT00469014|101220480|FG003|COMPLETED|Adaptive Randomization||10||
48364242|NCT00469014|101220477|FG000|NOT COMPLETED|Adaptive Randomization||1||
48364243|NCT00469014|101220478|FG001|NOT COMPLETED|Adaptive Randomization||1||
48364244|NCT00469014|101220479|FG002|NOT COMPLETED|Adaptive Randomization||1||
48364245|NCT00469014|101220480|FG003|NOT COMPLETED|Adaptive Randomization||1||
48364246|NCT02221739|101220481|FG000|STARTED|Overall Study||39||
48364247|NCT02221739|101220481|FG000|COMPLETED|Overall Study||21||
48364248|NCT02221739|101220481|FG000|NOT COMPLETED|Overall Study||18||
48364249|NCT01894516|101220482|FG000|STARTED|Period 1 (Baseline up to Week 12)||72||
48364250|NCT01894516|101220483|FG001|STARTED|Period 1 (Baseline up to Week 12)||72||
48364251|NCT01894516|101220484|FG002|STARTED|Period 1 (Baseline up to Week 12)||70||
48364252|NCT01894516|101220485|FG003|STARTED|Period 1 (Baseline up to Week 12)||69||
48364253|NCT01894516|101220482|FG000|COMPLETED|Period 1 (Baseline up to Week 12)||65||
48364254|NCT01894516|101220483|FG001|COMPLETED|Period 1 (Baseline up to Week 12)||67||
48364255|NCT01894516|101220484|FG002|COMPLETED|Period 1 (Baseline up to Week 12)||67||
48364256|NCT01894516|101220485|FG003|COMPLETED|Period 1 (Baseline up to Week 12)||66||
48364257|NCT01894516|101220482|FG000|NOT COMPLETED|Period 1 (Baseline up to Week 12)||7||
48364258|NCT01894516|101220483|FG001|NOT COMPLETED|Period 1 (Baseline up to Week 12)||5||
48364259|NCT01894516|101220484|FG002|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3||
48364260|NCT01894516|101220485|FG003|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3||
48364261|NCT01894516|101220482|FG000|STARTED|Period 2 (Week 13 to Week 24)||0||
48364262|NCT01894516|101220483|FG001|STARTED|Period 2 (Week 13 to Week 24)||52||
48364263|NCT01894516|101220484|FG002|STARTED|Period 2 (Week 13 to Week 24)||147||
48364264|NCT01894516|101220485|FG003|STARTED|Period 2 (Week 13 to Week 24)||66||
48364265|NCT01894516|101220482|FG000|COMPLETED|Period 2 (Week 13 to Week 24)||0||
48364266|NCT01894516|101220483|FG001|COMPLETED|Period 2 (Week 13 to Week 24)||50||
48364267|NCT01894516|101220484|FG002|COMPLETED|Period 2 (Week 13 to Week 24)||142||
48364268|NCT01894516|101220485|FG003|COMPLETED|Period 2 (Week 13 to Week 24)||65||
48364269|NCT01894516|101220482|FG000|NOT COMPLETED|Period 2 (Week 13 to Week 24)||0||
48364270|NCT01894516|101220483|FG001|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2||
48364271|NCT01894516|101220484|FG002|NOT COMPLETED|Period 2 (Week 13 to Week 24)||5||
48364272|NCT01894516|101220485|FG003|NOT COMPLETED|Period 2 (Week 13 to Week 24)||1||
48436534|NCT00029107|101403570|FG000|NOT COMPLETED|Overall Study||0||
48364273|NCT03918642|101220486|FG000|STARTED|Overall Study||66||
48364274|NCT03918642|101220487|FG001|STARTED|Overall Study||60||
48364275|NCT03918642|101220486|FG000|Completed Posttreatment (Week 10) Assessments|Overall Study||57||
48364276|NCT03918642|101220487|FG001|Completed Posttreatment (Week 10) Assessments|Overall Study||54||
48364277|NCT03918642|101220486|FG000|COMPLETED|Overall Study||54|6-month follow-up assessments|
48364278|NCT03918642|101220487|FG001|COMPLETED|Overall Study||50|6-month follow-up assessments|
48364279|NCT03918642|101220486|FG000|NOT COMPLETED|Overall Study||12||
48364280|NCT03918642|101220487|FG001|NOT COMPLETED|Overall Study||10||
48364281|NCT04329923|101220488|FG000|STARTED|Overall Study||17||
48364282|NCT04329923|101220489|FG001|STARTED|Overall Study||17||
48364283|NCT04329923|101220490|FG002|STARTED|Overall Study||4||
48364284|NCT04329923|101220491|FG003|STARTED|Overall Study||3||
48364285|NCT04329923|101220492|FG004|STARTED|Overall Study||66||
48364286|NCT04329923|101220493|FG005|STARTED|Overall Study||66||
48364287|NCT04329923|101220488|FG000|COMPLETED|Overall Study||16||
48364288|NCT04329923|101220489|FG001|COMPLETED|Overall Study||13||
48364289|NCT04329923|101220490|FG002|COMPLETED|Overall Study||3||
48364290|NCT04329923|101220491|FG003|COMPLETED|Overall Study||2||
48364291|NCT04329923|101220492|FG004|COMPLETED|Overall Study||64||
48364292|NCT04329923|101220493|FG005|COMPLETED|Overall Study||61||
48364293|NCT04329923|101220488|FG000|NOT COMPLETED|Overall Study||1||
48364294|NCT04329923|101220489|FG001|NOT COMPLETED|Overall Study||4||
48364295|NCT04329923|101220490|FG002|NOT COMPLETED|Overall Study||1||
48364296|NCT04329923|101220491|FG003|NOT COMPLETED|Overall Study||1||
48364297|NCT04329923|101220492|FG004|NOT COMPLETED|Overall Study||2||
48364298|NCT04329923|101220493|FG005|NOT COMPLETED|Overall Study||5||
48364299|NCT01878006|101220494|FG000|STARTED|Study Session 1||5||
48364300|NCT01878006|101220495|FG001|STARTED|Study Session 1||5||
48364301|NCT01878006|101220494|FG000|COMPLETED|Study Session 1||5||
48364302|NCT01878006|101220495|FG001|COMPLETED|Study Session 1||5||
48364303|NCT01878006|101220494|FG000|NOT COMPLETED|Study Session 1||0||
48364304|NCT01878006|101220495|FG001|NOT COMPLETED|Study Session 1||0||
48364305|NCT01878006|101220494|FG000|STARTED|Study Session 2||5||
48364306|NCT01878006|101220495|FG001|STARTED|Study Session 2||5||
48364307|NCT01878006|101220494|FG000|COMPLETED|Study Session 2||5||
48364308|NCT01878006|101220495|FG001|COMPLETED|Study Session 2||5||
48364309|NCT01878006|101220494|FG000|NOT COMPLETED|Study Session 2||0||
48364310|NCT01878006|101220495|FG001|NOT COMPLETED|Study Session 2||0||
48364311|NCT04940598|101220496|FG000|STARTED|Overall Study||5||
48364312|NCT04940598|101220497|FG001|STARTED|Overall Study||3||
48364313|NCT04940598|101220496|FG000|COMPLETED|Overall Study||5||
48364314|NCT04940598|101220497|FG001|COMPLETED|Overall Study||3||
48364315|NCT04940598|101220496|FG000|NOT COMPLETED|Overall Study||0||
48364316|NCT04940598|101220497|FG001|NOT COMPLETED|Overall Study||0||
48364317|NCT00739297|101220498|FG000|STARTED|First Intervention (Visit 3 to Visit 4)||17||
48364318|NCT00739297|101220499|FG001|STARTED|First Intervention (Visit 3 to Visit 4)||11||
48364319|NCT00739297|101220500|FG002|STARTED|First Intervention (Visit 3 to Visit 4)||6||
48364320|NCT00739297|101220501|FG003|STARTED|First Intervention (Visit 3 to Visit 4)||19||
48364321|NCT00739297|101220502|FG004|STARTED|First Intervention (Visit 3 to Visit 4)||6||
48364322|NCT00739297|101220503|FG005|STARTED|First Intervention (Visit 3 to Visit 4)||9||
48364323|NCT00739297|101220504|FG006|STARTED|First Intervention (Visit 3 to Visit 4)||68||
48364324|NCT00739297|101220498|FG000|COMPLETED|First Intervention (Visit 3 to Visit 4)||17||
48364325|NCT00739297|101220499|FG001|COMPLETED|First Intervention (Visit 3 to Visit 4)||11||
48364326|NCT00739297|101220500|FG002|COMPLETED|First Intervention (Visit 3 to Visit 4)||6||
48364327|NCT00739297|101220501|FG003|COMPLETED|First Intervention (Visit 3 to Visit 4)||19||
48364328|NCT00739297|101220502|FG004|COMPLETED|First Intervention (Visit 3 to Visit 4)||6||
48364329|NCT00739297|101220503|FG005|COMPLETED|First Intervention (Visit 3 to Visit 4)||9||
48364330|NCT00739297|101220504|FG006|COMPLETED|First Intervention (Visit 3 to Visit 4)||68||
48364331|NCT00739297|101220498|FG000|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0||
48364332|NCT00739297|101220499|FG001|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0||
48364333|NCT00739297|101220500|FG002|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0||
48364334|NCT00739297|101220501|FG003|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0||
48364335|NCT00739297|101220502|FG004|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0||
48364336|NCT00739297|101220503|FG005|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0||
48364337|NCT00739297|101220504|FG006|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0||
48364338|NCT00739297|101220498|FG000|STARTED|First Washout Period of 4-7 Days||17||
48364339|NCT00739297|101220499|FG001|STARTED|First Washout Period of 4-7 Days||11||
48364340|NCT00739297|101220500|FG002|STARTED|First Washout Period of 4-7 Days||6||
48364341|NCT00739297|101220501|FG003|STARTED|First Washout Period of 4-7 Days||19||
48364342|NCT00739297|101220502|FG004|STARTED|First Washout Period of 4-7 Days||6||
48364343|NCT00739297|101220503|FG005|STARTED|First Washout Period of 4-7 Days||9||
48364344|NCT00739297|101220504|FG006|STARTED|First Washout Period of 4-7 Days||68||
48364345|NCT00739297|101220498|FG000|COMPLETED|First Washout Period of 4-7 Days||17||
48364346|NCT00739297|101220499|FG001|COMPLETED|First Washout Period of 4-7 Days||11||
48364347|NCT00739297|101220500|FG002|COMPLETED|First Washout Period of 4-7 Days||6||
48364348|NCT00739297|101220501|FG003|COMPLETED|First Washout Period of 4-7 Days||17||
48364349|NCT00739297|101220502|FG004|COMPLETED|First Washout Period of 4-7 Days||6||
48364350|NCT00739297|101220503|FG005|COMPLETED|First Washout Period of 4-7 Days||9||
48364351|NCT00739297|101220504|FG006|COMPLETED|First Washout Period of 4-7 Days||66||
48364352|NCT00739297|101220498|FG000|NOT COMPLETED|First Washout Period of 4-7 Days||0||
48364353|NCT00739297|101220499|FG001|NOT COMPLETED|First Washout Period of 4-7 Days||0||
48364354|NCT00739297|101220500|FG002|NOT COMPLETED|First Washout Period of 4-7 Days||0||
48364355|NCT00739297|101220501|FG003|NOT COMPLETED|First Washout Period of 4-7 Days||2||
48364356|NCT00739297|101220502|FG004|NOT COMPLETED|First Washout Period of 4-7 Days||0||
48364357|NCT00739297|101220503|FG005|NOT COMPLETED|First Washout Period of 4-7 Days||0||
48364358|NCT00739297|101220504|FG006|NOT COMPLETED|First Washout Period of 4-7 Days||2||
48364359|NCT00739297|101220498|FG000|STARTED|Second Intervention (Visit 5 to Visit 6)||18||
48364360|NCT00739297|101220499|FG001|STARTED|Second Intervention (Visit 5 to Visit 6)||8||
48364361|NCT00739297|101220500|FG002|STARTED|Second Intervention (Visit 5 to Visit 6)||10||
48364362|NCT00739297|101220501|FG003|STARTED|Second Intervention (Visit 5 to Visit 6)||14||
48364363|NCT00739297|101220502|FG004|STARTED|Second Intervention (Visit 5 to Visit 6)||6||
48654803|NCT03737994|101941109|FG000|STARTED|Overall Study||3||
48364364|NCT00739297|101220503|FG005|STARTED|Second Intervention (Visit 5 to Visit 6)||10||
48364365|NCT00739297|101220504|FG006|STARTED|Second Intervention (Visit 5 to Visit 6)||66||
48364366|NCT00739297|101220498|FG000|COMPLETED|Second Intervention (Visit 5 to Visit 6)||18||
48364367|NCT00739297|101220499|FG001|COMPLETED|Second Intervention (Visit 5 to Visit 6)||8||
48364368|NCT00739297|101220500|FG002|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10||
48364369|NCT00739297|101220501|FG003|COMPLETED|Second Intervention (Visit 5 to Visit 6)||14||
48654804|NCT03737994|101941110|FG001|STARTED|Overall Study||1||
48364370|NCT00739297|101220502|FG004|COMPLETED|Second Intervention (Visit 5 to Visit 6)||6||
48364371|NCT00739297|101220503|FG005|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10||
48364372|NCT00739297|101220504|FG006|COMPLETED|Second Intervention (Visit 5 to Visit 6)||66||
48364373|NCT00739297|101220498|FG000|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0||
48364374|NCT00739297|101220499|FG001|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0||
48364375|NCT00739297|101220500|FG002|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0||
48364376|NCT00739297|101220501|FG003|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0||
48364377|NCT00739297|101220502|FG004|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0||
48364378|NCT00739297|101220503|FG005|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0||
48364379|NCT00739297|101220504|FG006|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0||
48364380|NCT00739297|101220498|FG000|STARTED|Second Washout Period of 4-7 Days||18||
48364381|NCT00739297|101220499|FG001|STARTED|Second Washout Period of 4-7 Days||8||
48364382|NCT00739297|101220500|FG002|STARTED|Second Washout Period of 4-7 Days||10||
48364383|NCT00739297|101220501|FG003|STARTED|Second Washout Period of 4-7 Days||14||
48364384|NCT00739297|101220502|FG004|STARTED|Second Washout Period of 4-7 Days||6||
48364385|NCT00739297|101220503|FG005|STARTED|Second Washout Period of 4-7 Days||10||
48364386|NCT00739297|101220504|FG006|STARTED|Second Washout Period of 4-7 Days||66||
48364387|NCT00739297|101220498|FG000|COMPLETED|Second Washout Period of 4-7 Days||18||
48364388|NCT00739297|101220499|FG001|COMPLETED|Second Washout Period of 4-7 Days||8||
48364389|NCT00739297|101220500|FG002|COMPLETED|Second Washout Period of 4-7 Days||10||
48364390|NCT00739297|101220501|FG003|COMPLETED|Second Washout Period of 4-7 Days||14||
48364391|NCT00739297|101220502|FG004|COMPLETED|Second Washout Period of 4-7 Days||6||
48364392|NCT00739297|101220503|FG005|COMPLETED|Second Washout Period of 4-7 Days||10||
48364393|NCT00739297|101220504|FG006|COMPLETED|Second Washout Period of 4-7 Days||66||
48364394|NCT00739297|101220498|FG000|NOT COMPLETED|Second Washout Period of 4-7 Days||0||
48364395|NCT00739297|101220499|FG001|NOT COMPLETED|Second Washout Period of 4-7 Days||0||
48364396|NCT00739297|101220500|FG002|NOT COMPLETED|Second Washout Period of 4-7 Days||0||
48364397|NCT00739297|101220501|FG003|NOT COMPLETED|Second Washout Period of 4-7 Days||0||
48364398|NCT00739297|101220502|FG004|NOT COMPLETED|Second Washout Period of 4-7 Days||0||
48364399|NCT00739297|101220503|FG005|NOT COMPLETED|Second Washout Period of 4-7 Days||0||
48364400|NCT00739297|101220504|FG006|NOT COMPLETED|Second Washout Period of 4-7 Days||0||
48364401|NCT00739297|101220498|FG000|STARTED|Third Intervention (Visit 7 to Visit 8)||16||
48364402|NCT00739297|101220499|FG001|STARTED|Third Intervention (Visit 7 to Visit 8)||12||
48364403|NCT00739297|101220500|FG002|STARTED|Third Intervention (Visit 7 to Visit 8)||6||
48364404|NCT00739297|101220501|FG003|STARTED|Third Intervention (Visit 7 to Visit 8)||18||
48364405|NCT00739297|101220502|FG004|STARTED|Third Intervention (Visit 7 to Visit 8)||6||
48364406|NCT00739297|101220503|FG005|STARTED|Third Intervention (Visit 7 to Visit 8)||8||
48364407|NCT00739297|101220504|FG006|STARTED|Third Intervention (Visit 7 to Visit 8)||66||
48364408|NCT00739297|101220498|FG000|COMPLETED|Third Intervention (Visit 7 to Visit 8)||16||
48364409|NCT00739297|101220499|FG001|COMPLETED|Third Intervention (Visit 7 to Visit 8)||12||
48364410|NCT00739297|101220500|FG002|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6||
48364411|NCT00739297|101220501|FG003|COMPLETED|Third Intervention (Visit 7 to Visit 8)||18||
48364412|NCT00739297|101220502|FG004|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6||
48364413|NCT00739297|101220503|FG005|COMPLETED|Third Intervention (Visit 7 to Visit 8)||8||
48364414|NCT00739297|101220504|FG006|COMPLETED|Third Intervention (Visit 7 to Visit 8)||66||
48364415|NCT00739297|101220498|FG000|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0||
48364416|NCT00739297|101220499|FG001|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0||
48364417|NCT00739297|101220500|FG002|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0||
48364418|NCT00739297|101220501|FG003|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0||
48364419|NCT00739297|101220502|FG004|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0||
48364420|NCT00739297|101220503|FG005|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0||
48364421|NCT00739297|101220504|FG006|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0||
48364422|NCT00739297|101220498|FG000|STARTED|Third Washout Period of 4-7 Days||16||
48364423|NCT00739297|101220499|FG001|STARTED|Third Washout Period of 4-7 Days||12||
48364424|NCT00739297|101220500|FG002|STARTED|Third Washout Period of 4-7 Days||6||
48364425|NCT00739297|101220501|FG003|STARTED|Third Washout Period of 4-7 Days||18||
48364426|NCT00739297|101220502|FG004|STARTED|Third Washout Period of 4-7 Days||6||
48364427|NCT00739297|101220503|FG005|STARTED|Third Washout Period of 4-7 Days||8||
48364428|NCT00739297|101220504|FG006|STARTED|Third Washout Period of 4-7 Days||66||
48364429|NCT00739297|101220498|FG000|COMPLETED|Third Washout Period of 4-7 Days||16||
48364430|NCT00739297|101220499|FG001|COMPLETED|Third Washout Period of 4-7 Days||12||
48364431|NCT00739297|101220500|FG002|COMPLETED|Third Washout Period of 4-7 Days||6||
48364432|NCT00739297|101220501|FG003|COMPLETED|Third Washout Period of 4-7 Days||18||
48364433|NCT00739297|101220502|FG004|COMPLETED|Third Washout Period of 4-7 Days||6||
48364434|NCT00739297|101220503|FG005|COMPLETED|Third Washout Period of 4-7 Days||8||
48364435|NCT00739297|101220504|FG006|COMPLETED|Third Washout Period of 4-7 Days||66||
48364436|NCT00739297|101220498|FG000|NOT COMPLETED|Third Washout Period of 4-7 Days||0||
48364437|NCT00739297|101220499|FG001|NOT COMPLETED|Third Washout Period of 4-7 Days||0||
48364438|NCT00739297|101220500|FG002|NOT COMPLETED|Third Washout Period of 4-7 Days||0||
48436535|NCT00029107|101403571|FG001|NOT COMPLETED|Overall Study||0||
48364439|NCT00739297|101220501|FG003|NOT COMPLETED|Third Washout Period of 4-7 Days||0||
48364440|NCT00739297|101220502|FG004|NOT COMPLETED|Third Washout Period of 4-7 Days||0||
48364441|NCT00739297|101220503|FG005|NOT COMPLETED|Third Washout Period of 4-7 Days||0||
48364442|NCT00739297|101220504|FG006|NOT COMPLETED|Third Washout Period of 4-7 Days||0||
48364443|NCT00739297|101220498|FG000|STARTED|Fourth Intervention(Visit 9 to Visit 10)||16||
48364444|NCT00739297|101220499|FG001|STARTED|Fourth Intervention(Visit 9 to Visit 10)||11||
48364445|NCT00739297|101220500|FG002|STARTED|Fourth Intervention(Visit 9 to Visit 10)||8||
48364446|NCT00739297|101220501|FG003|STARTED|Fourth Intervention(Visit 9 to Visit 10)||15||
48364447|NCT00739297|101220502|FG004|STARTED|Fourth Intervention(Visit 9 to Visit 10)||7||
48364448|NCT00739297|101220503|FG005|STARTED|Fourth Intervention(Visit 9 to Visit 10)||9||
48364449|NCT00739297|101220504|FG006|STARTED|Fourth Intervention(Visit 9 to Visit 10)||66||
48364450|NCT00739297|101220498|FG000|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||16||
48364451|NCT00739297|101220499|FG001|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||11||
48364452|NCT00739297|101220500|FG002|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8||
48364453|NCT00739297|101220501|FG003|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||15||
48364454|NCT00739297|101220502|FG004|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||7||
48364455|NCT00739297|101220503|FG005|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8||
48364456|NCT00739297|101220504|FG006|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||65||
48364457|NCT00739297|101220498|FG000|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0||
48364458|NCT00739297|101220499|FG001|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0||
48364459|NCT00739297|101220500|FG002|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0||
48364460|NCT00739297|101220501|FG003|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0||
48364461|NCT00739297|101220502|FG004|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0||
48364462|NCT00739297|101220503|FG005|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1||
48364463|NCT00739297|101220504|FG006|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1||
48364464|NCT02495077|101220505|FG000|STARTED|Overall Study||113||
48364465|NCT02495077|101220506|FG001|STARTED|Overall Study||112||
48364466|NCT02495077|101220507|FG002|STARTED|Overall Study||17||
48364467|NCT02495077|101220508|FG003|STARTED|Overall Study||48||
48364468|NCT02495077|101220505|FG000|COMPLETED|Overall Study||93||
48364469|NCT02495077|101220506|FG001|COMPLETED|Overall Study||91||
48364470|NCT02495077|101220507|FG002|COMPLETED|Overall Study||0||
48364471|NCT02495077|101220508|FG003|COMPLETED|Overall Study||0||
48364472|NCT02495077|101220505|FG000|NOT COMPLETED|Overall Study||20||
48364473|NCT02495077|101220506|FG001|NOT COMPLETED|Overall Study||21||
48364474|NCT02495077|101220507|FG002|NOT COMPLETED|Overall Study||17||
48364475|NCT02495077|101220508|FG003|NOT COMPLETED|Overall Study||48||
48364476|NCT04109443|101220509|FG000|STARTED|Overall Study||77||
48364477|NCT04109443|101220510|FG001|STARTED|Overall Study||77||
48364478|NCT04109443|101220509|FG000|COMPLETED|Overall Study||67||
48364479|NCT04109443|101220510|FG001|COMPLETED|Overall Study||65||
48364480|NCT04109443|101220509|FG000|NOT COMPLETED|Overall Study||10||
48364481|NCT04109443|101220510|FG001|NOT COMPLETED|Overall Study||12||
48364482|NCT01438710|101220511|FG000|STARTED|First Week of Treatment||0||
48364483|NCT01438710|101220512|FG001|STARTED|First Week of Treatment||44||
48364484|NCT01438710|101220511|FG000|COMPLETED|First Week of Treatment||0||
48364485|NCT01438710|101220512|FG001|COMPLETED|First Week of Treatment||41||
48364486|NCT01438710|101220511|FG000|NOT COMPLETED|First Week of Treatment||0||
48364487|NCT01438710|101220512|FG001|NOT COMPLETED|First Week of Treatment||3||
48364488|NCT01438710|101220511|FG000|STARTED|Second Week of Treatment||41||
48364489|NCT01438710|101220512|FG001|STARTED|Second Week of Treatment||0||
48364490|NCT01438710|101220511|FG000|COMPLETED|Second Week of Treatment||40||
48364491|NCT01438710|101220512|FG001|COMPLETED|Second Week of Treatment||0||
48364492|NCT01438710|101220511|FG000|NOT COMPLETED|Second Week of Treatment||1||
48364493|NCT01438710|101220512|FG001|NOT COMPLETED|Second Week of Treatment||0||
48364494|NCT00430781|101220513|FG000|STARTED|Interim Analysis; 11 February 2008||59||
48364495|NCT00430781|101220514|FG001|STARTED|Interim Analysis; 11 February 2008||58||
48364496|NCT00430781|101220515|FG002|STARTED|Interim Analysis; 11 February 2008||60||
48364497|NCT00430781|101220513|FG000|Ongoing|Interim Analysis; 11 February 2008||23||
48364498|NCT00430781|101220514|FG001|Ongoing|Interim Analysis; 11 February 2008||20||
48364499|NCT00430781|101220515|FG002|Ongoing|Interim Analysis; 11 February 2008||25||
48364500|NCT00430781|101220513|FG000|COMPLETED|Interim Analysis; 11 February 2008||0||
48364501|NCT00430781|101220514|FG001|COMPLETED|Interim Analysis; 11 February 2008||0||
48364502|NCT00430781|101220515|FG002|COMPLETED|Interim Analysis; 11 February 2008||0||
48364503|NCT00430781|101220513|FG000|NOT COMPLETED|Interim Analysis; 11 February 2008||59||
48364504|NCT00430781|101220514|FG001|NOT COMPLETED|Interim Analysis; 11 February 2008||58||
48364505|NCT00430781|101220515|FG002|NOT COMPLETED|Interim Analysis; 11 February 2008||60||
48364506|NCT00430781|101220513|FG000|STARTED|Final Analysis; 31 July 2008||0||
48364507|NCT00430781|101220514|FG001|STARTED|Final Analysis; 31 July 2008||78||
48364508|NCT00430781|101220515|FG002|STARTED|Final Analysis; 31 July 2008||74||
48364509|NCT00430781|101220513|FG000|Ongoing|Final Analysis; 31 July 2008||0||
48364510|NCT00430781|101220514|FG001|Ongoing|Final Analysis; 31 July 2008||29||
48364511|NCT00430781|101220515|FG002|Ongoing|Final Analysis; 31 July 2008||32||
48364512|NCT00430781|101220513|FG000|COMPLETED|Final Analysis; 31 July 2008||0||
48364513|NCT00430781|101220514|FG001|COMPLETED|Final Analysis; 31 July 2008||39||
48364514|NCT00430781|101220515|FG002|COMPLETED|Final Analysis; 31 July 2008||26||
48364515|NCT00430781|101220513|FG000|NOT COMPLETED|Final Analysis; 31 July 2008||0||
48364516|NCT00430781|101220514|FG001|NOT COMPLETED|Final Analysis; 31 July 2008||39||
48364517|NCT00430781|101220515|FG002|NOT COMPLETED|Final Analysis; 31 July 2008||48||
48364518|NCT00430781|101220513|FG000|STARTED|End-of-Study Analysis; 28 July 2011||77||
48364519|NCT00430781|101220514|FG001|STARTED|End-of-Study Analysis; 28 July 2011||77||
48364520|NCT00430781|101220515|FG002|STARTED|End-of-Study Analysis; 28 July 2011||74||
48364521|NCT00430781|101220513|FG000|COMPLETED|End-of-Study Analysis; 28 July 2011||53||
48364522|NCT00430781|101220514|FG001|COMPLETED|End-of-Study Analysis; 28 July 2011||59||
48364523|NCT00430781|101220515|FG002|COMPLETED|End-of-Study Analysis; 28 July 2011||54||
48364524|NCT00430781|101220513|FG000|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||24||
48364525|NCT00430781|101220514|FG001|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||18||
48364526|NCT00430781|101220515|FG002|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||20||
48364527|NCT00616239|101220516|FG000|STARTED|Overall Study||20||
48364528|NCT00616239|101220516|FG000|COMPLETED|Overall Study||18||
48364529|NCT00616239|101220516|FG000|NOT COMPLETED|Overall Study||2||
48364530|NCT03090191|101220517|FG000|STARTED|Overall Study||8766||
48364531|NCT03090191|101220518|FG001|STARTED|Overall Study||8769||
48364532|NCT03090191|101220517|FG000|Vaccinated at Month 0 (Dose 1)|Overall Study||8723|Among 8766 participants randomized to Clostridium difficile vaccine(Cdif.vac)group(grp),8723 received first dose, 8769 randomized to placebo grp,8717 received first dose. But 2 participants in Cdif.vac grp received placebo,1 participant in placebo grp received Cdif.vac for first dose.So, 8722 received Cdif.vac, 8718 received placebo for first dose. 8722 and 8718=participants in baseline characteristics, safety data summaries since safety population based on actual vaccine received at first dose.|
48364533|NCT03090191|101220518|FG001|Vaccinated at Month 0 (Dose 1)|Overall Study||8717|Among 8766 participants randomized to Clostridium difficile vaccine(Cdif.vac)group(grp),8723 received first dose, 8769 randomized to placebo grp,8717 received first dose. But 2 participants in Cdif.vac grp received placebo,1 participant in placebo grp received Cdif.vac for first dose.So, 8722 received Cdif.vac, 8718 received placebo for first dose. 8722 and 8718=participants in baseline characteristics, safety data summaries since safety population based on actual vaccine received at first dose.|
48364534|NCT03090191|101220517|FG000|Received Clostridium Difficile Vaccine|Overall Study||8721||
48364535|NCT03090191|101220518|FG001|Received Clostridium Difficile Vaccine|Overall Study||1||
48364536|NCT03090191|101220517|FG000|Received Placebo|Overall Study||2||
48364537|NCT03090191|101220518|FG001|Received Placebo|Overall Study||8716||
48364538|NCT03090191|101220517|FG000|Vaccinated at Month 1 (Dose 2)|Overall Study||8311||
48364539|NCT03090191|101220518|FG001|Vaccinated at Month 1 (Dose 2)|Overall Study||8331||
48364540|NCT03090191|101220517|FG000|Received Clostridium Difficile Vaccine|Overall Study||8310||
48364541|NCT03090191|101220518|FG001|Received Clostridium Difficile Vaccine|Overall Study||0||
48364542|NCT03090191|101220517|FG000|Received Placebo|Overall Study||1||
48364543|NCT03090191|101220518|FG001|Received Placebo|Overall Study||8331||
48364544|NCT03090191|101220517|FG000|Vaccinated at Month 6 (Dose 3)|Overall Study||7894||
48364545|NCT03090191|101220518|FG001|Vaccinated at Month 6 (Dose 3)|Overall Study||7967||
48364546|NCT03090191|101220517|FG000|Received Clostridium Difficile Vaccine|Overall Study||7894||
48364547|NCT03090191|101220518|FG001|Received Clostridium Difficile Vaccine|Overall Study||0||
48364548|NCT03090191|101220517|FG000|Received Placebo|Overall Study||0||
48364549|NCT03090191|101220518|FG001|Received Placebo|Overall Study||7967||
48364550|NCT03090191|101220517|FG000|COMPLETED|Overall Study||5533||
48188295|NCT01072929|100783207|FG001|COMPLETED|Overall Study||150||
48364551|NCT03090191|101220518|FG001|COMPLETED|Overall Study||5574||
48364552|NCT03090191|101220517|FG000|NOT COMPLETED|Overall Study||3233||
48364553|NCT03090191|101220518|FG001|NOT COMPLETED|Overall Study||3195||
48364554|NCT05207436|101220519|FG000|STARTED|Overall Study||20||
48364555|NCT05207436|101220519|FG000|COMPLETED|Overall Study||18||
48364556|NCT05207436|101220519|FG000|NOT COMPLETED|Overall Study||2||
48364557|NCT00530712|101220520|FG000|STARTED|Enrollment||287||
48364558|NCT00530712|101220520|FG000|COMPLETED|Enrollment||287||
48436536|NCT00442572|101403572|FG000|STARTED|Overall Study||17||
48188296|NCT01072929|100783208|FG002|COMPLETED|Overall Study||24||
48364559|NCT00530712|101220520|FG000|NOT COMPLETED|Enrollment||0||
48364560|NCT00530712|101220520|FG000|STARTED|30 Day Follow-up Visit||287||
48364561|NCT00530712|101220520|FG000|COMPLETED|30 Day Follow-up Visit||280||
48364562|NCT00530712|101220520|FG000|NOT COMPLETED|30 Day Follow-up Visit||7||
48364563|NCT00530712|101220520|FG000|STARTED|6 Month Follow-up Visit||287||
48364564|NCT00530712|101220520|FG000|COMPLETED|6 Month Follow-up Visit||275||
48364565|NCT00530712|101220520|FG000|NOT COMPLETED|6 Month Follow-up Visit||12||
48364566|NCT00530712|101220520|FG000|STARTED|12 Month Follow-up Visit||287||
48364567|NCT00530712|101220520|FG000|COMPLETED|12 Month Follow-up Visit||263||
48364568|NCT00530712|101220520|FG000|NOT COMPLETED|12 Month Follow-up Visit||24||
48364569|NCT00370149|101220521|FG000|STARTED|Overall Study||165||
48364570|NCT00370149|101220522|FG001|STARTED|Overall Study||161||
48364571|NCT00370149|101220521|FG000|COMPLETED|Overall Study||146||
48364572|NCT00370149|101220522|FG001|COMPLETED|Overall Study||142||
48364573|NCT00370149|101220521|FG000|NOT COMPLETED|Overall Study||19||
48364574|NCT00370149|101220522|FG001|NOT COMPLETED|Overall Study||19||
48364575|NCT00942877|101220523|FG000|STARTED|Overall Study||46||
48364576|NCT00942877|101220524|FG001|STARTED|Overall Study||7||
48364577|NCT00942877|101220523|FG000|COMPLETED|Overall Study||1||
48364578|NCT00942877|101220524|FG001|COMPLETED|Overall Study||3||
48364579|NCT00942877|101220523|FG000|NOT COMPLETED|Overall Study||45||
48364580|NCT00942877|101220524|FG001|NOT COMPLETED|Overall Study||4||
48364581|NCT02225223|101220525|FG000|STARTED|Overall Study||27||
48364582|NCT02225223|101220526|FG001|STARTED|Overall Study||8||
48364583|NCT02225223|101220525|FG000|COMPLETED|Overall Study||8||
48364584|NCT02225223|101220526|FG001|COMPLETED|Overall Study||3||
48364585|NCT02225223|101220525|FG000|NOT COMPLETED|Overall Study||19||
48364586|NCT02225223|101220526|FG001|NOT COMPLETED|Overall Study||5||
48364587|NCT03418662|101220527|FG000|STARTED|Overall Study||287||
48364588|NCT03418662|101220528|FG001|STARTED|Overall Study||282||
48364589|NCT03418662|101220527|FG000|COMPLETED|Overall Study||284||
48364590|NCT03418662|101220528|FG001|COMPLETED|Overall Study||278||
48364591|NCT03418662|101220527|FG000|NOT COMPLETED|Overall Study||3||
48364592|NCT03418662|101220528|FG001|NOT COMPLETED|Overall Study||4||
48364593|NCT04156646|101220529|FG000|STARTED|Treatment Period 1 (6 Days)||8||
48364594|NCT04156646|101220530|FG001|STARTED|Treatment Period 1 (6 Days)||8||
48364595|NCT04156646|101220529|FG000|COMPLETED|Treatment Period 1 (6 Days)||8||
48364596|NCT04156646|101220530|FG001|COMPLETED|Treatment Period 1 (6 Days)||8||
48364597|NCT04156646|101220529|FG000|NOT COMPLETED|Treatment Period 1 (6 Days)||0||
48364598|NCT04156646|101220530|FG001|NOT COMPLETED|Treatment Period 1 (6 Days)||0||
48364599|NCT04156646|101220529|FG000|STARTED|Wash-out Period (12- to 21-days)||8||
48364600|NCT04156646|101220530|FG001|STARTED|Wash-out Period (12- to 21-days)||8||
48364601|NCT04156646|101220529|FG000|COMPLETED|Wash-out Period (12- to 21-days)||8||
48364602|NCT04156646|101220530|FG001|COMPLETED|Wash-out Period (12- to 21-days)||8||
48364603|NCT04156646|101220529|FG000|NOT COMPLETED|Wash-out Period (12- to 21-days)||0||
48364604|NCT04156646|101220530|FG001|NOT COMPLETED|Wash-out Period (12- to 21-days)||0||
48364605|NCT04156646|101220529|FG000|STARTED|Treatment Period 2 (6 Days)||8||
48364606|NCT04156646|101220530|FG001|STARTED|Treatment Period 2 (6 Days)||8||
48364607|NCT04156646|101220529|FG000|COMPLETED|Treatment Period 2 (6 Days)||8||
48364608|NCT04156646|101220530|FG001|COMPLETED|Treatment Period 2 (6 Days)||8||
48364609|NCT04156646|101220529|FG000|NOT COMPLETED|Treatment Period 2 (6 Days)||0||
48364610|NCT04156646|101220530|FG001|NOT COMPLETED|Treatment Period 2 (6 Days)||0||
48364611|NCT04156646|101220529|FG000|STARTED|Wash-out Period (12- to 21-days)||8||
48364612|NCT04156646|101220530|FG001|STARTED|Wash-out Period (12- to 21-days)||8||
48364613|NCT04156646|101220529|FG000|COMPLETED|Wash-out Period (12- to 21-days)||8||
48364614|NCT04156646|101220530|FG001|COMPLETED|Wash-out Period (12- to 21-days)||8||
48364615|NCT04156646|101220529|FG000|NOT COMPLETED|Wash-out Period (12- to 21-days)||0||
48364616|NCT04156646|101220530|FG001|NOT COMPLETED|Wash-out Period (12- to 21-days)||0||
48364617|NCT04156646|101220529|FG000|STARTED|Treatment Period 3 (6 Days)||8||
48364618|NCT04156646|101220530|FG001|STARTED|Treatment Period 3 (6 Days)||8||
48364619|NCT04156646|101220529|FG000|COMPLETED|Treatment Period 3 (6 Days)||8||
48364620|NCT04156646|101220530|FG001|COMPLETED|Treatment Period 3 (6 Days)||7||
48364621|NCT04156646|101220529|FG000|NOT COMPLETED|Treatment Period 3 (6 Days)||0||
48364622|NCT04156646|101220530|FG001|NOT COMPLETED|Treatment Period 3 (6 Days)||1||
48364623|NCT03290300|101220531|FG000|STARTED|Overall Study||39||
48364624|NCT03290300|101220531|FG000|COMPLETED|Overall Study||36||
48364625|NCT03290300|101220531|FG000|NOT COMPLETED|Overall Study||3||
48364626|NCT02046564|101220532|FG000|STARTED|Overall Study||209||
48364627|NCT02046564|101220533|FG001|STARTED|Overall Study||203||
48364628|NCT02046564|101220532|FG000|COMPLETED|Overall Study||194||
48364629|NCT02046564|101220533|FG001|COMPLETED|Overall Study||183||
48364630|NCT02046564|101220532|FG000|NOT COMPLETED|Overall Study||15||
48364631|NCT02046564|101220533|FG001|NOT COMPLETED|Overall Study||20||
48364632|NCT00723840|101220534|FG000|STARTED|Overall Study||245||
48364633|NCT00723840|101220534|FG000|COMPLETED|Overall Study||163||
48364634|NCT00723840|101220534|FG000|NOT COMPLETED|Overall Study||82||
48364635|NCT02927171|101220535|FG000|STARTED|Overall Study||53||
48364636|NCT02927171|101220536|FG001|STARTED|Overall Study||51||
48364637|NCT02927171|101220535|FG000|COMPLETED|Overall Study||53||
48364638|NCT02927171|101220536|FG001|COMPLETED|Overall Study||50||
48364639|NCT02927171|101220535|FG000|NOT COMPLETED|Overall Study||0||
48364640|NCT02927171|101220536|FG001|NOT COMPLETED|Overall Study||1||
48364641|NCT00791128|101220537|FG000|STARTED|Overall Study||22||
48364642|NCT00791128|101220537|FG000|COMPLETED|Overall Study||13||
48436537|NCT00442572|101403573|FG001|STARTED|Overall Study||4||
48364643|NCT00791128|101220537|FG000|NOT COMPLETED|Overall Study||9||
48364644|NCT01732263|101220538|FG000|STARTED|Overall Study||23||
48364645|NCT01732263|101220539|FG001|STARTED|Overall Study||20||
48364646|NCT01732263|101220538|FG000|COMPLETED|Overall Study||23||
48364647|NCT01732263|101220539|FG001|COMPLETED|Overall Study||20||
48364648|NCT01732263|101220538|FG000|NOT COMPLETED|Overall Study||0||
48364649|NCT01732263|101220539|FG001|NOT COMPLETED|Overall Study||0||
48364650|NCT01221233|101220540|FG000|STARTED|Overall Study||18||
48364651|NCT01221233|101220541|FG001|STARTED|Overall Study||20||
48364652|NCT01221233|101220540|FG000|COMPLETED|Overall Study||15||
48364653|NCT01221233|101220541|FG001|COMPLETED|Overall Study||19||
48364654|NCT01221233|101220540|FG000|NOT COMPLETED|Overall Study||3||
48364655|NCT01221233|101220541|FG001|NOT COMPLETED|Overall Study||1||
48364656|NCT05032157|101220542|FG000|STARTED|Overall Study||300|All randomized patients, regardless of whether or not they received a dose of study drug.|
48364657|NCT05032157|101220543|FG001|STARTED|Overall Study||155|All randomized patients, regardless of whether or not they received a dose of study drug.|
48364658|NCT05032157|101220542|FG000|Full Analysis Set (FAS)|Overall Study||297|All patients to whom study treatment was assigned by randomization. Mis-randomized patients were excluded from FAS.|
48364659|NCT05032157|101220543|FG001|Full Analysis Set (FAS)|Overall Study||153|All patients to whom study treatment was assigned by randomization. Mis-randomized patients were excluded from FAS.|
48364660|NCT05032157|101220542|FG000|Safety Set (SAF)|Overall Study||297|All patients who received at least one dose of study treatment, whether or not randomized.|
48364661|NCT05032157|101220543|FG001|Safety Set (SAF)|Overall Study||153|All patients who received at least one dose of study treatment, whether or not randomized.|
48364662|NCT05032157|101220542|FG000|COMPLETED|Overall Study||230||
48364663|NCT05032157|101220543|FG001|COMPLETED|Overall Study||111||
48364664|NCT05032157|101220542|FG000|NOT COMPLETED|Overall Study||70||
48364665|NCT05032157|101220543|FG001|NOT COMPLETED|Overall Study||44||
48364666|NCT02392208|101220544|FG000|STARTED|Telavancin Before Hemodialysis||8||
48364667|NCT02392208|101220544|FG000|COMPLETED|Telavancin Before Hemodialysis||8||
48364668|NCT02392208|101220544|FG000|NOT COMPLETED|Telavancin Before Hemodialysis||0||
48364669|NCT02392208|101220544|FG000|STARTED|Telavancin After Hemodialysis||8||
48364670|NCT02392208|101220544|FG000|COMPLETED|Telavancin After Hemodialysis||8||
48364671|NCT02392208|101220544|FG000|NOT COMPLETED|Telavancin After Hemodialysis||0||
48364672|NCT04064684|101220545|FG000|STARTED|Overall Study||1||
48364673|NCT04064684|101220546|FG001|STARTED|Overall Study||1||
48364674|NCT04064684|101220545|FG000|COMPLETED|Overall Study||1||
48364675|NCT04064684|101220546|FG001|COMPLETED|Overall Study||1||
48364676|NCT04064684|101220545|FG000|NOT COMPLETED|Overall Study||0||
48364677|NCT04064684|101220546|FG001|NOT COMPLETED|Overall Study||0||
48364678|NCT00950352|101220547|FG000|STARTED|Overall Study||72||
48364679|NCT00950352|101220548|FG001|STARTED|Overall Study||32||
48364680|NCT00950352|101220547|FG000|COMPLETED|Overall Study||30||
48364681|NCT00950352|101220548|FG001|COMPLETED|Overall Study||21||
48364682|NCT00950352|101220547|FG000|NOT COMPLETED|Overall Study||42||
48364683|NCT00950352|101220548|FG001|NOT COMPLETED|Overall Study||11||
48364684|NCT04952389|101220549|FG000|STARTED|Overall Study||15||
48364685|NCT04952389|101220550|FG001|STARTED|Overall Study||15||
48364686|NCT04952389|101220549|FG000|COMPLETED|Overall Study||7||
48364687|NCT04952389|101220550|FG001|COMPLETED|Overall Study||11||
48364688|NCT04952389|101220549|FG000|NOT COMPLETED|Overall Study||8||
48364689|NCT04952389|101220550|FG001|NOT COMPLETED|Overall Study||4||
48364690|NCT03851744|101220551|FG000|STARTED|Overall Study||4||
48364691|NCT03851744|101220552|FG001|STARTED|Overall Study||6||
48364692|NCT03851744|101220551|FG000|COMPLETED|Overall Study||4||
48364693|NCT03851744|101220552|FG001|COMPLETED|Overall Study||4||
48364694|NCT03851744|101220551|FG000|NOT COMPLETED|Overall Study||0||
48364695|NCT03851744|101220552|FG001|NOT COMPLETED|Overall Study||2||
48364696|NCT01978912|101220553|FG000|STARTED|Overall Study||6||
48364697|NCT01978912|101220554|FG001|STARTED|Overall Study||6||
48765732|NCT02059278|102214710|FG001|STARTED|Overall Study||170||
48765733|NCT02059278|102214709|FG000|COMPLETED|Overall Study||162||
48765734|NCT02059278|102214710|FG001|COMPLETED|Overall Study||166||
48765735|NCT02059278|102214709|FG000|NOT COMPLETED|Overall Study||3||
48765736|NCT02059278|102214710|FG001|NOT COMPLETED|Overall Study||4||
48765737|NCT02191111|102214711|FG000|STARTED|Overall Study||0||5
48765738|NCT02191111|102214712|FG001|STARTED|Overall Study||0||5
48765739|NCT02191111|102214711|FG000|COMPLETED|Overall Study||0||5
48765740|NCT02191111|102214712|FG001|COMPLETED|Overall Study||0||5
48765741|NCT02191111|102214711|FG000|NOT COMPLETED|Overall Study||0||0
48765742|NCT02191111|102214712|FG001|NOT COMPLETED|Overall Study||0||0
48765743|NCT01615939|102214713|FG000|STARTED|Overall Study||13||
48765744|NCT01615939|102214714|FG001|STARTED|Overall Study||4||
48765745|NCT01615939|102214713|FG000|COMPLETED|Overall Study||8||
48765746|NCT01615939|102214714|FG001|COMPLETED|Overall Study||4||
48765747|NCT01615939|102214713|FG000|NOT COMPLETED|Overall Study||5||
48765748|NCT01615939|102214714|FG001|NOT COMPLETED|Overall Study||0||
48765749|NCT01910298|102214715|FG000|STARTED|Overall Study||76||
48765750|NCT01910298|102214716|FG001|STARTED|Overall Study||55||
48765751|NCT01910298|102214715|FG000|Safety Set|Overall Study||76||
48364698|NCT01978912|101220555|FG002|STARTED|Overall Study||6||
48364699|NCT01978912|101220556|FG003|STARTED|Overall Study||6||
48364700|NCT01978912|101220553|FG000|COMPLETED|Overall Study||3||
48364701|NCT01978912|101220554|FG001|COMPLETED|Overall Study||3||
48364702|NCT01978912|101220555|FG002|COMPLETED|Overall Study||3||
48364703|NCT01978912|101220556|FG003|COMPLETED|Overall Study||3||
48364704|NCT01978912|101220553|FG000|NOT COMPLETED|Overall Study||3||
48364705|NCT01978912|101220554|FG001|NOT COMPLETED|Overall Study||3||
48364706|NCT01978912|101220555|FG002|NOT COMPLETED|Overall Study||3||
48364707|NCT01978912|101220556|FG003|NOT COMPLETED|Overall Study||3||
48765752|NCT01910298|102214716|FG001|Safety Set|Overall Study||51||
48765753|NCT01910298|102214715|FG000|COMPLETED|Overall Study||71||
48765754|NCT01910298|102214716|FG001|COMPLETED|Overall Study||23||
48765755|NCT01910298|102214715|FG000|NOT COMPLETED|Overall Study||5||
48765756|NCT01910298|102214716|FG001|NOT COMPLETED|Overall Study||32||
48765757|NCT02383576|102214717|FG000|STARTED|Overall Study||94||
48765758|NCT02383576|102214718|FG001|STARTED|Overall Study||91||
48765759|NCT02383576|102214717|FG000|COMPLETED|Overall Study||31||
48765760|NCT02383576|102214718|FG001|COMPLETED|Overall Study||46||
48765761|NCT02383576|102214717|FG000|NOT COMPLETED|Overall Study||63||
48765762|NCT02383576|102214718|FG001|NOT COMPLETED|Overall Study||45||
48364708|NCT01413178|101220557|FG000|STARTED|Overall Study||105||
48364709|NCT01413178|101220558|FG001|STARTED|Overall Study||100||
48364710|NCT01413178|101220557|FG000|COMPLETED|Overall Study||104||
48364711|NCT01413178|101220558|FG001|COMPLETED|Overall Study||98||
48364712|NCT01413178|101220557|FG000|NOT COMPLETED|Overall Study||1||
48364713|NCT01413178|101220558|FG001|NOT COMPLETED|Overall Study||2||
48765763|NCT00812708|102214719|FG000|STARTED|Overall Study||72||
48765764|NCT00812708|102214719|FG000|Taken to Surgery for Device Implantation|Overall Study||66||
48765765|NCT00812708|102214719|FG000|COMPLETED|Overall Study||64||
48188297|NCT01072929|100783206|FG000|NOT COMPLETED|Overall Study||44||
48364714|NCT01512368|101220559|FG000|STARTED|Overall Study||63||
48364715|NCT01512368|101220559|FG000|COMPLETED|Overall Study||60||
48364716|NCT01512368|101220559|FG000|NOT COMPLETED|Overall Study||3||
48364717|NCT00492401|101220560|FG000|STARTED|Overall Study||55||
48364718|NCT00492401|101220560|FG000|COMPLETED|Overall Study||55||
48364719|NCT00492401|101220560|FG000|NOT COMPLETED|Overall Study||0||
48364720|NCT01731691|101220561|FG000|STARTED|Overall Study||3||
48364721|NCT01731691|101220562|FG001|STARTED|Overall Study||5||
48364722|NCT01731691|101220563|FG002|STARTED|Overall Study||4||
48364723|NCT01731691|101220561|FG000|COMPLETED|Overall Study||3||
48364724|NCT01731691|101220562|FG001|COMPLETED|Overall Study||5||
48364725|NCT01731691|101220563|FG002|COMPLETED|Overall Study||4||
48364726|NCT01731691|101220561|FG000|NOT COMPLETED|Overall Study||0||
48364727|NCT01731691|101220562|FG001|NOT COMPLETED|Overall Study||0||
48364728|NCT01731691|101220563|FG002|NOT COMPLETED|Overall Study||0||
48364729|NCT02760407|101220564|FG000|STARTED|Overall Study||479||
48364730|NCT02760407|101220565|FG001|STARTED|Overall Study||464||
48364731|NCT02760407|101220566|FG002|STARTED|Overall Study||462||
48364732|NCT02760407|101220567|FG003|STARTED|Overall Study||243||
48364733|NCT02760407|101220564|FG000|COMPLETED|Overall Study||443||
48364734|NCT02760407|101220565|FG001|COMPLETED|Overall Study||421||
48364735|NCT02760407|101220566|FG002|COMPLETED|Overall Study||412||
48364736|NCT02760407|101220567|FG003|COMPLETED|Overall Study||207||
48364737|NCT02760407|101220564|FG000|NOT COMPLETED|Overall Study||36||
48364738|NCT02760407|101220565|FG001|NOT COMPLETED|Overall Study||43||
48364739|NCT02760407|101220566|FG002|NOT COMPLETED|Overall Study||50||
48364740|NCT02760407|101220567|FG003|NOT COMPLETED|Overall Study||36||
48364741|NCT00751101|101220568|FG000|STARTED|Overall Study||12||
48364742|NCT00751101|101220569|FG001|STARTED|Overall Study||12||
48364743|NCT00751101|101220568|FG000|Started Capecitabine|Overall Study||11||
48364744|NCT00751101|101220569|FG001|Started Capecitabine|Overall Study||11||
48364745|NCT00751101|101220568|FG000|COMPLETED|Overall Study||10||
48364746|NCT00751101|101220569|FG001|COMPLETED|Overall Study||7||
48364747|NCT00751101|101220568|FG000|NOT COMPLETED|Overall Study||2||
48364748|NCT00751101|101220569|FG001|NOT COMPLETED|Overall Study||5||
48364749|NCT02983981|101220570|FG000|STARTED|Overall Study||20||
48364750|NCT02983981|101220570|FG000|COMPLETED|Overall Study||20||
48364751|NCT02983981|101220570|FG000|NOT COMPLETED|Overall Study||0||
48364752|NCT02740153|101220571|FG000|STARTED|Overall Study||101||
48765766|NCT00812708|102214719|FG000|NOT COMPLETED|Overall Study||8||
48765767|NCT01782378|102214720|FG000|STARTED|First Series||32||
48765768|NCT01782378|102214721|FG001|STARTED|First Series||31||
48765769|NCT01782378|102214720|FG000|COMPLETED|First Series||25||
48765770|NCT01782378|102214721|FG001|COMPLETED|First Series||23||
48436538|NCT00442572|101403572|FG000|COMPLETED|Overall Study||9||
48765771|NCT01782378|102214720|FG000|NOT COMPLETED|First Series||7||
48765772|NCT01782378|102214721|FG001|NOT COMPLETED|First Series||8||
48765773|NCT01782378|102214720|FG000|STARTED|Second Series||31||
48765774|NCT01782378|102214721|FG001|STARTED|Second Series||32||
48765775|NCT01782378|102214720|FG000|COMPLETED|Second Series||5||
48765776|NCT01782378|102214721|FG001|COMPLETED|Second Series||0||
48765777|NCT01782378|102214720|FG000|NOT COMPLETED|Second Series||26||
48188298|NCT01072929|100783207|FG001|NOT COMPLETED|Overall Study||51||
48765778|NCT01782378|102214721|FG001|NOT COMPLETED|Second Series||32||
48364753|NCT02740153|101220572|FG001|STARTED|Overall Study||86||
48765779|NCT04682366|102214722|FG000|STARTED|Overall Study||2||
48364754|NCT02740153|101220571|FG000|COMPLETED|Overall Study||101||
48364755|NCT02740153|101220572|FG001|COMPLETED|Overall Study||86||
48364756|NCT02740153|101220571|FG000|NOT COMPLETED|Overall Study||0||
48364757|NCT02740153|101220572|FG001|NOT COMPLETED|Overall Study||0||
48364758|NCT00751881|101220573|FG000|STARTED|Core Treatment Period||389||
48364759|NCT00751881|101220574|FG001|STARTED|Core Treatment Period||408||
48654805|NCT03737994|101941111|FG002|STARTED|Overall Study||0||
48765780|NCT04682366|102214723|FG001|STARTED|Overall Study||2||
48765781|NCT04682366|102214722|FG000|COMPLETED|Overall Study||1||
48765782|NCT04682366|102214723|FG001|COMPLETED|Overall Study||1||
48765783|NCT04682366|102214722|FG000|NOT COMPLETED|Overall Study||1||
48765784|NCT04682366|102214723|FG001|NOT COMPLETED|Overall Study||1||
48765785|NCT00199381|102214724|FG000|STARTED|Overall Study||504||
48364760|NCT00751881|101220575|FG002|STARTED|Core Treatment Period||372||
48364761|NCT00751881|101220573|FG000|Treated|Core Treatment Period||388||
48654806|NCT03737994|101941112|FG003|STARTED|Overall Study||2||
48364762|NCT00751881|101220574|FG001|Treated|Core Treatment Period||407||
48364763|NCT00751881|101220575|FG002|Treated|Core Treatment Period||370||
48364764|NCT00751881|101220573|FG000|COMPLETED|Core Treatment Period||263||
48364765|NCT00751881|101220574|FG001|COMPLETED|Core Treatment Period||273||
48364766|NCT00751881|101220575|FG002|COMPLETED|Core Treatment Period||244||
48364767|NCT00751881|101220573|FG000|NOT COMPLETED|Core Treatment Period||126||
48364768|NCT00751881|101220574|FG001|NOT COMPLETED|Core Treatment Period||135||
48364769|NCT00751881|101220575|FG002|NOT COMPLETED|Core Treatment Period||128||
48364770|NCT00751881|101220573|FG000|STARTED|Extension Study Period||253||
48364771|NCT00751881|101220574|FG001|STARTED|Extension Study Period||265||
48364772|NCT00751881|101220575|FG002|STARTED|Extension Study Period||233||
48364773|NCT00751881|101220573|FG000|COMPLETED|Extension Study Period||188||
48364774|NCT00751881|101220574|FG001|COMPLETED|Extension Study Period||194||
48364775|NCT00751881|101220575|FG002|COMPLETED|Extension Study Period||167||
48364776|NCT00751881|101220573|FG000|NOT COMPLETED|Extension Study Period||65||
48364777|NCT00751881|101220574|FG001|NOT COMPLETED|Extension Study Period||71||
48364778|NCT00751881|101220575|FG002|NOT COMPLETED|Extension Study Period||66||
48364779|NCT00546819|101220576|FG000|STARTED|Overall Study||207||
48364780|NCT00546819|101220577|FG001|STARTED|Overall Study||102||
48364781|NCT00546819|101220576|FG000|VACCINATED|Overall Study||206||
48364782|NCT00546819|101220577|FG001|VACCINATED|Overall Study||100||
48364783|NCT00546819|101220576|FG000|COMPLETED|Overall Study||199||
48364784|NCT00546819|101220577|FG001|COMPLETED|Overall Study||96||
48364785|NCT00546819|101220576|FG000|NOT COMPLETED|Overall Study||8||
48364786|NCT00546819|101220577|FG001|NOT COMPLETED|Overall Study||6||
48364787|NCT03472534|101220578|FG000|STARTED|Overall Study||46||184
48364788|NCT03472534|101220578|FG000|Diacerein 1% Ointment|Overall Study||46||46
48364789|NCT03472534|101220578|FG000|Vehicle Ointment|Overall Study||46||46
48364790|NCT03472534|101220578|FG000|0.2% Sodium Lauryl Sulfate (SLS)|Overall Study||46||46
48364791|NCT03472534|101220578|FG000|0.9% Saline|Overall Study||46||46
48364792|NCT03472534|101220578|FG000|COMPLETED|Overall Study||35||140
48364793|NCT03472534|101220578|FG000|NOT COMPLETED|Overall Study||11||44
48364794|NCT01713400|101220579|FG000|STARTED|Overall Study||15||
48364795|NCT01713400|101220580|FG001|STARTED|Overall Study||15||
48364796|NCT01713400|101220579|FG000|COMPLETED|Overall Study||15||
48364797|NCT01713400|101220580|FG001|COMPLETED|Overall Study||15||
48364798|NCT01713400|101220579|FG000|NOT COMPLETED|Overall Study||0||
48364799|NCT01713400|101220580|FG001|NOT COMPLETED|Overall Study||0||
48364800|NCT04337138|101220581|FG000|STARTED|Overall Study||32||
48364801|NCT04337138|101220581|FG000|COMPLETED|Overall Study||32||
48364802|NCT04337138|101220581|FG000|NOT COMPLETED|Overall Study||0||
48364803|NCT01950078|101220582|FG000|STARTED|Overall Study||1025||
48364804|NCT01950078|101220583|FG001|STARTED|Overall Study||508||
48364805|NCT01950078|101220582|FG000|COMPLETED|Overall Study||1005||
48188299|NCT01072929|100783208|FG002|NOT COMPLETED|Overall Study||9||
48188300|NCT01238575|100783209|FG000|STARTED|Overall Study||30||
48188301|NCT01238575|100783210|FG001|STARTED|Overall Study||32||
48188302|NCT01238575|100783209|FG000|COMPLETED|Overall Study||26||
48188303|NCT01238575|100783210|FG001|COMPLETED|Overall Study||28||
48364806|NCT01950078|101220583|FG001|COMPLETED|Overall Study||496||
48364807|NCT01950078|101220582|FG000|NOT COMPLETED|Overall Study||20||
48364808|NCT01950078|101220583|FG001|NOT COMPLETED|Overall Study||12||
48364809|NCT00224107|101220584|FG000|STARTED|Overall Study||233||
48364810|NCT00224107|101220585|FG001|STARTED|Overall Study||228||
48364811|NCT00224107|101220584|FG000|COMPLETED|Overall Study||202||
48364812|NCT00224107|101220585|FG001|COMPLETED|Overall Study||214||
48364813|NCT00224107|101220584|FG000|NOT COMPLETED|Overall Study||31||
48364814|NCT00224107|101220585|FG001|NOT COMPLETED|Overall Study||14||
48364815|NCT01544595|101220586|FG000|STARTED|Status at Week 68||301||
48364816|NCT01544595|101220587|FG001|STARTED|Status at Week 68||363||
48364817|NCT01544595|101220588|FG002|STARTED|Status at Week 68||150||
48364818|NCT01544595|101220589|FG003|STARTED|Status at Week 68||181||
48364819|NCT01544595|101220590|FG004|STARTED|Status at Week 68||0||
48364820|NCT01544595|101220591|FG005|STARTED|Status at Week 68||0||
48188304|NCT01238575|100783209|FG000|NOT COMPLETED|Overall Study||4||
48364821|NCT01544595|101220586|FG000|COMPLETED|Status at Week 68||262|Week 68|
48364822|NCT01544595|101220587|FG001|COMPLETED|Status at Week 68||346|Week 68|
48364823|NCT01544595|101220588|FG002|COMPLETED|Status at Week 68||87|Week 68|
48364824|NCT01544595|101220589|FG003|COMPLETED|Status at Week 68||130|Week 68|
48364825|NCT01544595|101220590|FG004|COMPLETED|Status at Week 68||0|Week 68|
48364826|NCT01544595|101220591|FG005|COMPLETED|Status at Week 68||0|Week 68|
48188305|NCT01238575|100783210|FG001|NOT COMPLETED|Overall Study||4||
48364827|NCT01544595|101220586|FG000|NOT COMPLETED|Status at Week 68||39||
48364828|NCT01544595|101220587|FG001|NOT COMPLETED|Status at Week 68||17||
48364829|NCT01544595|101220588|FG002|NOT COMPLETED|Status at Week 68||63||
48364830|NCT01544595|101220589|FG003|NOT COMPLETED|Status at Week 68||51||
48364831|NCT01544595|101220590|FG004|NOT COMPLETED|Status at Week 68||0||
48364832|NCT01544595|101220591|FG005|NOT COMPLETED|Status at Week 68||0||
48364833|NCT01544595|101220586|FG000|STARTED|Status at Week 156||301||
48364834|NCT01544595|101220587|FG001|STARTED|Status at Week 156||363||
48364835|NCT01544595|101220588|FG002|STARTED|Status at Week 156||150||
48364836|NCT01544595|101220589|FG003|STARTED|Status at Week 156||181||
48654807|NCT03737994|101941113|FG004|STARTED|Overall Study||3||
48654808|NCT03737994|101941114|FG005|STARTED|Overall Study||0||
48654809|NCT03737994|101941115|FG006|STARTED|Overall Study||1||
48654810|NCT03737994|101941109|FG000|Disease Assessment Population|Overall Study||3|Eligible participants who started protocol treatment and had post-baseline disease assessment.|
48364837|NCT01544595|101220590|FG004|STARTED|Status at Week 156||98||
48364838|NCT01544595|101220591|FG005|STARTED|Status at Week 156||53||
48364839|NCT01544595|101220586|FG000|COMPLETED|Status at Week 156||184|Week 156|
48364840|NCT01544595|101220587|FG001|COMPLETED|Status at Week 156||285|Week 156|
48364841|NCT01544595|101220588|FG002|COMPLETED|Status at Week 156||10|Week 156|
48364842|NCT01544595|101220589|FG003|COMPLETED|Status at Week 156||15|Week 156|
48364843|NCT01544595|101220590|FG004|COMPLETED|Status at Week 156||60|Week 156|
48364844|NCT01544595|101220591|FG005|COMPLETED|Status at Week 156||38|Week 156|
48364845|NCT01544595|101220586|FG000|NOT COMPLETED|Status at Week 156||117||
48364846|NCT01544595|101220587|FG001|NOT COMPLETED|Status at Week 156||78||
48364847|NCT01544595|101220588|FG002|NOT COMPLETED|Status at Week 156||140||
48364848|NCT01544595|101220589|FG003|NOT COMPLETED|Status at Week 156||166||
48364849|NCT01544595|101220590|FG004|NOT COMPLETED|Status at Week 156||38||
48364850|NCT01544595|101220591|FG005|NOT COMPLETED|Status at Week 156||15||
48364851|NCT05468086|101220592|FG000|STARTED|Overall Study||35||
48364852|NCT05468086|101220592|FG000|COMPLETED|Overall Study||31||
48364853|NCT05468086|101220592|FG000|NOT COMPLETED|Overall Study||4||
48364854|NCT02457897|101220593|FG000|STARTED|Part 1 Short-term (2 Weeks) Study||7||
48364855|NCT02457897|101220593|FG000|COMPLETED|Part 1 Short-term (2 Weeks) Study||7||
48364856|NCT02457897|101220593|FG000|NOT COMPLETED|Part 1 Short-term (2 Weeks) Study||0||
48364857|NCT02457897|101220593|FG000|STARTED|Part 2 Long-term (6 Month) Study||5||
48364858|NCT02457897|101220593|FG000|COMPLETED|Part 2 Long-term (6 Month) Study||5||
48364859|NCT02457897|101220593|FG000|NOT COMPLETED|Part 2 Long-term (6 Month) Study||0||
48364860|NCT01283581|101220594|FG000|STARTED|Overall Study||81||
48364861|NCT01283581|101220595|FG001|STARTED|Overall Study||77||
48364862|NCT01283581|101220596|FG002|STARTED|Overall Study||98||
48364863|NCT01283581|101220594|FG000|COMPLETED|Overall Study||69||
48364864|NCT01283581|101220595|FG001|COMPLETED|Overall Study||63||
48364865|NCT01283581|101220596|FG002|COMPLETED|Overall Study||78||
48364866|NCT01283581|101220594|FG000|NOT COMPLETED|Overall Study||12||
48364867|NCT01283581|101220595|FG001|NOT COMPLETED|Overall Study||14||
48364868|NCT01283581|101220596|FG002|NOT COMPLETED|Overall Study||20||
48364869|NCT03115801|101220597|FG000|STARTED|Overall Study||4||
48364870|NCT03115801|101220598|FG001|STARTED|Overall Study||2||
48364871|NCT03115801|101220597|FG000|COMPLETED|Overall Study||1||
48364872|NCT03115801|101220598|FG001|COMPLETED|Overall Study||0||
48364873|NCT03115801|101220597|FG000|NOT COMPLETED|Overall Study||3||
48364874|NCT03115801|101220598|FG001|NOT COMPLETED|Overall Study||2||
48364875|NCT01142323|101220599|FG000|STARTED|Overall Study||8||
48364876|NCT01142323|101220599|FG000|COMPLETED|Overall Study||8||
48364877|NCT01142323|101220599|FG000|NOT COMPLETED|Overall Study||0||
48364878|NCT03121352|101220600|FG000|STARTED|Overall Study||30||
48364879|NCT03121352|101220600|FG000|COMPLETED|Overall Study||30||
48364880|NCT03121352|101220600|FG000|NOT COMPLETED|Overall Study||0||
48364881|NCT01678807|101220601|FG000|STARTED|Overall Study||65||
48364882|NCT01678807|101220602|FG001|STARTED|Overall Study||65||
48364883|NCT01678807|101220603|FG002|STARTED|Overall Study||65||
48364884|NCT01678807|101220601|FG000|COMPLETED|Overall Study||61||
48364885|NCT01678807|101220602|FG001|COMPLETED|Overall Study||60||
48364886|NCT01678807|101220603|FG002|COMPLETED|Overall Study||65||
48364887|NCT01678807|101220601|FG000|NOT COMPLETED|Overall Study||4||
48364888|NCT01678807|101220602|FG001|NOT COMPLETED|Overall Study||5||
48188306|NCT01094743|100783211|FG000|STARTED|Period 1||52||
48188307|NCT01094743|100783211|FG000|COMPLETED|Period 1||50||
48364889|NCT01678807|101220603|FG002|NOT COMPLETED|Overall Study||0||
48364890|NCT01558089|101220604|FG000|STARTED|Overall Study||76||
48364891|NCT01558089|101220604|FG000|COMPLETED|Overall Study||63||
48364892|NCT01558089|101220604|FG000|NOT COMPLETED|Overall Study||13||
48364893|NCT02492750|101220605|FG000|STARTED|Overall Study||4||
48188308|NCT01094743|100783211|FG000|NOT COMPLETED|Period 1||2||
48188309|NCT01094743|100783211|FG000|STARTED|Period 2||50||
48188310|NCT01094743|100783211|FG000|COMPLETED|Period 2||50||
48188311|NCT01094743|100783211|FG000|NOT COMPLETED|Period 2||0||
48364894|NCT02492750|101220606|FG001|STARTED|Overall Study||4||
48364895|NCT02492750|101220607|FG002|STARTED|Overall Study||6||
48436539|NCT00442572|101403573|FG001|COMPLETED|Overall Study||1||
48188312|NCT00429702|100783212|FG000|STARTED|Overall Study||3||
48364896|NCT02492750|101220605|FG000|COMPLETED|Overall Study||4||
48364897|NCT02492750|101220606|FG001|COMPLETED|Overall Study||4||
48364898|NCT02492750|101220607|FG002|COMPLETED|Overall Study||6||
48364899|NCT02492750|101220605|FG000|NOT COMPLETED|Overall Study||0||
48364900|NCT02492750|101220606|FG001|NOT COMPLETED|Overall Study||0||
48364901|NCT02492750|101220607|FG002|NOT COMPLETED|Overall Study||0||
48657058|NCT03648372|101943777|FG020|STARTED|Overall Study||1||
48188313|NCT00429702|100783213|FG001|STARTED|Overall Study||4||
48364902|NCT03465735|101220608|FG000|STARTED|Overall Study||8||
48364903|NCT03465735|101220609|FG001|STARTED|Overall Study||7||
48364904|NCT03465735|101220608|FG000|COMPLETED|Overall Study||7||
48364905|NCT03465735|101220609|FG001|COMPLETED|Overall Study||5||
48654811|NCT03737994|101941110|FG001|Disease Assessment Population|Overall Study||1|Eligible participants who started protocol treatment and had post-baseline disease assessment.|
48654812|NCT03737994|101941111|FG002|Disease Assessment Population|Overall Study||0|Eligible participants who started protocol treatment and had post-baseline disease assessment.|
48654813|NCT03737994|101941112|FG003|Disease Assessment Population|Overall Study||2|Eligible participants who started protocol treatment and had post-baseline disease assessment.|
48654814|NCT03737994|101941113|FG004|Disease Assessment Population|Overall Study||2|Eligible participants who started protocol treatment and had post-baseline disease assessment.|
48654815|NCT03737994|101941114|FG005|Disease Assessment Population|Overall Study||0|Eligible participants who started protocol treatment and had post-baseline disease assessment.|
48654816|NCT03737994|101941115|FG006|Disease Assessment Population|Overall Study||0|Eligible participants who started protocol treatment and had post-baseline disease assessment.|
48654817|NCT03737994|101941109|FG000|Survival Population|Overall Study||3|Eligible participants who started protocol treatment and have post-baseline survival status.|
48654818|NCT03737994|101941110|FG001|Survival Population|Overall Study||1|Eligible participants who started protocol treatment and have post-baseline survival status.|
48654819|NCT03737994|101941111|FG002|Survival Population|Overall Study||0|Eligible participants who started protocol treatment and have post-baseline survival status.|
48654820|NCT03737994|101941112|FG003|Survival Population|Overall Study||2|Eligible participants who started protocol treatment and have post-baseline survival status.|
48654821|NCT03737994|101941113|FG004|Survival Population|Overall Study||3|Eligible participants who started protocol treatment and have post-baseline survival status.|
48654822|NCT03737994|101941114|FG005|Survival Population|Overall Study||0|Eligible participants who started protocol treatment and have post-baseline survival status.|
48654823|NCT03737994|101941115|FG006|Survival Population|Overall Study||0|Eligible participants who started protocol treatment and have post-baseline survival status.|
48654824|NCT03737994|101941109|FG000|Adverse Event Population|Overall Study||3|Eligible participants who started protocol treatment and have adverse event data.|
48654825|NCT03737994|101941110|FG001|Adverse Event Population|Overall Study||1|Eligible participants who started protocol treatment and have adverse event data.|
48654826|NCT03737994|101941111|FG002|Adverse Event Population|Overall Study||0|Eligible participants who started protocol treatment and have adverse event data.|
48654827|NCT03737994|101941112|FG003|Adverse Event Population|Overall Study||2|Eligible participants who started protocol treatment and have adverse event data.|
48654828|NCT03737994|101941113|FG004|Adverse Event Population|Overall Study||3|Eligible participants who started protocol treatment and have adverse event data.|
48654829|NCT03737994|101941114|FG005|Adverse Event Population|Overall Study||0|Eligible participants who started protocol treatment and have adverse event data.|
48654830|NCT03737994|101941115|FG006|Adverse Event Population|Overall Study||0|Eligible participants who started protocol treatment and have adverse event data.|
48654831|NCT03737994|101941109|FG000|COMPLETED|Overall Study||3|Participants contributing data to any results are considered to have completed the study.|
48654832|NCT03737994|101941110|FG001|COMPLETED|Overall Study||1|Participants contributing data to any results are considered to have completed the study.|
48654833|NCT03737994|101941111|FG002|COMPLETED|Overall Study||0|Participants contributing data to any results are considered to have completed the study.|
48654834|NCT03737994|101941112|FG003|COMPLETED|Overall Study||2|Participants contributing data to any results are considered to have completed the study.|
48654835|NCT03737994|101941113|FG004|COMPLETED|Overall Study||3|Participants contributing data to any results are considered to have completed the study.|
48654836|NCT03737994|101941114|FG005|COMPLETED|Overall Study||0|Participants contributing data to any results are considered to have completed the study.|
48654837|NCT03737994|101941115|FG006|COMPLETED|Overall Study||0|Participants contributing data to any results are considered to have completed the study.|
48654838|NCT03737994|101941109|FG000|NOT COMPLETED|Overall Study||0||
48654839|NCT03737994|101941110|FG001|NOT COMPLETED|Overall Study||0||
48654840|NCT03737994|101941111|FG002|NOT COMPLETED|Overall Study||0||
48654841|NCT03737994|101941112|FG003|NOT COMPLETED|Overall Study||0||
48654842|NCT03737994|101941113|FG004|NOT COMPLETED|Overall Study||0||
48654843|NCT03737994|101941114|FG005|NOT COMPLETED|Overall Study||0||
48654844|NCT03737994|101941115|FG006|NOT COMPLETED|Overall Study||1||
48654845|NCT02596893|101941116|FG000|STARTED|Overall Double-Blind Period Weeks 0-52||174||
48654846|NCT02596893|101941117|FG001|STARTED|Overall Double-Blind Period Weeks 0-52||176||
48654847|NCT02596893|101941118|FG002|STARTED|Overall Double-Blind Period Weeks 0-52||176||
48654848|NCT02596893|101941119|FG003|STARTED|Overall Double-Blind Period Weeks 0-52||175||
48654849|NCT02596893|101941116|FG000|COMPLETED|Overall Double-Blind Period Weeks 0-52||10||
48654850|NCT02596893|101941117|FG001|COMPLETED|Overall Double-Blind Period Weeks 0-52||8||
48654851|NCT02596893|101941118|FG002|COMPLETED|Overall Double-Blind Period Weeks 0-52||14||
48765786|NCT00199381|102214724|FG000|COMPLETED|Overall Study||0||
48765787|NCT00199381|102214724|FG000|NOT COMPLETED|Overall Study||504||
48765788|NCT02491632|102214725|FG000|STARTED|Overall Study||38||
48765789|NCT02491632|102214726|FG001|STARTED|Overall Study||38||
48765790|NCT02491632|102214725|FG000|COMPLETED|Overall Study||31||
48765791|NCT02491632|102214726|FG001|COMPLETED|Overall Study||29||
48765792|NCT02491632|102214725|FG000|NOT COMPLETED|Overall Study||7||
48765793|NCT02491632|102214726|FG001|NOT COMPLETED|Overall Study||9||
48765794|NCT01780974|102214727|FG000|STARTED|Overall Study||21||
48765795|NCT01780974|102214728|FG001|STARTED|Overall Study||21||
48765796|NCT01780974|102214727|FG000|COMPLETED|Overall Study||19||
48765797|NCT01780974|102214728|FG001|COMPLETED|Overall Study||18||
48765798|NCT01780974|102214727|FG000|NOT COMPLETED|Overall Study||2||
48654852|NCT02596893|101941119|FG003|COMPLETED|Overall Double-Blind Period Weeks 0-52||9||
48654853|NCT02596893|101941116|FG000|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||164||
48654854|NCT02596893|101941117|FG001|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||168||
48654855|NCT02596893|101941118|FG002|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||162||
48654856|NCT02596893|101941119|FG003|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||166||
48654857|NCT02596893|101941116|FG000|STARTED|Follow-Up Period Weeks 0 to 52||57||
48654858|NCT02596893|101941117|FG001|STARTED|Follow-Up Period Weeks 0 to 52||51||
48654859|NCT02596893|101941118|FG002|STARTED|Follow-Up Period Weeks 0 to 52||56||
48654860|NCT02596893|101941119|FG003|STARTED|Follow-Up Period Weeks 0 to 52||47||
48654861|NCT02596893|101941116|FG000|COMPLETED|Follow-Up Period Weeks 0 to 52||57||
48654862|NCT02596893|101941117|FG001|COMPLETED|Follow-Up Period Weeks 0 to 52||51||
48654863|NCT02596893|101941118|FG002|COMPLETED|Follow-Up Period Weeks 0 to 52||56||
48654864|NCT02596893|101941119|FG003|COMPLETED|Follow-Up Period Weeks 0 to 52||47||
48654865|NCT02596893|101941116|FG000|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0||
48654866|NCT02596893|101941117|FG001|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0||
48654867|NCT02596893|101941118|FG002|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0||
48654868|NCT02596893|101941119|FG003|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0||
48654869|NCT03021005|101941120|FG000|STARTED|Overall Study||102||
48654870|NCT03021005|101941121|FG001|STARTED|Overall Study||98||
48654871|NCT03021005|101941120|FG000|COMPLETED|Overall Study||63||
48654872|NCT03021005|101941121|FG001|COMPLETED|Overall Study||72||
48654873|NCT03021005|101941120|FG000|NOT COMPLETED|Overall Study||39||
48654874|NCT03021005|101941121|FG001|NOT COMPLETED|Overall Study||26||
48654875|NCT04818086|101941122|FG000|STARTED|Overall Study||12||
48654876|NCT04818086|101941123|FG001|STARTED|Overall Study||6||
48654877|NCT04818086|101941122|FG000|COMPLETED|Overall Study||11||
48654878|NCT04818086|101941123|FG001|COMPLETED|Overall Study||5||
48654879|NCT04818086|101941122|FG000|NOT COMPLETED|Overall Study||1||
48654880|NCT04818086|101941123|FG001|NOT COMPLETED|Overall Study||1||
48654881|NCT01682720|101941124|FG000|STARTED|Overall Study||85||
48654882|NCT01682720|101941125|FG001|STARTED|Overall Study||74||
48654883|NCT01682720|101941126|FG002|STARTED|Overall Study||12||
48654884|NCT01682720|101941127|FG003|STARTED|Overall Study||250||
48654885|NCT01682720|101941124|FG000|Included in Full Analysis Set|Overall Study||0||
48436540|NCT00442572|101403572|FG000|NOT COMPLETED|Overall Study||8||
48436541|NCT00442572|101403573|FG001|NOT COMPLETED|Overall Study||3||
48436542|NCT02060526|101403574|FG000|STARTED|Overall Study||7||
48654886|NCT01682720|101941125|FG001|Included in Full Analysis Set|Overall Study||73||
48654887|NCT01682720|101941126|FG002|Included in Full Analysis Set|Overall Study||11||
48654888|NCT01682720|101941127|FG003|Included in Full Analysis Set|Overall Study||250||
48654889|NCT01682720|101941124|FG000|COMPLETED|Overall Study||0||
48654890|NCT01682720|101941125|FG001|COMPLETED|Overall Study||69||
48654891|NCT01682720|101941126|FG002|COMPLETED|Overall Study||5||
48654892|NCT01682720|101941127|FG003|COMPLETED|Overall Study||211||
48654893|NCT01682720|101941124|FG000|NOT COMPLETED|Overall Study||85||
48654894|NCT01682720|101941125|FG001|NOT COMPLETED|Overall Study||5||
48654895|NCT01682720|101941126|FG002|NOT COMPLETED|Overall Study||7||
48654896|NCT01682720|101941127|FG003|NOT COMPLETED|Overall Study||39||
48654897|NCT01964560|101941128|FG000|STARTED|Overall Study||540||
48654898|NCT01964560|101941128|FG000|COMPLETED|Overall Study||395||
48654899|NCT01964560|101941128|FG000|NOT COMPLETED|Overall Study||145||
48654900|NCT03769116|101941129|FG000|STARTED|Part 1 - Double Blind||20||
48654901|NCT03769116|101941130|FG001|STARTED|Part 1 - Double Blind||21||
48654902|NCT03769116|101941129|FG000|Received At Least 1 Dose Of Study Drug|Part 1 - Double Blind||20||
48654903|NCT03769116|101941130|FG001|Received At Least 1 Dose Of Study Drug|Part 1 - Double Blind||21||
48654904|NCT03769116|101941129|FG000|COMPLETED|Part 1 - Double Blind||20||
48654905|NCT03769116|101941130|FG001|COMPLETED|Part 1 - Double Blind||21||
48654906|NCT03769116|101941129|FG000|NOT COMPLETED|Part 1 - Double Blind||0||
48654907|NCT03769116|101941130|FG001|NOT COMPLETED|Part 1 - Double Blind||0||
48654908|NCT03769116|101941129|FG000|STARTED|Part 2 - Double Blind||20||
48654909|NCT03769116|101941130|FG001|STARTED|Part 2 - Double Blind||21||
48654910|NCT03769116|101941129|FG000|Received At Least 1 Dose Of Study Drug|Part 2 - Double Blind||20||
48654911|NCT03769116|101941130|FG001|Received At Least 1 Dose Of Study Drug|Part 2 - Double Blind||21||
48654912|NCT03769116|101941129|FG000|COMPLETED|Part 2 - Double Blind||20||
48654913|NCT03769116|101941130|FG001|COMPLETED|Part 2 - Double Blind||21||
48654914|NCT03769116|101941129|FG000|NOT COMPLETED|Part 2 - Double Blind||0||
48654915|NCT03769116|101941130|FG001|NOT COMPLETED|Part 2 - Double Blind||0||
48654916|NCT03769116|101941129|FG000|STARTED|Part 3 - Open Label||20||
48654917|NCT03769116|101941130|FG001|STARTED|Part 3 - Open Label||21||
48654918|NCT03769116|101941129|FG000|Received At Least 1 Dose Of Study Drug|Part 3 - Open Label||0||
48654919|NCT03769116|101941130|FG001|Received At Least 1 Dose Of Study Drug|Part 3 - Open Label||0||
48654920|NCT03769116|101941129|FG000|COMPLETED|Part 3 - Open Label||17||
48654921|NCT03769116|101941130|FG001|COMPLETED|Part 3 - Open Label||19||
48436543|NCT02060526|101403575|FG001|STARTED|Overall Study||7||
48654922|NCT03769116|101941129|FG000|NOT COMPLETED|Part 3 - Open Label||3||
48436544|NCT02060526|101403576|FG002|STARTED|Overall Study||7||
48436545|NCT02060526|101403574|FG000|COMPLETED|Overall Study||7||
48654923|NCT03769116|101941130|FG001|NOT COMPLETED|Part 3 - Open Label||2||
48654924|NCT02169401|101941131|FG000|STARTED|Overall Study||135||
48654925|NCT02169401|101941131|FG000|COMPLETED|Overall Study||108||
48654926|NCT02169401|101941131|FG000|NOT COMPLETED|Overall Study||27||
48654927|NCT02605967|101941132|FG000|STARTED|Overall Study||82|All participants to whom study treatment was assigned by randomization|
48654928|NCT02605967|101941133|FG001|STARTED|Overall Study||40|All participants to whom study treatment was assigned by randomization|
48654929|NCT02605967|101941132|FG000|Safety Set|Overall Study||82|All participants who received at least one dose of study medication and had at least one valid post-screening/post-baseline safety assessment.|
48654930|NCT02605967|101941133|FG001|Safety Set|Overall Study||39|All participants who received at least one dose of study medication and had at least one valid post-screening/post-baseline safety assessment.|
48654931|NCT02605967|101941132|FG000|Crossover to Spartalizumab|Overall Study||0|Participants in Chemotherapy arm were allowed to crossover to spartalizumab treatment if they had radiological progression as per RECIST v1.1 by independent central review.|
48654932|NCT02605967|101941133|FG001|Crossover to Spartalizumab|Overall Study||27|Participants in Chemotherapy arm were allowed to crossover to spartalizumab treatment if they had radiological progression as per RECIST v1.1 by independent central review.|
48654933|NCT02605967|101941132|FG000|COMPLETED|Overall Study||0||
48654934|NCT02605967|101941133|FG001|COMPLETED|Overall Study||0||
48654935|NCT02605967|101941132|FG000|NOT COMPLETED|Overall Study||82||
48654936|NCT02605967|101941133|FG001|NOT COMPLETED|Overall Study||40||
48654937|NCT04439903|101941134|FG000|STARTED|Overall Study||18||
48654938|NCT04439903|101941134|FG000|COMPLETED|Overall Study||15||
48654939|NCT04439903|101941134|FG000|NOT COMPLETED|Overall Study||3||
48654940|NCT00545948|101941135|FG000|STARTED|Overall Study||9||
48654941|NCT00545948|101941136|FG001|STARTED|Overall Study||15||
48654942|NCT00545948|101941137|FG002|STARTED|Overall Study||7||
48765799|NCT01780974|102214728|FG001|NOT COMPLETED|Overall Study||3||
48765800|NCT01499940|102214729|FG000|STARTED|Overall Study||9||
48765801|NCT01499940|102214729|FG000|COMPLETED|Overall Study||0||
48765802|NCT01499940|102214729|FG000|NOT COMPLETED|Overall Study||9||
48765803|NCT01352715|102214730|FG000|STARTED|Overall Study||260||
48765804|NCT01352715|102214731|FG001|STARTED|Overall Study||255||
48765805|NCT01352715|102214730|FG000|COMPLETED|Overall Study||215||
48364906|NCT03465735|101220608|FG000|NOT COMPLETED|Overall Study||1||
48364907|NCT03465735|101220609|FG001|NOT COMPLETED|Overall Study||2||
48364908|NCT00784784|101220610|FG000|STARTED|Overall Study||22||
48364909|NCT00784784|101220611|FG001|STARTED|Overall Study||42||
48364910|NCT00784784|101220610|FG000|COMPLETED|Overall Study||20||
48364911|NCT00784784|101220611|FG001|COMPLETED|Overall Study||40||
48364912|NCT00784784|101220610|FG000|NOT COMPLETED|Overall Study||2||
48364913|NCT00784784|101220611|FG001|NOT COMPLETED|Overall Study||2||
48364914|NCT03141307|101220612|FG000|STARTED|In-Hospital||471||
48364915|NCT03141307|101220613|FG001|STARTED|In-Hospital||240||
48364916|NCT03141307|101220612|FG000|COMPLETED|In-Hospital||467||
48364917|NCT03141307|101220613|FG001|COMPLETED|In-Hospital||238||
48364918|NCT03141307|101220612|FG000|NOT COMPLETED|In-Hospital||4||
48364919|NCT03141307|101220613|FG001|NOT COMPLETED|In-Hospital||2||
48364920|NCT03141307|101220612|FG000|STARTED|Follow-Up||467||
48364921|NCT03141307|101220613|FG001|STARTED|Follow-Up||238||
48364922|NCT03141307|101220612|FG000|COMPLETED|Follow-Up||370||
48364923|NCT03141307|101220613|FG001|COMPLETED|Follow-Up||184||
48364924|NCT03141307|101220612|FG000|NOT COMPLETED|Follow-Up||97||
48364925|NCT03141307|101220613|FG001|NOT COMPLETED|Follow-Up||54||
48364926|NCT03662334|101223575|FG000|STARTED|Part 1: Treatment Period 1||0||
48364927|NCT03662334|101223576|FG001|STARTED|Part 1: Treatment Period 1||0||
48364928|NCT03662334|101223575|FG000|COMPLETED|Part 1: Treatment Period 1||0||
48364929|NCT03662334|101223576|FG001|COMPLETED|Part 1: Treatment Period 1||0||
48364930|NCT03662334|101223575|FG000|NOT COMPLETED|Part 1: Treatment Period 1||0||
48364931|NCT03662334|101223576|FG001|NOT COMPLETED|Part 1: Treatment Period 1||0||
48364932|NCT03662334|101223575|FG000|STARTED|Part 1: Treatment Period 2||0||
48364933|NCT03662334|101223576|FG001|STARTED|Part 1: Treatment Period 2||0||
48364934|NCT03662334|101223575|FG000|COMPLETED|Part 1: Treatment Period 2||0||
48364935|NCT03662334|101223576|FG001|COMPLETED|Part 1: Treatment Period 2||0||
48364936|NCT03662334|101223575|FG000|NOT COMPLETED|Part 1: Treatment Period 2||0||
48364937|NCT03662334|101223576|FG001|NOT COMPLETED|Part 1: Treatment Period 2||0||
48364938|NCT03662334|101223575|FG000|STARTED|Part 2: Treatment Period 1 (2 Days)||7||
48364939|NCT03662334|101223576|FG001|STARTED|Part 2: Treatment Period 1 (2 Days)||7||
48364940|NCT03662334|101223575|FG000|COMPLETED|Part 2: Treatment Period 1 (2 Days)||7||
48364941|NCT03662334|101223576|FG001|COMPLETED|Part 2: Treatment Period 1 (2 Days)||7||
48364942|NCT03662334|101223575|FG000|NOT COMPLETED|Part 2: Treatment Period 1 (2 Days)||0||
48364943|NCT03662334|101223576|FG001|NOT COMPLETED|Part 2: Treatment Period 1 (2 Days)||0||
48364944|NCT03662334|101223575|FG000|STARTED|Part 2: Treatment Period 2 (2 Days)||7||
48364945|NCT03662334|101223576|FG001|STARTED|Part 2: Treatment Period 2 (2 Days)||7||
48364946|NCT03662334|101223575|FG000|COMPLETED|Part 2: Treatment Period 2 (2 Days)||6||
48364947|NCT03662334|101223576|FG001|COMPLETED|Part 2: Treatment Period 2 (2 Days)||7||
48654943|NCT00545948|101941135|FG000|Assigned Treatment|Overall Study||9||
48765806|NCT01352715|102214731|FG001|COMPLETED|Overall Study||209||
48765807|NCT01352715|102214730|FG000|NOT COMPLETED|Overall Study||45||
48765808|NCT01352715|102214731|FG001|NOT COMPLETED|Overall Study||46||
48765809|NCT03431259|102214732|FG000|STARTED|Overall Study||115||
48364948|NCT03662334|101223575|FG000|NOT COMPLETED|Part 2: Treatment Period 2 (2 Days)||1||
48364949|NCT03662334|101223576|FG001|NOT COMPLETED|Part 2: Treatment Period 2 (2 Days)||0||
48364950|NCT03662334|101223575|FG000|STARTED|Part 3: Treatment Period 1||0||
48364951|NCT03662334|101223576|FG001|STARTED|Part 3: Treatment Period 1||0||
48364952|NCT03662334|101223575|FG000|COMPLETED|Part 3: Treatment Period 1||0||
48364953|NCT03662334|101223576|FG001|COMPLETED|Part 3: Treatment Period 1||0||
48364954|NCT03662334|101223575|FG000|NOT COMPLETED|Part 3: Treatment Period 1||0||
48364955|NCT03662334|101223576|FG001|NOT COMPLETED|Part 3: Treatment Period 1||0||
48364956|NCT03662334|101223575|FG000|STARTED|Part 3: Treatment Period 2||0||
48364957|NCT03662334|101223576|FG001|STARTED|Part 3: Treatment Period 2||0||
48364958|NCT03662334|101223575|FG000|COMPLETED|Part 3: Treatment Period 2||0||
48364959|NCT03662334|101223576|FG001|COMPLETED|Part 3: Treatment Period 2||0||
48364960|NCT03662334|101223575|FG000|NOT COMPLETED|Part 3: Treatment Period 2||0||
48364961|NCT03662334|101223576|FG001|NOT COMPLETED|Part 3: Treatment Period 2||0||
48364962|NCT02778880|101223577|FG000|STARTED|Overall Study||45||
48364963|NCT02778880|101223578|FG001|STARTED|Overall Study||45||
48364964|NCT02778880|101223577|FG000|COMPLETED|Overall Study||44||
48364965|NCT02778880|101223578|FG001|COMPLETED|Overall Study||42||
48364966|NCT02778880|101223577|FG000|NOT COMPLETED|Overall Study||1||
48364967|NCT02778880|101223578|FG001|NOT COMPLETED|Overall Study||3||
48364968|NCT01302769|101223579|FG000|STARTED|Overall Study||28||
48364969|NCT01302769|101223580|FG001|STARTED|Overall Study||28||
48364970|NCT01302769|101223579|FG000|COMPLETED|Overall Study||27||
48364971|NCT01302769|101223580|FG001|COMPLETED|Overall Study||27||
48364972|NCT01302769|101223579|FG000|NOT COMPLETED|Overall Study||1||
48364973|NCT01302769|101223580|FG001|NOT COMPLETED|Overall Study||1||
48364974|NCT00929578|101223581|FG000|STARTED|Overall Study||15||
48364975|NCT00929578|101223581|FG000|COMPLETED|Overall Study||15||
48364976|NCT00929578|101223581|FG000|NOT COMPLETED|Overall Study||0||
48364977|NCT03415464|101223582|FG000|STARTED|Overall Study||64||
48364978|NCT03415464|101223583|FG001|STARTED|Overall Study||41||
48364979|NCT03415464|101223582|FG000|COMPLETED|Overall Study||64||
48364980|NCT03415464|101223583|FG001|COMPLETED|Overall Study||41||
48364981|NCT03415464|101223582|FG000|NOT COMPLETED|Overall Study||0||
48364982|NCT03415464|101223583|FG001|NOT COMPLETED|Overall Study||0||
48364983|NCT01754688|101223584|FG000|STARTED|Overall Study||624||
48364984|NCT01754688|101223584|FG000|COMPLETED|Overall Study||624||
48364985|NCT01754688|101223584|FG000|NOT COMPLETED|Overall Study||0||
48364986|NCT00829166|101223585|FG000|STARTED|Overall Study||495||
48364987|NCT00829166|101223586|FG001|STARTED|Overall Study||496||
48364988|NCT00829166|101223585|FG000|Treated|Overall Study||490||
48364989|NCT00829166|101223586|FG001|Treated|Overall Study||488||
48364990|NCT00829166|101223585|FG000|COMPLETED|Overall Study||0||
48364991|NCT00829166|101223586|FG001|COMPLETED|Overall Study||0||
48364992|NCT00829166|101223585|FG000|NOT COMPLETED|Overall Study||495||
48364993|NCT00829166|101223586|FG001|NOT COMPLETED|Overall Study||496||
48364994|NCT00001259|101223587|FG000|STARTED|Study 1||10||
48364995|NCT00001259|101223588|FG001|STARTED|Study 1||10||
48364996|NCT00001259|101223589|FG002|STARTED|Study 1||0||
48364997|NCT00001259|101223590|FG003|STARTED|Study 1||0||
48364998|NCT00001259|101223591|FG004|STARTED|Study 1||0||
48364999|NCT00001259|101223592|FG005|STARTED|Study 1||0||
48365000|NCT00001259|101223593|FG006|STARTED|Study 1||0||
48365001|NCT00001259|101223587|FG000|Completed Phase 1|Study 1||10||
48365002|NCT00001259|101223588|FG001|Completed Phase 1|Study 1||10||
48365003|NCT00001259|101223589|FG002|Completed Phase 1|Study 1||0||
48365004|NCT00001259|101223590|FG003|Completed Phase 1|Study 1||0||
48365005|NCT00001259|101223591|FG004|Completed Phase 1|Study 1||0||
48365006|NCT00001259|101223592|FG005|Completed Phase 1|Study 1||0||
48365007|NCT00001259|101223593|FG006|Completed Phase 1|Study 1||0||
48365008|NCT00001259|101223587|FG000|Started Phase 2|Study 1||0||
48365009|NCT00001259|101223588|FG001|Started Phase 2|Study 1||0||
48365010|NCT00001259|101223589|FG002|Started Phase 2|Study 1||4||
48365011|NCT00001259|101223590|FG003|Started Phase 2|Study 1||6||
48365012|NCT00001259|101223591|FG004|Started Phase 2|Study 1||0||
48365013|NCT00001259|101223592|FG005|Started Phase 2|Study 1||0||
48365014|NCT00001259|101223593|FG006|Started Phase 2|Study 1||0||
48365015|NCT00001259|101223587|FG000|Completed Phase 2|Study 1||0||
48365016|NCT00001259|101223588|FG001|Completed Phase 2|Study 1||0||
48365017|NCT00001259|101223589|FG002|Completed Phase 2|Study 1||4||
48365018|NCT00001259|101223590|FG003|Completed Phase 2|Study 1||5||
48365019|NCT00001259|101223591|FG004|Completed Phase 2|Study 1||0||
48365020|NCT00001259|101223592|FG005|Completed Phase 2|Study 1||0||
48365021|NCT00001259|101223593|FG006|Completed Phase 2|Study 1||0||
48365022|NCT00001259|101223587|FG000|Started Phase 2 - Crossover Arm|Study 1||0||
48365023|NCT00001259|101223588|FG001|Started Phase 2 - Crossover Arm|Study 1||0||
48365024|NCT00001259|101223589|FG002|Started Phase 2 - Crossover Arm|Study 1||4||
48365025|NCT00001259|101223590|FG003|Started Phase 2 - Crossover Arm|Study 1||5||
48365026|NCT00001259|101223591|FG004|Started Phase 2 - Crossover Arm|Study 1||0||
48365027|NCT00001259|101223592|FG005|Started Phase 2 - Crossover Arm|Study 1||0||
48365028|NCT00001259|101223593|FG006|Started Phase 2 - Crossover Arm|Study 1||0||
48365029|NCT00001259|101223587|FG000|Completed Phase 2 - Crossover Arm|Study 1||0||
48365030|NCT00001259|101223588|FG001|Completed Phase 2 - Crossover Arm|Study 1||0||
48365031|NCT00001259|101223589|FG002|Completed Phase 2 - Crossover Arm|Study 1||4||
48365032|NCT00001259|101223590|FG003|Completed Phase 2 - Crossover Arm|Study 1||5||
48365033|NCT00001259|101223591|FG004|Completed Phase 2 - Crossover Arm|Study 1||0||
48365034|NCT00001259|101223592|FG005|Completed Phase 2 - Crossover Arm|Study 1||0||
48365035|NCT00001259|101223593|FG006|Completed Phase 2 - Crossover Arm|Study 1||0||
48365036|NCT00001259|101223587|FG000|COMPLETED|Study 1||10||
48365037|NCT00001259|101223588|FG001|COMPLETED|Study 1||10||
48365038|NCT00001259|101223589|FG002|COMPLETED|Study 1||0||
48365039|NCT00001259|101223590|FG003|COMPLETED|Study 1||0||
48365040|NCT00001259|101223591|FG004|COMPLETED|Study 1||0||
48365041|NCT00001259|101223592|FG005|COMPLETED|Study 1||0||
48365042|NCT00001259|101223593|FG006|COMPLETED|Study 1||0||
48365043|NCT00001259|101223587|FG000|NOT COMPLETED|Study 1||0||
48365044|NCT00001259|101223588|FG001|NOT COMPLETED|Study 1||0||
48365045|NCT00001259|101223589|FG002|NOT COMPLETED|Study 1||0||
48365046|NCT00001259|101223590|FG003|NOT COMPLETED|Study 1||0||
48365047|NCT00001259|101223591|FG004|NOT COMPLETED|Study 1||0||
48365048|NCT00001259|101223592|FG005|NOT COMPLETED|Study 1||0||
48365049|NCT00001259|101223593|FG006|NOT COMPLETED|Study 1||0||
48365050|NCT00001259|101223587|FG000|STARTED|Study 2||0||
48365051|NCT00001259|101223588|FG001|STARTED|Study 2||0||
48365052|NCT00001259|101223589|FG002|STARTED|Study 2||0||
48365053|NCT00001259|101223590|FG003|STARTED|Study 2||0||
48365054|NCT00001259|101223591|FG004|STARTED|Study 2||48||
48365055|NCT00001259|101223592|FG005|STARTED|Study 2||0||
48365056|NCT00001259|101223593|FG006|STARTED|Study 2||0||
48365057|NCT00001259|101223587|FG000|Completed Phase 1|Study 2||0||
48365058|NCT00001259|101223588|FG001|Completed Phase 1|Study 2||0||
48365059|NCT00001259|101223589|FG002|Completed Phase 1|Study 2||0||
48365060|NCT00001259|101223590|FG003|Completed Phase 1|Study 2||0||
48365061|NCT00001259|101223591|FG004|Completed Phase 1|Study 2||46||
48365062|NCT00001259|101223592|FG005|Completed Phase 1|Study 2||0||
48365063|NCT00001259|101223593|FG006|Completed Phase 1|Study 2||0||
48365064|NCT00001259|101223587|FG000|Started Phase 2|Study 2||0||
48365065|NCT00001259|101223588|FG001|Started Phase 2|Study 2||0||
48365066|NCT00001259|101223589|FG002|Started Phase 2|Study 2||0||
48365067|NCT00001259|101223590|FG003|Started Phase 2|Study 2||0||
48365068|NCT00001259|101223591|FG004|Started Phase 2|Study 2||0||
48365069|NCT00001259|101223592|FG005|Started Phase 2|Study 2||21||
48365070|NCT00001259|101223593|FG006|Started Phase 2|Study 2||17||
48365071|NCT00001259|101223587|FG000|Completed Phase 2|Study 2||0||
48365072|NCT00001259|101223588|FG001|Completed Phase 2|Study 2||0||
48365073|NCT00001259|101223589|FG002|Completed Phase 2|Study 2||0||
48365074|NCT00001259|101223590|FG003|Completed Phase 2|Study 2||0||
48365075|NCT00001259|101223591|FG004|Completed Phase 2|Study 2||0||
48365076|NCT00001259|101223592|FG005|Completed Phase 2|Study 2||21||
48365077|NCT00001259|101223593|FG006|Completed Phase 2|Study 2||17||
48365078|NCT00001259|101223587|FG000|Started Phase 2 - Crossover Arm|Study 2||0||
48365079|NCT00001259|101223588|FG001|Started Phase 2 - Crossover Arm|Study 2||0||
48365080|NCT00001259|101223589|FG002|Started Phase 2 - Crossover Arm|Study 2||0||
48365081|NCT00001259|101223590|FG003|Started Phase 2 - Crossover Arm|Study 2||0||
48365082|NCT00001259|101223591|FG004|Started Phase 2 - Crossover Arm|Study 2||0||
48365083|NCT00001259|101223592|FG005|Started Phase 2 - Crossover Arm|Study 2||21||
48365084|NCT00001259|101223593|FG006|Started Phase 2 - Crossover Arm|Study 2||17||
48365085|NCT00001259|101223587|FG000|Completed Phase 2 - Crossover Arm|Study 2||0||
48365086|NCT00001259|101223588|FG001|Completed Phase 2 - Crossover Arm|Study 2||0||
48365087|NCT00001259|101223589|FG002|Completed Phase 2 - Crossover Arm|Study 2||0||
48365088|NCT00001259|101223590|FG003|Completed Phase 2 - Crossover Arm|Study 2||0||
48365089|NCT00001259|101223591|FG004|Completed Phase 2 - Crossover Arm|Study 2||0||
48365090|NCT00001259|101223592|FG005|Completed Phase 2 - Crossover Arm|Study 2||21||
48365091|NCT00001259|101223593|FG006|Completed Phase 2 - Crossover Arm|Study 2||17||
48365092|NCT00001259|101223587|FG000|COMPLETED|Study 2||0||
48365093|NCT00001259|101223588|FG001|COMPLETED|Study 2||0||
48365094|NCT00001259|101223589|FG002|COMPLETED|Study 2||0||
48365095|NCT00001259|101223590|FG003|COMPLETED|Study 2||0||
48365096|NCT00001259|101223591|FG004|COMPLETED|Study 2||46||
48365097|NCT00001259|101223592|FG005|COMPLETED|Study 2||0||
48365098|NCT00001259|101223593|FG006|COMPLETED|Study 2||0||
48365099|NCT00001259|101223587|FG000|NOT COMPLETED|Study 2||0||
48365100|NCT00001259|101223588|FG001|NOT COMPLETED|Study 2||0||
48365101|NCT00001259|101223589|FG002|NOT COMPLETED|Study 2||0||
48365102|NCT00001259|101223590|FG003|NOT COMPLETED|Study 2||0||
48436546|NCT02060526|101403575|FG001|COMPLETED|Overall Study||7||
48365103|NCT00001259|101223591|FG004|NOT COMPLETED|Study 2||2||
48365104|NCT00001259|101223592|FG005|NOT COMPLETED|Study 2||0||
48365105|NCT00001259|101223593|FG006|NOT COMPLETED|Study 2||0||
48365106|NCT01600131|101223594|FG000|STARTED|Post-Test 1||86||
48365107|NCT01600131|101223595|FG001|STARTED|Post-Test 1||88||
48365108|NCT01600131|101223594|FG000|COMPLETED|Post-Test 1||43||
48365109|NCT01600131|101223595|FG001|COMPLETED|Post-Test 1||73||
48365110|NCT01600131|101223594|FG000|NOT COMPLETED|Post-Test 1||43||
48365111|NCT01600131|101223595|FG001|NOT COMPLETED|Post-Test 1||15||
48436547|NCT02060526|101403576|FG002|COMPLETED|Overall Study||7||
48365112|NCT01600131|101223594|FG000|STARTED|Post-Test 2||43||
48365113|NCT01600131|101223595|FG001|STARTED|Post-Test 2||73||
48365114|NCT01600131|101223594|FG000|COMPLETED|Post-Test 2||43||
48365115|NCT01600131|101223595|FG001|COMPLETED|Post-Test 2||71||
48365116|NCT01600131|101223594|FG000|NOT COMPLETED|Post-Test 2||0||
48365117|NCT01600131|101223595|FG001|NOT COMPLETED|Post-Test 2||2||
48365118|NCT02144220|101223596|FG000|STARTED|Overall Study||277||
48365119|NCT02144220|101223596|FG000|COMPLETED|Overall Study||258||
48365120|NCT02144220|101223596|FG000|NOT COMPLETED|Overall Study||19||
48365121|NCT00416351|101223597|FG000|STARTED|Overall Study||1||
48365122|NCT00416351|101223598|FG001|STARTED|Overall Study||3||
48365123|NCT00416351|101223599|FG002|STARTED|Overall Study||4||
48365124|NCT00416351|101223600|FG003|STARTED|Overall Study||17||
48365125|NCT00416351|101223601|FG004|STARTED|Overall Study||4||
48188314|NCT00429702|100783212|FG000|COMPLETED|Overall Study||3||
48188315|NCT00429702|100783213|FG001|COMPLETED|Overall Study||4||
48188316|NCT00429702|100783212|FG000|NOT COMPLETED|Overall Study||0||
48188317|NCT00429702|100783213|FG001|NOT COMPLETED|Overall Study||0||
48365126|NCT00416351|101223597|FG000|COMPLETED|Overall Study||1||
48365127|NCT00416351|101223598|FG001|COMPLETED|Overall Study||3||
48365128|NCT00416351|101223599|FG002|COMPLETED|Overall Study||4||
48365129|NCT00416351|101223600|FG003|COMPLETED|Overall Study||17||
48365130|NCT00416351|101223601|FG004|COMPLETED|Overall Study||4||
48365131|NCT00416351|101223597|FG000|NOT COMPLETED|Overall Study||0||
48365132|NCT00416351|101223598|FG001|NOT COMPLETED|Overall Study||0||
48365133|NCT00416351|101223599|FG002|NOT COMPLETED|Overall Study||0||
48365134|NCT00416351|101223600|FG003|NOT COMPLETED|Overall Study||0||
48365135|NCT00416351|101223601|FG004|NOT COMPLETED|Overall Study||0||
48365136|NCT00509873|101223602|FG000|STARTED|Overall Study||287||
48365137|NCT00509873|101223603|FG001|STARTED|Overall Study||291||
48365138|NCT00509873|101223602|FG000|COMPLETED|Overall Study||276||
48365139|NCT00509873|101223603|FG001|COMPLETED|Overall Study||276||
48365140|NCT00509873|101223602|FG000|NOT COMPLETED|Overall Study||11||
48365141|NCT00509873|101223603|FG001|NOT COMPLETED|Overall Study||15||
48365142|NCT00417612|101223604|FG000|STARTED|Overall Study||22||
48365143|NCT00417612|101223605|FG001|STARTED|Overall Study||11||
48365144|NCT00417612|101223604|FG000|COMPLETED|Overall Study||19||
48365145|NCT00417612|101223605|FG001|COMPLETED|Overall Study||8||
48365146|NCT00417612|101223604|FG000|NOT COMPLETED|Overall Study||3||
48365147|NCT00417612|101223605|FG001|NOT COMPLETED|Overall Study||3||
48365148|NCT01721369|101223606|FG000|STARTED|Overall Study||581||
48365149|NCT01721369|101223606|FG000|COMPLETED|Overall Study||569||
48365150|NCT01721369|101223606|FG000|NOT COMPLETED|Overall Study||12||
48365151|NCT00719732|101223607|FG000|STARTED|Overall Study||218||
48365152|NCT00719732|101223607|FG000|COMPLETED|Overall Study||196||
48365153|NCT00719732|101223607|FG000|NOT COMPLETED|Overall Study||22||
48365154|NCT03880227|101223608|FG000|STARTED|First Visit||20||
48365155|NCT03880227|101223609|FG001|STARTED|First Visit||21||
48365156|NCT03880227|101223610|FG002|STARTED|First Visit||22||
48365157|NCT03880227|101223611|FG003|STARTED|First Visit||18||
48365158|NCT03880227|101223608|FG000|COMPLETED|First Visit||19||
48365159|NCT03880227|101223609|FG001|COMPLETED|First Visit||21||
48365160|NCT03880227|101223610|FG002|COMPLETED|First Visit||22||
48365161|NCT03880227|101223611|FG003|COMPLETED|First Visit||18||
48365162|NCT03880227|101223608|FG000|NOT COMPLETED|First Visit||1||
48365163|NCT03880227|101223609|FG001|NOT COMPLETED|First Visit||0||
48365164|NCT03880227|101223610|FG002|NOT COMPLETED|First Visit||0||
48365165|NCT03880227|101223611|FG003|NOT COMPLETED|First Visit||0||
48365166|NCT03880227|101223608|FG000|STARTED|1 Week Washout/ Delay||19||
48365167|NCT03880227|101223609|FG001|STARTED|1 Week Washout/ Delay||21||
48365168|NCT03880227|101223610|FG002|STARTED|1 Week Washout/ Delay||22||
48365169|NCT03880227|101223611|FG003|STARTED|1 Week Washout/ Delay||18||
48365170|NCT03880227|101223608|FG000|COMPLETED|1 Week Washout/ Delay||19||
48365171|NCT03880227|101223609|FG001|COMPLETED|1 Week Washout/ Delay||20||
48365172|NCT03880227|101223610|FG002|COMPLETED|1 Week Washout/ Delay||19||
48365173|NCT03880227|101223611|FG003|COMPLETED|1 Week Washout/ Delay||18||
48365174|NCT03880227|101223608|FG000|NOT COMPLETED|1 Week Washout/ Delay||0||
48365175|NCT03880227|101223609|FG001|NOT COMPLETED|1 Week Washout/ Delay||1||
48365176|NCT03880227|101223610|FG002|NOT COMPLETED|1 Week Washout/ Delay||3||
48365177|NCT03880227|101223611|FG003|NOT COMPLETED|1 Week Washout/ Delay||0||
48365178|NCT03880227|101223608|FG000|STARTED|Second Visit||19||
48365179|NCT03880227|101223609|FG001|STARTED|Second Visit||20||
48365180|NCT03880227|101223610|FG002|STARTED|Second Visit||19||
48365181|NCT03880227|101223611|FG003|STARTED|Second Visit||18||
48365182|NCT03880227|101223608|FG000|COMPLETED|Second Visit||19||
48365183|NCT03880227|101223609|FG001|COMPLETED|Second Visit||20||
48365184|NCT03880227|101223610|FG002|COMPLETED|Second Visit||19||
48365185|NCT03880227|101223611|FG003|COMPLETED|Second Visit||18||
48365186|NCT03880227|101223608|FG000|NOT COMPLETED|Second Visit||0||
48188318|NCT02264574|100783214|FG000|STARTED|Overall Study||113||
48188319|NCT02264574|100783215|FG001|STARTED|Overall Study||116||
48188320|NCT02264574|100783214|FG000|COMPLETED|Overall Study||84|On-study until study termination by sponsor.|
48365187|NCT03880227|101223609|FG001|NOT COMPLETED|Second Visit||0||
48365188|NCT03880227|101223610|FG002|NOT COMPLETED|Second Visit||0||
48365189|NCT03880227|101223611|FG003|NOT COMPLETED|Second Visit||0||
48365190|NCT02345369|101223612|FG000|STARTED|Overall Study||0||
48365191|NCT02345369|101223613|FG001|STARTED|Overall Study||0||
48365192|NCT02345369|101223612|FG000|COMPLETED|Overall Study||0||
48365193|NCT02345369|101223613|FG001|COMPLETED|Overall Study||0||
48365194|NCT02345369|101223612|FG000|NOT COMPLETED|Overall Study||0||
48365195|NCT02345369|101223613|FG001|NOT COMPLETED|Overall Study||0||
48365196|NCT00500149|101223614|FG000|STARTED|Enrolled (Dose-optimization Phase)||129||
48365197|NCT00500149|101223615|FG001|STARTED|Enrolled (Dose-optimization Phase)||0||
48365198|NCT00500149|101223614|FG000|COMPLETED|Enrolled (Dose-optimization Phase)||117||
48365199|NCT00500149|101223615|FG001|COMPLETED|Enrolled (Dose-optimization Phase)||0||
48365200|NCT00500149|101223614|FG000|NOT COMPLETED|Enrolled (Dose-optimization Phase)||12||
48365201|NCT00500149|101223615|FG001|NOT COMPLETED|Enrolled (Dose-optimization Phase)||0||
48365202|NCT00500149|101223614|FG000|STARTED|First Intervention (Cross-over Phase)||58||
48365203|NCT00500149|101223615|FG001|STARTED|First Intervention (Cross-over Phase)||59||
48365204|NCT00500149|101223614|FG000|COMPLETED|First Intervention (Cross-over Phase)||56||
48365205|NCT00500149|101223615|FG001|COMPLETED|First Intervention (Cross-over Phase)||57||
48365206|NCT00500149|101223614|FG000|NOT COMPLETED|First Intervention (Cross-over Phase)||2||
48365207|NCT00500149|101223615|FG001|NOT COMPLETED|First Intervention (Cross-over Phase)||2||
48365208|NCT00500149|101223614|FG000|STARTED|Second Intervention (Cross-over Phase)||56||
48365209|NCT00500149|101223615|FG001|STARTED|Second Intervention (Cross-over Phase)||57||
48365210|NCT00500149|101223614|FG000|COMPLETED|Second Intervention (Cross-over Phase)||54||
48365211|NCT00500149|101223615|FG001|COMPLETED|Second Intervention (Cross-over Phase)||57||
48365212|NCT00500149|101223614|FG000|NOT COMPLETED|Second Intervention (Cross-over Phase)||2||
48365213|NCT00500149|101223615|FG001|NOT COMPLETED|Second Intervention (Cross-over Phase)||0||
48365214|NCT02088216|101223616|FG000|STARTED|Overall Study||81||
48365215|NCT02088216|101223617|FG001|STARTED|Overall Study||80||
48365216|NCT02088216|101223616|FG000|COMPLETED|Overall Study||69||
48365217|NCT02088216|101223617|FG001|COMPLETED|Overall Study||70||
48365218|NCT02088216|101223616|FG000|NOT COMPLETED|Overall Study||12||
48365219|NCT02088216|101223617|FG001|NOT COMPLETED|Overall Study||10||
48365220|NCT02239094|101223618|FG000|STARTED|Overall Study||20||
48365221|NCT02239094|101223618|FG000|COMPLETED|Overall Study||18||
48365222|NCT02239094|101223618|FG000|NOT COMPLETED|Overall Study||2||
48365223|NCT00843622|101223619|FG000|STARTED|Overall Study||125||
48365224|NCT00843622|101223620|FG001|STARTED|Overall Study||125||
48365225|NCT00843622|101223619|FG000|COMPLETED|Overall Study||82||
48365226|NCT00843622|101223620|FG001|COMPLETED|Overall Study||70||
48365227|NCT00843622|101223619|FG000|NOT COMPLETED|Overall Study||43||
48365228|NCT00843622|101223620|FG001|NOT COMPLETED|Overall Study||55||
48365229|NCT04281537|101223621|FG000|STARTED|Overall Study||76||
48365230|NCT04281537|101223622|FG001|STARTED|Overall Study||6||
48365231|NCT04281537|101223621|FG000|COMPLETED|Overall Study||76||
48365232|NCT04281537|101223622|FG001|COMPLETED|Overall Study||6||
48365233|NCT04281537|101223621|FG000|NOT COMPLETED|Overall Study||0||
48365234|NCT04281537|101223622|FG001|NOT COMPLETED|Overall Study||0||
48365235|NCT02213198|101223623|FG000|STARTED|Baseline||306||
48365236|NCT02213198|101223624|FG001|STARTED|Baseline||159||
48365237|NCT02213198|101223623|FG000|COMPLETED|Baseline||218||
48365238|NCT02213198|101223624|FG001|COMPLETED|Baseline||108||
48365239|NCT02213198|101223623|FG000|NOT COMPLETED|Baseline||88||
48365240|NCT02213198|101223624|FG001|NOT COMPLETED|Baseline||51||
48365241|NCT02213198|101223623|FG000|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||218||
48365242|NCT02213198|101223624|FG001|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||108||
48365243|NCT02213198|101223623|FG000|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||125||
48365244|NCT02213198|101223624|FG001|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||67||
48365245|NCT02213198|101223623|FG000|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||93||
48365246|NCT02213198|101223624|FG001|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||41||
48365247|NCT02213198|101223623|FG000|STARTED|Follow up 2 6 Months Post TCC Treatment||125||
48365248|NCT02213198|101223624|FG001|STARTED|Follow up 2 6 Months Post TCC Treatment||67||
48365249|NCT02213198|101223623|FG000|COMPLETED|Follow up 2 6 Months Post TCC Treatment||102||
48365250|NCT02213198|101223624|FG001|COMPLETED|Follow up 2 6 Months Post TCC Treatment||60||
48365251|NCT02213198|101223623|FG000|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||23||
48365252|NCT02213198|101223624|FG001|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||7||
48365253|NCT02948777|101223625|FG000|STARTED|Overall Study||14||
48365254|NCT02948777|101223625|FG000|COMPLETED|Overall Study||13||
48365255|NCT02948777|101223625|FG000|NOT COMPLETED|Overall Study||1||
48365256|NCT03395340|101223626|FG000|STARTED|Overall Study||1||
48365257|NCT03395340|101223626|FG000|COMPLETED|Overall Study||1||
48365258|NCT03395340|101223626|FG000|NOT COMPLETED|Overall Study||0||
48365259|NCT00691197|101223627|FG000|STARTED|Overall Study||166||
48365260|NCT00691197|101223628|FG001|STARTED|Overall Study||80||
48365261|NCT00691197|101223627|FG000|COMPLETED|Overall Study||155||
48365262|NCT00691197|101223628|FG001|COMPLETED|Overall Study||75||
48365263|NCT00691197|101223627|FG000|NOT COMPLETED|Overall Study||11||
48365264|NCT00691197|101223628|FG001|NOT COMPLETED|Overall Study||5||
48365265|NCT01024465|101223629|FG000|STARTED|Overall Study||26||
48365266|NCT01024465|101223629|FG000|COMPLETED|Overall Study||23||
48365267|NCT01024465|101223629|FG000|NOT COMPLETED|Overall Study||3||
48365268|NCT01148056|101223630|FG000|STARTED|Overall Study||2||
48365269|NCT01148056|101223630|FG000|COMPLETED|Overall Study||2||
48365270|NCT01148056|101223630|FG000|NOT COMPLETED|Overall Study||0||
48365271|NCT04493619|101223631|FG000|STARTED|Overall Study||14||
48365272|NCT04493619|101223632|FG001|STARTED|Overall Study||3||
48365273|NCT04493619|101223633|FG002|STARTED|Overall Study||7||
48365274|NCT04493619|101223634|FG003|STARTED|Overall Study||13||
48365275|NCT04493619|101223631|FG000|COMPLETED|Overall Study||0||
48365276|NCT04493619|101223632|FG001|COMPLETED|Overall Study||0||
48365277|NCT04493619|101223633|FG002|COMPLETED|Overall Study||0||
48365278|NCT04493619|101223634|FG003|COMPLETED|Overall Study||0||
48365279|NCT04493619|101223631|FG000|NOT COMPLETED|Overall Study||14||
48365280|NCT04493619|101223632|FG001|NOT COMPLETED|Overall Study||3||
48365281|NCT04493619|101223633|FG002|NOT COMPLETED|Overall Study||7||
48365282|NCT04493619|101223634|FG003|NOT COMPLETED|Overall Study||13||
48365283|NCT00064662|101223635|FG000|STARTED|Overall Study||329||
48365284|NCT00064662|101223636|FG001|STARTED|Overall Study||326||
48365285|NCT00064662|101223635|FG000|COMPLETED|Overall Study||255||
48365286|NCT00064662|101223636|FG001|COMPLETED|Overall Study||265||
48365287|NCT00064662|101223635|FG000|NOT COMPLETED|Overall Study||74||
48365288|NCT00064662|101223636|FG001|NOT COMPLETED|Overall Study||61||
48365289|NCT02101411|101223637|FG000|STARTED|Overall Study||111||
48365290|NCT02101411|101223638|FG001|STARTED|Overall Study||109||
48365291|NCT02101411|101223639|FG002|STARTED|Overall Study||114||
48365292|NCT02101411|101223637|FG000|COMPLETED|Overall Study||107||
48365293|NCT02101411|101223638|FG001|COMPLETED|Overall Study||102||
48365294|NCT02101411|101223639|FG002|COMPLETED|Overall Study||104||
48365295|NCT02101411|101223637|FG000|NOT COMPLETED|Overall Study||4||
48365296|NCT02101411|101223638|FG001|NOT COMPLETED|Overall Study||7||
48365297|NCT02101411|101223639|FG002|NOT COMPLETED|Overall Study||10||
48365298|NCT03729869|101223640|FG000|STARTED|Overall Study||40||
48365299|NCT03729869|101223641|FG001|STARTED|Overall Study||42||
48365300|NCT03729869|101223642|FG002|STARTED|Overall Study||35||
48365301|NCT03729869|101223643|FG003|STARTED|Overall Study||31||
48365302|NCT03729869|101223640|FG000|COMPLETED|Overall Study||39||
48365303|NCT03729869|101223641|FG001|COMPLETED|Overall Study||41||
48365304|NCT03729869|101223642|FG002|COMPLETED|Overall Study||35||
48365305|NCT03729869|101223643|FG003|COMPLETED|Overall Study||31||
48365306|NCT03729869|101223640|FG000|NOT COMPLETED|Overall Study||1||
48365307|NCT03729869|101223641|FG001|NOT COMPLETED|Overall Study||1||
48365308|NCT03729869|101223642|FG002|NOT COMPLETED|Overall Study||0||
48365309|NCT03729869|101223643|FG003|NOT COMPLETED|Overall Study||0||
48365310|NCT03008590|101223644|FG000|STARTED|Overall Study||14||
48365311|NCT03008590|101223645|FG001|STARTED|Overall Study||15||
48365312|NCT03008590|101223644|FG000|COMPLETED|Overall Study||11||
48365313|NCT03008590|101223645|FG001|COMPLETED|Overall Study||12||
48365314|NCT03008590|101223644|FG000|NOT COMPLETED|Overall Study||3||
48365315|NCT03008590|101223645|FG001|NOT COMPLETED|Overall Study||3||
48365316|NCT04985773|101223646|FG000|STARTED|Overall Study||200||
48365317|NCT04985773|101223646|FG000|COMPLETED|Overall Study||199||
48365318|NCT04985773|101223646|FG000|NOT COMPLETED|Overall Study||1||
48365319|NCT02517047|101223647|FG000|STARTED|Overall Study||26||
48365320|NCT02517047|101223647|FG000|COMPLETED|Overall Study||24||
48365321|NCT02517047|101223647|FG000|NOT COMPLETED|Overall Study||2||
48365322|NCT02413398|101223648|FG000|STARTED|Overall Study||160||
48654944|NCT00545948|101941136|FG001|Assigned Treatment|Overall Study||15||
48654945|NCT00545948|101941137|FG002|Assigned Treatment|Overall Study||0||
48365323|NCT02413398|101223649|FG001|STARTED|Overall Study||161||
48365324|NCT02413398|101223648|FG000|COMPLETED|Overall Study||156||
48365325|NCT02413398|101223649|FG001|COMPLETED|Overall Study||154||
48365326|NCT02413398|101223648|FG000|NOT COMPLETED|Overall Study||4||
48365327|NCT02413398|101223649|FG001|NOT COMPLETED|Overall Study||7||
48365328|NCT02110121|101223650|FG000|STARTED|Overall Study||58||
48365329|NCT02110121|101223651|FG001|STARTED|Overall Study||5||
48365330|NCT02110121|101223650|FG000|COMPLETED|Overall Study||42||
48654946|NCT00545948|101941135|FG000|COMPLETED|Overall Study||8||
48654947|NCT00545948|101941136|FG001|COMPLETED|Overall Study||14||
48654948|NCT00545948|101941137|FG002|COMPLETED|Overall Study||0||
48654949|NCT00545948|101941135|FG000|NOT COMPLETED|Overall Study||1||
48365331|NCT02110121|101223651|FG001|COMPLETED|Overall Study||5||
48365332|NCT02110121|101223650|FG000|NOT COMPLETED|Overall Study||16||
48365333|NCT02110121|101223651|FG001|NOT COMPLETED|Overall Study||0||
48365334|NCT01588197|101223652|FG000|STARTED|Overall Study||10||
48365335|NCT01588197|101223653|FG001|STARTED|Overall Study||10||
48365336|NCT01588197|101223652|FG000|COMPLETED|Overall Study||9||
48365337|NCT01588197|101223653|FG001|COMPLETED|Overall Study||9||
48365338|NCT01588197|101223652|FG000|NOT COMPLETED|Overall Study||1||
48365339|NCT01588197|101223653|FG001|NOT COMPLETED|Overall Study||1||
48365340|NCT01095250|101223654|FG000|STARTED|Overall Study||8||
48365341|NCT01095250|101223655|FG001|STARTED|Overall Study||10||
48365342|NCT01095250|101223656|FG002|STARTED|Overall Study||8||
48365343|NCT01095250|101223657|FG003|STARTED|Overall Study||5||
48365344|NCT01095250|101223654|FG000|COMPLETED|Overall Study||0||
48654950|NCT00545948|101941136|FG001|NOT COMPLETED|Overall Study||1||
48365345|NCT01095250|101223655|FG001|COMPLETED|Overall Study||0||
48365346|NCT01095250|101223656|FG002|COMPLETED|Overall Study||0||
48365347|NCT01095250|101223657|FG003|COMPLETED|Overall Study||0||
48365348|NCT01095250|101223654|FG000|NOT COMPLETED|Overall Study||8||
48365349|NCT01095250|101223655|FG001|NOT COMPLETED|Overall Study||10||
48365350|NCT01095250|101223656|FG002|NOT COMPLETED|Overall Study||8||
48365351|NCT01095250|101223657|FG003|NOT COMPLETED|Overall Study||5||
48365352|NCT02075255|101223658|FG000|STARTED|Overall Study||72||
48365353|NCT02075255|101223659|FG001|STARTED|Overall Study||73||
48365354|NCT02075255|101223660|FG002|STARTED|Overall Study||75||
48365355|NCT02075255|101223658|FG000|COMPLETED|Overall Study||68||
48365356|NCT02075255|101223659|FG001|COMPLETED|Overall Study||69||
48365357|NCT02075255|101223660|FG002|COMPLETED|Overall Study||72||
48365358|NCT02075255|101223658|FG000|NOT COMPLETED|Overall Study||4||
48365359|NCT02075255|101223659|FG001|NOT COMPLETED|Overall Study||4||
48365360|NCT02075255|101223660|FG002|NOT COMPLETED|Overall Study||3||
48365361|NCT01518192|101223661|FG000|STARTED|Overall Study||145||
48365362|NCT01518192|101223662|FG001|STARTED|Overall Study||140||
48365363|NCT01518192|101223663|FG002|STARTED|Overall Study||259||
48365364|NCT01518192|101223661|FG000|COMPLETED|Overall Study||116||
48365365|NCT01518192|101223662|FG001|COMPLETED|Overall Study||114||
48365366|NCT01518192|101223663|FG002|COMPLETED|Overall Study||224||
48365367|NCT01518192|101223661|FG000|NOT COMPLETED|Overall Study||29||
48365368|NCT01518192|101223662|FG001|NOT COMPLETED|Overall Study||26||
48365369|NCT01518192|101223663|FG002|NOT COMPLETED|Overall Study||35||
48365370|NCT01254604|101223664|FG000|STARTED|Overall Study||95||
48365371|NCT01254604|101223665|FG001|STARTED|Overall Study||95||
48365372|NCT01254604|101223664|FG000|Treated|Overall Study||93||
48365373|NCT01254604|101223665|FG001|Treated|Overall Study||94||
48365374|NCT01254604|101223664|FG000|COMPLETED|Overall Study||87||
48365375|NCT01254604|101223665|FG001|COMPLETED|Overall Study||86||
48365376|NCT01254604|101223664|FG000|NOT COMPLETED|Overall Study||8||
48365377|NCT01254604|101223665|FG001|NOT COMPLETED|Overall Study||9||
48365378|NCT01943539|101223666|FG000|STARTED|Overall Study||44||
48365379|NCT01943539|101223667|FG001|STARTED|Overall Study||40||
48365380|NCT01943539|101223666|FG000|COMPLETED|Overall Study||40||
48365381|NCT01943539|101223667|FG001|COMPLETED|Overall Study||40||
48365382|NCT01943539|101223666|FG000|NOT COMPLETED|Overall Study||4||
48365383|NCT01943539|101223667|FG001|NOT COMPLETED|Overall Study||0||
48365384|NCT04705597|101223668|FG000|STARTED|Overall Study||96||
48365385|NCT04705597|101223669|FG001|STARTED|Overall Study||98||
48365386|NCT04705597|101223668|FG000|COMPLETED|Overall Study||78||
48365387|NCT04705597|101223669|FG001|COMPLETED|Overall Study||87||
48365388|NCT04705597|101223668|FG000|NOT COMPLETED|Overall Study||18||
48365389|NCT04705597|101223669|FG001|NOT COMPLETED|Overall Study||11||
48365390|NCT00726323|101223670|FG000|STARTED|Overall Study||37||
48436548|NCT02060526|101403574|FG000|NOT COMPLETED|Overall Study||0||
48365391|NCT00726323|101223671|FG001|STARTED|Overall Study||37||
48365392|NCT00726323|101223670|FG000|COMPLETED|Overall Study||0||
48365393|NCT00726323|101223671|FG001|COMPLETED|Overall Study||6||
48365394|NCT00726323|101223670|FG000|NOT COMPLETED|Overall Study||37||
48365395|NCT00726323|101223671|FG001|NOT COMPLETED|Overall Study||31||
48365396|NCT01844700|101223672|FG000|STARTED|Overall Study||4||
48365397|NCT01844700|101223673|FG001|STARTED|Overall Study||3||
48365398|NCT01844700|101223672|FG000|COMPLETED|Overall Study||1||
48365399|NCT01844700|101223673|FG001|COMPLETED|Overall Study||2||
48365400|NCT01844700|101223672|FG000|NOT COMPLETED|Overall Study||3||
48365401|NCT01844700|101223673|FG001|NOT COMPLETED|Overall Study||1||
48365402|NCT02805907|101223674|FG000|STARTED|Overall Study||56||
48365403|NCT02805907|101223675|FG001|STARTED|Overall Study||56||
48365404|NCT02805907|101223674|FG000|COMPLETED|Overall Study||53||
48365405|NCT02805907|101223675|FG001|COMPLETED|Overall Study||53||
48365406|NCT02805907|101223674|FG000|NOT COMPLETED|Overall Study||3||
48365407|NCT02805907|101223675|FG001|NOT COMPLETED|Overall Study||3||
48365408|NCT01520324|101223676|FG000|STARTED|Overall Study||53||
48365409|NCT01520324|101223676|FG000|COMPLETED|Overall Study||52||
48365410|NCT01520324|101223676|FG000|NOT COMPLETED|Overall Study||1||
48365411|NCT00077623|101223677|FG000|STARTED|Overall Study||190||
48436549|NCT02060526|101403575|FG001|NOT COMPLETED|Overall Study||0||
48365412|NCT00077623|101223678|FG001|STARTED|Overall Study||191||
48365413|NCT00077623|101223679|FG002|STARTED|Overall Study||191||
48365414|NCT00077623|101223677|FG000|COMPLETED|Overall Study||154||
48365415|NCT00077623|101223678|FG001|COMPLETED|Overall Study||148||
48365416|NCT00077623|101223679|FG002|COMPLETED|Overall Study||159||
48365417|NCT00077623|101223677|FG000|NOT COMPLETED|Overall Study||36||
48365418|NCT00077623|101223678|FG001|NOT COMPLETED|Overall Study||43||
48365419|NCT00077623|101223679|FG002|NOT COMPLETED|Overall Study||32||
48365420|NCT02092415|101223680|FG000|STARTED|Overall Study||10||
48365421|NCT02092415|101223680|FG000|COMPLETED|Overall Study||10||
48365422|NCT02092415|101223680|FG000|NOT COMPLETED|Overall Study||0||
48365423|NCT00733512|101223681|FG000|STARTED|Overall Study||146||
48365424|NCT00733512|101223681|FG000|COMPLETED|Overall Study||146||
48365425|NCT00733512|101223681|FG000|NOT COMPLETED|Overall Study||0||
48365426|NCT01790438|101223682|FG000|STARTED|Overall Study||428||
48436550|NCT02060526|101403576|FG002|NOT COMPLETED|Overall Study||0||
48365427|NCT01790438|101223683|FG001|STARTED|Overall Study||213||
48365428|NCT01790438|101223682|FG000|Received at Least One Dose of Study Drug|Overall Study||427||
48365429|NCT01790438|101223683|FG001|Received at Least One Dose of Study Drug|Overall Study||212||
48365430|NCT01790438|101223682|FG000|COMPLETED|Overall Study||393||
48365431|NCT01790438|101223683|FG001|COMPLETED|Overall Study||202||
48365432|NCT01790438|101223682|FG000|NOT COMPLETED|Overall Study||35||
48365433|NCT01790438|101223683|FG001|NOT COMPLETED|Overall Study||11||
48365434|NCT00474630|101223684|FG000|STARTED|Overall Study||335||
48365435|NCT00474630|101223685|FG001|STARTED|Overall Study||170||
48365436|NCT00474630|101223684|FG000|COMPLETED|Overall Study||175||
48365437|NCT00474630|101223685|FG001|COMPLETED|Overall Study||100||
48365438|NCT00474630|101223684|FG000|NOT COMPLETED|Overall Study||160||
48365439|NCT00474630|101223685|FG001|NOT COMPLETED|Overall Study||70||
48365440|NCT04590937|101223686|FG000|STARTED|Period 1 - Cocktail||15||
48365441|NCT04590937|101223686|FG000|COMPLETED|Period 1 - Cocktail||15|"completed refers to: not prematurely discontinued from trial medication"|
48365442|NCT04590937|101223686|FG000|NOT COMPLETED|Period 1 - Cocktail||0||
48365443|NCT04590937|101223686|FG000|STARTED|Period 2 - BI 730357+Cocktail||15||
48365444|NCT04590937|101223686|FG000|Treated at Least One Dose of BI|Period 2 - BI 730357+Cocktail||15||
48365445|NCT04590937|101223686|FG000|Treated at Least One Dose of Cocktail+BI|Period 2 - BI 730357+Cocktail||14||
48365446|NCT04590937|101223686|FG000|COMPLETED|Period 2 - BI 730357+Cocktail||14|"completed refers to: not prematurely discontinued from trial medication"|
48365447|NCT04590937|101223686|FG000|NOT COMPLETED|Period 2 - BI 730357+Cocktail||1||
48365448|NCT01000064|101223687|FG000|STARTED|Overall Study||7||
48365449|NCT01000064|101223688|FG001|STARTED|Overall Study||6||
48365450|NCT01000064|101223687|FG000|COMPLETED|Overall Study||6||
48365451|NCT01000064|101223688|FG001|COMPLETED|Overall Study||5||
48365452|NCT01000064|101223687|FG000|NOT COMPLETED|Overall Study||1||
48365453|NCT01000064|101223688|FG001|NOT COMPLETED|Overall Study||1||
48365454|NCT04760314|101223689|FG000|STARTED|Induction Period||82||
48365455|NCT04760314|101223690|FG001|STARTED|Induction Period||81||
48365456|NCT04760314|101223691|FG002|STARTED|Induction Period||123||
48654951|NCT00545948|101941137|FG002|NOT COMPLETED|Overall Study||7||
48654952|NCT02662582|101941138|FG000|STARTED|Treatment Period 1 (14 Days)||23||
48654953|NCT02662582|101941139|FG001|STARTED|Treatment Period 1 (14 Days)||23||
48654954|NCT02662582|101941138|FG000|COMPLETED|Treatment Period 1 (14 Days)||18||
48654955|NCT02662582|101941139|FG001|COMPLETED|Treatment Period 1 (14 Days)||19||
48654956|NCT02662582|101941138|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||5||
48654957|NCT02662582|101941139|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||4||
48654958|NCT02662582|101941138|FG000|STARTED|Washout Period (14 Days)||18||
48654959|NCT02662582|101941139|FG001|STARTED|Washout Period (14 Days)||19||
48654960|NCT02662582|101941138|FG000|COMPLETED|Washout Period (14 Days)||18||
48654961|NCT02662582|101941139|FG001|COMPLETED|Washout Period (14 Days)||19||
48654962|NCT02662582|101941138|FG000|NOT COMPLETED|Washout Period (14 Days)||0||
48365457|NCT04760314|101223692|FG003|STARTED|Induction Period||0||
48365458|NCT04760314|101223693|FG004|STARTED|Induction Period||0||
48365459|NCT04760314|101223694|FG005|STARTED|Induction Period||0||
48365460|NCT04760314|101223695|FG006|STARTED|Induction Period||0||
48365461|NCT04760314|101223696|FG007|STARTED|Induction Period||0||
48365462|NCT04760314|101223697|FG008|STARTED|Induction Period||0||
48365463|NCT04760314|101223698|FG009|STARTED|Induction Period||0||
48365464|NCT04760314|101223699|FG010|STARTED|Induction Period||0||
48365465|NCT04760314|101223689|FG000|Received at Least One Dose of Study Drug|Induction Period||82||
48365466|NCT04760314|101223690|FG001|Received at Least One Dose of Study Drug|Induction Period||81||
48365467|NCT04760314|101223691|FG002|Received at Least One Dose of Study Drug|Induction Period||123||
48365468|NCT04760314|101223692|FG003|Received at Least One Dose of Study Drug|Induction Period||0||
48365469|NCT04760314|101223693|FG004|Received at Least One Dose of Study Drug|Induction Period||0||
48365470|NCT04760314|101223694|FG005|Received at Least One Dose of Study Drug|Induction Period||0||
48365471|NCT04760314|101223695|FG006|Received at Least One Dose of Study Drug|Induction Period||0||
48365472|NCT04760314|101223696|FG007|Received at Least One Dose of Study Drug|Induction Period||0||
48365473|NCT04760314|101223697|FG008|Received at Least One Dose of Study Drug|Induction Period||0||
48365474|NCT04760314|101223698|FG009|Received at Least One Dose of Study Drug|Induction Period||0||
48365475|NCT04760314|101223699|FG010|Received at Least One Dose of Study Drug|Induction Period||0||
48365476|NCT04760314|101223689|FG000|COMPLETED|Induction Period||82||
48365477|NCT04760314|101223690|FG001|COMPLETED|Induction Period||80||
48365478|NCT04760314|101223691|FG002|COMPLETED|Induction Period||120||
48365479|NCT04760314|101223692|FG003|COMPLETED|Induction Period||0||
48654963|NCT02662582|101941139|FG001|NOT COMPLETED|Washout Period (14 Days)||0||
48654964|NCT02662582|101941138|FG000|STARTED|Treatment Period 2 (14 Days)||18||
48365480|NCT04760314|101223693|FG004|COMPLETED|Induction Period||0||
48365481|NCT04760314|101223694|FG005|COMPLETED|Induction Period||0||
48365482|NCT04760314|101223695|FG006|COMPLETED|Induction Period||0||
48365483|NCT04760314|101223696|FG007|COMPLETED|Induction Period||0||
48365484|NCT04760314|101223697|FG008|COMPLETED|Induction Period||0||
48365485|NCT04760314|101223698|FG009|COMPLETED|Induction Period||0||
48365486|NCT04760314|101223699|FG010|COMPLETED|Induction Period||0||
48365487|NCT04760314|101223689|FG000|NOT COMPLETED|Induction Period||0||
48654965|NCT02662582|101941139|FG001|STARTED|Treatment Period 2 (14 Days)||19||
48654966|NCT02662582|101941138|FG000|COMPLETED|Treatment Period 2 (14 Days)||18||
48654967|NCT02662582|101941139|FG001|COMPLETED|Treatment Period 2 (14 Days)||19||
48365488|NCT04760314|101223690|FG001|NOT COMPLETED|Induction Period||1||
48365489|NCT04760314|101223691|FG002|NOT COMPLETED|Induction Period||3||
48365490|NCT04760314|101223692|FG003|NOT COMPLETED|Induction Period||0||
48365491|NCT04760314|101223693|FG004|NOT COMPLETED|Induction Period||0||
48365492|NCT04760314|101223694|FG005|NOT COMPLETED|Induction Period||0||
48365493|NCT04760314|101223695|FG006|NOT COMPLETED|Induction Period||0||
48365494|NCT04760314|101223696|FG007|NOT COMPLETED|Induction Period||0||
48365495|NCT04760314|101223697|FG008|NOT COMPLETED|Induction Period||0||
48365496|NCT04760314|101223698|FG009|NOT COMPLETED|Induction Period||0||
48365497|NCT04760314|101223699|FG010|NOT COMPLETED|Induction Period||0||
48365498|NCT04760314|101223689|FG000|STARTED|Maintenance Blinded Period||0||
48365499|NCT04760314|101223690|FG001|STARTED|Maintenance Blinded Period||0||
48365500|NCT04760314|101223691|FG002|STARTED|Maintenance Blinded Period||0||
48365501|NCT04760314|101223692|FG003|STARTED|Maintenance Blinded Period||11||
48365502|NCT04760314|101223693|FG004|STARTED|Maintenance Blinded Period||38||
48365503|NCT04760314|101223694|FG005|STARTED|Maintenance Blinded Period||33||
48365504|NCT04760314|101223695|FG006|STARTED|Maintenance Blinded Period||32||
48365505|NCT04760314|101223696|FG007|STARTED|Maintenance Blinded Period||0||
48365506|NCT04760314|101223697|FG008|STARTED|Maintenance Blinded Period||0||
48365507|NCT04760314|101223698|FG009|STARTED|Maintenance Blinded Period||0||
48365508|NCT04760314|101223699|FG010|STARTED|Maintenance Blinded Period||0||
48365509|NCT04760314|101223689|FG000|Received at Least One Dose of Study Drug|Maintenance Blinded Period||0||
48365510|NCT04760314|101223690|FG001|Received at Least One Dose of Study Drug|Maintenance Blinded Period||0||
48365511|NCT04760314|101223691|FG002|Received at Least One Dose of Study Drug|Maintenance Blinded Period||0||
48365512|NCT04760314|101223692|FG003|Received at Least One Dose of Study Drug|Maintenance Blinded Period||11||
48365513|NCT04760314|101223693|FG004|Received at Least One Dose of Study Drug|Maintenance Blinded Period||38||
48365514|NCT04760314|101223694|FG005|Received at Least One Dose of Study Drug|Maintenance Blinded Period||33||
48365515|NCT04760314|101223695|FG006|Received at Least One Dose of Study Drug|Maintenance Blinded Period||32||
48365516|NCT04760314|101223696|FG007|Received at Least One Dose of Study Drug|Maintenance Blinded Period||0||
48365517|NCT04760314|101223697|FG008|Received at Least One Dose of Study Drug|Maintenance Blinded Period||0||
48365518|NCT04760314|101223698|FG009|Received at Least One Dose of Study Drug|Maintenance Blinded Period||0||
48365519|NCT04760314|101223699|FG010|Received at Least One Dose of Study Drug|Maintenance Blinded Period||0||
48365520|NCT04760314|101223689|FG000|COMPLETED|Maintenance Blinded Period||0||
48365521|NCT04760314|101223690|FG001|COMPLETED|Maintenance Blinded Period||0||
48365522|NCT04760314|101223691|FG002|COMPLETED|Maintenance Blinded Period||0||
48365523|NCT04760314|101223692|FG003|COMPLETED|Maintenance Blinded Period||9||
48365524|NCT04760314|101223693|FG004|COMPLETED|Maintenance Blinded Period||35||
48365525|NCT04760314|101223694|FG005|COMPLETED|Maintenance Blinded Period||27||
48365526|NCT04760314|101223695|FG006|COMPLETED|Maintenance Blinded Period||27||
48365527|NCT04760314|101223696|FG007|COMPLETED|Maintenance Blinded Period||0||
48365528|NCT04760314|101223697|FG008|COMPLETED|Maintenance Blinded Period||0||
48365529|NCT04760314|101223698|FG009|COMPLETED|Maintenance Blinded Period||0||
48365530|NCT04760314|101223699|FG010|COMPLETED|Maintenance Blinded Period||0||
48365531|NCT04760314|101223689|FG000|NOT COMPLETED|Maintenance Blinded Period||0||
48365532|NCT04760314|101223690|FG001|NOT COMPLETED|Maintenance Blinded Period||0||
48365533|NCT04760314|101223691|FG002|NOT COMPLETED|Maintenance Blinded Period||0||
48365534|NCT04760314|101223692|FG003|NOT COMPLETED|Maintenance Blinded Period||2||
48365535|NCT04760314|101223693|FG004|NOT COMPLETED|Maintenance Blinded Period||3||
48365536|NCT04760314|101223694|FG005|NOT COMPLETED|Maintenance Blinded Period||6||
48365537|NCT04760314|101223695|FG006|NOT COMPLETED|Maintenance Blinded Period||5||
48365538|NCT04760314|101223696|FG007|NOT COMPLETED|Maintenance Blinded Period||0||
48365539|NCT04760314|101223697|FG008|NOT COMPLETED|Maintenance Blinded Period||0||
48365540|NCT04760314|101223698|FG009|NOT COMPLETED|Maintenance Blinded Period||0||
48365541|NCT04760314|101223699|FG010|NOT COMPLETED|Maintenance Blinded Period||0||
48365542|NCT04760314|101223689|FG000|STARTED|Maintenance Open Label Escape Arm||0||
48365543|NCT04760314|101223690|FG001|STARTED|Maintenance Open Label Escape Arm||0||
48365544|NCT04760314|101223691|FG002|STARTED|Maintenance Open Label Escape Arm||0||
48365545|NCT04760314|101223692|FG003|STARTED|Maintenance Open Label Escape Arm||0||
48365546|NCT04760314|101223693|FG004|STARTED|Maintenance Open Label Escape Arm||0||
48365547|NCT04760314|101223694|FG005|STARTED|Maintenance Open Label Escape Arm||0||
48365548|NCT04760314|101223695|FG006|STARTED|Maintenance Open Label Escape Arm||0||
48365549|NCT04760314|101223696|FG007|STARTED|Maintenance Open Label Escape Arm||71||
48365550|NCT04760314|101223697|FG008|STARTED|Maintenance Open Label Escape Arm||42||
48365551|NCT04760314|101223698|FG009|STARTED|Maintenance Open Label Escape Arm||55||
48188694|NCT05590910|100783311|FG001|NOT COMPLETED|Overall Study||0||
48436551|NCT01463631|101403577|FG000|STARTED|Overall Study||3||
48365552|NCT04760314|101223699|FG010|STARTED|Maintenance Open Label Escape Arm||8||
48365553|NCT04760314|101223689|FG000|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||0||
48365554|NCT04760314|101223690|FG001|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||0||
48365555|NCT04760314|101223691|FG002|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||0||
48365556|NCT04760314|101223692|FG003|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||0||
48365557|NCT04760314|101223693|FG004|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||0||
48365558|NCT04760314|101223694|FG005|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||0||
48365559|NCT04760314|101223695|FG006|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||0||
48365560|NCT04760314|101223696|FG007|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||71||
48365561|NCT04760314|101223697|FG008|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||42||
48365562|NCT04760314|101223698|FG009|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||55||
48365563|NCT04760314|101223699|FG010|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||8||
48365564|NCT04760314|101223689|FG000|COMPLETED|Maintenance Open Label Escape Arm||0||
48765810|NCT03431259|102214733|FG001|STARTED|Overall Study||117||
48765811|NCT03431259|102214732|FG000|COMPLETED|Overall Study||113||
48765812|NCT03431259|102214733|FG001|COMPLETED|Overall Study||116||
48765813|NCT03431259|102214732|FG000|NOT COMPLETED|Overall Study||2||
48765814|NCT03431259|102214733|FG001|NOT COMPLETED|Overall Study||1||
48765815|NCT02667119|102214734|FG000|STARTED|Overall Study||14||
48765816|NCT02667119|102214735|FG001|STARTED|Overall Study||13||
48765817|NCT02667119|102214734|FG000|COMPLETED|Overall Study||11||
48765818|NCT02667119|102214735|FG001|COMPLETED|Overall Study||13||
48765819|NCT02667119|102214734|FG000|NOT COMPLETED|Overall Study||3||
48765820|NCT02667119|102214735|FG001|NOT COMPLETED|Overall Study||0||
48765821|NCT02252666|102214736|FG000|STARTED|Overall Study||6||
48765822|NCT02252666|102214736|FG000|COMPLETED|Overall Study||6||
48765823|NCT02252666|102214736|FG000|NOT COMPLETED|Overall Study||0||
48765824|NCT04614363|102214737|FG000|STARTED|Overall Study||30||
48765825|NCT04614363|102214738|FG001|STARTED|Overall Study||50||
48765826|NCT04614363|102214737|FG000|COMPLETED|Overall Study||27||
48765827|NCT04614363|102214738|FG001|COMPLETED|Overall Study||49||
48765828|NCT04614363|102214737|FG000|NOT COMPLETED|Overall Study||3||
48765829|NCT04614363|102214738|FG001|NOT COMPLETED|Overall Study||1||
48765830|NCT01995838|102214739|FG000|STARTED|Overall Study||56||
48765831|NCT01995838|102214740|FG001|STARTED|Overall Study||32||
48765832|NCT01995838|102214741|FG002|STARTED|Overall Study||27||
48765833|NCT01995838|102214742|FG003|STARTED|Overall Study||38||
48765834|NCT01995838|102214743|FG004|STARTED|Overall Study||32||
48765835|NCT01995838|102214744|FG005|STARTED|Overall Study||56||
48765836|NCT01995838|102214745|FG006|STARTED|Overall Study||50||
48765837|NCT01995838|102214739|FG000|COMPLETED|Overall Study||51||
48765838|NCT01995838|102214740|FG001|COMPLETED|Overall Study||30||
48765839|NCT01995838|102214741|FG002|COMPLETED|Overall Study||27||
48765840|NCT01995838|102214742|FG003|COMPLETED|Overall Study||36||
48365565|NCT04760314|101223690|FG001|COMPLETED|Maintenance Open Label Escape Arm||0||
48365566|NCT04760314|101223691|FG002|COMPLETED|Maintenance Open Label Escape Arm||0||
48365567|NCT04760314|101223692|FG003|COMPLETED|Maintenance Open Label Escape Arm||0||
48365568|NCT04760314|101223693|FG004|COMPLETED|Maintenance Open Label Escape Arm||0||
48365569|NCT04760314|101223694|FG005|COMPLETED|Maintenance Open Label Escape Arm||0||
48365570|NCT04760314|101223695|FG006|COMPLETED|Maintenance Open Label Escape Arm||0||
48365571|NCT04760314|101223696|FG007|COMPLETED|Maintenance Open Label Escape Arm||63||
48365572|NCT04760314|101223697|FG008|COMPLETED|Maintenance Open Label Escape Arm||40||
48365573|NCT04760314|101223698|FG009|COMPLETED|Maintenance Open Label Escape Arm||48||
48365574|NCT04760314|101223699|FG010|COMPLETED|Maintenance Open Label Escape Arm||7||
48365575|NCT04760314|101223689|FG000|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
48365576|NCT04760314|101223690|FG001|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
48365577|NCT04760314|101223691|FG002|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
48436552|NCT01463631|101403578|FG001|STARTED|Overall Study||4||
48436553|NCT01463631|101403579|FG002|STARTED|Overall Study||5||
48436554|NCT01463631|101403580|FG003|STARTED|Overall Study||15||
48765841|NCT01995838|102214743|FG004|COMPLETED|Overall Study||30||
48765842|NCT01995838|102214744|FG005|COMPLETED|Overall Study||54||
48765843|NCT01995838|102214745|FG006|COMPLETED|Overall Study||45||
48765844|NCT01995838|102214739|FG000|NOT COMPLETED|Overall Study||5||
48765845|NCT01995838|102214740|FG001|NOT COMPLETED|Overall Study||2||
48765846|NCT01995838|102214741|FG002|NOT COMPLETED|Overall Study||0||
48765847|NCT01995838|102214742|FG003|NOT COMPLETED|Overall Study||2||
48765848|NCT01995838|102214743|FG004|NOT COMPLETED|Overall Study||2||
48765849|NCT01995838|102214744|FG005|NOT COMPLETED|Overall Study||2||
48765850|NCT01995838|102214745|FG006|NOT COMPLETED|Overall Study||5||
48765851|NCT00935584|102214746|FG000|STARTED|Overall Study||126||
48765852|NCT00935584|102214747|FG001|STARTED|Overall Study||23||
48765853|NCT00935584|102214746|FG000|COMPLETED|Overall Study||77||
48765854|NCT00935584|102214747|FG001|COMPLETED|Overall Study||19||
48765855|NCT00935584|102214746|FG000|NOT COMPLETED|Overall Study||49||
48765856|NCT00935584|102214747|FG001|NOT COMPLETED|Overall Study||4||
48765857|NCT03133793|102214748|FG000|STARTED|Overall Study||39||
48765858|NCT03133793|102214749|FG001|STARTED|Overall Study||39||
48765859|NCT03133793|102214750|FG002|STARTED|Overall Study||37||
48765860|NCT03133793|102214751|FG003|STARTED|Overall Study||38||
48765861|NCT03133793|102214748|FG000|COMPLETED|Overall Study||38||
48765862|NCT03133793|102214749|FG001|COMPLETED|Overall Study||35||
48765863|NCT03133793|102214750|FG002|COMPLETED|Overall Study||33||
48765864|NCT03133793|102214751|FG003|COMPLETED|Overall Study||33||
48765865|NCT03133793|102214748|FG000|NOT COMPLETED|Overall Study||1||
48765866|NCT03133793|102214749|FG001|NOT COMPLETED|Overall Study||4||
48765867|NCT03133793|102214750|FG002|NOT COMPLETED|Overall Study||4||
48765868|NCT03133793|102214751|FG003|NOT COMPLETED|Overall Study||5||
48765869|NCT00960999|102214752|FG000|STARTED|Overall Study||47||
48765870|NCT00960999|102214753|FG001|STARTED|Overall Study||47||
48765871|NCT00960999|102214752|FG000|Eligible|Overall Study||39||
48765872|NCT00960999|102214753|FG001|Eligible|Overall Study||45||
48765873|NCT00960999|102214752|FG000|Started Protocol Treatment|Overall Study||39|Eligible participants who started protocol treatment|
48765874|NCT00960999|102214753|FG001|Started Protocol Treatment|Overall Study||45|Eligible participants who started protocol treatment|
48765875|NCT00960999|102214752|FG000|Primary Endpoint Population|Overall Study||38|First 38 eligible participants on each arm who started treatment|
48765876|NCT00960999|102214753|FG001|Primary Endpoint Population|Overall Study||38|First 38 eligible participants on each arm who started treatment|
48765877|NCT00960999|102214752|FG000|Peak SUV at 8 Weeks|Overall Study||3|Eligible participants with peak standardized uptake value (SUV) at baseline and 8 weeks|
48765878|NCT00960999|102214753|FG001|Peak SUV at 8 Weeks|Overall Study||11|Eligible participants with peak standardized uptake value (SUV) at baseline and 8 weeks|
48765879|NCT00960999|102214752|FG000|Peak SUV at 1 Year|Overall Study||4|Eligible participants with peak standardized uptake value (SUV) at baseline and one year|
48765880|NCT00960999|102214753|FG001|Peak SUV at 1 Year|Overall Study||7|Eligible participants with peak standardized uptake value (SUV) at baseline and one year|
48765881|NCT00960999|102214752|FG000|Normalized SUV at 8 Weeks|Overall Study||3|Eligible participants with normalized standardized uptake value (SUV) at baseline and 8 weeks|
48765882|NCT00960999|102214753|FG001|Normalized SUV at 8 Weeks|Overall Study||9|Eligible participants with normalized standardized uptake value (SUV) at baseline and 8 weeks|
48765883|NCT00960999|102214752|FG000|Normalized SUV at 1 Year|Overall Study||4|Eligible participants with normalized standardized uptake value (SUV) at baseline and one year|
48765884|NCT00960999|102214753|FG001|Normalized SUV at 1 Year|Overall Study||7|Eligible participants with normalized standardized uptake value (SUV) at baseline and one year|
48765885|NCT00960999|102214752|FG000|FEV1 by Best Response|Overall Study||26|Eligible; FEV1 at baseline and 6 months; complete or partial response, or stable disease|
48765886|NCT00960999|102214753|FG001|FEV1 by Best Response|Overall Study||33|Eligible; FEV1 at baseline and 6 months; complete or partial response, or stable disease|
48765887|NCT00960999|102214752|FG000|DLCO by Best Response|Overall Study||23|Eligible; DLCO at baseline and 6 months; complete or partial response, or stable disease|
48765888|NCT00960999|102214753|FG001|DLCO by Best Response|Overall Study||28|Eligible; DLCO at baseline and 6 months; complete or partial response, or stable disease|
48765889|NCT00960999|102214752|FG000|COMPLETED|Overall Study||39|Subjects contributing data to results are considered to have completed the study.|
48765890|NCT00960999|102214753|FG001|COMPLETED|Overall Study||45|Subjects contributing data to results are considered to have completed the study.|
48765891|NCT00960999|102214752|FG000|NOT COMPLETED|Overall Study||8||
48765892|NCT00960999|102214753|FG001|NOT COMPLETED|Overall Study||2||
48765893|NCT03416985|102214754|FG000|STARTED|Overall Study||30||
48765894|NCT03416985|102214755|FG001|STARTED|Overall Study||30||
48765895|NCT03416985|102214756|FG002|STARTED|Overall Study||30||
48765896|NCT03416985|102214754|FG000|COMPLETED|Overall Study||28||
48765897|NCT03416985|102214755|FG001|COMPLETED|Overall Study||30||
48765898|NCT03416985|102214756|FG002|COMPLETED|Overall Study||24||
48765899|NCT03416985|102214754|FG000|NOT COMPLETED|Overall Study||2||
48765900|NCT03416985|102214755|FG001|NOT COMPLETED|Overall Study||0||
48765901|NCT03416985|102214756|FG002|NOT COMPLETED|Overall Study||6||
48765902|NCT05465317|102214757|FG000|STARTED|Overall Study||20279||
48765903|NCT05465317|102214758|FG001|STARTED|Overall Study||41918||
48765904|NCT05465317|102214757|FG000|COMPLETED|Overall Study||20279||
48765905|NCT05465317|102214758|FG001|COMPLETED|Overall Study||41918||
48765906|NCT05465317|102214757|FG000|NOT COMPLETED|Overall Study||0||
48765907|NCT05465317|102214758|FG001|NOT COMPLETED|Overall Study||0||
48765908|NCT00905164|102214759|FG000|STARTED|Period 1||12||
48765909|NCT00905164|102214760|FG001|STARTED|Period 1||12||
48765910|NCT00905164|102214759|FG000|COMPLETED|Period 1||12||
48765911|NCT00905164|102214760|FG001|COMPLETED|Period 1||11||
48765912|NCT00905164|102214759|FG000|NOT COMPLETED|Period 1||0||
48765913|NCT00905164|102214760|FG001|NOT COMPLETED|Period 1||1||
48765914|NCT00905164|102214759|FG000|STARTED|Period 2||12||
48765915|NCT00905164|102214760|FG001|STARTED|Period 2||11||
48765916|NCT00905164|102214759|FG000|COMPLETED|Period 2||12||
48765917|NCT00905164|102214760|FG001|COMPLETED|Period 2||11||
48765918|NCT00905164|102214759|FG000|NOT COMPLETED|Period 2||0||
48765919|NCT00905164|102214760|FG001|NOT COMPLETED|Period 2||0||
48765920|NCT02546388|102214761|FG000|STARTED|Overall Study||4||
48765921|NCT02546388|102214762|FG001|STARTED|Overall Study||13||
48188695|NCT02034435|100783312|FG000|STARTED|Overall Study||13||
48765922|NCT02546388|102214761|FG000|COMPLETED|Overall Study||4||
48765923|NCT02546388|102214762|FG001|COMPLETED|Overall Study||13||
48765924|NCT02546388|102214761|FG000|NOT COMPLETED|Overall Study||0||
48765925|NCT02546388|102214762|FG001|NOT COMPLETED|Overall Study||0||
48765926|NCT00124943|102214763|FG000|STARTED|Phase I||3||
48365578|NCT04760314|101223692|FG003|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
48365579|NCT04760314|101223693|FG004|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
48365580|NCT04760314|101223694|FG005|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
48365581|NCT04760314|101223695|FG006|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
48365582|NCT04760314|101223696|FG007|NOT COMPLETED|Maintenance Open Label Escape Arm||8||
48365583|NCT04760314|101223697|FG008|NOT COMPLETED|Maintenance Open Label Escape Arm||2||
48365584|NCT04760314|101223698|FG009|NOT COMPLETED|Maintenance Open Label Escape Arm||7||
48365585|NCT04760314|101223699|FG010|NOT COMPLETED|Maintenance Open Label Escape Arm||1||
48365586|NCT00592358|101223700|FG000|STARTED|Overall Study||17||
48365587|NCT00592358|101223700|FG000|COMPLETED|Overall Study||11||
48365588|NCT00592358|101223700|FG000|NOT COMPLETED|Overall Study||6||
48365589|NCT01486316|101223701|FG000|STARTED|Overall Study||7||
48365590|NCT01486316|101223702|FG001|STARTED|Overall Study||10||
48365591|NCT01486316|101223703|FG002|STARTED|Overall Study||5||
48365592|NCT01486316|101223704|FG003|STARTED|Overall Study||2||
48365593|NCT01486316|101223701|FG000|COMPLETED|Overall Study||3|18 Month/Exit Visit|
48365594|NCT01486316|101223702|FG001|COMPLETED|Overall Study||7|18 Month/Exit Visit|
48365595|NCT01486316|101223703|FG002|COMPLETED|Overall Study||0|18 Month/Exit Visit|
48365596|NCT01486316|101223704|FG003|COMPLETED|Overall Study||0|18 Month/Exit Visit|
48365597|NCT01486316|101223701|FG000|NOT COMPLETED|Overall Study||4||
48365598|NCT01486316|101223702|FG001|NOT COMPLETED|Overall Study||3||
48365599|NCT01486316|101223703|FG002|NOT COMPLETED|Overall Study||5||
48365600|NCT01486316|101223704|FG003|NOT COMPLETED|Overall Study||2||
48365601|NCT00205504|101223705|FG000|STARTED|Overall Study||21||
48365602|NCT00205504|101223706|FG001|STARTED|Overall Study||15||
48365603|NCT00205504|101223705|FG000|COMPLETED|Overall Study||14||
48365604|NCT00205504|101223706|FG001|COMPLETED|Overall Study||15||
48365605|NCT00205504|101223705|FG000|NOT COMPLETED|Overall Study||7||
48365606|NCT00205504|101223706|FG001|NOT COMPLETED|Overall Study||0||
48365607|NCT00872833|101223707|FG000|STARTED|Overall Study||15||
48365608|NCT00872833|101223708|FG001|STARTED|Overall Study||17||
48365609|NCT00872833|101223707|FG000|COMPLETED|Overall Study||15||
48365610|NCT00872833|101223708|FG001|COMPLETED|Overall Study||17||
48365611|NCT00872833|101223707|FG000|NOT COMPLETED|Overall Study||0||
48365612|NCT00872833|101223708|FG001|NOT COMPLETED|Overall Study||0||
48365613|NCT03159754|101223709|FG000|STARTED|Overall Study||24||
48365614|NCT03159754|101223710|FG001|STARTED|Overall Study||12||
48365615|NCT03159754|101223711|FG002|STARTED|Overall Study||4||
48365616|NCT03159754|101223709|FG000|COMPLETED|Overall Study||23||
48365617|NCT03159754|101223710|FG001|COMPLETED|Overall Study||12||
48365618|NCT03159754|101223711|FG002|COMPLETED|Overall Study||4||
48365619|NCT03159754|101223709|FG000|NOT COMPLETED|Overall Study||1||
48365620|NCT03159754|101223710|FG001|NOT COMPLETED|Overall Study||0||
48365621|NCT03159754|101223711|FG002|NOT COMPLETED|Overall Study||0||
48365622|NCT02874794|101223712|FG000|STARTED|Overall Study||233||
48365623|NCT02874794|101223713|FG001|STARTED|Overall Study||232||
48365624|NCT02874794|101223712|FG000|COMPLETED|Overall Study||226||
48365625|NCT02874794|101223713|FG001|COMPLETED|Overall Study||221||
48365626|NCT02874794|101223712|FG000|NOT COMPLETED|Overall Study||7||
48365627|NCT02874794|101223713|FG001|NOT COMPLETED|Overall Study||11||
48365628|NCT01751646|101223714|FG000|STARTED|Overall Study||109||
48365629|NCT01751646|101223715|FG001|STARTED|Overall Study||105||
48365630|NCT01751646|101223714|FG000|COMPLETED|Overall Study||98||
48365631|NCT01751646|101223715|FG001|COMPLETED|Overall Study||87||
48654968|NCT02662582|101941138|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
48654969|NCT02662582|101941139|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
48654970|NCT00569127|101941140|FG000|STARTED|Overall Study||214||
48654971|NCT00569127|101941141|FG001|STARTED|Overall Study||213||
48654972|NCT00569127|101941140|FG000|Eligible|Overall Study||200||
48654973|NCT00569127|101941141|FG001|Eligible|Overall Study||202||
48654974|NCT00569127|101941140|FG000|COMPLETED|Overall Study||0||
48654975|NCT00569127|101941141|FG001|COMPLETED|Overall Study||0||
48654976|NCT00569127|101941140|FG000|NOT COMPLETED|Overall Study||214||
48654977|NCT00569127|101941141|FG001|NOT COMPLETED|Overall Study||213||
48765927|NCT00124943|102214764|FG001|STARTED|Phase I||3||
48765928|NCT00124943|102214765|FG002|STARTED|Phase I||3||
48765929|NCT00124943|102214766|FG003|STARTED|Phase I||3||
48654978|NCT04971837|101941142|FG000|STARTED|Overall Study||26||
48765930|NCT00124943|102214763|FG000|COMPLETED|Phase I||3||
48765931|NCT00124943|102214764|FG001|COMPLETED|Phase I||3||
48365632|NCT01751646|101223714|FG000|NOT COMPLETED|Overall Study||11||
48365633|NCT01751646|101223715|FG001|NOT COMPLETED|Overall Study||18||
48365634|NCT01442129|101223716|FG000|STARTED|Overall Study||20||
48365635|NCT01442129|101223717|FG001|STARTED|Overall Study||10||
48365636|NCT01442129|101223716|FG000|COMPLETED|Overall Study||20||
48365637|NCT01442129|101223717|FG001|COMPLETED|Overall Study||10||
48365638|NCT01442129|101223716|FG000|NOT COMPLETED|Overall Study||0||
48365639|NCT01442129|101223717|FG001|NOT COMPLETED|Overall Study||0||
48657059|NCT03648372|101943757|FG000|COMPLETED|Overall Study||1||
48365640|NCT02401256|101223718|FG000|STARTED|Overall Study||70||
48365641|NCT02401256|101223718|FG000|Finished Phase 1|Overall Study||64||
48365642|NCT02401256|101223718|FG000|Finished Phase 2|Overall Study||58||
48365643|NCT02401256|101223718|FG000|Finished Phase 3|Overall Study||53||
48365644|NCT02401256|101223718|FG000|Analysed|Overall Study||61||
48365645|NCT02401256|101223718|FG000|COMPLETED|Overall Study||53||
48365646|NCT02401256|101223718|FG000|NOT COMPLETED|Overall Study||17||
48365647|NCT02839746|101223719|FG000|STARTED|Overall Study||671||
48365648|NCT02839746|101223719|FG000|COMPLETED|Overall Study||659||
48365649|NCT02839746|101223719|FG000|NOT COMPLETED|Overall Study||12||
48365650|NCT03132246|101223720|FG000|STARTED|Overall Study||260||
48365651|NCT03132246|101223720|FG000|COMPLETED|Overall Study||156||
48365652|NCT03132246|101223720|FG000|NOT COMPLETED|Overall Study||104||
48365653|NCT03043365|101223721|FG000|STARTED|Weeks 0 to Week 8||20||
48365654|NCT03043365|101223722|FG001|STARTED|Weeks 0 to Week 8||17||
48365655|NCT03043365|101223721|FG000|COMPLETED|Weeks 0 to Week 8||17||
48365656|NCT03043365|101223722|FG001|COMPLETED|Weeks 0 to Week 8||14||
48365657|NCT03043365|101223721|FG000|NOT COMPLETED|Weeks 0 to Week 8||3||
48365658|NCT03043365|101223722|FG001|NOT COMPLETED|Weeks 0 to Week 8||3||
48365659|NCT03043365|101223721|FG000|STARTED|Week 8 to Week 16 - Washout Period||17||
48365660|NCT03043365|101223722|FG001|STARTED|Week 8 to Week 16 - Washout Period||14||
48365661|NCT03043365|101223721|FG000|COMPLETED|Week 8 to Week 16 - Washout Period||16||
48365662|NCT03043365|101223722|FG001|COMPLETED|Week 8 to Week 16 - Washout Period||14||
48365663|NCT03043365|101223721|FG000|NOT COMPLETED|Week 8 to Week 16 - Washout Period||1||
48365664|NCT03043365|101223722|FG001|NOT COMPLETED|Week 8 to Week 16 - Washout Period||0||
48365665|NCT03043365|101223721|FG000|STARTED|Week 16 to Week 24||16||
48365666|NCT03043365|101223722|FG001|STARTED|Week 16 to Week 24||14||
48365667|NCT03043365|101223721|FG000|COMPLETED|Week 16 to Week 24||16||
48365668|NCT03043365|101223722|FG001|COMPLETED|Week 16 to Week 24||14||
48365669|NCT03043365|101223721|FG000|NOT COMPLETED|Week 16 to Week 24||0||
48365670|NCT03043365|101223722|FG001|NOT COMPLETED|Week 16 to Week 24||0||
48365671|NCT00886821|101223723|FG000|STARTED|Stage 1||7||
48365672|NCT00886821|101223724|FG001|STARTED|Stage 1||6||
48365673|NCT00886821|101223725|FG002|STARTED|Stage 1||6||
48365674|NCT00886821|101223726|FG003|STARTED|Stage 1||7||
48365675|NCT00886821|101223727|FG004|STARTED|Stage 1||6||
48365676|NCT00886821|101223728|FG005|STARTED|Stage 1||6||
48365677|NCT00886821|101223729|FG006|STARTED|Stage 1||6||
48365678|NCT00886821|101223730|FG007|STARTED|Stage 1||6||
48365679|NCT00886821|101223731|FG008|STARTED|Stage 1||6||
48365680|NCT00886821|101223732|FG009|STARTED|Stage 1||18||
48365681|NCT00886821|101223733|FG010|STARTED|Stage 1||0||
48365682|NCT00886821|101223734|FG011|STARTED|Stage 1||0||
48365683|NCT00886821|101223735|FG012|STARTED|Stage 1||0||
48365684|NCT00886821|101223736|FG013|STARTED|Stage 1||0||
48365685|NCT00886821|101223723|FG000|COMPLETED|Stage 1||7||
48365686|NCT00886821|101223724|FG001|COMPLETED|Stage 1||6||
48365687|NCT00886821|101223725|FG002|COMPLETED|Stage 1||6||
48365688|NCT00886821|101223726|FG003|COMPLETED|Stage 1||7||
48365689|NCT00886821|101223727|FG004|COMPLETED|Stage 1||6||
48365690|NCT00886821|101223728|FG005|COMPLETED|Stage 1||6||
48365691|NCT00886821|101223729|FG006|COMPLETED|Stage 1||6||
48365692|NCT00886821|101223730|FG007|COMPLETED|Stage 1||6||
48365693|NCT00886821|101223731|FG008|COMPLETED|Stage 1||6||
48365694|NCT00886821|101223732|FG009|COMPLETED|Stage 1||18||
48365695|NCT00886821|101223733|FG010|COMPLETED|Stage 1||0||
48365696|NCT00886821|101223734|FG011|COMPLETED|Stage 1||0||
48365697|NCT00886821|101223735|FG012|COMPLETED|Stage 1||0||
48365698|NCT00886821|101223736|FG013|COMPLETED|Stage 1||0||
48365699|NCT00886821|101223723|FG000|NOT COMPLETED|Stage 1||0||
48365700|NCT00886821|101223724|FG001|NOT COMPLETED|Stage 1||0||
48365701|NCT00886821|101223725|FG002|NOT COMPLETED|Stage 1||0||
48365702|NCT00886821|101223726|FG003|NOT COMPLETED|Stage 1||0||
48365703|NCT00886821|101223727|FG004|NOT COMPLETED|Stage 1||0||
48365704|NCT00886821|101223728|FG005|NOT COMPLETED|Stage 1||0||
48365705|NCT00886821|101223729|FG006|NOT COMPLETED|Stage 1||0||
48365706|NCT00886821|101223730|FG007|NOT COMPLETED|Stage 1||0||
48365707|NCT00886821|101223731|FG008|NOT COMPLETED|Stage 1||0||
48365708|NCT00886821|101223732|FG009|NOT COMPLETED|Stage 1||0||
48365709|NCT00886821|101223733|FG010|NOT COMPLETED|Stage 1||0||
48365710|NCT00886821|101223734|FG011|NOT COMPLETED|Stage 1||0||
48365711|NCT00886821|101223735|FG012|NOT COMPLETED|Stage 1||0||
48365712|NCT00886821|101223736|FG013|NOT COMPLETED|Stage 1||0||
48365713|NCT00886821|101223723|FG000|STARTED|Stage 2||0||
48365714|NCT00886821|101223724|FG001|STARTED|Stage 2||0||
48365715|NCT00886821|101223725|FG002|STARTED|Stage 2||0||
48365716|NCT00886821|101223726|FG003|STARTED|Stage 2||0||
48365717|NCT00886821|101223727|FG004|STARTED|Stage 2||0||
48365718|NCT00886821|101223728|FG005|STARTED|Stage 2||0||
48365719|NCT00886821|101223729|FG006|STARTED|Stage 2||0||
48365720|NCT00886821|101223730|FG007|STARTED|Stage 2||0||
48365721|NCT00886821|101223731|FG008|STARTED|Stage 2||0||
48365722|NCT00886821|101223732|FG009|STARTED|Stage 2||0||
48365723|NCT00886821|101223733|FG010|STARTED|Stage 2||9||
48365724|NCT00886821|101223734|FG011|STARTED|Stage 2||9||
48365725|NCT00886821|101223735|FG012|STARTED|Stage 2||13||
48365726|NCT00886821|101223736|FG013|STARTED|Stage 2||9||
48365727|NCT00886821|101223723|FG000|COMPLETED|Stage 2||0||
48365728|NCT00886821|101223724|FG001|COMPLETED|Stage 2||0||
48365729|NCT00886821|101223725|FG002|COMPLETED|Stage 2||0||
48365730|NCT00886821|101223726|FG003|COMPLETED|Stage 2||0||
48365731|NCT00886821|101223727|FG004|COMPLETED|Stage 2||0||
48365732|NCT00886821|101223728|FG005|COMPLETED|Stage 2||0||
48365733|NCT00886821|101223729|FG006|COMPLETED|Stage 2||0||
48365734|NCT00886821|101223730|FG007|COMPLETED|Stage 2||0||
48365735|NCT00886821|101223731|FG008|COMPLETED|Stage 2||0||
48365736|NCT00886821|101223732|FG009|COMPLETED|Stage 2||0||
48365737|NCT00886821|101223733|FG010|COMPLETED|Stage 2||9||
48365738|NCT00886821|101223734|FG011|COMPLETED|Stage 2||8||
48365739|NCT00886821|101223735|FG012|COMPLETED|Stage 2||8||
48365740|NCT00886821|101223736|FG013|COMPLETED|Stage 2||8||
48365741|NCT00886821|101223723|FG000|NOT COMPLETED|Stage 2||0||
48365742|NCT00886821|101223724|FG001|NOT COMPLETED|Stage 2||0||
48765932|NCT00124943|102214765|FG002|COMPLETED|Phase I||3||
48765933|NCT00124943|102214766|FG003|COMPLETED|Phase I||3||
48765934|NCT00124943|102214763|FG000|NOT COMPLETED|Phase I||0||
48765935|NCT00124943|102214764|FG001|NOT COMPLETED|Phase I||0||
48765936|NCT00124943|102214765|FG002|NOT COMPLETED|Phase I||0||
48765937|NCT00124943|102214766|FG003|NOT COMPLETED|Phase I||0||
48765938|NCT00124943|102214763|FG000|STARTED|Phase II||3||
48765939|NCT00124943|102214764|FG001|STARTED|Phase II||51||
48765940|NCT00124943|102214765|FG002|STARTED|Phase II||3||
48765941|NCT00124943|102214766|FG003|STARTED|Phase II||55||
48765942|NCT00124943|102214763|FG000|COMPLETED|Phase II||3||
48765943|NCT00124943|102214764|FG001|COMPLETED|Phase II||49||
48765944|NCT00124943|102214765|FG002|COMPLETED|Phase II||3||
48765945|NCT00124943|102214766|FG003|COMPLETED|Phase II||50||
48765946|NCT00124943|102214763|FG000|NOT COMPLETED|Phase II||0||
48765947|NCT00124943|102214764|FG001|NOT COMPLETED|Phase II||2||
48765948|NCT00124943|102214765|FG002|NOT COMPLETED|Phase II||0||
48765949|NCT00124943|102214766|FG003|NOT COMPLETED|Phase II||5||
48765950|NCT02636595|102214767|FG000|STARTED|Overall Study||121||
48765951|NCT02636595|102214767|FG000|COMPLETED|Overall Study||119||
48765952|NCT02636595|102214767|FG000|NOT COMPLETED|Overall Study||2||
48765953|NCT04177823|102214768|FG000|STARTED|Overall Study||6||
48765954|NCT04177823|102214768|FG000|COMPLETED|Overall Study||4||
48765955|NCT04177823|102214768|FG000|NOT COMPLETED|Overall Study||2||
48765956|NCT00836693|102214769|FG000|STARTED|Overall Study||147||
48765957|NCT00836693|102214770|FG001|STARTED|Overall Study||70||
48765958|NCT00836693|102214769|FG000|COMPLETED|Overall Study||130||
48765959|NCT00836693|102214770|FG001|COMPLETED|Overall Study||64||
48765960|NCT00836693|102214769|FG000|NOT COMPLETED|Overall Study||17||
48365743|NCT00886821|101223725|FG002|NOT COMPLETED|Stage 2||0||
48365744|NCT00886821|101223726|FG003|NOT COMPLETED|Stage 2||0||
48365745|NCT00886821|101223727|FG004|NOT COMPLETED|Stage 2||0||
48365746|NCT00886821|101223728|FG005|NOT COMPLETED|Stage 2||0||
48365747|NCT00886821|101223729|FG006|NOT COMPLETED|Stage 2||0||
48365748|NCT00886821|101223730|FG007|NOT COMPLETED|Stage 2||0||
48365749|NCT00886821|101223731|FG008|NOT COMPLETED|Stage 2||0||
48365750|NCT00886821|101223732|FG009|NOT COMPLETED|Stage 2||0||
48365751|NCT00886821|101223733|FG010|NOT COMPLETED|Stage 2||0||
48365752|NCT00886821|101223734|FG011|NOT COMPLETED|Stage 2||1||
48365753|NCT00886821|101223735|FG012|NOT COMPLETED|Stage 2||5||
48365754|NCT00886821|101223736|FG013|NOT COMPLETED|Stage 2||1||
48365755|NCT01797783|101223737|FG000|STARTED|Overall Study||52||
48365756|NCT01797783|101223738|FG001|STARTED|Overall Study||27||
48365757|NCT01797783|101223737|FG000|COMPLETED|Overall Study||50||
48365758|NCT01797783|101223738|FG001|COMPLETED|Overall Study||26||
48365759|NCT01797783|101223737|FG000|NOT COMPLETED|Overall Study||2||
48365760|NCT01797783|101223738|FG001|NOT COMPLETED|Overall Study||1||
48365761|NCT04072237|101223739|FG000|STARTED|Stage I: MarzAA 18 µg/kg IV||11||
48365762|NCT04072237|101223739|FG000|COMPLETED|Stage I: MarzAA 18 µg/kg IV||10||
48365763|NCT04072237|101223739|FG000|NOT COMPLETED|Stage I: MarzAA 18 µg/kg IV||1||
48365764|NCT04072237|101223739|FG000|STARTED|Stage 2: MarzAA 30 µg/kg SC||8||
48765961|NCT00836693|102214770|FG001|NOT COMPLETED|Overall Study||6||
48765962|NCT03405792|102214771|FG000|STARTED|Overall Study||31||
48765963|NCT03405792|102214772|FG001|STARTED|Overall Study||466||
48765964|NCT03405792|102214771|FG000|COMPLETED|Overall Study||26||
48765965|NCT03405792|102214772|FG001|COMPLETED|Overall Study||466||
48765966|NCT03405792|102214771|FG000|NOT COMPLETED|Overall Study||5||
48765967|NCT03405792|102214772|FG001|NOT COMPLETED|Overall Study||0||
48765968|NCT04322526|102214773|FG000|STARTED|First Intervention (1 Day)||13||
48765969|NCT04322526|102214774|FG001|STARTED|First Intervention (1 Day)||12||
48365765|NCT04072237|101223739|FG000|COMPLETED|Stage 2: MarzAA 30 µg/kg SC||8||
48365766|NCT04072237|101223739|FG000|NOT COMPLETED|Stage 2: MarzAA 30 µg/kg SC||0||
48365767|NCT04072237|101223739|FG000|STARTED|Stage 3: MarzAA 45 µg/kg SC||8||
48365768|NCT04072237|101223739|FG000|COMPLETED|Stage 3: MarzAA 45 µg/kg SC||8||
48365769|NCT04072237|101223739|FG000|NOT COMPLETED|Stage 3: MarzAA 45 µg/kg SC||0||
48365770|NCT04072237|101223739|FG000|STARTED|Stage 4: MarzAA 60 µg/kg SC||8||
48765970|NCT04322526|102214773|FG000|COMPLETED|First Intervention (1 Day)||12||
48765971|NCT04322526|102214774|FG001|COMPLETED|First Intervention (1 Day)||11||
48365771|NCT04072237|101223739|FG000|COMPLETED|Stage 4: MarzAA 60 µg/kg SC||8||
48365772|NCT04072237|101223739|FG000|NOT COMPLETED|Stage 4: MarzAA 60 µg/kg SC||0||
48765972|NCT04322526|102214773|FG000|NOT COMPLETED|First Intervention (1 Day)||1||
48765973|NCT04322526|102214774|FG001|NOT COMPLETED|First Intervention (1 Day)||1||
48365773|NCT04072237|101223739|FG000|STARTED|Stage 5: MarzAA 2 x 30 ug/kg SC||8||
48365774|NCT04072237|101223739|FG000|COMPLETED|Stage 5: MarzAA 2 x 30 ug/kg SC||8||
48365775|NCT04072237|101223739|FG000|NOT COMPLETED|Stage 5: MarzAA 2 x 30 ug/kg SC||0||
48365776|NCT04072237|101223739|FG000|STARTED|Stage 6: MarzAA 90 µg/kg SC||8||
48365777|NCT04072237|101223739|FG000|COMPLETED|Stage 6: MarzAA 90 µg/kg SC||8||
48365778|NCT04072237|101223739|FG000|NOT COMPLETED|Stage 6: MarzAA 90 µg/kg SC||0||
48365779|NCT04072237|101223739|FG000|STARTED|Stage 7: MarzAA 120 µg/kg SC||8||
48365780|NCT04072237|101223739|FG000|COMPLETED|Stage 7: MarzAA 120 µg/kg SC||8||
48365781|NCT04072237|101223739|FG000|NOT COMPLETED|Stage 7: MarzAA 120 µg/kg SC||0||
48365782|NCT04072237|101223739|FG000|STARTED|Stage 8: MarzAA 2 x 60 µg/kg Q3H SC||8||
48365783|NCT04072237|101223739|FG000|COMPLETED|Stage 8: MarzAA 2 x 60 µg/kg Q3H SC||8||
48365784|NCT04072237|101223739|FG000|NOT COMPLETED|Stage 8: MarzAA 2 x 60 µg/kg Q3H SC||0||
48365785|NCT04072237|101223739|FG000|STARTED|Stage 9: MarzAA 3 x 60 µg/kg Q3H SC||8||
48365786|NCT04072237|101223739|FG000|COMPLETED|Stage 9: MarzAA 3 x 60 µg/kg Q3H SC||8||
48365787|NCT04072237|101223739|FG000|NOT COMPLETED|Stage 9: MarzAA 3 x 60 µg/kg Q3H SC||0||
48365788|NCT00309777|101223740|FG000|STARTED|Overall Study||315||
48365789|NCT00309777|101223741|FG001|STARTED|Overall Study||108||
48365790|NCT00309777|101223742|FG002|STARTED|Overall Study||323||
48365791|NCT00309777|101223743|FG003|STARTED|Overall Study||111||
48365792|NCT00309777|101223740|FG000|Safety Population|Overall Study||311||
48365793|NCT00309777|101223741|FG001|Safety Population|Overall Study||107||
48365794|NCT00309777|101223742|FG002|Safety Population|Overall Study||320||
48365795|NCT00309777|101223743|FG003|Safety Population|Overall Study||110||
48365796|NCT00309777|101223740|FG000|COMPLETED|Overall Study||292||
48365797|NCT00309777|101223741|FG001|COMPLETED|Overall Study||99||
48365798|NCT00309777|101223742|FG002|COMPLETED|Overall Study||304||
48365799|NCT00309777|101223743|FG003|COMPLETED|Overall Study||107||
48365800|NCT00309777|101223740|FG000|NOT COMPLETED|Overall Study||23||
48365801|NCT00309777|101223741|FG001|NOT COMPLETED|Overall Study||9||
48365802|NCT00309777|101223742|FG002|NOT COMPLETED|Overall Study||19||
48365803|NCT00309777|101223743|FG003|NOT COMPLETED|Overall Study||4||
48365804|NCT03412630|101223744|FG000|STARTED|Overall Study||1||
48365805|NCT03412630|101223744|FG000|COMPLETED|Overall Study||1||
48365806|NCT03412630|101223744|FG000|NOT COMPLETED|Overall Study||0||
48365807|NCT00410280|101223745|FG000|STARTED|Overall Study||14||
48365808|NCT00410280|101223746|FG001|STARTED|Overall Study||13||
48365809|NCT00410280|101223745|FG000|COMPLETED|Overall Study||14||
48365810|NCT00410280|101223746|FG001|COMPLETED|Overall Study||13||
48365811|NCT00410280|101223745|FG000|NOT COMPLETED|Overall Study||0||
48365812|NCT00410280|101223746|FG001|NOT COMPLETED|Overall Study||0||
48365813|NCT02723162|101223747|FG000|STARTED|Overall Study||18||
48365814|NCT02723162|101223748|FG001|STARTED|Overall Study||15||
48365815|NCT02723162|101223749|FG002|STARTED|Overall Study||17||
48365816|NCT02723162|101223750|FG003|STARTED|Overall Study||17||
48365817|NCT02723162|101223747|FG000|Day 10 fMRI Visit|Overall Study||15||
48365818|NCT02723162|101223748|FG001|Day 10 fMRI Visit|Overall Study||11||
48365819|NCT02723162|101223749|FG002|Day 10 fMRI Visit|Overall Study||14||
48365820|NCT02723162|101223750|FG003|Day 10 fMRI Visit|Overall Study||15||
48365821|NCT02723162|101223747|FG000|COMPLETED|Overall Study||12||
48365822|NCT02723162|101223748|FG001|COMPLETED|Overall Study||10||
48365823|NCT02723162|101223749|FG002|COMPLETED|Overall Study||13||
48365824|NCT02723162|101223750|FG003|COMPLETED|Overall Study||12||
48365825|NCT02723162|101223747|FG000|NOT COMPLETED|Overall Study||6||
48365826|NCT02723162|101223748|FG001|NOT COMPLETED|Overall Study||5||
48365827|NCT02723162|101223749|FG002|NOT COMPLETED|Overall Study||4||
48765974|NCT04322526|102214773|FG000|STARTED|Washout (1 Week)||12||
48765975|NCT04322526|102214774|FG001|STARTED|Washout (1 Week)||11||
48765976|NCT04322526|102214773|FG000|COMPLETED|Washout (1 Week)||11||
48765977|NCT04322526|102214774|FG001|COMPLETED|Washout (1 Week)||9||
48765978|NCT04322526|102214773|FG000|NOT COMPLETED|Washout (1 Week)||1||
48765979|NCT04322526|102214774|FG001|NOT COMPLETED|Washout (1 Week)||2||
48765980|NCT04322526|102214773|FG000|STARTED|Second Intervention (1day)||11||
48765981|NCT04322526|102214774|FG001|STARTED|Second Intervention (1day)||9||
48765982|NCT04322526|102214773|FG000|COMPLETED|Second Intervention (1day)||11||
48765983|NCT04322526|102214774|FG001|COMPLETED|Second Intervention (1day)||9||
48765984|NCT04322526|102214773|FG000|NOT COMPLETED|Second Intervention (1day)||0||
48765985|NCT04322526|102214774|FG001|NOT COMPLETED|Second Intervention (1day)||0||
48765986|NCT00394095|102214775|FG000|STARTED|Overall Study||17||
48765987|NCT00394095|102214776|FG001|STARTED|Overall Study||14||
48765988|NCT00394095|102214775|FG000|Screened|Overall Study||17||
48765989|NCT00394095|102214776|FG001|Screened|Overall Study||14||
48765990|NCT00394095|102214775|FG000|COMPLETED|Overall Study||16||
48765991|NCT00394095|102214776|FG001|COMPLETED|Overall Study||14||
48188696|NCT02034435|100783313|FG001|STARTED|Overall Study||15||
48365828|NCT02723162|101223750|FG003|NOT COMPLETED|Overall Study||5||
48365829|NCT00864227|101223751|FG000|STARTED|Overall Study||54||
48365830|NCT00864227|101223751|FG000|COMPLETED|Overall Study||50||
48365831|NCT00864227|101223751|FG000|NOT COMPLETED|Overall Study||4||
48365832|NCT04525222|101223752|FG000|STARTED|Overall Study||119||
48365833|NCT04525222|101223753|FG001|STARTED|Overall Study||123||
48365834|NCT04525222|101223752|FG000|COMPLETED|Overall Study||100||
48365835|NCT04525222|101223753|FG001|COMPLETED|Overall Study||98||
48765992|NCT00394095|102214775|FG000|NOT COMPLETED|Overall Study||1||
48765993|NCT00394095|102214776|FG001|NOT COMPLETED|Overall Study||0||
48765994|NCT00832299|102214777|FG000|STARTED|Overall Study||2||
48765995|NCT00832299|102214777|FG000|COMPLETED|Overall Study||2||
48765996|NCT00832299|102214777|FG000|NOT COMPLETED|Overall Study||0||
48765997|NCT00425269|102214778|FG000|STARTED|Overall Study||101||
48765998|NCT00425269|102214779|FG001|STARTED|Overall Study||97||
48765999|NCT00425269|102214778|FG000|COMPLETED|Overall Study||82||
48766000|NCT00425269|102214779|FG001|COMPLETED|Overall Study||77||
48766001|NCT00425269|102214778|FG000|NOT COMPLETED|Overall Study||19||
48766002|NCT00425269|102214779|FG001|NOT COMPLETED|Overall Study||20||
48766003|NCT00093041|102214780|FG000|STARTED|Overall Study||4||
48766004|NCT00093041|102214781|FG001|STARTED|Overall Study||4||
48365836|NCT04525222|101223752|FG000|NOT COMPLETED|Overall Study||19||
48365837|NCT04525222|101223753|FG001|NOT COMPLETED|Overall Study||25||
48365838|NCT01254396|101223754|FG000|STARTED|First Intervention Period||6||
48365839|NCT01254396|101223755|FG001|STARTED|First Intervention Period||6||
48365840|NCT01254396|101223754|FG000|COMPLETED|First Intervention Period||6||
48365841|NCT01254396|101223755|FG001|COMPLETED|First Intervention Period||6||
48365842|NCT01254396|101223754|FG000|NOT COMPLETED|First Intervention Period||0||
48365843|NCT01254396|101223755|FG001|NOT COMPLETED|First Intervention Period||0||
48365844|NCT01254396|101223754|FG000|STARTED|Washout Period (at Least 1 Day)||6||
48365845|NCT01254396|101223755|FG001|STARTED|Washout Period (at Least 1 Day)||6||
48365846|NCT01254396|101223754|FG000|COMPLETED|Washout Period (at Least 1 Day)||6||
48365847|NCT01254396|101223755|FG001|COMPLETED|Washout Period (at Least 1 Day)||6||
48365848|NCT01254396|101223754|FG000|NOT COMPLETED|Washout Period (at Least 1 Day)||0||
48365849|NCT01254396|101223755|FG001|NOT COMPLETED|Washout Period (at Least 1 Day)||0||
48365850|NCT01254396|101223754|FG000|STARTED|Second Intervention Period||6||
48365851|NCT01254396|101223755|FG001|STARTED|Second Intervention Period||6||
48365852|NCT01254396|101223754|FG000|COMPLETED|Second Intervention Period||6||
48365853|NCT01254396|101223755|FG001|COMPLETED|Second Intervention Period||6||
48365854|NCT01254396|101223754|FG000|NOT COMPLETED|Second Intervention Period||0||
48365855|NCT01254396|101223755|FG001|NOT COMPLETED|Second Intervention Period||0||
48365856|NCT02209597|101223756|FG000|STARTED|Phase 1 Current Tx (Non-randomized)||74||
48365857|NCT02209597|101223756|FG000|COMPLETED|Phase 1 Current Tx (Non-randomized)||71||
48365858|NCT02209597|101223756|FG000|NOT COMPLETED|Phase 1 Current Tx (Non-randomized)||3||
48365859|NCT02209597|101223756|FG000|STARTED|Phase 2 (Randomized: 1 Brand, 3 Generic)||71||
48365860|NCT02209597|101223756|FG000|COMPLETED|Phase 2 (Randomized: 1 Brand, 3 Generic)||67||
48365861|NCT02209597|101223756|FG000|NOT COMPLETED|Phase 2 (Randomized: 1 Brand, 3 Generic)||4||
48365862|NCT02209597|101223756|FG000|STARTED|Phase 3 (Randomized: 1 Brand, 3 Generic)||67||
48365863|NCT02209597|101223756|FG000|COMPLETED|Phase 3 (Randomized: 1 Brand, 3 Generic)||67||
48365864|NCT02209597|101223756|FG000|NOT COMPLETED|Phase 3 (Randomized: 1 Brand, 3 Generic)||0||
48365865|NCT02209597|101223756|FG000|STARTED|Phase 4 (Randomized: 1 Brand, 3 Generic)||67||
48365866|NCT02209597|101223756|FG000|COMPLETED|Phase 4 (Randomized: 1 Brand, 3 Generic)||67||
48365867|NCT02209597|101223756|FG000|NOT COMPLETED|Phase 4 (Randomized: 1 Brand, 3 Generic)||0||
48365868|NCT01568905|101223757|FG000|STARTED|Overall Study||13||
48365869|NCT01568905|101223758|FG001|STARTED|Overall Study||11||
48365870|NCT01568905|101223759|FG002|STARTED|Overall Study||12||
48365871|NCT01568905|101223757|FG000|COMPLETED|Overall Study||12||
48365872|NCT01568905|101223758|FG001|COMPLETED|Overall Study||11||
48365873|NCT01568905|101223759|FG002|COMPLETED|Overall Study||12||
48365874|NCT01568905|101223757|FG000|NOT COMPLETED|Overall Study||1||
48365875|NCT01568905|101223758|FG001|NOT COMPLETED|Overall Study||0||
48365876|NCT01568905|101223759|FG002|NOT COMPLETED|Overall Study||0||
48365877|NCT04436510|101223760|FG000|STARTED|Overall Study||126||
48365878|NCT04436510|101223761|FG001|STARTED|Overall Study||41||
48365879|NCT04436510|101223760|FG000|COMPLETED|Overall Study||95||
48365880|NCT04436510|101223761|FG001|COMPLETED|Overall Study||35||
48365881|NCT04436510|101223760|FG000|NOT COMPLETED|Overall Study||31||
48365882|NCT04436510|101223761|FG001|NOT COMPLETED|Overall Study||6||
48365883|NCT00592501|101223762|FG000|STARTED|Overall Study||25||
48365884|NCT00592501|101223762|FG000|COMPLETED|Overall Study||23||
48365885|NCT00592501|101223762|FG000|NOT COMPLETED|Overall Study||2||
48365886|NCT04370028|101223763|FG000|STARTED|Overall Study||2583||
48365887|NCT04370028|101223763|FG000|COMPLETED|Overall Study||1876||
48365888|NCT04370028|101223763|FG000|NOT COMPLETED|Overall Study||707||
48365889|NCT00151411|101223764|FG000|STARTED|Overall Study||55||
48365890|NCT00151411|101223765|FG001|STARTED|Overall Study||59||
48365891|NCT00151411|101223764|FG000|COMPLETED|Overall Study||22||
48365892|NCT00151411|101223765|FG001|COMPLETED|Overall Study||16||
48365893|NCT00151411|101223764|FG000|NOT COMPLETED|Overall Study||33||
48365894|NCT00151411|101223765|FG001|NOT COMPLETED|Overall Study||43||
48365895|NCT02160977|101223766|FG000|STARTED|One Week After Surgery||45||
48365896|NCT02160977|101223767|FG001|STARTED|One Week After Surgery||45||
48766005|NCT00093041|102214782|FG002|STARTED|Overall Study||5||
48766006|NCT00093041|102214783|FG003|STARTED|Overall Study||4||
48766007|NCT00093041|102214784|FG004|STARTED|Overall Study||4||
48766008|NCT00093041|102214785|FG005|STARTED|Overall Study||7||
48766009|NCT00093041|102214780|FG000|COMPLETED|Overall Study||2||
48766010|NCT00093041|102214781|FG001|COMPLETED|Overall Study||1||
48365897|NCT02160977|101223766|FG000|COMPLETED|One Week After Surgery||45||
48365898|NCT02160977|101223767|FG001|COMPLETED|One Week After Surgery||45||
48365899|NCT02160977|101223766|FG000|NOT COMPLETED|One Week After Surgery||0||
48365900|NCT02160977|101223767|FG001|NOT COMPLETED|One Week After Surgery||0||
48365901|NCT02160977|101223766|FG000|STARTED|Six Weeks After Surgery||45||
48365902|NCT02160977|101223767|FG001|STARTED|Six Weeks After Surgery||45||
48365903|NCT02160977|101223766|FG000|COMPLETED|Six Weeks After Surgery||44||
48365904|NCT02160977|101223767|FG001|COMPLETED|Six Weeks After Surgery||45||
48365905|NCT02160977|101223766|FG000|NOT COMPLETED|Six Weeks After Surgery||1||
48365906|NCT02160977|101223767|FG001|NOT COMPLETED|Six Weeks After Surgery||0||
48365907|NCT02160977|101223766|FG000|STARTED|Three Months After Surgery||44||
48365908|NCT02160977|101223767|FG001|STARTED|Three Months After Surgery||45||
48365909|NCT02160977|101223766|FG000|COMPLETED|Three Months After Surgery||44||
48365910|NCT02160977|101223767|FG001|COMPLETED|Three Months After Surgery||43||
48365911|NCT02160977|101223766|FG000|NOT COMPLETED|Three Months After Surgery||0||
48365912|NCT02160977|101223767|FG001|NOT COMPLETED|Three Months After Surgery||2||
48654979|NCT04971837|101941142|FG000|Formulation 126 Without Meal,|Overall Study||15||
48654980|NCT04971837|101941142|FG000|Formulation 213 Without Meal|Overall Study||14||
48654981|NCT04971837|101941142|FG000|Formulation 625 Without Meal|Overall Study||16||
48654982|NCT04971837|101941142|FG000|Formulation 725 Without Meal|Overall Study||14||
48654983|NCT04971837|101941142|FG000|Formulation 088 Without Meal,|Overall Study||15||
48654984|NCT04971837|101941142|FG000|Formulation 725 With Meal|Overall Study||14||
48654985|NCT04971837|101941142|FG000|Placebo With Meal|Overall Study||14||
48654986|NCT04971837|101941142|FG000|COMPLETED|Overall Study||14||
48654987|NCT04971837|101941142|FG000|NOT COMPLETED|Overall Study||12||
48654988|NCT05261490|101941143|FG000|STARTED|Overall Study||3||
48654989|NCT05261490|101941144|FG001|STARTED|Overall Study||3||
48654990|NCT05261490|101941145|FG002|STARTED|Overall Study||4||
48654991|NCT05261490|101941143|FG000|Treated|Overall Study||3||
48654992|NCT05261490|101941144|FG001|Treated|Overall Study||3||
48654993|NCT05261490|101941145|FG002|Treated|Overall Study||4||
48654994|NCT05261490|101941143|FG000|COMPLETED|Overall Study||0||
48654995|NCT05261490|101941144|FG001|COMPLETED|Overall Study||0||
48654996|NCT05261490|101941145|FG002|COMPLETED|Overall Study||0||
48654997|NCT05261490|101941143|FG000|NOT COMPLETED|Overall Study||3||
48654998|NCT05261490|101941144|FG001|NOT COMPLETED|Overall Study||3||
48654999|NCT05261490|101941145|FG002|NOT COMPLETED|Overall Study||4||
48655000|NCT02613507|101941146|FG000|STARTED|Pre-Treamtent||338|Randomized|
48655001|NCT02613507|101941147|FG001|STARTED|Pre-Treamtent||166|Randomized|
48655002|NCT02613507|101941146|FG000|COMPLETED|Pre-Treamtent||337|Received Treatment|
48655003|NCT02613507|101941147|FG001|COMPLETED|Pre-Treamtent||156|Received Treatment|
48655004|NCT02613507|101941146|FG000|NOT COMPLETED|Pre-Treamtent||1||
48655005|NCT02613507|101941147|FG001|NOT COMPLETED|Pre-Treamtent||10||
48365913|NCT02160977|101223766|FG000|STARTED|Six Months After Surgery||44||
48365914|NCT02160977|101223767|FG001|STARTED|Six Months After Surgery||43||
48365915|NCT02160977|101223766|FG000|COMPLETED|Six Months After Surgery||42||
48365916|NCT02160977|101223767|FG001|COMPLETED|Six Months After Surgery||42||
48436555|NCT01463631|101403577|FG000|Received at Least One Dose of Study Drug|Overall Study||3||
48436556|NCT01463631|101403578|FG001|Received at Least One Dose of Study Drug|Overall Study||4||
48655006|NCT02613507|101941146|FG000|STARTED|Treatment||337|Treated|
48655007|NCT02613507|101941147|FG001|STARTED|Treatment||156|Treated|
48655008|NCT02613507|101941146|FG000|Crossover to Nivolumab|Treatment||0|Participants from the Docetaxel arm who changed treatment arms to receive Nivolumab|
48655009|NCT02613507|101941147|FG001|Crossover to Nivolumab|Treatment||9|Participants from the Docetaxel arm who changed treatment arms to receive Nivolumab|
48655010|NCT02613507|101941146|FG000|COMPLETED|Treatment||0|Continuing in the study|
48655011|NCT02613507|101941147|FG001|COMPLETED|Treatment||0|Continuing in the study|
48655012|NCT02613507|101941146|FG000|NOT COMPLETED|Treatment||337||
48365917|NCT02160977|101223766|FG000|NOT COMPLETED|Six Months After Surgery||2||
48365918|NCT02160977|101223767|FG001|NOT COMPLETED|Six Months After Surgery||1||
48365919|NCT01873742|101223768|FG000|STARTED|Overall Study||165||
48655013|NCT02613507|101941147|FG001|NOT COMPLETED|Treatment||156||
48655014|NCT04128228|101941148|FG000|STARTED|Overall Study||34||
48655015|NCT04128228|101941149|FG001|STARTED|Overall Study||33||
48655016|NCT04128228|101941150|FG002|STARTED|Overall Study||27||
48655017|NCT04128228|101941151|FG003|STARTED|Overall Study||37||
48655018|NCT04128228|101941148|FG000|COMPLETED|Overall Study||29||
48655019|NCT04128228|101941149|FG001|COMPLETED|Overall Study||28||
48655020|NCT04128228|101941150|FG002|COMPLETED|Overall Study||27||
48655021|NCT04128228|101941151|FG003|COMPLETED|Overall Study||37||
48655022|NCT04128228|101941148|FG000|NOT COMPLETED|Overall Study||5||
48655023|NCT04128228|101941149|FG001|NOT COMPLETED|Overall Study||5||
48655024|NCT04128228|101941150|FG002|NOT COMPLETED|Overall Study||0||
48365920|NCT01873742|101223769|FG001|STARTED|Overall Study||163||
48365921|NCT01873742|101223768|FG000|COMPLETED|Overall Study||97||
48365922|NCT01873742|101223769|FG001|COMPLETED|Overall Study||87||
48365923|NCT01873742|101223768|FG000|NOT COMPLETED|Overall Study||68||
48365924|NCT01873742|101223769|FG001|NOT COMPLETED|Overall Study||76||
48365925|NCT00641043|101223770|FG000|STARTED|Overall Study||130||
48365926|NCT00641043|101223771|FG001|STARTED|Overall Study||259||
48365927|NCT00641043|101223770|FG000|COMPLETED|Overall Study||111||
48365928|NCT00641043|101223771|FG001|COMPLETED|Overall Study||244||
48365929|NCT00641043|101223770|FG000|NOT COMPLETED|Overall Study||19||
48365930|NCT00641043|101223771|FG001|NOT COMPLETED|Overall Study||15||
48365931|NCT01319929|101223772|FG000|STARTED|First Treatment Period (4 Weeks)||20||
48365932|NCT01319929|101223773|FG001|STARTED|First Treatment Period (4 Weeks)||19||
48365933|NCT01319929|101223772|FG000|COMPLETED|First Treatment Period (4 Weeks)||17||
48365934|NCT01319929|101223773|FG001|COMPLETED|First Treatment Period (4 Weeks)||17||
48365935|NCT01319929|101223772|FG000|NOT COMPLETED|First Treatment Period (4 Weeks)||3||
48365936|NCT01319929|101223773|FG001|NOT COMPLETED|First Treatment Period (4 Weeks)||2||
48365937|NCT01319929|101223772|FG000|STARTED|Washout Period (3 Weeks)||17||
48365938|NCT01319929|101223773|FG001|STARTED|Washout Period (3 Weeks)||17||
48365939|NCT01319929|101223772|FG000|COMPLETED|Washout Period (3 Weeks)||17||
48365940|NCT01319929|101223773|FG001|COMPLETED|Washout Period (3 Weeks)||17||
48365941|NCT01319929|101223772|FG000|NOT COMPLETED|Washout Period (3 Weeks)||0||
48365942|NCT01319929|101223773|FG001|NOT COMPLETED|Washout Period (3 Weeks)||0||
48365943|NCT01319929|101223772|FG000|STARTED|Second Treatment Period (4 Weeks)||17||
48365944|NCT01319929|101223773|FG001|STARTED|Second Treatment Period (4 Weeks)||17||
48365945|NCT01319929|101223772|FG000|COMPLETED|Second Treatment Period (4 Weeks)||16||
48365946|NCT01319929|101223773|FG001|COMPLETED|Second Treatment Period (4 Weeks)||16||
48365947|NCT01319929|101223772|FG000|NOT COMPLETED|Second Treatment Period (4 Weeks)||1||
48365948|NCT01319929|101223773|FG001|NOT COMPLETED|Second Treatment Period (4 Weeks)||1||
48365949|NCT00787332|101223774|FG000|STARTED|Overall Study||8||
48365950|NCT00787332|101223775|FG001|STARTED|Overall Study||8||
48365951|NCT00787332|101223774|FG000|COMPLETED|Overall Study||8||
48365952|NCT00787332|101223775|FG001|COMPLETED|Overall Study||8||
48365953|NCT00787332|101223774|FG000|NOT COMPLETED|Overall Study||0||
48365954|NCT00787332|101223775|FG001|NOT COMPLETED|Overall Study||0||
48365955|NCT02345434|101223776|FG000|STARTED|Overall Study||763||
48365956|NCT02345434|101223777|FG001|STARTED|Overall Study||762||
48365957|NCT02345434|101223776|FG000|COMPLETED|Overall Study||758||
48365958|NCT02345434|101223777|FG001|COMPLETED|Overall Study||760||
48365959|NCT02345434|101223776|FG000|NOT COMPLETED|Overall Study||5||
48365960|NCT02345434|101223777|FG001|NOT COMPLETED|Overall Study||2||
48365961|NCT02186795|101223778|FG000|STARTED|Overall Study||24||
48365962|NCT02186795|101223779|FG001|STARTED|Overall Study||24||
48365963|NCT02186795|101223778|FG000|COMPLETED|Overall Study||24||
48365964|NCT02186795|101223779|FG001|COMPLETED|Overall Study||24||
48365965|NCT02186795|101223778|FG000|NOT COMPLETED|Overall Study||0||
48365966|NCT02186795|101223779|FG001|NOT COMPLETED|Overall Study||0||
48655025|NCT04128228|101941151|FG003|NOT COMPLETED|Overall Study||0||
48655026|NCT01386385|101941152|FG000|STARTED|Phase I 40mg: Concurrent CRT||8||
48655027|NCT01386385|101941153|FG001|STARTED|Phase I 40mg: Concurrent CRT||0||
48655028|NCT01386385|101941154|FG002|STARTED|Phase I 40mg: Concurrent CRT||0||
48655029|NCT01386385|101941155|FG003|STARTED|Phase I 40mg: Concurrent CRT||0||
48655030|NCT01386385|101941156|FG004|STARTED|Phase I 40mg: Concurrent CRT||0||
48655031|NCT01386385|101941157|FG005|STARTED|Phase I 40mg: Concurrent CRT||0||
48655032|NCT01386385|101941158|FG006|STARTED|Phase I 40mg: Concurrent CRT||0||
48766011|NCT00093041|102214782|FG002|COMPLETED|Overall Study||3||
48188321|NCT02264574|100783215|FG001|COMPLETED|Overall Study||86|On-study until study termination by sponsor.|
48365967|NCT03102736|101223780|FG000|STARTED|Overall Study||7||
48365968|NCT03102736|101223781|FG001|STARTED|Overall Study||9||
48365969|NCT03102736|101223780|FG000|COMPLETED|Overall Study||7||
48365970|NCT03102736|101223781|FG001|COMPLETED|Overall Study||9||
48365971|NCT03102736|101223780|FG000|NOT COMPLETED|Overall Study||0||
48365972|NCT03102736|101223781|FG001|NOT COMPLETED|Overall Study||0||
48365973|NCT02296840|101223782|FG000|STARTED|Overall Study||18||
48365974|NCT02296840|101223783|FG001|STARTED|Overall Study||27||
48365975|NCT02296840|101223782|FG000|COMPLETED|Overall Study||9||
48365976|NCT02296840|101223783|FG001|COMPLETED|Overall Study||8||
48365977|NCT02296840|101223782|FG000|NOT COMPLETED|Overall Study||9||
48365978|NCT02296840|101223783|FG001|NOT COMPLETED|Overall Study||19||
48365979|NCT02275026|101223784|FG000|STARTED|Overall Study||104||
48365980|NCT02275026|101223784|FG000|COMPLETED|Overall Study||71||
48655033|NCT01386385|101941159|FG007|STARTED|Phase I 40mg: Concurrent CRT||0||
48655034|NCT01386385|101941152|FG000|COMPLETED|Phase I 40mg: Concurrent CRT||6||
48655035|NCT01386385|101941153|FG001|COMPLETED|Phase I 40mg: Concurrent CRT||0||
48655036|NCT01386385|101941154|FG002|COMPLETED|Phase I 40mg: Concurrent CRT||0||
48365981|NCT02275026|101223784|FG000|NOT COMPLETED|Overall Study||33||
48365982|NCT01208662|101223785|FG000|STARTED|Induction and Consolidation||357||
48365983|NCT01208662|101223786|FG001|STARTED|Induction and Consolidation||365||
48365984|NCT01208662|101223787|FG002|STARTED|Induction and Consolidation||7||
48655037|NCT01386385|101941155|FG003|COMPLETED|Phase I 40mg: Concurrent CRT||0||
48188322|NCT02264574|100783214|FG000|NOT COMPLETED|Overall Study||29||
48365985|NCT01208662|101223785|FG000|Randomized|Induction and Consolidation||357|Participants were randomized after 1 cycle of therapy only if cycle 1 therapy was completed and/or participant did not withdraw.|
48365986|NCT01208662|101223786|FG001|Randomized|Induction and Consolidation||365|Participants were randomized after 1 cycle of therapy only if cycle 1 therapy was completed and/or participant did not withdraw.|
48365987|NCT01208662|101223787|FG002|Randomized|Induction and Consolidation||0|Participants were randomized after 1 cycle of therapy only if cycle 1 therapy was completed and/or participant did not withdraw.|
48365988|NCT01208662|101223785|FG000|Underwent Stem Cell Mobilization|Induction and Consolidation||324||
48365989|NCT01208662|101223786|FG001|Underwent Stem Cell Mobilization|Induction and Consolidation||330||
48365990|NCT01208662|101223787|FG002|Underwent Stem Cell Mobilization|Induction and Consolidation||0||
48365991|NCT01208662|101223785|FG000|COMPLETED|Induction and Consolidation||291||
48365992|NCT01208662|101223786|FG001|COMPLETED|Induction and Consolidation||289||
48365993|NCT01208662|101223787|FG002|COMPLETED|Induction and Consolidation||0||
48365994|NCT01208662|101223785|FG000|NOT COMPLETED|Induction and Consolidation||66||
48365995|NCT01208662|101223786|FG001|NOT COMPLETED|Induction and Consolidation||76||
48365996|NCT01208662|101223787|FG002|NOT COMPLETED|Induction and Consolidation||7||
48365997|NCT01208662|101223785|FG000|STARTED|Maintenance||291||
48365998|NCT01208662|101223786|FG001|STARTED|Maintenance||289||
48365999|NCT01208662|101223787|FG002|STARTED|Maintenance||0||
48366000|NCT01208662|101223785|FG000|Minimal Residual Disease (MRD) Evaluable at Maintenance Start|Maintenance||108|MRD evaluable subset represents participants with clonal sequence identified at baseline plus MRD assessment at start of maintenance.|
48366001|NCT01208662|101223786|FG001|Minimal Residual Disease (MRD) Evaluable at Maintenance Start|Maintenance||90|MRD evaluable subset represents participants with clonal sequence identified at baseline plus MRD assessment at start of maintenance.|
48366002|NCT01208662|101223787|FG002|Minimal Residual Disease (MRD) Evaluable at Maintenance Start|Maintenance||0|MRD evaluable subset represents participants with clonal sequence identified at baseline plus MRD assessment at start of maintenance.|
48366003|NCT01208662|101223785|FG000|COMPLETED|Maintenance||0|Given maintenance treatment duration is not fixed, all participants are considered as 'Not Completed'.|
48366004|NCT01208662|101223786|FG001|COMPLETED|Maintenance||0|Given maintenance treatment duration is not fixed, all participants are considered as 'Not Completed'.|
48366005|NCT01208662|101223787|FG002|COMPLETED|Maintenance||0|Given maintenance treatment duration is not fixed, all participants are considered as 'Not Completed'.|
48366006|NCT01208662|101223785|FG000|NOT COMPLETED|Maintenance||291||
48366007|NCT01208662|101223786|FG001|NOT COMPLETED|Maintenance||289||
48366008|NCT01208662|101223787|FG002|NOT COMPLETED|Maintenance||0||
48366009|NCT02062151|101223788|FG000|STARTED|Overall Study||21||
48366010|NCT02062151|101223788|FG000|COMPLETED|Overall Study||20||
48366011|NCT02062151|101223788|FG000|NOT COMPLETED|Overall Study||1||
48366012|NCT04011436|101223789|FG000|STARTED|Overall Study||20||
48366013|NCT04011436|101223790|FG001|STARTED|Overall Study||20||
48366014|NCT04011436|101223789|FG000|COMPLETED|Overall Study||19||
48366015|NCT04011436|101223790|FG001|COMPLETED|Overall Study||19||
48366016|NCT04011436|101223789|FG000|NOT COMPLETED|Overall Study||1||
48366017|NCT04011436|101223790|FG001|NOT COMPLETED|Overall Study||1||
48366018|NCT02747043|101223791|FG000|STARTED|Overall Study||128||
48366019|NCT02747043|101223792|FG001|STARTED|Overall Study||128||
48366020|NCT02747043|101223791|FG000|Treated|Overall Study||128||
48366021|NCT02747043|101223792|FG001|Treated|Overall Study||126||
48366022|NCT02747043|101223791|FG000|COMPLETED|Overall Study||118|Completed Week 28|
48366023|NCT02747043|101223792|FG001|COMPLETED|Overall Study||123|Completed Week 28|
48366024|NCT02747043|101223791|FG000|NOT COMPLETED|Overall Study||10||
48366025|NCT02747043|101223792|FG001|NOT COMPLETED|Overall Study||5||
48366026|NCT00328263|101223793|FG000|STARTED|Overall Study||216||
48366027|NCT00328263|101223794|FG001|STARTED|Overall Study||221||
48366028|NCT00328263|101223793|FG000|COMPLETED|Overall Study||213||
48366029|NCT00328263|101223794|FG001|COMPLETED|Overall Study||217||
48366030|NCT00328263|101223793|FG000|NOT COMPLETED|Overall Study||3||
48366031|NCT00328263|101223794|FG001|NOT COMPLETED|Overall Study||4||
48366032|NCT03952546|101223795|FG000|STARTED|Overall Study||82||
48366033|NCT03952546|101223796|FG001|STARTED|Overall Study||82||
48366034|NCT03952546|101223795|FG000|COMPLETED|Overall Study||82||
48366035|NCT03952546|101223796|FG001|COMPLETED|Overall Study||82||
48366036|NCT03952546|101223795|FG000|NOT COMPLETED|Overall Study||0||
48366037|NCT03952546|101223796|FG001|NOT COMPLETED|Overall Study||0||
48366038|NCT01382186|101223797|FG000|STARTED|Overall Study||33||
48366039|NCT01382186|101223798|FG001|STARTED|Overall Study||819||
48366040|NCT01382186|101223797|FG000|COMPLETED|Overall Study||32||
48366041|NCT01382186|101223798|FG001|COMPLETED|Overall Study||819||
48366042|NCT01382186|101223797|FG000|NOT COMPLETED|Overall Study||1||
48366043|NCT01382186|101223798|FG001|NOT COMPLETED|Overall Study||0||
48366044|NCT01936649|101223799|FG000|STARTED|Overall Study||63||
48366045|NCT01936649|101223799|FG000|Treated|Overall Study||51||
48366046|NCT01936649|101223799|FG000|COMPLETED|Overall Study||50||
48366047|NCT01936649|101223799|FG000|NOT COMPLETED|Overall Study||13||
48366048|NCT02421120|101223800|FG000|STARTED|Overall Study||21||
48366049|NCT02421120|101223800|FG000|COMPLETED|Overall Study||20||
48366050|NCT02421120|101223800|FG000|NOT COMPLETED|Overall Study||1||
48366051|NCT03303339|101223801|FG000|STARTED|Overall Study||3||
48366052|NCT03303339|101223802|FG001|STARTED|Overall Study||3||
48366053|NCT03303339|101223803|FG002|STARTED|Overall Study||3||
48366054|NCT03303339|101223804|FG003|STARTED|Overall Study||3||
48366055|NCT03303339|101223805|FG004|STARTED|Overall Study||5||
48366056|NCT03303339|101223806|FG005|STARTED|Overall Study||4||
48366057|NCT03303339|101223807|FG006|STARTED|Overall Study||3||
48366058|NCT03303339|101223808|FG007|STARTED|Overall Study||3||
48366059|NCT03303339|101223809|FG008|STARTED|Overall Study||4||
48366060|NCT03303339|101223810|FG009|STARTED|Overall Study||3||
48366061|NCT03303339|101223811|FG010|STARTED|Overall Study||6||
48366062|NCT03303339|101223812|FG011|STARTED|Overall Study||32||
48366063|NCT03303339|101223801|FG000|COMPLETED|Overall Study||0||
48366064|NCT03303339|101223802|FG001|COMPLETED|Overall Study||1||
48366065|NCT03303339|101223803|FG002|COMPLETED|Overall Study||1||
48366066|NCT03303339|101223804|FG003|COMPLETED|Overall Study||2||
48366067|NCT03303339|101223805|FG004|COMPLETED|Overall Study||0||
48366068|NCT03303339|101223806|FG005|COMPLETED|Overall Study||1||
48366069|NCT03303339|101223807|FG006|COMPLETED|Overall Study||0||
48366070|NCT03303339|101223808|FG007|COMPLETED|Overall Study||1||
48366071|NCT03303339|101223809|FG008|COMPLETED|Overall Study||0||
48366072|NCT03303339|101223810|FG009|COMPLETED|Overall Study||0||
48366073|NCT03303339|101223811|FG010|COMPLETED|Overall Study||1||
48366074|NCT03303339|101223812|FG011|COMPLETED|Overall Study||4||
48366075|NCT03303339|101223801|FG000|NOT COMPLETED|Overall Study||3||
48366076|NCT03303339|101223802|FG001|NOT COMPLETED|Overall Study||2||
48366077|NCT03303339|101223803|FG002|NOT COMPLETED|Overall Study||2||
48366078|NCT03303339|101223804|FG003|NOT COMPLETED|Overall Study||1||
48366079|NCT03303339|101223805|FG004|NOT COMPLETED|Overall Study||5||
48366080|NCT03303339|101223806|FG005|NOT COMPLETED|Overall Study||3||
48366081|NCT03303339|101223807|FG006|NOT COMPLETED|Overall Study||3||
48366082|NCT03303339|101223808|FG007|NOT COMPLETED|Overall Study||2||
48366083|NCT03303339|101223809|FG008|NOT COMPLETED|Overall Study||4||
48366084|NCT03303339|101223810|FG009|NOT COMPLETED|Overall Study||3||
48366085|NCT03303339|101223811|FG010|NOT COMPLETED|Overall Study||5||
48366086|NCT03303339|101223812|FG011|NOT COMPLETED|Overall Study||28||
48366087|NCT00734409|101223813|FG000|STARTED|Overall Study||155||
48366088|NCT00734409|101223814|FG001|STARTED|Overall Study||145||
48366089|NCT00734409|101223813|FG000|COMPLETED|Overall Study||155||
48366090|NCT00734409|101223814|FG001|COMPLETED|Overall Study||145||
48366091|NCT00734409|101223813|FG000|NOT COMPLETED|Overall Study||0||
48366092|NCT00734409|101223814|FG001|NOT COMPLETED|Overall Study||0||
48366093|NCT01225263|101223815|FG000|STARTED|Weeks 1 to 12||28||
48366094|NCT01225263|101223816|FG001|STARTED|Weeks 1 to 12||29||
48366095|NCT01225263|101223815|FG000|COMPLETED|Weeks 1 to 12||28||
48366096|NCT01225263|101223816|FG001|COMPLETED|Weeks 1 to 12||29||
48366097|NCT01225263|101223815|FG000|NOT COMPLETED|Weeks 1 to 12||0||
48366098|NCT01225263|101223816|FG001|NOT COMPLETED|Weeks 1 to 12||0||
48366099|NCT01225263|101223815|FG000|STARTED|Weeks 13 to 24||28||
48366100|NCT01225263|101223816|FG001|STARTED|Weeks 13 to 24||29||
48366101|NCT01225263|101223815|FG000|COMPLETED|Weeks 13 to 24||24||
48366102|NCT01225263|101223816|FG001|COMPLETED|Weeks 13 to 24||28||
48366103|NCT01225263|101223815|FG000|NOT COMPLETED|Weeks 13 to 24||4||
48366104|NCT01225263|101223816|FG001|NOT COMPLETED|Weeks 13 to 24||1||
48366105|NCT03026504|101223817|FG000|STARTED|Overall Study||15||
48366106|NCT03026504|101223817|FG000|COMPLETED|Overall Study||14||
48366107|NCT03026504|101223817|FG000|NOT COMPLETED|Overall Study||1||
48366108|NCT00426751|101223818|FG000|STARTED|Overall Study||226||
48655038|NCT01386385|101941156|FG004|COMPLETED|Phase I 40mg: Concurrent CRT||0||
48188323|NCT02264574|100783215|FG001|NOT COMPLETED|Overall Study||30||
48188324|NCT01657032|100783216|FG000|STARTED|Overall Study||44||
48188325|NCT01657032|100783217|FG001|STARTED|Overall Study||44||
48188326|NCT01657032|100783216|FG000|COMPLETED|Overall Study||44||
48366109|NCT00426751|101223819|FG001|STARTED|Overall Study||203||
48366110|NCT00426751|101223818|FG000|COMPLETED|Overall Study||204||
48366111|NCT00426751|101223819|FG001|COMPLETED|Overall Study||183||
48366112|NCT00426751|101223818|FG000|NOT COMPLETED|Overall Study||22||
48366113|NCT00426751|101223819|FG001|NOT COMPLETED|Overall Study||20||
48366114|NCT03454048|101223820|FG000|STARTED|Overall Study||6||
48366115|NCT03454048|101223821|FG001|STARTED|Overall Study||6||
48366116|NCT03454048|101223822|FG002|STARTED|Overall Study||6||
48366117|NCT03454048|101223823|FG003|STARTED|Overall Study||6||
48366118|NCT03454048|101223820|FG000|COMPLETED|Overall Study||6||
48366119|NCT03454048|101223821|FG001|COMPLETED|Overall Study||6||
48366120|NCT03454048|101223822|FG002|COMPLETED|Overall Study||6||
48366121|NCT03454048|101223823|FG003|COMPLETED|Overall Study||6||
48366122|NCT03454048|101223820|FG000|NOT COMPLETED|Overall Study||0||
48366123|NCT03454048|101223821|FG001|NOT COMPLETED|Overall Study||0||
48366124|NCT03454048|101223822|FG002|NOT COMPLETED|Overall Study||0||
48366125|NCT03454048|101223823|FG003|NOT COMPLETED|Overall Study||0||
48366126|NCT00515463|101223824|FG000|STARTED|Overall Study||155||
48366127|NCT00515463|101223825|FG001|STARTED|Overall Study||156||
48366128|NCT00515463|101223824|FG000|Received Study Medication|Overall Study||154||
48366129|NCT00515463|101223825|FG001|Received Study Medication|Overall Study||156||
48366130|NCT00515463|101223824|FG000|COMPLETED|Overall Study||141||
48366131|NCT00515463|101223825|FG001|COMPLETED|Overall Study||142||
48366132|NCT00515463|101223824|FG000|NOT COMPLETED|Overall Study||14||
48366133|NCT00515463|101223825|FG001|NOT COMPLETED|Overall Study||14||
48366134|NCT03894904|101223826|FG000|STARTED|Randomized Dosing (Doses 1 and 2)||46||
48366135|NCT03894904|101223827|FG001|STARTED|Randomized Dosing (Doses 1 and 2)||50||
48366136|NCT03894904|101223826|FG000|Received Dose 1|Randomized Dosing (Doses 1 and 2)||44||
48366137|NCT03894904|101223827|FG001|Received Dose 1|Randomized Dosing (Doses 1 and 2)||47||
48366138|NCT03894904|101223826|FG000|Received Dose 2|Randomized Dosing (Doses 1 and 2)||42||
48366139|NCT03894904|101223827|FG001|Received Dose 2|Randomized Dosing (Doses 1 and 2)||46||
48366140|NCT03894904|101223826|FG000|COMPLETED|Randomized Dosing (Doses 1 and 2)||42||
48366141|NCT03894904|101223827|FG001|COMPLETED|Randomized Dosing (Doses 1 and 2)||46||
48366142|NCT03894904|101223826|FG000|NOT COMPLETED|Randomized Dosing (Doses 1 and 2)||4||
48366143|NCT03894904|101223827|FG001|NOT COMPLETED|Randomized Dosing (Doses 1 and 2)||4||
48366144|NCT03894904|101223826|FG000|STARTED|Rescue Papaverine (Optional Dose 3)||7|Only participants who had suboptimal waveforms after the first 2 randomized doses in the previous period went on to receive rescue papaverine in this period. 7 in the Papaverine plus Heparin arm received rescue papaverine. 17 in the Heparin arm received rescue papaverine.|
48366145|NCT03894904|101223827|FG001|STARTED|Rescue Papaverine (Optional Dose 3)||17|Only participants who had suboptimal waveforms after the first 2 randomized doses in the previous period went on to receive rescue papaverine in this period. 7 in the Papaverine plus Heparin arm received rescue papaverine. 17 in the Heparin arm received rescue papaverine.|
48366146|NCT03894904|101223826|FG000|Received Rescue Papaverine|Rescue Papaverine (Optional Dose 3)||7||
48366147|NCT03894904|101223827|FG001|Received Rescue Papaverine|Rescue Papaverine (Optional Dose 3)||17||
48366148|NCT03894904|101223826|FG000|COMPLETED|Rescue Papaverine (Optional Dose 3)||7||
48366149|NCT03894904|101223827|FG001|COMPLETED|Rescue Papaverine (Optional Dose 3)||17||
48366150|NCT03894904|101223826|FG000|NOT COMPLETED|Rescue Papaverine (Optional Dose 3)||0||
48366151|NCT03894904|101223827|FG001|NOT COMPLETED|Rescue Papaverine (Optional Dose 3)||0||
48366152|NCT01214616|101223828|FG000|STARTED|Overall Study||3||
48366153|NCT01214616|101223829|FG001|STARTED|Overall Study||5||
48366154|NCT01214616|101223830|FG002|STARTED|Overall Study||3||
48366155|NCT01214616|101223831|FG003|STARTED|Overall Study||6||
48366156|NCT01214616|101223828|FG000|COMPLETED|Overall Study||0||
48366157|NCT01214616|101223829|FG001|COMPLETED|Overall Study||0||
48366158|NCT01214616|101223830|FG002|COMPLETED|Overall Study||0||
48366159|NCT01214616|101223831|FG003|COMPLETED|Overall Study||0||
48366160|NCT01214616|101223828|FG000|NOT COMPLETED|Overall Study||3||
48366161|NCT01214616|101223829|FG001|NOT COMPLETED|Overall Study||5||
48366162|NCT01214616|101223830|FG002|NOT COMPLETED|Overall Study||3||
48366163|NCT01214616|101223831|FG003|NOT COMPLETED|Overall Study||6||
48366164|NCT00352781|101223832|FG000|STARTED|Overall Study||1767||
48366165|NCT00352781|101223832|FG000|COMPLETED|Overall Study||884||
48366166|NCT00352781|101223832|FG000|NOT COMPLETED|Overall Study||883||
48366167|NCT02335450|101223833|FG000|STARTED|Overall Study||5||
48366168|NCT02335450|101223833|FG000|COMPLETED|Overall Study||4||
48366169|NCT02335450|101223833|FG000|NOT COMPLETED|Overall Study||1||
48366170|NCT02546856|101223834|FG000|STARTED|4 Months Evaluation||164||
48655039|NCT01386385|101941157|FG005|COMPLETED|Phase I 40mg: Concurrent CRT||0||
48655040|NCT01386385|101941158|FG006|COMPLETED|Phase I 40mg: Concurrent CRT||0||
48655041|NCT01386385|101941159|FG007|COMPLETED|Phase I 40mg: Concurrent CRT||0||
48655042|NCT01386385|101941152|FG000|NOT COMPLETED|Phase I 40mg: Concurrent CRT||2||
48655043|NCT01386385|101941153|FG001|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0||
48655044|NCT01386385|101941154|FG002|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0||
48655045|NCT01386385|101941155|FG003|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0||
48655046|NCT01386385|101941156|FG004|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0||
48655047|NCT01386385|101941157|FG005|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0||
48655048|NCT01386385|101941158|FG006|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0||
48655049|NCT01386385|101941159|FG007|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0||
48655050|NCT01386385|101941152|FG000|STARTED|Phase I 40mg: Consolidation Therapy||0||
48366171|NCT02546856|101223835|FG001|STARTED|4 Months Evaluation||156||
48366172|NCT02546856|101223834|FG000|COMPLETED|4 Months Evaluation||144||
48366173|NCT02546856|101223835|FG001|COMPLETED|4 Months Evaluation||145||
48366174|NCT02546856|101223834|FG000|NOT COMPLETED|4 Months Evaluation||20||
48366175|NCT02546856|101223835|FG001|NOT COMPLETED|4 Months Evaluation||11||
48366176|NCT02546856|101223834|FG000|STARTED|6 Months Evaluation||144||
48366177|NCT02546856|101223835|FG001|STARTED|6 Months Evaluation||145||
48366178|NCT02546856|101223834|FG000|COMPLETED|6 Months Evaluation||136||
48366179|NCT02546856|101223835|FG001|COMPLETED|6 Months Evaluation||138||
48366180|NCT02546856|101223834|FG000|NOT COMPLETED|6 Months Evaluation||8||
48366181|NCT02546856|101223835|FG001|NOT COMPLETED|6 Months Evaluation||7||
48366182|NCT03135028|101223836|FG000|STARTED|Overall Study||9||
48366183|NCT03135028|101223836|FG000|COMPLETED|Overall Study||0||
48366184|NCT03135028|101223836|FG000|NOT COMPLETED|Overall Study||9||
48655051|NCT01386385|101941153|FG001|STARTED|Phase I 40mg: Consolidation Therapy||4||
48655052|NCT01386385|101941154|FG002|STARTED|Phase I 40mg: Consolidation Therapy||0||
48655053|NCT01386385|101941155|FG003|STARTED|Phase I 40mg: Consolidation Therapy||0||
48655054|NCT01386385|101941156|FG004|STARTED|Phase I 40mg: Consolidation Therapy||0||
48655055|NCT01386385|101941157|FG005|STARTED|Phase I 40mg: Consolidation Therapy||0||
48655056|NCT01386385|101941158|FG006|STARTED|Phase I 40mg: Consolidation Therapy||0||
48655057|NCT01386385|101941159|FG007|STARTED|Phase I 40mg: Consolidation Therapy||0||
48655058|NCT01386385|101941152|FG000|COMPLETED|Phase I 40mg: Consolidation Therapy||0||
48366185|NCT01792986|101223837|FG000|STARTED|Overall Study||12||
48366186|NCT01792986|101223837|FG000|COMPLETED|Overall Study||12||
48436557|NCT01463631|101403579|FG002|Received at Least One Dose of Study Drug|Overall Study||5||
48436558|NCT01463631|101403580|FG003|Received at Least One Dose of Study Drug|Overall Study||15||
48436559|NCT01463631|101403577|FG000|COMPLETED|Overall Study||3||
48436560|NCT01463631|101403578|FG001|COMPLETED|Overall Study||4||
48436561|NCT01463631|101403579|FG002|COMPLETED|Overall Study||4||
48436562|NCT01463631|101403580|FG003|COMPLETED|Overall Study||9||
48436563|NCT01463631|101403577|FG000|NOT COMPLETED|Overall Study||0||
48436564|NCT01463631|101403578|FG001|NOT COMPLETED|Overall Study||0||
48436565|NCT01463631|101403579|FG002|NOT COMPLETED|Overall Study||1||
48436566|NCT01463631|101403580|FG003|NOT COMPLETED|Overall Study||6||
48436567|NCT03864406|101403581|FG000|STARTED|Overall Study||12||
48436568|NCT03864406|101403581|FG000|COMPLETED|Overall Study||12||
48436569|NCT03864406|101403581|FG000|NOT COMPLETED|Overall Study||0||
48436570|NCT01422876|101403582|FG000|STARTED|Week 24||137||
48436571|NCT01422876|101403583|FG001|STARTED|Week 24||136||
48436572|NCT01422876|101403584|FG002|STARTED|Week 24||141||
48436573|NCT01422876|101403585|FG003|STARTED|Week 24||140||
48436574|NCT01422876|101403586|FG004|STARTED|Week 24||132||
48436575|NCT01422876|101403587|FG005|STARTED|Week 24||137||
48436576|NCT01422876|101403588|FG006|STARTED|Week 24||136||
48436577|NCT01422876|101403589|FG007|STARTED|Week 24||135||
48436578|NCT01422876|101403590|FG008|STARTED|Week 24||134||
48436579|NCT01422876|101403591|FG009|STARTED|Week 24||135||
48436580|NCT01422876|101403582|FG000|COMPLETED|Week 24||131||
48436581|NCT01422876|101403583|FG001|COMPLETED|Week 24||133||
48436582|NCT01422876|101403584|FG002|COMPLETED|Week 24||136||
48436583|NCT01422876|101403585|FG003|COMPLETED|Week 24||132||
48436584|NCT01422876|101403586|FG004|COMPLETED|Week 24||125||
48436585|NCT01422876|101403587|FG005|COMPLETED|Week 24||131||
48436586|NCT01422876|101403588|FG006|COMPLETED|Week 24||130||
48436587|NCT01422876|101403589|FG007|COMPLETED|Week 24||128||
48436588|NCT01422876|101403590|FG008|COMPLETED|Week 24||128||
48436589|NCT01422876|101403591|FG009|COMPLETED|Week 24||125||
48436590|NCT01422876|101403582|FG000|NOT COMPLETED|Week 24||6||
48436591|NCT01422876|101403583|FG001|NOT COMPLETED|Week 24||3||
48436592|NCT01422876|101403584|FG002|NOT COMPLETED|Week 24||5||
48436593|NCT01422876|101403585|FG003|NOT COMPLETED|Week 24||8||
48436594|NCT01422876|101403586|FG004|NOT COMPLETED|Week 24||7||
48436595|NCT01422876|101403587|FG005|NOT COMPLETED|Week 24||6||
48436596|NCT01422876|101403588|FG006|NOT COMPLETED|Week 24||6||
48436597|NCT01422876|101403589|FG007|NOT COMPLETED|Week 24||7||
48436598|NCT01422876|101403590|FG008|NOT COMPLETED|Week 24||6||
48436599|NCT01422876|101403591|FG009|NOT COMPLETED|Week 24||10||
48436600|NCT01422876|101403582|FG000|STARTED|Week 52||137||
48366187|NCT01792986|101223837|FG000|NOT COMPLETED|Overall Study||0||
48366188|NCT02190435|101223838|FG000|STARTED|Overall Study||41||
48366189|NCT02190435|101223839|FG001|STARTED|Overall Study||24||
48366190|NCT02190435|101223838|FG000|COMPLETED|Overall Study||26||
48366191|NCT02190435|101223839|FG001|COMPLETED|Overall Study||24||
48366192|NCT02190435|101223838|FG000|NOT COMPLETED|Overall Study||15||
48366193|NCT02190435|101223839|FG001|NOT COMPLETED|Overall Study||0||
48366194|NCT00328198|101223840|FG000|STARTED|Treatment||86||
48366195|NCT00328198|101223840|FG000|COMPLETED|Treatment||48||
48366196|NCT00328198|101223840|FG000|NOT COMPLETED|Treatment||38||
48366197|NCT00328198|101223840|FG000|STARTED|Follow-up||78||
48366198|NCT00328198|101223840|FG000|COMPLETED|Follow-up||43||
48366199|NCT00328198|101223840|FG000|NOT COMPLETED|Follow-up||35||
48436601|NCT01422876|101403583|FG001|STARTED|Week 52||136||
48436602|NCT01422876|101403584|FG002|STARTED|Week 52||141||
48436603|NCT01422876|101403585|FG003|STARTED|Week 52||140||
48436604|NCT01422876|101403586|FG004|STARTED|Week 52||132||
48436605|NCT01422876|101403587|FG005|STARTED|Week 52||137||
48436606|NCT01422876|101403588|FG006|STARTED|Week 52||136||
48436607|NCT01422876|101403589|FG007|STARTED|Week 52||135||
48436608|NCT01422876|101403590|FG008|STARTED|Week 52||134||
48436609|NCT01422876|101403591|FG009|STARTED|Week 52||135||
48436610|NCT01422876|101403582|FG000|COMPLETED|Week 52||125||
48436611|NCT01422876|101403583|FG001|COMPLETED|Week 52||126||
48366200|NCT02243527|101227124|FG000|STARTED|Overall Study||12||
48366201|NCT02243527|101227125|FG001|STARTED|Overall Study||13||
48366202|NCT02243527|101227124|FG000|COMPLETED|Overall Study||12||
48366203|NCT02243527|101227125|FG001|COMPLETED|Overall Study||13||
48366204|NCT02243527|101227124|FG000|NOT COMPLETED|Overall Study||0||
48366205|NCT02243527|101227125|FG001|NOT COMPLETED|Overall Study||0||
48366206|NCT00992446|101227126|FG000|STARTED|Overall Study||27||
48366207|NCT00992446|101227126|FG000|COMPLETED|Overall Study||19||
48436612|NCT01422876|101403584|FG002|COMPLETED|Week 52||128||
48436613|NCT01422876|101403585|FG003|COMPLETED|Week 52||122||
48436614|NCT01422876|101403586|FG004|COMPLETED|Week 52||117||
48436615|NCT01422876|101403587|FG005|COMPLETED|Week 52||120||
48436616|NCT01422876|101403588|FG006|COMPLETED|Week 52||120||
48436617|NCT01422876|101403589|FG007|COMPLETED|Week 52||112||
48436618|NCT01422876|101403590|FG008|COMPLETED|Week 52||113||
48436619|NCT01422876|101403591|FG009|COMPLETED|Week 52||118||
48436620|NCT01422876|101403582|FG000|NOT COMPLETED|Week 52||12||
48436621|NCT01422876|101403583|FG001|NOT COMPLETED|Week 52||10||
48436622|NCT01422876|101403584|FG002|NOT COMPLETED|Week 52||13||
48436623|NCT01422876|101403585|FG003|NOT COMPLETED|Week 52||18||
48366208|NCT00992446|101227126|FG000|NOT COMPLETED|Overall Study||8||
48366209|NCT03010423|101227127|FG000|STARTED|Overall Study||8||
48366210|NCT03010423|101227127|FG000|COMPLETED|Overall Study||0||
48366211|NCT03010423|101227127|FG000|NOT COMPLETED|Overall Study||8||
48366212|NCT00436215|101227128|FG000|STARTED|Overall Study||55||
48366213|NCT00436215|101227128|FG000|COMPLETED|Overall Study||51||
48366214|NCT00436215|101227128|FG000|NOT COMPLETED|Overall Study||4||
48366215|NCT00085540|101227129|FG000|STARTED|Overall Study||8||
48366216|NCT00085540|101227130|FG001|STARTED|Overall Study||42||
48366217|NCT00085540|101227129|FG000|COMPLETED|Overall Study||8||
48366218|NCT00085540|101227130|FG001|COMPLETED|Overall Study||40||
48366219|NCT00085540|101227129|FG000|NOT COMPLETED|Overall Study||0||
48366220|NCT00085540|101227130|FG001|NOT COMPLETED|Overall Study||2||
48366221|NCT03677089|101227131|FG000|STARTED|Overall Study||148||
48366222|NCT03677089|101227131|FG000|Baseline/Pre-Intervention|Overall Study||137|5 participants attended but did not complete forms.|
48366223|NCT03677089|101227131|FG000|Mid-Intervention|Overall Study||120||
48366224|NCT03677089|101227131|FG000|Post-Intervention|Overall Study||117||
48366225|NCT03677089|101227131|FG000|Follow-Up|Overall Study||114||
48366226|NCT03677089|101227131|FG000|COMPLETED|Overall Study||114||
48366227|NCT03677089|101227131|FG000|NOT COMPLETED|Overall Study||34||
48366228|NCT02389946|101227132|FG000|STARTED|Overall Study||884||
48366229|NCT02389946|101227133|FG001|STARTED|Overall Study||450||
48366230|NCT02389946|101227132|FG000|COMPLETED|Overall Study||860||
48366231|NCT02389946|101227133|FG001|COMPLETED|Overall Study||435||
48366232|NCT02389946|101227132|FG000|NOT COMPLETED|Overall Study||24||
48366233|NCT02389946|101227133|FG001|NOT COMPLETED|Overall Study||15||
48366234|NCT00524745|101227134|FG000|STARTED|Overall Study||229||
48366235|NCT00524745|101227135|FG001|STARTED|Overall Study||206||
48366236|NCT00524745|101227136|FG002|STARTED|Overall Study||241||
48366237|NCT00524745|101227137|FG003|STARTED|Overall Study||227||
48366238|NCT00524745|101227134|FG000|COMPLETED|Overall Study||195||
48366239|NCT00524745|101227135|FG001|COMPLETED|Overall Study||193||
48366240|NCT00524745|101227136|FG002|COMPLETED|Overall Study||212||
48366241|NCT00524745|101227137|FG003|COMPLETED|Overall Study||205||
48366242|NCT00524745|101227134|FG000|NOT COMPLETED|Overall Study||34||
48366243|NCT00524745|101227135|FG001|NOT COMPLETED|Overall Study||13||
48366244|NCT00524745|101227136|FG002|NOT COMPLETED|Overall Study||29||
48366245|NCT00524745|101227137|FG003|NOT COMPLETED|Overall Study||22||
48366246|NCT05243550|101227138|FG000|STARTED|Overall Study||240||
48366247|NCT05243550|101227138|FG000|COMPLETED|Overall Study||43||
48366248|NCT05243550|101227138|FG000|NOT COMPLETED|Overall Study||197||
48366249|NCT00907478|101227139|FG000|STARTED|Overall Study||50||
48366250|NCT00907478|101227140|FG001|STARTED|Overall Study||50||
48366251|NCT00907478|101227141|FG002|STARTED|Overall Study||69||
48366252|NCT00907478|101227139|FG000|COMPLETED|Overall Study||23||
48366253|NCT00907478|101227140|FG001|COMPLETED|Overall Study||33||
48366254|NCT00907478|101227141|FG002|COMPLETED|Overall Study||47||
48366255|NCT00907478|101227139|FG000|NOT COMPLETED|Overall Study||27||
48366256|NCT00907478|101227140|FG001|NOT COMPLETED|Overall Study||17||
48366257|NCT00907478|101227141|FG002|NOT COMPLETED|Overall Study||22||
48655059|NCT01386385|101941153|FG001|COMPLETED|Phase I 40mg: Consolidation Therapy||4||
48655060|NCT01386385|101941154|FG002|COMPLETED|Phase I 40mg: Consolidation Therapy||0||
48655061|NCT01386385|101941155|FG003|COMPLETED|Phase I 40mg: Consolidation Therapy||0||
48655062|NCT01386385|101941156|FG004|COMPLETED|Phase I 40mg: Consolidation Therapy||0||
48366258|NCT01988012|101227142|FG000|STARTED|Overall Study||100||
48366259|NCT01988012|101227142|FG000|COMPLETED|Overall Study||85||
48366260|NCT01988012|101227142|FG000|NOT COMPLETED|Overall Study||15||
48366261|NCT00962065|101227143|FG000|STARTED|Overall Study||12||
48366262|NCT00962065|101227144|FG001|STARTED|Overall Study||12||
48366263|NCT00962065|101227145|FG002|STARTED|Overall Study||12||
48366264|NCT00962065|101227143|FG000|COMPLETED|Overall Study||12||
48366265|NCT00962065|101227144|FG001|COMPLETED|Overall Study||12||
48366266|NCT00962065|101227145|FG002|COMPLETED|Overall Study||12||
48366267|NCT00962065|101227143|FG000|NOT COMPLETED|Overall Study||0||
48366268|NCT00962065|101227144|FG001|NOT COMPLETED|Overall Study||0||
48366269|NCT00962065|101227145|FG002|NOT COMPLETED|Overall Study||0||
48366270|NCT04333433|101227146|FG000|STARTED|Overall Study||217||
48366271|NCT04333433|101227147|FG001|STARTED|Overall Study||62||
48655063|NCT01386385|101941157|FG005|COMPLETED|Phase I 40mg: Consolidation Therapy||0||
48366272|NCT04333433|101227146|FG000|COMPLETED|Overall Study||198||
48366273|NCT04333433|101227147|FG001|COMPLETED|Overall Study||58||
48366274|NCT04333433|101227146|FG000|NOT COMPLETED|Overall Study||19||
48366275|NCT04333433|101227147|FG001|NOT COMPLETED|Overall Study||4||
48366276|NCT00273858|101227148|FG000|STARTED|Overall Study||880||
48366277|NCT00273858|101227148|FG000|COMPLETED|Overall Study||343||
48366278|NCT00273858|101227148|FG000|NOT COMPLETED|Overall Study||537||
48366279|NCT00950612|101227149|FG000|STARTED|Overall Study||40||
48366280|NCT00950612|101227150|FG001|STARTED|Overall Study||20||
48366281|NCT00950612|101227149|FG000|COMPLETED|Overall Study||40||
48366282|NCT00950612|101227150|FG001|COMPLETED|Overall Study||20||
48366283|NCT00950612|101227149|FG000|NOT COMPLETED|Overall Study||0||
48366284|NCT00950612|101227150|FG001|NOT COMPLETED|Overall Study||0||
48366285|NCT02538666|101227151|FG000|STARTED|Pre-Treatment||300|Started = Randomized|
48366286|NCT02538666|101227152|FG001|STARTED|Pre-Treatment||304|Started = Randomized|
48366287|NCT02538666|101227153|FG002|STARTED|Pre-Treatment||303|Started = Randomized|
48366288|NCT02538666|101227151|FG000|Global|Pre-Treatment||275||
48366289|NCT02538666|101227152|FG001|Global|Pre-Treatment||280||
48366290|NCT02538666|101227153|FG002|Global|Pre-Treatment||279||
48366291|NCT02538666|101227151|FG000|China|Pre-Treatment||26||
48366292|NCT02538666|101227152|FG001|China|Pre-Treatment||25||
48366293|NCT02538666|101227153|FG002|China|Pre-Treatment||24||
48366294|NCT02538666|101227151|FG000|COMPLETED|Pre-Treatment||298|Completed = Treated|
48366295|NCT02538666|101227152|FG001|COMPLETED|Pre-Treatment||303|Completed = Treated|
48366296|NCT02538666|101227153|FG002|COMPLETED|Pre-Treatment||302|Completed = Treated|
48366297|NCT02538666|101227151|FG000|NOT COMPLETED|Pre-Treatment||2||
48366298|NCT02538666|101227152|FG001|NOT COMPLETED|Pre-Treatment||1||
48366299|NCT02538666|101227153|FG002|NOT COMPLETED|Pre-Treatment||1||
48366300|NCT02538666|101227151|FG000|STARTED|Treatment||298|Started = Started Treatment|
48366301|NCT02538666|101227152|FG001|STARTED|Treatment||303|Started = Started Treatment|
48366302|NCT02538666|101227153|FG002|STARTED|Treatment||302|Started = Started Treatment|
48366303|NCT02538666|101227151|FG000|Global|Treatment||273||
48366304|NCT02538666|101227152|FG001|Global|Treatment||279||
48366305|NCT02538666|101227153|FG002|Global|Treatment||278||
48366306|NCT02538666|101227151|FG000|China|Treatment||26||
48366307|NCT02538666|101227152|FG001|China|Treatment||25||
48366308|NCT02538666|101227153|FG002|China|Treatment||24||
48366309|NCT02538666|101227151|FG000|COMPLETED|Treatment||0|Completed = Continuing in treatment period|
48366310|NCT02538666|101227152|FG001|COMPLETED|Treatment||0|Completed = Continuing in treatment period|
48366311|NCT02538666|101227153|FG002|COMPLETED|Treatment||0|Completed = Continuing in treatment period|
48366312|NCT02538666|101227151|FG000|NOT COMPLETED|Treatment||298||
48366313|NCT02538666|101227152|FG001|NOT COMPLETED|Treatment||303||
48366314|NCT02538666|101227153|FG002|NOT COMPLETED|Treatment||302||
48366315|NCT00798967|101227154|FG000|STARTED|Overall Study||43||
48366316|NCT00798967|101227155|FG001|STARTED|Overall Study||43||
48366317|NCT00798967|101227154|FG000|Discontinued During Dosing Period|Overall Study||4||
48366318|NCT00798967|101227155|FG001|Discontinued During Dosing Period|Overall Study||4||
48366319|NCT00798967|101227154|FG000|COMPLETED|Overall Study||39||
48366320|NCT00798967|101227155|FG001|COMPLETED|Overall Study||39||
48366321|NCT00798967|101227154|FG000|NOT COMPLETED|Overall Study||4||
48366322|NCT00798967|101227155|FG001|NOT COMPLETED|Overall Study||4||
48366323|NCT01594476|101227156|FG000|STARTED|Overall Study||101||
48366324|NCT01594476|101227157|FG001|STARTED|Overall Study||100||
48655064|NCT01386385|101941158|FG006|COMPLETED|Phase I 40mg: Consolidation Therapy||0||
48655065|NCT01386385|101941159|FG007|COMPLETED|Phase I 40mg: Consolidation Therapy||0||
48655066|NCT01386385|101941152|FG000|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0||
48655067|NCT01386385|101941153|FG001|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0||
48655068|NCT01386385|101941154|FG002|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0||
48655069|NCT01386385|101941155|FG003|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0||
48655070|NCT01386385|101941156|FG004|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0||
48655071|NCT01386385|101941157|FG005|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0||
48366325|NCT01594476|101227156|FG000|Received Intervention|Overall Study||66||
48366326|NCT01594476|101227157|FG001|Received Intervention|Overall Study||73||
48366327|NCT01594476|101227156|FG000|Excluded After Allocation|Overall Study||1||
48366328|NCT01594476|101227157|FG001|Excluded After Allocation|Overall Study||3||
48366329|NCT01594476|101227156|FG000|IUD Removal|Overall Study||3|By 6 months|
48366330|NCT01594476|101227157|FG001|IUD Removal|Overall Study||5|By 6 months|
48366331|NCT01594476|101227156|FG000|IUD Expulsion|Overall Study||2|By 6 months|
48366332|NCT01594476|101227157|FG001|IUD Expulsion|Overall Study||0|By 6 months|
48366333|NCT01594476|101227156|FG000|Pregnant|Overall Study||2|By 6 months None had IUD in place at the time of pregnancy|
48366334|NCT01594476|101227157|FG001|Pregnant|Overall Study||5|By 6 months None had IUD in place at the time of pregnancy|
48366335|NCT01594476|101227156|FG000|COMPLETED|Overall Study||100|Analyzed for intent to treat|
48366336|NCT01594476|101227157|FG001|COMPLETED|Overall Study||97|Analyzed for intent to treat|
48366337|NCT01594476|101227156|FG000|NOT COMPLETED|Overall Study||1||
48366338|NCT01594476|101227157|FG001|NOT COMPLETED|Overall Study||3||
48436624|NCT01422876|101403586|FG004|NOT COMPLETED|Week 52||15||
48655072|NCT01386385|101941158|FG006|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0||
48655073|NCT01386385|101941159|FG007|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0||
48655074|NCT01386385|101941152|FG000|STARTED|Phase I 80mg: Concurrent CRT||0||
48366339|NCT00403117|101227158|FG000|STARTED|Overall Study||49||
48366340|NCT00403117|101227158|FG000|COMPLETED|Overall Study||29||
48366341|NCT00403117|101227158|FG000|NOT COMPLETED|Overall Study||20||
48366342|NCT04238663|101227159|FG000|STARTED|Overall Study||38||
48366343|NCT04238663|101227160|FG001|STARTED|Overall Study||38||
48366344|NCT04238663|101227161|FG002|STARTED|Overall Study||38||
48366345|NCT04238663|101227159|FG000|COMPLETED|Overall Study||38||
48366346|NCT04238663|101227160|FG001|COMPLETED|Overall Study||37||
48366347|NCT04238663|101227161|FG002|COMPLETED|Overall Study||38||
48366348|NCT04238663|101227159|FG000|NOT COMPLETED|Overall Study||0||
48366349|NCT04238663|101227160|FG001|NOT COMPLETED|Overall Study||1||
48366350|NCT04238663|101227161|FG002|NOT COMPLETED|Overall Study||0||
48366351|NCT02284906|101227162|FG000|STARTED|Overall Study||3||
48366352|NCT02284906|101227163|FG001|STARTED|Overall Study||18||
48366353|NCT02284906|101227164|FG002|STARTED|Overall Study||19||
48366354|NCT02284906|101227162|FG000|COMPLETED|Overall Study||0||
48366355|NCT02284906|101227163|FG001|COMPLETED|Overall Study||0||
48366356|NCT02284906|101227164|FG002|COMPLETED|Overall Study||0||
48366357|NCT02284906|101227162|FG000|NOT COMPLETED|Overall Study||3||
48366358|NCT02284906|101227163|FG001|NOT COMPLETED|Overall Study||18||
48366359|NCT02284906|101227164|FG002|NOT COMPLETED|Overall Study||19||
48366360|NCT01392989|101227165|FG000|STARTED|Total Lymphoid Irradiation (TLI)||44||
48366361|NCT01392989|101227165|FG000|COMPLETED|Total Lymphoid Irradiation (TLI)||44||
48366362|NCT01392989|101227165|FG000|NOT COMPLETED|Total Lymphoid Irradiation (TLI)||0||
48366363|NCT01392989|101227165|FG000|STARTED|CIK Cell Infusion||31||
48366364|NCT01392989|101227165|FG000|COMPLETED|CIK Cell Infusion||31||
48366365|NCT01392989|101227165|FG000|NOT COMPLETED|CIK Cell Infusion||0||
48366366|NCT00958568|101227166|FG000|STARTED|SPII (Wk 0-8, Acute Open-label)||892||
48366367|NCT00958568|101227167|FG001|STARTED|SPII (Wk 0-8, Acute Open-label)||0||
48366368|NCT00958568|101227168|FG002|STARTED|SPII (Wk 0-8, Acute Open-label)||0||
48366369|NCT00958568|101227169|FG003|STARTED|SPII (Wk 0-8, Acute Open-label)||0||
48366370|NCT00958568|101227166|FG000|COMPLETED|SPII (Wk 0-8, Acute Open-label)||655||
48366371|NCT00958568|101227167|FG001|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0||
48366372|NCT00958568|101227168|FG002|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0||
48366373|NCT00958568|101227169|FG003|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0||
48366374|NCT00958568|101227166|FG000|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||237||
48366375|NCT00958568|101227167|FG001|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0||
48366376|NCT00958568|101227168|FG002|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0||
48366377|NCT00958568|101227169|FG003|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0||
48366378|NCT00958568|101227166|FG000|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0||
48366379|NCT00958568|101227167|FG001|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||655||
48366380|NCT00958568|101227168|FG002|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0||
48366381|NCT00958568|101227169|FG003|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0||
48366382|NCT00958568|101227166|FG000|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0||
48366383|NCT00958568|101227167|FG001|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||444||
48366384|NCT00958568|101227168|FG002|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0||
48366385|NCT00958568|101227169|FG003|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0||
48366386|NCT00958568|101227166|FG000|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0||
48366387|NCT00958568|101227167|FG001|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||211||
48366388|NCT00958568|101227168|FG002|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0||
48366389|NCT00958568|101227169|FG003|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0||
48366390|NCT00958568|101227166|FG000|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0||
48366391|NCT00958568|101227167|FG001|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0||
48366392|NCT00958568|101227168|FG002|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||221||
48366393|NCT00958568|101227169|FG003|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||223||
48366394|NCT00958568|101227166|FG000|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0||
48366395|NCT00958568|101227167|FG001|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0||
48366396|NCT00958568|101227168|FG002|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||139||
48366397|NCT00958568|101227169|FG003|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||117||
48366398|NCT00958568|101227166|FG000|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0||
48366399|NCT00958568|101227167|FG001|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0||
48366400|NCT00958568|101227168|FG002|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||82||
48366401|NCT00958568|101227169|FG003|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||106||
48366402|NCT01753115|101227170|FG000|STARTED|Overall Study||44||
48366403|NCT01753115|101227171|FG001|STARTED|Overall Study||40||
48366404|NCT01753115|101227172|FG002|STARTED|Overall Study||70||
48366405|NCT01753115|101227170|FG000|Treated|Overall Study||38||
48366406|NCT01753115|101227171|FG001|Treated|Overall Study||39||
48366407|NCT01753115|101227172|FG002|Treated|Overall Study||67||
48366408|NCT01753115|101227170|FG000|COMPLETED|Overall Study||32||
48366409|NCT01753115|101227171|FG001|COMPLETED|Overall Study||25||
48436625|NCT01422876|101403587|FG005|NOT COMPLETED|Week 52||17||
48436626|NCT01422876|101403588|FG006|NOT COMPLETED|Week 52||16||
48655075|NCT01386385|101941153|FG001|STARTED|Phase I 80mg: Concurrent CRT||0||
48188327|NCT01657032|100783217|FG001|COMPLETED|Overall Study||37||
48188328|NCT01657032|100783216|FG000|NOT COMPLETED|Overall Study||0||
48188329|NCT01657032|100783217|FG001|NOT COMPLETED|Overall Study||7||
48366410|NCT01753115|101227172|FG002|COMPLETED|Overall Study||56||
48366411|NCT01753115|101227170|FG000|NOT COMPLETED|Overall Study||12||
48366412|NCT01753115|101227171|FG001|NOT COMPLETED|Overall Study||15||
48366413|NCT01753115|101227172|FG002|NOT COMPLETED|Overall Study||14||
48366414|NCT01128972|101227173|FG000|STARTED|Period I||7||
48366415|NCT01128972|101227174|FG001|STARTED|Period I||7||
48366416|NCT01128972|101227175|FG002|STARTED|Period I||7||
48366417|NCT01128972|101227176|FG003|STARTED|Period I||7||
48366418|NCT01128972|101227177|FG004|STARTED|Period I||8||
48436627|NCT01422876|101403589|FG007|NOT COMPLETED|Week 52||23||
48436628|NCT01422876|101403590|FG008|NOT COMPLETED|Week 52||21||
48436629|NCT01422876|101403591|FG009|NOT COMPLETED|Week 52||17||
48436630|NCT02965027|101403592|FG000|STARTED|Overall Study||59||
48436631|NCT02965027|101403593|FG001|STARTED|Overall Study||30||
48436632|NCT02965027|101403592|FG000|COMPLETED|Overall Study||52||
48436633|NCT02965027|101403593|FG001|COMPLETED|Overall Study||26||
48436634|NCT02965027|101403592|FG000|NOT COMPLETED|Overall Study||7||
48436635|NCT02965027|101403593|FG001|NOT COMPLETED|Overall Study||4||
48436636|NCT00943826|101403594|FG000|STARTED|Concurrent Phase||458||
48436637|NCT00943826|101403595|FG001|STARTED|Concurrent Phase||463||
48436638|NCT00943826|101403594|FG000|Treated|Concurrent Phase||452||
48436639|NCT00943826|101403595|FG001|Treated|Concurrent Phase||459||
48436640|NCT00943826|101403594|FG000|COMPLETED|Concurrent Phase||397||
48436641|NCT00943826|101403595|FG001|COMPLETED|Concurrent Phase||421||
48436642|NCT00943826|101403594|FG000|NOT COMPLETED|Concurrent Phase||61||
48436643|NCT00943826|101403595|FG001|NOT COMPLETED|Concurrent Phase||42||
48436644|NCT00943826|101403594|FG000|STARTED|Maintenance Phase||396||
48436645|NCT00943826|101403595|FG001|STARTED|Maintenance Phase||370||
48436646|NCT00943826|101403594|FG000|COMPLETED|Maintenance Phase||353||
48436647|NCT00943826|101403595|FG001|COMPLETED|Maintenance Phase||331||
48436648|NCT00943826|101403594|FG000|NOT COMPLETED|Maintenance Phase||43||
48436649|NCT00943826|101403595|FG001|NOT COMPLETED|Maintenance Phase||39||
48436650|NCT00943826|101403594|FG000|STARTED|Monotherapy Phase||269||
48436651|NCT00943826|101403595|FG001|STARTED|Monotherapy Phase||159||
48436652|NCT00943826|101403594|FG000|COMPLETED|Monotherapy Phase||204||
48436653|NCT00943826|101403595|FG001|COMPLETED|Monotherapy Phase||143||
48436654|NCT00943826|101403594|FG000|NOT COMPLETED|Monotherapy Phase||65||
48436655|NCT00943826|101403595|FG001|NOT COMPLETED|Monotherapy Phase||16||
48436656|NCT00943826|101403594|FG000|STARTED|After Primary Overall Survival Analysis||27||
48436657|NCT00943826|101403595|FG001|STARTED|After Primary Overall Survival Analysis||20||
48436658|NCT00943826|101403594|FG000|COMPLETED|After Primary Overall Survival Analysis||0||
48436659|NCT00943826|101403595|FG001|COMPLETED|After Primary Overall Survival Analysis||0||
48366419|NCT01128972|101227173|FG000|COMPLETED|Period I||7||
48366420|NCT01128972|101227174|FG001|COMPLETED|Period I||7||
48436660|NCT00943826|101403594|FG000|NOT COMPLETED|After Primary Overall Survival Analysis||27||
48366421|NCT01128972|101227175|FG002|COMPLETED|Period I||7||
48366422|NCT01128972|101227176|FG003|COMPLETED|Period I||7||
48366423|NCT01128972|101227177|FG004|COMPLETED|Period I||8||
48366424|NCT01128972|101227173|FG000|NOT COMPLETED|Period I||0||
48366425|NCT01128972|101227174|FG001|NOT COMPLETED|Period I||0||
48366426|NCT01128972|101227175|FG002|NOT COMPLETED|Period I||0||
48366427|NCT01128972|101227176|FG003|NOT COMPLETED|Period I||0||
48366428|NCT01128972|101227177|FG004|NOT COMPLETED|Period I||0||
48366429|NCT01128972|101227173|FG000|STARTED|Period II||7||
48366430|NCT01128972|101227174|FG001|STARTED|Period II||7||
48366431|NCT01128972|101227175|FG002|STARTED|Period II||7||
48366432|NCT01128972|101227176|FG003|STARTED|Period II||8||
48366433|NCT01128972|101227177|FG004|STARTED|Period II||7||
48366434|NCT01128972|101227173|FG000|COMPLETED|Period II||7||
48366435|NCT01128972|101227174|FG001|COMPLETED|Period II||7||
48366436|NCT01128972|101227175|FG002|COMPLETED|Period II||7||
48366437|NCT01128972|101227176|FG003|COMPLETED|Period II||8||
48366438|NCT01128972|101227177|FG004|COMPLETED|Period II||7||
48366439|NCT01128972|101227173|FG000|NOT COMPLETED|Period II||0||
48366440|NCT01128972|101227174|FG001|NOT COMPLETED|Period II||0||
48366441|NCT01128972|101227175|FG002|NOT COMPLETED|Period II||0||
48366442|NCT01128972|101227176|FG003|NOT COMPLETED|Period II||0||
48366443|NCT01128972|101227177|FG004|NOT COMPLETED|Period II||0||
48366444|NCT01128972|101227173|FG000|STARTED|Period III||7||
48366445|NCT01128972|101227174|FG001|STARTED|Period III||7||
48366446|NCT01128972|101227175|FG002|STARTED|Period III||8||
48366447|NCT01128972|101227176|FG003|STARTED|Period III||7||
48436661|NCT00943826|101403595|FG001|NOT COMPLETED|After Primary Overall Survival Analysis||20||
48436662|NCT04158466|101403596|FG000|STARTED|Overall Study||124||
48436663|NCT04158466|101403597|FG001|STARTED|Overall Study||127||
48436664|NCT04158466|101403596|FG000|COMPLETED|Overall Study||121||
48436665|NCT04158466|101403597|FG001|COMPLETED|Overall Study||126||
48436666|NCT04158466|101403596|FG000|NOT COMPLETED|Overall Study||3||
48436667|NCT04158466|101403597|FG001|NOT COMPLETED|Overall Study||1||
48436668|NCT03185949|101403598|FG000|STARTED|ITT Analysis||22|Assessed for eligibility|
48436669|NCT03185949|101403599|FG001|STARTED|ITT Analysis||22|Assessed for eligibility|
48436670|NCT03185949|101403598|FG000|COMPLETED|ITT Analysis||18||
48436671|NCT03185949|101403599|FG001|COMPLETED|ITT Analysis||19||
48436672|NCT03185949|101403598|FG000|NOT COMPLETED|ITT Analysis||4||
48436673|NCT03185949|101403599|FG001|NOT COMPLETED|ITT Analysis||3||
48436674|NCT03185949|101403598|FG000|STARTED|PP Analysis||18|All participants who were part of the ITT Population|
48436675|NCT03185949|101403599|FG001|STARTED|PP Analysis||19|All participants who were part of the ITT Population|
48366448|NCT01128972|101227177|FG004|STARTED|Period III||7||
48366449|NCT01128972|101227173|FG000|COMPLETED|Period III||7||
48366450|NCT01128972|101227174|FG001|COMPLETED|Period III||7||
48366451|NCT01128972|101227175|FG002|COMPLETED|Period III||8||
48366452|NCT01128972|101227176|FG003|COMPLETED|Period III||7||
48366453|NCT01128972|101227177|FG004|COMPLETED|Period III||7||
48366454|NCT01128972|101227173|FG000|NOT COMPLETED|Period III||0||
48366455|NCT01128972|101227174|FG001|NOT COMPLETED|Period III||0||
48366456|NCT01128972|101227175|FG002|NOT COMPLETED|Period III||0||
48366457|NCT01128972|101227176|FG003|NOT COMPLETED|Period III||0||
48366458|NCT01128972|101227177|FG004|NOT COMPLETED|Period III||0||
48366459|NCT01128972|101227173|FG000|STARTED|Period IV||7||
48366460|NCT01128972|101227174|FG001|STARTED|Period IV||8||
48366461|NCT01128972|101227175|FG002|STARTED|Period IV||7||
48366462|NCT01128972|101227176|FG003|STARTED|Period IV||7||
48366463|NCT01128972|101227177|FG004|STARTED|Period IV||7||
48366464|NCT01128972|101227173|FG000|COMPLETED|Period IV||7||
48436676|NCT03185949|101403598|FG000|COMPLETED|PP Analysis||16||
48436677|NCT03185949|101403599|FG001|COMPLETED|PP Analysis||15||
48655076|NCT01386385|101941154|FG002|STARTED|Phase I 80mg: Concurrent CRT||7||
48655077|NCT01386385|101941155|FG003|STARTED|Phase I 80mg: Concurrent CRT||0||
48655078|NCT01386385|101941156|FG004|STARTED|Phase I 80mg: Concurrent CRT||0||
48655079|NCT01386385|101941157|FG005|STARTED|Phase I 80mg: Concurrent CRT||0||
48655080|NCT01386385|101941158|FG006|STARTED|Phase I 80mg: Concurrent CRT||0||
48655081|NCT01386385|101941159|FG007|STARTED|Phase I 80mg: Concurrent CRT||0||
48655082|NCT01386385|101941152|FG000|COMPLETED|Phase I 80mg: Concurrent CRT||0||
48655083|NCT01386385|101941153|FG001|COMPLETED|Phase I 80mg: Concurrent CRT||0||
48655084|NCT01386385|101941154|FG002|COMPLETED|Phase I 80mg: Concurrent CRT||5||
48655085|NCT01386385|101941155|FG003|COMPLETED|Phase I 80mg: Concurrent CRT||0||
48655086|NCT01386385|101941156|FG004|COMPLETED|Phase I 80mg: Concurrent CRT||0||
48655087|NCT01386385|101941157|FG005|COMPLETED|Phase I 80mg: Concurrent CRT||0||
48655088|NCT01386385|101941158|FG006|COMPLETED|Phase I 80mg: Concurrent CRT||0||
48766012|NCT00093041|102214783|FG003|COMPLETED|Overall Study||3||
48766013|NCT00093041|102214784|FG004|COMPLETED|Overall Study||3||
48766014|NCT00093041|102214785|FG005|COMPLETED|Overall Study||4||
48766015|NCT00093041|102214780|FG000|NOT COMPLETED|Overall Study||2||
48766016|NCT00093041|102214781|FG001|NOT COMPLETED|Overall Study||3||
48766017|NCT00093041|102214782|FG002|NOT COMPLETED|Overall Study||2||
48766018|NCT00093041|102214783|FG003|NOT COMPLETED|Overall Study||1||
48766019|NCT00093041|102214784|FG004|NOT COMPLETED|Overall Study||1||
48655089|NCT01386385|101941159|FG007|COMPLETED|Phase I 80mg: Concurrent CRT||0||
48655090|NCT01386385|101941152|FG000|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0||
48655091|NCT01386385|101941153|FG001|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0||
48655092|NCT01386385|101941154|FG002|NOT COMPLETED|Phase I 80mg: Concurrent CRT||2||
48766020|NCT00093041|102214785|FG005|NOT COMPLETED|Overall Study||3||
48766021|NCT00807911|102214786|FG000|STARTED|Overall Study||161||
48766022|NCT00807911|102214787|FG001|STARTED|Overall Study||160||
48766023|NCT00807911|102214786|FG000|COMPLETED|Overall Study||149||
48766024|NCT00807911|102214787|FG001|COMPLETED|Overall Study||146||
48766025|NCT00807911|102214786|FG000|NOT COMPLETED|Overall Study||12||
48766026|NCT00807911|102214787|FG001|NOT COMPLETED|Overall Study||14||
48766027|NCT03542877|102214788|FG000|STARTED|Overall Study||44||
48766028|NCT03542877|102214788|FG000|COMPLETED|Overall Study||23||
48766029|NCT03542877|102214788|FG000|NOT COMPLETED|Overall Study||21||
48766030|NCT01122238|102214789|FG000|STARTED|Overall Study||30||
48766031|NCT01122238|102214790|FG001|STARTED|Overall Study||37||
48766032|NCT01122238|102214791|FG002|STARTED|Overall Study||33||
48766033|NCT01122238|102214792|FG003|STARTED|Overall Study||33||
48766034|NCT01122238|102214793|FG004|STARTED|Overall Study||33||
48766035|NCT01122238|102214794|FG005|STARTED|Overall Study||32||
48766036|NCT01122238|102214795|FG006|STARTED|Overall Study||35||
48766037|NCT01122238|102214796|FG007|STARTED|Overall Study||32||
48766038|NCT01122238|102214797|FG008|STARTED|Overall Study||32||
48766039|NCT01122238|102214798|FG009|STARTED|Overall Study||34||
48766040|NCT01122238|102214799|FG010|STARTED|Overall Study||32||
48766041|NCT01122238|102214800|FG011|STARTED|Overall Study||33||
48766042|NCT01122238|102214801|FG012|STARTED|Overall Study||30||
48766043|NCT01122238|102214802|FG013|STARTED|Overall Study||32||
48766044|NCT01122238|102214803|FG014|STARTED|Overall Study||28||
48366465|NCT01128972|101227174|FG001|COMPLETED|Period IV||8||
48366466|NCT01128972|101227175|FG002|COMPLETED|Period IV||7||
48366467|NCT01128972|101227176|FG003|COMPLETED|Period IV||7||
48366468|NCT01128972|101227177|FG004|COMPLETED|Period IV||7||
48366469|NCT01128972|101227173|FG000|NOT COMPLETED|Period IV||0||
48366470|NCT01128972|101227174|FG001|NOT COMPLETED|Period IV||0||
48366471|NCT01128972|101227175|FG002|NOT COMPLETED|Period IV||0||
48366472|NCT01128972|101227176|FG003|NOT COMPLETED|Period IV||0||
48366473|NCT01128972|101227177|FG004|NOT COMPLETED|Period IV||0||
48366474|NCT01128972|101227173|FG000|STARTED|Period V||8||
48436678|NCT03185949|101403598|FG000|NOT COMPLETED|PP Analysis||2||
48766045|NCT01122238|102214804|FG015|STARTED|Overall Study||31||
48366475|NCT01128972|101227174|FG001|STARTED|Period V||7||
48366476|NCT01128972|101227175|FG002|STARTED|Period V||7||
48366477|NCT01128972|101227176|FG003|STARTED|Period V||7||
48366478|NCT01128972|101227177|FG004|STARTED|Period V||7||
48366479|NCT01128972|101227173|FG000|COMPLETED|Period V||8||
48366480|NCT01128972|101227174|FG001|COMPLETED|Period V||7||
48766046|NCT01122238|102214789|FG000|COMPLETED|Overall Study||28||
48766047|NCT01122238|102214790|FG001|COMPLETED|Overall Study||36||
48766048|NCT01122238|102214791|FG002|COMPLETED|Overall Study||28||
48766049|NCT01122238|102214792|FG003|COMPLETED|Overall Study||33||
48766050|NCT01122238|102214793|FG004|COMPLETED|Overall Study||33||
48766051|NCT01122238|102214794|FG005|COMPLETED|Overall Study||31||
48766052|NCT01122238|102214795|FG006|COMPLETED|Overall Study||34||
48766053|NCT01122238|102214796|FG007|COMPLETED|Overall Study||32||
48366481|NCT01128972|101227175|FG002|COMPLETED|Period V||7||
48366482|NCT01128972|101227176|FG003|COMPLETED|Period V||7||
48366483|NCT01128972|101227177|FG004|COMPLETED|Period V||7||
48366484|NCT01128972|101227173|FG000|NOT COMPLETED|Period V||0||
48366485|NCT01128972|101227174|FG001|NOT COMPLETED|Period V||0||
48366486|NCT01128972|101227175|FG002|NOT COMPLETED|Period V||0||
48366487|NCT01128972|101227176|FG003|NOT COMPLETED|Period V||0||
48366488|NCT01128972|101227177|FG004|NOT COMPLETED|Period V||0||
48766054|NCT01122238|102214797|FG008|COMPLETED|Overall Study||31||
48766055|NCT01122238|102214798|FG009|COMPLETED|Overall Study||33||
48366489|NCT02560701|101227178|FG000|STARTED|Overall Study||8060||
48366490|NCT02560701|101227179|FG001|STARTED|Overall Study||89242||
48766056|NCT01122238|102214799|FG010|COMPLETED|Overall Study||32||
48766057|NCT01122238|102214800|FG011|COMPLETED|Overall Study||31||
48766058|NCT01122238|102214801|FG012|COMPLETED|Overall Study||28||
48766059|NCT01122238|102214802|FG013|COMPLETED|Overall Study||31||
48366491|NCT02560701|101227178|FG000|Carve Out|Overall Study||8060|Patients in employers who carved out mental health insurance coverage to a 3rd party vendor excluded|
48366492|NCT02560701|101227179|FG001|Carve Out|Overall Study||88729|Patients in employers who carved out mental health insurance coverage to a 3rd party vendor excluded|
48655093|NCT01386385|101941155|FG003|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0||
48655094|NCT01386385|101941156|FG004|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0||
48655095|NCT01386385|101941157|FG005|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0||
48655096|NCT01386385|101941158|FG006|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0||
48655097|NCT01386385|101941159|FG007|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0||
48655098|NCT01386385|101941152|FG000|STARTED|Phase I 80mg: Consolidation Therapy||0||
48655099|NCT01386385|101941153|FG001|STARTED|Phase I 80mg: Consolidation Therapy||0||
48655100|NCT01386385|101941154|FG002|STARTED|Phase I 80mg: Consolidation Therapy||0||
48766060|NCT01122238|102214803|FG014|COMPLETED|Overall Study||28||
48766061|NCT01122238|102214804|FG015|COMPLETED|Overall Study||31||
48766062|NCT01122238|102214789|FG000|NOT COMPLETED|Overall Study||2||
48766063|NCT01122238|102214790|FG001|NOT COMPLETED|Overall Study||1||
48766064|NCT01122238|102214791|FG002|NOT COMPLETED|Overall Study||5||
48766065|NCT01122238|102214792|FG003|NOT COMPLETED|Overall Study||0||
48766066|NCT01122238|102214793|FG004|NOT COMPLETED|Overall Study||0||
48766067|NCT01122238|102214794|FG005|NOT COMPLETED|Overall Study||1||
48766068|NCT01122238|102214795|FG006|NOT COMPLETED|Overall Study||1||
48766069|NCT01122238|102214796|FG007|NOT COMPLETED|Overall Study||0||
48766070|NCT01122238|102214797|FG008|NOT COMPLETED|Overall Study||1||
48766071|NCT01122238|102214798|FG009|NOT COMPLETED|Overall Study||1||
48766072|NCT01122238|102214799|FG010|NOT COMPLETED|Overall Study||0||
48766073|NCT01122238|102214800|FG011|NOT COMPLETED|Overall Study||2||
48766074|NCT01122238|102214801|FG012|NOT COMPLETED|Overall Study||2||
48766075|NCT01122238|102214802|FG013|NOT COMPLETED|Overall Study||1||
48766076|NCT01122238|102214803|FG014|NOT COMPLETED|Overall Study||0||
48766077|NCT01122238|102214804|FG015|NOT COMPLETED|Overall Study||0||
48766078|NCT04774094|102214805|FG000|STARTED|Overall Study||235||
48766079|NCT04774094|102214805|FG000|COMPLETED|Overall Study||191||
48766080|NCT04774094|102214805|FG000|NOT COMPLETED|Overall Study||44||
48766081|NCT02458313|102214806|FG000|STARTED|Overall Study||30||
48766082|NCT02458313|102214807|FG001|STARTED|Overall Study||31||
48766083|NCT02458313|102214806|FG000|COMPLETED|Overall Study||23||
48766084|NCT02458313|102214807|FG001|COMPLETED|Overall Study||21||
48766085|NCT02458313|102214806|FG000|NOT COMPLETED|Overall Study||7||
48766086|NCT02458313|102214807|FG001|NOT COMPLETED|Overall Study||10||
48766087|NCT03910244|102214808|FG000|STARTED|Overall Study||95||
48366493|NCT02560701|101227178|FG000|Restrict to Patients Between 12 and 64|Overall Study||7598||
48366494|NCT02560701|101227179|FG001|Restrict to Patients Between 12 and 64|Overall Study||82367||
48366495|NCT02560701|101227178|FG000|Bipolar Diagnosis Time Constraints|Overall Study||3533|Require most recent bipolar diagnosis to be between 5 years and 4 months prior to intervention date|
48766088|NCT03910244|102214809|FG001|STARTED|Overall Study||49||
48766089|NCT03910244|102214808|FG000|COMPLETED|Overall Study||63||
48766090|NCT03910244|102214809|FG001|COMPLETED|Overall Study||41||
48766091|NCT03910244|102214808|FG000|NOT COMPLETED|Overall Study||32||
48766092|NCT03910244|102214809|FG001|NOT COMPLETED|Overall Study||8||
48766093|NCT03722238|102214810|FG000|STARTED|Overall Study||608||
48766094|NCT03722238|102214811|FG001|STARTED|Overall Study||5||
48766095|NCT03722238|102214810|FG000|Safety Set|Overall Study||198||
48366496|NCT02560701|101227179|FG001|Bipolar Diagnosis Time Constraints|Overall Study||39427|Require most recent bipolar diagnosis to be between 5 years and 4 months prior to intervention date|
48366497|NCT02560701|101227178|FG000|Matched Cohort|Overall Study||3517||
48366498|NCT02560701|101227179|FG001|Matched Cohort|Overall Study||37776||
48366499|NCT02560701|101227178|FG000|COMPLETED|Overall Study||3517||
48366500|NCT02560701|101227179|FG001|COMPLETED|Overall Study||37776||
48766096|NCT03722238|102214811|FG001|Safety Set|Overall Study||5||
48766097|NCT03722238|102214810|FG000|Actual Drug Users|Overall Study||179||
48766098|NCT03722238|102214811|FG001|Actual Drug Users|Overall Study||5||
48766099|NCT03722238|102214810|FG000|COMPLETED|Overall Study||143|Completed=Participants for whom data collection was complete before early termination of the study.|
48766100|NCT03722238|102214811|FG001|COMPLETED|Overall Study||4|Completed=Participants for whom data collection was complete before early termination of the study.|
48766101|NCT03722238|102214810|FG000|NOT COMPLETED|Overall Study||465||
48766102|NCT03722238|102214811|FG001|NOT COMPLETED|Overall Study||1||
48766103|NCT00474487|102214812|FG000|STARTED|Overall Study||1606||
48766104|NCT00474487|102214813|FG001|STARTED|Overall Study||217||
48766105|NCT00474487|102214814|FG002|STARTED|Overall Study||899||
48766106|NCT00474487|102214815|FG003|STARTED|Overall Study||109||
48766107|NCT00474487|102214812|FG000|COMPLETED|Overall Study||1576||
48766108|NCT00474487|102214813|FG001|COMPLETED|Overall Study||215||
48766109|NCT00474487|102214814|FG002|COMPLETED|Overall Study||885||
48366501|NCT02560701|101227178|FG000|NOT COMPLETED|Overall Study||4543||
48366502|NCT02560701|101227179|FG001|NOT COMPLETED|Overall Study||51466||
48366503|NCT04004507|101227180|FG000|STARTED|Overall Study||16||32
48366504|NCT04004507|101227181|FG001|STARTED|Overall Study||8||16
48366505|NCT04004507|101227180|FG000|COMPLETED|Overall Study||16||32
48366506|NCT04004507|101227181|FG001|COMPLETED|Overall Study||8||16
48366507|NCT04004507|101227180|FG000|NOT COMPLETED|Overall Study||0||0
48366508|NCT04004507|101227181|FG001|NOT COMPLETED|Overall Study||0||0
48366509|NCT02926573|101227182|FG000|STARTED|Overall Study||55||
48366510|NCT02926573|101227183|FG001|STARTED|Overall Study||55||
48366511|NCT02926573|101227182|FG000|COMPLETED|Overall Study||44||
48366512|NCT02926573|101227183|FG001|COMPLETED|Overall Study||46||
48366513|NCT02926573|101227182|FG000|NOT COMPLETED|Overall Study||11||
48766110|NCT00474487|102214815|FG003|COMPLETED|Overall Study||109||
48766111|NCT00474487|102214812|FG000|NOT COMPLETED|Overall Study||30||
48766112|NCT00474487|102214813|FG001|NOT COMPLETED|Overall Study||2||
48766113|NCT00474487|102214814|FG002|NOT COMPLETED|Overall Study||14||
48766114|NCT00474487|102214815|FG003|NOT COMPLETED|Overall Study||0||
48766115|NCT05767749|102214816|FG000|STARTED|Overall Study||24||24
48366514|NCT02926573|101227183|FG001|NOT COMPLETED|Overall Study||9||
48366515|NCT02965534|101227184|FG000|STARTED|Overall Study||45||
48366516|NCT02965534|101227185|FG001|STARTED|Overall Study||55||
48366517|NCT02965534|101227184|FG000|COMPLETED|Overall Study||45||
48366518|NCT02965534|101227185|FG001|COMPLETED|Overall Study||55||
48366519|NCT02965534|101227184|FG000|NOT COMPLETED|Overall Study||0||
48366520|NCT02965534|101227185|FG001|NOT COMPLETED|Overall Study||0||
48436679|NCT03185949|101403599|FG001|NOT COMPLETED|PP Analysis||4||
48440001|NCT01143610|101410005|FG000|NOT COMPLETED|Overall Study||0||
48766116|NCT05767749|102214817|FG001|STARTED|Overall Study||24||24
48766117|NCT05767749|102214818|FG002|STARTED|Overall Study||25||25
48766118|NCT05767749|102214819|FG003|STARTED|Overall Study||25||25
48766119|NCT05767749|102214820|FG004|STARTED|Overall Study||26||26
48766120|NCT05767749|102214821|FG005|STARTED|Overall Study||26||26
48766121|NCT05767749|102214816|FG000|COMPLETED|Overall Study||24||24
48766122|NCT05767749|102214817|FG001|COMPLETED|Overall Study||24||24
48766123|NCT05767749|102214818|FG002|COMPLETED|Overall Study||23||23
48766124|NCT05767749|102214819|FG003|COMPLETED|Overall Study||23||23
48766125|NCT05767749|102214820|FG004|COMPLETED|Overall Study||24||24
48766126|NCT05767749|102214821|FG005|COMPLETED|Overall Study||24||24
48766127|NCT05767749|102214816|FG000|NOT COMPLETED|Overall Study||0||0
48766128|NCT05767749|102214817|FG001|NOT COMPLETED|Overall Study||0||0
48766129|NCT05767749|102214818|FG002|NOT COMPLETED|Overall Study||2||2
48766130|NCT05767749|102214819|FG003|NOT COMPLETED|Overall Study||2||2
48766131|NCT05767749|102214820|FG004|NOT COMPLETED|Overall Study||2||2
48766132|NCT05767749|102214821|FG005|NOT COMPLETED|Overall Study||2||2
48766133|NCT00347022|102214822|FG000|STARTED|Overall Study||74||
48366521|NCT02834403|101227186|FG000|STARTED|Overall Study||2||
48366522|NCT02834403|101227187|FG001|STARTED|Overall Study||2||
48366523|NCT02834403|101227188|FG002|STARTED|Overall Study||2||
48366524|NCT02834403|101227189|FG003|STARTED|Overall Study||2||
48366525|NCT02834403|101227190|FG004|STARTED|Overall Study||3||
48366526|NCT02834403|101227191|FG005|STARTED|Overall Study||4||
48366527|NCT02834403|101227192|FG006|STARTED|Overall Study||22||
48366528|NCT02834403|101227186|FG000|Evaluable Patients|Overall Study||2||
48366529|NCT02834403|101227187|FG001|Evaluable Patients|Overall Study||2||
48366530|NCT02834403|101227188|FG002|Evaluable Patients|Overall Study||2||
48366531|NCT02834403|101227189|FG003|Evaluable Patients|Overall Study||2||
48366532|NCT02834403|101227190|FG004|Evaluable Patients|Overall Study||3||
48366533|NCT02834403|101227191|FG005|Evaluable Patients|Overall Study||4||
48366534|NCT02834403|101227192|FG006|Evaluable Patients|Overall Study||20||
48366535|NCT02834403|101227186|FG000|COMPLETED|Overall Study||0||
48366536|NCT02834403|101227187|FG001|COMPLETED|Overall Study||0||
48366537|NCT02834403|101227188|FG002|COMPLETED|Overall Study||0||
48366538|NCT02834403|101227189|FG003|COMPLETED|Overall Study||1||
48766134|NCT00347022|102214823|FG001|STARTED|Overall Study||71||
48766135|NCT00347022|102214822|FG000|COMPLETED|Overall Study||62||
48766136|NCT00347022|102214823|FG001|COMPLETED|Overall Study||66||
48766137|NCT00347022|102214822|FG000|NOT COMPLETED|Overall Study||12||
48766138|NCT00347022|102214823|FG001|NOT COMPLETED|Overall Study||5||
48766139|NCT02939287|102214824|FG000|STARTED|Overall Study||18||
48766140|NCT02939287|102214825|FG001|STARTED|Overall Study||25||
48766141|NCT02939287|102214826|FG002|STARTED|Overall Study||9||
48766142|NCT02939287|102214824|FG000|COMPLETED|Overall Study||14||
48766143|NCT02939287|102214825|FG001|COMPLETED|Overall Study||21||
48766144|NCT02939287|102214826|FG002|COMPLETED|Overall Study||8||
48766145|NCT02939287|102214824|FG000|NOT COMPLETED|Overall Study||4||
48766146|NCT02939287|102214825|FG001|NOT COMPLETED|Overall Study||4||
48766147|NCT02939287|102214826|FG002|NOT COMPLETED|Overall Study||1||
48766148|NCT01815918|102214827|FG000|STARTED|Overall Study||30||
48766149|NCT01815918|102214828|FG001|STARTED|Overall Study||30||
48766150|NCT01815918|102214827|FG000|COMPLETED|Overall Study||12||
48766151|NCT01815918|102214828|FG001|COMPLETED|Overall Study||11||
48766152|NCT01815918|102214827|FG000|NOT COMPLETED|Overall Study||18||
48766153|NCT01815918|102214828|FG001|NOT COMPLETED|Overall Study||19||
48766154|NCT01951963|102214829|FG000|STARTED|Overall Study||31||
48766155|NCT01951963|102214830|FG001|STARTED|Overall Study||32||
48766156|NCT01951963|102214829|FG000|COMPLETED|Overall Study||31||
48766157|NCT01951963|102214830|FG001|COMPLETED|Overall Study||32||
48366539|NCT02834403|101227190|FG004|COMPLETED|Overall Study||0||
48366540|NCT02834403|101227191|FG005|COMPLETED|Overall Study||1||
48366541|NCT02834403|101227192|FG006|COMPLETED|Overall Study||4||
48366542|NCT02834403|101227186|FG000|NOT COMPLETED|Overall Study||2||
48366543|NCT02834403|101227187|FG001|NOT COMPLETED|Overall Study||2||
48366544|NCT02834403|101227188|FG002|NOT COMPLETED|Overall Study||2||
48366545|NCT02834403|101227189|FG003|NOT COMPLETED|Overall Study||1||
48366546|NCT02834403|101227190|FG004|NOT COMPLETED|Overall Study||3||
48366547|NCT02834403|101227191|FG005|NOT COMPLETED|Overall Study||3||
48366548|NCT02834403|101227192|FG006|NOT COMPLETED|Overall Study||18||
48366549|NCT01070550|101227193|FG000|STARTED|Overall Study||3356||
48366550|NCT01070550|101227194|FG001|STARTED|Overall Study||316||
48366551|NCT01070550|101227195|FG002|STARTED|Overall Study||744||
48366552|NCT01070550|101227196|FG003|STARTED|Overall Study||201||
48366553|NCT01070550|101227197|FG004|STARTED|Overall Study||21||
48366554|NCT01070550|101227198|FG005|STARTED|Overall Study||42||
48366555|NCT01070550|101227193|FG000|COMPLETED|Overall Study||2071||
48366556|NCT01070550|101227194|FG001|COMPLETED|Overall Study||254||
48366557|NCT01070550|101227195|FG002|COMPLETED|Overall Study||528||
48366558|NCT01070550|101227196|FG003|COMPLETED|Overall Study||124||
48366559|NCT01070550|101227197|FG004|COMPLETED|Overall Study||20||
48366560|NCT01070550|101227198|FG005|COMPLETED|Overall Study||35||
48366561|NCT01070550|101227193|FG000|NOT COMPLETED|Overall Study||1285||
48440002|NCT01143610|101410006|FG001|NOT COMPLETED|Overall Study||0||
48766158|NCT01951963|102214829|FG000|NOT COMPLETED|Overall Study||0||
48766159|NCT01951963|102214830|FG001|NOT COMPLETED|Overall Study||0||
48766160|NCT01187355|102214831|FG000|STARTED|Overall Study||294||
48766161|NCT01187355|102214832|FG001|STARTED|Overall Study||297||
48766162|NCT01187355|102214831|FG000|COMPLETED|Overall Study||276||
48766163|NCT01187355|102214832|FG001|COMPLETED|Overall Study||277||
48766164|NCT01187355|102214831|FG000|NOT COMPLETED|Overall Study||18||
48766165|NCT01187355|102214832|FG001|NOT COMPLETED|Overall Study||20||
48766166|NCT02110069|102214833|FG000|STARTED|Overall Study||2||
48766167|NCT02110069|102214834|FG001|STARTED|Overall Study||2||
48766168|NCT02110069|102214833|FG000|COMPLETED|Overall Study||0|second subject came off study at maintenance course 6 as family moved out of the country|
48366562|NCT01070550|101227194|FG001|NOT COMPLETED|Overall Study||62||
48366563|NCT01070550|101227195|FG002|NOT COMPLETED|Overall Study||216||
48366564|NCT01070550|101227196|FG003|NOT COMPLETED|Overall Study||77||
48366565|NCT01070550|101227197|FG004|NOT COMPLETED|Overall Study||1||
48366566|NCT01070550|101227198|FG005|NOT COMPLETED|Overall Study||7||
48366567|NCT02241512|101227199|FG000|STARTED|Overall Study||30||
48366568|NCT02241512|101227200|FG001|STARTED|Overall Study||29||
48366569|NCT02241512|101227199|FG000|COMPLETED|Overall Study||29||
48366570|NCT02241512|101227200|FG001|COMPLETED|Overall Study||29||
48366571|NCT02241512|101227199|FG000|NOT COMPLETED|Overall Study||1||
48366572|NCT02241512|101227200|FG001|NOT COMPLETED|Overall Study||0||
48366573|NCT00931892|101227201|FG000|STARTED|Completed Gluten Challenge||10||
48366574|NCT00931892|101227202|FG001|STARTED|Completed Gluten Challenge||10||
48366575|NCT00931892|101227201|FG000|COMPLETED|Completed Gluten Challenge||10||
48366576|NCT00931892|101227202|FG001|COMPLETED|Completed Gluten Challenge||10||
48366577|NCT00931892|101227201|FG000|NOT COMPLETED|Completed Gluten Challenge||0||
48366578|NCT00931892|101227202|FG001|NOT COMPLETED|Completed Gluten Challenge||0||
48366579|NCT00931892|101227201|FG000|STARTED|Completed Endoscopies||10||
48366580|NCT00931892|101227202|FG001|STARTED|Completed Endoscopies||10||
48366581|NCT00931892|101227201|FG000|First Endoscopy|Completed Endoscopies||10||
48366582|NCT00931892|101227202|FG001|First Endoscopy|Completed Endoscopies||10||
48766169|NCT02110069|102214834|FG001|COMPLETED|Overall Study||2|second subject came off study at maintenance course 6 as family moved out of the country|
48766170|NCT02110069|102214833|FG000|NOT COMPLETED|Overall Study||2||
48766171|NCT02110069|102214834|FG001|NOT COMPLETED|Overall Study||0||
48766172|NCT02923726|102214835|FG000|STARTED|Overall Study||1302||
48766173|NCT02923726|102214836|FG001|STARTED|Overall Study||1293||
48766174|NCT02923726|102214835|FG000|COMPLETED|Overall Study||769||
48766175|NCT02923726|102214836|FG001|COMPLETED|Overall Study||811||
48766176|NCT02923726|102214835|FG000|NOT COMPLETED|Overall Study||533||
48655101|NCT01386385|101941155|FG003|STARTED|Phase I 80mg: Consolidation Therapy||5||
48655102|NCT01386385|101941156|FG004|STARTED|Phase I 80mg: Consolidation Therapy||0||
48655103|NCT01386385|101941157|FG005|STARTED|Phase I 80mg: Consolidation Therapy||0||
48655104|NCT01386385|101941158|FG006|STARTED|Phase I 80mg: Consolidation Therapy||0||
48655105|NCT01386385|101941159|FG007|STARTED|Phase I 80mg: Consolidation Therapy||0||
48655106|NCT01386385|101941152|FG000|COMPLETED|Phase I 80mg: Consolidation Therapy||0||
48655107|NCT01386385|101941153|FG001|COMPLETED|Phase I 80mg: Consolidation Therapy||0||
48655108|NCT01386385|101941154|FG002|COMPLETED|Phase I 80mg: Consolidation Therapy||0||
48655109|NCT01386385|101941155|FG003|COMPLETED|Phase I 80mg: Consolidation Therapy||5||
48655110|NCT01386385|101941156|FG004|COMPLETED|Phase I 80mg: Consolidation Therapy||0||
48655111|NCT01386385|101941157|FG005|COMPLETED|Phase I 80mg: Consolidation Therapy||0||
48655112|NCT01386385|101941158|FG006|COMPLETED|Phase I 80mg: Consolidation Therapy||0||
48655113|NCT01386385|101941159|FG007|COMPLETED|Phase I 80mg: Consolidation Therapy||0||
48655114|NCT01386385|101941152|FG000|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0||
48655115|NCT01386385|101941153|FG001|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0||
48655116|NCT01386385|101941154|FG002|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0||
48655117|NCT01386385|101941155|FG003|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0||
48655118|NCT01386385|101941156|FG004|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0||
48655119|NCT01386385|101941157|FG005|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0||
48655120|NCT01386385|101941158|FG006|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0||
48655121|NCT01386385|101941159|FG007|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0||
48655122|NCT01386385|101941152|FG000|STARTED|Phase I 120mg: Concurrent CRT||0||
48655123|NCT01386385|101941153|FG001|STARTED|Phase I 120mg: Concurrent CRT||0||
48655124|NCT01386385|101941154|FG002|STARTED|Phase I 120mg: Concurrent CRT||0||
48655125|NCT01386385|101941155|FG003|STARTED|Phase I 120mg: Concurrent CRT||0||
48655126|NCT01386385|101941156|FG004|STARTED|Phase I 120mg: Concurrent CRT||6||
48655127|NCT01386385|101941157|FG005|STARTED|Phase I 120mg: Concurrent CRT||0||
48655128|NCT01386385|101941158|FG006|STARTED|Phase I 120mg: Concurrent CRT||0||
48655129|NCT01386385|101941159|FG007|STARTED|Phase I 120mg: Concurrent CRT||0||
48655130|NCT01386385|101941152|FG000|COMPLETED|Phase I 120mg: Concurrent CRT||0||
48655131|NCT01386385|101941153|FG001|COMPLETED|Phase I 120mg: Concurrent CRT||0||
48655132|NCT01386385|101941154|FG002|COMPLETED|Phase I 120mg: Concurrent CRT||0||
48655133|NCT01386385|101941155|FG003|COMPLETED|Phase I 120mg: Concurrent CRT||0||
48655134|NCT01386385|101941156|FG004|COMPLETED|Phase I 120mg: Concurrent CRT||5||
48655135|NCT01386385|101941157|FG005|COMPLETED|Phase I 120mg: Concurrent CRT||0||
48655136|NCT01386385|101941158|FG006|COMPLETED|Phase I 120mg: Concurrent CRT||0||
48655137|NCT01386385|101941159|FG007|COMPLETED|Phase I 120mg: Concurrent CRT||0||
48655138|NCT01386385|101941152|FG000|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0||
48655139|NCT01386385|101941153|FG001|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0||
48655140|NCT01386385|101941154|FG002|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0||
48655141|NCT01386385|101941155|FG003|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0||
48655142|NCT01386385|101941156|FG004|NOT COMPLETED|Phase I 120mg: Concurrent CRT||1||
48655143|NCT01386385|101941157|FG005|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0||
48655144|NCT01386385|101941158|FG006|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0||
48655145|NCT01386385|101941159|FG007|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0||
48655146|NCT01386385|101941152|FG000|STARTED|Phase I 120mg: Consolidation Therapy||0||
48655147|NCT01386385|101941153|FG001|STARTED|Phase I 120mg: Consolidation Therapy||0||
48766177|NCT02923726|102214836|FG001|NOT COMPLETED|Overall Study||482||
48655148|NCT01386385|101941154|FG002|STARTED|Phase I 120mg: Consolidation Therapy||0||
48655149|NCT01386385|101941155|FG003|STARTED|Phase I 120mg: Consolidation Therapy||0||
48655150|NCT01386385|101941156|FG004|STARTED|Phase I 120mg: Consolidation Therapy||0||
48655151|NCT01386385|101941157|FG005|STARTED|Phase I 120mg: Consolidation Therapy||5||
48655152|NCT01386385|101941158|FG006|STARTED|Phase I 120mg: Consolidation Therapy||0||
48655153|NCT01386385|101941159|FG007|STARTED|Phase I 120mg: Consolidation Therapy||0||
48655154|NCT01386385|101941152|FG000|COMPLETED|Phase I 120mg: Consolidation Therapy||0||
48655155|NCT01386385|101941153|FG001|COMPLETED|Phase I 120mg: Consolidation Therapy||0||
48766178|NCT04790916|102214837|FG000|STARTED|Overall Study||0||
48766179|NCT04790916|102214838|FG001|STARTED|Overall Study||0||
48188330|NCT01700530|100783218|FG000|STARTED|Overall Study||9||
48366583|NCT00931892|101227201|FG000|Second Endoscopy|Completed Endoscopies||10||
48655156|NCT01386385|101941154|FG002|COMPLETED|Phase I 120mg: Consolidation Therapy||0||
48655157|NCT01386385|101941155|FG003|COMPLETED|Phase I 120mg: Consolidation Therapy||0||
48366584|NCT00931892|101227202|FG001|Second Endoscopy|Completed Endoscopies||10||
48366585|NCT00931892|101227201|FG000|Third Endoscopy|Completed Endoscopies||10||
48366586|NCT00931892|101227202|FG001|Third Endoscopy|Completed Endoscopies||9||
48366587|NCT00931892|101227201|FG000|COMPLETED|Completed Endoscopies||10||
48366588|NCT00931892|101227202|FG001|COMPLETED|Completed Endoscopies||9||
48655158|NCT01386385|101941156|FG004|COMPLETED|Phase I 120mg: Consolidation Therapy||0||
48766180|NCT04790916|102214839|FG002|STARTED|Overall Study||0||
48766181|NCT04790916|102214837|FG000|COMPLETED|Overall Study||0||
48766182|NCT04790916|102214838|FG001|COMPLETED|Overall Study||0||
48766183|NCT04790916|102214839|FG002|COMPLETED|Overall Study||0||
48766184|NCT04790916|102214837|FG000|NOT COMPLETED|Overall Study||0||
48766185|NCT04790916|102214838|FG001|NOT COMPLETED|Overall Study||0||
48436680|NCT03185949|101403598|FG000|STARTED|Cross-over at 6 Months||16|At 6 months, study participants were unblinded and those in the sham control group were given the option to cross over.|
48436681|NCT03185949|101403599|FG001|STARTED|Cross-over at 6 Months||0|At 6 months, study participants were unblinded and those in the sham control group were given the option to cross over.|
48436682|NCT03185949|101403598|FG000|COMPLETED|Cross-over at 6 Months||15||
48436683|NCT03185949|101403599|FG001|COMPLETED|Cross-over at 6 Months||0||
48436684|NCT03185949|101403598|FG000|NOT COMPLETED|Cross-over at 6 Months||1||
48436685|NCT03185949|101403599|FG001|NOT COMPLETED|Cross-over at 6 Months||0||
48436686|NCT00956813|101403600|FG000|STARTED|Flaxseed and Placebo||105||
48436687|NCT00956813|101403601|FG001|STARTED|Flaxseed and Placebo||105||
48436688|NCT00956813|101403600|FG000|COMPLETED|Flaxseed and Placebo||97||
48436689|NCT00956813|101403601|FG001|COMPLETED|Flaxseed and Placebo||100||
48436690|NCT00956813|101403600|FG000|NOT COMPLETED|Flaxseed and Placebo||8||
48436691|NCT00956813|101403601|FG001|NOT COMPLETED|Flaxseed and Placebo||5||
48436692|NCT00956813|101403600|FG000|STARTED|Continuation Phase||80||
48655159|NCT01386385|101941157|FG005|COMPLETED|Phase I 120mg: Consolidation Therapy||5||
48655160|NCT01386385|101941158|FG006|COMPLETED|Phase I 120mg: Consolidation Therapy||0||
48655161|NCT01386385|101941159|FG007|COMPLETED|Phase I 120mg: Consolidation Therapy||0||
48655162|NCT01386385|101941152|FG000|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0||
48655163|NCT01386385|101941153|FG001|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0||
48655164|NCT01386385|101941154|FG002|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0||
48655165|NCT01386385|101941155|FG003|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0||
48655166|NCT01386385|101941156|FG004|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0||
48655167|NCT01386385|101941157|FG005|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0||
48655168|NCT01386385|101941158|FG006|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0||
48655169|NCT01386385|101941159|FG007|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0||
48655170|NCT01386385|101941152|FG000|STARTED|Phase II Concurrent CRT||0||
48655171|NCT01386385|101941153|FG001|STARTED|Phase II Concurrent CRT||0||
48655172|NCT01386385|101941154|FG002|STARTED|Phase II Concurrent CRT||0||
48655173|NCT01386385|101941155|FG003|STARTED|Phase II Concurrent CRT||0||
48655174|NCT01386385|101941156|FG004|STARTED|Phase II Concurrent CRT||0||
48655175|NCT01386385|101941157|FG005|STARTED|Phase II Concurrent CRT||0||
48655176|NCT01386385|101941158|FG006|STARTED|Phase II Concurrent CRT||18||
48655177|NCT01386385|101941159|FG007|STARTED|Phase II Concurrent CRT||13||
48655178|NCT01386385|101941152|FG000|COMPLETED|Phase II Concurrent CRT||0||
48655179|NCT01386385|101941153|FG001|COMPLETED|Phase II Concurrent CRT||0||
48655180|NCT01386385|101941154|FG002|COMPLETED|Phase II Concurrent CRT||0||
48655181|NCT01386385|101941155|FG003|COMPLETED|Phase II Concurrent CRT||0||
48655182|NCT01386385|101941156|FG004|COMPLETED|Phase II Concurrent CRT||0||
48655183|NCT01386385|101941157|FG005|COMPLETED|Phase II Concurrent CRT||0||
48655184|NCT01386385|101941158|FG006|COMPLETED|Phase II Concurrent CRT||12||
48655185|NCT01386385|101941159|FG007|COMPLETED|Phase II Concurrent CRT||10||
48766186|NCT04790916|102214839|FG002|NOT COMPLETED|Overall Study||0||
48766187|NCT00574197|102214840|FG000|STARTED|Overall Study||11||
48766188|NCT00574197|102214840|FG000|COMPLETED|Overall Study||6||
48436693|NCT00956813|101403601|FG001|STARTED|Continuation Phase||0||
48436694|NCT00956813|101403600|FG000|COMPLETED|Continuation Phase||80||
48436695|NCT00956813|101403601|FG001|COMPLETED|Continuation Phase||0||
48436696|NCT00956813|101403600|FG000|NOT COMPLETED|Continuation Phase||0||
48655186|NCT01386385|101941152|FG000|NOT COMPLETED|Phase II Concurrent CRT||0||
48655187|NCT01386385|101941153|FG001|NOT COMPLETED|Phase II Concurrent CRT||0||
48655188|NCT01386385|101941154|FG002|NOT COMPLETED|Phase II Concurrent CRT||0||
48655189|NCT01386385|101941155|FG003|NOT COMPLETED|Phase II Concurrent CRT||0||
48766189|NCT00574197|102214840|FG000|NOT COMPLETED|Overall Study||5||
48436697|NCT00956813|101403601|FG001|NOT COMPLETED|Continuation Phase||0||
48436698|NCT03504839|101403602|FG000|STARTED|Overall Study||53||
48436699|NCT03504839|101403602|FG000|COMPLETED|Overall Study||49||
48436700|NCT03504839|101403602|FG000|NOT COMPLETED|Overall Study||4||
48655190|NCT01386385|101941156|FG004|NOT COMPLETED|Phase II Concurrent CRT||0||
48655191|NCT01386385|101941157|FG005|NOT COMPLETED|Phase II Concurrent CRT||0||
48655192|NCT01386385|101941158|FG006|NOT COMPLETED|Phase II Concurrent CRT||6||
48655193|NCT01386385|101941159|FG007|NOT COMPLETED|Phase II Concurrent CRT||3||
48655194|NCT01386385|101941152|FG000|STARTED|Phase II: Consolidation Therapy||0||
48436701|NCT01898884|101403603|FG000|STARTED|Single Dose Period||8||
48655195|NCT01386385|101941153|FG001|STARTED|Phase II: Consolidation Therapy||0||
48655196|NCT01386385|101941154|FG002|STARTED|Phase II: Consolidation Therapy||0||
48655197|NCT01386385|101941155|FG003|STARTED|Phase II: Consolidation Therapy||0||
48655198|NCT01386385|101941156|FG004|STARTED|Phase II: Consolidation Therapy||0||
48655199|NCT01386385|101941157|FG005|STARTED|Phase II: Consolidation Therapy||0||
48655200|NCT01386385|101941158|FG006|STARTED|Phase II: Consolidation Therapy||13||
48655201|NCT01386385|101941159|FG007|STARTED|Phase II: Consolidation Therapy||10||
48655202|NCT01386385|101941152|FG000|COMPLETED|Phase II: Consolidation Therapy||0||
48655203|NCT01386385|101941153|FG001|COMPLETED|Phase II: Consolidation Therapy||0||
48766190|NCT03938259|102214841|FG000|STARTED|Overall Study||21||
48655204|NCT01386385|101941154|FG002|COMPLETED|Phase II: Consolidation Therapy||0||
48655205|NCT01386385|101941155|FG003|COMPLETED|Phase II: Consolidation Therapy||0||
48655206|NCT01386385|101941156|FG004|COMPLETED|Phase II: Consolidation Therapy||0||
48655207|NCT01386385|101941157|FG005|COMPLETED|Phase II: Consolidation Therapy||0||
48655208|NCT01386385|101941158|FG006|COMPLETED|Phase II: Consolidation Therapy||8||
48655209|NCT01386385|101941159|FG007|COMPLETED|Phase II: Consolidation Therapy||8||
48655210|NCT01386385|101941152|FG000|NOT COMPLETED|Phase II: Consolidation Therapy||0||
48655211|NCT01386385|101941153|FG001|NOT COMPLETED|Phase II: Consolidation Therapy||0||
48655212|NCT01386385|101941154|FG002|NOT COMPLETED|Phase II: Consolidation Therapy||0||
48655213|NCT01386385|101941155|FG003|NOT COMPLETED|Phase II: Consolidation Therapy||0||
48655214|NCT01386385|101941156|FG004|NOT COMPLETED|Phase II: Consolidation Therapy||0||
48655215|NCT01386385|101941157|FG005|NOT COMPLETED|Phase II: Consolidation Therapy||0||
48655216|NCT01386385|101941158|FG006|NOT COMPLETED|Phase II: Consolidation Therapy||5||
48655217|NCT01386385|101941159|FG007|NOT COMPLETED|Phase II: Consolidation Therapy||2||
48655218|NCT04128215|101941160|FG000|STARTED|Overall Study||9||
48655219|NCT04128215|101941161|FG001|STARTED|Overall Study||11||
48655220|NCT04128215|101941160|FG000|COMPLETED|Overall Study||9||
48655221|NCT04128215|101941161|FG001|COMPLETED|Overall Study||11||
48655222|NCT04128215|101941160|FG000|NOT COMPLETED|Overall Study||0||
48655223|NCT04128215|101941161|FG001|NOT COMPLETED|Overall Study||0||
48655224|NCT02620865|101941162|FG000|STARTED|Overall Study||2||
48655225|NCT02620865|101941162|FG000|COMPLETED|Overall Study||2||
48655226|NCT02620865|101941162|FG000|NOT COMPLETED|Overall Study||0||
48655227|NCT01565694|101941163|FG000|STARTED|Dose-Titration Period||76||
48655228|NCT01565694|101941163|FG000|COMPLETED|Dose-Titration Period||62||
48655229|NCT01565694|101941163|FG000|NOT COMPLETED|Dose-Titration Period||14||
48655230|NCT01565694|101941163|FG000|STARTED|Fixed-Dose Assessment Period||62||
48655231|NCT01565694|101941163|FG000|COMPLETED|Fixed-Dose Assessment Period||58||
48655232|NCT01565694|101941163|FG000|NOT COMPLETED|Fixed-Dose Assessment Period||4||
48655233|NCT01286272|101941164|FG000|STARTED|Overall Study||67||
48655234|NCT01286272|101941165|FG001|STARTED|Overall Study||65||
48655235|NCT01286272|101941164|FG000|COMPLETED|Overall Study||66||
48655236|NCT01286272|101941165|FG001|COMPLETED|Overall Study||62||
48655237|NCT01286272|101941164|FG000|NOT COMPLETED|Overall Study||1||
48655238|NCT01286272|101941165|FG001|NOT COMPLETED|Overall Study||3||
48655239|NCT01749293|101941166|FG000|STARTED|Overall Study||3||
48655240|NCT01749293|101941166|FG000|COMPLETED|Overall Study||3||
48655241|NCT01749293|101941166|FG000|NOT COMPLETED|Overall Study||0||
48655242|NCT02181413|101941167|FG000|STARTED|Overall Study||261||
48655243|NCT02181413|101941168|FG001|STARTED|Overall Study||395||
48655244|NCT02181413|101941167|FG000|Intent-to-Treat (ITT) Population|Overall Study||261||
48655245|NCT02181413|101941168|FG001|Intent-to-Treat (ITT) Population|Overall Study||395||
48655246|NCT02181413|101941167|FG000|Safety Population|Overall Study||259||
48655247|NCT02181413|101941168|FG001|Safety Population|Overall Study||394||
48655248|NCT02181413|101941167|FG000|Per Protocol (PP) Population|Overall Study||256||
48655249|NCT02181413|101941168|FG001|Per Protocol (PP) Population|Overall Study||387||
48655250|NCT02181413|101941167|FG000|COMPLETED|Overall Study||206||
48655251|NCT02181413|101941168|FG001|COMPLETED|Overall Study||322||
48655252|NCT02181413|101941167|FG000|NOT COMPLETED|Overall Study||55||
48655253|NCT02181413|101941168|FG001|NOT COMPLETED|Overall Study||73||
48655254|NCT04579380|101941169|FG000|STARTED|Overall Study||11||
48655255|NCT04579380|101941170|FG001|STARTED|Overall Study||31||
48655256|NCT04579380|101941171|FG002|STARTED|Overall Study||30||
48655257|NCT04579380|101941172|FG003|STARTED|Overall Study||25||
48655258|NCT04579380|101941173|FG004|STARTED|Overall Study||12||
48655259|NCT04579380|101941174|FG005|STARTED|Overall Study||31||
48655260|NCT04579380|101941175|FG006|STARTED|Overall Study||13||
48655261|NCT04579380|101941176|FG007|STARTED|Overall Study||31||
48655262|NCT04579380|101941177|FG008|STARTED|Overall Study||33||
48655263|NCT04579380|101941169|FG000|COMPLETED|Overall Study||0||
48655264|NCT04579380|101941170|FG001|COMPLETED|Overall Study||0||
48655265|NCT04579380|101941171|FG002|COMPLETED|Overall Study||0||
48655266|NCT04579380|101941172|FG003|COMPLETED|Overall Study||0||
48655267|NCT04579380|101941173|FG004|COMPLETED|Overall Study||0||
48655268|NCT04579380|101941174|FG005|COMPLETED|Overall Study||0||
48655269|NCT04579380|101941175|FG006|COMPLETED|Overall Study||0||
48655270|NCT04579380|101941176|FG007|COMPLETED|Overall Study||0||
48655271|NCT04579380|101941177|FG008|COMPLETED|Overall Study||0||
48655272|NCT04579380|101941169|FG000|NOT COMPLETED|Overall Study||11||
48655273|NCT04579380|101941170|FG001|NOT COMPLETED|Overall Study||31||
48655274|NCT04579380|101941171|FG002|NOT COMPLETED|Overall Study||30||
48655275|NCT04579380|101941172|FG003|NOT COMPLETED|Overall Study||25||
48655276|NCT04579380|101941173|FG004|NOT COMPLETED|Overall Study||12||
48655277|NCT04579380|101941174|FG005|NOT COMPLETED|Overall Study||31||
48655278|NCT04579380|101941175|FG006|NOT COMPLETED|Overall Study||13||
48655279|NCT04579380|101941176|FG007|NOT COMPLETED|Overall Study||31||
48655280|NCT04579380|101941177|FG008|NOT COMPLETED|Overall Study||33||
48655281|NCT05529173|101941178|FG000|STARTED|Overall Study||95||
48655282|NCT05529173|101941179|FG001|STARTED|Overall Study||97||
48655283|NCT05529173|101941178|FG000|COMPLETED|Overall Study||88||
48655284|NCT05529173|101941179|FG001|COMPLETED|Overall Study||91||
48436702|NCT01898884|101403604|FG001|STARTED|Single Dose Period||6||
48436703|NCT01898884|101403605|FG002|STARTED|Single Dose Period||6||
48436704|NCT01898884|101403606|FG003|STARTED|Single Dose Period||6||
48436705|NCT01898884|101403607|FG004|STARTED|Single Dose Period||6||
48436706|NCT01898884|101403608|FG005|STARTED|Single Dose Period||0||
48436707|NCT01898884|101403609|FG006|STARTED|Single Dose Period||0||
48436708|NCT01898884|101403610|FG007|STARTED|Single Dose Period||0||
48436709|NCT01898884|101403611|FG008|STARTED|Single Dose Period||0||
48436710|NCT01898884|101403603|FG000|COMPLETED|Single Dose Period||8||
48436711|NCT01898884|101403604|FG001|COMPLETED|Single Dose Period||6||
48436712|NCT01898884|101403605|FG002|COMPLETED|Single Dose Period||6||
48766191|NCT03938259|102214842|FG001|STARTED|Overall Study||31||
48766192|NCT03938259|102214841|FG000|COMPLETED|Overall Study||20||
48766193|NCT03938259|102214842|FG001|COMPLETED|Overall Study||30||
48766194|NCT03938259|102214841|FG000|NOT COMPLETED|Overall Study||1||
48766195|NCT03938259|102214842|FG001|NOT COMPLETED|Overall Study||1||
48766196|NCT04139798|102214843|FG000|STARTED|Overall Study||303||
48766197|NCT04139798|102214844|FG001|STARTED|Overall Study||294||
48766198|NCT04139798|102214843|FG000|COMPLETED|Overall Study||289||
48766199|NCT04139798|102214844|FG001|COMPLETED|Overall Study||279||
48766200|NCT04139798|102214843|FG000|NOT COMPLETED|Overall Study||14||
48766201|NCT04139798|102214844|FG001|NOT COMPLETED|Overall Study||15||
48188331|NCT01700530|100783219|FG001|STARTED|Overall Study||21||
48188332|NCT01700530|100783220|FG002|STARTED|Overall Study||20||
48188333|NCT01700530|100783218|FG000|COMPLETED|Overall Study||9||
48188334|NCT01700530|100783219|FG001|COMPLETED|Overall Study||18||
48188335|NCT01700530|100783220|FG002|COMPLETED|Overall Study||19||
48436713|NCT01898884|101403606|FG003|COMPLETED|Single Dose Period||6||
48436714|NCT01898884|101403607|FG004|COMPLETED|Single Dose Period||6||
48436715|NCT01898884|101403608|FG005|COMPLETED|Single Dose Period||0||
48436716|NCT01898884|101403609|FG006|COMPLETED|Single Dose Period||0||
48436717|NCT01898884|101403610|FG007|COMPLETED|Single Dose Period||0||
48436718|NCT01898884|101403611|FG008|COMPLETED|Single Dose Period||0||
48436719|NCT01898884|101403603|FG000|NOT COMPLETED|Single Dose Period||0||
48436720|NCT01898884|101403604|FG001|NOT COMPLETED|Single Dose Period||0||
48436721|NCT01898884|101403605|FG002|NOT COMPLETED|Single Dose Period||0||
48188336|NCT01700530|100783218|FG000|NOT COMPLETED|Overall Study||0||
48188337|NCT01700530|100783219|FG001|NOT COMPLETED|Overall Study||3||
48436722|NCT01898884|101403606|FG003|NOT COMPLETED|Single Dose Period||0||
48436723|NCT01898884|101403607|FG004|NOT COMPLETED|Single Dose Period||0||
48436724|NCT01898884|101403608|FG005|NOT COMPLETED|Single Dose Period||0||
48436725|NCT01898884|101403609|FG006|NOT COMPLETED|Single Dose Period||0||
48436726|NCT01898884|101403610|FG007|NOT COMPLETED|Single Dose Period||0||
48436727|NCT01898884|101403611|FG008|NOT COMPLETED|Single Dose Period||0||
48436728|NCT01898884|101403603|FG000|STARTED|Multiple Dose Period||0||
48436729|NCT01898884|101403604|FG001|STARTED|Multiple Dose Period||0||
48436730|NCT01898884|101403605|FG002|STARTED|Multiple Dose Period||0||
48436731|NCT01898884|101403606|FG003|STARTED|Multiple Dose Period||0||
48655285|NCT05529173|101941178|FG000|NOT COMPLETED|Overall Study||7||
48655286|NCT05529173|101941179|FG001|NOT COMPLETED|Overall Study||6||
48655287|NCT04189588|101941180|FG000|STARTED|Overall Study||17||
48655288|NCT04189588|101941181|FG001|STARTED|Overall Study||17||
48655289|NCT04189588|101941180|FG000|Completed Treatment|Overall Study||17||
48655290|NCT04189588|101941181|FG001|Completed Treatment|Overall Study||17||
48655291|NCT04189588|101941180|FG000|COMPLETED|Overall Study||17|Completed 28-day Follow-up Period|
48655292|NCT04189588|101941181|FG001|COMPLETED|Overall Study||15|Completed 28-day Follow-up Period|
48655293|NCT04189588|101941180|FG000|NOT COMPLETED|Overall Study||0||
48655294|NCT04189588|101941181|FG001|NOT COMPLETED|Overall Study||2||
48655295|NCT02181621|101941182|FG000|STARTED|Overall Study||9|Started = Initial Assessment|
48655296|NCT02181621|101941183|FG001|STARTED|Overall Study||10|Started = Initial Assessment|
48655297|NCT02181621|101941182|FG000|Week 1 Assessment|Overall Study||7||
48655298|NCT02181621|101941183|FG001|Week 1 Assessment|Overall Study||8||
48655299|NCT02181621|101941182|FG000|Week 2 Assessment|Overall Study||6||
48655300|NCT02181621|101941183|FG001|Week 2 Assessment|Overall Study||8||
48655301|NCT02181621|101941182|FG000|Week 3 Assessment|Overall Study||6||
48655302|NCT02181621|101941183|FG001|Week 3 Assessment|Overall Study||7||
48655303|NCT02181621|101941182|FG000|Week 4 Assessment|Overall Study||6||
48655304|NCT02181621|101941183|FG001|Week 4 Assessment|Overall Study||7||
48655305|NCT02181621|101941182|FG000|COMPLETED|Overall Study||7||
48655306|NCT02181621|101941183|FG001|COMPLETED|Overall Study||8||
48655307|NCT02181621|101941182|FG000|NOT COMPLETED|Overall Study||2||
48655308|NCT02181621|101941183|FG001|NOT COMPLETED|Overall Study||2||
48655309|NCT05073510|101941184|FG000|STARTED|Overall Study||187||
48655310|NCT05073510|101941184|FG000|COMPLETED|Overall Study||186||
48655311|NCT05073510|101941184|FG000|NOT COMPLETED|Overall Study||1||
48188338|NCT01700530|100783220|FG002|NOT COMPLETED|Overall Study||1||
48655312|NCT05574764|101941185|FG000|STARTED|Overall Study||37||
48655313|NCT05574764|101941186|FG001|STARTED|Overall Study||16||
48655314|NCT05574764|101941185|FG000|COMPLETED|Overall Study||37||
48766202|NCT04201262|102214845|FG000|STARTED|Overall Study||58||
48766203|NCT04201262|102214846|FG001|STARTED|Overall Study||47||
48766204|NCT04201262|102214845|FG000|Received at Least 1 Dose of Study Drug|Overall Study||58||
48766205|NCT04201262|102214846|FG001|Received at Least 1 Dose of Study Drug|Overall Study||47||
48766206|NCT04201262|102214845|FG000|COMPLETED|Overall Study||0||
48766207|NCT04201262|102214846|FG001|COMPLETED|Overall Study||44||
48766208|NCT04201262|102214845|FG000|NOT COMPLETED|Overall Study||58||
48766209|NCT04201262|102214846|FG001|NOT COMPLETED|Overall Study||3||
48766210|NCT00911170|102214847|FG000|STARTED|Treatment Period||424||
48655315|NCT05574764|101941186|FG001|COMPLETED|Overall Study||16||
48655316|NCT05574764|101941185|FG000|NOT COMPLETED|Overall Study||0||
48655317|NCT05574764|101941186|FG001|NOT COMPLETED|Overall Study||0||
48655318|NCT03671148|101941187|FG000|STARTED|Overall Study||220||
48655319|NCT03671148|101941188|FG001|STARTED|Overall Study||224||
48655320|NCT03671148|101941187|FG000|Received Study Drug|Overall Study||219||
48655321|NCT03671148|101941188|FG001|Received Study Drug|Overall Study||224||
48655322|NCT03671148|101941187|FG000|COMPLETED|Overall Study||199|Completed Period 1 Study Participation|
48655323|NCT03671148|101941188|FG001|COMPLETED|Overall Study||215|Completed Period 1 Study Participation|
48655324|NCT03671148|101941187|FG000|NOT COMPLETED|Overall Study||21||
48655325|NCT03671148|101941188|FG001|NOT COMPLETED|Overall Study||9||
48655326|NCT04072432|101941189|FG000|STARTED|Overall Study||6||
48655327|NCT04072432|101941190|FG001|STARTED|Overall Study||6||
48655328|NCT04072432|101941191|FG002|STARTED|Overall Study||6||
48655329|NCT04072432|101941189|FG000|COMPLETED|Overall Study||6||
48655330|NCT04072432|101941190|FG001|COMPLETED|Overall Study||6||
48655331|NCT04072432|101941191|FG002|COMPLETED|Overall Study||6||
48655332|NCT04072432|101941189|FG000|NOT COMPLETED|Overall Study||0||
48655333|NCT04072432|101941190|FG001|NOT COMPLETED|Overall Study||0||
48655334|NCT04072432|101941191|FG002|NOT COMPLETED|Overall Study||0||
48655335|NCT02152982|101941192|FG000|STARTED|Overall Study||224||
48655336|NCT02152982|101941193|FG001|STARTED|Overall Study||223||
48655337|NCT02152982|101941192|FG000|Started Treatment|Overall Study||212||
48655338|NCT02152982|101941193|FG001|Started Treatment|Overall Study||217||
48655339|NCT02152982|101941192|FG000|COMPLETED|Overall Study||208||
48655340|NCT02152982|101941193|FG001|COMPLETED|Overall Study||213||
48766211|NCT00911170|102214848|FG001|STARTED|Treatment Period||423||
48766212|NCT00911170|102214847|FG000|Received Chemotherapy|Treatment Period||423||
48766213|NCT00911170|102214848|FG001|Received Chemotherapy|Treatment Period||422||
48766214|NCT00911170|102214847|FG000|Received Bevacizumab|Treatment Period||423||
48766215|NCT00911170|102214848|FG001|Received Bevacizumab|Treatment Period||420||
48766216|NCT00911170|102214847|FG000|Received Investigational Product|Treatment Period||422||
48766217|NCT00911170|102214848|FG001|Received Investigational Product|Treatment Period||419||
48766218|NCT00911170|102214847|FG000|COMPLETED|Treatment Period||397||
48766219|NCT00911170|102214848|FG001|COMPLETED|Treatment Period||386||
48766220|NCT00911170|102214847|FG000|NOT COMPLETED|Treatment Period||27||
48766221|NCT00911170|102214848|FG001|NOT COMPLETED|Treatment Period||37||
48655341|NCT02152982|101941192|FG000|NOT COMPLETED|Overall Study||16||
48655342|NCT02152982|101941193|FG001|NOT COMPLETED|Overall Study||10||
48655343|NCT02362412|101941194|FG000|STARTED|Treatment Period II||9||
48655344|NCT02362412|101941195|FG001|STARTED|Treatment Period II||11||
48655345|NCT02362412|101941194|FG000|TREATED|Treatment Period II||9||
48655346|NCT02362412|101941195|FG001|TREATED|Treatment Period II||11||
48655347|NCT02362412|101941194|FG000|COMPLETED|Treatment Period II||9||
48655348|NCT02362412|101941195|FG001|COMPLETED|Treatment Period II||11||
48655349|NCT02362412|101941194|FG000|NOT COMPLETED|Treatment Period II||0||
48655350|NCT02362412|101941195|FG001|NOT COMPLETED|Treatment Period II||0||
48655351|NCT02362412|101941194|FG000|STARTED|Treatment Period III||9||
48655352|NCT02362412|101941195|FG001|STARTED|Treatment Period III||11||
48655353|NCT02362412|101941194|FG000|TREATED|Treatment Period III||9||
48655354|NCT02362412|101941195|FG001|TREATED|Treatment Period III||11||
48655355|NCT02362412|101941194|FG000|COMPLETED|Treatment Period III||9||
48655356|NCT02362412|101941195|FG001|COMPLETED|Treatment Period III||10||
48655357|NCT02362412|101941194|FG000|NOT COMPLETED|Treatment Period III||0||
48766222|NCT00911170|102214847|FG000|STARTED|Long Term Follow-Up||423||
48766223|NCT00911170|102214848|FG001|STARTED|Long Term Follow-Up||422||
48766224|NCT00911170|102214847|FG000|COMPLETED|Long Term Follow-Up||0||
48766225|NCT00911170|102214848|FG001|COMPLETED|Long Term Follow-Up||0||
48766226|NCT00911170|102214847|FG000|NOT COMPLETED|Long Term Follow-Up||423||
48766227|NCT00911170|102214848|FG001|NOT COMPLETED|Long Term Follow-Up||422||
48655358|NCT02362412|101941195|FG001|NOT COMPLETED|Treatment Period III||1||
48655359|NCT01725282|101941196|FG000|STARTED|Overall Study||44||
48655360|NCT01725282|101941197|FG001|STARTED|Overall Study||44||
48655361|NCT01725282|101941198|FG002|STARTED|Overall Study||41||
48655362|NCT01725282|101941199|FG003|STARTED|Overall Study||43||
48655363|NCT01725282|101941196|FG000|COMPLETED|Overall Study||42||
48655364|NCT01725282|101941197|FG001|COMPLETED|Overall Study||39||
48655365|NCT01725282|101941198|FG002|COMPLETED|Overall Study||33||
48655366|NCT01725282|101941199|FG003|COMPLETED|Overall Study||36||
48655367|NCT01725282|101941196|FG000|NOT COMPLETED|Overall Study||2||
48655368|NCT01725282|101941197|FG001|NOT COMPLETED|Overall Study||5||
48655369|NCT01725282|101941198|FG002|NOT COMPLETED|Overall Study||8||
48766228|NCT02770014|102214849|FG000|STARTED|Plasma Genotyping||43||
48766229|NCT02770014|102214849|FG000|COMPLETED|Plasma Genotyping||43||
48766230|NCT02770014|102214849|FG000|NOT COMPLETED|Plasma Genotyping||0||
48766231|NCT02770014|102214849|FG000|STARTED|EGFR Exon 19 Pos, Treated With Erlotinib||11||
48436732|NCT01898884|101403607|FG004|STARTED|Multiple Dose Period||0||
48436733|NCT01898884|101403608|FG005|STARTED|Multiple Dose Period||6||
48436734|NCT01898884|101403609|FG006|STARTED|Multiple Dose Period||6||
48436735|NCT01898884|101403610|FG007|STARTED|Multiple Dose Period||6||
48436736|NCT01898884|101403611|FG008|STARTED|Multiple Dose Period||6||
48436737|NCT01898884|101403603|FG000|Treated|Multiple Dose Period||0||
48436738|NCT01898884|101403604|FG001|Treated|Multiple Dose Period||0||
48436739|NCT01898884|101403605|FG002|Treated|Multiple Dose Period||0||
48436740|NCT01898884|101403606|FG003|Treated|Multiple Dose Period||0||
48436741|NCT01898884|101403607|FG004|Treated|Multiple Dose Period||0||
48436742|NCT01898884|101403608|FG005|Treated|Multiple Dose Period||6||
48436743|NCT01898884|101403609|FG006|Treated|Multiple Dose Period||6||
48436744|NCT01898884|101403610|FG007|Treated|Multiple Dose Period||6||
48436745|NCT01898884|101403611|FG008|Treated|Multiple Dose Period||5||
48436746|NCT01898884|101403603|FG000|COMPLETED|Multiple Dose Period||0||
48436747|NCT01898884|101403604|FG001|COMPLETED|Multiple Dose Period||0||
48436748|NCT01898884|101403605|FG002|COMPLETED|Multiple Dose Period||0||
48436749|NCT01898884|101403606|FG003|COMPLETED|Multiple Dose Period||0||
48436750|NCT01898884|101403607|FG004|COMPLETED|Multiple Dose Period||0||
48436751|NCT01898884|101403608|FG005|COMPLETED|Multiple Dose Period||6||
48766232|NCT02770014|102214849|FG000|COMPLETED|EGFR Exon 19 Pos, Treated With Erlotinib||6||
48766233|NCT02770014|102214849|FG000|NOT COMPLETED|EGFR Exon 19 Pos, Treated With Erlotinib||5||
48766234|NCT02976038|102214850|FG000|STARTED|Overall Study||28||
48766235|NCT02976038|102214850|FG000|COMPLETED|Overall Study||0||
48766236|NCT02976038|102214850|FG000|NOT COMPLETED|Overall Study||28||
48766237|NCT03780244|102214851|FG000|STARTED|Overall Study||59||
48766238|NCT03780244|102214852|FG001|STARTED|Overall Study||21||
48766239|NCT03780244|102214851|FG000|COMPLETED|Overall Study||58||
48766240|NCT03780244|102214852|FG001|COMPLETED|Overall Study||21||
48766241|NCT03780244|102214851|FG000|NOT COMPLETED|Overall Study||1||
48766242|NCT03780244|102214852|FG001|NOT COMPLETED|Overall Study||0||
48766243|NCT02612779|102218382|FG000|STARTED|Overall Study||68||
48366589|NCT00931892|101227201|FG000|NOT COMPLETED|Completed Endoscopies||0||
48366590|NCT00931892|101227202|FG001|NOT COMPLETED|Completed Endoscopies||1||
48366591|NCT01165203|101227203|FG000|STARTED|Active Phase||74||
48366592|NCT01165203|101227204|FG001|STARTED|Active Phase||49||
48366593|NCT01165203|101227203|FG000|COMPLETED|Active Phase||69||
48366594|NCT01165203|101227204|FG001|COMPLETED|Active Phase||47||
48366595|NCT01165203|101227203|FG000|NOT COMPLETED|Active Phase||5||
48766244|NCT02612779|102218383|FG001|STARTED|Overall Study||6||
48766245|NCT02612779|102218382|FG000|COMPLETED|Overall Study||0||
48766246|NCT02612779|102218383|FG001|COMPLETED|Overall Study||0||
48366596|NCT01165203|101227204|FG001|NOT COMPLETED|Active Phase||2||
48436752|NCT01898884|101403609|FG006|COMPLETED|Multiple Dose Period||5||
48436753|NCT01898884|101403610|FG007|COMPLETED|Multiple Dose Period||6||
48436754|NCT01898884|101403611|FG008|COMPLETED|Multiple Dose Period||5||
48436755|NCT01898884|101403603|FG000|NOT COMPLETED|Multiple Dose Period||0||
48436756|NCT01898884|101403604|FG001|NOT COMPLETED|Multiple Dose Period||0||
48766247|NCT02612779|102218382|FG000|NOT COMPLETED|Overall Study||68||
48766248|NCT02612779|102218383|FG001|NOT COMPLETED|Overall Study||6||
48766249|NCT02420821|102218384|FG000|STARTED|Overall Study||461||
48766250|NCT02420821|102218385|FG001|STARTED|Overall Study||454||
48766251|NCT02420821|102218384|FG000|COMPLETED|Overall Study||1||
48766252|NCT02420821|102218385|FG001|COMPLETED|Overall Study||1||
48766253|NCT02420821|102218384|FG000|NOT COMPLETED|Overall Study||460||
48766254|NCT02420821|102218385|FG001|NOT COMPLETED|Overall Study||453||
48766255|NCT00887809|102218386|FG000|STARTED|Overall Study||37||
48766256|NCT00887809|102218387|FG001|STARTED|Overall Study||10||
48766257|NCT00887809|102218386|FG000|COMPLETED|Overall Study||33||
48766258|NCT00887809|102218387|FG001|COMPLETED|Overall Study||10||
48366597|NCT01165203|101227203|FG000|STARTED|Extended Safety Follow-up Phase||74||
48366598|NCT01165203|101227204|FG001|STARTED|Extended Safety Follow-up Phase||49||
48366599|NCT01165203|101227203|FG000|COMPLETED|Extended Safety Follow-up Phase||67||
48436757|NCT01898884|101403605|FG002|NOT COMPLETED|Multiple Dose Period||0||
48436758|NCT01898884|101403606|FG003|NOT COMPLETED|Multiple Dose Period||0||
48436759|NCT01898884|101403607|FG004|NOT COMPLETED|Multiple Dose Period||0||
48436760|NCT01898884|101403608|FG005|NOT COMPLETED|Multiple Dose Period||0||
48436761|NCT01898884|101403609|FG006|NOT COMPLETED|Multiple Dose Period||1||
48436762|NCT01898884|101403610|FG007|NOT COMPLETED|Multiple Dose Period||0||
48436763|NCT01898884|101403611|FG008|NOT COMPLETED|Multiple Dose Period||1||
48436764|NCT00407966|101403612|FG000|STARTED|Overall Study||45||
48436765|NCT00407966|101403612|FG000|CR|Overall Study||30||
48766259|NCT00887809|102218386|FG000|NOT COMPLETED|Overall Study||4||
48766260|NCT00887809|102218387|FG001|NOT COMPLETED|Overall Study||0||
48766261|NCT00538902|102218388|FG000|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||60||
48766262|NCT00538902|102218389|FG001|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121||
48766263|NCT00538902|102218390|FG002|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121||
48366600|NCT01165203|101227204|FG001|COMPLETED|Extended Safety Follow-up Phase||45||
48766264|NCT00538902|102218388|FG000|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||59||
48766265|NCT00538902|102218389|FG001|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||119||
48766266|NCT00538902|102218390|FG002|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||116||
48766267|NCT00538902|102218388|FG000|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||1||
48766268|NCT00538902|102218389|FG001|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||2||
48766269|NCT00538902|102218390|FG002|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||5||
48766270|NCT00538902|102218388|FG000|STARTED|OL Wk 24 to End (Primary D/C Reasons)||59||
48766271|NCT00538902|102218389|FG001|STARTED|OL Wk 24 to End (Primary D/C Reasons)||119||
48766272|NCT00538902|102218390|FG002|STARTED|OL Wk 24 to End (Primary D/C Reasons)||116||
48766273|NCT00538902|102218388|FG000|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||23||
48766274|NCT00538902|102218389|FG001|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||55||
48766275|NCT00538902|102218390|FG002|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||52||
48766276|NCT00538902|102218388|FG000|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||36||
48766277|NCT00538902|102218389|FG001|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64||
48766278|NCT00538902|102218390|FG002|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64||
48766279|NCT05069948|102218391|FG000|STARTED|Overall Study||50||
48766280|NCT05069948|102218391|FG000|COMPLETED|Overall Study||50||
48766281|NCT05069948|102218391|FG000|NOT COMPLETED|Overall Study||0||
48766282|NCT03649646|102218392|FG000|STARTED|Overall Study||4542||
48766283|NCT03649646|102218392|FG000|COMPLETED|Overall Study||4075||
48766284|NCT03649646|102218392|FG000|NOT COMPLETED|Overall Study||467||
48766285|NCT03529695|102218393|FG000|STARTED|Overall Study||35||
48766286|NCT03529695|102218394|FG001|STARTED|Overall Study||42||
48766287|NCT03529695|102218395|FG002|STARTED|Overall Study||35||
48366601|NCT01165203|101227203|FG000|NOT COMPLETED|Extended Safety Follow-up Phase||7||
48366602|NCT01165203|101227204|FG001|NOT COMPLETED|Extended Safety Follow-up Phase||4||
48366603|NCT00390364|101227205|FG000|STARTED|Overall Study||1||
48366604|NCT00390364|101227205|FG000|COMPLETED|Overall Study||1||
48366605|NCT00390364|101227205|FG000|NOT COMPLETED|Overall Study||0||
48366606|NCT01671488|101227206|FG000|STARTED|Overall Study||11|This is for patients who signed consent|
48366607|NCT01671488|101227206|FG000|COMPLETED|Overall Study||10||
48366608|NCT01671488|101227206|FG000|NOT COMPLETED|Overall Study||1||
48366609|NCT01629667|101227207|FG000|STARTED|Overall Study||59||
48366610|NCT01629667|101227208|FG001|STARTED|Overall Study||58||
48366611|NCT01629667|101227209|FG002|STARTED|Overall Study||59||
48655370|NCT01725282|101941199|FG003|NOT COMPLETED|Overall Study||7||
48655371|NCT00461812|101941200|FG000|STARTED|Overall Study||10||
48655372|NCT00461812|101941200|FG000|COMPLETED|Overall Study||0||
48655373|NCT00461812|101941200|FG000|NOT COMPLETED|Overall Study||10||
48655374|NCT01391299|101941201|FG000|STARTED|Overall Study||57||
48655375|NCT01391299|101941202|FG001|STARTED|Overall Study||60||
48655376|NCT01391299|101941203|FG002|STARTED|Overall Study||58||
48655377|NCT01391299|101941201|FG000|COMPLETED|Overall Study||57||
48655378|NCT01391299|101941202|FG001|COMPLETED|Overall Study||59||
48655379|NCT01391299|101941203|FG002|COMPLETED|Overall Study||56||
48655380|NCT01391299|101941201|FG000|NOT COMPLETED|Overall Study||0||
48655381|NCT01391299|101941202|FG001|NOT COMPLETED|Overall Study||1||
48655382|NCT01391299|101941203|FG002|NOT COMPLETED|Overall Study||2||
48766288|NCT03529695|102218396|FG003|STARTED|Overall Study||42||
48766289|NCT03529695|102218393|FG000|COMPLETED|Overall Study||20||
48766290|NCT03529695|102218394|FG001|COMPLETED|Overall Study||22||
48766291|NCT03529695|102218395|FG002|COMPLETED|Overall Study||20||
48766292|NCT03529695|102218396|FG003|COMPLETED|Overall Study||22||
48766293|NCT03529695|102218393|FG000|NOT COMPLETED|Overall Study||15||
48766294|NCT03529695|102218394|FG001|NOT COMPLETED|Overall Study||20||
48766295|NCT03529695|102218395|FG002|NOT COMPLETED|Overall Study||15||
48766296|NCT03529695|102218396|FG003|NOT COMPLETED|Overall Study||20||
48766297|NCT01959503|102218397|FG000|STARTED|Overall Study||107||
48766298|NCT01959503|102218398|FG001|STARTED|Overall Study||51||
48766299|NCT01959503|102218397|FG000|COMPLETED|Overall Study||104||
48766300|NCT01959503|102218398|FG001|COMPLETED|Overall Study||49||
48766301|NCT01959503|102218397|FG000|NOT COMPLETED|Overall Study||3||
48766302|NCT01959503|102218398|FG001|NOT COMPLETED|Overall Study||2||
48766303|NCT04798196|102218399|FG000|STARTED|Overall Study||91||
48766304|NCT04798196|102218400|FG001|STARTED|Overall Study||91||
48366612|NCT01629667|101227207|FG000|Randomized and Treated|Overall Study||57||
48366613|NCT01629667|101227208|FG001|Randomized and Treated|Overall Study||57||
48366614|NCT01629667|101227209|FG002|Randomized and Treated|Overall Study||59||
48366615|NCT01629667|101227207|FG000|COMPLETED|Overall Study||12||
48366616|NCT01629667|101227208|FG001|COMPLETED|Overall Study||17||
48366617|NCT01629667|101227209|FG002|COMPLETED|Overall Study||14||
48366618|NCT01629667|101227207|FG000|NOT COMPLETED|Overall Study||47||
48366619|NCT01629667|101227208|FG001|NOT COMPLETED|Overall Study||41||
48366620|NCT01629667|101227209|FG002|NOT COMPLETED|Overall Study||45||
48366621|NCT02644525|101227210|FG000|STARTED|Group 1||2||
48366622|NCT02644525|101227211|FG001|STARTED|Group 1||5||
48366623|NCT02644525|101227212|FG002|STARTED|Group 1||0||
48366624|NCT02644525|101227213|FG003|STARTED|Group 1||0||
48655383|NCT01512251|101941204|FG000|STARTED|Dose Level -1||3||
48655384|NCT01512251|101941205|FG001|STARTED|Dose Level -1||5||
48655385|NCT01512251|101941204|FG000|COMPLETED|Dose Level -1||3||
48366625|NCT02644525|101227210|FG000|COMPLETED|Group 1||2||
48366626|NCT02644525|101227211|FG001|COMPLETED|Group 1||5||
48366627|NCT02644525|101227212|FG002|COMPLETED|Group 1||0||
48366628|NCT02644525|101227213|FG003|COMPLETED|Group 1||0||
48366629|NCT02644525|101227210|FG000|NOT COMPLETED|Group 1||0||
48366630|NCT02644525|101227211|FG001|NOT COMPLETED|Group 1||0||
48366631|NCT02644525|101227212|FG002|NOT COMPLETED|Group 1||0||
48366632|NCT02644525|101227213|FG003|NOT COMPLETED|Group 1||0||
48366633|NCT02644525|101227210|FG000|STARTED|Group 2||2||
48366634|NCT02644525|101227211|FG001|STARTED|Group 2||0||
48366635|NCT02644525|101227212|FG002|STARTED|Group 2||5||
48366636|NCT02644525|101227213|FG003|STARTED|Group 2||0||
48366637|NCT02644525|101227210|FG000|COMPLETED|Group 2||2||
48366638|NCT02644525|101227211|FG001|COMPLETED|Group 2||0||
48366639|NCT02644525|101227212|FG002|COMPLETED|Group 2||5||
48366640|NCT02644525|101227213|FG003|COMPLETED|Group 2||0||
48366641|NCT02644525|101227210|FG000|NOT COMPLETED|Group 2||0||
48366642|NCT02644525|101227211|FG001|NOT COMPLETED|Group 2||0||
48366643|NCT02644525|101227212|FG002|NOT COMPLETED|Group 2||0||
48366644|NCT02644525|101227213|FG003|NOT COMPLETED|Group 2||0||
48366645|NCT02644525|101227210|FG000|STARTED|Group 3||1||
48366646|NCT02644525|101227211|FG001|STARTED|Group 3||0||
48366647|NCT02644525|101227212|FG002|STARTED|Group 3||0||
48366648|NCT02644525|101227213|FG003|STARTED|Group 3||5||
48366649|NCT02644525|101227210|FG000|COMPLETED|Group 3||1||
48366650|NCT02644525|101227211|FG001|COMPLETED|Group 3||0||
48366651|NCT02644525|101227212|FG002|COMPLETED|Group 3||0||
48366652|NCT02644525|101227213|FG003|COMPLETED|Group 3||5||
48766305|NCT04798196|102218401|FG002|STARTED|Overall Study||86||
48766306|NCT04798196|102218399|FG000|4 Month Time Point|Overall Study||86||
48766307|NCT04798196|102218400|FG001|4 Month Time Point|Overall Study||86||
48766308|NCT04798196|102218401|FG002|4 Month Time Point|Overall Study||77||
48766309|NCT04798196|102218399|FG000|8 Month Time Point|Overall Study||84||
48766310|NCT04798196|102218400|FG001|8 Month Time Point|Overall Study||85||
48766311|NCT04798196|102218401|FG002|8 Month Time Point|Overall Study||80||
48766312|NCT04798196|102218399|FG000|COMPLETED|Overall Study||88||
48766313|NCT04798196|102218400|FG001|COMPLETED|Overall Study||90||
48766314|NCT04798196|102218401|FG002|COMPLETED|Overall Study||83||
48766315|NCT04798196|102218399|FG000|NOT COMPLETED|Overall Study||3||
48766316|NCT04798196|102218400|FG001|NOT COMPLETED|Overall Study||1||
48766317|NCT04798196|102218401|FG002|NOT COMPLETED|Overall Study||3||
48766318|NCT03220035|102218402|FG000|STARTED|Overall Study||4||
48366653|NCT02644525|101227210|FG000|NOT COMPLETED|Group 3||0||
48366654|NCT02644525|101227211|FG001|NOT COMPLETED|Group 3||0||
48366655|NCT02644525|101227212|FG002|NOT COMPLETED|Group 3||0||
48366656|NCT02644525|101227213|FG003|NOT COMPLETED|Group 3||0||
48366657|NCT01765764|101227214|FG000|STARTED|Treatment Period||118||
48366658|NCT01765764|101227215|FG001|STARTED|Treatment Period||118||
48366659|NCT01765764|101227216|FG002|STARTED|Treatment Period||121||
48366660|NCT01765764|101227214|FG000|COMPLETED|Treatment Period||115||
48366661|NCT01765764|101227215|FG001|COMPLETED|Treatment Period||109||
48366662|NCT01765764|101227216|FG002|COMPLETED|Treatment Period||115||
48366663|NCT01765764|101227214|FG000|NOT COMPLETED|Treatment Period||3||
48366664|NCT01765764|101227215|FG001|NOT COMPLETED|Treatment Period||9||
48366665|NCT01765764|101227216|FG002|NOT COMPLETED|Treatment Period||6||
48366666|NCT01765764|101227214|FG000|STARTED|Post-treatment Period||114||
48366667|NCT01765764|101227215|FG001|STARTED|Post-treatment Period||107||
48366668|NCT01765764|101227216|FG002|STARTED|Post-treatment Period||112||
48366669|NCT01765764|101227214|FG000|COMPLETED|Post-treatment Period||114||
48366670|NCT01765764|101227215|FG001|COMPLETED|Post-treatment Period||107||
48366671|NCT01765764|101227216|FG002|COMPLETED|Post-treatment Period||112||
48766319|NCT03220035|102218402|FG000|COMPLETED|Overall Study||0||
48766320|NCT03220035|102218402|FG000|NOT COMPLETED|Overall Study||4||
48766321|NCT02952820|102218403|FG000|STARTED|Placebo-Controlled Treatment (6 Months)||325||
48766322|NCT02952820|102218404|FG001|STARTED|Placebo-Controlled Treatment (6 Months)||323||
48766323|NCT02952820|102218405|FG002|STARTED|Placebo-Controlled Treatment (6 Months)||323||
48766324|NCT02952820|102218403|FG000|Treated|Placebo-Controlled Treatment (6 Months)||321||
48366672|NCT01765764|101227214|FG000|NOT COMPLETED|Post-treatment Period||0||
48366673|NCT01765764|101227215|FG001|NOT COMPLETED|Post-treatment Period||0||
48366674|NCT01765764|101227216|FG002|NOT COMPLETED|Post-treatment Period||0||
48366675|NCT02816710|101227217|FG000|STARTED|Overall Study||38||
48366676|NCT02816710|101227218|FG001|STARTED|Overall Study||38||
48366677|NCT02816710|101227219|FG002|STARTED|Overall Study||36||
48366678|NCT02816710|101227217|FG000|COMPLETED|Overall Study||34||
48366679|NCT02816710|101227218|FG001|COMPLETED|Overall Study||35||
48366680|NCT02816710|101227219|FG002|COMPLETED|Overall Study||29||
48436766|NCT00407966|101403612|FG000|COMPLETED|Overall Study||45||
48436767|NCT00407966|101403612|FG000|NOT COMPLETED|Overall Study||0||
48366681|NCT02816710|101227217|FG000|NOT COMPLETED|Overall Study||4||
48366682|NCT02816710|101227218|FG001|NOT COMPLETED|Overall Study||3||
48366683|NCT02816710|101227219|FG002|NOT COMPLETED|Overall Study||7||
48366684|NCT01312428|101227220|FG000|STARTED|Overall Study||3||
48366685|NCT01312428|101227221|FG001|STARTED|Overall Study||4||
48366686|NCT01312428|101227220|FG000|COMPLETED|Overall Study||0||
48366687|NCT01312428|101227221|FG001|COMPLETED|Overall Study||0||
48366688|NCT01312428|101227220|FG000|NOT COMPLETED|Overall Study||3||
48366689|NCT01312428|101227221|FG001|NOT COMPLETED|Overall Study||4||
48366690|NCT01327339|101227222|FG000|STARTED|Overall Study||755||
48366691|NCT01327339|101227222|FG000|COMPLETED|Overall Study||747||
48366692|NCT01327339|101227222|FG000|NOT COMPLETED|Overall Study||8||
48366693|NCT00114114|101227223|FG000|STARTED|Overall Study||26||
48366694|NCT00114114|101227224|FG001|STARTED|Overall Study||25||
48366695|NCT00114114|101227225|FG002|STARTED|Overall Study||31||
48366696|NCT00114114|101227226|FG003|STARTED|Overall Study||35||
48366697|NCT00114114|101227227|FG004|STARTED|Overall Study||29||
48366698|NCT00114114|101227228|FG005|STARTED|Overall Study||31||
48366699|NCT00114114|101227223|FG000|COMPLETED|Overall Study||21||
48366700|NCT00114114|101227224|FG001|COMPLETED|Overall Study||24||
48366701|NCT00114114|101227225|FG002|COMPLETED|Overall Study||30||
48366702|NCT00114114|101227226|FG003|COMPLETED|Overall Study||31||
48366703|NCT00114114|101227227|FG004|COMPLETED|Overall Study||27||
48366704|NCT00114114|101227228|FG005|COMPLETED|Overall Study||30||
48366705|NCT00114114|101227223|FG000|NOT COMPLETED|Overall Study||5||
48366706|NCT00114114|101227224|FG001|NOT COMPLETED|Overall Study||1||
48366707|NCT00114114|101227225|FG002|NOT COMPLETED|Overall Study||1||
48366708|NCT00114114|101227226|FG003|NOT COMPLETED|Overall Study||4||
48366709|NCT00114114|101227227|FG004|NOT COMPLETED|Overall Study||2||
48366710|NCT00114114|101227228|FG005|NOT COMPLETED|Overall Study||1||
48366711|NCT01323673|101227229|FG000|STARTED|Overall Study||62||
48366712|NCT01323673|101227230|FG001|STARTED|Overall Study||63||
48366713|NCT01323673|101227229|FG000|COMPLETED|Overall Study||59||
48366714|NCT01323673|101227230|FG001|COMPLETED|Overall Study||58||
48366715|NCT01323673|101227229|FG000|NOT COMPLETED|Overall Study||3||
48366716|NCT01323673|101227230|FG001|NOT COMPLETED|Overall Study||5||
48366717|NCT01729598|101227231|FG000|STARTED|Overall Study||10||
48366718|NCT01729598|101227232|FG001|STARTED|Overall Study||4||
48366719|NCT01729598|101227231|FG000|COMPLETED|Overall Study||10||
48366720|NCT01729598|101227232|FG001|COMPLETED|Overall Study||4||
48366721|NCT01729598|101227231|FG000|NOT COMPLETED|Overall Study||0||
48366722|NCT01729598|101227232|FG001|NOT COMPLETED|Overall Study||0||
48366723|NCT03990766|101227233|FG000|STARTED|Overall Study||14||
48366724|NCT03990766|101227234|FG001|STARTED|Overall Study||13||
48366725|NCT03990766|101227233|FG000|COMPLETED|Overall Study||12||
48366726|NCT03990766|101227234|FG001|COMPLETED|Overall Study||10||
48366727|NCT03990766|101227233|FG000|NOT COMPLETED|Overall Study||2||
48366728|NCT03990766|101227234|FG001|NOT COMPLETED|Overall Study||3||
48366729|NCT02773758|101227235|FG000|STARTED|Overall Study||71||
48366730|NCT02773758|101227236|FG001|STARTED|Overall Study||70||
48366731|NCT02773758|101227235|FG000|COMPLETED|Overall Study||71||
48366732|NCT02773758|101227236|FG001|COMPLETED|Overall Study||70||
48366733|NCT02773758|101227235|FG000|NOT COMPLETED|Overall Study||0||
48366734|NCT02773758|101227236|FG001|NOT COMPLETED|Overall Study||0||
48366735|NCT00515008|101227237|FG000|STARTED|Overall Study||33||
48366736|NCT00515008|101227238|FG001|STARTED|Overall Study||33||
48366737|NCT00515008|101227237|FG000|Completed 12 Week Evaluation|Overall Study||32||
48366738|NCT00515008|101227238|FG001|Completed 12 Week Evaluation|Overall Study||29||
48366739|NCT00515008|101227237|FG000|COMPLETED|Overall Study||30||
48366740|NCT00515008|101227238|FG001|COMPLETED|Overall Study||29||
48366741|NCT00515008|101227237|FG000|NOT COMPLETED|Overall Study||3||
48366742|NCT00515008|101227238|FG001|NOT COMPLETED|Overall Study||4||
48366743|NCT03692910|101227239|FG000|STARTED|Overall Study||35||
48366744|NCT03692910|101227240|FG001|STARTED|Overall Study||0||
48366745|NCT03692910|101227241|FG002|STARTED|Overall Study||0||
48366746|NCT03692910|101227239|FG000|COMPLETED|Overall Study||29||
48366747|NCT03692910|101227240|FG001|COMPLETED|Overall Study||0||
48366748|NCT03692910|101227241|FG002|COMPLETED|Overall Study||0||
48366749|NCT03692910|101227239|FG000|NOT COMPLETED|Overall Study||6||
48366750|NCT03692910|101227240|FG001|NOT COMPLETED|Overall Study||0||
48366751|NCT03692910|101227241|FG002|NOT COMPLETED|Overall Study||0||
48366752|NCT03230175|101227242|FG000|STARTED|Overall Study||32||
48366753|NCT03230175|101227242|FG000|COMPLETED|Overall Study||30||
48366754|NCT03230175|101227242|FG000|NOT COMPLETED|Overall Study||2||
48366755|NCT01943864|101227243|FG000|STARTED|Overall Study||20||
48366756|NCT01943864|101227243|FG000|COMPLETED|Overall Study||20||
48366757|NCT01943864|101227243|FG000|NOT COMPLETED|Overall Study||0||
48366758|NCT00504166|101227244|FG000|STARTED|Overall Study||26||
48366759|NCT00504166|101227245|FG001|STARTED|Overall Study||27||
48366760|NCT00504166|101227244|FG000|COMPLETED|Overall Study||20||
48366761|NCT00504166|101227245|FG001|COMPLETED|Overall Study||13||
48366762|NCT00504166|101227244|FG000|NOT COMPLETED|Overall Study||6||
48366763|NCT00504166|101227245|FG001|NOT COMPLETED|Overall Study||14||
48366764|NCT00783705|101227246|FG000|STARTED|Overall Study||44||
48366765|NCT00783705|101227247|FG001|STARTED|Overall Study||41||
48366766|NCT00783705|101227246|FG000|COMPLETED|Overall Study||38||
48366767|NCT00783705|101227247|FG001|COMPLETED|Overall Study||36||
48366768|NCT00783705|101227246|FG000|NOT COMPLETED|Overall Study||6||
48366769|NCT00783705|101227247|FG001|NOT COMPLETED|Overall Study||5||
48366770|NCT04237207|101227248|FG000|STARTED|Overall Study||10||
48366771|NCT04237207|101227249|FG001|STARTED|Overall Study||12||
48366772|NCT04237207|101227248|FG000|COMPLETED|Overall Study||10||
48366773|NCT04237207|101227249|FG001|COMPLETED|Overall Study||12||
48366774|NCT04237207|101227248|FG000|NOT COMPLETED|Overall Study||0||
48366775|NCT04237207|101227249|FG001|NOT COMPLETED|Overall Study||0||
48766325|NCT02952820|102218404|FG001|Treated|Placebo-Controlled Treatment (6 Months)||319||
48766326|NCT02952820|102218405|FG002|Treated|Placebo-Controlled Treatment (6 Months)||319||
48766327|NCT02952820|102218403|FG000|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||319||
48766328|NCT02952820|102218404|FG001|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||314||
48766329|NCT02952820|102218405|FG002|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||314||
48766330|NCT02952820|102218403|FG000|COMPLETED|Placebo-Controlled Treatment (6 Months)||261||
48766331|NCT02952820|102218404|FG001|COMPLETED|Placebo-Controlled Treatment (6 Months)||254||
48766332|NCT02952820|102218405|FG002|COMPLETED|Placebo-Controlled Treatment (6 Months)||235||
48766333|NCT02952820|102218403|FG000|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||64||
48366776|NCT03153111|101227250|FG000|STARTED|Overall Study||71||
48366777|NCT03153111|101227251|FG001|STARTED|Overall Study||71||
48366778|NCT03153111|101227250|FG000|COMPLETED|Overall Study||60||
48366779|NCT03153111|101227251|FG001|COMPLETED|Overall Study||62||
48366780|NCT03153111|101227250|FG000|NOT COMPLETED|Overall Study||11||
48366781|NCT03153111|101227251|FG001|NOT COMPLETED|Overall Study||9||
48366782|NCT01703819|101227252|FG000|STARTED|Overall Study||34||
48366783|NCT01703819|101227253|FG001|STARTED|Overall Study||32||
48366784|NCT01703819|101227252|FG000|COMPLETED|Overall Study||34||
48766334|NCT02952820|102218404|FG001|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||69||
48766335|NCT02952820|102218405|FG002|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||88||
48766336|NCT02952820|102218403|FG000|STARTED|Active Treatment Period (6 Months)||0||
48766337|NCT02952820|102218404|FG001|STARTED|Active Treatment Period (6 Months)||384||
48766338|NCT02952820|102218405|FG002|STARTED|Active Treatment Period (6 Months)||352||
48766339|NCT02952820|102218403|FG000|COMPLETED|Active Treatment Period (6 Months)||0||
48766340|NCT02952820|102218404|FG001|COMPLETED|Active Treatment Period (6 Months)||346||
48766341|NCT02952820|102218405|FG002|COMPLETED|Active Treatment Period (6 Months)||321||
48766342|NCT02952820|102218403|FG000|NOT COMPLETED|Active Treatment Period (6 Months)||0||
48766343|NCT02952820|102218404|FG001|NOT COMPLETED|Active Treatment Period (6 Months)||38||
48766344|NCT02952820|102218405|FG002|NOT COMPLETED|Active Treatment Period (6 Months)||31||
48766345|NCT00765206|102218406|FG000|STARTED|First Intervention||15||
48766346|NCT00765206|102218407|FG001|STARTED|First Intervention||15||
48766347|NCT00765206|102218408|FG002|STARTED|First Intervention||15||
48766348|NCT00765206|102218409|FG003|STARTED|First Intervention||15||
48766349|NCT00765206|102218406|FG000|COMPLETED|First Intervention||15||
48766350|NCT00765206|102218407|FG001|COMPLETED|First Intervention||15||
48766351|NCT00765206|102218408|FG002|COMPLETED|First Intervention||15||
48766352|NCT00765206|102218409|FG003|COMPLETED|First Intervention||15||
48766353|NCT00765206|102218406|FG000|NOT COMPLETED|First Intervention||0||
48766354|NCT00765206|102218407|FG001|NOT COMPLETED|First Intervention||0||
48766355|NCT00765206|102218408|FG002|NOT COMPLETED|First Intervention||0||
48766356|NCT00765206|102218409|FG003|NOT COMPLETED|First Intervention||0||
48766357|NCT00765206|102218406|FG000|STARTED|Washout Period of 14 Days||15||
48766358|NCT00765206|102218407|FG001|STARTED|Washout Period of 14 Days||15||
48766359|NCT00765206|102218408|FG002|STARTED|Washout Period of 14 Days||15||
48766360|NCT00765206|102218409|FG003|STARTED|Washout Period of 14 Days||15||
48766361|NCT00765206|102218406|FG000|COMPLETED|Washout Period of 14 Days||15||
48766362|NCT00765206|102218407|FG001|COMPLETED|Washout Period of 14 Days||15||
48766363|NCT00765206|102218408|FG002|COMPLETED|Washout Period of 14 Days||15||
48766364|NCT00765206|102218409|FG003|COMPLETED|Washout Period of 14 Days||15||
48766365|NCT00765206|102218406|FG000|NOT COMPLETED|Washout Period of 14 Days||0||
48766366|NCT00765206|102218407|FG001|NOT COMPLETED|Washout Period of 14 Days||0||
48766367|NCT00765206|102218408|FG002|NOT COMPLETED|Washout Period of 14 Days||0||
48766368|NCT00765206|102218409|FG003|NOT COMPLETED|Washout Period of 14 Days||0||
48766369|NCT00765206|102218406|FG000|STARTED|Second Intervention||15||
48766370|NCT00765206|102218407|FG001|STARTED|Second Intervention||15||
48366785|NCT01703819|101227253|FG001|COMPLETED|Overall Study||30||
48366786|NCT01703819|101227252|FG000|NOT COMPLETED|Overall Study||0||
48366787|NCT01703819|101227253|FG001|NOT COMPLETED|Overall Study||2||
48366788|NCT01745627|101227254|FG000|STARTED|Overall Study||42||
48436768|NCT01187511|101403613|FG000|STARTED|Overall Study||22||
48436769|NCT01187511|101403614|FG001|STARTED|Overall Study||22||
48766371|NCT00765206|102218408|FG002|STARTED|Second Intervention||15||
48766372|NCT00765206|102218409|FG003|STARTED|Second Intervention||15||
48766373|NCT00765206|102218406|FG000|COMPLETED|Second Intervention||15||
48766374|NCT00765206|102218407|FG001|COMPLETED|Second Intervention||15||
48766375|NCT00765206|102218408|FG002|COMPLETED|Second Intervention||15||
48188339|NCT01023178|100783221|FG000|STARTED|Overall Study||5||
48366789|NCT01745627|101227254|FG000|COMPLETED|Overall Study||20||
48366790|NCT01745627|101227254|FG000|NOT COMPLETED|Overall Study||22||
48366791|NCT01096550|101227255|FG000|STARTED|Overall Study||170||
48366792|NCT01096550|101227256|FG001|STARTED|Overall Study||175||
48366793|NCT01096550|101227255|FG000|COMPLETED|Overall Study||133||
48366794|NCT01096550|101227256|FG001|COMPLETED|Overall Study||146||
48436770|NCT01187511|101403613|FG000|COMPLETED|Overall Study||14||
48366795|NCT01096550|101227255|FG000|NOT COMPLETED|Overall Study||37||
48366796|NCT01096550|101227256|FG001|NOT COMPLETED|Overall Study||29||
48366797|NCT04003636|101227257|FG000|STARTED|Overall Study||533||
48366798|NCT04003636|101227258|FG001|STARTED|Overall Study||536||
48366799|NCT04003636|101227257|FG000|COMPLETED|Overall Study||0||
48655386|NCT01512251|101941205|FG001|COMPLETED|Dose Level -1||5||
48655387|NCT01512251|101941204|FG000|NOT COMPLETED|Dose Level -1||0||
48655388|NCT01512251|101941205|FG001|NOT COMPLETED|Dose Level -1||0||
48655389|NCT01512251|101941204|FG000|STARTED|Phase I, Dose 1||3||
48655390|NCT01512251|101941205|FG001|STARTED|Phase I, Dose 1||5||
48655391|NCT01512251|101941204|FG000|COMPLETED|Phase I, Dose 1||0||
48655392|NCT01512251|101941205|FG001|COMPLETED|Phase I, Dose 1||0||
48655393|NCT01512251|101941204|FG000|NOT COMPLETED|Phase I, Dose 1||3||
48655394|NCT01512251|101941205|FG001|NOT COMPLETED|Phase I, Dose 1||5||
48655395|NCT01512251|101941204|FG000|STARTED|Phase I, Dose 2||0||
48655396|NCT01512251|101941205|FG001|STARTED|Phase I, Dose 2||0||
48655397|NCT01512251|101941204|FG000|COMPLETED|Phase I, Dose 2||0||
48655398|NCT01512251|101941205|FG001|COMPLETED|Phase I, Dose 2||0||
48655399|NCT01512251|101941204|FG000|NOT COMPLETED|Phase I, Dose 2||0||
48655400|NCT01512251|101941205|FG001|NOT COMPLETED|Phase I, Dose 2||0||
48655401|NCT01512251|101941204|FG000|STARTED|Phase I, Dose 3||0||
48655402|NCT01512251|101941205|FG001|STARTED|Phase I, Dose 3||0||
48655403|NCT01512251|101941204|FG000|COMPLETED|Phase I, Dose 3||0||
48655404|NCT01512251|101941205|FG001|COMPLETED|Phase I, Dose 3||0||
48655405|NCT01512251|101941204|FG000|NOT COMPLETED|Phase I, Dose 3||0||
48655406|NCT01512251|101941205|FG001|NOT COMPLETED|Phase I, Dose 3||0||
48655407|NCT01512251|101941204|FG000|STARTED|Phase I, Dose 4||0||
48655408|NCT01512251|101941205|FG001|STARTED|Phase I, Dose 4||0||
48655409|NCT01512251|101941204|FG000|COMPLETED|Phase I, Dose 4||0||
48655410|NCT01512251|101941205|FG001|COMPLETED|Phase I, Dose 4||0||
48655411|NCT01512251|101941204|FG000|NOT COMPLETED|Phase I, Dose 4||0||
48655412|NCT01512251|101941205|FG001|NOT COMPLETED|Phase I, Dose 4||0||
48655413|NCT01512251|101941204|FG000|STARTED|Phase II||0||
48655414|NCT01512251|101941205|FG001|STARTED|Phase II||0||
48655415|NCT01512251|101941204|FG000|COMPLETED|Phase II||0||
48655416|NCT01512251|101941205|FG001|COMPLETED|Phase II||0||
48655417|NCT01512251|101941204|FG000|NOT COMPLETED|Phase II||0||
48655418|NCT01512251|101941205|FG001|NOT COMPLETED|Phase II||0||
48655419|NCT00770809|101941206|FG000|STARTED|Overall Study||118||
48655420|NCT00770809|101941207|FG001|STARTED|Overall Study||120||
48655421|NCT00770809|101941208|FG002|STARTED|Overall Study||67||
48655422|NCT00770809|101941206|FG000|COMPLETED|Overall Study||101||
48655423|NCT00770809|101941207|FG001|COMPLETED|Overall Study||110||
48655424|NCT00770809|101941208|FG002|COMPLETED|Overall Study||44||
48655425|NCT00770809|101941206|FG000|NOT COMPLETED|Overall Study||17||
48655426|NCT00770809|101941207|FG001|NOT COMPLETED|Overall Study||10||
48655427|NCT00770809|101941208|FG002|NOT COMPLETED|Overall Study||23||
48655428|NCT00782379|101941209|FG000|STARTED|Overall Study||20||
48655429|NCT00782379|101941209|FG000|COMPLETED|Overall Study||20||
48655430|NCT00782379|101941209|FG000|NOT COMPLETED|Overall Study||0||
48655431|NCT02719366|101941210|FG000|STARTED|First Intervention||6||
48655432|NCT02719366|101941211|FG001|STARTED|First Intervention||6||
48655433|NCT02719366|101941210|FG000|COMPLETED|First Intervention||6||
48655434|NCT02719366|101941211|FG001|COMPLETED|First Intervention||6||
48655435|NCT02719366|101941210|FG000|NOT COMPLETED|First Intervention||0||
48655436|NCT02719366|101941211|FG001|NOT COMPLETED|First Intervention||0||
48655437|NCT02719366|101941210|FG000|STARTED|Second Intervention||6||
48655438|NCT02719366|101941211|FG001|STARTED|Second Intervention||6||
48366800|NCT04003636|101227258|FG001|COMPLETED|Overall Study||0||
48655439|NCT02719366|101941210|FG000|COMPLETED|Second Intervention||6||
48655440|NCT02719366|101941211|FG001|COMPLETED|Second Intervention||6||
48655441|NCT02719366|101941210|FG000|NOT COMPLETED|Second Intervention||0||
48655442|NCT02719366|101941211|FG001|NOT COMPLETED|Second Intervention||0||
48655443|NCT03704922|101941212|FG000|STARTED|Overall Study||13||
48655444|NCT03704922|101941213|FG001|STARTED|Overall Study||13||
48655445|NCT03704922|101941212|FG000|COMPLETED|Overall Study||10||
48655446|NCT03704922|101941213|FG001|COMPLETED|Overall Study||10||
48655447|NCT03704922|101941212|FG000|NOT COMPLETED|Overall Study||3||
48655448|NCT03704922|101941213|FG001|NOT COMPLETED|Overall Study||3||
48655449|NCT01725308|101941214|FG000|STARTED|Treatment Period I||178||
48366801|NCT04003636|101227257|FG000|NOT COMPLETED|Overall Study||533||
48366802|NCT04003636|101227258|FG001|NOT COMPLETED|Overall Study||536||
48366803|NCT03020524|101227259|FG000|STARTED|Overall Study||3||
48366804|NCT03020524|101227260|FG001|STARTED|Overall Study||3||
48655450|NCT01725308|101941215|FG001|STARTED|Treatment Period I||74||
48655451|NCT01725308|101941216|FG002|STARTED|Treatment Period I||179||
48655452|NCT01725308|101941214|FG000|Treated|Treatment Period I||177||
48655453|NCT01725308|101941215|FG001|Treated|Treatment Period I||74||
48655454|NCT01725308|101941216|FG002|Treated|Treatment Period I||179||
48655455|NCT01725308|101941214|FG000|COMPLETED|Treatment Period I||134||
48655456|NCT01725308|101941215|FG001|COMPLETED|Treatment Period I||60||
48655457|NCT01725308|101941216|FG002|COMPLETED|Treatment Period I||138||
48655458|NCT01725308|101941214|FG000|NOT COMPLETED|Treatment Period I||44||
48655459|NCT01725308|101941215|FG001|NOT COMPLETED|Treatment Period I||14||
48655460|NCT01725308|101941216|FG002|NOT COMPLETED|Treatment Period I||41||
48366805|NCT03020524|101227261|FG002|STARTED|Overall Study||3||
48366806|NCT03020524|101227259|FG000|COMPLETED|Overall Study||3||
48366807|NCT03020524|101227260|FG001|COMPLETED|Overall Study||3||
48366808|NCT03020524|101227261|FG002|COMPLETED|Overall Study||3||
48366809|NCT03020524|101227259|FG000|NOT COMPLETED|Overall Study||0||
48366810|NCT03020524|101227260|FG001|NOT COMPLETED|Overall Study||0||
48366811|NCT03020524|101227261|FG002|NOT COMPLETED|Overall Study||0||
48366812|NCT00084682|101227262|FG000|STARTED|Overall Study||14||
48366813|NCT00084682|101227262|FG000|COMPLETED|Overall Study||13||
48366814|NCT00084682|101227262|FG000|NOT COMPLETED|Overall Study||1||
48366815|NCT01530399|101227263|FG000|STARTED|Overall Study||8||
48366816|NCT01530399|101227264|FG001|STARTED|Overall Study||10||
48366817|NCT01530399|101227265|FG002|STARTED|Overall Study||8||
48366818|NCT01530399|101227266|FG003|STARTED|Overall Study||10||
48366819|NCT01530399|101227267|FG004|STARTED|Overall Study||6||
48366820|NCT01530399|101227268|FG005|STARTED|Overall Study||7||
48366821|NCT01530399|101227263|FG000|COMPLETED|Overall Study||7||
48366822|NCT01530399|101227264|FG001|COMPLETED|Overall Study||8||
48366823|NCT01530399|101227265|FG002|COMPLETED|Overall Study||7||
48366824|NCT01530399|101227266|FG003|COMPLETED|Overall Study||10||
48366825|NCT01530399|101227267|FG004|COMPLETED|Overall Study||6||
48366826|NCT01530399|101227268|FG005|COMPLETED|Overall Study||6||
48366827|NCT01530399|101227263|FG000|NOT COMPLETED|Overall Study||1||
48366828|NCT01530399|101227264|FG001|NOT COMPLETED|Overall Study||2||
48366829|NCT01530399|101227265|FG002|NOT COMPLETED|Overall Study||1||
48366830|NCT01530399|101227266|FG003|NOT COMPLETED|Overall Study||0||
48366831|NCT01530399|101227267|FG004|NOT COMPLETED|Overall Study||0||
48366832|NCT01530399|101227268|FG005|NOT COMPLETED|Overall Study||1||
48366833|NCT01306058|101227269|FG000|STARTED|Overall Study||27||
48366834|NCT01306058|101227269|FG000|COMPLETED|Overall Study||25||
48366835|NCT01306058|101227269|FG000|NOT COMPLETED|Overall Study||2||
48366836|NCT00365976|101227270|FG000|STARTED|Overall Study||33||
48366837|NCT00365976|101227271|FG001|STARTED|Overall Study||25||
48366838|NCT00365976|101227270|FG000|COMPLETED|Overall Study||32||
48366839|NCT00365976|101227271|FG001|COMPLETED|Overall Study||20||
48366840|NCT00365976|101227270|FG000|NOT COMPLETED|Overall Study||1||
48366841|NCT00365976|101227271|FG001|NOT COMPLETED|Overall Study||5||
48366842|NCT01666444|101227272|FG000|STARTED|Overall Study||149||
48366843|NCT01666444|101227273|FG001|STARTED|Overall Study||148||
48366844|NCT01666444|101227272|FG000|COMPLETED|Overall Study||147||
48366845|NCT01666444|101227273|FG001|COMPLETED|Overall Study||147||
48366846|NCT01666444|101227272|FG000|NOT COMPLETED|Overall Study||2||
48366847|NCT01666444|101227273|FG001|NOT COMPLETED|Overall Study||1||
48366848|NCT03510663|101227274|FG000|STARTED|Overall Study||6||
48366849|NCT03510663|101227275|FG001|STARTED|Overall Study||6||
48655461|NCT01725308|101941214|FG000|STARTED|Treatment Period II||134||
48655462|NCT01725308|101941215|FG001|STARTED|Treatment Period II||60||
48655463|NCT01725308|101941216|FG002|STARTED|Treatment Period II||138||
48655464|NCT01725308|101941214|FG000|Treated|Treatment Period II||120||
48655465|NCT01725308|101941215|FG001|Treated|Treatment Period II||53||
48655466|NCT01725308|101941216|FG002|Treated|Treatment Period II||130||
48655467|NCT01725308|101941214|FG000|COMPLETED|Treatment Period II||79||
48655468|NCT01725308|101941215|FG001|COMPLETED|Treatment Period II||31||
48655469|NCT01725308|101941216|FG002|COMPLETED|Treatment Period II||74||
48655470|NCT01725308|101941214|FG000|NOT COMPLETED|Treatment Period II||55||
48655471|NCT01725308|101941215|FG001|NOT COMPLETED|Treatment Period II||29||
48655472|NCT01725308|101941216|FG002|NOT COMPLETED|Treatment Period II||64||
48655473|NCT01698905|101941217|FG000|STARTED|Overall Study||163||
48655474|NCT01698905|101941217|FG000|Still on Study Phase|Overall Study||0||
48655475|NCT01698905|101941217|FG000|TFR Phase|Overall Study||126||
48655476|NCT01698905|101941217|FG000|NTRI Phase|Overall Study||51||
48655477|NCT01698905|101941217|FG000|NTCT Phase|Overall Study||26||
48655478|NCT01698905|101941217|FG000|TFR-2 Phase|Overall Study||2||
48655479|NCT01698905|101941217|FG000|NTRI-2 Phase|Overall Study||1||
48655480|NCT01698905|101941217|FG000|NTCT-P Phase Phase|Overall Study||6||
48655481|NCT01698905|101941217|FG000|COMPLETED|Overall Study||152|Completed = Completed 52 weeks of NTCS phase|
48655482|NCT01698905|101941217|FG000|NOT COMPLETED|Overall Study||11||
48655483|NCT03878069|101941218|FG000|STARTED|Overall Study||7||
48655484|NCT03878069|101941219|FG001|STARTED|Overall Study||21||
48655485|NCT03878069|101941220|FG002|STARTED|Overall Study||4||
48655486|NCT03878069|101941218|FG000|COMPLETED|Overall Study||7||
48655487|NCT03878069|101941219|FG001|COMPLETED|Overall Study||20||
48655488|NCT03878069|101941220|FG002|COMPLETED|Overall Study||4||
48655489|NCT03878069|101941218|FG000|NOT COMPLETED|Overall Study||0||
48655490|NCT03878069|101941219|FG001|NOT COMPLETED|Overall Study||1||
48655491|NCT03878069|101941220|FG002|NOT COMPLETED|Overall Study||0||
48655492|NCT02226653|101941221|FG000|STARTED|Treatment Period 1 Fasted State||24||
48366850|NCT03510663|101227276|FG002|STARTED|Overall Study||6||
48366851|NCT03510663|101227277|FG003|STARTED|Overall Study||6||
48366852|NCT03510663|101227278|FG004|STARTED|Overall Study||6||
48366853|NCT03510663|101227279|FG005|STARTED|Overall Study||6||
48366854|NCT03510663|101227280|FG006|STARTED|Overall Study||6||
48366855|NCT03510663|101227281|FG007|STARTED|Overall Study||6||
48366856|NCT03510663|101227274|FG000|COMPLETED|Overall Study||6||
48366857|NCT03510663|101227275|FG001|COMPLETED|Overall Study||5||
48366858|NCT03510663|101227276|FG002|COMPLETED|Overall Study||6||
48366859|NCT03510663|101227277|FG003|COMPLETED|Overall Study||6||
48366860|NCT03510663|101227278|FG004|COMPLETED|Overall Study||6||
48366861|NCT03510663|101227279|FG005|COMPLETED|Overall Study||6||
48366862|NCT03510663|101227280|FG006|COMPLETED|Overall Study||6||
48366863|NCT03510663|101227281|FG007|COMPLETED|Overall Study||6||
48366864|NCT03510663|101227274|FG000|NOT COMPLETED|Overall Study||0||
48366865|NCT03510663|101227275|FG001|NOT COMPLETED|Overall Study||1||
48366866|NCT03510663|101227276|FG002|NOT COMPLETED|Overall Study||0||
48366867|NCT03510663|101227277|FG003|NOT COMPLETED|Overall Study||0||
48366868|NCT03510663|101227278|FG004|NOT COMPLETED|Overall Study||0||
48366869|NCT03510663|101227279|FG005|NOT COMPLETED|Overall Study||0||
48366870|NCT03510663|101227280|FG006|NOT COMPLETED|Overall Study||0||
48366871|NCT03510663|101227281|FG007|NOT COMPLETED|Overall Study||0||
48366872|NCT01842061|101227282|FG000|STARTED|Overall Study||13||
48366873|NCT01842061|101227283|FG001|STARTED|Overall Study||12||
48366874|NCT01842061|101227282|FG000|COMPLETED|Overall Study||12||
48366875|NCT01842061|101227283|FG001|COMPLETED|Overall Study||8||
48366876|NCT01842061|101227282|FG000|NOT COMPLETED|Overall Study||1||
48366877|NCT01842061|101227283|FG001|NOT COMPLETED|Overall Study||4||
48366878|NCT01585129|101227284|FG000|STARTED|Overall Study||41||
48366879|NCT01585129|101227285|FG001|STARTED|Overall Study||39||
48366880|NCT01585129|101227284|FG000|COMPLETED|Overall Study||41||
48366881|NCT01585129|101227285|FG001|COMPLETED|Overall Study||39||
48366882|NCT01585129|101227284|FG000|NOT COMPLETED|Overall Study||0||
48366883|NCT01585129|101227285|FG001|NOT COMPLETED|Overall Study||0||
48366884|NCT05094154|101227286|FG000|STARTED|Overall Study||1277||
48366885|NCT05094154|101227287|FG001|STARTED|Overall Study||1357||
48366886|NCT05094154|101227286|FG000|COMPLETED|Overall Study||1214||
48366887|NCT05094154|101227287|FG001|COMPLETED|Overall Study||1297||
48366888|NCT05094154|101227286|FG000|NOT COMPLETED|Overall Study||63||
48366889|NCT05094154|101227287|FG001|NOT COMPLETED|Overall Study||60||
48366890|NCT02229864|101227288|FG000|STARTED|Overall Study||12||
48766376|NCT00765206|102218409|FG003|COMPLETED|Second Intervention||15||
48766377|NCT00765206|102218406|FG000|NOT COMPLETED|Second Intervention||0||
48766378|NCT00765206|102218407|FG001|NOT COMPLETED|Second Intervention||0||
48766379|NCT00765206|102218408|FG002|NOT COMPLETED|Second Intervention||0||
48766380|NCT00765206|102218409|FG003|NOT COMPLETED|Second Intervention||0||
48766381|NCT00371150|102218410|FG000|STARTED|Overall Study||40||
48366891|NCT02229864|101227288|FG000|COMPLETED|Overall Study||9||
48366892|NCT02229864|101227288|FG000|NOT COMPLETED|Overall Study||3||
48366893|NCT00266110|101227289|FG000|STARTED|Overall Study||17||
48366894|NCT00266110|101227289|FG000|COMPLETED|Overall Study||10||
48366895|NCT00266110|101227289|FG000|NOT COMPLETED|Overall Study||7||
48366896|NCT01214434|101227290|FG000|STARTED|Overall Study||15||
48366897|NCT01214434|101227291|FG001|STARTED|Overall Study||27||
48366898|NCT01214434|101227290|FG000|COMPLETED|Overall Study||11||
48366899|NCT01214434|101227291|FG001|COMPLETED|Overall Study||25||
48366900|NCT01214434|101227290|FG000|NOT COMPLETED|Overall Study||4||
48366901|NCT01214434|101227291|FG001|NOT COMPLETED|Overall Study||2||
48366902|NCT02416908|101227292|FG000|STARTED|Dose Escalation Phase||6||
48366903|NCT02416908|101227293|FG001|STARTED|Dose Escalation Phase||0||
48366904|NCT02416908|101227294|FG002|STARTED|Dose Escalation Phase||34||
48366905|NCT02416908|101227295|FG003|STARTED|Dose Escalation Phase||0||
48366906|NCT02416908|101227292|FG000|COMPLETED|Dose Escalation Phase||6||
48366907|NCT02416908|101227293|FG001|COMPLETED|Dose Escalation Phase||0||
48366908|NCT02416908|101227294|FG002|COMPLETED|Dose Escalation Phase||30||
48366909|NCT02416908|101227295|FG003|COMPLETED|Dose Escalation Phase||0||
48366910|NCT02416908|101227292|FG000|NOT COMPLETED|Dose Escalation Phase||0||
48366911|NCT02416908|101227293|FG001|NOT COMPLETED|Dose Escalation Phase||0||
48366912|NCT02416908|101227294|FG002|NOT COMPLETED|Dose Escalation Phase||4||
48366913|NCT02416908|101227295|FG003|NOT COMPLETED|Dose Escalation Phase||0||
48766382|NCT00371150|102218411|FG001|STARTED|Overall Study||6||
48766383|NCT00371150|102218410|FG000|Discontinued Prior to Week 48 Visit|Overall Study||1||
48766384|NCT00371150|102218411|FG001|Discontinued Prior to Week 48 Visit|Overall Study||1||
48366914|NCT02416908|101227292|FG000|STARTED|Maintenance Phase||0||
48766385|NCT00371150|102218410|FG000|Discontinued at or After Week 48 Visit|Overall Study||2||
48766386|NCT00371150|102218411|FG001|Discontinued at or After Week 48 Visit|Overall Study||1||
48366915|NCT02416908|101227293|FG001|STARTED|Maintenance Phase||0||
48366916|NCT02416908|101227294|FG002|STARTED|Maintenance Phase||0||
48366917|NCT02416908|101227295|FG003|STARTED|Maintenance Phase||2||
48366918|NCT02416908|101227292|FG000|COMPLETED|Maintenance Phase||0||
48366919|NCT02416908|101227293|FG001|COMPLETED|Maintenance Phase||0||
48366920|NCT02416908|101227294|FG002|COMPLETED|Maintenance Phase||0||
48366921|NCT02416908|101227295|FG003|COMPLETED|Maintenance Phase||2||
48366922|NCT02416908|101227292|FG000|NOT COMPLETED|Maintenance Phase||0||
48366923|NCT02416908|101227293|FG001|NOT COMPLETED|Maintenance Phase||0||
48366924|NCT02416908|101227294|FG002|NOT COMPLETED|Maintenance Phase||0||
48366925|NCT02416908|101227295|FG003|NOT COMPLETED|Maintenance Phase||0||
48366926|NCT02052960|101227296|FG000|STARTED|Overall Study||117||
48366927|NCT02052960|101227297|FG001|STARTED|Overall Study||123||
48368137|NCT01819922|101230114|FG001|COMPLETED|First Intervention Period (1 Day)||6||
48366928|NCT02052960|101227296|FG000|Treated Patients|Overall Study||115|Included all patients who received at least 1 dose of trial medication. This population was used for safety analyses (= Safety Population).|
48366929|NCT02052960|101227297|FG001|Treated Patients|Overall Study||122|Included all patients who received at least 1 dose of trial medication. This population was used for safety analyses (= Safety Population).|
48366930|NCT02052960|101227296|FG000|COMPLETED|Overall Study||63||
48366931|NCT02052960|101227297|FG001|COMPLETED|Overall Study||77||
48766387|NCT00371150|102218410|FG000|COMPLETED|Overall Study||37||
48766388|NCT00371150|102218411|FG001|COMPLETED|Overall Study||4||
48766389|NCT00371150|102218410|FG000|NOT COMPLETED|Overall Study||3||
48766390|NCT00371150|102218411|FG001|NOT COMPLETED|Overall Study||2||
48766391|NCT00758667|102218412|FG000|STARTED|Overall Study||9||
48766392|NCT00758667|102218413|FG001|STARTED|Overall Study||11||
48766393|NCT00758667|102218412|FG000|COMPLETED|Overall Study||9||
48766394|NCT00758667|102218413|FG001|COMPLETED|Overall Study||11||
48766395|NCT00758667|102218412|FG000|NOT COMPLETED|Overall Study||0||
48766396|NCT00758667|102218413|FG001|NOT COMPLETED|Overall Study||0||
48766397|NCT03122509|102218414|FG000|STARTED|Overall Study||25||
48766398|NCT03122509|102218415|FG001|STARTED|Overall Study||0||
48766399|NCT03122509|102218414|FG000|COMPLETED|Overall Study||25||
48766400|NCT03122509|102218415|FG001|COMPLETED|Overall Study||0||
48766401|NCT03122509|102218414|FG000|NOT COMPLETED|Overall Study||0||
48766402|NCT03122509|102218415|FG001|NOT COMPLETED|Overall Study||0||
48766403|NCT00744497|102218416|FG000|STARTED|Overall Study||760||
48766404|NCT00744497|102218417|FG001|STARTED|Overall Study||762||
48766405|NCT00744497|102218416|FG000|Received Treatment|Overall Study||757||
48766406|NCT00744497|102218417|FG001|Received Treatment|Overall Study||761||
48766407|NCT00744497|102218416|FG000|COMPLETED|Overall Study||0||
48766408|NCT00744497|102218417|FG001|COMPLETED|Overall Study||0||
48766409|NCT00744497|102218416|FG000|NOT COMPLETED|Overall Study||760||
48766410|NCT00744497|102218417|FG001|NOT COMPLETED|Overall Study||762||
48766411|NCT03216512|102218418|FG000|STARTED|Overall Study||17||
48766412|NCT03216512|102218419|FG001|STARTED|Overall Study||14||
48766413|NCT03216512|102218418|FG000|COMPLETED|Overall Study||17||
48188340|NCT01023178|100783222|FG001|STARTED|Overall Study||8||
48366932|NCT02052960|101227296|FG000|NOT COMPLETED|Overall Study||54||
48366933|NCT02052960|101227297|FG001|NOT COMPLETED|Overall Study||46||
48366934|NCT01889810|101227298|FG000|STARTED|Overall Study||35||
48366935|NCT01889810|101227299|FG001|STARTED|Overall Study||31||
48366936|NCT01889810|101227298|FG000|COMPLETED|Overall Study||34||
48366937|NCT01889810|101227299|FG001|COMPLETED|Overall Study||30||
48366938|NCT01889810|101227298|FG000|NOT COMPLETED|Overall Study||1||
48366939|NCT01889810|101227299|FG001|NOT COMPLETED|Overall Study||1||
48366940|NCT00634543|101227300|FG000|STARTED|Overall Study||78||
48366941|NCT00634543|101227301|FG001|STARTED|Overall Study||84||
48366942|NCT00634543|101227300|FG000|Treated|Overall Study||76||
48366943|NCT00634543|101227301|FG001|Treated|Overall Study||80||
48366944|NCT00634543|101227300|FG000|COMPLETED|Overall Study||59||
48366945|NCT00634543|101227301|FG001|COMPLETED|Overall Study||63||
48766414|NCT03216512|102218419|FG001|COMPLETED|Overall Study||13||
48766415|NCT03216512|102218418|FG000|NOT COMPLETED|Overall Study||0||
48766416|NCT03216512|102218419|FG001|NOT COMPLETED|Overall Study||1||
48766417|NCT04467905|102218420|FG000|STARTED|Overall Study||29||
48766418|NCT04467905|102218421|FG001|STARTED|Overall Study||27||
48766419|NCT04467905|102218422|FG002|STARTED|Overall Study||13||
48766420|NCT04467905|102218420|FG000|Medication Was Administered|Overall Study||29||
48766421|NCT04467905|102218421|FG001|Medication Was Administered|Overall Study||27||
48766422|NCT04467905|102218422|FG002|Medication Was Administered|Overall Study||0||
48366946|NCT00634543|101227300|FG000|NOT COMPLETED|Overall Study||19||
48366947|NCT00634543|101227301|FG001|NOT COMPLETED|Overall Study||21||
48366948|NCT02084134|101227302|FG000|STARTED|Overall Study||23||
48366949|NCT02084134|101227303|FG001|STARTED|Overall Study||20||
48366950|NCT02084134|101227302|FG000|COMPLETED|Overall Study||19||
48366951|NCT02084134|101227303|FG001|COMPLETED|Overall Study||17||
48366952|NCT02084134|101227302|FG000|NOT COMPLETED|Overall Study||4||
48366953|NCT02084134|101227303|FG001|NOT COMPLETED|Overall Study||3||
48366954|NCT02508701|101227304|FG000|STARTED|Overall Study||9||
48366955|NCT02508701|101227305|FG001|STARTED|Overall Study||6||
48366956|NCT02508701|101227306|FG002|STARTED|Overall Study||5||
48366957|NCT02508701|101227307|FG003|STARTED|Overall Study||4||
48766423|NCT04467905|102218420|FG000|Medication Was Not Administered|Overall Study||0||
48766424|NCT04467905|102218421|FG001|Medication Was Not Administered|Overall Study||0||
48766425|NCT04467905|102218422|FG002|Medication Was Not Administered|Overall Study||13||
48766426|NCT04467905|102218420|FG000|Safety Population|Overall Study||29||
48766427|NCT04467905|102218421|FG001|Safety Population|Overall Study||27||
48766428|NCT04467905|102218422|FG002|Safety Population|Overall Study||0||
48766429|NCT04467905|102218420|FG000|mITT Population|Overall Study||29||
48766430|NCT04467905|102218421|FG001|mITT Population|Overall Study||27||
48766431|NCT04467905|102218422|FG002|mITT Population|Overall Study||0||
48766432|NCT04467905|102218420|FG000|Efficacy Population|Overall Study||25||
48766433|NCT04467905|102218421|FG001|Efficacy Population|Overall Study||24||
48766434|NCT04467905|102218422|FG002|Efficacy Population|Overall Study||0||
48766435|NCT04467905|102218420|FG000|COMPLETED|Overall Study||29||
48766436|NCT04467905|102218421|FG001|COMPLETED|Overall Study||27||
48655493|NCT02226653|101941222|FG001|STARTED|Treatment Period 1 Fasted State||24||
48655494|NCT02226653|101941221|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 Fasted State||24||
48655495|NCT02226653|101941222|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 Fasted State||24||
48655496|NCT02226653|101941221|FG000|COMPLETED|Treatment Period 1 Fasted State||24||
48655497|NCT02226653|101941222|FG001|COMPLETED|Treatment Period 1 Fasted State||24||
48655498|NCT02226653|101941221|FG000|NOT COMPLETED|Treatment Period 1 Fasted State||0||
48655499|NCT02226653|101941222|FG001|NOT COMPLETED|Treatment Period 1 Fasted State||0||
48655500|NCT02226653|101941221|FG000|STARTED|Washout Period 1 (at Least 21 Days)||24||
48655501|NCT02226653|101941222|FG001|STARTED|Washout Period 1 (at Least 21 Days)||24||
48655502|NCT02226653|101941221|FG000|COMPLETED|Washout Period 1 (at Least 21 Days)||24||
48655503|NCT02226653|101941222|FG001|COMPLETED|Washout Period 1 (at Least 21 Days)||24||
48655504|NCT02226653|101941221|FG000|NOT COMPLETED|Washout Period 1 (at Least 21 Days)||0||
48655505|NCT02226653|101941222|FG001|NOT COMPLETED|Washout Period 1 (at Least 21 Days)||0||
48655506|NCT02226653|101941221|FG000|STARTED|Treatment Period 2 Fasted State||24||
48655507|NCT02226653|101941222|FG001|STARTED|Treatment Period 2 Fasted State||24||
48655508|NCT02226653|101941221|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2 Fasted State||24||
48655509|NCT02226653|101941222|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2 Fasted State||24||
48655510|NCT02226653|101941221|FG000|COMPLETED|Treatment Period 2 Fasted State||23||
48655511|NCT02226653|101941222|FG001|COMPLETED|Treatment Period 2 Fasted State||24||
48655512|NCT02226653|101941221|FG000|NOT COMPLETED|Treatment Period 2 Fasted State||1||
48655513|NCT02226653|101941222|FG001|NOT COMPLETED|Treatment Period 2 Fasted State||0||
48655514|NCT02226653|101941221|FG000|STARTED|Washout Period 2 (at Least 21 Days)||23||
48655515|NCT02226653|101941222|FG001|STARTED|Washout Period 2 (at Least 21 Days)||24||
48655516|NCT02226653|101941221|FG000|COMPLETED|Washout Period 2 (at Least 21 Days)||23||
48655517|NCT02226653|101941222|FG001|COMPLETED|Washout Period 2 (at Least 21 Days)||24||
48655518|NCT02226653|101941221|FG000|NOT COMPLETED|Washout Period 2 (at Least 21 Days)||0||
48655519|NCT02226653|101941222|FG001|NOT COMPLETED|Washout Period 2 (at Least 21 Days)||0||
48655520|NCT02226653|101941221|FG000|STARTED|Treatment Period 3 Fasted State||23||
48655521|NCT02226653|101941222|FG001|STARTED|Treatment Period 3 Fasted State||24||
48655522|NCT02226653|101941221|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 3 Fasted State||23||
48655523|NCT02226653|101941222|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 3 Fasted State||24||
48655524|NCT02226653|101941221|FG000|COMPLETED|Treatment Period 3 Fasted State||23||
48655525|NCT02226653|101941222|FG001|COMPLETED|Treatment Period 3 Fasted State||24||
48655526|NCT02226653|101941221|FG000|NOT COMPLETED|Treatment Period 3 Fasted State||0||
48655527|NCT02226653|101941222|FG001|NOT COMPLETED|Treatment Period 3 Fasted State||0||
48655528|NCT02226653|101941221|FG000|STARTED|Washout Period 3 (at Least 21 Days)||23||
48655529|NCT02226653|101941222|FG001|STARTED|Washout Period 3 (at Least 21 Days)||24||
48655530|NCT02226653|101941221|FG000|COMPLETED|Washout Period 3 (at Least 21 Days)||23||
48655531|NCT02226653|101941222|FG001|COMPLETED|Washout Period 3 (at Least 21 Days)||24||
48655532|NCT02226653|101941221|FG000|NOT COMPLETED|Washout Period 3 (at Least 21 Days)||0||
48655533|NCT02226653|101941222|FG001|NOT COMPLETED|Washout Period 3 (at Least 21 Days)||0||
48655534|NCT02226653|101941221|FG000|STARTED|Treatment Period 4 Fasted State||23||
48655535|NCT02226653|101941222|FG001|STARTED|Treatment Period 4 Fasted State||24||
48655536|NCT02226653|101941221|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 4 Fasted State||23||
48655537|NCT02226653|101941222|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 4 Fasted State||24||
48655538|NCT02226653|101941221|FG000|COMPLETED|Treatment Period 4 Fasted State||23||
48655539|NCT02226653|101941222|FG001|COMPLETED|Treatment Period 4 Fasted State||24||
48655540|NCT02226653|101941221|FG000|NOT COMPLETED|Treatment Period 4 Fasted State||0||
48655541|NCT02226653|101941222|FG001|NOT COMPLETED|Treatment Period 4 Fasted State||0||
48655542|NCT02226653|101941221|FG000|STARTED|Washout Period 4 (at Least 21 Days)||23||
48655543|NCT02226653|101941222|FG001|STARTED|Washout Period 4 (at Least 21 Days)||24||
48655544|NCT02226653|101941221|FG000|COMPLETED|Washout Period 4 (at Least 21 Days)||23||
48655545|NCT02226653|101941222|FG001|COMPLETED|Washout Period 4 (at Least 21 Days)||24||
48655546|NCT02226653|101941221|FG000|NOT COMPLETED|Washout Period 4 (at Least 21 Days)||0||
48655547|NCT02226653|101941222|FG001|NOT COMPLETED|Washout Period 4 (at Least 21 Days)||0||
48655548|NCT02226653|101941221|FG000|STARTED|Treatment Period 5 Fed State||23||
48655549|NCT02226653|101941222|FG001|STARTED|Treatment Period 5 Fed State||24||
48655550|NCT02226653|101941221|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 5 Fed State||23||
48655551|NCT02226653|101941222|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 5 Fed State||24||
48655552|NCT02226653|101941221|FG000|COMPLETED|Treatment Period 5 Fed State||23||
48655553|NCT02226653|101941222|FG001|COMPLETED|Treatment Period 5 Fed State||23||
48655554|NCT02226653|101941221|FG000|NOT COMPLETED|Treatment Period 5 Fed State||0||
48655555|NCT02226653|101941222|FG001|NOT COMPLETED|Treatment Period 5 Fed State||1||
48655556|NCT02226653|101941221|FG000|STARTED|Washout Period 5 (at Least 21 Days)||23||
48655557|NCT02226653|101941222|FG001|STARTED|Washout Period 5 (at Least 21 Days)||23||
48655558|NCT02226653|101941221|FG000|COMPLETED|Washout Period 5 (at Least 21 Days)||23||
48766437|NCT04467905|102218422|FG002|COMPLETED|Overall Study||0||
48655559|NCT02226653|101941222|FG001|COMPLETED|Washout Period 5 (at Least 21 Days)||23||
48655560|NCT02226653|101941221|FG000|NOT COMPLETED|Washout Period 5 (at Least 21 Days)||0||
48766438|NCT04467905|102218420|FG000|NOT COMPLETED|Overall Study||0||
48766439|NCT04467905|102218421|FG001|NOT COMPLETED|Overall Study||0||
48766440|NCT04467905|102218422|FG002|NOT COMPLETED|Overall Study||13||
48766441|NCT03829228|102218423|FG000|STARTED|Overall Study||30||
48766442|NCT03829228|102218423|FG000|COMPLETED|Overall Study||29||
48766443|NCT03829228|102218423|FG000|NOT COMPLETED|Overall Study||1||
48766444|NCT02392637|102218424|FG000|STARTED|Overall Study||32||
48366958|NCT02508701|101227304|FG000|COMPLETED|Overall Study||0||
48366959|NCT02508701|101227305|FG001|COMPLETED|Overall Study||1||
48366960|NCT02508701|101227306|FG002|COMPLETED|Overall Study||0||
48366961|NCT02508701|101227307|FG003|COMPLETED|Overall Study||1||
48366962|NCT02508701|101227304|FG000|NOT COMPLETED|Overall Study||9||
48366963|NCT02508701|101227305|FG001|NOT COMPLETED|Overall Study||5||
48366964|NCT02508701|101227306|FG002|NOT COMPLETED|Overall Study||5||
48366965|NCT02508701|101227307|FG003|NOT COMPLETED|Overall Study||3||
48366966|NCT02341014|101227308|FG000|STARTED|Overall Study||6||
48366967|NCT02341014|101227309|FG001|STARTED|Overall Study||7||
48366968|NCT02341014|101227310|FG002|STARTED|Overall Study||0||
48366969|NCT02341014|101227311|FG003|STARTED|Overall Study||0||
48366970|NCT02341014|101227312|FG004|STARTED|Overall Study||14||
48366971|NCT02341014|101227308|FG000|COMPLETED|Overall Study||6||
48366972|NCT02341014|101227309|FG001|COMPLETED|Overall Study||6||
48366973|NCT02341014|101227310|FG002|COMPLETED|Overall Study||0||
48366974|NCT02341014|101227311|FG003|COMPLETED|Overall Study||0||
48366975|NCT02341014|101227312|FG004|COMPLETED|Overall Study||12||
48366976|NCT02341014|101227308|FG000|NOT COMPLETED|Overall Study||0||
48366977|NCT02341014|101227309|FG001|NOT COMPLETED|Overall Study||1||
48366978|NCT02341014|101227310|FG002|NOT COMPLETED|Overall Study||0||
48366979|NCT02341014|101227311|FG003|NOT COMPLETED|Overall Study||0||
48366980|NCT02341014|101227312|FG004|NOT COMPLETED|Overall Study||2||
48366981|NCT03191396|101227313|FG000|STARTED|Overall Study||290||
48366982|NCT03191396|101227314|FG001|STARTED|Overall Study||287||
48366983|NCT03191396|101227313|FG000|COMPLETED|Overall Study||287||
48366984|NCT03191396|101227314|FG001|COMPLETED|Overall Study||282||
48366985|NCT03191396|101227313|FG000|NOT COMPLETED|Overall Study||3||
48366986|NCT03191396|101227314|FG001|NOT COMPLETED|Overall Study||5||
48366987|NCT03028025|101227315|FG000|STARTED|Overall Study||90||
48366988|NCT03028025|101227316|FG001|STARTED|Overall Study||94||
48366989|NCT03028025|101227315|FG000|COMPLETED|Overall Study||87||
48366990|NCT03028025|101227316|FG001|COMPLETED|Overall Study||93||
48366991|NCT03028025|101227315|FG000|NOT COMPLETED|Overall Study||3||
48366992|NCT03028025|101227316|FG001|NOT COMPLETED|Overall Study||1||
48366993|NCT02657252|101227317|FG000|STARTED|Overall Study||57||57
48366994|NCT02657252|101227318|FG001|STARTED|Overall Study||58||58
48366995|NCT02657252|101227317|FG000|COMPLETED|Overall Study||47||47
48366996|NCT02657252|101227318|FG001|COMPLETED|Overall Study||51||51
48366997|NCT02657252|101227317|FG000|NOT COMPLETED|Overall Study||10||10
48366998|NCT02657252|101227318|FG001|NOT COMPLETED|Overall Study||7||7
48366999|NCT01985685|101227319|FG000|STARTED|Overall Study||27||
48367000|NCT01985685|101227320|FG001|STARTED|Overall Study||29||
48367001|NCT01985685|101227319|FG000|COMPLETED|Overall Study||27||
48367002|NCT01985685|101227320|FG001|COMPLETED|Overall Study||29||
48367003|NCT01985685|101227319|FG000|NOT COMPLETED|Overall Study||0||
48367004|NCT01985685|101227320|FG001|NOT COMPLETED|Overall Study||0||
48367005|NCT00175006|101227321|FG000|STARTED|Overall Study||13||
48436771|NCT01187511|101403614|FG001|COMPLETED|Overall Study||21||
48766445|NCT02392637|102218425|FG001|STARTED|Overall Study||28||
48766446|NCT02392637|102218424|FG000|COMPLETED|Overall Study||32||
48766447|NCT02392637|102218425|FG001|COMPLETED|Overall Study||28||
48367006|NCT00175006|101227321|FG000|COMPLETED|Overall Study||13||
48367007|NCT00175006|101227321|FG000|NOT COMPLETED|Overall Study||0||
48367008|NCT00700752|101227322|FG000|STARTED|First Intervention||20||
48367009|NCT00700752|101227323|FG001|STARTED|First Intervention||20||
48367010|NCT00700752|101227322|FG000|COMPLETED|First Intervention||20||
48367011|NCT00700752|101227323|FG001|COMPLETED|First Intervention||18||
48367012|NCT00700752|101227322|FG000|NOT COMPLETED|First Intervention||0||
48367013|NCT00700752|101227323|FG001|NOT COMPLETED|First Intervention||2||
48367014|NCT00700752|101227322|FG000|STARTED|Second Intervention||20||
48766448|NCT02392637|102218424|FG000|NOT COMPLETED|Overall Study||0||
48766449|NCT02392637|102218425|FG001|NOT COMPLETED|Overall Study||0||
48766450|NCT03129568|102218426|FG000|STARTED|Overall Study||5||
48766451|NCT03129568|102218426|FG000|COMPLETED|Overall Study||5||
48766452|NCT03129568|102218426|FG000|NOT COMPLETED|Overall Study||0||
48367015|NCT00700752|101227323|FG001|STARTED|Second Intervention||18||
48367016|NCT00700752|101227322|FG000|COMPLETED|Second Intervention||20||
48367017|NCT00700752|101227323|FG001|COMPLETED|Second Intervention||18||
48367018|NCT00700752|101227322|FG000|NOT COMPLETED|Second Intervention||0||
48367019|NCT00700752|101227323|FG001|NOT COMPLETED|Second Intervention||0||
48367020|NCT02650284|101227324|FG000|STARTED|Overall Study||8||
48367021|NCT02650284|101227325|FG001|STARTED|Overall Study||9||
48367022|NCT02650284|101227324|FG000|COMPLETED|Overall Study||5||
48367023|NCT02650284|101227325|FG001|COMPLETED|Overall Study||5||
48367024|NCT02650284|101227324|FG000|NOT COMPLETED|Overall Study||3||
48367025|NCT02650284|101227325|FG001|NOT COMPLETED|Overall Study||4||
48367026|NCT02807454|101227326|FG000|STARTED|Overall Study||32||
48367027|NCT02807454|101227327|FG001|STARTED|Overall Study||5||
48367028|NCT02807454|101227326|FG000|Participants in the D2 Arm Who Also Received Pomalidomide + Dexamethasone|Overall Study||7||
48367029|NCT02807454|101227327|FG001|Participants in the D2 Arm Who Also Received Pomalidomide + Dexamethasone|Overall Study||0||
48367030|NCT02807454|101227326|FG000|COMPLETED|Overall Study||0||
48367031|NCT02807454|101227327|FG001|COMPLETED|Overall Study||0||
48367032|NCT02807454|101227326|FG000|NOT COMPLETED|Overall Study||32||
48367033|NCT02807454|101227327|FG001|NOT COMPLETED|Overall Study||5||
48367034|NCT02222129|101227328|FG000|STARTED|Overall Study||100||
48367035|NCT02222129|101227329|FG001|STARTED|Overall Study||106||
48367036|NCT02222129|101227328|FG000|COMPLETED|Overall Study||100||
48367037|NCT02222129|101227329|FG001|COMPLETED|Overall Study||106||
48367038|NCT02222129|101227328|FG000|NOT COMPLETED|Overall Study||0||
48367039|NCT02222129|101227329|FG001|NOT COMPLETED|Overall Study||0||
48367040|NCT01097616|101227330|FG000|STARTED|Double-Blind (DB) Treatment (TRT) Phase||254||
48655561|NCT02226653|101941222|FG001|NOT COMPLETED|Washout Period 5 (at Least 21 Days)||0||
48655562|NCT04494971|101941223|FG000|STARTED|Overall Study||15||
48655563|NCT04494971|101941223|FG000|COMPLETED|Overall Study||15||
48655564|NCT04494971|101941223|FG000|NOT COMPLETED|Overall Study||0||
48655565|NCT04589988|101941224|FG000|STARTED|Overall Study||24||
48655566|NCT04589988|101941225|FG001|STARTED|Overall Study||26||
48655567|NCT04589988|101941224|FG000|COMPLETED|Overall Study||23||
48655568|NCT04589988|101941225|FG001|COMPLETED|Overall Study||24||
48655569|NCT04589988|101941224|FG000|NOT COMPLETED|Overall Study||1||
48655570|NCT04589988|101941225|FG001|NOT COMPLETED|Overall Study||2||
48655571|NCT01694186|101941226|FG000|STARTED|Overall Study||42||
48655572|NCT01694186|101941227|FG001|STARTED|Overall Study||87||
48655573|NCT01694186|101941226|FG000|COMPLETED|Overall Study||36||
48655574|NCT01694186|101941227|FG001|COMPLETED|Overall Study||80||
48655575|NCT01694186|101941226|FG000|NOT COMPLETED|Overall Study||6||
48655576|NCT01694186|101941227|FG001|NOT COMPLETED|Overall Study||7||
48655577|NCT02142803|101941228|FG000|STARTED|Registration to Initiation of Therapy||3||
48655578|NCT02142803|101941229|FG001|STARTED|Registration to Initiation of Therapy||3||
48655579|NCT02142803|101941230|FG002|STARTED|Registration to Initiation of Therapy||6||
48655580|NCT02142803|101941231|FG003|STARTED|Registration to Initiation of Therapy||38||
48655581|NCT02142803|101941228|FG000|COMPLETED|Registration to Initiation of Therapy||3||
48655582|NCT02142803|101941229|FG001|COMPLETED|Registration to Initiation of Therapy||3||
48655583|NCT02142803|101941230|FG002|COMPLETED|Registration to Initiation of Therapy||6||
48655584|NCT02142803|101941231|FG003|COMPLETED|Registration to Initiation of Therapy||37||
48655585|NCT02142803|101941228|FG000|NOT COMPLETED|Registration to Initiation of Therapy||0||
48655586|NCT02142803|101941229|FG001|NOT COMPLETED|Registration to Initiation of Therapy||0||
48655587|NCT02142803|101941230|FG002|NOT COMPLETED|Registration to Initiation of Therapy||0||
48655588|NCT02142803|101941231|FG003|NOT COMPLETED|Registration to Initiation of Therapy||1||
48655589|NCT02142803|101941228|FG000|STARTED|Study Therapy||3||
48655590|NCT02142803|101941229|FG001|STARTED|Study Therapy||3||
48655591|NCT02142803|101941230|FG002|STARTED|Study Therapy||6||
48655592|NCT02142803|101941231|FG003|STARTED|Study Therapy||37||
48655593|NCT02142803|101941228|FG000|COMPLETED|Study Therapy||3||
48655594|NCT02142803|101941229|FG001|COMPLETED|Study Therapy||3||
48655595|NCT02142803|101941230|FG002|COMPLETED|Study Therapy||6||
48655596|NCT02142803|101941231|FG003|COMPLETED|Study Therapy||37||
48655597|NCT02142803|101941228|FG000|NOT COMPLETED|Study Therapy||0||
48655598|NCT02142803|101941229|FG001|NOT COMPLETED|Study Therapy||0||
48655599|NCT02142803|101941230|FG002|NOT COMPLETED|Study Therapy||0||
48655600|NCT02142803|101941231|FG003|NOT COMPLETED|Study Therapy||0||
48655601|NCT04641975|101941232|FG000|STARTED|Overall Study||11||
48766453|NCT00091949|102218427|FG000|STARTED|Overall Study||1939||
48766454|NCT00091949|102218428|FG001|STARTED|Overall Study||1937||
48766455|NCT00091949|102218427|FG000|COMPLETED|Overall Study||1764||
48367041|NCT01097616|101227331|FG001|STARTED|Double-Blind (DB) Treatment (TRT) Phase||383||
48367042|NCT01097616|101227332|FG002|STARTED|Double-Blind (DB) Treatment (TRT) Phase||385||
48655602|NCT04641975|101941233|FG001|STARTED|Overall Study||12||
48655603|NCT04641975|101941234|FG002|STARTED|Overall Study||2||
48655604|NCT04641975|101941235|FG003|STARTED|Overall Study||1||
48655605|NCT04641975|101941232|FG000|COMPLETED|Overall Study||9||
48655606|NCT04641975|101941233|FG001|COMPLETED|Overall Study||10||
48655607|NCT04641975|101941234|FG002|COMPLETED|Overall Study||1||
48655608|NCT04641975|101941235|FG003|COMPLETED|Overall Study||0||
48655609|NCT04641975|101941232|FG000|NOT COMPLETED|Overall Study||2||
48655610|NCT04641975|101941233|FG001|NOT COMPLETED|Overall Study||2||
48766456|NCT00091949|102218428|FG001|COMPLETED|Overall Study||1786||
48766457|NCT00091949|102218427|FG000|NOT COMPLETED|Overall Study||175||
48367043|NCT01097616|101227333|FG003|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0||
48367044|NCT01097616|101227334|FG004|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0||
48367045|NCT01097616|101227335|FG005|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0||
48367046|NCT01097616|101227336|FG006|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0||
48367047|NCT01097616|101227337|FG007|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0||
48367048|NCT01097616|101227330|FG000|Treated|Double-Blind (DB) Treatment (TRT) Phase||254||
48367049|NCT01097616|101227331|FG001|Treated|Double-Blind (DB) Treatment (TRT) Phase||383||
48367050|NCT01097616|101227332|FG002|Treated|Double-Blind (DB) Treatment (TRT) Phase||384||
48655611|NCT04641975|101941234|FG002|NOT COMPLETED|Overall Study||1||
48367051|NCT01097616|101227333|FG003|Treated|Double-Blind (DB) Treatment (TRT) Phase||0||
48367052|NCT01097616|101227334|FG004|Treated|Double-Blind (DB) Treatment (TRT) Phase||0||
48367053|NCT01097616|101227335|FG005|Treated|Double-Blind (DB) Treatment (TRT) Phase||0||
48367054|NCT01097616|101227336|FG006|Treated|Double-Blind (DB) Treatment (TRT) Phase||0||
48367055|NCT01097616|101227337|FG007|Treated|Double-Blind (DB) Treatment (TRT) Phase||0||
48367056|NCT01097616|101227330|FG000|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||230||
48367057|NCT01097616|101227331|FG001|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||345||
48367058|NCT01097616|101227332|FG002|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||341||
48367059|NCT01097616|101227333|FG003|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
48367060|NCT01097616|101227334|FG004|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
48367061|NCT01097616|101227335|FG005|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
48367062|NCT01097616|101227336|FG006|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
48367063|NCT01097616|101227337|FG007|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
48367064|NCT01097616|101227330|FG000|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||24||
48655612|NCT04641975|101941235|FG003|NOT COMPLETED|Overall Study||1||
48655613|NCT01142388|101941236|FG000|STARTED|Overall Study||47||
48655614|NCT01142388|101941237|FG001|STARTED|Overall Study||47||
48655615|NCT01142388|101941236|FG000|Eligible|Overall Study||43||
48655616|NCT01142388|101941237|FG001|Eligible|Overall Study||44||
48655617|NCT01142388|101941236|FG000|Treated|Overall Study||40||
48655618|NCT01142388|101941237|FG001|Treated|Overall Study||44||
48655619|NCT01142388|101941236|FG000|COMPLETED|Overall Study||0||
48655620|NCT01142388|101941237|FG001|COMPLETED|Overall Study||0||
48655621|NCT01142388|101941236|FG000|NOT COMPLETED|Overall Study||47||
48655622|NCT01142388|101941237|FG001|NOT COMPLETED|Overall Study||47||
48655623|NCT04181762|101941238|FG000|STARTED|Overall Study||137|All randomized subjects were included in the Full Analysis Set and Safety Set.|
48655624|NCT04181762|101941239|FG001|STARTED|Overall Study||138|All randomized subjects were included in the Full Analysis Set and Safety Set.|
48655625|NCT04181762|101941238|FG000|Full Analysis Set 2|Overall Study||91|All analyzable subjects from the randomized set to whom study treatment was assigned and who had or would have had an opportunity to reach 52 weeks of treatment at the study termination (including subjects who discontinued study treatment).|
48655626|NCT04181762|101941239|FG001|Full Analysis Set 2|Overall Study||91|All analyzable subjects from the randomized set to whom study treatment was assigned and who had or would have had an opportunity to reach 52 weeks of treatment at the study termination (including subjects who discontinued study treatment).|
48655627|NCT04181762|101941238|FG000|Pharmacokinetic Set|Overall Study||136|All subjects who had at least one PK/PD assessment and received at least one dose of study drug|
48655628|NCT04181762|101941239|FG001|Pharmacokinetic Set|Overall Study||0|All subjects who had at least one PK/PD assessment and received at least one dose of study drug|
48655629|NCT04181762|101941238|FG000|COMPLETED|Overall Study||23|Completed study|
48655630|NCT04181762|101941239|FG001|COMPLETED|Overall Study||23|Completed study|
48655631|NCT04181762|101941238|FG000|NOT COMPLETED|Overall Study||114||
48655632|NCT04181762|101941239|FG001|NOT COMPLETED|Overall Study||115||
48655633|NCT05001165|101941240|FG000|STARTED|Overall Study||150||
48655634|NCT05001165|101941241|FG001|STARTED|Overall Study||150||
48655635|NCT05001165|101941240|FG000|COMPLETED|Overall Study||150||
48655636|NCT05001165|101941241|FG001|COMPLETED|Overall Study||150||
48655637|NCT05001165|101941240|FG000|NOT COMPLETED|Overall Study||0||
48655638|NCT05001165|101941241|FG001|NOT COMPLETED|Overall Study||0||
48655639|NCT04691492|101941242|FG000|STARTED|Overall Study||56||
48655640|NCT04691492|101941243|FG001|STARTED|Overall Study||52||
48367065|NCT01097616|101227331|FG001|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||38||
48367066|NCT01097616|101227332|FG002|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||44||
48367067|NCT01097616|101227333|FG003|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
48367068|NCT01097616|101227334|FG004|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
48367069|NCT01097616|101227335|FG005|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
48367070|NCT01097616|101227336|FG006|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
48367071|NCT01097616|101227337|FG007|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
48367072|NCT01097616|101227330|FG000|STARTED|Optional DB EXT Phase||100||
48367073|NCT01097616|101227331|FG001|STARTED|Optional DB EXT Phase||172||
48367074|NCT01097616|101227332|FG002|STARTED|Optional DB EXT Phase||151||
48367075|NCT01097616|101227333|FG003|STARTED|Optional DB EXT Phase||0||
48367076|NCT01097616|101227334|FG004|STARTED|Optional DB EXT Phase||0||
48367077|NCT01097616|101227335|FG005|STARTED|Optional DB EXT Phase||0||
48367078|NCT01097616|101227336|FG006|STARTED|Optional DB EXT Phase||0||
48367079|NCT01097616|101227337|FG007|STARTED|Optional DB EXT Phase||0||
48367080|NCT01097616|101227330|FG000|COMPLETED|Optional DB EXT Phase||85||
48367081|NCT01097616|101227331|FG001|COMPLETED|Optional DB EXT Phase||151||
48367082|NCT01097616|101227332|FG002|COMPLETED|Optional DB EXT Phase||141||
48367083|NCT01097616|101227333|FG003|COMPLETED|Optional DB EXT Phase||0||
48367084|NCT01097616|101227334|FG004|COMPLETED|Optional DB EXT Phase||0||
48367085|NCT01097616|101227335|FG005|COMPLETED|Optional DB EXT Phase||0||
48367086|NCT01097616|101227336|FG006|COMPLETED|Optional DB EXT Phase||0||
48367087|NCT01097616|101227337|FG007|COMPLETED|Optional DB EXT Phase||0||
48367088|NCT01097616|101227330|FG000|NOT COMPLETED|Optional DB EXT Phase||15||
48367089|NCT01097616|101227331|FG001|NOT COMPLETED|Optional DB EXT Phase||21||
48367090|NCT01097616|101227332|FG002|NOT COMPLETED|Optional DB EXT Phase||10||
48367091|NCT01097616|101227333|FG003|NOT COMPLETED|Optional DB EXT Phase||0||
48367092|NCT01097616|101227334|FG004|NOT COMPLETED|Optional DB EXT Phase||0||
48367093|NCT01097616|101227335|FG005|NOT COMPLETED|Optional DB EXT Phase||0||
48367094|NCT01097616|101227336|FG006|NOT COMPLETED|Optional DB EXT Phase||0||
48367095|NCT01097616|101227337|FG007|NOT COMPLETED|Optional DB EXT Phase||0||
48367096|NCT01097616|101227330|FG000|STARTED|DB RO Phase||0||
48367097|NCT01097616|101227331|FG001|STARTED|DB RO Phase||0||
48367098|NCT01097616|101227332|FG002|STARTED|DB RO Phase||0||
48367099|NCT01097616|101227333|FG003|STARTED|DB RO Phase||101||
48367100|NCT01097616|101227334|FG004|STARTED|DB RO Phase||112||
48367101|NCT01097616|101227335|FG005|STARTED|DB RO Phase||161||
48367102|NCT01097616|101227336|FG006|STARTED|DB RO Phase||162||
48367103|NCT01097616|101227337|FG007|STARTED|DB RO Phase||327||
48367104|NCT01097616|101227330|FG000|COMPLETED|DB RO Phase||0||
48367105|NCT01097616|101227331|FG001|COMPLETED|DB RO Phase||0||
48367106|NCT01097616|101227332|FG002|COMPLETED|DB RO Phase||0||
48367107|NCT01097616|101227333|FG003|COMPLETED|DB RO Phase||100||
48367108|NCT01097616|101227334|FG004|COMPLETED|DB RO Phase||111||
48367109|NCT01097616|101227335|FG005|COMPLETED|DB RO Phase||159||
48367110|NCT01097616|101227336|FG006|COMPLETED|DB RO Phase||161||
48367111|NCT01097616|101227337|FG007|COMPLETED|DB RO Phase||326||
48367112|NCT01097616|101227330|FG000|NOT COMPLETED|DB RO Phase||0||
48367113|NCT01097616|101227331|FG001|NOT COMPLETED|DB RO Phase||0||
48367114|NCT01097616|101227332|FG002|NOT COMPLETED|DB RO Phase||0||
48367115|NCT01097616|101227333|FG003|NOT COMPLETED|DB RO Phase||1||
48367116|NCT01097616|101227334|FG004|NOT COMPLETED|DB RO Phase||1||
48367117|NCT01097616|101227335|FG005|NOT COMPLETED|DB RO Phase||2||
48367118|NCT01097616|101227336|FG006|NOT COMPLETED|DB RO Phase||1||
48367119|NCT01097616|101227337|FG007|NOT COMPLETED|DB RO Phase||1||
48367120|NCT00089128|101227338|FG000|STARTED|Overall Study||16||
48367121|NCT00089128|101227338|FG000|COMPLETED|Overall Study||16||
48367122|NCT00089128|101227338|FG000|NOT COMPLETED|Overall Study||0||
48367123|NCT02050048|101227339|FG000|STARTED|Overall Study||14||
48367124|NCT02050048|101227340|FG001|STARTED|Overall Study||12||
48367125|NCT02050048|101227339|FG000|COMPLETED|Overall Study||9||
48367126|NCT02050048|101227340|FG001|COMPLETED|Overall Study||10||
48367127|NCT02050048|101227339|FG000|NOT COMPLETED|Overall Study||5||
48367128|NCT02050048|101227340|FG001|NOT COMPLETED|Overall Study||2||
48367129|NCT02232516|101227341|FG000|STARTED|Study Treatment Period: Cycles 1-3||30||
48367130|NCT02232516|101227341|FG000|Cycle 1|Study Treatment Period: Cycles 1-3||29||
48367131|NCT02232516|101227341|FG000|Cycle 2|Study Treatment Period: Cycles 1-3||23||
48367132|NCT02232516|101227341|FG000|Cycle 3|Study Treatment Period: Cycles 1-3||20||
48367133|NCT02232516|101227341|FG000|1st Response Assessment|Study Treatment Period: Cycles 1-3||23||
48367134|NCT02232516|101227341|FG000|COMPLETED|Study Treatment Period: Cycles 1-3||20||
48367135|NCT02232516|101227341|FG000|NOT COMPLETED|Study Treatment Period: Cycles 1-3||10||
48367136|NCT02232516|101227341|FG000|STARTED|Study Treatment Period: Cycles 4-6||20||
48367137|NCT02232516|101227341|FG000|Cycle 4|Study Treatment Period: Cycles 4-6||15||
48367138|NCT02232516|101227341|FG000|Cycle 5|Study Treatment Period: Cycles 4-6||13||
48367139|NCT02232516|101227341|FG000|Cycle 6|Study Treatment Period: Cycles 4-6||13||
48367140|NCT02232516|101227341|FG000|2nd Response Assessment|Study Treatment Period: Cycles 4-6||12||
48367141|NCT02232516|101227341|FG000|COMPLETED|Study Treatment Period: Cycles 4-6||13||
48367142|NCT02232516|101227341|FG000|NOT COMPLETED|Study Treatment Period: Cycles 4-6||7||
48367143|NCT02232516|101227341|FG000|STARTED|Study Treatment Period: Cycles 7-9||13||
48367144|NCT02232516|101227341|FG000|Cycle 7|Study Treatment Period: Cycles 7-9||6||
48367145|NCT02232516|101227341|FG000|Cycle 8|Study Treatment Period: Cycles 7-9||4||
48367146|NCT02232516|101227341|FG000|Cycle 9|Study Treatment Period: Cycles 7-9||3||
48367147|NCT02232516|101227341|FG000|3rd Response Assessment|Study Treatment Period: Cycles 7-9||3||
48367148|NCT02232516|101227341|FG000|COMPLETED|Study Treatment Period: Cycles 7-9||3||
48367149|NCT02232516|101227341|FG000|NOT COMPLETED|Study Treatment Period: Cycles 7-9||10||
48367150|NCT02232516|101227341|FG000|STARTED|Study Treatment Period: Cycles 10-12||3||
48367151|NCT02232516|101227341|FG000|Cycle 10|Study Treatment Period: Cycles 10-12||3||
48367152|NCT02232516|101227341|FG000|Cycle 11|Study Treatment Period: Cycles 10-12||3||
48367153|NCT02232516|101227341|FG000|Cycle 12|Study Treatment Period: Cycles 10-12||1||
48367154|NCT02232516|101227341|FG000|COMPLETED|Study Treatment Period: Cycles 10-12||1||
48367155|NCT02232516|101227341|FG000|NOT COMPLETED|Study Treatment Period: Cycles 10-12||2||
48367156|NCT02232516|101227341|FG000|STARTED|Survival Follow-up||29||
48367157|NCT02232516|101227341|FG000|COMPLETED|Survival Follow-up||5||
48367158|NCT02232516|101227341|FG000|NOT COMPLETED|Survival Follow-up||24||
48367159|NCT01582282|101227342|FG000|STARTED|Overall Study||15||
48367160|NCT01582282|101227343|FG001|STARTED|Overall Study||14||
48367161|NCT01582282|101227344|FG002|STARTED|Overall Study||8||
48367162|NCT01582282|101227342|FG000|COMPLETED|Overall Study||13||
48367163|NCT01582282|101227343|FG001|COMPLETED|Overall Study||12||
48367164|NCT01582282|101227344|FG002|COMPLETED|Overall Study||8||
48367165|NCT01582282|101227342|FG000|NOT COMPLETED|Overall Study||2||
48367166|NCT01582282|101227343|FG001|NOT COMPLETED|Overall Study||2||
48367167|NCT01582282|101227344|FG002|NOT COMPLETED|Overall Study||0||
48367168|NCT04013737|101227345|FG000|STARTED|Overall Study||18||
48367169|NCT04013737|101227346|FG001|STARTED|Overall Study||15||
48367170|NCT04013737|101227345|FG000|COMPLETED|Overall Study||18||
48367171|NCT04013737|101227346|FG001|COMPLETED|Overall Study||15||
48367172|NCT04013737|101227345|FG000|NOT COMPLETED|Overall Study||0||
48367173|NCT04013737|101227346|FG001|NOT COMPLETED|Overall Study||0||
48367174|NCT02092389|101227347|FG000|STARTED|Overall Study||10||
48367175|NCT02092389|101227347|FG000|COMPLETED|Overall Study||4||
48367176|NCT02092389|101227347|FG000|NOT COMPLETED|Overall Study||6||
48367177|NCT02605863|101227348|FG000|STARTED|Overall Study||1||
48367178|NCT02605863|101227349|FG001|STARTED|Overall Study||0||
48367179|NCT02605863|101227348|FG000|COMPLETED|Overall Study||1||
48367180|NCT02605863|101227349|FG001|COMPLETED|Overall Study||0||
48367181|NCT02605863|101227348|FG000|NOT COMPLETED|Overall Study||0||
48436772|NCT01187511|101403613|FG000|NOT COMPLETED|Overall Study||8||
48436773|NCT01187511|101403614|FG001|NOT COMPLETED|Overall Study||1||
48436774|NCT03225313|101403615|FG000|STARTED|Overall Study||25||
48436775|NCT03225313|101403616|FG001|STARTED|Overall Study||25||
48436776|NCT03225313|101403617|FG002|STARTED|Overall Study||25||
48436777|NCT03225313|101403615|FG000|COMPLETED|Overall Study||25||
48436778|NCT03225313|101403616|FG001|COMPLETED|Overall Study||25||
48436779|NCT03225313|101403617|FG002|COMPLETED|Overall Study||25||
48436780|NCT03225313|101403615|FG000|NOT COMPLETED|Overall Study||0||
48436781|NCT03225313|101403616|FG001|NOT COMPLETED|Overall Study||0||
48436782|NCT03225313|101403617|FG002|NOT COMPLETED|Overall Study||0||
48436783|NCT01725217|101403618|FG000|STARTED|Overall Study||66||
48436784|NCT01725217|101403619|FG001|STARTED|Overall Study||66||
48436785|NCT01725217|101403620|FG002|STARTED|Overall Study||66||
48436786|NCT01725217|101403618|FG000|COMPLETED|Overall Study||65||
48436787|NCT01725217|101403619|FG001|COMPLETED|Overall Study||66||
48436788|NCT01725217|101403620|FG002|COMPLETED|Overall Study||66||
48436789|NCT01725217|101403618|FG000|NOT COMPLETED|Overall Study||1||
48436790|NCT01725217|101403619|FG001|NOT COMPLETED|Overall Study||0||
48766458|NCT00091949|102218428|FG001|NOT COMPLETED|Overall Study||151||
48766459|NCT03525678|102218429|FG000|STARTED|Overall Study||97||
48367182|NCT02605863|101227349|FG001|NOT COMPLETED|Overall Study||0||
48436791|NCT01725217|101403620|FG002|NOT COMPLETED|Overall Study||0||
48436792|NCT04800510|101403621|FG000|STARTED|Overall Study||0||
48436793|NCT04800510|101403622|FG001|STARTED|Overall Study||4||
48436794|NCT04800510|101403623|FG002|STARTED|Overall Study||1||
48436795|NCT04800510|101403624|FG003|STARTED|Overall Study||1||
48367183|NCT00486226|101227350|FG000|STARTED|Overall Study||105||
48436796|NCT04800510|101403625|FG004|STARTED|Overall Study||2||
48436797|NCT04800510|101403626|FG005|STARTED|Overall Study||1||
48436798|NCT04800510|101403621|FG000|COMPLETED|Overall Study||0||
48436799|NCT04800510|101403622|FG001|COMPLETED|Overall Study||4||
48436800|NCT04800510|101403623|FG002|COMPLETED|Overall Study||1||
48436801|NCT04800510|101403624|FG003|COMPLETED|Overall Study||1||
48436802|NCT04800510|101403625|FG004|COMPLETED|Overall Study||2||
48436803|NCT04800510|101403626|FG005|COMPLETED|Overall Study||1||
48436804|NCT04800510|101403621|FG000|NOT COMPLETED|Overall Study||0||
48436805|NCT04800510|101403622|FG001|NOT COMPLETED|Overall Study||0||
48436806|NCT04800510|101403623|FG002|NOT COMPLETED|Overall Study||0||
48436807|NCT04800510|101403624|FG003|NOT COMPLETED|Overall Study||0||
48436808|NCT04800510|101403625|FG004|NOT COMPLETED|Overall Study||0||
48436809|NCT04800510|101403626|FG005|NOT COMPLETED|Overall Study||0||
48436810|NCT00539006|101403627|FG000|STARTED|Pre-treatment||96||
48436811|NCT00539006|101403628|FG001|STARTED|Pre-treatment||95||
48436812|NCT00539006|101403629|FG002|STARTED|Pre-treatment||95||
48436813|NCT00539006|101403630|FG003|STARTED|Pre-treatment||91||
48436814|NCT00539006|101403627|FG000|COMPLETED|Pre-treatment||96||
48766460|NCT03525678|102218430|FG001|STARTED|Overall Study||99||
48766461|NCT03525678|102218431|FG002|STARTED|Overall Study||25||
48436815|NCT00539006|101403628|FG001|COMPLETED|Pre-treatment||94||
48436816|NCT00539006|101403629|FG002|COMPLETED|Pre-treatment||95||
48436817|NCT00539006|101403630|FG003|COMPLETED|Pre-treatment||91||
48436818|NCT00539006|101403627|FG000|NOT COMPLETED|Pre-treatment||0||
48436819|NCT00539006|101403628|FG001|NOT COMPLETED|Pre-treatment||1||
48436820|NCT00539006|101403629|FG002|NOT COMPLETED|Pre-treatment||0||
48436821|NCT00539006|101403630|FG003|NOT COMPLETED|Pre-treatment||0||
48436822|NCT00539006|101403627|FG000|STARTED|Treatment Period 1||96||
48436823|NCT00539006|101403628|FG001|STARTED|Treatment Period 1||94||
48766462|NCT03525678|102218429|FG000|Received Study Treatment|Overall Study||95|3 randomized participants never received treatment (2-withdrawal by physician decision and 1-death).|
48367184|NCT00486226|101227350|FG000|COMPLETED|Overall Study||92||
48367185|NCT00486226|101227350|FG000|NOT COMPLETED|Overall Study||13||
48367186|NCT00279500|101227351|FG000|STARTED|Overall Study||6||
48367187|NCT00279500|101227351|FG000|COMPLETED|Overall Study||6||
48367188|NCT00279500|101227351|FG000|NOT COMPLETED|Overall Study||0||
48436824|NCT00539006|101403629|FG002|STARTED|Treatment Period 1||95||
48436825|NCT00539006|101403630|FG003|STARTED|Treatment Period 1||91||
48436826|NCT00539006|101403627|FG000|COMPLETED|Treatment Period 1||96||
48436827|NCT00539006|101403628|FG001|COMPLETED|Treatment Period 1||94||
48367189|NCT01858428|101227352|FG000|STARTED|Overall Study||100||
48436828|NCT00539006|101403629|FG002|COMPLETED|Treatment Period 1||93||
48436829|NCT00539006|101403630|FG003|COMPLETED|Treatment Period 1||90||
48436830|NCT00539006|101403627|FG000|NOT COMPLETED|Treatment Period 1||0||
48367190|NCT01858428|101227353|FG001|STARTED|Overall Study||200||
48367191|NCT01858428|101227352|FG000|COMPLETED|Overall Study||99||
48367192|NCT01858428|101227353|FG001|COMPLETED|Overall Study||190||
48367193|NCT01858428|101227352|FG000|NOT COMPLETED|Overall Study||1||
48367194|NCT01858428|101227353|FG001|NOT COMPLETED|Overall Study||10||
48766463|NCT03525678|102218430|FG001|Received Study Treatment|Overall Study||99|3 randomized participants never received treatment (2-withdrawal by physician decision and 1-death).|
48766464|NCT03525678|102218431|FG002|Received Study Treatment|Overall Study||24|3 randomized participants never received treatment (2-withdrawal by physician decision and 1-death).|
48367195|NCT01997567|101227354|FG000|STARTED|Overall Study||0||
48367196|NCT01997567|101227355|FG001|STARTED|Overall Study||0||
48367197|NCT01997567|101227354|FG000|COMPLETED|Overall Study||0||
48367198|NCT01997567|101227355|FG001|COMPLETED|Overall Study||0||
48367199|NCT01997567|101227354|FG000|NOT COMPLETED|Overall Study||0||
48655641|NCT04691492|101941242|FG000|COMPLETED|Overall Study||50||
48655642|NCT04691492|101941243|FG001|COMPLETED|Overall Study||52||
48655643|NCT04691492|101941242|FG000|NOT COMPLETED|Overall Study||6||
48655644|NCT04691492|101941243|FG001|NOT COMPLETED|Overall Study||0||
48655645|NCT00792948|101941244|FG000|STARTED|Overall Study||97||
48655646|NCT00792948|101941244|FG000|COMPLETED|Overall Study||69||
48655647|NCT00792948|101941244|FG000|NOT COMPLETED|Overall Study||28||
48655648|NCT05061095|101941245|FG000|STARTED|Overall Study||51||
48766465|NCT03525678|102218429|FG000|COMPLETED|Overall Study||0|Discontinued|
48766466|NCT03525678|102218430|FG001|COMPLETED|Overall Study||0|Discontinued|
48766467|NCT03525678|102218431|FG002|COMPLETED|Overall Study||0|Discontinued|
48367200|NCT01997567|101227355|FG001|NOT COMPLETED|Overall Study||0||
48367201|NCT00718861|101227356|FG000|STARTED|Overall Study||95||
48367202|NCT00718861|101227357|FG001|STARTED|Overall Study||95||
48367203|NCT00718861|101227356|FG000|Safety Set|Overall Study||92||
48367204|NCT00718861|101227357|FG001|Safety Set|Overall Study||95||
48367205|NCT00718861|101227356|FG000|Modified Intent to Treat|Overall Study||67||
48367206|NCT00718861|101227357|FG001|Modified Intent to Treat|Overall Study||69||
48367207|NCT00718861|101227356|FG000|COMPLETED|Overall Study||74||
48367208|NCT00718861|101227357|FG001|COMPLETED|Overall Study||77||
48367209|NCT00718861|101227356|FG000|NOT COMPLETED|Overall Study||21||
48367210|NCT00718861|101227357|FG001|NOT COMPLETED|Overall Study||18||
48367211|NCT02005601|101227358|FG000|STARTED|Overall Study||53||
48367212|NCT02005601|101227359|FG001|STARTED|Overall Study||53||
48367213|NCT02005601|101227358|FG000|COMPLETED|Overall Study||53||
48367214|NCT02005601|101227359|FG001|COMPLETED|Overall Study||53||
48367215|NCT02005601|101227358|FG000|NOT COMPLETED|Overall Study||0||
48367216|NCT02005601|101227359|FG001|NOT COMPLETED|Overall Study||0||
48367217|NCT02273323|101227360|FG000|STARTED|Overall Study||15||
48367218|NCT02273323|101227361|FG001|STARTED|Overall Study||15||
48367219|NCT02273323|101227360|FG000|COMPLETED|Overall Study||15||
48367220|NCT02273323|101227361|FG001|COMPLETED|Overall Study||15||
48367221|NCT02273323|101227360|FG000|NOT COMPLETED|Overall Study||0||
48367222|NCT02273323|101227361|FG001|NOT COMPLETED|Overall Study||0||
48367223|NCT00520676|101227362|FG000|STARTED|Overall Study||128||
48367224|NCT00520676|101227363|FG001|STARTED|Overall Study||132||
48367225|NCT00520676|101227362|FG000|Received at Least 1 Dose of Study Drug|Overall Study||118||
48367226|NCT00520676|101227363|FG001|Received at Least 1 Dose of Study Drug|Overall Study||127||
48367227|NCT00520676|101227362|FG000|Qualified Intent-to-treat (Q-ITT)|Overall Study||106||
48367228|NCT00520676|101227363|FG001|Qualified Intent-to-treat (Q-ITT)|Overall Study||105||
48367229|NCT00520676|101227362|FG000|COMPLETED|Overall Study||27||
48367230|NCT00520676|101227363|FG001|COMPLETED|Overall Study||29||
48367231|NCT00520676|101227362|FG000|NOT COMPLETED|Overall Study||101||
48367232|NCT00520676|101227363|FG001|NOT COMPLETED|Overall Study||103||
48367233|NCT02612077|101227364|FG000|STARTED|Overall Study||765||
48367234|NCT02612077|101227364|FG000|Did Not Receive Study Product|Overall Study||5||
48367235|NCT02612077|101227364|FG000|Safety Analysis Set|Overall Study||760||
48367236|NCT02612077|101227364|FG000|Efficacy Analysis Set|Overall Study||737||
48367237|NCT02612077|101227364|FG000|COMPLETED|Overall Study||299||
48367238|NCT02612077|101227364|FG000|NOT COMPLETED|Overall Study||466||
48367239|NCT04510922|101227365|FG000|STARTED|Overall Study||9||
48367240|NCT04510922|101227365|FG000|COMPLETED|Overall Study||9||
48367241|NCT04510922|101227365|FG000|NOT COMPLETED|Overall Study||0||
48367242|NCT03502707|101227366|FG000|STARTED|Overall Study||16||
48655649|NCT05061095|101941245|FG000|Enrolled and Registered|Overall Study||27||
48655650|NCT05061095|101941245|FG000|COMPLETED|Overall Study||19||
48655651|NCT05061095|101941245|FG000|NOT COMPLETED|Overall Study||32||
48655652|NCT00292370|101941246|FG000|STARTED|Phase I - Open-Label Paroxetine (OLP)||124||
48655653|NCT00292370|101941247|FG001|STARTED|Phase I - Open-Label Paroxetine (OLP)||0||
48655654|NCT00292370|101941248|FG002|STARTED|Phase I - Open-Label Paroxetine (OLP)||0||
48655655|NCT00292370|101941246|FG000|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||78||
48655656|NCT00292370|101941247|FG001|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0||
48655657|NCT00292370|101941248|FG002|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0||
48655658|NCT00292370|101941246|FG000|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||46||
48655659|NCT00292370|101941247|FG001|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0||
48367243|NCT03502707|101227367|FG001|STARTED|Overall Study||8||
48367244|NCT03502707|101227368|FG002|STARTED|Overall Study||8||
48367245|NCT03502707|101227369|FG003|STARTED|Overall Study||8||
48367246|NCT03502707|101227370|FG004|STARTED|Overall Study||8||
48367247|NCT03502707|101227371|FG005|STARTED|Overall Study||8||
48367248|NCT03502707|101227372|FG006|STARTED|Overall Study||8||
48367249|NCT03502707|101227373|FG007|STARTED|Overall Study||24||
48367250|NCT03502707|101227374|FG008|STARTED|Overall Study||42||
48367251|NCT03502707|101227375|FG009|STARTED|Overall Study||42||
48367252|NCT03502707|101227376|FG010|STARTED|Overall Study||42||
48655660|NCT00292370|101941248|FG002|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0||
48655661|NCT00292370|101941246|FG000|STARTED|Phase II: OLP + DB Quetiapine or Placebo||0||
48655662|NCT00292370|101941247|FG001|STARTED|Phase II: OLP + DB Quetiapine or Placebo||25||
48655663|NCT00292370|101941248|FG002|STARTED|Phase II: OLP + DB Quetiapine or Placebo||25||
48655664|NCT00292370|101941246|FG000|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0||
48766468|NCT03525678|102218429|FG000|NOT COMPLETED|Overall Study||97||
48766469|NCT03525678|102218430|FG001|NOT COMPLETED|Overall Study||99||
48766470|NCT03525678|102218431|FG002|NOT COMPLETED|Overall Study||25||
48766471|NCT01224145|102218432|FG000|STARTED|Overall Study||10||
48766472|NCT01224145|102218432|FG000|COMPLETED|Overall Study||10||
48766473|NCT01224145|102218432|FG000|NOT COMPLETED|Overall Study||0||
48367253|NCT03502707|101227377|FG011|STARTED|Overall Study||43||
48367254|NCT03502707|101227378|FG012|STARTED|Overall Study||36||
48367255|NCT03502707|101227379|FG013|STARTED|Overall Study||36||
48367256|NCT03502707|101227380|FG014|STARTED|Overall Study||24||
48367257|NCT03502707|101227381|FG015|STARTED|Overall Study||135||
48367258|NCT03502707|101227382|FG016|STARTED|Overall Study||136||
48188341|NCT01023178|100783223|FG002|STARTED|Overall Study||7||
48367259|NCT03502707|101227383|FG017|STARTED|Overall Study||45||
48367260|NCT03502707|101227366|FG000|Randomized and Vaccinated (Full Analysis Set)|Overall Study||16||
48367261|NCT03502707|101227367|FG001|Randomized and Vaccinated (Full Analysis Set)|Overall Study||8||
48367262|NCT03502707|101227368|FG002|Randomized and Vaccinated (Full Analysis Set)|Overall Study||8||
48367263|NCT03502707|101227369|FG003|Randomized and Vaccinated (Full Analysis Set)|Overall Study||8||
48367264|NCT03502707|101227370|FG004|Randomized and Vaccinated (Full Analysis Set)|Overall Study||8||
48367265|NCT03502707|101227371|FG005|Randomized and Vaccinated (Full Analysis Set)|Overall Study||8||
48367266|NCT03502707|101227372|FG006|Randomized and Vaccinated (Full Analysis Set)|Overall Study||8||
48367267|NCT03502707|101227373|FG007|Randomized and Vaccinated (Full Analysis Set)|Overall Study||24||
48367268|NCT03502707|101227374|FG008|Randomized and Vaccinated (Full Analysis Set)|Overall Study||42||
48367269|NCT03502707|101227375|FG009|Randomized and Vaccinated (Full Analysis Set)|Overall Study||42||
48367270|NCT03502707|101227376|FG010|Randomized and Vaccinated (Full Analysis Set)|Overall Study||42||
48367271|NCT03502707|101227377|FG011|Randomized and Vaccinated (Full Analysis Set)|Overall Study||42||
48367272|NCT03502707|101227378|FG012|Randomized and Vaccinated (Full Analysis Set)|Overall Study||36||
48367273|NCT03502707|101227379|FG013|Randomized and Vaccinated (Full Analysis Set)|Overall Study||36||
48367274|NCT03502707|101227380|FG014|Randomized and Vaccinated (Full Analysis Set)|Overall Study||24||
48367275|NCT03502707|101227381|FG015|Randomized and Vaccinated (Full Analysis Set)|Overall Study||135||
48367276|NCT03502707|101227382|FG016|Randomized and Vaccinated (Full Analysis Set)|Overall Study||136||
48367277|NCT03502707|101227383|FG017|Randomized and Vaccinated (Full Analysis Set)|Overall Study||44||
48367278|NCT03502707|101227366|FG000|COMPLETED|Overall Study||14||
48367279|NCT03502707|101227367|FG001|COMPLETED|Overall Study||7||
48367280|NCT03502707|101227368|FG002|COMPLETED|Overall Study||8||
48367281|NCT03502707|101227369|FG003|COMPLETED|Overall Study||7||
48367282|NCT03502707|101227370|FG004|COMPLETED|Overall Study||8||
48367283|NCT03502707|101227371|FG005|COMPLETED|Overall Study||6||
48367284|NCT03502707|101227372|FG006|COMPLETED|Overall Study||8||
48367285|NCT03502707|101227373|FG007|COMPLETED|Overall Study||16||
48367286|NCT03502707|101227374|FG008|COMPLETED|Overall Study||37||
48367287|NCT03502707|101227375|FG009|COMPLETED|Overall Study||34||
48367288|NCT03502707|101227376|FG010|COMPLETED|Overall Study||27||
48367289|NCT03502707|101227377|FG011|COMPLETED|Overall Study||17||
48367290|NCT03502707|101227378|FG012|COMPLETED|Overall Study||29||
48367291|NCT03502707|101227379|FG013|COMPLETED|Overall Study||32||
48367292|NCT03502707|101227380|FG014|COMPLETED|Overall Study||20||
48367293|NCT03502707|101227381|FG015|COMPLETED|Overall Study||76||
48367294|NCT03502707|101227382|FG016|COMPLETED|Overall Study||75||
48367295|NCT03502707|101227383|FG017|COMPLETED|Overall Study||24||
48367296|NCT03502707|101227366|FG000|NOT COMPLETED|Overall Study||2||
48367297|NCT03502707|101227367|FG001|NOT COMPLETED|Overall Study||1||
48367298|NCT03502707|101227368|FG002|NOT COMPLETED|Overall Study||0||
48367299|NCT03502707|101227369|FG003|NOT COMPLETED|Overall Study||1||
48367300|NCT03502707|101227370|FG004|NOT COMPLETED|Overall Study||0||
48367301|NCT03502707|101227371|FG005|NOT COMPLETED|Overall Study||2||
48367302|NCT03502707|101227372|FG006|NOT COMPLETED|Overall Study||0||
48655665|NCT00292370|101941247|FG001|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||21||
48655666|NCT00292370|101941248|FG002|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||18||
48655667|NCT00292370|101941246|FG000|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0||
48655668|NCT00292370|101941247|FG001|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||4||
48657060|NCT03648372|101943758|FG001|COMPLETED|Overall Study||0||
48766474|NCT00174187|102218433|FG000|STARTED|Period 1 (up to 3 Years)||15||
48655669|NCT00292370|101941248|FG002|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||7||
48655670|NCT03033576|101941249|FG000|STARTED|Overall Study||24||
48655671|NCT03033576|101941250|FG001|STARTED|Overall Study||70||
48655672|NCT03033576|101941249|FG000|Eligible|Overall Study||23||
48655673|NCT03033576|101941250|FG001|Eligible|Overall Study||69||
48655674|NCT03033576|101941249|FG000|Received Protocol-directed Therapy|Overall Study||23||
48655675|NCT03033576|101941250|FG001|Received Protocol-directed Therapy|Overall Study||68||
48655676|NCT03033576|101941249|FG000|COMPLETED|Overall Study||8||
48655677|NCT03033576|101941250|FG001|COMPLETED|Overall Study||0||
48655678|NCT03033576|101941249|FG000|NOT COMPLETED|Overall Study||16||
48655679|NCT03033576|101941250|FG001|NOT COMPLETED|Overall Study||70||
48655680|NCT01385995|101941251|FG000|STARTED|Period 1, 2 Months||25||
48655681|NCT01385995|101941252|FG001|STARTED|Period 1, 2 Months||25||
48655682|NCT01385995|101941251|FG000|COMPLETED|Period 1, 2 Months||24||
48655683|NCT01385995|101941252|FG001|COMPLETED|Period 1, 2 Months||25||
48655684|NCT01385995|101941251|FG000|NOT COMPLETED|Period 1, 2 Months||1||
48655685|NCT01385995|101941252|FG001|NOT COMPLETED|Period 1, 2 Months||0||
48655686|NCT01385995|101941251|FG000|STARTED|Washout Period, 1 Month||24||
48655687|NCT01385995|101941252|FG001|STARTED|Washout Period, 1 Month||25||
48655688|NCT01385995|101941251|FG000|COMPLETED|Washout Period, 1 Month||24||
48655689|NCT01385995|101941252|FG001|COMPLETED|Washout Period, 1 Month||25||
48655690|NCT01385995|101941251|FG000|NOT COMPLETED|Washout Period, 1 Month||0||
48655691|NCT01385995|101941252|FG001|NOT COMPLETED|Washout Period, 1 Month||0||
48655692|NCT01385995|101941251|FG000|STARTED|Period 2, 2 Months||24||
48655693|NCT01385995|101941252|FG001|STARTED|Period 2, 2 Months||25||
48655694|NCT01385995|101941251|FG000|COMPLETED|Period 2, 2 Months||24||
48655695|NCT01385995|101941252|FG001|COMPLETED|Period 2, 2 Months||25||
48655696|NCT01385995|101941251|FG000|NOT COMPLETED|Period 2, 2 Months||0||
48655697|NCT01385995|101941252|FG001|NOT COMPLETED|Period 2, 2 Months||0||
48655698|NCT00382928|101941253|FG000|STARTED|Overall Study||97||
48655699|NCT00382928|101941254|FG001|STARTED|Overall Study||95||
48655700|NCT00382928|101941253|FG000|COMPLETED|Overall Study||97||
48655701|NCT00382928|101941254|FG001|COMPLETED|Overall Study||95||
48655702|NCT00382928|101941253|FG000|NOT COMPLETED|Overall Study||0||
48655703|NCT00382928|101941254|FG001|NOT COMPLETED|Overall Study||0||
48655704|NCT01217411|101941255|FG000|STARTED|Overall Study||3||
48655705|NCT01217411|101941256|FG001|STARTED|Overall Study||2||
48655706|NCT01217411|101941255|FG000|5mg|Overall Study||3||
48655707|NCT01217411|101941256|FG001|5mg|Overall Study||2||
48655708|NCT01217411|101941255|FG000|10mg|Overall Study||0||
48655709|NCT01217411|101941256|FG001|10mg|Overall Study||0||
48655710|NCT01217411|101941255|FG000|20mg|Overall Study||0||
48655711|NCT01217411|101941256|FG001|20mg|Overall Study||0||
48655712|NCT01217411|101941255|FG000|COMPLETED|Overall Study||0||
48655713|NCT01217411|101941256|FG001|COMPLETED|Overall Study||0||
48655714|NCT01217411|101941255|FG000|NOT COMPLETED|Overall Study||3||
48655715|NCT01217411|101941256|FG001|NOT COMPLETED|Overall Study||2||
48655716|NCT03285893|101941257|FG000|STARTED|Overall Study||101||
48655717|NCT03285893|101941258|FG001|STARTED|Overall Study||101||
48655718|NCT03285893|101941259|FG002|STARTED|Overall Study||79||
48655719|NCT03285893|101941257|FG000|COMPLETED|Overall Study||101||
48655720|NCT03285893|101941258|FG001|COMPLETED|Overall Study||101||
48655721|NCT03285893|101941259|FG002|COMPLETED|Overall Study||79||
48655722|NCT03285893|101941257|FG000|NOT COMPLETED|Overall Study||0||
48655723|NCT03285893|101941258|FG001|NOT COMPLETED|Overall Study||0||
48655724|NCT03285893|101941259|FG002|NOT COMPLETED|Overall Study||0||
48655725|NCT02021318|101941260|FG000|STARTED|Overall Study||323||
48655726|NCT02021318|101941261|FG001|STARTED|Overall Study||293||
48655727|NCT02021318|101941260|FG000|COMPLETED|Overall Study||250||
48655728|NCT02021318|101941261|FG001|COMPLETED|Overall Study||230||
48655729|NCT02021318|101941260|FG000|NOT COMPLETED|Overall Study||73||
48655730|NCT02021318|101941261|FG001|NOT COMPLETED|Overall Study||63||
48655731|NCT02761057|101941262|FG000|STARTED|Overall Study||48||
48655732|NCT02761057|101941263|FG001|STARTED|Overall Study||46||
48655733|NCT02761057|101941264|FG002|STARTED|Overall Study||28||
48655734|NCT02761057|101941265|FG003|STARTED|Overall Study||30||
48655735|NCT02761057|101941262|FG000|Eligible|Overall Study||46||
48655736|NCT02761057|101941263|FG001|Eligible|Overall Study||44||
48655737|NCT02761057|101941264|FG002|Eligible|Overall Study||28||
48655738|NCT02761057|101941265|FG003|Eligible|Overall Study||29||
48655739|NCT02761057|101941262|FG000|Received Protocol Treatment|Overall Study||45||
48655740|NCT02761057|101941263|FG001|Received Protocol Treatment|Overall Study||43||
48655741|NCT02761057|101941264|FG002|Received Protocol Treatment|Overall Study||27||
48655742|NCT02761057|101941265|FG003|Received Protocol Treatment|Overall Study||28||
48655743|NCT02761057|101941262|FG000|COMPLETED|Overall Study||0||
48655744|NCT02761057|101941263|FG001|COMPLETED|Overall Study||0||
48655745|NCT02761057|101941264|FG002|COMPLETED|Overall Study||0||
48655746|NCT02761057|101941265|FG003|COMPLETED|Overall Study||0||
48655747|NCT02761057|101941262|FG000|NOT COMPLETED|Overall Study||48||
48655748|NCT02761057|101941263|FG001|NOT COMPLETED|Overall Study||46||
48655749|NCT02761057|101941264|FG002|NOT COMPLETED|Overall Study||28||
48655750|NCT02761057|101941265|FG003|NOT COMPLETED|Overall Study||30||
48655751|NCT00986102|101941266|FG000|STARTED|Overall Study||53||
48655752|NCT00986102|101941267|FG001|STARTED|Overall Study||77||
48766475|NCT00174187|102218434|FG001|STARTED|Period 1 (up to 3 Years)||15||
48766476|NCT00174187|102218435|FG002|STARTED|Period 1 (up to 3 Years)||0||
48766477|NCT00174187|102218433|FG000|COMPLETED|Period 1 (up to 3 Years)||15||
48766478|NCT00174187|102218434|FG001|COMPLETED|Period 1 (up to 3 Years)||11||
48766479|NCT00174187|102218435|FG002|COMPLETED|Period 1 (up to 3 Years)||0||
48766480|NCT00174187|102218433|FG000|NOT COMPLETED|Period 1 (up to 3 Years)||0||
48766481|NCT00174187|102218434|FG001|NOT COMPLETED|Period 1 (up to 3 Years)||4||
48766482|NCT00174187|102218435|FG002|NOT COMPLETED|Period 1 (up to 3 Years)||0||
48766483|NCT00174187|102218433|FG000|STARTED|Between Period 1 and Period 2||0||
48766484|NCT00174187|102218434|FG001|STARTED|Between Period 1 and Period 2||0||
48766485|NCT00174187|102218435|FG002|STARTED|Between Period 1 and Period 2||26||
48766486|NCT00174187|102218433|FG000|Consented|Between Period 1 and Period 2||0||
48766487|NCT00174187|102218434|FG001|Consented|Between Period 1 and Period 2||0||
48766488|NCT00174187|102218435|FG002|Consented|Between Period 1 and Period 2||24||
48766489|NCT00174187|102218433|FG000|COMPLETED|Between Period 1 and Period 2||0||
48766490|NCT00174187|102218434|FG001|COMPLETED|Between Period 1 and Period 2||0||
48367303|NCT03502707|101227373|FG007|NOT COMPLETED|Overall Study||8||
48367304|NCT03502707|101227374|FG008|NOT COMPLETED|Overall Study||5||
48367305|NCT03502707|101227375|FG009|NOT COMPLETED|Overall Study||8||
48367306|NCT03502707|101227376|FG010|NOT COMPLETED|Overall Study||15||
48367307|NCT03502707|101227377|FG011|NOT COMPLETED|Overall Study||26||
48436831|NCT00539006|101403628|FG001|NOT COMPLETED|Treatment Period 1||0||
48436832|NCT00539006|101403629|FG002|NOT COMPLETED|Treatment Period 1||2||
48436833|NCT00539006|101403630|FG003|NOT COMPLETED|Treatment Period 1||1||
48436834|NCT00539006|101403627|FG000|STARTED|Washout||96||
48436835|NCT00539006|101403628|FG001|STARTED|Washout||94||
48436836|NCT00539006|101403629|FG002|STARTED|Washout||93||
48436837|NCT00539006|101403630|FG003|STARTED|Washout||90||
48436838|NCT00539006|101403627|FG000|COMPLETED|Washout||76||
48436839|NCT00539006|101403628|FG001|COMPLETED|Washout||84||
48436840|NCT00539006|101403629|FG002|COMPLETED|Washout||77||
48436841|NCT00539006|101403630|FG003|COMPLETED|Washout||81||
48436842|NCT00539006|101403627|FG000|NOT COMPLETED|Washout||20||
48436843|NCT00539006|101403628|FG001|NOT COMPLETED|Washout||10||
48436844|NCT00539006|101403629|FG002|NOT COMPLETED|Washout||16||
48436845|NCT00539006|101403630|FG003|NOT COMPLETED|Washout||9||
48436846|NCT00539006|101403627|FG000|STARTED|Treatment Period 2||76||
48436847|NCT00539006|101403628|FG001|STARTED|Treatment Period 2||84||
48436848|NCT00539006|101403629|FG002|STARTED|Treatment Period 2||77||
48436849|NCT00539006|101403630|FG003|STARTED|Treatment Period 2||81||
48436850|NCT00539006|101403627|FG000|COMPLETED|Treatment Period 2||75||
48436851|NCT00539006|101403628|FG001|COMPLETED|Treatment Period 2||83||
48436852|NCT00539006|101403629|FG002|COMPLETED|Treatment Period 2||77||
48436853|NCT00539006|101403630|FG003|COMPLETED|Treatment Period 2||81||
48436854|NCT00539006|101403627|FG000|NOT COMPLETED|Treatment Period 2||1||
48436855|NCT00539006|101403628|FG001|NOT COMPLETED|Treatment Period 2||1||
48436856|NCT00539006|101403629|FG002|NOT COMPLETED|Treatment Period 2||0||
48436857|NCT00539006|101403630|FG003|NOT COMPLETED|Treatment Period 2||0||
48436858|NCT00539006|101403627|FG000|STARTED|Post-Study||75||
48436859|NCT00539006|101403628|FG001|STARTED|Post-Study||83||
48436860|NCT00539006|101403629|FG002|STARTED|Post-Study||77||
48436861|NCT00539006|101403630|FG003|STARTED|Post-Study||81||
48436862|NCT00539006|101403627|FG000|COMPLETED|Post-Study||75||
48436863|NCT00539006|101403628|FG001|COMPLETED|Post-Study||83||
48436864|NCT00539006|101403629|FG002|COMPLETED|Post-Study||77||
48766491|NCT00174187|102218435|FG002|COMPLETED|Between Period 1 and Period 2||21||
48766492|NCT00174187|102218433|FG000|NOT COMPLETED|Between Period 1 and Period 2||0||
48766493|NCT00174187|102218434|FG001|NOT COMPLETED|Between Period 1 and Period 2||0||
48766494|NCT00174187|102218435|FG002|NOT COMPLETED|Between Period 1 and Period 2||5||
48766495|NCT00174187|102218433|FG000|STARTED|Period 2 (After 3 Years)||0||
48766496|NCT00174187|102218434|FG001|STARTED|Period 2 (After 3 Years)||0||
48766497|NCT00174187|102218435|FG002|STARTED|Period 2 (After 3 Years)||21||
48766498|NCT00174187|102218433|FG000|COMPLETED|Period 2 (After 3 Years)||0||
48766499|NCT00174187|102218434|FG001|COMPLETED|Period 2 (After 3 Years)||0||
48766500|NCT00174187|102218435|FG002|COMPLETED|Period 2 (After 3 Years)||13||
48367308|NCT03502707|101227378|FG012|NOT COMPLETED|Overall Study||7||
48367309|NCT03502707|101227379|FG013|NOT COMPLETED|Overall Study||4||
48367310|NCT03502707|101227380|FG014|NOT COMPLETED|Overall Study||4||
48367311|NCT03502707|101227381|FG015|NOT COMPLETED|Overall Study||59||
48367312|NCT03502707|101227382|FG016|NOT COMPLETED|Overall Study||61||
48367313|NCT03502707|101227383|FG017|NOT COMPLETED|Overall Study||21||
48367314|NCT03666143|101227384|FG000|STARTED|Overall Study||216||
48188342|NCT01023178|100783221|FG000|COMPLETED|Overall Study||3||
48367315|NCT03666143|101227384|FG000|COMPLETED|Overall Study||0||
48367316|NCT03666143|101227384|FG000|NOT COMPLETED|Overall Study||216||
48367317|NCT04220866|101227385|FG000|STARTED|Overall Study||8|Randomized|
48367318|NCT04220866|101227386|FG001|STARTED|Overall Study||10|Randomized|
48436865|NCT00539006|101403630|FG003|COMPLETED|Post-Study||81||
48436866|NCT00539006|101403627|FG000|NOT COMPLETED|Post-Study||0||
48436867|NCT00539006|101403628|FG001|NOT COMPLETED|Post-Study||0||
48436868|NCT00539006|101403629|FG002|NOT COMPLETED|Post-Study||0||
48436869|NCT00539006|101403630|FG003|NOT COMPLETED|Post-Study||0||
48367319|NCT04220866|101227385|FG000|COMPLETED|Overall Study||0||
48367320|NCT04220866|101227386|FG001|COMPLETED|Overall Study||0||
48367321|NCT04220866|101227385|FG000|NOT COMPLETED|Overall Study||8||
48367322|NCT04220866|101227386|FG001|NOT COMPLETED|Overall Study||10||
48367323|NCT01733069|101227387|FG000|STARTED|Overall Study||264||
48367324|NCT01733069|101227388|FG001|STARTED|Overall Study||1598||
48367325|NCT01733069|101227387|FG000|COMPLETED|Overall Study||264||
48367326|NCT01733069|101227388|FG001|COMPLETED|Overall Study||1598||
48367327|NCT01733069|101227387|FG000|NOT COMPLETED|Overall Study||0||
48367328|NCT01733069|101227388|FG001|NOT COMPLETED|Overall Study||0||
48367329|NCT02702193|101227389|FG000|STARTED|Baseline Assessment/Randomization||86||
48367330|NCT02702193|101227390|FG001|STARTED|Baseline Assessment/Randomization||87||
48367331|NCT02702193|101227389|FG000|COMPLETED|Baseline Assessment/Randomization||85||
48367332|NCT02702193|101227390|FG001|COMPLETED|Baseline Assessment/Randomization||87||
48367333|NCT02702193|101227389|FG000|NOT COMPLETED|Baseline Assessment/Randomization||1||
48655753|NCT00986102|101941268|FG002|STARTED|Overall Study||19||
48655754|NCT00986102|101941269|FG003|STARTED|Overall Study||67||
48655755|NCT00986102|101941266|FG000|COMPLETED|Overall Study||52||
48655756|NCT00986102|101941267|FG001|COMPLETED|Overall Study||75||
48655757|NCT00986102|101941268|FG002|COMPLETED|Overall Study||19||
48655758|NCT00986102|101941269|FG003|COMPLETED|Overall Study||66||
48655759|NCT00986102|101941266|FG000|NOT COMPLETED|Overall Study||1||
48655760|NCT00986102|101941267|FG001|NOT COMPLETED|Overall Study||2||
48655761|NCT00986102|101941268|FG002|NOT COMPLETED|Overall Study||0||
48655762|NCT00986102|101941269|FG003|NOT COMPLETED|Overall Study||1||
48367334|NCT02702193|101227390|FG001|NOT COMPLETED|Baseline Assessment/Randomization||0||
48367335|NCT02702193|101227389|FG000|STARTED|4 Month Follow up||86||
48367336|NCT02702193|101227390|FG001|STARTED|4 Month Follow up||87||
48367337|NCT02702193|101227389|FG000|COMPLETED|4 Month Follow up||68||
48367338|NCT02702193|101227390|FG001|COMPLETED|4 Month Follow up||69||
48367339|NCT02702193|101227389|FG000|NOT COMPLETED|4 Month Follow up||18||
48367340|NCT02702193|101227390|FG001|NOT COMPLETED|4 Month Follow up||18||
48367341|NCT02702193|101227389|FG000|STARTED|8 Month Follow up||86||
48367342|NCT02702193|101227390|FG001|STARTED|8 Month Follow up||87||
48367343|NCT02702193|101227389|FG000|COMPLETED|8 Month Follow up||71||
48367344|NCT02702193|101227390|FG001|COMPLETED|8 Month Follow up||69||
48367345|NCT02702193|101227389|FG000|NOT COMPLETED|8 Month Follow up||15||
48367346|NCT02702193|101227390|FG001|NOT COMPLETED|8 Month Follow up||18||
48367347|NCT02702193|101227389|FG000|STARTED|12 Month Follow up||86||
48367348|NCT02702193|101227390|FG001|STARTED|12 Month Follow up||87||
48367349|NCT02702193|101227389|FG000|COMPLETED|12 Month Follow up||69||
48367350|NCT02702193|101227390|FG001|COMPLETED|12 Month Follow up||69||
48367351|NCT02702193|101227389|FG000|NOT COMPLETED|12 Month Follow up||17||
48367352|NCT02702193|101227390|FG001|NOT COMPLETED|12 Month Follow up||18||
48367353|NCT02090114|101227391|FG000|STARTED|Overall Study||30||
48436870|NCT02684370|101403631|FG000|STARTED|Part A||102|Intent-to-treat (ITT) population: All participants who were randomized at Week 0|
48436871|NCT02684370|101403632|FG001|STARTED|Part A||100|Intent-to-treat (ITT) population: All participants who were randomized at Week 0|
48655763|NCT05177328|101941270|FG000|STARTED|Overall Study||17||34
48655764|NCT05177328|101941270|FG000|Received ShA9 on Dominant Ventral Arm/Placebo on Non-Dominant Ventral Arm|Overall Study||9||18
48655765|NCT05177328|101941270|FG000|Received ShA9 on Non-Dominant Ventral Arm/Placebo on Dominant Ventral Arm|Overall Study||8||16
48655766|NCT05177328|101941270|FG000|COMPLETED|Overall Study||17||34
48655767|NCT05177328|101941270|FG000|NOT COMPLETED|Overall Study||0||0
48655768|NCT03596983|101941271|FG000|STARTED|Overall Study||44||
48655769|NCT03596983|101941271|FG000|COMPLETED|Overall Study||41||
48655770|NCT03596983|101941271|FG000|NOT COMPLETED|Overall Study||3||
48367354|NCT02090114|101227392|FG001|STARTED|Overall Study||29||
48367355|NCT02090114|101227393|FG002|STARTED|Overall Study||29||
48367356|NCT02090114|101227394|FG003|STARTED|Overall Study||8||
48367357|NCT02090114|101227391|FG000|COMPLETED|Overall Study||0||
48436872|NCT02684370|101403633|FG002|STARTED|Part A||304|Intent-to-treat (ITT) population: All participants who were randomized at Week 0|
48655771|NCT02953457|101941272|FG000|STARTED|Overall Study||10||
48655772|NCT02953457|101941273|FG001|STARTED|Overall Study||20||
48188343|NCT01023178|100783222|FG001|COMPLETED|Overall Study||6||
48367358|NCT02090114|101227392|FG001|COMPLETED|Overall Study||0||
48367359|NCT02090114|101227393|FG002|COMPLETED|Overall Study||0||
48367360|NCT02090114|101227394|FG003|COMPLETED|Overall Study||0||
48367361|NCT02090114|101227391|FG000|NOT COMPLETED|Overall Study||30||
48367362|NCT02090114|101227392|FG001|NOT COMPLETED|Overall Study||29||
48367363|NCT02090114|101227393|FG002|NOT COMPLETED|Overall Study||29||
48367364|NCT02090114|101227394|FG003|NOT COMPLETED|Overall Study||8||
48367365|NCT00325442|101227395|FG000|STARTED|Overall Study||176||
48367366|NCT00325442|101227396|FG001|STARTED|Overall Study||174||
48367367|NCT00325442|101227395|FG000|COMPLETED|Overall Study||167||
48367368|NCT00325442|101227396|FG001|COMPLETED|Overall Study||153||
48367369|NCT00325442|101227395|FG000|NOT COMPLETED|Overall Study||9||
48367370|NCT00325442|101227396|FG001|NOT COMPLETED|Overall Study||21||
48367371|NCT00769704|101227397|FG000|STARTED|Overall Study||141||
48367372|NCT00769704|101227398|FG001|STARTED|Overall Study||296||
48367373|NCT00769704|101227397|FG000|Intent-to-treat Population|Overall Study||141||
48367374|NCT00769704|101227398|FG001|Intent-to-treat Population|Overall Study||295||
48367375|NCT00769704|101227397|FG000|Received Treatment|Overall Study||127||
48367376|NCT00769704|101227398|FG001|Received Treatment|Overall Study||292||
48367377|NCT00769704|101227397|FG000|COMPLETED|Overall Study||30||
48367378|NCT00769704|101227398|FG001|COMPLETED|Overall Study||97||
48367379|NCT00769704|101227397|FG000|NOT COMPLETED|Overall Study||111||
48367380|NCT00769704|101227398|FG001|NOT COMPLETED|Overall Study||199||
48367381|NCT01257217|101227399|FG000|STARTED|Overall Study||15||
48367382|NCT01257217|101227400|FG001|STARTED|Overall Study||10||
48367383|NCT01257217|101227399|FG000|COMPLETED|Overall Study||13||
48367384|NCT01257217|101227400|FG001|COMPLETED|Overall Study||10||
48367385|NCT01257217|101227399|FG000|NOT COMPLETED|Overall Study||2||
48367386|NCT01257217|101227400|FG001|NOT COMPLETED|Overall Study||0||
48367387|NCT03648996|101227401|FG000|STARTED|Overall Study||9||
48436873|NCT02684370|101403634|FG003|STARTED|Part A||0|Intent-to-treat (ITT) population: All participants who were randomized at Week 0|
48436874|NCT02684370|101403635|FG004|STARTED|Part A||0|Intent-to-treat (ITT) population: All participants who were randomized at Week 0|
48436875|NCT02684370|101403636|FG005|STARTED|Part A||0|Intent-to-treat (ITT) population: All participants who were randomized at Week 0|
48436876|NCT02684370|101403631|FG000|COMPLETED|Part A||98||
48436877|NCT02684370|101403632|FG001|COMPLETED|Part A||99||
48436878|NCT02684370|101403633|FG002|COMPLETED|Part A||299||
48367388|NCT03648996|101227402|FG001|STARTED|Overall Study||7||
48367389|NCT03648996|101227403|FG002|STARTED|Overall Study||18||
48367390|NCT03648996|101227401|FG000|COMPLETED|Overall Study||7||
48367391|NCT03648996|101227402|FG001|COMPLETED|Overall Study||5||
48367392|NCT03648996|101227403|FG002|COMPLETED|Overall Study||16||
48367393|NCT03648996|101227401|FG000|NOT COMPLETED|Overall Study||2||
48367394|NCT03648996|101227402|FG001|NOT COMPLETED|Overall Study||2||
48367395|NCT03648996|101227403|FG002|NOT COMPLETED|Overall Study||2||
48367396|NCT00893113|101227404|FG000|STARTED|Overall Study||36||
48367397|NCT00893113|101227405|FG001|STARTED|Overall Study||38||
48367398|NCT00893113|101227404|FG000|COMPLETED|Overall Study||23||
48367399|NCT00893113|101227405|FG001|COMPLETED|Overall Study||22||
48367400|NCT00893113|101227404|FG000|NOT COMPLETED|Overall Study||13||
48367401|NCT00893113|101227405|FG001|NOT COMPLETED|Overall Study||16||
48367402|NCT03070730|101227406|FG000|STARTED|Overall Study||0||
48367403|NCT03070730|101227407|FG001|STARTED|Overall Study||0||
48367404|NCT03070730|101227408|FG002|STARTED|Overall Study||0||
48436879|NCT02684370|101403634|FG003|COMPLETED|Part A||0||
48436880|NCT02684370|101403635|FG004|COMPLETED|Part A||0||
48436881|NCT02684370|101403636|FG005|COMPLETED|Part A||0||
48436882|NCT02684370|101403631|FG000|NOT COMPLETED|Part A||4||
48436883|NCT02684370|101403632|FG001|NOT COMPLETED|Part A||1||
48436884|NCT02684370|101403633|FG002|NOT COMPLETED|Part A||5||
48436885|NCT02684370|101403634|FG003|NOT COMPLETED|Part A||0||
48436886|NCT02684370|101403635|FG004|NOT COMPLETED|Part A||0||
48436887|NCT02684370|101403636|FG005|NOT COMPLETED|Part A||0||
48436888|NCT02684370|101403631|FG000|STARTED|Part B||0||
48436889|NCT02684370|101403632|FG001|STARTED|Part B||0||
48436890|NCT02684370|101403633|FG002|STARTED|Part B||0||
48655773|NCT02953457|101941274|FG002|STARTED|Overall Study||10||
48655774|NCT02953457|101941272|FG000|COMPLETED|Overall Study||10||
48655775|NCT02953457|101941273|FG001|COMPLETED|Overall Study||20||
48655776|NCT02953457|101941274|FG002|COMPLETED|Overall Study||10||
48367405|NCT03070730|101227406|FG000|COMPLETED|Overall Study||0||
48655777|NCT02953457|101941272|FG000|NOT COMPLETED|Overall Study||0||
48655778|NCT02953457|101941273|FG001|NOT COMPLETED|Overall Study||0||
48655779|NCT02953457|101941274|FG002|NOT COMPLETED|Overall Study||0||
48655780|NCT02268851|101941275|FG000|STARTED|Overall Study||3||
48655781|NCT02268851|101941276|FG001|STARTED|Overall Study||3||
48655782|NCT02268851|101941277|FG002|STARTED|Overall Study||4||
48655783|NCT02268851|101941278|FG003|STARTED|Overall Study||3||
48655784|NCT02268851|101941279|FG004|STARTED|Overall Study||15||
48367406|NCT03070730|101227407|FG001|COMPLETED|Overall Study||0||
48367407|NCT03070730|101227408|FG002|COMPLETED|Overall Study||0||
48436891|NCT02684370|101403634|FG003|STARTED|Part B||97||
48436892|NCT02684370|101403635|FG004|STARTED|Part B||99||
48436893|NCT02684370|101403636|FG005|STARTED|Part B||297||
48436894|NCT02684370|101403631|FG000|COMPLETED|Part B||0||
48367408|NCT03070730|101227406|FG000|NOT COMPLETED|Overall Study||0||
48367409|NCT03070730|101227407|FG001|NOT COMPLETED|Overall Study||0||
48436895|NCT02684370|101403632|FG001|COMPLETED|Part B||0||
48436896|NCT02684370|101403633|FG002|COMPLETED|Part B||0||
48655785|NCT02268851|101941280|FG005|STARTED|Overall Study||15||
48367410|NCT03070730|101227408|FG002|NOT COMPLETED|Overall Study||0||
48367411|NCT01519427|101227409|FG000|STARTED|Overall Study||2||
48436897|NCT02684370|101403634|FG003|COMPLETED|Part B||95||
48367412|NCT01519427|101227409|FG000|COMPLETED|Overall Study||0||
48367413|NCT01519427|101227409|FG000|NOT COMPLETED|Overall Study||2||
48367414|NCT02615717|101227410|FG000|STARTED|Overall Study||3||
48655786|NCT02268851|101941275|FG000|COMPLETED|Overall Study||2||
48655787|NCT02268851|101941276|FG001|COMPLETED|Overall Study||0||
48436898|NCT02684370|101403635|FG004|COMPLETED|Part B||94||
48436899|NCT02684370|101403636|FG005|COMPLETED|Part B||289||
48436900|NCT02684370|101403631|FG000|NOT COMPLETED|Part B||0||
48436901|NCT02684370|101403632|FG001|NOT COMPLETED|Part B||0||
48436902|NCT02684370|101403633|FG002|NOT COMPLETED|Part B||0||
48436903|NCT02684370|101403634|FG003|NOT COMPLETED|Part B||2||
48436904|NCT02684370|101403635|FG004|NOT COMPLETED|Part B||5||
48436905|NCT02684370|101403636|FG005|NOT COMPLETED|Part B||8||
48436906|NCT04150107|101403637|FG000|STARTED|Period 1- Placebo run-in (All Patients)||14||
48436907|NCT04150107|101403638|FG001|STARTED|Period 1- Placebo run-in (All Patients)||16||
48436908|NCT04150107|101403637|FG000|COMPLETED|Period 1- Placebo run-in (All Patients)||14||
48436909|NCT04150107|101403638|FG001|COMPLETED|Period 1- Placebo run-in (All Patients)||16||
48436910|NCT04150107|101403637|FG000|NOT COMPLETED|Period 1- Placebo run-in (All Patients)||0||
48436911|NCT04150107|101403638|FG001|NOT COMPLETED|Period 1- Placebo run-in (All Patients)||0||
48436912|NCT04150107|101403637|FG000|STARTED|Period 2- Either Treatment A or B||14||
48436913|NCT04150107|101403638|FG001|STARTED|Period 2- Either Treatment A or B||16||
48436914|NCT04150107|101403637|FG000|COMPLETED|Period 2- Either Treatment A or B||14||
48436915|NCT04150107|101403638|FG001|COMPLETED|Period 2- Either Treatment A or B||16||
48436916|NCT04150107|101403637|FG000|NOT COMPLETED|Period 2- Either Treatment A or B||0||
48436917|NCT04150107|101403638|FG001|NOT COMPLETED|Period 2- Either Treatment A or B||0||
48436918|NCT04150107|101403637|FG000|STARTED|Period 3 Crossover-Treatment B or A||14||
48436919|NCT04150107|101403638|FG001|STARTED|Period 3 Crossover-Treatment B or A||16||
48436920|NCT04150107|101403637|FG000|COMPLETED|Period 3 Crossover-Treatment B or A||12||
48436921|NCT04150107|101403638|FG001|COMPLETED|Period 3 Crossover-Treatment B or A||15||
48436922|NCT04150107|101403637|FG000|NOT COMPLETED|Period 3 Crossover-Treatment B or A||2||
48436923|NCT04150107|101403638|FG001|NOT COMPLETED|Period 3 Crossover-Treatment B or A||1||
48436924|NCT03891602|101403639|FG000|STARTED|Overall Study||125||
48436925|NCT03891602|101403640|FG001|STARTED|Overall Study||529||
48436926|NCT03891602|101403639|FG000|COMPLETED|Overall Study||125||
48436927|NCT03891602|101403640|FG001|COMPLETED|Overall Study||529||
48436928|NCT03891602|101403639|FG000|NOT COMPLETED|Overall Study||0||
48436929|NCT03891602|101403640|FG001|NOT COMPLETED|Overall Study||0||
48436930|NCT03078504|101403641|FG000|STARTED|Overall Study||6||
48436931|NCT03078504|101403641|FG000|COMPLETED|Overall Study||6||
48436932|NCT03078504|101403641|FG000|NOT COMPLETED|Overall Study||0||
48436933|NCT01160770|101403642|FG000|STARTED|Overall Study||267||
48436934|NCT01160770|101403642|FG000|COMPLETED|Overall Study||188||
48436935|NCT01160770|101403642|FG000|NOT COMPLETED|Overall Study||79||
48436936|NCT04621227|101403643|FG000|STARTED|Period 1 (5 Days)||16||
48436937|NCT04621227|101403643|FG000|COMPLETED|Period 1 (5 Days)||16||
48436938|NCT04621227|101403643|FG000|NOT COMPLETED|Period 1 (5 Days)||0||
48436939|NCT04621227|101403643|FG000|STARTED|Period 2 (2 Days)||16||
48436940|NCT04621227|101403643|FG000|COMPLETED|Period 2 (2 Days)||16||
48436941|NCT04621227|101403643|FG000|NOT COMPLETED|Period 2 (2 Days)||0||
48436942|NCT04621227|101403643|FG000|STARTED|Period 3 (29 Days)||16||
48436943|NCT04621227|101403643|FG000|COMPLETED|Period 3 (29 Days)||14||
48436944|NCT04621227|101403643|FG000|NOT COMPLETED|Period 3 (29 Days)||2||
48436945|NCT04621227|101403643|FG000|STARTED|Period 4 (4 Days)||14||
48436946|NCT04621227|101403643|FG000|COMPLETED|Period 4 (4 Days)||14||
48436947|NCT04621227|101403643|FG000|NOT COMPLETED|Period 4 (4 Days)||0||
48436948|NCT04621227|101403643|FG000|STARTED|Period 5 (1 Day)||14||
48436949|NCT04621227|101403643|FG000|COMPLETED|Period 5 (1 Day)||14||
48436950|NCT04621227|101403643|FG000|NOT COMPLETED|Period 5 (1 Day)||0||
48436951|NCT04621227|101403643|FG000|STARTED|Period 6 (16 Days)||14||
48436952|NCT04621227|101403643|FG000|COMPLETED|Period 6 (16 Days)||14||
48436953|NCT04621227|101403643|FG000|NOT COMPLETED|Period 6 (16 Days)||0||
48436954|NCT04621227|101403643|FG000|STARTED|Period 7 (4 Days)||14||
48436955|NCT04621227|101403643|FG000|COMPLETED|Period 7 (4 Days)||14||
48436956|NCT04621227|101403643|FG000|NOT COMPLETED|Period 7 (4 Days)||0||
48436957|NCT04621227|101403643|FG000|STARTED|Period 8 (2 Days)||14||
48436958|NCT04621227|101403643|FG000|COMPLETED|Period 8 (2 Days)||13||
48436959|NCT04621227|101403643|FG000|NOT COMPLETED|Period 8 (2 Days)||1||
48436960|NCT00380861|101403644|FG000|STARTED|Overall Study||93||93
48436961|NCT00380861|101403645|FG001|STARTED|Overall Study||91||91
48436962|NCT00380861|101403644|FG000|COMPLETED|Overall Study||75||75
48436963|NCT00380861|101403645|FG001|COMPLETED|Overall Study||74||74
48436964|NCT00380861|101403644|FG000|NOT COMPLETED|Overall Study||18||18
48436965|NCT00380861|101403645|FG001|NOT COMPLETED|Overall Study||17||17
48436966|NCT01366846|101403646|FG000|STARTED|Overall Study||235||
48436967|NCT01366846|101403647|FG001|STARTED|Overall Study||228||
48436968|NCT01366846|101403648|FG002|STARTED|Overall Study||47||
48436969|NCT01366846|101403649|FG003|STARTED|Overall Study||46||
48436970|NCT01366846|101403646|FG000|COMPLETED|Overall Study||232||
48436971|NCT01366846|101403647|FG001|COMPLETED|Overall Study||224||
48436972|NCT01366846|101403648|FG002|COMPLETED|Overall Study||46||
48655788|NCT02268851|101941277|FG002|COMPLETED|Overall Study||3||
48436973|NCT01366846|101403649|FG003|COMPLETED|Overall Study||45||
48436974|NCT01366846|101403646|FG000|NOT COMPLETED|Overall Study||3||
48436975|NCT01366846|101403647|FG001|NOT COMPLETED|Overall Study||4||
48436976|NCT01366846|101403648|FG002|NOT COMPLETED|Overall Study||1||
48436977|NCT01366846|101403649|FG003|NOT COMPLETED|Overall Study||1||
48436978|NCT04633434|101403650|FG000|STARTED|Overall Study||49||
48436979|NCT04633434|101403651|FG001|STARTED|Overall Study||49||
48436980|NCT04633434|101403650|FG000|COMPLETED|Overall Study||17||
48436981|NCT04633434|101403651|FG001|COMPLETED|Overall Study||17||
48436982|NCT04633434|101403650|FG000|NOT COMPLETED|Overall Study||32||
48436983|NCT04633434|101403651|FG001|NOT COMPLETED|Overall Study||32||
48436984|NCT02513095|101403652|FG000|STARTED|Overall Study||17||
48436985|NCT02513095|101403653|FG001|STARTED|Overall Study||17||
48436986|NCT02513095|101403652|FG000|Treatment Phase - Up to 120 Minutes|Overall Study||17||
48436987|NCT02513095|101403653|FG001|Treatment Phase - Up to 120 Minutes|Overall Study||17||
48436988|NCT02513095|101403652|FG000|COMPLETED|Overall Study||17||
48436989|NCT02513095|101403653|FG001|COMPLETED|Overall Study||17||
48436990|NCT02513095|101403652|FG000|NOT COMPLETED|Overall Study||0||
48436991|NCT02513095|101403653|FG001|NOT COMPLETED|Overall Study||0||
48436992|NCT02586909|101403654|FG000|STARTED|Overall Study||1099||
48436993|NCT02586909|101403654|FG000|COMPLETED|Overall Study||151||
48436994|NCT02586909|101403654|FG000|NOT COMPLETED|Overall Study||948||
48436995|NCT03735680|101403655|FG000|STARTED|Overall Study||3||
48436996|NCT03735680|101403656|FG001|STARTED|Overall Study||3||
48436997|NCT03735680|101403657|FG002|STARTED|Overall Study||3||
48436998|NCT03735680|101403658|FG003|STARTED|Overall Study||4||
48436999|NCT03735680|101403659|FG004|STARTED|Overall Study||6||
48766501|NCT00174187|102218433|FG000|NOT COMPLETED|Period 2 (After 3 Years)||0||
48766502|NCT00174187|102218434|FG001|NOT COMPLETED|Period 2 (After 3 Years)||0||
48766503|NCT00174187|102218435|FG002|NOT COMPLETED|Period 2 (After 3 Years)||8||
48766504|NCT00571493|102218436|FG000|STARTED|Overall Study||3||
48766505|NCT00571493|102218437|FG001|STARTED|Overall Study||4||
48766506|NCT00571493|102218438|FG002|STARTED|Overall Study||3||
48766507|NCT00571493|102218439|FG003|STARTED|Overall Study||3||
48766508|NCT00571493|102218440|FG004|STARTED|Overall Study||11||
48766509|NCT00571493|102218441|FG005|STARTED|Overall Study||12||
48766510|NCT00571493|102218442|FG006|STARTED|Overall Study||6||
48766511|NCT00571493|102218436|FG000|COMPLETED|Overall Study||3||
48766512|NCT00571493|102218437|FG001|COMPLETED|Overall Study||4||
48766513|NCT00571493|102218438|FG002|COMPLETED|Overall Study||3||
48766514|NCT00571493|102218439|FG003|COMPLETED|Overall Study||3||
48766515|NCT00571493|102218440|FG004|COMPLETED|Overall Study||11||
48766516|NCT00571493|102218441|FG005|COMPLETED|Overall Study||12||
48766517|NCT00571493|102218442|FG006|COMPLETED|Overall Study||6||
48766518|NCT00571493|102218436|FG000|NOT COMPLETED|Overall Study||0||
48437000|NCT03735680|101403660|FG005|STARTED|Overall Study||11||
48437001|NCT03735680|101403655|FG000|COMPLETED|Overall Study||3||
48437002|NCT03735680|101403656|FG001|COMPLETED|Overall Study||2||
48437003|NCT03735680|101403657|FG002|COMPLETED|Overall Study||2||
48437004|NCT03735680|101403658|FG003|COMPLETED|Overall Study||4||
48437005|NCT03735680|101403659|FG004|COMPLETED|Overall Study||6||
48437006|NCT03735680|101403660|FG005|COMPLETED|Overall Study||10||
48437007|NCT03735680|101403655|FG000|NOT COMPLETED|Overall Study||0||
48766519|NCT00571493|102218437|FG001|NOT COMPLETED|Overall Study||0||
48437008|NCT03735680|101403656|FG001|NOT COMPLETED|Overall Study||1||
48437009|NCT03735680|101403657|FG002|NOT COMPLETED|Overall Study||1||
48437010|NCT03735680|101403658|FG003|NOT COMPLETED|Overall Study||0||
48437011|NCT03735680|101403659|FG004|NOT COMPLETED|Overall Study||0||
48437012|NCT03735680|101403660|FG005|NOT COMPLETED|Overall Study||1||
48437013|NCT01826201|101403661|FG000|STARTED|Overall Study||21||
48437014|NCT01826201|101403661|FG000|COMPLETED|Overall Study||17||
48437015|NCT01826201|101403661|FG000|NOT COMPLETED|Overall Study||4||
48437016|NCT00212446|101403662|FG000|STARTED|Overall Study||8||
48437017|NCT00212446|101403662|FG000|COMPLETED|Overall Study||8||
48437018|NCT00212446|101403662|FG000|NOT COMPLETED|Overall Study||0||
48437019|NCT00623441|101403663|FG000|STARTED|Overall Study||8314||
48437020|NCT00623441|101403663|FG000|COMPLETED|Overall Study||8314||
48437021|NCT00623441|101403663|FG000|NOT COMPLETED|Overall Study||0||
48437022|NCT01207219|101403664|FG000|STARTED|Overall Study||45||
48437023|NCT01207219|101403665|FG001|STARTED|Overall Study||40||
48437024|NCT01207219|101403666|FG002|STARTED|Overall Study||39||
48437025|NCT01207219|101403664|FG000|Included in ITT Analysis|Overall Study||40||
48437026|NCT01207219|101403665|FG001|Included in ITT Analysis|Overall Study||37||
48437027|NCT01207219|101403666|FG002|Included in ITT Analysis|Overall Study||38||
48437028|NCT01207219|101403664|FG000|COMPLETED|Overall Study||34||
48437029|NCT01207219|101403665|FG001|COMPLETED|Overall Study||29||
48437030|NCT01207219|101403666|FG002|COMPLETED|Overall Study||32||
48437031|NCT01207219|101403664|FG000|NOT COMPLETED|Overall Study||11||
48437032|NCT01207219|101403665|FG001|NOT COMPLETED|Overall Study||11||
48766520|NCT00571493|102218438|FG002|NOT COMPLETED|Overall Study||0||
48766521|NCT00571493|102218439|FG003|NOT COMPLETED|Overall Study||0||
48766522|NCT00571493|102218440|FG004|NOT COMPLETED|Overall Study||0||
48766523|NCT00571493|102218441|FG005|NOT COMPLETED|Overall Study||0||
48766524|NCT00571493|102218442|FG006|NOT COMPLETED|Overall Study||0||
48766525|NCT00106704|102218443|FG000|STARTED|Overall Study||222||
48766526|NCT00106704|102218444|FG001|STARTED|Overall Study||219||
48766527|NCT00106704|102218443|FG000|COMPLETED|Overall Study||91||
48766528|NCT00106704|102218444|FG001|COMPLETED|Overall Study||68||
48437033|NCT01207219|101403666|FG002|NOT COMPLETED|Overall Study||7||
48437034|NCT01068418|101403667|FG000|STARTED|Overall Study||26||
48437035|NCT01068418|101403667|FG000|Medication Washout|Overall Study||17||
48437036|NCT01068418|101403667|FG000|COMPLETED|Overall Study||14||
48437037|NCT01068418|101403667|FG000|NOT COMPLETED|Overall Study||12||
48437038|NCT03917654|101403668|FG000|STARTED|Year 1||15||
48437039|NCT03917654|101403669|FG001|STARTED|Year 1||15||
48437040|NCT03917654|101403670|FG002|STARTED|Year 1||15||
48437041|NCT03917654|101403671|FG003|STARTED|Year 1||15||
48437042|NCT03917654|101403672|FG004|STARTED|Year 1||99||
48437043|NCT03917654|101403673|FG005|STARTED|Year 1||87||
48437044|NCT03917654|101403674|FG006|STARTED|Year 1||192||
48437045|NCT03917654|101403675|FG007|STARTED|Year 1||177||
48437046|NCT03917654|101403676|FG008|STARTED|Year 1||227||
48437047|NCT03917654|101403677|FG009|STARTED|Year 1||267||
48437048|NCT03917654|101403678|FG010|STARTED|Year 1||97||
48437049|NCT03917654|101403679|FG011|STARTED|Year 1||95||
48437050|NCT03917654|101403668|FG000|COMPLETED|Year 1||14||
48437051|NCT03917654|101403669|FG001|COMPLETED|Year 1||13||
48437052|NCT03917654|101403670|FG002|COMPLETED|Year 1||13||
48437053|NCT03917654|101403671|FG003|COMPLETED|Year 1||15||
48437054|NCT03917654|101403672|FG004|COMPLETED|Year 1||94||
48437055|NCT03917654|101403673|FG005|COMPLETED|Year 1||82||
48437056|NCT03917654|101403674|FG006|COMPLETED|Year 1||173||
48437057|NCT03917654|101403675|FG007|COMPLETED|Year 1||162||
48437058|NCT03917654|101403676|FG008|COMPLETED|Year 1||218||
48437059|NCT03917654|101403677|FG009|COMPLETED|Year 1||257||
48437060|NCT03917654|101403678|FG010|COMPLETED|Year 1||92||
48437061|NCT03917654|101403679|FG011|COMPLETED|Year 1||87||
48437062|NCT03917654|101403668|FG000|NOT COMPLETED|Year 1||1||
48437063|NCT03917654|101403669|FG001|NOT COMPLETED|Year 1||2||
48437064|NCT03917654|101403670|FG002|NOT COMPLETED|Year 1||2||
48437065|NCT03917654|101403671|FG003|NOT COMPLETED|Year 1||0||
48437066|NCT03917654|101403672|FG004|NOT COMPLETED|Year 1||5||
48437067|NCT03917654|101403673|FG005|NOT COMPLETED|Year 1||5||
48437068|NCT03917654|101403674|FG006|NOT COMPLETED|Year 1||19||
48437069|NCT03917654|101403675|FG007|NOT COMPLETED|Year 1||15||
48437070|NCT03917654|101403676|FG008|NOT COMPLETED|Year 1||9||
48437071|NCT03917654|101403677|FG009|NOT COMPLETED|Year 1||10||
48437072|NCT03917654|101403678|FG010|NOT COMPLETED|Year 1||5||
48437073|NCT03917654|101403679|FG011|NOT COMPLETED|Year 1||8||
48437074|NCT03917654|101403668|FG000|STARTED|Year 2||13|Year 2 participants did not equal Year 1 participants for each arm, due to a number of participants electing not to rescreen for Year 2.|
48437075|NCT03917654|101403669|FG001|STARTED|Year 2||10|Year 2 participants did not equal Year 1 participants for each arm, due to a number of participants electing not to rescreen for Year 2.|
48437076|NCT03917654|101403670|FG002|STARTED|Year 2||13|Year 2 participants did not equal Year 1 participants for each arm, due to a number of participants electing not to rescreen for Year 2.|
48437077|NCT03917654|101403671|FG003|STARTED|Year 2||14|Year 2 participants did not equal Year 1 participants for each arm, due to a number of participants electing not to rescreen for Year 2.|
48437078|NCT03917654|101403672|FG004|STARTED|Year 2||86|Year 2 participants did not equal Year 1 participants for each arm, due to a number of participants electing not to rescreen for Year 2.|
48437079|NCT03917654|101403673|FG005|STARTED|Year 2||77|Year 2 participants did not equal Year 1 participants for each arm, due to a number of participants electing not to rescreen for Year 2.|
48437080|NCT03917654|101403674|FG006|STARTED|Year 2||152|Year 2 participants did not equal Year 1 participants for each arm, due to a number of participants electing not to rescreen for Year 2.|
48437081|NCT03917654|101403675|FG007|STARTED|Year 2||147|Year 2 participants did not equal Year 1 participants for each arm, due to a number of participants electing not to rescreen for Year 2.|
48437082|NCT03917654|101403676|FG008|STARTED|Year 2||199|Year 2 participants did not equal Year 1 participants for each arm, due to a number of participants electing not to rescreen for Year 2.|
48437083|NCT03917654|101403677|FG009|STARTED|Year 2||238|Year 2 participants did not equal Year 1 participants for each arm, due to a number of participants electing not to rescreen for Year 2.|
48437084|NCT03917654|101403678|FG010|STARTED|Year 2||90|Year 2 participants did not equal Year 1 participants for each arm, due to a number of participants electing not to rescreen for Year 2.|
48437085|NCT03917654|101403679|FG011|STARTED|Year 2||87|Year 2 participants did not equal Year 1 participants for each arm, due to a number of participants electing not to rescreen for Year 2.|
48437086|NCT03917654|101403668|FG000|Did Not Rescreen|Year 2||1||
48437087|NCT03917654|101403669|FG001|Did Not Rescreen|Year 2||3||
48437088|NCT03917654|101403670|FG002|Did Not Rescreen|Year 2||0||
48437089|NCT03917654|101403671|FG003|Did Not Rescreen|Year 2||1||
48437090|NCT03917654|101403672|FG004|Did Not Rescreen|Year 2||8||
48437091|NCT03917654|101403673|FG005|Did Not Rescreen|Year 2||5||
48655789|NCT02268851|101941278|FG003|COMPLETED|Overall Study||0||
48655790|NCT02268851|101941279|FG004|COMPLETED|Overall Study||8||
48655791|NCT02268851|101941280|FG005|COMPLETED|Overall Study||4||
48437092|NCT03917654|101403674|FG006|Did Not Rescreen|Year 2||21||
48437093|NCT03917654|101403675|FG007|Did Not Rescreen|Year 2||15||
48437094|NCT03917654|101403676|FG008|Did Not Rescreen|Year 2||19||
48367415|NCT02615717|101227411|FG001|STARTED|Overall Study||3||
48367416|NCT02615717|101227410|FG000|COMPLETED|Overall Study||3||
48367417|NCT02615717|101227411|FG001|COMPLETED|Overall Study||3||
48367418|NCT02615717|101227410|FG000|NOT COMPLETED|Overall Study||0||
48367419|NCT02615717|101227411|FG001|NOT COMPLETED|Overall Study||0||
48367420|NCT02452970|101227412|FG000|STARTED|Overall Study||4||
48367421|NCT02452970|101227412|FG000|COMPLETED|Overall Study||3||
48367422|NCT02452970|101227412|FG000|NOT COMPLETED|Overall Study||1||
48367423|NCT05258058|101227413|FG000|STARTED|Overall Study||12||
48367424|NCT05258058|101227413|FG000|COMPLETED|Overall Study||10||
48367425|NCT05258058|101227413|FG000|NOT COMPLETED|Overall Study||2||
48367426|NCT04748783|101227414|FG000|STARTED|Overall Study||0||
48367427|NCT04748783|101227415|FG001|STARTED|Overall Study||1||
48367428|NCT04748783|101227416|FG002|STARTED|Overall Study||0||
48367429|NCT04748783|101227417|FG003|STARTED|Overall Study||0||
48437095|NCT03917654|101403677|FG009|Did Not Rescreen|Year 2||19||
48437096|NCT03917654|101403678|FG010|Did Not Rescreen|Year 2||2||
48437097|NCT03917654|101403679|FG011|Did Not Rescreen|Year 2||0||
48437098|NCT03917654|101403668|FG000|COMPLETED|Year 2||10||
48437099|NCT03917654|101403669|FG001|COMPLETED|Year 2||9||
48437100|NCT03917654|101403670|FG002|COMPLETED|Year 2||13||
48437101|NCT03917654|101403671|FG003|COMPLETED|Year 2||14||
48437102|NCT03917654|101403672|FG004|COMPLETED|Year 2||82||
48437103|NCT03917654|101403673|FG005|COMPLETED|Year 2||75||
48437104|NCT03917654|101403674|FG006|COMPLETED|Year 2||138||
48437105|NCT03917654|101403675|FG007|COMPLETED|Year 2||139||
48437106|NCT03917654|101403676|FG008|COMPLETED|Year 2||185||
48437107|NCT03917654|101403677|FG009|COMPLETED|Year 2||226||
48437108|NCT03917654|101403678|FG010|COMPLETED|Year 2||89||
48437109|NCT03917654|101403679|FG011|COMPLETED|Year 2||83||
48437110|NCT03917654|101403668|FG000|NOT COMPLETED|Year 2||3||
48367430|NCT04748783|101227418|FG004|STARTED|Overall Study||1||
48367431|NCT04748783|101227414|FG000|COMPLETED|Overall Study||0||
48367432|NCT04748783|101227415|FG001|COMPLETED|Overall Study||1||
48367433|NCT04748783|101227416|FG002|COMPLETED|Overall Study||0||
48367434|NCT04748783|101227417|FG003|COMPLETED|Overall Study||0||
48367435|NCT04748783|101227418|FG004|COMPLETED|Overall Study||1||
48367436|NCT04748783|101227414|FG000|NOT COMPLETED|Overall Study||0||
48367437|NCT04748783|101227415|FG001|NOT COMPLETED|Overall Study||0||
48367438|NCT04748783|101227416|FG002|NOT COMPLETED|Overall Study||0||
48367439|NCT04748783|101227417|FG003|NOT COMPLETED|Overall Study||0||
48437111|NCT03917654|101403669|FG001|NOT COMPLETED|Year 2||1||
48437112|NCT03917654|101403670|FG002|NOT COMPLETED|Year 2||0||
48437113|NCT03917654|101403671|FG003|NOT COMPLETED|Year 2||0||
48437114|NCT03917654|101403672|FG004|NOT COMPLETED|Year 2||4||
48437115|NCT03917654|101403673|FG005|NOT COMPLETED|Year 2||2||
48437116|NCT03917654|101403674|FG006|NOT COMPLETED|Year 2||14||
48437117|NCT03917654|101403675|FG007|NOT COMPLETED|Year 2||8||
48437118|NCT03917654|101403676|FG008|NOT COMPLETED|Year 2||14||
48437119|NCT03917654|101403677|FG009|NOT COMPLETED|Year 2||12||
48437120|NCT03917654|101403678|FG010|NOT COMPLETED|Year 2||1||
48437121|NCT03917654|101403679|FG011|NOT COMPLETED|Year 2||4||
48437122|NCT03948646|101403680|FG000|STARTED|Overall Study||180||
48437123|NCT03948646|101403681|FG001|STARTED|Overall Study||171||
48437124|NCT03948646|101403680|FG000|COMPLETED|Overall Study||160||
48437125|NCT03948646|101403681|FG001|COMPLETED|Overall Study||155||
48437126|NCT03948646|101403680|FG000|NOT COMPLETED|Overall Study||20||
48437127|NCT03948646|101403681|FG001|NOT COMPLETED|Overall Study||16||
48437128|NCT05993299|101403682|FG000|STARTED|Overall Study||7||
48437129|NCT05993299|101403682|FG000|Received T Cell Infusion|Overall Study||5||
48437130|NCT05993299|101403682|FG000|COMPLETED|Overall Study||1||
48437131|NCT05993299|101403682|FG000|NOT COMPLETED|Overall Study||6||
48437132|NCT02325414|101403683|FG000|STARTED|Overall Study||30||
48437133|NCT02325414|101403684|FG001|STARTED|Overall Study||30||
48437134|NCT02325414|101403683|FG000|COMPLETED|Overall Study||22||
48437135|NCT02325414|101403684|FG001|COMPLETED|Overall Study||24||
48437136|NCT02325414|101403683|FG000|NOT COMPLETED|Overall Study||8||
48367440|NCT04748783|101227418|FG004|NOT COMPLETED|Overall Study||0||
48367441|NCT01996319|101227419|FG000|STARTED|Overall Study||96||
48367442|NCT01996319|101227420|FG001|STARTED|Overall Study||98||
48367443|NCT01996319|101227419|FG000|COMPLETED|Overall Study||88||
48437137|NCT02325414|101403684|FG001|NOT COMPLETED|Overall Study||6||
48437138|NCT03996694|101403685|FG000|STARTED|First Intervention (1 Day)||3||
48437139|NCT03996694|101403686|FG001|STARTED|First Intervention (1 Day)||3||
48437140|NCT03996694|101403687|FG002|STARTED|First Intervention (1 Day)||4||
48437141|NCT03996694|101403688|FG003|STARTED|First Intervention (1 Day)||3||
48437142|NCT03996694|101403689|FG004|STARTED|First Intervention (1 Day)||3||
48437143|NCT03996694|101403690|FG005|STARTED|First Intervention (1 Day)||3||
48437144|NCT03996694|101403685|FG000|COMPLETED|First Intervention (1 Day)||3||
48437145|NCT03996694|101403686|FG001|COMPLETED|First Intervention (1 Day)||3||
48437146|NCT03996694|101403687|FG002|COMPLETED|First Intervention (1 Day)||4||
48437147|NCT03996694|101403688|FG003|COMPLETED|First Intervention (1 Day)||3||
48437148|NCT03996694|101403689|FG004|COMPLETED|First Intervention (1 Day)||3||
48437149|NCT03996694|101403690|FG005|COMPLETED|First Intervention (1 Day)||3||
48437150|NCT03996694|101403685|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48655792|NCT02268851|101941275|FG000|NOT COMPLETED|Overall Study||1||
48655793|NCT02268851|101941276|FG001|NOT COMPLETED|Overall Study||3||
48655794|NCT02268851|101941277|FG002|NOT COMPLETED|Overall Study||1||
48655795|NCT02268851|101941278|FG003|NOT COMPLETED|Overall Study||3||
48655796|NCT02268851|101941279|FG004|NOT COMPLETED|Overall Study||7||
48437151|NCT03996694|101403686|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48437152|NCT03996694|101403687|FG002|NOT COMPLETED|First Intervention (1 Day)||0||
48437153|NCT03996694|101403688|FG003|NOT COMPLETED|First Intervention (1 Day)||0||
48437154|NCT03996694|101403689|FG004|NOT COMPLETED|First Intervention (1 Day)||0||
48437155|NCT03996694|101403690|FG005|NOT COMPLETED|First Intervention (1 Day)||0||
48655797|NCT02268851|101941280|FG005|NOT COMPLETED|Overall Study||11||
48655798|NCT03048019|101941281|FG000|STARTED|Overall Study||5||
48655799|NCT03048019|101941282|FG001|STARTED|Overall Study||5||
48655800|NCT03048019|101941281|FG000|COMPLETED|Overall Study||4||
48188344|NCT01023178|100783223|FG002|COMPLETED|Overall Study||4||
48188345|NCT01023178|100783221|FG000|NOT COMPLETED|Overall Study||2||
48188346|NCT01023178|100783222|FG001|NOT COMPLETED|Overall Study||2||
48188347|NCT01023178|100783223|FG002|NOT COMPLETED|Overall Study||3||
48188348|NCT01248221|100783224|FG000|STARTED|Overall Study||15||
48188349|NCT01248221|100783225|FG001|STARTED|Overall Study||15||
48188350|NCT01248221|100783224|FG000|COMPLETED|Overall Study||15||
48188351|NCT01248221|100783225|FG001|COMPLETED|Overall Study||15||
48188352|NCT01248221|100783224|FG000|NOT COMPLETED|Overall Study||0||
48188353|NCT01248221|100783225|FG001|NOT COMPLETED|Overall Study||0||
48188354|NCT00582790|100783226|FG000|STARTED|Overall Study||12||
48188355|NCT00582790|100783226|FG000|COMPLETED|Overall Study||11||
48188356|NCT00582790|100783226|FG000|NOT COMPLETED|Overall Study||1||
48188357|NCT03685747|100783227|FG000|STARTED|Overall Study||4||
48188358|NCT03685747|100783227|FG000|COMPLETED|Overall Study||4||
48188359|NCT03685747|100783227|FG000|NOT COMPLETED|Overall Study||0||
48188360|NCT01606189|100783228|FG000|STARTED|First Intenvention (14-20 Days)||8||
48188361|NCT01606189|100783229|FG001|STARTED|First Intenvention (14-20 Days)||8||
48188362|NCT01606189|100783230|FG002|STARTED|First Intenvention (14-20 Days)||8||
48188363|NCT01606189|100783231|FG003|STARTED|First Intenvention (14-20 Days)||8||
48188364|NCT01606189|100783232|FG004|STARTED|First Intenvention (14-20 Days)||8||
48188365|NCT01606189|100783233|FG005|STARTED|First Intenvention (14-20 Days)||8||
48188366|NCT01606189|100783228|FG000|COMPLETED|First Intenvention (14-20 Days)||8||
48188367|NCT01606189|100783229|FG001|COMPLETED|First Intenvention (14-20 Days)||8||
48188368|NCT01606189|100783230|FG002|COMPLETED|First Intenvention (14-20 Days)||8||
48188369|NCT01606189|100783231|FG003|COMPLETED|First Intenvention (14-20 Days)||8||
48188370|NCT01606189|100783232|FG004|COMPLETED|First Intenvention (14-20 Days)||8||
48188371|NCT01606189|100783233|FG005|COMPLETED|First Intenvention (14-20 Days)||8||
48188372|NCT01606189|100783228|FG000|NOT COMPLETED|First Intenvention (14-20 Days)||0||
48188373|NCT01606189|100783229|FG001|NOT COMPLETED|First Intenvention (14-20 Days)||0||
48437156|NCT03996694|101403685|FG000|STARTED|First Washout (7 Days)||3||
48437157|NCT03996694|101403686|FG001|STARTED|First Washout (7 Days)||3||
48437158|NCT03996694|101403687|FG002|STARTED|First Washout (7 Days)||4||
48437159|NCT03996694|101403688|FG003|STARTED|First Washout (7 Days)||3||
48188374|NCT01606189|100783230|FG002|NOT COMPLETED|First Intenvention (14-20 Days)||0||
48188375|NCT01606189|100783231|FG003|NOT COMPLETED|First Intenvention (14-20 Days)||0||
48188376|NCT01606189|100783232|FG004|NOT COMPLETED|First Intenvention (14-20 Days)||0||
48188377|NCT01606189|100783233|FG005|NOT COMPLETED|First Intenvention (14-20 Days)||0||
48188378|NCT01606189|100783228|FG000|STARTED|Second Intenvention (14-20 Days)||8||
48188379|NCT01606189|100783229|FG001|STARTED|Second Intenvention (14-20 Days)||8||
48188380|NCT01606189|100783230|FG002|STARTED|Second Intenvention (14-20 Days)||8||
48188381|NCT01606189|100783231|FG003|STARTED|Second Intenvention (14-20 Days)||8||
48437160|NCT03996694|101403689|FG004|STARTED|First Washout (7 Days)||3||
48437161|NCT03996694|101403690|FG005|STARTED|First Washout (7 Days)||3||
48437162|NCT03996694|101403685|FG000|COMPLETED|First Washout (7 Days)||3||
48437163|NCT03996694|101403686|FG001|COMPLETED|First Washout (7 Days)||2||
48437164|NCT03996694|101403687|FG002|COMPLETED|First Washout (7 Days)||2||
48437165|NCT03996694|101403688|FG003|COMPLETED|First Washout (7 Days)||3||
48437166|NCT03996694|101403689|FG004|COMPLETED|First Washout (7 Days)||3||
48437167|NCT03996694|101403690|FG005|COMPLETED|First Washout (7 Days)||3||
48437168|NCT03996694|101403685|FG000|NOT COMPLETED|First Washout (7 Days)||0||
48655801|NCT03048019|101941282|FG001|COMPLETED|Overall Study||5||
48655802|NCT03048019|101941281|FG000|NOT COMPLETED|Overall Study||1||
48655803|NCT03048019|101941282|FG001|NOT COMPLETED|Overall Study||0||
48655804|NCT01927861|101941283|FG000|STARTED|Pivotal Phase (104 Weeks)||25||
48188697|NCT02034435|100783314|FG002|STARTED|Overall Study||7||
48437169|NCT03996694|101403686|FG001|NOT COMPLETED|First Washout (7 Days)||1||
48437170|NCT03996694|101403687|FG002|NOT COMPLETED|First Washout (7 Days)||2||
48655805|NCT01927861|101941284|FG001|STARTED|Pivotal Phase (104 Weeks)||26||
48655806|NCT01927861|101941283|FG000|COMPLETED|Pivotal Phase (104 Weeks)||25||
48655807|NCT01927861|101941284|FG001|COMPLETED|Pivotal Phase (104 Weeks)||26||
48655808|NCT01927861|101941283|FG000|NOT COMPLETED|Pivotal Phase (104 Weeks)||0||
48655809|NCT01927861|101941284|FG001|NOT COMPLETED|Pivotal Phase (104 Weeks)||0||
48766529|NCT00106704|102218443|FG000|NOT COMPLETED|Overall Study||131||
48766530|NCT00106704|102218444|FG001|NOT COMPLETED|Overall Study||151||
48766531|NCT01942694|102218445|FG000|STARTED|Overall Study||1212||
48766532|NCT01942694|102218446|FG001|STARTED|Overall Study||1211||
48766533|NCT01942694|102218445|FG000|COMPLETED|Overall Study||1211||
48766534|NCT01942694|102218446|FG001|COMPLETED|Overall Study||1211||
48766535|NCT01942694|102218445|FG000|NOT COMPLETED|Overall Study||1||
48766536|NCT01942694|102218446|FG001|NOT COMPLETED|Overall Study||0||
48766537|NCT02606643|102218447|FG000|STARTED|Overall Study||68||
48766538|NCT02606643|102218448|FG001|STARTED|Overall Study||76||
48766539|NCT02606643|102218447|FG000|COMPLETED|Overall Study||67||
48766540|NCT02606643|102218448|FG001|COMPLETED|Overall Study||73||
48766541|NCT02606643|102218447|FG000|NOT COMPLETED|Overall Study||1||
48766542|NCT02606643|102218448|FG001|NOT COMPLETED|Overall Study||3||
48766543|NCT03102437|102218449|FG000|STARTED|Overall Study||70||
48766544|NCT03102437|102218450|FG001|STARTED|Overall Study||36||
48766545|NCT03102437|102218449|FG000|COMPLETED|Overall Study||65||
48766546|NCT03102437|102218450|FG001|COMPLETED|Overall Study||36||
48766547|NCT03102437|102218449|FG000|NOT COMPLETED|Overall Study||5||
48766548|NCT03102437|102218450|FG001|NOT COMPLETED|Overall Study||0||
48766549|NCT04163016|102218451|FG000|STARTED|Enrollment||1||
48766550|NCT04163016|102218452|FG001|STARTED|Enrollment||15||
48766551|NCT04163016|102218453|FG002|STARTED|Enrollment||1||
48367444|NCT01996319|101227420|FG001|COMPLETED|Overall Study||95||
48367445|NCT01996319|101227419|FG000|NOT COMPLETED|Overall Study||8||
48367446|NCT01996319|101227420|FG001|NOT COMPLETED|Overall Study||3||
48367447|NCT00044044|101227421|FG000|STARTED|Overall Study||71||
48367448|NCT00044044|101227422|FG001|STARTED|Overall Study||69||
48367449|NCT00044044|101227423|FG002|STARTED|Overall Study||71||
48367450|NCT00044044|101227424|FG003|STARTED|Overall Study||73||
48367451|NCT00044044|101227425|FG004|STARTED|Overall Study||72||
48367452|NCT00044044|101227421|FG000|COMPLETED|Overall Study||27||
48367453|NCT00044044|101227422|FG001|COMPLETED|Overall Study||28||
48367454|NCT00044044|101227423|FG002|COMPLETED|Overall Study||31||
48367455|NCT00044044|101227424|FG003|COMPLETED|Overall Study||29||
48367456|NCT00044044|101227425|FG004|COMPLETED|Overall Study||36||
48367457|NCT00044044|101227421|FG000|NOT COMPLETED|Overall Study||44||
48367458|NCT00044044|101227422|FG001|NOT COMPLETED|Overall Study||41||
48367459|NCT00044044|101227423|FG002|NOT COMPLETED|Overall Study||40||
48367460|NCT00044044|101227424|FG003|NOT COMPLETED|Overall Study||44||
48367461|NCT00044044|101227425|FG004|NOT COMPLETED|Overall Study||36||
48367462|NCT03792750|101227426|FG000|STARTED|Overall Study||12||
48367463|NCT03792750|101227426|FG000|COMPLETED|Overall Study||9||
48367464|NCT03792750|101227426|FG000|NOT COMPLETED|Overall Study||3||
48367465|NCT01070784|101227427|FG000|STARTED|Overall Study||130||
48367466|NCT01070784|101227428|FG001|STARTED|Overall Study||130||
48367467|NCT01070784|101227427|FG000|COMPLETED|Overall Study||110||
48367468|NCT01070784|101227428|FG001|COMPLETED|Overall Study||112||
48367469|NCT01070784|101227427|FG000|NOT COMPLETED|Overall Study||20||
48367470|NCT01070784|101227428|FG001|NOT COMPLETED|Overall Study||18||
48367471|NCT03823937|101227429|FG000|STARTED|Overall Study||30||
48367472|NCT03823937|101227430|FG001|STARTED|Overall Study||20||
48367473|NCT03823937|101227429|FG000|COMPLETED|Overall Study||30||
48367474|NCT03823937|101227430|FG001|COMPLETED|Overall Study||20||
48437171|NCT03996694|101403688|FG003|NOT COMPLETED|First Washout (7 Days)||0||
48437172|NCT03996694|101403689|FG004|NOT COMPLETED|First Washout (7 Days)||0||
48437173|NCT03996694|101403690|FG005|NOT COMPLETED|First Washout (7 Days)||0||
48437174|NCT03996694|101403685|FG000|STARTED|Second Intervention (1 Day)||3||
48437175|NCT03996694|101403686|FG001|STARTED|Second Intervention (1 Day)||2||
48437176|NCT03996694|101403687|FG002|STARTED|Second Intervention (1 Day)||2||
48437177|NCT03996694|101403688|FG003|STARTED|Second Intervention (1 Day)||3||
48437178|NCT03996694|101403689|FG004|STARTED|Second Intervention (1 Day)||3||
48766552|NCT04163016|102218454|FG003|STARTED|Enrollment||5||
48766553|NCT04163016|102218451|FG000|COMPLETED|Enrollment||0||
48766554|NCT04163016|102218452|FG001|COMPLETED|Enrollment||15||
48766555|NCT04163016|102218453|FG002|COMPLETED|Enrollment||1||
48367475|NCT03823937|101227429|FG000|NOT COMPLETED|Overall Study||0||
48367476|NCT03823937|101227430|FG001|NOT COMPLETED|Overall Study||0||
48367477|NCT01591018|101227431|FG000|STARTED|Overall Study||60||
48367478|NCT01591018|101227432|FG001|STARTED|Overall Study||60||
48367479|NCT01591018|101227431|FG000|COMPLETED|Overall Study||60||
48367480|NCT01591018|101227432|FG001|COMPLETED|Overall Study||60||
48367481|NCT01591018|101227431|FG000|NOT COMPLETED|Overall Study||0||
48367482|NCT01591018|101227432|FG001|NOT COMPLETED|Overall Study||0||
48367483|NCT01505491|101227433|FG000|STARTED|Overall Study||67||
48367484|NCT01505491|101227434|FG001|STARTED|Overall Study||62||
48367485|NCT01505491|101227435|FG002|STARTED|Overall Study||64||
48367486|NCT01505491|101227433|FG000|COMPLETED|Overall Study||65||
48367487|NCT01505491|101227434|FG001|COMPLETED|Overall Study||61||
48766556|NCT04163016|102218454|FG003|COMPLETED|Enrollment||5||
48766557|NCT04163016|102218451|FG000|NOT COMPLETED|Enrollment||1||
48766558|NCT04163016|102218452|FG001|NOT COMPLETED|Enrollment||0||
48367488|NCT01505491|101227435|FG002|COMPLETED|Overall Study||59||
48367489|NCT01505491|101227433|FG000|NOT COMPLETED|Overall Study||2||
48367490|NCT01505491|101227434|FG001|NOT COMPLETED|Overall Study||1||
48437179|NCT03996694|101403690|FG005|STARTED|Second Intervention (1 Day)||3||
48437180|NCT03996694|101403685|FG000|COMPLETED|Second Intervention (1 Day)||3||
48437181|NCT03996694|101403686|FG001|COMPLETED|Second Intervention (1 Day)||2||
48437182|NCT03996694|101403687|FG002|COMPLETED|Second Intervention (1 Day)||2||
48437183|NCT03996694|101403688|FG003|COMPLETED|Second Intervention (1 Day)||3||
48437184|NCT03996694|101403689|FG004|COMPLETED|Second Intervention (1 Day)||3||
48437185|NCT03996694|101403690|FG005|COMPLETED|Second Intervention (1 Day)||3||
48437186|NCT03996694|101403685|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48437187|NCT03996694|101403686|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48437188|NCT03996694|101403687|FG002|NOT COMPLETED|Second Intervention (1 Day)||0||
48437189|NCT03996694|101403688|FG003|NOT COMPLETED|Second Intervention (1 Day)||0||
48437190|NCT03996694|101403689|FG004|NOT COMPLETED|Second Intervention (1 Day)||0||
48437191|NCT03996694|101403690|FG005|NOT COMPLETED|Second Intervention (1 Day)||0||
48437192|NCT03996694|101403685|FG000|STARTED|Second Washout (7 Days)||3||
48437193|NCT03996694|101403686|FG001|STARTED|Second Washout (7 Days)||2||
48437194|NCT03996694|101403687|FG002|STARTED|Second Washout (7 Days)||2||
48437195|NCT03996694|101403688|FG003|STARTED|Second Washout (7 Days)||3||
48437196|NCT03996694|101403689|FG004|STARTED|Second Washout (7 Days)||3||
48437197|NCT03996694|101403690|FG005|STARTED|Second Washout (7 Days)||3||
48437198|NCT03996694|101403685|FG000|COMPLETED|Second Washout (7 Days)||3||
48437199|NCT03996694|101403686|FG001|COMPLETED|Second Washout (7 Days)||2||
48437200|NCT03996694|101403687|FG002|COMPLETED|Second Washout (7 Days)||2||
48437201|NCT03996694|101403688|FG003|COMPLETED|Second Washout (7 Days)||3||
48437202|NCT03996694|101403689|FG004|COMPLETED|Second Washout (7 Days)||3||
48437203|NCT03996694|101403690|FG005|COMPLETED|Second Washout (7 Days)||3||
48437204|NCT03996694|101403685|FG000|NOT COMPLETED|Second Washout (7 Days)||0||
48437205|NCT03996694|101403686|FG001|NOT COMPLETED|Second Washout (7 Days)||0||
48437206|NCT03996694|101403687|FG002|NOT COMPLETED|Second Washout (7 Days)||0||
48437207|NCT03996694|101403688|FG003|NOT COMPLETED|Second Washout (7 Days)||0||
48437208|NCT03996694|101403689|FG004|NOT COMPLETED|Second Washout (7 Days)||0||
48437209|NCT03996694|101403690|FG005|NOT COMPLETED|Second Washout (7 Days)||0||
48437210|NCT03996694|101403685|FG000|STARTED|Third Intervention (1 Day)||3||
48437211|NCT03996694|101403686|FG001|STARTED|Third Intervention (1 Day)||2||
48437212|NCT03996694|101403687|FG002|STARTED|Third Intervention (1 Day)||2||
48437213|NCT03996694|101403688|FG003|STARTED|Third Intervention (1 Day)||3||
48437214|NCT03996694|101403689|FG004|STARTED|Third Intervention (1 Day)||3||
48437215|NCT03996694|101403690|FG005|STARTED|Third Intervention (1 Day)||3||
48437216|NCT03996694|101403685|FG000|COMPLETED|Third Intervention (1 Day)||3||
48437217|NCT03996694|101403686|FG001|COMPLETED|Third Intervention (1 Day)||2||
48437218|NCT03996694|101403687|FG002|COMPLETED|Third Intervention (1 Day)||2||
48367491|NCT01505491|101227435|FG002|NOT COMPLETED|Overall Study||5||
48367492|NCT02188121|101227436|FG000|STARTED|Overall Study||99||
48367493|NCT02188121|101227437|FG001|STARTED|Overall Study||105||
48367494|NCT02188121|101227436|FG000|COMPLETED|Overall Study||79||
48367495|NCT02188121|101227437|FG001|COMPLETED|Overall Study||78||
48367496|NCT02188121|101227436|FG000|NOT COMPLETED|Overall Study||20||
48367497|NCT02188121|101227437|FG001|NOT COMPLETED|Overall Study||27||
48367498|NCT02412644|101227438|FG000|STARTED|Overall Study||21||
48367499|NCT02412644|101227439|FG001|STARTED|Overall Study||8||
48367500|NCT02412644|101227438|FG000|COMPLETED|Overall Study||6||
48367501|NCT02412644|101227439|FG001|COMPLETED|Overall Study||4||
48367502|NCT02412644|101227438|FG000|NOT COMPLETED|Overall Study||15||
48367503|NCT02412644|101227439|FG001|NOT COMPLETED|Overall Study||4||
48437219|NCT03996694|101403688|FG003|COMPLETED|Third Intervention (1 Day)||3||
48437220|NCT03996694|101403689|FG004|COMPLETED|Third Intervention (1 Day)||3||
48437221|NCT03996694|101403690|FG005|COMPLETED|Third Intervention (1 Day)||3||
48437222|NCT03996694|101403685|FG000|NOT COMPLETED|Third Intervention (1 Day)||0||
48437223|NCT03996694|101403686|FG001|NOT COMPLETED|Third Intervention (1 Day)||0||
48437224|NCT03996694|101403687|FG002|NOT COMPLETED|Third Intervention (1 Day)||0||
48437225|NCT03996694|101403688|FG003|NOT COMPLETED|Third Intervention (1 Day)||0||
48437226|NCT03996694|101403689|FG004|NOT COMPLETED|Third Intervention (1 Day)||0||
48437227|NCT03996694|101403690|FG005|NOT COMPLETED|Third Intervention (1 Day)||0||
48437228|NCT03996694|101403685|FG000|STARTED|Third Washout (7 Days)||3||
48437229|NCT03996694|101403686|FG001|STARTED|Third Washout (7 Days)||2||
48437230|NCT03996694|101403687|FG002|STARTED|Third Washout (7 Days)||2||
48437231|NCT03996694|101403688|FG003|STARTED|Third Washout (7 Days)||3||
48437232|NCT03996694|101403689|FG004|STARTED|Third Washout (7 Days)||3||
48437233|NCT03996694|101403690|FG005|STARTED|Third Washout (7 Days)||3||
48437234|NCT03996694|101403685|FG000|COMPLETED|Third Washout (7 Days)||3||
48437235|NCT03996694|101403686|FG001|COMPLETED|Third Washout (7 Days)||2||
48437236|NCT03996694|101403687|FG002|COMPLETED|Third Washout (7 Days)||2||
48437237|NCT03996694|101403688|FG003|COMPLETED|Third Washout (7 Days)||3||
48437238|NCT03996694|101403689|FG004|COMPLETED|Third Washout (7 Days)||2||
48367504|NCT02433210|101227440|FG000|STARTED|Overall Study||5||
48437239|NCT03996694|101403690|FG005|COMPLETED|Third Washout (7 Days)||3||
48437240|NCT03996694|101403685|FG000|NOT COMPLETED|Third Washout (7 Days)||0||
48437241|NCT03996694|101403686|FG001|NOT COMPLETED|Third Washout (7 Days)||0||
48367505|NCT02433210|101227441|FG001|STARTED|Overall Study||3||
48367506|NCT02433210|101227442|FG002|STARTED|Overall Study||3||
48437242|NCT03996694|101403687|FG002|NOT COMPLETED|Third Washout (7 Days)||0||
48437243|NCT03996694|101403688|FG003|NOT COMPLETED|Third Washout (7 Days)||0||
48437244|NCT03996694|101403689|FG004|NOT COMPLETED|Third Washout (7 Days)||1||
48437245|NCT03996694|101403690|FG005|NOT COMPLETED|Third Washout (7 Days)||0||
48437246|NCT03996694|101403685|FG000|STARTED|Fourth Intervention (1 Day)||3||
48437247|NCT03996694|101403686|FG001|STARTED|Fourth Intervention (1 Day)||2||
48437248|NCT03996694|101403687|FG002|STARTED|Fourth Intervention (1 Day)||2||
48437249|NCT03996694|101403688|FG003|STARTED|Fourth Intervention (1 Day)||3||
48437250|NCT03996694|101403689|FG004|STARTED|Fourth Intervention (1 Day)||2||
48367507|NCT02433210|101227440|FG000|COMPLETED|Overall Study||4||
48367508|NCT02433210|101227441|FG001|COMPLETED|Overall Study||3||
48367509|NCT02433210|101227442|FG002|COMPLETED|Overall Study||3||
48367510|NCT02433210|101227440|FG000|NOT COMPLETED|Overall Study||1||
48367511|NCT02433210|101227441|FG001|NOT COMPLETED|Overall Study||0||
48367512|NCT02433210|101227442|FG002|NOT COMPLETED|Overall Study||0||
48367513|NCT01043523|101227443|FG000|STARTED|Overall Study||52||
48367514|NCT01043523|101227443|FG000|Participants With Unenhanced Images|Overall Study||51||
48367515|NCT01043523|101227443|FG000|COMPLETED|Overall Study||52||
48367516|NCT01043523|101227443|FG000|NOT COMPLETED|Overall Study||0||
48367517|NCT04328623|101227444|FG000|STARTED|Overall Study||40||
48367518|NCT04328623|101227445|FG001|STARTED|Overall Study||40||
48367519|NCT04328623|101227444|FG000|Infiltration|Overall Study||40||
48367520|NCT04328623|101227445|FG001|Infiltration|Overall Study||39||
48367521|NCT04328623|101227444|FG000|COMPLETED|Overall Study||40||
48367522|NCT04328623|101227445|FG001|COMPLETED|Overall Study||39||
48367523|NCT04328623|101227444|FG000|NOT COMPLETED|Overall Study||0||
48367524|NCT04328623|101227445|FG001|NOT COMPLETED|Overall Study||1||
48437251|NCT03996694|101403690|FG005|STARTED|Fourth Intervention (1 Day)||3||
48367525|NCT01417780|101227446|FG000|STARTED|Overall Study||15|ITT Population|
48437252|NCT03996694|101403685|FG000|COMPLETED|Fourth Intervention (1 Day)||3||
48437253|NCT03996694|101403686|FG001|COMPLETED|Fourth Intervention (1 Day)||2||
48437254|NCT03996694|101403687|FG002|COMPLETED|Fourth Intervention (1 Day)||2||
48437255|NCT03996694|101403688|FG003|COMPLETED|Fourth Intervention (1 Day)||3||
48437256|NCT03996694|101403689|FG004|COMPLETED|Fourth Intervention (1 Day)||2||
48437257|NCT03996694|101403690|FG005|COMPLETED|Fourth Intervention (1 Day)||3||
48437258|NCT03996694|101403685|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0||
48437259|NCT03996694|101403686|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0||
48437260|NCT03996694|101403687|FG002|NOT COMPLETED|Fourth Intervention (1 Day)||0||
48437261|NCT03996694|101403688|FG003|NOT COMPLETED|Fourth Intervention (1 Day)||0||
48437262|NCT03996694|101403689|FG004|NOT COMPLETED|Fourth Intervention (1 Day)||0||
48437263|NCT03996694|101403690|FG005|NOT COMPLETED|Fourth Intervention (1 Day)||0||
48437264|NCT03996694|101403685|FG000|STARTED|Fourth Washout (7 Days)||3||
48437265|NCT03996694|101403686|FG001|STARTED|Fourth Washout (7 Days)||2||
48437266|NCT03996694|101403687|FG002|STARTED|Fourth Washout (7 Days)||2||
48437267|NCT03996694|101403688|FG003|STARTED|Fourth Washout (7 Days)||3||
48437268|NCT03996694|101403689|FG004|STARTED|Fourth Washout (7 Days)||2||
48437269|NCT03996694|101403690|FG005|STARTED|Fourth Washout (7 Days)||3||
48437270|NCT03996694|101403685|FG000|COMPLETED|Fourth Washout (7 Days)||3||
48437271|NCT03996694|101403686|FG001|COMPLETED|Fourth Washout (7 Days)||2||
48655810|NCT01927861|101941283|FG000|STARTED|Extension Phase (104 Weeks)||25||
48655811|NCT01927861|101941284|FG001|STARTED|Extension Phase (104 Weeks)||26||
48655812|NCT01927861|101941283|FG000|COMPLETED|Extension Phase (104 Weeks)||25||
48655813|NCT01927861|101941284|FG001|COMPLETED|Extension Phase (104 Weeks)||23||
48655814|NCT01927861|101941283|FG000|NOT COMPLETED|Extension Phase (104 Weeks)||0||
48655815|NCT01927861|101941284|FG001|NOT COMPLETED|Extension Phase (104 Weeks)||3||
48655816|NCT01927861|101941283|FG000|STARTED|Extended Treatment Phase (26 Weeks)||15||
48655817|NCT01927861|101941284|FG001|STARTED|Extended Treatment Phase (26 Weeks)||14||
48367526|NCT01417780|101227447|FG001|STARTED|Overall Study||17|ITT Population|
48367527|NCT01417780|101227448|FG002|STARTED|Overall Study||11|ITT Population|
48367528|NCT01417780|101227446|FG000|COMPLETED|Overall Study||14|ITT Population|
48367529|NCT01417780|101227447|FG001|COMPLETED|Overall Study||14|ITT Population|
48367530|NCT01417780|101227448|FG002|COMPLETED|Overall Study||9|ITT Population|
48367531|NCT01417780|101227446|FG000|NOT COMPLETED|Overall Study||1||
48437272|NCT03996694|101403687|FG002|COMPLETED|Fourth Washout (7 Days)||2||
48437273|NCT03996694|101403688|FG003|COMPLETED|Fourth Washout (7 Days)||3||
48437274|NCT03996694|101403689|FG004|COMPLETED|Fourth Washout (7 Days)||2||
48655818|NCT01927861|101941283|FG000|COMPLETED|Extended Treatment Phase (26 Weeks)||15||
48655819|NCT01927861|101941284|FG001|COMPLETED|Extended Treatment Phase (26 Weeks)||14||
48655820|NCT01927861|101941283|FG000|NOT COMPLETED|Extended Treatment Phase (26 Weeks)||0||
48655821|NCT01927861|101941284|FG001|NOT COMPLETED|Extended Treatment Phase (26 Weeks)||0||
48655822|NCT05206604|101941285|FG000|STARTED|Overall Study||4||
48655823|NCT05206604|101941286|FG001|STARTED|Overall Study||2||
48367532|NCT01417780|101227447|FG001|NOT COMPLETED|Overall Study||3||
48367533|NCT01417780|101227448|FG002|NOT COMPLETED|Overall Study||2||
48367534|NCT05232097|101227449|FG000|STARTED|Overall Study||11||
48367535|NCT05232097|101227449|FG000|COMPLETED|Overall Study||10||
48367536|NCT05232097|101227449|FG000|NOT COMPLETED|Overall Study||1||
48367537|NCT01259297|101227450|FG000|STARTED|Run-in Open Label Period (4-5 Weeks)||1335||
48437275|NCT03996694|101403690|FG005|COMPLETED|Fourth Washout (7 Days)||3||
48437276|NCT03996694|101403685|FG000|NOT COMPLETED|Fourth Washout (7 Days)||0||
48437277|NCT03996694|101403686|FG001|NOT COMPLETED|Fourth Washout (7 Days)||0||
48437278|NCT03996694|101403687|FG002|NOT COMPLETED|Fourth Washout (7 Days)||0||
48437279|NCT03996694|101403688|FG003|NOT COMPLETED|Fourth Washout (7 Days)||0||
48437280|NCT03996694|101403689|FG004|NOT COMPLETED|Fourth Washout (7 Days)||0||
48437281|NCT03996694|101403690|FG005|NOT COMPLETED|Fourth Washout (7 Days)||0||
48437282|NCT03996694|101403685|FG000|STARTED|Fifth Intervention (1 Day)||3||
48437283|NCT03996694|101403686|FG001|STARTED|Fifth Intervention (1 Day)||2||
48437284|NCT03996694|101403687|FG002|STARTED|Fifth Intervention (1 Day)||2||
48437285|NCT03996694|101403688|FG003|STARTED|Fifth Intervention (1 Day)||3||
48437286|NCT03996694|101403689|FG004|STARTED|Fifth Intervention (1 Day)||2||
48437287|NCT03996694|101403690|FG005|STARTED|Fifth Intervention (1 Day)||3||
48437288|NCT03996694|101403685|FG000|COMPLETED|Fifth Intervention (1 Day)||3||
48437289|NCT03996694|101403686|FG001|COMPLETED|Fifth Intervention (1 Day)||2||
48437290|NCT03996694|101403687|FG002|COMPLETED|Fifth Intervention (1 Day)||2||
48437291|NCT03996694|101403688|FG003|COMPLETED|Fifth Intervention (1 Day)||3||
48437292|NCT03996694|101403689|FG004|COMPLETED|Fifth Intervention (1 Day)||2||
48437293|NCT03996694|101403690|FG005|COMPLETED|Fifth Intervention (1 Day)||3||
48437294|NCT03996694|101403685|FG000|NOT COMPLETED|Fifth Intervention (1 Day)||0||
48437295|NCT03996694|101403686|FG001|NOT COMPLETED|Fifth Intervention (1 Day)||0||
48437296|NCT03996694|101403687|FG002|NOT COMPLETED|Fifth Intervention (1 Day)||0||
48437297|NCT03996694|101403688|FG003|NOT COMPLETED|Fifth Intervention (1 Day)||0||
48437298|NCT03996694|101403689|FG004|NOT COMPLETED|Fifth Intervention (1 Day)||0||
48437299|NCT03996694|101403690|FG005|NOT COMPLETED|Fifth Intervention (1 Day)||0||
48437300|NCT03996694|101403685|FG000|STARTED|Fifth Washout (7 Days)||3||
48437301|NCT03996694|101403686|FG001|STARTED|Fifth Washout (7 Days)||2||
48437302|NCT03996694|101403687|FG002|STARTED|Fifth Washout (7 Days)||2||
48437303|NCT03996694|101403688|FG003|STARTED|Fifth Washout (7 Days)||3||
48437304|NCT03996694|101403689|FG004|STARTED|Fifth Washout (7 Days)||2||
48437305|NCT03996694|101403690|FG005|STARTED|Fifth Washout (7 Days)||3||
48437306|NCT03996694|101403685|FG000|COMPLETED|Fifth Washout (7 Days)||3||
48437307|NCT03996694|101403686|FG001|COMPLETED|Fifth Washout (7 Days)||2||
48437308|NCT03996694|101403687|FG002|COMPLETED|Fifth Washout (7 Days)||2||
48437309|NCT03996694|101403688|FG003|COMPLETED|Fifth Washout (7 Days)||3||
48437310|NCT03996694|101403689|FG004|COMPLETED|Fifth Washout (7 Days)||2||
48437311|NCT03996694|101403690|FG005|COMPLETED|Fifth Washout (7 Days)||3||
48437312|NCT03996694|101403685|FG000|NOT COMPLETED|Fifth Washout (7 Days)||0||
48437313|NCT03996694|101403686|FG001|NOT COMPLETED|Fifth Washout (7 Days)||0||
48437314|NCT03996694|101403687|FG002|NOT COMPLETED|Fifth Washout (7 Days)||0||
48437315|NCT03996694|101403688|FG003|NOT COMPLETED|Fifth Washout (7 Days)||0||
48437316|NCT03996694|101403689|FG004|NOT COMPLETED|Fifth Washout (7 Days)||0||
48437317|NCT03996694|101403690|FG005|NOT COMPLETED|Fifth Washout (7 Days)||0||
48367538|NCT01259297|101227451|FG001|STARTED|Run-in Open Label Period (4-5 Weeks)||0||
48367539|NCT01259297|101227452|FG002|STARTED|Run-in Open Label Period (4-5 Weeks)||1001||
48367540|NCT01259297|101227453|FG003|STARTED|Run-in Open Label Period (4-5 Weeks)||0||
48367541|NCT01259297|101227454|FG004|STARTED|Run-in Open Label Period (4-5 Weeks)||0||
48367542|NCT01259297|101227455|FG005|STARTED|Run-in Open Label Period (4-5 Weeks)||0||
48367543|NCT01259297|101227456|FG006|STARTED|Run-in Open Label Period (4-5 Weeks)||0||
48367544|NCT01259297|101227457|FG007|STARTED|Run-in Open Label Period (4-5 Weeks)||0||
48367545|NCT01259297|101227450|FG000|COMPLETED|Run-in Open Label Period (4-5 Weeks)||980||
48367546|NCT01259297|101227451|FG001|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0||
48367547|NCT01259297|101227452|FG002|COMPLETED|Run-in Open Label Period (4-5 Weeks)||779||
48437318|NCT03996694|101403685|FG000|STARTED|Sixth Intervention (1 Day)||3||
48437319|NCT03996694|101403686|FG001|STARTED|Sixth Intervention (1 Day)||2||
48437320|NCT03996694|101403687|FG002|STARTED|Sixth Intervention (1 Day)||2||
48437321|NCT03996694|101403688|FG003|STARTED|Sixth Intervention (1 Day)||3||
48437322|NCT03996694|101403689|FG004|STARTED|Sixth Intervention (1 Day)||2||
48437323|NCT03996694|101403690|FG005|STARTED|Sixth Intervention (1 Day)||3||
48437324|NCT03996694|101403685|FG000|COMPLETED|Sixth Intervention (1 Day)||3||
48437325|NCT03996694|101403686|FG001|COMPLETED|Sixth Intervention (1 Day)||2||
48437326|NCT03996694|101403687|FG002|COMPLETED|Sixth Intervention (1 Day)||2||
48367548|NCT01259297|101227453|FG003|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0||
48367549|NCT01259297|101227454|FG004|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0||
48367550|NCT01259297|101227455|FG005|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0||
48367551|NCT01259297|101227456|FG006|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0||
48437327|NCT03996694|101403688|FG003|COMPLETED|Sixth Intervention (1 Day)||3||
48437328|NCT03996694|101403689|FG004|COMPLETED|Sixth Intervention (1 Day)||2||
48437329|NCT03996694|101403690|FG005|COMPLETED|Sixth Intervention (1 Day)||3||
48437330|NCT03996694|101403685|FG000|NOT COMPLETED|Sixth Intervention (1 Day)||0||
48437331|NCT03996694|101403686|FG001|NOT COMPLETED|Sixth Intervention (1 Day)||0||
48437332|NCT03996694|101403687|FG002|NOT COMPLETED|Sixth Intervention (1 Day)||0||
48437333|NCT03996694|101403688|FG003|NOT COMPLETED|Sixth Intervention (1 Day)||0||
48437334|NCT03996694|101403689|FG004|NOT COMPLETED|Sixth Intervention (1 Day)||0||
48437335|NCT03996694|101403690|FG005|NOT COMPLETED|Sixth Intervention (1 Day)||0||
48437336|NCT01198327|101403691|FG000|STARTED|Overall Study||66||
48437337|NCT01198327|101403691|FG000|COMPLETED|Overall Study||56||
48437338|NCT01198327|101403691|FG000|NOT COMPLETED|Overall Study||10||
48437339|NCT01682681|101403692|FG000|STARTED|Overall Study||1234||
48437340|NCT01682681|101403692|FG000|Treated|Overall Study||1232||
48437341|NCT01682681|101403692|FG000|COMPLETED|Overall Study||902||
48437342|NCT01682681|101403692|FG000|NOT COMPLETED|Overall Study||332||
48437343|NCT02940392|101403693|FG000|STARTED|Overall Study||15||
48437344|NCT02940392|101403693|FG000|COMPLETED|Overall Study||7||
48437345|NCT02940392|101403693|FG000|NOT COMPLETED|Overall Study||8||
48437346|NCT04583592|101403694|FG000|STARTED|Overall Study||194||
48437347|NCT04583592|101403695|FG001|STARTED|Overall Study||101||
48437348|NCT04583592|101403694|FG000|COMPLETED|Overall Study||194||
48367552|NCT01259297|101227457|FG007|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0||
48367553|NCT01259297|101227450|FG000|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||355||
48367554|NCT01259297|101227451|FG001|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0||
48367555|NCT01259297|101227452|FG002|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||222||
48367556|NCT01259297|101227453|FG003|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0||
48367557|NCT01259297|101227454|FG004|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0||
48437349|NCT04583592|101403695|FG001|COMPLETED|Overall Study||100||
48437350|NCT04583592|101403694|FG000|NOT COMPLETED|Overall Study||0||
48437351|NCT04583592|101403695|FG001|NOT COMPLETED|Overall Study||1||
48437352|NCT01329562|101403696|FG000|STARTED|Overall Study||20||
48437353|NCT01329562|101403697|FG001|STARTED|Overall Study||21||
48437354|NCT01329562|101403696|FG000|COMPLETED|Overall Study||11||
48437355|NCT01329562|101403697|FG001|COMPLETED|Overall Study||14||
48437356|NCT01329562|101403696|FG000|NOT COMPLETED|Overall Study||9||
48437357|NCT01329562|101403697|FG001|NOT COMPLETED|Overall Study||7||
48437358|NCT00679042|101403698|FG000|STARTED|Transplant + 1 Year Follow Up||21||
48437359|NCT00679042|101403698|FG000|COMPLETED|Transplant + 1 Year Follow Up||19||
48437360|NCT00679042|101403698|FG000|NOT COMPLETED|Transplant + 1 Year Follow Up||2||
48437361|NCT00679042|101403698|FG000|STARTED|5-Year Follow Up||19||
48188382|NCT01606189|100783232|FG004|STARTED|Second Intenvention (14-20 Days)||8||
48188383|NCT01606189|100783233|FG005|STARTED|Second Intenvention (14-20 Days)||8||
48367558|NCT01259297|101227455|FG005|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0||
48367559|NCT01259297|101227456|FG006|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0||
48367560|NCT01259297|101227457|FG007|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0||
48188384|NCT01606189|100783228|FG000|COMPLETED|Second Intenvention (14-20 Days)||8||
48188385|NCT01606189|100783229|FG001|COMPLETED|Second Intenvention (14-20 Days)||8||
48188386|NCT01606189|100783230|FG002|COMPLETED|Second Intenvention (14-20 Days)||8||
48367561|NCT01259297|101227450|FG000|STARTED|Double Blind Randomized Period||244||
48367562|NCT01259297|101227451|FG001|STARTED|Double Blind Randomized Period||232||
48367563|NCT01259297|101227452|FG002|STARTED|Double Blind Randomized Period||189||
48367564|NCT01259297|101227453|FG003|STARTED|Double Blind Randomized Period||195||
48367565|NCT01259297|101227454|FG004|STARTED|Double Blind Randomized Period||251||
48367566|NCT01259297|101227455|FG005|STARTED|Double Blind Randomized Period||253||
48367567|NCT01259297|101227456|FG006|STARTED|Double Blind Randomized Period||196||
48188387|NCT01606189|100783231|FG003|COMPLETED|Second Intenvention (14-20 Days)||8||
48188388|NCT01606189|100783232|FG004|COMPLETED|Second Intenvention (14-20 Days)||8||
48188389|NCT01606189|100783233|FG005|COMPLETED|Second Intenvention (14-20 Days)||7||
48188390|NCT01606189|100783228|FG000|NOT COMPLETED|Second Intenvention (14-20 Days)||0||
48367568|NCT01259297|101227457|FG007|STARTED|Double Blind Randomized Period||199||
48367569|NCT01259297|101227450|FG000|COMPLETED|Double Blind Randomized Period||242||
48367570|NCT01259297|101227451|FG001|COMPLETED|Double Blind Randomized Period||229||
48367571|NCT01259297|101227452|FG002|COMPLETED|Double Blind Randomized Period||188||
48367572|NCT01259297|101227453|FG003|COMPLETED|Double Blind Randomized Period||191||
48367573|NCT01259297|101227454|FG004|COMPLETED|Double Blind Randomized Period||247||
48437362|NCT00679042|101403698|FG000|COMPLETED|5-Year Follow Up||5||
48188698|NCT02034435|100783315|FG003|STARTED|Overall Study||9||
48367574|NCT01259297|101227455|FG005|COMPLETED|Double Blind Randomized Period||245||
48367575|NCT01259297|101227456|FG006|COMPLETED|Double Blind Randomized Period||190||
48367576|NCT01259297|101227457|FG007|COMPLETED|Double Blind Randomized Period||196||
48367577|NCT01259297|101227450|FG000|NOT COMPLETED|Double Blind Randomized Period||2||
48367578|NCT01259297|101227451|FG001|NOT COMPLETED|Double Blind Randomized Period||3||
48367579|NCT01259297|101227452|FG002|NOT COMPLETED|Double Blind Randomized Period||1||
48367580|NCT01259297|101227453|FG003|NOT COMPLETED|Double Blind Randomized Period||4||
48367581|NCT01259297|101227454|FG004|NOT COMPLETED|Double Blind Randomized Period||4||
48437363|NCT00679042|101403698|FG000|NOT COMPLETED|5-Year Follow Up||14||
48437364|NCT00679042|101403698|FG000|STARTED|10-Year Follow Up||5||
48437365|NCT00679042|101403698|FG000|COMPLETED|10-Year Follow Up||0||
48437366|NCT00679042|101403698|FG000|NOT COMPLETED|10-Year Follow Up||5||
48437367|NCT01389856|101403699|FG000|STARTED|Overall Study||13||
48437368|NCT01389856|101403700|FG001|STARTED|Overall Study||8||
48437369|NCT01389856|101403699|FG000|COMPLETED|Overall Study||13||
48437370|NCT01389856|101403700|FG001|COMPLETED|Overall Study||8||
48437371|NCT01389856|101403699|FG000|NOT COMPLETED|Overall Study||0||
48437372|NCT01389856|101403700|FG001|NOT COMPLETED|Overall Study||0||
48367582|NCT01259297|101227455|FG005|NOT COMPLETED|Double Blind Randomized Period||8||
48367583|NCT01259297|101227456|FG006|NOT COMPLETED|Double Blind Randomized Period||6||
48367584|NCT01259297|101227457|FG007|NOT COMPLETED|Double Blind Randomized Period||3||
48437373|NCT01071278|101403701|FG000|STARTED|Overall Study||2390||
48437374|NCT01071278|101403701|FG000|COMPLETED|Overall Study||1677||
48437375|NCT01071278|101403701|FG000|NOT COMPLETED|Overall Study||713||
48437376|NCT03644927|101403702|FG000|STARTED|Overall Study||1||
48437377|NCT03644927|101403703|FG001|STARTED|Overall Study||0||
48437378|NCT03644927|101403702|FG000|COMPLETED|Overall Study||0||
48437379|NCT03644927|101403703|FG001|COMPLETED|Overall Study||0||
48437380|NCT03644927|101403702|FG000|NOT COMPLETED|Overall Study||1||
48437381|NCT03644927|101403703|FG001|NOT COMPLETED|Overall Study||0||
48437382|NCT04359758|101403704|FG000|STARTED|Overall Study||56||
48437383|NCT04359758|101403705|FG001|STARTED|Overall Study||56||
48437384|NCT04359758|101403704|FG000|COMPLETED|Overall Study||53||
48437385|NCT04359758|101403705|FG001|COMPLETED|Overall Study||54||
48437386|NCT04359758|101403704|FG000|NOT COMPLETED|Overall Study||3||
48437387|NCT04359758|101403705|FG001|NOT COMPLETED|Overall Study||2||
48437388|NCT00761735|101403706|FG000|STARTED|Overall Study||94||
48188391|NCT01606189|100783229|FG001|NOT COMPLETED|Second Intenvention (14-20 Days)||0||
48188392|NCT01606189|100783230|FG002|NOT COMPLETED|Second Intenvention (14-20 Days)||0||
48188393|NCT01606189|100783231|FG003|NOT COMPLETED|Second Intenvention (14-20 Days)||0||
48188394|NCT01606189|100783232|FG004|NOT COMPLETED|Second Intenvention (14-20 Days)||0||
48188395|NCT01606189|100783233|FG005|NOT COMPLETED|Second Intenvention (14-20 Days)||1||
48367585|NCT00945750|101230030|FG000|STARTED|Period I||5||
48367586|NCT00945750|101230031|FG001|STARTED|Period I||5||
48367587|NCT00945750|101230032|FG002|STARTED|Period I||5||
48367588|NCT00945750|101230033|FG003|STARTED|Period I||5||
48367589|NCT00945750|101230034|FG004|STARTED|Period I||5||
48367590|NCT00945750|101230035|FG005|STARTED|Period I||5||
48367591|NCT00945750|101230030|FG000|COMPLETED|Period I||5||
48367592|NCT00945750|101230031|FG001|COMPLETED|Period I||5||
48367593|NCT00945750|101230032|FG002|COMPLETED|Period I||5||
48367594|NCT00945750|101230033|FG003|COMPLETED|Period I||5||
48367595|NCT00945750|101230034|FG004|COMPLETED|Period I||5||
48367596|NCT00945750|101230035|FG005|COMPLETED|Period I||5||
48367597|NCT00945750|101230030|FG000|NOT COMPLETED|Period I||0||
48367598|NCT00945750|101230031|FG001|NOT COMPLETED|Period I||0||
48367599|NCT00945750|101230032|FG002|NOT COMPLETED|Period I||0||
48367600|NCT00945750|101230033|FG003|NOT COMPLETED|Period I||0||
48367601|NCT00945750|101230034|FG004|NOT COMPLETED|Period I||0||
48367602|NCT00945750|101230035|FG005|NOT COMPLETED|Period I||0||
48367603|NCT00945750|101230030|FG000|STARTED|Period II||5||
48367604|NCT00945750|101230031|FG001|STARTED|Period II||5||
48367605|NCT00945750|101230032|FG002|STARTED|Period II||5||
48367606|NCT00945750|101230033|FG003|STARTED|Period II||5||
48367607|NCT00945750|101230034|FG004|STARTED|Period II||5||
48367608|NCT00945750|101230035|FG005|STARTED|Period II||5||
48367609|NCT00945750|101230030|FG000|COMPLETED|Period II||5||
48367610|NCT00945750|101230031|FG001|COMPLETED|Period II||5||
48367611|NCT00945750|101230032|FG002|COMPLETED|Period II||5||
48367612|NCT00945750|101230033|FG003|COMPLETED|Period II||5||
48367613|NCT00945750|101230034|FG004|COMPLETED|Period II||5||
48367614|NCT00945750|101230035|FG005|COMPLETED|Period II||5||
48367615|NCT00945750|101230030|FG000|NOT COMPLETED|Period II||0||
48367616|NCT00945750|101230031|FG001|NOT COMPLETED|Period II||0||
48367617|NCT00945750|101230032|FG002|NOT COMPLETED|Period II||0||
48367618|NCT00945750|101230033|FG003|NOT COMPLETED|Period II||0||
48367619|NCT00945750|101230034|FG004|NOT COMPLETED|Period II||0||
48367620|NCT00945750|101230035|FG005|NOT COMPLETED|Period II||0||
48367621|NCT00945750|101230030|FG000|STARTED|Period III||5||
48437389|NCT00761735|101403706|FG000|COMPLETED|Overall Study||80||
48437390|NCT00761735|101403706|FG000|NOT COMPLETED|Overall Study||14||
48437391|NCT03958045|101403707|FG000|STARTED|Overall Study||33||
48437392|NCT03958045|101403707|FG000|COMPLETED|Overall Study||32||
48367622|NCT00945750|101230031|FG001|STARTED|Period III||5||
48367623|NCT00945750|101230032|FG002|STARTED|Period III||5||
48367624|NCT00945750|101230033|FG003|STARTED|Period III||5||
48367625|NCT00945750|101230034|FG004|STARTED|Period III||5||
48367626|NCT00945750|101230035|FG005|STARTED|Period III||5||
48367627|NCT00945750|101230030|FG000|COMPLETED|Period III||5||
48437393|NCT03958045|101403707|FG000|NOT COMPLETED|Overall Study||1||
48437394|NCT01556490|101403708|FG000|STARTED|Randomized Patients Summary||263|The Overall Survival (OS) efficacy endpoints analyzed on the modified Intent-To-Treat (mITT) population, comprising 481/526 randomized patients who met eligibility criteria.|
48440003|NCT04854421|101410007|FG000|STARTED|Overall Study||54||
48367628|NCT00945750|101230031|FG001|COMPLETED|Period III||5||
48367629|NCT00945750|101230032|FG002|COMPLETED|Period III||5||
48367630|NCT00945750|101230033|FG003|COMPLETED|Period III||5||
48367631|NCT00945750|101230034|FG004|COMPLETED|Period III||5||
48367632|NCT00945750|101230035|FG005|COMPLETED|Period III||5||
48367633|NCT00945750|101230030|FG000|NOT COMPLETED|Period III||0||
48367634|NCT00945750|101230031|FG001|NOT COMPLETED|Period III||0||
48367635|NCT00945750|101230032|FG002|NOT COMPLETED|Period III||0||
48367636|NCT00945750|101230033|FG003|NOT COMPLETED|Period III||0||
48367637|NCT00945750|101230034|FG004|NOT COMPLETED|Period III||0||
48437395|NCT01556490|101403709|FG001|STARTED|Randomized Patients Summary||263|The Overall Survival (OS) efficacy endpoints analyzed on the modified Intent-To-Treat (mITT) population, comprising 481/526 randomized patients who met eligibility criteria.|
48437396|NCT01556490|101403708|FG000|COMPLETED|Randomized Patients Summary||241||
48437397|NCT01556490|101403709|FG001|COMPLETED|Randomized Patients Summary||240||
48437398|NCT01556490|101403708|FG000|NOT COMPLETED|Randomized Patients Summary||22||
48437399|NCT01556490|101403709|FG001|NOT COMPLETED|Randomized Patients Summary||23||
48437400|NCT01556490|101403708|FG000|STARTED|Overall Survival (OS)||241|Modified Intent-to-treat (mITT) Population: all randomized patients who met the trial eligibility criteria at randomization formed the mITT population. Patients were analyzed according to the group to which they were randomized. This population was used for all efficacy endpoints.|
48437401|NCT01556490|101403709|FG001|STARTED|Overall Survival (OS)||240|Modified Intent-to-treat (mITT) Population: all randomized patients who met the trial eligibility criteria at randomization formed the mITT population. Patients were analyzed according to the group to which they were randomized. This population was used for all efficacy endpoints.|
48437402|NCT01556490|101403708|FG000|COMPLETED|Overall Survival (OS)||229|mITT: Patients who died and patients who remained in follow-up at the data cut-off date (30Apr2022), are considered to have completed the study.|
48437403|NCT01556490|101403709|FG001|COMPLETED|Overall Survival (OS)||222|mITT: Patients who died and patients who remained in follow-up at the data cut-off date (30Apr2022), are considered to have completed the study.|
48437404|NCT01556490|101403708|FG000|NOT COMPLETED|Overall Survival (OS)||12||
48437405|NCT01556490|101403709|FG001|NOT COMPLETED|Overall Survival (OS)||18||
48437406|NCT00323362|101403710|FG000|STARTED|Overall Study||17||
48437407|NCT00323362|101403710|FG000|COMPLETED|Overall Study||17||
48437408|NCT00323362|101403710|FG000|NOT COMPLETED|Overall Study||0||
48437409|NCT03910439|101403711|FG000|STARTED|Overall Study||4||
48367638|NCT00945750|101230035|FG005|NOT COMPLETED|Period III||0||
48367639|NCT02094586|101230036|FG000|STARTED|Overall Study||927||
48437410|NCT03910439|101403711|FG000|COMPLETED|Overall Study||4||
48437411|NCT03910439|101403711|FG000|NOT COMPLETED|Overall Study||0||
48437412|NCT03724305|101403712|FG000|STARTED|Overall Study||21||
48437413|NCT03724305|101403712|FG000|COMPLETED|Overall Study||19||
48437414|NCT03724305|101403712|FG000|NOT COMPLETED|Overall Study||2||
48437415|NCT03128931|101403713|FG000|STARTED|Overall Study||45||
48766559|NCT04163016|102218453|FG002|NOT COMPLETED|Enrollment||0||
48766560|NCT04163016|102218454|FG003|NOT COMPLETED|Enrollment||0||
48766561|NCT04163016|102218451|FG000|STARTED|Treatment||0||
48367640|NCT02094586|101230037|FG001|STARTED|Overall Study||933||
48367641|NCT02094586|101230038|FG002|STARTED|Overall Study||935||
48367642|NCT02094586|101230039|FG003|STARTED|Overall Study||351||
48367643|NCT02094586|101230036|FG000|COMPLETED|Overall Study||848|Study Completion (Day 181) - Completion of study is based upon the Study Completion/Early Term eCRF|
48367644|NCT02094586|101230037|FG001|COMPLETED|Overall Study||866|Study Completion (Day 181) - Completion of study is based upon the Study Completion/Early Term eCRF|
48367645|NCT02094586|101230038|FG002|COMPLETED|Overall Study||876|Study Completion (Day 181) - Completion of study is based upon the Study Completion/Early Term eCRF|
48367646|NCT02094586|101230039|FG003|COMPLETED|Overall Study||331|Study Completion (Day 181) - Completion of study is based upon the Study Completion/Early Term eCRF|
48367647|NCT02094586|101230036|FG000|NOT COMPLETED|Overall Study||79||
48367648|NCT02094586|101230037|FG001|NOT COMPLETED|Overall Study||67||
48367649|NCT02094586|101230038|FG002|NOT COMPLETED|Overall Study||59||
48367650|NCT02094586|101230039|FG003|NOT COMPLETED|Overall Study||20||
48367651|NCT01809262|101230040|FG000|STARTED|Period 1 (First Dose + Washout)||4||
48367652|NCT01809262|101230041|FG001|STARTED|Period 1 (First Dose + Washout)||4||
48367653|NCT01809262|101230042|FG002|STARTED|Period 1 (First Dose + Washout)||4||
48367654|NCT01809262|101230043|FG003|STARTED|Period 1 (First Dose + Washout)||3||
48367655|NCT01809262|101230044|FG004|STARTED|Period 1 (First Dose + Washout)||4||
48367656|NCT01809262|101230045|FG005|STARTED|Period 1 (First Dose + Washout)||3||
48367657|NCT01809262|101230046|FG006|STARTED|Period 1 (First Dose + Washout)||3||
48766562|NCT04163016|102218452|FG001|STARTED|Treatment||15||
48766563|NCT04163016|102218453|FG002|STARTED|Treatment||1||
48766564|NCT04163016|102218454|FG003|STARTED|Treatment||5||
48766565|NCT04163016|102218451|FG000|COMPLETED|Treatment||0||
48766566|NCT04163016|102218452|FG001|COMPLETED|Treatment||12||
48766567|NCT04163016|102218453|FG002|COMPLETED|Treatment||1||
48766568|NCT04163016|102218454|FG003|COMPLETED|Treatment||3||
48367658|NCT01809262|101230047|FG007|STARTED|Period 1 (First Dose + Washout)||4||
48367659|NCT01809262|101230048|FG008|STARTED|Period 1 (First Dose + Washout)||3||
48367660|NCT01809262|101230049|FG009|STARTED|Period 1 (First Dose + Washout)||4||
48367661|NCT01809262|101230040|FG000|COMPLETED|Period 1 (First Dose + Washout)||4||
48367662|NCT01809262|101230041|FG001|COMPLETED|Period 1 (First Dose + Washout)||4||
48367663|NCT01809262|101230042|FG002|COMPLETED|Period 1 (First Dose + Washout)||4||
48367664|NCT01809262|101230043|FG003|COMPLETED|Period 1 (First Dose + Washout)||3||
48367665|NCT01809262|101230044|FG004|COMPLETED|Period 1 (First Dose + Washout)||3||
48367666|NCT01809262|101230045|FG005|COMPLETED|Period 1 (First Dose + Washout)||3||
48367667|NCT01809262|101230046|FG006|COMPLETED|Period 1 (First Dose + Washout)||3||
48367668|NCT01809262|101230047|FG007|COMPLETED|Period 1 (First Dose + Washout)||4||
48367669|NCT01809262|101230048|FG008|COMPLETED|Period 1 (First Dose + Washout)||3||
48367670|NCT01809262|101230049|FG009|COMPLETED|Period 1 (First Dose + Washout)||4||
48437416|NCT03128931|101403713|FG000|COMPLETED|Overall Study||41||
48437417|NCT03128931|101403713|FG000|NOT COMPLETED|Overall Study||4||
48437418|NCT01977482|101403714|FG000|STARTED|Overall Study||39||
48437419|NCT01977482|101403715|FG001|STARTED|Overall Study||39||
48437420|NCT01977482|101403716|FG002|STARTED|Overall Study||40||
48437421|NCT01977482|101403717|FG003|STARTED|Overall Study||39||
48437422|NCT01977482|101403718|FG004|STARTED|Overall Study||40||
48437423|NCT01977482|101403719|FG005|STARTED|Overall Study||19||
48437424|NCT01977482|101403714|FG000|COMPLETED|Overall Study||36||
48437425|NCT01977482|101403715|FG001|COMPLETED|Overall Study||30||
48437426|NCT01977482|101403716|FG002|COMPLETED|Overall Study||35||
48437427|NCT01977482|101403717|FG003|COMPLETED|Overall Study||35||
48437428|NCT01977482|101403718|FG004|COMPLETED|Overall Study||37||
48437429|NCT01977482|101403719|FG005|COMPLETED|Overall Study||14||
48437430|NCT01977482|101403714|FG000|NOT COMPLETED|Overall Study||3||
48437431|NCT01977482|101403715|FG001|NOT COMPLETED|Overall Study||9||
48437432|NCT01977482|101403716|FG002|NOT COMPLETED|Overall Study||5||
48437433|NCT01977482|101403717|FG003|NOT COMPLETED|Overall Study||4||
48437434|NCT01977482|101403718|FG004|NOT COMPLETED|Overall Study||3||
48437435|NCT01977482|101403719|FG005|NOT COMPLETED|Overall Study||5||
48437436|NCT00761085|101403720|FG000|STARTED|Overall Study||12||
48437437|NCT00761085|101403721|FG001|STARTED|Overall Study||12||
48437438|NCT00761085|101403722|FG002|STARTED|Overall Study||11||
48437439|NCT00761085|101403723|FG003|STARTED|Overall Study||12||
48437440|NCT00761085|101403720|FG000|COMPLETED|Overall Study||12||
48437441|NCT00761085|101403721|FG001|COMPLETED|Overall Study||6||
48437442|NCT00761085|101403722|FG002|COMPLETED|Overall Study||11||
48437443|NCT00761085|101403723|FG003|COMPLETED|Overall Study||8||
48437444|NCT00761085|101403720|FG000|NOT COMPLETED|Overall Study||0||
48437445|NCT00761085|101403721|FG001|NOT COMPLETED|Overall Study||6||
48437446|NCT00761085|101403722|FG002|NOT COMPLETED|Overall Study||0||
48437447|NCT00761085|101403723|FG003|NOT COMPLETED|Overall Study||4||
48437448|NCT03107715|101403724|FG000|STARTED|Overall Study||132||
48437449|NCT03107715|101403725|FG001|STARTED|Overall Study||111||
48437450|NCT03107715|101403724|FG000|COMPLETED|Overall Study||128||
48437451|NCT03107715|101403725|FG001|COMPLETED|Overall Study||104||
48437452|NCT03107715|101403724|FG000|NOT COMPLETED|Overall Study||4||
48437453|NCT03107715|101403725|FG001|NOT COMPLETED|Overall Study||7||
48437454|NCT03209973|101403726|FG000|STARTED|Overall Study||70||
48437455|NCT03209973|101403726|FG000|Completed Primary Outcome Period|Overall Study||66||
48437456|NCT03209973|101403726|FG000|COMPLETED|Overall Study||0||
48437457|NCT03209973|101403726|FG000|NOT COMPLETED|Overall Study||70||
48437458|NCT04633187|101403727|FG000|STARTED|Overall Study||5||
48437459|NCT04633187|101403728|FG001|STARTED|Overall Study||4||
48437460|NCT04633187|101403727|FG000|EDP-938 150 mg|Overall Study||1||
48437461|NCT04633187|101403728|FG001|EDP-938 150 mg|Overall Study||0||
48437462|NCT04633187|101403727|FG000|EDP-938 400 mg|Overall Study||1||
48437463|NCT04633187|101403728|FG001|EDP-938 400 mg|Overall Study||0||
48437464|NCT04633187|101403727|FG000|EDP-938 800 mg|Overall Study||3||
48437465|NCT04633187|101403728|FG001|EDP-938 800 mg|Overall Study||0||
48437466|NCT04633187|101403727|FG000|COMPLETED|Overall Study||5||
48437467|NCT04633187|101403728|FG001|COMPLETED|Overall Study||4||
48437468|NCT04633187|101403727|FG000|NOT COMPLETED|Overall Study||0||
48437469|NCT04633187|101403728|FG001|NOT COMPLETED|Overall Study||0||
48437470|NCT03781817|101403729|FG000|STARTED|Overall Study||17||
48437471|NCT03781817|101403730|FG001|STARTED|Overall Study||23||
48437472|NCT03781817|101403729|FG000|COMPLETED|Overall Study||17||
48437473|NCT03781817|101403730|FG001|COMPLETED|Overall Study||23||
48437474|NCT03781817|101403729|FG000|NOT COMPLETED|Overall Study||0||
48437475|NCT03781817|101403730|FG001|NOT COMPLETED|Overall Study||0||
48437476|NCT00939367|101403731|FG000|STARTED|First Intervention||15||
48437477|NCT00939367|101403732|FG001|STARTED|First Intervention||15||
48437478|NCT00939367|101403731|FG000|COMPLETED|First Intervention||15||
48437479|NCT00939367|101403732|FG001|COMPLETED|First Intervention||15||
48437480|NCT00939367|101403731|FG000|NOT COMPLETED|First Intervention||0||
48437481|NCT00939367|101403732|FG001|NOT COMPLETED|First Intervention||0||
48437482|NCT00939367|101403731|FG000|STARTED|Second Intervention||15||
48437483|NCT00939367|101403732|FG001|STARTED|Second Intervention||15||
48437484|NCT00939367|101403731|FG000|COMPLETED|Second Intervention||15||
48437485|NCT00939367|101403732|FG001|COMPLETED|Second Intervention||15||
48437486|NCT00939367|101403731|FG000|NOT COMPLETED|Second Intervention||0||
48437487|NCT00939367|101403732|FG001|NOT COMPLETED|Second Intervention||0||
48437488|NCT01789476|101403733|FG000|STARTED|Overall Study||34||
48437489|NCT01789476|101403734|FG001|STARTED|Overall Study||17||
48437490|NCT01789476|101403733|FG000|COMPLETED|Overall Study||26||
48437491|NCT01789476|101403734|FG001|COMPLETED|Overall Study||15||
48437492|NCT01789476|101403733|FG000|NOT COMPLETED|Overall Study||8||
48437493|NCT01789476|101403734|FG001|NOT COMPLETED|Overall Study||2||
48437494|NCT00924313|101403735|FG000|STARTED|Overall Study||40||
48437495|NCT00924313|101403735|FG000|COMPLETED|Overall Study||39||
48437496|NCT00924313|101403735|FG000|NOT COMPLETED|Overall Study||1||
48437497|NCT00807040|101403736|FG000|STARTED|Overall Study||126||
48437498|NCT00807040|101403737|FG001|STARTED|Overall Study||125||
48437499|NCT00807040|101403736|FG000|COMPLETED|Overall Study||90||
48437500|NCT00807040|101403737|FG001|COMPLETED|Overall Study||84||
48437501|NCT00807040|101403736|FG000|NOT COMPLETED|Overall Study||36||
48437502|NCT00807040|101403737|FG001|NOT COMPLETED|Overall Study||41||
48437503|NCT02339246|101403738|FG000|STARTED|First Intervention (7 Days)||0||
48437504|NCT02339246|101403739|FG001|STARTED|First Intervention (7 Days)||0||
48437505|NCT02339246|101403740|FG002|STARTED|First Intervention (7 Days)||31||
48437506|NCT02339246|101403738|FG000|COMPLETED|First Intervention (7 Days)||0||
48437507|NCT02339246|101403739|FG001|COMPLETED|First Intervention (7 Days)||0||
48437508|NCT02339246|101403740|FG002|COMPLETED|First Intervention (7 Days)||31||
48437509|NCT02339246|101403738|FG000|NOT COMPLETED|First Intervention (7 Days)||0||
48437510|NCT02339246|101403739|FG001|NOT COMPLETED|First Intervention (7 Days)||0||
48437511|NCT02339246|101403740|FG002|NOT COMPLETED|First Intervention (7 Days)||0||
48437512|NCT02339246|101403738|FG000|STARTED|Second Intervention (7 Days)||16||
48437513|NCT02339246|101403739|FG001|STARTED|Second Intervention (7 Days)||15||
48437514|NCT02339246|101403740|FG002|STARTED|Second Intervention (7 Days)||0||
48437515|NCT02339246|101403738|FG000|COMPLETED|Second Intervention (7 Days)||16||
48437516|NCT02339246|101403739|FG001|COMPLETED|Second Intervention (7 Days)||15||
48437517|NCT02339246|101403740|FG002|COMPLETED|Second Intervention (7 Days)||0||
48437518|NCT02339246|101403738|FG000|NOT COMPLETED|Second Intervention (7 Days)||0||
48437519|NCT02339246|101403739|FG001|NOT COMPLETED|Second Intervention (7 Days)||0||
48437520|NCT02339246|101403740|FG002|NOT COMPLETED|Second Intervention (7 Days)||0||
48437521|NCT02339246|101403738|FG000|STARTED|Third Period (7 Days)||15||
48437522|NCT02339246|101403739|FG001|STARTED|Third Period (7 Days)||16||
48437523|NCT02339246|101403740|FG002|STARTED|Third Period (7 Days)||0||
48437524|NCT02339246|101403738|FG000|COMPLETED|Third Period (7 Days)||15||
48437525|NCT02339246|101403739|FG001|COMPLETED|Third Period (7 Days)||16||
48437526|NCT02339246|101403740|FG002|COMPLETED|Third Period (7 Days)||0||
48437527|NCT02339246|101403738|FG000|NOT COMPLETED|Third Period (7 Days)||0||
48437528|NCT02339246|101403739|FG001|NOT COMPLETED|Third Period (7 Days)||0||
48437529|NCT02339246|101403740|FG002|NOT COMPLETED|Third Period (7 Days)||0||
48437530|NCT00449761|101403741|FG000|STARTED|Overall Study||27||
48437531|NCT00449761|101403741|FG000|COMPLETED|Overall Study||9||
48367671|NCT01809262|101230040|FG000|NOT COMPLETED|Period 1 (First Dose + Washout)||0||
48367672|NCT01809262|101230041|FG001|NOT COMPLETED|Period 1 (First Dose + Washout)||0||
48367673|NCT01809262|101230042|FG002|NOT COMPLETED|Period 1 (First Dose + Washout)||0||
48367674|NCT01809262|101230043|FG003|NOT COMPLETED|Period 1 (First Dose + Washout)||0||
48367675|NCT01809262|101230044|FG004|NOT COMPLETED|Period 1 (First Dose + Washout)||1||
48367676|NCT01809262|101230045|FG005|NOT COMPLETED|Period 1 (First Dose + Washout)||0||
48367677|NCT01809262|101230046|FG006|NOT COMPLETED|Period 1 (First Dose + Washout)||0||
48367678|NCT01809262|101230047|FG007|NOT COMPLETED|Period 1 (First Dose + Washout)||0||
48367679|NCT01809262|101230048|FG008|NOT COMPLETED|Period 1 (First Dose + Washout)||0||
48367680|NCT01809262|101230049|FG009|NOT COMPLETED|Period 1 (First Dose + Washout)||0||
48367681|NCT01809262|101230040|FG000|STARTED|Period 2 (Second Dose + Washout)||4||
48367682|NCT01809262|101230041|FG001|STARTED|Period 2 (Second Dose + Washout)||4||
48367683|NCT01809262|101230042|FG002|STARTED|Period 2 (Second Dose + Washout)||4||
48367684|NCT01809262|101230043|FG003|STARTED|Period 2 (Second Dose + Washout)||3||
48367685|NCT01809262|101230044|FG004|STARTED|Period 2 (Second Dose + Washout)||3||
48367686|NCT01809262|101230045|FG005|STARTED|Period 2 (Second Dose + Washout)||3||
48367687|NCT01809262|101230046|FG006|STARTED|Period 2 (Second Dose + Washout)||3||
48367688|NCT01809262|101230047|FG007|STARTED|Period 2 (Second Dose + Washout)||4||
48367689|NCT01809262|101230048|FG008|STARTED|Period 2 (Second Dose + Washout)||3||
48367690|NCT01809262|101230049|FG009|STARTED|Period 2 (Second Dose + Washout)||4||
48367691|NCT01809262|101230040|FG000|COMPLETED|Period 2 (Second Dose + Washout)||4||
48367692|NCT01809262|101230041|FG001|COMPLETED|Period 2 (Second Dose + Washout)||4||
48437532|NCT00449761|101403741|FG000|NOT COMPLETED|Overall Study||18||
48437533|NCT00938392|101403742|FG000|STARTED|Overall Study||362||
48437534|NCT00938392|101403743|FG001|STARTED|Overall Study||362||
48367693|NCT01809262|101230042|FG002|COMPLETED|Period 2 (Second Dose + Washout)||4||
48367694|NCT01809262|101230043|FG003|COMPLETED|Period 2 (Second Dose + Washout)||3||
48437535|NCT00938392|101403742|FG000|COMPLETED|Overall Study||360||
48437536|NCT00938392|101403743|FG001|COMPLETED|Overall Study||358||
48437537|NCT00938392|101403742|FG000|NOT COMPLETED|Overall Study||2||
48437538|NCT00938392|101403743|FG001|NOT COMPLETED|Overall Study||4||
48437539|NCT02806700|101403744|FG000|STARTED|Overall Study||316||
48437540|NCT02806700|101403745|FG001|STARTED|Overall Study||312||
48437541|NCT02806700|101403744|FG000|COMPLETED|Overall Study||226||
48437542|NCT02806700|101403745|FG001|COMPLETED|Overall Study||252||
48437543|NCT02806700|101403744|FG000|NOT COMPLETED|Overall Study||90||
48437544|NCT02806700|101403745|FG001|NOT COMPLETED|Overall Study||60||
48437545|NCT02303977|101403746|FG000|STARTED|Overall Study||37||
48437546|NCT02303977|101403746|FG000|COMPLETED|Overall Study||37||
48367695|NCT01809262|101230044|FG004|COMPLETED|Period 2 (Second Dose + Washout)||3||
48437547|NCT02303977|101403746|FG000|NOT COMPLETED|Overall Study||0||
48437548|NCT03205046|101403747|FG000|STARTED|Overall Study||13||
48437549|NCT03205046|101403748|FG001|STARTED|Overall Study||12||
48437550|NCT03205046|101403747|FG000|COMPLETED|Overall Study||0||
48437551|NCT03205046|101403748|FG001|COMPLETED|Overall Study||2||
48437552|NCT03205046|101403747|FG000|NOT COMPLETED|Overall Study||13||
48437553|NCT03205046|101403748|FG001|NOT COMPLETED|Overall Study||10||
48437554|NCT02787746|101403749|FG000|STARTED|Overall Study||241||
48437555|NCT02787746|101403749|FG000|COMPLETED|Overall Study||93||
48437556|NCT02787746|101403749|FG000|NOT COMPLETED|Overall Study||148||
48655824|NCT05206604|101941287|FG002|STARTED|Overall Study||4||
48655825|NCT05206604|101941288|FG003|STARTED|Overall Study||2||
48655826|NCT05206604|101941289|FG004|STARTED|Overall Study||4||
48655827|NCT05206604|101941290|FG005|STARTED|Overall Study||2||
48655828|NCT05206604|101941291|FG006|STARTED|Overall Study||4||
48655829|NCT05206604|101941292|FG007|STARTED|Overall Study||2||
48655830|NCT05206604|101941285|FG000|Received Treatment|Overall Study||4||
48655831|NCT05206604|101941286|FG001|Received Treatment|Overall Study||2||
48655832|NCT05206604|101941287|FG002|Received Treatment|Overall Study||4||
48655833|NCT05206604|101941288|FG003|Received Treatment|Overall Study||2||
48655834|NCT05206604|101941289|FG004|Received Treatment|Overall Study||4||
48655835|NCT05206604|101941290|FG005|Received Treatment|Overall Study||2||
48655836|NCT05206604|101941291|FG006|Received Treatment|Overall Study||4||
48655837|NCT05206604|101941292|FG007|Received Treatment|Overall Study||2||
48655838|NCT05206604|101941285|FG000|COMPLETED|Overall Study||4||
48655839|NCT05206604|101941286|FG001|COMPLETED|Overall Study||2||
48655840|NCT05206604|101941287|FG002|COMPLETED|Overall Study||4||
48655841|NCT05206604|101941288|FG003|COMPLETED|Overall Study||2||
48655842|NCT05206604|101941289|FG004|COMPLETED|Overall Study||4||
48655843|NCT05206604|101941290|FG005|COMPLETED|Overall Study||1||
48655844|NCT05206604|101941291|FG006|COMPLETED|Overall Study||4||
48655845|NCT05206604|101941292|FG007|COMPLETED|Overall Study||2||
48655846|NCT05206604|101941285|FG000|NOT COMPLETED|Overall Study||0||
48655847|NCT05206604|101941286|FG001|NOT COMPLETED|Overall Study||0||
48655848|NCT05206604|101941287|FG002|NOT COMPLETED|Overall Study||0||
48655849|NCT05206604|101941288|FG003|NOT COMPLETED|Overall Study||0||
48655850|NCT05206604|101941289|FG004|NOT COMPLETED|Overall Study||0||
48655851|NCT05206604|101941290|FG005|NOT COMPLETED|Overall Study||1||
48655852|NCT05206604|101941291|FG006|NOT COMPLETED|Overall Study||0||
48655853|NCT05206604|101941292|FG007|NOT COMPLETED|Overall Study||0||
48655854|NCT06048705|101941293|FG000|STARTED|Overall Study||1||
48655855|NCT06048705|101941294|FG001|STARTED|Overall Study||4||
48655856|NCT06048705|101941295|FG002|STARTED|Overall Study||2||
48655857|NCT06048705|101941293|FG000|Transferred to Long-term Follow-up Study|Overall Study||0||
48655858|NCT06048705|101941294|FG001|Transferred to Long-term Follow-up Study|Overall Study||2||
48655859|NCT06048705|101941295|FG002|Transferred to Long-term Follow-up Study|Overall Study||0||
48655860|NCT06048705|101941293|FG000|Death Post Lymphodepletion|Overall Study||0||
48655861|NCT06048705|101941294|FG001|Death Post Lymphodepletion|Overall Study||2||
48655862|NCT06048705|101941295|FG002|Death Post Lymphodepletion|Overall Study||0||
48655863|NCT06048705|101941293|FG000|COMPLETED|Overall Study||0|Participants who were transferred to the long-term follow-up protocol or have died are considered to have completed.|
48655864|NCT06048705|101941294|FG001|COMPLETED|Overall Study||4|Participants who were transferred to the long-term follow-up protocol or have died are considered to have completed.|
48655865|NCT06048705|101941295|FG002|COMPLETED|Overall Study||0|Participants who were transferred to the long-term follow-up protocol or have died are considered to have completed.|
48655866|NCT06048705|101941293|FG000|NOT COMPLETED|Overall Study||1||
48655867|NCT06048705|101941294|FG001|NOT COMPLETED|Overall Study||0||
48655868|NCT06048705|101941295|FG002|NOT COMPLETED|Overall Study||2||
48655869|NCT01331330|101941296|FG000|STARTED|Overall Study||5||
48655870|NCT01331330|101941297|FG001|STARTED|Overall Study||4||
48655871|NCT01331330|101941296|FG000|COMPLETED|Overall Study||3||
48655872|NCT01331330|101941297|FG001|COMPLETED|Overall Study||3||
48655873|NCT01331330|101941296|FG000|NOT COMPLETED|Overall Study||2||
48655874|NCT01331330|101941297|FG001|NOT COMPLETED|Overall Study||1||
48655875|NCT01045265|101941298|FG000|STARTED|Overall Study||16||
48655876|NCT01045265|101941298|FG000|COMPLETED|Overall Study||16||
48655877|NCT01045265|101941298|FG000|NOT COMPLETED|Overall Study||0||
48655878|NCT04229381|101941299|FG000|STARTED|Overall Study||18||
48437557|NCT00209560|101403750|FG000|STARTED|Overall Study||121||
48437558|NCT00209560|101403751|FG001|STARTED|Overall Study||42||
48437559|NCT00209560|101403750|FG000|COMPLETED|Overall Study||120||
48437560|NCT00209560|101403751|FG001|COMPLETED|Overall Study||42||
48655879|NCT04229381|101941299|FG000|COMPLETED|Overall Study||18||
48655880|NCT04229381|101941299|FG000|NOT COMPLETED|Overall Study||0||
48655881|NCT00345592|101941300|FG000|STARTED|Overall Study||199||
48655882|NCT00345592|101941301|FG001|STARTED|Overall Study||197||
48655883|NCT00345592|101941300|FG000|COMPLETED|Overall Study||174||
48655884|NCT00345592|101941301|FG001|COMPLETED|Overall Study||173||
48655885|NCT00345592|101941300|FG000|NOT COMPLETED|Overall Study||25||
48655886|NCT00345592|101941301|FG001|NOT COMPLETED|Overall Study||24||
48655887|NCT05226884|101941302|FG000|STARTED|Overall Study||155||
48437561|NCT00209560|101403750|FG000|NOT COMPLETED|Overall Study||1||
48437562|NCT00209560|101403751|FG001|NOT COMPLETED|Overall Study||0||
48437563|NCT00684645|101403752|FG000|STARTED|Overall Study||186||
48437564|NCT00684645|101403752|FG000|COMPLETED|Overall Study||72||
48437565|NCT00684645|101403752|FG000|NOT COMPLETED|Overall Study||114||
48437566|NCT01568255|101403753|FG000|STARTED|Overall Study||5||
48437567|NCT01568255|101403754|FG001|STARTED|Overall Study||6||
48437568|NCT01568255|101403753|FG000|COMPLETED|Overall Study||5||
48437569|NCT01568255|101403754|FG001|COMPLETED|Overall Study||6||
48437570|NCT01568255|101403753|FG000|NOT COMPLETED|Overall Study||0||
48437571|NCT01568255|101403754|FG001|NOT COMPLETED|Overall Study||0||
48437572|NCT00718809|101403755|FG000|STARTED|Overall Study||12||
48437573|NCT00718809|101403756|FG001|STARTED|Overall Study||9||
48437574|NCT00718809|101403755|FG000|COMPLETED|Overall Study||0||
48437575|NCT00718809|101403756|FG001|COMPLETED|Overall Study||0||
48437576|NCT00718809|101403755|FG000|NOT COMPLETED|Overall Study||12||
48437577|NCT00718809|101403756|FG001|NOT COMPLETED|Overall Study||9||
48437578|NCT01058707|101403757|FG000|STARTED|Overall Study||31||
48437579|NCT01058707|101403758|FG001|STARTED|Overall Study||30||
48437580|NCT01058707|101403759|FG002|STARTED|Overall Study||33||
48437581|NCT01058707|101403760|FG003|STARTED|Overall Study||22||
48437582|NCT01058707|101403761|FG004|STARTED|Overall Study||39||
48437583|NCT01058707|101403762|FG005|STARTED|Overall Study||17||
48437584|NCT01058707|101403763|FG006|STARTED|Overall Study||26||
48437585|NCT01058707|101403757|FG000|COMPLETED|Overall Study||0||
48437586|NCT01058707|101403758|FG001|COMPLETED|Overall Study||0||
48437587|NCT01058707|101403759|FG002|COMPLETED|Overall Study||0||
48437588|NCT01058707|101403760|FG003|COMPLETED|Overall Study||0||
48437589|NCT01058707|101403761|FG004|COMPLETED|Overall Study||0||
48367696|NCT01809262|101230045|FG005|COMPLETED|Period 2 (Second Dose + Washout)||3||
48367697|NCT01809262|101230046|FG006|COMPLETED|Period 2 (Second Dose + Washout)||3||
48367698|NCT01809262|101230047|FG007|COMPLETED|Period 2 (Second Dose + Washout)||4||
48367699|NCT01809262|101230048|FG008|COMPLETED|Period 2 (Second Dose + Washout)||3||
48367700|NCT01809262|101230049|FG009|COMPLETED|Period 2 (Second Dose + Washout)||4||
48367701|NCT01809262|101230040|FG000|NOT COMPLETED|Period 2 (Second Dose + Washout)||0||
48367702|NCT01809262|101230041|FG001|NOT COMPLETED|Period 2 (Second Dose + Washout)||0||
48367703|NCT01809262|101230042|FG002|NOT COMPLETED|Period 2 (Second Dose + Washout)||0||
48367704|NCT01809262|101230043|FG003|NOT COMPLETED|Period 2 (Second Dose + Washout)||0||
48367705|NCT01809262|101230044|FG004|NOT COMPLETED|Period 2 (Second Dose + Washout)||0||
48367706|NCT01809262|101230045|FG005|NOT COMPLETED|Period 2 (Second Dose + Washout)||0||
48367707|NCT01809262|101230046|FG006|NOT COMPLETED|Period 2 (Second Dose + Washout)||0||
48367708|NCT01809262|101230047|FG007|NOT COMPLETED|Period 2 (Second Dose + Washout)||0||
48367709|NCT01809262|101230048|FG008|NOT COMPLETED|Period 2 (Second Dose + Washout)||0||
48367710|NCT01809262|101230049|FG009|NOT COMPLETED|Period 2 (Second Dose + Washout)||0||
48437590|NCT01058707|101403762|FG005|COMPLETED|Overall Study||0||
48437591|NCT01058707|101403763|FG006|COMPLETED|Overall Study||0||
48766569|NCT04163016|102218451|FG000|NOT COMPLETED|Treatment||0||
48766570|NCT04163016|102218452|FG001|NOT COMPLETED|Treatment||3||
48766571|NCT04163016|102218453|FG002|NOT COMPLETED|Treatment||0||
48766572|NCT04163016|102218454|FG003|NOT COMPLETED|Treatment||2||
48766573|NCT01780506|102218455|FG000|STARTED|Double-Blind Phase||438||
48437592|NCT01058707|101403757|FG000|NOT COMPLETED|Overall Study||31||
48437593|NCT01058707|101403758|FG001|NOT COMPLETED|Overall Study||30||
48437594|NCT01058707|101403759|FG002|NOT COMPLETED|Overall Study||33||
48437595|NCT01058707|101403760|FG003|NOT COMPLETED|Overall Study||22||
48437596|NCT01058707|101403761|FG004|NOT COMPLETED|Overall Study||39||
48437597|NCT01058707|101403762|FG005|NOT COMPLETED|Overall Study||17||
48437598|NCT01058707|101403763|FG006|NOT COMPLETED|Overall Study||26||
48437599|NCT02596009|101403764|FG000|STARTED|Overall Study||14||
48437600|NCT02596009|101403765|FG001|STARTED|Overall Study||16||
48437601|NCT02596009|101403766|FG002|STARTED|Overall Study||16||
48437602|NCT02596009|101403767|FG003|STARTED|Overall Study||16||
48437603|NCT02596009|101403768|FG004|STARTED|Overall Study||18||
48437604|NCT02596009|101403769|FG005|STARTED|Overall Study||17||
48437605|NCT02596009|101403764|FG000|COMPLETED|Overall Study||14||
48437606|NCT02596009|101403765|FG001|COMPLETED|Overall Study||15||
48437607|NCT02596009|101403766|FG002|COMPLETED|Overall Study||16||
48437608|NCT02596009|101403767|FG003|COMPLETED|Overall Study||16||
48437609|NCT02596009|101403768|FG004|COMPLETED|Overall Study||18||
48437610|NCT02596009|101403769|FG005|COMPLETED|Overall Study||17||
48437611|NCT02596009|101403764|FG000|NOT COMPLETED|Overall Study||0||
48437612|NCT02596009|101403765|FG001|NOT COMPLETED|Overall Study||1||
48437613|NCT02596009|101403766|FG002|NOT COMPLETED|Overall Study||0||
48437614|NCT02596009|101403767|FG003|NOT COMPLETED|Overall Study||0||
48437615|NCT02596009|101403768|FG004|NOT COMPLETED|Overall Study||0||
48437616|NCT02596009|101403769|FG005|NOT COMPLETED|Overall Study||0||
48437617|NCT00333437|101403770|FG000|STARTED|Overall Study||7||
48437618|NCT00333437|101403770|FG000|COMPLETED|Overall Study||7||
48437619|NCT00333437|101403770|FG000|NOT COMPLETED|Overall Study||0||
48437620|NCT01054209|101403771|FG000|STARTED|Overall Study||58||
48437621|NCT01054209|101403772|FG001|STARTED|Overall Study||58||
48437622|NCT01054209|101403771|FG000|COMPLETED|Overall Study||58||
48437623|NCT01054209|101403772|FG001|COMPLETED|Overall Study||58||
48766574|NCT01780506|102218456|FG001|STARTED|Double-Blind Phase||434||
48766575|NCT01780506|102218455|FG000|COMPLETED|Double-Blind Phase||368||
48367711|NCT01809262|101230040|FG000|STARTED|Period 3 (Third Dose + Washout)||4||
48367712|NCT01809262|101230041|FG001|STARTED|Period 3 (Third Dose + Washout)||4||
48367713|NCT01809262|101230042|FG002|STARTED|Period 3 (Third Dose + Washout)||4||
48367714|NCT01809262|101230043|FG003|STARTED|Period 3 (Third Dose + Washout)||3||
48766576|NCT01780506|102218456|FG001|COMPLETED|Double-Blind Phase||356||
48437624|NCT01054209|101403771|FG000|NOT COMPLETED|Overall Study||0||
48437625|NCT01054209|101403772|FG001|NOT COMPLETED|Overall Study||0||
48437626|NCT02049931|101403773|FG000|STARTED|Overall Study||20||
48437627|NCT02049931|101403774|FG001|STARTED|Overall Study||20||
48437628|NCT02049931|101403775|FG002|STARTED|Overall Study||20||
48766577|NCT01780506|102218455|FG000|NOT COMPLETED|Double-Blind Phase||70||
48766578|NCT01780506|102218456|FG001|NOT COMPLETED|Double-Blind Phase||78||
48766579|NCT01780506|102218455|FG000|STARTED|Open-Label Extension Phase||90||
48766580|NCT01780506|102218456|FG001|STARTED|Open-Label Extension Phase||95||
48766581|NCT01780506|102218455|FG000|COMPLETED|Open-Label Extension Phase||90||
48766582|NCT01780506|102218456|FG001|COMPLETED|Open-Label Extension Phase||94||
48766583|NCT01780506|102218455|FG000|NOT COMPLETED|Open-Label Extension Phase||0||
48766584|NCT01780506|102218456|FG001|NOT COMPLETED|Open-Label Extension Phase||1||
48766585|NCT02691507|102218457|FG000|STARTED|Overall Study||40||
48766586|NCT02691507|102218458|FG001|STARTED|Overall Study||13||
48766587|NCT02691507|102218457|FG000|COMPLETED|Overall Study||40||
48766588|NCT02691507|102218458|FG001|COMPLETED|Overall Study||12||
48766589|NCT02691507|102218457|FG000|NOT COMPLETED|Overall Study||0||
48766590|NCT02691507|102218458|FG001|NOT COMPLETED|Overall Study||1||
48766591|NCT02833233|102218459|FG000|STARTED|Overall Study||5||
48766592|NCT02833233|102218459|FG000|COMPLETED|Overall Study||5||
48766593|NCT02833233|102218459|FG000|NOT COMPLETED|Overall Study||0||
48766594|NCT00674817|102218460|FG000|STARTED|Period 1||44||
48766595|NCT00674817|102218460|FG000|COMPLETED|Period 1||41||
48766596|NCT00674817|102218460|FG000|NOT COMPLETED|Period 1||3||
48766597|NCT00674817|102218460|FG000|STARTED|Period 2||41||
48188396|NCT01606189|100783228|FG000|STARTED|Third Intenvention (14-20 Days)||8||
48188397|NCT01606189|100783229|FG001|STARTED|Third Intenvention (14-20 Days)||8||
48188398|NCT01606189|100783230|FG002|STARTED|Third Intenvention (14-20 Days)||8||
48188399|NCT01606189|100783231|FG003|STARTED|Third Intenvention (14-20 Days)||8||
48188400|NCT01606189|100783232|FG004|STARTED|Third Intenvention (14-20 Days)||8||
48188401|NCT01606189|100783233|FG005|STARTED|Third Intenvention (14-20 Days)||7||
48188402|NCT01606189|100783228|FG000|COMPLETED|Third Intenvention (14-20 Days)||8||
48188403|NCT01606189|100783229|FG001|COMPLETED|Third Intenvention (14-20 Days)||8||
48188404|NCT01606189|100783230|FG002|COMPLETED|Third Intenvention (14-20 Days)||8||
48188405|NCT01606189|100783231|FG003|COMPLETED|Third Intenvention (14-20 Days)||8||
48188406|NCT01606189|100783232|FG004|COMPLETED|Third Intenvention (14-20 Days)||8||
48188407|NCT01606189|100783233|FG005|COMPLETED|Third Intenvention (14-20 Days)||6||
48188408|NCT01606189|100783228|FG000|NOT COMPLETED|Third Intenvention (14-20 Days)||0||
48188409|NCT01606189|100783229|FG001|NOT COMPLETED|Third Intenvention (14-20 Days)||0||
48188410|NCT01606189|100783230|FG002|NOT COMPLETED|Third Intenvention (14-20 Days)||0||
48188411|NCT01606189|100783231|FG003|NOT COMPLETED|Third Intenvention (14-20 Days)||0||
48188412|NCT01606189|100783232|FG004|NOT COMPLETED|Third Intenvention (14-20 Days)||0||
48188413|NCT01606189|100783233|FG005|NOT COMPLETED|Third Intenvention (14-20 Days)||1||
48188414|NCT00556543|100783234|FG000|STARTED|Overall Study||10||
48188415|NCT00556543|100783234|FG000|COMPLETED|Overall Study||10||
48188416|NCT00556543|100783234|FG000|NOT COMPLETED|Overall Study||0||
48188417|NCT00597870|100783235|FG000|STARTED|Overall Study||304||
48188418|NCT00597870|100783235|FG000|COMPLETED|Overall Study||304||
48188419|NCT00597870|100783235|FG000|NOT COMPLETED|Overall Study||0||
48188420|NCT04794062|100783236|FG000|STARTED|Overall Study||119||
48188421|NCT04794062|100783236|FG000|COMPLETED|Overall Study||106||
48188422|NCT04794062|100783236|FG000|NOT COMPLETED|Overall Study||13||
48188423|NCT01276535|100783237|FG000|STARTED|Overall Study||12||
48188424|NCT01276535|100783237|FG000|COMPLETED|Overall Study||12||
48188425|NCT01276535|100783237|FG000|NOT COMPLETED|Overall Study||0||
48188426|NCT02688621|100783238|FG000|STARTED|Overall Study||212||
48188427|NCT02688621|100783239|FG001|STARTED|Overall Study||206||
48188428|NCT02688621|100783238|FG000|COMPLETED|Overall Study||172||
48188429|NCT02688621|100783239|FG001|COMPLETED|Overall Study||188||
48188430|NCT02688621|100783238|FG000|NOT COMPLETED|Overall Study||40||
48188431|NCT02688621|100783239|FG001|NOT COMPLETED|Overall Study||18||
48188432|NCT03486197|100783240|FG000|STARTED|Overall Study||12||
48188433|NCT03486197|100783240|FG000|COMPLETED|Overall Study||12||
48766598|NCT00674817|102218460|FG000|COMPLETED|Period 2||41||
48766599|NCT00674817|102218460|FG000|NOT COMPLETED|Period 2||0||
48766600|NCT00674817|102218460|FG000|STARTED|Period 3||41||
48766601|NCT00674817|102218460|FG000|COMPLETED|Period 3||39||
48188434|NCT03486197|100783240|FG000|NOT COMPLETED|Overall Study||0||
48188435|NCT04435795|100783241|FG000|STARTED|Overall Study||108||
48188436|NCT04435795|100783242|FG001|STARTED|Overall Study||107||
48188437|NCT04435795|100783241|FG000|COMPLETED|Overall Study||105||
48188438|NCT04435795|100783242|FG001|COMPLETED|Overall Study||98||
48437629|NCT02049931|101403773|FG000|COMPLETED|Overall Study||17||
48437630|NCT02049931|101403774|FG001|COMPLETED|Overall Study||15||
48437631|NCT02049931|101403775|FG002|COMPLETED|Overall Study||17||
48766602|NCT00674817|102218460|FG000|NOT COMPLETED|Period 3||2||
48188439|NCT04435795|100783241|FG000|NOT COMPLETED|Overall Study||3||
48188440|NCT04435795|100783242|FG001|NOT COMPLETED|Overall Study||9||
48437632|NCT02049931|101403773|FG000|NOT COMPLETED|Overall Study||3||
48766603|NCT00674817|102218460|FG000|STARTED|Period 4||39||
48766604|NCT00674817|102218460|FG000|COMPLETED|Period 4||38||
48437633|NCT02049931|101403774|FG001|NOT COMPLETED|Overall Study||5||
48437634|NCT02049931|101403775|FG002|NOT COMPLETED|Overall Study||3||
48437635|NCT00648739|101403776|FG000|STARTED|Overall Study||4||
48437636|NCT00648739|101403777|FG001|STARTED|Overall Study||5||
48437637|NCT00648739|101403778|FG002|STARTED|Overall Study||3||
48437638|NCT00648739|101403779|FG003|STARTED|Overall Study||3||
48437639|NCT00648739|101403780|FG004|STARTED|Overall Study||3||
48437640|NCT00648739|101403781|FG005|STARTED|Overall Study||7||
48437641|NCT00648739|101403782|FG006|STARTED|Overall Study||1||
48437642|NCT00648739|101403776|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4||
48766605|NCT00674817|102218460|FG000|NOT COMPLETED|Period 4||1||
48766606|NCT00674817|102218460|FG000|STARTED|Period 5||38||
48766607|NCT00674817|102218460|FG000|COMPLETED|Period 5||38||
48766608|NCT00674817|102218460|FG000|NOT COMPLETED|Period 5||0||
48766609|NCT00674817|102218460|FG000|STARTED|Period 6||38||
48766610|NCT00674817|102218460|FG000|COMPLETED|Period 6||38||
48766611|NCT00674817|102218460|FG000|NOT COMPLETED|Period 6||0||
48766612|NCT02201394|102218461|FG000|STARTED|Loading Dose||20||
48766613|NCT02201394|102218461|FG000|COMPLETED|Loading Dose||20||
48766614|NCT02201394|102218461|FG000|NOT COMPLETED|Loading Dose||0||
48766615|NCT02201394|102218461|FG000|STARTED|Maintenance Dose||20||
48766616|NCT02201394|102218461|FG000|COMPLETED|Maintenance Dose||20||
48766617|NCT02201394|102218461|FG000|NOT COMPLETED|Maintenance Dose||0||
48766618|NCT02115048|102218462|FG000|STARTED|Overall Study||23||
48766619|NCT02115048|102218463|FG001|STARTED|Overall Study||21||
48766620|NCT02115048|102218462|FG000|COMPLETED|Overall Study||23|Trial terminated early and only 44 patients enrolled, preventing appropriate statistical calculation|
48766621|NCT02115048|102218463|FG001|COMPLETED|Overall Study||21|Trial terminated early and only 44 patients enrolled, preventing appropriate statistical calculation|
48766622|NCT02115048|102218462|FG000|NOT COMPLETED|Overall Study||0||
48766623|NCT02115048|102218463|FG001|NOT COMPLETED|Overall Study||0||
48766624|NCT04986904|102218464|FG000|STARTED|Overall Study||102|This is the number of participants who were enrolled in the trial.|
48766625|NCT04986904|102218464|FG000|Completed Baseline Assessment|Overall Study||101|This is the number of participants who completed the baseline assessment, and were therefore provided access to the SHUTi intervention.|
48766626|NCT04986904|102218464|FG000|Completed the 9-week Intervention Period|Overall Study||100|This is the number of participants who had access to SHUTi for the full 9-week intervention period, and were therefore counted towards the primary endpoint (i.e., level of engagement).|
48766627|NCT04986904|102218464|FG000|COMPLETED|Overall Study||90|This is the number of participants who completed post-assessment.|
48766628|NCT04986904|102218464|FG000|NOT COMPLETED|Overall Study||12||
48766629|NCT00949702|102218465|FG000|STARTED|Overall Study||132||
48766630|NCT00949702|102218465|FG000|COMPLETED|Overall Study||84||
48766631|NCT00949702|102218465|FG000|NOT COMPLETED|Overall Study||48||
48766632|NCT01958164|102218466|FG000|STARTED|Overall Study||6||
48766633|NCT01958164|102218467|FG001|STARTED|Overall Study||10||
48766634|NCT01958164|102218466|FG000|COMPLETED|Overall Study||4||
48766635|NCT01958164|102218467|FG001|COMPLETED|Overall Study||5||
48766636|NCT01958164|102218466|FG000|NOT COMPLETED|Overall Study||2||
48766637|NCT01958164|102218467|FG001|NOT COMPLETED|Overall Study||5||
48766638|NCT02120898|102218468|FG000|STARTED|Overall Study||187||
48766639|NCT02120898|102218469|FG001|STARTED|Overall Study||187||
48766640|NCT02120898|102218470|FG002|STARTED|Overall Study||93||
48766641|NCT02120898|102218468|FG000|Safety Population|Overall Study||187|All randomized participants who received study drug.|
48766642|NCT02120898|102218469|FG001|Safety Population|Overall Study||187|All randomized participants who received study drug.|
48766643|NCT02120898|102218470|FG002|Safety Population|Overall Study||93|All randomized participants who received study drug.|
48766644|NCT02120898|102218468|FG000|Intent-to-Treat (ITT) Population|Overall Study||183|Applied at least 1 dose of study drug, and returned for at least 1 post-baseline evaluation.|
48766645|NCT02120898|102218469|FG001|Intent-to-Treat (ITT) Population|Overall Study||185|Applied at least 1 dose of study drug, and returned for at least 1 post-baseline evaluation.|
48766646|NCT02120898|102218470|FG002|Intent-to-Treat (ITT) Population|Overall Study||93|Applied at least 1 dose of study drug, and returned for at least 1 post-baseline evaluation.|
48766647|NCT02120898|102218468|FG000|COMPLETED|Overall Study||178||
48766648|NCT02120898|102218469|FG001|COMPLETED|Overall Study||181||
48766649|NCT02120898|102218470|FG002|COMPLETED|Overall Study||89||
48766650|NCT02120898|102218468|FG000|NOT COMPLETED|Overall Study||9||
48188441|NCT01536262|100783243|FG000|STARTED|Overall Study||41||
48437643|NCT00648739|101403777|FG001|Received at Least 1 Dose of Study Drug|Overall Study||5||
48437644|NCT00648739|101403778|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
48437645|NCT00648739|101403779|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3||
48437646|NCT00648739|101403780|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3||
48766651|NCT02120898|102218469|FG001|NOT COMPLETED|Overall Study||6||
48188442|NCT01536262|100783244|FG001|STARTED|Overall Study||40||
48188443|NCT01536262|100783245|FG002|STARTED|Overall Study||41||
48437647|NCT00648739|101403781|FG005|Received at Least 1 Dose of Study Drug|Overall Study||7||
48437648|NCT00648739|101403782|FG006|Received at Least 1 Dose of Study Drug|Overall Study||1||
48437649|NCT00648739|101403776|FG000|COMPLETED|Overall Study||2||
48437650|NCT00648739|101403777|FG001|COMPLETED|Overall Study||3||
48437651|NCT00648739|101403778|FG002|COMPLETED|Overall Study||0||
48437652|NCT00648739|101403779|FG003|COMPLETED|Overall Study||1||
48437653|NCT00648739|101403780|FG004|COMPLETED|Overall Study||1||
48437654|NCT00648739|101403781|FG005|COMPLETED|Overall Study||2||
48437655|NCT00648739|101403782|FG006|COMPLETED|Overall Study||0||
48437656|NCT00648739|101403776|FG000|NOT COMPLETED|Overall Study||2||
48437657|NCT00648739|101403777|FG001|NOT COMPLETED|Overall Study||2||
48437658|NCT00648739|101403778|FG002|NOT COMPLETED|Overall Study||3||
48437659|NCT00648739|101403779|FG003|NOT COMPLETED|Overall Study||2||
48437660|NCT00648739|101403780|FG004|NOT COMPLETED|Overall Study||2||
48437661|NCT00648739|101403781|FG005|NOT COMPLETED|Overall Study||5||
48437662|NCT00648739|101403782|FG006|NOT COMPLETED|Overall Study||1||
48437663|NCT04753606|101403783|FG000|STARTED|Overall Study||40||
48437664|NCT04753606|101403784|FG001|STARTED|Overall Study||40||
48437665|NCT04753606|101403785|FG002|STARTED|Overall Study||40||
48437666|NCT04753606|101403783|FG000|COMPLETED|Overall Study||39||
48437667|NCT04753606|101403784|FG001|COMPLETED|Overall Study||40||
48437668|NCT04753606|101403785|FG002|COMPLETED|Overall Study||40||
48437669|NCT04753606|101403783|FG000|NOT COMPLETED|Overall Study||1||
48437670|NCT04753606|101403784|FG001|NOT COMPLETED|Overall Study||0||
48437671|NCT04753606|101403785|FG002|NOT COMPLETED|Overall Study||0||
48437672|NCT00474994|101403786|FG000|STARTED|Overall Study||53||
48437673|NCT00474994|101403786|FG000|COMPLETED|Overall Study||48||
48437674|NCT00474994|101403786|FG000|NOT COMPLETED|Overall Study||5||
48437675|NCT02222168|101403787|FG000|STARTED|Period 1 (Fasted or Fed)||9||
48437676|NCT02222168|101403788|FG001|STARTED|Period 1 (Fasted or Fed)||9||
48437677|NCT02222168|101403787|FG000|COMPLETED|Period 1 (Fasted or Fed)||9||
48437678|NCT02222168|101403788|FG001|COMPLETED|Period 1 (Fasted or Fed)||9||
48437679|NCT02222168|101403787|FG000|NOT COMPLETED|Period 1 (Fasted or Fed)||0||
48437680|NCT02222168|101403788|FG001|NOT COMPLETED|Period 1 (Fasted or Fed)||0||
48437681|NCT02222168|101403787|FG000|STARTED|Period 2 (Fasted or Fed)||9||
48437682|NCT02222168|101403788|FG001|STARTED|Period 2 (Fasted or Fed)||9||
48437683|NCT02222168|101403787|FG000|COMPLETED|Period 2 (Fasted or Fed)||9||
48437684|NCT02222168|101403788|FG001|COMPLETED|Period 2 (Fasted or Fed)||9||
48437685|NCT02222168|101403787|FG000|NOT COMPLETED|Period 2 (Fasted or Fed)||0||
48437686|NCT02222168|101403788|FG001|NOT COMPLETED|Period 2 (Fasted or Fed)||0||
48437687|NCT02222168|101403787|FG000|STARTED|Period 3 (Bed-time)||9||
48437688|NCT02222168|101403788|FG001|STARTED|Period 3 (Bed-time)||9||
48437689|NCT02222168|101403787|FG000|COMPLETED|Period 3 (Bed-time)||9||
48437690|NCT02222168|101403788|FG001|COMPLETED|Period 3 (Bed-time)||9||
48437691|NCT02222168|101403787|FG000|NOT COMPLETED|Period 3 (Bed-time)||0||
48437692|NCT02222168|101403788|FG001|NOT COMPLETED|Period 3 (Bed-time)||0||
48437693|NCT01497860|101403789|FG000|STARTED|Overall Study||12||
48437694|NCT01497860|101403789|FG000|COMPLETED|Overall Study||12||
48437695|NCT01497860|101403789|FG000|NOT COMPLETED|Overall Study||0||
48437696|NCT00968539|101403790|FG000|STARTED|Overall Study||64||
48766652|NCT02120898|102218470|FG002|NOT COMPLETED|Overall Study||4||
48766653|NCT05786651|102218471|FG000|STARTED|Overall Study||27||
48766654|NCT05786651|102218471|FG000|COMPLETED|Overall Study||26||
48766655|NCT05786651|102218471|FG000|NOT COMPLETED|Overall Study||1||
48437697|NCT00968539|101403791|FG001|STARTED|Overall Study||66||
48437698|NCT00968539|101403790|FG000|COMPLETED|Overall Study||63||
48437699|NCT00968539|101403791|FG001|COMPLETED|Overall Study||66||
48437700|NCT00968539|101403790|FG000|NOT COMPLETED|Overall Study||1||
48437701|NCT00968539|101403791|FG001|NOT COMPLETED|Overall Study||0||
48437702|NCT02912507|101403792|FG000|STARTED|Overall Study||5||5
48437703|NCT02912507|101403793|FG001|STARTED|Overall Study||5||5
48437704|NCT02912507|101403794|FG002|STARTED|Overall Study||5||5
48437705|NCT02912507|101403792|FG000|COMPLETED|Overall Study||1||1
48766656|NCT01213316|102218472|FG000|STARTED|Overall Study||451||
48437706|NCT02912507|101403793|FG001|COMPLETED|Overall Study||1||1
48437707|NCT02912507|101403794|FG002|COMPLETED|Overall Study||1||1
48437708|NCT02912507|101403792|FG000|NOT COMPLETED|Overall Study||4||4
48766657|NCT01213316|102218472|FG000|Amendment Cohort: Prolonged Participants|Overall Study||48||
48766658|NCT01213316|102218472|FG000|Amendment Cohort: Newly Enrolled|Overall Study||179||
48766659|NCT01213316|102218472|FG000|Discontinued Treatment Before 48 Weeks|Overall Study||67||
48766660|NCT01213316|102218472|FG000|Initial Cohort|Overall Study||272||
48766661|NCT01213316|102218472|FG000|COMPLETED|Overall Study||451||
48766662|NCT01213316|102218472|FG000|NOT COMPLETED|Overall Study||0||
48766663|NCT01598532|102218473|FG000|STARTED|Overall Study||22||
48437709|NCT02912507|101403793|FG001|NOT COMPLETED|Overall Study||4||4
48437710|NCT02912507|101403794|FG002|NOT COMPLETED|Overall Study||4||4
48437711|NCT03602976|101403795|FG000|STARTED|Overall Study||7||
48437712|NCT03602976|101403795|FG000|COMPLETED|Overall Study||6||
48437713|NCT03602976|101403795|FG000|NOT COMPLETED|Overall Study||1||
48437714|NCT02181127|101403796|FG000|STARTED|Overall Study||22||
48437715|NCT02181127|101403796|FG000|COMPLETED|Overall Study||22||
48437716|NCT02181127|101403796|FG000|NOT COMPLETED|Overall Study||0||
48437717|NCT01100073|101406417|FG000|STARTED|Overall Study||1699||
48437718|NCT01100073|101406417|FG000|COMPLETED|Overall Study||1599||
48437719|NCT01100073|101406417|FG000|NOT COMPLETED|Overall Study||100||
48437720|NCT02297438|101406418|FG000|STARTED|Overall Study||169||
48437721|NCT02297438|101406419|FG001|STARTED|Overall Study||171||
48437722|NCT02297438|101406418|FG000|Received Treatment|Overall Study||168||
48437723|NCT02297438|101406419|FG001|Received Treatment|Overall Study||171||
48437724|NCT02297438|101406418|FG000|COMPLETED|Overall Study||0||
48437725|NCT02297438|101406419|FG001|COMPLETED|Overall Study||0||
48437726|NCT02297438|101406418|FG000|NOT COMPLETED|Overall Study||169||
48437727|NCT02297438|101406419|FG001|NOT COMPLETED|Overall Study||171||
48437728|NCT00285012|101406420|FG000|STARTED|Assigned to Study Treatment (Tx)||250||
48437729|NCT00285012|101406421|FG001|STARTED|Assigned to Study Treatment (Tx)||254||
48437730|NCT00285012|101406420|FG000|COMPLETED|Assigned to Study Treatment (Tx)||248||
48437731|NCT00285012|101406421|FG001|COMPLETED|Assigned to Study Treatment (Tx)||251||
48437732|NCT00285012|101406420|FG000|NOT COMPLETED|Assigned to Study Treatment (Tx)||2||
48437733|NCT00285012|101406421|FG001|NOT COMPLETED|Assigned to Study Treatment (Tx)||3||
48437734|NCT00285012|101406420|FG000|STARTED|Received Study Tx||248||
48437735|NCT00285012|101406421|FG001|STARTED|Received Study Tx||251||
48437736|NCT00285012|101406420|FG000|Completed Tx (May Continue in Study)|Received Study Tx||207||
48437737|NCT00285012|101406421|FG001|Completed Tx (May Continue in Study)|Received Study Tx||193||
48437738|NCT00285012|101406420|FG000|Discontinued Tx (May Continue in Study)|Received Study Tx||41||
48437739|NCT00285012|101406421|FG001|Discontinued Tx (May Continue in Study)|Received Study Tx||58||
48437740|NCT00285012|101406420|FG000|COMPLETED|Received Study Tx||176||
48437741|NCT00285012|101406421|FG001|COMPLETED|Received Study Tx||157||
48437742|NCT00285012|101406420|FG000|NOT COMPLETED|Received Study Tx||72||
48655888|NCT05226884|101941303|FG001|STARTED|Overall Study||155||
48655889|NCT05226884|101941302|FG000|COMPLETED|Overall Study||155||
48655890|NCT05226884|101941303|FG001|COMPLETED|Overall Study||155||
48655891|NCT05226884|101941302|FG000|NOT COMPLETED|Overall Study||0||
48437743|NCT00285012|101406421|FG001|NOT COMPLETED|Received Study Tx||94||
48437744|NCT00401414|101406422|FG000|STARTED|Overall Study||118||
48437745|NCT00401414|101406423|FG001|STARTED|Overall Study||147||
48437746|NCT00401414|101406424|FG002|STARTED|Overall Study||79||
48437747|NCT00401414|101406422|FG000|COMPLETED|Overall Study||118||
48437748|NCT00401414|101406423|FG001|COMPLETED|Overall Study||147||
48437749|NCT00401414|101406424|FG002|COMPLETED|Overall Study||79||
48437750|NCT00401414|101406422|FG000|NOT COMPLETED|Overall Study||0||
48437751|NCT00401414|101406423|FG001|NOT COMPLETED|Overall Study||0||
48437752|NCT00401414|101406424|FG002|NOT COMPLETED|Overall Study||0||
48437753|NCT01605539|101406425|FG000|STARTED|Overall Study||3||
48437754|NCT01605539|101406426|FG001|STARTED|Overall Study||3||
48437755|NCT01605539|101406427|FG002|STARTED|Overall Study||4||
48437756|NCT01605539|101406425|FG000|COMPLETED|Overall Study||3||
48437757|NCT01605539|101406426|FG001|COMPLETED|Overall Study||2||
48437758|NCT01605539|101406427|FG002|COMPLETED|Overall Study||4||
48437759|NCT01605539|101406425|FG000|NOT COMPLETED|Overall Study||0||
48437760|NCT01605539|101406426|FG001|NOT COMPLETED|Overall Study||1||
48437761|NCT01605539|101406427|FG002|NOT COMPLETED|Overall Study||0||
48437762|NCT00584831|101406428|FG000|STARTED|Intervention 1||1||
48437763|NCT00584831|101406429|FG001|STARTED|Intervention 1||3||
48437764|NCT00584831|101406430|FG002|STARTED|Intervention 1||2||
48437765|NCT00584831|101406431|FG003|STARTED|Intervention 1||1||
48437766|NCT00584831|101406432|FG004|STARTED|Intervention 1||2||
48437767|NCT00584831|101406433|FG005|STARTED|Intervention 1||1||
48437768|NCT00584831|101406434|FG006|STARTED|Intervention 1||6||
48437769|NCT00584831|101406435|FG007|STARTED|Intervention 1||2||
48437770|NCT00584831|101406436|FG008|STARTED|Intervention 1||4||
48437771|NCT00584831|101406437|FG009|STARTED|Intervention 1||2||
48437772|NCT00584831|101406438|FG010|STARTED|Intervention 1||2||
48437773|NCT00584831|101406439|FG011|STARTED|Intervention 1||1||
48437774|NCT00584831|101406440|FG012|STARTED|Intervention 1||2||
48437775|NCT00584831|101406441|FG013|STARTED|Intervention 1||1||
48437776|NCT00584831|101406442|FG014|STARTED|Intervention 1||3||
48437777|NCT00584831|101406443|FG015|STARTED|Intervention 1||1||
48437778|NCT00584831|101406444|FG016|STARTED|Intervention 1||4||
48437779|NCT00584831|101406445|FG017|STARTED|Intervention 1||1||
48437780|NCT00584831|101406446|FG018|STARTED|Intervention 1||1||
48437781|NCT00584831|101406428|FG000|COMPLETED|Intervention 1||1||
48437782|NCT00584831|101406429|FG001|COMPLETED|Intervention 1||3||
48437783|NCT00584831|101406430|FG002|COMPLETED|Intervention 1||2||
48437784|NCT00584831|101406431|FG003|COMPLETED|Intervention 1||1||
48655892|NCT05226884|101941303|FG001|NOT COMPLETED|Overall Study||0||
48655893|NCT04135352|101941304|FG000|STARTED|Overall Study||3||
48655894|NCT04135352|101941305|FG001|STARTED|Overall Study||4||
48655895|NCT04135352|101941306|FG002|STARTED|Overall Study||13||
48655896|NCT04135352|101941307|FG003|STARTED|Overall Study||5||
48655897|NCT04135352|101941308|FG004|STARTED|Overall Study||5||
48655898|NCT04135352|101941309|FG005|STARTED|Overall Study||5||
48655899|NCT04135352|101941310|FG006|STARTED|Overall Study||0||
48655900|NCT04135352|101941311|FG007|STARTED|Overall Study||0||
48437785|NCT00584831|101406432|FG004|COMPLETED|Intervention 1||2||
48437786|NCT00584831|101406433|FG005|COMPLETED|Intervention 1||1||
48437787|NCT00584831|101406434|FG006|COMPLETED|Intervention 1||6||
48437788|NCT00584831|101406435|FG007|COMPLETED|Intervention 1||2||
48437789|NCT00584831|101406436|FG008|COMPLETED|Intervention 1||4||
48437790|NCT00584831|101406437|FG009|COMPLETED|Intervention 1||2||
48437791|NCT00584831|101406438|FG010|COMPLETED|Intervention 1||2||
48437792|NCT00584831|101406439|FG011|COMPLETED|Intervention 1||1||
48437793|NCT00584831|101406440|FG012|COMPLETED|Intervention 1||2||
48655901|NCT04135352|101941304|FG000|Treated|Overall Study||3||
48655902|NCT04135352|101941305|FG001|Treated|Overall Study||4||
48655903|NCT04135352|101941306|FG002|Treated|Overall Study||12||
48655904|NCT04135352|101941307|FG003|Treated|Overall Study||5||
48655905|NCT04135352|101941308|FG004|Treated|Overall Study||5||
48655906|NCT04135352|101941309|FG005|Treated|Overall Study||5||
48655907|NCT04135352|101941310|FG006|Treated|Overall Study||0||
48655908|NCT04135352|101941311|FG007|Treated|Overall Study||0||
48655909|NCT04135352|101941304|FG000|COMPLETED|Overall Study||0||
48655910|NCT04135352|101941305|FG001|COMPLETED|Overall Study||0||
48655911|NCT04135352|101941306|FG002|COMPLETED|Overall Study||0||
48655912|NCT04135352|101941307|FG003|COMPLETED|Overall Study||0||
48655913|NCT04135352|101941308|FG004|COMPLETED|Overall Study||0||
48655914|NCT04135352|101941309|FG005|COMPLETED|Overall Study||0||
48655915|NCT04135352|101941310|FG006|COMPLETED|Overall Study||0||
48655916|NCT04135352|101941311|FG007|COMPLETED|Overall Study||0||
48655917|NCT04135352|101941304|FG000|NOT COMPLETED|Overall Study||3||
48655918|NCT04135352|101941305|FG001|NOT COMPLETED|Overall Study||4||
48655919|NCT04135352|101941306|FG002|NOT COMPLETED|Overall Study||13||
48655920|NCT04135352|101941307|FG003|NOT COMPLETED|Overall Study||5||
48655921|NCT04135352|101941308|FG004|NOT COMPLETED|Overall Study||5||
48655922|NCT04135352|101941309|FG005|NOT COMPLETED|Overall Study||5||
48655923|NCT04135352|101941310|FG006|NOT COMPLETED|Overall Study||0||
48655924|NCT04135352|101941311|FG007|NOT COMPLETED|Overall Study||0||
48655925|NCT05964166|101941312|FG000|STARTED|Overall Study||14||
48655926|NCT05964166|101941313|FG001|STARTED|Overall Study||26||
48655927|NCT05964166|101941312|FG000|COMPLETED|Overall Study||14||
48655928|NCT05964166|101941313|FG001|COMPLETED|Overall Study||26||
48655929|NCT05964166|101941312|FG000|NOT COMPLETED|Overall Study||0||
48655930|NCT05964166|101941313|FG001|NOT COMPLETED|Overall Study||0||
48655931|NCT05715346|101941314|FG000|STARTED|Overall Study||11||
48655932|NCT05715346|101941315|FG001|STARTED|Overall Study||11||
48655933|NCT05715346|101941316|FG002|STARTED|Overall Study||11||
48655934|NCT05715346|101941314|FG000|COMPLETED|Overall Study||11||
48655935|NCT05715346|101941315|FG001|COMPLETED|Overall Study||11||
48655936|NCT05715346|101941316|FG002|COMPLETED|Overall Study||11||
48655937|NCT05715346|101941314|FG000|NOT COMPLETED|Overall Study||0||
48655938|NCT05715346|101941315|FG001|NOT COMPLETED|Overall Study||0||
48655939|NCT05715346|101941316|FG002|NOT COMPLETED|Overall Study||0||
48655940|NCT02536339|101941317|FG000|STARTED|Overall Study||40|Intention-to-Treat (ITT) Population|
48655941|NCT02536339|101941317|FG000|Received at Least One Dose of Study Drug|Overall Study||39|Safety Population|
48655942|NCT02536339|101941317|FG000|Efficacy-Evaluable Population|Overall Study||37||
48655943|NCT02536339|101941317|FG000|COMPLETED|Overall Study||12||
48655944|NCT02536339|101941317|FG000|NOT COMPLETED|Overall Study||28||
48655945|NCT02367040|101941318|FG000|STARTED|Overall Study||307||
48655946|NCT02367040|101941319|FG001|STARTED|Overall Study||151||
48655947|NCT02367040|101941318|FG000|Received Treatment|Overall Study||304||
48655948|NCT02367040|101941319|FG001|Received Treatment|Overall Study||149||
48655949|NCT02367040|101941318|FG000|COMPLETED|Overall Study||32|Ongoing with treatment at 2-year follow-up cut-off date|
48655950|NCT02367040|101941319|FG001|COMPLETED|Overall Study||10|Ongoing with treatment at 2-year follow-up cut-off date|
48655951|NCT02367040|101941318|FG000|NOT COMPLETED|Overall Study||275||
48655952|NCT02367040|101941319|FG001|NOT COMPLETED|Overall Study||141||
48655953|NCT00937937|101941320|FG000|STARTED|Overall Study||72||
48655954|NCT00937937|101941320|FG000|COMPLETED|Overall Study||0||
48655955|NCT00937937|101941320|FG000|NOT COMPLETED|Overall Study||72||
48655956|NCT04046952|101941321|FG000|STARTED|Overall Study||220||
48655957|NCT04046952|101941322|FG001|STARTED|Overall Study||223||
48655958|NCT04046952|101941321|FG000|COMPLETED|Overall Study||220||
48655959|NCT04046952|101941322|FG001|COMPLETED|Overall Study||223||
48655960|NCT04046952|101941321|FG000|NOT COMPLETED|Overall Study||0||
48655961|NCT04046952|101941322|FG001|NOT COMPLETED|Overall Study||0||
48655962|NCT03228537|101941323|FG000|STARTED|Neoadjuvant||28||
48655963|NCT03228537|101941323|FG000|COMPLETED|Neoadjuvant||21||
48655964|NCT03228537|101941323|FG000|NOT COMPLETED|Neoadjuvant||7||
48655965|NCT03228537|101941323|FG000|STARTED|Surgery||19||
48655966|NCT03228537|101941323|FG000|COMPLETED|Surgery||16||
48655967|NCT03228537|101941323|FG000|NOT COMPLETED|Surgery||3||
48655968|NCT03228537|101941323|FG000|STARTED|Maintenance||15||
48655969|NCT03228537|101941323|FG000|COMPLETED|Maintenance||4||
48655970|NCT03228537|101941323|FG000|NOT COMPLETED|Maintenance||11||
48655971|NCT03137407|101941324|FG000|STARTED|Overall Study||30||
48655972|NCT03137407|101941325|FG001|STARTED|Overall Study||29||
48655973|NCT03137407|101941324|FG000|COMPLETED|Overall Study||26||
48655974|NCT03137407|101941325|FG001|COMPLETED|Overall Study||23||
48655975|NCT03137407|101941324|FG000|NOT COMPLETED|Overall Study||4||
48655976|NCT03137407|101941325|FG001|NOT COMPLETED|Overall Study||6||
48655977|NCT02595879|101941326|FG000|STARTED|Cohort 1 / Dose Level 1||3||
48655978|NCT02595879|101941327|FG001|STARTED|Cohort 1 / Dose Level 1||0||
48655979|NCT02595879|101941326|FG000|COMPLETED|Cohort 1 / Dose Level 1||3||
48655980|NCT02595879|101941327|FG001|COMPLETED|Cohort 1 / Dose Level 1||0||
48655981|NCT02595879|101941326|FG000|NOT COMPLETED|Cohort 1 / Dose Level 1||0||
48655982|NCT02595879|101941327|FG001|NOT COMPLETED|Cohort 1 / Dose Level 1||0||
48655983|NCT02595879|101941326|FG000|STARTED|Cohort 2 / Dose Level 2||0||
48655984|NCT02595879|101941327|FG001|STARTED|Cohort 2 / Dose Level 2||4||
48655985|NCT02595879|101941326|FG000|COMPLETED|Cohort 2 / Dose Level 2||0||
48437794|NCT00584831|101406441|FG013|COMPLETED|Intervention 1||1||
48437795|NCT00584831|101406442|FG014|COMPLETED|Intervention 1||3||
48437796|NCT00584831|101406443|FG015|COMPLETED|Intervention 1||1||
48437797|NCT00584831|101406444|FG016|COMPLETED|Intervention 1||4||
48437798|NCT00584831|101406445|FG017|COMPLETED|Intervention 1||1||
48437799|NCT00584831|101406446|FG018|COMPLETED|Intervention 1||1||
48437800|NCT00584831|101406428|FG000|NOT COMPLETED|Intervention 1||0||
48437801|NCT00584831|101406429|FG001|NOT COMPLETED|Intervention 1||0||
48437802|NCT00584831|101406430|FG002|NOT COMPLETED|Intervention 1||0||
48437803|NCT00584831|101406431|FG003|NOT COMPLETED|Intervention 1||0||
48437804|NCT00584831|101406432|FG004|NOT COMPLETED|Intervention 1||0||
48437805|NCT00584831|101406433|FG005|NOT COMPLETED|Intervention 1||0||
48437806|NCT00584831|101406434|FG006|NOT COMPLETED|Intervention 1||0||
48437807|NCT00584831|101406435|FG007|NOT COMPLETED|Intervention 1||0||
48437808|NCT00584831|101406436|FG008|NOT COMPLETED|Intervention 1||0||
48437809|NCT00584831|101406437|FG009|NOT COMPLETED|Intervention 1||0||
48437810|NCT00584831|101406438|FG010|NOT COMPLETED|Intervention 1||0||
48437811|NCT00584831|101406439|FG011|NOT COMPLETED|Intervention 1||0||
48655986|NCT02595879|101941327|FG001|COMPLETED|Cohort 2 / Dose Level 2||4||
48655987|NCT02595879|101941326|FG000|NOT COMPLETED|Cohort 2 / Dose Level 2||0||
48655988|NCT02595879|101941327|FG001|NOT COMPLETED|Cohort 2 / Dose Level 2||0||
48655989|NCT02595879|101941326|FG000|STARTED|Cohort 3 / Dose Level 1||3||
48655990|NCT02595879|101941327|FG001|STARTED|Cohort 3 / Dose Level 1||0||
48655991|NCT02595879|101941326|FG000|COMPLETED|Cohort 3 / Dose Level 1||3||
48437812|NCT00584831|101406440|FG012|NOT COMPLETED|Intervention 1||0||
48437813|NCT00584831|101406441|FG013|NOT COMPLETED|Intervention 1||0||
48437814|NCT00584831|101406442|FG014|NOT COMPLETED|Intervention 1||0||
48437815|NCT00584831|101406443|FG015|NOT COMPLETED|Intervention 1||0||
48437816|NCT00584831|101406444|FG016|NOT COMPLETED|Intervention 1||0||
48437817|NCT00584831|101406445|FG017|NOT COMPLETED|Intervention 1||0||
48437818|NCT00584831|101406446|FG018|NOT COMPLETED|Intervention 1||0||
48437819|NCT00584831|101406428|FG000|STARTED|Intervention 2||1||
48437820|NCT00584831|101406429|FG001|STARTED|Intervention 2||3||
48437821|NCT00584831|101406430|FG002|STARTED|Intervention 2||2||
48437822|NCT00584831|101406431|FG003|STARTED|Intervention 2||1||
48437823|NCT00584831|101406432|FG004|STARTED|Intervention 2||2||
48437824|NCT00584831|101406433|FG005|STARTED|Intervention 2||1||
48437825|NCT00584831|101406434|FG006|STARTED|Intervention 2||6||
48437826|NCT00584831|101406435|FG007|STARTED|Intervention 2||2||
48437827|NCT00584831|101406436|FG008|STARTED|Intervention 2||4||
48437828|NCT00584831|101406437|FG009|STARTED|Intervention 2||2||
48437829|NCT00584831|101406438|FG010|STARTED|Intervention 2||2||
48437830|NCT00584831|101406439|FG011|STARTED|Intervention 2||1||
48437831|NCT00584831|101406440|FG012|STARTED|Intervention 2||2||
48437832|NCT00584831|101406441|FG013|STARTED|Intervention 2||1||
48437833|NCT00584831|101406442|FG014|STARTED|Intervention 2||3||
48437834|NCT00584831|101406443|FG015|STARTED|Intervention 2||1||
48437835|NCT00584831|101406444|FG016|STARTED|Intervention 2||4||
48655992|NCT02595879|101941327|FG001|COMPLETED|Cohort 3 / Dose Level 1||0||
48655993|NCT02595879|101941326|FG000|NOT COMPLETED|Cohort 3 / Dose Level 1||0||
48766664|NCT01598532|102218473|FG000|COMPLETED|Overall Study||11||
48766665|NCT01598532|102218473|FG000|NOT COMPLETED|Overall Study||11||
48766666|NCT00599014|102218474|FG000|STARTED|Overall Study||335||
48766667|NCT00599014|102218474|FG000|COMPLETED|Overall Study||335||
48766668|NCT00599014|102218474|FG000|NOT COMPLETED|Overall Study||0||
48766669|NCT01318915|102218475|FG000|STARTED|Overall Study||10||
48766670|NCT01318915|102218475|FG000|COMPLETED|Overall Study||9||
48437836|NCT00584831|101406445|FG017|STARTED|Intervention 2||1||
48437837|NCT00584831|101406446|FG018|STARTED|Intervention 2||1||
48437838|NCT00584831|101406428|FG000|COMPLETED|Intervention 2||1||
48437839|NCT00584831|101406429|FG001|COMPLETED|Intervention 2||3||
48437840|NCT00584831|101406430|FG002|COMPLETED|Intervention 2||2||
48437841|NCT00584831|101406431|FG003|COMPLETED|Intervention 2||1||
48437842|NCT00584831|101406432|FG004|COMPLETED|Intervention 2||2||
48655994|NCT02595879|101941327|FG001|NOT COMPLETED|Cohort 3 / Dose Level 1||0||
48766671|NCT01318915|102218475|FG000|NOT COMPLETED|Overall Study||1||
48766672|NCT01294553|102218476|FG000|STARTED|Overall Study||982||
48766673|NCT01294553|102218476|FG000|COMPLETED|Overall Study||713||
48437843|NCT00584831|101406433|FG005|COMPLETED|Intervention 2||1||
48437844|NCT00584831|101406434|FG006|COMPLETED|Intervention 2||6||
48655995|NCT02595879|101941326|FG000|STARTED|Expansion Cohort||11||
48655996|NCT02595879|101941327|FG001|STARTED|Expansion Cohort||0||
48437845|NCT00584831|101406435|FG007|COMPLETED|Intervention 2||2||
48437846|NCT00584831|101406436|FG008|COMPLETED|Intervention 2||4||
48437847|NCT00584831|101406437|FG009|COMPLETED|Intervention 2||2||
48437848|NCT00584831|101406438|FG010|COMPLETED|Intervention 2||2||
48437849|NCT00584831|101406439|FG011|COMPLETED|Intervention 2||1||
48437850|NCT00584831|101406440|FG012|COMPLETED|Intervention 2||2||
48437851|NCT00584831|101406441|FG013|COMPLETED|Intervention 2||1||
48437852|NCT00584831|101406442|FG014|COMPLETED|Intervention 2||3||
48437853|NCT00584831|101406443|FG015|COMPLETED|Intervention 2||1||
48655997|NCT02595879|101941326|FG000|COMPLETED|Expansion Cohort||10||
48766674|NCT01294553|102218476|FG000|NOT COMPLETED|Overall Study||269||
48766675|NCT01457703|102218477|FG000|STARTED|Overall Study||29||
48766676|NCT01457703|102218478|FG001|STARTED|Overall Study||33||
48437854|NCT00584831|101406444|FG016|COMPLETED|Intervention 2||4||
48437855|NCT00584831|101406445|FG017|COMPLETED|Intervention 2||1||
48437856|NCT00584831|101406446|FG018|COMPLETED|Intervention 2||1||
48437857|NCT00584831|101406428|FG000|NOT COMPLETED|Intervention 2||0||
48437858|NCT00584831|101406429|FG001|NOT COMPLETED|Intervention 2||0||
48437859|NCT00584831|101406430|FG002|NOT COMPLETED|Intervention 2||0||
48437860|NCT00584831|101406431|FG003|NOT COMPLETED|Intervention 2||0||
48437861|NCT00584831|101406432|FG004|NOT COMPLETED|Intervention 2||0||
48437862|NCT00584831|101406433|FG005|NOT COMPLETED|Intervention 2||0||
48437863|NCT00584831|101406434|FG006|NOT COMPLETED|Intervention 2||0||
48437864|NCT00584831|101406435|FG007|NOT COMPLETED|Intervention 2||0||
48437865|NCT00584831|101406436|FG008|NOT COMPLETED|Intervention 2||0||
48437866|NCT00584831|101406437|FG009|NOT COMPLETED|Intervention 2||0||
48437867|NCT00584831|101406438|FG010|NOT COMPLETED|Intervention 2||0||
48437868|NCT00584831|101406439|FG011|NOT COMPLETED|Intervention 2||0||
48437869|NCT00584831|101406440|FG012|NOT COMPLETED|Intervention 2||0||
48437870|NCT00584831|101406441|FG013|NOT COMPLETED|Intervention 2||0||
48437871|NCT00584831|101406442|FG014|NOT COMPLETED|Intervention 2||0||
48437872|NCT00584831|101406443|FG015|NOT COMPLETED|Intervention 2||0||
48437873|NCT00584831|101406444|FG016|NOT COMPLETED|Intervention 2||0||
48437874|NCT00584831|101406445|FG017|NOT COMPLETED|Intervention 2||0||
48437875|NCT00584831|101406446|FG018|NOT COMPLETED|Intervention 2||0||
48437876|NCT00584831|101406428|FG000|STARTED|Intervention 3||1||
48437877|NCT00584831|101406429|FG001|STARTED|Intervention 3||3||
48437878|NCT00584831|101406430|FG002|STARTED|Intervention 3||2||
48437879|NCT00584831|101406431|FG003|STARTED|Intervention 3||1||
48437880|NCT00584831|101406432|FG004|STARTED|Intervention 3||2||
48437881|NCT00584831|101406433|FG005|STARTED|Intervention 3||1||
48437882|NCT00584831|101406434|FG006|STARTED|Intervention 3||6||
48437883|NCT00584831|101406435|FG007|STARTED|Intervention 3||2||
48437884|NCT00584831|101406436|FG008|STARTED|Intervention 3||4||
48437885|NCT00584831|101406437|FG009|STARTED|Intervention 3||2||
48437886|NCT00584831|101406438|FG010|STARTED|Intervention 3||2||
48437887|NCT00584831|101406439|FG011|STARTED|Intervention 3||1||
48437888|NCT00584831|101406440|FG012|STARTED|Intervention 3||2||
48437889|NCT00584831|101406441|FG013|STARTED|Intervention 3||1||
48437890|NCT00584831|101406442|FG014|STARTED|Intervention 3||3||
48437891|NCT00584831|101406443|FG015|STARTED|Intervention 3||1||
48437892|NCT00584831|101406444|FG016|STARTED|Intervention 3||4||
48437893|NCT00584831|101406445|FG017|STARTED|Intervention 3||1||
48437894|NCT00584831|101406446|FG018|STARTED|Intervention 3||1||
48766677|NCT01457703|102218477|FG000|COMPLETED|Overall Study||23||
48766678|NCT01457703|102218478|FG001|COMPLETED|Overall Study||22||
48766679|NCT01457703|102218477|FG000|NOT COMPLETED|Overall Study||6||
48766680|NCT01457703|102218478|FG001|NOT COMPLETED|Overall Study||11||
48766681|NCT00577889|102218479|FG000|STARTED|Overall Study||9||
48766682|NCT00577889|102218480|FG001|STARTED|Overall Study||6||
48766683|NCT00577889|102218481|FG002|STARTED|Overall Study||6||
48766684|NCT00577889|102218479|FG000|COMPLETED|Overall Study||8||
48437895|NCT00584831|101406428|FG000|COMPLETED|Intervention 3||1||
48437896|NCT00584831|101406429|FG001|COMPLETED|Intervention 3||3||
48437897|NCT00584831|101406430|FG002|COMPLETED|Intervention 3||2||
48655998|NCT02595879|101941327|FG001|COMPLETED|Expansion Cohort||0||
48655999|NCT02595879|101941326|FG000|NOT COMPLETED|Expansion Cohort||1||
48656000|NCT02595879|101941327|FG001|NOT COMPLETED|Expansion Cohort||0||
48656001|NCT05293314|101941328|FG000|STARTED|Overall Study||228||
48656002|NCT05293314|101941329|FG001|STARTED|Overall Study||231||
48656003|NCT05293314|101941330|FG002|STARTED|Overall Study||85||
48656004|NCT05293314|101941328|FG000|COMPLETED|Overall Study||215||
48656005|NCT05293314|101941329|FG001|COMPLETED|Overall Study||221||
48766685|NCT00577889|102218480|FG001|COMPLETED|Overall Study||6||
48766686|NCT00577889|102218481|FG002|COMPLETED|Overall Study||6||
48766687|NCT00577889|102218479|FG000|NOT COMPLETED|Overall Study||1||
48766688|NCT00577889|102218480|FG001|NOT COMPLETED|Overall Study||0||
48766689|NCT00577889|102218481|FG002|NOT COMPLETED|Overall Study||0||
48766690|NCT02323217|102218482|FG000|STARTED|Overall Study||18||
48766691|NCT02323217|102218482|FG000|COMPLETED|Overall Study||18||
48766692|NCT02323217|102218482|FG000|NOT COMPLETED|Overall Study||0||
48766693|NCT02963506|102218483|FG000|STARTED|Double-Blind Period||60||
48766694|NCT02963506|102218484|FG001|STARTED|Double-Blind Period||61||
48766695|NCT02963506|102218485|FG002|STARTED|Double-Blind Period||61||
48437898|NCT00584831|101406431|FG003|COMPLETED|Intervention 3||1||
48437899|NCT00584831|101406432|FG004|COMPLETED|Intervention 3||2||
48437900|NCT00584831|101406433|FG005|COMPLETED|Intervention 3||1||
48437901|NCT00584831|101406434|FG006|COMPLETED|Intervention 3||6||
48437902|NCT00584831|101406435|FG007|COMPLETED|Intervention 3||2||
48766696|NCT02963506|102218486|FG003|STARTED|Double-Blind Period||60||
48437903|NCT00584831|101406436|FG008|COMPLETED|Intervention 3||4||
48656006|NCT05293314|101941330|FG002|COMPLETED|Overall Study||74||
48766697|NCT02963506|102218487|FG004|STARTED|Double-Blind Period||61||
48766698|NCT02963506|102218488|FG005|STARTED|Double-Blind Period||0||
48656007|NCT05293314|101941328|FG000|NOT COMPLETED|Overall Study||13||
48656008|NCT05293314|101941329|FG001|NOT COMPLETED|Overall Study||10||
48656009|NCT05293314|101941330|FG002|NOT COMPLETED|Overall Study||11||
48656010|NCT01433978|101941331|FG000|STARTED|Core Study||11||
48656011|NCT01433978|101941332|FG001|STARTED|Core Study||12||
48656012|NCT01433978|101941333|FG002|STARTED|Core Study||0||
48656013|NCT01433978|101941331|FG000|COMPLETED|Core Study||0||
48656014|NCT01433978|101941332|FG001|COMPLETED|Core Study||1||
48656015|NCT01433978|101941333|FG002|COMPLETED|Core Study||0||
48656016|NCT01433978|101941331|FG000|NOT COMPLETED|Core Study||11||
48656017|NCT01433978|101941332|FG001|NOT COMPLETED|Core Study||11||
48656018|NCT01433978|101941333|FG002|NOT COMPLETED|Core Study||0||
48656019|NCT01433978|101941331|FG000|STARTED|Extension Phase||0||
48656020|NCT01433978|101941332|FG001|STARTED|Extension Phase||0||
48656021|NCT01433978|101941333|FG002|STARTED|Extension Phase||6||
48656022|NCT01433978|101941331|FG000|COMPLETED|Extension Phase||0||
48656023|NCT01433978|101941332|FG001|COMPLETED|Extension Phase||0||
48656024|NCT01433978|101941333|FG002|COMPLETED|Extension Phase||0||
48656025|NCT01433978|101941331|FG000|NOT COMPLETED|Extension Phase||0||
48656026|NCT01433978|101941332|FG001|NOT COMPLETED|Extension Phase||0||
48656027|NCT01433978|101941333|FG002|NOT COMPLETED|Extension Phase||6||
48656028|NCT04042311|101941334|FG000|STARTED|Overall Study||70||
48656029|NCT04042311|101941334|FG000|Participants Enrolled in Workstream 1|Overall Study||30||
48656030|NCT04042311|101941334|FG000|Participants Completing Workstream 1|Overall Study||15||
48656031|NCT04042311|101941334|FG000|Participants Enrolled in Workstream 2|Overall Study||40||
48656032|NCT04042311|101941334|FG000|Participants Completing Workstream 2|Overall Study||31||
48656033|NCT04042311|101941334|FG000|COMPLETED|Overall Study||46||
48656034|NCT04042311|101941334|FG000|NOT COMPLETED|Overall Study||24||
48656035|NCT02527265|101941335|FG000|STARTED|Overall Study||15||
48656036|NCT02527265|101941336|FG001|STARTED|Overall Study||15||
48656037|NCT02527265|101941335|FG000|COMPLETED|Overall Study||13||
48656038|NCT02527265|101941336|FG001|COMPLETED|Overall Study||11||
48656039|NCT02527265|101941335|FG000|NOT COMPLETED|Overall Study||2||
48656040|NCT02527265|101941336|FG001|NOT COMPLETED|Overall Study||4||
48656041|NCT03865706|101941337|FG000|STARTED|Overall Study||30||
48656042|NCT03865706|101941338|FG001|STARTED|Overall Study||33||
48656043|NCT03865706|101941339|FG002|STARTED|Overall Study||31||
48656044|NCT03865706|101941337|FG000|COMPLETED|Overall Study||30||
48656045|NCT03865706|101941338|FG001|COMPLETED|Overall Study||30||
48656046|NCT03865706|101941339|FG002|COMPLETED|Overall Study||30||
48656047|NCT03865706|101941337|FG000|NOT COMPLETED|Overall Study||0||
48656048|NCT03865706|101941338|FG001|NOT COMPLETED|Overall Study||3||
48656049|NCT03865706|101941339|FG002|NOT COMPLETED|Overall Study||1||
48367715|NCT01809262|101230044|FG004|STARTED|Period 3 (Third Dose + Washout)||3||
48437904|NCT00584831|101406437|FG009|COMPLETED|Intervention 3||2||
48656050|NCT02100644|101941340|FG000|STARTED|LTG Escalation Phase||33||
48656051|NCT02100644|101941341|FG001|STARTED|LTG Escalation Phase||0||
48656052|NCT02100644|101941342|FG002|STARTED|LTG Escalation Phase||0||
48656053|NCT02100644|101941340|FG000|COMPLETED|LTG Escalation Phase||20||
48656054|NCT02100644|101941341|FG001|COMPLETED|LTG Escalation Phase||0||
48656055|NCT02100644|101941342|FG002|COMPLETED|LTG Escalation Phase||0||
48656056|NCT02100644|101941340|FG000|NOT COMPLETED|LTG Escalation Phase||13||
48656057|NCT02100644|101941341|FG001|NOT COMPLETED|LTG Escalation Phase||0||
48656058|NCT02100644|101941342|FG002|NOT COMPLETED|LTG Escalation Phase||0||
48656059|NCT02100644|101941340|FG000|STARTED|VPA Reduction Phase||0||
48656060|NCT02100644|101941341|FG001|STARTED|VPA Reduction Phase||20||
48656061|NCT02100644|101941342|FG002|STARTED|VPA Reduction Phase||0||
48656062|NCT02100644|101941340|FG000|COMPLETED|VPA Reduction Phase||0||
48656063|NCT02100644|101941341|FG001|COMPLETED|VPA Reduction Phase||20||
48367716|NCT01809262|101230045|FG005|STARTED|Period 3 (Third Dose + Washout)||3||
48437905|NCT00584831|101406438|FG010|COMPLETED|Intervention 3||2||
48656064|NCT02100644|101941342|FG002|COMPLETED|VPA Reduction Phase||0||
48656065|NCT02100644|101941340|FG000|NOT COMPLETED|VPA Reduction Phase||0||
48656066|NCT02100644|101941341|FG001|NOT COMPLETED|VPA Reduction Phase||0||
48656067|NCT02100644|101941342|FG002|NOT COMPLETED|VPA Reduction Phase||0||
48656068|NCT02100644|101941340|FG000|STARTED|LTG and VPA Maintenance Phase||0||
48656069|NCT02100644|101941341|FG001|STARTED|LTG and VPA Maintenance Phase||0||
48656070|NCT02100644|101941342|FG002|STARTED|LTG and VPA Maintenance Phase||20||
48656071|NCT02100644|101941340|FG000|COMPLETED|LTG and VPA Maintenance Phase||0||
48656072|NCT02100644|101941341|FG001|COMPLETED|LTG and VPA Maintenance Phase||0||
48656073|NCT02100644|101941342|FG002|COMPLETED|LTG and VPA Maintenance Phase||20||
48656074|NCT02100644|101941340|FG000|NOT COMPLETED|LTG and VPA Maintenance Phase||0||
48656075|NCT02100644|101941341|FG001|NOT COMPLETED|LTG and VPA Maintenance Phase||0||
48656076|NCT02100644|101941342|FG002|NOT COMPLETED|LTG and VPA Maintenance Phase||0||
48656077|NCT03975647|101941343|FG000|STARTED|Overall Study||231||
48656078|NCT03975647|101941344|FG001|STARTED|Overall Study||235||
48656079|NCT03975647|101941343|FG000|Intent-to-Treat (ITT) Analysis Set|Overall Study||228||
48656080|NCT03975647|101941344|FG001|Intent-to-Treat (ITT) Analysis Set|Overall Study||235||
48656081|NCT03975647|101941343|FG000|COMPLETED|Overall Study||151||
48656082|NCT03975647|101941344|FG001|COMPLETED|Overall Study||159||
48656083|NCT03975647|101941343|FG000|NOT COMPLETED|Overall Study||80||
48766699|NCT02963506|102218489|FG006|STARTED|Double-Blind Period||0||
48766700|NCT02963506|102218490|FG007|STARTED|Double-Blind Period||0||
48766701|NCT02963506|102218491|FG008|STARTED|Double-Blind Period||0||
48766702|NCT02963506|102218492|FG009|STARTED|Double-Blind Period||0||
48766703|NCT02963506|102218493|FG010|STARTED|Double-Blind Period||0||
48766704|NCT02963506|102218494|FG011|STARTED|Double-Blind Period||0||
48766705|NCT02963506|102218495|FG012|STARTED|Double-Blind Period||0||
48766706|NCT02963506|102218483|FG000|Completed Double-Blind Period|Double-Blind Period||60||
48766707|NCT02963506|102218484|FG001|Completed Double-Blind Period|Double-Blind Period||59||
48766708|NCT02963506|102218485|FG002|Completed Double-Blind Period|Double-Blind Period||59||
48766709|NCT02963506|102218486|FG003|Completed Double-Blind Period|Double-Blind Period||58||
48766710|NCT02963506|102218487|FG004|Completed Double-Blind Period|Double-Blind Period||61||
48766711|NCT02963506|102218488|FG005|Completed Double-Blind Period|Double-Blind Period||0||
48766712|NCT02963506|102218489|FG006|Completed Double-Blind Period|Double-Blind Period||0||
48766713|NCT02963506|102218490|FG007|Completed Double-Blind Period|Double-Blind Period||0||
48766714|NCT02963506|102218491|FG008|Completed Double-Blind Period|Double-Blind Period||0||
48766715|NCT02963506|102218492|FG009|Completed Double-Blind Period|Double-Blind Period||0||
48766716|NCT02963506|102218493|FG010|Completed Double-Blind Period|Double-Blind Period||0||
48766717|NCT02963506|102218494|FG011|Completed Double-Blind Period|Double-Blind Period||0||
48766718|NCT02963506|102218495|FG012|Completed Double-Blind Period|Double-Blind Period||0||
48766719|NCT02963506|102218483|FG000|Completed Week 12 - Started Dose-Blind|Double-Blind Period||60||
48766720|NCT02963506|102218484|FG001|Completed Week 12 - Started Dose-Blind|Double-Blind Period||58||
48766721|NCT02963506|102218485|FG002|Completed Week 12 - Started Dose-Blind|Double-Blind Period||59||
48766722|NCT02963506|102218486|FG003|Completed Week 12 - Started Dose-Blind|Double-Blind Period||58||
48766723|NCT02963506|102218487|FG004|Completed Week 12 - Started Dose-Blind|Double-Blind Period||61||
48766724|NCT02963506|102218488|FG005|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0||
48766725|NCT02963506|102218489|FG006|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0||
48766726|NCT02963506|102218490|FG007|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0||
48766727|NCT02963506|102218491|FG008|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0||
48766728|NCT02963506|102218492|FG009|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0||
48766729|NCT02963506|102218493|FG010|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0||
48766730|NCT02963506|102218494|FG011|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0||
48766731|NCT02963506|102218495|FG012|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0||
48766732|NCT02963506|102218483|FG000|COMPLETED|Double-Blind Period||60||
48437906|NCT00584831|101406439|FG011|COMPLETED|Intervention 3||1||
48437907|NCT00584831|101406440|FG012|COMPLETED|Intervention 3||2||
48437908|NCT00584831|101406441|FG013|COMPLETED|Intervention 3||1||
48437909|NCT00584831|101406442|FG014|COMPLETED|Intervention 3||3||
48437910|NCT00584831|101406443|FG015|COMPLETED|Intervention 3||1||
48437911|NCT00584831|101406444|FG016|COMPLETED|Intervention 3||4||
48437912|NCT00584831|101406445|FG017|COMPLETED|Intervention 3||1||
48437913|NCT00584831|101406446|FG018|COMPLETED|Intervention 3||1||
48437914|NCT00584831|101406428|FG000|NOT COMPLETED|Intervention 3||0||
48437915|NCT00584831|101406429|FG001|NOT COMPLETED|Intervention 3||0||
48437916|NCT00584831|101406430|FG002|NOT COMPLETED|Intervention 3||0||
48437917|NCT00584831|101406431|FG003|NOT COMPLETED|Intervention 3||0||
48766733|NCT02963506|102218484|FG001|COMPLETED|Double-Blind Period||58||
48766734|NCT02963506|102218485|FG002|COMPLETED|Double-Blind Period||59||
48766735|NCT02963506|102218486|FG003|COMPLETED|Double-Blind Period||58||
48766736|NCT02963506|102218487|FG004|COMPLETED|Double-Blind Period||61||
48766737|NCT02963506|102218488|FG005|COMPLETED|Double-Blind Period||0||
48766738|NCT02963506|102218489|FG006|COMPLETED|Double-Blind Period||0||
48766739|NCT02963506|102218490|FG007|COMPLETED|Double-Blind Period||0||
48766740|NCT02963506|102218491|FG008|COMPLETED|Double-Blind Period||0||
48766741|NCT02963506|102218492|FG009|COMPLETED|Double-Blind Period||0||
48766742|NCT02963506|102218493|FG010|COMPLETED|Double-Blind Period||0||
48766743|NCT02963506|102218494|FG011|COMPLETED|Double-Blind Period||0||
48766744|NCT02963506|102218495|FG012|COMPLETED|Double-Blind Period||0||
48766745|NCT02963506|102218483|FG000|NOT COMPLETED|Double-Blind Period||0||
48766746|NCT02963506|102218484|FG001|NOT COMPLETED|Double-Blind Period||3||
48766747|NCT02963506|102218485|FG002|NOT COMPLETED|Double-Blind Period||2||
48766748|NCT02963506|102218486|FG003|NOT COMPLETED|Double-Blind Period||2||
48766749|NCT02963506|102218487|FG004|NOT COMPLETED|Double-Blind Period||0||
48766750|NCT02963506|102218488|FG005|NOT COMPLETED|Double-Blind Period||0||
48766751|NCT02963506|102218489|FG006|NOT COMPLETED|Double-Blind Period||0||
48437918|NCT00584831|101406432|FG004|NOT COMPLETED|Intervention 3||0||
48437919|NCT00584831|101406433|FG005|NOT COMPLETED|Intervention 3||0||
48437920|NCT00584831|101406434|FG006|NOT COMPLETED|Intervention 3||0||
48437921|NCT00584831|101406435|FG007|NOT COMPLETED|Intervention 3||0||
48437922|NCT00584831|101406436|FG008|NOT COMPLETED|Intervention 3||0||
48437923|NCT00584831|101406437|FG009|NOT COMPLETED|Intervention 3||0||
48437924|NCT00584831|101406438|FG010|NOT COMPLETED|Intervention 3||0||
48437925|NCT00584831|101406439|FG011|NOT COMPLETED|Intervention 3||0||
48437926|NCT00584831|101406440|FG012|NOT COMPLETED|Intervention 3||0||
48437927|NCT00584831|101406441|FG013|NOT COMPLETED|Intervention 3||0||
48766752|NCT02963506|102218490|FG007|NOT COMPLETED|Double-Blind Period||0||
48437928|NCT00584831|101406442|FG014|NOT COMPLETED|Intervention 3||0||
48437929|NCT00584831|101406443|FG015|NOT COMPLETED|Intervention 3||0||
48437930|NCT00584831|101406444|FG016|NOT COMPLETED|Intervention 3||0||
48437931|NCT00584831|101406445|FG017|NOT COMPLETED|Intervention 3||0||
48437932|NCT00584831|101406446|FG018|NOT COMPLETED|Intervention 3||0||
48437933|NCT00584831|101406428|FG000|STARTED|Intervention 4||1||
48437934|NCT00584831|101406429|FG001|STARTED|Intervention 4||3||
48437935|NCT00584831|101406430|FG002|STARTED|Intervention 4||2||
48437936|NCT00584831|101406431|FG003|STARTED|Intervention 4||1||
48437937|NCT00584831|101406432|FG004|STARTED|Intervention 4||2||
48437938|NCT00584831|101406433|FG005|STARTED|Intervention 4||1||
48437939|NCT00584831|101406434|FG006|STARTED|Intervention 4||6||
48437940|NCT00584831|101406435|FG007|STARTED|Intervention 4||2||
48437941|NCT00584831|101406436|FG008|STARTED|Intervention 4||3||
48437942|NCT00584831|101406437|FG009|STARTED|Intervention 4||2||
48437943|NCT00584831|101406438|FG010|STARTED|Intervention 4||2||
48437944|NCT00584831|101406439|FG011|STARTED|Intervention 4||1||
48437945|NCT00584831|101406440|FG012|STARTED|Intervention 4||2||
48437946|NCT00584831|101406441|FG013|STARTED|Intervention 4||1||
48437947|NCT00584831|101406442|FG014|STARTED|Intervention 4||2||
48437948|NCT00584831|101406443|FG015|STARTED|Intervention 4||1||
48437949|NCT00584831|101406444|FG016|STARTED|Intervention 4||4||
48437950|NCT00584831|101406445|FG017|STARTED|Intervention 4||1||
48437951|NCT00584831|101406446|FG018|STARTED|Intervention 4||1||
48437952|NCT00584831|101406428|FG000|COMPLETED|Intervention 4||1||
48437953|NCT00584831|101406429|FG001|COMPLETED|Intervention 4||3||
48766753|NCT02963506|102218491|FG008|NOT COMPLETED|Double-Blind Period||0||
48766754|NCT02963506|102218492|FG009|NOT COMPLETED|Double-Blind Period||0||
48766755|NCT02963506|102218493|FG010|NOT COMPLETED|Double-Blind Period||0||
48766756|NCT02963506|102218494|FG011|NOT COMPLETED|Double-Blind Period||0||
48766757|NCT02963506|102218495|FG012|NOT COMPLETED|Double-Blind Period||0||
48766758|NCT02963506|102218483|FG000|STARTED|Dose-Blind Period||0||
48766759|NCT02963506|102218484|FG001|STARTED|Dose-Blind Period||0||
48766760|NCT02963506|102218485|FG002|STARTED|Dose-Blind Period||0||
48766761|NCT02963506|102218486|FG003|STARTED|Dose-Blind Period||0||
48766762|NCT02963506|102218487|FG004|STARTED|Dose-Blind Period||0||
48766763|NCT02963506|102218488|FG005|STARTED|Dose-Blind Period||24||
48766764|NCT02963506|102218489|FG006|STARTED|Dose-Blind Period||36||
48766765|NCT02963506|102218490|FG007|STARTED|Dose-Blind Period||31||
48766766|NCT02963506|102218491|FG008|STARTED|Dose-Blind Period||27||
48766767|NCT02963506|102218492|FG009|STARTED|Dose-Blind Period||34||
48766768|NCT02963506|102218493|FG010|STARTED|Dose-Blind Period||25||
48766769|NCT02963506|102218494|FG011|STARTED|Dose-Blind Period||58||
48766770|NCT02963506|102218495|FG012|STARTED|Dose-Blind Period||61||
48766771|NCT02963506|102218483|FG000|COMPLETED|Dose-Blind Period||0||
48437954|NCT00584831|101406430|FG002|COMPLETED|Intervention 4||2||
48437955|NCT00584831|101406431|FG003|COMPLETED|Intervention 4||1||
48437956|NCT00584831|101406432|FG004|COMPLETED|Intervention 4||2||
48437957|NCT00584831|101406433|FG005|COMPLETED|Intervention 4||1||
48437958|NCT00584831|101406434|FG006|COMPLETED|Intervention 4||6||
48437959|NCT00584831|101406435|FG007|COMPLETED|Intervention 4||2||
48656084|NCT03975647|101941344|FG001|NOT COMPLETED|Overall Study||76||
48656085|NCT03620981|101941345|FG000|STARTED|Overall Study||112||
48656086|NCT03620981|101941346|FG001|STARTED|Overall Study||149||
48656087|NCT03620981|101941347|FG002|STARTED|Overall Study||149||
48656088|NCT03620981|101941345|FG000|COMPLETED|Overall Study||83||
48656089|NCT03620981|101941346|FG001|COMPLETED|Overall Study||102||
48656090|NCT03620981|101941347|FG002|COMPLETED|Overall Study||116||
48656091|NCT03620981|101941345|FG000|NOT COMPLETED|Overall Study||29||
48656092|NCT03620981|101941346|FG001|NOT COMPLETED|Overall Study||47||
48437960|NCT00584831|101406436|FG008|COMPLETED|Intervention 4||3||
48437961|NCT00584831|101406437|FG009|COMPLETED|Intervention 4||2||
48437962|NCT00584831|101406438|FG010|COMPLETED|Intervention 4||2||
48437963|NCT00584831|101406439|FG011|COMPLETED|Intervention 4||1||
48437964|NCT00584831|101406440|FG012|COMPLETED|Intervention 4||2||
48437965|NCT00584831|101406441|FG013|COMPLETED|Intervention 4||1||
48437966|NCT00584831|101406442|FG014|COMPLETED|Intervention 4||2||
48437967|NCT00584831|101406443|FG015|COMPLETED|Intervention 4||1||
48656093|NCT03620981|101941347|FG002|NOT COMPLETED|Overall Study||33||
48766772|NCT02963506|102218484|FG001|COMPLETED|Dose-Blind Period||0||
48766773|NCT02963506|102218485|FG002|COMPLETED|Dose-Blind Period||0||
48766774|NCT02963506|102218486|FG003|COMPLETED|Dose-Blind Period||0||
48766775|NCT02963506|102218487|FG004|COMPLETED|Dose-Blind Period||0||
48437968|NCT00584831|101406444|FG016|COMPLETED|Intervention 4||4||
48437969|NCT00584831|101406445|FG017|COMPLETED|Intervention 4||1||
48437970|NCT00584831|101406446|FG018|COMPLETED|Intervention 4||1||
48656094|NCT00960856|101943618|FG000|STARTED|Period I||10||
48656095|NCT00960856|101943619|FG001|STARTED|Period I||9||
48437971|NCT00584831|101406428|FG000|NOT COMPLETED|Intervention 4||0||
48437972|NCT00584831|101406429|FG001|NOT COMPLETED|Intervention 4||0||
48437973|NCT00584831|101406430|FG002|NOT COMPLETED|Intervention 4||0||
48437974|NCT00584831|101406431|FG003|NOT COMPLETED|Intervention 4||0||
48437975|NCT00584831|101406432|FG004|NOT COMPLETED|Intervention 4||0||
48437976|NCT00584831|101406433|FG005|NOT COMPLETED|Intervention 4||0||
48656096|NCT00960856|101943620|FG002|STARTED|Period I||9||
48766776|NCT02963506|102218488|FG005|COMPLETED|Dose-Blind Period||20||
48656097|NCT00960856|101943621|FG003|STARTED|Period I||9||
48656098|NCT00960856|101943618|FG000|COMPLETED|Period I||10||
48656099|NCT00960856|101943619|FG001|COMPLETED|Period I||9||
48656100|NCT00960856|101943620|FG002|COMPLETED|Period I||9||
48656101|NCT00960856|101943621|FG003|COMPLETED|Period I||9||
48656102|NCT00960856|101943618|FG000|NOT COMPLETED|Period I||0||
48656103|NCT00960856|101943619|FG001|NOT COMPLETED|Period I||0||
48656104|NCT00960856|101943620|FG002|NOT COMPLETED|Period I||0||
48656105|NCT00960856|101943621|FG003|NOT COMPLETED|Period I||0||
48656106|NCT00960856|101943618|FG000|STARTED|Washout Period of 7 Days||10||
48656107|NCT00960856|101943619|FG001|STARTED|Washout Period of 7 Days||9||
48656108|NCT00960856|101943620|FG002|STARTED|Washout Period of 7 Days||9||
48656109|NCT00960856|101943621|FG003|STARTED|Washout Period of 7 Days||9||
48656110|NCT00960856|101943618|FG000|COMPLETED|Washout Period of 7 Days||10||
48656111|NCT00960856|101943619|FG001|COMPLETED|Washout Period of 7 Days||7||
48656112|NCT00960856|101943620|FG002|COMPLETED|Washout Period of 7 Days||9||
48656113|NCT00960856|101943621|FG003|COMPLETED|Washout Period of 7 Days||9||
48656114|NCT00960856|101943618|FG000|NOT COMPLETED|Washout Period of 7 Days||0||
48656115|NCT00960856|101943619|FG001|NOT COMPLETED|Washout Period of 7 Days||2||
48656116|NCT00960856|101943620|FG002|NOT COMPLETED|Washout Period of 7 Days||0||
48656117|NCT00960856|101943621|FG003|NOT COMPLETED|Washout Period of 7 Days||0||
48656118|NCT00960856|101943618|FG000|STARTED|Period II||10||
48656119|NCT00960856|101943619|FG001|STARTED|Period II||7||
48656120|NCT00960856|101943620|FG002|STARTED|Period II||9||
48656121|NCT00960856|101943621|FG003|STARTED|Period II||9||
48656122|NCT00960856|101943618|FG000|COMPLETED|Period II||10||
48656123|NCT00960856|101943619|FG001|COMPLETED|Period II||7||
48656124|NCT00960856|101943620|FG002|COMPLETED|Period II||9||
48656125|NCT00960856|101943621|FG003|COMPLETED|Period II||9||
48656126|NCT00960856|101943618|FG000|NOT COMPLETED|Period II||0||
48656127|NCT00960856|101943619|FG001|NOT COMPLETED|Period II||0||
48656128|NCT00960856|101943620|FG002|NOT COMPLETED|Period II||0||
48656129|NCT00960856|101943621|FG003|NOT COMPLETED|Period II||0||
48656130|NCT00960856|101943618|FG000|STARTED|Washout Period of 7 Days||10||
48656131|NCT00960856|101943619|FG001|STARTED|Washout Period of 7 Days||7||
48656132|NCT00960856|101943620|FG002|STARTED|Washout Period of 7 Days||9||
48656133|NCT00960856|101943621|FG003|STARTED|Washout Period of 7 Days||9||
48656134|NCT00960856|101943618|FG000|COMPLETED|Washout Period of 7 Days||10||
48656135|NCT00960856|101943619|FG001|COMPLETED|Washout Period of 7 Days||7||
48656136|NCT00960856|101943620|FG002|COMPLETED|Washout Period of 7 Days||9||
48656137|NCT00960856|101943621|FG003|COMPLETED|Washout Period of 7 Days||9||
48656138|NCT00960856|101943618|FG000|NOT COMPLETED|Washout Period of 7 Days||0||
48656139|NCT00960856|101943619|FG001|NOT COMPLETED|Washout Period of 7 Days||0||
48656140|NCT00960856|101943620|FG002|NOT COMPLETED|Washout Period of 7 Days||0||
48656141|NCT00960856|101943621|FG003|NOT COMPLETED|Washout Period of 7 Days||0||
48656142|NCT00960856|101943618|FG000|STARTED|Period III||10||
48656143|NCT00960856|101943619|FG001|STARTED|Period III||7||
48656144|NCT00960856|101943620|FG002|STARTED|Period III||9||
48656145|NCT00960856|101943621|FG003|STARTED|Period III||9||
48656146|NCT00960856|101943618|FG000|COMPLETED|Period III||10||
48656147|NCT00960856|101943619|FG001|COMPLETED|Period III||7||
48656148|NCT00960856|101943620|FG002|COMPLETED|Period III||9||
48656149|NCT00960856|101943621|FG003|COMPLETED|Period III||9||
48656150|NCT00960856|101943618|FG000|NOT COMPLETED|Period III||0||
48656151|NCT00960856|101943619|FG001|NOT COMPLETED|Period III||0||
48656152|NCT00960856|101943620|FG002|NOT COMPLETED|Period III||0||
48656153|NCT00960856|101943621|FG003|NOT COMPLETED|Period III||0||
48656154|NCT00960856|101943618|FG000|STARTED|Washout Period of 7 Days||10||
48656155|NCT00960856|101943619|FG001|STARTED|Washout Period of 7 Days||7||
48656156|NCT00960856|101943620|FG002|STARTED|Washout Period of 7 Days||9||
48656157|NCT00960856|101943621|FG003|STARTED|Washout Period of 7 Days||9||
48656158|NCT00960856|101943618|FG000|COMPLETED|Washout Period of 7 Days||10||
48656159|NCT00960856|101943619|FG001|COMPLETED|Washout Period of 7 Days||7||
48656160|NCT00960856|101943620|FG002|COMPLETED|Washout Period of 7 Days||8||
48656161|NCT00960856|101943621|FG003|COMPLETED|Washout Period of 7 Days||9||
48656162|NCT00960856|101943618|FG000|NOT COMPLETED|Washout Period of 7 Days||0||
48656163|NCT00960856|101943619|FG001|NOT COMPLETED|Washout Period of 7 Days||0||
48656164|NCT00960856|101943620|FG002|NOT COMPLETED|Washout Period of 7 Days||1||
48656165|NCT00960856|101943621|FG003|NOT COMPLETED|Washout Period of 7 Days||0||
48656166|NCT00960856|101943618|FG000|STARTED|Period IV||10||
48656167|NCT00960856|101943619|FG001|STARTED|Period IV||7||
48656168|NCT00960856|101943620|FG002|STARTED|Period IV||8||
48656169|NCT00960856|101943621|FG003|STARTED|Period IV||9||
48656170|NCT00960856|101943618|FG000|COMPLETED|Period IV||10||
48656171|NCT00960856|101943619|FG001|COMPLETED|Period IV||7||
48656172|NCT00960856|101943620|FG002|COMPLETED|Period IV||8||
48656173|NCT00960856|101943621|FG003|COMPLETED|Period IV||9||
48656174|NCT00960856|101943618|FG000|NOT COMPLETED|Period IV||0||
48656175|NCT00960856|101943619|FG001|NOT COMPLETED|Period IV||0||
48656176|NCT00960856|101943620|FG002|NOT COMPLETED|Period IV||0||
48656177|NCT00960856|101943621|FG003|NOT COMPLETED|Period IV||0||
48656178|NCT04209855|101943622|FG000|STARTED|Overall Study||227||
48656179|NCT04209855|101943623|FG001|STARTED|Overall Study||226||
48656180|NCT04209855|101943622|FG000|Received at Least 1 Dose of Study Drug|Overall Study||218||
48656181|NCT04209855|101943623|FG001|Received at Least 1 Dose of Study Drug|Overall Study||207||
48656182|NCT04209855|101943622|FG000|COMPLETED|Overall Study||32|Still on Treatment|
48656183|NCT04209855|101943623|FG001|COMPLETED|Overall Study||6|Still on Treatment|
48656184|NCT04209855|101943622|FG000|NOT COMPLETED|Overall Study||195||
48656185|NCT04209855|101943623|FG001|NOT COMPLETED|Overall Study||220||
48656186|NCT03186378|101943624|FG000|STARTED|Overall Study||17||
48656187|NCT03186378|101943625|FG001|STARTED|Overall Study||16||
48656188|NCT03186378|101943624|FG000|COMPLETED|Overall Study||16||
48656189|NCT03186378|101943625|FG001|COMPLETED|Overall Study||16||
48656190|NCT03186378|101943624|FG000|NOT COMPLETED|Overall Study||1||
48656191|NCT03186378|101943625|FG001|NOT COMPLETED|Overall Study||0||
48656192|NCT04105725|101943626|FG000|STARTED|Primary Intervention||37||
48656193|NCT04105725|101943627|FG001|STARTED|Primary Intervention||29||
48656194|NCT04105725|101943626|FG000|COMPLETED|Primary Intervention||37||
48656195|NCT04105725|101943627|FG001|COMPLETED|Primary Intervention||26||
48656196|NCT04105725|101943626|FG000|NOT COMPLETED|Primary Intervention||0||
48656197|NCT04105725|101943627|FG001|NOT COMPLETED|Primary Intervention||3||
48656198|NCT04105725|101943626|FG000|STARTED|Mini-Session Week 1||37||
48656199|NCT04105725|101943627|FG001|STARTED|Mini-Session Week 1||26||
48656200|NCT04105725|101943626|FG000|COMPLETED|Mini-Session Week 1||36||
48656201|NCT04105725|101943627|FG001|COMPLETED|Mini-Session Week 1||25||
48656202|NCT04105725|101943626|FG000|NOT COMPLETED|Mini-Session Week 1||1||
48656203|NCT04105725|101943627|FG001|NOT COMPLETED|Mini-Session Week 1||1||
48656204|NCT04105725|101943626|FG000|STARTED|Mini-Session Week 2||37||
48656205|NCT04105725|101943627|FG001|STARTED|Mini-Session Week 2||26||
48656206|NCT04105725|101943626|FG000|COMPLETED|Mini-Session Week 2||34||
48656207|NCT04105725|101943627|FG001|COMPLETED|Mini-Session Week 2||22||
48656208|NCT04105725|101943626|FG000|NOT COMPLETED|Mini-Session Week 2||3||
48656209|NCT04105725|101943627|FG001|NOT COMPLETED|Mini-Session Week 2||4||
48656210|NCT04105725|101943626|FG000|STARTED|Mini-Session Week 3||37||
48656211|NCT04105725|101943627|FG001|STARTED|Mini-Session Week 3||26||
48656212|NCT04105725|101943626|FG000|COMPLETED|Mini-Session Week 3||34||
48656213|NCT04105725|101943627|FG001|COMPLETED|Mini-Session Week 3||22||
48656214|NCT04105725|101943626|FG000|NOT COMPLETED|Mini-Session Week 3||3||
48656215|NCT04105725|101943627|FG001|NOT COMPLETED|Mini-Session Week 3||4||
48656216|NCT04105725|101943626|FG000|STARTED|Mini-Session Week 4||37||
48656217|NCT04105725|101943627|FG001|STARTED|Mini-Session Week 4||26||
48656218|NCT04105725|101943626|FG000|COMPLETED|Mini-Session Week 4||35||
48656219|NCT04105725|101943627|FG001|COMPLETED|Mini-Session Week 4||21||
48656220|NCT04105725|101943626|FG000|NOT COMPLETED|Mini-Session Week 4||2||
48656221|NCT04105725|101943627|FG001|NOT COMPLETED|Mini-Session Week 4||5||
48656222|NCT04105725|101943626|FG000|STARTED|Post-Intervention Survey||37||
48656223|NCT04105725|101943627|FG001|STARTED|Post-Intervention Survey||26||
48656224|NCT04105725|101943626|FG000|COMPLETED|Post-Intervention Survey||33||
48656225|NCT04105725|101943627|FG001|COMPLETED|Post-Intervention Survey||18||
48656226|NCT04105725|101943626|FG000|NOT COMPLETED|Post-Intervention Survey||4||
48656227|NCT04105725|101943627|FG001|NOT COMPLETED|Post-Intervention Survey||8||
48656228|NCT04105725|101943626|FG000|STARTED|3-Month Follow-up Survey||37||
48656229|NCT04105725|101943627|FG001|STARTED|3-Month Follow-up Survey||26||
48656230|NCT04105725|101943626|FG000|COMPLETED|3-Month Follow-up Survey||33||
48656231|NCT04105725|101943627|FG001|COMPLETED|3-Month Follow-up Survey||22||
48656232|NCT04105725|101943626|FG000|NOT COMPLETED|3-Month Follow-up Survey||4||
48656233|NCT04105725|101943627|FG001|NOT COMPLETED|3-Month Follow-up Survey||4||
48656234|NCT01886872|101943628|FG000|STARTED|Overall Study||183|Registered/Randomized|
48656235|NCT01886872|101943629|FG001|STARTED|Overall Study||182|Registered/Randomized|
48656236|NCT01886872|101943630|FG002|STARTED|Overall Study||182|Registered/Randomized|
48656237|NCT01886872|101943628|FG000|Evaluable for Secondary Endpoints|Overall Study||183||
48656238|NCT01886872|101943629|FG001|Evaluable for Secondary Endpoints|Overall Study||182||
48656239|NCT01886872|101943630|FG002|Evaluable for Secondary Endpoints|Overall Study||182||
48656240|NCT01886872|101943628|FG000|Evaluable for Adverse Events|Overall Study||176|All Patients who Started Therapy|
48656241|NCT01886872|101943629|FG001|Evaluable for Adverse Events|Overall Study||180|All Patients who Started Therapy|
48656242|NCT01886872|101943630|FG002|Evaluable for Adverse Events|Overall Study||181|All Patients who Started Therapy|
48656243|NCT01886872|101943628|FG000|Crossover Cohort|Overall Study||30|Arm A to Arm B|
48656244|NCT01886872|101943629|FG001|Crossover Cohort|Overall Study||0|Arm A to Arm B|
48656245|NCT01886872|101943630|FG002|Crossover Cohort|Overall Study||0|Arm A to Arm B|
48656246|NCT01886872|101943628|FG000|COMPLETED|Overall Study||176|All Eligible Patients Evaluable for the Primary Endpoint|
48766777|NCT02963506|102218489|FG006|COMPLETED|Dose-Blind Period||31||
48656247|NCT01886872|101943629|FG001|COMPLETED|Overall Study||178|All Eligible Patients Evaluable for the Primary Endpoint|
48656248|NCT01886872|101943630|FG002|COMPLETED|Overall Study||170|All Eligible Patients Evaluable for the Primary Endpoint|
48656249|NCT01886872|101943628|FG000|NOT COMPLETED|Overall Study||7||
48766778|NCT02963506|102218490|FG007|COMPLETED|Dose-Blind Period||26||
48766779|NCT02963506|102218491|FG008|COMPLETED|Dose-Blind Period||24||
48766780|NCT02963506|102218492|FG009|COMPLETED|Dose-Blind Period||30||
48766781|NCT02963506|102218493|FG010|COMPLETED|Dose-Blind Period||24||
48766782|NCT02963506|102218494|FG011|COMPLETED|Dose-Blind Period||56||
48766783|NCT02963506|102218495|FG012|COMPLETED|Dose-Blind Period||54||
48656250|NCT01886872|101943629|FG001|NOT COMPLETED|Overall Study||4||
48656251|NCT01886872|101943630|FG002|NOT COMPLETED|Overall Study||12||
48656252|NCT01902173|101943631|FG000|STARTED|Phase 1 Doublet Regimen Cohort 1||3||
48656253|NCT01902173|101943632|FG001|STARTED|Phase 1 Doublet Regimen Cohort 1||0||
48656254|NCT01902173|101943633|FG002|STARTED|Phase 1 Doublet Regimen Cohort 1||0||
48656255|NCT01902173|101943634|FG003|STARTED|Phase 1 Doublet Regimen Cohort 1||0||
48656256|NCT01902173|101943635|FG004|STARTED|Phase 1 Doublet Regimen Cohort 1||0||
48656257|NCT01902173|101943636|FG005|STARTED|Phase 1 Doublet Regimen Cohort 1||0||
48656258|NCT01902173|101943631|FG000|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0||
48656259|NCT01902173|101943632|FG001|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0||
48656260|NCT01902173|101943633|FG002|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0||
48656261|NCT01902173|101943634|FG003|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0||
48656262|NCT01902173|101943635|FG004|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0||
48656263|NCT01902173|101943636|FG005|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0||
48656264|NCT01902173|101943631|FG000|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||3||
48656265|NCT01902173|101943632|FG001|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0||
48656266|NCT01902173|101943633|FG002|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0||
48656267|NCT01902173|101943634|FG003|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0||
48656268|NCT01902173|101943635|FG004|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0||
48656269|NCT01902173|101943636|FG005|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0||
48656270|NCT01902173|101943631|FG000|STARTED|Phase 1 Doublet Regimen Cohort 2||0||
48656271|NCT01902173|101943632|FG001|STARTED|Phase 1 Doublet Regimen Cohort 2||9||
48656272|NCT01902173|101943633|FG002|STARTED|Phase 1 Doublet Regimen Cohort 2||0||
48656273|NCT01902173|101943634|FG003|STARTED|Phase 1 Doublet Regimen Cohort 2||0||
48656274|NCT01902173|101943635|FG004|STARTED|Phase 1 Doublet Regimen Cohort 2||0||
48656275|NCT01902173|101943636|FG005|STARTED|Phase 1 Doublet Regimen Cohort 2||0||
48656276|NCT01902173|101943631|FG000|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0||
48656277|NCT01902173|101943632|FG001|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0||
48656278|NCT01902173|101943633|FG002|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0||
48656279|NCT01902173|101943634|FG003|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0||
48656280|NCT01902173|101943635|FG004|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0||
48656281|NCT01902173|101943636|FG005|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0||
48656282|NCT01902173|101943631|FG000|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0||
48656283|NCT01902173|101943632|FG001|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||9||
48656284|NCT01902173|101943633|FG002|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0||
48656285|NCT01902173|101943634|FG003|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0||
48656286|NCT01902173|101943635|FG004|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0||
48656287|NCT01902173|101943636|FG005|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0||
48656288|NCT01902173|101943631|FG000|STARTED|Phase 1 Triplet Regimen Cohort 1||0||
48656289|NCT01902173|101943632|FG001|STARTED|Phase 1 Triplet Regimen Cohort 1||0||
48656290|NCT01902173|101943633|FG002|STARTED|Phase 1 Triplet Regimen Cohort 1||4||
48656291|NCT01902173|101943634|FG003|STARTED|Phase 1 Triplet Regimen Cohort 1||0||
48656292|NCT01902173|101943635|FG004|STARTED|Phase 1 Triplet Regimen Cohort 1||0||
48656293|NCT01902173|101943636|FG005|STARTED|Phase 1 Triplet Regimen Cohort 1||0||
48656294|NCT01902173|101943631|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0||
48656295|NCT01902173|101943632|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0||
48656296|NCT01902173|101943633|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0||
48656297|NCT01902173|101943634|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0||
48656298|NCT01902173|101943635|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0||
48656299|NCT01902173|101943636|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0||
48656300|NCT01902173|101943631|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0||
48656301|NCT01902173|101943632|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0||
48656302|NCT01902173|101943633|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||4||
48656303|NCT01902173|101943634|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0||
48656304|NCT01902173|101943635|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0||
48656305|NCT01902173|101943636|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0||
48656306|NCT01902173|101943631|FG000|STARTED|Phase 1 Triplet Regimen Cohort 2||0||
48656307|NCT01902173|101943632|FG001|STARTED|Phase 1 Triplet Regimen Cohort 2||0||
48656308|NCT01902173|101943633|FG002|STARTED|Phase 1 Triplet Regimen Cohort 2||0||
48656309|NCT01902173|101943634|FG003|STARTED|Phase 1 Triplet Regimen Cohort 2||3||
48656310|NCT01902173|101943635|FG004|STARTED|Phase 1 Triplet Regimen Cohort 2||0||
48656311|NCT01902173|101943636|FG005|STARTED|Phase 1 Triplet Regimen Cohort 2||0||
48656312|NCT01902173|101943631|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0||
48656313|NCT01902173|101943632|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0||
48656314|NCT01902173|101943633|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0||
48656315|NCT01902173|101943634|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0||
48656316|NCT01902173|101943635|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0||
48656317|NCT01902173|101943636|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0||
48656318|NCT01902173|101943631|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0||
48656319|NCT01902173|101943632|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0||
48656320|NCT01902173|101943633|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0||
48656321|NCT01902173|101943634|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||3||
48437977|NCT00584831|101406434|FG006|NOT COMPLETED|Intervention 4||0||
48437978|NCT00584831|101406435|FG007|NOT COMPLETED|Intervention 4||0||
48437979|NCT00584831|101406436|FG008|NOT COMPLETED|Intervention 4||0||
48437980|NCT00584831|101406437|FG009|NOT COMPLETED|Intervention 4||0||
48437981|NCT00584831|101406438|FG010|NOT COMPLETED|Intervention 4||0||
48437982|NCT00584831|101406439|FG011|NOT COMPLETED|Intervention 4||0||
48437983|NCT00584831|101406440|FG012|NOT COMPLETED|Intervention 4||0||
48437984|NCT00584831|101406441|FG013|NOT COMPLETED|Intervention 4||0||
48437985|NCT00584831|101406442|FG014|NOT COMPLETED|Intervention 4||0||
48437986|NCT00584831|101406443|FG015|NOT COMPLETED|Intervention 4||0||
48437987|NCT00584831|101406444|FG016|NOT COMPLETED|Intervention 4||0||
48437988|NCT00584831|101406445|FG017|NOT COMPLETED|Intervention 4||0||
48766784|NCT02963506|102218483|FG000|NOT COMPLETED|Dose-Blind Period||0||
48766785|NCT02963506|102218484|FG001|NOT COMPLETED|Dose-Blind Period||0||
48766786|NCT02963506|102218485|FG002|NOT COMPLETED|Dose-Blind Period||0||
48766787|NCT02963506|102218486|FG003|NOT COMPLETED|Dose-Blind Period||0||
48437989|NCT00584831|101406446|FG018|NOT COMPLETED|Intervention 4||0||
48437990|NCT04389294|101406447|FG000|STARTED|Overall Study||143||
48437991|NCT04389294|101406447|FG000|COMPLETED|Overall Study||143||
48437992|NCT04389294|101406447|FG000|NOT COMPLETED|Overall Study||0||
48437993|NCT00924820|101406448|FG000|STARTED|Overall Study||20||
48437994|NCT00924820|101406448|FG000|COMPLETED|Overall Study||13||
48437995|NCT00924820|101406448|FG000|NOT COMPLETED|Overall Study||7||
48437996|NCT04003103|101406449|FG000|STARTED|Overall Study||97||
48437997|NCT04003103|101406450|FG001|STARTED|Overall Study||97||
48437998|NCT04003103|101406451|FG002|STARTED|Overall Study||48||
48437999|NCT04003103|101406449|FG000|COMPLETED|Overall Study||82||
48438000|NCT04003103|101406450|FG001|COMPLETED|Overall Study||91||
48438001|NCT04003103|101406451|FG002|COMPLETED|Overall Study||45||
48438002|NCT04003103|101406449|FG000|NOT COMPLETED|Overall Study||15||
48438003|NCT04003103|101406450|FG001|NOT COMPLETED|Overall Study||6||
48438004|NCT04003103|101406451|FG002|NOT COMPLETED|Overall Study||3||
48438005|NCT01060007|101406452|FG000|STARTED|Overall Study||80||
48438006|NCT01060007|101406452|FG000|COMPLETED|Overall Study||76||
48438007|NCT01060007|101406452|FG000|NOT COMPLETED|Overall Study||4||
48438008|NCT04054011|101406453|FG000|STARTED|Overall Study||15||
48438009|NCT04054011|101406453|FG000|COMPLETED|Overall Study||12||
48438010|NCT04054011|101406453|FG000|NOT COMPLETED|Overall Study||3||
48438011|NCT03668613|101406454|FG000|STARTED|Overall Study||42||
48438012|NCT03668613|101406455|FG001|STARTED|Overall Study||42||
48438013|NCT03668613|101406454|FG000|COMPLETED|Overall Study||31||
48438014|NCT03668613|101406455|FG001|COMPLETED|Overall Study||36||
48438015|NCT03668613|101406454|FG000|NOT COMPLETED|Overall Study||11||
48438016|NCT03668613|101406455|FG001|NOT COMPLETED|Overall Study||6||
48438017|NCT03752866|101406456|FG000|STARTED|Overall Study||501||
48438018|NCT03752866|101406457|FG001|STARTED|Overall Study||500||
48438019|NCT03752866|101406456|FG000|COMPLETED|Overall Study||501||
48438020|NCT03752866|101406457|FG001|COMPLETED|Overall Study||500||
48438021|NCT03752866|101406456|FG000|NOT COMPLETED|Overall Study||0||
48438022|NCT03752866|101406457|FG001|NOT COMPLETED|Overall Study||0||
48438023|NCT02797951|101406458|FG000|STARTED|Overall Study||165||
48438024|NCT02797951|101406458|FG000|Received at Least One Dose of Study Drug|Overall Study||164||
48766788|NCT02963506|102218487|FG004|NOT COMPLETED|Dose-Blind Period||0||
48766789|NCT02963506|102218488|FG005|NOT COMPLETED|Dose-Blind Period||4||
48766790|NCT02963506|102218489|FG006|NOT COMPLETED|Dose-Blind Period||5||
48766791|NCT02963506|102218490|FG007|NOT COMPLETED|Dose-Blind Period||5||
48766792|NCT02963506|102218491|FG008|NOT COMPLETED|Dose-Blind Period||3||
48438025|NCT02797951|101406458|FG000|COMPLETED|Overall Study||116|Participants who continued until sponsor ended the study following regulatory approval or non-approval of study drug for cluster headache indication in a country/region.|
48438026|NCT02797951|101406458|FG000|NOT COMPLETED|Overall Study||49||
48438027|NCT01300741|101406459|FG000|STARTED|Overall Study||75||
48438028|NCT01300741|101406459|FG000|COMPLETED|Overall Study||72||
48438029|NCT01300741|101406459|FG000|NOT COMPLETED|Overall Study||3||
48438030|NCT04513665|101406460|FG000|STARTED|Overall Study||16||
48766793|NCT02963506|102218492|FG009|NOT COMPLETED|Dose-Blind Period||4||
48766794|NCT02963506|102218493|FG010|NOT COMPLETED|Dose-Blind Period||1||
48438031|NCT04513665|101406461|FG001|STARTED|Overall Study||0||
48438032|NCT04513665|101406460|FG000|COMPLETED|Overall Study||0||
48438033|NCT04513665|101406461|FG001|COMPLETED|Overall Study||0||
48438034|NCT04513665|101406460|FG000|NOT COMPLETED|Overall Study||16||
48438035|NCT04513665|101406461|FG001|NOT COMPLETED|Overall Study||0||
48438036|NCT02975882|101406462|FG000|STARTED|Overall Study||5||
48438037|NCT02975882|101406463|FG001|STARTED|Overall Study||13||
48438038|NCT02975882|101406464|FG002|STARTED|Overall Study||9||
48438039|NCT02975882|101406465|FG003|STARTED|Overall Study||6||
48438040|NCT02975882|101406462|FG000|COMPLETED|Overall Study||1||
48438041|NCT02975882|101406463|FG001|COMPLETED|Overall Study||0||
48656322|NCT01902173|101943635|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0||
48656323|NCT01902173|101943636|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0||
48656324|NCT01902173|101943631|FG000|STARTED|Phase 1 Triplet Regimen Cohort 3||0||
48656325|NCT01902173|101943632|FG001|STARTED|Phase 1 Triplet Regimen Cohort 3||0||
48367717|NCT01809262|101230046|FG006|STARTED|Period 3 (Third Dose + Washout)||3||
48367718|NCT01809262|101230047|FG007|STARTED|Period 3 (Third Dose + Washout)||4||
48367719|NCT01809262|101230048|FG008|STARTED|Period 3 (Third Dose + Washout)||3||
48367720|NCT01809262|101230049|FG009|STARTED|Period 3 (Third Dose + Washout)||4||
48367721|NCT01809262|101230040|FG000|COMPLETED|Period 3 (Third Dose + Washout)||4||
48367722|NCT01809262|101230041|FG001|COMPLETED|Period 3 (Third Dose + Washout)||3||
48367723|NCT01809262|101230042|FG002|COMPLETED|Period 3 (Third Dose + Washout)||4||
48367724|NCT01809262|101230043|FG003|COMPLETED|Period 3 (Third Dose + Washout)||3||
48367725|NCT01809262|101230044|FG004|COMPLETED|Period 3 (Third Dose + Washout)||3||
48367726|NCT01809262|101230045|FG005|COMPLETED|Period 3 (Third Dose + Washout)||3||
48367727|NCT01809262|101230046|FG006|COMPLETED|Period 3 (Third Dose + Washout)||3||
48367728|NCT01809262|101230047|FG007|COMPLETED|Period 3 (Third Dose + Washout)||4||
48367729|NCT01809262|101230048|FG008|COMPLETED|Period 3 (Third Dose + Washout)||3||
48367730|NCT01809262|101230049|FG009|COMPLETED|Period 3 (Third Dose + Washout)||4||
48367731|NCT01809262|101230040|FG000|NOT COMPLETED|Period 3 (Third Dose + Washout)||0||
48367732|NCT01809262|101230041|FG001|NOT COMPLETED|Period 3 (Third Dose + Washout)||1||
48367733|NCT01809262|101230042|FG002|NOT COMPLETED|Period 3 (Third Dose + Washout)||0||
48367734|NCT01809262|101230043|FG003|NOT COMPLETED|Period 3 (Third Dose + Washout)||0||
48367735|NCT01809262|101230044|FG004|NOT COMPLETED|Period 3 (Third Dose + Washout)||0||
48367736|NCT01809262|101230045|FG005|NOT COMPLETED|Period 3 (Third Dose + Washout)||0||
48367737|NCT01809262|101230046|FG006|NOT COMPLETED|Period 3 (Third Dose + Washout)||0||
48367738|NCT01809262|101230047|FG007|NOT COMPLETED|Period 3 (Third Dose + Washout)||0||
48367739|NCT01809262|101230048|FG008|NOT COMPLETED|Period 3 (Third Dose + Washout)||0||
48367740|NCT01809262|101230049|FG009|NOT COMPLETED|Period 3 (Third Dose + Washout)||0||
48367741|NCT01809262|101230040|FG000|STARTED|Period 4 (Fourth Dose + Washout)||4||
48367742|NCT01809262|101230041|FG001|STARTED|Period 4 (Fourth Dose + Washout)||3||
48367743|NCT01809262|101230042|FG002|STARTED|Period 4 (Fourth Dose + Washout)||4||
48367744|NCT01809262|101230043|FG003|STARTED|Period 4 (Fourth Dose + Washout)||3||
48367745|NCT01809262|101230044|FG004|STARTED|Period 4 (Fourth Dose + Washout)||3||
48367746|NCT01809262|101230045|FG005|STARTED|Period 4 (Fourth Dose + Washout)||3||
48367747|NCT01809262|101230046|FG006|STARTED|Period 4 (Fourth Dose + Washout)||3||
48367748|NCT01809262|101230047|FG007|STARTED|Period 4 (Fourth Dose + Washout)||4||
48367749|NCT01809262|101230048|FG008|STARTED|Period 4 (Fourth Dose + Washout)||3||
48367750|NCT01809262|101230049|FG009|STARTED|Period 4 (Fourth Dose + Washout)||4||
48367751|NCT01809262|101230040|FG000|COMPLETED|Period 4 (Fourth Dose + Washout)||4||
48367752|NCT01809262|101230041|FG001|COMPLETED|Period 4 (Fourth Dose + Washout)||3||
48367753|NCT01809262|101230042|FG002|COMPLETED|Period 4 (Fourth Dose + Washout)||4||
48367754|NCT01809262|101230043|FG003|COMPLETED|Period 4 (Fourth Dose + Washout)||3||
48367755|NCT01809262|101230044|FG004|COMPLETED|Period 4 (Fourth Dose + Washout)||3||
48367756|NCT01809262|101230045|FG005|COMPLETED|Period 4 (Fourth Dose + Washout)||3||
48367757|NCT01809262|101230046|FG006|COMPLETED|Period 4 (Fourth Dose + Washout)||3||
48367758|NCT01809262|101230047|FG007|COMPLETED|Period 4 (Fourth Dose + Washout)||4||
48367759|NCT01809262|101230048|FG008|COMPLETED|Period 4 (Fourth Dose + Washout)||3||
48367760|NCT01809262|101230049|FG009|COMPLETED|Period 4 (Fourth Dose + Washout)||4||
48367761|NCT01809262|101230040|FG000|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0||
48367762|NCT01809262|101230041|FG001|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0||
48367763|NCT01809262|101230042|FG002|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0||
48367764|NCT01809262|101230043|FG003|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0||
48367765|NCT01809262|101230044|FG004|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0||
48367766|NCT01809262|101230045|FG005|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0||
48367767|NCT01809262|101230046|FG006|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0||
48367768|NCT01809262|101230047|FG007|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0||
48367769|NCT01809262|101230048|FG008|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0||
48367770|NCT01809262|101230049|FG009|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0||
48367771|NCT01809262|101230040|FG000|STARTED|Period 5 (Fifth Dose + Washout)||4||
48367772|NCT01809262|101230041|FG001|STARTED|Period 5 (Fifth Dose + Washout)||3||
48656326|NCT01902173|101943633|FG002|STARTED|Phase 1 Triplet Regimen Cohort 3||0||
48656327|NCT01902173|101943634|FG003|STARTED|Phase 1 Triplet Regimen Cohort 3||0||
48367773|NCT01809262|101230042|FG002|STARTED|Period 5 (Fifth Dose + Washout)||4||
48367774|NCT01809262|101230043|FG003|STARTED|Period 5 (Fifth Dose + Washout)||3||
48367775|NCT01809262|101230044|FG004|STARTED|Period 5 (Fifth Dose + Washout)||3||
48367776|NCT01809262|101230045|FG005|STARTED|Period 5 (Fifth Dose + Washout)||3||
48367777|NCT01809262|101230046|FG006|STARTED|Period 5 (Fifth Dose + Washout)||3||
48367778|NCT01809262|101230047|FG007|STARTED|Period 5 (Fifth Dose + Washout)||4||
48367779|NCT01809262|101230048|FG008|STARTED|Period 5 (Fifth Dose + Washout)||3||
48367780|NCT01809262|101230049|FG009|STARTED|Period 5 (Fifth Dose + Washout)||4||
48367781|NCT01809262|101230040|FG000|COMPLETED|Period 5 (Fifth Dose + Washout)||4||
48367782|NCT01809262|101230041|FG001|COMPLETED|Period 5 (Fifth Dose + Washout)||3||
48367783|NCT01809262|101230042|FG002|COMPLETED|Period 5 (Fifth Dose + Washout)||4||
48656328|NCT01902173|101943635|FG004|STARTED|Phase 1 Triplet Regimen Cohort 3||3||
48656329|NCT01902173|101943636|FG005|STARTED|Phase 1 Triplet Regimen Cohort 3||0||
48656330|NCT01902173|101943631|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0||
48656331|NCT01902173|101943632|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0||
48656332|NCT01902173|101943633|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0||
48656333|NCT01902173|101943634|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0||
48438042|NCT02975882|101406464|FG002|COMPLETED|Overall Study||0||
48438043|NCT02975882|101406465|FG003|COMPLETED|Overall Study||0||
48438044|NCT02975882|101406462|FG000|NOT COMPLETED|Overall Study||4||
48438045|NCT02975882|101406463|FG001|NOT COMPLETED|Overall Study||13||
48438046|NCT02975882|101406464|FG002|NOT COMPLETED|Overall Study||9||
48438047|NCT02975882|101406465|FG003|NOT COMPLETED|Overall Study||6||
48438048|NCT00301873|101406466|FG000|STARTED|Overall Study||59||
48438049|NCT00301873|101406466|FG000|COMPLETED|Overall Study||59||
48438050|NCT00301873|101406466|FG000|NOT COMPLETED|Overall Study||0||
48438051|NCT00258310|101406467|FG000|STARTED|Overall Study||35||
48438052|NCT00258310|101406467|FG000|COMPLETED|Overall Study||35||
48438053|NCT00258310|101406467|FG000|NOT COMPLETED|Overall Study||0||
48438054|NCT00464308|101406468|FG000|STARTED|Overall Study||464||
48438055|NCT00464308|101406469|FG001|STARTED|Overall Study||469||
48438056|NCT00464308|101406470|FG002|STARTED|Overall Study||459||
48438057|NCT00464308|101406468|FG000|COMPLETED|Overall Study||395||
48438058|NCT00464308|101406469|FG001|COMPLETED|Overall Study||406||
48438059|NCT00464308|101406470|FG002|COMPLETED|Overall Study||400||
48438060|NCT00464308|101406468|FG000|NOT COMPLETED|Overall Study||69||
48438061|NCT00464308|101406469|FG001|NOT COMPLETED|Overall Study||63||
48438062|NCT00464308|101406470|FG002|NOT COMPLETED|Overall Study||59||
48438063|NCT03091478|101406471|FG000|STARTED|Overall Study||13||
48438064|NCT03091478|101406471|FG000|COMPLETED|Overall Study||13||
48438065|NCT03091478|101406471|FG000|NOT COMPLETED|Overall Study||0||
48367784|NCT01809262|101230043|FG003|COMPLETED|Period 5 (Fifth Dose + Washout)||3||
48367785|NCT01809262|101230044|FG004|COMPLETED|Period 5 (Fifth Dose + Washout)||3||
48367786|NCT01809262|101230045|FG005|COMPLETED|Period 5 (Fifth Dose + Washout)||3||
48367787|NCT01809262|101230046|FG006|COMPLETED|Period 5 (Fifth Dose + Washout)||3||
48367788|NCT01809262|101230047|FG007|COMPLETED|Period 5 (Fifth Dose + Washout)||4||
48367789|NCT01809262|101230048|FG008|COMPLETED|Period 5 (Fifth Dose + Washout)||3||
48367790|NCT01809262|101230049|FG009|COMPLETED|Period 5 (Fifth Dose + Washout)||4||
48367791|NCT01809262|101230040|FG000|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0||
48367792|NCT01809262|101230041|FG001|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0||
48367793|NCT01809262|101230042|FG002|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0||
48367794|NCT01809262|101230043|FG003|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0||
48367795|NCT01809262|101230044|FG004|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0||
48367796|NCT01809262|101230045|FG005|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0||
48367797|NCT01809262|101230046|FG006|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0||
48367798|NCT01809262|101230047|FG007|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0||
48367799|NCT01809262|101230048|FG008|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0||
48367800|NCT01809262|101230049|FG009|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0||
48367801|NCT00109733|101230050|FG000|STARTED|Overall Study||15||
48367802|NCT00109733|101230051|FG001|STARTED|Overall Study||16||
48367803|NCT00109733|101230050|FG000|COMPLETED|Overall Study||13||
48367804|NCT00109733|101230051|FG001|COMPLETED|Overall Study||12||
48367805|NCT00109733|101230050|FG000|NOT COMPLETED|Overall Study||2||
48438066|NCT05444114|101406472|FG000|STARTED|Overall Study||90||
48656334|NCT01902173|101943635|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0||
48656335|NCT01902173|101943636|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0||
48656336|NCT01902173|101943631|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0||
48656337|NCT01902173|101943632|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0||
48656338|NCT01902173|101943633|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0||
48656339|NCT01902173|101943634|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0||
48656340|NCT01902173|101943635|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||3||
48367806|NCT00109733|101230051|FG001|NOT COMPLETED|Overall Study||4||
48367807|NCT00619684|101230052|FG000|STARTED|Overall Study||18||
48367808|NCT00619684|101230052|FG000|COMPLETED|Overall Study||18||
48438067|NCT05444114|101406473|FG001|STARTED|Overall Study||92||
48438068|NCT05444114|101406472|FG000|Analysis Population|Overall Study||81||
48438069|NCT05444114|101406473|FG001|Analysis Population|Overall Study||90||
48438070|NCT05444114|101406472|FG000|COMPLETED|Overall Study||90||
48438071|NCT05444114|101406473|FG001|COMPLETED|Overall Study||92||
48438072|NCT05444114|101406472|FG000|NOT COMPLETED|Overall Study||0||
48438073|NCT05444114|101406473|FG001|NOT COMPLETED|Overall Study||0||
48438074|NCT02660489|101406474|FG000|STARTED|Overall Study||22||
48438075|NCT02660489|101406475|FG001|STARTED|Overall Study||22||
48438076|NCT02660489|101406474|FG000|COMPLETED|Overall Study||16||
48438077|NCT02660489|101406475|FG001|COMPLETED|Overall Study||14||
48438078|NCT02660489|101406474|FG000|NOT COMPLETED|Overall Study||6||
48438079|NCT02660489|101406475|FG001|NOT COMPLETED|Overall Study||8||
48438080|NCT00944125|101406476|FG000|STARTED|Baseline to 3 Months||19||
48438081|NCT00944125|101406477|FG001|STARTED|Baseline to 3 Months||22||
48438082|NCT00944125|101406476|FG000|COMPLETED|Baseline to 3 Months||19||
48438083|NCT00944125|101406477|FG001|COMPLETED|Baseline to 3 Months||22||
48438084|NCT00944125|101406476|FG000|NOT COMPLETED|Baseline to 3 Months||0||
48438085|NCT00944125|101406477|FG001|NOT COMPLETED|Baseline to 3 Months||0||
48438086|NCT00944125|101406476|FG000|STARTED|3 to 6 Months||19||
48438087|NCT00944125|101406477|FG001|STARTED|3 to 6 Months||22||
48438088|NCT00944125|101406476|FG000|COMPLETED|3 to 6 Months||19||
48438089|NCT00944125|101406477|FG001|COMPLETED|3 to 6 Months||20||
48438090|NCT00944125|101406476|FG000|NOT COMPLETED|3 to 6 Months||0||
48438091|NCT00944125|101406477|FG001|NOT COMPLETED|3 to 6 Months||2||
48438092|NCT00944125|101406476|FG000|STARTED|6 Months to Study Completion||19||
48438093|NCT00944125|101406477|FG001|STARTED|6 Months to Study Completion||20||
48438094|NCT00944125|101406476|FG000|COMPLETED|6 Months to Study Completion||19||
48438095|NCT00944125|101406477|FG001|COMPLETED|6 Months to Study Completion||18||
48438096|NCT00944125|101406476|FG000|NOT COMPLETED|6 Months to Study Completion||0||
48438097|NCT00944125|101406477|FG001|NOT COMPLETED|6 Months to Study Completion||2||
48438098|NCT00554788|101406478|FG000|STARTED|Overall Study||21||
48438099|NCT00554788|101406479|FG001|STARTED|Overall Study||18||
48438100|NCT00554788|101406480|FG002|STARTED|Overall Study||21||
48438101|NCT00554788|101406478|FG000|COMPLETED|Overall Study||14||
48438102|NCT00554788|101406479|FG001|COMPLETED|Overall Study||12||
48766795|NCT02963506|102218494|FG011|NOT COMPLETED|Dose-Blind Period||2||
48766796|NCT02963506|102218495|FG012|NOT COMPLETED|Dose-Blind Period||7||
48766797|NCT00945958|102218496|FG000|STARTED|Overall Study||161||
48766798|NCT00945958|102218496|FG000|COMPLETED|Overall Study||149||
48766799|NCT00945958|102218496|FG000|NOT COMPLETED|Overall Study||12||
48766800|NCT00963859|102218497|FG000|STARTED|Overall Study||11||
48766801|NCT00963859|102218497|FG000|COMPLETED|Overall Study||11||
48438103|NCT00554788|101406480|FG002|COMPLETED|Overall Study||7||
48438104|NCT00554788|101406478|FG000|NOT COMPLETED|Overall Study||7||
48438105|NCT00554788|101406479|FG001|NOT COMPLETED|Overall Study||6||
48438106|NCT00554788|101406480|FG002|NOT COMPLETED|Overall Study||14||
48438107|NCT03253809|101406481|FG000|STARTED|Overall Study||14||
48438108|NCT03253809|101406481|FG000|COMPLETED|Overall Study||0||
48438109|NCT03253809|101406481|FG000|NOT COMPLETED|Overall Study||14||
48438110|NCT03572049|101406482|FG000|STARTED|Overall Study||42||
48438111|NCT03572049|101406483|FG001|STARTED|Overall Study||46||
48438112|NCT03572049|101406482|FG000|COMPLETED|Overall Study||33||
48438113|NCT03572049|101406483|FG001|COMPLETED|Overall Study||35||
48438114|NCT03572049|101406482|FG000|NOT COMPLETED|Overall Study||9||
48438115|NCT03572049|101406483|FG001|NOT COMPLETED|Overall Study||11||
48438116|NCT02989922|101406484|FG000|STARTED|Overall Study||111||
48438117|NCT02989922|101406485|FG001|STARTED|Overall Study||109||
48438118|NCT02989922|101406484|FG000|Treated|Overall Study||109||
48438119|NCT02989922|101406485|FG001|Treated|Overall Study||108||
48438120|NCT02989922|101406484|FG000|COMPLETED|Overall Study||72||
48438121|NCT02989922|101406485|FG001|COMPLETED|Overall Study||81||
48438122|NCT02989922|101406484|FG000|NOT COMPLETED|Overall Study||39||
48438123|NCT02989922|101406485|FG001|NOT COMPLETED|Overall Study||28||
48438124|NCT00326625|101406486|FG000|STARTED|Overall Study||184||
48438125|NCT00326625|101406487|FG001|STARTED|Overall Study||182||
48438126|NCT00326625|101406486|FG000|COMPLETED|Overall Study||130||
48438127|NCT00326625|101406487|FG001|COMPLETED|Overall Study||144||
48438128|NCT00326625|101406486|FG000|NOT COMPLETED|Overall Study||54||
48438129|NCT00326625|101406487|FG001|NOT COMPLETED|Overall Study||38||
48438130|NCT03280628|101406488|FG000|STARTED|Overall Study||20||
48438131|NCT03280628|101406489|FG001|STARTED|Overall Study||17||
48438132|NCT03280628|101406490|FG002|STARTED|Overall Study||18||
48438133|NCT03280628|101406488|FG000|COMPLETED|Overall Study||12||
48438134|NCT03280628|101406489|FG001|COMPLETED|Overall Study||11||
48438135|NCT03280628|101406490|FG002|COMPLETED|Overall Study||7||
48438136|NCT03280628|101406488|FG000|NOT COMPLETED|Overall Study||8||
48438137|NCT03280628|101406489|FG001|NOT COMPLETED|Overall Study||6||
48438138|NCT03280628|101406490|FG002|NOT COMPLETED|Overall Study||11||
48766802|NCT00963859|102218497|FG000|NOT COMPLETED|Overall Study||0||
48766803|NCT00313014|102218498|FG000|STARTED|Overall Study||221||
48438139|NCT04158739|101406491|FG000|STARTED|Overall Study||7||
48438140|NCT04158739|101406492|FG001|STARTED|Overall Study||9||
48438141|NCT04158739|101406491|FG000|COMPLETED|Overall Study||0||
48766804|NCT00313014|102218499|FG001|STARTED|Overall Study||219||
48438142|NCT04158739|101406492|FG001|COMPLETED|Overall Study||0||
48438143|NCT04158739|101406491|FG000|NOT COMPLETED|Overall Study||7||
48438144|NCT04158739|101406492|FG001|NOT COMPLETED|Overall Study||9||
48438145|NCT01432600|101406493|FG000|STARTED|Overall Study||10||
48438146|NCT01432600|101406494|FG001|STARTED|Overall Study||36||
48438147|NCT01432600|101406495|FG002|STARTED|Overall Study||34||
48438148|NCT01432600|101406493|FG000|COMPLETED|Overall Study||10||
48438149|NCT01432600|101406494|FG001|COMPLETED|Overall Study||35||
48438150|NCT01432600|101406495|FG002|COMPLETED|Overall Study||33||
48438151|NCT01432600|101406493|FG000|NOT COMPLETED|Overall Study||0||
48438152|NCT01432600|101406494|FG001|NOT COMPLETED|Overall Study||1||
48438153|NCT01432600|101406495|FG002|NOT COMPLETED|Overall Study||1||
48438154|NCT00247416|101406496|FG000|STARTED|Overall Study||26||
48438155|NCT00247416|101406497|FG001|STARTED|Overall Study||33||
48438156|NCT00247416|101406496|FG000|COMPLETED|Overall Study||25||
48766805|NCT00313014|102218500|FG002|STARTED|Overall Study||220||
48438157|NCT00247416|101406497|FG001|COMPLETED|Overall Study||31||
48438158|NCT00247416|101406496|FG000|NOT COMPLETED|Overall Study||1||
48438159|NCT00247416|101406497|FG001|NOT COMPLETED|Overall Study||2||
48438160|NCT01569074|101406498|FG000|STARTED|Overall Study||31||
48438161|NCT01569074|101406499|FG001|STARTED|Overall Study||33||
48438162|NCT01569074|101406500|FG002|STARTED|Overall Study||33||
48438163|NCT01569074|101406501|FG003|STARTED|Overall Study||33||
48438164|NCT01569074|101406502|FG004|STARTED|Overall Study||33||
48438165|NCT01569074|101406498|FG000|Randomised But Did Not Receive Treatment|Overall Study||0||
48438166|NCT01569074|101406499|FG001|Randomised But Did Not Receive Treatment|Overall Study||0||
48438167|NCT01569074|101406500|FG002|Randomised But Did Not Receive Treatment|Overall Study||0||
48438168|NCT01569074|101406501|FG003|Randomised But Did Not Receive Treatment|Overall Study||0||
48438169|NCT01569074|101406502|FG004|Randomised But Did Not Receive Treatment|Overall Study||0||
48438170|NCT01569074|101406498|FG000|COMPLETED|Overall Study||24||
48438171|NCT01569074|101406499|FG001|COMPLETED|Overall Study||24||
48438172|NCT01569074|101406500|FG002|COMPLETED|Overall Study||21||
48438173|NCT01569074|101406501|FG003|COMPLETED|Overall Study||25||
48438174|NCT01569074|101406502|FG004|COMPLETED|Overall Study||25||
48438175|NCT01569074|101406498|FG000|NOT COMPLETED|Overall Study||7||
48438176|NCT01569074|101406499|FG001|NOT COMPLETED|Overall Study||9||
48438177|NCT01569074|101406500|FG002|NOT COMPLETED|Overall Study||12||
48438178|NCT01569074|101406501|FG003|NOT COMPLETED|Overall Study||8||
48438179|NCT01569074|101406502|FG004|NOT COMPLETED|Overall Study||8||
48438180|NCT02873195|101406503|FG000|STARTED|Overall Study||87||
48438181|NCT02873195|101406504|FG001|STARTED|Overall Study||46||
48438182|NCT02873195|101406503|FG000|Never Began Treatment (Cancel)|Overall Study||1|Participants who never began treatment are not evaluable for adverse events.|
48438183|NCT02873195|101406504|FG001|Never Began Treatment (Cancel)|Overall Study||0|Participants who never began treatment are not evaluable for adverse events.|
48438184|NCT02873195|101406503|FG000|COMPLETED|Overall Study||82|Modified Intent-to-treat (ITT) population|
48438185|NCT02873195|101406504|FG001|COMPLETED|Overall Study||46|Modified Intent-to-treat (ITT) population|
48438186|NCT02873195|101406503|FG000|NOT COMPLETED|Overall Study||5||
48438187|NCT02873195|101406504|FG001|NOT COMPLETED|Overall Study||0||
48438188|NCT00877799|101406505|FG000|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||25||
48438189|NCT00877799|101406506|FG001|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||22||
48438190|NCT00877799|101406507|FG002|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||21||
48438191|NCT00877799|101406508|FG003|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0||
48438192|NCT00877799|101406509|FG004|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0||
48438193|NCT00877799|101406505|FG000|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||22||
48438194|NCT00877799|101406506|FG001|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||17||
48438195|NCT00877799|101406507|FG002|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||18||
48438196|NCT00877799|101406508|FG003|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0||
48438197|NCT00877799|101406509|FG004|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0||
48438198|NCT00877799|101406505|FG000|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3||
48438199|NCT00877799|101406506|FG001|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||5||
48438200|NCT00877799|101406507|FG002|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3||
48438201|NCT00877799|101406508|FG003|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0||
48438202|NCT00877799|101406509|FG004|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0||
48438203|NCT00877799|101406505|FG000|STARTED|Cohort 2: Immediately Post-op (Day 0)||0||
48438204|NCT00877799|101406506|FG001|STARTED|Cohort 2: Immediately Post-op (Day 0)||0||
48438205|NCT00877799|101406507|FG002|STARTED|Cohort 2: Immediately Post-op (Day 0)||0||
48438206|NCT00877799|101406508|FG003|STARTED|Cohort 2: Immediately Post-op (Day 0)||26||
48438207|NCT00877799|101406509|FG004|STARTED|Cohort 2: Immediately Post-op (Day 0)||20||
48438208|NCT00877799|101406505|FG000|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0||
48438209|NCT00877799|101406506|FG001|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0||
48438210|NCT00877799|101406507|FG002|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0||
48438211|NCT00877799|101406508|FG003|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||24||
48438212|NCT00877799|101406509|FG004|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||19||
48438213|NCT00877799|101406505|FG000|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0||
48656341|NCT01902173|101943636|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0||
48656342|NCT01902173|101943631|FG000|STARTED|Phase 1 Triplet Regimen Cohort 4||0||
48656343|NCT01902173|101943632|FG001|STARTED|Phase 1 Triplet Regimen Cohort 4||0||
48656344|NCT01902173|101943633|FG002|STARTED|Phase 1 Triplet Regimen Cohort 4||0||
48656345|NCT01902173|101943634|FG003|STARTED|Phase 1 Triplet Regimen Cohort 4||0||
48656346|NCT01902173|101943635|FG004|STARTED|Phase 1 Triplet Regimen Cohort 4||0||
48656347|NCT01902173|101943636|FG005|STARTED|Phase 1 Triplet Regimen Cohort 4||5||
48656348|NCT01902173|101943631|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0||
48656349|NCT01902173|101943632|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0||
48656350|NCT01902173|101943633|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0||
48656351|NCT01902173|101943634|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0||
48438214|NCT00877799|101406506|FG001|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0||
48656352|NCT01902173|101943635|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0||
48766806|NCT00313014|102218498|FG000|COMPLETED|Overall Study||128||
48766807|NCT00313014|102218499|FG001|COMPLETED|Overall Study||146||
48438215|NCT00877799|101406507|FG002|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0||
48438216|NCT00877799|101406508|FG003|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||2||
48438217|NCT00877799|101406509|FG004|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||1||
48766808|NCT00313014|102218500|FG002|COMPLETED|Overall Study||159||
48766809|NCT00313014|102218498|FG000|NOT COMPLETED|Overall Study||93||
48766810|NCT00313014|102218499|FG001|NOT COMPLETED|Overall Study||73||
48766811|NCT00313014|102218500|FG002|NOT COMPLETED|Overall Study||61||
48766812|NCT04170608|102218501|FG000|STARTED|Overall Study||10||
48766813|NCT04170608|102218501|FG000|COMPLETED|Overall Study||10||
48766814|NCT04170608|102218501|FG000|NOT COMPLETED|Overall Study||0||
48766815|NCT01002339|102218502|FG000|STARTED|Overall Study||44||
48766816|NCT01002339|102218503|FG001|STARTED|Overall Study||43||
48766817|NCT01002339|102218504|FG002|STARTED|Overall Study||47||
48766818|NCT01002339|102218502|FG000|COMPLETED|Overall Study||44||
48766819|NCT01002339|102218503|FG001|COMPLETED|Overall Study||42||
48766820|NCT01002339|102218504|FG002|COMPLETED|Overall Study||42||
48766821|NCT01002339|102218502|FG000|NOT COMPLETED|Overall Study||0||
48766822|NCT01002339|102218503|FG001|NOT COMPLETED|Overall Study||1||
48766823|NCT01002339|102218504|FG002|NOT COMPLETED|Overall Study||5||
48766824|NCT02379728|102218505|FG000|STARTED|Overall Study||84||
48766825|NCT02379728|102218506|FG001|STARTED|Overall Study||16||
48766826|NCT02379728|102218507|FG002|STARTED|Overall Study||84||
48766827|NCT02379728|102218508|FG003|STARTED|Overall Study||16||
48766828|NCT02379728|102218505|FG000|COMPLETED|Overall Study||78||
48766829|NCT02379728|102218506|FG001|COMPLETED|Overall Study||16||
48766830|NCT02379728|102218507|FG002|COMPLETED|Overall Study||74||
48766831|NCT02379728|102218508|FG003|COMPLETED|Overall Study||13||
48766832|NCT02379728|102218505|FG000|NOT COMPLETED|Overall Study||6||
48438218|NCT03707145|101406510|FG000|STARTED|Overall Study||10||
48438219|NCT03707145|101406511|FG001|STARTED|Overall Study||11||
48438220|NCT03707145|101406512|FG002|STARTED|Overall Study||10||
48438221|NCT03707145|101406513|FG003|STARTED|Overall Study||11||
48438222|NCT03707145|101406510|FG000|COMPLETED|Overall Study||10||
48438223|NCT03707145|101406511|FG001|COMPLETED|Overall Study||10||
48656353|NCT01902173|101943636|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0||
48656354|NCT01902173|101943631|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0||
48656355|NCT01902173|101943632|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0||
48656356|NCT01902173|101943633|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0||
48656357|NCT01902173|101943634|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0||
48656358|NCT01902173|101943635|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0||
48656359|NCT01902173|101943636|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||5||
48656360|NCT01902173|101943631|FG000|STARTED|Phase II||0||
48656361|NCT01902173|101943632|FG001|STARTED|Phase II||0||
48656362|NCT01902173|101943633|FG002|STARTED|Phase II||0||
48656363|NCT01902173|101943634|FG003|STARTED|Phase II||0||
48656364|NCT01902173|101943635|FG004|STARTED|Phase II||0||
48656365|NCT01902173|101943636|FG005|STARTED|Phase II||0||
48656366|NCT01902173|101943631|FG000|COMPLETED|Phase II||0||
48656367|NCT01902173|101943632|FG001|COMPLETED|Phase II||0||
48656368|NCT01902173|101943633|FG002|COMPLETED|Phase II||0||
48656369|NCT01902173|101943634|FG003|COMPLETED|Phase II||0||
48656370|NCT01902173|101943635|FG004|COMPLETED|Phase II||0||
48656371|NCT01902173|101943636|FG005|COMPLETED|Phase II||0||
48656372|NCT01902173|101943631|FG000|NOT COMPLETED|Phase II||0||
48656373|NCT01902173|101943632|FG001|NOT COMPLETED|Phase II||0||
48656374|NCT01902173|101943633|FG002|NOT COMPLETED|Phase II||0||
48656375|NCT01902173|101943634|FG003|NOT COMPLETED|Phase II||0||
48656376|NCT01902173|101943635|FG004|NOT COMPLETED|Phase II||0||
48656377|NCT01902173|101943636|FG005|NOT COMPLETED|Phase II||0||
48656378|NCT05894564|101943637|FG000|STARTED|Overall Study||601||
48656379|NCT05894564|101943638|FG001|STARTED|Overall Study||607||
48656380|NCT05894564|101943637|FG000|COMPLETED|Overall Study||592||
48656381|NCT05894564|101943638|FG001|COMPLETED|Overall Study||589||
48656382|NCT05894564|101943637|FG000|NOT COMPLETED|Overall Study||9||
48656383|NCT05894564|101943638|FG001|NOT COMPLETED|Overall Study||18||
48656384|NCT06399471|101943639|FG000|STARTED|Overall Study||11||31
48656385|NCT06399471|101943639|FG000|Ottobock C-Leg 4.0|Overall Study||10||10
48766833|NCT02379728|102218506|FG001|NOT COMPLETED|Overall Study||0||
48766834|NCT02379728|102218507|FG002|NOT COMPLETED|Overall Study||10||
48766835|NCT02379728|102218508|FG003|NOT COMPLETED|Overall Study||3||
48766836|NCT01679314|102218509|FG000|STARTED|Overall Study||26||
48438224|NCT03707145|101406512|FG002|COMPLETED|Overall Study||9||
48438225|NCT03707145|101406513|FG003|COMPLETED|Overall Study||11||
48438226|NCT03707145|101406510|FG000|NOT COMPLETED|Overall Study||0||
48656386|NCT06399471|101943639|FG000|Ossur Power Knee|Overall Study||11||11
48656387|NCT06399471|101943639|FG000|Ossur Rheo|Overall Study||10||10
48656388|NCT06399471|101943639|FG000|COMPLETED|Overall Study||10||30
48656389|NCT06399471|101943639|FG000|NOT COMPLETED|Overall Study||1||1
48656390|NCT05652140|101943640|FG000|STARTED|Overall Study||22||
48656391|NCT05652140|101943641|FG001|STARTED|Overall Study||21||
48656392|NCT05652140|101943642|FG002|STARTED|Overall Study||57||
48656393|NCT05652140|101943643|FG003|STARTED|Overall Study||59||
48656394|NCT05652140|101943640|FG000|COMPLETED|Overall Study||15||
48766837|NCT01679314|102218510|FG001|STARTED|Overall Study||28||
48438227|NCT03707145|101406511|FG001|NOT COMPLETED|Overall Study||1||
48438228|NCT03707145|101406512|FG002|NOT COMPLETED|Overall Study||1||
48438229|NCT03707145|101406513|FG003|NOT COMPLETED|Overall Study||0||
48438230|NCT01308762|101406514|FG000|STARTED|Overall Study||6||
48438231|NCT01308762|101406515|FG001|STARTED|Overall Study||7||
48438232|NCT01308762|101406516|FG002|STARTED|Overall Study||6||
48438233|NCT01308762|101406514|FG000|COMPLETED|Overall Study||6||
48438234|NCT01308762|101406515|FG001|COMPLETED|Overall Study||6||
48188444|NCT01536262|100783243|FG000|COMPLETED|Overall Study||33||
48188445|NCT01536262|100783244|FG001|COMPLETED|Overall Study||38||
48188446|NCT01536262|100783245|FG002|COMPLETED|Overall Study||39||
48188447|NCT01536262|100783243|FG000|NOT COMPLETED|Overall Study||8||
48188448|NCT01536262|100783244|FG001|NOT COMPLETED|Overall Study||2||
48188449|NCT01536262|100783245|FG002|NOT COMPLETED|Overall Study||2||
48188450|NCT00409708|100783246|FG000|STARTED|Treatment||53||
48188451|NCT00409708|100783247|FG001|STARTED|Treatment||56||
48188452|NCT00409708|100783246|FG000|COMPLETED|Treatment||38||
48656395|NCT05652140|101943641|FG001|COMPLETED|Overall Study||5||
48656396|NCT05652140|101943642|FG002|COMPLETED|Overall Study||35||
48656397|NCT05652140|101943643|FG003|COMPLETED|Overall Study||28||
48656398|NCT05652140|101943640|FG000|NOT COMPLETED|Overall Study||7||
48656399|NCT05652140|101943641|FG001|NOT COMPLETED|Overall Study||16||
48656400|NCT05652140|101943642|FG002|NOT COMPLETED|Overall Study||22||
48656401|NCT05652140|101943643|FG003|NOT COMPLETED|Overall Study||31||
48656402|NCT02628145|101943644|FG000|STARTED|Overall Study||13||
48656403|NCT02628145|101943645|FG001|STARTED|Overall Study||12||
48656404|NCT02628145|101943644|FG000|COMPLETED|Overall Study||12||
48656405|NCT02628145|101943645|FG001|COMPLETED|Overall Study||10||
48656406|NCT02628145|101943644|FG000|NOT COMPLETED|Overall Study||1||
48656407|NCT02628145|101943645|FG001|NOT COMPLETED|Overall Study||2||
48656408|NCT04157738|101943646|FG000|STARTED|Overall Study||12||
48656409|NCT04157738|101943647|FG001|STARTED|Overall Study||12||
48656410|NCT04157738|101943646|FG000|COMPLETED|Overall Study||11||
48656411|NCT04157738|101943647|FG001|COMPLETED|Overall Study||10||
48656412|NCT04157738|101943646|FG000|NOT COMPLETED|Overall Study||1||
48656413|NCT04157738|101943647|FG001|NOT COMPLETED|Overall Study||2||
48656414|NCT01856192|101943648|FG000|STARTED|Overall Study||173||
48656415|NCT01856192|101943649|FG001|STARTED|Overall Study||176||
48656416|NCT01856192|101943648|FG000|Treated Patients|Overall Study||166||
48656417|NCT01856192|101943649|FG001|Treated Patients|Overall Study||171||
48656418|NCT01856192|101943648|FG000|Evaluable Patients (Eligible and Treated)|Overall Study||145||
48438235|NCT01308762|101406516|FG002|COMPLETED|Overall Study||6||
48438236|NCT01308762|101406514|FG000|NOT COMPLETED|Overall Study||0||
48438237|NCT01308762|101406515|FG001|NOT COMPLETED|Overall Study||1||
48438238|NCT01308762|101406516|FG002|NOT COMPLETED|Overall Study||0||
48438239|NCT01828164|101406517|FG000|STARTED|Overall Study||49||
48438240|NCT01828164|101406517|FG000|COMPLETED|Overall Study||32||
48438241|NCT01828164|101406517|FG000|NOT COMPLETED|Overall Study||17||
48438242|NCT04964960|101406518|FG000|STARTED|Overall Study||3||
48438243|NCT04964960|101406518|FG000|COMPLETED|Overall Study||2||
48438244|NCT04964960|101406518|FG000|NOT COMPLETED|Overall Study||1||
48438245|NCT00953017|101406519|FG000|STARTED|Overall Study||106||
48438246|NCT00953017|101406520|FG001|STARTED|Overall Study||107||
48656419|NCT01856192|101943649|FG001|Evaluable Patients (Eligible and Treated)|Overall Study||135||
48656420|NCT01856192|101943648|FG000|COMPLETED|Overall Study||124||
48656421|NCT01856192|101943649|FG001|COMPLETED|Overall Study||116||
48656422|NCT01856192|101943648|FG000|NOT COMPLETED|Overall Study||49||
48656423|NCT01856192|101943649|FG001|NOT COMPLETED|Overall Study||60||
48656424|NCT03533491|101943650|FG000|STARTED|Overall Study||60||
48656425|NCT03533491|101943650|FG000|COMPLETED|Overall Study||58||
48656426|NCT03533491|101943650|FG000|NOT COMPLETED|Overall Study||2||
48438247|NCT00953017|101406521|FG002|STARTED|Overall Study||106||
48438248|NCT00953017|101406522|FG003|STARTED|Overall Study||106||
48438249|NCT00953017|101406519|FG000|COMPLETED|Overall Study||101||
48438250|NCT00953017|101406520|FG001|COMPLETED|Overall Study||101||
48438251|NCT00953017|101406521|FG002|COMPLETED|Overall Study||100||
48438252|NCT00953017|101406522|FG003|COMPLETED|Overall Study||101||
48438253|NCT00953017|101406519|FG000|NOT COMPLETED|Overall Study||5||
48438254|NCT00953017|101406520|FG001|NOT COMPLETED|Overall Study||6||
48656427|NCT04398706|101943651|FG000|STARTED|Overall Study||35||
48656428|NCT04398706|101943652|FG001|STARTED|Overall Study||35||
48656429|NCT04398706|101943653|FG002|STARTED|Overall Study||35||
48656430|NCT04398706|101943654|FG003|STARTED|Overall Study||35||
48438255|NCT00953017|101406521|FG002|NOT COMPLETED|Overall Study||6||
48438256|NCT00953017|101406522|FG003|NOT COMPLETED|Overall Study||5||
48438257|NCT03563716|101406523|FG000|STARTED|Overall Study||68||
48438258|NCT03563716|101406524|FG001|STARTED|Overall Study||67||
48438259|NCT03563716|101406523|FG000|COMPLETED|Overall Study||0|Study still on-going|
48438260|NCT03563716|101406524|FG001|COMPLETED|Overall Study||0|Study still on-going|
48438261|NCT03563716|101406523|FG000|NOT COMPLETED|Overall Study||68||
48438262|NCT03563716|101406524|FG001|NOT COMPLETED|Overall Study||67||
48438263|NCT00296192|101406525|FG000|STARTED|Overall Study||17||
48438264|NCT00296192|101406526|FG001|STARTED|Overall Study||16||
48438265|NCT00296192|101406527|FG002|STARTED|Overall Study||16||
48438266|NCT00296192|101406528|FG003|STARTED|Overall Study||17||
48438267|NCT00296192|101406529|FG004|STARTED|Overall Study||16||
48656431|NCT04398706|101943655|FG004|STARTED|Overall Study||179||
48656432|NCT04398706|101943656|FG005|STARTED|Overall Study||178||
48656433|NCT04398706|101943657|FG006|STARTED|Overall Study||179||
48656434|NCT04398706|101943658|FG007|STARTED|Overall Study||176||
48656435|NCT04398706|101943651|FG000|COMPLETED|Overall Study||35||
48656436|NCT04398706|101943652|FG001|COMPLETED|Overall Study||31||
48656437|NCT04398706|101943653|FG002|COMPLETED|Overall Study||32||
48656438|NCT04398706|101943654|FG003|COMPLETED|Overall Study||32||
48656439|NCT04398706|101943655|FG004|COMPLETED|Overall Study||148||
48656440|NCT04398706|101943656|FG005|COMPLETED|Overall Study||147||
48656441|NCT04398706|101943657|FG006|COMPLETED|Overall Study||151||
48656442|NCT04398706|101943658|FG007|COMPLETED|Overall Study||160||
48656443|NCT04398706|101943651|FG000|NOT COMPLETED|Overall Study||0||
48656444|NCT04398706|101943652|FG001|NOT COMPLETED|Overall Study||4||
48656445|NCT04398706|101943653|FG002|NOT COMPLETED|Overall Study||3||
48656446|NCT04398706|101943654|FG003|NOT COMPLETED|Overall Study||3||
48656447|NCT04398706|101943655|FG004|NOT COMPLETED|Overall Study||31||
48656448|NCT04398706|101943656|FG005|NOT COMPLETED|Overall Study||31||
48656449|NCT04398706|101943657|FG006|NOT COMPLETED|Overall Study||28||
48656450|NCT04398706|101943658|FG007|NOT COMPLETED|Overall Study||16||
48656451|NCT05286385|101943659|FG000|STARTED|Overall Study||10||
48656452|NCT05286385|101943659|FG000|CP1150 Sound Processor|Overall Study||10||
48656453|NCT05286385|101943659|FG000|CP1150 Sound Processor With Modified Firmware|Overall Study||10||
48656454|NCT05286385|101943659|FG000|CP1150 Sound Processor With Forward Focus|Overall Study||10||
48656455|NCT05286385|101943659|FG000|CP1110 Sound Processor|Overall Study||10||
48656456|NCT05286385|101943659|FG000|COMPLETED|Overall Study||10||
48656457|NCT05286385|101943659|FG000|NOT COMPLETED|Overall Study||0||
48656458|NCT03734536|101943660|FG000|STARTED|Overall Study||59||
48656459|NCT03734536|101943661|FG001|STARTED|Overall Study||59||
48656460|NCT03734536|101943660|FG000|COMPLETED|Overall Study||48||
48656461|NCT03734536|101943661|FG001|COMPLETED|Overall Study||47||
48656462|NCT03734536|101943660|FG000|NOT COMPLETED|Overall Study||11||
48656463|NCT03734536|101943661|FG001|NOT COMPLETED|Overall Study||12||
48656464|NCT04765384|101943662|FG000|STARTED|Post-baseline: Adults||12||
48656465|NCT04765384|101943663|FG001|STARTED|Post-baseline: Adults||10||
48656466|NCT04765384|101943664|FG002|STARTED|Post-baseline: Adults||29||
48656467|NCT04765384|101943665|FG003|STARTED|Post-baseline: Adults||0||
48656468|NCT04765384|101943666|FG004|STARTED|Post-baseline: Adults||0||
48656469|NCT04765384|101943667|FG005|STARTED|Post-baseline: Adults||0||
48656470|NCT04765384|101943662|FG000|Adult Participants Who Received Booster Vaccination|Post-baseline: Adults||0||
48438268|NCT00296192|101406525|FG000|COMPLETED|Overall Study||17||
48438269|NCT00296192|101406526|FG001|COMPLETED|Overall Study||16||
48438270|NCT00296192|101406527|FG002|COMPLETED|Overall Study||16||
48438271|NCT00296192|101406528|FG003|COMPLETED|Overall Study||17||
48438272|NCT00296192|101406529|FG004|COMPLETED|Overall Study||16||
48438273|NCT00296192|101406525|FG000|NOT COMPLETED|Overall Study||0||
48438274|NCT00296192|101406526|FG001|NOT COMPLETED|Overall Study||0||
48438275|NCT00296192|101406527|FG002|NOT COMPLETED|Overall Study||0||
48438276|NCT00296192|101406528|FG003|NOT COMPLETED|Overall Study||0||
48438277|NCT00296192|101406529|FG004|NOT COMPLETED|Overall Study||0||
48438278|NCT02820324|101406530|FG000|STARTED|Overall Study||78||
48438279|NCT02820324|101406531|FG001|STARTED|Overall Study||82||
48438280|NCT02820324|101406532|FG002|STARTED|Overall Study||82||
48438281|NCT02820324|101406533|FG003|STARTED|Overall Study||82||
48438282|NCT02820324|101406534|FG004|STARTED|Overall Study||83||
48438283|NCT02820324|101406530|FG000|Treated With Study Medication|Overall Study||77||
48656471|NCT04765384|101943663|FG001|Adult Participants Who Received Booster Vaccination|Post-baseline: Adults||0||
48656472|NCT04765384|101943664|FG002|Adult Participants Who Received Booster Vaccination|Post-baseline: Adults||13||
48438284|NCT02820324|101406531|FG001|Treated With Study Medication|Overall Study||80||
48438285|NCT02820324|101406532|FG002|Treated With Study Medication|Overall Study||80||
48438286|NCT02820324|101406533|FG003|Treated With Study Medication|Overall Study||81||
48438287|NCT02820324|101406534|FG004|Treated With Study Medication|Overall Study||83||
48438288|NCT02820324|101406530|FG000|COMPLETED|Overall Study||76||
48656473|NCT04765384|101943665|FG003|Adult Participants Who Received Booster Vaccination|Post-baseline: Adults||0||
48656474|NCT04765384|101943666|FG004|Adult Participants Who Received Booster Vaccination|Post-baseline: Adults||0||
48656475|NCT04765384|101943667|FG005|Adult Participants Who Received Booster Vaccination|Post-baseline: Adults||0||
48656476|NCT04765384|101943662|FG000|Group 2|Post-baseline: Adults||0||
48438289|NCT02820324|101406531|FG001|COMPLETED|Overall Study||79||
48438290|NCT02820324|101406532|FG002|COMPLETED|Overall Study||79||
48438291|NCT02820324|101406533|FG003|COMPLETED|Overall Study||79||
48438292|NCT02820324|101406534|FG004|COMPLETED|Overall Study||80||
48438293|NCT02820324|101406530|FG000|NOT COMPLETED|Overall Study||2||
48438294|NCT02820324|101406531|FG001|NOT COMPLETED|Overall Study||3||
48438295|NCT02820324|101406532|FG002|NOT COMPLETED|Overall Study||3||
48766838|NCT01679314|102218509|FG000|COMPLETED|Overall Study||24||
48766839|NCT01679314|102218510|FG001|COMPLETED|Overall Study||28||
48766840|NCT01679314|102218509|FG000|NOT COMPLETED|Overall Study||2||
48438296|NCT02820324|101406533|FG003|NOT COMPLETED|Overall Study||3||
48438297|NCT02820324|101406534|FG004|NOT COMPLETED|Overall Study||3||
48438298|NCT03985293|101406535|FG000|STARTED|DOUBLE-BLIND TREATMENT||66||
48438299|NCT03985293|101406536|FG001|STARTED|DOUBLE-BLIND TREATMENT||68||
48438300|NCT03985293|101406537|FG002|STARTED|DOUBLE-BLIND TREATMENT||68||
48438301|NCT03985293|101406538|FG003|STARTED|DOUBLE-BLIND TREATMENT||71||
48438302|NCT03985293|101406539|FG004|STARTED|DOUBLE-BLIND TREATMENT||67||
48438303|NCT03985293|101406540|FG005|STARTED|DOUBLE-BLIND TREATMENT||71||
48438304|NCT03985293|101406535|FG000|COMPLETED|DOUBLE-BLIND TREATMENT||57||
48438305|NCT03985293|101406536|FG001|COMPLETED|DOUBLE-BLIND TREATMENT||54||
48438306|NCT03985293|101406537|FG002|COMPLETED|DOUBLE-BLIND TREATMENT||63||
48438307|NCT03985293|101406538|FG003|COMPLETED|DOUBLE-BLIND TREATMENT||57||
48438308|NCT03985293|101406539|FG004|COMPLETED|DOUBLE-BLIND TREATMENT||47||
48438309|NCT03985293|101406540|FG005|COMPLETED|DOUBLE-BLIND TREATMENT||38||
48438310|NCT03985293|101406535|FG000|NOT COMPLETED|DOUBLE-BLIND TREATMENT||9||
48438311|NCT03985293|101406536|FG001|NOT COMPLETED|DOUBLE-BLIND TREATMENT||14||
48438312|NCT03985293|101406537|FG002|NOT COMPLETED|DOUBLE-BLIND TREATMENT||5||
48438313|NCT03985293|101406538|FG003|NOT COMPLETED|DOUBLE-BLIND TREATMENT||14||
48438314|NCT03985293|101406539|FG004|NOT COMPLETED|DOUBLE-BLIND TREATMENT||20||
48438315|NCT03985293|101406540|FG005|NOT COMPLETED|DOUBLE-BLIND TREATMENT||33||
48438316|NCT03985293|101406535|FG000|STARTED|FOLLOW-UP||57||
48438317|NCT03985293|101406536|FG001|STARTED|FOLLOW-UP||54||
48438318|NCT03985293|101406537|FG002|STARTED|FOLLOW-UP||63||
48438319|NCT03985293|101406538|FG003|STARTED|FOLLOW-UP||57||
48438320|NCT03985293|101406539|FG004|STARTED|FOLLOW-UP||47||
48438321|NCT03985293|101406540|FG005|STARTED|FOLLOW-UP||38||
48438322|NCT03985293|101406535|FG000|COMPLETED|FOLLOW-UP||57||
48438323|NCT03985293|101406536|FG001|COMPLETED|FOLLOW-UP||54||
48438324|NCT03985293|101406537|FG002|COMPLETED|FOLLOW-UP||62||
48438325|NCT03985293|101406538|FG003|COMPLETED|FOLLOW-UP||57||
48438326|NCT03985293|101406539|FG004|COMPLETED|FOLLOW-UP||47||
48438327|NCT03985293|101406540|FG005|COMPLETED|FOLLOW-UP||38||
48438328|NCT03985293|101406535|FG000|NOT COMPLETED|FOLLOW-UP||0||
48438329|NCT03985293|101406536|FG001|NOT COMPLETED|FOLLOW-UP||0||
48438330|NCT03985293|101406537|FG002|NOT COMPLETED|FOLLOW-UP||1||
48438331|NCT03985293|101406538|FG003|NOT COMPLETED|FOLLOW-UP||0||
48438332|NCT03985293|101406539|FG004|NOT COMPLETED|FOLLOW-UP||0||
48438333|NCT03985293|101406540|FG005|NOT COMPLETED|FOLLOW-UP||0||
48438334|NCT05257109|101406541|FG000|STARTED|Overall Study||10||
48438335|NCT05257109|101406542|FG001|STARTED|Overall Study||8||
48656477|NCT04765384|101943663|FG001|Group 2|Post-baseline: Adults||1||
48656478|NCT04765384|101943664|FG002|Group 2|Post-baseline: Adults||0||
48656479|NCT04765384|101943665|FG003|Group 2|Post-baseline: Adults||0||
48656480|NCT04765384|101943666|FG004|Group 2|Post-baseline: Adults||0||
48656481|NCT04765384|101943667|FG005|Group 2|Post-baseline: Adults||0||
48656482|NCT04765384|101943662|FG000|Group 3|Post-baseline: Adults||0||
48656483|NCT04765384|101943663|FG001|Group 3|Post-baseline: Adults||9||
48656484|NCT04765384|101943664|FG002|Group 3|Post-baseline: Adults||0||
48656485|NCT04765384|101943665|FG003|Group 3|Post-baseline: Adults||0||
48438336|NCT05257109|101406543|FG002|STARTED|Overall Study||6||
48438337|NCT05257109|101406544|FG003|STARTED|Overall Study||7||
48656486|NCT04765384|101943666|FG004|Group 3|Post-baseline: Adults||0||
48656487|NCT04765384|101943667|FG005|Group 3|Post-baseline: Adults||0||
48656488|NCT04765384|101943662|FG000|COMPLETED|Post-baseline: Adults||10||
48656489|NCT04765384|101943663|FG001|COMPLETED|Post-baseline: Adults||8||
48766841|NCT01679314|102218510|FG001|NOT COMPLETED|Overall Study||0||
48438338|NCT05257109|101406541|FG000|COMPLETED|Overall Study||9||
48438339|NCT05257109|101406542|FG001|COMPLETED|Overall Study||8||
48438340|NCT05257109|101406543|FG002|COMPLETED|Overall Study||6||
48438341|NCT05257109|101406544|FG003|COMPLETED|Overall Study||7||
48438342|NCT05257109|101406541|FG000|NOT COMPLETED|Overall Study||1||
48438343|NCT05257109|101406542|FG001|NOT COMPLETED|Overall Study||0||
48438344|NCT05257109|101406543|FG002|NOT COMPLETED|Overall Study||0||
48438345|NCT05257109|101406544|FG003|NOT COMPLETED|Overall Study||0||
48438346|NCT01141569|101406545|FG000|STARTED|Overall Study||12||
48438347|NCT01141569|101406545|FG000|COMPLETED|Overall Study||12||
48438348|NCT01141569|101406545|FG000|NOT COMPLETED|Overall Study||0||
48438349|NCT04637815|101406546|FG000|STARTED|Overall Study||26||
48438350|NCT04637815|101406547|FG001|STARTED|Overall Study||13||
48438351|NCT04637815|101406546|FG000|COMPLETED|Overall Study||20||
48656490|NCT04765384|101943664|FG002|COMPLETED|Post-baseline: Adults||23||
48656491|NCT04765384|101943665|FG003|COMPLETED|Post-baseline: Adults||0||
48656492|NCT04765384|101943666|FG004|COMPLETED|Post-baseline: Adults||0||
48656493|NCT04765384|101943667|FG005|COMPLETED|Post-baseline: Adults||0||
48438352|NCT04637815|101406547|FG001|COMPLETED|Overall Study||11||
48438353|NCT04637815|101406546|FG000|NOT COMPLETED|Overall Study||6||
48438354|NCT04637815|101406547|FG001|NOT COMPLETED|Overall Study||2||
48438355|NCT00194116|101406548|FG000|STARTED|Overall Study||26||
48438356|NCT00194116|101406549|FG001|STARTED|Overall Study||28||
48438357|NCT00194116|101406548|FG000|COMPLETED|Overall Study||13||
48188453|NCT00409708|100783247|FG001|COMPLETED|Treatment||39||
48188454|NCT00409708|100783246|FG000|NOT COMPLETED|Treatment||15||
48188455|NCT00409708|100783247|FG001|NOT COMPLETED|Treatment||17||
48188456|NCT00409708|100783246|FG000|STARTED|Washout||38||
48188457|NCT00409708|100783247|FG001|STARTED|Washout||39||
48188458|NCT00409708|100783246|FG000|COMPLETED|Washout||17||
48188459|NCT00409708|100783247|FG001|COMPLETED|Washout||29||
48188460|NCT00409708|100783246|FG000|NOT COMPLETED|Washout||21||
48188461|NCT00409708|100783247|FG001|NOT COMPLETED|Washout||10||
48188462|NCT03308058|100783248|FG000|STARTED|Overall Study||23||
48188463|NCT03308058|100783249|FG001|STARTED|Overall Study||23||
48188464|NCT03308058|100783248|FG000|COMPLETED|Overall Study||23||
48438358|NCT00194116|101406549|FG001|COMPLETED|Overall Study||13||
48438359|NCT00194116|101406548|FG000|NOT COMPLETED|Overall Study||13||
48188465|NCT03308058|100783249|FG001|COMPLETED|Overall Study||23||
48188466|NCT03308058|100783248|FG000|NOT COMPLETED|Overall Study||0||
48188467|NCT03308058|100783249|FG001|NOT COMPLETED|Overall Study||0||
48188468|NCT01737268|100783250|FG000|STARTED|Overall Study||20||
48367809|NCT00619684|101230052|FG000|NOT COMPLETED|Overall Study||0||
48367810|NCT05091060|101230053|FG000|STARTED|Overall Study||5||
48367811|NCT05091060|101230053|FG000|COMPLETED|Overall Study||4||
48367812|NCT05091060|101230053|FG000|NOT COMPLETED|Overall Study||1||
48367813|NCT02991820|101230054|FG000|STARTED|Overall Study||12||
48438360|NCT00194116|101406549|FG001|NOT COMPLETED|Overall Study||15||
48438361|NCT00278473|101406550|FG000|STARTED|Overall Study||45||
48438362|NCT00278473|101406551|FG001|STARTED|Overall Study||43||
48438363|NCT00278473|101406550|FG000|COMPLETED|Overall Study||41||
48438364|NCT00278473|101406551|FG001|COMPLETED|Overall Study||40||
48656494|NCT04765384|101943662|FG000|NOT COMPLETED|Post-baseline: Adults||2||
48656495|NCT04765384|101943663|FG001|NOT COMPLETED|Post-baseline: Adults||2||
48188469|NCT01737268|100783250|FG000|Treated|Overall Study||20||
48367814|NCT02991820|101230055|FG001|STARTED|Overall Study||31||
48367815|NCT02991820|101230054|FG000|COMPLETED|Overall Study||12||
48367816|NCT02991820|101230055|FG001|COMPLETED|Overall Study||31||
48367817|NCT02991820|101230054|FG000|NOT COMPLETED|Overall Study||0||
48367818|NCT02991820|101230055|FG001|NOT COMPLETED|Overall Study||0||
48367819|NCT03242928|101230056|FG000|STARTED|Overall Study||31||
48367820|NCT03242928|101230057|FG001|STARTED|Overall Study||37||
48367821|NCT03242928|101230056|FG000|COMPLETED|Overall Study||22||
48367822|NCT03242928|101230057|FG001|COMPLETED|Overall Study||32||
48367823|NCT03242928|101230056|FG000|NOT COMPLETED|Overall Study||9||
48367824|NCT03242928|101230057|FG001|NOT COMPLETED|Overall Study||5||
48367825|NCT02207530|101230058|FG000|STARTED|Overall Study||112||
48367826|NCT02207530|101230058|FG000|COMPLETED|Overall Study||21||
48438365|NCT00278473|101406550|FG000|NOT COMPLETED|Overall Study||4||
48656496|NCT04765384|101943664|FG002|NOT COMPLETED|Post-baseline: Adults||6||
48656497|NCT04765384|101943665|FG003|NOT COMPLETED|Post-baseline: Adults||0||
48656498|NCT04765384|101943666|FG004|NOT COMPLETED|Post-baseline: Adults||0||
48656499|NCT04765384|101943667|FG005|NOT COMPLETED|Post-baseline: Adults||0||
48656500|NCT04765384|101943662|FG000|STARTED|Post-natal: Neonates and Infants||0||
48656501|NCT04765384|101943663|FG001|STARTED|Post-natal: Neonates and Infants||0||
48656502|NCT04765384|101943664|FG002|STARTED|Post-natal: Neonates and Infants||0||
48656503|NCT04765384|101943665|FG003|STARTED|Post-natal: Neonates and Infants||10||
48656504|NCT04765384|101943666|FG004|STARTED|Post-natal: Neonates and Infants||8||
48656505|NCT04765384|101943667|FG005|STARTED|Post-natal: Neonates and Infants||29||
48656506|NCT04765384|101943662|FG000|Group 2|Post-natal: Neonates and Infants||0||
48656507|NCT04765384|101943663|FG001|Group 2|Post-natal: Neonates and Infants||0||
48188470|NCT01737268|100783250|FG000|COMPLETED|Overall Study||11||
48188471|NCT01737268|100783250|FG000|NOT COMPLETED|Overall Study||9||
48367827|NCT02207530|101230058|FG000|NOT COMPLETED|Overall Study||91||
48367828|NCT01671085|101230059|FG000|STARTED|Overall Study||11||
48438366|NCT00278473|101406551|FG001|NOT COMPLETED|Overall Study||3||
48367829|NCT01671085|101230060|FG001|STARTED|Overall Study||2||
48367830|NCT01671085|101230059|FG000|Received at Least 1 Dose of Study Drug|Overall Study||11||
48438367|NCT01353586|101406552|FG000|STARTED|Overall Study||167||
48438368|NCT01353586|101406553|FG001|STARTED|Overall Study||19||
48656508|NCT04765384|101943664|FG002|Group 2|Post-natal: Neonates and Infants||0||
48188472|NCT00465361|100783251|FG000|STARTED|Baseline Assessment||7||
48438369|NCT01353586|101406552|FG000|Participated in Workflow Phase|Overall Study||20||
48438370|NCT01353586|101406553|FG001|Participated in Workflow Phase|Overall Study||0||
48438371|NCT01353586|101406552|FG000|Participated in Roll-in Phase|Overall Study||22||
48438372|NCT01353586|101406553|FG001|Participated in Roll-in Phase|Overall Study||0||
48438373|NCT01353586|101406552|FG000|Participated in SNA Substudy|Overall Study||19||
48438374|NCT01353586|101406553|FG001|Participated in SNA Substudy|Overall Study||19||
48438375|NCT01353586|101406552|FG000|COMPLETED|Overall Study||160||
48438376|NCT01353586|101406553|FG001|COMPLETED|Overall Study||17||
48438377|NCT01353586|101406552|FG000|NOT COMPLETED|Overall Study||7||
48438378|NCT01353586|101406553|FG001|NOT COMPLETED|Overall Study||2||
48438379|NCT01036594|101406554|FG000|STARTED|Run-In: Ketoconazole Only (200 mg)||32||
48438380|NCT01036594|101406555|FG001|STARTED|Run-In: Ketoconazole Only (200 mg)||0||
48438381|NCT01036594|101406554|FG000|COMPLETED|Run-In: Ketoconazole Only (200 mg)||31||
48438382|NCT01036594|101406555|FG001|COMPLETED|Run-In: Ketoconazole Only (200 mg)||0||
48438383|NCT01036594|101406554|FG000|NOT COMPLETED|Run-In: Ketoconazole Only (200 mg)||1||
48438384|NCT01036594|101406555|FG001|NOT COMPLETED|Run-In: Ketoconazole Only (200 mg)||0||
48438385|NCT01036594|101406554|FG000|STARTED|First Treatment Regimen||31||
48438386|NCT01036594|101406555|FG001|STARTED|First Treatment Regimen||0||
48438387|NCT01036594|101406554|FG000|COMPLETED|First Treatment Regimen||30||
48438388|NCT01036594|101406555|FG001|COMPLETED|First Treatment Regimen||0||
48438389|NCT01036594|101406554|FG000|NOT COMPLETED|First Treatment Regimen||1||
48438390|NCT01036594|101406555|FG001|NOT COMPLETED|First Treatment Regimen||0||
48438391|NCT01036594|101406554|FG000|STARTED|Week 12 Evaluation||30||
48438392|NCT01036594|101406555|FG001|STARTED|Week 12 Evaluation||0||
48438393|NCT01036594|101406554|FG000|COMPLETED|Week 12 Evaluation||24||
48438394|NCT01036594|101406555|FG001|COMPLETED|Week 12 Evaluation||0||
48438395|NCT01036594|101406554|FG000|NOT COMPLETED|Week 12 Evaluation||6||
48438396|NCT01036594|101406555|FG001|NOT COMPLETED|Week 12 Evaluation||0||
48438397|NCT01036594|101406554|FG000|STARTED|Treatment Regiments Post Week 12||15||
48438398|NCT01036594|101406555|FG001|STARTED|Treatment Regiments Post Week 12||9||
48438399|NCT01036594|101406554|FG000|COMPLETED|Treatment Regiments Post Week 12||13||
48438400|NCT01036594|101406555|FG001|COMPLETED|Treatment Regiments Post Week 12||5||
48438401|NCT01036594|101406554|FG000|NOT COMPLETED|Treatment Regiments Post Week 12||2||
48438402|NCT01036594|101406555|FG001|NOT COMPLETED|Treatment Regiments Post Week 12||4||
48438403|NCT01771627|101406556|FG000|STARTED|Overall Study||200||
48438404|NCT01771627|101406557|FG001|STARTED|Overall Study||100||
48438405|NCT01771627|101406556|FG000|COMPLETED|Overall Study||92||
48438406|NCT01771627|101406557|FG001|COMPLETED|Overall Study||50||
48438407|NCT01771627|101406556|FG000|NOT COMPLETED|Overall Study||108||
48438408|NCT01771627|101406557|FG001|NOT COMPLETED|Overall Study||50||
48438409|NCT00389168|101406558|FG000|STARTED|Overall Study||56||
48766842|NCT00071890|102218511|FG000|STARTED|Overall Study||81||
48766843|NCT00071890|102218512|FG001|STARTED|Overall Study||67||
48766844|NCT00071890|102218511|FG000|COMPLETED|Overall Study||81||
48766845|NCT00071890|102218512|FG001|COMPLETED|Overall Study||67||
48766846|NCT00071890|102218511|FG000|NOT COMPLETED|Overall Study||0||
48766847|NCT00071890|102218512|FG001|NOT COMPLETED|Overall Study||0||
48766848|NCT00815659|102218513|FG000|STARTED|Overall Study||97||
48438410|NCT00389168|101406559|FG001|STARTED|Overall Study||58||
48438411|NCT00389168|101406558|FG000|COMPLETED|Overall Study||47||
48438412|NCT00389168|101406559|FG001|COMPLETED|Overall Study||53||
48438413|NCT00389168|101406558|FG000|NOT COMPLETED|Overall Study||9||
48438414|NCT00389168|101406559|FG001|NOT COMPLETED|Overall Study||5||
48438415|NCT01157065|101406560|FG000|STARTED|Overall Study||38||
48438416|NCT01157065|101406561|FG001|STARTED|Overall Study||11||
48438417|NCT01157065|101406560|FG000|COMPLETED|Overall Study||38||
48438418|NCT01157065|101406561|FG001|COMPLETED|Overall Study||10||
48438419|NCT01157065|101406560|FG000|NOT COMPLETED|Overall Study||0||
48438420|NCT01157065|101406561|FG001|NOT COMPLETED|Overall Study||1||
48438421|NCT00326118|101406562|FG000|STARTED|Active Phase||324||
48438422|NCT00326118|101406563|FG001|STARTED|Active Phase||109||
48438423|NCT00326118|101406562|FG000|COMPLETED|Active Phase||320||
48438424|NCT00326118|101406563|FG001|COMPLETED|Active Phase||108||
48766849|NCT00815659|102218513|FG000|COMPLETED|Overall Study||74||
48766850|NCT00815659|102218513|FG000|NOT COMPLETED|Overall Study||23||
48766851|NCT04949490|102218514|FG000|STARTED|Group A and Group B||21||
48188473|NCT00465361|100783251|FG000|COMPLETED|Baseline Assessment||3||
48188474|NCT00465361|100783251|FG000|NOT COMPLETED|Baseline Assessment||4||
48188699|NCT02034435|100783312|FG000|Aim 1|Overall Study||13||
48438425|NCT00326118|101406562|FG000|NOT COMPLETED|Active Phase||4||
48438426|NCT00326118|101406563|FG001|NOT COMPLETED|Active Phase||1||
48438427|NCT00326118|101406562|FG000|STARTED|Year 1 Follow-up||295||
48438428|NCT00326118|101406563|FG001|STARTED|Year 1 Follow-up||100||
48438429|NCT00326118|101406562|FG000|COMPLETED|Year 1 Follow-up||295||
48438430|NCT00326118|101406563|FG001|COMPLETED|Year 1 Follow-up||100||
48438431|NCT00326118|101406562|FG000|NOT COMPLETED|Year 1 Follow-up||0||
48438432|NCT00326118|101406563|FG001|NOT COMPLETED|Year 1 Follow-up||0||
48438433|NCT00326118|101406562|FG000|STARTED|Year 2 Follow-up||270||
48438434|NCT00326118|101406563|FG001|STARTED|Year 2 Follow-up||92||
48766852|NCT04949490|102218515|FG001|STARTED|Group A and Group B||44||
48766853|NCT04949490|102218516|FG002|STARTED|Group A and Group B||61||
48438435|NCT00326118|101406562|FG000|COMPLETED|Year 2 Follow-up||270||
48438436|NCT00326118|101406563|FG001|COMPLETED|Year 2 Follow-up||92||
48438437|NCT00326118|101406562|FG000|NOT COMPLETED|Year 2 Follow-up||0||
48438438|NCT00326118|101406563|FG001|NOT COMPLETED|Year 2 Follow-up||0||
48438439|NCT00326118|101406562|FG000|STARTED|Year 3 Follow-up||256||
48438440|NCT00326118|101406563|FG001|STARTED|Year 3 Follow-up||89||
48438441|NCT00326118|101406562|FG000|COMPLETED|Year 3 Follow-up||256||
48438442|NCT00326118|101406563|FG001|COMPLETED|Year 3 Follow-up||89||
48438443|NCT00326118|101406562|FG000|NOT COMPLETED|Year 3 Follow-up||0||
48438444|NCT00326118|101406563|FG001|NOT COMPLETED|Year 3 Follow-up||0||
48438445|NCT00326118|101406562|FG000|STARTED|Year 4 Follow-up||228||
48438446|NCT00326118|101406563|FG001|STARTED|Year 4 Follow-up||80||
48438447|NCT00326118|101406562|FG000|COMPLETED|Year 4 Follow-up||228||
48438448|NCT00326118|101406563|FG001|COMPLETED|Year 4 Follow-up||80||
48438449|NCT00326118|101406562|FG000|NOT COMPLETED|Year 4 Follow-up||0||
48438450|NCT00326118|101406563|FG001|NOT COMPLETED|Year 4 Follow-up||0||
48438451|NCT00326118|101406562|FG000|STARTED|Year 5 Follow up||217||
48438452|NCT00326118|101406563|FG001|STARTED|Year 5 Follow up||78||
48438453|NCT00326118|101406562|FG000|COMPLETED|Year 5 Follow up||217||
48438454|NCT00326118|101406563|FG001|COMPLETED|Year 5 Follow up||78||
48438455|NCT00326118|101406562|FG000|NOT COMPLETED|Year 5 Follow up||0||
48438456|NCT00326118|101406563|FG001|NOT COMPLETED|Year 5 Follow up||0||
48438457|NCT05168657|101406564|FG000|STARTED|Overall Study||5||
48438458|NCT05168657|101406565|FG001|STARTED|Overall Study||5||
48438459|NCT05168657|101406566|FG002|STARTED|Overall Study||5||
48438460|NCT05168657|101406567|FG003|STARTED|Overall Study||5||
48438461|NCT05168657|101406568|FG004|STARTED|Overall Study||5||
48438462|NCT05168657|101406569|FG005|STARTED|Overall Study||5||
48438463|NCT05168657|101406570|FG006|STARTED|Overall Study||5||
48438464|NCT05168657|101406571|FG007|STARTED|Overall Study||5||
48438465|NCT05168657|101406564|FG000|COMPLETED|Overall Study||5||
48438466|NCT05168657|101406565|FG001|COMPLETED|Overall Study||5||
48438467|NCT05168657|101406566|FG002|COMPLETED|Overall Study||4||
48438468|NCT05168657|101406567|FG003|COMPLETED|Overall Study||5||
48438469|NCT05168657|101406568|FG004|COMPLETED|Overall Study||5||
48438470|NCT05168657|101406569|FG005|COMPLETED|Overall Study||5||
48656509|NCT04765384|101943665|FG003|Group 2|Post-natal: Neonates and Infants||0||
48656510|NCT04765384|101943666|FG004|Group 2|Post-natal: Neonates and Infants||1||
48656511|NCT04765384|101943667|FG005|Group 2|Post-natal: Neonates and Infants||0||
48656512|NCT04765384|101943662|FG000|Group 3|Post-natal: Neonates and Infants||0||
48656513|NCT04765384|101943663|FG001|Group 3|Post-natal: Neonates and Infants||0||
48656514|NCT04765384|101943664|FG002|Group 3|Post-natal: Neonates and Infants||0||
48656515|NCT04765384|101943665|FG003|Group 3|Post-natal: Neonates and Infants||0||
48656516|NCT04765384|101943666|FG004|Group 3|Post-natal: Neonates and Infants||7||
48656517|NCT04765384|101943667|FG005|Group 3|Post-natal: Neonates and Infants||0||
48656518|NCT04765384|101943662|FG000|COMPLETED|Post-natal: Neonates and Infants||0||
48656519|NCT04765384|101943663|FG001|COMPLETED|Post-natal: Neonates and Infants||0||
48656520|NCT04765384|101943664|FG002|COMPLETED|Post-natal: Neonates and Infants||0||
48656521|NCT04765384|101943665|FG003|COMPLETED|Post-natal: Neonates and Infants||9||
48656522|NCT04765384|101943666|FG004|COMPLETED|Post-natal: Neonates and Infants||8||
48656523|NCT04765384|101943667|FG005|COMPLETED|Post-natal: Neonates and Infants||21||
48656524|NCT04765384|101943662|FG000|NOT COMPLETED|Post-natal: Neonates and Infants||0||
48656525|NCT04765384|101943663|FG001|NOT COMPLETED|Post-natal: Neonates and Infants||0||
48656526|NCT04765384|101943664|FG002|NOT COMPLETED|Post-natal: Neonates and Infants||0||
48656527|NCT04765384|101943665|FG003|NOT COMPLETED|Post-natal: Neonates and Infants||1||
48656528|NCT04765384|101943666|FG004|NOT COMPLETED|Post-natal: Neonates and Infants||0||
48656529|NCT04765384|101943667|FG005|NOT COMPLETED|Post-natal: Neonates and Infants||8||
48656530|NCT02777190|101943668|FG000|STARTED|Overall Study||17||
48656531|NCT02777190|101943669|FG001|STARTED|Overall Study||17||
48656532|NCT02777190|101943668|FG000|COMPLETED|Overall Study||16||
48656533|NCT02777190|101943669|FG001|COMPLETED|Overall Study||11||
48656534|NCT02777190|101943668|FG000|NOT COMPLETED|Overall Study||1||
48656535|NCT02777190|101943669|FG001|NOT COMPLETED|Overall Study||6||
48438471|NCT05168657|101406570|FG006|COMPLETED|Overall Study||5||
48438472|NCT05168657|101406571|FG007|COMPLETED|Overall Study||5||
48438473|NCT05168657|101406564|FG000|NOT COMPLETED|Overall Study||0||
48438474|NCT05168657|101406565|FG001|NOT COMPLETED|Overall Study||0||
48438475|NCT05168657|101406566|FG002|NOT COMPLETED|Overall Study||1||
48438476|NCT05168657|101406567|FG003|NOT COMPLETED|Overall Study||0||
48438477|NCT05168657|101406568|FG004|NOT COMPLETED|Overall Study||0||
48438478|NCT05168657|101406569|FG005|NOT COMPLETED|Overall Study||0||
48438479|NCT05168657|101406570|FG006|NOT COMPLETED|Overall Study||0||
48438480|NCT05168657|101406571|FG007|NOT COMPLETED|Overall Study||0||
48438481|NCT02916056|101406572|FG000|STARTED|Overall Study||297||
48438482|NCT02916056|101406572|FG000|COMPLETED|Overall Study||0||
48656536|NCT04191135|101943670|FG000|STARTED|Induction Treatment||462||
48656537|NCT04191135|101943671|FG001|STARTED|Induction Treatment||0||
48766854|NCT04949490|102218517|FG003|STARTED|Group A and Group B||11||
48766855|NCT04949490|102218518|FG004|STARTED|Group A and Group B||0||
48766856|NCT04949490|102218519|FG005|STARTED|Group A and Group B||0||
48766857|NCT04949490|102218514|FG000|COMPLETED|Group A and Group B||21||
48367831|NCT01671085|101230060|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2||
48367832|NCT01671085|101230059|FG000|COMPLETED|Overall Study||10||
48367833|NCT01671085|101230060|FG001|COMPLETED|Overall Study||2||
48656538|NCT04191135|101943672|FG002|STARTED|Induction Treatment||0||
48656539|NCT04191135|101943670|FG000|Treated|Induction Treatment||460||
48656540|NCT04191135|101943671|FG001|Treated|Induction Treatment||0||
48656541|NCT04191135|101943672|FG002|Treated|Induction Treatment||0||
48656542|NCT04191135|101943670|FG000|COMPLETED|Induction Treatment||0||
48656543|NCT04191135|101943671|FG001|COMPLETED|Induction Treatment||0||
48656544|NCT04191135|101943672|FG002|COMPLETED|Induction Treatment||0||
48656545|NCT04191135|101943670|FG000|NOT COMPLETED|Induction Treatment||462||
48656546|NCT04191135|101943671|FG001|NOT COMPLETED|Induction Treatment||0||
48656547|NCT04191135|101943672|FG002|NOT COMPLETED|Induction Treatment||0||
48656548|NCT04191135|101943670|FG000|STARTED|Randomized Treatment||0||
48656549|NCT04191135|101943671|FG001|STARTED|Randomized Treatment||135||
48656550|NCT04191135|101943672|FG002|STARTED|Randomized Treatment||136||
48656551|NCT04191135|101943670|FG000|Treated|Randomized Treatment||0||
48656552|NCT04191135|101943671|FG001|Treated|Randomized Treatment||135||
48656553|NCT04191135|101943672|FG002|Treated|Randomized Treatment||133||
48656554|NCT04191135|101943670|FG000|COMPLETED|Randomized Treatment||0||
48656555|NCT04191135|101943671|FG001|COMPLETED|Randomized Treatment||0||
48656556|NCT04191135|101943672|FG002|COMPLETED|Randomized Treatment||0||
48656557|NCT04191135|101943670|FG000|NOT COMPLETED|Randomized Treatment||0||
48656558|NCT04191135|101943671|FG001|NOT COMPLETED|Randomized Treatment||135||
48656559|NCT04191135|101943672|FG002|NOT COMPLETED|Randomized Treatment||136||
48656560|NCT01064648|101943673|FG000|STARTED|Phase I Cohort1: Dose Level 1||7||
48656561|NCT01064648|101943674|FG001|STARTED|Phase I Cohort1: Dose Level 1||0||
48656562|NCT01064648|101943675|FG002|STARTED|Phase I Cohort1: Dose Level 1||0||
48656563|NCT01064648|101943676|FG003|STARTED|Phase I Cohort1: Dose Level 1||0||
48656564|NCT01064648|101943673|FG000|COMPLETED|Phase I Cohort1: Dose Level 1||0||
48656565|NCT01064648|101943674|FG001|COMPLETED|Phase I Cohort1: Dose Level 1||0||
48656566|NCT01064648|101943675|FG002|COMPLETED|Phase I Cohort1: Dose Level 1||0||
48656567|NCT01064648|101943676|FG003|COMPLETED|Phase I Cohort1: Dose Level 1||0||
48656568|NCT01064648|101943673|FG000|NOT COMPLETED|Phase I Cohort1: Dose Level 1||7||
48656569|NCT01064648|101943674|FG001|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0||
48656570|NCT01064648|101943675|FG002|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0||
48656571|NCT01064648|101943676|FG003|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0||
48766858|NCT04949490|102218515|FG001|COMPLETED|Group A and Group B||44||
48367834|NCT01671085|101230059|FG000|NOT COMPLETED|Overall Study||1||
48367835|NCT01671085|101230060|FG001|NOT COMPLETED|Overall Study||0||
48367836|NCT01848821|101230061|FG000|STARTED|Overall Study||7||10
48367837|NCT01848821|101230062|FG001|STARTED|Overall Study||7||10
48367838|NCT01848821|101230061|FG000|COMPLETED|Overall Study||7||10
48367839|NCT01848821|101230062|FG001|COMPLETED|Overall Study||7||10
48367840|NCT01848821|101230061|FG000|NOT COMPLETED|Overall Study||0||0
48367841|NCT01848821|101230062|FG001|NOT COMPLETED|Overall Study||0||0
48367842|NCT02582749|101230063|FG000|STARTED|Overall Study||5||
48367843|NCT02582749|101230064|FG001|STARTED|Overall Study||11||
48367844|NCT02582749|101230063|FG000|COMPLETED|Overall Study||0||
48367845|NCT02582749|101230064|FG001|COMPLETED|Overall Study||0||
48367846|NCT02582749|101230063|FG000|NOT COMPLETED|Overall Study||5||
48367847|NCT02582749|101230064|FG001|NOT COMPLETED|Overall Study||11||
48367848|NCT02564120|101230065|FG000|STARTED|Overall Study||1556||
48367849|NCT02564120|101230065|FG000|COMPLETED|Overall Study||1110||
48367850|NCT02564120|101230065|FG000|NOT COMPLETED|Overall Study||446||
48367851|NCT02099799|101230066|FG000|STARTED|Overall Study||75||
48367852|NCT02099799|101230067|FG001|STARTED|Overall Study||78||
48367853|NCT02099799|101230066|FG000|COMPLETED|Overall Study||60||
48367854|NCT02099799|101230067|FG001|COMPLETED|Overall Study||54||
48367855|NCT02099799|101230066|FG000|NOT COMPLETED|Overall Study||15||
48367856|NCT02099799|101230067|FG001|NOT COMPLETED|Overall Study||24||
48367857|NCT01847638|101230068|FG000|STARTED|Overall Study||25||
48367858|NCT01847638|101230069|FG001|STARTED|Overall Study||25||
48367859|NCT01847638|101230068|FG000|COMPLETED|Overall Study||25||
48367860|NCT01847638|101230069|FG001|COMPLETED|Overall Study||25||
48656572|NCT01064648|101943673|FG000|STARTED|Phase I Cohort 2: Dose Level 2||0||
48766859|NCT04949490|102218516|FG002|COMPLETED|Group A and Group B||60||
48766860|NCT04949490|102218517|FG003|COMPLETED|Group A and Group B||9||
48656573|NCT01064648|101943674|FG001|STARTED|Phase I Cohort 2: Dose Level 2||13||
48656574|NCT01064648|101943675|FG002|STARTED|Phase I Cohort 2: Dose Level 2||0||
48766861|NCT04949490|102218518|FG004|COMPLETED|Group A and Group B||0||
48656575|NCT01064648|101943676|FG003|STARTED|Phase I Cohort 2: Dose Level 2||0||
48656576|NCT01064648|101943673|FG000|COMPLETED|Phase I Cohort 2: Dose Level 2||0||
48656577|NCT01064648|101943674|FG001|COMPLETED|Phase I Cohort 2: Dose Level 2||0||
48656578|NCT01064648|101943675|FG002|COMPLETED|Phase I Cohort 2: Dose Level 2||0||
48656579|NCT01064648|101943676|FG003|COMPLETED|Phase I Cohort 2: Dose Level 2||0||
48656580|NCT01064648|101943673|FG000|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0||
48656581|NCT01064648|101943674|FG001|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||13||
48656582|NCT01064648|101943675|FG002|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0||
48656583|NCT01064648|101943676|FG003|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0||
48656584|NCT01064648|101943673|FG000|STARTED|Phase II||0||
48656585|NCT01064648|101943674|FG001|STARTED|Phase II||0||
48656586|NCT01064648|101943675|FG002|STARTED|Phase II||49||
48766862|NCT04949490|102218519|FG005|COMPLETED|Group A and Group B||0||
48766863|NCT04949490|102218514|FG000|NOT COMPLETED|Group A and Group B||0||
48766864|NCT04949490|102218515|FG001|NOT COMPLETED|Group A and Group B||0||
48766865|NCT04949490|102218516|FG002|NOT COMPLETED|Group A and Group B||1||
48766866|NCT04949490|102218517|FG003|NOT COMPLETED|Group A and Group B||2||
48438483|NCT02916056|101406572|FG000|NOT COMPLETED|Overall Study||297||
48438484|NCT03239340|101406573|FG000|STARTED|Overall Study||154||
48438485|NCT03239340|101406573|FG000|COMPLETED|Overall Study||33||
48438486|NCT03239340|101406573|FG000|NOT COMPLETED|Overall Study||121||
48438487|NCT02284880|101406574|FG000|STARTED|Overall Study||11||
48438488|NCT02284880|101406575|FG001|STARTED|Overall Study||9||
48438489|NCT02284880|101406576|FG002|STARTED|Overall Study||10||
48438490|NCT02284880|101406577|FG003|STARTED|Overall Study||10||
48438491|NCT02284880|101406574|FG000|First Period (4 Days)|Overall Study||11||
48438492|NCT02284880|101406575|FG001|First Period (4 Days)|Overall Study||9||
48438493|NCT02284880|101406576|FG002|First Period (4 Days)|Overall Study||10||
48438494|NCT02284880|101406577|FG003|First Period (4 Days)|Overall Study||10||
48438495|NCT02284880|101406574|FG000|Wash-out Period (7 Days)|Overall Study||11||
48438496|NCT02284880|101406575|FG001|Wash-out Period (7 Days)|Overall Study||9||
48438497|NCT02284880|101406576|FG002|Wash-out Period (7 Days)|Overall Study||10||
48438498|NCT02284880|101406577|FG003|Wash-out Period (7 Days)|Overall Study||10||
48438499|NCT02284880|101406574|FG000|Second Period (4 Days)|Overall Study||11||
48438500|NCT02284880|101406575|FG001|Second Period (4 Days)|Overall Study||9||
48438501|NCT02284880|101406576|FG002|Second Period (4 Days)|Overall Study||8||
48438502|NCT02284880|101406577|FG003|Second Period (4 Days)|Overall Study||10||
48438503|NCT02284880|101406574|FG000|COMPLETED|Overall Study||11||
48438504|NCT02284880|101406575|FG001|COMPLETED|Overall Study||9||
48438505|NCT02284880|101406576|FG002|COMPLETED|Overall Study||8||
48438506|NCT02284880|101406577|FG003|COMPLETED|Overall Study||10||
48438507|NCT02284880|101406574|FG000|NOT COMPLETED|Overall Study||0||
48438508|NCT02284880|101406575|FG001|NOT COMPLETED|Overall Study||0||
48438509|NCT02284880|101406576|FG002|NOT COMPLETED|Overall Study||2||
48438510|NCT02284880|101406577|FG003|NOT COMPLETED|Overall Study||0||
48438511|NCT03330275|101406578|FG000|STARTED|Visit 1 - Period 1||6||
48438512|NCT03330275|101406579|FG001|STARTED|Visit 1 - Period 1||6||
48438513|NCT03330275|101406580|FG002|STARTED|Visit 1 - Period 1||6||
48656587|NCT01064648|101943676|FG003|STARTED|Phase II||48||
48656588|NCT01064648|101943673|FG000|COMPLETED|Phase II||0||
48656589|NCT01064648|101943674|FG001|COMPLETED|Phase II||0||
48656590|NCT01064648|101943675|FG002|COMPLETED|Phase II||0||
48656591|NCT01064648|101943676|FG003|COMPLETED|Phase II||0||
48656592|NCT01064648|101943673|FG000|NOT COMPLETED|Phase II||0||
48656593|NCT01064648|101943674|FG001|NOT COMPLETED|Phase II||0||
48656594|NCT01064648|101943675|FG002|NOT COMPLETED|Phase II||49||
48656595|NCT01064648|101943676|FG003|NOT COMPLETED|Phase II||48||
48656596|NCT06083493|101943677|FG000|STARTED|Overall Study||30||
48656597|NCT06083493|101943678|FG001|STARTED|Overall Study||30||
48656598|NCT06083493|101943677|FG000|COMPLETED|Overall Study||27||
48656599|NCT06083493|101943678|FG001|COMPLETED|Overall Study||27||
48656600|NCT06083493|101943677|FG000|NOT COMPLETED|Overall Study||3||
48438514|NCT03330275|101406581|FG003|STARTED|Visit 1 - Period 1||6||
48438515|NCT03330275|101406582|FG004|STARTED|Visit 1 - Period 1||0||
48656601|NCT06083493|101943678|FG001|NOT COMPLETED|Overall Study||3||
48656602|NCT00588770|101943679|FG000|STARTED|Overall Study||200||
48656603|NCT00588770|101943680|FG001|STARTED|Overall Study||203||
48656604|NCT00588770|101943679|FG000|Eligible|Overall Study||188||
48766867|NCT04949490|102218518|FG004|NOT COMPLETED|Group A and Group B||0||
48766868|NCT04949490|102218519|FG005|NOT COMPLETED|Group A and Group B||0||
48766869|NCT04949490|102218514|FG000|STARTED|Subset Group B Immunogenicity Evaluation||0||
48766870|NCT04949490|102218515|FG001|STARTED|Subset Group B Immunogenicity Evaluation||0||
48766871|NCT04949490|102218516|FG002|STARTED|Subset Group B Immunogenicity Evaluation||0||
48766872|NCT04949490|102218517|FG003|STARTED|Subset Group B Immunogenicity Evaluation||0||
48656605|NCT00588770|101943680|FG001|Eligible|Overall Study||183||
48438516|NCT03330275|101406583|FG005|STARTED|Visit 1 - Period 1||0||
48188475|NCT00465361|100783251|FG000|STARTED|Post-Intervention Assessment||3||
48188476|NCT00465361|100783251|FG000|COMPLETED|Post-Intervention Assessment||3||
48188477|NCT00465361|100783251|FG000|NOT COMPLETED|Post-Intervention Assessment||0||
48188478|NCT00670540|100783252|FG000|STARTED|Overall Study||8256||
48188479|NCT00670540|100783252|FG000|COMPLETED|Overall Study||4931||
48188480|NCT00670540|100783252|FG000|NOT COMPLETED|Overall Study||3325||
48188481|NCT03829969|100783253|FG000|STARTED|Overall Study||257||
48188482|NCT03829969|100783254|FG001|STARTED|Overall Study||257||
48438517|NCT03330275|101406584|FG006|STARTED|Visit 1 - Period 1||0||
48438518|NCT03330275|101406585|FG007|STARTED|Visit 1 - Period 1||0||
48438519|NCT03330275|101406586|FG008|STARTED|Visit 1 - Period 1||0||
48438520|NCT03330275|101406587|FG009|STARTED|Visit 1 - Period 1||0||
48438521|NCT03330275|101406578|FG000|COMPLETED|Visit 1 - Period 1||6||
48438522|NCT03330275|101406579|FG001|COMPLETED|Visit 1 - Period 1||6||
48438523|NCT03330275|101406580|FG002|COMPLETED|Visit 1 - Period 1||6||
48438524|NCT03330275|101406581|FG003|COMPLETED|Visit 1 - Period 1||6||
48438525|NCT03330275|101406582|FG004|COMPLETED|Visit 1 - Period 1||0||
48438526|NCT03330275|101406583|FG005|COMPLETED|Visit 1 - Period 1||0||
48438527|NCT03330275|101406584|FG006|COMPLETED|Visit 1 - Period 1||0||
48438528|NCT03330275|101406585|FG007|COMPLETED|Visit 1 - Period 1||0||
48438529|NCT03330275|101406586|FG008|COMPLETED|Visit 1 - Period 1||0||
48438530|NCT03330275|101406587|FG009|COMPLETED|Visit 1 - Period 1||0||
48438531|NCT03330275|101406578|FG000|NOT COMPLETED|Visit 1 - Period 1||0||
48438532|NCT03330275|101406579|FG001|NOT COMPLETED|Visit 1 - Period 1||0||
48438533|NCT03330275|101406580|FG002|NOT COMPLETED|Visit 1 - Period 1||0||
48438534|NCT03330275|101406581|FG003|NOT COMPLETED|Visit 1 - Period 1||0||
48438535|NCT03330275|101406582|FG004|NOT COMPLETED|Visit 1 - Period 1||0||
48438536|NCT03330275|101406583|FG005|NOT COMPLETED|Visit 1 - Period 1||0||
48438537|NCT03330275|101406584|FG006|NOT COMPLETED|Visit 1 - Period 1||0||
48438538|NCT03330275|101406585|FG007|NOT COMPLETED|Visit 1 - Period 1||0||
48438539|NCT03330275|101406586|FG008|NOT COMPLETED|Visit 1 - Period 1||0||
48438540|NCT03330275|101406587|FG009|NOT COMPLETED|Visit 1 - Period 1||0||
48438541|NCT03330275|101406578|FG000|STARTED|Visit 1 - Period 2||6||
48438542|NCT03330275|101406579|FG001|STARTED|Visit 1 - Period 2||6||
48438543|NCT03330275|101406580|FG002|STARTED|Visit 1 - Period 2||6||
48438544|NCT03330275|101406581|FG003|STARTED|Visit 1 - Period 2||6||
48438545|NCT03330275|101406582|FG004|STARTED|Visit 1 - Period 2||0||
48438546|NCT03330275|101406583|FG005|STARTED|Visit 1 - Period 2||0||
48438547|NCT03330275|101406584|FG006|STARTED|Visit 1 - Period 2||0||
48438548|NCT03330275|101406585|FG007|STARTED|Visit 1 - Period 2||0||
48438549|NCT03330275|101406586|FG008|STARTED|Visit 1 - Period 2||0||
48438550|NCT03330275|101406587|FG009|STARTED|Visit 1 - Period 2||0||
48438551|NCT03330275|101406578|FG000|COMPLETED|Visit 1 - Period 2||6||
48438552|NCT03330275|101406579|FG001|COMPLETED|Visit 1 - Period 2||6||
48438553|NCT03330275|101406580|FG002|COMPLETED|Visit 1 - Period 2||6||
48438554|NCT03330275|101406581|FG003|COMPLETED|Visit 1 - Period 2||6||
48438555|NCT03330275|101406582|FG004|COMPLETED|Visit 1 - Period 2||0||
48438556|NCT03330275|101406583|FG005|COMPLETED|Visit 1 - Period 2||0||
48438557|NCT03330275|101406584|FG006|COMPLETED|Visit 1 - Period 2||0||
48438558|NCT03330275|101406585|FG007|COMPLETED|Visit 1 - Period 2||0||
48438559|NCT03330275|101406586|FG008|COMPLETED|Visit 1 - Period 2||0||
48438560|NCT03330275|101406587|FG009|COMPLETED|Visit 1 - Period 2||0||
48438561|NCT03330275|101406578|FG000|NOT COMPLETED|Visit 1 - Period 2||0||
48438562|NCT03330275|101406579|FG001|NOT COMPLETED|Visit 1 - Period 2||0||
48438563|NCT03330275|101406580|FG002|NOT COMPLETED|Visit 1 - Period 2||0||
48438564|NCT03330275|101406581|FG003|NOT COMPLETED|Visit 1 - Period 2||0||
48438565|NCT03330275|101406582|FG004|NOT COMPLETED|Visit 1 - Period 2||0||
48438566|NCT03330275|101406583|FG005|NOT COMPLETED|Visit 1 - Period 2||0||
48438567|NCT03330275|101406584|FG006|NOT COMPLETED|Visit 1 - Period 2||0||
48438568|NCT03330275|101406585|FG007|NOT COMPLETED|Visit 1 - Period 2||0||
48438569|NCT03330275|101406586|FG008|NOT COMPLETED|Visit 1 - Period 2||0||
48438570|NCT03330275|101406587|FG009|NOT COMPLETED|Visit 1 - Period 2||0||
48438571|NCT03330275|101406578|FG000|STARTED|Visits 2, 3 and 4 - Period 1||0||
48188483|NCT03829969|100783253|FG000|COMPLETED|Overall Study||257||
48188484|NCT03829969|100783254|FG001|COMPLETED|Overall Study||257||
48188485|NCT03829969|100783253|FG000|NOT COMPLETED|Overall Study||0||
48188486|NCT03829969|100783254|FG001|NOT COMPLETED|Overall Study||0||
48188487|NCT04536025|100783255|FG000|STARTED|Overall Study||38||
48438572|NCT03330275|101406579|FG001|STARTED|Visits 2, 3 and 4 - Period 1||0||
48438573|NCT03330275|101406580|FG002|STARTED|Visits 2, 3 and 4 - Period 1||0||
48438574|NCT03330275|101406581|FG003|STARTED|Visits 2, 3 and 4 - Period 1||0||
48438575|NCT03330275|101406582|FG004|STARTED|Visits 2, 3 and 4 - Period 1||4||
48438576|NCT03330275|101406583|FG005|STARTED|Visits 2, 3 and 4 - Period 1||4||
48438577|NCT03330275|101406584|FG006|STARTED|Visits 2, 3 and 4 - Period 1||4||
48438578|NCT03330275|101406585|FG007|STARTED|Visits 2, 3 and 4 - Period 1||4||
48438579|NCT03330275|101406586|FG008|STARTED|Visits 2, 3 and 4 - Period 1||4||
48438580|NCT03330275|101406587|FG009|STARTED|Visits 2, 3 and 4 - Period 1||4||
48440004|NCT04854421|101410008|FG001|STARTED|Overall Study||84||
48188488|NCT04536025|100783256|FG001|STARTED|Overall Study||17||
48188489|NCT04536025|100783257|FG002|STARTED|Overall Study||11||
48438581|NCT03330275|101406578|FG000|COMPLETED|Visits 2, 3 and 4 - Period 1||0||
48438582|NCT03330275|101406579|FG001|COMPLETED|Visits 2, 3 and 4 - Period 1||0||
48438583|NCT03330275|101406580|FG002|COMPLETED|Visits 2, 3 and 4 - Period 1||0||
48438584|NCT03330275|101406581|FG003|COMPLETED|Visits 2, 3 and 4 - Period 1||0||
48438585|NCT03330275|101406582|FG004|COMPLETED|Visits 2, 3 and 4 - Period 1||4||
48438586|NCT03330275|101406583|FG005|COMPLETED|Visits 2, 3 and 4 - Period 1||4||
48438587|NCT03330275|101406584|FG006|COMPLETED|Visits 2, 3 and 4 - Period 1||4||
48438588|NCT03330275|101406585|FG007|COMPLETED|Visits 2, 3 and 4 - Period 1||4||
48438589|NCT03330275|101406586|FG008|COMPLETED|Visits 2, 3 and 4 - Period 1||4||
48438590|NCT03330275|101406587|FG009|COMPLETED|Visits 2, 3 and 4 - Period 1||4||
48438591|NCT03330275|101406578|FG000|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0||
48438592|NCT03330275|101406579|FG001|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0||
48438593|NCT03330275|101406580|FG002|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0||
48438594|NCT03330275|101406581|FG003|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0||
48438595|NCT03330275|101406582|FG004|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0||
48438596|NCT03330275|101406583|FG005|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0||
48438597|NCT03330275|101406584|FG006|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0||
48438598|NCT03330275|101406585|FG007|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0||
48438599|NCT03330275|101406586|FG008|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0||
48438600|NCT03330275|101406587|FG009|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0||
48438601|NCT03330275|101406578|FG000|STARTED|Visits 2, 3 and 4 - Period 2||0||
48438602|NCT03330275|101406579|FG001|STARTED|Visits 2, 3 and 4 - Period 2||0||
48438603|NCT03330275|101406580|FG002|STARTED|Visits 2, 3 and 4 - Period 2||0||
48438604|NCT03330275|101406581|FG003|STARTED|Visits 2, 3 and 4 - Period 2||0||
48438605|NCT03330275|101406582|FG004|STARTED|Visits 2, 3 and 4 - Period 2||4||
48438606|NCT03330275|101406583|FG005|STARTED|Visits 2, 3 and 4 - Period 2||4||
48438607|NCT03330275|101406584|FG006|STARTED|Visits 2, 3 and 4 - Period 2||4||
48438608|NCT03330275|101406585|FG007|STARTED|Visits 2, 3 and 4 - Period 2||4||
48438609|NCT03330275|101406586|FG008|STARTED|Visits 2, 3 and 4 - Period 2||4||
48438610|NCT03330275|101406587|FG009|STARTED|Visits 2, 3 and 4 - Period 2||4||
48438611|NCT03330275|101406578|FG000|COMPLETED|Visits 2, 3 and 4 - Period 2||0||
48438612|NCT03330275|101406579|FG001|COMPLETED|Visits 2, 3 and 4 - Period 2||0||
48438613|NCT03330275|101406580|FG002|COMPLETED|Visits 2, 3 and 4 - Period 2||0||
48438614|NCT03330275|101406581|FG003|COMPLETED|Visits 2, 3 and 4 - Period 2||0||
48438615|NCT03330275|101406582|FG004|COMPLETED|Visits 2, 3 and 4 - Period 2||4||
48438616|NCT03330275|101406583|FG005|COMPLETED|Visits 2, 3 and 4 - Period 2||4||
48438617|NCT03330275|101406584|FG006|COMPLETED|Visits 2, 3 and 4 - Period 2||4||
48438618|NCT03330275|101406585|FG007|COMPLETED|Visits 2, 3 and 4 - Period 2||4||
48438619|NCT03330275|101406586|FG008|COMPLETED|Visits 2, 3 and 4 - Period 2||4||
48438620|NCT03330275|101406587|FG009|COMPLETED|Visits 2, 3 and 4 - Period 2||4||
48438621|NCT03330275|101406578|FG000|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0||
48188490|NCT04536025|100783255|FG000|COMPLETED|Overall Study||38||
48438622|NCT03330275|101406579|FG001|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0||
48438623|NCT03330275|101406580|FG002|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0||
48438624|NCT03330275|101406581|FG003|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0||
48438625|NCT03330275|101406582|FG004|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0||
48438626|NCT03330275|101406583|FG005|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0||
48438627|NCT03330275|101406584|FG006|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0||
48438628|NCT03330275|101406585|FG007|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0||
48438629|NCT03330275|101406586|FG008|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0||
48438630|NCT03330275|101406587|FG009|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0||
48438631|NCT03330275|101406578|FG000|STARTED|Visits 2, 3 and 4 - Period 3||0||
48438632|NCT03330275|101406579|FG001|STARTED|Visits 2, 3 and 4 - Period 3||0||
48438633|NCT03330275|101406580|FG002|STARTED|Visits 2, 3 and 4 - Period 3||0||
48438634|NCT03330275|101406581|FG003|STARTED|Visits 2, 3 and 4 - Period 3||0||
48438635|NCT03330275|101406582|FG004|STARTED|Visits 2, 3 and 4 - Period 3||4||
48438636|NCT03330275|101406583|FG005|STARTED|Visits 2, 3 and 4 - Period 3||4||
48438637|NCT03330275|101406584|FG006|STARTED|Visits 2, 3 and 4 - Period 3||4||
48438638|NCT03330275|101406585|FG007|STARTED|Visits 2, 3 and 4 - Period 3||4||
48438639|NCT03330275|101406586|FG008|STARTED|Visits 2, 3 and 4 - Period 3||4||
48438640|NCT03330275|101406587|FG009|STARTED|Visits 2, 3 and 4 - Period 3||4||
48438641|NCT03330275|101406578|FG000|COMPLETED|Visits 2, 3 and 4 - Period 3||0||
48438642|NCT03330275|101406579|FG001|COMPLETED|Visits 2, 3 and 4 - Period 3||0||
48438643|NCT03330275|101406580|FG002|COMPLETED|Visits 2, 3 and 4 - Period 3||0||
48438644|NCT03330275|101406581|FG003|COMPLETED|Visits 2, 3 and 4 - Period 3||0||
48438645|NCT03330275|101406582|FG004|COMPLETED|Visits 2, 3 and 4 - Period 3||4||
48438646|NCT03330275|101406583|FG005|COMPLETED|Visits 2, 3 and 4 - Period 3||4||
48438647|NCT03330275|101406584|FG006|COMPLETED|Visits 2, 3 and 4 - Period 3||4||
48438648|NCT03330275|101406585|FG007|COMPLETED|Visits 2, 3 and 4 - Period 3||4||
48438649|NCT03330275|101406586|FG008|COMPLETED|Visits 2, 3 and 4 - Period 3||4||
48438650|NCT03330275|101406587|FG009|COMPLETED|Visits 2, 3 and 4 - Period 3||4||
48438651|NCT03330275|101406578|FG000|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0||
48438652|NCT03330275|101406579|FG001|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0||
48438653|NCT03330275|101406580|FG002|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0||
48438654|NCT03330275|101406581|FG003|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0||
48438655|NCT03330275|101406582|FG004|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0||
48438656|NCT03330275|101406583|FG005|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0||
48438657|NCT03330275|101406584|FG006|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0||
48438658|NCT03330275|101406585|FG007|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0||
48438659|NCT03330275|101406586|FG008|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0||
48438660|NCT03330275|101406587|FG009|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0||
48438661|NCT03179462|101406588|FG000|STARTED|Overall Study||9||
48438662|NCT03179462|101406589|FG001|STARTED|Overall Study||10||
48438663|NCT03179462|101406590|FG002|STARTED|Overall Study||8||
48438664|NCT03179462|101406588|FG000|COMPLETED|Overall Study||8||
48438665|NCT03179462|101406589|FG001|COMPLETED|Overall Study||8||
48438666|NCT03179462|101406590|FG002|COMPLETED|Overall Study||8||
48438667|NCT03179462|101406588|FG000|NOT COMPLETED|Overall Study||1||
48438668|NCT03179462|101406589|FG001|NOT COMPLETED|Overall Study||2||
48438669|NCT03179462|101406590|FG002|NOT COMPLETED|Overall Study||0||
48438670|NCT00457249|101406591|FG000|STARTED|Overall Study||1170||
48438671|NCT00457249|101406592|FG001|STARTED|Overall Study||391||
48438672|NCT00457249|101406591|FG000|COMPLETED|Overall Study||1158||
48438673|NCT00457249|101406592|FG001|COMPLETED|Overall Study||389||
48438674|NCT00457249|101406591|FG000|NOT COMPLETED|Overall Study||12||
48438675|NCT00457249|101406592|FG001|NOT COMPLETED|Overall Study||2||
48438676|NCT01640964|101406593|FG000|STARTED|Overall Study||20||
48438677|NCT01640964|101406594|FG001|STARTED|Overall Study||20||
48438678|NCT01640964|101406595|FG002|STARTED|Overall Study||6||
48438679|NCT01640964|101406593|FG000|COMPLETED|Overall Study||19||
48438680|NCT01640964|101406594|FG001|COMPLETED|Overall Study||19||
48438681|NCT01640964|101406595|FG002|COMPLETED|Overall Study||3||
48766873|NCT04949490|102218518|FG004|STARTED|Subset Group B Immunogenicity Evaluation||22||
48766874|NCT04949490|102218519|FG005|STARTED|Subset Group B Immunogenicity Evaluation||11||
48766875|NCT04949490|102218514|FG000|COMPLETED|Subset Group B Immunogenicity Evaluation||0||
48766876|NCT04949490|102218515|FG001|COMPLETED|Subset Group B Immunogenicity Evaluation||0||
48766877|NCT04949490|102218516|FG002|COMPLETED|Subset Group B Immunogenicity Evaluation||0||
48766878|NCT04949490|102218517|FG003|COMPLETED|Subset Group B Immunogenicity Evaluation||0||
48438682|NCT01640964|101406593|FG000|NOT COMPLETED|Overall Study||1||
48438683|NCT01640964|101406594|FG001|NOT COMPLETED|Overall Study||1||
48438684|NCT01640964|101406595|FG002|NOT COMPLETED|Overall Study||3||
48438685|NCT00798161|101406596|FG000|STARTED|Overall Study||72||
48438686|NCT00798161|101406597|FG001|STARTED|Overall Study||144||
48438687|NCT00798161|101406598|FG002|STARTED|Overall Study||147||
48438688|NCT00798161|101406599|FG003|STARTED|Overall Study||142||
48438689|NCT00798161|101406600|FG004|STARTED|Overall Study||143||
48438690|NCT00798161|101406601|FG005|STARTED|Overall Study||143||
48438691|NCT00798161|101406602|FG006|STARTED|Overall Study||66||
48438692|NCT00798161|101406596|FG000|COMPLETED|Overall Study||54||
48438693|NCT00798161|101406597|FG001|COMPLETED|Overall Study||127||
48438694|NCT00798161|101406598|FG002|COMPLETED|Overall Study||126||
48438695|NCT00798161|101406599|FG003|COMPLETED|Overall Study||121||
48438696|NCT00798161|101406600|FG004|COMPLETED|Overall Study||127||
48438697|NCT00798161|101406601|FG005|COMPLETED|Overall Study||132||
48438698|NCT00798161|101406602|FG006|COMPLETED|Overall Study||56||
48438699|NCT00798161|101406596|FG000|NOT COMPLETED|Overall Study||18||
48438700|NCT00798161|101406597|FG001|NOT COMPLETED|Overall Study||17||
48438701|NCT00798161|101406598|FG002|NOT COMPLETED|Overall Study||21||
48438702|NCT00798161|101406599|FG003|NOT COMPLETED|Overall Study||21||
48438703|NCT00798161|101406600|FG004|NOT COMPLETED|Overall Study||16||
48438704|NCT00798161|101406601|FG005|NOT COMPLETED|Overall Study||11||
48438705|NCT00798161|101406602|FG006|NOT COMPLETED|Overall Study||10||
48438706|NCT03930615|101406603|FG000|STARTED|Overall Study||145|Randomized|
48438707|NCT03930615|101406604|FG001|STARTED|Overall Study||75|Randomized|
48438708|NCT03930615|101406603|FG000|Treated|Overall Study||144||
48438709|NCT03930615|101406604|FG001|Treated|Overall Study||74||
48438710|NCT03930615|101406603|FG000|COMPLETED|Overall Study||118||
48766879|NCT04949490|102218518|FG004|COMPLETED|Subset Group B Immunogenicity Evaluation||21||
48766880|NCT04949490|102218519|FG005|COMPLETED|Subset Group B Immunogenicity Evaluation||9||
48438711|NCT03930615|101406604|FG001|COMPLETED|Overall Study||63||
48438712|NCT03930615|101406603|FG000|NOT COMPLETED|Overall Study||27||
48766881|NCT04949490|102218514|FG000|NOT COMPLETED|Subset Group B Immunogenicity Evaluation||0||
48766882|NCT04949490|102218515|FG001|NOT COMPLETED|Subset Group B Immunogenicity Evaluation||0||
48438713|NCT03930615|101406604|FG001|NOT COMPLETED|Overall Study||12||
48438714|NCT03574818|101406605|FG000|STARTED|Overall Study||1||
48438715|NCT03574818|101406605|FG000|COMPLETED|Overall Study||1||
48438716|NCT03574818|101406605|FG000|NOT COMPLETED|Overall Study||0||
48438717|NCT00514501|101406606|FG000|STARTED|Overall Study||510||
48438718|NCT00514501|101406606|FG000|COMPLETED|Overall Study||507||
48438719|NCT00514501|101406606|FG000|NOT COMPLETED|Overall Study||3||
48438720|NCT00919932|101406607|FG000|STARTED|Overall Study||4||
48438721|NCT00919932|101406608|FG001|STARTED|Overall Study||5||
48438722|NCT00919932|101406607|FG000|COMPLETED|Overall Study||4||
48438723|NCT00919932|101406608|FG001|COMPLETED|Overall Study||5||
48438724|NCT00919932|101406607|FG000|NOT COMPLETED|Overall Study||0||
48438725|NCT00919932|101406608|FG001|NOT COMPLETED|Overall Study||0||
48438726|NCT01371981|101406609|FG000|STARTED|Overall Study||580||
48438727|NCT01371981|101406610|FG001|STARTED|Overall Study||591||
48438728|NCT01371981|101406611|FG002|STARTED|Overall Study||12||
48438729|NCT01371981|101406612|FG003|STARTED|Overall Study||33||
48438730|NCT01371981|101406613|FG004|STARTED|Overall Study||47||
48438731|NCT01371981|101406614|FG005|STARTED|Overall Study||382||
48438732|NCT01371981|101406609|FG000|COMPLETED|Overall Study||396||
48438733|NCT01371981|101406610|FG001|COMPLETED|Overall Study||399||
48438734|NCT01371981|101406611|FG002|COMPLETED|Overall Study||6||
48438735|NCT01371981|101406612|FG003|COMPLETED|Overall Study||12||
48438736|NCT01371981|101406613|FG004|COMPLETED|Overall Study||15||
48438737|NCT01371981|101406614|FG005|COMPLETED|Overall Study||368||
48438738|NCT01371981|101406609|FG000|NOT COMPLETED|Overall Study||184||
48438739|NCT01371981|101406610|FG001|NOT COMPLETED|Overall Study||192||
48438740|NCT01371981|101406611|FG002|NOT COMPLETED|Overall Study||6||
48438741|NCT01371981|101406612|FG003|NOT COMPLETED|Overall Study||21||
48438742|NCT01371981|101406613|FG004|NOT COMPLETED|Overall Study||32||
48438743|NCT01371981|101406614|FG005|NOT COMPLETED|Overall Study||14||
48438744|NCT06067191|101406615|FG000|STARTED|Overall Study||39||
48438745|NCT06067191|101406616|FG001|STARTED|Overall Study||40||
48438746|NCT06067191|101406615|FG000|COMPLETED|Overall Study||39||
48438747|NCT06067191|101406616|FG001|COMPLETED|Overall Study||39||
48438748|NCT06067191|101406615|FG000|NOT COMPLETED|Overall Study||0||
48766883|NCT04949490|102218516|FG002|NOT COMPLETED|Subset Group B Immunogenicity Evaluation||0||
48766884|NCT04949490|102218517|FG003|NOT COMPLETED|Subset Group B Immunogenicity Evaluation||0||
48367861|NCT01847638|101230068|FG000|NOT COMPLETED|Overall Study||0||
48438749|NCT06067191|101406616|FG001|NOT COMPLETED|Overall Study||1||
48438750|NCT00026312|101406617|FG000|STARTED|Overall Study||116||
48656606|NCT00588770|101943679|FG000|Start Protocol Therapy|Overall Study||200||
48656607|NCT00588770|101943680|FG001|Start Protocol Therapy|Overall Study||194||
48656608|NCT00588770|101943679|FG000|COMPLETED|Overall Study||41||
48656609|NCT00588770|101943680|FG001|COMPLETED|Overall Study||3||
48656610|NCT00588770|101943679|FG000|NOT COMPLETED|Overall Study||159||
48656611|NCT00588770|101943680|FG001|NOT COMPLETED|Overall Study||200||
48656612|NCT06003829|101943681|FG000|STARTED|Period 1 (Day 1 of the Study)||3||
48656613|NCT06003829|101943682|FG001|STARTED|Period 1 (Day 1 of the Study)||3||
48656614|NCT06003829|101943683|FG002|STARTED|Period 1 (Day 1 of the Study)||3||
48656615|NCT06003829|101943684|FG003|STARTED|Period 1 (Day 1 of the Study)||3||
48766885|NCT04949490|102218518|FG004|NOT COMPLETED|Subset Group B Immunogenicity Evaluation||1||
48367862|NCT01847638|101230069|FG001|NOT COMPLETED|Overall Study||0||
48367863|NCT02375698|101230070|FG000|STARTED|Overall Study||16||
48367864|NCT02375698|101230071|FG001|STARTED|Overall Study||6||
48367865|NCT02375698|101230070|FG000|COMPLETED|Overall Study||14||
48367866|NCT02375698|101230071|FG001|COMPLETED|Overall Study||4||
48438751|NCT00026312|101406618|FG001|STARTED|Overall Study||1333||
48438752|NCT00026312|101406617|FG000|COMPLETED|Overall Study||82||
48438753|NCT00026312|101406618|FG001|COMPLETED|Overall Study||1064||
48438754|NCT00026312|101406617|FG000|NOT COMPLETED|Overall Study||34||
48438755|NCT00026312|101406618|FG001|NOT COMPLETED|Overall Study||269||
48438756|NCT03345485|101406619|FG000|STARTED|Overall Study||3|Patients Treated|
48438757|NCT03345485|101406620|FG001|STARTED|Overall Study||3|Patients Treated|
48438758|NCT03345485|101406621|FG002|STARTED|Overall Study||3|Patients Treated|
48438759|NCT03345485|101406622|FG003|STARTED|Overall Study||3|Patients Treated|
48438760|NCT03345485|101406623|FG004|STARTED|Overall Study||8|Patients Treated|
48438761|NCT03345485|101406624|FG005|STARTED|Overall Study||2|Patients Treated|
48367867|NCT02375698|101230070|FG000|NOT COMPLETED|Overall Study||2||
48367868|NCT02375698|101230071|FG001|NOT COMPLETED|Overall Study||2||
48367869|NCT00301067|101230072|FG000|STARTED|Completed DLT Period/1st Cycle||4||
48367870|NCT00301067|101230073|FG001|STARTED|Completed DLT Period/1st Cycle||3||
48367871|NCT00301067|101230074|FG002|STARTED|Completed DLT Period/1st Cycle||3||
48367872|NCT00301067|101230075|FG003|STARTED|Completed DLT Period/1st Cycle||10||
48367873|NCT00301067|101230072|FG000|COMPLETED|Completed DLT Period/1st Cycle||3||
48438762|NCT03345485|101406625|FG006|STARTED|Overall Study||4|Patients Treated|
48438763|NCT03345485|101406626|FG007|STARTED|Overall Study||10|Patients Treated|
48438764|NCT03345485|101406627|FG008|STARTED|Overall Study||4|Patients Treated|
48438765|NCT03345485|101406628|FG009|STARTED|Overall Study||12|Patients Treated|
48438766|NCT03345485|101406629|FG010|STARTED|Overall Study||6|Patients Treated|
48438767|NCT03345485|101406630|FG011|STARTED|Overall Study||6|Patients Treated|
48438768|NCT03345485|101406631|FG012|STARTED|Overall Study||7|Patients Treated|
48440005|NCT04854421|101410007|FG000|COMPLETED|Overall Study||52||
48656616|NCT06003829|101943681|FG000|COMPLETED|Period 1 (Day 1 of the Study)||3||
48656617|NCT06003829|101943682|FG001|COMPLETED|Period 1 (Day 1 of the Study)||3||
48438769|NCT03345485|101406619|FG000|COMPLETED|Overall Study||3|Phase 1: Patients are reported as completed if they have completed cycle 1. Phase 2: Patients who have at least 1 post-baseline tumour response assessment is reported as completed.|
48438770|NCT03345485|101406620|FG001|COMPLETED|Overall Study||3|Phase 1: Patients are reported as completed if they have completed cycle 1. Phase 2: Patients who have at least 1 post-baseline tumour response assessment is reported as completed.|
48438771|NCT03345485|101406621|FG002|COMPLETED|Overall Study||3|Phase 1: Patients are reported as completed if they have completed cycle 1. Phase 2: Patients who have at least 1 post-baseline tumour response assessment is reported as completed.|
48438772|NCT03345485|101406622|FG003|COMPLETED|Overall Study||3|Phase 1: Patients are reported as completed if they have completed cycle 1. Phase 2: Patients who have at least 1 post-baseline tumour response assessment is reported as completed.|
48438773|NCT03345485|101406623|FG004|COMPLETED|Overall Study||8|Phase 1: Patients are reported as completed if they have completed cycle 1. Phase 2: Patients who have at least 1 post-baseline tumour response assessment is reported as completed.|
48438774|NCT03345485|101406624|FG005|COMPLETED|Overall Study||2|Phase 1: Patients are reported as completed if they have completed cycle 1. Phase 2: Patients who have at least 1 post-baseline tumour response assessment is reported as completed.|
48438775|NCT03345485|101406625|FG006|COMPLETED|Overall Study||3|Phase 1: Patients are reported as completed if they have completed cycle 1. Phase 2: Patients who have at least 1 post-baseline tumour response assessment is reported as completed.|
48438776|NCT03345485|101406626|FG007|COMPLETED|Overall Study||8|Phase 1: Patients are reported as completed if they have completed cycle 1. Phase 2: Patients who have at least 1 post-baseline tumour response assessment is reported as completed.|
48656618|NCT06003829|101943683|FG002|COMPLETED|Period 1 (Day 1 of the Study)||3||
48656619|NCT06003829|101943684|FG003|COMPLETED|Period 1 (Day 1 of the Study)||3||
48656620|NCT06003829|101943681|FG000|NOT COMPLETED|Period 1 (Day 1 of the Study)||0||
48656621|NCT06003829|101943682|FG001|NOT COMPLETED|Period 1 (Day 1 of the Study)||0||
48656622|NCT06003829|101943683|FG002|NOT COMPLETED|Period 1 (Day 1 of the Study)||0||
48656623|NCT06003829|101943684|FG003|NOT COMPLETED|Period 1 (Day 1 of the Study)||0||
48656624|NCT06003829|101943681|FG000|STARTED|Period 2 (Day 1 of the Study)||3||
48656625|NCT06003829|101943682|FG001|STARTED|Period 2 (Day 1 of the Study)||3||
48656626|NCT06003829|101943683|FG002|STARTED|Period 2 (Day 1 of the Study)||3||
48656627|NCT06003829|101943684|FG003|STARTED|Period 2 (Day 1 of the Study)||3||
48656628|NCT06003829|101943681|FG000|COMPLETED|Period 2 (Day 1 of the Study)||3||
48656629|NCT06003829|101943682|FG001|COMPLETED|Period 2 (Day 1 of the Study)||3||
48656630|NCT06003829|101943683|FG002|COMPLETED|Period 2 (Day 1 of the Study)||3||
48656631|NCT06003829|101943684|FG003|COMPLETED|Period 2 (Day 1 of the Study)||3||
48766886|NCT04949490|102218519|FG005|NOT COMPLETED|Subset Group B Immunogenicity Evaluation||2||
48766887|NCT01101867|102218520|FG000|STARTED|Overall Study||63||
48766888|NCT01101867|102218521|FG001|STARTED|Overall Study||63||
48766889|NCT01101867|102218520|FG000|COMPLETED|Overall Study||62||
48766890|NCT01101867|102218521|FG001|COMPLETED|Overall Study||59||
48766891|NCT01101867|102218520|FG000|NOT COMPLETED|Overall Study||1||
48766892|NCT01101867|102218521|FG001|NOT COMPLETED|Overall Study||4||
48766893|NCT03523988|102218522|FG000|STARTED|Overall Study||24||
48766894|NCT03523988|102218523|FG001|STARTED|Overall Study||24||
48766895|NCT03523988|102218524|FG002|STARTED|Overall Study||25||
48766896|NCT03523988|102218522|FG000|COMPLETED|Overall Study||7||
48766897|NCT03523988|102218523|FG001|COMPLETED|Overall Study||8||
48766898|NCT03523988|102218524|FG002|COMPLETED|Overall Study||7||
48766899|NCT03523988|102218522|FG000|NOT COMPLETED|Overall Study||17||
48766900|NCT03523988|102218523|FG001|NOT COMPLETED|Overall Study||16||
48766901|NCT03523988|102218524|FG002|NOT COMPLETED|Overall Study||18||
48766902|NCT01352793|102218525|FG000|STARTED|Overall Study||3804||
48766903|NCT01352793|102218526|FG001|STARTED|Overall Study||1908||
48766904|NCT01352793|102218525|FG000|Vaccination 1|Overall Study||3796||
48766905|NCT01352793|102218526|FG001|Vaccination 1|Overall Study||1908||
48766906|NCT01352793|102218525|FG000|Vaccination 2|Overall Study||3530||
48766907|NCT01352793|102218526|FG001|Vaccination 2|Overall Study||1806||
48766908|NCT01352793|102218525|FG000|Vaccination 3|Overall Study||3314||
48766909|NCT01352793|102218526|FG001|Vaccination 3|Overall Study||1710||
48766910|NCT01352793|102218525|FG000|COMPLETED|Overall Study||3219||
48766911|NCT01352793|102218526|FG001|COMPLETED|Overall Study||1663||
48766912|NCT01352793|102218525|FG000|NOT COMPLETED|Overall Study||585||
48766913|NCT01352793|102218526|FG001|NOT COMPLETED|Overall Study||245||
48766914|NCT02135432|102218527|FG000|STARTED|Overall Study||8||
48766915|NCT02135432|102218528|FG001|STARTED|Overall Study||4||
48766916|NCT02135432|102218527|FG000|COMPLETED|Overall Study||8||
48766917|NCT02135432|102218528|FG001|COMPLETED|Overall Study||4||
48766918|NCT02135432|102218527|FG000|NOT COMPLETED|Overall Study||0||
48766919|NCT02135432|102218528|FG001|NOT COMPLETED|Overall Study||0||
48766920|NCT00646048|102218529|FG000|STARTED|Overall Study||43||
48766921|NCT00646048|102218529|FG000|COMPLETED|Overall Study||27||
48766922|NCT00646048|102218529|FG000|NOT COMPLETED|Overall Study||16||
48766923|NCT01094119|102218530|FG000|STARTED|Overall Study||34||
48656632|NCT06003829|101943681|FG000|NOT COMPLETED|Period 2 (Day 1 of the Study)||0||
48656633|NCT06003829|101943682|FG001|NOT COMPLETED|Period 2 (Day 1 of the Study)||0||
48656634|NCT06003829|101943683|FG002|NOT COMPLETED|Period 2 (Day 1 of the Study)||0||
48766924|NCT01094119|102218531|FG001|STARTED|Overall Study||36||
48766925|NCT01094119|102218530|FG000|COMPLETED|Overall Study||32||
48766926|NCT01094119|102218531|FG001|COMPLETED|Overall Study||32||
48766927|NCT01094119|102218530|FG000|NOT COMPLETED|Overall Study||2||
48438777|NCT03345485|101406627|FG008|COMPLETED|Overall Study||4|Phase 1: Patients are reported as completed if they have completed cycle 1. Phase 2: Patients who have at least 1 post-baseline tumour response assessment is reported as completed.|
48438778|NCT03345485|101406628|FG009|COMPLETED|Overall Study||12|Phase 1: Patients are reported as completed if they have completed cycle 1. Phase 2: Patients who have at least 1 post-baseline tumour response assessment is reported as completed.|
48438779|NCT03345485|101406629|FG010|COMPLETED|Overall Study||4|Phase 1: Patients are reported as completed if they have completed cycle 1. Phase 2: Patients who have at least 1 post-baseline tumour response assessment is reported as completed.|
48438780|NCT03345485|101406630|FG011|COMPLETED|Overall Study||3|Phase 1: Patients are reported as completed if they have completed cycle 1. Phase 2: Patients who have at least 1 post-baseline tumour response assessment is reported as completed.|
48438781|NCT03345485|101406631|FG012|COMPLETED|Overall Study||4|Phase 1: Patients are reported as completed if they have completed cycle 1. Phase 2: Patients who have at least 1 post-baseline tumour response assessment is reported as completed.|
48438782|NCT03345485|101406619|FG000|NOT COMPLETED|Overall Study||0||
48438783|NCT03345485|101406620|FG001|NOT COMPLETED|Overall Study||0||
48438784|NCT03345485|101406621|FG002|NOT COMPLETED|Overall Study||0||
48438785|NCT03345485|101406622|FG003|NOT COMPLETED|Overall Study||0||
48438786|NCT03345485|101406623|FG004|NOT COMPLETED|Overall Study||0||
48438787|NCT03345485|101406624|FG005|NOT COMPLETED|Overall Study||0||
48438788|NCT03345485|101406625|FG006|NOT COMPLETED|Overall Study||1||
48438789|NCT03345485|101406626|FG007|NOT COMPLETED|Overall Study||2||
48766928|NCT01094119|102218531|FG001|NOT COMPLETED|Overall Study||4||
48766929|NCT02177032|102218532|FG000|STARTED|Overall Study||355||
48766930|NCT02177032|102218533|FG001|STARTED|Overall Study||88||
48766931|NCT02177032|102218534|FG002|STARTED|Overall Study||354||
48766932|NCT02177032|102218535|FG003|STARTED|Overall Study||88||
48766933|NCT02177032|102218532|FG000|COMPLETED|Overall Study||350||
48766934|NCT02177032|102218533|FG001|COMPLETED|Overall Study||86||
48766935|NCT02177032|102218534|FG002|COMPLETED|Overall Study||351||
48766936|NCT02177032|102218535|FG003|COMPLETED|Overall Study||88||
48766937|NCT02177032|102218532|FG000|NOT COMPLETED|Overall Study||5||
48766938|NCT02177032|102218533|FG001|NOT COMPLETED|Overall Study||2||
48766939|NCT02177032|102218534|FG002|NOT COMPLETED|Overall Study||3||
48766940|NCT02177032|102218535|FG003|NOT COMPLETED|Overall Study||0||
48766941|NCT01582477|102218536|FG000|STARTED|Overall Study||12||
48766942|NCT01582477|102218537|FG001|STARTED|Overall Study||12||
48766943|NCT01582477|102218536|FG000|COMPLETED|Overall Study||12||
48766944|NCT01582477|102218537|FG001|COMPLETED|Overall Study||12||
48766945|NCT01582477|102218536|FG000|NOT COMPLETED|Overall Study||0||
48766946|NCT01582477|102218537|FG001|NOT COMPLETED|Overall Study||0||
48766947|NCT01108185|102218538|FG000|STARTED|Overall Study||3181||
48766948|NCT01108185|102218538|FG000|Per Protocol Population|Overall Study||3181||
48766949|NCT01108185|102218538|FG000|COMPLETED|Overall Study||3154||
48766950|NCT01108185|102218538|FG000|NOT COMPLETED|Overall Study||27||
48766951|NCT03774576|102218539|FG000|STARTED|Period 1||14||
48766952|NCT03774576|102218539|FG000|COMPLETED|Period 1||14||
48766953|NCT03774576|102218539|FG000|NOT COMPLETED|Period 1||0||
48766954|NCT03774576|102218539|FG000|STARTED|Period 2||14||
48766955|NCT03774576|102218539|FG000|COMPLETED|Period 2||13||
48766956|NCT03774576|102218539|FG000|NOT COMPLETED|Period 2||1||
48766957|NCT02540629|102218540|FG000|STARTED|Overall Study||6201||
48766958|NCT02540629|102218541|FG001|STARTED|Overall Study||6469||
48766959|NCT02540629|102218540|FG000|COMPLETED|Overall Study||6201||
48766960|NCT02540629|102218541|FG001|COMPLETED|Overall Study||6469||
48438790|NCT03345485|101406627|FG008|NOT COMPLETED|Overall Study||0||
48438791|NCT03345485|101406628|FG009|NOT COMPLETED|Overall Study||0||
48438792|NCT03345485|101406629|FG010|NOT COMPLETED|Overall Study||2||
48438793|NCT03345485|101406630|FG011|NOT COMPLETED|Overall Study||3||
48438794|NCT03345485|101406631|FG012|NOT COMPLETED|Overall Study||3||
48438795|NCT04431960|101406632|FG000|STARTED|Overall Study||17||
48438796|NCT04431960|101406633|FG001|STARTED|Overall Study||16||
48766961|NCT02540629|102218540|FG000|NOT COMPLETED|Overall Study||0||
48766962|NCT02540629|102218541|FG001|NOT COMPLETED|Overall Study||0||
48766963|NCT04960202|102218542|FG000|STARTED|Overall Study||1120||
48766964|NCT04960202|102218543|FG001|STARTED|Overall Study||1126||
48766965|NCT04960202|102218542|FG000|Treated|Overall Study||1109||
48766966|NCT04960202|102218543|FG001|Treated|Overall Study||1115||
48766967|NCT04960202|102218542|FG000|COMPLETED|Overall Study||1045||
48766968|NCT04960202|102218543|FG001|COMPLETED|Overall Study||1039||
48766969|NCT04960202|102218542|FG000|NOT COMPLETED|Overall Study||75||
48766970|NCT04960202|102218543|FG001|NOT COMPLETED|Overall Study||87||
48438797|NCT04431960|101406634|FG002|STARTED|Overall Study||18||
48438798|NCT04431960|101406632|FG000|COMPLETED|Overall Study||16||
48438799|NCT04431960|101406633|FG001|COMPLETED|Overall Study||11||
48438800|NCT04431960|101406634|FG002|COMPLETED|Overall Study||13||
48438801|NCT04431960|101406632|FG000|NOT COMPLETED|Overall Study||1||
48438802|NCT04431960|101406633|FG001|NOT COMPLETED|Overall Study||5||
48438803|NCT04431960|101406634|FG002|NOT COMPLETED|Overall Study||5||
48438804|NCT02195921|101406635|FG000|STARTED|Overall Study||40||
48766971|NCT00414596|102218544|FG000|STARTED|Overall Study||20||
48766972|NCT00414596|102218544|FG000|COMPLETED|Overall Study||18||
48766973|NCT00414596|102218544|FG000|NOT COMPLETED|Overall Study||2||
48766974|NCT04313244|102218545|FG000|STARTED|Overall Study||307||
48766975|NCT04313244|102218546|FG001|STARTED|Overall Study||307||
48766976|NCT04313244|102218545|FG000|COMPLETED|Overall Study||302||
48766977|NCT04313244|102218546|FG001|COMPLETED|Overall Study||304||
48766978|NCT04313244|102218545|FG000|NOT COMPLETED|Overall Study||5||
48766979|NCT04313244|102218546|FG001|NOT COMPLETED|Overall Study||3||
48766980|NCT02937116|102218547|FG000|STARTED|Overall Study||3||
48766981|NCT02937116|102218548|FG001|STARTED|Overall Study||3||
48766982|NCT02937116|102218549|FG002|STARTED|Overall Study||3||
48766983|NCT02937116|102218550|FG003|STARTED|Overall Study||3||
48766984|NCT02937116|102218551|FG004|STARTED|Overall Study||22||
48438805|NCT02195921|101406636|FG001|STARTED|Overall Study||40||
48438806|NCT02195921|101406637|FG002|STARTED|Overall Study||40||
48438807|NCT02195921|101406638|FG003|STARTED|Overall Study||40||
48438808|NCT02195921|101406635|FG000|COMPLETED|Overall Study||39||
48438809|NCT02195921|101406636|FG001|COMPLETED|Overall Study||39||
48438810|NCT02195921|101406637|FG002|COMPLETED|Overall Study||39||
48438811|NCT02195921|101406638|FG003|COMPLETED|Overall Study||40||
48438812|NCT02195921|101406635|FG000|NOT COMPLETED|Overall Study||1||
48438813|NCT02195921|101406636|FG001|NOT COMPLETED|Overall Study||1||
48438814|NCT02195921|101406637|FG002|NOT COMPLETED|Overall Study||1||
48656635|NCT06003829|101943684|FG003|NOT COMPLETED|Period 2 (Day 1 of the Study)||0||
48656636|NCT06003829|101943681|FG000|STARTED|Period 3 (Day 1 of the Study)||3||
48656637|NCT06003829|101943682|FG001|STARTED|Period 3 (Day 1 of the Study)||3||
48656638|NCT06003829|101943683|FG002|STARTED|Period 3 (Day 1 of the Study)||3||
48656639|NCT06003829|101943684|FG003|STARTED|Period 3 (Day 1 of the Study)||3||
48656640|NCT06003829|101943681|FG000|COMPLETED|Period 3 (Day 1 of the Study)||3||
48656641|NCT06003829|101943682|FG001|COMPLETED|Period 3 (Day 1 of the Study)||3||
48656642|NCT06003829|101943683|FG002|COMPLETED|Period 3 (Day 1 of the Study)||3||
48656643|NCT06003829|101943684|FG003|COMPLETED|Period 3 (Day 1 of the Study)||3||
48656644|NCT06003829|101943681|FG000|NOT COMPLETED|Period 3 (Day 1 of the Study)||0||
48656645|NCT06003829|101943682|FG001|NOT COMPLETED|Period 3 (Day 1 of the Study)||0||
48656646|NCT06003829|101943683|FG002|NOT COMPLETED|Period 3 (Day 1 of the Study)||0||
48656647|NCT06003829|101943684|FG003|NOT COMPLETED|Period 3 (Day 1 of the Study)||0||
48656648|NCT06003829|101943681|FG000|STARTED|Period 4 (Day 1 of the Study)||3||
48656649|NCT06003829|101943682|FG001|STARTED|Period 4 (Day 1 of the Study)||3||
48656650|NCT06003829|101943683|FG002|STARTED|Period 4 (Day 1 of the Study)||3||
48656651|NCT06003829|101943684|FG003|STARTED|Period 4 (Day 1 of the Study)||3||
48656652|NCT06003829|101943681|FG000|COMPLETED|Period 4 (Day 1 of the Study)||3||
48656653|NCT06003829|101943682|FG001|COMPLETED|Period 4 (Day 1 of the Study)||3||
48656654|NCT06003829|101943683|FG002|COMPLETED|Period 4 (Day 1 of the Study)||3||
48656655|NCT06003829|101943684|FG003|COMPLETED|Period 4 (Day 1 of the Study)||3||
48656656|NCT06003829|101943681|FG000|NOT COMPLETED|Period 4 (Day 1 of the Study)||0||
48656657|NCT06003829|101943682|FG001|NOT COMPLETED|Period 4 (Day 1 of the Study)||0||
48656658|NCT06003829|101943683|FG002|NOT COMPLETED|Period 4 (Day 1 of the Study)||0||
48766985|NCT02937116|102218552|FG005|STARTED|Overall Study||87||
48766986|NCT02937116|102218553|FG006|STARTED|Overall Study||37||
48766987|NCT02937116|102218554|FG007|STARTED|Overall Study||21||
48766988|NCT02937116|102218555|FG008|STARTED|Overall Study||20||
48766989|NCT02937116|102218556|FG009|STARTED|Overall Study||20||
48766990|NCT02937116|102218557|FG010|STARTED|Overall Study||7||
48766991|NCT02937116|102218558|FG011|STARTED|Overall Study||7||
48766992|NCT02937116|102218547|FG000|COMPLETED|Overall Study||0||
48766993|NCT02937116|102218548|FG001|COMPLETED|Overall Study||0||
48656659|NCT06003829|101943684|FG003|NOT COMPLETED|Period 4 (Day 1 of the Study)||0||
48656660|NCT06003829|101943681|FG000|STARTED|Period 5 (Day 2 of the Study)||3||
48656661|NCT06003829|101943682|FG001|STARTED|Period 5 (Day 2 of the Study)||3||
48656662|NCT06003829|101943683|FG002|STARTED|Period 5 (Day 2 of the Study)||3||
48656663|NCT06003829|101943684|FG003|STARTED|Period 5 (Day 2 of the Study)||3||
48656664|NCT06003829|101943681|FG000|COMPLETED|Period 5 (Day 2 of the Study)||3||
48656665|NCT06003829|101943682|FG001|COMPLETED|Period 5 (Day 2 of the Study)||3||
48656666|NCT06003829|101943683|FG002|COMPLETED|Period 5 (Day 2 of the Study)||3||
48656667|NCT06003829|101943684|FG003|COMPLETED|Period 5 (Day 2 of the Study)||3||
48766994|NCT02937116|102218549|FG002|COMPLETED|Overall Study||0||
48766995|NCT02937116|102218550|FG003|COMPLETED|Overall Study||0||
48766996|NCT02937116|102218551|FG004|COMPLETED|Overall Study||0||
48766997|NCT02937116|102218552|FG005|COMPLETED|Overall Study||0||
48438815|NCT02195921|101406638|FG003|NOT COMPLETED|Overall Study||0||
48438816|NCT03099161|101406639|FG000|STARTED|Overall Study||3||
48438817|NCT03099161|101406640|FG001|STARTED|Overall Study||4||
48438818|NCT03099161|101406641|FG002|STARTED|Overall Study||3||
48438819|NCT03099161|101406639|FG000|COMPLETED|Overall Study||0||
48438820|NCT03099161|101406640|FG001|COMPLETED|Overall Study||0||
48438821|NCT03099161|101406641|FG002|COMPLETED|Overall Study||0||
48438822|NCT03099161|101406639|FG000|NOT COMPLETED|Overall Study||3||
48438823|NCT03099161|101406640|FG001|NOT COMPLETED|Overall Study||4||
48766998|NCT02937116|102218553|FG006|COMPLETED|Overall Study||0||
48766999|NCT02937116|102218554|FG007|COMPLETED|Overall Study||0||
48767000|NCT02937116|102218555|FG008|COMPLETED|Overall Study||0||
48438824|NCT03099161|101406641|FG002|NOT COMPLETED|Overall Study||3||
48438825|NCT00609115|101406642|FG000|STARTED|Controlled Period||44||
48438826|NCT00609115|101406643|FG001|STARTED|Controlled Period||39||
48438827|NCT00609115|101406644|FG002|STARTED|Controlled Period||0||
48767001|NCT02937116|102218556|FG009|COMPLETED|Overall Study||0||
48767002|NCT02937116|102218557|FG010|COMPLETED|Overall Study||0||
48767003|NCT02937116|102218558|FG011|COMPLETED|Overall Study||0||
48767004|NCT02937116|102218547|FG000|NOT COMPLETED|Overall Study||3||
48767005|NCT02937116|102218548|FG001|NOT COMPLETED|Overall Study||3||
48367874|NCT00301067|101230073|FG001|COMPLETED|Completed DLT Period/1st Cycle||3||
48438828|NCT00609115|101406642|FG000|COMPLETED|Controlled Period||38||
48438829|NCT00609115|101406643|FG001|COMPLETED|Controlled Period||35||
48438830|NCT00609115|101406644|FG002|COMPLETED|Controlled Period||0||
48438831|NCT00609115|101406642|FG000|NOT COMPLETED|Controlled Period||6||
48438832|NCT00609115|101406643|FG001|NOT COMPLETED|Controlled Period||4||
48438833|NCT00609115|101406644|FG002|NOT COMPLETED|Controlled Period||0||
48438834|NCT00609115|101406642|FG000|STARTED|Crossover Period||0||
48438835|NCT00609115|101406643|FG001|STARTED|Crossover Period||0||
48438836|NCT00609115|101406644|FG002|STARTED|Crossover Period||27||
48438837|NCT00609115|101406642|FG000|COMPLETED|Crossover Period||0||
48438838|NCT00609115|101406643|FG001|COMPLETED|Crossover Period||0||
48438839|NCT00609115|101406644|FG002|COMPLETED|Crossover Period||22||
48438840|NCT00609115|101406642|FG000|NOT COMPLETED|Crossover Period||0||
48438841|NCT00609115|101406643|FG001|NOT COMPLETED|Crossover Period||0||
48438842|NCT00609115|101406644|FG002|NOT COMPLETED|Crossover Period||5||
48438843|NCT01569594|101406645|FG000|STARTED|Overall Study||230||
48438844|NCT01569594|101406645|FG000|COMPLETED|Overall Study||163||
48438845|NCT01569594|101406645|FG000|NOT COMPLETED|Overall Study||67||
48438846|NCT03506724|101406646|FG000|STARTED|Overall Study||54||
48438847|NCT03506724|101406647|FG001|STARTED|Overall Study||55||
48438848|NCT03506724|101406646|FG000|COMPLETED|Overall Study||54||
48438849|NCT03506724|101406647|FG001|COMPLETED|Overall Study||55||
48438850|NCT03506724|101406646|FG000|NOT COMPLETED|Overall Study||0||
48367875|NCT00301067|101230074|FG002|COMPLETED|Completed DLT Period/1st Cycle||3||
48367876|NCT00301067|101230075|FG003|COMPLETED|Completed DLT Period/1st Cycle||9||
48367877|NCT00301067|101230072|FG000|NOT COMPLETED|Completed DLT Period/1st Cycle||1||
48367878|NCT00301067|101230073|FG001|NOT COMPLETED|Completed DLT Period/1st Cycle||0||
48367879|NCT00301067|101230074|FG002|NOT COMPLETED|Completed DLT Period/1st Cycle||0||
48367880|NCT00301067|101230075|FG003|NOT COMPLETED|Completed DLT Period/1st Cycle||1||
48367881|NCT00301067|101230072|FG000|STARTED|Reached 1st Response/2 Cycles||3||
48367882|NCT00301067|101230073|FG001|STARTED|Reached 1st Response/2 Cycles||3||
48367883|NCT00301067|101230074|FG002|STARTED|Reached 1st Response/2 Cycles||3||
48367884|NCT00301067|101230075|FG003|STARTED|Reached 1st Response/2 Cycles||9||
48367885|NCT00301067|101230072|FG000|COMPLETED|Reached 1st Response/2 Cycles||1||
48367886|NCT00301067|101230073|FG001|COMPLETED|Reached 1st Response/2 Cycles||2||
48367887|NCT00301067|101230074|FG002|COMPLETED|Reached 1st Response/2 Cycles||2||
48367888|NCT00301067|101230075|FG003|COMPLETED|Reached 1st Response/2 Cycles||7||
48438851|NCT03506724|101406647|FG001|NOT COMPLETED|Overall Study||0||
48438852|NCT00530621|101406648|FG000|STARTED|Overall Study||80||
48438853|NCT00530621|101406649|FG001|STARTED|Overall Study||80||
48438854|NCT00530621|101406648|FG000|Received at Least 1 Dose of Study Drug|Overall Study||79||
48438855|NCT00530621|101406649|FG001|Received at Least 1 Dose of Study Drug|Overall Study||80||
48438856|NCT00530621|101406648|FG000|COMPLETED|Overall Study||0||
48438857|NCT00530621|101406649|FG001|COMPLETED|Overall Study||0||
48438858|NCT00530621|101406648|FG000|NOT COMPLETED|Overall Study||80||
48438859|NCT00530621|101406649|FG001|NOT COMPLETED|Overall Study||80||
48438860|NCT01249625|101406650|FG000|STARTED|Overall Study||1374||
48438861|NCT01249625|101406651|FG001|STARTED|Overall Study||1488||
48438862|NCT01249625|101406650|FG000|COMPLETED|Overall Study||1374||
48438863|NCT01249625|101406651|FG001|COMPLETED|Overall Study||1488||
48438864|NCT01249625|101406650|FG000|NOT COMPLETED|Overall Study||0||
48438865|NCT01249625|101406651|FG001|NOT COMPLETED|Overall Study||0||
48438866|NCT00685763|101406652|FG000|STARTED|Overall Study||13||
48438867|NCT00685763|101406652|FG000|COMPLETED|Overall Study||11||
48438868|NCT00685763|101406652|FG000|NOT COMPLETED|Overall Study||2||
48438869|NCT01392469|101406653|FG000|STARTED|Overall Study||21||
48438870|NCT01392469|101406653|FG000|COMPLETED|Overall Study||17||
48767006|NCT02937116|102218549|FG002|NOT COMPLETED|Overall Study||3||
48767007|NCT02937116|102218550|FG003|NOT COMPLETED|Overall Study||3||
48767008|NCT02937116|102218551|FG004|NOT COMPLETED|Overall Study||22||
48767009|NCT02937116|102218552|FG005|NOT COMPLETED|Overall Study||87||
48767010|NCT02937116|102218553|FG006|NOT COMPLETED|Overall Study||37||
48767011|NCT02937116|102218554|FG007|NOT COMPLETED|Overall Study||21||
48767012|NCT02937116|102218555|FG008|NOT COMPLETED|Overall Study||20||
48767013|NCT02937116|102218556|FG009|NOT COMPLETED|Overall Study||20||
48438871|NCT01392469|101406653|FG000|NOT COMPLETED|Overall Study||4||
48438872|NCT03039686|101406654|FG000|STARTED|Double-blind Period||56||
48438873|NCT03039686|101406655|FG001|STARTED|Double-blind Period||55||
48438874|NCT03039686|101406656|FG002|STARTED|Double-blind Period||55||
48438875|NCT03039686|101406654|FG000|COMPLETED|Double-blind Period||29||
48438876|NCT03039686|101406655|FG001|COMPLETED|Double-blind Period||26||
48438877|NCT03039686|101406656|FG002|COMPLETED|Double-blind Period||32||
48438878|NCT03039686|101406654|FG000|NOT COMPLETED|Double-blind Period||27||
48438879|NCT03039686|101406655|FG001|NOT COMPLETED|Double-blind Period||29||
48438880|NCT03039686|101406656|FG002|NOT COMPLETED|Double-blind Period||23||
48438881|NCT03039686|101406654|FG000|STARTED|Open Label Period||0||
48188491|NCT04536025|100783256|FG001|COMPLETED|Overall Study||17||
48438882|NCT03039686|101406655|FG001|STARTED|Open Label Period||38||
48438883|NCT03039686|101406656|FG002|STARTED|Open Label Period||42||
48438884|NCT03039686|101406654|FG000|Completed DB, Did Not Start OL|Open Label Period||2||
48438885|NCT03039686|101406655|FG001|Completed DB, Did Not Start OL|Open Label Period||2||
48188492|NCT04536025|100783257|FG002|COMPLETED|Overall Study||11||
48188493|NCT04536025|100783255|FG000|NOT COMPLETED|Overall Study||0||
48188494|NCT04536025|100783256|FG001|NOT COMPLETED|Overall Study||0||
48188495|NCT04536025|100783257|FG002|NOT COMPLETED|Overall Study||0||
48188496|NCT04582045|100783258|FG000|STARTED|Overall Study||446||
48367889|NCT00301067|101230072|FG000|NOT COMPLETED|Reached 1st Response/2 Cycles||2||
48367890|NCT00301067|101230073|FG001|NOT COMPLETED|Reached 1st Response/2 Cycles||1||
48367891|NCT00301067|101230074|FG002|NOT COMPLETED|Reached 1st Response/2 Cycles||1||
48367892|NCT00301067|101230075|FG003|NOT COMPLETED|Reached 1st Response/2 Cycles||2||
48367893|NCT00301067|101230072|FG000|STARTED|Completed 4 Cycles of Treatment||1||
48367894|NCT00301067|101230073|FG001|STARTED|Completed 4 Cycles of Treatment||2||
48367895|NCT00301067|101230074|FG002|STARTED|Completed 4 Cycles of Treatment||2||
48367896|NCT00301067|101230075|FG003|STARTED|Completed 4 Cycles of Treatment||7||
48367897|NCT00301067|101230072|FG000|COMPLETED|Completed 4 Cycles of Treatment||0||
48367898|NCT00301067|101230073|FG001|COMPLETED|Completed 4 Cycles of Treatment||1||
48367899|NCT00301067|101230074|FG002|COMPLETED|Completed 4 Cycles of Treatment||0||
48367900|NCT00301067|101230075|FG003|COMPLETED|Completed 4 Cycles of Treatment||2||
48367901|NCT00301067|101230072|FG000|NOT COMPLETED|Completed 4 Cycles of Treatment||1||
48367902|NCT00301067|101230073|FG001|NOT COMPLETED|Completed 4 Cycles of Treatment||1||
48367903|NCT00301067|101230074|FG002|NOT COMPLETED|Completed 4 Cycles of Treatment||2||
48367904|NCT00301067|101230075|FG003|NOT COMPLETED|Completed 4 Cycles of Treatment||5||
48367905|NCT00301067|101230072|FG000|STARTED|Completed 12 Cycles of Treatment||0||
48367906|NCT00301067|101230073|FG001|STARTED|Completed 12 Cycles of Treatment||1||
48367907|NCT00301067|101230074|FG002|STARTED|Completed 12 Cycles of Treatment||0||
48367908|NCT00301067|101230075|FG003|STARTED|Completed 12 Cycles of Treatment||2||
48367909|NCT00301067|101230072|FG000|COMPLETED|Completed 12 Cycles of Treatment||0||
48367910|NCT00301067|101230073|FG001|COMPLETED|Completed 12 Cycles of Treatment||0||
48367911|NCT00301067|101230074|FG002|COMPLETED|Completed 12 Cycles of Treatment||0||
48438886|NCT03039686|101406656|FG002|Completed DB, Did Not Start OL|Open Label Period||3||
48438887|NCT03039686|101406654|FG000|COMPLETED|Open Label Period||0||
48438888|NCT03039686|101406655|FG001|COMPLETED|Open Label Period||0||
48438889|NCT03039686|101406656|FG002|COMPLETED|Open Label Period||0||
48438890|NCT03039686|101406654|FG000|NOT COMPLETED|Open Label Period||0||
48438891|NCT03039686|101406655|FG001|NOT COMPLETED|Open Label Period||38||
48438892|NCT03039686|101406656|FG002|NOT COMPLETED|Open Label Period||42||
48438893|NCT03940742|101406657|FG000|STARTED|Overall Study||13||
48438894|NCT03940742|101406658|FG001|STARTED|Overall Study||6||
48438895|NCT03940742|101406659|FG002|STARTED|Overall Study||6||
48438896|NCT03940742|101406660|FG003|STARTED|Overall Study||7||
48438897|NCT03940742|101406657|FG000|Received at Least One Dose of Study Drug|Overall Study||13||
48438898|NCT03940742|101406658|FG001|Received at Least One Dose of Study Drug|Overall Study||6||
48438899|NCT03940742|101406659|FG002|Received at Least One Dose of Study Drug|Overall Study||6||
48438900|NCT03940742|101406660|FG003|Received at Least One Dose of Study Drug|Overall Study||7||
48438901|NCT03940742|101406657|FG000|COMPLETED|Overall Study||13||
48438902|NCT03940742|101406658|FG001|COMPLETED|Overall Study||6||
48438903|NCT03940742|101406659|FG002|COMPLETED|Overall Study||6||
48438904|NCT03940742|101406660|FG003|COMPLETED|Overall Study||6||
48438905|NCT03940742|101406657|FG000|NOT COMPLETED|Overall Study||0||
48438906|NCT03940742|101406658|FG001|NOT COMPLETED|Overall Study||0||
48438907|NCT03940742|101406659|FG002|NOT COMPLETED|Overall Study||0||
48438908|NCT03940742|101406660|FG003|NOT COMPLETED|Overall Study||1||
48438909|NCT03541356|101406661|FG000|STARTED|Overall Study||8||
48438910|NCT03541356|101406662|FG001|STARTED|Overall Study||6||
48438911|NCT03541356|101406663|FG002|STARTED|Overall Study||6||
48438912|NCT03541356|101406664|FG003|STARTED|Overall Study||6||
48438913|NCT03541356|101406665|FG004|STARTED|Overall Study||6||
48438914|NCT03541356|101406661|FG000|COMPLETED|Overall Study||8||
48438915|NCT03541356|101406662|FG001|COMPLETED|Overall Study||6||
48438916|NCT03541356|101406663|FG002|COMPLETED|Overall Study||6||
48438917|NCT03541356|101406664|FG003|COMPLETED|Overall Study||6||
48438918|NCT03541356|101406665|FG004|COMPLETED|Overall Study||6||
48438919|NCT03541356|101406661|FG000|NOT COMPLETED|Overall Study||0||
48438920|NCT03541356|101406662|FG001|NOT COMPLETED|Overall Study||0||
48438921|NCT03541356|101406663|FG002|NOT COMPLETED|Overall Study||0||
48438922|NCT03541356|101406664|FG003|NOT COMPLETED|Overall Study||0||
48438923|NCT03541356|101406665|FG004|NOT COMPLETED|Overall Study||0||
48656668|NCT06003829|101943681|FG000|NOT COMPLETED|Period 5 (Day 2 of the Study)||0||
48656669|NCT06003829|101943682|FG001|NOT COMPLETED|Period 5 (Day 2 of the Study)||0||
48656670|NCT06003829|101943683|FG002|NOT COMPLETED|Period 5 (Day 2 of the Study)||0||
48656671|NCT06003829|101943684|FG003|NOT COMPLETED|Period 5 (Day 2 of the Study)||0||
48656672|NCT06003829|101943681|FG000|STARTED|Period 6 (Day 2 of the Study)||3||
48656673|NCT06003829|101943682|FG001|STARTED|Period 6 (Day 2 of the Study)||3||
48656674|NCT06003829|101943683|FG002|STARTED|Period 6 (Day 2 of the Study)||3||
48656675|NCT06003829|101943684|FG003|STARTED|Period 6 (Day 2 of the Study)||3||
48656676|NCT06003829|101943681|FG000|COMPLETED|Period 6 (Day 2 of the Study)||3||
48656677|NCT06003829|101943682|FG001|COMPLETED|Period 6 (Day 2 of the Study)||3||
48656678|NCT06003829|101943683|FG002|COMPLETED|Period 6 (Day 2 of the Study)||3||
48656679|NCT06003829|101943684|FG003|COMPLETED|Period 6 (Day 2 of the Study)||3||
48656680|NCT06003829|101943681|FG000|NOT COMPLETED|Period 6 (Day 2 of the Study)||0||
48656681|NCT06003829|101943682|FG001|NOT COMPLETED|Period 6 (Day 2 of the Study)||0||
48656682|NCT06003829|101943683|FG002|NOT COMPLETED|Period 6 (Day 2 of the Study)||0||
48656683|NCT06003829|101943684|FG003|NOT COMPLETED|Period 6 (Day 2 of the Study)||0||
48656684|NCT06003829|101943681|FG000|STARTED|Period 7 (Day 2 of the Study)||3||
48656685|NCT06003829|101943682|FG001|STARTED|Period 7 (Day 2 of the Study)||3||
48656686|NCT06003829|101943683|FG002|STARTED|Period 7 (Day 2 of the Study)||3||
48656687|NCT06003829|101943684|FG003|STARTED|Period 7 (Day 2 of the Study)||3||
48656688|NCT06003829|101943681|FG000|COMPLETED|Period 7 (Day 2 of the Study)||3||
48656689|NCT06003829|101943682|FG001|COMPLETED|Period 7 (Day 2 of the Study)||3||
48656690|NCT06003829|101943683|FG002|COMPLETED|Period 7 (Day 2 of the Study)||3||
48656691|NCT06003829|101943684|FG003|COMPLETED|Period 7 (Day 2 of the Study)||3||
48656692|NCT06003829|101943681|FG000|NOT COMPLETED|Period 7 (Day 2 of the Study)||0||
48656693|NCT06003829|101943682|FG001|NOT COMPLETED|Period 7 (Day 2 of the Study)||0||
48656694|NCT06003829|101943683|FG002|NOT COMPLETED|Period 7 (Day 2 of the Study)||0||
48656695|NCT06003829|101943684|FG003|NOT COMPLETED|Period 7 (Day 2 of the Study)||0||
48656696|NCT06003829|101943681|FG000|STARTED|Period 8 (Day 2 of the Study)||3||
48656697|NCT06003829|101943682|FG001|STARTED|Period 8 (Day 2 of the Study)||3||
48656698|NCT06003829|101943683|FG002|STARTED|Period 8 (Day 2 of the Study)||3||
48656699|NCT06003829|101943684|FG003|STARTED|Period 8 (Day 2 of the Study)||3||
48656700|NCT06003829|101943681|FG000|COMPLETED|Period 8 (Day 2 of the Study)||3||
48656701|NCT06003829|101943682|FG001|COMPLETED|Period 8 (Day 2 of the Study)||3||
48656702|NCT06003829|101943683|FG002|COMPLETED|Period 8 (Day 2 of the Study)||3||
48656703|NCT06003829|101943684|FG003|COMPLETED|Period 8 (Day 2 of the Study)||3||
48656704|NCT06003829|101943681|FG000|NOT COMPLETED|Period 8 (Day 2 of the Study)||0||
48656705|NCT06003829|101943682|FG001|NOT COMPLETED|Period 8 (Day 2 of the Study)||0||
48656706|NCT06003829|101943683|FG002|NOT COMPLETED|Period 8 (Day 2 of the Study)||0||
48656707|NCT06003829|101943684|FG003|NOT COMPLETED|Period 8 (Day 2 of the Study)||0||
48656708|NCT05346640|101943685|FG000|STARTED|Overall Study||60||
48656709|NCT05346640|101943685|FG000|COMPLETED|Overall Study||32||
48656710|NCT05346640|101943685|FG000|NOT COMPLETED|Overall Study||28||
48656711|NCT03549507|101943686|FG000|STARTED|Overall Study||1||
48656712|NCT03549507|101943686|FG000|COMPLETED|Overall Study||1||
48656713|NCT03549507|101943686|FG000|NOT COMPLETED|Overall Study||0||
48656714|NCT01871727|101943687|FG000|STARTED|Lead-In Part (1 Year 2 Months)||2||
48656715|NCT01871727|101943688|FG001|STARTED|Lead-In Part (1 Year 2 Months)||8||
48656716|NCT01871727|101943689|FG002|STARTED|Lead-In Part (1 Year 2 Months)||9||
48656717|NCT01871727|101943690|FG003|STARTED|Lead-In Part (1 Year 2 Months)||2||
48656718|NCT01871727|101943691|FG004|STARTED|Lead-In Part (1 Year 2 Months)||0||
48656719|NCT01871727|101943687|FG000|Primary Efficacy Analysis Set|Lead-In Part (1 Year 2 Months)||0||
48656720|NCT01871727|101943688|FG001|Primary Efficacy Analysis Set|Lead-In Part (1 Year 2 Months)||5||
48656721|NCT01871727|101943689|FG002|Primary Efficacy Analysis Set|Lead-In Part (1 Year 2 Months)||0||
48656722|NCT01871727|101943690|FG003|Primary Efficacy Analysis Set|Lead-In Part (1 Year 2 Months)||0||
48656723|NCT01871727|101943691|FG004|Primary Efficacy Analysis Set|Lead-In Part (1 Year 2 Months)||0||
48656724|NCT01871727|101943687|FG000|COMPLETED|Lead-In Part (1 Year 2 Months)||1||
48656725|NCT01871727|101943688|FG001|COMPLETED|Lead-In Part (1 Year 2 Months)||4||
48656726|NCT01871727|101943689|FG002|COMPLETED|Lead-In Part (1 Year 2 Months)||5||
48656727|NCT01871727|101943690|FG003|COMPLETED|Lead-In Part (1 Year 2 Months)||2||
48656728|NCT01871727|101943691|FG004|COMPLETED|Lead-In Part (1 Year 2 Months)||0||
48656729|NCT01871727|101943687|FG000|NOT COMPLETED|Lead-In Part (1 Year 2 Months)||1||
48656730|NCT01871727|101943688|FG001|NOT COMPLETED|Lead-In Part (1 Year 2 Months)||4||
48656731|NCT01871727|101943689|FG002|NOT COMPLETED|Lead-In Part (1 Year 2 Months)||4||
48656732|NCT01871727|101943690|FG003|NOT COMPLETED|Lead-In Part (1 Year 2 Months)||0||
48656733|NCT01871727|101943691|FG004|NOT COMPLETED|Lead-In Part (1 Year 2 Months)||0||
48656734|NCT01871727|101943687|FG000|STARTED|Main Study Part (2 Years 4 Months)||0||
48656735|NCT01871727|101943688|FG001|STARTED|Main Study Part (2 Years 4 Months)||0||
48438924|NCT00352664|101406666|FG000|STARTED|Overall Study||27||
48656736|NCT01871727|101943689|FG002|STARTED|Main Study Part (2 Years 4 Months)||0||
48438925|NCT00352664|101406667|FG001|STARTED|Overall Study||0||
48438926|NCT00352664|101406666|FG000|COMPLETED|Overall Study||20||
48767014|NCT02937116|102218557|FG010|NOT COMPLETED|Overall Study||7||
48767015|NCT02937116|102218558|FG011|NOT COMPLETED|Overall Study||7||
48767016|NCT02464540|102218559|FG000|STARTED|Overall Study||11|Participants enrolled in both arms, luting material to be used was randomly selected.|17
48438927|NCT00352664|101406667|FG001|COMPLETED|Overall Study||0||
48438928|NCT00352664|101406666|FG000|NOT COMPLETED|Overall Study||7||
48438929|NCT00352664|101406667|FG001|NOT COMPLETED|Overall Study||0||
48438930|NCT00560573|101406668|FG000|STARTED|Overall Study||6||
48438931|NCT00560573|101406669|FG001|STARTED|Overall Study||3||
48438932|NCT00560573|101406670|FG002|STARTED|Overall Study||6||
48767017|NCT02464540|102218560|FG001|STARTED|Overall Study||11|Participants enrolled in both arms, luting material to be used was randomly selected.|21
48767018|NCT02464540|102218559|FG000|COMPLETED|Overall Study||11||17
48438933|NCT00560573|101406671|FG003|STARTED|Overall Study||10||
48767019|NCT02464540|102218560|FG001|COMPLETED|Overall Study||11||21
48767020|NCT02464540|102218559|FG000|NOT COMPLETED|Overall Study||0||0
48767021|NCT02464540|102218560|FG001|NOT COMPLETED|Overall Study||0||0
48767022|NCT03123731|102218561|FG000|STARTED|Overall Study||32||
48767023|NCT03123731|102218562|FG001|STARTED|Overall Study||35||
48767024|NCT03123731|102218563|FG002|STARTED|Overall Study||33||
48767025|NCT03123731|102218561|FG000|COMPLETED|Overall Study||23||
48767026|NCT03123731|102218562|FG001|COMPLETED|Overall Study||21||
48767027|NCT03123731|102218563|FG002|COMPLETED|Overall Study||26||
48767028|NCT03123731|102218561|FG000|NOT COMPLETED|Overall Study||9||
48438934|NCT00560573|101406672|FG004|STARTED|Overall Study||8||
48438935|NCT00560573|101406673|FG005|STARTED|Overall Study||13||
48438936|NCT00560573|101406668|FG000|Treated|Overall Study||6||
48438937|NCT00560573|101406669|FG001|Treated|Overall Study||3||
48438938|NCT00560573|101406670|FG002|Treated|Overall Study||6||
48438939|NCT00560573|101406671|FG003|Treated|Overall Study||10||
48438940|NCT00560573|101406672|FG004|Treated|Overall Study||7||
48438941|NCT00560573|101406673|FG005|Treated|Overall Study||13||
48438942|NCT00560573|101406668|FG000|COMPLETED|Overall Study||0||
48438943|NCT00560573|101406669|FG001|COMPLETED|Overall Study||0||
48438944|NCT00560573|101406670|FG002|COMPLETED|Overall Study||0||
48438945|NCT00560573|101406671|FG003|COMPLETED|Overall Study||0||
48438946|NCT00560573|101406672|FG004|COMPLETED|Overall Study||1||
48438947|NCT00560573|101406673|FG005|COMPLETED|Overall Study||0||
48438948|NCT00560573|101406668|FG000|NOT COMPLETED|Overall Study||6||
48438949|NCT00560573|101406669|FG001|NOT COMPLETED|Overall Study||3||
48438950|NCT00560573|101406670|FG002|NOT COMPLETED|Overall Study||6||
48438951|NCT00560573|101406671|FG003|NOT COMPLETED|Overall Study||10||
48438952|NCT00560573|101406672|FG004|NOT COMPLETED|Overall Study||7||
48438953|NCT00560573|101406673|FG005|NOT COMPLETED|Overall Study||13||
48438954|NCT01710007|101406674|FG000|STARTED|Overall Study||103||
48438955|NCT01710007|101406675|FG001|STARTED|Overall Study||99||
48438956|NCT01710007|101406674|FG000|COMPLETED|Overall Study||87||
48438957|NCT01710007|101406675|FG001|COMPLETED|Overall Study||81||
48438958|NCT01710007|101406674|FG000|NOT COMPLETED|Overall Study||16||
48438959|NCT01710007|101406675|FG001|NOT COMPLETED|Overall Study||18||
48438960|NCT01153685|101406676|FG000|STARTED|Overall Study||50||
48438961|NCT01153685|101406677|FG001|STARTED|Overall Study||70||
48438962|NCT01153685|101406676|FG000|COMPLETED|Overall Study||50||
48438963|NCT01153685|101406677|FG001|COMPLETED|Overall Study||70||
48438964|NCT01153685|101406676|FG000|NOT COMPLETED|Overall Study||0||
48438965|NCT01153685|101406677|FG001|NOT COMPLETED|Overall Study||0||
48438966|NCT01035229|101406678|FG000|STARTED|Overall Study||362||
48767029|NCT03123731|102218562|FG001|NOT COMPLETED|Overall Study||14||
48767030|NCT03123731|102218563|FG002|NOT COMPLETED|Overall Study||7||
48767031|NCT01698333|102218564|FG000|STARTED|Overall Study||25||
48767032|NCT01698333|102218564|FG000|COMPLETED|Overall Study||25||
48438967|NCT01035229|101406679|FG001|STARTED|Overall Study||184||
48438968|NCT01035229|101406678|FG000|COMPLETED|Overall Study||0||
48767033|NCT01698333|102218564|FG000|NOT COMPLETED|Overall Study||0||
48767034|NCT05039086|102218565|FG000|STARTED|Overall Study||9968|Study cohort before 1:1 propensity score matching|
48767035|NCT05039086|102218566|FG001|STARTED|Overall Study||3053|Study cohort before 1:1 propensity score matching|
48438969|NCT01035229|101406679|FG001|COMPLETED|Overall Study||0||
48438970|NCT01035229|101406678|FG000|NOT COMPLETED|Overall Study||362||
48438971|NCT01035229|101406679|FG001|NOT COMPLETED|Overall Study||184||
48438972|NCT02243709|101406680|FG000|STARTED|Phase 1||12||
48438973|NCT02243709|101406681|FG001|STARTED|Phase 1||20||
48767036|NCT05039086|102218565|FG000|COMPLETED|Overall Study||2888|Study cohort after 1:1 propensity score matching|
48767037|NCT05039086|102218566|FG001|COMPLETED|Overall Study||2888|Study cohort after 1:1 propensity score matching|
48438974|NCT02243709|101406680|FG000|COMPLETED|Phase 1||11||
48438975|NCT02243709|101406681|FG001|COMPLETED|Phase 1||17||
48438976|NCT02243709|101406680|FG000|NOT COMPLETED|Phase 1||1||
48438977|NCT02243709|101406681|FG001|NOT COMPLETED|Phase 1||3||
48438978|NCT02243709|101406680|FG000|STARTED|Phase 2: Crossover to Opposite Condition||11||
48438979|NCT02243709|101406681|FG001|STARTED|Phase 2: Crossover to Opposite Condition||17||
48438980|NCT02243709|101406680|FG000|COMPLETED|Phase 2: Crossover to Opposite Condition||11||
48440006|NCT04854421|101410008|FG001|COMPLETED|Overall Study||82||
48438981|NCT02243709|101406681|FG001|COMPLETED|Phase 2: Crossover to Opposite Condition||17||
48438982|NCT02243709|101406680|FG000|NOT COMPLETED|Phase 2: Crossover to Opposite Condition||0||
48438983|NCT02243709|101406681|FG001|NOT COMPLETED|Phase 2: Crossover to Opposite Condition||0||
48438984|NCT05149989|101406682|FG000|STARTED|Overall Study||50||
48438985|NCT05149989|101406682|FG000|COMPLETED|Overall Study||50||
48438986|NCT05149989|101406682|FG000|NOT COMPLETED|Overall Study||0||
48438987|NCT00795210|101406683|FG000|STARTED|Overall Study||8||
48438988|NCT00795210|101406684|FG001|STARTED|Overall Study||12||
48438989|NCT00795210|101406685|FG002|STARTED|Overall Study||5||
48438990|NCT00795210|101406683|FG000|COMPLETED|Overall Study||8||
48438991|NCT00795210|101406684|FG001|COMPLETED|Overall Study||11||
48438992|NCT00795210|101406685|FG002|COMPLETED|Overall Study||3||
48438993|NCT00795210|101406683|FG000|NOT COMPLETED|Overall Study||0||
48438994|NCT00795210|101406684|FG001|NOT COMPLETED|Overall Study||1||
48438995|NCT00795210|101406685|FG002|NOT COMPLETED|Overall Study||2||
48438996|NCT02861534|101406686|FG000|STARTED|Overall Study||2526||
48438997|NCT02861534|101406687|FG001|STARTED|Overall Study||2524||
48438998|NCT02861534|101406686|FG000|Treated|Overall Study||2519||
48438999|NCT02861534|101406687|FG001|Treated|Overall Study||2515||
48439000|NCT02861534|101406686|FG000|COMPLETED|Overall Study||1952||
48439001|NCT02861534|101406687|FG001|COMPLETED|Overall Study||1937||
48439002|NCT02861534|101406686|FG000|NOT COMPLETED|Overall Study||574||
48439003|NCT02861534|101406687|FG001|NOT COMPLETED|Overall Study||587||
48439004|NCT00940446|101406688|FG000|STARTED|Overall Study||30||
48439005|NCT00940446|101406689|FG001|STARTED|Overall Study||30||
48439006|NCT00940446|101406688|FG000|COMPLETED|Overall Study||30||
48439007|NCT00940446|101406689|FG001|COMPLETED|Overall Study||30||
48439008|NCT00940446|101406688|FG000|NOT COMPLETED|Overall Study||0||
48439009|NCT00940446|101406689|FG001|NOT COMPLETED|Overall Study||0||
48439010|NCT02769832|101406690|FG000|STARTED|Overall Study||32||
48439011|NCT02769832|101406690|FG000|COMPLETED|Overall Study||2||
48439012|NCT02769832|101406690|FG000|NOT COMPLETED|Overall Study||30||
48439013|NCT01656850|101406691|FG000|STARTED|First Intervention (3 Months)||20||
48439014|NCT01656850|101406692|FG001|STARTED|First Intervention (3 Months)||20||
48439015|NCT01656850|101406691|FG000|COMPLETED|First Intervention (3 Months)||17||
48439016|NCT01656850|101406692|FG001|COMPLETED|First Intervention (3 Months)||16||
48439017|NCT01656850|101406691|FG000|NOT COMPLETED|First Intervention (3 Months)||3||
48767038|NCT05039086|102218565|FG000|NOT COMPLETED|Overall Study||7080||
48767039|NCT05039086|102218566|FG001|NOT COMPLETED|Overall Study||165||
48767040|NCT03096288|102218567|FG000|STARTED|Overall Study||19||
48767041|NCT03096288|102218568|FG001|STARTED|Overall Study||18||
48767042|NCT03096288|102218569|FG002|STARTED|Overall Study||22||
48767043|NCT03096288|102218570|FG003|STARTED|Overall Study||25||
48767044|NCT03096288|102218567|FG000|COMPLETED|Overall Study||19||
48439018|NCT01656850|101406692|FG001|NOT COMPLETED|First Intervention (3 Months)||4||
48439019|NCT01656850|101406691|FG000|STARTED|Washout (2 Weeks)||17||
48439020|NCT01656850|101406692|FG001|STARTED|Washout (2 Weeks)||16||
48439021|NCT01656850|101406691|FG000|COMPLETED|Washout (2 Weeks)||17||
48439022|NCT01656850|101406692|FG001|COMPLETED|Washout (2 Weeks)||16||
48439023|NCT01656850|101406691|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
48439024|NCT01656850|101406692|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
48439025|NCT01656850|101406691|FG000|STARTED|Second Intervention (3 Months)||17||
48439026|NCT01656850|101406692|FG001|STARTED|Second Intervention (3 Months)||16||
48439027|NCT01656850|101406691|FG000|COMPLETED|Second Intervention (3 Months)||17||
48439028|NCT01656850|101406692|FG001|COMPLETED|Second Intervention (3 Months)||16||
48767045|NCT03096288|102218568|FG001|COMPLETED|Overall Study||17||
48767046|NCT03096288|102218569|FG002|COMPLETED|Overall Study||22||
48767047|NCT03096288|102218570|FG003|COMPLETED|Overall Study||24||
48767048|NCT03096288|102218567|FG000|NOT COMPLETED|Overall Study||0||
48767049|NCT03096288|102218568|FG001|NOT COMPLETED|Overall Study||1||
48767050|NCT03096288|102218569|FG002|NOT COMPLETED|Overall Study||0||
48767051|NCT03096288|102218570|FG003|NOT COMPLETED|Overall Study||1||
48767052|NCT02435992|102218571|FG000|STARTED|Overall Study||429||
48439029|NCT01656850|101406691|FG000|NOT COMPLETED|Second Intervention (3 Months)||0||
48439030|NCT01656850|101406692|FG001|NOT COMPLETED|Second Intervention (3 Months)||0||
48767053|NCT02435992|102218572|FG001|STARTED|Overall Study||216||
48767054|NCT02435992|102218573|FG002|STARTED|Overall Study||367||
48767055|NCT02435992|102218574|FG003|STARTED|Overall Study||0||
48767056|NCT02435992|102218575|FG004|STARTED|Overall Study||0||
48767057|NCT02435992|102218571|FG000|Transition to Maintenance Period|Overall Study||233|Completed Induction Week 10, continuing into MP|
48767058|NCT02435992|102218572|FG001|Transition to Maintenance Period|Overall Study||69|Completed Induction Week 10, continuing into MP|
48439031|NCT02871921|101406693|FG000|STARTED|Overall Study||51||
48439032|NCT02871921|101406694|FG001|STARTED|Overall Study||49||
48439033|NCT02871921|101406695|FG002|STARTED|Overall Study||43||
48439034|NCT02871921|101406696|FG003|STARTED|Overall Study||43||
48439035|NCT02871921|101406693|FG000|Month 6|Overall Study||33||
48439036|NCT02871921|101406694|FG001|Month 6|Overall Study||41||
48439037|NCT02871921|101406695|FG002|Month 6|Overall Study||36||
48439038|NCT02871921|101406696|FG003|Month 6|Overall Study||31||
48439039|NCT02871921|101406693|FG000|Month 12|Overall Study||18||
48439040|NCT02871921|101406694|FG001|Month 12|Overall Study||22||
48439041|NCT02871921|101406695|FG002|Month 12|Overall Study||17||
48439042|NCT02871921|101406696|FG003|Month 12|Overall Study||14||
48439043|NCT02871921|101406693|FG000|COMPLETED|Overall Study||17||
48439044|NCT02871921|101406694|FG001|COMPLETED|Overall Study||22||
48439045|NCT02871921|101406695|FG002|COMPLETED|Overall Study||16||
48439046|NCT02871921|101406696|FG003|COMPLETED|Overall Study||13||
48439047|NCT02871921|101406693|FG000|NOT COMPLETED|Overall Study||34||
48439048|NCT02871921|101406694|FG001|NOT COMPLETED|Overall Study||27||
48439049|NCT02871921|101406695|FG002|NOT COMPLETED|Overall Study||27||
48439050|NCT02871921|101406696|FG003|NOT COMPLETED|Overall Study||30||
48439051|NCT00887965|101406697|FG000|STARTED|Overall Study||15||
48439052|NCT00887965|101406697|FG000|COMPLETED|Overall Study||15||
48439053|NCT00887965|101406697|FG000|NOT COMPLETED|Overall Study||0||
48439054|NCT02139969|101406698|FG000|STARTED|Overall Study||956||
48767059|NCT02435992|102218573|FG002|Transition to Maintenance Period|Overall Study||224|Completed Induction Week 10, continuing into MP|
48439055|NCT02139969|101406698|FG000|COMPLETED|Overall Study||956||
48439056|NCT02139969|101406698|FG000|NOT COMPLETED|Overall Study||0||
48439057|NCT02712359|101406699|FG000|STARTED|Epoch 001: Persistence at Year 8||300||
48439058|NCT02712359|101406700|FG001|STARTED|Epoch 001: Persistence at Year 8||300||
48439059|NCT02712359|101406701|FG002|STARTED|Epoch 001: Persistence at Year 8||0||
48439060|NCT02712359|101406702|FG003|STARTED|Epoch 001: Persistence at Year 8||0||
48439061|NCT02712359|101406699|FG000|COMPLETED|Epoch 001: Persistence at Year 8||300||
48439062|NCT02712359|101406700|FG001|COMPLETED|Epoch 001: Persistence at Year 8||300||
48439063|NCT02712359|101406701|FG002|COMPLETED|Epoch 001: Persistence at Year 8||0||
48439064|NCT02712359|101406702|FG003|COMPLETED|Epoch 001: Persistence at Year 8||0||
48439065|NCT02712359|101406699|FG000|NOT COMPLETED|Epoch 001: Persistence at Year 8||0||
48439066|NCT02712359|101406700|FG001|NOT COMPLETED|Epoch 001: Persistence at Year 8||0||
48439067|NCT02712359|101406701|FG002|NOT COMPLETED|Epoch 001: Persistence at Year 8||0||
48439068|NCT02712359|101406702|FG003|NOT COMPLETED|Epoch 001: Persistence at Year 8||0||
48439069|NCT02712359|101406699|FG000|STARTED|Epoch 002: Persistence at Year 10||0||
48439070|NCT02712359|101406700|FG001|STARTED|Epoch 002: Persistence at Year 10||0||
48439071|NCT02712359|101406701|FG002|STARTED|Epoch 002: Persistence at Year 10||299||
48439072|NCT02712359|101406702|FG003|STARTED|Epoch 002: Persistence at Year 10||300||
48439073|NCT02712359|101406699|FG000|COMPLETED|Epoch 002: Persistence at Year 10||0||
48439074|NCT02712359|101406700|FG001|COMPLETED|Epoch 002: Persistence at Year 10||0||
48439075|NCT02712359|101406701|FG002|COMPLETED|Epoch 002: Persistence at Year 10||299||
48439076|NCT02712359|101406702|FG003|COMPLETED|Epoch 002: Persistence at Year 10||300||
48439077|NCT02712359|101406699|FG000|NOT COMPLETED|Epoch 002: Persistence at Year 10||0||
48439078|NCT02712359|101406700|FG001|NOT COMPLETED|Epoch 002: Persistence at Year 10||0||
48439079|NCT02712359|101406701|FG002|NOT COMPLETED|Epoch 002: Persistence at Year 10||0||
48439080|NCT02712359|101406702|FG003|NOT COMPLETED|Epoch 002: Persistence at Year 10||0||
48439081|NCT05153629|101406703|FG000|STARTED|Overall Study||17||
48439082|NCT05153629|101406704|FG001|STARTED|Overall Study||13||
48439083|NCT05153629|101406703|FG000|COMPLETED|Overall Study||17||
48439084|NCT05153629|101406704|FG001|COMPLETED|Overall Study||11||
48439085|NCT05153629|101406703|FG000|NOT COMPLETED|Overall Study||0||
48439086|NCT05153629|101406704|FG001|NOT COMPLETED|Overall Study||2||
48439087|NCT00761761|101406705|FG000|STARTED|Overall Study||30||
48439088|NCT00761761|101406706|FG001|STARTED|Overall Study||30||
48439089|NCT00761761|101406705|FG000|COMPLETED|Overall Study||24||
48439090|NCT00761761|101406706|FG001|COMPLETED|Overall Study||29||
48439091|NCT00761761|101406705|FG000|NOT COMPLETED|Overall Study||6||
48767060|NCT02435992|102218574|FG003|Transition to Maintenance Period|Overall Study||0|Completed Induction Week 10, continuing into MP|
48767061|NCT02435992|102218575|FG004|Transition to Maintenance Period|Overall Study||0|Completed Induction Week 10, continuing into MP|
48767062|NCT02435992|102218571|FG000|Treated in Maintenance Period|Overall Study||0|Subjects who entered Maintenance Period from Induction period|
48767063|NCT02435992|102218572|FG001|Treated in Maintenance Period|Overall Study||69|Subjects who entered Maintenance Period from Induction period|
48767064|NCT02435992|102218573|FG002|Treated in Maintenance Period|Overall Study||0|Subjects who entered Maintenance Period from Induction period|
48767065|NCT02435992|102218574|FG003|Treated in Maintenance Period|Overall Study||230|Subjects who entered Maintenance Period from Induction period|
48767066|NCT02435992|102218575|FG004|Treated in Maintenance Period|Overall Study||227|Subjects who entered Maintenance Period from Induction period|
48767067|NCT02435992|102218571|FG000|COMPLETED|Overall Study||401||
48767068|NCT02435992|102218572|FG001|COMPLETED|Overall Study||192||
48767069|NCT02435992|102218573|FG002|COMPLETED|Overall Study||324||
48767070|NCT02435992|102218574|FG003|COMPLETED|Overall Study||0||
48767071|NCT02435992|102218575|FG004|COMPLETED|Overall Study||0||
48767072|NCT02435992|102218571|FG000|NOT COMPLETED|Overall Study||28||
48767073|NCT02435992|102218572|FG001|NOT COMPLETED|Overall Study||24||
48767074|NCT02435992|102218573|FG002|NOT COMPLETED|Overall Study||43||
48767075|NCT02435992|102218574|FG003|NOT COMPLETED|Overall Study||0||
48767076|NCT02435992|102218575|FG004|NOT COMPLETED|Overall Study||0||
48439092|NCT00761761|101406706|FG001|NOT COMPLETED|Overall Study||1||
48439093|NCT03733418|101406707|FG000|STARTED|Overall Study||47||
48439094|NCT03733418|101406708|FG001|STARTED|Overall Study||48||
48439095|NCT03733418|101406707|FG000|COMPLETED|Overall Study||47||
48439096|NCT03733418|101406708|FG001|COMPLETED|Overall Study||48||
48767077|NCT03044106|102218576|FG000|STARTED|Visit 1||22||
48767078|NCT03044106|102218577|FG001|STARTED|Visit 1||22||
48767079|NCT03044106|102218576|FG000|COMPLETED|Visit 1||22||
48767080|NCT03044106|102218577|FG001|COMPLETED|Visit 1||22||
48767081|NCT03044106|102218576|FG000|NOT COMPLETED|Visit 1||0||
48767082|NCT03044106|102218577|FG001|NOT COMPLETED|Visit 1||0||
48767083|NCT03044106|102218576|FG000|STARTED|Washout (1 Week)||22||
48767084|NCT03044106|102218577|FG001|STARTED|Washout (1 Week)||22||
48767085|NCT03044106|102218576|FG000|COMPLETED|Washout (1 Week)||22||
48767086|NCT03044106|102218577|FG001|COMPLETED|Washout (1 Week)||20||
48767087|NCT03044106|102218576|FG000|NOT COMPLETED|Washout (1 Week)||0||
48767088|NCT03044106|102218577|FG001|NOT COMPLETED|Washout (1 Week)||2||
48767089|NCT03044106|102218576|FG000|STARTED|Visit 2||22||
48767090|NCT03044106|102218577|FG001|STARTED|Visit 2||20||
48767091|NCT03044106|102218576|FG000|COMPLETED|Visit 2||22||
48767092|NCT03044106|102218577|FG001|COMPLETED|Visit 2||20||
48767093|NCT03044106|102218576|FG000|NOT COMPLETED|Visit 2||0||
48767094|NCT03044106|102218577|FG001|NOT COMPLETED|Visit 2||0||
48767095|NCT00912808|102218578|FG000|STARTED|First Intervention (6 Weeks)||11||
48767096|NCT00912808|102218579|FG001|STARTED|First Intervention (6 Weeks)||12||
48767097|NCT00912808|102218578|FG000|Received Intervention|First Intervention (6 Weeks)||11||
48767098|NCT00912808|102218579|FG001|Received Intervention|First Intervention (6 Weeks)||12||
48767099|NCT00912808|102218578|FG000|COMPLETED|First Intervention (6 Weeks)||9||
48767100|NCT00912808|102218579|FG001|COMPLETED|First Intervention (6 Weeks)||11||
48767101|NCT00912808|102218578|FG000|NOT COMPLETED|First Intervention (6 Weeks)||2||
48767102|NCT00912808|102218579|FG001|NOT COMPLETED|First Intervention (6 Weeks)||1||
48767103|NCT00912808|102218578|FG000|STARTED|Washout||9||
48767104|NCT00912808|102218579|FG001|STARTED|Washout||11||
48439097|NCT03733418|101406707|FG000|NOT COMPLETED|Overall Study||0||
48439098|NCT03733418|101406708|FG001|NOT COMPLETED|Overall Study||0||
48439099|NCT00822237|101406709|FG000|STARTED|Dose 1 Vaccination||299||
48439100|NCT00822237|101406710|FG001|STARTED|Dose 1 Vaccination||299||
48439101|NCT00822237|101406709|FG000|COMPLETED|Dose 1 Vaccination||274||
48439102|NCT00822237|101406710|FG001|COMPLETED|Dose 1 Vaccination||273||
48439103|NCT00822237|101406709|FG000|NOT COMPLETED|Dose 1 Vaccination||25||
48439104|NCT00822237|101406710|FG001|NOT COMPLETED|Dose 1 Vaccination||26||
48439105|NCT00822237|101406709|FG000|STARTED|Dose 2 Vaccination||274||
48439106|NCT00822237|101406710|FG001|STARTED|Dose 2 Vaccination||273||
48439107|NCT00822237|101406709|FG000|COMPLETED|Dose 2 Vaccination||270||
48439108|NCT00822237|101406710|FG001|COMPLETED|Dose 2 Vaccination||262||
48439109|NCT00822237|101406709|FG000|NOT COMPLETED|Dose 2 Vaccination||4||
48767105|NCT00912808|102218578|FG000|COMPLETED|Washout||9||
48767106|NCT00912808|102218579|FG001|COMPLETED|Washout||10||
48767107|NCT00912808|102218578|FG000|NOT COMPLETED|Washout||0||
48767108|NCT00912808|102218579|FG001|NOT COMPLETED|Washout||1||
48767109|NCT00912808|102218578|FG000|STARTED|Second Intervention (6 Weeks)||9||
48767110|NCT00912808|102218579|FG001|STARTED|Second Intervention (6 Weeks)||10||
48767111|NCT00912808|102218578|FG000|Received Intervention|Second Intervention (6 Weeks)||9||
48767112|NCT00912808|102218579|FG001|Received Intervention|Second Intervention (6 Weeks)||10||
48767113|NCT00912808|102218578|FG000|COMPLETED|Second Intervention (6 Weeks)||8||
48767114|NCT00912808|102218579|FG001|COMPLETED|Second Intervention (6 Weeks)||9||
48767115|NCT00912808|102218578|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||1||
48767116|NCT00912808|102218579|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||1||
48767117|NCT03848728|102218580|FG000|STARTED|Overall Study||1012||14
48767118|NCT03848728|102218581|FG001|STARTED|Overall Study||976||14
48767119|NCT03848728|102218580|FG000|COMPLETED|Overall Study||865||14
48767120|NCT03848728|102218581|FG001|COMPLETED|Overall Study||809||14
48767121|NCT03848728|102218580|FG000|NOT COMPLETED|Overall Study||147||0
48767122|NCT03848728|102218581|FG001|NOT COMPLETED|Overall Study||167||0
48767123|NCT02161016|102218582|FG000|STARTED|Overall Study||1||
48767124|NCT02161016|102218582|FG000|COMPLETED|Overall Study||0||
48767125|NCT02161016|102218582|FG000|NOT COMPLETED|Overall Study||1||
48439110|NCT00822237|101406710|FG001|NOT COMPLETED|Dose 2 Vaccination||11||
48439111|NCT01907516|101406711|FG000|STARTED|First Intervention (3 Weeks)||50||
48439112|NCT01907516|101406712|FG001|STARTED|First Intervention (3 Weeks)||50||
48767126|NCT01028820|102218583|FG000|STARTED|Overall Study||13||
48767127|NCT01028820|102218583|FG000|COMPLETED|Overall Study||12||
48767128|NCT01028820|102218583|FG000|NOT COMPLETED|Overall Study||1||
48767129|NCT00568022|102218584|FG000|STARTED|Overall Study||3||
48767130|NCT00568022|102218585|FG001|STARTED|Overall Study||3||
48767131|NCT00568022|102218586|FG002|STARTED|Overall Study||3||
48767132|NCT00568022|102218584|FG000|COMPLETED|Overall Study||3||
48767133|NCT00568022|102218585|FG001|COMPLETED|Overall Study||3||
48767134|NCT00568022|102218586|FG002|COMPLETED|Overall Study||3||
48767135|NCT00568022|102218584|FG000|NOT COMPLETED|Overall Study||0||
48767136|NCT00568022|102218585|FG001|NOT COMPLETED|Overall Study||0||
48439113|NCT01907516|101406711|FG000|COMPLETED|First Intervention (3 Weeks)||40||
48439114|NCT01907516|101406712|FG001|COMPLETED|First Intervention (3 Weeks)||34||
48439115|NCT01907516|101406711|FG000|NOT COMPLETED|First Intervention (3 Weeks)||10||
48439116|NCT01907516|101406712|FG001|NOT COMPLETED|First Intervention (3 Weeks)||16||
48439117|NCT01907516|101406711|FG000|STARTED|Second Intervention (3 Weeks)||40||
48439118|NCT01907516|101406712|FG001|STARTED|Second Intervention (3 Weeks)||34||
48439119|NCT01907516|101406711|FG000|COMPLETED|Second Intervention (3 Weeks)||40||
48439120|NCT01907516|101406712|FG001|COMPLETED|Second Intervention (3 Weeks)||34||
48767137|NCT00568022|102218586|FG002|NOT COMPLETED|Overall Study||0||
48767138|NCT03697252|102218587|FG000|STARTED|Overall Study||90||
48767139|NCT03697252|102218588|FG001|STARTED|Overall Study||92||
48767140|NCT03697252|102218587|FG000|COMPLETED|Overall Study||72||
48767141|NCT03697252|102218588|FG001|COMPLETED|Overall Study||73||
48767142|NCT03697252|102218587|FG000|NOT COMPLETED|Overall Study||18||
48767143|NCT03697252|102218588|FG001|NOT COMPLETED|Overall Study||19||
48767144|NCT05494385|102218589|FG000|STARTED|Overall Study||59||
48767145|NCT05494385|102218590|FG001|STARTED|Overall Study||55||
48767146|NCT05494385|102218589|FG000|COMPLETED|Overall Study||59||
48767147|NCT05494385|102218590|FG001|COMPLETED|Overall Study||55||
48767148|NCT05494385|102218589|FG000|NOT COMPLETED|Overall Study||0||
48767149|NCT05494385|102218590|FG001|NOT COMPLETED|Overall Study||0||
48767150|NCT00267059|102218591|FG000|STARTED|Overall Study||44||
48767151|NCT00267059|102218591|FG000|COMPLETED|Overall Study||44||
48767152|NCT00267059|102218591|FG000|NOT COMPLETED|Overall Study||0||
48767153|NCT05050318|102218592|FG000|STARTED|Overall Study||29||
48767154|NCT05050318|102218593|FG001|STARTED|Overall Study||31||
48439121|NCT01907516|101406711|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0||
48439122|NCT01907516|101406712|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0||
48439123|NCT00446134|101406713|FG000|STARTED|Overall Study||69||
48439124|NCT00446134|101406714|FG001|STARTED|Overall Study||70||
48439125|NCT00446134|101406715|FG002|STARTED|Overall Study||69||
48439126|NCT00446134|101406716|FG003|STARTED|Overall Study||70||
48439127|NCT00446134|101406713|FG000|COMPLETED|Overall Study||35||
48439128|NCT00446134|101406714|FG001|COMPLETED|Overall Study||25||
48439129|NCT00446134|101406715|FG002|COMPLETED|Overall Study||26||
48439130|NCT00446134|101406716|FG003|COMPLETED|Overall Study||25||
48439131|NCT00446134|101406713|FG000|NOT COMPLETED|Overall Study||34||
48439132|NCT00446134|101406714|FG001|NOT COMPLETED|Overall Study||45||
48439133|NCT00446134|101406715|FG002|NOT COMPLETED|Overall Study||43||
48439134|NCT00446134|101406716|FG003|NOT COMPLETED|Overall Study||45||
48439135|NCT02304302|101406717|FG000|STARTED|Overall Study||79||
48439136|NCT02304302|101406718|FG001|STARTED|Overall Study||81||
48439137|NCT02304302|101406717|FG000|COMPLETED|Overall Study||76||
48439138|NCT02304302|101406718|FG001|COMPLETED|Overall Study||73||
48767155|NCT05050318|102218594|FG002|STARTED|Overall Study||30||
48767156|NCT05050318|102218592|FG000|Vaccinated|Overall Study||28||
48767157|NCT05050318|102218593|FG001|Vaccinated|Overall Study||31||
48767158|NCT05050318|102218594|FG002|Vaccinated|Overall Study||30||
48767159|NCT05050318|102218592|FG000|COMPLETED|Overall Study||28||
48767160|NCT05050318|102218593|FG001|COMPLETED|Overall Study||31||
48767161|NCT05050318|102218594|FG002|COMPLETED|Overall Study||30||
48767162|NCT05050318|102218592|FG000|NOT COMPLETED|Overall Study||1||
48439139|NCT02304302|101406717|FG000|NOT COMPLETED|Overall Study||3||
48439140|NCT02304302|101406718|FG001|NOT COMPLETED|Overall Study||8||
48439141|NCT00595946|101406719|FG000|STARTED|Overall Study||218||
48439142|NCT00595946|101406720|FG001|STARTED|Overall Study||221||
48439143|NCT00595946|101406719|FG000|COMPLETED|Overall Study||154||
48439144|NCT00595946|101406720|FG001|COMPLETED|Overall Study||152||
48439145|NCT00595946|101406719|FG000|NOT COMPLETED|Overall Study||64||
48439146|NCT00595946|101406720|FG001|NOT COMPLETED|Overall Study||69||
48439147|NCT03170271|101409829|FG000|STARTED|Overall Study||431|Randomized|
48439148|NCT03170271|101409830|FG001|STARTED|Overall Study||229|Randomized|
48767163|NCT05050318|102218593|FG001|NOT COMPLETED|Overall Study||0||
48767164|NCT05050318|102218594|FG002|NOT COMPLETED|Overall Study||0||
48767165|NCT03415685|102218595|FG000|STARTED|Overall Study||11||
48767166|NCT03415685|102218596|FG001|STARTED|Overall Study||28||
48767167|NCT03415685|102218595|FG000|COMPLETED|Overall Study||11||
48767168|NCT03415685|102218596|FG001|COMPLETED|Overall Study||9||
48767169|NCT03415685|102218595|FG000|NOT COMPLETED|Overall Study||0||
48439149|NCT03170271|101409829|FG000|Received Treatment|Overall Study||427||
48439150|NCT03170271|101409830|FG001|Received Treatment|Overall Study||229||
48439151|NCT03170271|101409829|FG000|COMPLETED|Overall Study||398|Completed double-blind period of study|
48767170|NCT03415685|102218596|FG001|NOT COMPLETED|Overall Study||19||
48767171|NCT04684836|102218597|FG000|STARTED|Overall Study||17226||
48767172|NCT04684836|102218598|FG001|STARTED|Overall Study||15874||
48767173|NCT04684836|102218597|FG000|COMPLETED|Overall Study||17226||
48439152|NCT03170271|101409830|FG001|COMPLETED|Overall Study||218|Completed double-blind period of study|
48439153|NCT03170271|101409829|FG000|NOT COMPLETED|Overall Study||33||
48767174|NCT04684836|102218598|FG001|COMPLETED|Overall Study||15874||
48767175|NCT04684836|102218597|FG000|NOT COMPLETED|Overall Study||0||
48767176|NCT04684836|102218598|FG001|NOT COMPLETED|Overall Study||0||
48767177|NCT00003469|102218599|FG000|STARTED|Overall Study||4||
48767178|NCT00003469|102218599|FG000|COMPLETED|Overall Study||4||
48767179|NCT00003469|102218599|FG000|NOT COMPLETED|Overall Study||0||
48767180|NCT04225897|102218600|FG000|STARTED|Part A (Screening Visit to Day 7)||3||
48767181|NCT04225897|102218601|FG001|STARTED|Part A (Screening Visit to Day 7)||7||
48767182|NCT04225897|102218602|FG002|STARTED|Part A (Screening Visit to Day 7)||3||
48767183|NCT04225897|102218603|FG003|STARTED|Part A (Screening Visit to Day 7)||6||
48767184|NCT04225897|102218604|FG004|STARTED|Part A (Screening Visit to Day 7)||0||
48767185|NCT04225897|102218605|FG005|STARTED|Part A (Screening Visit to Day 7)||0||
48767186|NCT04225897|102218606|FG006|STARTED|Part A (Screening Visit to Day 7)||0||
48767187|NCT04225897|102218607|FG007|STARTED|Part A (Screening Visit to Day 7)||0||
48767188|NCT04225897|102218608|FG008|STARTED|Part A (Screening Visit to Day 7)||0||
48767189|NCT04225897|102218609|FG009|STARTED|Part A (Screening Visit to Day 7)||0||
48767190|NCT04225897|102218610|FG010|STARTED|Part A (Screening Visit to Day 7)||0||
48439154|NCT03170271|101409830|FG001|NOT COMPLETED|Overall Study||11||
48439155|NCT03387423|101409831|FG000|STARTED|Overall Study||779||
48439156|NCT03387423|101409832|FG001|STARTED|Overall Study||440||
48439157|NCT03387423|101409833|FG002|STARTED|Overall Study||111||
48439158|NCT03387423|101409834|FG003|STARTED|Overall Study||129||
48439159|NCT03387423|101409831|FG000|COMPLETED|Overall Study||521||
48439160|NCT03387423|101409832|FG001|COMPLETED|Overall Study||304||
48439161|NCT03387423|101409833|FG002|COMPLETED|Overall Study||90||
48656737|NCT01871727|101943690|FG003|STARTED|Main Study Part (2 Years 4 Months)||0||
48656738|NCT01871727|101943691|FG004|STARTED|Main Study Part (2 Years 4 Months)||91||
48656739|NCT01871727|101943687|FG000|Primary Efficacy Analysis Set|Main Study Part (2 Years 4 Months)||0||
48656740|NCT01871727|101943688|FG001|Primary Efficacy Analysis Set|Main Study Part (2 Years 4 Months)||0||
48656741|NCT01871727|101943689|FG002|Primary Efficacy Analysis Set|Main Study Part (2 Years 4 Months)||0||
48656742|NCT01871727|101943690|FG003|Primary Efficacy Analysis Set|Main Study Part (2 Years 4 Months)||0||
48656743|NCT01871727|101943691|FG004|Primary Efficacy Analysis Set|Main Study Part (2 Years 4 Months)||64||
48656744|NCT01871727|101943687|FG000|COMPLETED|Main Study Part (2 Years 4 Months)||0||
48656745|NCT01871727|101943688|FG001|COMPLETED|Main Study Part (2 Years 4 Months)||0||
48656746|NCT01871727|101943689|FG002|COMPLETED|Main Study Part (2 Years 4 Months)||0||
48656747|NCT01871727|101943690|FG003|COMPLETED|Main Study Part (2 Years 4 Months)||0||
48656748|NCT01871727|101943691|FG004|COMPLETED|Main Study Part (2 Years 4 Months)||46||
48656749|NCT01871727|101943687|FG000|NOT COMPLETED|Main Study Part (2 Years 4 Months)||0||
48656750|NCT01871727|101943688|FG001|NOT COMPLETED|Main Study Part (2 Years 4 Months)||0||
48656751|NCT01871727|101943689|FG002|NOT COMPLETED|Main Study Part (2 Years 4 Months)||0||
48656752|NCT01871727|101943690|FG003|NOT COMPLETED|Main Study Part (2 Years 4 Months)||0||
48656753|NCT01871727|101943691|FG004|NOT COMPLETED|Main Study Part (2 Years 4 Months)||45||
48656754|NCT03760081|101943692|FG000|STARTED|Overall Study||6||
48656755|NCT03760081|101943693|FG001|STARTED|Overall Study||13||
48656756|NCT03760081|101943692|FG000|COMPLETED|Overall Study||0||
48656757|NCT03760081|101943693|FG001|COMPLETED|Overall Study||1||
48656758|NCT03760081|101943692|FG000|NOT COMPLETED|Overall Study||6||
48656759|NCT03760081|101943693|FG001|NOT COMPLETED|Overall Study||12||
48656760|NCT03921541|101943694|FG000|STARTED|Double Blind Treatment Period||21||
48656761|NCT03921541|101943695|FG001|STARTED|Double Blind Treatment Period||11||
48656762|NCT03921541|101943694|FG000|COMPLETED|Double Blind Treatment Period||20||
48656763|NCT03921541|101943695|FG001|COMPLETED|Double Blind Treatment Period||11||
48656764|NCT03921541|101943694|FG000|NOT COMPLETED|Double Blind Treatment Period||1||
48656765|NCT03921541|101943695|FG001|NOT COMPLETED|Double Blind Treatment Period||0||
48656766|NCT03921541|101943694|FG000|STARTED|Long Term Extension||20||
48656767|NCT03921541|101943695|FG001|STARTED|Long Term Extension||11||
48656768|NCT03921541|101943694|FG000|COMPLETED|Long Term Extension||20||
48656769|NCT03921541|101943695|FG001|COMPLETED|Long Term Extension||11||
48656770|NCT03921541|101943694|FG000|NOT COMPLETED|Long Term Extension||0||
48656771|NCT03921541|101943695|FG001|NOT COMPLETED|Long Term Extension||0||
48656772|NCT04380753|101943696|FG000|STARTED|Overall Study||12||
48656773|NCT04380753|101943696|FG000|COMPLETED|Overall Study||6||
48656774|NCT04380753|101943696|FG000|NOT COMPLETED|Overall Study||6||
48656775|NCT03268499|101943697|FG000|STARTED|Overall Study||40||
48656776|NCT03268499|101943698|FG001|STARTED|Overall Study||40||
48656777|NCT03268499|101943697|FG000|COMPLETED|Overall Study||38||
48656778|NCT03268499|101943698|FG001|COMPLETED|Overall Study||39||
48656779|NCT03268499|101943697|FG000|NOT COMPLETED|Overall Study||2||
48656780|NCT03268499|101943698|FG001|NOT COMPLETED|Overall Study||1||
48656781|NCT03976375|101943699|FG000|STARTED|Overall Study||185||
48656782|NCT03976375|101943700|FG001|STARTED|Overall Study||189||
48767191|NCT04225897|102218611|FG011|STARTED|Part A (Screening Visit to Day 7)||0||
48767192|NCT04225897|102218600|FG000|Treated|Part A (Screening Visit to Day 7)||3||
48656783|NCT03976375|101943701|FG002|STARTED|Overall Study||48||
48656784|NCT03976375|101943699|FG000|Treated|Overall Study||181||
48656785|NCT03976375|101943700|FG001|Treated|Overall Study||177||
48656786|NCT03976375|101943701|FG002|Treated|Overall Study||47||
48656787|NCT03976375|101943699|FG000|COMPLETED|Overall Study||0||
48439162|NCT03387423|101409834|FG003|COMPLETED|Overall Study||105||
48439163|NCT03387423|101409831|FG000|NOT COMPLETED|Overall Study||258||
48439164|NCT03387423|101409832|FG001|NOT COMPLETED|Overall Study||136||
48656788|NCT03976375|101943700|FG001|COMPLETED|Overall Study||0||
48656789|NCT03976375|101943701|FG002|COMPLETED|Overall Study||0||
48656790|NCT03976375|101943699|FG000|NOT COMPLETED|Overall Study||185||
48656791|NCT03976375|101943700|FG001|NOT COMPLETED|Overall Study||189||
48656792|NCT03976375|101943701|FG002|NOT COMPLETED|Overall Study||48||
48656793|NCT00861705|101943702|FG000|STARTED|Overall Study||115||
48656794|NCT00861705|101943703|FG001|STARTED|Overall Study||113||
48656795|NCT00861705|101943704|FG002|STARTED|Overall Study||113||
48656796|NCT00861705|101943705|FG003|STARTED|Overall Study||113||
48656797|NCT00861705|101943702|FG000|COMPLETED|Overall Study||108||
48656798|NCT00861705|101943703|FG001|COMPLETED|Overall Study||110||
48656799|NCT00861705|101943704|FG002|COMPLETED|Overall Study||113||
48656800|NCT00861705|101943705|FG003|COMPLETED|Overall Study||112||
48656801|NCT00861705|101943702|FG000|NOT COMPLETED|Overall Study||7||
48767193|NCT04225897|102218601|FG001|Treated|Part A (Screening Visit to Day 7)||7||
48767194|NCT04225897|102218602|FG002|Treated|Part A (Screening Visit to Day 7)||3||
48767195|NCT04225897|102218603|FG003|Treated|Part A (Screening Visit to Day 7)||6||
48767196|NCT04225897|102218604|FG004|Treated|Part A (Screening Visit to Day 7)||0||
48439165|NCT03387423|101409833|FG002|NOT COMPLETED|Overall Study||21||
48439166|NCT03387423|101409834|FG003|NOT COMPLETED|Overall Study||24||
48439167|NCT03409328|101409835|FG000|STARTED|Overall Study||31||
48439168|NCT03409328|101409836|FG001|STARTED|Overall Study||29||
48439169|NCT03409328|101409835|FG000|COMPLETED|Overall Study||25||
48439170|NCT03409328|101409836|FG001|COMPLETED|Overall Study||26||
48439171|NCT03409328|101409835|FG000|NOT COMPLETED|Overall Study||6||
48439172|NCT03409328|101409836|FG001|NOT COMPLETED|Overall Study||3||
48439173|NCT01915498|101409837|FG000|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7||
48439174|NCT01915498|101409838|FG001|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7||
48439175|NCT01915498|101409839|FG002|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7||
48439176|NCT01915498|101409840|FG003|STARTED|Main Analysis (Sept 2013 - Sept 2017)||8||
48439177|NCT01915498|101409841|FG004|STARTED|Main Analysis (Sept 2013 - Sept 2017)||5||
48439178|NCT01915498|101409842|FG005|STARTED|Main Analysis (Sept 2013 - Sept 2017)||9||
48439179|NCT01915498|101409843|FG006|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7||
48439180|NCT01915498|101409844|FG007|STARTED|Main Analysis (Sept 2013 - Sept 2017)||22||
48439181|NCT01915498|101409845|FG008|STARTED|Main Analysis (Sept 2013 - Sept 2017)||6||
48439182|NCT01915498|101409846|FG009|STARTED|Main Analysis (Sept 2013 - Sept 2017)||14||
48439183|NCT01915498|101409847|FG010|STARTED|Main Analysis (Sept 2013 - Sept 2017)||9||
48439184|NCT01915498|101409848|FG011|STARTED|Main Analysis (Sept 2013 - Sept 2017)||5||
48439185|NCT01915498|101409849|FG012|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7||
48767197|NCT04225897|102218605|FG005|Treated|Part A (Screening Visit to Day 7)||0||
48767198|NCT04225897|102218606|FG006|Treated|Part A (Screening Visit to Day 7)||0||
48767199|NCT04225897|102218607|FG007|Treated|Part A (Screening Visit to Day 7)||0||
48767200|NCT04225897|102218608|FG008|Treated|Part A (Screening Visit to Day 7)||0||
48767201|NCT04225897|102218609|FG009|Treated|Part A (Screening Visit to Day 7)||0||
48767202|NCT04225897|102218610|FG010|Treated|Part A (Screening Visit to Day 7)||0||
48439186|NCT01915498|101409850|FG013|STARTED|Main Analysis (Sept 2013 - Sept 2017)||49||
48439187|NCT01915498|101409851|FG014|STARTED|Main Analysis (Sept 2013 - Sept 2017)||25||
48439188|NCT01915498|101409852|FG015|STARTED|Main Analysis (Sept 2013 - Sept 2017)||25||
48439189|NCT01915498|101409853|FG016|STARTED|Main Analysis (Sept 2013 - Sept 2017)||27||
48439190|NCT01915498|101409854|FG017|STARTED|Main Analysis (Sept 2013 - Sept 2017)||106||
48439191|NCT01915498|101409855|FG018|STARTED|Main Analysis (Sept 2013 - Sept 2017)||0||
48439192|NCT01915498|101409837|FG000|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0|Completed indicates participants continuing treatment as of 01 September|
48767203|NCT04225897|102218611|FG011|Treated|Part A (Screening Visit to Day 7)||0||
48767204|NCT04225897|102218600|FG000|COMPLETED|Part A (Screening Visit to Day 7)||3||
48439193|NCT01915498|101409838|FG001|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0|Completed indicates participants continuing treatment as of 01 September|
48439194|NCT01915498|101409839|FG002|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0|Completed indicates participants continuing treatment as of 01 September|
48439195|NCT01915498|101409840|FG003|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0|Completed indicates participants continuing treatment as of 01 September|
48439196|NCT01915498|101409841|FG004|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0|Completed indicates participants continuing treatment as of 01 September|
48439197|NCT01915498|101409842|FG005|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0|Completed indicates participants continuing treatment as of 01 September|
48439198|NCT01915498|101409843|FG006|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0|Completed indicates participants continuing treatment as of 01 September|
48656802|NCT00861705|101943703|FG001|NOT COMPLETED|Overall Study||3||
48656803|NCT00861705|101943704|FG002|NOT COMPLETED|Overall Study||0||
48656804|NCT00861705|101943705|FG003|NOT COMPLETED|Overall Study||1||
48656805|NCT05263791|101943706|FG000|STARTED|Overall Study||284||
48767205|NCT04225897|102218601|FG001|COMPLETED|Part A (Screening Visit to Day 7)||6||
48767206|NCT04225897|102218602|FG002|COMPLETED|Part A (Screening Visit to Day 7)||1||
48767207|NCT04225897|102218603|FG003|COMPLETED|Part A (Screening Visit to Day 7)||6||
48767208|NCT04225897|102218604|FG004|COMPLETED|Part A (Screening Visit to Day 7)||0||
48767209|NCT04225897|102218605|FG005|COMPLETED|Part A (Screening Visit to Day 7)||0||
48767210|NCT04225897|102218606|FG006|COMPLETED|Part A (Screening Visit to Day 7)||0||
48767211|NCT04225897|102218607|FG007|COMPLETED|Part A (Screening Visit to Day 7)||0||
48767212|NCT04225897|102218608|FG008|COMPLETED|Part A (Screening Visit to Day 7)||0||
48767213|NCT04225897|102218609|FG009|COMPLETED|Part A (Screening Visit to Day 7)||0||
48767214|NCT04225897|102218610|FG010|COMPLETED|Part A (Screening Visit to Day 7)||0||
48767215|NCT04225897|102218611|FG011|COMPLETED|Part A (Screening Visit to Day 7)||0||
48767216|NCT04225897|102218600|FG000|NOT COMPLETED|Part A (Screening Visit to Day 7)||0||
48767217|NCT04225897|102218601|FG001|NOT COMPLETED|Part A (Screening Visit to Day 7)||1||
48767218|NCT04225897|102218602|FG002|NOT COMPLETED|Part A (Screening Visit to Day 7)||2||
48767219|NCT04225897|102218603|FG003|NOT COMPLETED|Part A (Screening Visit to Day 7)||0||
48767220|NCT04225897|102218604|FG004|NOT COMPLETED|Part A (Screening Visit to Day 7)||0||
48767221|NCT04225897|102218605|FG005|NOT COMPLETED|Part A (Screening Visit to Day 7)||0||
48767222|NCT04225897|102218606|FG006|NOT COMPLETED|Part A (Screening Visit to Day 7)||0||
48767223|NCT04225897|102218607|FG007|NOT COMPLETED|Part A (Screening Visit to Day 7)||0||
48767224|NCT04225897|102218608|FG008|NOT COMPLETED|Part A (Screening Visit to Day 7)||0||
48767225|NCT04225897|102218609|FG009|NOT COMPLETED|Part A (Screening Visit to Day 7)||0||
48767226|NCT04225897|102218610|FG010|NOT COMPLETED|Part A (Screening Visit to Day 7)||0||
48767227|NCT04225897|102218611|FG011|NOT COMPLETED|Part A (Screening Visit to Day 7)||0||
48767228|NCT04225897|102218600|FG000|STARTED|Part B (Screening Visit to Day 12)||0||
48767229|NCT04225897|102218601|FG001|STARTED|Part B (Screening Visit to Day 12)||0||
48767230|NCT04225897|102218602|FG002|STARTED|Part B (Screening Visit to Day 12)||0||
48767231|NCT04225897|102218603|FG003|STARTED|Part B (Screening Visit to Day 12)||0||
48767232|NCT04225897|102218604|FG004|STARTED|Part B (Screening Visit to Day 12)||3||
48767233|NCT04225897|102218605|FG005|STARTED|Part B (Screening Visit to Day 12)||3||
48767234|NCT04225897|102218606|FG006|STARTED|Part B (Screening Visit to Day 12)||4||
48767235|NCT04225897|102218607|FG007|STARTED|Part B (Screening Visit to Day 12)||3||
48767236|NCT04225897|102218608|FG008|STARTED|Part B (Screening Visit to Day 12)||1||
48767237|NCT04225897|102218609|FG009|STARTED|Part B (Screening Visit to Day 12)||4||
48367912|NCT00301067|101230075|FG003|COMPLETED|Completed 12 Cycles of Treatment||0||
48367913|NCT00301067|101230072|FG000|NOT COMPLETED|Completed 12 Cycles of Treatment||0||
48367914|NCT00301067|101230073|FG001|NOT COMPLETED|Completed 12 Cycles of Treatment||1||
48367915|NCT00301067|101230074|FG002|NOT COMPLETED|Completed 12 Cycles of Treatment||0||
48439199|NCT01915498|101409844|FG007|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||1|Completed indicates participants continuing treatment as of 01 September|
48439200|NCT01915498|101409845|FG008|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0|Completed indicates participants continuing treatment as of 01 September|
48439201|NCT01915498|101409846|FG009|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0|Completed indicates participants continuing treatment as of 01 September|
48439202|NCT01915498|101409847|FG010|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0|Completed indicates participants continuing treatment as of 01 September|
48439203|NCT01915498|101409848|FG011|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||1|Completed indicates participants continuing treatment as of 01 September|
48439204|NCT01915498|101409849|FG012|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0|Completed indicates participants continuing treatment as of 01 September|
48439205|NCT01915498|101409850|FG013|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||3|Completed indicates participants continuing treatment as of 01 September|
48439206|NCT01915498|101409851|FG014|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0|Completed indicates participants continuing treatment as of 01 September|
48439207|NCT01915498|101409852|FG015|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||2|Completed indicates participants continuing treatment as of 01 September|
48767238|NCT04225897|102218610|FG010|STARTED|Part B (Screening Visit to Day 12)||6||
48767239|NCT04225897|102218611|FG011|STARTED|Part B (Screening Visit to Day 12)||8||
48767240|NCT04225897|102218600|FG000|Treated|Part B (Screening Visit to Day 12)||0||
48767241|NCT04225897|102218601|FG001|Treated|Part B (Screening Visit to Day 12)||0||
48767242|NCT04225897|102218602|FG002|Treated|Part B (Screening Visit to Day 12)||0||
48767243|NCT04225897|102218603|FG003|Treated|Part B (Screening Visit to Day 12)||0||
48767244|NCT04225897|102218604|FG004|Treated|Part B (Screening Visit to Day 12)||3||
48767245|NCT04225897|102218605|FG005|Treated|Part B (Screening Visit to Day 12)||3||
48767246|NCT04225897|102218606|FG006|Treated|Part B (Screening Visit to Day 12)||4||
48767247|NCT04225897|102218607|FG007|Treated|Part B (Screening Visit to Day 12)||3||
48767248|NCT04225897|102218608|FG008|Treated|Part B (Screening Visit to Day 12)||1||
48767249|NCT04225897|102218609|FG009|Treated|Part B (Screening Visit to Day 12)||4||
48767250|NCT04225897|102218610|FG010|Treated|Part B (Screening Visit to Day 12)||6||
48767251|NCT04225897|102218611|FG011|Treated|Part B (Screening Visit to Day 12)||8||
48767252|NCT04225897|102218600|FG000|COMPLETED|Part B (Screening Visit to Day 12)||0||
48767253|NCT04225897|102218601|FG001|COMPLETED|Part B (Screening Visit to Day 12)||0||
48767254|NCT04225897|102218602|FG002|COMPLETED|Part B (Screening Visit to Day 12)||0||
48367916|NCT00301067|101230075|FG003|NOT COMPLETED|Completed 12 Cycles of Treatment||2||
48367917|NCT00301067|101230072|FG000|STARTED|Follow up Until Death||4|All patients that receive treatment on study go into the follow up period for study.|
48367918|NCT00301067|101230073|FG001|STARTED|Follow up Until Death||3|All patients that receive treatment on study go into the follow up period for study.|
48367919|NCT00301067|101230074|FG002|STARTED|Follow up Until Death||3|All patients that receive treatment on study go into the follow up period for study.|
48767255|NCT04225897|102218603|FG003|COMPLETED|Part B (Screening Visit to Day 12)||0||
48767256|NCT04225897|102218604|FG004|COMPLETED|Part B (Screening Visit to Day 12)||3||
48767257|NCT04225897|102218605|FG005|COMPLETED|Part B (Screening Visit to Day 12)||3||
48767258|NCT04225897|102218606|FG006|COMPLETED|Part B (Screening Visit to Day 12)||4||
48767259|NCT04225897|102218607|FG007|COMPLETED|Part B (Screening Visit to Day 12)||2||
48767260|NCT04225897|102218608|FG008|COMPLETED|Part B (Screening Visit to Day 12)||1||
48767261|NCT04225897|102218609|FG009|COMPLETED|Part B (Screening Visit to Day 12)||4||
48767262|NCT04225897|102218610|FG010|COMPLETED|Part B (Screening Visit to Day 12)||6||
48439208|NCT01915498|101409853|FG016|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||3|Completed indicates participants continuing treatment as of 01 September|
48439209|NCT01915498|101409854|FG017|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||6|Completed indicates participants continuing treatment as of 01 September|
48439210|NCT01915498|101409855|FG018|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0|Completed indicates participants continuing treatment as of 01 September|
48439211|NCT01915498|101409837|FG000|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7||
48439212|NCT01915498|101409838|FG001|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7||
48439213|NCT01915498|101409839|FG002|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7||
48439214|NCT01915498|101409840|FG003|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||8||
48439215|NCT01915498|101409841|FG004|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||5||
48439216|NCT01915498|101409842|FG005|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||9||
48439217|NCT01915498|101409843|FG006|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7||
48439218|NCT01915498|101409844|FG007|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||21||
48439219|NCT01915498|101409845|FG008|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||6||
48439220|NCT01915498|101409846|FG009|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||14||
48439221|NCT01915498|101409847|FG010|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||9||
48439222|NCT01915498|101409848|FG011|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||4||
48439223|NCT01915498|101409849|FG012|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7||
48439224|NCT01915498|101409850|FG013|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||46||
48439225|NCT01915498|101409851|FG014|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||25||
48439226|NCT01915498|101409852|FG015|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||23||
48439227|NCT01915498|101409853|FG016|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||24||
48439228|NCT01915498|101409854|FG017|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||100||
48439229|NCT01915498|101409855|FG018|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0||
48439230|NCT01915498|101409837|FG000|STARTED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439231|NCT01915498|101409838|FG001|STARTED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439232|NCT01915498|101409839|FG002|STARTED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439233|NCT01915498|101409840|FG003|STARTED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439234|NCT01915498|101409841|FG004|STARTED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439235|NCT01915498|101409842|FG005|STARTED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439236|NCT01915498|101409843|FG006|STARTED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439237|NCT01915498|101409844|FG007|STARTED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439238|NCT01915498|101409845|FG008|STARTED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439239|NCT01915498|101409846|FG009|STARTED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439240|NCT01915498|101409847|FG010|STARTED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439241|NCT01915498|101409848|FG011|STARTED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439242|NCT01915498|101409849|FG012|STARTED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439243|NCT01915498|101409850|FG013|STARTED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439244|NCT01915498|101409851|FG014|STARTED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439245|NCT01915498|101409852|FG015|STARTED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439246|NCT01915498|101409853|FG016|STARTED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439247|NCT01915498|101409854|FG017|STARTED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439248|NCT01915498|101409855|FG018|STARTED|Safety Follow-up (Sep 2017 to July 2019)||16||
48439249|NCT01915498|101409837|FG000|COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439250|NCT01915498|101409838|FG001|COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439251|NCT01915498|101409839|FG002|COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439252|NCT01915498|101409840|FG003|COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439253|NCT01915498|101409841|FG004|COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439254|NCT01915498|101409842|FG005|COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48767263|NCT04225897|102218611|FG011|COMPLETED|Part B (Screening Visit to Day 12)||8||
48767264|NCT04225897|102218600|FG000|NOT COMPLETED|Part B (Screening Visit to Day 12)||0||
48767265|NCT04225897|102218601|FG001|NOT COMPLETED|Part B (Screening Visit to Day 12)||0||
48767266|NCT04225897|102218602|FG002|NOT COMPLETED|Part B (Screening Visit to Day 12)||0||
48767267|NCT04225897|102218603|FG003|NOT COMPLETED|Part B (Screening Visit to Day 12)||0||
48767268|NCT04225897|102218604|FG004|NOT COMPLETED|Part B (Screening Visit to Day 12)||0||
48767269|NCT04225897|102218605|FG005|NOT COMPLETED|Part B (Screening Visit to Day 12)||0||
48439255|NCT01915498|101409843|FG006|COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439256|NCT01915498|101409844|FG007|COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439257|NCT01915498|101409845|FG008|COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439258|NCT01915498|101409846|FG009|COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439259|NCT01915498|101409847|FG010|COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439260|NCT01915498|101409848|FG011|COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439261|NCT01915498|101409849|FG012|COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439262|NCT01915498|101409850|FG013|COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439263|NCT01915498|101409851|FG014|COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439264|NCT01915498|101409852|FG015|COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439265|NCT01915498|101409853|FG016|COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48767270|NCT04225897|102218606|FG006|NOT COMPLETED|Part B (Screening Visit to Day 12)||0||
48767271|NCT04225897|102218607|FG007|NOT COMPLETED|Part B (Screening Visit to Day 12)||1||
48767272|NCT04225897|102218608|FG008|NOT COMPLETED|Part B (Screening Visit to Day 12)||0||
48767273|NCT04225897|102218609|FG009|NOT COMPLETED|Part B (Screening Visit to Day 12)||0||
48767274|NCT04225897|102218610|FG010|NOT COMPLETED|Part B (Screening Visit to Day 12)||0||
48767275|NCT04225897|102218611|FG011|NOT COMPLETED|Part B (Screening Visit to Day 12)||0||
48767276|NCT01047358|102218612|FG000|STARTED|Overall Study||206||
48767277|NCT01047358|102218612|FG000|COMPLETED|Overall Study||206||
48188497|NCT04582045|100783259|FG001|STARTED|Overall Study||440||
48439266|NCT01915498|101409854|FG017|COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439267|NCT01915498|101409855|FG018|COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||14||
48439268|NCT01915498|101409837|FG000|NOT COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439269|NCT01915498|101409838|FG001|NOT COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439270|NCT01915498|101409839|FG002|NOT COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439271|NCT01915498|101409840|FG003|NOT COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439272|NCT01915498|101409841|FG004|NOT COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439273|NCT01915498|101409842|FG005|NOT COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439274|NCT01915498|101409843|FG006|NOT COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439275|NCT01915498|101409844|FG007|NOT COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439276|NCT01915498|101409845|FG008|NOT COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439277|NCT01915498|101409846|FG009|NOT COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439278|NCT01915498|101409847|FG010|NOT COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439279|NCT01915498|101409848|FG011|NOT COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48767278|NCT01047358|102218612|FG000|NOT COMPLETED|Overall Study||0||
48767279|NCT03651479|102218613|FG000|STARTED|Overall Study||20||
48767280|NCT03651479|102218614|FG001|STARTED|Overall Study||20||
48767281|NCT03651479|102218613|FG000|COMPLETED|Overall Study||20||
48767282|NCT03651479|102218614|FG001|COMPLETED|Overall Study||20||
48767283|NCT03651479|102218613|FG000|NOT COMPLETED|Overall Study||0||
48767284|NCT03651479|102218614|FG001|NOT COMPLETED|Overall Study||0||
48767285|NCT02153086|102218615|FG000|STARTED|Overall Study||236||
48767286|NCT02153086|102218615|FG000|COMPLETED|Overall Study||232||
48767287|NCT02153086|102218615|FG000|NOT COMPLETED|Overall Study||4||
48767288|NCT01353898|102218616|FG000|STARTED|Overall Study||2||
48767289|NCT01353898|102218617|FG001|STARTED|Overall Study||2||
48439280|NCT01915498|101409849|FG012|NOT COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439281|NCT01915498|101409850|FG013|NOT COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439282|NCT01915498|101409851|FG014|NOT COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439283|NCT01915498|101409852|FG015|NOT COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439284|NCT01915498|101409853|FG016|NOT COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439285|NCT01915498|101409854|FG017|NOT COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||0||
48439286|NCT01915498|101409855|FG018|NOT COMPLETED|Safety Follow-up (Sep 2017 to July 2019)||2||
48439287|NCT01915498|101409837|FG000|STARTED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439288|NCT01915498|101409838|FG001|STARTED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439289|NCT01915498|101409839|FG002|STARTED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439290|NCT01915498|101409840|FG003|STARTED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439291|NCT01915498|101409841|FG004|STARTED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439292|NCT01915498|101409842|FG005|STARTED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439293|NCT01915498|101409843|FG006|STARTED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439294|NCT01915498|101409844|FG007|STARTED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439295|NCT01915498|101409845|FG008|STARTED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439296|NCT01915498|101409846|FG009|STARTED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439297|NCT01915498|101409847|FG010|STARTED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439298|NCT01915498|101409848|FG011|STARTED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439299|NCT01915498|101409849|FG012|STARTED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439300|NCT01915498|101409850|FG013|STARTED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439301|NCT01915498|101409851|FG014|STARTED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439302|NCT01915498|101409852|FG015|STARTED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439303|NCT01915498|101409853|FG016|STARTED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439304|NCT01915498|101409854|FG017|STARTED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48767290|NCT01353898|102218618|FG002|STARTED|Overall Study||2||
48767291|NCT01353898|102218619|FG003|STARTED|Overall Study||2||
48767292|NCT01353898|102218620|FG004|STARTED|Overall Study||2||
48767293|NCT01353898|102218621|FG005|STARTED|Overall Study||2||
48767294|NCT01353898|102218616|FG000|COMPLETED|Overall Study||2||
48767295|NCT01353898|102218617|FG001|COMPLETED|Overall Study||2||
48767296|NCT01353898|102218618|FG002|COMPLETED|Overall Study||2||
48767297|NCT01353898|102218619|FG003|COMPLETED|Overall Study||2||
48767298|NCT01353898|102218620|FG004|COMPLETED|Overall Study||2||
48767299|NCT01353898|102218621|FG005|COMPLETED|Overall Study||1||
48767300|NCT01353898|102218616|FG000|NOT COMPLETED|Overall Study||0||
48188498|NCT04582045|100783260|FG002|STARTED|Overall Study||95||
48439305|NCT01915498|101409855|FG018|STARTED|Safety Follow up (Aug 2019 to Sep 2023)||2||
48439306|NCT01915498|101409837|FG000|COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439307|NCT01915498|101409838|FG001|COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439308|NCT01915498|101409839|FG002|COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439309|NCT01915498|101409840|FG003|COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439310|NCT01915498|101409841|FG004|COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439311|NCT01915498|101409842|FG005|COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439312|NCT01915498|101409843|FG006|COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439313|NCT01915498|101409844|FG007|COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439314|NCT01915498|101409845|FG008|COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439315|NCT01915498|101409846|FG009|COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439316|NCT01915498|101409847|FG010|COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439317|NCT01915498|101409848|FG011|COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439318|NCT01915498|101409849|FG012|COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48767301|NCT01353898|102218617|FG001|NOT COMPLETED|Overall Study||0||
48767302|NCT01353898|102218618|FG002|NOT COMPLETED|Overall Study||0||
48767303|NCT01353898|102218619|FG003|NOT COMPLETED|Overall Study||0||
48767304|NCT01353898|102218620|FG004|NOT COMPLETED|Overall Study||0||
48767305|NCT01353898|102218621|FG005|NOT COMPLETED|Overall Study||1||
48767306|NCT02007096|102218622|FG000|STARTED|Overall Study||63||
48767307|NCT02007096|102218623|FG001|STARTED|Overall Study||64||
48767308|NCT02007096|102218622|FG000|COMPLETED|Overall Study||52||
48767309|NCT02007096|102218623|FG001|COMPLETED|Overall Study||48||
48767310|NCT02007096|102218622|FG000|NOT COMPLETED|Overall Study||11||
48767311|NCT02007096|102218623|FG001|NOT COMPLETED|Overall Study||16||
48767312|NCT00321620|102218624|FG000|STARTED|Overall Study||951||
48767313|NCT00321620|102218625|FG001|STARTED|Overall Study||950||
48767314|NCT00321620|102218624|FG000|Received Investigational Product|Overall Study||946||
48767315|NCT00321620|102218625|FG001|Received Investigational Product|Overall Study||942||
48767316|NCT00321620|102218624|FG000|COMPLETED|Overall Study||208||
48767317|NCT00321620|102218625|FG001|COMPLETED|Overall Study||228||
48188499|NCT04582045|100783261|FG003|STARTED|Overall Study||83||
48767318|NCT00321620|102218624|FG000|NOT COMPLETED|Overall Study||743||
48767319|NCT00321620|102218625|FG001|NOT COMPLETED|Overall Study||722||
48767320|NCT01615120|102218626|FG000|STARTED|Overall Study||38||
48767321|NCT01615120|102218627|FG001|STARTED|Overall Study||39||
48767322|NCT01615120|102218626|FG000|COMPLETED|Overall Study||23||
48767323|NCT01615120|102218627|FG001|COMPLETED|Overall Study||19||
48767324|NCT01615120|102218626|FG000|NOT COMPLETED|Overall Study||15||
48439319|NCT01915498|101409850|FG013|COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439320|NCT01915498|101409851|FG014|COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439321|NCT01915498|101409852|FG015|COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439322|NCT01915498|101409853|FG016|COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439323|NCT01915498|101409854|FG017|COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439324|NCT01915498|101409855|FG018|COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439325|NCT01915498|101409837|FG000|NOT COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439326|NCT01915498|101409838|FG001|NOT COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439327|NCT01915498|101409839|FG002|NOT COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439328|NCT01915498|101409840|FG003|NOT COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439329|NCT01915498|101409841|FG004|NOT COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439330|NCT01915498|101409842|FG005|NOT COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439331|NCT01915498|101409843|FG006|NOT COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439332|NCT01915498|101409844|FG007|NOT COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439333|NCT01915498|101409845|FG008|NOT COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439334|NCT01915498|101409846|FG009|NOT COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439335|NCT01915498|101409847|FG010|NOT COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439336|NCT01915498|101409848|FG011|NOT COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439337|NCT01915498|101409849|FG012|NOT COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439338|NCT01915498|101409850|FG013|NOT COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439339|NCT01915498|101409851|FG014|NOT COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439340|NCT01915498|101409852|FG015|NOT COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439341|NCT01915498|101409853|FG016|NOT COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439342|NCT01915498|101409854|FG017|NOT COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||0||
48439343|NCT01915498|101409855|FG018|NOT COMPLETED|Safety Follow up (Aug 2019 to Sep 2023)||2||
48439344|NCT00962013|101409856|FG000|STARTED|Overall Study||120||
48439345|NCT00962013|101409856|FG000|COMPLETED|Overall Study||52||
48439346|NCT00962013|101409856|FG000|NOT COMPLETED|Overall Study||68||
48439347|NCT03606109|101409857|FG000|STARTED|Overall Study||31||
48439348|NCT03606109|101409858|FG001|STARTED|Overall Study||27||
48439349|NCT03606109|101409857|FG000|COMPLETED|Overall Study||29||
48439350|NCT03606109|101409858|FG001|COMPLETED|Overall Study||26||
48439351|NCT03606109|101409857|FG000|NOT COMPLETED|Overall Study||2||
48439352|NCT03606109|101409858|FG001|NOT COMPLETED|Overall Study||1||
48439353|NCT04355767|101409859|FG000|STARTED|Overall Study||257||
48439354|NCT04355767|101409860|FG001|STARTED|Overall Study||254||
48656806|NCT05263791|101943706|FG000|COMPLETED|Overall Study||255||
48656807|NCT05263791|101943706|FG000|NOT COMPLETED|Overall Study||29||
48439355|NCT04355767|101409859|FG000|Intention-to-treat Population|Overall Study||257||
48439356|NCT04355767|101409860|FG001|Intention-to-treat Population|Overall Study||254||
48439357|NCT04355767|101409859|FG000|Had Data for 15-day Outcome|Overall Study||257||
48439358|NCT04355767|101409860|FG001|Had Data for 15-day Outcome|Overall Study||254||
48439359|NCT04355767|101409859|FG000|COMPLETED|Overall Study||250||
48439360|NCT04355767|101409860|FG001|COMPLETED|Overall Study||251||
48439361|NCT04355767|101409859|FG000|NOT COMPLETED|Overall Study||7||
48439362|NCT04355767|101409860|FG001|NOT COMPLETED|Overall Study||3||
48439363|NCT01736527|101409861|FG000|STARTED|Overall Study||12||
48439364|NCT01736527|101409861|FG000|COMPLETED|Overall Study||12||
48439365|NCT01736527|101409861|FG000|NOT COMPLETED|Overall Study||0||
48439366|NCT02353572|101409862|FG000|STARTED|Overall Study||3||
48439367|NCT02353572|101409862|FG000|COMPLETED|Overall Study||0||
48439368|NCT02353572|101409862|FG000|NOT COMPLETED|Overall Study||3||
48439369|NCT02719639|101409863|FG000|STARTED|Overall Study||7443||
48439370|NCT02719639|101409863|FG000|COMPLETED|Overall Study||7443||
48439371|NCT02719639|101409863|FG000|NOT COMPLETED|Overall Study||0||
48439372|NCT01901393|101409864|FG000|STARTED|Overall Study||51||
48439373|NCT01901393|101409865|FG001|STARTED|Overall Study||49||
48439374|NCT01901393|101409864|FG000|COMPLETED|Overall Study||50||
48439375|NCT01901393|101409865|FG001|COMPLETED|Overall Study||49||
48439376|NCT01901393|101409864|FG000|NOT COMPLETED|Overall Study||1||
48439377|NCT01901393|101409865|FG001|NOT COMPLETED|Overall Study||0||
48439378|NCT03075215|101409866|FG000|STARTED|12-Month Primary Endpoint||2005||
48439379|NCT03075215|101409866|FG000|COMPLETED|12-Month Primary Endpoint||1586||
48439380|NCT03075215|101409866|FG000|NOT COMPLETED|12-Month Primary Endpoint||419||
48439381|NCT03075215|101409866|FG000|STARTED|Post Market Clinical Follow-Up ONLY||103||
48439382|NCT03075215|101409866|FG000|COMPLETED|Post Market Clinical Follow-Up ONLY||63||
48439383|NCT03075215|101409866|FG000|NOT COMPLETED|Post Market Clinical Follow-Up ONLY||40||
48439384|NCT01354015|101409867|FG000|STARTED|Overall Study||50||
48188500|NCT04582045|100783258|FG000|COMPLETED|Overall Study||446||
48439385|NCT01354015|101409868|FG001|STARTED|Overall Study||48||
48439386|NCT01354015|101409867|FG000|COMPLETED|Overall Study||44||
48656808|NCT05626686|101943707|FG000|STARTED|Overall Study||39||
48439387|NCT01354015|101409868|FG001|COMPLETED|Overall Study||43||
48439388|NCT01354015|101409867|FG000|NOT COMPLETED|Overall Study||6||
48439389|NCT01354015|101409868|FG001|NOT COMPLETED|Overall Study||5||
48439390|NCT04611152|101409869|FG000|STARTED|Overall Study||230||
48656809|NCT05626686|101943707|FG000|COMPLETED|Overall Study||33||
48439391|NCT04611152|101409870|FG001|STARTED|Overall Study||230||
48439392|NCT04611152|101409869|FG000|COMPLETED|Overall Study||204|Completed is defined as participants who completed treatment through Week 64.|
48439393|NCT04611152|101409870|FG001|COMPLETED|Overall Study||211|Completed is defined as participants who completed treatment through Week 64.|
48439394|NCT04611152|101409869|FG000|NOT COMPLETED|Overall Study||26||
48439395|NCT04611152|101409870|FG001|NOT COMPLETED|Overall Study||19||
48439396|NCT01939834|101409871|FG000|STARTED|First Phase (Overnight CLC or SAP)||5||
48767325|NCT01615120|102218627|FG001|NOT COMPLETED|Overall Study||20||
48767326|NCT01189032|102218628|FG000|STARTED|Overall Study||94||
48767327|NCT01189032|102218629|FG001|STARTED|Overall Study||96||
48767328|NCT01189032|102218630|FG002|STARTED|Overall Study||96||
48767329|NCT01189032|102218628|FG000|COMPLETED|Overall Study||89||
48767330|NCT01189032|102218629|FG001|COMPLETED|Overall Study||89||
48767331|NCT01189032|102218630|FG002|COMPLETED|Overall Study||90||
48767332|NCT01189032|102218628|FG000|NOT COMPLETED|Overall Study||5||
48767333|NCT01189032|102218629|FG001|NOT COMPLETED|Overall Study||7||
48767334|NCT01189032|102218630|FG002|NOT COMPLETED|Overall Study||6||
48767335|NCT04434937|102218631|FG000|STARTED|Overall Study||42||
48767336|NCT04434937|102218631|FG000|COMPLETED|Overall Study||0||
48767337|NCT04434937|102218631|FG000|NOT COMPLETED|Overall Study||42||
48767338|NCT01967940|102218632|FG000|STARTED|Part 1||12||
48767339|NCT01967940|102218633|FG001|STARTED|Part 1||28||
48767340|NCT01967940|102218634|FG002|STARTED|Part 1||15||
48767341|NCT01967940|102218635|FG003|STARTED|Part 1||0||
48767342|NCT01967940|102218632|FG000|COMPLETED|Part 1||12||
48767343|NCT01967940|102218633|FG001|COMPLETED|Part 1||28||
48767344|NCT01967940|102218634|FG002|COMPLETED|Part 1||15||
48767345|NCT01967940|102218635|FG003|COMPLETED|Part 1||0||
48767346|NCT01967940|102218632|FG000|NOT COMPLETED|Part 1||0||
48767347|NCT01967940|102218633|FG001|NOT COMPLETED|Part 1||0||
48767348|NCT01967940|102218634|FG002|NOT COMPLETED|Part 1||0||
48767349|NCT01967940|102218635|FG003|NOT COMPLETED|Part 1||0||
48439397|NCT01939834|101409872|FG001|STARTED|First Phase (Overnight CLC or SAP)||5||
48439398|NCT01939834|101409871|FG000|COMPLETED|First Phase (Overnight CLC or SAP)||5||
48439399|NCT01939834|101409872|FG001|COMPLETED|First Phase (Overnight CLC or SAP)||5||
48439400|NCT01939834|101409871|FG000|NOT COMPLETED|First Phase (Overnight CLC or SAP)||0||
48439401|NCT01939834|101409872|FG001|NOT COMPLETED|First Phase (Overnight CLC or SAP)||0||
48439402|NCT01939834|101409871|FG000|STARTED|Second Phase (SAP or Overnight CLC)||5||
48439403|NCT01939834|101409872|FG001|STARTED|Second Phase (SAP or Overnight CLC)||5||
48439404|NCT01939834|101409871|FG000|COMPLETED|Second Phase (SAP or Overnight CLC)||5||
48439405|NCT01939834|101409872|FG001|COMPLETED|Second Phase (SAP or Overnight CLC)||5||
48439406|NCT01939834|101409871|FG000|NOT COMPLETED|Second Phase (SAP or Overnight CLC)||0||
48439407|NCT01939834|101409872|FG001|NOT COMPLETED|Second Phase (SAP or Overnight CLC)||0||
48439408|NCT00538473|101409873|FG000|STARTED|Overall Study||33||
48439409|NCT00538473|101409874|FG001|STARTED|Overall Study||35||
48439410|NCT00538473|101409873|FG000|COMPLETED|Overall Study||32||
48439411|NCT00538473|101409874|FG001|COMPLETED|Overall Study||35||
48439412|NCT00538473|101409873|FG000|NOT COMPLETED|Overall Study||1||
48439413|NCT00538473|101409874|FG001|NOT COMPLETED|Overall Study||0||
48439414|NCT00663039|101409875|FG000|STARTED|Overall Study||14||
48439415|NCT00663039|101409876|FG001|STARTED|Overall Study||13||
48439416|NCT00663039|101409875|FG000|COMPLETED|Overall Study||10||
48439417|NCT00663039|101409876|FG001|COMPLETED|Overall Study||9||
48439418|NCT00663039|101409875|FG000|NOT COMPLETED|Overall Study||4||
48439419|NCT00663039|101409876|FG001|NOT COMPLETED|Overall Study||4||
48439420|NCT01615822|101409877|FG000|STARTED|Period 1||8||
48767350|NCT01967940|102218632|FG000|STARTED|Part 2||0||
48767351|NCT01967940|102218633|FG001|STARTED|Part 2||0||
48767352|NCT01967940|102218634|FG002|STARTED|Part 2||0||
48767353|NCT01967940|102218635|FG003|STARTED|Part 2||38||
48767354|NCT01967940|102218632|FG000|COMPLETED|Part 2||0||
48767355|NCT01967940|102218633|FG001|COMPLETED|Part 2||0||
48188501|NCT04582045|100783259|FG001|COMPLETED|Overall Study||440||
48188502|NCT04582045|100783260|FG002|COMPLETED|Overall Study||95||
48439421|NCT01615822|101409878|FG001|STARTED|Period 1||11||
48439422|NCT01615822|101409879|FG002|STARTED|Period 1||6||
48439423|NCT01615822|101409877|FG000|COMPLETED|Period 1||7||
48767356|NCT01967940|102218634|FG002|COMPLETED|Part 2||0||
48767357|NCT01967940|102218635|FG003|COMPLETED|Part 2||35||
48767358|NCT01967940|102218632|FG000|NOT COMPLETED|Part 2||0||
48767359|NCT01967940|102218633|FG001|NOT COMPLETED|Part 2||0||
48767360|NCT01967940|102218634|FG002|NOT COMPLETED|Part 2||0||
48767361|NCT01967940|102218635|FG003|NOT COMPLETED|Part 2||3||
48767362|NCT01389596|102218636|FG000|STARTED|Overall Study||104||
48767363|NCT01389596|102218637|FG001|STARTED|Overall Study||97||
48188503|NCT04582045|100783261|FG003|COMPLETED|Overall Study||83||
48188504|NCT04582045|100783258|FG000|NOT COMPLETED|Overall Study||0||
48767364|NCT01389596|102218638|FG002|STARTED|Overall Study||94||
48767365|NCT01389596|102218636|FG000|COMPLETED|Overall Study||94||
48767366|NCT01389596|102218637|FG001|COMPLETED|Overall Study||81||
48767367|NCT01389596|102218638|FG002|COMPLETED|Overall Study||84||
48767368|NCT01389596|102218636|FG000|NOT COMPLETED|Overall Study||10||
48767369|NCT01389596|102218637|FG001|NOT COMPLETED|Overall Study||16||
48767370|NCT01389596|102218638|FG002|NOT COMPLETED|Overall Study||10||
48767371|NCT04081103|102218639|FG000|STARTED|Overall Study||12||12
48439424|NCT01615822|101409878|FG001|COMPLETED|Period 1||9||
48439425|NCT01615822|101409879|FG002|COMPLETED|Period 1||6||
48439426|NCT01615822|101409877|FG000|NOT COMPLETED|Period 1||1||
48439427|NCT01615822|101409878|FG001|NOT COMPLETED|Period 1||2||
48439428|NCT01615822|101409879|FG002|NOT COMPLETED|Period 1||0||
48439429|NCT01615822|101409877|FG000|STARTED|Period 2||7||
48439430|NCT01615822|101409878|FG001|STARTED|Period 2||9||
48439431|NCT01615822|101409879|FG002|STARTED|Period 2||6||
48439432|NCT01615822|101409877|FG000|COMPLETED|Period 2||7||
48439433|NCT01615822|101409878|FG001|COMPLETED|Period 2||8||
48439434|NCT01615822|101409879|FG002|COMPLETED|Period 2||4||
48439435|NCT01615822|101409877|FG000|NOT COMPLETED|Period 2||0||
48439436|NCT01615822|101409878|FG001|NOT COMPLETED|Period 2||1||
48439437|NCT01615822|101409879|FG002|NOT COMPLETED|Period 2||2||
48439438|NCT01988337|101409880|FG000|STARTED|Overall Study||56||130
48439439|NCT01988337|101409880|FG000|Intervention (at Baseline)|Overall Study||56||130
48439440|NCT01988337|101409880|FG000|6 Months Follow up|Overall Study||43||102
48439441|NCT01988337|101409880|FG000|12 Months Follow up|Overall Study||43||102
48439442|NCT01988337|101409880|FG000|COMPLETED|Overall Study||0|36 month follow up was expected for completion.|0
48439443|NCT01988337|101409880|FG000|NOT COMPLETED|Overall Study||56||130
48439444|NCT04456998|101409881|FG000|STARTED|Overall Study||42||
48439445|NCT04456998|101409882|FG001|STARTED|Overall Study||44||
48439446|NCT04456998|101409881|FG000|COMPLETED|Overall Study||42||
48439447|NCT04456998|101409882|FG001|COMPLETED|Overall Study||38||
48439448|NCT04456998|101409881|FG000|NOT COMPLETED|Overall Study||0||
48439449|NCT04456998|101409882|FG001|NOT COMPLETED|Overall Study||6||
48439450|NCT01843660|101409883|FG000|STARTED|Overall Study||1059||
48439451|NCT01843660|101409883|FG000|COMPLETED|Overall Study||1029||
48439452|NCT01843660|101409883|FG000|NOT COMPLETED|Overall Study||30||
48439453|NCT03273257|101409884|FG000|STARTED|Overall Study||7||
48439454|NCT03273257|101409885|FG001|STARTED|Overall Study||7||
48439455|NCT03273257|101409884|FG000|Started Treatment|Overall Study||7||
48439456|NCT03273257|101409885|FG001|Started Treatment|Overall Study||6||
48439457|NCT03273257|101409884|FG000|Underwent PEA|Overall Study||6||
48439458|NCT03273257|101409885|FG001|Underwent PEA|Overall Study||5||
48439459|NCT03273257|101409884|FG000|COMPLETED|Overall Study||3||
48439460|NCT03273257|101409885|FG001|COMPLETED|Overall Study||3||
48439461|NCT03273257|101409884|FG000|NOT COMPLETED|Overall Study||4||
48439462|NCT03273257|101409885|FG001|NOT COMPLETED|Overall Study||4||
48439463|NCT00916617|101409886|FG000|STARTED|Overall Study||24||
48439464|NCT00916617|101409887|FG001|STARTED|Overall Study||21||
48439465|NCT00916617|101409888|FG002|STARTED|Overall Study||10||
48439466|NCT00916617|101409889|FG003|STARTED|Overall Study||7||
48439467|NCT00916617|101409886|FG000|COMPLETED|Overall Study||1||
48439468|NCT00916617|101409887|FG001|COMPLETED|Overall Study||0||
48439469|NCT00916617|101409888|FG002|COMPLETED|Overall Study||0||
48439470|NCT00916617|101409889|FG003|COMPLETED|Overall Study||0||
48439471|NCT00916617|101409886|FG000|NOT COMPLETED|Overall Study||23||
48439472|NCT00916617|101409887|FG001|NOT COMPLETED|Overall Study||21||
48439473|NCT00916617|101409888|FG002|NOT COMPLETED|Overall Study||10||
48439474|NCT00916617|101409889|FG003|NOT COMPLETED|Overall Study||7||
48439475|NCT01067339|101409890|FG000|STARTED|Overall Study||31||
48439476|NCT01067339|101409891|FG001|STARTED|Overall Study||34||
48439477|NCT01067339|101409890|FG000|COMPLETED|Overall Study||25||
48439478|NCT01067339|101409891|FG001|COMPLETED|Overall Study||29||
48439479|NCT01067339|101409890|FG000|NOT COMPLETED|Overall Study||6||
48439480|NCT01067339|101409891|FG001|NOT COMPLETED|Overall Study||5||
48439481|NCT00902265|101409892|FG000|STARTED|Overall Study||138||
48439482|NCT00902265|101409892|FG000|Participants Who Received Treatment|Overall Study||137||
48439483|NCT00902265|101409892|FG000|COMPLETED|Overall Study||132||
48439484|NCT00902265|101409892|FG000|NOT COMPLETED|Overall Study||6||
48439485|NCT01190202|101409893|FG000|STARTED|Overall Study||6404||
48439486|NCT01190202|101409894|FG001|STARTED|Overall Study||6414||
48439487|NCT01190202|101409895|FG002|STARTED|Overall Study||6400||
48439488|NCT01190202|101409896|FG003|STARTED|Overall Study||2400||
48439489|NCT01190202|101409893|FG000|COMPLETED|Overall Study||6404||
48439490|NCT01190202|101409894|FG001|COMPLETED|Overall Study||6414||
48439491|NCT01190202|101409895|FG002|COMPLETED|Overall Study||6400||
48439492|NCT01190202|101409896|FG003|COMPLETED|Overall Study||2400||
48439493|NCT01190202|101409893|FG000|NOT COMPLETED|Overall Study||0||
48439494|NCT01190202|101409894|FG001|NOT COMPLETED|Overall Study||0||
48439495|NCT01190202|101409895|FG002|NOT COMPLETED|Overall Study||0||
48439496|NCT01190202|101409896|FG003|NOT COMPLETED|Overall Study||0||
48439497|NCT02953873|101409897|FG000|STARTED|Overall Study||25||
48439498|NCT02953873|101409897|FG000|COMPLETED|Overall Study||25||
48439499|NCT02953873|101409897|FG000|NOT COMPLETED|Overall Study||0||
48439500|NCT03029104|101409898|FG000|STARTED|Overall Study||745||
48439501|NCT03029104|101409899|FG001|STARTED|Overall Study||735||
48439502|NCT03029104|101409900|FG002|STARTED|Overall Study||748||
48439503|NCT03029104|101409898|FG000|COMPLETED|Overall Study||612||
48439504|NCT03029104|101409899|FG001|COMPLETED|Overall Study||597||
48439505|NCT03029104|101409900|FG002|COMPLETED|Overall Study||623||
48439506|NCT03029104|101409898|FG000|NOT COMPLETED|Overall Study||133||
48439507|NCT03029104|101409899|FG001|NOT COMPLETED|Overall Study||138||
48439508|NCT03029104|101409900|FG002|NOT COMPLETED|Overall Study||125||
48439509|NCT00556166|101409901|FG000|STARTED|Overall Study||4||
48439510|NCT00556166|101409901|FG000|COMPLETED|Overall Study||3||
48439511|NCT00556166|101409901|FG000|NOT COMPLETED|Overall Study||1||
48439512|NCT01341067|101409902|FG000|STARTED|Overall Study||30||
48439513|NCT01341067|101409902|FG000|COMPLETED|Overall Study||26||
48439514|NCT01341067|101409902|FG000|NOT COMPLETED|Overall Study||4||
48439515|NCT03728257|101409903|FG000|STARTED|Overall Study||44||
48439516|NCT03728257|101409904|FG001|STARTED|Overall Study||44||
48439517|NCT03728257|101409903|FG000|COMPLETED|Overall Study||41||
48439518|NCT03728257|101409904|FG001|COMPLETED|Overall Study||44||
48439519|NCT03728257|101409903|FG000|NOT COMPLETED|Overall Study||3||
48439520|NCT03728257|101409904|FG001|NOT COMPLETED|Overall Study||0||
48439521|NCT02626910|101409905|FG000|STARTED|Overall Study||23||
48439522|NCT02626910|101409906|FG001|STARTED|Overall Study||10||
48439523|NCT02626910|101409907|FG002|STARTED|Overall Study||6||
48439524|NCT02626910|101409908|FG003|STARTED|Overall Study||10||
48439525|NCT02626910|101409905|FG000|COMPLETED|Overall Study||23||
48439526|NCT02626910|101409906|FG001|COMPLETED|Overall Study||10||
48439527|NCT02626910|101409907|FG002|COMPLETED|Overall Study||6||
48439528|NCT02626910|101409908|FG003|COMPLETED|Overall Study||10||
48439529|NCT02626910|101409905|FG000|NOT COMPLETED|Overall Study||0||
48439530|NCT02626910|101409906|FG001|NOT COMPLETED|Overall Study||0||
48439531|NCT02626910|101409907|FG002|NOT COMPLETED|Overall Study||0||
48439532|NCT02626910|101409908|FG003|NOT COMPLETED|Overall Study||0||
48439533|NCT00980460|101409909|FG000|STARTED|Overall Study||8||
48439534|NCT00980460|101409910|FG001|STARTED|Overall Study||51||
48439535|NCT00980460|101409911|FG002|STARTED|Overall Study||105||
48439536|NCT00980460|101409912|FG003|STARTED|Overall Study||32||
48439537|NCT00980460|101409913|FG004|STARTED|Overall Study||40||
48439538|NCT00980460|101409909|FG000|COMPLETED|Overall Study||8||
48439539|NCT00980460|101409910|FG001|COMPLETED|Overall Study||47||
48439540|NCT00980460|101409911|FG002|COMPLETED|Overall Study||70||
48439541|NCT00980460|101409912|FG003|COMPLETED|Overall Study||14||
48439542|NCT00980460|101409913|FG004|COMPLETED|Overall Study||24||
48439543|NCT00980460|101409909|FG000|NOT COMPLETED|Overall Study||0||
48439544|NCT00980460|101409910|FG001|NOT COMPLETED|Overall Study||4||
48439545|NCT00980460|101409911|FG002|NOT COMPLETED|Overall Study||35||
48439546|NCT00980460|101409912|FG003|NOT COMPLETED|Overall Study||18||
48439547|NCT00980460|101409913|FG004|NOT COMPLETED|Overall Study||16||
48439548|NCT03252756|101409914|FG000|STARTED|Overall Study||13||
48439549|NCT03252756|101409915|FG001|STARTED|Overall Study||14||
48439550|NCT03252756|101409914|FG000|COMPLETED|Overall Study||10||
48439551|NCT03252756|101409915|FG001|COMPLETED|Overall Study||8||
48439552|NCT03252756|101409914|FG000|NOT COMPLETED|Overall Study||3||
48439553|NCT03252756|101409915|FG001|NOT COMPLETED|Overall Study||6||
48767372|NCT04081103|102218640|FG001|STARTED|Overall Study||12||12
48767373|NCT04081103|102218641|FG002|STARTED|Overall Study||11||11
48767374|NCT04081103|102218639|FG000|COMPLETED|Overall Study||11||11
48767375|NCT04081103|102218640|FG001|COMPLETED|Overall Study||11||11
48439554|NCT01265875|101409916|FG000|STARTED|Overall Study||12||
48439555|NCT01265875|101409916|FG000|COMPLETED|Overall Study||11||
48439556|NCT01265875|101409916|FG000|NOT COMPLETED|Overall Study||1||
48439557|NCT01638416|101409917|FG000|STARTED|Overall Study||2490||
48439558|NCT01638416|101409918|FG001|STARTED|Overall Study||2504||
48439559|NCT01638416|101409917|FG000|COMPLETED|Overall Study||2457||
48439560|NCT01638416|101409918|FG001|COMPLETED|Overall Study||2462||
48439561|NCT01638416|101409917|FG000|NOT COMPLETED|Overall Study||33||
48439562|NCT01638416|101409918|FG001|NOT COMPLETED|Overall Study||42||
48439563|NCT03867500|101409919|FG000|STARTED|Niacin Infusion Intervention||12||
48656810|NCT05626686|101943707|FG000|NOT COMPLETED|Overall Study||6||
48656811|NCT04334681|101943708|FG000|STARTED|Overall Study||135||
48656812|NCT04334681|101943709|FG001|STARTED|Overall Study||143||
48656813|NCT04334681|101943708|FG000|COMPLETED|Overall Study||135||
48656814|NCT04334681|101943709|FG001|COMPLETED|Overall Study||143||
48656815|NCT04334681|101943708|FG000|NOT COMPLETED|Overall Study||0||
48439564|NCT03867500|101409919|FG000|COMPLETED|Niacin Infusion Intervention||12||
48439565|NCT03867500|101409919|FG000|NOT COMPLETED|Niacin Infusion Intervention||0||
48656816|NCT04334681|101943709|FG001|NOT COMPLETED|Overall Study||0||
48439566|NCT03867500|101409919|FG000|STARTED|Saline Infustion Intervention||12||
48439567|NCT03867500|101409919|FG000|COMPLETED|Saline Infustion Intervention||11||
48439568|NCT03867500|101409919|FG000|NOT COMPLETED|Saline Infustion Intervention||1||
48439569|NCT00290511|101409920|FG000|STARTED|Overall Study||49||
48439570|NCT00290511|101409920|FG000|No Treatment Per Protocol|Overall Study||2||
48656817|NCT02864914|101943710|FG000|STARTED|Overall Study||76174||
48767376|NCT04081103|102218641|FG002|COMPLETED|Overall Study||9||9
48439571|NCT00290511|101409920|FG000|Toxicity Assessment|Overall Study||47||
48439572|NCT00290511|101409920|FG000|Response Assessment|Overall Study||45||
48439573|NCT00290511|101409920|FG000|COMPLETED|Overall Study||45||
48439574|NCT00290511|101409920|FG000|NOT COMPLETED|Overall Study||4||
48439575|NCT01267227|101409921|FG000|STARTED|Overall Study||20||
48439576|NCT01267227|101409922|FG001|STARTED|Overall Study||20||
48439577|NCT01267227|101409923|FG002|STARTED|Overall Study||20||
48439578|NCT01267227|101409924|FG003|STARTED|Overall Study||20||
48656818|NCT02864914|101943711|FG001|STARTED|Overall Study||257406||
48767377|NCT04081103|102218639|FG000|NOT COMPLETED|Overall Study||1||1
48767378|NCT04081103|102218640|FG001|NOT COMPLETED|Overall Study||1||1
48767379|NCT04081103|102218641|FG002|NOT COMPLETED|Overall Study||2||2
48767380|NCT02066181|102218642|FG000|STARTED|Overall Study||50||
48767381|NCT02066181|102218643|FG001|STARTED|Overall Study||37||
48767382|NCT02066181|102218642|FG000|Crossed Over|Overall Study||0||
48767383|NCT02066181|102218643|FG001|Crossed Over|Overall Study||28||
48767384|NCT02066181|102218642|FG000|COMPLETED|Overall Study||49||
48767385|NCT02066181|102218643|FG001|COMPLETED|Overall Study||36||
48767386|NCT02066181|102218642|FG000|NOT COMPLETED|Overall Study||1||
48767387|NCT02066181|102218643|FG001|NOT COMPLETED|Overall Study||1||
48767388|NCT00459316|102218644|FG000|STARTED|Steps 1 & 2||280||
48767389|NCT00459316|102218645|FG001|STARTED|Steps 1 & 2||39||
48767390|NCT00459316|102218646|FG002|STARTED|Steps 1 & 2||59||
48767391|NCT00459316|102218644|FG000|COMPLETED|Steps 1 & 2||259||
48767392|NCT00459316|102218645|FG001|COMPLETED|Steps 1 & 2||32||
48767393|NCT00459316|102218646|FG002|COMPLETED|Steps 1 & 2||57||
48767394|NCT00459316|102218644|FG000|NOT COMPLETED|Steps 1 & 2||21||
48767395|NCT00459316|102218645|FG001|NOT COMPLETED|Steps 1 & 2||7||
48767396|NCT00459316|102218646|FG002|NOT COMPLETED|Steps 1 & 2||2||
48767397|NCT00459316|102218644|FG000|STARTED|Step 3||152||
48767398|NCT00459316|102218645|FG001|STARTED|Step 3||0||
48767399|NCT00459316|102218646|FG002|STARTED|Step 3||40||
48767400|NCT00459316|102218644|FG000|COMPLETED|Step 3||149||
48767401|NCT00459316|102218645|FG001|COMPLETED|Step 3||0||
48767402|NCT00459316|102218646|FG002|COMPLETED|Step 3||39||
48767403|NCT00459316|102218644|FG000|NOT COMPLETED|Step 3||3||
48767404|NCT00459316|102218645|FG001|NOT COMPLETED|Step 3||0||
48767405|NCT00459316|102218646|FG002|NOT COMPLETED|Step 3||1||
48767406|NCT01458392|102218647|FG000|STARTED|Overall Study||2||
48767407|NCT01458392|102218648|FG001|STARTED|Overall Study||13||
48767408|NCT01458392|102218649|FG002|STARTED|Overall Study||31||
48767409|NCT01458392|102218647|FG000|COMPLETED|Overall Study||0||
48767410|NCT01458392|102218648|FG001|COMPLETED|Overall Study||0||
48767411|NCT01458392|102218649|FG002|COMPLETED|Overall Study||0||
48767412|NCT01458392|102218647|FG000|NOT COMPLETED|Overall Study||2||
48767413|NCT01458392|102218648|FG001|NOT COMPLETED|Overall Study||13||
48767414|NCT01458392|102218649|FG002|NOT COMPLETED|Overall Study||31||
48767415|NCT03213691|102218650|FG000|STARTED|Overall Study||21||
48767416|NCT03213691|102218650|FG000|COMPLETED|Overall Study||0||
48767417|NCT03213691|102218650|FG000|NOT COMPLETED|Overall Study||21||
48767418|NCT01198795|102218651|FG000|STARTED|Overall Study||162||
48767419|NCT01198795|102218651|FG000|COMPLETED|Overall Study||80||
48767420|NCT01198795|102218651|FG000|NOT COMPLETED|Overall Study||82||
48767421|NCT01322945|102218652|FG000|STARTED|Overall Study||52||
48767422|NCT01322945|102218653|FG001|STARTED|Overall Study||42||
48767423|NCT01322945|102218652|FG000|COMPLETED|Overall Study||52||
48767424|NCT01322945|102218653|FG001|COMPLETED|Overall Study||42||
48767425|NCT01322945|102218652|FG000|NOT COMPLETED|Overall Study||0||
48767426|NCT01322945|102218653|FG001|NOT COMPLETED|Overall Study||0||
48767427|NCT02900378|102218654|FG000|STARTED|Randomization (Visit 2)||310|All randomized patients|
48767428|NCT02900378|102218655|FG001|STARTED|Randomization (Visit 2)||311|All randomized patients|
48767429|NCT02900378|102218654|FG000|COMPLETED|Randomization (Visit 2)||287||
48767430|NCT02900378|102218655|FG001|COMPLETED|Randomization (Visit 2)||283||
48767431|NCT02900378|102218654|FG000|NOT COMPLETED|Randomization (Visit 2)||23||
48767432|NCT02900378|102218655|FG001|NOT COMPLETED|Randomization (Visit 2)||28||
48767433|NCT02900378|102218654|FG000|STARTED|Treatment Phase||309|All randomized patients with at least 1 dose of study treatment|
48767434|NCT02900378|102218655|FG001|STARTED|Treatment Phase||310|All randomized patients with at least 1 dose of study treatment|
48767435|NCT02900378|102218654|FG000|Full Analysis Set|Treatment Phase||302|At least 1 dose of study treatment and 1 post baseline safety assessment|
48767436|NCT02900378|102218655|FG001|Full Analysis Set|Treatment Phase||302|At least 1 dose of study treatment and 1 post baseline safety assessment|
48767437|NCT02900378|102218654|FG000|COMPLETED|Treatment Phase||309||
48767438|NCT02900378|102218655|FG001|COMPLETED|Treatment Phase||310||
48767439|NCT02900378|102218654|FG000|NOT COMPLETED|Treatment Phase||0||
48767440|NCT02900378|102218655|FG001|NOT COMPLETED|Treatment Phase||0||
48767441|NCT03694353|102218656|FG000|STARTED|Overall Study||37||
48767442|NCT03694353|102218656|FG000|COMPLETED|Overall Study||35||
48767443|NCT03694353|102218656|FG000|NOT COMPLETED|Overall Study||2||
48767444|NCT01599637|102218657|FG000|STARTED|Overall Study||20||
48767445|NCT01599637|102218658|FG001|STARTED|Overall Study||10||
48767446|NCT01599637|102218659|FG002|STARTED|Overall Study||10||
48767447|NCT01599637|102218657|FG000|COMPLETED|Overall Study||19||
48767448|NCT01599637|102218658|FG001|COMPLETED|Overall Study||8||
48767449|NCT01599637|102218659|FG002|COMPLETED|Overall Study||10||
48767450|NCT01599637|102218657|FG000|NOT COMPLETED|Overall Study||1||
48767451|NCT01599637|102218658|FG001|NOT COMPLETED|Overall Study||2||
48767452|NCT01599637|102218659|FG002|NOT COMPLETED|Overall Study||0||
48767453|NCT01271946|102218660|FG000|STARTED|Overall Study||346||
48767454|NCT01271946|102218661|FG001|STARTED|Overall Study||5||
48767455|NCT01271946|102218660|FG000|COMPLETED|Overall Study||346||
48767456|NCT01271946|102218661|FG001|COMPLETED|Overall Study||5||
48767457|NCT01271946|102218660|FG000|NOT COMPLETED|Overall Study||0||
48767458|NCT01271946|102218661|FG001|NOT COMPLETED|Overall Study||0||
48767459|NCT04119414|102218662|FG000|STARTED|Overall Study||600||8
48767460|NCT04119414|102218662|FG000|COMPLETED|Overall Study||300||4
48767461|NCT04119414|102218662|FG000|NOT COMPLETED|Overall Study||300||4
48767462|NCT04498832|102218663|FG000|STARTED|Overall Study||1049||
48767463|NCT04498832|102218664|FG001|STARTED|Overall Study||1051||
48767464|NCT04498832|102218663|FG000|COMPLETED|Overall Study||1048||
48767465|NCT04498832|102218664|FG001|COMPLETED|Overall Study||1047||
48767466|NCT04498832|102218663|FG000|NOT COMPLETED|Overall Study||1||
48767467|NCT04498832|102218664|FG001|NOT COMPLETED|Overall Study||4||
48767468|NCT02158442|102218665|FG000|STARTED|Overall Study||8||
48767469|NCT02158442|102218666|FG001|STARTED|Overall Study||7||
48767470|NCT02158442|102218665|FG000|COMPLETED|Overall Study||6||
48767471|NCT02158442|102218666|FG001|COMPLETED|Overall Study||7||
48767472|NCT02158442|102218665|FG000|NOT COMPLETED|Overall Study||2||
48767473|NCT02158442|102218666|FG001|NOT COMPLETED|Overall Study||0||
48767474|NCT00888134|102218667|FG000|STARTED|Treatment With Study Drug||28||
48767475|NCT00888134|102218667|FG000|COMPLETED|Treatment With Study Drug||27||
48767476|NCT00888134|102218667|FG000|NOT COMPLETED|Treatment With Study Drug||1||
48767477|NCT00888134|102218667|FG000|STARTED|Follow-up||27||
48767478|NCT00888134|102218667|FG000|COMPLETED|Follow-up||26||
48767479|NCT00888134|102218667|FG000|NOT COMPLETED|Follow-up||1||
48767480|NCT01314313|102218668|FG000|STARTED|Overall Study||1011||
48767481|NCT01314313|102218669|FG001|STARTED|Overall Study||1021||
48767482|NCT01314313|102218668|FG000|As Treated|Overall Study||994||
48767483|NCT01314313|102218669|FG001|As Treated|Overall Study||944||
48767484|NCT01314313|102218668|FG000|Valve Implanted|Overall Study||974||
48767485|NCT01314313|102218669|FG001|Valve Implanted|Overall Study||936||
48767486|NCT01314313|102218668|FG000|COMPLETED|Overall Study||784|This is two year follow-up|
48767487|NCT01314313|102218669|FG001|COMPLETED|Overall Study||710|This is two year follow-up|
48767488|NCT01314313|102218668|FG000|NOT COMPLETED|Overall Study||227||
48767489|NCT01314313|102218669|FG001|NOT COMPLETED|Overall Study||311||
48767490|NCT01723384|102218670|FG000|STARTED|Overall Study||15||
48439579|NCT01267227|101409921|FG000|COMPLETED|Overall Study||19||
48439580|NCT01267227|101409922|FG001|COMPLETED|Overall Study||19||
48439581|NCT01267227|101409923|FG002|COMPLETED|Overall Study||18||
48439582|NCT01267227|101409924|FG003|COMPLETED|Overall Study||17||
48439583|NCT01267227|101409921|FG000|NOT COMPLETED|Overall Study||1||
48439584|NCT01267227|101409922|FG001|NOT COMPLETED|Overall Study||1||
48439585|NCT01267227|101409923|FG002|NOT COMPLETED|Overall Study||2||
48439586|NCT01267227|101409924|FG003|NOT COMPLETED|Overall Study||3||
48439587|NCT04192747|101409925|FG000|STARTED|Overall Study||223||
48439588|NCT04192747|101409926|FG001|STARTED|Overall Study||222||
48439589|NCT04192747|101409925|FG000|COMPLETED|Overall Study||221||
48439590|NCT04192747|101409926|FG001|COMPLETED|Overall Study||215||
48439591|NCT04192747|101409925|FG000|NOT COMPLETED|Overall Study||2||
48439592|NCT04192747|101409926|FG001|NOT COMPLETED|Overall Study||7||
48439593|NCT02674568|101409927|FG000|STARTED|Overall Study||339||
48439594|NCT02674568|101409927|FG000|Delta-like Protein 3 (DLL3) High|Overall Study||238|"DLL3 High Participants: tumors with ≥75% of cells expressing DLL3 are classified as DLL3 high"|
48439595|NCT02674568|101409927|FG000|DLL3 Positive|Overall Study||287|"DLL3 Positive Participants: tumors with ≥25% cells expressing DLL3 are classified as DLL3 positive"|
48439596|NCT02674568|101409927|FG000|COMPLETED|Overall Study||0|'Completed'=still on study; 'Not Completed'=discontinued study|
48439597|NCT02674568|101409927|FG000|NOT COMPLETED|Overall Study||339||
48367920|NCT00301067|101230075|FG003|STARTED|Follow up Until Death||3|All patients that receive treatment on study go into the follow up period for study.|
48367921|NCT00301067|101230072|FG000|COMPLETED|Follow up Until Death||3||
48439598|NCT00577031|101409928|FG000|STARTED|Overall Study||205||
48439599|NCT00577031|101409928|FG000|COMPLETED|Overall Study||0||
48439600|NCT00577031|101409928|FG000|NOT COMPLETED|Overall Study||205||
48767491|NCT01723384|102218671|FG001|STARTED|Overall Study||15||
48767492|NCT01723384|102218670|FG000|COMPLETED|Overall Study||15||
48767493|NCT01723384|102218671|FG001|COMPLETED|Overall Study||15||
48767494|NCT01723384|102218670|FG000|NOT COMPLETED|Overall Study||0||
48367922|NCT00301067|101230073|FG001|COMPLETED|Follow up Until Death||3||
48439601|NCT01320826|101409929|FG000|STARTED|Overall Study||577||
48439602|NCT01320826|101409929|FG000|COMPLETED|Overall Study||577||
48767495|NCT01723384|102218671|FG001|NOT COMPLETED|Overall Study||0||
48767496|NCT02004093|102218672|FG000|STARTED|Overall Study||75||
48767497|NCT02004093|102218673|FG001|STARTED|Overall Study||74||
48767498|NCT02004093|102218672|FG000|COMPLETED|Overall Study||1||
48767499|NCT02004093|102218673|FG001|COMPLETED|Overall Study||1||
48367923|NCT00301067|101230074|FG002|COMPLETED|Follow up Until Death||3||
48367924|NCT00301067|101230075|FG003|COMPLETED|Follow up Until Death||2||
48367925|NCT00301067|101230072|FG000|NOT COMPLETED|Follow up Until Death||1||
48367926|NCT00301067|101230073|FG001|NOT COMPLETED|Follow up Until Death||0||
48367927|NCT00301067|101230074|FG002|NOT COMPLETED|Follow up Until Death||0||
48367928|NCT00301067|101230075|FG003|NOT COMPLETED|Follow up Until Death||1||
48367929|NCT01856491|101230076|FG000|STARTED|Overall Study||167||
48367930|NCT01856491|101230076|FG000|COMPLETED|Overall Study||152||
48767500|NCT02004093|102218672|FG000|NOT COMPLETED|Overall Study||74||
48767501|NCT02004093|102218673|FG001|NOT COMPLETED|Overall Study||73||
48767502|NCT00785785|102218674|FG000|STARTED|Core Phase up to 36 Months||324||
48767503|NCT00785785|102218675|FG001|STARTED|Core Phase up to 36 Months||320||
48439603|NCT01320826|101409929|FG000|NOT COMPLETED|Overall Study||0||
48439604|NCT00902486|101409930|FG000|STARTED|Treatment Period (Weeks 0 Through 12)||31||
48439605|NCT00902486|101409931|FG001|STARTED|Treatment Period (Weeks 0 Through 12)||0||
48439606|NCT00902486|101409932|FG002|STARTED|Treatment Period (Weeks 0 Through 12)||0||
48439607|NCT00902486|101409933|FG003|STARTED|Treatment Period (Weeks 0 Through 12)||32||
48439608|NCT00902486|101409934|FG004|STARTED|Treatment Period (Weeks 0 Through 12)||32||
48439609|NCT00902486|101409935|FG005|STARTED|Treatment Period (Weeks 0 Through 12)||32||
48439610|NCT00902486|101409930|FG000|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31||
48439611|NCT00902486|101409931|FG001|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||0||
48439612|NCT00902486|101409932|FG002|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||0||
48439613|NCT00902486|101409933|FG003|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31||
48439614|NCT00902486|101409934|FG004|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||32||
48439615|NCT00902486|101409935|FG005|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31||
48439616|NCT00902486|101409930|FG000|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||31||
48439617|NCT00902486|101409931|FG001|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||0||
48439618|NCT00902486|101409932|FG002|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||0||
48439619|NCT00902486|101409933|FG003|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||31||
48439620|NCT00902486|101409934|FG004|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||32||
48439621|NCT00902486|101409935|FG005|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||30||
48439622|NCT00902486|101409930|FG000|COMPLETED|Treatment Period (Weeks 0 Through 12)||29|Participants completing Week 12|
48439623|NCT00902486|101409931|FG001|COMPLETED|Treatment Period (Weeks 0 Through 12)||0|Participants completing Week 12|
48439624|NCT00902486|101409932|FG002|COMPLETED|Treatment Period (Weeks 0 Through 12)||0|Participants completing Week 12|
48439625|NCT00902486|101409933|FG003|COMPLETED|Treatment Period (Weeks 0 Through 12)||29|Participants completing Week 12|
48439626|NCT00902486|101409934|FG004|COMPLETED|Treatment Period (Weeks 0 Through 12)||30|Participants completing Week 12|
48439627|NCT00902486|101409935|FG005|COMPLETED|Treatment Period (Weeks 0 Through 12)||27|Participants completing Week 12|
48439628|NCT00902486|101409930|FG000|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||2||
48439629|NCT00902486|101409931|FG001|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||0||
48439630|NCT00902486|101409932|FG002|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||0||
48439631|NCT00902486|101409933|FG003|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||3||
48439632|NCT00902486|101409934|FG004|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||2||
48439633|NCT00902486|101409935|FG005|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||5||
48439634|NCT00902486|101409930|FG000|STARTED|Extension Period (Weeks 12 Through 24)||0||
48439635|NCT00902486|101409931|FG001|STARTED|Extension Period (Weeks 12 Through 24)||14||
48439636|NCT00902486|101409932|FG002|STARTED|Extension Period (Weeks 12 Through 24)||15||
48439637|NCT00902486|101409933|FG003|STARTED|Extension Period (Weeks 12 Through 24)||29||
48439638|NCT00902486|101409934|FG004|STARTED|Extension Period (Weeks 12 Through 24)||30||
48439639|NCT00902486|101409935|FG005|STARTED|Extension Period (Weeks 12 Through 24)||27||
48439640|NCT00902486|101409930|FG000|COMPLETED|Extension Period (Weeks 12 Through 24)||0||
48439641|NCT00902486|101409931|FG001|COMPLETED|Extension Period (Weeks 12 Through 24)||14||
48439642|NCT00902486|101409932|FG002|COMPLETED|Extension Period (Weeks 12 Through 24)||13||
48439643|NCT00902486|101409933|FG003|COMPLETED|Extension Period (Weeks 12 Through 24)||27||
48439644|NCT00902486|101409934|FG004|COMPLETED|Extension Period (Weeks 12 Through 24)||29||
48439645|NCT00902486|101409935|FG005|COMPLETED|Extension Period (Weeks 12 Through 24)||24||
48439646|NCT00902486|101409930|FG000|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||0||
48439647|NCT00902486|101409931|FG001|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||0||
48439648|NCT00902486|101409932|FG002|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||2||
48439649|NCT00902486|101409933|FG003|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||2||
48439650|NCT00902486|101409934|FG004|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||1||
48439651|NCT00902486|101409935|FG005|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||3||
48440007|NCT04854421|101410007|FG000|NOT COMPLETED|Overall Study||2||
48656819|NCT02864914|101943710|FG000|Propensity Score-trimmed Cohort for DKA|Overall Study||64599|The propensity score (PS)-trimmed cohort was created by trimming extreme values of PS from a Diabetic ketoacidosis (DKA)-specific PS model including all DKA-related variables.|
48656820|NCT02864914|101943711|FG001|Propensity Score-trimmed Cohort for DKA|Overall Study||203315|The propensity score (PS)-trimmed cohort was created by trimming extreme values of PS from a Diabetic ketoacidosis (DKA)-specific PS model including all DKA-related variables.|
48656821|NCT02864914|101943710|FG000|Propensity Score-trimmed Cohort for AKI|Overall Study||58393|The propensity score (PS)-trimmed cohort was created by trimming extreme values of PS from a acute kidney injury (AKI)-specific PS model including all AKI-related variables.|
48656822|NCT02864914|101943711|FG001|Propensity Score-trimmed Cohort for AKI|Overall Study||167823|The propensity score (PS)-trimmed cohort was created by trimming extreme values of PS from a acute kidney injury (AKI)-specific PS model including all AKI-related variables.|
48656823|NCT02864914|101943710|FG000|Propensity Score-trimmed Cohort for ALI2|Overall Study||62917|The propensity score (PS)-trimmed cohort was created by trimming extreme values of PS from a Acute liver injury with or without predisposing conditions (ALI2)-specific PS model including all ALI2-related variables.|
48657061|NCT03648372|101943759|FG002|COMPLETED|Overall Study||0||
48657062|NCT03648372|101943760|FG003|COMPLETED|Overall Study||0||
48439652|NCT00902486|101409930|FG000|STARTED|Follow-up (After Week 24)||0|Number of participants completed treatment|
48767504|NCT00785785|102218674|FG000|COMPLETED|Core Phase up to 36 Months||0||
48767505|NCT00785785|102218675|FG001|COMPLETED|Core Phase up to 36 Months||0||
48767506|NCT00785785|102218674|FG000|NOT COMPLETED|Core Phase up to 36 Months||324||
48767507|NCT00785785|102218675|FG001|NOT COMPLETED|Core Phase up to 36 Months||320||
48767508|NCT00785785|102218674|FG000|STARTED|Optional Extension Phase||39||
48767509|NCT00785785|102218675|FG001|STARTED|Optional Extension Phase||125||
48439653|NCT00902486|101409931|FG001|STARTED|Follow-up (After Week 24)||14|Number of participants completed treatment|
48439654|NCT00902486|101409932|FG002|STARTED|Follow-up (After Week 24)||13|Number of participants completed treatment|
48439655|NCT00902486|101409933|FG003|STARTED|Follow-up (After Week 24)||27|Number of participants completed treatment|
48439656|NCT00902486|101409934|FG004|STARTED|Follow-up (After Week 24)||29|Number of participants completed treatment|
48439657|NCT00902486|101409935|FG005|STARTED|Follow-up (After Week 24)||24|Number of participants completed treatment|
48439658|NCT00902486|101409930|FG000|Safety Evaluable Participants|Follow-up (After Week 24)||0|Population is inclusive of all safety participants continuing after Week 12.|
48439659|NCT00902486|101409931|FG001|Safety Evaluable Participants|Follow-up (After Week 24)||14|Population is inclusive of all safety participants continuing after Week 12.|
48439660|NCT00902486|101409932|FG002|Safety Evaluable Participants|Follow-up (After Week 24)||15|Population is inclusive of all safety participants continuing after Week 12.|
48439661|NCT00902486|101409933|FG003|Safety Evaluable Participants|Follow-up (After Week 24)||29|Population is inclusive of all safety participants continuing after Week 12.|
48439662|NCT00902486|101409934|FG004|Safety Evaluable Participants|Follow-up (After Week 24)||30|Population is inclusive of all safety participants continuing after Week 12.|
48439663|NCT00902486|101409935|FG005|Safety Evaluable Participants|Follow-up (After Week 24)||27|Population is inclusive of all safety participants continuing after Week 12.|
48439664|NCT00902486|101409930|FG000|COMPLETED|Follow-up (After Week 24)||0||
48439665|NCT00902486|101409931|FG001|COMPLETED|Follow-up (After Week 24)||14||
48439666|NCT00902486|101409932|FG002|COMPLETED|Follow-up (After Week 24)||13||
48439667|NCT00902486|101409933|FG003|COMPLETED|Follow-up (After Week 24)||26||
48439668|NCT00902486|101409934|FG004|COMPLETED|Follow-up (After Week 24)||29||
48439669|NCT00902486|101409935|FG005|COMPLETED|Follow-up (After Week 24)||24||
48439670|NCT00902486|101409930|FG000|NOT COMPLETED|Follow-up (After Week 24)||0||
48439671|NCT00902486|101409931|FG001|NOT COMPLETED|Follow-up (After Week 24)||0||
48439672|NCT00902486|101409932|FG002|NOT COMPLETED|Follow-up (After Week 24)||0||
48439673|NCT00902486|101409933|FG003|NOT COMPLETED|Follow-up (After Week 24)||1||
48439674|NCT00902486|101409934|FG004|NOT COMPLETED|Follow-up (After Week 24)||0||
48439675|NCT00902486|101409935|FG005|NOT COMPLETED|Follow-up (After Week 24)||0||
48439676|NCT00592007|101409936|FG000|STARTED|Overall Study||7||
48439677|NCT00592007|101409936|FG000|COMPLETED|Overall Study||5||
48439678|NCT00592007|101409936|FG000|NOT COMPLETED|Overall Study||2||
48439679|NCT00633009|101409937|FG000|STARTED|Overall Study||12||
48439680|NCT00633009|101409938|FG001|STARTED|Overall Study||27||
48439681|NCT00633009|101409939|FG002|STARTED|Overall Study||11||
48439682|NCT00633009|101409937|FG000|COMPLETED|Overall Study||8||
48439683|NCT00633009|101409938|FG001|COMPLETED|Overall Study||23||
48439684|NCT00633009|101409939|FG002|COMPLETED|Overall Study||10||
48439685|NCT00633009|101409937|FG000|NOT COMPLETED|Overall Study||4||
48439686|NCT00633009|101409938|FG001|NOT COMPLETED|Overall Study||4||
48439687|NCT00633009|101409939|FG002|NOT COMPLETED|Overall Study||1||
48439688|NCT00183170|101409940|FG000|STARTED|First Intervention||103||
48439689|NCT00183170|101409941|FG001|STARTED|First Intervention||109||
48439690|NCT00183170|101409940|FG000|COMPLETED|First Intervention||101||
48439691|NCT00183170|101409941|FG001|COMPLETED|First Intervention||109||
48656824|NCT02864914|101943711|FG001|Propensity Score-trimmed Cohort for ALI2|Overall Study||197172|The propensity score (PS)-trimmed cohort was created by trimming extreme values of PS from a Acute liver injury with or without predisposing conditions (ALI2)-specific PS model including all ALI2-related variables.|
48656825|NCT02864914|101943710|FG000|Propensity Score-trimmed Cohort for CKD - CPRD Only|Overall Study||13256|The propensity score (PS)-trimmed cohort was created by trimming extreme values of PS from a Chronic kidney disease (CKD)-specific PS model including all CKD-related variables. CKD was evaluated only in CPRD database.|
48656826|NCT02864914|101943711|FG001|Propensity Score-trimmed Cohort for CKD - CPRD Only|Overall Study||62435|The propensity score (PS)-trimmed cohort was created by trimming extreme values of PS from a Chronic kidney disease (CKD)-specific PS model including all CKD-related variables. CKD was evaluated only in CPRD database.|
48656827|NCT02864914|101943710|FG000|Propensity Score-trimmed Cohort for GIM - CPRD Only|Overall Study||8272|The propensity score (PS)-trimmed cohort in males was created by trimming extreme values of PS from a genital infection in males (GIM)-specific PS model including all GIM-related variables. GIM was evaluated only in CPRD database.|
48656828|NCT02864914|101943711|FG001|Propensity Score-trimmed Cohort for GIM - CPRD Only|Overall Study||45683|The propensity score (PS)-trimmed cohort in males was created by trimming extreme values of PS from a genital infection in males (GIM)-specific PS model including all GIM-related variables. GIM was evaluated only in CPRD database.|
48656829|NCT02864914|101943710|FG000|Propensity Score-trimmed Cohort for UTI - CPRD Only|Overall Study||14050|The propensity score (PS)-trimmed cohort was created by trimming extreme values of PS from a Urinary tract infection (UTI)-specific PS model including all UTI-related variables. UTI was evaluated only in CPRD database.|
48657063|NCT03648372|101943761|FG004|COMPLETED|Overall Study||1||
48657064|NCT03648372|101943762|FG005|COMPLETED|Overall Study||1||
48767510|NCT00785785|102218674|FG000|COMPLETED|Optional Extension Phase||0||
48767511|NCT00785785|102218675|FG001|COMPLETED|Optional Extension Phase||0||
48767512|NCT00785785|102218674|FG000|NOT COMPLETED|Optional Extension Phase||39||
48767513|NCT00785785|102218675|FG001|NOT COMPLETED|Optional Extension Phase||125||
48767514|NCT03217071|102218676|FG000|STARTED|Overall Study||6||
48767515|NCT03217071|102218677|FG001|STARTED|Overall Study||6||
48767516|NCT03217071|102218676|FG000|COMPLETED|Overall Study||6||
48767517|NCT03217071|102218677|FG001|COMPLETED|Overall Study||6||
48439692|NCT00183170|101409940|FG000|NOT COMPLETED|First Intervention||2||
48439693|NCT00183170|101409941|FG001|NOT COMPLETED|First Intervention||0||
48439694|NCT00183170|101409940|FG000|STARTED|Washout 1 Week||101||
48439695|NCT00183170|101409941|FG001|STARTED|Washout 1 Week||109||
48439696|NCT00183170|101409940|FG000|COMPLETED|Washout 1 Week||95||
48439697|NCT00183170|101409941|FG001|COMPLETED|Washout 1 Week||101||
48439698|NCT00183170|101409940|FG000|NOT COMPLETED|Washout 1 Week||6||
48439699|NCT00183170|101409941|FG001|NOT COMPLETED|Washout 1 Week||8||
48439700|NCT00183170|101409940|FG000|STARTED|Second Intervention||95||
48439701|NCT00183170|101409941|FG001|STARTED|Second Intervention||101||
48439702|NCT00183170|101409940|FG000|COMPLETED|Second Intervention||94||
48439703|NCT00183170|101409941|FG001|COMPLETED|Second Intervention||99||
48439704|NCT00183170|101409940|FG000|NOT COMPLETED|Second Intervention||1||
48439705|NCT00183170|101409941|FG001|NOT COMPLETED|Second Intervention||2||
48656830|NCT02864914|101943711|FG001|Propensity Score-trimmed Cohort for UTI - CPRD Only|Overall Study||77330|The propensity score (PS)-trimmed cohort was created by trimming extreme values of PS from a Urinary tract infection (UTI)-specific PS model including all UTI-related variables. UTI was evaluated only in CPRD database.|
48656831|NCT02864914|101943710|FG000|Propensity Score-trimmed Cohort for GIF - CPRD Only|Overall Study||5802|The propensity score (PS)-trimmed cohort in females was created by trimming extreme values of PS from a genital infection in females (GIF)-specific PS model including all GIF-related variables. GIF was evaluated only in CPRD database.|
48656832|NCT02864914|101943711|FG001|Propensity Score-trimmed Cohort for GIF - CPRD Only|Overall Study||31904|The propensity score (PS)-trimmed cohort in females was created by trimming extreme values of PS from a genital infection in females (GIF)-specific PS model including all GIF-related variables. GIF was evaluated only in CPRD database.|
48656833|NCT02864914|101943710|FG000|Propensity Score-trimmed Cohort for ALI1|Overall Study||36053|The propensity score (PS)-trimmed cohort was created by trimming extreme values of PS from a Acute liver injury with no predisposing conditions (ALI1)-specific PS model including all ALI1-related variables. The number of participants from the Danish Registries treated with empagliflozin, and treated with DPP-4 inhibitors and ≥ 3 glucose-lowering drugs are not reported due to the Danish small cell count policy.|
48656834|NCT02864914|101943711|FG001|Propensity Score-trimmed Cohort for ALI1|Overall Study||154554|The propensity score (PS)-trimmed cohort was created by trimming extreme values of PS from a Acute liver injury with no predisposing conditions (ALI1)-specific PS model including all ALI1-related variables. The number of participants from the Danish Registries treated with empagliflozin, and treated with DPP-4 inhibitors and ≥ 3 glucose-lowering drugs are not reported due to the Danish small cell count policy.|
48656835|NCT02864914|101943710|FG000|COMPLETED|Overall Study||76174||
48656836|NCT02864914|101943711|FG001|COMPLETED|Overall Study||257406||
48656837|NCT02864914|101943710|FG000|NOT COMPLETED|Overall Study||0||
48656838|NCT02864914|101943711|FG001|NOT COMPLETED|Overall Study||0||
48656839|NCT01270555|101943712|FG000|STARTED|Overall Study||32||
48656840|NCT01270555|101943712|FG000|COMPLETED|Overall Study||19||
48656841|NCT01270555|101943712|FG000|NOT COMPLETED|Overall Study||13||
48656842|NCT02446600|101943713|FG000|STARTED|Overall Study||187||
48656843|NCT02446600|101943714|FG001|STARTED|Overall Study||190||
48656844|NCT02446600|101943715|FG002|STARTED|Overall Study||189||
48656845|NCT02446600|101943716|FG003|STARTED|Overall Study||13||
48656846|NCT02446600|101943713|FG000|COMPLETED|Overall Study||147||
48656847|NCT02446600|101943714|FG001|COMPLETED|Overall Study||178||
48656848|NCT02446600|101943715|FG002|COMPLETED|Overall Study||162||
48656849|NCT02446600|101943716|FG003|COMPLETED|Overall Study||12||
48656850|NCT02446600|101943713|FG000|NOT COMPLETED|Overall Study||40||
48656851|NCT02446600|101943714|FG001|NOT COMPLETED|Overall Study||12||
48767518|NCT03217071|102218676|FG000|NOT COMPLETED|Overall Study||0||
48767519|NCT03217071|102218677|FG001|NOT COMPLETED|Overall Study||0||
48767520|NCT01808456|102222760|FG000|STARTED|Overall Study||30||
48767521|NCT01808456|102222761|FG001|STARTED|Overall Study||32||
48767522|NCT01808456|102222760|FG000|COMPLETED|Overall Study||26||
48439706|NCT00299546|101409942|FG000|STARTED|Overall Study||155||
48439707|NCT00299546|101409943|FG001|STARTED|Overall Study||153||
48439708|NCT00299546|101409944|FG002|STARTED|Overall Study||153||
48439709|NCT00299546|101409942|FG000|COMPLETED|Overall Study||55||
48439710|NCT00299546|101409943|FG001|COMPLETED|Overall Study||61||
48439711|NCT00299546|101409944|FG002|COMPLETED|Overall Study||67||
48439712|NCT00299546|101409942|FG000|NOT COMPLETED|Overall Study||100||
48439713|NCT00299546|101409943|FG001|NOT COMPLETED|Overall Study||92||
48439714|NCT00299546|101409944|FG002|NOT COMPLETED|Overall Study||86||
48439715|NCT00440193|101409945|FG000|STARTED|Treatment Period||1731||
48439716|NCT00440193|101409946|FG001|STARTED|Treatment Period||1718||
48439717|NCT00440193|101409945|FG000|Participants Received Treatment|Treatment Period||1718||
48767523|NCT01808456|102222761|FG001|COMPLETED|Overall Study||30||
48439718|NCT00440193|101409946|FG001|Participants Received Treatment|Treatment Period||1711||
48439719|NCT00440193|101409945|FG000|COMPLETED|Treatment Period||1426||
48439720|NCT00440193|101409946|FG001|COMPLETED|Treatment Period||1367||
48439721|NCT00440193|101409945|FG000|NOT COMPLETED|Treatment Period||305||
48439722|NCT00440193|101409946|FG001|NOT COMPLETED|Treatment Period||351||
48439723|NCT00440193|101409945|FG000|STARTED|Observational Period||1425||
48439724|NCT00440193|101409946|FG001|STARTED|Observational Period||1407||
48439725|NCT00440193|101409945|FG000|COMPLETED|Observational Period||1380||
48439726|NCT00440193|101409946|FG001|COMPLETED|Observational Period||1369||
48439727|NCT00440193|101409945|FG000|NOT COMPLETED|Observational Period||45||
48439728|NCT00440193|101409946|FG001|NOT COMPLETED|Observational Period||38||
48439729|NCT03731325|101409947|FG000|STARTED|Overall Study||4||
48439730|NCT03731325|101409948|FG001|STARTED|Overall Study||3||
48439731|NCT03731325|101409947|FG000|COMPLETED|Overall Study||4||
48439732|NCT03731325|101409948|FG001|COMPLETED|Overall Study||3||
48439733|NCT03731325|101409947|FG000|NOT COMPLETED|Overall Study||0||
48439734|NCT03731325|101409948|FG001|NOT COMPLETED|Overall Study||0||
48439735|NCT01165424|101409949|FG000|STARTED|Overall Study||80||
48439736|NCT01165424|101409949|FG000|COMPLETED|Overall Study||76||
48439737|NCT01165424|101409949|FG000|NOT COMPLETED|Overall Study||4||
48439738|NCT02175472|101409950|FG000|STARTED|Overall Study||45||
48439739|NCT02175472|101409951|FG001|STARTED|Overall Study||47||
48439740|NCT02175472|101409950|FG000|COMPLETED|Overall Study||38||
48439741|NCT02175472|101409951|FG001|COMPLETED|Overall Study||45||
48439742|NCT02175472|101409950|FG000|NOT COMPLETED|Overall Study||7||
48439743|NCT02175472|101409951|FG001|NOT COMPLETED|Overall Study||2||
48439744|NCT04139642|101409952|FG000|STARTED|Historical Control Period (12 Months)||20||8
48439745|NCT04139642|101409953|FG001|STARTED|Historical Control Period (12 Months)||22||8
48439746|NCT04139642|101409952|FG000|COMPLETED|Historical Control Period (12 Months)||20||8
48439747|NCT04139642|101409953|FG001|COMPLETED|Historical Control Period (12 Months)||22||8
48439748|NCT04139642|101409952|FG000|NOT COMPLETED|Historical Control Period (12 Months)||0||0
48439749|NCT04139642|101409953|FG001|NOT COMPLETED|Historical Control Period (12 Months)||0||0
48439750|NCT04139642|101409952|FG000|STARTED|First Intervention (9 Months)||20||8
48439751|NCT04139642|101409953|FG001|STARTED|First Intervention (9 Months)||22||8
48439752|NCT04139642|101409952|FG000|COMPLETED|First Intervention (9 Months)||20||8
48439753|NCT04139642|101409953|FG001|COMPLETED|First Intervention (9 Months)||21||7
48439754|NCT04139642|101409952|FG000|NOT COMPLETED|First Intervention (9 Months)||0||0
48439755|NCT04139642|101409953|FG001|NOT COMPLETED|First Intervention (9 Months)||1||1
48439756|NCT04139642|101409952|FG000|STARTED|Second Intervention (9 Months)||20||8
48439757|NCT04139642|101409953|FG001|STARTED|Second Intervention (9 Months)||21||7
48439758|NCT04139642|101409952|FG000|COMPLETED|Second Intervention (9 Months)||20||8
48439759|NCT04139642|101409953|FG001|COMPLETED|Second Intervention (9 Months)||21||7
48439760|NCT04139642|101409952|FG000|NOT COMPLETED|Second Intervention (9 Months)||0||0
48439761|NCT04139642|101409953|FG001|NOT COMPLETED|Second Intervention (9 Months)||0||0
48439762|NCT01140815|101409954|FG000|STARTED|Overall Study||25||
48439763|NCT01140815|101409955|FG001|STARTED|Overall Study||25||
48439764|NCT01140815|101409954|FG000|COMPLETED|Overall Study||25||
48439765|NCT01140815|101409955|FG001|COMPLETED|Overall Study||25||
48439766|NCT01140815|101409954|FG000|NOT COMPLETED|Overall Study||0||
48439767|NCT01140815|101409955|FG001|NOT COMPLETED|Overall Study||0||
48439768|NCT03515681|101409956|FG000|STARTED|Overall Study||70||
48439769|NCT03515681|101409957|FG001|STARTED|Overall Study||70||
48439770|NCT03515681|101409956|FG000|Randomized|Overall Study||70||
48439771|NCT03515681|101409957|FG001|Randomized|Overall Study||70||
48439772|NCT03515681|101409956|FG000|Completed at 6 Months|Overall Study||61||
48439773|NCT03515681|101409957|FG001|Completed at 6 Months|Overall Study||62||
48439774|NCT03515681|101409956|FG000|COMPLETED|Overall Study||37|Completed at 12 months|
48439775|NCT03515681|101409957|FG001|COMPLETED|Overall Study||25|Completed at 12 months|
48656852|NCT02446600|101943715|FG002|NOT COMPLETED|Overall Study||27||
48656853|NCT02446600|101943716|FG003|NOT COMPLETED|Overall Study||1||
48656854|NCT03941860|101943717|FG000|STARTED|Overall Study||0||
48656855|NCT03941860|101943718|FG001|STARTED|Overall Study||1||
48656856|NCT03941860|101943717|FG000|COMPLETED|Overall Study||0||
48656857|NCT03941860|101943718|FG001|COMPLETED|Overall Study||0||
48656858|NCT03941860|101943717|FG000|NOT COMPLETED|Overall Study||0||
48656859|NCT03941860|101943718|FG001|NOT COMPLETED|Overall Study||1||
48656860|NCT03375164|101943719|FG000|STARTED|Overall Study||4||
48656861|NCT03375164|101943719|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4||
48767524|NCT01808456|102222760|FG000|NOT COMPLETED|Overall Study||4||
48767525|NCT01808456|102222761|FG001|NOT COMPLETED|Overall Study||2||
48439776|NCT03515681|101409956|FG000|NOT COMPLETED|Overall Study||33||
48439777|NCT03515681|101409957|FG001|NOT COMPLETED|Overall Study||45||
48439778|NCT02181634|101409958|FG000|STARTED|Overall Study||74||
48439779|NCT02181634|101409958|FG000|Eligible and Treated|Overall Study||73||
48439780|NCT02181634|101409958|FG000|COMPLETED|Overall Study||2||
48439781|NCT02181634|101409958|FG000|NOT COMPLETED|Overall Study||72||
48439782|NCT00359073|101409959|FG000|STARTED|Overall Study||12||
48439783|NCT00359073|101409960|FG001|STARTED|Overall Study||13||
48656862|NCT03375164|101943719|FG000|COMPLETED|Overall Study||4||
48656863|NCT03375164|101943719|FG000|NOT COMPLETED|Overall Study||0||
48656864|NCT03735498|101943720|FG000|STARTED|Overall Study||13||
48439784|NCT00359073|101409959|FG000|COMPLETED|Overall Study||8||
48439785|NCT00359073|101409960|FG001|COMPLETED|Overall Study||11||
48439786|NCT00359073|101409959|FG000|NOT COMPLETED|Overall Study||4||
48767526|NCT01578486|102222762|FG000|STARTED|Overall Study||13||
48767527|NCT01578486|102222762|FG000|COMPLETED|Overall Study||8||
48767528|NCT01578486|102222762|FG000|NOT COMPLETED|Overall Study||5||
48767529|NCT02057250|102222763|FG000|STARTED|AID Assessment Phase||56||
48767530|NCT02057250|102222764|FG001|STARTED|AID Assessment Phase||53||
48767531|NCT02057250|102222765|FG002|STARTED|AID Assessment Phase||52||
48767532|NCT02057250|102222766|FG003|STARTED|AID Assessment Phase||56||
48767533|NCT02057250|102222767|FG004|STARTED|AID Assessment Phase||0||
48767534|NCT02057250|102222763|FG000|COMPLETED|AID Assessment Phase||52||
48767535|NCT02057250|102222764|FG001|COMPLETED|AID Assessment Phase||50||
48767536|NCT02057250|102222765|FG002|COMPLETED|AID Assessment Phase||45||
48767537|NCT02057250|102222766|FG003|COMPLETED|AID Assessment Phase||54||
48767538|NCT02057250|102222767|FG004|COMPLETED|AID Assessment Phase||0||
48439787|NCT00359073|101409960|FG001|NOT COMPLETED|Overall Study||2||
48439788|NCT02985515|101409961|FG000|STARTED|Olfaction Testing||20|30 day period|
48439789|NCT02985515|101409962|FG001|STARTED|Olfaction Testing||31|30 day period|
48439790|NCT02985515|101409961|FG000|COMPLETED|Olfaction Testing||20||
48439791|NCT02985515|101409962|FG001|COMPLETED|Olfaction Testing||23||
48439792|NCT02985515|101409961|FG000|NOT COMPLETED|Olfaction Testing||0||
48439793|NCT02985515|101409962|FG001|NOT COMPLETED|Olfaction Testing||8||
48439794|NCT02985515|101409961|FG000|STARTED|Smell Training||0||
48439795|NCT02985515|101409962|FG001|STARTED|Smell Training||23||
48439796|NCT02985515|101409961|FG000|COMPLETED|Smell Training||0||
48439797|NCT02985515|101409962|FG001|COMPLETED|Smell Training||23||
48439798|NCT02985515|101409961|FG000|NOT COMPLETED|Smell Training||0||
48439799|NCT02985515|101409962|FG001|NOT COMPLETED|Smell Training||0||
48439800|NCT02152631|101409963|FG000|STARTED|Overall Study||270||
48439801|NCT02152631|101409964|FG001|STARTED|Overall Study||183||
48439802|NCT02152631|101409963|FG000|Received at Least One Dose of Study Drug|Overall Study||265||
48439803|NCT02152631|101409964|FG001|Received at Least One Dose of Study Drug|Overall Study||175||
48439804|NCT02152631|101409963|FG000|Off Treatment|Overall Study||246||
48439805|NCT02152631|101409964|FG001|Off Treatment|Overall Study||172||
48439806|NCT02152631|101409963|FG000|Death Due to Any Cause|Overall Study||30||
48439807|NCT02152631|101409964|FG001|Death Due to Any Cause|Overall Study||20||
48439808|NCT02152631|101409963|FG000|Progressive Disease|Overall Study||174||
48439809|NCT02152631|101409964|FG001|Progressive Disease|Overall Study||137||
48439810|NCT02152631|101409963|FG000|COMPLETED|Overall Study||204||
48439811|NCT02152631|101409964|FG001|COMPLETED|Overall Study||157||
48439812|NCT02152631|101409963|FG000|NOT COMPLETED|Overall Study||66||
48439813|NCT02152631|101409964|FG001|NOT COMPLETED|Overall Study||26||
48439814|NCT02771340|101409965|FG000|STARTED|Overall Study||2||
48439815|NCT02771340|101409966|FG001|STARTED|Overall Study||3||
48439816|NCT02771340|101409967|FG002|STARTED|Overall Study||5||
48439817|NCT02771340|101409965|FG000|COMPLETED|Overall Study||2||
48439818|NCT02771340|101409966|FG001|COMPLETED|Overall Study||3||
48439819|NCT02771340|101409967|FG002|COMPLETED|Overall Study||5||
48439820|NCT02771340|101409965|FG000|NOT COMPLETED|Overall Study||0||
48439821|NCT02771340|101409966|FG001|NOT COMPLETED|Overall Study||0||
48439822|NCT02771340|101409967|FG002|NOT COMPLETED|Overall Study||0||
48439823|NCT03151707|101409968|FG000|STARTED|Overall Study||11||
48439824|NCT03151707|101409968|FG000|COMPLETED|Overall Study||5||
48439825|NCT03151707|101409968|FG000|NOT COMPLETED|Overall Study||6||
48439826|NCT02508649|101409969|FG000|STARTED|Overall Study||283||
48439827|NCT02508649|101409970|FG001|STARTED|Overall Study||197||
48439828|NCT02508649|101409971|FG002|STARTED|Overall Study||189||
48439829|NCT02508649|101409972|FG003|STARTED|Overall Study||199||
48767539|NCT02057250|102222763|FG000|NOT COMPLETED|AID Assessment Phase||4||
48767540|NCT02057250|102222764|FG001|NOT COMPLETED|AID Assessment Phase||3||
48767541|NCT02057250|102222765|FG002|NOT COMPLETED|AID Assessment Phase||7||
48439830|NCT02508649|101409969|FG000|Dosed|Overall Study||266||
48439831|NCT02508649|101409970|FG001|Dosed|Overall Study||191||
48439832|NCT02508649|101409971|FG002|Dosed|Overall Study||177||
48439833|NCT02508649|101409972|FG003|Dosed|Overall Study||194||
48439834|NCT02508649|101409969|FG000|COMPLETED|Overall Study||265||
48439835|NCT02508649|101409970|FG001|COMPLETED|Overall Study||184||
48767542|NCT02057250|102222766|FG003|NOT COMPLETED|AID Assessment Phase||2||
48188505|NCT04582045|100783259|FG001|NOT COMPLETED|Overall Study||0||
48767543|NCT02057250|102222767|FG004|NOT COMPLETED|AID Assessment Phase||0||
48767544|NCT02057250|102222763|FG000|STARTED|Extension Phase||0||
48767545|NCT02057250|102222764|FG001|STARTED|Extension Phase||0||
48767546|NCT02057250|102222765|FG002|STARTED|Extension Phase||0||
48767547|NCT02057250|102222766|FG003|STARTED|Extension Phase||0||
48439836|NCT02508649|101409971|FG002|COMPLETED|Overall Study||174||
48439837|NCT02508649|101409972|FG003|COMPLETED|Overall Study||189||
48439838|NCT02508649|101409969|FG000|NOT COMPLETED|Overall Study||18||
48439839|NCT02508649|101409970|FG001|NOT COMPLETED|Overall Study||13||
48439840|NCT02508649|101409971|FG002|NOT COMPLETED|Overall Study||15||
48439841|NCT02508649|101409972|FG003|NOT COMPLETED|Overall Study||10||
48439842|NCT00320801|101409973|FG000|STARTED|Open-label Run-in Period||188||
48439843|NCT00320801|101409974|FG001|STARTED|Open-label Run-in Period||0||
48439844|NCT00320801|101409975|FG002|STARTED|Open-label Run-in Period||0||
48439845|NCT00320801|101409976|FG003|STARTED|Open-label Run-in Period||0||
48439846|NCT00320801|101409973|FG000|COMPLETED|Open-label Run-in Period||96||
48439847|NCT00320801|101409974|FG001|COMPLETED|Open-label Run-in Period||0||
48439848|NCT00320801|101409975|FG002|COMPLETED|Open-label Run-in Period||0||
48439849|NCT00320801|101409976|FG003|COMPLETED|Open-label Run-in Period||0||
48439850|NCT00320801|101409973|FG000|NOT COMPLETED|Open-label Run-in Period||92||
48439851|NCT00320801|101409974|FG001|NOT COMPLETED|Open-label Run-in Period||0||
48439852|NCT00320801|101409975|FG002|NOT COMPLETED|Open-label Run-in Period||0||
48439853|NCT00320801|101409976|FG003|NOT COMPLETED|Open-label Run-in Period||0||
48439854|NCT00320801|101409973|FG000|STARTED|Double-blind Phase||0||
48439855|NCT00320801|101409974|FG001|STARTED|Double-blind Phase||47||
48439856|NCT00320801|101409975|FG002|STARTED|Double-blind Phase||49||
48439857|NCT00320801|101409976|FG003|STARTED|Double-blind Phase||0||
48439858|NCT00320801|101409973|FG000|COMPLETED|Double-blind Phase||0||
48439859|NCT00320801|101409974|FG001|COMPLETED|Double-blind Phase||36||
48439860|NCT00320801|101409975|FG002|COMPLETED|Double-blind Phase||35||
48439861|NCT00320801|101409976|FG003|COMPLETED|Double-blind Phase||0||
48439862|NCT00320801|101409973|FG000|NOT COMPLETED|Double-blind Phase||0||
48439863|NCT00320801|101409974|FG001|NOT COMPLETED|Double-blind Phase||11||
48439864|NCT00320801|101409975|FG002|NOT COMPLETED|Double-blind Phase||14||
48439865|NCT00320801|101409976|FG003|NOT COMPLETED|Double-blind Phase||0||
48439866|NCT00320801|101409973|FG000|STARTED|Extension Phase||0||
48439867|NCT00320801|101409974|FG001|STARTED|Extension Phase||0||
48439868|NCT00320801|101409975|FG002|STARTED|Extension Phase||0||
48439869|NCT00320801|101409976|FG003|STARTED|Extension Phase||55||
48439870|NCT00320801|101409973|FG000|COMPLETED|Extension Phase||0||
48439871|NCT00320801|101409974|FG001|COMPLETED|Extension Phase||0||
48439872|NCT00320801|101409975|FG002|COMPLETED|Extension Phase||0||
48439873|NCT00320801|101409976|FG003|COMPLETED|Extension Phase||7||
48439874|NCT00320801|101409973|FG000|NOT COMPLETED|Extension Phase||0||
48439875|NCT00320801|101409974|FG001|NOT COMPLETED|Extension Phase||0||
48439876|NCT00320801|101409975|FG002|NOT COMPLETED|Extension Phase||0||
48439877|NCT00320801|101409976|FG003|NOT COMPLETED|Extension Phase||48||
48439878|NCT00563706|101409977|FG000|STARTED|DB Treatment Period (Day 1 up to Day 28)||37||
48439879|NCT00563706|101409978|FG001|STARTED|DB Treatment Period (Day 1 up to Day 28)||18||
48439880|NCT00563706|101409979|FG002|STARTED|DB Treatment Period (Day 1 up to Day 28)||8||
48439881|NCT00563706|101409980|FG003|STARTED|DB Treatment Period (Day 1 up to Day 28)||19||
48767548|NCT02057250|102222767|FG004|STARTED|Extension Phase||192||
48767549|NCT02057250|102222763|FG000|Treated|Extension Phase||0||
48767550|NCT02057250|102222764|FG001|Treated|Extension Phase||0||
48767551|NCT02057250|102222765|FG002|Treated|Extension Phase||0||
48767552|NCT02057250|102222766|FG003|Treated|Extension Phase||0||
48767553|NCT02057250|102222767|FG004|Treated|Extension Phase||188||
48767554|NCT02057250|102222763|FG000|COMPLETED|Extension Phase||0||
48767555|NCT02057250|102222764|FG001|COMPLETED|Extension Phase||0||
48767556|NCT02057250|102222765|FG002|COMPLETED|Extension Phase||0||
48767557|NCT02057250|102222766|FG003|COMPLETED|Extension Phase||0||
48767558|NCT02057250|102222767|FG004|COMPLETED|Extension Phase||156||
48767559|NCT02057250|102222763|FG000|NOT COMPLETED|Extension Phase||0||
48767560|NCT02057250|102222764|FG001|NOT COMPLETED|Extension Phase||0||
48767561|NCT02057250|102222765|FG002|NOT COMPLETED|Extension Phase||0||
48767562|NCT02057250|102222766|FG003|NOT COMPLETED|Extension Phase||0||
48767563|NCT02057250|102222767|FG004|NOT COMPLETED|Extension Phase||36||
48767564|NCT00842335|102222768|FG000|STARTED|Overall Study||18||
48767565|NCT00842335|102222768|FG000|COMPLETED|Overall Study||18||
48767566|NCT00842335|102222768|FG000|NOT COMPLETED|Overall Study||0||
48767567|NCT01614886|102222769|FG000|STARTED|Overall Study||107||
48767568|NCT01614886|102222770|FG001|STARTED|Overall Study||109||
48767569|NCT01614886|102222769|FG000|Safety Population (SAF)|Overall Study||107||
48439882|NCT00563706|101409981|FG004|STARTED|DB Treatment Period (Day 1 up to Day 28)||16||
48439883|NCT00563706|101409982|FG005|STARTED|DB Treatment Period (Day 1 up to Day 28)||19||
48439884|NCT00563706|101409983|FG006|STARTED|DB Treatment Period (Day 1 up to Day 28)||12||
48439885|NCT00563706|101409984|FG007|STARTED|DB Treatment Period (Day 1 up to Day 28)||30||
48439886|NCT00563706|101409985|FG008|STARTED|DB Treatment Period (Day 1 up to Day 28)||43||
48439887|NCT00563706|101409977|FG000|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||20||
48439888|NCT00563706|101409978|FG001|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||13||
48439889|NCT00563706|101409979|FG002|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3||
48439890|NCT00563706|101409980|FG003|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9||
48439891|NCT00563706|101409981|FG004|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11||
48439892|NCT00563706|101409982|FG005|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14||
48439893|NCT00563706|101409983|FG006|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9||
48439894|NCT00563706|101409984|FG007|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||16||
48439895|NCT00563706|101409985|FG008|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||32||
48439896|NCT00563706|101409977|FG000|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||17||
48439897|NCT00563706|101409978|FG001|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5||
48439898|NCT00563706|101409979|FG002|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5||
48439899|NCT00563706|101409980|FG003|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||10||
48439900|NCT00563706|101409981|FG004|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5||
48440008|NCT04854421|101410008|FG001|NOT COMPLETED|Overall Study||2||
48440031|NCT05378269|101410019|FG004|STARTED|Overall Study||3||
48440032|NCT05378269|101410015|FG000|COMPLETED|Overall Study||3||
48440033|NCT05378269|101410016|FG001|COMPLETED|Overall Study||3||
48440034|NCT05378269|101410017|FG002|COMPLETED|Overall Study||2||
48440035|NCT05378269|101410018|FG003|COMPLETED|Overall Study||3||
48440036|NCT05378269|101410019|FG004|COMPLETED|Overall Study||3||
48440037|NCT05378269|101410015|FG000|NOT COMPLETED|Overall Study||1||
48440038|NCT05378269|101410016|FG001|NOT COMPLETED|Overall Study||0||
48440039|NCT05378269|101410017|FG002|NOT COMPLETED|Overall Study||2||
48440040|NCT05378269|101410018|FG003|NOT COMPLETED|Overall Study||0||
48440041|NCT05378269|101410019|FG004|NOT COMPLETED|Overall Study||0||
48440042|NCT02395536|101410020|FG000|STARTED|Overall Study||264||
48440043|NCT02395536|101410021|FG001|STARTED|Overall Study||257||
48440044|NCT02395536|101410020|FG000|REVEAL LINQ Insertion|Overall Study||251|Number of subjects randomized that actually had a REVEAL LINQ insertion attempt|
48440045|NCT02395536|101410021|FG001|REVEAL LINQ Insertion|Overall Study||231|Number of subjects randomized that actually had a REVEAL LINQ insertion attempt|
48440046|NCT02395536|101410020|FG000|COMPLETED|Overall Study||244||
48440047|NCT02395536|101410021|FG001|COMPLETED|Overall Study||227||
48440048|NCT02395536|101410020|FG000|NOT COMPLETED|Overall Study||20||
48440049|NCT02395536|101410021|FG001|NOT COMPLETED|Overall Study||30||
48440050|NCT03858998|101410022|FG000|STARTED|Overall Study||250||
48440051|NCT03858998|101410023|FG001|STARTED|Overall Study||250||
48440052|NCT03858998|101410022|FG000|COMPLETED|Overall Study||250||
48440053|NCT03858998|101410023|FG001|COMPLETED|Overall Study||250||
48440054|NCT03858998|101410022|FG000|NOT COMPLETED|Overall Study||0||
48440055|NCT03858998|101410023|FG001|NOT COMPLETED|Overall Study||0||
48440056|NCT03030638|101410024|FG000|STARTED|Overall Study||1386||
48440057|NCT03030638|101410025|FG001|STARTED|Overall Study||1841||
48440058|NCT03030638|101410026|FG002|STARTED|Overall Study||1712||
48440059|NCT03030638|101410027|FG003|STARTED|Overall Study||6406||
48440060|NCT03030638|101410028|FG004|STARTED|Overall Study||696||
48440061|NCT03030638|101410029|FG005|STARTED|Overall Study||1592||
48440062|NCT03030638|101410030|FG006|STARTED|Overall Study||364||
48440063|NCT03030638|101410031|FG007|STARTED|Overall Study||127||
48440064|NCT03030638|101410024|FG000|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||372||
48440065|NCT03030638|101410025|FG001|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||636||
48440066|NCT03030638|101410026|FG002|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0||
48440067|NCT03030638|101410027|FG003|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0||
48440068|NCT03030638|101410028|FG004|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0||
48440069|NCT03030638|101410029|FG005|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0||
48440070|NCT03030638|101410030|FG006|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0||
48440071|NCT03030638|101410031|FG007|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0||
48440072|NCT03030638|101410024|FG000|COMPLETED|Overall Study||1386||
48440073|NCT03030638|101410025|FG001|COMPLETED|Overall Study||1841||
48440074|NCT03030638|101410026|FG002|COMPLETED|Overall Study||1712||
48440075|NCT03030638|101410027|FG003|COMPLETED|Overall Study||6406||
48440076|NCT03030638|101410028|FG004|COMPLETED|Overall Study||696||
48440077|NCT03030638|101410029|FG005|COMPLETED|Overall Study||1592||
48440078|NCT03030638|101410030|FG006|COMPLETED|Overall Study||364||
48767789|NCT03863080|102222826|FG001|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0||
48440079|NCT03030638|101410031|FG007|COMPLETED|Overall Study||127||
48440080|NCT03030638|101410024|FG000|NOT COMPLETED|Overall Study||0||
48440081|NCT03030638|101410025|FG001|NOT COMPLETED|Overall Study||0||
48440082|NCT03030638|101410026|FG002|NOT COMPLETED|Overall Study||0||
48440083|NCT03030638|101410027|FG003|NOT COMPLETED|Overall Study||0||
48440084|NCT03030638|101410028|FG004|NOT COMPLETED|Overall Study||0||
48440085|NCT03030638|101410029|FG005|NOT COMPLETED|Overall Study||0||
48440086|NCT03030638|101410030|FG006|NOT COMPLETED|Overall Study||0||
48440087|NCT03030638|101410031|FG007|NOT COMPLETED|Overall Study||0||
48440088|NCT03224234|101410032|FG000|STARTED|Main Study||40||
48440089|NCT03224234|101410033|FG001|STARTED|Main Study||40||
48440090|NCT03224234|101410032|FG000|COMPLETED|Main Study||35||
48440091|NCT03224234|101410033|FG001|COMPLETED|Main Study||35||
48440092|NCT03224234|101410032|FG000|NOT COMPLETED|Main Study||5||
48440093|NCT03224234|101410033|FG001|NOT COMPLETED|Main Study||5||
48440094|NCT03224234|101410032|FG000|STARTED|Pilot||11||
48440095|NCT03224234|101410033|FG001|STARTED|Pilot||7||
48440096|NCT03224234|101410032|FG000|COMPLETED|Pilot||11||
48767790|NCT03863080|102222827|FG002|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||1||
48767791|NCT03863080|102222828|FG003|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0||
48767792|NCT03863080|102222825|FG000|STARTED|Open Label Extension Period (12 Weeks)||0||
48440097|NCT03224234|101410033|FG001|COMPLETED|Pilot||7||
48440098|NCT03224234|101410032|FG000|NOT COMPLETED|Pilot||0||
48440099|NCT03224234|101410033|FG001|NOT COMPLETED|Pilot||0||
48440100|NCT02234427|101410034|FG000|STARTED|Overall Study||34||
48440101|NCT02234427|101410034|FG000|COMPLETED|Overall Study||33||
48440102|NCT02234427|101410034|FG000|NOT COMPLETED|Overall Study||1||
48440103|NCT00669110|101410035|FG000|STARTED|Overall Study||20||
48440104|NCT00669110|101410036|FG001|STARTED|Overall Study||20||
48440105|NCT00669110|101410035|FG000|COMPLETED|Overall Study||12||
48440106|NCT00669110|101410036|FG001|COMPLETED|Overall Study||7||
48440107|NCT00669110|101410035|FG000|NOT COMPLETED|Overall Study||8||
48440108|NCT00669110|101410036|FG001|NOT COMPLETED|Overall Study||13||
48440109|NCT00238108|101410037|FG000|STARTED|Overall Study||8||
48440110|NCT00238108|101410038|FG001|STARTED|Overall Study||8||
48440111|NCT00238108|101410037|FG000|COMPLETED|Overall Study||8||
48440112|NCT00238108|101410038|FG001|COMPLETED|Overall Study||8||
48440113|NCT00238108|101410037|FG000|NOT COMPLETED|Overall Study||0||
48440114|NCT00238108|101410038|FG001|NOT COMPLETED|Overall Study||0||
48767793|NCT03863080|102222826|FG001|STARTED|Open Label Extension Period (12 Weeks)||0||
48767794|NCT03863080|102222827|FG002|STARTED|Open Label Extension Period (12 Weeks)||0||
48767795|NCT03863080|102222828|FG003|STARTED|Open Label Extension Period (12 Weeks)||15||
48440115|NCT00557830|101410039|FG000|STARTED|Screening Treatment Phase||12||
48440116|NCT00557830|101410040|FG001|STARTED|Screening Treatment Phase||0||
48440117|NCT00557830|101410041|FG002|STARTED|Screening Treatment Phase||0||
48440118|NCT00557830|101410039|FG000|COMPLETED|Screening Treatment Phase||6||
48440119|NCT00557830|101410040|FG001|COMPLETED|Screening Treatment Phase||0||
48440120|NCT00557830|101410041|FG002|COMPLETED|Screening Treatment Phase||0||
48440121|NCT00557830|101410039|FG000|NOT COMPLETED|Screening Treatment Phase||6||
48440122|NCT00557830|101410040|FG001|NOT COMPLETED|Screening Treatment Phase||0||
48440123|NCT00557830|101410041|FG002|NOT COMPLETED|Screening Treatment Phase||0||
48440124|NCT00557830|101410039|FG000|STARTED|Treatment Phase||0||
48440125|NCT00557830|101410040|FG001|STARTED|Treatment Phase||4||
48440126|NCT00557830|101410041|FG002|STARTED|Treatment Phase||2||
48440127|NCT00557830|101410039|FG000|COMPLETED|Treatment Phase||0||
48440128|NCT00557830|101410040|FG001|COMPLETED|Treatment Phase||4||
48440129|NCT00557830|101410041|FG002|COMPLETED|Treatment Phase||2||
48440130|NCT00557830|101410039|FG000|NOT COMPLETED|Treatment Phase||0||
48440131|NCT00557830|101410040|FG001|NOT COMPLETED|Treatment Phase||0||
48440132|NCT00557830|101410041|FG002|NOT COMPLETED|Treatment Phase||0||
48440133|NCT04278872|101410042|FG000|STARTED|Overall Study||7||
48440134|NCT04278872|101410043|FG001|STARTED|Overall Study||6||
48440135|NCT04278872|101410042|FG000|COMPLETED|Overall Study||4||
48440136|NCT04278872|101410043|FG001|COMPLETED|Overall Study||5||
48440137|NCT04278872|101410042|FG000|NOT COMPLETED|Overall Study||3||
48440138|NCT04278872|101410043|FG001|NOT COMPLETED|Overall Study||1||
48440139|NCT02212834|101410044|FG000|STARTED|Overall Study||33938||33,938
48440140|NCT02212834|101410045|FG001|STARTED|Overall Study||2506||2,506
48440141|NCT02212834|101410044|FG000|COMPLETED|Overall Study||33938||33,938
48440142|NCT02212834|101410045|FG001|COMPLETED|Overall Study||2506||2,506
48440143|NCT02212834|101410044|FG000|NOT COMPLETED|Overall Study||0||NA
48440144|NCT02212834|101410045|FG001|NOT COMPLETED|Overall Study||0||NA
48440145|NCT02181673|101410046|FG000|STARTED|Up to Week 24||239||
48440146|NCT02181673|101410047|FG001|STARTED|Up to Week 24||0||
48440147|NCT02181673|101410048|FG002|STARTED|Up to Week 24||241||
48440148|NCT02181673|101410046|FG000|Treated|Up to Week 24||239||
48440149|NCT02181673|101410047|FG001|Treated|Up to Week 24||0||
48440150|NCT02181673|101410048|FG002|Treated|Up to Week 24||240||
48440151|NCT02181673|101410046|FG000|COMPLETED|Up to Week 24||222||
48440152|NCT02181673|101410047|FG001|COMPLETED|Up to Week 24||0||
48440153|NCT02181673|101410048|FG002|COMPLETED|Up to Week 24||230||
48440154|NCT02181673|101410046|FG000|NOT COMPLETED|Up to Week 24||17||
48440155|NCT02181673|101410047|FG001|NOT COMPLETED|Up to Week 24||0||
48440156|NCT02181673|101410048|FG002|NOT COMPLETED|Up to Week 24||11||
48440157|NCT02181673|101410046|FG000|STARTED|Week 24-Week 60||0||
48440158|NCT02181673|101410047|FG001|STARTED|Week 24-Week 60||222||
48440159|NCT02181673|101410048|FG002|STARTED|Week 24-Week 60||230||
48440160|NCT02181673|101410046|FG000|Treated|Week 24-Week 60||0||
48440161|NCT02181673|101410047|FG001|Treated|Week 24-Week 60||220||
48440162|NCT02181673|101410048|FG002|Treated|Week 24-Week 60||230||
48440163|NCT02181673|101410046|FG000|COMPLETED|Week 24-Week 60||0||
48440164|NCT02181673|101410047|FG001|COMPLETED|Week 24-Week 60||214||
48440165|NCT02181673|101410048|FG002|COMPLETED|Week 24-Week 60||213||
48440166|NCT02181673|101410046|FG000|NOT COMPLETED|Week 24-Week 60||0||
48767796|NCT03863080|102222825|FG000|COMPLETED|Open Label Extension Period (12 Weeks)||0||
48440167|NCT02181673|101410047|FG001|NOT COMPLETED|Week 24-Week 60||8||
48440168|NCT02181673|101410048|FG002|NOT COMPLETED|Week 24-Week 60||17||
48440169|NCT02786810|101410049|FG000|STARTED|Overall Study||10||
48440170|NCT02786810|101410049|FG000|COMPLETED|Overall Study||10||
48440171|NCT02786810|101410049|FG000|NOT COMPLETED|Overall Study||0||
48440172|NCT04362761|101410050|FG000|STARTED|Part A (48 Weeks)||172||
48440173|NCT04362761|101410050|FG000|COMPLETED|Part A (48 Weeks)||159||
48440174|NCT04362761|101410050|FG000|NOT COMPLETED|Part A (48 Weeks)||13||
48767797|NCT03863080|102222826|FG001|COMPLETED|Open Label Extension Period (12 Weeks)||0||
48767798|NCT03863080|102222827|FG002|COMPLETED|Open Label Extension Period (12 Weeks)||0||
48767799|NCT03863080|102222828|FG003|COMPLETED|Open Label Extension Period (12 Weeks)||9||
48188756|NCT01902901|100783329|FG001|NOT COMPLETED|Overall Study||2||
48440175|NCT04362761|101410050|FG000|STARTED|Part B (86 Weeks)||50||
48440176|NCT04362761|101410050|FG000|COMPLETED|Part B (86 Weeks)||0||
48440177|NCT04362761|101410050|FG000|NOT COMPLETED|Part B (86 Weeks)||50||
48440178|NCT04512976|101410051|FG000|STARTED|Overall Study||11||
48440179|NCT04512976|101410052|FG001|STARTED|Overall Study||10||
48440180|NCT04512976|101410053|FG002|STARTED|Overall Study||10||
48440181|NCT04512976|101410054|FG003|STARTED|Overall Study||10||
48440182|NCT04512976|101410055|FG004|STARTED|Overall Study||10||
48440183|NCT04512976|101410056|FG005|STARTED|Overall Study||14||
48440184|NCT04512976|101410051|FG000|COMPLETED|Overall Study||11||
48440185|NCT04512976|101410052|FG001|COMPLETED|Overall Study||10||
48440186|NCT04512976|101410053|FG002|COMPLETED|Overall Study||10||
48440187|NCT04512976|101410054|FG003|COMPLETED|Overall Study||10||
48440188|NCT04512976|101410055|FG004|COMPLETED|Overall Study||10||
48440189|NCT04512976|101410056|FG005|COMPLETED|Overall Study||11||
48440190|NCT04512976|101410051|FG000|NOT COMPLETED|Overall Study||0||
48440191|NCT04512976|101410052|FG001|NOT COMPLETED|Overall Study||0||
48440192|NCT04512976|101410053|FG002|NOT COMPLETED|Overall Study||0||
48440193|NCT04512976|101410054|FG003|NOT COMPLETED|Overall Study||0||
48440194|NCT04512976|101410055|FG004|NOT COMPLETED|Overall Study||0||
48440195|NCT04512976|101410056|FG005|NOT COMPLETED|Overall Study||3||
48440196|NCT02384200|101410057|FG000|STARTED|Overall Study||43||
48440197|NCT02384200|101410058|FG001|STARTED|Overall Study||43||
48440198|NCT02384200|101410057|FG000|COMPLETED|Overall Study||43||
48440199|NCT02384200|101410058|FG001|COMPLETED|Overall Study||43||
48440200|NCT02384200|101410057|FG000|NOT COMPLETED|Overall Study||0||
48440201|NCT02384200|101410058|FG001|NOT COMPLETED|Overall Study||0||
48440202|NCT03597620|101410059|FG000|STARTED|Overall Study||6||
48440203|NCT03597620|101410060|FG001|STARTED|Overall Study||5||
48440204|NCT03597620|101410059|FG000|COMPLETED|Overall Study||4||
48440205|NCT03597620|101410060|FG001|COMPLETED|Overall Study||5||
48440206|NCT03597620|101410059|FG000|NOT COMPLETED|Overall Study||2||
48440207|NCT03597620|101410060|FG001|NOT COMPLETED|Overall Study||0||
48440208|NCT03205163|101410061|FG000|STARTED|ATP (LDC: 3 Days; HDC: 4 Days)||7||
48440209|NCT03205163|101410062|FG001|STARTED|ATP (LDC: 3 Days; HDC: 4 Days)||9||
48440210|NCT03205163|101410061|FG000|Safety Population|ATP (LDC: 3 Days; HDC: 4 Days)||7||
48440211|NCT03205163|101410062|FG001|Safety Population|ATP (LDC: 3 Days; HDC: 4 Days)||9||
48440212|NCT03205163|101410061|FG000|COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||6||
48440213|NCT03205163|101410062|FG001|COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||9||
48440214|NCT03205163|101410061|FG000|NOT COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||1||
48440215|NCT03205163|101410062|FG001|NOT COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||0||
48440216|NCT03205163|101410061|FG000|STARTED|BTP (LDC: 28 Days; HDC: 28 Days)||6||
48440217|NCT03205163|101410062|FG001|STARTED|BTP (LDC: 28 Days; HDC: 28 Days)||9||
48440218|NCT03205163|101410061|FG000|Safety Population|BTP (LDC: 28 Days; HDC: 28 Days)||6||
48440219|NCT03205163|101410062|FG001|Safety Population|BTP (LDC: 28 Days; HDC: 28 Days)||9||
48440220|NCT03205163|101410061|FG000|COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||6||
48440221|NCT03205163|101410062|FG001|COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||9||
48440222|NCT03205163|101410061|FG000|NOT COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||0||
48440223|NCT03205163|101410062|FG001|NOT COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||0||
48440224|NCT00891527|101410063|FG000|STARTED|Overall Study||50||
48440225|NCT00891527|101410063|FG000|COMPLETED|Overall Study||48||
48440226|NCT00891527|101410063|FG000|NOT COMPLETED|Overall Study||2||
48440227|NCT05279807|101410064|FG000|STARTED|Overall Study||144||
48440228|NCT05279807|101410065|FG001|STARTED|Overall Study||133||
48440229|NCT05279807|101410064|FG000|COMPLETED|Overall Study||142||
48440230|NCT05279807|101410065|FG001|COMPLETED|Overall Study||132||
48440231|NCT05279807|101410064|FG000|NOT COMPLETED|Overall Study||2||
48440232|NCT05279807|101410065|FG001|NOT COMPLETED|Overall Study||1||
48440233|NCT04484805|101410066|FG000|STARTED|Overall Study||6||
48440234|NCT04484805|101410067|FG001|STARTED|Overall Study||6||
48440235|NCT04484805|101410066|FG000|COMPLETED|Overall Study||4||
48440236|NCT04484805|101410067|FG001|COMPLETED|Overall Study||6||
48440237|NCT04484805|101410066|FG000|NOT COMPLETED|Overall Study||2||
48440238|NCT04484805|101410067|FG001|NOT COMPLETED|Overall Study||0||
48440239|NCT01125358|101410068|FG000|STARTED|Overall Study||21||
48440240|NCT01125358|101410069|FG001|STARTED|Overall Study||21||
48440241|NCT01125358|101410070|FG002|STARTED|Overall Study||20||
48440242|NCT01125358|101410071|FG003|STARTED|Overall Study||20||
48440243|NCT01125358|101410068|FG000|Received at Least 1 Dose of Study Drug|Overall Study||21||
48440244|NCT01125358|101410069|FG001|Received at Least 1 Dose of Study Drug|Overall Study||21||
48440245|NCT01125358|101410070|FG002|Received at Least 1 Dose of Study Drug|Overall Study||20||
48440246|NCT01125358|101410071|FG003|Received at Least 1 Dose of Study Drug|Overall Study||20||
48440247|NCT01125358|101410068|FG000|Placebo Responder|Overall Study||1||
48440248|NCT01125358|101410069|FG001|Placebo Responder|Overall Study||0||
48440249|NCT01125358|101410070|FG002|Placebo Responder|Overall Study||0||
48440250|NCT01125358|101410071|FG003|Placebo Responder|Overall Study||0||
48657137|NCT01844986|101943787|FG000|STARTED|Overall Study (Global Cohort)||260|(Randomised to study treatment)|
48657138|NCT01844986|101943788|FG001|STARTED|Overall Study (Global Cohort)||131|(Randomised to study treatment)|
48657139|NCT01844986|101943787|FG000|COMPLETED|Overall Study (Global Cohort)||183|(Ongoing study at time of PFS analysis DCO:17 May 2018)|
48657140|NCT01844986|101943788|FG001|COMPLETED|Overall Study (Global Cohort)||91|(Ongoing study at time of PFS analysis DCO:17 May 2018)|
48657141|NCT01844986|101943787|FG000|NOT COMPLETED|Overall Study (Global Cohort)||77||
48657142|NCT01844986|101943788|FG001|NOT COMPLETED|Overall Study (Global Cohort)||40||
48657143|NCT01844986|101943787|FG000|STARTED|Overall Study (China Cohort)||44|(Randomised to study treatment)|
48670037|NCT03601897|101974868|FG002|NOT COMPLETED|Overall Study||7||
48440251|NCT01125358|101410068|FG000|COMPLETED|Overall Study||9||
48440252|NCT01125358|101410069|FG001|COMPLETED|Overall Study||17||
48440253|NCT01125358|101410070|FG002|COMPLETED|Overall Study||11||
48440254|NCT01125358|101410071|FG003|COMPLETED|Overall Study||12||
48440255|NCT01125358|101410068|FG000|NOT COMPLETED|Overall Study||12||
48440256|NCT01125358|101410069|FG001|NOT COMPLETED|Overall Study||4||
48440257|NCT01125358|101410070|FG002|NOT COMPLETED|Overall Study||9||
48440258|NCT01125358|101410071|FG003|NOT COMPLETED|Overall Study||8||
48440259|NCT03464110|101410072|FG000|STARTED|Overall Study||20||
48440260|NCT03464110|101410073|FG001|STARTED|Overall Study||20||
48440261|NCT03464110|101410074|FG002|STARTED|Overall Study||120||
48440262|NCT03464110|101410075|FG003|STARTED|Overall Study||120||
48440263|NCT03464110|101410072|FG000|COMPLETED|Overall Study||20||
48440264|NCT03464110|101410073|FG001|COMPLETED|Overall Study||20||
48440265|NCT03464110|101410074|FG002|COMPLETED|Overall Study||120||
48440266|NCT03464110|101410075|FG003|COMPLETED|Overall Study||120||
48440267|NCT03464110|101410072|FG000|NOT COMPLETED|Overall Study||0||
48440268|NCT03464110|101410073|FG001|NOT COMPLETED|Overall Study||0||
48440269|NCT03464110|101410074|FG002|NOT COMPLETED|Overall Study||0||
48440270|NCT03464110|101410075|FG003|NOT COMPLETED|Overall Study||0||
48440271|NCT04341727|101410076|FG000|STARTED|Overall Study||9||
48440272|NCT04341727|101410077|FG001|STARTED|Overall Study||7||
48440273|NCT04341727|101410078|FG002|STARTED|Overall Study||7||
48440274|NCT04341727|101410079|FG003|STARTED|Overall Study||7||
48440275|NCT04341727|101410076|FG000|COMPLETED|Overall Study||9||
48440276|NCT04341727|101410077|FG001|COMPLETED|Overall Study||7||
48440277|NCT04341727|101410078|FG002|COMPLETED|Overall Study||6||
48440278|NCT04341727|101410079|FG003|COMPLETED|Overall Study||6||
48440279|NCT04341727|101410076|FG000|NOT COMPLETED|Overall Study||0||
48440280|NCT04341727|101410077|FG001|NOT COMPLETED|Overall Study||0||
48440281|NCT04341727|101410078|FG002|NOT COMPLETED|Overall Study||1||
48440282|NCT04341727|101410079|FG003|NOT COMPLETED|Overall Study||1||
48440283|NCT00558831|101410080|FG000|STARTED|Overall Study||11||
48440284|NCT00558831|101410080|FG000|COMPLETED|Overall Study||10||
48440285|NCT00558831|101410080|FG000|NOT COMPLETED|Overall Study||1||
48440286|NCT04342390|101410081|FG000|STARTED|Overall Study||34||
48440287|NCT04342390|101410082|FG001|STARTED|Overall Study||6||
48440288|NCT04342390|101410081|FG000|COMPLETED|Overall Study||31||
48440289|NCT04342390|101410082|FG001|COMPLETED|Overall Study||6||
48440290|NCT04342390|101410081|FG000|NOT COMPLETED|Overall Study||3||
48440291|NCT04342390|101410082|FG001|NOT COMPLETED|Overall Study||0||
48440292|NCT00276458|101410083|FG000|STARTED|Overall Study||98||
48440293|NCT00276458|101410084|FG001|STARTED|Overall Study||98||
48657144|NCT01844986|101943788|FG001|STARTED|Overall Study (China Cohort)||20|(Randomised to study treatment)|
48657145|NCT01844986|101943787|FG000|COMPLETED|Overall Study (China Cohort)||33|(Ongoing study at time of PFS analysis DCO:17 May 2018)|
48657146|NCT01844986|101943788|FG001|COMPLETED|Overall Study (China Cohort)||14|(Ongoing study at time of PFS analysis DCO:17 May 2018)|
48657147|NCT01844986|101943787|FG000|NOT COMPLETED|Overall Study (China Cohort)||11||
48657148|NCT01844986|101943788|FG001|NOT COMPLETED|Overall Study (China Cohort)||6||
48657149|NCT01104870|101943789|FG000|STARTED|Overall Study||11||
48657150|NCT01104870|101943790|FG001|STARTED|Overall Study||19||
48657151|NCT01104870|101943791|FG002|STARTED|Overall Study||20||
48657152|NCT01104870|101943789|FG000|COMPLETED|Overall Study||10||
48767800|NCT03863080|102222825|FG000|NOT COMPLETED|Open Label Extension Period (12 Weeks)||0||
48188757|NCT03382821|100786078|FG000|STARTED|Overall Study||60||
48440294|NCT00276458|101410083|FG000|COMPLETED|Overall Study||92||
48440295|NCT00276458|101410084|FG001|COMPLETED|Overall Study||91||
48440296|NCT00276458|101410083|FG000|NOT COMPLETED|Overall Study||6||
48440297|NCT00276458|101410084|FG001|NOT COMPLETED|Overall Study||7||
48440298|NCT01600755|101410085|FG000|STARTED|Overall Study||53||
48440299|NCT01600755|101410085|FG000|Iltamiocel Injection|Overall Study||48||
48440300|NCT01600755|101410085|FG000|3-Month Follow-Up|Overall Study||48||
48440301|NCT01600755|101410085|FG000|6-Month Follow-Up|Overall Study||48||
48440302|NCT01600755|101410085|FG000|12-Month Follow-Up|Overall Study||47||
48440303|NCT01600755|101410085|FG000|COMPLETED|Overall Study||47||
48657153|NCT01104870|101943790|FG001|COMPLETED|Overall Study||18||
48657154|NCT01104870|101943791|FG002|COMPLETED|Overall Study||18||
48657155|NCT01104870|101943789|FG000|NOT COMPLETED|Overall Study||1||
48657156|NCT01104870|101943790|FG001|NOT COMPLETED|Overall Study||1||
48657157|NCT01104870|101943791|FG002|NOT COMPLETED|Overall Study||2||
48657158|NCT03249558|101943792|FG000|STARTED|Overall Study||21||
48440304|NCT01600755|101410085|FG000|NOT COMPLETED|Overall Study||6||
48440305|NCT02875340|101410086|FG000|STARTED|Overall Study||8||
48440306|NCT02875340|101410086|FG000|COMPLETED|Overall Study||0||
48440307|NCT02875340|101410086|FG000|NOT COMPLETED|Overall Study||8||
48657159|NCT03249558|101943793|FG001|STARTED|Overall Study||19||
48657160|NCT03249558|101943794|FG002|STARTED|Overall Study||19||
48767801|NCT03863080|102222826|FG001|NOT COMPLETED|Open Label Extension Period (12 Weeks)||0||
48767802|NCT03863080|102222827|FG002|NOT COMPLETED|Open Label Extension Period (12 Weeks)||0||
48767803|NCT03863080|102222828|FG003|NOT COMPLETED|Open Label Extension Period (12 Weeks)||6||
48767804|NCT02531802|102222829|FG000|STARTED|Received Vaccination 1||15||
48767805|NCT02531802|102222830|FG001|STARTED|Received Vaccination 1||15||
48767806|NCT02531802|102222831|FG002|STARTED|Received Vaccination 1||15||
48440308|NCT00308230|101410087|FG000|STARTED|Overall Study||6||
48440309|NCT00308230|101410088|FG001|STARTED|Overall Study||8||
48440310|NCT00308230|101410089|FG002|STARTED|Overall Study||20||
48440311|NCT00308230|101410087|FG000|COMPLETED|Overall Study||6||
48440312|NCT00308230|101410088|FG001|COMPLETED|Overall Study||8||
48440313|NCT00308230|101410089|FG002|COMPLETED|Overall Study||20||
48440314|NCT00308230|101410087|FG000|NOT COMPLETED|Overall Study||0||
48440315|NCT00308230|101410088|FG001|NOT COMPLETED|Overall Study||0||
48440316|NCT00308230|101410089|FG002|NOT COMPLETED|Overall Study||0||
48440317|NCT01513759|101410090|FG000|STARTED|Overall Study||150||
48440318|NCT01513759|101410090|FG000|At Least One Device Successfully Placed|Overall Study||149||
48440319|NCT01513759|101410090|FG000|COMPLETED|Overall Study||145||
48440320|NCT01513759|101410090|FG000|NOT COMPLETED|Overall Study||5||
48440321|NCT01819467|101410091|FG000|STARTED|Overall Study||20|29|
48440322|NCT01819467|101410092|FG001|STARTED|Overall Study||9|29|
48440323|NCT01819467|101410091|FG000|COMPLETED|Overall Study||0|Study terminated|
48440324|NCT01819467|101410092|FG001|COMPLETED|Overall Study||0|Study terminated|
48440325|NCT01819467|101410091|FG000|NOT COMPLETED|Overall Study||20||
48440326|NCT01819467|101410092|FG001|NOT COMPLETED|Overall Study||9||
48440327|NCT02587117|101410093|FG000|STARTED|Overall Study||13||
48440328|NCT02587117|101410094|FG001|STARTED|Overall Study||15||
48440329|NCT02587117|101410093|FG000|COMPLETED|Overall Study||13||
48440330|NCT02587117|101410094|FG001|COMPLETED|Overall Study||15||
48440331|NCT02587117|101410093|FG000|NOT COMPLETED|Overall Study||0||
48657161|NCT03249558|101943792|FG000|COMPLETED|Overall Study||10||
48657162|NCT03249558|101943793|FG001|COMPLETED|Overall Study||12||
48657163|NCT03249558|101943794|FG002|COMPLETED|Overall Study||6||
48657164|NCT03249558|101943792|FG000|NOT COMPLETED|Overall Study||11||
48657165|NCT03249558|101943793|FG001|NOT COMPLETED|Overall Study||7||
48657166|NCT03249558|101943794|FG002|NOT COMPLETED|Overall Study||13||
48657167|NCT01081262|101943795|FG000|STARTED|Overall Study||13||
48657168|NCT01081262|101943796|FG001|STARTED|Overall Study||13||
48657169|NCT01081262|101943797|FG002|STARTED|Overall Study||13||
48657170|NCT01081262|101943798|FG003|STARTED|Overall Study||11||
48657171|NCT01081262|101943795|FG000|COMPLETED|Overall Study||13||
48657172|NCT01081262|101943796|FG001|COMPLETED|Overall Study||13||
48657173|NCT01081262|101943797|FG002|COMPLETED|Overall Study||13||
48657174|NCT01081262|101943798|FG003|COMPLETED|Overall Study||11||
48657175|NCT01081262|101943795|FG000|NOT COMPLETED|Overall Study||0||
48657176|NCT01081262|101943796|FG001|NOT COMPLETED|Overall Study||0||
48657177|NCT01081262|101943797|FG002|NOT COMPLETED|Overall Study||0||
48657178|NCT01081262|101943798|FG003|NOT COMPLETED|Overall Study||0||
48657179|NCT02217982|101943799|FG000|STARTED|Overall Study||1||
48657180|NCT02217982|101943800|FG001|STARTED|Overall Study||4||
48657181|NCT02217982|101943799|FG000|COMPLETED|Overall Study||0||
48657182|NCT02217982|101943800|FG001|COMPLETED|Overall Study||3||
48657183|NCT02217982|101943799|FG000|NOT COMPLETED|Overall Study||1||
48657184|NCT02217982|101943800|FG001|NOT COMPLETED|Overall Study||1||
48657185|NCT03052257|101943801|FG000|STARTED|Overall Study||100||
48657186|NCT03052257|101943802|FG001|STARTED|Overall Study||100||
48657187|NCT03052257|101943801|FG000|COMPLETED|Overall Study||95||
48657188|NCT03052257|101943802|FG001|COMPLETED|Overall Study||97||
48657189|NCT03052257|101943801|FG000|NOT COMPLETED|Overall Study||5||
48657190|NCT03052257|101943802|FG001|NOT COMPLETED|Overall Study||3||
48657191|NCT03000166|101943803|FG000|STARTED|Overall Study||25||
48767807|NCT02531802|102222832|FG003|STARTED|Received Vaccination 1||15||
48767808|NCT02531802|102222833|FG004|STARTED|Received Vaccination 1||15||
48767809|NCT02531802|102222834|FG005|STARTED|Received Vaccination 1||3||
48767810|NCT02531802|102222835|FG006|STARTED|Received Vaccination 1||15||
48440332|NCT02587117|101410094|FG001|NOT COMPLETED|Overall Study||0||
48440333|NCT01527942|101410095|FG000|STARTED|Overall Study||16||
48440334|NCT01527942|101410096|FG001|STARTED|Overall Study||18||
48657192|NCT03000166|101943804|FG001|STARTED|Overall Study||22||
48657193|NCT03000166|101943803|FG000|COMPLETED|Overall Study||25||
48657194|NCT03000166|101943804|FG001|COMPLETED|Overall Study||19||
48657195|NCT03000166|101943803|FG000|NOT COMPLETED|Overall Study||0||
48657196|NCT03000166|101943804|FG001|NOT COMPLETED|Overall Study||3||
48767811|NCT02531802|102222836|FG007|STARTED|Received Vaccination 1||15||
48440335|NCT01527942|101410095|FG000|COMPLETED|Overall Study||16||
48440336|NCT01527942|101410096|FG001|COMPLETED|Overall Study||18||
48440337|NCT01527942|101410095|FG000|NOT COMPLETED|Overall Study||0||
48440338|NCT01527942|101410096|FG001|NOT COMPLETED|Overall Study||0||
48657197|NCT03537729|101943805|FG000|STARTED|Overall Study||55||5
48657198|NCT03537729|101943806|FG001|STARTED|Overall Study||62||5
48657199|NCT03537729|101943807|FG002|STARTED|Overall Study||55||5
48657200|NCT03537729|101943805|FG000|Completed Month 0|Overall Study||43||5
48657201|NCT03537729|101943806|FG001|Completed Month 0|Overall Study||57||5
48767812|NCT02531802|102222837|FG008|STARTED|Received Vaccination 1||15||
48767813|NCT02531802|102222838|FG009|STARTED|Received Vaccination 1||52||
48767814|NCT02531802|102222839|FG010|STARTED|Received Vaccination 1||15||
48767815|NCT02531802|102222840|FG011|STARTED|Received Vaccination 1||15||
48767816|NCT02531802|102222841|FG012|STARTED|Received Vaccination 1||15||
48767817|NCT02531802|102222842|FG013|STARTED|Received Vaccination 1||15||
48767818|NCT02531802|102222843|FG014|STARTED|Received Vaccination 1||40||
48767819|NCT02531802|102222844|FG015|STARTED|Received Vaccination 1||30||
48767820|NCT02531802|102222845|FG016|STARTED|Received Vaccination 1||30||
48767821|NCT02531802|102222846|FG017|STARTED|Received Vaccination 1||30||
48767822|NCT02531802|102222847|FG018|STARTED|Received Vaccination 1||30||
48440339|NCT03003793|101410097|FG000|STARTED|Overall Study||16||
48440340|NCT03003793|101410098|FG001|STARTED|Overall Study||16||
48440341|NCT03003793|101410097|FG000|COMPLETED|Overall Study||16||
48440342|NCT03003793|101410098|FG001|COMPLETED|Overall Study||16||
48440343|NCT03003793|101410097|FG000|NOT COMPLETED|Overall Study||0||
48440344|NCT03003793|101410098|FG001|NOT COMPLETED|Overall Study||0||
48440345|NCT01683331|101410099|FG000|STARTED|Overall Study||18||
48440346|NCT01683331|101410100|FG001|STARTED|Overall Study||18||
48440347|NCT01683331|101410099|FG000|Began Dosage|Overall Study||18||
48440348|NCT01683331|101410100|FG001|Began Dosage|Overall Study||18||
48440349|NCT01683331|101410099|FG000|12 Months|Overall Study||18||
48440350|NCT01683331|101410100|FG001|12 Months|Overall Study||18||
48440351|NCT01683331|101410099|FG000|24 Months|Overall Study||18||
48440352|NCT01683331|101410100|FG001|24 Months|Overall Study||18||
48767823|NCT02531802|102222848|FG019|STARTED|Received Vaccination 1||30||
48767824|NCT02531802|102222849|FG020|STARTED|Received Vaccination 1||50||
48767825|NCT02531802|102222829|FG000|COMPLETED|Received Vaccination 1||15||
48767826|NCT02531802|102222830|FG001|COMPLETED|Received Vaccination 1||15||
48767827|NCT02531802|102222831|FG002|COMPLETED|Received Vaccination 1||15||
48368138|NCT01819922|101230113|FG000|NOT COMPLETED|First Intervention Period (1 Day)||0||
48368139|NCT01819922|101230114|FG001|NOT COMPLETED|First Intervention Period (1 Day)||0||
48368140|NCT01819922|101230113|FG000|STARTED|Washout Period (at Least 7-10 Days)||6||
48368141|NCT01819922|101230114|FG001|STARTED|Washout Period (at Least 7-10 Days)||6||
48368142|NCT01819922|101230113|FG000|COMPLETED|Washout Period (at Least 7-10 Days)||6||
48368143|NCT01819922|101230114|FG001|COMPLETED|Washout Period (at Least 7-10 Days)||6||
48440353|NCT01683331|101410099|FG000|COMPLETED|Overall Study||18||
48440354|NCT01683331|101410100|FG001|COMPLETED|Overall Study||18||
48767828|NCT02531802|102222832|FG003|COMPLETED|Received Vaccination 1||15||
48368144|NCT01819922|101230113|FG000|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0||
48368145|NCT01819922|101230114|FG001|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0||
48368146|NCT01819922|101230113|FG000|STARTED|Second Intervention Period (1 Day)||6||
48368147|NCT01819922|101230114|FG001|STARTED|Second Intervention Period (1 Day)||6||
48368148|NCT01819922|101230113|FG000|COMPLETED|Second Intervention Period (1 Day)||6||
48368149|NCT01819922|101230114|FG001|COMPLETED|Second Intervention Period (1 Day)||6||
48368150|NCT01819922|101230113|FG000|NOT COMPLETED|Second Intervention Period (1 Day)||0||
48368151|NCT01819922|101230114|FG001|NOT COMPLETED|Second Intervention Period (1 Day)||0||
48368152|NCT00938327|101230115|FG000|STARTED|Overall Study||332||
48368153|NCT00938327|101230115|FG000|COMPLETED|Overall Study||272||
48368154|NCT00938327|101230115|FG000|NOT COMPLETED|Overall Study||60||
48368155|NCT03408873|101230116|FG000|STARTED|Visit 1 Assessment (Baseline)||30||
48368156|NCT03408873|101230116|FG000|COMPLETED|Visit 1 Assessment (Baseline)||27||
48368157|NCT03408873|101230116|FG000|NOT COMPLETED|Visit 1 Assessment (Baseline)||3||
48368158|NCT03408873|101230116|FG000|STARTED|Visit 2 Assessment||27||
48368159|NCT03408873|101230116|FG000|COMPLETED|Visit 2 Assessment||26||
48368160|NCT03408873|101230116|FG000|NOT COMPLETED|Visit 2 Assessment||1||
48368161|NCT03408873|101230116|FG000|STARTED|Visit 3 Assessment||26||
48368162|NCT03408873|101230116|FG000|COMPLETED|Visit 3 Assessment||25||
48440355|NCT01683331|101410099|FG000|NOT COMPLETED|Overall Study||0||
48440356|NCT01683331|101410100|FG001|NOT COMPLETED|Overall Study||0||
48767829|NCT02531802|102222833|FG004|COMPLETED|Received Vaccination 1||15||
48767830|NCT02531802|102222834|FG005|COMPLETED|Received Vaccination 1||3||
48767831|NCT02531802|102222835|FG006|COMPLETED|Received Vaccination 1||15||
48767832|NCT02531802|102222836|FG007|COMPLETED|Received Vaccination 1||15||
48767833|NCT02531802|102222837|FG008|COMPLETED|Received Vaccination 1||15||
48767834|NCT02531802|102222838|FG009|COMPLETED|Received Vaccination 1||52||
48767835|NCT02531802|102222839|FG010|COMPLETED|Received Vaccination 1||15||
48767836|NCT02531802|102222840|FG011|COMPLETED|Received Vaccination 1||15||
48767837|NCT02531802|102222841|FG012|COMPLETED|Received Vaccination 1||15||
48368163|NCT03408873|101230116|FG000|NOT COMPLETED|Visit 3 Assessment||1||
48368164|NCT03408873|101230116|FG000|STARTED|Visit 4 Assessment||25||
48368165|NCT03408873|101230116|FG000|COMPLETED|Visit 4 Assessment||23||
48368166|NCT03408873|101230116|FG000|NOT COMPLETED|Visit 4 Assessment||2||
48368167|NCT03408873|101230116|FG000|STARTED|Visit 5 Assessment||23||
48368168|NCT03408873|101230116|FG000|COMPLETED|Visit 5 Assessment||22||
48368169|NCT03408873|101230116|FG000|NOT COMPLETED|Visit 5 Assessment||1||
48368170|NCT03408873|101230116|FG000|STARTED|Visit 6 Assessment||22||
48368171|NCT03408873|101230116|FG000|COMPLETED|Visit 6 Assessment||21||
48368172|NCT03408873|101230116|FG000|NOT COMPLETED|Visit 6 Assessment||1||
48368173|NCT03408873|101230116|FG000|STARTED|Visit 7 Assessment||21||
48767838|NCT02531802|102222842|FG013|COMPLETED|Received Vaccination 1||15||
48767839|NCT02531802|102222843|FG014|COMPLETED|Received Vaccination 1||40||
48767840|NCT02531802|102222844|FG015|COMPLETED|Received Vaccination 1||30||
48767841|NCT02531802|102222845|FG016|COMPLETED|Received Vaccination 1||30||
48767842|NCT02531802|102222846|FG017|COMPLETED|Received Vaccination 1||30||
48767843|NCT02531802|102222847|FG018|COMPLETED|Received Vaccination 1||30||
48767844|NCT02531802|102222848|FG019|COMPLETED|Received Vaccination 1||30||
48767845|NCT02531802|102222849|FG020|COMPLETED|Received Vaccination 1||50||
48767846|NCT02531802|102222829|FG000|NOT COMPLETED|Received Vaccination 1||0||
48767847|NCT02531802|102222830|FG001|NOT COMPLETED|Received Vaccination 1||0||
48767848|NCT02531802|102222831|FG002|NOT COMPLETED|Received Vaccination 1||0||
48767849|NCT02531802|102222832|FG003|NOT COMPLETED|Received Vaccination 1||0||
48767850|NCT02531802|102222833|FG004|NOT COMPLETED|Received Vaccination 1||0||
48767851|NCT02531802|102222834|FG005|NOT COMPLETED|Received Vaccination 1||0||
48767852|NCT02531802|102222835|FG006|NOT COMPLETED|Received Vaccination 1||0||
48767853|NCT02531802|102222836|FG007|NOT COMPLETED|Received Vaccination 1||0||
48767854|NCT02531802|102222837|FG008|NOT COMPLETED|Received Vaccination 1||0||
48767855|NCT02531802|102222838|FG009|NOT COMPLETED|Received Vaccination 1||0||
48767856|NCT02531802|102222839|FG010|NOT COMPLETED|Received Vaccination 1||0||
48767857|NCT02531802|102222840|FG011|NOT COMPLETED|Received Vaccination 1||0||
48767858|NCT02531802|102222841|FG012|NOT COMPLETED|Received Vaccination 1||0||
48767859|NCT02531802|102222842|FG013|NOT COMPLETED|Received Vaccination 1||0||
48767860|NCT02531802|102222843|FG014|NOT COMPLETED|Received Vaccination 1||0||
48767861|NCT02531802|102222844|FG015|NOT COMPLETED|Received Vaccination 1||0||
48767862|NCT02531802|102222845|FG016|NOT COMPLETED|Received Vaccination 1||0||
48767863|NCT02531802|102222846|FG017|NOT COMPLETED|Received Vaccination 1||0||
48767864|NCT02531802|102222847|FG018|NOT COMPLETED|Received Vaccination 1||0||
48767865|NCT02531802|102222848|FG019|NOT COMPLETED|Received Vaccination 1||0||
48767866|NCT02531802|102222849|FG020|NOT COMPLETED|Received Vaccination 1||0||
48767867|NCT02531802|102222829|FG000|STARTED|Received Vaccination 2||15||
48767868|NCT02531802|102222830|FG001|STARTED|Received Vaccination 2||15||
48767869|NCT02531802|102222831|FG002|STARTED|Received Vaccination 2||15||
48767870|NCT02531802|102222832|FG003|STARTED|Received Vaccination 2||15||
48767871|NCT02531802|102222833|FG004|STARTED|Received Vaccination 2||15||
48767872|NCT02531802|102222834|FG005|STARTED|Received Vaccination 2||3||
48767873|NCT02531802|102222835|FG006|STARTED|Received Vaccination 2||15||
48767874|NCT02531802|102222836|FG007|STARTED|Received Vaccination 2||15||
48767875|NCT02531802|102222837|FG008|STARTED|Received Vaccination 2||15||
48767876|NCT02531802|102222838|FG009|STARTED|Received Vaccination 2||52||
48767877|NCT02531802|102222839|FG010|STARTED|Received Vaccination 2||15||
48767878|NCT02531802|102222840|FG011|STARTED|Received Vaccination 2||15||
48767879|NCT02531802|102222841|FG012|STARTED|Received Vaccination 2||15||
48767880|NCT02531802|102222842|FG013|STARTED|Received Vaccination 2||15||
48767881|NCT02531802|102222843|FG014|STARTED|Received Vaccination 2||40||
48767882|NCT02531802|102222844|FG015|STARTED|Received Vaccination 2||30||
48767883|NCT02531802|102222845|FG016|STARTED|Received Vaccination 2||30||
48767884|NCT02531802|102222846|FG017|STARTED|Received Vaccination 2||30||
48767885|NCT02531802|102222847|FG018|STARTED|Received Vaccination 2||30||
48767886|NCT02531802|102222848|FG019|STARTED|Received Vaccination 2||30||
48767887|NCT02531802|102222849|FG020|STARTED|Received Vaccination 2||50||
48767888|NCT02531802|102222829|FG000|COMPLETED|Received Vaccination 2||15||
48767889|NCT02531802|102222830|FG001|COMPLETED|Received Vaccination 2||15||
48767890|NCT02531802|102222831|FG002|COMPLETED|Received Vaccination 2||14||
48767891|NCT02531802|102222832|FG003|COMPLETED|Received Vaccination 2||15||
48767892|NCT02531802|102222833|FG004|COMPLETED|Received Vaccination 2||15||
48767893|NCT02531802|102222834|FG005|COMPLETED|Received Vaccination 2||0||
48767894|NCT02531802|102222835|FG006|COMPLETED|Received Vaccination 2||15||
48767895|NCT02531802|102222836|FG007|COMPLETED|Received Vaccination 2||15||
48767896|NCT02531802|102222837|FG008|COMPLETED|Received Vaccination 2||15||
48767897|NCT02531802|102222838|FG009|COMPLETED|Received Vaccination 2||49||
48767898|NCT02531802|102222839|FG010|COMPLETED|Received Vaccination 2||13||
48767899|NCT02531802|102222840|FG011|COMPLETED|Received Vaccination 2||15||
48767900|NCT02531802|102222841|FG012|COMPLETED|Received Vaccination 2||13||
48767901|NCT02531802|102222842|FG013|COMPLETED|Received Vaccination 2||13||
48767902|NCT02531802|102222843|FG014|COMPLETED|Received Vaccination 2||39||
48767903|NCT02531802|102222844|FG015|COMPLETED|Received Vaccination 2||30||
48767904|NCT02531802|102222845|FG016|COMPLETED|Received Vaccination 2||30||
48767905|NCT02531802|102222846|FG017|COMPLETED|Received Vaccination 2||26||
48767906|NCT02531802|102222847|FG018|COMPLETED|Received Vaccination 2||27||
48767907|NCT02531802|102222848|FG019|COMPLETED|Received Vaccination 2||29||
48767908|NCT02531802|102222849|FG020|COMPLETED|Received Vaccination 2||49||
48767909|NCT02531802|102222829|FG000|NOT COMPLETED|Received Vaccination 2||0||
48767910|NCT02531802|102222830|FG001|NOT COMPLETED|Received Vaccination 2||0||
48767911|NCT02531802|102222831|FG002|NOT COMPLETED|Received Vaccination 2||1||
48767912|NCT02531802|102222832|FG003|NOT COMPLETED|Received Vaccination 2||0||
48767913|NCT02531802|102222833|FG004|NOT COMPLETED|Received Vaccination 2||0||
48767914|NCT02531802|102222834|FG005|NOT COMPLETED|Received Vaccination 2||3||
48767915|NCT02531802|102222835|FG006|NOT COMPLETED|Received Vaccination 2||0||
48767916|NCT02531802|102222836|FG007|NOT COMPLETED|Received Vaccination 2||0||
48767917|NCT02531802|102222837|FG008|NOT COMPLETED|Received Vaccination 2||0||
48767918|NCT02531802|102222838|FG009|NOT COMPLETED|Received Vaccination 2||3||
48767919|NCT02531802|102222839|FG010|NOT COMPLETED|Received Vaccination 2||2||
48767920|NCT02531802|102222840|FG011|NOT COMPLETED|Received Vaccination 2||0||
48767921|NCT02531802|102222841|FG012|NOT COMPLETED|Received Vaccination 2||2||
48767922|NCT02531802|102222842|FG013|NOT COMPLETED|Received Vaccination 2||2||
48767923|NCT02531802|102222843|FG014|NOT COMPLETED|Received Vaccination 2||1||
48767924|NCT02531802|102222844|FG015|NOT COMPLETED|Received Vaccination 2||0||
48767925|NCT02531802|102222845|FG016|NOT COMPLETED|Received Vaccination 2||0||
48767926|NCT02531802|102222846|FG017|NOT COMPLETED|Received Vaccination 2||4||
48767927|NCT02531802|102222847|FG018|NOT COMPLETED|Received Vaccination 2||3||
48767928|NCT02531802|102222848|FG019|NOT COMPLETED|Received Vaccination 2||1||
48767929|NCT02531802|102222849|FG020|NOT COMPLETED|Received Vaccination 2||1||
48767930|NCT01074814|102222850|FG000|STARTED|Overall Study||25||
48767931|NCT01074814|102222850|FG000|COMPLETED|Overall Study||25||
48767932|NCT01074814|102222850|FG000|NOT COMPLETED|Overall Study||0||
48767933|NCT01491607|102222851|FG000|STARTED|Overall Study||200||
48767934|NCT01491607|102222851|FG000|COMPLETED|Overall Study||190||
48767935|NCT01491607|102222851|FG000|NOT COMPLETED|Overall Study||10||
48767936|NCT05101122|102222852|FG000|STARTED|Atomoxetine Only||15||
48767937|NCT05101122|102222852|FG000|COMPLETED|Atomoxetine Only||14||
48767938|NCT05101122|102222852|FG000|NOT COMPLETED|Atomoxetine Only||1||
48767939|NCT05101122|102222852|FG000|STARTED|AD313 40/2.5||14||
48767940|NCT05101122|102222852|FG000|COMPLETED|AD313 40/2.5||12||
48767941|NCT05101122|102222852|FG000|NOT COMPLETED|AD313 40/2.5||2||
48767942|NCT05101122|102222852|FG000|STARTED|AD313 80/5||12||
48767943|NCT05101122|102222852|FG000|COMPLETED|AD313 80/5||11||
48767944|NCT05101122|102222852|FG000|NOT COMPLETED|AD313 80/5||1||
48767945|NCT05101122|102222852|FG000|STARTED|AD313 80/10||11||
48767946|NCT05101122|102222852|FG000|COMPLETED|AD313 80/10||10||
48767947|NCT05101122|102222852|FG000|NOT COMPLETED|AD313 80/10||1||
48188758|NCT03382821|100786079|FG001|STARTED|Overall Study||60||
48368174|NCT03408873|101230116|FG000|COMPLETED|Visit 7 Assessment||21||
48368175|NCT03408873|101230116|FG000|NOT COMPLETED|Visit 7 Assessment||0||
48440357|NCT01803464|101413030|FG000|STARTED|Overall Study||5||
48440358|NCT01803464|101413031|FG001|STARTED|Overall Study||4||
48440359|NCT01803464|101413032|FG002|STARTED|Overall Study||10||
48440360|NCT01803464|101413033|FG003|STARTED|Overall Study||10||
48440361|NCT01803464|101413030|FG000|COMPLETED|Overall Study||4||
48440362|NCT01803464|101413031|FG001|COMPLETED|Overall Study||4||
48440363|NCT01803464|101413032|FG002|COMPLETED|Overall Study||6||
48440364|NCT01803464|101413033|FG003|COMPLETED|Overall Study||10||
48767948|NCT03472885|102222853|FG000|STARTED|24-Week Treatment Period||12||
48767949|NCT03472885|102222853|FG000|Safety Population: Received at Least 1 Dose of Study Drug|24-Week Treatment Period||12||
48767950|NCT03472885|102222853|FG000|Efficacy Population: Received Study Drug for at Least 4 Weeks|24-Week Treatment Period||11||
48767951|NCT03472885|102222853|FG000|COMPLETED|24-Week Treatment Period||11||
48767952|NCT03472885|102222853|FG000|NOT COMPLETED|24-Week Treatment Period||1||
48767953|NCT03472885|102222853|FG000|STARTED|LTE Period (Maximum Exposure: 1463 Days)||11||
48767954|NCT03472885|102222853|FG000|COMPLETED|LTE Period (Maximum Exposure: 1463 Days)||11||
48767955|NCT03472885|102222853|FG000|NOT COMPLETED|LTE Period (Maximum Exposure: 1463 Days)||0||
48767956|NCT02911844|102222854|FG000|STARTED|Overall Study||5||
48767957|NCT02911844|102222854|FG000|COMPLETED|Overall Study||5||
48767958|NCT02911844|102222854|FG000|NOT COMPLETED|Overall Study||0||
48767959|NCT02651675|102222855|FG000|STARTED|Overall Study||3||
48767960|NCT02651675|102222856|FG001|STARTED|Overall Study||3||
48767961|NCT02651675|102222857|FG002|STARTED|Overall Study||3||
48767962|NCT02651675|102222855|FG000|COMPLETED|Overall Study||3||
48767963|NCT02651675|102222856|FG001|COMPLETED|Overall Study||3||
48767964|NCT02651675|102222857|FG002|COMPLETED|Overall Study||2||
48767965|NCT02651675|102222855|FG000|NOT COMPLETED|Overall Study||0||
48767966|NCT02651675|102222856|FG001|NOT COMPLETED|Overall Study||0||
48368176|NCT01912872|101230117|FG000|STARTED|Overall Study||16||
48368177|NCT01912872|101230118|FG001|STARTED|Overall Study||17||
48368178|NCT01912872|101230119|FG002|STARTED|Overall Study||40||
48368179|NCT01912872|101230120|FG003|STARTED|Overall Study||39||
48368180|NCT01912872|101230117|FG000|Completed Study Treatment at Month 12|Overall Study||11||
48368181|NCT01912872|101230118|FG001|Completed Study Treatment at Month 12|Overall Study||13||
48368182|NCT01912872|101230119|FG002|Completed Study Treatment at Month 12|Overall Study||30||
48368183|NCT01912872|101230120|FG003|Completed Study Treatment at Month 12|Overall Study||27||
48368184|NCT01912872|101230117|FG000|Discontinued Treatment Prior to Month 12|Overall Study||5||
48440365|NCT01803464|101413030|FG000|NOT COMPLETED|Overall Study||1||
48440366|NCT01803464|101413031|FG001|NOT COMPLETED|Overall Study||0||
48440367|NCT01803464|101413032|FG002|NOT COMPLETED|Overall Study||4||
48767967|NCT02651675|102222857|FG002|NOT COMPLETED|Overall Study||1||
48767968|NCT00260533|102222858|FG000|STARTED|Overall Study||14||
48767969|NCT00260533|102222859|FG001|STARTED|Overall Study||13||
48767970|NCT00260533|102222858|FG000|COMPLETED|Overall Study||11||
48767971|NCT00260533|102222859|FG001|COMPLETED|Overall Study||10||
48767972|NCT00260533|102222858|FG000|NOT COMPLETED|Overall Study||3||
48767973|NCT00260533|102222859|FG001|NOT COMPLETED|Overall Study||3||
48767974|NCT00999804|102222860|FG000|STARTED|Overall Study||85||
48767975|NCT00999804|102222861|FG001|STARTED|Overall Study||43||
48767976|NCT00999804|102222860|FG000|COMPLETED|Overall Study||64||
48767977|NCT00999804|102222861|FG001|COMPLETED|Overall Study||38||
48767978|NCT00999804|102222860|FG000|NOT COMPLETED|Overall Study||21||
48767979|NCT00999804|102222861|FG001|NOT COMPLETED|Overall Study||5||
48767980|NCT00722072|102222862|FG000|STARTED|Overall Study||12||
48767981|NCT00722072|102222862|FG000|COMPLETED|Overall Study||9||
48767982|NCT00722072|102222862|FG000|NOT COMPLETED|Overall Study||3||
48767983|NCT02048670|102222863|FG000|STARTED|Overall Study||6||
48767984|NCT02048670|102222864|FG001|STARTED|Overall Study||6||
48440368|NCT01803464|101413033|FG003|NOT COMPLETED|Overall Study||0||
48440369|NCT04881448|101413034|FG000|STARTED|Overall Study||223||
48440370|NCT04881448|101413034|FG000|COMPLETED|Overall Study||0||
48440371|NCT04881448|101413034|FG000|NOT COMPLETED|Overall Study||223||
48440372|NCT01029769|101413035|FG000|STARTED|Period 1: Initial 2-week Treatment||163||
48440373|NCT01029769|101413036|FG001|STARTED|Period 1: Initial 2-week Treatment||164||
48440374|NCT01029769|101413037|FG002|STARTED|Period 1: Initial 2-week Treatment||0||
48440375|NCT01029769|101413038|FG003|STARTED|Period 1: Initial 2-week Treatment||0||
48440376|NCT01029769|101413039|FG004|STARTED|Period 1: Initial 2-week Treatment||0||
48440377|NCT01029769|101413035|FG000|COMPLETED|Period 1: Initial 2-week Treatment||140||
48440378|NCT01029769|101413036|FG001|COMPLETED|Period 1: Initial 2-week Treatment||145||
48440379|NCT01029769|101413037|FG002|COMPLETED|Period 1: Initial 2-week Treatment||0||
48440380|NCT01029769|101413038|FG003|COMPLETED|Period 1: Initial 2-week Treatment||0||
48440381|NCT01029769|101413039|FG004|COMPLETED|Period 1: Initial 2-week Treatment||0||
48440382|NCT01029769|101413035|FG000|NOT COMPLETED|Period 1: Initial 2-week Treatment||23||
48440383|NCT01029769|101413036|FG001|NOT COMPLETED|Period 1: Initial 2-week Treatment||19||
48440384|NCT01029769|101413037|FG002|NOT COMPLETED|Period 1: Initial 2-week Treatment||0||
48440385|NCT01029769|101413038|FG003|NOT COMPLETED|Period 1: Initial 2-week Treatment||0||
48440386|NCT01029769|101413039|FG004|NOT COMPLETED|Period 1: Initial 2-week Treatment||0||
48440387|NCT01029769|101413035|FG000|STARTED|Period 2: Extended 6-week Treatment||0||
48440388|NCT01029769|101413036|FG001|STARTED|Period 2: Extended 6-week Treatment||0||
48767985|NCT02048670|102222863|FG000|COMPLETED|Overall Study||6||
48767986|NCT02048670|102222864|FG001|COMPLETED|Overall Study||6||
48767987|NCT02048670|102222863|FG000|NOT COMPLETED|Overall Study||0||
48767988|NCT02048670|102222864|FG001|NOT COMPLETED|Overall Study||0||
48767989|NCT03367793|102222865|FG000|STARTED|Initial Acuity at Dispense Visit (10min)||5||
48767990|NCT03367793|102222866|FG001|STARTED|Initial Acuity at Dispense Visit (10min)||5||
48767991|NCT03367793|102222867|FG002|STARTED|Initial Acuity at Dispense Visit (10min)||5||
48767992|NCT03367793|102222868|FG003|STARTED|Initial Acuity at Dispense Visit (10min)||5||
48767993|NCT03367793|102222869|FG004|STARTED|Initial Acuity at Dispense Visit (10min)||5||
48767994|NCT03367793|102222870|FG005|STARTED|Initial Acuity at Dispense Visit (10min)||5||
48767995|NCT03367793|102222865|FG000|COMPLETED|Initial Acuity at Dispense Visit (10min)||5||
48368185|NCT01912872|101230118|FG001|Discontinued Treatment Prior to Month 12|Overall Study||4||
48368186|NCT01912872|101230119|FG002|Discontinued Treatment Prior to Month 12|Overall Study||10||
48368187|NCT01912872|101230120|FG003|Discontinued Treatment Prior to Month 12|Overall Study||11||
48368188|NCT01912872|101230117|FG000|COMPLETED|Overall Study||11||
48368189|NCT01912872|101230118|FG001|COMPLETED|Overall Study||13||
48368190|NCT01912872|101230119|FG002|COMPLETED|Overall Study||30||
48368191|NCT01912872|101230120|FG003|COMPLETED|Overall Study||27||
48368192|NCT01912872|101230117|FG000|NOT COMPLETED|Overall Study||5||
48368193|NCT01912872|101230118|FG001|NOT COMPLETED|Overall Study||4||
48368194|NCT01912872|101230119|FG002|NOT COMPLETED|Overall Study||10||
48368195|NCT01912872|101230120|FG003|NOT COMPLETED|Overall Study||12||
48368196|NCT04983940|101230121|FG000|STARTED|Overall Study||41||
48368197|NCT04983940|101230121|FG000|COMPLETED|Overall Study||25||
48368198|NCT04983940|101230121|FG000|NOT COMPLETED|Overall Study||16||
48368199|NCT03288779|101230122|FG000|STARTED|Overall Study||6||
48368200|NCT03288779|101230122|FG000|COMPLETED|Overall Study||3||
48368201|NCT03288779|101230122|FG000|NOT COMPLETED|Overall Study||3||
48368202|NCT01981122|101230123|FG000|STARTED|Overall Study||25||
48368203|NCT01981122|101230124|FG001|STARTED|Overall Study||27||
48368204|NCT01981122|101230123|FG000|COMPLETED|Overall Study||11||
48368205|NCT01981122|101230124|FG001|COMPLETED|Overall Study||7||
48368206|NCT01981122|101230123|FG000|NOT COMPLETED|Overall Study||14||
48368207|NCT01981122|101230124|FG001|NOT COMPLETED|Overall Study||20||
48368208|NCT01280123|101230125|FG000|STARTED|Overall Study||72||
48440389|NCT01029769|101413037|FG002|STARTED|Period 2: Extended 6-week Treatment||140||
48440390|NCT01029769|101413038|FG003|STARTED|Period 2: Extended 6-week Treatment||70||
48440391|NCT01029769|101413039|FG004|STARTED|Period 2: Extended 6-week Treatment||72||
48440392|NCT01029769|101413035|FG000|COMPLETED|Period 2: Extended 6-week Treatment||0||
48767996|NCT03367793|102222866|FG001|COMPLETED|Initial Acuity at Dispense Visit (10min)||5||
48767997|NCT03367793|102222867|FG002|COMPLETED|Initial Acuity at Dispense Visit (10min)||5||
48767998|NCT03367793|102222868|FG003|COMPLETED|Initial Acuity at Dispense Visit (10min)||5||
48767999|NCT03367793|102222869|FG004|COMPLETED|Initial Acuity at Dispense Visit (10min)||5||
48768000|NCT03367793|102222870|FG005|COMPLETED|Initial Acuity at Dispense Visit (10min)||5||
48440393|NCT01029769|101413036|FG001|COMPLETED|Period 2: Extended 6-week Treatment||0||
48440394|NCT01029769|101413037|FG002|COMPLETED|Period 2: Extended 6-week Treatment||104||
48440395|NCT01029769|101413038|FG003|COMPLETED|Period 2: Extended 6-week Treatment||60||
48440396|NCT01029769|101413039|FG004|COMPLETED|Period 2: Extended 6-week Treatment||55||
48768001|NCT03367793|102222865|FG000|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0||
48768002|NCT03367793|102222866|FG001|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0||
48768003|NCT03367793|102222867|FG002|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0||
48768004|NCT03367793|102222868|FG003|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0||
48768005|NCT03367793|102222869|FG004|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0||
48768006|NCT03367793|102222870|FG005|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0||
48768007|NCT03367793|102222865|FG000|STARTED|Treatment 1 Dispense to 2 Months Wear||5||
48768008|NCT03367793|102222866|FG001|STARTED|Treatment 1 Dispense to 2 Months Wear||5||
48440397|NCT01029769|101413035|FG000|NOT COMPLETED|Period 2: Extended 6-week Treatment||0||
48440398|NCT01029769|101413036|FG001|NOT COMPLETED|Period 2: Extended 6-week Treatment||0||
48440399|NCT01029769|101413037|FG002|NOT COMPLETED|Period 2: Extended 6-week Treatment||36||
48440400|NCT01029769|101413038|FG003|NOT COMPLETED|Period 2: Extended 6-week Treatment||10||
48440401|NCT01029769|101413039|FG004|NOT COMPLETED|Period 2: Extended 6-week Treatment||17||
48440402|NCT00391092|101413040|FG000|STARTED|Overall Study||208||
48440403|NCT00391092|101413041|FG001|STARTED|Overall Study||216||
48440404|NCT00391092|101413040|FG000|Received Treatment|Overall Study||206||
48440405|NCT00391092|101413041|FG001|Received Treatment|Overall Study||215||
48440406|NCT00391092|101413040|FG000|COMPLETED|Overall Study||0||
48440407|NCT00391092|101413041|FG001|COMPLETED|Overall Study||0||
48440408|NCT00391092|101413040|FG000|NOT COMPLETED|Overall Study||208||
48440409|NCT00391092|101413041|FG001|NOT COMPLETED|Overall Study||216||
48440410|NCT00646282|101413042|FG000|STARTED|Overall Study||4||
48440411|NCT00646282|101413043|FG001|STARTED|Overall Study||4||
48440412|NCT00646282|101413042|FG000|COMPLETED|Overall Study||0||
48440413|NCT00646282|101413043|FG001|COMPLETED|Overall Study||0||
48440414|NCT00646282|101413042|FG000|NOT COMPLETED|Overall Study||4||
48440415|NCT00646282|101413043|FG001|NOT COMPLETED|Overall Study||4||
48440416|NCT04639310|101413044|FG000|STARTED|Overall Study||5||
48440417|NCT04639310|101413045|FG001|STARTED|Overall Study||3||
48440418|NCT04639310|101413044|FG000|COMPLETED|Overall Study||5||
48440419|NCT04639310|101413045|FG001|COMPLETED|Overall Study||2||
48440420|NCT04639310|101413044|FG000|NOT COMPLETED|Overall Study||0||
48440421|NCT04639310|101413045|FG001|NOT COMPLETED|Overall Study||1||
48440422|NCT01598740|101413046|FG000|STARTED|Period 1||9||
48440423|NCT01598740|101413047|FG001|STARTED|Period 1||9||
48440424|NCT01598740|101413046|FG000|COMPLETED|Period 1||9||
48440425|NCT01598740|101413047|FG001|COMPLETED|Period 1||9||
48440426|NCT01598740|101413046|FG000|NOT COMPLETED|Period 1||0||
48440427|NCT01598740|101413047|FG001|NOT COMPLETED|Period 1||0||
48440428|NCT01598740|101413046|FG000|STARTED|Period 2||8||
48440429|NCT01598740|101413047|FG001|STARTED|Period 2||9||
48440430|NCT01598740|101413046|FG000|COMPLETED|Period 2||7||
48440431|NCT01598740|101413047|FG001|COMPLETED|Period 2||9||
48440432|NCT01598740|101413046|FG000|NOT COMPLETED|Period 2||1||
48440433|NCT01598740|101413047|FG001|NOT COMPLETED|Period 2||0||
48768009|NCT03367793|102222867|FG002|STARTED|Treatment 1 Dispense to 2 Months Wear||5||
48768010|NCT03367793|102222868|FG003|STARTED|Treatment 1 Dispense to 2 Months Wear||5||
48768011|NCT03367793|102222869|FG004|STARTED|Treatment 1 Dispense to 2 Months Wear||5||
48768012|NCT03367793|102222870|FG005|STARTED|Treatment 1 Dispense to 2 Months Wear||5||
48768013|NCT03367793|102222865|FG000|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5||
48768014|NCT03367793|102222866|FG001|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5||
48440434|NCT02918318|101413048|FG000|STARTED|Double-blind Induction Phase: 4 Weeks||41||
48440435|NCT02918318|101413049|FG001|STARTED|Double-blind Induction Phase: 4 Weeks||40||
48440436|NCT02918318|101413050|FG002|STARTED|Double-blind Induction Phase: 4 Weeks||41||
48440437|NCT02918318|101413051|FG003|STARTED|Double-blind Induction Phase: 4 Weeks||80||
48440438|NCT02918318|101413052|FG004|STARTED|Double-blind Induction Phase: 4 Weeks||0||
48440439|NCT02918318|101413048|FG000|Responders|Double-blind Induction Phase: 4 Weeks||13||
48440440|NCT02918318|101413049|FG001|Responders|Double-blind Induction Phase: 4 Weeks||11||
48440441|NCT02918318|101413050|FG002|Responders|Double-blind Induction Phase: 4 Weeks||17||
48440442|NCT02918318|101413051|FG003|Responders|Double-blind Induction Phase: 4 Weeks||27||
48440443|NCT02918318|101413052|FG004|Responders|Double-blind Induction Phase: 4 Weeks||0||
48440444|NCT02918318|101413048|FG000|COMPLETED|Double-blind Induction Phase: 4 Weeks||39||
48440445|NCT02918318|101413049|FG001|COMPLETED|Double-blind Induction Phase: 4 Weeks||33||
48440446|NCT02918318|101413050|FG002|COMPLETED|Double-blind Induction Phase: 4 Weeks||39||
48440447|NCT02918318|101413051|FG003|COMPLETED|Double-blind Induction Phase: 4 Weeks||72||
48440448|NCT02918318|101413052|FG004|COMPLETED|Double-blind Induction Phase: 4 Weeks||0||
48440449|NCT02918318|101413048|FG000|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||2||
48440450|NCT02918318|101413049|FG001|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||7||
48440451|NCT02918318|101413050|FG002|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||2||
48440452|NCT02918318|101413051|FG003|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||8||
48440453|NCT02918318|101413052|FG004|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||0||
48768015|NCT03367793|102222867|FG002|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5||
48768016|NCT03367793|102222868|FG003|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5||
48768017|NCT03367793|102222869|FG004|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5||
48768018|NCT03367793|102222870|FG005|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5||
48768019|NCT03367793|102222865|FG000|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0||
48768020|NCT03367793|102222866|FG001|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0||
48768021|NCT03367793|102222867|FG002|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0||
48768022|NCT03367793|102222868|FG003|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0||
48768023|NCT03367793|102222869|FG004|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0||
48768024|NCT03367793|102222870|FG005|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0||
48768025|NCT03367793|102222865|FG000|STARTED|Treatment 2 Dispense to 2 Months Wear||5||
48768026|NCT03367793|102222866|FG001|STARTED|Treatment 2 Dispense to 2 Months Wear||5||
48768027|NCT03367793|102222867|FG002|STARTED|Treatment 2 Dispense to 2 Months Wear||5||
48768028|NCT03367793|102222868|FG003|STARTED|Treatment 2 Dispense to 2 Months Wear||5||
48768029|NCT03367793|102222869|FG004|STARTED|Treatment 2 Dispense to 2 Months Wear||5||
48768030|NCT03367793|102222870|FG005|STARTED|Treatment 2 Dispense to 2 Months Wear||5||
48768031|NCT03367793|102222865|FG000|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5||
48768032|NCT03367793|102222866|FG001|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5||
48768033|NCT03367793|102222867|FG002|COMPLETED|Treatment 2 Dispense to 2 Months Wear||4||
48768034|NCT03367793|102222868|FG003|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5||
48768035|NCT03367793|102222869|FG004|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5||
48768036|NCT03367793|102222870|FG005|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5||
48768037|NCT03367793|102222865|FG000|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0||
48768038|NCT03367793|102222866|FG001|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0||
48768039|NCT03367793|102222867|FG002|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||1||
48768040|NCT03367793|102222868|FG003|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0||
48768041|NCT03367793|102222869|FG004|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0||
48768042|NCT03367793|102222870|FG005|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0||
48768043|NCT03367793|102222865|FG000|STARTED|Treatment 3 Dispense to 2 Months Wear||5||
48768044|NCT03367793|102222866|FG001|STARTED|Treatment 3 Dispense to 2 Months Wear||5||
48768045|NCT03367793|102222867|FG002|STARTED|Treatment 3 Dispense to 2 Months Wear||5||
48768046|NCT03367793|102222868|FG003|STARTED|Treatment 3 Dispense to 2 Months Wear||5||
48768047|NCT03367793|102222869|FG004|STARTED|Treatment 3 Dispense to 2 Months Wear||5||
48768048|NCT03367793|102222870|FG005|STARTED|Treatment 3 Dispense to 2 Months Wear||5||
48768049|NCT03367793|102222865|FG000|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5||
48768050|NCT03367793|102222866|FG001|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5||
48768051|NCT03367793|102222867|FG002|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5||
48768052|NCT03367793|102222868|FG003|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5||
48768053|NCT03367793|102222869|FG004|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5||
48768054|NCT03367793|102222870|FG005|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5||
48768055|NCT03367793|102222865|FG000|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0||
48768056|NCT03367793|102222866|FG001|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0||
48768057|NCT03367793|102222867|FG002|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0||
48768058|NCT03367793|102222868|FG003|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0||
48768059|NCT03367793|102222869|FG004|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0||
48768060|NCT03367793|102222870|FG005|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0||
48768061|NCT02129699|102222871|FG000|STARTED|Overall Study||255||
48768062|NCT02129699|102222872|FG001|STARTED|Overall Study||259||
48768063|NCT02129699|102222871|FG000|COMPLETED|Overall Study||252||
48768064|NCT02129699|102222872|FG001|COMPLETED|Overall Study||257||
48768065|NCT02129699|102222871|FG000|NOT COMPLETED|Overall Study||3||
48768066|NCT02129699|102222872|FG001|NOT COMPLETED|Overall Study||2||
48768067|NCT02557139|102222873|FG000|STARTED|Overall Study||8||
48768068|NCT02557139|102222874|FG001|STARTED|Overall Study||8||
48768069|NCT02557139|102222875|FG002|STARTED|Overall Study||7||
48768070|NCT02557139|102222873|FG000|COMPLETED|Overall Study||6||
48440454|NCT02918318|101413048|FG000|STARTED|Double-blind Follow-up Phase: 4 Weeks||27||
48440455|NCT02918318|101413049|FG001|STARTED|Double-blind Follow-up Phase: 4 Weeks||28||
48768071|NCT02557139|102222874|FG001|COMPLETED|Overall Study||8||
48768072|NCT02557139|102222875|FG002|COMPLETED|Overall Study||5||
48768073|NCT02557139|102222873|FG000|NOT COMPLETED|Overall Study||2||
48768074|NCT02557139|102222874|FG001|NOT COMPLETED|Overall Study||0||
48768075|NCT02557139|102222875|FG002|NOT COMPLETED|Overall Study||2||
48768076|NCT00391586|102222876|FG000|STARTED|Overall Study||45||
48768077|NCT00391586|102222876|FG000|Received First-line Erlotinib|Overall Study||43||
48768078|NCT00391586|102222876|FG000|Received Platinum-based Chemotherapy|Overall Study||10||
48768079|NCT00391586|102222876|FG000|COMPLETED|Overall Study||21||
48768080|NCT00391586|102222876|FG000|NOT COMPLETED|Overall Study||24||
48768081|NCT03219723|102222877|FG000|STARTED|Overall Study||560||
48768082|NCT03219723|102222877|FG000|COMPLETED|Overall Study||550||
48440456|NCT02918318|101413050|FG002|STARTED|Double-blind Follow-up Phase: 4 Weeks||24||
48188759|NCT03382821|100786078|FG000|COMPLETED|Overall Study||60||
48188760|NCT03382821|100786079|FG001|COMPLETED|Overall Study||57||
48188761|NCT03382821|100786078|FG000|NOT COMPLETED|Overall Study||0||
48440457|NCT02918318|101413051|FG003|STARTED|Double-blind Follow-up Phase: 4 Weeks||53||
48768083|NCT03219723|102222877|FG000|NOT COMPLETED|Overall Study||10||
48768084|NCT05567783|102222878|FG000|STARTED|Overall Study||989||
48768085|NCT05567783|102222879|FG001|STARTED|Overall Study||995||
48768086|NCT05567783|102222880|FG002|STARTED|Overall Study||993||
48768087|NCT05567783|102222878|FG000|Received Study Intervention|Overall Study||981||
48440458|NCT02918318|101413052|FG004|STARTED|Double-blind Follow-up Phase: 4 Weeks||0||
48440459|NCT02918318|101413048|FG000|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||26||
48440460|NCT02918318|101413049|FG001|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||28||
48440461|NCT02918318|101413050|FG002|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||23||
48440462|NCT02918318|101413051|FG003|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||50||
48440463|NCT02918318|101413052|FG004|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0||
48440464|NCT02918318|101413048|FG000|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||1||
48440465|NCT02918318|101413049|FG001|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0||
48440466|NCT02918318|101413050|FG002|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||1||
48440467|NCT02918318|101413051|FG003|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||3||
48440468|NCT02918318|101413052|FG004|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0||
48440469|NCT02918318|101413048|FG000|STARTED|Posttreatment Phase: Up to 24 Weeks||13||
48440470|NCT02918318|101413049|FG001|STARTED|Posttreatment Phase: Up to 24 Weeks||11||
48440471|NCT02918318|101413050|FG002|STARTED|Posttreatment Phase: Up to 24 Weeks||17||
48440472|NCT02918318|101413051|FG003|STARTED|Posttreatment Phase: Up to 24 Weeks||27||
48440473|NCT02918318|101413052|FG004|STARTED|Posttreatment Phase: Up to 24 Weeks||0||
48440474|NCT02918318|101413048|FG000|COMPLETED|Posttreatment Phase: Up to 24 Weeks||12||
48440475|NCT02918318|101413049|FG001|COMPLETED|Posttreatment Phase: Up to 24 Weeks||8||
48440476|NCT02918318|101413050|FG002|COMPLETED|Posttreatment Phase: Up to 24 Weeks||16||
48440477|NCT02918318|101413051|FG003|COMPLETED|Posttreatment Phase: Up to 24 Weeks||25||
48440478|NCT02918318|101413052|FG004|COMPLETED|Posttreatment Phase: Up to 24 Weeks||0||
48440479|NCT02918318|101413048|FG000|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||1||
48440480|NCT02918318|101413049|FG001|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||3||
48440481|NCT02918318|101413050|FG002|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||1||
48440482|NCT02918318|101413051|FG003|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||2||
48440483|NCT02918318|101413052|FG004|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||0||
48440484|NCT02918318|101413048|FG000|STARTED|Open Label Treatment Phase: 4 Weeks||0||
48440485|NCT02918318|101413049|FG001|STARTED|Open Label Treatment Phase: 4 Weeks||0||
48440486|NCT02918318|101413050|FG002|STARTED|Open Label Treatment Phase: 4 Weeks||0||
48440487|NCT02918318|101413051|FG003|STARTED|Open Label Treatment Phase: 4 Weeks||0||
48440488|NCT02918318|101413052|FG004|STARTED|Open Label Treatment Phase: 4 Weeks||48||
48440489|NCT02918318|101413048|FG000|COMPLETED|Open Label Treatment Phase: 4 Weeks||0||
48440490|NCT02918318|101413049|FG001|COMPLETED|Open Label Treatment Phase: 4 Weeks||0||
48440491|NCT02918318|101413050|FG002|COMPLETED|Open Label Treatment Phase: 4 Weeks||0||
48440492|NCT02918318|101413051|FG003|COMPLETED|Open Label Treatment Phase: 4 Weeks||0||
48440493|NCT02918318|101413052|FG004|COMPLETED|Open Label Treatment Phase: 4 Weeks||47||
48440494|NCT02918318|101413048|FG000|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0||
48440495|NCT02918318|101413049|FG001|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0||
48440496|NCT02918318|101413050|FG002|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0||
48440497|NCT02918318|101413051|FG003|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0||
48440498|NCT02918318|101413052|FG004|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||1||
48440499|NCT02918318|101413048|FG000|STARTED|Open Label Follow-up Phase: 4 Weeks||0||
48440500|NCT02918318|101413049|FG001|STARTED|Open Label Follow-up Phase: 4 Weeks||0||
48440501|NCT02918318|101413050|FG002|STARTED|Open Label Follow-up Phase: 4 Weeks||0||
48440502|NCT02918318|101413051|FG003|STARTED|Open Label Follow-up Phase: 4 Weeks||0||
48440503|NCT02918318|101413052|FG004|STARTED|Open Label Follow-up Phase: 4 Weeks||48||
48440504|NCT02918318|101413048|FG000|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0||
48440505|NCT02918318|101413049|FG001|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0||
48440506|NCT02918318|101413050|FG002|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0||
48440507|NCT02918318|101413051|FG003|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0||
48440508|NCT02918318|101413052|FG004|COMPLETED|Open Label Follow-up Phase: 4 Weeks||47||
48440509|NCT02918318|101413048|FG000|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0||
48440510|NCT02918318|101413049|FG001|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0||
48440511|NCT02918318|101413050|FG002|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0||
48440512|NCT02918318|101413051|FG003|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0||
48440513|NCT02918318|101413052|FG004|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||1||
48440514|NCT02424799|101413053|FG000|STARTED|Part A (Up to Day 11)||9||
48440515|NCT02424799|101413054|FG001|STARTED|Part A (Up to Day 11)||8||
48440516|NCT02424799|101413055|FG002|STARTED|Part A (Up to Day 11)||0||
48768088|NCT05567783|102222879|FG001|Received Study Intervention|Overall Study||992||
48768089|NCT05567783|102222880|FG002|Received Study Intervention|Overall Study||983||
48768090|NCT05567783|102222878|FG000|COMPLETED|Overall Study||0||
48768091|NCT05567783|102222879|FG001|COMPLETED|Overall Study||0||
48440517|NCT02424799|101413056|FG003|STARTED|Part A (Up to Day 11)||0||
48440518|NCT02424799|101413057|FG004|STARTED|Part A (Up to Day 11)||0||
48440519|NCT02424799|101413058|FG005|STARTED|Part A (Up to Day 11)||0||
48768092|NCT05567783|102222880|FG002|COMPLETED|Overall Study||0||
48768093|NCT05567783|102222878|FG000|NOT COMPLETED|Overall Study||989||
48768094|NCT05567783|102222879|FG001|NOT COMPLETED|Overall Study||995||
48440520|NCT02424799|101413053|FG000|COMPLETED|Part A (Up to Day 11)||9||
48440521|NCT02424799|101413054|FG001|COMPLETED|Part A (Up to Day 11)||8||
48440522|NCT02424799|101413055|FG002|COMPLETED|Part A (Up to Day 11)||0||
48440523|NCT02424799|101413056|FG003|COMPLETED|Part A (Up to Day 11)||0||
48440524|NCT02424799|101413057|FG004|COMPLETED|Part A (Up to Day 11)||0||
48440525|NCT02424799|101413058|FG005|COMPLETED|Part A (Up to Day 11)||0||
48440526|NCT02424799|101413053|FG000|NOT COMPLETED|Part A (Up to Day 11)||0||
48440527|NCT02424799|101413054|FG001|NOT COMPLETED|Part A (Up to Day 11)||0||
48440528|NCT02424799|101413055|FG002|NOT COMPLETED|Part A (Up to Day 11)||0||
48440529|NCT02424799|101413056|FG003|NOT COMPLETED|Part A (Up to Day 11)||0||
48440530|NCT02424799|101413057|FG004|NOT COMPLETED|Part A (Up to Day 11)||0||
48440531|NCT02424799|101413058|FG005|NOT COMPLETED|Part A (Up to Day 11)||0||
48440532|NCT02424799|101413053|FG000|STARTED|Part B (Up to Day 19)||0||
48440533|NCT02424799|101413054|FG001|STARTED|Part B (Up to Day 19)||0||
48440534|NCT02424799|101413055|FG002|STARTED|Part B (Up to Day 19)||3||
48440535|NCT02424799|101413056|FG003|STARTED|Part B (Up to Day 19)||9||
48440536|NCT02424799|101413057|FG004|STARTED|Part B (Up to Day 19)||0||
48440537|NCT02424799|101413058|FG005|STARTED|Part B (Up to Day 19)||0||
48440538|NCT02424799|101413053|FG000|COMPLETED|Part B (Up to Day 19)||0||
48440539|NCT02424799|101413054|FG001|COMPLETED|Part B (Up to Day 19)||0||
48440540|NCT02424799|101413055|FG002|COMPLETED|Part B (Up to Day 19)||3||
48440541|NCT02424799|101413056|FG003|COMPLETED|Part B (Up to Day 19)||9||
48440542|NCT02424799|101413057|FG004|COMPLETED|Part B (Up to Day 19)||0||
48440543|NCT02424799|101413058|FG005|COMPLETED|Part B (Up to Day 19)||0||
48440544|NCT02424799|101413053|FG000|NOT COMPLETED|Part B (Up to Day 19)||0||
48440545|NCT02424799|101413054|FG001|NOT COMPLETED|Part B (Up to Day 19)||0||
48440546|NCT02424799|101413055|FG002|NOT COMPLETED|Part B (Up to Day 19)||0||
48440547|NCT02424799|101413056|FG003|NOT COMPLETED|Part B (Up to Day 19)||0||
48440548|NCT02424799|101413057|FG004|NOT COMPLETED|Part B (Up to Day 19)||0||
48440549|NCT02424799|101413058|FG005|NOT COMPLETED|Part B (Up to Day 19)||0||
48440550|NCT02424799|101413053|FG000|STARTED|Part C (Up to Day 23)||0||
48440551|NCT02424799|101413054|FG001|STARTED|Part C (Up to Day 23)||0||
48440552|NCT02424799|101413055|FG002|STARTED|Part C (Up to Day 23)||0||
48440553|NCT02424799|101413056|FG003|STARTED|Part C (Up to Day 23)||0||
48440554|NCT02424799|101413057|FG004|STARTED|Part C (Up to Day 23)||1||
48440555|NCT02424799|101413058|FG005|STARTED|Part C (Up to Day 23)||4||
48440556|NCT02424799|101413053|FG000|COMPLETED|Part C (Up to Day 23)||0||
48440557|NCT02424799|101413054|FG001|COMPLETED|Part C (Up to Day 23)||0||
48440558|NCT02424799|101413055|FG002|COMPLETED|Part C (Up to Day 23)||0||
48440559|NCT02424799|101413056|FG003|COMPLETED|Part C (Up to Day 23)||0||
48440560|NCT02424799|101413057|FG004|COMPLETED|Part C (Up to Day 23)||1||
48440561|NCT02424799|101413058|FG005|COMPLETED|Part C (Up to Day 23)||4||
48440562|NCT02424799|101413053|FG000|NOT COMPLETED|Part C (Up to Day 23)||0||
48440563|NCT02424799|101413054|FG001|NOT COMPLETED|Part C (Up to Day 23)||0||
48440564|NCT02424799|101413055|FG002|NOT COMPLETED|Part C (Up to Day 23)||0||
48440565|NCT02424799|101413056|FG003|NOT COMPLETED|Part C (Up to Day 23)||0||
48440566|NCT02424799|101413057|FG004|NOT COMPLETED|Part C (Up to Day 23)||0||
48440567|NCT02424799|101413058|FG005|NOT COMPLETED|Part C (Up to Day 23)||0||
48440568|NCT00391118|101413059|FG000|STARTED|Overall Study||11||
48768095|NCT05567783|102222880|FG002|NOT COMPLETED|Overall Study||993||
48768096|NCT00871975|102222881|FG000|STARTED|Overall Study||155||
48768097|NCT00871975|102222881|FG000|COMPLETED|Overall Study||133||
48768098|NCT00871975|102222881|FG000|NOT COMPLETED|Overall Study||22||
48440569|NCT00391118|101413060|FG001|STARTED|Overall Study||69||
48440570|NCT00391118|101413061|FG002|STARTED|Overall Study||73||
48440571|NCT00391118|101413059|FG000|Received ≥1 Dose of Assigned Study Drug|Overall Study||11||
48440572|NCT00391118|101413060|FG001|Received ≥1 Dose of Assigned Study Drug|Overall Study||67||
48440573|NCT00391118|101413061|FG002|Received ≥1 Dose of Assigned Study Drug|Overall Study||72||
48440574|NCT00391118|101413059|FG000|COMPLETED|Overall Study||0||
48440575|NCT00391118|101413060|FG001|COMPLETED|Overall Study||14||
48440576|NCT00391118|101413061|FG002|COMPLETED|Overall Study||15||
48440577|NCT00391118|101413059|FG000|NOT COMPLETED|Overall Study||11||
48440578|NCT00391118|101413060|FG001|NOT COMPLETED|Overall Study||55||
48440579|NCT00391118|101413061|FG002|NOT COMPLETED|Overall Study||58||
48440580|NCT00397904|101413062|FG000|STARTED|Overall Study||16||
48440581|NCT00397904|101413062|FG000|COMPLETED|Overall Study||16||
48440582|NCT00397904|101413062|FG000|NOT COMPLETED|Overall Study||0||
48440583|NCT03083639|101413063|FG000|STARTED|Intervention Period 1 (1 Day)||26||
48768099|NCT02917122|102222882|FG000|STARTED|Overall Study||8||
48768100|NCT02917122|102222883|FG001|STARTED|Overall Study||7||
48768101|NCT02917122|102222882|FG000|COMPLETED|Overall Study||8||
48440584|NCT03083639|101413064|FG001|STARTED|Intervention Period 1 (1 Day)||26||
48440585|NCT03083639|101413063|FG000|COMPLETED|Intervention Period 1 (1 Day)||26||
48440586|NCT03083639|101413064|FG001|COMPLETED|Intervention Period 1 (1 Day)||26||
48440587|NCT03083639|101413063|FG000|NOT COMPLETED|Intervention Period 1 (1 Day)||0||
48768102|NCT02917122|102222883|FG001|COMPLETED|Overall Study||7||
48768103|NCT02917122|102222882|FG000|NOT COMPLETED|Overall Study||0||
48440588|NCT03083639|101413064|FG001|NOT COMPLETED|Intervention Period 1 (1 Day)||0||
48440589|NCT03083639|101413063|FG000|STARTED|Washout Period (at Least 6 Days)||26||
48440590|NCT03083639|101413064|FG001|STARTED|Washout Period (at Least 6 Days)||26||
48440591|NCT03083639|101413063|FG000|COMPLETED|Washout Period (at Least 6 Days)||25||
48440592|NCT03083639|101413064|FG001|COMPLETED|Washout Period (at Least 6 Days)||25||
48440593|NCT03083639|101413063|FG000|NOT COMPLETED|Washout Period (at Least 6 Days)||1||
48440594|NCT03083639|101413064|FG001|NOT COMPLETED|Washout Period (at Least 6 Days)||1||
48440595|NCT03083639|101413063|FG000|STARTED|Intervention Period 2 (1 Day)||25||
48440596|NCT03083639|101413064|FG001|STARTED|Intervention Period 2 (1 Day)||25||
48440597|NCT03083639|101413063|FG000|COMPLETED|Intervention Period 2 (1 Day)||25||
48440598|NCT03083639|101413064|FG001|COMPLETED|Intervention Period 2 (1 Day)||25||
48440599|NCT03083639|101413063|FG000|NOT COMPLETED|Intervention Period 2 (1 Day)||0||
48440600|NCT03083639|101413064|FG001|NOT COMPLETED|Intervention Period 2 (1 Day)||0||
48440601|NCT02453282|101413065|FG000|STARTED|Overall Study||374||
48440602|NCT02453282|101413066|FG001|STARTED|Overall Study||372||
48440603|NCT02453282|101413067|FG002|STARTED|Overall Study||372||
48440604|NCT02453282|101413065|FG000|Received Treatment|Overall Study||369||
48440605|NCT02453282|101413066|FG001|Received Treatment|Overall Study||371||
48440606|NCT02453282|101413067|FG002|Received Treatment|Overall Study||352||
48440607|NCT02453282|101413065|FG000|COMPLETED|Overall Study||0||
48440608|NCT02453282|101413066|FG001|COMPLETED|Overall Study||0||
48768104|NCT02917122|102222883|FG001|NOT COMPLETED|Overall Study||0||
48768105|NCT03944577|102222884|FG000|STARTED|Overall Study||26||
48768106|NCT03944577|102222884|FG000|COMPLETED|Overall Study||23||
48768107|NCT03944577|102222884|FG000|NOT COMPLETED|Overall Study||3||
48768108|NCT02784548|102222885|FG000|STARTED|Overall Study||15||
48768109|NCT02784548|102222885|FG000|COMPLETED|Overall Study||15||
48768110|NCT02784548|102222885|FG000|NOT COMPLETED|Overall Study||0||
48768111|NCT01454102|102222886|FG000|STARTED|Overall Study||12||
48768112|NCT01454102|102222887|FG001|STARTED|Overall Study||15||
48768113|NCT01454102|102222888|FG002|STARTED|Overall Study||15||
48768114|NCT01454102|102222889|FG003|STARTED|Overall Study||12||
48440609|NCT02453282|101413067|FG002|COMPLETED|Overall Study||0||
48440610|NCT02453282|101413065|FG000|NOT COMPLETED|Overall Study||374||
48440611|NCT02453282|101413066|FG001|NOT COMPLETED|Overall Study||372||
48440612|NCT02453282|101413067|FG002|NOT COMPLETED|Overall Study||372||
48440613|NCT03466060|101413068|FG000|STARTED|Period 1||19||
48440614|NCT03466060|101413069|FG001|STARTED|Period 1||18||
48440615|NCT03466060|101413070|FG002|STARTED|Period 1||20||
48440616|NCT03466060|101413071|FG003|STARTED|Period 1||18||
48440617|NCT03466060|101413072|FG004|STARTED|Period 1||20||
48440618|NCT03466060|101413073|FG005|STARTED|Period 1||18||
48440619|NCT03466060|101413068|FG000|COMPLETED|Period 1||19||
48440620|NCT03466060|101413069|FG001|COMPLETED|Period 1||16||
48440621|NCT03466060|101413070|FG002|COMPLETED|Period 1||17||
48440622|NCT03466060|101413071|FG003|COMPLETED|Period 1||17||
48657202|NCT03537729|101943807|FG002|Completed Month 0|Overall Study||50||5
48657203|NCT03537729|101943805|FG000|Completed Month 1|Overall Study||39||5
48657204|NCT03537729|101943806|FG001|Completed Month 1|Overall Study||54||5
48657205|NCT03537729|101943807|FG002|Completed Month 1|Overall Study||47||5
48657206|NCT03537729|101943805|FG000|Completed Month 3|Overall Study||35||5
48657207|NCT03537729|101943806|FG001|Completed Month 3|Overall Study||52||5
48657208|NCT03537729|101943807|FG002|Completed Month 3|Overall Study||46||5
48657209|NCT03537729|101943805|FG000|Completed Month 6|Overall Study||27||3
48657210|NCT03537729|101943806|FG001|Completed Month 6|Overall Study||33||3
48657211|NCT03537729|101943807|FG002|Completed Month 6|Overall Study||25||3
48657212|NCT03537729|101943805|FG000|COMPLETED|Overall Study||25||3
48657213|NCT03537729|101943806|FG001|COMPLETED|Overall Study||28||3
48657214|NCT03537729|101943807|FG002|COMPLETED|Overall Study||21||3
48657215|NCT03537729|101943805|FG000|NOT COMPLETED|Overall Study||30||2
48657216|NCT03537729|101943806|FG001|NOT COMPLETED|Overall Study||34||2
48657217|NCT03537729|101943807|FG002|NOT COMPLETED|Overall Study||34||2
48657218|NCT01386645|101943808|FG000|STARTED|Overall Study||18||
48657219|NCT01386645|101943809|FG001|STARTED|Overall Study||19||
48657220|NCT01386645|101943810|FG002|STARTED|Overall Study||19||
48657221|NCT01386645|101943808|FG000|COMPLETED|Overall Study||18||
48657222|NCT01386645|101943809|FG001|COMPLETED|Overall Study||18||
48768115|NCT01454102|102222890|FG004|STARTED|Overall Study||21||
48768116|NCT01454102|102222891|FG005|STARTED|Overall Study||52||
48768117|NCT01454102|102222892|FG006|STARTED|Overall Study||24||
48440623|NCT03466060|101413072|FG004|COMPLETED|Period 1||20||
48440624|NCT03466060|101413073|FG005|COMPLETED|Period 1||18||
48440625|NCT03466060|101413068|FG000|NOT COMPLETED|Period 1||0||
48440626|NCT03466060|101413069|FG001|NOT COMPLETED|Period 1||2||
48440627|NCT03466060|101413070|FG002|NOT COMPLETED|Period 1||3||
48440628|NCT03466060|101413071|FG003|NOT COMPLETED|Period 1||1||
48440629|NCT03466060|101413072|FG004|NOT COMPLETED|Period 1||0||
48440630|NCT03466060|101413073|FG005|NOT COMPLETED|Period 1||0||
48440631|NCT03466060|101413068|FG000|STARTED|Period 2||19||
48440632|NCT03466060|101413069|FG001|STARTED|Period 2||16||
48440633|NCT03466060|101413070|FG002|STARTED|Period 2||17||
48440634|NCT03466060|101413071|FG003|STARTED|Period 2||17||
48440635|NCT03466060|101413072|FG004|STARTED|Period 2||20||
48768118|NCT01454102|102222893|FG007|STARTED|Overall Study||25||
48768119|NCT01454102|102222894|FG008|STARTED|Overall Study||13||
48768120|NCT01454102|102222895|FG009|STARTED|Overall Study||13||
48768121|NCT01454102|102222896|FG010|STARTED|Overall Study||12||
48768122|NCT01454102|102222897|FG011|STARTED|Overall Study||31||
48768123|NCT01454102|102222898|FG012|STARTED|Overall Study||40||
48768124|NCT01454102|102222899|FG013|STARTED|Overall Study||38||
48768125|NCT01454102|102222900|FG014|STARTED|Overall Study||39||
48768126|NCT01454102|102222901|FG015|STARTED|Overall Study||14||
48768127|NCT01454102|102222886|FG000|COMPLETED|Overall Study||12||
48768128|NCT01454102|102222887|FG001|COMPLETED|Overall Study||15||
48768129|NCT01454102|102222888|FG002|COMPLETED|Overall Study||15||
48768130|NCT01454102|102222889|FG003|COMPLETED|Overall Study||12||
48768131|NCT01454102|102222890|FG004|COMPLETED|Overall Study||18||
48440636|NCT03466060|101413073|FG005|STARTED|Period 2||18||
48440637|NCT03466060|101413068|FG000|COMPLETED|Period 2||19||
48440638|NCT03466060|101413069|FG001|COMPLETED|Period 2||16||
48440639|NCT03466060|101413070|FG002|COMPLETED|Period 2||16||
48657223|NCT01386645|101943810|FG002|COMPLETED|Overall Study||17||
48657224|NCT01386645|101943808|FG000|NOT COMPLETED|Overall Study||0||
48657225|NCT01386645|101943809|FG001|NOT COMPLETED|Overall Study||1||
48657226|NCT01386645|101943810|FG002|NOT COMPLETED|Overall Study||2||
48657227|NCT03359395|101943811|FG000|STARTED|First Intervention A / B||49||
48657228|NCT03359395|101943812|FG001|STARTED|First Intervention A / B||50||
48657229|NCT03359395|101943811|FG000|COMPLETED|First Intervention A / B||46||
48657230|NCT03359395|101943812|FG001|COMPLETED|First Intervention A / B||47||
48657231|NCT03359395|101943811|FG000|NOT COMPLETED|First Intervention A / B||3||
48657232|NCT03359395|101943812|FG001|NOT COMPLETED|First Intervention A / B||3||
48657233|NCT03359395|101943811|FG000|STARTED|Second Intervention B/A||46||
48657234|NCT03359395|101943812|FG001|STARTED|Second Intervention B/A||47||
48657235|NCT03359395|101943811|FG000|COMPLETED|Second Intervention B/A||43||
48657236|NCT03359395|101943812|FG001|COMPLETED|Second Intervention B/A||44||
48657237|NCT03359395|101943811|FG000|NOT COMPLETED|Second Intervention B/A||3||
48657238|NCT03359395|101943812|FG001|NOT COMPLETED|Second Intervention B/A||3||
48657239|NCT03163264|101943813|FG000|STARTED|Overall Study||120||
48657240|NCT03163264|101943814|FG001|STARTED|Overall Study||161||
48657241|NCT03163264|101943815|FG002|STARTED|Overall Study||10||
48657242|NCT03163264|101943816|FG003|STARTED|Overall Study||10||
48657243|NCT03163264|101943813|FG000|COMPLETED|Overall Study||90||
48657244|NCT03163264|101943814|FG001|COMPLETED|Overall Study||136||
48657245|NCT03163264|101943815|FG002|COMPLETED|Overall Study||6||
48657246|NCT03163264|101943816|FG003|COMPLETED|Overall Study||8||
48657247|NCT03163264|101943813|FG000|NOT COMPLETED|Overall Study||30||
48657248|NCT03163264|101943814|FG001|NOT COMPLETED|Overall Study||25||
48657249|NCT03163264|101943815|FG002|NOT COMPLETED|Overall Study||4||
48657250|NCT03163264|101943816|FG003|NOT COMPLETED|Overall Study||2||
48768132|NCT01454102|102222891|FG005|COMPLETED|Overall Study||49||
48768133|NCT01454102|102222892|FG006|COMPLETED|Overall Study||22||
48440640|NCT03466060|101413071|FG003|COMPLETED|Period 2||17||
48440641|NCT03466060|101413072|FG004|COMPLETED|Period 2||20||
48440642|NCT03466060|101413073|FG005|COMPLETED|Period 2||18||
48768134|NCT01454102|102222893|FG007|COMPLETED|Overall Study||25||
48440643|NCT03466060|101413068|FG000|NOT COMPLETED|Period 2||0||
48440644|NCT03466060|101413069|FG001|NOT COMPLETED|Period 2||0||
48440645|NCT03466060|101413070|FG002|NOT COMPLETED|Period 2||1||
48440646|NCT03466060|101413071|FG003|NOT COMPLETED|Period 2||0||
48440647|NCT03466060|101413072|FG004|NOT COMPLETED|Period 2||0||
48440648|NCT03466060|101413073|FG005|NOT COMPLETED|Period 2||0||
48440649|NCT00941681|101413074|FG000|STARTED|Overall Study||12||
48440650|NCT00941681|101413075|FG001|STARTED|Overall Study||11||
48188762|NCT03382821|100786079|FG001|NOT COMPLETED|Overall Study||3||
48440651|NCT00941681|101413076|FG002|STARTED|Overall Study||12||
48440652|NCT00941681|101413074|FG000|COMPLETED|Overall Study||12||
48440653|NCT00941681|101413075|FG001|COMPLETED|Overall Study||10||
48657251|NCT02350998|101945970|FG000|STARTED|Overall Study||33||
48657252|NCT02350998|101945970|FG000|COMPLETED|Overall Study||33||
48440654|NCT00941681|101413076|FG002|COMPLETED|Overall Study||12||
48440655|NCT00941681|101413074|FG000|NOT COMPLETED|Overall Study||0||
48768135|NCT01454102|102222894|FG008|COMPLETED|Overall Study||12||
48440656|NCT00941681|101413075|FG001|NOT COMPLETED|Overall Study||1||
48657253|NCT02350998|101945970|FG000|NOT COMPLETED|Overall Study||0||
48657254|NCT05273437|101945971|FG000|STARTED|Overall Study||50||
48657255|NCT05273437|101945971|FG000|COMPLETED|Overall Study||48||
48657256|NCT05273437|101945971|FG000|NOT COMPLETED|Overall Study||2||
48768136|NCT01454102|102222895|FG009|COMPLETED|Overall Study||13||
48768137|NCT01454102|102222896|FG010|COMPLETED|Overall Study||12||
48768138|NCT01454102|102222897|FG011|COMPLETED|Overall Study||27||
48768139|NCT01454102|102222898|FG012|COMPLETED|Overall Study||33||
48768140|NCT01454102|102222899|FG013|COMPLETED|Overall Study||34||
48768141|NCT01454102|102222900|FG014|COMPLETED|Overall Study||36||
48440657|NCT00941681|101413076|FG002|NOT COMPLETED|Overall Study||0||
48440658|NCT04969263|101413077|FG000|STARTED|Overall Study||81||
48440659|NCT04969263|101413077|FG000|COMPLETED|Overall Study||72||
48440660|NCT04969263|101413077|FG000|NOT COMPLETED|Overall Study||9||
48440661|NCT02723786|101413078|FG000|STARTED|Overall Study||7||
48768142|NCT01454102|102222901|FG015|COMPLETED|Overall Study||13||
48440662|NCT02723786|101413078|FG000|COMPLETED|Overall Study||6||
48440663|NCT02723786|101413078|FG000|NOT COMPLETED|Overall Study||1||
48440664|NCT04776135|101413079|FG000|STARTED|Period 1||18||
48440665|NCT04776135|101413080|FG001|STARTED|Period 1||18||
48440666|NCT04776135|101413079|FG000|COMPLETED|Period 1||18||
48440667|NCT04776135|101413080|FG001|COMPLETED|Period 1||18||
48440668|NCT04776135|101413079|FG000|NOT COMPLETED|Period 1||0||
48440669|NCT04776135|101413080|FG001|NOT COMPLETED|Period 1||0||
48768143|NCT01454102|102222886|FG000|NOT COMPLETED|Overall Study||0||
48768144|NCT01454102|102222887|FG001|NOT COMPLETED|Overall Study||0||
48768145|NCT01454102|102222888|FG002|NOT COMPLETED|Overall Study||0||
48768146|NCT01454102|102222889|FG003|NOT COMPLETED|Overall Study||0||
48768147|NCT01454102|102222890|FG004|NOT COMPLETED|Overall Study||3||
48768148|NCT01454102|102222891|FG005|NOT COMPLETED|Overall Study||3||
48768149|NCT01454102|102222892|FG006|NOT COMPLETED|Overall Study||2||
48768150|NCT01454102|102222893|FG007|NOT COMPLETED|Overall Study||0||
48768151|NCT01454102|102222894|FG008|NOT COMPLETED|Overall Study||1||
48768152|NCT01454102|102222895|FG009|NOT COMPLETED|Overall Study||0||
48440670|NCT04776135|101413079|FG000|STARTED|Period 2||18||
48440671|NCT04776135|101413080|FG001|STARTED|Period 2||18||
48440672|NCT04776135|101413079|FG000|COMPLETED|Period 2||18||
48440673|NCT04776135|101413080|FG001|COMPLETED|Period 2||18||
48440674|NCT04776135|101413079|FG000|NOT COMPLETED|Period 2||0||
48440675|NCT04776135|101413080|FG001|NOT COMPLETED|Period 2||0||
48440676|NCT00367601|101413081|FG000|STARTED|Overall Study||25||
48440677|NCT00367601|101413081|FG000|COMPLETED|Overall Study||25||
48440678|NCT00367601|101413081|FG000|NOT COMPLETED|Overall Study||0||
48440679|NCT02866695|101413082|FG000|STARTED|Overall Study||20||
48440680|NCT02866695|101413082|FG000|COMPLETED|Overall Study||18||
48440681|NCT02866695|101413082|FG000|NOT COMPLETED|Overall Study||2||
48440682|NCT02466776|101413083|FG000|STARTED|Overall Study||119||
48440683|NCT02466776|101413084|FG001|STARTED|Overall Study||119||
48440684|NCT02466776|101413083|FG000|COMPLETED|Overall Study||119||
48440685|NCT02466776|101413084|FG001|COMPLETED|Overall Study||119||
48440686|NCT02466776|101413083|FG000|NOT COMPLETED|Overall Study||0||
48440687|NCT02466776|101413084|FG001|NOT COMPLETED|Overall Study||0||
48440688|NCT01591499|101413085|FG000|STARTED|Baseline Visit||33||
48440689|NCT01591499|101413086|FG001|STARTED|Baseline Visit||39||
48440690|NCT01591499|101413087|FG002|STARTED|Baseline Visit||31||
48440691|NCT01591499|101413088|FG003|STARTED|Baseline Visit||39||
48440692|NCT01591499|101413085|FG000|COMPLETED|Baseline Visit||33||
48440693|NCT01591499|101413086|FG001|COMPLETED|Baseline Visit||37||
48440694|NCT01591499|101413087|FG002|COMPLETED|Baseline Visit||31||
48440695|NCT01591499|101413088|FG003|COMPLETED|Baseline Visit||37||
48440696|NCT01591499|101413085|FG000|NOT COMPLETED|Baseline Visit||0||
48440697|NCT01591499|101413086|FG001|NOT COMPLETED|Baseline Visit||2||
48440698|NCT01591499|101413087|FG002|NOT COMPLETED|Baseline Visit||0||
48440699|NCT01591499|101413088|FG003|NOT COMPLETED|Baseline Visit||2||
48440700|NCT01591499|101413085|FG000|STARTED|First Intervention (up to 24 Days)||33||
48440701|NCT01591499|101413086|FG001|STARTED|First Intervention (up to 24 Days)||37||
48440702|NCT01591499|101413087|FG002|STARTED|First Intervention (up to 24 Days)||31||
48440703|NCT01591499|101413088|FG003|STARTED|First Intervention (up to 24 Days)||37||
48440704|NCT01591499|101413085|FG000|COMPLETED|First Intervention (up to 24 Days)||33||
48768153|NCT01454102|102222896|FG010|NOT COMPLETED|Overall Study||0||
48768154|NCT01454102|102222897|FG011|NOT COMPLETED|Overall Study||4||
48768155|NCT01454102|102222898|FG012|NOT COMPLETED|Overall Study||7||
48768156|NCT01454102|102222899|FG013|NOT COMPLETED|Overall Study||4||
48768157|NCT01454102|102222900|FG014|NOT COMPLETED|Overall Study||3||
48768158|NCT01454102|102222901|FG015|NOT COMPLETED|Overall Study||1||
48768159|NCT01523366|102222902|FG000|STARTED|Treatment Period 1||20||
48768160|NCT01523366|102222903|FG001|STARTED|Treatment Period 1||20||
48768161|NCT01523366|102222902|FG000|COMPLETED|Treatment Period 1||19||
48768162|NCT01523366|102222903|FG001|COMPLETED|Treatment Period 1||20||
48768163|NCT01523366|102222902|FG000|NOT COMPLETED|Treatment Period 1||1||
48768164|NCT01523366|102222903|FG001|NOT COMPLETED|Treatment Period 1||0||
48768165|NCT01523366|102222902|FG000|STARTED|Washout Period - 10-14 Days||19||
48768166|NCT01523366|102222903|FG001|STARTED|Washout Period - 10-14 Days||20||
48768167|NCT01523366|102222902|FG000|COMPLETED|Washout Period - 10-14 Days||19||
48768168|NCT01523366|102222903|FG001|COMPLETED|Washout Period - 10-14 Days||20||
48657257|NCT03973489|101945972|FG000|STARTED|First Intervention (1 Day)||4||
48768169|NCT01523366|102222902|FG000|NOT COMPLETED|Washout Period - 10-14 Days||0||
48768170|NCT01523366|102222903|FG001|NOT COMPLETED|Washout Period - 10-14 Days||0||
48188763|NCT01562743|100786080|FG000|STARTED|Overall Study||185||
48440705|NCT01591499|101413086|FG001|COMPLETED|First Intervention (up to 24 Days)||37||
48440706|NCT01591499|101413087|FG002|COMPLETED|First Intervention (up to 24 Days)||31||
48440707|NCT01591499|101413088|FG003|COMPLETED|First Intervention (up to 24 Days)||37||
48440708|NCT01591499|101413085|FG000|NOT COMPLETED|First Intervention (up to 24 Days)||0||
48440709|NCT01591499|101413086|FG001|NOT COMPLETED|First Intervention (up to 24 Days)||0||
48440710|NCT01591499|101413087|FG002|NOT COMPLETED|First Intervention (up to 24 Days)||0||
48440711|NCT01591499|101413088|FG003|NOT COMPLETED|First Intervention (up to 24 Days)||0||
48440712|NCT01591499|101413085|FG000|STARTED|Second Intervention (up to 24 Days)||33||
48440713|NCT01591499|101413086|FG001|STARTED|Second Intervention (up to 24 Days)||37||
48440714|NCT01591499|101413087|FG002|STARTED|Second Intervention (up to 24 Days)||31||
48440715|NCT01591499|101413088|FG003|STARTED|Second Intervention (up to 24 Days)||37||
48440716|NCT01591499|101413085|FG000|COMPLETED|Second Intervention (up to 24 Days)||27||
48440717|NCT01591499|101413086|FG001|COMPLETED|Second Intervention (up to 24 Days)||34||
48440718|NCT01591499|101413087|FG002|COMPLETED|Second Intervention (up to 24 Days)||28||
48440719|NCT01591499|101413088|FG003|COMPLETED|Second Intervention (up to 24 Days)||34||
48440720|NCT01591499|101413085|FG000|NOT COMPLETED|Second Intervention (up to 24 Days)||6||
48440721|NCT01591499|101413086|FG001|NOT COMPLETED|Second Intervention (up to 24 Days)||3||
48440722|NCT01591499|101413087|FG002|NOT COMPLETED|Second Intervention (up to 24 Days)||3||
48440723|NCT01591499|101413088|FG003|NOT COMPLETED|Second Intervention (up to 24 Days)||3||
48440724|NCT02610842|101413089|FG000|STARTED|Overall Study||27||
48440725|NCT02610842|101413089|FG000|COMPLETED|Overall Study||22||
48440726|NCT02610842|101413089|FG000|NOT COMPLETED|Overall Study||5||
48440727|NCT05552430|101413090|FG000|STARTED|Overall Study||10||
48440728|NCT05552430|101413090|FG000|COMPLETED|Overall Study||10||
48440729|NCT05552430|101413090|FG000|NOT COMPLETED|Overall Study||0||
48440730|NCT02545868|101413091|FG000|STARTED|Overall Study||33||
48440731|NCT02545868|101413092|FG001|STARTED|Overall Study||35||
48440732|NCT02545868|101413093|FG002|STARTED|Overall Study||34||
48440733|NCT02545868|101413091|FG000|COMPLETED|Overall Study||2||
48440734|NCT02545868|101413092|FG001|COMPLETED|Overall Study||1||
48440735|NCT02545868|101413093|FG002|COMPLETED|Overall Study||0||
48440736|NCT02545868|101413091|FG000|NOT COMPLETED|Overall Study||31||
48768171|NCT01523366|102222902|FG000|STARTED|Treatment Period 2||19||
48768172|NCT01523366|102222903|FG001|STARTED|Treatment Period 2||20||
48768173|NCT01523366|102222902|FG000|COMPLETED|Treatment Period 2||18||
48768174|NCT01523366|102222903|FG001|COMPLETED|Treatment Period 2||20||
48768175|NCT01523366|102222902|FG000|NOT COMPLETED|Treatment Period 2||1||
48768176|NCT01523366|102222903|FG001|NOT COMPLETED|Treatment Period 2||0||
48768177|NCT00525161|102222904|FG000|STARTED|Overall Study||11||
48768178|NCT00525161|102222904|FG000|COMPLETED|Overall Study||10||
48768179|NCT00525161|102222904|FG000|NOT COMPLETED|Overall Study||1||
48768180|NCT03126591|102222905|FG000|STARTED|Overall Study||7||
48768181|NCT03126591|102222906|FG001|STARTED|Overall Study||6||
48768182|NCT03126591|102222907|FG002|STARTED|Overall Study||28||
48768183|NCT03126591|102222905|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7||
48768184|NCT03126591|102222906|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
48768185|NCT03126591|102222907|FG002|Received at Least 1 Dose of Study Drug|Overall Study||28||
48440737|NCT02545868|101413092|FG001|NOT COMPLETED|Overall Study||34||
48440738|NCT02545868|101413093|FG002|NOT COMPLETED|Overall Study||34||
48440739|NCT03130777|101413094|FG000|STARTED|Overall Study||61||
48440740|NCT03130777|101413095|FG001|STARTED|Overall Study||25||
48440741|NCT03130777|101413094|FG000|COMPLETED|Overall Study||60||
48440742|NCT03130777|101413095|FG001|COMPLETED|Overall Study||24||
48440743|NCT03130777|101413094|FG000|NOT COMPLETED|Overall Study||1||
48440744|NCT03130777|101413095|FG001|NOT COMPLETED|Overall Study||1||
48440745|NCT04928794|101413096|FG000|STARTED|Overall Study||8||8
48440746|NCT04928794|101413097|FG001|STARTED|Overall Study||8||8
48440747|NCT04928794|101413096|FG000|COMPLETED|Overall Study||8||8
48440748|NCT04928794|101413097|FG001|COMPLETED|Overall Study||8||8
48768186|NCT03126591|102222905|FG000|COMPLETED|Overall Study||0||
48768187|NCT03126591|102222906|FG001|COMPLETED|Overall Study||0||
48768188|NCT03126591|102222907|FG002|COMPLETED|Overall Study||1||
48768189|NCT03126591|102222905|FG000|NOT COMPLETED|Overall Study||7||
48768190|NCT03126591|102222906|FG001|NOT COMPLETED|Overall Study||6||
48768191|NCT03126591|102222907|FG002|NOT COMPLETED|Overall Study||27||
48768192|NCT04396756|102222908|FG000|STARTED|Overall Study||1||
48768193|NCT04396756|102222909|FG001|STARTED|Overall Study||22||
48768194|NCT04396756|102222910|FG002|STARTED|Overall Study||23||
48768195|NCT04396756|102222911|FG003|STARTED|Overall Study||22||
48768196|NCT04396756|102222912|FG004|STARTED|Overall Study||21||
48768197|NCT04396756|102222913|FG005|STARTED|Overall Study||31||
48768198|NCT04396756|102222908|FG000|Received Placebo|Overall Study||0||
48768199|NCT04396756|102222909|FG001|Received Placebo|Overall Study||0||
48768200|NCT04396756|102222910|FG002|Received Placebo|Overall Study||0||
48768201|NCT04396756|102222911|FG003|Received Placebo|Overall Study||0||
48768202|NCT04396756|102222912|FG004|Received Placebo|Overall Study||1||
48768203|NCT04396756|102222913|FG005|Received Placebo|Overall Study||0||
48768204|NCT04396756|102222908|FG000|COMPLETED|Overall Study||1||
48768205|NCT04396756|102222909|FG001|COMPLETED|Overall Study||21||
48440749|NCT04928794|101413096|FG000|NOT COMPLETED|Overall Study||0||0
48440750|NCT04928794|101413097|FG001|NOT COMPLETED|Overall Study||0||0
48440751|NCT03914469|101413098|FG000|STARTED|Overall Study||6||
48440752|NCT03914469|101413099|FG001|STARTED|Overall Study||6||
48440753|NCT03914469|101413098|FG000|COMPLETED|Overall Study||5||
48440754|NCT03914469|101413099|FG001|COMPLETED|Overall Study||2||
48440755|NCT03914469|101413098|FG000|NOT COMPLETED|Overall Study||1||
48440756|NCT03914469|101413099|FG001|NOT COMPLETED|Overall Study||4||
48188764|NCT01562743|100786080|FG000|COMPLETED|Overall Study||133||
48368209|NCT01280123|101230126|FG001|STARTED|Overall Study||67||
48368210|NCT01280123|101230127|FG002|STARTED|Overall Study||71||
48368211|NCT01280123|101230125|FG000|COMPLETED|Overall Study||71||
48368212|NCT01280123|101230126|FG001|COMPLETED|Overall Study||63||
48368213|NCT01280123|101230127|FG002|COMPLETED|Overall Study||70||
48368214|NCT01280123|101230125|FG000|NOT COMPLETED|Overall Study||1||
48368215|NCT01280123|101230126|FG001|NOT COMPLETED|Overall Study||4||
48368216|NCT01280123|101230127|FG002|NOT COMPLETED|Overall Study||1||
48440757|NCT00816166|101413100|FG000|STARTED|Overall Study||59||
48657258|NCT03973489|101945973|FG001|STARTED|First Intervention (1 Day)||3||
48657259|NCT03973489|101945974|FG002|STARTED|First Intervention (1 Day)||2||
48657260|NCT03973489|101945975|FG003|STARTED|First Intervention (1 Day)||5||
48657261|NCT03973489|101945976|FG004|STARTED|First Intervention (1 Day)||4||
48657262|NCT03973489|101945977|FG005|STARTED|First Intervention (1 Day)||4||
48657263|NCT03973489|101945978|FG006|STARTED|First Intervention (1 Day)||2||
48657264|NCT03973489|101945979|FG007|STARTED|First Intervention (1 Day)||2||
48657265|NCT03973489|101945972|FG000|COMPLETED|First Intervention (1 Day)||4||
48368217|NCT01400971|101230128|FG000|STARTED|Overall Study||4299||
48440758|NCT00816166|101413101|FG001|STARTED|Overall Study||53||
48440759|NCT00816166|101413100|FG000|ITT Population (Met Eligibility)|Overall Study||58||
48440760|NCT00816166|101413101|FG001|ITT Population (Met Eligibility)|Overall Study||53||
48440761|NCT00816166|101413100|FG000|COMPLETED|Overall Study||49||
48440762|NCT00816166|101413101|FG001|COMPLETED|Overall Study||41||
48440763|NCT00816166|101413100|FG000|NOT COMPLETED|Overall Study||10||
48440764|NCT00816166|101413101|FG001|NOT COMPLETED|Overall Study||12||
48657266|NCT03973489|101945973|FG001|COMPLETED|First Intervention (1 Day)||3||
48657267|NCT03973489|101945974|FG002|COMPLETED|First Intervention (1 Day)||2||
48657268|NCT03973489|101945975|FG003|COMPLETED|First Intervention (1 Day)||5||
48657269|NCT03973489|101945976|FG004|COMPLETED|First Intervention (1 Day)||4||
48657270|NCT03973489|101945977|FG005|COMPLETED|First Intervention (1 Day)||4||
48657271|NCT03973489|101945978|FG006|COMPLETED|First Intervention (1 Day)||2||
48657272|NCT03973489|101945979|FG007|COMPLETED|First Intervention (1 Day)||2||
48657273|NCT03973489|101945972|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48368218|NCT01400971|101230128|FG000|Complete Treatment Data|Overall Study||2528||
48368219|NCT01400971|101230128|FG000|COMPLETED|Overall Study||3382||
48368220|NCT01400971|101230128|FG000|NOT COMPLETED|Overall Study||917||
48368221|NCT03403491|101230129|FG000|STARTED|Overall Study||20||
48368222|NCT03403491|101230130|FG001|STARTED|Overall Study||23||
48368223|NCT03403491|101230129|FG000|COMPLETED|Overall Study||17|Definition: at least 21 days of patient-reported weight data|
48368224|NCT03403491|101230130|FG001|COMPLETED|Overall Study||18|Definition: at least 21 days of patient-reported weight data|
48368225|NCT03403491|101230129|FG000|NOT COMPLETED|Overall Study||3||
48368226|NCT03403491|101230130|FG001|NOT COMPLETED|Overall Study||5||
48368227|NCT00935857|101230131|FG000|STARTED|Overall Study||14||
48368228|NCT00935857|101230132|FG001|STARTED|Overall Study||16||
48368229|NCT00935857|101230131|FG000|COMPLETED|Overall Study||14||
48368230|NCT00935857|101230132|FG001|COMPLETED|Overall Study||16||
48368231|NCT00935857|101230131|FG000|NOT COMPLETED|Overall Study||0||
48368232|NCT00935857|101230132|FG001|NOT COMPLETED|Overall Study||0||
48368233|NCT03643432|101230133|FG000|STARTED|Overall Study||27||
48368234|NCT03643432|101230134|FG001|STARTED|Overall Study||21||
48440765|NCT03980561|101413102|FG000|STARTED|Overall Study||90||
48440766|NCT03980561|101413103|FG001|STARTED|Overall Study||84||
48368235|NCT03643432|101230133|FG000|COMPLETED|Overall Study||26||
48368236|NCT03643432|101230134|FG001|COMPLETED|Overall Study||21||
48368237|NCT03643432|101230133|FG000|NOT COMPLETED|Overall Study||1||
48368238|NCT03643432|101230134|FG001|NOT COMPLETED|Overall Study||0||
48368239|NCT00611455|101230135|FG000|STARTED|DB Treatment Period (24 Weeks)||134||
48368240|NCT00611455|101230136|FG001|STARTED|DB Treatment Period (24 Weeks)||131||
48368241|NCT00611455|101230137|FG002|STARTED|DB Treatment Period (24 Weeks)||0||
48368242|NCT00611455|101230135|FG000|COMPLETED|DB Treatment Period (24 Weeks)||121||
48368243|NCT00611455|101230136|FG001|COMPLETED|DB Treatment Period (24 Weeks)||117||
48368244|NCT00611455|101230137|FG002|COMPLETED|DB Treatment Period (24 Weeks)||0||
48368245|NCT00611455|101230135|FG000|NOT COMPLETED|DB Treatment Period (24 Weeks)||13||
48368246|NCT00611455|101230136|FG001|NOT COMPLETED|DB Treatment Period (24 Weeks)||14||
48368247|NCT00611455|101230137|FG002|NOT COMPLETED|DB Treatment Period (24 Weeks)||0||
48368248|NCT00611455|101230135|FG000|STARTED|OL Treatment Period (120 Weeks)||0||
48368249|NCT00611455|101230136|FG001|STARTED|OL Treatment Period (120 Weeks)||231||
48368250|NCT00611455|101230137|FG002|STARTED|OL Treatment Period (120 Weeks)||0||
48368251|NCT00611455|101230135|FG000|COMPLETED|OL Treatment Period (120 Weeks)||0||
48368252|NCT00611455|101230136|FG001|COMPLETED|OL Treatment Period (120 Weeks)||52||
48368253|NCT00611455|101230137|FG002|COMPLETED|OL Treatment Period (120 Weeks)||0||
48368254|NCT00611455|101230135|FG000|NOT COMPLETED|OL Treatment Period (120 Weeks)||0||
48368255|NCT00611455|101230136|FG001|NOT COMPLETED|OL Treatment Period (120 Weeks)||179||
48368256|NCT00611455|101230137|FG002|NOT COMPLETED|OL Treatment Period (120 Weeks)||0||
48368257|NCT00611455|101230135|FG000|STARTED|Follow-up Period (Approximately 2 Years)||0||
48368258|NCT00611455|101230136|FG001|STARTED|Follow-up Period (Approximately 2 Years)||0||
48440767|NCT03980561|101413102|FG000|COMPLETED|Overall Study||61||
48768206|NCT04396756|102222910|FG002|COMPLETED|Overall Study||23||
48440768|NCT03980561|101413103|FG001|COMPLETED|Overall Study||59||
48440769|NCT03980561|101413102|FG000|NOT COMPLETED|Overall Study||29||
48440770|NCT03980561|101413103|FG001|NOT COMPLETED|Overall Study||25||
48440771|NCT00661960|101413104|FG000|STARTED|Overall Study||5||
48440772|NCT00661960|101413105|FG001|STARTED|Overall Study||10||
48440773|NCT00661960|101413106|FG002|STARTED|Overall Study||10||
48440774|NCT00661960|101413104|FG000|COMPLETED|Overall Study||5||
48440775|NCT00661960|101413105|FG001|COMPLETED|Overall Study||7||
48440776|NCT00661960|101413106|FG002|COMPLETED|Overall Study||9||
48440777|NCT00661960|101413104|FG000|NOT COMPLETED|Overall Study||0||
48440778|NCT00661960|101413105|FG001|NOT COMPLETED|Overall Study||3||
48440779|NCT00661960|101413106|FG002|NOT COMPLETED|Overall Study||1||
48440780|NCT03252015|101413107|FG000|STARTED|Overall Study||12||
48440781|NCT03252015|101413108|FG001|STARTED|Overall Study||28||
48440782|NCT03252015|101413109|FG002|STARTED|Overall Study||15||
48440783|NCT03252015|101413110|FG003|STARTED|Overall Study||15||
48440784|NCT03252015|101413107|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12||
48440785|NCT03252015|101413108|FG001|Received at Least 1 Dose of Study Drug|Overall Study||28||
48440786|NCT03252015|101413109|FG002|Received at Least 1 Dose of Study Drug|Overall Study||15||
48440787|NCT03252015|101413110|FG003|Received at Least 1 Dose of Study Drug|Overall Study||15||
48440788|NCT03252015|101413107|FG000|COMPLETED|Overall Study||11||
48440789|NCT03252015|101413108|FG001|COMPLETED|Overall Study||27||
48440790|NCT03252015|101413109|FG002|COMPLETED|Overall Study||14||
48440791|NCT03252015|101413110|FG003|COMPLETED|Overall Study||14||
48440792|NCT03252015|101413107|FG000|NOT COMPLETED|Overall Study||1||
48440793|NCT03252015|101413108|FG001|NOT COMPLETED|Overall Study||1||
48440794|NCT03252015|101413109|FG002|NOT COMPLETED|Overall Study||1||
48440795|NCT03252015|101413110|FG003|NOT COMPLETED|Overall Study||1||
48440796|NCT02666768|101413111|FG000|STARTED|Overall Study||5||
48440797|NCT02666768|101413111|FG000|COMPLETED|Overall Study||1||
48440798|NCT02666768|101413111|FG000|NOT COMPLETED|Overall Study||4||
48440799|NCT02701049|101413112|FG000|STARTED|Overall Study||209||
48440800|NCT02701049|101413113|FG001|STARTED|Overall Study||342||
48440801|NCT02701049|101413114|FG002|STARTED|Overall Study||198||
48440802|NCT02701049|101413112|FG000|COMPLETED|Overall Study||209||
48440803|NCT02701049|101413113|FG001|COMPLETED|Overall Study||342||
48440804|NCT02701049|101413114|FG002|COMPLETED|Overall Study||198||
48440805|NCT02701049|101413112|FG000|NOT COMPLETED|Overall Study||0||
48440806|NCT02701049|101413113|FG001|NOT COMPLETED|Overall Study||0||
48440807|NCT02701049|101413114|FG002|NOT COMPLETED|Overall Study||0||
48440808|NCT00110084|101413115|FG000|STARTED|Overall Study||50||
48440809|NCT00110084|101413115|FG000|COMPLETED|Overall Study||22||
48440810|NCT00110084|101413115|FG000|NOT COMPLETED|Overall Study||28||
48440811|NCT02332655|101413116|FG000|STARTED|Overall Study||5||
48440812|NCT02332655|101413116|FG000|COMPLETED|Overall Study||4||
48440813|NCT02332655|101413116|FG000|NOT COMPLETED|Overall Study||1||
48440814|NCT04692103|101413117|FG000|STARTED|Overall Study||2||
48440815|NCT04692103|101413117|FG000|COMPLETED|Overall Study||2||
48440816|NCT04692103|101413117|FG000|NOT COMPLETED|Overall Study||0||
48440817|NCT00244881|101413118|FG000|STARTED|Overall Study||26||
48440818|NCT00244881|101413118|FG000|COMPLETED|Overall Study||23||
48440819|NCT00244881|101413118|FG000|NOT COMPLETED|Overall Study||3||
48440820|NCT01293682|101413119|FG000|STARTED|Overall Study||12||
48768207|NCT04396756|102222911|FG003|COMPLETED|Overall Study||20||
48768208|NCT04396756|102222912|FG004|COMPLETED|Overall Study||15||
48768209|NCT04396756|102222913|FG005|COMPLETED|Overall Study||25||
48440821|NCT01293682|101413119|FG000|COMPLETED|Overall Study||12||
48440822|NCT01293682|101413119|FG000|NOT COMPLETED|Overall Study||0||
48440823|NCT02238639|101413120|FG000|STARTED|Overall Study||374||
48440824|NCT02238639|101413121|FG001|STARTED|Overall Study||372||
48440825|NCT02238639|101413120|FG000|COMPLETED|Overall Study||370||
48440826|NCT02238639|101413121|FG001|COMPLETED|Overall Study||367||
48440827|NCT02238639|101413120|FG000|NOT COMPLETED|Overall Study||4||
48440828|NCT02238639|101413121|FG001|NOT COMPLETED|Overall Study||5||
48768210|NCT04396756|102222908|FG000|NOT COMPLETED|Overall Study||0||
48440829|NCT03668379|101413122|FG000|STARTED|Stage 1 Intervention (Months 1-2)||5||
48440830|NCT03668379|101413123|FG001|STARTED|Stage 1 Intervention (Months 1-2)||5||
48440831|NCT03668379|101413124|FG002|STARTED|Stage 1 Intervention (Months 1-2)||0||
48440832|NCT03668379|101413125|FG003|STARTED|Stage 1 Intervention (Months 1-2)||0||
48440833|NCT03668379|101413126|FG004|STARTED|Stage 1 Intervention (Months 1-2)||0||
48440834|NCT03668379|101413127|FG005|STARTED|Stage 1 Intervention (Months 1-2)||0||
48440835|NCT03668379|101413122|FG000|COMPLETED|Stage 1 Intervention (Months 1-2)||4||
48440836|NCT03668379|101413123|FG001|COMPLETED|Stage 1 Intervention (Months 1-2)||3||
48440837|NCT03668379|101413124|FG002|COMPLETED|Stage 1 Intervention (Months 1-2)||0||
48440838|NCT03668379|101413125|FG003|COMPLETED|Stage 1 Intervention (Months 1-2)||0||
48440839|NCT03668379|101413126|FG004|COMPLETED|Stage 1 Intervention (Months 1-2)||0||
48440840|NCT03668379|101413127|FG005|COMPLETED|Stage 1 Intervention (Months 1-2)||0||
48440841|NCT03668379|101413122|FG000|NOT COMPLETED|Stage 1 Intervention (Months 1-2)||1||
48768211|NCT04396756|102222909|FG001|NOT COMPLETED|Overall Study||1||
48768212|NCT04396756|102222910|FG002|NOT COMPLETED|Overall Study||0||
48440842|NCT03668379|101413123|FG001|NOT COMPLETED|Stage 1 Intervention (Months 1-2)||2||
48440843|NCT03668379|101413124|FG002|NOT COMPLETED|Stage 1 Intervention (Months 1-2)||0||
48440844|NCT03668379|101413125|FG003|NOT COMPLETED|Stage 1 Intervention (Months 1-2)||0||
48440845|NCT03668379|101413126|FG004|NOT COMPLETED|Stage 1 Intervention (Months 1-2)||0||
48440846|NCT03668379|101413127|FG005|NOT COMPLETED|Stage 1 Intervention (Months 1-2)||0||
48440847|NCT03668379|101413122|FG000|STARTED|Stage 2 Intervention (Months 3-4)||4||
48440848|NCT03668379|101413123|FG001|STARTED|Stage 2 Intervention (Months 3-4)||3||
48440849|NCT03668379|101413124|FG002|STARTED|Stage 2 Intervention (Months 3-4)||0||
48440850|NCT03668379|101413125|FG003|STARTED|Stage 2 Intervention (Months 3-4)||0||
48440851|NCT03668379|101413126|FG004|STARTED|Stage 2 Intervention (Months 3-4)||0||
48440852|NCT03668379|101413127|FG005|STARTED|Stage 2 Intervention (Months 3-4)||0||
48440853|NCT03668379|101413122|FG000|COMPLETED|Stage 2 Intervention (Months 3-4)||3||
48440854|NCT03668379|101413123|FG001|COMPLETED|Stage 2 Intervention (Months 3-4)||1||
48440855|NCT03668379|101413124|FG002|COMPLETED|Stage 2 Intervention (Months 3-4)||0||
48440856|NCT03668379|101413125|FG003|COMPLETED|Stage 2 Intervention (Months 3-4)||0||
48440857|NCT03668379|101413126|FG004|COMPLETED|Stage 2 Intervention (Months 3-4)||0||
48440858|NCT03668379|101413127|FG005|COMPLETED|Stage 2 Intervention (Months 3-4)||0||
48440859|NCT03668379|101413122|FG000|NOT COMPLETED|Stage 2 Intervention (Months 3-4)||1||
48440860|NCT03668379|101413123|FG001|NOT COMPLETED|Stage 2 Intervention (Months 3-4)||2||
48440861|NCT03668379|101413124|FG002|NOT COMPLETED|Stage 2 Intervention (Months 3-4)||0||
48440862|NCT03668379|101413125|FG003|NOT COMPLETED|Stage 2 Intervention (Months 3-4)||0||
48440863|NCT03668379|101413126|FG004|NOT COMPLETED|Stage 2 Intervention (Months 3-4)||0||
48440864|NCT03668379|101413127|FG005|NOT COMPLETED|Stage 2 Intervention (Months 3-4)||0||
48440865|NCT02080273|101413128|FG000|STARTED|Overall Study||45||
48440866|NCT02080273|101413129|FG001|STARTED|Overall Study||45||
48440867|NCT02080273|101413130|FG002|STARTED|Overall Study||45||
48440868|NCT02080273|101413128|FG000|COMPLETED|Overall Study||45||
48440869|NCT02080273|101413129|FG001|COMPLETED|Overall Study||45||
48440870|NCT02080273|101413130|FG002|COMPLETED|Overall Study||45||
48440871|NCT02080273|101413128|FG000|NOT COMPLETED|Overall Study||0||
48440872|NCT02080273|101413129|FG001|NOT COMPLETED|Overall Study||0||
48440873|NCT02080273|101413130|FG002|NOT COMPLETED|Overall Study||0||
48440874|NCT03683719|101413131|FG000|STARTED|Overall Study||52||
48440875|NCT03683719|101413132|FG001|STARTED|Overall Study||51||
48440876|NCT03683719|101413133|FG002|STARTED|Overall Study||52||
48440877|NCT03683719|101413134|FG003|STARTED|Overall Study||53||
48440878|NCT03683719|101413135|FG004|STARTED|Overall Study||50||
48440879|NCT03683719|101413131|FG000|COMPLETED|Overall Study||40||
48440880|NCT03683719|101413132|FG001|COMPLETED|Overall Study||38||
48440881|NCT03683719|101413133|FG002|COMPLETED|Overall Study||44||
48440882|NCT03683719|101413134|FG003|COMPLETED|Overall Study||46||
48440883|NCT03683719|101413135|FG004|COMPLETED|Overall Study||36||
48440884|NCT03683719|101413131|FG000|NOT COMPLETED|Overall Study||12||
48440885|NCT03683719|101413132|FG001|NOT COMPLETED|Overall Study||13||
48440886|NCT03683719|101413133|FG002|NOT COMPLETED|Overall Study||8||
48440887|NCT03683719|101413134|FG003|NOT COMPLETED|Overall Study||7||
48440888|NCT03683719|101413135|FG004|NOT COMPLETED|Overall Study||14||
48440889|NCT01940276|101413136|FG000|STARTED|Overall Study||50||
48440890|NCT01940276|101413137|FG001|STARTED|Overall Study||50||
48440891|NCT01940276|101413136|FG000|COMPLETED|Overall Study||50||
48440892|NCT01940276|101413137|FG001|COMPLETED|Overall Study||50||
48440893|NCT01940276|101413136|FG000|NOT COMPLETED|Overall Study||0||
48657274|NCT03973489|101945973|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48440894|NCT01940276|101413137|FG001|NOT COMPLETED|Overall Study||0||
48440895|NCT03972709|101413138|FG000|STARTED|Overall Study||149||
48440896|NCT03972709|101413139|FG001|STARTED|Overall Study||75||
48440897|NCT03972709|101413140|FG002|STARTED|Overall Study||148||
48440898|NCT03972709|101413138|FG000|COMPLETED|Overall Study||67||
48440899|NCT03972709|101413139|FG001|COMPLETED|Overall Study||35||
48440900|NCT03972709|101413140|FG002|COMPLETED|Overall Study||72||
48440901|NCT03972709|101413138|FG000|NOT COMPLETED|Overall Study||82||
48440902|NCT03972709|101413139|FG001|NOT COMPLETED|Overall Study||40||
48440903|NCT03972709|101413140|FG002|NOT COMPLETED|Overall Study||76||
48440904|NCT00665366|101413141|FG000|STARTED|Overall Study||189||
48440905|NCT00665366|101413142|FG001|STARTED|Overall Study||181||
48440906|NCT00665366|101413141|FG000|COMPLETED|Overall Study||131||
48440907|NCT00665366|101413142|FG001|COMPLETED|Overall Study||122||
48440908|NCT00665366|101413141|FG000|NOT COMPLETED|Overall Study||58||
48657275|NCT03973489|101945974|FG002|NOT COMPLETED|First Intervention (1 Day)||0||
48657276|NCT03973489|101945975|FG003|NOT COMPLETED|First Intervention (1 Day)||0||
48440909|NCT00665366|101413142|FG001|NOT COMPLETED|Overall Study||59||
48440910|NCT00242567|101413143|FG000|STARTED|Overall Study||259||
48440911|NCT00242567|101413144|FG001|STARTED|Overall Study||263||
48440912|NCT00242567|101413143|FG000|Received at Least 1 Dose of Study Drug|Overall Study||259||
48657277|NCT03973489|101945976|FG004|NOT COMPLETED|First Intervention (1 Day)||0||
48440913|NCT00242567|101413144|FG001|Received at Least 1 Dose of Study Drug|Overall Study||72||
48440914|NCT00242567|101413143|FG000|Never Received Study Drug|Overall Study||0||
48440915|NCT00242567|101413144|FG001|Never Received Study Drug|Overall Study||191||
48657278|NCT03973489|101945977|FG005|NOT COMPLETED|First Intervention (1 Day)||0||
48657279|NCT03973489|101945978|FG006|NOT COMPLETED|First Intervention (1 Day)||0||
48657280|NCT03973489|101945979|FG007|NOT COMPLETED|First Intervention (1 Day)||0||
48768213|NCT04396756|102222911|FG003|NOT COMPLETED|Overall Study||2||
48768214|NCT04396756|102222912|FG004|NOT COMPLETED|Overall Study||6||
48768215|NCT04396756|102222913|FG005|NOT COMPLETED|Overall Study||6||
48768216|NCT01096875|102222914|FG000|STARTED|Overall Study||30||
48768217|NCT01096875|102222915|FG001|STARTED|Overall Study||30||
48768218|NCT01096875|102222914|FG000|COMPLETED|Overall Study||30||
48768219|NCT01096875|102222915|FG001|COMPLETED|Overall Study||29||
48768220|NCT01096875|102222914|FG000|NOT COMPLETED|Overall Study||0||
48768221|NCT01096875|102222915|FG001|NOT COMPLETED|Overall Study||1||
48768222|NCT02156076|102222916|FG000|STARTED|Treatment Period||7||
48768223|NCT02156076|102222917|FG001|STARTED|Treatment Period||7||
48768224|NCT02156076|102222918|FG002|STARTED|Treatment Period||6||
48768225|NCT02156076|102222919|FG003|STARTED|Treatment Period||6||
48768226|NCT02156076|102222916|FG000|COMPLETED|Treatment Period||7||
48768227|NCT02156076|102222917|FG001|COMPLETED|Treatment Period||5||
48768228|NCT02156076|102222918|FG002|COMPLETED|Treatment Period||4||
48368259|NCT00611455|101230137|FG002|STARTED|Follow-up Period (Approximately 2 Years)||260||
48440916|NCT00242567|101413143|FG000|COMPLETED|Overall Study||93||
48440917|NCT00242567|101413144|FG001|COMPLETED|Overall Study||123||
48440918|NCT00242567|101413143|FG000|NOT COMPLETED|Overall Study||166||
48440919|NCT00242567|101413144|FG001|NOT COMPLETED|Overall Study||140||
48440920|NCT02860039|101413145|FG000|STARTED|Overall Study||85||
48440921|NCT02860039|101413146|FG001|STARTED|Overall Study||85||
48440922|NCT02860039|101413145|FG000|Visit 1|Overall Study||85|Study vaccine administered.|
48440923|NCT02860039|101413146|FG001|Visit 1|Overall Study||85|Study vaccine administered.|
48440924|NCT02860039|101413145|FG000|Visit 2|Overall Study||84|Study vaccine administered.|
48440925|NCT02860039|101413146|FG001|Visit 2|Overall Study||83|Study vaccine administered.|
48440926|NCT02860039|101413145|FG000|Visit 3|Overall Study||78||
48440927|NCT02860039|101413146|FG001|Visit 3|Overall Study||83||
48440928|NCT02860039|101413145|FG000|Visit 4|Overall Study||74||
48440929|NCT02860039|101413146|FG001|Visit 4|Overall Study||81||
48440930|NCT02860039|101413145|FG000|Visit 1 Repeat|Overall Study||32|This visit was attended by subjects who enrolled for a second year following their first year of enrollment, and the study vaccine was administered. See protocol for criteria.|
48440931|NCT02860039|101413146|FG001|Visit 1 Repeat|Overall Study||34|This visit was attended by subjects who enrolled for a second year following their first year of enrollment, and the study vaccine was administered. See protocol for criteria.|
48657281|NCT03973489|101945972|FG000|STARTED|Washout Period (at Least 3 Days)||4||
48657282|NCT03973489|101945973|FG001|STARTED|Washout Period (at Least 3 Days)||3||
48657283|NCT03973489|101945974|FG002|STARTED|Washout Period (at Least 3 Days)||2||
48657284|NCT03973489|101945975|FG003|STARTED|Washout Period (at Least 3 Days)||5||
48657285|NCT03973489|101945976|FG004|STARTED|Washout Period (at Least 3 Days)||4||
48657286|NCT03973489|101945977|FG005|STARTED|Washout Period (at Least 3 Days)||4||
48657287|NCT03973489|101945978|FG006|STARTED|Washout Period (at Least 3 Days)||2||
48657288|NCT03973489|101945979|FG007|STARTED|Washout Period (at Least 3 Days)||2||
48657289|NCT03973489|101945972|FG000|COMPLETED|Washout Period (at Least 3 Days)||2||
48657290|NCT03973489|101945973|FG001|COMPLETED|Washout Period (at Least 3 Days)||3||
48657291|NCT03973489|101945974|FG002|COMPLETED|Washout Period (at Least 3 Days)||2||
48657292|NCT03973489|101945975|FG003|COMPLETED|Washout Period (at Least 3 Days)||3||
48657293|NCT03973489|101945976|FG004|COMPLETED|Washout Period (at Least 3 Days)||1||
48657294|NCT03973489|101945977|FG005|COMPLETED|Washout Period (at Least 3 Days)||4||
48657295|NCT03973489|101945978|FG006|COMPLETED|Washout Period (at Least 3 Days)||1||
48657296|NCT03973489|101945979|FG007|COMPLETED|Washout Period (at Least 3 Days)||2||
48657297|NCT03973489|101945972|FG000|NOT COMPLETED|Washout Period (at Least 3 Days)||2||
48657298|NCT03973489|101945973|FG001|NOT COMPLETED|Washout Period (at Least 3 Days)||0||
48657299|NCT03973489|101945974|FG002|NOT COMPLETED|Washout Period (at Least 3 Days)||0||
48657300|NCT03973489|101945975|FG003|NOT COMPLETED|Washout Period (at Least 3 Days)||2||
48657301|NCT03973489|101945976|FG004|NOT COMPLETED|Washout Period (at Least 3 Days)||3||
48657302|NCT03973489|101945977|FG005|NOT COMPLETED|Washout Period (at Least 3 Days)||0||
48657303|NCT03973489|101945978|FG006|NOT COMPLETED|Washout Period (at Least 3 Days)||1||
48657304|NCT03973489|101945979|FG007|NOT COMPLETED|Washout Period (at Least 3 Days)||0||
48657305|NCT03973489|101945972|FG000|STARTED|Second Intervention (1 Day)||2||
48657306|NCT03973489|101945973|FG001|STARTED|Second Intervention (1 Day)||3||
48657307|NCT03973489|101945974|FG002|STARTED|Second Intervention (1 Day)||2||
48657308|NCT03973489|101945975|FG003|STARTED|Second Intervention (1 Day)||3||
48768229|NCT02156076|102222919|FG003|COMPLETED|Treatment Period||4||
48768230|NCT02156076|102222916|FG000|NOT COMPLETED|Treatment Period||0||
48768231|NCT02156076|102222917|FG001|NOT COMPLETED|Treatment Period||2||
48768232|NCT02156076|102222918|FG002|NOT COMPLETED|Treatment Period||2||
48768233|NCT02156076|102222919|FG003|NOT COMPLETED|Treatment Period||2||
48768234|NCT02156076|102222916|FG000|STARTED|Follow-up Period||7||
48768235|NCT02156076|102222917|FG001|STARTED|Follow-up Period||5||
48768236|NCT02156076|102222918|FG002|STARTED|Follow-up Period||4||
48440932|NCT02860039|101413145|FG000|Visit 2 Repeat|Overall Study||31|This visit was attended by subjects who enrolled for a second year following their first year of enrollment, and the study vaccine was administered. See protocol for criteria.|
48440933|NCT02860039|101413146|FG001|Visit 2 Repeat|Overall Study||34|This visit was attended by subjects who enrolled for a second year following their first year of enrollment, and the study vaccine was administered. See protocol for criteria.|
48440934|NCT02860039|101413145|FG000|Visit 3 Repeat|Overall Study||30|This visit was attended by subjects who enrolled for a second year following their first year of enrollment. See protocol for criteria.|
48440935|NCT02860039|101413146|FG001|Visit 3 Repeat|Overall Study||34|This visit was attended by subjects who enrolled for a second year following their first year of enrollment. See protocol for criteria.|
48440936|NCT02860039|101413145|FG000|Visit 4 Repeat|Overall Study||26|This visit was attended by subjects who enrolled for a second year following their first year of enrollment. See protocol for criteria.|
48768237|NCT02156076|102222919|FG003|STARTED|Follow-up Period||4||
48768238|NCT02156076|102222916|FG000|COMPLETED|Follow-up Period||6||
48768239|NCT02156076|102222917|FG001|COMPLETED|Follow-up Period||5||
48768240|NCT02156076|102222918|FG002|COMPLETED|Follow-up Period||4||
48768241|NCT02156076|102222919|FG003|COMPLETED|Follow-up Period||4||
48768242|NCT02156076|102222916|FG000|NOT COMPLETED|Follow-up Period||1||
48768243|NCT02156076|102222917|FG001|NOT COMPLETED|Follow-up Period||0||
48768244|NCT02156076|102222918|FG002|NOT COMPLETED|Follow-up Period||0||
48768245|NCT02156076|102222919|FG003|NOT COMPLETED|Follow-up Period||0||
48768246|NCT00826202|102222920|FG000|STARTED|Overall Study||20||
48768247|NCT00826202|102222921|FG001|STARTED|Overall Study||24||
48768248|NCT00826202|102222920|FG000|Completed Visit 4 (1st Efficacy Visit)|Overall Study||15||
48768249|NCT00826202|102222921|FG001|Completed Visit 4 (1st Efficacy Visit)|Overall Study||20||
48768250|NCT00826202|102222920|FG000|COMPLETED|Overall Study||10||
48768251|NCT00826202|102222921|FG001|COMPLETED|Overall Study||11||
48440937|NCT02860039|101413146|FG001|Visit 4 Repeat|Overall Study||22|This visit was attended by subjects who enrolled for a second year following their first year of enrollment. See protocol for criteria.|
48440938|NCT02860039|101413145|FG000|COMPLETED|Overall Study||74|"This includes subjects who completed all four visits for their first year of enrollment. This does not account for those who participated in a repeater year."|
48440939|NCT02860039|101413146|FG001|COMPLETED|Overall Study||81|"This includes subjects who completed all four visits for their first year of enrollment. This does not account for those who participated in a repeater year."|
48440940|NCT02860039|101413145|FG000|NOT COMPLETED|Overall Study||11||
48440941|NCT02860039|101413146|FG001|NOT COMPLETED|Overall Study||4||
48440942|NCT00890409|101413147|FG000|STARTED|Overall Study||116||
48440943|NCT00890409|101413148|FG001|STARTED|Overall Study||140||
48440944|NCT00890409|101413147|FG000|COMPLETED|Overall Study||96||
48440945|NCT00890409|101413148|FG001|COMPLETED|Overall Study||119||
48440946|NCT00890409|101413147|FG000|NOT COMPLETED|Overall Study||20||
48768252|NCT00826202|102222920|FG000|NOT COMPLETED|Overall Study||10||
48768253|NCT00826202|102222921|FG001|NOT COMPLETED|Overall Study||13||
48768254|NCT02015637|102222922|FG000|STARTED|Overall Study||306||
48768255|NCT02015637|102222923|FG001|STARTED|Overall Study||154||
48768256|NCT02015637|102222922|FG000|COMPLETED|Overall Study||298||
48768257|NCT02015637|102222923|FG001|COMPLETED|Overall Study||149||
48768258|NCT02015637|102222922|FG000|NOT COMPLETED|Overall Study||8||
48768259|NCT02015637|102222923|FG001|NOT COMPLETED|Overall Study||5||
48768260|NCT04845568|102222924|FG000|STARTED|Overall Study||26||
48768261|NCT04845568|102222925|FG001|STARTED|Overall Study||28||
48768262|NCT04845568|102222924|FG000|COMPLETED|Overall Study||26||
48768263|NCT04845568|102222925|FG001|COMPLETED|Overall Study||28||
48768264|NCT04845568|102222924|FG000|NOT COMPLETED|Overall Study||0||
48768265|NCT04845568|102222925|FG001|NOT COMPLETED|Overall Study||0||
48768266|NCT03879772|102222926|FG000|STARTED|Overall Study||137||
48768267|NCT03879772|102222927|FG001|STARTED|Overall Study||135||
48768268|NCT03879772|102222928|FG002|STARTED|Overall Study||133||
48768269|NCT03879772|102222929|FG003|STARTED|Overall Study||138||
48768270|NCT03879772|102222930|FG004|STARTED|Overall Study||136||
48768271|NCT03879772|102222926|FG000|COMPLETED|Overall Study||133||
48768272|NCT03879772|102222927|FG001|COMPLETED|Overall Study||132||
48768273|NCT03879772|102222928|FG002|COMPLETED|Overall Study||123||
48768274|NCT03879772|102222929|FG003|COMPLETED|Overall Study||130||
48768275|NCT03879772|102222930|FG004|COMPLETED|Overall Study||128||
48768276|NCT03879772|102222926|FG000|NOT COMPLETED|Overall Study||4||
48768277|NCT03879772|102222927|FG001|NOT COMPLETED|Overall Study||3||
48768278|NCT03879772|102222928|FG002|NOT COMPLETED|Overall Study||10||
48768279|NCT03879772|102222929|FG003|NOT COMPLETED|Overall Study||8||
48768280|NCT03879772|102222930|FG004|NOT COMPLETED|Overall Study||8||
48768281|NCT02593006|102222931|FG000|STARTED|Overall Study||257||
48768282|NCT02593006|102222932|FG001|STARTED|Overall Study||100||
48768283|NCT02593006|102222933|FG002|STARTED|Overall Study||43||
48768284|NCT02593006|102222931|FG000|COMPLETED|Overall Study||250||
48768285|NCT02593006|102222932|FG001|COMPLETED|Overall Study||93||
48768286|NCT02593006|102222933|FG002|COMPLETED|Overall Study||38||
48768287|NCT02593006|102222931|FG000|NOT COMPLETED|Overall Study||7||
48768288|NCT02593006|102222932|FG001|NOT COMPLETED|Overall Study||7||
48768289|NCT02593006|102222933|FG002|NOT COMPLETED|Overall Study||5||
48768290|NCT00763035|102222934|FG000|STARTED|First Intervention||10||
48768291|NCT00763035|102222935|FG001|STARTED|First Intervention||4||
48768292|NCT00763035|102222934|FG000|COMPLETED|First Intervention||9||
48440947|NCT00890409|101413148|FG001|NOT COMPLETED|Overall Study||21||
48440948|NCT01607398|101413149|FG000|STARTED|Overall Study||28||
48440949|NCT01607398|101413150|FG001|STARTED|Overall Study||28||
48440950|NCT01607398|101413149|FG000|COMPLETED|Overall Study||26||
48440951|NCT01607398|101413150|FG001|COMPLETED|Overall Study||26||
48440952|NCT01607398|101413149|FG000|NOT COMPLETED|Overall Study||2||
48440953|NCT01607398|101413150|FG001|NOT COMPLETED|Overall Study||2||
48440954|NCT03305159|101413151|FG000|STARTED|Overall Study||66||
48440955|NCT03305159|101413152|FG001|STARTED|Overall Study||68||
48440956|NCT03305159|101413151|FG000|COMPLETED|Overall Study||63||
48440957|NCT03305159|101413152|FG001|COMPLETED|Overall Study||60||
48440958|NCT03305159|101413151|FG000|NOT COMPLETED|Overall Study||3||
48440959|NCT03305159|101413152|FG001|NOT COMPLETED|Overall Study||8||
48188765|NCT01562743|100786080|FG000|NOT COMPLETED|Overall Study||52||
48368260|NCT00611455|101230135|FG000|COMPLETED|Follow-up Period (Approximately 2 Years)||0||
48368261|NCT00611455|101230136|FG001|COMPLETED|Follow-up Period (Approximately 2 Years)||0||
48368262|NCT00611455|101230137|FG002|COMPLETED|Follow-up Period (Approximately 2 Years)||49||
48368263|NCT00611455|101230135|FG000|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0||
48368264|NCT00611455|101230136|FG001|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0||
48368265|NCT00611455|101230137|FG002|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||211||
48368266|NCT02775864|101230138|FG000|STARTED|Overall Study||26014||
48368267|NCT02775864|101230139|FG001|STARTED|Overall Study||31117||
48368268|NCT02775864|101230140|FG002|STARTED|Overall Study||11941||
48440960|NCT03901352|101413153|FG000|STARTED|Double-blind Phase||150||
48440961|NCT03901352|101413154|FG001|STARTED|Double-blind Phase||150||
48440962|NCT03901352|101413153|FG000|COMPLETED|Double-blind Phase||133||
48440963|NCT03901352|101413154|FG001|COMPLETED|Double-blind Phase||136||
48440964|NCT03901352|101413153|FG000|NOT COMPLETED|Double-blind Phase||17||
48440965|NCT03901352|101413154|FG001|NOT COMPLETED|Double-blind Phase||14||
48440966|NCT03901352|101413153|FG000|STARTED|Open-label Extension Phase||210||
48440967|NCT03901352|101413154|FG001|STARTED|Open-label Extension Phase||0||
48440968|NCT03901352|101413153|FG000|COMPLETED|Open-label Extension Phase||170||
48440969|NCT03901352|101413154|FG001|COMPLETED|Open-label Extension Phase||0||
48440970|NCT03901352|101413153|FG000|NOT COMPLETED|Open-label Extension Phase||40||
48368269|NCT02775864|101230141|FG003|STARTED|Overall Study||12849||
48368270|NCT02775864|101230138|FG000|COMPLETED|Overall Study||22772||
48368271|NCT02775864|101230139|FG001|COMPLETED|Overall Study||26218||
48368272|NCT02775864|101230140|FG002|COMPLETED|Overall Study||10081||
48368273|NCT02775864|101230141|FG003|COMPLETED|Overall Study||10765||
48368274|NCT02775864|101230138|FG000|NOT COMPLETED|Overall Study||3242||
48368275|NCT02775864|101230139|FG001|NOT COMPLETED|Overall Study||4899||
48368276|NCT02775864|101230140|FG002|NOT COMPLETED|Overall Study||1860||
48368277|NCT02775864|101230141|FG003|NOT COMPLETED|Overall Study||2084||
48368278|NCT02137772|101230142|FG000|STARTED|Overall Study||376||
48368279|NCT02137772|101230143|FG001|STARTED|Overall Study||194||
48368280|NCT02137772|101230142|FG000|Treated Participants|Overall Study||373||
48368281|NCT02137772|101230143|FG001|Treated Participants|Overall Study||192||
48368282|NCT02137772|101230142|FG000|COMPLETED|Overall Study||244||
48368283|NCT02137772|101230143|FG001|COMPLETED|Overall Study||119||
48368284|NCT02137772|101230142|FG000|NOT COMPLETED|Overall Study||132||
48368285|NCT02137772|101230143|FG001|NOT COMPLETED|Overall Study||75||
48368286|NCT04747808|101230144|FG000|STARTED|Overall Study||5||
48368287|NCT04747808|101230144|FG000|COMPLETED|Overall Study||5||
48368288|NCT04747808|101230144|FG000|NOT COMPLETED|Overall Study||0||
48368289|NCT01704781|101230145|FG000|STARTED|Overall Study||3||
48368290|NCT01704781|101230146|FG001|STARTED|Overall Study||3||
48368291|NCT01704781|101230147|FG002|STARTED|Overall Study||6||
48368292|NCT01704781|101230148|FG003|STARTED|Overall Study||12||
48368293|NCT01704781|101230149|FG004|STARTED|Overall Study||12||
48368294|NCT01704781|101230145|FG000|COMPLETED|Overall Study||3||
48368295|NCT01704781|101230146|FG001|COMPLETED|Overall Study||3||
48368296|NCT01704781|101230147|FG002|COMPLETED|Overall Study||6||
48368297|NCT01704781|101230148|FG003|COMPLETED|Overall Study||12||
48368298|NCT01704781|101230149|FG004|COMPLETED|Overall Study||12||
48368299|NCT01704781|101230145|FG000|NOT COMPLETED|Overall Study||0||
48368300|NCT01704781|101230146|FG001|NOT COMPLETED|Overall Study||0||
48368301|NCT01704781|101230147|FG002|NOT COMPLETED|Overall Study||0||
48368302|NCT01704781|101230148|FG003|NOT COMPLETED|Overall Study||0||
48368303|NCT01704781|101230149|FG004|NOT COMPLETED|Overall Study||0||
48368304|NCT03865407|101230150|FG000|STARTED|Overall Study||10||
48368305|NCT03865407|101230151|FG001|STARTED|Overall Study||7||
48368306|NCT03865407|101230150|FG000|COMPLETED|Overall Study||7||
48368307|NCT03865407|101230151|FG001|COMPLETED|Overall Study||7||
48368308|NCT03865407|101230150|FG000|NOT COMPLETED|Overall Study||3||
48368309|NCT03865407|101230151|FG001|NOT COMPLETED|Overall Study||0||
48368310|NCT02284399|101230152|FG000|STARTED|Overall Study||1414||
48440971|NCT03901352|101413154|FG001|NOT COMPLETED|Open-label Extension Phase||0||
48440972|NCT00517868|101413155|FG000|STARTED|Overall Study||18||
48368311|NCT02284399|101230153|FG001|STARTED|Overall Study||3074||
48368312|NCT02284399|101230152|FG000|COMPLETED|Overall Study||1414||
48368313|NCT02284399|101230153|FG001|COMPLETED|Overall Study||3074||
48368314|NCT02284399|101230152|FG000|NOT COMPLETED|Overall Study||0||
48440973|NCT00517868|101413156|FG001|STARTED|Overall Study||10||
48440974|NCT00517868|101413155|FG000|COMPLETED|Overall Study||16||
48440975|NCT00517868|101413156|FG001|COMPLETED|Overall Study||10||
48440976|NCT00517868|101413155|FG000|NOT COMPLETED|Overall Study||2||
48440977|NCT00517868|101413156|FG001|NOT COMPLETED|Overall Study||0||
48440978|NCT00769132|101413157|FG000|STARTED|Period 1||7||
48440979|NCT00769132|101413158|FG001|STARTED|Period 1||6||
48440980|NCT00769132|101413159|FG002|STARTED|Period 1||6||
48440981|NCT00769132|101413160|FG003|STARTED|Period 1||7||
48440982|NCT00769132|101413157|FG000|COMPLETED|Period 1||6||
48440983|NCT00769132|101413158|FG001|COMPLETED|Period 1||6||
48440984|NCT00769132|101413159|FG002|COMPLETED|Period 1||6||
48440985|NCT00769132|101413160|FG003|COMPLETED|Period 1||6||
48440986|NCT00769132|101413157|FG000|NOT COMPLETED|Period 1||1||
48440987|NCT00769132|101413158|FG001|NOT COMPLETED|Period 1||0||
48440988|NCT00769132|101413159|FG002|NOT COMPLETED|Period 1||0||
48440989|NCT00769132|101413160|FG003|NOT COMPLETED|Period 1||1||
48440990|NCT00769132|101413157|FG000|STARTED|Period 2||6||
48440991|NCT00769132|101413158|FG001|STARTED|Period 2||6||
48440992|NCT00769132|101413159|FG002|STARTED|Period 2||6||
48440993|NCT00769132|101413160|FG003|STARTED|Period 2||6||
48440994|NCT00769132|101413157|FG000|COMPLETED|Period 2||6||
48440995|NCT00769132|101413158|FG001|COMPLETED|Period 2||6||
48440996|NCT00769132|101413159|FG002|COMPLETED|Period 2||6||
48440997|NCT00769132|101413160|FG003|COMPLETED|Period 2||5||
48440998|NCT00769132|101413157|FG000|NOT COMPLETED|Period 2||0||
48440999|NCT00769132|101413158|FG001|NOT COMPLETED|Period 2||0||
48441000|NCT00769132|101413159|FG002|NOT COMPLETED|Period 2||0||
48441001|NCT00769132|101413160|FG003|NOT COMPLETED|Period 2||1||
48441002|NCT00769132|101413157|FG000|STARTED|Period 3||6||
48441003|NCT00769132|101413158|FG001|STARTED|Period 3||6||
48441004|NCT00769132|101413159|FG002|STARTED|Period 3||6||
48441005|NCT00769132|101413160|FG003|STARTED|Period 3||5||
48768293|NCT00763035|102222935|FG001|COMPLETED|First Intervention||3||
48768294|NCT00763035|102222934|FG000|NOT COMPLETED|First Intervention||1||
48768295|NCT00763035|102222935|FG001|NOT COMPLETED|First Intervention||1||
48768296|NCT00763035|102222934|FG000|STARTED|Second Intervention||9||
48768297|NCT00763035|102222935|FG001|STARTED|Second Intervention||3||
48768298|NCT00763035|102222934|FG000|COMPLETED|Second Intervention||6||
48768299|NCT00763035|102222935|FG001|COMPLETED|Second Intervention||3||
48768300|NCT00763035|102222934|FG000|NOT COMPLETED|Second Intervention||3||
48768301|NCT00763035|102222935|FG001|NOT COMPLETED|Second Intervention||0||
48768302|NCT00539591|102222936|FG000|STARTED|Overall Study||23||
48188766|NCT03905811|100786081|FG000|STARTED|Overall Study||8||
48441006|NCT00769132|101413157|FG000|COMPLETED|Period 3||5||
48441007|NCT00769132|101413158|FG001|COMPLETED|Period 3||6||
48441008|NCT00769132|101413159|FG002|COMPLETED|Period 3||6||
48441009|NCT00769132|101413160|FG003|COMPLETED|Period 3||5||
48441010|NCT00769132|101413157|FG000|NOT COMPLETED|Period 3||1||
48441011|NCT00769132|101413158|FG001|NOT COMPLETED|Period 3||0||
48441012|NCT00769132|101413159|FG002|NOT COMPLETED|Period 3||0||
48441013|NCT00769132|101413160|FG003|NOT COMPLETED|Period 3||0||
48441014|NCT00769132|101413157|FG000|STARTED|Period 4||5||
48441015|NCT00769132|101413158|FG001|STARTED|Period 4||6||
48441016|NCT00769132|101413159|FG002|STARTED|Period 4||6||
48441017|NCT00769132|101413160|FG003|STARTED|Period 4||5||
48441018|NCT00769132|101413157|FG000|COMPLETED|Period 4||5||
48768303|NCT00539591|102222937|FG001|STARTED|Overall Study||2||
48768304|NCT00539591|102222938|FG002|STARTED|Overall Study||4||
48768305|NCT00539591|102222936|FG000|COMPLETED|Overall Study||18||
48768306|NCT00539591|102222937|FG001|COMPLETED|Overall Study||0||
48768307|NCT00539591|102222938|FG002|COMPLETED|Overall Study||1||
48768308|NCT00539591|102222936|FG000|NOT COMPLETED|Overall Study||5||
48768309|NCT00539591|102222937|FG001|NOT COMPLETED|Overall Study||2||
48768310|NCT00539591|102222938|FG002|NOT COMPLETED|Overall Study||3||
48768311|NCT02121535|102222939|FG000|STARTED|Period 1 (8 Trial Days)||36||
48768312|NCT02121535|102222940|FG001|STARTED|Period 1 (8 Trial Days)||36||
48441019|NCT00769132|101413158|FG001|COMPLETED|Period 4||5||
48441020|NCT00769132|101413159|FG002|COMPLETED|Period 4||6||
48441021|NCT00769132|101413160|FG003|COMPLETED|Period 4||5||
48441022|NCT00769132|101413157|FG000|NOT COMPLETED|Period 4||0||
48441023|NCT00769132|101413158|FG001|NOT COMPLETED|Period 4||1||
48441024|NCT00769132|101413159|FG002|NOT COMPLETED|Period 4||0||
48768313|NCT02121535|102222939|FG000|COMPLETED|Period 1 (8 Trial Days)||36||
48768314|NCT02121535|102222940|FG001|COMPLETED|Period 1 (8 Trial Days)||35||
48768315|NCT02121535|102222939|FG000|NOT COMPLETED|Period 1 (8 Trial Days)||0||
48441025|NCT00769132|101413160|FG003|NOT COMPLETED|Period 4||0||
48441026|NCT01371006|101413161|FG000|STARTED|Overall Study||14||
48441027|NCT01371006|101413162|FG001|STARTED|Overall Study||15||
48441028|NCT01371006|101413161|FG000|COMPLETED|Overall Study||13||
48441029|NCT01371006|101413162|FG001|COMPLETED|Overall Study||15||
48441030|NCT01371006|101413161|FG000|NOT COMPLETED|Overall Study||1||
48441031|NCT01371006|101413162|FG001|NOT COMPLETED|Overall Study||0||
48441032|NCT00864084|101413163|FG000|STARTED|Overall Study||14||
48441033|NCT00864084|101413163|FG000|COMPLETED|Overall Study||11||
48441034|NCT00864084|101413163|FG000|NOT COMPLETED|Overall Study||3||
48441035|NCT01407107|101413164|FG000|STARTED|Overall Study||7||
48441036|NCT01407107|101413165|FG001|STARTED|Overall Study||3||
48441037|NCT01407107|101413166|FG002|STARTED|Overall Study||3||
48441038|NCT01407107|101413164|FG000|COMPLETED|Overall Study||7||
48441039|NCT01407107|101413165|FG001|COMPLETED|Overall Study||3||
48441040|NCT01407107|101413166|FG002|COMPLETED|Overall Study||3||
48441041|NCT01407107|101413164|FG000|NOT COMPLETED|Overall Study||0||
48441042|NCT01407107|101413165|FG001|NOT COMPLETED|Overall Study||0||
48441043|NCT01407107|101413166|FG002|NOT COMPLETED|Overall Study||0||
48441044|NCT00703261|101413167|FG000|STARTED|Overall Study||42||
48441045|NCT00703261|101413168|FG001|STARTED|Overall Study||41||
48441046|NCT00703261|101413167|FG000|COMPLETED|Overall Study||36||
48441047|NCT00703261|101413168|FG001|COMPLETED|Overall Study||35||
48441048|NCT00703261|101413167|FG000|NOT COMPLETED|Overall Study||6||
48441049|NCT00703261|101413168|FG001|NOT COMPLETED|Overall Study||6||
48441050|NCT04285983|101413169|FG000|STARTED|Overall Study||89||
48441051|NCT04285983|101413169|FG000|COMPLETED|Overall Study||83||
48441052|NCT04285983|101413169|FG000|NOT COMPLETED|Overall Study||6||
48441053|NCT04935931|101413170|FG000|STARTED|Overall Study||13||
48441054|NCT04935931|101413170|FG000|COMPLETED|Overall Study||12||
48441055|NCT04935931|101413170|FG000|NOT COMPLETED|Overall Study||1||
48441056|NCT03353415|101413171|FG000|STARTED|Masked CGM Wear||25|"26 individuals were enrolled, however one individual was withdrawn prior to participation due to hospitalization. No study visits were attended or study related activities initiated for this person.~25 participants completed the visit 1 baseline evaluation."|
48441057|NCT03353415|101413171|FG000|COMPLETED|Masked CGM Wear||23||
48441058|NCT03353415|101413171|FG000|NOT COMPLETED|Masked CGM Wear||2||
48441059|NCT03353415|101413171|FG000|STARTED|Unmasked CGM Wear||23||
48441060|NCT03353415|101413171|FG000|COMPLETED|Unmasked CGM Wear||22||
48441061|NCT03353415|101413171|FG000|NOT COMPLETED|Unmasked CGM Wear||1||
48441062|NCT04736316|101413172|FG000|STARTED|Overall Study||31||
48441063|NCT04736316|101413173|FG001|STARTED|Overall Study||61||
48441064|NCT04736316|101413172|FG000|COMPLETED|Overall Study||31||
48441065|NCT04736316|101413173|FG001|COMPLETED|Overall Study||61||
48441066|NCT04736316|101413172|FG000|NOT COMPLETED|Overall Study||0||
48441067|NCT04736316|101413173|FG001|NOT COMPLETED|Overall Study||0||
48441068|NCT01360021|101413174|FG000|STARTED|Overall Study||71||
48441069|NCT01360021|101413175|FG001|STARTED|Overall Study||71||
48441070|NCT01360021|101413176|FG002|STARTED|Overall Study||72||
48441071|NCT01360021|101413174|FG000|COMPLETED|Overall Study||63||
48441072|NCT01360021|101413175|FG001|COMPLETED|Overall Study||67||
48441073|NCT01360021|101413176|FG002|COMPLETED|Overall Study||65||
48441074|NCT01360021|101413174|FG000|NOT COMPLETED|Overall Study||8||
48441075|NCT01360021|101413175|FG001|NOT COMPLETED|Overall Study||4||
48441076|NCT01360021|101413176|FG002|NOT COMPLETED|Overall Study||7||
48441077|NCT02192307|101413177|FG000|STARTED|Overall Study||30||
48441078|NCT02192307|101413178|FG001|STARTED|Overall Study||30||
48441079|NCT02192307|101413177|FG000|COMPLETED|Overall Study||30||
48441080|NCT02192307|101413178|FG001|COMPLETED|Overall Study||30||
48441081|NCT02192307|101413177|FG000|NOT COMPLETED|Overall Study||0||
48441082|NCT02192307|101413178|FG001|NOT COMPLETED|Overall Study||0||
48441083|NCT01260194|101413179|FG000|STARTED|Overall Study||4||
48441084|NCT01260194|101413179|FG000|COMPLETED|Overall Study||3||
48441085|NCT01260194|101413179|FG000|NOT COMPLETED|Overall Study||1||
48441086|NCT01023815|101413180|FG000|STARTED|Pre-randomization Period (Day 1 to 90)||328||
48441087|NCT01023815|101413181|FG001|STARTED|Pre-randomization Period (Day 1 to 90)||0||
48441088|NCT01023815|101413182|FG002|STARTED|Pre-randomization Period (Day 1 to 90)||0||
48441089|NCT01023815|101413183|FG003|STARTED|Pre-randomization Period (Day 1 to 90)||0||
48441090|NCT01023815|101413180|FG000|COMPLETED|Pre-randomization Period (Day 1 to 90)||184||
48441091|NCT01023815|101413181|FG001|COMPLETED|Pre-randomization Period (Day 1 to 90)||0||
48441092|NCT01023815|101413182|FG002|COMPLETED|Pre-randomization Period (Day 1 to 90)||0||
48657309|NCT03973489|101945976|FG004|STARTED|Second Intervention (1 Day)||1||
48657310|NCT03973489|101945977|FG005|STARTED|Second Intervention (1 Day)||4||
48657311|NCT03973489|101945978|FG006|STARTED|Second Intervention (1 Day)||1||
48657312|NCT03973489|101945979|FG007|STARTED|Second Intervention (1 Day)||2||
48657313|NCT03973489|101945972|FG000|COMPLETED|Second Intervention (1 Day)||2||
48657314|NCT03973489|101945973|FG001|COMPLETED|Second Intervention (1 Day)||3||
48657315|NCT03973489|101945974|FG002|COMPLETED|Second Intervention (1 Day)||2||
48657316|NCT03973489|101945975|FG003|COMPLETED|Second Intervention (1 Day)||2||
48657317|NCT03973489|101945976|FG004|COMPLETED|Second Intervention (1 Day)||1||
48657318|NCT03973489|101945977|FG005|COMPLETED|Second Intervention (1 Day)||4||
48657319|NCT03973489|101945978|FG006|COMPLETED|Second Intervention (1 Day)||1||
48657320|NCT03973489|101945979|FG007|COMPLETED|Second Intervention (1 Day)||2||
48657321|NCT03973489|101945972|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48657322|NCT03973489|101945973|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48657323|NCT03973489|101945974|FG002|NOT COMPLETED|Second Intervention (1 Day)||0||
48657324|NCT03973489|101945975|FG003|NOT COMPLETED|Second Intervention (1 Day)||1||
48657325|NCT03973489|101945976|FG004|NOT COMPLETED|Second Intervention (1 Day)||0||
48441093|NCT01023815|101413183|FG003|COMPLETED|Pre-randomization Period (Day 1 to 90)||0||
48441094|NCT01023815|101413180|FG000|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||144||
48657326|NCT03973489|101945977|FG005|NOT COMPLETED|Second Intervention (1 Day)||0||
48441095|NCT01023815|101413181|FG001|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0||
48768316|NCT02121535|102222940|FG001|NOT COMPLETED|Period 1 (8 Trial Days)||1||
48441096|NCT01023815|101413182|FG002|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0||
48441097|NCT01023815|101413183|FG003|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0||
48441098|NCT01023815|101413180|FG000|STARTED|Randomized Period (Day 90 to Month 12)||0||
48768317|NCT02121535|102222939|FG000|STARTED|Period 2 (8 Trial Days)||36||
48768318|NCT02121535|102222940|FG001|STARTED|Period 2 (8 Trial Days)||35||
48768319|NCT02121535|102222939|FG000|COMPLETED|Period 2 (8 Trial Days)||36||
48768320|NCT02121535|102222940|FG001|COMPLETED|Period 2 (8 Trial Days)||35||
48768321|NCT02121535|102222939|FG000|NOT COMPLETED|Period 2 (8 Trial Days)||0||
48768322|NCT02121535|102222940|FG001|NOT COMPLETED|Period 2 (8 Trial Days)||0||
48768323|NCT02121535|102222939|FG000|STARTED|Period 3 (8 Trial Days)||36||
48768324|NCT02121535|102222940|FG001|STARTED|Period 3 (8 Trial Days)||35||
48768325|NCT02121535|102222939|FG000|COMPLETED|Period 3 (8 Trial Days)||35||
48768326|NCT02121535|102222940|FG001|COMPLETED|Period 3 (8 Trial Days)||35||
48441099|NCT01023815|101413181|FG001|STARTED|Randomized Period (Day 90 to Month 12)||45||
48441100|NCT01023815|101413182|FG002|STARTED|Randomized Period (Day 90 to Month 12)||68||
48441101|NCT01023815|101413183|FG003|STARTED|Randomized Period (Day 90 to Month 12)||71||
48441102|NCT01023815|101413180|FG000|COMPLETED|Randomized Period (Day 90 to Month 12)||0||
48441103|NCT01023815|101413181|FG001|COMPLETED|Randomized Period (Day 90 to Month 12)||42||
48441104|NCT01023815|101413182|FG002|COMPLETED|Randomized Period (Day 90 to Month 12)||60||
48441105|NCT01023815|101413183|FG003|COMPLETED|Randomized Period (Day 90 to Month 12)||68||
48441106|NCT01023815|101413180|FG000|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||0||
48441107|NCT01023815|101413181|FG001|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3||
48441108|NCT01023815|101413182|FG002|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||8||
48441109|NCT01023815|101413183|FG003|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3||
48441110|NCT04798027|101413184|FG000|STARTED|Overall Study||10||
48441111|NCT04798027|101413185|FG001|STARTED|Overall Study||25||
48441112|NCT04798027|101413186|FG002|STARTED|Overall Study||10||
48441113|NCT04798027|101413187|FG003|STARTED|Overall Study||27||
48441114|NCT04798027|101413188|FG004|STARTED|Overall Study||26||
48441115|NCT04798027|101413189|FG005|STARTED|Overall Study||13||
48441116|NCT04798027|101413190|FG006|STARTED|Overall Study||28||
48441117|NCT04798027|101413191|FG007|STARTED|Overall Study||29||
48441118|NCT04798027|101413192|FG008|STARTED|Overall Study||14||
48441119|NCT04798027|101413184|FG000|Vaccinated on Day 1|Overall Study||10||
48657327|NCT03973489|101945978|FG006|NOT COMPLETED|Second Intervention (1 Day)||0||
48657328|NCT03973489|101945979|FG007|NOT COMPLETED|Second Intervention (1 Day)||0||
48657329|NCT05013905|101945980|FG000|STARTED|Overall Study||55||
48657330|NCT05013905|101945980|FG000|COMPLETED|Overall Study||53||
48657331|NCT05013905|101945980|FG000|NOT COMPLETED|Overall Study||2||
48657332|NCT05788328|101945981|FG000|STARTED|Treatment Period 1 (3 Days)||16||
48657333|NCT05788328|101945981|FG000|COMPLETED|Treatment Period 1 (3 Days)||16||
48657334|NCT05788328|101945981|FG000|NOT COMPLETED|Treatment Period 1 (3 Days)||0||
48657335|NCT05788328|101945981|FG000|STARTED|Treatment Period 2 (4 Days)||16||
48657336|NCT05788328|101945981|FG000|COMPLETED|Treatment Period 2 (4 Days)||16||
48657337|NCT05788328|101945981|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
48657338|NCT05788328|101945981|FG000|STARTED|Treatment Period 3 (8 Days)||16||
48657339|NCT05788328|101945981|FG000|COMPLETED|Treatment Period 3 (8 Days)||16||
48657340|NCT05788328|101945981|FG000|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
48657341|NCT05788328|101945981|FG000|STARTED|Treatment Period 4 (5 Days)||16||
48657342|NCT05788328|101945981|FG000|COMPLETED|Treatment Period 4 (5 Days)||15||
48657343|NCT05788328|101945981|FG000|NOT COMPLETED|Treatment Period 4 (5 Days)||1||
48657344|NCT05788328|101945981|FG000|STARTED|Treatment Period 5 (4 Days)||15||
48657345|NCT05788328|101945981|FG000|COMPLETED|Treatment Period 5 (4 Days)||15||
48657346|NCT05788328|101945981|FG000|NOT COMPLETED|Treatment Period 5 (4 Days)||0||
48657347|NCT05788328|101945981|FG000|STARTED|Treatment Period 6 (17 Days)||15||
48657348|NCT05788328|101945981|FG000|COMPLETED|Treatment Period 6 (17 Days)||15||
48657349|NCT05788328|101945981|FG000|NOT COMPLETED|Treatment Period 6 (17 Days)||0||
48657350|NCT05788328|101945981|FG000|STARTED|Treatment Period 7 (2 Days)||15||
48657351|NCT05788328|101945981|FG000|COMPLETED|Treatment Period 7 (2 Days)||15||
48657352|NCT05788328|101945981|FG000|NOT COMPLETED|Treatment Period 7 (2 Days)||0||
48657353|NCT05788328|101945981|FG000|STARTED|Treatment Period 8 (4 Days)||15||
48657354|NCT05788328|101945981|FG000|COMPLETED|Treatment Period 8 (4 Days)||14||
48657355|NCT05788328|101945981|FG000|NOT COMPLETED|Treatment Period 8 (4 Days)||1||
48657356|NCT03258593|101945982|FG000|STARTED|Run-In Induction Phase||12||
48657357|NCT03258593|101945983|FG001|STARTED|Run-In Induction Phase||0||
48657358|NCT03258593|101945984|FG002|STARTED|Run-In Induction Phase||0||
48657359|NCT03258593|101945985|FG003|STARTED|Run-In Induction Phase||0||
48657360|NCT03258593|101945982|FG000|COMPLETED|Run-In Induction Phase||12||
48657361|NCT03258593|101945983|FG001|COMPLETED|Run-In Induction Phase||0||
48657362|NCT03258593|101945984|FG002|COMPLETED|Run-In Induction Phase||0||
48657363|NCT03258593|101945985|FG003|COMPLETED|Run-In Induction Phase||0||
48657364|NCT03258593|101945982|FG000|NOT COMPLETED|Run-In Induction Phase||0||
48657365|NCT03258593|101945983|FG001|NOT COMPLETED|Run-In Induction Phase||0||
48657366|NCT03258593|101945984|FG002|NOT COMPLETED|Run-In Induction Phase||0||
48768327|NCT02121535|102222939|FG000|NOT COMPLETED|Period 3 (8 Trial Days)||1||
48768328|NCT02121535|102222940|FG001|NOT COMPLETED|Period 3 (8 Trial Days)||0||
48768329|NCT02121535|102222939|FG000|STARTED|Period 4 (8 Trial Days)||35||
48768330|NCT02121535|102222940|FG001|STARTED|Period 4 (8 Trial Days)||35||
48768331|NCT02121535|102222939|FG000|COMPLETED|Period 4 (8 Trial Days)||35||
48768332|NCT02121535|102222940|FG001|COMPLETED|Period 4 (8 Trial Days)||35||
48768333|NCT02121535|102222939|FG000|NOT COMPLETED|Period 4 (8 Trial Days)||0||
48768334|NCT02121535|102222940|FG001|NOT COMPLETED|Period 4 (8 Trial Days)||0||
48768335|NCT01662765|102222941|FG000|STARTED|Overall Study||42||
48768336|NCT01662765|102222942|FG001|STARTED|Overall Study||42||
48768337|NCT01662765|102222941|FG000|COMPLETED|Overall Study||41||
48768338|NCT01662765|102222942|FG001|COMPLETED|Overall Study||40||
48768339|NCT01662765|102222941|FG000|NOT COMPLETED|Overall Study||1||
48768340|NCT01662765|102222942|FG001|NOT COMPLETED|Overall Study||2||
48768341|NCT00632814|102222943|FG000|STARTED|Overall Study||11||
48768342|NCT00632814|102222944|FG001|STARTED|Overall Study||13||
48768343|NCT00632814|102222945|FG002|STARTED|Overall Study||8||
48768344|NCT00632814|102222943|FG000|COMPLETED|Overall Study||11||
48768345|NCT00632814|102222944|FG001|COMPLETED|Overall Study||13||
48768346|NCT00632814|102222945|FG002|COMPLETED|Overall Study||8||
48768347|NCT00632814|102222943|FG000|NOT COMPLETED|Overall Study||0||
48768348|NCT00632814|102222944|FG001|NOT COMPLETED|Overall Study||0||
48768349|NCT00632814|102222945|FG002|NOT COMPLETED|Overall Study||0||
48768350|NCT01868997|102222946|FG000|STARTED|Overall Study||45||
48768351|NCT01868997|102222947|FG001|STARTED|Overall Study||42||
48768352|NCT01868997|102222946|FG000|COMPLETED|Overall Study||38||
48768353|NCT01868997|102222947|FG001|COMPLETED|Overall Study||36||
48768354|NCT01868997|102222946|FG000|NOT COMPLETED|Overall Study||7||
48768355|NCT01868997|102222947|FG001|NOT COMPLETED|Overall Study||6||
48768356|NCT03481595|102222948|FG000|STARTED|Overall Study||146||
48768357|NCT03481595|102222949|FG001|STARTED|Overall Study||148||
48768358|NCT03481595|102222948|FG000|COMPLETED|Overall Study||143||
48768359|NCT03481595|102222949|FG001|COMPLETED|Overall Study||127||
48768360|NCT03481595|102222948|FG000|NOT COMPLETED|Overall Study||3||
48768361|NCT03481595|102222949|FG001|NOT COMPLETED|Overall Study||21||
48768362|NCT02981446|102222950|FG000|STARTED|Overall Study||185||
48768363|NCT02981446|102222951|FG001|STARTED|Overall Study||185||
48768364|NCT02981446|102222950|FG000|COMPLETED|Overall Study||170||
48768365|NCT02981446|102222951|FG001|COMPLETED|Overall Study||177||
48768366|NCT02981446|102222950|FG000|NOT COMPLETED|Overall Study||15||
48768367|NCT02981446|102222951|FG001|NOT COMPLETED|Overall Study||8||
48768368|NCT03058146|102222952|FG000|STARTED|Overall Study||21||
48768369|NCT03058146|102222953|FG001|STARTED|Overall Study||23||
48768370|NCT03058146|102222952|FG000|COMPLETED|Overall Study||17||
48768371|NCT03058146|102222953|FG001|COMPLETED|Overall Study||21||
48768372|NCT03058146|102222952|FG000|NOT COMPLETED|Overall Study||4||
48768373|NCT03058146|102222953|FG001|NOT COMPLETED|Overall Study||2||
48768374|NCT04476797|102222954|FG000|STARTED|Overall Study||7||
48768375|NCT04476797|102222955|FG001|STARTED|Overall Study||20||
48768376|NCT04476797|102222956|FG002|STARTED|Overall Study||20||
48768377|NCT04476797|102222954|FG000|COMPLETED|Overall Study||6||
48768378|NCT04476797|102222955|FG001|COMPLETED|Overall Study||1||
48768379|NCT04476797|102222956|FG002|COMPLETED|Overall Study||1||
48768380|NCT04476797|102222954|FG000|NOT COMPLETED|Overall Study||1||
48768381|NCT04476797|102222955|FG001|NOT COMPLETED|Overall Study||19||
48768382|NCT04476797|102222956|FG002|NOT COMPLETED|Overall Study||19||
48768383|NCT01286480|102222957|FG000|STARTED|Overall Study||32||
48768384|NCT01286480|102222958|FG001|STARTED|Overall Study||34||
48768385|NCT01286480|102222957|FG000|COMPLETED|Overall Study||27||
48768386|NCT01286480|102222958|FG001|COMPLETED|Overall Study||31||
48768387|NCT01286480|102222957|FG000|NOT COMPLETED|Overall Study||5||
48768388|NCT01286480|102222958|FG001|NOT COMPLETED|Overall Study||3||
48768389|NCT03801408|102222959|FG000|STARTED|Overall Study||145||
48768390|NCT03801408|102222959|FG000|COMPLETED|Overall Study||145||
48768391|NCT03801408|102222959|FG000|NOT COMPLETED|Overall Study||0||
48768392|NCT00918255|102222960|FG000|STARTED|Overall Study||51||
48768393|NCT00918255|102222961|FG001|STARTED|Overall Study||52||
48768394|NCT00918255|102222962|FG002|STARTED|Overall Study||51||
48768395|NCT00918255|102222960|FG000|COMPLETED|Overall Study||45||
48768396|NCT00918255|102222961|FG001|COMPLETED|Overall Study||52||
48768397|NCT00918255|102222962|FG002|COMPLETED|Overall Study||46||
48768398|NCT00918255|102222960|FG000|NOT COMPLETED|Overall Study||6||
48768399|NCT00918255|102222961|FG001|NOT COMPLETED|Overall Study||0||
48188767|NCT03905811|100786082|FG001|STARTED|Overall Study||5||
48188768|NCT03905811|100786081|FG000|COMPLETED|Overall Study||6||
48768400|NCT00918255|102222962|FG002|NOT COMPLETED|Overall Study||5||
48768401|NCT00716417|102222963|FG000|STARTED|Overall Study||3||
48768402|NCT00716417|102222964|FG001|STARTED|Overall Study||6||
48768403|NCT00716417|102222965|FG002|STARTED|Overall Study||5||
48768404|NCT00716417|102222966|FG003|STARTED|Overall Study||11||
48768405|NCT00716417|102222967|FG004|STARTED|Overall Study||1||
48768406|NCT00716417|102222968|FG005|STARTED|Overall Study||3||
48768407|NCT00716417|102222969|FG006|STARTED|Overall Study||7||
48768408|NCT00716417|102222970|FG007|STARTED|Overall Study||3||
48768409|NCT00716417|102222971|FG008|STARTED|Overall Study||5||
48768410|NCT00716417|102222972|FG009|STARTED|Overall Study||3||
48768411|NCT00716417|102222963|FG000|COMPLETED|Overall Study||0||
48768412|NCT00716417|102222964|FG001|COMPLETED|Overall Study||0||
48441120|NCT04798027|101413185|FG001|Vaccinated on Day 1|Overall Study||25||
48441121|NCT04798027|101413186|FG002|Vaccinated on Day 1|Overall Study||10||
48441122|NCT04798027|101413187|FG003|Vaccinated on Day 1|Overall Study||27||
48441123|NCT04798027|101413188|FG004|Vaccinated on Day 1|Overall Study||25||
48441124|NCT04798027|101413189|FG005|Vaccinated on Day 1|Overall Study||13||
48188769|NCT03905811|100786082|FG001|COMPLETED|Overall Study||5||
48441125|NCT04798027|101413190|FG006|Vaccinated on Day 1|Overall Study||28||
48441126|NCT04798027|101413191|FG007|Vaccinated on Day 1|Overall Study||28||
48441127|NCT04798027|101413192|FG008|Vaccinated on Day 1|Overall Study||14||
48657367|NCT03258593|101945985|FG003|NOT COMPLETED|Run-In Induction Phase||0||
48657368|NCT03258593|101945982|FG000|STARTED|Run-In Maintenance Phase||12||
48657369|NCT03258593|101945983|FG001|STARTED|Run-In Maintenance Phase||0||
48657370|NCT03258593|101945984|FG002|STARTED|Run-In Maintenance Phase||0||
48657371|NCT03258593|101945985|FG003|STARTED|Run-In Maintenance Phase||0||
48657372|NCT03258593|101945982|FG000|COMPLETED|Run-In Maintenance Phase||5||
48657373|NCT03258593|101945983|FG001|COMPLETED|Run-In Maintenance Phase||0||
48657374|NCT03258593|101945984|FG002|COMPLETED|Run-In Maintenance Phase||0||
48657375|NCT03258593|101945985|FG003|COMPLETED|Run-In Maintenance Phase||0||
48657376|NCT03258593|101945982|FG000|NOT COMPLETED|Run-In Maintenance Phase||7||
48657377|NCT03258593|101945983|FG001|NOT COMPLETED|Run-In Maintenance Phase||0||
48657378|NCT03258593|101945984|FG002|NOT COMPLETED|Run-In Maintenance Phase||0||
48657379|NCT03258593|101945985|FG003|NOT COMPLETED|Run-In Maintenance Phase||0||
48657380|NCT03258593|101945982|FG000|STARTED|Expansion Induction Phase||0||
48657381|NCT03258593|101945983|FG001|STARTED|Expansion Induction Phase||3||
48657382|NCT03258593|101945984|FG002|STARTED|Expansion Induction Phase||0||
48657383|NCT03258593|101945985|FG003|STARTED|Expansion Induction Phase||0||
48657384|NCT03258593|101945982|FG000|COMPLETED|Expansion Induction Phase||0||
48657385|NCT03258593|101945983|FG001|COMPLETED|Expansion Induction Phase||3||
48657386|NCT03258593|101945984|FG002|COMPLETED|Expansion Induction Phase||0||
48657387|NCT03258593|101945985|FG003|COMPLETED|Expansion Induction Phase||0||
48657388|NCT03258593|101945982|FG000|NOT COMPLETED|Expansion Induction Phase||0||
48657389|NCT03258593|101945983|FG001|NOT COMPLETED|Expansion Induction Phase||0||
48657390|NCT03258593|101945984|FG002|NOT COMPLETED|Expansion Induction Phase||0||
48657391|NCT03258593|101945985|FG003|NOT COMPLETED|Expansion Induction Phase||0||
48657392|NCT03258593|101945982|FG000|STARTED|Expansion Maintenance Phase||0||
48657393|NCT03258593|101945983|FG001|STARTED|Expansion Maintenance Phase||3||
48657394|NCT03258593|101945984|FG002|STARTED|Expansion Maintenance Phase||0||
48657395|NCT03258593|101945985|FG003|STARTED|Expansion Maintenance Phase||0||
48657396|NCT03258593|101945982|FG000|COMPLETED|Expansion Maintenance Phase||0||
48657397|NCT03258593|101945983|FG001|COMPLETED|Expansion Maintenance Phase||1||
48657398|NCT03258593|101945984|FG002|COMPLETED|Expansion Maintenance Phase||0||
48657399|NCT03258593|101945985|FG003|COMPLETED|Expansion Maintenance Phase||0||
48657400|NCT03258593|101945982|FG000|NOT COMPLETED|Expansion Maintenance Phase||0||
48657401|NCT03258593|101945983|FG001|NOT COMPLETED|Expansion Maintenance Phase||2||
48657402|NCT03258593|101945984|FG002|NOT COMPLETED|Expansion Maintenance Phase||0||
48657403|NCT03258593|101945985|FG003|NOT COMPLETED|Expansion Maintenance Phase||0||
48657404|NCT04392362|101945986|FG000|STARTED|Overall Study||23||
48657405|NCT04392362|101945987|FG001|STARTED|Overall Study||7||
48657406|NCT04392362|101945986|FG000|COMPLETED|Overall Study||23||
48657407|NCT04392362|101945987|FG001|COMPLETED|Overall Study||7||
48657408|NCT04392362|101945986|FG000|NOT COMPLETED|Overall Study||0||
48657409|NCT04392362|101945987|FG001|NOT COMPLETED|Overall Study||0||
48657410|NCT03606213|101945988|FG000|STARTED|Overall Study||15||
48657411|NCT03606213|101945989|FG001|STARTED|Overall Study||16||
48657412|NCT03606213|101945990|FG002|STARTED|Overall Study||14||
48657413|NCT03606213|101945991|FG003|STARTED|Overall Study||11||
48657414|NCT03606213|101945988|FG000|COMPLETED|Overall Study||15||
48768413|NCT00716417|102222965|FG002|COMPLETED|Overall Study||0||
48768414|NCT00716417|102222966|FG003|COMPLETED|Overall Study||0||
48768415|NCT00716417|102222967|FG004|COMPLETED|Overall Study||0||
48768416|NCT00716417|102222968|FG005|COMPLETED|Overall Study||0||
48768417|NCT00716417|102222969|FG006|COMPLETED|Overall Study||0||
48768418|NCT00716417|102222970|FG007|COMPLETED|Overall Study||0||
48188770|NCT03905811|100786081|FG000|NOT COMPLETED|Overall Study||2||
48768419|NCT00716417|102222971|FG008|COMPLETED|Overall Study||0||
48768420|NCT00716417|102222972|FG009|COMPLETED|Overall Study||0||
48768421|NCT00716417|102222963|FG000|NOT COMPLETED|Overall Study||3||
48188771|NCT03905811|100786082|FG001|NOT COMPLETED|Overall Study||0||
48441128|NCT04798027|101413184|FG000|Vaccinated on Day 22|Overall Study||10||
48441129|NCT04798027|101413185|FG001|Vaccinated on Day 22|Overall Study||24||
48441130|NCT04798027|101413186|FG002|Vaccinated on Day 22|Overall Study||10||
48441131|NCT04798027|101413187|FG003|Vaccinated on Day 22|Overall Study||0||
48441132|NCT04798027|101413188|FG004|Vaccinated on Day 22|Overall Study||0||
48441133|NCT04798027|101413189|FG005|Vaccinated on Day 22|Overall Study||0||
48657415|NCT03606213|101945989|FG001|COMPLETED|Overall Study||16||
48657416|NCT03606213|101945990|FG002|COMPLETED|Overall Study||14||
48657417|NCT03606213|101945991|FG003|COMPLETED|Overall Study||11||
48657418|NCT03606213|101945988|FG000|NOT COMPLETED|Overall Study||0||
48657419|NCT03606213|101945989|FG001|NOT COMPLETED|Overall Study||0||
48657420|NCT03606213|101945990|FG002|NOT COMPLETED|Overall Study||0||
48768422|NCT00716417|102222964|FG001|NOT COMPLETED|Overall Study||6||
48768423|NCT00716417|102222965|FG002|NOT COMPLETED|Overall Study||5||
48768424|NCT00716417|102222966|FG003|NOT COMPLETED|Overall Study||11||
48768425|NCT00716417|102222967|FG004|NOT COMPLETED|Overall Study||1||
48768426|NCT00716417|102222968|FG005|NOT COMPLETED|Overall Study||3||
48768427|NCT00716417|102222969|FG006|NOT COMPLETED|Overall Study||7||
48768428|NCT00716417|102222970|FG007|NOT COMPLETED|Overall Study||3||
48768429|NCT00716417|102222971|FG008|NOT COMPLETED|Overall Study||5||
48768430|NCT00716417|102222972|FG009|NOT COMPLETED|Overall Study||3||
48441134|NCT04798027|101413190|FG006|Vaccinated on Day 22|Overall Study||19||
48441135|NCT04798027|101413191|FG007|Vaccinated on Day 22|Overall Study||19||
48441136|NCT04798027|101413192|FG008|Vaccinated on Day 22|Overall Study||9||
48441137|NCT04798027|101413184|FG000|Safety Analysis Set (SafAS)|Overall Study||18|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
48441138|NCT04798027|101413185|FG001|Safety Analysis Set (SafAS)|Overall Study||17|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
48441139|NCT04798027|101413186|FG002|Safety Analysis Set (SafAS)|Overall Study||10|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
48441140|NCT04798027|101413187|FG003|Safety Analysis Set (SafAS)|Overall Study||36|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
48441141|NCT04798027|101413188|FG004|Safety Analysis Set (SafAS)|Overall Study||34|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
48441142|NCT04798027|101413189|FG005|Safety Analysis Set (SafAS)|Overall Study||18|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
48441143|NCT04798027|101413190|FG006|Safety Analysis Set (SafAS)|Overall Study||19|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
48441144|NCT04798027|101413191|FG007|Safety Analysis Set (SafAS)|Overall Study||19|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
48657421|NCT03606213|101945991|FG003|NOT COMPLETED|Overall Study||0||
48768431|NCT00384670|102222973|FG000|STARTED|Overall Study||7||
48768432|NCT00384670|102222973|FG000|COMPLETED|Overall Study||7||
48768433|NCT00384670|102222973|FG000|NOT COMPLETED|Overall Study||0||
48768434|NCT01601236|102222974|FG000|STARTED|Overall Study||7||
48657422|NCT02506153|101945992|FG000|STARTED|Overall Study||654||
48657423|NCT02506153|101945993|FG001|STARTED|Overall Study||647||
48657424|NCT02506153|101945992|FG000|COMPLETED|Overall Study||52||
48657425|NCT02506153|101945993|FG001|COMPLETED|Overall Study||366||
48657426|NCT02506153|101945992|FG000|NOT COMPLETED|Overall Study||602||
48657427|NCT02506153|101945993|FG001|NOT COMPLETED|Overall Study||281||
48657428|NCT02965456|101945994|FG000|STARTED|Overall Study||413||
48657429|NCT02965456|101945995|FG001|STARTED|Overall Study||407||
48657430|NCT02965456|101945994|FG000|Intent-to-treat (ITT) Population|Overall Study||413|All randomized participants who received study drug.|
48657431|NCT02965456|101945995|FG001|Intent-to-treat (ITT) Population|Overall Study||407|All randomized participants who received study drug.|
48657432|NCT02965456|101945994|FG000|Safety Population|Overall Study||389|All randomized participants with ≥1 confirmed dose of study drug and ≥1 post baseline evaluation.|
48657433|NCT02965456|101945995|FG001|Safety Population|Overall Study||398|All randomized participants with ≥1 confirmed dose of study drug and ≥1 post baseline evaluation.|
48657434|NCT02965456|101945994|FG000|COMPLETED|Overall Study||342||
48657435|NCT02965456|101945995|FG001|COMPLETED|Overall Study||364||
48657436|NCT02965456|101945994|FG000|NOT COMPLETED|Overall Study||71||
48657437|NCT02965456|101945995|FG001|NOT COMPLETED|Overall Study||43||
48657438|NCT02899754|101945996|FG000|STARTED|Overall Study||69||
48657439|NCT02899754|101945997|FG001|STARTED|Overall Study||71||
48657440|NCT02899754|101945996|FG000|COMPLETED|Overall Study||62||
48657441|NCT02899754|101945997|FG001|COMPLETED|Overall Study||62||
48657442|NCT02899754|101945996|FG000|NOT COMPLETED|Overall Study||7||
48657443|NCT02899754|101945997|FG001|NOT COMPLETED|Overall Study||9||
48657444|NCT03408808|101945998|FG000|STARTED|Overall Study||8||
48657445|NCT03408808|101945999|FG001|STARTED|Overall Study||9||
48657446|NCT03408808|101945998|FG000|COMPLETED|Overall Study||8||
48657447|NCT03408808|101945999|FG001|COMPLETED|Overall Study||8||
48657448|NCT03408808|101945998|FG000|NOT COMPLETED|Overall Study||0||
48657449|NCT03408808|101945999|FG001|NOT COMPLETED|Overall Study||1||
48657450|NCT00666978|101946000|FG000|STARTED|Overall Study||270||
48657451|NCT00666978|101946001|FG001|STARTED|Overall Study||270||
48657452|NCT00666978|101946000|FG000|COMPLETED|Overall Study||192||
48657453|NCT00666978|101946001|FG001|COMPLETED|Overall Study||187||
48657454|NCT00666978|101946000|FG000|NOT COMPLETED|Overall Study||78||
48657455|NCT00666978|101946001|FG001|NOT COMPLETED|Overall Study||83||
48657456|NCT04551053|101946002|FG000|STARTED|Overall Study||90||
48657457|NCT04551053|101946003|FG001|STARTED|Overall Study||87||
48657458|NCT04551053|101946002|FG000|COMPLETED|Overall Study||0||
48768435|NCT01601236|102222975|FG001|STARTED|Overall Study||3||
48768436|NCT01601236|102222976|FG002|STARTED|Overall Study||14||
48768437|NCT01601236|102222977|FG003|STARTED|Overall Study||6||
48768438|NCT01601236|102222978|FG004|STARTED|Overall Study||3||
48768439|NCT01601236|102222979|FG005|STARTED|Overall Study||1||
48768440|NCT01601236|102222974|FG000|COMPLETED|Overall Study||2||
48768441|NCT01601236|102222975|FG001|COMPLETED|Overall Study||2||
48768442|NCT01601236|102222976|FG002|COMPLETED|Overall Study||8||
48768443|NCT01601236|102222977|FG003|COMPLETED|Overall Study||4||
48768444|NCT01601236|102222978|FG004|COMPLETED|Overall Study||0||
48768445|NCT01601236|102222979|FG005|COMPLETED|Overall Study||0||
48768446|NCT01601236|102222974|FG000|NOT COMPLETED|Overall Study||5||
48768447|NCT01601236|102222975|FG001|NOT COMPLETED|Overall Study||1||
48768448|NCT01601236|102222976|FG002|NOT COMPLETED|Overall Study||6||
48768449|NCT01601236|102222977|FG003|NOT COMPLETED|Overall Study||2||
48188772|NCT02809911|100786083|FG000|STARTED|Overall Study||22||
48441145|NCT04798027|101413192|FG008|Safety Analysis Set (SafAS)|Overall Study||9|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
48768450|NCT01601236|102222978|FG004|NOT COMPLETED|Overall Study||3||
48768451|NCT01601236|102222979|FG005|NOT COMPLETED|Overall Study||1||
48768452|NCT03038100|102222980|FG000|STARTED|Overall Study||650||
48768453|NCT03038100|102222981|FG001|STARTED|Overall Study||651||
48768454|NCT03038100|102222980|FG000|COMPLETED|Overall Study||0||
48768455|NCT03038100|102222981|FG001|COMPLETED|Overall Study||0||
48768456|NCT03038100|102222980|FG000|NOT COMPLETED|Overall Study||650||
48768457|NCT03038100|102222981|FG001|NOT COMPLETED|Overall Study||651||
48768458|NCT04154904|102222982|FG000|STARTED|Study Start-up Visit||10||
48768459|NCT04154904|102222983|FG001|STARTED|Study Start-up Visit||10||
48768460|NCT04154904|102222984|FG002|STARTED|Study Start-up Visit||10||
48188773|NCT02809911|100786084|FG001|STARTED|Overall Study||19||
48188774|NCT02809911|100786083|FG000|COMPLETED|Overall Study||22||
48188775|NCT02809911|100786084|FG001|COMPLETED|Overall Study||19||
48188776|NCT02809911|100786083|FG000|NOT COMPLETED|Overall Study||0||
48188777|NCT02809911|100786084|FG001|NOT COMPLETED|Overall Study||0||
48441146|NCT04798027|101413184|FG000|COMPLETED|Overall Study||0||
48441147|NCT04798027|101413185|FG001|COMPLETED|Overall Study||0||
48441148|NCT04798027|101413186|FG002|COMPLETED|Overall Study||0||
48441149|NCT04798027|101413187|FG003|COMPLETED|Overall Study||0||
48441150|NCT04798027|101413188|FG004|COMPLETED|Overall Study||0||
48441151|NCT04798027|101413189|FG005|COMPLETED|Overall Study||0||
48441152|NCT04798027|101413190|FG006|COMPLETED|Overall Study||0||
48441153|NCT04798027|101413191|FG007|COMPLETED|Overall Study||0||
48441154|NCT04798027|101413192|FG008|COMPLETED|Overall Study||0||
48441155|NCT04798027|101413184|FG000|NOT COMPLETED|Overall Study||10||
48441156|NCT04798027|101413185|FG001|NOT COMPLETED|Overall Study||25||
48441157|NCT04798027|101413186|FG002|NOT COMPLETED|Overall Study||10||
48441158|NCT04798027|101413187|FG003|NOT COMPLETED|Overall Study||27||
48441159|NCT04798027|101413188|FG004|NOT COMPLETED|Overall Study||26||
48441160|NCT04798027|101413189|FG005|NOT COMPLETED|Overall Study||13||
48441161|NCT04798027|101413190|FG006|NOT COMPLETED|Overall Study||28||
48441162|NCT04798027|101413191|FG007|NOT COMPLETED|Overall Study||29||
48441163|NCT04798027|101413192|FG008|NOT COMPLETED|Overall Study||14||
48768461|NCT04154904|102222982|FG000|COMPLETED|Study Start-up Visit||10||
48768462|NCT04154904|102222983|FG001|COMPLETED|Study Start-up Visit||10||
48768463|NCT04154904|102222984|FG002|COMPLETED|Study Start-up Visit||10||
48768464|NCT04154904|102222982|FG000|NOT COMPLETED|Study Start-up Visit||0||
48768465|NCT04154904|102222983|FG001|NOT COMPLETED|Study Start-up Visit||0||
48768466|NCT04154904|102222984|FG002|NOT COMPLETED|Study Start-up Visit||0||
48768467|NCT04154904|102222982|FG000|STARTED|At Home Period (28 Days)||10||
48768468|NCT04154904|102222983|FG001|STARTED|At Home Period (28 Days)||10||
48768469|NCT04154904|102222984|FG002|STARTED|At Home Period (28 Days)||10||
48768470|NCT04154904|102222982|FG000|COMPLETED|At Home Period (28 Days)||10||
48768471|NCT04154904|102222983|FG001|COMPLETED|At Home Period (28 Days)||10||
48768472|NCT04154904|102222984|FG002|COMPLETED|At Home Period (28 Days)||9||
48768473|NCT04154904|102222982|FG000|NOT COMPLETED|At Home Period (28 Days)||0||
48768474|NCT04154904|102222983|FG001|NOT COMPLETED|At Home Period (28 Days)||0||
48768475|NCT04154904|102222984|FG002|NOT COMPLETED|At Home Period (28 Days)||1||
48768476|NCT04154904|102222982|FG000|STARTED|Study Close-out Visit||10||
48768477|NCT04154904|102222983|FG001|STARTED|Study Close-out Visit||10||
48768478|NCT04154904|102222984|FG002|STARTED|Study Close-out Visit||9||
48768479|NCT04154904|102222982|FG000|COMPLETED|Study Close-out Visit||10||
48768480|NCT04154904|102222983|FG001|COMPLETED|Study Close-out Visit||10||
48768481|NCT04154904|102222984|FG002|COMPLETED|Study Close-out Visit||9||
48768482|NCT04154904|102222982|FG000|NOT COMPLETED|Study Close-out Visit||0||
48768483|NCT04154904|102222983|FG001|NOT COMPLETED|Study Close-out Visit||0||
48768484|NCT04154904|102222984|FG002|NOT COMPLETED|Study Close-out Visit||0||
48768485|NCT02512783|102222985|FG000|STARTED|Overall Study||96||
48768486|NCT02512783|102222986|FG001|STARTED|Overall Study||75||
48768487|NCT02512783|102222985|FG000|COMPLETED|Overall Study||96||
48768488|NCT02512783|102222986|FG001|COMPLETED|Overall Study||75||
48768489|NCT02512783|102222985|FG000|NOT COMPLETED|Overall Study||0||
48441164|NCT03690206|101413193|FG000|STARTED|Overall Study||35||
48441165|NCT03690206|101413194|FG001|STARTED|Overall Study||35||
48441166|NCT03690206|101413195|FG002|STARTED|Overall Study||36||
48441167|NCT03690206|101413193|FG000|COMPLETED|Overall Study||31||
48441168|NCT03690206|101413194|FG001|COMPLETED|Overall Study||35||
48441169|NCT03690206|101413195|FG002|COMPLETED|Overall Study||36||
48441170|NCT03690206|101413193|FG000|NOT COMPLETED|Overall Study||4||
48441171|NCT03690206|101413194|FG001|NOT COMPLETED|Overall Study||0||
48441172|NCT03690206|101413195|FG002|NOT COMPLETED|Overall Study||0||
48441173|NCT01833897|101413196|FG000|STARTED|Overall Study||8||
48441174|NCT01833897|101413196|FG000|COMPLETED|Overall Study||7||
48441175|NCT01833897|101413196|FG000|NOT COMPLETED|Overall Study||1||
48441176|NCT00463385|101413197|FG000|STARTED|Overall Study||22||
48441177|NCT00463385|101413198|FG001|STARTED|Overall Study||22||
48441178|NCT00463385|101413199|FG002|STARTED|Overall Study||22||
48441179|NCT00463385|101413200|FG003|STARTED|Overall Study||22||
48441180|NCT00463385|101413197|FG000|Treated|Overall Study||22||
48441181|NCT00463385|101413198|FG001|Treated|Overall Study||22||
48441182|NCT00463385|101413199|FG002|Treated|Overall Study||19||
48368315|NCT02284399|101230153|FG001|NOT COMPLETED|Overall Study||0||
48368316|NCT00591227|101230154|FG000|STARTED|Overall Study||89||
48441183|NCT00463385|101413200|FG003|Treated|Overall Study||22||
48441184|NCT00463385|101413197|FG000|COMPLETED|Overall Study||0||
48441185|NCT00463385|101413198|FG001|COMPLETED|Overall Study||0||
48441186|NCT00463385|101413199|FG002|COMPLETED|Overall Study||0||
48441187|NCT00463385|101413200|FG003|COMPLETED|Overall Study||0||
48441188|NCT00463385|101413197|FG000|NOT COMPLETED|Overall Study||22||
48441189|NCT00463385|101413198|FG001|NOT COMPLETED|Overall Study||22||
48441190|NCT00463385|101413199|FG002|NOT COMPLETED|Overall Study||22||
48441191|NCT00463385|101413200|FG003|NOT COMPLETED|Overall Study||22||
48441192|NCT00491322|101413201|FG000|STARTED|Overall Study||41||
48441193|NCT00491322|101413202|FG001|STARTED|Overall Study||51||
48441194|NCT00491322|101413201|FG000|COMPLETED|Overall Study||40||
48441195|NCT00491322|101413202|FG001|COMPLETED|Overall Study||50||
48441196|NCT00491322|101413201|FG000|NOT COMPLETED|Overall Study||1||
48441197|NCT00491322|101413202|FG001|NOT COMPLETED|Overall Study||1||
48441198|NCT02392559|101413203|FG000|STARTED|Overall Study||53|Randomized|
48441199|NCT02392559|101413204|FG001|STARTED|Overall Study||105|Randomized|
48441200|NCT02392559|101413203|FG000|Randomized and Dosed|Overall Study||53||
48441201|NCT02392559|101413204|FG001|Randomized and Dosed|Overall Study||104||
48441202|NCT02392559|101413203|FG000|COMPLETED|Overall Study||53||
48441203|NCT02392559|101413204|FG001|COMPLETED|Overall Study||104||
48441204|NCT02392559|101413203|FG000|NOT COMPLETED|Overall Study||0||
48441205|NCT02392559|101413204|FG001|NOT COMPLETED|Overall Study||1||
48657459|NCT04551053|101946003|FG001|COMPLETED|Overall Study||0||
48768490|NCT02512783|102222986|FG001|NOT COMPLETED|Overall Study||0||
48768491|NCT03337477|102222987|FG000|STARTED|Overall Study||33|Randomized|
48768492|NCT03337477|102222988|FG001|STARTED|Overall Study||37|Randomized|
48368317|NCT00591227|101230155|FG001|STARTED|Overall Study||87||
48368318|NCT00591227|101230154|FG000|COMPLETED|Overall Study||89||
48368319|NCT00591227|101230155|FG001|COMPLETED|Overall Study||87||
48368320|NCT00591227|101230154|FG000|NOT COMPLETED|Overall Study||0||
48441206|NCT00390572|101413205|FG000|STARTED|Overall Study||68||
48441207|NCT00390572|101413206|FG001|STARTED|Overall Study||69||
48441208|NCT00390572|101413205|FG000|COMPLETED|Overall Study||60||
48441209|NCT00390572|101413206|FG001|COMPLETED|Overall Study||64||
48441210|NCT00390572|101413205|FG000|NOT COMPLETED|Overall Study||8||
48441211|NCT00390572|101413206|FG001|NOT COMPLETED|Overall Study||5||
48441212|NCT02384239|101413207|FG000|STARTED|Overall Study||36||
48441213|NCT02384239|101413208|FG001|STARTED|Overall Study||34||
48657460|NCT04551053|101946002|FG000|NOT COMPLETED|Overall Study||90||
48657461|NCT04551053|101946003|FG001|NOT COMPLETED|Overall Study||87||
48657462|NCT02633527|101946004|FG000|STARTED|Overall Study||24||
48368321|NCT00591227|101230155|FG001|NOT COMPLETED|Overall Study||0||
48368322|NCT00863928|101230156|FG000|STARTED|Overall Study||94||
48368323|NCT00863928|101230157|FG001|STARTED|Overall Study||41||
48368324|NCT00863928|101230156|FG000|COMPLETED|Overall Study||58||
48368325|NCT00863928|101230157|FG001|COMPLETED|Overall Study||41||
48368326|NCT00863928|101230156|FG000|NOT COMPLETED|Overall Study||36||
48368327|NCT00863928|101230157|FG001|NOT COMPLETED|Overall Study||0||
48368328|NCT00536731|101230158|FG000|STARTED|Overall Study||253||
48368329|NCT00536731|101230159|FG001|STARTED|Overall Study||246||
48441214|NCT02384239|101413207|FG000|COMPLETED|Overall Study||36||
48441215|NCT02384239|101413208|FG001|COMPLETED|Overall Study||34||
48441216|NCT02384239|101413207|FG000|NOT COMPLETED|Overall Study||0||
48441217|NCT02384239|101413208|FG001|NOT COMPLETED|Overall Study||0||
48441218|NCT01017731|101413209|FG000|STARTED|Overall Study||68||
48441219|NCT01017731|101413209|FG000|Received at Least 1 Dose of Study Drug|Overall Study||66||
48441220|NCT01017731|101413209|FG000|COMPLETED|Overall Study||60||
48441221|NCT01017731|101413209|FG000|NOT COMPLETED|Overall Study||8||
48441222|NCT03099655|101413210|FG000|STARTED|Overall Study||440||
48441223|NCT03099655|101413210|FG000|COMPLETED|Overall Study||379||
48441224|NCT03099655|101413210|FG000|NOT COMPLETED|Overall Study||61||
48441225|NCT02024386|101413211|FG000|STARTED|Overall Study||6||
48441226|NCT02024386|101413212|FG001|STARTED|Overall Study||11||
48441227|NCT02024386|101413213|FG002|STARTED|Overall Study||5||
48441228|NCT02024386|101413211|FG000|COMPLETED|Overall Study||6||
48441229|NCT02024386|101413212|FG001|COMPLETED|Overall Study||11||
48441230|NCT02024386|101413213|FG002|COMPLETED|Overall Study||5||
48441231|NCT02024386|101413211|FG000|NOT COMPLETED|Overall Study||0||
48441232|NCT02024386|101413212|FG001|NOT COMPLETED|Overall Study||0||
48441233|NCT02024386|101413213|FG002|NOT COMPLETED|Overall Study||0||
48441234|NCT01525407|101413214|FG000|STARTED|Overall Study||41||
48441235|NCT01525407|101413215|FG001|STARTED|Overall Study||42||
48441236|NCT01525407|101413214|FG000|COMPLETED|Overall Study||38||
48441237|NCT01525407|101413215|FG001|COMPLETED|Overall Study||38||
48441238|NCT01525407|101413214|FG000|NOT COMPLETED|Overall Study||3||
48441239|NCT01525407|101413215|FG001|NOT COMPLETED|Overall Study||4||
48441240|NCT02148835|101413216|FG000|STARTED|Overall Study||22||
48441241|NCT02148835|101413217|FG001|STARTED|Overall Study||22||
48441242|NCT02148835|101413216|FG000|COMPLETED|Overall Study||22||
48441243|NCT02148835|101413217|FG001|COMPLETED|Overall Study||22||
48441244|NCT02148835|101413216|FG000|NOT COMPLETED|Overall Study||0||
48441245|NCT02148835|101413217|FG001|NOT COMPLETED|Overall Study||0||
48441246|NCT01965431|101413218|FG000|STARTED|Overall Study||8||
48441247|NCT01965431|101413219|FG001|STARTED|Overall Study||8||
48441248|NCT01965431|101413220|FG002|STARTED|Overall Study||8||
48441249|NCT01965431|101413221|FG003|STARTED|Overall Study||8||
48768493|NCT03337477|102222987|FG000|COMPLETED|Overall Study||22||
48441250|NCT01965431|101413222|FG004|STARTED|Overall Study||8||
48441251|NCT01965431|101413223|FG005|STARTED|Overall Study||8||
48441252|NCT01965431|101413218|FG000|COMPLETED|Overall Study||2||
48441253|NCT01965431|101413219|FG001|COMPLETED|Overall Study||2||
48441254|NCT01965431|101413220|FG002|COMPLETED|Overall Study||2||
48441255|NCT01965431|101413221|FG003|COMPLETED|Overall Study||2||
48441256|NCT01965431|101413222|FG004|COMPLETED|Overall Study||2||
48441257|NCT01965431|101413223|FG005|COMPLETED|Overall Study||2||
48441258|NCT01965431|101413218|FG000|NOT COMPLETED|Overall Study||6||
48441259|NCT01965431|101413219|FG001|NOT COMPLETED|Overall Study||6||
48441260|NCT01965431|101413220|FG002|NOT COMPLETED|Overall Study||6||
48441261|NCT01965431|101413221|FG003|NOT COMPLETED|Overall Study||6||
48441262|NCT01965431|101413222|FG004|NOT COMPLETED|Overall Study||6||
48441263|NCT01965431|101413223|FG005|NOT COMPLETED|Overall Study||6||
48441264|NCT02662556|101413224|FG000|STARTED|Overall Study||140||
48441265|NCT02662556|101413224|FG000|COMPLETED|Overall Study||132||
48441266|NCT02662556|101413224|FG000|NOT COMPLETED|Overall Study||8||
48441267|NCT04764669|101413225|FG000|STARTED|Overall Study||10||
48441268|NCT04764669|101413226|FG001|STARTED|Overall Study||11||
48441269|NCT04764669|101413227|FG002|STARTED|Overall Study||10||
48441270|NCT04764669|101413228|FG003|STARTED|Overall Study||3||
48441271|NCT04764669|101413225|FG000|COMPLETED|Overall Study||7||
48441272|NCT04764669|101413226|FG001|COMPLETED|Overall Study||11||
48441273|NCT04764669|101413227|FG002|COMPLETED|Overall Study||8||
48441274|NCT04764669|101413228|FG003|COMPLETED|Overall Study||3||
48657463|NCT02633527|101946005|FG001|STARTED|Overall Study||48||
48441275|NCT04764669|101413225|FG000|NOT COMPLETED|Overall Study||3||
48441276|NCT04764669|101413226|FG001|NOT COMPLETED|Overall Study||0||
48441277|NCT04764669|101413227|FG002|NOT COMPLETED|Overall Study||2||
48441278|NCT04764669|101413228|FG003|NOT COMPLETED|Overall Study||0||
48441279|NCT01410565|101413229|FG000|STARTED|Open Label Phase Apaziquone||0||
48441280|NCT01410565|101413230|FG001|STARTED|Open Label Phase Apaziquone||0||
48441281|NCT01410565|101413231|FG002|STARTED|Open Label Phase Apaziquone||66||
48441282|NCT01410565|101413229|FG000|COMPLETED|Open Label Phase Apaziquone||0||
48441283|NCT01410565|101413230|FG001|COMPLETED|Open Label Phase Apaziquone||0||
48441284|NCT01410565|101413231|FG002|COMPLETED|Open Label Phase Apaziquone||58||
48441285|NCT01410565|101413229|FG000|NOT COMPLETED|Open Label Phase Apaziquone||0||
48441286|NCT01410565|101413230|FG001|NOT COMPLETED|Open Label Phase Apaziquone||0||
48441287|NCT01410565|101413231|FG002|NOT COMPLETED|Open Label Phase Apaziquone||8||
48441288|NCT01410565|101413229|FG000|STARTED|Double Blind Phase||13||
48441289|NCT01410565|101413230|FG001|STARTED|Double Blind Phase||15||
48657464|NCT02633527|101946006|FG002|STARTED|Overall Study||50||
48657465|NCT02633527|101946007|FG003|STARTED|Overall Study||49||
48657466|NCT02633527|101946008|FG004|STARTED|Overall Study||51||
48657467|NCT02633527|101946004|FG000|COMPLETED|Overall Study||21||
48441290|NCT01410565|101413231|FG002|STARTED|Double Blind Phase||0||
48441291|NCT01410565|101413229|FG000|COMPLETED|Double Blind Phase||0||
48441292|NCT01410565|101413230|FG001|COMPLETED|Double Blind Phase||0||
48441293|NCT01410565|101413231|FG002|COMPLETED|Double Blind Phase||0||
48441294|NCT01410565|101413229|FG000|NOT COMPLETED|Double Blind Phase||13||
48441295|NCT01410565|101413230|FG001|NOT COMPLETED|Double Blind Phase||15||
48441296|NCT01410565|101413231|FG002|NOT COMPLETED|Double Blind Phase||0||
48657468|NCT02633527|101946005|FG001|COMPLETED|Overall Study||37||
48657469|NCT02633527|101946006|FG002|COMPLETED|Overall Study||33||
48657470|NCT02633527|101946007|FG003|COMPLETED|Overall Study||35||
48657471|NCT02633527|101946008|FG004|COMPLETED|Overall Study||34||
48657472|NCT02633527|101946004|FG000|NOT COMPLETED|Overall Study||3||
48657473|NCT02633527|101946005|FG001|NOT COMPLETED|Overall Study||11||
48657474|NCT02633527|101946006|FG002|NOT COMPLETED|Overall Study||17||
48657475|NCT02633527|101946007|FG003|NOT COMPLETED|Overall Study||14||
48657476|NCT02633527|101946008|FG004|NOT COMPLETED|Overall Study||17||
48657477|NCT04136288|101946009|FG000|STARTED|Overall Study||6||
48657478|NCT04136288|101946009|FG000|COMPLETED|Overall Study||6||
48657479|NCT04136288|101946009|FG000|NOT COMPLETED|Overall Study||0||
48657480|NCT02504775|101946010|FG000|STARTED|Period 1||14||
48657481|NCT02504775|101946011|FG001|STARTED|Period 1||14||
48657482|NCT02504775|101946010|FG000|COMPLETED|Period 1||14||
48657483|NCT02504775|101946011|FG001|COMPLETED|Period 1||14||
48657484|NCT02504775|101946010|FG000|NOT COMPLETED|Period 1||0||
48657485|NCT02504775|101946011|FG001|NOT COMPLETED|Period 1||0||
48768494|NCT03337477|102222988|FG001|COMPLETED|Overall Study||24||
48768495|NCT03337477|102222987|FG000|NOT COMPLETED|Overall Study||11||
48768496|NCT03337477|102222988|FG001|NOT COMPLETED|Overall Study||13||
48768497|NCT02699749|102222989|FG000|STARTED|Overall Study||3||
48768498|NCT02699749|102222990|FG001|STARTED|Overall Study||3||
48768499|NCT02699749|102222991|FG002|STARTED|Overall Study||16||
48768500|NCT02699749|102222992|FG003|STARTED|Overall Study||3||
48768501|NCT02699749|102222993|FG004|STARTED|Overall Study||3||
48768502|NCT02699749|102222994|FG005|STARTED|Overall Study||9||
48768503|NCT02699749|102222995|FG006|STARTED|Overall Study||6||
48768504|NCT02699749|102222996|FG007|STARTED|Overall Study||6||
48768505|NCT02699749|102222997|FG008|STARTED|Overall Study||6||
48768506|NCT02699749|102222998|FG009|STARTED|Overall Study||6||
48768507|NCT02699749|102222999|FG010|STARTED|Overall Study||6||
48768508|NCT02699749|102223000|FG011|STARTED|Overall Study||4||
48768509|NCT02699749|102223001|FG012|STARTED|Overall Study||3||
48768510|NCT02699749|102223002|FG013|STARTED|Overall Study||6||
48768511|NCT02699749|102222989|FG000|COMPLETED|Overall Study||0||
48768512|NCT02699749|102222990|FG001|COMPLETED|Overall Study||0||
48188778|NCT05196737|100786085|FG000|STARTED|Non-intervention Week||11||
48188779|NCT05196737|100786085|FG000|Timepoint 1/Pre-DDN|Non-intervention Week||9||
48188780|NCT05196737|100786085|FG000|Timepoint 2/Post Immediate DDN)|Non-intervention Week||9||
48657486|NCT02504775|101946010|FG000|STARTED|Washout||14||
48657487|NCT02504775|101946011|FG001|STARTED|Washout||14||
48657488|NCT02504775|101946010|FG000|COMPLETED|Washout||14||
48657489|NCT02504775|101946011|FG001|COMPLETED|Washout||14||
48657490|NCT02504775|101946010|FG000|NOT COMPLETED|Washout||0||
48657491|NCT02504775|101946011|FG001|NOT COMPLETED|Washout||0||
48657492|NCT02504775|101946010|FG000|STARTED|Period 2||14||
48657493|NCT02504775|101946011|FG001|STARTED|Period 2||14||
48657494|NCT02504775|101946010|FG000|COMPLETED|Period 2||14||
48657495|NCT02504775|101946011|FG001|COMPLETED|Period 2||14||
48657496|NCT02504775|101946010|FG000|NOT COMPLETED|Period 2||0||
48657497|NCT02504775|101946011|FG001|NOT COMPLETED|Period 2||0||
48657498|NCT04260607|101946012|FG000|STARTED|Overall Study||1||
48657499|NCT04260607|101946013|FG001|STARTED|Overall Study||0||
48657500|NCT04260607|101946012|FG000|COMPLETED|Overall Study||1||
48657501|NCT04260607|101946013|FG001|COMPLETED|Overall Study||0||
48768513|NCT02699749|102222991|FG002|COMPLETED|Overall Study||0||
48768514|NCT02699749|102222992|FG003|COMPLETED|Overall Study||0||
48768515|NCT02699749|102222993|FG004|COMPLETED|Overall Study||0||
48768516|NCT02699749|102222994|FG005|COMPLETED|Overall Study||0||
48768517|NCT02699749|102222995|FG006|COMPLETED|Overall Study||0||
48768518|NCT02699749|102222996|FG007|COMPLETED|Overall Study||0||
48768519|NCT02699749|102222997|FG008|COMPLETED|Overall Study||0||
48768520|NCT02699749|102222998|FG009|COMPLETED|Overall Study||0||
48768521|NCT02699749|102222999|FG010|COMPLETED|Overall Study||0||
48768522|NCT02699749|102223000|FG011|COMPLETED|Overall Study||0||
48768523|NCT02699749|102223001|FG012|COMPLETED|Overall Study||0||
48657502|NCT04260607|101946012|FG000|NOT COMPLETED|Overall Study||0||
48657503|NCT04260607|101946013|FG001|NOT COMPLETED|Overall Study||0||
48657504|NCT03258554|101946014|FG000|STARTED|Lead-in Component||10||
48657505|NCT03258554|101946015|FG001|STARTED|Lead-in Component||0||
48657506|NCT03258554|101946016|FG002|STARTED|Lead-in Component||0||
48657507|NCT03258554|101946014|FG000|Started Treatment|Lead-in Component||10||
48657508|NCT03258554|101946015|FG001|Started Treatment|Lead-in Component||0||
48657509|NCT03258554|101946016|FG002|Started Treatment|Lead-in Component||0||
48657510|NCT03258554|101946014|FG000|COMPLETED|Lead-in Component||10||
48657511|NCT03258554|101946015|FG001|COMPLETED|Lead-in Component||0||
48657512|NCT03258554|101946016|FG002|COMPLETED|Lead-in Component||0||
48657513|NCT03258554|101946014|FG000|NOT COMPLETED|Lead-in Component||0||
48657514|NCT03258554|101946015|FG001|NOT COMPLETED|Lead-in Component||0||
48657515|NCT03258554|101946016|FG002|NOT COMPLETED|Lead-in Component||0||
48657516|NCT03258554|101946014|FG000|STARTED|Randomized Component||0||
48657517|NCT03258554|101946015|FG001|STARTED|Randomized Component||63||
48657518|NCT03258554|101946016|FG002|STARTED|Randomized Component||123||
48657519|NCT03258554|101946014|FG000|Started Treatment|Randomized Component||0||
48768524|NCT02699749|102223002|FG013|COMPLETED|Overall Study||0||
48768525|NCT02699749|102222989|FG000|NOT COMPLETED|Overall Study||3||
48768526|NCT02699749|102222990|FG001|NOT COMPLETED|Overall Study||3||
48768527|NCT02699749|102222991|FG002|NOT COMPLETED|Overall Study||16||
48768528|NCT02699749|102222992|FG003|NOT COMPLETED|Overall Study||3||
48768529|NCT02699749|102222993|FG004|NOT COMPLETED|Overall Study||3||
48768530|NCT02699749|102222994|FG005|NOT COMPLETED|Overall Study||9||
48768531|NCT02699749|102222995|FG006|NOT COMPLETED|Overall Study||6||
48768532|NCT02699749|102222996|FG007|NOT COMPLETED|Overall Study||6||
48768533|NCT02699749|102222997|FG008|NOT COMPLETED|Overall Study||6||
48768534|NCT02699749|102222998|FG009|NOT COMPLETED|Overall Study||6||
48768535|NCT02699749|102222999|FG010|NOT COMPLETED|Overall Study||6||
48188781|NCT05196737|100786085|FG000|Timepoint 3/Post 90 Minutes DDN|Non-intervention Week||9||
48657520|NCT03258554|101946015|FG001|Started Treatment|Randomized Component||61||
48657521|NCT03258554|101946016|FG002|Started Treatment|Randomized Component||119||
48657522|NCT03258554|101946014|FG000|COMPLETED|Randomized Component||0||
48657523|NCT03258554|101946015|FG001|COMPLETED|Randomized Component||63||
48657524|NCT03258554|101946016|FG002|COMPLETED|Randomized Component||123||
48657525|NCT03258554|101946014|FG000|NOT COMPLETED|Randomized Component||0||
48657526|NCT03258554|101946015|FG001|NOT COMPLETED|Randomized Component||0||
48657527|NCT03258554|101946016|FG002|NOT COMPLETED|Randomized Component||0||
48657528|NCT00658814|101946017|FG000|STARTED|Remission Induction Chemotherapy||83||
48657529|NCT00658814|101946018|FG001|STARTED|Remission Induction Chemotherapy||59||
48657530|NCT00658814|101946017|FG000|Eligible|Remission Induction Chemotherapy||82||
48657531|NCT00658814|101946018|FG001|Eligible|Remission Induction Chemotherapy||57||
48657532|NCT00658814|101946017|FG000|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||79||
48657533|NCT00658814|101946018|FG001|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||54||
48657534|NCT00658814|101946017|FG000|COMPLETED|Remission Induction Chemotherapy||75||
48657535|NCT00658814|101946018|FG001|COMPLETED|Remission Induction Chemotherapy||41||
48657536|NCT00658814|101946017|FG000|NOT COMPLETED|Remission Induction Chemotherapy||8||
48657537|NCT00658814|101946018|FG001|NOT COMPLETED|Remission Induction Chemotherapy||18||
48768536|NCT02699749|102223000|FG011|NOT COMPLETED|Overall Study||4||
48768537|NCT02699749|102223001|FG012|NOT COMPLETED|Overall Study||3||
48768538|NCT02699749|102223002|FG013|NOT COMPLETED|Overall Study||6||
48768539|NCT03131570|102223003|FG000|STARTED|Overall Study||12||
48768540|NCT03131570|102223004|FG001|STARTED|Overall Study||11||
48768541|NCT03131570|102223003|FG000|COMPLETED|Overall Study||11||
48768542|NCT03131570|102223004|FG001|COMPLETED|Overall Study||11||
48657538|NCT00658814|101946017|FG000|STARTED|Consolidation Therapy||24||
48657539|NCT00658814|101946018|FG001|STARTED|Consolidation Therapy||13||
48657540|NCT00658814|101946017|FG000|Eligible|Consolidation Therapy||22||
48657541|NCT00658814|101946018|FG001|Eligible|Consolidation Therapy||11||
48657542|NCT00658814|101946017|FG000|COMPLETED|Consolidation Therapy||22||
48657543|NCT00658814|101946018|FG001|COMPLETED|Consolidation Therapy||10||
48657544|NCT00658814|101946017|FG000|NOT COMPLETED|Consolidation Therapy||2||
48657545|NCT00658814|101946018|FG001|NOT COMPLETED|Consolidation Therapy||3||
48657546|NCT00658814|101946017|FG000|STARTED|Maintenance Therapy||20||
48657547|NCT00658814|101946018|FG001|STARTED|Maintenance Therapy||8||
48657548|NCT00658814|101946017|FG000|Eligible|Maintenance Therapy||19||
48657549|NCT00658814|101946018|FG001|Eligible|Maintenance Therapy||8||
48657550|NCT00658814|101946017|FG000|COMPLETED|Maintenance Therapy||17||
48657551|NCT00658814|101946018|FG001|COMPLETED|Maintenance Therapy||7||
48657552|NCT00658814|101946017|FG000|NOT COMPLETED|Maintenance Therapy||3||
48657553|NCT00658814|101946018|FG001|NOT COMPLETED|Maintenance Therapy||1||
48657554|NCT05497960|101946019|FG000|STARTED|Overall Study||28||
48657555|NCT05497960|101946019|FG000|COMPLETED|Overall Study||22||
48657556|NCT05497960|101946019|FG000|NOT COMPLETED|Overall Study||6||
48657557|NCT04491955|101946020|FG000|STARTED|Overall Study||12||
48657558|NCT04491955|101946021|FG001|STARTED|Overall Study||8||
48657559|NCT04491955|101946022|FG002|STARTED|Overall Study||6||
48657560|NCT04491955|101946023|FG003|STARTED|Overall Study||6||
48657561|NCT04491955|101946020|FG000|COMPLETED|Overall Study||12||
48657562|NCT04491955|101946021|FG001|COMPLETED|Overall Study||8||
48657563|NCT04491955|101946022|FG002|COMPLETED|Overall Study||6||
48657564|NCT04491955|101946023|FG003|COMPLETED|Overall Study||6||
48657565|NCT04491955|101946020|FG000|NOT COMPLETED|Overall Study||0||
48657566|NCT04491955|101946021|FG001|NOT COMPLETED|Overall Study||0||
48657567|NCT04491955|101946022|FG002|NOT COMPLETED|Overall Study||0||
48657568|NCT04491955|101946023|FG003|NOT COMPLETED|Overall Study||0||
48657569|NCT02317042|101946024|FG000|STARTED|Overall Study||11|Cross over design. 11/25 started with AutoEPAP and 14/25 started with FixedEPAP|
48657570|NCT02317042|101946025|FG001|STARTED|Overall Study||14|Cross over design. 11/25 started with AutoEPAP and 14/25 started with FixedEPAP|
48657571|NCT02317042|101946024|FG000|COMPLETED|Overall Study||11||
48657572|NCT02317042|101946025|FG001|COMPLETED|Overall Study||14||
48657573|NCT02317042|101946024|FG000|NOT COMPLETED|Overall Study||0||
48657574|NCT02317042|101946025|FG001|NOT COMPLETED|Overall Study||0||
48657575|NCT03581292|101946026|FG000|STARTED|Overall Study||24||
48657576|NCT03581292|101946027|FG001|STARTED|Overall Study||14||
48657577|NCT03581292|101946026|FG000|COMPLETED|Overall Study||11||
48657578|NCT03581292|101946027|FG001|COMPLETED|Overall Study||9||
48657579|NCT03581292|101946026|FG000|NOT COMPLETED|Overall Study||13||
48657580|NCT03581292|101946027|FG001|NOT COMPLETED|Overall Study||5||
48657581|NCT02661815|101946028|FG000|STARTED|Overall Study||6||
48768543|NCT03131570|102223003|FG000|NOT COMPLETED|Overall Study||1||
48768544|NCT03131570|102223004|FG001|NOT COMPLETED|Overall Study||0||
48768545|NCT03114683|102223005|FG000|STARTED|Overall Study||96||
48768546|NCT03114683|102223005|FG000|COMPLETED|Overall Study||52||
48768547|NCT03114683|102223005|FG000|NOT COMPLETED|Overall Study||44||
48441297|NCT03889197|101413232|FG000|STARTED|Overall Study||45||
48441298|NCT03889197|101413233|FG001|STARTED|Overall Study||45||
48441299|NCT03889197|101413232|FG000|COMPLETED|Overall Study||43||
48441300|NCT03889197|101413233|FG001|COMPLETED|Overall Study||43||
48441301|NCT03889197|101413232|FG000|NOT COMPLETED|Overall Study||2||
48441302|NCT03889197|101413233|FG001|NOT COMPLETED|Overall Study||2||
48441303|NCT00124579|101413234|FG000|STARTED|Induction||7||
48441304|NCT00124579|101413234|FG000|COMPLETED|Induction||2||
48441305|NCT00124579|101413234|FG000|NOT COMPLETED|Induction||5||
48441306|NCT00124579|101413234|FG000|STARTED|Maintenance||2||
48441307|NCT00124579|101413234|FG000|COMPLETED|Maintenance||0||
48441308|NCT00124579|101413234|FG000|NOT COMPLETED|Maintenance||2||
48441309|NCT00552812|101413235|FG000|STARTED|Overall Study||105||
48441310|NCT00552812|101413235|FG000|COMPLETED|Overall Study||85||
48441311|NCT00552812|101413235|FG000|NOT COMPLETED|Overall Study||20||
48441312|NCT05458895|101413236|FG000|STARTED|Overall Study||88||
48441313|NCT05458895|101413236|FG000|Usual Brand e-Cigarette|Overall Study||87||
48441314|NCT05458895|101413236|FG000|Low Concentration Free-base Nicotine (1%), Menthol Flavor|Overall Study||65||
48441315|NCT05458895|101413236|FG000|Low Concentration Free-base Nicotine (1%), Tobacco Flavor|Overall Study||64||
48441316|NCT05458895|101413236|FG000|Low Concentration Nicotine Salt (1%), Menthol Flavor|Overall Study||61||
48441317|NCT05458895|101413236|FG000|Low Concentration Nicotine Salt (1%), Tobacco Flavor|Overall Study||64||
48441318|NCT05458895|101413236|FG000|High Concentration Free-base Nicotine (1%), Menthol Flavor|Overall Study||64||
48441319|NCT05458895|101413236|FG000|High Concentration Free-base Nicotine (1%), Tobacco Flavor|Overall Study||63||
48441320|NCT05458895|101413236|FG000|High Concentration Nicotine Salt (1%), Menthol Flavor|Overall Study||60||
48441321|NCT05458895|101413236|FG000|High Concentration Nicotine Salt (1%), Tobacco Flavor|Overall Study||65||
48441322|NCT05458895|101413236|FG000|COMPLETED|Overall Study||60||
48441323|NCT05458895|101413236|FG000|NOT COMPLETED|Overall Study||28||
48441324|NCT03724422|101413237|FG000|STARTED|Overall Study||1||
48768548|NCT02364570|102223006|FG000|STARTED|Overall Study||1||
48768549|NCT02364570|102223007|FG001|STARTED|Overall Study||1||
48768550|NCT02364570|102223008|FG002|STARTED|Overall Study||2||
48768551|NCT02364570|102223009|FG003|STARTED|Overall Study||1||
48768552|NCT02364570|102223010|FG004|STARTED|Overall Study||1||
48768553|NCT02364570|102223011|FG005|STARTED|Overall Study||1||
48768554|NCT02364570|102223012|FG006|STARTED|Overall Study||2||
48768555|NCT02364570|102223013|FG007|STARTED|Overall Study||1||
48768556|NCT02364570|102223014|FG008|STARTED|Overall Study||2||
48768557|NCT02364570|102223015|FG009|STARTED|Overall Study||1||
48768558|NCT02364570|102223016|FG010|STARTED|Overall Study||1||
48768559|NCT02364570|102223017|FG011|STARTED|Overall Study||1||
48768560|NCT02364570|102223018|FG012|STARTED|Overall Study||1||
48768561|NCT02364570|102223019|FG013|STARTED|Overall Study||2||
48768562|NCT02364570|102223020|FG014|STARTED|Overall Study||1||
48768563|NCT02364570|102223021|FG015|STARTED|Overall Study||1||
48768564|NCT02364570|102223006|FG000|COMPLETED|Overall Study||1||
48768565|NCT02364570|102223007|FG001|COMPLETED|Overall Study||1||
48768566|NCT02364570|102223008|FG002|COMPLETED|Overall Study||2||
48768567|NCT02364570|102223009|FG003|COMPLETED|Overall Study||1||
48768568|NCT02364570|102223010|FG004|COMPLETED|Overall Study||1||
48768569|NCT02364570|102223011|FG005|COMPLETED|Overall Study||1||
48768570|NCT02364570|102223012|FG006|COMPLETED|Overall Study||2||
48188782|NCT05196737|100786085|FG000|Timepoint 4/Post 24 Hours DDN|Non-intervention Week||9||
48188783|NCT05196737|100786085|FG000|Timepoint 5/Post 72 Hours DDN|Non-intervention Week||9||
48188784|NCT05196737|100786085|FG000|COMPLETED|Non-intervention Week||9||
48188785|NCT05196737|100786085|FG000|NOT COMPLETED|Non-intervention Week||2||
48188786|NCT05196737|100786085|FG000|STARTED|Dry Needling Reflex Measurment Week||9||
48188787|NCT05196737|100786085|FG000|Timepoint 1/Pre-DDN|Dry Needling Reflex Measurment Week||9||
48188788|NCT05196737|100786085|FG000|Timepoint 2/Post Immediate DDN)|Dry Needling Reflex Measurment Week||9||
48188789|NCT05196737|100786085|FG000|Timepoint 3/Post 90 Minutes DDN|Dry Needling Reflex Measurment Week||9||
48188790|NCT05196737|100786085|FG000|Timepoint 4/Post 24 Hours DDN|Dry Needling Reflex Measurment Week||9||
48441325|NCT03724422|101413238|FG001|STARTED|Overall Study||2||
48441326|NCT03724422|101413237|FG000|COMPLETED|Overall Study||1||
48441327|NCT03724422|101413238|FG001|COMPLETED|Overall Study||0||
48441328|NCT03724422|101413237|FG000|NOT COMPLETED|Overall Study||0||
48441329|NCT03724422|101413238|FG001|NOT COMPLETED|Overall Study||2||
48441330|NCT00511329|101413239|FG000|STARTED|Overall Study||0||
48441331|NCT00511329|101413239|FG000|COMPLETED|Overall Study||0||
48441332|NCT00511329|101413239|FG000|NOT COMPLETED|Overall Study||0||
48441333|NCT03387267|101413240|FG000|STARTED|Overall Study||452||
48441334|NCT03387267|101413240|FG000|COMPLETED|Overall Study||438||
48441335|NCT03387267|101413240|FG000|NOT COMPLETED|Overall Study||14||
48441336|NCT01806259|101413241|FG000|STARTED|Overall Study||96||
48441337|NCT01806259|101413242|FG001|STARTED|Overall Study||107||
48441338|NCT01806259|101413241|FG000|COMPLETED|Overall Study||96||
48768571|NCT02364570|102223013|FG007|COMPLETED|Overall Study||1||
48768572|NCT02364570|102223014|FG008|COMPLETED|Overall Study||2||
48768573|NCT02364570|102223015|FG009|COMPLETED|Overall Study||1||
48768574|NCT02364570|102223016|FG010|COMPLETED|Overall Study||1||
48768575|NCT02364570|102223017|FG011|COMPLETED|Overall Study||1||
48768576|NCT02364570|102223018|FG012|COMPLETED|Overall Study||1||
48768577|NCT02364570|102223019|FG013|COMPLETED|Overall Study||2||
48768578|NCT02364570|102223020|FG014|COMPLETED|Overall Study||1||
48768579|NCT02364570|102223021|FG015|COMPLETED|Overall Study||1||
48768580|NCT02364570|102223006|FG000|NOT COMPLETED|Overall Study||0||
48768581|NCT02364570|102223007|FG001|NOT COMPLETED|Overall Study||0||
48768582|NCT02364570|102223008|FG002|NOT COMPLETED|Overall Study||0||
48768583|NCT02364570|102223009|FG003|NOT COMPLETED|Overall Study||0||
48441339|NCT01806259|101413242|FG001|COMPLETED|Overall Study||107||
48441340|NCT01806259|101413241|FG000|NOT COMPLETED|Overall Study||0||
48441341|NCT01806259|101413242|FG001|NOT COMPLETED|Overall Study||0||
48768584|NCT02364570|102223010|FG004|NOT COMPLETED|Overall Study||0||
48768585|NCT02364570|102223011|FG005|NOT COMPLETED|Overall Study||0||
48768586|NCT02364570|102223012|FG006|NOT COMPLETED|Overall Study||0||
48768587|NCT02364570|102223013|FG007|NOT COMPLETED|Overall Study||0||
48768588|NCT02364570|102223014|FG008|NOT COMPLETED|Overall Study||0||
48768589|NCT02364570|102223015|FG009|NOT COMPLETED|Overall Study||0||
48768590|NCT02364570|102223016|FG010|NOT COMPLETED|Overall Study||0||
48768591|NCT02364570|102223017|FG011|NOT COMPLETED|Overall Study||0||
48768592|NCT02364570|102223018|FG012|NOT COMPLETED|Overall Study||0||
48768593|NCT02364570|102223019|FG013|NOT COMPLETED|Overall Study||0||
48768594|NCT02364570|102223020|FG014|NOT COMPLETED|Overall Study||0||
48768595|NCT02364570|102223021|FG015|NOT COMPLETED|Overall Study||0||
48768596|NCT02083354|102223022|FG000|STARTED|Overall Study||77||
48768597|NCT02083354|102223022|FG000|COMPLETED|Overall Study||13|These subjects show as ongoing in the clinical database even though no subjects are currently ongoing, as no changes to the data were permitted after 30-Jun-2019 due to local regulations in China.|
48768598|NCT02083354|102223022|FG000|NOT COMPLETED|Overall Study||64||
48768599|NCT03408392|102223023|FG000|STARTED|Treatment Period 1 (16 Days)||14||
48768600|NCT03408392|102223024|FG001|STARTED|Treatment Period 1 (16 Days)||14||
48768601|NCT03408392|102223023|FG000|COMPLETED|Treatment Period 1 (16 Days)||14||
48768602|NCT03408392|102223024|FG001|COMPLETED|Treatment Period 1 (16 Days)||14||
48768603|NCT03408392|102223023|FG000|NOT COMPLETED|Treatment Period 1 (16 Days)||0||
48657582|NCT02661815|101946029|FG001|STARTED|Overall Study||0||
48657583|NCT02661815|101946030|FG002|STARTED|Overall Study||0||
48657584|NCT02661815|101946031|FG003|STARTED|Overall Study||0||
48657585|NCT02661815|101946028|FG000|COMPLETED|Overall Study||5||
48657586|NCT02661815|101946029|FG001|COMPLETED|Overall Study||0||
48657587|NCT02661815|101946030|FG002|COMPLETED|Overall Study||0||
48657588|NCT02661815|101946031|FG003|COMPLETED|Overall Study||0||
48768604|NCT03408392|102223024|FG001|NOT COMPLETED|Treatment Period 1 (16 Days)||0||
48768605|NCT03408392|102223023|FG000|STARTED|Wash-out Period (14 Days)||14||
48768606|NCT03408392|102223024|FG001|STARTED|Wash-out Period (14 Days)||14||
48768607|NCT03408392|102223023|FG000|COMPLETED|Wash-out Period (14 Days)||14||
48768608|NCT03408392|102223024|FG001|COMPLETED|Wash-out Period (14 Days)||14||
48768609|NCT03408392|102223023|FG000|NOT COMPLETED|Wash-out Period (14 Days)||0||
48768610|NCT03408392|102223024|FG001|NOT COMPLETED|Wash-out Period (14 Days)||0||
48768611|NCT03408392|102223023|FG000|STARTED|Treatment Period 2 (16 Days)||14||
48768612|NCT03408392|102223024|FG001|STARTED|Treatment Period 2 (16 Days)||14||
48768613|NCT03408392|102223023|FG000|COMPLETED|Treatment Period 2 (16 Days)||14||
48441342|NCT02780115|101413243|FG000|STARTED|Overall Study||28||
48441343|NCT02780115|101413244|FG001|STARTED|Overall Study||30||
48441344|NCT02780115|101413245|FG002|STARTED|Overall Study||30||
48441345|NCT02780115|101413246|FG003|STARTED|Overall Study||32||
48441346|NCT02780115|101413247|FG004|STARTED|Overall Study||31||
48657589|NCT02661815|101946028|FG000|NOT COMPLETED|Overall Study||1||
48657590|NCT02661815|101946029|FG001|NOT COMPLETED|Overall Study||0||
48657591|NCT02661815|101946030|FG002|NOT COMPLETED|Overall Study||0||
48657592|NCT02661815|101946031|FG003|NOT COMPLETED|Overall Study||0||
48657593|NCT01539525|101946032|FG000|STARTED|Overall Study||145||
48657594|NCT01539525|101946033|FG001|STARTED|Overall Study||143||
48657595|NCT01539525|101946034|FG002|STARTED|Overall Study||151||
48657596|NCT01539525|101946032|FG000|COMPLETED|Overall Study||125||
48657597|NCT01539525|101946033|FG001|COMPLETED|Overall Study||127||
48657598|NCT01539525|101946034|FG002|COMPLETED|Overall Study||134||
48657599|NCT01539525|101946032|FG000|NOT COMPLETED|Overall Study||20||
48657600|NCT01539525|101946033|FG001|NOT COMPLETED|Overall Study||16||
48657601|NCT01539525|101946034|FG002|NOT COMPLETED|Overall Study||17||
48657602|NCT03319654|101946035|FG000|STARTED|Overall Study||114||
48657603|NCT03319654|101946035|FG000|COMPLETED|Overall Study||114||
48657604|NCT03319654|101946035|FG000|NOT COMPLETED|Overall Study||0||
48657605|NCT02844075|101946036|FG000|STARTED|Overall Study||28||
48657606|NCT02844075|101946036|FG000|COMPLETED|Overall Study||28||
48657607|NCT02844075|101946036|FG000|NOT COMPLETED|Overall Study||0||
48657608|NCT04629157|101946037|FG000|STARTED|Overall Study||322||
48657609|NCT04629157|101946037|FG000|COMPLETED|Overall Study||322||
48657610|NCT04629157|101946037|FG000|NOT COMPLETED|Overall Study||0||
48657611|NCT00769379|101946038|FG000|STARTED|Overall Study||1008||
48768614|NCT03408392|102223024|FG001|COMPLETED|Treatment Period 2 (16 Days)||14||
48768615|NCT03408392|102223023|FG000|NOT COMPLETED|Treatment Period 2 (16 Days)||0||
48768616|NCT03408392|102223024|FG001|NOT COMPLETED|Treatment Period 2 (16 Days)||0||
48768617|NCT00767364|102223025|FG000|STARTED|Overall Study||5||
48441347|NCT02780115|101413243|FG000|COMPLETED|Overall Study||28||
48441348|NCT02780115|101413244|FG001|COMPLETED|Overall Study||29||
48441349|NCT02780115|101413245|FG002|COMPLETED|Overall Study||29||
48441350|NCT02780115|101413246|FG003|COMPLETED|Overall Study||31||
48441351|NCT02780115|101413247|FG004|COMPLETED|Overall Study||30||
48441352|NCT02780115|101413243|FG000|NOT COMPLETED|Overall Study||0||
48441353|NCT02780115|101413244|FG001|NOT COMPLETED|Overall Study||1||
48441354|NCT02780115|101413245|FG002|NOT COMPLETED|Overall Study||1||
48441355|NCT02780115|101413246|FG003|NOT COMPLETED|Overall Study||1||
48441356|NCT02780115|101413247|FG004|NOT COMPLETED|Overall Study||1||
48441357|NCT03359473|101413248|FG000|STARTED|Overall Study||23||
48441358|NCT03359473|101413249|FG001|STARTED|Overall Study||24||
48441359|NCT03359473|101413250|FG002|STARTED|Overall Study||24||
48441360|NCT03359473|101413251|FG003|STARTED|Overall Study||25||
48441361|NCT03359473|101413248|FG000|COMPLETED|Overall Study||21||
48441362|NCT03359473|101413249|FG001|COMPLETED|Overall Study||18||
48441363|NCT03359473|101413250|FG002|COMPLETED|Overall Study||18||
48441364|NCT03359473|101413251|FG003|COMPLETED|Overall Study||20||
48657612|NCT00769379|101946039|FG001|STARTED|Overall Study||1006||
48657613|NCT00769379|101946038|FG000|COMPLETED|Overall Study||1005||
48657614|NCT00769379|101946039|FG001|COMPLETED|Overall Study||993||
48657615|NCT00769379|101946038|FG000|NOT COMPLETED|Overall Study||3||
48657616|NCT00769379|101946039|FG001|NOT COMPLETED|Overall Study||13||
48657617|NCT04309500|101946040|FG000|STARTED|Overall Study||5||
48657618|NCT04309500|101946041|FG001|STARTED|Overall Study||5||
48657619|NCT04309500|101946042|FG002|STARTED|Overall Study||5||
48657620|NCT04309500|101946043|FG003|STARTED|Overall Study||5||
48657621|NCT04309500|101946040|FG000|Immediate|Overall Study||5||
48657622|NCT04309500|101946041|FG001|Immediate|Overall Study||5||
48657623|NCT04309500|101946042|FG002|Immediate|Overall Study||5||
48657624|NCT04309500|101946043|FG003|Immediate|Overall Study||5||
48657625|NCT04309500|101946040|FG000|1 Week Later|Overall Study||5||
48657626|NCT04309500|101946041|FG001|1 Week Later|Overall Study||5||
48768618|NCT00767364|102223026|FG001|STARTED|Overall Study||3||
48768619|NCT00767364|102223025|FG000|COMPLETED|Overall Study||5||
48768620|NCT00767364|102223026|FG001|COMPLETED|Overall Study||3||
48768621|NCT00767364|102223025|FG000|NOT COMPLETED|Overall Study||0||
48768622|NCT00767364|102223026|FG001|NOT COMPLETED|Overall Study||0||
48768623|NCT01702311|102223027|FG000|STARTED|Overall Study||122||
48768624|NCT01702311|102223028|FG001|STARTED|Overall Study||113||
48768625|NCT01702311|102223027|FG000|COMPLETED|Overall Study||106||
48768626|NCT01702311|102223028|FG001|COMPLETED|Overall Study||100||
48768627|NCT01702311|102223027|FG000|NOT COMPLETED|Overall Study||16||
48768628|NCT01702311|102223028|FG001|NOT COMPLETED|Overall Study||13||
48768629|NCT02131259|102223029|FG000|STARTED|Overall Study||1602||
48768630|NCT02131259|102223029|FG000|COMPLETED|Overall Study||377||
48368330|NCT00536731|101230160|FG002|STARTED|Overall Study||243||
48441365|NCT03359473|101413248|FG000|NOT COMPLETED|Overall Study||2||
48441366|NCT03359473|101413249|FG001|NOT COMPLETED|Overall Study||6||
48441367|NCT03359473|101413250|FG002|NOT COMPLETED|Overall Study||6||
48441368|NCT03359473|101413251|FG003|NOT COMPLETED|Overall Study||5||
48441369|NCT01311505|101413252|FG000|STARTED|First Intervention Period||10||
48441370|NCT01311505|101413253|FG001|STARTED|First Intervention Period||11||
48657627|NCT04309500|101946042|FG002|1 Week Later|Overall Study||5||
48657628|NCT04309500|101946043|FG003|1 Week Later|Overall Study||5||
48657629|NCT04309500|101946040|FG000|6 Weeks Later|Overall Study||4||
48657630|NCT04309500|101946041|FG001|6 Weeks Later|Overall Study||5||
48657631|NCT04309500|101946042|FG002|6 Weeks Later|Overall Study||4||
48657632|NCT04309500|101946043|FG003|6 Weeks Later|Overall Study||5||
48657633|NCT04309500|101946040|FG000|COMPLETED|Overall Study||4||
48657634|NCT04309500|101946041|FG001|COMPLETED|Overall Study||5||
48657635|NCT04309500|101946042|FG002|COMPLETED|Overall Study||5||
48657636|NCT04309500|101946043|FG003|COMPLETED|Overall Study||5||
48441371|NCT01311505|101413252|FG000|COMPLETED|First Intervention Period||10||
48441372|NCT01311505|101413253|FG001|COMPLETED|First Intervention Period||10||
48441373|NCT01311505|101413252|FG000|NOT COMPLETED|First Intervention Period||0||
48441374|NCT01311505|101413253|FG001|NOT COMPLETED|First Intervention Period||1||
48441375|NCT01311505|101413252|FG000|STARTED|Washout Period (at Least 7 Days)||10||
48441376|NCT01311505|101413253|FG001|STARTED|Washout Period (at Least 7 Days)||10||
48441377|NCT01311505|101413252|FG000|COMPLETED|Washout Period (at Least 7 Days)||10||
48441378|NCT01311505|101413253|FG001|COMPLETED|Washout Period (at Least 7 Days)||10||
48441379|NCT01311505|101413252|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48441380|NCT01311505|101413253|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48441381|NCT01311505|101413252|FG000|STARTED|Second Intervention Period||10||
48441382|NCT01311505|101413253|FG001|STARTED|Second Intervention Period||10||
48441383|NCT01311505|101413252|FG000|COMPLETED|Second Intervention Period||10||
48657637|NCT04309500|101946040|FG000|NOT COMPLETED|Overall Study||1||
48768631|NCT02131259|102223029|FG000|NOT COMPLETED|Overall Study||1225||
48768632|NCT00732030|102223030|FG000|STARTED|Overall Study||26||
48768633|NCT00732030|102223030|FG000|COMPLETED|Overall Study||24||
48768634|NCT00732030|102223030|FG000|NOT COMPLETED|Overall Study||2||
48768635|NCT02878343|102223031|FG000|STARTED|Overall Study||86||
48768636|NCT02878343|102223032|FG001|STARTED|Overall Study||86||
48441384|NCT01311505|101413253|FG001|COMPLETED|Second Intervention Period||10||
48441385|NCT01311505|101413252|FG000|NOT COMPLETED|Second Intervention Period||0||
48441386|NCT01311505|101413253|FG001|NOT COMPLETED|Second Intervention Period||0||
48441387|NCT01876082|101413254|FG000|STARTED|Overall Study||48||
48441388|NCT01876082|101413255|FG001|STARTED|Overall Study||24||
48441389|NCT01876082|101413254|FG000|Safety Population|Overall Study||48|subjects having received at least one administration of treatment allocated by randomization.|
48441390|NCT01876082|101413255|FG001|Safety Population|Overall Study||22|subjects having received at least one administration of treatment allocated by randomization.|
48441391|NCT01876082|101413254|FG000|COMPLETED|Overall Study||46|Subjects contributing data to the primary endpoint analysis (6-month non-progression) are considered to have completed the study.|
48441392|NCT01876082|101413255|FG001|COMPLETED|Overall Study||20|Subjects contributing data to the primary endpoint analysis (6-month non-progression) are considered to have completed the study.|
48441393|NCT01876082|101413254|FG000|NOT COMPLETED|Overall Study||2||
48441394|NCT01876082|101413255|FG001|NOT COMPLETED|Overall Study||4||
48441395|NCT02216214|101413256|FG000|STARTED|Overall Study||443||
48441396|NCT02216214|101413257|FG001|STARTED|Overall Study||445||
48441397|NCT02216214|101413256|FG000|Treated|Overall Study||442||
48441398|NCT02216214|101413257|FG001|Treated|Overall Study||445||
48441399|NCT02216214|101413256|FG000|COMPLETED|Overall Study||400||
48441400|NCT02216214|101413257|FG001|COMPLETED|Overall Study||409||
48441401|NCT02216214|101413256|FG000|NOT COMPLETED|Overall Study||43||
48441402|NCT02216214|101413257|FG001|NOT COMPLETED|Overall Study||36||
48441403|NCT02406937|101413258|FG000|STARTED|Overall Study||60||
48441404|NCT02406937|101413259|FG001|STARTED|Overall Study||60||
48441405|NCT02406937|101413260|FG002|STARTED|Overall Study||60||
48441406|NCT02406937|101413258|FG000|COMPLETED|Overall Study||59||
48441407|NCT02406937|101413259|FG001|COMPLETED|Overall Study||59||
48441408|NCT02406937|101413260|FG002|COMPLETED|Overall Study||58||
48441409|NCT02406937|101413258|FG000|NOT COMPLETED|Overall Study||1||
48441410|NCT02406937|101413259|FG001|NOT COMPLETED|Overall Study||1||
48441411|NCT02406937|101413260|FG002|NOT COMPLETED|Overall Study||2||
48441412|NCT02251431|101413261|FG000|STARTED|Overall Study||29||
48441413|NCT02251431|101413262|FG001|STARTED|Overall Study||28||
48441414|NCT02251431|101413261|FG000|COMPLETED|Overall Study||29||
48441415|NCT02251431|101413262|FG001|COMPLETED|Overall Study||28||
48441416|NCT02251431|101413261|FG000|NOT COMPLETED|Overall Study||0||
48768637|NCT02878343|102223033|FG002|STARTED|Overall Study||86||
48768638|NCT02878343|102223034|FG003|STARTED|Overall Study||86||
48768639|NCT02878343|102223031|FG000|COMPLETED|Overall Study||65||
48768640|NCT02878343|102223032|FG001|COMPLETED|Overall Study||66||
48768641|NCT02878343|102223033|FG002|COMPLETED|Overall Study||65||
48768642|NCT02878343|102223034|FG003|COMPLETED|Overall Study||66||
48768643|NCT02878343|102223031|FG000|NOT COMPLETED|Overall Study||21||
48768644|NCT02878343|102223032|FG001|NOT COMPLETED|Overall Study||20||
48768645|NCT02878343|102223033|FG002|NOT COMPLETED|Overall Study||21||
48768646|NCT02878343|102223034|FG003|NOT COMPLETED|Overall Study||20||
48768647|NCT03125395|102223035|FG000|STARTED|Overall Study||57||
48768648|NCT03125395|102223035|FG000|Study 115B FAS|Overall Study||60|Participants enrolled and exposed to any amount of study drug in parent study VX15-809-115.|
48768649|NCT03125395|102223035|FG000|Study 116 FAS|Overall Study||57|Participants enrolled and exposed to any amount of study drug in current study VX16-809-116.|
48768650|NCT03125395|102223035|FG000|Study 116 LCI Substudy Set|Overall Study||31||
48768651|NCT03125395|102223035|FG000|COMPLETED|Overall Study||47||
48768652|NCT03125395|102223035|FG000|NOT COMPLETED|Overall Study||10||
48768653|NCT00497081|102223036|FG000|STARTED|Overall Study||30||
48768654|NCT00497081|102223037|FG001|STARTED|Overall Study||30||
48768655|NCT00497081|102223036|FG000|COMPLETED|Overall Study||28||
48768656|NCT00497081|102223037|FG001|COMPLETED|Overall Study||28||
48768657|NCT00497081|102223036|FG000|NOT COMPLETED|Overall Study||2||
48768658|NCT00497081|102223037|FG001|NOT COMPLETED|Overall Study||2||
48768659|NCT00408317|102223038|FG000|STARTED|First Intervention Period||14||
48768660|NCT00408317|102223039|FG001|STARTED|First Intervention Period||17||
48441417|NCT02251431|101413262|FG001|NOT COMPLETED|Overall Study||0||
48441418|NCT01717521|101413263|FG000|STARTED|Overall Study||20||
48441419|NCT01717521|101413263|FG000|COMPLETED|Overall Study||20||
48441420|NCT01717521|101413263|FG000|NOT COMPLETED|Overall Study||0||
48441421|NCT02843529|101413264|FG000|STARTED|Overall Study||244||
48441422|NCT02843529|101413265|FG001|STARTED|Overall Study||304||
48441423|NCT02843529|101413264|FG000|COMPLETED|Overall Study||213||
48441424|NCT02843529|101413265|FG001|COMPLETED|Overall Study||283||
48441425|NCT02843529|101413264|FG000|NOT COMPLETED|Overall Study||31||
48441426|NCT02843529|101413265|FG001|NOT COMPLETED|Overall Study||21||
48441427|NCT02886494|101413266|FG000|STARTED|Overall Study||60||
48441428|NCT02886494|101413267|FG001|STARTED|Overall Study||20||
48441429|NCT02886494|101413266|FG000|COMPLETED|Overall Study||43||
48441430|NCT02886494|101413267|FG001|COMPLETED|Overall Study||16||
48441431|NCT02886494|101413266|FG000|NOT COMPLETED|Overall Study||17||
48441432|NCT02886494|101413267|FG001|NOT COMPLETED|Overall Study||4||
48768661|NCT00408317|102223038|FG000|COMPLETED|First Intervention Period||14||
48768662|NCT00408317|102223039|FG001|COMPLETED|First Intervention Period||16||
48768663|NCT00408317|102223038|FG000|NOT COMPLETED|First Intervention Period||0||
48768664|NCT00408317|102223039|FG001|NOT COMPLETED|First Intervention Period||1||
48441433|NCT01414062|101413268|FG000|STARTED|Overall Study||36||
48441434|NCT01414062|101413269|FG001|STARTED|Overall Study||34||
48441435|NCT01414062|101413268|FG000|COMPLETED|Overall Study||31||
48441436|NCT01414062|101413269|FG001|COMPLETED|Overall Study||30||
48768665|NCT00408317|102223038|FG000|STARTED|Second Intervention Period||14||
48768666|NCT00408317|102223039|FG001|STARTED|Second Intervention Period||16||
48768667|NCT00408317|102223038|FG000|COMPLETED|Second Intervention Period||12||
48768668|NCT00408317|102223039|FG001|COMPLETED|Second Intervention Period||14||
48768669|NCT00408317|102223038|FG000|NOT COMPLETED|Second Intervention Period||2||
48441437|NCT01414062|101413268|FG000|NOT COMPLETED|Overall Study||5||
48441438|NCT01414062|101413269|FG001|NOT COMPLETED|Overall Study||4||
48441439|NCT00626574|101413270|FG000|STARTED|Overall Study||2||
48441440|NCT00626574|101413271|FG001|STARTED|Overall Study||1||
48441441|NCT00626574|101413270|FG000|COMPLETED|Overall Study||2||
48441442|NCT00626574|101413271|FG001|COMPLETED|Overall Study||1||
48441443|NCT00626574|101413270|FG000|NOT COMPLETED|Overall Study||0||
48441444|NCT00626574|101413271|FG001|NOT COMPLETED|Overall Study||0||
48441445|NCT02380716|101413272|FG000|STARTED|Overall Study||21||
48441446|NCT02380716|101413272|FG000|Primary Endpoint Analyzed|Overall Study||19||
48441447|NCT02380716|101413272|FG000|COMPLETED|Overall Study||1||
48441448|NCT02380716|101413272|FG000|NOT COMPLETED|Overall Study||20||
48441449|NCT00602927|101413273|FG000|STARTED|Period 1: 13 Days||19||
48441450|NCT00602927|101413274|FG001|STARTED|Period 1: 13 Days||19||
48441451|NCT00602927|101413273|FG000|COMPLETED|Period 1: 13 Days||15||
48441452|NCT00602927|101413274|FG001|COMPLETED|Period 1: 13 Days||14||
48441453|NCT00602927|101413273|FG000|NOT COMPLETED|Period 1: 13 Days||4||
48441454|NCT00602927|101413274|FG001|NOT COMPLETED|Period 1: 13 Days||5||
48441455|NCT00602927|101413273|FG000|STARTED|Period 2: 14 Days||15||
48441456|NCT00602927|101413274|FG001|STARTED|Period 2: 14 Days||14||
48441457|NCT00602927|101413273|FG000|COMPLETED|Period 2: 14 Days||15||
48441458|NCT00602927|101413274|FG001|COMPLETED|Period 2: 14 Days||12||
48441459|NCT00602927|101413273|FG000|NOT COMPLETED|Period 2: 14 Days||0||
48441460|NCT00602927|101413274|FG001|NOT COMPLETED|Period 2: 14 Days||2||
48441461|NCT00602927|101413273|FG000|STARTED|Period 3: 13 Days||15||
48441462|NCT00602927|101413274|FG001|STARTED|Period 3: 13 Days||12||
48441463|NCT00602927|101413273|FG000|COMPLETED|Period 3: 13 Days||13||
48441464|NCT00602927|101413274|FG001|COMPLETED|Period 3: 13 Days||9||
48441465|NCT00602927|101413273|FG000|NOT COMPLETED|Period 3: 13 Days||2||
48441466|NCT00602927|101413274|FG001|NOT COMPLETED|Period 3: 13 Days||3||
48441467|NCT00532779|101413275|FG000|STARTED|Overall Study||578||
48441468|NCT00532779|101413276|FG001|STARTED|Overall Study||583||
48441469|NCT00532779|101413277|FG002|STARTED|Overall Study||581||
48441470|NCT00532779|101413275|FG000|COMPLETED|Overall Study||284||
48441471|NCT00532779|101413276|FG001|COMPLETED|Overall Study||296||
48441472|NCT00532779|101413277|FG002|COMPLETED|Overall Study||290||
48441473|NCT00532779|101413275|FG000|NOT COMPLETED|Overall Study||294||
48441474|NCT00532779|101413276|FG001|NOT COMPLETED|Overall Study||287||
48441475|NCT00532779|101413277|FG002|NOT COMPLETED|Overall Study||291||
48441476|NCT00572468|101413278|FG000|STARTED|Overall Study||22||
48441477|NCT00572468|101413279|FG001|STARTED|Overall Study||20||
48441478|NCT00572468|101413278|FG000|COMPLETED|Overall Study||20||
48657638|NCT04309500|101946041|FG001|NOT COMPLETED|Overall Study||0||
48657639|NCT04309500|101946042|FG002|NOT COMPLETED|Overall Study||0||
48657640|NCT04309500|101946043|FG003|NOT COMPLETED|Overall Study||0||
48657641|NCT02553473|101946044|FG000|STARTED|Overall Study||61||
48657642|NCT02553473|101946045|FG001|STARTED|Overall Study||60||
48657643|NCT02553473|101946044|FG000|COMPLETED|Overall Study||54||
48657644|NCT02553473|101946045|FG001|COMPLETED|Overall Study||55||
48657645|NCT02553473|101946044|FG000|NOT COMPLETED|Overall Study||7||
48657646|NCT02553473|101946045|FG001|NOT COMPLETED|Overall Study||5||
48657647|NCT01674062|101946046|FG000|STARTED|Overall Study||66||
48441479|NCT00572468|101413279|FG001|COMPLETED|Overall Study||16||
48441480|NCT00572468|101413278|FG000|NOT COMPLETED|Overall Study||2||
48441481|NCT00572468|101413279|FG001|NOT COMPLETED|Overall Study||4||
48441482|NCT00713830|101413280|FG000|STARTED|Overall Study||286||
48441483|NCT00713830|101413281|FG001|STARTED|Overall Study||573||
48441484|NCT00713830|101413280|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study||286||
48441485|NCT00713830|101413281|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||570||
48441486|NCT00713830|101413280|FG000|Safety Population|Overall Study||285||
48441487|NCT00713830|101413281|FG001|Safety Population|Overall Study||574||
48441488|NCT00713830|101413280|FG000|Subgroup for Standardized Meal Test|Overall Study||155||
48441489|NCT00713830|101413281|FG001|Subgroup for Standardized Meal Test|Overall Study||313||
48657648|NCT01674062|101946047|FG001|STARTED|Overall Study||29||
48657649|NCT01674062|101946046|FG000|COMPLETED|Overall Study||0||
48768670|NCT00408317|102223039|FG001|NOT COMPLETED|Second Intervention Period||2||
48657650|NCT01674062|101946047|FG001|COMPLETED|Overall Study||0||
48657651|NCT01674062|101946046|FG000|NOT COMPLETED|Overall Study||66||
48657652|NCT01674062|101946047|FG001|NOT COMPLETED|Overall Study||29||
48657653|NCT03247673|101946048|FG000|STARTED|Overall Study||46||
48657654|NCT03247673|101946049|FG001|STARTED|Overall Study||47||
48657655|NCT03247673|101946050|FG002|STARTED|Overall Study||48||
48657656|NCT03247673|101946048|FG000|COMPLETED|Overall Study||45||
48657657|NCT03247673|101946049|FG001|COMPLETED|Overall Study||47||
48657658|NCT03247673|101946050|FG002|COMPLETED|Overall Study||44||
48657659|NCT03247673|101946048|FG000|NOT COMPLETED|Overall Study||1||
48657660|NCT03247673|101946049|FG001|NOT COMPLETED|Overall Study||0||
48657661|NCT03247673|101946050|FG002|NOT COMPLETED|Overall Study||4||
48657662|NCT04379271|101946051|FG000|STARTED|Overall Study||110||
48657663|NCT04379271|101946052|FG001|STARTED|Overall Study||110||
48657664|NCT04379271|101946051|FG000|COMPLETED|Overall Study||93||
48657665|NCT04379271|101946052|FG001|COMPLETED|Overall Study||97||
48657666|NCT04379271|101946051|FG000|NOT COMPLETED|Overall Study||17||
48657667|NCT04379271|101946052|FG001|NOT COMPLETED|Overall Study||13||
48657668|NCT03304639|101946053|FG000|STARTED|Overall Study||4||
48657669|NCT03304639|101946054|FG001|STARTED|Overall Study||5||
48657670|NCT03304639|101946053|FG000|COMPLETED|Overall Study||4||
48657671|NCT03304639|101946054|FG001|COMPLETED|Overall Study||5||
48657672|NCT03304639|101946053|FG000|NOT COMPLETED|Overall Study||0||
48657673|NCT03304639|101946054|FG001|NOT COMPLETED|Overall Study||0||
48657674|NCT03238196|101946055|FG000|STARTED|Overall Study||22||
48768671|NCT02851615|102223040|FG000|STARTED|Overall Study||27||
48768672|NCT02851615|102223041|FG001|STARTED|Overall Study||31||
48768673|NCT02851615|102223040|FG000|COMPLETED|Overall Study||26||
48768674|NCT02851615|102223041|FG001|COMPLETED|Overall Study||27||
48768675|NCT02851615|102223040|FG000|NOT COMPLETED|Overall Study||1||
48768676|NCT02851615|102223041|FG001|NOT COMPLETED|Overall Study||4||
48768677|NCT03857867|102223042|FG000|STARTED|Overall Study||7||
48768678|NCT03857867|102223042|FG000|COMPLETED|Overall Study||6||
48768679|NCT03857867|102223042|FG000|NOT COMPLETED|Overall Study||1||
48768680|NCT01021020|102223043|FG000|STARTED|Period I||28||
48768681|NCT01021020|102223043|FG000|COMPLETED|Period I||26||
48768682|NCT01021020|102223043|FG000|NOT COMPLETED|Period I||2||
48768683|NCT01021020|102223043|FG000|STARTED|14 Day Washout Period A||26||
48768684|NCT01021020|102223043|FG000|COMPLETED|14 Day Washout Period A||25||
48657675|NCT03238196|101946056|FG001|STARTED|Overall Study||3||
48657676|NCT03238196|101946057|FG002|STARTED|Overall Study||6||
48657677|NCT03238196|101946058|FG003|STARTED|Overall Study||4||
48657678|NCT03238196|101946055|FG000|COMPLETED|Overall Study||0||
48188791|NCT05196737|100786085|FG000|Timepoint 4/Post 24 Hours DDN|Dry Needling Reflex Measurment Week||9||
48188792|NCT05196737|100786085|FG000|Timepoint 5/Post 72 Hours DDN|Dry Needling Reflex Measurment Week||8||
48188793|NCT05196737|100786085|FG000|COMPLETED|Dry Needling Reflex Measurment Week||8||
48188794|NCT05196737|100786085|FG000|NOT COMPLETED|Dry Needling Reflex Measurment Week||1||
48188795|NCT02141581|100786086|FG000|STARTED|Overall Study||42||
48188796|NCT02141581|100786087|FG001|STARTED|Overall Study||19||
48188797|NCT02141581|100786088|FG002|STARTED|Overall Study||25||
48188798|NCT02141581|100786086|FG000|COMPLETED|Overall Study||42||
48657679|NCT03238196|101946056|FG001|COMPLETED|Overall Study||0||
48657680|NCT03238196|101946057|FG002|COMPLETED|Overall Study||0||
48657681|NCT03238196|101946058|FG003|COMPLETED|Overall Study||0||
48657682|NCT03238196|101946055|FG000|NOT COMPLETED|Overall Study||22||
48657683|NCT03238196|101946056|FG001|NOT COMPLETED|Overall Study||3||
48657684|NCT03238196|101946057|FG002|NOT COMPLETED|Overall Study||6||
48657685|NCT03238196|101946058|FG003|NOT COMPLETED|Overall Study||4||
48657686|NCT00203242|101946059|FG000|STARTED|Overall Study||15||
48657687|NCT00203242|101946059|FG000|COMPLETED|Overall Study||14||
48768685|NCT01021020|102223043|FG000|NOT COMPLETED|14 Day Washout Period A||1||
48768686|NCT01021020|102223043|FG000|STARTED|Period II||25||
48768687|NCT01021020|102223043|FG000|COMPLETED|Period II||25||
48768688|NCT01021020|102223043|FG000|NOT COMPLETED|Period II||0||
48441490|NCT00713830|101413280|FG000|COMPLETED|Overall Study||204||
48441491|NCT00713830|101413281|FG001|COMPLETED|Overall Study||396||
48441492|NCT00713830|101413280|FG000|NOT COMPLETED|Overall Study||82||
48441493|NCT00713830|101413281|FG001|NOT COMPLETED|Overall Study||177||
48441494|NCT00345969|101413282|FG000|STARTED|Overall Study||12||
48441495|NCT00345969|101413283|FG001|STARTED|Overall Study||13||
48441496|NCT00345969|101413282|FG000|COMPLETED|Overall Study||11||
48441497|NCT00345969|101413283|FG001|COMPLETED|Overall Study||11||
48441498|NCT00345969|101413282|FG000|NOT COMPLETED|Overall Study||1||
48441499|NCT00345969|101413283|FG001|NOT COMPLETED|Overall Study||2||
48441500|NCT00447265|101413284|FG000|STARTED|Overall Study||1||
48441501|NCT00447265|101413285|FG001|STARTED|Overall Study||0||
48441502|NCT00447265|101413284|FG000|COMPLETED|Overall Study||0||
48441503|NCT00447265|101413285|FG001|COMPLETED|Overall Study||0||
48441504|NCT00447265|101413284|FG000|NOT COMPLETED|Overall Study||1||
48441505|NCT00447265|101413285|FG001|NOT COMPLETED|Overall Study||0||
48441506|NCT00337727|101413286|FG000|STARTED|Overall Study||430||
48441507|NCT00337727|101413287|FG001|STARTED|Overall Study||418||
48441508|NCT00337727|101413286|FG000|COMPLETED|Overall Study||412||
48441509|NCT00337727|101413287|FG001|COMPLETED|Overall Study||406||
48441510|NCT00337727|101413286|FG000|NOT COMPLETED|Overall Study||18||
48441511|NCT00337727|101413287|FG001|NOT COMPLETED|Overall Study||12||
48441512|NCT01177735|101413288|FG000|STARTED|Overall Study||71||
48441513|NCT01177735|101413288|FG000|COMPLETED|Overall Study||0||
48441514|NCT01177735|101413288|FG000|NOT COMPLETED|Overall Study||71||
48441515|NCT00157573|101413289|FG000|STARTED|Overall Study||35||
48441516|NCT00157573|101413290|FG001|STARTED|Overall Study||37||
48441517|NCT00157573|101413289|FG000|COMPLETED|Overall Study||35||
48441518|NCT00157573|101413290|FG001|COMPLETED|Overall Study||37||
48441519|NCT00157573|101413289|FG000|NOT COMPLETED|Overall Study||0||
48441520|NCT00157573|101413290|FG001|NOT COMPLETED|Overall Study||0||
48441521|NCT02033382|101413291|FG000|STARTED|Overall Study||83||
48188799|NCT02141581|100786087|FG001|COMPLETED|Overall Study||19||
48188800|NCT02141581|100786088|FG002|COMPLETED|Overall Study||25||
48188801|NCT02141581|100786086|FG000|NOT COMPLETED|Overall Study||0||
48188802|NCT02141581|100786087|FG001|NOT COMPLETED|Overall Study||0||
48441522|NCT02033382|101413292|FG001|STARTED|Overall Study||82||
48441523|NCT02033382|101413291|FG000|COMPLETED|Overall Study||32||
48441524|NCT02033382|101413292|FG001|COMPLETED|Overall Study||36||
48441525|NCT02033382|101413291|FG000|NOT COMPLETED|Overall Study||51||
48441526|NCT02033382|101413292|FG001|NOT COMPLETED|Overall Study||46||
48441527|NCT00903409|101413293|FG000|STARTED|Overall Study||88||
48441528|NCT00903409|101413294|FG001|STARTED|Overall Study||100||
48441529|NCT00903409|101413293|FG000|COMPLETED|Overall Study||62||
48441530|NCT00903409|101413294|FG001|COMPLETED|Overall Study||73||
48441531|NCT00903409|101413293|FG000|NOT COMPLETED|Overall Study||26||
48441532|NCT00903409|101413294|FG001|NOT COMPLETED|Overall Study||27||
48441533|NCT00518011|101413295|FG000|STARTED|Overall Study||9||
48441534|NCT00518011|101413296|FG001|STARTED|Overall Study||8||
48441535|NCT00518011|101413295|FG000|COMPLETED|Overall Study||0||
48441536|NCT00518011|101413296|FG001|COMPLETED|Overall Study||0||
48441537|NCT00518011|101413295|FG000|NOT COMPLETED|Overall Study||9||
48441538|NCT00518011|101413296|FG001|NOT COMPLETED|Overall Study||8||
48441539|NCT03992261|101413297|FG000|STARTED|Overall Study||24||
48441540|NCT03992261|101413297|FG000|COMPLETED|Overall Study||24||
48441541|NCT03992261|101413297|FG000|NOT COMPLETED|Overall Study||0||
48441542|NCT02815540|101413298|FG000|STARTED|Overall Study||2||
48441543|NCT02815540|101413298|FG000|COMPLETED|Overall Study||0||
48441544|NCT02815540|101413298|FG000|NOT COMPLETED|Overall Study||2||
48441545|NCT02694393|101413299|FG000|STARTED|Overall Study||2||
48441546|NCT02694393|101413299|FG000|COMPLETED|Overall Study||1||
48441547|NCT02694393|101413299|FG000|NOT COMPLETED|Overall Study||1||
48441548|NCT01002118|101413300|FG000|STARTED|Overall Study||1||
48441549|NCT01002118|101413300|FG000|Randomized Only Patient|Overall Study||1||
48441550|NCT01002118|101413300|FG000|COMPLETED|Overall Study||1||
48441551|NCT01002118|101413300|FG000|NOT COMPLETED|Overall Study||0||
48441552|NCT01923961|101413301|FG000|STARTED|First Intervention||3||
48441553|NCT01923961|101413302|FG001|STARTED|First Intervention||3||
48441554|NCT01923961|101413303|FG002|STARTED|First Intervention||2||
48441555|NCT01923961|101413301|FG000|COMPLETED|First Intervention||3||
48441556|NCT01923961|101413302|FG001|COMPLETED|First Intervention||3||
48441557|NCT01923961|101413303|FG002|COMPLETED|First Intervention||2||
48441558|NCT01923961|101413301|FG000|NOT COMPLETED|First Intervention||0||
48441559|NCT01923961|101413302|FG001|NOT COMPLETED|First Intervention||0||
48188803|NCT02141581|100786088|FG002|NOT COMPLETED|Overall Study||0||
48441560|NCT01923961|101413303|FG002|NOT COMPLETED|First Intervention||0||
48441561|NCT01923961|101413301|FG000|STARTED|Washout (1 Week)||3||
48441562|NCT01923961|101413302|FG001|STARTED|Washout (1 Week)||3||
48441563|NCT01923961|101413303|FG002|STARTED|Washout (1 Week)||2||
48441564|NCT01923961|101413301|FG000|COMPLETED|Washout (1 Week)||3||
48441565|NCT01923961|101413302|FG001|COMPLETED|Washout (1 Week)||3||
48441566|NCT01923961|101413303|FG002|COMPLETED|Washout (1 Week)||2||
48441567|NCT01923961|101413301|FG000|NOT COMPLETED|Washout (1 Week)||0||
48441568|NCT01923961|101413302|FG001|NOT COMPLETED|Washout (1 Week)||0||
48441569|NCT01923961|101413303|FG002|NOT COMPLETED|Washout (1 Week)||0||
48441570|NCT01923961|101413301|FG000|STARTED|Second Intervention||3||
48441571|NCT01923961|101413302|FG001|STARTED|Second Intervention||3||
48441572|NCT01923961|101413303|FG002|STARTED|Second Intervention||2||
48441573|NCT01923961|101413301|FG000|COMPLETED|Second Intervention||3||
48441574|NCT01923961|101413302|FG001|COMPLETED|Second Intervention||3||
48441575|NCT01923961|101413303|FG002|COMPLETED|Second Intervention||2||
48441576|NCT01923961|101413301|FG000|NOT COMPLETED|Second Intervention||0||
48441577|NCT01923961|101413302|FG001|NOT COMPLETED|Second Intervention||0||
48441578|NCT01923961|101413303|FG002|NOT COMPLETED|Second Intervention||0||
48657688|NCT00203242|101946059|FG000|NOT COMPLETED|Overall Study||1||
48657689|NCT02844816|101946060|FG000|STARTED|Overall Study||101||
48657690|NCT02844816|101946061|FG001|STARTED|Overall Study||71||
48657691|NCT02844816|101946060|FG000|Safety Analysis Population|Overall Study||96||
48657692|NCT02844816|101946061|FG001|Safety Analysis Population|Overall Study||70||
48657693|NCT02844816|101946060|FG000|Eligible and Evaluable|Overall Study||74||
48657694|NCT02844816|101946061|FG001|Eligible and Evaluable|Overall Study||55||
48657695|NCT02844816|101946060|FG000|COMPLETED|Overall Study||13||
48657696|NCT02844816|101946061|FG001|COMPLETED|Overall Study||20||
48657697|NCT02844816|101946060|FG000|NOT COMPLETED|Overall Study||88||
48657698|NCT02844816|101946061|FG001|NOT COMPLETED|Overall Study||51||
48657699|NCT04889950|101946062|FG000|STARTED|Overall Study||11||22
48657700|NCT04889950|101946063|FG001|STARTED|Overall Study||10||20
48657701|NCT04889950|101946062|FG000|COMPLETED|Overall Study||9||18
48657702|NCT04889950|101946063|FG001|COMPLETED|Overall Study||10||20
48657703|NCT04889950|101946062|FG000|NOT COMPLETED|Overall Study||2||4
48657704|NCT04889950|101946063|FG001|NOT COMPLETED|Overall Study||0||0
48657705|NCT04486677|101946064|FG000|STARTED|Overall Study||30||
48657706|NCT04486677|101946065|FG001|STARTED|Overall Study||50||
48657707|NCT04486677|101946064|FG000|COMPLETED|Overall Study||21||
48657708|NCT04486677|101946065|FG001|COMPLETED|Overall Study||34||
48657709|NCT04486677|101946064|FG000|NOT COMPLETED|Overall Study||9||
48657710|NCT04486677|101946065|FG001|NOT COMPLETED|Overall Study||16||
48657711|NCT00619242|101946066|FG000|STARTED|Overall Study||3||
48657712|NCT00619242|101946066|FG000|COMPLETED|Overall Study||3||
48657713|NCT00619242|101946066|FG000|NOT COMPLETED|Overall Study||0||
48657714|NCT02025010|101946067|FG000|STARTED|Overall Study||60||
48657715|NCT02025010|101946067|FG000|COMPLETED|Overall Study||0||
48657716|NCT02025010|101946067|FG000|NOT COMPLETED|Overall Study||60||
48657717|NCT04315961|101946068|FG000|STARTED|Overall Study||0||
48657718|NCT04315961|101946068|FG000|COMPLETED|Overall Study||0||
48657719|NCT04315961|101946068|FG000|NOT COMPLETED|Overall Study||0||
48657720|NCT01292265|101946069|FG000|STARTED|Overall Study||3||
48657721|NCT01292265|101946069|FG000|COMPLETED|Overall Study||3||
48768689|NCT01021020|102223043|FG000|STARTED|14 Day Washout Period B||25||
48768690|NCT01021020|102223043|FG000|COMPLETED|14 Day Washout Period B||25||
48768691|NCT01021020|102223043|FG000|NOT COMPLETED|14 Day Washout Period B||0||
48768692|NCT01021020|102223043|FG000|STARTED|Period III||25||
48441579|NCT01923961|101413301|FG000|STARTED|Washout (1 Week)||3||
48657722|NCT01292265|101946069|FG000|NOT COMPLETED|Overall Study||0||
48657723|NCT03093246|101946070|FG000|STARTED|Overall Study||19||
48657724|NCT03093246|101946071|FG001|STARTED|Overall Study||19||
48657725|NCT03093246|101946070|FG000|COMPLETED|Overall Study||19||
48657726|NCT03093246|101946071|FG001|COMPLETED|Overall Study||19||
48657727|NCT03093246|101946070|FG000|NOT COMPLETED|Overall Study||0||
48657728|NCT03093246|101946071|FG001|NOT COMPLETED|Overall Study||0||
48657729|NCT04126174|101946072|FG000|STARTED|Overall Study||41||41
48657730|NCT04126174|101946073|FG001|STARTED|Overall Study||41||41
48657731|NCT04126174|101946072|FG000|COMPLETED|Overall Study||38||38
48657732|NCT04126174|101946073|FG001|COMPLETED|Overall Study||38||38
48768693|NCT01021020|102223043|FG000|COMPLETED|Period III||25||
48768694|NCT01021020|102223043|FG000|NOT COMPLETED|Period III||0||
48768695|NCT00940771|102223044|FG000|STARTED|Pre-Entry||10||
48768696|NCT00940771|102223044|FG000|COMPLETED|Pre-Entry||10||
48768697|NCT00940771|102223044|FG000|NOT COMPLETED|Pre-Entry||0||
48441580|NCT01923961|101413302|FG001|STARTED|Washout (1 Week)||3||
48441581|NCT01923961|101413303|FG002|STARTED|Washout (1 Week)||2||
48441582|NCT01923961|101413301|FG000|COMPLETED|Washout (1 Week)||3||
48441583|NCT01923961|101413302|FG001|COMPLETED|Washout (1 Week)||3||
48657733|NCT04126174|101946072|FG000|NOT COMPLETED|Overall Study||3||3
48657734|NCT04126174|101946073|FG001|NOT COMPLETED|Overall Study||3||3
48657735|NCT00101400|101946074|FG000|STARTED|Treatment||54||
48657736|NCT00101400|101946074|FG000|COMPLETED|Treatment||54||
48657737|NCT00101400|101946074|FG000|NOT COMPLETED|Treatment||0||
48657738|NCT00101400|101946074|FG000|STARTED|Survival Follow-Up||51||
48657739|NCT00101400|101946074|FG000|COMPLETED|Survival Follow-Up||44||
48657740|NCT00101400|101946074|FG000|NOT COMPLETED|Survival Follow-Up||7||
48657741|NCT02514746|101946075|FG000|STARTED|Overall Study||437|All enrolled participants|
48768698|NCT00940771|102223044|FG000|STARTED|4 Weeks||10||
48768699|NCT00940771|102223044|FG000|COMPLETED|4 Weeks||10||
48768700|NCT00940771|102223044|FG000|NOT COMPLETED|4 Weeks||0||
48768701|NCT00940771|102223044|FG000|STARTED|12 Weeks||10||
48768702|NCT00940771|102223044|FG000|COMPLETED|12 Weeks||10||
48768703|NCT00940771|102223044|FG000|NOT COMPLETED|12 Weeks||0||
48768704|NCT00940771|102223044|FG000|STARTED|24 Weeks||10||
48768705|NCT00940771|102223044|FG000|COMPLETED|24 Weeks||10||
48768706|NCT00940771|102223044|FG000|NOT COMPLETED|24 Weeks||0||
48768707|NCT02919995|102223045|FG000|STARTED|Overall Study||1||
48768708|NCT02919995|102223046|FG001|STARTED|Overall Study||2||
48768709|NCT02919995|102223047|FG002|STARTED|Overall Study||2||
48768710|NCT02919995|102223048|FG003|STARTED|Overall Study||2||
48768711|NCT02919995|102223049|FG004|STARTED|Overall Study||1||
48768712|NCT02919995|102223050|FG005|STARTED|Overall Study||2||
48768713|NCT02919995|102223045|FG000|COMPLETED|Overall Study||1||
48768714|NCT02919995|102223046|FG001|COMPLETED|Overall Study||2||
48768715|NCT02919995|102223047|FG002|COMPLETED|Overall Study||2||
48768716|NCT02919995|102223048|FG003|COMPLETED|Overall Study||2||
48768717|NCT02919995|102223049|FG004|COMPLETED|Overall Study||1||
48768718|NCT02919995|102223050|FG005|COMPLETED|Overall Study||1||
48768719|NCT02919995|102223045|FG000|NOT COMPLETED|Overall Study||0||
48768720|NCT02919995|102223046|FG001|NOT COMPLETED|Overall Study||0||
48768721|NCT02919995|102223047|FG002|NOT COMPLETED|Overall Study||0||
48768722|NCT02919995|102223048|FG003|NOT COMPLETED|Overall Study||0||
48768723|NCT02919995|102223049|FG004|NOT COMPLETED|Overall Study||0||
48768724|NCT02919995|102223050|FG005|NOT COMPLETED|Overall Study||1||
48768725|NCT01383356|102223051|FG000|STARTED|Period 1||29||
48768726|NCT01383356|102223052|FG001|STARTED|Period 1||29||
48768727|NCT01383356|102223051|FG000|COMPLETED|Period 1||21||
48768728|NCT01383356|102223052|FG001|COMPLETED|Period 1||23||
48768729|NCT01383356|102223051|FG000|NOT COMPLETED|Period 1||8||
48768730|NCT01383356|102223052|FG001|NOT COMPLETED|Period 1||6||
48768731|NCT01383356|102223051|FG000|STARTED|Washout Period (at Least 35 Days)||21||
48768732|NCT01383356|102223052|FG001|STARTED|Washout Period (at Least 35 Days)||23||
48188804|NCT01446003|100786089|FG000|STARTED|Period 1||16||
48441584|NCT01923961|101413303|FG002|COMPLETED|Washout (1 Week)||2||
48441585|NCT01923961|101413301|FG000|NOT COMPLETED|Washout (1 Week)||0||
48441586|NCT01923961|101413302|FG001|NOT COMPLETED|Washout (1 Week)||0||
48657742|NCT02514746|101946076|FG001|STARTED|Overall Study||124|All enrolled participants|
48657743|NCT02514746|101946075|FG000|Valid Serology 3 Years Post Primary Dose|Overall Study||437||
48657744|NCT02514746|101946076|FG001|Valid Serology 3 Years Post Primary Dose|Overall Study||123||
48657745|NCT02514746|101946075|FG000|Valid Serology 4 Years Post Primary Dose|Overall Study||424||
48657746|NCT02514746|101946076|FG001|Valid Serology 4 Years Post Primary Dose|Overall Study||109||
48657747|NCT02514746|101946075|FG000|Received CD-JEV Booster Vaccine|Overall Study||424||
48657748|NCT02514746|101946076|FG001|Received CD-JEV Booster Vaccine|Overall Study||109||
48657749|NCT02514746|101946075|FG000|COMPLETED|Overall Study||415|Completed all study visits through 28 days post booster vaccination.|
48657750|NCT02514746|101946076|FG001|COMPLETED|Overall Study||109|Completed all study visits through 28 days post booster vaccination.|
48657751|NCT02514746|101946075|FG000|NOT COMPLETED|Overall Study||22||
48657752|NCT02514746|101946076|FG001|NOT COMPLETED|Overall Study||15||
48657753|NCT01028560|101946077|FG000|STARTED|Overall Study||27||
48657754|NCT01028560|101946078|FG001|STARTED|Overall Study||31||
48768733|NCT01383356|102223051|FG000|COMPLETED|Washout Period (at Least 35 Days)||21||
48768734|NCT01383356|102223052|FG001|COMPLETED|Washout Period (at Least 35 Days)||23||
48768735|NCT01383356|102223051|FG000|NOT COMPLETED|Washout Period (at Least 35 Days)||0||
48768736|NCT01383356|102223052|FG001|NOT COMPLETED|Washout Period (at Least 35 Days)||0||
48768737|NCT01383356|102223051|FG000|STARTED|Period 2||21||
48768738|NCT01383356|102223052|FG001|STARTED|Period 2||23||
48768739|NCT01383356|102223051|FG000|COMPLETED|Period 2||21||
48768740|NCT01383356|102223052|FG001|COMPLETED|Period 2||23||
48768741|NCT01383356|102223051|FG000|NOT COMPLETED|Period 2||0||
48768742|NCT01383356|102223052|FG001|NOT COMPLETED|Period 2||0||
48768743|NCT01532986|102223053|FG000|STARTED|Overall Study||166||
48768744|NCT01532986|102223054|FG001|STARTED|Overall Study||162||
48768745|NCT01532986|102223053|FG000|COMPLETED|Overall Study||143||
48768746|NCT01532986|102223054|FG001|COMPLETED|Overall Study||138||
48768747|NCT01532986|102223053|FG000|NOT COMPLETED|Overall Study||23||
48768748|NCT01532986|102223054|FG001|NOT COMPLETED|Overall Study||24||
48768749|NCT02202759|102223055|FG000|STARTED|Overall Study||9||
48768750|NCT02202759|102223056|FG001|STARTED|Overall Study||15||
48768751|NCT02202759|102223057|FG002|STARTED|Overall Study||14||
48768752|NCT02202759|102223055|FG000|COMPLETED|Overall Study||0||
48768753|NCT02202759|102223056|FG001|COMPLETED|Overall Study||0||
48768754|NCT02202759|102223057|FG002|COMPLETED|Overall Study||0||
48768755|NCT02202759|102223055|FG000|NOT COMPLETED|Overall Study||9||
48768756|NCT02202759|102223056|FG001|NOT COMPLETED|Overall Study||15||
48768757|NCT02202759|102223057|FG002|NOT COMPLETED|Overall Study||14||
48768758|NCT00425802|102223058|FG000|STARTED|Overall Study||61||
48768759|NCT00425802|102223058|FG000|COMPLETED|Overall Study||61||
48768760|NCT00425802|102223058|FG000|NOT COMPLETED|Overall Study||0||
48768761|NCT01497496|102223059|FG000|STARTED|Overall Study||29||
48768762|NCT01497496|102223059|FG000|COMPLETED|Overall Study||29||
48768763|NCT01497496|102223059|FG000|NOT COMPLETED|Overall Study||0||
48768764|NCT03581279|102223060|FG000|STARTED|Overall Study||18||
48768765|NCT03581279|102223061|FG001|STARTED|Overall Study||0||
48768766|NCT03581279|102223060|FG000|COMPLETED|Overall Study||16||
48768767|NCT03581279|102223061|FG001|COMPLETED|Overall Study||0||
48441587|NCT01923961|101413303|FG002|NOT COMPLETED|Washout (1 Week)||0||
48441588|NCT01923961|101413301|FG000|STARTED|Third Intervention||3||
48441589|NCT01923961|101413302|FG001|STARTED|Third Intervention||3||
48441590|NCT01923961|101413303|FG002|STARTED|Third Intervention||2||
48441591|NCT01923961|101413301|FG000|COMPLETED|Third Intervention||3||
48441592|NCT01923961|101413302|FG001|COMPLETED|Third Intervention||3||
48441593|NCT01923961|101413303|FG002|COMPLETED|Third Intervention||2||
48441594|NCT01923961|101413301|FG000|NOT COMPLETED|Third Intervention||0||
48441595|NCT01923961|101413302|FG001|NOT COMPLETED|Third Intervention||0||
48441596|NCT01923961|101413303|FG002|NOT COMPLETED|Third Intervention||0||
48441597|NCT04469465|101413304|FG000|STARTED|Treatment Period 1 (TP1)||57||
48441598|NCT04469465|101413305|FG001|STARTED|Treatment Period 1 (TP1)||29||
48441599|NCT04469465|101413304|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 (TP1)||57|Full Analysis Set/Safety Set|
48441600|NCT04469465|101413305|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 (TP1)||29|Full Analysis Set/Safety Set|
48657755|NCT01028560|101946077|FG000|Started Study Protocol|Overall Study||23|Only participants who started the study protocol were included in the analysis (total n=50)|
48657756|NCT01028560|101946078|FG001|Started Study Protocol|Overall Study||27|Only participants who started the study protocol were included in the analysis (total n=50)|
48657757|NCT01028560|101946077|FG000|COMPLETED|Overall Study||17||
48657758|NCT01028560|101946078|FG001|COMPLETED|Overall Study||13||
48657759|NCT01028560|101946077|FG000|NOT COMPLETED|Overall Study||10||
48657760|NCT01028560|101946078|FG001|NOT COMPLETED|Overall Study||18||
48657761|NCT04652765|101946079|FG000|STARTED|Overall Study||1||
48657762|NCT04652765|101946080|FG001|STARTED|Overall Study||2||
48657763|NCT04652765|101946081|FG002|STARTED|Overall Study||3||
48657764|NCT04652765|101946079|FG000|COMPLETED|Overall Study||1||
48657765|NCT04652765|101946080|FG001|COMPLETED|Overall Study||2||
48657766|NCT04652765|101946081|FG002|COMPLETED|Overall Study||2||
48657767|NCT04652765|101946079|FG000|NOT COMPLETED|Overall Study||0||
48657768|NCT04652765|101946080|FG001|NOT COMPLETED|Overall Study||0||
48657769|NCT04652765|101946081|FG002|NOT COMPLETED|Overall Study||1||
48657770|NCT04290676|101946082|FG000|STARTED|Overall Study||527||641
48657771|NCT04290676|101946082|FG000|COMPLETED|Overall Study||527||641
48657772|NCT04290676|101946082|FG000|NOT COMPLETED|Overall Study||0||0
48657773|NCT00089583|101946083|FG000|STARTED|Overall Study||20||
48657774|NCT00089583|101946084|FG001|STARTED|Overall Study||89||
48657775|NCT00089583|101946083|FG000|COMPLETED|Overall Study||13||
48657776|NCT00089583|101946084|FG001|COMPLETED|Overall Study||51||
48657777|NCT00089583|101946083|FG000|NOT COMPLETED|Overall Study||7||
48657778|NCT00089583|101946084|FG001|NOT COMPLETED|Overall Study||38||
48657779|NCT01248468|101946085|FG000|STARTED|Overall Study||299||
48657780|NCT01248468|101946086|FG001|STARTED|Overall Study||304||
48657781|NCT01248468|101946087|FG002|STARTED|Overall Study||149||
48657782|NCT01248468|101946085|FG000|Safety Population|Overall Study||266||
48657783|NCT01248468|101946086|FG001|Safety Population|Overall Study||271||
48657784|NCT01248468|101946087|FG002|Safety Population|Overall Study||133||
48657785|NCT01248468|101946085|FG000|ITT Population|Overall Study||256||
48657786|NCT01248468|101946086|FG001|ITT Population|Overall Study||261||
48657787|NCT01248468|101946087|FG002|ITT Population|Overall Study||125||
48657788|NCT01248468|101946085|FG000|COMPLETED|Overall Study||284||
48657789|NCT01248468|101946086|FG001|COMPLETED|Overall Study||290||
48657790|NCT01248468|101946087|FG002|COMPLETED|Overall Study||145||
48657791|NCT01248468|101946085|FG000|NOT COMPLETED|Overall Study||15||
48657792|NCT01248468|101946086|FG001|NOT COMPLETED|Overall Study||14||
48657793|NCT01248468|101946087|FG002|NOT COMPLETED|Overall Study||4||
48657794|NCT00979615|101946088|FG000|STARTED|Overall Study||63||
48657795|NCT00979615|101946089|FG001|STARTED|Overall Study||66||
48657796|NCT00979615|101946088|FG000|COMPLETED|Overall Study||57||
48657797|NCT00979615|101946089|FG001|COMPLETED|Overall Study||58||
48657798|NCT00979615|101946088|FG000|NOT COMPLETED|Overall Study||6||
48657799|NCT00979615|101946089|FG001|NOT COMPLETED|Overall Study||8||
48657800|NCT04409418|101946090|FG000|STARTED|Overall Study||24||
48657801|NCT04409418|101946091|FG001|STARTED|Overall Study||64||
48657802|NCT04409418|101946090|FG000|COMPLETED|Overall Study||24||
48657803|NCT04409418|101946091|FG001|COMPLETED|Overall Study||64||
48657804|NCT04409418|101946090|FG000|NOT COMPLETED|Overall Study||0||
48657805|NCT04409418|101946091|FG001|NOT COMPLETED|Overall Study||0||
48657806|NCT00079781|101946092|FG000|STARTED|Pre-implant Period||45||
48657807|NCT00079781|101946093|FG001|STARTED|Pre-implant Period||10||
48657808|NCT00079781|101946094|FG002|STARTED|Pre-implant Period||15||
48768768|NCT03581279|102223060|FG000|NOT COMPLETED|Overall Study||2||
48768769|NCT03581279|102223061|FG001|NOT COMPLETED|Overall Study||0||
48657809|NCT00079781|101946092|FG000|COMPLETED|Pre-implant Period||42||
48657810|NCT00079781|101946093|FG001|COMPLETED|Pre-implant Period||9||
48657811|NCT00079781|101946094|FG002|COMPLETED|Pre-implant Period||14||
48768770|NCT02481219|102223062|FG000|STARTED|Overall Study||60||
48768771|NCT02481219|102223063|FG001|STARTED|Overall Study||62||
48768772|NCT02481219|102223062|FG000|COMPLETED|Overall Study||58||
48768773|NCT02481219|102223063|FG001|COMPLETED|Overall Study||61||
48768774|NCT02481219|102223062|FG000|NOT COMPLETED|Overall Study||2||
48768775|NCT02481219|102223063|FG001|NOT COMPLETED|Overall Study||1||
48768776|NCT01295814|102223064|FG000|STARTED|Overall Study||22||
48768777|NCT01295814|102223065|FG001|STARTED|Overall Study||21||
48768778|NCT01295814|102223064|FG000|COMPLETED|Overall Study||20||
48768779|NCT01295814|102223065|FG001|COMPLETED|Overall Study||19||
48768780|NCT01295814|102223064|FG000|NOT COMPLETED|Overall Study||2||
48768781|NCT01295814|102223065|FG001|NOT COMPLETED|Overall Study||2||
48768782|NCT00643864|102223066|FG000|STARTED|Pre-test Assessment||3||
48441601|NCT04469465|101413304|FG000|Interim Efficacy Analysis Set|Treatment Period 1 (TP1)||42|Per the prespecified plan for interim analysis, the first 75% of randomized participants formed the Interim Analysis Set for efficacy analysis.|
48441602|NCT04469465|101413305|FG001|Interim Efficacy Analysis Set|Treatment Period 1 (TP1)||21|Per the prespecified plan for interim analysis, the first 75% of randomized participants formed the Interim Analysis Set for efficacy analysis.|
48441603|NCT04469465|101413304|FG000|COMPLETED|Treatment Period 1 (TP1)||55|Completed TP1|
48441604|NCT04469465|101413305|FG001|COMPLETED|Treatment Period 1 (TP1)||27|Completed TP1|
48441605|NCT04469465|101413304|FG000|NOT COMPLETED|Treatment Period 1 (TP1)||2||
48441606|NCT04469465|101413305|FG001|NOT COMPLETED|Treatment Period 1 (TP1)||2||
48441607|NCT04469465|101413304|FG000|STARTED|Treatment Period 2 (TP2)||55||
48441608|NCT04469465|101413305|FG001|STARTED|Treatment Period 2 (TP2)||27||
48441609|NCT04469465|101413304|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2 (TP2)||55|Full Analysis Set/Safety Set|
48441610|NCT04469465|101413305|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2 (TP2)||27|Full Analysis Set/Safety Set|
48441611|NCT04469465|101413304|FG000|COMPLETED|Treatment Period 2 (TP2)||54||
48441612|NCT04469465|101413305|FG001|COMPLETED|Treatment Period 2 (TP2)||26||
48441613|NCT04469465|101413304|FG000|NOT COMPLETED|Treatment Period 2 (TP2)||1||
48441614|NCT04469465|101413305|FG001|NOT COMPLETED|Treatment Period 2 (TP2)||1||
48441615|NCT04469465|101413304|FG000|STARTED|Long-Term Extension (LTE)||54||
48768783|NCT00643864|102223066|FG000|COMPLETED|Pre-test Assessment||3||
48768784|NCT00643864|102223066|FG000|NOT COMPLETED|Pre-test Assessment||0||
48768785|NCT00643864|102223066|FG000|STARTED|Post-test Assessment||3||
48768786|NCT00643864|102223066|FG000|COMPLETED|Post-test Assessment||3||
48768787|NCT00643864|102223066|FG000|NOT COMPLETED|Post-test Assessment||0||
48768788|NCT02118584|102223067|FG000|STARTED|Part 1: Open Label Extension Period||1026||
48768789|NCT02118584|102223068|FG001|STARTED|Part 1: Open Label Extension Period||747||
48768790|NCT02118584|102223069|FG002|STARTED|Part 1: Open Label Extension Period||0||
48768791|NCT02118584|102223067|FG000|COMPLETED|Part 1: Open Label Extension Period||9||
48768792|NCT02118584|102223068|FG001|COMPLETED|Part 1: Open Label Extension Period||747||
48768793|NCT02118584|102223069|FG002|COMPLETED|Part 1: Open Label Extension Period||0||
48768794|NCT02118584|102223067|FG000|NOT COMPLETED|Part 1: Open Label Extension Period||1017||
48768795|NCT02118584|102223068|FG001|NOT COMPLETED|Part 1: Open Label Extension Period||0||
48768796|NCT02118584|102223069|FG002|NOT COMPLETED|Part 1: Open Label Extension Period||0||
48768797|NCT02118584|102223067|FG000|STARTED|Part 2: PML Safety Monitoring Period||0||
48768798|NCT02118584|102223068|FG001|STARTED|Part 2: PML Safety Monitoring Period||747||
48768799|NCT02118584|102223069|FG002|STARTED|Part 2: PML Safety Monitoring Period||49||
48768800|NCT02118584|102223067|FG000|COMPLETED|Part 2: PML Safety Monitoring Period||0||
48768801|NCT02118584|102223068|FG001|COMPLETED|Part 2: PML Safety Monitoring Period||317||
48768802|NCT02118584|102223069|FG002|COMPLETED|Part 2: PML Safety Monitoring Period||43||
48768803|NCT02118584|102223067|FG000|NOT COMPLETED|Part 2: PML Safety Monitoring Period||0||
48768804|NCT02118584|102223068|FG001|NOT COMPLETED|Part 2: PML Safety Monitoring Period||430||
48441616|NCT04469465|101413305|FG001|STARTED|Long-Term Extension (LTE)||26||
48441617|NCT04469465|101413304|FG000|Received at Least 1 Dose of Study Drug|Long-Term Extension (LTE)||54|Safety Set|
48441618|NCT04469465|101413305|FG001|Received at Least 1 Dose of Study Drug|Long-Term Extension (LTE)||26|Safety Set|
48441619|NCT04469465|101413304|FG000|COMPLETED|Long-Term Extension (LTE)||46||
48441620|NCT04469465|101413305|FG001|COMPLETED|Long-Term Extension (LTE)||24||
48441621|NCT04469465|101413304|FG000|NOT COMPLETED|Long-Term Extension (LTE)||8||
48441622|NCT04469465|101413305|FG001|NOT COMPLETED|Long-Term Extension (LTE)||2||
48441623|NCT01700907|101413306|FG000|STARTED|Overall Study||10||
48768805|NCT02118584|102223069|FG002|NOT COMPLETED|Part 2: PML Safety Monitoring Period||6||
48768806|NCT00912197|102223070|FG000|STARTED|Overall Study||15||
48768807|NCT00912197|102223071|FG001|STARTED|Overall Study||13||
48768808|NCT00912197|102223070|FG000|COMPLETED|Overall Study||12||
48768809|NCT00912197|102223071|FG001|COMPLETED|Overall Study||10||
48768810|NCT00912197|102223070|FG000|NOT COMPLETED|Overall Study||3||
48768811|NCT00912197|102223071|FG001|NOT COMPLETED|Overall Study||3||
48768812|NCT02844569|102223072|FG000|STARTED|Overall Study||12||
48768813|NCT02844569|102223073|FG001|STARTED|Overall Study||12||
48768814|NCT02844569|102223072|FG000|COMPLETED|Overall Study||12||
48768815|NCT02844569|102223073|FG001|COMPLETED|Overall Study||12||
48768816|NCT02844569|102223072|FG000|NOT COMPLETED|Overall Study||0||
48768817|NCT02844569|102223073|FG001|NOT COMPLETED|Overall Study||0||
48768818|NCT01498068|102223074|FG000|STARTED|Overall Study||16||
48768819|NCT01498068|102223075|FG001|STARTED|Overall Study||20||
48768820|NCT01498068|102223074|FG000|COMPLETED|Overall Study||15||
48441624|NCT01700907|101413307|FG001|STARTED|Overall Study||10||
48441625|NCT01700907|101413306|FG000|COMPLETED|Overall Study||10||
48441626|NCT01700907|101413307|FG001|COMPLETED|Overall Study||10||
48441627|NCT01700907|101413306|FG000|NOT COMPLETED|Overall Study||0||
48441628|NCT01700907|101413307|FG001|NOT COMPLETED|Overall Study||0||
48441629|NCT03701516|101413308|FG000|STARTED|Period 1||131||
48441630|NCT03701516|101413309|FG001|STARTED|Period 1||132||
48441631|NCT03701516|101413308|FG000|COMPLETED|Period 1||127||
48441632|NCT03701516|101413309|FG001|COMPLETED|Period 1||127||
48441633|NCT03701516|101413308|FG000|NOT COMPLETED|Period 1||4||
48441634|NCT03701516|101413309|FG001|NOT COMPLETED|Period 1||5||
48441635|NCT03701516|101413308|FG000|STARTED|Period 2||127||
48441636|NCT03701516|101413309|FG001|STARTED|Period 2||127||
48441637|NCT03701516|101413308|FG000|COMPLETED|Period 2||126||
48441638|NCT03701516|101413309|FG001|COMPLETED|Period 2||126||
48441639|NCT03701516|101413308|FG000|NOT COMPLETED|Period 2||1||
48441640|NCT03701516|101413309|FG001|NOT COMPLETED|Period 2||1||
48441641|NCT00396318|101413310|FG000|STARTED|At Least One Dose of Tenecteplase (MITT)||246||
48441642|NCT00396318|101413310|FG000|COMPLETED|At Least One Dose of Tenecteplase (MITT)||241||
48441643|NCT00396318|101413310|FG000|NOT COMPLETED|At Least One Dose of Tenecteplase (MITT)||5||
48441644|NCT00396318|101413310|FG000|STARTED|48- to 96-Hour Follow-Up Period||246||
48441645|NCT00396318|101413310|FG000|COMPLETED|48- to 96-Hour Follow-Up Period||241||
48441646|NCT00396318|101413310|FG000|NOT COMPLETED|48- to 96-Hour Follow-Up Period||5||
48441647|NCT00396318|101413310|FG000|STARTED|7-Day Post-Treatment Contact||241||
48657812|NCT00079781|101946092|FG000|NOT COMPLETED|Pre-implant Period||3||
48657813|NCT00079781|101946093|FG001|NOT COMPLETED|Pre-implant Period||1||
48657814|NCT00079781|101946094|FG002|NOT COMPLETED|Pre-implant Period||1||
48657815|NCT00079781|101946092|FG000|STARTED|Evaluation Period||42||
48657816|NCT00079781|101946093|FG001|STARTED|Evaluation Period||9||
48768821|NCT01498068|102223075|FG001|COMPLETED|Overall Study||19||
48768822|NCT01498068|102223074|FG000|NOT COMPLETED|Overall Study||1||
48768823|NCT01498068|102223075|FG001|NOT COMPLETED|Overall Study||1||
48768824|NCT02839200|102223076|FG000|STARTED|Overall Study||60||
48768825|NCT02839200|102223077|FG001|STARTED|Overall Study||59||
48441648|NCT00396318|101413310|FG000|COMPLETED|7-Day Post-Treatment Contact||240||
48441649|NCT00396318|101413310|FG000|NOT COMPLETED|7-Day Post-Treatment Contact||1||
48441650|NCT00742859|101416040|FG000|STARTED|Overall Study||127||
48768826|NCT02839200|102223078|FG002|STARTED|Overall Study||60||
48441651|NCT00742859|101416041|FG001|STARTED|Overall Study||127||
48657817|NCT00079781|101946094|FG002|STARTED|Evaluation Period||14||
48657818|NCT00079781|101946092|FG000|COMPLETED|Evaluation Period||42||
48657819|NCT00079781|101946093|FG001|COMPLETED|Evaluation Period||9||
48657820|NCT00079781|101946094|FG002|COMPLETED|Evaluation Period||14||
48657821|NCT00079781|101946092|FG000|NOT COMPLETED|Evaluation Period||0||
48657822|NCT00079781|101946093|FG001|NOT COMPLETED|Evaluation Period||0||
48657823|NCT00079781|101946094|FG002|NOT COMPLETED|Evaluation Period||0||
48657824|NCT00079781|101946092|FG000|STARTED|Follow-up Period||42||
48657825|NCT00079781|101946093|FG001|STARTED|Follow-up Period||9||
48657826|NCT00079781|101946094|FG002|STARTED|Follow-up Period||14||
48657827|NCT00079781|101946092|FG000|COMPLETED|Follow-up Period||38||
48768827|NCT02839200|102223079|FG003|STARTED|Overall Study||61||
48768828|NCT02839200|102223080|FG004|STARTED|Overall Study||60||
48768829|NCT02839200|102223081|FG005|STARTED|Overall Study||60||
48768830|NCT02839200|102223076|FG000|COMPLETED|Overall Study||56||
48768831|NCT02839200|102223077|FG001|COMPLETED|Overall Study||58||
48441652|NCT00742859|101416042|FG002|STARTED|Overall Study||127||
48441653|NCT00742859|101416043|FG003|STARTED|Overall Study||127||
48441654|NCT00742859|101416040|FG000|COMPLETED|Overall Study||116||
48441655|NCT00742859|101416041|FG001|COMPLETED|Overall Study||115||
48441656|NCT00742859|101416042|FG002|COMPLETED|Overall Study||116||
48657828|NCT00079781|101946093|FG001|COMPLETED|Follow-up Period||9||
48657829|NCT00079781|101946094|FG002|COMPLETED|Follow-up Period||12||
48657830|NCT00079781|101946092|FG000|NOT COMPLETED|Follow-up Period||4||
48657831|NCT00079781|101946093|FG001|NOT COMPLETED|Follow-up Period||0||
48657832|NCT00079781|101946094|FG002|NOT COMPLETED|Follow-up Period||2||
48657833|NCT00289978|101946095|FG000|STARTED|Overall Study||429||
48657834|NCT00289978|101946096|FG001|STARTED|Overall Study||425||
48657835|NCT00289978|101946097|FG002|STARTED|Overall Study||418||
48768832|NCT02839200|102223078|FG002|COMPLETED|Overall Study||59||
48441657|NCT00742859|101416043|FG003|COMPLETED|Overall Study||119||
48657836|NCT00289978|101946095|FG000|COMPLETED|Overall Study||332||
48768833|NCT02839200|102223079|FG003|COMPLETED|Overall Study||61||
48768834|NCT02839200|102223080|FG004|COMPLETED|Overall Study||58||
48768835|NCT02839200|102223081|FG005|COMPLETED|Overall Study||59||
48768836|NCT02839200|102223076|FG000|NOT COMPLETED|Overall Study||4||
48768837|NCT02839200|102223077|FG001|NOT COMPLETED|Overall Study||1||
48441658|NCT00742859|101416040|FG000|NOT COMPLETED|Overall Study||11||
48441659|NCT00742859|101416041|FG001|NOT COMPLETED|Overall Study||12||
48657837|NCT00289978|101946096|FG001|COMPLETED|Overall Study||369||
48657838|NCT00289978|101946097|FG002|COMPLETED|Overall Study||332||
48657839|NCT00289978|101946095|FG000|NOT COMPLETED|Overall Study||97||
48768838|NCT02839200|102223078|FG002|NOT COMPLETED|Overall Study||1||
48768839|NCT02839200|102223079|FG003|NOT COMPLETED|Overall Study||0||
48768840|NCT02839200|102223080|FG004|NOT COMPLETED|Overall Study||2||
48768841|NCT02839200|102223081|FG005|NOT COMPLETED|Overall Study||1||
48768842|NCT01213472|102223082|FG000|STARTED|Overall Study||33||
48768843|NCT01213472|102223082|FG000|COMPLETED|Overall Study||6||
48441660|NCT00742859|101416042|FG002|NOT COMPLETED|Overall Study||11||
48441661|NCT00742859|101416043|FG003|NOT COMPLETED|Overall Study||8||
48441662|NCT04762771|101416044|FG000|STARTED|Overall Study||1||
48768844|NCT01213472|102223082|FG000|NOT COMPLETED|Overall Study||27||
48768845|NCT01658436|102223083|FG000|STARTED|Overall Study||20||
48768846|NCT01658436|102223084|FG001|STARTED|Overall Study||11||
48768847|NCT01658436|102223083|FG000|COMPLETED|Overall Study||0||
48768848|NCT01658436|102223084|FG001|COMPLETED|Overall Study||0||
48768849|NCT01658436|102223083|FG000|NOT COMPLETED|Overall Study||20||
48768850|NCT01658436|102223084|FG001|NOT COMPLETED|Overall Study||11||
48768851|NCT01881828|102223085|FG000|STARTED|Overall Study||71||
48768852|NCT01881828|102223086|FG001|STARTED|Overall Study||69||
48441663|NCT04762771|101416045|FG001|STARTED|Overall Study||1||
48441664|NCT04762771|101416044|FG000|COMPLETED|Overall Study||1||
48441665|NCT04762771|101416045|FG001|COMPLETED|Overall Study||1||
48441666|NCT04762771|101416044|FG000|NOT COMPLETED|Overall Study||0||
48441667|NCT04762771|101416045|FG001|NOT COMPLETED|Overall Study||0||
48441668|NCT03778190|101416046|FG000|STARTED|Overall Study||10||
48441669|NCT03778190|101416046|FG000|COMPLETED|Overall Study||10||
48188805|NCT01446003|100786090|FG001|STARTED|Period 1||15||
48441670|NCT03778190|101416046|FG000|NOT COMPLETED|Overall Study||0||
48441671|NCT00447694|101416047|FG000|STARTED|Overall Study||28||
48441672|NCT00447694|101416047|FG000|COMPLETED|Overall Study||22||
48441673|NCT00447694|101416047|FG000|NOT COMPLETED|Overall Study||6||
48441674|NCT01327989|101416048|FG000|STARTED|Overall Study||202||
48441675|NCT01327989|101416048|FG000|COMPLETED|Overall Study||188||
48441676|NCT01327989|101416048|FG000|NOT COMPLETED|Overall Study||14||
48441677|NCT03107442|101416049|FG000|STARTED|Overall Study||26||
48441678|NCT03107442|101416050|FG001|STARTED|Overall Study||32||
48441679|NCT03107442|101416049|FG000|COMPLETED|Overall Study||18||
48441680|NCT03107442|101416050|FG001|COMPLETED|Overall Study||28||
48441681|NCT03107442|101416049|FG000|NOT COMPLETED|Overall Study||8||
48441682|NCT03107442|101416050|FG001|NOT COMPLETED|Overall Study||4||
48441683|NCT00265239|101416051|FG000|STARTED|Overall Study||52||
48441684|NCT00265239|101416052|FG001|STARTED|Overall Study||52||
48441685|NCT00265239|101416051|FG000|COMPLETED|Overall Study||50||
48441686|NCT00265239|101416052|FG001|COMPLETED|Overall Study||51||
48441687|NCT00265239|101416051|FG000|NOT COMPLETED|Overall Study||2||
48441688|NCT00265239|101416052|FG001|NOT COMPLETED|Overall Study||1||
48441689|NCT02964910|101416053|FG000|STARTED|Overall Study||235||
48441690|NCT02964910|101416054|FG001|STARTED|Overall Study||240||
48441691|NCT02964910|101416053|FG000|COMPLETED|Overall Study||192||
48188806|NCT01446003|100786089|FG000|COMPLETED|Period 1||14||
48441692|NCT02964910|101416054|FG001|COMPLETED|Overall Study||196||
48441693|NCT02964910|101416053|FG000|NOT COMPLETED|Overall Study||43||
48441694|NCT02964910|101416054|FG001|NOT COMPLETED|Overall Study||44||
48441695|NCT02007512|101416055|FG000|STARTED|Double Blind Treatment Period||63||
48441696|NCT02007512|101416056|FG001|STARTED|Double Blind Treatment Period||64||
48657840|NCT00289978|101946096|FG001|NOT COMPLETED|Overall Study||56||
48657841|NCT00289978|101946097|FG002|NOT COMPLETED|Overall Study||86||
48657842|NCT01796470|101946098|FG000|STARTED|Overall Study||35||
48657843|NCT01796470|101946099|FG001|STARTED|Overall Study||14||
48768853|NCT01881828|102223085|FG000|COMPLETED|Overall Study||71||
48441697|NCT02007512|101416057|FG002|STARTED|Double Blind Treatment Period||60||
48441698|NCT02007512|101416058|FG003|STARTED|Double Blind Treatment Period||60||
48441699|NCT02007512|101416055|FG000|Treated|Double Blind Treatment Period||62||
48441700|NCT02007512|101416056|FG001|Treated|Double Blind Treatment Period||63||
48441701|NCT02007512|101416057|FG002|Treated|Double Blind Treatment Period||60||
48441702|NCT02007512|101416058|FG003|Treated|Double Blind Treatment Period||60||
48441703|NCT02007512|101416055|FG000|COMPLETED|Double Blind Treatment Period||0||
48441704|NCT02007512|101416056|FG001|COMPLETED|Double Blind Treatment Period||0||
48657844|NCT01796470|101946100|FG002|STARTED|Overall Study||6||
48657845|NCT01796470|101946101|FG003|STARTED|Overall Study||3||
48657846|NCT01796470|101946102|FG004|STARTED|Overall Study||8||
48768854|NCT01881828|102223086|FG001|COMPLETED|Overall Study||69||
48768855|NCT01881828|102223085|FG000|NOT COMPLETED|Overall Study||0||
48657847|NCT01796470|101946098|FG000|Entospletinib Monotherapy|Overall Study||4|Participants who received monotherapy when combination therapy was discontinued.|
48768856|NCT01881828|102223086|FG001|NOT COMPLETED|Overall Study||0||
48768857|NCT04135417|102223087|FG000|STARTED|Overall Study||30||
48768858|NCT04135417|102223087|FG000|COMPLETED|Overall Study||30||
48768859|NCT04135417|102223087|FG000|NOT COMPLETED|Overall Study||0||
48768860|NCT02892344|102223088|FG000|STARTED|Overall Study||398||
48768861|NCT02892344|102223089|FG001|STARTED|Overall Study||404||
48768862|NCT02892344|102223088|FG000|Full Analysis Set|Overall Study||395||
48368331|NCT00536731|101230158|FG000|COMPLETED|Overall Study||249||
48368332|NCT00536731|101230159|FG001|COMPLETED|Overall Study||241||
48441705|NCT02007512|101416057|FG002|COMPLETED|Double Blind Treatment Period||0||
48441706|NCT02007512|101416058|FG003|COMPLETED|Double Blind Treatment Period||0||
48441707|NCT02007512|101416055|FG000|NOT COMPLETED|Double Blind Treatment Period||63||
48441708|NCT02007512|101416056|FG001|NOT COMPLETED|Double Blind Treatment Period||64||
48441709|NCT02007512|101416057|FG002|NOT COMPLETED|Double Blind Treatment Period||60||
48441710|NCT02007512|101416058|FG003|NOT COMPLETED|Double Blind Treatment Period||60||
48441711|NCT02007512|101416055|FG000|STARTED|Open Label Treatment Period||0||
48441712|NCT02007512|101416056|FG001|STARTED|Open Label Treatment Period||21||
48441713|NCT02007512|101416057|FG002|STARTED|Open Label Treatment Period||0||
48441714|NCT02007512|101416058|FG003|STARTED|Open Label Treatment Period||12||
48441715|NCT02007512|101416055|FG000|COMPLETED|Open Label Treatment Period||0||
48441716|NCT02007512|101416056|FG001|COMPLETED|Open Label Treatment Period||0||
48441717|NCT02007512|101416057|FG002|COMPLETED|Open Label Treatment Period||0||
48441718|NCT02007512|101416058|FG003|COMPLETED|Open Label Treatment Period||0||
48441719|NCT02007512|101416055|FG000|NOT COMPLETED|Open Label Treatment Period||0||
48441720|NCT02007512|101416056|FG001|NOT COMPLETED|Open Label Treatment Period||21||
48441721|NCT02007512|101416057|FG002|NOT COMPLETED|Open Label Treatment Period||0||
48441722|NCT02007512|101416058|FG003|NOT COMPLETED|Open Label Treatment Period||12||
48441723|NCT04166851|101416059|FG000|STARTED|Overall Study||14||
48441724|NCT04166851|101416060|FG001|STARTED|Overall Study||9||
48441725|NCT04166851|101416059|FG000|COMPLETED|Overall Study||14||
48441726|NCT04166851|101416060|FG001|COMPLETED|Overall Study||9||
48441727|NCT04166851|101416059|FG000|NOT COMPLETED|Overall Study||0||
48441728|NCT04166851|101416060|FG001|NOT COMPLETED|Overall Study||0||
48441729|NCT04736576|101416061|FG000|STARTED|Overall Study||78||
48768863|NCT02892344|102223089|FG001|Full Analysis Set|Overall Study||399||
48768864|NCT02892344|102223088|FG000|COMPLETED|Overall Study||394||
48768865|NCT02892344|102223089|FG001|COMPLETED|Overall Study||383||
48768866|NCT02892344|102223088|FG000|NOT COMPLETED|Overall Study||4||
48768867|NCT02892344|102223089|FG001|NOT COMPLETED|Overall Study||21||
48768868|NCT02233517|102223090|FG000|STARTED|Overall Study||19||
48768869|NCT02233517|102223091|FG001|STARTED|Overall Study||17||
48768870|NCT02233517|102223090|FG000|COMPLETED|Overall Study||12||
48768871|NCT02233517|102223091|FG001|COMPLETED|Overall Study||13||
48768872|NCT02233517|102223090|FG000|NOT COMPLETED|Overall Study||7||
48768873|NCT02233517|102223091|FG001|NOT COMPLETED|Overall Study||4||
48368333|NCT00536731|101230160|FG002|COMPLETED|Overall Study||238||
48368334|NCT00536731|101230158|FG000|NOT COMPLETED|Overall Study||4||
48368335|NCT00536731|101230159|FG001|NOT COMPLETED|Overall Study||5||
48368336|NCT00536731|101230160|FG002|NOT COMPLETED|Overall Study||5||
48368337|NCT00502905|101230161|FG000|STARTED|Overall Study||196||
48368338|NCT00502905|101230161|FG000|COMPLETED|Overall Study||196||
48368339|NCT00502905|101230161|FG000|NOT COMPLETED|Overall Study||0||
48368340|NCT01097330|101230162|FG000|STARTED|Overall Study||7||
48368341|NCT01097330|101230163|FG001|STARTED|Overall Study||5||
48368342|NCT01097330|101230162|FG000|COMPLETED|Overall Study||0||
48368343|NCT01097330|101230163|FG001|COMPLETED|Overall Study||0||
48368344|NCT01097330|101230162|FG000|NOT COMPLETED|Overall Study||7||
48368345|NCT01097330|101230163|FG001|NOT COMPLETED|Overall Study||5||
48368346|NCT02045277|101230164|FG000|STARTED|Overall Study||59||
48368347|NCT02045277|101230165|FG001|STARTED|Overall Study||63||
48368348|NCT02045277|101230166|FG002|STARTED|Overall Study||59||
48368349|NCT02045277|101230167|FG003|STARTED|Overall Study||31||
48368350|NCT02045277|101230164|FG000|COMPLETED|Overall Study||55||
48368351|NCT02045277|101230165|FG001|COMPLETED|Overall Study||62||
48368352|NCT02045277|101230166|FG002|COMPLETED|Overall Study||47||
48368353|NCT02045277|101230167|FG003|COMPLETED|Overall Study||29||
48368354|NCT02045277|101230164|FG000|NOT COMPLETED|Overall Study||4||
48368355|NCT02045277|101230165|FG001|NOT COMPLETED|Overall Study||1||
48368356|NCT02045277|101230166|FG002|NOT COMPLETED|Overall Study||12||
48368357|NCT02045277|101230167|FG003|NOT COMPLETED|Overall Study||2||
48368358|NCT02853331|101230168|FG000|STARTED|Overall Study||432||
48368359|NCT02853331|101230169|FG001|STARTED|Overall Study||429||
48368360|NCT02853331|101230168|FG000|Treated|Overall Study||429||
48368361|NCT02853331|101230169|FG001|Treated|Overall Study||425||
48368362|NCT02853331|101230168|FG000|COMPLETED|Overall Study||0||
48368363|NCT02853331|101230169|FG001|COMPLETED|Overall Study||0||
48368364|NCT02853331|101230168|FG000|NOT COMPLETED|Overall Study||432||
48368365|NCT02853331|101230169|FG001|NOT COMPLETED|Overall Study||429||
48368366|NCT00669539|101230170|FG000|STARTED|Overall Study||94||
48368367|NCT00669539|101230171|FG001|STARTED|Overall Study||52||
48368368|NCT00669539|101230170|FG000|COMPLETED|Overall Study||86||
48368369|NCT00669539|101230171|FG001|COMPLETED|Overall Study||43||
48368370|NCT00669539|101230170|FG000|NOT COMPLETED|Overall Study||8||
48368371|NCT00669539|101230171|FG001|NOT COMPLETED|Overall Study||9||
48368372|NCT01461863|101230172|FG000|STARTED|Overall Study||48||
48368373|NCT01461863|101230173|FG001|STARTED|Overall Study||48||
48368374|NCT01461863|101230172|FG000|COMPLETED|Overall Study||48||
48368375|NCT01461863|101230173|FG001|COMPLETED|Overall Study||48||
48768874|NCT01249261|102223092|FG000|STARTED|Overall Study||30||
48441730|NCT04736576|101416062|FG001|STARTED|Overall Study||21||
48441731|NCT04736576|101416061|FG000|COMPLETED|Overall Study||74||
48441732|NCT04736576|101416062|FG001|COMPLETED|Overall Study||20||
48441733|NCT04736576|101416061|FG000|NOT COMPLETED|Overall Study||4||
48441734|NCT04736576|101416062|FG001|NOT COMPLETED|Overall Study||1||
48768875|NCT01249261|102223093|FG001|STARTED|Overall Study||31||
48768876|NCT01249261|102223092|FG000|COMPLETED|Overall Study||29||
48768877|NCT01249261|102223093|FG001|COMPLETED|Overall Study||31||
48768878|NCT01249261|102223092|FG000|NOT COMPLETED|Overall Study||1||
48768879|NCT01249261|102223093|FG001|NOT COMPLETED|Overall Study||0||
48768880|NCT02148874|102223094|FG000|STARTED|Overall Study||201||
48768881|NCT02148874|102223095|FG001|STARTED|Overall Study||86||
48441735|NCT02682069|101416063|FG000|STARTED|Overall Study||30||
48441736|NCT02682069|101416063|FG000|COMPLETED|Overall Study||30||
48441737|NCT02682069|101416063|FG000|NOT COMPLETED|Overall Study||0||
48441738|NCT03022799|101416064|FG000|STARTED|Overall Study||6||
48441739|NCT03022799|101416065|FG001|STARTED|Overall Study||6||
48657848|NCT01796470|101946099|FG001|Entospletinib Monotherapy|Overall Study||4|Participants who received monotherapy when combination therapy was discontinued.|
48657849|NCT01796470|101946100|FG002|Entospletinib Monotherapy|Overall Study||0|Participants who received monotherapy when combination therapy was discontinued.|
48657850|NCT01796470|101946101|FG003|Entospletinib Monotherapy|Overall Study||0|Participants who received monotherapy when combination therapy was discontinued.|
48657851|NCT01796470|101946102|FG004|Entospletinib Monotherapy|Overall Study||0|Participants who received monotherapy when combination therapy was discontinued.|
48657852|NCT01796470|101946098|FG000|COMPLETED|Overall Study||0||
48657853|NCT01796470|101946099|FG001|COMPLETED|Overall Study||0||
48657854|NCT01796470|101946100|FG002|COMPLETED|Overall Study||0||
48657855|NCT01796470|101946101|FG003|COMPLETED|Overall Study||0||
48657856|NCT01796470|101946102|FG004|COMPLETED|Overall Study||0||
48657857|NCT01796470|101946098|FG000|NOT COMPLETED|Overall Study||35||
48657858|NCT01796470|101946099|FG001|NOT COMPLETED|Overall Study||14||
48657859|NCT01796470|101946100|FG002|NOT COMPLETED|Overall Study||6||
48657860|NCT01796470|101946101|FG003|NOT COMPLETED|Overall Study||3||
48657861|NCT01796470|101946102|FG004|NOT COMPLETED|Overall Study||8||
48657862|NCT03956082|101946103|FG000|STARTED|Overall Study||15||
48657863|NCT03956082|101946103|FG000|COMPLETED|Overall Study||9||
48657864|NCT03956082|101946103|FG000|NOT COMPLETED|Overall Study||6||
48657865|NCT05943990|101946104|FG000|STARTED|Overall Study||2||
48657866|NCT05943990|101946105|FG001|STARTED|Overall Study||2||
48657867|NCT05943990|101946106|FG002|STARTED|Overall Study||1||
48657868|NCT05943990|101946104|FG000|COMPLETED|Overall Study||2|Participants who received T cell infusion and were followed up in this study until death or until transfer to the separate long term follow-up study are considered to have completed.|
48768882|NCT02148874|102223094|FG000|COMPLETED|Overall Study||194||
48441740|NCT03022799|101416066|FG002|STARTED|Overall Study||6||
48441741|NCT03022799|101416067|FG003|STARTED|Overall Study||6||
48441742|NCT03022799|101416068|FG004|STARTED|Overall Study||6||
48441743|NCT03022799|101416069|FG005|STARTED|Overall Study||6||
48441744|NCT03022799|101416070|FG006|STARTED|Overall Study||12||
48657869|NCT05943990|101946105|FG001|COMPLETED|Overall Study||2|Participants who received T cell infusion and were followed up in this study until death or until transfer to the separate long term follow-up study are considered to have completed.|
48657870|NCT05943990|101946106|FG002|COMPLETED|Overall Study||0|Participants who received T cell infusion and were followed up in this study until death or until transfer to the separate long term follow-up study are considered to have completed.|
48657871|NCT05943990|101946104|FG000|NOT COMPLETED|Overall Study||0||
48657872|NCT05943990|101946105|FG001|NOT COMPLETED|Overall Study||0||
48768883|NCT02148874|102223095|FG001|COMPLETED|Overall Study||84||
48768884|NCT02148874|102223094|FG000|NOT COMPLETED|Overall Study||7||
48441745|NCT03022799|101416071|FG007|STARTED|Overall Study||6||
48441746|NCT03022799|101416072|FG008|STARTED|Overall Study||6||
48441747|NCT03022799|101416073|FG009|STARTED|Overall Study||6||
48441748|NCT03022799|101416074|FG010|STARTED|Overall Study||6||
48441749|NCT03022799|101416075|FG011|STARTED|Overall Study||6||
48441750|NCT03022799|101416076|FG012|STARTED|Overall Study||10||
48441751|NCT03022799|101416064|FG000|COMPLETED|Overall Study||6||
48441752|NCT03022799|101416065|FG001|COMPLETED|Overall Study||6||
48441753|NCT03022799|101416066|FG002|COMPLETED|Overall Study||6||
48441754|NCT03022799|101416067|FG003|COMPLETED|Overall Study||6||
48441755|NCT03022799|101416068|FG004|COMPLETED|Overall Study||6||
48441756|NCT03022799|101416069|FG005|COMPLETED|Overall Study||6||
48441757|NCT03022799|101416070|FG006|COMPLETED|Overall Study||12||
48441758|NCT03022799|101416071|FG007|COMPLETED|Overall Study||6||
48441759|NCT03022799|101416072|FG008|COMPLETED|Overall Study||6||
48441760|NCT03022799|101416073|FG009|COMPLETED|Overall Study||5||
48768885|NCT02148874|102223095|FG001|NOT COMPLETED|Overall Study||2||
48768886|NCT00472576|102223096|FG000|STARTED|First Intervention||2||
48768887|NCT00472576|102223097|FG001|STARTED|First Intervention||3||
48768888|NCT00472576|102223096|FG000|COMPLETED|First Intervention||2||
48768889|NCT00472576|102223097|FG001|COMPLETED|First Intervention||3||
48768890|NCT00472576|102223096|FG000|NOT COMPLETED|First Intervention||0||
48768891|NCT00472576|102223097|FG001|NOT COMPLETED|First Intervention||0||
48768892|NCT00472576|102223096|FG000|STARTED|Second Intervention||2||
48768893|NCT00472576|102223097|FG001|STARTED|Second Intervention||3||
48768894|NCT00472576|102223096|FG000|COMPLETED|Second Intervention||2||
48768895|NCT00472576|102223097|FG001|COMPLETED|Second Intervention||3||
48768896|NCT00472576|102223096|FG000|NOT COMPLETED|Second Intervention||0||
48768897|NCT00472576|102223097|FG001|NOT COMPLETED|Second Intervention||0||
48768898|NCT01356628|102223098|FG000|STARTED|Overall Study||23||
48768899|NCT01356628|102223098|FG000|COMPLETED|Overall Study||23||
48768900|NCT01356628|102223098|FG000|NOT COMPLETED|Overall Study||0||
48768901|NCT01162096|102223099|FG000|STARTED|Overall Study||34||
48768902|NCT01162096|102223099|FG000|COMPLETED|Overall Study||34||
48768903|NCT01162096|102223099|FG000|NOT COMPLETED|Overall Study||0||
48441761|NCT03022799|101416074|FG010|COMPLETED|Overall Study||5||
48441762|NCT03022799|101416075|FG011|COMPLETED|Overall Study||6||
48441763|NCT03022799|101416076|FG012|COMPLETED|Overall Study||10||
48441764|NCT03022799|101416064|FG000|NOT COMPLETED|Overall Study||0||
48441765|NCT03022799|101416065|FG001|NOT COMPLETED|Overall Study||0||
48441766|NCT03022799|101416066|FG002|NOT COMPLETED|Overall Study||0||
48441767|NCT03022799|101416067|FG003|NOT COMPLETED|Overall Study||0||
48441768|NCT03022799|101416068|FG004|NOT COMPLETED|Overall Study||0||
48441769|NCT03022799|101416069|FG005|NOT COMPLETED|Overall Study||0||
48441770|NCT03022799|101416070|FG006|NOT COMPLETED|Overall Study||0||
48657873|NCT05943990|101946106|FG002|NOT COMPLETED|Overall Study||1||
48657874|NCT00678574|101946107|FG000|STARTED|Overall Study||18||
48657875|NCT00678574|101946108|FG001|STARTED|Overall Study||27||
48657876|NCT00678574|101946107|FG000|COMPLETED|Overall Study||18||
48657877|NCT00678574|101946108|FG001|COMPLETED|Overall Study||27||
48657878|NCT00678574|101946107|FG000|NOT COMPLETED|Overall Study||0||
48657879|NCT00678574|101946108|FG001|NOT COMPLETED|Overall Study||0||
48657880|NCT03939494|101946109|FG000|STARTED|Overall Study||39||
48657881|NCT03939494|101946110|FG001|STARTED|Overall Study||22||
48657882|NCT03939494|101946109|FG000|COMPLETED|Overall Study||14||
48657883|NCT03939494|101946110|FG001|COMPLETED|Overall Study||11||
48657884|NCT03939494|101946109|FG000|NOT COMPLETED|Overall Study||25||
48657885|NCT03939494|101946110|FG001|NOT COMPLETED|Overall Study||11||
48657886|NCT00069953|101946111|FG000|STARTED|Overall Study||43||
48657887|NCT00069953|101946111|FG000|COMPLETED|Overall Study||41||
48657888|NCT00069953|101946111|FG000|NOT COMPLETED|Overall Study||2||
48657889|NCT01341990|101946112|FG000|STARTED|Overall Study||35||
48657890|NCT01341990|101946113|FG001|STARTED|Overall Study||33||
48657891|NCT01341990|101946112|FG000|COMPLETED|Overall Study||32||
48768904|NCT03824769|102223100|FG000|STARTED|Phase I (Weight Loss): 16 Weeks||24||
48768905|NCT03824769|102223101|FG001|STARTED|Phase I (Weight Loss): 16 Weeks||28||
48768906|NCT03824769|102223102|FG002|STARTED|Phase I (Weight Loss): 16 Weeks||108||
48768907|NCT03824769|102223100|FG000|COMPLETED|Phase I (Weight Loss): 16 Weeks||24||
48768908|NCT03824769|102223101|FG001|COMPLETED|Phase I (Weight Loss): 16 Weeks||28||
48768909|NCT03824769|102223102|FG002|COMPLETED|Phase I (Weight Loss): 16 Weeks||0||
48768910|NCT03824769|102223100|FG000|NOT COMPLETED|Phase I (Weight Loss): 16 Weeks||0||
48768911|NCT03824769|102223101|FG001|NOT COMPLETED|Phase I (Weight Loss): 16 Weeks||0||
48768912|NCT03824769|102223102|FG002|NOT COMPLETED|Phase I (Weight Loss): 16 Weeks||108||
48768913|NCT03824769|102223100|FG000|STARTED|Phase II (Weight Maintenance): 4 Months||24||
48768914|NCT03824769|102223101|FG001|STARTED|Phase II (Weight Maintenance): 4 Months||28||
48768915|NCT03824769|102223102|FG002|STARTED|Phase II (Weight Maintenance): 4 Months||0||
48768916|NCT03824769|102223100|FG000|1 Month Assessment|Phase II (Weight Maintenance): 4 Months||22||
48441771|NCT03022799|101416071|FG007|NOT COMPLETED|Overall Study||0||
48657892|NCT01341990|101946113|FG001|COMPLETED|Overall Study||32||
48657893|NCT01341990|101946112|FG000|NOT COMPLETED|Overall Study||3||
48657894|NCT01341990|101946113|FG001|NOT COMPLETED|Overall Study||1||
48657895|NCT03023683|101946114|FG000|STARTED|Overall Study||0||
48657896|NCT03023683|101946115|FG001|STARTED|Overall Study||18||
48368376|NCT01461863|101230172|FG000|NOT COMPLETED|Overall Study||0||
48368377|NCT01461863|101230173|FG001|NOT COMPLETED|Overall Study||0||
48768917|NCT03824769|102223101|FG001|1 Month Assessment|Phase II (Weight Maintenance): 4 Months||27||
48768918|NCT03824769|102223102|FG002|1 Month Assessment|Phase II (Weight Maintenance): 4 Months||0||
48768919|NCT03824769|102223100|FG000|2 Month Assessment|Phase II (Weight Maintenance): 4 Months||21||
48768920|NCT03824769|102223101|FG001|2 Month Assessment|Phase II (Weight Maintenance): 4 Months||26||
48441772|NCT03022799|101416072|FG008|NOT COMPLETED|Overall Study||0||
48441773|NCT03022799|101416073|FG009|NOT COMPLETED|Overall Study||1||
48441774|NCT03022799|101416074|FG010|NOT COMPLETED|Overall Study||1||
48441775|NCT03022799|101416075|FG011|NOT COMPLETED|Overall Study||0||
48441776|NCT03022799|101416076|FG012|NOT COMPLETED|Overall Study||0||
48441777|NCT04671329|101416077|FG000|STARTED|Overall Study||67||
48441778|NCT04671329|101416077|FG000|COMPLETED|Overall Study||60||
48441779|NCT04671329|101416077|FG000|NOT COMPLETED|Overall Study||7||
48441780|NCT03862807|101416078|FG000|STARTED|Overall Study||24||
48368378|NCT00406640|101230174|FG000|STARTED|Acute Phase||296||
48368379|NCT00406640|101230175|FG001|STARTED|Acute Phase||299||
48441781|NCT03862807|101416078|FG000|Treated|Overall Study||23||
48441782|NCT03862807|101416078|FG000|Completed Treatment|Overall Study||22||
48441783|NCT03862807|101416078|FG000|COMPLETED|Overall Study||23||
48441784|NCT03862807|101416078|FG000|NOT COMPLETED|Overall Study||1||
48441785|NCT01419028|101416079|FG000|STARTED|Overall Study||48||
48441786|NCT01419028|101416079|FG000|COMPLETED|Overall Study||48||
48441787|NCT01419028|101416079|FG000|NOT COMPLETED|Overall Study||0||
48441788|NCT00537056|101416080|FG000|STARTED|Baseline PET/CT||17||
48441789|NCT00537056|101416080|FG000|COMPLETED|Baseline PET/CT||17||
48441790|NCT00537056|101416080|FG000|NOT COMPLETED|Baseline PET/CT||0||
48441791|NCT00537056|101416080|FG000|STARTED|Interim PET/CT||17||
48441792|NCT00537056|101416080|FG000|COMPLETED|Interim PET/CT||12||
48441793|NCT00537056|101416080|FG000|NOT COMPLETED|Interim PET/CT||5||
48441794|NCT00537056|101416080|FG000|STARTED|12-month Follow-up||17||
48441795|NCT00537056|101416080|FG000|COMPLETED|12-month Follow-up||17||
48441796|NCT00537056|101416080|FG000|NOT COMPLETED|12-month Follow-up||0||
48441797|NCT01870921|101416081|FG000|STARTED|Overall Study||2004||
48441798|NCT01870921|101416081|FG000|COMPLETED|Overall Study||1914||
48441799|NCT01870921|101416081|FG000|NOT COMPLETED|Overall Study||90||
48441800|NCT03505606|101416082|FG000|STARTED|Overall Study||25||
48441801|NCT03505606|101416083|FG001|STARTED|Overall Study||25||
48441802|NCT03505606|101416084|FG002|STARTED|Overall Study||26||
48441803|NCT03505606|101416082|FG000|COMPLETED|Overall Study||24||
48441804|NCT03505606|101416083|FG001|COMPLETED|Overall Study||22||
48441805|NCT03505606|101416084|FG002|COMPLETED|Overall Study||22||
48441806|NCT03505606|101416082|FG000|NOT COMPLETED|Overall Study||1||
48441807|NCT03505606|101416083|FG001|NOT COMPLETED|Overall Study||3||
48441808|NCT03505606|101416084|FG002|NOT COMPLETED|Overall Study||4||
48657897|NCT03023683|101946114|FG000|COMPLETED|Overall Study||0||
48657898|NCT03023683|101946115|FG001|COMPLETED|Overall Study||17||
48657899|NCT03023683|101946114|FG000|NOT COMPLETED|Overall Study||0||
48657900|NCT03023683|101946115|FG001|NOT COMPLETED|Overall Study||1||
48657901|NCT01569763|101946116|FG000|STARTED|Overall Study||102||
48657902|NCT01569763|101946117|FG001|STARTED|Overall Study||51||
48657903|NCT01569763|101946116|FG000|Treated|Overall Study||102||
48657904|NCT01569763|101946117|FG001|Treated|Overall Study||51||
48657905|NCT01569763|101946116|FG000|COMPLETED|Overall Study||99||
48657906|NCT01569763|101946117|FG001|COMPLETED|Overall Study||44||
48657907|NCT01569763|101946116|FG000|NOT COMPLETED|Overall Study||3||
48657908|NCT01569763|101946117|FG001|NOT COMPLETED|Overall Study||7||
48368380|NCT00406640|101230174|FG000|COMPLETED|Acute Phase||245||
48368381|NCT00406640|101230175|FG001|COMPLETED|Acute Phase||256||
48368382|NCT00406640|101230174|FG000|NOT COMPLETED|Acute Phase||51||
48368383|NCT00406640|101230175|FG001|NOT COMPLETED|Acute Phase||43||
48368384|NCT00406640|101230174|FG000|STARTED|DB Continuation Phase for Responders||172||
48368385|NCT00406640|101230175|FG001|STARTED|DB Continuation Phase for Responders||188||
48368386|NCT00406640|101230174|FG000|COMPLETED|DB Continuation Phase for Responders||139||
48368387|NCT00406640|101230175|FG001|COMPLETED|DB Continuation Phase for Responders||151||
48368388|NCT00406640|101230174|FG000|NOT COMPLETED|DB Continuation Phase for Responders||33||
48441809|NCT01523301|101416085|FG000|STARTED|Overall Study||184||
48441810|NCT01523301|101416086|FG001|STARTED|Overall Study||196||
48441811|NCT01523301|101416085|FG000|COMPLETED|Overall Study||149||
48441812|NCT01523301|101416086|FG001|COMPLETED|Overall Study||164||
48441813|NCT01523301|101416085|FG000|NOT COMPLETED|Overall Study||35||
48441814|NCT01523301|101416086|FG001|NOT COMPLETED|Overall Study||32||
48441815|NCT04499391|101416087|FG000|STARTED|Overall Study||0|Participants were not assigned to Arm/Groups|68
48441816|NCT04499391|101416088|FG001|STARTED|Overall Study||0|Participants were not assigned to Arm/Groups|68
48441817|NCT04499391|101416087|FG000|COMPLETED|Overall Study||0|Participants were not assigned to Arm/Groups|64
48657909|NCT03654326|101946118|FG000|STARTED|Overall Study||94||
48657910|NCT03654326|101946119|FG001|STARTED|Overall Study||93||
48657911|NCT03654326|101946118|FG000|COMPLETED|Overall Study||88||
48441818|NCT04499391|101416088|FG001|COMPLETED|Overall Study||0|Participants were not assigned to Arm/Groups|62
48441819|NCT04499391|101416087|FG000|NOT COMPLETED|Overall Study||0||4
48441820|NCT04499391|101416088|FG001|NOT COMPLETED|Overall Study||0||6
48441821|NCT05013749|101416089|FG000|STARTED|Overall Study||31||
48441822|NCT05013749|101416090|FG001|STARTED|Overall Study||29||
48441823|NCT05013749|101416089|FG000|Participants That Received a Different Intervention Than They Were Originally Randomized to|Overall Study||7||
48441824|NCT05013749|101416090|FG001|Participants That Received a Different Intervention Than They Were Originally Randomized to|Overall Study||9||
48441825|NCT05013749|101416089|FG000|COMPLETED|Overall Study||24||
48441826|NCT05013749|101416090|FG001|COMPLETED|Overall Study||18||
48441827|NCT05013749|101416089|FG000|NOT COMPLETED|Overall Study||7||
48441828|NCT05013749|101416090|FG001|NOT COMPLETED|Overall Study||11||
48441829|NCT00564486|101416091|FG000|STARTED|Overall Study||43||
48441830|NCT00564486|101416092|FG001|STARTED|Overall Study||92||
48441831|NCT00564486|101416093|FG002|STARTED|Overall Study||42||
48441832|NCT00564486|101416094|FG003|STARTED|Overall Study||67||
48441833|NCT00564486|101416091|FG000|COMPLETED|Overall Study||36||
48441834|NCT00564486|101416092|FG001|COMPLETED|Overall Study||91||
48441835|NCT00564486|101416093|FG002|COMPLETED|Overall Study||39||
48441836|NCT00564486|101416094|FG003|COMPLETED|Overall Study||60||
48441837|NCT00564486|101416091|FG000|NOT COMPLETED|Overall Study||7||
48441838|NCT00564486|101416092|FG001|NOT COMPLETED|Overall Study||1||
48441839|NCT00564486|101416093|FG002|NOT COMPLETED|Overall Study||3||
48441840|NCT00564486|101416094|FG003|NOT COMPLETED|Overall Study||7||
48441841|NCT02926053|101416095|FG000|STARTED|Overall Study||5||
48441842|NCT02926053|101416095|FG000|COMPLETED|Overall Study||5||
48441843|NCT02926053|101416095|FG000|NOT COMPLETED|Overall Study||0||
48441844|NCT04527549|101416096|FG000|STARTED|Overall Study||3||
48441845|NCT04527549|101416097|FG001|STARTED|Overall Study||2||
48768921|NCT03824769|102223102|FG002|2 Month Assessment|Phase II (Weight Maintenance): 4 Months||0||
48188807|NCT01446003|100786090|FG001|COMPLETED|Period 1||15||
48188808|NCT01446003|100786089|FG000|NOT COMPLETED|Period 1||2||
48188809|NCT01446003|100786090|FG001|NOT COMPLETED|Period 1||0||
48188810|NCT01446003|100786089|FG000|STARTED|Period 2||14||
48188811|NCT01446003|100786090|FG001|STARTED|Period 2||15||
48188812|NCT01446003|100786089|FG000|COMPLETED|Period 2||13||
48188813|NCT01446003|100786090|FG001|COMPLETED|Period 2||15||
48441846|NCT04527549|101416096|FG000|COMPLETED|Overall Study||2||
48768922|NCT03824769|102223100|FG000|COMPLETED|Phase II (Weight Maintenance): 4 Months||22||
48768923|NCT03824769|102223101|FG001|COMPLETED|Phase II (Weight Maintenance): 4 Months||28||
48768924|NCT03824769|102223102|FG002|COMPLETED|Phase II (Weight Maintenance): 4 Months||0||
48768925|NCT03824769|102223100|FG000|NOT COMPLETED|Phase II (Weight Maintenance): 4 Months||2||
48768926|NCT03824769|102223101|FG001|NOT COMPLETED|Phase II (Weight Maintenance): 4 Months||0||
48768927|NCT03824769|102223102|FG002|NOT COMPLETED|Phase II (Weight Maintenance): 4 Months||0||
48768928|NCT00942604|102223103|FG000|STARTED|Overall Study||100||
48768929|NCT00942604|102223104|FG001|STARTED|Overall Study||103||
48188814|NCT01446003|100786089|FG000|NOT COMPLETED|Period 2||1||
48188815|NCT01446003|100786090|FG001|NOT COMPLETED|Period 2||0||
48188816|NCT01682538|100786091|FG000|STARTED|Overall Study||12||
48188817|NCT01682538|100786091|FG000|COMPLETED|Overall Study||12||
48188818|NCT01682538|100786091|FG000|NOT COMPLETED|Overall Study||0||
48188819|NCT00124982|100786092|FG000|STARTED|Short-term Period||449||
48441847|NCT04527549|101416097|FG001|COMPLETED|Overall Study||1||
48441848|NCT04527549|101416096|FG000|NOT COMPLETED|Overall Study||1||
48441849|NCT04527549|101416097|FG001|NOT COMPLETED|Overall Study||1||
48441850|NCT04645342|101416098|FG000|STARTED|Overall Study||36||
48441851|NCT04645342|101416099|FG001|STARTED|Overall Study||39||
48441852|NCT04645342|101416098|FG000|COMPLETED|Overall Study||36||
48441853|NCT04645342|101416099|FG001|COMPLETED|Overall Study||39||
48441854|NCT04645342|101416098|FG000|NOT COMPLETED|Overall Study||0||
48441855|NCT04645342|101416099|FG001|NOT COMPLETED|Overall Study||0||
48441856|NCT00138658|101416100|FG000|STARTED|Overall Study||81||
48188820|NCT00124982|100786093|FG001|STARTED|Short-term Period||597||
48441857|NCT00138658|101416100|FG000|COMPLETED|Overall Study||20||
48441858|NCT00138658|101416100|FG000|NOT COMPLETED|Overall Study||61||
48441859|NCT00068770|101416101|FG000|STARTED|Overall Study||13||
48441860|NCT00068770|101416102|FG001|STARTED|Overall Study||22||
48441861|NCT00068770|101416101|FG000|COMPLETED|Overall Study||13||
48768930|NCT00942604|102223103|FG000|COMPLETED|Overall Study||98||
48768931|NCT00942604|102223104|FG001|COMPLETED|Overall Study||99||
48768932|NCT00942604|102223103|FG000|NOT COMPLETED|Overall Study||2||
48768933|NCT00942604|102223104|FG001|NOT COMPLETED|Overall Study||4||
48768934|NCT03414983|102223105|FG000|STARTED|Pre-Treatment||127|Started=Randomized|
48768935|NCT03414983|102223106|FG001|STARTED|Pre-Treatment||68|Started=Randomized|
48768936|NCT03414983|102223105|FG000|COMPLETED|Pre-Treatment||123|Completed=Treated|
48188821|NCT00124982|100786094|FG002|STARTED|Short-term Period||0||
48188822|NCT00124982|100786092|FG000|COMPLETED|Short-term Period||377||
48768937|NCT03414983|102223106|FG001|COMPLETED|Pre-Treatment||62|Completed=Treated|
48768938|NCT03414983|102223105|FG000|NOT COMPLETED|Pre-Treatment||4||
48768939|NCT03414983|102223106|FG001|NOT COMPLETED|Pre-Treatment||6||
48768940|NCT03414983|102223105|FG000|STARTED|Treatment||123|Started=Treated|
48768941|NCT03414983|102223106|FG001|STARTED|Treatment||62|Started=Treated|
48768942|NCT03414983|102223105|FG000|COMPLETED|Treatment||9||
48768943|NCT03414983|102223106|FG001|COMPLETED|Treatment||0||
48768944|NCT03414983|102223105|FG000|NOT COMPLETED|Treatment||114||
48768945|NCT03414983|102223106|FG001|NOT COMPLETED|Treatment||62||
48768946|NCT00432172|102223107|FG000|STARTED|Overall Study||47||
48768947|NCT00432172|102223108|FG001|STARTED|Overall Study||48||
48441862|NCT00068770|101416102|FG001|COMPLETED|Overall Study||22||
48441863|NCT00068770|101416101|FG000|NOT COMPLETED|Overall Study||0||
48441864|NCT00068770|101416102|FG001|NOT COMPLETED|Overall Study||0||
48768948|NCT00432172|102223109|FG002|STARTED|Overall Study||46||
48768949|NCT00432172|102223110|FG003|STARTED|Overall Study||48||
48768950|NCT00432172|102223107|FG000|COMPLETED|Overall Study||41||
48768951|NCT00432172|102223108|FG001|COMPLETED|Overall Study||41||
48768952|NCT00432172|102223109|FG002|COMPLETED|Overall Study||35||
48768953|NCT00432172|102223110|FG003|COMPLETED|Overall Study||41||
48768954|NCT00432172|102223107|FG000|NOT COMPLETED|Overall Study||6||
48768955|NCT00432172|102223108|FG001|NOT COMPLETED|Overall Study||7||
48441865|NCT03033069|101416103|FG000|STARTED|Overall Study||82||
48441866|NCT03033069|101416104|FG001|STARTED|Overall Study||75||
48441867|NCT03033069|101416105|FG002|STARTED|Overall Study||81||
48441868|NCT03033069|101416106|FG003|STARTED|Overall Study||83||
48441869|NCT03033069|101416103|FG000|Safety Sample|Overall Study||80|Safety Sample included all participants who were randomized into this trial and were administered at least one dose of double-blind investigational medicinal product (IMP).|
48441870|NCT03033069|101416104|FG001|Safety Sample|Overall Study||75|Safety Sample included all participants who were randomized into this trial and were administered at least one dose of double-blind investigational medicinal product (IMP).|
48441871|NCT03033069|101416105|FG002|Safety Sample|Overall Study||79|Safety Sample included all participants who were randomized into this trial and were administered at least one dose of double-blind investigational medicinal product (IMP).|
48441872|NCT03033069|101416106|FG003|Safety Sample|Overall Study||82|Safety Sample included all participants who were randomized into this trial and were administered at least one dose of double-blind investigational medicinal product (IMP).|
48441873|NCT03033069|101416103|FG000|Intent to Treat (ITT) Sample|Overall Study||79|ITT Sample included all participants who were randomized in the trial and took at least one dose of double-blind IMP and have a Baseline and at least one post Baseline evaluation for the clinician-administered PTSD scale for diagnostic and statistical manual of mental disorders, 5th edition (DSM-5) CAPS-5 total score.|
48441874|NCT03033069|101416104|FG001|Intent to Treat (ITT) Sample|Overall Study||72|ITT Sample included all participants who were randomized in the trial and took at least one dose of double-blind IMP and have a Baseline and at least one post Baseline evaluation for the clinician-administered PTSD scale for diagnostic and statistical manual of mental disorders, 5th edition (DSM-5) CAPS-5 total score.|
48441875|NCT03033069|101416105|FG002|Intent to Treat (ITT) Sample|Overall Study||77|ITT Sample included all participants who were randomized in the trial and took at least one dose of double-blind IMP and have a Baseline and at least one post Baseline evaluation for the clinician-administered PTSD scale for diagnostic and statistical manual of mental disorders, 5th edition (DSM-5) CAPS-5 total score.|
48441876|NCT03033069|101416106|FG003|Intent to Treat (ITT) Sample|Overall Study||80|ITT Sample included all participants who were randomized in the trial and took at least one dose of double-blind IMP and have a Baseline and at least one post Baseline evaluation for the clinician-administered PTSD scale for diagnostic and statistical manual of mental disorders, 5th edition (DSM-5) CAPS-5 total score.|
48441877|NCT03033069|101416103|FG000|COMPLETED|Overall Study||58||
48441878|NCT03033069|101416104|FG001|COMPLETED|Overall Study||50||
48441879|NCT03033069|101416105|FG002|COMPLETED|Overall Study||59||
48441880|NCT03033069|101416106|FG003|COMPLETED|Overall Study||64||
48441881|NCT03033069|101416103|FG000|NOT COMPLETED|Overall Study||24||
48441882|NCT03033069|101416104|FG001|NOT COMPLETED|Overall Study||25||
48441883|NCT03033069|101416105|FG002|NOT COMPLETED|Overall Study||22||
48441884|NCT03033069|101416106|FG003|NOT COMPLETED|Overall Study||19||
48441885|NCT02446496|101416107|FG000|STARTED|Overall Study||24||
48441886|NCT02446496|101416107|FG000|COMPLETED|Overall Study||24||
48441887|NCT02446496|101416107|FG000|NOT COMPLETED|Overall Study||0||
48441888|NCT03387735|101416108|FG000|STARTED|Overall Study||168||
48441889|NCT03387735|101416109|FG001|STARTED|Overall Study||176||
48441890|NCT03387735|101416108|FG000|COMPLETED|Overall Study||160||
48441891|NCT03387735|101416109|FG001|COMPLETED|Overall Study||160||
48441892|NCT03387735|101416108|FG000|NOT COMPLETED|Overall Study||8||
48441893|NCT03387735|101416109|FG001|NOT COMPLETED|Overall Study||16||
48441894|NCT00896038|101416110|FG000|STARTED|Overall Study||30||
48441895|NCT00896038|101416111|FG001|STARTED|Overall Study||28||
48441896|NCT00896038|101416110|FG000|COMPLETED|Overall Study||26||
48768956|NCT00432172|102223109|FG002|NOT COMPLETED|Overall Study||11||
48768957|NCT00432172|102223110|FG003|NOT COMPLETED|Overall Study||7||
48768958|NCT03771664|102223111|FG000|STARTED|Overall Study||43||
48768959|NCT03771664|102223112|FG001|STARTED|Overall Study||44||
48768960|NCT03771664|102223111|FG000|Full Analysis Set (FAS)|Overall Study||43|FAS included all randomized participants with valid baseline and at least one post-baseline efficacy evaluation.|
48768961|NCT03771664|102223112|FG001|Full Analysis Set (FAS)|Overall Study||43|FAS included all randomized participants with valid baseline and at least one post-baseline efficacy evaluation.|
48441897|NCT00896038|101416111|FG001|COMPLETED|Overall Study||27||
48441898|NCT00896038|101416110|FG000|NOT COMPLETED|Overall Study||4||
48441899|NCT00896038|101416111|FG001|NOT COMPLETED|Overall Study||1||
48441900|NCT02822612|101416112|FG000|STARTED|Overall Study||14||
48441901|NCT02822612|101416113|FG001|STARTED|Overall Study||13||
48441902|NCT02822612|101416114|FG002|STARTED|Overall Study||14||
48441903|NCT02822612|101416115|FG003|STARTED|Overall Study||4||
48441904|NCT02822612|101416116|FG004|STARTED|Overall Study||15||
48441905|NCT02822612|101416112|FG000|COMPLETED|Overall Study||14||
48441906|NCT02822612|101416113|FG001|COMPLETED|Overall Study||13||
48441907|NCT02822612|101416114|FG002|COMPLETED|Overall Study||14||
48441908|NCT02822612|101416115|FG003|COMPLETED|Overall Study||4||
48441909|NCT02822612|101416116|FG004|COMPLETED|Overall Study||15||
48441910|NCT02822612|101416112|FG000|NOT COMPLETED|Overall Study||0||
48441911|NCT02822612|101416113|FG001|NOT COMPLETED|Overall Study||0||
48441912|NCT02822612|101416114|FG002|NOT COMPLETED|Overall Study||0||
48441913|NCT02822612|101416115|FG003|NOT COMPLETED|Overall Study||0||
48441914|NCT02822612|101416116|FG004|NOT COMPLETED|Overall Study||0||
48441915|NCT01164137|101416117|FG000|STARTED|Overall Study||80||
48441916|NCT01164137|101416118|FG001|STARTED|Overall Study||76||
48441917|NCT01164137|101416117|FG000|COMPLETED|Overall Study||77||
48441918|NCT01164137|101416118|FG001|COMPLETED|Overall Study||76||
48441919|NCT01164137|101416117|FG000|NOT COMPLETED|Overall Study||3||
48441920|NCT01164137|101416118|FG001|NOT COMPLETED|Overall Study||0||
48768962|NCT03771664|102223111|FG000|Safety Set|Overall Study||43|Safety set included all participants who received at least 1 dose of double-blind study drug.|
48768963|NCT03771664|102223112|FG001|Safety Set|Overall Study||43|Safety set included all participants who received at least 1 dose of double-blind study drug.|
48768964|NCT03771664|102223111|FG000|COMPLETED|Overall Study||40||
48768965|NCT03771664|102223112|FG001|COMPLETED|Overall Study||39||
48768966|NCT03771664|102223111|FG000|NOT COMPLETED|Overall Study||3||
48768967|NCT03771664|102223112|FG001|NOT COMPLETED|Overall Study||5||
48768968|NCT00686712|102223113|FG000|STARTED|Overall Study||30||
48768969|NCT00686712|102223114|FG001|STARTED|Overall Study||25||
48768970|NCT00686712|102223115|FG002|STARTED|Overall Study||30||
48768971|NCT00686712|102223113|FG000|COMPLETED|Overall Study||20||
48768972|NCT00686712|102223114|FG001|COMPLETED|Overall Study||14||
48768973|NCT00686712|102223115|FG002|COMPLETED|Overall Study||17||
48768974|NCT00686712|102223113|FG000|NOT COMPLETED|Overall Study||10||
48768975|NCT00686712|102223114|FG001|NOT COMPLETED|Overall Study||11||
48768976|NCT00686712|102223115|FG002|NOT COMPLETED|Overall Study||13||
48768977|NCT01219881|102223116|FG000|STARTED|Overall Study||38||
48768978|NCT01219881|102223117|FG001|STARTED|Overall Study||37||
48768979|NCT01219881|102223116|FG000|COMPLETED|Overall Study||34||
48768980|NCT01219881|102223117|FG001|COMPLETED|Overall Study||32||
48768981|NCT01219881|102223116|FG000|NOT COMPLETED|Overall Study||4||
48768982|NCT01219881|102223117|FG001|NOT COMPLETED|Overall Study||5||
48768983|NCT04634253|102223118|FG000|STARTED|Overall Study||24||
48768984|NCT04634253|102223119|FG001|STARTED|Overall Study||25||
48768985|NCT04634253|102223120|FG002|STARTED|Overall Study||49||
48768986|NCT04634253|102223118|FG000|Received at Least One Dose|Overall Study||24||
48768987|NCT04634253|102223119|FG001|Received at Least One Dose|Overall Study||25||
48768988|NCT04634253|102223120|FG002|Received at Least One Dose|Overall Study||49||
48768989|NCT04634253|102223118|FG000|COMPLETED|Overall Study||22||
48441921|NCT00806416|101416119|FG000|STARTED|Period 1 - Part I||107||
48441922|NCT00806416|101416120|FG001|STARTED|Period 1 - Part I||107||
48441923|NCT00806416|101416121|FG002|STARTED|Period 1 - Part I||0||
48441924|NCT00806416|101416122|FG003|STARTED|Period 1 - Part I||0||
48441925|NCT00806416|101416119|FG000|COMPLETED|Period 1 - Part I||104||
48441926|NCT00806416|101416120|FG001|COMPLETED|Period 1 - Part I||103||
48441927|NCT00806416|101416121|FG002|COMPLETED|Period 1 - Part I||0||
48441928|NCT00806416|101416122|FG003|COMPLETED|Period 1 - Part I||0||
48441929|NCT00806416|101416119|FG000|NOT COMPLETED|Period 1 - Part I||3||
48441930|NCT00806416|101416120|FG001|NOT COMPLETED|Period 1 - Part I||4||
48441931|NCT00806416|101416121|FG002|NOT COMPLETED|Period 1 - Part I||0||
48441932|NCT00806416|101416122|FG003|NOT COMPLETED|Period 1 - Part I||0||
48441933|NCT00806416|101416119|FG000|STARTED|Period 2 - Part I||104||
48441934|NCT00806416|101416120|FG001|STARTED|Period 2 - Part I||103||
48441935|NCT00806416|101416121|FG002|STARTED|Period 2 - Part I||0||
48768990|NCT04634253|102223119|FG001|COMPLETED|Overall Study||23||
48768991|NCT04634253|102223120|FG002|COMPLETED|Overall Study||46||
48768992|NCT04634253|102223118|FG000|NOT COMPLETED|Overall Study||2||
48768993|NCT04634253|102223119|FG001|NOT COMPLETED|Overall Study||2||
48768994|NCT04634253|102223120|FG002|NOT COMPLETED|Overall Study||3||
48768995|NCT00242502|102223121|FG000|STARTED|Overall Study||59||
48768996|NCT00242502|102223121|FG000|COMPLETED|Overall Study||59||
48768997|NCT00242502|102223121|FG000|NOT COMPLETED|Overall Study||0||
48441936|NCT00806416|101416122|FG003|STARTED|Period 2 - Part I||0||
48441937|NCT00806416|101416119|FG000|COMPLETED|Period 2 - Part I||104||
48441938|NCT00806416|101416120|FG001|COMPLETED|Period 2 - Part I||103||
48441939|NCT00806416|101416121|FG002|COMPLETED|Period 2 - Part I||0||
48441940|NCT00806416|101416122|FG003|COMPLETED|Period 2 - Part I||0||
48441941|NCT00806416|101416119|FG000|NOT COMPLETED|Period 2 - Part I||0||
48441942|NCT00806416|101416120|FG001|NOT COMPLETED|Period 2 - Part I||0||
48441943|NCT00806416|101416121|FG002|NOT COMPLETED|Period 2 - Part I||0||
48768998|NCT01192191|102223122|FG000|STARTED|Overall Study||60||
48441944|NCT00806416|101416122|FG003|NOT COMPLETED|Period 2 - Part I||0||
48441945|NCT00806416|101416119|FG000|STARTED|Period 1 - Part II||0||
48441946|NCT00806416|101416120|FG001|STARTED|Period 1 - Part II||0||
48441947|NCT00806416|101416121|FG002|STARTED|Period 1 - Part II||14||
48441948|NCT00806416|101416122|FG003|STARTED|Period 1 - Part II||16||
48441949|NCT00806416|101416119|FG000|COMPLETED|Period 1 - Part II||0||
48441950|NCT00806416|101416120|FG001|COMPLETED|Period 1 - Part II||0||
48441951|NCT00806416|101416121|FG002|COMPLETED|Period 1 - Part II||14||
48441952|NCT00806416|101416122|FG003|COMPLETED|Period 1 - Part II||14||
48441953|NCT00806416|101416119|FG000|NOT COMPLETED|Period 1 - Part II||0||
48441954|NCT00806416|101416120|FG001|NOT COMPLETED|Period 1 - Part II||0||
48441955|NCT00806416|101416121|FG002|NOT COMPLETED|Period 1 - Part II||0||
48657912|NCT03654326|101946119|FG001|COMPLETED|Overall Study||87||
48657913|NCT03654326|101946118|FG000|NOT COMPLETED|Overall Study||6||
48657914|NCT03654326|101946119|FG001|NOT COMPLETED|Overall Study||6||
48657915|NCT01217047|101946120|FG000|STARTED|Overall Study||3||
48657916|NCT01217047|101946121|FG001|STARTED|Overall Study||4||
48657917|NCT01217047|101946122|FG002|STARTED|Overall Study||3||
48657918|NCT01217047|101946120|FG000|COMPLETED|Overall Study||3||
48657919|NCT01217047|101946121|FG001|COMPLETED|Overall Study||3||
48657920|NCT01217047|101946122|FG002|COMPLETED|Overall Study||3||
48657921|NCT01217047|101946120|FG000|NOT COMPLETED|Overall Study||0||
48768999|NCT01192191|102223123|FG001|STARTED|Overall Study||127||
48769000|NCT01192191|102223122|FG000|COMPLETED|Overall Study||49||
48769001|NCT01192191|102223123|FG001|COMPLETED|Overall Study||106||
48769002|NCT01192191|102223122|FG000|NOT COMPLETED|Overall Study||11||
48769003|NCT01192191|102223123|FG001|NOT COMPLETED|Overall Study||21||
48769004|NCT00068692|102223124|FG000|STARTED|Step 1: Registration||128|Randomization (arms I-III in both groups) was step 2.|
48769005|NCT00068692|102223125|FG001|STARTED|Step 1: Registration||97|Randomization (arms I-III in both groups) was step 2.|
48769006|NCT00068692|102223126|FG002|STARTED|Step 1: Registration||0|Randomization (arms I-III in both groups) was step 2.|
48769007|NCT00068692|102223127|FG003|STARTED|Step 1: Registration||0|Randomization (arms I-III in both groups) was step 2.|
48769008|NCT00068692|102223128|FG004|STARTED|Step 1: Registration||0|Randomization (arms I-III in both groups) was step 2.|
48769009|NCT00068692|102223129|FG005|STARTED|Step 1: Registration||0|Randomization (arms I-III in both groups) was step 2.|
48769010|NCT00068692|102223130|FG006|STARTED|Step 1: Registration||0|Randomization (arms I-III in both groups) was step 2.|
48769011|NCT00068692|102223131|FG007|STARTED|Step 1: Registration||0|Randomization (arms I-III in both groups) was step 2.|
48769012|NCT00068692|102223124|FG000|Started Concurrent Chemo/Radiation|Step 1: Registration||125||
48769013|NCT00068692|102223125|FG001|Started Concurrent Chemo/Radiation|Step 1: Registration||0||
48368389|NCT00406640|101230175|FG001|NOT COMPLETED|DB Continuation Phase for Responders||37||
48368390|NCT00406640|101230174|FG000|STARTED|OL Extension Phase for Non-Responders||69||
48368391|NCT00406640|101230175|FG001|STARTED|OL Extension Phase for Non-Responders||60||
48657922|NCT01217047|101946121|FG001|NOT COMPLETED|Overall Study||1||
48657923|NCT01217047|101946122|FG002|NOT COMPLETED|Overall Study||0||
48657924|NCT01887600|101946123|FG000|STARTED|Overall Study||391||
48657925|NCT01887600|101946124|FG001|STARTED|Overall Study||203||
48657926|NCT01887600|101946123|FG000|Treatment Received|Overall Study||391||
48657927|NCT01887600|101946124|FG001|Treatment Received|Overall Study||203||
48769014|NCT00068692|102223126|FG002|Started Concurrent Chemo/Radiation|Step 1: Registration||0||
48368392|NCT00406640|101230174|FG000|COMPLETED|OL Extension Phase for Non-Responders||47||
48368393|NCT00406640|101230175|FG001|COMPLETED|OL Extension Phase for Non-Responders||36||
48368394|NCT00406640|101230174|FG000|NOT COMPLETED|OL Extension Phase for Non-Responders||22||
48368395|NCT00406640|101230175|FG001|NOT COMPLETED|OL Extension Phase for Non-Responders||24||
48368396|NCT01345786|101230176|FG000|STARTED|Overall Study||41||
48368397|NCT01345786|101230177|FG001|STARTED|Overall Study||41||
48368398|NCT01345786|101230178|FG002|STARTED|Overall Study||38||
48441956|NCT00806416|101416122|FG003|NOT COMPLETED|Period 1 - Part II||2||
48441957|NCT00806416|101416119|FG000|STARTED|Period 2 - Part II||0||
48441958|NCT00806416|101416120|FG001|STARTED|Period 2 - Part II||0||
48441959|NCT00806416|101416121|FG002|STARTED|Period 2 - Part II||14||
48657928|NCT01887600|101946123|FG000|COMPLETED|Overall Study||245||
48368399|NCT01345786|101230179|FG003|STARTED|Overall Study||38||
48368400|NCT01345786|101230176|FG000|Treated|Overall Study||41||
48368401|NCT01345786|101230177|FG001|Treated|Overall Study||41||
48368402|NCT01345786|101230178|FG002|Treated|Overall Study||37||
48368403|NCT01345786|101230179|FG003|Treated|Overall Study||37||
48368404|NCT01345786|101230176|FG000|COMPLETED|Overall Study||35||
48368405|NCT01345786|101230177|FG001|COMPLETED|Overall Study||33||
48368406|NCT01345786|101230178|FG002|COMPLETED|Overall Study||33||
48368407|NCT01345786|101230179|FG003|COMPLETED|Overall Study||35||
48368408|NCT01345786|101230176|FG000|NOT COMPLETED|Overall Study||6||
48368409|NCT01345786|101230177|FG001|NOT COMPLETED|Overall Study||8||
48368410|NCT01345786|101230178|FG002|NOT COMPLETED|Overall Study||5||
48441960|NCT00806416|101416122|FG003|STARTED|Period 2 - Part II||14||
48441961|NCT00806416|101416119|FG000|COMPLETED|Period 2 - Part II||0||
48441962|NCT00806416|101416120|FG001|COMPLETED|Period 2 - Part II||0||
48657929|NCT01887600|101946124|FG001|COMPLETED|Overall Study||89||
48441963|NCT00806416|101416121|FG002|COMPLETED|Period 2 - Part II||14||
48441964|NCT00806416|101416122|FG003|COMPLETED|Period 2 - Part II||14||
48441965|NCT00806416|101416119|FG000|NOT COMPLETED|Period 2 - Part II||0||
48441966|NCT00806416|101416120|FG001|NOT COMPLETED|Period 2 - Part II||0||
48441967|NCT00806416|101416121|FG002|NOT COMPLETED|Period 2 - Part II||0||
48441968|NCT00806416|101416122|FG003|NOT COMPLETED|Period 2 - Part II||0||
48441969|NCT01294709|101416123|FG000|STARTED|Period 1||31||
48441970|NCT01294709|101416124|FG001|STARTED|Period 1||33||
48441971|NCT01294709|101416123|FG000|COMPLETED|Period 1||30||
48441972|NCT01294709|101416124|FG001|COMPLETED|Period 1||32||
48441973|NCT01294709|101416123|FG000|NOT COMPLETED|Period 1||1||
48441974|NCT01294709|101416124|FG001|NOT COMPLETED|Period 1||1||
48441975|NCT01294709|101416123|FG000|STARTED|Washout Period||30||
48441976|NCT01294709|101416124|FG001|STARTED|Washout Period||32||
48441977|NCT01294709|101416123|FG000|COMPLETED|Washout Period||29||
48441978|NCT01294709|101416124|FG001|COMPLETED|Washout Period||31||
48441979|NCT01294709|101416123|FG000|NOT COMPLETED|Washout Period||1||
48441980|NCT01294709|101416124|FG001|NOT COMPLETED|Washout Period||1||
48441981|NCT01294709|101416123|FG000|STARTED|Period 2||29||
48441982|NCT01294709|101416124|FG001|STARTED|Period 2||31||
48441983|NCT01294709|101416123|FG000|COMPLETED|Period 2||28||
48441984|NCT01294709|101416124|FG001|COMPLETED|Period 2||31||
48441985|NCT01294709|101416123|FG000|NOT COMPLETED|Period 2||1||
48441986|NCT01294709|101416124|FG001|NOT COMPLETED|Period 2||0||
48441987|NCT02086968|101416125|FG000|STARTED|Overall Study||100||
48441988|NCT02086968|101416126|FG001|STARTED|Overall Study||98||
48441989|NCT02086968|101416125|FG000|COMPLETED|Overall Study||92||
48441990|NCT02086968|101416126|FG001|COMPLETED|Overall Study||85||
48441991|NCT02086968|101416125|FG000|NOT COMPLETED|Overall Study||8||
48441992|NCT02086968|101416126|FG001|NOT COMPLETED|Overall Study||13||
48441993|NCT02998645|101416127|FG000|STARTED|Treatment Period 1||54||
48441994|NCT02998645|101416127|FG000|East/Southeast Asian Ethnicity|Treatment Period 1||18||
48441995|NCT02998645|101416127|FG000|Non-East/Southeast Asian Ethnicity|Treatment Period 1||36||
48441996|NCT02998645|101416127|FG000|COMPLETED|Treatment Period 1||35||
48441997|NCT02998645|101416127|FG000|NOT COMPLETED|Treatment Period 1||19||
48441998|NCT02998645|101416127|FG000|STARTED|Treatment Period 2||21|Participants who were responders at Month 6|
48441999|NCT02998645|101416127|FG000|COMPLETED|Treatment Period 2||11||
48442000|NCT02998645|101416127|FG000|NOT COMPLETED|Treatment Period 2||10||
48442001|NCT01211873|101416128|FG000|STARTED|Overall Study||245||
48442002|NCT01211873|101416129|FG001|STARTED|Overall Study||119||
48442003|NCT01211873|101416130|FG002|STARTED|Overall Study||38||
48442004|NCT01211873|101416128|FG000|COMPLETED|Overall Study||240||
48442005|NCT01211873|101416129|FG001|COMPLETED|Overall Study||117||
48442006|NCT01211873|101416130|FG002|COMPLETED|Overall Study||36||
48442007|NCT01211873|101416128|FG000|NOT COMPLETED|Overall Study||5||
48442008|NCT01211873|101416129|FG001|NOT COMPLETED|Overall Study||2||
48442009|NCT01211873|101416130|FG002|NOT COMPLETED|Overall Study||2||
48442010|NCT00518531|101416131|FG000|STARTED|Treatment Period 1||124||
48442011|NCT00518531|101416132|FG001|STARTED|Treatment Period 1||126||
48442012|NCT00518531|101416131|FG000|Received Treatment|Treatment Period 1||119||
48442013|NCT00518531|101416132|FG001|Received Treatment|Treatment Period 1||124||
48188823|NCT00124982|100786093|FG001|COMPLETED|Short-term Period||483||
48442014|NCT00518531|101416131|FG000|COMPLETED|Treatment Period 1||106||
48442015|NCT00518531|101416132|FG001|COMPLETED|Treatment Period 1||114||
48442016|NCT00518531|101416131|FG000|NOT COMPLETED|Treatment Period 1||18||
48442017|NCT00518531|101416132|FG001|NOT COMPLETED|Treatment Period 1||12||
48442018|NCT00518531|101416131|FG000|STARTED|Treatment Period 2||106||
48442019|NCT00518531|101416132|FG001|STARTED|Treatment Period 2||115||
48442020|NCT00518531|101416131|FG000|Received Treatment|Treatment Period 2||106||
48442021|NCT00518531|101416132|FG001|Received Treatment|Treatment Period 2||110||
48442022|NCT00518531|101416131|FG000|COMPLETED|Treatment Period 2||103||
48442023|NCT00518531|101416132|FG001|COMPLETED|Treatment Period 2||95||
48442024|NCT00518531|101416131|FG000|NOT COMPLETED|Treatment Period 2||3||
48442025|NCT00518531|101416132|FG001|NOT COMPLETED|Treatment Period 2||20||
48442026|NCT02263118|101416133|FG000|STARTED|Overall Study||24||
48442027|NCT02263118|101416134|FG001|STARTED|Overall Study||32||
48442028|NCT02263118|101416135|FG002|STARTED|Overall Study||30||
48442029|NCT02263118|101416136|FG003|STARTED|Overall Study||14||
48442030|NCT02263118|101416133|FG000|COMPLETED|Overall Study||20||
48442031|NCT02263118|101416134|FG001|COMPLETED|Overall Study||24||
48442032|NCT02263118|101416135|FG002|COMPLETED|Overall Study||22||
48657930|NCT01887600|101946123|FG000|NOT COMPLETED|Overall Study||146||
48188824|NCT00124982|100786094|FG002|COMPLETED|Short-term Period||0||
48442033|NCT02263118|101416136|FG003|COMPLETED|Overall Study||12||
48442034|NCT02263118|101416133|FG000|NOT COMPLETED|Overall Study||4||
48442035|NCT02263118|101416134|FG001|NOT COMPLETED|Overall Study||8||
48442036|NCT02263118|101416135|FG002|NOT COMPLETED|Overall Study||8||
48442037|NCT02263118|101416136|FG003|NOT COMPLETED|Overall Study||2||
48442038|NCT00544713|101416137|FG000|STARTED|Overall Study||114||
48442039|NCT00544713|101416138|FG001|STARTED|Overall Study||114||
48442040|NCT00544713|101416137|FG000|COMPLETED|Overall Study||111||
48442041|NCT00544713|101416138|FG001|COMPLETED|Overall Study||109||
48442042|NCT00544713|101416137|FG000|NOT COMPLETED|Overall Study||3||
48442043|NCT00544713|101416138|FG001|NOT COMPLETED|Overall Study||5||
48442044|NCT02594384|101416139|FG000|STARTED|Overall Study||3||
48769015|NCT00068692|102223127|FG003|Started Concurrent Chemo/Radiation|Step 1: Registration||0||
48442045|NCT02594384|101416140|FG001|STARTED|Overall Study||8||
48442046|NCT02594384|101416141|FG002|STARTED|Overall Study||5||
48769016|NCT00068692|102223128|FG004|Started Concurrent Chemo/Radiation|Step 1: Registration||0||
48769017|NCT00068692|102223129|FG005|Started Concurrent Chemo/Radiation|Step 1: Registration||0||
48769018|NCT00068692|102223130|FG006|Started Concurrent Chemo/Radiation|Step 1: Registration||0||
48769019|NCT00068692|102223131|FG007|Started Concurrent Chemo/Radiation|Step 1: Registration||0||
48769020|NCT00068692|102223124|FG000|Reported AE Data|Step 1: Registration||123||
48769021|NCT00068692|102223125|FG001|Reported AE Data|Step 1: Registration||0||
48769022|NCT00068692|102223126|FG002|Reported AE Data|Step 1: Registration||0||
48769023|NCT00068692|102223127|FG003|Reported AE Data|Step 1: Registration||0||
48769024|NCT00068692|102223128|FG004|Reported AE Data|Step 1: Registration||0||
48769025|NCT00068692|102223129|FG005|Reported AE Data|Step 1: Registration||0||
48769026|NCT00068692|102223130|FG006|Reported AE Data|Step 1: Registration||0||
48769027|NCT00068692|102223131|FG007|Reported AE Data|Step 1: Registration||0||
48769028|NCT00068692|102223124|FG000|COMPLETED|Step 1: Registration||88|Of the 88 patients completed step 1 treatment, 5 of them decided not to randomize to step 2|
48769029|NCT00068692|102223125|FG001|COMPLETED|Step 1: Registration||96|Of the 88 patients completed step 1 treatment, 5 of them decided not to randomize to step 2|
48769030|NCT00068692|102223126|FG002|COMPLETED|Step 1: Registration||0|Of the 88 patients completed step 1 treatment, 5 of them decided not to randomize to step 2|
48769031|NCT00068692|102223127|FG003|COMPLETED|Step 1: Registration||0|Of the 88 patients completed step 1 treatment, 5 of them decided not to randomize to step 2|
48442047|NCT02594384|101416142|FG003|STARTED|Overall Study||4||
48442048|NCT02594384|101416143|FG004|STARTED|Overall Study||3||
48442049|NCT02594384|101416144|FG005|STARTED|Overall Study||20||
48442050|NCT02594384|101416145|FG006|STARTED|Overall Study||12||
48442051|NCT02594384|101416146|FG007|STARTED|Overall Study||7||
48442052|NCT02594384|101416139|FG000|COMPLETED|Overall Study||0||
48442053|NCT02594384|101416140|FG001|COMPLETED|Overall Study||0||
48442054|NCT02594384|101416141|FG002|COMPLETED|Overall Study||0||
48442055|NCT02594384|101416142|FG003|COMPLETED|Overall Study||0||
48442056|NCT02594384|101416143|FG004|COMPLETED|Overall Study||0||
48442057|NCT02594384|101416144|FG005|COMPLETED|Overall Study||1||
48442058|NCT02594384|101416145|FG006|COMPLETED|Overall Study||3||
48442059|NCT02594384|101416146|FG007|COMPLETED|Overall Study||0||
48442060|NCT02594384|101416139|FG000|NOT COMPLETED|Overall Study||3||
48442061|NCT02594384|101416140|FG001|NOT COMPLETED|Overall Study||8||
48442062|NCT02594384|101416141|FG002|NOT COMPLETED|Overall Study||5||
48442063|NCT02594384|101416142|FG003|NOT COMPLETED|Overall Study||4||
48442064|NCT02594384|101416143|FG004|NOT COMPLETED|Overall Study||3||
48442065|NCT02594384|101416144|FG005|NOT COMPLETED|Overall Study||19||
48442066|NCT02594384|101416145|FG006|NOT COMPLETED|Overall Study||9||
48442067|NCT02594384|101416146|FG007|NOT COMPLETED|Overall Study||7||
48442068|NCT00057330|101416147|FG000|STARTED|Overall Study||4577||
48442069|NCT00057330|101416148|FG001|STARTED|Overall Study||3746||
48442070|NCT00057330|101416147|FG000|COMPLETED|Overall Study||3445||
48442071|NCT00057330|101416148|FG001|COMPLETED|Overall Study||2826||
48442072|NCT00057330|101416147|FG000|NOT COMPLETED|Overall Study||1132||
48442073|NCT00057330|101416148|FG001|NOT COMPLETED|Overall Study||920||
48442074|NCT02949219|101416149|FG000|STARTED|Overall Study||41||
48442075|NCT02949219|101416149|FG000|COMPLETED|Overall Study||40||
48442076|NCT02949219|101416149|FG000|NOT COMPLETED|Overall Study||1||
48442077|NCT00834288|101416150|FG000|STARTED|Treatment Phase I||13||
48442078|NCT00834288|101416151|FG001|STARTED|Treatment Phase I||13||
48442079|NCT00834288|101416150|FG000|COMPLETED|Treatment Phase I||13||
48442080|NCT00834288|101416151|FG001|COMPLETED|Treatment Phase I||13||
48442081|NCT00834288|101416150|FG000|NOT COMPLETED|Treatment Phase I||0||
48442082|NCT00834288|101416151|FG001|NOT COMPLETED|Treatment Phase I||0||
48442083|NCT00834288|101416150|FG000|STARTED|Treatment Phase II||13||
48769032|NCT00068692|102223128|FG004|COMPLETED|Step 1: Registration||0|Of the 88 patients completed step 1 treatment, 5 of them decided not to randomize to step 2|
48769033|NCT00068692|102223129|FG005|COMPLETED|Step 1: Registration||0|Of the 88 patients completed step 1 treatment, 5 of them decided not to randomize to step 2|
48442084|NCT00834288|101416151|FG001|STARTED|Treatment Phase II||13||
48442085|NCT00834288|101416150|FG000|COMPLETED|Treatment Phase II||13||
48769034|NCT00068692|102223130|FG006|COMPLETED|Step 1: Registration||0|Of the 88 patients completed step 1 treatment, 5 of them decided not to randomize to step 2|
48769035|NCT00068692|102223131|FG007|COMPLETED|Step 1: Registration||0|Of the 88 patients completed step 1 treatment, 5 of them decided not to randomize to step 2|
48769036|NCT00068692|102223124|FG000|NOT COMPLETED|Step 1: Registration||40||
48442086|NCT00834288|101416151|FG001|COMPLETED|Treatment Phase II||13||
48442087|NCT00834288|101416150|FG000|NOT COMPLETED|Treatment Phase II||0||
48442088|NCT00834288|101416151|FG001|NOT COMPLETED|Treatment Phase II||0||
48442089|NCT01268683|101416152|FG000|STARTED|Overall Study||10||
48442090|NCT01268683|101416152|FG000|COMPLETED|Overall Study||8||
48442091|NCT01268683|101416152|FG000|NOT COMPLETED|Overall Study||2||
48442092|NCT00683046|101416153|FG000|STARTED|Overall Study||204||
48769037|NCT00068692|102223125|FG001|NOT COMPLETED|Step 1: Registration||1||
48769038|NCT00068692|102223126|FG002|NOT COMPLETED|Step 1: Registration||0||
48769039|NCT00068692|102223127|FG003|NOT COMPLETED|Step 1: Registration||0||
48769040|NCT00068692|102223128|FG004|NOT COMPLETED|Step 1: Registration||0||
48769041|NCT00068692|102223129|FG005|NOT COMPLETED|Step 1: Registration||0||
48769042|NCT00068692|102223130|FG006|NOT COMPLETED|Step 1: Registration||0||
48769043|NCT00068692|102223131|FG007|NOT COMPLETED|Step 1: Registration||0||
48769044|NCT00068692|102223124|FG000|STARTED|Step 2: Randomization||0|Randomization (arms I-III in both groups) was step 2.|
48769045|NCT00068692|102223125|FG001|STARTED|Step 2: Randomization||0|Randomization (arms I-III in both groups) was step 2.|
48769046|NCT00068692|102223126|FG002|STARTED|Step 2: Randomization||28|Randomization (arms I-III in both groups) was step 2.|
48442093|NCT00683046|101416153|FG000|COMPLETED|Overall Study||204||
48442094|NCT00683046|101416153|FG000|NOT COMPLETED|Overall Study||0||
48442095|NCT00123110|101416154|FG000|STARTED|Overall Study||12||
48442096|NCT00123110|101416155|FG001|STARTED|Overall Study||12||
48442097|NCT00123110|101416156|FG002|STARTED|Overall Study||11||
48442098|NCT00123110|101416154|FG000|COMPLETED|Overall Study||12||
48442099|NCT00123110|101416155|FG001|COMPLETED|Overall Study||12||
48442100|NCT00123110|101416156|FG002|COMPLETED|Overall Study||11||
48442101|NCT00123110|101416154|FG000|NOT COMPLETED|Overall Study||0||
48769047|NCT00068692|102223127|FG003|STARTED|Step 2: Randomization||25|Randomization (arms I-III in both groups) was step 2.|
48442102|NCT00123110|101416155|FG001|NOT COMPLETED|Overall Study||0||
48442103|NCT00123110|101416156|FG002|NOT COMPLETED|Overall Study||0||
48442104|NCT02325401|101416157|FG000|STARTED|Overall Study||6||
48442105|NCT02325401|101416158|FG001|STARTED|Overall Study||9||
48442106|NCT02325401|101416159|FG002|STARTED|Overall Study||5||
48657931|NCT01887600|101946124|FG001|NOT COMPLETED|Overall Study||114||
48657932|NCT05071027|101946125|FG000|STARTED|Overall Study||3||
48657933|NCT05071027|101946126|FG001|STARTED|Overall Study||6||
48657934|NCT05071027|101946125|FG000|COMPLETED|Overall Study||2||
48657935|NCT05071027|101946126|FG001|COMPLETED|Overall Study||2||
48657936|NCT05071027|101946125|FG000|NOT COMPLETED|Overall Study||1||
48657937|NCT05071027|101946126|FG001|NOT COMPLETED|Overall Study||4||
48657938|NCT01575548|101946127|FG000|STARTED|Overall Study||66||
48657939|NCT01575548|101946128|FG001|STARTED|Overall Study||63||
48657940|NCT01575548|101946127|FG000|Received Protocol Therapy|Overall Study||63||
48657941|NCT01575548|101946128|FG001|Received Protocol Therapy|Overall Study||61||
48657942|NCT01575548|101946127|FG000|COMPLETED|Overall Study||26||
48657943|NCT01575548|101946128|FG001|COMPLETED|Overall Study||30||
48657944|NCT01575548|101946127|FG000|NOT COMPLETED|Overall Study||40||
48657945|NCT01575548|101946128|FG001|NOT COMPLETED|Overall Study||33||
48657946|NCT02006836|101946129|FG000|STARTED|Case-control Period: Month 1- Month 6||20||
48769048|NCT00068692|102223128|FG004|STARTED|Step 2: Randomization||30|Randomization (arms I-III in both groups) was step 2.|
48769049|NCT00068692|102223129|FG005|STARTED|Step 2: Randomization||31|Randomization (arms I-III in both groups) was step 2.|
48769050|NCT00068692|102223130|FG006|STARTED|Step 2: Randomization||33|Randomization (arms I-III in both groups) was step 2.|
48769051|NCT00068692|102223131|FG007|STARTED|Step 2: Randomization||32|Randomization (arms I-III in both groups) was step 2.|
48769052|NCT00068692|102223124|FG000|Treated|Step 2: Randomization||0||
48769053|NCT00068692|102223125|FG001|Treated|Step 2: Randomization||0||
48769054|NCT00068692|102223126|FG002|Treated|Step 2: Randomization||27||
48769055|NCT00068692|102223127|FG003|Treated|Step 2: Randomization||25||
48769056|NCT00068692|102223128|FG004|Treated|Step 2: Randomization||29||
48769057|NCT00068692|102223129|FG005|Treated|Step 2: Randomization||31||
48769058|NCT00068692|102223130|FG006|Treated|Step 2: Randomization||33||
48769059|NCT00068692|102223131|FG007|Treated|Step 2: Randomization||32||
48769060|NCT00068692|102223124|FG000|Had Sphincter Preservation|Step 2: Randomization||0||
48769061|NCT00068692|102223125|FG001|Had Sphincter Preservation|Step 2: Randomization||0||
48769062|NCT00068692|102223126|FG002|Had Sphincter Preservation|Step 2: Randomization||28||
48769063|NCT00068692|102223127|FG003|Had Sphincter Preservation|Step 2: Randomization||25||
48769064|NCT00068692|102223128|FG004|Had Sphincter Preservation|Step 2: Randomization||28||
48442107|NCT02325401|101416157|FG000|COMPLETED|Overall Study||6||
48442108|NCT02325401|101416158|FG001|COMPLETED|Overall Study||8||
48442109|NCT02325401|101416159|FG002|COMPLETED|Overall Study||4||
48442110|NCT02325401|101416157|FG000|NOT COMPLETED|Overall Study||0||
48442111|NCT02325401|101416158|FG001|NOT COMPLETED|Overall Study||1||
48442112|NCT02325401|101416159|FG002|NOT COMPLETED|Overall Study||1||
48442113|NCT04476654|101416160|FG000|STARTED|Overall Study||29||
48442114|NCT04476654|101416161|FG001|STARTED|Overall Study||28||
48442115|NCT04476654|101416160|FG000|COMPLETED|Overall Study||26||
48442116|NCT04476654|101416161|FG001|COMPLETED|Overall Study||26||
48442117|NCT04476654|101416160|FG000|NOT COMPLETED|Overall Study||3||
48442118|NCT04476654|101416161|FG001|NOT COMPLETED|Overall Study||2||
48442119|NCT03486327|101416162|FG000|STARTED|Overall Study||4||
48657947|NCT02006836|101946130|FG001|STARTED|Case-control Period: Month 1- Month 6||20||
48657948|NCT02006836|101946131|FG002|STARTED|Case-control Period: Month 1- Month 6||0||
48769065|NCT00068692|102223129|FG005|Had Sphincter Preservation|Step 2: Randomization||31||
48769066|NCT00068692|102223130|FG006|Had Sphincter Preservation|Step 2: Randomization||33||
48442120|NCT03486327|101416163|FG001|STARTED|Overall Study||0||
48442121|NCT03486327|101416164|FG002|STARTED|Overall Study||0||
48442122|NCT03486327|101416162|FG000|COMPLETED|Overall Study||4||
48657949|NCT02006836|101946129|FG000|COMPLETED|Case-control Period: Month 1- Month 6||20||
48657950|NCT02006836|101946130|FG001|COMPLETED|Case-control Period: Month 1- Month 6||20||
48657951|NCT02006836|101946131|FG002|COMPLETED|Case-control Period: Month 1- Month 6||0||
48657952|NCT02006836|101946129|FG000|NOT COMPLETED|Case-control Period: Month 1- Month 6||0||
48657953|NCT02006836|101946130|FG001|NOT COMPLETED|Case-control Period: Month 1- Month 6||0||
48657954|NCT02006836|101946131|FG002|NOT COMPLETED|Case-control Period: Month 1- Month 6||0||
48657955|NCT02006836|101946129|FG000|STARTED|Self-control Period: Month 7-month 12||0||
48657956|NCT02006836|101946130|FG001|STARTED|Self-control Period: Month 7-month 12||0||
48657957|NCT02006836|101946131|FG002|STARTED|Self-control Period: Month 7-month 12||19||
48657958|NCT02006836|101946129|FG000|COMPLETED|Self-control Period: Month 7-month 12||0||
48657959|NCT02006836|101946130|FG001|COMPLETED|Self-control Period: Month 7-month 12||0||
48657960|NCT02006836|101946131|FG002|COMPLETED|Self-control Period: Month 7-month 12||19||
48657961|NCT02006836|101946129|FG000|NOT COMPLETED|Self-control Period: Month 7-month 12||0||
48657962|NCT02006836|101946130|FG001|NOT COMPLETED|Self-control Period: Month 7-month 12||0||
48769067|NCT00068692|102223131|FG007|Had Sphincter Preservation|Step 2: Randomization||30||
48769068|NCT00068692|102223124|FG000|Reported AE Data|Step 2: Randomization||0||
48769069|NCT00068692|102223125|FG001|Reported AE Data|Step 2: Randomization||0||
48769070|NCT00068692|102223126|FG002|Reported AE Data|Step 2: Randomization||27||
48769071|NCT00068692|102223127|FG003|Reported AE Data|Step 2: Randomization||22||
48769072|NCT00068692|102223128|FG004|Reported AE Data|Step 2: Randomization||28||
48769073|NCT00068692|102223129|FG005|Reported AE Data|Step 2: Randomization||31||
48769074|NCT00068692|102223130|FG006|Reported AE Data|Step 2: Randomization||33||
48188825|NCT00124982|100786092|FG000|NOT COMPLETED|Short-term Period||72||
48188826|NCT00124982|100786093|FG001|NOT COMPLETED|Short-term Period||114||
48188827|NCT00124982|100786094|FG002|NOT COMPLETED|Short-term Period||0||
48188828|NCT00124982|100786092|FG000|STARTED|Long-term Period||0||
48188829|NCT00124982|100786093|FG001|STARTED|Long-term Period||0||
48188830|NCT00124982|100786094|FG002|STARTED|Long-term Period||530||
48188831|NCT00124982|100786092|FG000|COMPLETED|Long-term Period||0||
48188832|NCT00124982|100786093|FG001|COMPLETED|Long-term Period||0||
48188833|NCT00124982|100786094|FG002|COMPLETED|Long-term Period||441||
48188834|NCT00124982|100786092|FG000|NOT COMPLETED|Long-term Period||0||
48368411|NCT01345786|101230179|FG003|NOT COMPLETED|Overall Study||3||
48368412|NCT04267562|101230180|FG000|STARTED|Assessed for Eligibility||219||
48368413|NCT04267562|101230180|FG000|COMPLETED|Assessed for Eligibility||114||
48368414|NCT04267562|101230180|FG000|NOT COMPLETED|Assessed for Eligibility||105||
48368415|NCT04267562|101230180|FG000|STARTED|Treated-Enrolled||114||
48368416|NCT04267562|101230180|FG000|COMPLETED|Treated-Enrolled||114||
48368417|NCT04267562|101230180|FG000|NOT COMPLETED|Treated-Enrolled||0||
48368418|NCT04267562|101230180|FG000|STARTED|24-Hour Contact||114||
48368419|NCT04267562|101230180|FG000|COMPLETED|24-Hour Contact||114||
48368420|NCT04267562|101230180|FG000|NOT COMPLETED|24-Hour Contact||0||
48368421|NCT04267562|101230180|FG000|STARTED|Week 2||114||
48368422|NCT04267562|101230180|FG000|COMPLETED|Week 2||114||
48368423|NCT04267562|101230180|FG000|NOT COMPLETED|Week 2||0||
48368424|NCT04267562|101230180|FG000|STARTED|Month 3||114||
48368425|NCT04267562|101230180|FG000|COMPLETED|Month 3||114||
48368426|NCT04267562|101230180|FG000|NOT COMPLETED|Month 3||0||
48368427|NCT04267562|101230180|FG000|STARTED|Month 6||114||
48368428|NCT04267562|101230180|FG000|COMPLETED|Month 6||114||
48368429|NCT04267562|101230180|FG000|NOT COMPLETED|Month 6||0||
48368430|NCT04267562|101230180|FG000|STARTED|Month 12||114||
48368431|NCT04267562|101230180|FG000|COMPLETED|Month 12||114||
48368432|NCT04267562|101230180|FG000|NOT COMPLETED|Month 12||0||
48368433|NCT04267562|101230180|FG000|STARTED|Month 24||114||
48368434|NCT04267562|101230180|FG000|COMPLETED|Month 24||112||
48368435|NCT04267562|101230180|FG000|NOT COMPLETED|Month 24||2||
48368436|NCT04267562|101230180|FG000|STARTED|Month 36||112||
48368437|NCT04267562|101230180|FG000|COMPLETED|Month 36||107||
48368438|NCT04267562|101230180|FG000|NOT COMPLETED|Month 36||5||
48368439|NCT01539837|101230181|FG000|STARTED|Overall Study||8||
48368440|NCT01539837|101230182|FG001|STARTED|Overall Study||7||
48368441|NCT01539837|101230183|FG002|STARTED|Overall Study||7||
48368442|NCT01539837|101230181|FG000|COMPLETED|Overall Study||8||
48368443|NCT01539837|101230182|FG001|COMPLETED|Overall Study||6||
48368444|NCT01539837|101230183|FG002|COMPLETED|Overall Study||5||
48368445|NCT01539837|101230181|FG000|NOT COMPLETED|Overall Study||0||
48368446|NCT01539837|101230182|FG001|NOT COMPLETED|Overall Study||1||
48368447|NCT01539837|101230183|FG002|NOT COMPLETED|Overall Study||2||
48368448|NCT01757704|101230184|FG000|STARTED|Overall Study||11||
48368449|NCT01757704|101230185|FG001|STARTED|Overall Study||13||
48368450|NCT01757704|101230184|FG000|COMPLETED|Overall Study||10||
48368451|NCT01757704|101230185|FG001|COMPLETED|Overall Study||10||
48442123|NCT03486327|101416163|FG001|COMPLETED|Overall Study||0||
48368452|NCT01757704|101230184|FG000|NOT COMPLETED|Overall Study||1||
48442124|NCT03486327|101416164|FG002|COMPLETED|Overall Study||0||
48368453|NCT01757704|101230185|FG001|NOT COMPLETED|Overall Study||3||
48368454|NCT01519570|101230186|FG000|STARTED|Overall Study||500||
48368455|NCT01519570|101230187|FG001|STARTED|Overall Study||2089||
48442125|NCT03486327|101416162|FG000|NOT COMPLETED|Overall Study||0||
48442126|NCT03486327|101416163|FG001|NOT COMPLETED|Overall Study||0||
48442127|NCT03486327|101416164|FG002|NOT COMPLETED|Overall Study||0||
48442128|NCT04854707|101416165|FG000|STARTED|Overall Study||2625||
48442129|NCT04854707|101416166|FG001|STARTED|Overall Study||2183||
48442130|NCT04854707|101416167|FG002|STARTED|Overall Study||676||
48442131|NCT04854707|101416165|FG000|COMPLETED|Overall Study||2547||
48442132|NCT04854707|101416166|FG001|COMPLETED|Overall Study||2124||
48442133|NCT04854707|101416167|FG002|COMPLETED|Overall Study||646||
48442134|NCT04854707|101416165|FG000|NOT COMPLETED|Overall Study||78||
48442135|NCT04854707|101416166|FG001|NOT COMPLETED|Overall Study||59||
48442136|NCT04854707|101416167|FG002|NOT COMPLETED|Overall Study||30||
48442137|NCT03255226|101416168|FG000|STARTED|Overall Study||60||
48442138|NCT03255226|101416168|FG000|COMPLETED|Overall Study||46||
48657963|NCT02006836|101946131|FG002|NOT COMPLETED|Self-control Period: Month 7-month 12||0||
48657964|NCT03193437|101946132|FG000|STARTED|Overall Study||8||
48657965|NCT03193437|101946132|FG000|COMPLETED|Overall Study||0||
48657966|NCT03193437|101946132|FG000|NOT COMPLETED|Overall Study||8||
48657967|NCT00214526|101946133|FG000|STARTED|Randomized||56||
48769075|NCT00068692|102223131|FG007|Reported AE Data|Step 2: Randomization||32||
48188835|NCT00124982|100786093|FG001|NOT COMPLETED|Long-term Period||0||
48188836|NCT00124982|100786094|FG002|NOT COMPLETED|Long-term Period||89||
48188837|NCT04096365|100786095|FG000|STARTED|Overall Study||12||
48188838|NCT04096365|100786095|FG000|COMPLETED|Overall Study||11||
48657968|NCT00214526|101946134|FG001|STARTED|Randomized||56||
48368456|NCT01519570|101230186|FG000|COMPLETED|Overall Study||500||
48368457|NCT01519570|101230187|FG001|COMPLETED|Overall Study||2089||
48368458|NCT01519570|101230186|FG000|NOT COMPLETED|Overall Study||0||
48368459|NCT01519570|101230187|FG001|NOT COMPLETED|Overall Study||0||
48368460|NCT00858702|101230188|FG000|STARTED|Overall Study||53||
48368461|NCT00858702|101230189|FG001|STARTED|Overall Study||52||
48368462|NCT00858702|101230188|FG000|COMPLETED|Overall Study||48||
48368463|NCT00858702|101230189|FG001|COMPLETED|Overall Study||50||
48368464|NCT00858702|101230188|FG000|NOT COMPLETED|Overall Study||5||
48368465|NCT00858702|101230189|FG001|NOT COMPLETED|Overall Study||2||
48368466|NCT00112151|101230190|FG000|STARTED|Overall Study||28||
48368467|NCT00112151|101230191|FG001|STARTED|Overall Study||28||
48368468|NCT00112151|101230192|FG002|STARTED|Overall Study||28||
48368469|NCT00112151|101230193|FG003|STARTED|Overall Study||27||
48368470|NCT00112151|101230194|FG004|STARTED|Overall Study||28||
48368471|NCT00112151|101230195|FG005|STARTED|Overall Study||28||
48368472|NCT00112151|101230190|FG000|COMPLETED|Overall Study||24||
48368473|NCT00112151|101230191|FG001|COMPLETED|Overall Study||23||
48368474|NCT00112151|101230192|FG002|COMPLETED|Overall Study||25||
48368475|NCT00112151|101230193|FG003|COMPLETED|Overall Study||24||
48368476|NCT00112151|101230194|FG004|COMPLETED|Overall Study||22||
48368477|NCT00112151|101230195|FG005|COMPLETED|Overall Study||25||
48368478|NCT00112151|101230190|FG000|NOT COMPLETED|Overall Study||4||
48368479|NCT00112151|101230191|FG001|NOT COMPLETED|Overall Study||5||
48442139|NCT03255226|101416168|FG000|NOT COMPLETED|Overall Study||14||
48442140|NCT01071083|101416169|FG000|STARTED|Overall Study||42||
48442141|NCT01071083|101416170|FG001|STARTED|Overall Study||45||
48442142|NCT01071083|101416171|FG002|STARTED|Overall Study||17||
48442143|NCT01071083|101416172|FG003|STARTED|Overall Study||17||
48442144|NCT01071083|101416173|FG004|STARTED|Overall Study||54||
48442145|NCT01071083|101416169|FG000|COMPLETED|Overall Study||35||
48442146|NCT01071083|101416170|FG001|COMPLETED|Overall Study||43||
48442147|NCT01071083|101416171|FG002|COMPLETED|Overall Study||12||
48442148|NCT01071083|101416172|FG003|COMPLETED|Overall Study||15||
48442149|NCT01071083|101416173|FG004|COMPLETED|Overall Study||46||
48442150|NCT01071083|101416169|FG000|NOT COMPLETED|Overall Study||7||
48442151|NCT01071083|101416170|FG001|NOT COMPLETED|Overall Study||2||
48442152|NCT01071083|101416171|FG002|NOT COMPLETED|Overall Study||5||
48442153|NCT01071083|101416172|FG003|NOT COMPLETED|Overall Study||2||
48442154|NCT01071083|101416173|FG004|NOT COMPLETED|Overall Study||8||
48442155|NCT01230502|101416174|FG000|STARTED|Overall Study||9||
48442156|NCT01230502|101416175|FG001|STARTED|Overall Study||0||
48442157|NCT01230502|101416176|FG002|STARTED|Overall Study||0||
48442158|NCT01230502|101416174|FG000|COMPLETED|Overall Study||9||
48442159|NCT01230502|101416175|FG001|COMPLETED|Overall Study||0||
48442160|NCT01230502|101416176|FG002|COMPLETED|Overall Study||0||
48442161|NCT01230502|101416174|FG000|NOT COMPLETED|Overall Study||0||
48442162|NCT01230502|101416175|FG001|NOT COMPLETED|Overall Study||0||
48442163|NCT01230502|101416176|FG002|NOT COMPLETED|Overall Study||0||
48442164|NCT03265483|101416177|FG000|STARTED|Overall Study||87||
48769076|NCT00068692|102223124|FG000|COMPLETED|Step 2: Randomization||0||
48368480|NCT00112151|101230192|FG002|NOT COMPLETED|Overall Study||3||
48368481|NCT00112151|101230193|FG003|NOT COMPLETED|Overall Study||3||
48442165|NCT03265483|101416178|FG001|STARTED|Overall Study||93||
48657969|NCT00214526|101946133|FG000|COMPLETED|Randomized||55||
48368482|NCT00112151|101230194|FG004|NOT COMPLETED|Overall Study||6||
48368483|NCT00112151|101230195|FG005|NOT COMPLETED|Overall Study||3||
48442166|NCT03265483|101416177|FG000|COMPLETED|Overall Study||87||
48442167|NCT03265483|101416178|FG001|COMPLETED|Overall Study||93||
48442168|NCT03265483|101416177|FG000|NOT COMPLETED|Overall Study||0||
48368484|NCT04489771|101230196|FG000|STARTED|Overall Study||78||
48368485|NCT04489771|101230197|FG001|STARTED|Overall Study||76||
48368486|NCT04489771|101230196|FG000|COMPLETED|Overall Study||0||
48442169|NCT03265483|101416178|FG001|NOT COMPLETED|Overall Study||0||
48442170|NCT00798707|101416179|FG000|STARTED|Overall Study||235||
48442171|NCT00798707|101416180|FG001|STARTED|Overall Study||237||
48442172|NCT00798707|101416181|FG002|STARTED|Overall Study||237||
48442173|NCT00798707|101416179|FG000|Treated|Overall Study||231||
48442174|NCT00798707|101416180|FG001|Treated|Overall Study||232||
48442175|NCT00798707|101416181|FG002|Treated|Overall Study||236||
48442176|NCT00798707|101416179|FG000|COMPLETED|Overall Study||209||
48442177|NCT00798707|101416180|FG001|COMPLETED|Overall Study||204||
48442178|NCT00798707|101416181|FG002|COMPLETED|Overall Study||215||
48442179|NCT00798707|101416179|FG000|NOT COMPLETED|Overall Study||26||
48442180|NCT00798707|101416180|FG001|NOT COMPLETED|Overall Study||33||
48442181|NCT00798707|101416181|FG002|NOT COMPLETED|Overall Study||22||
48442182|NCT05959564|101416182|FG000|STARTED|Overall Study||152||
48442183|NCT05959564|101416183|FG001|STARTED|Overall Study||154||
48442184|NCT05959564|101416184|FG002|STARTED|Overall Study||150||
48442185|NCT05959564|101416182|FG000|COMPLETED|Overall Study||152||
48657970|NCT00214526|101946134|FG001|COMPLETED|Randomized||54||
48657971|NCT00214526|101946133|FG000|NOT COMPLETED|Randomized||1||
48657972|NCT00214526|101946134|FG001|NOT COMPLETED|Randomized||2||
48657973|NCT00214526|101946133|FG000|STARTED|Treatment Period||55||
48657974|NCT00214526|101946134|FG001|STARTED|Treatment Period||54||
48657975|NCT00214526|101946133|FG000|COMPLETED|Treatment Period||53||
48657976|NCT00214526|101946134|FG001|COMPLETED|Treatment Period||49||
48657977|NCT00214526|101946133|FG000|NOT COMPLETED|Treatment Period||2||
48657978|NCT00214526|101946134|FG001|NOT COMPLETED|Treatment Period||5||
48657979|NCT00214526|101946133|FG000|STARTED|Post-Treatment Period||53||
48657980|NCT00214526|101946134|FG001|STARTED|Post-Treatment Period||49||
48657981|NCT00214526|101946133|FG000|COMPLETED|Post-Treatment Period||52||
48657982|NCT00214526|101946134|FG001|COMPLETED|Post-Treatment Period||49||
48657983|NCT00214526|101946133|FG000|NOT COMPLETED|Post-Treatment Period||1||
48657984|NCT00214526|101946134|FG001|NOT COMPLETED|Post-Treatment Period||0||
48657985|NCT00421408|101946135|FG000|STARTED|Overall Study||102||
48657986|NCT00421408|101946136|FG001|STARTED|Overall Study||106||
48657987|NCT00421408|101946135|FG000|COMPLETED|Overall Study||60||
48657988|NCT00421408|101946136|FG001|COMPLETED|Overall Study||61||
48657989|NCT00421408|101946135|FG000|NOT COMPLETED|Overall Study||42||
48657990|NCT00421408|101946136|FG001|NOT COMPLETED|Overall Study||45||
48657991|NCT03810495|101946137|FG000|STARTED|Overall Study||20||
48657992|NCT03810495|101946137|FG000|COMPLETED|Overall Study||17||
48368487|NCT04489771|101230197|FG001|COMPLETED|Overall Study||0||
48657993|NCT03810495|101946137|FG000|NOT COMPLETED|Overall Study||3||
48368488|NCT04489771|101230196|FG000|NOT COMPLETED|Overall Study||78||
48368489|NCT04489771|101230197|FG001|NOT COMPLETED|Overall Study||76||
48368490|NCT00812916|101230198|FG000|STARTED|Overall Study||206||
48368491|NCT00812916|101230198|FG000|Data Available|Overall Study||205||
48368492|NCT00812916|101230198|FG000|CFAE - Guided Ablation|Overall Study||203||
48368493|NCT00812916|101230198|FG000|COMPLETED|Overall Study||203||
48368494|NCT00812916|101230198|FG000|NOT COMPLETED|Overall Study||3||
48368495|NCT01454401|101230199|FG000|STARTED|Overall Study||44||
48368496|NCT01454401|101230199|FG000|COMPLETED|Overall Study||39||
48368497|NCT01454401|101230199|FG000|NOT COMPLETED|Overall Study||5||
48368498|NCT01605396|101230200|FG000|STARTED|Overall Study||40||
48368499|NCT01605396|101230201|FG001|STARTED|Overall Study||40||
48368500|NCT01605396|101230200|FG000|Treated|Overall Study||39||
48368501|NCT01605396|101230201|FG001|Treated|Overall Study||40||
48368502|NCT01605396|101230200|FG000|COMPLETED|Overall Study||0||
48368503|NCT01605396|101230201|FG001|COMPLETED|Overall Study||0||
48368504|NCT01605396|101230200|FG000|NOT COMPLETED|Overall Study||40||
48368505|NCT01605396|101230201|FG001|NOT COMPLETED|Overall Study||40||
48442186|NCT05959564|101416183|FG001|COMPLETED|Overall Study||154||
48442187|NCT05959564|101416184|FG002|COMPLETED|Overall Study||150||
48442188|NCT05959564|101416182|FG000|NOT COMPLETED|Overall Study||0||
48442189|NCT05959564|101416183|FG001|NOT COMPLETED|Overall Study||0||
48442190|NCT05959564|101416184|FG002|NOT COMPLETED|Overall Study||0||
48442191|NCT03706209|101416185|FG000|STARTED|Overall Study||52||
48442192|NCT03706209|101416186|FG001|STARTED|Overall Study||48||
48442193|NCT03706209|101416187|FG002|STARTED|Overall Study||55||
48442194|NCT03706209|101416185|FG000|COMPLETED|Overall Study||36||
48442195|NCT03706209|101416186|FG001|COMPLETED|Overall Study||39||
48442196|NCT03706209|101416187|FG002|COMPLETED|Overall Study||39||
48442197|NCT03706209|101416185|FG000|NOT COMPLETED|Overall Study||16||
48442198|NCT03706209|101416186|FG001|NOT COMPLETED|Overall Study||9||
48368506|NCT01372878|101230202|FG000|STARTED|Overall Study||884||
48442199|NCT03706209|101416187|FG002|NOT COMPLETED|Overall Study||16||
48442200|NCT00203892|101416188|FG000|STARTED|Overall Study||7||
48657994|NCT00684554|101946138|FG000|STARTED|Overall Study||10||
48368507|NCT01372878|101230202|FG000|COMPLETED|Overall Study||700||
48442201|NCT00203892|101416189|FG001|STARTED|Overall Study||10||
48442202|NCT00203892|101416190|FG002|STARTED|Overall Study||6||
48442203|NCT00203892|101416188|FG000|Received at Least 3 Doses of CEA Vaccine|Overall Study||5||
48657995|NCT00684554|101946139|FG001|STARTED|Overall Study||10||
48442204|NCT00203892|101416189|FG001|Received at Least 3 Doses of CEA Vaccine|Overall Study||5||
48442205|NCT00203892|101416190|FG002|Received at Least 3 Doses of CEA Vaccine|Overall Study||4||
48442206|NCT00203892|101416188|FG000|COMPLETED|Overall Study||5||
48442207|NCT00203892|101416189|FG001|COMPLETED|Overall Study||8||
48442208|NCT00203892|101416190|FG002|COMPLETED|Overall Study||6||
48442209|NCT00203892|101416188|FG000|NOT COMPLETED|Overall Study||2||
48769077|NCT00068692|102223125|FG001|COMPLETED|Step 2: Randomization||0||
48769078|NCT00068692|102223126|FG002|COMPLETED|Step 2: Randomization||18||
48769079|NCT00068692|102223127|FG003|COMPLETED|Step 2: Randomization||13||
48769080|NCT00068692|102223128|FG004|COMPLETED|Step 2: Randomization||21||
48769081|NCT00068692|102223129|FG005|COMPLETED|Step 2: Randomization||25||
48442210|NCT00203892|101416189|FG001|NOT COMPLETED|Overall Study||2||
48442211|NCT00203892|101416190|FG002|NOT COMPLETED|Overall Study||0||
48442212|NCT05037409|101416191|FG000|STARTED|Blinded Treatment (1 Day)||5||
48442213|NCT05037409|101416192|FG001|STARTED|Blinded Treatment (1 Day)||6||
48442214|NCT05037409|101416193|FG002|STARTED|Blinded Treatment (1 Day)||2||
48442215|NCT05037409|101416191|FG000|Treated|Blinded Treatment (1 Day)||5||
48442216|NCT05037409|101416192|FG001|Treated|Blinded Treatment (1 Day)||5||
48442217|NCT05037409|101416193|FG002|Treated|Blinded Treatment (1 Day)||2||
48442218|NCT05037409|101416191|FG000|COMPLETED|Blinded Treatment (1 Day)||5||
48442219|NCT05037409|101416192|FG001|COMPLETED|Blinded Treatment (1 Day)||5||
48442220|NCT05037409|101416193|FG002|COMPLETED|Blinded Treatment (1 Day)||2||
48442221|NCT05037409|101416191|FG000|NOT COMPLETED|Blinded Treatment (1 Day)||0||
48442222|NCT05037409|101416192|FG001|NOT COMPLETED|Blinded Treatment (1 Day)||1||
48442223|NCT05037409|101416193|FG002|NOT COMPLETED|Blinded Treatment (1 Day)||0||
48442224|NCT05037409|101416191|FG000|STARTED|Follow-up ( Up to Day 157)||5||
48442225|NCT05037409|101416192|FG001|STARTED|Follow-up ( Up to Day 157)||5||
48442226|NCT05037409|101416193|FG002|STARTED|Follow-up ( Up to Day 157)||2||
48442227|NCT05037409|101416191|FG000|COMPLETED|Follow-up ( Up to Day 157)||5||
48442228|NCT05037409|101416192|FG001|COMPLETED|Follow-up ( Up to Day 157)||5||
48442229|NCT05037409|101416193|FG002|COMPLETED|Follow-up ( Up to Day 157)||2||
48442230|NCT05037409|101416191|FG000|NOT COMPLETED|Follow-up ( Up to Day 157)||0||
48442231|NCT05037409|101416192|FG001|NOT COMPLETED|Follow-up ( Up to Day 157)||0||
48442232|NCT05037409|101416193|FG002|NOT COMPLETED|Follow-up ( Up to Day 157)||0||
48442233|NCT01500434|101416194|FG000|STARTED|Overall Study||102||
48442234|NCT01500434|101416194|FG000|COMPLETED|Overall Study||95||
48442235|NCT01500434|101416194|FG000|NOT COMPLETED|Overall Study||7||
48442236|NCT01596088|101416195|FG000|STARTED|Overall Study||2||
48442237|NCT01596088|101416195|FG000|COMPLETED|Overall Study||2||
48442238|NCT01596088|101416195|FG000|NOT COMPLETED|Overall Study||0||
48442239|NCT02058368|101416196|FG000|STARTED|Overall Study||302||
48442240|NCT02058368|101416197|FG001|STARTED|Overall Study||305||
48442241|NCT02058368|101416196|FG000|COMPLETED|Overall Study||261||
48442242|NCT02058368|101416197|FG001|COMPLETED|Overall Study||251||
48442243|NCT02058368|101416196|FG000|NOT COMPLETED|Overall Study||41||
48442244|NCT02058368|101416197|FG001|NOT COMPLETED|Overall Study||54||
48442245|NCT03231709|101416198|FG000|STARTED|Treatment Period 1||30||
48442246|NCT03231709|101416199|FG001|STARTED|Treatment Period 1||30||
48442247|NCT03231709|101416198|FG000|COMPLETED|Treatment Period 1||30||
48442248|NCT03231709|101416199|FG001|COMPLETED|Treatment Period 1||29||
48442249|NCT03231709|101416198|FG000|NOT COMPLETED|Treatment Period 1||0||
48442250|NCT03231709|101416199|FG001|NOT COMPLETED|Treatment Period 1||1||
48442251|NCT03231709|101416198|FG000|STARTED|Treatment Period 2||30||
48442252|NCT03231709|101416199|FG001|STARTED|Treatment Period 2||29||
48769082|NCT00068692|102223130|FG006|COMPLETED|Step 2: Randomization||29||
48769083|NCT00068692|102223131|FG007|COMPLETED|Step 2: Randomization||24||
48769084|NCT00068692|102223124|FG000|NOT COMPLETED|Step 2: Randomization||0||
48769085|NCT00068692|102223125|FG001|NOT COMPLETED|Step 2: Randomization||0||
48769086|NCT00068692|102223126|FG002|NOT COMPLETED|Step 2: Randomization||10||
48188839|NCT04096365|100786095|FG000|NOT COMPLETED|Overall Study||1||
48188840|NCT01641861|100786096|FG000|STARTED|Overall Study||246||
48188841|NCT01641861|100786097|FG001|STARTED|Overall Study||242||
48188842|NCT01641861|100786096|FG000|COMPLETED|Overall Study||211||
48188843|NCT01641861|100786097|FG001|COMPLETED|Overall Study||217||
48188844|NCT01641861|100786096|FG000|NOT COMPLETED|Overall Study||35||
48188845|NCT01641861|100786097|FG001|NOT COMPLETED|Overall Study||25||
48188846|NCT03682536|100786098|FG000|STARTED|Randomization||182|Randomized|
48188847|NCT03682536|100786099|FG001|STARTED|Randomization||181|Randomized|
48188848|NCT03682536|100786098|FG000|COMPLETED|Randomization||182|Continuing to Treatment Period|
48188849|NCT03682536|100786099|FG001|COMPLETED|Randomization||179|Continuing to Treatment Period|
48188850|NCT03682536|100786098|FG000|NOT COMPLETED|Randomization||0||
48769087|NCT00068692|102223127|FG003|NOT COMPLETED|Step 2: Randomization||12||
48769088|NCT00068692|102223128|FG004|NOT COMPLETED|Step 2: Randomization||9||
48769089|NCT00068692|102223129|FG005|NOT COMPLETED|Step 2: Randomization||6||
48769090|NCT00068692|102223130|FG006|NOT COMPLETED|Step 2: Randomization||4||
48769091|NCT00068692|102223131|FG007|NOT COMPLETED|Step 2: Randomization||8||
48769092|NCT01704599|102223132|FG000|STARTED|Overall Study||8||
48769093|NCT01704599|102223132|FG000|COMPLETED|Overall Study||7||
48769094|NCT01704599|102223132|FG000|NOT COMPLETED|Overall Study||1||
48442253|NCT03231709|101416198|FG000|COMPLETED|Treatment Period 2||30||
48442254|NCT03231709|101416199|FG001|COMPLETED|Treatment Period 2||28||
48442255|NCT03231709|101416198|FG000|NOT COMPLETED|Treatment Period 2||0||
48769095|NCT02863419|102223133|FG000|STARTED|Overall Study||285||
48769096|NCT02863419|102223134|FG001|STARTED|Overall Study||284||
48769097|NCT02863419|102223135|FG002|STARTED|Overall Study||142||
48769098|NCT02863419|102223133|FG000|Full Analysis Set (FAS)|Overall Study||285||
48769099|NCT02863419|102223134|FG001|Full Analysis Set (FAS)|Overall Study||284||
48769100|NCT02863419|102223135|FG002|Full Analysis Set (FAS)|Overall Study||142||
48442256|NCT03231709|101416199|FG001|NOT COMPLETED|Treatment Period 2||1||
48442257|NCT01777191|101416200|FG000|STARTED|Treatment Period (Per) (Week 0-Week 12)||102||
48442258|NCT01777191|101416201|FG001|STARTED|Treatment Period (Per) (Week 0-Week 12)||102||
48442259|NCT01777191|101416200|FG000|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||96||
48442260|NCT01777191|101416201|FG001|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||94||
48442261|NCT01777191|101416200|FG000|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||6||
48442262|NCT01777191|101416201|FG001|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||8||
48442263|NCT01777191|101416200|FG000|STARTED|Safety Extension Per (Week 12-Week 48)||94||
48442264|NCT01777191|101416201|FG001|STARTED|Safety Extension Per (Week 12-Week 48)||91||
48188851|NCT03682536|100786099|FG001|NOT COMPLETED|Randomization||2||
48188852|NCT03682536|100786098|FG000|STARTED|Treatment||182||
48188853|NCT03682536|100786099|FG001|STARTED|Treatment||179||
48442265|NCT01777191|101416200|FG000|COMPLETED|Safety Extension Per (Week 12-Week 48)||85||
48442266|NCT01777191|101416201|FG001|COMPLETED|Safety Extension Per (Week 12-Week 48)||78||
48442267|NCT01777191|101416200|FG000|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||9||
48442268|NCT01777191|101416201|FG001|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||13||
48442269|NCT05113277|101416202|FG000|STARTED|Overall Study||26||
48442270|NCT05113277|101416203|FG001|STARTED|Overall Study||25||
48442271|NCT05113277|101416202|FG000|COMPLETED|Overall Study||18||
48442272|NCT05113277|101416203|FG001|COMPLETED|Overall Study||17||
48442273|NCT05113277|101416202|FG000|NOT COMPLETED|Overall Study||8||
48442274|NCT05113277|101416203|FG001|NOT COMPLETED|Overall Study||8||
48442275|NCT01064830|101416204|FG000|STARTED|Overall Study||10||
48442276|NCT01064830|101416205|FG001|STARTED|Overall Study||11||
48442277|NCT01064830|101416204|FG000|COMPLETED|Overall Study||8||
48442278|NCT01064830|101416205|FG001|COMPLETED|Overall Study||7||
48442279|NCT01064830|101416204|FG000|NOT COMPLETED|Overall Study||2||
48442280|NCT01064830|101416205|FG001|NOT COMPLETED|Overall Study||4||
48442281|NCT00318409|101416206|FG000|STARTED|Overall Study||20||
48442282|NCT00318409|101416207|FG001|STARTED|Overall Study||10||
48442283|NCT00318409|101416206|FG000|COMPLETED|Overall Study||18||
48442284|NCT00318409|101416207|FG001|COMPLETED|Overall Study||9||
48442285|NCT00318409|101416206|FG000|NOT COMPLETED|Overall Study||2||
48442286|NCT00318409|101416207|FG001|NOT COMPLETED|Overall Study||1||
48442287|NCT00281827|101416208|FG000|STARTED|Overall Study||22||
48442288|NCT00281827|101416208|FG000|COMPLETED|Overall Study||22||
48442289|NCT00281827|101416208|FG000|NOT COMPLETED|Overall Study||0||
48442290|NCT00297882|101416209|FG000|STARTED|Day 14||204||
48442291|NCT00297882|101416210|FG001|STARTED|Day 14||612||
48442292|NCT00297882|101416209|FG000|COMPLETED|Day 14||192||
48442293|NCT00297882|101416210|FG001|COMPLETED|Day 14||563||
48442294|NCT00297882|101416209|FG000|NOT COMPLETED|Day 14||12||
48442295|NCT00297882|101416210|FG001|NOT COMPLETED|Day 14||49||
48442296|NCT00297882|101416209|FG000|STARTED|Day 28||192||
48442297|NCT00297882|101416210|FG001|STARTED|Day 28||563||
48442298|NCT00297882|101416209|FG000|COMPLETED|Day 28||176||
48442299|NCT00297882|101416210|FG001|COMPLETED|Day 28||540||
48442300|NCT00297882|101416209|FG000|NOT COMPLETED|Day 28||16||
48442301|NCT00297882|101416210|FG001|NOT COMPLETED|Day 28||23||
48442302|NCT01977625|101416211|FG000|STARTED|First Intervention (4 Weeks)||11||
48442303|NCT01977625|101416212|FG001|STARTED|First Intervention (4 Weeks)||7||
48442304|NCT01977625|101416211|FG000|COMPLETED|First Intervention (4 Weeks)||8||
48442305|NCT01977625|101416212|FG001|COMPLETED|First Intervention (4 Weeks)||7||
48442306|NCT01977625|101416211|FG000|NOT COMPLETED|First Intervention (4 Weeks)||3||
48442307|NCT01977625|101416212|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0||
48769101|NCT02863419|102223133|FG000|Safety Analysis Set (SAS)|Overall Study||285||
48769102|NCT02863419|102223134|FG001|Safety Analysis Set (SAS)|Overall Study||284||
48769103|NCT02863419|102223135|FG002|Safety Analysis Set (SAS)|Overall Study||142||
48769104|NCT02863419|102223133|FG000|COMPLETED|Overall Study||277||
48769105|NCT02863419|102223134|FG001|COMPLETED|Overall Study||274||
48769106|NCT02863419|102223135|FG002|COMPLETED|Overall Study||134||
48769107|NCT02863419|102223133|FG000|NOT COMPLETED|Overall Study||8||
48769108|NCT02863419|102223134|FG001|NOT COMPLETED|Overall Study||10||
48769109|NCT02863419|102223135|FG002|NOT COMPLETED|Overall Study||8||
48769110|NCT01281124|102223136|FG000|STARTED|Overall Study||1||
48188854|NCT03682536|100786098|FG000|COMPLETED|Treatment||78|Continuing in the Treatment Period|
48769111|NCT01281124|102223136|FG000|COMPLETED|Overall Study||0||
48769112|NCT01281124|102223136|FG000|NOT COMPLETED|Overall Study||1||
48188855|NCT03682536|100786099|FG001|COMPLETED|Treatment||53|Continuing in the Treatment Period|
48188856|NCT03682536|100786098|FG000|NOT COMPLETED|Treatment||104||
48188857|NCT03682536|100786099|FG001|NOT COMPLETED|Treatment||126||
48442308|NCT01977625|101416211|FG000|STARTED|Washout (2 Weeks)||8||
48442309|NCT01977625|101416212|FG001|STARTED|Washout (2 Weeks)||7||
48442310|NCT01977625|101416211|FG000|COMPLETED|Washout (2 Weeks)||8||
48442311|NCT01977625|101416212|FG001|COMPLETED|Washout (2 Weeks)||7||
48442312|NCT01977625|101416211|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
48442313|NCT01977625|101416212|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
48442314|NCT01977625|101416211|FG000|STARTED|Second Intervention (4 Weeks)||8||
48442315|NCT01977625|101416212|FG001|STARTED|Second Intervention (4 Weeks)||7||
48442316|NCT01977625|101416211|FG000|COMPLETED|Second Intervention (4 Weeks)||7||
48442317|NCT01977625|101416212|FG001|COMPLETED|Second Intervention (4 Weeks)||7||
48442318|NCT01977625|101416211|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1||
48442319|NCT01977625|101416212|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0||
48442320|NCT00722007|101416213|FG000|STARTED|Overall Study||147||160
48442321|NCT00722007|101416213|FG000|COMPLETED|Overall Study||117||128
48442322|NCT00722007|101416213|FG000|NOT COMPLETED|Overall Study||30||32
48442323|NCT00131573|101416214|FG000|STARTED|Overall Study||46||
48442324|NCT00131573|101416215|FG001|STARTED|Overall Study||39||
48442325|NCT00131573|101416214|FG000|COMPLETED|Overall Study||13||
48442326|NCT00131573|101416215|FG001|COMPLETED|Overall Study||13||
48442327|NCT00131573|101416214|FG000|NOT COMPLETED|Overall Study||33||
48442328|NCT00131573|101416215|FG001|NOT COMPLETED|Overall Study||26||
48442329|NCT01856257|101416216|FG000|STARTED|Overall Study||29||
48442330|NCT01856257|101416217|FG001|STARTED|Overall Study||29||
48442331|NCT01856257|101416218|FG002|STARTED|Overall Study||11||
48442332|NCT01856257|101416219|FG003|STARTED|Overall Study||2||
48442333|NCT01856257|101416216|FG000|COMPLETED|Overall Study||26||
48442334|NCT01856257|101416217|FG001|COMPLETED|Overall Study||28||
48442335|NCT01856257|101416218|FG002|COMPLETED|Overall Study||11||
48442336|NCT01856257|101416219|FG003|COMPLETED|Overall Study||0||
48442337|NCT01856257|101416216|FG000|NOT COMPLETED|Overall Study||3||
48442338|NCT01856257|101416217|FG001|NOT COMPLETED|Overall Study||1||
48442339|NCT01856257|101416218|FG002|NOT COMPLETED|Overall Study||0||
48442340|NCT01856257|101416219|FG003|NOT COMPLETED|Overall Study||2||
48442341|NCT04980391|101416220|FG000|STARTED|Overall Study||113||
48442342|NCT04980391|101416221|FG001|STARTED|Overall Study||56||
48442343|NCT04980391|101416222|FG002|STARTED|Overall Study||132||
48442344|NCT04980391|101416223|FG003|STARTED|Overall Study||66||
48442345|NCT04980391|101416220|FG000|COMPLETED|Overall Study||107||
48442346|NCT04980391|101416221|FG001|COMPLETED|Overall Study||52||
48442347|NCT04980391|101416222|FG002|COMPLETED|Overall Study||124||
48442348|NCT04980391|101416223|FG003|COMPLETED|Overall Study||61||
48442349|NCT04980391|101416220|FG000|NOT COMPLETED|Overall Study||6||
48442350|NCT04980391|101416221|FG001|NOT COMPLETED|Overall Study||4||
48442351|NCT04980391|101416222|FG002|NOT COMPLETED|Overall Study||8||
48442352|NCT04980391|101416223|FG003|NOT COMPLETED|Overall Study||5||
48442353|NCT02204449|101416224|FG000|STARTED|Overall Study||46||
48442354|NCT02204449|101416225|FG001|STARTED|Overall Study||48||
48442355|NCT02204449|101416224|FG000|COMPLETED|Overall Study||39||
48442356|NCT02204449|101416225|FG001|COMPLETED|Overall Study||37||
48442357|NCT02204449|101416224|FG000|NOT COMPLETED|Overall Study||7||
48442358|NCT02204449|101416225|FG001|NOT COMPLETED|Overall Study||11||
48442359|NCT01244516|101416226|FG000|STARTED|Period 1 (Baseline to 1-week Visit)||170||
48442360|NCT01244516|101416227|FG001|STARTED|Period 1 (Baseline to 1-week Visit)||177||
48442361|NCT01244516|101416228|FG002|STARTED|Period 1 (Baseline to 1-week Visit)||173||
48442362|NCT01244516|101416226|FG000|COMPLETED|Period 1 (Baseline to 1-week Visit)||166||
48442363|NCT01244516|101416227|FG001|COMPLETED|Period 1 (Baseline to 1-week Visit)||171||
48442364|NCT01244516|101416228|FG002|COMPLETED|Period 1 (Baseline to 1-week Visit)||170||
48442365|NCT01244516|101416226|FG000|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||4||
48442366|NCT01244516|101416227|FG001|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||6||
48442367|NCT01244516|101416228|FG002|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||3||
48442368|NCT01244516|101416226|FG000|STARTED|Period 2 (1-week to 2-week Visit)||166||
48442369|NCT01244516|101416227|FG001|STARTED|Period 2 (1-week to 2-week Visit)||171||
48442370|NCT01244516|101416228|FG002|STARTED|Period 2 (1-week to 2-week Visit)||170||
48442371|NCT01244516|101416226|FG000|COMPLETED|Period 2 (1-week to 2-week Visit)||163||
48442372|NCT01244516|101416227|FG001|COMPLETED|Period 2 (1-week to 2-week Visit)||170||
48442373|NCT01244516|101416228|FG002|COMPLETED|Period 2 (1-week to 2-week Visit)||168||
48442374|NCT01244516|101416226|FG000|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||3||
48442375|NCT01244516|101416227|FG001|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||1||
48442376|NCT01244516|101416228|FG002|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||2||
48442377|NCT05083559|101416229|FG000|STARTED|Dexcom Training Visit (30 Minutes)||7||
48442378|NCT05083559|101416230|FG001|STARTED|Dexcom Training Visit (30 Minutes)||8||
48442379|NCT05083559|101416229|FG000|COMPLETED|Dexcom Training Visit (30 Minutes)||7||
48442380|NCT05083559|101416230|FG001|COMPLETED|Dexcom Training Visit (30 Minutes)||8||
48769113|NCT02079246|102223137|FG000|STARTED|OLEX||1463||
48769114|NCT02079246|102223138|FG001|STARTED|OLEX||0||
48442381|NCT05083559|101416229|FG000|NOT COMPLETED|Dexcom Training Visit (30 Minutes)||0||
48442382|NCT05083559|101416230|FG001|NOT COMPLETED|Dexcom Training Visit (30 Minutes)||0||
48442383|NCT05083559|101416229|FG000|STARTED|First Rest Period (1-12 Weeks)||7||
48442384|NCT05083559|101416230|FG001|STARTED|First Rest Period (1-12 Weeks)||8||
48442385|NCT05083559|101416229|FG000|COMPLETED|First Rest Period (1-12 Weeks)||7||
48442386|NCT05083559|101416230|FG001|COMPLETED|First Rest Period (1-12 Weeks)||8||
48442387|NCT05083559|101416229|FG000|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
48442388|NCT05083559|101416230|FG001|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
48442389|NCT05083559|101416229|FG000|STARTED|First Intervention (~8 Hours)||7||
48442390|NCT05083559|101416230|FG001|STARTED|First Intervention (~8 Hours)||8||
48442391|NCT05083559|101416229|FG000|COMPLETED|First Intervention (~8 Hours)||3||
48442392|NCT05083559|101416230|FG001|COMPLETED|First Intervention (~8 Hours)||7||
48442393|NCT05083559|101416229|FG000|NOT COMPLETED|First Intervention (~8 Hours)||4||
48442394|NCT05083559|101416230|FG001|NOT COMPLETED|First Intervention (~8 Hours)||1||
48769115|NCT02079246|102223137|FG000|COMPLETED|OLEX||1235||
48769116|NCT02079246|102223138|FG001|COMPLETED|OLEX||0||
48769117|NCT02079246|102223137|FG000|NOT COMPLETED|OLEX||228||
48769118|NCT02079246|102223138|FG001|NOT COMPLETED|OLEX||0||
48442395|NCT05083559|101416229|FG000|STARTED|Second at Home Period (3-30 Days)||7||
48442396|NCT05083559|101416230|FG001|STARTED|Second at Home Period (3-30 Days)||8||
48442397|NCT05083559|101416229|FG000|COMPLETED|Second at Home Period (3-30 Days)||5||
48442398|NCT05083559|101416230|FG001|COMPLETED|Second at Home Period (3-30 Days)||8||
48442399|NCT05083559|101416229|FG000|NOT COMPLETED|Second at Home Period (3-30 Days)||2||
48442400|NCT05083559|101416230|FG001|NOT COMPLETED|Second at Home Period (3-30 Days)||0||
48442401|NCT05083559|101416229|FG000|STARTED|Second Intervention Visit (~8 Hours)||5||
48442402|NCT05083559|101416230|FG001|STARTED|Second Intervention Visit (~8 Hours)||8||
48442403|NCT05083559|101416229|FG000|COMPLETED|Second Intervention Visit (~8 Hours)||4||
48442404|NCT05083559|101416230|FG001|COMPLETED|Second Intervention Visit (~8 Hours)||8||
48442405|NCT05083559|101416229|FG000|NOT COMPLETED|Second Intervention Visit (~8 Hours)||1||
48442406|NCT05083559|101416230|FG001|NOT COMPLETED|Second Intervention Visit (~8 Hours)||0||
48442407|NCT00819091|101416231|FG000|STARTED|Overall Study||84||
48442408|NCT00819091|101416232|FG001|STARTED|Overall Study||161||
48442409|NCT00819091|101416231|FG000|COMPLETED|Overall Study||77||
48442410|NCT00819091|101416232|FG001|COMPLETED|Overall Study||151||
48442411|NCT00819091|101416231|FG000|NOT COMPLETED|Overall Study||7||
48442412|NCT00819091|101416232|FG001|NOT COMPLETED|Overall Study||10||
48442413|NCT04797637|101416233|FG000|STARTED|Overall Study||141||
48442414|NCT04797637|101416234|FG001|STARTED|Overall Study||137||
48442415|NCT04797637|101416233|FG000|COMPLETED|Overall Study||118||
48442416|NCT04797637|101416234|FG001|COMPLETED|Overall Study||104||
48442417|NCT04797637|101416233|FG000|NOT COMPLETED|Overall Study||23||
48442418|NCT04797637|101416234|FG001|NOT COMPLETED|Overall Study||33||
48442419|NCT02704130|101416235|FG000|STARTED|Overall Study||5||
48657996|NCT00684554|101946138|FG000|COMPLETED|Overall Study||10||
48657997|NCT00684554|101946139|FG001|COMPLETED|Overall Study||10||
48657998|NCT00684554|101946138|FG000|NOT COMPLETED|Overall Study||0||
48657999|NCT00684554|101946139|FG001|NOT COMPLETED|Overall Study||0||
48658000|NCT00655356|101946140|FG000|STARTED|Overall Study||110||
48769119|NCT02079246|102223137|FG000|STARTED|OLEX-MEM||0||
48769120|NCT02079246|102223138|FG001|STARTED|OLEX-MEM||101||
48658001|NCT00655356|101946141|FG001|STARTED|Overall Study||108||
48658002|NCT00655356|101946140|FG000|COMPLETED|Overall Study||93||
48769121|NCT02079246|102223137|FG000|COMPLETED|OLEX-MEM||0||
48769122|NCT02079246|102223138|FG001|COMPLETED|OLEX-MEM||82||
48769123|NCT02079246|102223137|FG000|NOT COMPLETED|OLEX-MEM||0||
48769124|NCT02079246|102223138|FG001|NOT COMPLETED|OLEX-MEM||19||
48769125|NCT01337960|102223139|FG000|STARTED|Overall Study||14||
48442420|NCT02704130|101416236|FG001|STARTED|Overall Study||3||
48442421|NCT02704130|101416235|FG000|COMPLETED|Overall Study||0||
48442422|NCT02704130|101416236|FG001|COMPLETED|Overall Study||0||
48442423|NCT02704130|101416235|FG000|NOT COMPLETED|Overall Study||5||
48442424|NCT02704130|101416236|FG001|NOT COMPLETED|Overall Study||3||
48442425|NCT03020966|101416237|FG000|STARTED|Overall Study||77||
48442426|NCT03020966|101416238|FG001|STARTED|Overall Study||77||
48442427|NCT03020966|101416237|FG000|COMPLETED|Overall Study||75||
48442428|NCT03020966|101416238|FG001|COMPLETED|Overall Study||77||
48442429|NCT03020966|101416237|FG000|NOT COMPLETED|Overall Study||2||
48442430|NCT03020966|101416238|FG001|NOT COMPLETED|Overall Study||0||
48442431|NCT02618772|101416239|FG000|STARTED|Overall Study||39||
48442432|NCT02618772|101416240|FG001|STARTED|Overall Study||40||
48442433|NCT02618772|101416239|FG000|Withdrawal by Subject|Overall Study||1||
48442434|NCT02618772|101416240|FG001|Withdrawal by Subject|Overall Study||0||
48658003|NCT00655356|101946141|FG001|COMPLETED|Overall Study||98||
48658004|NCT00655356|101946140|FG000|NOT COMPLETED|Overall Study||17||
48769126|NCT01337960|102223140|FG001|STARTED|Overall Study||14||
48769127|NCT01337960|102223141|FG002|STARTED|Overall Study||6||
48442435|NCT02618772|101416239|FG000|COMPLETED|Overall Study||38||
48442436|NCT02618772|101416240|FG001|COMPLETED|Overall Study||40||
48442437|NCT02618772|101416239|FG000|NOT COMPLETED|Overall Study||1||
48442438|NCT02618772|101416240|FG001|NOT COMPLETED|Overall Study||0||
48442439|NCT04141670|101416241|FG000|STARTED|Overall Study||3||
48442440|NCT04141670|101416242|FG001|STARTED|Overall Study||4||
48442441|NCT04141670|101416241|FG000|COMPLETED|Overall Study||3||
48442442|NCT04141670|101416242|FG001|COMPLETED|Overall Study||4||
48769128|NCT01337960|102223139|FG000|COMPLETED|Overall Study||12||
48769129|NCT01337960|102223140|FG001|COMPLETED|Overall Study||14||
48769130|NCT01337960|102223141|FG002|COMPLETED|Overall Study||6||
48769131|NCT01337960|102223139|FG000|NOT COMPLETED|Overall Study||2||
48769132|NCT01337960|102223140|FG001|NOT COMPLETED|Overall Study||0||
48769133|NCT01337960|102223141|FG002|NOT COMPLETED|Overall Study||0||
48769134|NCT02930824|102223142|FG000|STARTED|Overall Study||62||
48769135|NCT02930824|102223143|FG001|STARTED|Overall Study||63||
48368508|NCT01372878|101230202|FG000|NOT COMPLETED|Overall Study||184||
48368509|NCT00651118|101230203|FG000|STARTED|Overall Study||207||
48368510|NCT00651118|101230204|FG001|STARTED|Overall Study||207||
48368511|NCT00651118|101230205|FG002|STARTED|Overall Study||208||
48368512|NCT00651118|101230206|FG003|STARTED|Overall Study||210||
48368513|NCT00651118|101230203|FG000|COMPLETED|Overall Study||198||
48368514|NCT00651118|101230204|FG001|COMPLETED|Overall Study||200||
48368515|NCT00651118|101230205|FG002|COMPLETED|Overall Study||197||
48442443|NCT04141670|101416241|FG000|NOT COMPLETED|Overall Study||0||
48442444|NCT04141670|101416242|FG001|NOT COMPLETED|Overall Study||0||
48442445|NCT04686500|101416243|FG000|STARTED|Overall Study||10||
48442446|NCT04686500|101416243|FG000|COMPLETED|Overall Study||10||
48442447|NCT04686500|101416243|FG000|NOT COMPLETED|Overall Study||0||
48442448|NCT02487979|101416244|FG000|STARTED|Overall Study||22||
48442449|NCT02487979|101416244|FG000|COMPLETED|Overall Study||1||
48442450|NCT02487979|101416244|FG000|NOT COMPLETED|Overall Study||21||
48442451|NCT03491800|101416245|FG000|STARTED|Overall Study||23||
48769136|NCT02930824|102223144|FG002|STARTED|Overall Study||30||
48368516|NCT00651118|101230206|FG003|COMPLETED|Overall Study||203||
48368517|NCT00651118|101230203|FG000|NOT COMPLETED|Overall Study||9||
48368518|NCT00651118|101230204|FG001|NOT COMPLETED|Overall Study||7||
48368519|NCT00651118|101230205|FG002|NOT COMPLETED|Overall Study||11||
48368520|NCT00651118|101230206|FG003|NOT COMPLETED|Overall Study||7||
48368521|NCT00069095|101230207|FG000|STARTED|Primary Treatment Phase||317||
48368522|NCT00069095|101230208|FG001|STARTED|Primary Treatment Phase||317||
48368523|NCT00069095|101230209|FG002|STARTED|Primary Treatment Phase||350||
48368524|NCT00069095|101230210|FG003|STARTED|Primary Treatment Phase||351||
48368525|NCT00069095|101230211|FG004|STARTED|Primary Treatment Phase||350||
48368526|NCT00069095|101230212|FG005|STARTED|Primary Treatment Phase||349||
48368527|NCT00069095|101230207|FG000|COMPLETED|Primary Treatment Phase||22||
48368528|NCT00069095|101230208|FG001|COMPLETED|Primary Treatment Phase||15||
48368529|NCT00069095|101230209|FG002|COMPLETED|Primary Treatment Phase||36||
48368530|NCT00069095|101230210|FG003|COMPLETED|Primary Treatment Phase||31||
48368531|NCT00069095|101230211|FG004|COMPLETED|Primary Treatment Phase||48||
48368532|NCT00069095|101230212|FG005|COMPLETED|Primary Treatment Phase||48||
48368533|NCT00069095|101230207|FG000|NOT COMPLETED|Primary Treatment Phase||295||
48368534|NCT00069095|101230208|FG001|NOT COMPLETED|Primary Treatment Phase||302||
48368535|NCT00069095|101230209|FG002|NOT COMPLETED|Primary Treatment Phase||314||
48368536|NCT00069095|101230210|FG003|NOT COMPLETED|Primary Treatment Phase||320||
48368537|NCT00069095|101230211|FG004|NOT COMPLETED|Primary Treatment Phase||302||
48368538|NCT00069095|101230212|FG005|NOT COMPLETED|Primary Treatment Phase||301||
48368539|NCT00069095|101230207|FG000|STARTED|Post-study Treatment Phase||8||
48368540|NCT00069095|101230208|FG001|STARTED|Post-study Treatment Phase||13||
48368541|NCT00069095|101230209|FG002|STARTED|Post-study Treatment Phase||21||
48368542|NCT00069095|101230210|FG003|STARTED|Post-study Treatment Phase||17||
48368543|NCT00069095|101230211|FG004|STARTED|Post-study Treatment Phase||36||
48368544|NCT00069095|101230212|FG005|STARTED|Post-study Treatment Phase||29||
48368545|NCT00069095|101230207|FG000|COMPLETED|Post-study Treatment Phase||0||
48368546|NCT00069095|101230208|FG001|COMPLETED|Post-study Treatment Phase||0||
48368547|NCT00069095|101230209|FG002|COMPLETED|Post-study Treatment Phase||0||
48368548|NCT00069095|101230210|FG003|COMPLETED|Post-study Treatment Phase||0||
48368549|NCT00069095|101230211|FG004|COMPLETED|Post-study Treatment Phase||0||
48368550|NCT00069095|101230212|FG005|COMPLETED|Post-study Treatment Phase||0||
48368551|NCT00069095|101230207|FG000|NOT COMPLETED|Post-study Treatment Phase||8||
48368552|NCT00069095|101230208|FG001|NOT COMPLETED|Post-study Treatment Phase||13||
48368553|NCT00069095|101230209|FG002|NOT COMPLETED|Post-study Treatment Phase||21||
48442452|NCT03491800|101416246|FG001|STARTED|Overall Study||23||
48442453|NCT03491800|101416247|FG002|STARTED|Overall Study||7||
48442454|NCT03491800|101416245|FG000|COMPLETED|Overall Study||23||
48442455|NCT03491800|101416246|FG001|COMPLETED|Overall Study||23||
48442456|NCT03491800|101416247|FG002|COMPLETED|Overall Study||7||
48769137|NCT02930824|102223145|FG003|STARTED|Overall Study||30||
48442457|NCT03491800|101416245|FG000|NOT COMPLETED|Overall Study||0||
48442458|NCT03491800|101416246|FG001|NOT COMPLETED|Overall Study||0||
48442459|NCT03491800|101416247|FG002|NOT COMPLETED|Overall Study||0||
48442460|NCT03065517|101416248|FG000|STARTED|Overall Study||110||
48442461|NCT03065517|101416249|FG001|STARTED|Overall Study||106||
48442462|NCT03065517|101416248|FG000|COMPLETED|Overall Study||84||
48442463|NCT03065517|101416249|FG001|COMPLETED|Overall Study||90||
48442464|NCT03065517|101416248|FG000|NOT COMPLETED|Overall Study||26||
48658005|NCT00655356|101946141|FG001|NOT COMPLETED|Overall Study||10||
48658006|NCT05287685|101946142|FG000|STARTED|Open Trial||10||
48658007|NCT05287685|101946143|FG001|STARTED|Open Trial||0||
48769138|NCT02930824|102223142|FG000|COMPLETED|Overall Study||56||
48769139|NCT02930824|102223143|FG001|COMPLETED|Overall Study||57||
48769140|NCT02930824|102223144|FG002|COMPLETED|Overall Study||20||
48769141|NCT02930824|102223145|FG003|COMPLETED|Overall Study||23||
48769142|NCT02930824|102223142|FG000|NOT COMPLETED|Overall Study||6||
48769143|NCT02930824|102223143|FG001|NOT COMPLETED|Overall Study||6||
48769144|NCT02930824|102223144|FG002|NOT COMPLETED|Overall Study||10||
48769145|NCT02930824|102223145|FG003|NOT COMPLETED|Overall Study||7||
48769146|NCT02015910|102223146|FG000|STARTED|Overall Study||0||
48769147|NCT02015910|102223147|FG001|STARTED|Overall Study||1||
48769148|NCT02015910|102223146|FG000|COMPLETED|Overall Study||0||
48769149|NCT02015910|102223147|FG001|COMPLETED|Overall Study||1||
48769150|NCT02015910|102223146|FG000|NOT COMPLETED|Overall Study||0||
48769151|NCT02015910|102223147|FG001|NOT COMPLETED|Overall Study||0||
48769152|NCT02199184|102223148|FG000|STARTED|Overall Study||14||
48769153|NCT02199184|102223148|FG000|COMPLETED|Overall Study||14||
48769154|NCT02199184|102223148|FG000|NOT COMPLETED|Overall Study||0||
48769155|NCT01499355|102223149|FG000|STARTED|Run-In Period||276||
48769156|NCT01499355|102223150|FG001|STARTED|Run-In Period||0||
48769157|NCT01499355|102223151|FG002|STARTED|Run-In Period||0||
48769158|NCT01499355|102223152|FG003|STARTED|Run-In Period||0||
48769159|NCT01499355|102223149|FG000|COMPLETED|Run-In Period||245||
48769160|NCT01499355|102223150|FG001|COMPLETED|Run-In Period||0||
48442465|NCT03065517|101416249|FG001|NOT COMPLETED|Overall Study||16||
48658008|NCT05287685|101946142|FG000|Received Intervention|Open Trial||10||
48658009|NCT05287685|101946143|FG001|Received Intervention|Open Trial||0||
48658010|NCT05287685|101946142|FG000|Post-test|Open Trial||10||
48658011|NCT05287685|101946143|FG001|Post-test|Open Trial||0||
48658012|NCT05287685|101946142|FG000|COMPLETED|Open Trial||10||
48658013|NCT05287685|101946143|FG001|COMPLETED|Open Trial||0||
48658014|NCT05287685|101946142|FG000|NOT COMPLETED|Open Trial||0||
48658015|NCT05287685|101946143|FG001|NOT COMPLETED|Open Trial||0||
48658016|NCT05287685|101946142|FG000|STARTED|Pilot Randomized Controlled Trial||18||
48658017|NCT05287685|101946143|FG001|STARTED|Pilot Randomized Controlled Trial||16||
48658018|NCT05287685|101946142|FG000|Received Intervention|Pilot Randomized Controlled Trial||16||
48658019|NCT05287685|101946143|FG001|Received Intervention|Pilot Randomized Controlled Trial||15||
48658020|NCT05287685|101946142|FG000|Post-test|Pilot Randomized Controlled Trial||16||
48658021|NCT05287685|101946143|FG001|Post-test|Pilot Randomized Controlled Trial||15||
48658022|NCT05287685|101946142|FG000|COMPLETED|Pilot Randomized Controlled Trial||15||
48658023|NCT05287685|101946143|FG001|COMPLETED|Pilot Randomized Controlled Trial||15||
48658024|NCT05287685|101946142|FG000|NOT COMPLETED|Pilot Randomized Controlled Trial||3||
48658025|NCT05287685|101946143|FG001|NOT COMPLETED|Pilot Randomized Controlled Trial||1||
48658026|NCT02336555|101946144|FG000|STARTED|Treatment Period 1 (28 Days)||18||
48769161|NCT01499355|102223151|FG002|COMPLETED|Run-In Period||0||
48769162|NCT01499355|102223152|FG003|COMPLETED|Run-In Period||0||
48769163|NCT01499355|102223149|FG000|NOT COMPLETED|Run-In Period||31||
48769164|NCT01499355|102223150|FG001|NOT COMPLETED|Run-In Period||0||
48769165|NCT01499355|102223151|FG002|NOT COMPLETED|Run-In Period||0||
48769166|NCT01499355|102223152|FG003|NOT COMPLETED|Run-In Period||0||
48769167|NCT01499355|102223149|FG000|STARTED|Double-Blind Period||0||
48769168|NCT01499355|102223150|FG001|STARTED|Double-Blind Period||63||
48769169|NCT01499355|102223151|FG002|STARTED|Double-Blind Period||63||
48769170|NCT01499355|102223152|FG003|STARTED|Double-Blind Period||62||
48769171|NCT01499355|102223149|FG000|COMPLETED|Double-Blind Period||0||
48769172|NCT01499355|102223150|FG001|COMPLETED|Double-Blind Period||40||
48658027|NCT02336555|101946145|FG001|STARTED|Treatment Period 1 (28 Days)||17||
48658028|NCT02336555|101946144|FG000|COMPLETED|Treatment Period 1 (28 Days)||16||
48658029|NCT02336555|101946145|FG001|COMPLETED|Treatment Period 1 (28 Days)||16||
48769173|NCT01499355|102223151|FG002|COMPLETED|Double-Blind Period||38||
48769174|NCT01499355|102223152|FG003|COMPLETED|Double-Blind Period||39||
48769175|NCT01499355|102223149|FG000|NOT COMPLETED|Double-Blind Period||0||
48442466|NCT04578548|101416250|FG000|STARTED|Double-blind Treatment Period (52 Weeks)||44||
48442467|NCT04578548|101416251|FG001|STARTED|Double-blind Treatment Period (52 Weeks)||22||
48442468|NCT04578548|101416250|FG000|COMPLETED|Double-blind Treatment Period (52 Weeks)||41||
48658030|NCT02336555|101946144|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||2||
48658031|NCT02336555|101946145|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||1||
48658032|NCT02336555|101946144|FG000|STARTED|Treatment Period 2 (28 Days)||16||
48769176|NCT01499355|102223150|FG001|NOT COMPLETED|Double-Blind Period||23||
48769177|NCT01499355|102223151|FG002|NOT COMPLETED|Double-Blind Period||25||
48769178|NCT01499355|102223152|FG003|NOT COMPLETED|Double-Blind Period||23||
48769179|NCT00533117|102223153|FG000|STARTED|Overall Study||18||
48769180|NCT00533117|102223154|FG001|STARTED|Overall Study||19||
48442469|NCT04578548|101416251|FG001|COMPLETED|Double-blind Treatment Period (52 Weeks)||20||
48442470|NCT04578548|101416250|FG000|NOT COMPLETED|Double-blind Treatment Period (52 Weeks)||3||
48442471|NCT04578548|101416251|FG001|NOT COMPLETED|Double-blind Treatment Period (52 Weeks)||2||
48658033|NCT02336555|101946145|FG001|STARTED|Treatment Period 2 (28 Days)||16||
48658034|NCT02336555|101946144|FG000|COMPLETED|Treatment Period 2 (28 Days)||16||
48658035|NCT02336555|101946145|FG001|COMPLETED|Treatment Period 2 (28 Days)||15||
48658036|NCT02336555|101946144|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
48658037|NCT02336555|101946145|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||1||
48658038|NCT00692237|101946146|FG000|STARTED|Overall Study||30||
48658039|NCT00692237|101946147|FG001|STARTED|Overall Study||29||
48658040|NCT00692237|101946146|FG000|COMPLETED|Overall Study||29||
48769181|NCT00533117|102223155|FG002|STARTED|Overall Study||20||
48769182|NCT00533117|102223156|FG003|STARTED|Overall Study||18||
48368554|NCT00069095|101230210|FG003|NOT COMPLETED|Post-study Treatment Phase||17||
48442472|NCT04578548|101416250|FG000|STARTED|Open-Label Treatment Period (52 Weeks)||39||
48442473|NCT04578548|101416251|FG001|STARTED|Open-Label Treatment Period (52 Weeks)||20||
48442474|NCT04578548|101416250|FG000|COMPLETED|Open-Label Treatment Period (52 Weeks)||3||
48442475|NCT04578548|101416251|FG001|COMPLETED|Open-Label Treatment Period (52 Weeks)||4||
48442476|NCT04578548|101416250|FG000|NOT COMPLETED|Open-Label Treatment Period (52 Weeks)||36||
48442477|NCT04578548|101416251|FG001|NOT COMPLETED|Open-Label Treatment Period (52 Weeks)||16||
48442478|NCT00535873|101416252|FG000|STARTED|Overall Study||60||
48442479|NCT00535873|101416252|FG000|COMPLETED|Overall Study||60||
48442480|NCT00535873|101416252|FG000|NOT COMPLETED|Overall Study||0||
48442481|NCT04635631|101416253|FG000|STARTED|Overall Study||15||
48442482|NCT04635631|101416253|FG000|COMPLETED|Overall Study||0||
48442483|NCT04635631|101416253|FG000|NOT COMPLETED|Overall Study||15||
48442484|NCT05144477|101416254|FG000|STARTED|Overall Study||11||
48442485|NCT05144477|101416255|FG001|STARTED|Overall Study||5||
48442486|NCT05144477|101416254|FG000|COMPLETED|Overall Study||10||
48658041|NCT00692237|101946147|FG001|COMPLETED|Overall Study||25||
48658042|NCT00692237|101946146|FG000|NOT COMPLETED|Overall Study||1||
48658043|NCT00692237|101946147|FG001|NOT COMPLETED|Overall Study||4||
48658044|NCT00912873|101946148|FG000|STARTED|Overall Study||26||
48769183|NCT00533117|102223153|FG000|COMPLETED|Overall Study||14||
48769184|NCT00533117|102223154|FG001|COMPLETED|Overall Study||14||
48368555|NCT00069095|101230211|FG004|NOT COMPLETED|Post-study Treatment Phase||36||
48368556|NCT00069095|101230212|FG005|NOT COMPLETED|Post-study Treatment Phase||29||
48368557|NCT00069095|101230207|FG000|STARTED|Follow-up Phase||284||
48368558|NCT00069095|101230208|FG001|STARTED|Follow-up Phase||299||
48368559|NCT00069095|101230209|FG002|STARTED|Follow-up Phase||298||
48368560|NCT00069095|101230210|FG003|STARTED|Follow-up Phase||299||
48368561|NCT00069095|101230211|FG004|STARTED|Follow-up Phase||278||
48368562|NCT00069095|101230212|FG005|STARTED|Follow-up Phase||272||
48368563|NCT00069095|101230207|FG000|COMPLETED|Follow-up Phase||110||
48368564|NCT00069095|101230208|FG001|COMPLETED|Follow-up Phase||93||
48368565|NCT00069095|101230209|FG002|COMPLETED|Follow-up Phase||178||
48368566|NCT00069095|101230210|FG003|COMPLETED|Follow-up Phase||187||
48368567|NCT00069095|101230211|FG004|COMPLETED|Follow-up Phase||186||
48368568|NCT00069095|101230212|FG005|COMPLETED|Follow-up Phase||171||
48368569|NCT00069095|101230207|FG000|NOT COMPLETED|Follow-up Phase||174||
48368570|NCT00069095|101230208|FG001|NOT COMPLETED|Follow-up Phase||206||
48368571|NCT00069095|101230209|FG002|NOT COMPLETED|Follow-up Phase||120||
48368572|NCT00069095|101230210|FG003|NOT COMPLETED|Follow-up Phase||112||
48368573|NCT00069095|101230211|FG004|NOT COMPLETED|Follow-up Phase||92||
48368574|NCT00069095|101230212|FG005|NOT COMPLETED|Follow-up Phase||101||
48368575|NCT02316470|101230213|FG000|STARTED|Overall Study||148||
48368576|NCT02316470|101230214|FG001|STARTED|Overall Study||152||
48368577|NCT02316470|101230215|FG002|STARTED|Overall Study||152||
48368578|NCT02316470|101230216|FG003|STARTED|Overall Study||48||
48368579|NCT02316470|101230213|FG000|COMPLETED|Overall Study||143||
48368580|NCT02316470|101230214|FG001|COMPLETED|Overall Study||146||
48368581|NCT02316470|101230215|FG002|COMPLETED|Overall Study||147||
48368582|NCT02316470|101230216|FG003|COMPLETED|Overall Study||46||
48368583|NCT02316470|101230213|FG000|NOT COMPLETED|Overall Study||5||
48368584|NCT02316470|101230214|FG001|NOT COMPLETED|Overall Study||6||
48368585|NCT02316470|101230215|FG002|NOT COMPLETED|Overall Study||5||
48368586|NCT02316470|101230216|FG003|NOT COMPLETED|Overall Study||2||
48769185|NCT00533117|102223155|FG002|COMPLETED|Overall Study||14||
48442487|NCT05144477|101416255|FG001|COMPLETED|Overall Study||4||
48442488|NCT05144477|101416254|FG000|NOT COMPLETED|Overall Study||1||
48442489|NCT05144477|101416255|FG001|NOT COMPLETED|Overall Study||1||
48442490|NCT01387672|101416256|FG000|STARTED|Overall Study||39||
48368587|NCT04359823|101230217|FG000|STARTED|Overall Study||17||
48368588|NCT04359823|101230218|FG001|STARTED|Overall Study||14||
48442491|NCT01387672|101416257|FG001|STARTED|Overall Study||38||
48442492|NCT01387672|101416258|FG002|STARTED|Overall Study||38||
48442493|NCT01387672|101416259|FG003|STARTED|Overall Study||39||
48442494|NCT01387672|101416260|FG004|STARTED|Overall Study||38||
48442495|NCT01387672|101416261|FG005|STARTED|Overall Study||37||
48442496|NCT01387672|101416256|FG000|COMPLETED|Overall Study||32||
48769186|NCT00533117|102223156|FG003|COMPLETED|Overall Study||13||
48442497|NCT01387672|101416257|FG001|COMPLETED|Overall Study||31||
48442498|NCT01387672|101416258|FG002|COMPLETED|Overall Study||33||
48442499|NCT01387672|101416259|FG003|COMPLETED|Overall Study||35||
48442500|NCT01387672|101416260|FG004|COMPLETED|Overall Study||34||
48442501|NCT01387672|101416261|FG005|COMPLETED|Overall Study||37||
48442502|NCT01387672|101416256|FG000|NOT COMPLETED|Overall Study||7||
48442503|NCT01387672|101416257|FG001|NOT COMPLETED|Overall Study||7||
48442504|NCT01387672|101416258|FG002|NOT COMPLETED|Overall Study||5||
48442505|NCT01387672|101416259|FG003|NOT COMPLETED|Overall Study||4||
48442506|NCT01387672|101416260|FG004|NOT COMPLETED|Overall Study||4||
48442507|NCT01387672|101416261|FG005|NOT COMPLETED|Overall Study||0||
48442508|NCT00460421|101416262|FG000|STARTED|Overall Study||9||
48442509|NCT00460421|101416263|FG001|STARTED|Overall Study||9||
48442510|NCT00460421|101416264|FG002|STARTED|Overall Study||9||
48442511|NCT00460421|101416262|FG000|COMPLETED|Overall Study||9||
48442512|NCT00460421|101416263|FG001|COMPLETED|Overall Study||9||
48442513|NCT00460421|101416264|FG002|COMPLETED|Overall Study||9||
48442514|NCT00460421|101416262|FG000|NOT COMPLETED|Overall Study||0||
48442515|NCT00460421|101416263|FG001|NOT COMPLETED|Overall Study||0||
48442516|NCT00460421|101416264|FG002|NOT COMPLETED|Overall Study||0||
48442517|NCT04311411|101416265|FG000|STARTED|Overall Study||39||
48442518|NCT04311411|101416266|FG001|STARTED|Overall Study||37||
48442519|NCT04311411|101416267|FG002|STARTED|Overall Study||38||
48442520|NCT04311411|101416265|FG000|Received at Least One Dose of Study Drug|Overall Study||39||
48442521|NCT04311411|101416266|FG001|Received at Least One Dose of Study Drug|Overall Study||37||
48442522|NCT04311411|101416267|FG002|Received at Least One Dose of Study Drug|Overall Study||38||
48442523|NCT04311411|101416265|FG000|COMPLETED|Overall Study||34||
48442524|NCT04311411|101416266|FG001|COMPLETED|Overall Study||31||
48442525|NCT04311411|101416267|FG002|COMPLETED|Overall Study||36||
48442526|NCT04311411|101416265|FG000|NOT COMPLETED|Overall Study||5||
48442527|NCT04311411|101416266|FG001|NOT COMPLETED|Overall Study||6||
48442528|NCT04311411|101416267|FG002|NOT COMPLETED|Overall Study||2||
48442529|NCT03069365|101416268|FG000|STARTED|Overall Study||101||
48442530|NCT03069365|101416268|FG000|COMPLETED|Overall Study||100||
48769187|NCT00533117|102223153|FG000|NOT COMPLETED|Overall Study||4||
48769188|NCT00533117|102223154|FG001|NOT COMPLETED|Overall Study||5||
48769189|NCT00533117|102223155|FG002|NOT COMPLETED|Overall Study||6||
48769190|NCT00533117|102223156|FG003|NOT COMPLETED|Overall Study||5||
48769191|NCT03112603|102223157|FG000|STARTED|End of Randomization Period||165||
48769192|NCT03112603|102223158|FG001|STARTED|End of Randomization Period||164||
48769193|NCT03112603|102223159|FG002|STARTED|End of Randomization Period||0||
48769194|NCT03112603|102223157|FG000|COMPLETED|End of Randomization Period||29||
48769195|NCT03112603|102223158|FG001|COMPLETED|End of Randomization Period||24||
48769196|NCT03112603|102223159|FG002|COMPLETED|End of Randomization Period||0||
48442531|NCT03069365|101416268|FG000|NOT COMPLETED|Overall Study||1||
48442532|NCT00503035|101416269|FG000|STARTED|Overall Study||47||
48442533|NCT00503035|101416269|FG000|COMPLETED|Overall Study||27||
48442534|NCT00503035|101416269|FG000|NOT COMPLETED|Overall Study||20||
48442535|NCT02547779|101416270|FG000|STARTED|Overall Study||5214||
48442536|NCT02547779|101416271|FG001|STARTED|Overall Study||5207||
48442537|NCT02547779|101416270|FG000|COMPLETED|Overall Study||5214||
48769197|NCT03112603|102223157|FG000|NOT COMPLETED|End of Randomization Period||136||
48769198|NCT03112603|102223158|FG001|NOT COMPLETED|End of Randomization Period||140||
48769199|NCT03112603|102223159|FG002|NOT COMPLETED|End of Randomization Period||0||
48769200|NCT03112603|102223157|FG000|STARTED|End of Cross Over Period||0||
48769201|NCT03112603|102223158|FG001|STARTED|End of Cross Over Period||0||
48769202|NCT03112603|102223159|FG002|STARTED|End of Cross Over Period||70||
48442538|NCT02547779|101416271|FG001|COMPLETED|Overall Study||5207||
48442539|NCT02547779|101416270|FG000|NOT COMPLETED|Overall Study||0||
48769203|NCT03112603|102223157|FG000|COMPLETED|End of Cross Over Period||0||
48769204|NCT03112603|102223158|FG001|COMPLETED|End of Cross Over Period||0||
48769205|NCT03112603|102223159|FG002|COMPLETED|End of Cross Over Period||16||
48769206|NCT03112603|102223157|FG000|NOT COMPLETED|End of Cross Over Period||0||
48769207|NCT03112603|102223158|FG001|NOT COMPLETED|End of Cross Over Period||0||
48769208|NCT03112603|102223159|FG002|NOT COMPLETED|End of Cross Over Period||54||
48769209|NCT03524729|102223160|FG000|STARTED|Overall Study||2||
48769210|NCT03524729|102223161|FG001|STARTED|Overall Study||1||
48769211|NCT03524729|102223162|FG002|STARTED|Overall Study||2||
48769212|NCT03524729|102223163|FG003|STARTED|Overall Study||2||
48769213|NCT03524729|102223164|FG004|STARTED|Overall Study||2||
48769214|NCT03524729|102223165|FG005|STARTED|Overall Study||2||
48442540|NCT02547779|101416271|FG001|NOT COMPLETED|Overall Study||0||
48442541|NCT04305184|101416272|FG000|STARTED|SAD: Days 1 to 57||4||
48442542|NCT04305184|101416273|FG001|STARTED|SAD: Days 1 to 57||4||
48442543|NCT04305184|101416274|FG002|STARTED|SAD: Days 1 to 57||4||
48442544|NCT04305184|101416275|FG003|STARTED|SAD: Days 1 to 57||4||
48442545|NCT04305184|101416276|FG004|STARTED|SAD: Days 1 to 57||4||
48442546|NCT04305184|101416277|FG005|STARTED|SAD: Days 1 to 57||0||
48442547|NCT04305184|101416278|FG006|STARTED|SAD: Days 1 to 57||0||
48442548|NCT04305184|101416279|FG007|STARTED|SAD: Days 1 to 57||0||
48442549|NCT04305184|101416272|FG000|COMPLETED|SAD: Days 1 to 57||4||
48442550|NCT04305184|101416273|FG001|COMPLETED|SAD: Days 1 to 57||4||
48442551|NCT04305184|101416274|FG002|COMPLETED|SAD: Days 1 to 57||4||
48442552|NCT04305184|101416275|FG003|COMPLETED|SAD: Days 1 to 57||4||
48442553|NCT04305184|101416276|FG004|COMPLETED|SAD: Days 1 to 57||4||
48442554|NCT04305184|101416277|FG005|COMPLETED|SAD: Days 1 to 57||0||
48442555|NCT04305184|101416278|FG006|COMPLETED|SAD: Days 1 to 57||0||
48442556|NCT04305184|101416279|FG007|COMPLETED|SAD: Days 1 to 57||0||
48442557|NCT04305184|101416272|FG000|NOT COMPLETED|SAD: Days 1 to 57||0||
48442558|NCT04305184|101416273|FG001|NOT COMPLETED|SAD: Days 1 to 57||0||
48442559|NCT04305184|101416274|FG002|NOT COMPLETED|SAD: Days 1 to 57||0||
48442560|NCT04305184|101416275|FG003|NOT COMPLETED|SAD: Days 1 to 57||0||
48442561|NCT04305184|101416276|FG004|NOT COMPLETED|SAD: Days 1 to 57||0||
48442562|NCT04305184|101416277|FG005|NOT COMPLETED|SAD: Days 1 to 57||0||
48442563|NCT04305184|101416278|FG006|NOT COMPLETED|SAD: Days 1 to 57||0||
48442564|NCT04305184|101416279|FG007|NOT COMPLETED|SAD: Days 1 to 57||0||
48442565|NCT04305184|101416272|FG000|STARTED|MAD: Day 1 to 85||0||
48442566|NCT04305184|101416273|FG001|STARTED|MAD: Day 1 to 85||0||
48442567|NCT04305184|101416274|FG002|STARTED|MAD: Day 1 to 85||0||
48658045|NCT00912873|101946149|FG001|STARTED|Overall Study||24||
48658046|NCT00912873|101946148|FG000|COMPLETED|Overall Study||26||
48658047|NCT00912873|101946149|FG001|COMPLETED|Overall Study||24||
48658048|NCT00912873|101946148|FG000|NOT COMPLETED|Overall Study||0||
48368589|NCT04359823|101230217|FG000|COMPLETED|Overall Study||17||
48368590|NCT04359823|101230218|FG001|COMPLETED|Overall Study||12||
48368591|NCT04359823|101230217|FG000|NOT COMPLETED|Overall Study||0||
48658049|NCT00912873|101946149|FG001|NOT COMPLETED|Overall Study||0||
48188858|NCT04170023|100786100|FG000|STARTED|Treatment Period||12||
48368592|NCT04359823|101230218|FG001|NOT COMPLETED|Overall Study||2||
48368593|NCT02844582|101230219|FG000|STARTED|Overall Study||2||
48368594|NCT02844582|101230219|FG000|COMPLETED|Overall Study||2||
48368595|NCT02844582|101230219|FG000|NOT COMPLETED|Overall Study||0||
48368596|NCT00500045|101230220|FG000|STARTED|Overall Study||0||
48368597|NCT00500045|101230220|FG000|COMPLETED|Overall Study||0||
48368598|NCT00500045|101230220|FG000|NOT COMPLETED|Overall Study||0||
48658050|NCT05094102|101946150|FG000|STARTED|Overall Study||9||
48658051|NCT05094102|101946150|FG000|COMPLETED|Overall Study||9||
48658052|NCT05094102|101946150|FG000|NOT COMPLETED|Overall Study||0||
48658053|NCT02502383|101946151|FG000|STARTED|Overall Study||504||4
48658054|NCT02502383|101946152|FG001|STARTED|Overall Study||487||4
48658055|NCT02502383|101946151|FG000|Midpoint|Overall Study||410||4
48658056|NCT02502383|101946152|FG001|Midpoint|Overall Study||391||4
48658057|NCT02502383|101946151|FG000|COMPLETED|Overall Study||343||4
48658058|NCT02502383|101946152|FG001|COMPLETED|Overall Study||332||4
48658059|NCT02502383|101946151|FG000|NOT COMPLETED|Overall Study||161||0
48658060|NCT02502383|101946152|FG001|NOT COMPLETED|Overall Study||155||0
48658061|NCT01093573|101946153|FG000|STARTED|Overall Study||3||
48658062|NCT01093573|101946154|FG001|STARTED|Overall Study||3||
48658063|NCT01093573|101946155|FG002|STARTED|Overall Study||28||
48658064|NCT01093573|101946153|FG000|COMPLETED|Overall Study||3||
48658065|NCT01093573|101946154|FG001|COMPLETED|Overall Study||3||
48658066|NCT01093573|101946155|FG002|COMPLETED|Overall Study||26||
48658067|NCT01093573|101946153|FG000|NOT COMPLETED|Overall Study||0||
48658068|NCT01093573|101946154|FG001|NOT COMPLETED|Overall Study||0||
48658069|NCT01093573|101946155|FG002|NOT COMPLETED|Overall Study||2||
48658070|NCT02757768|101946156|FG000|STARTED|Overall Study||356||
48658071|NCT02757768|101946157|FG001|STARTED|Overall Study||359||
48658072|NCT02757768|101946156|FG000|Treated|Overall Study||352||
48658073|NCT02757768|101946157|FG001|Treated|Overall Study||354||
48658074|NCT02757768|101946156|FG000|COMPLETED|Overall Study||323||
48658075|NCT02757768|101946157|FG001|COMPLETED|Overall Study||331||
48658076|NCT02757768|101946156|FG000|NOT COMPLETED|Overall Study||33||
48658077|NCT02757768|101946157|FG001|NOT COMPLETED|Overall Study||28||
48658078|NCT02242903|101946158|FG000|STARTED|Overall Study||12||
48658079|NCT02242903|101946159|FG001|STARTED|Overall Study||6||
48658080|NCT02242903|101946160|FG002|STARTED|Overall Study||6||
48658081|NCT02242903|101946161|FG003|STARTED|Overall Study||6||
48658082|NCT02242903|101946162|FG004|STARTED|Overall Study||6||
48658083|NCT02242903|101946163|FG005|STARTED|Overall Study||6||
48658084|NCT02242903|101946164|FG006|STARTED|Overall Study||6||
48658085|NCT02242903|101946158|FG000|Received at Least One Dose of Study Drug|Overall Study||12||
48188859|NCT04170023|100786101|FG001|STARTED|Treatment Period||11||
48368599|NCT02460822|101230221|FG000|STARTED|Overall Study||16||
48442568|NCT04305184|101416275|FG003|STARTED|MAD: Day 1 to 85||0||
48368600|NCT02460822|101230221|FG000|COMPLETED|Overall Study||15||
48368601|NCT02460822|101230221|FG000|NOT COMPLETED|Overall Study||1||
48442569|NCT04305184|101416276|FG004|STARTED|MAD: Day 1 to 85||0||
48442570|NCT04305184|101416277|FG005|STARTED|MAD: Day 1 to 85||6||
48442571|NCT04305184|101416278|FG006|STARTED|MAD: Day 1 to 85||6||
48442572|NCT04305184|101416279|FG007|STARTED|MAD: Day 1 to 85||4||
48658086|NCT02242903|101946159|FG001|Received at Least One Dose of Study Drug|Overall Study||6||
48658087|NCT02242903|101946160|FG002|Received at Least One Dose of Study Drug|Overall Study||6||
48658088|NCT02242903|101946161|FG003|Received at Least One Dose of Study Drug|Overall Study||6||
48658089|NCT02242903|101946162|FG004|Received at Least One Dose of Study Drug|Overall Study||6||
48658090|NCT02242903|101946163|FG005|Received at Least One Dose of Study Drug|Overall Study||6||
48769215|NCT03524729|102223160|FG000|COMPLETED|Overall Study||2||
48769216|NCT03524729|102223161|FG001|COMPLETED|Overall Study||1||
48769217|NCT03524729|102223162|FG002|COMPLETED|Overall Study||2||
48769218|NCT03524729|102223163|FG003|COMPLETED|Overall Study||1||
48769219|NCT03524729|102223164|FG004|COMPLETED|Overall Study||2||
48188860|NCT04170023|100786102|FG002|STARTED|Treatment Period||6||
48188861|NCT04170023|100786100|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||12||
48188862|NCT04170023|100786101|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||11||
48188863|NCT04170023|100786102|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||6||
48188864|NCT04170023|100786100|FG000|COMPLETED|Treatment Period||12||
48442573|NCT04305184|101416272|FG000|COMPLETED|MAD: Day 1 to 85||0||
48442574|NCT04305184|101416273|FG001|COMPLETED|MAD: Day 1 to 85||0||
48442575|NCT04305184|101416274|FG002|COMPLETED|MAD: Day 1 to 85||0||
48442576|NCT04305184|101416275|FG003|COMPLETED|MAD: Day 1 to 85||0||
48442577|NCT04305184|101416276|FG004|COMPLETED|MAD: Day 1 to 85||0||
48442578|NCT04305184|101416277|FG005|COMPLETED|MAD: Day 1 to 85||6||
48442579|NCT04305184|101416278|FG006|COMPLETED|MAD: Day 1 to 85||6||
48442580|NCT04305184|101416279|FG007|COMPLETED|MAD: Day 1 to 85||4||
48442581|NCT04305184|101416272|FG000|NOT COMPLETED|MAD: Day 1 to 85||0||
48442582|NCT04305184|101416273|FG001|NOT COMPLETED|MAD: Day 1 to 85||0||
48442583|NCT04305184|101416274|FG002|NOT COMPLETED|MAD: Day 1 to 85||0||
48442584|NCT04305184|101416275|FG003|NOT COMPLETED|MAD: Day 1 to 85||0||
48442585|NCT04305184|101416276|FG004|NOT COMPLETED|MAD: Day 1 to 85||0||
48442586|NCT04305184|101416277|FG005|NOT COMPLETED|MAD: Day 1 to 85||0||
48442587|NCT04305184|101416278|FG006|NOT COMPLETED|MAD: Day 1 to 85||0||
48442588|NCT04305184|101416279|FG007|NOT COMPLETED|MAD: Day 1 to 85||0||
48442589|NCT04369885|101416280|FG000|STARTED|Overall Study||12||
48442590|NCT04369885|101416280|FG000|COMPLETED|Overall Study||10||
48442591|NCT04369885|101416280|FG000|NOT COMPLETED|Overall Study||2||
48442592|NCT00424632|101416281|FG000|STARTED|Overall Study||1||
48442593|NCT00424632|101416282|FG001|STARTED|Overall Study||1||
48442594|NCT00424632|101416283|FG002|STARTED|Overall Study||1||
48442595|NCT00424632|101416284|FG003|STARTED|Overall Study||4||
48442596|NCT00424632|101416285|FG004|STARTED|Overall Study||3||
48442597|NCT00424632|101416286|FG005|STARTED|Overall Study||15||
48442598|NCT00424632|101416287|FG006|STARTED|Overall Study||7||
48442599|NCT00424632|101416288|FG007|STARTED|Overall Study||3||
48442600|NCT00424632|101416289|FG008|STARTED|Overall Study||16||
48442601|NCT00424632|101416290|FG009|STARTED|Overall Study||6||
48442602|NCT00424632|101416281|FG000|COMPLETED|Overall Study||0||
48442603|NCT00424632|101416282|FG001|COMPLETED|Overall Study||0||
48442604|NCT00424632|101416283|FG002|COMPLETED|Overall Study||0||
48442605|NCT00424632|101416284|FG003|COMPLETED|Overall Study||0||
48442606|NCT00424632|101416285|FG004|COMPLETED|Overall Study||0||
48442607|NCT00424632|101416286|FG005|COMPLETED|Overall Study||0||
48442608|NCT00424632|101416287|FG006|COMPLETED|Overall Study||0||
48442609|NCT00424632|101416288|FG007|COMPLETED|Overall Study||0||
48442610|NCT00424632|101416289|FG008|COMPLETED|Overall Study||0||
48442611|NCT00424632|101416290|FG009|COMPLETED|Overall Study||0||
48442612|NCT00424632|101416281|FG000|NOT COMPLETED|Overall Study||1||
48442613|NCT00424632|101416282|FG001|NOT COMPLETED|Overall Study||1||
48442614|NCT00424632|101416283|FG002|NOT COMPLETED|Overall Study||1||
48442615|NCT00424632|101416284|FG003|NOT COMPLETED|Overall Study||4||
48442616|NCT00424632|101416285|FG004|NOT COMPLETED|Overall Study||3||
48442617|NCT00424632|101416286|FG005|NOT COMPLETED|Overall Study||15||
48442618|NCT00424632|101416287|FG006|NOT COMPLETED|Overall Study||7||
48658091|NCT02242903|101946164|FG006|Received at Least One Dose of Study Drug|Overall Study||6||
48658092|NCT02242903|101946158|FG000|COMPLETED|Overall Study||11||
48658093|NCT02242903|101946159|FG001|COMPLETED|Overall Study||6||
48658094|NCT02242903|101946160|FG002|COMPLETED|Overall Study||6||
48658095|NCT02242903|101946161|FG003|COMPLETED|Overall Study||6||
48658096|NCT02242903|101946162|FG004|COMPLETED|Overall Study||6||
48769220|NCT03524729|102223165|FG005|COMPLETED|Overall Study||1||
48188865|NCT04170023|100786101|FG001|COMPLETED|Treatment Period||11||
48658097|NCT02242903|101946163|FG005|COMPLETED|Overall Study||6||
48658098|NCT02242903|101946164|FG006|COMPLETED|Overall Study||6||
48658099|NCT02242903|101946158|FG000|NOT COMPLETED|Overall Study||1||
48658100|NCT02242903|101946159|FG001|NOT COMPLETED|Overall Study||0||
48658101|NCT02242903|101946160|FG002|NOT COMPLETED|Overall Study||0||
48188866|NCT04170023|100786102|FG002|COMPLETED|Treatment Period||6||
48442619|NCT00424632|101416288|FG007|NOT COMPLETED|Overall Study||3||
48658102|NCT02242903|101946161|FG003|NOT COMPLETED|Overall Study||0||
48769221|NCT03524729|102223160|FG000|NOT COMPLETED|Overall Study||0||
48769222|NCT03524729|102223161|FG001|NOT COMPLETED|Overall Study||0||
48769223|NCT03524729|102223162|FG002|NOT COMPLETED|Overall Study||0||
48442620|NCT00424632|101416289|FG008|NOT COMPLETED|Overall Study||16||
48442621|NCT00424632|101416290|FG009|NOT COMPLETED|Overall Study||6||
48442622|NCT02525627|101416291|FG000|STARTED|Overall Study||16||
48442623|NCT02525627|101416292|FG001|STARTED|Overall Study||18||
48442624|NCT02525627|101416291|FG000|COMPLETED|Overall Study||2||
48442625|NCT02525627|101416292|FG001|COMPLETED|Overall Study||5||
48442626|NCT02525627|101416291|FG000|NOT COMPLETED|Overall Study||14||
48658103|NCT02242903|101946162|FG004|NOT COMPLETED|Overall Study||0||
48442627|NCT02525627|101416292|FG001|NOT COMPLETED|Overall Study||13||
48442628|NCT02277548|101416293|FG000|STARTED|Overall Study||9||
48442629|NCT02277548|101416294|FG001|STARTED|Overall Study||11||
48442630|NCT02277548|101416293|FG000|COMPLETED|Overall Study||9||
48442631|NCT02277548|101416294|FG001|COMPLETED|Overall Study||9||
48442632|NCT02277548|101416293|FG000|NOT COMPLETED|Overall Study||0||
48442633|NCT02277548|101416294|FG001|NOT COMPLETED|Overall Study||2||
48442634|NCT03747939|101416295|FG000|STARTED|Placebo-controlled Phase (Weeks 0 - 24)||105||
48442635|NCT03747939|101416296|FG001|STARTED|Placebo-controlled Phase (Weeks 0 - 24)||203||
48442636|NCT03747939|101416297|FG002|STARTED|Placebo-controlled Phase (Weeks 0 - 24)||0||
48442637|NCT03747939|101416298|FG003|STARTED|Placebo-controlled Phase (Weeks 0 - 24)||0||
48442638|NCT03747939|101416295|FG000|Full Analysis Set|Placebo-controlled Phase (Weeks 0 - 24)||105||
48442639|NCT03747939|101416296|FG001|Full Analysis Set|Placebo-controlled Phase (Weeks 0 - 24)||203||
48442640|NCT03747939|101416297|FG002|Full Analysis Set|Placebo-controlled Phase (Weeks 0 - 24)||0||
48442641|NCT03747939|101416298|FG003|Full Analysis Set|Placebo-controlled Phase (Weeks 0 - 24)||0||
48442642|NCT03747939|101416295|FG000|Safety Analysis Set|Placebo-controlled Phase (Weeks 0 - 24)||104|Included participants according to the treatment they actually received.|
48188867|NCT04170023|100786100|FG000|NOT COMPLETED|Treatment Period||0||
48442643|NCT03747939|101416296|FG001|Safety Analysis Set|Placebo-controlled Phase (Weeks 0 - 24)||204|Included participants according to the treatment they actually received.|
48442644|NCT03747939|101416297|FG002|Safety Analysis Set|Placebo-controlled Phase (Weeks 0 - 24)||0|Included participants according to the treatment they actually received.|
48442645|NCT03747939|101416298|FG003|Safety Analysis Set|Placebo-controlled Phase (Weeks 0 - 24)||0|Included participants according to the treatment they actually received.|
48442646|NCT03747939|101416295|FG000|Escaped Early at Week 16|Placebo-controlled Phase (Weeks 0 - 24)||24||
48442647|NCT03747939|101416296|FG001|Escaped Early at Week 16|Placebo-controlled Phase (Weeks 0 - 24)||21||
48442648|NCT03747939|101416297|FG002|Escaped Early at Week 16|Placebo-controlled Phase (Weeks 0 - 24)||0||
48442649|NCT03747939|101416298|FG003|Escaped Early at Week 16|Placebo-controlled Phase (Weeks 0 - 24)||0||
48442650|NCT03747939|101416295|FG000|Completed Week 16 and Continued|Placebo-controlled Phase (Weeks 0 - 24)||92||
48442651|NCT03747939|101416296|FG001|Completed Week 16 and Continued|Placebo-controlled Phase (Weeks 0 - 24)||172||
48442652|NCT03747939|101416297|FG002|Completed Week 16 and Continued|Placebo-controlled Phase (Weeks 0 - 24)||0||
48442653|NCT03747939|101416298|FG003|Completed Week 16 and Continued|Placebo-controlled Phase (Weeks 0 - 24)||0||
48442654|NCT03747939|101416295|FG000|COMPLETED|Placebo-controlled Phase (Weeks 0 - 24)||87|Completed to Week 24 and continued to extension phase|
48442655|NCT03747939|101416296|FG001|COMPLETED|Placebo-controlled Phase (Weeks 0 - 24)||162|Completed to Week 24 and continued to extension phase|
48442656|NCT03747939|101416297|FG002|COMPLETED|Placebo-controlled Phase (Weeks 0 - 24)||0|Completed to Week 24 and continued to extension phase|
48442657|NCT03747939|101416298|FG003|COMPLETED|Placebo-controlled Phase (Weeks 0 - 24)||0|Completed to Week 24 and continued to extension phase|
48442658|NCT03747939|101416295|FG000|NOT COMPLETED|Placebo-controlled Phase (Weeks 0 - 24)||18||
48442659|NCT03747939|101416296|FG001|NOT COMPLETED|Placebo-controlled Phase (Weeks 0 - 24)||41||
48442660|NCT03747939|101416297|FG002|NOT COMPLETED|Placebo-controlled Phase (Weeks 0 - 24)||0||
48442661|NCT03747939|101416298|FG003|NOT COMPLETED|Placebo-controlled Phase (Weeks 0 - 24)||0||
48442662|NCT03747939|101416295|FG000|STARTED|Apremilast Extension (Weeks 24 - 48)||0||
48442663|NCT03747939|101416296|FG001|STARTED|Apremilast Extension (Weeks 24 - 48)||0||
48442664|NCT03747939|101416297|FG002|STARTED|Apremilast Extension (Weeks 24 - 48)||87||
48442665|NCT03747939|101416298|FG003|STARTED|Apremilast Extension (Weeks 24 - 48)||162||
48442666|NCT03747939|101416295|FG000|Received 1 Dose of Investigational Product|Apremilast Extension (Weeks 24 - 48)||0||
48442667|NCT03747939|101416296|FG001|Received 1 Dose of Investigational Product|Apremilast Extension (Weeks 24 - 48)||0||
48442668|NCT03747939|101416297|FG002|Received 1 Dose of Investigational Product|Apremilast Extension (Weeks 24 - 48)||86||
48442669|NCT03747939|101416298|FG003|Received 1 Dose of Investigational Product|Apremilast Extension (Weeks 24 - 48)||160||
48442670|NCT03747939|101416295|FG000|COMPLETED|Apremilast Extension (Weeks 24 - 48)||0||
48442671|NCT03747939|101416296|FG001|COMPLETED|Apremilast Extension (Weeks 24 - 48)||0||
48442672|NCT03747939|101416297|FG002|COMPLETED|Apremilast Extension (Weeks 24 - 48)||77||
48442673|NCT03747939|101416298|FG003|COMPLETED|Apremilast Extension (Weeks 24 - 48)||133||
48442674|NCT03747939|101416295|FG000|NOT COMPLETED|Apremilast Extension (Weeks 24 - 48)||0||
48442675|NCT03747939|101416296|FG001|NOT COMPLETED|Apremilast Extension (Weeks 24 - 48)||0||
48442676|NCT03747939|101416297|FG002|NOT COMPLETED|Apremilast Extension (Weeks 24 - 48)||10||
48442677|NCT03747939|101416298|FG003|NOT COMPLETED|Apremilast Extension (Weeks 24 - 48)||29||
48442678|NCT00555399|101420150|FG000|STARTED|Overall Study||3||
48442679|NCT00555399|101420151|FG001|STARTED|Overall Study||3||
48442680|NCT00555399|101420152|FG002|STARTED|Overall Study||8||
48658104|NCT02242903|101946163|FG005|NOT COMPLETED|Overall Study||0||
48658105|NCT02242903|101946164|FG006|NOT COMPLETED|Overall Study||0||
48658106|NCT03688139|101946165|FG000|STARTED|Overall Study||32||
48658107|NCT03688139|101946166|FG001|STARTED|Overall Study||33||
48658108|NCT03688139|101946165|FG000|COMPLETED|Overall Study||28||
48658109|NCT03688139|101946166|FG001|COMPLETED|Overall Study||29||
48658110|NCT03688139|101946165|FG000|NOT COMPLETED|Overall Study||4||
48658111|NCT03688139|101946166|FG001|NOT COMPLETED|Overall Study||4||
48769224|NCT03524729|102223163|FG003|NOT COMPLETED|Overall Study||1||
48769225|NCT03524729|102223164|FG004|NOT COMPLETED|Overall Study||0||
48442681|NCT00555399|101420153|FG003|STARTED|Overall Study||6||
48442682|NCT00555399|101420154|FG004|STARTED|Overall Study||3||
48442683|NCT00555399|101420155|FG005|STARTED|Overall Study||3||
48442684|NCT00555399|101420156|FG006|STARTED|Overall Study||5||
48442685|NCT00555399|101420157|FG007|STARTED|Overall Study||6||
48442686|NCT00555399|101420158|FG008|STARTED|Overall Study||5||
48442687|NCT00555399|101420159|FG009|STARTED|Overall Study||3||
48442688|NCT00555399|101420160|FG010|STARTED|Overall Study||3||
48442689|NCT00555399|101420161|FG011|STARTED|Overall Study||7||
48442690|NCT00555399|101420150|FG000|COMPLETED|Overall Study||3||
48442691|NCT00555399|101420151|FG001|COMPLETED|Overall Study||3||
48442692|NCT00555399|101420152|FG002|COMPLETED|Overall Study||6||
48442693|NCT00555399|101420153|FG003|COMPLETED|Overall Study||6||
48442694|NCT00555399|101420154|FG004|COMPLETED|Overall Study||3||
48442695|NCT00555399|101420155|FG005|COMPLETED|Overall Study||3||
48442696|NCT00555399|101420156|FG006|COMPLETED|Overall Study||5||
48442697|NCT00555399|101420157|FG007|COMPLETED|Overall Study||6||
48442698|NCT00555399|101420158|FG008|COMPLETED|Overall Study||5||
48442699|NCT00555399|101420159|FG009|COMPLETED|Overall Study||3||
48442700|NCT00555399|101420160|FG010|COMPLETED|Overall Study||3||
48442701|NCT00555399|101420161|FG011|COMPLETED|Overall Study||6||
48442702|NCT00555399|101420150|FG000|NOT COMPLETED|Overall Study||0||
48442703|NCT00555399|101420151|FG001|NOT COMPLETED|Overall Study||0||
48442704|NCT00555399|101420152|FG002|NOT COMPLETED|Overall Study||2||
48442705|NCT00555399|101420153|FG003|NOT COMPLETED|Overall Study||0||
48442706|NCT00555399|101420154|FG004|NOT COMPLETED|Overall Study||0||
48442707|NCT00555399|101420155|FG005|NOT COMPLETED|Overall Study||0||
48442708|NCT00555399|101420156|FG006|NOT COMPLETED|Overall Study||0||
48442709|NCT00555399|101420157|FG007|NOT COMPLETED|Overall Study||0||
48442710|NCT00555399|101420158|FG008|NOT COMPLETED|Overall Study||0||
48442711|NCT00555399|101420159|FG009|NOT COMPLETED|Overall Study||0||
48442712|NCT00555399|101420160|FG010|NOT COMPLETED|Overall Study||0||
48442713|NCT00555399|101420161|FG011|NOT COMPLETED|Overall Study||1||
48442714|NCT03332212|101420162|FG000|STARTED|Overall Study||19||
48442715|NCT03332212|101420163|FG001|STARTED|Overall Study||18||
48442716|NCT03332212|101420164|FG002|STARTED|Overall Study||17||
48442717|NCT03332212|101420165|FG003|STARTED|Overall Study||18||
48442718|NCT03332212|101420162|FG000|Treated|Overall Study||19||
48442719|NCT03332212|101420163|FG001|Treated|Overall Study||17||
48442720|NCT03332212|101420164|FG002|Treated|Overall Study||17||
48442721|NCT03332212|101420165|FG003|Treated|Overall Study||18||
48442722|NCT03332212|101420162|FG000|COMPLETED|Overall Study||18||
48442723|NCT03332212|101420163|FG001|COMPLETED|Overall Study||16||
48442724|NCT03332212|101420164|FG002|COMPLETED|Overall Study||17||
48442725|NCT03332212|101420165|FG003|COMPLETED|Overall Study||17||
48442726|NCT03332212|101420162|FG000|NOT COMPLETED|Overall Study||1||
48442727|NCT03332212|101420163|FG001|NOT COMPLETED|Overall Study||2||
48442728|NCT03332212|101420164|FG002|NOT COMPLETED|Overall Study||0||
48442729|NCT03332212|101420165|FG003|NOT COMPLETED|Overall Study||1||
48442730|NCT01215955|101420166|FG000|STARTED|Overall Study||268||
48442731|NCT01215955|101420167|FG001|STARTED|Overall Study||263||
48442732|NCT01215955|101420168|FG002|STARTED|Overall Study||292||
48442733|NCT01215955|101420169|FG003|STARTED|Overall Study||294||
48442734|NCT01215955|101420166|FG000|Received at Least 1 Dose of Study Drug|Overall Study||267||
48442735|NCT01215955|101420167|FG001|Received at Least 1 Dose of Study Drug|Overall Study||261||
48442736|NCT01215955|101420168|FG002|Received at Least 1 Dose of Study Drug|Overall Study||288||
48442737|NCT01215955|101420169|FG003|Received at Least 1 Dose of Study Drug|Overall Study||290||
48442738|NCT01215955|101420166|FG000|COMPLETED|Overall Study||223||
48442739|NCT01215955|101420167|FG001|COMPLETED|Overall Study||210||
48442740|NCT01215955|101420168|FG002|COMPLETED|Overall Study||244||
48442741|NCT01215955|101420169|FG003|COMPLETED|Overall Study||241||
48442742|NCT01215955|101420166|FG000|NOT COMPLETED|Overall Study||45||
48442743|NCT01215955|101420167|FG001|NOT COMPLETED|Overall Study||53||
48442744|NCT01215955|101420168|FG002|NOT COMPLETED|Overall Study||48||
48442745|NCT01215955|101420169|FG003|NOT COMPLETED|Overall Study||53||
48442746|NCT02641730|101420170|FG000|STARTED|Placebo Controlled Period (Week 0 - 16)||53||
48442747|NCT02641730|101420171|FG001|STARTED|Placebo Controlled Period (Week 0 - 16)||0||
48442748|NCT02641730|101420172|FG002|STARTED|Placebo Controlled Period (Week 0 - 16)||0||
48442749|NCT02641730|101420173|FG003|STARTED|Placebo Controlled Period (Week 0 - 16)||54||
48442750|NCT02641730|101420174|FG004|STARTED|Placebo Controlled Period (Week 0 - 16)||52||
48442751|NCT02641730|101420170|FG000|COMPLETED|Placebo Controlled Period (Week 0 - 16)||51||
48442752|NCT02641730|101420171|FG001|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0||
48442753|NCT02641730|101420172|FG002|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0||
48442754|NCT02641730|101420173|FG003|COMPLETED|Placebo Controlled Period (Week 0 - 16)||53||
48442755|NCT02641730|101420174|FG004|COMPLETED|Placebo Controlled Period (Week 0 - 16)||50||
48442756|NCT02641730|101420170|FG000|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||2||
48442757|NCT02641730|101420171|FG001|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0||
48442758|NCT02641730|101420172|FG002|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0||
48442759|NCT02641730|101420173|FG003|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||1||
48442760|NCT02641730|101420174|FG004|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||2||
48442761|NCT02641730|101420170|FG000|STARTED|After Controlled Period (Week 16 - 52)||0||
48442762|NCT02641730|101420171|FG001|STARTED|After Controlled Period (Week 16 - 52)||25||
48442763|NCT02641730|101420172|FG002|STARTED|After Controlled Period (Week 16 - 52)||26||
48442764|NCT02641730|101420173|FG003|STARTED|After Controlled Period (Week 16 - 52)||53||
48442765|NCT02641730|101420174|FG004|STARTED|After Controlled Period (Week 16 - 52)||50||
48442766|NCT02641730|101420170|FG000|COMPLETED|After Controlled Period (Week 16 - 52)||0||
48442767|NCT02641730|101420171|FG001|COMPLETED|After Controlled Period (Week 16 - 52)||21||
48442768|NCT02641730|101420172|FG002|COMPLETED|After Controlled Period (Week 16 - 52)||24||
48442769|NCT02641730|101420173|FG003|COMPLETED|After Controlled Period (Week 16 - 52)||45||
48442770|NCT02641730|101420174|FG004|COMPLETED|After Controlled Period (Week 16 - 52)||44||
48442771|NCT02641730|101420170|FG000|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0||
48442772|NCT02641730|101420171|FG001|NOT COMPLETED|After Controlled Period (Week 16 - 52)||4||
48442773|NCT02641730|101420172|FG002|NOT COMPLETED|After Controlled Period (Week 16 - 52)||2||
48442774|NCT02641730|101420173|FG003|NOT COMPLETED|After Controlled Period (Week 16 - 52)||8||
48442775|NCT02641730|101420174|FG004|NOT COMPLETED|After Controlled Period (Week 16 - 52)||6||
48442776|NCT02641730|101420170|FG000|STARTED|Observational Period (Week 60 - Week 84)||0||
48442777|NCT02641730|101420171|FG001|STARTED|Observational Period (Week 60 - Week 84)||21||
48442778|NCT02641730|101420172|FG002|STARTED|Observational Period (Week 60 - Week 84)||24||
48442779|NCT02641730|101420173|FG003|STARTED|Observational Period (Week 60 - Week 84)||45||
48442780|NCT02641730|101420174|FG004|STARTED|Observational Period (Week 60 - Week 84)||44||
48442781|NCT02641730|101420170|FG000|COMPLETED|Observational Period (Week 60 - Week 84)||0||
48442782|NCT02641730|101420171|FG001|COMPLETED|Observational Period (Week 60 - Week 84)||21||
48442783|NCT02641730|101420172|FG002|COMPLETED|Observational Period (Week 60 - Week 84)||24||
48442784|NCT02641730|101420173|FG003|COMPLETED|Observational Period (Week 60 - Week 84)||45||
48442785|NCT02641730|101420174|FG004|COMPLETED|Observational Period (Week 60 - Week 84)||43||
48442786|NCT02641730|101420170|FG000|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0||
48442787|NCT02641730|101420171|FG001|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0||
48442788|NCT02641730|101420172|FG002|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0||
48442789|NCT02641730|101420173|FG003|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0||
48442790|NCT02641730|101420174|FG004|NOT COMPLETED|Observational Period (Week 60 - Week 84)||1||
48442791|NCT04732728|101420175|FG000|STARTED|Overall Study||727||
48442792|NCT04732728|101420175|FG000|COMPLETED|Overall Study||579||
48442793|NCT04732728|101420175|FG000|NOT COMPLETED|Overall Study||148||
48442794|NCT00595127|101420176|FG000|STARTED|Overall Study||21||
48442795|NCT00595127|101420176|FG000|COMPLETED|Overall Study||11||
48442796|NCT00595127|101420176|FG000|NOT COMPLETED|Overall Study||10||
48442797|NCT02032823|101420177|FG000|STARTED|Overall Study||921||
48442798|NCT02032823|101420178|FG001|STARTED|Overall Study||915||
48442799|NCT02032823|101420177|FG000|COMPLETED|Overall Study||0||
48442800|NCT02032823|101420178|FG001|COMPLETED|Overall Study||0||
48442801|NCT02032823|101420177|FG000|NOT COMPLETED|Overall Study||921||
48442802|NCT02032823|101420178|FG001|NOT COMPLETED|Overall Study||915||
48442803|NCT03664024|101420179|FG000|STARTED|Overall Study||118||
48442804|NCT03664024|101420179|FG000|Treated|Overall Study||117||
48442805|NCT03664024|101420179|FG000|COMPLETED|Overall Study||0||
48442806|NCT03664024|101420179|FG000|NOT COMPLETED|Overall Study||118||
48442807|NCT04007406|101420180|FG000|STARTED|Overall Study||10||
48442808|NCT04007406|101420181|FG001|STARTED|Overall Study||12||
48442809|NCT04007406|101420182|FG002|STARTED|Overall Study||13||
48442810|NCT04007406|101420180|FG000|COMPLETED|Overall Study||10||
48442811|NCT04007406|101420181|FG001|COMPLETED|Overall Study||12||
48442812|NCT04007406|101420182|FG002|COMPLETED|Overall Study||13||
48442813|NCT04007406|101420180|FG000|NOT COMPLETED|Overall Study||0||
48442814|NCT04007406|101420181|FG001|NOT COMPLETED|Overall Study||0||
48442815|NCT04007406|101420182|FG002|NOT COMPLETED|Overall Study||0||
48442816|NCT04777591|101420183|FG000|STARTED|Overall Study||59||
48442817|NCT04777591|101420184|FG001|STARTED|Overall Study||58||
48442818|NCT04777591|101420183|FG000|COMPLETED|Overall Study||59||
48442819|NCT04777591|101420184|FG001|COMPLETED|Overall Study||58||
48442820|NCT04777591|101420183|FG000|NOT COMPLETED|Overall Study||0||
48442821|NCT04777591|101420184|FG001|NOT COMPLETED|Overall Study||0||
48442822|NCT02132936|101420185|FG000|STARTED|Overall Study||185||
48442823|NCT02132936|101420186|FG001|STARTED|Overall Study||47||
48442824|NCT02132936|101420187|FG002|STARTED|Overall Study||188||
48442825|NCT02132936|101420188|FG003|STARTED|Overall Study||43||
48442826|NCT02132936|101420185|FG000|COMPLETED|Overall Study||175||
48442827|NCT02132936|101420186|FG001|COMPLETED|Overall Study||38||
48442828|NCT02132936|101420187|FG002|COMPLETED|Overall Study||174||
48442829|NCT02132936|101420188|FG003|COMPLETED|Overall Study||29||
48442830|NCT02132936|101420185|FG000|NOT COMPLETED|Overall Study||10||
48442831|NCT02132936|101420186|FG001|NOT COMPLETED|Overall Study||9||
48442832|NCT02132936|101420187|FG002|NOT COMPLETED|Overall Study||14||
48442833|NCT02132936|101420188|FG003|NOT COMPLETED|Overall Study||14||
48442834|NCT03286426|101420189|FG000|STARTED|Overall Study||3||
48442835|NCT03286426|101420189|FG000|COMPLETED|Overall Study||0||
48442836|NCT03286426|101420189|FG000|NOT COMPLETED|Overall Study||3||
48442837|NCT01548573|101420190|FG000|STARTED|Overall Study||19||
48442838|NCT01548573|101420190|FG000|COMPLETED|Overall Study||14||
48442839|NCT01548573|101420190|FG000|NOT COMPLETED|Overall Study||5||
48442840|NCT01788163|101420191|FG000|STARTED|Overall Study||1458||
48442841|NCT01788163|101420192|FG001|STARTED|Overall Study||271||
48442842|NCT01788163|101420193|FG002|STARTED|Overall Study||62||
48442843|NCT01788163|101420194|FG003|STARTED|Overall Study||71||
48442844|NCT01788163|101420195|FG004|STARTED|Overall Study||94||
48442845|NCT01788163|101420196|FG005|STARTED|Overall Study||102||
48442846|NCT01788163|101420197|FG006|STARTED|Overall Study||50||
48442847|NCT01788163|101420198|FG007|STARTED|Overall Study||302||
48442848|NCT01788163|101420199|FG008|STARTED|Overall Study||972||
48658112|NCT01489826|101946167|FG000|STARTED|Overall Study||3||
48658113|NCT01489826|101946168|FG001|STARTED|Overall Study||3||
48658114|NCT01489826|101946169|FG002|STARTED|Overall Study||3||
48658115|NCT01489826|101946170|FG003|STARTED|Overall Study||7||
48658116|NCT01489826|101946171|FG004|STARTED|Overall Study||3||
48769226|NCT03524729|102223165|FG005|NOT COMPLETED|Overall Study||1||
48769227|NCT02516241|102223166|FG000|STARTED|Overall Study||342||
48769228|NCT02516241|102223167|FG001|STARTED|Overall Study||346||
48769229|NCT02516241|102223168|FG002|STARTED|Overall Study||344||
48769230|NCT02516241|102223166|FG000|Received Treatment|Overall Study||340||
48769231|NCT02516241|102223167|FG001|Received Treatment|Overall Study||345||
48769232|NCT02516241|102223168|FG002|Received Treatment|Overall Study||313||
48442849|NCT01788163|101420191|FG000|COMPLETED|Overall Study||1403||
48442850|NCT01788163|101420192|FG001|COMPLETED|Overall Study||271||
48442851|NCT01788163|101420193|FG002|COMPLETED|Overall Study||62||
48442852|NCT01788163|101420194|FG003|COMPLETED|Overall Study||71||
48442853|NCT01788163|101420195|FG004|COMPLETED|Overall Study||94||
48442854|NCT01788163|101420196|FG005|COMPLETED|Overall Study||95||
48442855|NCT01788163|101420197|FG006|COMPLETED|Overall Study||49||
48442856|NCT01788163|101420198|FG007|COMPLETED|Overall Study||254||
48442857|NCT01788163|101420199|FG008|COMPLETED|Overall Study||956||
48442858|NCT01788163|101420191|FG000|NOT COMPLETED|Overall Study||55||
48442859|NCT01788163|101420192|FG001|NOT COMPLETED|Overall Study||0||
48769233|NCT02516241|102223166|FG000|COMPLETED|Overall Study||0||
48769234|NCT02516241|102223167|FG001|COMPLETED|Overall Study||0||
48769235|NCT02516241|102223168|FG002|COMPLETED|Overall Study||0||
48769236|NCT02516241|102223166|FG000|NOT COMPLETED|Overall Study||342||
48769237|NCT02516241|102223167|FG001|NOT COMPLETED|Overall Study||346||
48769238|NCT02516241|102223168|FG002|NOT COMPLETED|Overall Study||344||
48769239|NCT01772316|102225800|FG000|STARTED|Overall Study||47||
48442860|NCT01788163|101420193|FG002|NOT COMPLETED|Overall Study||0||
48442861|NCT01788163|101420194|FG003|NOT COMPLETED|Overall Study||0||
48442862|NCT01788163|101420195|FG004|NOT COMPLETED|Overall Study||0||
48769240|NCT01772316|102225800|FG000|COMPLETED|Overall Study||40||
48442863|NCT01788163|101420196|FG005|NOT COMPLETED|Overall Study||7||
48658117|NCT01489826|101946172|FG005|STARTED|Overall Study||3||
48658118|NCT01489826|101946173|FG006|STARTED|Overall Study||9||
48658119|NCT01489826|101946174|FG007|STARTED|Overall Study||3||
48658120|NCT01489826|101946175|FG008|STARTED|Overall Study||6||
48658121|NCT01489826|101946167|FG000|COMPLETED|Overall Study||3||
48658122|NCT01489826|101946168|FG001|COMPLETED|Overall Study||3||
48658123|NCT01489826|101946169|FG002|COMPLETED|Overall Study||3||
48769241|NCT01772316|102225800|FG000|NOT COMPLETED|Overall Study||7||
48769242|NCT00787644|102225801|FG000|STARTED|Overall Study||12||
48769243|NCT00787644|102225802|FG001|STARTED|Overall Study||11||
48769244|NCT00787644|102225801|FG000|COMPLETED|Overall Study||10||
48769245|NCT00787644|102225802|FG001|COMPLETED|Overall Study||9||
48769246|NCT00787644|102225801|FG000|NOT COMPLETED|Overall Study||2||
48769247|NCT00787644|102225802|FG001|NOT COMPLETED|Overall Study||2||
48769248|NCT02648919|102225803|FG000|STARTED|Overall Study||6||
48769249|NCT02648919|102225803|FG000|COMPLETED|Overall Study||6||
48769250|NCT02648919|102225803|FG000|NOT COMPLETED|Overall Study||0||
48769251|NCT02902237|102225804|FG000|STARTED|Overall Study||17||
48769252|NCT02902237|102225804|FG000|COMPLETED|Overall Study||17||
48769253|NCT02902237|102225804|FG000|NOT COMPLETED|Overall Study||0||
48769254|NCT01662102|102225805|FG000|STARTED|Overall Study||1||
48769255|NCT01662102|102225806|FG001|STARTED|Overall Study||0||
48769256|NCT01662102|102225805|FG000|COMPLETED|Overall Study||0||
48769257|NCT01662102|102225806|FG001|COMPLETED|Overall Study||0||
48769258|NCT01662102|102225805|FG000|NOT COMPLETED|Overall Study||1||
48769259|NCT01662102|102225806|FG001|NOT COMPLETED|Overall Study||0||
48769260|NCT02454517|102225807|FG000|STARTED|Overall Study||58||
48769261|NCT02454517|102225808|FG001|STARTED|Overall Study||59||
48769262|NCT02454517|102225807|FG000|COMPLETED|Overall Study||50||
48769263|NCT02454517|102225808|FG001|COMPLETED|Overall Study||50||
48442864|NCT01788163|101420197|FG006|NOT COMPLETED|Overall Study||1||
48442865|NCT01788163|101420198|FG007|NOT COMPLETED|Overall Study||48||
48442866|NCT01788163|101420199|FG008|NOT COMPLETED|Overall Study||16||
48442867|NCT01139801|101420200|FG000|STARTED|Overall Study||25||
48442868|NCT01139801|101420201|FG001|STARTED|Overall Study||25||
48442869|NCT01139801|101420200|FG000|COMPLETED|Overall Study||25||
48442870|NCT01139801|101420201|FG001|COMPLETED|Overall Study||25||
48658124|NCT01489826|101946170|FG003|COMPLETED|Overall Study||7||
48658125|NCT01489826|101946171|FG004|COMPLETED|Overall Study||3||
48658126|NCT01489826|101946172|FG005|COMPLETED|Overall Study||3||
48769264|NCT02454517|102225807|FG000|NOT COMPLETED|Overall Study||8||
48769265|NCT02454517|102225808|FG001|NOT COMPLETED|Overall Study||9||
48769266|NCT01721044|102225809|FG000|STARTED|Treatment Period||176||
48442871|NCT01139801|101420200|FG000|NOT COMPLETED|Overall Study||0||
48442872|NCT01139801|101420201|FG001|NOT COMPLETED|Overall Study||0||
48442873|NCT03681769|101420202|FG000|STARTED|Overall Study||11||
48442874|NCT03681769|101420203|FG001|STARTED|Overall Study||11||
48442875|NCT03681769|101420202|FG000|COMPLETED|Overall Study||10||
48442876|NCT03681769|101420203|FG001|COMPLETED|Overall Study||10||
48442877|NCT03681769|101420202|FG000|NOT COMPLETED|Overall Study||1||
48442878|NCT03681769|101420203|FG001|NOT COMPLETED|Overall Study||1||
48442879|NCT00185731|101420204|FG000|STARTED|Overall Study||25||
48442880|NCT00185731|101420204|FG000|COMPLETED|Overall Study||23||
48442881|NCT00185731|101420204|FG000|NOT COMPLETED|Overall Study||2||
48442882|NCT01306968|101420205|FG000|STARTED|Overall Study||7||
48442883|NCT01306968|101420206|FG001|STARTED|Overall Study||23||
48442884|NCT01306968|101420207|FG002|STARTED|Overall Study||24||
48442885|NCT01306968|101420208|FG003|STARTED|Overall Study||25||
48442886|NCT01306968|101420205|FG000|COMPLETED|Overall Study||6||
48442887|NCT01306968|101420206|FG001|COMPLETED|Overall Study||20||
48442888|NCT01306968|101420207|FG002|COMPLETED|Overall Study||23||
48442889|NCT01306968|101420208|FG003|COMPLETED|Overall Study||21||
48442890|NCT01306968|101420205|FG000|NOT COMPLETED|Overall Study||1||
48442891|NCT01306968|101420206|FG001|NOT COMPLETED|Overall Study||3||
48442892|NCT01306968|101420207|FG002|NOT COMPLETED|Overall Study||1||
48442893|NCT01306968|101420208|FG003|NOT COMPLETED|Overall Study||4||
48442894|NCT01817764|101420209|FG000|STARTED|Overall Study||353||
48442895|NCT01817764|101420210|FG001|STARTED|Overall Study||353||
48658127|NCT01489826|101946173|FG006|COMPLETED|Overall Study||9||
48658128|NCT01489826|101946174|FG007|COMPLETED|Overall Study||3||
48658129|NCT01489826|101946175|FG008|COMPLETED|Overall Study||6||
48658130|NCT01489826|101946167|FG000|NOT COMPLETED|Overall Study||0||
48658131|NCT01489826|101946168|FG001|NOT COMPLETED|Overall Study||0||
48658132|NCT01489826|101946169|FG002|NOT COMPLETED|Overall Study||0||
48658133|NCT01489826|101946170|FG003|NOT COMPLETED|Overall Study||0||
48658134|NCT01489826|101946171|FG004|NOT COMPLETED|Overall Study||0||
48658135|NCT01489826|101946172|FG005|NOT COMPLETED|Overall Study||0||
48658136|NCT01489826|101946173|FG006|NOT COMPLETED|Overall Study||0||
48658137|NCT01489826|101946174|FG007|NOT COMPLETED|Overall Study||0||
48658138|NCT01489826|101946175|FG008|NOT COMPLETED|Overall Study||0||
48658139|NCT02715856|101946176|FG000|STARTED|Overall Study||18||
48658140|NCT02715856|101946177|FG001|STARTED|Overall Study||52||
48658141|NCT02715856|101946176|FG000|COMPLETED|Overall Study||0||
48658142|NCT02715856|101946177|FG001|COMPLETED|Overall Study||0||
48658143|NCT02715856|101946176|FG000|NOT COMPLETED|Overall Study||18||
48658144|NCT02715856|101946177|FG001|NOT COMPLETED|Overall Study||52||
48658145|NCT04019704|101946178|FG000|STARTED|Overall Study||163||
48658146|NCT04019704|101946179|FG001|STARTED|Overall Study||164||
48658147|NCT04019704|101946178|FG000|COMPLETED|Overall Study||123||
48658148|NCT04019704|101946179|FG001|COMPLETED|Overall Study||147||
48658149|NCT04019704|101946178|FG000|NOT COMPLETED|Overall Study||40||
48658150|NCT04019704|101946179|FG001|NOT COMPLETED|Overall Study||17||
48658151|NCT01423084|101946180|FG000|STARTED|Overall Study||170||
48658152|NCT01423084|101946181|FG001|STARTED|Overall Study||174||
48658153|NCT01423084|101946180|FG000|COMPLETED|Overall Study||168||
48658154|NCT01423084|101946181|FG001|COMPLETED|Overall Study||170||
48658155|NCT01423084|101946180|FG000|NOT COMPLETED|Overall Study||2||
48658156|NCT01423084|101946181|FG001|NOT COMPLETED|Overall Study||4||
48658157|NCT02771145|101946182|FG000|STARTED|Overall Study||90||
48658158|NCT02771145|101946182|FG000|COMPLETED|Overall Study||86||
48769267|NCT01721044|102225810|FG001|STARTED|Treatment Period||174||
48769268|NCT01721044|102225811|FG002|STARTED|Treatment Period||177||
48769269|NCT01721044|102225809|FG000|Rescue Week 16-24|Treatment Period||56||
48769270|NCT01721044|102225810|FG001|Rescue Week 16-24|Treatment Period||38||
48769271|NCT01721044|102225811|FG002|Rescue Week 16-24|Treatment Period||33||
48769272|NCT01721044|102225809|FG000|COMPLETED|Treatment Period||144||
48769273|NCT01721044|102225810|FG001|COMPLETED|Treatment Period||157||
48769274|NCT01721044|102225811|FG002|COMPLETED|Treatment Period||158||
48769275|NCT01721044|102225809|FG000|NOT COMPLETED|Treatment Period||32||
48442896|NCT01817764|101420209|FG000|COMPLETED|Overall Study||319||
48442897|NCT01817764|101420210|FG001|COMPLETED|Overall Study||315||
48442898|NCT01817764|101420209|FG000|NOT COMPLETED|Overall Study||34||
48658159|NCT02771145|101946182|FG000|NOT COMPLETED|Overall Study||4||
48658160|NCT05852470|101946183|FG000|STARTED|Overall Study||73||
48442899|NCT01817764|101420210|FG001|NOT COMPLETED|Overall Study||38||
48442900|NCT02531698|101420211|FG000|STARTED|Overall Study||294||
48442901|NCT02531698|101420212|FG001|STARTED|Overall Study||106||
48442902|NCT02531698|101420211|FG000|COMPLETED|Overall Study||283||
48442903|NCT02531698|101420212|FG001|COMPLETED|Overall Study||104||
48658161|NCT05852470|101946184|FG001|STARTED|Overall Study||77||
48658162|NCT05852470|101946183|FG000|Full Analysis Set|Overall Study||73||
48658163|NCT05852470|101946184|FG001|Full Analysis Set|Overall Study||76||
48658164|NCT05852470|101946183|FG000|COMPLETED|Overall Study||73||
48658165|NCT05852470|101946184|FG001|COMPLETED|Overall Study||76||
48658166|NCT05852470|101946183|FG000|NOT COMPLETED|Overall Study||0||
48658167|NCT05852470|101946184|FG001|NOT COMPLETED|Overall Study||1||
48769276|NCT01721044|102225810|FG001|NOT COMPLETED|Treatment Period||17||
48769277|NCT01721044|102225811|FG002|NOT COMPLETED|Treatment Period||19||
48769278|NCT01721044|102225809|FG000|STARTED|Follow Up||19||
48769279|NCT01721044|102225810|FG001|STARTED|Follow Up||9||
48769280|NCT01721044|102225811|FG002|STARTED|Follow Up||20||
48769281|NCT01721044|102225809|FG000|COMPLETED|Follow Up||19||
48769282|NCT01721044|102225810|FG001|COMPLETED|Follow Up||9||
48769283|NCT01721044|102225811|FG002|COMPLETED|Follow Up||20||
48769284|NCT01721044|102225809|FG000|NOT COMPLETED|Follow Up||0||
48769285|NCT01721044|102225810|FG001|NOT COMPLETED|Follow Up||0||
48769286|NCT01721044|102225811|FG002|NOT COMPLETED|Follow Up||0||
48769287|NCT00705016|102225812|FG000|STARTED|Overall Study||62||
48769288|NCT00705016|102225813|FG001|STARTED|Overall Study||60||
48188868|NCT04170023|100786101|FG001|NOT COMPLETED|Treatment Period||0||
48442904|NCT02531698|101420211|FG000|NOT COMPLETED|Overall Study||11||
48442905|NCT02531698|101420212|FG001|NOT COMPLETED|Overall Study||2||
48442906|NCT00759668|101420213|FG000|STARTED|Overall Study||17||
48442907|NCT00759668|101420214|FG001|STARTED|Overall Study||18||
48442908|NCT00759668|101420213|FG000|COMPLETED|Overall Study||16||
48442909|NCT00759668|101420214|FG001|COMPLETED|Overall Study||15||
48442910|NCT00759668|101420213|FG000|NOT COMPLETED|Overall Study||1||
48442911|NCT00759668|101420214|FG001|NOT COMPLETED|Overall Study||3||
48442912|NCT00720304|101420215|FG000|STARTED|Overall Study||37||
48442913|NCT00720304|101420216|FG001|STARTED|Overall Study||6||
48442914|NCT00720304|101420215|FG000|COMPLETED|Overall Study||8||
48442915|NCT00720304|101420216|FG001|COMPLETED|Overall Study||1||
48442916|NCT00720304|101420215|FG000|NOT COMPLETED|Overall Study||29||
48442917|NCT00720304|101420216|FG001|NOT COMPLETED|Overall Study||5||
48442918|NCT04449354|101420217|FG000|STARTED|Overall Study||16||
48442919|NCT04449354|101420217|FG000|COMPLETED|Overall Study||15||
48442920|NCT04449354|101420217|FG000|NOT COMPLETED|Overall Study||1||
48442921|NCT01861717|101420218|FG000|STARTED|Overall Study||4|started = signed consent|
48442922|NCT01861717|101420218|FG000|COMPLETED|Overall Study||2||
48442923|NCT01861717|101420218|FG000|NOT COMPLETED|Overall Study||2||
48442924|NCT00038467|101420219|FG000|STARTED|Overall Study||2352||
48442925|NCT00038467|101420220|FG001|STARTED|Overall Study||2372||
48442926|NCT00038467|101420219|FG000|Treated|Overall Study||2321||
48442927|NCT00038467|101420220|FG001|Treated|Overall Study||2337||
48442928|NCT00038467|101420219|FG000|COMPLETED|Overall Study||1810||
48442929|NCT00038467|101420220|FG001|COMPLETED|Overall Study||1830||
48769289|NCT00705016|102225814|FG002|STARTED|Overall Study||62||
48769290|NCT00705016|102225812|FG000|COMPLETED|Overall Study||2||
48769291|NCT00705016|102225813|FG001|COMPLETED|Overall Study||2||
48769292|NCT00705016|102225814|FG002|COMPLETED|Overall Study||4||
48769293|NCT00705016|102225812|FG000|NOT COMPLETED|Overall Study||60||
48769294|NCT00705016|102225813|FG001|NOT COMPLETED|Overall Study||58||
48769295|NCT00705016|102225814|FG002|NOT COMPLETED|Overall Study||58||
48769296|NCT00638014|102225815|FG000|STARTED|Overall Study||23||
48769297|NCT00638014|102225816|FG001|STARTED|Overall Study||28||
48769298|NCT00638014|102225815|FG000|COMPLETED|Overall Study||23||
48769299|NCT00638014|102225816|FG001|COMPLETED|Overall Study||28||
48769300|NCT00638014|102225815|FG000|NOT COMPLETED|Overall Study||0||
48769301|NCT00638014|102225816|FG001|NOT COMPLETED|Overall Study||0||
48442930|NCT00038467|101420219|FG000|NOT COMPLETED|Overall Study||542||
48442931|NCT00038467|101420220|FG001|NOT COMPLETED|Overall Study||542||
48442932|NCT02115373|101420221|FG000|STARTED|Overall Study||4||
48769302|NCT00874510|102225817|FG000|STARTED|Year 1||88||
48769303|NCT00874510|102225818|FG001|STARTED|Year 1||85||
48769304|NCT00874510|102225817|FG000|COMPLETED|Year 1||88||
48769305|NCT00874510|102225818|FG001|COMPLETED|Year 1||85||
48769306|NCT00874510|102225817|FG000|NOT COMPLETED|Year 1||0||
48769307|NCT00874510|102225818|FG001|NOT COMPLETED|Year 1||0||
48769308|NCT00874510|102225817|FG000|STARTED|Year 2||92||
48769309|NCT00874510|102225818|FG001|STARTED|Year 2||87||
48769310|NCT00874510|102225817|FG000|COMPLETED|Year 2||92||
48769311|NCT00874510|102225818|FG001|COMPLETED|Year 2||87||
48442933|NCT02115373|101420222|FG001|STARTED|Overall Study||13||
48769312|NCT00874510|102225817|FG000|NOT COMPLETED|Year 2||0||
48769313|NCT00874510|102225818|FG001|NOT COMPLETED|Year 2||0||
48769314|NCT00724698|102225819|FG000|STARTED|Overall Study||3011||
48769315|NCT00724698|102225819|FG000|COMPLETED|Overall Study||2921||
48769316|NCT00724698|102225819|FG000|NOT COMPLETED|Overall Study||90||
48769317|NCT00335777|102225820|FG000|STARTED|Enrolled and Dispensed Study Medication||64||
48769318|NCT00335777|102225820|FG000|COMPLETED|Enrolled and Dispensed Study Medication||35||
48769319|NCT00335777|102225820|FG000|NOT COMPLETED|Enrolled and Dispensed Study Medication||29||
48442934|NCT02115373|101420223|FG002|STARTED|Overall Study||49||
48442935|NCT02115373|101420221|FG000|COMPLETED|Overall Study||4||
48442936|NCT02115373|101420222|FG001|COMPLETED|Overall Study||13||
48442937|NCT02115373|101420223|FG002|COMPLETED|Overall Study||49||
48442938|NCT02115373|101420221|FG000|NOT COMPLETED|Overall Study||0||
48442939|NCT02115373|101420222|FG001|NOT COMPLETED|Overall Study||0||
48769320|NCT00335777|102225820|FG000|STARTED|Treated 2 Headaches Per Protocol||35||
48769321|NCT00335777|102225820|FG000|COMPLETED|Treated 2 Headaches Per Protocol||22||
48769322|NCT00335777|102225820|FG000|NOT COMPLETED|Treated 2 Headaches Per Protocol||13||
48769323|NCT03094325|102225821|FG000|STARTED|Overall Study||10||
48442940|NCT02115373|101420223|FG002|NOT COMPLETED|Overall Study||0||
48442941|NCT01652872|101420224|FG000|STARTED|Overall Study||377||
48442942|NCT01652872|101420225|FG001|STARTED|Overall Study||379||
48188869|NCT04170023|100786102|FG002|NOT COMPLETED|Treatment Period||0||
48188870|NCT04170023|100786100|FG000|STARTED|LTE Period||12||
48188871|NCT04170023|100786101|FG001|STARTED|LTE Period||11||
48188872|NCT04170023|100786102|FG002|STARTED|LTE Period||6||
48368602|NCT00935220|101230222|FG000|STARTED|Overall Study||41||
48442943|NCT01652872|101420224|FG000|Received Investigational Product|Overall Study||377||
48442944|NCT01652872|101420225|FG001|Received Investigational Product|Overall Study||377||
48442945|NCT01652872|101420224|FG000|COMPLETED|Overall Study||232||
48442946|NCT01652872|101420225|FG001|COMPLETED|Overall Study||226||
48442947|NCT01652872|101420224|FG000|NOT COMPLETED|Overall Study||145||
48442948|NCT01652872|101420225|FG001|NOT COMPLETED|Overall Study||153||
48442949|NCT00499252|101420226|FG000|STARTED|Overall Study||51||
48442950|NCT00499252|101420226|FG000|COMPLETED|Overall Study||39||
48442951|NCT00499252|101420226|FG000|NOT COMPLETED|Overall Study||12||
48442952|NCT00433771|101420227|FG000|STARTED|Overall Study||74||
48442953|NCT00433771|101420227|FG000|COMPLETED|Overall Study||55||
48442954|NCT00433771|101420227|FG000|NOT COMPLETED|Overall Study||19||
48442955|NCT01491737|101420228|FG000|STARTED|Overall Study||129|Intent-to-Treat (ITT) Population|
48442956|NCT01491737|101420229|FG001|STARTED|Overall Study||129|Intent-to-Treat (ITT) Population|
48658168|NCT05370209|101946185|FG000|STARTED|Overall Study||28||
48769324|NCT03094325|102225821|FG000|TEE Before Cardiopulmonary Bypass|Overall Study||10||
48188873|NCT04170023|100786100|FG000|Received at Least 1 Dose of Study Drug|LTE Period||12||
48368603|NCT00935220|101230222|FG000|COMPLETED|Overall Study||39||
48368604|NCT00935220|101230222|FG000|NOT COMPLETED|Overall Study||2||
48368605|NCT00392444|101230223|FG000|STARTED|Overall Study||39||
48368606|NCT00392444|101230223|FG000|COMPLETED|Overall Study||39||
48368607|NCT00392444|101230223|FG000|NOT COMPLETED|Overall Study||0||
48368608|NCT02691247|101230224|FG000|STARTED|Overall Study||40||
48368609|NCT02691247|101230225|FG001|STARTED|Overall Study||24||
48368610|NCT02691247|101230226|FG002|STARTED|Overall Study||46||
48368611|NCT02691247|101230224|FG000|COMPLETED|Overall Study||37||
48368612|NCT02691247|101230225|FG001|COMPLETED|Overall Study||22||
48368613|NCT02691247|101230226|FG002|COMPLETED|Overall Study||43||
48368614|NCT02691247|101230224|FG000|NOT COMPLETED|Overall Study||3||
48368615|NCT02691247|101230225|FG001|NOT COMPLETED|Overall Study||2||
48368616|NCT02691247|101230226|FG002|NOT COMPLETED|Overall Study||3||
48368617|NCT00637273|101230227|FG000|STARTED|Overall Study||170||
48368618|NCT00637273|101230228|FG001|STARTED|Overall Study||172||
48368619|NCT00637273|101230229|FG002|STARTED|Overall Study||172||
48368620|NCT00637273|101230227|FG000|Intent to Treat (ITT)|Overall Study||160||
48368621|NCT00637273|101230228|FG001|Intent to Treat (ITT)|Overall Study||166||
48368622|NCT00637273|101230229|FG002|Intent to Treat (ITT)|Overall Study||165||
48368623|NCT00637273|101230227|FG000|COMPLETED|Overall Study||127||
48368624|NCT00637273|101230228|FG001|COMPLETED|Overall Study||144||
48368625|NCT00637273|101230229|FG002|COMPLETED|Overall Study||131||
48368626|NCT00637273|101230227|FG000|NOT COMPLETED|Overall Study||43||
48368627|NCT00637273|101230228|FG001|NOT COMPLETED|Overall Study||28||
48368628|NCT00637273|101230229|FG002|NOT COMPLETED|Overall Study||41||
48368629|NCT00728507|101230230|FG000|STARTED|Overall Study||62||
48368630|NCT00728507|101230231|FG001|STARTED|Overall Study||59||
48368631|NCT00728507|101230230|FG000|COMPLETED|Overall Study||60||
48368632|NCT00728507|101230231|FG001|COMPLETED|Overall Study||51||
48368633|NCT00728507|101230230|FG000|NOT COMPLETED|Overall Study||2||
48368634|NCT00728507|101230231|FG001|NOT COMPLETED|Overall Study||8||
48368635|NCT01881620|101230232|FG000|STARTED|Overall Study||109||
48368636|NCT01881620|101230232|FG000|COMPLETED|Overall Study||105||
48368637|NCT01881620|101230232|FG000|NOT COMPLETED|Overall Study||4||
48368638|NCT02134314|101230233|FG000|STARTED|Overall Study||35||
48368639|NCT02134314|101230234|FG001|STARTED|Overall Study||35||
48368640|NCT02134314|101230233|FG000|COMPLETED|Overall Study||34||
48368641|NCT02134314|101230234|FG001|COMPLETED|Overall Study||34||
48368642|NCT02134314|101230233|FG000|NOT COMPLETED|Overall Study||1||
48368643|NCT02134314|101230234|FG001|NOT COMPLETED|Overall Study||1||
48368644|NCT00401622|101230235|FG000|STARTED|Overall Study||160||
48368645|NCT00401622|101230236|FG001|STARTED|Overall Study||160||
48368646|NCT00401622|101230235|FG000|COMPLETED|Overall Study||126||
48368647|NCT00401622|101230236|FG001|COMPLETED|Overall Study||117||
48368648|NCT00401622|101230235|FG000|NOT COMPLETED|Overall Study||34||
48368649|NCT00401622|101230236|FG001|NOT COMPLETED|Overall Study||43||
48368650|NCT03458000|101230237|FG000|STARTED|Overall Study||13||
48368651|NCT03458000|101230238|FG001|STARTED|Overall Study||11||
48368652|NCT03458000|101230237|FG000|COMPLETED|Overall Study||13||
48368653|NCT03458000|101230238|FG001|COMPLETED|Overall Study||11||
48368654|NCT03458000|101230237|FG000|NOT COMPLETED|Overall Study||0||
48368655|NCT03458000|101230238|FG001|NOT COMPLETED|Overall Study||0||
48368656|NCT02584634|101230239|FG000|STARTED|Overall Study||12||
48368657|NCT02584634|101230240|FG001|STARTED|Overall Study||31||
48368658|NCT02584634|101230239|FG000|COMPLETED|Overall Study||0||
48442957|NCT01491737|101420228|FG000|Received at Least One Dose of Study Drug|Overall Study||127|Safety Population|
48442958|NCT01491737|101420229|FG001|Received at Least One Dose of Study Drug|Overall Study||124|Safety Population|
48442959|NCT01491737|101420228|FG000|Entered Follow-Up (Post-Treatment)|Overall Study||120||
48442960|NCT01491737|101420229|FG001|Entered Follow-Up (Post-Treatment)|Overall Study||116||
48442961|NCT01491737|101420228|FG000|COMPLETED|Overall Study||0||
48442962|NCT01491737|101420229|FG001|COMPLETED|Overall Study||0||
48442963|NCT01491737|101420228|FG000|NOT COMPLETED|Overall Study||129||
48442964|NCT01491737|101420229|FG001|NOT COMPLETED|Overall Study||129||
48442965|NCT01473589|101420230|FG000|STARTED|Overall Study||60||
48442966|NCT01473589|101420231|FG001|STARTED|Overall Study||62||
48442967|NCT01473589|101420230|FG000|Received at Least 1 Dose of Study Drug|Overall Study||60||
48442968|NCT01473589|101420231|FG001|Received at Least 1 Dose of Study Drug|Overall Study||61||
48442969|NCT01473589|101420230|FG000|Completed 6 Months|Overall Study||51||
48442970|NCT01473589|101420231|FG001|Completed 6 Months|Overall Study||54||
48769325|NCT03094325|102225821|FG000|OPIE Before Cardiopulmonary Bypass|Overall Study||10||
48769326|NCT03094325|102225821|FG000|TEE After Cardiopulmonary Bypass|Overall Study||10||
48769327|NCT03094325|102225821|FG000|OPIE After Cardiopulmonary Bypass|Overall Study||10||
48769328|NCT03094325|102225821|FG000|COMPLETED|Overall Study||10||
48769329|NCT03094325|102225821|FG000|NOT COMPLETED|Overall Study||0||
48769330|NCT04069702|102225822|FG000|STARTED|Overall Study||20||
48769331|NCT04069702|102225822|FG000|COMPLETED|Overall Study||20||
48769332|NCT04069702|102225822|FG000|NOT COMPLETED|Overall Study||0||
48769333|NCT01747876|102225823|FG000|STARTED|Overall Study||5||
48769334|NCT01747876|102225824|FG001|STARTED|Overall Study||15||
48769335|NCT01747876|102225825|FG002|STARTED|Overall Study||12||
48769336|NCT01747876|102225823|FG000|COMPLETED|Overall Study||0||
48769337|NCT01747876|102225824|FG001|COMPLETED|Overall Study||0||
48769338|NCT01747876|102225825|FG002|COMPLETED|Overall Study||0||
48769339|NCT01747876|102225823|FG000|NOT COMPLETED|Overall Study||5||
48769340|NCT01747876|102225824|FG001|NOT COMPLETED|Overall Study||15||
48769341|NCT01747876|102225825|FG002|NOT COMPLETED|Overall Study||12||
48442971|NCT01473589|101420230|FG000|Completed 12 Months|Overall Study||49||
48769342|NCT03821402|102225826|FG000|STARTED|Overall Study||22||
48769343|NCT03821402|102225827|FG001|STARTED|Overall Study||19||
48769344|NCT03821402|102225828|FG002|STARTED|Overall Study||18||
48769345|NCT03821402|102225829|FG003|STARTED|Overall Study||24||
48769346|NCT03821402|102225826|FG000|COMPLETED|Overall Study||15||
48769347|NCT03821402|102225827|FG001|COMPLETED|Overall Study||12||
48769348|NCT03821402|102225828|FG002|COMPLETED|Overall Study||15||
48442972|NCT01473589|101420231|FG001|Completed 12 Months|Overall Study||48||
48442973|NCT01473589|101420230|FG000|COMPLETED|Overall Study||49||
48442974|NCT01473589|101420231|FG001|COMPLETED|Overall Study||46||
48769349|NCT03821402|102225829|FG003|COMPLETED|Overall Study||18||
48442975|NCT01473589|101420230|FG000|NOT COMPLETED|Overall Study||11||
48442976|NCT01473589|101420231|FG001|NOT COMPLETED|Overall Study||16||
48442977|NCT05795062|101420232|FG000|STARTED|Overall Study||11966||
48442978|NCT05795062|101420233|FG001|STARTED|Overall Study||1979||
48442979|NCT05795062|101420232|FG000|COMPLETED|Overall Study||11966||
48442980|NCT05795062|101420233|FG001|COMPLETED|Overall Study||1979||
48442981|NCT05795062|101420232|FG000|NOT COMPLETED|Overall Study||0||
48442982|NCT05795062|101420233|FG001|NOT COMPLETED|Overall Study||0||
48442983|NCT00960687|101420234|FG000|STARTED|First Intervention||27||
48442984|NCT00960687|101420235|FG001|STARTED|First Intervention||27||
48442985|NCT00960687|101420234|FG000|COMPLETED|First Intervention||27||
48442986|NCT00960687|101420235|FG001|COMPLETED|First Intervention||27||
48442987|NCT00960687|101420234|FG000|NOT COMPLETED|First Intervention||0||
48442988|NCT00960687|101420235|FG001|NOT COMPLETED|First Intervention||0||
48442989|NCT00960687|101420234|FG000|STARTED|Washout Period of 7 Days||27||
48442990|NCT00960687|101420235|FG001|STARTED|Washout Period of 7 Days||27||
48442991|NCT00960687|101420234|FG000|COMPLETED|Washout Period of 7 Days||23||
48442992|NCT00960687|101420235|FG001|COMPLETED|Washout Period of 7 Days||24||
48442993|NCT00960687|101420234|FG000|NOT COMPLETED|Washout Period of 7 Days||4||
48769350|NCT03821402|102225826|FG000|NOT COMPLETED|Overall Study||7||
48769351|NCT03821402|102225827|FG001|NOT COMPLETED|Overall Study||7||
48769352|NCT03821402|102225828|FG002|NOT COMPLETED|Overall Study||3||
48769353|NCT03821402|102225829|FG003|NOT COMPLETED|Overall Study||6||
48769354|NCT01194856|102225830|FG000|STARTED|Overall Study||1||
48769355|NCT01194856|102225831|FG001|STARTED|Overall Study||0||
48769356|NCT01194856|102225830|FG000|COMPLETED|Overall Study||0||
48769357|NCT01194856|102225831|FG001|COMPLETED|Overall Study||0||
48769358|NCT01194856|102225830|FG000|NOT COMPLETED|Overall Study||1||
48769359|NCT01194856|102225831|FG001|NOT COMPLETED|Overall Study||0||
48769360|NCT04237116|102225832|FG000|STARTED|Overall Study||7||
48442994|NCT00960687|101420235|FG001|NOT COMPLETED|Washout Period of 7 Days||3||
48442995|NCT00960687|101420234|FG000|STARTED|Second Intervention||23||
48442996|NCT00960687|101420235|FG001|STARTED|Second Intervention||24||
48442997|NCT00960687|101420234|FG000|COMPLETED|Second Intervention||23||
48442998|NCT00960687|101420235|FG001|COMPLETED|Second Intervention||24||
48769361|NCT04237116|102225833|FG001|STARTED|Overall Study||3||
48769362|NCT04237116|102225832|FG000|COMPLETED|Overall Study||3||
48769363|NCT04237116|102225833|FG001|COMPLETED|Overall Study||1||
48769364|NCT04237116|102225832|FG000|NOT COMPLETED|Overall Study||4||
48769365|NCT04237116|102225833|FG001|NOT COMPLETED|Overall Study||2||
48769366|NCT03841604|102225834|FG000|STARTED|Overall Study||46||
48769367|NCT03841604|102225835|FG001|STARTED|Overall Study||25||
48442999|NCT00960687|101420234|FG000|NOT COMPLETED|Second Intervention||0||
48443000|NCT00960687|101420235|FG001|NOT COMPLETED|Second Intervention||0||
48443001|NCT02803138|101420236|FG000|STARTED|Overall Study||236|Treatment was not started in 20 participants.|
48443002|NCT02803138|101420236|FG000|COMPLETED|Overall Study||166||
48443003|NCT02803138|101420236|FG000|NOT COMPLETED|Overall Study||70||
48443004|NCT05166512|101420237|FG000|STARTED|Randomized||22||
48443005|NCT05166512|101420238|FG001|STARTED|Randomized||23||
48443006|NCT05166512|101420237|FG000|COMPLETED|Randomized||19||
48443007|NCT05166512|101420238|FG001|COMPLETED|Randomized||23||
48443008|NCT05166512|101420237|FG000|NOT COMPLETED|Randomized||3||
48443009|NCT05166512|101420238|FG001|NOT COMPLETED|Randomized||0||
48443010|NCT05166512|101420237|FG000|STARTED|Baseline Data Collection||19||
48443011|NCT05166512|101420238|FG001|STARTED|Baseline Data Collection||23||
48443012|NCT05166512|101420237|FG000|DPP Session 0|Baseline Data Collection||19||
48443013|NCT05166512|101420238|FG001|DPP Session 0|Baseline Data Collection||23||
48443014|NCT05166512|101420237|FG000|DPP Session 1|Baseline Data Collection||18||
48443015|NCT05166512|101420238|FG001|DPP Session 1|Baseline Data Collection||20||
48443016|NCT05166512|101420237|FG000|COMPLETED|Baseline Data Collection||16||
48443017|NCT05166512|101420238|FG001|COMPLETED|Baseline Data Collection||20||
48443018|NCT05166512|101420237|FG000|NOT COMPLETED|Baseline Data Collection||3||
48443019|NCT05166512|101420238|FG001|NOT COMPLETED|Baseline Data Collection||3||
48443020|NCT05166512|101420237|FG000|STARTED|4 Month Data Collection||16||
48443021|NCT05166512|101420238|FG001|STARTED|4 Month Data Collection||20||
48443022|NCT05166512|101420237|FG000|COMPLETED|4 Month Data Collection||14||
48443023|NCT05166512|101420238|FG001|COMPLETED|4 Month Data Collection||15||
48443024|NCT05166512|101420237|FG000|NOT COMPLETED|4 Month Data Collection||2||
48443025|NCT05166512|101420238|FG001|NOT COMPLETED|4 Month Data Collection||5||
48443026|NCT05166512|101420237|FG000|STARTED|12 Month Data Collection||14||
48443027|NCT05166512|101420238|FG001|STARTED|12 Month Data Collection||15||
48443028|NCT05166512|101420237|FG000|COMPLETED|12 Month Data Collection||10||
48443029|NCT05166512|101420238|FG001|COMPLETED|12 Month Data Collection||14||
48443030|NCT05166512|101420237|FG000|NOT COMPLETED|12 Month Data Collection||4||
48443031|NCT05166512|101420238|FG001|NOT COMPLETED|12 Month Data Collection||1||
48443032|NCT04059484|101420239|FG000|STARTED|Overall Study||147||
48443033|NCT04059484|101420240|FG001|STARTED|Overall Study||143||
48443034|NCT04059484|101420239|FG000|COMPLETED|Overall Study||0||
48443035|NCT04059484|101420240|FG001|COMPLETED|Overall Study||0||
48443036|NCT04059484|101420239|FG000|NOT COMPLETED|Overall Study||147||
48443037|NCT04059484|101420240|FG001|NOT COMPLETED|Overall Study||143||
48443038|NCT04856917|101420241|FG000|STARTED|Overall Study||42||
48443039|NCT04856917|101420242|FG001|STARTED|Overall Study||40||
48443040|NCT04856917|101420243|FG002|STARTED|Overall Study||41||
48443041|NCT04856917|101420241|FG000|Safety Analysis Set|Overall Study||41|The Safety Analysis Set included all randomized participants who received at least 1 dose of imsidolimab or placebo.|
48443042|NCT04856917|101420242|FG001|Safety Analysis Set|Overall Study||39|The Safety Analysis Set included all randomized participants who received at least 1 dose of imsidolimab or placebo.|
48443043|NCT04856917|101420243|FG002|Safety Analysis Set|Overall Study||41|The Safety Analysis Set included all randomized participants who received at least 1 dose of imsidolimab or placebo.|
48443044|NCT04856917|101420241|FG000|COMPLETED|Overall Study||34||
48443045|NCT04856917|101420242|FG001|COMPLETED|Overall Study||34||
48443046|NCT04856917|101420243|FG002|COMPLETED|Overall Study||37||
48443047|NCT04856917|101420241|FG000|NOT COMPLETED|Overall Study||8||
48443048|NCT04856917|101420242|FG001|NOT COMPLETED|Overall Study||6||
48443049|NCT04856917|101420243|FG002|NOT COMPLETED|Overall Study||4||
48443050|NCT02628418|101420244|FG000|STARTED|Overall Study||15||
48443051|NCT02628418|101420245|FG001|STARTED|Overall Study||15||
48443052|NCT02628418|101420244|FG000|COMPLETED|Overall Study||14||
48443053|NCT02628418|101420245|FG001|COMPLETED|Overall Study||13||
48443054|NCT02628418|101420244|FG000|NOT COMPLETED|Overall Study||1||
48443055|NCT02628418|101420245|FG001|NOT COMPLETED|Overall Study||2||
48443056|NCT01248130|101420246|FG000|STARTED|Overall Study||3||
48443057|NCT01248130|101420247|FG001|STARTED|Overall Study||4||
48443058|NCT01248130|101420246|FG000|COMPLETED|Overall Study||1||
48443059|NCT01248130|101420247|FG001|COMPLETED|Overall Study||4||
48443060|NCT01248130|101420246|FG000|NOT COMPLETED|Overall Study||2||
48443061|NCT01248130|101420247|FG001|NOT COMPLETED|Overall Study||0||
48443062|NCT01721200|101420248|FG000|STARTED|Overall Study||62||
48443063|NCT01721200|101420249|FG001|STARTED|Overall Study||63||
48443064|NCT01721200|101420248|FG000|Completed 2 Week Follow-up|Overall Study||60||
48443065|NCT01721200|101420249|FG001|Completed 2 Week Follow-up|Overall Study||61||
48658169|NCT05370209|101946185|FG000|COMPLETED|Overall Study||28||
48443066|NCT01721200|101420248|FG000|COMPLETED|Overall Study||59||
48443067|NCT01721200|101420249|FG001|COMPLETED|Overall Study||58||
48443068|NCT01721200|101420248|FG000|NOT COMPLETED|Overall Study||3||
48443069|NCT01721200|101420249|FG001|NOT COMPLETED|Overall Study||5||
48443070|NCT05004181|101420250|FG000|STARTED|Overall Study||21||
48443071|NCT05004181|101420251|FG001|STARTED|Overall Study||20||
48443072|NCT05004181|101420252|FG002|STARTED|Overall Study||20||
48443073|NCT05004181|101420253|FG003|STARTED|Overall Study||20||
48443074|NCT05004181|101420254|FG004|STARTED|Overall Study||42||
48443075|NCT05004181|101420255|FG005|STARTED|Overall Study||17||
48443076|NCT05004181|101420256|FG006|STARTED|Overall Study||349||
48443077|NCT05004181|101420257|FG007|STARTED|Overall Study||352||
48443078|NCT05004181|101420258|FG008|STARTED|Overall Study||361||
48443079|NCT05004181|101420259|FG009|STARTED|Overall Study||72||
48443080|NCT05004181|101420260|FG010|STARTED|Overall Study||71||
48443081|NCT05004181|101420261|FG011|STARTED|Overall Study||35||
48443082|NCT05004181|101420250|FG000|COMPLETED|Overall Study||14||
48443083|NCT05004181|101420251|FG001|COMPLETED|Overall Study||10||
48443084|NCT05004181|101420252|FG002|COMPLETED|Overall Study||15||
48443085|NCT05004181|101420253|FG003|COMPLETED|Overall Study||12||
48443086|NCT05004181|101420254|FG004|COMPLETED|Overall Study||29||
48443087|NCT05004181|101420255|FG005|COMPLETED|Overall Study||13||
48443088|NCT05004181|101420256|FG006|COMPLETED|Overall Study||280||
48443089|NCT05004181|101420257|FG007|COMPLETED|Overall Study||291||
48443090|NCT05004181|101420258|FG008|COMPLETED|Overall Study||299||
48443091|NCT05004181|101420259|FG009|COMPLETED|Overall Study||60||
48443092|NCT05004181|101420260|FG010|COMPLETED|Overall Study||55||
48443093|NCT05004181|101420261|FG011|COMPLETED|Overall Study||30||
48443094|NCT05004181|101420250|FG000|NOT COMPLETED|Overall Study||7||
48443095|NCT05004181|101420251|FG001|NOT COMPLETED|Overall Study||10||
48443096|NCT05004181|101420252|FG002|NOT COMPLETED|Overall Study||5||
48443097|NCT05004181|101420253|FG003|NOT COMPLETED|Overall Study||8||
48443098|NCT05004181|101420254|FG004|NOT COMPLETED|Overall Study||13||
48443099|NCT05004181|101420255|FG005|NOT COMPLETED|Overall Study||4||
48443100|NCT05004181|101420256|FG006|NOT COMPLETED|Overall Study||69||
48443101|NCT05004181|101420257|FG007|NOT COMPLETED|Overall Study||61||
48443102|NCT05004181|101420258|FG008|NOT COMPLETED|Overall Study||62||
48443103|NCT05004181|101420259|FG009|NOT COMPLETED|Overall Study||12||
48443104|NCT05004181|101420260|FG010|NOT COMPLETED|Overall Study||16||
48443105|NCT05004181|101420261|FG011|NOT COMPLETED|Overall Study||5||
48443106|NCT03425331|101420262|FG000|STARTED|Overall Study||5||
48443107|NCT03425331|101420262|FG000|COMPLETED|Overall Study||0||
48443108|NCT03425331|101420262|FG000|NOT COMPLETED|Overall Study||5||
48443109|NCT01345058|101420263|FG000|STARTED|Overall Study||20||
48443110|NCT01345058|101420264|FG001|STARTED|Overall Study||36||
48443111|NCT01345058|101420263|FG000|Received Lacosamide|Overall Study||19||
48443112|NCT01345058|101420264|FG001|Received Lacosamide|Overall Study||0||
48443113|NCT01345058|101420263|FG000|COMPLETED|Overall Study||15||
48443114|NCT01345058|101420264|FG001|COMPLETED|Overall Study||36||
48443115|NCT01345058|101420263|FG000|NOT COMPLETED|Overall Study||5||
48443116|NCT01345058|101420264|FG001|NOT COMPLETED|Overall Study||0||
48443117|NCT01700335|101420265|FG000|STARTED|Overall Study||3||
48443118|NCT01700335|101420266|FG001|STARTED|Overall Study||6||
48443119|NCT01700335|101420265|FG000|COMPLETED|Overall Study||2||
48443120|NCT01700335|101420266|FG001|COMPLETED|Overall Study||2||
48443121|NCT01700335|101420265|FG000|NOT COMPLETED|Overall Study||1||
48443122|NCT01700335|101420266|FG001|NOT COMPLETED|Overall Study||4||
48443123|NCT03123120|101420267|FG000|STARTED|Overall Study||8||
48443124|NCT03123120|101420268|FG001|STARTED|Overall Study||14||
48443125|NCT03123120|101420267|FG000|Safety Analysis Set (SAF)|Overall Study||7|1 patient who was randomized to placebo accidentally received one dose of Spesolimab and was analyzed in the Spesolimab group in the SAF|
48443126|NCT03123120|101420268|FG001|Safety Analysis Set (SAF)|Overall Study||15|1 patient who was randomized to placebo accidentally received one dose of Spesolimab and was analyzed in the Spesolimab group in the SAF|
48443127|NCT03123120|101420267|FG000|COMPLETED|Overall Study||8|Completed planned observation time.|
48443128|NCT03123120|101420268|FG001|COMPLETED|Overall Study||12|Completed planned observation time.|
48443129|NCT03123120|101420267|FG000|NOT COMPLETED|Overall Study||0||
48443130|NCT03123120|101420268|FG001|NOT COMPLETED|Overall Study||2||
48443131|NCT01426828|101420269|FG000|STARTED|Overall Study Evaluations||22||
48443132|NCT01426828|101420270|FG001|STARTED|Overall Study Evaluations||18||
48443133|NCT01426828|101420269|FG000|COMPLETED|Overall Study Evaluations||17||
48443134|NCT01426828|101420270|FG001|COMPLETED|Overall Study Evaluations||15||
48443135|NCT01426828|101420269|FG000|NOT COMPLETED|Overall Study Evaluations||5||
48443136|NCT01426828|101420270|FG001|NOT COMPLETED|Overall Study Evaluations||3||
48443137|NCT01426828|101420269|FG000|STARTED|Immune Response Analysis||17||
48443138|NCT01426828|101420270|FG001|STARTED|Immune Response Analysis||15||
48443139|NCT01426828|101420269|FG000|COMPLETED|Immune Response Analysis||8|Only those subjects that had sufficient PBMC samples from pre-vaccination (D0), and Day 30, Day 90 and Day 180 time points for NanoString gene expression analysis were included in the immune response analysis.|
48443140|NCT01426828|101420270|FG001|COMPLETED|Immune Response Analysis||8|Only those subjects that had sufficient PBMC samples from pre-vaccination (D0), and Day 30, Day 90 and Day 180 time points for NanoString gene expression analysis were included in the immune response analysis.|
48443141|NCT01426828|101420269|FG000|NOT COMPLETED|Immune Response Analysis||9||
48443142|NCT01426828|101420270|FG001|NOT COMPLETED|Immune Response Analysis||7||
48658170|NCT05370209|101946185|FG000|NOT COMPLETED|Overall Study||0||
48658171|NCT02091960|101946186|FG000|STARTED|Overall Study||103||
48443143|NCT00605839|101420271|FG000|STARTED|Overall Study||40||
48443144|NCT00605839|101420272|FG001|STARTED|Overall Study||37||
48658172|NCT02091960|101946186|FG000|Received Treatment|Overall Study||103||
48658173|NCT02091960|101946186|FG000|COMPLETED|Overall Study||52||
48769368|NCT03841604|102225834|FG000|COMPLETED|Overall Study||38||
48443145|NCT00605839|101420273|FG002|STARTED|Overall Study||28||
48443146|NCT00605839|101420271|FG000|COMPLETED|Overall Study||39||
48769369|NCT03841604|102225835|FG001|COMPLETED|Overall Study||22||
48443147|NCT00605839|101420272|FG001|COMPLETED|Overall Study||37||
48443148|NCT00605839|101420273|FG002|COMPLETED|Overall Study||28||
48443149|NCT00605839|101420271|FG000|NOT COMPLETED|Overall Study||1||
48443150|NCT00605839|101420272|FG001|NOT COMPLETED|Overall Study||0||
48443151|NCT00605839|101420273|FG002|NOT COMPLETED|Overall Study||0||
48443152|NCT00865306|101420274|FG000|STARTED|Controlled Trial||34||
48443153|NCT00865306|101420275|FG001|STARTED|Controlled Trial||30||
48443154|NCT00865306|101420274|FG000|COMPLETED|Controlled Trial||29||
48443155|NCT00865306|101420275|FG001|COMPLETED|Controlled Trial||28||
48443156|NCT00865306|101420274|FG000|NOT COMPLETED|Controlled Trial||5||
48443157|NCT00865306|101420275|FG001|NOT COMPLETED|Controlled Trial||2||
48443158|NCT00865306|101420274|FG000|STARTED|One-Year Follow-Up||29||
48443159|NCT00865306|101420275|FG001|STARTED|One-Year Follow-Up||15||
48443160|NCT00865306|101420274|FG000|COMPLETED|One-Year Follow-Up||29||
48443161|NCT00865306|101420275|FG001|COMPLETED|One-Year Follow-Up||15||
48443162|NCT00865306|101420274|FG000|NOT COMPLETED|One-Year Follow-Up||0||
48443163|NCT00865306|101420275|FG001|NOT COMPLETED|One-Year Follow-Up||0||
48443164|NCT06371079|101420276|FG000|STARTED|Overall Study||134||211
48443165|NCT06371079|101420277|FG001|STARTED|Overall Study||314||446
48443166|NCT06371079|101420276|FG000|COMPLETED|Overall Study||46||78
48443167|NCT06371079|101420277|FG001|COMPLETED|Overall Study||67||121
48443168|NCT06371079|101420276|FG000|NOT COMPLETED|Overall Study||88||133
48443169|NCT06371079|101420277|FG001|NOT COMPLETED|Overall Study||247||325
48443170|NCT03907540|101420278|FG000|STARTED|Overall Study||5||
48443171|NCT03907540|101420278|FG000|Completed Part 1|Overall Study||5||
48443172|NCT03907540|101420278|FG000|Completed Part 2|Overall Study||5||
48443173|NCT03907540|101420278|FG000|COMPLETED|Overall Study||5||
48443174|NCT03907540|101420278|FG000|NOT COMPLETED|Overall Study||0||
48443175|NCT03256526|101420279|FG000|STARTED|Overall Study||19||
48443176|NCT03256526|101420280|FG001|STARTED|Overall Study||17||
48443177|NCT03256526|101420281|FG002|STARTED|Overall Study||17||
48443178|NCT03256526|101420279|FG000|COMPLETED|Overall Study||17||
48443179|NCT03256526|101420280|FG001|COMPLETED|Overall Study||17||
48443180|NCT03256526|101420281|FG002|COMPLETED|Overall Study||14||
48443181|NCT03256526|101420279|FG000|NOT COMPLETED|Overall Study||2||
48443182|NCT03256526|101420280|FG001|NOT COMPLETED|Overall Study||0||
48443183|NCT03256526|101420281|FG002|NOT COMPLETED|Overall Study||3||
48658174|NCT02091960|101946186|FG000|NOT COMPLETED|Overall Study||51||
48658175|NCT03555994|101946187|FG000|STARTED|Overall Study||9||
48658176|NCT03555994|101946188|FG001|STARTED|Overall Study||12||
48658177|NCT03555994|101946189|FG002|STARTED|Overall Study||10||
48658178|NCT03555994|101946190|FG003|STARTED|Overall Study||9||
48658179|NCT03555994|101946191|FG004|STARTED|Overall Study||11||
48658180|NCT03555994|101946187|FG000|COMPLETED|Overall Study||9||
48658181|NCT03555994|101946188|FG001|COMPLETED|Overall Study||10||
48658182|NCT03555994|101946189|FG002|COMPLETED|Overall Study||10||
48658183|NCT03555994|101946190|FG003|COMPLETED|Overall Study||9||
48658184|NCT03555994|101946191|FG004|COMPLETED|Overall Study||11||
48658185|NCT03555994|101946187|FG000|NOT COMPLETED|Overall Study||0||
48658186|NCT03555994|101946188|FG001|NOT COMPLETED|Overall Study||2||
48658187|NCT03555994|101946189|FG002|NOT COMPLETED|Overall Study||0||
48658188|NCT03555994|101946190|FG003|NOT COMPLETED|Overall Study||0||
48658189|NCT03555994|101946191|FG004|NOT COMPLETED|Overall Study||0||
48658190|NCT00600704|101946192|FG000|STARTED|Overall Study||100||
48658191|NCT00600704|101946193|FG001|STARTED|Overall Study||92||
48658192|NCT00600704|101946192|FG000|COMPLETED|Overall Study||100||
48658193|NCT00600704|101946193|FG001|COMPLETED|Overall Study||92||
48658194|NCT00600704|101946192|FG000|NOT COMPLETED|Overall Study||0||
48658195|NCT00600704|101946193|FG001|NOT COMPLETED|Overall Study||0||
48658196|NCT02481141|101946194|FG000|STARTED|Overall Study||35||
48769370|NCT03841604|102225834|FG000|NOT COMPLETED|Overall Study||8||
48658197|NCT02481141|101946195|FG001|STARTED|Overall Study||18||
48658198|NCT02481141|101946194|FG000|COMPLETED|Overall Study||26||
48658199|NCT02481141|101946195|FG001|COMPLETED|Overall Study||13||
48658200|NCT02481141|101946194|FG000|NOT COMPLETED|Overall Study||9||
48658201|NCT02481141|101946195|FG001|NOT COMPLETED|Overall Study||5||
48658202|NCT02970812|101946196|FG000|STARTED|Overall Study||30||
48658203|NCT02970812|101946197|FG001|STARTED|Overall Study||30||
48658204|NCT02970812|101946196|FG000|COMPLETED|Overall Study||22||
48658205|NCT02970812|101946197|FG001|COMPLETED|Overall Study||28||
48769371|NCT03841604|102225835|FG001|NOT COMPLETED|Overall Study||3||
48769372|NCT02690948|102225836|FG000|STARTED|Overall Study||9||
48658206|NCT02970812|101946196|FG000|NOT COMPLETED|Overall Study||8||
48658207|NCT02970812|101946197|FG001|NOT COMPLETED|Overall Study||2||
48443184|NCT01610284|101420282|FG000|STARTED|Randomization Phase||576|All randomized patients (FAS)|
48443185|NCT01610284|101420283|FG001|STARTED|Randomization Phase||571|All randomized patients (FAS)|
48443186|NCT01610284|101420282|FG000|Safety Set (SS)|Randomization Phase||573|At least 1 dose of study treatment and a 1 post baseline safety assessment|
48443187|NCT01610284|101420283|FG001|Safety Set (SS)|Randomization Phase||570|At least 1 dose of study treatment and a 1 post baseline safety assessment|
48658208|NCT02365688|101946198|FG000|STARTED|Overall Study||18||
48658209|NCT02365688|101946198|FG000|COMPLETED|Overall Study||18||
48658210|NCT02365688|101946198|FG000|NOT COMPLETED|Overall Study||0||
48658211|NCT04473937|101948887|FG000|STARTED|Overall Study||3||
48443188|NCT01610284|101420282|FG000|COMPLETED|Randomization Phase||574|Randomized and treated|
48443189|NCT01610284|101420283|FG001|COMPLETED|Randomization Phase||569|Randomized and treated|
48443190|NCT01610284|101420282|FG000|NOT COMPLETED|Randomization Phase||2||
48443191|NCT01610284|101420283|FG001|NOT COMPLETED|Randomization Phase||2||
48443192|NCT01610284|101420282|FG000|STARTED|Treatment Phase||574|All patients in FAS that were treated|
48443193|NCT01610284|101420283|FG001|STARTED|Treatment Phase||569|All patients in FAS that were treated|
48443194|NCT01610284|101420282|FG000|BKM120 Pharmacokinetic Analysis Set|Treatment Phase||93|At least one dose of Buparlisib and 1 evaluable buparlisib concentration measurement|
48443195|NCT01610284|101420283|FG001|BKM120 Pharmacokinetic Analysis Set|Treatment Phase||0|At least one dose of Buparlisib and 1 evaluable buparlisib concentration measurement|
48443196|NCT01610284|101420282|FG000|Full Pharmacokinetic Analysis Set (FPAS)|Treatment Phase||35|A subset of the patients in the Buparlisib PAS|
48443197|NCT01610284|101420283|FG001|Full Pharmacokinetic Analysis Set (FPAS)|Treatment Phase||0|A subset of the patients in the Buparlisib PAS|
48443198|NCT01610284|101420282|FG000|COMPLETED|Treatment Phase||0||
48443199|NCT01610284|101420283|FG001|COMPLETED|Treatment Phase||0||
48443200|NCT01610284|101420282|FG000|NOT COMPLETED|Treatment Phase||574||
48443201|NCT01610284|101420283|FG001|NOT COMPLETED|Treatment Phase||569||
48658212|NCT04473937|101948887|FG000|COMPLETED|Overall Study||3||
48658213|NCT04473937|101948887|FG000|NOT COMPLETED|Overall Study||0||
48658214|NCT04957082|101948888|FG000|STARTED|Overall Study||229||
48658215|NCT04957082|101948889|FG001|STARTED|Overall Study||207||
48658216|NCT04957082|101948890|FG002|STARTED|Overall Study||230||
48658217|NCT04957082|101948888|FG000|COMPLETED|Overall Study||198||
48658218|NCT04957082|101948889|FG001|COMPLETED|Overall Study||128||
48658219|NCT04957082|101948890|FG002|COMPLETED|Overall Study||161||
48658220|NCT04957082|101948888|FG000|NOT COMPLETED|Overall Study||31||
48658221|NCT04957082|101948889|FG001|NOT COMPLETED|Overall Study||79||
48658222|NCT04957082|101948890|FG002|NOT COMPLETED|Overall Study||69||
48658223|NCT02301793|101948891|FG000|STARTED|Pre Education Study Period||0||2722
48769373|NCT02690948|102225837|FG001|STARTED|Overall Study||7||
48769374|NCT02690948|102225836|FG000|COMPLETED|Overall Study||9||
48658224|NCT02301793|101948892|FG001|STARTED|Pre Education Study Period||0||2603
48658225|NCT02301793|101948891|FG000|COMPLETED|Pre Education Study Period||0||2722
48658226|NCT02301793|101948892|FG001|COMPLETED|Pre Education Study Period||0||2603
48658227|NCT02301793|101948891|FG000|NOT COMPLETED|Pre Education Study Period||0||0
48658228|NCT02301793|101948892|FG001|NOT COMPLETED|Pre Education Study Period||0||0
48658229|NCT02301793|101948891|FG000|STARTED|During and Post Education Study Period||488||6566
48658230|NCT02301793|101948892|FG001|STARTED|During and Post Education Study Period||445||5355
48658231|NCT02301793|101948891|FG000|COMPLETED|During and Post Education Study Period||405||6566
48658232|NCT02301793|101948892|FG001|COMPLETED|During and Post Education Study Period||396||5355
48658233|NCT02301793|101948891|FG000|NOT COMPLETED|During and Post Education Study Period||83||0
48658234|NCT02301793|101948892|FG001|NOT COMPLETED|During and Post Education Study Period||49||0
48658235|NCT00395447|101948893|FG000|STARTED|Overall Study||1031||
48658236|NCT00395447|101948894|FG001|STARTED|Overall Study||713||
48658237|NCT00395447|101948893|FG000|COMPLETED|Overall Study||910||
48658238|NCT00395447|101948894|FG001|COMPLETED|Overall Study||602||
48658239|NCT00395447|101948893|FG000|NOT COMPLETED|Overall Study||121||
48658240|NCT00395447|101948894|FG001|NOT COMPLETED|Overall Study||111||
48658241|NCT04710303|101948895|FG000|STARTED|Overall Study||10||
48658242|NCT04710303|101948896|FG001|STARTED|Overall Study||11||
48658243|NCT04710303|101948897|FG002|STARTED|Overall Study||10||
48658244|NCT04710303|101948898|FG003|STARTED|Overall Study||10||
48658245|NCT04710303|101948895|FG000|COMPLETED|Overall Study||10||
48658246|NCT04710303|101948896|FG001|COMPLETED|Overall Study||7||
48658247|NCT04710303|101948897|FG002|COMPLETED|Overall Study||10||
48658248|NCT04710303|101948898|FG003|COMPLETED|Overall Study||10||
48769375|NCT02690948|102225837|FG001|COMPLETED|Overall Study||7||
48769376|NCT02690948|102225836|FG000|NOT COMPLETED|Overall Study||0||
48443202|NCT01610284|101420282|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase||89|All patients who discontinued treatment and entered Post-Treatment Efficacy Follow-Up Phase|
48443203|NCT01610284|101420283|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase||29|All patients who discontinued treatment and entered Post-Treatment Efficacy Follow-Up Phase|
48443204|NCT01610284|101420282|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
48443205|NCT01610284|101420283|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
48443206|NCT01610284|101420282|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||89||
48658249|NCT04710303|101948895|FG000|NOT COMPLETED|Overall Study||0||
48658250|NCT04710303|101948896|FG001|NOT COMPLETED|Overall Study||4||
48658251|NCT04710303|101948897|FG002|NOT COMPLETED|Overall Study||0||
48658252|NCT04710303|101948898|FG003|NOT COMPLETED|Overall Study||0||
48658253|NCT04223687|101948899|FG000|STARTED|Overall Study||163||
48658254|NCT04223687|101948900|FG001|STARTED|Overall Study||163||
48658255|NCT04223687|101948899|FG000|COMPLETED|Overall Study||162||
48658256|NCT04223687|101948900|FG001|COMPLETED|Overall Study||163||
48658257|NCT04223687|101948899|FG000|NOT COMPLETED|Overall Study||1||
48658258|NCT04223687|101948900|FG001|NOT COMPLETED|Overall Study||0||
48658259|NCT03138382|101948901|FG000|STARTED|Overall Study||10||
48658260|NCT03138382|101948902|FG001|STARTED|Overall Study||10||
48658261|NCT03138382|101948901|FG000|COMPLETED|Overall Study||10||
48658262|NCT03138382|101948902|FG001|COMPLETED|Overall Study||10||
48769377|NCT02690948|102225837|FG001|NOT COMPLETED|Overall Study||0||
48769378|NCT03822117|102225838|FG000|STARTED|Overall Study||49||
48769379|NCT03822117|102225839|FG001|STARTED|Overall Study||32||
48769380|NCT03822117|102225840|FG002|STARTED|Overall Study||26||
48769381|NCT03822117|102225841|FG003|STARTED|Overall Study||4||
48769382|NCT03822117|102225838|FG000|COMPLETED|Overall Study||0||
48443207|NCT01610284|101420283|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||29||
48443208|NCT02181842|101420284|FG000|STARTED|Overall Study||246||
48443209|NCT02181842|101420284|FG000|COMPLETED|Overall Study||244||
48769383|NCT03822117|102225839|FG001|COMPLETED|Overall Study||0||
48769384|NCT03822117|102225840|FG002|COMPLETED|Overall Study||0||
48769385|NCT03822117|102225841|FG003|COMPLETED|Overall Study||0||
48769386|NCT03822117|102225838|FG000|NOT COMPLETED|Overall Study||49||
48769387|NCT03822117|102225839|FG001|NOT COMPLETED|Overall Study||32||
48769388|NCT03822117|102225840|FG002|NOT COMPLETED|Overall Study||26||
48769389|NCT03822117|102225841|FG003|NOT COMPLETED|Overall Study||4||
48769390|NCT02264249|102225842|FG000|STARTED|Overall Study||21||
48769391|NCT02264249|102225843|FG001|STARTED|Overall Study||187||
48769392|NCT02264249|102225844|FG002|STARTED|Overall Study||241||
48769393|NCT02264249|102225842|FG000|COMPLETED|Overall Study||21||
48769394|NCT02264249|102225843|FG001|COMPLETED|Overall Study||187||
48769395|NCT02264249|102225844|FG002|COMPLETED|Overall Study||241||
48769396|NCT02264249|102225842|FG000|NOT COMPLETED|Overall Study||0||
48769397|NCT02264249|102225843|FG001|NOT COMPLETED|Overall Study||0||
48769398|NCT02264249|102225844|FG002|NOT COMPLETED|Overall Study||0||
48769399|NCT03023397|102225845|FG000|STARTED|Run-In||8||
48769400|NCT03023397|102225846|FG001|STARTED|Run-In||3||
48769401|NCT03023397|102225847|FG002|STARTED|Run-In||1||
48769402|NCT03023397|102225845|FG000|COMPLETED|Run-In||6||
48769403|NCT03023397|102225846|FG001|COMPLETED|Run-In||3||
48769404|NCT03023397|102225847|FG002|COMPLETED|Run-In||1||
48769405|NCT03023397|102225845|FG000|NOT COMPLETED|Run-In||2||
48769406|NCT03023397|102225846|FG001|NOT COMPLETED|Run-In||0||
48769407|NCT03023397|102225847|FG002|NOT COMPLETED|Run-In||0||
48443210|NCT02181842|101420284|FG000|NOT COMPLETED|Overall Study||2||
48443211|NCT02642991|101420285|FG000|STARTED|First Intervention||22||
48443212|NCT02642991|101420286|FG001|STARTED|First Intervention||22||
48443213|NCT02642991|101420285|FG000|COMPLETED|First Intervention||22||
48443214|NCT02642991|101420286|FG001|COMPLETED|First Intervention||22||
48658263|NCT03138382|101948901|FG000|NOT COMPLETED|Overall Study||0||
48658264|NCT03138382|101948902|FG001|NOT COMPLETED|Overall Study||0||
48658265|NCT01272219|101948903|FG000|STARTED|Main Period: Week 0 to Week 56||959||
48658266|NCT01272219|101948904|FG001|STARTED|Main Period: Week 0 to Week 56||0||
48658267|NCT01272219|101948905|FG002|STARTED|Main Period: Week 0 to Week 56||0||
48658268|NCT01272219|101948906|FG003|STARTED|Main Period: Week 0 to Week 56||487||
48658269|NCT01272219|101948907|FG004|STARTED|Main Period: Week 0 to Week 56||1528||
48658270|NCT01272219|101948908|FG005|STARTED|Main Period: Week 0 to Week 56||757||
48658271|NCT01272219|101948903|FG000|Exposed|Main Period: Week 0 to Week 56||957||
48658272|NCT01272219|101948904|FG001|Exposed|Main Period: Week 0 to Week 56||0||
48658273|NCT01272219|101948905|FG002|Exposed|Main Period: Week 0 to Week 56||0||
48658274|NCT01272219|101948906|FG003|Exposed|Main Period: Week 0 to Week 56||487||
48658275|NCT01272219|101948907|FG004|Exposed|Main Period: Week 0 to Week 56||1524||
48769408|NCT03023397|102225845|FG000|STARTED|Main Study||6||
48769409|NCT03023397|102225846|FG001|STARTED|Main Study||3||
48769410|NCT03023397|102225847|FG002|STARTED|Main Study||1||
48769411|NCT03023397|102225845|FG000|COMPLETED|Main Study||6||
48769412|NCT03023397|102225846|FG001|COMPLETED|Main Study||3||
48769413|NCT03023397|102225847|FG002|COMPLETED|Main Study||1||
48769414|NCT03023397|102225845|FG000|NOT COMPLETED|Main Study||0||
48769415|NCT03023397|102225846|FG001|NOT COMPLETED|Main Study||0||
48769416|NCT03023397|102225847|FG002|NOT COMPLETED|Main Study||0||
48769417|NCT03387085|102225848|FG000|STARTED|Overall Study||9||
48769418|NCT03387085|102225848|FG000|COMPLETED|Overall Study||2||
48769419|NCT03387085|102225848|FG000|NOT COMPLETED|Overall Study||7||
48769420|NCT02558296|102225849|FG000|STARTED|Completed the Study Through Week 24||1133||
48769421|NCT02558296|102225850|FG001|STARTED|Completed the Study Through Week 24||567||
48769422|NCT02558296|102225849|FG000|COMPLETED|Completed the Study Through Week 24||1089||
48769423|NCT02558296|102225850|FG001|COMPLETED|Completed the Study Through Week 24||542||
48188874|NCT04170023|100786101|FG001|Received at Least 1 Dose of Study Drug|LTE Period||11||
48443215|NCT02642991|101420285|FG000|NOT COMPLETED|First Intervention||0||
48658276|NCT01272219|101948908|FG005|Exposed|Main Period: Week 0 to Week 56||755||
48658277|NCT01272219|101948903|FG000|COMPLETED|Main Period: Week 0 to Week 56||679||
48658278|NCT01272219|101948904|FG001|COMPLETED|Main Period: Week 0 to Week 56||0||
48769424|NCT02558296|102225849|FG000|NOT COMPLETED|Completed the Study Through Week 24||44||
48769425|NCT02558296|102225850|FG001|NOT COMPLETED|Completed the Study Through Week 24||25||
48769426|NCT02558296|102225849|FG000|STARTED|Completed the Study||1133|The number of participants started is equal to ITT population|
48769427|NCT02558296|102225850|FG001|STARTED|Completed the Study||567|The number of participants started is equal to ITT population|
48769428|NCT02558296|102225849|FG000|COMPLETED|Completed the Study||987||
48658279|NCT01272219|101948905|FG002|COMPLETED|Main Period: Week 0 to Week 56||0||
48443216|NCT02642991|101420286|FG001|NOT COMPLETED|First Intervention||0||
48443217|NCT02642991|101420285|FG000|STARTED|Second Intervention||22||
48443218|NCT02642991|101420286|FG001|STARTED|Second Intervention||22||
48443219|NCT02642991|101420285|FG000|COMPLETED|Second Intervention||22||
48443220|NCT02642991|101420286|FG001|COMPLETED|Second Intervention||22||
48443221|NCT02642991|101420285|FG000|NOT COMPLETED|Second Intervention||0||
48443222|NCT02642991|101420286|FG001|NOT COMPLETED|Second Intervention||0||
48658280|NCT01272219|101948906|FG003|COMPLETED|Main Period: Week 0 to Week 56||296||
48658281|NCT01272219|101948907|FG004|COMPLETED|Main Period: Week 0 to Week 56||1110||
48658282|NCT01272219|101948908|FG005|COMPLETED|Main Period: Week 0 to Week 56||505||
48658283|NCT01272219|101948903|FG000|NOT COMPLETED|Main Period: Week 0 to Week 56||280||
48368659|NCT02584634|101230240|FG001|COMPLETED|Overall Study||0||
48368660|NCT02584634|101230239|FG000|NOT COMPLETED|Overall Study||12||
48368661|NCT02584634|101230240|FG001|NOT COMPLETED|Overall Study||31||
48368662|NCT02260193|101230241|FG000|STARTED|Overall Study||30||
48368663|NCT02260193|101230242|FG001|STARTED|Overall Study||33||
48368664|NCT02260193|101230243|FG002|STARTED|Overall Study||31||
48368665|NCT02260193|101230241|FG000|COMPLETED|Overall Study||24||
48368666|NCT02260193|101230242|FG001|COMPLETED|Overall Study||24||
48368667|NCT02260193|101230243|FG002|COMPLETED|Overall Study||21||
48368668|NCT02260193|101230241|FG000|NOT COMPLETED|Overall Study||6||
48368669|NCT02260193|101230242|FG001|NOT COMPLETED|Overall Study||9||
48368670|NCT02260193|101230243|FG002|NOT COMPLETED|Overall Study||10||
48368671|NCT02761993|101230244|FG000|STARTED|Overall Study||52||
48368672|NCT02761993|101230245|FG001|STARTED|Overall Study||49||
48368673|NCT02761993|101230246|FG002|STARTED|Overall Study||50||
48368674|NCT02761993|101230244|FG000|COMPLETED|Overall Study||50||
48368675|NCT02761993|101230245|FG001|COMPLETED|Overall Study||43||
48368676|NCT02761993|101230246|FG002|COMPLETED|Overall Study||46||
48368677|NCT02761993|101230244|FG000|NOT COMPLETED|Overall Study||2||
48368678|NCT02761993|101230245|FG001|NOT COMPLETED|Overall Study||6||
48368679|NCT02761993|101230246|FG002|NOT COMPLETED|Overall Study||4||
48368680|NCT00130208|101230247|FG000|STARTED|Maintenance Period (26 Weeks)||524||
48368681|NCT00130208|101230248|FG001|STARTED|Maintenance Period (26 Weeks)||532||
48368682|NCT00130208|101230247|FG000|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||492|Valid albumin creatinine ratio at baseline and week 26|
48368683|NCT00130208|101230248|FG001|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||494|Valid albumin creatinine ratio at baseline and week 26|
48368684|NCT00130208|101230247|FG000|COMPLETED|Maintenance Period (26 Weeks)||500||
48368685|NCT00130208|101230248|FG001|COMPLETED|Maintenance Period (26 Weeks)||502||
48368686|NCT00130208|101230247|FG000|NOT COMPLETED|Maintenance Period (26 Weeks)||24||
48368687|NCT00130208|101230248|FG001|NOT COMPLETED|Maintenance Period (26 Weeks)||30||
48368688|NCT00130208|101230247|FG000|STARTED|Washout Period (8 Weeks)||500||
48368689|NCT00130208|101230248|FG001|STARTED|Washout Period (8 Weeks)||502||
48368690|NCT00130208|101230247|FG000|COMPLETED|Washout Period (8 Weeks)||494||
48368691|NCT00130208|101230248|FG001|COMPLETED|Washout Period (8 Weeks)||490||
48368692|NCT00130208|101230247|FG000|NOT COMPLETED|Washout Period (8 Weeks)||6||
48368693|NCT00130208|101230248|FG001|NOT COMPLETED|Washout Period (8 Weeks)||12||
48368694|NCT01391312|101230249|FG000|STARTED|Overall Study||20||
48443223|NCT02572427|101420287|FG000|STARTED|Overall Study||37||
48443224|NCT02572427|101420288|FG001|STARTED|Overall Study||45||
48443225|NCT02572427|101420287|FG000|COMPLETED|Overall Study||31||
48443226|NCT02572427|101420288|FG001|COMPLETED|Overall Study||36||
48368695|NCT01391312|101230250|FG001|STARTED|Overall Study||20||
48368696|NCT01391312|101230249|FG000|COMPLETED|Overall Study||18||
48368697|NCT01391312|101230250|FG001|COMPLETED|Overall Study||19||
48368698|NCT01391312|101230249|FG000|NOT COMPLETED|Overall Study||2||
48368699|NCT01391312|101230250|FG001|NOT COMPLETED|Overall Study||1||
48368700|NCT02773914|101230251|FG000|STARTED|Overall Study||78||
48368701|NCT02773914|101230252|FG001|STARTED|Overall Study||77||
48368702|NCT02773914|101230251|FG000|COMPLETED|Overall Study||38||
48368703|NCT02773914|101230252|FG001|COMPLETED|Overall Study||40||
48368704|NCT02773914|101230251|FG000|NOT COMPLETED|Overall Study||40||
48368705|NCT02773914|101230252|FG001|NOT COMPLETED|Overall Study||37||
48368706|NCT04978376|101230253|FG000|STARTED|Overall Study||4||
48368707|NCT04978376|101230254|FG001|STARTED|Overall Study||4||
48368708|NCT04978376|101230255|FG002|STARTED|Overall Study||5||
48368709|NCT04978376|101230256|FG003|STARTED|Overall Study||4||
48368710|NCT04978376|101230253|FG000|COMPLETED|Overall Study||4||
48368711|NCT04978376|101230254|FG001|COMPLETED|Overall Study||4||
48443227|NCT02572427|101420287|FG000|NOT COMPLETED|Overall Study||6||
48368712|NCT04978376|101230255|FG002|COMPLETED|Overall Study||5||
48368713|NCT04978376|101230256|FG003|COMPLETED|Overall Study||4||
48368714|NCT04978376|101230253|FG000|NOT COMPLETED|Overall Study||0||
48368715|NCT04978376|101230254|FG001|NOT COMPLETED|Overall Study||0||
48368716|NCT04978376|101230255|FG002|NOT COMPLETED|Overall Study||0||
48368717|NCT04978376|101230256|FG003|NOT COMPLETED|Overall Study||0||
48368718|NCT02869867|101230257|FG000|STARTED|Overall Study||50||
48368719|NCT02869867|101230258|FG001|STARTED|Overall Study||50||
48368720|NCT02869867|101230257|FG000|COMPLETED|Overall Study||44||
48443228|NCT02572427|101420288|FG001|NOT COMPLETED|Overall Study||9||
48443229|NCT01741259|101420289|FG000|STARTED|Overall Study||133||
48443230|NCT01741259|101420290|FG001|STARTED|Overall Study||135||
48443231|NCT01741259|101420289|FG000|COMPLETED|Overall Study||127||
48443232|NCT01741259|101420290|FG001|COMPLETED|Overall Study||129||
48443233|NCT01741259|101420289|FG000|NOT COMPLETED|Overall Study||6||
48443234|NCT01741259|101420290|FG001|NOT COMPLETED|Overall Study||6||
48443235|NCT00956709|101420291|FG000|STARTED|Overall Study||16||
48443236|NCT00956709|101420292|FG001|STARTED|Overall Study||19||
48443237|NCT00956709|101420291|FG000|COMPLETED|Overall Study||16||
48443238|NCT00956709|101420292|FG001|COMPLETED|Overall Study||19||
48443239|NCT00956709|101420291|FG000|NOT COMPLETED|Overall Study||0||
48443240|NCT00956709|101420292|FG001|NOT COMPLETED|Overall Study||0||
48443241|NCT01447628|101420293|FG000|STARTED|Week 0 to Week 12 (1st Intervention)||19||
48443242|NCT01447628|101420294|FG001|STARTED|Week 0 to Week 12 (1st Intervention)||20||
48443243|NCT01447628|101420295|FG002|STARTED|Week 0 to Week 12 (1st Intervention)||12||
48443244|NCT01447628|101420296|FG003|STARTED|Week 0 to Week 12 (1st Intervention)||5||
48443245|NCT01447628|101420293|FG000|COMPLETED|Week 0 to Week 12 (1st Intervention)||19||
48443246|NCT01447628|101420294|FG001|COMPLETED|Week 0 to Week 12 (1st Intervention)||20||
48443247|NCT01447628|101420295|FG002|COMPLETED|Week 0 to Week 12 (1st Intervention)||12||
48443248|NCT01447628|101420296|FG003|COMPLETED|Week 0 to Week 12 (1st Intervention)||4||
48443249|NCT01447628|101420293|FG000|NOT COMPLETED|Week 0 to Week 12 (1st Intervention)||0||
48443250|NCT01447628|101420294|FG001|NOT COMPLETED|Week 0 to Week 12 (1st Intervention)||0||
48443251|NCT01447628|101420295|FG002|NOT COMPLETED|Week 0 to Week 12 (1st Intervention)||0||
48443252|NCT01447628|101420296|FG003|NOT COMPLETED|Week 0 to Week 12 (1st Intervention)||1||
48443253|NCT01447628|101420293|FG000|STARTED|Week 12 to Week 24 (2nd Intervention)||19||
48443254|NCT01447628|101420294|FG001|STARTED|Week 12 to Week 24 (2nd Intervention)||20||
48443255|NCT01447628|101420295|FG002|STARTED|Week 12 to Week 24 (2nd Intervention)||12||
48443256|NCT01447628|101420296|FG003|STARTED|Week 12 to Week 24 (2nd Intervention)||4||
48443257|NCT01447628|101420293|FG000|COMPLETED|Week 12 to Week 24 (2nd Intervention)||19||
48443258|NCT01447628|101420294|FG001|COMPLETED|Week 12 to Week 24 (2nd Intervention)||20||
48443259|NCT01447628|101420295|FG002|COMPLETED|Week 12 to Week 24 (2nd Intervention)||12||
48443260|NCT01447628|101420296|FG003|COMPLETED|Week 12 to Week 24 (2nd Intervention)||4||
48443261|NCT01447628|101420293|FG000|NOT COMPLETED|Week 12 to Week 24 (2nd Intervention)||0||
48443262|NCT01447628|101420294|FG001|NOT COMPLETED|Week 12 to Week 24 (2nd Intervention)||0||
48443263|NCT01447628|101420295|FG002|NOT COMPLETED|Week 12 to Week 24 (2nd Intervention)||0||
48443264|NCT01447628|101420296|FG003|NOT COMPLETED|Week 12 to Week 24 (2nd Intervention)||0||
48443265|NCT05981365|101420297|FG000|STARTED|Period 1||26||
48443266|NCT05981365|101420298|FG001|STARTED|Period 1||18||
48443267|NCT05981365|101420297|FG000|COMPLETED|Period 1||25||
48443268|NCT05981365|101420298|FG001|COMPLETED|Period 1||18||
48443269|NCT05981365|101420297|FG000|NOT COMPLETED|Period 1||1||
48443270|NCT05981365|101420298|FG001|NOT COMPLETED|Period 1||0||
48443271|NCT05981365|101420297|FG000|STARTED|Washout Period||25||
48443272|NCT05981365|101420298|FG001|STARTED|Washout Period||18||
48443273|NCT05981365|101420297|FG000|COMPLETED|Washout Period||25||
48443274|NCT05981365|101420298|FG001|COMPLETED|Washout Period||18||
48443275|NCT05981365|101420297|FG000|NOT COMPLETED|Washout Period||0||
48443276|NCT05981365|101420298|FG001|NOT COMPLETED|Washout Period||0||
48443277|NCT05981365|101420297|FG000|STARTED|Period 2||25||
48443278|NCT05981365|101420298|FG001|STARTED|Period 2||18||
48443279|NCT05981365|101420297|FG000|COMPLETED|Period 2||25||
48443280|NCT05981365|101420298|FG001|COMPLETED|Period 2||18||
48443281|NCT05981365|101420297|FG000|NOT COMPLETED|Period 2||0||
48443282|NCT05981365|101420298|FG001|NOT COMPLETED|Period 2||0||
48443283|NCT03533608|101420299|FG000|STARTED|Overall Study||39||
48443284|NCT03533608|101420299|FG000|COMPLETED|Overall Study||34||
48443285|NCT03533608|101420299|FG000|NOT COMPLETED|Overall Study||5||
48443286|NCT00686231|101420300|FG000|STARTED|Dose Test - Visit 1||12||
48443287|NCT00686231|101420301|FG001|STARTED|Dose Test - Visit 1||7||
48443288|NCT00686231|101420302|FG002|STARTED|Dose Test - Visit 1||0||
48443289|NCT00686231|101420303|FG003|STARTED|Dose Test - Visit 1||0||
48443290|NCT00686231|101420300|FG000|COMPLETED|Dose Test - Visit 1||12||
48443291|NCT00686231|101420301|FG001|COMPLETED|Dose Test - Visit 1||7||
48443292|NCT00686231|101420302|FG002|COMPLETED|Dose Test - Visit 1||0||
48443293|NCT00686231|101420303|FG003|COMPLETED|Dose Test - Visit 1||0||
48443294|NCT00686231|101420300|FG000|NOT COMPLETED|Dose Test - Visit 1||0||
48443295|NCT00686231|101420301|FG001|NOT COMPLETED|Dose Test - Visit 1||0||
48443296|NCT00686231|101420302|FG002|NOT COMPLETED|Dose Test - Visit 1||0||
48443297|NCT00686231|101420303|FG003|NOT COMPLETED|Dose Test - Visit 1||0||
48443298|NCT00686231|101420300|FG000|STARTED|Combination Test - Visit 2||0||
48443299|NCT00686231|101420301|FG001|STARTED|Combination Test - Visit 2||0||
48443300|NCT00686231|101420302|FG002|STARTED|Combination Test - Visit 2||10||
48443301|NCT00686231|101420303|FG003|STARTED|Combination Test - Visit 2||9||
48443302|NCT00686231|101420300|FG000|COMPLETED|Combination Test - Visit 2||0||
48443303|NCT00686231|101420301|FG001|COMPLETED|Combination Test - Visit 2||0||
48443304|NCT00686231|101420302|FG002|COMPLETED|Combination Test - Visit 2||10||
48443305|NCT00686231|101420303|FG003|COMPLETED|Combination Test - Visit 2||9||
48443306|NCT00686231|101420300|FG000|NOT COMPLETED|Combination Test - Visit 2||0||
48443307|NCT00686231|101420301|FG001|NOT COMPLETED|Combination Test - Visit 2||0||
48443308|NCT00686231|101420302|FG002|NOT COMPLETED|Combination Test - Visit 2||0||
48443309|NCT00686231|101420303|FG003|NOT COMPLETED|Combination Test - Visit 2||0||
48443310|NCT04136626|101420304|FG000|STARTED|Treatment Phase||60||
48443311|NCT04136626|101420305|FG001|STARTED|Treatment Phase||60||
48443312|NCT04136626|101420304|FG000|COMPLETED|Treatment Phase||57||
48443313|NCT04136626|101420305|FG001|COMPLETED|Treatment Phase||46||
48443314|NCT04136626|101420304|FG000|NOT COMPLETED|Treatment Phase||3||
48443315|NCT04136626|101420305|FG001|NOT COMPLETED|Treatment Phase||14||
48443316|NCT04136626|101420304|FG000|STARTED|12-month Follow-up||57||
48443317|NCT04136626|101420305|FG001|STARTED|12-month Follow-up||46||
48443318|NCT04136626|101420304|FG000|3-month Follow-up|12-month Follow-up||52||
48443319|NCT04136626|101420305|FG001|3-month Follow-up|12-month Follow-up||41||
48443320|NCT04136626|101420304|FG000|COMPLETED|12-month Follow-up||49||
48443321|NCT04136626|101420305|FG001|COMPLETED|12-month Follow-up||39||
48443322|NCT04136626|101420304|FG000|NOT COMPLETED|12-month Follow-up||8||
48443323|NCT04136626|101420305|FG001|NOT COMPLETED|12-month Follow-up||7||
48443324|NCT02362646|101420306|FG000|STARTED|Overall Study||106||
48443325|NCT02362646|101420307|FG001|STARTED|Overall Study||53||
48443326|NCT02362646|101420306|FG000|COMPLETED|Overall Study||68||
48443327|NCT02362646|101420307|FG001|COMPLETED|Overall Study||29||
48443328|NCT02362646|101420306|FG000|NOT COMPLETED|Overall Study||38||
48443329|NCT02362646|101420307|FG001|NOT COMPLETED|Overall Study||24||
48443330|NCT03533829|101420308|FG000|STARTED|Overall Study||10||
48443331|NCT03533829|101420309|FG001|STARTED|Overall Study||10||
48443332|NCT03533829|101420310|FG002|STARTED|Overall Study||10||
48443333|NCT03533829|101420308|FG000|COMPLETED|Overall Study||10||
48443334|NCT03533829|101420309|FG001|COMPLETED|Overall Study||10||
48443335|NCT03533829|101420310|FG002|COMPLETED|Overall Study||10||
48443336|NCT03533829|101420308|FG000|NOT COMPLETED|Overall Study||0||
48443337|NCT03533829|101420309|FG001|NOT COMPLETED|Overall Study||0||
48443338|NCT03533829|101420310|FG002|NOT COMPLETED|Overall Study||0||
48368721|NCT02869867|101230258|FG001|COMPLETED|Overall Study||45||
48368722|NCT02869867|101230257|FG000|NOT COMPLETED|Overall Study||6||
48368723|NCT02869867|101230258|FG001|NOT COMPLETED|Overall Study||5||
48368724|NCT00950690|101230259|FG000|STARTED|Overall Study||1349||
48368725|NCT00950690|101230259|FG000|COMPLETED|Overall Study||1105||
48368726|NCT00950690|101230259|FG000|NOT COMPLETED|Overall Study||244||
48368727|NCT01915849|101230260|FG000|STARTED|Treatment Period 1 (4 Days)||5||
48368728|NCT01915849|101230261|FG001|STARTED|Treatment Period 1 (4 Days)||3||
48368729|NCT01915849|101230262|FG002|STARTED|Treatment Period 1 (4 Days)||3||
48368730|NCT01915849|101230263|FG003|STARTED|Treatment Period 1 (4 Days)||3||
48368731|NCT01915849|101230260|FG000|COMPLETED|Treatment Period 1 (4 Days)||3||
48368732|NCT01915849|101230261|FG001|COMPLETED|Treatment Period 1 (4 Days)||3||
48368733|NCT01915849|101230262|FG002|COMPLETED|Treatment Period 1 (4 Days)||3||
48368734|NCT01915849|101230263|FG003|COMPLETED|Treatment Period 1 (4 Days)||3||
48368735|NCT01915849|101230260|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||2||
48368736|NCT01915849|101230261|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
48368737|NCT01915849|101230262|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
48368738|NCT01915849|101230263|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
48368739|NCT01915849|101230260|FG000|STARTED|Treatment Period 2 (4 Days)||3||
48368740|NCT01915849|101230261|FG001|STARTED|Treatment Period 2 (4 Days)||3||
48368741|NCT01915849|101230262|FG002|STARTED|Treatment Period 2 (4 Days)||3||
48368742|NCT01915849|101230263|FG003|STARTED|Treatment Period 2 (4 Days)||3||
48368743|NCT01915849|101230260|FG000|COMPLETED|Treatment Period 2 (4 Days)||3||
48368744|NCT01915849|101230261|FG001|COMPLETED|Treatment Period 2 (4 Days)||3||
48443339|NCT01216319|101420311|FG000|STARTED|Overall Study||50||
48443340|NCT01216319|101420311|FG000|COMPLETED|Overall Study||46||
48443341|NCT01216319|101420311|FG000|NOT COMPLETED|Overall Study||4||
48443342|NCT04035694|101420312|FG000|STARTED|Overall Study||374||
48443343|NCT04035694|101420313|FG001|STARTED|Overall Study||216||
48443344|NCT04035694|101420312|FG000|COMPLETED|Overall Study||374||
48443345|NCT04035694|101420313|FG001|COMPLETED|Overall Study||216||
48443346|NCT04035694|101420312|FG000|NOT COMPLETED|Overall Study||0||
48443347|NCT04035694|101420313|FG001|NOT COMPLETED|Overall Study||0||
48443348|NCT01299272|101420314|FG000|STARTED|Acute Open-label (OL) Period||1249||
48443349|NCT01299272|101420315|FG001|STARTED|Acute Open-label (OL) Period||0||
48658284|NCT01272219|101948904|FG001|NOT COMPLETED|Main Period: Week 0 to Week 56||0||
48658285|NCT01272219|101948905|FG002|NOT COMPLETED|Main Period: Week 0 to Week 56||0||
48658286|NCT01272219|101948906|FG003|NOT COMPLETED|Main Period: Week 0 to Week 56||191||
48368745|NCT01915849|101230262|FG002|COMPLETED|Treatment Period 2 (4 Days)||3||
48368746|NCT01915849|101230263|FG003|COMPLETED|Treatment Period 2 (4 Days)||3||
48368747|NCT01915849|101230260|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
48368748|NCT01915849|101230261|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
48368749|NCT01915849|101230262|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
48443350|NCT01299272|101420316|FG002|STARTED|Acute Open-label (OL) Period||0||
48443351|NCT01299272|101420317|FG003|STARTED|Acute Open-label (OL) Period||0||
48443352|NCT01299272|101420314|FG000|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||271||
48443353|NCT01299272|101420315|FG001|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0||
48443354|NCT01299272|101420316|FG002|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0||
48443355|NCT01299272|101420317|FG003|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0||
48443356|NCT01299272|101420314|FG000|COMPLETED|Acute Open-label (OL) Period||835||
48443357|NCT01299272|101420315|FG001|COMPLETED|Acute Open-label (OL) Period||0||
48443358|NCT01299272|101420316|FG002|COMPLETED|Acute Open-label (OL) Period||0||
48443359|NCT01299272|101420317|FG003|COMPLETED|Acute Open-label (OL) Period||0||
48443360|NCT01299272|101420314|FG000|NOT COMPLETED|Acute Open-label (OL) Period||414||
48443361|NCT01299272|101420315|FG001|NOT COMPLETED|Acute Open-label (OL) Period||0||
48443362|NCT01299272|101420316|FG002|NOT COMPLETED|Acute Open-label (OL) Period||0||
48443363|NCT01299272|101420317|FG003|NOT COMPLETED|Acute Open-label (OL) Period||0||
48443364|NCT01299272|101420314|FG000|STARTED|Stabilization Open-label (OL) Period||0||
48443365|NCT01299272|101420315|FG001|STARTED|Stabilization Open-label (OL) Period||835||
48443366|NCT01299272|101420316|FG002|STARTED|Stabilization Open-label (OL) Period||0||
48443367|NCT01299272|101420317|FG003|STARTED|Stabilization Open-label (OL) Period||0||
48443368|NCT01299272|101420314|FG000|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0||
48443369|NCT01299272|101420315|FG001|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||164||
48443370|NCT01299272|101420316|FG002|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0||
48670038|NCT03601897|101974869|FG003|NOT COMPLETED|Overall Study||2||
48368750|NCT01915849|101230263|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
48368751|NCT01915849|101230260|FG000|STARTED|Treatment Period 3 (4 Days)||3||
48368752|NCT01915849|101230261|FG001|STARTED|Treatment Period 3 (4 Days)||3||
48368753|NCT01915849|101230262|FG002|STARTED|Treatment Period 3 (4 Days)||3||
48368754|NCT01915849|101230263|FG003|STARTED|Treatment Period 3 (4 Days)||3||
48368755|NCT01915849|101230260|FG000|COMPLETED|Treatment Period 3 (4 Days)||3||
48368756|NCT01915849|101230261|FG001|COMPLETED|Treatment Period 3 (4 Days)||3||
48368757|NCT01915849|101230262|FG002|COMPLETED|Treatment Period 3 (4 Days)||3||
48368758|NCT01915849|101230263|FG003|COMPLETED|Treatment Period 3 (4 Days)||3||
48368759|NCT01915849|101230260|FG000|NOT COMPLETED|Treatment Period 3 (4 Days)||0||
48368760|NCT01915849|101230261|FG001|NOT COMPLETED|Treatment Period 3 (4 Days)||0||
48368761|NCT01915849|101230262|FG002|NOT COMPLETED|Treatment Period 3 (4 Days)||0||
48368762|NCT01915849|101230263|FG003|NOT COMPLETED|Treatment Period 3 (4 Days)||0||
48368763|NCT01915849|101230260|FG000|STARTED|Treatment Period 4 (4 Days)||3||
48368764|NCT01915849|101230261|FG001|STARTED|Treatment Period 4 (4 Days)||3||
48368765|NCT01915849|101230262|FG002|STARTED|Treatment Period 4 (4 Days)||3||
48368766|NCT01915849|101230263|FG003|STARTED|Treatment Period 4 (4 Days)||3||
48368767|NCT01915849|101230260|FG000|COMPLETED|Treatment Period 4 (4 Days)||3||
48368768|NCT01915849|101230261|FG001|COMPLETED|Treatment Period 4 (4 Days)||3||
48368769|NCT01915849|101230262|FG002|COMPLETED|Treatment Period 4 (4 Days)||3||
48368770|NCT01915849|101230263|FG003|COMPLETED|Treatment Period 4 (4 Days)||3||
48368771|NCT01915849|101230260|FG000|NOT COMPLETED|Treatment Period 4 (4 Days)||0||
48368772|NCT01915849|101230261|FG001|NOT COMPLETED|Treatment Period 4 (4 Days)||0||
48368773|NCT01915849|101230262|FG002|NOT COMPLETED|Treatment Period 4 (4 Days)||0||
48368774|NCT01915849|101230263|FG003|NOT COMPLETED|Treatment Period 4 (4 Days)||0||
48368775|NCT01084499|101230264|FG000|STARTED|Overall Study||13||
48368776|NCT01084499|101230265|FG001|STARTED|Overall Study||13||
48368777|NCT01084499|101230264|FG000|Washout (5 Weeks)|Overall Study||13||
48368778|NCT01084499|101230265|FG001|Washout (5 Weeks)|Overall Study||13||
48368779|NCT01084499|101230264|FG000|COMPLETED|Overall Study||13||
48368780|NCT01084499|101230265|FG001|COMPLETED|Overall Study||13||
48368781|NCT01084499|101230264|FG000|NOT COMPLETED|Overall Study||0||
48368782|NCT01084499|101230265|FG001|NOT COMPLETED|Overall Study||0||
48368783|NCT00521339|101230266|FG000|STARTED|Treatment Phase||31||
48368784|NCT00521339|101230267|FG001|STARTED|Treatment Phase||0||
48368785|NCT00521339|101230268|FG002|STARTED|Treatment Phase||0||
48368786|NCT00521339|101230266|FG000|Received Apremilast|Treatment Phase||30||
48368787|NCT00521339|101230267|FG001|Received Apremilast|Treatment Phase||0||
48368788|NCT00521339|101230268|FG002|Received Apremilast|Treatment Phase||0||
48368789|NCT00521339|101230266|FG000|COMPLETED|Treatment Phase||19||
48368790|NCT00521339|101230267|FG001|COMPLETED|Treatment Phase||0||
48443371|NCT01299272|101420317|FG003|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0||
48443372|NCT01299272|101420314|FG000|COMPLETED|Stabilization Open-label (OL) Period||0||
48443373|NCT01299272|101420315|FG001|COMPLETED|Stabilization Open-label (OL) Period||586||
48443374|NCT01299272|101420316|FG002|COMPLETED|Stabilization Open-label (OL) Period||0||
48443375|NCT01299272|101420317|FG003|COMPLETED|Stabilization Open-label (OL) Period||0||
48443376|NCT01299272|101420314|FG000|NOT COMPLETED|Stabilization Open-label (OL) Period||0||
48443377|NCT01299272|101420315|FG001|NOT COMPLETED|Stabilization Open-label (OL) Period||249||
48443378|NCT01299272|101420316|FG002|NOT COMPLETED|Stabilization Open-label (OL) Period||0||
48368791|NCT00521339|101230268|FG002|COMPLETED|Treatment Phase||0||
48368792|NCT00521339|101230266|FG000|NOT COMPLETED|Treatment Phase||12||
48368793|NCT00521339|101230267|FG001|NOT COMPLETED|Treatment Phase||0||
48368794|NCT00521339|101230268|FG002|NOT COMPLETED|Treatment Phase||0||
48368795|NCT00521339|101230266|FG000|STARTED|Treatment Extension Phase||0||
48368796|NCT00521339|101230267|FG001|STARTED|Treatment Extension Phase||4||
48368797|NCT00521339|101230268|FG002|STARTED|Treatment Extension Phase||7||
48368798|NCT00521339|101230266|FG000|COMPLETED|Treatment Extension Phase||0||
48368799|NCT00521339|101230267|FG001|COMPLETED|Treatment Extension Phase||4||
48368800|NCT00521339|101230268|FG002|COMPLETED|Treatment Extension Phase||4||
48443379|NCT01299272|101420317|FG003|NOT COMPLETED|Stabilization Open-label (OL) Period||0||
48443380|NCT01299272|101420314|FG000|STARTED|Double-blind (DB) Randomized Period||0||
48443381|NCT01299272|101420315|FG001|STARTED|Double-blind (DB) Randomized Period||0||
48443382|NCT01299272|101420316|FG002|STARTED|Double-blind (DB) Randomized Period||294||
48443383|NCT01299272|101420317|FG003|STARTED|Double-blind (DB) Randomized Period||292||
48443384|NCT01299272|101420314|FG000|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0||
48443385|NCT01299272|101420315|FG001|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0||
48443386|NCT01299272|101420316|FG002|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||129||
48443387|NCT01299272|101420317|FG003|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0||
48443388|NCT01299272|101420314|FG000|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0||
48443389|NCT01299272|101420315|FG001|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0||
48443390|NCT01299272|101420316|FG002|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||132||
48443391|NCT01299272|101420317|FG003|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||268||
48443392|NCT01299272|101420314|FG000|COMPLETED|Double-blind (DB) Randomized Period||0||
48443393|NCT01299272|101420315|FG001|COMPLETED|Double-blind (DB) Randomized Period||0||
48443394|NCT01299272|101420316|FG002|COMPLETED|Double-blind (DB) Randomized Period||224||
48443395|NCT01299272|101420317|FG003|COMPLETED|Double-blind (DB) Randomized Period||234||
48443396|NCT01299272|101420314|FG000|NOT COMPLETED|Double-blind (DB) Randomized Period||0||
48443397|NCT01299272|101420315|FG001|NOT COMPLETED|Double-blind (DB) Randomized Period||0||
48443398|NCT01299272|101420316|FG002|NOT COMPLETED|Double-blind (DB) Randomized Period||70||
48443399|NCT01299272|101420317|FG003|NOT COMPLETED|Double-blind (DB) Randomized Period||58||
48443400|NCT03926728|101420318|FG000|STARTED|Overall Study||2||
48443401|NCT03926728|101420319|FG001|STARTED|Overall Study||9||
48443402|NCT03926728|101420320|FG002|STARTED|Overall Study||3||
48443403|NCT03926728|101420321|FG003|STARTED|Overall Study||9||
48443404|NCT03926728|101420322|FG004|STARTED|Overall Study||3||
48443405|NCT03926728|101420323|FG005|STARTED|Overall Study||9||
48443406|NCT03926728|101420324|FG006|STARTED|Overall Study||3||
48443407|NCT03926728|101420325|FG007|STARTED|Overall Study||9||
48443408|NCT03926728|101420326|FG008|STARTED|Overall Study||3||
48443409|NCT03926728|101420327|FG009|STARTED|Overall Study||9||
48443410|NCT03926728|101420328|FG010|STARTED|Overall Study||3||
48443411|NCT03926728|101420329|FG011|STARTED|Overall Study||3||
48443412|NCT03926728|101420318|FG000|COMPLETED|Overall Study||2||
48443413|NCT03926728|101420319|FG001|COMPLETED|Overall Study||8||
48443414|NCT03926728|101420320|FG002|COMPLETED|Overall Study||2||
48443415|NCT03926728|101420321|FG003|COMPLETED|Overall Study||9||
48443416|NCT03926728|101420322|FG004|COMPLETED|Overall Study||3||
48443417|NCT03926728|101420323|FG005|COMPLETED|Overall Study||8||
48443418|NCT03926728|101420324|FG006|COMPLETED|Overall Study||2||
48443419|NCT03926728|101420325|FG007|COMPLETED|Overall Study||9||
48443420|NCT03926728|101420326|FG008|COMPLETED|Overall Study||3||
48443421|NCT03926728|101420327|FG009|COMPLETED|Overall Study||8||
48443422|NCT03926728|101420328|FG010|COMPLETED|Overall Study||3||
48443423|NCT03926728|101420329|FG011|COMPLETED|Overall Study||3||
48443424|NCT03926728|101420318|FG000|NOT COMPLETED|Overall Study||0||
48443425|NCT03926728|101420319|FG001|NOT COMPLETED|Overall Study||1||
48443426|NCT03926728|101420320|FG002|NOT COMPLETED|Overall Study||1||
48443427|NCT03926728|101420321|FG003|NOT COMPLETED|Overall Study||0||
48443428|NCT03926728|101420322|FG004|NOT COMPLETED|Overall Study||0||
48443429|NCT03926728|101420323|FG005|NOT COMPLETED|Overall Study||1||
48443430|NCT03926728|101420324|FG006|NOT COMPLETED|Overall Study||1||
48443431|NCT03926728|101420325|FG007|NOT COMPLETED|Overall Study||0||
48443432|NCT03926728|101420326|FG008|NOT COMPLETED|Overall Study||0||
48658287|NCT01272219|101948907|FG004|NOT COMPLETED|Main Period: Week 0 to Week 56||418||
48443433|NCT03926728|101420327|FG009|NOT COMPLETED|Overall Study||1||
48443434|NCT03926728|101420328|FG010|NOT COMPLETED|Overall Study||0||
48443435|NCT03926728|101420329|FG011|NOT COMPLETED|Overall Study||0||
48443436|NCT03751124|101420330|FG000|STARTED|Overall Study||115||
48443437|NCT03751124|101420331|FG001|STARTED|Overall Study||114||
48443438|NCT03751124|101420330|FG000|Received at Least 1 Dose of Study Drug|Overall Study||115||
48443439|NCT03751124|101420331|FG001|Received at Least 1 Dose of Study Drug|Overall Study||113||
48443440|NCT03751124|101420330|FG000|COMPLETED|Overall Study||89||
48443441|NCT03751124|101420331|FG001|COMPLETED|Overall Study||86||
48658288|NCT01272219|101948908|FG005|NOT COMPLETED|Main Period: Week 0 to Week 56||252||
48658289|NCT01272219|101948903|FG000|STARTED|Re-randomised Period: Week 56 to Week 68||0||
48769429|NCT02558296|102225850|FG001|COMPLETED|Completed the Study||482||
48443442|NCT03751124|101420330|FG000|NOT COMPLETED|Overall Study||26||
48443443|NCT03751124|101420331|FG001|NOT COMPLETED|Overall Study||28||
48443444|NCT02703779|101420332|FG000|STARTED|Overall Study||51||
48443445|NCT02703779|101420333|FG001|STARTED|Overall Study||50||
48443446|NCT02703779|101420332|FG000|COMPLETED|Overall Study||51||
48443447|NCT02703779|101420333|FG001|COMPLETED|Overall Study||50||
48443448|NCT02703779|101420332|FG000|NOT COMPLETED|Overall Study||0||
48443449|NCT02703779|101420333|FG001|NOT COMPLETED|Overall Study||0||
48443450|NCT01186744|101420334|FG000|STARTED|Overall Study||218||
48443451|NCT01186744|101420335|FG001|STARTED|Overall Study||157||
48443452|NCT01186744|101420336|FG002|STARTED|Overall Study||31||
48188875|NCT04170023|100786102|FG002|Received at Least 1 Dose of Study Drug|LTE Period||6||
48188876|NCT04170023|100786100|FG000|COMPLETED|LTE Period||0||
48188877|NCT04170023|100786101|FG001|COMPLETED|LTE Period||0||
48188878|NCT04170023|100786102|FG002|COMPLETED|LTE Period||1||
48188879|NCT04170023|100786100|FG000|NOT COMPLETED|LTE Period||12||
48188880|NCT04170023|100786101|FG001|NOT COMPLETED|LTE Period||11||
48188881|NCT04170023|100786102|FG002|NOT COMPLETED|LTE Period||5||
48188882|NCT02724020|100786103|FG000|STARTED|Overall Study||32||
48188883|NCT02724020|100786104|FG001|STARTED|Overall Study||32||
48188884|NCT02724020|100786105|FG002|STARTED|Overall Study||32||
48188885|NCT02724020|100786103|FG000|Treated (Safety Analysis Set)|Overall Study||32||
48188886|NCT02724020|100786104|FG001|Treated (Safety Analysis Set)|Overall Study||32||
48188887|NCT02724020|100786105|FG002|Treated (Safety Analysis Set)|Overall Study||31||
48188888|NCT02724020|100786103|FG000|COMPLETED|Overall Study||0||
48188889|NCT02724020|100786104|FG001|COMPLETED|Overall Study||0||
48188890|NCT02724020|100786105|FG002|COMPLETED|Overall Study||0||
48188891|NCT02724020|100786103|FG000|NOT COMPLETED|Overall Study||32||
48188892|NCT02724020|100786104|FG001|NOT COMPLETED|Overall Study||32||
48188893|NCT02724020|100786105|FG002|NOT COMPLETED|Overall Study||32||
48368801|NCT00521339|101230266|FG000|NOT COMPLETED|Treatment Extension Phase||0||
48368802|NCT00521339|101230267|FG001|NOT COMPLETED|Treatment Extension Phase||0||
48368803|NCT00521339|101230268|FG002|NOT COMPLETED|Treatment Extension Phase||3||
48368804|NCT00521339|101230266|FG000|STARTED|Observational Follow Up Phase||14||
48368805|NCT00521339|101230267|FG001|STARTED|Observational Follow Up Phase||4||
48368806|NCT00521339|101230268|FG002|STARTED|Observational Follow Up Phase||4||
48368807|NCT00521339|101230266|FG000|COMPLETED|Observational Follow Up Phase||14||
48368808|NCT00521339|101230267|FG001|COMPLETED|Observational Follow Up Phase||4||
48368809|NCT00521339|101230268|FG002|COMPLETED|Observational Follow Up Phase||4||
48368810|NCT00521339|101230266|FG000|NOT COMPLETED|Observational Follow Up Phase||0||
48368811|NCT00521339|101230267|FG001|NOT COMPLETED|Observational Follow Up Phase||0||
48368812|NCT00521339|101230268|FG002|NOT COMPLETED|Observational Follow Up Phase||0||
48368813|NCT00406315|101230269|FG000|STARTED|Overall Study||241||
48368814|NCT00406315|101230269|FG000|COMPLETED|Overall Study||100||
48368815|NCT00406315|101230269|FG000|NOT COMPLETED|Overall Study||141||
48368816|NCT00698516|101230270|FG000|STARTED|Overall Study||50||
48368817|NCT00698516|101230270|FG000|COMPLETED|Overall Study||45||
48368818|NCT00698516|101230270|FG000|NOT COMPLETED|Overall Study||5||
48368819|NCT01592851|101230271|FG000|STARTED|Overall Study||56||
48368820|NCT01592851|101230272|FG001|STARTED|Overall Study||57||
48368821|NCT01592851|101230271|FG000|COMPLETED|Overall Study||56||
48368822|NCT01592851|101230272|FG001|COMPLETED|Overall Study||57||
48368823|NCT01592851|101230271|FG000|NOT COMPLETED|Overall Study||0||
48368824|NCT01592851|101230272|FG001|NOT COMPLETED|Overall Study||0||
48368825|NCT01259492|101230273|FG000|STARTED|Period 1 (9 Weeks)||181||
48368826|NCT01259492|101230274|FG001|STARTED|Period 1 (9 Weeks)||182||
48368827|NCT01259492|101230275|FG002|STARTED|Period 1 (9 Weeks)||181||
48368828|NCT01259492|101230276|FG003|STARTED|Period 1 (9 Weeks)||181||
48368829|NCT01259492|101230273|FG000|Full Analysis Set|Period 1 (9 Weeks)||174||
48443453|NCT01186744|101420337|FG003|STARTED|Overall Study||82||
48658290|NCT01272219|101948904|FG001|STARTED|Re-randomised Period: Week 56 to Week 68||351||
48658291|NCT01272219|101948905|FG002|STARTED|Re-randomised Period: Week 56 to Week 68||350||
48368830|NCT01259492|101230274|FG001|Full Analysis Set|Period 1 (9 Weeks)||175||
48368831|NCT01259492|101230275|FG002|Full Analysis Set|Period 1 (9 Weeks)||179||
48443454|NCT01186744|101420338|FG004|STARTED|Overall Study||45||
48443455|NCT01186744|101420339|FG005|STARTED|Overall Study||133||
48443456|NCT01186744|101420334|FG000|COMPLETED|Overall Study||10||
48443457|NCT01186744|101420335|FG001|COMPLETED|Overall Study||5||
48658292|NCT01272219|101948906|FG003|STARTED|Re-randomised Period: Week 56 to Week 68||304||
48658293|NCT01272219|101948907|FG004|STARTED|Re-randomised Period: Week 56 to Week 68||0||
48769430|NCT02558296|102225849|FG000|NOT COMPLETED|Completed the Study||146||
48769431|NCT02558296|102225850|FG001|NOT COMPLETED|Completed the Study||85||
48368832|NCT01259492|101230276|FG003|Full Analysis Set|Period 1 (9 Weeks)||172||
48368833|NCT01259492|101230273|FG000|COMPLETED|Period 1 (9 Weeks)||152||
48368834|NCT01259492|101230274|FG001|COMPLETED|Period 1 (9 Weeks)||141||
48368835|NCT01259492|101230275|FG002|COMPLETED|Period 1 (9 Weeks)||138||
48368836|NCT01259492|101230276|FG003|COMPLETED|Period 1 (9 Weeks)||153||
48443458|NCT01186744|101420336|FG002|COMPLETED|Overall Study||25||
48443459|NCT01186744|101420337|FG003|COMPLETED|Overall Study||70||
48188894|NCT00724061|100786106|FG000|STARTED|Dose Escalation Phase||7||
48443460|NCT01186744|101420338|FG004|COMPLETED|Overall Study||39||
48188895|NCT00724061|100786106|FG000|COMPLETED|Dose Escalation Phase||2||
48188896|NCT00724061|100786106|FG000|NOT COMPLETED|Dose Escalation Phase||5||
48188897|NCT00724061|100786106|FG000|STARTED|Maintenance Therapy||2||
48188898|NCT00724061|100786106|FG000|COMPLETED|Maintenance Therapy||2||
48443461|NCT01186744|101420339|FG005|COMPLETED|Overall Study||107||
48443462|NCT01186744|101420334|FG000|NOT COMPLETED|Overall Study||208||
48443463|NCT01186744|101420335|FG001|NOT COMPLETED|Overall Study||152||
48443464|NCT01186744|101420336|FG002|NOT COMPLETED|Overall Study||6||
48443465|NCT01186744|101420337|FG003|NOT COMPLETED|Overall Study||12||
48443466|NCT01186744|101420338|FG004|NOT COMPLETED|Overall Study||6||
48443467|NCT01186744|101420339|FG005|NOT COMPLETED|Overall Study||26||
48443468|NCT01126359|101420340|FG000|STARTED|First Intervention (20-minutes)||5||
48443469|NCT01126359|101420341|FG001|STARTED|First Intervention (20-minutes)||6||
48443470|NCT01126359|101420340|FG000|COMPLETED|First Intervention (20-minutes)||5||
48443471|NCT01126359|101420341|FG001|COMPLETED|First Intervention (20-minutes)||5||
48443472|NCT01126359|101420340|FG000|NOT COMPLETED|First Intervention (20-minutes)||0||
48443473|NCT01126359|101420341|FG001|NOT COMPLETED|First Intervention (20-minutes)||1||
48443474|NCT01126359|101420340|FG000|STARTED|Dressing Replacement/Healing (48-hours)||5||
48443475|NCT01126359|101420341|FG001|STARTED|Dressing Replacement/Healing (48-hours)||5||
48443476|NCT01126359|101420340|FG000|COMPLETED|Dressing Replacement/Healing (48-hours)||5||
48658294|NCT01272219|101948908|FG005|STARTED|Re-randomised Period: Week 56 to Week 68||0||
48658295|NCT01272219|101948903|FG000|COMPLETED|Re-randomised Period: Week 56 to Week 68||0||
48658296|NCT01272219|101948904|FG001|COMPLETED|Re-randomised Period: Week 56 to Week 68||342||
48658297|NCT01272219|101948905|FG002|COMPLETED|Re-randomised Period: Week 56 to Week 68||343||
48658298|NCT01272219|101948906|FG003|COMPLETED|Re-randomised Period: Week 56 to Week 68||289||
48658299|NCT01272219|101948907|FG004|COMPLETED|Re-randomised Period: Week 56 to Week 68||0||
48658300|NCT01272219|101948908|FG005|COMPLETED|Re-randomised Period: Week 56 to Week 68||0||
48658301|NCT01272219|101948903|FG000|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0||
48658302|NCT01272219|101948904|FG001|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||9||
48658303|NCT01272219|101948905|FG002|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||7||
48658304|NCT01272219|101948906|FG003|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||15||
48658305|NCT01272219|101948907|FG004|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0||
48658306|NCT01272219|101948908|FG005|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0||
48658307|NCT01272219|101948903|FG000|STARTED|Main + Extension Period: Week 0-172||0||
48658308|NCT01272219|101948904|FG001|STARTED|Main + Extension Period: Week 0-172||0||
48658309|NCT01272219|101948905|FG002|STARTED|Main + Extension Period: Week 0-172||0||
48658310|NCT01272219|101948906|FG003|STARTED|Main + Extension Period: Week 0-172||0||
48658311|NCT01272219|101948907|FG004|STARTED|Main + Extension Period: Week 0-172||1505||
48658312|NCT01272219|101948908|FG005|STARTED|Main + Extension Period: Week 0-172||749||
48658313|NCT01272219|101948903|FG000|Exposed|Main + Extension Period: Week 0-172||0||
48658314|NCT01272219|101948904|FG001|Exposed|Main + Extension Period: Week 0-172||0||
48658315|NCT01272219|101948905|FG002|Exposed|Main + Extension Period: Week 0-172||0||
48658316|NCT01272219|101948906|FG003|Exposed|Main + Extension Period: Week 0-172||0||
48658317|NCT01272219|101948907|FG004|Exposed|Main + Extension Period: Week 0-172||1501||
48658318|NCT01272219|101948908|FG005|Exposed|Main + Extension Period: Week 0-172||747||
48658319|NCT01272219|101948903|FG000|COMPLETED|Main + Extension Period: Week 0-172||0||
48658320|NCT01272219|101948904|FG001|COMPLETED|Main + Extension Period: Week 0-172||0||
48658321|NCT01272219|101948905|FG002|COMPLETED|Main + Extension Period: Week 0-172||0||
48658322|NCT01272219|101948906|FG003|COMPLETED|Main + Extension Period: Week 0-172||0||
48658323|NCT01272219|101948907|FG004|COMPLETED|Main + Extension Period: Week 0-172||783||
48658324|NCT01272219|101948908|FG005|COMPLETED|Main + Extension Period: Week 0-172||327||
48658325|NCT01272219|101948903|FG000|NOT COMPLETED|Main + Extension Period: Week 0-172||0||
48658326|NCT01272219|101948904|FG001|NOT COMPLETED|Main + Extension Period: Week 0-172||0||
48658327|NCT01272219|101948905|FG002|NOT COMPLETED|Main + Extension Period: Week 0-172||0||
48658328|NCT01272219|101948906|FG003|NOT COMPLETED|Main + Extension Period: Week 0-172||0||
48188899|NCT00724061|100786106|FG000|NOT COMPLETED|Maintenance Therapy||0||
48443477|NCT01126359|101420341|FG001|COMPLETED|Dressing Replacement/Healing (48-hours)||5||
48443478|NCT01126359|101420340|FG000|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0||
48658329|NCT01272219|101948907|FG004|NOT COMPLETED|Main + Extension Period: Week 0-172||722||
48658330|NCT01272219|101948908|FG005|NOT COMPLETED|Main + Extension Period: Week 0-172||422||
48658331|NCT05430919|101948909|FG000|STARTED|Overall Study||55||
48658332|NCT05430919|101948910|FG001|STARTED|Overall Study||55||
48658333|NCT05430919|101948911|FG002|STARTED|Overall Study||52||
48658334|NCT05430919|101948912|FG003|STARTED|Overall Study||55||
48658335|NCT05430919|101948909|FG000|COMPLETED|Overall Study||52||
48658336|NCT05430919|101948910|FG001|COMPLETED|Overall Study||54||
48658337|NCT05430919|101948911|FG002|COMPLETED|Overall Study||51||
48658338|NCT05430919|101948912|FG003|COMPLETED|Overall Study||54||
48658339|NCT05430919|101948909|FG000|NOT COMPLETED|Overall Study||3||
48658340|NCT05430919|101948910|FG001|NOT COMPLETED|Overall Study||1||
48658341|NCT05430919|101948911|FG002|NOT COMPLETED|Overall Study||1||
48658342|NCT05430919|101948912|FG003|NOT COMPLETED|Overall Study||1||
48188900|NCT00562965|100786107|FG000|STARTED|Overall Study||15||
48443479|NCT01126359|101420341|FG001|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0||
48443480|NCT01126359|101420340|FG000|STARTED|Second Intervention (20-minutes)||5||
48443481|NCT01126359|101420341|FG001|STARTED|Second Intervention (20-minutes)||5||
48443482|NCT01126359|101420340|FG000|COMPLETED|Second Intervention (20-minutes)||5||
48443483|NCT01126359|101420341|FG001|COMPLETED|Second Intervention (20-minutes)||5||
48443484|NCT01126359|101420340|FG000|NOT COMPLETED|Second Intervention (20-minutes)||0||
48443485|NCT01126359|101420341|FG001|NOT COMPLETED|Second Intervention (20-minutes)||0||
48443486|NCT03594175|101420342|FG000|STARTED|Overall Study||261||
48443487|NCT03594175|101420343|FG001|STARTED|Overall Study||28||
48443488|NCT03594175|101420344|FG002|STARTED|Overall Study||173||
48443489|NCT03594175|101420342|FG000|COMPLETED|Overall Study||245||
48443490|NCT03594175|101420343|FG001|COMPLETED|Overall Study||25||
48443491|NCT03594175|101420344|FG002|COMPLETED|Overall Study||166||
48443492|NCT03594175|101420342|FG000|NOT COMPLETED|Overall Study||16||
48443493|NCT03594175|101420343|FG001|NOT COMPLETED|Overall Study||3||
48443494|NCT03594175|101420344|FG002|NOT COMPLETED|Overall Study||7||
48443495|NCT02787785|101420345|FG000|STARTED|Overall Study||11||
48443496|NCT02787785|101420346|FG001|STARTED|Overall Study||29||
48368837|NCT01259492|101230273|FG000|NOT COMPLETED|Period 1 (9 Weeks)||29||
48368838|NCT01259492|101230274|FG001|NOT COMPLETED|Period 1 (9 Weeks)||41||
48368839|NCT01259492|101230275|FG002|NOT COMPLETED|Period 1 (9 Weeks)||43||
48368840|NCT01259492|101230276|FG003|NOT COMPLETED|Period 1 (9 Weeks)||28||
48368841|NCT01259492|101230273|FG000|STARTED|Period 2 (Week 10 to Week 14)||152||
48368842|NCT01259492|101230274|FG001|STARTED|Period 2 (Week 10 to Week 14)||141||
48368843|NCT01259492|101230275|FG002|STARTED|Period 2 (Week 10 to Week 14)||138||
48368844|NCT01259492|101230276|FG003|STARTED|Period 2 (Week 10 to Week 14)||153||
48443497|NCT02787785|101420345|FG000|COMPLETED|Overall Study||7||
48443498|NCT02787785|101420346|FG001|COMPLETED|Overall Study||19||
48443499|NCT02787785|101420345|FG000|NOT COMPLETED|Overall Study||4||
48443500|NCT02787785|101420346|FG001|NOT COMPLETED|Overall Study||10||
48443501|NCT04101721|101420347|FG000|STARTED|Overall Study||27|Randomized and Treated|50
48443502|NCT04101721|101420348|FG001|STARTED|Overall Study||93|Randomized and Treated|179
48443503|NCT04101721|101420347|FG000|COMPLETED|Overall Study||26||48
48443504|NCT04101721|101420348|FG001|COMPLETED|Overall Study||87||168
48443505|NCT04101721|101420347|FG000|NOT COMPLETED|Overall Study||1||2
48443506|NCT04101721|101420348|FG001|NOT COMPLETED|Overall Study||6||11
48658343|NCT01275677|101948913|FG000|STARTED|Overall Study||1630||
48658344|NCT01275677|101948914|FG001|STARTED|Overall Study||1640||
48658345|NCT01275677|101948913|FG000|COMPLETED|Overall Study||1602||
48658346|NCT01275677|101948914|FG001|COMPLETED|Overall Study||1598||
48658347|NCT01275677|101948913|FG000|NOT COMPLETED|Overall Study||28||
48658348|NCT01275677|101948914|FG001|NOT COMPLETED|Overall Study||42||
48658349|NCT01908699|101948915|FG000|STARTED|Overall Study||137|Started = Randomized|
48658350|NCT01908699|101948916|FG001|STARTED|Overall Study||136|Started = Randomized|
48658351|NCT01908699|101948915|FG000|Received at Least 1 Dose of Study Drug|Overall Study||136||
48658352|NCT01908699|101948916|FG001|Received at Least 1 Dose of Study Drug|Overall Study||135||
48658353|NCT01908699|101948915|FG000|COMPLETED|Overall Study||62||
48443507|NCT02795780|101420349|FG000|STARTED|Overall Study||25||
48443508|NCT02795780|101420350|FG001|STARTED|Overall Study||54||
48658354|NCT01908699|101948916|FG001|COMPLETED|Overall Study||58||
48443509|NCT02795780|101420349|FG000|COMPLETED|Overall Study||25||
48443510|NCT02795780|101420350|FG001|COMPLETED|Overall Study||54||
48443511|NCT02795780|101420349|FG000|NOT COMPLETED|Overall Study||0||
48443512|NCT02795780|101420350|FG001|NOT COMPLETED|Overall Study||0||
48443513|NCT00996918|101420351|FG000|STARTED|Overall Study||39||
48443514|NCT00996918|101420352|FG001|STARTED|Overall Study||66||
48658355|NCT01908699|101948915|FG000|NOT COMPLETED|Overall Study||75||
48658356|NCT01908699|101948916|FG001|NOT COMPLETED|Overall Study||78||
48658357|NCT04590963|101948917|FG000|STARTED|Overall Study||247||
48368845|NCT01259492|101230273|FG000|COMPLETED|Period 2 (Week 10 to Week 14)||127||
48368846|NCT01259492|101230274|FG001|COMPLETED|Period 2 (Week 10 to Week 14)||123||
48368847|NCT01259492|101230275|FG002|COMPLETED|Period 2 (Week 10 to Week 14)||114||
48368848|NCT01259492|101230276|FG003|COMPLETED|Period 2 (Week 10 to Week 14)||125||
48368849|NCT01259492|101230273|FG000|NOT COMPLETED|Period 2 (Week 10 to Week 14)||25||
48368850|NCT01259492|101230274|FG001|NOT COMPLETED|Period 2 (Week 10 to Week 14)||18||
48368851|NCT01259492|101230275|FG002|NOT COMPLETED|Period 2 (Week 10 to Week 14)||24||
48368852|NCT01259492|101230276|FG003|NOT COMPLETED|Period 2 (Week 10 to Week 14)||28||
48368853|NCT01259492|101230273|FG000|STARTED|Period 3 (Week 15 to End of Week 40)||114||
48443515|NCT00996918|101420353|FG002|STARTED|Overall Study||37||
48443516|NCT00996918|101420354|FG003|STARTED|Overall Study||56||
48658358|NCT04590963|101948918|FG001|STARTED|Overall Study||123||
48658359|NCT04590963|101948917|FG000|Treated|Overall Study||246||
48443517|NCT00996918|101420355|FG004|STARTED|Overall Study||4||
48443518|NCT00996918|101420351|FG000|Treated|Overall Study||39||
48443519|NCT00996918|101420352|FG001|Treated|Overall Study||66||
48443520|NCT00996918|101420353|FG002|Treated|Overall Study||37||
48443521|NCT00996918|101420354|FG003|Treated|Overall Study||56||
48443522|NCT00996918|101420355|FG004|Treated|Overall Study||4||
48443523|NCT00996918|101420351|FG000|COMPLETED|Overall Study||0||
48443524|NCT00996918|101420352|FG001|COMPLETED|Overall Study||0||
48443525|NCT00996918|101420353|FG002|COMPLETED|Overall Study||0||
48443526|NCT00996918|101420354|FG003|COMPLETED|Overall Study||0||
48443527|NCT00996918|101420355|FG004|COMPLETED|Overall Study||0||
48443528|NCT00996918|101420351|FG000|NOT COMPLETED|Overall Study||39||
48443529|NCT00996918|101420352|FG001|NOT COMPLETED|Overall Study||66||
48443530|NCT00996918|101420353|FG002|NOT COMPLETED|Overall Study||37||
48443531|NCT00996918|101420354|FG003|NOT COMPLETED|Overall Study||56||
48443532|NCT00996918|101420355|FG004|NOT COMPLETED|Overall Study||4||
48443533|NCT04816877|101420356|FG000|STARTED|Overall Study||3||
48443534|NCT04816877|101420357|FG001|STARTED|Overall Study||4||
48443535|NCT04816877|101420356|FG000|COMPLETED|Overall Study||2||
48443536|NCT04816877|101420357|FG001|COMPLETED|Overall Study||4||
48443537|NCT04816877|101420356|FG000|NOT COMPLETED|Overall Study||1||
48443538|NCT04816877|101420357|FG001|NOT COMPLETED|Overall Study||0||
48443539|NCT03126682|101420358|FG000|STARTED|Overall Study||5||
48443540|NCT03126682|101420359|FG001|STARTED|Overall Study||5||
48443541|NCT03126682|101420358|FG000|COMPLETED|Overall Study||5||
48443542|NCT03126682|101420359|FG001|COMPLETED|Overall Study||5||
48443543|NCT03126682|101420358|FG000|NOT COMPLETED|Overall Study||0||
48443544|NCT03126682|101420359|FG001|NOT COMPLETED|Overall Study||0||
48443545|NCT02953418|101420360|FG000|STARTED|Overall Study||34||
48443546|NCT02953418|101420360|FG000|COMPLETED|Overall Study||34||
48443547|NCT02953418|101420360|FG000|NOT COMPLETED|Overall Study||0||
48443548|NCT03506646|101420361|FG000|STARTED|First Intervention (Day 1)||6||
48443549|NCT03506646|101420362|FG001|STARTED|First Intervention (Day 1)||5||
48443550|NCT03506646|101420361|FG000|COMPLETED|First Intervention (Day 1)||6||
48443551|NCT03506646|101420362|FG001|COMPLETED|First Intervention (Day 1)||5||
48658360|NCT04590963|101948918|FG001|Treated|Overall Study||122||
48658361|NCT04590963|101948917|FG000|COMPLETED|Overall Study||0||
48658362|NCT04590963|101948918|FG001|COMPLETED|Overall Study||0||
48658363|NCT04590963|101948917|FG000|NOT COMPLETED|Overall Study||247||
48658364|NCT04590963|101948918|FG001|NOT COMPLETED|Overall Study||123||
48658365|NCT02940223|101948919|FG000|STARTED|Overall Study||2||
48658366|NCT02940223|101948920|FG001|STARTED|Overall Study||0||
48658367|NCT02940223|101948919|FG000|COMPLETED|Overall Study||0||
48658368|NCT02940223|101948920|FG001|COMPLETED|Overall Study||0||
48658369|NCT02940223|101948919|FG000|NOT COMPLETED|Overall Study||2||
48658370|NCT02940223|101948920|FG001|NOT COMPLETED|Overall Study||0||
48658371|NCT04725188|101948921|FG000|STARTED|Overall Study||87||
48658372|NCT04725188|101948922|FG001|STARTED|Overall Study||83||
48368854|NCT01259492|101230274|FG001|STARTED|Period 3 (Week 15 to End of Week 40)||132||
48368855|NCT01259492|101230275|FG002|STARTED|Period 3 (Week 15 to End of Week 40)||120||
48368856|NCT01259492|101230276|FG003|STARTED|Period 3 (Week 15 to End of Week 40)||123||
48368857|NCT01259492|101230273|FG000|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||110||
48368858|NCT01259492|101230274|FG001|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||128||
48368859|NCT01259492|101230275|FG002|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||114||
48368860|NCT01259492|101230276|FG003|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||115||
48368861|NCT01259492|101230273|FG000|COMPLETED|Period 3 (Week 15 to End of Week 40)||60||
48368862|NCT01259492|101230274|FG001|COMPLETED|Period 3 (Week 15 to End of Week 40)||63||
48368863|NCT01259492|101230275|FG002|COMPLETED|Period 3 (Week 15 to End of Week 40)||70||
48368864|NCT01259492|101230276|FG003|COMPLETED|Period 3 (Week 15 to End of Week 40)||42||
48368865|NCT01259492|101230273|FG000|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||54||
48368866|NCT01259492|101230274|FG001|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||69||
48368867|NCT01259492|101230275|FG002|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||50||
48368868|NCT01259492|101230276|FG003|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||81||
48368869|NCT02028338|101230277|FG000|STARTED|Overall Study||73||
48368870|NCT02028338|101230278|FG001|STARTED|Overall Study||23||
48368871|NCT02028338|101230277|FG000|COMPLETED|Overall Study||69||
48368872|NCT02028338|101230278|FG001|COMPLETED|Overall Study||22||
48368873|NCT02028338|101230277|FG000|NOT COMPLETED|Overall Study||4||
48368874|NCT02028338|101230278|FG001|NOT COMPLETED|Overall Study||1||
48368875|NCT03117049|101230279|FG000|STARTED|Overall Study||275|Randomized|
48368876|NCT03117049|101230280|FG001|STARTED|Overall Study||275|Randomized|
48443552|NCT03506646|101420361|FG000|NOT COMPLETED|First Intervention (Day 1)||0||
48443553|NCT03506646|101420362|FG001|NOT COMPLETED|First Intervention (Day 1)||0||
48443554|NCT03506646|101420361|FG000|STARTED|Washout (14 Days)||6||
48443555|NCT03506646|101420362|FG001|STARTED|Washout (14 Days)||5||
48443556|NCT03506646|101420361|FG000|COMPLETED|Washout (14 Days)||6||
48443557|NCT03506646|101420362|FG001|COMPLETED|Washout (14 Days)||5||
48443558|NCT03506646|101420361|FG000|NOT COMPLETED|Washout (14 Days)||0||
48658373|NCT04725188|101948923|FG002|STARTED|Overall Study||85||
48658374|NCT04725188|101948921|FG000|COMPLETED|Overall Study||0||
48658375|NCT04725188|101948922|FG001|COMPLETED|Overall Study||0||
48443559|NCT03506646|101420362|FG001|NOT COMPLETED|Washout (14 Days)||0||
48443560|NCT03506646|101420361|FG000|STARTED|Second Intervention (1 Day)||6||
48443561|NCT03506646|101420362|FG001|STARTED|Second Intervention (1 Day)||5||
48443562|NCT03506646|101420361|FG000|COMPLETED|Second Intervention (1 Day)||6||
48443563|NCT03506646|101420362|FG001|COMPLETED|Second Intervention (1 Day)||5||
48443564|NCT03506646|101420361|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48443565|NCT03506646|101420362|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48443566|NCT03330847|101420363|FG000|STARTED|Overall Study||114||
48443567|NCT03330847|101420364|FG001|STARTED|Overall Study||112||
48443568|NCT03330847|101420365|FG002|STARTED|Overall Study||47||
48443569|NCT03330847|101420363|FG000|COMPLETED|Overall Study||52||
48443570|NCT03330847|101420364|FG001|COMPLETED|Overall Study||47||
48443571|NCT03330847|101420365|FG002|COMPLETED|Overall Study||32||
48443572|NCT03330847|101420363|FG000|NOT COMPLETED|Overall Study||62||
48443573|NCT03330847|101420364|FG001|NOT COMPLETED|Overall Study||65||
48443574|NCT03330847|101420365|FG002|NOT COMPLETED|Overall Study||15||
48443575|NCT03927989|101420366|FG000|STARTED|Overall Study||21||
48443576|NCT03927989|101420367|FG001|STARTED|Overall Study||20||
48443577|NCT03927989|101420366|FG000|COMPLETED|Overall Study||21||
48443578|NCT03927989|101420367|FG001|COMPLETED|Overall Study||19||
48443579|NCT03927989|101420366|FG000|NOT COMPLETED|Overall Study||0||
48443580|NCT03927989|101420367|FG001|NOT COMPLETED|Overall Study||1||
48443581|NCT03457727|101420368|FG000|STARTED|Part 1, Period 1 (1 Day)||8||
48443582|NCT03457727|101420369|FG001|STARTED|Part 1, Period 1 (1 Day)||8||
48443583|NCT03457727|101420370|FG002|STARTED|Part 1, Period 1 (1 Day)||0||
48443584|NCT03457727|101420371|FG003|STARTED|Part 1, Period 1 (1 Day)||0||
48443585|NCT03457727|101420368|FG000|COMPLETED|Part 1, Period 1 (1 Day)||8||
48443586|NCT03457727|101420369|FG001|COMPLETED|Part 1, Period 1 (1 Day)||8||
48443587|NCT03457727|101420370|FG002|COMPLETED|Part 1, Period 1 (1 Day)||0||
48443588|NCT03457727|101420371|FG003|COMPLETED|Part 1, Period 1 (1 Day)||0||
48443589|NCT03457727|101420368|FG000|NOT COMPLETED|Part 1, Period 1 (1 Day)||0||
48443590|NCT03457727|101420369|FG001|NOT COMPLETED|Part 1, Period 1 (1 Day)||0||
48443591|NCT03457727|101420370|FG002|NOT COMPLETED|Part 1, Period 1 (1 Day)||0||
48443592|NCT03457727|101420371|FG003|NOT COMPLETED|Part 1, Period 1 (1 Day)||0||
48443593|NCT03457727|101420368|FG000|STARTED|Part 1, Washout Period 1 (5 Days)||8||
48443594|NCT03457727|101420369|FG001|STARTED|Part 1, Washout Period 1 (5 Days)||8||
48443595|NCT03457727|101420370|FG002|STARTED|Part 1, Washout Period 1 (5 Days)||0||
48188901|NCT00562965|100786108|FG001|STARTED|Overall Study||14||
48188902|NCT00562965|100786107|FG000|Treated|Overall Study||15||
48188903|NCT00562965|100786108|FG001|Treated|Overall Study||13||
48188904|NCT00562965|100786107|FG000|COMPLETED|Overall Study||12||
48188905|NCT00562965|100786108|FG001|COMPLETED|Overall Study||8||
48443596|NCT03457727|101420371|FG003|STARTED|Part 1, Washout Period 1 (5 Days)||0||
48443597|NCT03457727|101420368|FG000|COMPLETED|Part 1, Washout Period 1 (5 Days)||8||
48443598|NCT03457727|101420369|FG001|COMPLETED|Part 1, Washout Period 1 (5 Days)||8||
48443599|NCT03457727|101420370|FG002|COMPLETED|Part 1, Washout Period 1 (5 Days)||0||
48443600|NCT03457727|101420371|FG003|COMPLETED|Part 1, Washout Period 1 (5 Days)||0||
48443601|NCT03457727|101420368|FG000|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0||
48443602|NCT03457727|101420369|FG001|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0||
48443603|NCT03457727|101420370|FG002|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0||
48443604|NCT03457727|101420371|FG003|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0||
48443605|NCT03457727|101420368|FG000|STARTED|Part 1, Period 2 (1 Day)||8||
48443606|NCT03457727|101420369|FG001|STARTED|Part 1, Period 2 (1 Day)||8||
48443607|NCT03457727|101420370|FG002|STARTED|Part 1, Period 2 (1 Day)||0||
48443608|NCT03457727|101420371|FG003|STARTED|Part 1, Period 2 (1 Day)||0||
48443609|NCT03457727|101420368|FG000|COMPLETED|Part 1, Period 2 (1 Day)||8||
48443610|NCT03457727|101420369|FG001|COMPLETED|Part 1, Period 2 (1 Day)||8||
48443611|NCT03457727|101420370|FG002|COMPLETED|Part 1, Period 2 (1 Day)||0||
48443612|NCT03457727|101420371|FG003|COMPLETED|Part 1, Period 2 (1 Day)||0||
48443613|NCT03457727|101420368|FG000|NOT COMPLETED|Part 1, Period 2 (1 Day)||0||
48443614|NCT03457727|101420369|FG001|NOT COMPLETED|Part 1, Period 2 (1 Day)||0||
48443615|NCT03457727|101420370|FG002|NOT COMPLETED|Part 1, Period 2 (1 Day)||0||
48443616|NCT03457727|101420371|FG003|NOT COMPLETED|Part 1, Period 2 (1 Day)||0||
48443617|NCT03457727|101420368|FG000|STARTED|Part 1, Washout Period 2 (5 Days)||8||
48443618|NCT03457727|101420369|FG001|STARTED|Part 1, Washout Period 2 (5 Days)||8||
48443619|NCT03457727|101420370|FG002|STARTED|Part 1, Washout Period 2 (5 Days)||0||
48443620|NCT03457727|101420371|FG003|STARTED|Part 1, Washout Period 2 (5 Days)||0||
48443621|NCT03457727|101420368|FG000|COMPLETED|Part 1, Washout Period 2 (5 Days)||8||
48443622|NCT03457727|101420369|FG001|COMPLETED|Part 1, Washout Period 2 (5 Days)||8||
48443623|NCT03457727|101420370|FG002|COMPLETED|Part 1, Washout Period 2 (5 Days)||0||
48443624|NCT03457727|101420371|FG003|COMPLETED|Part 1, Washout Period 2 (5 Days)||0||
48443625|NCT03457727|101420368|FG000|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0||
48443626|NCT03457727|101420369|FG001|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0||
48443627|NCT03457727|101420370|FG002|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0||
48443628|NCT03457727|101420371|FG003|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0||
48188906|NCT00562965|100786107|FG000|NOT COMPLETED|Overall Study||3||
48188907|NCT00562965|100786108|FG001|NOT COMPLETED|Overall Study||6||
48769432|NCT01244893|102225851|FG000|STARTED|Baseline||22||
48188908|NCT02323880|100786109|FG000|STARTED|Overall Study||6||
48443629|NCT03457727|101420368|FG000|STARTED|Part 1, Period 3 (1 Day)||8||
48443630|NCT03457727|101420369|FG001|STARTED|Part 1, Period 3 (1 Day)||8||
48443631|NCT03457727|101420370|FG002|STARTED|Part 1, Period 3 (1 Day)||0||
48443632|NCT03457727|101420371|FG003|STARTED|Part 1, Period 3 (1 Day)||0||
48443633|NCT03457727|101420368|FG000|COMPLETED|Part 1, Period 3 (1 Day)||8||
48443634|NCT03457727|101420369|FG001|COMPLETED|Part 1, Period 3 (1 Day)||8||
48769433|NCT01244893|102225852|FG001|STARTED|Baseline||22||
48769434|NCT01244893|102225851|FG000|COMPLETED|Baseline||22||
48769435|NCT01244893|102225852|FG001|COMPLETED|Baseline||21||
48769436|NCT01244893|102225851|FG000|NOT COMPLETED|Baseline||0||
48769437|NCT01244893|102225852|FG001|NOT COMPLETED|Baseline||1||
48769438|NCT01244893|102225851|FG000|STARTED|1-Week Follow Up||22||
48769439|NCT01244893|102225852|FG001|STARTED|1-Week Follow Up||21||
48769440|NCT01244893|102225851|FG000|COMPLETED|1-Week Follow Up||21||
48769441|NCT01244893|102225852|FG001|COMPLETED|1-Week Follow Up||21||
48769442|NCT01244893|102225851|FG000|NOT COMPLETED|1-Week Follow Up||1||
48769443|NCT01244893|102225852|FG001|NOT COMPLETED|1-Week Follow Up||0||
48769444|NCT01244893|102225851|FG000|STARTED|Final Visit||21||
48769445|NCT01244893|102225852|FG001|STARTED|Final Visit||21||
48769446|NCT01244893|102225851|FG000|COMPLETED|Final Visit||21||
48769447|NCT01244893|102225852|FG001|COMPLETED|Final Visit||21||
48769448|NCT01244893|102225851|FG000|NOT COMPLETED|Final Visit||0||
48769449|NCT01244893|102225852|FG001|NOT COMPLETED|Final Visit||0||
48769450|NCT00735436|102225853|FG000|STARTED|Overall Study||18||
48769451|NCT00735436|102225853|FG000|COMPLETED|Overall Study||18||
48769452|NCT00735436|102225853|FG000|NOT COMPLETED|Overall Study||0||
48769453|NCT03531112|102225854|FG000|STARTED|Overall Study||20||
48769454|NCT03531112|102225855|FG001|STARTED|Overall Study||0||
48769455|NCT03531112|102225854|FG000|Month 4|Overall Study||17||
48769456|NCT03531112|102225855|FG001|Month 4|Overall Study||0||
48769457|NCT03531112|102225854|FG000|Month 6 (Follow-Up)|Overall Study||13||
48769458|NCT03531112|102225855|FG001|Month 6 (Follow-Up)|Overall Study||0||
48769459|NCT03531112|102225854|FG000|COMPLETED|Overall Study||13||
48769460|NCT03531112|102225855|FG001|COMPLETED|Overall Study||0||
48769461|NCT03531112|102225854|FG000|NOT COMPLETED|Overall Study||7||
48769462|NCT03531112|102225855|FG001|NOT COMPLETED|Overall Study||0||
48769463|NCT03769519|102225856|FG000|STARTED|Overall Study||14||
48769464|NCT03769519|102225857|FG001|STARTED|Overall Study||15||
48769465|NCT03769519|102225856|FG000|COMPLETED|Overall Study||14||
48769466|NCT03769519|102225857|FG001|COMPLETED|Overall Study||14||
48769467|NCT03769519|102225856|FG000|NOT COMPLETED|Overall Study||0||
48769468|NCT03769519|102225857|FG001|NOT COMPLETED|Overall Study||1||
48769469|NCT04308291|102225858|FG000|STARTED|Run-In Phase||290||
48769470|NCT04308291|102225858|FG000|COMPLETED|Run-In Phase||286||
48769471|NCT04308291|102225858|FG000|NOT COMPLETED|Run-In Phase||4||
48769472|NCT04308291|102225858|FG000|STARTED|Study Phase 6-M||286||
48769473|NCT04308291|102225858|FG000|COMPLETED|Study Phase 6-M||270||
48769474|NCT04308291|102225858|FG000|NOT COMPLETED|Study Phase 6-M||16||
48769475|NCT04308291|102225858|FG000|STARTED|Study Phase 12-M||270||
48769476|NCT04308291|102225858|FG000|COMPLETED|Study Phase 12-M||256||
48769477|NCT04308291|102225858|FG000|NOT COMPLETED|Study Phase 12-M||14||
48769478|NCT02437344|102225859|FG000|STARTED|Overall Study||16||
48769479|NCT02437344|102225859|FG000|COMPLETED|Overall Study||15||
48769480|NCT02437344|102225859|FG000|NOT COMPLETED|Overall Study||1||
48769481|NCT01001325|102225860|FG000|STARTED|Overall Study||234||
48769482|NCT01001325|102225861|FG001|STARTED|Overall Study||234||
48769483|NCT01001325|102225860|FG000|COMPLETED|Overall Study||216||
48769484|NCT01001325|102225861|FG001|COMPLETED|Overall Study||224||
48769485|NCT01001325|102225860|FG000|NOT COMPLETED|Overall Study||18||
48769486|NCT01001325|102225861|FG001|NOT COMPLETED|Overall Study||10||
48769487|NCT03610269|102225862|FG000|STARTED|Overall Study||143||
48188909|NCT02323880|100786110|FG001|STARTED|Overall Study||13||
48769488|NCT03610269|102225862|FG000|COMPLETED|Overall Study||127||
48769489|NCT03610269|102225862|FG000|NOT COMPLETED|Overall Study||16||
48769490|NCT01369888|102225863|FG000|STARTED|Overall Study||1||
48769491|NCT01369888|102225864|FG001|STARTED|Overall Study||2||
48769492|NCT01369888|102225865|FG002|STARTED|Overall Study||0||
48769493|NCT01369888|102225866|FG003|STARTED|Overall Study||0||
48769494|NCT01369888|102225863|FG000|COMPLETED|Overall Study||1||
48188910|NCT02323880|100786111|FG002|STARTED|Overall Study||6||
48443635|NCT03457727|101420370|FG002|COMPLETED|Part 1, Period 3 (1 Day)||0||
48769495|NCT01369888|102225864|FG001|COMPLETED|Overall Study||2||
48769496|NCT01369888|102225865|FG002|COMPLETED|Overall Study||0||
48769497|NCT01369888|102225866|FG003|COMPLETED|Overall Study||0||
48769498|NCT01369888|102225863|FG000|NOT COMPLETED|Overall Study||0||
48769499|NCT01369888|102225864|FG001|NOT COMPLETED|Overall Study||0||
48769500|NCT01369888|102225865|FG002|NOT COMPLETED|Overall Study||0||
48769501|NCT01369888|102225866|FG003|NOT COMPLETED|Overall Study||0||
48769502|NCT02989597|102225867|FG000|STARTED|Overall Study||5||
48769503|NCT02989597|102225868|FG001|STARTED|Overall Study||5||
48769504|NCT02989597|102225867|FG000|COMPLETED|Overall Study||5||
48769505|NCT02989597|102225868|FG001|COMPLETED|Overall Study||5||
48769506|NCT02989597|102225867|FG000|NOT COMPLETED|Overall Study||0||
48769507|NCT02989597|102225868|FG001|NOT COMPLETED|Overall Study||0||
48769508|NCT02683577|102225869|FG000|STARTED|Overall Study||8||
48769509|NCT02683577|102225870|FG001|STARTED|Overall Study||8||
48769510|NCT02683577|102225871|FG002|STARTED|Overall Study||8||
48769511|NCT02683577|102225869|FG000|COMPLETED|Overall Study||8||
48443636|NCT03457727|101420371|FG003|COMPLETED|Part 1, Period 3 (1 Day)||0||
48443637|NCT03457727|101420368|FG000|NOT COMPLETED|Part 1, Period 3 (1 Day)||0||
48443638|NCT03457727|101420369|FG001|NOT COMPLETED|Part 1, Period 3 (1 Day)||0||
48443639|NCT03457727|101420370|FG002|NOT COMPLETED|Part 1, Period 3 (1 Day)||0||
48443640|NCT03457727|101420371|FG003|NOT COMPLETED|Part 1, Period 3 (1 Day)||0||
48443641|NCT03457727|101420368|FG000|STARTED|Part 1, Washout Period 3 (5 Days)||8||
48443642|NCT03457727|101420369|FG001|STARTED|Part 1, Washout Period 3 (5 Days)||8||
48443643|NCT03457727|101420370|FG002|STARTED|Part 1, Washout Period 3 (5 Days)||0||
48443644|NCT03457727|101420371|FG003|STARTED|Part 1, Washout Period 3 (5 Days)||0||
48443645|NCT03457727|101420368|FG000|COMPLETED|Part 1, Washout Period 3 (5 Days)||8||
48769512|NCT02683577|102225870|FG001|COMPLETED|Overall Study||8||
48769513|NCT02683577|102225871|FG002|COMPLETED|Overall Study||8||
48769514|NCT02683577|102225869|FG000|NOT COMPLETED|Overall Study||0||
48769515|NCT02683577|102225870|FG001|NOT COMPLETED|Overall Study||0||
48443646|NCT03457727|101420369|FG001|COMPLETED|Part 1, Washout Period 3 (5 Days)||8||
48443647|NCT03457727|101420370|FG002|COMPLETED|Part 1, Washout Period 3 (5 Days)||0||
48443648|NCT03457727|101420371|FG003|COMPLETED|Part 1, Washout Period 3 (5 Days)||0||
48443649|NCT03457727|101420368|FG000|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0||
48443650|NCT03457727|101420369|FG001|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0||
48443651|NCT03457727|101420370|FG002|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0||
48443652|NCT03457727|101420371|FG003|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0||
48443653|NCT03457727|101420368|FG000|STARTED|Part 1, Period 4 (1 Day)||8||
48443654|NCT03457727|101420369|FG001|STARTED|Part 1, Period 4 (1 Day)||8||
48443655|NCT03457727|101420370|FG002|STARTED|Part 1, Period 4 (1 Day)||0||
48443656|NCT03457727|101420371|FG003|STARTED|Part 1, Period 4 (1 Day)||0||
48443657|NCT03457727|101420368|FG000|COMPLETED|Part 1, Period 4 (1 Day)||8||
48443658|NCT03457727|101420369|FG001|COMPLETED|Part 1, Period 4 (1 Day)||8||
48443659|NCT03457727|101420370|FG002|COMPLETED|Part 1, Period 4 (1 Day)||0||
48443660|NCT03457727|101420371|FG003|COMPLETED|Part 1, Period 4 (1 Day)||0||
48443661|NCT03457727|101420368|FG000|NOT COMPLETED|Part 1, Period 4 (1 Day)||0||
48443662|NCT03457727|101420369|FG001|NOT COMPLETED|Part 1, Period 4 (1 Day)||0||
48443663|NCT03457727|101420370|FG002|NOT COMPLETED|Part 1, Period 4 (1 Day)||0||
48443664|NCT03457727|101420371|FG003|NOT COMPLETED|Part 1, Period 4 (1 Day)||0||
48443665|NCT03457727|101420368|FG000|STARTED|Part 2, Period 1 (1 Day)||0||
48443666|NCT03457727|101420369|FG001|STARTED|Part 2, Period 1 (1 Day)||0||
48769516|NCT02683577|102225871|FG002|NOT COMPLETED|Overall Study||0||
48769517|NCT04441892|102225872|FG000|STARTED|Overall Study||28||
48769518|NCT04441892|102225873|FG001|STARTED|Overall Study||5||
48769519|NCT04441892|102225872|FG000|COMPLETED|Overall Study||28||
48769520|NCT04441892|102225873|FG001|COMPLETED|Overall Study||5||
48769521|NCT04441892|102225872|FG000|NOT COMPLETED|Overall Study||0||
48769522|NCT04441892|102225873|FG001|NOT COMPLETED|Overall Study||0||
48769523|NCT02266888|102225874|FG000|STARTED|Overall Study||15||
48443667|NCT03457727|101420370|FG002|STARTED|Part 2, Period 1 (1 Day)||12||
48443668|NCT03457727|101420371|FG003|STARTED|Part 2, Period 1 (1 Day)||12||
48443669|NCT03457727|101420368|FG000|COMPLETED|Part 2, Period 1 (1 Day)||0||
48443670|NCT03457727|101420369|FG001|COMPLETED|Part 2, Period 1 (1 Day)||0||
48443671|NCT03457727|101420370|FG002|COMPLETED|Part 2, Period 1 (1 Day)||12||
48443672|NCT03457727|101420371|FG003|COMPLETED|Part 2, Period 1 (1 Day)||12||
48443673|NCT03457727|101420368|FG000|NOT COMPLETED|Part 2, Period 1 (1 Day)||0||
48443674|NCT03457727|101420369|FG001|NOT COMPLETED|Part 2, Period 1 (1 Day)||0||
48443675|NCT03457727|101420370|FG002|NOT COMPLETED|Part 2, Period 1 (1 Day)||0||
48443676|NCT03457727|101420371|FG003|NOT COMPLETED|Part 2, Period 1 (1 Day)||0||
48443677|NCT03457727|101420368|FG000|STARTED|Part 2, Washout Period 1 (5 Days)||0||
48443678|NCT03457727|101420369|FG001|STARTED|Part 2, Washout Period 1 (5 Days)||0||
48443679|NCT03457727|101420370|FG002|STARTED|Part 2, Washout Period 1 (5 Days)||12||
48443680|NCT03457727|101420371|FG003|STARTED|Part 2, Washout Period 1 (5 Days)||12||
48443681|NCT03457727|101420368|FG000|COMPLETED|Part 2, Washout Period 1 (5 Days)||0||
48443682|NCT03457727|101420369|FG001|COMPLETED|Part 2, Washout Period 1 (5 Days)||0||
48443683|NCT03457727|101420370|FG002|COMPLETED|Part 2, Washout Period 1 (5 Days)||12||
48769524|NCT02266888|102225875|FG001|STARTED|Overall Study||12||
48769525|NCT02266888|102225876|FG002|STARTED|Overall Study||11||
48769526|NCT02266888|102225877|FG003|STARTED|Overall Study||7||
48769527|NCT02266888|102225874|FG000|COMPLETED|Overall Study||8||
48769528|NCT02266888|102225875|FG001|COMPLETED|Overall Study||8||
48769529|NCT02266888|102225876|FG002|COMPLETED|Overall Study||0||
48443684|NCT03457727|101420371|FG003|COMPLETED|Part 2, Washout Period 1 (5 Days)||11||
48769530|NCT02266888|102225877|FG003|COMPLETED|Overall Study||0||
48769531|NCT02266888|102225874|FG000|NOT COMPLETED|Overall Study||7||
48769532|NCT02266888|102225875|FG001|NOT COMPLETED|Overall Study||4||
48769533|NCT02266888|102225876|FG002|NOT COMPLETED|Overall Study||11||
48443685|NCT03457727|101420368|FG000|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0||
48443686|NCT03457727|101420369|FG001|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0||
48443687|NCT03457727|101420370|FG002|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0||
48443688|NCT03457727|101420371|FG003|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||1||
48443689|NCT03457727|101420368|FG000|STARTED|Part 2, Period 2 (1 Day)||0||
48443690|NCT03457727|101420369|FG001|STARTED|Part 2, Period 2 (1 Day)||0||
48443691|NCT03457727|101420370|FG002|STARTED|Part 2, Period 2 (1 Day)||12||
48443692|NCT03457727|101420371|FG003|STARTED|Part 2, Period 2 (1 Day)||11||
48443693|NCT03457727|101420368|FG000|COMPLETED|Part 2, Period 2 (1 Day)||0||
48443694|NCT03457727|101420369|FG001|COMPLETED|Part 2, Period 2 (1 Day)||0||
48443695|NCT03457727|101420370|FG002|COMPLETED|Part 2, Period 2 (1 Day)||12||
48443696|NCT03457727|101420371|FG003|COMPLETED|Part 2, Period 2 (1 Day)||11||
48443697|NCT03457727|101420368|FG000|NOT COMPLETED|Part 2, Period 2 (1 Day)||0||
48443698|NCT03457727|101420369|FG001|NOT COMPLETED|Part 2, Period 2 (1 Day)||0||
48443699|NCT03457727|101420370|FG002|NOT COMPLETED|Part 2, Period 2 (1 Day)||0||
48443700|NCT03457727|101420371|FG003|NOT COMPLETED|Part 2, Period 2 (1 Day)||0||
48443701|NCT03457727|101420368|FG000|STARTED|Part 2, Washout Period 2 (5 Days)||0||
48769534|NCT02266888|102225877|FG003|NOT COMPLETED|Overall Study||7||
48769535|NCT01193244|102225878|FG000|STARTED|Overall Study||779||
48769536|NCT01193244|102225879|FG001|STARTED|Overall Study||781||
48443702|NCT03457727|101420369|FG001|STARTED|Part 2, Washout Period 2 (5 Days)||0||
48443703|NCT03457727|101420370|FG002|STARTED|Part 2, Washout Period 2 (5 Days)||12||
48443704|NCT03457727|101420371|FG003|STARTED|Part 2, Washout Period 2 (5 Days)||11||
48443705|NCT03457727|101420368|FG000|COMPLETED|Part 2, Washout Period 2 (5 Days)||0||
48443706|NCT03457727|101420369|FG001|COMPLETED|Part 2, Washout Period 2 (5 Days)||0||
48443707|NCT03457727|101420370|FG002|COMPLETED|Part 2, Washout Period 2 (5 Days)||12||
48443708|NCT03457727|101420371|FG003|COMPLETED|Part 2, Washout Period 2 (5 Days)||11||
48443709|NCT03457727|101420368|FG000|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0||
48443710|NCT03457727|101420369|FG001|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0||
48443711|NCT03457727|101420370|FG002|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0||
48443712|NCT03457727|101420371|FG003|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0||
48443713|NCT03457727|101420368|FG000|STARTED|Part 2, Period 3 (1 Day)||0||
48443714|NCT03457727|101420369|FG001|STARTED|Part 2, Period 3 (1 Day)||0||
48443715|NCT03457727|101420370|FG002|STARTED|Part 2, Period 3 (1 Day)||12||
48443716|NCT03457727|101420371|FG003|STARTED|Part 2, Period 3 (1 Day)||11||
48443717|NCT03457727|101420368|FG000|COMPLETED|Part 2, Period 3 (1 Day)||0||
48443718|NCT03457727|101420369|FG001|COMPLETED|Part 2, Period 3 (1 Day)||0||
48443719|NCT03457727|101420370|FG002|COMPLETED|Part 2, Period 3 (1 Day)||12||
48443720|NCT03457727|101420371|FG003|COMPLETED|Part 2, Period 3 (1 Day)||11||
48443721|NCT03457727|101420368|FG000|NOT COMPLETED|Part 2, Period 3 (1 Day)||0||
48443722|NCT03457727|101420369|FG001|NOT COMPLETED|Part 2, Period 3 (1 Day)||0||
48443723|NCT03457727|101420370|FG002|NOT COMPLETED|Part 2, Period 3 (1 Day)||0||
48443724|NCT03457727|101420371|FG003|NOT COMPLETED|Part 2, Period 3 (1 Day)||0||
48443725|NCT03457727|101420368|FG000|STARTED|Part 2, Washout Period 3 (5 Days)||0||
48443726|NCT03457727|101420369|FG001|STARTED|Part 2, Washout Period 3 (5 Days)||0||
48443727|NCT03457727|101420370|FG002|STARTED|Part 2, Washout Period 3 (5 Days)||12||
48443728|NCT03457727|101420371|FG003|STARTED|Part 2, Washout Period 3 (5 Days)||11||
48443729|NCT03457727|101420368|FG000|COMPLETED|Part 2, Washout Period 3 (5 Days)||0||
48443730|NCT03457727|101420369|FG001|COMPLETED|Part 2, Washout Period 3 (5 Days)||0||
48443731|NCT03457727|101420370|FG002|COMPLETED|Part 2, Washout Period 3 (5 Days)||12||
48443732|NCT03457727|101420371|FG003|COMPLETED|Part 2, Washout Period 3 (5 Days)||11||
48443733|NCT03457727|101420368|FG000|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0||
48443734|NCT03457727|101420369|FG001|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0||
48443735|NCT03457727|101420370|FG002|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0||
48443736|NCT03457727|101420371|FG003|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0||
48443737|NCT03457727|101420368|FG000|STARTED|Part 2, Period 4 (1 Day)||0||
48443738|NCT03457727|101420369|FG001|STARTED|Part 2, Period 4 (1 Day)||0||
48769537|NCT01193244|102225878|FG000|Treated|Overall Study||770||
48769538|NCT01193244|102225879|FG001|Treated|Overall Study||784||
48443739|NCT03457727|101420370|FG002|STARTED|Part 2, Period 4 (1 Day)||12||
48443740|NCT03457727|101420371|FG003|STARTED|Part 2, Period 4 (1 Day)||0||
48443741|NCT03457727|101420368|FG000|COMPLETED|Part 2, Period 4 (1 Day)||0||
48443742|NCT03457727|101420369|FG001|COMPLETED|Part 2, Period 4 (1 Day)||0||
48443743|NCT03457727|101420370|FG002|COMPLETED|Part 2, Period 4 (1 Day)||12||
48658376|NCT04725188|101948923|FG002|COMPLETED|Overall Study||0||
48658377|NCT04725188|101948921|FG000|NOT COMPLETED|Overall Study||87||
48658378|NCT04725188|101948922|FG001|NOT COMPLETED|Overall Study||83||
48658379|NCT04725188|101948923|FG002|NOT COMPLETED|Overall Study||85||
48658380|NCT02496156|101948924|FG000|STARTED|Overall Study||67||67
48658381|NCT02496156|101948925|FG001|STARTED|Overall Study||66||66
48658382|NCT02496156|101948924|FG000|COMPLETED|Overall Study||62||62
48658383|NCT02496156|101948925|FG001|COMPLETED|Overall Study||53||53
48658384|NCT02496156|101948924|FG000|NOT COMPLETED|Overall Study||5||5
48658385|NCT02496156|101948925|FG001|NOT COMPLETED|Overall Study||13||13
48658386|NCT03280615|101948926|FG000|STARTED|Overall Study||50||
48443744|NCT03457727|101420371|FG003|COMPLETED|Part 2, Period 4 (1 Day)||0||
48443745|NCT03457727|101420368|FG000|NOT COMPLETED|Part 2, Period 4 (1 Day)||0||
48443746|NCT03457727|101420369|FG001|NOT COMPLETED|Part 2, Period 4 (1 Day)||0||
48443747|NCT03457727|101420370|FG002|NOT COMPLETED|Part 2, Period 4 (1 Day)||0||
48443748|NCT03457727|101420371|FG003|NOT COMPLETED|Part 2, Period 4 (1 Day)||0||
48443749|NCT03526679|101420372|FG000|STARTED|Overall Study||30||
48443750|NCT03526679|101420372|FG000|COMPLETED|Overall Study||28||
48443751|NCT03526679|101420372|FG000|NOT COMPLETED|Overall Study||2||
48443752|NCT03494816|101420373|FG000|STARTED|Overall Study||24||
48443753|NCT03494816|101420373|FG000|COMPLETED|Overall Study||18||
48443754|NCT03494816|101420373|FG000|NOT COMPLETED|Overall Study||6||
48443755|NCT00442338|101420374|FG000|STARTED|Overall Study||30||
48443756|NCT00442338|101420375|FG001|STARTED|Overall Study||30||
48443757|NCT00442338|101420376|FG002|STARTED|Overall Study||31||
48443758|NCT00442338|101420374|FG000|COMPLETED|Overall Study||30||
48443759|NCT00442338|101420375|FG001|COMPLETED|Overall Study||30||
48443760|NCT00442338|101420376|FG002|COMPLETED|Overall Study||31||
48443761|NCT00442338|101420374|FG000|NOT COMPLETED|Overall Study||0||
48443762|NCT00442338|101420375|FG001|NOT COMPLETED|Overall Study||0||
48443763|NCT00442338|101420376|FG002|NOT COMPLETED|Overall Study||0||
48443764|NCT03993288|101420377|FG000|STARTED|Overall Study||133|All randomized participants|
48443765|NCT03993288|101420378|FG001|STARTED|Overall Study||134|All randomized participants|
48443766|NCT03993288|101420377|FG000|Intention-to-treat (ITT) Population|Overall Study||123|All randomized participants who received at least one dose of the investigational product or comparator and had hemoglobin data both before and after treatment|
48443767|NCT03993288|101420378|FG001|Intention-to-treat (ITT) Population|Overall Study||129|All randomized participants who received at least one dose of the investigational product or comparator and had hemoglobin data both before and after treatment|
48443768|NCT03993288|101420377|FG000|Safety Analysis Set|Overall Study||133|All randomized participants who received at least one dose of the test drug/comparator drug|
48443769|NCT03993288|101420378|FG001|Safety Analysis Set|Overall Study||134|All randomized participants who received at least one dose of the test drug/comparator drug|
48443770|NCT03993288|101420377|FG000|COMPLETED|Overall Study||123||
48443771|NCT03993288|101420378|FG001|COMPLETED|Overall Study||129||
48443772|NCT03993288|101420377|FG000|NOT COMPLETED|Overall Study||10||
48443773|NCT03993288|101420378|FG001|NOT COMPLETED|Overall Study||5||
48769539|NCT01193244|102225878|FG000|COMPLETED|Overall Study||391||
48769540|NCT01193244|102225879|FG001|COMPLETED|Overall Study||391||
48769541|NCT01193244|102225878|FG000|NOT COMPLETED|Overall Study||388||
48769542|NCT01193244|102225879|FG001|NOT COMPLETED|Overall Study||390||
48769543|NCT00614432|102225880|FG000|STARTED|Overall Study||4||
48769544|NCT00614432|102225881|FG001|STARTED|Overall Study||6||
48769545|NCT00614432|102225880|FG000|COMPLETED|Overall Study||4||
48769546|NCT00614432|102225881|FG001|COMPLETED|Overall Study||6||
48769547|NCT00614432|102225880|FG000|NOT COMPLETED|Overall Study||0||
48769548|NCT00614432|102225881|FG001|NOT COMPLETED|Overall Study||0||
48769549|NCT03486834|102225882|FG000|STARTED|Overall Study||733||
48769550|NCT03486834|102225883|FG001|STARTED|Overall Study||733||
48769551|NCT03486834|102225884|FG002|STARTED|Overall Study||734||
48769552|NCT03486834|102225882|FG000|Treatment 1|Overall Study||729||
48769553|NCT03486834|102225883|FG001|Treatment 1|Overall Study||729||
48769554|NCT03486834|102225884|FG002|Treatment 1|Overall Study||733||
48769555|NCT03486834|102225882|FG000|Treatment 2|Overall Study||680||
48769556|NCT03486834|102225883|FG001|Treatment 2|Overall Study||680||
48769557|NCT03486834|102225884|FG002|Treatment 2|Overall Study||679||
48769558|NCT03486834|102225882|FG000|Treatment 3|Overall Study||614||
48769559|NCT03486834|102225883|FG001|Treatment 3|Overall Study||631||
48769560|NCT03486834|102225884|FG002|Treatment 3|Overall Study||622||
48769561|NCT03486834|102225882|FG000|COMPLETED|Overall Study||614||
48769562|NCT03486834|102225883|FG001|COMPLETED|Overall Study||631||
48769563|NCT03486834|102225884|FG002|COMPLETED|Overall Study||622||
48769564|NCT03486834|102225882|FG000|NOT COMPLETED|Overall Study||119||
48769565|NCT03486834|102225883|FG001|NOT COMPLETED|Overall Study||102||
48769566|NCT03486834|102225884|FG002|NOT COMPLETED|Overall Study||112||
48769567|NCT03155841|102225885|FG000|STARTED|Overall Study||300||
48769568|NCT03155841|102225886|FG001|STARTED|Overall Study||300||
48769569|NCT03155841|102225885|FG000|COMPLETED|Overall Study||297||
48769570|NCT03155841|102225886|FG001|COMPLETED|Overall Study||296||
48769571|NCT03155841|102225885|FG000|NOT COMPLETED|Overall Study||3||
48769572|NCT03155841|102225886|FG001|NOT COMPLETED|Overall Study||4||
48769573|NCT00521404|102225887|FG000|STARTED|Overall Study||62||
48769574|NCT00521404|102225887|FG000|COMPLETED|Overall Study||0||
48769575|NCT00521404|102225887|FG000|NOT COMPLETED|Overall Study||62||
48769576|NCT00830440|102225888|FG000|STARTED|Overall Study||32||
48769577|NCT00830440|102225889|FG001|STARTED|Overall Study||11||
48769578|NCT00830440|102225888|FG000|Received Device|Overall Study||26||
48769579|NCT00830440|102225889|FG001|Received Device|Overall Study||0||
48769580|NCT00830440|102225888|FG000|Completed 12 Week Follow up|Overall Study||24||
48769581|NCT00830440|102225889|FG001|Completed 12 Week Follow up|Overall Study||11||
48769582|NCT00830440|102225888|FG000|Completed 16 Week Follow up|Overall Study||4||
48769583|NCT00830440|102225889|FG001|Completed 16 Week Follow up|Overall Study||0||
48769584|NCT00830440|102225888|FG000|Completed 24 Week Follow up|Overall Study||3||
48769585|NCT00830440|102225889|FG001|Completed 24 Week Follow up|Overall Study||0||
48188911|NCT02323880|100786112|FG003|STARTED|Overall Study||6||
48443774|NCT03992456|101420379|FG000|STARTED|Overall Study||5||
48443775|NCT03992456|101420380|FG001|STARTED|Overall Study||6||
48443776|NCT03992456|101420379|FG000|COMPLETED|Overall Study||0||
48443777|NCT03992456|101420380|FG001|COMPLETED|Overall Study||0||
48443778|NCT03992456|101420379|FG000|NOT COMPLETED|Overall Study||5||
48443779|NCT03992456|101420380|FG001|NOT COMPLETED|Overall Study||6||
48443780|NCT00929201|101420381|FG000|STARTED|Period 1||30||
48443781|NCT00929201|101420382|FG001|STARTED|Period 1||31||
48443782|NCT00929201|101420381|FG000|COMPLETED|Period 1||30||
48443783|NCT00929201|101420382|FG001|COMPLETED|Period 1||30||
48443784|NCT00929201|101420381|FG000|NOT COMPLETED|Period 1||0||
48443785|NCT00929201|101420382|FG001|NOT COMPLETED|Period 1||1||
48443786|NCT00929201|101420381|FG000|STARTED|7-day Washout||30||
48443787|NCT00929201|101420382|FG001|STARTED|7-day Washout||30||
48443788|NCT00929201|101420381|FG000|COMPLETED|7-day Washout||30||
48443789|NCT00929201|101420382|FG001|COMPLETED|7-day Washout||30||
48443790|NCT00929201|101420381|FG000|NOT COMPLETED|7-day Washout||0||
48443791|NCT00929201|101420382|FG001|NOT COMPLETED|7-day Washout||0||
48443792|NCT00929201|101420381|FG000|STARTED|Period 2||30||
48443793|NCT00929201|101420382|FG001|STARTED|Period 2||30||
48443794|NCT00929201|101420381|FG000|COMPLETED|Period 2||30||
48443795|NCT00929201|101420382|FG001|COMPLETED|Period 2||30||
48443796|NCT00929201|101420381|FG000|NOT COMPLETED|Period 2||0||
48443797|NCT00929201|101420382|FG001|NOT COMPLETED|Period 2||0||
48443798|NCT00398632|101420383|FG000|STARTED|Overall Study||6||
48443799|NCT00398632|101420383|FG000|COMPLETED|Overall Study||4||
48443800|NCT00398632|101420383|FG000|NOT COMPLETED|Overall Study||2||
48443801|NCT00424515|101420384|FG000|STARTED|Overall Study||11||
48443802|NCT00424515|101420385|FG001|STARTED|Overall Study||13||
48769586|NCT00830440|102225888|FG000|COMPLETED|Overall Study||24||
48443803|NCT00424515|101420384|FG000|COMPLETED|Overall Study||0||
48443804|NCT00424515|101420385|FG001|COMPLETED|Overall Study||0||
48443805|NCT00424515|101420384|FG000|NOT COMPLETED|Overall Study||11||
48443806|NCT00424515|101420385|FG001|NOT COMPLETED|Overall Study||13||
48443807|NCT02050373|101420386|FG000|STARTED|Overall Study||34||
48443808|NCT02050373|101420387|FG001|STARTED|Overall Study||34||
48443809|NCT02050373|101420386|FG000|COMPLETED|Overall Study||27||
48443810|NCT02050373|101420387|FG001|COMPLETED|Overall Study||24||
48443811|NCT02050373|101420386|FG000|NOT COMPLETED|Overall Study||7||
48443812|NCT02050373|101420387|FG001|NOT COMPLETED|Overall Study||10||
48443813|NCT02709759|101420388|FG000|STARTED|Overall Study||24||
48443814|NCT02709759|101420389|FG001|STARTED|Overall Study||24||
48443815|NCT02709759|101420390|FG002|STARTED|Overall Study||23||
48443816|NCT02709759|101420391|FG003|STARTED|Overall Study||23||
48443817|NCT02709759|101420392|FG004|STARTED|Overall Study||23||
48443818|NCT02709759|101420393|FG005|STARTED|Overall Study||23||
48443819|NCT02709759|101420394|FG006|STARTED|Overall Study||24||
48443820|NCT02709759|101420395|FG007|STARTED|Overall Study||24||
48443821|NCT02709759|101420388|FG000|COMPLETED|Overall Study||16||
48443822|NCT02709759|101420389|FG001|COMPLETED|Overall Study||16||
48443823|NCT02709759|101420390|FG002|COMPLETED|Overall Study||18||
48443824|NCT02709759|101420391|FG003|COMPLETED|Overall Study||18||
48443825|NCT02709759|101420392|FG004|COMPLETED|Overall Study||14||
48443826|NCT02709759|101420393|FG005|COMPLETED|Overall Study||16||
48443827|NCT02709759|101420394|FG006|COMPLETED|Overall Study||16||
48443828|NCT02709759|101420395|FG007|COMPLETED|Overall Study||16||
48443829|NCT02709759|101420388|FG000|NOT COMPLETED|Overall Study||8||
48443830|NCT02709759|101420389|FG001|NOT COMPLETED|Overall Study||8||
48443831|NCT02709759|101420390|FG002|NOT COMPLETED|Overall Study||5||
48443832|NCT02709759|101420391|FG003|NOT COMPLETED|Overall Study||5||
48443833|NCT02709759|101420392|FG004|NOT COMPLETED|Overall Study||9||
48443834|NCT02709759|101420393|FG005|NOT COMPLETED|Overall Study||7||
48443835|NCT02709759|101420394|FG006|NOT COMPLETED|Overall Study||8||
48443836|NCT02709759|101420395|FG007|NOT COMPLETED|Overall Study||8||
48443837|NCT00514709|101420396|FG000|STARTED|Overall Study||1230||
48443838|NCT00514709|101420397|FG001|STARTED|Overall Study||613||
48443839|NCT00514709|101420396|FG000|COMPLETED|Overall Study||1230||
48443840|NCT00514709|101420397|FG001|COMPLETED|Overall Study||613||
48443841|NCT00514709|101420396|FG000|NOT COMPLETED|Overall Study||0||
48443842|NCT00514709|101420397|FG001|NOT COMPLETED|Overall Study||0||
48443843|NCT01342367|101420398|FG000|STARTED|Overall Study||32||
48443844|NCT01342367|101420399|FG001|STARTED|Overall Study||42||
48443845|NCT01342367|101420398|FG000|COMPLETED|Overall Study||30||
48443846|NCT01342367|101420399|FG001|COMPLETED|Overall Study||40||
48443847|NCT01342367|101420398|FG000|NOT COMPLETED|Overall Study||2||
48443848|NCT01342367|101420399|FG001|NOT COMPLETED|Overall Study||2||
48443849|NCT01150409|101420400|FG000|STARTED|Overall Study||11||
48443850|NCT01150409|101420401|FG001|STARTED|Overall Study||0||
48443851|NCT01150409|101420400|FG000|COMPLETED|Overall Study||11||
48443852|NCT01150409|101420401|FG001|COMPLETED|Overall Study||0||
48443853|NCT01150409|101420400|FG000|NOT COMPLETED|Overall Study||0||
48443854|NCT01150409|101420401|FG001|NOT COMPLETED|Overall Study||0||
48443855|NCT01612780|101420402|FG000|STARTED|Overall Study||82||
48443856|NCT01612780|101420402|FG000|COMPLETED|Overall Study||76||
48443857|NCT01612780|101420402|FG000|NOT COMPLETED|Overall Study||6||
48443858|NCT05005130|101420403|FG000|STARTED|Time Period 1 Baseline (T0)||227|Unique patient participants enrolled into each Time Period.|1
48443859|NCT05005130|101420404|FG001|STARTED|Time Period 1 Baseline (T0)||221|Unique patient participants enrolled into each Time Period.|1
48443860|NCT05005130|101420403|FG000|Healthcare Providers|Time Period 1 Baseline (T0)||20||1
48443861|NCT05005130|101420404|FG001|Healthcare Providers|Time Period 1 Baseline (T0)||0||0
48443862|NCT05005130|101420403|FG000|COMPLETED|Time Period 1 Baseline (T0)||226||1
48443863|NCT05005130|101420404|FG001|COMPLETED|Time Period 1 Baseline (T0)||221||1
48443864|NCT05005130|101420403|FG000|NOT COMPLETED|Time Period 1 Baseline (T0)||1||0
48443865|NCT05005130|101420404|FG001|NOT COMPLETED|Time Period 1 Baseline (T0)||0||0
48443866|NCT05005130|101420403|FG000|STARTED|Time Period 2 Midline Survey (T1)||188|Unique patient participants enrolled into each time period.|1
48443867|NCT05005130|101420404|FG001|STARTED|Time Period 2 Midline Survey (T1)||188|Unique patient participants enrolled into each time period.|1
48443868|NCT05005130|101420403|FG000|COMPLETED|Time Period 2 Midline Survey (T1)||187||1
48443869|NCT05005130|101420404|FG001|COMPLETED|Time Period 2 Midline Survey (T1)||186||1
48443870|NCT05005130|101420403|FG000|NOT COMPLETED|Time Period 2 Midline Survey (T1)||1||0
48443871|NCT05005130|101420404|FG001|NOT COMPLETED|Time Period 2 Midline Survey (T1)||2||0
48443872|NCT05005130|101420403|FG000|STARTED|Time Period 3 Endline Survey (T2)||158|Unique patient participants enrolled into each time period.|1
48443873|NCT05005130|101420404|FG001|STARTED|Time Period 3 Endline Survey (T2)||119|Unique patient participants enrolled into each time period.|1
48443874|NCT05005130|101420403|FG000|Healthcare Providers|Time Period 3 Endline Survey (T2)||0||0
48443875|NCT05005130|101420404|FG001|Healthcare Providers|Time Period 3 Endline Survey (T2)||8||1
48443876|NCT05005130|101420403|FG000|COMPLETED|Time Period 3 Endline Survey (T2)||152||1
48443877|NCT05005130|101420404|FG001|COMPLETED|Time Period 3 Endline Survey (T2)||118||1
48443878|NCT05005130|101420403|FG000|NOT COMPLETED|Time Period 3 Endline Survey (T2)||6||0
48443879|NCT05005130|101420404|FG001|NOT COMPLETED|Time Period 3 Endline Survey (T2)||1||0
48443880|NCT05150340|101420405|FG000|STARTED|Epoch 1||16||
48443881|NCT05150340|101420406|FG001|STARTED|Epoch 1||0||
48443882|NCT05150340|101420405|FG000|Pharmacokinetic Analysis Set 1|Epoch 1||16|Pharmacokinetic Analysis Set 1 included participants for analysis of total serum IgG trough levels for total serum levels of IgG and IgG subclasses.|
48443883|NCT05150340|101420406|FG001|Pharmacokinetic Analysis Set 1|Epoch 1||0|Pharmacokinetic Analysis Set 1 included participants for analysis of total serum IgG trough levels for total serum levels of IgG and IgG subclasses.|
48443884|NCT05150340|101420405|FG000|Pharmacokinetic Analysis Set 2|Epoch 1||0|Pharmacokinetic analysis set 2 included the analysis of PK parameters for total serum levels of IgG, for baseline-corrected total serum levels of IgG, and for IgG subclasses in Epoch 2 participants. (N=16). There were 4 participants aged 12 years or older who consented to blood sampling for analysis of PK parameters, and Pharmacokinetic Analysis Set 2 analysis was performed on a subset consisting of these 4 participants.|
48443885|NCT05150340|101420406|FG001|Pharmacokinetic Analysis Set 2|Epoch 1||0|Pharmacokinetic analysis set 2 included the analysis of PK parameters for total serum levels of IgG, for baseline-corrected total serum levels of IgG, and for IgG subclasses in Epoch 2 participants. (N=16). There were 4 participants aged 12 years or older who consented to blood sampling for analysis of PK parameters, and Pharmacokinetic Analysis Set 2 analysis was performed on a subset consisting of these 4 participants.|
48443886|NCT05150340|101420405|FG000|COMPLETED|Epoch 1||16||
48443887|NCT05150340|101420406|FG001|COMPLETED|Epoch 1||0||
48443888|NCT05150340|101420405|FG000|NOT COMPLETED|Epoch 1||0||
48443889|NCT05150340|101420406|FG001|NOT COMPLETED|Epoch 1||0||
48443890|NCT05150340|101420405|FG000|STARTED|Epoch 2||0||
48443891|NCT05150340|101420406|FG001|STARTED|Epoch 2||16||
48443892|NCT05150340|101420405|FG000|Pharmacokinetic Analysis Set 1|Epoch 2||0|Pharmacokinetic Analysis (PK) Set 1 included participants for analysis of total serum IgG trough levels for total serum levels of IgG and IgG subclasses.|
48443893|NCT05150340|101420406|FG001|Pharmacokinetic Analysis Set 1|Epoch 2||16|Pharmacokinetic Analysis (PK) Set 1 included participants for analysis of total serum IgG trough levels for total serum levels of IgG and IgG subclasses.|
48443894|NCT05150340|101420405|FG000|Pharmacokinetic Analysis Set 2|Epoch 2||0|Pharmacokinetic analysis set 2 included the analysis of PK parameters for total serum levels of IgG, for baseline-corrected total serum levels of IgG, and for IgG subclasses in Epoch 2 participants. (N=16). There were 4 participants aged 12 years or older who consented to blood sampling for analysis of PK parameters, and Pharmacokinetic Analysis Set 2 analysis was performed on a subset consisting of these 4 participants.|
48443895|NCT05150340|101420406|FG001|Pharmacokinetic Analysis Set 2|Epoch 2||4|Pharmacokinetic analysis set 2 included the analysis of PK parameters for total serum levels of IgG, for baseline-corrected total serum levels of IgG, and for IgG subclasses in Epoch 2 participants. (N=16). There were 4 participants aged 12 years or older who consented to blood sampling for analysis of PK parameters, and Pharmacokinetic Analysis Set 2 analysis was performed on a subset consisting of these 4 participants.|
48443896|NCT05150340|101420405|FG000|COMPLETED|Epoch 2||0||
48443897|NCT05150340|101420406|FG001|COMPLETED|Epoch 2||16||
48443898|NCT05150340|101420405|FG000|NOT COMPLETED|Epoch 2||0||
48443899|NCT05150340|101420406|FG001|NOT COMPLETED|Epoch 2||0||
48443900|NCT01556165|101420407|FG000|STARTED|Overall Study||65||
48443901|NCT01556165|101420408|FG001|STARTED|Overall Study||65||
48443902|NCT01556165|101420407|FG000|COMPLETED|Overall Study||53||
48443903|NCT01556165|101420408|FG001|COMPLETED|Overall Study||58||
48443904|NCT01556165|101420407|FG000|NOT COMPLETED|Overall Study||12||
48443905|NCT01556165|101420408|FG001|NOT COMPLETED|Overall Study||7||
48443906|NCT01005407|101420409|FG000|STARTED|Overall Study||1969||
48443907|NCT01005407|101420410|FG001|STARTED|Overall Study||483||
48443908|NCT01005407|101420409|FG000|COMPLETED|Overall Study||1818||
48443909|NCT01005407|101420410|FG001|COMPLETED|Overall Study||451||
48443910|NCT01005407|101420409|FG000|NOT COMPLETED|Overall Study||151||
48443911|NCT01005407|101420410|FG001|NOT COMPLETED|Overall Study||32||
48443912|NCT01102972|101420411|FG000|STARTED|Overall Study||199||
48443913|NCT01102972|101420412|FG001|STARTED|Overall Study||97||
48443914|NCT01102972|101420411|FG000|Completed Week 24|Overall Study||180||
48443915|NCT01102972|101420412|FG001|Completed Week 24|Overall Study||88||
48443916|NCT01102972|101420411|FG000|COMPLETED|Overall Study||170||
48443917|NCT01102972|101420412|FG001|COMPLETED|Overall Study||83||
48443918|NCT01102972|101420411|FG000|NOT COMPLETED|Overall Study||29||
48443919|NCT01102972|101420412|FG001|NOT COMPLETED|Overall Study||14||
48443920|NCT02617446|101420413|FG000|STARTED|Overall Study||39||
48443921|NCT02617446|101420414|FG001|STARTED|Overall Study||41||
48443922|NCT02617446|101420415|FG002|STARTED|Overall Study||40||
48443923|NCT02617446|101420413|FG000|COMPLETED|Overall Study||35||
48443924|NCT02617446|101420414|FG001|COMPLETED|Overall Study||39||
48443925|NCT02617446|101420415|FG002|COMPLETED|Overall Study||33||
48443926|NCT02617446|101420413|FG000|NOT COMPLETED|Overall Study||4||
48443927|NCT02617446|101420414|FG001|NOT COMPLETED|Overall Study||2||
48443928|NCT02617446|101420415|FG002|NOT COMPLETED|Overall Study||7||
48443929|NCT00639158|101420416|FG000|STARTED|Overall Study||272||
48443930|NCT00639158|101420417|FG001|STARTED|Overall Study||270||
48443931|NCT00639158|101420416|FG000|COMPLETED|Overall Study||246||
48443932|NCT00639158|101420417|FG001|COMPLETED|Overall Study||240||
48443933|NCT00639158|101420416|FG000|NOT COMPLETED|Overall Study||26||
48443934|NCT00639158|101420417|FG001|NOT COMPLETED|Overall Study||30||
48443935|NCT04930536|101422243|FG000|STARTED|Overall Study||90||
48443936|NCT04930536|101422244|FG001|STARTED|Overall Study||13||
48443937|NCT04930536|101422243|FG000|COMPLETED|Overall Study||82||
48443938|NCT04930536|101422244|FG001|COMPLETED|Overall Study||8||
48443939|NCT04930536|101422243|FG000|NOT COMPLETED|Overall Study||8||
48443940|NCT04930536|101422244|FG001|NOT COMPLETED|Overall Study||5||
48769587|NCT00830440|102225889|FG001|COMPLETED|Overall Study||11||
48443941|NCT01107834|101422245|FG000|STARTED|Overall Study||30||
48443942|NCT01107834|101422246|FG001|STARTED|Overall Study||30||
48443943|NCT01107834|101422245|FG000|COMPLETED|Overall Study||30||
48443944|NCT01107834|101422246|FG001|COMPLETED|Overall Study||30||
48443945|NCT01107834|101422245|FG000|NOT COMPLETED|Overall Study||0||
48443946|NCT01107834|101422246|FG001|NOT COMPLETED|Overall Study||0||
48443947|NCT02118896|101422247|FG000|STARTED|Overall Study||47||
48443948|NCT02118896|101422248|FG001|STARTED|Overall Study||47||
48443949|NCT02118896|101422249|FG002|STARTED|Overall Study||67||
48443950|NCT02118896|101422250|FG003|STARTED|Overall Study||79||
48443951|NCT02118896|101422251|FG004|STARTED|Overall Study||130||
48443952|NCT02118896|101422252|FG005|STARTED|Overall Study||191||
48443953|NCT02118896|101422253|FG006|STARTED|Overall Study||85||
48443954|NCT02118896|101422254|FG007|STARTED|Overall Study||107||
48443955|NCT02118896|101422255|FG008|STARTED|Overall Study||88||
48443956|NCT02118896|101422256|FG009|STARTED|Overall Study||9||
48769588|NCT00830440|102225888|FG000|NOT COMPLETED|Overall Study||8||
48769589|NCT00830440|102225889|FG001|NOT COMPLETED|Overall Study||0||
48769590|NCT02668653|102225890|FG000|STARTED|Overall Study||268||
48443957|NCT02118896|101422247|FG000|COMPLETED|Overall Study||30||
48443958|NCT02118896|101422248|FG001|COMPLETED|Overall Study||32||
48443959|NCT02118896|101422249|FG002|COMPLETED|Overall Study||53||
48443960|NCT02118896|101422250|FG003|COMPLETED|Overall Study||55||
48443961|NCT02118896|101422251|FG004|COMPLETED|Overall Study||113||
48443962|NCT02118896|101422252|FG005|COMPLETED|Overall Study||163||
48443963|NCT02118896|101422253|FG006|COMPLETED|Overall Study||83||
48443964|NCT02118896|101422254|FG007|COMPLETED|Overall Study||105||
48443965|NCT02118896|101422255|FG008|COMPLETED|Overall Study||84||
48443966|NCT02118896|101422256|FG009|COMPLETED|Overall Study||7||
48443967|NCT02118896|101422247|FG000|NOT COMPLETED|Overall Study||17||
48443968|NCT02118896|101422248|FG001|NOT COMPLETED|Overall Study||15||
48443969|NCT02118896|101422249|FG002|NOT COMPLETED|Overall Study||14||
48443970|NCT02118896|101422250|FG003|NOT COMPLETED|Overall Study||24||
48443971|NCT02118896|101422251|FG004|NOT COMPLETED|Overall Study||17||
48443972|NCT02118896|101422252|FG005|NOT COMPLETED|Overall Study||28||
48443973|NCT02118896|101422253|FG006|NOT COMPLETED|Overall Study||2||
48769591|NCT02668653|102225891|FG001|STARTED|Overall Study||271||
48443974|NCT02118896|101422254|FG007|NOT COMPLETED|Overall Study||2||
48443975|NCT02118896|101422255|FG008|NOT COMPLETED|Overall Study||4||
48443976|NCT02118896|101422256|FG009|NOT COMPLETED|Overall Study||2||
48443977|NCT05604521|101422257|FG000|STARTED|Overall Study||24||
48443978|NCT05604521|101422258|FG001|STARTED|Overall Study||7||
48443979|NCT05604521|101422257|FG000|COMPLETED|Overall Study||0||
48443980|NCT05604521|101422258|FG001|COMPLETED|Overall Study||0||
48443981|NCT05604521|101422257|FG000|NOT COMPLETED|Overall Study||24||
48443982|NCT05604521|101422258|FG001|NOT COMPLETED|Overall Study||7||
48443983|NCT04824560|101422259|FG000|STARTED|Overall Study||17||
48443984|NCT04824560|101422259|FG000|COMPLETED|Overall Study||5||
48443985|NCT04824560|101422259|FG000|NOT COMPLETED|Overall Study||12||
48443986|NCT03612713|101422260|FG000|STARTED|Overall Study||10||
48443987|NCT03612713|101422261|FG001|STARTED|Overall Study||10||
48443988|NCT03612713|101422260|FG000|COMPLETED|Overall Study||7||
48443989|NCT03612713|101422261|FG001|COMPLETED|Overall Study||8||
48443990|NCT03612713|101422260|FG000|NOT COMPLETED|Overall Study||3||
48443991|NCT03612713|101422261|FG001|NOT COMPLETED|Overall Study||2||
48769592|NCT02668653|102225890|FG000|Safety Analysis Set|Overall Study||265||
48769593|NCT02668653|102225891|FG001|Safety Analysis Set|Overall Study||268||
48769594|NCT02668653|102225890|FG000|COMPLETED|Overall Study||56||
48769595|NCT02668653|102225891|FG001|COMPLETED|Overall Study||52||
48769596|NCT02668653|102225890|FG000|NOT COMPLETED|Overall Study||212||
48769597|NCT02668653|102225891|FG001|NOT COMPLETED|Overall Study||219||
48769598|NCT03041181|102225892|FG000|STARTED|Overall Study||1||
48769599|NCT03041181|102225893|FG001|STARTED|Overall Study||2||
48769600|NCT03041181|102225892|FG000|COMPLETED|Overall Study||0||
48769601|NCT03041181|102225893|FG001|COMPLETED|Overall Study||0||
48769602|NCT03041181|102225892|FG000|NOT COMPLETED|Overall Study||1||
48769603|NCT03041181|102225893|FG001|NOT COMPLETED|Overall Study||2||
48769604|NCT03511937|102225894|FG000|STARTED|Overall Study||200||
48769605|NCT03511937|102225895|FG001|STARTED|Overall Study||200||
48769606|NCT03511937|102225894|FG000|COMPLETED|Overall Study||200||
48769607|NCT03511937|102225895|FG001|COMPLETED|Overall Study||200||
48769608|NCT03511937|102225894|FG000|NOT COMPLETED|Overall Study||0||
48769609|NCT03511937|102225895|FG001|NOT COMPLETED|Overall Study||0||
48769610|NCT03312634|102225896|FG000|STARTED|Overall Study||107||
48769611|NCT03312634|102225897|FG001|STARTED|Overall Study||114||
48769612|NCT03312634|102225896|FG000|COMPLETED|Overall Study||49||
48769613|NCT03312634|102225897|FG001|COMPLETED|Overall Study||33||
48769614|NCT03312634|102225896|FG000|NOT COMPLETED|Overall Study||58||
48769615|NCT03312634|102225897|FG001|NOT COMPLETED|Overall Study||81||
48769616|NCT03614156|102225898|FG000|STARTED|Open-Label Treatment Period||363||
48769617|NCT03614156|102225899|FG001|STARTED|Open-Label Treatment Period||0||
48769618|NCT03614156|102225900|FG002|STARTED|Open-Label Treatment Period||0||
48769619|NCT03614156|102225901|FG003|STARTED|Open-Label Treatment Period||0||
48769620|NCT03614156|102225898|FG000|COMPLETED|Open-Label Treatment Period||209||
48188912|NCT02323880|100786113|FG004|STARTED|Overall Study||6||
48188913|NCT02323880|100786114|FG005|STARTED|Overall Study||10||
48443992|NCT00414011|101422262|FG000|STARTED|Overall Study||40||
48443993|NCT00414011|101422262|FG000|COMPLETED|Overall Study||35||
48443994|NCT00414011|101422262|FG000|NOT COMPLETED|Overall Study||5||
48443995|NCT02530320|101422263|FG000|STARTED|Overall Study||34||
48443996|NCT02530320|101422263|FG000|COMPLETED|Overall Study||34||
48443997|NCT02530320|101422263|FG000|NOT COMPLETED|Overall Study||0||
48769621|NCT03614156|102225899|FG001|COMPLETED|Open-Label Treatment Period||0||
48769622|NCT03614156|102225900|FG002|COMPLETED|Open-Label Treatment Period||0||
48769623|NCT03614156|102225901|FG003|COMPLETED|Open-Label Treatment Period||0||
48769624|NCT03614156|102225898|FG000|NOT COMPLETED|Open-Label Treatment Period||154||
48769625|NCT03614156|102225899|FG001|NOT COMPLETED|Open-Label Treatment Period||0||
48769626|NCT03614156|102225900|FG002|NOT COMPLETED|Open-Label Treatment Period||0||
48769627|NCT03614156|102225901|FG003|NOT COMPLETED|Open-Label Treatment Period||0||
48769628|NCT03614156|102225898|FG000|STARTED|Double-Blind Treatment Period (DBTP)||0||
48769629|NCT03614156|102225899|FG001|STARTED|Double-Blind Treatment Period (DBTP)||40||
48769630|NCT03614156|102225900|FG002|STARTED|Double-Blind Treatment Period (DBTP)||42||
48769631|NCT03614156|102225901|FG003|STARTED|Double-Blind Treatment Period (DBTP)||55||
48769632|NCT03614156|102225898|FG000|COMPLETED|Double-Blind Treatment Period (DBTP)||0||
48769633|NCT03614156|102225899|FG001|COMPLETED|Double-Blind Treatment Period (DBTP)||10||
48769634|NCT03614156|102225900|FG002|COMPLETED|Double-Blind Treatment Period (DBTP)||11||
48769635|NCT03614156|102225901|FG003|COMPLETED|Double-Blind Treatment Period (DBTP)||10||
48188914|NCT02323880|100786115|FG006|STARTED|Overall Study||6||
48188915|NCT02323880|100786116|FG007|STARTED|Overall Study||6||
48188916|NCT02323880|100786109|FG000|COMPLETED|Overall Study||0||
48188917|NCT02323880|100786110|FG001|COMPLETED|Overall Study||0||
48188918|NCT02323880|100786111|FG002|COMPLETED|Overall Study||0||
48188919|NCT02323880|100786112|FG003|COMPLETED|Overall Study||0||
48188920|NCT02323880|100786113|FG004|COMPLETED|Overall Study||0||
48188921|NCT02323880|100786114|FG005|COMPLETED|Overall Study||0||
48188922|NCT02323880|100786115|FG006|COMPLETED|Overall Study||0||
48188923|NCT02323880|100786116|FG007|COMPLETED|Overall Study||0||
48188924|NCT02323880|100786109|FG000|NOT COMPLETED|Overall Study||6||
48188925|NCT02323880|100786110|FG001|NOT COMPLETED|Overall Study||13||
48188926|NCT02323880|100786111|FG002|NOT COMPLETED|Overall Study||6||
48188927|NCT02323880|100786112|FG003|NOT COMPLETED|Overall Study||6||
48188928|NCT02323880|100786113|FG004|NOT COMPLETED|Overall Study||6||
48188929|NCT02323880|100786114|FG005|NOT COMPLETED|Overall Study||10||
48443998|NCT04682639|101422264|FG000|STARTED|Double-Blind Treatment Period (24 Weeks)||41||
48443999|NCT04682639|101422265|FG001|STARTED|Double-Blind Treatment Period (24 Weeks)||39||
48769636|NCT03614156|102225898|FG000|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||0||
48769637|NCT03614156|102225899|FG001|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||30||
48769638|NCT03614156|102225900|FG002|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||31||
48769639|NCT03614156|102225901|FG003|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||45||
48444000|NCT04682639|101422266|FG002|STARTED|Double-Blind Treatment Period (24 Weeks)||28||
48444001|NCT04682639|101422267|FG003|STARTED|Double-Blind Treatment Period (24 Weeks)||0||
48444002|NCT04682639|101422268|FG004|STARTED|Double-Blind Treatment Period (24 Weeks)||0||
48444003|NCT04682639|101422264|FG000|COMPLETED|Double-Blind Treatment Period (24 Weeks)||30||
48444004|NCT04682639|101422265|FG001|COMPLETED|Double-Blind Treatment Period (24 Weeks)||31||
48444005|NCT04682639|101422266|FG002|COMPLETED|Double-Blind Treatment Period (24 Weeks)||24||
48444006|NCT04682639|101422267|FG003|COMPLETED|Double-Blind Treatment Period (24 Weeks)||0||
48444007|NCT04682639|101422268|FG004|COMPLETED|Double-Blind Treatment Period (24 Weeks)||0||
48658387|NCT03280615|101948927|FG001|STARTED|Overall Study||50||
48658388|NCT03280615|101948926|FG000|COMPLETED|Overall Study||46||
48658389|NCT03280615|101948927|FG001|COMPLETED|Overall Study||45||
48658390|NCT03280615|101948926|FG000|NOT COMPLETED|Overall Study||4||
48658391|NCT03280615|101948927|FG001|NOT COMPLETED|Overall Study||5||
48658392|NCT03378635|101948928|FG000|STARTED|Overall Study||84|Started is defined as randomized|
48658393|NCT03378635|101948929|FG001|STARTED|Overall Study||43|Started is defined as randomized|
48769640|NCT03614156|102225898|FG000|STARTED|Safety Follow-Up Period||165||
48769641|NCT03614156|102225899|FG001|STARTED|Safety Follow-Up Period||26||
48769642|NCT03614156|102225900|FG002|STARTED|Safety Follow-Up Period||30||
48769643|NCT03614156|102225901|FG003|STARTED|Safety Follow-Up Period||35||
48769644|NCT03614156|102225898|FG000|COMPLETED|Safety Follow-Up Period||162||
48444008|NCT04682639|101422264|FG000|NOT COMPLETED|Double-Blind Treatment Period (24 Weeks)||11||
48444009|NCT04682639|101422265|FG001|NOT COMPLETED|Double-Blind Treatment Period (24 Weeks)||8||
48444010|NCT04682639|101422266|FG002|NOT COMPLETED|Double-Blind Treatment Period (24 Weeks)||4||
48444011|NCT04682639|101422267|FG003|NOT COMPLETED|Double-Blind Treatment Period (24 Weeks)||0||
48444012|NCT04682639|101422268|FG004|NOT COMPLETED|Double-Blind Treatment Period (24 Weeks)||0||
48444013|NCT04682639|101422264|FG000|STARTED|OLE Period (28 Weeks)||30||
48769645|NCT03614156|102225899|FG001|COMPLETED|Safety Follow-Up Period||26||
48769646|NCT03614156|102225900|FG002|COMPLETED|Safety Follow-Up Period||29||
48769647|NCT03614156|102225901|FG003|COMPLETED|Safety Follow-Up Period||34||
48444014|NCT04682639|101422265|FG001|STARTED|OLE Period (28 Weeks)||31||
48444015|NCT04682639|101422266|FG002|STARTED|OLE Period (28 Weeks)||0||
48444016|NCT04682639|101422267|FG003|STARTED|OLE Period (28 Weeks)||12||
48444017|NCT04682639|101422268|FG004|STARTED|OLE Period (28 Weeks)||12||
48444018|NCT04682639|101422264|FG000|COMPLETED|OLE Period (28 Weeks)||21||
48444019|NCT04682639|101422265|FG001|COMPLETED|OLE Period (28 Weeks)||24||
48444020|NCT04682639|101422266|FG002|COMPLETED|OLE Period (28 Weeks)||0||
48444021|NCT04682639|101422267|FG003|COMPLETED|OLE Period (28 Weeks)||11||
48444022|NCT04682639|101422268|FG004|COMPLETED|OLE Period (28 Weeks)||10||
48444023|NCT04682639|101422264|FG000|NOT COMPLETED|OLE Period (28 Weeks)||9||
48444024|NCT04682639|101422265|FG001|NOT COMPLETED|OLE Period (28 Weeks)||7||
48444025|NCT04682639|101422266|FG002|NOT COMPLETED|OLE Period (28 Weeks)||0||
48658394|NCT03378635|101948930|FG002|STARTED|Overall Study||43|Started is defined as randomized|
48658395|NCT03378635|101948928|FG000|Randomized and Exposed to Treatment|Overall Study||82||
48658396|NCT03378635|101948929|FG001|Randomized and Exposed to Treatment|Overall Study||43||
48769648|NCT03614156|102225898|FG000|NOT COMPLETED|Safety Follow-Up Period||3||
48769649|NCT03614156|102225899|FG001|NOT COMPLETED|Safety Follow-Up Period||0||
48769650|NCT03614156|102225900|FG002|NOT COMPLETED|Safety Follow-Up Period||1||
48769651|NCT03614156|102225901|FG003|NOT COMPLETED|Safety Follow-Up Period||1||
48769652|NCT01263197|102225902|FG000|STARTED|First Intervention (Period 1)||8||
48444026|NCT04682639|101422267|FG003|NOT COMPLETED|OLE Period (28 Weeks)||1||
48444027|NCT04682639|101422268|FG004|NOT COMPLETED|OLE Period (28 Weeks)||2||
48444028|NCT00256217|101422269|FG000|STARTED|Overall Study||42||
48444029|NCT00256217|101422269|FG000|COMPLETED|Overall Study||34||
48444030|NCT00256217|101422269|FG000|NOT COMPLETED|Overall Study||8||
48444031|NCT05354206|101422270|FG000|STARTED|Overall Study||20||
48444032|NCT05354206|101422271|FG001|STARTED|Overall Study||0||
48444033|NCT05354206|101422270|FG000|Withdrawals|Overall Study||1||
48444034|NCT05354206|101422271|FG001|Withdrawals|Overall Study||0||
48444035|NCT05354206|101422270|FG000|Exclusions|Overall Study||3||
48444036|NCT05354206|101422271|FG001|Exclusions|Overall Study||0||
48444037|NCT05354206|101422270|FG000|COMPLETED|Overall Study||19||
48658397|NCT03378635|101948930|FG002|Randomized and Exposed to Treatment|Overall Study||43||
48769653|NCT01263197|102225903|FG001|STARTED|First Intervention (Period 1)||8||
48769654|NCT01263197|102225904|FG002|STARTED|First Intervention (Period 1)||8||
48769655|NCT01263197|102225905|FG003|STARTED|First Intervention (Period 1)||8||
48769656|NCT01263197|102225906|FG004|STARTED|First Intervention (Period 1)||8||
48769657|NCT01263197|102225907|FG005|STARTED|First Intervention (Period 1)||8||
48769658|NCT01263197|102225902|FG000|COMPLETED|First Intervention (Period 1)||8||
48769659|NCT01263197|102225903|FG001|COMPLETED|First Intervention (Period 1)||8||
48769660|NCT01263197|102225904|FG002|COMPLETED|First Intervention (Period 1)||8||
48444038|NCT05354206|101422271|FG001|COMPLETED|Overall Study||0||
48444039|NCT05354206|101422270|FG000|NOT COMPLETED|Overall Study||1||
48444040|NCT05354206|101422271|FG001|NOT COMPLETED|Overall Study||0||
48444041|NCT01211613|101422272|FG000|STARTED|Overall Study||37||
48444042|NCT01211613|101422273|FG001|STARTED|Overall Study||35||
48444043|NCT01211613|101422274|FG002|STARTED|Overall Study||35||
48444044|NCT01211613|101422272|FG000|COMPLETED|Overall Study||34||
48769661|NCT01263197|102225905|FG003|COMPLETED|First Intervention (Period 1)||8||
48769662|NCT01263197|102225906|FG004|COMPLETED|First Intervention (Period 1)||8||
48769663|NCT01263197|102225907|FG005|COMPLETED|First Intervention (Period 1)||7||
48769664|NCT01263197|102225902|FG000|NOT COMPLETED|First Intervention (Period 1)||0||
48769665|NCT01263197|102225903|FG001|NOT COMPLETED|First Intervention (Period 1)||0||
48769666|NCT01263197|102225904|FG002|NOT COMPLETED|First Intervention (Period 1)||0||
48769667|NCT01263197|102225905|FG003|NOT COMPLETED|First Intervention (Period 1)||0||
48769668|NCT01263197|102225906|FG004|NOT COMPLETED|First Intervention (Period 1)||0||
48769669|NCT01263197|102225907|FG005|NOT COMPLETED|First Intervention (Period 1)||1||
48769670|NCT01263197|102225902|FG000|STARTED|Washout Period 1||8||
48769671|NCT01263197|102225903|FG001|STARTED|Washout Period 1||8||
48769672|NCT01263197|102225904|FG002|STARTED|Washout Period 1||8||
48769673|NCT01263197|102225905|FG003|STARTED|Washout Period 1||8||
48769674|NCT01263197|102225906|FG004|STARTED|Washout Period 1||8||
48769675|NCT01263197|102225907|FG005|STARTED|Washout Period 1||7||
48444045|NCT01211613|101422273|FG001|COMPLETED|Overall Study||33||
48444046|NCT01211613|101422274|FG002|COMPLETED|Overall Study||33||
48658398|NCT03378635|101948928|FG000|COMPLETED|Overall Study||82||
48658399|NCT03378635|101948929|FG001|COMPLETED|Overall Study||43||
48658400|NCT03378635|101948930|FG002|COMPLETED|Overall Study||43||
48658401|NCT03378635|101948928|FG000|NOT COMPLETED|Overall Study||2||
48658402|NCT03378635|101948929|FG001|NOT COMPLETED|Overall Study||0||
48658403|NCT03378635|101948930|FG002|NOT COMPLETED|Overall Study||0||
48658404|NCT00866775|101948931|FG000|STARTED|Overall Study||65||
48658405|NCT00866775|101948932|FG001|STARTED|Overall Study||128||
48658406|NCT00866775|101948931|FG000|COMPLETED|Overall Study||29||
48658407|NCT00866775|101948932|FG001|COMPLETED|Overall Study||76||
48658408|NCT00866775|101948931|FG000|NOT COMPLETED|Overall Study||36||
48658409|NCT00866775|101948932|FG001|NOT COMPLETED|Overall Study||52||
48658410|NCT04077437|101948933|FG000|STARTED|Overall Study||53||
48658411|NCT04077437|101948934|FG001|STARTED|Overall Study||51||
48658412|NCT04077437|101948933|FG000|COMPLETED|Overall Study||52||
48658413|NCT04077437|101948934|FG001|COMPLETED|Overall Study||42||
48769676|NCT01263197|102225902|FG000|COMPLETED|Washout Period 1||8||
48769677|NCT01263197|102225903|FG001|COMPLETED|Washout Period 1||8||
48769678|NCT01263197|102225904|FG002|COMPLETED|Washout Period 1||8||
48769679|NCT01263197|102225905|FG003|COMPLETED|Washout Period 1||8||
48769680|NCT01263197|102225906|FG004|COMPLETED|Washout Period 1||7||
48769681|NCT01263197|102225907|FG005|COMPLETED|Washout Period 1||7||
48769682|NCT01263197|102225902|FG000|NOT COMPLETED|Washout Period 1||0||
48769683|NCT01263197|102225903|FG001|NOT COMPLETED|Washout Period 1||0||
48769684|NCT01263197|102225904|FG002|NOT COMPLETED|Washout Period 1||0||
48769685|NCT01263197|102225905|FG003|NOT COMPLETED|Washout Period 1||0||
48769686|NCT01263197|102225906|FG004|NOT COMPLETED|Washout Period 1||1||
48769687|NCT01263197|102225907|FG005|NOT COMPLETED|Washout Period 1||0||
48769688|NCT01263197|102225902|FG000|STARTED|Second Intervention (Period 2)||8||
48769689|NCT01263197|102225903|FG001|STARTED|Second Intervention (Period 2)||8||
48769690|NCT01263197|102225904|FG002|STARTED|Second Intervention (Period 2)||8||
48769691|NCT01263197|102225905|FG003|STARTED|Second Intervention (Period 2)||8||
48769692|NCT01263197|102225906|FG004|STARTED|Second Intervention (Period 2)||7||
48769693|NCT01263197|102225907|FG005|STARTED|Second Intervention (Period 2)||7||
48769694|NCT01263197|102225902|FG000|COMPLETED|Second Intervention (Period 2)||8||
48769695|NCT01263197|102225903|FG001|COMPLETED|Second Intervention (Period 2)||8||
48769696|NCT01263197|102225904|FG002|COMPLETED|Second Intervention (Period 2)||8||
48769697|NCT01263197|102225905|FG003|COMPLETED|Second Intervention (Period 2)||8||
48769698|NCT01263197|102225906|FG004|COMPLETED|Second Intervention (Period 2)||7||
48769699|NCT01263197|102225907|FG005|COMPLETED|Second Intervention (Period 2)||7||
48769700|NCT01263197|102225902|FG000|NOT COMPLETED|Second Intervention (Period 2)||0||
48444047|NCT01211613|101422272|FG000|NOT COMPLETED|Overall Study||3||
48444048|NCT01211613|101422273|FG001|NOT COMPLETED|Overall Study||2||
48444049|NCT01211613|101422274|FG002|NOT COMPLETED|Overall Study||2||
48444050|NCT00630994|101422275|FG000|STARTED|Overall Study||4||
48444051|NCT00630994|101422275|FG000|COMPLETED|Overall Study||0||
48444052|NCT00630994|101422275|FG000|NOT COMPLETED|Overall Study||4||
48658414|NCT04077437|101948933|FG000|NOT COMPLETED|Overall Study||1||
48658415|NCT04077437|101948934|FG001|NOT COMPLETED|Overall Study||9||
48658416|NCT01046669|101948935|FG000|STARTED|Overall Study||226||
48444053|NCT02856282|101422276|FG000|STARTED|Overall Study||46||
48444054|NCT02856282|101422276|FG000|COMPLETED|Overall Study||45||
48769701|NCT01263197|102225903|FG001|NOT COMPLETED|Second Intervention (Period 2)||0||
48444055|NCT02856282|101422276|FG000|NOT COMPLETED|Overall Study||1||
48658417|NCT01046669|101948936|FG001|STARTED|Overall Study||224||
48658418|NCT01046669|101948935|FG000|COMPLETED|Overall Study||226||
48658419|NCT01046669|101948936|FG001|COMPLETED|Overall Study||223||
48769702|NCT01263197|102225904|FG002|NOT COMPLETED|Second Intervention (Period 2)||0||
48769703|NCT01263197|102225905|FG003|NOT COMPLETED|Second Intervention (Period 2)||0||
48769704|NCT01263197|102225906|FG004|NOT COMPLETED|Second Intervention (Period 2)||0||
48769705|NCT01263197|102225907|FG005|NOT COMPLETED|Second Intervention (Period 2)||0||
48769706|NCT01263197|102225902|FG000|STARTED|Washout Period 2||8||
48658420|NCT01046669|101948935|FG000|NOT COMPLETED|Overall Study||0||
48658421|NCT01046669|101948936|FG001|NOT COMPLETED|Overall Study||1||
48658422|NCT02268305|101948937|FG000|STARTED|Overall Study||50||
48658423|NCT02268305|101948938|FG001|STARTED|Overall Study||50||
48658424|NCT02268305|101948937|FG000|COMPLETED|Overall Study||46||
48658425|NCT02268305|101948938|FG001|COMPLETED|Overall Study||40||
48658426|NCT02268305|101948937|FG000|NOT COMPLETED|Overall Study||4||
48769707|NCT01263197|102225903|FG001|STARTED|Washout Period 2||8||
48769708|NCT01263197|102225904|FG002|STARTED|Washout Period 2||8||
48769709|NCT01263197|102225905|FG003|STARTED|Washout Period 2||8||
48769710|NCT01263197|102225906|FG004|STARTED|Washout Period 2||7||
48769711|NCT01263197|102225907|FG005|STARTED|Washout Period 2||7||
48769712|NCT01263197|102225902|FG000|COMPLETED|Washout Period 2||8||
48769713|NCT01263197|102225903|FG001|COMPLETED|Washout Period 2||8||
48769714|NCT01263197|102225904|FG002|COMPLETED|Washout Period 2||8||
48769715|NCT01263197|102225905|FG003|COMPLETED|Washout Period 2||7||
48769716|NCT01263197|102225906|FG004|COMPLETED|Washout Period 2||7||
48769717|NCT01263197|102225907|FG005|COMPLETED|Washout Period 2||6||
48769718|NCT01263197|102225902|FG000|NOT COMPLETED|Washout Period 2||0||
48769719|NCT01263197|102225903|FG001|NOT COMPLETED|Washout Period 2||0||
48769720|NCT01263197|102225904|FG002|NOT COMPLETED|Washout Period 2||0||
48769721|NCT01263197|102225905|FG003|NOT COMPLETED|Washout Period 2||1||
48769722|NCT01263197|102225906|FG004|NOT COMPLETED|Washout Period 2||0||
48769723|NCT01263197|102225907|FG005|NOT COMPLETED|Washout Period 2||1||
48769724|NCT01263197|102225902|FG000|STARTED|Third Intervention (Period 3)||8||
48769725|NCT01263197|102225903|FG001|STARTED|Third Intervention (Period 3)||8||
48769726|NCT01263197|102225904|FG002|STARTED|Third Intervention (Period 3)||8||
48769727|NCT01263197|102225905|FG003|STARTED|Third Intervention (Period 3)||7||
48769728|NCT01263197|102225906|FG004|STARTED|Third Intervention (Period 3)||7||
48769729|NCT01263197|102225907|FG005|STARTED|Third Intervention (Period 3)||6||
48769730|NCT01263197|102225902|FG000|COMPLETED|Third Intervention (Period 3)||8||
48769731|NCT01263197|102225903|FG001|COMPLETED|Third Intervention (Period 3)||7||
48769732|NCT01263197|102225904|FG002|COMPLETED|Third Intervention (Period 3)||8||
48769733|NCT01263197|102225905|FG003|COMPLETED|Third Intervention (Period 3)||7||
48769734|NCT01263197|102225906|FG004|COMPLETED|Third Intervention (Period 3)||7||
48769735|NCT01263197|102225907|FG005|COMPLETED|Third Intervention (Period 3)||6||
48769736|NCT01263197|102225902|FG000|NOT COMPLETED|Third Intervention (Period 3)||0||
48769737|NCT01263197|102225903|FG001|NOT COMPLETED|Third Intervention (Period 3)||1||
48769738|NCT01263197|102225904|FG002|NOT COMPLETED|Third Intervention (Period 3)||0||
48769739|NCT01263197|102225905|FG003|NOT COMPLETED|Third Intervention (Period 3)||0||
48769740|NCT01263197|102225906|FG004|NOT COMPLETED|Third Intervention (Period 3)||0||
48769741|NCT01263197|102225907|FG005|NOT COMPLETED|Third Intervention (Period 3)||0||
48769742|NCT00318643|102225908|FG000|STARTED|Overall Study||3||
48769743|NCT00318643|102225909|FG001|STARTED|Overall Study||3||
48769744|NCT00318643|102225910|FG002|STARTED|Overall Study||6||
48769745|NCT00318643|102225911|FG003|STARTED|Overall Study||3||
48769746|NCT00318643|102225912|FG004|STARTED|Overall Study||12||
48769747|NCT00318643|102225908|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
48769748|NCT00318643|102225909|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3||
48188930|NCT02323880|100786115|FG006|NOT COMPLETED|Overall Study||6||
48188931|NCT02323880|100786116|FG007|NOT COMPLETED|Overall Study||6||
48769749|NCT00318643|102225910|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
48769750|NCT00318643|102225911|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3||
48769751|NCT00318643|102225912|FG004|Received at Least 1 Dose of Study Drug|Overall Study||12||
48368877|NCT03117049|101230279|FG000|COMPLETED|Overall Study||74|Continued at least one study treatment at the time of cut-off|
48769752|NCT00318643|102225908|FG000|COMPLETED|Overall Study||3||
48769753|NCT00318643|102225909|FG001|COMPLETED|Overall Study||3||
48658427|NCT02268305|101948938|FG001|NOT COMPLETED|Overall Study||10||
48769754|NCT00318643|102225910|FG002|COMPLETED|Overall Study||6||
48769755|NCT00318643|102225911|FG003|COMPLETED|Overall Study||3||
48769756|NCT00318643|102225912|FG004|COMPLETED|Overall Study||9||
48769757|NCT00318643|102225908|FG000|NOT COMPLETED|Overall Study||0||
48368878|NCT03117049|101230280|FG001|COMPLETED|Overall Study||44|Continued at least one study treatment at the time of cut-off|
48368879|NCT03117049|101230279|FG000|NOT COMPLETED|Overall Study||201||
48658428|NCT02184442|101948939|FG000|STARTED|Overall Study||284||
48769758|NCT00318643|102225909|FG001|NOT COMPLETED|Overall Study||0||
48769759|NCT00318643|102225910|FG002|NOT COMPLETED|Overall Study||0||
48769760|NCT00318643|102225911|FG003|NOT COMPLETED|Overall Study||0||
48769761|NCT00318643|102225912|FG004|NOT COMPLETED|Overall Study||3||
48769762|NCT00760617|102225913|FG000|STARTED|Overall Study||266||
48658429|NCT02184442|101948940|FG001|STARTED|Overall Study||276||
48658430|NCT02184442|101948939|FG000|As-Treated|Overall Study||282||
48769763|NCT00760617|102225914|FG001|STARTED|Overall Study||144||
48769764|NCT00760617|102225915|FG002|STARTED|Overall Study||116||
48769765|NCT00760617|102225913|FG000|COMPLETED|Overall Study||261||
48769766|NCT00760617|102225914|FG001|COMPLETED|Overall Study||142||
48769767|NCT00760617|102225915|FG002|COMPLETED|Overall Study||111||
48769768|NCT00760617|102225913|FG000|NOT COMPLETED|Overall Study||5||
48769769|NCT00760617|102225914|FG001|NOT COMPLETED|Overall Study||2||
48769770|NCT00760617|102225915|FG002|NOT COMPLETED|Overall Study||5||
48769771|NCT00089752|102225916|FG000|STARTED|Overall Study||141||
48769772|NCT00089752|102225917|FG001|STARTED|Overall Study||140||
48769773|NCT00089752|102225916|FG000|COMPLETED|Overall Study||121||
48769774|NCT00089752|102225917|FG001|COMPLETED|Overall Study||118||
48769775|NCT00089752|102225916|FG000|NOT COMPLETED|Overall Study||20||
48769776|NCT00089752|102225917|FG001|NOT COMPLETED|Overall Study||22||
48769777|NCT00148317|102225918|FG000|STARTED|Consolidation (VEL + DEX)||38||
48769778|NCT00148317|102225918|FG000|DOXIL Added at Cycle 3|Consolidation (VEL + DEX)||16||
48769779|NCT00148317|102225918|FG000|DOXIL Added at Cycle 5|Consolidation (VEL + DEX)||12||
48769780|NCT00148317|102225918|FG000|no DOXIL Added|Consolidation (VEL + DEX)||10||
48769781|NCT00148317|102225918|FG000|COMPLETED|Consolidation (VEL + DEX)||38||
48769782|NCT00148317|102225918|FG000|NOT COMPLETED|Consolidation (VEL + DEX)||0||
48769783|NCT00148317|102225918|FG000|STARTED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||38||
48769784|NCT00148317|102225918|FG000|COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||27||
48769785|NCT00148317|102225918|FG000|NOT COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||11||
48769786|NCT02382705|102225919|FG000|STARTED|Overall Study||57||
48769787|NCT02382705|102225919|FG000|COMPLETED|Overall Study||33||
48769788|NCT02382705|102225919|FG000|NOT COMPLETED|Overall Study||24||
48769789|NCT01104311|102225920|FG000|STARTED|Overall Study||66||
48769790|NCT01104311|102225921|FG001|STARTED|Overall Study||66||
48769791|NCT01104311|102225920|FG000|COMPLETED|Overall Study||56||
48769792|NCT01104311|102225921|FG001|COMPLETED|Overall Study||54||
48769793|NCT01104311|102225920|FG000|NOT COMPLETED|Overall Study||10||
48769794|NCT01104311|102225921|FG001|NOT COMPLETED|Overall Study||12||
48769795|NCT01528332|102225922|FG000|STARTED|Overall Study||85||
48769796|NCT01528332|102225923|FG001|STARTED|Overall Study||86||
48769797|NCT01528332|102225922|FG000|COMPLETED|Overall Study||81||
48769798|NCT01528332|102225923|FG001|COMPLETED|Overall Study||84||
48769799|NCT01528332|102225922|FG000|NOT COMPLETED|Overall Study||4||
48769800|NCT01528332|102225923|FG001|NOT COMPLETED|Overall Study||2||
48769801|NCT02085161|102225924|FG000|STARTED|Overall Study||76||
48769802|NCT02085161|102225925|FG001|STARTED|Overall Study||76||
48769803|NCT02085161|102225926|FG002|STARTED|Overall Study||76||
48769804|NCT02085161|102225927|FG003|STARTED|Overall Study||76||
48769805|NCT02085161|102225924|FG000|COMPLETED|Overall Study||64||
48769806|NCT02085161|102225925|FG001|COMPLETED|Overall Study||66||
48769807|NCT02085161|102225926|FG002|COMPLETED|Overall Study||71||
48769808|NCT02085161|102225927|FG003|COMPLETED|Overall Study||66||
48769809|NCT02085161|102225924|FG000|NOT COMPLETED|Overall Study||12||
48769810|NCT02085161|102225925|FG001|NOT COMPLETED|Overall Study||10||
48769811|NCT02085161|102225926|FG002|NOT COMPLETED|Overall Study||5||
48769812|NCT02085161|102225927|FG003|NOT COMPLETED|Overall Study||10||
48769813|NCT01654302|102225928|FG000|STARTED|First Intervention (Day 1)||20||
48769814|NCT01654302|102225929|FG001|STARTED|First Intervention (Day 1)||20||
48769815|NCT01654302|102225928|FG000|COMPLETED|First Intervention (Day 1)||20||
48769816|NCT01654302|102225929|FG001|COMPLETED|First Intervention (Day 1)||20||
48769817|NCT01654302|102225928|FG000|NOT COMPLETED|First Intervention (Day 1)||0||
48444056|NCT02864953|101422277|FG000|STARTED|Overall Study||268||
48444057|NCT02864953|101422278|FG001|STARTED|Overall Study||267||
48444058|NCT02864953|101422277|FG000|COMPLETED|Overall Study||215||
48444059|NCT02864953|101422278|FG001|COMPLETED|Overall Study||213||
48444060|NCT02864953|101422277|FG000|NOT COMPLETED|Overall Study||53||
48444061|NCT02864953|101422278|FG001|NOT COMPLETED|Overall Study||54||
48444062|NCT00455923|101422279|FG000|STARTED|Overall Study||50||
48769818|NCT01654302|102225929|FG001|NOT COMPLETED|First Intervention (Day 1)||0||
48769819|NCT01654302|102225928|FG000|STARTED|Second Intervention (Day 7)||20||
48769820|NCT01654302|102225929|FG001|STARTED|Second Intervention (Day 7)||20||
48188932|NCT04653051|100786117|FG000|STARTED|Last Consultation Visit at the Hospital||111||115
48444063|NCT00455923|101422280|FG001|STARTED|Overall Study||50||
48444064|NCT00455923|101422279|FG000|COMPLETED|Overall Study||47||
48444065|NCT00455923|101422280|FG001|COMPLETED|Overall Study||47||
48444066|NCT00455923|101422279|FG000|NOT COMPLETED|Overall Study||3||
48444067|NCT00455923|101422280|FG001|NOT COMPLETED|Overall Study||3||
48769821|NCT01654302|102225928|FG000|COMPLETED|Second Intervention (Day 7)||19||
48769822|NCT01654302|102225929|FG001|COMPLETED|Second Intervention (Day 7)||19||
48769823|NCT01654302|102225928|FG000|NOT COMPLETED|Second Intervention (Day 7)||1||
48769824|NCT01654302|102225929|FG001|NOT COMPLETED|Second Intervention (Day 7)||1||
48769825|NCT01759446|102225930|FG000|STARTED|Overall Study||9||
48769826|NCT01759446|102225931|FG001|STARTED|Overall Study||9||
48769827|NCT01759446|102225932|FG002|STARTED|Overall Study||9||
48769828|NCT01759446|102225933|FG003|STARTED|Overall Study||9||
48444068|NCT03976076|101422281|FG000|STARTED|Overall Study||12||
48444069|NCT03976076|101422281|FG000|COMPLETED|Overall Study||10||
48769829|NCT01759446|102225934|FG004|STARTED|Overall Study||8||
48769830|NCT01759446|102225930|FG000|COMPLETED|Overall Study||8||
48769831|NCT01759446|102225931|FG001|COMPLETED|Overall Study||8||
48769832|NCT01759446|102225932|FG002|COMPLETED|Overall Study||8||
48769833|NCT01759446|102225933|FG003|COMPLETED|Overall Study||8||
48769834|NCT01759446|102225934|FG004|COMPLETED|Overall Study||8||
48769835|NCT01759446|102225930|FG000|NOT COMPLETED|Overall Study||1||
48769836|NCT01759446|102225931|FG001|NOT COMPLETED|Overall Study||1||
48444070|NCT03976076|101422281|FG000|NOT COMPLETED|Overall Study||2||
48444071|NCT03981614|101422282|FG000|STARTED|Overall Study||47||
48444072|NCT03981614|101422283|FG001|STARTED|Overall Study||46||
48444073|NCT03981614|101422284|FG002|STARTED|Overall Study||9||
48444074|NCT03981614|101422282|FG000|Crossed Over to Arm A|Overall Study||0||
48444075|NCT03981614|101422283|FG001|Crossed Over to Arm A|Overall Study||21||
48444076|NCT03981614|101422284|FG002|Crossed Over to Arm A|Overall Study||0||
48444077|NCT03981614|101422282|FG000|COMPLETED|Overall Study||42||
48444078|NCT03981614|101422283|FG001|COMPLETED|Overall Study||41||
48444079|NCT03981614|101422284|FG002|COMPLETED|Overall Study||8||
48444080|NCT03981614|101422282|FG000|NOT COMPLETED|Overall Study||5||
48444081|NCT03981614|101422283|FG001|NOT COMPLETED|Overall Study||5||
48444082|NCT03981614|101422284|FG002|NOT COMPLETED|Overall Study||1||
48444083|NCT03047031|101422285|FG000|STARTED|Overall Study||14||
48444084|NCT03047031|101422286|FG001|STARTED|Overall Study||4||
48444085|NCT03047031|101422287|FG002|STARTED|Overall Study||3||
48444086|NCT03047031|101422285|FG000|COMPLETED|Overall Study||2|Completed the study|
48444087|NCT03047031|101422286|FG001|COMPLETED|Overall Study||0|Completed the study|
48444088|NCT03047031|101422287|FG002|COMPLETED|Overall Study||0|Completed the study|
48444089|NCT03047031|101422285|FG000|NOT COMPLETED|Overall Study||12||
48444090|NCT03047031|101422286|FG001|NOT COMPLETED|Overall Study||4||
48444091|NCT03047031|101422287|FG002|NOT COMPLETED|Overall Study||3||
48444092|NCT04489888|101422288|FG000|STARTED|Overall Study||101||
48444093|NCT04489888|101422288|FG000|COMPLETED|Overall Study||0||
48444094|NCT04489888|101422288|FG000|NOT COMPLETED|Overall Study||101||
48444095|NCT02936479|101422289|FG000|STARTED|Overall Study||1||
48444096|NCT02936479|101422289|FG000|COMPLETED|Overall Study||1||
48444097|NCT02936479|101422289|FG000|NOT COMPLETED|Overall Study||0||
48444098|NCT00953927|101422290|FG000|STARTED|Overall Study||1399||
48444099|NCT00953927|101422291|FG001|STARTED|Overall Study||1398||
48444100|NCT00953927|101422290|FG000|COMPLETED|Overall Study||1294||
48444101|NCT00953927|101422291|FG001|COMPLETED|Overall Study||1303||
48444102|NCT00953927|101422290|FG000|NOT COMPLETED|Overall Study||105||
48444103|NCT00953927|101422291|FG001|NOT COMPLETED|Overall Study||95||
48444104|NCT03273712|101422292|FG000|STARTED|Overall Study||39||
48444105|NCT03273712|101422292|FG000|COMPLETED|Overall Study||32||
48444106|NCT03273712|101422292|FG000|NOT COMPLETED|Overall Study||7||
48444107|NCT03891875|101422293|FG000|STARTED|Overall Study||117||
48444108|NCT03891875|101422294|FG001|STARTED|Overall Study||59||
48769837|NCT01759446|102225932|FG002|NOT COMPLETED|Overall Study||1||
48769838|NCT01759446|102225933|FG003|NOT COMPLETED|Overall Study||1||
48769839|NCT01759446|102225934|FG004|NOT COMPLETED|Overall Study||0||
48769840|NCT00454324|102225935|FG000|STARTED|Overall Study||14||
48444109|NCT03891875|101422293|FG000|COMPLETED|Overall Study||83||
48444110|NCT03891875|101422294|FG001|COMPLETED|Overall Study||51||
48444111|NCT03891875|101422293|FG000|NOT COMPLETED|Overall Study||34||
48444112|NCT03891875|101422294|FG001|NOT COMPLETED|Overall Study||8||
48444113|NCT02842086|101422295|FG000|STARTED|Overall Study||2700||
48444114|NCT02842086|101422296|FG001|STARTED|Overall Study||2699||
48444115|NCT02842086|101422295|FG000|COMPLETED|Overall Study||2156|Completed the Double Blind Phase|
48444116|NCT02842086|101422296|FG001|COMPLETED|Overall Study||2206|Completed the Double Blind Phase|
48444117|NCT02842086|101422295|FG000|NOT COMPLETED|Overall Study||544||
48444118|NCT02842086|101422296|FG001|NOT COMPLETED|Overall Study||493||
48444119|NCT04840901|101422297|FG000|STARTED|Overall Study||123||
48444120|NCT04840901|101422298|FG001|STARTED|Overall Study||119||
48444121|NCT04840901|101422297|FG000|Received at Least One Dose of Study Drug|Overall Study||122||
48444122|NCT04840901|101422298|FG001|Received at Least One Dose of Study Drug|Overall Study||119||
48444123|NCT04840901|101422297|FG000|COMPLETED|Overall Study||118||
48444124|NCT04840901|101422298|FG001|COMPLETED|Overall Study||117||
48444125|NCT04840901|101422297|FG000|NOT COMPLETED|Overall Study||5||
48444126|NCT04840901|101422298|FG001|NOT COMPLETED|Overall Study||2||
48444127|NCT02740660|101422299|FG000|STARTED|Overall Study||6||
48444128|NCT02740660|101422300|FG001|STARTED|Overall Study||6||
48444129|NCT02740660|101422299|FG000|COMPLETED|Overall Study||6||
48444130|NCT02740660|101422300|FG001|COMPLETED|Overall Study||6||
48444131|NCT02740660|101422299|FG000|NOT COMPLETED|Overall Study||0||
48444132|NCT02740660|101422300|FG001|NOT COMPLETED|Overall Study||0||
48444133|NCT03125915|101422301|FG000|STARTED|Baseline and Intervention||32||
48444134|NCT03125915|101422302|FG001|STARTED|Baseline and Intervention||40||
48444135|NCT03125915|101422303|FG002|STARTED|Baseline and Intervention||34||
48769841|NCT00454324|102225936|FG001|STARTED|Overall Study||13||
48769842|NCT00454324|102225935|FG000|COMPLETED|Overall Study||14||
48444136|NCT03125915|101422304|FG003|STARTED|Baseline and Intervention||34||
48444137|NCT03125915|101422301|FG000|COMPLETED|Baseline and Intervention||32||
48444138|NCT03125915|101422302|FG001|COMPLETED|Baseline and Intervention||40||
48444139|NCT03125915|101422303|FG002|COMPLETED|Baseline and Intervention||34||
48444140|NCT03125915|101422304|FG003|COMPLETED|Baseline and Intervention||34||
48444141|NCT03125915|101422301|FG000|NOT COMPLETED|Baseline and Intervention||0||
48444142|NCT03125915|101422302|FG001|NOT COMPLETED|Baseline and Intervention||0||
48444143|NCT03125915|101422303|FG002|NOT COMPLETED|Baseline and Intervention||0||
48444144|NCT03125915|101422304|FG003|NOT COMPLETED|Baseline and Intervention||0||
48444145|NCT03125915|101422301|FG000|STARTED|1 Month Follow up||32||
48188933|NCT04653051|100786117|FG000|COMPLETED|Last Consultation Visit at the Hospital||111||115
48444146|NCT03125915|101422302|FG001|STARTED|1 Month Follow up||40||
48444147|NCT03125915|101422303|FG002|STARTED|1 Month Follow up||34||
48444148|NCT03125915|101422304|FG003|STARTED|1 Month Follow up||34||
48444149|NCT03125915|101422301|FG000|COMPLETED|1 Month Follow up||29||
48444150|NCT03125915|101422302|FG001|COMPLETED|1 Month Follow up||37||
48444151|NCT03125915|101422303|FG002|COMPLETED|1 Month Follow up||32||
48444152|NCT03125915|101422304|FG003|COMPLETED|1 Month Follow up||31||
48444153|NCT03125915|101422301|FG000|NOT COMPLETED|1 Month Follow up||3||
48444154|NCT03125915|101422302|FG001|NOT COMPLETED|1 Month Follow up||3||
48444155|NCT03125915|101422303|FG002|NOT COMPLETED|1 Month Follow up||2||
48444156|NCT03125915|101422304|FG003|NOT COMPLETED|1 Month Follow up||3||
48444157|NCT03125915|101422301|FG000|STARTED|3 Month Follow-up||32||
48444158|NCT03125915|101422302|FG001|STARTED|3 Month Follow-up||40||
48444159|NCT03125915|101422303|FG002|STARTED|3 Month Follow-up||34||
48444160|NCT03125915|101422304|FG003|STARTED|3 Month Follow-up||34||
48444161|NCT03125915|101422301|FG000|COMPLETED|3 Month Follow-up||26||
48444162|NCT03125915|101422302|FG001|COMPLETED|3 Month Follow-up||36||
48444163|NCT03125915|101422303|FG002|COMPLETED|3 Month Follow-up||30||
48444164|NCT03125915|101422304|FG003|COMPLETED|3 Month Follow-up||32||
48444165|NCT03125915|101422301|FG000|NOT COMPLETED|3 Month Follow-up||6||
48444166|NCT03125915|101422302|FG001|NOT COMPLETED|3 Month Follow-up||4||
48444167|NCT03125915|101422303|FG002|NOT COMPLETED|3 Month Follow-up||4||
48444168|NCT03125915|101422304|FG003|NOT COMPLETED|3 Month Follow-up||2||
48444169|NCT03125915|101422301|FG000|STARTED|6 Month Follow-up||32||
48444170|NCT03125915|101422302|FG001|STARTED|6 Month Follow-up||40||
48444171|NCT03125915|101422303|FG002|STARTED|6 Month Follow-up||34||
48444172|NCT03125915|101422304|FG003|STARTED|6 Month Follow-up||34||
48444173|NCT03125915|101422301|FG000|COMPLETED|6 Month Follow-up||25||
48444174|NCT03125915|101422302|FG001|COMPLETED|6 Month Follow-up||37||
48444175|NCT03125915|101422303|FG002|COMPLETED|6 Month Follow-up||28||
48444176|NCT03125915|101422304|FG003|COMPLETED|6 Month Follow-up||31||
48444177|NCT03125915|101422301|FG000|NOT COMPLETED|6 Month Follow-up||7||
48444178|NCT03125915|101422302|FG001|NOT COMPLETED|6 Month Follow-up||3||
48444179|NCT03125915|101422303|FG002|NOT COMPLETED|6 Month Follow-up||6||
48444180|NCT03125915|101422304|FG003|NOT COMPLETED|6 Month Follow-up||3||
48444181|NCT02587325|101422305|FG000|STARTED|16-Week Dose-finding Safety Part||4||
48444182|NCT02587325|101422306|FG001|STARTED|16-Week Dose-finding Safety Part||3||
48444183|NCT02587325|101422307|FG002|STARTED|16-Week Dose-finding Safety Part||4||
48444184|NCT02587325|101422308|FG003|STARTED|16-Week Dose-finding Safety Part||3||
48444185|NCT02587325|101422309|FG004|STARTED|16-Week Dose-finding Safety Part||1||
48444186|NCT02587325|101422305|FG000|COMPLETED|16-Week Dose-finding Safety Part||3||
48444187|NCT02587325|101422306|FG001|COMPLETED|16-Week Dose-finding Safety Part||3||
48444188|NCT02587325|101422307|FG002|COMPLETED|16-Week Dose-finding Safety Part||4||
48444189|NCT02587325|101422308|FG003|COMPLETED|16-Week Dose-finding Safety Part||2||
48444190|NCT02587325|101422309|FG004|COMPLETED|16-Week Dose-finding Safety Part||1||
48444191|NCT02587325|101422305|FG000|NOT COMPLETED|16-Week Dose-finding Safety Part||1||
48444192|NCT02587325|101422306|FG001|NOT COMPLETED|16-Week Dose-finding Safety Part||0||
48444193|NCT02587325|101422307|FG002|NOT COMPLETED|16-Week Dose-finding Safety Part||0||
48444194|NCT02587325|101422308|FG003|NOT COMPLETED|16-Week Dose-finding Safety Part||1||
48444195|NCT02587325|101422309|FG004|NOT COMPLETED|16-Week Dose-finding Safety Part||0||
48444196|NCT02587325|101422305|FG000|STARTED|32-Week Optional Extension Part||0|Optional up to 32-Week Therapy (Extension Part): After the Dose Cohort 1 completed the first 16-Week therapy, the protocol was amended to include an optional up to 32 additional weeks of therapy for patients with clinical evidence of benefit as determined by the site investigator, considering available safety and efficacy outcomes at the Week 17 assessment.|
48444197|NCT02587325|101422306|FG001|STARTED|32-Week Optional Extension Part||1|Optional up to 32-Week Therapy (Extension Part): After the Dose Cohort 1 completed the first 16-Week therapy, the protocol was amended to include an optional up to 32 additional weeks of therapy for patients with clinical evidence of benefit as determined by the site investigator, considering available safety and efficacy outcomes at the Week 17 assessment.|
48444198|NCT02587325|101422307|FG002|STARTED|32-Week Optional Extension Part||4|Optional up to 32-Week Therapy (Extension Part): After the Dose Cohort 1 completed the first 16-Week therapy, the protocol was amended to include an optional up to 32 additional weeks of therapy for patients with clinical evidence of benefit as determined by the site investigator, considering available safety and efficacy outcomes at the Week 17 assessment.|
48658431|NCT02184442|101948940|FG001|As-Treated|Overall Study||271||
48658432|NCT02184442|101948939|FG000|Valve-Implant|Overall Study||280||
48658433|NCT02184442|101948940|FG001|Valve-Implant|Overall Study||263||
48658434|NCT02184442|101948939|FG000|COMPLETED|Overall Study||220|One-year Follow-up|
48658435|NCT02184442|101948940|FG001|COMPLETED|Overall Study||200|One-year Follow-up|
48658436|NCT02184442|101948939|FG000|NOT COMPLETED|Overall Study||64||
48658437|NCT02184442|101948940|FG001|NOT COMPLETED|Overall Study||76||
48658438|NCT02702999|101948941|FG000|STARTED|Overall Study||102||
48658439|NCT02702999|101948942|FG001|STARTED|Overall Study||104||
48658440|NCT02702999|101948941|FG000|COMPLETED|Overall Study||102||
48769843|NCT00454324|102225936|FG001|COMPLETED|Overall Study||13||
48769844|NCT00454324|102225935|FG000|NOT COMPLETED|Overall Study||0||
48769845|NCT00454324|102225936|FG001|NOT COMPLETED|Overall Study||0||
48769846|NCT01472289|102225937|FG000|STARTED|Overall Study||17||
48769847|NCT01472289|102225937|FG000|COMPLETED|Overall Study||15||
48769848|NCT01472289|102225937|FG000|NOT COMPLETED|Overall Study||2||
48769849|NCT02170077|102225938|FG000|STARTED|Overall Study||50||
48769850|NCT02170077|102225939|FG001|STARTED|Overall Study||47||
48769851|NCT02170077|102225940|FG002|STARTED|Overall Study||47||
48769852|NCT02170077|102225938|FG000|Intent to Treat (ITT) Population|Overall Study||50||
48769853|NCT02170077|102225939|FG001|Intent to Treat (ITT) Population|Overall Study||46||
48769854|NCT02170077|102225940|FG002|Intent to Treat (ITT) Population|Overall Study||47||
48769855|NCT02170077|102225938|FG000|COMPLETED|Overall Study||41||
48769856|NCT02170077|102225939|FG001|COMPLETED|Overall Study||34||
48769857|NCT02170077|102225940|FG002|COMPLETED|Overall Study||35||
48769858|NCT02170077|102225938|FG000|NOT COMPLETED|Overall Study||9||
48769859|NCT02170077|102225939|FG001|NOT COMPLETED|Overall Study||13||
48769860|NCT02170077|102225940|FG002|NOT COMPLETED|Overall Study||12||
48769861|NCT03611829|102225941|FG000|STARTED|Overall Study||43||
48769862|NCT03611829|102225942|FG001|STARTED|Overall Study||44||
48188934|NCT04653051|100786117|FG000|NOT COMPLETED|Last Consultation Visit at the Hospital||0||0
48658441|NCT02702999|101948942|FG001|COMPLETED|Overall Study||104||
48658442|NCT02702999|101948941|FG000|NOT COMPLETED|Overall Study||0||
48658443|NCT02702999|101948942|FG001|NOT COMPLETED|Overall Study||0||
48658444|NCT02554474|101948943|FG000|STARTED|Overall Study||59||
48658445|NCT02554474|101948944|FG001|STARTED|Overall Study||59||
48658446|NCT02554474|101948943|FG000|COMPLETED|Overall Study||56||
48658447|NCT02554474|101948944|FG001|COMPLETED|Overall Study||57||
48658448|NCT02554474|101948943|FG000|NOT COMPLETED|Overall Study||3||
48658449|NCT02554474|101948944|FG001|NOT COMPLETED|Overall Study||2||
48658450|NCT04562090|101948945|FG000|STARTED|Overall Study||84||
48658451|NCT04562090|101948946|FG001|STARTED|Overall Study||165||
48658452|NCT04562090|101948945|FG000|Participants (Never-Up Titrated)|Overall Study||44||
48658453|NCT04562090|101948946|FG001|Participants (Never-Up Titrated)|Overall Study||0||
48658454|NCT04562090|101948945|FG000|Participants (Up Titrated to 50 mg)|Overall Study||39||
48658455|NCT04562090|101948946|FG001|Participants (Up Titrated to 50 mg)|Overall Study||0||
48658456|NCT04562090|101948945|FG000|Treated|Overall Study||83||
48658457|NCT04562090|101948946|FG001|Treated|Overall Study||165||
48658458|NCT04562090|101948945|FG000|COMPLETED|Overall Study||78||
48658459|NCT04562090|101948946|FG001|COMPLETED|Overall Study||153||
48658460|NCT04562090|101948945|FG000|NOT COMPLETED|Overall Study||6||
48658461|NCT04562090|101948946|FG001|NOT COMPLETED|Overall Study||12||
48658462|NCT00787800|101948947|FG000|STARTED|Overall Study||50||
48658463|NCT00787800|101948948|FG001|STARTED|Overall Study||50||
48658464|NCT00787800|101948947|FG000|COMPLETED|Overall Study||47||
48658465|NCT00787800|101948948|FG001|COMPLETED|Overall Study||43||
48658466|NCT00787800|101948947|FG000|NOT COMPLETED|Overall Study||3||
48658467|NCT00787800|101948948|FG001|NOT COMPLETED|Overall Study||7||
48658468|NCT00504556|101948949|FG000|STARTED|Overall Study||235||
48658469|NCT00504556|101948950|FG001|STARTED|Overall Study||245||
48658470|NCT00504556|101948951|FG002|STARTED|Overall Study||235||
48658471|NCT00504556|101948952|FG003|STARTED|Overall Study||180||
48658472|NCT00504556|101948953|FG004|STARTED|Overall Study||251||
48658473|NCT00504556|101948949|FG000|Safety Analysis Set|Overall Study||235||
48658474|NCT00504556|101948950|FG001|Safety Analysis Set|Overall Study||244||
48658475|NCT00504556|101948951|FG002|Safety Analysis Set|Overall Study||234||
48658476|NCT00504556|101948952|FG003|Safety Analysis Set|Overall Study||180||
48658477|NCT00504556|101948953|FG004|Safety Analysis Set|Overall Study||250||
48658478|NCT00504556|101948949|FG000|Per Protocol Analysis Set|Overall Study||235||
48658479|NCT00504556|101948950|FG001|Per Protocol Analysis Set|Overall Study||243||
48658480|NCT00504556|101948951|FG002|Per Protocol Analysis Set|Overall Study||234||
48658481|NCT00504556|101948952|FG003|Per Protocol Analysis Set|Overall Study||180||
48658482|NCT00504556|101948953|FG004|Per Protocol Analysis Set|Overall Study||250||
48658483|NCT00504556|101948949|FG000|Pharmacodynamic Analysis Set|Overall Study||230||
48658484|NCT00504556|101948950|FG001|Pharmacodynamic Analysis Set|Overall Study||236||
48670039|NCT03601897|101974870|FG004|NOT COMPLETED|Overall Study||6||
48444199|NCT02587325|101422308|FG003|STARTED|32-Week Optional Extension Part||1|Optional up to 32-Week Therapy (Extension Part): After the Dose Cohort 1 completed the first 16-Week therapy, the protocol was amended to include an optional up to 32 additional weeks of therapy for patients with clinical evidence of benefit as determined by the site investigator, considering available safety and efficacy outcomes at the Week 17 assessment.|
48444200|NCT02587325|101422309|FG004|STARTED|32-Week Optional Extension Part||1|Optional up to 32-Week Therapy (Extension Part): After the Dose Cohort 1 completed the first 16-Week therapy, the protocol was amended to include an optional up to 32 additional weeks of therapy for patients with clinical evidence of benefit as determined by the site investigator, considering available safety and efficacy outcomes at the Week 17 assessment.|
48444201|NCT02587325|101422305|FG000|COMPLETED|32-Week Optional Extension Part||0|"The Optional up to 32-Week therapy (Extension Part) was a therapy maintenance opportunity as long as clinically/medically indicated per the treating physician."|
48444202|NCT02587325|101422306|FG001|COMPLETED|32-Week Optional Extension Part||1|"The Optional up to 32-Week therapy (Extension Part) was a therapy maintenance opportunity as long as clinically/medically indicated per the treating physician."|
48444203|NCT02587325|101422307|FG002|COMPLETED|32-Week Optional Extension Part||2|"The Optional up to 32-Week therapy (Extension Part) was a therapy maintenance opportunity as long as clinically/medically indicated per the treating physician."|
48444204|NCT02587325|101422308|FG003|COMPLETED|32-Week Optional Extension Part||1|"The Optional up to 32-Week therapy (Extension Part) was a therapy maintenance opportunity as long as clinically/medically indicated per the treating physician."|
48444205|NCT02587325|101422309|FG004|COMPLETED|32-Week Optional Extension Part||0|"The Optional up to 32-Week therapy (Extension Part) was a therapy maintenance opportunity as long as clinically/medically indicated per the treating physician."|
48444206|NCT02587325|101422305|FG000|NOT COMPLETED|32-Week Optional Extension Part||0||
48444207|NCT02587325|101422306|FG001|NOT COMPLETED|32-Week Optional Extension Part||0||
48444208|NCT02587325|101422307|FG002|NOT COMPLETED|32-Week Optional Extension Part||2||
48444209|NCT02587325|101422308|FG003|NOT COMPLETED|32-Week Optional Extension Part||0||
48444210|NCT02587325|101422309|FG004|NOT COMPLETED|32-Week Optional Extension Part||1||
48444211|NCT00826176|101422310|FG000|STARTED|Overall Study||128||
48444212|NCT00826176|101422311|FG001|STARTED|Overall Study||36||
48444213|NCT00826176|101422310|FG000|COMPLETED|Overall Study||115||
48444214|NCT00826176|101422311|FG001|COMPLETED|Overall Study||36||
48444215|NCT00826176|101422310|FG000|NOT COMPLETED|Overall Study||13||
48444216|NCT00826176|101422311|FG001|NOT COMPLETED|Overall Study||0||
48444217|NCT01346501|101422312|FG000|STARTED|Overall Study||79||
48368880|NCT03117049|101230280|FG001|NOT COMPLETED|Overall Study||231||
48368881|NCT01241513|101230281|FG000|STARTED|Overall Study||10||
48368882|NCT01241513|101230282|FG001|STARTED|Overall Study||9||
48368883|NCT01241513|101230281|FG000|COMPLETED|Overall Study||10||
48444218|NCT01346501|101422313|FG001|STARTED|Overall Study||93||
48444219|NCT01346501|101422312|FG000|COMPLETED|Overall Study||68||
48444220|NCT01346501|101422313|FG001|COMPLETED|Overall Study||80||
48444221|NCT01346501|101422312|FG000|NOT COMPLETED|Overall Study||11||
48444222|NCT01346501|101422313|FG001|NOT COMPLETED|Overall Study||13||
48444223|NCT00797316|101422314|FG000|STARTED|Overall Study||267||
48444224|NCT00797316|101422315|FG001|STARTED|Overall Study||265||
48444225|NCT00797316|101422314|FG000|COMPLETED|Overall Study||244||
48769863|NCT03611829|102225941|FG000|COMPLETED|Overall Study||21||
48769864|NCT03611829|102225942|FG001|COMPLETED|Overall Study||19||
48188935|NCT04653051|100786117|FG000|STARTED|Follow-up Phone Call||111||114
48368884|NCT01241513|101230282|FG001|COMPLETED|Overall Study||9||
48444226|NCT00797316|101422315|FG001|COMPLETED|Overall Study||233||
48444227|NCT00797316|101422314|FG000|NOT COMPLETED|Overall Study||23||
48444228|NCT00797316|101422315|FG001|NOT COMPLETED|Overall Study||32||
48444229|NCT02737072|101422316|FG000|STARTED|Overall Study||3||
48444230|NCT02737072|101422317|FG001|STARTED|Overall Study||3||
48444231|NCT02737072|101422318|FG002|STARTED|Overall Study||3||
48444232|NCT02737072|101422316|FG000|Received at Least One Dose of Drug|Overall Study||3||
48444233|NCT02737072|101422317|FG001|Received at Least One Dose of Drug|Overall Study||3||
48444234|NCT02737072|101422318|FG002|Received at Least One Dose of Drug|Overall Study||3||
48444235|NCT02737072|101422316|FG000|COMPLETED|Overall Study||3||
48444236|NCT02737072|101422317|FG001|COMPLETED|Overall Study||3||
48769865|NCT03611829|102225941|FG000|NOT COMPLETED|Overall Study||22||
48769866|NCT03611829|102225942|FG001|NOT COMPLETED|Overall Study||25||
48769867|NCT02873377|102225943|FG000|STARTED|Period 1: Enrollment||65||
48769868|NCT02873377|102225944|FG001|STARTED|Period 1: Enrollment||69||
48769869|NCT02873377|102225943|FG000|COMPLETED|Period 1: Enrollment||65||
48769870|NCT02873377|102225944|FG001|COMPLETED|Period 1: Enrollment||69||
48769871|NCT02873377|102225943|FG000|NOT COMPLETED|Period 1: Enrollment||0||
48769872|NCT02873377|102225944|FG001|NOT COMPLETED|Period 1: Enrollment||0||
48769873|NCT02873377|102225943|FG000|STARTED|Period Title 2: 3 Months Follow up||65||
48769874|NCT02873377|102225944|FG001|STARTED|Period Title 2: 3 Months Follow up||69||
48769875|NCT02873377|102225943|FG000|COMPLETED|Period Title 2: 3 Months Follow up||43||
48769876|NCT02873377|102225944|FG001|COMPLETED|Period Title 2: 3 Months Follow up||47||
48769877|NCT02873377|102225943|FG000|NOT COMPLETED|Period Title 2: 3 Months Follow up||22||
48368885|NCT01241513|101230281|FG000|NOT COMPLETED|Overall Study||0||
48368886|NCT01241513|101230282|FG001|NOT COMPLETED|Overall Study||0||
48368887|NCT02379923|101230283|FG000|STARTED|Overall Study||163||
48368888|NCT02379923|101230283|FG000|COMPLETED|Overall Study||158||
48368889|NCT02379923|101230283|FG000|NOT COMPLETED|Overall Study||5||
48444237|NCT02737072|101422318|FG002|COMPLETED|Overall Study||3||
48444238|NCT02737072|101422316|FG000|NOT COMPLETED|Overall Study||0||
48444239|NCT02737072|101422317|FG001|NOT COMPLETED|Overall Study||0||
48444240|NCT02737072|101422318|FG002|NOT COMPLETED|Overall Study||0||
48444241|NCT02656875|101422319|FG000|STARTED|Overall Study||768||
48444242|NCT02656875|101422319|FG000|COMPLETED|Overall Study||698||
48444243|NCT02656875|101422319|FG000|NOT COMPLETED|Overall Study||70||
48444244|NCT00567996|101422320|FG000|STARTED|Overall Study||333||
48444245|NCT00567996|101422321|FG001|STARTED|Overall Study||334||
48444246|NCT00567996|101422322|FG002|STARTED|Overall Study||335||
48444247|NCT00567996|101422320|FG000|Intent-to-treat: Received Study Drug|Overall Study||330||
48658485|NCT00504556|101948951|FG002|Pharmacodynamic Analysis Set|Overall Study||228||
48658486|NCT00504556|101948952|FG003|Pharmacodynamic Analysis Set|Overall Study||170||
48658487|NCT00504556|101948953|FG004|Pharmacodynamic Analysis Set|Overall Study||244||
48658488|NCT00504556|101948949|FG000|COMPLETED|Overall Study||200||
48658489|NCT00504556|101948950|FG001|COMPLETED|Overall Study||207||
48658490|NCT00504556|101948951|FG002|COMPLETED|Overall Study||204||
48769878|NCT02873377|102225944|FG001|NOT COMPLETED|Period Title 2: 3 Months Follow up||22||
48769879|NCT02873377|102225943|FG000|STARTED|Period Title 3: 6 Months Follow up||65||
48769880|NCT02873377|102225944|FG001|STARTED|Period Title 3: 6 Months Follow up||69||
48769881|NCT02873377|102225943|FG000|COMPLETED|Period Title 3: 6 Months Follow up||50||
48769882|NCT02873377|102225944|FG001|COMPLETED|Period Title 3: 6 Months Follow up||46||
48769883|NCT02873377|102225943|FG000|NOT COMPLETED|Period Title 3: 6 Months Follow up||15||
48769884|NCT02873377|102225944|FG001|NOT COMPLETED|Period Title 3: 6 Months Follow up||23||
48769885|NCT01744977|102225945|FG000|STARTED|Overall Study||120||
48769886|NCT01744977|102225946|FG001|STARTED|Overall Study||120||
48769887|NCT01744977|102225945|FG000|6 Month Completed|Overall Study||113||
48769888|NCT01744977|102225946|FG001|6 Month Completed|Overall Study||115||
48769889|NCT01744977|102225945|FG000|COMPLETED|Overall Study||109||
48769890|NCT01744977|102225946|FG001|COMPLETED|Overall Study||115||
48769891|NCT01744977|102225945|FG000|NOT COMPLETED|Overall Study||11||
48769892|NCT01744977|102225946|FG001|NOT COMPLETED|Overall Study||5||
48769893|NCT02504151|102225947|FG000|STARTED|First Intervention (4 Weeks)||8||
48769894|NCT02504151|102225948|FG001|STARTED|First Intervention (4 Weeks)||10||
48769895|NCT02504151|102225947|FG000|COMPLETED|First Intervention (4 Weeks)||7||
48769896|NCT02504151|102225948|FG001|COMPLETED|First Intervention (4 Weeks)||9||
48769897|NCT02504151|102225947|FG000|NOT COMPLETED|First Intervention (4 Weeks)||1||
48769898|NCT02504151|102225948|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1||
48769899|NCT02504151|102225947|FG000|STARTED|Washout (2 Weeks)||7||
48769900|NCT02504151|102225948|FG001|STARTED|Washout (2 Weeks)||9||
48769901|NCT02504151|102225947|FG000|COMPLETED|Washout (2 Weeks)||6||
48769902|NCT02504151|102225948|FG001|COMPLETED|Washout (2 Weeks)||9||
48769903|NCT02504151|102225947|FG000|NOT COMPLETED|Washout (2 Weeks)||1||
48769904|NCT02504151|102225948|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
48769905|NCT02504151|102225947|FG000|STARTED|Second Intervention (4 Weeks)||6||
48769906|NCT02504151|102225948|FG001|STARTED|Second Intervention (4 Weeks)||9||
48769907|NCT02504151|102225947|FG000|COMPLETED|Second Intervention (4 Weeks)||4||
48769908|NCT02504151|102225948|FG001|COMPLETED|Second Intervention (4 Weeks)||7||
48769909|NCT02504151|102225947|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||2||
48769910|NCT02504151|102225948|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||2||
48769911|NCT01551186|102225949|FG000|STARTED|Overall Study||50||
48769912|NCT01551186|102225950|FG001|STARTED|Overall Study||53||
48769913|NCT01551186|102225949|FG000|COMPLETED|Overall Study||30||
48769914|NCT01551186|102225950|FG001|COMPLETED|Overall Study||40||
48769915|NCT01551186|102225949|FG000|NOT COMPLETED|Overall Study||20||
48769916|NCT01551186|102225950|FG001|NOT COMPLETED|Overall Study||13||
48769917|NCT02592798|102225951|FG000|STARTED|Double-Blind Period 1 (DB1)||17||
48444248|NCT00567996|101422321|FG001|Intent-to-treat: Received Study Drug|Overall Study||333||
48444249|NCT00567996|101422322|FG002|Intent-to-treat: Received Study Drug|Overall Study||335||
48444250|NCT00567996|101422320|FG000|COMPLETED|Overall Study||289||
48444251|NCT00567996|101422321|FG001|COMPLETED|Overall Study||284||
48444252|NCT00567996|101422322|FG002|COMPLETED|Overall Study||265||
48444253|NCT00567996|101422320|FG000|NOT COMPLETED|Overall Study||44||
48444254|NCT00567996|101422321|FG001|NOT COMPLETED|Overall Study||50||
48444255|NCT00567996|101422322|FG002|NOT COMPLETED|Overall Study||70||
48769918|NCT02592798|102225952|FG001|STARTED|Double-Blind Period 1 (DB1)||19||
48188936|NCT04653051|100786117|FG000|COMPLETED|Follow-up Phone Call||111||114
48188937|NCT04653051|100786117|FG000|NOT COMPLETED|Follow-up Phone Call||0||0
48444256|NCT03934437|101422323|FG000|STARTED|Overall Study||225||
48444257|NCT03934437|101422324|FG001|STARTED|Overall Study||226||
48658491|NCT00504556|101948952|FG003|COMPLETED|Overall Study||52||
48658492|NCT00504556|101948953|FG004|COMPLETED|Overall Study||226||
48658493|NCT00504556|101948949|FG000|NOT COMPLETED|Overall Study||35||
48658494|NCT00504556|101948950|FG001|NOT COMPLETED|Overall Study||38||
48444258|NCT03934437|101422323|FG000|COMPLETED|Overall Study||223||
48444259|NCT03934437|101422324|FG001|COMPLETED|Overall Study||225||
48444260|NCT03934437|101422323|FG000|NOT COMPLETED|Overall Study||2||
48658495|NCT00504556|101948951|FG002|NOT COMPLETED|Overall Study||31||
48658496|NCT00504556|101948952|FG003|NOT COMPLETED|Overall Study||128||
48658497|NCT00504556|101948953|FG004|NOT COMPLETED|Overall Study||25||
48658498|NCT03810365|101948954|FG000|STARTED|Overall Study||66||
48658499|NCT03810365|101948955|FG001|STARTED|Overall Study||66||
48658500|NCT03810365|101948954|FG000|COMPLETED|Overall Study||60||
48658501|NCT03810365|101948955|FG001|COMPLETED|Overall Study||59||
48658502|NCT03810365|101948954|FG000|NOT COMPLETED|Overall Study||6||
48658503|NCT03810365|101948955|FG001|NOT COMPLETED|Overall Study||7||
48658504|NCT03232892|101948956|FG000|STARTED|Overall Study||1||
48658505|NCT03232892|101948956|FG000|COMPLETED|Overall Study||1||
48444261|NCT03934437|101422324|FG001|NOT COMPLETED|Overall Study||1||
48444262|NCT03111407|101422325|FG000|STARTED|Overall Study||45||
48444263|NCT03111407|101422326|FG001|STARTED|Overall Study||27||
48444264|NCT03111407|101422325|FG000|COMPLETED|Overall Study||44||
48444265|NCT03111407|101422326|FG001|COMPLETED|Overall Study||26||
48444266|NCT03111407|101422325|FG000|NOT COMPLETED|Overall Study||1||
48444267|NCT03111407|101422326|FG001|NOT COMPLETED|Overall Study||1||
48444268|NCT01955473|101422327|FG000|STARTED|Overall Study||3||
48444269|NCT01955473|101422328|FG001|STARTED|Overall Study||6||
48444270|NCT01955473|101422329|FG002|STARTED|Overall Study||6||
48444271|NCT01955473|101422330|FG003|STARTED|Overall Study||6||
48444272|NCT01955473|101422331|FG004|STARTED|Overall Study||30||
48444273|NCT01955473|101422327|FG000|COMPLETED|Overall Study||3||
48444274|NCT01955473|101422328|FG001|COMPLETED|Overall Study||6||
48444275|NCT01955473|101422329|FG002|COMPLETED|Overall Study||6||
48444276|NCT01955473|101422330|FG003|COMPLETED|Overall Study||6||
48444277|NCT01955473|101422331|FG004|COMPLETED|Overall Study||30||
48444278|NCT01955473|101422327|FG000|NOT COMPLETED|Overall Study||0||
48444279|NCT01955473|101422328|FG001|NOT COMPLETED|Overall Study||0||
48444280|NCT01955473|101422329|FG002|NOT COMPLETED|Overall Study||0||
48444281|NCT01955473|101422330|FG003|NOT COMPLETED|Overall Study||0||
48444282|NCT01955473|101422331|FG004|NOT COMPLETED|Overall Study||0||
48444283|NCT00928135|101422332|FG000|STARTED|Overall Study||30||
48444284|NCT00928135|101422333|FG001|STARTED|Overall Study||30||
48444285|NCT00928135|101422332|FG000|COMPLETED|Overall Study||29||
48444286|NCT00928135|101422333|FG001|COMPLETED|Overall Study||30||
48444287|NCT00928135|101422332|FG000|NOT COMPLETED|Overall Study||1||
48444288|NCT00928135|101422333|FG001|NOT COMPLETED|Overall Study||0||
48444289|NCT00902278|101422334|FG000|STARTED|Overall Study||54||
48444290|NCT00902278|101422335|FG001|STARTED|Overall Study||36||
48444291|NCT00902278|101422336|FG002|STARTED|Overall Study||54||
48444292|NCT00902278|101422337|FG003|STARTED|Overall Study||12||
48444293|NCT00902278|101422338|FG004|STARTED|Overall Study||37||
48444294|NCT00902278|101422334|FG000|COMPLETED|Overall Study||50||
48444295|NCT00902278|101422335|FG001|COMPLETED|Overall Study||34||
48444296|NCT00902278|101422336|FG002|COMPLETED|Overall Study||49||
48444297|NCT00902278|101422337|FG003|COMPLETED|Overall Study||12||
48444298|NCT00902278|101422338|FG004|COMPLETED|Overall Study||35||
48444299|NCT00902278|101422334|FG000|NOT COMPLETED|Overall Study||4||
48444300|NCT00902278|101422335|FG001|NOT COMPLETED|Overall Study||2||
48444301|NCT00902278|101422336|FG002|NOT COMPLETED|Overall Study||5||
48444302|NCT00902278|101422337|FG003|NOT COMPLETED|Overall Study||0||
48444303|NCT00902278|101422338|FG004|NOT COMPLETED|Overall Study||2||
48444304|NCT05899218|101422339|FG000|STARTED|Overall Study||10||
48444305|NCT05899218|101422340|FG001|STARTED|Overall Study||10||
48444306|NCT05899218|101422339|FG000|COMPLETED|Overall Study||7||
48444307|NCT05899218|101422340|FG001|COMPLETED|Overall Study||8||
48444308|NCT05899218|101422339|FG000|NOT COMPLETED|Overall Study||3||
48444309|NCT05899218|101422340|FG001|NOT COMPLETED|Overall Study||2||
48444310|NCT01257737|101422341|FG000|STARTED|Overall Study||45||
48444311|NCT01257737|101422342|FG001|STARTED|Overall Study||43||
48444312|NCT01257737|101422341|FG000|COMPLETED|Overall Study||43||
48444313|NCT01257737|101422342|FG001|COMPLETED|Overall Study||39||
48444314|NCT01257737|101422341|FG000|NOT COMPLETED|Overall Study||2||
48444315|NCT01257737|101422342|FG001|NOT COMPLETED|Overall Study||4||
48658506|NCT03232892|101948956|FG000|NOT COMPLETED|Overall Study||0||
48658507|NCT02365064|101948957|FG000|STARTED|Overall Study||31||
48444316|NCT01080209|101422343|FG000|STARTED|Overall Study||28||
48444317|NCT01080209|101422344|FG001|STARTED|Overall Study||53||
48444318|NCT01080209|101422345|FG002|STARTED|Overall Study||33||
48444319|NCT01080209|101422346|FG003|STARTED|Overall Study||42||
48444320|NCT01080209|101422347|FG004|STARTED|Overall Study||6||
48444321|NCT01080209|101422348|FG005|STARTED|Overall Study||2||
48444322|NCT01080209|101422349|FG006|STARTED|Overall Study||51||
48444323|NCT01080209|101422343|FG000|COMPLETED|Overall Study||22||
48444324|NCT01080209|101422344|FG001|COMPLETED|Overall Study||42||
48444325|NCT01080209|101422345|FG002|COMPLETED|Overall Study||28||
48444326|NCT01080209|101422346|FG003|COMPLETED|Overall Study||37||
48444327|NCT01080209|101422347|FG004|COMPLETED|Overall Study||6||
48444328|NCT01080209|101422348|FG005|COMPLETED|Overall Study||2||
48444329|NCT01080209|101422349|FG006|COMPLETED|Overall Study||44||
48444330|NCT01080209|101422343|FG000|NOT COMPLETED|Overall Study||6||
48444331|NCT01080209|101422344|FG001|NOT COMPLETED|Overall Study||11||
48444332|NCT01080209|101422345|FG002|NOT COMPLETED|Overall Study||5||
48658508|NCT02365064|101948958|FG001|STARTED|Overall Study||47||
48658509|NCT02365064|101948957|FG000|Included in ITT Analysis|Overall Study||29||
48658510|NCT02365064|101948958|FG001|Included in ITT Analysis|Overall Study||32||
48444333|NCT01080209|101422346|FG003|NOT COMPLETED|Overall Study||5||
48444334|NCT01080209|101422347|FG004|NOT COMPLETED|Overall Study||0||
48444335|NCT01080209|101422348|FG005|NOT COMPLETED|Overall Study||0||
48444336|NCT01080209|101422349|FG006|NOT COMPLETED|Overall Study||7||
48444337|NCT02748616|101422350|FG000|STARTED|Overall Study||9||
48444338|NCT02748616|101422350|FG000|COMPLETED|Overall Study||2||
48444339|NCT02748616|101422350|FG000|NOT COMPLETED|Overall Study||7||
48444340|NCT02076113|101422351|FG000|STARTED|Overall Study||63||
48444341|NCT02076113|101422352|FG001|STARTED|Overall Study||100||
48444342|NCT02076113|101422351|FG000|Surgery as Randomized|Overall Study||62||
48444343|NCT02076113|101422352|FG001|Surgery as Randomized|Overall Study||96||
48444344|NCT02076113|101422351|FG000|3-Month Follow-up|Overall Study||56||
48444345|NCT02076113|101422352|FG001|3-Month Follow-up|Overall Study||90||
48444346|NCT02076113|101422351|FG000|6-Month Follow-up|Overall Study||53||
48444347|NCT02076113|101422352|FG001|6-Month Follow-up|Overall Study||91||
48444348|NCT02076113|101422351|FG000|1-Year Follow-up|Overall Study||60||
48444349|NCT02076113|101422352|FG001|1-Year Follow-up|Overall Study||95||
48444350|NCT02076113|101422351|FG000|2-Year Follow-up|Overall Study||51||
48444351|NCT02076113|101422352|FG001|2-Year Follow-up|Overall Study||79||
48444352|NCT02076113|101422351|FG000|COMPLETED|Overall Study||56||
48444353|NCT02076113|101422352|FG001|COMPLETED|Overall Study||93||
48444354|NCT02076113|101422351|FG000|NOT COMPLETED|Overall Study||7||
48444355|NCT02076113|101422352|FG001|NOT COMPLETED|Overall Study||7||
48444356|NCT05789420|101422353|FG000|STARTED|Screening and Safety Assessments||32||
48444357|NCT05789420|101422353|FG000|COMPLETED|Screening and Safety Assessments||31||
48444358|NCT05789420|101422353|FG000|NOT COMPLETED|Screening and Safety Assessments||1||
48444359|NCT05789420|101422353|FG000|STARTED|Enrollment||31||
48444360|NCT05789420|101422353|FG000|COMPLETED|Enrollment||31||
48444361|NCT05789420|101422353|FG000|NOT COMPLETED|Enrollment||0||
48444362|NCT05789420|101422353|FG000|STARTED|Randomization to Product Assessments||31||
48444363|NCT05789420|101422353|FG000|P1R Stick|Randomization to Product Assessments||30|Regular flavor tobacco stick|
48444364|NCT05789420|101422353|FG000|P1M Stick|Randomization to Product Assessments||30|Mentholated flavor tobacco stick|
48444365|NCT05789420|101422353|FG000|CIG|Randomization to Product Assessments||30|Subject's preferred brand of commercially available, regular or mentholated cigarettes|
48444366|NCT05789420|101422353|FG000|COMPLETED|Randomization to Product Assessments||30||
48444367|NCT05789420|101422353|FG000|NOT COMPLETED|Randomization to Product Assessments||1||
48444368|NCT04440163|101422354|FG000|STARTED|Vaccination Phase (Approx. 7 Months)||552||
48444369|NCT04440163|101422355|FG001|STARTED|Vaccination Phase (Approx. 7 Months)||276||
48444370|NCT04440163|101422356|FG002|STARTED|Vaccination Phase (Approx. 7 Months)||528||
48444371|NCT04440163|101422357|FG003|STARTED|Vaccination Phase (Approx. 7 Months)||261||
48444372|NCT04440163|101422358|FG004|STARTED|Vaccination Phase (Approx. 7 Months)||544||
48444373|NCT04440163|101422359|FG005|STARTED|Vaccination Phase (Approx. 7 Months)||57||
48444374|NCT04440163|101422360|FG006|STARTED|Vaccination Phase (Approx. 7 Months)||154||
48444375|NCT04440163|101422361|FG007|STARTED|Vaccination Phase (Approx. 7 Months)||59||
48444376|NCT04440163|101422354|FG000|Vaccination 1|Vaccination Phase (Approx. 7 Months)||547||
48444377|NCT04440163|101422355|FG001|Vaccination 1|Vaccination Phase (Approx. 7 Months)||274||
48444378|NCT04440163|101422356|FG002|Vaccination 1|Vaccination Phase (Approx. 7 Months)||526||
48444379|NCT04440163|101422357|FG003|Vaccination 1|Vaccination Phase (Approx. 7 Months)||261||
48444380|NCT04440163|101422358|FG004|Vaccination 1|Vaccination Phase (Approx. 7 Months)||537||
48444381|NCT04440163|101422359|FG005|Vaccination 1|Vaccination Phase (Approx. 7 Months)||56||
48444382|NCT04440163|101422360|FG006|Vaccination 1|Vaccination Phase (Approx. 7 Months)||153||
48444383|NCT04440163|101422361|FG007|Vaccination 1|Vaccination Phase (Approx. 7 Months)||59||
48444384|NCT04440163|101422354|FG000|Vaccination 2|Vaccination Phase (Approx. 7 Months)||500||
48444385|NCT04440163|101422355|FG001|Vaccination 2|Vaccination Phase (Approx. 7 Months)||254||
48444386|NCT04440163|101422356|FG002|Vaccination 2|Vaccination Phase (Approx. 7 Months)||453||
48444387|NCT04440163|101422357|FG003|Vaccination 2|Vaccination Phase (Approx. 7 Months)||218||
48444388|NCT04440163|101422358|FG004|Vaccination 2|Vaccination Phase (Approx. 7 Months)||481||
48444389|NCT04440163|101422359|FG005|Vaccination 2|Vaccination Phase (Approx. 7 Months)||46||
48444390|NCT04440163|101422360|FG006|Vaccination 2|Vaccination Phase (Approx. 7 Months)||123||
48444391|NCT04440163|101422361|FG007|Vaccination 2|Vaccination Phase (Approx. 7 Months)||45||
48444392|NCT04440163|101422354|FG000|COMPLETED|Vaccination Phase (Approx. 7 Months)||490||
48444393|NCT04440163|101422355|FG001|COMPLETED|Vaccination Phase (Approx. 7 Months)||248||
48444394|NCT04440163|101422356|FG002|COMPLETED|Vaccination Phase (Approx. 7 Months)||440||
48444395|NCT04440163|101422357|FG003|COMPLETED|Vaccination Phase (Approx. 7 Months)||209||
48444396|NCT04440163|101422358|FG004|COMPLETED|Vaccination Phase (Approx. 7 Months)||476||
48444397|NCT04440163|101422359|FG005|COMPLETED|Vaccination Phase (Approx. 7 Months)||45||
48444398|NCT04440163|101422360|FG006|COMPLETED|Vaccination Phase (Approx. 7 Months)||122||
48444399|NCT04440163|101422361|FG007|COMPLETED|Vaccination Phase (Approx. 7 Months)||44||
48444400|NCT04440163|101422354|FG000|NOT COMPLETED|Vaccination Phase (Approx. 7 Months)||62||
48444401|NCT04440163|101422355|FG001|NOT COMPLETED|Vaccination Phase (Approx. 7 Months)||28||
48658511|NCT02365064|101948957|FG000|COMPLETED|Overall Study||21||
48658512|NCT02365064|101948958|FG001|COMPLETED|Overall Study||19||
48658513|NCT02365064|101948957|FG000|NOT COMPLETED|Overall Study||10||
48444402|NCT04440163|101422356|FG002|NOT COMPLETED|Vaccination Phase (Approx. 7 Months)||88||
48444403|NCT04440163|101422357|FG003|NOT COMPLETED|Vaccination Phase (Approx. 7 Months)||52||
48444404|NCT04440163|101422358|FG004|NOT COMPLETED|Vaccination Phase (Approx. 7 Months)||68||
48444405|NCT04440163|101422359|FG005|NOT COMPLETED|Vaccination Phase (Approx. 7 Months)||12||
48444406|NCT04440163|101422360|FG006|NOT COMPLETED|Vaccination Phase (Approx. 7 Months)||32||
48444407|NCT04440163|101422361|FG007|NOT COMPLETED|Vaccination Phase (Approx. 7 Months)||15||
48444408|NCT04440163|101422354|FG000|STARTED|Follow-up Phase (Approx. 5 Months)||490||
48444409|NCT04440163|101422355|FG001|STARTED|Follow-up Phase (Approx. 5 Months)||248||
48444410|NCT04440163|101422356|FG002|STARTED|Follow-up Phase (Approx. 5 Months)||440||
48444411|NCT04440163|101422357|FG003|STARTED|Follow-up Phase (Approx. 5 Months)||209||
48444412|NCT04440163|101422358|FG004|STARTED|Follow-up Phase (Approx. 5 Months)||476||
48444413|NCT04440163|101422359|FG005|STARTED|Follow-up Phase (Approx. 5 Months)||45||
48444414|NCT04440163|101422360|FG006|STARTED|Follow-up Phase (Approx. 5 Months)||122||
48444415|NCT04440163|101422361|FG007|STARTED|Follow-up Phase (Approx. 5 Months)||44||
48444416|NCT04440163|101422354|FG000|COMPLETED|Follow-up Phase (Approx. 5 Months)||487||
48444417|NCT04440163|101422355|FG001|COMPLETED|Follow-up Phase (Approx. 5 Months)||243||
48444418|NCT04440163|101422356|FG002|COMPLETED|Follow-up Phase (Approx. 5 Months)||440||
48444419|NCT04440163|101422357|FG003|COMPLETED|Follow-up Phase (Approx. 5 Months)||208||
48444420|NCT04440163|101422358|FG004|COMPLETED|Follow-up Phase (Approx. 5 Months)||475||
48444421|NCT04440163|101422359|FG005|COMPLETED|Follow-up Phase (Approx. 5 Months)||45||
48444422|NCT04440163|101422360|FG006|COMPLETED|Follow-up Phase (Approx. 5 Months)||120||
48444423|NCT04440163|101422361|FG007|COMPLETED|Follow-up Phase (Approx. 5 Months)||43||
48444424|NCT04440163|101422354|FG000|NOT COMPLETED|Follow-up Phase (Approx. 5 Months)||3||
48444425|NCT04440163|101422355|FG001|NOT COMPLETED|Follow-up Phase (Approx. 5 Months)||5||
48444426|NCT04440163|101422356|FG002|NOT COMPLETED|Follow-up Phase (Approx. 5 Months)||0||
48444427|NCT04440163|101422357|FG003|NOT COMPLETED|Follow-up Phase (Approx. 5 Months)||1||
48444428|NCT04440163|101422358|FG004|NOT COMPLETED|Follow-up Phase (Approx. 5 Months)||1||
48444429|NCT04440163|101422359|FG005|NOT COMPLETED|Follow-up Phase (Approx. 5 Months)||0||
48444430|NCT04440163|101422360|FG006|NOT COMPLETED|Follow-up Phase (Approx. 5 Months)||2||
48444431|NCT04440163|101422361|FG007|NOT COMPLETED|Follow-up Phase (Approx. 5 Months)||1||
48444432|NCT01933932|101422362|FG000|STARTED|Overall Study||254||
48444433|NCT01933932|101422363|FG001|STARTED|Overall Study||256||
48444434|NCT01933932|101422362|FG000|COMPLETED|Overall Study||70||
48444435|NCT01933932|101422363|FG001|COMPLETED|Overall Study||78||
48444436|NCT01933932|101422362|FG000|NOT COMPLETED|Overall Study||184||
48444437|NCT01933932|101422363|FG001|NOT COMPLETED|Overall Study||178||
48444438|NCT01066039|101422364|FG000|STARTED|Overall Study||202||
48444439|NCT01066039|101422364|FG000|Treated|Overall Study||200||
48444440|NCT01066039|101422364|FG000|COMPLETED|Overall Study||158||
48444441|NCT01066039|101422364|FG000|NOT COMPLETED|Overall Study||44||
48444442|NCT00358670|101422365|FG000|STARTED|Overall Study||222||
48444443|NCT00358670|101422366|FG001|STARTED|Overall Study||219||
48444444|NCT00358670|101422365|FG000|COMPLETED|Overall Study||0||
48444445|NCT00358670|101422366|FG001|COMPLETED|Overall Study||0||
48444446|NCT00358670|101422365|FG000|NOT COMPLETED|Overall Study||222||
48444447|NCT00358670|101422366|FG001|NOT COMPLETED|Overall Study||219||
48444448|NCT03443973|101422367|FG000|STARTED|Double-blind Treatment Period||477||
48444449|NCT03443973|101422368|FG001|STARTED|Double-blind Treatment Period||498||
48444450|NCT03443973|101422369|FG002|STARTED|Double-blind Treatment Period||0||
48444451|NCT03443973|101422370|FG003|STARTED|Double-blind Treatment Period||0||
48444452|NCT03443973|101422367|FG000|Safety-evaluable Set|Double-blind Treatment Period||474|Safety-evaluable set included all participants randomized during the global phase, who received at least one dose of study drug. In DBT period, three participants randomized to placebo arm received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set.|
48658514|NCT02365064|101948958|FG001|NOT COMPLETED|Overall Study||28||
48444453|NCT03443973|101422368|FG001|Safety-evaluable Set|Double-blind Treatment Period||501|Safety-evaluable set included all participants randomized during the global phase, who received at least one dose of study drug. In DBT period, three participants randomized to placebo arm received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set.|
48444454|NCT03443973|101422369|FG002|Safety-evaluable Set|Double-blind Treatment Period||0|Safety-evaluable set included all participants randomized during the global phase, who received at least one dose of study drug. In DBT period, three participants randomized to placebo arm received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set.|
48444455|NCT03443973|101422370|FG003|Safety-evaluable Set|Double-blind Treatment Period||0|Safety-evaluable set included all participants randomized during the global phase, who received at least one dose of study drug. In DBT period, three participants randomized to placebo arm received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set.|
48444456|NCT03443973|101422367|FG000|COMPLETED|Double-blind Treatment Period||397||
48444457|NCT03443973|101422368|FG001|COMPLETED|Double-blind Treatment Period||372||
48444458|NCT03443973|101422369|FG002|COMPLETED|Double-blind Treatment Period||0||
48444459|NCT03443973|101422370|FG003|COMPLETED|Double-blind Treatment Period||0||
48658515|NCT04989218|101948959|FG000|STARTED|Overall Study||1||
48658516|NCT04989218|101948959|FG000|COMPLETED|Overall Study||1||
48658517|NCT04989218|101948959|FG000|NOT COMPLETED|Overall Study||0||
48188938|NCT00689104|100786118|FG000|STARTED|Overall Study||497||
48444460|NCT03443973|101422367|FG000|NOT COMPLETED|Double-blind Treatment Period||80||
48444461|NCT03443973|101422368|FG001|NOT COMPLETED|Double-blind Treatment Period||126||
48444462|NCT03443973|101422369|FG002|NOT COMPLETED|Double-blind Treatment Period||0||
48444463|NCT03443973|101422370|FG003|NOT COMPLETED|Double-blind Treatment Period||0||
48444464|NCT03443973|101422367|FG000|STARTED|Open-label Extension Period||0||
48444465|NCT03443973|101422368|FG001|STARTED|Open-label Extension Period||0||
48444466|NCT03443973|101422369|FG002|STARTED|Open-label Extension Period||13||
48444467|NCT03443973|101422370|FG003|STARTED|Open-label Extension Period||14||
48444468|NCT03443973|101422367|FG000|COMPLETED|Open-label Extension Period||0||
48444469|NCT03443973|101422368|FG001|COMPLETED|Open-label Extension Period||0||
48444470|NCT03443973|101422369|FG002|COMPLETED|Open-label Extension Period||8||
48444471|NCT03443973|101422370|FG003|COMPLETED|Open-label Extension Period||13||
48444472|NCT03443973|101422367|FG000|NOT COMPLETED|Open-label Extension Period||0||
48444473|NCT03443973|101422368|FG001|NOT COMPLETED|Open-label Extension Period||0||
48769919|NCT02592798|102225951|FG000|COMPLETED|Double-Blind Period 1 (DB1)||14||
48769920|NCT02592798|102225952|FG001|COMPLETED|Double-Blind Period 1 (DB1)||13||
48769921|NCT02592798|102225951|FG000|NOT COMPLETED|Double-Blind Period 1 (DB1)||3||
48769922|NCT02592798|102225952|FG001|NOT COMPLETED|Double-Blind Period 1 (DB1)||6||
48769923|NCT02592798|102225951|FG000|STARTED|Transition From DB1 to DB2||14||
48769924|NCT02592798|102225952|FG001|STARTED|Transition From DB1 to DB2||13||
48769925|NCT02592798|102225951|FG000|COMPLETED|Transition From DB1 to DB2||11||
48769926|NCT02592798|102225952|FG001|COMPLETED|Transition From DB1 to DB2||11||
48368890|NCT02599766|101232644|FG000|STARTED|Overall Study||22||
48368891|NCT02599766|101232644|FG000|COMPLETED|Overall Study||19||
48368892|NCT02599766|101232644|FG000|NOT COMPLETED|Overall Study||3||
48368893|NCT01905397|101232645|FG000|STARTED|Overall Study||82||
48368894|NCT01905397|101232646|FG001|STARTED|Overall Study||82||
48368895|NCT01905397|101232645|FG000|COMPLETED|Overall Study||63||
48368896|NCT01905397|101232646|FG001|COMPLETED|Overall Study||75||
48368897|NCT01905397|101232645|FG000|NOT COMPLETED|Overall Study||19||
48368898|NCT01905397|101232646|FG001|NOT COMPLETED|Overall Study||7||
48368899|NCT01734993|101232647|FG000|STARTED|Overall Study||11||
48368900|NCT01734993|101232647|FG000|COMPLETED|Overall Study||9||
48368901|NCT01734993|101232647|FG000|NOT COMPLETED|Overall Study||2||
48368902|NCT01617434|101232648|FG000|STARTED|Overall Study||226||
48368903|NCT01617434|101232649|FG001|STARTED|Overall Study||225||
48368904|NCT01617434|101232648|FG000|Exposed|Overall Study||225||
48368905|NCT01617434|101232649|FG001|Exposed|Overall Study||225||
48368906|NCT01617434|101232648|FG000|COMPLETED|Overall Study||191||
48368907|NCT01617434|101232649|FG001|COMPLETED|Overall Study||174||
48368908|NCT01617434|101232648|FG000|NOT COMPLETED|Overall Study||35||
48368909|NCT01617434|101232649|FG001|NOT COMPLETED|Overall Study||51||
48368910|NCT02606045|101232650|FG000|STARTED|Overall Study||18||
48368911|NCT02606045|101232651|FG001|STARTED|Overall Study||21||
48368912|NCT02606045|101232650|FG000|COMPLETED|Overall Study||17||
48368913|NCT02606045|101232651|FG001|COMPLETED|Overall Study||19||
48368914|NCT02606045|101232650|FG000|NOT COMPLETED|Overall Study||1||
48368915|NCT02606045|101232651|FG001|NOT COMPLETED|Overall Study||2||
48368916|NCT04743635|101232652|FG000|STARTED|Overall Study||68||
48368917|NCT04743635|101232653|FG001|STARTED|Overall Study||6||
48368918|NCT04743635|101232652|FG000|COMPLETED|Overall Study||66||
48368919|NCT04743635|101232653|FG001|COMPLETED|Overall Study||6||
48368920|NCT04743635|101232652|FG000|NOT COMPLETED|Overall Study||2||
48368921|NCT04743635|101232653|FG001|NOT COMPLETED|Overall Study||0||
48368922|NCT01937130|101232654|FG000|STARTED|Overall Study||5||
48368923|NCT01937130|101232655|FG001|STARTED|Overall Study||7||
48368924|NCT01937130|101232656|FG002|STARTED|Overall Study||5||
48368925|NCT01937130|101232657|FG003|STARTED|Overall Study||4||
48368926|NCT01937130|101232654|FG000|COMPLETED|Overall Study||0||
48368927|NCT01937130|101232655|FG001|COMPLETED|Overall Study||3||
48368928|NCT01937130|101232656|FG002|COMPLETED|Overall Study||2||
48368929|NCT01937130|101232657|FG003|COMPLETED|Overall Study||2||
48368930|NCT01937130|101232654|FG000|NOT COMPLETED|Overall Study||5||
48368931|NCT01937130|101232655|FG001|NOT COMPLETED|Overall Study||4||
48368932|NCT01937130|101232656|FG002|NOT COMPLETED|Overall Study||3||
48368933|NCT01937130|101232657|FG003|NOT COMPLETED|Overall Study||2||
48368934|NCT00114972|101232658|FG000|STARTED|Overall Study||897||
48368935|NCT00114972|101232659|FG001|STARTED|Overall Study||903||
48368936|NCT00114972|101232658|FG000|COMPLETED|Overall Study||849||
48368937|NCT00114972|101232659|FG001|COMPLETED|Overall Study||891||
48368938|NCT00114972|101232658|FG000|NOT COMPLETED|Overall Study||48||
48368939|NCT00114972|101232659|FG001|NOT COMPLETED|Overall Study||12||
48368940|NCT02750813|101232660|FG000|STARTED|Period 1, First 14 Days of Wear||125||
48368941|NCT02750813|101232661|FG001|STARTED|Period 1, First 14 Days of Wear||121||
48368942|NCT02750813|101232660|FG000|COMPLETED|Period 1, First 14 Days of Wear||124||
48368943|NCT02750813|101232661|FG001|COMPLETED|Period 1, First 14 Days of Wear||120||
48368944|NCT02750813|101232660|FG000|NOT COMPLETED|Period 1, First 14 Days of Wear||1||
48368945|NCT02750813|101232661|FG001|NOT COMPLETED|Period 1, First 14 Days of Wear||1||
48368946|NCT02750813|101232660|FG000|STARTED|Period 2, Second 14 Days of Wear||124||
48368947|NCT02750813|101232661|FG001|STARTED|Period 2, Second 14 Days of Wear||120||
48444474|NCT03443973|101422369|FG002|NOT COMPLETED|Open-label Extension Period||5||
48444475|NCT03443973|101422370|FG003|NOT COMPLETED|Open-label Extension Period||1||
48444476|NCT03811366|101422371|FG000|STARTED|Overall Study||12||24
48444477|NCT03811366|101422371|FG000|COMPLETED|Overall Study||12||24
48444478|NCT03811366|101422371|FG000|NOT COMPLETED|Overall Study||0||0
48444479|NCT01754480|101422372|FG000|STARTED|Part I + Part II (Overall Study)||163||
48444480|NCT01754480|101422373|FG001|STARTED|Part I + Part II (Overall Study)||162||
48444481|NCT01754480|101422372|FG000|Completed Study up to Week 6|Part I + Part II (Overall Study)||147||
48444482|NCT01754480|101422373|FG001|Completed Study up to Week 6|Part I + Part II (Overall Study)||153||
48444483|NCT01754480|101422372|FG000|COMPLETED|Part I + Part II (Overall Study)||138||
48444484|NCT01754480|101422373|FG001|COMPLETED|Part I + Part II (Overall Study)||139||
48444485|NCT01754480|101422372|FG000|NOT COMPLETED|Part I + Part II (Overall Study)||25||
48444486|NCT01754480|101422373|FG001|NOT COMPLETED|Part I + Part II (Overall Study)||23||
48444487|NCT01754480|101422372|FG000|STARTED|Primary Part II||111||
48444488|NCT01754480|101422373|FG001|STARTED|Primary Part II||113||
48444489|NCT01754480|101422372|FG000|Completed Study up to Week 6|Primary Part II||100||
48444490|NCT01754480|101422373|FG001|Completed Study up to Week 6|Primary Part II||108||
48444491|NCT01754480|101422372|FG000|COMPLETED|Primary Part II||96||
48444492|NCT01754480|101422373|FG001|COMPLETED|Primary Part II||102||
48444493|NCT01754480|101422372|FG000|NOT COMPLETED|Primary Part II||15||
48444494|NCT01754480|101422373|FG001|NOT COMPLETED|Primary Part II||11||
48444495|NCT03638102|101422374|FG000|STARTED|Overall Study||12||
48444496|NCT03638102|101422375|FG001|STARTED|Overall Study||6||
48444497|NCT03638102|101422374|FG000|COMPLETED|Overall Study||9||
48444498|NCT03638102|101422375|FG001|COMPLETED|Overall Study||5||
48444499|NCT03638102|101422374|FG000|NOT COMPLETED|Overall Study||3||
48444500|NCT03638102|101422375|FG001|NOT COMPLETED|Overall Study||1||
48444501|NCT00998582|101422376|FG000|STARTED|Overall Study||13||
48444502|NCT00998582|101422377|FG001|STARTED|Overall Study||14||
48444503|NCT00998582|101422376|FG000|COMPLETED|Overall Study||13||
48444504|NCT00998582|101422377|FG001|COMPLETED|Overall Study||14||
48444505|NCT00998582|101422376|FG000|NOT COMPLETED|Overall Study||0||
48444506|NCT00998582|101422377|FG001|NOT COMPLETED|Overall Study||0||
48444507|NCT02380248|101422378|FG000|STARTED|Overall Study||200||
48444508|NCT02380248|101422378|FG000|COMPLETED|Overall Study||186||
48444509|NCT02380248|101422378|FG000|NOT COMPLETED|Overall Study||14||
48444510|NCT01793285|101422379|FG000|STARTED|Overall Study||85||
48444511|NCT01793285|101422379|FG000|COMPLETED|Overall Study||85||
48444512|NCT01793285|101422379|FG000|NOT COMPLETED|Overall Study||0||
48444513|NCT04456764|101422380|FG000|STARTED|Overall Study||385||54
48444514|NCT04456764|101422381|FG001|STARTED|Overall Study||323||54
48444515|NCT04456764|101422380|FG000|COMPLETED|Overall Study||319||47
48444516|NCT04456764|101422381|FG001|COMPLETED|Overall Study||272||44
48444517|NCT04456764|101422380|FG000|NOT COMPLETED|Overall Study||66||7
48444518|NCT04456764|101422381|FG001|NOT COMPLETED|Overall Study||51||10
48444519|NCT03237481|101422382|FG000|STARTED|Overall Study||164||
48444520|NCT03237481|101422383|FG001|STARTED|Overall Study||172||
48444521|NCT03237481|101422384|FG002|STARTED|Overall Study||82||
48444522|NCT03237481|101422382|FG000|COMPLETED|Overall Study||159||
48444523|NCT03237481|101422383|FG001|COMPLETED|Overall Study||170||
48444524|NCT03237481|101422384|FG002|COMPLETED|Overall Study||81||
48444525|NCT03237481|101422382|FG000|NOT COMPLETED|Overall Study||5||
48444526|NCT03237481|101422383|FG001|NOT COMPLETED|Overall Study||2||
48444527|NCT03237481|101422384|FG002|NOT COMPLETED|Overall Study||1||
48444528|NCT01516684|101422385|FG000|STARTED|Overall Study||0||85
48444529|NCT01516684|101422386|FG001|STARTED|Overall Study||0||85
48444530|NCT01516684|101422385|FG000|COMPLETED|Overall Study||0|Overall number of units (trials) completed was 152|75
48444531|NCT01516684|101422386|FG001|COMPLETED|Overall Study||0|Overall number of units (trials) completed was 152|77
48444532|NCT01516684|101422385|FG000|NOT COMPLETED|Overall Study||0||10
48444533|NCT01516684|101422386|FG001|NOT COMPLETED|Overall Study||0||8
48444534|NCT00788008|101422387|FG000|STARTED|Overall Study||98||
48444535|NCT00788008|101422388|FG001|STARTED|Overall Study||101||
48444536|NCT00788008|101422387|FG000|COMPLETED|Overall Study||98||
48444537|NCT00788008|101422388|FG001|COMPLETED|Overall Study||101||
48444538|NCT00788008|101422387|FG000|NOT COMPLETED|Overall Study||0||
48444539|NCT00788008|101422388|FG001|NOT COMPLETED|Overall Study||0||
48444540|NCT01783860|101422389|FG000|STARTED|Overall Study||50||
48444541|NCT01783860|101422390|FG001|STARTED|Overall Study||50||
48444542|NCT01783860|101422389|FG000|COMPLETED|Overall Study||50||
48444543|NCT01783860|101422390|FG001|COMPLETED|Overall Study||50||
48444544|NCT01783860|101422389|FG000|NOT COMPLETED|Overall Study||0||
48444545|NCT01783860|101422390|FG001|NOT COMPLETED|Overall Study||0||
48444546|NCT03428217|101422391|FG000|STARTED|Overall Study||223||
48444547|NCT03428217|101422392|FG001|STARTED|Overall Study||221||
48444548|NCT03428217|101422391|FG000|Received at Least 1 Dose of Study Drug|Overall Study||221||
48444549|NCT03428217|101422392|FG001|Received at Least 1 Dose of Study Drug|Overall Study||221||
48444550|NCT03428217|101422391|FG000|COMPLETED|Overall Study||0|Participants received study treatment until disease progression or unacceptable toxicity, whichever occurred first.|
48444551|NCT03428217|101422392|FG001|COMPLETED|Overall Study||0|Participants received study treatment until disease progression or unacceptable toxicity, whichever occurred first.|
48444552|NCT03428217|101422391|FG000|NOT COMPLETED|Overall Study||223||
48444553|NCT03428217|101422392|FG001|NOT COMPLETED|Overall Study||221||
48444554|NCT02184169|101422393|FG000|STARTED|Overall Study||21||
48444555|NCT02184169|101422394|FG001|STARTED|Overall Study||6||
48444556|NCT02184169|101422393|FG000|COMPLETED|Overall Study||21||
48444557|NCT02184169|101422394|FG001|COMPLETED|Overall Study||6||
48444558|NCT02184169|101422393|FG000|NOT COMPLETED|Overall Study||0||
48444559|NCT02184169|101422394|FG001|NOT COMPLETED|Overall Study||0||
48444560|NCT05346237|101422395|FG000|STARTED|Overall Study||50||
48444561|NCT05346237|101422395|FG000|COMPLETED|Overall Study||50||
48444562|NCT05346237|101422395|FG000|NOT COMPLETED|Overall Study||0||
48444563|NCT05674721|101422396|FG000|STARTED|Treatment Period 1 (Up to 3 Days)||22||
48444564|NCT05674721|101422397|FG001|STARTED|Treatment Period 1 (Up to 3 Days)||22||
48444565|NCT05674721|101422396|FG000|COMPLETED|Treatment Period 1 (Up to 3 Days)||22||
48444566|NCT05674721|101422397|FG001|COMPLETED|Treatment Period 1 (Up to 3 Days)||22||
48444567|NCT05674721|101422396|FG000|NOT COMPLETED|Treatment Period 1 (Up to 3 Days)||0||
48444568|NCT05674721|101422397|FG001|NOT COMPLETED|Treatment Period 1 (Up to 3 Days)||0||
48444569|NCT05674721|101422396|FG000|STARTED|Washout Period (Up to 7 Days)||22||
48444570|NCT05674721|101422397|FG001|STARTED|Washout Period (Up to 7 Days)||22||
48444571|NCT05674721|101422396|FG000|COMPLETED|Washout Period (Up to 7 Days)||22||
48444572|NCT05674721|101422397|FG001|COMPLETED|Washout Period (Up to 7 Days)||20||
48444573|NCT05674721|101422396|FG000|NOT COMPLETED|Washout Period (Up to 7 Days)||0||
48769927|NCT02592798|102225951|FG000|NOT COMPLETED|Transition From DB1 to DB2||3||
48769928|NCT02592798|102225952|FG001|NOT COMPLETED|Transition From DB1 to DB2||2||
48769929|NCT02592798|102225951|FG000|STARTED|Double-Blind Period 2 (DB2)||11||
48769930|NCT02592798|102225952|FG001|STARTED|Double-Blind Period 2 (DB2)||11||
48444574|NCT05674721|101422397|FG001|NOT COMPLETED|Washout Period (Up to 7 Days)||2||
48444575|NCT05674721|101422396|FG000|STARTED|Treatment Period 2 (Up to 3 Days)||22||
48444576|NCT05674721|101422397|FG001|STARTED|Treatment Period 2 (Up to 3 Days)||20||
48444577|NCT05674721|101422396|FG000|COMPLETED|Treatment Period 2 (Up to 3 Days)||22||
48444578|NCT05674721|101422397|FG001|COMPLETED|Treatment Period 2 (Up to 3 Days)||20||
48444579|NCT05674721|101422396|FG000|NOT COMPLETED|Treatment Period 2 (Up to 3 Days)||0||
48658518|NCT02544763|101948960|FG000|STARTED|Overall Study||75||
48444580|NCT05674721|101422397|FG001|NOT COMPLETED|Treatment Period 2 (Up to 3 Days)||0||
48444581|NCT03851107|101422398|FG000|STARTED|Overall Study||9||
48444582|NCT03851107|101422398|FG000|COMPLETED|Overall Study||7||
48444583|NCT03851107|101422398|FG000|NOT COMPLETED|Overall Study||2||
48444584|NCT02094573|101422399|FG000|STARTED|Overall Study||112||
48444585|NCT02094573|101422400|FG001|STARTED|Overall Study||110||
48658519|NCT02544763|101948961|FG001|STARTED|Overall Study||73||
48658520|NCT02544763|101948962|FG002|STARTED|Overall Study||76||
48658521|NCT02544763|101948960|FG000|COMPLETED|Overall Study||65||
48658522|NCT02544763|101948961|FG001|COMPLETED|Overall Study||61||
48658523|NCT02544763|101948962|FG002|COMPLETED|Overall Study||75||
48658524|NCT02544763|101948960|FG000|NOT COMPLETED|Overall Study||10||
48658525|NCT02544763|101948961|FG001|NOT COMPLETED|Overall Study||12||
48658526|NCT02544763|101948962|FG002|NOT COMPLETED|Overall Study||1||
48658527|NCT02691494|101948963|FG000|STARTED|Treatment Period||94|randomized and treated|
48658528|NCT02691494|101948964|FG001|STARTED|Treatment Period||95|randomized and treated|
48658529|NCT02691494|101948965|FG002|STARTED|Treatment Period||189|randomized and treated|
48658530|NCT02691494|101948963|FG000|COMPLETED|Treatment Period||72||
48658531|NCT02691494|101948964|FG001|COMPLETED|Treatment Period||69||
48658532|NCT02691494|101948965|FG002|COMPLETED|Treatment Period||148||
48658533|NCT02691494|101948963|FG000|NOT COMPLETED|Treatment Period||22||
48658534|NCT02691494|101948964|FG001|NOT COMPLETED|Treatment Period||26||
48658535|NCT02691494|101948965|FG002|NOT COMPLETED|Treatment Period||41||
48444586|NCT02094573|101422399|FG000|Treated|Overall Study||109||
48444587|NCT02094573|101422400|FG001|Treated|Overall Study||110||
48444588|NCT02094573|101422399|FG000|COMPLETED|Overall Study||0|Completed = Participants who completed the treatment.|
48444589|NCT02094573|101422400|FG001|COMPLETED|Overall Study||0|Completed = Participants who completed the treatment.|
48444590|NCT02094573|101422399|FG000|NOT COMPLETED|Overall Study||112||
48444591|NCT02094573|101422400|FG001|NOT COMPLETED|Overall Study||110||
48444592|NCT03514121|101422401|FG000|STARTED|Overall Study||1||
48444593|NCT03514121|101422402|FG001|STARTED|Overall Study||1||
48444594|NCT03514121|101422403|FG002|STARTED|Overall Study||3||
48444595|NCT03514121|101422404|FG003|STARTED|Overall Study||1||
48444596|NCT03514121|101422405|FG004|STARTED|Overall Study||3||
48444597|NCT03514121|101422406|FG005|STARTED|Overall Study||8||
48444598|NCT03514121|101422407|FG006|STARTED|Overall Study||8||
48444599|NCT03514121|101422408|FG007|STARTED|Overall Study||4||
48444600|NCT03514121|101422409|FG008|STARTED|Overall Study||54||
48444601|NCT03514121|101422410|FG009|STARTED|Overall Study||12||
48444602|NCT03514121|101422401|FG000|Received Any Study Treatment|Overall Study||1||
48444603|NCT03514121|101422402|FG001|Received Any Study Treatment|Overall Study||1||
48658536|NCT02691494|101948963|FG000|STARTED|Post-Treatment Follow-Up Period||14||
48444604|NCT03514121|101422403|FG002|Received Any Study Treatment|Overall Study||3||
48444605|NCT03514121|101422404|FG003|Received Any Study Treatment|Overall Study||1||
48444606|NCT03514121|101422405|FG004|Received Any Study Treatment|Overall Study||3||
48444607|NCT03514121|101422406|FG005|Received Any Study Treatment|Overall Study||8||
48444608|NCT03514121|101422407|FG006|Received Any Study Treatment|Overall Study||8||
48444609|NCT03514121|101422408|FG007|Received Any Study Treatment|Overall Study||4||
48444610|NCT03514121|101422409|FG008|Received Any Study Treatment|Overall Study||54||
48444611|NCT03514121|101422410|FG009|Received Any Study Treatment|Overall Study||12||
48444612|NCT03514121|101422401|FG000|1b Monotherapy (Breast)|Overall Study||0||
48444613|NCT03514121|101422402|FG001|1b Monotherapy (Breast)|Overall Study||0||
48444614|NCT03514121|101422403|FG002|1b Monotherapy (Breast)|Overall Study||0||
48444615|NCT03514121|101422404|FG003|1b Monotherapy (Breast)|Overall Study||0||
48444616|NCT03514121|101422405|FG004|1b Monotherapy (Breast)|Overall Study||0||
48444617|NCT03514121|101422406|FG005|1b Monotherapy (Breast)|Overall Study||0||
48444618|NCT03514121|101422407|FG006|1b Monotherapy (Breast)|Overall Study||0||
48444619|NCT03514121|101422408|FG007|1b Monotherapy (Breast)|Overall Study||0||
48444620|NCT03514121|101422409|FG008|1b Monotherapy (Breast)|Overall Study||21||
48444621|NCT03514121|101422410|FG009|1b Monotherapy (Breast)|Overall Study||0||
48444622|NCT03514121|101422401|FG000|1b Monotherapy (Ovarian)|Overall Study||0||
48444623|NCT03514121|101422402|FG001|1b Monotherapy (Ovarian)|Overall Study||0||
48444624|NCT03514121|101422403|FG002|1b Monotherapy (Ovarian)|Overall Study||0||
48188939|NCT00689104|100786119|FG001|STARTED|Overall Study||497||
48188940|NCT00689104|100786120|FG002|STARTED|Overall Study||498||
48188941|NCT00689104|100786121|FG003|STARTED|Overall Study||495||
48188942|NCT00689104|100786118|FG000|Safety Analysis Set (SAF)|Overall Study||494||
48188943|NCT00689104|100786119|FG001|Safety Analysis Set (SAF)|Overall Study||493||
48188944|NCT00689104|100786120|FG002|Safety Analysis Set (SAF)|Overall Study||496||
48188945|NCT00689104|100786121|FG003|Safety Analysis Set (SAF)|Overall Study||495||
48188946|NCT00689104|100786118|FG000|Full Analysis Set (FAS)|Overall Study||480||
48188947|NCT00689104|100786119|FG001|Full Analysis Set (FAS)|Overall Study||473||
48188948|NCT00689104|100786120|FG002|Full Analysis Set (FAS)|Overall Study||478||
48188949|NCT00689104|100786121|FG003|Full Analysis Set (FAS)|Overall Study||475||
48188950|NCT00689104|100786118|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study||291||
48188951|NCT00689104|100786119|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study||293||
48188952|NCT00689104|100786120|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study||281||
48368948|NCT02750813|101232660|FG000|COMPLETED|Period 2, Second 14 Days of Wear||124||
48368949|NCT02750813|101232661|FG001|COMPLETED|Period 2, Second 14 Days of Wear||120||
48368950|NCT02750813|101232660|FG000|NOT COMPLETED|Period 2, Second 14 Days of Wear||0||
48368951|NCT02750813|101232661|FG001|NOT COMPLETED|Period 2, Second 14 Days of Wear||0||
48368952|NCT02123017|101232662|FG000|STARTED|Overall Study||8||
48368953|NCT02123017|101232663|FG001|STARTED|Overall Study||12||
48368954|NCT02123017|101232664|FG002|STARTED|Overall Study||12||
48368955|NCT02123017|101232662|FG000|COMPLETED|Overall Study||8||
48368956|NCT02123017|101232663|FG001|COMPLETED|Overall Study||12||
48368957|NCT02123017|101232664|FG002|COMPLETED|Overall Study||12||
48368958|NCT02123017|101232662|FG000|NOT COMPLETED|Overall Study||0||
48368959|NCT02123017|101232663|FG001|NOT COMPLETED|Overall Study||0||
48368960|NCT02123017|101232664|FG002|NOT COMPLETED|Overall Study||0||
48444625|NCT03514121|101422404|FG003|1b Monotherapy (Ovarian)|Overall Study||0||
48444626|NCT03514121|101422405|FG004|1b Monotherapy (Ovarian)|Overall Study||0||
48444627|NCT03514121|101422406|FG005|1b Monotherapy (Ovarian)|Overall Study||0||
48444628|NCT03514121|101422407|FG006|1b Monotherapy (Ovarian)|Overall Study||0||
48444629|NCT03514121|101422408|FG007|1b Monotherapy (Ovarian)|Overall Study||0||
48444630|NCT03514121|101422409|FG008|1b Monotherapy (Ovarian)|Overall Study||17||
48444631|NCT03514121|101422410|FG009|1b Monotherapy (Ovarian)|Overall Study||0||
48444632|NCT03514121|101422401|FG000|1b Monotherapy (Endometrial)|Overall Study||0||
48444633|NCT03514121|101422402|FG001|1b Monotherapy (Endometrial)|Overall Study||0||
48444634|NCT03514121|101422403|FG002|1b Monotherapy (Endometrial)|Overall Study||0||
48444635|NCT03514121|101422404|FG003|1b Monotherapy (Endometrial)|Overall Study||0||
48444636|NCT03514121|101422405|FG004|1b Monotherapy (Endometrial)|Overall Study||0||
48444637|NCT03514121|101422406|FG005|1b Monotherapy (Endometrial)|Overall Study||0||
48444638|NCT03514121|101422407|FG006|1b Monotherapy (Endometrial)|Overall Study||0||
48444639|NCT03514121|101422408|FG007|1b Monotherapy (Endometrial)|Overall Study||0||
48444640|NCT03514121|101422409|FG008|1b Monotherapy (Endometrial)|Overall Study||16||
48444641|NCT03514121|101422410|FG009|1b Monotherapy (Endometrial)|Overall Study||0||
48444642|NCT03514121|101422401|FG000|Phase 1a Combination Safety Lead-In|Overall Study||0||
48444643|NCT03514121|101422402|FG001|Phase 1a Combination Safety Lead-In|Overall Study||0||
48444644|NCT03514121|101422403|FG002|Phase 1a Combination Safety Lead-In|Overall Study||0||
48444645|NCT03514121|101422404|FG003|Phase 1a Combination Safety Lead-In|Overall Study||0||
48444646|NCT03514121|101422405|FG004|Phase 1a Combination Safety Lead-In|Overall Study||0||
48444647|NCT03514121|101422406|FG005|Phase 1a Combination Safety Lead-In|Overall Study||0||
48368961|NCT01954121|101232665|FG000|STARTED|Overall Study||220||
48368962|NCT01954121|101232666|FG001|STARTED|Overall Study||216||
48368963|NCT01954121|101232665|FG000|COMPLETED|Overall Study||93||
48368964|NCT01954121|101232666|FG001|COMPLETED|Overall Study||125||
48368965|NCT01954121|101232665|FG000|NOT COMPLETED|Overall Study||127||
48368966|NCT01954121|101232666|FG001|NOT COMPLETED|Overall Study||91||
48368967|NCT02345642|101232667|FG000|STARTED|Overall Study||10||
48368968|NCT02345642|101232668|FG001|STARTED|Overall Study||10||
48444648|NCT03514121|101422407|FG006|Phase 1a Combination Safety Lead-In|Overall Study||0||
48444649|NCT03514121|101422408|FG007|Phase 1a Combination Safety Lead-In|Overall Study||0||
48444650|NCT03514121|101422409|FG008|Phase 1a Combination Safety Lead-In|Overall Study||0||
48444651|NCT03514121|101422410|FG009|Phase 1a Combination Safety Lead-In|Overall Study||5||
48444652|NCT03514121|101422401|FG000|Phase 1b Combination|Overall Study||0||
48444653|NCT03514121|101422402|FG001|Phase 1b Combination|Overall Study||0||
48444654|NCT03514121|101422403|FG002|Phase 1b Combination|Overall Study||0||
48444655|NCT03514121|101422404|FG003|Phase 1b Combination|Overall Study||0||
48444656|NCT03514121|101422405|FG004|Phase 1b Combination|Overall Study||0||
48444657|NCT03514121|101422406|FG005|Phase 1b Combination|Overall Study||0||
48444658|NCT03514121|101422407|FG006|Phase 1b Combination|Overall Study||0||
48444659|NCT03514121|101422408|FG007|Phase 1b Combination|Overall Study||0||
48444660|NCT03514121|101422409|FG008|Phase 1b Combination|Overall Study||0||
48444661|NCT03514121|101422410|FG009|Phase 1b Combination|Overall Study||7||
48444662|NCT03514121|101422401|FG000|COMPLETED|Overall Study||1||
48444663|NCT03514121|101422402|FG001|COMPLETED|Overall Study||0||
48444664|NCT03514121|101422403|FG002|COMPLETED|Overall Study||1||
48444665|NCT03514121|101422404|FG003|COMPLETED|Overall Study||1||
48444666|NCT03514121|101422405|FG004|COMPLETED|Overall Study||1||
48444667|NCT03514121|101422406|FG005|COMPLETED|Overall Study||1||
48444668|NCT03514121|101422407|FG006|COMPLETED|Overall Study||1||
48444669|NCT03514121|101422408|FG007|COMPLETED|Overall Study||0||
48444670|NCT03514121|101422409|FG008|COMPLETED|Overall Study||1||
48444671|NCT03514121|101422410|FG009|COMPLETED|Overall Study||1||
48444672|NCT03514121|101422401|FG000|NOT COMPLETED|Overall Study||0||
48444673|NCT03514121|101422402|FG001|NOT COMPLETED|Overall Study||1||
48444674|NCT03514121|101422403|FG002|NOT COMPLETED|Overall Study||2||
48444675|NCT03514121|101422404|FG003|NOT COMPLETED|Overall Study||0||
48444676|NCT03514121|101422405|FG004|NOT COMPLETED|Overall Study||2||
48444677|NCT03514121|101422406|FG005|NOT COMPLETED|Overall Study||7||
48444678|NCT03514121|101422407|FG006|NOT COMPLETED|Overall Study||7||
48444679|NCT03514121|101422408|FG007|NOT COMPLETED|Overall Study||4||
48444680|NCT03514121|101422409|FG008|NOT COMPLETED|Overall Study||53||
48444681|NCT03514121|101422410|FG009|NOT COMPLETED|Overall Study||11||
48444682|NCT03079869|101422411|FG000|STARTED|Overall Study||28||
48444683|NCT03079869|101422412|FG001|STARTED|Overall Study||27||
48444684|NCT03079869|101422411|FG000|COMPLETED|Overall Study||15||
48444685|NCT03079869|101422412|FG001|COMPLETED|Overall Study||16||
48444686|NCT03079869|101422411|FG000|NOT COMPLETED|Overall Study||13||
48444687|NCT03079869|101422412|FG001|NOT COMPLETED|Overall Study||11||
48658537|NCT02691494|101948964|FG001|STARTED|Post-Treatment Follow-Up Period||25||
48444688|NCT01238172|101422413|FG000|STARTED|Overall Study||237|Intention-to-treat (ITT) Cohort|
48444689|NCT01238172|101422414|FG001|STARTED|Overall Study||241|Intention-to-treat (ITT) Cohort|
48444690|NCT01238172|101422413|FG000|COMPLETED|Overall Study||226|modified intention-to-treat (m-ITT) Cohort|
48444691|NCT01238172|101422414|FG001|COMPLETED|Overall Study||217|modified intention-to-treat (m-ITT) Cohort|
48444692|NCT01238172|101422413|FG000|NOT COMPLETED|Overall Study||11||
48444693|NCT01238172|101422414|FG001|NOT COMPLETED|Overall Study||24||
48444694|NCT00402779|101422415|FG000|STARTED|Overall Study||152||
48444695|NCT00402779|101422416|FG001|STARTED|Overall Study||151||
48444696|NCT00402779|101422415|FG000|COMPLETED|Overall Study||75||
48368969|NCT02345642|101232667|FG000|COMPLETED|Overall Study||10||
48368970|NCT02345642|101232668|FG001|COMPLETED|Overall Study||10||
48368971|NCT02345642|101232667|FG000|NOT COMPLETED|Overall Study||0||
48368972|NCT02345642|101232668|FG001|NOT COMPLETED|Overall Study||0||
48368973|NCT05301322|101232669|FG000|STARTED|Overall Study||705||
48368974|NCT05301322|101232670|FG001|STARTED|Overall Study||698||
48368975|NCT05301322|101232669|FG000|Not Vaccinated|Overall Study||3||
48368976|NCT05301322|101232670|FG001|Not Vaccinated|Overall Study||1||
48368977|NCT05301322|101232669|FG000|Vaccination 1|Overall Study||702||
48368978|NCT05301322|101232670|FG001|Vaccination 1|Overall Study||697||
48368979|NCT05301322|101232669|FG000|Vaccination 2|Overall Study||688||
48368980|NCT05301322|101232670|FG001|Vaccination 2|Overall Study||693||
48444697|NCT00402779|101422416|FG001|COMPLETED|Overall Study||75||
48444698|NCT00402779|101422415|FG000|NOT COMPLETED|Overall Study||77||
48444699|NCT00402779|101422416|FG001|NOT COMPLETED|Overall Study||76||
48444700|NCT03286400|101422417|FG000|STARTED|Overall Study||127||
48444701|NCT03286400|101422417|FG000|COMPLETED|Overall Study||102||
48444702|NCT03286400|101422417|FG000|NOT COMPLETED|Overall Study||25||
48444703|NCT01966107|101422418|FG000|STARTED|Overall Study||1812||
48444704|NCT01966107|101422419|FG001|STARTED|Overall Study||1818||
48658538|NCT02691494|101948965|FG002|STARTED|Post-Treatment Follow-Up Period||59||
48444705|NCT01966107|101422418|FG000|Full Analysis Set|Overall Study||1791|Subjects included in full analysis set (FAS)|
48368981|NCT05301322|101232669|FG000|COMPLETED|Overall Study||686||
48368982|NCT05301322|101232670|FG001|COMPLETED|Overall Study||692||
48368983|NCT05301322|101232669|FG000|NOT COMPLETED|Overall Study||19||
48444706|NCT01966107|101422419|FG001|Full Analysis Set|Overall Study||1798|Subjects included in full analysis set (FAS)|
48444707|NCT01966107|101422418|FG000|COMPLETED|Overall Study||1010|Subjects who remained on treatment through this time point|
48444708|NCT01966107|101422419|FG001|COMPLETED|Overall Study||937|Subjects who remained on treatment through this time point|
48444709|NCT01966107|101422418|FG000|NOT COMPLETED|Overall Study||802||
48444710|NCT01966107|101422419|FG001|NOT COMPLETED|Overall Study||881||
48444711|NCT02125734|101422420|FG000|STARTED|Period 1||40||
48444712|NCT02125734|101422421|FG001|STARTED|Period 1||48||
48444713|NCT02125734|101422420|FG000|COMPLETED|Period 1||40||
48444714|NCT02125734|101422421|FG001|COMPLETED|Period 1||48||
48444715|NCT02125734|101422420|FG000|NOT COMPLETED|Period 1||0||
48444716|NCT02125734|101422421|FG001|NOT COMPLETED|Period 1||0||
48444717|NCT02125734|101422420|FG000|STARTED|Period 2||40||
48444718|NCT02125734|101422421|FG001|STARTED|Period 2||48||
48444719|NCT02125734|101422420|FG000|COMPLETED|Period 2||40||
48444720|NCT02125734|101422421|FG001|COMPLETED|Period 2||47||
48444721|NCT02125734|101422420|FG000|NOT COMPLETED|Period 2||0||
48444722|NCT02125734|101422421|FG001|NOT COMPLETED|Period 2||1||
48444723|NCT02494583|101422422|FG000|STARTED|Overall Study||256||
48444724|NCT02494583|101422423|FG001|STARTED|Overall Study||257||
48444725|NCT02494583|101422424|FG002|STARTED|Overall Study||250||
48444726|NCT02494583|101422422|FG000|Received First Course of Pembrolizumab|Overall Study||254||
48444727|NCT02494583|101422423|FG001|Received First Course of Pembrolizumab|Overall Study||250||
48444728|NCT02494583|101422424|FG002|Received First Course of Pembrolizumab|Overall Study||244||
48658539|NCT02691494|101948963|FG000|COMPLETED|Post-Treatment Follow-Up Period||9||
48658540|NCT02691494|101948964|FG001|COMPLETED|Post-Treatment Follow-Up Period||18||
48658541|NCT02691494|101948965|FG002|COMPLETED|Post-Treatment Follow-Up Period||42||
48658542|NCT02691494|101948963|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||5||
48658543|NCT02691494|101948964|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||7||
48658544|NCT02691494|101948965|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||17||
48658545|NCT02011542|101948966|FG000|STARTED|Overall Study||30||
48658546|NCT02011542|101948966|FG000|COMPLETED|Overall Study||29||
48658547|NCT02011542|101948966|FG000|NOT COMPLETED|Overall Study||1||
48658548|NCT00890656|101948967|FG000|STARTED|Overall Study||90||
48658549|NCT00890656|101948967|FG000|COMPLETED|Overall Study||90||
48658550|NCT00890656|101948967|FG000|NOT COMPLETED|Overall Study||0||
48658551|NCT02327143|101948968|FG000|STARTED|Day 1: Time 0 Hrs to 6 Hrs||11||
48658552|NCT02327143|101948969|FG001|STARTED|Day 1: Time 0 Hrs to 6 Hrs||0||
48658553|NCT02327143|101948968|FG000|COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||11||
48658554|NCT02327143|101948969|FG001|COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0||
48658555|NCT02327143|101948968|FG000|NOT COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0||
48658556|NCT02327143|101948969|FG001|NOT COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0||
48658557|NCT02327143|101948968|FG000|STARTED|Day 1: Time 6 Hrs - to Day 9||0||
48658558|NCT02327143|101948969|FG001|STARTED|Day 1: Time 6 Hrs - to Day 9||11||
48658559|NCT02327143|101948968|FG000|COMPLETED|Day 1: Time 6 Hrs - to Day 9||0||
48658560|NCT02327143|101948969|FG001|COMPLETED|Day 1: Time 6 Hrs - to Day 9||11||
48658561|NCT02327143|101948968|FG000|NOT COMPLETED|Day 1: Time 6 Hrs - to Day 9||0||
48658562|NCT02327143|101948969|FG001|NOT COMPLETED|Day 1: Time 6 Hrs - to Day 9||0||
48658563|NCT03878602|101948970|FG000|STARTED|Overall Study||75||
48658564|NCT03878602|101948971|FG001|STARTED|Overall Study||67||
48658565|NCT03878602|101948970|FG000|COMPLETED|Overall Study||66||
48658566|NCT03878602|101948971|FG001|COMPLETED|Overall Study||66||
48658567|NCT03878602|101948970|FG000|NOT COMPLETED|Overall Study||9||
48444729|NCT02494583|101422422|FG000|Received Second Course of Pembrolizumab|Overall Study||4||
48444730|NCT02494583|101422423|FG001|Received Second Course of Pembrolizumab|Overall Study||5||
48444731|NCT02494583|101422424|FG002|Received Second Course of Pembrolizumab|Overall Study||0||
48444732|NCT02494583|101422422|FG000|COMPLETED|Overall Study||0||
48444733|NCT02494583|101422423|FG001|COMPLETED|Overall Study||0||
48444734|NCT02494583|101422424|FG002|COMPLETED|Overall Study||0||
48658568|NCT03878602|101948971|FG001|NOT COMPLETED|Overall Study||1||
48658569|NCT01897896|101948972|FG000|STARTED|Overall Study||82||
48658570|NCT01897896|101948973|FG001|STARTED|Overall Study||37||
48658571|NCT01897896|101948972|FG000|COMPLETED|Overall Study||56||
48658572|NCT01897896|101948973|FG001|COMPLETED|Overall Study||25||
48658573|NCT01897896|101948972|FG000|NOT COMPLETED|Overall Study||26||
48658574|NCT01897896|101948973|FG001|NOT COMPLETED|Overall Study||12||
48658575|NCT03124602|101948974|FG000|STARTED|Overall Study||35||
48658576|NCT03124602|101948974|FG000|COMPLETED|Overall Study||25||
48658577|NCT03124602|101948974|FG000|NOT COMPLETED|Overall Study||10||
48658578|NCT01916226|101948975|FG000|STARTED|Overall Study||170||
48658579|NCT01916226|101948976|FG001|STARTED|Overall Study||170||
48658580|NCT01916226|101948977|FG002|STARTED|Overall Study||171||
48658581|NCT01916226|101948978|FG003|STARTED|Overall Study||171||
48658582|NCT01916226|101948975|FG000|COMPLETED|Overall Study||169||
48658583|NCT01916226|101948976|FG001|COMPLETED|Overall Study||169||
48658584|NCT01916226|101948977|FG002|COMPLETED|Overall Study||168||
48658585|NCT01916226|101948978|FG003|COMPLETED|Overall Study||167||
48658586|NCT01916226|101948975|FG000|NOT COMPLETED|Overall Study||1||
48658587|NCT01916226|101948976|FG001|NOT COMPLETED|Overall Study||1||
48658588|NCT01916226|101948977|FG002|NOT COMPLETED|Overall Study||3||
48658589|NCT01916226|101948978|FG003|NOT COMPLETED|Overall Study||4||
48658590|NCT00124657|101948979|FG000|STARTED|Overall Study||18||
48658591|NCT00124657|101948980|FG001|STARTED|Overall Study||5||
48658592|NCT00124657|101948981|FG002|STARTED|Overall Study||39||
48658593|NCT00124657|101948979|FG000|COMPLETED|Overall Study||2||
48658594|NCT00124657|101948980|FG001|COMPLETED|Overall Study||0||
48658595|NCT00124657|101948981|FG002|COMPLETED|Overall Study||7||
48658596|NCT00124657|101948979|FG000|NOT COMPLETED|Overall Study||16||
48769931|NCT02592798|102225951|FG000|COMPLETED|Double-Blind Period 2 (DB2)||6||
48769932|NCT02592798|102225952|FG001|COMPLETED|Double-Blind Period 2 (DB2)||9||
48769933|NCT02592798|102225951|FG000|NOT COMPLETED|Double-Blind Period 2 (DB2)||5||
48188953|NCT00689104|100786121|FG003|Full Analysis Set Incontinence (FAS-I)|Overall Study||300||
48368984|NCT05301322|101232670|FG001|NOT COMPLETED|Overall Study||6||
48444735|NCT02494583|101422422|FG000|NOT COMPLETED|Overall Study||256||
48444736|NCT02494583|101422423|FG001|NOT COMPLETED|Overall Study||257||
48444737|NCT02494583|101422424|FG002|NOT COMPLETED|Overall Study||250||
48444738|NCT03591107|101422425|FG000|STARTED|Overall Study||21||
48444739|NCT03591107|101422426|FG001|STARTED|Overall Study||21||
48658597|NCT00124657|101948980|FG001|NOT COMPLETED|Overall Study||5||
48658598|NCT00124657|101948981|FG002|NOT COMPLETED|Overall Study||32||
48769934|NCT02592798|102225952|FG001|NOT COMPLETED|Double-Blind Period 2 (DB2)||2||
48769935|NCT02592798|102225951|FG000|STARTED|Transition From DB2 to OLE||6||
48769936|NCT02592798|102225952|FG001|STARTED|Transition From DB2 to OLE||9||
48368985|NCT00978445|101232671|FG000|STARTED|Overall Study||12||
48368986|NCT00978445|101232672|FG001|STARTED|Overall Study||13||
48368987|NCT00978445|101232671|FG000|COMPLETED|Overall Study||10||
48368988|NCT00978445|101232672|FG001|COMPLETED|Overall Study||12||
48368989|NCT00978445|101232671|FG000|NOT COMPLETED|Overall Study||2||
48368990|NCT00978445|101232672|FG001|NOT COMPLETED|Overall Study||1||
48368991|NCT03123939|101232673|FG000|STARTED|Overall Study||74|enrolled participants|
48368992|NCT03123939|101232673|FG000|CTL019 Infused|Overall Study||69|all enrolled participants who received CTL019 infusion|
48368993|NCT03123939|101232673|FG000|Full Analysis Set (FAS)|Overall Study||69|all enrolled participants who received CTL019 infusion|
48368994|NCT03123939|101232673|FG000|Cellular Kinetic Analysis Set (CKAS)|Overall Study||69|participants who had at least 1 sample providing evaluable data|
48368995|NCT03123939|101232673|FG000|Safety Set (SAF)|Overall Study||69|all enrolled participants who received CTL019 infusion|
48368996|NCT03123939|101232673|FG000|COMPLETED|Overall Study||33||
48368997|NCT03123939|101232673|FG000|NOT COMPLETED|Overall Study||41||
48368998|NCT04465370|101232674|FG000|STARTED|Overall Study||89||
48368999|NCT04465370|101232674|FG000|COMPLETED|Overall Study||60||
48369000|NCT04465370|101232674|FG000|NOT COMPLETED|Overall Study||29||
48369001|NCT03345836|101232675|FG000|STARTED|Period 1: DB and OL Induction (12 Weeks)||171||
48369002|NCT03345836|101232676|FG001|STARTED|Period 1: DB and OL Induction (12 Weeks)||324||
48369003|NCT03345836|101232677|FG002|STARTED|Period 1: DB and OL Induction (12 Weeks)||129||
48369004|NCT03345836|101232678|FG003|STARTED|Period 1: DB and OL Induction (12 Weeks)||0||
48369005|NCT03345836|101232679|FG004|STARTED|Period 1: DB and OL Induction (12 Weeks)||0||
48369006|NCT03345836|101232680|FG005|STARTED|Period 1: DB and OL Induction (12 Weeks)||0||
48369007|NCT03345836|101232675|FG000|COMPLETED|Period 1: DB and OL Induction (12 Weeks)||149|Completed=completed the study|
48369008|NCT03345836|101232676|FG001|COMPLETED|Period 1: DB and OL Induction (12 Weeks)||291|Completed=completed the study|
48444740|NCT03591107|101422425|FG000|COMPLETED|Overall Study||20||
48444741|NCT03591107|101422426|FG001|COMPLETED|Overall Study||16||
48188954|NCT00689104|100786118|FG000|COMPLETED|Overall Study||453||
48188955|NCT00689104|100786119|FG001|COMPLETED|Overall Study||440||
48369009|NCT03345836|101232677|FG002|COMPLETED|Period 1: DB and OL Induction (12 Weeks)||123|Completed=completed the study|
48369010|NCT03345836|101232678|FG003|COMPLETED|Period 1: DB and OL Induction (12 Weeks)||0|Completed=completed the study|
48369011|NCT03345836|101232679|FG004|COMPLETED|Period 1: DB and OL Induction (12 Weeks)||0|Completed=completed the study|
48369012|NCT03345836|101232680|FG005|COMPLETED|Period 1: DB and OL Induction (12 Weeks)||0|Completed=completed the study|
48369013|NCT03345836|101232675|FG000|NOT COMPLETED|Period 1: DB and OL Induction (12 Weeks)||22||
48369014|NCT03345836|101232676|FG001|NOT COMPLETED|Period 1: DB and OL Induction (12 Weeks)||33||
48369015|NCT03345836|101232677|FG002|NOT COMPLETED|Period 1: DB and OL Induction (12 Weeks)||6||
48369016|NCT03345836|101232678|FG003|NOT COMPLETED|Period 1: DB and OL Induction (12 Weeks)||0||
48369017|NCT03345836|101232679|FG004|NOT COMPLETED|Period 1: DB and OL Induction (12 Weeks)||0||
48369018|NCT03345836|101232680|FG005|NOT COMPLETED|Period 1: DB and OL Induction (12 Weeks)||0||
48369019|NCT03345836|101232675|FG000|STARTED|Period 2: 12-Week Extended Treatment||0||
48444742|NCT03591107|101422425|FG000|NOT COMPLETED|Overall Study||1||
48444743|NCT03591107|101422426|FG001|NOT COMPLETED|Overall Study||5||
48658599|NCT00324857|101948982|FG000|STARTED|Overall Study||167||
48658600|NCT00324857|101948983|FG001|STARTED|Overall Study||168||
48658601|NCT00324857|101948984|FG002|STARTED|Overall Study||165||
48658602|NCT00324857|101948985|FG003|STARTED|Overall Study||163||
48658603|NCT00324857|101948982|FG000|COMPLETED|Overall Study||161||
48658604|NCT00324857|101948983|FG001|COMPLETED|Overall Study||162||
48658605|NCT00324857|101948984|FG002|COMPLETED|Overall Study||158||
48769937|NCT02592798|102225951|FG000|COMPLETED|Transition From DB2 to OLE||5||
48769938|NCT02592798|102225952|FG001|COMPLETED|Transition From DB2 to OLE||9||
48769939|NCT02592798|102225951|FG000|NOT COMPLETED|Transition From DB2 to OLE||1||
48769940|NCT02592798|102225952|FG001|NOT COMPLETED|Transition From DB2 to OLE||0||
48769941|NCT02592798|102225951|FG000|STARTED|Open Label Period (OLE)||10|The starting pool of OLE period consists of participants who completed the Double-Blind Period + participants who escaped from DB1 and/or DB2 to OLE period|
48769942|NCT02592798|102225952|FG001|STARTED|Open Label Period (OLE)||13|The starting pool of OLE period consists of participants who completed the Double-Blind Period + participants who escaped from DB1 and/or DB2 to OLE period|
48769943|NCT02592798|102225951|FG000|COMPLETED|Open Label Period (OLE)||6||
48769944|NCT02592798|102225952|FG001|COMPLETED|Open Label Period (OLE)||4||
48769945|NCT02592798|102225951|FG000|NOT COMPLETED|Open Label Period (OLE)||4||
48769946|NCT02592798|102225952|FG001|NOT COMPLETED|Open Label Period (OLE)||9||
48769947|NCT04273737|102225953|FG000|STARTED|Overall Study||11||
48769948|NCT04273737|102225953|FG000|COMPLETED|Overall Study||11||
48769949|NCT04273737|102225953|FG000|NOT COMPLETED|Overall Study||0||
48769950|NCT01598506|102225954|FG000|STARTED|Overall Study||22||
48769951|NCT01598506|102225954|FG000|COMPLETED|Overall Study||20||
48769952|NCT01598506|102225954|FG000|NOT COMPLETED|Overall Study||2||
48769953|NCT00446849|102225955|FG000|STARTED|Acute Phase||138||
48769954|NCT00446849|102225955|FG000|COMPLETED|Acute Phase||56||
48769955|NCT00446849|102225955|FG000|NOT COMPLETED|Acute Phase||82||
48769956|NCT00446849|102225955|FG000|STARTED|Maintenance Phase||208||
48769957|NCT00446849|102225955|FG000|COMPLETED|Maintenance Phase||138||
48769958|NCT00446849|102225955|FG000|NOT COMPLETED|Maintenance Phase||70||
48769959|NCT01055197|102225956|FG000|STARTED|Overall Study||51||
48769960|NCT01055197|102225957|FG001|STARTED|Overall Study||46||
48769961|NCT01055197|102225956|FG000|COMPLETED|Overall Study||42||
48769962|NCT01055197|102225957|FG001|COMPLETED|Overall Study||44||
48769963|NCT01055197|102225956|FG000|NOT COMPLETED|Overall Study||9||
48769964|NCT01055197|102225957|FG001|NOT COMPLETED|Overall Study||2||
48769965|NCT02628873|102225958|FG000|STARTED|First Test (1 Hour)||14||
48769966|NCT02628873|102225959|FG001|STARTED|First Test (1 Hour)||7||
48769967|NCT02628873|102225958|FG000|COMPLETED|First Test (1 Hour)||14||
48769968|NCT02628873|102225959|FG001|COMPLETED|First Test (1 Hour)||7||
48769969|NCT02628873|102225958|FG000|NOT COMPLETED|First Test (1 Hour)||0||
48769970|NCT02628873|102225959|FG001|NOT COMPLETED|First Test (1 Hour)||0||
48769971|NCT02628873|102225958|FG000|STARTED|Break (1 Hour)||14||
48769972|NCT02628873|102225959|FG001|STARTED|Break (1 Hour)||7||
48769973|NCT02628873|102225958|FG000|COMPLETED|Break (1 Hour)||14||
48769974|NCT02628873|102225959|FG001|COMPLETED|Break (1 Hour)||6||
48769975|NCT02628873|102225958|FG000|NOT COMPLETED|Break (1 Hour)||0||
48769976|NCT02628873|102225959|FG001|NOT COMPLETED|Break (1 Hour)||1||
48769977|NCT02628873|102225958|FG000|STARTED|Second Test (1 Hour)||14||
48769978|NCT02628873|102225959|FG001|STARTED|Second Test (1 Hour)||6||
48769979|NCT02628873|102225958|FG000|COMPLETED|Second Test (1 Hour)||13||
48769980|NCT02628873|102225959|FG001|COMPLETED|Second Test (1 Hour)||6||
48769981|NCT02628873|102225958|FG000|NOT COMPLETED|Second Test (1 Hour)||1||
48769982|NCT02628873|102225959|FG001|NOT COMPLETED|Second Test (1 Hour)||0||
48769983|NCT00734500|102225960|FG000|STARTED|Overall Study||15||
48769984|NCT00734500|102225960|FG000|COMPLETED|Overall Study||14||
48769985|NCT00734500|102225960|FG000|NOT COMPLETED|Overall Study||1||
48769986|NCT00750438|102225961|FG000|STARTED|Overall Study||31||
48769987|NCT00750438|102225962|FG001|STARTED|Overall Study||29||
48769988|NCT00750438|102225961|FG000|COMPLETED|Overall Study||24||
48769989|NCT00750438|102225962|FG001|COMPLETED|Overall Study||25||
48188956|NCT00689104|100786120|FG002|COMPLETED|Overall Study||453||
48188957|NCT00689104|100786121|FG003|COMPLETED|Overall Study||445||
48188958|NCT00689104|100786118|FG000|NOT COMPLETED|Overall Study||44||
48769990|NCT00750438|102225961|FG000|NOT COMPLETED|Overall Study||7||
48769991|NCT00750438|102225962|FG001|NOT COMPLETED|Overall Study||4||
48769992|NCT03288103|102225963|FG000|STARTED|Overall Study||10||
48769993|NCT03288103|102225964|FG001|STARTED|Overall Study||2||
48769994|NCT03288103|102225965|FG002|STARTED|Overall Study||10||
48769995|NCT03288103|102225963|FG000|COMPLETED|Overall Study||10||
48769996|NCT03288103|102225964|FG001|COMPLETED|Overall Study||2||
48769997|NCT03288103|102225965|FG002|COMPLETED|Overall Study||10||
48769998|NCT03288103|102225963|FG000|NOT COMPLETED|Overall Study||0||
48769999|NCT03288103|102225964|FG001|NOT COMPLETED|Overall Study||0||
48770000|NCT03288103|102225965|FG002|NOT COMPLETED|Overall Study||0||
48770001|NCT01292629|102225966|FG000|STARTED|Overall Study||125||
48770002|NCT01292629|102225966|FG000|COMPLETED|Overall Study||125||
48770003|NCT01292629|102225966|FG000|NOT COMPLETED|Overall Study||0||
48188959|NCT00689104|100786119|FG001|NOT COMPLETED|Overall Study||57||
48188960|NCT00689104|100786120|FG002|NOT COMPLETED|Overall Study||45||
48444744|NCT00728988|101422427|FG000|STARTED|Overall Study||247||
48444745|NCT00728988|101422428|FG001|STARTED|Overall Study||252||
48770004|NCT00600080|102225967|FG000|STARTED|Period 1: Baseline to One-week||28||
48770005|NCT00600080|102225968|FG001|STARTED|Period 1: Baseline to One-week||32||
48770006|NCT00600080|102225967|FG000|COMPLETED|Period 1: Baseline to One-week||28||
48770007|NCT00600080|102225968|FG001|COMPLETED|Period 1: Baseline to One-week||32||
48188961|NCT00689104|100786121|FG003|NOT COMPLETED|Overall Study||50||
48770008|NCT00600080|102225967|FG000|NOT COMPLETED|Period 1: Baseline to One-week||0||
48770009|NCT00600080|102225968|FG001|NOT COMPLETED|Period 1: Baseline to One-week||0||
48770010|NCT00600080|102225967|FG000|STARTED|Period 2: One-week to Two-weeks||28||
48770011|NCT00600080|102225968|FG001|STARTED|Period 2: One-week to Two-weeks||32||
48770012|NCT00600080|102225967|FG000|COMPLETED|Period 2: One-week to Two-weeks||28||
48770013|NCT00600080|102225968|FG001|COMPLETED|Period 2: One-week to Two-weeks||32||
48770014|NCT00600080|102225967|FG000|NOT COMPLETED|Period 2: One-week to Two-weeks||0||
48770015|NCT00600080|102225968|FG001|NOT COMPLETED|Period 2: One-week to Two-weeks||0||
48770016|NCT04226742|102225969|FG000|STARTED|Overall Study||56||
48444746|NCT00728988|101422427|FG000|Treated|Overall Study||245||
48444747|NCT00728988|101422428|FG001|Treated|Overall Study||250||
48444748|NCT00728988|101422427|FG000|Full Analysis Set|Overall Study||163||
48444749|NCT00728988|101422428|FG001|Full Analysis Set|Overall Study||172||
48444750|NCT00728988|101422427|FG000|COMPLETED|Overall Study||154||
48444751|NCT00728988|101422428|FG001|COMPLETED|Overall Study||164||
48444752|NCT00728988|101422427|FG000|NOT COMPLETED|Overall Study||93||
48444753|NCT00728988|101422428|FG001|NOT COMPLETED|Overall Study||88||
48444754|NCT03474640|101422429|FG000|STARTED|Overall Study||3||
48444755|NCT03474640|101422430|FG001|STARTED|Overall Study||8||
48444756|NCT03474640|101422431|FG002|STARTED|Overall Study||7||
48444757|NCT03474640|101422432|FG003|STARTED|Overall Study||42||
48444758|NCT03474640|101422433|FG004|STARTED|Overall Study||59||
48444759|NCT03474640|101422434|FG005|STARTED|Overall Study||11||
48444760|NCT03474640|101422435|FG006|STARTED|Overall Study||29||
48444761|NCT03474640|101422436|FG007|STARTED|Overall Study||22||
48444762|NCT03474640|101422437|FG008|STARTED|Overall Study||3||
48444763|NCT03474640|101422429|FG000|COMPLETED|Overall Study||0||
48444764|NCT03474640|101422430|FG001|COMPLETED|Overall Study||0||
48444765|NCT03474640|101422431|FG002|COMPLETED|Overall Study||2||
48444766|NCT03474640|101422432|FG003|COMPLETED|Overall Study||8||
48444767|NCT03474640|101422433|FG004|COMPLETED|Overall Study||7||
48444768|NCT03474640|101422434|FG005|COMPLETED|Overall Study||1||
48444769|NCT03474640|101422435|FG006|COMPLETED|Overall Study||3||
48444770|NCT03474640|101422436|FG007|COMPLETED|Overall Study||6||
48444771|NCT03474640|101422437|FG008|COMPLETED|Overall Study||1||
48444772|NCT03474640|101422429|FG000|NOT COMPLETED|Overall Study||3||
48444773|NCT03474640|101422430|FG001|NOT COMPLETED|Overall Study||8||
48444774|NCT03474640|101422431|FG002|NOT COMPLETED|Overall Study||5||
48444775|NCT03474640|101422432|FG003|NOT COMPLETED|Overall Study||34||
48444776|NCT03474640|101422433|FG004|NOT COMPLETED|Overall Study||52||
48444777|NCT03474640|101422434|FG005|NOT COMPLETED|Overall Study||10||
48444778|NCT03474640|101422435|FG006|NOT COMPLETED|Overall Study||26||
48444779|NCT03474640|101422436|FG007|NOT COMPLETED|Overall Study||16||
48444780|NCT03474640|101422437|FG008|NOT COMPLETED|Overall Study||2||
48444781|NCT00500656|101422438|FG000|STARTED|Controlled Phase||36||
48444782|NCT00500656|101422439|FG001|STARTED|Controlled Phase||38||
48444783|NCT00500656|101422440|FG002|STARTED|Controlled Phase||3||
48444784|NCT00500656|101422441|FG003|STARTED|Controlled Phase||8||
48444785|NCT00500656|101422438|FG000|COMPLETED|Controlled Phase||26||
48444786|NCT00500656|101422439|FG001|COMPLETED|Controlled Phase||28||
48444787|NCT00500656|101422440|FG002|COMPLETED|Controlled Phase||2||
48444788|NCT00500656|101422441|FG003|COMPLETED|Controlled Phase||0||
48658606|NCT00324857|101948985|FG003|COMPLETED|Overall Study||158||
48770017|NCT04226742|102225970|FG001|STARTED|Overall Study||51||
48770018|NCT04226742|102225969|FG000|COMPLETED|Overall Study||35||
48770019|NCT04226742|102225970|FG001|COMPLETED|Overall Study||35||
48188962|NCT00224133|100786122|FG000|STARTED|Overall Study||661||
48444789|NCT00500656|101422438|FG000|NOT COMPLETED|Controlled Phase||10||
48444790|NCT00500656|101422439|FG001|NOT COMPLETED|Controlled Phase||10||
48444791|NCT00500656|101422440|FG002|NOT COMPLETED|Controlled Phase||1||
48444792|NCT00500656|101422441|FG003|NOT COMPLETED|Controlled Phase||8||
48444793|NCT00500656|101422438|FG000|STARTED|Open Label Extension (OLE) Phase||23||
48444794|NCT00500656|101422439|FG001|STARTED|Open Label Extension (OLE) Phase||21||
48658607|NCT00324857|101948982|FG000|NOT COMPLETED|Overall Study||6||
48658608|NCT00324857|101948983|FG001|NOT COMPLETED|Overall Study||6||
48658609|NCT00324857|101948984|FG002|NOT COMPLETED|Overall Study||7||
48658610|NCT00324857|101948985|FG003|NOT COMPLETED|Overall Study||5||
48658611|NCT01608308|101948986|FG000|STARTED|Overall Study||31||
48658612|NCT01608308|101948987|FG001|STARTED|Overall Study||31||
48658613|NCT01608308|101948986|FG000|COMPLETED|Overall Study||31||
48658614|NCT01608308|101948987|FG001|COMPLETED|Overall Study||29||
48658615|NCT01608308|101948986|FG000|NOT COMPLETED|Overall Study||0||
48658616|NCT01608308|101948987|FG001|NOT COMPLETED|Overall Study||2||
48658617|NCT00128492|101948988|FG000|STARTED|Overall Study||85||
48444795|NCT00500656|101422440|FG002|STARTED|Open Label Extension (OLE) Phase||2||
48444796|NCT00500656|101422441|FG003|STARTED|Open Label Extension (OLE) Phase||8||
48444797|NCT00500656|101422438|FG000|COMPLETED|Open Label Extension (OLE) Phase||16||
48444798|NCT00500656|101422439|FG001|COMPLETED|Open Label Extension (OLE) Phase||9||
48444799|NCT00500656|101422440|FG002|COMPLETED|Open Label Extension (OLE) Phase||1||
48658618|NCT00128492|101948989|FG001|STARTED|Overall Study||189||
48658619|NCT00128492|101948988|FG000|COMPLETED|Overall Study||65||
48770020|NCT04226742|102225969|FG000|NOT COMPLETED|Overall Study||21||
48770021|NCT04226742|102225970|FG001|NOT COMPLETED|Overall Study||16||
48770022|NCT00936715|102225971|FG000|STARTED|Overall Study||24||
48770023|NCT00936715|102225971|FG000|COMPLETED|Overall Study||18||
48770024|NCT00936715|102225971|FG000|NOT COMPLETED|Overall Study||6||
48770025|NCT01670487|102225972|FG000|STARTED|Overall Study||150||
48770026|NCT01670487|102225973|FG001|STARTED|Overall Study||150||
48770027|NCT01670487|102225972|FG000|COMPLETED|Overall Study||150||
48770028|NCT01670487|102225973|FG001|COMPLETED|Overall Study||150||
48770029|NCT01670487|102225972|FG000|NOT COMPLETED|Overall Study||0||
48770030|NCT01670487|102225973|FG001|NOT COMPLETED|Overall Study||0||
48770031|NCT01147874|102225974|FG000|STARTED|Overall Study||1013||
48770032|NCT01147874|102225974|FG000|COMPLETED|Overall Study||946||
48770033|NCT01147874|102225974|FG000|NOT COMPLETED|Overall Study||67||
48770034|NCT02991040|102225975|FG000|STARTED|Overall Study||100||
48770035|NCT02991040|102225975|FG000|COMPLETED|Overall Study||96||
48770036|NCT02991040|102225975|FG000|NOT COMPLETED|Overall Study||4||
48188963|NCT00224133|100786122|FG000|COMPLETED|Overall Study||435||
48444800|NCT00500656|101422441|FG003|COMPLETED|Open Label Extension (OLE) Phase||6||
48188964|NCT00224133|100786122|FG000|NOT COMPLETED|Overall Study||226||
48188965|NCT02459587|100786123|FG000|STARTED|3-Month Follow-up Assessment||157||
48188966|NCT02459587|100786124|FG001|STARTED|3-Month Follow-up Assessment||150||
48188967|NCT02459587|100786123|FG000|COMPLETED|3-Month Follow-up Assessment||125||
48188968|NCT02459587|100786124|FG001|COMPLETED|3-Month Follow-up Assessment||119||
48188969|NCT02459587|100786123|FG000|NOT COMPLETED|3-Month Follow-up Assessment||32||
48188970|NCT02459587|100786124|FG001|NOT COMPLETED|3-Month Follow-up Assessment||31||
48188971|NCT02459587|100786123|FG000|STARTED|6-month Follow-up Assessment||152||
48188972|NCT02459587|100786124|FG001|STARTED|6-month Follow-up Assessment||141||
48188973|NCT02459587|100786123|FG000|COMPLETED|6-month Follow-up Assessment||128||
48188974|NCT02459587|100786124|FG001|COMPLETED|6-month Follow-up Assessment||116||
48188975|NCT02459587|100786123|FG000|NOT COMPLETED|6-month Follow-up Assessment||24||
48188976|NCT02459587|100786124|FG001|NOT COMPLETED|6-month Follow-up Assessment||25||
48188977|NCT02459587|100786123|FG000|STARTED|12-month Follow-up Assessment||149||
48188978|NCT02459587|100786124|FG001|STARTED|12-month Follow-up Assessment||138||
48188979|NCT02459587|100786123|FG000|COMPLETED|12-month Follow-up Assessment||127||
48188980|NCT02459587|100786124|FG001|COMPLETED|12-month Follow-up Assessment||111||
48188981|NCT02459587|100786123|FG000|NOT COMPLETED|12-month Follow-up Assessment||22||
48188982|NCT02459587|100786124|FG001|NOT COMPLETED|12-month Follow-up Assessment||27||
48188983|NCT00525057|100786125|FG000|STARTED|Overall Study||25||
48444801|NCT00500656|101422438|FG000|NOT COMPLETED|Open Label Extension (OLE) Phase||7||
48444802|NCT00500656|101422439|FG001|NOT COMPLETED|Open Label Extension (OLE) Phase||12||
48444803|NCT00500656|101422440|FG002|NOT COMPLETED|Open Label Extension (OLE) Phase||1||
48444804|NCT00500656|101422441|FG003|NOT COMPLETED|Open Label Extension (OLE) Phase||2||
48444805|NCT04192799|101422442|FG000|STARTED|Step 1: Months 1-6||134||18
48444806|NCT04192799|101422443|FG001|STARTED|Step 1: Months 1-6||0||0
48444807|NCT04192799|101422444|FG002|STARTED|Step 1: Months 1-6||0||0
48444808|NCT04192799|101422445|FG003|STARTED|Step 1: Months 1-6||0||0
48444809|NCT04192799|101422442|FG000|Patient Directly Admitted|Step 1: Months 1-6||8||18
48444810|NCT04192799|101422443|FG001|Patient Directly Admitted|Step 1: Months 1-6||0||0
48444811|NCT04192799|101422444|FG002|Patient Directly Admitted|Step 1: Months 1-6||0||0
48444812|NCT04192799|101422445|FG003|Patient Directly Admitted|Step 1: Months 1-6||0||0
48444813|NCT04192799|101422442|FG000|Patient Admitted Through ED|Step 1: Months 1-6||126||18
48444814|NCT04192799|101422443|FG001|Patient Admitted Through ED|Step 1: Months 1-6||0||0
48444815|NCT04192799|101422444|FG002|Patient Admitted Through ED|Step 1: Months 1-6||0||0
48444816|NCT04192799|101422445|FG003|Patient Admitted Through ED|Step 1: Months 1-6||0||0
48444817|NCT04192799|101422442|FG000|COMPLETED|Step 1: Months 1-6||134||18
48444818|NCT04192799|101422443|FG001|COMPLETED|Step 1: Months 1-6||0||0
48444819|NCT04192799|101422444|FG002|COMPLETED|Step 1: Months 1-6||0||0
48444820|NCT04192799|101422445|FG003|COMPLETED|Step 1: Months 1-6||0||0
48444821|NCT04192799|101422442|FG000|NOT COMPLETED|Step 1: Months 1-6||0||0
48444822|NCT04192799|101422443|FG001|NOT COMPLETED|Step 1: Months 1-6||0||0
48770037|NCT03739203|102225976|FG000|STARTED|Double-blind Treatment Period (6 Weeks)||250||
48770038|NCT03739203|102225977|FG001|STARTED|Double-blind Treatment Period (6 Weeks)||250||
48770039|NCT03739203|102225978|FG002|STARTED|Double-blind Treatment Period (6 Weeks)||251||
48444823|NCT04192799|101422444|FG002|NOT COMPLETED|Step 1: Months 1-6||0||0
48444824|NCT04192799|101422445|FG003|NOT COMPLETED|Step 1: Months 1-6||0||0
48444825|NCT04192799|101422442|FG000|STARTED|Step 2: Months 7-12||98||18
48444826|NCT04192799|101422443|FG001|STARTED|Step 2: Months 7-12||60||17
48444827|NCT04192799|101422444|FG002|STARTED|Step 2: Months 7-12||0||0
48444828|NCT04192799|101422445|FG003|STARTED|Step 2: Months 7-12||0||0
48444829|NCT04192799|101422442|FG000|Patient Directly Admitted|Step 2: Months 7-12||8||18
48444830|NCT04192799|101422443|FG001|Patient Directly Admitted|Step 2: Months 7-12||3||17
48444831|NCT04192799|101422444|FG002|Patient Directly Admitted|Step 2: Months 7-12||0||0
48770040|NCT03739203|102225976|FG000|Modified Intent-to Treat (mITT) Population|Double-blind Treatment Period (6 Weeks)||249|mITT population included all randomized participants who had ≥1 postbaseline assessment of the Montgomery-Asberg Depression Rating Scale (MADRS) total score.|
48770041|NCT03739203|102225977|FG001|Modified Intent-to Treat (mITT) Population|Double-blind Treatment Period (6 Weeks)||250|mITT population included all randomized participants who had ≥1 postbaseline assessment of the Montgomery-Asberg Depression Rating Scale (MADRS) total score.|
48444832|NCT04192799|101422445|FG003|Patient Directly Admitted|Step 2: Months 7-12||0||0
48444833|NCT04192799|101422442|FG000|Patient Admitted Through ED|Step 2: Months 7-12||90||18
48444834|NCT04192799|101422443|FG001|Patient Admitted Through ED|Step 2: Months 7-12||57||17
48444835|NCT04192799|101422444|FG002|Patient Admitted Through ED|Step 2: Months 7-12||0||0
48444836|NCT04192799|101422445|FG003|Patient Admitted Through ED|Step 2: Months 7-12||0||0
48444837|NCT04192799|101422442|FG000|COMPLETED|Step 2: Months 7-12||98||18
48444838|NCT04192799|101422443|FG001|COMPLETED|Step 2: Months 7-12||60||17
48444839|NCT04192799|101422444|FG002|COMPLETED|Step 2: Months 7-12||0||0
48444840|NCT04192799|101422445|FG003|COMPLETED|Step 2: Months 7-12||0||0
48444841|NCT04192799|101422442|FG000|NOT COMPLETED|Step 2: Months 7-12||0||0
48444842|NCT04192799|101422443|FG001|NOT COMPLETED|Step 2: Months 7-12||0||0
48770042|NCT03739203|102225978|FG002|Modified Intent-to Treat (mITT) Population|Double-blind Treatment Period (6 Weeks)||251|mITT population included all randomized participants who had ≥1 postbaseline assessment of the Montgomery-Asberg Depression Rating Scale (MADRS) total score.|
48770043|NCT03739203|102225976|FG000|COMPLETED|Double-blind Treatment Period (6 Weeks)||235||
48770044|NCT03739203|102225977|FG001|COMPLETED|Double-blind Treatment Period (6 Weeks)||233||
48770045|NCT03739203|102225978|FG002|COMPLETED|Double-blind Treatment Period (6 Weeks)||226||
48770046|NCT03739203|102225976|FG000|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||15||
48770047|NCT03739203|102225977|FG001|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||17||
48770048|NCT03739203|102225978|FG002|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||25||
48770049|NCT03739203|102225976|FG000|STARTED|Safety Follow-Up Period (4 Weeks)||242|As per protocol-defined criteria, some of the participants discontinued from the Double-blind Period but entered the Safety Follow-up Period.|
48770050|NCT03739203|102225977|FG001|STARTED|Safety Follow-Up Period (4 Weeks)||242|As per protocol-defined criteria, some of the participants discontinued from the Double-blind Period but entered the Safety Follow-up Period.|
48770051|NCT03739203|102225978|FG002|STARTED|Safety Follow-Up Period (4 Weeks)||242|As per protocol-defined criteria, some of the participants discontinued from the Double-blind Period but entered the Safety Follow-up Period.|
48770052|NCT03739203|102225976|FG000|COMPLETED|Safety Follow-Up Period (4 Weeks)||240||
48770053|NCT03739203|102225977|FG001|COMPLETED|Safety Follow-Up Period (4 Weeks)||240||
48770054|NCT03739203|102225978|FG002|COMPLETED|Safety Follow-Up Period (4 Weeks)||238||
48770055|NCT03739203|102225976|FG000|NOT COMPLETED|Safety Follow-Up Period (4 Weeks)||2||
48770056|NCT03739203|102225977|FG001|NOT COMPLETED|Safety Follow-Up Period (4 Weeks)||2||
48770057|NCT03739203|102225978|FG002|NOT COMPLETED|Safety Follow-Up Period (4 Weeks)||4||
48770058|NCT05764785|102225979|FG000|STARTED|Overall Study||25||
48770059|NCT05764785|102225980|FG001|STARTED|Overall Study||38||
48770060|NCT05764785|102225979|FG000|COMPLETED|Overall Study||23||
48770061|NCT05764785|102225980|FG001|COMPLETED|Overall Study||30||
48770062|NCT05764785|102225979|FG000|NOT COMPLETED|Overall Study||2||
48770063|NCT05764785|102225980|FG001|NOT COMPLETED|Overall Study||8||
48770064|NCT04320316|102225981|FG000|STARTED|Overall Study||1|Patient started on Burosumab and the dose was adjusted upwards every 4 weeks because of still having relatively low Phsophorus level.|
48770065|NCT04320316|102225981|FG000|COMPLETED|Overall Study||1||
48770066|NCT04320316|102225981|FG000|NOT COMPLETED|Overall Study||0||
48770067|NCT03183869|102225982|FG000|STARTED|Overall Study||4||
48770068|NCT03183869|102225983|FG001|STARTED|Overall Study||7||
48770069|NCT03183869|102225982|FG000|COMPLETED|Overall Study||0||
48770070|NCT03183869|102225983|FG001|COMPLETED|Overall Study||2||
48770071|NCT03183869|102225982|FG000|NOT COMPLETED|Overall Study||4||
48770072|NCT03183869|102225983|FG001|NOT COMPLETED|Overall Study||5||
48770073|NCT00080535|102225984|FG000|STARTED|Overall Study||10||
48770074|NCT00080535|102225984|FG000|COMPLETED|Overall Study||10||
48770075|NCT00080535|102225984|FG000|NOT COMPLETED|Overall Study||0||
48770076|NCT03629535|102225985|FG000|STARTED|Overall Study||8||
48770077|NCT03629535|102225985|FG000|COMPLETED|Overall Study||8||
48770078|NCT03629535|102225985|FG000|NOT COMPLETED|Overall Study||0||
48188984|NCT00525057|100786126|FG001|STARTED|Overall Study||25||
48188985|NCT00525057|100786125|FG000|COMPLETED|Overall Study||25||
48444843|NCT04192799|101422444|FG002|NOT COMPLETED|Step 2: Months 7-12||0||0
48444844|NCT04192799|101422445|FG003|NOT COMPLETED|Step 2: Months 7-12||0||0
48444845|NCT04192799|101422442|FG000|STARTED|Step 3: Months 13-21||239||18
48188986|NCT00525057|100786126|FG001|COMPLETED|Overall Study||25||
48444846|NCT04192799|101422443|FG001|STARTED|Step 3: Months 13-21||146||17
48444847|NCT04192799|101422444|FG002|STARTED|Step 3: Months 13-21||164||17
48444848|NCT04192799|101422445|FG003|STARTED|Step 3: Months 13-21||0||0
48444849|NCT04192799|101422442|FG000|Patient Directly Admitted|Step 3: Months 13-21||23||18
48444850|NCT04192799|101422443|FG001|Patient Directly Admitted|Step 3: Months 13-21||13||17
48444851|NCT04192799|101422444|FG002|Patient Directly Admitted|Step 3: Months 13-21||9||17
48444852|NCT04192799|101422445|FG003|Patient Directly Admitted|Step 3: Months 13-21||0||0
48444853|NCT04192799|101422442|FG000|Patient Admitted Through ED|Step 3: Months 13-21||216||18
48444854|NCT04192799|101422443|FG001|Patient Admitted Through ED|Step 3: Months 13-21||133||17
48770079|NCT03529669|102225986|FG000|STARTED|Overall Study||41||
48770080|NCT03529669|102225986|FG000|COMPLETED|Overall Study||41||
48770081|NCT03529669|102225986|FG000|NOT COMPLETED|Overall Study||0||
48770082|NCT04546672|102225987|FG000|STARTED|Overall Study||60||
48770083|NCT04546672|102225988|FG001|STARTED|Overall Study||60||
48770084|NCT04546672|102225987|FG000|COMPLETED|Overall Study||60||
48770085|NCT04546672|102225988|FG001|COMPLETED|Overall Study||60||
48770086|NCT04546672|102225987|FG000|NOT COMPLETED|Overall Study||0||
48770087|NCT04546672|102225988|FG001|NOT COMPLETED|Overall Study||0||
48770088|NCT03252431|102225989|FG000|STARTED|Overall Study||197||
48770089|NCT03252431|102225990|FG001|STARTED|Overall Study||196||
48444855|NCT04192799|101422444|FG002|Patient Admitted Through ED|Step 3: Months 13-21||155||17
48444856|NCT04192799|101422445|FG003|Patient Admitted Through ED|Step 3: Months 13-21||0||0
48444857|NCT04192799|101422442|FG000|COMPLETED|Step 3: Months 13-21||239||18
48444858|NCT04192799|101422443|FG001|COMPLETED|Step 3: Months 13-21||146||17
48444859|NCT04192799|101422444|FG002|COMPLETED|Step 3: Months 13-21||164||17
48444860|NCT04192799|101422445|FG003|COMPLETED|Step 3: Months 13-21||0||0
48444861|NCT04192799|101422442|FG000|NOT COMPLETED|Step 3: Months 13-21||0||0
48444862|NCT04192799|101422443|FG001|NOT COMPLETED|Step 3: Months 13-21||0||0
48444863|NCT04192799|101422444|FG002|NOT COMPLETED|Step 3: Months 13-21||0||0
48444864|NCT04192799|101422445|FG003|NOT COMPLETED|Step 3: Months 13-21||0||0
48444865|NCT04192799|101422442|FG000|STARTED|Step 4: Months 22-39||344||18
48444866|NCT04192799|101422443|FG001|STARTED|Step 4: Months 22-39||246||17
48444867|NCT04192799|101422444|FG002|STARTED|Step 4: Months 22-39||259||17
48444868|NCT04192799|101422445|FG003|STARTED|Step 4: Months 22-39||307||17
48444869|NCT04192799|101422442|FG000|Patient Directly Admitted|Step 4: Months 22-39||28||18
48444870|NCT04192799|101422443|FG001|Patient Directly Admitted|Step 4: Months 22-39||17||17
48444871|NCT04192799|101422444|FG002|Patient Directly Admitted|Step 4: Months 22-39||18||17
48444872|NCT04192799|101422445|FG003|Patient Directly Admitted|Step 4: Months 22-39||18||17
48444873|NCT04192799|101422442|FG000|Patient Admitted Through ED|Step 4: Months 22-39||316||18
48444874|NCT04192799|101422443|FG001|Patient Admitted Through ED|Step 4: Months 22-39||229||17
48444875|NCT04192799|101422444|FG002|Patient Admitted Through ED|Step 4: Months 22-39||241||17
48444876|NCT04192799|101422445|FG003|Patient Admitted Through ED|Step 4: Months 22-39||289||17
48444877|NCT04192799|101422442|FG000|COMPLETED|Step 4: Months 22-39||344||18
48444878|NCT04192799|101422443|FG001|COMPLETED|Step 4: Months 22-39||246||17
48444879|NCT04192799|101422444|FG002|COMPLETED|Step 4: Months 22-39||259||17
48444880|NCT04192799|101422445|FG003|COMPLETED|Step 4: Months 22-39||307||17
48444881|NCT04192799|101422442|FG000|NOT COMPLETED|Step 4: Months 22-39||0||0
48444882|NCT04192799|101422443|FG001|NOT COMPLETED|Step 4: Months 22-39||0||0
48444883|NCT04192799|101422444|FG002|NOT COMPLETED|Step 4: Months 22-39||0||0
48770090|NCT03252431|102225989|FG000|COMPLETED|Overall Study||186||
48770091|NCT03252431|102225990|FG001|COMPLETED|Overall Study||187||
48770092|NCT03252431|102225989|FG000|NOT COMPLETED|Overall Study||11||
48770093|NCT03252431|102225990|FG001|NOT COMPLETED|Overall Study||9||
48770094|NCT00753506|102225991|FG000|STARTED|Overall Study||33||
48770095|NCT00753506|102225992|FG001|STARTED|Overall Study||33||
48770096|NCT00753506|102225991|FG000|COMPLETED|Overall Study||26||
48770097|NCT00753506|102225992|FG001|COMPLETED|Overall Study||31||
48770098|NCT00753506|102225991|FG000|NOT COMPLETED|Overall Study||7||
48770099|NCT00753506|102225992|FG001|NOT COMPLETED|Overall Study||2||
48770100|NCT02871934|102225993|FG000|STARTED|Overall Study||193||
48770101|NCT02871934|102225994|FG001|STARTED|Overall Study||215||
48770102|NCT02871934|102225993|FG000|COMPLETED|Overall Study||193||
48770103|NCT02871934|102225994|FG001|COMPLETED|Overall Study||215||
48770104|NCT02871934|102225993|FG000|NOT COMPLETED|Overall Study||0||
48770105|NCT02871934|102225994|FG001|NOT COMPLETED|Overall Study||0||
48770106|NCT01208207|102225995|FG000|STARTED|Part I||702||
48770107|NCT01208207|102225996|FG001|STARTED|Part I||156||
48770108|NCT01208207|102225997|FG002|STARTED|Part I||157||
48770109|NCT01208207|102225998|FG003|STARTED|Part I||0||
48770110|NCT01208207|102225999|FG004|STARTED|Part I||0||
48444884|NCT04192799|101422445|FG003|NOT COMPLETED|Step 4: Months 22-39||0||0
48444885|NCT05788237|101422446|FG000|STARTED|SSA (Approximately 2 Months)||125||
48444886|NCT05788237|101422447|FG001|STARTED|SSA (Approximately 2 Months)||126||
48444887|NCT05788237|101422448|FG002|STARTED|SSA (Approximately 2 Months)||0||
48444888|NCT05788237|101422449|FG003|STARTED|SSA (Approximately 2 Months)||0||
48444889|NCT05788237|101422446|FG000|Vaccination 1|SSA (Approximately 2 Months)||125||
48770111|NCT01208207|102226000|FG005|STARTED|Part I||0||
48770112|NCT01208207|102226001|FG006|STARTED|Part I||0||
48770113|NCT01208207|102225995|FG000|COMPLETED|Part I||632||
48770114|NCT01208207|102225996|FG001|COMPLETED|Part I||145||
48770115|NCT01208207|102225997|FG002|COMPLETED|Part I||142||
48770116|NCT01208207|102225998|FG003|COMPLETED|Part I||0||
48770117|NCT01208207|102225999|FG004|COMPLETED|Part I||0||
48770118|NCT01208207|102226000|FG005|COMPLETED|Part I||0||
48770119|NCT01208207|102226001|FG006|COMPLETED|Part I||0||
48770120|NCT01208207|102225995|FG000|NOT COMPLETED|Part I||70||
48770121|NCT01208207|102225996|FG001|NOT COMPLETED|Part I||11||
48770122|NCT01208207|102225997|FG002|NOT COMPLETED|Part I||15||
48770123|NCT01208207|102225998|FG003|NOT COMPLETED|Part I||0||
48770124|NCT01208207|102225999|FG004|NOT COMPLETED|Part I||0||
48444890|NCT05788237|101422447|FG001|Vaccination 1|SSA (Approximately 2 Months)||126||
48444891|NCT05788237|101422448|FG002|Vaccination 1|SSA (Approximately 2 Months)||0||
48444892|NCT05788237|101422449|FG003|Vaccination 1|SSA (Approximately 2 Months)||0||
48444893|NCT05788237|101422446|FG000|Vaccination 2|SSA (Approximately 2 Months)||121||
48444894|NCT05788237|101422447|FG001|Vaccination 2|SSA (Approximately 2 Months)||116||
48444895|NCT05788237|101422448|FG002|Vaccination 2|SSA (Approximately 2 Months)||0||
48444896|NCT05788237|101422449|FG003|Vaccination 2|SSA (Approximately 2 Months)||0||
48444897|NCT05788237|101422446|FG000|COMPLETED|SSA (Approximately 2 Months)||120||
48444898|NCT05788237|101422447|FG001|COMPLETED|SSA (Approximately 2 Months)||113||
48444899|NCT05788237|101422448|FG002|COMPLETED|SSA (Approximately 2 Months)||0||
48444900|NCT05788237|101422449|FG003|COMPLETED|SSA (Approximately 2 Months)||0||
48444901|NCT05788237|101422446|FG000|NOT COMPLETED|SSA (Approximately 2 Months)||5||
48444902|NCT05788237|101422447|FG001|NOT COMPLETED|SSA (Approximately 2 Months)||13||
48444903|NCT05788237|101422448|FG002|NOT COMPLETED|SSA (Approximately 2 Months)||0||
48444904|NCT05788237|101422449|FG003|NOT COMPLETED|SSA (Approximately 2 Months)||0||
48444905|NCT05788237|101422446|FG000|STARTED|SSB (Approximately 1 Month)||0||
48444906|NCT05788237|101422447|FG001|STARTED|SSB (Approximately 1 Month)||0||
48444907|NCT05788237|101422448|FG002|STARTED|SSB (Approximately 1 Month)||102||
48444908|NCT05788237|101422449|FG003|STARTED|SSB (Approximately 1 Month)||102||
48444909|NCT05788237|101422446|FG000|Vaccination|SSB (Approximately 1 Month)||0||
48444910|NCT05788237|101422447|FG001|Vaccination|SSB (Approximately 1 Month)||0||
48444911|NCT05788237|101422448|FG002|Vaccination|SSB (Approximately 1 Month)||101||
48444912|NCT05788237|101422449|FG003|Vaccination|SSB (Approximately 1 Month)||102||
48444913|NCT05788237|101422446|FG000|COMPLETED|SSB (Approximately 1 Month)||0||
48444914|NCT05788237|101422447|FG001|COMPLETED|SSB (Approximately 1 Month)||0||
48444915|NCT05788237|101422448|FG002|COMPLETED|SSB (Approximately 1 Month)||101||
48770125|NCT01208207|102226000|FG005|NOT COMPLETED|Part I||0||
48770126|NCT01208207|102226001|FG006|NOT COMPLETED|Part I||0||
48188987|NCT00525057|100786125|FG000|NOT COMPLETED|Overall Study||0||
48188988|NCT00525057|100786126|FG001|NOT COMPLETED|Overall Study||0||
48188989|NCT02401529|100786127|FG000|STARTED|Overall Study||59||
48188990|NCT02401529|100786128|FG001|STARTED|Overall Study||57||
48444916|NCT05788237|101422449|FG003|COMPLETED|SSB (Approximately 1 Month)||100||
48444917|NCT05788237|101422446|FG000|NOT COMPLETED|SSB (Approximately 1 Month)||0||
48444918|NCT05788237|101422447|FG001|NOT COMPLETED|SSB (Approximately 1 Month)||0||
48444919|NCT05788237|101422448|FG002|NOT COMPLETED|SSB (Approximately 1 Month)||1||
48444920|NCT05788237|101422449|FG003|NOT COMPLETED|SSB (Approximately 1 Month)||2||
48444921|NCT00759759|101422450|FG000|STARTED|Overall Study||18||
48444922|NCT00759759|101422451|FG001|STARTED|Overall Study||18||
48444923|NCT00759759|101422450|FG000|COMPLETED|Overall Study||14||
48444924|NCT00759759|101422451|FG001|COMPLETED|Overall Study||17||
48444925|NCT00759759|101422450|FG000|NOT COMPLETED|Overall Study||4||
48444926|NCT00759759|101422451|FG001|NOT COMPLETED|Overall Study||1||
48444927|NCT02720094|101425544|FG000|STARTED|Overall Study||2283||
48444928|NCT02720094|101425545|FG001|STARTED|Overall Study||2287||
48444929|NCT02720094|101425544|FG000|Ongoing|Overall Study||2210|Ongoing in the study indicates the participant has not terminated study.|
48444930|NCT02720094|101425545|FG001|Ongoing|Overall Study||2203|Ongoing in the study indicates the participant has not terminated study.|
48444931|NCT02720094|101425544|FG000|Terminated From the Study|Overall Study||67|Excludes participants who completed the study.|
48444932|NCT02720094|101425545|FG001|Terminated From the Study|Overall Study||78|Excludes participants who completed the study.|
48444933|NCT02720094|101425544|FG000|COMPLETED|Overall Study||7|Completed the study indicates a participant has seroconverted or has entered Step 3 after reaching Week 145 visit and was subsequently followed for 48 weeks in Step 3 without prior IP discontinuation or study termination or has entered Step 3 after discontinuation of IP and was subsequently followed for 48 weeks and was followed for a total of 3 years from enrollment.|
48658620|NCT00128492|101948989|FG001|COMPLETED|Overall Study||130||
48658621|NCT00128492|101948988|FG000|NOT COMPLETED|Overall Study||20||
48658622|NCT00128492|101948989|FG001|NOT COMPLETED|Overall Study||59||
48658623|NCT03301415|101948990|FG000|STARTED|Overall Study||7||
48658624|NCT03301415|101948990|FG000|COMPLETED|Overall Study||3||
48658625|NCT03301415|101948990|FG000|NOT COMPLETED|Overall Study||4||
48658626|NCT00382863|101948991|FG000|STARTED|Overall Study||96||
48658627|NCT00382863|101948992|FG001|STARTED|Overall Study||114||
48658628|NCT00382863|101948991|FG000|COMPLETED|Overall Study||81||
48658629|NCT00382863|101948992|FG001|COMPLETED|Overall Study||78||
48658630|NCT00382863|101948991|FG000|NOT COMPLETED|Overall Study||15||
48658631|NCT00382863|101948992|FG001|NOT COMPLETED|Overall Study||36||
48658632|NCT03715829|101948993|FG000|STARTED|Dose Ranging Period||65|The first 6 treatment groups entered this Dose Ranging Period.|
48658633|NCT03715829|101948994|FG001|STARTED|Dose Ranging Period||67|The first 6 treatment groups entered this Dose Ranging Period.|
48658634|NCT03715829|101948995|FG002|STARTED|Dose Ranging Period||67|The first 6 treatment groups entered this Dose Ranging Period.|
48658635|NCT03715829|101948996|FG003|STARTED|Dose Ranging Period||50|The first 6 treatment groups entered this Dose Ranging Period.|
48658636|NCT03715829|101948997|FG004|STARTED|Dose Ranging Period||49|The first 6 treatment groups entered this Dose Ranging Period.|
48670040|NCT03601897|101974871|FG005|NOT COMPLETED|Overall Study||3||
48770127|NCT01208207|102225995|FG000|STARTED|Part II||0||
48188991|NCT02401529|100786127|FG000|COMPLETED|Overall Study||50||
48444934|NCT02720094|101425545|FG001|COMPLETED|Overall Study||6|Completed the study indicates a participant has seroconverted or has entered Step 3 after reaching Week 145 visit and was subsequently followed for 48 weeks in Step 3 without prior IP discontinuation or study termination or has entered Step 3 after discontinuation of IP and was subsequently followed for 48 weeks and was followed for a total of 3 years from enrollment.|
48444935|NCT02720094|101425544|FG000|NOT COMPLETED|Overall Study||2276||
48444936|NCT02720094|101425545|FG001|NOT COMPLETED|Overall Study||2281||
48770128|NCT01208207|102225996|FG001|STARTED|Part II||0||
48770129|NCT01208207|102225997|FG002|STARTED|Part II||0||
48770130|NCT01208207|102225998|FG003|STARTED|Part II||314||
48770131|NCT01208207|102225999|FG004|STARTED|Part II||318||
48770132|NCT01208207|102226000|FG005|STARTED|Part II||145||
48770133|NCT01208207|102226001|FG006|STARTED|Part II||142||
48770134|NCT01208207|102225995|FG000|COMPLETED|Part II||0||
48770135|NCT01208207|102225996|FG001|COMPLETED|Part II||0||
48770136|NCT01208207|102225997|FG002|COMPLETED|Part II||0||
48770137|NCT01208207|102225998|FG003|COMPLETED|Part II||282||
48770138|NCT01208207|102225999|FG004|COMPLETED|Part II||295||
48770139|NCT01208207|102226000|FG005|COMPLETED|Part II||129||
48770140|NCT01208207|102226001|FG006|COMPLETED|Part II||131||
48770141|NCT01208207|102225995|FG000|NOT COMPLETED|Part II||0||
48770142|NCT01208207|102225996|FG001|NOT COMPLETED|Part II||0||
48444937|NCT03722849|101425546|FG000|STARTED|Overall Study||29||
48444938|NCT03722849|101425547|FG001|STARTED|Overall Study||29||
48444939|NCT03722849|101425546|FG000|COMPLETED|Overall Study||28||
48444940|NCT03722849|101425547|FG001|COMPLETED|Overall Study||28||
48444941|NCT03722849|101425546|FG000|NOT COMPLETED|Overall Study||1||
48444942|NCT03722849|101425547|FG001|NOT COMPLETED|Overall Study||1||
48444943|NCT02499406|101425548|FG000|STARTED|Overall Study||17||
48444944|NCT02499406|101425548|FG000|COMPLETED|Overall Study||13||
48444945|NCT02499406|101425548|FG000|NOT COMPLETED|Overall Study||4||
48444946|NCT04380701|101425549|FG000|STARTED|Overall Study||12||
48444947|NCT04380701|101425550|FG001|STARTED|Overall Study||12||
48444948|NCT04380701|101425551|FG002|STARTED|Overall Study||6||
48444949|NCT04380701|101425552|FG003|STARTED|Overall Study||12||
48444950|NCT04380701|101425553|FG004|STARTED|Overall Study||12||
48444951|NCT04380701|101425554|FG005|STARTED|Overall Study||12||
48444952|NCT04380701|101425555|FG006|STARTED|Overall Study||12||
48444953|NCT04380701|101425556|FG007|STARTED|Overall Study||12||
48444954|NCT04380701|101425557|FG008|STARTED|Overall Study||12||
48444955|NCT04380701|101425558|FG009|STARTED|Overall Study||12||
48444956|NCT04380701|101425559|FG010|STARTED|Overall Study||12||
48444957|NCT04380701|101425560|FG011|STARTED|Overall Study||12||
48444958|NCT04380701|101425561|FG012|STARTED|Overall Study||12||
48444959|NCT04380701|101425562|FG013|STARTED|Overall Study||12||
48444960|NCT04380701|101425563|FG014|STARTED|Overall Study||12||
48444961|NCT04380701|101425564|FG015|STARTED|Overall Study||12||
48444962|NCT04380701|101425565|FG016|STARTED|Overall Study||12||
48444963|NCT04380701|101425566|FG017|STARTED|Overall Study||12||
48444964|NCT04380701|101425567|FG018|STARTED|Overall Study||12||
48444965|NCT04380701|101425568|FG019|STARTED|Overall Study||12||
48444966|NCT04380701|101425569|FG020|STARTED|Overall Study||12||
48444967|NCT04380701|101425570|FG021|STARTED|Overall Study||15||
48444968|NCT04380701|101425571|FG022|STARTED|Overall Study||15||
48444969|NCT04380701|101425572|FG023|STARTED|Overall Study||30||
48444970|NCT04380701|101425573|FG024|STARTED|Overall Study||90||
48444971|NCT04380701|101425574|FG025|STARTED|Overall Study||20||
48444972|NCT04380701|101425575|FG026|STARTED|Overall Study||12||
48444973|NCT04380701|101425576|FG027|STARTED|Overall Study||12||
48444974|NCT04380701|101425577|FG028|STARTED|Overall Study||12||
48444975|NCT04380701|101425578|FG029|STARTED|Overall Study||12||
48444976|NCT04380701|101425579|FG030|STARTED|Overall Study||12||
48444977|NCT04380701|101425580|FG031|STARTED|Overall Study||12||
48444978|NCT04380701|101425581|FG032|STARTED|Overall Study||12||
48444979|NCT04380701|101425582|FG033|STARTED|Overall Study||12||
48658637|NCT03715829|101948998|FG005|STARTED|Dose Ranging Period||66|The first 6 treatment groups entered this Dose Ranging Period.|
48658638|NCT03715829|101948999|FG006|STARTED|Dose Ranging Period||0|The first 6 treatment groups entered this Dose Ranging Period.|
48658639|NCT03715829|101949000|FG007|STARTED|Dose Ranging Period||0|The first 6 treatment groups entered this Dose Ranging Period.|
48658640|NCT03715829|101949001|FG008|STARTED|Dose Ranging Period||0|The first 6 treatment groups entered this Dose Ranging Period.|
48658641|NCT03715829|101949002|FG009|STARTED|Dose Ranging Period||0|The first 6 treatment groups entered this Dose Ranging Period.|
48658642|NCT03715829|101949003|FG010|STARTED|Dose Ranging Period||0|The first 6 treatment groups entered this Dose Ranging Period.|
48770143|NCT01208207|102225997|FG002|NOT COMPLETED|Part II||0||
48770144|NCT01208207|102225998|FG003|NOT COMPLETED|Part II||32||
48770145|NCT01208207|102225999|FG004|NOT COMPLETED|Part II||23||
48770146|NCT01208207|102226000|FG005|NOT COMPLETED|Part II||16||
48770147|NCT01208207|102226001|FG006|NOT COMPLETED|Part II||11||
48770148|NCT02215252|102226002|FG000|STARTED|Overall Study||44||
48770149|NCT02215252|102226003|FG001|STARTED|Overall Study||46||
48188992|NCT02401529|100786128|FG001|COMPLETED|Overall Study||50||
48444980|NCT04380701|101425549|FG000|Completed End of Treatment|Overall Study||12||
48444981|NCT04380701|101425550|FG001|Completed End of Treatment|Overall Study||12||
48444982|NCT04380701|101425551|FG002|Completed End of Treatment|Overall Study||6||
48444983|NCT04380701|101425552|FG003|Completed End of Treatment|Overall Study||12||
48444984|NCT04380701|101425553|FG004|Completed End of Treatment|Overall Study||12||
48444985|NCT04380701|101425554|FG005|Completed End of Treatment|Overall Study||11||
48444986|NCT04380701|101425555|FG006|Completed End of Treatment|Overall Study||10||
48444987|NCT04380701|101425556|FG007|Completed End of Treatment|Overall Study||11||
48444988|NCT04380701|101425557|FG008|Completed End of Treatment|Overall Study||11||
48444989|NCT04380701|101425558|FG009|Completed End of Treatment|Overall Study||12||
48444990|NCT04380701|101425559|FG010|Completed End of Treatment|Overall Study||12||
48444991|NCT04380701|101425560|FG011|Completed End of Treatment|Overall Study||12||
48444992|NCT04380701|101425561|FG012|Completed End of Treatment|Overall Study||12||
48444993|NCT04380701|101425562|FG013|Completed End of Treatment|Overall Study||11||
48444994|NCT04380701|101425563|FG014|Completed End of Treatment|Overall Study||12||
48444995|NCT04380701|101425564|FG015|Completed End of Treatment|Overall Study||11||
48444996|NCT04380701|101425565|FG016|Completed End of Treatment|Overall Study||12||
48444997|NCT04380701|101425566|FG017|Completed End of Treatment|Overall Study||12||
48444998|NCT04380701|101425567|FG018|Completed End of Treatment|Overall Study||12||
48444999|NCT04380701|101425568|FG019|Completed End of Treatment|Overall Study||12||
48770150|NCT02215252|102226004|FG002|STARTED|Overall Study||45||
48770151|NCT02215252|102226002|FG000|COMPLETED|Overall Study||42||
48770152|NCT02215252|102226003|FG001|COMPLETED|Overall Study||38||
48770153|NCT02215252|102226004|FG002|COMPLETED|Overall Study||41||
48770154|NCT02215252|102226002|FG000|NOT COMPLETED|Overall Study||2||
48770155|NCT02215252|102226003|FG001|NOT COMPLETED|Overall Study||8||
48770156|NCT02215252|102226004|FG002|NOT COMPLETED|Overall Study||4||
48770157|NCT02453321|102226005|FG000|STARTED|Overall Study||20||
48770158|NCT02453321|102226006|FG001|STARTED|Overall Study||21||
48770159|NCT02453321|102226007|FG002|STARTED|Overall Study||21||
48770160|NCT02453321|102226005|FG000|COMPLETED|Overall Study||19||
48770161|NCT02453321|102226006|FG001|COMPLETED|Overall Study||19||
48445000|NCT04380701|101425569|FG020|Completed End of Treatment|Overall Study||12||
48445001|NCT04380701|101425570|FG021|Completed End of Treatment|Overall Study||15||
48445002|NCT04380701|101425571|FG022|Completed End of Treatment|Overall Study||15||
48445003|NCT04380701|101425572|FG023|Completed End of Treatment|Overall Study||30||
48445004|NCT04380701|101425573|FG024|Completed End of Treatment|Overall Study||89||
48445005|NCT04380701|101425574|FG025|Completed End of Treatment|Overall Study||19||
48445006|NCT04380701|101425575|FG026|Completed End of Treatment|Overall Study||12||
48445007|NCT04380701|101425576|FG027|Completed End of Treatment|Overall Study||12||
48445008|NCT04380701|101425577|FG028|Completed End of Treatment|Overall Study||12||
48445009|NCT04380701|101425578|FG029|Completed End of Treatment|Overall Study||11||
48445010|NCT04380701|101425579|FG030|Completed End of Treatment|Overall Study||12||
48445011|NCT04380701|101425580|FG031|Completed End of Treatment|Overall Study||12||
48445012|NCT04380701|101425581|FG032|Completed End of Treatment|Overall Study||11||
48445013|NCT04380701|101425582|FG033|Completed End of Treatment|Overall Study||12||
48445014|NCT04380701|101425549|FG000|Completed End of Follow-up Phase|Overall Study||12||
48445015|NCT04380701|101425550|FG001|Completed End of Follow-up Phase|Overall Study||12||
48445016|NCT04380701|101425551|FG002|Completed End of Follow-up Phase|Overall Study||6||
48445017|NCT04380701|101425552|FG003|Completed End of Follow-up Phase|Overall Study||12||
48445018|NCT04380701|101425553|FG004|Completed End of Follow-up Phase|Overall Study||12||
48445019|NCT04380701|101425554|FG005|Completed End of Follow-up Phase|Overall Study||11||
48445020|NCT04380701|101425555|FG006|Completed End of Follow-up Phase|Overall Study||10||
48445021|NCT04380701|101425556|FG007|Completed End of Follow-up Phase|Overall Study||11||
48445022|NCT04380701|101425557|FG008|Completed End of Follow-up Phase|Overall Study||11||
48445023|NCT04380701|101425558|FG009|Completed End of Follow-up Phase|Overall Study||11||
48445024|NCT04380701|101425559|FG010|Completed End of Follow-up Phase|Overall Study||12||
48445025|NCT04380701|101425560|FG011|Completed End of Follow-up Phase|Overall Study||11||
48445026|NCT04380701|101425561|FG012|Completed End of Follow-up Phase|Overall Study||12||
48770162|NCT02453321|102226007|FG002|COMPLETED|Overall Study||19||
48770163|NCT02453321|102226005|FG000|NOT COMPLETED|Overall Study||1||
48770164|NCT02453321|102226006|FG001|NOT COMPLETED|Overall Study||2||
48770165|NCT02453321|102226007|FG002|NOT COMPLETED|Overall Study||2||
48770166|NCT01116986|102226008|FG000|STARTED|Overall Study||24||
48770167|NCT01116986|102226009|FG001|STARTED|Overall Study||19||
48770168|NCT01116986|102226010|FG002|STARTED|Overall Study||18||
48770169|NCT01116986|102226011|FG003|STARTED|Overall Study||22||
48770170|NCT01116986|102226012|FG004|STARTED|Overall Study||24||
48770171|NCT01116986|102226013|FG005|STARTED|Overall Study||22||
48770172|NCT01116986|102226014|FG006|STARTED|Overall Study||22||
48770173|NCT01116986|102226015|FG007|STARTED|Overall Study||22||
48770174|NCT01116986|102226016|FG008|STARTED|Overall Study||20||
48770175|NCT01116986|102226017|FG009|STARTED|Overall Study||23||
48770176|NCT01116986|102226018|FG010|STARTED|Overall Study||19||
48770177|NCT01116986|102226019|FG011|STARTED|Overall Study||20||
48770178|NCT01116986|102226020|FG012|STARTED|Overall Study||17||
48770179|NCT01116986|102226021|FG013|STARTED|Overall Study||19||
48445027|NCT04380701|101425562|FG013|Completed End of Follow-up Phase|Overall Study||11||
48445028|NCT04380701|101425563|FG014|Completed End of Follow-up Phase|Overall Study||12||
48445029|NCT04380701|101425564|FG015|Completed End of Follow-up Phase|Overall Study||11||
48445030|NCT04380701|101425565|FG016|Completed End of Follow-up Phase|Overall Study||11||
48445031|NCT04380701|101425566|FG017|Completed End of Follow-up Phase|Overall Study||12||
48445032|NCT04380701|101425567|FG018|Completed End of Follow-up Phase|Overall Study||12||
48445033|NCT04380701|101425568|FG019|Completed End of Follow-up Phase|Overall Study||11||
48445034|NCT04380701|101425569|FG020|Completed End of Follow-up Phase|Overall Study||11||
48445035|NCT04380701|101425570|FG021|Completed End of Follow-up Phase|Overall Study||0||
48445036|NCT04380701|101425571|FG022|Completed End of Follow-up Phase|Overall Study||0||
48445037|NCT04380701|101425572|FG023|Completed End of Follow-up Phase|Overall Study||0||
48445038|NCT04380701|101425573|FG024|Completed End of Follow-up Phase|Overall Study||0||
48445039|NCT04380701|101425574|FG025|Completed End of Follow-up Phase|Overall Study||19||
48445040|NCT04380701|101425575|FG026|Completed End of Follow-up Phase|Overall Study||12||
48445041|NCT04380701|101425576|FG027|Completed End of Follow-up Phase|Overall Study||12||
48445042|NCT04380701|101425577|FG028|Completed End of Follow-up Phase|Overall Study||12||
48445043|NCT04380701|101425578|FG029|Completed End of Follow-up Phase|Overall Study||10||
48445044|NCT04380701|101425579|FG030|Completed End of Follow-up Phase|Overall Study||12||
48445045|NCT04380701|101425580|FG031|Completed End of Follow-up Phase|Overall Study||12||
48445046|NCT04380701|101425581|FG032|Completed End of Follow-up Phase|Overall Study||11||
48445047|NCT04380701|101425582|FG033|Completed End of Follow-up Phase|Overall Study||11||
48445048|NCT04380701|101425549|FG000|COMPLETED|Overall Study||12||
48445049|NCT04380701|101425550|FG001|COMPLETED|Overall Study||12||
48445050|NCT04380701|101425551|FG002|COMPLETED|Overall Study||6||
48445051|NCT04380701|101425552|FG003|COMPLETED|Overall Study||12||
48445052|NCT04380701|101425553|FG004|COMPLETED|Overall Study||12||
48445053|NCT04380701|101425554|FG005|COMPLETED|Overall Study||11||
48445054|NCT04380701|101425555|FG006|COMPLETED|Overall Study||10||
48445055|NCT04380701|101425556|FG007|COMPLETED|Overall Study||11||
48445056|NCT04380701|101425557|FG008|COMPLETED|Overall Study||11||
48445057|NCT04380701|101425558|FG009|COMPLETED|Overall Study||11||
48445058|NCT04380701|101425559|FG010|COMPLETED|Overall Study||12||
48445059|NCT04380701|101425560|FG011|COMPLETED|Overall Study||11||
48445060|NCT04380701|101425561|FG012|COMPLETED|Overall Study||12||
48445061|NCT04380701|101425562|FG013|COMPLETED|Overall Study||11||
48445062|NCT04380701|101425563|FG014|COMPLETED|Overall Study||12||
48445063|NCT04380701|101425564|FG015|COMPLETED|Overall Study||11||
48445064|NCT04380701|101425565|FG016|COMPLETED|Overall Study||11||
48445065|NCT04380701|101425566|FG017|COMPLETED|Overall Study||12||
48445066|NCT04380701|101425567|FG018|COMPLETED|Overall Study||12||
48445067|NCT04380701|101425568|FG019|COMPLETED|Overall Study||11||
48445068|NCT04380701|101425569|FG020|COMPLETED|Overall Study||11||
48445069|NCT04380701|101425570|FG021|COMPLETED|Overall Study||0||
48445070|NCT04380701|101425571|FG022|COMPLETED|Overall Study||0||
48445071|NCT04380701|101425572|FG023|COMPLETED|Overall Study||0||
48445072|NCT04380701|101425573|FG024|COMPLETED|Overall Study||0||
48445073|NCT04380701|101425574|FG025|COMPLETED|Overall Study||19||
48445074|NCT04380701|101425575|FG026|COMPLETED|Overall Study||12||
48445075|NCT04380701|101425576|FG027|COMPLETED|Overall Study||12||
48445076|NCT04380701|101425577|FG028|COMPLETED|Overall Study||12||
48445077|NCT04380701|101425578|FG029|COMPLETED|Overall Study||10||
48445078|NCT04380701|101425579|FG030|COMPLETED|Overall Study||12||
48445079|NCT04380701|101425580|FG031|COMPLETED|Overall Study||12||
48445080|NCT04380701|101425581|FG032|COMPLETED|Overall Study||11||
48445081|NCT04380701|101425582|FG033|COMPLETED|Overall Study||11||
48445082|NCT04380701|101425549|FG000|NOT COMPLETED|Overall Study||0||
48445083|NCT04380701|101425550|FG001|NOT COMPLETED|Overall Study||0||
48445084|NCT04380701|101425551|FG002|NOT COMPLETED|Overall Study||0||
48445085|NCT04380701|101425552|FG003|NOT COMPLETED|Overall Study||0||
48445086|NCT04380701|101425553|FG004|NOT COMPLETED|Overall Study||0||
48445087|NCT04380701|101425554|FG005|NOT COMPLETED|Overall Study||1||
48445088|NCT04380701|101425555|FG006|NOT COMPLETED|Overall Study||2||
48445089|NCT04380701|101425556|FG007|NOT COMPLETED|Overall Study||1||
48445090|NCT04380701|101425557|FG008|NOT COMPLETED|Overall Study||1||
48445091|NCT04380701|101425558|FG009|NOT COMPLETED|Overall Study||1||
48445092|NCT04380701|101425559|FG010|NOT COMPLETED|Overall Study||0||
48445093|NCT04380701|101425560|FG011|NOT COMPLETED|Overall Study||1||
48445094|NCT04380701|101425561|FG012|NOT COMPLETED|Overall Study||0||
48445095|NCT04380701|101425562|FG013|NOT COMPLETED|Overall Study||1||
48445096|NCT04380701|101425563|FG014|NOT COMPLETED|Overall Study||0||
48445097|NCT04380701|101425564|FG015|NOT COMPLETED|Overall Study||1||
48445098|NCT04380701|101425565|FG016|NOT COMPLETED|Overall Study||1||
48445099|NCT04380701|101425566|FG017|NOT COMPLETED|Overall Study||0||
48445100|NCT04380701|101425567|FG018|NOT COMPLETED|Overall Study||0||
48445101|NCT04380701|101425568|FG019|NOT COMPLETED|Overall Study||1||
48445102|NCT04380701|101425569|FG020|NOT COMPLETED|Overall Study||1||
48445103|NCT04380701|101425570|FG021|NOT COMPLETED|Overall Study||15||
48445104|NCT04380701|101425571|FG022|NOT COMPLETED|Overall Study||15||
48445105|NCT04380701|101425572|FG023|NOT COMPLETED|Overall Study||30||
48445106|NCT04380701|101425573|FG024|NOT COMPLETED|Overall Study||90||
48445107|NCT04380701|101425574|FG025|NOT COMPLETED|Overall Study||1||
48445108|NCT04380701|101425575|FG026|NOT COMPLETED|Overall Study||0||
48445109|NCT04380701|101425576|FG027|NOT COMPLETED|Overall Study||0||
48445110|NCT04380701|101425577|FG028|NOT COMPLETED|Overall Study||0||
48445111|NCT04380701|101425578|FG029|NOT COMPLETED|Overall Study||2||
48445112|NCT04380701|101425579|FG030|NOT COMPLETED|Overall Study||0||
48445113|NCT04380701|101425580|FG031|NOT COMPLETED|Overall Study||0||
48445114|NCT04380701|101425581|FG032|NOT COMPLETED|Overall Study||1||
48445115|NCT04380701|101425582|FG033|NOT COMPLETED|Overall Study||1||
48445116|NCT03275168|101425583|FG000|STARTED|Overall Study||34||
48445117|NCT03275168|101425584|FG001|STARTED|Overall Study||34||
48445118|NCT03275168|101425583|FG000|COMPLETED|Overall Study||27||
48445119|NCT03275168|101425584|FG001|COMPLETED|Overall Study||25||
48445120|NCT03275168|101425583|FG000|NOT COMPLETED|Overall Study||7||
48445121|NCT03275168|101425584|FG001|NOT COMPLETED|Overall Study||9||
48445122|NCT01785472|101425585|FG000|STARTED|Overall Study||479||
48445123|NCT01785472|101425586|FG001|STARTED|Overall Study||473||
48445124|NCT01785472|101425587|FG002|STARTED|Overall Study||486||
48445125|NCT01785472|101425585|FG000|Full Analysis Set (FAS)|Overall Study||479||
48445126|NCT01785472|101425586|FG001|Full Analysis Set (FAS)|Overall Study||472||
48445127|NCT01785472|101425587|FG002|Full Analysis Set (FAS)|Overall Study||484||
48445128|NCT01785472|101425585|FG000|Safety Set (SAF)|Overall Study||478||
48445129|NCT01785472|101425586|FG001|Safety Set (SAF)|Overall Study||472||
48445130|NCT01785472|101425587|FG002|Safety Set (SAF)|Overall Study||484||
48445131|NCT01785472|101425585|FG000|COMPLETED|Overall Study||455||
48445132|NCT01785472|101425586|FG001|COMPLETED|Overall Study||454||
48445133|NCT01785472|101425587|FG002|COMPLETED|Overall Study||464||
48445134|NCT01785472|101425585|FG000|NOT COMPLETED|Overall Study||24||
48445135|NCT01785472|101425586|FG001|NOT COMPLETED|Overall Study||19||
48445136|NCT01785472|101425587|FG002|NOT COMPLETED|Overall Study||22||
48445137|NCT05048342|101425588|FG000|STARTED|Overall Study||71|All enrolled patients were included in both the Full analysis set (FAS) and Safety set (SAF)|
48445138|NCT05048342|101425588|FG000|COMPLETED|Overall Study||68||
48445139|NCT05048342|101425588|FG000|NOT COMPLETED|Overall Study||3||
48445140|NCT01031134|101425589|FG000|STARTED|Overall Study||114||
48445141|NCT01031134|101425590|FG001|STARTED|Overall Study||88||
48445142|NCT01031134|101425589|FG000|COMPLETED|Overall Study||103||
48445143|NCT01031134|101425590|FG001|COMPLETED|Overall Study||78||
48445144|NCT01031134|101425589|FG000|NOT COMPLETED|Overall Study||11||
48445145|NCT01031134|101425590|FG001|NOT COMPLETED|Overall Study||10||
48445146|NCT03739684|101425591|FG000|STARTED|Overall Study||208||
48445147|NCT03739684|101425591|FG000|COMPLETED|Overall Study||195||
48445148|NCT03739684|101425591|FG000|NOT COMPLETED|Overall Study||13||
48445149|NCT03974516|101425592|FG000|STARTED|Overall Study||6||
48445150|NCT03974516|101425593|FG001|STARTED|Overall Study||7||
48445151|NCT03974516|101425592|FG000|COMPLETED|Overall Study||6||
48445152|NCT03974516|101425593|FG001|COMPLETED|Overall Study||7||
48658643|NCT03715829|101948993|FG000|COMPLETED|Dose Ranging Period||53||
48770180|NCT01116986|102226022|FG014|STARTED|Overall Study||17||
48770181|NCT01116986|102226023|FG015|STARTED|Overall Study||21||
48188993|NCT02401529|100786127|FG000|NOT COMPLETED|Overall Study||9||
48188994|NCT02401529|100786128|FG001|NOT COMPLETED|Overall Study||7||
48188995|NCT00318656|100786129|FG000|STARTED|Overall Study||12||
48188996|NCT00318656|100786130|FG001|STARTED|Overall Study||11||
48445153|NCT03974516|101425592|FG000|NOT COMPLETED|Overall Study||0||
48445154|NCT03974516|101425593|FG001|NOT COMPLETED|Overall Study||0||
48445155|NCT05166421|101425594|FG000|STARTED|Overall Study||76||
48445156|NCT05166421|101425595|FG001|STARTED|Overall Study||72||
48770182|NCT01116986|102226024|FG016|STARTED|Overall Study||16||
48770183|NCT01116986|102226025|FG017|STARTED|Overall Study||24||
48445157|NCT05166421|101425596|FG002|STARTED|Overall Study||76||
48445158|NCT05166421|101425594|FG000|COMPLETED|Overall Study||64||
48445159|NCT05166421|101425595|FG001|COMPLETED|Overall Study||67||
48445160|NCT05166421|101425596|FG002|COMPLETED|Overall Study||62||
48445161|NCT05166421|101425594|FG000|NOT COMPLETED|Overall Study||12||
48445162|NCT05166421|101425595|FG001|NOT COMPLETED|Overall Study||5||
48445163|NCT05166421|101425596|FG002|NOT COMPLETED|Overall Study||14||
48445164|NCT03029000|101425597|FG000|STARTED|Overall Study||1||
48445165|NCT03029000|101425597|FG000|COMPLETED|Overall Study||1||
48445166|NCT03029000|101425597|FG000|NOT COMPLETED|Overall Study||0||
48188997|NCT00318656|100786129|FG000|COMPLETED|Overall Study||12||
48188998|NCT00318656|100786130|FG001|COMPLETED|Overall Study||9||
48445167|NCT00000135|101425598|FG000|STARTED|Overall Study||104||
48188999|NCT00318656|100786129|FG000|NOT COMPLETED|Overall Study||0||
48445168|NCT00000135|101425599|FG001|STARTED|Overall Study||105||
48445169|NCT00000135|101425598|FG000|COMPLETED|Overall Study||77||
48445170|NCT00000135|101425599|FG001|COMPLETED|Overall Study||91||
48445171|NCT00000135|101425598|FG000|NOT COMPLETED|Overall Study||27||
48445172|NCT00000135|101425599|FG001|NOT COMPLETED|Overall Study||14||
48445173|NCT00981019|101425600|FG000|STARTED|Overall Study||778||
48445174|NCT00981019|101425600|FG000|COMPLETED|Overall Study||301||
48445175|NCT00981019|101425600|FG000|NOT COMPLETED|Overall Study||477||
48445176|NCT01053078|101425601|FG000|STARTED|Overall Study||14||
48658644|NCT03715829|101948994|FG001|COMPLETED|Dose Ranging Period||58||
48658645|NCT03715829|101948995|FG002|COMPLETED|Dose Ranging Period||54||
48770184|NCT01116986|102226026|FG018|STARTED|Overall Study||23||
48445177|NCT01053078|101425602|FG001|STARTED|Overall Study||15||
48445178|NCT01053078|101425601|FG000|COMPLETED|Overall Study||10||
48445179|NCT01053078|101425602|FG001|COMPLETED|Overall Study||12||
48445180|NCT01053078|101425601|FG000|NOT COMPLETED|Overall Study||4||
48445181|NCT01053078|101425602|FG001|NOT COMPLETED|Overall Study||3||
48445182|NCT00585039|101425603|FG000|STARTED|Overall Study||57||
48445183|NCT00585039|101425604|FG001|STARTED|Overall Study||44||
48445184|NCT00585039|101425603|FG000|COMPLETED|Overall Study||55||
48445185|NCT00585039|101425604|FG001|COMPLETED|Overall Study||44||
48445186|NCT00585039|101425603|FG000|NOT COMPLETED|Overall Study||2||
48445187|NCT00585039|101425604|FG001|NOT COMPLETED|Overall Study||0||
48445188|NCT04929522|101425605|FG000|STARTED|Overall Study||40||
48445189|NCT04929522|101425606|FG001|STARTED|Overall Study||40||
48445190|NCT04929522|101425607|FG002|STARTED|Overall Study||40||
48445191|NCT04929522|101425608|FG003|STARTED|Overall Study||40||
48445192|NCT04929522|101425605|FG000|COMPLETED|Overall Study||40||
48445193|NCT04929522|101425606|FG001|COMPLETED|Overall Study||40||
48445194|NCT04929522|101425607|FG002|COMPLETED|Overall Study||40||
48770185|NCT01116986|102226027|FG019|STARTED|Overall Study||15||
48189000|NCT00318656|100786130|FG001|NOT COMPLETED|Overall Study||2||
48189001|NCT02783950|100786131|FG000|STARTED|Overall Study||182||
48189002|NCT02783950|100786132|FG001|STARTED|Overall Study||174||
48189003|NCT02783950|100786131|FG000|COMPLETED|Overall Study||175|Includes all patients who were followed for at least 18 months or had an event prior to 18 months|
48369020|NCT03345836|101232676|FG001|STARTED|Period 2: 12-Week Extended Treatment||0||
48369021|NCT03345836|101232677|FG002|STARTED|Period 2: 12-Week Extended Treatment||0||
48369022|NCT03345836|101232678|FG003|STARTED|Period 2: 12-Week Extended Treatment||78||
48369023|NCT03345836|101232679|FG004|STARTED|Period 2: 12-Week Extended Treatment||69||
48369024|NCT03345836|101232680|FG005|STARTED|Period 2: 12-Week Extended Treatment||14||
48369025|NCT03345836|101232675|FG000|COMPLETED|Period 2: 12-Week Extended Treatment||0|Completed=completed the study|
48369026|NCT03345836|101232676|FG001|COMPLETED|Period 2: 12-Week Extended Treatment||0|Completed=completed the study|
48369027|NCT03345836|101232677|FG002|COMPLETED|Period 2: 12-Week Extended Treatment||0|Completed=completed the study|
48369028|NCT03345836|101232678|FG003|COMPLETED|Period 2: 12-Week Extended Treatment||67|Completed=completed the study|
48369029|NCT03345836|101232679|FG004|COMPLETED|Period 2: 12-Week Extended Treatment||51|Completed=completed the study|
48369030|NCT03345836|101232680|FG005|COMPLETED|Period 2: 12-Week Extended Treatment||8|Completed=completed the study|
48369031|NCT03345836|101232675|FG000|NOT COMPLETED|Period 2: 12-Week Extended Treatment||0||
48369032|NCT03345836|101232676|FG001|NOT COMPLETED|Period 2: 12-Week Extended Treatment||0||
48369033|NCT03345836|101232677|FG002|NOT COMPLETED|Period 2: 12-Week Extended Treatment||0||
48369034|NCT03345836|101232678|FG003|NOT COMPLETED|Period 2: 12-Week Extended Treatment||11||
48369035|NCT03345836|101232679|FG004|NOT COMPLETED|Period 2: 12-Week Extended Treatment||18||
48369036|NCT03345836|101232680|FG005|NOT COMPLETED|Period 2: 12-Week Extended Treatment||6||
48369037|NCT01842620|101232681|FG000|STARTED|Period 1||13||
48369038|NCT01842620|101232682|FG001|STARTED|Period 1||12||
48369039|NCT01842620|101232681|FG000|COMPLETED|Period 1||12||
48369040|NCT01842620|101232682|FG001|COMPLETED|Period 1||12||
48369041|NCT01842620|101232681|FG000|NOT COMPLETED|Period 1||1||
48369042|NCT01842620|101232682|FG001|NOT COMPLETED|Period 1||0||
48369043|NCT01842620|101232681|FG000|STARTED|Washout Period||12||
48369044|NCT01842620|101232682|FG001|STARTED|Washout Period||12||
48369045|NCT01842620|101232681|FG000|COMPLETED|Washout Period||12||
48369046|NCT01842620|101232682|FG001|COMPLETED|Washout Period||12||
48369047|NCT01842620|101232681|FG000|NOT COMPLETED|Washout Period||0||
48369048|NCT01842620|101232682|FG001|NOT COMPLETED|Washout Period||0||
48445195|NCT04929522|101425608|FG003|COMPLETED|Overall Study||40||
48445196|NCT04929522|101425605|FG000|NOT COMPLETED|Overall Study||0||
48445197|NCT04929522|101425606|FG001|NOT COMPLETED|Overall Study||0||
48445198|NCT04929522|101425607|FG002|NOT COMPLETED|Overall Study||0||
48445199|NCT04929522|101425608|FG003|NOT COMPLETED|Overall Study||0||
48445200|NCT00756652|101425609|FG000|STARTED|Original Phase||41452||
48445201|NCT00756652|101425610|FG001|STARTED|Original Phase||1039||
48445202|NCT00756652|101425609|FG000|COMPLETED|Original Phase||6063||
48445203|NCT00756652|101425610|FG001|COMPLETED|Original Phase||118||
48445204|NCT00756652|101425609|FG000|NOT COMPLETED|Original Phase||35389||
48445205|NCT00756652|101425610|FG001|NOT COMPLETED|Original Phase||921||
48445206|NCT00756652|101425609|FG000|STARTED|Re-Op Phase||11101||
48445207|NCT00756652|101425610|FG001|STARTED|Re-Op Phase||0||
48369049|NCT01842620|101232681|FG000|STARTED|Period 2||12||
48369050|NCT01842620|101232682|FG001|STARTED|Period 2||12||
48369051|NCT01842620|101232681|FG000|COMPLETED|Period 2||12||
48369052|NCT01842620|101232682|FG001|COMPLETED|Period 2||12||
48369053|NCT01842620|101232681|FG000|NOT COMPLETED|Period 2||0||
48369054|NCT01842620|101232682|FG001|NOT COMPLETED|Period 2||0||
48369055|NCT01295905|101232683|FG000|STARTED|Overall Study||60||
48369056|NCT01295905|101232684|FG001|STARTED|Overall Study||30||
48369057|NCT01295905|101232683|FG000|COMPLETED|Overall Study||58||
48369058|NCT01295905|101232684|FG001|COMPLETED|Overall Study||30||
48369059|NCT01295905|101232683|FG000|NOT COMPLETED|Overall Study||2||
48445208|NCT00756652|101425609|FG000|COMPLETED|Re-Op Phase||8225||
48445209|NCT00756652|101425610|FG001|COMPLETED|Re-Op Phase||0||
48445210|NCT00756652|101425609|FG000|NOT COMPLETED|Re-Op Phase||2876||
48445211|NCT00756652|101425610|FG001|NOT COMPLETED|Re-Op Phase||0||
48445212|NCT00808015|101425611|FG000|STARTED|Overall Study||1377||
48445213|NCT00808015|101425611|FG000|Treated|Overall Study||1373||
48445214|NCT00808015|101425611|FG000|COMPLETED|Overall Study||1033||
48445215|NCT00808015|101425611|FG000|NOT COMPLETED|Overall Study||344||
48445216|NCT01643928|101425612|FG000|STARTED|Overall Study||58||
48445217|NCT01643928|101425613|FG001|STARTED|Overall Study||32||
48445218|NCT01643928|101425614|FG002|STARTED|Overall Study||33||
48445219|NCT01643928|101425615|FG003|STARTED|Overall Study||30||
48445220|NCT01643928|101425616|FG004|STARTED|Overall Study||30||
48445221|NCT01643928|101425612|FG000|COMPLETED|Overall Study||48||
48445222|NCT01643928|101425613|FG001|COMPLETED|Overall Study||30||
48445223|NCT01643928|101425614|FG002|COMPLETED|Overall Study||30||
48445224|NCT01643928|101425615|FG003|COMPLETED|Overall Study||27||
48445225|NCT01643928|101425616|FG004|COMPLETED|Overall Study||28||
48445226|NCT01643928|101425612|FG000|NOT COMPLETED|Overall Study||10||
48445227|NCT01643928|101425613|FG001|NOT COMPLETED|Overall Study||2||
48445228|NCT01643928|101425614|FG002|NOT COMPLETED|Overall Study||3||
48445229|NCT01643928|101425615|FG003|NOT COMPLETED|Overall Study||3||
48445230|NCT01643928|101425616|FG004|NOT COMPLETED|Overall Study||2||
48445231|NCT00566969|101425617|FG000|STARTED|Overall Study||34||
48445232|NCT00566969|101425618|FG001|STARTED|Overall Study||37||
48445233|NCT00566969|101425619|FG002|STARTED|Overall Study||35||
48445234|NCT00566969|101425617|FG000|COMPLETED|Overall Study||19||
48445235|NCT00566969|101425618|FG001|COMPLETED|Overall Study||28||
48445236|NCT00566969|101425619|FG002|COMPLETED|Overall Study||23||
48445237|NCT00566969|101425617|FG000|NOT COMPLETED|Overall Study||15||
48445238|NCT00566969|101425618|FG001|NOT COMPLETED|Overall Study||9||
48445239|NCT00566969|101425619|FG002|NOT COMPLETED|Overall Study||12||
48445240|NCT03593356|101425620|FG000|STARTED|Age 1 Wave||400||
48445241|NCT03593356|101425621|FG001|STARTED|Age 1 Wave||600||
48445242|NCT03593356|101425620|FG000|COMPLETED|Age 1 Wave||383||
48445243|NCT03593356|101425621|FG001|COMPLETED|Age 1 Wave||548||
48445244|NCT03593356|101425620|FG000|NOT COMPLETED|Age 1 Wave||17||
48445245|NCT03593356|101425621|FG001|NOT COMPLETED|Age 1 Wave||52||
48445246|NCT03593356|101425620|FG000|STARTED|Age 2 Wave||397||
48445247|NCT03593356|101425621|FG001|STARTED|Age 2 Wave||599||
48445248|NCT03593356|101425620|FG000|COMPLETED|Age 2 Wave||377||
48445249|NCT03593356|101425621|FG001|COMPLETED|Age 2 Wave||545||
48445250|NCT03593356|101425620|FG000|NOT COMPLETED|Age 2 Wave||20||
48445251|NCT03593356|101425621|FG001|NOT COMPLETED|Age 2 Wave||54||
48445252|NCT03593356|101425620|FG000|STARTED|Age 3 Wave||397||
48445253|NCT03593356|101425621|FG001|STARTED|Age 3 Wave||598||
48445254|NCT03593356|101425620|FG000|COMPLETED|Age 3 Wave||380||
48445255|NCT03593356|101425621|FG001|COMPLETED|Age 3 Wave||542||
48445256|NCT03593356|101425620|FG000|NOT COMPLETED|Age 3 Wave||17||
48445257|NCT03593356|101425621|FG001|NOT COMPLETED|Age 3 Wave||56||
48445258|NCT03593356|101425620|FG000|STARTED|Age 4 Wave||395||
48445259|NCT03593356|101425621|FG001|STARTED|Age 4 Wave||589||
48445260|NCT03593356|101425620|FG000|COMPLETED|Age 4 Wave||375||
48445261|NCT03593356|101425621|FG001|COMPLETED|Age 4 Wave||517||
48445262|NCT03593356|101425620|FG000|NOT COMPLETED|Age 4 Wave||20||
48445263|NCT03593356|101425621|FG001|NOT COMPLETED|Age 4 Wave||72||
48445264|NCT01563029|101425622|FG000|STARTED|Overall Study||119||
48445265|NCT01563029|101425623|FG001|STARTED|Overall Study||118||
48445266|NCT01563029|101425624|FG002|STARTED|Overall Study||120||
48445267|NCT01563029|101425625|FG003|STARTED|Overall Study||118||
48445268|NCT01563029|101425626|FG004|STARTED|Overall Study||118||
48445269|NCT01563029|101425622|FG000|COMPLETED|Overall Study||66||
48445270|NCT01563029|101425623|FG001|COMPLETED|Overall Study||94||
48445271|NCT01563029|101425624|FG002|COMPLETED|Overall Study||87||
48445272|NCT01563029|101425625|FG003|COMPLETED|Overall Study||85||
48445273|NCT01563029|101425626|FG004|COMPLETED|Overall Study||89||
48445274|NCT01563029|101425622|FG000|NOT COMPLETED|Overall Study||53||
48445275|NCT01563029|101425623|FG001|NOT COMPLETED|Overall Study||24||
48445276|NCT01563029|101425624|FG002|NOT COMPLETED|Overall Study||33||
48445277|NCT01563029|101425625|FG003|NOT COMPLETED|Overall Study||33||
48445278|NCT01563029|101425626|FG004|NOT COMPLETED|Overall Study||29||
48445279|NCT03338673|101425627|FG000|STARTED|Overall Study||6||
48445280|NCT03338673|101425628|FG001|STARTED|Overall Study||6||
48445281|NCT03338673|101425627|FG000|COMPLETED|Overall Study||5||
48445282|NCT03338673|101425628|FG001|COMPLETED|Overall Study||5||
48445283|NCT03338673|101425627|FG000|NOT COMPLETED|Overall Study||1||
48445284|NCT03338673|101425628|FG001|NOT COMPLETED|Overall Study||1||
48445285|NCT01850108|101425629|FG000|STARTED|Overall Study||26||
48445286|NCT01850108|101425629|FG000|COMPLETED|Overall Study||18||
48445287|NCT01850108|101425629|FG000|NOT COMPLETED|Overall Study||8||
48445288|NCT02411110|101425630|FG000|STARTED|Treatment Period 1||65||
48445289|NCT02411110|101425631|FG001|STARTED|Treatment Period 1||66||
48445290|NCT02411110|101425630|FG000|COMPLETED|Treatment Period 1||56||
48445291|NCT02411110|101425631|FG001|COMPLETED|Treatment Period 1||59||
48445292|NCT02411110|101425630|FG000|NOT COMPLETED|Treatment Period 1||9||
48445293|NCT02411110|101425631|FG001|NOT COMPLETED|Treatment Period 1||7||
48445294|NCT02411110|101425630|FG000|STARTED|Treatment Period 2||50||
48445295|NCT02411110|101425631|FG001|STARTED|Treatment Period 2||48||
48445296|NCT02411110|101425630|FG000|COMPLETED|Treatment Period 2||49||
48445297|NCT02411110|101425631|FG001|COMPLETED|Treatment Period 2||44||
48445298|NCT02411110|101425630|FG000|NOT COMPLETED|Treatment Period 2||1||
48445299|NCT02411110|101425631|FG001|NOT COMPLETED|Treatment Period 2||4||
48445300|NCT03403712|101425632|FG000|STARTED|Overall Study||200||
48445301|NCT03403712|101425633|FG001|STARTED|Overall Study||202||
48445302|NCT03403712|101425632|FG000|COMPLETED|Overall Study||95||
48445303|NCT03403712|101425633|FG001|COMPLETED|Overall Study||102||
48445304|NCT03403712|101425632|FG000|NOT COMPLETED|Overall Study||105||
48189004|NCT02783950|100786132|FG001|COMPLETED|Overall Study||165|Includes all patients who were followed for at least 18 months or had an event prior to 18 months|
48445305|NCT03403712|101425633|FG001|NOT COMPLETED|Overall Study||100||
48445306|NCT02564952|101425634|FG000|STARTED|Overall Study||18||
48445307|NCT02564952|101425634|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18||
48189005|NCT02783950|100786131|FG000|NOT COMPLETED|Overall Study||7||
48189006|NCT02783950|100786132|FG001|NOT COMPLETED|Overall Study||9||
48189007|NCT01938664|100786133|FG000|STARTED|Overall Study||20||
48189008|NCT01938664|100786134|FG001|STARTED|Overall Study||10||
48189009|NCT01938664|100786133|FG000|COMPLETED|Overall Study||5|This only includes subjects that completed 4 weeks of study treatment until the efficacy analysis.|
48189010|NCT01938664|100786134|FG001|COMPLETED|Overall Study||0|This only includes subjects that completed 4 weeks of study treatment until the efficacy analysis.|
48189011|NCT01938664|100786133|FG000|NOT COMPLETED|Overall Study||15||
48189012|NCT01938664|100786134|FG001|NOT COMPLETED|Overall Study||10||
48189013|NCT00940017|100786135|FG000|STARTED|Overall Study||24||
48189014|NCT00940017|100786135|FG000|Subjects Treated|Overall Study||21||
48189015|NCT00940017|100786135|FG000|COMPLETED|Overall Study||20||
48189016|NCT00940017|100786135|FG000|NOT COMPLETED|Overall Study||4||
48189017|NCT04776213|100786136|FG000|STARTED|Overall Study||280||
48189018|NCT04776213|100786136|FG000|COMPLETED|Overall Study||269||
48189019|NCT04776213|100786136|FG000|NOT COMPLETED|Overall Study||11||
48189020|NCT02335268|100786137|FG000|STARTED|Overall Study||51||
48189021|NCT02335268|100786138|FG001|STARTED|Overall Study||26||
48189022|NCT02335268|100786137|FG000|COMPLETED|Overall Study||34||
48189023|NCT02335268|100786138|FG001|COMPLETED|Overall Study||20||
48189024|NCT02335268|100786137|FG000|NOT COMPLETED|Overall Study||17||
48189025|NCT02335268|100786138|FG001|NOT COMPLETED|Overall Study||6||
48189026|NCT00162942|100786139|FG000|STARTED|Overall Study||157||
48189027|NCT00162942|100786140|FG001|STARTED|Overall Study||78||
48189028|NCT00162942|100786139|FG000|Week 12|Overall Study||127||
48189029|NCT00162942|100786140|FG001|Week 12|Overall Study||61||
48189030|NCT00162942|100786139|FG000|COMPLETED|Overall Study||51||
48189031|NCT00162942|100786140|FG001|COMPLETED|Overall Study||26||
48189032|NCT00162942|100786139|FG000|NOT COMPLETED|Overall Study||106||
48189033|NCT00162942|100786140|FG001|NOT COMPLETED|Overall Study||52||
48189034|NCT03003962|100786141|FG000|STARTED|Overall Study||335|Randomized|
48189035|NCT03003962|100786142|FG001|STARTED|Overall Study||334|Randomized|
48189036|NCT03003962|100786141|FG000|PD L1 TC ≥ 25% LREM Analysis Set|Overall Study||278||
48189037|NCT03003962|100786142|FG001|PD L1 TC ≥ 25% LREM Analysis Set|Overall Study||271||
48189038|NCT03003962|100786141|FG000|PD L1 TC ≥ 50% Analysis Set|Overall Study||247||
48189039|NCT03003962|100786142|FG001|PD L1 TC ≥ 50% Analysis Set|Overall Study||246||
48189040|NCT03003962|100786141|FG000|PD L1 TC ≥ 50% LREM Analysis Set|Overall Study||207||
48189041|NCT03003962|100786142|FG001|PD L1 TC ≥ 50% LREM Analysis Set|Overall Study||199||
48189042|NCT03003962|100786141|FG000|COMPLETED|Overall Study||1||
48189043|NCT03003962|100786142|FG001|COMPLETED|Overall Study||0||
48189044|NCT03003962|100786141|FG000|NOT COMPLETED|Overall Study||334||
48189045|NCT03003962|100786142|FG001|NOT COMPLETED|Overall Study||334||
48189046|NCT02561455|100786143|FG000|STARTED|Overall Study||2||
48369060|NCT01295905|101232684|FG001|NOT COMPLETED|Overall Study||0||
48369061|NCT03519308|101232685|FG000|STARTED|Overall Study||2||
48369062|NCT03519308|101232686|FG001|STARTED|Overall Study||1||
48369063|NCT03519308|101232685|FG000|COMPLETED|Overall Study||2||
48369064|NCT03519308|101232686|FG001|COMPLETED|Overall Study||1||
48369065|NCT03519308|101232685|FG000|NOT COMPLETED|Overall Study||0||
48369066|NCT03519308|101232686|FG001|NOT COMPLETED|Overall Study||0||
48369067|NCT02064439|101232687|FG000|STARTED|Overall Study||1127||
48369068|NCT02064439|101232688|FG001|STARTED|Overall Study||1107||
48369069|NCT02064439|101232689|FG002|STARTED|Overall Study||1131||
48369070|NCT02064439|101232687|FG000|COMPLETED|Overall Study||984||
48445308|NCT02564952|101425634|FG000|Completed OLE Titration Period|Overall Study||16|OLE population: enrolled participants with ≥1 dose of study drug from Day 2 of Visit 4 onwards.|
48445309|NCT02564952|101425634|FG000|COMPLETED|Overall Study||7||
48445310|NCT02564952|101425634|FG000|NOT COMPLETED|Overall Study||11||
48445311|NCT00833976|101425635|FG000|STARTED|Overall Study||65||
48445312|NCT00833976|101425635|FG000|COMPLETED|Overall Study||14||
48658646|NCT03715829|101948996|FG003|COMPLETED|Dose Ranging Period||36||
48189047|NCT02561455|100786144|FG001|STARTED|Overall Study||3||
48189048|NCT02561455|100786145|FG002|STARTED|Overall Study||3||
48369071|NCT02064439|101232688|FG001|COMPLETED|Overall Study||969||
48369072|NCT02064439|101232689|FG002|COMPLETED|Overall Study||949||
48369073|NCT02064439|101232687|FG000|NOT COMPLETED|Overall Study||143||
48369074|NCT02064439|101232688|FG001|NOT COMPLETED|Overall Study||138||
48369075|NCT02064439|101232689|FG002|NOT COMPLETED|Overall Study||182||
48658647|NCT03715829|101948997|FG004|COMPLETED|Dose Ranging Period||42||
48445313|NCT00833976|101425635|FG000|NOT COMPLETED|Overall Study||51||
48445314|NCT03127943|101425636|FG000|STARTED|First Intervention||12||
48445315|NCT03127943|101425637|FG001|STARTED|First Intervention||12||
48445316|NCT03127943|101425636|FG000|COMPLETED|First Intervention||12||
48445317|NCT03127943|101425637|FG001|COMPLETED|First Intervention||12||
48445318|NCT03127943|101425636|FG000|NOT COMPLETED|First Intervention||0||
48445319|NCT03127943|101425637|FG001|NOT COMPLETED|First Intervention||0||
48445320|NCT03127943|101425636|FG000|STARTED|Washout (1 Week)||12||
48658648|NCT03715829|101948998|FG005|COMPLETED|Dose Ranging Period||55||
48658649|NCT03715829|101948999|FG006|COMPLETED|Dose Ranging Period||0||
48658650|NCT03715829|101949000|FG007|COMPLETED|Dose Ranging Period||0||
48658651|NCT03715829|101949001|FG008|COMPLETED|Dose Ranging Period||0||
48658652|NCT03715829|101949002|FG009|COMPLETED|Dose Ranging Period||0||
48658653|NCT03715829|101949003|FG010|COMPLETED|Dose Ranging Period||0||
48658654|NCT03715829|101948993|FG000|NOT COMPLETED|Dose Ranging Period||12||
48658655|NCT03715829|101948994|FG001|NOT COMPLETED|Dose Ranging Period||9||
48658656|NCT03715829|101948995|FG002|NOT COMPLETED|Dose Ranging Period||13||
48658657|NCT03715829|101948996|FG003|NOT COMPLETED|Dose Ranging Period||14||
48770186|NCT01116986|102226028|FG020|STARTED|Overall Study||24||
48770187|NCT01116986|102226029|FG021|STARTED|Overall Study||20||
48770188|NCT01116986|102226030|FG022|STARTED|Overall Study||23||
48770189|NCT01116986|102226031|FG023|STARTED|Overall Study||21||
48770190|NCT01116986|102226032|FG024|STARTED|Overall Study||18||
48770191|NCT01116986|102226033|FG025|STARTED|Overall Study||19||
48770192|NCT01116986|102226034|FG026|STARTED|Overall Study||18||
48770193|NCT01116986|102226035|FG027|STARTED|Overall Study||19||
48770194|NCT01116986|102226036|FG028|STARTED|Overall Study||17||
48770195|NCT01116986|102226037|FG029|STARTED|Overall Study||17||
48770196|NCT01116986|102226038|FG030|STARTED|Overall Study||17||
48770197|NCT01116986|102226039|FG031|STARTED|Overall Study||17||
48189049|NCT02561455|100786146|FG003|STARTED|Overall Study||1||
48369076|NCT02402218|101232690|FG000|STARTED|Overall Study||36||
48658658|NCT03715829|101948997|FG004|NOT COMPLETED|Dose Ranging Period||7||
48658659|NCT03715829|101948998|FG005|NOT COMPLETED|Dose Ranging Period||11||
48658660|NCT03715829|101948999|FG006|NOT COMPLETED|Dose Ranging Period||0||
48658661|NCT03715829|101949000|FG007|NOT COMPLETED|Dose Ranging Period||0||
48658662|NCT03715829|101949001|FG008|NOT COMPLETED|Dose Ranging Period||0||
48658663|NCT03715829|101949002|FG009|NOT COMPLETED|Dose Ranging Period||0||
48658664|NCT03715829|101949003|FG010|NOT COMPLETED|Dose Ranging Period||0||
48770198|NCT01116986|102226008|FG000|COMPLETED|Overall Study||22||
48770199|NCT01116986|102226009|FG001|COMPLETED|Overall Study||16||
48770200|NCT01116986|102226010|FG002|COMPLETED|Overall Study||16||
48770201|NCT01116986|102226011|FG003|COMPLETED|Overall Study||20||
48770202|NCT01116986|102226012|FG004|COMPLETED|Overall Study||20||
48770203|NCT01116986|102226013|FG005|COMPLETED|Overall Study||20||
48770204|NCT01116986|102226014|FG006|COMPLETED|Overall Study||20||
48770205|NCT01116986|102226015|FG007|COMPLETED|Overall Study||20||
48770206|NCT01116986|102226016|FG008|COMPLETED|Overall Study||19||
48369077|NCT02402218|101232691|FG001|STARTED|Overall Study||54||
48369078|NCT02402218|101232692|FG002|STARTED|Overall Study||54||
48369079|NCT02402218|101232690|FG000|Initiated Treatment With LDV/SOF|Overall Study||24||
48369080|NCT02402218|101232691|FG001|Initiated Treatment With LDV/SOF|Overall Study||45||
48369081|NCT02402218|101232692|FG002|Initiated Treatment With LDV/SOF|Overall Study||41||
48369082|NCT02402218|101232690|FG000|Completed Treatment With LDV/SOF|Overall Study||23||
48369083|NCT02402218|101232691|FG001|Completed Treatment With LDV/SOF|Overall Study||42||
48369084|NCT02402218|101232692|FG002|Completed Treatment With LDV/SOF|Overall Study||39||
48369085|NCT02402218|101232690|FG000|Achieved Sustained Virologic Response|Overall Study||22||
48369086|NCT02402218|101232691|FG001|Achieved Sustained Virologic Response|Overall Study||41||
48369087|NCT02402218|101232692|FG002|Achieved Sustained Virologic Response|Overall Study||37||
48369088|NCT02402218|101232690|FG000|COMPLETED|Overall Study||22||
48369089|NCT02402218|101232691|FG001|COMPLETED|Overall Study||41||
48369090|NCT02402218|101232692|FG002|COMPLETED|Overall Study||37||
48369091|NCT02402218|101232690|FG000|NOT COMPLETED|Overall Study||14||
48369092|NCT02402218|101232691|FG001|NOT COMPLETED|Overall Study||13||
48369093|NCT02402218|101232692|FG002|NOT COMPLETED|Overall Study||17||
48369094|NCT00633139|101232693|FG000|STARTED|Overall Study||4||
48369095|NCT00633139|101232694|FG001|STARTED|Overall Study||5||
48369096|NCT00633139|101232695|FG002|STARTED|Overall Study||4||
48369097|NCT00633139|101232693|FG000|COMPLETED|Overall Study||4||
48369098|NCT00633139|101232694|FG001|COMPLETED|Overall Study||4||
48369099|NCT00633139|101232695|FG002|COMPLETED|Overall Study||3||
48369100|NCT00633139|101232693|FG000|NOT COMPLETED|Overall Study||0||
48369101|NCT00633139|101232694|FG001|NOT COMPLETED|Overall Study||1||
48369102|NCT00633139|101232695|FG002|NOT COMPLETED|Overall Study||1||
48369103|NCT02440178|101232696|FG000|STARTED|Overall Study||66||
48369104|NCT02440178|101232696|FG000|COMPLETED|Overall Study||46||
48369105|NCT02440178|101232696|FG000|NOT COMPLETED|Overall Study||20||
48369106|NCT01106534|101232697|FG000|STARTED|Overall Study||2997||
48369107|NCT01106534|101232697|FG000|COMPLETED|Overall Study||2960||
48369108|NCT01106534|101232697|FG000|NOT COMPLETED|Overall Study||37||
48369109|NCT00320385|101232698|FG000|STARTED|Overall Study||148||
48670041|NCT03601897|101974872|FG006|NOT COMPLETED|Overall Study||16||
48770207|NCT01116986|102226017|FG009|COMPLETED|Overall Study||19||
48445321|NCT03127943|101425637|FG001|STARTED|Washout (1 Week)||12||
48445322|NCT03127943|101425636|FG000|COMPLETED|Washout (1 Week)||12||
48445323|NCT03127943|101425637|FG001|COMPLETED|Washout (1 Week)||12||
48445324|NCT03127943|101425636|FG000|NOT COMPLETED|Washout (1 Week)||0||
48445325|NCT03127943|101425637|FG001|NOT COMPLETED|Washout (1 Week)||0||
48445326|NCT03127943|101425636|FG000|STARTED|Second Intervention||12||
48445327|NCT03127943|101425637|FG001|STARTED|Second Intervention||12||
48445328|NCT03127943|101425636|FG000|COMPLETED|Second Intervention||12||
48445329|NCT03127943|101425637|FG001|COMPLETED|Second Intervention||12||
48445330|NCT03127943|101425636|FG000|NOT COMPLETED|Second Intervention||0||
48445331|NCT03127943|101425637|FG001|NOT COMPLETED|Second Intervention||0||
48445332|NCT00378482|101425638|FG000|STARTED|Overall Study||37|37|
48445333|NCT00378482|101425638|FG000|COMPLETED|Overall Study||6|6|
48445334|NCT00378482|101425638|FG000|NOT COMPLETED|Overall Study||31||
48445335|NCT01093482|101425639|FG000|STARTED|Overall Study||8151||
48445336|NCT01093482|101425639|FG000|COMPLETED|Overall Study||8151||
48445337|NCT01093482|101425639|FG000|NOT COMPLETED|Overall Study||0||
48445338|NCT04199104|101425640|FG000|STARTED|Overall Study||256||
48445339|NCT04199104|101425641|FG001|STARTED|Overall Study||255||
48445340|NCT04199104|101425640|FG000|Treated|Overall Study||254||
48445341|NCT04199104|101425641|FG001|Treated|Overall Study||253||
48445342|NCT04199104|101425640|FG000|Received Second Course|Overall Study||2||
48770208|NCT01116986|102226018|FG010|COMPLETED|Overall Study||18||
48770209|NCT01116986|102226019|FG011|COMPLETED|Overall Study||20||
48770210|NCT01116986|102226020|FG012|COMPLETED|Overall Study||16||
48770211|NCT01116986|102226021|FG013|COMPLETED|Overall Study||16||
48770212|NCT01116986|102226022|FG014|COMPLETED|Overall Study||17||
48770213|NCT01116986|102226023|FG015|COMPLETED|Overall Study||15||
48770214|NCT01116986|102226024|FG016|COMPLETED|Overall Study||13||
48770215|NCT01116986|102226025|FG017|COMPLETED|Overall Study||19||
48770216|NCT01116986|102226026|FG018|COMPLETED|Overall Study||20||
48445343|NCT04199104|101425641|FG001|Received Second Course|Overall Study||0||
48445344|NCT04199104|101425640|FG000|COMPLETED|Overall Study||0||
48445345|NCT04199104|101425641|FG001|COMPLETED|Overall Study||0||
48445346|NCT04199104|101425640|FG000|NOT COMPLETED|Overall Study||256||
48445347|NCT04199104|101425641|FG001|NOT COMPLETED|Overall Study||255||
48445348|NCT00689273|101425642|FG000|STARTED|Overall Study||79||
48445349|NCT00689273|101425643|FG001|STARTED|Overall Study||78||
48445350|NCT00689273|101425642|FG000|Treated|Overall Study||78||
48445351|NCT00689273|101425643|FG001|Treated|Overall Study||78||
48445352|NCT00689273|101425642|FG000|COMPLETED|Overall Study||66||
48445353|NCT00689273|101425643|FG001|COMPLETED|Overall Study||73||
48445354|NCT00689273|101425642|FG000|NOT COMPLETED|Overall Study||13||
48445355|NCT00689273|101425643|FG001|NOT COMPLETED|Overall Study||5||
48445356|NCT00597727|101425644|FG000|STARTED|12 Month Blinded Phase||14||
48445357|NCT00597727|101425645|FG001|STARTED|12 Month Blinded Phase||15||
48658665|NCT03715829|101948993|FG000|STARTED|Extension Period||0|"The last 5 EXT treatment groups entered this Extension Period.~Three participants were lost to follow-up after completing the Dose Ranging Period, and no extension treatment was recorded for these 3 participants. A total of 295 participants were assigned to the Extension Period, among whom 293 received treatment."|
48658666|NCT03715829|101948994|FG001|STARTED|Extension Period||0|"The last 5 EXT treatment groups entered this Extension Period.~Three participants were lost to follow-up after completing the Dose Ranging Period, and no extension treatment was recorded for these 3 participants. A total of 295 participants were assigned to the Extension Period, among whom 293 received treatment."|
48670042|NCT03601897|101974873|FG007|NOT COMPLETED|Overall Study||5||
48670043|NCT03601897|101974874|FG008|NOT COMPLETED|Overall Study||13||
48770217|NCT01116986|102226027|FG019|COMPLETED|Overall Study||13||
48770218|NCT01116986|102226028|FG020|COMPLETED|Overall Study||22||
48770219|NCT01116986|102226029|FG021|COMPLETED|Overall Study||18||
48770220|NCT01116986|102226030|FG022|COMPLETED|Overall Study||19||
48770221|NCT01116986|102226031|FG023|COMPLETED|Overall Study||19||
48770222|NCT01116986|102226032|FG024|COMPLETED|Overall Study||15||
48445358|NCT00597727|101425646|FG002|STARTED|12 Month Blinded Phase||0||
48770223|NCT01116986|102226033|FG025|COMPLETED|Overall Study||19||
48770224|NCT01116986|102226034|FG026|COMPLETED|Overall Study||14||
48770225|NCT01116986|102226035|FG027|COMPLETED|Overall Study||18||
48445359|NCT00597727|101425647|FG003|STARTED|12 Month Blinded Phase||27||
48445360|NCT00597727|101425648|FG004|STARTED|12 Month Blinded Phase||4||
48445361|NCT00597727|101425644|FG000|COMPLETED|12 Month Blinded Phase||14||
48445362|NCT00597727|101425645|FG001|COMPLETED|12 Month Blinded Phase||15||
48445363|NCT00597727|101425646|FG002|COMPLETED|12 Month Blinded Phase||0||
48445364|NCT00597727|101425647|FG003|COMPLETED|12 Month Blinded Phase||17||
48445365|NCT00597727|101425648|FG004|COMPLETED|12 Month Blinded Phase||3||
48445366|NCT00597727|101425644|FG000|NOT COMPLETED|12 Month Blinded Phase||0||
48770226|NCT01116986|102226036|FG028|COMPLETED|Overall Study||17||
48770227|NCT01116986|102226037|FG029|COMPLETED|Overall Study||17||
48770228|NCT01116986|102226038|FG030|COMPLETED|Overall Study||16||
48445367|NCT00597727|101425645|FG001|NOT COMPLETED|12 Month Blinded Phase||0||
48445368|NCT00597727|101425646|FG002|NOT COMPLETED|12 Month Blinded Phase||0||
48658667|NCT03715829|101948995|FG002|STARTED|Extension Period||0|"The last 5 EXT treatment groups entered this Extension Period.~Three participants were lost to follow-up after completing the Dose Ranging Period, and no extension treatment was recorded for these 3 participants. A total of 295 participants were assigned to the Extension Period, among whom 293 received treatment."|
48658668|NCT03715829|101948996|FG003|STARTED|Extension Period||0|"The last 5 EXT treatment groups entered this Extension Period.~Three participants were lost to follow-up after completing the Dose Ranging Period, and no extension treatment was recorded for these 3 participants. A total of 295 participants were assigned to the Extension Period, among whom 293 received treatment."|
48658669|NCT03715829|101948997|FG004|STARTED|Extension Period||0|"The last 5 EXT treatment groups entered this Extension Period.~Three participants were lost to follow-up after completing the Dose Ranging Period, and no extension treatment was recorded for these 3 participants. A total of 295 participants were assigned to the Extension Period, among whom 293 received treatment."|
48658670|NCT03715829|101948998|FG005|STARTED|Extension Period||0|"The last 5 EXT treatment groups entered this Extension Period.~Three participants were lost to follow-up after completing the Dose Ranging Period, and no extension treatment was recorded for these 3 participants. A total of 295 participants were assigned to the Extension Period, among whom 293 received treatment."|
48658671|NCT03715829|101948999|FG006|STARTED|Extension Period||55|"The last 5 EXT treatment groups entered this Extension Period.~Three participants were lost to follow-up after completing the Dose Ranging Period, and no extension treatment was recorded for these 3 participants. A total of 295 participants were assigned to the Extension Period, among whom 293 received treatment."|
48658672|NCT03715829|101949000|FG007|STARTED|Extension Period||43|"The last 5 EXT treatment groups entered this Extension Period.~Three participants were lost to follow-up after completing the Dose Ranging Period, and no extension treatment was recorded for these 3 participants. A total of 295 participants were assigned to the Extension Period, among whom 293 received treatment."|
48658673|NCT03715829|101949001|FG008|STARTED|Extension Period||187|"The last 5 EXT treatment groups entered this Extension Period.~Three participants were lost to follow-up after completing the Dose Ranging Period, and no extension treatment was recorded for these 3 participants. A total of 295 participants were assigned to the Extension Period, among whom 293 received treatment."|
48658674|NCT03715829|101949002|FG009|STARTED|Extension Period||6|"The last 5 EXT treatment groups entered this Extension Period.~Three participants were lost to follow-up after completing the Dose Ranging Period, and no extension treatment was recorded for these 3 participants. A total of 295 participants were assigned to the Extension Period, among whom 293 received treatment."|
48658675|NCT03715829|101949003|FG010|STARTED|Extension Period||2|"The last 5 EXT treatment groups entered this Extension Period.~Three participants were lost to follow-up after completing the Dose Ranging Period, and no extension treatment was recorded for these 3 participants. A total of 295 participants were assigned to the Extension Period, among whom 293 received treatment."|
48658676|NCT03715829|101948993|FG000|COMPLETED|Extension Period||0||
48658677|NCT03715829|101948994|FG001|COMPLETED|Extension Period||0||
48658678|NCT03715829|101948995|FG002|COMPLETED|Extension Period||0||
48658679|NCT03715829|101948996|FG003|COMPLETED|Extension Period||0||
48658680|NCT03715829|101948997|FG004|COMPLETED|Extension Period||0||
48658681|NCT03715829|101948998|FG005|COMPLETED|Extension Period||0||
48658682|NCT03715829|101948999|FG006|COMPLETED|Extension Period||47||
48658683|NCT03715829|101949000|FG007|COMPLETED|Extension Period||27||
48658684|NCT03715829|101949001|FG008|COMPLETED|Extension Period||158||
48658685|NCT03715829|101949002|FG009|COMPLETED|Extension Period||3||
48658686|NCT03715829|101949003|FG010|COMPLETED|Extension Period||2||
48658687|NCT03715829|101948993|FG000|NOT COMPLETED|Extension Period||0||
48658688|NCT03715829|101948994|FG001|NOT COMPLETED|Extension Period||0||
48658689|NCT03715829|101948995|FG002|NOT COMPLETED|Extension Period||0||
48658690|NCT03715829|101948996|FG003|NOT COMPLETED|Extension Period||0||
48658691|NCT03715829|101948997|FG004|NOT COMPLETED|Extension Period||0||
48658692|NCT03715829|101948998|FG005|NOT COMPLETED|Extension Period||0||
48658693|NCT03715829|101948999|FG006|NOT COMPLETED|Extension Period||8||
48658694|NCT03715829|101949000|FG007|NOT COMPLETED|Extension Period||16||
48658695|NCT03715829|101949001|FG008|NOT COMPLETED|Extension Period||29||
48658696|NCT03715829|101949002|FG009|NOT COMPLETED|Extension Period||3||
48658697|NCT03715829|101949003|FG010|NOT COMPLETED|Extension Period||0||
48658698|NCT01903733|101949004|FG000|STARTED|Overall Study||250||
48658699|NCT01903733|101949005|FG001|STARTED|Overall Study||284||
48658700|NCT01903733|101949006|FG002|STARTED|Overall Study||119||
48658701|NCT01903733|101949007|FG003|STARTED|Overall Study||167||
48658702|NCT01903733|101949004|FG000|Full Analysis Set|Overall Study||250|(participants randomized to bosutinib arm in B1871008 and all dosed participants in B1871006)|
48658703|NCT01903733|101949005|FG001|Full Analysis Set|Overall Study||284|(participants randomized to bosutinib arm in B1871008 and all dosed participants in B1871006)|
48658704|NCT01903733|101949006|FG002|Full Analysis Set|Overall Study||119|(participants randomized to bosutinib arm in B1871008 and all dosed participants in B1871006)|
48658705|NCT01903733|101949007|FG003|Full Analysis Set|Overall Study||167|(participants randomized to bosutinib arm in B1871008 and all dosed participants in B1871006)|
48658706|NCT01903733|101949004|FG000|Safety Analysis Set|Overall Study||248|(all dosed participants in B1871008 and B1871006)|
48658707|NCT01903733|101949005|FG001|Safety Analysis Set|Overall Study||284|(all dosed participants in B1871008 and B1871006)|
48658708|NCT01903733|101949006|FG002|Safety Analysis Set|Overall Study||119|(all dosed participants in B1871008 and B1871006)|
48369110|NCT00320385|101232699|FG001|STARTED|Overall Study||148||
48369111|NCT00320385|101232698|FG000|COMPLETED|Overall Study||130||
48369112|NCT00320385|101232699|FG001|COMPLETED|Overall Study||126||
48369113|NCT00320385|101232698|FG000|NOT COMPLETED|Overall Study||18||
48445369|NCT00597727|101425647|FG003|NOT COMPLETED|12 Month Blinded Phase||10||
48445370|NCT00597727|101425648|FG004|NOT COMPLETED|12 Month Blinded Phase||1||
48770229|NCT01116986|102226039|FG031|COMPLETED|Overall Study||14||
48770230|NCT01116986|102226008|FG000|NOT COMPLETED|Overall Study||2||
48770231|NCT01116986|102226009|FG001|NOT COMPLETED|Overall Study||3||
48770232|NCT01116986|102226010|FG002|NOT COMPLETED|Overall Study||2||
48770233|NCT01116986|102226011|FG003|NOT COMPLETED|Overall Study||2||
48770234|NCT01116986|102226012|FG004|NOT COMPLETED|Overall Study||4||
48770235|NCT01116986|102226013|FG005|NOT COMPLETED|Overall Study||2||
48770236|NCT01116986|102226014|FG006|NOT COMPLETED|Overall Study||2||
48770237|NCT01116986|102226015|FG007|NOT COMPLETED|Overall Study||2||
48770238|NCT01116986|102226016|FG008|NOT COMPLETED|Overall Study||1||
48770239|NCT01116986|102226017|FG009|NOT COMPLETED|Overall Study||4||
48770240|NCT01116986|102226018|FG010|NOT COMPLETED|Overall Study||1||
48770241|NCT01116986|102226019|FG011|NOT COMPLETED|Overall Study||0||
48770242|NCT01116986|102226020|FG012|NOT COMPLETED|Overall Study||1||
48770243|NCT01116986|102226021|FG013|NOT COMPLETED|Overall Study||3||
48770244|NCT01116986|102226022|FG014|NOT COMPLETED|Overall Study||0||
48770245|NCT01116986|102226023|FG015|NOT COMPLETED|Overall Study||6||
48770246|NCT01116986|102226024|FG016|NOT COMPLETED|Overall Study||3||
48770247|NCT01116986|102226025|FG017|NOT COMPLETED|Overall Study||5||
48770248|NCT01116986|102226026|FG018|NOT COMPLETED|Overall Study||3||
48770249|NCT01116986|102226027|FG019|NOT COMPLETED|Overall Study||2||
48770250|NCT01116986|102226028|FG020|NOT COMPLETED|Overall Study||2||
48770251|NCT01116986|102226029|FG021|NOT COMPLETED|Overall Study||2||
48770252|NCT01116986|102226030|FG022|NOT COMPLETED|Overall Study||4||
48770253|NCT01116986|102226031|FG023|NOT COMPLETED|Overall Study||2||
48770254|NCT01116986|102226032|FG024|NOT COMPLETED|Overall Study||3||
48770255|NCT01116986|102226033|FG025|NOT COMPLETED|Overall Study||0||
48770256|NCT01116986|102226034|FG026|NOT COMPLETED|Overall Study||4||
48770257|NCT01116986|102226035|FG027|NOT COMPLETED|Overall Study||1||
48770258|NCT01116986|102226036|FG028|NOT COMPLETED|Overall Study||0||
48770259|NCT01116986|102226037|FG029|NOT COMPLETED|Overall Study||0||
48770260|NCT01116986|102226038|FG030|NOT COMPLETED|Overall Study||1||
48770261|NCT01116986|102226039|FG031|NOT COMPLETED|Overall Study||3||
48770262|NCT01393392|102226040|FG000|STARTED|Overall Study||44||
48445371|NCT00597727|101425644|FG000|STARTED|Open-label Extended Maintenance Phase||0||
48445372|NCT00597727|101425645|FG001|STARTED|Open-label Extended Maintenance Phase||0||
48445373|NCT00597727|101425646|FG002|STARTED|Open-label Extended Maintenance Phase||29||
48445374|NCT00597727|101425647|FG003|STARTED|Open-label Extended Maintenance Phase||17||
48445375|NCT00597727|101425648|FG004|STARTED|Open-label Extended Maintenance Phase||3||
48445376|NCT00597727|101425644|FG000|COMPLETED|Open-label Extended Maintenance Phase||0||
48445377|NCT00597727|101425645|FG001|COMPLETED|Open-label Extended Maintenance Phase||0||
48445378|NCT00597727|101425646|FG002|COMPLETED|Open-label Extended Maintenance Phase||23||
48445379|NCT00597727|101425647|FG003|COMPLETED|Open-label Extended Maintenance Phase||14||
48445380|NCT00597727|101425648|FG004|COMPLETED|Open-label Extended Maintenance Phase||1||
48445381|NCT00597727|101425644|FG000|NOT COMPLETED|Open-label Extended Maintenance Phase||0||
48445382|NCT00597727|101425645|FG001|NOT COMPLETED|Open-label Extended Maintenance Phase||0||
48445383|NCT00597727|101425646|FG002|NOT COMPLETED|Open-label Extended Maintenance Phase||6||
48445384|NCT00597727|101425647|FG003|NOT COMPLETED|Open-label Extended Maintenance Phase||3||
48445385|NCT00597727|101425648|FG004|NOT COMPLETED|Open-label Extended Maintenance Phase||2||
48445386|NCT02367781|101425649|FG000|STARTED|Overall Study||483||
48445387|NCT02367781|101425650|FG001|STARTED|Overall Study||240||
48445388|NCT02367781|101425649|FG000|COMPLETED|Overall Study||0||
48445389|NCT02367781|101425650|FG001|COMPLETED|Overall Study||0||
48445390|NCT02367781|101425649|FG000|NOT COMPLETED|Overall Study||483||
48445391|NCT02367781|101425650|FG001|NOT COMPLETED|Overall Study||240||
48445392|NCT02360124|101425651|FG000|STARTED|Overall Study||108||
48445393|NCT02360124|101425652|FG001|STARTED|Overall Study||107||
48445394|NCT02360124|101425653|FG002|STARTED|Overall Study||108||
48445395|NCT02360124|101425651|FG000|COMPLETED|Overall Study||80||
48445396|NCT02360124|101425652|FG001|COMPLETED|Overall Study||95||
48770263|NCT01393392|102226041|FG001|STARTED|Overall Study||43||
48770264|NCT01393392|102226040|FG000|COMPLETED|Overall Study||33||
48770265|NCT01393392|102226041|FG001|COMPLETED|Overall Study||24||
48770266|NCT01393392|102226040|FG000|NOT COMPLETED|Overall Study||11||
48770267|NCT01393392|102226041|FG001|NOT COMPLETED|Overall Study||19||
48770268|NCT02786394|102226042|FG000|STARTED|Overall Study||11||
48770269|NCT02786394|102226042|FG000|COMPLETED|Overall Study||10||
48770270|NCT02786394|102226042|FG000|NOT COMPLETED|Overall Study||1||
48770271|NCT01106690|102226043|FG000|STARTED|Core Period: Baseline to Week 26||115||
48770272|NCT01106690|102226044|FG001|STARTED|Core Period: Baseline to Week 26||113||
48770273|NCT01106690|102226045|FG002|STARTED|Core Period: Baseline to Week 26||114||
48770274|NCT01106690|102226043|FG000|COMPLETED|Core Period: Baseline to Week 26||91||
48770275|NCT01106690|102226044|FG001|COMPLETED|Core Period: Baseline to Week 26||104||
48770276|NCT01106690|102226045|FG002|COMPLETED|Core Period: Baseline to Week 26||101||
48770277|NCT01106690|102226043|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||24||
48770278|NCT01106690|102226044|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||9||
48770279|NCT01106690|102226045|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||13||
48445397|NCT02360124|101425653|FG002|COMPLETED|Overall Study||82||
48445398|NCT02360124|101425651|FG000|NOT COMPLETED|Overall Study||28||
48445399|NCT02360124|101425652|FG001|NOT COMPLETED|Overall Study||12||
48445400|NCT02360124|101425653|FG002|NOT COMPLETED|Overall Study||26||
48445401|NCT04723173|101425654|FG000|STARTED|Measure of Detection Threshold (in dB)||10||
48445402|NCT04723173|101425654|FG000|Feature for Soft Sounds On|Measure of Detection Threshold (in dB)||10||
48445403|NCT04723173|101425654|FG000|Feature for Soft Sounds Off|Measure of Detection Threshold (in dB)||10||
48445404|NCT04723173|101425654|FG000|COMPLETED|Measure of Detection Threshold (in dB)||10||
48445405|NCT04723173|101425654|FG000|NOT COMPLETED|Measure of Detection Threshold (in dB)||0||
48445406|NCT04723173|101425654|FG000|STARTED|Subjective Listening Effort Scaling||9||
48445407|NCT04723173|101425654|FG000|DNC on|Subjective Listening Effort Scaling||9||
48445408|NCT04723173|101425654|FG000|DNC Off|Subjective Listening Effort Scaling||9||
48445409|NCT04723173|101425654|FG000|COMPLETED|Subjective Listening Effort Scaling||8|This test compared the activated and deactivated feature for noisy situations. It was done in a single appointment and each participant performed randomized the test with both conditions. The reason for the smaller sample size (10 started the study, just 9 this test period) is that 1 participant left the study prior to the test and 1 participant started the test, but was not able to perform the test as the study protocol required. Nevertheless this participant completed the rest of the study.|
48445410|NCT04723173|101425654|FG000|NOT COMPLETED|Subjective Listening Effort Scaling||1||
48445411|NCT04723173|101425654|FG000|STARTED|Subjective Ratings of Sound Samples||9||
48445412|NCT04723173|101425654|FG000|DNC on|Subjective Ratings of Sound Samples||9||
48445413|NCT04723173|101425654|FG000|DNC Off|Subjective Ratings of Sound Samples||9||
48445414|NCT04723173|101425654|FG000|COMPLETED|Subjective Ratings of Sound Samples||9||
48445415|NCT04723173|101425654|FG000|NOT COMPLETED|Subjective Ratings of Sound Samples||0||
48770280|NCT01106690|102226043|FG000|STARTED|Extension Period: Week 26 to Week 52||90||
48770281|NCT01106690|102226044|FG001|STARTED|Extension Period: Week 26 to Week 52||103||
48770282|NCT01106690|102226045|FG002|STARTED|Extension Period: Week 26 to Week 52||96||
48770283|NCT01106690|102226043|FG000|COMPLETED|Extension Period: Week 26 to Week 52||78||
48770284|NCT01106690|102226044|FG001|COMPLETED|Extension Period: Week 26 to Week 52||96||
48770285|NCT01106690|102226045|FG002|COMPLETED|Extension Period: Week 26 to Week 52||89||
48770286|NCT01106690|102226043|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||12||
48770287|NCT01106690|102226044|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||7||
48770288|NCT01106690|102226045|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||7||
48770289|NCT03131219|102226046|FG000|STARTED|Initial Evaluation Period||24||
48770290|NCT03131219|102226047|FG001|STARTED|Initial Evaluation Period||10||
48770291|NCT03131219|102226046|FG000|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||24||
48770292|NCT03131219|102226047|FG001|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||10||
48770293|NCT03131219|102226046|FG000|COMPLETED|Initial Evaluation Period||17||
48770294|NCT03131219|102226047|FG001|COMPLETED|Initial Evaluation Period||10||
48770295|NCT03131219|102226046|FG000|NOT COMPLETED|Initial Evaluation Period||7||
48770296|NCT03131219|102226047|FG001|NOT COMPLETED|Initial Evaluation Period||0||
48770297|NCT03131219|102226046|FG000|STARTED|Extension Period||17||
48770298|NCT03131219|102226047|FG001|STARTED|Extension Period||10||
48770299|NCT03131219|102226046|FG000|Received At Least 1 Dose of Study Drug|Extension Period||17||
48770300|NCT03131219|102226047|FG001|Received At Least 1 Dose of Study Drug|Extension Period||10||
48770301|NCT03131219|102226046|FG000|COMPLETED|Extension Period||16||
48770302|NCT03131219|102226047|FG001|COMPLETED|Extension Period||10||
48445416|NCT00951899|101425655|FG000|STARTED|Overall Study||19||
48445417|NCT00951899|101425656|FG001|STARTED|Overall Study||19||
48445418|NCT00951899|101425655|FG000|COMPLETED|Overall Study||19||
48445419|NCT00951899|101425656|FG001|COMPLETED|Overall Study||19||
48445420|NCT00951899|101425655|FG000|NOT COMPLETED|Overall Study||0||
48445421|NCT00951899|101425656|FG001|NOT COMPLETED|Overall Study||0||
48445422|NCT03610646|101425657|FG000|STARTED|Overall Study||179||
48445423|NCT03610646|101425658|FG001|STARTED|Overall Study||176||
48445424|NCT03610646|101425657|FG000|Treated|Overall Study||178||
48445425|NCT03610646|101425658|FG001|Treated|Overall Study||176||
48445426|NCT03610646|101425657|FG000|COMPLETED|Overall Study||161||
48445427|NCT03610646|101425658|FG001|COMPLETED|Overall Study||158||
48445428|NCT03610646|101425657|FG000|NOT COMPLETED|Overall Study||18||
48445429|NCT03610646|101425658|FG001|NOT COMPLETED|Overall Study||18||
48445430|NCT05302414|101425659|FG000|STARTED|Pretest to Posttest||44||
48445431|NCT05302414|101425660|FG001|STARTED|Pretest to Posttest||40||
48445432|NCT05302414|101425661|FG002|STARTED|Pretest to Posttest||40||
48445433|NCT05302414|101425659|FG000|COMPLETED|Pretest to Posttest||32||
48445434|NCT05302414|101425660|FG001|COMPLETED|Pretest to Posttest||32||
48445435|NCT05302414|101425661|FG002|COMPLETED|Pretest to Posttest||32||
48445436|NCT05302414|101425659|FG000|NOT COMPLETED|Pretest to Posttest||12||
48445437|NCT05302414|101425660|FG001|NOT COMPLETED|Pretest to Posttest||8||
48445438|NCT05302414|101425661|FG002|NOT COMPLETED|Pretest to Posttest||8||
48445439|NCT05302414|101425659|FG000|STARTED|Posttest to Three Months Follow-up||32||
48770303|NCT03131219|102226046|FG000|NOT COMPLETED|Extension Period||1||
48770304|NCT03131219|102226047|FG001|NOT COMPLETED|Extension Period||0||
48770305|NCT02958917|102226048|FG000|STARTED|Overall Study||27||
48770306|NCT02958917|102226049|FG001|STARTED|Overall Study||13||
48770307|NCT02958917|102226048|FG000|COMPLETED|Overall Study||27|The study was terminated prematurely in December 2020 following the randomization of 40 patients due to the ongoing impacts of the COVID-19 pandemic.|
48770308|NCT02958917|102226049|FG001|COMPLETED|Overall Study||13|The study was terminated prematurely in December 2020 following the randomization of 40 patients due to the ongoing impacts of the COVID-19 pandemic.|
48770309|NCT02958917|102226048|FG000|NOT COMPLETED|Overall Study||0||
48770310|NCT02958917|102226049|FG001|NOT COMPLETED|Overall Study||0||
48770311|NCT03449667|102226050|FG000|STARTED|Initial Treatment||71||
48770312|NCT03449667|102226051|FG001|STARTED|Initial Treatment||73||
48770313|NCT03449667|102226050|FG000|COMPLETED|Initial Treatment||71||
48770314|NCT03449667|102226051|FG001|COMPLETED|Initial Treatment||73||
48770315|NCT03449667|102226050|FG000|NOT COMPLETED|Initial Treatment||0||
48770316|NCT03449667|102226051|FG001|NOT COMPLETED|Initial Treatment||0||
48770317|NCT03449667|102226050|FG000|STARTED|Optional Crossover Treatment||71||
48770318|NCT03449667|102226051|FG001|STARTED|Optional Crossover Treatment||73||
48770319|NCT03449667|102226050|FG000|COMPLETED|Optional Crossover Treatment||42||
48770320|NCT03449667|102226051|FG001|COMPLETED|Optional Crossover Treatment||49||
48770321|NCT03449667|102226050|FG000|NOT COMPLETED|Optional Crossover Treatment||29||
48770322|NCT03449667|102226051|FG001|NOT COMPLETED|Optional Crossover Treatment||24||
48770323|NCT04406857|102226052|FG000|STARTED|Overall Study||1||
48189050|NCT02561455|100786143|FG000|COMPLETED|Overall Study||0||
48369114|NCT00320385|101232699|FG001|NOT COMPLETED|Overall Study||22||
48658709|NCT01903733|101949007|FG003|Safety Analysis Set|Overall Study||167|(all dosed participants in B1871008 and B1871006)|
48658710|NCT01903733|101949004|FG000|Enrolled in B1871040|Overall Study||124||
48658711|NCT01903733|101949005|FG001|Enrolled in B1871040|Overall Study||90||
48658712|NCT01903733|101949006|FG002|Enrolled in B1871040|Overall Study||28||
48658713|NCT01903733|101949007|FG003|Enrolled in B1871040|Overall Study||18||
48658714|NCT01903733|101949004|FG000|Treated in B1871040|Overall Study||98||
48658715|NCT01903733|101949005|FG001|Treated in B1871040|Overall Study||69||
48658716|NCT01903733|101949006|FG002|Treated in B1871040|Overall Study||13||
48658717|NCT01903733|101949007|FG003|Treated in B1871040|Overall Study||8||
48658718|NCT01903733|101949004|FG000|COMPLETED|Overall Study||144||
48770324|NCT04406857|102226052|FG000|COMPLETED|Overall Study||1||
48770325|NCT04406857|102226052|FG000|NOT COMPLETED|Overall Study||0||
48770326|NCT01987453|102226053|FG000|STARTED|Overall Study||51||
48770327|NCT01987453|102226054|FG001|STARTED|Overall Study||41||
48770328|NCT01987453|102226055|FG002|STARTED|Overall Study||8||
48770329|NCT01987453|102226053|FG000|COMPLETED|Overall Study||50||
48770330|NCT01987453|102226054|FG001|COMPLETED|Overall Study||29||
48770331|NCT01987453|102226055|FG002|COMPLETED|Overall Study||7||
48770332|NCT01987453|102226053|FG000|NOT COMPLETED|Overall Study||1||
48770333|NCT01987453|102226054|FG001|NOT COMPLETED|Overall Study||12||
48770334|NCT01987453|102226055|FG002|NOT COMPLETED|Overall Study||1||
48770335|NCT02396199|102226056|FG000|STARTED|Overall Study||80||
48770336|NCT02396199|102226056|FG000|Started 6-Month|Overall Study||79||
48770337|NCT02396199|102226056|FG000|Completed 6-Month|Overall Study||76||
48770338|NCT02396199|102226056|FG000|Started 12-Month|Overall Study||76||
48770339|NCT02396199|102226056|FG000|COMPLETED|Overall Study||75||
48770340|NCT02396199|102226056|FG000|NOT COMPLETED|Overall Study||5||
48770341|NCT02631590|102226057|FG000|STARTED|Overall Study||24||
48770342|NCT02631590|102226057|FG000|COMPLETED|Overall Study||24||
48770343|NCT02631590|102226057|FG000|NOT COMPLETED|Overall Study||0||
48770344|NCT00067002|102226058|FG000|STARTED|Overall Study||52||
48770345|NCT00067002|102226059|FG001|STARTED|Overall Study||53||
48770346|NCT00067002|102226058|FG000|COMPLETED|Overall Study||45||
48770347|NCT00067002|102226059|FG001|COMPLETED|Overall Study||44||
48770348|NCT00067002|102226058|FG000|NOT COMPLETED|Overall Study||7||
48770349|NCT00067002|102226059|FG001|NOT COMPLETED|Overall Study||9||
48770350|NCT00354432|102226060|FG000|STARTED|Overall Study||30||
48770351|NCT00354432|102226061|FG001|STARTED|Overall Study||30||
48770352|NCT00354432|102226062|FG002|STARTED|Overall Study||30||
48770353|NCT00354432|102226063|FG003|STARTED|Overall Study||30||
48770354|NCT00354432|102226060|FG000|COMPLETED|Overall Study||24||
48770355|NCT00354432|102226061|FG001|COMPLETED|Overall Study||22||
48770356|NCT00354432|102226062|FG002|COMPLETED|Overall Study||20||
48770357|NCT00354432|102226063|FG003|COMPLETED|Overall Study||20||
48770358|NCT00354432|102226060|FG000|NOT COMPLETED|Overall Study||6||
48770359|NCT00354432|102226061|FG001|NOT COMPLETED|Overall Study||8||
48770360|NCT00354432|102226062|FG002|NOT COMPLETED|Overall Study||10||
48770361|NCT00354432|102226063|FG003|NOT COMPLETED|Overall Study||10||
48770362|NCT04059159|102226064|FG000|STARTED|Overall Study||8||
48770363|NCT04059159|102226064|FG000|COMPLETED|Overall Study||3||
48369115|NCT00430625|101232700|FG000|STARTED|Overall Study||13||
48658719|NCT01903733|101949005|FG001|COMPLETED|Overall Study||158||
48658720|NCT01903733|101949006|FG002|COMPLETED|Overall Study||58||
48658721|NCT01903733|101949007|FG003|COMPLETED|Overall Study||48||
48658722|NCT01903733|101949004|FG000|NOT COMPLETED|Overall Study||106||
48658723|NCT01903733|101949005|FG001|NOT COMPLETED|Overall Study||126||
48658724|NCT01903733|101949006|FG002|NOT COMPLETED|Overall Study||61||
48658725|NCT01903733|101949007|FG003|NOT COMPLETED|Overall Study||119||
48658726|NCT00383565|101949008|FG000|STARTED|Overall Study||9||
48770364|NCT04059159|102226064|FG000|NOT COMPLETED|Overall Study||5||
48770365|NCT03762317|102226065|FG000|STARTED|Overall Study||5||
48770366|NCT03762317|102226066|FG001|STARTED|Overall Study||5||
48770367|NCT03762317|102226065|FG000|COMPLETED|Overall Study||5||
48770368|NCT03762317|102226066|FG001|COMPLETED|Overall Study||5||
48770369|NCT03762317|102226065|FG000|NOT COMPLETED|Overall Study||0||
48770370|NCT03762317|102226066|FG001|NOT COMPLETED|Overall Study||0||
48445440|NCT05302414|101425660|FG001|STARTED|Posttest to Three Months Follow-up||32||
48445441|NCT05302414|101425661|FG002|STARTED|Posttest to Three Months Follow-up||32||
48445442|NCT05302414|101425659|FG000|COMPLETED|Posttest to Three Months Follow-up||16||
48445443|NCT05302414|101425660|FG001|COMPLETED|Posttest to Three Months Follow-up||16||
48445444|NCT05302414|101425661|FG002|COMPLETED|Posttest to Three Months Follow-up||16||
48445445|NCT05302414|101425659|FG000|NOT COMPLETED|Posttest to Three Months Follow-up||16||
48445446|NCT05302414|101425660|FG001|NOT COMPLETED|Posttest to Three Months Follow-up||16||
48445447|NCT05302414|101425661|FG002|NOT COMPLETED|Posttest to Three Months Follow-up||16||
48445448|NCT03291847|101425662|FG000|STARTED|Overall Study||42||
48445449|NCT03291847|101425662|FG000|COMPLETED|Overall Study||24|There were 26 fetuses associated with 24 women|
48445450|NCT03291847|101425662|FG000|NOT COMPLETED|Overall Study||18||
48445451|NCT00981409|101425663|FG000|STARTED|Overall Study||30||
48445452|NCT00981409|101425664|FG001|STARTED|Overall Study||11||
48445453|NCT00981409|101425663|FG000|COMPLETED|Overall Study||24||
48445454|NCT00981409|101425664|FG001|COMPLETED|Overall Study||10||
48445455|NCT00981409|101425663|FG000|NOT COMPLETED|Overall Study||6||
48445456|NCT00981409|101425664|FG001|NOT COMPLETED|Overall Study||1||
48445457|NCT00759174|101425665|FG000|STARTED|Overall Study||76||
48445458|NCT00759174|101425666|FG001|STARTED|Overall Study||597||
48445459|NCT00759174|101425665|FG000|COMPLETED|Overall Study||76||
48445460|NCT00759174|101425666|FG001|COMPLETED|Overall Study||595||
48445461|NCT00759174|101425665|FG000|NOT COMPLETED|Overall Study||0||
48445462|NCT00759174|101425666|FG001|NOT COMPLETED|Overall Study||2||
48445463|NCT01468974|101425667|FG000|STARTED|1 Month Follow-up||35||
48445464|NCT01468974|101425667|FG000|COMPLETED|1 Month Follow-up||34||
48445465|NCT01468974|101425667|FG000|NOT COMPLETED|1 Month Follow-up||1||
48445466|NCT01468974|101425667|FG000|STARTED|6 Months Follow-up||34||
48445467|NCT01468974|101425667|FG000|COMPLETED|6 Months Follow-up||34||
48445468|NCT01468974|101425667|FG000|NOT COMPLETED|6 Months Follow-up||0||
48445469|NCT01468974|101425667|FG000|STARTED|1 Year Follow-up||34||
48445470|NCT01468974|101425667|FG000|COMPLETED|1 Year Follow-up||34||
48445471|NCT01468974|101425667|FG000|NOT COMPLETED|1 Year Follow-up||0||
48445472|NCT01468974|101425667|FG000|STARTED|2 Years Follow-up||34||
48770371|NCT05024032|102226067|FG000|STARTED|Overall Study||70||
48770372|NCT05024032|102226068|FG001|STARTED|Overall Study||71||
48770373|NCT05024032|102226069|FG002|STARTED|Overall Study||69||
48770374|NCT05024032|102226067|FG000|Received At Least One Dose|Overall Study||70||
48770375|NCT05024032|102226068|FG001|Received At Least One Dose|Overall Study||71||
48770376|NCT05024032|102226069|FG002|Received At Least One Dose|Overall Study||69||
48770377|NCT05024032|102226067|FG000|COMPLETED|Overall Study||69||
48189051|NCT02561455|100786144|FG001|COMPLETED|Overall Study||1||
48189052|NCT02561455|100786145|FG002|COMPLETED|Overall Study||0||
48189053|NCT02561455|100786146|FG003|COMPLETED|Overall Study||0||
48445473|NCT01468974|101425667|FG000|COMPLETED|2 Years Follow-up||32||
48445474|NCT01468974|101425667|FG000|NOT COMPLETED|2 Years Follow-up||2||
48445475|NCT01468974|101425667|FG000|STARTED|3 Years Follow-up||32||
48445476|NCT01468974|101425667|FG000|COMPLETED|3 Years Follow-up||26||
48445477|NCT01468974|101425667|FG000|NOT COMPLETED|3 Years Follow-up||6||
48445478|NCT06251154|101425668|FG000|STARTED|Period 1: Lens 1, 15 Minutes||50||
48445479|NCT06251154|101425669|FG001|STARTED|Period 1: Lens 1, 15 Minutes||0||
48445480|NCT06251154|101425668|FG000|COMPLETED|Period 1: Lens 1, 15 Minutes||50||
48445481|NCT06251154|101425669|FG001|COMPLETED|Period 1: Lens 1, 15 Minutes||0||
48445482|NCT06251154|101425668|FG000|NOT COMPLETED|Period 1: Lens 1, 15 Minutes||0||
48445483|NCT06251154|101425669|FG001|NOT COMPLETED|Period 1: Lens 1, 15 Minutes||0||
48445484|NCT06251154|101425668|FG000|STARTED|Period 2: Lens 2, 15 Minutes||0||
48445485|NCT06251154|101425669|FG001|STARTED|Period 2: Lens 2, 15 Minutes||50||
48445486|NCT06251154|101425668|FG000|COMPLETED|Period 2: Lens 2, 15 Minutes||0||
48445487|NCT06251154|101425669|FG001|COMPLETED|Period 2: Lens 2, 15 Minutes||50||
48445488|NCT06251154|101425668|FG000|NOT COMPLETED|Period 2: Lens 2, 15 Minutes||0||
48445489|NCT06251154|101425669|FG001|NOT COMPLETED|Period 2: Lens 2, 15 Minutes||0||
48445490|NCT01687400|101425670|FG000|STARTED|Overall Study||114||
48445491|NCT01687400|101425670|FG000|COMPLETED|Overall Study||114||
48445492|NCT01687400|101425670|FG000|NOT COMPLETED|Overall Study||0||
48445493|NCT00445458|101425671|FG000|STARTED|Overall Study||3||
48445494|NCT00445458|101425672|FG001|STARTED|Overall Study||5||
48445495|NCT00445458|101425673|FG002|STARTED|Overall Study||71||
48445496|NCT00445458|101425674|FG003|STARTED|Overall Study||31||
48445497|NCT00445458|101425671|FG000|COMPLETED|Overall Study||0||
48445498|NCT00445458|101425672|FG001|COMPLETED|Overall Study||0||
48445499|NCT00445458|101425673|FG002|COMPLETED|Overall Study||3||
48445500|NCT00445458|101425674|FG003|COMPLETED|Overall Study||3||
48445501|NCT00445458|101425671|FG000|NOT COMPLETED|Overall Study||3||
48770378|NCT05024032|102226068|FG001|COMPLETED|Overall Study||67||
48445502|NCT00445458|101425672|FG001|NOT COMPLETED|Overall Study||5||
48445503|NCT00445458|101425673|FG002|NOT COMPLETED|Overall Study||68||
48445504|NCT00445458|101425674|FG003|NOT COMPLETED|Overall Study||28||
48445505|NCT05293743|101425675|FG000|STARTED|Overall Study||5||
48445506|NCT05293743|101425676|FG001|STARTED|Overall Study||7||
48445507|NCT05293743|101425675|FG000|COMPLETED|Overall Study||4||
48445508|NCT05293743|101425676|FG001|COMPLETED|Overall Study||7||
48445509|NCT05293743|101425675|FG000|NOT COMPLETED|Overall Study||1||
48445510|NCT05293743|101425676|FG001|NOT COMPLETED|Overall Study||0||
48445511|NCT00005879|101425677|FG000|STARTED|Overall Study||101||
48445512|NCT00005879|101425678|FG001|STARTED|Overall Study||98||
48445513|NCT00005879|101425677|FG000|COMPLETED|Overall Study||93||
48445514|NCT00005879|101425678|FG001|COMPLETED|Overall Study||88||
48445515|NCT00005879|101425677|FG000|NOT COMPLETED|Overall Study||8||
48445516|NCT00005879|101425678|FG001|NOT COMPLETED|Overall Study||10||
48445517|NCT06610279|101425679|FG000|STARTED|Part 1||12||
48445518|NCT06610279|101425680|FG001|STARTED|Part 1||6||
48445519|NCT06610279|101425681|FG002|STARTED|Part 1||6||
48445520|NCT06610279|101425682|FG003|STARTED|Part 1||6||
48445521|NCT06610279|101425683|FG004|STARTED|Part 1||6||
48445522|NCT06610279|101425684|FG005|STARTED|Part 1||6||
48445523|NCT06610279|101425685|FG006|STARTED|Part 1||6||
48445524|NCT06610279|101425686|FG007|STARTED|Part 1||0||
48445525|NCT06610279|101425687|FG008|STARTED|Part 1||0||
48445526|NCT06610279|101425679|FG000|COMPLETED|Part 1||12||
48770379|NCT05024032|102226069|FG002|COMPLETED|Overall Study||65||
48770380|NCT05024032|102226067|FG000|NOT COMPLETED|Overall Study||1||
48770381|NCT05024032|102226068|FG001|NOT COMPLETED|Overall Study||4||
48770382|NCT05024032|102226069|FG002|NOT COMPLETED|Overall Study||4||
48770383|NCT03584789|102226070|FG000|STARTED|Overall Study||1739||17
48445527|NCT06610279|101425680|FG001|COMPLETED|Part 1||6||
48445528|NCT06610279|101425681|FG002|COMPLETED|Part 1||6||
48445529|NCT06610279|101425682|FG003|COMPLETED|Part 1||6||
48445530|NCT06610279|101425683|FG004|COMPLETED|Part 1||6||
48445531|NCT06610279|101425684|FG005|COMPLETED|Part 1||6||
48445532|NCT06610279|101425685|FG006|COMPLETED|Part 1||6||
48445533|NCT06610279|101425686|FG007|COMPLETED|Part 1||0||
48445534|NCT06610279|101425687|FG008|COMPLETED|Part 1||0||
48445535|NCT06610279|101425679|FG000|NOT COMPLETED|Part 1||0||
48445536|NCT06610279|101425680|FG001|NOT COMPLETED|Part 1||0||
48445537|NCT06610279|101425681|FG002|NOT COMPLETED|Part 1||0||
48445538|NCT06610279|101425682|FG003|NOT COMPLETED|Part 1||0||
48658727|NCT00383565|101949008|FG000|COMPLETED|Overall Study||9||
48658728|NCT00383565|101949008|FG000|NOT COMPLETED|Overall Study||0||
48658729|NCT02290574|101949009|FG000|STARTED|Overall Study||14||
48658730|NCT02290574|101949009|FG000|COMPLETED|Overall Study||13||
48658731|NCT02290574|101949009|FG000|NOT COMPLETED|Overall Study||1||
48658732|NCT02915601|101949010|FG000|STARTED|Overall Study||55||
48658733|NCT02915601|101949011|FG001|STARTED|Overall Study||54||
48658734|NCT02915601|101949010|FG000|COMPLETED|Overall Study||44||
48658735|NCT02915601|101949011|FG001|COMPLETED|Overall Study||46||
48658736|NCT02915601|101949010|FG000|NOT COMPLETED|Overall Study||11||
48658737|NCT02915601|101949011|FG001|NOT COMPLETED|Overall Study||8||
48658738|NCT02811419|101949012|FG000|STARTED|Overall Study||369||
48658739|NCT02811419|101949013|FG001|STARTED|Overall Study||371||
48658740|NCT02811419|101949012|FG000|COMPLETED|Overall Study||357||
48770384|NCT03584789|102226071|FG001|STARTED|Overall Study||2297||16
48770385|NCT03584789|102226072|FG002|STARTED|Overall Study||1686||17
48770386|NCT03584789|102226070|FG000|COMPLETED|Overall Study||1720||16
48770387|NCT03584789|102226071|FG001|COMPLETED|Overall Study||2269||14
48445539|NCT06610279|101425683|FG004|NOT COMPLETED|Part 1||0||
48445540|NCT06610279|101425684|FG005|NOT COMPLETED|Part 1||0||
48445541|NCT06610279|101425685|FG006|NOT COMPLETED|Part 1||0||
48445542|NCT06610279|101425686|FG007|NOT COMPLETED|Part 1||0||
48445543|NCT06610279|101425687|FG008|NOT COMPLETED|Part 1||0||
48445544|NCT06610279|101425679|FG000|STARTED|Part 2||0||
48445545|NCT06610279|101425680|FG001|STARTED|Part 2||0||
48445546|NCT06610279|101425681|FG002|STARTED|Part 2||0||
48445547|NCT06610279|101425682|FG003|STARTED|Part 2||0||
48445548|NCT06610279|101425683|FG004|STARTED|Part 2||0||
48445549|NCT06610279|101425684|FG005|STARTED|Part 2||0||
48445550|NCT06610279|101425685|FG006|STARTED|Part 2||0||
48445551|NCT06610279|101425686|FG007|STARTED|Part 2||0||
48445552|NCT06610279|101425687|FG008|STARTED|Part 2||0||
48445553|NCT06610279|101425679|FG000|COMPLETED|Part 2||0||
48445554|NCT06610279|101425680|FG001|COMPLETED|Part 2||0||
48658741|NCT02811419|101949013|FG001|COMPLETED|Overall Study||358||
48658742|NCT02811419|101949012|FG000|NOT COMPLETED|Overall Study||12||
48658743|NCT02811419|101949013|FG001|NOT COMPLETED|Overall Study||13||
48770388|NCT03584789|102226072|FG002|COMPLETED|Overall Study||1660||13
48445555|NCT06610279|101425681|FG002|COMPLETED|Part 2||0||
48445556|NCT06610279|101425682|FG003|COMPLETED|Part 2||0||
48445557|NCT06610279|101425683|FG004|COMPLETED|Part 2||0||
48445558|NCT06610279|101425684|FG005|COMPLETED|Part 2||0||
48445559|NCT06610279|101425685|FG006|COMPLETED|Part 2||0||
48658744|NCT02003898|101949014|FG000|STARTED|Overall Study||372||
48658745|NCT02003898|101949014|FG000|COMPLETED|Overall Study||305||
48658746|NCT02003898|101949014|FG000|NOT COMPLETED|Overall Study||67||
48770389|NCT03584789|102226070|FG000|NOT COMPLETED|Overall Study||19||1
48445560|NCT06610279|101425686|FG007|COMPLETED|Part 2||0||
48445561|NCT06610279|101425687|FG008|COMPLETED|Part 2||0||
48445562|NCT06610279|101425679|FG000|NOT COMPLETED|Part 2||0||
48445563|NCT06610279|101425680|FG001|NOT COMPLETED|Part 2||0||
48445564|NCT06610279|101425681|FG002|NOT COMPLETED|Part 2||0||
48445565|NCT06610279|101425682|FG003|NOT COMPLETED|Part 2||0||
48445566|NCT06610279|101425683|FG004|NOT COMPLETED|Part 2||0||
48445567|NCT06610279|101425684|FG005|NOT COMPLETED|Part 2||0||
48445568|NCT06610279|101425685|FG006|NOT COMPLETED|Part 2||0||
48445569|NCT06610279|101425686|FG007|NOT COMPLETED|Part 2||0||
48445570|NCT06610279|101425687|FG008|NOT COMPLETED|Part 2||0||
48445571|NCT06610279|101425679|FG000|STARTED|Part 3||0||
48445572|NCT06610279|101425680|FG001|STARTED|Part 3||0||
48445573|NCT06610279|101425681|FG002|STARTED|Part 3||0||
48445574|NCT06610279|101425682|FG003|STARTED|Part 3||0||
48445575|NCT06610279|101425683|FG004|STARTED|Part 3||0||
48445576|NCT06610279|101425684|FG005|STARTED|Part 3||0||
48445577|NCT06610279|101425685|FG006|STARTED|Part 3||0||
48445578|NCT06610279|101425686|FG007|STARTED|Part 3||0||
48445579|NCT06610279|101425687|FG008|STARTED|Part 3||0||
48445580|NCT06610279|101425679|FG000|COMPLETED|Part 3||0||
48445581|NCT06610279|101425680|FG001|COMPLETED|Part 3||0||
48445582|NCT06610279|101425681|FG002|COMPLETED|Part 3||0||
48445583|NCT06610279|101425682|FG003|COMPLETED|Part 3||0||
48445584|NCT06610279|101425683|FG004|COMPLETED|Part 3||0||
48445585|NCT06610279|101425684|FG005|COMPLETED|Part 3||0||
48445586|NCT06610279|101425685|FG006|COMPLETED|Part 3||0||
48770390|NCT03584789|102226071|FG001|NOT COMPLETED|Overall Study||28||2
48770391|NCT03584789|102226072|FG002|NOT COMPLETED|Overall Study||26||4
48770392|NCT02461134|102226073|FG000|STARTED|Overall Study||1||
48770393|NCT02461134|102226073|FG000|COMPLETED|Overall Study||0||
48770394|NCT02461134|102226073|FG000|NOT COMPLETED|Overall Study||1||
48770395|NCT00807001|102226074|FG000|STARTED|Overall Study||8||
48770396|NCT00807001|102226075|FG001|STARTED|Overall Study||8||
48770397|NCT00807001|102226076|FG002|STARTED|Overall Study||8||
48770398|NCT00807001|102226077|FG003|STARTED|Overall Study||8||
48770399|NCT00807001|102226078|FG004|STARTED|Overall Study||9||
48770400|NCT00807001|102226074|FG000|COMPLETED|Overall Study||8||
48770401|NCT00807001|102226075|FG001|COMPLETED|Overall Study||7||
48770402|NCT00807001|102226076|FG002|COMPLETED|Overall Study||8||
48770403|NCT00807001|102226077|FG003|COMPLETED|Overall Study||8||
48770404|NCT00807001|102226078|FG004|COMPLETED|Overall Study||9||
48770405|NCT00807001|102226074|FG000|NOT COMPLETED|Overall Study||0||
48770406|NCT00807001|102226075|FG001|NOT COMPLETED|Overall Study||1||
48770407|NCT00807001|102226076|FG002|NOT COMPLETED|Overall Study||0||
48770408|NCT00807001|102226077|FG003|NOT COMPLETED|Overall Study||0||
48770409|NCT00807001|102226078|FG004|NOT COMPLETED|Overall Study||0||
48770410|NCT01597596|102226079|FG000|STARTED|Overall Study||1||
48770411|NCT01597596|102226080|FG001|STARTED|Overall Study||3||
48770412|NCT01597596|102226079|FG000|COMPLETED|Overall Study||0||
48770413|NCT01597596|102226080|FG001|COMPLETED|Overall Study||2||
48770414|NCT01597596|102226079|FG000|NOT COMPLETED|Overall Study||1||
48770415|NCT01597596|102226080|FG001|NOT COMPLETED|Overall Study||1||
48770416|NCT04592887|102226081|FG000|STARTED|Overall Study||10||
48770417|NCT04592887|102226081|FG000|COMPLETED|Overall Study||10||
48770418|NCT04592887|102226081|FG000|NOT COMPLETED|Overall Study||0||
48770419|NCT02766023|102226082|FG000|STARTED|Overall Study||152||
48445587|NCT06610279|101425686|FG007|COMPLETED|Part 3||0||
48445588|NCT06610279|101425687|FG008|COMPLETED|Part 3||0||
48445589|NCT06610279|101425679|FG000|NOT COMPLETED|Part 3||0||
48445590|NCT06610279|101425680|FG001|NOT COMPLETED|Part 3||0||
48445591|NCT06610279|101425681|FG002|NOT COMPLETED|Part 3||0||
48445592|NCT06610279|101425682|FG003|NOT COMPLETED|Part 3||0||
48445593|NCT06610279|101425683|FG004|NOT COMPLETED|Part 3||0||
48445594|NCT06610279|101425684|FG005|NOT COMPLETED|Part 3||0||
48445595|NCT06610279|101425685|FG006|NOT COMPLETED|Part 3||0||
48445596|NCT06610279|101425686|FG007|NOT COMPLETED|Part 3||0||
48445597|NCT06610279|101425687|FG008|NOT COMPLETED|Part 3||0||
48770420|NCT02766023|102226083|FG001|STARTED|Overall Study||76||
48770421|NCT02766023|102226082|FG000|COMPLETED|Overall Study||122||
48770422|NCT02766023|102226083|FG001|COMPLETED|Overall Study||59||
48770423|NCT02766023|102226082|FG000|NOT COMPLETED|Overall Study||30||
48445598|NCT04057118|101425688|FG000|STARTED|Overall Study||41||
48445599|NCT04057118|101425689|FG001|STARTED|Overall Study||41||
48445600|NCT04057118|101425690|FG002|STARTED|Overall Study||40||
48445601|NCT04057118|101425691|FG003|STARTED|Overall Study||41||
48445602|NCT04057118|101425688|FG000|COMPLETED|Overall Study||38||
48770424|NCT02766023|102226083|FG001|NOT COMPLETED|Overall Study||17||
48770425|NCT02000440|102226084|FG000|STARTED|Overall Study||17||
48770426|NCT02000440|102226084|FG000|COMPLETED|Overall Study||13||
48770427|NCT02000440|102226084|FG000|NOT COMPLETED|Overall Study||4||
48770428|NCT00976560|102226085|FG000|STARTED|Overall Study||64||
48445603|NCT04057118|101425689|FG001|COMPLETED|Overall Study||39||
48445604|NCT04057118|101425690|FG002|COMPLETED|Overall Study||37||
48445605|NCT04057118|101425691|FG003|COMPLETED|Overall Study||36||
48445606|NCT04057118|101425688|FG000|NOT COMPLETED|Overall Study||3||
48770429|NCT00976560|102226086|FG001|STARTED|Overall Study||64||
48770430|NCT00976560|102226085|FG000|COMPLETED|Overall Study||50||
48770431|NCT00976560|102226086|FG001|COMPLETED|Overall Study||51||
48770432|NCT00976560|102226085|FG000|NOT COMPLETED|Overall Study||14||
48770433|NCT00976560|102226086|FG001|NOT COMPLETED|Overall Study||13||
48770434|NCT00477386|102226087|FG000|STARTED|Overall Study||11||
48770435|NCT00477386|102226088|FG001|STARTED|Overall Study||17||
48770436|NCT00477386|102226087|FG000|COMPLETED|Overall Study||0||
48770437|NCT00477386|102226088|FG001|COMPLETED|Overall Study||0||
48770438|NCT00477386|102226087|FG000|NOT COMPLETED|Overall Study||11||
48770439|NCT00477386|102226088|FG001|NOT COMPLETED|Overall Study||17||
48770440|NCT00889720|102226089|FG000|STARTED|Overall Study||16||
48770441|NCT00889720|102226089|FG000|Surgical Population|Overall Study||12||
48770442|NCT00889720|102226089|FG000|COMPLETED|Overall Study||8||
48770443|NCT00889720|102226089|FG000|NOT COMPLETED|Overall Study||8||
48770444|NCT01569607|102226090|FG000|STARTED|Overall Study||11||
48770445|NCT01569607|102226091|FG001|STARTED|Overall Study||11||
48770446|NCT01569607|102226090|FG000|COMPLETED|Overall Study||10||
48770447|NCT01569607|102226091|FG001|COMPLETED|Overall Study||10||
48770448|NCT01569607|102226090|FG000|NOT COMPLETED|Overall Study||1||
48770449|NCT01569607|102226091|FG001|NOT COMPLETED|Overall Study||1||
48770450|NCT02500797|102226092|FG000|STARTED|Overall Study||43||
48770451|NCT02500797|102226093|FG001|STARTED|Overall Study||42||
48770452|NCT02500797|102226094|FG002|STARTED|Overall Study||15||
48445607|NCT04057118|101425689|FG001|NOT COMPLETED|Overall Study||2||
48445608|NCT04057118|101425690|FG002|NOT COMPLETED|Overall Study||3||
48445609|NCT04057118|101425691|FG003|NOT COMPLETED|Overall Study||5||
48445610|NCT01838863|101425692|FG000|STARTED|Overall Study||75||
48445611|NCT01838863|101425693|FG001|STARTED|Overall Study||69||
48445612|NCT01838863|101425692|FG000|COMPLETED|Overall Study||65||
48445613|NCT01838863|101425693|FG001|COMPLETED|Overall Study||60||
48445614|NCT01838863|101425692|FG000|NOT COMPLETED|Overall Study||10||
48445615|NCT01838863|101425693|FG001|NOT COMPLETED|Overall Study||9||
48445616|NCT03692078|101425694|FG000|STARTED|Overall Study||18||
48445617|NCT03692078|101425695|FG001|STARTED|Overall Study||40||
48445618|NCT03692078|101425696|FG002|STARTED|Overall Study||42||
48445619|NCT03692078|101425697|FG003|STARTED|Overall Study||41||
48445620|NCT03692078|101425698|FG004|STARTED|Overall Study||30||
48445621|NCT03692078|101425699|FG005|STARTED|Overall Study||30||
48445622|NCT03692078|101425700|FG006|STARTED|Overall Study||30||
48445623|NCT03692078|101425694|FG000|COMPLETED|Overall Study||0||
48445624|NCT03692078|101425695|FG001|COMPLETED|Overall Study||38||
48445625|NCT03692078|101425696|FG002|COMPLETED|Overall Study||42||
48445626|NCT03692078|101425697|FG003|COMPLETED|Overall Study||40||
48770453|NCT02500797|102226095|FG003|STARTED|Overall Study||14||
48770454|NCT02500797|102226096|FG004|STARTED|Overall Study||14||
48770455|NCT02500797|102226097|FG005|STARTED|Overall Study||15||
48770456|NCT02500797|102226098|FG006|STARTED|Overall Study||10||
48770457|NCT02500797|102226099|FG007|STARTED|Overall Study||11||
48770458|NCT02500797|102226092|FG000|Arm I Crossover|Overall Study||4|Arm I Patients who progress after 10 weeks on single agent nivolumab and cross over to Arm II.|
48770459|NCT02500797|102226093|FG001|Arm I Crossover|Overall Study||0|Arm I Patients who progress after 10 weeks on single agent nivolumab and cross over to Arm II.|
48770460|NCT02500797|102226094|FG002|Arm I Crossover|Overall Study||6|Arm I Patients who progress after 10 weeks on single agent nivolumab and cross over to Arm II.|
48770461|NCT02500797|102226095|FG003|Arm I Crossover|Overall Study||0|Arm I Patients who progress after 10 weeks on single agent nivolumab and cross over to Arm II.|
48770462|NCT02500797|102226096|FG004|Arm I Crossover|Overall Study||1|Arm I Patients who progress after 10 weeks on single agent nivolumab and cross over to Arm II.|
48770463|NCT02500797|102226097|FG005|Arm I Crossover|Overall Study||0|Arm I Patients who progress after 10 weeks on single agent nivolumab and cross over to Arm II.|
48770464|NCT02500797|102226098|FG006|Arm I Crossover|Overall Study||2|Arm I Patients who progress after 10 weeks on single agent nivolumab and cross over to Arm II.|
48770465|NCT02500797|102226099|FG007|Arm I Crossover|Overall Study||0|Arm I Patients who progress after 10 weeks on single agent nivolumab and cross over to Arm II.|
48770466|NCT02500797|102226092|FG000|COMPLETED|Overall Study||42||
48770467|NCT02500797|102226093|FG001|COMPLETED|Overall Study||42||
48770468|NCT02500797|102226094|FG002|COMPLETED|Overall Study||15||
48770469|NCT02500797|102226095|FG003|COMPLETED|Overall Study||14||
48770470|NCT02500797|102226096|FG004|COMPLETED|Overall Study||13||
48770471|NCT02500797|102226097|FG005|COMPLETED|Overall Study||14||
48445627|NCT03692078|101425698|FG004|COMPLETED|Overall Study||25||
48770472|NCT02500797|102226098|FG006|COMPLETED|Overall Study||10||
48770473|NCT02500797|102226099|FG007|COMPLETED|Overall Study||11||
48770474|NCT02500797|102226092|FG000|NOT COMPLETED|Overall Study||1||
48770475|NCT02500797|102226093|FG001|NOT COMPLETED|Overall Study||0||
48770476|NCT02500797|102226094|FG002|NOT COMPLETED|Overall Study||0||
48770477|NCT02500797|102226095|FG003|NOT COMPLETED|Overall Study||0||
48770478|NCT02500797|102226096|FG004|NOT COMPLETED|Overall Study||1||
48770479|NCT02500797|102226097|FG005|NOT COMPLETED|Overall Study||1||
48770480|NCT02500797|102226098|FG006|NOT COMPLETED|Overall Study||0||
48445628|NCT03692078|101425699|FG005|COMPLETED|Overall Study||26||
48445629|NCT03692078|101425700|FG006|COMPLETED|Overall Study||27||
48445630|NCT03692078|101425694|FG000|NOT COMPLETED|Overall Study||18||
48445631|NCT03692078|101425695|FG001|NOT COMPLETED|Overall Study||2||
48445632|NCT03692078|101425696|FG002|NOT COMPLETED|Overall Study||0||
48445633|NCT03692078|101425697|FG003|NOT COMPLETED|Overall Study||1||
48445634|NCT03692078|101425698|FG004|NOT COMPLETED|Overall Study||5||
48445635|NCT03692078|101425699|FG005|NOT COMPLETED|Overall Study||4||
48445636|NCT03692078|101425700|FG006|NOT COMPLETED|Overall Study||3||
48445637|NCT03543046|101425701|FG000|STARTED|Overall Study||14||
48445638|NCT03543046|101425702|FG001|STARTED|Overall Study||13||
48445639|NCT03543046|101425701|FG000|COMPLETED|Overall Study||11||
48445640|NCT03543046|101425702|FG001|COMPLETED|Overall Study||11||
48445641|NCT03543046|101425701|FG000|NOT COMPLETED|Overall Study||3||
48445642|NCT03543046|101425702|FG001|NOT COMPLETED|Overall Study||2||
48445643|NCT03909971|101425703|FG000|STARTED|Overall Study||67||
48445644|NCT03909971|101425704|FG001|STARTED|Overall Study||42||
48445645|NCT03909971|101425703|FG000|COMPLETED|Overall Study||57||
48445646|NCT03909971|101425704|FG001|COMPLETED|Overall Study||20||
48445647|NCT03909971|101425703|FG000|NOT COMPLETED|Overall Study||10||
48445648|NCT03909971|101425704|FG001|NOT COMPLETED|Overall Study||22||
48445649|NCT01010230|101425705|FG000|STARTED|Overall Study||32||
48445650|NCT01010230|101425706|FG001|STARTED|Overall Study||33||
48445651|NCT01010230|101425705|FG000|COMPLETED|Overall Study||22||
48445652|NCT01010230|101425706|FG001|COMPLETED|Overall Study||26||
48445653|NCT01010230|101425705|FG000|NOT COMPLETED|Overall Study||10||
48445654|NCT01010230|101425706|FG001|NOT COMPLETED|Overall Study||7||
48445655|NCT05246111|101425707|FG000|STARTED|Period 01||6||
48445656|NCT05246111|101425708|FG001|STARTED|Period 01||0||
48445657|NCT05246111|101425707|FG000|COMPLETED|Period 01||5||
48445658|NCT05246111|101425708|FG001|COMPLETED|Period 01||0||
48445659|NCT05246111|101425707|FG000|NOT COMPLETED|Period 01||1||
48445660|NCT05246111|101425708|FG001|NOT COMPLETED|Period 01||0||
48770481|NCT02500797|102226099|FG007|NOT COMPLETED|Overall Study||0||
48770482|NCT01354314|102226100|FG000|STARTED|Overall Study||12||
48770483|NCT01354314|102226101|FG001|STARTED|Overall Study||11||
48770484|NCT01354314|102226102|FG002|STARTED|Overall Study||11||
48445661|NCT05246111|101425707|FG000|STARTED|Period 02||0||
48445662|NCT05246111|101425708|FG001|STARTED|Period 02||5||
48445663|NCT05246111|101425707|FG000|COMPLETED|Period 02||0||
48445664|NCT05246111|101425708|FG001|COMPLETED|Period 02||5||
48445665|NCT05246111|101425707|FG000|NOT COMPLETED|Period 02||0||
48445666|NCT05246111|101425708|FG001|NOT COMPLETED|Period 02||0||
48445667|NCT02964078|101425709|FG000|STARTED|Overall Study||27||
48445668|NCT02964078|101425709|FG000|COMPLETED|Overall Study||27||
48445669|NCT02964078|101425709|FG000|NOT COMPLETED|Overall Study||0||
48445670|NCT03284424|101425710|FG000|STARTED|Overall Study||105||
48445671|NCT03284424|101425711|FG001|STARTED|Overall Study||54||
48445672|NCT03284424|101425710|FG000|Participants That Received a Second Course of Pembrolizumab|Overall Study||2||
48445673|NCT03284424|101425711|FG001|Participants That Received a Second Course of Pembrolizumab|Overall Study||1||
48445674|NCT03284424|101425710|FG000|COMPLETED|Overall Study||0||
48445675|NCT03284424|101425711|FG001|COMPLETED|Overall Study||0||
48658747|NCT01309100|101949015|FG000|STARTED|Overall Study||144||
48658748|NCT01309100|101949015|FG000|COMPLETED|Overall Study||142||
48658749|NCT01309100|101949015|FG000|NOT COMPLETED|Overall Study||2||
48658750|NCT01507103|101949016|FG000|STARTED|Overall Study||41||
48658751|NCT01507103|101949017|FG001|STARTED|Overall Study||41||
48658752|NCT01507103|101949018|FG002|STARTED|Overall Study||42||
48658753|NCT01507103|101949016|FG000|COMPLETED|Overall Study||41||
48658754|NCT01507103|101949017|FG001|COMPLETED|Overall Study||41||
48658755|NCT01507103|101949018|FG002|COMPLETED|Overall Study||42||
48658756|NCT01507103|101949016|FG000|NOT COMPLETED|Overall Study||0||
48658757|NCT01507103|101949017|FG001|NOT COMPLETED|Overall Study||0||
48658758|NCT01507103|101949018|FG002|NOT COMPLETED|Overall Study||0||
48658759|NCT00392288|101949019|FG000|STARTED|Overall Study||175||
48770485|NCT01354314|102226103|FG003|STARTED|Overall Study||11||
48770486|NCT01354314|102226100|FG000|Completed (ITT)|Overall Study||11|Completed trial with evaluable data for intention to treat analysis.|
48770487|NCT01354314|102226101|FG001|Completed (ITT)|Overall Study||11|Completed trial with evaluable data for intention to treat analysis.|
48770488|NCT01354314|102226102|FG002|Completed (ITT)|Overall Study||9|Completed trial with evaluable data for intention to treat analysis.|
48770489|NCT01354314|102226103|FG003|Completed (ITT)|Overall Study||10|Completed trial with evaluable data for intention to treat analysis.|
48770490|NCT01354314|102226100|FG000|COMPLETED|Overall Study||6|Per protocol: evaluable outcome measures and 90+ percent of target study treatment total dose.|
48770491|NCT01354314|102226101|FG001|COMPLETED|Overall Study||8|Per protocol: evaluable outcome measures and 90+ percent of target study treatment total dose.|
48658760|NCT00392288|101949020|FG001|STARTED|Overall Study||177||
48658761|NCT00392288|101949021|FG002|STARTED|Overall Study||176||
48445676|NCT03284424|101425710|FG000|NOT COMPLETED|Overall Study||105||
48445677|NCT03284424|101425711|FG001|NOT COMPLETED|Overall Study||54||
48445678|NCT01256398|101425712|FG000|STARTED|Overall Study||66||
48658762|NCT00392288|101949019|FG000|Treatment Period|Overall Study||172||
48658763|NCT00392288|101949020|FG001|Treatment Period|Overall Study||174||
48658764|NCT00392288|101949021|FG002|Treatment Period|Overall Study||175||
48658765|NCT00392288|101949019|FG000|COMPLETED|Overall Study||143||
48658766|NCT00392288|101949020|FG001|COMPLETED|Overall Study||155||
48658767|NCT00392288|101949021|FG002|COMPLETED|Overall Study||159||
48770492|NCT01354314|102226102|FG002|COMPLETED|Overall Study||3|Per protocol: evaluable outcome measures and 90+ percent of target study treatment total dose.|
48770493|NCT01354314|102226103|FG003|COMPLETED|Overall Study||5|Per protocol: evaluable outcome measures and 90+ percent of target study treatment total dose.|
48770494|NCT01354314|102226100|FG000|NOT COMPLETED|Overall Study||6||
48770495|NCT01354314|102226101|FG001|NOT COMPLETED|Overall Study||3||
48189054|NCT02561455|100786143|FG000|NOT COMPLETED|Overall Study||2||
48445679|NCT01256398|101425712|FG000|COMPLETED|Overall Study||65||
48445680|NCT01256398|101425712|FG000|NOT COMPLETED|Overall Study||1||
48445681|NCT01305265|101425713|FG000|STARTED|Overall Study||71||
48445682|NCT01305265|101425714|FG001|STARTED|Overall Study||70||
48445683|NCT01305265|101425713|FG000|COMPLETED|Overall Study||69||
48445684|NCT01305265|101425714|FG001|COMPLETED|Overall Study||64||
48445685|NCT01305265|101425713|FG000|NOT COMPLETED|Overall Study||2||
48445686|NCT01305265|101425714|FG001|NOT COMPLETED|Overall Study||6||
48445687|NCT01115699|101425715|FG000|STARTED|Overall Study||2||
48445688|NCT01115699|101425715|FG000|COMPLETED|Overall Study||2||
48445689|NCT01115699|101425715|FG000|NOT COMPLETED|Overall Study||0||
48445690|NCT01485588|101425716|FG000|STARTED|Overall Study||6||
48445691|NCT01485588|101425717|FG001|STARTED|Overall Study||6||
48445692|NCT01485588|101425718|FG002|STARTED|Overall Study||6||
48445693|NCT01485588|101425716|FG000|COMPLETED|Overall Study||6||
48445694|NCT01485588|101425717|FG001|COMPLETED|Overall Study||6||
48445695|NCT01485588|101425718|FG002|COMPLETED|Overall Study||6||
48445696|NCT01485588|101425716|FG000|NOT COMPLETED|Overall Study||0||
48445697|NCT01485588|101425717|FG001|NOT COMPLETED|Overall Study||0||
48445698|NCT01485588|101425718|FG002|NOT COMPLETED|Overall Study||0||
48445699|NCT01466673|101425719|FG000|STARTED|Overall Study||100||
48445700|NCT01466673|101425720|FG001|STARTED|Overall Study||101||
48445701|NCT01466673|101425719|FG000|COMPLETED|Overall Study||93||
48445702|NCT01466673|101425720|FG001|COMPLETED|Overall Study||95||
48445703|NCT01466673|101425719|FG000|NOT COMPLETED|Overall Study||7||
48445704|NCT01466673|101425720|FG001|NOT COMPLETED|Overall Study||6||
48445705|NCT03402126|101425721|FG000|STARTED|Overall Study||138||
48445706|NCT03402126|101425721|FG000|COMPLETED|Overall Study||76||
48445707|NCT03402126|101425721|FG000|NOT COMPLETED|Overall Study||62||
48445708|NCT03869684|101425722|FG000|STARTED|Overall Study||3||
48445709|NCT03869684|101425723|FG001|STARTED|Overall Study||5||
48445710|NCT03869684|101425724|FG002|STARTED|Overall Study||5||
48445711|NCT03869684|101425722|FG000|COMPLETED|Overall Study||1||
48658768|NCT00392288|101949019|FG000|NOT COMPLETED|Overall Study||32||
48658769|NCT00392288|101949020|FG001|NOT COMPLETED|Overall Study||22||
48658770|NCT00392288|101949021|FG002|NOT COMPLETED|Overall Study||17||
48658771|NCT04821245|101949022|FG000|STARTED|Overall Study||36||
48658772|NCT04821245|101949022|FG000|COMPLETED|Overall Study||27||
48658773|NCT04821245|101949022|FG000|NOT COMPLETED|Overall Study||9||
48658774|NCT00185614|101949023|FG000|STARTED|Autologous HCT (Auto-HCT)||63||
48658775|NCT00185614|101949023|FG000|COMPLETED|Autologous HCT (Auto-HCT)||63||
48658776|NCT00185614|101949023|FG000|NOT COMPLETED|Autologous HCT (Auto-HCT)||0||
48658777|NCT00185614|101949023|FG000|STARTED|Inter-treatment Period||63||
48658778|NCT00185614|101949023|FG000|COMPLETED|Inter-treatment Period||59||
48658779|NCT00185614|101949023|FG000|NOT COMPLETED|Inter-treatment Period||4||
48658780|NCT00185614|101949023|FG000|STARTED|Allogenic HCT (Allo-HCT)||59||
48658781|NCT00185614|101949023|FG000|COMPLETED|Allogenic HCT (Allo-HCT)||59||
48770496|NCT01354314|102226102|FG002|NOT COMPLETED|Overall Study||8||
48770497|NCT01354314|102226103|FG003|NOT COMPLETED|Overall Study||6||
48770498|NCT04266717|102226104|FG000|STARTED|Overall Study||10||
48770499|NCT04266717|102226105|FG001|STARTED|Overall Study||10||
48770500|NCT04266717|102226104|FG000|COMPLETED|Overall Study||10||
48770501|NCT04266717|102226105|FG001|COMPLETED|Overall Study||10||
48770502|NCT04266717|102226104|FG000|NOT COMPLETED|Overall Study||0||
48189055|NCT02561455|100786144|FG001|NOT COMPLETED|Overall Study||2||
48369116|NCT00430625|101232701|FG001|STARTED|Overall Study||12||
48445712|NCT03869684|101425723|FG001|COMPLETED|Overall Study||2||
48445713|NCT03869684|101425724|FG002|COMPLETED|Overall Study||2||
48445714|NCT03869684|101425722|FG000|NOT COMPLETED|Overall Study||2||
48445715|NCT03869684|101425723|FG001|NOT COMPLETED|Overall Study||3||
48445716|NCT03869684|101425724|FG002|NOT COMPLETED|Overall Study||3||
48445717|NCT01141049|101425725|FG000|STARTED|Overall Study||19||
48445718|NCT01141049|101425726|FG001|STARTED|Overall Study||21||
48445719|NCT01141049|101425725|FG000|COMPLETED|Overall Study||14||
48445720|NCT01141049|101425726|FG001|COMPLETED|Overall Study||13||
48445721|NCT01141049|101425725|FG000|NOT COMPLETED|Overall Study||5||
48445722|NCT01141049|101425726|FG001|NOT COMPLETED|Overall Study||8||
48445723|NCT02305329|101425727|FG000|STARTED|Overall Study||14||
48445724|NCT02305329|101425728|FG001|STARTED|Overall Study||14||
48445725|NCT02305329|101425729|FG002|STARTED|Overall Study||14||
48445726|NCT02305329|101425730|FG003|STARTED|Overall Study||14||
48445727|NCT02305329|101425727|FG000|Period 1|Overall Study||14||
48658782|NCT00185614|101949023|FG000|NOT COMPLETED|Allogenic HCT (Allo-HCT)||0||
48658783|NCT02770365|101949024|FG000|STARTED|Overall Study||277||
48658784|NCT02770365|101949025|FG001|STARTED|Overall Study||279||
48445728|NCT02305329|101425728|FG001|Period 1|Overall Study||14||
48445729|NCT02305329|101425729|FG002|Period 1|Overall Study||14||
48445730|NCT02305329|101425730|FG003|Period 1|Overall Study||14||
48445731|NCT02305329|101425727|FG000|Period 2|Overall Study||14||
48445732|NCT02305329|101425728|FG001|Period 2|Overall Study||13||
48445733|NCT02305329|101425729|FG002|Period 2|Overall Study||14||
48445734|NCT02305329|101425730|FG003|Period 2|Overall Study||14||
48445735|NCT02305329|101425727|FG000|COMPLETED|Overall Study||14||
48445736|NCT02305329|101425728|FG001|COMPLETED|Overall Study||13||
48445737|NCT02305329|101425729|FG002|COMPLETED|Overall Study||14||
48445738|NCT02305329|101425730|FG003|COMPLETED|Overall Study||14||
48445739|NCT02305329|101425727|FG000|NOT COMPLETED|Overall Study||0||
48445740|NCT02305329|101425728|FG001|NOT COMPLETED|Overall Study||1||
48445741|NCT02305329|101425729|FG002|NOT COMPLETED|Overall Study||0||
48445742|NCT02305329|101425730|FG003|NOT COMPLETED|Overall Study||0||
48445743|NCT03746080|101425731|FG000|STARTED|Overall Study||17||
48445744|NCT03746080|101425731|FG000|On Treatment|Overall Study||17||
48445745|NCT03746080|101425731|FG000|Completed Treatment|Overall Study||17||
48445746|NCT03746080|101425731|FG000|COMPLETED|Overall Study||0||
48445747|NCT03746080|101425731|FG000|NOT COMPLETED|Overall Study||17||
48445748|NCT00572156|101425732|FG000|STARTED|Overall Study||26||
48445749|NCT00572156|101425733|FG001|STARTED|Overall Study||27||
48445750|NCT00572156|101425734|FG002|STARTED|Overall Study||27||
48445751|NCT00572156|101425735|FG003|STARTED|Overall Study||26||
48445752|NCT00572156|101425732|FG000|COMPLETED|Overall Study||0||
48445753|NCT00572156|101425733|FG001|COMPLETED|Overall Study||1||
48445754|NCT00572156|101425734|FG002|COMPLETED|Overall Study||0||
48445755|NCT00572156|101425735|FG003|COMPLETED|Overall Study||1||
48445756|NCT00572156|101425732|FG000|NOT COMPLETED|Overall Study||26||
48445757|NCT00572156|101425733|FG001|NOT COMPLETED|Overall Study||26||
48445758|NCT00572156|101425734|FG002|NOT COMPLETED|Overall Study||27||
48445759|NCT00572156|101425735|FG003|NOT COMPLETED|Overall Study||25||
48445760|NCT00411762|101425736|FG000|STARTED|Overall Study||25||
48445761|NCT00411762|101425736|FG000|COMPLETED|Overall Study||20||
48445762|NCT00411762|101425736|FG000|NOT COMPLETED|Overall Study||5||
48445763|NCT01988493|101425737|FG000|STARTED|Overall Study||7||
48445764|NCT01988493|101425738|FG001|STARTED|Overall Study||14||
48445765|NCT01988493|101425739|FG002|STARTED|Overall Study||6||
48445766|NCT01988493|101425740|FG003|STARTED|Overall Study||45||
48445767|NCT01988493|101425741|FG004|STARTED|Overall Study||45||
48445768|NCT01988493|101425737|FG000|Treated|Overall Study||7||
48445769|NCT01988493|101425738|FG001|Treated|Overall Study||14||
48445770|NCT01988493|101425739|FG002|Treated|Overall Study||6||
48445771|NCT01988493|101425740|FG003|Treated|Overall Study||45||
48445772|NCT01988493|101425741|FG004|Treated|Overall Study||44||
48445773|NCT01988493|101425737|FG000|Safety Population|Overall Study||7||
48445774|NCT01988493|101425738|FG001|Safety Population|Overall Study||14||
48445775|NCT01988493|101425739|FG002|Safety Population|Overall Study||6||
48445776|NCT01988493|101425740|FG003|Safety Population|Overall Study||45||
48445777|NCT01988493|101425741|FG004|Safety Population|Overall Study||44||
48445778|NCT01988493|101425737|FG000|COMPLETED|Overall Study||7||
48445779|NCT01988493|101425738|FG001|COMPLETED|Overall Study||14||
48445780|NCT01988493|101425739|FG002|COMPLETED|Overall Study||6||
48445781|NCT01988493|101425740|FG003|COMPLETED|Overall Study||45||
48445782|NCT01988493|101425741|FG004|COMPLETED|Overall Study||44||
48445783|NCT01988493|101425737|FG000|NOT COMPLETED|Overall Study||0||
48445784|NCT01988493|101425738|FG001|NOT COMPLETED|Overall Study||0||
48445785|NCT01988493|101425739|FG002|NOT COMPLETED|Overall Study||0||
48445786|NCT01988493|101425740|FG003|NOT COMPLETED|Overall Study||0||
48445787|NCT01988493|101425741|FG004|NOT COMPLETED|Overall Study||1||
48445788|NCT02703454|101425742|FG000|STARTED|Overall Study||24||
48658785|NCT02770365|101949026|FG002|STARTED|Overall Study||139||
48658786|NCT02770365|101949024|FG000|COMPLETED|Overall Study||272||
48658787|NCT02770365|101949025|FG001|COMPLETED|Overall Study||275||
48445789|NCT02703454|101425743|FG001|STARTED|Overall Study||27||
48445790|NCT02703454|101425742|FG000|Treated|Overall Study||23||
48445791|NCT02703454|101425743|FG001|Treated|Overall Study||24||
48445792|NCT02703454|101425742|FG000|COMPLETED|Overall Study||13||
48445793|NCT02703454|101425743|FG001|COMPLETED|Overall Study||11||
48445794|NCT02703454|101425742|FG000|NOT COMPLETED|Overall Study||11||
48445795|NCT02703454|101425743|FG001|NOT COMPLETED|Overall Study||16||
48445796|NCT01508325|101425744|FG000|STARTED|Overall Study||93||
48445797|NCT01508325|101425745|FG001|STARTED|Overall Study||93||
48445798|NCT01508325|101425744|FG000|COMPLETED|Overall Study||75||
48445799|NCT01508325|101425745|FG001|COMPLETED|Overall Study||72||
48445800|NCT01508325|101425744|FG000|NOT COMPLETED|Overall Study||18||
48445801|NCT01508325|101425745|FG001|NOT COMPLETED|Overall Study||21||
48445802|NCT03576131|101425746|FG000|STARTED|Overall Study||10||
48445803|NCT03576131|101425747|FG001|STARTED|Overall Study||7||
48445804|NCT03576131|101425748|FG002|STARTED|Overall Study||4||
48445805|NCT03576131|101425749|FG003|STARTED|Overall Study||11||
48445806|NCT03576131|101425750|FG004|STARTED|Overall Study||7||
48445807|NCT03576131|101425751|FG005|STARTED|Overall Study||7||
48445808|NCT03576131|101425752|FG006|STARTED|Overall Study||1||
48658788|NCT02770365|101949026|FG002|COMPLETED|Overall Study||139||
48445809|NCT03576131|101425753|FG007|STARTED|Overall Study||1||
48445810|NCT03576131|101425746|FG000|COMPLETED|Overall Study||1||
48445811|NCT03576131|101425747|FG001|COMPLETED|Overall Study||2||
48445812|NCT03576131|101425748|FG002|COMPLETED|Overall Study||0||
48445813|NCT03576131|101425749|FG003|COMPLETED|Overall Study||0||
48445814|NCT03576131|101425750|FG004|COMPLETED|Overall Study||0||
48445815|NCT03576131|101425751|FG005|COMPLETED|Overall Study||0||
48445816|NCT03576131|101425752|FG006|COMPLETED|Overall Study||0||
48445817|NCT03576131|101425753|FG007|COMPLETED|Overall Study||0||
48445818|NCT03576131|101425746|FG000|NOT COMPLETED|Overall Study||9||
48445819|NCT03576131|101425747|FG001|NOT COMPLETED|Overall Study||5||
48445820|NCT03576131|101425748|FG002|NOT COMPLETED|Overall Study||4||
48445821|NCT03576131|101425749|FG003|NOT COMPLETED|Overall Study||11||
48445822|NCT03576131|101425750|FG004|NOT COMPLETED|Overall Study||7||
48445823|NCT03576131|101425751|FG005|NOT COMPLETED|Overall Study||7||
48445824|NCT03576131|101425752|FG006|NOT COMPLETED|Overall Study||1||
48445825|NCT03576131|101425753|FG007|NOT COMPLETED|Overall Study||1||
48445826|NCT02229487|101425754|FG000|STARTED|Overall Study||24||
48445827|NCT02229487|101425755|FG001|STARTED|Overall Study||27||
48445828|NCT02229487|101425754|FG000|COMPLETED|Overall Study||24||
48445829|NCT02229487|101425755|FG001|COMPLETED|Overall Study||27||
48445830|NCT02229487|101425754|FG000|NOT COMPLETED|Overall Study||0||
48445831|NCT02229487|101425755|FG001|NOT COMPLETED|Overall Study||0||
48445832|NCT02574260|101425756|FG000|STARTED|Overall Study||3||
48445833|NCT02574260|101425756|FG000|COMPLETED|Overall Study||2||
48658789|NCT02770365|101949024|FG000|NOT COMPLETED|Overall Study||5||
48658790|NCT02770365|101949025|FG001|NOT COMPLETED|Overall Study||4||
48658791|NCT02770365|101949026|FG002|NOT COMPLETED|Overall Study||0||
48658792|NCT02529488|101949027|FG000|STARTED|Overall Study||149||
48658793|NCT02529488|101949027|FG000|COMPLETED|Overall Study||145||
48658794|NCT02529488|101949027|FG000|NOT COMPLETED|Overall Study||4||
48658795|NCT03111108|101949028|FG000|STARTED|Overall Study||53||
48658796|NCT03111108|101949029|FG001|STARTED|Overall Study||64||
48770503|NCT04266717|102226105|FG001|NOT COMPLETED|Overall Study||0||
48770504|NCT03537404|102229205|FG000|STARTED|First Intervention (A or B or C)||18||
48770505|NCT03537404|102229206|FG001|STARTED|First Intervention (A or B or C)||18||
48770506|NCT03537404|102229205|FG000|COMPLETED|First Intervention (A or B or C)||18||
48770507|NCT03537404|102229206|FG001|COMPLETED|First Intervention (A or B or C)||18||
48770508|NCT03537404|102229205|FG000|NOT COMPLETED|First Intervention (A or B or C)||0||
48770509|NCT03537404|102229206|FG001|NOT COMPLETED|First Intervention (A or B or C)||0||
48770510|NCT03537404|102229205|FG000|STARTED|First Washout Period (8 Days)||18||
48189056|NCT02561455|100786145|FG002|NOT COMPLETED|Overall Study||3||
48445834|NCT02574260|101425756|FG000|NOT COMPLETED|Overall Study||1||
48658797|NCT03111108|101949028|FG000|COMPLETED|Overall Study||52||
48658798|NCT03111108|101949029|FG001|COMPLETED|Overall Study||63||
48658799|NCT03111108|101949028|FG000|NOT COMPLETED|Overall Study||1||
48658800|NCT03111108|101949029|FG001|NOT COMPLETED|Overall Study||1||
48658801|NCT01546987|101949030|FG000|STARTED|Overall Study||118||
48658802|NCT01546987|101949031|FG001|STARTED|Overall Study||120||
48658803|NCT01546987|101949030|FG000|Eligible|Overall Study||115||
48658804|NCT01546987|101949031|FG001|Eligible|Overall Study||116||
48770511|NCT03537404|102229206|FG001|STARTED|First Washout Period (8 Days)||18||
48770512|NCT03537404|102229205|FG000|COMPLETED|First Washout Period (8 Days)||18||
48770513|NCT03537404|102229206|FG001|COMPLETED|First Washout Period (8 Days)||18||
48770514|NCT03537404|102229205|FG000|NOT COMPLETED|First Washout Period (8 Days)||0||
48770515|NCT03537404|102229206|FG001|NOT COMPLETED|First Washout Period (8 Days)||0||
48770516|NCT03537404|102229205|FG000|STARTED|Second Intervention (A or B or C)||18||
48189057|NCT02561455|100786146|FG003|NOT COMPLETED|Overall Study||1||
48445835|NCT02989610|101425757|FG000|STARTED|Overall Study||234||
48445836|NCT02989610|101425757|FG000|COMPLETED|Overall Study||184||
48445837|NCT02989610|101425757|FG000|NOT COMPLETED|Overall Study||50||
48445838|NCT03725722|101425758|FG000|STARTED|Overall Study||49|Number of subjects randomized|
48445839|NCT03725722|101425759|FG001|STARTED|Overall Study||50|Number of subjects randomized|
48445840|NCT03725722|101425760|FG002|STARTED|Overall Study||50|Number of subjects randomized|
48445841|NCT03725722|101425761|FG003|STARTED|Overall Study||52|Number of subjects randomized|
48445842|NCT03725722|101425762|FG004|STARTED|Overall Study||50|Number of subjects randomized|
48445843|NCT03725722|101425758|FG000|COMPLETED|Overall Study||38||
48445844|NCT03725722|101425759|FG001|COMPLETED|Overall Study||44||
48445845|NCT03725722|101425760|FG002|COMPLETED|Overall Study||44||
48445846|NCT03725722|101425761|FG003|COMPLETED|Overall Study||46||
48445847|NCT03725722|101425762|FG004|COMPLETED|Overall Study||36||
48445848|NCT03725722|101425758|FG000|NOT COMPLETED|Overall Study||11||
48445849|NCT03725722|101425759|FG001|NOT COMPLETED|Overall Study||6||
48445850|NCT03725722|101425760|FG002|NOT COMPLETED|Overall Study||6||
48445851|NCT03725722|101425761|FG003|NOT COMPLETED|Overall Study||6||
48445852|NCT03725722|101425762|FG004|NOT COMPLETED|Overall Study||14||
48445853|NCT05473247|101425763|FG000|STARTED|Overall Study||20||
48189058|NCT03282123|100786147|FG000|STARTED|Overall Study||38||
48658805|NCT01546987|101949030|FG000|Eligible Participants Who Consented to Quality of Life (QOL) Component|Overall Study||103||
48658806|NCT01546987|101949031|FG001|Eligible Participants Who Consented to Quality of Life (QOL) Component|Overall Study||94||
48770517|NCT03537404|102229206|FG001|STARTED|Second Intervention (A or B or C)||18||
48770518|NCT03537404|102229205|FG000|COMPLETED|Second Intervention (A or B or C)||18||
48189059|NCT03282123|100786147|FG000|COMPLETED|Overall Study||33||
48189060|NCT03282123|100786147|FG000|NOT COMPLETED|Overall Study||5||
48770519|NCT03537404|102229206|FG001|COMPLETED|Second Intervention (A or B or C)||18||
48445854|NCT05473247|101425763|FG000|COMPLETED|Overall Study||19||
48445855|NCT05473247|101425763|FG000|NOT COMPLETED|Overall Study||1||
48445856|NCT02413879|101425764|FG000|STARTED|Overall Study||86||
48445857|NCT02413879|101425764|FG000|COMPLETED|Overall Study||86||
48445858|NCT02413879|101425764|FG000|NOT COMPLETED|Overall Study||0||
48445859|NCT05553600|101425765|FG000|STARTED|Prior to First Menstrual Cycle Starting||201||
48445860|NCT05553600|101425766|FG001|STARTED|Prior to First Menstrual Cycle Starting||203||
48445861|NCT05553600|101425767|FG002|STARTED|Prior to First Menstrual Cycle Starting||166||
48445862|NCT05553600|101425768|FG003|STARTED|Prior to First Menstrual Cycle Starting||162||
48445863|NCT05553600|101425765|FG000|COMPLETED|Prior to First Menstrual Cycle Starting||174||
48445864|NCT05553600|101425766|FG001|COMPLETED|Prior to First Menstrual Cycle Starting||173||
48445865|NCT05553600|101425767|FG002|COMPLETED|Prior to First Menstrual Cycle Starting||145||
48445866|NCT05553600|101425768|FG003|COMPLETED|Prior to First Menstrual Cycle Starting||140||
48445867|NCT05553600|101425765|FG000|NOT COMPLETED|Prior to First Menstrual Cycle Starting||27||
48445868|NCT05553600|101425766|FG001|NOT COMPLETED|Prior to First Menstrual Cycle Starting||30||
48445869|NCT05553600|101425767|FG002|NOT COMPLETED|Prior to First Menstrual Cycle Starting||21||
48445870|NCT05553600|101425768|FG003|NOT COMPLETED|Prior to First Menstrual Cycle Starting||22||
48445871|NCT05553600|101425765|FG000|STARTED|Prior to Second Menstrual Cycle Starting||174||
48445872|NCT05553600|101425766|FG001|STARTED|Prior to Second Menstrual Cycle Starting||173||
48445873|NCT05553600|101425767|FG002|STARTED|Prior to Second Menstrual Cycle Starting||145||
48445874|NCT05553600|101425768|FG003|STARTED|Prior to Second Menstrual Cycle Starting||140||
48445875|NCT05553600|101425765|FG000|COMPLETED|Prior to Second Menstrual Cycle Starting||156||
48445876|NCT05553600|101425766|FG001|COMPLETED|Prior to Second Menstrual Cycle Starting||151||
48445877|NCT05553600|101425767|FG002|COMPLETED|Prior to Second Menstrual Cycle Starting||132||
48445878|NCT05553600|101425768|FG003|COMPLETED|Prior to Second Menstrual Cycle Starting||121||
48445879|NCT05553600|101425765|FG000|NOT COMPLETED|Prior to Second Menstrual Cycle Starting||18||
48445880|NCT05553600|101425766|FG001|NOT COMPLETED|Prior to Second Menstrual Cycle Starting||22||
48445881|NCT05553600|101425767|FG002|NOT COMPLETED|Prior to Second Menstrual Cycle Starting||13||
48445882|NCT05553600|101425768|FG003|NOT COMPLETED|Prior to Second Menstrual Cycle Starting||19||
48445883|NCT05553600|101425765|FG000|STARTED|After Second Menstrual Cycle Began||156||
48445884|NCT05553600|101425766|FG001|STARTED|After Second Menstrual Cycle Began||151||
48445885|NCT05553600|101425767|FG002|STARTED|After Second Menstrual Cycle Began||132||
48445886|NCT05553600|101425768|FG003|STARTED|After Second Menstrual Cycle Began||121||
48445887|NCT05553600|101425765|FG000|COMPLETED|After Second Menstrual Cycle Began||155||
48445888|NCT05553600|101425766|FG001|COMPLETED|After Second Menstrual Cycle Began||151||
48658807|NCT01546987|101949030|FG000|COMPLETED|Overall Study||115||
48658808|NCT01546987|101949031|FG001|COMPLETED|Overall Study||116||
48658809|NCT01546987|101949030|FG000|NOT COMPLETED|Overall Study||3||
48658810|NCT01546987|101949031|FG001|NOT COMPLETED|Overall Study||4||
48658811|NCT03992482|101949032|FG000|STARTED|Overall Study||13||
48770520|NCT03537404|102229205|FG000|NOT COMPLETED|Second Intervention (A or B or C)||0||
48770521|NCT03537404|102229206|FG001|NOT COMPLETED|Second Intervention (A or B or C)||0||
48770522|NCT03537404|102229205|FG000|STARTED|Second Washout Period (8 Days)||18||
48189061|NCT01169519|100786148|FG000|STARTED|Overall Study||21||
48658812|NCT03992482|101949033|FG001|STARTED|Overall Study||14||
48658813|NCT03992482|101949032|FG000|COMPLETED|Overall Study||13||
48658814|NCT03992482|101949033|FG001|COMPLETED|Overall Study||14||
48658815|NCT03992482|101949032|FG000|NOT COMPLETED|Overall Study||0||
48658816|NCT03992482|101949033|FG001|NOT COMPLETED|Overall Study||0||
48658817|NCT01347086|101949034|FG000|STARTED|Overall Study||2||
48658818|NCT01347086|101949035|FG001|STARTED|Overall Study||6||
48445889|NCT05553600|101425767|FG002|COMPLETED|After Second Menstrual Cycle Began||132||
48445890|NCT05553600|101425768|FG003|COMPLETED|After Second Menstrual Cycle Began||121||
48445891|NCT05553600|101425765|FG000|NOT COMPLETED|After Second Menstrual Cycle Began||1||
48445892|NCT05553600|101425766|FG001|NOT COMPLETED|After Second Menstrual Cycle Began||0||
48445893|NCT05553600|101425767|FG002|NOT COMPLETED|After Second Menstrual Cycle Began||0||
48445894|NCT05553600|101425768|FG003|NOT COMPLETED|After Second Menstrual Cycle Began||0||
48445895|NCT02056431|101425769|FG000|STARTED|Overall Study||604||
48445896|NCT02056431|101425770|FG001|STARTED|Overall Study||666||
48445897|NCT02056431|101425769|FG000|COMPLETED|Overall Study||560||
48445898|NCT02056431|101425770|FG001|COMPLETED|Overall Study||619||
48445899|NCT02056431|101425769|FG000|NOT COMPLETED|Overall Study||44||
48445900|NCT02056431|101425770|FG001|NOT COMPLETED|Overall Study||47||
48445901|NCT00817778|101425771|FG000|STARTED|Overall Study||19||
48445902|NCT00817778|101425772|FG001|STARTED|Overall Study||8||
48445903|NCT00817778|101425771|FG000|COMPLETED|Overall Study||16||
48445904|NCT00817778|101425772|FG001|COMPLETED|Overall Study||5||
48658819|NCT01347086|101949036|FG002|STARTED|Overall Study||7||
48658820|NCT01347086|101949037|FG003|STARTED|Overall Study||6||
48658821|NCT01347086|101949038|FG004|STARTED|Overall Study||6||
48445905|NCT00817778|101425771|FG000|NOT COMPLETED|Overall Study||3||
48445906|NCT00817778|101425772|FG001|NOT COMPLETED|Overall Study||3||
48445907|NCT01878500|101425773|FG000|STARTED|Overall Study||47||
48445908|NCT01878500|101425773|FG000|COMPLETED|Overall Study||47||
48445909|NCT01878500|101425773|FG000|NOT COMPLETED|Overall Study||0||
48445910|NCT01453101|101425774|FG000|STARTED|Overall Study||54||
48445911|NCT01453101|101425774|FG000|COMPLETED|Overall Study||54||
48445912|NCT01453101|101425774|FG000|NOT COMPLETED|Overall Study||0||
48445913|NCT03151226|101425775|FG000|STARTED|Overall Study||3||
48445914|NCT03151226|101425775|FG000|COMPLETED|Overall Study||0||
48445915|NCT03151226|101425775|FG000|NOT COMPLETED|Overall Study||3||
48445916|NCT00822679|101425776|FG000|STARTED|Overall Study||0||
48445917|NCT00822679|101425777|FG001|STARTED|Overall Study||0||
48445918|NCT00822679|101425776|FG000|COMPLETED|Overall Study||0||
48445919|NCT00822679|101425777|FG001|COMPLETED|Overall Study||0||
48445920|NCT00822679|101425776|FG000|NOT COMPLETED|Overall Study||0||
48445921|NCT00822679|101425777|FG001|NOT COMPLETED|Overall Study||0||
48445922|NCT04466956|101425778|FG000|STARTED|Overall Study||25||
48445923|NCT04466956|101425779|FG001|STARTED|Overall Study||25||
48445924|NCT04466956|101425778|FG000|COMPLETED|Overall Study||25||
48445925|NCT04466956|101425779|FG001|COMPLETED|Overall Study||25||
48445926|NCT04466956|101425778|FG000|NOT COMPLETED|Overall Study||0||
48445927|NCT04466956|101425779|FG001|NOT COMPLETED|Overall Study||0||
48445928|NCT03159611|101425780|FG000|STARTED|Overall Study||95||
48445929|NCT03159611|101425781|FG001|STARTED|Overall Study||87||
48445930|NCT03159611|101425780|FG000|COMPLETED|Overall Study||72||
48445931|NCT03159611|101425781|FG001|COMPLETED|Overall Study||72||
48445932|NCT03159611|101425780|FG000|NOT COMPLETED|Overall Study||23||
48445933|NCT03159611|101425781|FG001|NOT COMPLETED|Overall Study||15||
48445934|NCT00530088|101425782|FG000|STARTED|Overall Study||30||
48445935|NCT00530088|101425782|FG000|COMPLETED|Overall Study||20||
48445936|NCT00530088|101425782|FG000|NOT COMPLETED|Overall Study||10||
48445937|NCT01831596|101425783|FG000|STARTED|Overall Study||59||
48445938|NCT01831596|101425783|FG000|COMPLETED|Overall Study||51||
48445939|NCT01831596|101425783|FG000|NOT COMPLETED|Overall Study||8||
48445940|NCT01220128|101425784|FG000|STARTED|Overall Study||15||
48445941|NCT01220128|101425785|FG001|STARTED|Overall Study||7||
48445942|NCT01220128|101425786|FG002|STARTED|Overall Study||9||
48445943|NCT01220128|101425787|FG003|STARTED|Overall Study||6||
48445944|NCT01220128|101425788|FG004|STARTED|Overall Study||11||
48445945|NCT01220128|101425789|FG005|STARTED|Overall Study||4||
48445946|NCT01220128|101425790|FG006|STARTED|Overall Study||8||
48445947|NCT01220128|101425784|FG000|COMPLETED|Overall Study||11||
48445948|NCT01220128|101425785|FG001|COMPLETED|Overall Study||6||
48445949|NCT01220128|101425786|FG002|COMPLETED|Overall Study||6||
48445950|NCT01220128|101425787|FG003|COMPLETED|Overall Study||6||
48445951|NCT01220128|101425788|FG004|COMPLETED|Overall Study||11||
48445952|NCT01220128|101425789|FG005|COMPLETED|Overall Study||4||
48445953|NCT01220128|101425790|FG006|COMPLETED|Overall Study||3||
48445954|NCT01220128|101425784|FG000|NOT COMPLETED|Overall Study||4||
48445955|NCT01220128|101425785|FG001|NOT COMPLETED|Overall Study||1||
48445956|NCT01220128|101425786|FG002|NOT COMPLETED|Overall Study||3||
48445957|NCT01220128|101425787|FG003|NOT COMPLETED|Overall Study||0||
48445958|NCT01220128|101425788|FG004|NOT COMPLETED|Overall Study||0||
48445959|NCT01220128|101425789|FG005|NOT COMPLETED|Overall Study||0||
48445960|NCT01220128|101425790|FG006|NOT COMPLETED|Overall Study||5||
48445961|NCT03911960|101425791|FG000|STARTED|Overall Study||9||
48445962|NCT03911960|101425792|FG001|STARTED|Overall Study||5||
48445963|NCT03911960|101425791|FG000|COMPLETED|Overall Study||4||
48445964|NCT03911960|101425792|FG001|COMPLETED|Overall Study||2||
48445965|NCT03911960|101425791|FG000|NOT COMPLETED|Overall Study||5||
48445966|NCT03911960|101425792|FG001|NOT COMPLETED|Overall Study||3||
48770523|NCT03537404|102229206|FG001|STARTED|Second Washout Period (8 Days)||18||
48770524|NCT03537404|102229205|FG000|COMPLETED|Second Washout Period (8 Days)||18||
48770525|NCT03537404|102229206|FG001|COMPLETED|Second Washout Period (8 Days)||18||
48770526|NCT03537404|102229205|FG000|NOT COMPLETED|Second Washout Period (8 Days)||0||
48445967|NCT00545441|101425793|FG000|STARTED|Overall Study||44||
48445968|NCT00545441|101425794|FG001|STARTED|Overall Study||42||
48445969|NCT00545441|101425793|FG000|COMPLETED|Overall Study||26||
48445970|NCT00545441|101425794|FG001|COMPLETED|Overall Study||26||
48445971|NCT00545441|101425793|FG000|NOT COMPLETED|Overall Study||18||
48445972|NCT00545441|101425794|FG001|NOT COMPLETED|Overall Study||16||
48445973|NCT00883740|101425795|FG000|STARTED|First Intervention||60||
48445974|NCT00883740|101425796|FG001|STARTED|First Intervention||59||
48445975|NCT00883740|101425795|FG000|COMPLETED|First Intervention||53||
48445976|NCT00883740|101425796|FG001|COMPLETED|First Intervention||51||
48445977|NCT00883740|101425795|FG000|NOT COMPLETED|First Intervention||7||
48445978|NCT00883740|101425796|FG001|NOT COMPLETED|First Intervention||8||
48445979|NCT00883740|101425795|FG000|STARTED|Taper and Washout Period (2 Weeks)||54||
48445980|NCT00883740|101425796|FG001|STARTED|Taper and Washout Period (2 Weeks)||51||
48445981|NCT00883740|101425795|FG000|COMPLETED|Taper and Washout Period (2 Weeks)||54||
48445982|NCT00883740|101425796|FG001|COMPLETED|Taper and Washout Period (2 Weeks)||51||
48445983|NCT00883740|101425795|FG000|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0||
48445984|NCT00883740|101425796|FG001|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0||
48445985|NCT00883740|101425795|FG000|STARTED|Second Intervention||53||
48445986|NCT00883740|101425796|FG001|STARTED|Second Intervention||51||
48445987|NCT00883740|101425795|FG000|COMPLETED|Second Intervention||52||
48445988|NCT00883740|101425796|FG001|COMPLETED|Second Intervention||50||
48445989|NCT00883740|101425795|FG000|NOT COMPLETED|Second Intervention||1||
48445990|NCT00883740|101425796|FG001|NOT COMPLETED|Second Intervention||1||
48445991|NCT04662086|101425797|FG000|STARTED|Overall Study||60||
48445992|NCT04662086|101425798|FG001|STARTED|Overall Study||60||
48445993|NCT04662086|101425799|FG002|STARTED|Overall Study||2||
48445994|NCT04662086|101425797|FG000|Received Allocated Treatment|Overall Study||59||
48445995|NCT04662086|101425798|FG001|Received Allocated Treatment|Overall Study||59||
48445996|NCT04662086|101425799|FG002|Received Allocated Treatment|Overall Study||2||
48445997|NCT04662086|101425797|FG000|COMPLETED|Overall Study||55||
48445998|NCT04662086|101425798|FG001|COMPLETED|Overall Study||56||
48445999|NCT04662086|101425799|FG002|COMPLETED|Overall Study||1||
48446000|NCT04662086|101425797|FG000|NOT COMPLETED|Overall Study||5||
48446001|NCT04662086|101425798|FG001|NOT COMPLETED|Overall Study||4||
48446002|NCT04662086|101425799|FG002|NOT COMPLETED|Overall Study||1||
48446003|NCT01892020|101425800|FG000|STARTED|Period 1||81||
48446004|NCT01892020|101425801|FG001|STARTED|Period 1||80||
48446005|NCT01892020|101425800|FG000|COMPLETED|Period 1||78||
48446006|NCT01892020|101425801|FG001|COMPLETED|Period 1||74||
48446007|NCT01892020|101425800|FG000|NOT COMPLETED|Period 1||3||
48446008|NCT01892020|101425801|FG001|NOT COMPLETED|Period 1||6||
48446009|NCT01892020|101425800|FG000|STARTED|Period 2||78||
48446010|NCT01892020|101425801|FG001|STARTED|Period 2||74||
48446011|NCT01892020|101425800|FG000|COMPLETED|Period 2||77||
48446012|NCT01892020|101425801|FG001|COMPLETED|Period 2||74||
48446013|NCT01892020|101425800|FG000|NOT COMPLETED|Period 2||1||
48446014|NCT01892020|101425801|FG001|NOT COMPLETED|Period 2||0||
48446015|NCT03669640|101425802|FG000|STARTED|Overall Study||15||
48446016|NCT03669640|101425803|FG001|STARTED|Overall Study||12||
48446017|NCT03669640|101425804|FG002|STARTED|Overall Study||37||
48446018|NCT03669640|101425805|FG003|STARTED|Overall Study||5||
48446019|NCT03669640|101425806|FG004|STARTED|Overall Study||30||
48446020|NCT03669640|101425807|FG005|STARTED|Overall Study||32||
48446021|NCT03669640|101425802|FG000|COMPLETED|Overall Study||10||
48446022|NCT03669640|101425803|FG001|COMPLETED|Overall Study||7||
48446023|NCT03669640|101425804|FG002|COMPLETED|Overall Study||33||
48446024|NCT03669640|101425805|FG003|COMPLETED|Overall Study||5||
48446025|NCT03669640|101425806|FG004|COMPLETED|Overall Study||27||
48446026|NCT03669640|101425807|FG005|COMPLETED|Overall Study||29||
48446027|NCT03669640|101425802|FG000|NOT COMPLETED|Overall Study||5||
48446028|NCT03669640|101425803|FG001|NOT COMPLETED|Overall Study||5||
48446029|NCT03669640|101425804|FG002|NOT COMPLETED|Overall Study||4||
48446030|NCT03669640|101425805|FG003|NOT COMPLETED|Overall Study||0||
48446031|NCT03669640|101425806|FG004|NOT COMPLETED|Overall Study||3||
48446032|NCT03669640|101425807|FG005|NOT COMPLETED|Overall Study||3||
48446033|NCT00835068|101425808|FG000|STARTED|Overall Study||57||
48446034|NCT00835068|101425809|FG001|STARTED|Overall Study||1||
48446035|NCT00835068|101425808|FG000|COMPLETED|Overall Study||47||
48446036|NCT00835068|101425809|FG001|COMPLETED|Overall Study||0||
48446037|NCT00835068|101425808|FG000|NOT COMPLETED|Overall Study||10||
48446038|NCT00835068|101425809|FG001|NOT COMPLETED|Overall Study||1||
48446039|NCT00915473|101425810|FG000|STARTED|Screening||35||
48446040|NCT00915473|101425811|FG001|STARTED|Screening||35||
48446041|NCT00915473|101425810|FG000|COMPLETED|Screening||34||
48446042|NCT00915473|101425811|FG001|COMPLETED|Screening||35||
48446043|NCT00915473|101425810|FG000|NOT COMPLETED|Screening||1||
48446044|NCT00915473|101425811|FG001|NOT COMPLETED|Screening||0||
48446045|NCT00915473|101425810|FG000|STARTED|Injection||34||
48446046|NCT00915473|101425811|FG001|STARTED|Injection||35||
48446047|NCT00915473|101425810|FG000|COMPLETED|Injection||34||
48446048|NCT00915473|101425811|FG001|COMPLETED|Injection||35||
48446049|NCT00915473|101425810|FG000|NOT COMPLETED|Injection||0||
48446050|NCT00915473|101425811|FG001|NOT COMPLETED|Injection||0||
48446051|NCT00915473|101425810|FG000|STARTED|4-week Follow Up||34||
48446052|NCT00915473|101425811|FG001|STARTED|4-week Follow Up||35||
48446053|NCT00915473|101425810|FG000|COMPLETED|4-week Follow Up||33||
48446054|NCT00915473|101425811|FG001|COMPLETED|4-week Follow Up||30||
48446055|NCT00915473|101425810|FG000|NOT COMPLETED|4-week Follow Up||1||
48446056|NCT00915473|101425811|FG001|NOT COMPLETED|4-week Follow Up||5||
48446057|NCT02261974|101425812|FG000|STARTED|Overall Study||123||
48446058|NCT02261974|101425813|FG001|STARTED|Overall Study||63||
48446059|NCT02261974|101425812|FG000|Treated|Overall Study||117||
48446060|NCT02261974|101425813|FG001|Treated|Overall Study||57||
48446061|NCT02261974|101425812|FG000|COMPLETED|Overall Study||108||
48446062|NCT02261974|101425813|FG001|COMPLETED|Overall Study||56||
48446063|NCT02261974|101425812|FG000|NOT COMPLETED|Overall Study||15||
48446064|NCT02261974|101425813|FG001|NOT COMPLETED|Overall Study||7||
48446065|NCT01494649|101428384|FG000|STARTED|Overall Study||59||
48446066|NCT01494649|101428385|FG001|STARTED|Overall Study||59||
48446067|NCT01494649|101428384|FG000|COMPLETED|Overall Study||59||
48446068|NCT01494649|101428385|FG001|COMPLETED|Overall Study||58||
48446069|NCT01494649|101428384|FG000|NOT COMPLETED|Overall Study||0||
48446070|NCT01494649|101428385|FG001|NOT COMPLETED|Overall Study||1||
48446071|NCT00343642|101428386|FG000|STARTED|Overall Study||19||
48446072|NCT00343642|101428387|FG001|STARTED|Overall Study||19||
48446073|NCT00343642|101428388|FG002|STARTED|Overall Study||16||
48446074|NCT00343642|101428386|FG000|Upto 3 Months Complete or Flare|Overall Study||2||
48446075|NCT00343642|101428387|FG001|Upto 3 Months Complete or Flare|Overall Study||0||
48446076|NCT00343642|101428388|FG002|Upto 3 Months Complete or Flare|Overall Study||1||
48446077|NCT00343642|101428386|FG000|3-6 Months Complete or Flare|Overall Study||4||
48446078|NCT00343642|101428387|FG001|3-6 Months Complete or Flare|Overall Study||2||
48446079|NCT00343642|101428388|FG002|3-6 Months Complete or Flare|Overall Study||2||
48446080|NCT00343642|101428386|FG000|COMPLETED|Overall Study||10||
48446081|NCT00343642|101428387|FG001|COMPLETED|Overall Study||11||
48446082|NCT00343642|101428388|FG002|COMPLETED|Overall Study||9||
48446083|NCT00343642|101428386|FG000|NOT COMPLETED|Overall Study||9||
48446084|NCT00343642|101428387|FG001|NOT COMPLETED|Overall Study||8||
48446085|NCT00343642|101428388|FG002|NOT COMPLETED|Overall Study||7||
48446086|NCT06079853|101428389|FG000|STARTED|Overall Study||25||
48446087|NCT06079853|101428389|FG000|COMPLETED|Overall Study||25||
48446088|NCT06079853|101428389|FG000|NOT COMPLETED|Overall Study||0||
48446089|NCT01158976|101428390|FG000|STARTED|Overall Study||43||
48446090|NCT01158976|101428391|FG001|STARTED|Overall Study||21||
48446091|NCT01158976|101428390|FG000|COMPLETED|Overall Study||34||
48446092|NCT01158976|101428391|FG001|COMPLETED|Overall Study||17||
48446093|NCT01158976|101428390|FG000|NOT COMPLETED|Overall Study||9||
48446094|NCT01158976|101428391|FG001|NOT COMPLETED|Overall Study||4||
48446095|NCT01325701|101428392|FG000|STARTED|Overall Study||70||
48446096|NCT01325701|101428393|FG001|STARTED|Overall Study||8||
48446097|NCT01325701|101428392|FG000|COMPLETED|Overall Study||49||
48446098|NCT01325701|101428393|FG001|COMPLETED|Overall Study||5||
48446099|NCT01325701|101428392|FG000|NOT COMPLETED|Overall Study||21||
48446100|NCT01325701|101428393|FG001|NOT COMPLETED|Overall Study||3||
48446101|NCT01286207|101428394|FG000|STARTED|Overall Study||751||
48446102|NCT01286207|101428395|FG001|STARTED|Overall Study||857||
48446103|NCT01286207|101428396|FG002|STARTED|Overall Study||351||
48446104|NCT01286207|101428394|FG000|COMPLETED|Overall Study||453||
48446105|NCT01286207|101428395|FG001|COMPLETED|Overall Study||609||
48446106|NCT01286207|101428396|FG002|COMPLETED|Overall Study||261||
48446107|NCT01286207|101428394|FG000|NOT COMPLETED|Overall Study||298||
48446108|NCT01286207|101428395|FG001|NOT COMPLETED|Overall Study||248||
48446109|NCT01286207|101428396|FG002|NOT COMPLETED|Overall Study||90||
48446110|NCT01818414|101428397|FG000|STARTED|Overall Study||14||
48446111|NCT01818414|101428398|FG001|STARTED|Overall Study||15||
48446112|NCT01818414|101428397|FG000|COMPLETED|Overall Study||14||
48446113|NCT01818414|101428398|FG001|COMPLETED|Overall Study||15||
48446114|NCT01818414|101428397|FG000|NOT COMPLETED|Overall Study||0||
48446115|NCT01818414|101428398|FG001|NOT COMPLETED|Overall Study||0||
48446116|NCT00535301|101428399|FG000|STARTED|Overall Study||38||
48446117|NCT00535301|101428400|FG001|STARTED|Overall Study||38||
48446118|NCT00535301|101428399|FG000|COMPLETED|Overall Study||33||
48446119|NCT00535301|101428400|FG001|COMPLETED|Overall Study||33||
48446120|NCT00535301|101428399|FG000|NOT COMPLETED|Overall Study||5||
48446121|NCT00535301|101428400|FG001|NOT COMPLETED|Overall Study||5||
48658822|NCT01347086|101949039|FG005|STARTED|Overall Study||6||
48446122|NCT00874757|101428401|FG000|STARTED|Overall Study||20||
48446123|NCT00874757|101428401|FG000|COMPLETED|Overall Study||16||
48446124|NCT00874757|101428401|FG000|NOT COMPLETED|Overall Study||4||
48446125|NCT03853213|101428402|FG000|STARTED|Overall Study||11||
48446126|NCT03853213|101428403|FG001|STARTED|Overall Study||9||
48446127|NCT03853213|101428402|FG000|COMPLETED|Overall Study||10||
48446128|NCT03853213|101428403|FG001|COMPLETED|Overall Study||7||
48446129|NCT03853213|101428402|FG000|NOT COMPLETED|Overall Study||1||
48446130|NCT03853213|101428403|FG001|NOT COMPLETED|Overall Study||2||
48446131|NCT04348292|101428404|FG000|STARTED|Overall Study||3||
48446132|NCT04348292|101428404|FG000|COMPLETED|Overall Study||3||
48446133|NCT04348292|101428404|FG000|NOT COMPLETED|Overall Study||0||
48446134|NCT03141931|101428405|FG000|STARTED|Overall Study||61||
48446135|NCT03141931|101428406|FG001|STARTED|Overall Study||58||
48446136|NCT03141931|101428405|FG000|COMPLETED|Overall Study||49||
48446137|NCT03141931|101428406|FG001|COMPLETED|Overall Study||52||
48446138|NCT03141931|101428405|FG000|NOT COMPLETED|Overall Study||12||
48446139|NCT03141931|101428406|FG001|NOT COMPLETED|Overall Study||6||
48446140|NCT00774202|101428407|FG000|STARTED|Overall Study||9||
48446141|NCT00774202|101428408|FG001|STARTED|Overall Study||8||
48446142|NCT00774202|101428407|FG000|COMPLETED|Overall Study||9||
48446143|NCT00774202|101428408|FG001|COMPLETED|Overall Study||8||
48446144|NCT00774202|101428407|FG000|NOT COMPLETED|Overall Study||0||
48446145|NCT00774202|101428408|FG001|NOT COMPLETED|Overall Study||0||
48446146|NCT03491228|101428409|FG000|STARTED|Overall Study||107||
48446147|NCT03491228|101428409|FG000|COMPLETED|Overall Study||107||
48446148|NCT03491228|101428409|FG000|NOT COMPLETED|Overall Study||0||
48446149|NCT01307631|101428410|FG000|STARTED|Overall Study||9||
48446150|NCT01307631|101428411|FG001|STARTED|Overall Study||28||
48446151|NCT01307631|101428410|FG000|COMPLETED|Overall Study||9||
48446152|NCT01307631|101428411|FG001|COMPLETED|Overall Study||28||
48446153|NCT01307631|101428410|FG000|NOT COMPLETED|Overall Study||0||
48446154|NCT01307631|101428411|FG001|NOT COMPLETED|Overall Study||0||
48446155|NCT00396981|101428412|FG000|STARTED|Overall Study||311||
48446156|NCT00396981|101428413|FG001|STARTED|Overall Study||315||
48446157|NCT00396981|101428412|FG000|COMPLETED|Overall Study||296||
48446158|NCT00396981|101428413|FG001|COMPLETED|Overall Study||306||
48446159|NCT00396981|101428412|FG000|NOT COMPLETED|Overall Study||15||
48446160|NCT00396981|101428413|FG001|NOT COMPLETED|Overall Study||9||
48446161|NCT03674827|101428414|FG000|STARTED|Treatment Phase||3||
48446162|NCT03674827|101428415|FG001|STARTED|Treatment Phase||5||
48446163|NCT03674827|101428416|FG002|STARTED|Treatment Phase||3||
48446164|NCT03674827|101428417|FG003|STARTED|Treatment Phase||4||
48446165|NCT03674827|101428418|FG004|STARTED|Treatment Phase||5||
48446166|NCT03674827|101428419|FG005|STARTED|Treatment Phase||16||
48446167|NCT03674827|101428414|FG000|COMPLETED|Treatment Phase||0||
48446168|NCT03674827|101428415|FG001|COMPLETED|Treatment Phase||0||
48446169|NCT03674827|101428416|FG002|COMPLETED|Treatment Phase||0||
48446170|NCT03674827|101428417|FG003|COMPLETED|Treatment Phase||0||
48446171|NCT03674827|101428418|FG004|COMPLETED|Treatment Phase||0||
48446172|NCT03674827|101428419|FG005|COMPLETED|Treatment Phase||0||
48446173|NCT03674827|101428414|FG000|NOT COMPLETED|Treatment Phase||3||
48446174|NCT03674827|101428415|FG001|NOT COMPLETED|Treatment Phase||5||
48446175|NCT03674827|101428416|FG002|NOT COMPLETED|Treatment Phase||3||
48446176|NCT03674827|101428417|FG003|NOT COMPLETED|Treatment Phase||4||
48446177|NCT03674827|101428418|FG004|NOT COMPLETED|Treatment Phase||5||
48446178|NCT03674827|101428419|FG005|NOT COMPLETED|Treatment Phase||16||
48446179|NCT03674827|101428414|FG000|STARTED|Long-Term Follow-up Phase||3||
48446180|NCT03674827|101428415|FG001|STARTED|Long-Term Follow-up Phase||5||
48446181|NCT03674827|101428416|FG002|STARTED|Long-Term Follow-up Phase||3||
48446182|NCT03674827|101428417|FG003|STARTED|Long-Term Follow-up Phase||4||
48446183|NCT03674827|101428418|FG004|STARTED|Long-Term Follow-up Phase||5||
48446184|NCT03674827|101428419|FG005|STARTED|Long-Term Follow-up Phase||16||
48446185|NCT03674827|101428414|FG000|COMPLETED|Long-Term Follow-up Phase||0||
48446186|NCT03674827|101428415|FG001|COMPLETED|Long-Term Follow-up Phase||0||
48658823|NCT01347086|101949040|FG006|STARTED|Overall Study||7||
48658824|NCT01347086|101949041|FG007|STARTED|Overall Study||7||
48658825|NCT01347086|101949042|FG008|STARTED|Overall Study||6||
48658826|NCT01347086|101949043|FG009|STARTED|Overall Study||7||
48658827|NCT01347086|101949034|FG000|COMPLETED|Overall Study||2||
48658828|NCT01347086|101949035|FG001|COMPLETED|Overall Study||6||
48446187|NCT03674827|101428416|FG002|COMPLETED|Long-Term Follow-up Phase||0||
48658829|NCT01347086|101949036|FG002|COMPLETED|Overall Study||6||
48658830|NCT01347086|101949037|FG003|COMPLETED|Overall Study||6||
48446188|NCT03674827|101428417|FG003|COMPLETED|Long-Term Follow-up Phase||0||
48446189|NCT03674827|101428418|FG004|COMPLETED|Long-Term Follow-up Phase||0||
48446190|NCT03674827|101428419|FG005|COMPLETED|Long-Term Follow-up Phase||0||
48446191|NCT03674827|101428414|FG000|NOT COMPLETED|Long-Term Follow-up Phase||3||
48446192|NCT03674827|101428415|FG001|NOT COMPLETED|Long-Term Follow-up Phase||5||
48446193|NCT03674827|101428416|FG002|NOT COMPLETED|Long-Term Follow-up Phase||3||
48446194|NCT03674827|101428417|FG003|NOT COMPLETED|Long-Term Follow-up Phase||4||
48446195|NCT03674827|101428418|FG004|NOT COMPLETED|Long-Term Follow-up Phase||5||
48446196|NCT03674827|101428419|FG005|NOT COMPLETED|Long-Term Follow-up Phase||16||
48446197|NCT03496207|101428420|FG000|STARTED|Base Study||0||
48446198|NCT03496207|101428421|FG001|STARTED|Base Study||0||
48446199|NCT03496207|101428422|FG002|STARTED|Base Study||32||
48446200|NCT03496207|101428423|FG003|STARTED|Base Study||32||
48446201|NCT03496207|101428424|FG004|STARTED|Base Study||42||
48446202|NCT03496207|101428420|FG000|COMPLETED|Base Study||0||
48446203|NCT03496207|101428421|FG001|COMPLETED|Base Study||0||
48446204|NCT03496207|101428422|FG002|COMPLETED|Base Study||30||
48446205|NCT03496207|101428423|FG003|COMPLETED|Base Study||31||
48446206|NCT03496207|101428424|FG004|COMPLETED|Base Study||36||
48446207|NCT03496207|101428420|FG000|NOT COMPLETED|Base Study||0||
48446208|NCT03496207|101428421|FG001|NOT COMPLETED|Base Study||0||
48446209|NCT03496207|101428422|FG002|NOT COMPLETED|Base Study||2||
48446210|NCT03496207|101428423|FG003|NOT COMPLETED|Base Study||1||
48446211|NCT03496207|101428424|FG004|NOT COMPLETED|Base Study||6||
48446212|NCT03496207|101428420|FG000|STARTED|Extension Period||15||
48446213|NCT03496207|101428421|FG001|STARTED|Extension Period||15||
48446214|NCT03496207|101428422|FG002|STARTED|Extension Period||0||
48446215|NCT03496207|101428423|FG003|STARTED|Extension Period||31||
48446216|NCT03496207|101428424|FG004|STARTED|Extension Period||36||
48446217|NCT03496207|101428420|FG000|COMPLETED|Extension Period||13||
48446218|NCT03496207|101428421|FG001|COMPLETED|Extension Period||15||
48446219|NCT03496207|101428422|FG002|COMPLETED|Extension Period||0||
48446220|NCT03496207|101428423|FG003|COMPLETED|Extension Period||28||
48446221|NCT03496207|101428424|FG004|COMPLETED|Extension Period||31||
48446222|NCT03496207|101428420|FG000|NOT COMPLETED|Extension Period||2||
48446223|NCT03496207|101428421|FG001|NOT COMPLETED|Extension Period||0||
48446224|NCT03496207|101428422|FG002|NOT COMPLETED|Extension Period||0||
48446225|NCT03496207|101428423|FG003|NOT COMPLETED|Extension Period||3||
48658831|NCT01347086|101949038|FG004|COMPLETED|Overall Study||6||
48658832|NCT01347086|101949039|FG005|COMPLETED|Overall Study||6||
48446226|NCT03496207|101428424|FG004|NOT COMPLETED|Extension Period||5||
48446227|NCT04465916|101428425|FG000|STARTED|Overall Study||19||
48446228|NCT04465916|101428426|FG001|STARTED|Overall Study||7||
48446229|NCT04465916|101428425|FG000|COMPLETED|Overall Study||19||
48446230|NCT04465916|101428426|FG001|COMPLETED|Overall Study||6||
48446231|NCT04465916|101428425|FG000|NOT COMPLETED|Overall Study||0||
48446232|NCT04465916|101428426|FG001|NOT COMPLETED|Overall Study||1||
48446233|NCT03567239|101428427|FG000|STARTED|Overall Study||5||
48446234|NCT03567239|101428427|FG000|COMPLETED|Overall Study||5||
48446235|NCT03567239|101428427|FG000|NOT COMPLETED|Overall Study||0||
48446236|NCT01339000|101428428|FG000|STARTED|Overall Study||1||
48446237|NCT01339000|101428429|FG001|STARTED|Overall Study||0||
48446238|NCT01339000|101428428|FG000|COMPLETED|Overall Study||0||
48446239|NCT01339000|101428429|FG001|COMPLETED|Overall Study||0||
48446240|NCT01339000|101428428|FG000|NOT COMPLETED|Overall Study||1||
48446241|NCT01339000|101428429|FG001|NOT COMPLETED|Overall Study||0||
48446242|NCT00457418|101428430|FG000|STARTED|Pharmacokinetic (PK) Sampling Phase||32||
48446243|NCT00457418|101428430|FG000|COMPLETED|Pharmacokinetic (PK) Sampling Phase||27||
48446244|NCT00457418|101428430|FG000|NOT COMPLETED|Pharmacokinetic (PK) Sampling Phase||5||
48446245|NCT00457418|101428430|FG000|STARTED|Post PK Maintenance||31||
48446246|NCT00457418|101428430|FG000|COMPLETED|Post PK Maintenance||3||
48446247|NCT00457418|101428430|FG000|NOT COMPLETED|Post PK Maintenance||28||
48446248|NCT01396161|101428431|FG000|STARTED|Overall Study||12||
48446249|NCT01396161|101428432|FG001|STARTED|Overall Study||5||
48446250|NCT01396161|101428433|FG002|STARTED|Overall Study||9||
48446251|NCT01396161|101428434|FG003|STARTED|Overall Study||9||
48446252|NCT01396161|101428435|FG004|STARTED|Overall Study||9||
48446253|NCT01396161|101428436|FG005|STARTED|Overall Study||9||
48446254|NCT01396161|101428437|FG006|STARTED|Overall Study||11||
48446255|NCT01396161|101428431|FG000|COMPLETED|Overall Study||12||
48446256|NCT01396161|101428432|FG001|COMPLETED|Overall Study||5||
48446257|NCT01396161|101428433|FG002|COMPLETED|Overall Study||9||
48446258|NCT01396161|101428434|FG003|COMPLETED|Overall Study||9||
48658833|NCT01347086|101949040|FG006|COMPLETED|Overall Study||6||
48658834|NCT01347086|101949041|FG007|COMPLETED|Overall Study||6||
48658835|NCT01347086|101949042|FG008|COMPLETED|Overall Study||6||
48658836|NCT01347086|101949043|FG009|COMPLETED|Overall Study||6||
48658837|NCT01347086|101949034|FG000|NOT COMPLETED|Overall Study||0||
48658838|NCT01347086|101949035|FG001|NOT COMPLETED|Overall Study||0||
48658839|NCT01347086|101949036|FG002|NOT COMPLETED|Overall Study||1||
48658840|NCT01347086|101949037|FG003|NOT COMPLETED|Overall Study||0||
48658841|NCT01347086|101949038|FG004|NOT COMPLETED|Overall Study||0||
48658842|NCT01347086|101949039|FG005|NOT COMPLETED|Overall Study||0||
48446259|NCT01396161|101428435|FG004|COMPLETED|Overall Study||8||
48446260|NCT01396161|101428436|FG005|COMPLETED|Overall Study||9||
48446261|NCT01396161|101428437|FG006|COMPLETED|Overall Study||10||
48446262|NCT01396161|101428431|FG000|NOT COMPLETED|Overall Study||0||
48446263|NCT01396161|101428432|FG001|NOT COMPLETED|Overall Study||0||
48446264|NCT01396161|101428433|FG002|NOT COMPLETED|Overall Study||0||
48446265|NCT01396161|101428434|FG003|NOT COMPLETED|Overall Study||0||
48446266|NCT01396161|101428435|FG004|NOT COMPLETED|Overall Study||1||
48446267|NCT01396161|101428436|FG005|NOT COMPLETED|Overall Study||0||
48446268|NCT01396161|101428437|FG006|NOT COMPLETED|Overall Study||1||
48446269|NCT01976663|101428438|FG000|STARTED|Overall Study||126||
48446270|NCT01976663|101428438|FG000|Received Touch-up Treatment|Overall Study||63||
48446271|NCT01976663|101428438|FG000|Received Asymmetry Correction|Overall Study||45||
48446272|NCT01976663|101428438|FG000|Received Repeat Treatment|Overall Study||85||
48446273|NCT01976663|101428438|FG000|COMPLETED|Overall Study||84||
48446274|NCT01976663|101428438|FG000|NOT COMPLETED|Overall Study||42||
48446275|NCT02525562|101428439|FG000|STARTED|Overall Study||223||
48446276|NCT02525562|101428440|FG001|STARTED|Overall Study||0||
48446277|NCT02525562|101428441|FG002|STARTED|Overall Study||0||
48446278|NCT02525562|101428439|FG000|COMPLETED|Overall Study||0||
48446279|NCT02525562|101428440|FG001|COMPLETED|Overall Study||0||
48446280|NCT02525562|101428441|FG002|COMPLETED|Overall Study||0||
48446281|NCT02525562|101428439|FG000|NOT COMPLETED|Overall Study||223||
48446282|NCT02525562|101428440|FG001|NOT COMPLETED|Overall Study||0||
48446283|NCT02525562|101428441|FG002|NOT COMPLETED|Overall Study||0||
48446284|NCT00254488|101428442|FG000|STARTED|Overall Study||112||
48658843|NCT01347086|101949040|FG006|NOT COMPLETED|Overall Study||1||
48658844|NCT01347086|101949041|FG007|NOT COMPLETED|Overall Study||1||
48658845|NCT01347086|101949042|FG008|NOT COMPLETED|Overall Study||0||
48658846|NCT01347086|101949043|FG009|NOT COMPLETED|Overall Study||1||
48446285|NCT00254488|101428443|FG001|STARTED|Overall Study||112||
48446286|NCT00254488|101428442|FG000|COMPLETED|Overall Study||55||
48446287|NCT00254488|101428443|FG001|COMPLETED|Overall Study||63||
48446288|NCT00254488|101428442|FG000|NOT COMPLETED|Overall Study||57||
48446289|NCT00254488|101428443|FG001|NOT COMPLETED|Overall Study||49||
48446290|NCT02163694|101428444|FG000|STARTED|Overall Study||172||
48446291|NCT02163694|101428445|FG001|STARTED|Overall Study||337||
48658847|NCT03255200|101949044|FG000|STARTED|Overall Study||87||
48658848|NCT03255200|101949044|FG000|Implanted|Overall Study||87||
48446292|NCT02163694|101428444|FG000|COMPLETED|Overall Study||18||
48446293|NCT02163694|101428445|FG001|COMPLETED|Overall Study||70||
48446294|NCT02163694|101428444|FG000|NOT COMPLETED|Overall Study||154||
48446295|NCT02163694|101428445|FG001|NOT COMPLETED|Overall Study||267||
48446296|NCT01227954|101428446|FG000|STARTED|Overall Study||113||
48446297|NCT01227954|101428446|FG000|COMPLETED|Overall Study||100||
48446298|NCT01227954|101428446|FG000|NOT COMPLETED|Overall Study||13||
48446299|NCT04440007|101428447|FG000|STARTED|Overall Study||48||
48446300|NCT04440007|101428448|FG001|STARTED|Overall Study||48||
48446301|NCT04440007|101428447|FG000|COMPLETED|Overall Study||36||
48446302|NCT04440007|101428448|FG001|COMPLETED|Overall Study||36||
48446303|NCT04440007|101428447|FG000|NOT COMPLETED|Overall Study||12||
48446304|NCT04440007|101428448|FG001|NOT COMPLETED|Overall Study||12||
48446305|NCT03343054|101428449|FG000|STARTED|Dose Escalation Period (Up to 286 Days)||3||
48446306|NCT03343054|101428450|FG001|STARTED|Dose Escalation Period (Up to 286 Days)||6||
48446307|NCT03343054|101428451|FG002|STARTED|Dose Escalation Period (Up to 286 Days)||0||
48446308|NCT03343054|101428449|FG000|COMPLETED|Dose Escalation Period (Up to 286 Days)||0||
48446309|NCT03343054|101428450|FG001|COMPLETED|Dose Escalation Period (Up to 286 Days)||0||
48446310|NCT03343054|101428451|FG002|COMPLETED|Dose Escalation Period (Up to 286 Days)||0||
48446311|NCT03343054|101428449|FG000|NOT COMPLETED|Dose Escalation Period (Up to 286 Days)||3||
48446312|NCT03343054|101428450|FG001|NOT COMPLETED|Dose Escalation Period (Up to 286 Days)||6||
48446313|NCT03343054|101428451|FG002|NOT COMPLETED|Dose Escalation Period (Up to 286 Days)||0||
48446314|NCT03343054|101428449|FG000|STARTED|Dose Expansion Period (Up to 502 Days)||0||
48446315|NCT03343054|101428450|FG001|STARTED|Dose Expansion Period (Up to 502 Days)||0||
48446316|NCT03343054|101428451|FG002|STARTED|Dose Expansion Period (Up to 502 Days)||19||
48446317|NCT03343054|101428449|FG000|COMPLETED|Dose Expansion Period (Up to 502 Days)||0||
48446318|NCT03343054|101428450|FG001|COMPLETED|Dose Expansion Period (Up to 502 Days)||0||
48446319|NCT03343054|101428451|FG002|COMPLETED|Dose Expansion Period (Up to 502 Days)||0||
48446320|NCT03343054|101428449|FG000|NOT COMPLETED|Dose Expansion Period (Up to 502 Days)||0||
48446321|NCT03343054|101428450|FG001|NOT COMPLETED|Dose Expansion Period (Up to 502 Days)||0||
48446322|NCT03343054|101428451|FG002|NOT COMPLETED|Dose Expansion Period (Up to 502 Days)||19||
48446323|NCT00061945|101428452|FG000|STARTED|Registration Through Course 3||119||
48446324|NCT00061945|101428453|FG001|STARTED|Registration Through Course 3||181||
48446325|NCT00061945|101428452|FG000|COMPLETED|Registration Through Course 3||25||
48446326|NCT00061945|101428453|FG001|COMPLETED|Registration Through Course 3||66||
48446327|NCT00061945|101428452|FG000|NOT COMPLETED|Registration Through Course 3||94||
48446328|NCT00061945|101428453|FG001|NOT COMPLETED|Registration Through Course 3||115||
48446329|NCT00061945|101428452|FG000|STARTED|Course IV: Alemtuzumab||25||
48770527|NCT03537404|102229206|FG001|NOT COMPLETED|Second Washout Period (8 Days)||0||
48770528|NCT03537404|102229205|FG000|STARTED|Third Intervention (A or B or C)||18||
48770529|NCT03537404|102229206|FG001|STARTED|Third Intervention (A or B or C)||18||
48770530|NCT03537404|102229205|FG000|COMPLETED|Third Intervention (A or B or C)||18||
48770531|NCT03537404|102229206|FG001|COMPLETED|Third Intervention (A or B or C)||18||
48770532|NCT03537404|102229205|FG000|NOT COMPLETED|Third Intervention (A or B or C)||0||
48770533|NCT03537404|102229206|FG001|NOT COMPLETED|Third Intervention (A or B or C)||0||
48369117|NCT00430625|101232700|FG000|COMPLETED|Overall Study||13||
48369118|NCT00430625|101232701|FG001|COMPLETED|Overall Study||12||
48369119|NCT00430625|101232700|FG000|NOT COMPLETED|Overall Study||0||
48369120|NCT00430625|101232701|FG001|NOT COMPLETED|Overall Study||0||
48369121|NCT04286867|101232702|FG000|STARTED|Overall Study||32||
48369122|NCT04286867|101232703|FG001|STARTED|Overall Study||32||
48369123|NCT04286867|101232702|FG000|COMPLETED|Overall Study||29||
48369124|NCT04286867|101232703|FG001|COMPLETED|Overall Study||30||
48369125|NCT04286867|101232702|FG000|NOT COMPLETED|Overall Study||3||
48369126|NCT04286867|101232703|FG001|NOT COMPLETED|Overall Study||2||
48369127|NCT04229446|101232704|FG000|STARTED|Overall Study||134||
48369128|NCT04229446|101232705|FG001|STARTED|Overall Study||142||
48369129|NCT04229446|101232704|FG000|COMPLETED|Overall Study||117||
48369130|NCT04229446|101232705|FG001|COMPLETED|Overall Study||124||
48369131|NCT04229446|101232704|FG000|NOT COMPLETED|Overall Study||17||
48369132|NCT04229446|101232705|FG001|NOT COMPLETED|Overall Study||18||
48369133|NCT02429427|101232706|FG000|STARTED|Overall Study||1763||
48369134|NCT02429427|101232707|FG001|STARTED|Overall Study||876||
48369135|NCT02429427|101232706|FG000|COMPLETED|Overall Study||1392||
48369136|NCT02429427|101232707|FG001|COMPLETED|Overall Study||697||
48369137|NCT02429427|101232706|FG000|NOT COMPLETED|Overall Study||371||
48369138|NCT02429427|101232707|FG001|NOT COMPLETED|Overall Study||179||
48369139|NCT02543398|101232708|FG000|STARTED|Overall Study||20||
48369140|NCT02543398|101232709|FG001|STARTED|Overall Study||20||
48369141|NCT02543398|101232708|FG000|COMPLETED|Overall Study||20||
48369142|NCT02543398|101232709|FG001|COMPLETED|Overall Study||20||
48369143|NCT02543398|101232708|FG000|NOT COMPLETED|Overall Study||0||
48369144|NCT02543398|101232709|FG001|NOT COMPLETED|Overall Study||0||
48369145|NCT00833248|101232710|FG000|STARTED|Overall Study||181||
48369146|NCT00833248|101232711|FG001|STARTED|Overall Study||65||
48369147|NCT00833248|101232710|FG000|Full Analysis Set (FAS)|Overall Study||180||
48369148|NCT00833248|101232711|FG001|Full Analysis Set (FAS)|Overall Study||64||
48369149|NCT00833248|101232710|FG000|Per Protocol (PP) Analysis Set|Overall Study||164||
48446330|NCT00061945|101428453|FG001|STARTED|Course IV: Alemtuzumab||66||
48446331|NCT00061945|101428452|FG000|COMPLETED|Course IV: Alemtuzumab||18||
48446332|NCT00061945|101428453|FG001|COMPLETED|Course IV: Alemtuzumab||50||
48446333|NCT00061945|101428452|FG000|NOT COMPLETED|Course IV: Alemtuzumab||7||
48446334|NCT00061945|101428453|FG001|NOT COMPLETED|Course IV: Alemtuzumab||16||
48446335|NCT01932801|101428454|FG000|STARTED|Overall Study||74||
48446336|NCT01932801|101428455|FG001|STARTED|Overall Study||78||
48446337|NCT01932801|101428456|FG002|STARTED|Overall Study||79||
48446338|NCT01932801|101428457|FG003|STARTED|Overall Study||77||
48446339|NCT01932801|101428454|FG000|Week 0 Session|Overall Study||67||
48446340|NCT01932801|101428455|FG001|Week 0 Session|Overall Study||66||
48446341|NCT01932801|101428456|FG002|Week 0 Session|Overall Study||71||
48446342|NCT01932801|101428457|FG003|Week 0 Session|Overall Study||65||
48446343|NCT01932801|101428454|FG000|Week 4 Session|Overall Study||54||
48446344|NCT01932801|101428455|FG001|Week 4 Session|Overall Study||54||
48446345|NCT01932801|101428456|FG002|Week 4 Session|Overall Study||60||
48446346|NCT01932801|101428457|FG003|Week 4 Session|Overall Study||41||
48446347|NCT01932801|101428454|FG000|Week 8 Session|Overall Study||51||
48446348|NCT01932801|101428455|FG001|Week 8 Session|Overall Study||48||
48446349|NCT01932801|101428456|FG002|Week 8 Session|Overall Study||56||
48446350|NCT01932801|101428457|FG003|Week 8 Session|Overall Study||42||
48446351|NCT01932801|101428454|FG000|Week 12 Session|Overall Study||56||
48446352|NCT01932801|101428455|FG001|Week 12 Session|Overall Study||50||
48446353|NCT01932801|101428456|FG002|Week 12 Session|Overall Study||55||
48446354|NCT01932801|101428457|FG003|Week 12 Session|Overall Study||40||
48446355|NCT01932801|101428454|FG000|Week 24 Session|Overall Study||49||
48446356|NCT01932801|101428455|FG001|Week 24 Session|Overall Study||46||
48446357|NCT01932801|101428456|FG002|Week 24 Session|Overall Study||53||
48446358|NCT01932801|101428457|FG003|Week 24 Session|Overall Study||40||
48770534|NCT05038982|102229207|FG000|STARTED|Overall Study||10||
48770535|NCT05038982|102229208|FG001|STARTED|Overall Study||10||
48770536|NCT05038982|102229207|FG000|End of Intervention Period. Week 12: Per Protocol Population|Overall Study||10||
48770537|NCT05038982|102229208|FG001|End of Intervention Period. Week 12: Per Protocol Population|Overall Study||10||
48770538|NCT05038982|102229207|FG000|Follow-up Period (4 Weeks)|Overall Study||10||
48770539|NCT05038982|102229208|FG001|Follow-up Period (4 Weeks)|Overall Study||8||
48770540|NCT05038982|102229207|FG000|COMPLETED|Overall Study||10||
48770541|NCT05038982|102229208|FG001|COMPLETED|Overall Study||8||
48770542|NCT05038982|102229207|FG000|NOT COMPLETED|Overall Study||0||
48770543|NCT05038982|102229208|FG001|NOT COMPLETED|Overall Study||2||
48770544|NCT02224560|102229209|FG000|STARTED|Overall Study||76||
48770545|NCT02224560|102229210|FG001|STARTED|Overall Study||73||
48770546|NCT02224560|102229211|FG002|STARTED|Overall Study||76||
48770547|NCT02224560|102229209|FG000|Safety Analysis Set|Overall Study||82|Received at least 1 dose of IMP; analyzed as per actual treatment received.|
48446359|NCT01932801|101428454|FG000|Week 36 Session|Overall Study||48||
48446360|NCT01932801|101428455|FG001|Week 36 Session|Overall Study||48||
48446361|NCT01932801|101428456|FG002|Week 36 Session|Overall Study||54||
48446362|NCT01932801|101428457|FG003|Week 36 Session|Overall Study||40||
48446363|NCT01932801|101428454|FG000|COMPLETED|Overall Study||48||
48446364|NCT01932801|101428455|FG001|COMPLETED|Overall Study||48||
48446365|NCT01932801|101428456|FG002|COMPLETED|Overall Study||54||
48446366|NCT01932801|101428457|FG003|COMPLETED|Overall Study||40||
48446367|NCT01932801|101428454|FG000|NOT COMPLETED|Overall Study||26||
48770548|NCT02224560|102229210|FG001|Safety Analysis Set|Overall Study||67|Received at least 1 dose of IMP; analyzed as per actual treatment received.|
48770549|NCT02224560|102229211|FG002|Safety Analysis Set|Overall Study||76|Received at least 1 dose of IMP; analyzed as per actual treatment received.|
48446368|NCT01932801|101428455|FG001|NOT COMPLETED|Overall Study||30||
48446369|NCT01932801|101428456|FG002|NOT COMPLETED|Overall Study||25||
48446370|NCT01932801|101428457|FG003|NOT COMPLETED|Overall Study||37||
48446371|NCT00828516|101428458|FG000|STARTED|Clinical Phase: Series 1||35||
48446372|NCT00828516|101428458|FG000|COMPLETED|Clinical Phase: Series 1||33||
48446373|NCT00828516|101428458|FG000|NOT COMPLETED|Clinical Phase: Series 1||2||
48446374|NCT00828516|101428458|FG000|STARTED|Clinical Phase: Series 2||30||
48446375|NCT00828516|101428458|FG000|COMPLETED|Clinical Phase: Series 2||30||
48446376|NCT00828516|101428458|FG000|NOT COMPLETED|Clinical Phase: Series 2||0||
48446377|NCT02773446|101428459|FG000|STARTED|First Admission||7||
48446378|NCT02773446|101428460|FG001|STARTED|First Admission||7||
48446379|NCT02773446|101428461|FG002|STARTED|First Admission||7||
48446380|NCT02773446|101428462|FG003|STARTED|First Admission||7||
48446381|NCT02773446|101428463|FG004|STARTED|First Admission||0||
48446382|NCT02773446|101428464|FG005|STARTED|First Admission||0||
48446383|NCT02773446|101428459|FG000|COMPLETED|First Admission||6||
48446384|NCT02773446|101428460|FG001|COMPLETED|First Admission||7||
48446385|NCT02773446|101428461|FG002|COMPLETED|First Admission||7||
48446386|NCT02773446|101428462|FG003|COMPLETED|First Admission||6||
48446387|NCT02773446|101428463|FG004|COMPLETED|First Admission||0||
48446388|NCT02773446|101428464|FG005|COMPLETED|First Admission||0||
48446389|NCT02773446|101428459|FG000|NOT COMPLETED|First Admission||1||
48446390|NCT02773446|101428460|FG001|NOT COMPLETED|First Admission||0||
48446391|NCT02773446|101428461|FG002|NOT COMPLETED|First Admission||0||
48446392|NCT02773446|101428462|FG003|NOT COMPLETED|First Admission||1||
48446393|NCT02773446|101428463|FG004|NOT COMPLETED|First Admission||0||
48446394|NCT02773446|101428464|FG005|NOT COMPLETED|First Admission||0||
48446395|NCT02773446|101428459|FG000|STARTED|Second Admission||0||
48446396|NCT02773446|101428460|FG001|STARTED|Second Admission||0||
48446397|NCT02773446|101428461|FG002|STARTED|Second Admission||0||
48446398|NCT02773446|101428462|FG003|STARTED|Second Admission||0||
48446399|NCT02773446|101428463|FG004|STARTED|Second Admission||11||
48446400|NCT02773446|101428464|FG005|STARTED|Second Admission||19||
48446401|NCT02773446|101428459|FG000|COMPLETED|Second Admission||0||
48446402|NCT02773446|101428460|FG001|COMPLETED|Second Admission||0||
48446403|NCT02773446|101428461|FG002|COMPLETED|Second Admission||0||
48446404|NCT02773446|101428462|FG003|COMPLETED|Second Admission||0||
48446405|NCT02773446|101428463|FG004|COMPLETED|Second Admission||11||
48446406|NCT02773446|101428464|FG005|COMPLETED|Second Admission||19||
48446407|NCT02773446|101428459|FG000|NOT COMPLETED|Second Admission||0||
48446408|NCT02773446|101428460|FG001|NOT COMPLETED|Second Admission||0||
48446409|NCT02773446|101428461|FG002|NOT COMPLETED|Second Admission||0||
48446410|NCT02773446|101428462|FG003|NOT COMPLETED|Second Admission||0||
48446411|NCT02773446|101428463|FG004|NOT COMPLETED|Second Admission||0||
48446412|NCT02773446|101428464|FG005|NOT COMPLETED|Second Admission||0||
48446413|NCT01456494|101428465|FG000|STARTED|Initial Inpatient Visit||24||
48446414|NCT01456494|101428466|FG001|STARTED|Initial Inpatient Visit||26||
48446415|NCT01456494|101428465|FG000|COMPLETED|Initial Inpatient Visit||24||
48446416|NCT01456494|101428466|FG001|COMPLETED|Initial Inpatient Visit||26||
48446417|NCT01456494|101428465|FG000|NOT COMPLETED|Initial Inpatient Visit||0||
48446418|NCT01456494|101428466|FG001|NOT COMPLETED|Initial Inpatient Visit||0||
48446419|NCT01456494|101428465|FG000|STARTED|Follow-Up Visit (Post 30-day Discharge)||24||
48446420|NCT01456494|101428466|FG001|STARTED|Follow-Up Visit (Post 30-day Discharge)||26||
48446421|NCT01456494|101428465|FG000|COMPLETED|Follow-Up Visit (Post 30-day Discharge)||19||
48446422|NCT01456494|101428466|FG001|COMPLETED|Follow-Up Visit (Post 30-day Discharge)||20||
48446423|NCT01456494|101428465|FG000|NOT COMPLETED|Follow-Up Visit (Post 30-day Discharge)||5||
48446424|NCT01456494|101428466|FG001|NOT COMPLETED|Follow-Up Visit (Post 30-day Discharge)||6||
48446425|NCT02996448|101428467|FG000|STARTED|Overall Study||3||
48446426|NCT02996448|101428467|FG000|COMPLETED|Overall Study||0||
48446427|NCT02996448|101428467|FG000|NOT COMPLETED|Overall Study||3||
48446428|NCT04317053|101428468|FG000|STARTED|Overall Study||126||
48446429|NCT04317053|101428469|FG001|STARTED|Overall Study||127||
48446430|NCT04317053|101428468|FG000|COMPLETED|Overall Study||122||
48446431|NCT04317053|101428469|FG001|COMPLETED|Overall Study||125||
48446432|NCT04317053|101428468|FG000|NOT COMPLETED|Overall Study||4||
48446433|NCT04317053|101428469|FG001|NOT COMPLETED|Overall Study||2||
48446434|NCT01956123|101428470|FG000|STARTED|COS Cycle 2||252||
48446435|NCT01956123|101428471|FG001|STARTED|COS Cycle 2||261||
48446436|NCT01956123|101428472|FG002|STARTED|COS Cycle 2||0||
48446437|NCT01956123|101428473|FG003|STARTED|COS Cycle 2||0||
48446438|NCT01956123|101428470|FG000|COMPLETED|COS Cycle 2||238||
48446439|NCT01956123|101428471|FG001|COMPLETED|COS Cycle 2||254||
48658849|NCT03255200|101949044|FG000|Month 3|Overall Study||85||
48658850|NCT03255200|101949044|FG000|Month 6|Overall Study||85||
48658851|NCT03255200|101949044|FG000|Year 1|Overall Study||80||
48658852|NCT03255200|101949044|FG000|Year 2|Overall Study||74||
48770550|NCT02224560|102229209|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||76|Received at least 1 dose of IMP with at least 1 post-baseline efficacy endpoint measurement.|
48770551|NCT02224560|102229210|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||73|Received at least 1 dose of IMP with at least 1 post-baseline efficacy endpoint measurement.|
48446440|NCT01956123|101428472|FG002|COMPLETED|COS Cycle 2||0||
48446441|NCT01956123|101428473|FG003|COMPLETED|COS Cycle 2||0||
48446442|NCT01956123|101428470|FG000|NOT COMPLETED|COS Cycle 2||14||
48446443|NCT01956123|101428471|FG001|NOT COMPLETED|COS Cycle 2||7||
48446444|NCT01956123|101428472|FG002|NOT COMPLETED|COS Cycle 2||0||
48446445|NCT01956123|101428473|FG003|NOT COMPLETED|COS Cycle 2||0||
48446446|NCT01956123|101428470|FG000|STARTED|COS Cycle 3||0||
48446447|NCT01956123|101428471|FG001|STARTED|COS Cycle 3||0||
48446448|NCT01956123|101428472|FG002|STARTED|COS Cycle 3||95||
48446449|NCT01956123|101428473|FG003|STARTED|COS Cycle 3||93||
48446450|NCT01956123|101428470|FG000|COMPLETED|COS Cycle 3||0||
48446451|NCT01956123|101428471|FG001|COMPLETED|COS Cycle 3||0||
48446452|NCT01956123|101428472|FG002|COMPLETED|COS Cycle 3||89||
48446453|NCT01956123|101428473|FG003|COMPLETED|COS Cycle 3||91||
48446454|NCT01956123|101428470|FG000|NOT COMPLETED|COS Cycle 3||0||
48446455|NCT01956123|101428471|FG001|NOT COMPLETED|COS Cycle 3||0||
48446456|NCT01956123|101428472|FG002|NOT COMPLETED|COS Cycle 3||6||
48446457|NCT01956123|101428473|FG003|NOT COMPLETED|COS Cycle 3||2||
48446458|NCT00665704|101428474|FG000|STARTED|Overall Study||9||
48446459|NCT00665704|101428474|FG000|COMPLETED|Overall Study||9||
48658853|NCT03255200|101949044|FG000|COMPLETED|Overall Study||74||
48658854|NCT03255200|101949044|FG000|NOT COMPLETED|Overall Study||13||
48658855|NCT03063164|101949045|FG000|STARTED|Overall Study||7||7
48658856|NCT03063164|101949046|FG001|STARTED|Overall Study||7||7
48446460|NCT00665704|101428474|FG000|NOT COMPLETED|Overall Study||0||
48446461|NCT04529096|101428475|FG000|STARTED|Overall Study||100||
48446462|NCT04529096|101428476|FG001|STARTED|Overall Study||49||
48658857|NCT03063164|101949045|FG000|COMPLETED|Overall Study||7||7
48770552|NCT02224560|102229211|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||76|Received at least 1 dose of IMP with at least 1 post-baseline efficacy endpoint measurement.|
48770553|NCT02224560|102229209|FG000|COMPLETED|Overall Study||67||
48770554|NCT02224560|102229210|FG001|COMPLETED|Overall Study||71||
48770555|NCT02224560|102229211|FG002|COMPLETED|Overall Study||74||
48770556|NCT02224560|102229209|FG000|NOT COMPLETED|Overall Study||9||
48770557|NCT02224560|102229210|FG001|NOT COMPLETED|Overall Study||2||
48770558|NCT02224560|102229211|FG002|NOT COMPLETED|Overall Study||2||
48770559|NCT00531661|102229212|FG000|STARTED|6 Months||270||
48770560|NCT00531661|102229213|FG001|STARTED|6 Months||280||
48770561|NCT00531661|102229212|FG000|COMPLETED|6 Months||244||
48770562|NCT00531661|102229213|FG001|COMPLETED|6 Months||254||
48770563|NCT00531661|102229212|FG000|NOT COMPLETED|6 Months||26||
48770564|NCT00531661|102229213|FG001|NOT COMPLETED|6 Months||26||
48770565|NCT00531661|102229212|FG000|STARTED|Study Duration: 15 Months Avg. Follow-up||244||
48770566|NCT00531661|102229213|FG001|STARTED|Study Duration: 15 Months Avg. Follow-up||254||
48770567|NCT00531661|102229212|FG000|COMPLETED|Study Duration: 15 Months Avg. Follow-up||186||
48770568|NCT00531661|102229213|FG001|COMPLETED|Study Duration: 15 Months Avg. Follow-up||197||
48770569|NCT00531661|102229212|FG000|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||58||
48770570|NCT00531661|102229213|FG001|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||57||
48770571|NCT00616759|102229214|FG000|STARTED|Overall Study||10||
48770572|NCT00616759|102229215|FG001|STARTED|Overall Study||10||
48770573|NCT00616759|102229214|FG000|COMPLETED|Overall Study||7||
48770574|NCT00616759|102229215|FG001|COMPLETED|Overall Study||8||
48770575|NCT00616759|102229214|FG000|NOT COMPLETED|Overall Study||3||
48770576|NCT00616759|102229215|FG001|NOT COMPLETED|Overall Study||2||
48770577|NCT01523756|102229216|FG000|STARTED|Baseline Period||11||
48770578|NCT01523756|102229217|FG001|STARTED|Baseline Period||9||
48770579|NCT01523756|102229216|FG000|COMPLETED|Baseline Period||11||
48770580|NCT01523756|102229217|FG001|COMPLETED|Baseline Period||8||
48770581|NCT01523756|102229216|FG000|NOT COMPLETED|Baseline Period||0||
48770582|NCT01523756|102229217|FG001|NOT COMPLETED|Baseline Period||1||
48770583|NCT01523756|102229216|FG000|STARTED|Test Period 1||11||
48770584|NCT01523756|102229217|FG001|STARTED|Test Period 1||8||
48446463|NCT04529096|101428475|FG000|Received at Least 1 Dose of Study Drug|Overall Study||100||
48446464|NCT04529096|101428476|FG001|Received at Least 1 Dose of Study Drug|Overall Study||49||
48446465|NCT04529096|101428475|FG000|COMPLETED|Overall Study||86||
48446466|NCT04529096|101428476|FG001|COMPLETED|Overall Study||43||
48446467|NCT04529096|101428475|FG000|NOT COMPLETED|Overall Study||14||
48446468|NCT04529096|101428476|FG001|NOT COMPLETED|Overall Study||6||
48446469|NCT01875991|101428477|FG000|STARTED|Overall Study||108||
48446470|NCT01875991|101428478|FG001|STARTED|Overall Study||109||
48446471|NCT01875991|101428477|FG000|Received Etanercept in Period 1|Overall Study||108||
48446472|NCT01875991|101428478|FG001|Received Etanercept in Period 1|Overall Study||108||
48446473|NCT01875991|101428477|FG000|Received Etanercept in Period 2|Overall Study||102||
48446474|NCT01875991|101428478|FG001|Received Etanercept in Period 2|Overall Study||103||
48446475|NCT01875991|101428477|FG000|COMPLETED|Overall Study||101||
48446476|NCT01875991|101428478|FG001|COMPLETED|Overall Study||103||
48446477|NCT01875991|101428477|FG000|NOT COMPLETED|Overall Study||7||
48446478|NCT01875991|101428478|FG001|NOT COMPLETED|Overall Study||6||
48446479|NCT00683904|101428479|FG000|STARTED|Dose Level 1||6||
48446480|NCT00683904|101428480|FG001|STARTED|Dose Level 1||0||
48446481|NCT00683904|101428479|FG000|COMPLETED|Dose Level 1||3||
48446482|NCT00683904|101428480|FG001|COMPLETED|Dose Level 1||0||
48446483|NCT00683904|101428479|FG000|NOT COMPLETED|Dose Level 1||3||
48446484|NCT00683904|101428480|FG001|NOT COMPLETED|Dose Level 1||0||
48446485|NCT00683904|101428479|FG000|STARTED|Dose Level 2||0||
48446486|NCT00683904|101428480|FG001|STARTED|Dose Level 2||6||
48446487|NCT00683904|101428479|FG000|COMPLETED|Dose Level 2||0||
48446488|NCT00683904|101428480|FG001|COMPLETED|Dose Level 2||4||
48446489|NCT00683904|101428479|FG000|NOT COMPLETED|Dose Level 2||0||
48446490|NCT00683904|101428480|FG001|NOT COMPLETED|Dose Level 2||2||
48446491|NCT01856686|101428481|FG000|STARTED|Overall Study||31||
48446492|NCT01856686|101428482|FG001|STARTED|Overall Study||33||
48446493|NCT01856686|101428481|FG000|COMPLETED|Overall Study||26||
48770585|NCT01523756|102229216|FG000|COMPLETED|Test Period 1||10||
48770586|NCT01523756|102229217|FG001|COMPLETED|Test Period 1||8||
48770587|NCT01523756|102229216|FG000|NOT COMPLETED|Test Period 1||1||
48446494|NCT01856686|101428482|FG001|COMPLETED|Overall Study||22||
48446495|NCT01856686|101428481|FG000|NOT COMPLETED|Overall Study||5||
48446496|NCT01856686|101428482|FG001|NOT COMPLETED|Overall Study||11||
48446497|NCT00965263|101428483|FG000|STARTED|Overall Study||6||
48446498|NCT00965263|101428484|FG001|STARTED|Overall Study||9||
48446499|NCT00965263|101428483|FG000|COMPLETED|Overall Study||4||
48446500|NCT00965263|101428484|FG001|COMPLETED|Overall Study||6||
48446501|NCT00965263|101428483|FG000|NOT COMPLETED|Overall Study||2||
48446502|NCT00965263|101428484|FG001|NOT COMPLETED|Overall Study||3||
48446503|NCT00486642|101428485|FG000|STARTED|Overall Study||10||
48446504|NCT00486642|101428486|FG001|STARTED|Overall Study||13||
48770588|NCT01523756|102229217|FG001|NOT COMPLETED|Test Period 1||0||
48770589|NCT01523756|102229216|FG000|STARTED|Test Period 2||10||
48770590|NCT01523756|102229217|FG001|STARTED|Test Period 2||8||
48446505|NCT00486642|101428485|FG000|COMPLETED|Overall Study||10||
48446506|NCT00486642|101428486|FG001|COMPLETED|Overall Study||13||
48446507|NCT00486642|101428485|FG000|NOT COMPLETED|Overall Study||0||
48446508|NCT00486642|101428486|FG001|NOT COMPLETED|Overall Study||0||
48446509|NCT00337129|101428487|FG000|STARTED|Overall Study||40||
48446510|NCT00337129|101428487|FG000|COMPLETED|Overall Study||0||
48446511|NCT00337129|101428487|FG000|NOT COMPLETED|Overall Study||40||
48446512|NCT03512067|101428488|FG000|STARTED|Overall Study||1||
48446513|NCT03512067|101428488|FG000|COMPLETED|Overall Study||1||
48446514|NCT03512067|101428488|FG000|NOT COMPLETED|Overall Study||0||
48446515|NCT00791154|101428489|FG000|STARTED|Overall Study||6||
48446516|NCT00791154|101428490|FG001|STARTED|Overall Study||8||
48446517|NCT00791154|101428491|FG002|STARTED|Overall Study||6||
48446518|NCT00791154|101428492|FG003|STARTED|Overall Study||8||
48446519|NCT00791154|101428493|FG004|STARTED|Overall Study||62||
48446520|NCT00791154|101428494|FG005|STARTED|Overall Study||62||
48446521|NCT00791154|101428495|FG006|STARTED|Overall Study||61||
48446522|NCT00791154|101428489|FG000|COMPLETED|Overall Study||0||
48446523|NCT00791154|101428490|FG001|COMPLETED|Overall Study||0||
48446524|NCT00791154|101428491|FG002|COMPLETED|Overall Study||0||
48446525|NCT00791154|101428492|FG003|COMPLETED|Overall Study||0||
48446526|NCT00791154|101428493|FG004|COMPLETED|Overall Study||0||
48446527|NCT00791154|101428494|FG005|COMPLETED|Overall Study||0||
48446528|NCT00791154|101428495|FG006|COMPLETED|Overall Study||0||
48446529|NCT00791154|101428489|FG000|NOT COMPLETED|Overall Study||6||
48446530|NCT00791154|101428490|FG001|NOT COMPLETED|Overall Study||8||
48446531|NCT00791154|101428491|FG002|NOT COMPLETED|Overall Study||6||
48446532|NCT00791154|101428492|FG003|NOT COMPLETED|Overall Study||8||
48446533|NCT00791154|101428493|FG004|NOT COMPLETED|Overall Study||62||
48446534|NCT00791154|101428494|FG005|NOT COMPLETED|Overall Study||62||
48446535|NCT00791154|101428495|FG006|NOT COMPLETED|Overall Study||61||
48446536|NCT01441401|101428496|FG000|STARTED|Overall Study||82||
48446537|NCT01441401|101428496|FG000|COMPLETED|Overall Study||82||
48446538|NCT01441401|101428496|FG000|NOT COMPLETED|Overall Study||0||
48446539|NCT01154673|101428497|FG000|STARTED|Overall Study||16||
48446540|NCT01154673|101428498|FG001|STARTED|Overall Study||16||
48446541|NCT01154673|101428497|FG000|COMPLETED|Overall Study||14||
48446542|NCT01154673|101428498|FG001|COMPLETED|Overall Study||16||
48446543|NCT01154673|101428497|FG000|NOT COMPLETED|Overall Study||2||
48446544|NCT01154673|101428498|FG001|NOT COMPLETED|Overall Study||0||
48446545|NCT00116207|101428499|FG000|STARTED|Overall Study||22||
48446546|NCT00116207|101428500|FG001|STARTED|Overall Study||22||
48446547|NCT00116207|101428499|FG000|COMPLETED|Overall Study||13||
48446548|NCT00116207|101428500|FG001|COMPLETED|Overall Study||18||
48446549|NCT00116207|101428499|FG000|NOT COMPLETED|Overall Study||9||
48446550|NCT00116207|101428500|FG001|NOT COMPLETED|Overall Study||4||
48446551|NCT03663205|101428501|FG000|STARTED|Overall Study||223||
48446552|NCT03663205|101428502|FG001|STARTED|Overall Study||111||
48446553|NCT03663205|101428501|FG000|Randomized But Not Treated|Overall Study||1||
48446554|NCT03663205|101428502|FG001|Randomized But Not Treated|Overall Study||1||
48446555|NCT03663205|101428501|FG000|COMPLETED|Overall Study||0||
48446556|NCT03663205|101428502|FG001|COMPLETED|Overall Study||0||
48446557|NCT03663205|101428501|FG000|NOT COMPLETED|Overall Study||223||
48446558|NCT03663205|101428502|FG001|NOT COMPLETED|Overall Study||111||
48446559|NCT04057573|101428503|FG000|STARTED|24-Week Double-Blind Period||229||
48446560|NCT04057573|101428504|FG001|STARTED|24-Week Double-Blind Period||115||
48446561|NCT04057573|101428505|FG002|STARTED|24-Week Double-Blind Period||0||
48770591|NCT01523756|102229216|FG000|COMPLETED|Test Period 2||10||
48446562|NCT04057573|101428506|FG003|STARTED|24-Week Double-Blind Period||0||
48446563|NCT04057573|101428503|FG000|ITT Population|24-Week Double-Blind Period||229||
48446564|NCT04057573|101428504|FG001|ITT Population|24-Week Double-Blind Period||115||
48446565|NCT04057573|101428505|FG002|ITT Population|24-Week Double-Blind Period||0||
48446566|NCT04057573|101428506|FG003|ITT Population|24-Week Double-Blind Period||0||
48446567|NCT04057573|101428503|FG000|ITT Population, Excluding Non-compliant Site|24-Week Double-Blind Period||222||
48446568|NCT04057573|101428504|FG001|ITT Population, Excluding Non-compliant Site|24-Week Double-Blind Period||109||
48446569|NCT04057573|101428505|FG002|ITT Population, Excluding Non-compliant Site|24-Week Double-Blind Period||0||
48446570|NCT04057573|101428506|FG003|ITT Population, Excluding Non-compliant Site|24-Week Double-Blind Period||0||
48446571|NCT04057573|101428503|FG000|COMPLETED|24-Week Double-Blind Period||199||
48446572|NCT04057573|101428504|FG001|COMPLETED|24-Week Double-Blind Period||98||
48446573|NCT04057573|101428505|FG002|COMPLETED|24-Week Double-Blind Period||0||
48446574|NCT04057573|101428506|FG003|COMPLETED|24-Week Double-Blind Period||0||
48446575|NCT04057573|101428503|FG000|NOT COMPLETED|24-Week Double-Blind Period||30||
48446576|NCT04057573|101428504|FG001|NOT COMPLETED|24-Week Double-Blind Period||17||
48446577|NCT04057573|101428505|FG002|NOT COMPLETED|24-Week Double-Blind Period||0||
48446578|NCT04057573|101428506|FG003|NOT COMPLETED|24-Week Double-Blind Period||0||
48446579|NCT04057573|101428503|FG000|STARTED|28-Week Treatment Extension Period||0||
48446580|NCT04057573|101428504|FG001|STARTED|28-Week Treatment Extension Period||0||
48770592|NCT01523756|102229217|FG001|COMPLETED|Test Period 2||7||
48446581|NCT04057573|101428505|FG002|STARTED|28-Week Treatment Extension Period||199||
48446582|NCT04057573|101428506|FG003|STARTED|28-Week Treatment Extension Period||98||
48446583|NCT04057573|101428503|FG000|COMPLETED|28-Week Treatment Extension Period||0||
48446584|NCT04057573|101428504|FG001|COMPLETED|28-Week Treatment Extension Period||0||
48446585|NCT04057573|101428505|FG002|COMPLETED|28-Week Treatment Extension Period||178||
48446586|NCT04057573|101428506|FG003|COMPLETED|28-Week Treatment Extension Period||79||
48446587|NCT04057573|101428503|FG000|NOT COMPLETED|28-Week Treatment Extension Period||0||
48446588|NCT04057573|101428504|FG001|NOT COMPLETED|28-Week Treatment Extension Period||0||
48446589|NCT04057573|101428505|FG002|NOT COMPLETED|28-Week Treatment Extension Period||21||
48446590|NCT04057573|101428506|FG003|NOT COMPLETED|28-Week Treatment Extension Period||19||
48446591|NCT02742818|101428507|FG000|STARTED|Overall Study||25||
48446592|NCT02742818|101428508|FG001|STARTED|Overall Study||25||
48446593|NCT02742818|101428507|FG000|COMPLETED|Overall Study||25||
48446594|NCT02742818|101428508|FG001|COMPLETED|Overall Study||23||
48446595|NCT02742818|101428507|FG000|NOT COMPLETED|Overall Study||0||
48446596|NCT02742818|101428508|FG001|NOT COMPLETED|Overall Study||2||
48446597|NCT03870737|101428509|FG000|STARTED|Overall Study||22||
48446598|NCT03870737|101428509|FG000|COMPLETED|Overall Study||20||
48446599|NCT03870737|101428509|FG000|NOT COMPLETED|Overall Study||2||
48446600|NCT02367729|101428510|FG000|STARTED|Overall Study||60||
48446601|NCT02367729|101428511|FG001|STARTED|Overall Study||55||
48446602|NCT02367729|101428510|FG000|COMPLETED|Overall Study||57||
48446603|NCT02367729|101428511|FG001|COMPLETED|Overall Study||47||
48446604|NCT02367729|101428510|FG000|NOT COMPLETED|Overall Study||3||
48446605|NCT02367729|101428511|FG001|NOT COMPLETED|Overall Study||8||
48446606|NCT01333475|101428512|FG000|STARTED|Overall Study||12||
48446607|NCT01333475|101428513|FG001|STARTED|Overall Study||9||
48446608|NCT01333475|101428512|FG000|COMPLETED|Overall Study||10||
48446609|NCT01333475|101428513|FG001|COMPLETED|Overall Study||6||
48446610|NCT01333475|101428512|FG000|NOT COMPLETED|Overall Study||2||
48446611|NCT01333475|101428513|FG001|NOT COMPLETED|Overall Study||3||
48446612|NCT03120520|101428514|FG000|STARTED|Overall Study||31||
48446613|NCT03120520|101428515|FG001|STARTED|Overall Study||31||
48446614|NCT03120520|101428516|FG002|STARTED|Overall Study||30||
48446615|NCT03120520|101428517|FG003|STARTED|Overall Study||32||
48446616|NCT03120520|101428514|FG000|COMPLETED|Overall Study||27||
48446617|NCT03120520|101428515|FG001|COMPLETED|Overall Study||27||
48446618|NCT03120520|101428516|FG002|COMPLETED|Overall Study||26||
48446619|NCT03120520|101428517|FG003|COMPLETED|Overall Study||29||
48446620|NCT03120520|101428514|FG000|NOT COMPLETED|Overall Study||4||
48446621|NCT03120520|101428515|FG001|NOT COMPLETED|Overall Study||4||
48446622|NCT03120520|101428516|FG002|NOT COMPLETED|Overall Study||4||
48446623|NCT03120520|101428517|FG003|NOT COMPLETED|Overall Study||3||
48446624|NCT01998035|101428518|FG000|STARTED|Phase 1: Dose Level 1||6||
48446625|NCT01998035|101428519|FG001|STARTED|Phase 1: Dose Level 1||0||
48446626|NCT01998035|101428520|FG002|STARTED|Phase 1: Dose Level 1||0||
48770593|NCT01523756|102229216|FG000|NOT COMPLETED|Test Period 2||0||
48770594|NCT01523756|102229217|FG001|NOT COMPLETED|Test Period 2||1||
48770595|NCT02416206|102229218|FG000|STARTED|Overall Study||65||
48446627|NCT01998035|101428521|FG003|STARTED|Phase 1: Dose Level 1||0||
48446628|NCT01998035|101428522|FG004|STARTED|Phase 1: Dose Level 1||0||
48446629|NCT01998035|101428523|FG005|STARTED|Phase 1: Dose Level 1||0||
48446630|NCT01998035|101428524|FG006|STARTED|Phase 1: Dose Level 1||0||
48446631|NCT01998035|101428525|FG007|STARTED|Phase 1: Dose Level 1||0||
48446632|NCT01998035|101428518|FG000|COMPLETED|Phase 1: Dose Level 1||6||
48446633|NCT01998035|101428519|FG001|COMPLETED|Phase 1: Dose Level 1||0||
48446634|NCT01998035|101428520|FG002|COMPLETED|Phase 1: Dose Level 1||0||
48446635|NCT01998035|101428521|FG003|COMPLETED|Phase 1: Dose Level 1||0||
48446636|NCT01998035|101428522|FG004|COMPLETED|Phase 1: Dose Level 1||0||
48446637|NCT01998035|101428523|FG005|COMPLETED|Phase 1: Dose Level 1||0||
48446638|NCT01998035|101428524|FG006|COMPLETED|Phase 1: Dose Level 1||0||
48770596|NCT02416206|102229218|FG000|COMPLETED|Overall Study||65||
48770597|NCT02416206|102229218|FG000|NOT COMPLETED|Overall Study||0||
48770598|NCT03297112|102229219|FG000|STARTED|Overall Study||12||
48770599|NCT03297112|102229219|FG000|COMPLETED|Overall Study||12||
48770600|NCT03297112|102229219|FG000|NOT COMPLETED|Overall Study||0||
48446639|NCT01998035|101428525|FG007|COMPLETED|Phase 1: Dose Level 1||0||
48446640|NCT01998035|101428518|FG000|NOT COMPLETED|Phase 1: Dose Level 1||0||
48446641|NCT01998035|101428519|FG001|NOT COMPLETED|Phase 1: Dose Level 1||0||
48446642|NCT01998035|101428520|FG002|NOT COMPLETED|Phase 1: Dose Level 1||0||
48770601|NCT02180100|102229220|FG000|STARTED|Overall Study||70||
48770602|NCT02180100|102229221|FG001|STARTED|Overall Study||70||
48770603|NCT02180100|102229220|FG000|COMPLETED|Overall Study||58||
48770604|NCT02180100|102229221|FG001|COMPLETED|Overall Study||66||
48770605|NCT02180100|102229220|FG000|NOT COMPLETED|Overall Study||12||
48770606|NCT02180100|102229221|FG001|NOT COMPLETED|Overall Study||4||
48770607|NCT04016623|102229222|FG000|STARTED|Pair 1 Test / Control Dispense||10||20
48446643|NCT01998035|101428521|FG003|NOT COMPLETED|Phase 1: Dose Level 1||0||
48446644|NCT01998035|101428522|FG004|NOT COMPLETED|Phase 1: Dose Level 1||0||
48446645|NCT01998035|101428523|FG005|NOT COMPLETED|Phase 1: Dose Level 1||0||
48446646|NCT01998035|101428524|FG006|NOT COMPLETED|Phase 1: Dose Level 1||0||
48446647|NCT01998035|101428525|FG007|NOT COMPLETED|Phase 1: Dose Level 1||0||
48446648|NCT01998035|101428518|FG000|STARTED|Phase 1: Dose Level 2||0||
48446649|NCT01998035|101428519|FG001|STARTED|Phase 1: Dose Level 2||3||
48446650|NCT01998035|101428520|FG002|STARTED|Phase 1: Dose Level 2||0||
48446651|NCT01998035|101428521|FG003|STARTED|Phase 1: Dose Level 2||0||
48446652|NCT01998035|101428522|FG004|STARTED|Phase 1: Dose Level 2||0||
48446653|NCT01998035|101428523|FG005|STARTED|Phase 1: Dose Level 2||0||
48446654|NCT01998035|101428524|FG006|STARTED|Phase 1: Dose Level 2||0||
48446655|NCT01998035|101428525|FG007|STARTED|Phase 1: Dose Level 2||0||
48446656|NCT01998035|101428518|FG000|COMPLETED|Phase 1: Dose Level 2||0||
48446657|NCT01998035|101428519|FG001|COMPLETED|Phase 1: Dose Level 2||3||
48446658|NCT01998035|101428520|FG002|COMPLETED|Phase 1: Dose Level 2||0||
48446659|NCT01998035|101428521|FG003|COMPLETED|Phase 1: Dose Level 2||0||
48446660|NCT01998035|101428522|FG004|COMPLETED|Phase 1: Dose Level 2||0||
48446661|NCT01998035|101428523|FG005|COMPLETED|Phase 1: Dose Level 2||0||
48446662|NCT01998035|101428524|FG006|COMPLETED|Phase 1: Dose Level 2||0||
48446663|NCT01998035|101428525|FG007|COMPLETED|Phase 1: Dose Level 2||0||
48446664|NCT01998035|101428518|FG000|NOT COMPLETED|Phase 1: Dose Level 2||0||
48446665|NCT01998035|101428519|FG001|NOT COMPLETED|Phase 1: Dose Level 2||0||
48446666|NCT01998035|101428520|FG002|NOT COMPLETED|Phase 1: Dose Level 2||0||
48446667|NCT01998035|101428521|FG003|NOT COMPLETED|Phase 1: Dose Level 2||0||
48446668|NCT01998035|101428522|FG004|NOT COMPLETED|Phase 1: Dose Level 2||0||
48770608|NCT04016623|102229222|FG000|COMPLETED|Pair 1 Test / Control Dispense||10||20
48770609|NCT04016623|102229222|FG000|NOT COMPLETED|Pair 1 Test / Control Dispense||0||0
48770610|NCT04016623|102229222|FG000|STARTED|Pair 1 Test /Control Follow up||10||20
48770611|NCT04016623|102229222|FG000|COMPLETED|Pair 1 Test /Control Follow up||10||20
48770612|NCT04016623|102229222|FG000|NOT COMPLETED|Pair 1 Test /Control Follow up||0||0
48770613|NCT04016623|102229222|FG000|STARTED|Pair 2 Test / Control Dispense||10||20
48770614|NCT04016623|102229222|FG000|COMPLETED|Pair 2 Test / Control Dispense||10||20
48770615|NCT04016623|102229222|FG000|NOT COMPLETED|Pair 2 Test / Control Dispense||0||0
48770616|NCT04016623|102229222|FG000|STARTED|Pair 2 Test /Control Follow up||10||20
48770617|NCT04016623|102229222|FG000|COMPLETED|Pair 2 Test /Control Follow up||10||20
48770618|NCT04016623|102229222|FG000|NOT COMPLETED|Pair 2 Test /Control Follow up||0||0
48770619|NCT04016623|102229222|FG000|STARTED|Pair 3 Test / Control Dispense||10||20
48446669|NCT01998035|101428523|FG005|NOT COMPLETED|Phase 1: Dose Level 2||0||
48446670|NCT01998035|101428524|FG006|NOT COMPLETED|Phase 1: Dose Level 2||0||
48770620|NCT04016623|102229222|FG000|COMPLETED|Pair 3 Test / Control Dispense||10||20
48770621|NCT04016623|102229222|FG000|NOT COMPLETED|Pair 3 Test / Control Dispense||0||0
48770622|NCT04016623|102229222|FG000|STARTED|Pair 3 Test /Control Follow up||10||20
48189062|NCT01169519|100786148|FG000|COMPLETED|Overall Study||21||
48446671|NCT01998035|101428525|FG007|NOT COMPLETED|Phase 1: Dose Level 2||0||
48446672|NCT01998035|101428518|FG000|STARTED|Phase 1: Dose Level 3||0||
48446673|NCT01998035|101428519|FG001|STARTED|Phase 1: Dose Level 3||0||
48446674|NCT01998035|101428520|FG002|STARTED|Phase 1: Dose Level 3||3||
48446675|NCT01998035|101428521|FG003|STARTED|Phase 1: Dose Level 3||0||
48446676|NCT01998035|101428522|FG004|STARTED|Phase 1: Dose Level 3||0||
48446677|NCT01998035|101428523|FG005|STARTED|Phase 1: Dose Level 3||0||
48446678|NCT01998035|101428524|FG006|STARTED|Phase 1: Dose Level 3||0||
48446679|NCT01998035|101428525|FG007|STARTED|Phase 1: Dose Level 3||0||
48446680|NCT01998035|101428518|FG000|COMPLETED|Phase 1: Dose Level 3||0||
48446681|NCT01998035|101428519|FG001|COMPLETED|Phase 1: Dose Level 3||0||
48446682|NCT01998035|101428520|FG002|COMPLETED|Phase 1: Dose Level 3||3||
48446683|NCT01998035|101428521|FG003|COMPLETED|Phase 1: Dose Level 3||0||
48446684|NCT01998035|101428522|FG004|COMPLETED|Phase 1: Dose Level 3||0||
48446685|NCT01998035|101428523|FG005|COMPLETED|Phase 1: Dose Level 3||0||
48446686|NCT01998035|101428524|FG006|COMPLETED|Phase 1: Dose Level 3||0||
48446687|NCT01998035|101428525|FG007|COMPLETED|Phase 1: Dose Level 3||0||
48446688|NCT01998035|101428518|FG000|NOT COMPLETED|Phase 1: Dose Level 3||0||
48446689|NCT01998035|101428519|FG001|NOT COMPLETED|Phase 1: Dose Level 3||0||
48446690|NCT01998035|101428520|FG002|NOT COMPLETED|Phase 1: Dose Level 3||0||
48446691|NCT01998035|101428521|FG003|NOT COMPLETED|Phase 1: Dose Level 3||0||
48770623|NCT04016623|102229222|FG000|COMPLETED|Pair 3 Test /Control Follow up||10||20
48770624|NCT04016623|102229222|FG000|NOT COMPLETED|Pair 3 Test /Control Follow up||0||0
48770625|NCT04016623|102229222|FG000|STARTED|Pair 4 Test / Control Dispense||10||20
48770626|NCT04016623|102229222|FG000|COMPLETED|Pair 4 Test / Control Dispense||10||20
48770627|NCT04016623|102229222|FG000|NOT COMPLETED|Pair 4 Test / Control Dispense||0||0
48770628|NCT04016623|102229222|FG000|STARTED|Pair 4 Test /Control Follow up||10||20
48770629|NCT04016623|102229222|FG000|COMPLETED|Pair 4 Test /Control Follow up||10||20
48770630|NCT04016623|102229222|FG000|NOT COMPLETED|Pair 4 Test /Control Follow up||0||0
48770631|NCT00071058|102229223|FG000|STARTED|Overall Study||50||
48658858|NCT03063164|101949046|FG001|COMPLETED|Overall Study||7||7
48658859|NCT03063164|101949045|FG000|NOT COMPLETED|Overall Study||0||0
48658860|NCT03063164|101949046|FG001|NOT COMPLETED|Overall Study||0||0
48658861|NCT02094885|101949047|FG000|STARTED|Overall Study||125||
48658862|NCT02094885|101949048|FG001|STARTED|Overall Study||127||
48658863|NCT02094885|101949047|FG000|COMPLETED|Overall Study||123||
48658864|NCT02094885|101949048|FG001|COMPLETED|Overall Study||122||
48658865|NCT02094885|101949047|FG000|NOT COMPLETED|Overall Study||2||
48658866|NCT02094885|101949048|FG001|NOT COMPLETED|Overall Study||5||
48658867|NCT04535362|101949049|FG000|STARTED|Overall Study||8||
48658868|NCT04535362|101949050|FG001|STARTED|Overall Study||8||
48658869|NCT04535362|101949049|FG000|Entered Phase 1|Overall Study||8||
48658870|NCT04535362|101949050|FG001|Entered Phase 1|Overall Study||8||
48658871|NCT04535362|101949049|FG000|Completed Phase 1|Overall Study||8||
48658872|NCT04535362|101949050|FG001|Completed Phase 1|Overall Study||8||
48658873|NCT04535362|101949049|FG000|Entered Phase 2|Overall Study||8||
48658874|NCT04535362|101949050|FG001|Entered Phase 2|Overall Study||8||
48658875|NCT04535362|101949049|FG000|Completed Phase 2|Overall Study||5||
48658876|NCT04535362|101949050|FG001|Completed Phase 2|Overall Study||7||
48658877|NCT04535362|101949049|FG000|COMPLETED|Overall Study||5||
48658878|NCT04535362|101949050|FG001|COMPLETED|Overall Study||7||
48658879|NCT04535362|101949049|FG000|NOT COMPLETED|Overall Study||3||
48658880|NCT04535362|101949050|FG001|NOT COMPLETED|Overall Study||1||
48658881|NCT01013870|101949051|FG000|STARTED|Overall Study||28||
48658882|NCT01013870|101949052|FG001|STARTED|Overall Study||24||
48658883|NCT01013870|101949051|FG000|COMPLETED|Overall Study||27||
48658884|NCT01013870|101949052|FG001|COMPLETED|Overall Study||21||
48658885|NCT01013870|101949051|FG000|NOT COMPLETED|Overall Study||1||
48658886|NCT01013870|101949052|FG001|NOT COMPLETED|Overall Study||3||
48658887|NCT00088881|101949053|FG000|STARTED|Step 1 - R-CHOP||62||
48658888|NCT00088881|101949053|FG000|Eligible and Treated|Step 1 - R-CHOP||53||
48658889|NCT00088881|101949053|FG000|COMPLETED|Step 1 - R-CHOP||48||
48658890|NCT00088881|101949053|FG000|NOT COMPLETED|Step 1 - R-CHOP||14||
48658891|NCT00088881|101949053|FG000|STARTED|Step 2 - Zevalin™ Radioimmunotherapy||56||
48658892|NCT00088881|101949053|FG000|Eligible and Treated|Step 2 - Zevalin™ Radioimmunotherapy||48||
48658893|NCT00088881|101949053|FG000|COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||45||
48658894|NCT00088881|101949053|FG000|NOT COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||11||
48658895|NCT00088881|101949053|FG000|STARTED|Step 3 - Radiation Therapy||1||
48658896|NCT00088881|101949053|FG000|COMPLETED|Step 3 - Radiation Therapy||1||
48658897|NCT00088881|101949053|FG000|NOT COMPLETED|Step 3 - Radiation Therapy||0||
48658898|NCT00742157|101949054|FG000|STARTED|Overall Study||5||
48658899|NCT00742157|101949054|FG000|COMPLETED|Overall Study||5||
48658900|NCT00742157|101949054|FG000|NOT COMPLETED|Overall Study||0||
48658901|NCT00215657|101949055|FG000|STARTED|Overall Study||26||
48658902|NCT00215657|101949056|FG001|STARTED|Overall Study||12||
48658903|NCT00215657|101949057|FG002|STARTED|Overall Study||13||
48658904|NCT00215657|101949058|FG003|STARTED|Overall Study||24||
48658905|NCT00215657|101949059|FG004|STARTED|Overall Study||27||
48658906|NCT00215657|101949060|FG005|STARTED|Overall Study||24||
48658907|NCT00215657|101949061|FG006|STARTED|Overall Study||27||
48658908|NCT00215657|101949062|FG007|STARTED|Overall Study||27||
48658909|NCT00215657|101949055|FG000|Intention-to-treat Population|Overall Study||25||
48658910|NCT00215657|101949056|FG001|Intention-to-treat Population|Overall Study||12||
48658911|NCT00215657|101949057|FG002|Intention-to-treat Population|Overall Study||12||
48658912|NCT00215657|101949058|FG003|Intention-to-treat Population|Overall Study||24||
48658913|NCT00215657|101949059|FG004|Intention-to-treat Population|Overall Study||24||
48658914|NCT00215657|101949060|FG005|Intention-to-treat Population|Overall Study||24||
48658915|NCT00215657|101949061|FG006|Intention-to-treat Population|Overall Study||24||
48658916|NCT00215657|101949062|FG007|Intention-to-treat Population|Overall Study||27||
48658917|NCT00215657|101949055|FG000|Started FE200486 CS07A|Overall Study||20||
48658918|NCT00215657|101949056|FG001|Started FE200486 CS07A|Overall Study||6||
48658919|NCT00215657|101949057|FG002|Started FE200486 CS07A|Overall Study||7||
48658920|NCT00215657|101949058|FG003|Started FE200486 CS07A|Overall Study||24||
48658921|NCT00215657|101949059|FG004|Started FE200486 CS07A|Overall Study||17||
48658922|NCT00215657|101949060|FG005|Started FE200486 CS07A|Overall Study||20||
48658923|NCT00215657|101949061|FG006|Started FE200486 CS07A|Overall Study||14||
48658924|NCT00215657|101949062|FG007|Started FE200486 CS07A|Overall Study||23||
48658925|NCT00215657|101949055|FG000|COMPLETED|Overall Study||4||
48658926|NCT00215657|101949056|FG001|COMPLETED|Overall Study||1||
48658927|NCT00215657|101949057|FG002|COMPLETED|Overall Study||2||
48658928|NCT00215657|101949058|FG003|COMPLETED|Overall Study||6||
48658929|NCT00215657|101949059|FG004|COMPLETED|Overall Study||4||
48658930|NCT00215657|101949060|FG005|COMPLETED|Overall Study||4||
48658931|NCT00215657|101949061|FG006|COMPLETED|Overall Study||4||
48658932|NCT00215657|101949062|FG007|COMPLETED|Overall Study||11||
48658933|NCT00215657|101949055|FG000|NOT COMPLETED|Overall Study||22||
48658934|NCT00215657|101949056|FG001|NOT COMPLETED|Overall Study||11||
48658935|NCT00215657|101949057|FG002|NOT COMPLETED|Overall Study||11||
48446692|NCT01998035|101428522|FG004|NOT COMPLETED|Phase 1: Dose Level 3||0||
48446693|NCT01998035|101428523|FG005|NOT COMPLETED|Phase 1: Dose Level 3||0||
48446694|NCT01998035|101428524|FG006|NOT COMPLETED|Phase 1: Dose Level 3||0||
48446695|NCT01998035|101428525|FG007|NOT COMPLETED|Phase 1: Dose Level 3||0||
48446696|NCT01998035|101428518|FG000|STARTED|Phase 1: Dose Level 4||0||
48446697|NCT01998035|101428519|FG001|STARTED|Phase 1: Dose Level 4||0||
48446698|NCT01998035|101428520|FG002|STARTED|Phase 1: Dose Level 4||0||
48446699|NCT01998035|101428521|FG003|STARTED|Phase 1: Dose Level 4||3||
48446700|NCT01998035|101428522|FG004|STARTED|Phase 1: Dose Level 4||0||
48770632|NCT00071058|102229223|FG000|COMPLETED|Overall Study||49||
48770633|NCT00071058|102229223|FG000|NOT COMPLETED|Overall Study||1||
48369150|NCT00833248|101232711|FG001|Per Protocol (PP) Analysis Set|Overall Study||57||
48446701|NCT01998035|101428523|FG005|STARTED|Phase 1: Dose Level 4||0||
48446702|NCT01998035|101428524|FG006|STARTED|Phase 1: Dose Level 4||0||
48446703|NCT01998035|101428525|FG007|STARTED|Phase 1: Dose Level 4||0||
48446704|NCT01998035|101428518|FG000|COMPLETED|Phase 1: Dose Level 4||0||
48446705|NCT01998035|101428519|FG001|COMPLETED|Phase 1: Dose Level 4||0||
48446706|NCT01998035|101428520|FG002|COMPLETED|Phase 1: Dose Level 4||0||
48446707|NCT01998035|101428521|FG003|COMPLETED|Phase 1: Dose Level 4||3||
48446708|NCT01998035|101428522|FG004|COMPLETED|Phase 1: Dose Level 4||0||
48446709|NCT01998035|101428523|FG005|COMPLETED|Phase 1: Dose Level 4||0||
48446710|NCT01998035|101428524|FG006|COMPLETED|Phase 1: Dose Level 4||0||
48446711|NCT01998035|101428525|FG007|COMPLETED|Phase 1: Dose Level 4||0||
48369151|NCT00833248|101232710|FG000|Safety Analysis Set|Overall Study||181||
48369152|NCT00833248|101232711|FG001|Safety Analysis Set|Overall Study||64||
48369153|NCT00833248|101232710|FG000|COMPLETED|Overall Study||177||
48369154|NCT00833248|101232711|FG001|COMPLETED|Overall Study||62||
48369155|NCT00833248|101232710|FG000|NOT COMPLETED|Overall Study||4||
48369156|NCT00833248|101232711|FG001|NOT COMPLETED|Overall Study||3||
48446712|NCT01998035|101428518|FG000|NOT COMPLETED|Phase 1: Dose Level 4||0||
48446713|NCT01998035|101428519|FG001|NOT COMPLETED|Phase 1: Dose Level 4||0||
48446714|NCT01998035|101428520|FG002|NOT COMPLETED|Phase 1: Dose Level 4||0||
48446715|NCT01998035|101428521|FG003|NOT COMPLETED|Phase 1: Dose Level 4||0||
48446716|NCT01998035|101428522|FG004|NOT COMPLETED|Phase 1: Dose Level 4||0||
48446717|NCT01998035|101428523|FG005|NOT COMPLETED|Phase 1: Dose Level 4||0||
48446718|NCT01998035|101428524|FG006|NOT COMPLETED|Phase 1: Dose Level 4||0||
48446719|NCT01998035|101428525|FG007|NOT COMPLETED|Phase 1: Dose Level 4||0||
48446720|NCT01998035|101428518|FG000|STARTED|Phase 1: Dose Level 5||0||
48446721|NCT01998035|101428519|FG001|STARTED|Phase 1: Dose Level 5||0||
48446722|NCT01998035|101428520|FG002|STARTED|Phase 1: Dose Level 5||0||
48446723|NCT01998035|101428521|FG003|STARTED|Phase 1: Dose Level 5||0||
48446724|NCT01998035|101428522|FG004|STARTED|Phase 1: Dose Level 5||3||
48446725|NCT01998035|101428523|FG005|STARTED|Phase 1: Dose Level 5||0||
48446726|NCT01998035|101428524|FG006|STARTED|Phase 1: Dose Level 5||0||
48446727|NCT01998035|101428525|FG007|STARTED|Phase 1: Dose Level 5||0||
48446728|NCT01998035|101428518|FG000|COMPLETED|Phase 1: Dose Level 5||0||
48446729|NCT01998035|101428519|FG001|COMPLETED|Phase 1: Dose Level 5||0||
48446730|NCT01998035|101428520|FG002|COMPLETED|Phase 1: Dose Level 5||0||
48446731|NCT01998035|101428521|FG003|COMPLETED|Phase 1: Dose Level 5||0||
48446732|NCT01998035|101428522|FG004|COMPLETED|Phase 1: Dose Level 5||3||
48446733|NCT01998035|101428523|FG005|COMPLETED|Phase 1: Dose Level 5||0||
48446734|NCT01998035|101428524|FG006|COMPLETED|Phase 1: Dose Level 5||0||
48446735|NCT01998035|101428525|FG007|COMPLETED|Phase 1: Dose Level 5||0||
48446736|NCT01998035|101428518|FG000|NOT COMPLETED|Phase 1: Dose Level 5||0||
48446737|NCT01998035|101428519|FG001|NOT COMPLETED|Phase 1: Dose Level 5||0||
48446738|NCT01998035|101428520|FG002|NOT COMPLETED|Phase 1: Dose Level 5||0||
48446739|NCT01998035|101428521|FG003|NOT COMPLETED|Phase 1: Dose Level 5||0||
48446740|NCT01998035|101428522|FG004|NOT COMPLETED|Phase 1: Dose Level 5||0||
48446741|NCT01998035|101428523|FG005|NOT COMPLETED|Phase 1: Dose Level 5||0||
48446742|NCT01998035|101428524|FG006|NOT COMPLETED|Phase 1: Dose Level 5||0||
48446743|NCT01998035|101428525|FG007|NOT COMPLETED|Phase 1: Dose Level 5||0||
48446744|NCT01998035|101428518|FG000|STARTED|Phase 1: Dose Level 6||0||
48446745|NCT01998035|101428519|FG001|STARTED|Phase 1: Dose Level 6||0||
48446746|NCT01998035|101428520|FG002|STARTED|Phase 1: Dose Level 6||0||
48446747|NCT01998035|101428521|FG003|STARTED|Phase 1: Dose Level 6||0||
48446748|NCT01998035|101428522|FG004|STARTED|Phase 1: Dose Level 6||0||
48446749|NCT01998035|101428523|FG005|STARTED|Phase 1: Dose Level 6||3||
48369157|NCT00844428|101232712|FG000|STARTED|Screening Period||23||
48369158|NCT00844428|101232712|FG000|COMPLETED|Screening Period||20||
48770634|NCT04987333|102229224|FG000|STARTED|Overall Study||8||
48770635|NCT04987333|102229225|FG001|STARTED|Overall Study||8||
48770636|NCT04987333|102229226|FG002|STARTED|Overall Study||8||
48369159|NCT00844428|101232712|FG000|NOT COMPLETED|Screening Period||3||
48770637|NCT04987333|102229227|FG003|STARTED|Overall Study||8||
48770638|NCT04987333|102229224|FG000|COMPLETED|Overall Study||8||
48770639|NCT04987333|102229225|FG001|COMPLETED|Overall Study||8||
48770640|NCT04987333|102229226|FG002|COMPLETED|Overall Study||8||
48770641|NCT04987333|102229227|FG003|COMPLETED|Overall Study||8||
48446750|NCT01998035|101428524|FG006|STARTED|Phase 1: Dose Level 6||0||
48446751|NCT01998035|101428525|FG007|STARTED|Phase 1: Dose Level 6||0||
48446752|NCT01998035|101428518|FG000|COMPLETED|Phase 1: Dose Level 6||0||
48446753|NCT01998035|101428519|FG001|COMPLETED|Phase 1: Dose Level 6||0||
48446754|NCT01998035|101428520|FG002|COMPLETED|Phase 1: Dose Level 6||0||
48446755|NCT01998035|101428521|FG003|COMPLETED|Phase 1: Dose Level 6||0||
48446756|NCT01998035|101428522|FG004|COMPLETED|Phase 1: Dose Level 6||0||
48446757|NCT01998035|101428523|FG005|COMPLETED|Phase 1: Dose Level 6||3||
48446758|NCT01998035|101428524|FG006|COMPLETED|Phase 1: Dose Level 6||0||
48446759|NCT01998035|101428525|FG007|COMPLETED|Phase 1: Dose Level 6||0||
48446760|NCT01998035|101428518|FG000|NOT COMPLETED|Phase 1: Dose Level 6||0||
48446761|NCT01998035|101428519|FG001|NOT COMPLETED|Phase 1: Dose Level 6||0||
48446762|NCT01998035|101428520|FG002|NOT COMPLETED|Phase 1: Dose Level 6||0||
48446763|NCT01998035|101428521|FG003|NOT COMPLETED|Phase 1: Dose Level 6||0||
48446764|NCT01998035|101428522|FG004|NOT COMPLETED|Phase 1: Dose Level 6||0||
48446765|NCT01998035|101428523|FG005|NOT COMPLETED|Phase 1: Dose Level 6||0||
48446766|NCT01998035|101428524|FG006|NOT COMPLETED|Phase 1: Dose Level 6||0||
48446767|NCT01998035|101428525|FG007|NOT COMPLETED|Phase 1: Dose Level 6||0||
48446768|NCT01998035|101428518|FG000|STARTED|Phase 1: Dose Level 6 (Expanded Cohort)||0||
48446769|NCT01998035|101428519|FG001|STARTED|Phase 1: Dose Level 6 (Expanded Cohort)||0||
48446770|NCT01998035|101428520|FG002|STARTED|Phase 1: Dose Level 6 (Expanded Cohort)||0||
48446771|NCT01998035|101428521|FG003|STARTED|Phase 1: Dose Level 6 (Expanded Cohort)||0||
48446772|NCT01998035|101428522|FG004|STARTED|Phase 1: Dose Level 6 (Expanded Cohort)||0||
48446773|NCT01998035|101428523|FG005|STARTED|Phase 1: Dose Level 6 (Expanded Cohort)||0||
48446774|NCT01998035|101428524|FG006|STARTED|Phase 1: Dose Level 6 (Expanded Cohort)||5||
48446775|NCT01998035|101428525|FG007|STARTED|Phase 1: Dose Level 6 (Expanded Cohort)||0||
48446776|NCT01998035|101428518|FG000|COMPLETED|Phase 1: Dose Level 6 (Expanded Cohort)||0||
48446777|NCT01998035|101428519|FG001|COMPLETED|Phase 1: Dose Level 6 (Expanded Cohort)||0||
48446778|NCT01998035|101428520|FG002|COMPLETED|Phase 1: Dose Level 6 (Expanded Cohort)||0||
48446779|NCT01998035|101428521|FG003|COMPLETED|Phase 1: Dose Level 6 (Expanded Cohort)||0||
48770642|NCT04987333|102229224|FG000|NOT COMPLETED|Overall Study||0||
48770643|NCT04987333|102229225|FG001|NOT COMPLETED|Overall Study||0||
48446780|NCT01998035|101428522|FG004|COMPLETED|Phase 1: Dose Level 6 (Expanded Cohort)||0||
48446781|NCT01998035|101428523|FG005|COMPLETED|Phase 1: Dose Level 6 (Expanded Cohort)||0||
48446782|NCT01998035|101428524|FG006|COMPLETED|Phase 1: Dose Level 6 (Expanded Cohort)||5||
48446783|NCT01998035|101428525|FG007|COMPLETED|Phase 1: Dose Level 6 (Expanded Cohort)||0||
48446784|NCT01998035|101428518|FG000|NOT COMPLETED|Phase 1: Dose Level 6 (Expanded Cohort)||0||
48446785|NCT01998035|101428519|FG001|NOT COMPLETED|Phase 1: Dose Level 6 (Expanded Cohort)||0||
48446786|NCT01998035|101428520|FG002|NOT COMPLETED|Phase 1: Dose Level 6 (Expanded Cohort)||0||
48446787|NCT01998035|101428521|FG003|NOT COMPLETED|Phase 1: Dose Level 6 (Expanded Cohort)||0||
48446788|NCT01998035|101428522|FG004|NOT COMPLETED|Phase 1: Dose Level 6 (Expanded Cohort)||0||
48446789|NCT01998035|101428523|FG005|NOT COMPLETED|Phase 1: Dose Level 6 (Expanded Cohort)||0||
48446790|NCT01998035|101428524|FG006|NOT COMPLETED|Phase 1: Dose Level 6 (Expanded Cohort)||0||
48446791|NCT01998035|101428525|FG007|NOT COMPLETED|Phase 1: Dose Level 6 (Expanded Cohort)||0||
48446792|NCT01998035|101428518|FG000|STARTED|Phase 2: MTD||0||
48446793|NCT01998035|101428519|FG001|STARTED|Phase 2: MTD||0||
48446794|NCT01998035|101428520|FG002|STARTED|Phase 2: MTD||0||
48446795|NCT01998035|101428521|FG003|STARTED|Phase 2: MTD||0||
48446796|NCT01998035|101428522|FG004|STARTED|Phase 2: MTD||0||
48446797|NCT01998035|101428523|FG005|STARTED|Phase 2: MTD||0||
48446798|NCT01998035|101428524|FG006|STARTED|Phase 2: MTD||0||
48446799|NCT01998035|101428525|FG007|STARTED|Phase 2: MTD||25||
48446800|NCT01998035|101428518|FG000|COMPLETED|Phase 2: MTD||0||
48446801|NCT01998035|101428519|FG001|COMPLETED|Phase 2: MTD||0||
48446802|NCT01998035|101428520|FG002|COMPLETED|Phase 2: MTD||0||
48446803|NCT01998035|101428521|FG003|COMPLETED|Phase 2: MTD||0||
48446804|NCT01998035|101428522|FG004|COMPLETED|Phase 2: MTD||0||
48446805|NCT01998035|101428523|FG005|COMPLETED|Phase 2: MTD||0||
48658936|NCT00215657|101949058|FG003|NOT COMPLETED|Overall Study||18||
48446806|NCT01998035|101428524|FG006|COMPLETED|Phase 2: MTD||0||
48446807|NCT01998035|101428525|FG007|COMPLETED|Phase 2: MTD||25||
48446808|NCT01998035|101428518|FG000|NOT COMPLETED|Phase 2: MTD||0||
48446809|NCT01998035|101428519|FG001|NOT COMPLETED|Phase 2: MTD||0||
48446810|NCT01998035|101428520|FG002|NOT COMPLETED|Phase 2: MTD||0||
48446811|NCT01998035|101428521|FG003|NOT COMPLETED|Phase 2: MTD||0||
48446812|NCT01998035|101428522|FG004|NOT COMPLETED|Phase 2: MTD||0||
48446813|NCT01998035|101428523|FG005|NOT COMPLETED|Phase 2: MTD||0||
48770644|NCT04987333|102229226|FG002|NOT COMPLETED|Overall Study||0||
48770645|NCT04987333|102229227|FG003|NOT COMPLETED|Overall Study||0||
48770646|NCT00286468|102229228|FG000|STARTED|Overall Study||99||
48770647|NCT00286468|102229229|FG001|STARTED|Overall Study||203||
48770648|NCT00286468|102229230|FG002|STARTED|Overall Study||198||
48770649|NCT00286468|102229228|FG000|COMPLETED|Overall Study||62||
48770650|NCT00286468|102229229|FG001|COMPLETED|Overall Study||153||
48446814|NCT01998035|101428524|FG006|NOT COMPLETED|Phase 2: MTD||0||
48446815|NCT01998035|101428525|FG007|NOT COMPLETED|Phase 2: MTD||0||
48446816|NCT01999322|101428526|FG000|STARTED|Overall Study||25||
48446817|NCT01999322|101428527|FG001|STARTED|Overall Study||12||
48446818|NCT01999322|101428526|FG000|COMPLETED|Overall Study||24||
48658937|NCT00215657|101949059|FG004|NOT COMPLETED|Overall Study||23||
48658938|NCT00215657|101949060|FG005|NOT COMPLETED|Overall Study||20||
48658939|NCT00215657|101949061|FG006|NOT COMPLETED|Overall Study||23||
48658940|NCT00215657|101949062|FG007|NOT COMPLETED|Overall Study||16||
48770651|NCT00286468|102229230|FG002|COMPLETED|Overall Study||148||
48770652|NCT00286468|102229228|FG000|NOT COMPLETED|Overall Study||37||
48770653|NCT00286468|102229229|FG001|NOT COMPLETED|Overall Study||50||
48770654|NCT00286468|102229230|FG002|NOT COMPLETED|Overall Study||50||
48770655|NCT01635439|102229231|FG000|STARTED|Overall Study||100||
48770656|NCT01635439|102229232|FG001|STARTED|Overall Study||100||
48770657|NCT01635439|102229231|FG000|COMPLETED|Overall Study||100||
48770658|NCT01635439|102229232|FG001|COMPLETED|Overall Study||100||
48770659|NCT01635439|102229231|FG000|NOT COMPLETED|Overall Study||0||
48770660|NCT01635439|102229232|FG001|NOT COMPLETED|Overall Study||0||
48770661|NCT04355169|102229233|FG000|STARTED|Overall Study||0||
48770662|NCT04355169|102229234|FG001|STARTED|Overall Study||0||
48770663|NCT04355169|102229235|FG002|STARTED|Overall Study||0||
48770664|NCT04355169|102229236|FG003|STARTED|Overall Study||0||
48770665|NCT04355169|102229233|FG000|COMPLETED|Overall Study||0||
48770666|NCT04355169|102229234|FG001|COMPLETED|Overall Study||0||
48770667|NCT04355169|102229235|FG002|COMPLETED|Overall Study||0||
48770668|NCT04355169|102229236|FG003|COMPLETED|Overall Study||0||
48770669|NCT04355169|102229233|FG000|NOT COMPLETED|Overall Study||0||
48770670|NCT04355169|102229234|FG001|NOT COMPLETED|Overall Study||0||
48770671|NCT04355169|102229235|FG002|NOT COMPLETED|Overall Study||0||
48770672|NCT04355169|102229236|FG003|NOT COMPLETED|Overall Study||0||
48770673|NCT00427765|102229237|FG000|STARTED|Overall Study||164||
48770674|NCT00427765|102229237|FG000|COMPLETED|Overall Study||164||
48770675|NCT00427765|102229237|FG000|NOT COMPLETED|Overall Study||0||
48770676|NCT01198977|102229238|FG000|STARTED|Overall Study||31||
48446819|NCT01999322|101428527|FG001|COMPLETED|Overall Study||12||
48770677|NCT01198977|102229239|FG001|STARTED|Overall Study||33||
48770678|NCT01198977|102229238|FG000|COMPLETED|Overall Study||30||
48770679|NCT01198977|102229239|FG001|COMPLETED|Overall Study||33||
48770680|NCT01198977|102229238|FG000|NOT COMPLETED|Overall Study||1||
48770681|NCT01198977|102229239|FG001|NOT COMPLETED|Overall Study||0||
48446820|NCT01999322|101428526|FG000|NOT COMPLETED|Overall Study||1||
48446821|NCT01999322|101428527|FG001|NOT COMPLETED|Overall Study||0||
48446822|NCT01791127|101428528|FG000|STARTED|Overall Study||1758||
48658941|NCT00309946|101949063|FG000|STARTED|Overall Study||51||
48658942|NCT00309946|101949063|FG000|COMPLETED|Overall Study||50||
48658943|NCT00309946|101949063|FG000|NOT COMPLETED|Overall Study||1||
48658944|NCT03794544|101949064|FG000|STARTED|Overall Study||27||
48658945|NCT03794544|101949065|FG001|STARTED|Overall Study||21||
48658946|NCT03794544|101949066|FG002|STARTED|Overall Study||20||
48658947|NCT03794544|101949067|FG003|STARTED|Overall Study||16||
48658948|NCT03794544|101949064|FG000|Treated|Overall Study||26||
48658949|NCT03794544|101949065|FG001|Treated|Overall Study||21||
48658950|NCT03794544|101949066|FG002|Treated|Overall Study||20||
48658951|NCT03794544|101949067|FG003|Treated|Overall Study||16||
48658952|NCT03794544|101949064|FG000|COMPLETED|Overall Study||26||
48658953|NCT03794544|101949065|FG001|COMPLETED|Overall Study||18||
48658954|NCT03794544|101949066|FG002|COMPLETED|Overall Study||19||
48658955|NCT03794544|101949067|FG003|COMPLETED|Overall Study||15||
48658956|NCT03794544|101949064|FG000|NOT COMPLETED|Overall Study||1||
48658957|NCT03794544|101949065|FG001|NOT COMPLETED|Overall Study||3||
48658958|NCT03794544|101949066|FG002|NOT COMPLETED|Overall Study||1||
48658959|NCT03794544|101949067|FG003|NOT COMPLETED|Overall Study||1||
48658960|NCT01514279|101949068|FG000|STARTED|Overall Study||118||
48658961|NCT01514279|101949069|FG001|STARTED|Overall Study||123||
48658962|NCT01514279|101949070|FG002|STARTED|Overall Study||119||
48658963|NCT01514279|101949068|FG000|COMPLETED|Overall Study||107||
48658964|NCT01514279|101949069|FG001|COMPLETED|Overall Study||110||
48658965|NCT01514279|101949070|FG002|COMPLETED|Overall Study||114||
48658966|NCT01514279|101949068|FG000|NOT COMPLETED|Overall Study||11||
48658967|NCT01514279|101949069|FG001|NOT COMPLETED|Overall Study||13||
48770682|NCT01716234|102229240|FG000|STARTED|Overall Study||24||
48770683|NCT01716234|102229241|FG001|STARTED|Overall Study||22||
48446823|NCT01791127|101428528|FG000|COMPLETED|Overall Study||286||
48446824|NCT01791127|101428528|FG000|NOT COMPLETED|Overall Study||1472||
48446825|NCT00602979|101428529|FG000|STARTED|Overall Study||48||
48658968|NCT01514279|101949070|FG002|NOT COMPLETED|Overall Study||5||
48658969|NCT02189629|101949071|FG000|STARTED|Overall Study||453||
48658970|NCT02189629|101949071|FG000|COMPLETED|Overall Study||348||
48658971|NCT02189629|101949071|FG000|NOT COMPLETED|Overall Study||105||
48658972|NCT05938816|101949072|FG000|STARTED|Overall Study||0||
48658973|NCT05938816|101949073|FG001|STARTED|Overall Study||0||
48658974|NCT05938816|101949072|FG000|COMPLETED|Overall Study||0||
48770684|NCT01716234|102229242|FG002|STARTED|Overall Study||20||
48770685|NCT01716234|102229243|FG003|STARTED|Overall Study||28||
48770686|NCT01716234|102229244|FG004|STARTED|Overall Study||15||
48770687|NCT01716234|102229245|FG005|STARTED|Overall Study||32||
48770688|NCT01716234|102229246|FG006|STARTED|Overall Study||1||
48770689|NCT01716234|102229240|FG000|Treated|Overall Study||22||
48770690|NCT01716234|102229241|FG001|Treated|Overall Study||21||
48770691|NCT01716234|102229242|FG002|Treated|Overall Study||19||
48770692|NCT01716234|102229243|FG003|Treated|Overall Study||28||
48770693|NCT01716234|102229244|FG004|Treated|Overall Study||15||
48770694|NCT01716234|102229245|FG005|Treated|Overall Study||30||
48770695|NCT01716234|102229246|FG006|Treated|Overall Study||1||
48770696|NCT01716234|102229240|FG000|COMPLETED|Overall Study||14||
48770697|NCT01716234|102229241|FG001|COMPLETED|Overall Study||12||
48770698|NCT01716234|102229242|FG002|COMPLETED|Overall Study||15||
48770699|NCT01716234|102229243|FG003|COMPLETED|Overall Study||16||
48770700|NCT01716234|102229244|FG004|COMPLETED|Overall Study||10||
48770701|NCT01716234|102229245|FG005|COMPLETED|Overall Study||18||
48770702|NCT01716234|102229246|FG006|COMPLETED|Overall Study||1||
48770703|NCT01716234|102229240|FG000|NOT COMPLETED|Overall Study||10||
48770704|NCT01716234|102229241|FG001|NOT COMPLETED|Overall Study||10||
48770705|NCT01716234|102229242|FG002|NOT COMPLETED|Overall Study||5||
48770706|NCT01716234|102229243|FG003|NOT COMPLETED|Overall Study||12||
48770707|NCT01716234|102229244|FG004|NOT COMPLETED|Overall Study||5||
48770708|NCT01716234|102229245|FG005|NOT COMPLETED|Overall Study||14||
48770709|NCT01716234|102229246|FG006|NOT COMPLETED|Overall Study||0||
48446826|NCT00602979|101428530|FG001|STARTED|Overall Study||48||
48446827|NCT00602979|101428531|FG002|STARTED|Overall Study||48||
48658975|NCT05938816|101949073|FG001|COMPLETED|Overall Study||0||
48658976|NCT05938816|101949072|FG000|NOT COMPLETED|Overall Study||0||
48658977|NCT05938816|101949073|FG001|NOT COMPLETED|Overall Study||0||
48658978|NCT01378273|101949074|FG000|STARTED|Overall Study||464||
48658979|NCT01378273|101949075|FG001|STARTED|Overall Study||477||
48658980|NCT01378273|101949074|FG000|COMPLETED|Overall Study||460||
48658981|NCT01378273|101949075|FG001|COMPLETED|Overall Study||476||
48658982|NCT01378273|101949074|FG000|NOT COMPLETED|Overall Study||4||
48658983|NCT01378273|101949075|FG001|NOT COMPLETED|Overall Study||1||
48658984|NCT01027754|101949076|FG000|STARTED|Overall Study||57||
48658985|NCT01027754|101949077|FG001|STARTED|Overall Study||55||
48658986|NCT01027754|101949076|FG000|COMPLETED|Overall Study||55||
48658987|NCT01027754|101949077|FG001|COMPLETED|Overall Study||47||
48658988|NCT01027754|101949076|FG000|NOT COMPLETED|Overall Study||2||
48658989|NCT01027754|101949077|FG001|NOT COMPLETED|Overall Study||8||
48658990|NCT03996395|101949078|FG000|STARTED|Overall Study||21||
48658991|NCT03996395|101949078|FG000|COMPLETED|Overall Study||9||
48658992|NCT03996395|101949078|FG000|NOT COMPLETED|Overall Study||12||
48658993|NCT02264821|101949079|FG000|STARTED|Overall Study||64||
48658994|NCT02264821|101949080|FG001|STARTED|Overall Study||64||
48658995|NCT02264821|101949081|FG002|STARTED|Overall Study||64||
48658996|NCT02264821|101949079|FG000|COMPLETED|Overall Study||63||
48658997|NCT02264821|101949080|FG001|COMPLETED|Overall Study||61||
48658998|NCT02264821|101949081|FG002|COMPLETED|Overall Study||58||
48658999|NCT02264821|101949079|FG000|NOT COMPLETED|Overall Study||1||
48659000|NCT02264821|101949080|FG001|NOT COMPLETED|Overall Study||3||
48659001|NCT02264821|101949081|FG002|NOT COMPLETED|Overall Study||6||
48659002|NCT01444924|101949082|FG000|STARTED|Overall Study||31||
48659003|NCT01444924|101949083|FG001|STARTED|Overall Study||33||
48659004|NCT01444924|101949082|FG000|COMPLETED|Overall Study||31||
48659005|NCT01444924|101949083|FG001|COMPLETED|Overall Study||33||
48659006|NCT01444924|101949082|FG000|NOT COMPLETED|Overall Study||0||
48659007|NCT01444924|101949083|FG001|NOT COMPLETED|Overall Study||0||
48659008|NCT01687595|101949084|FG000|STARTED|Overall Study||70||
48659009|NCT01687595|101949085|FG001|STARTED|Overall Study||10||
48659010|NCT01687595|101949084|FG000|Received at Least 1 Dose of Study Drug|Overall Study||70||
48659011|NCT01687595|101949085|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10||
48659012|NCT01687595|101949084|FG000|COMPLETED|Overall Study||0||
48770710|NCT02387502|102229247|FG000|STARTED|Overall Study||40||
48770711|NCT02387502|102229248|FG001|STARTED|Overall Study||40||
48770712|NCT02387502|102229249|FG002|STARTED|Overall Study||40||
48446828|NCT00602979|101428532|FG003|STARTED|Overall Study||48||
48770713|NCT02387502|102229247|FG000|COMPLETED|Overall Study||40||
48770714|NCT02387502|102229248|FG001|COMPLETED|Overall Study||40||
48770715|NCT02387502|102229249|FG002|COMPLETED|Overall Study||40||
48770716|NCT02387502|102229247|FG000|NOT COMPLETED|Overall Study||0||
48770717|NCT02387502|102229248|FG001|NOT COMPLETED|Overall Study||0||
48770718|NCT02387502|102229249|FG002|NOT COMPLETED|Overall Study||0||
48770719|NCT03008369|102229250|FG000|STARTED|Overall Study||3||
48446829|NCT00602979|101428533|FG004|STARTED|Overall Study||48||
48446830|NCT00602979|101428529|FG000|COMPLETED|Overall Study||45||
48446831|NCT00602979|101428530|FG001|COMPLETED|Overall Study||45||
48446832|NCT00602979|101428531|FG002|COMPLETED|Overall Study||45||
48659013|NCT01687595|101949085|FG001|COMPLETED|Overall Study||0||
48659014|NCT01687595|101949084|FG000|NOT COMPLETED|Overall Study||70||
48659015|NCT01687595|101949085|FG001|NOT COMPLETED|Overall Study||10||
48659016|NCT01084135|101949086|FG000|STARTED|12 Week||4||
48659017|NCT01084135|101949087|FG001|STARTED|12 Week||4||
48659018|NCT01084135|101949086|FG000|COMPLETED|12 Week||4||
48659019|NCT01084135|101949087|FG001|COMPLETED|12 Week||4||
48770720|NCT03008369|102229250|FG000|COMPLETED|Overall Study||3||
48659020|NCT01084135|101949086|FG000|NOT COMPLETED|12 Week||0||
48659021|NCT01084135|101949087|FG001|NOT COMPLETED|12 Week||0||
48659022|NCT01084135|101949086|FG000|STARTED|20 Week||12||
48659023|NCT01084135|101949087|FG001|STARTED|20 Week||11||
48659024|NCT01084135|101949086|FG000|COMPLETED|20 Week||12||
48659025|NCT01084135|101949087|FG001|COMPLETED|20 Week||10||
48659026|NCT01084135|101949086|FG000|NOT COMPLETED|20 Week||0||
48659027|NCT01084135|101949087|FG001|NOT COMPLETED|20 Week||1||
48659028|NCT01663363|101949088|FG000|STARTED|Overall Study||170||
48659029|NCT01663363|101949088|FG000|COMPLETED|Overall Study||170||
48659030|NCT01663363|101949088|FG000|NOT COMPLETED|Overall Study||0||
48659031|NCT05122143|101949089|FG000|STARTED|Overall Study||6||
48659032|NCT05122143|101949090|FG001|STARTED|Overall Study||6||
48659033|NCT05122143|101949091|FG002|STARTED|Overall Study||6||
48659034|NCT05122143|101949092|FG003|STARTED|Overall Study||6||
48659035|NCT05122143|101949093|FG004|STARTED|Overall Study||7||
48659036|NCT05122143|101949094|FG005|STARTED|Overall Study||6||
48659037|NCT05122143|101949089|FG000|COMPLETED|Overall Study||5||
48659038|NCT05122143|101949090|FG001|COMPLETED|Overall Study||6||
48659039|NCT05122143|101949091|FG002|COMPLETED|Overall Study||5||
48659040|NCT05122143|101949092|FG003|COMPLETED|Overall Study||6||
48659041|NCT05122143|101949093|FG004|COMPLETED|Overall Study||5||
48659042|NCT05122143|101949094|FG005|COMPLETED|Overall Study||6||
48659043|NCT05122143|101949089|FG000|NOT COMPLETED|Overall Study||1||
48659044|NCT05122143|101949090|FG001|NOT COMPLETED|Overall Study||0||
48659045|NCT05122143|101949091|FG002|NOT COMPLETED|Overall Study||1||
48659046|NCT05122143|101949092|FG003|NOT COMPLETED|Overall Study||0||
48659047|NCT05122143|101949093|FG004|NOT COMPLETED|Overall Study||2||
48659048|NCT05122143|101949094|FG005|NOT COMPLETED|Overall Study||0||
48659049|NCT03907579|101949095|FG000|STARTED|Overall Study||100||
48659050|NCT03907579|101949095|FG000|COMPLETED|Overall Study||100||
48659051|NCT03907579|101949095|FG000|NOT COMPLETED|Overall Study||0||
48659052|NCT00637156|101949096|FG000|STARTED|Overall Study||209||
48659053|NCT00637156|101949097|FG001|STARTED|Overall Study||188||
48659054|NCT00637156|101949096|FG000|COMPLETED|Overall Study||199||
48659055|NCT00637156|101949097|FG001|COMPLETED|Overall Study||164||
48659056|NCT00637156|101949096|FG000|NOT COMPLETED|Overall Study||10||
48659057|NCT00637156|101949097|FG001|NOT COMPLETED|Overall Study||24||
48659058|NCT01548885|101949098|FG000|STARTED|Overall Study||146||
48659059|NCT01548885|101949098|FG000|COMPLETED|Overall Study||146||
48659060|NCT01548885|101949098|FG000|NOT COMPLETED|Overall Study||0||
48659061|NCT01659151|101949099|FG000|STARTED|Overall Study||17||
48659062|NCT01659151|101949099|FG000|COMPLETED|Overall Study||16||
48659063|NCT01659151|101949099|FG000|NOT COMPLETED|Overall Study||1||
48659064|NCT04565353|101949100|FG000|STARTED|Overall Study||3742||
48659065|NCT04565353|101949101|FG001|STARTED|Overall Study||3737||
48659066|NCT04565353|101949102|FG002|STARTED|Overall Study||3709||
48659067|NCT04565353|101949103|FG003|STARTED|Overall Study||3735||
48659068|NCT04565353|101949104|FG004|STARTED|Overall Study||3758||
48659069|NCT04565353|101949105|FG005|STARTED|Overall Study||3769||
48659070|NCT04565353|101949106|FG006|STARTED|Overall Study||3719||
48659071|NCT04565353|101949107|FG007|STARTED|Overall Study||3732||
48659072|NCT04565353|101949108|FG008|STARTED|Overall Study||3728||
48659073|NCT04565353|101949109|FG009|STARTED|Overall Study||3777||
48659074|NCT04565353|101949110|FG010|STARTED|Overall Study||3672||
48659075|NCT04565353|101949111|FG011|STARTED|Overall Study||3751||
48659076|NCT04565353|101949112|FG012|STARTED|Overall Study||3737||
48659077|NCT04565353|101949113|FG013|STARTED|Overall Study||3714||
48659078|NCT04565353|101949114|FG014|STARTED|Overall Study||3773||
48659079|NCT04565353|101949115|FG015|STARTED|Overall Study||3739||
48659080|NCT04565353|101949116|FG016|STARTED|Overall Study||3776||
48659081|NCT04565353|101949117|FG017|STARTED|Overall Study||3744||
48659082|NCT04565353|101949118|FG018|STARTED|Overall Study||3741||
48659083|NCT04565353|101949119|FG019|STARTED|Overall Study||3758||
48659084|NCT04565353|101949100|FG000|COMPLETED|Overall Study||3742||
48659085|NCT04565353|101949101|FG001|COMPLETED|Overall Study||3688||
48659086|NCT04565353|101949102|FG002|COMPLETED|Overall Study||3670||
48659087|NCT04565353|101949103|FG003|COMPLETED|Overall Study||3693||
48659088|NCT04565353|101949104|FG004|COMPLETED|Overall Study||3717||
48659089|NCT04565353|101949105|FG005|COMPLETED|Overall Study||3716||
48659090|NCT04565353|101949106|FG006|COMPLETED|Overall Study||3665||
48659091|NCT04565353|101949107|FG007|COMPLETED|Overall Study||3693||
48659092|NCT04565353|101949108|FG008|COMPLETED|Overall Study||3662||
48659093|NCT04565353|101949109|FG009|COMPLETED|Overall Study||3734||
48659094|NCT04565353|101949110|FG010|COMPLETED|Overall Study||3623||
48659095|NCT04565353|101949111|FG011|COMPLETED|Overall Study||3710||
48659096|NCT04565353|101949112|FG012|COMPLETED|Overall Study||3685||
48659097|NCT04565353|101949113|FG013|COMPLETED|Overall Study||3664||
48659098|NCT04565353|101949114|FG014|COMPLETED|Overall Study||3736||
48659099|NCT04565353|101949115|FG015|COMPLETED|Overall Study||3690||
48659100|NCT04565353|101949116|FG016|COMPLETED|Overall Study||3734||
48659101|NCT04565353|101949117|FG017|COMPLETED|Overall Study||3696||
48659102|NCT04565353|101949118|FG018|COMPLETED|Overall Study||3698||
48659103|NCT04565353|101949119|FG019|COMPLETED|Overall Study||3712||
48659104|NCT04565353|101949100|FG000|NOT COMPLETED|Overall Study||0||
48446833|NCT00602979|101428532|FG003|COMPLETED|Overall Study||45||
48446834|NCT00602979|101428533|FG004|COMPLETED|Overall Study||45||
48446835|NCT00602979|101428529|FG000|NOT COMPLETED|Overall Study||3||
48446836|NCT00602979|101428530|FG001|NOT COMPLETED|Overall Study||3||
48446837|NCT00602979|101428531|FG002|NOT COMPLETED|Overall Study||3||
48446838|NCT00602979|101428532|FG003|NOT COMPLETED|Overall Study||3||
48446839|NCT00602979|101428533|FG004|NOT COMPLETED|Overall Study||3||
48446840|NCT00701558|101428534|FG000|STARTED|Overall Study||19||
48446841|NCT00701558|101428534|FG000|COMPLETED|Overall Study||4||
48446842|NCT00701558|101428534|FG000|NOT COMPLETED|Overall Study||15||
48446843|NCT00390949|101428535|FG000|STARTED|Overall Study||4662||
48446844|NCT00390949|101428536|FG001|STARTED|Overall Study||4792||
48446845|NCT00390949|101428535|FG000|COMPLETED|Overall Study||2564||
48446846|NCT00390949|101428536|FG001|COMPLETED|Overall Study||2664||
48446847|NCT00390949|101428535|FG000|NOT COMPLETED|Overall Study||2098||
48446848|NCT00390949|101428536|FG001|NOT COMPLETED|Overall Study||2128||
48446849|NCT00435825|101428537|FG000|STARTED|Overall Study||141||
48446850|NCT00435825|101428538|FG001|STARTED|Overall Study||136||
48446851|NCT00435825|101428539|FG002|STARTED|Overall Study||138||
48446852|NCT00435825|101428540|FG003|STARTED|Overall Study||136||
48446853|NCT00435825|101428537|FG000|Received Study Drug|Overall Study||140||
48446854|NCT00435825|101428538|FG001|Received Study Drug|Overall Study||136||
48446855|NCT00435825|101428539|FG002|Received Study Drug|Overall Study||136||
48659105|NCT04565353|101949101|FG001|NOT COMPLETED|Overall Study||49||
48659106|NCT04565353|101949102|FG002|NOT COMPLETED|Overall Study||39||
48659107|NCT04565353|101949103|FG003|NOT COMPLETED|Overall Study||42||
48659108|NCT04565353|101949104|FG004|NOT COMPLETED|Overall Study||41||
48659109|NCT04565353|101949105|FG005|NOT COMPLETED|Overall Study||53||
48659110|NCT04565353|101949106|FG006|NOT COMPLETED|Overall Study||54||
48659111|NCT04565353|101949107|FG007|NOT COMPLETED|Overall Study||39||
48659112|NCT04565353|101949108|FG008|NOT COMPLETED|Overall Study||66||
48659113|NCT04565353|101949109|FG009|NOT COMPLETED|Overall Study||43||
48659114|NCT04565353|101949110|FG010|NOT COMPLETED|Overall Study||49||
48659115|NCT04565353|101949111|FG011|NOT COMPLETED|Overall Study||41||
48770721|NCT03008369|102229250|FG000|NOT COMPLETED|Overall Study||0||
48770722|NCT01441076|102229251|FG000|STARTED|Overall Study||6||
48189063|NCT01169519|100786148|FG000|NOT COMPLETED|Overall Study||0||
48189064|NCT00708097|100786149|FG000|STARTED|Period 1||11||
48189065|NCT00708097|100786150|FG001|STARTED|Period 1||12||
48189066|NCT00708097|100786151|FG002|STARTED|Period 1||12||
48659116|NCT04565353|101949112|FG012|NOT COMPLETED|Overall Study||52||
48659117|NCT04565353|101949113|FG013|NOT COMPLETED|Overall Study||50||
48659118|NCT04565353|101949114|FG014|NOT COMPLETED|Overall Study||37||
48659119|NCT04565353|101949115|FG015|NOT COMPLETED|Overall Study||49||
48659120|NCT04565353|101949116|FG016|NOT COMPLETED|Overall Study||42||
48659121|NCT04565353|101949117|FG017|NOT COMPLETED|Overall Study||48||
48659122|NCT04565353|101949118|FG018|NOT COMPLETED|Overall Study||43||
48659123|NCT04565353|101949119|FG019|NOT COMPLETED|Overall Study||46||
48659124|NCT01714063|101949120|FG000|STARTED|Overall Study||34||
48659125|NCT01714063|101949120|FG000|COMPLETED|Overall Study||32||
48659126|NCT01714063|101949120|FG000|NOT COMPLETED|Overall Study||2||
48659127|NCT00561821|101949121|FG000|STARTED|Overall Study||132||
48659128|NCT00561821|101949122|FG001|STARTED|Overall Study||136||
48659129|NCT00561821|101949123|FG002|STARTED|Overall Study||134||
48659130|NCT00561821|101949124|FG003|STARTED|Overall Study||136||
48659131|NCT00561821|101949121|FG000|Treated|Overall Study||132||
48446856|NCT00435825|101428540|FG003|Received Study Drug|Overall Study||136||
48446857|NCT00435825|101428537|FG000|Entered Follow-up|Overall Study||140||
48446858|NCT00435825|101428538|FG001|Entered Follow-up|Overall Study||132||
48446859|NCT00435825|101428539|FG002|Entered Follow-up|Overall Study||135||
48446860|NCT00435825|101428540|FG003|Entered Follow-up|Overall Study||133||
48446861|NCT00435825|101428537|FG000|Completed 24 Weeks Treatment|Overall Study||128||
48446862|NCT00435825|101428538|FG001|Completed 24 Weeks Treatment|Overall Study||126||
48446863|NCT00435825|101428539|FG002|Completed 24 Weeks Treatment|Overall Study||134||
48446864|NCT00435825|101428540|FG003|Completed 24 Weeks Treatment|Overall Study||131||
48446865|NCT00435825|101428537|FG000|Completed 48 Weeks Treatment|Overall Study||0||
48446866|NCT00435825|101428538|FG001|Completed 48 Weeks Treatment|Overall Study||0||
48189067|NCT00708097|100786152|FG003|STARTED|Period 1||11||
48189068|NCT00708097|100786153|FG004|STARTED|Period 1||11||
48446867|NCT00435825|101428539|FG002|Completed 48 Weeks Treatment|Overall Study||124||
48446868|NCT00435825|101428540|FG003|Completed 48 Weeks Treatment|Overall Study||117||
48446869|NCT00435825|101428537|FG000|COMPLETED|Overall Study||123||
48446870|NCT00435825|101428538|FG001|COMPLETED|Overall Study||124||
48446871|NCT00435825|101428539|FG002|COMPLETED|Overall Study||127||
48446872|NCT00435825|101428540|FG003|COMPLETED|Overall Study||120||
48659132|NCT00561821|101949122|FG001|Treated|Overall Study||136||
48659133|NCT00561821|101949123|FG002|Treated|Overall Study||133||
48659134|NCT00561821|101949124|FG003|Treated|Overall Study||136||
48659135|NCT00561821|101949121|FG000|COMPLETED|Overall Study||127||
48659136|NCT00561821|101949122|FG001|COMPLETED|Overall Study||130||
48659137|NCT00561821|101949123|FG002|COMPLETED|Overall Study||132||
48770723|NCT01441076|102229251|FG000|COMPLETED|Overall Study||4||
48770724|NCT01441076|102229251|FG000|NOT COMPLETED|Overall Study||2||
48770725|NCT03399552|102229252|FG000|STARTED|Overall Study||15||
48770726|NCT03399552|102229252|FG000|COMPLETED|Overall Study||13||
48770727|NCT03399552|102229252|FG000|NOT COMPLETED|Overall Study||2||
48770728|NCT02797613|102229253|FG000|STARTED|Overall Study||55||
48770729|NCT02797613|102229254|FG001|STARTED|Overall Study||55||
48770730|NCT02797613|102229253|FG000|COMPLETED|Overall Study||55||
48770731|NCT02797613|102229254|FG001|COMPLETED|Overall Study||55||
48770732|NCT02797613|102229253|FG000|NOT COMPLETED|Overall Study||0||
48770733|NCT02797613|102229254|FG001|NOT COMPLETED|Overall Study||0||
48770734|NCT01526577|102229255|FG000|STARTED|Overall Study||49||
48770735|NCT01526577|102229256|FG001|STARTED|Overall Study||12||
48770736|NCT01526577|102229257|FG002|STARTED|Overall Study||33||
48770737|NCT01526577|102229258|FG003|STARTED|Overall Study||9||
48770738|NCT01526577|102229259|FG004|STARTED|Overall Study||10||
48770739|NCT01526577|102229255|FG000|COMPLETED|Overall Study||48||
48770740|NCT01526577|102229256|FG001|COMPLETED|Overall Study||12||
48770741|NCT01526577|102229257|FG002|COMPLETED|Overall Study||32||
48770742|NCT01526577|102229258|FG003|COMPLETED|Overall Study||8||
48770743|NCT01526577|102229259|FG004|COMPLETED|Overall Study||8||
48770744|NCT01526577|102229255|FG000|NOT COMPLETED|Overall Study||1||
48770745|NCT01526577|102229256|FG001|NOT COMPLETED|Overall Study||0||
48770746|NCT01526577|102229257|FG002|NOT COMPLETED|Overall Study||1||
48770747|NCT01526577|102229258|FG003|NOT COMPLETED|Overall Study||1||
48446873|NCT00435825|101428537|FG000|NOT COMPLETED|Overall Study||18||
48446874|NCT00435825|101428538|FG001|NOT COMPLETED|Overall Study||12||
48446875|NCT00435825|101428539|FG002|NOT COMPLETED|Overall Study||11||
48446876|NCT00435825|101428540|FG003|NOT COMPLETED|Overall Study||16||
48446877|NCT00190684|101428541|FG000|STARTED|Overall Study||1553||
48446878|NCT00190684|101428541|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1551||
48446879|NCT00190684|101428541|FG000|COMPLETED|Overall Study||64||
48446880|NCT00190684|101428541|FG000|NOT COMPLETED|Overall Study||1489||
48446881|NCT00430638|101428542|FG000|STARTED|Overall Study||138||
48446882|NCT00430638|101428543|FG001|STARTED|Overall Study||140||
48446883|NCT00430638|101428542|FG000|COMPLETED|Overall Study||60||
48446884|NCT00430638|101428543|FG001|COMPLETED|Overall Study||92||
48446885|NCT00430638|101428542|FG000|NOT COMPLETED|Overall Study||78||
48446886|NCT00430638|101428543|FG001|NOT COMPLETED|Overall Study||48||
48446887|NCT04991311|101428544|FG000|STARTED|Overall Study||10||
48446888|NCT04991311|101428544|FG000|COMPLETED|Overall Study||9||
48446889|NCT04991311|101428544|FG000|NOT COMPLETED|Overall Study||1||
48659138|NCT00561821|101949124|FG003|COMPLETED|Overall Study||133||
48659139|NCT00561821|101949121|FG000|NOT COMPLETED|Overall Study||5||
48659140|NCT00561821|101949122|FG001|NOT COMPLETED|Overall Study||6||
48659141|NCT00561821|101949123|FG002|NOT COMPLETED|Overall Study||2||
48659142|NCT00561821|101949124|FG003|NOT COMPLETED|Overall Study||3||
48659143|NCT02105012|101949125|FG000|STARTED|Overall Study||147||
48659144|NCT02105012|101949125|FG000|BD MDI 320 µg|Overall Study||124||
48659145|NCT02105012|101949125|FG000|BD MDI 160 µg|Overall Study||132||
48659146|NCT02105012|101949125|FG000|BD MDI 80 µg|Overall Study||64||
48659147|NCT02105012|101949125|FG000|BD MDI 40 µg|Overall Study||63||
48659148|NCT02105012|101949125|FG000|Placebo MDI|Overall Study||127||
48659149|NCT02105012|101949125|FG000|COMPLETED|Overall Study||114||
48659150|NCT02105012|101949125|FG000|NOT COMPLETED|Overall Study||33||
48659151|NCT04341012|101949126|FG000|STARTED|Overall Study||11||
48659152|NCT04341012|101949127|FG001|STARTED|Overall Study||35||
48659153|NCT04341012|101949126|FG000|COMPLETED|Overall Study||11||
48770748|NCT01526577|102229259|FG004|NOT COMPLETED|Overall Study||2||
48770749|NCT02581410|102229260|FG000|STARTED|Vaccination Phase||215||
48446890|NCT00854607|101428545|FG000|STARTED|Enrollment||116||
48446891|NCT00854607|101428545|FG000|COMPLETED|Enrollment||116||
48659154|NCT04341012|101949127|FG001|COMPLETED|Overall Study||35||
48659155|NCT04341012|101949126|FG000|NOT COMPLETED|Overall Study||0||
48659156|NCT04341012|101949127|FG001|NOT COMPLETED|Overall Study||0||
48659157|NCT03829683|101949128|FG000|STARTED|Overall Study||10||
48659158|NCT03829683|101949129|FG001|STARTED|Overall Study||10||
48659159|NCT03829683|101949128|FG000|COMPLETED|Overall Study||5||
48659160|NCT03829683|101949129|FG001|COMPLETED|Overall Study||8||
48659161|NCT03829683|101949128|FG000|NOT COMPLETED|Overall Study||5||
48659162|NCT03829683|101949129|FG001|NOT COMPLETED|Overall Study||2||
48659163|NCT00966446|101949130|FG000|STARTED|Overall Study||76||
48659164|NCT00966446|101949131|FG001|STARTED|Overall Study||74||
48770750|NCT02581410|102229261|FG001|STARTED|Vaccination Phase||215||
48770751|NCT02581410|102229260|FG000|COMPLETED|Vaccination Phase||213||
48770752|NCT02581410|102229261|FG001|COMPLETED|Vaccination Phase||212||
48770753|NCT02581410|102229260|FG000|NOT COMPLETED|Vaccination Phase||2||
48770754|NCT02581410|102229261|FG001|NOT COMPLETED|Vaccination Phase||3||
48770755|NCT02581410|102229260|FG000|STARTED|End of Study Phase||215||
48770756|NCT02581410|102229261|FG001|STARTED|End of Study Phase||215||
48770757|NCT02581410|102229260|FG000|COMPLETED|End of Study Phase||210||
48770758|NCT02581410|102229261|FG001|COMPLETED|End of Study Phase||204||
48770759|NCT02581410|102229260|FG000|NOT COMPLETED|End of Study Phase||5||
48446892|NCT00854607|101428545|FG000|NOT COMPLETED|Enrollment||0||
48446893|NCT00854607|101428545|FG000|STARTED|2 Weeks After Start Anti-fungal Therapy||116||
48446894|NCT00854607|101428545|FG000|COMPLETED|2 Weeks After Start Anti-fungal Therapy||51||
48446895|NCT00854607|101428545|FG000|NOT COMPLETED|2 Weeks After Start Anti-fungal Therapy||65||
48446896|NCT00540007|101428546|FG000|STARTED|Overall Study||38||
48446897|NCT00540007|101428547|FG001|STARTED|Overall Study||42||
48446898|NCT00540007|101428546|FG000|COMPLETED|Overall Study||38||
48446899|NCT00540007|101428547|FG001|COMPLETED|Overall Study||42||
48446900|NCT00540007|101428546|FG000|NOT COMPLETED|Overall Study||0||
48446901|NCT00540007|101428547|FG001|NOT COMPLETED|Overall Study||0||
48446902|NCT00628745|101428548|FG000|STARTED|Overall Study||1648||
48446903|NCT00628745|101428549|FG001|STARTED|Overall Study||662||
48446904|NCT00628745|101428550|FG002|STARTED|Overall Study||196||
48446905|NCT00628745|101428551|FG003|STARTED|Overall Study||15||
48446906|NCT00628745|101428552|FG004|STARTED|Overall Study||4197||
48446907|NCT00628745|101428548|FG000|COMPLETED|Overall Study||4||
48446908|NCT00628745|101428549|FG001|COMPLETED|Overall Study||0||
48446909|NCT00628745|101428550|FG002|COMPLETED|Overall Study||1||
48446910|NCT00628745|101428551|FG003|COMPLETED|Overall Study||0||
48446911|NCT00628745|101428552|FG004|COMPLETED|Overall Study||8||
48446912|NCT00628745|101428548|FG000|NOT COMPLETED|Overall Study||1644||
48446913|NCT00628745|101428549|FG001|NOT COMPLETED|Overall Study||662||
48446914|NCT00628745|101428550|FG002|NOT COMPLETED|Overall Study||195||
48446915|NCT00628745|101428551|FG003|NOT COMPLETED|Overall Study||15||
48446916|NCT00628745|101428552|FG004|NOT COMPLETED|Overall Study||4189||
48446917|NCT01179191|101428553|FG000|STARTED|Titration Phase (up to 6 Weeks)||684||
48446918|NCT01179191|101428553|FG000|COMPLETED|Titration Phase (up to 6 Weeks)||351||
48446919|NCT01179191|101428553|FG000|NOT COMPLETED|Titration Phase (up to 6 Weeks)||333||
48446920|NCT01179191|101428553|FG000|STARTED|Maintenance Phase (8 Weeks)||351||
48446921|NCT01179191|101428553|FG000|COMPLETED|Maintenance Phase (8 Weeks)||234||
48446922|NCT01179191|101428553|FG000|NOT COMPLETED|Maintenance Phase (8 Weeks)||117||
48446923|NCT01529749|101428554|FG000|STARTED|Overall Study||12||
48446924|NCT01529749|101428555|FG001|STARTED|Overall Study||12||
48446925|NCT01529749|101428556|FG002|STARTED|Overall Study||12||
48446926|NCT01529749|101428557|FG003|STARTED|Overall Study||12||
48446927|NCT01529749|101428554|FG000|COMPLETED|Overall Study||12||
48446928|NCT01529749|101428555|FG001|COMPLETED|Overall Study||10||
48446929|NCT01529749|101428556|FG002|COMPLETED|Overall Study||10||
48446930|NCT01529749|101428557|FG003|COMPLETED|Overall Study||10||
48446931|NCT01529749|101428554|FG000|NOT COMPLETED|Overall Study||0||
48446932|NCT01529749|101428555|FG001|NOT COMPLETED|Overall Study||2||
48446933|NCT01529749|101428556|FG002|NOT COMPLETED|Overall Study||2||
48446934|NCT01529749|101428557|FG003|NOT COMPLETED|Overall Study||2||
48446935|NCT04476017|101428558|FG000|STARTED|Part A (28 Days)||11||
48446936|NCT04476017|101428559|FG001|STARTED|Part A (28 Days)||0||
48446937|NCT04476017|101428558|FG000|COMPLETED|Part A (28 Days)||10||
48446938|NCT04476017|101428559|FG001|COMPLETED|Part A (28 Days)||0||
48446939|NCT04476017|101428558|FG000|NOT COMPLETED|Part A (28 Days)||1||
48446940|NCT04476017|101428559|FG001|NOT COMPLETED|Part A (28 Days)||0||
48446941|NCT04476017|101428558|FG000|STARTED|Part B (42 Days)||0|Part B of this study was started after completion of Part A. Participants who completed Part A of the study were not included in Part B of the study. Unique participants were enrolled in Part B.|
48446942|NCT04476017|101428559|FG001|STARTED|Part B (42 Days)||7|Part B of this study was started after completion of Part A. Participants who completed Part A of the study were not included in Part B of the study. Unique participants were enrolled in Part B.|
48446943|NCT04476017|101428558|FG000|COMPLETED|Part B (42 Days)||0||
48446944|NCT04476017|101428559|FG001|COMPLETED|Part B (42 Days)||7||
48446945|NCT04476017|101428558|FG000|NOT COMPLETED|Part B (42 Days)||0||
48446946|NCT04476017|101428559|FG001|NOT COMPLETED|Part B (42 Days)||0||
48446947|NCT02706041|101428560|FG000|STARTED|Overall Study||18||
48446948|NCT02706041|101428561|FG001|STARTED|Overall Study||21||
48446949|NCT02706041|101428560|FG000|Received Allocated Intervention|Overall Study||18||
48446950|NCT02706041|101428561|FG001|Received Allocated Intervention|Overall Study||18||
48446951|NCT02706041|101428560|FG000|COMPLETED|Overall Study||18||
48446952|NCT02706041|101428561|FG001|COMPLETED|Overall Study||18||
48446953|NCT02706041|101428560|FG000|NOT COMPLETED|Overall Study||0||
48446954|NCT02706041|101428561|FG001|NOT COMPLETED|Overall Study||3||
48446955|NCT01393626|101428562|FG000|STARTED|Overall Study||91||
48446956|NCT01393626|101428563|FG001|STARTED|Overall Study||86||
48446957|NCT01393626|101428564|FG002|STARTED|Overall Study||86||
48446958|NCT01393626|101428565|FG003|STARTED|Overall Study||16||
48446959|NCT01393626|101428562|FG000|COMPLETED|Overall Study||73||
48446960|NCT01393626|101428563|FG001|COMPLETED|Overall Study||74||
48446961|NCT01393626|101428564|FG002|COMPLETED|Overall Study||74||
48446962|NCT01393626|101428565|FG003|COMPLETED|Overall Study||15||
48446963|NCT01393626|101428562|FG000|NOT COMPLETED|Overall Study||18||
48446964|NCT01393626|101428563|FG001|NOT COMPLETED|Overall Study||12||
48446965|NCT01393626|101428564|FG002|NOT COMPLETED|Overall Study||12||
48446966|NCT01393626|101428565|FG003|NOT COMPLETED|Overall Study||1||
48446967|NCT03151967|101428566|FG000|STARTED|Overall Study||14||
48446968|NCT03151967|101428567|FG001|STARTED|Overall Study||13||
48446969|NCT03151967|101428566|FG000|COMPLETED|Overall Study||12||
48446970|NCT03151967|101428567|FG001|COMPLETED|Overall Study||12||
48446971|NCT03151967|101428566|FG000|NOT COMPLETED|Overall Study||2||
48446972|NCT03151967|101428567|FG001|NOT COMPLETED|Overall Study||1||
48446973|NCT01162135|101428568|FG000|STARTED|Overall Study||16||
48446974|NCT01162135|101428568|FG000|COMPLETED|Overall Study||13||
48446975|NCT01162135|101428568|FG000|NOT COMPLETED|Overall Study||3||
48446976|NCT02328404|101428569|FG000|STARTED|Overall Study||30||
48446977|NCT02328404|101428570|FG001|STARTED|Overall Study||30||
48446978|NCT02328404|101428569|FG000|COMPLETED|Overall Study||29||
48446979|NCT02328404|101428570|FG001|COMPLETED|Overall Study||29||
48446980|NCT02328404|101428569|FG000|NOT COMPLETED|Overall Study||1||
48446981|NCT02328404|101428570|FG001|NOT COMPLETED|Overall Study||1||
48446982|NCT02406742|101428571|FG000|STARTED|Overall Study||14||
48446983|NCT02406742|101428572|FG001|STARTED|Overall Study||16||
48446984|NCT02406742|101428573|FG002|STARTED|Overall Study||16||
48446985|NCT02406742|101428571|FG000|Dose Escalation 1|Overall Study||3|CC-122 0.25mg|
48446986|NCT02406742|101428572|FG001|Dose Escalation 1|Overall Study||0|CC-122 0.25mg|
48446987|NCT02406742|101428573|FG002|Dose Escalation 1|Overall Study||0|CC-122 0.25mg|
48446988|NCT02406742|101428571|FG000|Dose Escalation 2|Overall Study||9|CC-122 0.5mg|
48446989|NCT02406742|101428572|FG001|Dose Escalation 2|Overall Study||5|CC-122 0.5mg|
48446990|NCT02406742|101428573|FG002|Dose Escalation 2|Overall Study||3|CC-122 0.5mg|
48446991|NCT02406742|101428571|FG000|Dose Escalation 3|Overall Study||2|CC-122 1.0mg|
48446992|NCT02406742|101428572|FG001|Dose Escalation 3|Overall Study||3|CC-122 1.0mg|
48446993|NCT02406742|101428573|FG002|Dose Escalation 3|Overall Study||3|CC-122 1.0mg|
48446994|NCT02406742|101428571|FG000|Dose Escalation 4|Overall Study||0|CC-122 2.0mg|
48446995|NCT02406742|101428572|FG001|Dose Escalation 4|Overall Study||3|CC-122 2.0mg|
48446996|NCT02406742|101428573|FG002|Dose Escalation 4|Overall Study||3|CC-122 2.0mg|
48446997|NCT02406742|101428571|FG000|Dose Escalation 5|Overall Study||0|CC-122 3.0mg|
48446998|NCT02406742|101428572|FG001|Dose Escalation 5|Overall Study||5|CC-122 3.0mg|
48446999|NCT02406742|101428573|FG002|Dose Escalation 5|Overall Study||5|CC-122 3.0mg|
48447000|NCT02406742|101428571|FG000|COMPLETED|Overall Study||0||
48447001|NCT02406742|101428572|FG001|COMPLETED|Overall Study||0||
48447002|NCT02406742|101428573|FG002|COMPLETED|Overall Study||0||
48447003|NCT02406742|101428571|FG000|NOT COMPLETED|Overall Study||14||
48447004|NCT02406742|101428572|FG001|NOT COMPLETED|Overall Study||16||
48447005|NCT02406742|101428573|FG002|NOT COMPLETED|Overall Study||16||
48447006|NCT02428231|101428574|FG000|STARTED|Overall Study||30||
48447007|NCT02428231|101428575|FG001|STARTED|Overall Study||32||
48447008|NCT02428231|101428574|FG000|COMPLETED|Overall Study||17||
48447009|NCT02428231|101428575|FG001|COMPLETED|Overall Study||15||
48447010|NCT02428231|101428574|FG000|NOT COMPLETED|Overall Study||13||
48447011|NCT02428231|101428575|FG001|NOT COMPLETED|Overall Study||17||
48447012|NCT00057785|101428576|FG000|STARTED|Overall Study||68||
48447013|NCT00057785|101428576|FG000|COMPLETED|Overall Study||68||
48447014|NCT00057785|101428576|FG000|NOT COMPLETED|Overall Study||0||
48447015|NCT02729545|101428577|FG000|STARTED|Overall Study||30||
48447016|NCT02729545|101428578|FG001|STARTED|Overall Study||30||
48447017|NCT02729545|101428577|FG000|COMPLETED|Overall Study||27||
48447018|NCT02729545|101428578|FG001|COMPLETED|Overall Study||25||
48447019|NCT02729545|101428577|FG000|NOT COMPLETED|Overall Study||3||
48447020|NCT02729545|101428578|FG001|NOT COMPLETED|Overall Study||5||
48447021|NCT03895307|101428579|FG000|STARTED|Overall Study||21||
48447022|NCT03895307|101428580|FG001|STARTED|Overall Study||20||
48447023|NCT03895307|101428581|FG002|STARTED|Overall Study||22||
48447024|NCT03895307|101428582|FG003|STARTED|Overall Study||21||
48447025|NCT03895307|101428579|FG000|COMPLETED|Overall Study||19||
48447026|NCT03895307|101428580|FG001|COMPLETED|Overall Study||20||
48447027|NCT03895307|101428581|FG002|COMPLETED|Overall Study||20||
48447028|NCT03895307|101428582|FG003|COMPLETED|Overall Study||21||
48447029|NCT03895307|101428579|FG000|NOT COMPLETED|Overall Study||2||
48447030|NCT03895307|101428580|FG001|NOT COMPLETED|Overall Study||0||
48447031|NCT03895307|101428581|FG002|NOT COMPLETED|Overall Study||2||
48447032|NCT03895307|101428582|FG003|NOT COMPLETED|Overall Study||0||
48447033|NCT00765999|101428583|FG000|STARTED|Overall Study||1554||
48447034|NCT00765999|101428583|FG000|COMPLETED|Overall Study||770||
48447035|NCT00765999|101428583|FG000|NOT COMPLETED|Overall Study||784||
48447036|NCT00837031|101428584|FG000|STARTED|Overall Study||72||
48447037|NCT00837031|101428584|FG000|COMPLETED|Overall Study||72||
48447038|NCT00837031|101428584|FG000|NOT COMPLETED|Overall Study||0||
48447039|NCT00323635|101428585|FG000|STARTED|Overall Study||10||
48447040|NCT00323635|101428586|FG001|STARTED|Overall Study||9||
48447041|NCT00323635|101428585|FG000|COMPLETED|Overall Study||10||
48447042|NCT00323635|101428586|FG001|COMPLETED|Overall Study||9||
48447043|NCT00323635|101428585|FG000|NOT COMPLETED|Overall Study||0||
48447044|NCT00323635|101428586|FG001|NOT COMPLETED|Overall Study||0||
48447045|NCT00566618|101428587|FG000|STARTED|Overall Study||1||
48447046|NCT00566618|101428588|FG001|STARTED|Overall Study||6||
48447047|NCT00566618|101428589|FG002|STARTED|Overall Study||18||
48447048|NCT00566618|101428587|FG000|COMPLETED|Overall Study||0||
48447049|NCT00566618|101428588|FG001|COMPLETED|Overall Study||0||
48447050|NCT00566618|101428589|FG002|COMPLETED|Overall Study||0||
48447051|NCT00566618|101428587|FG000|NOT COMPLETED|Overall Study||1||
48447052|NCT00566618|101428588|FG001|NOT COMPLETED|Overall Study||6||
48447053|NCT00566618|101428589|FG002|NOT COMPLETED|Overall Study||18||
48447054|NCT01372254|101428590|FG000|STARTED|Overall Study||47||
48447055|NCT01372254|101428591|FG001|STARTED|Overall Study||49||
48447056|NCT01372254|101428590|FG000|COMPLETED|Overall Study||43||
48447057|NCT01372254|101428591|FG001|COMPLETED|Overall Study||46||
48447058|NCT01372254|101428590|FG000|NOT COMPLETED|Overall Study||4||
48447059|NCT01372254|101428591|FG001|NOT COMPLETED|Overall Study||3||
48447060|NCT04523831|101428592|FG000|STARTED|Overall Study||200||
48447061|NCT04523831|101428593|FG001|STARTED|Overall Study||200||
48447062|NCT04523831|101428592|FG000|COMPLETED|Overall Study||183||
48447063|NCT04523831|101428593|FG001|COMPLETED|Overall Study||180||
48447064|NCT04523831|101428592|FG000|NOT COMPLETED|Overall Study||17||
48447065|NCT04523831|101428593|FG001|NOT COMPLETED|Overall Study||20||
48447066|NCT00656019|101428594|FG000|STARTED|Overall Study||29||
48447067|NCT00656019|101428595|FG001|STARTED|Overall Study||19||
48447068|NCT00656019|101428596|FG002|STARTED|Overall Study||11||
48447069|NCT00656019|101428597|FG003|STARTED|Overall Study||4||
48447070|NCT00656019|101428594|FG000|COMPLETED|Overall Study||15||
48447071|NCT00656019|101428595|FG001|COMPLETED|Overall Study||18||
48447072|NCT00656019|101428596|FG002|COMPLETED|Overall Study||11||
48447073|NCT00656019|101428597|FG003|COMPLETED|Overall Study||4||
48447074|NCT00656019|101428594|FG000|NOT COMPLETED|Overall Study||14||
48447075|NCT00656019|101428595|FG001|NOT COMPLETED|Overall Study||1||
48447076|NCT00656019|101428596|FG002|NOT COMPLETED|Overall Study||0||
48447077|NCT00656019|101428597|FG003|NOT COMPLETED|Overall Study||0||
48447078|NCT00858234|101428598|FG000|STARTED|Overall Study||9||
48447079|NCT00858234|101428598|FG000|COMPLETED|Overall Study||0||
48447080|NCT00858234|101428598|FG000|NOT COMPLETED|Overall Study||9||
48447081|NCT00995930|101428599|FG000|STARTED|Overall Study||94||
48447082|NCT00995930|101428600|FG001|STARTED|Overall Study||95||
48447083|NCT00995930|101428599|FG000|Safety Analysis Set|Overall Study||94||
48447084|NCT00995930|101428600|FG001|Safety Analysis Set|Overall Study||95||
48447085|NCT00995930|101428599|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||0||
48447086|NCT00995930|101428600|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||95||
48447087|NCT00995930|101428599|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||92||
48447088|NCT00995930|101428600|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||92||
48447089|NCT00995930|101428599|FG000|Imaging Analysis Set|Overall Study||92||
48447090|NCT00995930|101428600|FG001|Imaging Analysis Set|Overall Study||92||
48447091|NCT00995930|101428599|FG000|COMPLETED|Overall Study||73||
48447092|NCT00995930|101428600|FG001|COMPLETED|Overall Study||67||
48447093|NCT00995930|101428599|FG000|NOT COMPLETED|Overall Study||21||
48447094|NCT00995930|101428600|FG001|NOT COMPLETED|Overall Study||28||
48447095|NCT03174925|101428601|FG000|STARTED|Overall Study||55||
48447096|NCT03174925|101428601|FG000|COMPLETED|Overall Study||52||
48447097|NCT03174925|101428601|FG000|NOT COMPLETED|Overall Study||3||
48447098|NCT00963599|101428602|FG000|STARTED|Overall Study||149||
48447099|NCT00963599|101428603|FG001|STARTED|Overall Study||155||
48447100|NCT00963599|101428604|FG002|STARTED|Overall Study||301||
48447101|NCT00963599|101428605|FG003|STARTED|Overall Study||302||
48447102|NCT00963599|101428602|FG000|COMPLETED|Overall Study||143||
48447103|NCT00963599|101428603|FG001|COMPLETED|Overall Study||149||
48447104|NCT00963599|101428604|FG002|COMPLETED|Overall Study||292||
48447105|NCT00963599|101428605|FG003|COMPLETED|Overall Study||288||
48447106|NCT00963599|101428602|FG000|NOT COMPLETED|Overall Study||6||
48447107|NCT00963599|101428603|FG001|NOT COMPLETED|Overall Study||6||
48447108|NCT00963599|101428604|FG002|NOT COMPLETED|Overall Study||9||
48447109|NCT00963599|101428605|FG003|NOT COMPLETED|Overall Study||14||
48447110|NCT00716586|101428606|FG000|STARTED|Overall Study||44||
48447111|NCT00716586|101428606|FG000|COMPLETED|Overall Study||44||
48447112|NCT00716586|101428606|FG000|NOT COMPLETED|Overall Study||0||
48447113|NCT00755937|101428607|FG000|STARTED|Recruitment||556||
48447114|NCT00755937|101428607|FG000|COMPLETED|Recruitment||392||
48447115|NCT00755937|101428607|FG000|NOT COMPLETED|Recruitment||164||
48189069|NCT00708097|100786149|FG000|COMPLETED|Period 1||11||
48189070|NCT00708097|100786150|FG001|COMPLETED|Period 1||11||
48447116|NCT00755937|101428607|FG000|STARTED|Observational Follow-up||392||
48447117|NCT00755937|101428607|FG000|COMPLETED|Observational Follow-up||244||
48447118|NCT00755937|101428607|FG000|NOT COMPLETED|Observational Follow-up||148||
48447119|NCT01166997|101428608|FG000|STARTED|Overall Study||29||
48447120|NCT01166997|101428609|FG001|STARTED|Overall Study||30||
48447121|NCT01166997|101428608|FG000|COMPLETED|Overall Study||27||
48447122|NCT01166997|101428609|FG001|COMPLETED|Overall Study||30||
48447123|NCT01166997|101428608|FG000|NOT COMPLETED|Overall Study||2||
48447124|NCT01166997|101428609|FG001|NOT COMPLETED|Overall Study||0||
48447125|NCT01610167|101428610|FG000|STARTED|Overall Study||52||
48447126|NCT01610167|101428611|FG001|STARTED|Overall Study||49||
48447127|NCT01610167|101428612|FG002|STARTED|Overall Study||50||
48447128|NCT01610167|101428610|FG000|COMPLETED|Overall Study||52||
48447129|NCT01610167|101428611|FG001|COMPLETED|Overall Study||49||
48447130|NCT01610167|101428612|FG002|COMPLETED|Overall Study||48||
48447131|NCT01610167|101428610|FG000|NOT COMPLETED|Overall Study||0||
48447132|NCT01610167|101428611|FG001|NOT COMPLETED|Overall Study||0||
48447133|NCT01610167|101428612|FG002|NOT COMPLETED|Overall Study||2||
48447134|NCT02524665|101428613|FG000|STARTED|Overall Study||20||
48447135|NCT02524665|101428613|FG000|COMPLETED|Overall Study||19||
48447136|NCT02524665|101428613|FG000|NOT COMPLETED|Overall Study||1||
48447137|NCT02357173|101428614|FG000|STARTED|Overall Study||25||
48447138|NCT02357173|101428615|FG001|STARTED|Overall Study||21||
48770760|NCT02581410|102229261|FG001|NOT COMPLETED|End of Study Phase||11||
48770761|NCT00891904|102229262|FG000|STARTED|Overall Study||2||
48770762|NCT00891904|102229262|FG000|COMPLETED|Overall Study||0||
48770763|NCT00891904|102229262|FG000|NOT COMPLETED|Overall Study||2||
48770764|NCT01931566|102229263|FG000|STARTED|Overall Study||433||
48770765|NCT01931566|102229264|FG001|STARTED|Overall Study||1516||
48770766|NCT01931566|102229265|FG002|STARTED|Overall Study||1545||
48770767|NCT01931566|102229263|FG000|Treated|Overall Study||427||
48770768|NCT01931566|102229264|FG001|Treated|Overall Study||1507||
48770769|NCT01931566|102229265|FG002|Treated|Overall Study||1531||
48770770|NCT01931566|102229263|FG000|COMPLETED|Overall Study||4|Completed here refers to those participants who completed study drug.|
48770771|NCT01931566|102229264|FG001|COMPLETED|Overall Study||40|Completed here refers to those participants who completed study drug.|
48770772|NCT01931566|102229265|FG002|COMPLETED|Overall Study||39|Completed here refers to those participants who completed study drug.|
48770773|NCT01931566|102229263|FG000|NOT COMPLETED|Overall Study||429||
48770774|NCT01931566|102229264|FG001|NOT COMPLETED|Overall Study||1476||
48770775|NCT01931566|102229265|FG002|NOT COMPLETED|Overall Study||1506||
48770776|NCT02268175|102229266|FG000|STARTED|Overall Study||50||
48770777|NCT02268175|102229267|FG001|STARTED|Overall Study||25||
48770778|NCT02268175|102229266|FG000|COMPLETED|Overall Study||50||
48770779|NCT02268175|102229267|FG001|COMPLETED|Overall Study||25||
48770780|NCT02268175|102229266|FG000|NOT COMPLETED|Overall Study||0||
48770781|NCT02268175|102229267|FG001|NOT COMPLETED|Overall Study||0||
48770782|NCT02395081|102229268|FG000|STARTED|Overall Study||119||
48770783|NCT02395081|102229269|FG001|STARTED|Overall Study||121||
48770784|NCT02395081|102229270|FG002|STARTED|Overall Study||120||
48770785|NCT02395081|102229268|FG000|COMPLETED|Overall Study||112||
48770786|NCT02395081|102229269|FG001|COMPLETED|Overall Study||116||
48770787|NCT02395081|102229270|FG002|COMPLETED|Overall Study||116||
48770788|NCT02395081|102229268|FG000|NOT COMPLETED|Overall Study||7||
48770789|NCT02395081|102229269|FG001|NOT COMPLETED|Overall Study||5||
48770790|NCT02395081|102229270|FG002|NOT COMPLETED|Overall Study||4||
48770791|NCT03388164|102229271|FG000|STARTED|Overall Study||10||
48659165|NCT00966446|101949132|FG002|STARTED|Overall Study||73||
48447139|NCT02357173|101428616|FG002|STARTED|Overall Study||22||
48447140|NCT02357173|101428614|FG000|COMPLETED|Overall Study||19||
48447141|NCT02357173|101428615|FG001|COMPLETED|Overall Study||15||
48447142|NCT02357173|101428616|FG002|COMPLETED|Overall Study||16||
48447143|NCT02357173|101428614|FG000|NOT COMPLETED|Overall Study||6||
48447144|NCT02357173|101428615|FG001|NOT COMPLETED|Overall Study||6||
48659166|NCT00966446|101949130|FG000|COMPLETED|Overall Study||48||
48659167|NCT00966446|101949131|FG001|COMPLETED|Overall Study||49||
48659168|NCT00966446|101949132|FG002|COMPLETED|Overall Study||52||
48659169|NCT00966446|101949130|FG000|NOT COMPLETED|Overall Study||28||
48659170|NCT00966446|101949131|FG001|NOT COMPLETED|Overall Study||25||
48659171|NCT00966446|101949132|FG002|NOT COMPLETED|Overall Study||21||
48659172|NCT00449787|101949133|FG000|STARTED|Overall Study||203||
48659173|NCT00449787|101949134|FG001|STARTED|Overall Study||198||
48659174|NCT00449787|101949133|FG000|COMPLETED|Overall Study||98||
48659175|NCT00449787|101949134|FG001|COMPLETED|Overall Study||98||
48659176|NCT00449787|101949133|FG000|NOT COMPLETED|Overall Study||105||
48659177|NCT00449787|101949134|FG001|NOT COMPLETED|Overall Study||100||
48659178|NCT04691115|101949135|FG000|STARTED|Overall Study||18||
48659179|NCT04691115|101949136|FG001|STARTED|Overall Study||6||
48659180|NCT04691115|101949137|FG002|STARTED|Overall Study||6||
48659181|NCT04691115|101949138|FG003|STARTED|Overall Study||6||
48659182|NCT04691115|101949139|FG004|STARTED|Overall Study||6||
48659183|NCT04691115|101949140|FG005|STARTED|Overall Study||7||
48659184|NCT04691115|101949141|FG006|STARTED|Overall Study||6||
48659185|NCT04691115|101949142|FG007|STARTED|Overall Study||6||
48659186|NCT04691115|101949143|FG008|STARTED|Overall Study||6||
48659187|NCT04691115|101949144|FG009|STARTED|Overall Study||6||
48659188|NCT04691115|101949145|FG010|STARTED|Overall Study||6||
48659189|NCT04691115|101949146|FG011|STARTED|Overall Study||6||
48659190|NCT04691115|101949147|FG012|STARTED|Overall Study||6||
48659191|NCT04691115|101949148|FG013|STARTED|Overall Study||6||
48659192|NCT04691115|101949135|FG000|COMPLETED|Overall Study||18||
48659193|NCT04691115|101949136|FG001|COMPLETED|Overall Study||6||
48659194|NCT04691115|101949137|FG002|COMPLETED|Overall Study||6||
48659195|NCT04691115|101949138|FG003|COMPLETED|Overall Study||6||
48659196|NCT04691115|101949139|FG004|COMPLETED|Overall Study||6||
48659197|NCT04691115|101949140|FG005|COMPLETED|Overall Study||6||
48659198|NCT04691115|101949141|FG006|COMPLETED|Overall Study||6||
48659199|NCT04691115|101949142|FG007|COMPLETED|Overall Study||6||
48770792|NCT03388164|102229272|FG001|STARTED|Overall Study||10||
48770793|NCT03388164|102229271|FG000|COMPLETED|Overall Study||7||
48770794|NCT03388164|102229272|FG001|COMPLETED|Overall Study||9||
48770795|NCT03388164|102229271|FG000|NOT COMPLETED|Overall Study||3||
48770796|NCT03388164|102229272|FG001|NOT COMPLETED|Overall Study||1||
48770797|NCT04198714|102229273|FG000|STARTED|Overall Study||36||
48770798|NCT04198714|102229274|FG001|STARTED|Overall Study||36||
48770799|NCT04198714|102229273|FG000|COMPLETED|Overall Study||36||
48770800|NCT04198714|102229274|FG001|COMPLETED|Overall Study||35||
48770801|NCT04198714|102229273|FG000|NOT COMPLETED|Overall Study||0||
48770802|NCT04198714|102229274|FG001|NOT COMPLETED|Overall Study||1||
48770803|NCT03906448|102229275|FG000|STARTED|Overall Study||1||
48770804|NCT03906448|102229276|FG001|STARTED|Overall Study||0||
48770805|NCT03906448|102229275|FG000|COMPLETED|Overall Study||1||
48770806|NCT03906448|102229276|FG001|COMPLETED|Overall Study||0||
48770807|NCT03906448|102229275|FG000|NOT COMPLETED|Overall Study||0||
48770808|NCT03906448|102229276|FG001|NOT COMPLETED|Overall Study||0||
48770809|NCT03881852|102229277|FG000|STARTED|Overall Study||11||
48770810|NCT03881852|102229278|FG001|STARTED|Overall Study||10||
48770811|NCT03881852|102229277|FG000|Dosed With AXS-12|Overall Study||11||
48770812|NCT03881852|102229278|FG001|Dosed With AXS-12|Overall Study||10||
48770813|NCT03881852|102229277|FG000|Dosed With Placebo|Overall Study||10||
48770814|NCT03881852|102229278|FG001|Dosed With Placebo|Overall Study||10||
48770815|NCT03881852|102229277|FG000|COMPLETED|Overall Study||10||
48770816|NCT03881852|102229278|FG001|COMPLETED|Overall Study||10||
48770817|NCT03881852|102229277|FG000|NOT COMPLETED|Overall Study||1||
48770818|NCT03881852|102229278|FG001|NOT COMPLETED|Overall Study||0||
48770819|NCT04292899|102229279|FG000|STARTED|Overall Study||200||
48770820|NCT04292899|102229280|FG001|STARTED|Overall Study||197||
48770821|NCT04292899|102229281|FG002|STARTED|Overall Study||844||
48770822|NCT04292899|102229282|FG003|STARTED|Overall Study||3597||
48770823|NCT04292899|102229279|FG000|COMPLETED|Overall Study||168||
48770824|NCT04292899|102229280|FG001|COMPLETED|Overall Study||164||
48770825|NCT04292899|102229281|FG002|COMPLETED|Overall Study||621||
48770826|NCT04292899|102229282|FG003|COMPLETED|Overall Study||2952||
48770827|NCT04292899|102229279|FG000|NOT COMPLETED|Overall Study||32||
48770828|NCT04292899|102229280|FG001|NOT COMPLETED|Overall Study||33||
48770829|NCT04292899|102229281|FG002|NOT COMPLETED|Overall Study||223||
48770830|NCT04292899|102229282|FG003|NOT COMPLETED|Overall Study||645||
48770831|NCT02578706|102229283|FG000|STARTED|Overall Study||9||
48770832|NCT02578706|102229284|FG001|STARTED|Overall Study||10||
48770833|NCT02578706|102229285|FG002|STARTED|Overall Study||8||
48770834|NCT02578706|102229283|FG000|COMPLETED|Overall Study||8||
48770835|NCT02578706|102229284|FG001|COMPLETED|Overall Study||5||
48770836|NCT02578706|102229285|FG002|COMPLETED|Overall Study||8||
48770837|NCT02578706|102229283|FG000|NOT COMPLETED|Overall Study||1||
48770838|NCT02578706|102229284|FG001|NOT COMPLETED|Overall Study||5||
48770839|NCT02578706|102229285|FG002|NOT COMPLETED|Overall Study||0||
48770840|NCT01600716|102229286|FG000|STARTED|Overall Study||66||
48770841|NCT01600716|102229287|FG001|STARTED|Overall Study||78||
48659200|NCT04691115|101949143|FG008|COMPLETED|Overall Study||6||
48659201|NCT04691115|101949144|FG009|COMPLETED|Overall Study||6||
48659202|NCT04691115|101949145|FG010|COMPLETED|Overall Study||6||
48659203|NCT04691115|101949146|FG011|COMPLETED|Overall Study||6||
48659204|NCT04691115|101949147|FG012|COMPLETED|Overall Study||6||
48770842|NCT01600716|102229286|FG000|COMPLETED|Overall Study||59||
48770843|NCT01600716|102229287|FG001|COMPLETED|Overall Study||71||
48770844|NCT01600716|102229286|FG000|NOT COMPLETED|Overall Study||7||
48770845|NCT01600716|102229287|FG001|NOT COMPLETED|Overall Study||7||
48770846|NCT00831181|102229288|FG000|STARTED|Overall Study||27||
48770847|NCT00831181|102229288|FG000|COMPLETED|Overall Study||15||
48770848|NCT00831181|102229288|FG000|NOT COMPLETED|Overall Study||12||
48659205|NCT04691115|101949148|FG013|COMPLETED|Overall Study||6||
48659206|NCT04691115|101949135|FG000|NOT COMPLETED|Overall Study||0||
48659207|NCT04691115|101949136|FG001|NOT COMPLETED|Overall Study||0||
48659208|NCT04691115|101949137|FG002|NOT COMPLETED|Overall Study||0||
48659209|NCT04691115|101949138|FG003|NOT COMPLETED|Overall Study||0||
48659210|NCT04691115|101949139|FG004|NOT COMPLETED|Overall Study||0||
48659211|NCT04691115|101949140|FG005|NOT COMPLETED|Overall Study||1||
48659212|NCT04691115|101949141|FG006|NOT COMPLETED|Overall Study||0||
48659213|NCT04691115|101949142|FG007|NOT COMPLETED|Overall Study||0||
48770849|NCT02506244|102229289|FG000|STARTED|Overall Study||1366||
48770850|NCT02506244|102229290|FG001|STARTED|Overall Study||1293||
48770851|NCT02506244|102229291|FG002|STARTED|Overall Study||3476||
48770852|NCT02506244|102229289|FG000|COMPLETED|Overall Study||908||
48770853|NCT02506244|102229290|FG001|COMPLETED|Overall Study||834||
48770854|NCT02506244|102229291|FG002|COMPLETED|Overall Study||3476||
48770855|NCT02506244|102229289|FG000|NOT COMPLETED|Overall Study||458||
48659214|NCT04691115|101949143|FG008|NOT COMPLETED|Overall Study||0||
48770856|NCT02506244|102229290|FG001|NOT COMPLETED|Overall Study||459||
48770857|NCT02506244|102229291|FG002|NOT COMPLETED|Overall Study||0||
48770858|NCT02189317|102229292|FG000|STARTED|Overall Study||16||
48770859|NCT02189317|102229293|FG001|STARTED|Overall Study||16||
48770860|NCT02189317|102229292|FG000|COMPLETED|Overall Study||16||
48770861|NCT02189317|102229293|FG001|COMPLETED|Overall Study||16||
48447145|NCT02357173|101428616|FG002|NOT COMPLETED|Overall Study||6||
48447146|NCT01052038|101428617|FG000|STARTED|Overall Study||40||
48447147|NCT01052038|101428618|FG001|STARTED|Overall Study||40||
48447148|NCT01052038|101428619|FG002|STARTED|Overall Study||40||
48447149|NCT01052038|101428617|FG000|COMPLETED|Overall Study||36||
48447150|NCT01052038|101428618|FG001|COMPLETED|Overall Study||34||
48447151|NCT01052038|101428619|FG002|COMPLETED|Overall Study||36||
48447152|NCT01052038|101428617|FG000|NOT COMPLETED|Overall Study||4||
48447153|NCT01052038|101428618|FG001|NOT COMPLETED|Overall Study||6||
48447154|NCT01052038|101428619|FG002|NOT COMPLETED|Overall Study||4||
48447155|NCT00306852|101428620|FG000|STARTED|Overall Study||105||
48447156|NCT00306852|101428621|FG001|STARTED|Overall Study||107||
48447157|NCT00306852|101428620|FG000|COMPLETED|Overall Study||76||
48447158|NCT00306852|101428621|FG001|COMPLETED|Overall Study||69||
48447159|NCT00306852|101428620|FG000|NOT COMPLETED|Overall Study||29||
48447160|NCT00306852|101428621|FG001|NOT COMPLETED|Overall Study||38||
48447161|NCT03454672|101428622|FG000|STARTED|Overall Study||34||
48447162|NCT03454672|101428623|FG001|STARTED|Overall Study||34||
48447163|NCT03454672|101428622|FG000|COMPLETED|Overall Study||25||
48447164|NCT03454672|101428623|FG001|COMPLETED|Overall Study||22||
48447165|NCT03454672|101428622|FG000|NOT COMPLETED|Overall Study||9||
48447166|NCT03454672|101428623|FG001|NOT COMPLETED|Overall Study||12||
48447167|NCT04253756|101428624|FG000|STARTED|Overall Study||26||
48447168|NCT04253756|101428624|FG000|Procedure 1: 18 Guage|Overall Study||12||
48447169|NCT04253756|101428624|FG000|Procedure 1: 20 Gauge|Overall Study||14||
48447170|NCT04253756|101428624|FG000|Procedure 2: 18 Gauge|Overall Study||9||
48447171|NCT04253756|101428624|FG000|Procedure 2: 20 Gauge|Overall Study||7||
48447172|NCT04253756|101428624|FG000|Procedure 3: 18 Gauge|Overall Study||6||
48447173|NCT04253756|101428624|FG000|Procedure 3: 20 Gauge|Overall Study||5||
48447174|NCT04253756|101428624|FG000|Procedure 4: 18 Gauge|Overall Study||5||
48447175|NCT04253756|101428624|FG000|Procedure 4: 20 Gauge|Overall Study||3||
48447176|NCT04253756|101428624|FG000|Procedure 5: 18 Gauge|Overall Study||2||
48447177|NCT04253756|101428624|FG000|Procedure 5: 20 Gauge|Overall Study||3||
48447178|NCT04253756|101428624|FG000|Procedure 6: 18 Gauge|Overall Study||1||
48447179|NCT04253756|101428624|FG000|Procedure 6: 20 Gauge|Overall Study||2||
48447180|NCT04253756|101428624|FG000|Procedure 7: 18 Gauge|Overall Study||1||
48447181|NCT04253756|101428624|FG000|Procedure 7: 20 Gauge|Overall Study||1||
48447182|NCT04253756|101428624|FG000|Procedure 8: 18 Gauge|Overall Study||0||
48447183|NCT04253756|101428624|FG000|Procedure 8: 20 Gauge|Overall Study||2||
48447184|NCT04253756|101428624|FG000|COMPLETED|Overall Study||21||
48447185|NCT04253756|101428624|FG000|NOT COMPLETED|Overall Study||5||
48447186|NCT00904189|101428625|FG000|STARTED|Overall Study||2||
48447187|NCT00904189|101428625|FG000|COMPLETED|Overall Study||2||
48447188|NCT00904189|101428625|FG000|NOT COMPLETED|Overall Study||0||
48447189|NCT02955394|101428626|FG000|STARTED|Overall Study||27||
48447190|NCT02955394|101428627|FG001|STARTED|Overall Study||34||
48447191|NCT02955394|101428626|FG000|COMPLETED|Overall Study||25||
48447192|NCT02955394|101428627|FG001|COMPLETED|Overall Study||32||
48447193|NCT02955394|101428626|FG000|NOT COMPLETED|Overall Study||2||
48447194|NCT02955394|101428627|FG001|NOT COMPLETED|Overall Study||2||
48447195|NCT00530439|101428628|FG000|STARTED|Overall Study||180||
48447196|NCT00530439|101428629|FG001|STARTED|Overall Study||180||
48447197|NCT00530439|101428628|FG000|COMPLETED|Overall Study||150||
48447198|NCT00530439|101428629|FG001|COMPLETED|Overall Study||154||
48447199|NCT00530439|101428628|FG000|NOT COMPLETED|Overall Study||30||
48447200|NCT00530439|101428629|FG001|NOT COMPLETED|Overall Study||26||
48447201|NCT00869141|101428630|FG000|STARTED|Overall Study||26||
48447202|NCT00869141|101428631|FG001|STARTED|Overall Study||26||
48447203|NCT00869141|101428630|FG000|COMPLETED|Overall Study||26||
48447204|NCT00869141|101428631|FG001|COMPLETED|Overall Study||26||
48447205|NCT00869141|101428630|FG000|NOT COMPLETED|Overall Study||0||
48659215|NCT04691115|101949144|FG009|NOT COMPLETED|Overall Study||0||
48659216|NCT04691115|101949145|FG010|NOT COMPLETED|Overall Study||0||
48659217|NCT04691115|101949146|FG011|NOT COMPLETED|Overall Study||0||
48659218|NCT04691115|101949147|FG012|NOT COMPLETED|Overall Study||0||
48659219|NCT04691115|101949148|FG013|NOT COMPLETED|Overall Study||0||
48659220|NCT04875533|101949149|FG000|STARTED|Overall Study||711|Participants Vaccinated with Vaccination 1|
48659221|NCT04875533|101949150|FG001|STARTED|Overall Study||710|Participants Vaccinated with Vaccination 1|
48659222|NCT04875533|101949149|FG000|Vaccinated With Vaccination 2|Overall Study||695||
48659223|NCT04875533|101949150|FG001|Vaccinated With Vaccination 2|Overall Study||699||
48770862|NCT02189317|102229292|FG000|NOT COMPLETED|Overall Study||0||
48447206|NCT00869141|101428631|FG001|NOT COMPLETED|Overall Study||0||
48447207|NCT02177773|101428632|FG000|STARTED|Overall Study||300||
48447208|NCT02177773|101428632|FG000|COMPLETED|Overall Study||300||
48447209|NCT02177773|101428632|FG000|NOT COMPLETED|Overall Study||0||
48447210|NCT00386100|101428633|FG000|STARTED|Overall Study||340||
48447211|NCT00386100|101428634|FG001|STARTED|Overall Study||348||
48447212|NCT00386100|101428633|FG000|COMPLETED|Overall Study||186||
48447213|NCT00386100|101428634|FG001|COMPLETED|Overall Study||217||
48447214|NCT00386100|101428633|FG000|NOT COMPLETED|Overall Study||154||
48447215|NCT00386100|101428634|FG001|NOT COMPLETED|Overall Study||131||
48447216|NCT03349437|101428635|FG000|STARTED|Screening||25||
48447217|NCT03349437|101428636|FG001|STARTED|Screening||0||
48447218|NCT03349437|101428637|FG002|STARTED|Screening||0||
48447219|NCT03349437|101428635|FG000|COMPLETED|Screening||20||
48447220|NCT03349437|101428636|FG001|COMPLETED|Screening||0||
48447221|NCT03349437|101428637|FG002|COMPLETED|Screening||0||
48447222|NCT03349437|101428635|FG000|NOT COMPLETED|Screening||5||
48447223|NCT03349437|101428636|FG001|NOT COMPLETED|Screening||0||
48447224|NCT03349437|101428637|FG002|NOT COMPLETED|Screening||0||
48447225|NCT03349437|101428635|FG000|STARTED|Intervention||0||
48447226|NCT03349437|101428636|FG001|STARTED|Intervention||10||
48447227|NCT03349437|101428637|FG002|STARTED|Intervention||10||
48447228|NCT03349437|101428635|FG000|COMPLETED|Intervention||0||
48447229|NCT03349437|101428636|FG001|COMPLETED|Intervention||10||
48447230|NCT03349437|101428637|FG002|COMPLETED|Intervention||10||
48659224|NCT04875533|101949149|FG000|COMPLETED|Overall Study||692||
48659225|NCT04875533|101949150|FG001|COMPLETED|Overall Study||699||
48659226|NCT04875533|101949149|FG000|NOT COMPLETED|Overall Study||19||
48659227|NCT04875533|101949150|FG001|NOT COMPLETED|Overall Study||11||
48659228|NCT00720083|101949151|FG000|STARTED|Overall Study||17||
48770863|NCT02189317|102229293|FG001|NOT COMPLETED|Overall Study||0||
48770864|NCT04048356|102229294|FG000|STARTED|Overall Study||72||
48770865|NCT04048356|102229295|FG001|STARTED|Overall Study||65||
48770866|NCT04048356|102229294|FG000|COMPLETED|Overall Study||61||
48770867|NCT04048356|102229295|FG001|COMPLETED|Overall Study||58||
48770868|NCT04048356|102229294|FG000|NOT COMPLETED|Overall Study||11||
48770869|NCT04048356|102229295|FG001|NOT COMPLETED|Overall Study||7||
48770870|NCT00439517|102229296|FG000|STARTED|Overall Study||152||
48770871|NCT00439517|102229297|FG001|STARTED|Overall Study||150||
48770872|NCT00439517|102229296|FG000|COMPLETED|Overall Study||150||
48770873|NCT00439517|102229297|FG001|COMPLETED|Overall Study||150||
48770874|NCT00439517|102229296|FG000|NOT COMPLETED|Overall Study||2||
48770875|NCT00439517|102229297|FG001|NOT COMPLETED|Overall Study||0||
48770876|NCT02419001|102229298|FG000|STARTED|Period 1- Ceftriaxone Without SYN-004||6||
48770877|NCT02419001|102229299|FG001|STARTED|Period 1- Ceftriaxone Without SYN-004||5||
48770878|NCT02419001|102229298|FG000|COMPLETED|Period 1- Ceftriaxone Without SYN-004||5||
48770879|NCT02419001|102229299|FG001|COMPLETED|Period 1- Ceftriaxone Without SYN-004||5||
48770880|NCT02419001|102229298|FG000|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||1||
48770881|NCT02419001|102229299|FG001|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||0||
48770882|NCT02419001|102229298|FG000|STARTED|Period 2- Ceftriaxone With SYN-004||5||
48770883|NCT02419001|102229299|FG001|STARTED|Period 2- Ceftriaxone With SYN-004||5||
48770884|NCT02419001|102229298|FG000|COMPLETED|Period 2- Ceftriaxone With SYN-004||5||
48447231|NCT03349437|101428635|FG000|NOT COMPLETED|Intervention||0||
48447232|NCT03349437|101428636|FG001|NOT COMPLETED|Intervention||0||
48447233|NCT03349437|101428637|FG002|NOT COMPLETED|Intervention||0||
48447234|NCT00246441|101428638|FG000|STARTED|Overall Study||20||
48447235|NCT00246441|101428639|FG001|STARTED|Overall Study||22||
48447236|NCT00246441|101428638|FG000|COMPLETED|Overall Study||19||
48447237|NCT00246441|101428639|FG001|COMPLETED|Overall Study||22||
48447238|NCT00246441|101428638|FG000|NOT COMPLETED|Overall Study||1||
48447239|NCT00246441|101428639|FG001|NOT COMPLETED|Overall Study||0||
48447240|NCT04604496|101428640|FG000|STARTED|Open Label Treatment||6||
48447241|NCT04604496|101428641|FG001|STARTED|Open Label Treatment||6||
48447242|NCT04604496|101428642|FG002|STARTED|Open Label Treatment||6||
48447243|NCT04604496|101428643|FG003|STARTED|Open Label Treatment||6||
48447244|NCT04604496|101428640|FG000|COMPLETED|Open Label Treatment||6||
48447245|NCT04604496|101428641|FG001|COMPLETED|Open Label Treatment||6||
48659229|NCT00720083|101949152|FG001|STARTED|Overall Study||15||
48659230|NCT00720083|101949151|FG000|COMPLETED|Overall Study||16||
48659231|NCT00720083|101949152|FG001|COMPLETED|Overall Study||13||
48659232|NCT00720083|101949151|FG000|NOT COMPLETED|Overall Study||1||
48659233|NCT00720083|101949152|FG001|NOT COMPLETED|Overall Study||2||
48659234|NCT03069924|101949153|FG000|STARTED|Overall Study||183||
48447246|NCT04604496|101428642|FG002|COMPLETED|Open Label Treatment||6||
48447247|NCT04604496|101428643|FG003|COMPLETED|Open Label Treatment||6||
48447248|NCT04604496|101428640|FG000|NOT COMPLETED|Open Label Treatment||0||
48447249|NCT04604496|101428641|FG001|NOT COMPLETED|Open Label Treatment||0||
48447250|NCT04604496|101428642|FG002|NOT COMPLETED|Open Label Treatment||0||
48447251|NCT04604496|101428643|FG003|NOT COMPLETED|Open Label Treatment||0||
48447252|NCT04604496|101428640|FG000|STARTED|Follow-Up||6||
48447253|NCT04604496|101428641|FG001|STARTED|Follow-Up||6||
48447254|NCT04604496|101428642|FG002|STARTED|Follow-Up||6||
48447255|NCT04604496|101428643|FG003|STARTED|Follow-Up||6||
48447256|NCT04604496|101428640|FG000|COMPLETED|Follow-Up||6||
48447257|NCT04604496|101428641|FG001|COMPLETED|Follow-Up||6||
48447258|NCT04604496|101428642|FG002|COMPLETED|Follow-Up||6||
48447259|NCT04604496|101428643|FG003|COMPLETED|Follow-Up||6||
48447260|NCT04604496|101428640|FG000|NOT COMPLETED|Follow-Up||0||
48447261|NCT04604496|101428641|FG001|NOT COMPLETED|Follow-Up||0||
48447262|NCT04604496|101428642|FG002|NOT COMPLETED|Follow-Up||0||
48447263|NCT04604496|101428643|FG003|NOT COMPLETED|Follow-Up||0||
48659235|NCT03069924|101949154|FG001|STARTED|Overall Study||184||
48659236|NCT03069924|101949153|FG000|COMPLETED|Overall Study||126||
48770885|NCT02419001|102229299|FG001|COMPLETED|Period 2- Ceftriaxone With SYN-004||5||
48447264|NCT00294632|101431499|FG000|STARTED|Phase I Dose Escalation Period||14||
48447265|NCT00294632|101431500|FG001|STARTED|Phase I Dose Escalation Period||0||
48447266|NCT00294632|101431499|FG000|Cohort 1: 10 mg|Phase I Dose Escalation Period||3||
48447267|NCT00294632|101431500|FG001|Cohort 1: 10 mg|Phase I Dose Escalation Period||0||
48447268|NCT00294632|101431499|FG000|Cohort 2: 15 mg|Phase I Dose Escalation Period||3||
48447269|NCT00294632|101431500|FG001|Cohort 2: 15 mg|Phase I Dose Escalation Period||0||
48447270|NCT00294632|101431499|FG000|Cohort 3: 20 mg|Phase I Dose Escalation Period||6||
48447271|NCT00294632|101431500|FG001|Cohort 3: 20 mg|Phase I Dose Escalation Period||0||
48447272|NCT00294632|101431499|FG000|Cohort 4: 25 mg|Phase I Dose Escalation Period||2||
48447273|NCT00294632|101431500|FG001|Cohort 4: 25 mg|Phase I Dose Escalation Period||0||
48447274|NCT00294632|101431499|FG000|COMPLETED|Phase I Dose Escalation Period||14||
48447275|NCT00294632|101431500|FG001|COMPLETED|Phase I Dose Escalation Period||0||
48447276|NCT00294632|101431499|FG000|NOT COMPLETED|Phase I Dose Escalation Period||0||
48447277|NCT00294632|101431500|FG001|NOT COMPLETED|Phase I Dose Escalation Period||0||
48447278|NCT00294632|101431499|FG000|STARTED|Phase II: 20 mg Lenalidomide||6||
48447279|NCT00294632|101431500|FG001|STARTED|Phase II: 20 mg Lenalidomide||38||
48447280|NCT00294632|101431499|FG000|COMPLETED|Phase II: 20 mg Lenalidomide||6||
48447281|NCT00294632|101431500|FG001|COMPLETED|Phase II: 20 mg Lenalidomide||38||
48447282|NCT00294632|101431499|FG000|NOT COMPLETED|Phase II: 20 mg Lenalidomide||0||
48447283|NCT00294632|101431500|FG001|NOT COMPLETED|Phase II: 20 mg Lenalidomide||0||
48447284|NCT04084028|101431501|FG000|STARTED|Overall Study||18||
48447285|NCT04084028|101431502|FG001|STARTED|Overall Study||16||
48447286|NCT04084028|101431503|FG002|STARTED|Overall Study||9||
48447287|NCT04084028|101431504|FG003|STARTED|Overall Study||10||
48447288|NCT04084028|101431501|FG000|COMPLETED|Overall Study||18||
48447289|NCT04084028|101431502|FG001|COMPLETED|Overall Study||16||
48447290|NCT04084028|101431503|FG002|COMPLETED|Overall Study||9||
48447291|NCT04084028|101431504|FG003|COMPLETED|Overall Study||10||
48659237|NCT03069924|101949154|FG001|COMPLETED|Overall Study||116||
48659238|NCT03069924|101949153|FG000|NOT COMPLETED|Overall Study||57||
48659239|NCT03069924|101949154|FG001|NOT COMPLETED|Overall Study||68||
48659240|NCT02842242|101949155|FG000|STARTED|Overall Study||11||
48659241|NCT02842242|101949156|FG001|STARTED|Overall Study||10||
48659242|NCT02842242|101949155|FG000|COMPLETED|Overall Study||10||
48659243|NCT02842242|101949156|FG001|COMPLETED|Overall Study||10||
48659244|NCT02842242|101949155|FG000|NOT COMPLETED|Overall Study||1||
48659245|NCT02842242|101949156|FG001|NOT COMPLETED|Overall Study||0||
48659246|NCT04212442|101949157|FG000|STARTED|Overall Study||47||8
48659247|NCT04212442|101949158|FG001|STARTED|Overall Study||28||7
48659248|NCT04212442|101949157|FG000|COMPLETED|Overall Study||42||8
48659249|NCT04212442|101949158|FG001|COMPLETED|Overall Study||23||7
48659250|NCT04212442|101949157|FG000|NOT COMPLETED|Overall Study||5||0
48659251|NCT04212442|101949158|FG001|NOT COMPLETED|Overall Study||5||0
48659252|NCT05528445|101949159|FG000|STARTED|Overall Study||77||
48659253|NCT05528445|101949159|FG000|COMPLETED|Overall Study||77||
48659254|NCT05528445|101949159|FG000|NOT COMPLETED|Overall Study||0||
48659255|NCT03574389|101951626|FG000|STARTED|Vaccination Period||125||
48659256|NCT03574389|101951627|FG001|STARTED|Vaccination Period||236||
48659257|NCT03574389|101951628|FG002|STARTED|Vaccination Period||117||
48659258|NCT03574389|101951629|FG003|STARTED|Vaccination Period||165||
48659259|NCT03574389|101951630|FG004|STARTED|Vaccination Period||83||
48659260|NCT03574389|101951631|FG005|STARTED|Vaccination Period||138||
48659261|NCT03574389|101951632|FG006|STARTED|Vaccination Period||68||
48659262|NCT03574389|101951626|FG000|Vaccination 1|Vaccination Period||125||
48447292|NCT04084028|101431501|FG000|NOT COMPLETED|Overall Study||0||
48447293|NCT04084028|101431502|FG001|NOT COMPLETED|Overall Study||0||
48447294|NCT04084028|101431503|FG002|NOT COMPLETED|Overall Study||0||
48447295|NCT04084028|101431504|FG003|NOT COMPLETED|Overall Study||0||
48447296|NCT02517099|101431505|FG000|STARTED|Overall Study||30||
48447297|NCT02517099|101431506|FG001|STARTED|Overall Study||30||
48447298|NCT02517099|101431505|FG000|COMPLETED|Overall Study||25||
48447299|NCT02517099|101431506|FG001|COMPLETED|Overall Study||27||
48447300|NCT02517099|101431505|FG000|NOT COMPLETED|Overall Study||5||
48447301|NCT02517099|101431506|FG001|NOT COMPLETED|Overall Study||3||
48659263|NCT03574389|101951627|FG001|Vaccination 1|Vaccination Period||236||
48659264|NCT03574389|101951628|FG002|Vaccination 1|Vaccination Period||117||
48659265|NCT03574389|101951629|FG003|Vaccination 1|Vaccination Period||165||
48659266|NCT03574389|101951630|FG004|Vaccination 1|Vaccination Period||83||
48659267|NCT03574389|101951631|FG005|Vaccination 1|Vaccination Period||138||
48659268|NCT03574389|101951632|FG006|Vaccination 1|Vaccination Period||68||
48447302|NCT01087801|101431507|FG000|STARTED|Overall Study||30||
48659269|NCT03574389|101951626|FG000|Vaccination 2|Vaccination Period||114||
48447303|NCT01087801|101431508|FG001|STARTED|Overall Study||34||
48659270|NCT03574389|101951627|FG001|Vaccination 2|Vaccination Period||219||
48447304|NCT01087801|101431507|FG000|COMPLETED|Overall Study||26||
48447305|NCT01087801|101431508|FG001|COMPLETED|Overall Study||29||
48659271|NCT03574389|101951628|FG002|Vaccination 2|Vaccination Period||107||
48659272|NCT03574389|101951629|FG003|Vaccination 2|Vaccination Period||146||
48659273|NCT03574389|101951630|FG004|Vaccination 2|Vaccination Period||0||
48659274|NCT03574389|101951631|FG005|Vaccination 2|Vaccination Period||0||
48659275|NCT03574389|101951632|FG006|Vaccination 2|Vaccination Period||0||
48447306|NCT01087801|101431507|FG000|NOT COMPLETED|Overall Study||4||
48447307|NCT01087801|101431508|FG001|NOT COMPLETED|Overall Study||5||
48447308|NCT00666718|101431509|FG000|STARTED|Overall Study||187||
48447309|NCT00666718|101431510|FG001|STARTED|Overall Study||187||
48447310|NCT00666718|101431509|FG000|COMPLETED|Overall Study||175||
48447311|NCT00666718|101431510|FG001|COMPLETED|Overall Study||169||
48447312|NCT00666718|101431509|FG000|NOT COMPLETED|Overall Study||12||
48659276|NCT03574389|101951626|FG000|Vaccination 3|Vaccination Period||111||
48659277|NCT03574389|101951627|FG001|Vaccination 3|Vaccination Period||214||
48659278|NCT03574389|101951628|FG002|Vaccination 3|Vaccination Period||0||
48659279|NCT03574389|101951629|FG003|Vaccination 3|Vaccination Period||0||
48447313|NCT00666718|101431510|FG001|NOT COMPLETED|Overall Study||18||
48447314|NCT02360059|101431511|FG000|STARTED|Overall Study||1||
48447315|NCT02360059|101431512|FG001|STARTED|Overall Study||0||
48447316|NCT02360059|101431511|FG000|COMPLETED|Overall Study||1||
48447317|NCT02360059|101431512|FG001|COMPLETED|Overall Study||0||
48447318|NCT02360059|101431511|FG000|NOT COMPLETED|Overall Study||0||
48447319|NCT02360059|101431512|FG001|NOT COMPLETED|Overall Study||0||
48447320|NCT00919802|101431513|FG000|STARTED|First Intervention - (24 Hours)||12||
48447321|NCT00919802|101431514|FG001|STARTED|First Intervention - (24 Hours)||13||
48447322|NCT00919802|101431513|FG000|COMPLETED|First Intervention - (24 Hours)||12||
48447323|NCT00919802|101431514|FG001|COMPLETED|First Intervention - (24 Hours)||13||
48447324|NCT00919802|101431513|FG000|NOT COMPLETED|First Intervention - (24 Hours)||0||
48447325|NCT00919802|101431514|FG001|NOT COMPLETED|First Intervention - (24 Hours)||0||
48447326|NCT00919802|101431513|FG000|STARTED|Second Intervention - (24 Hours)||12||
48447327|NCT00919802|101431514|FG001|STARTED|Second Intervention - (24 Hours)||13||
48447328|NCT00919802|101431513|FG000|COMPLETED|Second Intervention - (24 Hours)||12||
48447329|NCT00919802|101431514|FG001|COMPLETED|Second Intervention - (24 Hours)||13||
48659280|NCT03574389|101951630|FG004|Vaccination 3|Vaccination Period||0||
48659281|NCT03574389|101951631|FG005|Vaccination 3|Vaccination Period||0||
48659282|NCT03574389|101951632|FG006|Vaccination 3|Vaccination Period||0||
48659283|NCT03574389|101951626|FG000|Vaccination 4|Vaccination Period||92||
48659284|NCT03574389|101951627|FG001|Vaccination 4|Vaccination Period||0||
48659285|NCT03574389|101951628|FG002|Vaccination 4|Vaccination Period||0||
48659286|NCT03574389|101951629|FG003|Vaccination 4|Vaccination Period||0||
48659287|NCT03574389|101951630|FG004|Vaccination 4|Vaccination Period||0||
48659288|NCT03574389|101951631|FG005|Vaccination 4|Vaccination Period||0||
48659289|NCT03574389|101951632|FG006|Vaccination 4|Vaccination Period||0||
48659290|NCT03574389|101951626|FG000|COMPLETED|Vaccination Period||90||
48659291|NCT03574389|101951627|FG001|COMPLETED|Vaccination Period||214||
48659292|NCT03574389|101951628|FG002|COMPLETED|Vaccination Period||107||
48659293|NCT03574389|101951629|FG003|COMPLETED|Vaccination Period||146||
48659294|NCT03574389|101951630|FG004|COMPLETED|Vaccination Period||83||
48659295|NCT03574389|101951631|FG005|COMPLETED|Vaccination Period||138||
48659296|NCT03574389|101951632|FG006|COMPLETED|Vaccination Period||68||
48659297|NCT03574389|101951626|FG000|NOT COMPLETED|Vaccination Period||35||
48659298|NCT03574389|101951627|FG001|NOT COMPLETED|Vaccination Period||22||
48659299|NCT03574389|101951628|FG002|NOT COMPLETED|Vaccination Period||10||
48659300|NCT03574389|101951629|FG003|NOT COMPLETED|Vaccination Period||19||
48659301|NCT03574389|101951630|FG004|NOT COMPLETED|Vaccination Period||0||
48659302|NCT03574389|101951631|FG005|NOT COMPLETED|Vaccination Period||0||
48659303|NCT03574389|101951632|FG006|NOT COMPLETED|Vaccination Period||0||
48770886|NCT02419001|102229298|FG000|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0||
48770887|NCT02419001|102229299|FG001|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0||
48770888|NCT00874094|102229300|FG000|STARTED|Overall Study||15||
48770889|NCT00874094|102229300|FG000|COMPLETED|Overall Study||15||
48770890|NCT00874094|102229300|FG000|NOT COMPLETED|Overall Study||0||
48770891|NCT00885170|102229301|FG000|STARTED|Overall Study||124||
48770892|NCT00885170|102229302|FG001|STARTED|Overall Study||122||
48770893|NCT00885170|102229301|FG000|Treated|Overall Study||122||
48770894|NCT00885170|102229302|FG001|Treated|Overall Study||121||
48770895|NCT00885170|102229301|FG000|COMPLETED|Overall Study||86||
48770896|NCT00885170|102229302|FG001|COMPLETED|Overall Study||99||
48770897|NCT00885170|102229301|FG000|NOT COMPLETED|Overall Study||38||
48659304|NCT03574389|101951626|FG000|STARTED|Follow-up Period||90||
48659305|NCT03574389|101951627|FG001|STARTED|Follow-up Period||214||
48659306|NCT03574389|101951628|FG002|STARTED|Follow-up Period||107||
48659307|NCT03574389|101951629|FG003|STARTED|Follow-up Period||146||
48770898|NCT00885170|102229302|FG001|NOT COMPLETED|Overall Study||23||
48770899|NCT02551887|102229303|FG000|STARTED|Overall Study||301||
48189071|NCT00708097|100786151|FG002|COMPLETED|Period 1||12||
48447330|NCT00919802|101431513|FG000|NOT COMPLETED|Second Intervention - (24 Hours)||0||
48447331|NCT00919802|101431514|FG001|NOT COMPLETED|Second Intervention - (24 Hours)||0||
48659308|NCT03574389|101951630|FG004|STARTED|Follow-up Period||83||
48659309|NCT03574389|101951631|FG005|STARTED|Follow-up Period||138||
48770900|NCT02551887|102229304|FG001|STARTED|Overall Study||124||
48770901|NCT02551887|102229305|FG002|STARTED|Overall Study||222||
48659310|NCT03574389|101951632|FG006|STARTED|Follow-up Period||68||
48659311|NCT03574389|101951626|FG000|COMPLETED|Follow-up Period||89||
48659312|NCT03574389|101951627|FG001|COMPLETED|Follow-up Period||201||
48659313|NCT03574389|101951628|FG002|COMPLETED|Follow-up Period||98||
48770902|NCT02551887|102229303|FG000|COMPLETED|Overall Study||301||
48447332|NCT02239601|101431515|FG000|STARTED|Overall Study||29||
48447333|NCT02239601|101431516|FG001|STARTED|Overall Study||32||
48447334|NCT02239601|101431515|FG000|COMPLETED|Overall Study||22||
48770903|NCT02551887|102229304|FG001|COMPLETED|Overall Study||124||
48770904|NCT02551887|102229305|FG002|COMPLETED|Overall Study||222||
48770905|NCT02551887|102229303|FG000|NOT COMPLETED|Overall Study||0||
48770906|NCT02551887|102229304|FG001|NOT COMPLETED|Overall Study||0||
48770907|NCT02551887|102229305|FG002|NOT COMPLETED|Overall Study||0||
48770908|NCT04671017|102229306|FG000|STARTED|Overall Study||51||
48447335|NCT02239601|101431516|FG001|COMPLETED|Overall Study||26||
48447336|NCT02239601|101431515|FG000|NOT COMPLETED|Overall Study||7||
48447337|NCT02239601|101431516|FG001|NOT COMPLETED|Overall Study||6||
48447338|NCT01005680|101431517|FG000|STARTED|Overall Study||126||
48447339|NCT01005680|101431518|FG001|STARTED|Overall Study||130||
48447340|NCT01005680|101431517|FG000|Received at Least 1 Dose of Study Drug|Overall Study||125||
48447341|NCT01005680|101431518|FG001|Received at Least 1 Dose of Study Drug|Overall Study||127||
48447342|NCT01005680|101431517|FG000|COMPLETED|Overall Study||120||
48447343|NCT01005680|101431518|FG001|COMPLETED|Overall Study||119||
48447344|NCT01005680|101431517|FG000|NOT COMPLETED|Overall Study||6||
48447345|NCT01005680|101431518|FG001|NOT COMPLETED|Overall Study||11||
48447346|NCT01289990|101431519|FG000|STARTED|Overall Study||224||
48447347|NCT01289990|101431520|FG001|STARTED|Overall Study||224||
48447348|NCT01289990|101431521|FG002|STARTED|Overall Study||228||
48447349|NCT01289990|101431522|FG003|STARTED|Overall Study||223||
48447350|NCT01289990|101431523|FG004|STARTED|Overall Study||165||
48447351|NCT01289990|101431524|FG005|STARTED|Overall Study||168||
48447352|NCT01289990|101431525|FG006|STARTED|Overall Study||166||
48447353|NCT01289990|101431526|FG007|STARTED|Overall Study||217||
48447354|NCT01289990|101431527|FG008|STARTED|Overall Study||214||
48447355|NCT01289990|101431528|FG009|STARTED|Overall Study||207||
48447356|NCT01289990|101431529|FG010|STARTED|Overall Study||226||
48447357|NCT01289990|101431530|FG011|STARTED|Overall Study||218||
48447358|NCT01289990|101431531|FG012|STARTED|Overall Study||225||
48447359|NCT01289990|101431519|FG000|COMPLETED|Overall Study||147||
48447360|NCT01289990|101431520|FG001|COMPLETED|Overall Study||143||
48447361|NCT01289990|101431521|FG002|COMPLETED|Overall Study||119||
48447362|NCT01289990|101431522|FG003|COMPLETED|Overall Study||136||
48447363|NCT01289990|101431523|FG004|COMPLETED|Overall Study||93||
48447364|NCT01289990|101431524|FG005|COMPLETED|Overall Study||94||
48447365|NCT01289990|101431525|FG006|COMPLETED|Overall Study||78||
48447366|NCT01289990|101431526|FG007|COMPLETED|Overall Study||162||
48447367|NCT01289990|101431527|FG008|COMPLETED|Overall Study||139||
48659314|NCT03574389|101951629|FG003|COMPLETED|Follow-up Period||137||
48659315|NCT03574389|101951630|FG004|COMPLETED|Follow-up Period||76||
48770909|NCT04671017|102229307|FG001|STARTED|Overall Study||51||
48447368|NCT01289990|101431528|FG009|COMPLETED|Overall Study||121||
48447369|NCT01289990|101431529|FG010|COMPLETED|Overall Study||150||
48447370|NCT01289990|101431530|FG011|COMPLETED|Overall Study||150||
48447371|NCT01289990|101431531|FG012|COMPLETED|Overall Study||127||
48189072|NCT00708097|100786152|FG003|COMPLETED|Period 1||9||
48189073|NCT00708097|100786153|FG004|COMPLETED|Period 1||10||
48189074|NCT00708097|100786149|FG000|NOT COMPLETED|Period 1||0||
48189075|NCT00708097|100786150|FG001|NOT COMPLETED|Period 1||1||
48447372|NCT01289990|101431519|FG000|NOT COMPLETED|Overall Study||77||
48447373|NCT01289990|101431520|FG001|NOT COMPLETED|Overall Study||81||
48447374|NCT01289990|101431521|FG002|NOT COMPLETED|Overall Study||109||
48447375|NCT01289990|101431522|FG003|NOT COMPLETED|Overall Study||87||
48447376|NCT01289990|101431523|FG004|NOT COMPLETED|Overall Study||72||
48659316|NCT03574389|101951631|FG005|COMPLETED|Follow-up Period||131||
48659317|NCT03574389|101951632|FG006|COMPLETED|Follow-up Period||67||
48659318|NCT03574389|101951626|FG000|NOT COMPLETED|Follow-up Period||1||
48659319|NCT03574389|101951627|FG001|NOT COMPLETED|Follow-up Period||13||
48659320|NCT03574389|101951628|FG002|NOT COMPLETED|Follow-up Period||9||
48447377|NCT01289990|101431524|FG005|NOT COMPLETED|Overall Study||74||
48189076|NCT00708097|100786151|FG002|NOT COMPLETED|Period 1||0||
48189077|NCT00708097|100786152|FG003|NOT COMPLETED|Period 1||2||
48189078|NCT00708097|100786153|FG004|NOT COMPLETED|Period 1||1||
48447378|NCT01289990|101431525|FG006|NOT COMPLETED|Overall Study||88||
48447379|NCT01289990|101431526|FG007|NOT COMPLETED|Overall Study||55||
48447380|NCT01289990|101431527|FG008|NOT COMPLETED|Overall Study||75||
48447381|NCT01289990|101431528|FG009|NOT COMPLETED|Overall Study||86||
48447382|NCT01289990|101431529|FG010|NOT COMPLETED|Overall Study||76||
48447383|NCT01289990|101431530|FG011|NOT COMPLETED|Overall Study||68||
48447384|NCT01289990|101431531|FG012|NOT COMPLETED|Overall Study||98||
48447385|NCT00529802|101431532|FG000|STARTED|Evaluable for Primary Endpoint||60||
48659321|NCT03574389|101951629|FG003|NOT COMPLETED|Follow-up Period||9||
48659322|NCT03574389|101951630|FG004|NOT COMPLETED|Follow-up Period||7||
48659323|NCT03574389|101951631|FG005|NOT COMPLETED|Follow-up Period||7||
48659324|NCT03574389|101951632|FG006|NOT COMPLETED|Follow-up Period||1||
48659325|NCT01934231|101951633|FG000|STARTED|Overall Study||27||
48659326|NCT01934231|101951633|FG000|COMPLETED|Overall Study||27||
48659327|NCT01934231|101951633|FG000|NOT COMPLETED|Overall Study||0||
48659328|NCT01122680|101951634|FG000|STARTED|Period 1 (4 Weeks)||29||
48659329|NCT01122680|101951635|FG001|STARTED|Period 1 (4 Weeks)||26||
48770910|NCT04671017|102229308|FG002|STARTED|Overall Study||51||
48770911|NCT04671017|102229306|FG000|COMPLETED|Overall Study||51||
48770912|NCT04671017|102229307|FG001|COMPLETED|Overall Study||51||
48770913|NCT04671017|102229308|FG002|COMPLETED|Overall Study||51||
48770914|NCT04671017|102229306|FG000|NOT COMPLETED|Overall Study||0||
48770915|NCT04671017|102229307|FG001|NOT COMPLETED|Overall Study||0||
48770916|NCT04671017|102229308|FG002|NOT COMPLETED|Overall Study||0||
48770917|NCT01807624|102229309|FG000|STARTED|Overall Study||24||
48770918|NCT01807624|102229309|FG000|COMPLETED|Overall Study||24||
48770919|NCT01807624|102229309|FG000|NOT COMPLETED|Overall Study||0||
48770920|NCT03040336|102229310|FG000|STARTED|Overall Study||10||
48770921|NCT03040336|102229311|FG001|STARTED|Overall Study||7||
48770922|NCT03040336|102229310|FG000|COMPLETED|Overall Study||7||
48770923|NCT03040336|102229311|FG001|COMPLETED|Overall Study||4||
48770924|NCT03040336|102229310|FG000|NOT COMPLETED|Overall Study||3||
48770925|NCT03040336|102229311|FG001|NOT COMPLETED|Overall Study||3||
48770926|NCT03557034|102229312|FG000|STARTED|Overall Study||49||
48770927|NCT03557034|102229313|FG001|STARTED|Overall Study||51||
48770928|NCT03557034|102229312|FG000|Randomization|Overall Study||49||
48770929|NCT03557034|102229313|FG001|Randomization|Overall Study||51||
48447386|NCT00529802|101431532|FG000|COMPLETED|Evaluable for Primary Endpoint||50||
48447387|NCT00529802|101431532|FG000|NOT COMPLETED|Evaluable for Primary Endpoint||10||
48447388|NCT00529802|101431532|FG000|STARTED|Evaluable for Secondary Endpoint||50||
48447389|NCT00529802|101431532|FG000|COMPLETED|Evaluable for Secondary Endpoint||48||
48447390|NCT00529802|101431532|FG000|NOT COMPLETED|Evaluable for Secondary Endpoint||2||
48447391|NCT03067506|101431533|FG000|STARTED|Overall Study||30||
48447392|NCT03067506|101431533|FG000|COMPLETED|Overall Study||30||
48447393|NCT03067506|101431533|FG000|NOT COMPLETED|Overall Study||0||
48447394|NCT04508621|101431534|FG000|STARTED|Overall Study||256||
48447395|NCT04508621|101431535|FG001|STARTED|Overall Study||258||
48447396|NCT04508621|101431534|FG000|COMPLETED|Overall Study||189||
48447397|NCT04508621|101431535|FG001|COMPLETED|Overall Study||210||
48447398|NCT04508621|101431534|FG000|NOT COMPLETED|Overall Study||67||
48447399|NCT04508621|101431535|FG001|NOT COMPLETED|Overall Study||48||
48447400|NCT00323271|101431536|FG000|STARTED|Overall Study||13||
48447401|NCT00323271|101431537|FG001|STARTED|Overall Study||12||
48447402|NCT00323271|101431536|FG000|COMPLETED|Overall Study||11||
48447403|NCT00323271|101431537|FG001|COMPLETED|Overall Study||9||
48447404|NCT00323271|101431536|FG000|NOT COMPLETED|Overall Study||2||
48447405|NCT00323271|101431537|FG001|NOT COMPLETED|Overall Study||3||
48447406|NCT00734617|101431538|FG000|STARTED|Overall Study||249||
48659330|NCT01122680|101951636|FG002|STARTED|Period 1 (4 Weeks)||26||
48659331|NCT01122680|101951637|FG003|STARTED|Period 1 (4 Weeks)||24||
48659332|NCT01122680|101951634|FG000|COMPLETED|Period 1 (4 Weeks)||26||
48659333|NCT01122680|101951635|FG001|COMPLETED|Period 1 (4 Weeks)||25||
48659334|NCT01122680|101951636|FG002|COMPLETED|Period 1 (4 Weeks)||26||
48659335|NCT01122680|101951637|FG003|COMPLETED|Period 1 (4 Weeks)||24||
48659336|NCT01122680|101951634|FG000|NOT COMPLETED|Period 1 (4 Weeks)||3||
48659337|NCT01122680|101951635|FG001|NOT COMPLETED|Period 1 (4 Weeks)||1||
48659338|NCT01122680|101951636|FG002|NOT COMPLETED|Period 1 (4 Weeks)||0||
48659339|NCT01122680|101951637|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0||
48659340|NCT01122680|101951634|FG000|STARTED|Period 2 (4 Weeks)||26||
48659341|NCT01122680|101951635|FG001|STARTED|Period 2 (4 Weeks)||25||
48659342|NCT01122680|101951636|FG002|STARTED|Period 2 (4 Weeks)||26||
48659343|NCT01122680|101951637|FG003|STARTED|Period 2 (4 Weeks)||24||
48659344|NCT01122680|101951634|FG000|COMPLETED|Period 2 (4 Weeks)||25||
48659345|NCT01122680|101951635|FG001|COMPLETED|Period 2 (4 Weeks)||25||
48659346|NCT01122680|101951636|FG002|COMPLETED|Period 2 (4 Weeks)||26||
48770930|NCT03557034|102229312|FG000|COMPLETED|Overall Study||48||
48770931|NCT03557034|102229313|FG001|COMPLETED|Overall Study||51||
48770932|NCT03557034|102229312|FG000|NOT COMPLETED|Overall Study||1||
48770933|NCT03557034|102229313|FG001|NOT COMPLETED|Overall Study||0||
48770934|NCT00628108|102229314|FG000|STARTED|Overall Study||23||
48770935|NCT00628108|102229315|FG001|STARTED|Overall Study||46||
48770936|NCT00628108|102229314|FG000|Safety Population|Overall Study||24||
48770937|NCT00628108|102229315|FG001|Safety Population|Overall Study||45||
48770938|NCT00628108|102229314|FG000|COMPLETED|Overall Study||22||
48770939|NCT00628108|102229315|FG001|COMPLETED|Overall Study||43||
48770940|NCT00628108|102229314|FG000|NOT COMPLETED|Overall Study||1||
48447407|NCT00734617|101431539|FG001|STARTED|Overall Study||230||
48447408|NCT00734617|101431538|FG000|COMPLETED|Overall Study||142||
48447409|NCT00734617|101431539|FG001|COMPLETED|Overall Study||128||
48447410|NCT00734617|101431538|FG000|NOT COMPLETED|Overall Study||107||
48447411|NCT00734617|101431539|FG001|NOT COMPLETED|Overall Study||102||
48659347|NCT01122680|101951637|FG003|COMPLETED|Period 2 (4 Weeks)||23||
48659348|NCT01122680|101951634|FG000|NOT COMPLETED|Period 2 (4 Weeks)||1||
48659349|NCT01122680|101951635|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0||
48770941|NCT00628108|102229315|FG001|NOT COMPLETED|Overall Study||3||
48770942|NCT03848832|102229316|FG000|STARTED|Overall Study||10||
48770943|NCT03848832|102229317|FG001|STARTED|Overall Study||9||
48770944|NCT03848832|102229318|FG002|STARTED|Overall Study||10||
48770945|NCT03848832|102229316|FG000|COMPLETED|Overall Study||7||
48770946|NCT03848832|102229317|FG001|COMPLETED|Overall Study||6||
48770947|NCT03848832|102229318|FG002|COMPLETED|Overall Study||4||
48447412|NCT00975884|101431540|FG000|STARTED|Overall Study||184||
48447413|NCT00975884|101431541|FG001|STARTED|Overall Study||122||
48447414|NCT00975884|101431540|FG000|COMPLETED|Overall Study||168||
48447415|NCT00975884|101431541|FG001|COMPLETED|Overall Study||107||
48447416|NCT00975884|101431540|FG000|NOT COMPLETED|Overall Study||16||
48447417|NCT00975884|101431541|FG001|NOT COMPLETED|Overall Study||15||
48447418|NCT04651218|101431542|FG000|STARTED|Overall Study||16||
48447419|NCT04651218|101431543|FG001|STARTED|Overall Study||16||
48447420|NCT04651218|101431542|FG000|COMPLETED|Overall Study||16||
48447421|NCT04651218|101431543|FG001|COMPLETED|Overall Study||14||
48447422|NCT04651218|101431542|FG000|NOT COMPLETED|Overall Study||0||
48447423|NCT04651218|101431543|FG001|NOT COMPLETED|Overall Study||2||
48447424|NCT00393978|101431544|FG000|STARTED|Overall Study||37||
48447425|NCT00393978|101431545|FG001|STARTED|Overall Study||38||
48447426|NCT00393978|101431544|FG000|COMPLETED|Overall Study||21||
48447427|NCT00393978|101431545|FG001|COMPLETED|Overall Study||18||
48447428|NCT00393978|101431544|FG000|NOT COMPLETED|Overall Study||16||
48447429|NCT00393978|101431545|FG001|NOT COMPLETED|Overall Study||20||
48447430|NCT00478673|101431546|FG000|STARTED|30-Days Post-Procedure||298||
48447431|NCT00478673|101431546|FG000|COMPLETED|30-Days Post-Procedure||288||
48447432|NCT00478673|101431546|FG000|NOT COMPLETED|30-Days Post-Procedure||10||
48447433|NCT00478673|101431546|FG000|STARTED|12-Months Post-Procedure||295||
48447434|NCT00478673|101431546|FG000|COMPLETED|12-Months Post-Procedure||231||
48447435|NCT00478673|101431546|FG000|NOT COMPLETED|12-Months Post-Procedure||64||
48447436|NCT03250507|101431547|FG000|STARTED|Overall Study||30||
48447437|NCT03250507|101431548|FG001|STARTED|Overall Study||30||
48447438|NCT03250507|101431549|FG002|STARTED|Overall Study||30||
48447439|NCT03250507|101431547|FG000|COMPLETED|Overall Study||30||
48447440|NCT03250507|101431548|FG001|COMPLETED|Overall Study||30||
48447441|NCT03250507|101431549|FG002|COMPLETED|Overall Study||30||
48447442|NCT03250507|101431547|FG000|NOT COMPLETED|Overall Study||0||
48447443|NCT03250507|101431548|FG001|NOT COMPLETED|Overall Study||0||
48447444|NCT03250507|101431549|FG002|NOT COMPLETED|Overall Study||0||
48447445|NCT00720473|101431550|FG000|STARTED|Overall Study||45||
48447446|NCT00720473|101431551|FG001|STARTED|Overall Study||24||
48447447|NCT00720473|101431550|FG000|COMPLETED|Overall Study||15||
48447448|NCT00720473|101431551|FG001|COMPLETED|Overall Study||16||
48447449|NCT00720473|101431550|FG000|NOT COMPLETED|Overall Study||30||
48447450|NCT00720473|101431551|FG001|NOT COMPLETED|Overall Study||8||
48447451|NCT02173301|101431552|FG000|STARTED|Overall Study||49||
48447452|NCT02173301|101431553|FG001|STARTED|Overall Study||55||
48447453|NCT02173301|101431554|FG002|STARTED|Overall Study||48||
48447454|NCT02173301|101431555|FG003|STARTED|Overall Study||48||
48447455|NCT02173301|101431552|FG000|COMPLETED|Overall Study||29||
48447456|NCT02173301|101431553|FG001|COMPLETED|Overall Study||32||
48447457|NCT02173301|101431554|FG002|COMPLETED|Overall Study||28||
48447458|NCT02173301|101431555|FG003|COMPLETED|Overall Study||33||
48447459|NCT02173301|101431552|FG000|NOT COMPLETED|Overall Study||20||
48447460|NCT02173301|101431553|FG001|NOT COMPLETED|Overall Study||23||
48447461|NCT02173301|101431554|FG002|NOT COMPLETED|Overall Study||20||
48447462|NCT02173301|101431555|FG003|NOT COMPLETED|Overall Study||15||
48447463|NCT00758706|101431556|FG000|STARTED|Overall Study||26||
48447464|NCT00758706|101431557|FG001|STARTED|Overall Study||29||
48447465|NCT00758706|101431556|FG000|COMPLETED|Overall Study||22||
48447466|NCT00758706|101431557|FG001|COMPLETED|Overall Study||25||
48447467|NCT00758706|101431556|FG000|NOT COMPLETED|Overall Study||4||
48447468|NCT00758706|101431557|FG001|NOT COMPLETED|Overall Study||4||
48447469|NCT03503474|101431558|FG000|STARTED|Overall Study||103||
48447470|NCT03503474|101431559|FG001|STARTED|Overall Study||3050||
48447471|NCT03503474|101431558|FG000|COMPLETED|Overall Study||103||
48447472|NCT03503474|101431559|FG001|COMPLETED|Overall Study||3050||
48447473|NCT03503474|101431558|FG000|NOT COMPLETED|Overall Study||0||
48447474|NCT03503474|101431559|FG001|NOT COMPLETED|Overall Study||0||
48447475|NCT00423488|101431560|FG000|STARTED|Overall Study||42||
48447476|NCT00423488|101431561|FG001|STARTED|Overall Study||51||
48447477|NCT00423488|101431560|FG000|COMPLETED|Overall Study||37||
48447478|NCT00423488|101431561|FG001|COMPLETED|Overall Study||50||
48447479|NCT00423488|101431560|FG000|NOT COMPLETED|Overall Study||5||
48447480|NCT00423488|101431561|FG001|NOT COMPLETED|Overall Study||1||
48447481|NCT04388527|101431562|FG000|STARTED|Overall Study||32||
48447482|NCT04388527|101431562|FG000|COMPLETED|Overall Study||15||
48447483|NCT04388527|101431562|FG000|NOT COMPLETED|Overall Study||17||
48447484|NCT01123980|101431563|FG000|STARTED|Overall Study||261||
48447485|NCT01123980|101431564|FG001|STARTED|Overall Study||260||
48447486|NCT01123980|101431563|FG000|COMPLETED|Overall Study||242||
48447487|NCT01123980|101431564|FG001|COMPLETED|Overall Study||236||
48447488|NCT01123980|101431563|FG000|NOT COMPLETED|Overall Study||19||
48447489|NCT01123980|101431564|FG001|NOT COMPLETED|Overall Study||24||
48447490|NCT00996632|101431565|FG000|STARTED|Overall Study||38||
48447491|NCT00996632|101431566|FG001|STARTED|Overall Study||56||
48447492|NCT00996632|101431565|FG000|COMPLETED|Overall Study||38||
48447493|NCT00996632|101431566|FG001|COMPLETED|Overall Study||56||
48447494|NCT00996632|101431565|FG000|NOT COMPLETED|Overall Study||0||
48447495|NCT00996632|101431566|FG001|NOT COMPLETED|Overall Study||0||
48659350|NCT01122680|101951636|FG002|NOT COMPLETED|Period 2 (4 Weeks)||0||
48659351|NCT01122680|101951637|FG003|NOT COMPLETED|Period 2 (4 Weeks)||1||
48659352|NCT01122680|101951634|FG000|STARTED|Period 3 (4 Weeks)||25||
48659353|NCT01122680|101951635|FG001|STARTED|Period 3 (4 Weeks)||25||
48659354|NCT01122680|101951636|FG002|STARTED|Period 3 (4 Weeks)||26||
48659355|NCT01122680|101951637|FG003|STARTED|Period 3 (4 Weeks)||23||
48659356|NCT01122680|101951634|FG000|COMPLETED|Period 3 (4 Weeks)||24||
48659357|NCT01122680|101951635|FG001|COMPLETED|Period 3 (4 Weeks)||24||
48659358|NCT01122680|101951636|FG002|COMPLETED|Period 3 (4 Weeks)||26||
48659359|NCT01122680|101951637|FG003|COMPLETED|Period 3 (4 Weeks)||23||
48659360|NCT01122680|101951634|FG000|NOT COMPLETED|Period 3 (4 Weeks)||1||
48659361|NCT01122680|101951635|FG001|NOT COMPLETED|Period 3 (4 Weeks)||1||
48659362|NCT01122680|101951636|FG002|NOT COMPLETED|Period 3 (4 Weeks)||0||
48659363|NCT01122680|101951637|FG003|NOT COMPLETED|Period 3 (4 Weeks)||0||
48659364|NCT00397046|101951638|FG000|STARTED|Overall Study||3||
48659365|NCT00397046|101951639|FG001|STARTED|Overall Study||3||
48659366|NCT00397046|101951640|FG002|STARTED|Overall Study||10||
48659367|NCT00397046|101951641|FG003|STARTED|Overall Study||5||
48659368|NCT00397046|101951638|FG000|COMPLETED|Overall Study||0||
48659369|NCT00397046|101951639|FG001|COMPLETED|Overall Study||0||
48659370|NCT00397046|101951640|FG002|COMPLETED|Overall Study||0||
48659371|NCT00397046|101951641|FG003|COMPLETED|Overall Study||0||
48659372|NCT00397046|101951638|FG000|NOT COMPLETED|Overall Study||3||
48659373|NCT00397046|101951639|FG001|NOT COMPLETED|Overall Study||3||
48659374|NCT00397046|101951640|FG002|NOT COMPLETED|Overall Study||10||
48659375|NCT00397046|101951641|FG003|NOT COMPLETED|Overall Study||5||
48659376|NCT02542280|101951642|FG000|STARTED|Overall Study||174||
48659377|NCT02542280|101951643|FG001|STARTED|Overall Study||175||
48659378|NCT02542280|101951642|FG000|COMPLETED|Overall Study||162||
48659379|NCT02542280|101951643|FG001|COMPLETED|Overall Study||167||
48659380|NCT02542280|101951642|FG000|NOT COMPLETED|Overall Study||12||
48659381|NCT02542280|101951643|FG001|NOT COMPLETED|Overall Study||8||
48659382|NCT00521352|101951644|FG000|STARTED|Overall Study||12||
48659383|NCT00521352|101951645|FG001|STARTED|Overall Study||13||
48659384|NCT00521352|101951644|FG000|COMPLETED|Overall Study||11||
48659385|NCT00521352|101951645|FG001|COMPLETED|Overall Study||10||
48659386|NCT00521352|101951644|FG000|NOT COMPLETED|Overall Study||1||
48659387|NCT00521352|101951645|FG001|NOT COMPLETED|Overall Study||3||
48659388|NCT00855166|101951646|FG000|STARTED|Overall Study||91||
48659389|NCT00855166|101951647|FG001|STARTED|Overall Study||91||
48659390|NCT00855166|101951646|FG000|COMPLETED|Overall Study||86||
48659391|NCT00855166|101951647|FG001|COMPLETED|Overall Study||83||
48659392|NCT00855166|101951646|FG000|NOT COMPLETED|Overall Study||5||
48659393|NCT00855166|101951647|FG001|NOT COMPLETED|Overall Study||8||
48659394|NCT04717479|101951648|FG000|STARTED|Overall Study||41||
48659395|NCT04717479|101951649|FG001|STARTED|Overall Study||39||
48659396|NCT04717479|101951648|FG000|COMPLETED|Overall Study||34||
48659397|NCT04717479|101951649|FG001|COMPLETED|Overall Study||35||
48659398|NCT04717479|101951648|FG000|NOT COMPLETED|Overall Study||7||
48659399|NCT04717479|101951649|FG001|NOT COMPLETED|Overall Study||4||
48659400|NCT00773461|101951650|FG000|STARTED|Overall Study||70||
48659401|NCT00773461|101951651|FG001|STARTED|Overall Study||139||
48659402|NCT00773461|101951650|FG000|COMPLETED|Overall Study||65||
48659403|NCT00773461|101951651|FG001|COMPLETED|Overall Study||135||
48659404|NCT00773461|101951650|FG000|NOT COMPLETED|Overall Study||5||
48659405|NCT00773461|101951651|FG001|NOT COMPLETED|Overall Study||4||
48659406|NCT03538808|101951652|FG000|STARTED|Overall Study||20||
48659407|NCT03538808|101951653|FG001|STARTED|Overall Study||20||
48659408|NCT03538808|101951654|FG002|STARTED|Overall Study||20||
48659409|NCT03538808|101951655|FG003|STARTED|Overall Study||20||
48659410|NCT03538808|101951652|FG000|COMPLETED|Overall Study||18||
48659411|NCT03538808|101951653|FG001|COMPLETED|Overall Study||20||
48659412|NCT03538808|101951654|FG002|COMPLETED|Overall Study||16||
48659413|NCT03538808|101951655|FG003|COMPLETED|Overall Study||18||
48659414|NCT03538808|101951652|FG000|NOT COMPLETED|Overall Study||2||
48659415|NCT03538808|101951653|FG001|NOT COMPLETED|Overall Study||0||
48659416|NCT03538808|101951654|FG002|NOT COMPLETED|Overall Study||4||
48659417|NCT03538808|101951655|FG003|NOT COMPLETED|Overall Study||2||
48659418|NCT01903720|101951656|FG000|STARTED|Overall Study||71||
48659419|NCT01903720|101951656|FG000|COMPLETED|Overall Study||59||
48659420|NCT01903720|101951656|FG000|NOT COMPLETED|Overall Study||12||
48659421|NCT02101853|101951657|FG000|STARTED|Block 1 Induction||669||
48659422|NCT02101853|101951658|FG001|STARTED|Block 1 Induction||0||
48659423|NCT02101853|101951659|FG002|STARTED|Block 1 Induction||0||
48659424|NCT02101853|101951660|FG003|STARTED|Block 1 Induction||0||
48659425|NCT02101853|101951661|FG004|STARTED|Block 1 Induction||0||
48659426|NCT02101853|101951662|FG005|STARTED|Block 1 Induction||0||
48659427|NCT02101853|101951657|FG000|COMPLETED|Block 1 Induction||494||
48659428|NCT02101853|101951658|FG001|COMPLETED|Block 1 Induction||0||
48770948|NCT03848832|102229316|FG000|NOT COMPLETED|Overall Study||3||
48770949|NCT03848832|102229317|FG001|NOT COMPLETED|Overall Study||3||
48770950|NCT03848832|102229318|FG002|NOT COMPLETED|Overall Study||6||
48770951|NCT02608684|102229319|FG000|STARTED|Overall Study||21||
48770952|NCT02608684|102229319|FG000|COMPLETED|Overall Study||18||
48770953|NCT02608684|102229319|FG000|NOT COMPLETED|Overall Study||3||
48770954|NCT00369265|102229320|FG000|STARTED|Overall Study||4||
48770955|NCT00369265|102229321|FG001|STARTED|Overall Study||7||
48770956|NCT00369265|102229320|FG000|COMPLETED|Overall Study||0||
48770957|NCT00369265|102229321|FG001|COMPLETED|Overall Study||0||
48770958|NCT00369265|102229320|FG000|NOT COMPLETED|Overall Study||4||
48770959|NCT00369265|102229321|FG001|NOT COMPLETED|Overall Study||7||
48770960|NCT00880919|102229322|FG000|STARTED|Overall Study||33||
48770961|NCT00880919|102229323|FG001|STARTED|Overall Study||33||
48770962|NCT00880919|102229324|FG002|STARTED|Overall Study||29||
48770963|NCT00880919|102229322|FG000|COMPLETED|Overall Study||18||
48447496|NCT03333382|101431567|FG000|STARTED|Overall Study||1||
48447497|NCT03333382|101431568|FG001|STARTED|Overall Study||0||
48447498|NCT03333382|101431567|FG000|COMPLETED|Overall Study||0||
48447499|NCT03333382|101431568|FG001|COMPLETED|Overall Study||0||
48447500|NCT03333382|101431567|FG000|NOT COMPLETED|Overall Study||1||
48447501|NCT03333382|101431568|FG001|NOT COMPLETED|Overall Study||0||
48447502|NCT01900392|101431569|FG000|STARTED|Overall Study||39||
48447503|NCT01900392|101431570|FG001|STARTED|Overall Study||75||
48447504|NCT01900392|101431571|FG002|STARTED|Overall Study||77||
48447505|NCT01900392|101431569|FG000|COMPLETED|Overall Study||38||
48447506|NCT01900392|101431570|FG001|COMPLETED|Overall Study||74||
48447507|NCT01900392|101431571|FG002|COMPLETED|Overall Study||77||
48447508|NCT01900392|101431569|FG000|NOT COMPLETED|Overall Study||1||
48447509|NCT01900392|101431570|FG001|NOT COMPLETED|Overall Study||1||
48447510|NCT01900392|101431571|FG002|NOT COMPLETED|Overall Study||0||
48447511|NCT01398982|101431572|FG000|STARTED|Overall Study||44||
48447512|NCT01398982|101431573|FG001|STARTED|Overall Study||49||
48447513|NCT01398982|101431572|FG000|COMPLETED|Overall Study||38||
48447514|NCT01398982|101431573|FG001|COMPLETED|Overall Study||47||
48447515|NCT01398982|101431572|FG000|NOT COMPLETED|Overall Study||6||
48447516|NCT01398982|101431573|FG001|NOT COMPLETED|Overall Study||2||
48447517|NCT01458132|101431574|FG000|STARTED|Overall Study||15||
48447518|NCT01458132|101431575|FG001|STARTED|Overall Study||4||
48447519|NCT01458132|101431574|FG000|COMPLETED|Overall Study||0||
48447520|NCT01458132|101431575|FG001|COMPLETED|Overall Study||1||
48447521|NCT01458132|101431574|FG000|NOT COMPLETED|Overall Study||15||
48447522|NCT01458132|101431575|FG001|NOT COMPLETED|Overall Study||3||
48447523|NCT01652573|101431576|FG000|STARTED|Overall Study||10||
48447524|NCT01652573|101431577|FG001|STARTED|Overall Study||11||
48447525|NCT01652573|101431576|FG000|COMPLETED|Overall Study||10||
48447526|NCT01652573|101431577|FG001|COMPLETED|Overall Study||10||
48447527|NCT01652573|101431576|FG000|NOT COMPLETED|Overall Study||0||
48447528|NCT01652573|101431577|FG001|NOT COMPLETED|Overall Study||1||
48447529|NCT04333199|101431578|FG000|STARTED|Evaluated Patients||1669||
48447530|NCT04333199|101431579|FG001|STARTED|Evaluated Patients||1672||
48447531|NCT04333199|101431580|FG002|STARTED|Evaluated Patients||1671||
48447532|NCT04333199|101431578|FG000|COMPLETED|Evaluated Patients||1669|Removed patients not found in EHR|
48447533|NCT04333199|101431579|FG001|COMPLETED|Evaluated Patients||1671|Removed patients not found in EHR|
48447534|NCT04333199|101431580|FG002|COMPLETED|Evaluated Patients||1669|Removed patients not found in EHR|
48447535|NCT04333199|101431578|FG000|NOT COMPLETED|Evaluated Patients||0||
48770964|NCT00880919|102229323|FG001|COMPLETED|Overall Study||19||
48770965|NCT00880919|102229324|FG002|COMPLETED|Overall Study||23||
48770966|NCT00880919|102229322|FG000|NOT COMPLETED|Overall Study||15||
48770967|NCT00880919|102229323|FG001|NOT COMPLETED|Overall Study||14||
48770968|NCT00880919|102229324|FG002|NOT COMPLETED|Overall Study||6||
48770969|NCT00847210|102229325|FG000|STARTED|Overall Study||18||
48447536|NCT04333199|101431579|FG001|NOT COMPLETED|Evaluated Patients||1||
48447537|NCT04333199|101431580|FG002|NOT COMPLETED|Evaluated Patients||2||
48447538|NCT04333199|101431578|FG000|STARTED|Emailed Patients||0||
48447539|NCT04333199|101431579|FG001|STARTED|Emailed Patients||1671||
48447540|NCT04333199|101431580|FG002|STARTED|Emailed Patients||1669||
48447541|NCT04333199|101431578|FG000|Valid Email Address|Emailed Patients||0|Email address not flagged as invalid by email delivery software|
48447542|NCT04333199|101431579|FG001|Valid Email Address|Emailed Patients||1495|Email address not flagged as invalid by email delivery software|
48447543|NCT04333199|101431580|FG002|Valid Email Address|Emailed Patients||1441|Email address not flagged as invalid by email delivery software|
48447544|NCT04333199|101431578|FG000|COMPLETED|Emailed Patients||0|Email delivered (did not bounce back)|
48447545|NCT04333199|101431579|FG001|COMPLETED|Emailed Patients||1399|Email delivered (did not bounce back)|
48447546|NCT04333199|101431580|FG002|COMPLETED|Emailed Patients||1351|Email delivered (did not bounce back)|
48447547|NCT04333199|101431578|FG000|NOT COMPLETED|Emailed Patients||0||
48447548|NCT04333199|101431579|FG001|NOT COMPLETED|Emailed Patients||272||
48770970|NCT00847210|102229326|FG001|STARTED|Overall Study||18||
48770971|NCT00847210|102229325|FG000|COMPLETED|Overall Study||18||
48770972|NCT00847210|102229326|FG001|COMPLETED|Overall Study||18||
48770973|NCT00847210|102229325|FG000|NOT COMPLETED|Overall Study||0||
48770974|NCT00847210|102229326|FG001|NOT COMPLETED|Overall Study||0||
48447549|NCT04333199|101431580|FG002|NOT COMPLETED|Emailed Patients||318||
48447550|NCT00943384|101431581|FG000|STARTED|Overall Study||104||
48447551|NCT00943384|101431581|FG000|Treated|Overall Study||81||
48447552|NCT00943384|101431581|FG000|Treated on Protocol|Overall Study||76||
48447553|NCT00943384|101431581|FG000|COMPLETED|Overall Study||55||
48447554|NCT00943384|101431581|FG000|NOT COMPLETED|Overall Study||49||
48447555|NCT03593772|101431582|FG000|STARTED|Overall Study||196||
48447556|NCT03593772|101431583|FG001|STARTED|Overall Study||198||
48447557|NCT03593772|101431584|FG002|STARTED|Overall Study||168||
48447558|NCT03593772|101431585|FG003|STARTED|Overall Study||168||
48447559|NCT03593772|101431582|FG000|Completed Baseline Data Collection|Overall Study||141||
48447560|NCT03593772|101431583|FG001|Completed Baseline Data Collection|Overall Study||137||
48447561|NCT03593772|101431584|FG002|Completed Baseline Data Collection|Overall Study||136||
48447562|NCT03593772|101431585|FG003|Completed Baseline Data Collection|Overall Study||133||
48447563|NCT03593772|101431582|FG000|Activated in Protocol|Overall Study||133|Participants are activated if both Veteran and Partner register for the Mission Reconnect website, the partner acknowledges receipt of VA privacy practices, and both Veteran and Partner complete Baseline data collection activities.|
48447564|NCT03593772|101431583|FG001|Activated in Protocol|Overall Study||133|Participants are activated if both Veteran and Partner register for the Mission Reconnect website, the partner acknowledges receipt of VA privacy practices, and both Veteran and Partner complete Baseline data collection activities.|
48447565|NCT03593772|101431584|FG002|Activated in Protocol|Overall Study||133|Participants are activated if both Veteran and Partner register for the Mission Reconnect website, the partner acknowledges receipt of VA privacy practices, and both Veteran and Partner complete Baseline data collection activities.|
48447566|NCT03593772|101431585|FG003|Activated in Protocol|Overall Study||133|Participants are activated if both Veteran and Partner register for the Mission Reconnect website, the partner acknowledges receipt of VA privacy practices, and both Veteran and Partner complete Baseline data collection activities.|
48447567|NCT03593772|101431582|FG000|COMPLETED|Overall Study||106||
48447568|NCT03593772|101431583|FG001|COMPLETED|Overall Study||106||
48447569|NCT03593772|101431584|FG002|COMPLETED|Overall Study||129||
48447570|NCT03593772|101431585|FG003|COMPLETED|Overall Study||129||
48447571|NCT03593772|101431582|FG000|NOT COMPLETED|Overall Study||90||
48447572|NCT03593772|101431583|FG001|NOT COMPLETED|Overall Study||92||
48447573|NCT03593772|101431584|FG002|NOT COMPLETED|Overall Study||39||
48447574|NCT03593772|101431585|FG003|NOT COMPLETED|Overall Study||39||
48447575|NCT02702271|101431586|FG000|STARTED|Overall Study||400||
48447576|NCT02702271|101431587|FG001|STARTED|Overall Study||58||
48447577|NCT02702271|101431586|FG000|COMPLETED|Overall Study||337||
48447578|NCT02702271|101431587|FG001|COMPLETED|Overall Study||49||
48447579|NCT02702271|101431586|FG000|NOT COMPLETED|Overall Study||63||
48447580|NCT02702271|101431587|FG001|NOT COMPLETED|Overall Study||9||
48447581|NCT02567266|101431588|FG000|STARTED|Overall Study||68||
48447582|NCT02567266|101431589|FG001|STARTED|Overall Study||60||
48447583|NCT02567266|101431590|FG002|STARTED|Overall Study||68||
48447584|NCT02567266|101431588|FG000|Midpoint (8 Weeks)|Overall Study||54||
48447585|NCT02567266|101431589|FG001|Midpoint (8 Weeks)|Overall Study||52||
48447586|NCT02567266|101431590|FG002|Midpoint (8 Weeks)|Overall Study||55||
48447587|NCT02567266|101431588|FG000|Post (16 Weeks)|Overall Study||49||
48447588|NCT02567266|101431589|FG001|Post (16 Weeks)|Overall Study||43||
48447589|NCT02567266|101431590|FG002|Post (16 Weeks)|Overall Study||53||
48447590|NCT02567266|101431588|FG000|Follow-up (28 Weeks)|Overall Study||45||
48447591|NCT02567266|101431589|FG001|Follow-up (28 Weeks)|Overall Study||45||
48447592|NCT02567266|101431590|FG002|Follow-up (28 Weeks)|Overall Study||52||
48447593|NCT02567266|101431588|FG000|COMPLETED|Overall Study||45||
48447594|NCT02567266|101431589|FG001|COMPLETED|Overall Study||45||
48447595|NCT02567266|101431590|FG002|COMPLETED|Overall Study||52||
48447596|NCT02567266|101431588|FG000|NOT COMPLETED|Overall Study||23||
48447597|NCT02567266|101431589|FG001|NOT COMPLETED|Overall Study||15||
48447598|NCT02567266|101431590|FG002|NOT COMPLETED|Overall Study||16||
48447599|NCT01880541|101431591|FG000|STARTED|Overall Study||10||
48447600|NCT01880541|101431592|FG001|STARTED|Overall Study||20||
48447601|NCT01880541|101431591|FG000|COMPLETED|Overall Study||10||
48770975|NCT02536963|102229327|FG000|STARTED|Overall Study||318||
48770976|NCT02536963|102229327|FG000|COMPLETED|Overall Study||300||
48770977|NCT02536963|102229327|FG000|NOT COMPLETED|Overall Study||18||
48447602|NCT01880541|101431592|FG001|COMPLETED|Overall Study||20||
48447603|NCT01880541|101431591|FG000|NOT COMPLETED|Overall Study||0||
48447604|NCT01880541|101431592|FG001|NOT COMPLETED|Overall Study||0||
48447605|NCT02426125|101431593|FG000|STARTED|Overall Study||263||
48447606|NCT02426125|101431594|FG001|STARTED|Overall Study||267||
48447607|NCT02426125|101431593|FG000|Received at Least One Dose of Study Drug|Overall Study||258||
48447608|NCT02426125|101431594|FG001|Received at Least One Dose of Study Drug|Overall Study||265||
48447609|NCT02426125|101431593|FG000|COMPLETED|Overall Study||46||
48447610|NCT02426125|101431594|FG001|COMPLETED|Overall Study||39||
48447611|NCT02426125|101431593|FG000|NOT COMPLETED|Overall Study||217||
48447612|NCT02426125|101431594|FG001|NOT COMPLETED|Overall Study||228||
48447613|NCT05406596|101431595|FG000|STARTED|Overall Study||86||
48770978|NCT03066947|102229328|FG000|STARTED|Overall Study||24||
48770979|NCT03066947|102229328|FG000|COMPLETED|Overall Study||14||
48770980|NCT03066947|102229328|FG000|NOT COMPLETED|Overall Study||10||
48770981|NCT03562377|102229329|FG000|STARTED|Treatment Period||107||
48770982|NCT03562377|102229330|FG001|STARTED|Treatment Period||108||
48447614|NCT05406596|101431595|FG000|COMPLETED|Overall Study||86||
48447615|NCT05406596|101431595|FG000|NOT COMPLETED|Overall Study||0||
48447616|NCT02149199|101431596|FG000|STARTED|Overall Study||1277||
48447617|NCT02149199|101431597|FG001|STARTED|Overall Study||1277||
48447618|NCT02149199|101431598|FG002|STARTED|Overall Study||1282||
48447619|NCT02149199|101431596|FG000|COMPLETED|Overall Study||1144||
48447620|NCT02149199|101431597|FG001|COMPLETED|Overall Study||1084||
48447621|NCT02149199|101431598|FG002|COMPLETED|Overall Study||1135||
48447622|NCT02149199|101431596|FG000|NOT COMPLETED|Overall Study||133||
48447623|NCT02149199|101431597|FG001|NOT COMPLETED|Overall Study||193||
48447624|NCT02149199|101431598|FG002|NOT COMPLETED|Overall Study||147||
48447625|NCT02858076|101431599|FG000|STARTED|Overall Study||100||
48447626|NCT02858076|101431600|FG001|STARTED|Overall Study||105||
48447627|NCT02858076|101431599|FG000|COMPLETED|Overall Study||90||
48447628|NCT02858076|101431600|FG001|COMPLETED|Overall Study||87||
48447629|NCT02858076|101431599|FG000|NOT COMPLETED|Overall Study||10||
48447630|NCT02858076|101431600|FG001|NOT COMPLETED|Overall Study||18||
48447631|NCT01787188|101431601|FG000|STARTED|Overall Study||139||
48447632|NCT01787188|101431602|FG001|STARTED|Overall Study||130||
48447633|NCT01787188|101431603|FG002|STARTED|Overall Study||134||
48447634|NCT01787188|101431601|FG000|COMPLETED|Overall Study||122||
48447635|NCT01787188|101431602|FG001|COMPLETED|Overall Study||112||
48447636|NCT01787188|101431603|FG002|COMPLETED|Overall Study||116||
48770983|NCT03562377|102229329|FG000|Safety Analysis Set|Treatment Period||107|Defined as all participants randomised to treatment who were exposed to IMP (tralokinumab/placebo).|
48770984|NCT03562377|102229330|FG001|Safety Analysis Set|Treatment Period||107|Defined as all participants randomised to treatment who were exposed to IMP (tralokinumab/placebo).|
48770985|NCT03562377|102229329|FG000|Per Protocol Anaysis Set|Treatment Period||88|Excluding participants who did not receive vaccines, violated selected eligiblity criteria, etc.|
48447637|NCT01787188|101431601|FG000|NOT COMPLETED|Overall Study||17||
48447638|NCT01787188|101431602|FG001|NOT COMPLETED|Overall Study||18||
48447639|NCT01787188|101431603|FG002|NOT COMPLETED|Overall Study||18||
48770986|NCT03562377|102229330|FG001|Per Protocol Anaysis Set|Treatment Period||78|Excluding participants who did not receive vaccines, violated selected eligiblity criteria, etc.|
48770987|NCT03562377|102229329|FG000|Full Analysis Set|Treatment Period||106|Defined as all participants randomised to treatment who were exposed to IMP (tralokinumab/placebo)|
48770988|NCT03562377|102229330|FG001|Full Analysis Set|Treatment Period||108|Defined as all participants randomised to treatment who were exposed to IMP (tralokinumab/placebo)|
48770989|NCT03562377|102229329|FG000|COMPLETED|Treatment Period||100||
48770990|NCT03562377|102229330|FG001|COMPLETED|Treatment Period||89||
48770991|NCT03562377|102229329|FG000|NOT COMPLETED|Treatment Period||7||
48447640|NCT01364259|101431604|FG000|STARTED|Overall Study||9||
48447641|NCT01364259|101431605|FG001|STARTED|Overall Study||8||
48447642|NCT01364259|101431604|FG000|COMPLETED|Overall Study||9||
48447643|NCT01364259|101431605|FG001|COMPLETED|Overall Study||8||
48447644|NCT01364259|101431604|FG000|NOT COMPLETED|Overall Study||0||
48447645|NCT01364259|101431605|FG001|NOT COMPLETED|Overall Study||0||
48770992|NCT03562377|102229330|FG001|NOT COMPLETED|Treatment Period||19||
48770993|NCT03562377|102229329|FG000|STARTED|Safety Follow-up Period||75||
48770994|NCT03562377|102229330|FG001|STARTED|Safety Follow-up Period||75||
48770995|NCT03562377|102229329|FG000|COMPLETED|Safety Follow-up Period||16||
48770996|NCT03562377|102229330|FG001|COMPLETED|Safety Follow-up Period||18||
48770997|NCT03562377|102229329|FG000|NOT COMPLETED|Safety Follow-up Period||59||
48770998|NCT03562377|102229330|FG001|NOT COMPLETED|Safety Follow-up Period||57||
48770999|NCT03350672|102229331|FG000|STARTED|Overall Study||17||
48771000|NCT03350672|102229332|FG001|STARTED|Overall Study||10||
48771001|NCT03350672|102229333|FG002|STARTED|Overall Study||10||
48447646|NCT02756078|101431606|FG000|STARTED|Period 1||85||
48447647|NCT02756078|101431607|FG001|STARTED|Period 1||86||
48447648|NCT02756078|101431606|FG000|COMPLETED|Period 1||76||
48447649|NCT02756078|101431607|FG001|COMPLETED|Period 1||64||
48447650|NCT02756078|101431606|FG000|NOT COMPLETED|Period 1||9||
48447651|NCT02756078|101431607|FG001|NOT COMPLETED|Period 1||22||
48447652|NCT02756078|101431606|FG000|STARTED|Period 2||76||
48447653|NCT02756078|101431607|FG001|STARTED|Period 2||64||
48447654|NCT02756078|101431606|FG000|COMPLETED|Period 2||70||
48447655|NCT02756078|101431607|FG001|COMPLETED|Period 2||57||
48447656|NCT02756078|101431606|FG000|NOT COMPLETED|Period 2||6||
48447657|NCT02756078|101431607|FG001|NOT COMPLETED|Period 2||7||
48447658|NCT05319977|101431608|FG000|STARTED|Overall Study||60||
48189079|NCT00708097|100786149|FG000|STARTED|Period 2||10||
48771002|NCT03350672|102229331|FG000|COMPLETED|Overall Study||10||
48771003|NCT03350672|102229332|FG001|COMPLETED|Overall Study||10||
48771004|NCT03350672|102229333|FG002|COMPLETED|Overall Study||10||
48771005|NCT03350672|102229331|FG000|NOT COMPLETED|Overall Study||7||
48771006|NCT03350672|102229332|FG001|NOT COMPLETED|Overall Study||0||
48771007|NCT03350672|102229333|FG002|NOT COMPLETED|Overall Study||0||
48771008|NCT03666663|102229334|FG000|STARTED|Overall Study||3||
48771009|NCT03666663|102229335|FG001|STARTED|Overall Study||1||
48771010|NCT03666663|102229336|FG002|STARTED|Overall Study||3||
48771011|NCT03666663|102229337|FG003|STARTED|Overall Study||3||
48771012|NCT03666663|102229334|FG000|COMPLETED|Overall Study||3||
48771013|NCT03666663|102229335|FG001|COMPLETED|Overall Study||1||
48771014|NCT03666663|102229336|FG002|COMPLETED|Overall Study||1||
48771015|NCT03666663|102229337|FG003|COMPLETED|Overall Study||1||
48771016|NCT03666663|102229334|FG000|NOT COMPLETED|Overall Study||0||
48771017|NCT03666663|102229335|FG001|NOT COMPLETED|Overall Study||0||
48771018|NCT03666663|102229336|FG002|NOT COMPLETED|Overall Study||2||
48771019|NCT03666663|102229337|FG003|NOT COMPLETED|Overall Study||2||
48771020|NCT03809104|102229338|FG000|STARTED|Overall Study||43||
48771021|NCT03809104|102229338|FG000|COMPLETED|Overall Study||40||
48771022|NCT03809104|102229338|FG000|NOT COMPLETED|Overall Study||3||
48771023|NCT05660577|102229339|FG000|STARTED|Overall Study||301||
48771024|NCT05660577|102229339|FG000|COMPLETED|Overall Study||292||
48771025|NCT05660577|102229339|FG000|NOT COMPLETED|Overall Study||9||
48771026|NCT00719472|102229340|FG000|STARTED|Enrolled in Study||451||
48771027|NCT00719472|102229340|FG000|COMPLETED|Enrolled in Study||425||
48771028|NCT00719472|102229340|FG000|NOT COMPLETED|Enrolled in Study||26||
48771029|NCT00719472|102229340|FG000|STARTED|Received Cycle 1 Treatment||425||
48771030|NCT00719472|102229340|FG000|COMPLETED|Received Cycle 1 Treatment||372||
48771031|NCT00719472|102229340|FG000|NOT COMPLETED|Received Cycle 1 Treatment||53||
48771032|NCT00719472|102229340|FG000|STARTED|Received Cycle 2 Treatment||372||
48771033|NCT00719472|102229340|FG000|COMPLETED|Received Cycle 2 Treatment||304||
48771034|NCT00719472|102229340|FG000|NOT COMPLETED|Received Cycle 2 Treatment||68||
48771035|NCT00131248|102229341|FG000|STARTED|Intervention 1 (3-day Course)||9||
48771036|NCT00131248|102229342|FG001|STARTED|Intervention 1 (3-day Course)||9||
48771037|NCT00131248|102229341|FG000|COMPLETED|Intervention 1 (3-day Course)||8||
48771038|NCT00131248|102229342|FG001|COMPLETED|Intervention 1 (3-day Course)||9||
48771039|NCT00131248|102229341|FG000|NOT COMPLETED|Intervention 1 (3-day Course)||1||
48771040|NCT00131248|102229342|FG001|NOT COMPLETED|Intervention 1 (3-day Course)||0||
48771041|NCT00131248|102229341|FG000|STARTED|Washout (24 Hour)||8||
48771042|NCT00131248|102229342|FG001|STARTED|Washout (24 Hour)||9||
48771043|NCT00131248|102229341|FG000|COMPLETED|Washout (24 Hour)||8||
48771044|NCT00131248|102229342|FG001|COMPLETED|Washout (24 Hour)||9||
48771045|NCT00131248|102229341|FG000|NOT COMPLETED|Washout (24 Hour)||0||
48771046|NCT00131248|102229342|FG001|NOT COMPLETED|Washout (24 Hour)||0||
48771047|NCT00131248|102229341|FG000|STARTED|Intervention 2 (7-day Course)||8||
48771048|NCT00131248|102229342|FG001|STARTED|Intervention 2 (7-day Course)||9||
48771049|NCT00131248|102229341|FG000|COMPLETED|Intervention 2 (7-day Course)||8||
48771050|NCT00131248|102229342|FG001|COMPLETED|Intervention 2 (7-day Course)||9||
48771051|NCT00131248|102229341|FG000|NOT COMPLETED|Intervention 2 (7-day Course)||0||
48771052|NCT00131248|102229342|FG001|NOT COMPLETED|Intervention 2 (7-day Course)||0||
48771053|NCT00131248|102229341|FG000|STARTED|Washout 2 (24 Hours)||8||
48447659|NCT05319977|101431608|FG000|COMPLETED|Overall Study||60||
48447660|NCT05319977|101431608|FG000|NOT COMPLETED|Overall Study||0||
48447661|NCT00417859|101431609|FG000|STARTED|Overall Study||26||
48447662|NCT00417859|101431610|FG001|STARTED|Overall Study||30||
48447663|NCT00417859|101431609|FG000|COMPLETED|Overall Study||26||
48771054|NCT00131248|102229342|FG001|STARTED|Washout 2 (24 Hours)||9||
48771055|NCT00131248|102229341|FG000|COMPLETED|Washout 2 (24 Hours)||8||
48771056|NCT00131248|102229342|FG001|COMPLETED|Washout 2 (24 Hours)||9||
48771057|NCT00131248|102229341|FG000|NOT COMPLETED|Washout 2 (24 Hours)||0||
48771058|NCT00131248|102229342|FG001|NOT COMPLETED|Washout 2 (24 Hours)||0||
48771059|NCT00131248|102229341|FG000|STARTED|Intervention 3 (4-day Course)||8||
48771060|NCT00131248|102229342|FG001|STARTED|Intervention 3 (4-day Course)||9||
48771061|NCT00131248|102229341|FG000|COMPLETED|Intervention 3 (4-day Course)||8||
48771062|NCT00131248|102229342|FG001|COMPLETED|Intervention 3 (4-day Course)||9||
48771063|NCT00131248|102229341|FG000|NOT COMPLETED|Intervention 3 (4-day Course)||0||
48771064|NCT00131248|102229342|FG001|NOT COMPLETED|Intervention 3 (4-day Course)||0||
48771065|NCT05021978|102229343|FG000|STARTED|PART A OLT Phase (Day 1 to Day 21)||7||
48771066|NCT05021978|102229344|FG001|STARTED|PART A OLT Phase (Day 1 to Day 21)||0||
48771067|NCT05021978|102229345|FG002|STARTED|PART A OLT Phase (Day 1 to Day 21)||0||
48771068|NCT05021978|102229346|FG003|STARTED|PART A OLT Phase (Day 1 to Day 21)||0||
48771069|NCT05021978|102229343|FG000|COMPLETED|PART A OLT Phase (Day 1 to Day 21)||6||
48771070|NCT05021978|102229344|FG001|COMPLETED|PART A OLT Phase (Day 1 to Day 21)||0||
48771071|NCT05021978|102229345|FG002|COMPLETED|PART A OLT Phase (Day 1 to Day 21)||0||
48771072|NCT05021978|102229346|FG003|COMPLETED|PART A OLT Phase (Day 1 to Day 21)||0||
48771073|NCT05021978|102229343|FG000|NOT COMPLETED|PART A OLT Phase (Day 1 to Day 21)||1||
48771074|NCT05021978|102229344|FG001|NOT COMPLETED|PART A OLT Phase (Day 1 to Day 21)||0||
48771075|NCT05021978|102229345|FG002|NOT COMPLETED|PART A OLT Phase (Day 1 to Day 21)||0||
48771076|NCT05021978|102229346|FG003|NOT COMPLETED|PART A OLT Phase (Day 1 to Day 21)||0||
48771077|NCT05021978|102229343|FG000|STARTED|PART B OLT Phase (Day 1 to Day 42)||0||
48771078|NCT05021978|102229344|FG001|STARTED|PART B OLT Phase (Day 1 to Day 42)||17||
48771079|NCT05021978|102229345|FG002|STARTED|PART B OLT Phase (Day 1 to Day 42)||0||
48771080|NCT05021978|102229346|FG003|STARTED|PART B OLT Phase (Day 1 to Day 42)||0||
48771081|NCT05021978|102229343|FG000|COMPLETED|PART B OLT Phase (Day 1 to Day 42)||0||
48771082|NCT05021978|102229344|FG001|COMPLETED|PART B OLT Phase (Day 1 to Day 42)||11||
48771083|NCT05021978|102229345|FG002|COMPLETED|PART B OLT Phase (Day 1 to Day 42)||0||
48771084|NCT05021978|102229346|FG003|COMPLETED|PART B OLT Phase (Day 1 to Day 42)||0||
48771085|NCT05021978|102229343|FG000|NOT COMPLETED|PART B OLT Phase (Day 1 to Day 42)||0||
48771086|NCT05021978|102229344|FG001|NOT COMPLETED|PART B OLT Phase (Day 1 to Day 42)||6||
48771087|NCT05021978|102229345|FG002|NOT COMPLETED|PART B OLT Phase (Day 1 to Day 42)||0||
48771088|NCT05021978|102229346|FG003|NOT COMPLETED|PART B OLT Phase (Day 1 to Day 42)||0||
48771089|NCT05021978|102229343|FG000|STARTED|PART B RWD Phase (Day 43 to Day 70)||0||
48771090|NCT05021978|102229344|FG001|STARTED|PART B RWD Phase (Day 43 to Day 70)||0||
48771091|NCT05021978|102229345|FG002|STARTED|PART B RWD Phase (Day 43 to Day 70)||6||
48771092|NCT05021978|102229346|FG003|STARTED|PART B RWD Phase (Day 43 to Day 70)||5||
48771093|NCT05021978|102229343|FG000|COMPLETED|PART B RWD Phase (Day 43 to Day 70)||0||
48771094|NCT05021978|102229344|FG001|COMPLETED|PART B RWD Phase (Day 43 to Day 70)||0||
48771095|NCT05021978|102229345|FG002|COMPLETED|PART B RWD Phase (Day 43 to Day 70)||6||
48771096|NCT05021978|102229346|FG003|COMPLETED|PART B RWD Phase (Day 43 to Day 70)||5||
48771097|NCT05021978|102229343|FG000|NOT COMPLETED|PART B RWD Phase (Day 43 to Day 70)||0||
48771098|NCT05021978|102229344|FG001|NOT COMPLETED|PART B RWD Phase (Day 43 to Day 70)||0||
48771099|NCT05021978|102229345|FG002|NOT COMPLETED|PART B RWD Phase (Day 43 to Day 70)||0||
48771100|NCT05021978|102229346|FG003|NOT COMPLETED|PART B RWD Phase (Day 43 to Day 70)||0||
48771101|NCT01327482|102229347|FG000|STARTED|Overall Study||10||
48771102|NCT01327482|102229347|FG000|COMPLETED|Overall Study||9||
48771103|NCT01327482|102229347|FG000|NOT COMPLETED|Overall Study||1||
48771104|NCT03818321|102229348|FG000|STARTED|Overall Study||94||
48771105|NCT03818321|102229349|FG001|STARTED|Overall Study||91||
48771106|NCT03818321|102229348|FG000|COMPLETED|Overall Study||93||
48771107|NCT03818321|102229349|FG001|COMPLETED|Overall Study||89||
48771108|NCT03818321|102229348|FG000|NOT COMPLETED|Overall Study||1||
48447664|NCT00417859|101431610|FG001|COMPLETED|Overall Study||29||
48447665|NCT00417859|101431609|FG000|NOT COMPLETED|Overall Study||0||
48447666|NCT00417859|101431610|FG001|NOT COMPLETED|Overall Study||1||
48447667|NCT00468312|101431611|FG000|STARTED|Overall Study||220||
48447668|NCT00468312|101431612|FG001|STARTED|Overall Study||209||
48447669|NCT00468312|101431611|FG000|COMPLETED|Overall Study||216||
48447670|NCT00468312|101431612|FG001|COMPLETED|Overall Study||204||
48447671|NCT00468312|101431611|FG000|NOT COMPLETED|Overall Study||4||
48447672|NCT00468312|101431612|FG001|NOT COMPLETED|Overall Study||5||
48447673|NCT02556931|101431613|FG000|STARTED|Overall Study||57||
48447674|NCT02556931|101431614|FG001|STARTED|Overall Study||60||
48447675|NCT02556931|101431613|FG000|COMPLETED|Overall Study||57||
48447676|NCT02556931|101431614|FG001|COMPLETED|Overall Study||60||
48447677|NCT02556931|101431613|FG000|NOT COMPLETED|Overall Study||0||
48447678|NCT02556931|101431614|FG001|NOT COMPLETED|Overall Study||0||
48447679|NCT01397656|101431615|FG000|STARTED|Overall Study||33||
48447680|NCT01397656|101431616|FG001|STARTED|Overall Study||30||
48447681|NCT01397656|101431615|FG000|COMPLETED|Overall Study||33||
48447682|NCT01397656|101431616|FG001|COMPLETED|Overall Study||30||
48447683|NCT01397656|101431615|FG000|NOT COMPLETED|Overall Study||0||
48447684|NCT01397656|101431616|FG001|NOT COMPLETED|Overall Study||0||
48447685|NCT00203931|101431617|FG000|STARTED|Overall Study||27||
48447686|NCT00203931|101431618|FG001|STARTED|Overall Study||28||
48447687|NCT00203931|101431617|FG000|COMPLETED|Overall Study||20||
48447688|NCT00203931|101431618|FG001|COMPLETED|Overall Study||23||
48447689|NCT00203931|101431617|FG000|NOT COMPLETED|Overall Study||7||
48447690|NCT00203931|101431618|FG001|NOT COMPLETED|Overall Study||5||
48447691|NCT01374906|101431619|FG000|STARTED|Overall Study||74||
48447692|NCT01374906|101431620|FG001|STARTED|Overall Study||76||
48447693|NCT01374906|101431619|FG000|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||24||
48447694|NCT01374906|101431620|FG001|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||22||
48447695|NCT01374906|101431619|FG000|Completed Core Phase|Overall Study||50||
48447696|NCT01374906|101431620|FG001|Completed Core Phase|Overall Study||54||
48447697|NCT01374906|101431619|FG000|Completed Core/Did Not Enter Ext. Phase|Overall Study||10||
48447698|NCT01374906|101431620|FG001|Completed Core/Did Not Enter Ext. Phase|Overall Study||13||
48447699|NCT01374906|101431619|FG000|Completed Core Phase/Entered Ext. Phase|Overall Study||40||
48447700|NCT01374906|101431620|FG001|Completed Core Phase/Entered Ext. Phase|Overall Study||41||
48447701|NCT01374906|101431619|FG000|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||16||
48447702|NCT01374906|101431620|FG001|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||26||
48447703|NCT01374906|101431619|FG000|Completed Extension Phase|Overall Study||24||
48447704|NCT01374906|101431620|FG001|Completed Extension Phase|Overall Study||15||
48447705|NCT01374906|101431619|FG000|COMPLETED|Overall Study||34||
48447706|NCT01374906|101431620|FG001|COMPLETED|Overall Study||28||
48447707|NCT01374906|101431619|FG000|NOT COMPLETED|Overall Study||40||
48447708|NCT01374906|101431620|FG001|NOT COMPLETED|Overall Study||48||
48447709|NCT00589693|101431621|FG000|STARTED|Overall Study||115||
48447710|NCT00589693|101431622|FG001|STARTED|Overall Study||112||
48447711|NCT00589693|101431621|FG000|COMPLETED|Overall Study||71||
48447712|NCT00589693|101431622|FG001|COMPLETED|Overall Study||83||
48447713|NCT00589693|101431621|FG000|NOT COMPLETED|Overall Study||44||
48447714|NCT00589693|101431622|FG001|NOT COMPLETED|Overall Study||29||
48447715|NCT00434148|101431623|FG000|STARTED|Overall Study||82||
48447716|NCT00434148|101431624|FG001|STARTED|Overall Study||80||
48447717|NCT00434148|101431623|FG000|Completed Month 12|Overall Study||39||
48447718|NCT00434148|101431624|FG001|Completed Month 12|Overall Study||39||
48447719|NCT00434148|101431623|FG000|Completed m. 12; Did Not Enter Extension|Overall Study||13||
48447720|NCT00434148|101431624|FG001|Completed m. 12; Did Not Enter Extension|Overall Study||7||
48447721|NCT00434148|101431623|FG000|Completed Month 12; Entered Extension|Overall Study||26||
48447722|NCT00434148|101431624|FG001|Completed Month 12; Entered Extension|Overall Study||32||
48447723|NCT00434148|101431623|FG000|COMPLETED|Overall Study||13||
48447724|NCT00434148|101431624|FG001|COMPLETED|Overall Study||7||
48447725|NCT00434148|101431623|FG000|NOT COMPLETED|Overall Study||69||
48447726|NCT00434148|101431624|FG001|NOT COMPLETED|Overall Study||73||
48447727|NCT04542330|101431625|FG000|STARTED|Overall Study||838||
48447728|NCT04542330|101431626|FG001|STARTED|Overall Study||838||
48447729|NCT04542330|101431625|FG000|COMPLETED|Overall Study||838||
48447730|NCT04542330|101431626|FG001|COMPLETED|Overall Study||838||
48447731|NCT04542330|101431625|FG000|NOT COMPLETED|Overall Study||0||
48447732|NCT04542330|101431626|FG001|NOT COMPLETED|Overall Study||0||
48447733|NCT00467038|101431627|FG000|STARTED|Overall Study||11||
48447734|NCT00467038|101431628|FG001|STARTED|Overall Study||11||
48447735|NCT00467038|101431627|FG000|COMPLETED|Overall Study||11||
48447736|NCT00467038|101431628|FG001|COMPLETED|Overall Study||11||
48447737|NCT00467038|101431627|FG000|NOT COMPLETED|Overall Study||0||
48447738|NCT00467038|101431628|FG001|NOT COMPLETED|Overall Study||0||
48447739|NCT01682512|101431629|FG000|STARTED|Overall Study||116||
48447740|NCT01682512|101431630|FG001|STARTED|Overall Study||111||
48447741|NCT01682512|101431631|FG002|STARTED|Overall Study||66||
48447742|NCT01682512|101431629|FG000|Randomized in Part-I|Overall Study||66||
48447743|NCT01682512|101431630|FG001|Randomized in Part-I|Overall Study||65||
48447744|NCT01682512|101431631|FG002|Randomized in Part-I|Overall Study||66||
48447745|NCT01682512|101431629|FG000|Randomized in Part-II|Overall Study||50||
48447746|NCT01682512|101431630|FG001|Randomized in Part-II|Overall Study||46||
48447747|NCT01682512|101431631|FG002|Randomized in Part-II|Overall Study||0||
48447748|NCT01682512|101431629|FG000|COMPLETED|Overall Study||44||
48447749|NCT01682512|101431630|FG001|COMPLETED|Overall Study||40||
48447750|NCT01682512|101431631|FG002|COMPLETED|Overall Study||48||
48447751|NCT01682512|101431629|FG000|NOT COMPLETED|Overall Study||72||
48447752|NCT01682512|101431630|FG001|NOT COMPLETED|Overall Study||71||
48447753|NCT01682512|101431631|FG002|NOT COMPLETED|Overall Study||18||
48659429|NCT02101853|101951659|FG002|COMPLETED|Block 1 Induction||0||
48659430|NCT02101853|101951660|FG003|COMPLETED|Block 1 Induction||0||
48659431|NCT02101853|101951661|FG004|COMPLETED|Block 1 Induction||0||
48659432|NCT02101853|101951662|FG005|COMPLETED|Block 1 Induction||0||
48659433|NCT02101853|101951657|FG000|NOT COMPLETED|Block 1 Induction||175||
48659434|NCT02101853|101951658|FG001|NOT COMPLETED|Block 1 Induction||0||
48659435|NCT02101853|101951659|FG002|NOT COMPLETED|Block 1 Induction||0||
48659436|NCT02101853|101951660|FG003|NOT COMPLETED|Block 1 Induction||0||
48659437|NCT02101853|101951661|FG004|NOT COMPLETED|Block 1 Induction||0||
48659438|NCT02101853|101951662|FG005|NOT COMPLETED|Block 1 Induction||0||
48659439|NCT02101853|101951657|FG000|STARTED|Post Induction Randomization||0||
48659440|NCT02101853|101951658|FG001|STARTED|Post Induction Randomization||109||
48659441|NCT02101853|101951659|FG002|STARTED|Post Induction Randomization||107||
48659442|NCT02101853|101951660|FG003|STARTED|Post Induction Randomization||129||
48659443|NCT02101853|101951661|FG004|STARTED|Post Induction Randomization||127||
48659444|NCT02101853|101951662|FG005|STARTED|Post Induction Randomization||0||
48659445|NCT02101853|101951657|FG000|COMPLETED|Post Induction Randomization||0||
48659446|NCT02101853|101951658|FG001|COMPLETED|Post Induction Randomization||14||
48659447|NCT02101853|101951659|FG002|COMPLETED|Post Induction Randomization||31||
48659448|NCT02101853|101951660|FG003|COMPLETED|Post Induction Randomization||78||
48659449|NCT02101853|101951661|FG004|COMPLETED|Post Induction Randomization||79||
48659450|NCT02101853|101951662|FG005|COMPLETED|Post Induction Randomization||0||
48659451|NCT02101853|101951657|FG000|NOT COMPLETED|Post Induction Randomization||0||
48659452|NCT02101853|101951658|FG001|NOT COMPLETED|Post Induction Randomization||95||
48659453|NCT02101853|101951659|FG002|NOT COMPLETED|Post Induction Randomization||76||
48659454|NCT02101853|101951660|FG003|NOT COMPLETED|Post Induction Randomization||51||
48659455|NCT02101853|101951661|FG004|NOT COMPLETED|Post Induction Randomization||48||
48659456|NCT02101853|101951662|FG005|NOT COMPLETED|Post Induction Randomization||0||
48659457|NCT02101853|101951657|FG000|STARTED|Blinatumomab Salvage Therapy||0||
48659458|NCT02101853|101951658|FG001|STARTED|Blinatumomab Salvage Therapy||0||
48659459|NCT02101853|101951659|FG002|STARTED|Blinatumomab Salvage Therapy||0||
48659460|NCT02101853|101951660|FG003|STARTED|Blinatumomab Salvage Therapy||0||
48659461|NCT02101853|101951661|FG004|STARTED|Blinatumomab Salvage Therapy||0||
48659462|NCT02101853|101951662|FG005|STARTED|Blinatumomab Salvage Therapy||27||
48659463|NCT02101853|101951657|FG000|COMPLETED|Blinatumomab Salvage Therapy||0||
48659464|NCT02101853|101951658|FG001|COMPLETED|Blinatumomab Salvage Therapy||0||
48659465|NCT02101853|101951659|FG002|COMPLETED|Blinatumomab Salvage Therapy||0||
48659466|NCT02101853|101951660|FG003|COMPLETED|Blinatumomab Salvage Therapy||0||
48659467|NCT02101853|101951661|FG004|COMPLETED|Blinatumomab Salvage Therapy||0||
48659468|NCT02101853|101951662|FG005|COMPLETED|Blinatumomab Salvage Therapy||2||
48659469|NCT02101853|101951657|FG000|NOT COMPLETED|Blinatumomab Salvage Therapy||0||
48659470|NCT02101853|101951658|FG001|NOT COMPLETED|Blinatumomab Salvage Therapy||0||
48659471|NCT02101853|101951659|FG002|NOT COMPLETED|Blinatumomab Salvage Therapy||0||
48659472|NCT02101853|101951660|FG003|NOT COMPLETED|Blinatumomab Salvage Therapy||0||
48659473|NCT02101853|101951661|FG004|NOT COMPLETED|Blinatumomab Salvage Therapy||0||
48659474|NCT02101853|101951662|FG005|NOT COMPLETED|Blinatumomab Salvage Therapy||25||
48659475|NCT02683954|101951663|FG000|STARTED|Overall Study||30||
48659476|NCT02683954|101951664|FG001|STARTED|Overall Study||30||
48659477|NCT02683954|101951663|FG000|COMPLETED|Overall Study||30||
48659478|NCT02683954|101951664|FG001|COMPLETED|Overall Study||30||
48659479|NCT02683954|101951663|FG000|NOT COMPLETED|Overall Study||0||
48659480|NCT02683954|101951664|FG001|NOT COMPLETED|Overall Study||0||
48659481|NCT01379937|101951665|FG000|STARTED|Overall Study||156||
48659482|NCT01379937|101951666|FG001|STARTED|Overall Study||156||
48659483|NCT01379937|101951667|FG002|STARTED|Overall Study||104||
48659484|NCT01379937|101951668|FG003|STARTED|Overall Study||104||
48659485|NCT01379937|101951665|FG000|COMPLETED|Overall Study||155||
48659486|NCT01379937|101951666|FG001|COMPLETED|Overall Study||153||
48659487|NCT01379937|101951667|FG002|COMPLETED|Overall Study||102||
48659488|NCT01379937|101951668|FG003|COMPLETED|Overall Study||103||
48659489|NCT01379937|101951665|FG000|NOT COMPLETED|Overall Study||1||
48447754|NCT02913261|101431632|FG000|STARTED|Overall Study||154||
48447755|NCT02913261|101431633|FG001|STARTED|Overall Study||155||
48447756|NCT02913261|101431632|FG000|Not Treated|Overall Study||2||
48659490|NCT01379937|101951666|FG001|NOT COMPLETED|Overall Study||3||
48659491|NCT01379937|101951667|FG002|NOT COMPLETED|Overall Study||2||
48659492|NCT01379937|101951668|FG003|NOT COMPLETED|Overall Study||1||
48659493|NCT01244412|101951669|FG000|STARTED|Overall Study||1||
48659494|NCT01244412|101951669|FG000|COMPLETED|Overall Study||1||
48659495|NCT01244412|101951669|FG000|NOT COMPLETED|Overall Study||0||
48447757|NCT02913261|101431633|FG001|Not Treated|Overall Study||5||
48447758|NCT02913261|101431632|FG000|Crossover Treatment at End of Randomized Treatment|Overall Study||0||
48447759|NCT02913261|101431633|FG001|Crossover Treatment at End of Randomized Treatment|Overall Study||49||
48447760|NCT02913261|101431632|FG000|Entered Long-term Follow-up|Overall Study||102||
48447761|NCT02913261|101431633|FG001|Entered Long-term Follow-up|Overall Study||51||
48771109|NCT03818321|102229349|FG001|NOT COMPLETED|Overall Study||2||
48771110|NCT02654769|102229350|FG000|STARTED|Overall Study||149||
48771111|NCT02654769|102229351|FG001|STARTED|Overall Study||149||
48771112|NCT02654769|102229352|FG002|STARTED|Overall Study||143||
48771113|NCT02654769|102229350|FG000|COMPLETED|Overall Study||145||
48771114|NCT02654769|102229351|FG001|COMPLETED|Overall Study||148||
48771115|NCT02654769|102229352|FG002|COMPLETED|Overall Study||142||
48771116|NCT02654769|102229350|FG000|NOT COMPLETED|Overall Study||4||
48771117|NCT02654769|102229351|FG001|NOT COMPLETED|Overall Study||1||
48771118|NCT02654769|102229352|FG002|NOT COMPLETED|Overall Study||1||
48771119|NCT01143246|102229353|FG000|STARTED|Overall Study||97||
48771120|NCT01143246|102229354|FG001|STARTED|Overall Study||99||
48771121|NCT01143246|102229353|FG000|Intent to Treat (ITT)|Overall Study||97|All randomized participants who had at least one baseline assessment.|
48771122|NCT01143246|102229354|FG001|Intent to Treat (ITT)|Overall Study||99|All randomized participants who had at least one baseline assessment.|
48771123|NCT01143246|102229353|FG000|Safety Population (Treated Participants)|Overall Study||93|Eight participants did not receive treatment and were excluded from Safety Population.|
48771124|NCT01143246|102229354|FG001|Safety Population (Treated Participants)|Overall Study||95|Eight participants did not receive treatment and were excluded from Safety Population.|
48771125|NCT01143246|102229353|FG000|COMPLETED|Overall Study||52||
48771126|NCT01143246|102229354|FG001|COMPLETED|Overall Study||48||
48771127|NCT01143246|102229353|FG000|NOT COMPLETED|Overall Study||45||
48771128|NCT01143246|102229354|FG001|NOT COMPLETED|Overall Study||51||
48771129|NCT00297258|102229355|FG000|STARTED|Overall Study||142||
48771130|NCT00297258|102229355|FG000|COMPLETED|Overall Study||0||
48771131|NCT00297258|102229355|FG000|NOT COMPLETED|Overall Study||142||
48771132|NCT04295720|102229356|FG000|STARTED|Overall Study||1||
48659496|NCT02735642|101951670|FG000|STARTED|Overall Study||1046||
48659497|NCT02735642|101951671|FG001|STARTED|Overall Study||152||
48659498|NCT02735642|101951670|FG000|COMPLETED|Overall Study||1046||
48659499|NCT02735642|101951671|FG001|COMPLETED|Overall Study||152||
48659500|NCT02735642|101951670|FG000|NOT COMPLETED|Overall Study||0||
48659501|NCT02735642|101951671|FG001|NOT COMPLETED|Overall Study||0||
48659502|NCT01827306|101951672|FG000|STARTED|Overall Study||21||
48659503|NCT01827306|101951673|FG001|STARTED|Overall Study||13||
48771133|NCT04295720|102229356|FG000|COMPLETED|Overall Study||1||
48771134|NCT04295720|102229356|FG000|NOT COMPLETED|Overall Study||0||
48447762|NCT02913261|101431632|FG000|Completed Screening & Randomized|Overall Study||154||
48447763|NCT02913261|101431633|FG001|Completed Screening & Randomized|Overall Study||155||
48447764|NCT02913261|101431632|FG000|Completed Screening & Not Randomized|Overall Study||0||
48659504|NCT01827306|101951672|FG000|COMPLETED|Overall Study||10||
48659505|NCT01827306|101951673|FG001|COMPLETED|Overall Study||8||
48659506|NCT01827306|101951672|FG000|NOT COMPLETED|Overall Study||11||
48189080|NCT00708097|100786150|FG001|STARTED|Period 2||12||
48189081|NCT00708097|100786151|FG002|STARTED|Period 2||10||
48447765|NCT02913261|101431633|FG001|Completed Screening & Not Randomized|Overall Study||1||
48447766|NCT02913261|101431632|FG000|COMPLETED|Overall Study||35|Completed = Completed the treatment period Not Completed = Discontinued from treatment period|
48447767|NCT02913261|101431633|FG001|COMPLETED|Overall Study||20|Completed = Completed the treatment period Not Completed = Discontinued from treatment period|
48659507|NCT01827306|101951673|FG001|NOT COMPLETED|Overall Study||5||
48659508|NCT04349371|101951674|FG000|STARTED|Overall Study||0||
48659509|NCT04349371|101951675|FG001|STARTED|Overall Study||0||
48659510|NCT04349371|101951674|FG000|COMPLETED|Overall Study||0||
48659511|NCT04349371|101951675|FG001|COMPLETED|Overall Study||0||
48659512|NCT04349371|101951674|FG000|NOT COMPLETED|Overall Study||0||
48771135|NCT00118417|102229357|FG000|STARTED|Phase I (Weeks 0 to 6)||39||
48771136|NCT00118417|102229358|FG001|STARTED|Phase I (Weeks 0 to 6)||0||
48771137|NCT00118417|102229357|FG000|COMPLETED|Phase I (Weeks 0 to 6)||21||
48771138|NCT00118417|102229358|FG001|COMPLETED|Phase I (Weeks 0 to 6)||0||
48771139|NCT00118417|102229357|FG000|NOT COMPLETED|Phase I (Weeks 0 to 6)||18||
48771140|NCT00118417|102229358|FG001|NOT COMPLETED|Phase I (Weeks 0 to 6)||0||
48771141|NCT00118417|102229357|FG000|STARTED|Phase II (Weeks 6 to 12)||11||
48771142|NCT00118417|102229358|FG001|STARTED|Phase II (Weeks 6 to 12)||13||
48771143|NCT00118417|102229357|FG000|COMPLETED|Phase II (Weeks 6 to 12)||9||
48659513|NCT04349371|101951675|FG001|NOT COMPLETED|Overall Study||0||
48659514|NCT01722643|101951676|FG000|STARTED|Overall Study||30||
48771144|NCT00118417|102229358|FG001|COMPLETED|Phase II (Weeks 6 to 12)||10||
48189082|NCT00708097|100786152|FG003|STARTED|Period 2||11||
48771145|NCT00118417|102229357|FG000|NOT COMPLETED|Phase II (Weeks 6 to 12)||2||
48771146|NCT00118417|102229358|FG001|NOT COMPLETED|Phase II (Weeks 6 to 12)||3||
48771147|NCT00118417|102229357|FG000|STARTED|Phase III (Weeks 12 to 24)||9||
48771148|NCT00118417|102229358|FG001|STARTED|Phase III (Weeks 12 to 24)||10||
48447768|NCT02913261|101431632|FG000|NOT COMPLETED|Overall Study||119||
48659515|NCT01722643|101951677|FG001|STARTED|Overall Study||31||
48659516|NCT01722643|101951676|FG000|COMPLETED|Overall Study||30||
48659517|NCT01722643|101951677|FG001|COMPLETED|Overall Study||30||
48659518|NCT01722643|101951676|FG000|NOT COMPLETED|Overall Study||0||
48659519|NCT01722643|101951677|FG001|NOT COMPLETED|Overall Study||1||
48659520|NCT02695771|101951678|FG000|STARTED|Overall Study||29||
48659521|NCT02695771|101951679|FG001|STARTED|Overall Study||26||
48659522|NCT02695771|101951680|FG002|STARTED|Overall Study||27||
48659523|NCT02695771|101951678|FG000|COMPLETED|Overall Study||29||
48659524|NCT02695771|101951679|FG001|COMPLETED|Overall Study||26||
48659525|NCT02695771|101951680|FG002|COMPLETED|Overall Study||27||
48659526|NCT02695771|101951678|FG000|NOT COMPLETED|Overall Study||0||
48659527|NCT02695771|101951679|FG001|NOT COMPLETED|Overall Study||0||
48659528|NCT02695771|101951680|FG002|NOT COMPLETED|Overall Study||0||
48659529|NCT03318393|101951681|FG000|STARTED|Overall Study||14||
48659530|NCT03318393|101951682|FG001|STARTED|Overall Study||16||
48659531|NCT03318393|101951681|FG000|COMPLETED|Overall Study||14||
48659532|NCT03318393|101951682|FG001|COMPLETED|Overall Study||16||
48659533|NCT03318393|101951681|FG000|NOT COMPLETED|Overall Study||0||
48659534|NCT03318393|101951682|FG001|NOT COMPLETED|Overall Study||0||
48659535|NCT04755231|101951683|FG000|STARTED|Overall Study||144||288
48659536|NCT04755231|101951683|FG000|Attempted Implantation, First Eye|Overall Study||144||144
48659537|NCT04755231|101951683|FG000|Attempted Implantation Second Eye|Overall Study||142||142
48659538|NCT04755231|101951683|FG000|Successful Implantation, First Eye|Overall Study||144||144
48659539|NCT04755231|101951683|FG000|Successful Implantation Second Eye|Overall Study||142||142
48771149|NCT00118417|102229357|FG000|COMPLETED|Phase III (Weeks 12 to 24)||8||
48771150|NCT00118417|102229358|FG001|COMPLETED|Phase III (Weeks 12 to 24)||9||
48771151|NCT00118417|102229357|FG000|NOT COMPLETED|Phase III (Weeks 12 to 24)||1||
48771152|NCT00118417|102229358|FG001|NOT COMPLETED|Phase III (Weeks 12 to 24)||1||
48771153|NCT02688777|102229359|FG000|STARTED|Overall Study||32||
48771154|NCT02688777|102229360|FG001|STARTED|Overall Study||30||
48771155|NCT02688777|102229359|FG000|COMPLETED|Overall Study||25||
48771156|NCT02688777|102229360|FG001|COMPLETED|Overall Study||19||
48771157|NCT02688777|102229359|FG000|NOT COMPLETED|Overall Study||7||
48771158|NCT02688777|102229360|FG001|NOT COMPLETED|Overall Study||11||
48369160|NCT00844428|101232712|FG000|STARTED|Observation Period (8 Weeks)||20||
48447769|NCT02913261|101431633|FG001|NOT COMPLETED|Overall Study||135||
48447770|NCT02320838|101431634|FG000|STARTED|First Intervention (1 Day)||8||
48447771|NCT02320838|101431635|FG001|STARTED|First Intervention (1 Day)||8||
48659540|NCT04755231|101951683|FG000|COMPLETED|Overall Study||134||268
48659541|NCT04755231|101951683|FG000|NOT COMPLETED|Overall Study||10||20
48659542|NCT02766478|101951684|FG000|STARTED|Overall Study||6||
48659543|NCT02766478|101951685|FG001|STARTED|Overall Study||4||
48659544|NCT02766478|101951684|FG000|COMPLETED|Overall Study||5||
48659545|NCT02766478|101951685|FG001|COMPLETED|Overall Study||3||
48659546|NCT02766478|101951684|FG000|NOT COMPLETED|Overall Study||1||
48659547|NCT02766478|101951685|FG001|NOT COMPLETED|Overall Study||1||
48659548|NCT02364271|101951686|FG000|STARTED|Overall Study||479||
48659549|NCT02364271|101951687|FG001|STARTED|Overall Study||123||
48659550|NCT02364271|101951686|FG000|COMPLETED|Overall Study||479||
48659551|NCT02364271|101951687|FG001|COMPLETED|Overall Study||123||
48659552|NCT02364271|101951686|FG000|NOT COMPLETED|Overall Study||0||
48659553|NCT02364271|101951687|FG001|NOT COMPLETED|Overall Study||0||
48659554|NCT02231580|101951688|FG000|STARTED|Overall Study||14||
48659555|NCT02231580|101951689|FG001|STARTED|Overall Study||3||
48659556|NCT02231580|101951688|FG000|Cohort 1|Overall Study||8||
48659557|NCT02231580|101951689|FG001|Cohort 1|Overall Study||2||
48659558|NCT02231580|101951688|FG000|Cohort 2|Overall Study||6||
48659559|NCT02231580|101951689|FG001|Cohort 2|Overall Study||1||
48659560|NCT02231580|101951688|FG000|COMPLETED|Overall Study||9||
48659561|NCT02231580|101951689|FG001|COMPLETED|Overall Study||3||
48659562|NCT02231580|101951688|FG000|NOT COMPLETED|Overall Study||5||
48659563|NCT02231580|101951689|FG001|NOT COMPLETED|Overall Study||0||
48659564|NCT00295503|101951690|FG000|STARTED|Overall Study||53||
48659565|NCT00295503|101951690|FG000|COMPLETED|Overall Study||53||
48659566|NCT00295503|101951690|FG000|NOT COMPLETED|Overall Study||0||
48659567|NCT01848457|101951691|FG000|STARTED|Overall Study||4||
48659568|NCT01848457|101951692|FG001|STARTED|Overall Study||3||
48659569|NCT01848457|101951693|FG002|STARTED|Overall Study||3||
48659570|NCT01848457|101951694|FG003|STARTED|Overall Study||3||
48659571|NCT01848457|101951691|FG000|Baseline|Overall Study||4||
48659572|NCT01848457|101951692|FG001|Baseline|Overall Study||3||
48659573|NCT01848457|101951693|FG002|Baseline|Overall Study||3||
48659574|NCT01848457|101951694|FG003|Baseline|Overall Study||3||
48659575|NCT01848457|101951691|FG000|Cycle 1|Overall Study||4||
48659576|NCT01848457|101951692|FG001|Cycle 1|Overall Study||3||
48659577|NCT01848457|101951693|FG002|Cycle 1|Overall Study||3||
48659578|NCT01848457|101951694|FG003|Cycle 1|Overall Study||3||
48659579|NCT01848457|101951691|FG000|Cycle 2|Overall Study||3||
48659580|NCT01848457|101951692|FG001|Cycle 2|Overall Study||3||
48659581|NCT01848457|101951693|FG002|Cycle 2|Overall Study||3||
48771159|NCT01709084|102229361|FG000|STARTED|Overall Study||213||
48771160|NCT01709084|102229362|FG001|STARTED|Overall Study||213||
48771161|NCT01709084|102229361|FG000|Treated|Overall Study||213||
48771162|NCT01709084|102229362|FG001|Treated|Overall Study||211||
48771163|NCT01709084|102229361|FG000|COMPLETED|Overall Study||197||
48771164|NCT01709084|102229362|FG001|COMPLETED|Overall Study||198||
48369161|NCT00844428|101232712|FG000|COMPLETED|Observation Period (8 Weeks)||20||
48369162|NCT00844428|101232712|FG000|NOT COMPLETED|Observation Period (8 Weeks)||0||
48369163|NCT00844428|101232712|FG000|STARTED|Treatment Period (26 Weeks)||20||
48369164|NCT00844428|101232712|FG000|COMPLETED|Treatment Period (26 Weeks)||20||
48369165|NCT00844428|101232712|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||0||
48447772|NCT02320838|101431636|FG002|STARTED|First Intervention (1 Day)||8||
48447773|NCT02320838|101431637|FG003|STARTED|First Intervention (1 Day)||7||
48447774|NCT02320838|101431638|FG004|STARTED|First Intervention (1 Day)||7||
48447775|NCT02320838|101431634|FG000|COMPLETED|First Intervention (1 Day)||8||
48447776|NCT02320838|101431635|FG001|COMPLETED|First Intervention (1 Day)||8||
48447777|NCT02320838|101431636|FG002|COMPLETED|First Intervention (1 Day)||8||
48771165|NCT01709084|102229361|FG000|NOT COMPLETED|Overall Study||16||
48771166|NCT01709084|102229362|FG001|NOT COMPLETED|Overall Study||15||
48771167|NCT04396639|102229363|FG000|STARTED|Overall Study||50||
48771168|NCT04396639|102229363|FG000|Completed Follow up|Overall Study||48||
48369166|NCT00844428|101232712|FG000|STARTED|Extension Treatment Period||19||
48369167|NCT00844428|101232712|FG000|COMPLETED|Extension Treatment Period||18||
48369168|NCT00844428|101232712|FG000|NOT COMPLETED|Extension Treatment Period||1||
48369169|NCT00844428|101232712|FG000|STARTED|Post Treatment Period (Patients Who Disc||5||
48369170|NCT00844428|101232712|FG000|COMPLETED|Post Treatment Period (Patients Who Disc||4||
48369171|NCT00844428|101232712|FG000|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1||
48369172|NCT00540449|101232713|FG000|STARTED|Overall Study||346||
48369173|NCT00540449|101232714|FG001|STARTED|Overall Study||344||
48369174|NCT00540449|101232713|FG000|COMPLETED|Overall Study||262||
48369175|NCT00540449|101232714|FG001|COMPLETED|Overall Study||266||
48369176|NCT00540449|101232713|FG000|NOT COMPLETED|Overall Study||84||
48369177|NCT00540449|101232714|FG001|NOT COMPLETED|Overall Study||78||
48369178|NCT01783522|101232715|FG000|STARTED|Overall Study||4||
48369179|NCT01783522|101232716|FG001|STARTED|Overall Study||5||
48369180|NCT01783522|101232715|FG000|COMPLETED|Overall Study||4||
48369181|NCT01783522|101232716|FG001|COMPLETED|Overall Study||5||
48369182|NCT01783522|101232715|FG000|NOT COMPLETED|Overall Study||0||
48369183|NCT01783522|101232716|FG001|NOT COMPLETED|Overall Study||0||
48369184|NCT02024711|101232717|FG000|STARTED|Overall Study||130||
48369185|NCT02024711|101232718|FG001|STARTED|Overall Study||132||
48369186|NCT02024711|101232717|FG000|COMPLETED|Overall Study||129||
48369187|NCT02024711|101232718|FG001|COMPLETED|Overall Study||128||
48369188|NCT02024711|101232717|FG000|NOT COMPLETED|Overall Study||1||
48369189|NCT02024711|101232718|FG001|NOT COMPLETED|Overall Study||4||
48369190|NCT01356602|101232719|FG000|STARTED|Overall Study||133||
48369191|NCT01356602|101232720|FG001|STARTED|Overall Study||132||
48369192|NCT01356602|101232721|FG002|STARTED|Overall Study||132||
48369193|NCT01356602|101232719|FG000|Safety Set|Overall Study||133||
48369194|NCT01356602|101232720|FG001|Safety Set|Overall Study||133||
48369195|NCT01356602|101232721|FG002|Safety Set|Overall Study||133||
48369196|NCT01356602|101232719|FG000|Full Analysis Set|Overall Study||131||
48369197|NCT01356602|101232720|FG001|Full Analysis Set|Overall Study||129||
48369198|NCT01356602|101232721|FG002|Full Analysis Set|Overall Study||129||
48369199|NCT01356602|101232719|FG000|COMPLETED|Overall Study||124||
48369200|NCT01356602|101232720|FG001|COMPLETED|Overall Study||117||
48771169|NCT04396639|102229363|FG000|COMPLETED|Overall Study||48||
48771170|NCT04396639|102229363|FG000|NOT COMPLETED|Overall Study||2||
48771171|NCT01942837|102229364|FG000|STARTED|Overall Study||67||
48771172|NCT01942837|102229364|FG000|COMPLETED|Overall Study||0||
48369201|NCT01356602|101232721|FG002|COMPLETED|Overall Study||108||
48369202|NCT01356602|101232719|FG000|NOT COMPLETED|Overall Study||9||
48369203|NCT01356602|101232720|FG001|NOT COMPLETED|Overall Study||15||
48369204|NCT01356602|101232721|FG002|NOT COMPLETED|Overall Study||24||
48369205|NCT04070378|101232722|FG000|STARTED|Overall Study||16||
48369206|NCT04070378|101232722|FG000|Subjects Who Received at Least One Dose of Study Drug.|Overall Study||9||
48369207|NCT04070378|101232722|FG000|COMPLETED|Overall Study||6||
48369208|NCT04070378|101232722|FG000|NOT COMPLETED|Overall Study||10||
48369209|NCT01605071|101232723|FG000|STARTED|Overall Study||27|Includes those who were randomized and dropped or randomized, completed initial testing then dropped|
48369210|NCT01605071|101232724|FG001|STARTED|Overall Study||26|Includes those who were randomized and dropped or randomized, completed initial testing then dropped|
48369211|NCT01605071|101232723|FG000|COMPLETED|Overall Study||24||
48369212|NCT01605071|101232724|FG001|COMPLETED|Overall Study||24||
48369213|NCT01605071|101232723|FG000|NOT COMPLETED|Overall Study||3||
48369214|NCT01605071|101232724|FG001|NOT COMPLETED|Overall Study||2||
48369215|NCT03566108|101232725|FG000|STARTED|Overall Study||2||3
48447778|NCT02320838|101431637|FG003|COMPLETED|First Intervention (1 Day)||7||
48447779|NCT02320838|101431638|FG004|COMPLETED|First Intervention (1 Day)||7||
48369216|NCT03566108|101232726|FG001|STARTED|Overall Study||1||1
48369217|NCT03566108|101232727|FG002|STARTED|Overall Study||6||15
48771173|NCT01942837|102229364|FG000|NOT COMPLETED|Overall Study||67||
48771174|NCT01385293|102229365|FG000|STARTED|Overall Study||30||
48771175|NCT01385293|102229365|FG000|COMPLETED|Overall Study||30||
48369218|NCT03566108|101232728|FG003|STARTED|Overall Study||6||10
48369219|NCT03566108|101232725|FG000|COMPLETED|Overall Study||2||3
48369220|NCT03566108|101232726|FG001|COMPLETED|Overall Study||1||1
48369221|NCT03566108|101232727|FG002|COMPLETED|Overall Study||6||15
48369222|NCT03566108|101232728|FG003|COMPLETED|Overall Study||6||10
48369223|NCT03566108|101232725|FG000|NOT COMPLETED|Overall Study||0||0
48369224|NCT03566108|101232726|FG001|NOT COMPLETED|Overall Study||0||0
48369225|NCT03566108|101232727|FG002|NOT COMPLETED|Overall Study||0||0
48369226|NCT03566108|101232728|FG003|NOT COMPLETED|Overall Study||0||0
48369227|NCT03774745|101232729|FG000|STARTED|Overall Study||6||
48369228|NCT03774745|101232730|FG001|STARTED|Overall Study||6||
48447780|NCT02320838|101431634|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48447781|NCT02320838|101431635|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48447782|NCT02320838|101431636|FG002|NOT COMPLETED|First Intervention (1 Day)||0||
48369229|NCT03774745|101232729|FG000|Follow-Up 1|Overall Study||5|3 +/- 1 day after enrollment|
48369230|NCT03774745|101232730|FG001|Follow-Up 1|Overall Study||6|3 +/- 1 day after enrollment|
48369231|NCT03774745|101232729|FG000|Follow-up 2|Overall Study||4|7 +/1 day after enrollment|
48369232|NCT03774745|101232730|FG001|Follow-up 2|Overall Study||2|7 +/1 day after enrollment|
48369233|NCT03774745|101232729|FG000|COMPLETED|Overall Study||4|15 +/- 1 day after enrollment|
48369234|NCT03774745|101232730|FG001|COMPLETED|Overall Study||2|15 +/- 1 day after enrollment|
48369235|NCT03774745|101232729|FG000|NOT COMPLETED|Overall Study||2||
48369236|NCT03774745|101232730|FG001|NOT COMPLETED|Overall Study||4||
48369237|NCT03268746|101232731|FG000|STARTED|Overall Study||45|Attempted Implantation|
48369238|NCT03268746|101232731|FG000|COMPLETED|Overall Study||44||
48369239|NCT03268746|101232731|FG000|NOT COMPLETED|Overall Study||1||
48369240|NCT03042611|101232732|FG000|STARTED|Core Phase||308||
48369241|NCT03042611|101232733|FG001|STARTED|Core Phase||152||
48369242|NCT03042611|101232734|FG002|STARTED|Core Phase||0||
48369243|NCT03042611|101232735|FG003|STARTED|Core Phase||0||
48369244|NCT03042611|101232732|FG000|Received at Least 1 Dose of Study Drug|Core Phase||307||
48369245|NCT03042611|101232733|FG001|Received at Least 1 Dose of Study Drug|Core Phase||151||
48369246|NCT03042611|101232734|FG002|Received at Least 1 Dose of Study Drug|Core Phase||0||
48369247|NCT03042611|101232735|FG003|Received at Least 1 Dose of Study Drug|Core Phase||0||
48369248|NCT03042611|101232732|FG000|COMPLETED|Core Phase||52||
48369249|NCT03042611|101232733|FG001|COMPLETED|Core Phase||28||
48369250|NCT03042611|101232734|FG002|COMPLETED|Core Phase||0||
48369251|NCT03042611|101232735|FG003|COMPLETED|Core Phase||0||
48369252|NCT03042611|101232732|FG000|NOT COMPLETED|Core Phase||256||
48369253|NCT03042611|101232733|FG001|NOT COMPLETED|Core Phase||124||
48369254|NCT03042611|101232734|FG002|NOT COMPLETED|Core Phase||0||
48369255|NCT03042611|101232735|FG003|NOT COMPLETED|Core Phase||0||
48369256|NCT03042611|101232732|FG000|STARTED|Extension Phase||0||
48369257|NCT03042611|101232733|FG001|STARTED|Extension Phase||0||
48369258|NCT03042611|101232734|FG002|STARTED|Extension Phase||52||
48369259|NCT03042611|101232735|FG003|STARTED|Extension Phase||28||
48369260|NCT03042611|101232732|FG000|COMPLETED|Extension Phase||0||
48369261|NCT03042611|101232733|FG001|COMPLETED|Extension Phase||0||
48369262|NCT03042611|101232734|FG002|COMPLETED|Extension Phase||0||
48369263|NCT03042611|101232735|FG003|COMPLETED|Extension Phase||0||
48369264|NCT03042611|101232732|FG000|NOT COMPLETED|Extension Phase||0||
48369265|NCT03042611|101232733|FG001|NOT COMPLETED|Extension Phase||0||
48369266|NCT03042611|101232734|FG002|NOT COMPLETED|Extension Phase||52||
48369267|NCT03042611|101232735|FG003|NOT COMPLETED|Extension Phase||28||
48369268|NCT03844633|101232736|FG000|STARTED|1 Week FU||16||
48369269|NCT03844633|101232737|FG001|STARTED|1 Week FU||15||
48369270|NCT03844633|101232738|FG002|STARTED|1 Week FU||17||
48369271|NCT03844633|101232736|FG000|COMPLETED|1 Week FU||16||
48369272|NCT03844633|101232737|FG001|COMPLETED|1 Week FU||14||
48369273|NCT03844633|101232738|FG002|COMPLETED|1 Week FU||13||
48369274|NCT03844633|101232736|FG000|NOT COMPLETED|1 Week FU||0||
48369275|NCT03844633|101232737|FG001|NOT COMPLETED|1 Week FU||1||
48369276|NCT03844633|101232738|FG002|NOT COMPLETED|1 Week FU||4||
48369277|NCT03844633|101232736|FG000|STARTED|12-month Follow-up||16||
48369278|NCT03844633|101232737|FG001|STARTED|12-month Follow-up||15||
48369279|NCT03844633|101232738|FG002|STARTED|12-month Follow-up||17||
48369280|NCT03844633|101232736|FG000|COMPLETED|12-month Follow-up||9||
48369281|NCT03844633|101232737|FG001|COMPLETED|12-month Follow-up||10||
48369282|NCT03844633|101232738|FG002|COMPLETED|12-month Follow-up||9||
48369283|NCT03844633|101232736|FG000|NOT COMPLETED|12-month Follow-up||7||
48369284|NCT03844633|101232737|FG001|NOT COMPLETED|12-month Follow-up||5||
48369285|NCT03844633|101232738|FG002|NOT COMPLETED|12-month Follow-up||8||
48369286|NCT01166659|101232739|FG000|STARTED|Overall Study||48||
48369287|NCT01166659|101232739|FG000|COMPLETED|Overall Study||35||
48369288|NCT01166659|101232739|FG000|NOT COMPLETED|Overall Study||13||
48369289|NCT03165981|101232740|FG000|STARTED|Overall Study||110|Intent-to-treat Population: enrolled, randomized and received at least one study vaccine at V1|
48369290|NCT03165981|101232741|FG001|STARTED|Overall Study||111|Intent-to-treat Population: enrolled, randomized and received at least one study vaccine at V1|
48369291|NCT03165981|101232740|FG000|Per Protocol Population|Overall Study||99|Excludes those w/o valid temperature data on D1-2 following V1-2 or with major protocol violations|
48369292|NCT03165981|101232741|FG001|Per Protocol Population|Overall Study||107|Excludes those w/o valid temperature data on D1-2 following V1-2 or with major protocol violations|
48447783|NCT02320838|101431637|FG003|NOT COMPLETED|First Intervention (1 Day)||0||
48447784|NCT02320838|101431638|FG004|NOT COMPLETED|First Intervention (1 Day)||0||
48447785|NCT02320838|101431634|FG000|STARTED|Washout (1 Day)||8||
48447786|NCT02320838|101431635|FG001|STARTED|Washout (1 Day)||8||
48447787|NCT02320838|101431636|FG002|STARTED|Washout (1 Day)||8||
48447788|NCT02320838|101431637|FG003|STARTED|Washout (1 Day)||7||
48447789|NCT02320838|101431638|FG004|STARTED|Washout (1 Day)||7||
48447790|NCT02320838|101431634|FG000|COMPLETED|Washout (1 Day)||8||
48447791|NCT02320838|101431635|FG001|COMPLETED|Washout (1 Day)||8||
48447792|NCT02320838|101431636|FG002|COMPLETED|Washout (1 Day)||8||
48447793|NCT02320838|101431637|FG003|COMPLETED|Washout (1 Day)||7||
48447794|NCT02320838|101431638|FG004|COMPLETED|Washout (1 Day)||7||
48447795|NCT02320838|101431634|FG000|NOT COMPLETED|Washout (1 Day)||0||
48659582|NCT01848457|101951694|FG003|Cycle 2|Overall Study||3||
48659583|NCT01848457|101951691|FG000|Cycle 3|Overall Study||3||
48659584|NCT01848457|101951692|FG001|Cycle 3|Overall Study||3||
48659585|NCT01848457|101951693|FG002|Cycle 3|Overall Study||3||
48659586|NCT01848457|101951694|FG003|Cycle 3|Overall Study||3||
48659587|NCT01848457|101951691|FG000|Cycle 4|Overall Study||3||
48659588|NCT01848457|101951692|FG001|Cycle 4|Overall Study||3||
48659589|NCT01848457|101951693|FG002|Cycle 4|Overall Study||3||
48659590|NCT01848457|101951694|FG003|Cycle 4|Overall Study||3||
48659591|NCT01848457|101951691|FG000|COMPLETED|Overall Study||3||
48659592|NCT01848457|101951692|FG001|COMPLETED|Overall Study||3||
48659593|NCT01848457|101951693|FG002|COMPLETED|Overall Study||3||
48659594|NCT01848457|101951694|FG003|COMPLETED|Overall Study||3||
48659595|NCT01848457|101951691|FG000|NOT COMPLETED|Overall Study||1||
48659596|NCT01848457|101951692|FG001|NOT COMPLETED|Overall Study||0||
48659597|NCT01848457|101951693|FG002|NOT COMPLETED|Overall Study||0||
48659598|NCT01848457|101951694|FG003|NOT COMPLETED|Overall Study||0||
48771176|NCT01385293|102229365|FG000|NOT COMPLETED|Overall Study||0||
48771177|NCT00275509|102229366|FG000|STARTED|Overall Study||30||
48771178|NCT00275509|102229367|FG001|STARTED|Overall Study||26||
48771179|NCT00275509|102229366|FG000|COMPLETED|Overall Study||30||
48771180|NCT00275509|102229367|FG001|COMPLETED|Overall Study||25||
48771181|NCT00275509|102229366|FG000|NOT COMPLETED|Overall Study||0||
48659599|NCT04008069|101951695|FG000|STARTED|Open-Label Period||15||
48659600|NCT04008069|101951696|FG001|STARTED|Open-Label Period||0||
48659601|NCT04008069|101951697|FG002|STARTED|Open-Label Period||0||
48659602|NCT04008069|101951695|FG000|Completed Treatment up to Week 16|Open-Label Period||10||
48659603|NCT04008069|101951696|FG001|Completed Treatment up to Week 16|Open-Label Period||0||
48659604|NCT04008069|101951697|FG002|Completed Treatment up to Week 16|Open-Label Period||0||
48659605|NCT04008069|101951695|FG000|COMPLETED|Open-Label Period||10||
48659606|NCT04008069|101951696|FG001|COMPLETED|Open-Label Period||0||
48659607|NCT04008069|101951697|FG002|COMPLETED|Open-Label Period||0||
48659608|NCT04008069|101951695|FG000|NOT COMPLETED|Open-Label Period||5||
48659609|NCT04008069|101951696|FG001|NOT COMPLETED|Open-Label Period||0||
48659610|NCT04008069|101951697|FG002|NOT COMPLETED|Open-Label Period||0||
48659611|NCT04008069|101951695|FG000|STARTED|Randomized-Withdrawal Period||0||
48659612|NCT04008069|101951696|FG001|STARTED|Randomized-Withdrawal Period||2||
48659613|NCT04008069|101951697|FG002|STARTED|Randomized-Withdrawal Period||8||
48659614|NCT04008069|101951695|FG000|Completed Treatment With Study Drug|Randomized-Withdrawal Period||0||
48771182|NCT00275509|102229367|FG001|NOT COMPLETED|Overall Study||1||
48771183|NCT01120964|102229368|FG000|STARTED|Overall Study||11||
48771184|NCT01120964|102229369|FG001|STARTED|Overall Study||11||
48771185|NCT01120964|102229368|FG000|COMPLETED|Overall Study||10||
48771186|NCT01120964|102229369|FG001|COMPLETED|Overall Study||11||
48447796|NCT02320838|101431635|FG001|NOT COMPLETED|Washout (1 Day)||0||
48447797|NCT02320838|101431636|FG002|NOT COMPLETED|Washout (1 Day)||0||
48447798|NCT02320838|101431637|FG003|NOT COMPLETED|Washout (1 Day)||0||
48447799|NCT02320838|101431638|FG004|NOT COMPLETED|Washout (1 Day)||0||
48447800|NCT02320838|101431634|FG000|STARTED|Second Intervention (1 Day)||8||
48447801|NCT02320838|101431635|FG001|STARTED|Second Intervention (1 Day)||8||
48447802|NCT02320838|101431636|FG002|STARTED|Second Intervention (1 Day)||8||
48447803|NCT02320838|101431637|FG003|STARTED|Second Intervention (1 Day)||7||
48447804|NCT02320838|101431638|FG004|STARTED|Second Intervention (1 Day)||7||
48447805|NCT02320838|101431634|FG000|COMPLETED|Second Intervention (1 Day)||8||
48447806|NCT02320838|101431635|FG001|COMPLETED|Second Intervention (1 Day)||8||
48447807|NCT02320838|101431636|FG002|COMPLETED|Second Intervention (1 Day)||8||
48447808|NCT02320838|101431637|FG003|COMPLETED|Second Intervention (1 Day)||7||
48447809|NCT02320838|101431638|FG004|COMPLETED|Second Intervention (1 Day)||7||
48447810|NCT02320838|101431634|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48447811|NCT02320838|101431635|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48659615|NCT04008069|101951696|FG001|Completed Treatment With Study Drug|Randomized-Withdrawal Period||1||
48659616|NCT04008069|101951697|FG002|Completed Treatment With Study Drug|Randomized-Withdrawal Period||5||
48659617|NCT04008069|101951695|FG000|COMPLETED|Randomized-Withdrawal Period||0||
48771187|NCT01120964|102229368|FG000|NOT COMPLETED|Overall Study||1||
48771188|NCT01120964|102229369|FG001|NOT COMPLETED|Overall Study||0||
48771189|NCT00473564|102229370|FG000|STARTED|Overall Study||170||
48771190|NCT00473564|102229370|FG000|COMPLETED|Overall Study||147||
48771191|NCT00473564|102229370|FG000|NOT COMPLETED|Overall Study||23||
48771192|NCT00043979|102229371|FG000|STARTED|Period 1||30||
48771193|NCT00043979|102229372|FG001|STARTED|Period 1||17||
48771194|NCT00043979|102229373|FG002|STARTED|Period 1||13||
48771195|NCT00043979|102229371|FG000|COMPLETED|Period 1||23||
48771196|NCT00043979|102229372|FG001|COMPLETED|Period 1||13||
48771197|NCT00043979|102229373|FG002|COMPLETED|Period 1||10||
48771198|NCT00043979|102229371|FG000|NOT COMPLETED|Period 1||7||
48447812|NCT02320838|101431636|FG002|NOT COMPLETED|Second Intervention (1 Day)||0||
48447813|NCT02320838|101431637|FG003|NOT COMPLETED|Second Intervention (1 Day)||0||
48447814|NCT02320838|101431638|FG004|NOT COMPLETED|Second Intervention (1 Day)||0||
48447815|NCT02320838|101431634|FG000|STARTED|Washout (1 Day)||8||
48447816|NCT02320838|101431635|FG001|STARTED|Washout (1 Day)||8||
48447817|NCT02320838|101431636|FG002|STARTED|Washout (1 Day)||8||
48447818|NCT02320838|101431637|FG003|STARTED|Washout (1 Day)||7||
48447819|NCT02320838|101431638|FG004|STARTED|Washout (1 Day)||7||
48447820|NCT02320838|101431634|FG000|COMPLETED|Washout (1 Day)||8||
48447821|NCT02320838|101431635|FG001|COMPLETED|Washout (1 Day)||8||
48447822|NCT02320838|101431636|FG002|COMPLETED|Washout (1 Day)||8||
48447823|NCT02320838|101431637|FG003|COMPLETED|Washout (1 Day)||7||
48447824|NCT02320838|101431638|FG004|COMPLETED|Washout (1 Day)||7||
48447825|NCT02320838|101431634|FG000|NOT COMPLETED|Washout (1 Day)||0||
48447826|NCT02320838|101431635|FG001|NOT COMPLETED|Washout (1 Day)||0||
48447827|NCT02320838|101431636|FG002|NOT COMPLETED|Washout (1 Day)||0||
48447828|NCT02320838|101431637|FG003|NOT COMPLETED|Washout (1 Day)||0||
48447829|NCT02320838|101431638|FG004|NOT COMPLETED|Washout (1 Day)||0||
48447830|NCT02320838|101431634|FG000|STARTED|Third Intervention (1 Day)||8||
48447831|NCT02320838|101431635|FG001|STARTED|Third Intervention (1 Day)||8||
48447832|NCT02320838|101431636|FG002|STARTED|Third Intervention (1 Day)||8||
48447833|NCT02320838|101431637|FG003|STARTED|Third Intervention (1 Day)||7||
48447834|NCT02320838|101431638|FG004|STARTED|Third Intervention (1 Day)||7||
48447835|NCT02320838|101431634|FG000|COMPLETED|Third Intervention (1 Day)||8||
48447836|NCT02320838|101431635|FG001|COMPLETED|Third Intervention (1 Day)||8||
48447837|NCT02320838|101431636|FG002|COMPLETED|Third Intervention (1 Day)||8||
48447838|NCT02320838|101431637|FG003|COMPLETED|Third Intervention (1 Day)||7||
48447839|NCT02320838|101431638|FG004|COMPLETED|Third Intervention (1 Day)||7||
48447840|NCT02320838|101431634|FG000|NOT COMPLETED|Third Intervention (1 Day)||0||
48447841|NCT02320838|101431635|FG001|NOT COMPLETED|Third Intervention (1 Day)||0||
48659618|NCT04008069|101951696|FG001|COMPLETED|Randomized-Withdrawal Period||1||
48659619|NCT04008069|101951697|FG002|COMPLETED|Randomized-Withdrawal Period||5||
48659620|NCT04008069|101951695|FG000|NOT COMPLETED|Randomized-Withdrawal Period||0||
48659621|NCT04008069|101951696|FG001|NOT COMPLETED|Randomized-Withdrawal Period||1||
48659622|NCT04008069|101951697|FG002|NOT COMPLETED|Randomized-Withdrawal Period||3||
48659623|NCT04065841|101951698|FG000|STARTED|Overall Study||54||
48659624|NCT04065841|101951699|FG001|STARTED|Overall Study||55||
48659625|NCT04065841|101951700|FG002|STARTED|Overall Study||84||
48659626|NCT04065841|101951701|FG003|STARTED|Overall Study||41||
48659627|NCT04065841|101951698|FG000|COMPLETED|Overall Study||25||
48659628|NCT04065841|101951699|FG001|COMPLETED|Overall Study||33||
48771199|NCT00043979|102229372|FG001|NOT COMPLETED|Period 1||4||
48771200|NCT00043979|102229373|FG002|NOT COMPLETED|Period 1||3||
48771201|NCT00043979|102229371|FG000|STARTED|Period 2||0||
48771202|NCT00043979|102229372|FG001|STARTED|Period 2||13||
48771203|NCT00043979|102229373|FG002|STARTED|Period 2||10||
48771204|NCT00043979|102229371|FG000|COMPLETED|Period 2||0||
48771205|NCT00043979|102229372|FG001|COMPLETED|Period 2||13||
48771206|NCT00043979|102229373|FG002|COMPLETED|Period 2||10||
48771207|NCT00043979|102229371|FG000|NOT COMPLETED|Period 2||0||
48771208|NCT00043979|102229372|FG001|NOT COMPLETED|Period 2||0||
48771209|NCT00043979|102229373|FG002|NOT COMPLETED|Period 2||0||
48771210|NCT01749215|102229374|FG000|STARTED|Overall Study||72||
48771211|NCT01749215|102229375|FG001|STARTED|Overall Study||79||
48771212|NCT01749215|102229374|FG000|COMPLETED|Overall Study||47||
48771213|NCT01749215|102229375|FG001|COMPLETED|Overall Study||53||
48771214|NCT01749215|102229374|FG000|NOT COMPLETED|Overall Study||25||
48771215|NCT01749215|102229375|FG001|NOT COMPLETED|Overall Study||26||
48771216|NCT00658359|102229376|FG000|STARTED|Overall Study||64||
48447842|NCT02320838|101431636|FG002|NOT COMPLETED|Third Intervention (1 Day)||0||
48447843|NCT02320838|101431637|FG003|NOT COMPLETED|Third Intervention (1 Day)||0||
48447844|NCT02320838|101431638|FG004|NOT COMPLETED|Third Intervention (1 Day)||0||
48447845|NCT00319020|101431639|FG000|STARTED|Overall Study||15||
48447846|NCT00319020|101431640|FG001|STARTED|Overall Study||21||
48447847|NCT00319020|101431639|FG000|Enrollment in FUTURE 2 (F-2)|Overall Study||13||
48447848|NCT00319020|101431640|FG001|Enrollment in FUTURE 2 (F-2)|Overall Study||20||
48447849|NCT00319020|101431639|FG000|COMPLETED|Overall Study||8||
48447850|NCT00319020|101431640|FG001|COMPLETED|Overall Study||8||
48447851|NCT00319020|101431639|FG000|NOT COMPLETED|Overall Study||7||
48659629|NCT04065841|101951700|FG002|COMPLETED|Overall Study||42||
48659630|NCT04065841|101951701|FG003|COMPLETED|Overall Study||21||
48771217|NCT00658359|102229377|FG001|STARTED|Overall Study||60||
48771218|NCT00658359|102229378|FG002|STARTED|Overall Study||54||
48447852|NCT00319020|101431640|FG001|NOT COMPLETED|Overall Study||13||
48447853|NCT01959230|101431641|FG000|STARTED|Overall Study||40||
48447854|NCT01959230|101431642|FG001|STARTED|Overall Study||20||
48447855|NCT01959230|101431641|FG000|Received at Least 1 Dose of Study Drug|Overall Study||40||
48447856|NCT01959230|101431642|FG001|Received at Least 1 Dose of Study Drug|Overall Study||20||
48447857|NCT01959230|101431641|FG000|COMPLETED|Overall Study||36||
48447858|NCT01959230|101431642|FG001|COMPLETED|Overall Study||19||
48447859|NCT01959230|101431641|FG000|NOT COMPLETED|Overall Study||4||
48447860|NCT01959230|101431642|FG001|NOT COMPLETED|Overall Study||1||
48447861|NCT03506425|101431643|FG000|STARTED|Overall Study||5||
48447862|NCT03506425|101431644|FG001|STARTED|Overall Study||5||
48771219|NCT00658359|102229376|FG000|COMPLETED|Overall Study||36||
48771220|NCT00658359|102229377|FG001|COMPLETED|Overall Study||15||
48771221|NCT00658359|102229378|FG002|COMPLETED|Overall Study||8||
48771222|NCT00658359|102229376|FG000|NOT COMPLETED|Overall Study||28||
48771223|NCT00658359|102229377|FG001|NOT COMPLETED|Overall Study||45||
48771224|NCT00658359|102229378|FG002|NOT COMPLETED|Overall Study||46||
48771225|NCT02392624|102229379|FG000|STARTED|Overall Study||71||
48771226|NCT02392624|102229380|FG001|STARTED|Overall Study||81||
48771227|NCT02392624|102229381|FG002|STARTED|Overall Study||53||
48771228|NCT02392624|102229379|FG000|COMPLETED|Overall Study||0||
48771229|NCT02392624|102229380|FG001|COMPLETED|Overall Study||66||
48771230|NCT02392624|102229381|FG002|COMPLETED|Overall Study||40||
48771231|NCT02392624|102229379|FG000|NOT COMPLETED|Overall Study||71||
48771232|NCT02392624|102229380|FG001|NOT COMPLETED|Overall Study||15||
48771233|NCT02392624|102229381|FG002|NOT COMPLETED|Overall Study||13||
48771234|NCT02633306|102229382|FG000|STARTED|Overall Study||9||
48189083|NCT00708097|100786153|FG004|STARTED|Period 2||10||
48447863|NCT03506425|101431645|FG002|STARTED|Overall Study||5||
48447864|NCT03506425|101431643|FG000|COMPLETED|Overall Study||3||
48447865|NCT03506425|101431644|FG001|COMPLETED|Overall Study||2||
48447866|NCT03506425|101431645|FG002|COMPLETED|Overall Study||4||
48447867|NCT03506425|101431643|FG000|NOT COMPLETED|Overall Study||2||
48447868|NCT03506425|101431644|FG001|NOT COMPLETED|Overall Study||3||
48447869|NCT03506425|101431645|FG002|NOT COMPLETED|Overall Study||1||
48447870|NCT00315328|101431646|FG000|STARTED|Overall Study||98||
48447871|NCT00315328|101431647|FG001|STARTED|Overall Study||95||
48447872|NCT00315328|101431648|FG002|STARTED|Overall Study||18||
48447873|NCT00315328|101431649|FG003|STARTED|Overall Study||22||
48447874|NCT00315328|101431646|FG000|5 Week Visit|Overall Study||91||
48447875|NCT00315328|101431647|FG001|5 Week Visit|Overall Study||89||
48447876|NCT00315328|101431648|FG002|5 Week Visit|Overall Study||17||
48447877|NCT00315328|101431649|FG003|5 Week Visit|Overall Study||19||
48447878|NCT00315328|101431646|FG000|COMPLETED|Overall Study||84||
48447879|NCT00315328|101431647|FG001|COMPLETED|Overall Study||88||
48447880|NCT00315328|101431648|FG002|COMPLETED|Overall Study||13||
48447881|NCT00315328|101431649|FG003|COMPLETED|Overall Study||20||
48447882|NCT00315328|101431646|FG000|NOT COMPLETED|Overall Study||14||
48447883|NCT00315328|101431647|FG001|NOT COMPLETED|Overall Study||7||
48447884|NCT00315328|101431648|FG002|NOT COMPLETED|Overall Study||5||
48447885|NCT00315328|101431649|FG003|NOT COMPLETED|Overall Study||2||
48447886|NCT00450177|101431650|FG000|STARTED|Overall Study||97||
48447887|NCT00450177|101431651|FG001|STARTED|Overall Study||103||
48447888|NCT00450177|101431650|FG000|COMPLETED|Overall Study||88||
48447889|NCT00450177|101431651|FG001|COMPLETED|Overall Study||92||
48447890|NCT00450177|101431650|FG000|NOT COMPLETED|Overall Study||9||
48447891|NCT00450177|101431651|FG001|NOT COMPLETED|Overall Study||11||
48447892|NCT02192541|101431652|FG000|STARTED|Overall Study||2||
48447893|NCT02192541|101431653|FG001|STARTED|Overall Study||3||
48447894|NCT02192541|101431652|FG000|Treated|Overall Study||2||
48447895|NCT02192541|101431653|FG001|Treated|Overall Study||3||
48447896|NCT02192541|101431652|FG000|Evaluable for Response|Overall Study||1||
48447897|NCT02192541|101431653|FG001|Evaluable for Response|Overall Study||3||
48447898|NCT02192541|101431652|FG000|COMPLETED|Overall Study||2||
48447899|NCT02192541|101431653|FG001|COMPLETED|Overall Study||3||
48447900|NCT02192541|101431652|FG000|NOT COMPLETED|Overall Study||0||
48447901|NCT02192541|101431653|FG001|NOT COMPLETED|Overall Study||0||
48659631|NCT04065841|101951698|FG000|NOT COMPLETED|Overall Study||29||
48189084|NCT00708097|100786149|FG000|COMPLETED|Period 2||10||
48447902|NCT02322242|101431654|FG000|STARTED|Overall Study||92||
48659632|NCT04065841|101951699|FG001|NOT COMPLETED|Overall Study||22||
48659633|NCT04065841|101951700|FG002|NOT COMPLETED|Overall Study||42||
48659634|NCT04065841|101951701|FG003|NOT COMPLETED|Overall Study||20||
48659635|NCT00879619|101951702|FG000|STARTED|Overall Study||4||
48659636|NCT00879619|101951702|FG000|COMPLETED|Overall Study||4||
48447903|NCT02322242|101431655|FG001|STARTED|Overall Study||90||
48447904|NCT02322242|101431654|FG000|Primary Outcome|Overall Study||92||
48447905|NCT02322242|101431655|FG001|Primary Outcome|Overall Study||90||
48447906|NCT02322242|101431654|FG000|1 Week Follow-up|Overall Study||90||
48447907|NCT02322242|101431655|FG001|1 Week Follow-up|Overall Study||89||
48447908|NCT02322242|101431654|FG000|COMPLETED|Overall Study||92||
48447909|NCT02322242|101431655|FG001|COMPLETED|Overall Study||90||
48659637|NCT00879619|101951702|FG000|NOT COMPLETED|Overall Study||0||
48771235|NCT02633306|102229382|FG000|COMPLETED|Overall Study||6||
48447910|NCT02322242|101431654|FG000|NOT COMPLETED|Overall Study||0||
48447911|NCT02322242|101431655|FG001|NOT COMPLETED|Overall Study||0||
48447912|NCT01189071|101431656|FG000|STARTED|Overall Study||0||
48447913|NCT01189071|101431657|FG001|STARTED|Overall Study||0||
48447914|NCT01189071|101431656|FG000|COMPLETED|Overall Study||0||
48447915|NCT01189071|101431657|FG001|COMPLETED|Overall Study||0||
48447916|NCT01189071|101431656|FG000|NOT COMPLETED|Overall Study||0||
48189085|NCT00708097|100786150|FG001|COMPLETED|Period 2||11||
48189086|NCT00708097|100786151|FG002|COMPLETED|Period 2||9||
48447917|NCT01189071|101431657|FG001|NOT COMPLETED|Overall Study||0||
48447918|NCT00782275|101431658|FG000|STARTED|Overall Study||41||
48447919|NCT00782275|101431658|FG000|Treated|Overall Study||40||
48447920|NCT00782275|101431658|FG000|Prior VEGFR Response Evaluable|Overall Study||39|Pts were classified by response to previous VEGFR TKI therapy at baseline: refractory or responsive.|
48447921|NCT00782275|101431658|FG000|COMPLETED|Overall Study||0||
48447922|NCT00782275|101431658|FG000|NOT COMPLETED|Overall Study||41||
48447923|NCT04179474|101431659|FG000|STARTED|Treatment Period 1 (First Intervention)||20||
48447924|NCT04179474|101431660|FG001|STARTED|Treatment Period 1 (First Intervention)||20||
48447925|NCT04179474|101431659|FG000|COMPLETED|Treatment Period 1 (First Intervention)||20||
48447926|NCT04179474|101431660|FG001|COMPLETED|Treatment Period 1 (First Intervention)||20||
48447927|NCT04179474|101431659|FG000|NOT COMPLETED|Treatment Period 1 (First Intervention)||0||
48447928|NCT04179474|101431660|FG001|NOT COMPLETED|Treatment Period 1 (First Intervention)||0||
48447929|NCT04179474|101431659|FG000|STARTED|Treatment Period 2 (Second Intervention)||19||
48447930|NCT04179474|101431660|FG001|STARTED|Treatment Period 2 (Second Intervention)||20||
48447931|NCT04179474|101431659|FG000|COMPLETED|Treatment Period 2 (Second Intervention)||19||
48447932|NCT04179474|101431660|FG001|COMPLETED|Treatment Period 2 (Second Intervention)||20||
48447933|NCT04179474|101431659|FG000|NOT COMPLETED|Treatment Period 2 (Second Intervention)||0||
48447934|NCT04179474|101431660|FG001|NOT COMPLETED|Treatment Period 2 (Second Intervention)||0||
48447935|NCT04179474|101431659|FG000|STARTED|Treatment Period 3 (Third Intervention)||19||
48447936|NCT04179474|101431660|FG001|STARTED|Treatment Period 3 (Third Intervention)||19||
48447937|NCT04179474|101431659|FG000|COMPLETED|Treatment Period 3 (Third Intervention)||19||
48447938|NCT04179474|101431660|FG001|COMPLETED|Treatment Period 3 (Third Intervention)||19||
48447939|NCT04179474|101431659|FG000|NOT COMPLETED|Treatment Period 3 (Third Intervention)||0||
48447940|NCT04179474|101431660|FG001|NOT COMPLETED|Treatment Period 3 (Third Intervention)||0||
48447941|NCT03499249|101431661|FG000|STARTED|Overall Study||13||
48447942|NCT03499249|101431661|FG000|COMPLETED|Overall Study||12||
48447943|NCT03499249|101431661|FG000|NOT COMPLETED|Overall Study||1||
48447944|NCT02067585|101431662|FG000|STARTED|Overall Study||16||
48447945|NCT02067585|101431663|FG001|STARTED|Overall Study||16||
48447946|NCT02067585|101431664|FG002|STARTED|Overall Study||16||
48447947|NCT02067585|101431662|FG000|COMPLETED|Overall Study||16||
48447948|NCT02067585|101431663|FG001|COMPLETED|Overall Study||16||
48447949|NCT02067585|101431664|FG002|COMPLETED|Overall Study||16||
48447950|NCT02067585|101431662|FG000|NOT COMPLETED|Overall Study||0||
48447951|NCT02067585|101431663|FG001|NOT COMPLETED|Overall Study||0||
48447952|NCT02067585|101431664|FG002|NOT COMPLETED|Overall Study||0||
48447953|NCT00995488|101431665|FG000|STARTED|Overall Study||16||
48447954|NCT00995488|101431665|FG000|COMPLETED|Overall Study||15||
48447955|NCT00995488|101431665|FG000|NOT COMPLETED|Overall Study||1||
48447956|NCT02528318|101431666|FG000|STARTED|Overall Study||8||
48447957|NCT02528318|101431667|FG001|STARTED|Overall Study||8||
48447958|NCT02528318|101431668|FG002|STARTED|Overall Study||8||
48447959|NCT02528318|101431669|FG003|STARTED|Overall Study||0||
48447960|NCT02528318|101431670|FG004|STARTED|Overall Study||24||
48447961|NCT02528318|101431666|FG000|COMPLETED|Overall Study||8||
48447962|NCT02528318|101431667|FG001|COMPLETED|Overall Study||8||
48447963|NCT02528318|101431668|FG002|COMPLETED|Overall Study||8||
48447964|NCT02528318|101431669|FG003|COMPLETED|Overall Study||0||
48447965|NCT02528318|101431670|FG004|COMPLETED|Overall Study||24||
48447966|NCT02528318|101431666|FG000|NOT COMPLETED|Overall Study||0||
48447967|NCT02528318|101431667|FG001|NOT COMPLETED|Overall Study||0||
48447968|NCT02528318|101431668|FG002|NOT COMPLETED|Overall Study||0||
48447969|NCT02528318|101431669|FG003|NOT COMPLETED|Overall Study||0||
48659638|NCT01767857|101951703|FG000|STARTED|Overall Study||430||
48659639|NCT01767857|101951704|FG001|STARTED|Overall Study||213||
48189087|NCT00708097|100786152|FG003|COMPLETED|Period 2||10||
48447970|NCT02528318|101431670|FG004|NOT COMPLETED|Overall Study||0||
48189088|NCT00708097|100786153|FG004|COMPLETED|Period 2||10||
48447971|NCT03515837|101431671|FG000|STARTED|Overall Study||245||
48447972|NCT03515837|101431672|FG001|STARTED|Overall Study||247||
48447973|NCT03515837|101431671|FG000|Treated|Overall Study||245||
48447974|NCT03515837|101431672|FG001|Treated|Overall Study||246||
48447975|NCT03515837|101431671|FG000|Switched Over to Pembro Monotherapy|Overall Study||0||
48659640|NCT01767857|101951703|FG000|Treated|Overall Study||411||
48447976|NCT03515837|101431672|FG001|Switched Over to Pembro Monotherapy|Overall Study||50||
48447977|NCT03515837|101431671|FG000|COMPLETED|Overall Study||0||
48447978|NCT03515837|101431672|FG001|COMPLETED|Overall Study||0||
48447979|NCT03515837|101431671|FG000|NOT COMPLETED|Overall Study||245||
48447980|NCT03515837|101431672|FG001|NOT COMPLETED|Overall Study||247||
48447981|NCT01488071|101431673|FG000|STARTED|Overall Study||253||
48447982|NCT01488071|101431674|FG001|STARTED|Overall Study||242||
48447983|NCT01488071|101431673|FG000|COMPLETED|Overall Study||200||
48447984|NCT01488071|101431674|FG001|COMPLETED|Overall Study||179||
48447985|NCT01488071|101431673|FG000|NOT COMPLETED|Overall Study||53||
48447986|NCT01488071|101431674|FG001|NOT COMPLETED|Overall Study||63||
48447987|NCT00550420|101431675|FG000|STARTED|Overall Study||331||
48447988|NCT00550420|101431675|FG000|COMPLETED|Overall Study||26||
48447989|NCT00550420|101431675|FG000|NOT COMPLETED|Overall Study||305||
48447990|NCT00657917|101431676|FG000|STARTED|Overall Study||1||
48447991|NCT00657917|101431676|FG000|COMPLETED|Overall Study||1||
48447992|NCT00657917|101431676|FG000|NOT COMPLETED|Overall Study||0||
48447993|NCT01461369|101431677|FG000|STARTED|Overall Study||104||
48447994|NCT01461369|101431678|FG001|STARTED|Overall Study||98||
48447995|NCT01461369|101431679|FG002|STARTED|Overall Study||103||
48447996|NCT01461369|101431677|FG000|COMPLETED|Overall Study||91||
48447997|NCT01461369|101431678|FG001|COMPLETED|Overall Study||81||
48447998|NCT01461369|101431679|FG002|COMPLETED|Overall Study||86||
48447999|NCT01461369|101431677|FG000|NOT COMPLETED|Overall Study||13||
48448000|NCT01461369|101431678|FG001|NOT COMPLETED|Overall Study||17||
48448001|NCT01461369|101431679|FG002|NOT COMPLETED|Overall Study||17||
48448002|NCT01238211|101431680|FG000|STARTED|Overall Study||61||
48448003|NCT01238211|101431680|FG000|COMPLETED|Overall Study||3||
48448004|NCT01238211|101431680|FG000|NOT COMPLETED|Overall Study||58||
48448005|NCT00078312|101431681|FG000|STARTED|Overall Study||328||
48448006|NCT00078312|101431681|FG000|COMPLETED|Overall Study||151||
48448007|NCT00078312|101431681|FG000|NOT COMPLETED|Overall Study||177||
48448008|NCT03672396|101431682|FG000|STARTED|Overall Study||22||
48448009|NCT03672396|101431682|FG000|COMPLETED|Overall Study||16||
48771236|NCT02633306|102229382|FG000|NOT COMPLETED|Overall Study||3||
48771237|NCT02318706|102229383|FG000|STARTED|Double-blind Phase||334||
48771238|NCT02318706|102229384|FG001|STARTED|Double-blind Phase||166||
48771239|NCT02318706|102229385|FG002|STARTED|Double-blind Phase||168||
48771240|NCT02318706|102229386|FG003|STARTED|Double-blind Phase||166||
48771241|NCT02318706|102229387|FG004|STARTED|Double-blind Phase||0||
48771242|NCT02318706|102229383|FG000|COMPLETED|Double-blind Phase||309||
48448010|NCT03672396|101431682|FG000|NOT COMPLETED|Overall Study||6||
48448011|NCT01083758|101431683|FG000|STARTED|Overall Study||31||
48448012|NCT01083758|101431683|FG000|COMPLETED|Overall Study||29||
48448013|NCT01083758|101431683|FG000|NOT COMPLETED|Overall Study||2||
48448014|NCT01577966|101431684|FG000|STARTED|Overall Study||9||
48448015|NCT01577966|101431684|FG000|COMPLETED|Overall Study||9||
48448016|NCT01577966|101431684|FG000|NOT COMPLETED|Overall Study||0||
48448017|NCT00388674|101431685|FG000|STARTED|Initial Treatment||6216||
48448018|NCT00388674|101431686|FG001|STARTED|Initial Treatment||6162||
48448019|NCT00388674|101431685|FG000|COMPLETED|Initial Treatment||4388||
48448020|NCT00388674|101431686|FG001|COMPLETED|Initial Treatment||3576||
48448021|NCT00388674|101431685|FG000|NOT COMPLETED|Initial Treatment||1828||
48448022|NCT00388674|101431686|FG001|NOT COMPLETED|Initial Treatment||2586||
48448023|NCT00388674|101431685|FG000|STARTED|End of Study||6216||
48448024|NCT00388674|101431686|FG001|STARTED|End of Study||6162||
48448025|NCT00388674|101431685|FG000|COMPLETED|End of Study||4482||
48448026|NCT00388674|101431686|FG001|COMPLETED|End of Study||3993||
48448027|NCT00388674|101431685|FG000|NOT COMPLETED|End of Study||1734||
48448028|NCT00388674|101431686|FG001|NOT COMPLETED|End of Study||2169||
48448029|NCT00810615|101431687|FG000|STARTED|Overall Study||25||
48448030|NCT00810615|101431688|FG001|STARTED|Overall Study||25||
48448031|NCT00810615|101431687|FG000|COMPLETED|Overall Study||24||
48448032|NCT00810615|101431688|FG001|COMPLETED|Overall Study||24||
48448033|NCT00810615|101431687|FG000|NOT COMPLETED|Overall Study||1||
48448034|NCT00810615|101431688|FG001|NOT COMPLETED|Overall Study||1||
48448035|NCT01954082|101431689|FG000|STARTED|Overall Study||317||
48448036|NCT01954082|101431690|FG001|STARTED|Overall Study||321||
48448037|NCT01954082|101431689|FG000|Treated|Overall Study||313||
48448038|NCT01954082|101431690|FG001|Treated|Overall Study||319||
48448039|NCT01954082|101431689|FG000|COMPLETED|Overall Study||249||
48448040|NCT01954082|101431690|FG001|COMPLETED|Overall Study||264||
48448041|NCT01954082|101431689|FG000|NOT COMPLETED|Overall Study||68||
48448042|NCT01954082|101431690|FG001|NOT COMPLETED|Overall Study||57||
48448043|NCT04236635|101431691|FG000|STARTED|Overall Study||2||
48448044|NCT04236635|101431692|FG001|STARTED|Overall Study||1||
48448045|NCT04236635|101431693|FG002|STARTED|Overall Study||1||
48448046|NCT04236635|101431694|FG003|STARTED|Overall Study||4||
48448047|NCT04236635|101431695|FG004|STARTED|Overall Study||1||
48448048|NCT04236635|101431696|FG005|STARTED|Overall Study||1||
48448049|NCT04236635|101431691|FG000|Safety Population|Overall Study||2|All participants who received at least 1 injection of study drug irrespective of the timing window of abdominoplasty.|
48448050|NCT04236635|101431692|FG001|Safety Population|Overall Study||1|All participants who received at least 1 injection of study drug irrespective of the timing window of abdominoplasty.|
48448051|NCT04236635|101431693|FG002|Safety Population|Overall Study||1|All participants who received at least 1 injection of study drug irrespective of the timing window of abdominoplasty.|
48448052|NCT04236635|101431694|FG003|Safety Population|Overall Study||4|All participants who received at least 1 injection of study drug irrespective of the timing window of abdominoplasty.|
48448053|NCT04236635|101431695|FG004|Safety Population|Overall Study||1|All participants who received at least 1 injection of study drug irrespective of the timing window of abdominoplasty.|
48448054|NCT04236635|101431696|FG005|Safety Population|Overall Study||1|All participants who received at least 1 injection of study drug irrespective of the timing window of abdominoplasty.|
48448055|NCT04236635|101431691|FG000|Evaluable Population|Overall Study||2|All participants who received at least 1 injection of study drug, underwent abdominoplasty within the protocol specified timelines, and had a histopathology and immunohistochemistry report.|
48448056|NCT04236635|101431692|FG001|Evaluable Population|Overall Study||1|All participants who received at least 1 injection of study drug, underwent abdominoplasty within the protocol specified timelines, and had a histopathology and immunohistochemistry report.|
48448057|NCT04236635|101431693|FG002|Evaluable Population|Overall Study||1|All participants who received at least 1 injection of study drug, underwent abdominoplasty within the protocol specified timelines, and had a histopathology and immunohistochemistry report.|
48448058|NCT04236635|101431694|FG003|Evaluable Population|Overall Study||2|All participants who received at least 1 injection of study drug, underwent abdominoplasty within the protocol specified timelines, and had a histopathology and immunohistochemistry report.|
48448059|NCT04236635|101431695|FG004|Evaluable Population|Overall Study||1|All participants who received at least 1 injection of study drug, underwent abdominoplasty within the protocol specified timelines, and had a histopathology and immunohistochemistry report.|
48448060|NCT04236635|101431696|FG005|Evaluable Population|Overall Study||1|All participants who received at least 1 injection of study drug, underwent abdominoplasty within the protocol specified timelines, and had a histopathology and immunohistochemistry report.|
48448061|NCT04236635|101431691|FG000|COMPLETED|Overall Study||2||
48448062|NCT04236635|101431692|FG001|COMPLETED|Overall Study||1||
48448063|NCT04236635|101431693|FG002|COMPLETED|Overall Study||1||
48448064|NCT04236635|101431694|FG003|COMPLETED|Overall Study||4||
48448065|NCT04236635|101431695|FG004|COMPLETED|Overall Study||1||
48448066|NCT04236635|101431696|FG005|COMPLETED|Overall Study||1||
48448067|NCT04236635|101431691|FG000|NOT COMPLETED|Overall Study||0||
48448068|NCT04236635|101431692|FG001|NOT COMPLETED|Overall Study||0||
48448069|NCT04236635|101431693|FG002|NOT COMPLETED|Overall Study||0||
48448070|NCT04236635|101431694|FG003|NOT COMPLETED|Overall Study||0||
48448071|NCT04236635|101431695|FG004|NOT COMPLETED|Overall Study||0||
48448072|NCT04236635|101431696|FG005|NOT COMPLETED|Overall Study||0||
48448073|NCT03056001|101431697|FG000|STARTED|Overall Study||30||
48448074|NCT03056001|101431697|FG000|COMPLETED|Overall Study||6||
48448075|NCT03056001|101431697|FG000|NOT COMPLETED|Overall Study||24||
48448076|NCT01169844|101431698|FG000|STARTED|Overall Study||19||
48448077|NCT01169844|101431699|FG001|STARTED|Overall Study||9||
48448078|NCT01169844|101431698|FG000|COMPLETED|Overall Study||14||
48448079|NCT01169844|101431699|FG001|COMPLETED|Overall Study||8||
48448080|NCT01169844|101431698|FG000|NOT COMPLETED|Overall Study||5||
48448081|NCT01169844|101431699|FG001|NOT COMPLETED|Overall Study||1||
48448082|NCT02533505|101431700|FG000|STARTED|Overall Study||26||
48448083|NCT02533505|101431701|FG001|STARTED|Overall Study||25||
48448084|NCT02533505|101431700|FG000|COMPLETED|Overall Study||23||
48448085|NCT02533505|101431701|FG001|COMPLETED|Overall Study||24||
48448086|NCT02533505|101431700|FG000|NOT COMPLETED|Overall Study||3||
48448087|NCT02533505|101431701|FG001|NOT COMPLETED|Overall Study||1||
48448088|NCT03336645|101431702|FG000|STARTED|Overall Study||25||
48448089|NCT03336645|101431702|FG000|COMPLETED|Overall Study||25||
48448090|NCT03336645|101431702|FG000|NOT COMPLETED|Overall Study||0||
48448091|NCT04193033|101431703|FG000|STARTED|Overall Study||0||3
48448092|NCT04193033|101431704|FG001|STARTED|Overall Study||0||3
48448093|NCT04193033|101431705|FG002|STARTED|Overall Study||0||3
48448094|NCT04193033|101431703|FG000|COMPLETED|Overall Study||0||3
48448095|NCT04193033|101431704|FG001|COMPLETED|Overall Study||0||3
48448096|NCT04193033|101431705|FG002|COMPLETED|Overall Study||0||3
48448097|NCT04193033|101431703|FG000|NOT COMPLETED|Overall Study||0||0
48448098|NCT04193033|101431704|FG001|NOT COMPLETED|Overall Study||0||0
48448099|NCT04193033|101431705|FG002|NOT COMPLETED|Overall Study||0||0
48771243|NCT02318706|102229384|FG001|COMPLETED|Double-blind Phase||154||
48448100|NCT03087773|101431706|FG000|STARTED|Overall Study||237||
48448101|NCT03087773|101431707|FG001|STARTED|Overall Study||239||
48448102|NCT03087773|101431706|FG000|COMPLETED|Overall Study||217||
48448103|NCT03087773|101431707|FG001|COMPLETED|Overall Study||227||
48448104|NCT03087773|101431706|FG000|NOT COMPLETED|Overall Study||20||
48448105|NCT03087773|101431707|FG001|NOT COMPLETED|Overall Study||12||
48448106|NCT02561000|101431708|FG000|STARTED|Overall Study||34|Randomization|
48448107|NCT02561000|101431709|FG001|STARTED|Overall Study||35|Randomization|
48448108|NCT02561000|101431710|FG002|STARTED|Overall Study||31|Randomization|
48659641|NCT01767857|101951704|FG001|Treated|Overall Study||200||
48659642|NCT01767857|101951703|FG000|COMPLETED|Overall Study||0||
48659643|NCT01767857|101951704|FG001|COMPLETED|Overall Study||0||
48771244|NCT02318706|102229385|FG002|COMPLETED|Double-blind Phase||150||
48771245|NCT02318706|102229386|FG003|COMPLETED|Double-blind Phase||142||
48771246|NCT02318706|102229387|FG004|COMPLETED|Double-blind Phase||0||
48771247|NCT02318706|102229383|FG000|NOT COMPLETED|Double-blind Phase||25||
48448109|NCT02561000|101431708|FG000|Safety Population|Overall Study||35|The Safety population included randomized participants who received any amount of the study drug dose of the double-blind IP infusion (summarized and analyzed as treated).|
48448110|NCT02561000|101431709|FG001|Safety Population|Overall Study||31|The Safety population included randomized participants who received any amount of the study drug dose of the double-blind IP infusion (summarized and analyzed as treated).|
48448111|NCT02561000|101431710|FG002|Safety Population|Overall Study||31|The Safety population included randomized participants who received any amount of the study drug dose of the double-blind IP infusion (summarized and analyzed as treated).|
48448112|NCT02561000|101431708|FG000|Intent-to-Treat (ITT) Population at 30 Days|Overall Study||34|The Intent-to-treat (ITT) population included all randomized participants, regardless of study drug intake, who underwent at least 1 follow-up assessment within 30 days after study drug dosing.|
48448113|NCT02561000|101431709|FG001|Intent-to-Treat (ITT) Population at 30 Days|Overall Study||33|The Intent-to-treat (ITT) population included all randomized participants, regardless of study drug intake, who underwent at least 1 follow-up assessment within 30 days after study drug dosing.|
48659644|NCT01767857|101951703|FG000|NOT COMPLETED|Overall Study||430||
48448114|NCT02561000|101431710|FG002|Intent-to-Treat (ITT) Population at 30 Days|Overall Study||31|The Intent-to-treat (ITT) population included all randomized participants, regardless of study drug intake, who underwent at least 1 follow-up assessment within 30 days after study drug dosing.|
48448115|NCT02561000|101431708|FG000|Intent-to-Treat (ITT) Population at 90 Days|Overall Study||33|The Intent-to-treat (ITT) population included all randomized participants, regardless of study drug intake, who underwent at least 1 follow-up assessment after 30 days up until 90 days after study drug dosing.|
48448116|NCT02561000|101431709|FG001|Intent-to-Treat (ITT) Population at 90 Days|Overall Study||31|The Intent-to-treat (ITT) population included all randomized participants, regardless of study drug intake, who underwent at least 1 follow-up assessment after 30 days up until 90 days after study drug dosing.|
48448117|NCT02561000|101431710|FG002|Intent-to-Treat (ITT) Population at 90 Days|Overall Study||31|The Intent-to-treat (ITT) population included all randomized participants, regardless of study drug intake, who underwent at least 1 follow-up assessment after 30 days up until 90 days after study drug dosing.|
48448118|NCT02561000|101431708|FG000|COMPLETED|Overall Study||32|Completion of the 90-day follow-up time point after study drug dosing.|
48448119|NCT02561000|101431709|FG001|COMPLETED|Overall Study||31|Completion of the 90-day follow-up time point after study drug dosing.|
48448120|NCT02561000|101431710|FG002|COMPLETED|Overall Study||31|Completion of the 90-day follow-up time point after study drug dosing.|
48448121|NCT02561000|101431708|FG000|NOT COMPLETED|Overall Study||2||
48448122|NCT02561000|101431709|FG001|NOT COMPLETED|Overall Study||4||
48448123|NCT02561000|101431710|FG002|NOT COMPLETED|Overall Study||0||
48448124|NCT03944707|101431711|FG000|STARTED|Overall Study||47||
48448125|NCT03944707|101431712|FG001|STARTED|Overall Study||29||
48448126|NCT03944707|101431711|FG000|PK Analysis Set|Overall Study||33|All subjects with at least one available valid pharmacokinetics (PK) concentration measurement, who received any study drug and with no protocol deviations that affected PK data.|
48448127|NCT03944707|101431712|FG001|PK Analysis Set|Overall Study||0|All subjects with at least one available valid pharmacokinetics (PK) concentration measurement, who received any study drug and with no protocol deviations that affected PK data.|
48448128|NCT03944707|101431711|FG000|PD Analysis Set|Overall Study||47|All subjects with available pharmacodynamics (PD) data and no protocol deviations with relevant impact on PD data. A subject with available PD data was a subject with at least one on-treatment spirometry assessment or with PD diary data for at least 14 days.|
48448129|NCT03944707|101431712|FG001|PD Analysis Set|Overall Study||29|All subjects with available pharmacodynamics (PD) data and no protocol deviations with relevant impact on PD data. A subject with available PD data was a subject with at least one on-treatment spirometry assessment or with PD diary data for at least 14 days.|
48448130|NCT03944707|101431711|FG000|COMPLETED|Overall Study||35||
48448131|NCT03944707|101431712|FG001|COMPLETED|Overall Study||19||
48448132|NCT03944707|101431711|FG000|NOT COMPLETED|Overall Study||12||
48448133|NCT03944707|101431712|FG001|NOT COMPLETED|Overall Study||10||
48448134|NCT01629134|101431713|FG000|STARTED|Overall Study||62||
48448135|NCT01629134|101431713|FG000|COMPLETED|Overall Study||62||
48448136|NCT01629134|101431713|FG000|NOT COMPLETED|Overall Study||0||
48448137|NCT02046369|101431714|FG000|STARTED|Overall Study||176||
48448138|NCT02046369|101431715|FG001|STARTED|Overall Study||174||
48448139|NCT02046369|101431714|FG000|COMPLETED|Overall Study||162||
48448140|NCT02046369|101431715|FG001|COMPLETED|Overall Study||156||
48448141|NCT02046369|101431714|FG000|NOT COMPLETED|Overall Study||14||
48448142|NCT02046369|101431715|FG001|NOT COMPLETED|Overall Study||18||
48448143|NCT00997672|101431716|FG000|STARTED|Overall Study||4||
48448144|NCT00997672|101431717|FG001|STARTED|Overall Study||5||
48448145|NCT00997672|101431716|FG000|COMPLETED|Overall Study||0||
48448146|NCT00997672|101431717|FG001|COMPLETED|Overall Study||1||
48448147|NCT00997672|101431716|FG000|NOT COMPLETED|Overall Study||4||
48448148|NCT00997672|101431717|FG001|NOT COMPLETED|Overall Study||4||
48448149|NCT00350337|101431718|FG000|STARTED|Overall Study||22||
48448150|NCT00350337|101431719|FG001|STARTED|Overall Study||22||
48448151|NCT00350337|101431720|FG002|STARTED|Overall Study||21||
48448152|NCT00350337|101431721|FG003|STARTED|Overall Study||21||
48448153|NCT00350337|101431718|FG000|COMPLETED|Overall Study||17||
48448154|NCT00350337|101431719|FG001|COMPLETED|Overall Study||19||
48448155|NCT00350337|101431720|FG002|COMPLETED|Overall Study||18||
48448156|NCT00350337|101431721|FG003|COMPLETED|Overall Study||21||
48659645|NCT01767857|101951704|FG001|NOT COMPLETED|Overall Study||213||
48659646|NCT01514422|101951705|FG000|STARTED|Overall Study||20||
48659647|NCT01514422|101951705|FG000|COMPLETED|Overall Study||19||
48659648|NCT01514422|101951705|FG000|NOT COMPLETED|Overall Study||1||
48771248|NCT02318706|102229384|FG001|NOT COMPLETED|Double-blind Phase||12||
48771249|NCT02318706|102229385|FG002|NOT COMPLETED|Double-blind Phase||18||
48771250|NCT02318706|102229386|FG003|NOT COMPLETED|Double-blind Phase||24||
48771251|NCT02318706|102229387|FG004|NOT COMPLETED|Double-blind Phase||0||
48771252|NCT02318706|102229383|FG000|STARTED|Open-label Extension Phase||0||
48771253|NCT02318706|102229384|FG001|STARTED|Open-label Extension Phase||0||
48448157|NCT00350337|101431718|FG000|NOT COMPLETED|Overall Study||5||
48448158|NCT00350337|101431719|FG001|NOT COMPLETED|Overall Study||3||
48659649|NCT01517178|101951706|FG000|STARTED|Period 1||16||
48771254|NCT02318706|102229385|FG002|STARTED|Open-label Extension Phase||0||
48771255|NCT02318706|102229386|FG003|STARTED|Open-label Extension Phase||0||
48771256|NCT02318706|102229387|FG004|STARTED|Open-label Extension Phase||214||
48771257|NCT02318706|102229383|FG000|COMPLETED|Open-label Extension Phase||0||
48771258|NCT02318706|102229384|FG001|COMPLETED|Open-label Extension Phase||0||
48189089|NCT00708097|100786149|FG000|NOT COMPLETED|Period 2||0||
48189090|NCT00708097|100786150|FG001|NOT COMPLETED|Period 2||1||
48189091|NCT00708097|100786151|FG002|NOT COMPLETED|Period 2||1||
48189092|NCT00708097|100786152|FG003|NOT COMPLETED|Period 2||1||
48189093|NCT00708097|100786153|FG004|NOT COMPLETED|Period 2||0||
48189094|NCT00708097|100786149|FG000|STARTED|Period 3||9||
48189095|NCT00708097|100786150|FG001|STARTED|Period 3||11||
48189096|NCT00708097|100786151|FG002|STARTED|Period 3||10||
48189097|NCT00708097|100786152|FG003|STARTED|Period 3||10||
48189098|NCT00708097|100786153|FG004|STARTED|Period 3||10||
48189099|NCT00708097|100786149|FG000|COMPLETED|Period 3||9||
48189100|NCT00708097|100786150|FG001|COMPLETED|Period 3||11||
48189101|NCT00708097|100786151|FG002|COMPLETED|Period 3||10||
48189102|NCT00708097|100786152|FG003|COMPLETED|Period 3||10||
48189103|NCT00708097|100786153|FG004|COMPLETED|Period 3||10||
48189104|NCT00708097|100786149|FG000|NOT COMPLETED|Period 3||0||
48189105|NCT00708097|100786150|FG001|NOT COMPLETED|Period 3||0||
48189106|NCT00708097|100786151|FG002|NOT COMPLETED|Period 3||0||
48189107|NCT00708097|100786152|FG003|NOT COMPLETED|Period 3||0||
48189108|NCT00708097|100786153|FG004|NOT COMPLETED|Period 3||0||
48369293|NCT03165981|101232740|FG000|COMPLETED|Overall Study||99||
48448159|NCT00350337|101431720|FG002|NOT COMPLETED|Overall Study||3||
48448160|NCT00350337|101431721|FG003|NOT COMPLETED|Overall Study||0||
48448161|NCT01106352|101431722|FG000|STARTED|Overall Study||7||
48448162|NCT01106352|101431723|FG001|STARTED|Overall Study||3||
48448163|NCT01106352|101431724|FG002|STARTED|Overall Study||7||
48448164|NCT01106352|101431725|FG003|STARTED|Overall Study||36||
48448165|NCT01106352|101431726|FG004|STARTED|Overall Study||17||
48659650|NCT01517178|101951707|FG001|STARTED|Period 1||11||
48659651|NCT01517178|101951706|FG000|COMPLETED|Period 1||12||
48659652|NCT01517178|101951707|FG001|COMPLETED|Period 1||6||
48659653|NCT01517178|101951706|FG000|NOT COMPLETED|Period 1||4||
48659654|NCT01517178|101951707|FG001|NOT COMPLETED|Period 1||5||
48659655|NCT01517178|101951706|FG000|STARTED|Period 2||11||
48659656|NCT01517178|101951707|FG001|STARTED|Period 2||6||
48659657|NCT01517178|101951706|FG000|COMPLETED|Period 2||5||
48659658|NCT01517178|101951707|FG001|COMPLETED|Period 2||4||
48659659|NCT01517178|101951706|FG000|NOT COMPLETED|Period 2||6||
48659660|NCT01517178|101951707|FG001|NOT COMPLETED|Period 2||2||
48771259|NCT02318706|102229385|FG002|COMPLETED|Open-label Extension Phase||0||
48771260|NCT02318706|102229386|FG003|COMPLETED|Open-label Extension Phase||0||
48771261|NCT02318706|102229387|FG004|COMPLETED|Open-label Extension Phase||172||
48771262|NCT02318706|102229383|FG000|NOT COMPLETED|Open-label Extension Phase||0||
48771263|NCT02318706|102229384|FG001|NOT COMPLETED|Open-label Extension Phase||0||
48771264|NCT02318706|102229385|FG002|NOT COMPLETED|Open-label Extension Phase||0||
48771265|NCT02318706|102229386|FG003|NOT COMPLETED|Open-label Extension Phase||0||
48771266|NCT02318706|102229387|FG004|NOT COMPLETED|Open-label Extension Phase||42||
48771267|NCT01076361|102229388|FG000|STARTED|Overall Study||370||
48771268|NCT01076361|102229388|FG000|COMPLETED|Overall Study||349||
48771269|NCT01076361|102229388|FG000|NOT COMPLETED|Overall Study||21||
48771270|NCT00892099|102229389|FG000|STARTED|Overall Study||36||
48771271|NCT00892099|102229390|FG001|STARTED|Overall Study||33||
48771272|NCT00892099|102229391|FG002|STARTED|Overall Study||36||
48771273|NCT00892099|102229389|FG000|COMPLETED|Overall Study||31||
48771274|NCT00892099|102229390|FG001|COMPLETED|Overall Study||32||
48771275|NCT00892099|102229391|FG002|COMPLETED|Overall Study||29||
48771276|NCT00892099|102229389|FG000|NOT COMPLETED|Overall Study||5||
48771277|NCT00892099|102229390|FG001|NOT COMPLETED|Overall Study||1||
48771278|NCT00892099|102229391|FG002|NOT COMPLETED|Overall Study||7||
48659661|NCT05451329|101951708|FG000|STARTED|Overall Study||23||
48659662|NCT05451329|101951709|FG001|STARTED|Overall Study||22||
48189109|NCT00708097|100786149|FG000|STARTED|Period 4||12||
48189110|NCT00708097|100786150|FG001|STARTED|Period 4||9||
48189111|NCT00708097|100786151|FG002|STARTED|Period 4||10||
48189112|NCT00708097|100786152|FG003|STARTED|Period 4||11||
48189113|NCT00708097|100786153|FG004|STARTED|Period 4||8||
48189114|NCT00708097|100786149|FG000|COMPLETED|Period 4||12||
48189115|NCT00708097|100786150|FG001|COMPLETED|Period 4||9||
48189116|NCT00708097|100786151|FG002|COMPLETED|Period 4||10||
48369294|NCT03165981|101232741|FG001|COMPLETED|Overall Study||107||
48369295|NCT03165981|101232740|FG000|NOT COMPLETED|Overall Study||11||
48369296|NCT03165981|101232741|FG001|NOT COMPLETED|Overall Study||4||
48771279|NCT00759941|102229392|FG000|STARTED|Overall Study||42||
48771280|NCT00759941|102229393|FG001|STARTED|Overall Study||44||
48659663|NCT05451329|101951710|FG002|STARTED|Overall Study||23||
48659664|NCT05451329|101951708|FG000|COMPLETED|Overall Study||20||
48659665|NCT05451329|101951709|FG001|COMPLETED|Overall Study||20||
48659666|NCT05451329|101951710|FG002|COMPLETED|Overall Study||23||
48659667|NCT05451329|101951708|FG000|NOT COMPLETED|Overall Study||3||
48659668|NCT05451329|101951709|FG001|NOT COMPLETED|Overall Study||2||
48659669|NCT05451329|101951710|FG002|NOT COMPLETED|Overall Study||0||
48659670|NCT02395627|101951711|FG000|STARTED|Overall Study||18||
48659671|NCT02395627|101951712|FG001|STARTED|Overall Study||16||
48659672|NCT02395627|101951713|FG002|STARTED|Overall Study||4||
48659673|NCT02395627|101951711|FG000|COMPLETED|Overall Study||15||
48659674|NCT02395627|101951712|FG001|COMPLETED|Overall Study||13||
48659675|NCT02395627|101951713|FG002|COMPLETED|Overall Study||4||
48659676|NCT02395627|101951711|FG000|NOT COMPLETED|Overall Study||3||
48659677|NCT02395627|101951712|FG001|NOT COMPLETED|Overall Study||3||
48659678|NCT02395627|101951713|FG002|NOT COMPLETED|Overall Study||0||
48659679|NCT02918630|101951714|FG000|STARTED|Overall Study||4||
48659680|NCT02918630|101951715|FG001|STARTED|Overall Study||3||
48659681|NCT02918630|101951714|FG000|COMPLETED|Overall Study||4||
48659682|NCT02918630|101951715|FG001|COMPLETED|Overall Study||3||
48659683|NCT02918630|101951714|FG000|NOT COMPLETED|Overall Study||0||
48659684|NCT02918630|101951715|FG001|NOT COMPLETED|Overall Study||0||
48659685|NCT01079390|101951716|FG000|STARTED|Overall Study||15||
48659686|NCT01079390|101951717|FG001|STARTED|Overall Study||15||
48659687|NCT01079390|101951718|FG002|STARTED|Overall Study||14||
48659688|NCT01079390|101951716|FG000|COMPLETED|Overall Study||10||
48659689|NCT01079390|101951717|FG001|COMPLETED|Overall Study||10||
48659690|NCT01079390|101951718|FG002|COMPLETED|Overall Study||10||
48659691|NCT01079390|101951716|FG000|NOT COMPLETED|Overall Study||5||
48659692|NCT01079390|101951717|FG001|NOT COMPLETED|Overall Study||5||
48659693|NCT01079390|101951718|FG002|NOT COMPLETED|Overall Study||4||
48659694|NCT04507269|101951719|FG000|STARTED|Overall Study||4||
48659695|NCT04507269|101951720|FG001|STARTED|Overall Study||4||
48659696|NCT04507269|101951721|FG002|STARTED|Overall Study||3||
48659697|NCT04507269|101951722|FG003|STARTED|Overall Study||4||
48659698|NCT04507269|101951723|FG004|STARTED|Overall Study||4||
48659699|NCT04507269|101951724|FG005|STARTED|Overall Study||2||
48659700|NCT04507269|101951719|FG000|Dosed|Overall Study||4||
48659701|NCT04507269|101951720|FG001|Dosed|Overall Study||4||
48659702|NCT04507269|101951721|FG002|Dosed|Overall Study||3||
48659703|NCT04507269|101951722|FG003|Dosed|Overall Study||4||
48659704|NCT04507269|101951723|FG004|Dosed|Overall Study||4||
48659705|NCT04507269|101951724|FG005|Dosed|Overall Study||2||
48659706|NCT04507269|101951719|FG000|COMPLETED|Overall Study||3||
48659707|NCT04507269|101951720|FG001|COMPLETED|Overall Study||3||
48659708|NCT04507269|101951721|FG002|COMPLETED|Overall Study||3||
48659709|NCT04507269|101951722|FG003|COMPLETED|Overall Study||4||
48659710|NCT04507269|101951723|FG004|COMPLETED|Overall Study||3||
48659711|NCT04507269|101951724|FG005|COMPLETED|Overall Study||2||
48659712|NCT04507269|101951719|FG000|NOT COMPLETED|Overall Study||1||
48659713|NCT04507269|101951720|FG001|NOT COMPLETED|Overall Study||1||
48659714|NCT04507269|101951721|FG002|NOT COMPLETED|Overall Study||0||
48659715|NCT04507269|101951722|FG003|NOT COMPLETED|Overall Study||0||
48659716|NCT04507269|101951723|FG004|NOT COMPLETED|Overall Study||1||
48659717|NCT04507269|101951724|FG005|NOT COMPLETED|Overall Study||0||
48659718|NCT04180462|101951725|FG000|STARTED|Overall Study||2151||10
48659719|NCT04180462|101951726|FG001|STARTED|Overall Study||1615||10
48659720|NCT04180462|101951725|FG000|COMPLETED|Overall Study||2151||10
48659721|NCT04180462|101951726|FG001|COMPLETED|Overall Study||1615||10
48659722|NCT04180462|101951725|FG000|NOT COMPLETED|Overall Study||0||0
48659723|NCT04180462|101951726|FG001|NOT COMPLETED|Overall Study||0||0
48771281|NCT00759941|102229392|FG000|COMPLETED|Overall Study||39||
48659724|NCT03829514|101951727|FG000|STARTED|Overall Study||10||
48659725|NCT03829514|101951727|FG000|COMPLETED|Overall Study||10||
48771282|NCT00759941|102229393|FG001|COMPLETED|Overall Study||43||
48771283|NCT00759941|102229392|FG000|NOT COMPLETED|Overall Study||3||
48771284|NCT00759941|102229393|FG001|NOT COMPLETED|Overall Study||1||
48659726|NCT03829514|101951727|FG000|NOT COMPLETED|Overall Study||0||
48659727|NCT00752219|101951728|FG000|STARTED|Overall Study||102||
48659728|NCT00752219|101951729|FG001|STARTED|Overall Study||102||
48659729|NCT00752219|101951728|FG000|Treated|Overall Study||101||
48659730|NCT00752219|101951729|FG001|Treated|Overall Study||102||
48659731|NCT00752219|101951728|FG000|COMPLETED|Overall Study||91||
48659732|NCT00752219|101951729|FG001|COMPLETED|Overall Study||96||
48659733|NCT00752219|101951728|FG000|NOT COMPLETED|Overall Study||11||
48659734|NCT00752219|101951729|FG001|NOT COMPLETED|Overall Study||6||
48659735|NCT00236197|101951730|FG000|STARTED|Overall Study||312||
48659736|NCT00236197|101951731|FG001|STARTED|Overall Study||307||
48659737|NCT00236197|101951730|FG000|COMPLETED|Overall Study||307||
48659738|NCT00236197|101951731|FG001|COMPLETED|Overall Study||293||
48659739|NCT00236197|101951730|FG000|NOT COMPLETED|Overall Study||5||
48771285|NCT00927953|102229394|FG000|STARTED|Overall Study||6||
48448166|NCT01106352|101431722|FG000|Started Dose Escalation|Overall Study||7||
48448167|NCT01106352|101431723|FG001|Started Dose Escalation|Overall Study||3||
48448168|NCT01106352|101431724|FG002|Started Dose Escalation|Overall Study||7||
48448169|NCT01106352|101431725|FG003|Started Dose Escalation|Overall Study||0||
48448170|NCT01106352|101431726|FG004|Started Dose Escalation|Overall Study||0||
48659740|NCT00236197|101951731|FG001|NOT COMPLETED|Overall Study||14||
48659741|NCT01084759|101951732|FG000|STARTED|Overall Study||16||
48659742|NCT01084759|101951732|FG000|COMPLETED|Overall Study||14||
48659743|NCT01084759|101951732|FG000|NOT COMPLETED|Overall Study||2||
48659744|NCT04903093|101951733|FG000|STARTED|Overall Study||3||
48659745|NCT04903093|101951734|FG001|STARTED|Overall Study||3||
48659746|NCT04903093|101951735|FG002|STARTED|Overall Study||3||
48659747|NCT04903093|101951736|FG003|STARTED|Overall Study||4||
48659748|NCT04903093|101951737|FG004|STARTED|Overall Study||3||
48659749|NCT04903093|101951738|FG005|STARTED|Overall Study||3||
48659750|NCT04903093|101951733|FG000|COMPLETED|Overall Study||3||
48659751|NCT04903093|101951734|FG001|COMPLETED|Overall Study||3||
48659752|NCT04903093|101951735|FG002|COMPLETED|Overall Study||3||
48659753|NCT04903093|101951736|FG003|COMPLETED|Overall Study||3||
48659754|NCT04903093|101951737|FG004|COMPLETED|Overall Study||3||
48659755|NCT04903093|101951738|FG005|COMPLETED|Overall Study||3||
48659756|NCT04903093|101951733|FG000|NOT COMPLETED|Overall Study||0||
48659757|NCT04903093|101951734|FG001|NOT COMPLETED|Overall Study||0||
48659758|NCT04903093|101951735|FG002|NOT COMPLETED|Overall Study||0||
48659759|NCT04903093|101951736|FG003|NOT COMPLETED|Overall Study||1||
48659760|NCT04903093|101951737|FG004|NOT COMPLETED|Overall Study||0||
48659761|NCT04903093|101951738|FG005|NOT COMPLETED|Overall Study||0||
48659762|NCT02451007|101951739|FG000|STARTED|Overall Study||39||
48659763|NCT02451007|101951739|FG000|COMPLETED|Overall Study||32||
48659764|NCT02451007|101951739|FG000|NOT COMPLETED|Overall Study||7||
48659765|NCT02489045|101951740|FG000|STARTED|Overall Study||178||
48659766|NCT02489045|101951740|FG000|COMPLETED|Overall Study||125||
48659767|NCT02489045|101951740|FG000|NOT COMPLETED|Overall Study||53||
48659768|NCT02489045|101951740|FG000|STARTED|Follow-up||21||
48659769|NCT02489045|101951740|FG000|COMPLETED|Follow-up||11||
48659770|NCT02489045|101951740|FG000|NOT COMPLETED|Follow-up||10||
48659771|NCT00594308|101951741|FG000|STARTED|Overall Study||10||
48659772|NCT00594308|101951741|FG000|COMPLETED|Overall Study||10||
48659773|NCT00594308|101951741|FG000|NOT COMPLETED|Overall Study||0||
48659774|NCT00993473|101951742|FG000|STARTED|Overall Study||61||
48659775|NCT00993473|101951743|FG001|STARTED|Overall Study||64||
48659776|NCT00993473|101951742|FG000|COMPLETED|Overall Study||57||
48659777|NCT00993473|101951743|FG001|COMPLETED|Overall Study||54||
48659778|NCT00993473|101951742|FG000|NOT COMPLETED|Overall Study||4||
48659779|NCT00993473|101951743|FG001|NOT COMPLETED|Overall Study||10||
48659780|NCT04003389|101951744|FG000|STARTED|Overall Study||611||
48659781|NCT04003389|101951745|FG001|STARTED|Overall Study||611||
48659782|NCT04003389|101951746|FG002|STARTED|Overall Study||609||
48659783|NCT04003389|101951744|FG000|Treated|Overall Study||610||
48659784|NCT04003389|101951745|FG001|Treated|Overall Study||611||
48659785|NCT04003389|101951746|FG002|Treated|Overall Study||609||
48659786|NCT04003389|101951744|FG000|COMPLETED|Overall Study||410||
48659787|NCT04003389|101951745|FG001|COMPLETED|Overall Study||451||
48659788|NCT04003389|101951746|FG002|COMPLETED|Overall Study||444||
48659789|NCT04003389|101951744|FG000|NOT COMPLETED|Overall Study||201||
48659790|NCT04003389|101951745|FG001|NOT COMPLETED|Overall Study||160||
48659791|NCT04003389|101951746|FG002|NOT COMPLETED|Overall Study||165||
48659792|NCT00488293|101951747|FG000|STARTED|Overall Study||196||
48659793|NCT00488293|101951748|FG001|STARTED|Overall Study||196||
48659794|NCT00488293|101951747|FG000|COMPLETED|Overall Study||160||
48659795|NCT00488293|101951748|FG001|COMPLETED|Overall Study||166||
48659796|NCT00488293|101951747|FG000|NOT COMPLETED|Overall Study||36||
48659797|NCT00488293|101951748|FG001|NOT COMPLETED|Overall Study||30||
48771286|NCT00927953|102229395|FG001|STARTED|Overall Study||7||
48448171|NCT01106352|101431722|FG000|Completed Dose Escalation|Overall Study||6||
48448172|NCT01106352|101431723|FG001|Completed Dose Escalation|Overall Study||3||
48448173|NCT01106352|101431724|FG002|Completed Dose Escalation|Overall Study||5||
48448174|NCT01106352|101431725|FG003|Completed Dose Escalation|Overall Study||0||
48659798|NCT03813121|101951749|FG000|STARTED|Overall Study||4||
48659799|NCT03813121|101951750|FG001|STARTED|Overall Study||6||
48659800|NCT03813121|101951749|FG000|COMPLETED|Overall Study||4||
48659801|NCT03813121|101951750|FG001|COMPLETED|Overall Study||6||
48659802|NCT03813121|101951749|FG000|NOT COMPLETED|Overall Study||0||
48659803|NCT03813121|101951750|FG001|NOT COMPLETED|Overall Study||0||
48659804|NCT00489476|101951751|FG000|STARTED|Overall Study||39||
48659805|NCT00489476|101951752|FG001|STARTED|Overall Study||43||
48659806|NCT00489476|101951753|FG002|STARTED|Overall Study||43||
48659807|NCT00489476|101951754|FG003|STARTED|Overall Study||43||
48659808|NCT00489476|101951751|FG000|COMPLETED|Overall Study||39||
48659809|NCT00489476|101951752|FG001|COMPLETED|Overall Study||42||
48448175|NCT01106352|101431726|FG004|Completed Dose Escalation|Overall Study||0||
48448176|NCT01106352|101431722|FG000|Started Safety Cohort|Overall Study||0||
48448177|NCT01106352|101431723|FG001|Started Safety Cohort|Overall Study||0||
48448178|NCT01106352|101431724|FG002|Started Safety Cohort|Overall Study||0||
48448179|NCT01106352|101431725|FG003|Started Safety Cohort|Overall Study||36||
48448180|NCT01106352|101431726|FG004|Started Safety Cohort|Overall Study||17||
48448181|NCT01106352|101431722|FG000|Treated Safety Cohort|Overall Study||0||
48448182|NCT01106352|101431723|FG001|Treated Safety Cohort|Overall Study||0||
48448183|NCT01106352|101431724|FG002|Treated Safety Cohort|Overall Study||0||
48448184|NCT01106352|101431725|FG003|Treated Safety Cohort|Overall Study||33||
48448185|NCT01106352|101431726|FG004|Treated Safety Cohort|Overall Study||13||
48448186|NCT01106352|101431722|FG000|Completed Safety Cohort|Overall Study||0||
48448187|NCT01106352|101431723|FG001|Completed Safety Cohort|Overall Study||0||
48448188|NCT01106352|101431724|FG002|Completed Safety Cohort|Overall Study||0||
48448189|NCT01106352|101431725|FG003|Completed Safety Cohort|Overall Study||23||
48448190|NCT01106352|101431726|FG004|Completed Safety Cohort|Overall Study||9||
48448191|NCT01106352|101431722|FG000|COMPLETED|Overall Study||6||
48448192|NCT01106352|101431723|FG001|COMPLETED|Overall Study||3||
48448193|NCT01106352|101431724|FG002|COMPLETED|Overall Study||5||
48448194|NCT01106352|101431725|FG003|COMPLETED|Overall Study||23||
48448195|NCT01106352|101431726|FG004|COMPLETED|Overall Study||9||
48448196|NCT01106352|101431722|FG000|NOT COMPLETED|Overall Study||1||
48448197|NCT01106352|101431723|FG001|NOT COMPLETED|Overall Study||0||
48448198|NCT01106352|101431724|FG002|NOT COMPLETED|Overall Study||2||
48448199|NCT01106352|101431725|FG003|NOT COMPLETED|Overall Study||13||
48448200|NCT01106352|101431726|FG004|NOT COMPLETED|Overall Study||8||
48448201|NCT00647426|101431727|FG000|STARTED|Overall Study||7||
48448202|NCT00647426|101431727|FG000|COMPLETED|Overall Study||5||
48448203|NCT00647426|101431727|FG000|NOT COMPLETED|Overall Study||2||
48448204|NCT05349188|101431728|FG000|STARTED|Overall Study||30||
48448205|NCT05349188|101431729|FG001|STARTED|Overall Study||30||
48448206|NCT05349188|101431728|FG000|First Intervention Block (2 Weeks)|Overall Study||30||
48448207|NCT05349188|101431729|FG001|First Intervention Block (2 Weeks)|Overall Study||30||
48448208|NCT05349188|101431728|FG000|Second Intervention Block (2 Weeks)|Overall Study||30||
48659810|NCT00489476|101951753|FG002|COMPLETED|Overall Study||43||
48659811|NCT00489476|101951754|FG003|COMPLETED|Overall Study||43||
48659812|NCT00489476|101951751|FG000|NOT COMPLETED|Overall Study||0||
48771287|NCT00927953|102229394|FG000|COMPLETED|Overall Study||4||
48771288|NCT00927953|102229395|FG001|COMPLETED|Overall Study||6||
48771289|NCT00927953|102229394|FG000|NOT COMPLETED|Overall Study||2||
48771290|NCT00927953|102229395|FG001|NOT COMPLETED|Overall Study||1||
48771291|NCT02304367|102229396|FG000|STARTED|Overall Study||17||
48771292|NCT02304367|102229396|FG000|Completed 48 Weeks of Study Drug|Overall Study||16||
48771293|NCT02304367|102229396|FG000|Completed 144 Weeks of Study Drug|Overall Study||12||
48771294|NCT02304367|102229396|FG000|COMPLETED|Overall Study||9||
48771295|NCT02304367|102229396|FG000|NOT COMPLETED|Overall Study||8||
48189117|NCT00708097|100786152|FG003|COMPLETED|Period 4||11||
48189118|NCT00708097|100786153|FG004|COMPLETED|Period 4||8||
48369297|NCT01383200|101232742|FG000|STARTED|Overall Study||5||
48369298|NCT01383200|101232743|FG001|STARTED|Overall Study||6||
48369299|NCT01383200|101232742|FG000|COMPLETED|Overall Study||5||
48369300|NCT01383200|101232743|FG001|COMPLETED|Overall Study||6||
48369301|NCT01383200|101232742|FG000|NOT COMPLETED|Overall Study||0||
48369302|NCT01383200|101232743|FG001|NOT COMPLETED|Overall Study||0||
48369303|NCT00733356|101232744|FG000|STARTED|Vyvanse Dose Titration||28||
48369304|NCT00733356|101232744|FG000|COMPLETED|Vyvanse Dose Titration||26||
48369305|NCT00733356|101232744|FG000|NOT COMPLETED|Vyvanse Dose Titration||2||
48369306|NCT00733356|101232744|FG000|STARTED|Modified Lab School, Reading Evaluation||26||
48369307|NCT00733356|101232744|FG000|COMPLETED|Modified Lab School, Reading Evaluation||26||
48369308|NCT00733356|101232744|FG000|NOT COMPLETED|Modified Lab School, Reading Evaluation||0||
48369309|NCT02889510|101232745|FG000|STARTED|Overall Study||35||
48369310|NCT02889510|101232746|FG001|STARTED|Overall Study||37||
48369311|NCT02889510|101232745|FG000|COMPLETED|Overall Study||27||
48369312|NCT02889510|101232746|FG001|COMPLETED|Overall Study||32||
48369313|NCT02889510|101232745|FG000|NOT COMPLETED|Overall Study||8||
48369314|NCT02889510|101232746|FG001|NOT COMPLETED|Overall Study||5||
48369315|NCT00001262|101232747|FG000|STARTED|Overall Study||35||
48369316|NCT00001262|101232748|FG001|STARTED|Overall Study||22||
48369317|NCT00001262|101232749|FG002|STARTED|Overall Study||3||
48369318|NCT00001262|101232747|FG000|COMPLETED|Overall Study||25||
48369319|NCT00001262|101232748|FG001|COMPLETED|Overall Study||8||
48369320|NCT00001262|101232749|FG002|COMPLETED|Overall Study||3||
48369321|NCT00001262|101232747|FG000|NOT COMPLETED|Overall Study||10||
48369322|NCT00001262|101232748|FG001|NOT COMPLETED|Overall Study||14||
48369323|NCT00001262|101232749|FG002|NOT COMPLETED|Overall Study||0||
48448209|NCT05349188|101431729|FG001|Second Intervention Block (2 Weeks)|Overall Study||30||
48448210|NCT05349188|101431728|FG000|Third Intervention Block (2 Weeks)|Overall Study||29||
48448211|NCT05349188|101431729|FG001|Third Intervention Block (2 Weeks)|Overall Study||30||
48448212|NCT05349188|101431728|FG000|Fourth Intervention Block (2 Weeks)|Overall Study||29||
48448213|NCT05349188|101431729|FG001|Fourth Intervention Block (2 Weeks)|Overall Study||30||
48448214|NCT05349188|101431728|FG000|Fifth Intervention Block (2 Weeks)|Overall Study||29||
48448215|NCT05349188|101431729|FG001|Fifth Intervention Block (2 Weeks)|Overall Study||30||
48448216|NCT05349188|101431728|FG000|Sixth Intervention Block (2 Weeks)|Overall Study||29||
48448217|NCT05349188|101431729|FG001|Sixth Intervention Block (2 Weeks)|Overall Study||30||
48448218|NCT05349188|101431728|FG000|COMPLETED|Overall Study||29||
48448219|NCT05349188|101431729|FG001|COMPLETED|Overall Study||30||
48448220|NCT05349188|101431728|FG000|NOT COMPLETED|Overall Study||1||
48448221|NCT05349188|101431729|FG001|NOT COMPLETED|Overall Study||0||
48448222|NCT00709735|101431730|FG000|STARTED|Overall Study||11||
48659813|NCT00489476|101951752|FG001|NOT COMPLETED|Overall Study||1||
48659814|NCT00489476|101951753|FG002|NOT COMPLETED|Overall Study||0||
48448223|NCT00709735|101431731|FG001|STARTED|Overall Study||12||
48448224|NCT00709735|101431730|FG000|COMPLETED|Overall Study||8||
48448225|NCT00709735|101431731|FG001|COMPLETED|Overall Study||10||
48448226|NCT00709735|101431730|FG000|NOT COMPLETED|Overall Study||3||
48448227|NCT00709735|101431731|FG001|NOT COMPLETED|Overall Study||2||
48448228|NCT05180630|101431732|FG000|STARTED|First Intervention||6||
48448229|NCT05180630|101431733|FG001|STARTED|First Intervention||6||
48448230|NCT05180630|101431734|FG002|STARTED|First Intervention||5||
48448231|NCT05180630|101431732|FG000|COMPLETED|First Intervention||6||
48448232|NCT05180630|101431733|FG001|COMPLETED|First Intervention||6||
48448233|NCT05180630|101431734|FG002|COMPLETED|First Intervention||2||
48448234|NCT05180630|101431732|FG000|NOT COMPLETED|First Intervention||0||
48448235|NCT05180630|101431733|FG001|NOT COMPLETED|First Intervention||0||
48448236|NCT05180630|101431734|FG002|NOT COMPLETED|First Intervention||3||
48448237|NCT05180630|101431732|FG000|STARTED|Second Intervention||6||
48448238|NCT05180630|101431733|FG001|STARTED|Second Intervention||6||
48448239|NCT05180630|101431734|FG002|STARTED|Second Intervention||2||
48448240|NCT05180630|101431732|FG000|COMPLETED|Second Intervention||6||
48448241|NCT05180630|101431733|FG001|COMPLETED|Second Intervention||6||
48448242|NCT05180630|101431734|FG002|COMPLETED|Second Intervention||2||
48448243|NCT05180630|101431732|FG000|NOT COMPLETED|Second Intervention||0||
48448244|NCT05180630|101431733|FG001|NOT COMPLETED|Second Intervention||0||
48448245|NCT05180630|101431734|FG002|NOT COMPLETED|Second Intervention||0||
48448246|NCT05180630|101431732|FG000|STARTED|Third Intervention||6||
48448247|NCT05180630|101431733|FG001|STARTED|Third Intervention||6||
48448248|NCT05180630|101431734|FG002|STARTED|Third Intervention||2||
48448249|NCT05180630|101431732|FG000|COMPLETED|Third Intervention||6||
48448250|NCT05180630|101431733|FG001|COMPLETED|Third Intervention||6||
48448251|NCT05180630|101431734|FG002|COMPLETED|Third Intervention||2||
48448252|NCT05180630|101431732|FG000|NOT COMPLETED|Third Intervention||0||
48448253|NCT05180630|101431733|FG001|NOT COMPLETED|Third Intervention||0||
48448254|NCT05180630|101431734|FG002|NOT COMPLETED|Third Intervention||0||
48448255|NCT02962739|101431735|FG000|STARTED|Overall Study||6||
48448256|NCT02962739|101431736|FG001|STARTED|Overall Study||7||
48448257|NCT02962739|101431737|FG002|STARTED|Overall Study||7||
48448258|NCT02962739|101431738|FG003|STARTED|Overall Study||6||
48448259|NCT02962739|101431739|FG004|STARTED|Overall Study||6||
48448260|NCT02962739|101431740|FG005|STARTED|Overall Study||6||
48448261|NCT02962739|101431735|FG000|COMPLETED|Overall Study||6||
48448262|NCT02962739|101431736|FG001|COMPLETED|Overall Study||6||
48448263|NCT02962739|101431737|FG002|COMPLETED|Overall Study||6||
48448264|NCT02962739|101431738|FG003|COMPLETED|Overall Study||6||
48448265|NCT02962739|101431739|FG004|COMPLETED|Overall Study||5||
48448266|NCT02962739|101431740|FG005|COMPLETED|Overall Study||6||
48448267|NCT02962739|101431735|FG000|NOT COMPLETED|Overall Study||0||
48448268|NCT02962739|101431736|FG001|NOT COMPLETED|Overall Study||1||
48448269|NCT02962739|101431737|FG002|NOT COMPLETED|Overall Study||1||
48448270|NCT02962739|101431738|FG003|NOT COMPLETED|Overall Study||0||
48448271|NCT02962739|101431739|FG004|NOT COMPLETED|Overall Study||1||
48448272|NCT02962739|101431740|FG005|NOT COMPLETED|Overall Study||0||
48448273|NCT01629693|101431741|FG000|STARTED|Overall Study||193||
48659815|NCT00489476|101951754|FG003|NOT COMPLETED|Overall Study||0||
48448274|NCT01629693|101431742|FG001|STARTED|Overall Study||188||
48448275|NCT01629693|101431741|FG000|COMPLETED|Overall Study||188||
48448276|NCT01629693|101431742|FG001|COMPLETED|Overall Study||178||
48448277|NCT01629693|101431741|FG000|NOT COMPLETED|Overall Study||5||
48448278|NCT01629693|101431742|FG001|NOT COMPLETED|Overall Study||10||
48448279|NCT04572399|101431743|FG000|STARTED|Overall Study||5||
48448280|NCT04572399|101431743|FG000|COMPLETED|Overall Study||5||
48448281|NCT04572399|101431743|FG000|NOT COMPLETED|Overall Study||0||
48659816|NCT05069415|101951755|FG000|STARTED|Overall Study||38||
48659817|NCT05069415|101951756|FG001|STARTED|Overall Study||37||
48448282|NCT03091400|101431744|FG000|STARTED|Phase 1 - 6 Weeks||5||
48448283|NCT03091400|101431745|FG001|STARTED|Phase 1 - 6 Weeks||6||
48448284|NCT03091400|101431744|FG000|COMPLETED|Phase 1 - 6 Weeks||5||
48659818|NCT05069415|101951755|FG000|COMPLETED|Overall Study||34||
48448285|NCT03091400|101431745|FG001|COMPLETED|Phase 1 - 6 Weeks||6||
48448286|NCT03091400|101431744|FG000|NOT COMPLETED|Phase 1 - 6 Weeks||0||
48771296|NCT02819804|102229397|FG000|STARTED|Complete Cycle 1 (28 Days)||1||
48771297|NCT02819804|102229397|FG000|COMPLETED|Complete Cycle 1 (28 Days)||0||
48771298|NCT02819804|102229397|FG000|NOT COMPLETED|Complete Cycle 1 (28 Days)||1||
48771299|NCT02819804|102229397|FG000|STARTED|Start Cycle 2 and Beyond||0||
48448287|NCT03091400|101431745|FG001|NOT COMPLETED|Phase 1 - 6 Weeks||0||
48448288|NCT03091400|101431744|FG000|STARTED|Washout - 2 Weeks||5||
48448289|NCT03091400|101431745|FG001|STARTED|Washout - 2 Weeks||6||
48448290|NCT03091400|101431744|FG000|COMPLETED|Washout - 2 Weeks||4||
48448291|NCT03091400|101431745|FG001|COMPLETED|Washout - 2 Weeks||6||
48448292|NCT03091400|101431744|FG000|NOT COMPLETED|Washout - 2 Weeks||1||
48448293|NCT03091400|101431745|FG001|NOT COMPLETED|Washout - 2 Weeks||0||
48448294|NCT03091400|101431744|FG000|STARTED|Phase 2 - 6 Weeks||4||
48448295|NCT03091400|101431745|FG001|STARTED|Phase 2 - 6 Weeks||6||
48448296|NCT03091400|101431744|FG000|COMPLETED|Phase 2 - 6 Weeks||4||
48448297|NCT03091400|101431745|FG001|COMPLETED|Phase 2 - 6 Weeks||6||
48448298|NCT03091400|101431744|FG000|NOT COMPLETED|Phase 2 - 6 Weeks||0||
48448299|NCT03091400|101431745|FG001|NOT COMPLETED|Phase 2 - 6 Weeks||0||
48448300|NCT00929864|101431746|FG000|STARTED|Overall Study||318||
48448301|NCT00929864|101431747|FG001|STARTED|Overall Study||328||
48448302|NCT00929864|101431746|FG000|COMPLETED|Overall Study||252||
48448303|NCT00929864|101431747|FG001|COMPLETED|Overall Study||245||
48448304|NCT00929864|101431746|FG000|NOT COMPLETED|Overall Study||66||
48448305|NCT00929864|101431747|FG001|NOT COMPLETED|Overall Study||83||
48448306|NCT01383954|101431748|FG000|STARTED|Overall Study||52||
48448307|NCT01383954|101431748|FG000|Safety Population: Received Treatment|Overall Study||48||
48448308|NCT01383954|101431748|FG000|COMPLETED|Overall Study||38|Completed = completed at least 2 weeks of being on study medication|
48448309|NCT01383954|101431748|FG000|NOT COMPLETED|Overall Study||14||
48448310|NCT04000373|101431749|FG000|STARTED|Overall Study||5||
48448311|NCT04000373|101431749|FG000|COMPLETED|Overall Study||5||
48448312|NCT04000373|101431749|FG000|NOT COMPLETED|Overall Study||0||
48448313|NCT00763269|101431750|FG000|STARTED|Overall Study||314||
48448314|NCT00763269|101431751|FG001|STARTED|Overall Study||312||
48448315|NCT00763269|101431750|FG000|COMPLETED|Overall Study||302||
48448316|NCT00763269|101431751|FG001|COMPLETED|Overall Study||299||
48448317|NCT00763269|101431750|FG000|NOT COMPLETED|Overall Study||12||
48448318|NCT00763269|101431751|FG001|NOT COMPLETED|Overall Study||13||
48448319|NCT01128153|101431752|FG000|STARTED|Overall Study||129||
48659819|NCT05069415|101951756|FG001|COMPLETED|Overall Study||37||
48659820|NCT05069415|101951755|FG000|NOT COMPLETED|Overall Study||4||
48659821|NCT05069415|101951756|FG001|NOT COMPLETED|Overall Study||0||
48659822|NCT01251757|101951757|FG000|STARTED|Overall Study||7255||
48659823|NCT01251757|101951758|FG001|STARTED|Overall Study||7247||
48659824|NCT01251757|101951759|FG002|STARTED|Overall Study||7250||
48659825|NCT01251757|101951757|FG000|COMPLETED|Overall Study||7255||
48659826|NCT01251757|101951758|FG001|COMPLETED|Overall Study||7247||
48659827|NCT01251757|101951759|FG002|COMPLETED|Overall Study||7250||
48659828|NCT01251757|101951757|FG000|NOT COMPLETED|Overall Study||0||
48771300|NCT02819804|102229397|FG000|COMPLETED|Start Cycle 2 and Beyond||0||
48771301|NCT02819804|102229397|FG000|NOT COMPLETED|Start Cycle 2 and Beyond||0||
48771302|NCT02819804|102229397|FG000|STARTED|Follow-up for 1 Year||1|All patients that are treated on the study go into the follow-up period.|
48448320|NCT01128153|101431753|FG001|STARTED|Overall Study||128||
48448321|NCT01128153|101431752|FG000|Full Analysis Set|Overall Study||127||
48659829|NCT01251757|101951758|FG001|NOT COMPLETED|Overall Study||0||
48659830|NCT01251757|101951759|FG002|NOT COMPLETED|Overall Study||0||
48659831|NCT00107614|101951760|FG000|STARTED|Overall Study||12||
48771303|NCT02819804|102229397|FG000|COMPLETED|Follow-up for 1 Year||1||
48771304|NCT02819804|102229397|FG000|NOT COMPLETED|Follow-up for 1 Year||0||
48771305|NCT01867671|102229398|FG000|STARTED|Overall Study||96||
48771306|NCT01867671|102229399|FG001|STARTED|Overall Study||50||
48771307|NCT01867671|102229398|FG000|COMPLETED|Overall Study||67||
48771308|NCT01867671|102229399|FG001|COMPLETED|Overall Study||22||
48771309|NCT01867671|102229398|FG000|NOT COMPLETED|Overall Study||29||
48771310|NCT01867671|102229399|FG001|NOT COMPLETED|Overall Study||28||
48771311|NCT00599339|102229400|FG000|STARTED|Overall Study||2195||
48771312|NCT00599339|102229400|FG000|Safety Set|Overall Study||2179||
48448322|NCT01128153|101431753|FG001|Full Analysis Set|Overall Study||128||
48448323|NCT01128153|101431752|FG000|COMPLETED|Overall Study||113||
48448324|NCT01128153|101431753|FG001|COMPLETED|Overall Study||113||
48448325|NCT01128153|101431752|FG000|NOT COMPLETED|Overall Study||16||
48448326|NCT01128153|101431753|FG001|NOT COMPLETED|Overall Study||15||
48448327|NCT00740480|101431754|FG000|STARTED|Overall Study||25||
48448328|NCT00740480|101431754|FG000|COMPLETED|Overall Study||23||
48448329|NCT00740480|101431754|FG000|NOT COMPLETED|Overall Study||2||
48448330|NCT00096200|101431755|FG000|STARTED|Overall Study||9||
48448331|NCT00096200|101431756|FG001|STARTED|Overall Study||30||
48448332|NCT00096200|101431757|FG002|STARTED|Overall Study||5||
48448333|NCT00096200|101431755|FG000|COMPLETED|Overall Study||8||
48448334|NCT00096200|101431756|FG001|COMPLETED|Overall Study||23||
48659832|NCT00107614|101951760|FG000|COMPLETED|Overall Study||0||
48659833|NCT00107614|101951760|FG000|NOT COMPLETED|Overall Study||12||
48448335|NCT00096200|101431757|FG002|COMPLETED|Overall Study||5||
48448336|NCT00096200|101431755|FG000|NOT COMPLETED|Overall Study||1||
48448337|NCT00096200|101431756|FG001|NOT COMPLETED|Overall Study||7||
48448338|NCT00096200|101431757|FG002|NOT COMPLETED|Overall Study||0||
48771313|NCT00599339|102229400|FG000|COMPLETED|Overall Study||1531||
48771314|NCT00599339|102229400|FG000|NOT COMPLETED|Overall Study||664||
48771315|NCT05488535|102229401|FG000|STARTED|Overall Study||101||
48448339|NCT02200614|101431758|FG000|STARTED|Double Blind Treatment||955|Randomized|
48448340|NCT02200614|101431759|FG001|STARTED|Double Blind Treatment||554|Randomized|
48448341|NCT02200614|101431758|FG000|COMPLETED|Double Blind Treatment||591|Ongoing with treatment|
48448342|NCT02200614|101431759|FG001|COMPLETED|Double Blind Treatment||170|Ongoing with treatment|
48448343|NCT02200614|101431758|FG000|NOT COMPLETED|Double Blind Treatment||364||
48448344|NCT02200614|101431759|FG001|NOT COMPLETED|Double Blind Treatment||384||
48448345|NCT02200614|101431758|FG000|STARTED|Open Label||591||
48448346|NCT02200614|101431759|FG001|STARTED|Open Label||170||
48448347|NCT02200614|101431758|FG000|COMPLETED|Open Label||295|Moving to roll-over study|
48448348|NCT02200614|101431759|FG001|COMPLETED|Open Label||114|Moving to roll-over study|
48448349|NCT02200614|101431758|FG000|NOT COMPLETED|Open Label||296||
48448350|NCT02200614|101431759|FG001|NOT COMPLETED|Open Label||56||
48448351|NCT02016755|101431760|FG000|STARTED|Overall Study||10||
48448352|NCT02016755|101431760|FG000|Completed Month 18 Clinic Visit|Overall Study||5||
48448353|NCT02016755|101431760|FG000|Completed Month 36 LTFU Questionnaire|Overall Study||3||
48448354|NCT02016755|101431760|FG000|COMPLETED|Overall Study||3||
48448355|NCT02016755|101431760|FG000|NOT COMPLETED|Overall Study||7||
48448356|NCT05003167|101431761|FG000|STARTED|Overall Study||13||
48448357|NCT05003167|101431761|FG000|COMPLETED|Overall Study||12||
48448358|NCT05003167|101431761|FG000|NOT COMPLETED|Overall Study||1||
48448359|NCT05478603|101431762|FG000|STARTED|Overall Study||6||
48448360|NCT05478603|101431763|FG001|STARTED|Overall Study||6||
48448361|NCT05478603|101431764|FG002|STARTED|Overall Study||6||
48448362|NCT05478603|101431765|FG003|STARTED|Overall Study||6||
48448363|NCT05478603|101431762|FG000|COMPLETED|Overall Study||6|The entire study including follow-up phase.|
48448364|NCT05478603|101431763|FG001|COMPLETED|Overall Study||5|The entire study including follow-up phase.|
48448365|NCT05478603|101431764|FG002|COMPLETED|Overall Study||6|The entire study including follow-up phase.|
48448366|NCT05478603|101431765|FG003|COMPLETED|Overall Study||6|The entire study including follow-up phase.|
48448367|NCT05478603|101431762|FG000|NOT COMPLETED|Overall Study||0||
48448368|NCT05478603|101431763|FG001|NOT COMPLETED|Overall Study||1||
48448369|NCT05478603|101431764|FG002|NOT COMPLETED|Overall Study||0||
48448370|NCT05478603|101431765|FG003|NOT COMPLETED|Overall Study||0||
48448371|NCT04330482|101431766|FG000|STARTED|Overall Study||20||
48448372|NCT04330482|101431767|FG001|STARTED|Overall Study||20||
48448373|NCT04330482|101431766|FG000|COMPLETED|Overall Study||18||
48448374|NCT04330482|101431767|FG001|COMPLETED|Overall Study||16||
48448375|NCT04330482|101431766|FG000|NOT COMPLETED|Overall Study||2||
48448376|NCT04330482|101431767|FG001|NOT COMPLETED|Overall Study||4||
48448377|NCT00552617|101431768|FG000|STARTED|Overall Study||10||
48448378|NCT00552617|101431769|FG001|STARTED|Overall Study||10||
48448379|NCT00552617|101431770|FG002|STARTED|Overall Study||10||
48448380|NCT00552617|101431771|FG003|STARTED|Overall Study||10||
48448381|NCT00552617|101431772|FG004|STARTED|Overall Study||10||
48448382|NCT00552617|101431773|FG005|STARTED|Overall Study||10||
48448383|NCT00552617|101431774|FG006|STARTED|Overall Study||10||
48448384|NCT00552617|101431775|FG007|STARTED|Overall Study||10||
48448385|NCT00552617|101431776|FG008|STARTED|Overall Study||10||
48448386|NCT00552617|101431777|FG009|STARTED|Overall Study||10||
48448387|NCT00552617|101431768|FG000|Treated|Overall Study||10||
48448388|NCT00552617|101431769|FG001|Treated|Overall Study||10||
48448389|NCT00552617|101431770|FG002|Treated|Overall Study||9||
48448390|NCT00552617|101431771|FG003|Treated|Overall Study||10||
48448391|NCT00552617|101431772|FG004|Treated|Overall Study||10||
48448392|NCT00552617|101431773|FG005|Treated|Overall Study||10||
48771316|NCT05488535|102229401|FG000|COMPLETED|Overall Study||96||
48771317|NCT05488535|102229401|FG000|NOT COMPLETED|Overall Study||5||
48771318|NCT01083771|102229402|FG000|STARTED|Overall Study||21||
48771319|NCT01083771|102229402|FG000|COMPLETED|Overall Study||16||
48771320|NCT01083771|102229402|FG000|NOT COMPLETED|Overall Study||5||
48771321|NCT00998296|102229403|FG000|STARTED|Overall Study||6||
48771322|NCT00998296|102229404|FG001|STARTED|Overall Study||3||
48771323|NCT00998296|102229405|FG002|STARTED|Overall Study||3||
48448393|NCT00552617|101431774|FG006|Treated|Overall Study||10||
48448394|NCT00552617|101431775|FG007|Treated|Overall Study||10||
48448395|NCT00552617|101431776|FG008|Treated|Overall Study||10||
48448396|NCT00552617|101431777|FG009|Treated|Overall Study||9||
48448397|NCT00552617|101431768|FG000|COMPLETED|Overall Study||10||
48448398|NCT00552617|101431769|FG001|COMPLETED|Overall Study||10||
48771324|NCT00998296|102229406|FG003|STARTED|Overall Study||3||
48771325|NCT00998296|102229407|FG004|STARTED|Overall Study||8||
48448399|NCT00552617|101431770|FG002|COMPLETED|Overall Study||9||
48448400|NCT00552617|101431771|FG003|COMPLETED|Overall Study||9||
48771326|NCT00998296|102229408|FG005|STARTED|Overall Study||3||
48771327|NCT00998296|102229409|FG006|STARTED|Overall Study||7||
48771328|NCT00998296|102229410|FG007|STARTED|Overall Study||6||
48448401|NCT00552617|101431772|FG004|COMPLETED|Overall Study||10||
48448402|NCT00552617|101431773|FG005|COMPLETED|Overall Study||8||
48448403|NCT00552617|101431774|FG006|COMPLETED|Overall Study||10||
48448404|NCT00552617|101431775|FG007|COMPLETED|Overall Study||10||
48448405|NCT00552617|101431776|FG008|COMPLETED|Overall Study||8||
48448406|NCT00552617|101431777|FG009|COMPLETED|Overall Study||9||
48448407|NCT00552617|101431768|FG000|NOT COMPLETED|Overall Study||0||
48448408|NCT00552617|101431769|FG001|NOT COMPLETED|Overall Study||0||
48448409|NCT00552617|101431770|FG002|NOT COMPLETED|Overall Study||1||
48448410|NCT00552617|101431771|FG003|NOT COMPLETED|Overall Study||1||
48448411|NCT00552617|101431772|FG004|NOT COMPLETED|Overall Study||0||
48448412|NCT00552617|101431773|FG005|NOT COMPLETED|Overall Study||2||
48448413|NCT00552617|101431774|FG006|NOT COMPLETED|Overall Study||0||
48448414|NCT00552617|101431775|FG007|NOT COMPLETED|Overall Study||0||
48448415|NCT00552617|101431776|FG008|NOT COMPLETED|Overall Study||2||
48448416|NCT00552617|101431777|FG009|NOT COMPLETED|Overall Study||1||
48448417|NCT01864525|101431778|FG000|STARTED|Overall Study||10||
48448418|NCT01864525|101431779|FG001|STARTED|Overall Study||7||
48448419|NCT01864525|101431778|FG000|COMPLETED|Overall Study||9||
48448420|NCT01864525|101431779|FG001|COMPLETED|Overall Study||7||
48448421|NCT01864525|101431778|FG000|NOT COMPLETED|Overall Study||1||
48448422|NCT01864525|101431779|FG001|NOT COMPLETED|Overall Study||0||
48448423|NCT00934622|101431780|FG000|STARTED|Overall Study||76||
48448424|NCT00934622|101431780|FG000|COMPLETED|Overall Study||68||
48448425|NCT00934622|101431780|FG000|NOT COMPLETED|Overall Study||8||
48659834|NCT00266032|101951761|FG000|STARTED|Treatment||691||
48659835|NCT00266032|101951762|FG001|STARTED|Treatment||236||
48659836|NCT00266032|101951763|FG002|STARTED|Treatment||239||
48659837|NCT00266032|101951761|FG000|Patients Treated|Treatment||684||
48659838|NCT00266032|101951762|FG001|Patients Treated|Treatment||221||
48659839|NCT00266032|101951763|FG002|Patients Treated|Treatment||229||
48659840|NCT00266032|101951761|FG000|Patients Treated and in FAS|Treatment||642||
48659841|NCT00266032|101951762|FG001|Patients Treated and in FAS|Treatment||209||
48659842|NCT00266032|101951763|FG002|Patients Treated and in FAS|Treatment||216||
48659843|NCT00266032|101951761|FG000|COMPLETED|Treatment||580||
48659844|NCT00266032|101951762|FG001|COMPLETED|Treatment||172||
48659845|NCT00266032|101951763|FG002|COMPLETED|Treatment||192||
48659846|NCT00266032|101951761|FG000|NOT COMPLETED|Treatment||111||
48659847|NCT00266032|101951762|FG001|NOT COMPLETED|Treatment||64||
48659848|NCT00266032|101951763|FG002|NOT COMPLETED|Treatment||47||
48659849|NCT00266032|101951761|FG000|STARTED|Open-label Safety Extension||489||
48659850|NCT00266032|101951762|FG001|STARTED|Open-label Safety Extension||129||
48659851|NCT00266032|101951763|FG002|STARTED|Open-label Safety Extension||165||
48659852|NCT00266032|101951761|FG000|COMPLETED|Open-label Safety Extension||448||
48659853|NCT00266032|101951762|FG001|COMPLETED|Open-label Safety Extension||115||
48659854|NCT00266032|101951763|FG002|COMPLETED|Open-label Safety Extension||140||
48659855|NCT00266032|101951761|FG000|NOT COMPLETED|Open-label Safety Extension||41||
48659856|NCT00266032|101951762|FG001|NOT COMPLETED|Open-label Safety Extension||14||
48659857|NCT00266032|101951763|FG002|NOT COMPLETED|Open-label Safety Extension||25||
48659858|NCT01260311|101951764|FG000|STARTED|Overall Study||508||
48659859|NCT01260311|101951764|FG000|COMPLETED|Overall Study||381||
48659860|NCT01260311|101951764|FG000|NOT COMPLETED|Overall Study||127||
48659861|NCT03882801|101951765|FG000|STARTED|Period 1||12||
48659862|NCT03882801|101951766|FG001|STARTED|Period 1||12||
48659863|NCT03882801|101951765|FG000|Treated|Period 1||11||
48659864|NCT03882801|101951766|FG001|Treated|Period 1||12||
48659865|NCT03882801|101951765|FG000|COMPLETED|Period 1||10||
48659866|NCT03882801|101951766|FG001|COMPLETED|Period 1||10||
48659867|NCT03882801|101951765|FG000|NOT COMPLETED|Period 1||2||
48659868|NCT03882801|101951766|FG001|NOT COMPLETED|Period 1||2||
48659869|NCT03882801|101951765|FG000|STARTED|Washout Period||10||
48659870|NCT03882801|101951766|FG001|STARTED|Washout Period||10||
48659871|NCT03882801|101951765|FG000|COMPLETED|Washout Period||10||
48659872|NCT03882801|101951766|FG001|COMPLETED|Washout Period||9||
48771329|NCT00998296|102229411|FG008|STARTED|Overall Study||6||
48771330|NCT00998296|102229412|FG009|STARTED|Overall Study||18||
48659873|NCT03882801|101951765|FG000|NOT COMPLETED|Washout Period||0||
48659874|NCT03882801|101951766|FG001|NOT COMPLETED|Washout Period||1||
48659875|NCT03882801|101951765|FG000|STARTED|Period 2||10||
48659876|NCT03882801|101951766|FG001|STARTED|Period 2||9||
48659877|NCT03882801|101951765|FG000|COMPLETED|Period 2||10||
48771331|NCT00998296|102229413|FG010|STARTED|Overall Study||7||
48771332|NCT00998296|102229403|FG000|COMPLETED|Overall Study||6||
48771333|NCT00998296|102229404|FG001|COMPLETED|Overall Study||2||
48771334|NCT00998296|102229405|FG002|COMPLETED|Overall Study||3||
48659878|NCT03882801|101951766|FG001|COMPLETED|Period 2||8||
48659879|NCT03882801|101951765|FG000|NOT COMPLETED|Period 2||0||
48659880|NCT03882801|101951766|FG001|NOT COMPLETED|Period 2||1||
48659881|NCT02349477|101951767|FG000|STARTED|Overall Study||44||
48659882|NCT02349477|101951768|FG001|STARTED|Overall Study||46||
48659883|NCT02349477|101951767|FG000|COMPLETED|Overall Study||31||
48659884|NCT02349477|101951768|FG001|COMPLETED|Overall Study||28||
48659885|NCT02349477|101951767|FG000|NOT COMPLETED|Overall Study||13||
48659886|NCT02349477|101951768|FG001|NOT COMPLETED|Overall Study||18||
48771335|NCT00998296|102229406|FG003|COMPLETED|Overall Study||3||
48448426|NCT01050673|101434730|FG000|STARTED|Overall Study||21||
48448427|NCT01050673|101434731|FG001|STARTED|Overall Study||19||
48448428|NCT01050673|101434730|FG000|COMPLETED|Overall Study||17||
48448429|NCT01050673|101434731|FG001|COMPLETED|Overall Study||14||
48448430|NCT01050673|101434730|FG000|NOT COMPLETED|Overall Study||4||
48448431|NCT01050673|101434731|FG001|NOT COMPLETED|Overall Study||5||
48448432|NCT02777931|101434732|FG000|STARTED|Overall Study||49|All randomized subjects (Intent to Treat Population)|
48448433|NCT02777931|101434733|FG001|STARTED|Overall Study||52|All randomized subjects (Intent to Treat Population)|
48448434|NCT02777931|101434732|FG000|Safety Population|Overall Study||47|All randomized subjects who took at least 1 dose of study drug|
48448435|NCT02777931|101434733|FG001|Safety Population|Overall Study||50|All randomized subjects who took at least 1 dose of study drug|
48448436|NCT02777931|101434732|FG000|Modified Intent to Treat Population|Overall Study||46|Subjects who took at least 1 dose of study drug and have valid baseline and post baseline assessment|
48448437|NCT02777931|101434733|FG001|Modified Intent to Treat Population|Overall Study||50|Subjects who took at least 1 dose of study drug and have valid baseline and post baseline assessment|
48448438|NCT02777931|101434732|FG000|COMPLETED|Overall Study||37||
48448439|NCT02777931|101434733|FG001|COMPLETED|Overall Study||39||
48448440|NCT02777931|101434732|FG000|NOT COMPLETED|Overall Study||12||
48448441|NCT02777931|101434733|FG001|NOT COMPLETED|Overall Study||13||
48448442|NCT02407756|101434734|FG000|STARTED|Overall Study||20||
48448443|NCT02407756|101434735|FG001|STARTED|Overall Study||18||
48448444|NCT02407756|101434736|FG002|STARTED|Overall Study||20||
48448445|NCT02407756|101434737|FG003|STARTED|Overall Study||19||
48448446|NCT02407756|101434734|FG000|Treated|Overall Study||20||
48448447|NCT02407756|101434735|FG001|Treated|Overall Study||18||
48448448|NCT02407756|101434736|FG002|Treated|Overall Study||20||
48448449|NCT02407756|101434737|FG003|Treated|Overall Study||19||
48448450|NCT02407756|101434734|FG000|COMPLETED|Overall Study||20||
48448451|NCT02407756|101434735|FG001|COMPLETED|Overall Study||18||
48448452|NCT02407756|101434736|FG002|COMPLETED|Overall Study||20||
48448453|NCT02407756|101434737|FG003|COMPLETED|Overall Study||19||
48448454|NCT02407756|101434734|FG000|NOT COMPLETED|Overall Study||0||
48448455|NCT02407756|101434735|FG001|NOT COMPLETED|Overall Study||0||
48448456|NCT02407756|101434736|FG002|NOT COMPLETED|Overall Study||0||
48448457|NCT02407756|101434737|FG003|NOT COMPLETED|Overall Study||0||
48448458|NCT02609178|101434738|FG000|STARTED|First Crown||0||
48448459|NCT02609178|101434739|FG001|STARTED|First Crown||1||
48448460|NCT02609178|101434740|FG002|STARTED|First Crown||6||
48448461|NCT02609178|101434741|FG003|STARTED|First Crown||3||
48448462|NCT02609178|101434742|FG004|STARTED|First Crown||0||
48448463|NCT02609178|101434743|FG005|STARTED|First Crown||2||
48448464|NCT02609178|101434738|FG000|COMPLETED|First Crown||0||
48448465|NCT02609178|101434739|FG001|COMPLETED|First Crown||1||
48448466|NCT02609178|101434740|FG002|COMPLETED|First Crown||5||
48448467|NCT02609178|101434741|FG003|COMPLETED|First Crown||2||
48448468|NCT02609178|101434742|FG004|COMPLETED|First Crown||0||
48448469|NCT02609178|101434743|FG005|COMPLETED|First Crown||2||
48448470|NCT02609178|101434738|FG000|NOT COMPLETED|First Crown||0||
48448471|NCT02609178|101434739|FG001|NOT COMPLETED|First Crown||0||
48448472|NCT02609178|101434740|FG002|NOT COMPLETED|First Crown||1||
48448473|NCT02609178|101434741|FG003|NOT COMPLETED|First Crown||1||
48448474|NCT02609178|101434742|FG004|NOT COMPLETED|First Crown||0||
48448475|NCT02609178|101434743|FG005|NOT COMPLETED|First Crown||0||
48448476|NCT02609178|101434738|FG000|STARTED|5-minute Washout Time||0||
48448477|NCT02609178|101434739|FG001|STARTED|5-minute Washout Time||1||
48659887|NCT00680914|101951769|FG000|STARTED|Overall Study||374||
48659888|NCT00680914|101951770|FG001|STARTED|Overall Study||129||
48659889|NCT00680914|101951769|FG000|COMPLETED|Overall Study||364||
48659890|NCT00680914|101951770|FG001|COMPLETED|Overall Study||125||
48659891|NCT00680914|101951769|FG000|NOT COMPLETED|Overall Study||10||
48659892|NCT00680914|101951770|FG001|NOT COMPLETED|Overall Study||4||
48659893|NCT00004228|101951771|FG000|STARTED|Overall Study||60||
48659894|NCT00004228|101951772|FG001|STARTED|Overall Study||66||
48659895|NCT00004228|101951773|FG002|STARTED|Overall Study||65||
48659896|NCT00004228|101951774|FG003|STARTED|Overall Study||13||
48659897|NCT00004228|101951775|FG004|STARTED|Overall Study||67||
48659898|NCT00004228|101951776|FG005|STARTED|Overall Study||65||
48771336|NCT00998296|102229407|FG004|COMPLETED|Overall Study||6||
48771337|NCT00998296|102229408|FG005|COMPLETED|Overall Study||3||
48771338|NCT00998296|102229409|FG006|COMPLETED|Overall Study||6||
48771339|NCT00998296|102229410|FG007|COMPLETED|Overall Study||4||
48771340|NCT00998296|102229411|FG008|COMPLETED|Overall Study||4||
48448478|NCT02609178|101434740|FG002|STARTED|5-minute Washout Time||5||
48448479|NCT02609178|101434741|FG003|STARTED|5-minute Washout Time||2||
48448480|NCT02609178|101434742|FG004|STARTED|5-minute Washout Time||0||
48448481|NCT02609178|101434743|FG005|STARTED|5-minute Washout Time||2||
48771341|NCT00998296|102229412|FG009|COMPLETED|Overall Study||0||
48771342|NCT00998296|102229413|FG010|COMPLETED|Overall Study||0||
48448482|NCT02609178|101434738|FG000|COMPLETED|5-minute Washout Time||0||
48448483|NCT02609178|101434739|FG001|COMPLETED|5-minute Washout Time||1||
48659899|NCT00004228|101951777|FG006|STARTED|Overall Study||57||
48659900|NCT00004228|101951771|FG000|COMPLETED|Overall Study||51||
48659901|NCT00004228|101951772|FG001|COMPLETED|Overall Study||51||
48448484|NCT02609178|101434740|FG002|COMPLETED|5-minute Washout Time||5||
48448485|NCT02609178|101434741|FG003|COMPLETED|5-minute Washout Time||2||
48448486|NCT02609178|101434742|FG004|COMPLETED|5-minute Washout Time||0||
48448487|NCT02609178|101434743|FG005|COMPLETED|5-minute Washout Time||2||
48448488|NCT02609178|101434738|FG000|NOT COMPLETED|5-minute Washout Time||0||
48448489|NCT02609178|101434739|FG001|NOT COMPLETED|5-minute Washout Time||0||
48448490|NCT02609178|101434740|FG002|NOT COMPLETED|5-minute Washout Time||0||
48771343|NCT00998296|102229403|FG000|NOT COMPLETED|Overall Study||0||
48771344|NCT00998296|102229404|FG001|NOT COMPLETED|Overall Study||1||
48771345|NCT00998296|102229405|FG002|NOT COMPLETED|Overall Study||0||
48771346|NCT00998296|102229406|FG003|NOT COMPLETED|Overall Study||0||
48771347|NCT00998296|102229407|FG004|NOT COMPLETED|Overall Study||2||
48771348|NCT00998296|102229408|FG005|NOT COMPLETED|Overall Study||0||
48771349|NCT00998296|102229409|FG006|NOT COMPLETED|Overall Study||1||
48771350|NCT00998296|102229410|FG007|NOT COMPLETED|Overall Study||2||
48771351|NCT00998296|102229411|FG008|NOT COMPLETED|Overall Study||2||
48771352|NCT00998296|102229412|FG009|NOT COMPLETED|Overall Study||18||
48771353|NCT00998296|102229413|FG010|NOT COMPLETED|Overall Study||7||
48771354|NCT02535806|102229414|FG000|STARTED|Overall Study||2||
48771355|NCT02535806|102229414|FG000|COMPLETED|Overall Study||2||
48771356|NCT02535806|102229414|FG000|NOT COMPLETED|Overall Study||0||
48771357|NCT00541385|102229415|FG000|STARTED|Overall Study||355||
48771358|NCT00541385|102229416|FG001|STARTED|Overall Study||180||
48771359|NCT00541385|102229415|FG000|COMPLETED|Overall Study||274||
48771360|NCT00541385|102229416|FG001|COMPLETED|Overall Study||142||
48771361|NCT00541385|102229415|FG000|NOT COMPLETED|Overall Study||81||
48771362|NCT00541385|102229416|FG001|NOT COMPLETED|Overall Study||38||
48771363|NCT00560352|102229417|FG000|STARTED|Overall Study||7||
48771364|NCT00560352|102229418|FG001|STARTED|Overall Study||3||
48771365|NCT00560352|102229419|FG002|STARTED|Overall Study||4||
48771366|NCT00560352|102229417|FG000|COMPLETED|Overall Study||0||
48771367|NCT00560352|102229418|FG001|COMPLETED|Overall Study||0||
48771368|NCT00560352|102229419|FG002|COMPLETED|Overall Study||0||
48771369|NCT00560352|102229417|FG000|NOT COMPLETED|Overall Study||7||
48448491|NCT02609178|101434741|FG003|NOT COMPLETED|5-minute Washout Time||0||
48448492|NCT02609178|101434742|FG004|NOT COMPLETED|5-minute Washout Time||0||
48448493|NCT02609178|101434743|FG005|NOT COMPLETED|5-minute Washout Time||0||
48771370|NCT00560352|102229418|FG001|NOT COMPLETED|Overall Study||3||
48771371|NCT00560352|102229419|FG002|NOT COMPLETED|Overall Study||4||
48771372|NCT00929695|102229420|FG000|STARTED|Overall Study||81||
48771373|NCT00929695|102229421|FG001|STARTED|Overall Study||83||
48771374|NCT00929695|102229420|FG000|COMPLETED|Overall Study||73||
48771375|NCT00929695|102229421|FG001|COMPLETED|Overall Study||77||
48771376|NCT00929695|102229420|FG000|NOT COMPLETED|Overall Study||8||
48771377|NCT00929695|102229421|FG001|NOT COMPLETED|Overall Study||6||
48771378|NCT01635153|102229422|FG000|STARTED|Overall Study||72||
48771379|NCT01635153|102229423|FG001|STARTED|Overall Study||79||
48771380|NCT01635153|102229422|FG000|COMPLETED|Overall Study||32||
48771381|NCT01635153|102229423|FG001|COMPLETED|Overall Study||36||
48771382|NCT01635153|102229422|FG000|NOT COMPLETED|Overall Study||40||
48771383|NCT01635153|102229423|FG001|NOT COMPLETED|Overall Study||43||
48448494|NCT02609178|101434738|FG000|STARTED|Second Crown||0||
48448495|NCT02609178|101434739|FG001|STARTED|Second Crown||1||
48448496|NCT02609178|101434740|FG002|STARTED|Second Crown||5||
48448497|NCT02609178|101434741|FG003|STARTED|Second Crown||2||
48771384|NCT05097963|102229424|FG000|STARTED|Overall Study||63||
48771385|NCT05097963|102229424|FG000|COMPLETED|Overall Study||29||
48771386|NCT05097963|102229424|FG000|NOT COMPLETED|Overall Study||34||
48771387|NCT01635504|102229425|FG000|STARTED|Overall Study||5||
48771388|NCT01635504|102229425|FG000|COMPLETED|Overall Study||5||
48771389|NCT01635504|102229425|FG000|NOT COMPLETED|Overall Study||0||
48448498|NCT02609178|101434742|FG004|STARTED|Second Crown||0||
48448499|NCT02609178|101434743|FG005|STARTED|Second Crown||2||
48448500|NCT02609178|101434738|FG000|COMPLETED|Second Crown||0||
48448501|NCT02609178|101434739|FG001|COMPLETED|Second Crown||1||
48448502|NCT02609178|101434740|FG002|COMPLETED|Second Crown||5||
48448503|NCT02609178|101434741|FG003|COMPLETED|Second Crown||2||
48448504|NCT02609178|101434742|FG004|COMPLETED|Second Crown||0||
48448505|NCT02609178|101434743|FG005|COMPLETED|Second Crown||2||
48448506|NCT02609178|101434738|FG000|NOT COMPLETED|Second Crown||0||
48448507|NCT02609178|101434739|FG001|NOT COMPLETED|Second Crown||0||
48448508|NCT02609178|101434740|FG002|NOT COMPLETED|Second Crown||0||
48448509|NCT02609178|101434741|FG003|NOT COMPLETED|Second Crown||0||
48659902|NCT00004228|101951773|FG002|COMPLETED|Overall Study||46||
48659903|NCT00004228|101951774|FG003|COMPLETED|Overall Study||6||
48659904|NCT00004228|101951775|FG004|COMPLETED|Overall Study||51||
48659905|NCT00004228|101951776|FG005|COMPLETED|Overall Study||51||
48659906|NCT00004228|101951777|FG006|COMPLETED|Overall Study||45||
48659907|NCT00004228|101951771|FG000|NOT COMPLETED|Overall Study||9||
48659908|NCT00004228|101951772|FG001|NOT COMPLETED|Overall Study||15||
48659909|NCT00004228|101951773|FG002|NOT COMPLETED|Overall Study||19||
48659910|NCT00004228|101951774|FG003|NOT COMPLETED|Overall Study||7||
48659911|NCT00004228|101951775|FG004|NOT COMPLETED|Overall Study||16||
48659912|NCT00004228|101951776|FG005|NOT COMPLETED|Overall Study||14||
48659913|NCT00004228|101951777|FG006|NOT COMPLETED|Overall Study||12||
48659914|NCT01585207|101951778|FG000|STARTED|Overall Study||4||
48659915|NCT01585207|101951778|FG000|COMPLETED|Overall Study||4||
48659916|NCT01585207|101951778|FG000|NOT COMPLETED|Overall Study||0||
48659917|NCT00903344|101951779|FG000|STARTED|Overall Study||12||
48659918|NCT00903344|101951780|FG001|STARTED|Overall Study||10||
48659919|NCT00903344|101951779|FG000|3 Month Visit|Overall Study||10||
48659920|NCT00903344|101951780|FG001|3 Month Visit|Overall Study||10||
48659921|NCT00903344|101951779|FG000|6 Month Visit|Overall Study||9||
48659922|NCT00903344|101951780|FG001|6 Month Visit|Overall Study||10||
48659923|NCT00903344|101951779|FG000|COMPLETED|Overall Study||7||
48659924|NCT00903344|101951780|FG001|COMPLETED|Overall Study||7||
48659925|NCT00903344|101951779|FG000|NOT COMPLETED|Overall Study||5||
48659926|NCT00903344|101951780|FG001|NOT COMPLETED|Overall Study||3||
48771390|NCT03418714|102229426|FG000|STARTED|Overall Study||13||
48771391|NCT03418714|102229426|FG000|COMPLETED|Overall Study||12||
48771392|NCT03418714|102229426|FG000|NOT COMPLETED|Overall Study||1||
48659927|NCT01922895|101951781|FG000|STARTED|Overall Study||24||
48659928|NCT01922895|101951782|FG001|STARTED|Overall Study||21||
48659929|NCT01922895|101951781|FG000|COMPLETED|Overall Study||18||
48659930|NCT01922895|101951782|FG001|COMPLETED|Overall Study||7||
48659931|NCT01922895|101951781|FG000|NOT COMPLETED|Overall Study||6||
48659932|NCT01922895|101951782|FG001|NOT COMPLETED|Overall Study||14||
48659933|NCT03791060|101951783|FG000|STARTED|Overall Study||4||
48659934|NCT03791060|101951783|FG000|COMPLETED|Overall Study||3||
48659935|NCT03791060|101951783|FG000|NOT COMPLETED|Overall Study||1||
48659936|NCT02925143|101951784|FG000|STARTED|Overall Study||6525||
48659937|NCT02925143|101951784|FG000|Participants Receiving Depolarizing Neuromuscular Blocking Agent (NMBA) (Succinylcholine)|Overall Study||3099||
48659938|NCT02925143|101951784|FG000|Participants Receiving Non-depolarizing Neuromuscular Blocking Agent (NMBA)|Overall Study||3426||
48659939|NCT02925143|101951784|FG000|COMPLETED|Overall Study||6525||
48771393|NCT02283827|102229427|FG000|STARTED|Overall Study||16||
48771394|NCT02283827|102229428|FG001|STARTED|Overall Study||16||
48771395|NCT02283827|102229427|FG000|COMPLETED|Overall Study||15||
48771396|NCT02283827|102229428|FG001|COMPLETED|Overall Study||13||
48771397|NCT02283827|102229427|FG000|NOT COMPLETED|Overall Study||1||
48448510|NCT02609178|101434742|FG004|NOT COMPLETED|Second Crown||0||
48448511|NCT02609178|101434743|FG005|NOT COMPLETED|Second Crown||0||
48448512|NCT02609178|101434738|FG000|STARTED|5-minute Washout Time||0||
48448513|NCT02609178|101434739|FG001|STARTED|5-minute Washout Time||1||
48659940|NCT02925143|101951784|FG000|NOT COMPLETED|Overall Study||0||
48659941|NCT01557569|101951785|FG000|STARTED|Overall Study||6||
48659942|NCT01557569|101951786|FG001|STARTED|Overall Study||7||
48771398|NCT02283827|102229428|FG001|NOT COMPLETED|Overall Study||3||
48771399|NCT03181932|102229429|FG000|STARTED|Period 1 (Double-blind Period)||90|The number of started participants include both age groups (participants 6-21 years and \>21 years). The primary efficacy population was the 6-21 years age group. All Outcome Results are presented for the primary age group. The Baseline Characteristics and Safety Results are presented for all participants.|
48189119|NCT00708097|100786149|FG000|NOT COMPLETED|Period 4||0||
48448514|NCT02609178|101434740|FG002|STARTED|5-minute Washout Time||5||
48448515|NCT02609178|101434741|FG003|STARTED|5-minute Washout Time||2||
48448516|NCT02609178|101434742|FG004|STARTED|5-minute Washout Time||0||
48448517|NCT02609178|101434743|FG005|STARTED|5-minute Washout Time||2||
48659943|NCT01557569|101951785|FG000|Completed 2-wk Residential Stay|Overall Study||3||
48659944|NCT01557569|101951786|FG001|Completed 2-wk Residential Stay|Overall Study||1||
48659945|NCT01557569|101951785|FG000|COMPLETED|Overall Study||1||
48659946|NCT01557569|101951786|FG001|COMPLETED|Overall Study||0||
48659947|NCT01557569|101951785|FG000|NOT COMPLETED|Overall Study||5||
48659948|NCT01557569|101951786|FG001|NOT COMPLETED|Overall Study||7||
48659949|NCT00635050|101951787|FG000|STARTED|Overall Study||32||
48659950|NCT00635050|101951787|FG000|COMPLETED|Overall Study||31||
48659951|NCT00635050|101951787|FG000|NOT COMPLETED|Overall Study||1||
48448518|NCT02609178|101434738|FG000|COMPLETED|5-minute Washout Time||0||
48448519|NCT02609178|101434739|FG001|COMPLETED|5-minute Washout Time||1||
48448520|NCT02609178|101434740|FG002|COMPLETED|5-minute Washout Time||5||
48659952|NCT02570425|101951788|FG000|STARTED|Visit 1||274||
48659953|NCT02570425|101951789|FG001|STARTED|Visit 1||242||
48659954|NCT02570425|101951788|FG000|COMPLETED|Visit 1||274||
48659955|NCT02570425|101951789|FG001|COMPLETED|Visit 1||242||
48659956|NCT02570425|101951788|FG000|NOT COMPLETED|Visit 1||0||
48659957|NCT02570425|101951789|FG001|NOT COMPLETED|Visit 1||0||
48659958|NCT02570425|101951788|FG000|STARTED|Visit 2||251||
48659959|NCT02570425|101951789|FG001|STARTED|Visit 2||247||
48659960|NCT02570425|101951788|FG000|COMPLETED|Visit 2||251||
48659961|NCT02570425|101951789|FG001|COMPLETED|Visit 2||247||
48659962|NCT02570425|101951788|FG000|NOT COMPLETED|Visit 2||0||
48659963|NCT02570425|101951789|FG001|NOT COMPLETED|Visit 2||0||
48659964|NCT02570425|101951788|FG000|STARTED|Visit 3||229||
48659965|NCT02570425|101951789|FG001|STARTED|Visit 3||231||
48659966|NCT02570425|101951788|FG000|COMPLETED|Visit 3||229||
48659967|NCT02570425|101951789|FG001|COMPLETED|Visit 3||231||
48659968|NCT02570425|101951788|FG000|NOT COMPLETED|Visit 3||0||
48659969|NCT02570425|101951789|FG001|NOT COMPLETED|Visit 3||0||
48659970|NCT00257933|101951790|FG000|STARTED|Overall Study||74||
48659971|NCT00257933|101951791|FG001|STARTED|Overall Study||78||
48659972|NCT00257933|101951790|FG000|COMPLETED|Overall Study||74||
48659973|NCT00257933|101951791|FG001|COMPLETED|Overall Study||78||
48659974|NCT00257933|101951790|FG000|NOT COMPLETED|Overall Study||0||
48659975|NCT00257933|101951791|FG001|NOT COMPLETED|Overall Study||0||
48659976|NCT03177798|101951792|FG000|STARTED|Overall Study||5||
48659977|NCT03177798|101951793|FG001|STARTED|Overall Study||6||
48659978|NCT03177798|101951792|FG000|Intervention 1|Overall Study||5||
48659979|NCT03177798|101951793|FG001|Intervention 1|Overall Study||6||
48659980|NCT03177798|101951792|FG000|Washout|Overall Study||5||
48659981|NCT03177798|101951793|FG001|Washout|Overall Study||6||
48659982|NCT03177798|101951792|FG000|Intervention 2|Overall Study||5||
48659983|NCT03177798|101951793|FG001|Intervention 2|Overall Study||6||
48659984|NCT03177798|101951792|FG000|COMPLETED|Overall Study||5||
48659985|NCT03177798|101951793|FG001|COMPLETED|Overall Study||6||
48659986|NCT03177798|101951792|FG000|NOT COMPLETED|Overall Study||0||
48659987|NCT03177798|101951793|FG001|NOT COMPLETED|Overall Study||0||
48659988|NCT04642079|101951794|FG000|STARTED|Overall Study||210||
48659989|NCT04642079|101951795|FG001|STARTED|Overall Study||219||
48659990|NCT04642079|101951796|FG002|STARTED|Overall Study||203||
48659991|NCT04642079|101951797|FG003|STARTED|Overall Study||207||
48659992|NCT04642079|101951794|FG000|Vaccinated|Overall Study||209||
48659993|NCT04642079|101951795|FG001|Vaccinated|Overall Study||216||
48659994|NCT04642079|101951796|FG002|Vaccinated|Overall Study||201||
48659995|NCT04642079|101951797|FG003|Vaccinated|Overall Study||205||
48659996|NCT04642079|101951794|FG000|COMPLETED|Overall Study||207||
48659997|NCT04642079|101951795|FG001|COMPLETED|Overall Study||210||
48659998|NCT04642079|101951796|FG002|COMPLETED|Overall Study||199||
48659999|NCT04642079|101951797|FG003|COMPLETED|Overall Study||203||
48660000|NCT04642079|101951794|FG000|NOT COMPLETED|Overall Study||3||
48660001|NCT04642079|101951795|FG001|NOT COMPLETED|Overall Study||9||
48660002|NCT04642079|101951796|FG002|NOT COMPLETED|Overall Study||4||
48660003|NCT04642079|101951797|FG003|NOT COMPLETED|Overall Study||4||
48660004|NCT00987935|101951798|FG000|STARTED|Overall Study||4||
48660005|NCT00987935|101951799|FG001|STARTED|Overall Study||3||
48660006|NCT00987935|101951800|FG002|STARTED|Overall Study||3||
48660007|NCT00987935|101951801|FG003|STARTED|Overall Study||3||
48660008|NCT00987935|101951802|FG004|STARTED|Overall Study||7||
48660009|NCT00987935|101951803|FG005|STARTED|Overall Study||3||
48771400|NCT03181932|102229430|FG001|STARTED|Period 1 (Double-blind Period)||98|The number of started participants include both age groups (participants 6-21 years and \>21 years). The primary efficacy population was the 6-21 years age group. All Outcome Results are presented for the primary age group. The Baseline Characteristics and Safety Results are presented for all participants.|
48771401|NCT03181932|102229429|FG000|COMPLETED|Period 1 (Double-blind Period)||79||
48771402|NCT03181932|102229430|FG001|COMPLETED|Period 1 (Double-blind Period)||85||
48448521|NCT02609178|101434741|FG003|COMPLETED|5-minute Washout Time||2||
48448522|NCT02609178|101434742|FG004|COMPLETED|5-minute Washout Time||0||
48660010|NCT00987935|101951804|FG006|STARTED|Overall Study||16||
48660011|NCT00987935|101951805|FG007|STARTED|Overall Study||63||
48660012|NCT00987935|101951806|FG008|STARTED|Overall Study||32||
48660013|NCT00987935|101951798|FG000|COMPLETED|Overall Study||0||
48660014|NCT00987935|101951799|FG001|COMPLETED|Overall Study||0||
48660015|NCT00987935|101951800|FG002|COMPLETED|Overall Study||0||
48660016|NCT00987935|101951801|FG003|COMPLETED|Overall Study||0||
48660017|NCT00987935|101951802|FG004|COMPLETED|Overall Study||0||
48660018|NCT00987935|101951803|FG005|COMPLETED|Overall Study||0||
48660019|NCT00987935|101951804|FG006|COMPLETED|Overall Study||1||
48660020|NCT00987935|101951805|FG007|COMPLETED|Overall Study||1||
48660021|NCT00987935|101951806|FG008|COMPLETED|Overall Study||0||
48660022|NCT00987935|101951798|FG000|NOT COMPLETED|Overall Study||4||
48660023|NCT00987935|101951799|FG001|NOT COMPLETED|Overall Study||3||
48660024|NCT00987935|101951800|FG002|NOT COMPLETED|Overall Study||3||
48448523|NCT02609178|101434743|FG005|COMPLETED|5-minute Washout Time||2||
48448524|NCT02609178|101434738|FG000|NOT COMPLETED|5-minute Washout Time||0||
48448525|NCT02609178|101434739|FG001|NOT COMPLETED|5-minute Washout Time||0||
48448526|NCT02609178|101434740|FG002|NOT COMPLETED|5-minute Washout Time||0||
48448527|NCT02609178|101434741|FG003|NOT COMPLETED|5-minute Washout Time||0||
48448528|NCT02609178|101434742|FG004|NOT COMPLETED|5-minute Washout Time||0||
48448529|NCT02609178|101434743|FG005|NOT COMPLETED|5-minute Washout Time||0||
48448530|NCT02609178|101434738|FG000|STARTED|Third Crown||0||
48448531|NCT02609178|101434739|FG001|STARTED|Third Crown||1||
48660025|NCT00987935|101951801|FG003|NOT COMPLETED|Overall Study||3||
48660026|NCT00987935|101951802|FG004|NOT COMPLETED|Overall Study||7||
48660027|NCT00987935|101951803|FG005|NOT COMPLETED|Overall Study||3||
48660028|NCT00987935|101951804|FG006|NOT COMPLETED|Overall Study||15||
48771403|NCT03181932|102229429|FG000|NOT COMPLETED|Period 1 (Double-blind Period)||11||
48771404|NCT03181932|102229430|FG001|NOT COMPLETED|Period 1 (Double-blind Period)||13||
48771405|NCT03181932|102229429|FG000|STARTED|Period 2 (Open-label Period)||75|The numbers refer to the treatment that the participants received during Period 1. 6 participants (4 in the vancomycin group and 2 in the placebo group) who completed Period 1 decided not to participate in Period 2.|
48771406|NCT03181932|102229430|FG001|STARTED|Period 2 (Open-label Period)||83|The numbers refer to the treatment that the participants received during Period 1. 6 participants (4 in the vancomycin group and 2 in the placebo group) who completed Period 1 decided not to participate in Period 2.|
48771407|NCT03181932|102229429|FG000|COMPLETED|Period 2 (Open-label Period)||67||
48771408|NCT03181932|102229430|FG001|COMPLETED|Period 2 (Open-label Period)||70||
48771409|NCT03181932|102229429|FG000|NOT COMPLETED|Period 2 (Open-label Period)||8||
48771410|NCT03181932|102229430|FG001|NOT COMPLETED|Period 2 (Open-label Period)||13||
48771411|NCT01976091|102229431|FG000|STARTED|Overall Study||1||
48660029|NCT00987935|101951805|FG007|NOT COMPLETED|Overall Study||62||
48660030|NCT00987935|101951806|FG008|NOT COMPLETED|Overall Study||32||
48660031|NCT01620047|101951807|FG000|STARTED|Overall Study||20||
48660032|NCT01620047|101951808|FG001|STARTED|Overall Study||20||
48660033|NCT01620047|101951809|FG002|STARTED|Overall Study||20||
48660034|NCT01620047|101951807|FG000|COMPLETED|Overall Study||20||
48660035|NCT01620047|101951808|FG001|COMPLETED|Overall Study||20||
48660036|NCT01620047|101951809|FG002|COMPLETED|Overall Study||20||
48660037|NCT01620047|101951807|FG000|NOT COMPLETED|Overall Study||0||
48660038|NCT01620047|101951808|FG001|NOT COMPLETED|Overall Study||0||
48660039|NCT01620047|101951809|FG002|NOT COMPLETED|Overall Study||0||
48660040|NCT00458705|101951810|FG000|STARTED|Overall Study||45||
48660041|NCT00458705|101951810|FG000|COMPLETED|Overall Study||40||
48660042|NCT00458705|101951810|FG000|NOT COMPLETED|Overall Study||5||
48660043|NCT00662038|101951811|FG000|STARTED|Overall Study||1058||
48660044|NCT00662038|101951811|FG000|COMPLETED|Overall Study||427||
48660045|NCT00662038|101951811|FG000|NOT COMPLETED|Overall Study||631||
48660046|NCT02757963|101951812|FG000|STARTED|Overall Study||1658||
48660047|NCT02757963|101951812|FG000|COMPLETED|Overall Study||561||
48660048|NCT02757963|101951812|FG000|NOT COMPLETED|Overall Study||1097||
48660049|NCT01251861|101951813|FG000|STARTED|Overall Study||54||
48660050|NCT01251861|101951814|FG001|STARTED|Overall Study||54||
48660051|NCT01251861|101951813|FG000|Pts Who Received Protocol Therapy|Overall Study||50||
48660052|NCT01251861|101951814|FG001|Pts Who Received Protocol Therapy|Overall Study||53||
48660053|NCT01251861|101951813|FG000|Pts w/ Follow-up PSA Lower Than Baseline|Overall Study||49||
48660054|NCT01251861|101951814|FG001|Pts w/ Follow-up PSA Lower Than Baseline|Overall Study||47||
48660055|NCT01251861|101951813|FG000|Pts With PSA Response|Overall Study||44||
48660056|NCT01251861|101951814|FG001|Pts With PSA Response|Overall Study||36||
48660057|NCT01251861|101951813|FG000|COMPLETED|Overall Study||36||
48660058|NCT01251861|101951814|FG001|COMPLETED|Overall Study||26||
48660059|NCT01251861|101951813|FG000|NOT COMPLETED|Overall Study||18||
48660060|NCT01251861|101951814|FG001|NOT COMPLETED|Overall Study||28||
48660061|NCT00493285|101951815|FG000|STARTED|Overall Study||13||
48660062|NCT00493285|101951816|FG001|STARTED|Overall Study||6||
48660063|NCT00493285|101951817|FG002|STARTED|Overall Study||9||
48660064|NCT00493285|101951818|FG003|STARTED|Overall Study||6||
48660065|NCT00493285|101951819|FG004|STARTED|Overall Study||10||
48660066|NCT00493285|101951820|FG005|STARTED|Overall Study||5||
48660067|NCT00493285|101951815|FG000|COMPLETED|Overall Study||13||
48189120|NCT00708097|100786150|FG001|NOT COMPLETED|Period 4||0||
48448532|NCT02609178|101434740|FG002|STARTED|Third Crown||5||
48448533|NCT02609178|101434741|FG003|STARTED|Third Crown||2||
48448534|NCT02609178|101434742|FG004|STARTED|Third Crown||0||
48448535|NCT02609178|101434743|FG005|STARTED|Third Crown||2||
48448536|NCT02609178|101434738|FG000|COMPLETED|Third Crown||0||
48448537|NCT02609178|101434739|FG001|COMPLETED|Third Crown||1||
48660068|NCT00493285|101951816|FG001|COMPLETED|Overall Study||6||
48660069|NCT00493285|101951817|FG002|COMPLETED|Overall Study||9||
48660070|NCT00493285|101951818|FG003|COMPLETED|Overall Study||6||
48660071|NCT00493285|101951819|FG004|COMPLETED|Overall Study||9||
48660072|NCT00493285|101951820|FG005|COMPLETED|Overall Study||5||
48660073|NCT00493285|101951815|FG000|NOT COMPLETED|Overall Study||0||
48660074|NCT00493285|101951816|FG001|NOT COMPLETED|Overall Study||0||
48660075|NCT00493285|101951817|FG002|NOT COMPLETED|Overall Study||0||
48660076|NCT00493285|101951818|FG003|NOT COMPLETED|Overall Study||0||
48660077|NCT00493285|101951819|FG004|NOT COMPLETED|Overall Study||1||
48660078|NCT00493285|101951820|FG005|NOT COMPLETED|Overall Study||0||
48660079|NCT00552279|101951821|FG000|STARTED|Overall Study||403||
48771412|NCT01976091|102229432|FG001|STARTED|Overall Study||3||
48771413|NCT01976091|102229433|FG002|STARTED|Overall Study||2||
48771414|NCT01976091|102229431|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1||
48771415|NCT01976091|102229432|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3||
48771416|NCT01976091|102229433|FG002|Received at Least 1 Dose of Study Drug|Overall Study||2||
48771417|NCT01976091|102229431|FG000|COMPLETED|Overall Study||1||
48771418|NCT01976091|102229432|FG001|COMPLETED|Overall Study||3||
48771419|NCT01976091|102229433|FG002|COMPLETED|Overall Study||2||
48771420|NCT01976091|102229431|FG000|NOT COMPLETED|Overall Study||0||
48771421|NCT01976091|102229432|FG001|NOT COMPLETED|Overall Study||0||
48771422|NCT01976091|102229433|FG002|NOT COMPLETED|Overall Study||0||
48771423|NCT02461758|102229434|FG000|STARTED|Overall Study||20||
48771424|NCT02461758|102229435|FG001|STARTED|Overall Study||20||
48771425|NCT02461758|102229436|FG002|STARTED|Overall Study||26||
48771426|NCT02461758|102229437|FG003|STARTED|Overall Study||15||
48771427|NCT02461758|102229434|FG000|COMPLETED|Overall Study||20||
48771428|NCT02461758|102229435|FG001|COMPLETED|Overall Study||19||
48771429|NCT02461758|102229436|FG002|COMPLETED|Overall Study||25||
48771430|NCT02461758|102229437|FG003|COMPLETED|Overall Study||15||
48771431|NCT02461758|102229434|FG000|NOT COMPLETED|Overall Study||0||
48771432|NCT02461758|102229435|FG001|NOT COMPLETED|Overall Study||1||
48771433|NCT02461758|102229436|FG002|NOT COMPLETED|Overall Study||1||
48771434|NCT02461758|102229437|FG003|NOT COMPLETED|Overall Study||0||
48771435|NCT00198822|102229438|FG000|STARTED|Overall Study||19876||
48771436|NCT00198822|102229439|FG001|STARTED|Overall Study||19826||
48771437|NCT00198822|102229440|FG002|STARTED|Overall Study||20019||
48771438|NCT00198822|102229438|FG000|COMPLETED|Overall Study||19862||
48771439|NCT00198822|102229439|FG001|COMPLETED|Overall Study||19806||
48771440|NCT00198822|102229440|FG002|COMPLETED|Overall Study||19998||
48771441|NCT00198822|102229438|FG000|NOT COMPLETED|Overall Study||14||
48771442|NCT00198822|102229439|FG001|NOT COMPLETED|Overall Study||20||
48771443|NCT00198822|102229440|FG002|NOT COMPLETED|Overall Study||21||
48771444|NCT00756613|102229441|FG000|STARTED|Overall Study||512||
48771445|NCT00756613|102229442|FG001|STARTED|Overall Study||532||
48771446|NCT00756613|102229441|FG000|COMPLETED|Overall Study||426||
48771447|NCT00756613|102229442|FG001|COMPLETED|Overall Study||462||
48771448|NCT00756613|102229441|FG000|NOT COMPLETED|Overall Study||86||
48771449|NCT00756613|102229442|FG001|NOT COMPLETED|Overall Study||70||
48771450|NCT00930046|102229443|FG000|STARTED|Overall Study||8||
48771451|NCT00930046|102229444|FG001|STARTED|Overall Study||7||
48771452|NCT00930046|102229443|FG000|COMPLETED|Overall Study||7||
48771453|NCT00930046|102229444|FG001|COMPLETED|Overall Study||5||
48771454|NCT00930046|102229443|FG000|NOT COMPLETED|Overall Study||1||
48771455|NCT00930046|102229444|FG001|NOT COMPLETED|Overall Study||2||
48771456|NCT04615832|102229445|FG000|STARTED|Overall Study||44||
48771457|NCT04615832|102229445|FG000|COMPLETED|Overall Study||44||
48771458|NCT04615832|102229445|FG000|NOT COMPLETED|Overall Study||0||
48771459|NCT02565108|102229446|FG000|STARTED|Overall Study||16|Randomized|
48771460|NCT02565108|102229447|FG001|STARTED|Overall Study||4|Randomized|
48771461|NCT02565108|102229446|FG000|Safety Set|Overall Study||16|Received at least 1 IMP dose; analyzed as treatment received.|
48771462|NCT02565108|102229447|FG001|Safety Set|Overall Study||4|Received at least 1 IMP dose; analyzed as treatment received.|
48771463|NCT02565108|102229446|FG000|Pharmacokinetic (PK) Set|Overall Study||10|Received at least 1 IMP dose, had not reduced CLB dose between Days 1 and 33, and provided PK data.|
48771464|NCT02565108|102229447|FG001|Pharmacokinetic (PK) Set|Overall Study||3|Received at least 1 IMP dose, had not reduced CLB dose between Days 1 and 33, and provided PK data.|
48771465|NCT02565108|102229446|FG000|COMPLETED|Overall Study||14||
48771466|NCT02565108|102229447|FG001|COMPLETED|Overall Study||4||
48771467|NCT02565108|102229446|FG000|NOT COMPLETED|Overall Study||2||
48771468|NCT02565108|102229447|FG001|NOT COMPLETED|Overall Study||0||
48660080|NCT00552279|101951822|FG001|STARTED|Overall Study||401||
48660081|NCT00552279|101951821|FG000|COMPLETED|Overall Study||389||
48660082|NCT00552279|101951822|FG001|COMPLETED|Overall Study||398||
48660083|NCT00552279|101951821|FG000|NOT COMPLETED|Overall Study||14||
48771469|NCT03543878|102229448|FG000|STARTED|Overall Study||5||
48771470|NCT03543878|102229449|FG001|STARTED|Overall Study||5||
48771471|NCT03543878|102229448|FG000|COMPLETED|Overall Study||5||
48771472|NCT03543878|102229449|FG001|COMPLETED|Overall Study||5||
48771473|NCT03543878|102229448|FG000|NOT COMPLETED|Overall Study||0||
48771474|NCT03543878|102229449|FG001|NOT COMPLETED|Overall Study||0||
48771475|NCT02832115|102229450|FG000|STARTED|Overall Study||48||
48771476|NCT02832115|102229451|FG001|STARTED|Overall Study||52||
48771477|NCT02832115|102229450|FG000|COMPLETED|Overall Study||48||
48771478|NCT02832115|102229451|FG001|COMPLETED|Overall Study||52||
48771479|NCT02832115|102229450|FG000|NOT COMPLETED|Overall Study||0||
48771480|NCT02832115|102229451|FG001|NOT COMPLETED|Overall Study||0||
48771481|NCT01519921|102229452|FG000|STARTED|Overall Study||86||
48771482|NCT01519921|102229453|FG001|STARTED|Overall Study||64||
48660084|NCT00552279|101951822|FG001|NOT COMPLETED|Overall Study||3||
48660085|NCT04101331|101951823|FG000|STARTED|Overall Study||108||
48771483|NCT01519921|102229452|FG000|COMPLETED|Overall Study||65||
48771484|NCT01519921|102229453|FG001|COMPLETED|Overall Study||49||
48771485|NCT01519921|102229452|FG000|NOT COMPLETED|Overall Study||21||
48771486|NCT01519921|102229453|FG001|NOT COMPLETED|Overall Study||15||
48771487|NCT01039519|102229454|FG000|STARTED|Treatment||27||
48771488|NCT01039519|102229454|FG000|COMPLETED|Treatment||0||
48771489|NCT01039519|102229454|FG000|NOT COMPLETED|Treatment||27||
48771490|NCT01039519|102229454|FG000|STARTED|Survival Follow-up||27||
48771491|NCT01039519|102229454|FG000|COMPLETED|Survival Follow-up||0||
48771492|NCT01039519|102229454|FG000|NOT COMPLETED|Survival Follow-up||27||
48771493|NCT00803569|102229455|FG000|STARTED|Overall Study||13||
48771494|NCT00803569|102229455|FG000|COMPLETED|Overall Study||9||
48771495|NCT00803569|102229455|FG000|NOT COMPLETED|Overall Study||4||
48771496|NCT02393378|102229456|FG000|STARTED|Overall Study||3||
48771497|NCT02393378|102229457|FG001|STARTED|Overall Study||4||
48771498|NCT02393378|102229456|FG000|COMPLETED|Overall Study||3||
48771499|NCT02393378|102229457|FG001|COMPLETED|Overall Study||4||
48771500|NCT02393378|102229456|FG000|NOT COMPLETED|Overall Study||0||
48771501|NCT02393378|102229457|FG001|NOT COMPLETED|Overall Study||0||
48771502|NCT01391546|102229458|FG000|STARTED|Overall Study||177||
48771503|NCT01391546|102229459|FG001|STARTED|Overall Study||177||
48771504|NCT01391546|102229458|FG000|Vaccinated|Overall Study||176||
48660086|NCT04101331|101951823|FG000|COMPLETED|Overall Study||3||
48660087|NCT04101331|101951823|FG000|NOT COMPLETED|Overall Study||105||
48660088|NCT05700422|101951824|FG000|STARTED|Overall Study||39||
48660089|NCT05700422|101951824|FG000|COMPLETED|Overall Study||35||
48660090|NCT05700422|101951824|FG000|NOT COMPLETED|Overall Study||4||
48660091|NCT01335685|101951825|FG000|STARTED|Overall Study||7||
48660092|NCT01335685|101951826|FG001|STARTED|Overall Study||4||
48660093|NCT01335685|101951827|FG002|STARTED|Overall Study||3||
48660094|NCT01335685|101951828|FG003|STARTED|Overall Study||26||
48660095|NCT01335685|101951829|FG004|STARTED|Overall Study||5||
48660096|NCT01335685|101951830|FG005|STARTED|Overall Study||6||
48660097|NCT01335685|101951831|FG006|STARTED|Overall Study||4||
48660098|NCT01335685|101951832|FG007|STARTED|Overall Study||6||
48660099|NCT01335685|101951825|FG000|COMPLETED|Overall Study||4||
48660100|NCT01335685|101951826|FG001|COMPLETED|Overall Study||3||
48660101|NCT01335685|101951827|FG002|COMPLETED|Overall Study||1||
48660102|NCT01335685|101951828|FG003|COMPLETED|Overall Study||15||
48660103|NCT01335685|101951829|FG004|COMPLETED|Overall Study||5||
48660104|NCT01335685|101951830|FG005|COMPLETED|Overall Study||1||
48660105|NCT01335685|101951831|FG006|COMPLETED|Overall Study||2||
48660106|NCT01335685|101951832|FG007|COMPLETED|Overall Study||3||
48660107|NCT01335685|101951825|FG000|NOT COMPLETED|Overall Study||3||
48660108|NCT01335685|101951826|FG001|NOT COMPLETED|Overall Study||1||
48660109|NCT01335685|101951827|FG002|NOT COMPLETED|Overall Study||2||
48660110|NCT01335685|101951828|FG003|NOT COMPLETED|Overall Study||11||
48660111|NCT01335685|101951829|FG004|NOT COMPLETED|Overall Study||0||
48660112|NCT01335685|101951830|FG005|NOT COMPLETED|Overall Study||5||
48771505|NCT01391546|102229459|FG001|Vaccinated|Overall Study||177||
48771506|NCT01391546|102229458|FG000|COMPLETED|Overall Study||176||
48771507|NCT01391546|102229459|FG001|COMPLETED|Overall Study||177||
48771508|NCT01391546|102229458|FG000|NOT COMPLETED|Overall Study||1||
48771509|NCT01391546|102229459|FG001|NOT COMPLETED|Overall Study||0||
48771510|NCT01378871|102229460|FG000|STARTED|Overall Study||1||
48771511|NCT01378871|102229460|FG000|COMPLETED|Overall Study||1||
48771512|NCT01378871|102229460|FG000|NOT COMPLETED|Overall Study||0||
48771513|NCT03352609|102229461|FG000|STARTED|Overall Study||2||
48771514|NCT03352609|102229462|FG001|STARTED|Overall Study||3||
48771515|NCT03352609|102229461|FG000|COMPLETED|Overall Study||2||
48771516|NCT03352609|102229462|FG001|COMPLETED|Overall Study||3||
48771517|NCT03352609|102229461|FG000|NOT COMPLETED|Overall Study||0||
48660113|NCT01335685|101951831|FG006|NOT COMPLETED|Overall Study||2||
48660114|NCT01335685|101951832|FG007|NOT COMPLETED|Overall Study||3||
48660115|NCT01027351|101951833|FG000|STARTED|Overall Study||29||
48660116|NCT01027351|101951834|FG001|STARTED|Overall Study||19||
48660117|NCT01027351|101951835|FG002|STARTED|Overall Study||14||
48771518|NCT03352609|102229462|FG001|NOT COMPLETED|Overall Study||0||
48771519|NCT03403283|102229463|FG000|STARTED|Overall Study||30||
48771520|NCT03403283|102229464|FG001|STARTED|Overall Study||15||
48771521|NCT03403283|102229463|FG000|COMPLETED|Overall Study||30||
48771522|NCT03403283|102229464|FG001|COMPLETED|Overall Study||15||
48771523|NCT03403283|102229463|FG000|NOT COMPLETED|Overall Study||0||
48771524|NCT03403283|102229464|FG001|NOT COMPLETED|Overall Study||0||
48771525|NCT01166282|102229465|FG000|STARTED|Double-blind Period||15||
48771526|NCT01166282|102229466|FG001|STARTED|Double-blind Period||31||
48771527|NCT01166282|102229467|FG002|STARTED|Double-blind Period||0||
48771528|NCT01166282|102229465|FG000|COMPLETED|Double-blind Period||15||
48660118|NCT01027351|101951836|FG003|STARTED|Overall Study||8||
48660119|NCT01027351|101951837|FG004|STARTED|Overall Study||43||
48660120|NCT01027351|101951838|FG005|STARTED|Overall Study||50||
48660121|NCT01027351|101951833|FG000|COMPLETED|Overall Study||26||
48660122|NCT01027351|101951834|FG001|COMPLETED|Overall Study||18||
48660123|NCT01027351|101951835|FG002|COMPLETED|Overall Study||13||
48660124|NCT01027351|101951836|FG003|COMPLETED|Overall Study||6||
48660125|NCT01027351|101951837|FG004|COMPLETED|Overall Study||32||
48771529|NCT01166282|102229466|FG001|COMPLETED|Double-blind Period||31||
48771530|NCT01166282|102229467|FG002|COMPLETED|Double-blind Period||0||
48771531|NCT01166282|102229465|FG000|NOT COMPLETED|Double-blind Period||0||
48771532|NCT01166282|102229466|FG001|NOT COMPLETED|Double-blind Period||0||
48771533|NCT01166282|102229467|FG002|NOT COMPLETED|Double-blind Period||0||
48771534|NCT01166282|102229465|FG000|STARTED|Open-label Period||0||
48771535|NCT01166282|102229466|FG001|STARTED|Open-label Period||0||
48771536|NCT01166282|102229467|FG002|STARTED|Open-label Period||46||
48771537|NCT01166282|102229465|FG000|COMPLETED|Open-label Period||0||
48771538|NCT01166282|102229466|FG001|COMPLETED|Open-label Period||0||
48771539|NCT01166282|102229467|FG002|COMPLETED|Open-label Period||29||
48771540|NCT01166282|102229465|FG000|NOT COMPLETED|Open-label Period||0||
48771541|NCT01166282|102229466|FG001|NOT COMPLETED|Open-label Period||0||
48771542|NCT01166282|102229467|FG002|NOT COMPLETED|Open-label Period||17||
48771543|NCT01462370|102229468|FG000|STARTED|Overall Study||69||
48771544|NCT01462370|102229469|FG001|STARTED|Overall Study||70||
48771545|NCT01462370|102229468|FG000|COMPLETED|Overall Study||68||
48771546|NCT01462370|102229469|FG001|COMPLETED|Overall Study||65||
48771547|NCT01462370|102229468|FG000|NOT COMPLETED|Overall Study||1||
48771548|NCT01462370|102229469|FG001|NOT COMPLETED|Overall Study||5||
48771549|NCT04355143|102229470|FG000|STARTED|Overall Study||48||
48771550|NCT04355143|102229471|FG001|STARTED|Overall Study||45||
48771551|NCT04355143|102229470|FG000|COMPLETED|Overall Study||48||
48771552|NCT04355143|102229471|FG001|COMPLETED|Overall Study||45||
48771553|NCT04355143|102229470|FG000|NOT COMPLETED|Overall Study||0||
48771554|NCT04355143|102229471|FG001|NOT COMPLETED|Overall Study||0||
48448538|NCT02609178|101434740|FG002|COMPLETED|Third Crown||5||
48448539|NCT02609178|101434741|FG003|COMPLETED|Third Crown||2||
48448540|NCT02609178|101434742|FG004|COMPLETED|Third Crown||0||
48448541|NCT02609178|101434743|FG005|COMPLETED|Third Crown||2||
48448542|NCT02609178|101434738|FG000|NOT COMPLETED|Third Crown||0||
48448543|NCT02609178|101434739|FG001|NOT COMPLETED|Third Crown||0||
48448544|NCT02609178|101434740|FG002|NOT COMPLETED|Third Crown||0||
48448545|NCT02609178|101434741|FG003|NOT COMPLETED|Third Crown||0||
48448546|NCT02609178|101434742|FG004|NOT COMPLETED|Third Crown||0||
48448547|NCT02609178|101434743|FG005|NOT COMPLETED|Third Crown||0||
48448548|NCT02307188|101434744|FG000|STARTED|Overall Study||5||
48448549|NCT02307188|101434744|FG000|COMPLETED|Overall Study||1||
48448550|NCT02307188|101434744|FG000|NOT COMPLETED|Overall Study||4||
48448551|NCT00289731|101434745|FG000|STARTED|Overall Study||199||
48448552|NCT00289731|101434746|FG001|STARTED|Overall Study||200||
48448553|NCT00289731|101434747|FG002|STARTED|Overall Study||197||
48448554|NCT00289731|101434745|FG000|COMPLETED|Overall Study||197||
48448555|NCT00289731|101434746|FG001|COMPLETED|Overall Study||198||
48448556|NCT00289731|101434747|FG002|COMPLETED|Overall Study||195||
48448557|NCT00289731|101434745|FG000|NOT COMPLETED|Overall Study||2||
48448558|NCT00289731|101434746|FG001|NOT COMPLETED|Overall Study||2||
48448559|NCT00289731|101434747|FG002|NOT COMPLETED|Overall Study||2||
48448560|NCT00837577|101434748|FG000|STARTED|Double-blind Period||70||
48448561|NCT00837577|101434749|FG001|STARTED|Double-blind Period||63||
48448562|NCT00837577|101434748|FG000|COMPLETED|Double-blind Period||68||
48448563|NCT00837577|101434749|FG001|COMPLETED|Double-blind Period||63||
48448564|NCT00837577|101434748|FG000|NOT COMPLETED|Double-blind Period||2||
48448565|NCT00837577|101434749|FG001|NOT COMPLETED|Double-blind Period||0||
48448566|NCT00837577|101434748|FG000|STARTED|Open-label Period||68||
48448567|NCT00837577|101434749|FG001|STARTED|Open-label Period||63||
48448568|NCT00837577|101434748|FG000|COMPLETED|Open-label Period||60||
48448569|NCT00837577|101434749|FG001|COMPLETED|Open-label Period||54||
48448570|NCT00837577|101434748|FG000|NOT COMPLETED|Open-label Period||8||
48448571|NCT00837577|101434749|FG001|NOT COMPLETED|Open-label Period||9||
48448572|NCT00743119|101434750|FG000|STARTED|Overall Study||34||
48448573|NCT00743119|101434750|FG000|COMPLETED|Overall Study||30||
48771555|NCT00343460|102229472|FG000|STARTED|Cycle 1||475||
48448574|NCT00743119|101434750|FG000|NOT COMPLETED|Overall Study||4||
48448575|NCT00291330|101434751|FG000|STARTED|Overall Study||1273||
48448576|NCT00291330|101434752|FG001|STARTED|Overall Study||1266||
48448577|NCT00291330|101434751|FG000|COMPLETED|Overall Study||1172||
48448578|NCT00291330|101434752|FG001|COMPLETED|Overall Study||1169||
48448579|NCT00291330|101434751|FG000|NOT COMPLETED|Overall Study||101||
48448580|NCT00291330|101434752|FG001|NOT COMPLETED|Overall Study||97||
48448581|NCT01382901|101434753|FG000|STARTED|Overall Study||24||
48448582|NCT01382901|101434754|FG001|STARTED|Overall Study||21||
48448583|NCT01382901|101434753|FG000|COMPLETED|Overall Study||7||
48448584|NCT01382901|101434754|FG001|COMPLETED|Overall Study||7||
48448585|NCT01382901|101434753|FG000|NOT COMPLETED|Overall Study||17||
48448586|NCT01382901|101434754|FG001|NOT COMPLETED|Overall Study||14||
48771556|NCT00343460|102229473|FG001|STARTED|Cycle 1||481||
48771557|NCT00343460|102229474|FG002|STARTED|Cycle 1||472||
48448587|NCT01890694|101434755|FG000|STARTED|Overall Study||1||
48771558|NCT00343460|102229472|FG000|COMPLETED|Cycle 1||453||
48771559|NCT00343460|102229473|FG001|COMPLETED|Cycle 1||459||
48448588|NCT01890694|101434756|FG001|STARTED|Overall Study||1||
48448589|NCT01890694|101434755|FG000|COMPLETED|Overall Study||0||
48448590|NCT01890694|101434756|FG001|COMPLETED|Overall Study||0||
48771560|NCT00343460|102229474|FG002|COMPLETED|Cycle 1||454||
48448591|NCT01890694|101434755|FG000|NOT COMPLETED|Overall Study||1||
48448592|NCT01890694|101434756|FG001|NOT COMPLETED|Overall Study||1||
48448593|NCT02284373|101434757|FG000|STARTED|Overall Study||5||
48448594|NCT02284373|101434758|FG001|STARTED|Overall Study||5||
48448595|NCT02284373|101434759|FG002|STARTED|Overall Study||29||
48448596|NCT02284373|101434757|FG000|COMPLETED|Overall Study||5||
48448597|NCT02284373|101434758|FG001|COMPLETED|Overall Study||2||
48448598|NCT02284373|101434759|FG002|COMPLETED|Overall Study||29||
48448599|NCT02284373|101434757|FG000|NOT COMPLETED|Overall Study||0||
48448600|NCT02284373|101434758|FG001|NOT COMPLETED|Overall Study||3||
48448601|NCT02284373|101434759|FG002|NOT COMPLETED|Overall Study||0||
48448602|NCT00660049|101434760|FG000|STARTED|Overall Study||12||
48448603|NCT00660049|101434760|FG000|COMPLETED|Overall Study||6||
48448604|NCT00660049|101434760|FG000|NOT COMPLETED|Overall Study||6||
48448605|NCT02923115|101434761|FG000|STARTED|Overall Study||12|Randomized|
48448606|NCT02923115|101434762|FG001|STARTED|Overall Study||16|Randomized|
48448607|NCT02923115|101434763|FG002|STARTED|Overall Study||23|Randomized|
48448608|NCT02923115|101434764|FG003|STARTED|Overall Study||23|Randomized|
48448609|NCT02923115|101434765|FG004|STARTED|Overall Study||22|Randomized|
48448610|NCT02923115|101434766|FG005|STARTED|Overall Study||38|Randomized|
48448611|NCT02923115|101434761|FG000|Treated|Overall Study||12||
48448612|NCT02923115|101434762|FG001|Treated|Overall Study||16||
48448613|NCT02923115|101434763|FG002|Treated|Overall Study||20||
48448614|NCT02923115|101434764|FG003|Treated|Overall Study||22||
48448615|NCT02923115|101434765|FG004|Treated|Overall Study||17||
48448616|NCT02923115|101434766|FG005|Treated|Overall Study||38||
48448617|NCT02923115|101434761|FG000|COMPLETED|Overall Study||12||
48448618|NCT02923115|101434762|FG001|COMPLETED|Overall Study||15||
48448619|NCT02923115|101434763|FG002|COMPLETED|Overall Study||20||
48448620|NCT02923115|101434764|FG003|COMPLETED|Overall Study||21||
48448621|NCT02923115|101434765|FG004|COMPLETED|Overall Study||17||
48448622|NCT02923115|101434766|FG005|COMPLETED|Overall Study||38||
48448623|NCT02923115|101434761|FG000|NOT COMPLETED|Overall Study||0||
48448624|NCT02923115|101434762|FG001|NOT COMPLETED|Overall Study||1||
48448625|NCT02923115|101434763|FG002|NOT COMPLETED|Overall Study||3||
48448626|NCT02923115|101434764|FG003|NOT COMPLETED|Overall Study||2||
48448627|NCT02923115|101434765|FG004|NOT COMPLETED|Overall Study||5||
48448628|NCT02923115|101434766|FG005|NOT COMPLETED|Overall Study||0||
48448629|NCT04529499|101434767|FG000|STARTED|Overall Study||175||
48448630|NCT04529499|101434768|FG001|STARTED|Overall Study||178||
48448631|NCT04529499|101434767|FG000|Discharged From Hospital Before Day 28|Overall Study||136|Stage I|
48448632|NCT04529499|101434768|FG001|Discharged From Hospital Before Day 28|Overall Study||136|Stage I|
48448633|NCT04529499|101434767|FG000|Completed 10-day Treatment Course of IMP|Overall Study||150|Stage I|
48448634|NCT04529499|101434768|FG001|Completed 10-day Treatment Course of IMP|Overall Study||147|Stage I|
48448635|NCT04529499|101434767|FG000|Completed Day 14 Telephonic Visit|Overall Study||107|Stage I|
48448636|NCT04529499|101434768|FG001|Completed Day 14 Telephonic Visit|Overall Study||102|Stage I|
48448637|NCT04529499|101434767|FG000|Completed Day 21 Telephonic Visit|Overall Study||119|Stage I|
48448638|NCT04529499|101434768|FG001|Completed Day 21 Telephonic Visit|Overall Study||120|Stage I|
48448639|NCT04529499|101434767|FG000|Completed Day 28 Telephonic Visit|Overall Study||134|Stage I|
48448640|NCT04529499|101434768|FG001|Completed Day 28 Telephonic Visit|Overall Study||131|Stage I|
48448641|NCT04529499|101434767|FG000|Completed Days 14, 21 and 28 Telephonic Visits in Stage I|Overall Study||98|Stage I|
48448642|NCT04529499|101434768|FG001|Completed Days 14, 21 and 28 Telephonic Visits in Stage I|Overall Study||94|Stage I|
48448643|NCT04529499|101434767|FG000|Continue to be in Hospital as of Day 28|Overall Study||6||
48448644|NCT04529499|101434768|FG001|Continue to be in Hospital as of Day 28|Overall Study||4||
48448645|NCT04529499|101434767|FG000|Completed Day 42 Telephonic Visit|Overall Study||136|Stage II|
48448646|NCT04529499|101434768|FG001|Completed Day 42 Telephonic Visit|Overall Study||135|Stage II|
48448647|NCT04529499|101434767|FG000|Completed Day 60 Telephonic Visit|Overall Study||129|Stage II|
48448648|NCT04529499|101434768|FG001|Completed Day 60 Telephonic Visit|Overall Study||132|Stage II|
48448649|NCT04529499|101434767|FG000|Completed Days 42 and 60 Telephonic Visits in Stage II|Overall Study||126|Stage II|
48448650|NCT04529499|101434768|FG001|Completed Days 42 and 60 Telephonic Visits in Stage II|Overall Study||130|Stage II|
48448651|NCT04529499|101434767|FG000|Continued to be in Hospital When Study Was Terminated|Overall Study||11||
48448652|NCT04529499|101434768|FG001|Continued to be in Hospital When Study Was Terminated|Overall Study||17||
48448653|NCT04529499|101434767|FG000|COMPLETED|Overall Study||139|Stage I|
48448654|NCT04529499|101434768|FG001|COMPLETED|Overall Study||138|Stage I|
48448655|NCT04529499|101434767|FG000|NOT COMPLETED|Overall Study||36||
48771561|NCT00343460|102229472|FG000|NOT COMPLETED|Cycle 1||22||
48771562|NCT00343460|102229473|FG001|NOT COMPLETED|Cycle 1||22||
48771563|NCT00343460|102229474|FG002|NOT COMPLETED|Cycle 1||18||
48771564|NCT00343460|102229472|FG000|STARTED|Cycle 2 - 4||584||
48771565|NCT00343460|102229473|FG001|STARTED|Cycle 2 - 4||565||
48771566|NCT00343460|102229474|FG002|STARTED|Cycle 2 - 4||0||
48771567|NCT00343460|102229472|FG000|COMPLETED|Cycle 2 - 4||528||
48448656|NCT04529499|101434768|FG001|NOT COMPLETED|Overall Study||40||
48448657|NCT03276962|101434769|FG000|STARTED|Overall Study||298||
48448658|NCT03276962|101434770|FG001|STARTED|Overall Study||294||
48771568|NCT00343460|102229473|FG001|COMPLETED|Cycle 2 - 4||515||
48771569|NCT00343460|102229474|FG002|COMPLETED|Cycle 2 - 4||0||
48448659|NCT03276962|101434771|FG002|STARTED|Overall Study||304||
48771570|NCT00343460|102229472|FG000|NOT COMPLETED|Cycle 2 - 4||56||
48771571|NCT00343460|102229473|FG001|NOT COMPLETED|Cycle 2 - 4||50||
48771572|NCT00343460|102229474|FG002|NOT COMPLETED|Cycle 2 - 4||0||
48771573|NCT02377817|102229475|FG000|STARTED|Overall Study||13||
48771574|NCT02377817|102229476|FG001|STARTED|Overall Study||10||
48771575|NCT02377817|102229475|FG000|COMPLETED|Overall Study||10||
48771576|NCT02377817|102229476|FG001|COMPLETED|Overall Study||10||
48771577|NCT02377817|102229475|FG000|NOT COMPLETED|Overall Study||3||
48771578|NCT02377817|102229476|FG001|NOT COMPLETED|Overall Study||0||
48771579|NCT01436435|102229477|FG000|STARTED|Overall Study||241||
48771580|NCT01436435|102229477|FG000|COMPLETED|Overall Study||177||
48771581|NCT01436435|102229477|FG000|NOT COMPLETED|Overall Study||64||
48771582|NCT04639258|102229478|FG000|STARTED|Overall Study||11||
48771583|NCT04639258|102229478|FG000|COMPLETED|Overall Study||0||
48771584|NCT04639258|102229478|FG000|NOT COMPLETED|Overall Study||11||
48771585|NCT00357006|102229479|FG000|STARTED|Overall Study||62||
48771586|NCT00357006|102229480|FG001|STARTED|Overall Study||56||
48771587|NCT00357006|102229481|FG002|STARTED|Overall Study||62||
48771588|NCT00357006|102229479|FG000|COMPLETED|Overall Study||60||
48771589|NCT00357006|102229480|FG001|COMPLETED|Overall Study||51||
48771590|NCT00357006|102229481|FG002|COMPLETED|Overall Study||59||
48771591|NCT00357006|102229479|FG000|NOT COMPLETED|Overall Study||2||
48771592|NCT00357006|102229480|FG001|NOT COMPLETED|Overall Study||5||
48771593|NCT00357006|102229481|FG002|NOT COMPLETED|Overall Study||3||
48448660|NCT03276962|101434772|FG003|STARTED|Overall Study||311||
48448661|NCT03276962|101434773|FG004|STARTED|Overall Study||293||
48448662|NCT03276962|101434769|FG000|COMPLETED|Overall Study||229||
48448663|NCT03276962|101434770|FG001|COMPLETED|Overall Study||232||
48448664|NCT03276962|101434771|FG002|COMPLETED|Overall Study||242||
48448665|NCT03276962|101434772|FG003|COMPLETED|Overall Study||247||
48448666|NCT03276962|101434773|FG004|COMPLETED|Overall Study||237||
48448667|NCT03276962|101434769|FG000|NOT COMPLETED|Overall Study||69||
48448668|NCT03276962|101434770|FG001|NOT COMPLETED|Overall Study||62||
48448669|NCT03276962|101434771|FG002|NOT COMPLETED|Overall Study||62||
48448670|NCT03276962|101434772|FG003|NOT COMPLETED|Overall Study||64||
48448671|NCT03276962|101434773|FG004|NOT COMPLETED|Overall Study||56||
48448672|NCT00068445|101434774|FG000|STARTED|Randomization||65||
48448673|NCT00068445|101434775|FG001|STARTED|Randomization||66||
48448674|NCT00068445|101434774|FG000|COMPLETED|Randomization||63||
48448675|NCT00068445|101434775|FG001|COMPLETED|Randomization||62||
48448676|NCT00068445|101434774|FG000|NOT COMPLETED|Randomization||2||
48448677|NCT00068445|101434775|FG001|NOT COMPLETED|Randomization||4||
48448678|NCT00068445|101434774|FG000|STARTED|Treatment||63||
48448679|NCT00068445|101434775|FG001|STARTED|Treatment||62||
48448680|NCT00068445|101434774|FG000|COMPLETED|Treatment||34||
48448681|NCT00068445|101434775|FG001|COMPLETED|Treatment||46||
48448682|NCT00068445|101434774|FG000|NOT COMPLETED|Treatment||29||
48448683|NCT00068445|101434775|FG001|NOT COMPLETED|Treatment||16||
48448684|NCT02237118|101434776|FG000|STARTED|Overall Study||60||
48448685|NCT02237118|101434777|FG001|STARTED|Overall Study||63||
48448686|NCT02237118|101434776|FG000|COMPLETED|Overall Study||59||
48448687|NCT02237118|101434777|FG001|COMPLETED|Overall Study||62||
48448688|NCT02237118|101434776|FG000|NOT COMPLETED|Overall Study||1||
48448689|NCT02237118|101434777|FG001|NOT COMPLETED|Overall Study||1||
48448690|NCT04701658|101434778|FG000|STARTED|Overall Study||109||
48448691|NCT04701658|101434778|FG000|Received Single Dose of Bamlanivimab|Overall Study||109||
48448692|NCT04701658|101434778|FG000|COMPLETED|Overall Study||103||
48448693|NCT04701658|101434778|FG000|NOT COMPLETED|Overall Study||6||
48660126|NCT01027351|101951838|FG005|COMPLETED|Overall Study||45||
48660127|NCT01027351|101951833|FG000|NOT COMPLETED|Overall Study||3||
48660128|NCT01027351|101951834|FG001|NOT COMPLETED|Overall Study||1||
48660129|NCT01027351|101951835|FG002|NOT COMPLETED|Overall Study||1||
48660130|NCT01027351|101951836|FG003|NOT COMPLETED|Overall Study||2||
48660131|NCT01027351|101951837|FG004|NOT COMPLETED|Overall Study||11||
48660132|NCT01027351|101951838|FG005|NOT COMPLETED|Overall Study||5||
48660133|NCT00594997|101951839|FG000|STARTED|Overall Study||1562||
48660134|NCT00594997|101951840|FG001|STARTED|Overall Study||2008||
48660135|NCT00594997|101951839|FG000|COMPLETED|Overall Study||1562||
48660136|NCT00594997|101951840|FG001|COMPLETED|Overall Study||2008||
48771594|NCT00938704|102229482|FG000|STARTED|Overall Study||33||
48771595|NCT00938704|102229483|FG001|STARTED|Overall Study||37||
48660137|NCT00594997|101951839|FG000|NOT COMPLETED|Overall Study||0||
48771596|NCT00938704|102229482|FG000|COMPLETED|Overall Study||33||
48448694|NCT00990093|101434779|FG000|STARTED|Test Period 1 (1-14 Days)||19||
48660138|NCT00594997|101951840|FG001|NOT COMPLETED|Overall Study||0||
48771597|NCT00938704|102229483|FG001|COMPLETED|Overall Study||37||
48448695|NCT00990093|101434780|FG001|STARTED|Test Period 1 (1-14 Days)||17||
48448696|NCT00990093|101434779|FG000|COMPLETED|Test Period 1 (1-14 Days)||15||
48448697|NCT00990093|101434780|FG001|COMPLETED|Test Period 1 (1-14 Days)||15||
48448698|NCT00990093|101434779|FG000|NOT COMPLETED|Test Period 1 (1-14 Days)||4||
48660139|NCT01050218|101951841|FG000|STARTED|Overall Study||237||
48660140|NCT01050218|101951841|FG000|COMPLETED|Overall Study||142||
48660141|NCT01050218|101951841|FG000|NOT COMPLETED|Overall Study||95||
48448699|NCT00990093|101434780|FG001|NOT COMPLETED|Test Period 1 (1-14 Days)||2||
48448700|NCT00990093|101434779|FG000|STARTED|Test Period 2 (15-28 Days)||15||
48448701|NCT00990093|101434780|FG001|STARTED|Test Period 2 (15-28 Days)||15||
48448702|NCT00990093|101434779|FG000|COMPLETED|Test Period 2 (15-28 Days)||13||
48448703|NCT00990093|101434780|FG001|COMPLETED|Test Period 2 (15-28 Days)||14||
48448704|NCT00990093|101434779|FG000|NOT COMPLETED|Test Period 2 (15-28 Days)||2||
48448705|NCT00990093|101434780|FG001|NOT COMPLETED|Test Period 2 (15-28 Days)||1||
48448706|NCT02353299|101434781|FG000|STARTED|First Intervention (1 Night)||13||
48448707|NCT02353299|101434782|FG001|STARTED|First Intervention (1 Night)||13||
48448708|NCT02353299|101434783|FG002|STARTED|First Intervention (1 Night)||13||
48448709|NCT02353299|101434784|FG003|STARTED|First Intervention (1 Night)||13||
48448710|NCT02353299|101434781|FG000|COMPLETED|First Intervention (1 Night)||13||
48448711|NCT02353299|101434782|FG001|COMPLETED|First Intervention (1 Night)||13||
48448712|NCT02353299|101434783|FG002|COMPLETED|First Intervention (1 Night)||13||
48448713|NCT02353299|101434784|FG003|COMPLETED|First Intervention (1 Night)||13||
48448714|NCT02353299|101434781|FG000|NOT COMPLETED|First Intervention (1 Night)||0||
48448715|NCT02353299|101434782|FG001|NOT COMPLETED|First Intervention (1 Night)||0||
48448716|NCT02353299|101434783|FG002|NOT COMPLETED|First Intervention (1 Night)||0||
48448717|NCT02353299|101434784|FG003|NOT COMPLETED|First Intervention (1 Night)||0||
48448718|NCT02353299|101434781|FG000|STARTED|Second Intervention (1 Night)||13||
48448719|NCT02353299|101434782|FG001|STARTED|Second Intervention (1 Night)||13||
48448720|NCT02353299|101434783|FG002|STARTED|Second Intervention (1 Night)||13||
48448721|NCT02353299|101434784|FG003|STARTED|Second Intervention (1 Night)||13||
48448722|NCT02353299|101434781|FG000|COMPLETED|Second Intervention (1 Night)||13||
48448723|NCT02353299|101434782|FG001|COMPLETED|Second Intervention (1 Night)||13||
48448724|NCT02353299|101434783|FG002|COMPLETED|Second Intervention (1 Night)||13||
48448725|NCT02353299|101434784|FG003|COMPLETED|Second Intervention (1 Night)||13||
48448726|NCT02353299|101434781|FG000|NOT COMPLETED|Second Intervention (1 Night)||0||
48448727|NCT02353299|101434782|FG001|NOT COMPLETED|Second Intervention (1 Night)||0||
48448728|NCT02353299|101434783|FG002|NOT COMPLETED|Second Intervention (1 Night)||0||
48448729|NCT02353299|101434784|FG003|NOT COMPLETED|Second Intervention (1 Night)||0||
48448730|NCT02353299|101434781|FG000|STARTED|Third Intervention (1 Night)||13||
48448731|NCT02353299|101434782|FG001|STARTED|Third Intervention (1 Night)||13||
48448732|NCT02353299|101434783|FG002|STARTED|Third Intervention (1 Night)||13||
48448733|NCT02353299|101434784|FG003|STARTED|Third Intervention (1 Night)||13||
48448734|NCT02353299|101434781|FG000|COMPLETED|Third Intervention (1 Night)||13||
48448735|NCT02353299|101434782|FG001|COMPLETED|Third Intervention (1 Night)||13||
48448736|NCT02353299|101434783|FG002|COMPLETED|Third Intervention (1 Night)||13||
48448737|NCT02353299|101434784|FG003|COMPLETED|Third Intervention (1 Night)||13||
48448738|NCT02353299|101434781|FG000|NOT COMPLETED|Third Intervention (1 Night)||0||
48448739|NCT02353299|101434782|FG001|NOT COMPLETED|Third Intervention (1 Night)||0||
48448740|NCT02353299|101434783|FG002|NOT COMPLETED|Third Intervention (1 Night)||0||
48448741|NCT02353299|101434784|FG003|NOT COMPLETED|Third Intervention (1 Night)||0||
48448742|NCT02353299|101434781|FG000|STARTED|Fourth Intervention (1 Night)||13||
48448743|NCT02353299|101434782|FG001|STARTED|Fourth Intervention (1 Night)||12||
48448744|NCT02353299|101434783|FG002|STARTED|Fourth Intervention (1 Night)||13||
48448745|NCT02353299|101434784|FG003|STARTED|Fourth Intervention (1 Night)||13||
48448746|NCT02353299|101434781|FG000|COMPLETED|Fourth Intervention (1 Night)||13||
48448747|NCT02353299|101434782|FG001|COMPLETED|Fourth Intervention (1 Night)||12||
48448748|NCT02353299|101434783|FG002|COMPLETED|Fourth Intervention (1 Night)||13||
48448749|NCT02353299|101434784|FG003|COMPLETED|Fourth Intervention (1 Night)||13||
48448750|NCT02353299|101434781|FG000|NOT COMPLETED|Fourth Intervention (1 Night)||0||
48448751|NCT02353299|101434782|FG001|NOT COMPLETED|Fourth Intervention (1 Night)||0||
48448752|NCT02353299|101434783|FG002|NOT COMPLETED|Fourth Intervention (1 Night)||0||
48448753|NCT02353299|101434784|FG003|NOT COMPLETED|Fourth Intervention (1 Night)||0||
48448754|NCT00406107|101434785|FG000|STARTED|Overall Study||15||
48448755|NCT00406107|101434786|FG001|STARTED|Overall Study||5||
48448756|NCT00406107|101434785|FG000|COMPLETED|Overall Study||14||
48448757|NCT00406107|101434786|FG001|COMPLETED|Overall Study||4||
48448758|NCT00406107|101434785|FG000|NOT COMPLETED|Overall Study||1||
48448759|NCT00406107|101434786|FG001|NOT COMPLETED|Overall Study||1||
48448760|NCT00068406|101434787|FG000|STARTED|Overall Study||61||
48448761|NCT00068406|101434787|FG000|COMPLETED|Overall Study||58||
48448762|NCT00068406|101434787|FG000|NOT COMPLETED|Overall Study||3||
48448763|NCT02951884|101434788|FG000|STARTED|Overall Study||0||
48448764|NCT02951884|101434789|FG001|STARTED|Overall Study||1||
48448765|NCT02951884|101434790|FG002|STARTED|Overall Study||1||
48448766|NCT02951884|101434788|FG000|COMPLETED|Overall Study||0||
48448767|NCT02951884|101434789|FG001|COMPLETED|Overall Study||1||
48448768|NCT02951884|101434790|FG002|COMPLETED|Overall Study||1||
48448769|NCT02951884|101434788|FG000|NOT COMPLETED|Overall Study||0||
48448770|NCT02951884|101434789|FG001|NOT COMPLETED|Overall Study||0||
48448771|NCT02951884|101434790|FG002|NOT COMPLETED|Overall Study||0||
48448772|NCT02018042|101434791|FG000|STARTED|Overall Study||15||
48448773|NCT02018042|101434791|FG000|COMPLETED|Overall Study||14||
48448774|NCT02018042|101434791|FG000|NOT COMPLETED|Overall Study||1||
48448775|NCT01393717|101434792|FG000|STARTED|Overall Study||37||
48448776|NCT01393717|101434793|FG001|STARTED|Overall Study||20||
48448777|NCT01393717|101434792|FG000|COMPLETED|Overall Study||37||
48448778|NCT01393717|101434793|FG001|COMPLETED|Overall Study||20||
48448779|NCT01393717|101434792|FG000|NOT COMPLETED|Overall Study||0||
48448780|NCT01393717|101434793|FG001|NOT COMPLETED|Overall Study||0||
48448781|NCT01246986|101434794|FG000|STARTED|Overall Study||37||
48660142|NCT01267136|101951842|FG000|STARTED|Overall Study||42||
48660143|NCT01267136|101951843|FG001|STARTED|Overall Study||42||
48660144|NCT01267136|101951842|FG000|COMPLETED|Overall Study||38||
48660145|NCT01267136|101951843|FG001|COMPLETED|Overall Study||36||
48660146|NCT01267136|101951842|FG000|NOT COMPLETED|Overall Study||4||
48660147|NCT01267136|101951843|FG001|NOT COMPLETED|Overall Study||6||
48660148|NCT00563316|101951844|FG000|STARTED|Overall Study||28||
48660149|NCT00563316|101951844|FG000|Received Investigational Product|Overall Study||27||
48660150|NCT00563316|101951844|FG000|COMPLETED|Overall Study||16||
48660151|NCT00563316|101951844|FG000|NOT COMPLETED|Overall Study||12||
48660152|NCT02214212|101951845|FG000|STARTED|Overall Study||66||
48660153|NCT02214212|101951846|FG001|STARTED|Overall Study||65||
48660154|NCT02214212|101951845|FG000|COMPLETED|Overall Study||57||
48660155|NCT02214212|101951846|FG001|COMPLETED|Overall Study||59||
48660156|NCT02214212|101951845|FG000|NOT COMPLETED|Overall Study||9||
48660157|NCT02214212|101951846|FG001|NOT COMPLETED|Overall Study||6||
48660158|NCT04130425|101951847|FG000|STARTED|Overall Study||30||
48660159|NCT04130425|101951847|FG000|COMPLETED|Overall Study||30||
48660160|NCT04130425|101951847|FG000|NOT COMPLETED|Overall Study||0||
48660161|NCT00050011|101951848|FG000|STARTED|Overall Study||301||
48660162|NCT00050011|101951849|FG001|STARTED|Overall Study||301||
48660163|NCT00050011|101951848|FG000|Intent-to-treat Population|Overall Study||300||
48660164|NCT00050011|101951849|FG001|Intent-to-treat Population|Overall Study||300||
48660165|NCT00050011|101951848|FG000|COMPLETED|Overall Study||180||
48660166|NCT00050011|101951849|FG001|COMPLETED|Overall Study||175||
48660167|NCT00050011|101951848|FG000|NOT COMPLETED|Overall Study||121||
48660168|NCT00050011|101951849|FG001|NOT COMPLETED|Overall Study||126||
48660169|NCT03004183|101951850|FG000|STARTED|Overall Study||57||
48660170|NCT03004183|101951850|FG000|TNBC|Overall Study||28||
48660171|NCT03004183|101951850|FG000|NSCLC|Overall Study||29||
48660172|NCT03004183|101951850|FG000|COMPLETED|Overall Study||7||
48660173|NCT03004183|101951850|FG000|NOT COMPLETED|Overall Study||50||
48660174|NCT03885206|101951851|FG000|STARTED|Overall Study||49||
48660175|NCT03885206|101951852|FG001|STARTED|Overall Study||115||
48660176|NCT03885206|101951851|FG000|COMPLETED|Overall Study||26||
48660177|NCT03885206|101951852|FG001|COMPLETED|Overall Study||70||
48660178|NCT03885206|101951851|FG000|NOT COMPLETED|Overall Study||23||
48660179|NCT03885206|101951852|FG001|NOT COMPLETED|Overall Study||45||
48660180|NCT01723839|101951853|FG000|STARTED|Overall Study||21||
48660181|NCT01723839|101951853|FG000|COMPLETED|Overall Study||12||
48660182|NCT01723839|101951853|FG000|NOT COMPLETED|Overall Study||9||
48660183|NCT04204902|101951854|FG000|STARTED|Treatment Period 1 (Day 1)||9||
48660184|NCT04204902|101951855|FG001|STARTED|Treatment Period 1 (Day 1)||9||
48660185|NCT04204902|101951854|FG000|COMPLETED|Treatment Period 1 (Day 1)||9||
48660186|NCT04204902|101951855|FG001|COMPLETED|Treatment Period 1 (Day 1)||9||
48660187|NCT04204902|101951854|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48660188|NCT04204902|101951855|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48771598|NCT00938704|102229482|FG000|NOT COMPLETED|Overall Study||0||
48448782|NCT01246986|101434795|FG001|STARTED|Overall Study||72||
48448783|NCT01246986|101434796|FG002|STARTED|Overall Study||40||
48448784|NCT01246986|101434797|FG003|STARTED|Overall Study||3||
48448785|NCT01246986|101434798|FG004|STARTED|Overall Study||44||
48448786|NCT01246986|101434799|FG005|STARTED|Overall Study||3||
48448787|NCT01246986|101434800|FG006|STARTED|Overall Study||5||
48448788|NCT01246986|101434794|FG000|Received at Least 1 Dose of Study Drug|Overall Study||37||
48448789|NCT01246986|101434795|FG001|Received at Least 1 Dose of Study Drug|Overall Study||72||
48771599|NCT00938704|102229483|FG001|NOT COMPLETED|Overall Study||0||
48771600|NCT00482053|102229484|FG000|STARTED|Autologous Peripheral Stem Cells||3||
48771601|NCT00482053|102229484|FG000|COMPLETED|Autologous Peripheral Stem Cells||3||
48448790|NCT01246986|101434796|FG002|Received at Least 1 Dose of Study Drug|Overall Study||40||
48448791|NCT01246986|101434797|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3||
48448792|NCT01246986|101434798|FG004|Received at Least 1 Dose of Study Drug|Overall Study||44||
48448793|NCT01246986|101434799|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3||
48660189|NCT04204902|101951854|FG000|STARTED|Washout Period (21 Days)||9||
48660190|NCT04204902|101951855|FG001|STARTED|Washout Period (21 Days)||9||
48660191|NCT04204902|101951854|FG000|COMPLETED|Washout Period (21 Days)||9||
48660192|NCT04204902|101951855|FG001|COMPLETED|Washout Period (21 Days)||9||
48660193|NCT04204902|101951854|FG000|NOT COMPLETED|Washout Period (21 Days)||0||
48660194|NCT04204902|101951855|FG001|NOT COMPLETED|Washout Period (21 Days)||0||
48660195|NCT04204902|101951854|FG000|STARTED|Treatment Period 2 (Day 22)||9||
48448794|NCT01246986|101434800|FG006|Received at Least 1 Dose of Study Drug|Overall Study||5||
48448795|NCT01246986|101434794|FG000|COMPLETED|Overall Study||34||
48448796|NCT01246986|101434795|FG001|COMPLETED|Overall Study||67||
48448797|NCT01246986|101434796|FG002|COMPLETED|Overall Study||34||
48448798|NCT01246986|101434797|FG003|COMPLETED|Overall Study||3||
48448799|NCT01246986|101434798|FG004|COMPLETED|Overall Study||40||
48448800|NCT01246986|101434799|FG005|COMPLETED|Overall Study||2||
48448801|NCT01246986|101434800|FG006|COMPLETED|Overall Study||5||
48448802|NCT01246986|101434794|FG000|NOT COMPLETED|Overall Study||3||
48448803|NCT01246986|101434795|FG001|NOT COMPLETED|Overall Study||5||
48448804|NCT01246986|101434796|FG002|NOT COMPLETED|Overall Study||6||
48448805|NCT01246986|101434797|FG003|NOT COMPLETED|Overall Study||0||
48448806|NCT01246986|101434798|FG004|NOT COMPLETED|Overall Study||4||
48448807|NCT01246986|101434799|FG005|NOT COMPLETED|Overall Study||1||
48448808|NCT01246986|101434800|FG006|NOT COMPLETED|Overall Study||0||
48448809|NCT01697449|101434801|FG000|STARTED|Overall Study||191||
48448810|NCT01697449|101434801|FG000|COMPLETED|Overall Study||101||
48448811|NCT01697449|101434801|FG000|NOT COMPLETED|Overall Study||90||
48448812|NCT03550794|101434802|FG000|STARTED|Overall Study||46||
48448813|NCT03550794|101434803|FG001|STARTED|Overall Study||49||
48448814|NCT03550794|101434802|FG000|COMPLETED|Overall Study||42||
48448815|NCT03550794|101434803|FG001|COMPLETED|Overall Study||46||
48448816|NCT03550794|101434802|FG000|NOT COMPLETED|Overall Study||4||
48448817|NCT03550794|101434803|FG001|NOT COMPLETED|Overall Study||3||
48448818|NCT03876873|101434804|FG000|STARTED|Overall Study||9||
48448819|NCT03876873|101434805|FG001|STARTED|Overall Study||12||
48448820|NCT03876873|101434804|FG000|COMPLETED|Overall Study||9||
48448821|NCT03876873|101434805|FG001|COMPLETED|Overall Study||11||
48448822|NCT03876873|101434804|FG000|NOT COMPLETED|Overall Study||0||
48448823|NCT03876873|101434805|FG001|NOT COMPLETED|Overall Study||1||
48448824|NCT00640614|101434806|FG000|STARTED|Overall Study||125||
48448825|NCT00640614|101434807|FG001|STARTED|Overall Study||110||
48448826|NCT00640614|101434806|FG000|COMPLETED|Overall Study||124||
48448827|NCT00640614|101434807|FG001|COMPLETED|Overall Study||110||
48448828|NCT00640614|101434806|FG000|NOT COMPLETED|Overall Study||1||
48448829|NCT00640614|101434807|FG001|NOT COMPLETED|Overall Study||0||
48660196|NCT04204902|101951855|FG001|STARTED|Treatment Period 2 (Day 22)||9||
48660197|NCT04204902|101951854|FG000|COMPLETED|Treatment Period 2 (Day 22)||9||
48660198|NCT04204902|101951855|FG001|COMPLETED|Treatment Period 2 (Day 22)||8||
48660199|NCT04204902|101951854|FG000|NOT COMPLETED|Treatment Period 2 (Day 22)||0||
48771602|NCT00482053|102229484|FG000|NOT COMPLETED|Autologous Peripheral Stem Cells||0||
48771603|NCT00482053|102229484|FG000|STARTED|Inter-treatment Period||3||
48771604|NCT00482053|102229484|FG000|COMPLETED|Inter-treatment Period||2||
48771605|NCT00482053|102229484|FG000|NOT COMPLETED|Inter-treatment Period||1||
48771606|NCT00482053|102229484|FG000|STARTED|Allogeneic Peripheral Stem Cells||2||
48771607|NCT00482053|102229484|FG000|COMPLETED|Allogeneic Peripheral Stem Cells||2||
48771608|NCT00482053|102229484|FG000|NOT COMPLETED|Allogeneic Peripheral Stem Cells||0||
48448830|NCT01835470|101434808|FG000|STARTED|Short Term Treatment Period (to Week 16)||20||
48448831|NCT01835470|101434808|FG000|COMPLETED|Short Term Treatment Period (to Week 16)||20||
48660200|NCT04204902|101951855|FG001|NOT COMPLETED|Treatment Period 2 (Day 22)||1||
48660201|NCT01509404|101951856|FG000|STARTED|Overall Study||20||
48448832|NCT01835470|101434808|FG000|NOT COMPLETED|Short Term Treatment Period (to Week 16)||0||
48448833|NCT01835470|101434808|FG000|STARTED|Long Term Treatment Period||20||
48448834|NCT01835470|101434808|FG000|COMPLETED|Long Term Treatment Period||16||
48448835|NCT01835470|101434808|FG000|NOT COMPLETED|Long Term Treatment Period||4||
48448836|NCT01412710|101434809|FG000|STARTED|Overall Study||50||
48660202|NCT01509404|101951857|FG001|STARTED|Overall Study||20||
48660203|NCT01509404|101951856|FG000|COMPLETED|Overall Study||20||
48660204|NCT01509404|101951857|FG001|COMPLETED|Overall Study||20||
48660205|NCT01509404|101951856|FG000|NOT COMPLETED|Overall Study||0||
48660206|NCT01509404|101951857|FG001|NOT COMPLETED|Overall Study||0||
48660207|NCT01421459|101951858|FG000|STARTED|Overall Study||379||
48660208|NCT01421459|101951859|FG001|STARTED|Overall Study||380||
48660209|NCT01421459|101951858|FG000|Received at Least 1 Dose of Study Drug|Overall Study||376||
48660210|NCT01421459|101951859|FG001|Received at Least 1 Dose of Study Drug|Overall Study||380||
48660211|NCT01421459|101951858|FG000|COMPLETED|Overall Study||334||
48448837|NCT01412710|101434810|FG001|STARTED|Overall Study||27||
48448838|NCT01412710|101434809|FG000|COMPLETED|Overall Study||46||
48448839|NCT01412710|101434810|FG001|COMPLETED|Overall Study||22||
48448840|NCT01412710|101434809|FG000|NOT COMPLETED|Overall Study||4||
48448841|NCT01412710|101434810|FG001|NOT COMPLETED|Overall Study||5||
48448842|NCT00566631|101434811|FG000|STARTED|Part 1: Core Treatment Phase||294||
48660212|NCT01421459|101951859|FG001|COMPLETED|Overall Study||328||
48660213|NCT01421459|101951858|FG000|NOT COMPLETED|Overall Study||45||
48771609|NCT03937570|102229485|FG000|STARTED|Overall Study||13||
48660214|NCT01421459|101951859|FG001|NOT COMPLETED|Overall Study||52||
48660215|NCT02595437|101951860|FG000|STARTED|Triferic Via IV||22||
48448843|NCT00566631|101434811|FG000|COMPLETED|Part 1: Core Treatment Phase||234||
48448844|NCT00566631|101434811|FG000|NOT COMPLETED|Part 1: Core Treatment Phase||60||
48448845|NCT00566631|101434811|FG000|STARTED|Between Treatment and Extension Phase||234||
48660216|NCT02595437|101951860|FG000|COMPLETED|Triferic Via IV||21||
48660217|NCT02595437|101951860|FG000|NOT COMPLETED|Triferic Via IV||1||
48660218|NCT02595437|101951860|FG000|STARTED|Triferic Via Hemodialysate||21||
48660219|NCT02595437|101951860|FG000|COMPLETED|Triferic Via Hemodialysate||21||
48660220|NCT02595437|101951860|FG000|NOT COMPLETED|Triferic Via Hemodialysate||0||
48369324|NCT02742649|101232750|FG000|STARTED|Pre-Randomization Washout Period||55||
48448846|NCT00566631|101434811|FG000|COMPLETED|Between Treatment and Extension Phase||139||
48448847|NCT00566631|101434811|FG000|NOT COMPLETED|Between Treatment and Extension Phase||95||
48448848|NCT00566631|101434811|FG000|STARTED|Part 2: Extension Phase||139||
48448849|NCT00566631|101434811|FG000|COMPLETED|Part 2: Extension Phase||57||
48448850|NCT00566631|101434811|FG000|NOT COMPLETED|Part 2: Extension Phase||82||
48448851|NCT01445873|101434812|FG000|STARTED|Overall Study||36||
48448852|NCT01445873|101434812|FG000|COMPLETED|Overall Study||36||
48448853|NCT01445873|101434812|FG000|NOT COMPLETED|Overall Study||0||
48448854|NCT02441179|101434813|FG000|STARTED|Overall Study||18||
48448855|NCT02441179|101434814|FG001|STARTED|Overall Study||17||
48448856|NCT02441179|101434813|FG000|COMPLETED|Overall Study||17||
48448857|NCT02441179|101434814|FG001|COMPLETED|Overall Study||16||
48448858|NCT02441179|101434813|FG000|NOT COMPLETED|Overall Study||1||
48448859|NCT02441179|101434814|FG001|NOT COMPLETED|Overall Study||1||
48448860|NCT03940586|101434815|FG000|STARTED|Overall Study||28|Randomized|
48448861|NCT03940586|101434816|FG001|STARTED|Overall Study||29|Randomized|
48448862|NCT03940586|101434817|FG002|STARTED|Overall Study||8|Randomized|
48448863|NCT03940586|101434815|FG000|Treated|Overall Study||28||
48448864|NCT03940586|101434816|FG001|Treated|Overall Study||27||
48448865|NCT03940586|101434817|FG002|Treated|Overall Study||8||
48448866|NCT03940586|101434815|FG000|COMPLETED|Overall Study||21|Through Week 48|
48448867|NCT03940586|101434816|FG001|COMPLETED|Overall Study||21|Through Week 48|
48448868|NCT03940586|101434817|FG002|COMPLETED|Overall Study||6|Through Week 48|
48448869|NCT03940586|101434815|FG000|NOT COMPLETED|Overall Study||7||
48448870|NCT03940586|101434816|FG001|NOT COMPLETED|Overall Study||8||
48448871|NCT03940586|101434817|FG002|NOT COMPLETED|Overall Study||2||
48448872|NCT03964220|101434818|FG000|STARTED|Overall Study||2619||
48448873|NCT03964220|101434819|FG001|STARTED|Overall Study||5238||
48448874|NCT03964220|101434818|FG000|COMPLETED|Overall Study||2619||
48448875|NCT03964220|101434819|FG001|COMPLETED|Overall Study||5238||
48448876|NCT03964220|101434818|FG000|NOT COMPLETED|Overall Study||0||
48448877|NCT03964220|101434819|FG001|NOT COMPLETED|Overall Study||0||
48448878|NCT01020773|101434820|FG000|STARTED|Overall Study||35||
48448879|NCT01020773|101434821|FG001|STARTED|Overall Study||32||
48448880|NCT01020773|101434820|FG000|COMPLETED|Overall Study||31||
48448881|NCT01020773|101434821|FG001|COMPLETED|Overall Study||29||
48448882|NCT01020773|101434820|FG000|NOT COMPLETED|Overall Study||4||
48448883|NCT01020773|101434821|FG001|NOT COMPLETED|Overall Study||3||
48448884|NCT02295280|101434822|FG000|STARTED|Overall Study||35||
48448885|NCT02295280|101434823|FG001|STARTED|Overall Study||35||
48448886|NCT02295280|101434822|FG000|COMPLETED|Overall Study||35||
48448887|NCT02295280|101434823|FG001|COMPLETED|Overall Study||34||
48660221|NCT01773889|101951861|FG000|STARTED|Overall Study||2||
48660222|NCT01773889|101951861|FG000|COMPLETED|Overall Study||0||
48660223|NCT01773889|101951861|FG000|NOT COMPLETED|Overall Study||2||
48448888|NCT02295280|101434822|FG000|NOT COMPLETED|Overall Study||0||
48448889|NCT02295280|101434823|FG001|NOT COMPLETED|Overall Study||1||
48448890|NCT01456000|101434824|FG000|STARTED|Overall Study||178||
48448891|NCT01456000|101434825|FG001|STARTED|Overall Study||175||
48448892|NCT01456000|101434824|FG000|COMPLETED|Overall Study||170||
48448893|NCT01456000|101434825|FG001|COMPLETED|Overall Study||172||
48448894|NCT01456000|101434824|FG000|NOT COMPLETED|Overall Study||8||
48448895|NCT01456000|101434825|FG001|NOT COMPLETED|Overall Study||3||
48448896|NCT02362594|101434826|FG000|STARTED|Overall Study||514||
48448897|NCT02362594|101434827|FG001|STARTED|Overall Study||505||
48448898|NCT02362594|101434826|FG000|Treated|Overall Study||509||
48448899|NCT02362594|101434827|FG001|Treated|Overall Study||502||
48448900|NCT02362594|101434826|FG000|Continuing Part 1 Adjuvant Therapy|Overall Study||41||
48448901|NCT02362594|101434827|FG001|Continuing Part 1 Adjuvant Therapy|Overall Study||21||
48448902|NCT02362594|101434826|FG000|COMPLETED|Overall Study||264|Completed Part 1 Adjuvant Therapy|
48448903|NCT02362594|101434827|FG001|COMPLETED|Overall Study||280|Completed Part 1 Adjuvant Therapy|
48448904|NCT02362594|101434826|FG000|NOT COMPLETED|Overall Study||250||
48448905|NCT02362594|101434827|FG001|NOT COMPLETED|Overall Study||225||
48448906|NCT00665626|101434828|FG000|STARTED|Overall Study||73||
48448907|NCT00665626|101434829|FG001|STARTED|Overall Study||146||
48448908|NCT00665626|101434828|FG000|COMPLETED|Overall Study||63||
48448909|NCT00665626|101434829|FG001|COMPLETED|Overall Study||124||
48448910|NCT00665626|101434828|FG000|NOT COMPLETED|Overall Study||10||
48448911|NCT00665626|101434829|FG001|NOT COMPLETED|Overall Study||22||
48448912|NCT02875067|101434830|FG000|STARTED|Overall Study||6||
48448913|NCT02875067|101434830|FG000|COMPLETED|Overall Study||0||
48448914|NCT02875067|101434830|FG000|NOT COMPLETED|Overall Study||6||
48660224|NCT00983801|101951862|FG000|STARTED|Overall Study||52||
48448915|NCT02135094|101434831|FG000|STARTED|Overall Study||25||
48448916|NCT02135094|101434832|FG001|STARTED|Overall Study||8||
48448917|NCT02135094|101434831|FG000|Week 2|Overall Study||25||
48448918|NCT02135094|101434832|FG001|Week 2|Overall Study||8||
48448919|NCT02135094|101434831|FG000|Week 3|Overall Study||25||
48448920|NCT02135094|101434832|FG001|Week 3|Overall Study||8||
48448921|NCT02135094|101434831|FG000|Week 4|Overall Study||25||
48448922|NCT02135094|101434832|FG001|Week 4|Overall Study||8||
48448923|NCT02135094|101434831|FG000|COMPLETED|Overall Study||25||
48448924|NCT02135094|101434832|FG001|COMPLETED|Overall Study||8||
48660225|NCT00983801|101951862|FG000|COMPLETED|Overall Study||52||
48660226|NCT00983801|101951862|FG000|NOT COMPLETED|Overall Study||0||
48771610|NCT03937570|102229486|FG001|STARTED|Overall Study||14||
48771611|NCT03937570|102229485|FG000|COMPLETED|Overall Study||13||
48771612|NCT03937570|102229486|FG001|COMPLETED|Overall Study||14||
48448925|NCT02135094|101434831|FG000|NOT COMPLETED|Overall Study||0||
48448926|NCT02135094|101434832|FG001|NOT COMPLETED|Overall Study||0||
48448927|NCT00886782|101434833|FG000|STARTED|Overall Study||3||
48448928|NCT00886782|101434834|FG001|STARTED|Overall Study||3||
48448929|NCT00886782|101434835|FG002|STARTED|Overall Study||5||
48448930|NCT00886782|101434833|FG000|COMPLETED|Overall Study||0||
48448931|NCT00886782|101434834|FG001|COMPLETED|Overall Study||0||
48448932|NCT00886782|101434835|FG002|COMPLETED|Overall Study||0||
48448933|NCT00886782|101434833|FG000|NOT COMPLETED|Overall Study||3||
48448934|NCT00886782|101434834|FG001|NOT COMPLETED|Overall Study||3||
48448935|NCT00886782|101434835|FG002|NOT COMPLETED|Overall Study||5||
48448936|NCT01890109|101434836|FG000|STARTED|Overall Study||52||
48448937|NCT01890109|101434837|FG001|STARTED|Overall Study||51||
48448938|NCT01890109|101434836|FG000|Received Study Treatment|Overall Study||52||
48448939|NCT01890109|101434837|FG001|Received Study Treatment|Overall Study||50||
48448940|NCT01890109|101434836|FG000|COMPLETED|Overall Study||51||
48448941|NCT01890109|101434837|FG001|COMPLETED|Overall Study||46||
48448942|NCT01890109|101434836|FG000|NOT COMPLETED|Overall Study||1||
48448943|NCT01890109|101434837|FG001|NOT COMPLETED|Overall Study||5||
48448944|NCT00857493|101434838|FG000|STARTED|Overall Study||62||
48448945|NCT00857493|101434839|FG001|STARTED|Overall Study||58||
48448946|NCT00857493|101434838|FG000|COMPLETED|Overall Study||59|active study phase|
48448947|NCT00857493|101434839|FG001|COMPLETED|Overall Study||58|active study phase|
48448948|NCT00857493|101434838|FG000|NOT COMPLETED|Overall Study||3||
48448949|NCT00857493|101434839|FG001|NOT COMPLETED|Overall Study||0||
48448950|NCT01542684|101434840|FG000|STARTED|Overall Study||8||
48448951|NCT01542684|101434840|FG000|COMPLETED|Overall Study||8||
48448952|NCT01542684|101434840|FG000|NOT COMPLETED|Overall Study||0||
48448953|NCT00448630|101434841|FG000|STARTED|Overall Study||328||
48448954|NCT00448630|101434841|FG000|COMPLETED|Overall Study||301||
48448955|NCT00448630|101434841|FG000|NOT COMPLETED|Overall Study||27||
48448956|NCT02432456|101434842|FG000|STARTED|Overall Study||75||
48448957|NCT02432456|101434843|FG001|STARTED|Overall Study||75||
48448958|NCT02432456|101434842|FG000|COMPLETED|Overall Study||75||
48448959|NCT02432456|101434843|FG001|COMPLETED|Overall Study||75||
48448960|NCT02432456|101434842|FG000|NOT COMPLETED|Overall Study||0||
48448961|NCT02432456|101434843|FG001|NOT COMPLETED|Overall Study||0||
48448962|NCT03547531|101434844|FG000|STARTED|Overall Study||62||
48448963|NCT03547531|101434845|FG001|STARTED|Overall Study||62||
48448964|NCT03547531|101434844|FG000|COMPLETED|Overall Study||60||
48448965|NCT03547531|101434845|FG001|COMPLETED|Overall Study||58||
48448966|NCT03547531|101434844|FG000|NOT COMPLETED|Overall Study||2||
48448967|NCT03547531|101434845|FG001|NOT COMPLETED|Overall Study||4||
48448968|NCT00438932|101434846|FG000|STARTED|Overall Study||4||
48448969|NCT00438932|101434847|FG001|STARTED|Overall Study||4||
48448970|NCT00438932|101434848|FG002|STARTED|Overall Study||4||
48448971|NCT00438932|101434849|FG003|STARTED|Overall Study||4||
48448972|NCT00438932|101434846|FG000|COMPLETED|Overall Study||4||
48448973|NCT00438932|101434847|FG001|COMPLETED|Overall Study||4||
48448974|NCT00438932|101434848|FG002|COMPLETED|Overall Study||4||
48448975|NCT00438932|101434849|FG003|COMPLETED|Overall Study||4||
48448976|NCT00438932|101434846|FG000|NOT COMPLETED|Overall Study||0||
48448977|NCT00438932|101434847|FG001|NOT COMPLETED|Overall Study||0||
48448978|NCT00438932|101434848|FG002|NOT COMPLETED|Overall Study||0||
48448979|NCT00438932|101434849|FG003|NOT COMPLETED|Overall Study||0||
48448980|NCT03118765|101434850|FG000|STARTED|Overall Study||30||
48660227|NCT01681849|101951863|FG000|STARTED|Overall Study||15||
48771613|NCT03937570|102229485|FG000|NOT COMPLETED|Overall Study||0||
48448981|NCT03118765|101434851|FG001|STARTED|Overall Study||32||
48448982|NCT03118765|101434852|FG002|STARTED|Overall Study||31||
48448983|NCT03118765|101434853|FG003|STARTED|Overall Study||32||
48448984|NCT03118765|101434854|FG004|STARTED|Overall Study||30||
48448985|NCT03118765|101434850|FG000|COMPLETED|Overall Study||26||
48448986|NCT03118765|101434851|FG001|COMPLETED|Overall Study||30||
48448987|NCT03118765|101434852|FG002|COMPLETED|Overall Study||26||
48448988|NCT03118765|101434853|FG003|COMPLETED|Overall Study||29||
48448989|NCT03118765|101434854|FG004|COMPLETED|Overall Study||28||
48448990|NCT03118765|101434850|FG000|NOT COMPLETED|Overall Study||4||
48448991|NCT03118765|101434851|FG001|NOT COMPLETED|Overall Study||2||
48660228|NCT01681849|101951864|FG001|STARTED|Overall Study||13||
48771614|NCT03937570|102229486|FG001|NOT COMPLETED|Overall Study||0||
48771615|NCT01397968|102229487|FG000|STARTED|Double-blind Period of Study YKP3089C013||113||
48771616|NCT01397968|102229488|FG001|STARTED|Double-blind Period of Study YKP3089C013||109||
48448992|NCT03118765|101434852|FG002|NOT COMPLETED|Overall Study||5||
48448993|NCT03118765|101434853|FG003|NOT COMPLETED|Overall Study||3||
48448994|NCT03118765|101434854|FG004|NOT COMPLETED|Overall Study||2||
48448995|NCT01392170|101434855|FG000|STARTED|Overall Study||2||
48448996|NCT01392170|101434855|FG000|COMPLETED|Overall Study||0||
48448997|NCT01392170|101434855|FG000|NOT COMPLETED|Overall Study||2||
48448998|NCT03959137|101434856|FG000|STARTED|Overall Study||215||
48448999|NCT03959137|101434856|FG000|COMPLETED|Overall Study||209||
48449000|NCT03959137|101434856|FG000|NOT COMPLETED|Overall Study||6||
48449001|NCT02476851|101434857|FG000|STARTED|Overall Study||31||
48449002|NCT02476851|101434858|FG001|STARTED|Overall Study||31||
48449003|NCT02476851|101434857|FG000|COMPLETED|Overall Study||30||
48449004|NCT02476851|101434858|FG001|COMPLETED|Overall Study||30||
48449005|NCT02476851|101434857|FG000|NOT COMPLETED|Overall Study||1||
48449006|NCT02476851|101434858|FG001|NOT COMPLETED|Overall Study||1||
48449007|NCT04974645|101434859|FG000|STARTED|Overall Study||10||
48449008|NCT04974645|101434860|FG001|STARTED|Overall Study||10||
48449009|NCT04974645|101434859|FG000|COMPLETED|Overall Study||10||
48449010|NCT04974645|101434860|FG001|COMPLETED|Overall Study||10||
48449011|NCT04974645|101434859|FG000|NOT COMPLETED|Overall Study||0||
48449012|NCT04974645|101434860|FG001|NOT COMPLETED|Overall Study||0||
48449013|NCT00829439|101434861|FG000|STARTED|Overall Study||3||
48449014|NCT00829439|101434862|FG001|STARTED|Overall Study||3||
48449015|NCT00829439|101434863|FG002|STARTED|Overall Study||6||
48449016|NCT00829439|101434864|FG003|STARTED|Overall Study||4||
48449017|NCT00829439|101434861|FG000|COMPLETED|Overall Study||3||
48449018|NCT00829439|101434862|FG001|COMPLETED|Overall Study||3||
48449019|NCT00829439|101434863|FG002|COMPLETED|Overall Study||5||
48449020|NCT00829439|101434864|FG003|COMPLETED|Overall Study||4||
48449021|NCT00829439|101434861|FG000|NOT COMPLETED|Overall Study||0||
48449022|NCT00829439|101434862|FG001|NOT COMPLETED|Overall Study||0||
48449023|NCT00829439|101434863|FG002|NOT COMPLETED|Overall Study||1||
48449024|NCT00829439|101434864|FG003|NOT COMPLETED|Overall Study||0||
48771617|NCT01397968|102229487|FG000|COMPLETED|Double-blind Period of Study YKP3089C013||102||
48771618|NCT01397968|102229488|FG001|COMPLETED|Double-blind Period of Study YKP3089C013||99||
48771619|NCT01397968|102229487|FG000|NOT COMPLETED|Double-blind Period of Study YKP3089C013||11||
48771620|NCT01397968|102229488|FG001|NOT COMPLETED|Double-blind Period of Study YKP3089C013||10||
48449025|NCT02862535|101434865|FG000|STARTED|Overall Study||9||
48449026|NCT02862535|101434866|FG001|STARTED|Overall Study||6||
48449027|NCT02862535|101434867|FG002|STARTED|Overall Study||10||
48449028|NCT02862535|101434868|FG003|STARTED|Overall Study||11||
48449029|NCT02862535|101434865|FG000|COMPLETED|Overall Study||0||
48449030|NCT02862535|101434866|FG001|COMPLETED|Overall Study||0||
48449031|NCT02862535|101434867|FG002|COMPLETED|Overall Study||0||
48449032|NCT02862535|101434868|FG003|COMPLETED|Overall Study||0||
48449033|NCT02862535|101434865|FG000|NOT COMPLETED|Overall Study||9||
48449034|NCT02862535|101434866|FG001|NOT COMPLETED|Overall Study||6||
48449035|NCT02862535|101434867|FG002|NOT COMPLETED|Overall Study||10||
48449036|NCT02862535|101434868|FG003|NOT COMPLETED|Overall Study||11||
48449037|NCT03791619|101434869|FG000|STARTED|Overall Study||260||
48449038|NCT03791619|101434870|FG001|STARTED|Overall Study||215||
48449039|NCT03791619|101434869|FG000|COMPLETED|Overall Study||256||
48449040|NCT03791619|101434870|FG001|COMPLETED|Overall Study||209||
48449041|NCT03791619|101434869|FG000|NOT COMPLETED|Overall Study||4||
48449042|NCT03791619|101434870|FG001|NOT COMPLETED|Overall Study||6||
48449043|NCT02011516|101434871|FG000|STARTED|Overall Study||8||
48449044|NCT02011516|101434872|FG001|STARTED|Overall Study||8||
48449045|NCT02011516|101434871|FG000|COMPLETED|Overall Study||4||
48449046|NCT02011516|101434872|FG001|COMPLETED|Overall Study||6||
48449047|NCT02011516|101434871|FG000|NOT COMPLETED|Overall Study||4||
48771621|NCT01397968|102229487|FG000|STARTED|Open-label Extension Study YKP3089C013||76|Not all subjects moved from double-blind to open-label extension.|
48771622|NCT01397968|102229488|FG001|STARTED|Open-label Extension Study YKP3089C013||73|Not all subjects moved from double-blind to open-label extension.|
48449048|NCT02011516|101434872|FG001|NOT COMPLETED|Overall Study||2||
48449049|NCT02613416|101434873|FG000|STARTED|Overall Study||30||
48449050|NCT02613416|101434873|FG000|COMPLETED|Overall Study||30||
48449051|NCT02613416|101434873|FG000|NOT COMPLETED|Overall Study||0||
48449052|NCT03840135|101434874|FG000|STARTED|Overall Study||86||
48449053|NCT03840135|101434875|FG001|STARTED|Overall Study||86||
48449054|NCT03840135|101434874|FG000|COMPLETED|Overall Study||79||
48449055|NCT03840135|101434875|FG001|COMPLETED|Overall Study||85||
48449056|NCT03840135|101434874|FG000|NOT COMPLETED|Overall Study||7||
48449057|NCT03840135|101434875|FG001|NOT COMPLETED|Overall Study||1||
48449058|NCT02176642|101434876|FG000|STARTED|Overall Study||18||
48449059|NCT02176642|101434877|FG001|STARTED|Overall Study||17||
48449060|NCT02176642|101434876|FG000|COMPLETED|Overall Study||18||
48449061|NCT02176642|101434877|FG001|COMPLETED|Overall Study||16||
48449062|NCT02176642|101434876|FG000|NOT COMPLETED|Overall Study||0||
48449063|NCT02176642|101434877|FG001|NOT COMPLETED|Overall Study||1||
48449064|NCT01174368|101434878|FG000|STARTED|Overall Study||1||
48449065|NCT01174368|101434878|FG000|COMPLETED|Overall Study||0||
48449066|NCT01174368|101434878|FG000|NOT COMPLETED|Overall Study||1||
48449067|NCT04088734|101434879|FG000|STARTED|Overall Study||5||
48449068|NCT04088734|101434879|FG000|COMPLETED|Overall Study||0||
48449069|NCT04088734|101434879|FG000|NOT COMPLETED|Overall Study||5||
48449070|NCT01678924|101434880|FG000|STARTED|Overall Study||64||
48449071|NCT01678924|101434881|FG001|STARTED|Overall Study||63||
48449072|NCT01678924|101434882|FG002|STARTED|Overall Study||30||
48449073|NCT01678924|101434883|FG003|STARTED|Overall Study||123||
48449074|NCT01678924|101434880|FG000|COMPLETED|Overall Study||54||
48449075|NCT01678924|101434881|FG001|COMPLETED|Overall Study||51||
48449076|NCT01678924|101434882|FG002|COMPLETED|Overall Study||28||
48449077|NCT01678924|101434883|FG003|COMPLETED|Overall Study||105||
48449078|NCT01678924|101434880|FG000|NOT COMPLETED|Overall Study||10||
48449079|NCT01678924|101434881|FG001|NOT COMPLETED|Overall Study||12||
48449080|NCT01678924|101434882|FG002|NOT COMPLETED|Overall Study||2||
48449081|NCT01678924|101434883|FG003|NOT COMPLETED|Overall Study||18||
48449082|NCT03608696|101434884|FG000|STARTED|Overall Study||10||
48449083|NCT03608696|101434884|FG000|COMPLETED|Overall Study||10||
48449084|NCT03608696|101434884|FG000|NOT COMPLETED|Overall Study||0||
48449085|NCT04288115|101434885|FG000|STARTED|Overall Study||24||
48449086|NCT04288115|101434886|FG001|STARTED|Overall Study||26||
48449087|NCT04288115|101434885|FG000|COMPLETED|Overall Study||21||
48449088|NCT04288115|101434886|FG001|COMPLETED|Overall Study||23||
48449089|NCT04288115|101434885|FG000|NOT COMPLETED|Overall Study||3||
48449090|NCT04288115|101434886|FG001|NOT COMPLETED|Overall Study||3||
48449091|NCT00479401|101434887|FG000|STARTED|Overall Study||223||
48449092|NCT00479401|101434888|FG001|STARTED|Overall Study||213||
48449093|NCT00479401|101434889|FG002|STARTED|Overall Study||103||
48449094|NCT00479401|101434887|FG000|COMPLETED|Overall Study||174||
48449095|NCT00479401|101434888|FG001|COMPLETED|Overall Study||176||
48449096|NCT00479401|101434889|FG002|COMPLETED|Overall Study||91||
48449097|NCT00479401|101434887|FG000|NOT COMPLETED|Overall Study||49||
48449098|NCT00479401|101434888|FG001|NOT COMPLETED|Overall Study||37||
48449099|NCT00479401|101434889|FG002|NOT COMPLETED|Overall Study||12||
48449100|NCT02953262|101434890|FG000|STARTED|Overall Study||68||
48449101|NCT02953262|101434891|FG001|STARTED|Overall Study||69||
48449102|NCT02953262|101434892|FG002|STARTED|Overall Study||68||
48449103|NCT02953262|101434893|FG003|STARTED|Overall Study||70||
48449104|NCT02953262|101434890|FG000|COMPLETED|Overall Study||65||
48449105|NCT02953262|101434891|FG001|COMPLETED|Overall Study||63||
48449106|NCT02953262|101434892|FG002|COMPLETED|Overall Study||65||
48449107|NCT02953262|101434893|FG003|COMPLETED|Overall Study||67||
48449108|NCT02953262|101434890|FG000|NOT COMPLETED|Overall Study||3||
48449109|NCT02953262|101434891|FG001|NOT COMPLETED|Overall Study||6||
48449110|NCT02953262|101434892|FG002|NOT COMPLETED|Overall Study||3||
48449111|NCT02953262|101434893|FG003|NOT COMPLETED|Overall Study||3||
48449112|NCT00725725|101434894|FG000|STARTED|Overall Study||14||
48449113|NCT00725725|101434895|FG001|STARTED|Overall Study||15||
48449114|NCT00725725|101434896|FG002|STARTED|Overall Study||17||
48449115|NCT00725725|101434894|FG000|Treated|Overall Study||11||
48449116|NCT00725725|101434895|FG001|Treated|Overall Study||15||
48449117|NCT00725725|101434896|FG002|Treated|Overall Study||14||
48449118|NCT00725725|101434894|FG000|COMPLETED|Overall Study||10||
48189121|NCT00708097|100786151|FG002|NOT COMPLETED|Period 4||0||
48449119|NCT00725725|101434895|FG001|COMPLETED|Overall Study||11||
48449120|NCT00725725|101434896|FG002|COMPLETED|Overall Study||12||
48660229|NCT01681849|101951865|FG002|STARTED|Overall Study||56||
48660230|NCT01681849|101951863|FG000|COMPLETED|Overall Study||7||
48660231|NCT01681849|101951864|FG001|COMPLETED|Overall Study||6||
48660232|NCT01681849|101951865|FG002|COMPLETED|Overall Study||17||
48449121|NCT00725725|101434894|FG000|NOT COMPLETED|Overall Study||4||
48449122|NCT00725725|101434895|FG001|NOT COMPLETED|Overall Study||4||
48449123|NCT00725725|101434896|FG002|NOT COMPLETED|Overall Study||5||
48449124|NCT02523274|101434897|FG000|STARTED|Overall Study||20||
48449125|NCT02523274|101434898|FG001|STARTED|Overall Study||20||
48449126|NCT02523274|101434899|FG002|STARTED|Overall Study||20||
48449127|NCT02523274|101434897|FG000|COMPLETED|Overall Study||19||
48449128|NCT02523274|101434898|FG001|COMPLETED|Overall Study||18||
48449129|NCT02523274|101434899|FG002|COMPLETED|Overall Study||18||
48449130|NCT02523274|101434897|FG000|NOT COMPLETED|Overall Study||1||
48449131|NCT02523274|101434898|FG001|NOT COMPLETED|Overall Study||2||
48449132|NCT02523274|101434899|FG002|NOT COMPLETED|Overall Study||2||
48449133|NCT02030834|101434900|FG000|STARTED|Overall Study||50||
48660233|NCT01681849|101951863|FG000|NOT COMPLETED|Overall Study||8||
48449134|NCT02030834|101434901|FG001|STARTED|Overall Study||3||
48449135|NCT02030834|101434902|FG002|STARTED|Overall Study||10||
48449136|NCT02030834|101434900|FG000|COMPLETED|Overall Study||39||
48449137|NCT02030834|101434901|FG001|COMPLETED|Overall Study||3||
48449138|NCT02030834|101434902|FG002|COMPLETED|Overall Study||7||
48449139|NCT02030834|101434900|FG000|NOT COMPLETED|Overall Study||11||
48660234|NCT01681849|101951864|FG001|NOT COMPLETED|Overall Study||7||
48449140|NCT02030834|101434901|FG001|NOT COMPLETED|Overall Study||0||
48449141|NCT02030834|101434902|FG002|NOT COMPLETED|Overall Study||3||
48449142|NCT00091507|101434903|FG000|STARTED|Overall Study||432||
48449143|NCT00091507|101434904|FG001|STARTED|Overall Study||479||
48449144|NCT00091507|101434903|FG000|COMPLETED|Overall Study||411||
48449145|NCT00091507|101434904|FG001|COMPLETED|Overall Study||460||
48449146|NCT00091507|101434903|FG000|NOT COMPLETED|Overall Study||21||
48449147|NCT00091507|101434904|FG001|NOT COMPLETED|Overall Study||19||
48449148|NCT00103259|101434905|FG000|STARTED|Overall Study||27||
48449149|NCT00103259|101434906|FG001|STARTED|Overall Study||44||
48449150|NCT00103259|101434905|FG000|Eligible|Overall Study||27||
48449151|NCT00103259|101434906|FG001|Eligible|Overall Study||41||
48449152|NCT00103259|101434905|FG000|Treated|Overall Study||23||
48449153|NCT00103259|101434906|FG001|Treated|Overall Study||41||
48449154|NCT00103259|101434905|FG000|Eligible and Treated|Overall Study||23||
48449155|NCT00103259|101434906|FG001|Eligible and Treated|Overall Study||38||
48449156|NCT00103259|101434905|FG000|Cross Over to the Other Arm|Overall Study||0||
48449157|NCT00103259|101434906|FG001|Cross Over to the Other Arm|Overall Study||11||
48449158|NCT00103259|101434905|FG000|Eligible Patients Who Cross Over|Overall Study||0||
48449159|NCT00103259|101434906|FG001|Eligible Patients Who Cross Over|Overall Study||10||
48449160|NCT00103259|101434905|FG000|COMPLETED|Overall Study||15||
48449161|NCT00103259|101434906|FG001|COMPLETED|Overall Study||32||
48449162|NCT00103259|101434905|FG000|NOT COMPLETED|Overall Study||12||
48449163|NCT00103259|101434906|FG001|NOT COMPLETED|Overall Study||12||
48449164|NCT04098068|101434907|FG000|STARTED|Overall Study||12||
48449165|NCT04098068|101434907|FG000|COMPLETED|Overall Study||2||
48449166|NCT04098068|101434907|FG000|NOT COMPLETED|Overall Study||10||
48449167|NCT03078192|101434908|FG000|STARTED|Overall Study||30||
48449168|NCT03078192|101434909|FG001|STARTED|Overall Study||32||
48449169|NCT03078192|101434908|FG000|COMPLETED|Overall Study||28||
48449170|NCT03078192|101434909|FG001|COMPLETED|Overall Study||28||
48449171|NCT03078192|101434908|FG000|NOT COMPLETED|Overall Study||2||
48449172|NCT03078192|101434909|FG001|NOT COMPLETED|Overall Study||4||
48449173|NCT02623426|101434910|FG000|STARTED|Overall Study||65||77
48449174|NCT02623426|101434911|FG001|STARTED|Overall Study||65||79
48449175|NCT02623426|101434912|FG002|STARTED|Overall Study||64||69
48449176|NCT02623426|101434910|FG000|4 Week Visit|Overall Study||65||77
48449177|NCT02623426|101434911|FG001|4 Week Visit|Overall Study||64||78
48449178|NCT02623426|101434912|FG002|4 Week Visit|Overall Study||63||68
48449179|NCT02623426|101434910|FG000|8 Week Visit|Overall Study||65||77
48449180|NCT02623426|101434911|FG001|8 Week Visit|Overall Study||64||78
48449181|NCT02623426|101434912|FG002|8 Week Visit|Overall Study||61||66
48449182|NCT02623426|101434910|FG000|COMPLETED|Overall Study||64|12 week visit|76
48449183|NCT02623426|101434911|FG001|COMPLETED|Overall Study||63|12 week visit|77
48449184|NCT02623426|101434912|FG002|COMPLETED|Overall Study||61|12 week visit|66
48449185|NCT02623426|101434910|FG000|NOT COMPLETED|Overall Study||1||1
48449186|NCT02623426|101434911|FG001|NOT COMPLETED|Overall Study||2||2
48449187|NCT02623426|101434912|FG002|NOT COMPLETED|Overall Study||3||3
48660235|NCT01681849|101951865|FG002|NOT COMPLETED|Overall Study||39||
48449188|NCT01585831|101434913|FG000|STARTED|Overall Study||28||
48449189|NCT01585831|101434914|FG001|STARTED|Overall Study||20||
48449190|NCT01585831|101434913|FG000|COMPLETED|Overall Study||26||
48449191|NCT01585831|101434914|FG001|COMPLETED|Overall Study||18||
48449192|NCT01585831|101434913|FG000|NOT COMPLETED|Overall Study||2||
48449193|NCT01585831|101434914|FG001|NOT COMPLETED|Overall Study||2||
48449194|NCT03304210|101434915|FG000|STARTED|Overall Study||2||
48449195|NCT03304210|101434916|FG001|STARTED|Overall Study||2||
48449196|NCT03304210|101434917|FG002|STARTED|Overall Study||3||
48449197|NCT03304210|101434918|FG003|STARTED|Overall Study||3||
48449198|NCT03304210|101434919|FG004|STARTED|Overall Study||10||
48449199|NCT03304210|101434915|FG000|COMPLETED|Overall Study||2||
48449200|NCT03304210|101434916|FG001|COMPLETED|Overall Study||2||
48449201|NCT03304210|101434917|FG002|COMPLETED|Overall Study||3||
48449202|NCT03304210|101434918|FG003|COMPLETED|Overall Study||3||
48449203|NCT03304210|101434919|FG004|COMPLETED|Overall Study||10||
48449204|NCT03304210|101434915|FG000|NOT COMPLETED|Overall Study||0||
48449205|NCT03304210|101434916|FG001|NOT COMPLETED|Overall Study||0||
48660236|NCT03607500|101951866|FG000|STARTED|Overall Study||1||
48449206|NCT03304210|101434917|FG002|NOT COMPLETED|Overall Study||0||
48449207|NCT03304210|101434918|FG003|NOT COMPLETED|Overall Study||0||
48449208|NCT03304210|101434919|FG004|NOT COMPLETED|Overall Study||0||
48660237|NCT03607500|101951867|FG001|STARTED|Overall Study||0||
48660238|NCT03607500|101951866|FG000|COMPLETED|Overall Study||1||
48660239|NCT03607500|101951867|FG001|COMPLETED|Overall Study||0||
48449209|NCT01117090|101434920|FG000|STARTED|Overall Study||47||
48449210|NCT01117090|101434920|FG000|COMPLETED|Overall Study||47||
48449211|NCT01117090|101434920|FG000|NOT COMPLETED|Overall Study||0||
48449212|NCT03092089|101434921|FG000|STARTED|Overall Study||15||
48449213|NCT03092089|101434921|FG000|COMPLETED|Overall Study||15||
48449214|NCT03092089|101434921|FG000|NOT COMPLETED|Overall Study||0||
48449215|NCT01083901|101434922|FG000|STARTED|Overall Study||13||
48449216|NCT01083901|101434923|FG001|STARTED|Overall Study||8||
48449217|NCT01083901|101434924|FG002|STARTED|Overall Study||13||
48660240|NCT03607500|101951866|FG000|NOT COMPLETED|Overall Study||0||
48449218|NCT01083901|101434922|FG000|COMPLETED|Overall Study||12||
48449219|NCT01083901|101434923|FG001|COMPLETED|Overall Study||6||
48449220|NCT01083901|101434924|FG002|COMPLETED|Overall Study||11||
48449221|NCT01083901|101434922|FG000|NOT COMPLETED|Overall Study||1||
48449222|NCT01083901|101434923|FG001|NOT COMPLETED|Overall Study||2||
48449223|NCT01083901|101434924|FG002|NOT COMPLETED|Overall Study||2||
48449224|NCT02354352|101434925|FG000|STARTED|Overall Study||26||
48449225|NCT02354352|101434926|FG001|STARTED|Overall Study||26||
48449226|NCT02354352|101434925|FG000|2 Weeks|Overall Study||26||
48449227|NCT02354352|101434926|FG001|2 Weeks|Overall Study||25||
48449228|NCT02354352|101434925|FG000|1 Month|Overall Study||24||
48449229|NCT02354352|101434926|FG001|1 Month|Overall Study||23||
48449230|NCT02354352|101434925|FG000|2 Months|Overall Study||24||
48449231|NCT02354352|101434926|FG001|2 Months|Overall Study||22||
48449232|NCT02354352|101434925|FG000|3 Months|Overall Study||25||
48449233|NCT02354352|101434926|FG001|3 Months|Overall Study||23||
48449234|NCT02354352|101434925|FG000|6 Months|Overall Study||25||
48449235|NCT02354352|101434926|FG001|6 Months|Overall Study||23||
48449236|NCT02354352|101434925|FG000|9 Months|Overall Study||25||
48449237|NCT02354352|101434926|FG001|9 Months|Overall Study||23||
48449238|NCT02354352|101434925|FG000|COMPLETED|Overall Study||23||
48449239|NCT02354352|101434926|FG001|COMPLETED|Overall Study||23||
48449240|NCT02354352|101434925|FG000|NOT COMPLETED|Overall Study||3||
48449241|NCT02354352|101434926|FG001|NOT COMPLETED|Overall Study||3||
48449242|NCT02535247|101434927|FG000|STARTED|Overall Study||17||
48449243|NCT02535247|101434928|FG001|STARTED|Overall Study||0||
48449244|NCT02535247|101434927|FG000|COMPLETED|Overall Study||13||
48449245|NCT02535247|101434928|FG001|COMPLETED|Overall Study||0||
48449246|NCT02535247|101434927|FG000|NOT COMPLETED|Overall Study||4||
48449247|NCT02535247|101434928|FG001|NOT COMPLETED|Overall Study||0||
48449248|NCT02602080|101434929|FG000|STARTED|Overall Study||21||
48449249|NCT02602080|101434930|FG001|STARTED|Overall Study||16||
48449250|NCT02602080|101434931|FG002|STARTED|Overall Study||18||
48449251|NCT02602080|101434929|FG000|COMPLETED|Overall Study||15||
48449252|NCT02602080|101434930|FG001|COMPLETED|Overall Study||15||
48449253|NCT02602080|101434931|FG002|COMPLETED|Overall Study||15||
48449254|NCT02602080|101434929|FG000|NOT COMPLETED|Overall Study||6||
48449255|NCT02602080|101434930|FG001|NOT COMPLETED|Overall Study||1||
48449256|NCT02602080|101434931|FG002|NOT COMPLETED|Overall Study||3||
48449257|NCT03216954|101434932|FG000|STARTED|Overall Study||4||
48449258|NCT03216954|101434933|FG001|STARTED|Overall Study||3||
48449259|NCT03216954|101434934|FG002|STARTED|Overall Study||3||
48449260|NCT03216954|101434935|FG003|STARTED|Overall Study||3||
48449261|NCT03216954|101434936|FG004|STARTED|Overall Study||1||
48449262|NCT03216954|101434932|FG000|COMPLETED|Overall Study||2||
48449263|NCT03216954|101434933|FG001|COMPLETED|Overall Study||2||
48449264|NCT03216954|101434934|FG002|COMPLETED|Overall Study||2||
48449265|NCT03216954|101434935|FG003|COMPLETED|Overall Study||3||
48449266|NCT03216954|101434936|FG004|COMPLETED|Overall Study||0||
48449267|NCT03216954|101434932|FG000|NOT COMPLETED|Overall Study||2||
48449268|NCT03216954|101434933|FG001|NOT COMPLETED|Overall Study||1||
48449269|NCT03216954|101434934|FG002|NOT COMPLETED|Overall Study||1||
48449270|NCT03216954|101434935|FG003|NOT COMPLETED|Overall Study||0||
48449271|NCT03216954|101434936|FG004|NOT COMPLETED|Overall Study||1||
48449272|NCT04628221|101434937|FG000|STARTED|Overall Study||40||
48771623|NCT01397968|102229487|FG000|COMPLETED|Open-label Extension Study YKP3089C013||40||
48449273|NCT04628221|101434937|FG000|COMPLETED|Overall Study||40||
48449274|NCT04628221|101434937|FG000|NOT COMPLETED|Overall Study||0||
48449275|NCT01896700|101434938|FG000|STARTED|Overall Study||12||
48449276|NCT01896700|101434939|FG001|STARTED|Overall Study||12||
48449277|NCT01896700|101434938|FG000|COMPLETED|Overall Study||8||
48449278|NCT01896700|101434939|FG001|COMPLETED|Overall Study||6||
48449279|NCT01896700|101434938|FG000|NOT COMPLETED|Overall Study||4||
48449280|NCT01896700|101434939|FG001|NOT COMPLETED|Overall Study||6||
48449281|NCT03361917|101434940|FG000|STARTED|Overall Study||99||
48449282|NCT03361917|101434941|FG001|STARTED|Overall Study||101||
48449283|NCT03361917|101434940|FG000|COMPLETED|Overall Study||99||
48449284|NCT03361917|101434941|FG001|COMPLETED|Overall Study||101||
48449285|NCT03361917|101434940|FG000|NOT COMPLETED|Overall Study||0||
48449286|NCT03361917|101434941|FG001|NOT COMPLETED|Overall Study||0||
48449287|NCT01185639|101434942|FG000|STARTED|Overall Study||29||
48449288|NCT01185639|101434942|FG000|COMPLETED|Overall Study||27||
48449289|NCT01185639|101434942|FG000|NOT COMPLETED|Overall Study||2||
48449290|NCT00614458|101434943|FG000|STARTED|Overall Study||6||
48449291|NCT00614458|101434943|FG000|COMPLETED|Overall Study||6||
48449292|NCT00614458|101434943|FG000|NOT COMPLETED|Overall Study||0||
48449293|NCT03958071|101434944|FG000|STARTED|Overall Study||347||
48449294|NCT03958071|101434945|FG001|STARTED|Overall Study||423||
48449295|NCT03958071|101434946|FG002|STARTED|Overall Study||12494||
48449296|NCT03958071|101434944|FG000|COMPLETED|Overall Study||347||
48771624|NCT01397968|102229488|FG001|COMPLETED|Open-label Extension Study YKP3089C013||37||
48449297|NCT03958071|101434945|FG001|COMPLETED|Overall Study||423||
48449298|NCT03958071|101434946|FG002|COMPLETED|Overall Study||12494||
48449299|NCT03958071|101434944|FG000|NOT COMPLETED|Overall Study||0||
48449300|NCT03958071|101434945|FG001|NOT COMPLETED|Overall Study||0||
48449301|NCT03958071|101434946|FG002|NOT COMPLETED|Overall Study||0||
48449302|NCT02038959|101434947|FG000|STARTED|Overall Study||98||
48449303|NCT02038959|101434948|FG001|STARTED|Overall Study||97||
48449304|NCT02038959|101434947|FG000|COMPLETED|Overall Study||92||
48449305|NCT02038959|101434948|FG001|COMPLETED|Overall Study||89||
48449306|NCT02038959|101434947|FG000|NOT COMPLETED|Overall Study||6||
48449307|NCT02038959|101434948|FG001|NOT COMPLETED|Overall Study||8||
48449308|NCT02006407|101434949|FG000|STARTED|Overall Study||5||
48449309|NCT02006407|101434949|FG000|COMPLETED|Overall Study||5||
48449310|NCT02006407|101434949|FG000|NOT COMPLETED|Overall Study||0||
48449311|NCT00176501|101434950|FG000|STARTED|Overall Study||3||
48449312|NCT00176501|101434950|FG000|COMPLETED|Overall Study||3||
48449313|NCT00176501|101434950|FG000|NOT COMPLETED|Overall Study||0||
48449314|NCT03467971|101434951|FG000|STARTED|Treatment Period 1||10||
48449315|NCT03467971|101434952|FG001|STARTED|Treatment Period 1||11||
48449316|NCT03467971|101434951|FG000|COMPLETED|Treatment Period 1||10||
48449317|NCT03467971|101434952|FG001|COMPLETED|Treatment Period 1||11||
48449318|NCT03467971|101434951|FG000|NOT COMPLETED|Treatment Period 1||0||
48449319|NCT03467971|101434952|FG001|NOT COMPLETED|Treatment Period 1||0||
48449320|NCT03467971|101434951|FG000|STARTED|Treatment Period 2||10||
48449321|NCT03467971|101434952|FG001|STARTED|Treatment Period 2||11||
48449322|NCT03467971|101434951|FG000|COMPLETED|Treatment Period 2||10||
48449323|NCT03467971|101434952|FG001|COMPLETED|Treatment Period 2||10||
48449324|NCT03467971|101434951|FG000|NOT COMPLETED|Treatment Period 2||0||
48449325|NCT03467971|101434952|FG001|NOT COMPLETED|Treatment Period 2||1||
48449326|NCT00827073|101434953|FG000|STARTED|Overall Study||20||
48449327|NCT00827073|101434954|FG001|STARTED|Overall Study||20||
48449328|NCT00827073|101434953|FG000|COMPLETED|Overall Study||20||
48449329|NCT00827073|101434954|FG001|COMPLETED|Overall Study||20||
48449330|NCT00827073|101434953|FG000|NOT COMPLETED|Overall Study||0||
48449331|NCT00827073|101434954|FG001|NOT COMPLETED|Overall Study||0||
48449332|NCT01733186|101434955|FG000|STARTED|Overall Study||6||
48449333|NCT01733186|101434956|FG001|STARTED|Overall Study||6||
48449334|NCT01733186|101434955|FG000|COMPLETED|Overall Study||6||
48449335|NCT01733186|101434956|FG001|COMPLETED|Overall Study||6||
48449336|NCT01733186|101434955|FG000|NOT COMPLETED|Overall Study||0||
48449337|NCT01733186|101434956|FG001|NOT COMPLETED|Overall Study||0||
48449338|NCT03797222|101434957|FG000|STARTED|Overall Study||14||
48449339|NCT03797222|101434957|FG000|COMPLETED|Overall Study||13||
48449340|NCT03797222|101434957|FG000|NOT COMPLETED|Overall Study||1||
48449341|NCT02643394|101434958|FG000|STARTED|Overall Study||55||
48449342|NCT02643394|101434959|FG001|STARTED|Overall Study||55||
48449343|NCT02643394|101434958|FG000|COMPLETED|Overall Study||51||
48449344|NCT02643394|101434959|FG001|COMPLETED|Overall Study||50||
48449345|NCT02643394|101434958|FG000|NOT COMPLETED|Overall Study||4||
48449346|NCT02643394|101434959|FG001|NOT COMPLETED|Overall Study||5||
48449347|NCT00563524|101434960|FG000|STARTED|Overall Study||13||
48449348|NCT00563524|101434961|FG001|STARTED|Overall Study||12||
48449349|NCT00563524|101434962|FG002|STARTED|Overall Study||13||
48449350|NCT00563524|101434963|FG003|STARTED|Overall Study||12||
48449351|NCT00563524|101434964|FG004|STARTED|Overall Study||13||
48449352|NCT00563524|101434965|FG005|STARTED|Overall Study||13||
48449353|NCT00563524|101434960|FG000|COMPLETED|Overall Study||11||
48449354|NCT00563524|101434961|FG001|COMPLETED|Overall Study||9||
48449355|NCT00563524|101434962|FG002|COMPLETED|Overall Study||10||
48771625|NCT01397968|102229487|FG000|NOT COMPLETED|Open-label Extension Study YKP3089C013||36||
48771626|NCT01397968|102229488|FG001|NOT COMPLETED|Open-label Extension Study YKP3089C013||36||
48771627|NCT01746901|102229489|FG000|STARTED|Naloxone Challenge Phase||75||
48771628|NCT01746901|102229490|FG001|STARTED|Naloxone Challenge Phase||0||
48771629|NCT01746901|102229491|FG002|STARTED|Naloxone Challenge Phase||0||
48771630|NCT01746901|102229492|FG003|STARTED|Naloxone Challenge Phase||0||
48771631|NCT01746901|102229493|FG004|STARTED|Naloxone Challenge Phase||0||
48771632|NCT01746901|102229494|FG005|STARTED|Naloxone Challenge Phase||0||
48771633|NCT01746901|102229495|FG006|STARTED|Naloxone Challenge Phase||0||
48449356|NCT00563524|101434963|FG003|COMPLETED|Overall Study||12||
48449357|NCT00563524|101434964|FG004|COMPLETED|Overall Study||11||
48449358|NCT00563524|101434965|FG005|COMPLETED|Overall Study||12||
48449359|NCT00563524|101434960|FG000|NOT COMPLETED|Overall Study||2||
48449360|NCT00563524|101434961|FG001|NOT COMPLETED|Overall Study||3||
48449361|NCT00563524|101434962|FG002|NOT COMPLETED|Overall Study||3||
48449362|NCT00563524|101434963|FG003|NOT COMPLETED|Overall Study||0||
48449363|NCT00563524|101434964|FG004|NOT COMPLETED|Overall Study||2||
48449364|NCT00563524|101434965|FG005|NOT COMPLETED|Overall Study||1||
48449365|NCT00627458|101434966|FG000|STARTED|Overall Study||127||
48449366|NCT00627458|101434967|FG001|STARTED|Overall Study||137||
48449367|NCT00627458|101434968|FG002|STARTED|Overall Study||139||
48449368|NCT00627458|101434966|FG000|COMPLETED|Overall Study||123||
48449369|NCT00627458|101434967|FG001|COMPLETED|Overall Study||130||
48449370|NCT00627458|101434968|FG002|COMPLETED|Overall Study||133||
48449371|NCT00627458|101434966|FG000|NOT COMPLETED|Overall Study||4||
48449372|NCT00627458|101434967|FG001|NOT COMPLETED|Overall Study||7||
48449373|NCT00627458|101434968|FG002|NOT COMPLETED|Overall Study||6||
48449374|NCT01766310|101434969|FG000|STARTED|Overall Study||24||
48449375|NCT01766310|101434970|FG001|STARTED|Overall Study||26||
48449376|NCT01766310|101434969|FG000|COMPLETED|Overall Study||23||
48449377|NCT01766310|101434970|FG001|COMPLETED|Overall Study||23||
48449378|NCT01766310|101434969|FG000|NOT COMPLETED|Overall Study||1||
48449379|NCT01766310|101434970|FG001|NOT COMPLETED|Overall Study||3||
48449380|NCT00176852|101434971|FG000|STARTED|Overall Study||3||
48449381|NCT00176852|101434972|FG001|STARTED|Overall Study||5||
48449382|NCT00176852|101434973|FG002|STARTED|Overall Study||14||
48449383|NCT00176852|101434971|FG000|COMPLETED|Overall Study||3||
48449384|NCT00176852|101434972|FG001|COMPLETED|Overall Study||5||
48449385|NCT00176852|101434973|FG002|COMPLETED|Overall Study||14||
48449386|NCT00176852|101434971|FG000|NOT COMPLETED|Overall Study||0||
48771634|NCT01746901|102229496|FG007|STARTED|Naloxone Challenge Phase||0||
48771635|NCT01746901|102229497|FG008|STARTED|Naloxone Challenge Phase||0||
48771636|NCT01746901|102229489|FG000|COMPLETED|Naloxone Challenge Phase||72||
48771637|NCT01746901|102229490|FG001|COMPLETED|Naloxone Challenge Phase||0||
48771638|NCT01746901|102229491|FG002|COMPLETED|Naloxone Challenge Phase||0||
48771639|NCT01746901|102229492|FG003|COMPLETED|Naloxone Challenge Phase||0||
48449387|NCT00176852|101434972|FG001|NOT COMPLETED|Overall Study||0||
48449388|NCT00176852|101434973|FG002|NOT COMPLETED|Overall Study||0||
48449389|NCT00127192|101434974|FG000|STARTED|Overall Study||80||
48449390|NCT00127192|101434975|FG001|STARTED|Overall Study||72||
48449391|NCT00127192|101434976|FG002|STARTED|Overall Study||70||
48449392|NCT00127192|101434977|FG003|STARTED|Overall Study||68||
48449393|NCT00127192|101434978|FG004|STARTED|Overall Study||73||
48449394|NCT00127192|101434974|FG000|COMPLETED|Overall Study||77||
48449395|NCT00127192|101434975|FG001|COMPLETED|Overall Study||71||
48449396|NCT00127192|101434976|FG002|COMPLETED|Overall Study||68||
48449397|NCT00127192|101434977|FG003|COMPLETED|Overall Study||67||
48449398|NCT00127192|101434978|FG004|COMPLETED|Overall Study||68||
48449399|NCT00127192|101434974|FG000|NOT COMPLETED|Overall Study||3||
48449400|NCT00127192|101434975|FG001|NOT COMPLETED|Overall Study||1||
48449401|NCT00127192|101434976|FG002|NOT COMPLETED|Overall Study||2||
48449402|NCT00127192|101434977|FG003|NOT COMPLETED|Overall Study||1||
48449403|NCT00127192|101434978|FG004|NOT COMPLETED|Overall Study||5||
48449404|NCT02248285|101434979|FG000|STARTED|Overall Study||687||
48449405|NCT02248285|101434980|FG001|STARTED|Overall Study||858||
48449406|NCT02248285|101434979|FG000|COMPLETED|Overall Study||586||
48449407|NCT02248285|101434980|FG001|COMPLETED|Overall Study||571||
48449408|NCT02248285|101434979|FG000|NOT COMPLETED|Overall Study||101||
48449409|NCT02248285|101434980|FG001|NOT COMPLETED|Overall Study||287||
48449410|NCT02156466|101434981|FG000|STARTED|Overall Study||8||
48449411|NCT02156466|101434982|FG001|STARTED|Overall Study||8||
48449412|NCT02156466|101434983|FG002|STARTED|Overall Study||8||
48449413|NCT02156466|101434984|FG003|STARTED|Overall Study||9||
48449414|NCT02156466|101434985|FG004|STARTED|Overall Study||8||
48449415|NCT02156466|101434981|FG000|COMPLETED|Overall Study||8||
48449416|NCT02156466|101434982|FG001|COMPLETED|Overall Study||8||
48449417|NCT02156466|101434983|FG002|COMPLETED|Overall Study||7||
48771640|NCT01746901|102229493|FG004|COMPLETED|Naloxone Challenge Phase||0||
48771641|NCT01746901|102229494|FG005|COMPLETED|Naloxone Challenge Phase||0||
48771642|NCT01746901|102229495|FG006|COMPLETED|Naloxone Challenge Phase||0||
48771643|NCT01746901|102229496|FG007|COMPLETED|Naloxone Challenge Phase||0||
48771644|NCT01746901|102229497|FG008|COMPLETED|Naloxone Challenge Phase||0||
48771645|NCT01746901|102229489|FG000|NOT COMPLETED|Naloxone Challenge Phase||3||
48771646|NCT01746901|102229490|FG001|NOT COMPLETED|Naloxone Challenge Phase||0||
48771647|NCT01746901|102229491|FG002|NOT COMPLETED|Naloxone Challenge Phase||0||
48771648|NCT01746901|102229492|FG003|NOT COMPLETED|Naloxone Challenge Phase||0||
48771649|NCT01746901|102229493|FG004|NOT COMPLETED|Naloxone Challenge Phase||0||
48771650|NCT01746901|102229494|FG005|NOT COMPLETED|Naloxone Challenge Phase||0||
48771651|NCT01746901|102229495|FG006|NOT COMPLETED|Naloxone Challenge Phase||0||
48189122|NCT00708097|100786152|FG003|NOT COMPLETED|Period 4||0||
48449418|NCT02156466|101434984|FG003|COMPLETED|Overall Study||7||
48449419|NCT02156466|101434985|FG004|COMPLETED|Overall Study||8||
48449420|NCT02156466|101434981|FG000|NOT COMPLETED|Overall Study||0||
48449421|NCT02156466|101434982|FG001|NOT COMPLETED|Overall Study||0||
48449422|NCT02156466|101434983|FG002|NOT COMPLETED|Overall Study||1||
48449423|NCT02156466|101434984|FG003|NOT COMPLETED|Overall Study||2||
48449424|NCT02156466|101434985|FG004|NOT COMPLETED|Overall Study||0||
48449425|NCT04071392|101434986|FG000|STARTED|Overall Study||12||
48449426|NCT04071392|101434987|FG001|STARTED|Overall Study||12||
48660241|NCT03607500|101951867|FG001|NOT COMPLETED|Overall Study||0||
48771652|NCT01746901|102229496|FG007|NOT COMPLETED|Naloxone Challenge Phase||0||
48771653|NCT01746901|102229497|FG008|NOT COMPLETED|Naloxone Challenge Phase||0||
48771654|NCT01746901|102229489|FG000|STARTED|Drug Discrimination Phase: Day 1||0||
48771655|NCT01746901|102229490|FG001|STARTED|Drug Discrimination Phase: Day 1||36||
48449427|NCT04071392|101434986|FG000|COMPLETED|Overall Study||10||
48449428|NCT04071392|101434987|FG001|COMPLETED|Overall Study||10||
48449429|NCT04071392|101434986|FG000|NOT COMPLETED|Overall Study||2||
48449430|NCT04071392|101434987|FG001|NOT COMPLETED|Overall Study||2||
48449431|NCT01032330|101434988|FG000|STARTED|Overall Study||183||
48771656|NCT01746901|102229491|FG002|STARTED|Drug Discrimination Phase: Day 1||36||
48449432|NCT01032330|101434989|FG001|STARTED|Overall Study||175||
48449433|NCT01032330|101434990|FG002|STARTED|Overall Study||97||
48449434|NCT01032330|101434991|FG003|STARTED|Overall Study||104||
48449435|NCT01032330|101434988|FG000|COMPLETED|Overall Study||165||
48449436|NCT01032330|101434989|FG001|COMPLETED|Overall Study||151||
48449437|NCT01032330|101434990|FG002|COMPLETED|Overall Study||87||
48449438|NCT01032330|101434991|FG003|COMPLETED|Overall Study||90||
48449439|NCT01032330|101434988|FG000|NOT COMPLETED|Overall Study||18||
48449440|NCT01032330|101434989|FG001|NOT COMPLETED|Overall Study||24||
48449441|NCT01032330|101434990|FG002|NOT COMPLETED|Overall Study||10||
48449442|NCT01032330|101434991|FG003|NOT COMPLETED|Overall Study||14||
48449443|NCT00479765|101434992|FG000|STARTED|Overall Study||4||
48449444|NCT00479765|101434992|FG000|COMPLETED|Overall Study||0||
48449445|NCT00479765|101434992|FG000|NOT COMPLETED|Overall Study||4||
48449446|NCT01917188|101434993|FG000|STARTED|Overall Study||29||
48449447|NCT01917188|101434994|FG001|STARTED|Overall Study||23||
48449448|NCT01917188|101434995|FG002|STARTED|Overall Study||20||
48449449|NCT01917188|101434993|FG000|COMPLETED|Overall Study||17||
48449450|NCT01917188|101434994|FG001|COMPLETED|Overall Study||17||
48449451|NCT01917188|101434995|FG002|COMPLETED|Overall Study||11||
48449452|NCT01917188|101434993|FG000|NOT COMPLETED|Overall Study||12||
48449453|NCT01917188|101434994|FG001|NOT COMPLETED|Overall Study||6||
48449454|NCT01917188|101434995|FG002|NOT COMPLETED|Overall Study||9||
48449455|NCT00295620|101434996|FG000|STARTED|Overall Study||1732|ITT: all randomized, signed Informed Consent|
48449456|NCT00295620|101434997|FG001|STARTED|Overall Study||1738|ITT: all randomized, signed Informed Consent|
48449457|NCT00295620|101434996|FG000|Safety Analysis Set|Overall Study||1705|All randomized, at least one dose|
48449458|NCT00295620|101434997|FG001|Safety Analysis Set|Overall Study||1710|All randomized, at least one dose|
48449459|NCT00295620|101434996|FG000|COMPLETED|Overall Study||860||
48449460|NCT00295620|101434997|FG001|COMPLETED|Overall Study||842||
48449461|NCT00295620|101434996|FG000|NOT COMPLETED|Overall Study||872||
48449462|NCT00295620|101434997|FG001|NOT COMPLETED|Overall Study||896||
48449463|NCT00972153|101434998|FG000|STARTED|Overall Study||12||
48449464|NCT00972153|101434999|FG001|STARTED|Overall Study||12||
48449465|NCT00972153|101435000|FG002|STARTED|Overall Study||12||
48449466|NCT00972153|101434998|FG000|COMPLETED|Overall Study||12||
48449467|NCT00972153|101434999|FG001|COMPLETED|Overall Study||11||
48449468|NCT00972153|101435000|FG002|COMPLETED|Overall Study||12||
48449469|NCT00972153|101434998|FG000|NOT COMPLETED|Overall Study||0||
48449470|NCT00972153|101434999|FG001|NOT COMPLETED|Overall Study||1||
48449471|NCT00972153|101435000|FG002|NOT COMPLETED|Overall Study||0||
48449472|NCT04318535|101435001|FG000|STARTED|Treatment Period 1 (Day -1 to Day 5)||12||
48449473|NCT04318535|101435002|FG001|STARTED|Treatment Period 1 (Day -1 to Day 5)||12||
48449474|NCT04318535|101435003|FG002|STARTED|Treatment Period 1 (Day -1 to Day 5)||12||
48449475|NCT04318535|101435001|FG000|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12||
48449476|NCT04318535|101435002|FG001|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12||
48449477|NCT04318535|101435003|FG002|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12||
48449478|NCT04318535|101435001|FG000|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0||
48449479|NCT04318535|101435002|FG001|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0||
48449480|NCT04318535|101435003|FG002|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0||
48449481|NCT04318535|101435001|FG000|STARTED|Period1washout(Atleast 7 Days Post-dose)||12||
48449482|NCT04318535|101435002|FG001|STARTED|Period1washout(Atleast 7 Days Post-dose)||12||
48449483|NCT04318535|101435003|FG002|STARTED|Period1washout(Atleast 7 Days Post-dose)||12||
48449484|NCT04318535|101435001|FG000|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12||
48449485|NCT04318535|101435002|FG001|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12||
48449486|NCT04318535|101435003|FG002|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12||
48449487|NCT04318535|101435001|FG000|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0||
48449488|NCT04318535|101435002|FG001|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0||
48449489|NCT04318535|101435003|FG002|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0||
48449490|NCT04318535|101435001|FG000|STARTED|Treatment Period 2 (Day 7 to Day 12)||12||
48449491|NCT04318535|101435002|FG001|STARTED|Treatment Period 2 (Day 7 to Day 12)||12||
48449492|NCT04318535|101435003|FG002|STARTED|Treatment Period 2 (Day 7 to Day 12)||12||
48449493|NCT04318535|101435001|FG000|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12||
48449494|NCT04318535|101435002|FG001|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12||
48449495|NCT04318535|101435003|FG002|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12||
48449496|NCT04318535|101435001|FG000|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0||
48449497|NCT04318535|101435002|FG001|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0||
48449498|NCT04318535|101435003|FG002|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0||
48449499|NCT04318535|101435001|FG000|STARTED|Period2washout(Atleast 7 Days Post-dose)||12||
48449500|NCT04318535|101435002|FG001|STARTED|Period2washout(Atleast 7 Days Post-dose)||12||
48449501|NCT04318535|101435003|FG002|STARTED|Period2washout(Atleast 7 Days Post-dose)||12||
48449502|NCT04318535|101435001|FG000|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||12||
48449503|NCT04318535|101435002|FG001|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||11||
48449504|NCT04318535|101435003|FG002|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||12||
48449505|NCT04318535|101435001|FG000|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||0||
48660242|NCT02197065|101951868|FG000|STARTED|Overall Study||10||
48449506|NCT04318535|101435002|FG001|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||1||
48449507|NCT04318535|101435003|FG002|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||0||
48449508|NCT04318535|101435001|FG000|STARTED|Treatment Period 3 (Day 17 to Day 22)||12||
48449509|NCT04318535|101435002|FG001|STARTED|Treatment Period 3 (Day 17 to Day 22)||11||
48449510|NCT04318535|101435003|FG002|STARTED|Treatment Period 3 (Day 17 to Day 22)||12||
48449511|NCT04318535|101435001|FG000|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||12||
48449512|NCT04318535|101435002|FG001|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||11||
48449513|NCT04318535|101435003|FG002|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||12||
48449514|NCT04318535|101435001|FG000|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0||
48449515|NCT04318535|101435002|FG001|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0||
48449516|NCT04318535|101435003|FG002|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0||
48449517|NCT04556838|101435004|FG000|STARTED|Overall Study||57||
48449518|NCT04556838|101435005|FG001|STARTED|Overall Study||56||
48449519|NCT04556838|101435006|FG002|STARTED|Overall Study||56||
48449520|NCT04556838|101435004|FG000|COMPLETED|Overall Study||53||
48449521|NCT04556838|101435005|FG001|COMPLETED|Overall Study||53||
48449522|NCT04556838|101435006|FG002|COMPLETED|Overall Study||51||
48449523|NCT04556838|101435004|FG000|NOT COMPLETED|Overall Study||4||
48449524|NCT04556838|101435005|FG001|NOT COMPLETED|Overall Study||3||
48449525|NCT04556838|101435006|FG002|NOT COMPLETED|Overall Study||5||
48449526|NCT01895088|101435007|FG000|STARTED|Overall Study||271||
48449527|NCT01895088|101435007|FG000|COMPLETED|Overall Study||253||
48449528|NCT01895088|101435007|FG000|NOT COMPLETED|Overall Study||18||
48449529|NCT00297492|101436904|FG000|STARTED|Set Quit Date||297||
48449530|NCT00297492|101436905|FG001|STARTED|Set Quit Date||299||
48449531|NCT00297492|101436906|FG002|STARTED|Set Quit Date||150||
48449532|NCT00297492|101436904|FG000|COMPLETED|Set Quit Date||290||
48449533|NCT00297492|101436905|FG001|COMPLETED|Set Quit Date||286||
48449534|NCT00297492|101436906|FG002|COMPLETED|Set Quit Date||145||
48449535|NCT00297492|101436904|FG000|NOT COMPLETED|Set Quit Date||7||
48449536|NCT00297492|101436905|FG001|NOT COMPLETED|Set Quit Date||13||
48449537|NCT00297492|101436906|FG002|NOT COMPLETED|Set Quit Date||5||
48449538|NCT00297492|101436904|FG000|STARTED|6 Month Follow-up||290||
48449539|NCT00297492|101436905|FG001|STARTED|6 Month Follow-up||286||
48449540|NCT00297492|101436906|FG002|STARTED|6 Month Follow-up||145||
48449541|NCT00297492|101436904|FG000|COMPLETED|6 Month Follow-up||227||
48449542|NCT00297492|101436905|FG001|COMPLETED|6 Month Follow-up||237||
48449543|NCT00297492|101436906|FG002|COMPLETED|6 Month Follow-up||118||
48449544|NCT00297492|101436904|FG000|NOT COMPLETED|6 Month Follow-up||63||
48449545|NCT00297492|101436905|FG001|NOT COMPLETED|6 Month Follow-up||49||
48449546|NCT00297492|101436906|FG002|NOT COMPLETED|6 Month Follow-up||27||
48449547|NCT00717873|101436907|FG000|STARTED|Overall Study||46||
48449548|NCT00717873|101436908|FG001|STARTED|Overall Study||59||
48449549|NCT00717873|101436907|FG000|COMPLETED|Overall Study||46||
48449550|NCT00717873|101436908|FG001|COMPLETED|Overall Study||59||
48449551|NCT00717873|101436907|FG000|NOT COMPLETED|Overall Study||0||
48449552|NCT00717873|101436908|FG001|NOT COMPLETED|Overall Study||0||
48449553|NCT01143272|101436909|FG000|STARTED|Overall Study||246||
48449554|NCT01143272|101436910|FG001|STARTED|Overall Study||231||
48449555|NCT01143272|101436909|FG000|COMPLETED|Overall Study||246||
48449556|NCT01143272|101436910|FG001|COMPLETED|Overall Study||231||
48449557|NCT01143272|101436909|FG000|NOT COMPLETED|Overall Study||0||
48449558|NCT01143272|101436910|FG001|NOT COMPLETED|Overall Study||0||
48449559|NCT00021229|101436911|FG000|STARTED|Overall Study||36||
48449560|NCT00021229|101436912|FG001|STARTED|Overall Study||33||
48449561|NCT00021229|101436913|FG002|STARTED|Overall Study||16||
48449562|NCT00021229|101436911|FG000|Enrolled in Phase I|Overall Study||35||
48449563|NCT00021229|101436912|FG001|Enrolled in Phase I|Overall Study||33||
48449564|NCT00021229|101436913|FG002|Enrolled in Phase I|Overall Study||16||
48449565|NCT00021229|101436911|FG000|Maximum Tolerated Dose (MTD) Estimation|Overall Study||23||
48449566|NCT00021229|101436912|FG001|Maximum Tolerated Dose (MTD) Estimation|Overall Study||20||
48449567|NCT00021229|101436913|FG002|Maximum Tolerated Dose (MTD) Estimation|Overall Study||12||
48449568|NCT00021229|101436911|FG000|Enrolled in Phase II|Overall Study||14||
48449569|NCT00021229|101436912|FG001|Enrolled in Phase II|Overall Study||0||
48449570|NCT00021229|101436913|FG002|Enrolled in Phase II|Overall Study||0||
48449571|NCT00021229|101436911|FG000|COMPLETED|Overall Study||1||
48449572|NCT00021229|101436912|FG001|COMPLETED|Overall Study||0||
48449573|NCT00021229|101436913|FG002|COMPLETED|Overall Study||0||
48449574|NCT00021229|101436911|FG000|NOT COMPLETED|Overall Study||35||
48449575|NCT00021229|101436912|FG001|NOT COMPLETED|Overall Study||33||
48449576|NCT00021229|101436913|FG002|NOT COMPLETED|Overall Study||16||
48449577|NCT00738920|101436914|FG000|STARTED|Baseline to 2-Week Follow-Up||145||
48449578|NCT00738920|101436915|FG001|STARTED|Baseline to 2-Week Follow-Up||146||
48449579|NCT00738920|101436916|FG002|STARTED|Baseline to 2-Week Follow-Up||145||
48449580|NCT00738920|101436914|FG000|COMPLETED|Baseline to 2-Week Follow-Up||129||
48449581|NCT00738920|101436915|FG001|COMPLETED|Baseline to 2-Week Follow-Up||123||
48449582|NCT00738920|101436916|FG002|COMPLETED|Baseline to 2-Week Follow-Up||130||
48449583|NCT00738920|101436914|FG000|NOT COMPLETED|Baseline to 2-Week Follow-Up||16||
48449584|NCT00738920|101436915|FG001|NOT COMPLETED|Baseline to 2-Week Follow-Up||23||
48449585|NCT00738920|101436916|FG002|NOT COMPLETED|Baseline to 2-Week Follow-Up||15||
48449586|NCT00738920|101436914|FG000|STARTED|2-Week Follow-Up to 3-Month Follow-Up||129||
48449587|NCT00738920|101436915|FG001|STARTED|2-Week Follow-Up to 3-Month Follow-Up||123||
48449588|NCT00738920|101436916|FG002|STARTED|2-Week Follow-Up to 3-Month Follow-Up||130||
48449589|NCT00738920|101436914|FG000|COMPLETED|2-Week Follow-Up to 3-Month Follow-Up||121||
48660243|NCT02197065|101951869|FG001|STARTED|Overall Study||10||
48660244|NCT02197065|101951868|FG000|COMPLETED|Overall Study||10||
48660245|NCT02197065|101951869|FG001|COMPLETED|Overall Study||10||
48660246|NCT02197065|101951868|FG000|NOT COMPLETED|Overall Study||0||
48660247|NCT02197065|101951869|FG001|NOT COMPLETED|Overall Study||0||
48660248|NCT00548691|101951870|FG000|STARTED|Overall Study||258||
48660249|NCT00548691|101951871|FG001|STARTED|Overall Study||259||
48660250|NCT00548691|101951870|FG000|COMPLETED|Overall Study||251||
48660251|NCT00548691|101951871|FG001|COMPLETED|Overall Study||250||
48660252|NCT00548691|101951870|FG000|NOT COMPLETED|Overall Study||7||
48660253|NCT00548691|101951871|FG001|NOT COMPLETED|Overall Study||9||
48660254|NCT02769481|101951872|FG000|STARTED|Overall Study||213||
48660255|NCT02769481|101951873|FG001|STARTED|Overall Study||213||
48660256|NCT02769481|101951872|FG000|Study Complete at Week 60|Overall Study||193||
48660257|NCT02769481|101951873|FG001|Study Complete at Week 60|Overall Study||192||
48771657|NCT01746901|102229492|FG003|STARTED|Drug Discrimination Phase: Day 1||0||
48771658|NCT01746901|102229493|FG004|STARTED|Drug Discrimination Phase: Day 1||0||
48771659|NCT01746901|102229494|FG005|STARTED|Drug Discrimination Phase: Day 1||0||
48771660|NCT01746901|102229495|FG006|STARTED|Drug Discrimination Phase: Day 1||0||
48771661|NCT01746901|102229496|FG007|STARTED|Drug Discrimination Phase: Day 1||0||
48771662|NCT01746901|102229497|FG008|STARTED|Drug Discrimination Phase: Day 1||0||
48771663|NCT01746901|102229489|FG000|COMPLETED|Drug Discrimination Phase: Day 1||0||
48771664|NCT01746901|102229490|FG001|COMPLETED|Drug Discrimination Phase: Day 1||33||
48771665|NCT01746901|102229491|FG002|COMPLETED|Drug Discrimination Phase: Day 1||36||
48771666|NCT01746901|102229492|FG003|COMPLETED|Drug Discrimination Phase: Day 1||0||
48771667|NCT01746901|102229493|FG004|COMPLETED|Drug Discrimination Phase: Day 1||0||
48771668|NCT01746901|102229494|FG005|COMPLETED|Drug Discrimination Phase: Day 1||0||
48771669|NCT01746901|102229495|FG006|COMPLETED|Drug Discrimination Phase: Day 1||0||
48771670|NCT01746901|102229496|FG007|COMPLETED|Drug Discrimination Phase: Day 1||0||
48660258|NCT02769481|101951872|FG000|COMPLETED|Overall Study||180||
48771671|NCT01746901|102229497|FG008|COMPLETED|Drug Discrimination Phase: Day 1||0||
48771672|NCT01746901|102229489|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
48771673|NCT01746901|102229490|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 1||3||
48771674|NCT01746901|102229491|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
48449590|NCT00738920|101436915|FG001|COMPLETED|2-Week Follow-Up to 3-Month Follow-Up||111||
48449591|NCT00738920|101436916|FG002|COMPLETED|2-Week Follow-Up to 3-Month Follow-Up||118||
48449592|NCT00738920|101436914|FG000|NOT COMPLETED|2-Week Follow-Up to 3-Month Follow-Up||8||
48449593|NCT00738920|101436915|FG001|NOT COMPLETED|2-Week Follow-Up to 3-Month Follow-Up||12||
48449594|NCT00738920|101436916|FG002|NOT COMPLETED|2-Week Follow-Up to 3-Month Follow-Up||12||
48449595|NCT00738920|101436914|FG000|STARTED|3-Month Follow-Up to 6-Month Follow-Up||121||
48449596|NCT00738920|101436915|FG001|STARTED|3-Month Follow-Up to 6-Month Follow-Up||111||
48449597|NCT00738920|101436916|FG002|STARTED|3-Month Follow-Up to 6-Month Follow-Up||118||
48449598|NCT00738920|101436914|FG000|COMPLETED|3-Month Follow-Up to 6-Month Follow-Up||117||
48449599|NCT00738920|101436915|FG001|COMPLETED|3-Month Follow-Up to 6-Month Follow-Up||111||
48449600|NCT00738920|101436916|FG002|COMPLETED|3-Month Follow-Up to 6-Month Follow-Up||115||
48449601|NCT00738920|101436914|FG000|NOT COMPLETED|3-Month Follow-Up to 6-Month Follow-Up||4||
48449602|NCT00738920|101436915|FG001|NOT COMPLETED|3-Month Follow-Up to 6-Month Follow-Up||0||
48449603|NCT00738920|101436916|FG002|NOT COMPLETED|3-Month Follow-Up to 6-Month Follow-Up||3||
48449604|NCT00738920|101436914|FG000|STARTED|6-Month Follow-Up to 9-Month Follow-Up||117||
48660259|NCT02769481|101951873|FG001|COMPLETED|Overall Study||177||
48660260|NCT02769481|101951872|FG000|NOT COMPLETED|Overall Study||33||
48660261|NCT02769481|101951873|FG001|NOT COMPLETED|Overall Study||36||
48660262|NCT00912509|101951874|FG000|STARTED|Overall Study||20||
48660263|NCT00912509|101951875|FG001|STARTED|Overall Study||10||
48449605|NCT00738920|101436915|FG001|STARTED|6-Month Follow-Up to 9-Month Follow-Up||111||
48449606|NCT00738920|101436916|FG002|STARTED|6-Month Follow-Up to 9-Month Follow-Up||115||
48449607|NCT00738920|101436914|FG000|COMPLETED|6-Month Follow-Up to 9-Month Follow-Up||113||
48449608|NCT00738920|101436915|FG001|COMPLETED|6-Month Follow-Up to 9-Month Follow-Up||104||
48449609|NCT00738920|101436916|FG002|COMPLETED|6-Month Follow-Up to 9-Month Follow-Up||103||
48449610|NCT00738920|101436914|FG000|NOT COMPLETED|6-Month Follow-Up to 9-Month Follow-Up||4||
48449611|NCT00738920|101436915|FG001|NOT COMPLETED|6-Month Follow-Up to 9-Month Follow-Up||7||
48449612|NCT00738920|101436916|FG002|NOT COMPLETED|6-Month Follow-Up to 9-Month Follow-Up||12||
48449613|NCT00738920|101436914|FG000|STARTED|9-Month Follow-Up to 12-Month Follow-Up||113||
48449614|NCT00738920|101436915|FG001|STARTED|9-Month Follow-Up to 12-Month Follow-Up||104||
48449615|NCT00738920|101436916|FG002|STARTED|9-Month Follow-Up to 12-Month Follow-Up||103||
48449616|NCT00738920|101436914|FG000|COMPLETED|9-Month Follow-Up to 12-Month Follow-Up||112||
48449617|NCT00738920|101436915|FG001|COMPLETED|9-Month Follow-Up to 12-Month Follow-Up||103||
48449618|NCT00738920|101436916|FG002|COMPLETED|9-Month Follow-Up to 12-Month Follow-Up||102||
48449619|NCT00738920|101436914|FG000|NOT COMPLETED|9-Month Follow-Up to 12-Month Follow-Up||1||
48449620|NCT00738920|101436915|FG001|NOT COMPLETED|9-Month Follow-Up to 12-Month Follow-Up||1||
48449621|NCT00738920|101436916|FG002|NOT COMPLETED|9-Month Follow-Up to 12-Month Follow-Up||1||
48449622|NCT00727298|101436917|FG000|STARTED|Overall Study||4485||
48449623|NCT00727298|101436917|FG000|COMPLETED|Overall Study||3228||
48449624|NCT00727298|101436917|FG000|NOT COMPLETED|Overall Study||1257||
48449625|NCT02096029|101436918|FG000|STARTED|Overall Study||652||
48449626|NCT02096029|101436919|FG001|STARTED|Overall Study||593||
48449627|NCT02096029|101436918|FG000|COMPLETED|Overall Study||652||
48449628|NCT02096029|101436919|FG001|COMPLETED|Overall Study||593||
48449629|NCT02096029|101436918|FG000|NOT COMPLETED|Overall Study||0||
48449630|NCT02096029|101436919|FG001|NOT COMPLETED|Overall Study||0||
48449631|NCT01418352|101436920|FG000|STARTED|Overall Study||20||
48449632|NCT01418352|101436921|FG001|STARTED|Overall Study||21||
48449633|NCT01418352|101436922|FG002|STARTED|Overall Study||21||
48449634|NCT01418352|101436923|FG003|STARTED|Overall Study||21||
48449635|NCT01418352|101436920|FG000|COMPLETED|Overall Study||17||
48449636|NCT01418352|101436921|FG001|COMPLETED|Overall Study||17||
48449637|NCT01418352|101436922|FG002|COMPLETED|Overall Study||16||
48449638|NCT01418352|101436923|FG003|COMPLETED|Overall Study||18||
48449639|NCT01418352|101436920|FG000|NOT COMPLETED|Overall Study||3||
48449640|NCT01418352|101436921|FG001|NOT COMPLETED|Overall Study||4||
48449641|NCT01418352|101436922|FG002|NOT COMPLETED|Overall Study||5||
48449642|NCT01418352|101436923|FG003|NOT COMPLETED|Overall Study||3||
48449643|NCT02245360|101436924|FG000|STARTED|Overall Study||53||
48449644|NCT02245360|101436925|FG001|STARTED|Overall Study||54||
48449645|NCT02245360|101436924|FG000|COMPLETED|Overall Study||48||
48449646|NCT02245360|101436925|FG001|COMPLETED|Overall Study||52||
48449647|NCT02245360|101436924|FG000|NOT COMPLETED|Overall Study||5||
48449648|NCT02245360|101436925|FG001|NOT COMPLETED|Overall Study||2||
48449649|NCT02995694|101436926|FG000|STARTED|Overall Study||215||
48449650|NCT02995694|101436927|FG001|STARTED|Overall Study||211||
48449651|NCT02995694|101436928|FG002|STARTED|Overall Study||109||
48449652|NCT02995694|101436926|FG000|COMPLETED|Overall Study||181||
48449653|NCT02995694|101436927|FG001|COMPLETED|Overall Study||183||
48449654|NCT02995694|101436928|FG002|COMPLETED|Overall Study||94||
48449655|NCT02995694|101436926|FG000|NOT COMPLETED|Overall Study||34||
48449656|NCT02995694|101436927|FG001|NOT COMPLETED|Overall Study||28||
48449657|NCT02995694|101436928|FG002|NOT COMPLETED|Overall Study||15||
48449658|NCT02983227|101436929|FG000|STARTED|Overall Study||410||
48449659|NCT02983227|101436930|FG001|STARTED|Overall Study||86||
48449660|NCT02983227|101436929|FG000|COMPLETED|Overall Study||351||
48449661|NCT02983227|101436930|FG001|COMPLETED|Overall Study||72||
48449662|NCT02983227|101436929|FG000|NOT COMPLETED|Overall Study||59||
48449663|NCT02983227|101436930|FG001|NOT COMPLETED|Overall Study||14||
48449664|NCT01989195|101436931|FG000|STARTED|Overall Study||6||
48449665|NCT01989195|101436931|FG000|COMPLETED|Overall Study||6||
48449666|NCT01989195|101436931|FG000|NOT COMPLETED|Overall Study||0||
48449667|NCT01825876|101436932|FG000|STARTED|Period 1||17||
48449668|NCT01825876|101436933|FG001|STARTED|Period 1||0||
48449669|NCT01825876|101436932|FG000|Received 1 Dose of Study Drug|Period 1||17||
48449670|NCT01825876|101436933|FG001|Received 1 Dose of Study Drug|Period 1||0||
48449671|NCT01825876|101436932|FG000|COMPLETED|Period 1||17||
48449672|NCT01825876|101436933|FG001|COMPLETED|Period 1||0||
48771675|NCT01746901|102229492|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
48771676|NCT01746901|102229493|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
48771677|NCT01746901|102229494|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
48449673|NCT01825876|101436932|FG000|NOT COMPLETED|Period 1||0||
48449674|NCT01825876|101436933|FG001|NOT COMPLETED|Period 1||0||
48449675|NCT01825876|101436932|FG000|STARTED|Period 2||0||
48449676|NCT01825876|101436933|FG001|STARTED|Period 2||17||
48449677|NCT01825876|101436932|FG000|Received 1 Dose of Study Drug|Period 2||0||
48449678|NCT01825876|101436933|FG001|Received 1 Dose of Study Drug|Period 2||17||
48449679|NCT01825876|101436932|FG000|COMPLETED|Period 2||0||
48449680|NCT01825876|101436933|FG001|COMPLETED|Period 2||16||
48449681|NCT01825876|101436932|FG000|NOT COMPLETED|Period 2||0||
48449682|NCT01825876|101436933|FG001|NOT COMPLETED|Period 2||1||
48660264|NCT00912509|101951874|FG000|COMPLETED|Overall Study||15||
48660265|NCT00912509|101951875|FG001|COMPLETED|Overall Study||7||
48660266|NCT00912509|101951874|FG000|NOT COMPLETED|Overall Study||5||
48660267|NCT00912509|101951875|FG001|NOT COMPLETED|Overall Study||3||
48660268|NCT00318136|101954498|FG000|STARTED|Overall Study||47||
48771678|NCT01746901|102229495|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
48771679|NCT01746901|102229496|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
48771680|NCT01746901|102229497|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
48771681|NCT01746901|102229489|FG000|STARTED|Drug Discrimination Phase: Day 2||0||
48771682|NCT01746901|102229490|FG001|STARTED|Drug Discrimination Phase: Day 2||33||
48771683|NCT01746901|102229491|FG002|STARTED|Drug Discrimination Phase: Day 2||36||
48771684|NCT01746901|102229492|FG003|STARTED|Drug Discrimination Phase: Day 2||0||
48771685|NCT01746901|102229493|FG004|STARTED|Drug Discrimination Phase: Day 2||0||
48771686|NCT01746901|102229494|FG005|STARTED|Drug Discrimination Phase: Day 2||0||
48189123|NCT00708097|100786153|FG004|NOT COMPLETED|Period 4||0||
48189124|NCT00708097|100786149|FG000|STARTED|Period 5||8||
48189125|NCT00708097|100786150|FG001|STARTED|Period 5||9||
48189126|NCT00708097|100786151|FG002|STARTED|Period 5||11||
48449683|NCT02846740|101436934|FG000|STARTED|Overall Study||15||
48449684|NCT02846740|101436935|FG001|STARTED|Overall Study||15||
48449685|NCT02846740|101436934|FG000|COMPLETED|Overall Study||15||
48449686|NCT02846740|101436935|FG001|COMPLETED|Overall Study||14||
48449687|NCT02846740|101436934|FG000|NOT COMPLETED|Overall Study||0||
48449688|NCT02846740|101436935|FG001|NOT COMPLETED|Overall Study||1||
48449689|NCT01963676|101436936|FG000|STARTED|Overall Study||14||
48449690|NCT01963676|101436937|FG001|STARTED|Overall Study||13||
48449691|NCT01963676|101436936|FG000|COMPLETED|Overall Study||13||
48449692|NCT01963676|101436937|FG001|COMPLETED|Overall Study||13||
48449693|NCT01963676|101436936|FG000|NOT COMPLETED|Overall Study||1||
48449694|NCT01963676|101436937|FG001|NOT COMPLETED|Overall Study||0||
48449695|NCT02239692|101436938|FG000|STARTED|Overall Study||73||
48449696|NCT02239692|101436939|FG001|STARTED|Overall Study||131||
48189127|NCT00708097|100786152|FG003|STARTED|Period 5||10||
48449697|NCT02239692|101436938|FG000|Intention-to-treat Analysis Set|Overall Study||73||
48449698|NCT02239692|101436939|FG001|Intention-to-treat Analysis Set|Overall Study||131||
48449699|NCT02239692|101436938|FG000|Per-protocol Analysis Set|Overall Study||66||
48449700|NCT02239692|101436939|FG001|Per-protocol Analysis Set|Overall Study||120||
48449701|NCT02239692|101436938|FG000|Safety Analysis Set|Overall Study||70||
48449702|NCT02239692|101436939|FG001|Safety Analysis Set|Overall Study||125||
48449703|NCT02239692|101436938|FG000|COMPLETED|Overall Study||67||
48449704|NCT02239692|101436939|FG001|COMPLETED|Overall Study||118||
48449705|NCT02239692|101436938|FG000|NOT COMPLETED|Overall Study||6||
48449706|NCT02239692|101436939|FG001|NOT COMPLETED|Overall Study||13||
48449707|NCT02277639|101436940|FG000|STARTED|Overall Study||0||
48449708|NCT02277639|101436941|FG001|STARTED|Overall Study||2||
48449709|NCT02277639|101436940|FG000|COMPLETED|Overall Study||0||
48449710|NCT02277639|101436941|FG001|COMPLETED|Overall Study||2||
48449711|NCT02277639|101436940|FG000|NOT COMPLETED|Overall Study||0||
48449712|NCT02277639|101436941|FG001|NOT COMPLETED|Overall Study||0||
48449713|NCT01467570|101436942|FG000|STARTED|Overall Study||75||
48449714|NCT01467570|101436943|FG001|STARTED|Overall Study||72||
48449715|NCT01467570|101436942|FG000|COMPLETED|Overall Study||67||
48449716|NCT01467570|101436943|FG001|COMPLETED|Overall Study||63||
48449717|NCT01467570|101436942|FG000|NOT COMPLETED|Overall Study||8||
48449718|NCT01467570|101436943|FG001|NOT COMPLETED|Overall Study||9||
48449719|NCT01247974|101436944|FG000|STARTED|Overall Study||217||
48449720|NCT01247974|101436945|FG001|STARTED|Overall Study||222||
48449721|NCT01247974|101436944|FG000|COMPLETED|Overall Study||191||
48449722|NCT01247974|101436945|FG001|COMPLETED|Overall Study||203||
48449723|NCT01247974|101436944|FG000|NOT COMPLETED|Overall Study||26||
48449724|NCT01247974|101436945|FG001|NOT COMPLETED|Overall Study||19||
48660269|NCT00318136|101954498|FG000|COMPLETED|Overall Study||2||
48660270|NCT00318136|101954498|FG000|NOT COMPLETED|Overall Study||45||
48660271|NCT01689649|101954499|FG000|STARTED|Overall Study||139||
48660272|NCT01689649|101954499|FG000|COMPLETED|Overall Study||117||
48660273|NCT01689649|101954499|FG000|NOT COMPLETED|Overall Study||22||
48660274|NCT03773562|101954500|FG000|STARTED|Overall Study||50||
48660275|NCT03773562|101954500|FG000|COMPLETED|Overall Study||29||
48771687|NCT01746901|102229495|FG006|STARTED|Drug Discrimination Phase: Day 2||0||
48771688|NCT01746901|102229496|FG007|STARTED|Drug Discrimination Phase: Day 2||0||
48771689|NCT01746901|102229497|FG008|STARTED|Drug Discrimination Phase: Day 2||0||
48771690|NCT01746901|102229489|FG000|COMPLETED|Drug Discrimination Phase: Day 2||0||
48771691|NCT01746901|102229490|FG001|COMPLETED|Drug Discrimination Phase: Day 2||19||
48189128|NCT00708097|100786153|FG004|STARTED|Period 5||12||
48189129|NCT00708097|100786149|FG000|COMPLETED|Period 5||8||
48449725|NCT02956005|101436946|FG000|STARTED|Overall Study||18||
48449726|NCT02956005|101436946|FG000|COMPLETED|Overall Study||2||
48449727|NCT02956005|101436946|FG000|NOT COMPLETED|Overall Study||16||
48449728|NCT00670267|101436947|FG000|STARTED|Overall Study||10||
48660276|NCT03773562|101954500|FG000|NOT COMPLETED|Overall Study||21||
48660277|NCT05216380|101954501|FG000|STARTED|Overall Study||69||
48449729|NCT00670267|101436947|FG000|COMPLETED|Overall Study||9||
48449730|NCT00670267|101436947|FG000|NOT COMPLETED|Overall Study||1||
48449731|NCT01399125|101436948|FG000|STARTED|Overall Study||248||
48449732|NCT01399125|101436949|FG001|STARTED|Overall Study||253||
48449733|NCT01399125|101436948|FG000|Per Protocol (PP) Population|Overall Study||192||
48449734|NCT01399125|101436949|FG001|Per Protocol (PP) Population|Overall Study||188||
48449735|NCT01399125|101436948|FG000|COMPLETED|Overall Study||197||
48449736|NCT01399125|101436949|FG001|COMPLETED|Overall Study||193||
48449737|NCT01399125|101436948|FG000|NOT COMPLETED|Overall Study||51||
48449738|NCT01399125|101436949|FG001|NOT COMPLETED|Overall Study||60||
48449739|NCT02580201|101436950|FG000|STARTED|Overall Study||50||
48449740|NCT02580201|101436951|FG001|STARTED|Overall Study||104||
48449741|NCT02580201|101436950|FG000|COMPLETED|Overall Study||50||
48449742|NCT02580201|101436951|FG001|COMPLETED|Overall Study||104||
48449743|NCT02580201|101436950|FG000|NOT COMPLETED|Overall Study||0||
48449744|NCT02580201|101436951|FG001|NOT COMPLETED|Overall Study||0||
48449745|NCT03001011|101436952|FG000|STARTED|Overall Study||101||
48449746|NCT03001011|101436953|FG001|STARTED|Overall Study||101||
48449747|NCT03001011|101436952|FG000|COMPLETED|Overall Study||74||
48449748|NCT03001011|101436953|FG001|COMPLETED|Overall Study||80||
48449749|NCT03001011|101436952|FG000|NOT COMPLETED|Overall Study||27||
48449750|NCT03001011|101436953|FG001|NOT COMPLETED|Overall Study||21||
48449751|NCT00201734|101436954|FG000|STARTED|Overall Study||32||
48449752|NCT00201734|101436955|FG001|STARTED|Overall Study||25||
48449753|NCT00201734|101436954|FG000|Patients Not Evaluable|Overall Study||3||
48449754|NCT00201734|101436955|FG001|Patients Not Evaluable|Overall Study||0||
48449755|NCT00201734|101436954|FG000|COMPLETED|Overall Study||29||
48660278|NCT05216380|101954501|FG000|Patient Participants|Overall Study||54||
48660279|NCT05216380|101954501|FG000|Clinician Participants|Overall Study||15||
48660280|NCT05216380|101954501|FG000|COMPLETED|Overall Study||69||
48660281|NCT05216380|101954501|FG000|NOT COMPLETED|Overall Study||0||
48660282|NCT00846482|101954502|FG000|STARTED|Overall Study||64||
48660283|NCT00846482|101954502|FG000|COMPLETED|Overall Study||54||
48660284|NCT00846482|101954502|FG000|NOT COMPLETED|Overall Study||10||
48449756|NCT00201734|101436955|FG001|COMPLETED|Overall Study||25||
48449757|NCT00201734|101436954|FG000|NOT COMPLETED|Overall Study||3||
48449758|NCT00201734|101436955|FG001|NOT COMPLETED|Overall Study||0||
48449759|NCT01858558|101436956|FG000|STARTED|Overall Study||70||
48449760|NCT01858558|101436957|FG001|STARTED|Overall Study||31||
48449761|NCT01858558|101436956|FG000|COMPLETED|Overall Study||61||
48449762|NCT01858558|101436957|FG001|COMPLETED|Overall Study||29||
48449763|NCT01858558|101436956|FG000|NOT COMPLETED|Overall Study||9||
48449764|NCT01858558|101436957|FG001|NOT COMPLETED|Overall Study||2||
48449765|NCT01339858|101436958|FG000|STARTED|Overall Study||30||
48449766|NCT01339858|101436959|FG001|STARTED|Overall Study||30||
48449767|NCT01339858|101436958|FG000|COMPLETED|Overall Study||14||
48449768|NCT01339858|101436959|FG001|COMPLETED|Overall Study||18||
48449769|NCT01339858|101436958|FG000|NOT COMPLETED|Overall Study||16||
48449770|NCT01339858|101436959|FG001|NOT COMPLETED|Overall Study||12||
48449771|NCT01335399|101436960|FG000|STARTED|Pre-treatment Period||374|Started = randomized|
48449772|NCT01335399|101436961|FG001|STARTED|Pre-treatment Period||374|Started = randomized|
48449773|NCT01335399|101436960|FG000|COMPLETED|Pre-treatment Period||371|Completed = continued to the treatment period|
48449774|NCT01335399|101436961|FG001|COMPLETED|Pre-treatment Period||371|Completed = continued to the treatment period|
48449775|NCT01335399|101436960|FG000|NOT COMPLETED|Pre-treatment Period||3||
48449776|NCT01335399|101436961|FG001|NOT COMPLETED|Pre-treatment Period||3||
48449777|NCT01335399|101436960|FG000|STARTED|Treatment Period||371||
48449778|NCT01335399|101436961|FG001|STARTED|Treatment Period||371||
48449779|NCT01335399|101436960|FG000|COMPLETED|Treatment Period||0||
48449780|NCT01335399|101436961|FG001|COMPLETED|Treatment Period||0||
48449781|NCT01335399|101436960|FG000|NOT COMPLETED|Treatment Period||371||
48449782|NCT01335399|101436961|FG001|NOT COMPLETED|Treatment Period||371||
48449783|NCT00524394|101436962|FG000|STARTED|Overall Study||2||
48449784|NCT00524394|101436962|FG000|COMPLETED|Overall Study||1||
48449785|NCT00524394|101436962|FG000|NOT COMPLETED|Overall Study||1||
48449786|NCT01602198|101436963|FG000|STARTED|Overall Study||0||
48449787|NCT01602198|101436964|FG001|STARTED|Overall Study||1||
48449788|NCT01602198|101436963|FG000|COMPLETED|Overall Study||0||
48449789|NCT01602198|101436964|FG001|COMPLETED|Overall Study||1||
48660285|NCT04484428|101954503|FG000|STARTED|Overall Study||63||
48660286|NCT04484428|101954504|FG001|STARTED|Overall Study||63||
48660287|NCT04484428|101954503|FG000|COMPLETED|Overall Study||56||
48660288|NCT04484428|101954504|FG001|COMPLETED|Overall Study||60||
48660289|NCT04484428|101954503|FG000|NOT COMPLETED|Overall Study||7||
48660290|NCT04484428|101954504|FG001|NOT COMPLETED|Overall Study||3||
48449790|NCT01602198|101436963|FG000|NOT COMPLETED|Overall Study||0||
48449791|NCT01602198|101436964|FG001|NOT COMPLETED|Overall Study||0||
48449792|NCT01784419|101436965|FG000|STARTED|Overall Study||10||
48449793|NCT01784419|101436965|FG000|COMPLETED|Overall Study||7||
48449794|NCT01784419|101436965|FG000|NOT COMPLETED|Overall Study||3||
48449795|NCT01337609|101436966|FG000|STARTED|Overall Study||1||
48660291|NCT02837952|101954505|FG000|STARTED|Overall Study||41||
48660292|NCT02837952|101954506|FG001|STARTED|Overall Study||82||
48660293|NCT02837952|101954505|FG000|COMPLETED|Overall Study||36||
48189130|NCT00708097|100786150|FG001|COMPLETED|Period 5||9||
48189131|NCT00708097|100786151|FG002|COMPLETED|Period 5||11||
48189132|NCT00708097|100786152|FG003|COMPLETED|Period 5||10||
48189133|NCT00708097|100786153|FG004|COMPLETED|Period 5||12||
48189134|NCT00708097|100786149|FG000|NOT COMPLETED|Period 5||0||
48189135|NCT00708097|100786150|FG001|NOT COMPLETED|Period 5||0||
48369325|NCT02742649|101232751|FG001|STARTED|Pre-Randomization Washout Period||0||
48369326|NCT02742649|101232752|FG002|STARTED|Pre-Randomization Washout Period||0||
48369327|NCT02742649|101232753|FG003|STARTED|Pre-Randomization Washout Period||0||
48369328|NCT02742649|101232754|FG004|STARTED|Pre-Randomization Washout Period||0||
48369329|NCT02742649|101232750|FG000|COMPLETED|Pre-Randomization Washout Period||50||
48369330|NCT02742649|101232751|FG001|COMPLETED|Pre-Randomization Washout Period||0||
48369331|NCT02742649|101232752|FG002|COMPLETED|Pre-Randomization Washout Period||0||
48369332|NCT02742649|101232753|FG003|COMPLETED|Pre-Randomization Washout Period||0||
48369333|NCT02742649|101232754|FG004|COMPLETED|Pre-Randomization Washout Period||0||
48369334|NCT02742649|101232750|FG000|NOT COMPLETED|Pre-Randomization Washout Period||5||
48369335|NCT02742649|101232751|FG001|NOT COMPLETED|Pre-Randomization Washout Period||0||
48369336|NCT02742649|101232752|FG002|NOT COMPLETED|Pre-Randomization Washout Period||0||
48369337|NCT02742649|101232753|FG003|NOT COMPLETED|Pre-Randomization Washout Period||0||
48369338|NCT02742649|101232754|FG004|NOT COMPLETED|Pre-Randomization Washout Period||0||
48369339|NCT02742649|101232750|FG000|STARTED|Double-Blind Treatment Period||0||
48369340|NCT02742649|101232751|FG001|STARTED|Double-Blind Treatment Period||17||
48369341|NCT02742649|101232752|FG002|STARTED|Double-Blind Treatment Period||17||
48369342|NCT02742649|101232753|FG003|STARTED|Double-Blind Treatment Period||16||
48369343|NCT02742649|101232754|FG004|STARTED|Double-Blind Treatment Period||0||
48369344|NCT02742649|101232750|FG000|COMPLETED|Double-Blind Treatment Period||0||
48369345|NCT02742649|101232751|FG001|COMPLETED|Double-Blind Treatment Period||16||
48369346|NCT02742649|101232752|FG002|COMPLETED|Double-Blind Treatment Period||17||
48369347|NCT02742649|101232753|FG003|COMPLETED|Double-Blind Treatment Period||16||
48369348|NCT02742649|101232754|FG004|COMPLETED|Double-Blind Treatment Period||0||
48369349|NCT02742649|101232750|FG000|NOT COMPLETED|Double-Blind Treatment Period||0||
48369350|NCT02742649|101232751|FG001|NOT COMPLETED|Double-Blind Treatment Period||1||
48369351|NCT02742649|101232752|FG002|NOT COMPLETED|Double-Blind Treatment Period||0||
48369352|NCT02742649|101232753|FG003|NOT COMPLETED|Double-Blind Treatment Period||0||
48369353|NCT02742649|101232754|FG004|NOT COMPLETED|Double-Blind Treatment Period||0||
48369354|NCT02742649|101232750|FG000|STARTED|Open-Label Period||0||
48369355|NCT02742649|101232751|FG001|STARTED|Open-Label Period||0||
48369356|NCT02742649|101232752|FG002|STARTED|Open-Label Period||0||
48369357|NCT02742649|101232753|FG003|STARTED|Open-Label Period||0||
48369358|NCT02742649|101232754|FG004|STARTED|Open-Label Period||49||
48369359|NCT02742649|101232750|FG000|COMPLETED|Open-Label Period||0||
48369360|NCT02742649|101232751|FG001|COMPLETED|Open-Label Period||0||
48369361|NCT02742649|101232752|FG002|COMPLETED|Open-Label Period||0||
48369362|NCT02742649|101232753|FG003|COMPLETED|Open-Label Period||0||
48369363|NCT02742649|101232754|FG004|COMPLETED|Open-Label Period||48||
48369364|NCT02742649|101232750|FG000|NOT COMPLETED|Open-Label Period||0||
48369365|NCT02742649|101232751|FG001|NOT COMPLETED|Open-Label Period||0||
48369366|NCT02742649|101232752|FG002|NOT COMPLETED|Open-Label Period||0||
48369367|NCT02742649|101232753|FG003|NOT COMPLETED|Open-Label Period||0||
48369368|NCT02742649|101232754|FG004|NOT COMPLETED|Open-Label Period||1||
48369369|NCT01455428|101232755|FG000|STARTED|Overall Study||112||
48369370|NCT01455428|101232756|FG001|STARTED|Overall Study||110||
48369371|NCT01455428|101232755|FG000|Treated|Overall Study||111||
48369372|NCT01455428|101232756|FG001|Treated|Overall Study||109||
48369373|NCT01455428|101232755|FG000|COMPLETED|Overall Study||98||
48369374|NCT01455428|101232756|FG001|COMPLETED|Overall Study||92||
48369375|NCT01455428|101232755|FG000|NOT COMPLETED|Overall Study||14||
48369376|NCT01455428|101232756|FG001|NOT COMPLETED|Overall Study||18||
48369377|NCT02778867|101232757|FG000|STARTED|Phase 1||67||
48369378|NCT02778867|101232758|FG001|STARTED|Phase 1||62||
48369379|NCT02778867|101232759|FG002|STARTED|Phase 1||0||
48369380|NCT02778867|101232760|FG003|STARTED|Phase 1||0||
48369381|NCT02778867|101232757|FG000|COMPLETED|Phase 1||65||
48369382|NCT02778867|101232758|FG001|COMPLETED|Phase 1||59||
48369383|NCT02778867|101232759|FG002|COMPLETED|Phase 1||0||
48369384|NCT02778867|101232760|FG003|COMPLETED|Phase 1||0||
48369385|NCT02778867|101232757|FG000|NOT COMPLETED|Phase 1||2||
48189136|NCT00708097|100786151|FG002|NOT COMPLETED|Period 5||0||
48369386|NCT02778867|101232758|FG001|NOT COMPLETED|Phase 1||3||
48369387|NCT02778867|101232759|FG002|NOT COMPLETED|Phase 1||0||
48369388|NCT02778867|101232760|FG003|NOT COMPLETED|Phase 1||0||
48369389|NCT02778867|101232757|FG000|STARTED|Phase 2||0||
48369390|NCT02778867|101232758|FG001|STARTED|Phase 2||0||
48369391|NCT02778867|101232759|FG002|STARTED|Phase 2||21||
48449796|NCT01337609|101436967|FG001|STARTED|Overall Study||2||
48449797|NCT01337609|101436968|FG002|STARTED|Overall Study||2||
48449798|NCT01337609|101436966|FG000|COMPLETED|Overall Study||0||
48449799|NCT01337609|101436967|FG001|COMPLETED|Overall Study||2||
48449800|NCT01337609|101436968|FG002|COMPLETED|Overall Study||2||
48449801|NCT01337609|101436966|FG000|NOT COMPLETED|Overall Study||1||
48449802|NCT01337609|101436967|FG001|NOT COMPLETED|Overall Study||0||
48449803|NCT01337609|101436968|FG002|NOT COMPLETED|Overall Study||0||
48449804|NCT02162511|101436969|FG000|STARTED|Overall Study||0||
48449805|NCT02162511|101436970|FG001|STARTED|Overall Study||0||
48449806|NCT02162511|101436971|FG002|STARTED|Overall Study||3||
48449807|NCT02162511|101436969|FG000|Achieved Engraftment|Overall Study||0||
48449808|NCT02162511|101436970|FG001|Achieved Engraftment|Overall Study||0||
48449809|NCT02162511|101436971|FG002|Achieved Engraftment|Overall Study||1||
48660294|NCT02837952|101954506|FG001|COMPLETED|Overall Study||76||
48660295|NCT02837952|101954505|FG000|NOT COMPLETED|Overall Study||5||
48660296|NCT02837952|101954506|FG001|NOT COMPLETED|Overall Study||6||
48660297|NCT00376558|101954507|FG000|STARTED|Overall Study||25||
48660298|NCT00376558|101954508|FG001|STARTED|Overall Study||25||
48660299|NCT00376558|101954507|FG000|COMPLETED|Overall Study||25||
48660300|NCT00376558|101954508|FG001|COMPLETED|Overall Study||25||
48660301|NCT00376558|101954507|FG000|NOT COMPLETED|Overall Study||0||
48660302|NCT00376558|101954508|FG001|NOT COMPLETED|Overall Study||0||
48660303|NCT00663260|101954509|FG000|STARTED|Overall Study||84||
48660304|NCT00663260|101954510|FG001|STARTED|Overall Study||83||
48660305|NCT00663260|101954511|FG002|STARTED|Overall Study||85||
48660306|NCT00663260|101954509|FG000|COMPLETED|Overall Study||63||
48660307|NCT00663260|101954510|FG001|COMPLETED|Overall Study||72||
48660308|NCT00663260|101954511|FG002|COMPLETED|Overall Study||69||
48771692|NCT01746901|102229491|FG002|COMPLETED|Drug Discrimination Phase: Day 2||22||
48771693|NCT01746901|102229492|FG003|COMPLETED|Drug Discrimination Phase: Day 2||0||
48771694|NCT01746901|102229493|FG004|COMPLETED|Drug Discrimination Phase: Day 2||0||
48771695|NCT01746901|102229494|FG005|COMPLETED|Drug Discrimination Phase: Day 2||0||
48771696|NCT01746901|102229495|FG006|COMPLETED|Drug Discrimination Phase: Day 2||0||
48771697|NCT01746901|102229496|FG007|COMPLETED|Drug Discrimination Phase: Day 2||0||
48771698|NCT01746901|102229497|FG008|COMPLETED|Drug Discrimination Phase: Day 2||0||
48449810|NCT02162511|101436969|FG000|COMPLETED|Overall Study||0||
48771699|NCT01746901|102229489|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
48771700|NCT01746901|102229490|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 2||14||
48771701|NCT01746901|102229491|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 2||14||
48771702|NCT01746901|102229492|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
48771703|NCT01746901|102229493|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
48771704|NCT01746901|102229494|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
48771705|NCT01746901|102229495|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
48771706|NCT01746901|102229496|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
48771707|NCT01746901|102229497|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
48771708|NCT01746901|102229489|FG000|STARTED|Treatment Phase: First Intervention||0||
48771709|NCT01746901|102229490|FG001|STARTED|Treatment Phase: First Intervention||0||
48771710|NCT01746901|102229491|FG002|STARTED|Treatment Phase: First Intervention||0||
48771711|NCT01746901|102229492|FG003|STARTED|Treatment Phase: First Intervention||6||
48660309|NCT00663260|101954509|FG000|NOT COMPLETED|Overall Study||21||
48660310|NCT00663260|101954510|FG001|NOT COMPLETED|Overall Study||11||
48660311|NCT00663260|101954511|FG002|NOT COMPLETED|Overall Study||16||
48660312|NCT00605657|101954512|FG000|STARTED|Overall Study||5||
48660313|NCT00605657|101954512|FG000|COMPLETED|Overall Study||3||
48660314|NCT00605657|101954512|FG000|NOT COMPLETED|Overall Study||2||
48660315|NCT03109769|101954513|FG000|STARTED|Overall Study||22||
48449811|NCT02162511|101436970|FG001|COMPLETED|Overall Study||0||
48449812|NCT02162511|101436971|FG002|COMPLETED|Overall Study||1||
48449813|NCT02162511|101436969|FG000|NOT COMPLETED|Overall Study||0||
48449814|NCT02162511|101436970|FG001|NOT COMPLETED|Overall Study||0||
48449815|NCT02162511|101436971|FG002|NOT COMPLETED|Overall Study||2||
48449816|NCT00267007|101436972|FG000|STARTED|Overall Study||19||
48449817|NCT00267007|101436973|FG001|STARTED|Overall Study||11||
48449818|NCT00267007|101436972|FG000|COMPLETED|Overall Study||11||
48449819|NCT00267007|101436973|FG001|COMPLETED|Overall Study||10||
48449820|NCT00267007|101436972|FG000|NOT COMPLETED|Overall Study||8||
48449821|NCT00267007|101436973|FG001|NOT COMPLETED|Overall Study||1||
48449822|NCT01676311|101436974|FG000|STARTED|Overall Study||7||
48449823|NCT01676311|101436975|FG001|STARTED|Overall Study||7||
48449824|NCT01676311|101436974|FG000|COMPLETED|Overall Study||7||
48449825|NCT01676311|101436975|FG001|COMPLETED|Overall Study||5||
48449826|NCT01676311|101436974|FG000|NOT COMPLETED|Overall Study||0||
48449827|NCT01676311|101436975|FG001|NOT COMPLETED|Overall Study||2||
48449828|NCT01155284|101436976|FG000|STARTED|Overall Study||47||
48449829|NCT01155284|101436977|FG001|STARTED|Overall Study||23||
48660316|NCT03109769|101954514|FG001|STARTED|Overall Study||22||
48660317|NCT03109769|101954513|FG000|COMPLETED|Overall Study||22||
48660318|NCT03109769|101954514|FG001|COMPLETED|Overall Study||22||
48660319|NCT03109769|101954513|FG000|NOT COMPLETED|Overall Study||0||
48660320|NCT03109769|101954514|FG001|NOT COMPLETED|Overall Study||0||
48660321|NCT05333965|101954515|FG000|STARTED|First Intervention||13||
48660322|NCT05333965|101954516|FG001|STARTED|First Intervention||13||
48660323|NCT05333965|101954515|FG000|COMPLETED|First Intervention||13||
48660324|NCT05333965|101954516|FG001|COMPLETED|First Intervention||11||
48660325|NCT05333965|101954515|FG000|NOT COMPLETED|First Intervention||0||
48660326|NCT05333965|101954516|FG001|NOT COMPLETED|First Intervention||2||
48660327|NCT05333965|101954515|FG000|STARTED|Second Intervention||13||
48660328|NCT05333965|101954516|FG001|STARTED|Second Intervention||11||
48660329|NCT05333965|101954515|FG000|COMPLETED|Second Intervention||13||
48660330|NCT05333965|101954516|FG001|COMPLETED|Second Intervention||11||
48660331|NCT05333965|101954515|FG000|NOT COMPLETED|Second Intervention||0||
48660332|NCT05333965|101954516|FG001|NOT COMPLETED|Second Intervention||0||
48660333|NCT03400787|101954517|FG000|STARTED|Overall Study||66||
48660334|NCT03400787|101954518|FG001|STARTED|Overall Study||71||
48660335|NCT03400787|101954517|FG000|3-Month Follow-up|Overall Study||64|1 participant randomized to sham inadvertently received an implant and was analyzed as treated.|
48660336|NCT03400787|101954518|FG001|3-Month Follow-up|Overall Study||63|1 participant randomized to sham inadvertently received an implant and was analyzed as treated.|
48660337|NCT03400787|101954517|FG000|COMPLETED|Overall Study||64||
48660338|NCT03400787|101954518|FG001|COMPLETED|Overall Study||63||
48660339|NCT03400787|101954517|FG000|NOT COMPLETED|Overall Study||2||
48660340|NCT03400787|101954518|FG001|NOT COMPLETED|Overall Study||8||
48660341|NCT01111552|101954519|FG000|STARTED|Phase B (Day 1 to Week 8)||237||
48660342|NCT01111552|101954520|FG001|STARTED|Phase B (Day 1 to Week 8)||0||
48660343|NCT01111552|101954521|FG002|STARTED|Phase B (Day 1 to Week 8)||0||
48660344|NCT01111552|101954522|FG003|STARTED|Phase B (Day 1 to Week 8)||0||
48660345|NCT01111552|101954523|FG004|STARTED|Phase B (Day 1 to Week 8)||0||
48660346|NCT01111552|101954519|FG000|COMPLETED|Phase B (Day 1 to Week 8)||120||
48660347|NCT01111552|101954520|FG001|COMPLETED|Phase B (Day 1 to Week 8)||0||
48660348|NCT01111552|101954521|FG002|COMPLETED|Phase B (Day 1 to Week 8)||0||
48660349|NCT01111552|101954522|FG003|COMPLETED|Phase B (Day 1 to Week 8)||0||
48660350|NCT01111552|101954523|FG004|COMPLETED|Phase B (Day 1 to Week 8)||0||
48660351|NCT01111552|101954519|FG000|NOT COMPLETED|Phase B (Day 1 to Week 8)||117||
48660352|NCT01111552|101954520|FG001|NOT COMPLETED|Phase B (Day 1 to Week 8)||0||
48660353|NCT01111552|101954521|FG002|NOT COMPLETED|Phase B (Day 1 to Week 8)||0||
48660354|NCT01111552|101954522|FG003|NOT COMPLETED|Phase B (Day 1 to Week 8)||0||
48660355|NCT01111552|101954523|FG004|NOT COMPLETED|Phase B (Day 1 to Week 8)||0||
48660356|NCT01111552|101954519|FG000|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||0||
48660357|NCT01111552|101954520|FG001|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||54||
48660358|NCT01111552|101954521|FG002|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||22||
48660359|NCT01111552|101954522|FG003|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||21||
48660360|NCT01111552|101954523|FG004|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||23||
48660361|NCT01111552|101954519|FG000|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0||
48660362|NCT01111552|101954520|FG001|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||45||
48660363|NCT01111552|101954521|FG002|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||17||
48660364|NCT01111552|101954522|FG003|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||17||
48660365|NCT01111552|101954523|FG004|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||18||
48660366|NCT01111552|101954519|FG000|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0||
48660367|NCT01111552|101954520|FG001|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||9||
48660368|NCT01111552|101954521|FG002|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||5||
48660369|NCT01111552|101954522|FG003|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||4||
48660370|NCT01111552|101954523|FG004|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||5||
48660371|NCT02254460|101954524|FG000|STARTED|Overall Study||13||
48660372|NCT02254460|101954525|FG001|STARTED|Overall Study||12||
48660373|NCT02254460|101954524|FG000|COMPLETED|Overall Study||12||
48660374|NCT02254460|101954525|FG001|COMPLETED|Overall Study||12||
48660375|NCT02254460|101954524|FG000|NOT COMPLETED|Overall Study||1||
48660376|NCT02254460|101954525|FG001|NOT COMPLETED|Overall Study||0||
48660377|NCT01149460|101954526|FG000|STARTED|Overall Study||18||
48660378|NCT01149460|101954527|FG001|STARTED|Overall Study||18||
48660379|NCT01149460|101954526|FG000|COMPLETED|Overall Study||18||
48660380|NCT01149460|101954527|FG001|COMPLETED|Overall Study||16||
48660381|NCT01149460|101954526|FG000|NOT COMPLETED|Overall Study||0||
48660382|NCT01149460|101954527|FG001|NOT COMPLETED|Overall Study||2||
48660383|NCT01882829|101954528|FG000|STARTED|Overall Study||20||
48660384|NCT01882829|101954528|FG000|COMPLETED|Overall Study||14||
48660385|NCT01882829|101954528|FG000|NOT COMPLETED|Overall Study||6||
48660386|NCT01629563|101954529|FG000|STARTED|Overall Study||228|FAS population analysed As Randomised, Safety population analysed As Treated|
48660387|NCT01629563|101954530|FG001|STARTED|Overall Study||223|FAS population analysed As Randomised, Safety population analysed As Treated|
48660388|NCT01629563|101954529|FG000|Safety Population|Overall Study||230||
48660389|NCT01629563|101954530|FG001|Safety Population|Overall Study||221||
48660390|NCT01629563|101954529|FG000|Started Treatment Course 2|Overall Study||213||
48771712|NCT01746901|102229493|FG004|STARTED|Treatment Phase: First Intervention||6||
48771713|NCT01746901|102229494|FG005|STARTED|Treatment Phase: First Intervention||7||
48660391|NCT01629563|101954530|FG001|Started Treatment Course 2|Overall Study||207||
48660392|NCT01629563|101954529|FG000|Started Treatment Course 3|Overall Study||191||
48660393|NCT01629563|101954530|FG001|Started Treatment Course 3|Overall Study||190||
48660394|NCT01629563|101954529|FG000|Started Treatment Course 4|Overall Study||178||
48660395|NCT01629563|101954530|FG001|Started Treatment Course 4|Overall Study||176||
48660396|NCT01629563|101954529|FG000|COMPLETED|Overall Study||167||
48660397|NCT01629563|101954530|FG001|COMPLETED|Overall Study||170||
48660398|NCT01629563|101954529|FG000|NOT COMPLETED|Overall Study||61||
48660399|NCT01629563|101954530|FG001|NOT COMPLETED|Overall Study||53||
48660400|NCT03139721|101954531|FG000|STARTED|Overall Study||89||
48660401|NCT03139721|101954532|FG001|STARTED|Overall Study||11||
48660402|NCT03139721|101954531|FG000|Primary Endpoint|Overall Study||83||
48660403|NCT03139721|101954532|FG001|Primary Endpoint|Overall Study||10||
48660404|NCT03139721|101954531|FG000|COMPLETED|Overall Study||68||
48660405|NCT03139721|101954532|FG001|COMPLETED|Overall Study||10||
48660406|NCT03139721|101954531|FG000|NOT COMPLETED|Overall Study||21||
48660407|NCT03139721|101954532|FG001|NOT COMPLETED|Overall Study||1||
48660408|NCT03449147|101954533|FG000|STARTED|52-week Treatment Period||436||
48660409|NCT03449147|101954534|FG001|STARTED|52-week Treatment Period||442||
48660410|NCT03449147|101954535|FG002|STARTED|52-week Treatment Period||439||
48660411|NCT03449147|101954533|FG000|COMPLETED|52-week Treatment Period||382||
48660412|NCT03449147|101954534|FG001|COMPLETED|52-week Treatment Period||368||
48660413|NCT03449147|101954535|FG002|COMPLETED|52-week Treatment Period||355||
48660414|NCT03449147|101954533|FG000|NOT COMPLETED|52-week Treatment Period||54||
48660415|NCT03449147|101954534|FG001|NOT COMPLETED|52-week Treatment Period||74||
48660416|NCT03449147|101954535|FG002|NOT COMPLETED|52-week Treatment Period||84||
48660417|NCT03449147|101954533|FG000|STARTED|12-Week Off-Treatment Durability Period||48||
48660418|NCT03449147|101954534|FG001|STARTED|12-Week Off-Treatment Durability Period||37||
48660419|NCT03449147|101954535|FG002|STARTED|12-Week Off-Treatment Durability Period||37||
48660420|NCT03449147|101954533|FG000|COMPLETED|12-Week Off-Treatment Durability Period||47||
48660421|NCT03449147|101954534|FG001|COMPLETED|12-Week Off-Treatment Durability Period||36||
48660422|NCT03449147|101954535|FG002|COMPLETED|12-Week Off-Treatment Durability Period||37||
48660423|NCT03449147|101954533|FG000|NOT COMPLETED|12-Week Off-Treatment Durability Period||1||
48660424|NCT03449147|101954534|FG001|NOT COMPLETED|12-Week Off-Treatment Durability Period||1||
48660425|NCT03449147|101954535|FG002|NOT COMPLETED|12-Week Off-Treatment Durability Period||0||
48660426|NCT02272985|101954536|FG000|STARTED|Overall Study||15||
48660427|NCT02272985|101954536|FG000|COMPLETED|Overall Study||12||
48660428|NCT02272985|101954536|FG000|NOT COMPLETED|Overall Study||3||
48660429|NCT02214628|101954537|FG000|STARTED|Overall Study||63||
48660430|NCT02214628|101954538|FG001|STARTED|Overall Study||38||
48660431|NCT02214628|101954537|FG000|COMPLETED|Overall Study||36||
48660432|NCT02214628|101954538|FG001|COMPLETED|Overall Study||9||
48660433|NCT02214628|101954537|FG000|NOT COMPLETED|Overall Study||27||
48660434|NCT02214628|101954538|FG001|NOT COMPLETED|Overall Study||29||
48660435|NCT01772693|101954539|FG000|STARTED|Overall Study||20||
48660436|NCT01772693|101954540|FG001|STARTED|Overall Study||7||
48660437|NCT01772693|101954539|FG000|COMPLETED|Overall Study||14||
48660438|NCT01772693|101954540|FG001|COMPLETED|Overall Study||6||
48660439|NCT01772693|101954539|FG000|NOT COMPLETED|Overall Study||6||
48660440|NCT01772693|101954540|FG001|NOT COMPLETED|Overall Study||1||
48660441|NCT03647137|101954541|FG000|STARTED|Overall Study||13||
48660442|NCT03647137|101954542|FG001|STARTED|Overall Study||7||
48660443|NCT03647137|101954543|FG002|STARTED|Overall Study||10||
48660444|NCT03647137|101954544|FG003|STARTED|Overall Study||7||
48660445|NCT03647137|101954541|FG000|Received DTBZ, PIB, and FEOVB PET Scan|Overall Study||11||
48660446|NCT03647137|101954542|FG001|Received DTBZ, PIB, and FEOVB PET Scan|Overall Study||6||
48660447|NCT03647137|101954543|FG002|Received DTBZ, PIB, and FEOVB PET Scan|Overall Study||9||
48660448|NCT03647137|101954544|FG003|Received DTBZ, PIB, and FEOVB PET Scan|Overall Study||5||
48660449|NCT03647137|101954541|FG000|COMPLETED|Overall Study||11||
48660450|NCT03647137|101954542|FG001|COMPLETED|Overall Study||6||
48660451|NCT03647137|101954543|FG002|COMPLETED|Overall Study||9||
48660452|NCT03647137|101954544|FG003|COMPLETED|Overall Study||5||
48660453|NCT03647137|101954541|FG000|NOT COMPLETED|Overall Study||2||
48660454|NCT03647137|101954542|FG001|NOT COMPLETED|Overall Study||1||
48660455|NCT03647137|101954543|FG002|NOT COMPLETED|Overall Study||1||
48660456|NCT03647137|101954544|FG003|NOT COMPLETED|Overall Study||2||
48660457|NCT05593770|101954545|FG000|STARTED|Overall Study||14||
48660458|NCT05593770|101954546|FG001|STARTED|Overall Study||14||
48660459|NCT05593770|101954545|FG000|COMPLETED|Overall Study||12||
48660460|NCT05593770|101954546|FG001|COMPLETED|Overall Study||9||
48660461|NCT05593770|101954545|FG000|NOT COMPLETED|Overall Study||2||
48660462|NCT05593770|101954546|FG001|NOT COMPLETED|Overall Study||5||
48660463|NCT03508440|101954547|FG000|STARTED|Overall Study||1||
48660464|NCT03508440|101954548|FG001|STARTED|Overall Study||9||
48660465|NCT03508440|101954549|FG002|STARTED|Overall Study||0||
48660466|NCT03508440|101954547|FG000|COMPLETED|Overall Study||1||
48660467|NCT03508440|101954548|FG001|COMPLETED|Overall Study||9||
48660468|NCT03508440|101954549|FG002|COMPLETED|Overall Study||0||
48660469|NCT03508440|101954547|FG000|NOT COMPLETED|Overall Study||0||
48660470|NCT03508440|101954548|FG001|NOT COMPLETED|Overall Study||0||
48660471|NCT03508440|101954549|FG002|NOT COMPLETED|Overall Study||0||
48660472|NCT00908141|101954550|FG000|STARTED|Overall Study||8||
48660473|NCT00908141|101954551|FG001|STARTED|Overall Study||9||
48660474|NCT00908141|101954550|FG000|COMPLETED|Overall Study||8||
48660475|NCT00908141|101954551|FG001|COMPLETED|Overall Study||8||
48660476|NCT00908141|101954550|FG000|NOT COMPLETED|Overall Study||0||
48660477|NCT00908141|101954551|FG001|NOT COMPLETED|Overall Study||1||
48660478|NCT02904265|101954552|FG000|STARTED|Overall Study||1||
48660479|NCT02904265|101954553|FG001|STARTED|Overall Study||2||
48660480|NCT02904265|101954552|FG000|COMPLETED|Overall Study||0||
48660481|NCT02904265|101954553|FG001|COMPLETED|Overall Study||0||
48660482|NCT02904265|101954552|FG000|NOT COMPLETED|Overall Study||1||
48660483|NCT02904265|101954553|FG001|NOT COMPLETED|Overall Study||2||
48660484|NCT01550965|101954554|FG000|STARTED|Overall Study||463||
48660485|NCT01550965|101954554|FG000|COMPLETED|Overall Study||353||
48660486|NCT01550965|101954554|FG000|NOT COMPLETED|Overall Study||110||
48660487|NCT00803049|101954555|FG000|STARTED|Overall Study||129||
48660488|NCT00803049|101954556|FG001|STARTED|Overall Study||252||
48660489|NCT00803049|101954557|FG002|STARTED|Overall Study||108||
48660490|NCT00803049|101954558|FG003|STARTED|Overall Study||253||
48449830|NCT01155284|101436976|FG000|COMPLETED|Overall Study||40||
48449831|NCT01155284|101436977|FG001|COMPLETED|Overall Study||18||
48449832|NCT01155284|101436976|FG000|NOT COMPLETED|Overall Study||7||
48449833|NCT01155284|101436977|FG001|NOT COMPLETED|Overall Study||5||
48449834|NCT03031431|101436978|FG000|STARTED|Overall Study||130||204
48449835|NCT03031431|101436978|FG000|COMPLETED|Overall Study||129||203
48449836|NCT03031431|101436978|FG000|NOT COMPLETED|Overall Study||1||1
48449837|NCT01202994|101436979|FG000|STARTED|Overall Study||27||
48449838|NCT01202994|101436979|FG000|COMPLETED|Overall Study||27||
48449839|NCT01202994|101436979|FG000|NOT COMPLETED|Overall Study||0||
48449840|NCT01600014|101436980|FG000|STARTED|1. Cycle & Observation Period D1 to W52||450||
48449841|NCT01600014|101436981|FG001|STARTED|1. Cycle & Observation Period D1 to W52||0||
48449842|NCT01600014|101436980|FG000|COMPLETED|1. Cycle & Observation Period D1 to W52||162||
48449843|NCT01600014|101436981|FG001|COMPLETED|1. Cycle & Observation Period D1 to W52||0||
48449844|NCT01600014|101436980|FG000|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||288||
48449845|NCT01600014|101436981|FG001|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||0||
48449846|NCT01600014|101436980|FG000|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||92||
48449847|NCT01600014|101436981|FG001|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||49||
48449848|NCT01600014|101436980|FG000|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||80||
48449849|NCT01600014|101436981|FG001|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||39||
48449850|NCT01600014|101436980|FG000|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||12||
48449851|NCT01600014|101436981|FG001|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||10||
48449852|NCT01600014|101436980|FG000|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||42||
48449853|NCT01600014|101436981|FG001|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||20||
48449854|NCT01600014|101436980|FG000|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||39||
48449855|NCT01600014|101436981|FG001|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||20||
48449856|NCT01600014|101436980|FG000|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||3||
48771714|NCT01746901|102229495|FG006|STARTED|Treatment Phase: First Intervention||8||
48771715|NCT01746901|102229496|FG007|STARTED|Treatment Phase: First Intervention||7||
48449857|NCT01600014|101436981|FG001|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||0||
48449858|NCT00667719|101436982|FG000|STARTED|Overall Study||564||
48449859|NCT00667719|101436982|FG000|COMPLETED|Overall Study||493||
48449860|NCT00667719|101436982|FG000|NOT COMPLETED|Overall Study||71||
48449861|NCT00918229|101436983|FG000|STARTED|Overall Study||24||
48449862|NCT00918229|101436983|FG000|COMPLETED|Overall Study||24||
48449863|NCT00918229|101436983|FG000|NOT COMPLETED|Overall Study||0||
48449864|NCT02253654|101436984|FG000|STARTED|Overall Study||108||
48449865|NCT02253654|101436985|FG001|STARTED|Overall Study||108||
48449866|NCT02253654|101436984|FG000|Received Treatment|Overall Study||104||
48660491|NCT00803049|101954555|FG000|Treated|Overall Study||129||
48660492|NCT00803049|101954556|FG001|Treated|Overall Study||252||
48660493|NCT00803049|101954557|FG002|Treated|Overall Study||108||
48660494|NCT00803049|101954558|FG003|Treated|Overall Study||251||
48660495|NCT00803049|101954555|FG000|Safety Population|Overall Study||129||
48449867|NCT02253654|101436985|FG001|Received Treatment|Overall Study||107||
48449868|NCT02253654|101436984|FG000|COMPLETED|Overall Study||85||
48449869|NCT02253654|101436985|FG001|COMPLETED|Overall Study||90||
48449870|NCT02253654|101436984|FG000|NOT COMPLETED|Overall Study||23||
48449871|NCT02253654|101436985|FG001|NOT COMPLETED|Overall Study||18||
48449872|NCT02595528|101436986|FG000|STARTED|Overall Study||41||
48449873|NCT02595528|101436987|FG001|STARTED|Overall Study||40||
48449874|NCT02595528|101436988|FG002|STARTED|Overall Study||42||
48449875|NCT02595528|101436989|FG003|STARTED|Overall Study||40||
48449876|NCT02595528|101436986|FG000|COMPLETED|Overall Study||39||
48449877|NCT02595528|101436987|FG001|COMPLETED|Overall Study||37||
48449878|NCT02595528|101436988|FG002|COMPLETED|Overall Study||41||
48449879|NCT02595528|101436989|FG003|COMPLETED|Overall Study||36||
48449880|NCT02595528|101436986|FG000|NOT COMPLETED|Overall Study||2||
48449881|NCT02595528|101436987|FG001|NOT COMPLETED|Overall Study||3||
48660496|NCT00803049|101954556|FG001|Safety Population|Overall Study||254||
48660497|NCT00803049|101954557|FG002|Safety Population|Overall Study||107||
48771716|NCT01746901|102229497|FG008|STARTED|Treatment Phase: First Intervention||7||
48660498|NCT00803049|101954558|FG003|Safety Population|Overall Study||250||
48660499|NCT00803049|101954555|FG000|COMPLETED|Overall Study||68||
48449882|NCT02595528|101436988|FG002|NOT COMPLETED|Overall Study||1||
48449883|NCT02595528|101436989|FG003|NOT COMPLETED|Overall Study||4||
48449884|NCT02072174|101436990|FG000|STARTED|Overall Study||290||
48449885|NCT02072174|101436991|FG001|STARTED|Overall Study||279||
48449886|NCT02072174|101436990|FG000|COMPLETED|Overall Study||258||
48449887|NCT02072174|101436991|FG001|COMPLETED|Overall Study||240||
48449888|NCT02072174|101436990|FG000|NOT COMPLETED|Overall Study||32||
48449889|NCT02072174|101436991|FG001|NOT COMPLETED|Overall Study||39||
48449890|NCT01355523|101436992|FG000|STARTED|Overall Study||28||
48449891|NCT01355523|101436993|FG001|STARTED|Overall Study||26||
48449892|NCT01355523|101436992|FG000|COMPLETED|Overall Study||27||
48449893|NCT01355523|101436993|FG001|COMPLETED|Overall Study||16||
48449894|NCT01355523|101436992|FG000|NOT COMPLETED|Overall Study||1||
48449895|NCT01355523|101436993|FG001|NOT COMPLETED|Overall Study||10||
48449896|NCT00084617|101436994|FG000|STARTED|Overall Study||39||
48449897|NCT00084617|101436994|FG000|COMPLETED|Overall Study||30||
48449898|NCT00084617|101436994|FG000|NOT COMPLETED|Overall Study||9||
48449899|NCT03634488|101436995|FG000|STARTED|Overall Study||56||
48449900|NCT03634488|101436996|FG001|STARTED|Overall Study||54||
48771717|NCT01746901|102229489|FG000|COMPLETED|Treatment Phase: First Intervention||0||
48449901|NCT03634488|101436997|FG002|STARTED|Overall Study||22||
48449902|NCT03634488|101436995|FG000|COMPLETED|Overall Study||54||
48449903|NCT03634488|101436996|FG001|COMPLETED|Overall Study||54||
48449904|NCT03634488|101436997|FG002|COMPLETED|Overall Study||22||
48449905|NCT03634488|101436995|FG000|NOT COMPLETED|Overall Study||2||
48449906|NCT03634488|101436996|FG001|NOT COMPLETED|Overall Study||0||
48449907|NCT03634488|101436997|FG002|NOT COMPLETED|Overall Study||0||
48449908|NCT00367679|101436998|FG000|STARTED|Overall Study||35||
48449909|NCT00367679|101436998|FG000|COMPLETED|Overall Study||35||
48449910|NCT00367679|101436998|FG000|NOT COMPLETED|Overall Study||0||
48449911|NCT03569020|101436999|FG000|STARTED|Period 1||22||
48449912|NCT03569020|101437000|FG001|STARTED|Period 1||21||
48449913|NCT03569020|101436999|FG000|COMPLETED|Period 1||22||
48449914|NCT03569020|101437000|FG001|COMPLETED|Period 1||21||
48449915|NCT03569020|101436999|FG000|NOT COMPLETED|Period 1||0||
48449916|NCT03569020|101437000|FG001|NOT COMPLETED|Period 1||0||
48449917|NCT03569020|101436999|FG000|STARTED|Period 2||22||
48449918|NCT03569020|101437000|FG001|STARTED|Period 2||21||
48449919|NCT03569020|101436999|FG000|COMPLETED|Period 2||22||
48449920|NCT03569020|101437000|FG001|COMPLETED|Period 2||21||
48449921|NCT03569020|101436999|FG000|NOT COMPLETED|Period 2||0||
48449922|NCT03569020|101437000|FG001|NOT COMPLETED|Period 2||0||
48449923|NCT01749033|101437001|FG000|STARTED|Overall Study||150||
48449924|NCT01749033|101437002|FG001|STARTED|Overall Study||150||
48449925|NCT01749033|101437003|FG002|STARTED|Overall Study||150||
48449926|NCT01749033|101437001|FG000|COMPLETED|Overall Study||147||
48449927|NCT01749033|101437002|FG001|COMPLETED|Overall Study||145||
48449928|NCT01749033|101437003|FG002|COMPLETED|Overall Study||149||
48449929|NCT01749033|101437001|FG000|NOT COMPLETED|Overall Study||3||
48771718|NCT01746901|102229490|FG001|COMPLETED|Treatment Phase: First Intervention||0||
48771719|NCT01746901|102229491|FG002|COMPLETED|Treatment Phase: First Intervention||0||
48771720|NCT01746901|102229492|FG003|COMPLETED|Treatment Phase: First Intervention||6||
48771721|NCT01746901|102229493|FG004|COMPLETED|Treatment Phase: First Intervention||6||
48771722|NCT01746901|102229494|FG005|COMPLETED|Treatment Phase: First Intervention||7||
48771723|NCT01746901|102229495|FG006|COMPLETED|Treatment Phase: First Intervention||7||
48771724|NCT01746901|102229496|FG007|COMPLETED|Treatment Phase: First Intervention||7||
48771725|NCT01746901|102229497|FG008|COMPLETED|Treatment Phase: First Intervention||7||
48189137|NCT00708097|100786152|FG003|NOT COMPLETED|Period 5||0||
48189138|NCT00708097|100786153|FG004|NOT COMPLETED|Period 5||0||
48189139|NCT04655313|100786154|FG000|STARTED|Overall Study||20||
48449930|NCT01749033|101437002|FG001|NOT COMPLETED|Overall Study||5||
48449931|NCT01749033|101437003|FG002|NOT COMPLETED|Overall Study||1||
48771726|NCT01746901|102229489|FG000|NOT COMPLETED|Treatment Phase: First Intervention||0||
48771727|NCT01746901|102229490|FG001|NOT COMPLETED|Treatment Phase: First Intervention||0||
48771728|NCT01746901|102229491|FG002|NOT COMPLETED|Treatment Phase: First Intervention||0||
48771729|NCT01746901|102229492|FG003|NOT COMPLETED|Treatment Phase: First Intervention||0||
48369392|NCT02778867|101232760|FG003|STARTED|Phase 2||11||
48449932|NCT04247594|101437004|FG000|STARTED|Overall Study||6||
48449933|NCT04247594|101437004|FG000|COMPLETED|Overall Study||2||
48449934|NCT04247594|101437004|FG000|NOT COMPLETED|Overall Study||4||
48449935|NCT04726514|101437005|FG000|STARTED|Overall Study||10||
48449936|NCT04726514|101437005|FG000|COMPLETED|Overall Study||8||
48449937|NCT04726514|101437005|FG000|NOT COMPLETED|Overall Study||2||
48449938|NCT01697397|101437006|FG000|STARTED|Overall Study||88||
48449939|NCT01697397|101437006|FG000|COMPLETED|Overall Study||88||
48449940|NCT01697397|101437006|FG000|NOT COMPLETED|Overall Study||0||
48449941|NCT00569231|101437007|FG000|STARTED|Overall Study||18||
48449942|NCT00569231|101437007|FG000|COMPLETED|Overall Study||11||
48449943|NCT00569231|101437007|FG000|NOT COMPLETED|Overall Study||7||
48449944|NCT02577900|101437008|FG000|STARTED|Overall Study||11||
48449945|NCT02577900|101437009|FG001|STARTED|Overall Study||10||
48449946|NCT02577900|101437010|FG002|STARTED|Overall Study||10||
48449947|NCT02577900|101437008|FG000|COMPLETED|Overall Study||11||
48771730|NCT01746901|102229493|FG004|NOT COMPLETED|Treatment Phase: First Intervention||0||
48771731|NCT01746901|102229494|FG005|NOT COMPLETED|Treatment Phase: First Intervention||0||
48771732|NCT01746901|102229495|FG006|NOT COMPLETED|Treatment Phase: First Intervention||1||
48771733|NCT01746901|102229496|FG007|NOT COMPLETED|Treatment Phase: First Intervention||0||
48771734|NCT01746901|102229497|FG008|NOT COMPLETED|Treatment Phase: First Intervention||0||
48771735|NCT01746901|102229489|FG000|STARTED|Treatment Phase: Washout Period 1||0||
48771736|NCT01746901|102229490|FG001|STARTED|Treatment Phase: Washout Period 1||0||
48771737|NCT01746901|102229491|FG002|STARTED|Treatment Phase: Washout Period 1||0||
48771738|NCT01746901|102229492|FG003|STARTED|Treatment Phase: Washout Period 1||6||
48771739|NCT01746901|102229493|FG004|STARTED|Treatment Phase: Washout Period 1||6||
48771740|NCT01746901|102229494|FG005|STARTED|Treatment Phase: Washout Period 1||7||
48771741|NCT01746901|102229495|FG006|STARTED|Treatment Phase: Washout Period 1||7||
48771742|NCT01746901|102229496|FG007|STARTED|Treatment Phase: Washout Period 1||7||
48771743|NCT01746901|102229497|FG008|STARTED|Treatment Phase: Washout Period 1||7||
48771744|NCT01746901|102229489|FG000|COMPLETED|Treatment Phase: Washout Period 1||0||
48771745|NCT01746901|102229490|FG001|COMPLETED|Treatment Phase: Washout Period 1||0||
48771746|NCT01746901|102229491|FG002|COMPLETED|Treatment Phase: Washout Period 1||0||
48771747|NCT01746901|102229492|FG003|COMPLETED|Treatment Phase: Washout Period 1||6||
48771748|NCT01746901|102229493|FG004|COMPLETED|Treatment Phase: Washout Period 1||6||
48771749|NCT01746901|102229494|FG005|COMPLETED|Treatment Phase: Washout Period 1||7||
48771750|NCT01746901|102229495|FG006|COMPLETED|Treatment Phase: Washout Period 1||7||
48771751|NCT01746901|102229496|FG007|COMPLETED|Treatment Phase: Washout Period 1||7||
48771752|NCT01746901|102229497|FG008|COMPLETED|Treatment Phase: Washout Period 1||7||
48771753|NCT01746901|102229489|FG000|NOT COMPLETED|Treatment Phase: Washout Period 1||0||
48771754|NCT01746901|102229490|FG001|NOT COMPLETED|Treatment Phase: Washout Period 1||0||
48771755|NCT01746901|102229491|FG002|NOT COMPLETED|Treatment Phase: Washout Period 1||0||
48771756|NCT01746901|102229492|FG003|NOT COMPLETED|Treatment Phase: Washout Period 1||0||
48771757|NCT01746901|102229493|FG004|NOT COMPLETED|Treatment Phase: Washout Period 1||0||
48771758|NCT01746901|102229494|FG005|NOT COMPLETED|Treatment Phase: Washout Period 1||0||
48771759|NCT01746901|102229495|FG006|NOT COMPLETED|Treatment Phase: Washout Period 1||0||
48771760|NCT01746901|102229496|FG007|NOT COMPLETED|Treatment Phase: Washout Period 1||0||
48771761|NCT01746901|102229497|FG008|NOT COMPLETED|Treatment Phase: Washout Period 1||0||
48771762|NCT01746901|102229489|FG000|STARTED|Treatment Phase: Second Intervention||0||
48771763|NCT01746901|102229490|FG001|STARTED|Treatment Phase: Second Intervention||0||
48771764|NCT01746901|102229491|FG002|STARTED|Treatment Phase: Second Intervention||0||
48771765|NCT01746901|102229492|FG003|STARTED|Treatment Phase: Second Intervention||6||
48771766|NCT01746901|102229493|FG004|STARTED|Treatment Phase: Second Intervention||6||
48771767|NCT01746901|102229494|FG005|STARTED|Treatment Phase: Second Intervention||7||
48771768|NCT01746901|102229495|FG006|STARTED|Treatment Phase: Second Intervention||7||
48771769|NCT01746901|102229496|FG007|STARTED|Treatment Phase: Second Intervention||7||
48771770|NCT01746901|102229497|FG008|STARTED|Treatment Phase: Second Intervention||7||
48771771|NCT01746901|102229489|FG000|COMPLETED|Treatment Phase: Second Intervention||0||
48771772|NCT01746901|102229490|FG001|COMPLETED|Treatment Phase: Second Intervention||0||
48771773|NCT01746901|102229491|FG002|COMPLETED|Treatment Phase: Second Intervention||0||
48771774|NCT01746901|102229492|FG003|COMPLETED|Treatment Phase: Second Intervention||6||
48771775|NCT01746901|102229493|FG004|COMPLETED|Treatment Phase: Second Intervention||6||
48771776|NCT01746901|102229494|FG005|COMPLETED|Treatment Phase: Second Intervention||7||
48771777|NCT01746901|102229495|FG006|COMPLETED|Treatment Phase: Second Intervention||7||
48771778|NCT01746901|102229496|FG007|COMPLETED|Treatment Phase: Second Intervention||6||
48771779|NCT01746901|102229497|FG008|COMPLETED|Treatment Phase: Second Intervention||7||
48771780|NCT01746901|102229489|FG000|NOT COMPLETED|Treatment Phase: Second Intervention||0||
48771781|NCT01746901|102229490|FG001|NOT COMPLETED|Treatment Phase: Second Intervention||0||
48771782|NCT01746901|102229491|FG002|NOT COMPLETED|Treatment Phase: Second Intervention||0||
48771783|NCT01746901|102229492|FG003|NOT COMPLETED|Treatment Phase: Second Intervention||0||
48771784|NCT01746901|102229493|FG004|NOT COMPLETED|Treatment Phase: Second Intervention||0||
48771785|NCT01746901|102229494|FG005|NOT COMPLETED|Treatment Phase: Second Intervention||0||
48771786|NCT01746901|102229495|FG006|NOT COMPLETED|Treatment Phase: Second Intervention||0||
48771787|NCT01746901|102229496|FG007|NOT COMPLETED|Treatment Phase: Second Intervention||1||
48771788|NCT01746901|102229497|FG008|NOT COMPLETED|Treatment Phase: Second Intervention||0||
48771789|NCT01746901|102229489|FG000|STARTED|Treatment Phase: Washout Period 2||0||
48771790|NCT01746901|102229490|FG001|STARTED|Treatment Phase: Washout Period 2||0||
48771791|NCT01746901|102229491|FG002|STARTED|Treatment Phase: Washout Period 2||0||
48771792|NCT01746901|102229492|FG003|STARTED|Treatment Phase: Washout Period 2||6||
48771793|NCT01746901|102229493|FG004|STARTED|Treatment Phase: Washout Period 2||6||
48771794|NCT01746901|102229494|FG005|STARTED|Treatment Phase: Washout Period 2||7||
48771795|NCT01746901|102229495|FG006|STARTED|Treatment Phase: Washout Period 2||7||
48771796|NCT01746901|102229496|FG007|STARTED|Treatment Phase: Washout Period 2||6||
48771797|NCT01746901|102229497|FG008|STARTED|Treatment Phase: Washout Period 2||7||
48771798|NCT01746901|102229489|FG000|COMPLETED|Treatment Phase: Washout Period 2||0||
48771799|NCT01746901|102229490|FG001|COMPLETED|Treatment Phase: Washout Period 2||0||
48771800|NCT01746901|102229491|FG002|COMPLETED|Treatment Phase: Washout Period 2||0||
48449948|NCT02577900|101437009|FG001|COMPLETED|Overall Study||10||
48449949|NCT02577900|101437010|FG002|COMPLETED|Overall Study||10||
48449950|NCT02577900|101437008|FG000|NOT COMPLETED|Overall Study||0||
48449951|NCT02577900|101437009|FG001|NOT COMPLETED|Overall Study||0||
48449952|NCT02577900|101437010|FG002|NOT COMPLETED|Overall Study||0||
48449953|NCT02522949|101437011|FG000|STARTED|Overall Study||23||
48449954|NCT02522949|101437012|FG001|STARTED|Overall Study||23||
48449955|NCT02522949|101437011|FG000|COMPLETED|Overall Study||23||
48449956|NCT02522949|101437012|FG001|COMPLETED|Overall Study||23||
48449957|NCT02522949|101437011|FG000|NOT COMPLETED|Overall Study||0||
48449958|NCT02522949|101437012|FG001|NOT COMPLETED|Overall Study||0||
48449959|NCT00931385|101437013|FG000|STARTED|Overall Study||25||
48449960|NCT00931385|101437014|FG001|STARTED|Overall Study||23||
48449961|NCT00931385|101437015|FG002|STARTED|Overall Study||25||
48449962|NCT00931385|101437016|FG003|STARTED|Overall Study||26||
48449963|NCT00931385|101437013|FG000|COMPLETED|Overall Study||23||
48449964|NCT00931385|101437014|FG001|COMPLETED|Overall Study||21||
48449965|NCT00931385|101437015|FG002|COMPLETED|Overall Study||24||
48449966|NCT00931385|101437016|FG003|COMPLETED|Overall Study||21||
48449967|NCT00931385|101437013|FG000|NOT COMPLETED|Overall Study||2||
48449968|NCT00931385|101437014|FG001|NOT COMPLETED|Overall Study||2||
48449969|NCT00931385|101437015|FG002|NOT COMPLETED|Overall Study||1||
48449970|NCT00931385|101437016|FG003|NOT COMPLETED|Overall Study||5||
48449971|NCT04056299|101437017|FG000|STARTED|Overall Study||9||
48449972|NCT04056299|101437018|FG001|STARTED|Overall Study||6||
48449973|NCT04056299|101437017|FG000|COMPLETED|Overall Study||6||
48449974|NCT04056299|101437018|FG001|COMPLETED|Overall Study||3||
48449975|NCT04056299|101437017|FG000|NOT COMPLETED|Overall Study||3||
48449976|NCT04056299|101437018|FG001|NOT COMPLETED|Overall Study||3||
48449977|NCT04385199|101437019|FG000|STARTED|Overall Study||20||
48449978|NCT04385199|101437020|FG001|STARTED|Overall Study||10||
48449979|NCT04385199|101437019|FG000|COMPLETED|Overall Study||19||
48449980|NCT04385199|101437020|FG001|COMPLETED|Overall Study||10||
48449981|NCT04385199|101437019|FG000|NOT COMPLETED|Overall Study||1||
48449982|NCT04385199|101437020|FG001|NOT COMPLETED|Overall Study||0||
48449983|NCT01358708|101437021|FG000|STARTED|Double-Blind Treatment Phase||13||
48449984|NCT01358708|101437022|FG001|STARTED|Double-Blind Treatment Phase||13||
48449985|NCT01358708|101437021|FG000|Randomized|Double-Blind Treatment Phase||13||
48449986|NCT01358708|101437022|FG001|Randomized|Double-Blind Treatment Phase||13||
48449987|NCT01358708|101437021|FG000|Received Study Medication|Double-Blind Treatment Phase||12||
48449988|NCT01358708|101437022|FG001|Received Study Medication|Double-Blind Treatment Phase||13||
48449989|NCT01358708|101437021|FG000|COMPLETED|Double-Blind Treatment Phase||10||
48449990|NCT01358708|101437022|FG001|COMPLETED|Double-Blind Treatment Phase||13||
48449991|NCT01358708|101437021|FG000|NOT COMPLETED|Double-Blind Treatment Phase||3||
48449992|NCT01358708|101437022|FG001|NOT COMPLETED|Double-Blind Treatment Phase||0||
48449993|NCT01358708|101437021|FG000|STARTED|Open-Label Treatment Phase||5||
48771801|NCT01746901|102229492|FG003|COMPLETED|Treatment Phase: Washout Period 2||6||
48771802|NCT01746901|102229493|FG004|COMPLETED|Treatment Phase: Washout Period 2||6||
48771803|NCT01746901|102229494|FG005|COMPLETED|Treatment Phase: Washout Period 2||7||
48771804|NCT01746901|102229495|FG006|COMPLETED|Treatment Phase: Washout Period 2||7||
48449994|NCT01358708|101437022|FG001|STARTED|Open-Label Treatment Phase||12||
48449995|NCT01358708|101437021|FG000|COMPLETED|Open-Label Treatment Phase||5||
48449996|NCT01358708|101437022|FG001|COMPLETED|Open-Label Treatment Phase||12||
48449997|NCT01358708|101437021|FG000|NOT COMPLETED|Open-Label Treatment Phase||0||
48449998|NCT01358708|101437022|FG001|NOT COMPLETED|Open-Label Treatment Phase||0||
48449999|NCT01958593|101437023|FG000|STARTED|Stage 1||2||
48450000|NCT01958593|101437024|FG001|STARTED|Stage 1||4||
48450001|NCT01958593|101437023|FG000|COMPLETED|Stage 1||2||
48450002|NCT01958593|101437024|FG001|COMPLETED|Stage 1||4||
48450003|NCT01958593|101437023|FG000|NOT COMPLETED|Stage 1||0||
48450004|NCT01958593|101437024|FG001|NOT COMPLETED|Stage 1||0||
48450005|NCT01958593|101437023|FG000|STARTED|Stage 2||2||
48450006|NCT01958593|101437024|FG001|STARTED|Stage 2||0||
48450007|NCT01958593|101437023|FG000|COMPLETED|Stage 2||2||
48450008|NCT01958593|101437024|FG001|COMPLETED|Stage 2||0||
48450009|NCT01958593|101437023|FG000|NOT COMPLETED|Stage 2||0||
48450010|NCT01958593|101437024|FG001|NOT COMPLETED|Stage 2||0||
48450011|NCT03471182|101437025|FG000|STARTED|Overall Study||17||
48450012|NCT03471182|101437026|FG001|STARTED|Overall Study||8||
48450013|NCT03471182|101437027|FG002|STARTED|Overall Study||20||
48450014|NCT03471182|101437025|FG000|Completed MRI Procedures|Overall Study||16||
48450015|NCT03471182|101437026|FG001|Completed MRI Procedures|Overall Study||7||
48450016|NCT03471182|101437027|FG002|Completed MRI Procedures|Overall Study||0||
48450017|NCT03471182|101437025|FG000|Completed PET Procedures|Overall Study||15||
48450018|NCT03471182|101437026|FG001|Completed PET Procedures|Overall Study||0||
48450019|NCT03471182|101437027|FG002|Completed PET Procedures|Overall Study||0||
48450020|NCT03471182|101437025|FG000|Completing Both MRI and PET|Overall Study||14||
48450021|NCT03471182|101437026|FG001|Completing Both MRI and PET|Overall Study||0||
48450022|NCT03471182|101437027|FG002|Completing Both MRI and PET|Overall Study||0||
48450023|NCT03471182|101437025|FG000|COMPLETED|Overall Study||14||
48450024|NCT03471182|101437026|FG001|COMPLETED|Overall Study||7||
48450025|NCT03471182|101437027|FG002|COMPLETED|Overall Study||20||
48660500|NCT00803049|101954556|FG001|COMPLETED|Overall Study||134||
48660501|NCT00803049|101954557|FG002|COMPLETED|Overall Study||64||
48660502|NCT00803049|101954558|FG003|COMPLETED|Overall Study||151||
48660503|NCT00803049|101954555|FG000|NOT COMPLETED|Overall Study||61||
48660504|NCT00803049|101954556|FG001|NOT COMPLETED|Overall Study||118||
48660505|NCT00803049|101954557|FG002|NOT COMPLETED|Overall Study||44||
48660506|NCT00803049|101954558|FG003|NOT COMPLETED|Overall Study||102||
48660507|NCT01258985|101954559|FG000|STARTED|Overall Study||106||
48660508|NCT01258985|101954560|FG001|STARTED|Overall Study||98||
48660509|NCT01258985|101954559|FG000|COMPLETED|Overall Study||106||
48660510|NCT01258985|101954560|FG001|COMPLETED|Overall Study||98||
48660511|NCT01258985|101954559|FG000|NOT COMPLETED|Overall Study||0||
48771805|NCT01746901|102229496|FG007|COMPLETED|Treatment Phase: Washout Period 2||6||
48771806|NCT01746901|102229497|FG008|COMPLETED|Treatment Phase: Washout Period 2||7||
48771807|NCT01746901|102229489|FG000|NOT COMPLETED|Treatment Phase: Washout Period 2||0||
48771808|NCT01746901|102229490|FG001|NOT COMPLETED|Treatment Phase: Washout Period 2||0||
48771809|NCT01746901|102229491|FG002|NOT COMPLETED|Treatment Phase: Washout Period 2||0||
48771810|NCT01746901|102229492|FG003|NOT COMPLETED|Treatment Phase: Washout Period 2||0||
48771811|NCT01746901|102229493|FG004|NOT COMPLETED|Treatment Phase: Washout Period 2||0||
48771812|NCT01746901|102229494|FG005|NOT COMPLETED|Treatment Phase: Washout Period 2||0||
48771813|NCT01746901|102229495|FG006|NOT COMPLETED|Treatment Phase: Washout Period 2||0||
48771814|NCT01746901|102229496|FG007|NOT COMPLETED|Treatment Phase: Washout Period 2||0||
48771815|NCT01746901|102229497|FG008|NOT COMPLETED|Treatment Phase: Washout Period 2||0||
48771816|NCT01746901|102229489|FG000|STARTED|Treatment Phase: Third Intervention||0||
48771817|NCT01746901|102229490|FG001|STARTED|Treatment Phase: Third Intervention||0||
48189140|NCT04655313|100786154|FG000|COMPLETED|Overall Study||20|Seven of the 20 participants who completed the study are continuing in study ARQ-151-306.|
48450026|NCT03471182|101437025|FG000|NOT COMPLETED|Overall Study||3||
48450027|NCT03471182|101437026|FG001|NOT COMPLETED|Overall Study||1||
48450028|NCT03471182|101437027|FG002|NOT COMPLETED|Overall Study||0||
48450029|NCT00802529|101437028|FG000|STARTED|Overall Study||30||
48450030|NCT00802529|101437029|FG001|STARTED|Overall Study||30||
48450031|NCT00802529|101437028|FG000|COMPLETED|Overall Study||30||
48450032|NCT00802529|101437029|FG001|COMPLETED|Overall Study||29||
48450033|NCT00802529|101437028|FG000|NOT COMPLETED|Overall Study||0||
48450034|NCT00802529|101437029|FG001|NOT COMPLETED|Overall Study||1||
48450035|NCT00849524|101437030|FG000|STARTED|Overall Study||6||
48450036|NCT00849524|101437030|FG000|COMPLETED|Overall Study||3||
48450037|NCT00849524|101437030|FG000|NOT COMPLETED|Overall Study||3||
48450038|NCT01799213|101437031|FG000|STARTED|Overall Study||180||
48450039|NCT01799213|101437032|FG001|STARTED|Overall Study||184||
48450040|NCT01799213|101437031|FG000|COMPLETED|Overall Study||173||
48450041|NCT01799213|101437032|FG001|COMPLETED|Overall Study||178||
48450042|NCT01799213|101437031|FG000|NOT COMPLETED|Overall Study||7||
48450043|NCT01799213|101437032|FG001|NOT COMPLETED|Overall Study||6||
48450044|NCT00481871|101437033|FG000|STARTED|Overall Study||7||
48450045|NCT00481871|101437034|FG001|STARTED|Overall Study||10||
48450046|NCT00481871|101437035|FG002|STARTED|Overall Study||18||
48450047|NCT00481871|101437036|FG003|STARTED|Overall Study||38||
48450048|NCT00481871|101437037|FG004|STARTED|Overall Study||34||
48450049|NCT00481871|101437033|FG000|COMPLETED|Overall Study||7||
48450050|NCT00481871|101437034|FG001|COMPLETED|Overall Study||10||
48450051|NCT00481871|101437035|FG002|COMPLETED|Overall Study||17||
48450052|NCT00481871|101437036|FG003|COMPLETED|Overall Study||38||
48450053|NCT00481871|101437037|FG004|COMPLETED|Overall Study||34||
48450054|NCT00481871|101437033|FG000|NOT COMPLETED|Overall Study||0||
48450055|NCT00481871|101437034|FG001|NOT COMPLETED|Overall Study||0||
48450056|NCT00481871|101437035|FG002|NOT COMPLETED|Overall Study||1||
48450057|NCT00481871|101437036|FG003|NOT COMPLETED|Overall Study||0||
48450058|NCT00481871|101437037|FG004|NOT COMPLETED|Overall Study||0||
48450059|NCT01964898|101437038|FG000|STARTED|Overall Study||31||
48450060|NCT01964898|101437039|FG001|STARTED|Overall Study||33||
48450061|NCT01964898|101437038|FG000|12 Week Assessment|Overall Study||25||
48450062|NCT01964898|101437039|FG001|12 Week Assessment|Overall Study||30||
48450063|NCT01964898|101437038|FG000|COMPLETED|Overall Study||24|Completed assessment 6 months post-discharge|
48450064|NCT01964898|101437039|FG001|COMPLETED|Overall Study||26|Completed assessment 6 months post-discharge|
48450065|NCT01964898|101437038|FG000|NOT COMPLETED|Overall Study||7||
48450066|NCT01964898|101437039|FG001|NOT COMPLETED|Overall Study||7||
48450067|NCT03611751|101437040|FG000|STARTED|Pre-treatment||511||
48450068|NCT03611751|101437041|FG001|STARTED|Pre-treatment||255||
48660512|NCT01258985|101954560|FG001|NOT COMPLETED|Overall Study||0||
48660513|NCT04362254|101954561|FG000|STARTED|Overall Study||12||
48660514|NCT04362254|101954561|FG000|COMPLETED|Overall Study||0|Completed trial medication administration|
48660515|NCT04362254|101954561|FG000|NOT COMPLETED|Overall Study||12||
48660516|NCT04668599|101954562|FG000|STARTED|Baseline to Completion of Rehab||106||
48660517|NCT04668599|101954562|FG000|COMPLETED|Baseline to Completion of Rehab||63||
48660518|NCT04668599|101954562|FG000|NOT COMPLETED|Baseline to Completion of Rehab||43||
48660519|NCT04668599|101954562|FG000|STARTED|Completion of Rehab to 3-Month Followup||63||
48660520|NCT04668599|101954562|FG000|COMPLETED|Completion of Rehab to 3-Month Followup||63||
48771818|NCT01746901|102229491|FG002|STARTED|Treatment Phase: Third Intervention||0||
48660521|NCT04668599|101954562|FG000|NOT COMPLETED|Completion of Rehab to 3-Month Followup||0||
48660522|NCT02402907|101954563|FG000|STARTED|Overall Study||682||
48660523|NCT02402907|101954564|FG001|STARTED|Overall Study||674||
48660524|NCT02402907|101954563|FG000|COMPLETED|Overall Study||662||
48660525|NCT02402907|101954564|FG001|COMPLETED|Overall Study||647||
48660526|NCT02402907|101954563|FG000|NOT COMPLETED|Overall Study||20||
48660527|NCT02402907|101954564|FG001|NOT COMPLETED|Overall Study||27||
48660528|NCT02118831|101954565|FG000|STARTED|Overall Study||21||
48771819|NCT01746901|102229492|FG003|STARTED|Treatment Phase: Third Intervention||6||
48771820|NCT01746901|102229493|FG004|STARTED|Treatment Phase: Third Intervention||6||
48771821|NCT01746901|102229494|FG005|STARTED|Treatment Phase: Third Intervention||7||
48771822|NCT01746901|102229495|FG006|STARTED|Treatment Phase: Third Intervention||7||
48771823|NCT01746901|102229496|FG007|STARTED|Treatment Phase: Third Intervention||6||
48771824|NCT01746901|102229497|FG008|STARTED|Treatment Phase: Third Intervention||7||
48771825|NCT01746901|102229489|FG000|COMPLETED|Treatment Phase: Third Intervention||0||
48771826|NCT01746901|102229490|FG001|COMPLETED|Treatment Phase: Third Intervention||0||
48771827|NCT01746901|102229491|FG002|COMPLETED|Treatment Phase: Third Intervention||0||
48771828|NCT01746901|102229492|FG003|COMPLETED|Treatment Phase: Third Intervention||6||
48771829|NCT01746901|102229493|FG004|COMPLETED|Treatment Phase: Third Intervention||6||
48771830|NCT01746901|102229494|FG005|COMPLETED|Treatment Phase: Third Intervention||6||
48771831|NCT01746901|102229495|FG006|COMPLETED|Treatment Phase: Third Intervention||6||
48771832|NCT01746901|102229496|FG007|COMPLETED|Treatment Phase: Third Intervention||6||
48771833|NCT01746901|102229497|FG008|COMPLETED|Treatment Phase: Third Intervention||7||
48771834|NCT01746901|102229489|FG000|NOT COMPLETED|Treatment Phase: Third Intervention||0||
48771835|NCT01746901|102229490|FG001|NOT COMPLETED|Treatment Phase: Third Intervention||0||
48771836|NCT01746901|102229491|FG002|NOT COMPLETED|Treatment Phase: Third Intervention||0||
48771837|NCT01746901|102229492|FG003|NOT COMPLETED|Treatment Phase: Third Intervention||0||
48771838|NCT01746901|102229493|FG004|NOT COMPLETED|Treatment Phase: Third Intervention||0||
48771839|NCT01746901|102229494|FG005|NOT COMPLETED|Treatment Phase: Third Intervention||1||
48450069|NCT03611751|101437042|FG002|STARTED|Pre-treatment||254||
48450070|NCT03611751|101437040|FG000|COMPLETED|Pre-treatment||510||
48450071|NCT03611751|101437041|FG001|COMPLETED|Pre-treatment||254||
48450072|NCT03611751|101437042|FG002|COMPLETED|Pre-treatment||254||
48450073|NCT03611751|101437040|FG000|NOT COMPLETED|Pre-treatment||1||
48450074|NCT03611751|101437041|FG001|NOT COMPLETED|Pre-treatment||1||
48450075|NCT03611751|101437042|FG002|NOT COMPLETED|Pre-treatment||0||
48450076|NCT03611751|101437040|FG000|STARTED|Treatment Week 0 - Week 16||510||
48450077|NCT03611751|101437041|FG001|STARTED|Treatment Week 0 - Week 16||254||
48450078|NCT03611751|101437042|FG002|STARTED|Treatment Week 0 - Week 16||254||
48450079|NCT03611751|101437040|FG000|COMPLETED|Treatment Week 0 - Week 16||456||
48450080|NCT03611751|101437041|FG001|COMPLETED|Treatment Week 0 - Week 16||212||
48450081|NCT03611751|101437042|FG002|COMPLETED|Treatment Week 0 - Week 16||217||
48450082|NCT03611751|101437040|FG000|NOT COMPLETED|Treatment Week 0 - Week 16||54||
48450083|NCT03611751|101437041|FG001|NOT COMPLETED|Treatment Week 0 - Week 16||42||
48450084|NCT03611751|101437042|FG002|NOT COMPLETED|Treatment Week 0 - Week 16||37||
48450085|NCT03611751|101437040|FG000|STARTED|Treatment Week 16 - Week 24||667||
48450086|NCT03611751|101437041|FG001|STARTED|Treatment Week 16 - Week 24||0||
48450087|NCT03611751|101437042|FG002|STARTED|Treatment Week 16 - Week 24||217||
48450088|NCT03611751|101437040|FG000|COMPLETED|Treatment Week 16 - Week 24||642||
48450089|NCT03611751|101437041|FG001|COMPLETED|Treatment Week 16 - Week 24||0||
48450090|NCT03611751|101437042|FG002|COMPLETED|Treatment Week 16 - Week 24||208||
48450091|NCT03611751|101437040|FG000|NOT COMPLETED|Treatment Week 16 - Week 24||25||
48450092|NCT03611751|101437041|FG001|NOT COMPLETED|Treatment Week 16 - Week 24||0||
48450093|NCT03611751|101437042|FG002|NOT COMPLETED|Treatment Week 16 - Week 24||9||
48450094|NCT03611751|101437040|FG000|STARTED|Treatment Week 24 - Week 52||604||
48450095|NCT03611751|101437041|FG001|STARTED|Treatment Week 24 - Week 52||247||
48450096|NCT03611751|101437042|FG002|STARTED|Treatment Week 24 - Week 52||0||
48450097|NCT03611751|101437040|FG000|COMPLETED|Treatment Week 24 - Week 52||535||
48450098|NCT03611751|101437041|FG001|COMPLETED|Treatment Week 24 - Week 52||214||
48450099|NCT03611751|101437042|FG002|COMPLETED|Treatment Week 24 - Week 52||0||
48450100|NCT03611751|101437040|FG000|NOT COMPLETED|Treatment Week 24 - Week 52||69||
48450101|NCT03611751|101437041|FG001|NOT COMPLETED|Treatment Week 24 - Week 52||33||
48771840|NCT01746901|102229495|FG006|NOT COMPLETED|Treatment Phase: Third Intervention||1||
48450102|NCT03611751|101437042|FG002|NOT COMPLETED|Treatment Week 24 - Week 52||0||
48450103|NCT01715415|101437043|FG000|STARTED|Double-blind Treatment||297||
48450104|NCT01715415|101437044|FG001|STARTED|Double-blind Treatment||98||
48450105|NCT01715415|101437043|FG000|Randomized But Not Treated|Double-blind Treatment||0||
48660529|NCT02118831|101954566|FG001|STARTED|Overall Study||15||
48660530|NCT02118831|101954567|FG002|STARTED|Overall Study||20||
48660531|NCT02118831|101954565|FG000|COMPLETED|Overall Study||21||
48660532|NCT02118831|101954566|FG001|COMPLETED|Overall Study||15||
48660533|NCT02118831|101954567|FG002|COMPLETED|Overall Study||20||
48660534|NCT02118831|101954565|FG000|NOT COMPLETED|Overall Study||0||
48660535|NCT02118831|101954566|FG001|NOT COMPLETED|Overall Study||0||
48660536|NCT02118831|101954567|FG002|NOT COMPLETED|Overall Study||0||
48660537|NCT02090894|101954568|FG000|STARTED|Overall Study||11||
48450106|NCT01715415|101437044|FG001|Randomized But Not Treated|Double-blind Treatment||1||
48450107|NCT01715415|101437043|FG000|COMPLETED|Double-blind Treatment||292||
48450108|NCT01715415|101437044|FG001|COMPLETED|Double-blind Treatment||96||
48450109|NCT01715415|101437043|FG000|NOT COMPLETED|Double-blind Treatment||5||
48450110|NCT01715415|101437044|FG001|NOT COMPLETED|Double-blind Treatment||2||
48450111|NCT01715415|101437043|FG000|STARTED|Open-label Treatment||0||
48450112|NCT01715415|101437044|FG001|STARTED|Open-label Treatment||96||
48450113|NCT01715415|101437043|FG000|COMPLETED|Open-label Treatment||0||
48450114|NCT01715415|101437044|FG001|COMPLETED|Open-label Treatment||94||
48450115|NCT01715415|101437043|FG000|NOT COMPLETED|Open-label Treatment||0||
48450116|NCT01715415|101437044|FG001|NOT COMPLETED|Open-label Treatment||2||
48450117|NCT01543607|101437045|FG000|STARTED|Overall Study||1||
48450118|NCT01543607|101437045|FG000|COMPLETED|Overall Study||1||
48450119|NCT01543607|101437045|FG000|NOT COMPLETED|Overall Study||0||
48450120|NCT02020785|101437046|FG000|STARTED|First Intervention (3 Weeks)||15||
48450121|NCT02020785|101437047|FG001|STARTED|First Intervention (3 Weeks)||16||
48450122|NCT02020785|101437046|FG000|COMPLETED|First Intervention (3 Weeks)||15||
48450123|NCT02020785|101437047|FG001|COMPLETED|First Intervention (3 Weeks)||16||
48450124|NCT02020785|101437046|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0||
48450125|NCT02020785|101437047|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0||
48450126|NCT02020785|101437046|FG000|STARTED|Second Intervention (3 Weeks)||15||
48450127|NCT02020785|101437047|FG001|STARTED|Second Intervention (3 Weeks)||16||
48450128|NCT02020785|101437046|FG000|COMPLETED|Second Intervention (3 Weeks)||15||
48450129|NCT02020785|101437047|FG001|COMPLETED|Second Intervention (3 Weeks)||16||
48450130|NCT02020785|101437046|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0||
48450131|NCT02020785|101437047|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0||
48450132|NCT01246973|101437048|FG000|STARTED|Overall Study||344||
48450133|NCT01246973|101437049|FG001|STARTED|Overall Study||342||
48450134|NCT01246973|101437048|FG000|COMPLETED|Overall Study||283||
48450135|NCT01246973|101437049|FG001|COMPLETED|Overall Study||295||
48450136|NCT01246973|101437048|FG000|NOT COMPLETED|Overall Study||61||
48450137|NCT01246973|101437049|FG001|NOT COMPLETED|Overall Study||47||
48450138|NCT02009982|101437050|FG000|STARTED|Overall Study||1||
48450139|NCT02009982|101437051|FG001|STARTED|Overall Study||2||
48450140|NCT02009982|101437050|FG000|COMPLETED|Overall Study||1||
48450141|NCT02009982|101437051|FG001|COMPLETED|Overall Study||2||
48450142|NCT02009982|101437050|FG000|NOT COMPLETED|Overall Study||0||
48450143|NCT02009982|101437051|FG001|NOT COMPLETED|Overall Study||0||
48450144|NCT00751998|101437052|FG000|STARTED|Overall Study||297||
48450145|NCT00751998|101437052|FG000|COMPLETED|Overall Study||277||
48450146|NCT00751998|101437052|FG000|NOT COMPLETED|Overall Study||20||
48450147|NCT02039817|101437053|FG000|STARTED|Overall Study||8||
48450148|NCT02039817|101437054|FG001|STARTED|Overall Study||8||
48450149|NCT02039817|101437053|FG000|COMPLETED|Overall Study||8||
48450150|NCT02039817|101437054|FG001|COMPLETED|Overall Study||8||
48450151|NCT02039817|101437053|FG000|NOT COMPLETED|Overall Study||0||
48450152|NCT02039817|101437054|FG001|NOT COMPLETED|Overall Study||0||
48450153|NCT00520494|101437055|FG000|STARTED|Overall Study||18||
48450154|NCT00520494|101437055|FG000|COMPLETED|Overall Study||17||
48450155|NCT00520494|101437055|FG000|NOT COMPLETED|Overall Study||1||
48450156|NCT02869295|101437056|FG000|STARTED|Overall Study||4||
48450157|NCT02869295|101437057|FG001|STARTED|Overall Study||11||
48450158|NCT02869295|101437058|FG002|STARTED|Overall Study||6||
48450159|NCT02869295|101437059|FG003|STARTED|Overall Study||6||
48450160|NCT02869295|101437060|FG004|STARTED|Overall Study||1||
48450161|NCT02869295|101437056|FG000|COMPLETED|Overall Study||0||
48450162|NCT02869295|101437057|FG001|COMPLETED|Overall Study||0||
48450163|NCT02869295|101437058|FG002|COMPLETED|Overall Study||0||
48450164|NCT02869295|101437059|FG003|COMPLETED|Overall Study||0||
48450165|NCT02869295|101437060|FG004|COMPLETED|Overall Study||0||
48450166|NCT02869295|101437056|FG000|NOT COMPLETED|Overall Study||4||
48450167|NCT02869295|101437057|FG001|NOT COMPLETED|Overall Study||11||
48450168|NCT02869295|101437058|FG002|NOT COMPLETED|Overall Study||6||
48450169|NCT02869295|101437059|FG003|NOT COMPLETED|Overall Study||6||
48450170|NCT02869295|101437060|FG004|NOT COMPLETED|Overall Study||1||
48450171|NCT03372083|101437061|FG000|STARTED|Overall Study||44|All enrolled patients were included in both the full analysis set (FAS) and the safety set|
48450172|NCT03372083|101437061|FG000|COMPLETED|Overall Study||39||
48450173|NCT03372083|101437061|FG000|NOT COMPLETED|Overall Study||5||
48450174|NCT01039584|101437062|FG000|STARTED|Overall Study||246||
48450175|NCT01039584|101437063|FG001|STARTED|Overall Study||243||
48450176|NCT01039584|101437064|FG002|STARTED|Overall Study||122||
48450177|NCT01039584|101437062|FG000|COMPLETED|Overall Study||143||
48450178|NCT01039584|101437063|FG001|COMPLETED|Overall Study||146||
48450179|NCT01039584|101437064|FG002|COMPLETED|Overall Study||65||
48450180|NCT01039584|101437062|FG000|NOT COMPLETED|Overall Study||103||
48450181|NCT01039584|101437063|FG001|NOT COMPLETED|Overall Study||97||
48450182|NCT01039584|101437064|FG002|NOT COMPLETED|Overall Study||57||
48450183|NCT02458365|101437065|FG000|STARTED|Overall Study||2000||
48450184|NCT02458365|101437066|FG001|STARTED|Overall Study||1901||
48450185|NCT02458365|101437065|FG000|COMPLETED|Overall Study||1723||
48450186|NCT02458365|101437066|FG001|COMPLETED|Overall Study||1607||
48450187|NCT02458365|101437065|FG000|NOT COMPLETED|Overall Study||277||
48450188|NCT02458365|101437066|FG001|NOT COMPLETED|Overall Study||294||
48450189|NCT01656967|101437067|FG000|STARTED|Overall Study||33||
48450190|NCT01656967|101437068|FG001|STARTED|Overall Study||33||
48450191|NCT01656967|101437067|FG000|SGA Placement|Overall Study||32||
48450192|NCT01656967|101437068|FG001|SGA Placement|Overall Study||33||
48450193|NCT01656967|101437067|FG000|ETT Insertion|Overall Study||29||
48450194|NCT01656967|101437068|FG001|ETT Insertion|Overall Study||31||
48450195|NCT01656967|101437067|FG000|COMPLETED|Overall Study||29||
48450196|NCT01656967|101437068|FG001|COMPLETED|Overall Study||31||
48450197|NCT01656967|101437067|FG000|NOT COMPLETED|Overall Study||4||
48450198|NCT01656967|101437068|FG001|NOT COMPLETED|Overall Study||2||
48450199|NCT01453374|101437069|FG000|STARTED|Overall Study||27||
48450200|NCT01453374|101437069|FG000|COMPLETED|Overall Study||9||
48450201|NCT01453374|101437069|FG000|NOT COMPLETED|Overall Study||18||
48450202|NCT03007537|101437070|FG000|STARTED|Overall Study||51||
48450203|NCT03007537|101437071|FG001|STARTED|Overall Study||50||
48450204|NCT03007537|101437070|FG000|COMPLETED|Overall Study||46||
48450205|NCT03007537|101437071|FG001|COMPLETED|Overall Study||46||
48450206|NCT03007537|101437070|FG000|NOT COMPLETED|Overall Study||5||
48450207|NCT03007537|101437071|FG001|NOT COMPLETED|Overall Study||4||
48450208|NCT00267020|101437072|FG000|STARTED|Overall Study||86||
48771841|NCT01746901|102229496|FG007|NOT COMPLETED|Treatment Phase: Third Intervention||0||
48771842|NCT01746901|102229497|FG008|NOT COMPLETED|Treatment Phase: Third Intervention||0||
48771843|NCT01746901|102229489|FG000|STARTED|Treatment Phase: Washout Period 3||0||
48771844|NCT01746901|102229490|FG001|STARTED|Treatment Phase: Washout Period 3||0||
48450209|NCT00267020|101437073|FG001|STARTED|Overall Study||44||
48450210|NCT00267020|101437072|FG000|Received at Least 1 Dose|Overall Study||82||
48660538|NCT02090894|101954568|FG000|COMPLETED|Overall Study||11||
48660539|NCT02090894|101954568|FG000|NOT COMPLETED|Overall Study||0||
48660540|NCT03635996|101954569|FG000|STARTED|Overall Study||169||
48660541|NCT03635996|101954569|FG000|Patients Not Treated With Etripamil|Overall Study||64||
48660542|NCT03635996|101954569|FG000|Safety Population|Overall Study||105||
48660543|NCT03635996|101954569|FG000|Efficacy Population|Overall Study||92||
48660544|NCT03635996|101954569|FG000|COMPLETED|Overall Study||2||
48660545|NCT03635996|101954569|FG000|NOT COMPLETED|Overall Study||167||
48660546|NCT00913835|101954570|FG000|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||63||
48660547|NCT00913835|101954571|FG001|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||62||
48660548|NCT00913835|101954570|FG000|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||62||
48660549|NCT00913835|101954571|FG001|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||61||
48660550|NCT00913835|101954570|FG000|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55||
48660551|NCT00913835|101954571|FG001|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55||
48660552|NCT00913835|101954570|FG000|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||8||
48660553|NCT00913835|101954571|FG001|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||7||
48660554|NCT00913835|101954570|FG000|STARTED|Lip Dox: Olaratumab Monotherapy||0||
48771845|NCT01746901|102229491|FG002|STARTED|Treatment Phase: Washout Period 3||0||
48771846|NCT01746901|102229492|FG003|STARTED|Treatment Phase: Washout Period 3||6||
48771847|NCT01746901|102229493|FG004|STARTED|Treatment Phase: Washout Period 3||6||
48771848|NCT01746901|102229494|FG005|STARTED|Treatment Phase: Washout Period 3||6||
48450211|NCT00267020|101437073|FG001|Received at Least 1 Dose|Overall Study||39||
48450212|NCT00267020|101437072|FG000|Per-Protocol Population|Overall Study||81||
48450213|NCT00267020|101437073|FG001|Per-Protocol Population|Overall Study||38||
48450214|NCT00267020|101437072|FG000|COMPLETED|Overall Study||0||
48450215|NCT00267020|101437073|FG001|COMPLETED|Overall Study||1||
48450216|NCT00267020|101437072|FG000|NOT COMPLETED|Overall Study||86||
48450217|NCT00267020|101437073|FG001|NOT COMPLETED|Overall Study||43||
48450218|NCT00183469|101437074|FG000|STARTED|Overall Study||41||
48450219|NCT00183469|101437075|FG001|STARTED|Overall Study||45||
48450220|NCT00183469|101437074|FG000|COMPLETED|Overall Study||13||
48450221|NCT00183469|101437075|FG001|COMPLETED|Overall Study||16||
48450222|NCT00183469|101437074|FG000|NOT COMPLETED|Overall Study||28||
48450223|NCT00183469|101437075|FG001|NOT COMPLETED|Overall Study||29||
48450224|NCT02475980|101437076|FG000|STARTED|Overall Study||13||
48450225|NCT02475980|101437076|FG000|COMPLETED|Overall Study||8||
48450226|NCT02475980|101437076|FG000|NOT COMPLETED|Overall Study||5||
48450227|NCT00033631|101437077|FG000|STARTED|Overall Study||769||
48450228|NCT00033631|101437078|FG001|STARTED|Overall Study||763||
48660555|NCT00913835|101954571|FG001|STARTED|Lip Dox: Olaratumab Monotherapy||28||
48660556|NCT00913835|101954570|FG000|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||0||
48660557|NCT00913835|101954571|FG001|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||28||
48771849|NCT01746901|102229495|FG006|STARTED|Treatment Phase: Washout Period 3||6||
48771850|NCT01746901|102229496|FG007|STARTED|Treatment Phase: Washout Period 3||6||
48450229|NCT00033631|101437077|FG000|COMPLETED|Overall Study||751||
48450230|NCT00033631|101437078|FG001|COMPLETED|Overall Study||748||
48450231|NCT00033631|101437077|FG000|NOT COMPLETED|Overall Study||18||
48450232|NCT00033631|101437078|FG001|NOT COMPLETED|Overall Study||15||
48450233|NCT02059187|101437079|FG000|STARTED|Overall Study||265||
48450234|NCT02059187|101437080|FG001|STARTED|Overall Study||266||
48450235|NCT02059187|101437079|FG000|COMPLETED|Overall Study||240||
48450236|NCT02059187|101437080|FG001|COMPLETED|Overall Study||244||
48450237|NCT02059187|101437079|FG000|NOT COMPLETED|Overall Study||25||
48450238|NCT02059187|101437080|FG001|NOT COMPLETED|Overall Study||22||
48450239|NCT00534209|101437081|FG000|STARTED|Overall Study||1||
48450240|NCT00534209|101437081|FG000|COMPLETED|Overall Study||1||
48450241|NCT00534209|101437081|FG000|NOT COMPLETED|Overall Study||0||
48450242|NCT02625207|101437082|FG000|STARTED|Part 1 (6 Days)||11||
48450243|NCT02625207|101437083|FG001|STARTED|Part 1 (6 Days)||12||
48450244|NCT02625207|101437084|FG002|STARTED|Part 1 (6 Days)||12||
48450245|NCT02625207|101437085|FG003|STARTED|Part 1 (6 Days)||12||
48450246|NCT02625207|101437082|FG000|COMPLETED|Part 1 (6 Days)||11||
48450247|NCT02625207|101437083|FG001|COMPLETED|Part 1 (6 Days)||12||
48450248|NCT02625207|101437084|FG002|COMPLETED|Part 1 (6 Days)||12||
48450249|NCT02625207|101437085|FG003|COMPLETED|Part 1 (6 Days)||12||
48450250|NCT02625207|101437082|FG000|NOT COMPLETED|Part 1 (6 Days)||0||
48450251|NCT02625207|101437083|FG001|NOT COMPLETED|Part 1 (6 Days)||0||
48450252|NCT02625207|101437084|FG002|NOT COMPLETED|Part 1 (6 Days)||0||
48450253|NCT02625207|101437085|FG003|NOT COMPLETED|Part 1 (6 Days)||0||
48450254|NCT02625207|101437082|FG000|STARTED|Part 2 (11 Days)||11||
48450255|NCT02625207|101437083|FG001|STARTED|Part 2 (11 Days)||0||
48450256|NCT02625207|101437084|FG002|STARTED|Part 2 (11 Days)||12||
48450257|NCT02625207|101437085|FG003|STARTED|Part 2 (11 Days)||0||
48450258|NCT02625207|101437082|FG000|COMPLETED|Part 2 (11 Days)||11||
48450259|NCT02625207|101437083|FG001|COMPLETED|Part 2 (11 Days)||0||
48450260|NCT02625207|101437084|FG002|COMPLETED|Part 2 (11 Days)||12||
48450261|NCT02625207|101437085|FG003|COMPLETED|Part 2 (11 Days)||0||
48450262|NCT02625207|101437082|FG000|NOT COMPLETED|Part 2 (11 Days)||0||
48450263|NCT02625207|101437083|FG001|NOT COMPLETED|Part 2 (11 Days)||0||
48450264|NCT02625207|101437084|FG002|NOT COMPLETED|Part 2 (11 Days)||0||
48450265|NCT02625207|101437085|FG003|NOT COMPLETED|Part 2 (11 Days)||0||
48450266|NCT01586624|101437086|FG000|STARTED|Overall Study||6||
48450267|NCT01586624|101437087|FG001|STARTED|Overall Study||6||
48450268|NCT01586624|101437088|FG002|STARTED|Overall Study||6||
48450269|NCT01586624|101437089|FG003|STARTED|Overall Study||7||
48450270|NCT01586624|101437090|FG004|STARTED|Overall Study||9||
48450271|NCT01586624|101437091|FG005|STARTED|Overall Study||8||
48450272|NCT01586624|101437092|FG006|STARTED|Overall Study||8||
48450273|NCT01586624|101437093|FG007|STARTED|Overall Study||11||
48450274|NCT01586624|101437086|FG000|COMPLETED|Overall Study||2||
48450275|NCT01586624|101437087|FG001|COMPLETED|Overall Study||2||
48450276|NCT01586624|101437088|FG002|COMPLETED|Overall Study||1||
48450277|NCT01586624|101437089|FG003|COMPLETED|Overall Study||0||
48450278|NCT01586624|101437090|FG004|COMPLETED|Overall Study||1||
48450279|NCT01586624|101437091|FG005|COMPLETED|Overall Study||0||
48450280|NCT01586624|101437092|FG006|COMPLETED|Overall Study||0||
48450281|NCT01586624|101437093|FG007|COMPLETED|Overall Study||1||
48450282|NCT01586624|101437086|FG000|NOT COMPLETED|Overall Study||4||
48450283|NCT01586624|101437087|FG001|NOT COMPLETED|Overall Study||4||
48450284|NCT01586624|101437088|FG002|NOT COMPLETED|Overall Study||5||
48450285|NCT01586624|101437089|FG003|NOT COMPLETED|Overall Study||7||
48450286|NCT01586624|101437090|FG004|NOT COMPLETED|Overall Study||8||
48450287|NCT01586624|101437091|FG005|NOT COMPLETED|Overall Study||8||
48450288|NCT01586624|101437092|FG006|NOT COMPLETED|Overall Study||8||
48450289|NCT01586624|101437093|FG007|NOT COMPLETED|Overall Study||10||
48450290|NCT01984229|101437094|FG000|STARTED|Period 1||6||
48660558|NCT00913835|101954570|FG000|COMPLETED|Lip Dox: Olaratumab Monotherapy||0||
48660559|NCT00913835|101954571|FG001|COMPLETED|Lip Dox: Olaratumab Monotherapy||25||
48660560|NCT00913835|101954570|FG000|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||0||
48670044|NCT03601897|101974875|FG009|NOT COMPLETED|Overall Study||11||
48450291|NCT01984229|101437095|FG001|STARTED|Period 1||17||
48450292|NCT01984229|101437094|FG000|COMPLETED|Period 1||6||
48450293|NCT01984229|101437095|FG001|COMPLETED|Period 1||17||
48450294|NCT01984229|101437094|FG000|NOT COMPLETED|Period 1||0||
48450295|NCT01984229|101437095|FG001|NOT COMPLETED|Period 1||0||
48450296|NCT01984229|101437094|FG000|STARTED|Period 2||6||
48450297|NCT01984229|101437095|FG001|STARTED|Period 2||17||
48450298|NCT01984229|101437094|FG000|COMPLETED|Period 2||6||
48450299|NCT01984229|101437095|FG001|COMPLETED|Period 2||17||
48450300|NCT01984229|101437094|FG000|NOT COMPLETED|Period 2||0||
48450301|NCT01984229|101437095|FG001|NOT COMPLETED|Period 2||0||
48450302|NCT01984229|101437094|FG000|STARTED|Period 3||6||
48450303|NCT01984229|101437095|FG001|STARTED|Period 3||17||
48450304|NCT01984229|101437094|FG000|COMPLETED|Period 3||6||
48450305|NCT01984229|101437095|FG001|COMPLETED|Period 3||17||
48450306|NCT01984229|101437094|FG000|NOT COMPLETED|Period 3||0||
48450307|NCT01984229|101437095|FG001|NOT COMPLETED|Period 3||0||
48450308|NCT01984229|101437094|FG000|STARTED|Safety Follow-up Period||6||
48450309|NCT01984229|101437095|FG001|STARTED|Safety Follow-up Period||17||
48450310|NCT01984229|101437094|FG000|COMPLETED|Safety Follow-up Period||4||
48450311|NCT01984229|101437095|FG001|COMPLETED|Safety Follow-up Period||16||
48450312|NCT01984229|101437094|FG000|NOT COMPLETED|Safety Follow-up Period||2||
48450313|NCT01984229|101437095|FG001|NOT COMPLETED|Safety Follow-up Period||1||
48450314|NCT01364298|101437096|FG000|STARTED|Overall Study||176||
48450315|NCT01364298|101437097|FG001|STARTED|Overall Study||177||
48450316|NCT01364298|101437096|FG000|Treated|Overall Study||174||
48450317|NCT01364298|101437097|FG001|Treated|Overall Study||174||
48450318|NCT01364298|101437096|FG000|COMPLETED|Overall Study||162||
48450319|NCT01364298|101437097|FG001|COMPLETED|Overall Study||154||
48450320|NCT01364298|101437096|FG000|NOT COMPLETED|Overall Study||14||
48450321|NCT01364298|101437097|FG001|NOT COMPLETED|Overall Study||23||
48450322|NCT04444752|101437098|FG000|STARTED|Overall Study||57||
48660561|NCT00913835|101954571|FG001|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||3||
48660562|NCT03726879|101954572|FG000|STARTED|Overall Study||226||
48660563|NCT03726879|101954573|FG001|STARTED|Overall Study||228||
48660564|NCT03726879|101954572|FG000|COMPLETED|Overall Study||206||
48660565|NCT03726879|101954573|FG001|COMPLETED|Overall Study||205||
48660566|NCT03726879|101954572|FG000|NOT COMPLETED|Overall Study||20||
48660567|NCT03726879|101954573|FG001|NOT COMPLETED|Overall Study||23||
48660568|NCT04003142|101954574|FG000|STARTED|Double-blind Period (12 Weeks)||168||
48660569|NCT04003142|101954575|FG001|STARTED|Double-blind Period (12 Weeks)||166||
48660570|NCT04003142|101954576|FG002|STARTED|Double-blind Period (12 Weeks)||167||
48660571|NCT04003142|101954577|FG003|STARTED|Double-blind Period (12 Weeks)||0||
48660572|NCT04003142|101954578|FG004|STARTED|Double-blind Period (12 Weeks)||0||
48660573|NCT04003142|101954574|FG000|Treated|Double-blind Period (12 Weeks)||167||
48660574|NCT04003142|101954575|FG001|Treated|Double-blind Period (12 Weeks)||166||
48660575|NCT04003142|101954576|FG002|Treated|Double-blind Period (12 Weeks)||167||
48660576|NCT04003142|101954577|FG003|Treated|Double-blind Period (12 Weeks)||0||
48660577|NCT04003142|101954578|FG004|Treated|Double-blind Period (12 Weeks)||0||
48660578|NCT04003142|101954574|FG000|COMPLETED|Double-blind Period (12 Weeks)||151||
48660579|NCT04003142|101954575|FG001|COMPLETED|Double-blind Period (12 Weeks)||152||
48660580|NCT04003142|101954576|FG002|COMPLETED|Double-blind Period (12 Weeks)||155||
48660581|NCT04003142|101954577|FG003|COMPLETED|Double-blind Period (12 Weeks)||0||
48660582|NCT04003142|101954578|FG004|COMPLETED|Double-blind Period (12 Weeks)||0||
48660583|NCT04003142|101954574|FG000|NOT COMPLETED|Double-blind Period (12 Weeks)||17||
48660584|NCT04003142|101954575|FG001|NOT COMPLETED|Double-blind Period (12 Weeks)||14||
48660585|NCT04003142|101954576|FG002|NOT COMPLETED|Double-blind Period (12 Weeks)||12||
48660586|NCT04003142|101954577|FG003|NOT COMPLETED|Double-blind Period (12 Weeks)||0||
48660587|NCT04003142|101954578|FG004|NOT COMPLETED|Double-blind Period (12 Weeks)||0||
48660588|NCT04003142|101954574|FG000|STARTED|Extension Period (40 Weeks)||0||
48660589|NCT04003142|101954575|FG001|STARTED|Extension Period (40 Weeks)||152||
48660590|NCT04003142|101954576|FG002|STARTED|Extension Period (40 Weeks)||154||
48660591|NCT04003142|101954577|FG003|STARTED|Extension Period (40 Weeks)||76||
48660592|NCT04003142|101954578|FG004|STARTED|Extension Period (40 Weeks)||75||
48660593|NCT04003142|101954574|FG000|COMPLETED|Extension Period (40 Weeks)||0||
48660594|NCT04003142|101954575|FG001|COMPLETED|Extension Period (40 Weeks)||125||
48660595|NCT04003142|101954576|FG002|COMPLETED|Extension Period (40 Weeks)||132||
48660596|NCT04003142|101954577|FG003|COMPLETED|Extension Period (40 Weeks)||63||
48660597|NCT04003142|101954578|FG004|COMPLETED|Extension Period (40 Weeks)||63||
48660598|NCT04003142|101954574|FG000|NOT COMPLETED|Extension Period (40 Weeks)||0||
48660599|NCT04003142|101954575|FG001|NOT COMPLETED|Extension Period (40 Weeks)||27||
48660600|NCT04003142|101954576|FG002|NOT COMPLETED|Extension Period (40 Weeks)||22||
48660601|NCT04003142|101954577|FG003|NOT COMPLETED|Extension Period (40 Weeks)||13||
48660602|NCT04003142|101954578|FG004|NOT COMPLETED|Extension Period (40 Weeks)||12||
48660603|NCT02727699|101954579|FG000|STARTED|Overall Study||91||
48450323|NCT04444752|101437099|FG001|STARTED|Overall Study||57||
48450324|NCT04444752|101437100|FG002|STARTED|Overall Study||56||
48450325|NCT04444752|101437101|FG003|STARTED|Overall Study||56||
48450326|NCT04444752|101437098|FG000|COMPLETED|Overall Study||46||
48450327|NCT04444752|101437099|FG001|COMPLETED|Overall Study||45||
48450328|NCT04444752|101437100|FG002|COMPLETED|Overall Study||50||
48450329|NCT04444752|101437101|FG003|COMPLETED|Overall Study||40||
48660604|NCT02727699|101954580|FG001|STARTED|Overall Study||94||
48660605|NCT02727699|101954579|FG000|COMPLETED|Overall Study||82||
48660606|NCT02727699|101954580|FG001|COMPLETED|Overall Study||89||
48660607|NCT02727699|101954579|FG000|NOT COMPLETED|Overall Study||9||
48660608|NCT02727699|101954580|FG001|NOT COMPLETED|Overall Study||5||
48450330|NCT04444752|101437098|FG000|NOT COMPLETED|Overall Study||11||
48450331|NCT04444752|101437099|FG001|NOT COMPLETED|Overall Study||12||
48450332|NCT04444752|101437100|FG002|NOT COMPLETED|Overall Study||6||
48450333|NCT04444752|101437101|FG003|NOT COMPLETED|Overall Study||16||
48450334|NCT00575328|101437102|FG000|STARTED|Overall Study||4||
48450335|NCT00575328|101437103|FG001|STARTED|Overall Study||4||
48450336|NCT00575328|101437102|FG000|COMPLETED|Overall Study||1||
48450337|NCT00575328|101437103|FG001|COMPLETED|Overall Study||2||
48450338|NCT00575328|101437102|FG000|NOT COMPLETED|Overall Study||3||
48450339|NCT00575328|101437103|FG001|NOT COMPLETED|Overall Study||2||
48660609|NCT02180867|101954581|FG000|STARTED|Overall Study||10||
48660610|NCT02180867|101954582|FG001|STARTED|Overall Study||11||
48660611|NCT02180867|101954583|FG002|STARTED|Overall Study||10||
48660612|NCT02180867|101954584|FG003|STARTED|Overall Study||49||
48660613|NCT02180867|101954585|FG004|STARTED|Overall Study||48||
48660614|NCT02180867|101954586|FG005|STARTED|Overall Study||6||
48660615|NCT02180867|101954587|FG006|STARTED|Overall Study||6||
48660616|NCT02180867|101954581|FG000|Pediatric Patients|Overall Study||6||
48660617|NCT02180867|101954582|FG001|Pediatric Patients|Overall Study||4||
48660618|NCT02180867|101954583|FG002|Pediatric Patients|Overall Study||3||
48660619|NCT02180867|101954584|FG003|Pediatric Patients|Overall Study||18||
48660620|NCT02180867|101954585|FG004|Pediatric Patients|Overall Study||19||
48660621|NCT02180867|101954586|FG005|Pediatric Patients|Overall Study||1||
48660622|NCT02180867|101954587|FG006|Pediatric Patients|Overall Study||0||
48660623|NCT02180867|101954581|FG000|Adult Patients|Overall Study||4||
48660624|NCT02180867|101954582|FG001|Adult Patients|Overall Study||7||
48660625|NCT02180867|101954583|FG002|Adult Patients|Overall Study||7||
48660626|NCT02180867|101954584|FG003|Adult Patients|Overall Study||31||
48660627|NCT02180867|101954585|FG004|Adult Patients|Overall Study||29||
48660628|NCT02180867|101954586|FG005|Adult Patients|Overall Study||5||
48660629|NCT02180867|101954587|FG006|Adult Patients|Overall Study||6||
48660630|NCT02180867|101954581|FG000|COMPLETED|Overall Study||4||
48771851|NCT01746901|102229497|FG008|STARTED|Treatment Phase: Washout Period 3||7||
48771852|NCT01746901|102229489|FG000|COMPLETED|Treatment Phase: Washout Period 3||0||
48771853|NCT01746901|102229490|FG001|COMPLETED|Treatment Phase: Washout Period 3||0||
48771854|NCT01746901|102229491|FG002|COMPLETED|Treatment Phase: Washout Period 3||0||
48450340|NCT00449930|101437104|FG000|STARTED|Overall Study||528||
48450341|NCT00449930|101437105|FG001|STARTED|Overall Study||522||
48450342|NCT00449930|101437104|FG000|COMPLETED|Overall Study||467||
48450343|NCT00449930|101437105|FG001|COMPLETED|Overall Study||447||
48450344|NCT00449930|101437104|FG000|NOT COMPLETED|Overall Study||61||
48660631|NCT02180867|101954582|FG001|COMPLETED|Overall Study||0||
48660632|NCT02180867|101954583|FG002|COMPLETED|Overall Study||6||
48660633|NCT02180867|101954584|FG003|COMPLETED|Overall Study||23||
48660634|NCT02180867|101954585|FG004|COMPLETED|Overall Study||21||
48660635|NCT02180867|101954586|FG005|COMPLETED|Overall Study||3||
48771855|NCT01746901|102229492|FG003|COMPLETED|Treatment Phase: Washout Period 3||6||
48771856|NCT01746901|102229493|FG004|COMPLETED|Treatment Phase: Washout Period 3||6||
48450345|NCT00449930|101437105|FG001|NOT COMPLETED|Overall Study||75||
48450346|NCT03707522|101437106|FG000|STARTED|Overall Study||31||
48450347|NCT03707522|101437107|FG001|STARTED|Overall Study||36||
48450348|NCT03707522|101437108|FG002|STARTED|Overall Study||52||
48450349|NCT03707522|101437109|FG003|STARTED|Overall Study||43||
48450350|NCT03707522|101437106|FG000|COMPLETED|Overall Study||7||
48450351|NCT03707522|101437107|FG001|COMPLETED|Overall Study||9||
48450352|NCT03707522|101437108|FG002|COMPLETED|Overall Study||11||
48450353|NCT03707522|101437109|FG003|COMPLETED|Overall Study||7||
48450354|NCT03707522|101437106|FG000|NOT COMPLETED|Overall Study||24||
48450355|NCT03707522|101437107|FG001|NOT COMPLETED|Overall Study||27||
48450356|NCT03707522|101437108|FG002|NOT COMPLETED|Overall Study||41||
48450357|NCT03707522|101437109|FG003|NOT COMPLETED|Overall Study||36||
48450358|NCT02576054|101437110|FG000|STARTED|Overall Study||101||
48450359|NCT02576054|101437110|FG000|Vaccination 1|Overall Study||100||
48450360|NCT02576054|101437110|FG000|Vaccination 2|Overall Study||100||
48450361|NCT02576054|101437110|FG000|Vaccination 3|Overall Study||100||
48450362|NCT02576054|101437110|FG000|COMPLETED|Overall Study||100||
48450363|NCT02576054|101437110|FG000|NOT COMPLETED|Overall Study||1||
48660636|NCT02180867|101954587|FG006|COMPLETED|Overall Study||1||
48660637|NCT02180867|101954581|FG000|NOT COMPLETED|Overall Study||6||
48660638|NCT02180867|101954582|FG001|NOT COMPLETED|Overall Study||11||
48660639|NCT02180867|101954583|FG002|NOT COMPLETED|Overall Study||4||
48660640|NCT02180867|101954584|FG003|NOT COMPLETED|Overall Study||26||
48660641|NCT02180867|101954585|FG004|NOT COMPLETED|Overall Study||27||
48660642|NCT02180867|101954586|FG005|NOT COMPLETED|Overall Study||3||
48660643|NCT02180867|101954587|FG006|NOT COMPLETED|Overall Study||5||
48660644|NCT03719300|101954588|FG000|STARTED|Overall Study||32||
48660645|NCT03719300|101954588|FG000|COMPLETED|Overall Study||32||
48450364|NCT02482571|101437111|FG000|STARTED|Overall Study||25||
48450365|NCT02482571|101437111|FG000|COMPLETED|Overall Study||17||
48450366|NCT02482571|101437111|FG000|NOT COMPLETED|Overall Study||8||
48450367|NCT01721967|101437112|FG000|STARTED|Overall Study||14||
48450368|NCT01721967|101437112|FG000|COMPLETED|Overall Study||11||
48450369|NCT01721967|101437112|FG000|NOT COMPLETED|Overall Study||3||
48450370|NCT02493088|101437113|FG000|STARTED|Overall Study||11||
48660646|NCT03719300|101954588|FG000|NOT COMPLETED|Overall Study||0||
48660647|NCT03160573|101954589|FG000|STARTED|First Sequence (3 Weeks)||23||
48660648|NCT03160573|101954590|FG001|STARTED|First Sequence (3 Weeks)||26||
48450371|NCT02493088|101437113|FG000|COMPLETED|Overall Study||11||
48450372|NCT02493088|101437113|FG000|NOT COMPLETED|Overall Study||0||
48450373|NCT03162354|101437114|FG000|STARTED|Overall Study||183||4
48450374|NCT03162354|101437115|FG001|STARTED|Overall Study||237||4
48660649|NCT03160573|101954591|FG002|STARTED|First Sequence (3 Weeks)||25||
48660650|NCT03160573|101954592|FG003|STARTED|First Sequence (3 Weeks)||25||
48450375|NCT03162354|101437114|FG000|COMPLETED|Overall Study||183||4
48450376|NCT03162354|101437115|FG001|COMPLETED|Overall Study||237||4
48450377|NCT03162354|101437114|FG000|NOT COMPLETED|Overall Study||0||0
48450378|NCT03162354|101437115|FG001|NOT COMPLETED|Overall Study||0||0
48450379|NCT01296152|101437116|FG000|STARTED|Overall Study||25||
48450380|NCT01296152|101437116|FG000|COMPLETED|Overall Study||24||
48450381|NCT01296152|101437116|FG000|NOT COMPLETED|Overall Study||1||
48450382|NCT05016765|101437117|FG000|STARTED|Overall Study||31||
48450383|NCT05016765|101437117|FG000|Completed At Least 1 EMA (Ecological Momentary Assessment) Survey|Overall Study||30||
48450384|NCT05016765|101437117|FG000|COMPLETED|Overall Study||27||
48189141|NCT04655313|100786154|FG000|NOT COMPLETED|Overall Study||0||
48189142|NCT03176134|100786155|FG000|STARTED|Overall Study||44||
48450385|NCT05016765|101437117|FG000|NOT COMPLETED|Overall Study||4||
48450386|NCT00681824|101439656|FG000|STARTED|Overall Study||28||
48450387|NCT00681824|101439657|FG001|STARTED|Overall Study||13||
48450388|NCT00681824|101439658|FG002|STARTED|Overall Study||34||
48450389|NCT00681824|101439656|FG000|COMPLETED|Overall Study||27||
48450390|NCT00681824|101439657|FG001|COMPLETED|Overall Study||12||
48450391|NCT00681824|101439658|FG002|COMPLETED|Overall Study||33||
48450392|NCT00681824|101439656|FG000|NOT COMPLETED|Overall Study||1||
48450393|NCT00681824|101439657|FG001|NOT COMPLETED|Overall Study||1||
48450394|NCT00681824|101439658|FG002|NOT COMPLETED|Overall Study||1||
48450395|NCT00823459|101439659|FG000|STARTED|Overall Study||58||
48450396|NCT00823459|101439659|FG000|COMPLETED|Overall Study||58||
48450397|NCT00823459|101439659|FG000|NOT COMPLETED|Overall Study||0||
48450398|NCT02419469|101439660|FG000|STARTED|Overall Study||1||
48450399|NCT02419469|101439660|FG000|COMPLETED|Overall Study||0||
48450400|NCT02419469|101439660|FG000|NOT COMPLETED|Overall Study||1||
48450401|NCT01542736|101439661|FG000|STARTED|Overall Study||8||
48450402|NCT01542736|101439661|FG000|COMPLETED|Overall Study||7||
48450403|NCT01542736|101439661|FG000|NOT COMPLETED|Overall Study||1||
48450404|NCT01027884|101439662|FG000|STARTED|Overall Study||34||
48450405|NCT01027884|101439663|FG001|STARTED|Overall Study||32||
48450406|NCT01027884|101439662|FG000|COMPLETED|Overall Study||30||
48450407|NCT01027884|101439663|FG001|COMPLETED|Overall Study||25||
48450408|NCT01027884|101439662|FG000|NOT COMPLETED|Overall Study||4||
48450409|NCT01027884|101439663|FG001|NOT COMPLETED|Overall Study||7||
48450410|NCT02643966|101439664|FG000|STARTED|First Screening Round||6266||
48450411|NCT02643966|101439664|FG000|COMPLETED|First Screening Round||6178||
48450412|NCT02643966|101439664|FG000|NOT COMPLETED|First Screening Round||88||
48450413|NCT02643966|101439664|FG000|STARTED|Between First and Second Screening||6178||
48450414|NCT02643966|101439664|FG000|COMPLETED|Between First and Second Screening||6020||
48450415|NCT02643966|101439664|FG000|NOT COMPLETED|Between First and Second Screening||158||
48450416|NCT02643966|101439664|FG000|STARTED|Second Screening Round||6020||
48450417|NCT02643966|101439664|FG000|COMPLETED|Second Screening Round||5937||
48450418|NCT02643966|101439664|FG000|NOT COMPLETED|Second Screening Round||83||
48450419|NCT02643966|101439664|FG000|STARTED|Between Second and Third Screening||5937||
48450420|NCT02643966|101439664|FG000|COMPLETED|Between Second and Third Screening||5680||
48450421|NCT02643966|101439664|FG000|NOT COMPLETED|Between Second and Third Screening||257||
48450422|NCT02643966|101439664|FG000|STARTED|Third Screening Round||5680||
48450423|NCT02643966|101439664|FG000|COMPLETED|Third Screening Round||5437||
48450424|NCT02643966|101439664|FG000|NOT COMPLETED|Third Screening Round||243||
48450425|NCT01154127|101439665|FG000|STARTED|Period 1 (21 Days)||55||
48450426|NCT01154127|101439666|FG001|STARTED|Period 1 (21 Days)||53||
48450427|NCT01154127|101439665|FG000|COMPLETED|Period 1 (21 Days)||52||
48450428|NCT01154127|101439666|FG001|COMPLETED|Period 1 (21 Days)||47||
48450429|NCT01154127|101439665|FG000|NOT COMPLETED|Period 1 (21 Days)||3||
48450430|NCT01154127|101439666|FG001|NOT COMPLETED|Period 1 (21 Days)||6||
48450431|NCT01154127|101439665|FG000|STARTED|Washout (14 - 28 Days)||52||
48450432|NCT01154127|101439666|FG001|STARTED|Washout (14 - 28 Days)||47||
48450433|NCT01154127|101439665|FG000|COMPLETED|Washout (14 - 28 Days)||49||
48450434|NCT01154127|101439666|FG001|COMPLETED|Washout (14 - 28 Days)||47||
48450435|NCT01154127|101439665|FG000|NOT COMPLETED|Washout (14 - 28 Days)||3||
48450436|NCT01154127|101439666|FG001|NOT COMPLETED|Washout (14 - 28 Days)||0||
48450437|NCT01154127|101439665|FG000|STARTED|Period 2 (21 Days)||49||
48450438|NCT01154127|101439666|FG001|STARTED|Period 2 (21 Days)||47||
48450439|NCT01154127|101439665|FG000|COMPLETED|Period 2 (21 Days)||49||
48450440|NCT01154127|101439666|FG001|COMPLETED|Period 2 (21 Days)||46||
48450441|NCT01154127|101439665|FG000|NOT COMPLETED|Period 2 (21 Days)||0||
48450442|NCT01154127|101439666|FG001|NOT COMPLETED|Period 2 (21 Days)||1||
48450443|NCT00383019|101439667|FG000|STARTED|Overall Study||144||
48450444|NCT00383019|101439668|FG001|STARTED|Overall Study||145||
48450445|NCT00383019|101439667|FG000|COMPLETED|Overall Study||139||
48450446|NCT00383019|101439668|FG001|COMPLETED|Overall Study||143||
48450447|NCT00383019|101439667|FG000|NOT COMPLETED|Overall Study||5||
48450448|NCT00383019|101439668|FG001|NOT COMPLETED|Overall Study||2||
48450449|NCT01977352|101439669|FG000|STARTED|Overall Study||21||
48450450|NCT01977352|101439670|FG001|STARTED|Overall Study||21||
48450451|NCT01977352|101439669|FG000|COMPLETED|Overall Study||20||
48450452|NCT01977352|101439670|FG001|COMPLETED|Overall Study||19||
48450453|NCT01977352|101439669|FG000|NOT COMPLETED|Overall Study||1||
48450454|NCT01977352|101439670|FG001|NOT COMPLETED|Overall Study||2||
48450455|NCT00051636|101439671|FG000|STARTED|Period 1 - Core||90||
48450456|NCT00051636|101439672|FG001|STARTED|Period 1 - Core||82||
48450457|NCT00051636|101439671|FG000|COMPLETED|Period 1 - Core||86||
48450458|NCT00051636|101439672|FG001|COMPLETED|Period 1 - Core||76||
48450459|NCT00051636|101439671|FG000|NOT COMPLETED|Period 1 - Core||4||
48450460|NCT00051636|101439672|FG001|NOT COMPLETED|Period 1 - Core||6||
48450461|NCT00051636|101439671|FG000|STARTED|Period 2- Extended Observation Period||75||
48450462|NCT00051636|101439672|FG001|STARTED|Period 2- Extended Observation Period||52||
48450463|NCT00051636|101439671|FG000|COMPLETED|Period 2- Extended Observation Period||5||
48450464|NCT00051636|101439672|FG001|COMPLETED|Period 2- Extended Observation Period||22||
48450465|NCT00051636|101439671|FG000|NOT COMPLETED|Period 2- Extended Observation Period||70||
48450466|NCT00051636|101439672|FG001|NOT COMPLETED|Period 2- Extended Observation Period||30||
48450467|NCT03182686|101439673|FG000|STARTED|Overall Study||144||
48450468|NCT03182686|101439674|FG001|STARTED|Overall Study||24||
48450469|NCT03182686|101439673|FG000|COMPLETED|Overall Study||137||
48450470|NCT03182686|101439674|FG001|COMPLETED|Overall Study||24||
48450471|NCT03182686|101439673|FG000|NOT COMPLETED|Overall Study||7||
48450472|NCT03182686|101439674|FG001|NOT COMPLETED|Overall Study||0||
48450473|NCT04499235|101439675|FG000|STARTED|Overall Study||5||
48450474|NCT04499235|101439676|FG001|STARTED|Overall Study||1||
48450475|NCT04499235|101439675|FG000|COMPLETED|Overall Study||5||
48450476|NCT04499235|101439676|FG001|COMPLETED|Overall Study||1||
48450477|NCT04499235|101439675|FG000|NOT COMPLETED|Overall Study||0||
48450478|NCT04499235|101439676|FG001|NOT COMPLETED|Overall Study||0||
48450479|NCT00833547|101439677|FG000|STARTED|Overall Study||13||
48450480|NCT00833547|101439678|FG001|STARTED|Overall Study||12||
48450481|NCT00833547|101439677|FG000|COMPLETED|Overall Study||11||
48450482|NCT00833547|101439678|FG001|COMPLETED|Overall Study||10||
48189143|NCT03176134|100786156|FG001|STARTED|Overall Study||15||
48189144|NCT03176134|100786157|FG002|STARTED|Overall Study||16||
48450483|NCT00833547|101439677|FG000|NOT COMPLETED|Overall Study||2||
48450484|NCT00833547|101439678|FG001|NOT COMPLETED|Overall Study||2||
48450485|NCT00344305|101439679|FG000|STARTED|Overall Study||100||
48450486|NCT00344305|101439680|FG001|STARTED|Overall Study||100||
48450487|NCT00344305|101439679|FG000|COMPLETED|Overall Study||98||
48450488|NCT00344305|101439680|FG001|COMPLETED|Overall Study||99||
48450489|NCT00344305|101439679|FG000|NOT COMPLETED|Overall Study||2||
48450490|NCT00344305|101439680|FG001|NOT COMPLETED|Overall Study||1||
48450491|NCT00827359|101439681|FG000|STARTED|Overall Study||25||
48450492|NCT00827359|101439681|FG000|Treated|Overall Study||24||
48450493|NCT00827359|101439681|FG000|COMPLETED|Overall Study||0||
48450494|NCT00827359|101439681|FG000|NOT COMPLETED|Overall Study||25||
48450495|NCT03061279|101439682|FG000|STARTED|Overall Study||0||
48450496|NCT03061279|101439683|FG001|STARTED|Overall Study||1||
48450497|NCT03061279|101439682|FG000|COMPLETED|Overall Study||0||
48450498|NCT03061279|101439683|FG001|COMPLETED|Overall Study||0||
48450499|NCT03061279|101439682|FG000|NOT COMPLETED|Overall Study||0||
48450500|NCT03061279|101439683|FG001|NOT COMPLETED|Overall Study||1||
48450501|NCT02766088|101439684|FG000|STARTED|Overall Study||850||
48450502|NCT02766088|101439684|FG000|COMPLETED|Overall Study||344||
48450503|NCT02766088|101439684|FG000|NOT COMPLETED|Overall Study||506||
48450504|NCT01120600|101439685|FG000|STARTED|Overall Study||147||
48450505|NCT01120600|101439686|FG001|STARTED|Overall Study||147||
48450506|NCT01120600|101439685|FG000|Treated|Overall Study||146||
48450507|NCT01120600|101439686|FG001|Treated|Overall Study||146||
48450508|NCT01120600|101439685|FG000|COMPLETED|Overall Study||128||
48450509|NCT01120600|101439686|FG001|COMPLETED|Overall Study||115||
48450510|NCT01120600|101439685|FG000|NOT COMPLETED|Overall Study||19||
48450511|NCT01120600|101439686|FG001|NOT COMPLETED|Overall Study||32||
48450512|NCT01147016|101439687|FG000|STARTED|Overall Study||8||
48450513|NCT01147016|101439687|FG000|COMPLETED|Overall Study||8||
48450514|NCT01147016|101439687|FG000|NOT COMPLETED|Overall Study||0||
48450515|NCT00640822|101439688|FG000|STARTED|Overall Study||322||
48450516|NCT00640822|101439689|FG001|STARTED|Overall Study||317||
48450517|NCT00640822|101439690|FG002|STARTED|Overall Study||102||
48670045|NCT03601897|101974876|FG010|NOT COMPLETED|Overall Study||13||
48189145|NCT03176134|100786158|FG003|STARTED|Overall Study||5||
48450518|NCT00640822|101439688|FG000|COMPLETED|Overall Study||279||
48450519|NCT00640822|101439689|FG001|COMPLETED|Overall Study||258||
48450520|NCT00640822|101439690|FG002|COMPLETED|Overall Study||77||
48450521|NCT00640822|101439688|FG000|NOT COMPLETED|Overall Study||43||
48450522|NCT00640822|101439689|FG001|NOT COMPLETED|Overall Study||59||
48450523|NCT00640822|101439690|FG002|NOT COMPLETED|Overall Study||25||
48450524|NCT02766400|101439691|FG000|STARTED|Overall Study||21||
48450525|NCT02766400|101439692|FG001|STARTED|Overall Study||22||
48450526|NCT02766400|101439691|FG000|COMPLETED|Overall Study||19||
48450527|NCT02766400|101439692|FG001|COMPLETED|Overall Study||20||
48450528|NCT02766400|101439691|FG000|NOT COMPLETED|Overall Study||2||
48450529|NCT02766400|101439692|FG001|NOT COMPLETED|Overall Study||2||
48450530|NCT02280356|101439693|FG000|STARTED|Overall Study||45||
48450531|NCT02280356|101439693|FG000|COMPLETED|Overall Study||40||
48450532|NCT02280356|101439693|FG000|NOT COMPLETED|Overall Study||5||
48450533|NCT03724968|101439694|FG000|STARTED|Overall Study||0||
48450534|NCT03724968|101439695|FG001|STARTED|Overall Study||2||
48450535|NCT03724968|101439694|FG000|COMPLETED|Overall Study||0||
48450536|NCT03724968|101439695|FG001|COMPLETED|Overall Study||0||
48450537|NCT03724968|101439694|FG000|NOT COMPLETED|Overall Study||0||
48450538|NCT03724968|101439695|FG001|NOT COMPLETED|Overall Study||2||
48450539|NCT00366678|101439696|FG000|STARTED|Infant Series||304||
48450540|NCT00366678|101439697|FG001|STARTED|Infant Series||309||
48450541|NCT00366678|101439698|FG002|STARTED|Infant Series||0||
48450542|NCT00366678|101439696|FG000|Vaccinated Dose 1|Infant Series||302||
48450543|NCT00366678|101439697|FG001|Vaccinated Dose 1|Infant Series||309||
48450544|NCT00366678|101439698|FG002|Vaccinated Dose 1|Infant Series||0||
48450545|NCT00366678|101439696|FG000|Vaccinated Dose 2|Infant Series||295||
48450546|NCT00366678|101439697|FG001|Vaccinated Dose 2|Infant Series||304||
48450547|NCT00366678|101439698|FG002|Vaccinated Dose 2|Infant Series||0||
48450548|NCT00366678|101439696|FG000|Vaccinated Dose 3|Infant Series||291||
48450549|NCT00366678|101439697|FG001|Vaccinated Dose 3|Infant Series||302||
48450550|NCT00366678|101439698|FG002|Vaccinated Dose 3|Infant Series||0||
48660651|NCT03160573|101954589|FG000|COMPLETED|First Sequence (3 Weeks)||22||
48660652|NCT03160573|101954590|FG001|COMPLETED|First Sequence (3 Weeks)||23||
48660653|NCT03160573|101954591|FG002|COMPLETED|First Sequence (3 Weeks)||23||
48660654|NCT03160573|101954592|FG003|COMPLETED|First Sequence (3 Weeks)||23||
48660655|NCT03160573|101954589|FG000|NOT COMPLETED|First Sequence (3 Weeks)||1||
48660656|NCT03160573|101954590|FG001|NOT COMPLETED|First Sequence (3 Weeks)||3||
48660657|NCT03160573|101954591|FG002|NOT COMPLETED|First Sequence (3 Weeks)||2||
48660658|NCT03160573|101954592|FG003|NOT COMPLETED|First Sequence (3 Weeks)||2||
48660659|NCT03160573|101954589|FG000|STARTED|Washout (2 Weeks)||22||
48660660|NCT03160573|101954590|FG001|STARTED|Washout (2 Weeks)||23||
48660661|NCT03160573|101954591|FG002|STARTED|Washout (2 Weeks)||23||
48660662|NCT03160573|101954592|FG003|STARTED|Washout (2 Weeks)||23||
48660663|NCT03160573|101954589|FG000|COMPLETED|Washout (2 Weeks)||22||
48660664|NCT03160573|101954590|FG001|COMPLETED|Washout (2 Weeks)||23||
48660665|NCT03160573|101954591|FG002|COMPLETED|Washout (2 Weeks)||23||
48660666|NCT03160573|101954592|FG003|COMPLETED|Washout (2 Weeks)||23||
48660667|NCT03160573|101954589|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
48660668|NCT03160573|101954590|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
48660669|NCT03160573|101954591|FG002|NOT COMPLETED|Washout (2 Weeks)||0||
48660670|NCT03160573|101954592|FG003|NOT COMPLETED|Washout (2 Weeks)||0||
48660671|NCT03160573|101954589|FG000|STARTED|Second Sequence (3 Weeks)||22||
48660672|NCT03160573|101954590|FG001|STARTED|Second Sequence (3 Weeks)||23||
48660673|NCT03160573|101954591|FG002|STARTED|Second Sequence (3 Weeks)||23||
48660674|NCT03160573|101954592|FG003|STARTED|Second Sequence (3 Weeks)||23||
48660675|NCT03160573|101954589|FG000|COMPLETED|Second Sequence (3 Weeks)||22||
48660676|NCT03160573|101954590|FG001|COMPLETED|Second Sequence (3 Weeks)||23||
48660677|NCT03160573|101954591|FG002|COMPLETED|Second Sequence (3 Weeks)||23||
48771857|NCT01746901|102229494|FG005|COMPLETED|Treatment Phase: Washout Period 3||6||
48771858|NCT01746901|102229495|FG006|COMPLETED|Treatment Phase: Washout Period 3||6||
48771859|NCT01746901|102229496|FG007|COMPLETED|Treatment Phase: Washout Period 3||6||
48771860|NCT01746901|102229497|FG008|COMPLETED|Treatment Phase: Washout Period 3||7||
48771861|NCT01746901|102229489|FG000|NOT COMPLETED|Treatment Phase: Washout Period 3||0||
48771862|NCT01746901|102229490|FG001|NOT COMPLETED|Treatment Phase: Washout Period 3||0||
48771863|NCT01746901|102229491|FG002|NOT COMPLETED|Treatment Phase: Washout Period 3||0||
48771864|NCT01746901|102229492|FG003|NOT COMPLETED|Treatment Phase: Washout Period 3||0||
48450551|NCT00366678|101439696|FG000|COMPLETED|Infant Series||290||
48450552|NCT00366678|101439697|FG001|COMPLETED|Infant Series||299||
48450553|NCT00366678|101439698|FG002|COMPLETED|Infant Series||0||
48450554|NCT00366678|101439696|FG000|NOT COMPLETED|Infant Series||14||
48450555|NCT00366678|101439697|FG001|NOT COMPLETED|Infant Series||10||
48660678|NCT03160573|101954592|FG003|COMPLETED|Second Sequence (3 Weeks)||23||
48660679|NCT03160573|101954589|FG000|NOT COMPLETED|Second Sequence (3 Weeks)||0||
48660680|NCT03160573|101954590|FG001|NOT COMPLETED|Second Sequence (3 Weeks)||0||
48660681|NCT03160573|101954591|FG002|NOT COMPLETED|Second Sequence (3 Weeks)||0||
48771865|NCT01746901|102229493|FG004|NOT COMPLETED|Treatment Phase: Washout Period 3||0||
48660682|NCT03160573|101954592|FG003|NOT COMPLETED|Second Sequence (3 Weeks)||0||
48660683|NCT03633058|101954593|FG000|STARTED|Overall Study||5||
48660684|NCT03633058|101954594|FG001|STARTED|Overall Study||6||
48660685|NCT03633058|101954595|FG002|STARTED|Overall Study||6||
48660686|NCT03633058|101954596|FG003|STARTED|Overall Study||6||
48660687|NCT03633058|101954593|FG000|COMPLETED|Overall Study||5||
48660688|NCT03633058|101954594|FG001|COMPLETED|Overall Study||6||
48450556|NCT00366678|101439698|FG002|NOT COMPLETED|Infant Series||0||
48450557|NCT00366678|101439696|FG000|STARTED|After Infant||290||
48450558|NCT00366678|101439697|FG001|STARTED|After Infant||299||
48450559|NCT00366678|101439698|FG002|STARTED|After Infant||0||
48450560|NCT00366678|101439696|FG000|COMPLETED|After Infant||273||
48450561|NCT00366678|101439697|FG001|COMPLETED|After Infant||289||
48450562|NCT00366678|101439698|FG002|COMPLETED|After Infant||0||
48450563|NCT00366678|101439696|FG000|NOT COMPLETED|After Infant||17||
48450564|NCT00366678|101439697|FG001|NOT COMPLETED|After Infant||10||
48450565|NCT00366678|101439698|FG002|NOT COMPLETED|After Infant||0||
48450566|NCT00366678|101439696|FG000|STARTED|Toddler Dose||273||
48450567|NCT00366678|101439697|FG001|STARTED|Toddler Dose||152||
48450568|NCT00366678|101439698|FG002|STARTED|Toddler Dose||137||
48450569|NCT00366678|101439696|FG000|COMPLETED|Toddler Dose||268||
48450570|NCT00366678|101439697|FG001|COMPLETED|Toddler Dose||151||
48450571|NCT00366678|101439698|FG002|COMPLETED|Toddler Dose||137||
48450572|NCT00366678|101439696|FG000|NOT COMPLETED|Toddler Dose||5||
48450573|NCT00366678|101439697|FG001|NOT COMPLETED|Toddler Dose||1||
48450574|NCT00366678|101439698|FG002|NOT COMPLETED|Toddler Dose||0||
48450575|NCT00524576|101439699|FG000|STARTED|Overall Study||97||
48450576|NCT00524576|101439700|FG001|STARTED|Overall Study||47||
48450577|NCT00524576|101439699|FG000|COMPLETED|Overall Study||97||
48450578|NCT00524576|101439700|FG001|COMPLETED|Overall Study||47||
48450579|NCT00524576|101439699|FG000|NOT COMPLETED|Overall Study||0||
48450580|NCT00524576|101439700|FG001|NOT COMPLETED|Overall Study||0||
48450581|NCT03125629|101439701|FG000|STARTED|Overall Study||53||
48450582|NCT03125629|101439701|FG000|COMPLETED|Overall Study||50||
48450583|NCT03125629|101439701|FG000|NOT COMPLETED|Overall Study||3||
48450584|NCT00197184|101439702|FG000|STARTED|Overall Study||139||
48450585|NCT00197184|101439703|FG001|STARTED|Overall Study||137||
48450586|NCT00197184|101439702|FG000|COMPLETED|Overall Study||139||
48450587|NCT00197184|101439703|FG001|COMPLETED|Overall Study||137||
48450588|NCT00197184|101439702|FG000|NOT COMPLETED|Overall Study||0||
48450589|NCT00197184|101439703|FG001|NOT COMPLETED|Overall Study||0||
48450590|NCT03124797|101439704|FG000|STARTED|Overall Study||18||
48450591|NCT03124797|101439704|FG000|COMPLETED|Overall Study||18||
48450592|NCT03124797|101439704|FG000|NOT COMPLETED|Overall Study||0||
48450593|NCT03264066|101439705|FG000|STARTED|Overall Study||20||
48450594|NCT03264066|101439706|FG001|STARTED|Overall Study||20||
48450595|NCT03264066|101439707|FG002|STARTED|Overall Study||17||
48450596|NCT03264066|101439708|FG003|STARTED|Overall Study||20||
48450597|NCT03264066|101439709|FG004|STARTED|Overall Study||7||
48450598|NCT03264066|101439710|FG005|STARTED|Overall Study||3||
48450599|NCT03264066|101439705|FG000|COMPLETED|Overall Study||0||
48450600|NCT03264066|101439706|FG001|COMPLETED|Overall Study||0||
48450601|NCT03264066|101439707|FG002|COMPLETED|Overall Study||0||
48450602|NCT03264066|101439708|FG003|COMPLETED|Overall Study||0||
48450603|NCT03264066|101439709|FG004|COMPLETED|Overall Study||0||
48450604|NCT03264066|101439710|FG005|COMPLETED|Overall Study||0||
48450605|NCT03264066|101439705|FG000|NOT COMPLETED|Overall Study||20||
48450606|NCT03264066|101439706|FG001|NOT COMPLETED|Overall Study||20||
48450607|NCT03264066|101439707|FG002|NOT COMPLETED|Overall Study||17||
48450608|NCT03264066|101439708|FG003|NOT COMPLETED|Overall Study||20||
48450609|NCT03264066|101439709|FG004|NOT COMPLETED|Overall Study||7||
48450610|NCT03264066|101439710|FG005|NOT COMPLETED|Overall Study||3||
48450611|NCT01074307|101439711|FG000|STARTED|Overall Study||66||
48450612|NCT01074307|101439712|FG001|STARTED|Overall Study||114||
48450613|NCT01074307|101439711|FG000|COMPLETED|Overall Study||44||
48450614|NCT01074307|101439712|FG001|COMPLETED|Overall Study||102||
48450615|NCT01074307|101439711|FG000|NOT COMPLETED|Overall Study||22||
48450616|NCT01074307|101439712|FG001|NOT COMPLETED|Overall Study||12||
48450617|NCT00493181|101439713|FG000|STARTED|Overall Study||8||
48450618|NCT00493181|101439713|FG000|COMPLETED|Overall Study||8||
48450619|NCT00493181|101439713|FG000|NOT COMPLETED|Overall Study||0||
48450620|NCT01422720|101439714|FG000|STARTED|Overall Study||72||
48450621|NCT01422720|101439714|FG000|Safety Set|Overall Study||72||
48450622|NCT01422720|101439714|FG000|Full Analysis Set (FAS)|Overall Study||71||
48450623|NCT01422720|101439714|FG000|Per-Protocol Set (PPS)|Overall Study||55||
48450624|NCT01422720|101439714|FG000|COMPLETED|Overall Study||50||
48450625|NCT01422720|101439714|FG000|NOT COMPLETED|Overall Study||22||
48450626|NCT00457665|101439715|FG000|STARTED|12 Months||28||
48450627|NCT00457665|101439716|FG001|STARTED|12 Months||28||
48450628|NCT00457665|101439715|FG000|COMPLETED|12 Months||20||
48450629|NCT00457665|101439716|FG001|COMPLETED|12 Months||19||
48450630|NCT00457665|101439715|FG000|NOT COMPLETED|12 Months||8||
48450631|NCT00457665|101439716|FG001|NOT COMPLETED|12 Months||9||
48450632|NCT00457665|101439715|FG000|STARTED|24 Months||20||
48450633|NCT00457665|101439716|FG001|STARTED|24 Months||19||
48450634|NCT00457665|101439715|FG000|COMPLETED|24 Months||15||
48450635|NCT00457665|101439716|FG001|COMPLETED|24 Months||11||
48450636|NCT00457665|101439715|FG000|NOT COMPLETED|24 Months||5||
48450637|NCT00457665|101439716|FG001|NOT COMPLETED|24 Months||8||
48450638|NCT04147611|101439717|FG000|STARTED|Overall Study||9||
48450639|NCT04147611|101439718|FG001|STARTED|Overall Study||13||
48450640|NCT04147611|101439717|FG000|COMPLETED|Overall Study||9||
48450641|NCT04147611|101439718|FG001|COMPLETED|Overall Study||12||
48450642|NCT04147611|101439717|FG000|NOT COMPLETED|Overall Study||0||
48450643|NCT04147611|101439718|FG001|NOT COMPLETED|Overall Study||1||
48450644|NCT00123487|101439719|FG000|STARTED|Randomized||306||
48450645|NCT00123487|101439720|FG001|STARTED|Randomized||305||
48450646|NCT00123487|101439719|FG000|COMPLETED|Randomized||305||
48450647|NCT00123487|101439720|FG001|COMPLETED|Randomized||304||
48450648|NCT00123487|101439719|FG000|NOT COMPLETED|Randomized||1||
48450649|NCT00123487|101439720|FG001|NOT COMPLETED|Randomized||1||
48450650|NCT00123487|101439719|FG000|STARTED|Treated With Study Drug||304||
48450651|NCT00123487|101439720|FG001|STARTED|Treated With Study Drug||305||
48450652|NCT00123487|101439719|FG000|COMPLETED|Treated With Study Drug||0||
48450653|NCT00123487|101439720|FG001|COMPLETED|Treated With Study Drug||0||
48450654|NCT00123487|101439719|FG000|NOT COMPLETED|Treated With Study Drug||304||
48450655|NCT00123487|101439720|FG001|NOT COMPLETED|Treated With Study Drug||305||
48450656|NCT02007369|101439721|FG000|STARTED|Overall Study||42||
48450657|NCT02007369|101439722|FG001|STARTED|Overall Study||40||
48660689|NCT03633058|101954595|FG002|COMPLETED|Overall Study||5||
48660690|NCT03633058|101954596|FG003|COMPLETED|Overall Study||6||
48660691|NCT03633058|101954593|FG000|NOT COMPLETED|Overall Study||0||
48660692|NCT03633058|101954594|FG001|NOT COMPLETED|Overall Study||0||
48660693|NCT03633058|101954595|FG002|NOT COMPLETED|Overall Study||1||
48660694|NCT03633058|101954596|FG003|NOT COMPLETED|Overall Study||0||
48660695|NCT01791205|101954597|FG000|STARTED|Phase I||152||
48660696|NCT01791205|101954598|FG001|STARTED|Phase I||152||
48660697|NCT01791205|101954597|FG000|COMPLETED|Phase I||152||
48660698|NCT01791205|101954598|FG001|COMPLETED|Phase I||152||
48450658|NCT02007369|101439723|FG002|STARTED|Overall Study||54||
48450659|NCT02007369|101439721|FG000|COMPLETED|Overall Study||42||
48450660|NCT02007369|101439722|FG001|COMPLETED|Overall Study||40||
48450661|NCT02007369|101439723|FG002|COMPLETED|Overall Study||54||
48450662|NCT02007369|101439721|FG000|NOT COMPLETED|Overall Study||0||
48450663|NCT02007369|101439722|FG001|NOT COMPLETED|Overall Study||0||
48450664|NCT02007369|101439723|FG002|NOT COMPLETED|Overall Study||0||
48450665|NCT03726437|101439724|FG000|STARTED|Overall Study||444|Randomized to RealConsent|
48450666|NCT03726437|101439725|FG001|STARTED|Overall Study||437|Randomized to RealConsent|
48450667|NCT03726437|101439724|FG000|COMPLETED|Overall Study||359|Completed 6-month follow-up assessments.|
48450668|NCT03726437|101439725|FG001|COMPLETED|Overall Study||361|Completed 6-month follow-up assessments.|
48450669|NCT03726437|101439724|FG000|NOT COMPLETED|Overall Study||85||
48660699|NCT01791205|101954597|FG000|NOT COMPLETED|Phase I||0||
48660700|NCT01791205|101954598|FG001|NOT COMPLETED|Phase I||0||
48660701|NCT01791205|101954597|FG000|STARTED|Phase II||104||
48660702|NCT01791205|101954598|FG001|STARTED|Phase II||0||
48660703|NCT01791205|101954597|FG000|COMPLETED|Phase II||92||
48660704|NCT01791205|101954598|FG001|COMPLETED|Phase II||0||
48660705|NCT01791205|101954597|FG000|NOT COMPLETED|Phase II||12||
48660706|NCT01791205|101954598|FG001|NOT COMPLETED|Phase II||0||
48660707|NCT01603368|101954599|FG000|STARTED|Overall Study||68||
48660708|NCT01603368|101954600|FG001|STARTED|Overall Study||66||
48660709|NCT01603368|101954599|FG000|COMPLETED|Overall Study||68||
48660710|NCT01603368|101954600|FG001|COMPLETED|Overall Study||66||
48660711|NCT01603368|101954599|FG000|NOT COMPLETED|Overall Study||0||
48660712|NCT01603368|101954600|FG001|NOT COMPLETED|Overall Study||0||
48660713|NCT01350479|101954601|FG000|STARTED|Overall Study||94||
48660714|NCT01350479|101954602|FG001|STARTED|Overall Study||106||
48660715|NCT01350479|101954601|FG000|COMPLETED|Overall Study||94||
48450670|NCT03726437|101439725|FG001|NOT COMPLETED|Overall Study||76||
48450671|NCT00701935|101439726|FG000|STARTED|Overall Study||43||
48660716|NCT01350479|101954602|FG001|COMPLETED|Overall Study||106||
48660717|NCT01350479|101954601|FG000|NOT COMPLETED|Overall Study||0||
48660718|NCT01350479|101954602|FG001|NOT COMPLETED|Overall Study||0||
48660719|NCT01213251|101954603|FG000|STARTED|Overall Study||40||
48660720|NCT01213251|101954604|FG001|STARTED|Overall Study||41||
48660721|NCT01213251|101954605|FG002|STARTED|Overall Study||45||
48660722|NCT01213251|101954603|FG000|COMPLETED|Overall Study||34||
48660723|NCT01213251|101954604|FG001|COMPLETED|Overall Study||37||
48660724|NCT01213251|101954605|FG002|COMPLETED|Overall Study||34||
48660725|NCT01213251|101954603|FG000|NOT COMPLETED|Overall Study||6||
48660726|NCT01213251|101954604|FG001|NOT COMPLETED|Overall Study||4||
48660727|NCT01213251|101954605|FG002|NOT COMPLETED|Overall Study||11||
48660728|NCT00480025|101954606|FG000|STARTED|Overall Study||1515||
48660729|NCT00480025|101954607|FG001|STARTED|Overall Study||757||
48660730|NCT00480025|101954606|FG000|COMPLETED|Overall Study||763||
48660731|NCT00480025|101954607|FG001|COMPLETED|Overall Study||388||
48660732|NCT00480025|101954606|FG000|NOT COMPLETED|Overall Study||752||
48660733|NCT00480025|101954607|FG001|NOT COMPLETED|Overall Study||369||
48660734|NCT00595075|101954608|FG000|STARTED|Overall Study||6||
48660735|NCT00595075|101954609|FG001|STARTED|Overall Study||5||
48450672|NCT00701935|101439727|FG001|STARTED|Overall Study||37||
48450673|NCT00701935|101439726|FG000|COMPLETED|Overall Study||27||
48450674|NCT00701935|101439727|FG001|COMPLETED|Overall Study||26||
48450675|NCT00701935|101439726|FG000|NOT COMPLETED|Overall Study||16||
48450676|NCT00701935|101439727|FG001|NOT COMPLETED|Overall Study||11||
48450677|NCT02402933|101439728|FG000|STARTED|Overall Study||26||
48450678|NCT02402933|101439728|FG000|Received at Least One Dose of Study Drug|Overall Study||22||
48660736|NCT00595075|101954608|FG000|COMPLETED|Overall Study||5||
48660737|NCT00595075|101954609|FG001|COMPLETED|Overall Study||5||
48660738|NCT00595075|101954608|FG000|NOT COMPLETED|Overall Study||1||
48660739|NCT00595075|101954609|FG001|NOT COMPLETED|Overall Study||0||
48450679|NCT02402933|101439728|FG000|COMPLETED|Overall Study||12||
48450680|NCT02402933|101439728|FG000|NOT COMPLETED|Overall Study||14||
48450681|NCT00729365|101439729|FG000|STARTED|Overall Study||33||
48450682|NCT00729365|101439730|FG001|STARTED|Overall Study||6||
48450683|NCT00729365|101439731|FG002|STARTED|Overall Study||7||
48450684|NCT00729365|101439729|FG000|COMPLETED|Overall Study||0||
48450685|NCT00729365|101439730|FG001|COMPLETED|Overall Study||0||
48450686|NCT00729365|101439731|FG002|COMPLETED|Overall Study||0||
48450687|NCT00729365|101439729|FG000|NOT COMPLETED|Overall Study||33||
48450688|NCT00729365|101439730|FG001|NOT COMPLETED|Overall Study||6||
48450689|NCT00729365|101439731|FG002|NOT COMPLETED|Overall Study||7||
48450690|NCT00973856|101439732|FG000|STARTED|Overall Study||3||5
48450691|NCT00973856|101439733|FG001|STARTED|Overall Study||2||5
48450692|NCT00973856|101439732|FG000|COMPLETED|Overall Study||3||5
48660740|NCT01813227|101954610|FG000|STARTED|Overall Study||7||
48660741|NCT01813227|101954610|FG000|COMPLETED|Overall Study||7||
48660742|NCT01813227|101954610|FG000|NOT COMPLETED|Overall Study||0||
48660743|NCT04985682|101954611|FG000|STARTED|Overall Study||50||
48660744|NCT04985682|101954611|FG000|COMPLETED|Overall Study||49||
48660745|NCT04985682|101954611|FG000|NOT COMPLETED|Overall Study||1||
48660746|NCT00489359|101954612|FG000|STARTED|Overall Study||20||
48660747|NCT00489359|101954613|FG001|STARTED|Overall Study||66||
48660748|NCT00489359|101954612|FG000|COMPLETED|Overall Study||13||
48660749|NCT00489359|101954613|FG001|COMPLETED|Overall Study||37||
48660750|NCT00489359|101954612|FG000|NOT COMPLETED|Overall Study||7||
48660751|NCT00489359|101954613|FG001|NOT COMPLETED|Overall Study||29||
48660752|NCT02067156|101954614|FG000|STARTED|Overall Study||26||
48189146|NCT03176134|100786159|FG004|STARTED|Overall Study||15||
48660753|NCT02067156|101954614|FG000|COMPLETED|Overall Study||22||
48660754|NCT02067156|101954614|FG000|NOT COMPLETED|Overall Study||4||
48660755|NCT04115293|101954615|FG000|STARTED|Overall Study||88||
48660756|NCT04115293|101954616|FG001|STARTED|Overall Study||86||
48771866|NCT01746901|102229494|FG005|NOT COMPLETED|Treatment Phase: Washout Period 3||0||
48771867|NCT01746901|102229495|FG006|NOT COMPLETED|Treatment Phase: Washout Period 3||0||
48771868|NCT01746901|102229496|FG007|NOT COMPLETED|Treatment Phase: Washout Period 3||0||
48771869|NCT01746901|102229497|FG008|NOT COMPLETED|Treatment Phase: Washout Period 3||0||
48450693|NCT00973856|101439733|FG001|COMPLETED|Overall Study||2||5
48450694|NCT00973856|101439732|FG000|NOT COMPLETED|Overall Study||0||0
48450695|NCT00973856|101439733|FG001|NOT COMPLETED|Overall Study||0||0
48450696|NCT02713243|101439734|FG000|STARTED|Overall Study||10||
48450697|NCT02713243|101439735|FG001|STARTED|Overall Study||10||
48450698|NCT02713243|101439734|FG000|PD Analysis Set|Overall Study||9||
48450699|NCT02713243|101439735|FG001|PD Analysis Set|Overall Study||10||
48450700|NCT02713243|101439734|FG000|PK Analysis Set|Overall Study||8||
48450701|NCT02713243|101439735|FG001|PK Analysis Set|Overall Study||9||
48450702|NCT02713243|101439734|FG000|COMPLETED|Overall Study||9||
48450703|NCT02713243|101439735|FG001|COMPLETED|Overall Study||8||
48450704|NCT02713243|101439734|FG000|NOT COMPLETED|Overall Study||1||
48450705|NCT02713243|101439735|FG001|NOT COMPLETED|Overall Study||2||
48450706|NCT00283686|101439736|FG000|STARTED|Overall Study||140||
48450707|NCT00283686|101439737|FG001|STARTED|Overall Study||133||
48450708|NCT00283686|101439738|FG002|STARTED|Overall Study||144||
48450709|NCT00283686|101439739|FG003|STARTED|Overall Study||141||
48450710|NCT00283686|101439736|FG000|COMPLETED|Overall Study||111||
48450711|NCT00283686|101439737|FG001|COMPLETED|Overall Study||92||
48450712|NCT00283686|101439738|FG002|COMPLETED|Overall Study||111||
48450713|NCT00283686|101439739|FG003|COMPLETED|Overall Study||109||
48450714|NCT00283686|101439736|FG000|NOT COMPLETED|Overall Study||29||
48450715|NCT00283686|101439737|FG001|NOT COMPLETED|Overall Study||41||
48450716|NCT00283686|101439738|FG002|NOT COMPLETED|Overall Study||33||
48450717|NCT00283686|101439739|FG003|NOT COMPLETED|Overall Study||32||
48450718|NCT00964223|101439740|FG000|STARTED|Split Face Treatment (Weeks 1 and 2)||28||
48450719|NCT00964223|101439740|FG000|COMPLETED|Split Face Treatment (Weeks 1 and 2)||28||
48450720|NCT00964223|101439740|FG000|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0||
48450721|NCT00964223|101439740|FG000|STARTED|Full Face Treatment (Weeks 5 and 8)||28||
48450722|NCT00964223|101439740|FG000|COMPLETED|Full Face Treatment (Weeks 5 and 8)||27||
48450723|NCT00964223|101439740|FG000|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||1||
48450724|NCT02720224|101439741|FG000|STARTED|Overall Study||6||
48450725|NCT02720224|101439741|FG000|COMPLETED|Overall Study||6||
48450726|NCT02720224|101439741|FG000|NOT COMPLETED|Overall Study||0||
48450727|NCT02412956|101439742|FG000|STARTED|Overall Study||44||
48450728|NCT02412956|101439743|FG001|STARTED|Overall Study||47||
48450729|NCT02412956|101439744|FG002|STARTED|Overall Study||8||
48450730|NCT02412956|101439742|FG000|COMPLETED|Overall Study||35||
48450731|NCT02412956|101439743|FG001|COMPLETED|Overall Study||30||
48450732|NCT02412956|101439744|FG002|COMPLETED|Overall Study||8||
48450733|NCT02412956|101439742|FG000|NOT COMPLETED|Overall Study||9||
48450734|NCT02412956|101439743|FG001|NOT COMPLETED|Overall Study||17||
48450735|NCT02412956|101439744|FG002|NOT COMPLETED|Overall Study||0||
48450736|NCT03005379|101439745|FG000|STARTED|Overall Study||76||
48450737|NCT03005379|101439746|FG001|STARTED|Overall Study||77||
48450738|NCT03005379|101439745|FG000|COMPLETED|Overall Study||76||
48660757|NCT04115293|101954615|FG000|COMPLETED|Overall Study||84||
48771870|NCT01746901|102229489|FG000|STARTED|Treatment Phase: Fourth Intervention||0||
48771871|NCT01746901|102229490|FG001|STARTED|Treatment Phase: Fourth Intervention||0||
48771872|NCT01746901|102229491|FG002|STARTED|Treatment Phase: Fourth Intervention||0||
48771873|NCT01746901|102229492|FG003|STARTED|Treatment Phase: Fourth Intervention||6||
48771874|NCT01746901|102229493|FG004|STARTED|Treatment Phase: Fourth Intervention||6||
48450739|NCT03005379|101439746|FG001|COMPLETED|Overall Study||76||
48450740|NCT03005379|101439745|FG000|NOT COMPLETED|Overall Study||0||
48450741|NCT03005379|101439746|FG001|NOT COMPLETED|Overall Study||1||
48450742|NCT02124746|101439747|FG000|STARTED|Overall Study||30||
48450743|NCT02124746|101439748|FG001|STARTED|Overall Study||22||
48450744|NCT02124746|101439749|FG002|STARTED|Overall Study||22||
48450745|NCT02124746|101439747|FG000|COMPLETED|Overall Study||11||
48450746|NCT02124746|101439748|FG001|COMPLETED|Overall Study||4||
48450747|NCT02124746|101439749|FG002|COMPLETED|Overall Study||0||
48450748|NCT02124746|101439747|FG000|NOT COMPLETED|Overall Study||19||
48450749|NCT02124746|101439748|FG001|NOT COMPLETED|Overall Study||18||
48450750|NCT02124746|101439749|FG002|NOT COMPLETED|Overall Study||22||
48450751|NCT01160198|101439750|FG000|STARTED|Overall Study||89||
48450752|NCT01160198|101439751|FG001|STARTED|Overall Study||91||
48450753|NCT01160198|101439752|FG002|STARTED|Overall Study||90||
48450754|NCT01160198|101439750|FG000|COMPLETED|Overall Study||87||
48450755|NCT01160198|101439751|FG001|COMPLETED|Overall Study||88||
48660758|NCT04115293|101954616|FG001|COMPLETED|Overall Study||82||
48660759|NCT04115293|101954615|FG000|NOT COMPLETED|Overall Study||4||
48660760|NCT04115293|101954616|FG001|NOT COMPLETED|Overall Study||4||
48660761|NCT02799043|101954617|FG000|STARTED|Overall Study||133||
48660762|NCT02799043|101954618|FG001|STARTED|Overall Study||136||
48450756|NCT01160198|101439752|FG002|COMPLETED|Overall Study||89||
48450757|NCT01160198|101439750|FG000|NOT COMPLETED|Overall Study||2||
48450758|NCT01160198|101439751|FG001|NOT COMPLETED|Overall Study||3||
48450759|NCT01160198|101439752|FG002|NOT COMPLETED|Overall Study||1||
48450760|NCT03811249|101439753|FG000|STARTED|Overall Study||287||565
48450761|NCT03811249|101439753|FG000|COMPLETED|Overall Study||219||433
48660763|NCT02799043|101954617|FG000|Treated|Overall Study||131|Intention to treat population.|
48660764|NCT02799043|101954618|FG001|Treated|Overall Study||134|Intention to treat population.|
48660765|NCT02799043|101954617|FG000|COMPLETED|Overall Study||122||
48660766|NCT02799043|101954618|FG001|COMPLETED|Overall Study||121||
48660767|NCT02799043|101954617|FG000|NOT COMPLETED|Overall Study||11||
48771875|NCT01746901|102229494|FG005|STARTED|Treatment Phase: Fourth Intervention||6||
48771876|NCT01746901|102229495|FG006|STARTED|Treatment Phase: Fourth Intervention||6||
48771877|NCT01746901|102229496|FG007|STARTED|Treatment Phase: Fourth Intervention||6||
48450762|NCT03811249|101439753|FG000|NOT COMPLETED|Overall Study||68||132
48450763|NCT01829295|101439754|FG000|STARTED|0-6 Months||107||
48450764|NCT01829295|101439755|FG001|STARTED|0-6 Months||109||
48450765|NCT01829295|101439756|FG002|STARTED|0-6 Months||0||
48450766|NCT01829295|101439757|FG003|STARTED|0-6 Months||0||
48450767|NCT01829295|101439754|FG000|COMPLETED|0-6 Months||96||
48450768|NCT01829295|101439755|FG001|COMPLETED|0-6 Months||98||
48450769|NCT01829295|101439756|FG002|COMPLETED|0-6 Months||0||
48450770|NCT01829295|101439757|FG003|COMPLETED|0-6 Months||0||
48450771|NCT01829295|101439754|FG000|NOT COMPLETED|0-6 Months||11||
48450772|NCT01829295|101439755|FG001|NOT COMPLETED|0-6 Months||11||
48450773|NCT01829295|101439756|FG002|NOT COMPLETED|0-6 Months||0||
48450774|NCT01829295|101439757|FG003|NOT COMPLETED|0-6 Months||0||
48450775|NCT01829295|101439754|FG000|STARTED|6-12 Months||64||
48450776|NCT01829295|101439755|FG001|STARTED|6-12 Months||56||
48450777|NCT01829295|101439756|FG002|STARTED|6-12 Months||32||
48450778|NCT01829295|101439757|FG003|STARTED|6-12 Months||42||
48450779|NCT01829295|101439754|FG000|COMPLETED|6-12 Months||60||
48450780|NCT01829295|101439755|FG001|COMPLETED|6-12 Months||54||
48450781|NCT01829295|101439756|FG002|COMPLETED|6-12 Months||20||
48450782|NCT01829295|101439757|FG003|COMPLETED|6-12 Months||29||
48450783|NCT01829295|101439754|FG000|NOT COMPLETED|6-12 Months||4||
48450784|NCT01829295|101439755|FG001|NOT COMPLETED|6-12 Months||2||
48450785|NCT01829295|101439756|FG002|NOT COMPLETED|6-12 Months||12||
48450786|NCT01829295|101439757|FG003|NOT COMPLETED|6-12 Months||13||
48450787|NCT00142454|101439758|FG000|STARTED|Overall Study||9||
48450788|NCT00142454|101439758|FG000|COMPLETED|Overall Study||9||
48450789|NCT00142454|101439758|FG000|NOT COMPLETED|Overall Study||0||
48450790|NCT01901146|101439759|FG000|STARTED|Neoadjuvant Phase||364||
48450791|NCT01901146|101439760|FG001|STARTED|Neoadjuvant Phase||361||
48450792|NCT01901146|101439761|FG002|STARTED|Neoadjuvant Phase||0||
48450793|NCT01901146|101439762|FG003|STARTED|Neoadjuvant Phase||0||
48450794|NCT01901146|101439763|FG004|STARTED|Neoadjuvant Phase||0||
48450795|NCT01901146|101439759|FG000|COMPLETED|Neoadjuvant Phase||358||
48450796|NCT01901146|101439760|FG001|COMPLETED|Neoadjuvant Phase||347||
48450797|NCT01901146|101439761|FG002|COMPLETED|Neoadjuvant Phase||0||
48450798|NCT01901146|101439762|FG003|COMPLETED|Neoadjuvant Phase||0||
48450799|NCT01901146|101439763|FG004|COMPLETED|Neoadjuvant Phase||0||
48450800|NCT01901146|101439759|FG000|NOT COMPLETED|Neoadjuvant Phase||6||
48450801|NCT01901146|101439760|FG001|NOT COMPLETED|Neoadjuvant Phase||14||
48450802|NCT01901146|101439761|FG002|NOT COMPLETED|Neoadjuvant Phase||0||
48450803|NCT01901146|101439762|FG003|NOT COMPLETED|Neoadjuvant Phase||0||
48450804|NCT01901146|101439763|FG004|NOT COMPLETED|Neoadjuvant Phase||0||
48450805|NCT01901146|101439759|FG000|STARTED|Adjuvant Phase||0||
48450806|NCT01901146|101439760|FG001|STARTED|Adjuvant Phase||0||
48450807|NCT01901146|101439761|FG002|STARTED|Adjuvant Phase||349||
48450808|NCT01901146|101439762|FG003|STARTED|Adjuvant Phase||171||
48450809|NCT01901146|101439763|FG004|STARTED|Adjuvant Phase||171||
48450810|NCT01901146|101439759|FG000|COMPLETED|Adjuvant Phase||0||
48450811|NCT01901146|101439760|FG001|COMPLETED|Adjuvant Phase||0||
48450812|NCT01901146|101439761|FG002|COMPLETED|Adjuvant Phase||323||
48450813|NCT01901146|101439762|FG003|COMPLETED|Adjuvant Phase||164||
48450814|NCT01901146|101439763|FG004|COMPLETED|Adjuvant Phase||157||
48450815|NCT01901146|101439759|FG000|NOT COMPLETED|Adjuvant Phase||0||
48450816|NCT01901146|101439760|FG001|NOT COMPLETED|Adjuvant Phase||0||
48450817|NCT01901146|101439761|FG002|NOT COMPLETED|Adjuvant Phase||26||
48450818|NCT01901146|101439762|FG003|NOT COMPLETED|Adjuvant Phase||7||
48450819|NCT01901146|101439763|FG004|NOT COMPLETED|Adjuvant Phase||14||
48450820|NCT00568776|101439764|FG000|STARTED|Overall Study||83||
48450821|NCT00568776|101439765|FG001|STARTED|Overall Study||88||
48450822|NCT00568776|101439766|FG002|STARTED|Overall Study||89||
48450823|NCT00568776|101439767|FG003|STARTED|Overall Study||91||
48450824|NCT00568776|101439764|FG000|COMPLETED|Overall Study||53||
48450825|NCT00568776|101439765|FG001|COMPLETED|Overall Study||52||
48450826|NCT00568776|101439766|FG002|COMPLETED|Overall Study||15||
48450827|NCT00568776|101439767|FG003|COMPLETED|Overall Study||19||
48450828|NCT00568776|101439764|FG000|NOT COMPLETED|Overall Study||30||
48450829|NCT00568776|101439765|FG001|NOT COMPLETED|Overall Study||36||
48450830|NCT00568776|101439766|FG002|NOT COMPLETED|Overall Study||74||
48450831|NCT00568776|101439767|FG003|NOT COMPLETED|Overall Study||72||
48450832|NCT04313023|101439768|FG000|STARTED|Overall Study||108||
48450833|NCT04313023|101439769|FG001|STARTED|Overall Study||109||
48450834|NCT04313023|101439768|FG000|COMPLETED|Overall Study||100||
48450835|NCT04313023|101439769|FG001|COMPLETED|Overall Study||107||
48450836|NCT04313023|101439768|FG000|NOT COMPLETED|Overall Study||8||
48450837|NCT04313023|101439769|FG001|NOT COMPLETED|Overall Study||2||
48450838|NCT01142466|101439770|FG000|STARTED|Overall Study||15||
48450839|NCT01142466|101439771|FG001|STARTED|Overall Study||15||
48450840|NCT01142466|101439770|FG000|COMPLETED|Overall Study||12||
48450841|NCT01142466|101439771|FG001|COMPLETED|Overall Study||13||
48450842|NCT01142466|101439770|FG000|NOT COMPLETED|Overall Study||3||
48450843|NCT01142466|101439771|FG001|NOT COMPLETED|Overall Study||2||
48450844|NCT00581386|101439772|FG000|STARTED|Overall Study||73||
48450845|NCT00581386|101439773|FG001|STARTED|Overall Study||73||
48450846|NCT00581386|101439774|FG002|STARTED|Overall Study||72||
48450847|NCT00581386|101439772|FG000|COMPLETED|Overall Study||73||
48450848|NCT00581386|101439773|FG001|COMPLETED|Overall Study||73||
48450849|NCT00581386|101439774|FG002|COMPLETED|Overall Study||72||
48450850|NCT00581386|101439772|FG000|NOT COMPLETED|Overall Study||0||
48450851|NCT00581386|101439773|FG001|NOT COMPLETED|Overall Study||0||
48450852|NCT00581386|101439774|FG002|NOT COMPLETED|Overall Study||0||
48450853|NCT01625286|101439775|FG000|STARTED|Overall Study||12|RANDOMIZATION CODE ALLOCATED|
48450854|NCT01625286|101439776|FG001|STARTED|Overall Study||8|RANDOMIZATION CODE ALLOCATED|
48450855|NCT01625286|101439777|FG002|STARTED|Overall Study||5|RANDOMIZATION CODE ALLOCATED|
48450856|NCT01625286|101439778|FG003|STARTED|Overall Study||7|RANDOMIZATION CODE ALLOCATED|
48450857|NCT01625286|101439779|FG004|STARTED|Overall Study||6|RANDOMIZATION CODE ALLOCATED|
48450858|NCT01625286|101439780|FG005|STARTED|Overall Study||54|RANDOMIZATION CODE ALLOCATED|
48450859|NCT01625286|101439781|FG006|STARTED|Overall Study||56|RANDOMIZATION CODE ALLOCATED|
48450860|NCT01625286|101439775|FG000|Received AZD5363/Placebo Treatment|Overall Study||12||
48450861|NCT01625286|101439776|FG001|Received AZD5363/Placebo Treatment|Overall Study||8||
48450862|NCT01625286|101439777|FG002|Received AZD5363/Placebo Treatment|Overall Study||5||
48450863|NCT01625286|101439778|FG003|Received AZD5363/Placebo Treatment|Overall Study||7||
48450864|NCT01625286|101439779|FG004|Received AZD5363/Placebo Treatment|Overall Study||6||
48450865|NCT01625286|101439780|FG005|Received AZD5363/Placebo Treatment|Overall Study||54||
48450866|NCT01625286|101439781|FG006|Received AZD5363/Placebo Treatment|Overall Study||55||
48450867|NCT01625286|101439775|FG000|Did Not Receive AZD5363/Placebo Trt|Overall Study||0||
48450868|NCT01625286|101439776|FG001|Did Not Receive AZD5363/Placebo Trt|Overall Study||0||
48450869|NCT01625286|101439777|FG002|Did Not Receive AZD5363/Placebo Trt|Overall Study||0||
48450870|NCT01625286|101439778|FG003|Did Not Receive AZD5363/Placebo Trt|Overall Study||0||
48450871|NCT01625286|101439779|FG004|Did Not Receive AZD5363/Placebo Trt|Overall Study||0||
48450872|NCT01625286|101439780|FG005|Did Not Receive AZD5363/Placebo Trt|Overall Study||0||
48450873|NCT01625286|101439781|FG006|Did Not Receive AZD5363/Placebo Trt|Overall Study||1||
48450874|NCT01625286|101439775|FG000|COMPLETED|Overall Study||6|Completed Study includes patients who were on study or treatment at the final database lock for primary analysis|
48450875|NCT01625286|101439776|FG001|COMPLETED|Overall Study||4|Completed Study includes patients who were on study or treatment at the final database lock for primary analysis|
48450876|NCT01625286|101439777|FG002|COMPLETED|Overall Study||0|Completed Study includes patients who were on study or treatment at the final database lock for primary analysis|
48450877|NCT01625286|101439778|FG003|COMPLETED|Overall Study||0|Completed Study includes patients who were on study or treatment at the final database lock for primary analysis|
48660768|NCT02799043|101954618|FG001|NOT COMPLETED|Overall Study||15||
48450878|NCT01625286|101439779|FG004|COMPLETED|Overall Study||0|Completed Study includes patients who were on study or treatment at the final database lock for primary analysis|
48450879|NCT01625286|101439780|FG005|COMPLETED|Overall Study||40|Completed Study includes patients who were on study or treatment at the final database lock for primary analysis|
48450880|NCT01625286|101439781|FG006|COMPLETED|Overall Study||37|Completed Study includes patients who were on study or treatment at the final database lock for primary analysis|
48771878|NCT01746901|102229497|FG008|STARTED|Treatment Phase: Fourth Intervention||7||
48771879|NCT01746901|102229489|FG000|COMPLETED|Treatment Phase: Fourth Intervention||0||
48771880|NCT01746901|102229490|FG001|COMPLETED|Treatment Phase: Fourth Intervention||0||
48771881|NCT01746901|102229491|FG002|COMPLETED|Treatment Phase: Fourth Intervention||0||
48771882|NCT01746901|102229492|FG003|COMPLETED|Treatment Phase: Fourth Intervention||5||
48771883|NCT01746901|102229493|FG004|COMPLETED|Treatment Phase: Fourth Intervention||6||
48771884|NCT01746901|102229494|FG005|COMPLETED|Treatment Phase: Fourth Intervention||5||
48771885|NCT01746901|102229495|FG006|COMPLETED|Treatment Phase: Fourth Intervention||5||
48771886|NCT01746901|102229496|FG007|COMPLETED|Treatment Phase: Fourth Intervention||6||
48771887|NCT01746901|102229497|FG008|COMPLETED|Treatment Phase: Fourth Intervention||5||
48771888|NCT01746901|102229489|FG000|NOT COMPLETED|Treatment Phase: Fourth Intervention||0||
48771889|NCT01746901|102229490|FG001|NOT COMPLETED|Treatment Phase: Fourth Intervention||0||
48771890|NCT01746901|102229491|FG002|NOT COMPLETED|Treatment Phase: Fourth Intervention||0||
48450881|NCT01625286|101439775|FG000|NOT COMPLETED|Overall Study||6||
48450882|NCT01625286|101439776|FG001|NOT COMPLETED|Overall Study||4||
48450883|NCT01625286|101439777|FG002|NOT COMPLETED|Overall Study||5||
48450884|NCT01625286|101439778|FG003|NOT COMPLETED|Overall Study||7||
48450885|NCT01625286|101439779|FG004|NOT COMPLETED|Overall Study||6||
48450886|NCT01625286|101439780|FG005|NOT COMPLETED|Overall Study||14||
48450887|NCT01625286|101439781|FG006|NOT COMPLETED|Overall Study||19||
48450888|NCT00096486|101439782|FG000|STARTED|Overall Study||4||
48660769|NCT03941093|101954619|FG000|STARTED|Overall Study||143||
48660770|NCT03941093|101954620|FG001|STARTED|Overall Study||141||
48660771|NCT03941093|101954619|FG000|Received At Least 1 Dose of Study Drug|Overall Study||142||
48660772|NCT03941093|101954620|FG001|Received At Least 1 Dose of Study Drug|Overall Study||141||
48660773|NCT03941093|101954619|FG000|COMPLETED|Overall Study||134||
48660774|NCT03941093|101954620|FG001|COMPLETED|Overall Study||134||
48660775|NCT03941093|101954619|FG000|NOT COMPLETED|Overall Study||9||
48660776|NCT03941093|101954620|FG001|NOT COMPLETED|Overall Study||7||
48660777|NCT04104477|101954621|FG000|STARTED|Overall Study||15||
48660778|NCT04104477|101954622|FG001|STARTED|Overall Study||16||
48660779|NCT04104477|101954621|FG000|COMPLETED|Overall Study||15||
48660780|NCT04104477|101954622|FG001|COMPLETED|Overall Study||16||
48660781|NCT04104477|101954621|FG000|NOT COMPLETED|Overall Study||0||
48660782|NCT04104477|101954622|FG001|NOT COMPLETED|Overall Study||0||
48660783|NCT04910165|101954623|FG000|STARTED|Overall Study||50||
48660784|NCT04910165|101954624|FG001|STARTED|Overall Study||50||
48660785|NCT04910165|101954623|FG000|COMPLETED|Overall Study||50||
48660786|NCT04910165|101954624|FG001|COMPLETED|Overall Study||50||
48660787|NCT04910165|101954623|FG000|NOT COMPLETED|Overall Study||0||
48660788|NCT04910165|101954624|FG001|NOT COMPLETED|Overall Study||0||
48660789|NCT04526158|101954625|FG000|STARTED|Overall Study||270||
48660790|NCT04526158|101954626|FG001|STARTED|Overall Study||271||
48660791|NCT04526158|101954627|FG002|STARTED|Overall Study||270||
48660792|NCT04526158|101954625|FG000|COMPLETED|Overall Study||225||
48660793|NCT04526158|101954626|FG001|COMPLETED|Overall Study||225||
48660794|NCT04526158|101954627|FG002|COMPLETED|Overall Study||244||
48660795|NCT04526158|101954625|FG000|NOT COMPLETED|Overall Study||45||
48660796|NCT04526158|101954626|FG001|NOT COMPLETED|Overall Study||46||
48660797|NCT04526158|101954627|FG002|NOT COMPLETED|Overall Study||26||
48450889|NCT00096486|101439783|FG001|STARTED|Overall Study||6||
48450890|NCT00096486|101439784|FG002|STARTED|Overall Study||26||
48450891|NCT00096486|101439785|FG003|STARTED|Overall Study||38||
48450892|NCT00096486|101439782|FG000|COMPLETED|Overall Study||4||
48450893|NCT00096486|101439783|FG001|COMPLETED|Overall Study||6||
48660798|NCT04066829|101954628|FG000|STARTED|Overall Study||70||
48660799|NCT04066829|101954629|FG001|STARTED|Overall Study||61||
48660800|NCT04066829|101954630|FG002|STARTED|Overall Study||46||
48660801|NCT04066829|101954631|FG003|STARTED|Overall Study||60||
48660802|NCT04066829|101954628|FG000|Participants Who Completed the Post-operative Day 14 Survey Assessing Secondary Outcomes.|Overall Study||44||
48660803|NCT04066829|101954629|FG001|Participants Who Completed the Post-operative Day 14 Survey Assessing Secondary Outcomes.|Overall Study||40||
48660804|NCT04066829|101954630|FG002|Participants Who Completed the Post-operative Day 14 Survey Assessing Secondary Outcomes.|Overall Study||26||
48660805|NCT04066829|101954631|FG003|Participants Who Completed the Post-operative Day 14 Survey Assessing Secondary Outcomes.|Overall Study||40||
48660806|NCT04066829|101954628|FG000|COMPLETED|Overall Study||70||
48771891|NCT01746901|102229492|FG003|NOT COMPLETED|Treatment Phase: Fourth Intervention||1||
48771892|NCT01746901|102229493|FG004|NOT COMPLETED|Treatment Phase: Fourth Intervention||0||
48771893|NCT01746901|102229494|FG005|NOT COMPLETED|Treatment Phase: Fourth Intervention||1||
48771894|NCT01746901|102229495|FG006|NOT COMPLETED|Treatment Phase: Fourth Intervention||1||
48771895|NCT01746901|102229496|FG007|NOT COMPLETED|Treatment Phase: Fourth Intervention||0||
48771896|NCT01746901|102229497|FG008|NOT COMPLETED|Treatment Phase: Fourth Intervention||2||
48660807|NCT04066829|101954629|FG001|COMPLETED|Overall Study||61||
48660808|NCT04066829|101954630|FG002|COMPLETED|Overall Study||46||
48660809|NCT04066829|101954631|FG003|COMPLETED|Overall Study||60||
48660810|NCT04066829|101954628|FG000|NOT COMPLETED|Overall Study||0||
48660811|NCT04066829|101954629|FG001|NOT COMPLETED|Overall Study||0||
48660812|NCT04066829|101954630|FG002|NOT COMPLETED|Overall Study||0||
48660813|NCT04066829|101954631|FG003|NOT COMPLETED|Overall Study||0||
48660814|NCT03460704|101954632|FG000|STARTED|Overall Study||152||
48660815|NCT03460704|101954633|FG001|STARTED|Overall Study||135||
48450894|NCT00096486|101439784|FG002|COMPLETED|Overall Study||24||
48450895|NCT00096486|101439785|FG003|COMPLETED|Overall Study||36||
48450896|NCT00096486|101439782|FG000|NOT COMPLETED|Overall Study||0||
48450897|NCT00096486|101439783|FG001|NOT COMPLETED|Overall Study||0||
48450898|NCT00096486|101439784|FG002|NOT COMPLETED|Overall Study||2||
48450899|NCT00096486|101439785|FG003|NOT COMPLETED|Overall Study||2||
48450900|NCT00331773|101439786|FG000|STARTED|Overall Study||558||
48450901|NCT00331773|101439787|FG001|STARTED|Overall Study||557||
48450902|NCT00331773|101439786|FG000|COMPLETED|Overall Study||542||
48450903|NCT00331773|101439787|FG001|COMPLETED|Overall Study||550||
48450904|NCT00331773|101439786|FG000|NOT COMPLETED|Overall Study||16||
48450905|NCT00331773|101439787|FG001|NOT COMPLETED|Overall Study||7||
48450906|NCT02164539|101439788|FG000|STARTED|Treatment Phase A (4 Weeks)||41||
48450907|NCT02164539|101439789|FG001|STARTED|Treatment Phase A (4 Weeks)||42||
48450908|NCT02164539|101439790|FG002|STARTED|Treatment Phase A (4 Weeks)||40||
48450909|NCT02164539|101439791|FG003|STARTED|Treatment Phase A (4 Weeks)||46||
48450910|NCT02164539|101439792|FG004|STARTED|Treatment Phase A (4 Weeks)||85||
48450911|NCT02164539|101439793|FG005|STARTED|Treatment Phase A (4 Weeks)||84||
48450912|NCT02164539|101439794|FG006|STARTED|Treatment Phase A (4 Weeks)||0||
48450913|NCT02164539|101439788|FG000|COMPLETED|Treatment Phase A (4 Weeks)||39||
48450914|NCT02164539|101439789|FG001|COMPLETED|Treatment Phase A (4 Weeks)||42||
48450915|NCT02164539|101439790|FG002|COMPLETED|Treatment Phase A (4 Weeks)||39||
48450916|NCT02164539|101439791|FG003|COMPLETED|Treatment Phase A (4 Weeks)||44||
48450917|NCT02164539|101439792|FG004|COMPLETED|Treatment Phase A (4 Weeks)||82||
48450918|NCT02164539|101439793|FG005|COMPLETED|Treatment Phase A (4 Weeks)||83||
48450919|NCT02164539|101439794|FG006|COMPLETED|Treatment Phase A (4 Weeks)||0||
48450920|NCT02164539|101439788|FG000|NOT COMPLETED|Treatment Phase A (4 Weeks)||2||
48450921|NCT02164539|101439789|FG001|NOT COMPLETED|Treatment Phase A (4 Weeks)||0||
48450922|NCT02164539|101439790|FG002|NOT COMPLETED|Treatment Phase A (4 Weeks)||1||
48450923|NCT02164539|101439791|FG003|NOT COMPLETED|Treatment Phase A (4 Weeks)||2||
48450924|NCT02164539|101439792|FG004|NOT COMPLETED|Treatment Phase A (4 Weeks)||3||
48450925|NCT02164539|101439793|FG005|NOT COMPLETED|Treatment Phase A (4 Weeks)||1||
48450926|NCT02164539|101439794|FG006|NOT COMPLETED|Treatment Phase A (4 Weeks)||0||
48450927|NCT02164539|101439788|FG000|STARTED|Treatment Phase B (1 Week)||0||
48450928|NCT02164539|101439789|FG001|STARTED|Treatment Phase B (1 Week)||0||
48450929|NCT02164539|101439790|FG002|STARTED|Treatment Phase B (1 Week)||0||
48450930|NCT02164539|101439791|FG003|STARTED|Treatment Phase B (1 Week)||0||
48450931|NCT02164539|101439792|FG004|STARTED|Treatment Phase B (1 Week)||166||
48450932|NCT02164539|101439793|FG005|STARTED|Treatment Phase B (1 Week)||0||
48450933|NCT02164539|101439794|FG006|STARTED|Treatment Phase B (1 Week)||163||
48450934|NCT02164539|101439788|FG000|COMPLETED|Treatment Phase B (1 Week)||0||
48450935|NCT02164539|101439789|FG001|COMPLETED|Treatment Phase B (1 Week)||0||
48450936|NCT02164539|101439790|FG002|COMPLETED|Treatment Phase B (1 Week)||0||
48450937|NCT02164539|101439791|FG003|COMPLETED|Treatment Phase B (1 Week)||0||
48450938|NCT02164539|101439792|FG004|COMPLETED|Treatment Phase B (1 Week)||163||
48450939|NCT02164539|101439793|FG005|COMPLETED|Treatment Phase B (1 Week)||0||
48660816|NCT03460704|101954632|FG000|Modified Intention to Treat Population - (mITT)|Overall Study||152||
48660817|NCT03460704|101954633|FG001|Modified Intention to Treat Population - (mITT)|Overall Study||135||
48660818|NCT03460704|101954632|FG000|Safety Population - (SAF)|Overall Study||152||
48660819|NCT03460704|101954633|FG001|Safety Population - (SAF)|Overall Study||135||
48660820|NCT03460704|101954632|FG000|Per-Protocol Population - (PP)|Overall Study||112||
48660821|NCT03460704|101954633|FG001|Per-Protocol Population - (PP)|Overall Study||98||
48450940|NCT02164539|101439794|FG006|COMPLETED|Treatment Phase B (1 Week)||162||
48450941|NCT02164539|101439788|FG000|NOT COMPLETED|Treatment Phase B (1 Week)||0||
48450942|NCT02164539|101439789|FG001|NOT COMPLETED|Treatment Phase B (1 Week)||0||
48450943|NCT02164539|101439790|FG002|NOT COMPLETED|Treatment Phase B (1 Week)||0||
48450944|NCT02164539|101439791|FG003|NOT COMPLETED|Treatment Phase B (1 Week)||0||
48450945|NCT02164539|101439792|FG004|NOT COMPLETED|Treatment Phase B (1 Week)||3||
48450946|NCT02164539|101439793|FG005|NOT COMPLETED|Treatment Phase B (1 Week)||0||
48450947|NCT02164539|101439794|FG006|NOT COMPLETED|Treatment Phase B (1 Week)||1||
48450948|NCT02164539|101439788|FG000|STARTED|Treatment Phase C (1 Week)||79||
48450949|NCT02164539|101439789|FG001|STARTED|Treatment Phase C (1 Week)||0||
48450950|NCT02164539|101439790|FG002|STARTED|Treatment Phase C (1 Week)||0||
48450951|NCT02164539|101439791|FG003|STARTED|Treatment Phase C (1 Week)||0||
48450952|NCT02164539|101439792|FG004|STARTED|Treatment Phase C (1 Week)||84||
48660822|NCT03460704|101954632|FG000|COMPLETED|Overall Study||94||
48450953|NCT02164539|101439793|FG005|STARTED|Treatment Phase C (1 Week)||82||
48450954|NCT02164539|101439794|FG006|STARTED|Treatment Phase C (1 Week)||80||
48450955|NCT02164539|101439788|FG000|COMPLETED|Treatment Phase C (1 Week)||78||
48450956|NCT02164539|101439789|FG001|COMPLETED|Treatment Phase C (1 Week)||0||
48450957|NCT02164539|101439790|FG002|COMPLETED|Treatment Phase C (1 Week)||0||
48450958|NCT02164539|101439791|FG003|COMPLETED|Treatment Phase C (1 Week)||0||
48450959|NCT02164539|101439792|FG004|COMPLETED|Treatment Phase C (1 Week)||84||
48450960|NCT02164539|101439793|FG005|COMPLETED|Treatment Phase C (1 Week)||82||
48450961|NCT02164539|101439794|FG006|COMPLETED|Treatment Phase C (1 Week)||78||
48450962|NCT02164539|101439788|FG000|NOT COMPLETED|Treatment Phase C (1 Week)||1||
48450963|NCT02164539|101439789|FG001|NOT COMPLETED|Treatment Phase C (1 Week)||0||
48450964|NCT02164539|101439790|FG002|NOT COMPLETED|Treatment Phase C (1 Week)||0||
48450965|NCT02164539|101439791|FG003|NOT COMPLETED|Treatment Phase C (1 Week)||0||
48450966|NCT02164539|101439792|FG004|NOT COMPLETED|Treatment Phase C (1 Week)||0||
48450967|NCT02164539|101439793|FG005|NOT COMPLETED|Treatment Phase C (1 Week)||0||
48450968|NCT02164539|101439794|FG006|NOT COMPLETED|Treatment Phase C (1 Week)||2||
48771897|NCT01746901|102229489|FG000|STARTED|Treatment Phase: Washout Period 4||0||
48771898|NCT01746901|102229490|FG001|STARTED|Treatment Phase: Washout Period 4||0||
48771899|NCT01746901|102229491|FG002|STARTED|Treatment Phase: Washout Period 4||0||
48771900|NCT01746901|102229492|FG003|STARTED|Treatment Phase: Washout Period 4||5||
48771901|NCT01746901|102229493|FG004|STARTED|Treatment Phase: Washout Period 4||6||
48771902|NCT01746901|102229494|FG005|STARTED|Treatment Phase: Washout Period 4||5||
48771903|NCT01746901|102229495|FG006|STARTED|Treatment Phase: Washout Period 4||5||
48771904|NCT01746901|102229496|FG007|STARTED|Treatment Phase: Washout Period 4||6||
48771905|NCT01746901|102229497|FG008|STARTED|Treatment Phase: Washout Period 4||5||
48771906|NCT01746901|102229489|FG000|COMPLETED|Treatment Phase: Washout Period 4||0||
48771907|NCT01746901|102229490|FG001|COMPLETED|Treatment Phase: Washout Period 4||0||
48771908|NCT01746901|102229491|FG002|COMPLETED|Treatment Phase: Washout Period 4||0||
48771909|NCT01746901|102229492|FG003|COMPLETED|Treatment Phase: Washout Period 4||5||
48771910|NCT01746901|102229493|FG004|COMPLETED|Treatment Phase: Washout Period 4||6||
48771911|NCT01746901|102229494|FG005|COMPLETED|Treatment Phase: Washout Period 4||5||
48771912|NCT01746901|102229495|FG006|COMPLETED|Treatment Phase: Washout Period 4||5||
48771913|NCT01746901|102229496|FG007|COMPLETED|Treatment Phase: Washout Period 4||6||
48771914|NCT01746901|102229497|FG008|COMPLETED|Treatment Phase: Washout Period 4||5||
48771915|NCT01746901|102229489|FG000|NOT COMPLETED|Treatment Phase: Washout Period 4||0||
48450969|NCT00044005|101439795|FG000|STARTED|Overall Study||32||
48771916|NCT01746901|102229490|FG001|NOT COMPLETED|Treatment Phase: Washout Period 4||0||
48771917|NCT01746901|102229491|FG002|NOT COMPLETED|Treatment Phase: Washout Period 4||0||
48771918|NCT01746901|102229492|FG003|NOT COMPLETED|Treatment Phase: Washout Period 4||0||
48771919|NCT01746901|102229493|FG004|NOT COMPLETED|Treatment Phase: Washout Period 4||0||
48771920|NCT01746901|102229494|FG005|NOT COMPLETED|Treatment Phase: Washout Period 4||0||
48771921|NCT01746901|102229495|FG006|NOT COMPLETED|Treatment Phase: Washout Period 4||0||
48771922|NCT01746901|102229496|FG007|NOT COMPLETED|Treatment Phase: Washout Period 4||0||
48771923|NCT01746901|102229497|FG008|NOT COMPLETED|Treatment Phase: Washout Period 4||0||
48771924|NCT01746901|102229489|FG000|STARTED|Treatment Phase: Fifth Intervention||0||
48771925|NCT01746901|102229490|FG001|STARTED|Treatment Phase: Fifth Intervention||0||
48771926|NCT01746901|102229491|FG002|STARTED|Treatment Phase: Fifth Intervention||0||
48771927|NCT01746901|102229492|FG003|STARTED|Treatment Phase: Fifth Intervention||5||
48771928|NCT01746901|102229493|FG004|STARTED|Treatment Phase: Fifth Intervention||6||
48771929|NCT01746901|102229494|FG005|STARTED|Treatment Phase: Fifth Intervention||5||
48771930|NCT01746901|102229495|FG006|STARTED|Treatment Phase: Fifth Intervention||5||
48771931|NCT01746901|102229496|FG007|STARTED|Treatment Phase: Fifth Intervention||6||
48771932|NCT01746901|102229497|FG008|STARTED|Treatment Phase: Fifth Intervention||5||
48771933|NCT01746901|102229489|FG000|COMPLETED|Treatment Phase: Fifth Intervention||0||
48771934|NCT01746901|102229490|FG001|COMPLETED|Treatment Phase: Fifth Intervention||0||
48771935|NCT01746901|102229491|FG002|COMPLETED|Treatment Phase: Fifth Intervention||0||
48771936|NCT01746901|102229492|FG003|COMPLETED|Treatment Phase: Fifth Intervention||5||
48771937|NCT01746901|102229493|FG004|COMPLETED|Treatment Phase: Fifth Intervention||6||
48450970|NCT00044005|101439796|FG001|STARTED|Overall Study||33||
48450971|NCT00044005|101439797|FG002|STARTED|Overall Study||33||
48450972|NCT00044005|101439795|FG000|COMPLETED|Overall Study||13||
48450973|NCT00044005|101439796|FG001|COMPLETED|Overall Study||19||
48450974|NCT00044005|101439797|FG002|COMPLETED|Overall Study||11||
48450975|NCT00044005|101439795|FG000|NOT COMPLETED|Overall Study||19||
48450976|NCT00044005|101439796|FG001|NOT COMPLETED|Overall Study||14||
48450977|NCT00044005|101439797|FG002|NOT COMPLETED|Overall Study||22||
48450978|NCT03296553|101439798|FG000|STARTED|Overall Study||20||
48771938|NCT01746901|102229494|FG005|COMPLETED|Treatment Phase: Fifth Intervention||5||
48771939|NCT01746901|102229495|FG006|COMPLETED|Treatment Phase: Fifth Intervention||5||
48771940|NCT01746901|102229496|FG007|COMPLETED|Treatment Phase: Fifth Intervention||6||
48189147|NCT03176134|100786160|FG005|STARTED|Overall Study||5||
48189148|NCT03176134|100786161|FG006|STARTED|Overall Study||0||
48189149|NCT03176134|100786162|FG007|STARTED|Overall Study||0||
48450979|NCT03296553|101439799|FG001|STARTED|Overall Study||20||
48450980|NCT03296553|101439798|FG000|COMPLETED|Overall Study||18||
48189150|NCT03176134|100786155|FG000|COMPLETED|Overall Study||42||
48450981|NCT03296553|101439799|FG001|COMPLETED|Overall Study||19||
48450982|NCT03296553|101439798|FG000|NOT COMPLETED|Overall Study||2||
48450983|NCT03296553|101439799|FG001|NOT COMPLETED|Overall Study||1||
48450984|NCT03927781|101439800|FG000|STARTED|Overall Study||10||
48450985|NCT03927781|101439800|FG000|COMPLETED|Overall Study||10||
48450986|NCT03927781|101439800|FG000|NOT COMPLETED|Overall Study||0||
48450987|NCT01197456|101439801|FG000|STARTED|Overall Study||171||
48450988|NCT01197456|101439802|FG001|STARTED|Overall Study||61||
48450989|NCT01197456|101439801|FG000|COMPLETED|Overall Study||171||
48450990|NCT01197456|101439802|FG001|COMPLETED|Overall Study||61||
48450991|NCT01197456|101439801|FG000|NOT COMPLETED|Overall Study||0||
48450992|NCT01197456|101439802|FG001|NOT COMPLETED|Overall Study||0||
48450993|NCT00619619|101439803|FG000|STARTED|Overall Study||6||
48450994|NCT00619619|101439804|FG001|STARTED|Overall Study||7||
48450995|NCT00619619|101439805|FG002|STARTED|Overall Study||9||
48450996|NCT00619619|101439806|FG003|STARTED|Overall Study||7||
48450997|NCT00619619|101439807|FG004|STARTED|Overall Study||7||
48450998|NCT00619619|101439808|FG005|STARTED|Overall Study||7||
48450999|NCT00619619|101439809|FG006|STARTED|Overall Study||8||
48451000|NCT00619619|101439810|FG007|STARTED|Overall Study||8||
48451001|NCT00619619|101439803|FG000|Entered the Extension Study|Overall Study||6||
48451002|NCT00619619|101439804|FG001|Entered the Extension Study|Overall Study||5||
48451003|NCT00619619|101439805|FG002|Entered the Extension Study|Overall Study||8||
48451004|NCT00619619|101439806|FG003|Entered the Extension Study|Overall Study||3||
48451005|NCT00619619|101439807|FG004|Entered the Extension Study|Overall Study||7||
48451006|NCT00619619|101439808|FG005|Entered the Extension Study|Overall Study||6||
48451007|NCT00619619|101439809|FG006|Entered the Extension Study|Overall Study||6||
48451008|NCT00619619|101439810|FG007|Entered the Extension Study|Overall Study||7||
48451009|NCT00619619|101439803|FG000|COMPLETED|Overall Study||6||
48451010|NCT00619619|101439804|FG001|COMPLETED|Overall Study||7||
48451011|NCT00619619|101439805|FG002|COMPLETED|Overall Study||8||
48451012|NCT00619619|101439806|FG003|COMPLETED|Overall Study||6||
48451013|NCT00619619|101439807|FG004|COMPLETED|Overall Study||5||
48451014|NCT00619619|101439808|FG005|COMPLETED|Overall Study||7||
48451015|NCT00619619|101439809|FG006|COMPLETED|Overall Study||7||
48451016|NCT00619619|101439810|FG007|COMPLETED|Overall Study||5||
48451017|NCT00619619|101439803|FG000|NOT COMPLETED|Overall Study||0||
48451018|NCT00619619|101439804|FG001|NOT COMPLETED|Overall Study||0||
48451019|NCT00619619|101439805|FG002|NOT COMPLETED|Overall Study||1||
48451020|NCT00619619|101439806|FG003|NOT COMPLETED|Overall Study||1||
48451021|NCT00619619|101439807|FG004|NOT COMPLETED|Overall Study||2||
48451022|NCT00619619|101439808|FG005|NOT COMPLETED|Overall Study||0||
48451023|NCT00619619|101439809|FG006|NOT COMPLETED|Overall Study||1||
48451024|NCT00619619|101439810|FG007|NOT COMPLETED|Overall Study||3||
48451025|NCT03056352|101439811|FG000|STARTED|Overall Study||21||
48451026|NCT03056352|101439811|FG000|COMPLETED|Overall Study||20||
48451027|NCT03056352|101439811|FG000|NOT COMPLETED|Overall Study||1||
48451028|NCT04553484|101439812|FG000|STARTED|Overall Study||657||
48451029|NCT04553484|101439812|FG000|COMPLETED|Overall Study||657||
48451030|NCT04553484|101439812|FG000|NOT COMPLETED|Overall Study||0||
48451031|NCT01493531|101439813|FG000|STARTED|Overall Study||204||
48451032|NCT01493531|101439814|FG001|STARTED|Overall Study||200||
48451033|NCT01493531|101439815|FG002|STARTED|Overall Study||206||
48451034|NCT01493531|101439813|FG000|COMPLETED|Overall Study||163||
48451035|NCT01493531|101439814|FG001|COMPLETED|Overall Study||150||
48451036|NCT01493531|101439815|FG002|COMPLETED|Overall Study||158||
48771941|NCT01746901|102229497|FG008|COMPLETED|Treatment Phase: Fifth Intervention||5||
48451037|NCT01493531|101439813|FG000|NOT COMPLETED|Overall Study||41||
48451038|NCT01493531|101439814|FG001|NOT COMPLETED|Overall Study||50||
48451039|NCT01493531|101439815|FG002|NOT COMPLETED|Overall Study||48||
48451040|NCT02017535|101439816|FG000|STARTED|Overall Study||9||
48189151|NCT03176134|100786156|FG001|COMPLETED|Overall Study||13||
48451041|NCT02017535|101439817|FG001|STARTED|Overall Study||3||
48451042|NCT02017535|101439818|FG002|STARTED|Overall Study||2||
48451043|NCT02017535|101439819|FG003|STARTED|Overall Study||1||
48451044|NCT02017535|101439816|FG000|COMPLETED|Overall Study||8||
48451045|NCT02017535|101439817|FG001|COMPLETED|Overall Study||3||
48451046|NCT02017535|101439818|FG002|COMPLETED|Overall Study||2||
48451047|NCT02017535|101439819|FG003|COMPLETED|Overall Study||1||
48451048|NCT02017535|101439816|FG000|NOT COMPLETED|Overall Study||1||
48451049|NCT02017535|101439817|FG001|NOT COMPLETED|Overall Study||0||
48451050|NCT02017535|101439818|FG002|NOT COMPLETED|Overall Study||0||
48451051|NCT02017535|101439819|FG003|NOT COMPLETED|Overall Study||0||
48451052|NCT04322968|101439820|FG000|STARTED|Overall Study||11||
48771942|NCT01746901|102229489|FG000|NOT COMPLETED|Treatment Phase: Fifth Intervention||0||
48771943|NCT01746901|102229490|FG001|NOT COMPLETED|Treatment Phase: Fifth Intervention||0||
48771944|NCT01746901|102229491|FG002|NOT COMPLETED|Treatment Phase: Fifth Intervention||0||
48771945|NCT01746901|102229492|FG003|NOT COMPLETED|Treatment Phase: Fifth Intervention||0||
48771946|NCT01746901|102229493|FG004|NOT COMPLETED|Treatment Phase: Fifth Intervention||0||
48189152|NCT03176134|100786157|FG002|COMPLETED|Overall Study||14||
48189153|NCT03176134|100786158|FG003|COMPLETED|Overall Study||5||
48451053|NCT04322968|101439821|FG001|STARTED|Overall Study||10||
48451054|NCT04322968|101439822|FG002|STARTED|Overall Study||10||
48451055|NCT04322968|101439823|FG003|STARTED|Overall Study||10||
48451056|NCT04322968|101439820|FG000|COMPLETED|Overall Study||10||
48451057|NCT04322968|101439821|FG001|COMPLETED|Overall Study||9||
48451058|NCT04322968|101439822|FG002|COMPLETED|Overall Study||10||
48451059|NCT04322968|101439823|FG003|COMPLETED|Overall Study||10||
48451060|NCT04322968|101439820|FG000|NOT COMPLETED|Overall Study||1||
48451061|NCT04322968|101439821|FG001|NOT COMPLETED|Overall Study||1||
48451062|NCT04322968|101439822|FG002|NOT COMPLETED|Overall Study||0||
48451063|NCT04322968|101439823|FG003|NOT COMPLETED|Overall Study||0||
48451064|NCT04636398|101439824|FG000|STARTED|Overall Study||29||
48451065|NCT04636398|101439824|FG000|COMPLETED|Overall Study||29||
48451066|NCT04636398|101439824|FG000|NOT COMPLETED|Overall Study||0||
48451067|NCT00789828|101439825|FG000|STARTED|Core Period (48 Weeks)||78||
48451068|NCT00789828|101439826|FG001|STARTED|Core Period (48 Weeks)||39||
48451069|NCT00789828|101439825|FG000|COMPLETED|Core Period (48 Weeks)||78||
48451070|NCT00789828|101439826|FG001|COMPLETED|Core Period (48 Weeks)||33||
48451071|NCT00789828|101439825|FG000|NOT COMPLETED|Core Period (48 Weeks)||0||
48451072|NCT00789828|101439826|FG001|NOT COMPLETED|Core Period (48 Weeks)||6||
48451073|NCT00789828|101439825|FG000|STARTED|Open-label Extension Period (4 Years)||111||
48451074|NCT00789828|101439826|FG001|STARTED|Open-label Extension Period (4 Years)||0||
48451075|NCT00789828|101439825|FG000|COMPLETED|Open-label Extension Period (4 Years)||82||
48451076|NCT00789828|101439826|FG001|COMPLETED|Open-label Extension Period (4 Years)||0||
48451077|NCT00789828|101439825|FG000|NOT COMPLETED|Open-label Extension Period (4 Years)||29||
48451078|NCT00789828|101439826|FG001|NOT COMPLETED|Open-label Extension Period (4 Years)||0||
48451079|NCT02580318|101439827|FG000|STARTED|Overall Study||54||
48451080|NCT02580318|101439827|FG000|Poor Effort|Overall Study||53||
48451081|NCT02580318|101439827|FG000|Hyperventilation (Immediate)|Overall Study||54||
48451082|NCT02580318|101439827|FG000|Hyperventilation (5 Minutes)|Overall Study||54||
48451083|NCT02580318|101439827|FG000|Hyperventilation (10 Minutes)|Overall Study||54||
48451084|NCT02580318|101439827|FG000|Drinking Water (Immediate)|Overall Study||51||
48451085|NCT02580318|101439827|FG000|Drinking Water (5 Minutes)|Overall Study||54||
48451086|NCT02580318|101439827|FG000|COMPLETED|Overall Study||54||
48451087|NCT02580318|101439827|FG000|NOT COMPLETED|Overall Study||0||
48451088|NCT01559818|101439828|FG000|STARTED|Overall Study||10||
48451089|NCT01559818|101439828|FG000|COMPLETED|Overall Study||3||
48451090|NCT01559818|101439828|FG000|NOT COMPLETED|Overall Study||7||
48451091|NCT01336608|101439829|FG000|STARTED|2-week, Single-blind Run-In Period||559||
48451092|NCT01336608|101439830|FG001|STARTED|2-week, Single-blind Run-In Period||0||
48451093|NCT01336608|101439831|FG002|STARTED|2-week, Single-blind Run-In Period||0||
48451094|NCT01336608|101439832|FG003|STARTED|2-week, Single-blind Run-In Period||0||
48451095|NCT01336608|101439829|FG000|COMPLETED|2-week, Single-blind Run-In Period||444||
48451096|NCT01336608|101439830|FG001|COMPLETED|2-week, Single-blind Run-In Period||0||
48451097|NCT01336608|101439831|FG002|COMPLETED|2-week, Single-blind Run-In Period||0||
48451098|NCT01336608|101439832|FG003|COMPLETED|2-week, Single-blind Run-In Period||0||
48451099|NCT01336608|101439829|FG000|NOT COMPLETED|2-week, Single-blind Run-In Period||115||
48451100|NCT01336608|101439830|FG001|NOT COMPLETED|2-week, Single-blind Run-In Period||0||
48451101|NCT01336608|101439831|FG002|NOT COMPLETED|2-week, Single-blind Run-In Period||0||
48451102|NCT01336608|101439832|FG003|NOT COMPLETED|2-week, Single-blind Run-In Period||0||
48451103|NCT01336608|101439829|FG000|STARTED|24-week, Double-blind Treatment Period||0||
48451104|NCT01336608|101439830|FG001|STARTED|24-week, Double-blind Treatment Period||141||
48451105|NCT01336608|101439831|FG002|STARTED|24-week, Double-blind Treatment Period||154||
48451106|NCT01336608|101439832|FG003|STARTED|24-week, Double-blind Treatment Period||135||
48451107|NCT01336608|101439829|FG000|Completed the Treatment Period|24-week, Double-blind Treatment Period||0||
48451108|NCT01336608|101439830|FG001|Completed the Treatment Period|24-week, Double-blind Treatment Period||96||
48451109|NCT01336608|101439831|FG002|Completed the Treatment Period|24-week, Double-blind Treatment Period||124||
48451110|NCT01336608|101439832|FG003|Completed the Treatment Period|24-week, Double-blind Treatment Period||110||
48451111|NCT01336608|101439829|FG000|COMPLETED|24-week, Double-blind Treatment Period||0||
48451112|NCT01336608|101439830|FG001|COMPLETED|24-week, Double-blind Treatment Period||97||
48451113|NCT01336608|101439831|FG002|COMPLETED|24-week, Double-blind Treatment Period||124||
48451114|NCT01336608|101439832|FG003|COMPLETED|24-week, Double-blind Treatment Period||111||
48451115|NCT01336608|101439829|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0||
48451116|NCT01336608|101439830|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||44||
48451117|NCT01336608|101439831|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||30||
48451118|NCT01336608|101439832|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||24||
48451119|NCT00078819|101439833|FG000|STARTED|Double-blind Treatment Period: Week 1-12||105||
48451120|NCT00078819|101439834|FG001|STARTED|Double-blind Treatment Period: Week 1-12||106||
48451121|NCT00078819|101439835|FG002|STARTED|Double-blind Treatment Period: Week 1-12||0||
48660823|NCT03460704|101954633|FG001|COMPLETED|Overall Study||89||
48189154|NCT03176134|100786159|FG004|COMPLETED|Overall Study||15||
48189155|NCT03176134|100786160|FG005|COMPLETED|Overall Study||5||
48451122|NCT00078819|101439836|FG003|STARTED|Double-blind Treatment Period: Week 1-12||0||
48451123|NCT00078819|101439833|FG000|Entered Escape|Double-blind Treatment Period: Week 1-12||27||
48451124|NCT00078819|101439834|FG001|Entered Escape|Double-blind Treatment Period: Week 1-12||5||
48451125|NCT00078819|101439835|FG002|Entered Escape|Double-blind Treatment Period: Week 1-12||0||
48451126|NCT00078819|101439836|FG003|Entered Escape|Double-blind Treatment Period: Week 1-12||0||
48451127|NCT00078819|101439833|FG000|COMPLETED|Double-blind Treatment Period: Week 1-12||104|Includes participants who escaped early|
48451128|NCT00078819|101439834|FG001|COMPLETED|Double-blind Treatment Period: Week 1-12||105|Includes participants who escaped early|
48451129|NCT00078819|101439835|FG002|COMPLETED|Double-blind Treatment Period: Week 1-12||0|Includes participants who escaped early|
48451130|NCT00078819|101439836|FG003|COMPLETED|Double-blind Treatment Period: Week 1-12||0|Includes participants who escaped early|
48451131|NCT00078819|101439833|FG000|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||1||
48451132|NCT00078819|101439834|FG001|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||1||
48451133|NCT00078819|101439835|FG002|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||0||
48451134|NCT00078819|101439836|FG003|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||0||
48451135|NCT00078819|101439833|FG000|STARTED|Open-label Treatment Period: Weeks 13-36||103||
48451136|NCT00078819|101439834|FG001|STARTED|Open-label Treatment Period: Weeks 13-36||105||
48451137|NCT00078819|101439835|FG002|STARTED|Open-label Treatment Period: Weeks 13-36||0||
48451138|NCT00078819|101439836|FG003|STARTED|Open-label Treatment Period: Weeks 13-36||0||
48451139|NCT00078819|101439833|FG000|COMPLETED|Open-label Treatment Period: Weeks 13-36||63|Includes participants who completed week 36 with a PASI response|
48451140|NCT00078819|101439834|FG001|COMPLETED|Open-label Treatment Period: Weeks 13-36||75|Includes participants who completed week 36 with a PASI response|
48451141|NCT00078819|101439835|FG002|COMPLETED|Open-label Treatment Period: Weeks 13-36||0|Includes participants who completed week 36 with a PASI response|
48451142|NCT00078819|101439836|FG003|COMPLETED|Open-label Treatment Period: Weeks 13-36||0|Includes participants who completed week 36 with a PASI response|
48451143|NCT00078819|101439833|FG000|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||40||
48451144|NCT00078819|101439834|FG001|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||30||
48451145|NCT00078819|101439835|FG002|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||0||
48660824|NCT03460704|101954632|FG000|NOT COMPLETED|Overall Study||58||
48660825|NCT03460704|101954633|FG001|NOT COMPLETED|Overall Study||46||
48660826|NCT01877278|101954634|FG000|STARTED|Overall Study||33||
48660827|NCT01877278|101954635|FG001|STARTED|Overall Study||33||
48660828|NCT01877278|101954634|FG000|COMPLETED|Overall Study||30||
48660829|NCT01877278|101954635|FG001|COMPLETED|Overall Study||30||
48660830|NCT01877278|101954634|FG000|NOT COMPLETED|Overall Study||3||
48660831|NCT01877278|101954635|FG001|NOT COMPLETED|Overall Study||3||
48660832|NCT04250207|101954636|FG000|STARTED|12 Week Treatment||21||
48660833|NCT04250207|101954637|FG001|STARTED|12 Week Treatment||22||
48660834|NCT04250207|101954638|FG002|STARTED|12 Week Treatment||22||
48660835|NCT04250207|101954636|FG000|COMPLETED|12 Week Treatment||21||
48660836|NCT04250207|101954637|FG001|COMPLETED|12 Week Treatment||22||
48660837|NCT04250207|101954638|FG002|COMPLETED|12 Week Treatment||20||
48660838|NCT04250207|101954636|FG000|NOT COMPLETED|12 Week Treatment||0||
48660839|NCT04250207|101954637|FG001|NOT COMPLETED|12 Week Treatment||0||
48660840|NCT04250207|101954638|FG002|NOT COMPLETED|12 Week Treatment||2||
48660841|NCT04250207|101954636|FG000|STARTED|40 Week Follow-up Observation||21||
48660842|NCT04250207|101954637|FG001|STARTED|40 Week Follow-up Observation||22||
48660843|NCT04250207|101954638|FG002|STARTED|40 Week Follow-up Observation||22||
48660844|NCT04250207|101954636|FG000|COMPLETED|40 Week Follow-up Observation||21||
48189156|NCT03176134|100786161|FG006|COMPLETED|Overall Study||0||
48189157|NCT03176134|100786162|FG007|COMPLETED|Overall Study||0||
48369393|NCT02778867|101232757|FG000|COMPLETED|Phase 2||0||
48189158|NCT03176134|100786155|FG000|NOT COMPLETED|Overall Study||2||
48189159|NCT03176134|100786156|FG001|NOT COMPLETED|Overall Study||2||
48369394|NCT02778867|101232758|FG001|COMPLETED|Phase 2||0||
48369395|NCT02778867|101232759|FG002|COMPLETED|Phase 2||20||
48369396|NCT02778867|101232760|FG003|COMPLETED|Phase 2||9||
48369397|NCT02778867|101232757|FG000|NOT COMPLETED|Phase 2||0||
48369398|NCT02778867|101232758|FG001|NOT COMPLETED|Phase 2||0||
48369399|NCT02778867|101232759|FG002|NOT COMPLETED|Phase 2||1||
48369400|NCT02778867|101232760|FG003|NOT COMPLETED|Phase 2||2||
48369401|NCT00387660|101232761|FG000|STARTED|Overall Study||40||
48369402|NCT00387660|101232762|FG001|STARTED|Overall Study||40||
48369403|NCT00387660|101232761|FG000|COMPLETED|Overall Study||40||
48369404|NCT00387660|101232762|FG001|COMPLETED|Overall Study||40||
48369405|NCT00387660|101232761|FG000|NOT COMPLETED|Overall Study||0||
48369406|NCT00387660|101232762|FG001|NOT COMPLETED|Overall Study||0||
48369407|NCT03100435|101232763|FG000|STARTED|Overall Study||8||64
48369408|NCT03100435|101232763|FG000|YAG Laser|Overall Study||8||16
48369409|NCT03100435|101232763|FG000|Carbon Fiber Curette|Overall Study||8||16
48369410|NCT03100435|101232763|FG000|Titanium Brush|Overall Study||8||16
48369411|NCT03100435|101232763|FG000|Not Decontaminated|Overall Study||8||16
48369412|NCT03100435|101232763|FG000|COMPLETED|Overall Study||8||59
48660845|NCT04250207|101954637|FG001|COMPLETED|40 Week Follow-up Observation||21||
48660846|NCT04250207|101954638|FG002|COMPLETED|40 Week Follow-up Observation||20||
48660847|NCT04250207|101954636|FG000|NOT COMPLETED|40 Week Follow-up Observation||0||
48771947|NCT01746901|102229494|FG005|NOT COMPLETED|Treatment Phase: Fifth Intervention||0||
48771948|NCT01746901|102229495|FG006|NOT COMPLETED|Treatment Phase: Fifth Intervention||0||
48771949|NCT01746901|102229496|FG007|NOT COMPLETED|Treatment Phase: Fifth Intervention||0||
48771950|NCT01746901|102229497|FG008|NOT COMPLETED|Treatment Phase: Fifth Intervention||0||
48771951|NCT01746901|102229489|FG000|STARTED|Treatment Phase: Washout Period 5||0||
48771952|NCT01746901|102229490|FG001|STARTED|Treatment Phase: Washout Period 5||0||
48771953|NCT01746901|102229491|FG002|STARTED|Treatment Phase: Washout Period 5||0||
48451146|NCT00078819|101439836|FG003|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||0||
48451147|NCT00078819|101439833|FG000|STARTED|Withdrawal Period: Weeks 37-48||0||
48451148|NCT00078819|101439834|FG001|STARTED|Withdrawal Period: Weeks 37-48||0||
48451149|NCT00078819|101439835|FG002|STARTED|Withdrawal Period: Weeks 37-48||69||
48451150|NCT00078819|101439836|FG003|STARTED|Withdrawal Period: Weeks 37-48||69||
48451151|NCT00078819|101439833|FG000|Received Study Drug|Withdrawal Period: Weeks 37-48||0||
48771954|NCT01746901|102229492|FG003|STARTED|Treatment Phase: Washout Period 5||5||
48771955|NCT01746901|102229493|FG004|STARTED|Treatment Phase: Washout Period 5||6||
48771956|NCT01746901|102229494|FG005|STARTED|Treatment Phase: Washout Period 5||5||
48771957|NCT01746901|102229495|FG006|STARTED|Treatment Phase: Washout Period 5||5||
48771958|NCT01746901|102229496|FG007|STARTED|Treatment Phase: Washout Period 5||6||
48771959|NCT01746901|102229497|FG008|STARTED|Treatment Phase: Washout Period 5||5||
48771960|NCT01746901|102229489|FG000|COMPLETED|Treatment Phase: Washout Period 5||0||
48771961|NCT01746901|102229490|FG001|COMPLETED|Treatment Phase: Washout Period 5||0||
48771962|NCT01746901|102229491|FG002|COMPLETED|Treatment Phase: Washout Period 5||0||
48771963|NCT01746901|102229492|FG003|COMPLETED|Treatment Phase: Washout Period 5||5||
48771964|NCT01746901|102229493|FG004|COMPLETED|Treatment Phase: Washout Period 5||6||
48771965|NCT01746901|102229494|FG005|COMPLETED|Treatment Phase: Washout Period 5||5||
48771966|NCT01746901|102229495|FG006|COMPLETED|Treatment Phase: Washout Period 5||5||
48771967|NCT01746901|102229496|FG007|COMPLETED|Treatment Phase: Washout Period 5||6||
48771968|NCT01746901|102229497|FG008|COMPLETED|Treatment Phase: Washout Period 5||5||
48771969|NCT01746901|102229489|FG000|NOT COMPLETED|Treatment Phase: Washout Period 5||0||
48771970|NCT01746901|102229490|FG001|NOT COMPLETED|Treatment Phase: Washout Period 5||0||
48771971|NCT01746901|102229491|FG002|NOT COMPLETED|Treatment Phase: Washout Period 5||0||
48771972|NCT01746901|102229492|FG003|NOT COMPLETED|Treatment Phase: Washout Period 5||0||
48771973|NCT01746901|102229493|FG004|NOT COMPLETED|Treatment Phase: Washout Period 5||0||
48771974|NCT01746901|102229494|FG005|NOT COMPLETED|Treatment Phase: Washout Period 5||0||
48771975|NCT01746901|102229495|FG006|NOT COMPLETED|Treatment Phase: Washout Period 5||0||
48771976|NCT01746901|102229496|FG007|NOT COMPLETED|Treatment Phase: Washout Period 5||0||
48771977|NCT01746901|102229497|FG008|NOT COMPLETED|Treatment Phase: Washout Period 5||0||
48771978|NCT01746901|102229489|FG000|STARTED|Treatment Phase: Sixth Intervention||0||
48771979|NCT01746901|102229490|FG001|STARTED|Treatment Phase: Sixth Intervention||0||
48771980|NCT01746901|102229491|FG002|STARTED|Treatment Phase: Sixth Intervention||0||
48771981|NCT01746901|102229492|FG003|STARTED|Treatment Phase: Sixth Intervention||5||
48771982|NCT01746901|102229493|FG004|STARTED|Treatment Phase: Sixth Intervention||6||
48771983|NCT01746901|102229494|FG005|STARTED|Treatment Phase: Sixth Intervention||5||
48771984|NCT01746901|102229495|FG006|STARTED|Treatment Phase: Sixth Intervention||5||
48369413|NCT03100435|101232763|FG000|NOT COMPLETED|Overall Study||0||5
48369414|NCT02552355|101232764|FG000|STARTED|Overall Study||14||
48369415|NCT02552355|101232765|FG001|STARTED|Overall Study||13||
48369416|NCT02552355|101232766|FG002|STARTED|Overall Study||14||
48369417|NCT02552355|101232767|FG003|STARTED|Overall Study||15||
48369418|NCT02552355|101232764|FG000|COMPLETED|Overall Study||14||
48369419|NCT02552355|101232765|FG001|COMPLETED|Overall Study||11||
48369420|NCT02552355|101232766|FG002|COMPLETED|Overall Study||12||
48369421|NCT02552355|101232767|FG003|COMPLETED|Overall Study||14||
48369422|NCT02552355|101232764|FG000|NOT COMPLETED|Overall Study||0||
48369423|NCT02552355|101232765|FG001|NOT COMPLETED|Overall Study||2||
48369424|NCT02552355|101232766|FG002|NOT COMPLETED|Overall Study||2||
48369425|NCT02552355|101232767|FG003|NOT COMPLETED|Overall Study||1||
48369426|NCT02200458|101232768|FG000|STARTED|Overall Study||62||
48369427|NCT02200458|101232768|FG000|COMPLETED|Overall Study||62||
48369428|NCT02200458|101232768|FG000|NOT COMPLETED|Overall Study||0||
48369429|NCT01103349|101232769|FG000|STARTED|Overall Study||95||
48369430|NCT01103349|101232770|FG001|STARTED|Overall Study||81||
48369431|NCT01103349|101232771|FG002|STARTED|Overall Study||67||
48451152|NCT00078819|101439834|FG001|Received Study Drug|Withdrawal Period: Weeks 37-48||0||
48451153|NCT00078819|101439835|FG002|Received Study Drug|Withdrawal Period: Weeks 37-48||69||
48660848|NCT04250207|101954637|FG001|NOT COMPLETED|40 Week Follow-up Observation||1||
48660849|NCT04250207|101954638|FG002|NOT COMPLETED|40 Week Follow-up Observation||2||
48660850|NCT01487161|101954639|FG000|STARTED|Overall Study||58||
48660851|NCT01487161|101954640|FG001|STARTED|Overall Study||59||
48369432|NCT01103349|101232769|FG000|COMPLETED|Overall Study||84||
48369433|NCT01103349|101232770|FG001|COMPLETED|Overall Study||74||
48660852|NCT01487161|101954641|FG002|STARTED|Overall Study||60||
48451154|NCT00078819|101439836|FG003|Received Study Drug|Withdrawal Period: Weeks 37-48||68||
48451155|NCT00078819|101439833|FG000|COMPLETED|Withdrawal Period: Weeks 37-48||0||
48451156|NCT00078819|101439834|FG001|COMPLETED|Withdrawal Period: Weeks 37-48||0||
48451157|NCT00078819|101439835|FG002|COMPLETED|Withdrawal Period: Weeks 37-48||40||
48451158|NCT00078819|101439836|FG003|COMPLETED|Withdrawal Period: Weeks 37-48||55||
48451159|NCT00078819|101439833|FG000|NOT COMPLETED|Withdrawal Period: Weeks 37-48||0||
48451160|NCT00078819|101439834|FG001|NOT COMPLETED|Withdrawal Period: Weeks 37-48||0||
48451161|NCT00078819|101439835|FG002|NOT COMPLETED|Withdrawal Period: Weeks 37-48||29||
48451162|NCT00078819|101439836|FG003|NOT COMPLETED|Withdrawal Period: Weeks 37-48||14||
48451163|NCT00078819|101439833|FG000|STARTED|Re-treatment Period||0||
48451164|NCT00078819|101439834|FG001|STARTED|Re-treatment Period||0||
48451165|NCT00078819|101439835|FG002|STARTED|Re-treatment Period||29||
48451166|NCT00078819|101439836|FG003|STARTED|Re-treatment Period||13||
48451167|NCT00078819|101439833|FG000|Received Study Drug|Re-treatment Period||0||
48451168|NCT00078819|101439834|FG001|Received Study Drug|Re-treatment Period||0||
48451169|NCT00078819|101439835|FG002|Received Study Drug|Re-treatment Period||30||
48451170|NCT00078819|101439836|FG003|Received Study Drug|Re-treatment Period||12||
48451171|NCT00078819|101439833|FG000|COMPLETED|Re-treatment Period||0||
48451172|NCT00078819|101439834|FG001|COMPLETED|Re-treatment Period||0||
48451173|NCT00078819|101439835|FG002|COMPLETED|Re-treatment Period||29||
48451174|NCT00078819|101439836|FG003|COMPLETED|Re-treatment Period||13||
48451175|NCT00078819|101439833|FG000|NOT COMPLETED|Re-treatment Period||0||
48451176|NCT00078819|101439834|FG001|NOT COMPLETED|Re-treatment Period||0||
48451177|NCT00078819|101439835|FG002|NOT COMPLETED|Re-treatment Period||0||
48451178|NCT00078819|101439836|FG003|NOT COMPLETED|Re-treatment Period||0||
48451179|NCT03156270|101439837|FG000|STARTED|Overall Study||20||
48451180|NCT03156270|101439837|FG000|COMPLETED|Overall Study||18||
48451181|NCT03156270|101439837|FG000|NOT COMPLETED|Overall Study||2||
48451182|NCT02464059|101439838|FG000|STARTED|Overall Study||23||
48451183|NCT02464059|101439838|FG000|COMPLETED|Overall Study||17||
48451184|NCT02464059|101439838|FG000|NOT COMPLETED|Overall Study||6||
48451185|NCT03302299|101439839|FG000|STARTED|Overall Study||302||
48451186|NCT03302299|101439839|FG000|Completed 3 Month Visit|Overall Study||295||
48451187|NCT03302299|101439839|FG000|Completed 6 Month Visit|Overall Study||289||
48451188|NCT03302299|101439839|FG000|COMPLETED|Overall Study||301|Completed study enrollment and initiated isoniazid (INH) course.|
48451189|NCT03302299|101439839|FG000|NOT COMPLETED|Overall Study||1||
48451190|NCT00869089|101439840|FG000|STARTED|Overall Study||5||
48451191|NCT00869089|101439840|FG000|COMPLETED|Overall Study||2||
48451192|NCT00869089|101439840|FG000|NOT COMPLETED|Overall Study||3||
48451193|NCT00891878|101439841|FG000|STARTED|Overall Study||6||
48451194|NCT00891878|101439842|FG001|STARTED|Overall Study||6||
48451195|NCT00891878|101439841|FG000|COMPLETED|Overall Study||6||
48451196|NCT00891878|101439842|FG001|COMPLETED|Overall Study||6||
48451197|NCT00891878|101439841|FG000|NOT COMPLETED|Overall Study||0||
48451198|NCT00891878|101439842|FG001|NOT COMPLETED|Overall Study||0||
48451199|NCT00272961|101439843|FG000|STARTED|Placebo Run-in Phase: Up to Week 2||60||
48451200|NCT00272961|101439844|FG001|STARTED|Placebo Run-in Phase: Up to Week 2||0||
48451201|NCT00272961|101439845|FG002|STARTED|Placebo Run-in Phase: Up to Week 2||0||
48451202|NCT00272961|101439846|FG003|STARTED|Placebo Run-in Phase: Up to Week 2||0||
48451203|NCT00272961|101439847|FG004|STARTED|Placebo Run-in Phase: Up to Week 2||0||
48451204|NCT00272961|101439843|FG000|COMPLETED|Placebo Run-in Phase: Up to Week 2||49||
48451205|NCT00272961|101439844|FG001|COMPLETED|Placebo Run-in Phase: Up to Week 2||0||
48451206|NCT00272961|101439845|FG002|COMPLETED|Placebo Run-in Phase: Up to Week 2||0||
48451207|NCT00272961|101439846|FG003|COMPLETED|Placebo Run-in Phase: Up to Week 2||0||
48451208|NCT00272961|101439847|FG004|COMPLETED|Placebo Run-in Phase: Up to Week 2||0||
48451209|NCT00272961|101439843|FG000|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||11||
48451210|NCT00272961|101439844|FG001|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0||
48451211|NCT00272961|101439845|FG002|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0||
48451212|NCT00272961|101439846|FG003|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0||
48451213|NCT00272961|101439847|FG004|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0||
48451214|NCT00272961|101439843|FG000|STARTED|Treatment Phase: Week 3 Up to Week 12||10||
48451215|NCT00272961|101439844|FG001|STARTED|Treatment Phase: Week 3 Up to Week 12||8||
48451216|NCT00272961|101439845|FG002|STARTED|Treatment Phase: Week 3 Up to Week 12||11||
48451217|NCT00272961|101439846|FG003|STARTED|Treatment Phase: Week 3 Up to Week 12||10||
48451218|NCT00272961|101439847|FG004|STARTED|Treatment Phase: Week 3 Up to Week 12||10||
48451219|NCT00272961|101439843|FG000|COMPLETED|Treatment Phase: Week 3 Up to Week 12||8||
48451220|NCT00272961|101439844|FG001|COMPLETED|Treatment Phase: Week 3 Up to Week 12||4||
48451221|NCT00272961|101439845|FG002|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7||
48451222|NCT00272961|101439846|FG003|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7||
48451223|NCT00272961|101439847|FG004|COMPLETED|Treatment Phase: Week 3 Up to Week 12||6||
48451224|NCT00272961|101439843|FG000|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||2||
48451225|NCT00272961|101439844|FG001|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4||
48451226|NCT00272961|101439845|FG002|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4||
48451227|NCT00272961|101439846|FG003|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||3||
48451228|NCT00272961|101439847|FG004|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4||
48451229|NCT01612702|101439848|FG000|STARTED|Overall Study||146||
48451230|NCT01612702|101439849|FG001|STARTED|Overall Study||145||
48451231|NCT01612702|101439848|FG000|COMPLETED|Overall Study||135||
48451232|NCT01612702|101439849|FG001|COMPLETED|Overall Study||134||
48660853|NCT01487161|101954642|FG003|STARTED|Overall Study||52||
48660854|NCT01487161|101954639|FG000|COMPLETED|Overall Study||56||
48660855|NCT01487161|101954640|FG001|COMPLETED|Overall Study||57||
48660856|NCT01487161|101954641|FG002|COMPLETED|Overall Study||59||
48660857|NCT01487161|101954642|FG003|COMPLETED|Overall Study||50||
48660858|NCT01487161|101954639|FG000|NOT COMPLETED|Overall Study||2||
48660859|NCT01487161|101954640|FG001|NOT COMPLETED|Overall Study||2||
48660860|NCT01487161|101954641|FG002|NOT COMPLETED|Overall Study||1||
48660861|NCT01487161|101954642|FG003|NOT COMPLETED|Overall Study||2||
48660862|NCT01793129|101954643|FG000|STARTED|Overall Study||88||
48660863|NCT01793129|101954644|FG001|STARTED|Overall Study||80||
48660864|NCT01793129|101954643|FG000|COMPLETED|Overall Study||85||
48660865|NCT01793129|101954644|FG001|COMPLETED|Overall Study||71||
48660866|NCT01793129|101954643|FG000|NOT COMPLETED|Overall Study||3||
48660867|NCT01793129|101954644|FG001|NOT COMPLETED|Overall Study||9||
48660868|NCT04045145|101954645|FG000|STARTED|Overall Study||8||
48660869|NCT04045145|101954645|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8||
48660870|NCT04045145|101954645|FG000|COMPLETED|Overall Study||8||
48660871|NCT04045145|101954645|FG000|NOT COMPLETED|Overall Study||0||
48660872|NCT05033561|101954646|FG000|STARTED|Overall Study||302||
48660873|NCT05033561|101954647|FG001|STARTED|Overall Study||300||
48660874|NCT05033561|101954648|FG002|STARTED|Overall Study||303||
48660875|NCT05033561|101954646|FG000|COMPLETED|Overall Study||297||
48660876|NCT05033561|101954647|FG001|COMPLETED|Overall Study||297||
48660877|NCT05033561|101954648|FG002|COMPLETED|Overall Study||298||
48660878|NCT05033561|101954646|FG000|NOT COMPLETED|Overall Study||5||
48660879|NCT05033561|101954647|FG001|NOT COMPLETED|Overall Study||3||
48451233|NCT01612702|101439848|FG000|NOT COMPLETED|Overall Study||11||
48451234|NCT01612702|101439849|FG001|NOT COMPLETED|Overall Study||11||
48451235|NCT01032759|101439850|FG000|STARTED|Overall Study||32||
48451236|NCT01032759|101439851|FG001|STARTED|Overall Study||31||
48451237|NCT01032759|101439850|FG000|Completed 24 Hour Assessment|Overall Study||32||
48660880|NCT05033561|101954648|FG002|NOT COMPLETED|Overall Study||5||
48660881|NCT01866150|101954649|FG000|STARTED|Overall Study||450||
48660882|NCT01866150|101954649|FG000|COMPLETED|Overall Study||450||
48660883|NCT01866150|101954649|FG000|NOT COMPLETED|Overall Study||0||
48660884|NCT00713193|101954650|FG000|STARTED|Overall Study||12||
48660885|NCT00713193|101954651|FG001|STARTED|Overall Study||14||
48660886|NCT00713193|101954650|FG000|COMPLETED|Overall Study||12||
48660887|NCT00713193|101954651|FG001|COMPLETED|Overall Study||14||
48660888|NCT00713193|101954650|FG000|NOT COMPLETED|Overall Study||0||
48660889|NCT00713193|101954651|FG001|NOT COMPLETED|Overall Study||0||
48660890|NCT05007639|101954652|FG000|STARTED|Overall Study||274||
48660891|NCT05007639|101954652|FG000|COMPLETED|Overall Study||274||
48660892|NCT05007639|101954652|FG000|NOT COMPLETED|Overall Study||0||
48660893|NCT02420314|101954653|FG000|STARTED|Overall Study||40||
48660894|NCT02420314|101954653|FG000|COMPLETED|Overall Study||38||
48660895|NCT02420314|101954653|FG000|NOT COMPLETED|Overall Study||2||
48660896|NCT01592747|101954654|FG000|STARTED|Overall Study||160||
48660897|NCT01592747|101954655|FG001|STARTED|Overall Study||161||
48660898|NCT01592747|101954656|FG002|STARTED|Overall Study||158||
48660899|NCT01592747|101954654|FG000|COMPLETED|Overall Study||44||
48660900|NCT01592747|101954655|FG001|COMPLETED|Overall Study||50||
48660901|NCT01592747|101954656|FG002|COMPLETED|Overall Study||50||
48660902|NCT01592747|101954654|FG000|NOT COMPLETED|Overall Study||116||
48660903|NCT01592747|101954655|FG001|NOT COMPLETED|Overall Study||111||
48660904|NCT01592747|101954656|FG002|NOT COMPLETED|Overall Study||108||
48660905|NCT02933151|101954657|FG000|STARTED|Overall Study||4763||52
48660906|NCT02933151|101954658|FG001|STARTED|Overall Study||5133||53
48660907|NCT02933151|101954657|FG000|COMPLETED|Overall Study||2215||52
48660908|NCT02933151|101954658|FG001|COMPLETED|Overall Study||2320||53
48660909|NCT02933151|101954657|FG000|NOT COMPLETED|Overall Study||2548||0
48660910|NCT02933151|101954658|FG001|NOT COMPLETED|Overall Study||2813||0
48660911|NCT05185453|101954659|FG000|STARTED|Overall Study||45||2
48660912|NCT05185453|101954660|FG001|STARTED|Overall Study||29||2
48660913|NCT05185453|101954659|FG000|Youth Started|Overall Study||34||2
48660914|NCT05185453|101954660|FG001|Youth Started|Overall Study||29||2
48660915|NCT05185453|101954659|FG000|Adults Started|Overall Study||11||2
48660916|NCT05185453|101954660|FG001|Adults Started|Overall Study||0||0
48660917|NCT05185453|101954659|FG000|Youth Completed Baseline Survey|Overall Study||34||2
48660918|NCT05185453|101954660|FG001|Youth Completed Baseline Survey|Overall Study||29||2
48660919|NCT05185453|101954659|FG000|Adults Completed Baseline Survey|Overall Study||11||2
48660920|NCT05185453|101954660|FG001|Adults Completed Baseline Survey|Overall Study||0||0
48660921|NCT05185453|101954659|FG000|Youth Completed End of Program Survey|Overall Study||26||2
48660922|NCT05185453|101954660|FG001|Youth Completed End of Program Survey|Overall Study||26||2
48660923|NCT05185453|101954659|FG000|Adults Completed End of Program Survey|Overall Study||6||2
48670046|NCT05757193|101974877|FG000|STARTED|Overall Study||10||
48451238|NCT01032759|101439851|FG001|Completed 24 Hour Assessment|Overall Study||30||
48660924|NCT05185453|101954660|FG001|Adults Completed End of Program Survey|Overall Study||0||0
48660925|NCT05185453|101954659|FG000|COMPLETED|Overall Study||32||2
48660926|NCT05185453|101954660|FG001|COMPLETED|Overall Study||26||2
48660927|NCT05185453|101954659|FG000|NOT COMPLETED|Overall Study||13||0
48771985|NCT01746901|102229496|FG007|STARTED|Treatment Phase: Sixth Intervention||6||
48771986|NCT01746901|102229497|FG008|STARTED|Treatment Phase: Sixth Intervention||5||
48771987|NCT01746901|102229489|FG000|COMPLETED|Treatment Phase: Sixth Intervention||0||
48451239|NCT01032759|101439850|FG000|Completed 48 Hour Assessment|Overall Study||31||
48451240|NCT01032759|101439851|FG001|Completed 48 Hour Assessment|Overall Study||28||
48451241|NCT01032759|101439850|FG000|COMPLETED|Overall Study||31||
48451242|NCT01032759|101439851|FG001|COMPLETED|Overall Study||28||
48451243|NCT01032759|101439850|FG000|NOT COMPLETED|Overall Study||1||
48451244|NCT01032759|101439851|FG001|NOT COMPLETED|Overall Study||3||
48451245|NCT05028751|101439852|FG000|STARTED|Overall Study||14||
48451246|NCT05028751|101439853|FG001|STARTED|Overall Study||3||
48451247|NCT05028751|101439854|FG002|STARTED|Overall Study||3||
48451248|NCT05028751|101439855|FG003|STARTED|Overall Study||4||
48451249|NCT05028751|101439852|FG000|COMPLETED|Overall Study||0||
48451250|NCT05028751|101439853|FG001|COMPLETED|Overall Study||0||
48451251|NCT05028751|101439854|FG002|COMPLETED|Overall Study||0||
48451252|NCT05028751|101439855|FG003|COMPLETED|Overall Study||0||
48451253|NCT05028751|101439852|FG000|NOT COMPLETED|Overall Study||14||
48451254|NCT05028751|101439853|FG001|NOT COMPLETED|Overall Study||3||
48451255|NCT05028751|101439854|FG002|NOT COMPLETED|Overall Study||3||
48451256|NCT05028751|101439855|FG003|NOT COMPLETED|Overall Study||4||
48451257|NCT00397839|101439856|FG000|STARTED|Overall Study||48||
48451258|NCT00397839|101439857|FG001|STARTED|Overall Study||87||
48451259|NCT00397839|101439856|FG000|COMPLETED|Overall Study||41||
48451260|NCT00397839|101439857|FG001|COMPLETED|Overall Study||69||
48451261|NCT00397839|101439856|FG000|NOT COMPLETED|Overall Study||7||
48451262|NCT00397839|101439857|FG001|NOT COMPLETED|Overall Study||18||
48451263|NCT03187080|101439858|FG000|STARTED|Overall Study||65||
48451264|NCT03187080|101439859|FG001|STARTED|Overall Study||0||
48451265|NCT03187080|101439860|FG002|STARTED|Overall Study||0||
48451266|NCT03187080|101439861|FG003|STARTED|Overall Study||0||
48451267|NCT03187080|101439862|FG004|STARTED|Overall Study||16||
48451268|NCT03187080|101439863|FG005|STARTED|Overall Study||0||
48451269|NCT03187080|101439864|FG006|STARTED|Overall Study||32||
48451270|NCT03187080|101439865|FG007|STARTED|Overall Study||0||
48451271|NCT03187080|101439858|FG000|COMPLETED|Overall Study||65||
48451272|NCT03187080|101439859|FG001|COMPLETED|Overall Study||0||
48451273|NCT03187080|101439860|FG002|COMPLETED|Overall Study||0||
48451274|NCT03187080|101439861|FG003|COMPLETED|Overall Study||0||
48451275|NCT03187080|101439862|FG004|COMPLETED|Overall Study||16||
48451276|NCT03187080|101439863|FG005|COMPLETED|Overall Study||0||
48451277|NCT03187080|101439864|FG006|COMPLETED|Overall Study||32||
48451278|NCT03187080|101439865|FG007|COMPLETED|Overall Study||0||
48451279|NCT03187080|101439858|FG000|NOT COMPLETED|Overall Study||0||
48451280|NCT03187080|101439859|FG001|NOT COMPLETED|Overall Study||0||
48451281|NCT03187080|101439860|FG002|NOT COMPLETED|Overall Study||0||
48451282|NCT03187080|101439861|FG003|NOT COMPLETED|Overall Study||0||
48451283|NCT03187080|101439862|FG004|NOT COMPLETED|Overall Study||0||
48451284|NCT03187080|101439863|FG005|NOT COMPLETED|Overall Study||0||
48451285|NCT03187080|101439864|FG006|NOT COMPLETED|Overall Study||0||
48451286|NCT03187080|101439865|FG007|NOT COMPLETED|Overall Study||0||
48451287|NCT03044431|101439866|FG000|STARTED|Overall Study||207||
48451288|NCT03044431|101439866|FG000|COMPLETED|Overall Study||148||
48451289|NCT03044431|101439866|FG000|NOT COMPLETED|Overall Study||59||
48451290|NCT04347161|101439867|FG000|STARTED|Overall Study||38||
48451291|NCT04347161|101439868|FG001|STARTED|Overall Study||37||
48451292|NCT04347161|101439867|FG000|COMPLETED|Overall Study||36||
48451293|NCT04347161|101439868|FG001|COMPLETED|Overall Study||33||
48451294|NCT04347161|101439867|FG000|NOT COMPLETED|Overall Study||2||
48451295|NCT04347161|101439868|FG001|NOT COMPLETED|Overall Study||4||
48451296|NCT02290028|101439869|FG000|STARTED|Overall Study||2226||
48451297|NCT02290028|101439869|FG000|COMPLETED|Overall Study||0||
48451298|NCT02290028|101439869|FG000|NOT COMPLETED|Overall Study||2226||
48451299|NCT03360656|101439870|FG000|STARTED|Overall Study||30||
48660928|NCT05185453|101954660|FG001|NOT COMPLETED|Overall Study||3||0
48660929|NCT02698787|101954661|FG000|STARTED|First Intervention (3 Months)||6||
48660930|NCT02698787|101954662|FG001|STARTED|First Intervention (3 Months)||5||
48660931|NCT02698787|101954661|FG000|COMPLETED|First Intervention (3 Months)||6||
48660932|NCT02698787|101954662|FG001|COMPLETED|First Intervention (3 Months)||5||
48660933|NCT02698787|101954661|FG000|NOT COMPLETED|First Intervention (3 Months)||0||
48660934|NCT02698787|101954662|FG001|NOT COMPLETED|First Intervention (3 Months)||0||
48660935|NCT02698787|101954661|FG000|STARTED|Second Intervention (3 Months)||6||
48660936|NCT02698787|101954662|FG001|STARTED|Second Intervention (3 Months)||5||
48660937|NCT02698787|101954661|FG000|COMPLETED|Second Intervention (3 Months)||6||
48660938|NCT02698787|101954662|FG001|COMPLETED|Second Intervention (3 Months)||4||
48451300|NCT03360656|101439870|FG000|COMPLETED|Overall Study||30||
48451301|NCT03360656|101439870|FG000|NOT COMPLETED|Overall Study||0||
48451302|NCT00704717|101439871|FG000|STARTED|Overall Study||185||
48451303|NCT00704717|101439871|FG000|COMPLETED|Overall Study||185||
48451304|NCT00704717|101439871|FG000|NOT COMPLETED|Overall Study||0||
48451305|NCT00420849|101439872|FG000|STARTED|Overall Study||587||
48451306|NCT00420849|101439872|FG000|COMPLETED|Overall Study||256||
48451307|NCT00420849|101439872|FG000|NOT COMPLETED|Overall Study||331||
48451308|NCT00986154|101439873|FG000|STARTED|Overall Study||4143||
48451309|NCT00986154|101439874|FG001|STARTED|Overall Study||4149||
48451310|NCT00986154|101439873|FG000|Safety Analysis Set (Received Drug)|Overall Study||4118||
48451311|NCT00986154|101439874|FG001|Safety Analysis Set (Received Drug)|Overall Study||4122||
48451312|NCT00986154|101439873|FG000|COMPLETED|Overall Study||3937||
48451313|NCT00986154|101439874|FG001|COMPLETED|Overall Study||3955||
48451314|NCT00986154|101439873|FG000|NOT COMPLETED|Overall Study||206||
48451315|NCT00986154|101439874|FG001|NOT COMPLETED|Overall Study||194||
48451316|NCT00659581|101439875|FG000|STARTED|Overall Study||20994||
48451317|NCT00659581|101439875|FG000|COMPLETED|Overall Study||12412||
48451318|NCT00659581|101439875|FG000|NOT COMPLETED|Overall Study||8582||
48451319|NCT02122471|101439876|FG000|STARTED|Overall Study||445||
48451320|NCT02122471|101439877|FG001|STARTED|Overall Study||443||
48451321|NCT02122471|101439878|FG002|STARTED|Overall Study||449||
48451322|NCT02122471|101439876|FG000|COMPLETED|Overall Study||406||
48451323|NCT02122471|101439877|FG001|COMPLETED|Overall Study||392||
48451324|NCT02122471|101439878|FG002|COMPLETED|Overall Study||405||
48451325|NCT02122471|101439876|FG000|NOT COMPLETED|Overall Study||39||
48451326|NCT02122471|101439877|FG001|NOT COMPLETED|Overall Study||51||
48451327|NCT02122471|101439878|FG002|NOT COMPLETED|Overall Study||44||
48451328|NCT00149669|101439879|FG000|STARTED|Overall Study||32||
48451329|NCT00149669|101439880|FG001|STARTED|Overall Study||35||
48451330|NCT00149669|101439879|FG000|COMPLETED|Overall Study||29||
48451331|NCT00149669|101439880|FG001|COMPLETED|Overall Study||30||
48451332|NCT00149669|101439879|FG000|NOT COMPLETED|Overall Study||3||
48451333|NCT00149669|101439880|FG001|NOT COMPLETED|Overall Study||5||
48451334|NCT00871728|101439881|FG000|STARTED|Overall Study||132||
48451335|NCT00871728|101439881|FG000|Treated|Overall Study||130||
48451336|NCT00871728|101439881|FG000|COMPLETED|Overall Study||112||
48451337|NCT00871728|101439881|FG000|NOT COMPLETED|Overall Study||20||
48451338|NCT00597207|101439882|FG000|STARTED|Overall Study||2099||
48451339|NCT00597207|101439883|FG001|STARTED|Overall Study||2132||
48451340|NCT00597207|101439882|FG000|COMPLETED|Overall Study||2094||
48451341|NCT00597207|101439883|FG001|COMPLETED|Overall Study||2125||
48451342|NCT00597207|101439882|FG000|NOT COMPLETED|Overall Study||5||
48451343|NCT00597207|101439883|FG001|NOT COMPLETED|Overall Study||7||
48451344|NCT01255722|101439884|FG000|STARTED|Overall Study||155||
48451345|NCT01255722|101439885|FG001|STARTED|Overall Study||160||
48451346|NCT01255722|101439886|FG002|STARTED|Overall Study||153||
48451347|NCT01255722|101439884|FG000|COMPLETED|Overall Study||152||
48451348|NCT01255722|101439885|FG001|COMPLETED|Overall Study||159||
48451349|NCT01255722|101439886|FG002|COMPLETED|Overall Study||152||
48451350|NCT01255722|101439884|FG000|NOT COMPLETED|Overall Study||3||
48451351|NCT01255722|101439885|FG001|NOT COMPLETED|Overall Study||1||
48451352|NCT01255722|101439886|FG002|NOT COMPLETED|Overall Study||1||
48451353|NCT04128696|101439887|FG000|STARTED|Overall Study||158|Enrolled population|
48451354|NCT04128696|101439888|FG001|STARTED|Overall Study||157|Enrolled population|
48451355|NCT04128696|101439887|FG000|Modified Intent to Treat (mITT) Population|Overall Study||157|2 participants (1 from each arm) were dosed after the date of DIL requesting immediate discontinuation of feladilimab/placebo and were not included in the mITT population.|
48451356|NCT04128696|101439888|FG001|Modified Intent to Treat (mITT) Population|Overall Study||156|2 participants (1 from each arm) were dosed after the date of DIL requesting immediate discontinuation of feladilimab/placebo and were not included in the mITT population.|
48451357|NCT04128696|101439887|FG000|Safety Population|Overall Study||159|"Two participants were initially randomized to placebo+pembrolizumab arm but were dosed with feladilimab. Therefore, they were included in the in the feladilimab+pembrolizumab arm of the safety population.~The 2 participants enrolled but excluded from the mITT population (one from each arm) were both included in the placebo+pembrolizumab arm for the safety population, as both participants were only dosed with pembrolizumab."|
48451358|NCT04128696|101439888|FG001|Safety Population|Overall Study||156|"Two participants were initially randomized to placebo+pembrolizumab arm but were dosed with feladilimab. Therefore, they were included in the in the feladilimab+pembrolizumab arm of the safety population.~The 2 participants enrolled but excluded from the mITT population (one from each arm) were both included in the placebo+pembrolizumab arm for the safety population, as both participants were only dosed with pembrolizumab."|
48451359|NCT04128696|101439887|FG000|COMPLETED|Overall Study||115||
48189160|NCT03176134|100786157|FG002|NOT COMPLETED|Overall Study||2||
48451360|NCT04128696|101439888|FG001|COMPLETED|Overall Study||98||
48451361|NCT04128696|101439887|FG000|NOT COMPLETED|Overall Study||43||
48451362|NCT04128696|101439888|FG001|NOT COMPLETED|Overall Study||59||
48451363|NCT00579254|101439889|FG000|STARTED|Overall Study||112||
48451364|NCT00579254|101439889|FG000|COMPLETED|Overall Study||0||
48451365|NCT00579254|101439889|FG000|NOT COMPLETED|Overall Study||112||
48189161|NCT03176134|100786158|FG003|NOT COMPLETED|Overall Study||0||
48660939|NCT02698787|101954661|FG000|NOT COMPLETED|Second Intervention (3 Months)||0||
48660940|NCT02698787|101954662|FG001|NOT COMPLETED|Second Intervention (3 Months)||1||
48660941|NCT03917901|101954663|FG000|STARTED|Overall Study||65||
48660942|NCT03917901|101954664|FG001|STARTED|Overall Study||66||
48660943|NCT03917901|101954663|FG000|1-Week Follow-up|Overall Study||59||
48660944|NCT03917901|101954664|FG001|1-Week Follow-up|Overall Study||60||
48660945|NCT03917901|101954663|FG000|2-Week Follow-up|Overall Study||62||
48771988|NCT01746901|102229490|FG001|COMPLETED|Treatment Phase: Sixth Intervention||0||
48771989|NCT01746901|102229491|FG002|COMPLETED|Treatment Phase: Sixth Intervention||0||
48771990|NCT01746901|102229492|FG003|COMPLETED|Treatment Phase: Sixth Intervention||5||
48771991|NCT01746901|102229493|FG004|COMPLETED|Treatment Phase: Sixth Intervention||6||
48771992|NCT01746901|102229494|FG005|COMPLETED|Treatment Phase: Sixth Intervention||5||
48771993|NCT01746901|102229495|FG006|COMPLETED|Treatment Phase: Sixth Intervention||5||
48771994|NCT01746901|102229496|FG007|COMPLETED|Treatment Phase: Sixth Intervention||6||
48771995|NCT01746901|102229497|FG008|COMPLETED|Treatment Phase: Sixth Intervention||5||
48451366|NCT02964897|101439890|FG000|STARTED|Overall Study||43||
48451367|NCT02964897|101439891|FG001|STARTED|Overall Study||36||
48451368|NCT02964897|101439890|FG000|COMPLETED|Overall Study||43||
48451369|NCT02964897|101439891|FG001|COMPLETED|Overall Study||36||
48451370|NCT02964897|101439890|FG000|NOT COMPLETED|Overall Study||0||
48451371|NCT02964897|101439891|FG001|NOT COMPLETED|Overall Study||0||
48451372|NCT01890785|101439892|FG000|STARTED|First Intervention||5||
48451373|NCT01890785|101439893|FG001|STARTED|First Intervention||5||
48451374|NCT01890785|101439894|FG002|STARTED|First Intervention||5||
48451375|NCT01890785|101439895|FG003|STARTED|First Intervention||5||
48451376|NCT01890785|101439896|FG004|STARTED|First Intervention||5||
48451377|NCT01890785|101439897|FG005|STARTED|First Intervention||5||
48451378|NCT01890785|101439892|FG000|COMPLETED|First Intervention||5||
48451379|NCT01890785|101439893|FG001|COMPLETED|First Intervention||5||
48451380|NCT01890785|101439894|FG002|COMPLETED|First Intervention||5||
48451381|NCT01890785|101439895|FG003|COMPLETED|First Intervention||5||
48451382|NCT01890785|101439896|FG004|COMPLETED|First Intervention||5||
48451383|NCT01890785|101439897|FG005|COMPLETED|First Intervention||5||
48451384|NCT01890785|101439892|FG000|NOT COMPLETED|First Intervention||0||
48451385|NCT01890785|101439893|FG001|NOT COMPLETED|First Intervention||0||
48451386|NCT01890785|101439894|FG002|NOT COMPLETED|First Intervention||0||
48451387|NCT01890785|101439895|FG003|NOT COMPLETED|First Intervention||0||
48451388|NCT01890785|101439896|FG004|NOT COMPLETED|First Intervention||0||
48451389|NCT01890785|101439897|FG005|NOT COMPLETED|First Intervention||0||
48451390|NCT01890785|101439892|FG000|STARTED|Second Intervention||5||
48451391|NCT01890785|101439893|FG001|STARTED|Second Intervention||5||
48451392|NCT01890785|101439894|FG002|STARTED|Second Intervention||5||
48451393|NCT01890785|101439895|FG003|STARTED|Second Intervention||5||
48771996|NCT01746901|102229489|FG000|NOT COMPLETED|Treatment Phase: Sixth Intervention||0||
48451394|NCT01890785|101439896|FG004|STARTED|Second Intervention||5||
48451395|NCT01890785|101439897|FG005|STARTED|Second Intervention||5||
48451396|NCT01890785|101439892|FG000|COMPLETED|Second Intervention||5||
48451397|NCT01890785|101439893|FG001|COMPLETED|Second Intervention||5||
48451398|NCT01890785|101439894|FG002|COMPLETED|Second Intervention||5||
48451399|NCT01890785|101439895|FG003|COMPLETED|Second Intervention||5||
48451400|NCT01890785|101439896|FG004|COMPLETED|Second Intervention||5||
48451401|NCT01890785|101439897|FG005|COMPLETED|Second Intervention||5||
48451402|NCT01890785|101439892|FG000|NOT COMPLETED|Second Intervention||0||
48451403|NCT01890785|101439893|FG001|NOT COMPLETED|Second Intervention||0||
48451404|NCT01890785|101439894|FG002|NOT COMPLETED|Second Intervention||0||
48451405|NCT01890785|101439895|FG003|NOT COMPLETED|Second Intervention||0||
48451406|NCT01890785|101439896|FG004|NOT COMPLETED|Second Intervention||0||
48451407|NCT01890785|101439897|FG005|NOT COMPLETED|Second Intervention||0||
48451408|NCT01890785|101439892|FG000|STARTED|Third Intervention||5||
48451409|NCT01890785|101439893|FG001|STARTED|Third Intervention||5||
48451410|NCT01890785|101439894|FG002|STARTED|Third Intervention||5||
48451411|NCT01890785|101439895|FG003|STARTED|Third Intervention||5||
48451412|NCT01890785|101439896|FG004|STARTED|Third Intervention||5||
48451413|NCT01890785|101439897|FG005|STARTED|Third Intervention||5||
48451414|NCT01890785|101439892|FG000|COMPLETED|Third Intervention||5||
48451415|NCT01890785|101439893|FG001|COMPLETED|Third Intervention||4||
48660946|NCT03917901|101954664|FG001|2-Week Follow-up|Overall Study||57||
48660947|NCT03917901|101954663|FG000|1-Month Follow-up|Overall Study||61||
48660948|NCT03917901|101954664|FG001|1-Month Follow-up|Overall Study||63||
48660949|NCT03917901|101954663|FG000|COMPLETED|Overall Study||65||
48660950|NCT03917901|101954664|FG001|COMPLETED|Overall Study||66||
48660951|NCT03917901|101954663|FG000|NOT COMPLETED|Overall Study||0||
48660952|NCT03917901|101954664|FG001|NOT COMPLETED|Overall Study||0||
48660953|NCT02093520|101954665|FG000|STARTED|Overall Study||149||
48660954|NCT02093520|101954666|FG001|STARTED|Overall Study||153||
48660955|NCT02093520|101954665|FG000|COMPLETED|Overall Study||143||
48660956|NCT02093520|101954666|FG001|COMPLETED|Overall Study||131||
48451416|NCT01890785|101439894|FG002|COMPLETED|Third Intervention||5||
48451417|NCT01890785|101439895|FG003|COMPLETED|Third Intervention||5||
48451418|NCT01890785|101439896|FG004|COMPLETED|Third Intervention||5||
48451419|NCT01890785|101439897|FG005|COMPLETED|Third Intervention||5||
48451420|NCT01890785|101439892|FG000|NOT COMPLETED|Third Intervention||0||
48451421|NCT01890785|101439893|FG001|NOT COMPLETED|Third Intervention||1||
48451422|NCT01890785|101439894|FG002|NOT COMPLETED|Third Intervention||0||
48451423|NCT01890785|101439895|FG003|NOT COMPLETED|Third Intervention||0||
48451424|NCT01890785|101439896|FG004|NOT COMPLETED|Third Intervention||0||
48451425|NCT01890785|101439897|FG005|NOT COMPLETED|Third Intervention||0||
48451426|NCT03412019|101439898|FG000|STARTED|Overall Study||11||
48451427|NCT03412019|101439899|FG001|STARTED|Overall Study||11||
48451428|NCT03412019|101439898|FG000|COMPLETED|Overall Study||10||
48451429|NCT03412019|101439899|FG001|COMPLETED|Overall Study||10||
48451430|NCT03412019|101439898|FG000|NOT COMPLETED|Overall Study||1||
48451431|NCT03412019|101439899|FG001|NOT COMPLETED|Overall Study||1||
48451432|NCT00786019|101439900|FG000|STARTED|Overall Study||20||
48451433|NCT00786019|101439901|FG001|STARTED|Overall Study||27||
48451434|NCT00786019|101439900|FG000|COMPLETED|Overall Study||15||
48451435|NCT00786019|101439901|FG001|COMPLETED|Overall Study||17||
48451436|NCT00786019|101439900|FG000|NOT COMPLETED|Overall Study||5||
48451437|NCT00786019|101439901|FG001|NOT COMPLETED|Overall Study||10||
48451438|NCT00802633|101439902|FG000|STARTED|Overall Study||40||
48451439|NCT00802633|101439903|FG001|STARTED|Overall Study||40||
48451440|NCT00802633|101439902|FG000|COMPLETED|Overall Study||40||
48451441|NCT00802633|101439903|FG001|COMPLETED|Overall Study||40||
48451442|NCT00802633|101439902|FG000|NOT COMPLETED|Overall Study||0||
48451443|NCT00802633|101439903|FG001|NOT COMPLETED|Overall Study||0||
48451444|NCT00736099|101439904|FG000|STARTED|Overall Study||1532||
48451445|NCT00736099|101439905|FG001|STARTED|Overall Study||589||
48451446|NCT00736099|101439904|FG000|COMPLETED|Overall Study||1349||
48451447|NCT00736099|101439905|FG001|COMPLETED|Overall Study||531||
48451448|NCT00736099|101439904|FG000|NOT COMPLETED|Overall Study||183||
48451449|NCT00736099|101439905|FG001|NOT COMPLETED|Overall Study||58||
48451450|NCT03803085|101439906|FG000|STARTED|Overall Study||30||
48451451|NCT03803085|101439907|FG001|STARTED|Overall Study||30||
48451452|NCT03803085|101439906|FG000|COMPLETED|Overall Study||28||
48451453|NCT03803085|101439907|FG001|COMPLETED|Overall Study||28||
48451454|NCT03803085|101439906|FG000|NOT COMPLETED|Overall Study||2||
48451455|NCT03803085|101439907|FG001|NOT COMPLETED|Overall Study||2||
48451456|NCT00895583|101439908|FG000|STARTED|Overall Study||131||
48451457|NCT00895583|101439909|FG001|STARTED|Overall Study||123||
48451458|NCT00895583|101439908|FG000|COMPLETED|Overall Study||87||
48451459|NCT00895583|101439909|FG001|COMPLETED|Overall Study||111||
48451460|NCT00895583|101439908|FG000|NOT COMPLETED|Overall Study||44||
48451461|NCT00895583|101439909|FG001|NOT COMPLETED|Overall Study||12||
48451462|NCT02496221|101439910|FG000|STARTED|Treatment Period 1 - 4 Days||10||
48451463|NCT02496221|101439911|FG001|STARTED|Treatment Period 1 - 4 Days||10||
48451464|NCT02496221|101439910|FG000|COMPLETED|Treatment Period 1 - 4 Days||10||
48451465|NCT02496221|101439911|FG001|COMPLETED|Treatment Period 1 - 4 Days||10||
48451466|NCT02496221|101439910|FG000|NOT COMPLETED|Treatment Period 1 - 4 Days||0||
48451467|NCT02496221|101439911|FG001|NOT COMPLETED|Treatment Period 1 - 4 Days||0||
48451468|NCT02496221|101439910|FG000|STARTED|Treatment Period 2 - 4 Days||10||
48451469|NCT02496221|101439911|FG001|STARTED|Treatment Period 2 - 4 Days||10||
48451470|NCT02496221|101439910|FG000|COMPLETED|Treatment Period 2 - 4 Days||8||
48451471|NCT02496221|101439911|FG001|COMPLETED|Treatment Period 2 - 4 Days||9||
48451472|NCT02496221|101439910|FG000|NOT COMPLETED|Treatment Period 2 - 4 Days||2||
48451473|NCT02496221|101439911|FG001|NOT COMPLETED|Treatment Period 2 - 4 Days||1||
48451474|NCT01946282|101439912|FG000|STARTED|Year 1||6565||
48451475|NCT01946282|101439913|FG001|STARTED|Year 1||1000||
48451476|NCT01946282|101439914|FG002|STARTED|Year 1||1000||
48451477|NCT01946282|101439912|FG000|COMPLETED|Year 1||2379|Number of returned FIT kits|
48451478|NCT01946282|101439913|FG001|COMPLETED|Year 1||392|Number of returned FIT kits|
48451479|NCT01946282|101439914|FG002|COMPLETED|Year 1||346|Number of returned FIT kits|
48451480|NCT01946282|101439912|FG000|NOT COMPLETED|Year 1||4186||
48451481|NCT01946282|101439913|FG001|NOT COMPLETED|Year 1||608||
48451482|NCT01946282|101439914|FG002|NOT COMPLETED|Year 1||654||
48451483|NCT01946282|101439912|FG000|STARTED|Year 2||2051||
48451484|NCT01946282|101439913|FG001|STARTED|Year 2||341||
48451485|NCT01946282|101439914|FG002|STARTED|Year 2||299||
48451486|NCT01946282|101439912|FG000|COMPLETED|Year 2||1248||
48451487|NCT01946282|101439913|FG001|COMPLETED|Year 2||210||
48451488|NCT01946282|101439914|FG002|COMPLETED|Year 2||184||
48451489|NCT01946282|101439912|FG000|NOT COMPLETED|Year 2||803||
48451490|NCT01946282|101439913|FG001|NOT COMPLETED|Year 2||131||
48451491|NCT01946282|101439914|FG002|NOT COMPLETED|Year 2||115||
48451492|NCT01946282|101439912|FG000|STARTED|Year 3||1144||
48451493|NCT01946282|101439913|FG001|STARTED|Year 3||184||
48451494|NCT01946282|101439914|FG002|STARTED|Year 3||170||
48451495|NCT01946282|101439912|FG000|COMPLETED|Year 3||856||
48451496|NCT01946282|101439913|FG001|COMPLETED|Year 3||141||
48451497|NCT01946282|101439914|FG002|COMPLETED|Year 3||140||
48451498|NCT01946282|101439912|FG000|NOT COMPLETED|Year 3||288||
48451499|NCT01946282|101439913|FG001|NOT COMPLETED|Year 3||43||
48451500|NCT01946282|101439914|FG002|NOT COMPLETED|Year 3||30||
48451501|NCT01614925|101439915|FG000|STARTED|Overall Study||18||
48451502|NCT01614925|101439916|FG001|STARTED|Overall Study||17||
48451503|NCT01614925|101439915|FG000|COMPLETED|Overall Study||14||
48451504|NCT01614925|101439916|FG001|COMPLETED|Overall Study||15||
48451505|NCT01614925|101439915|FG000|NOT COMPLETED|Overall Study||4||
48451506|NCT01614925|101439916|FG001|NOT COMPLETED|Overall Study||2||
48451507|NCT00683332|101439917|FG000|STARTED|Overall Study||621||
48451508|NCT00683332|101439917|FG000|COMPLETED|Overall Study||621||
48451509|NCT00683332|101439917|FG000|NOT COMPLETED|Overall Study||0||
48451510|NCT01011907|101439918|FG000|STARTED|Overall Study||31||
48451511|NCT01011907|101439919|FG001|STARTED|Overall Study||33||
48451512|NCT01011907|101439918|FG000|COMPLETED|Overall Study||17||
48451513|NCT01011907|101439919|FG001|COMPLETED|Overall Study||18||
48451514|NCT01011907|101439918|FG000|NOT COMPLETED|Overall Study||14||
48451515|NCT01011907|101439919|FG001|NOT COMPLETED|Overall Study||15||
48451516|NCT01619085|101439920|FG000|STARTED|Overall Study||752||
48451517|NCT01619085|101439920|FG000|Treated|Overall Study||751||
48451518|NCT01619085|101439920|FG000|COMPLETED|Overall Study||227|'completed' stands for not prematurely discontinued from trial medication|
48451519|NCT01619085|101439920|FG000|NOT COMPLETED|Overall Study||525||
48451520|NCT05105711|101439921|FG000|STARTED|Overall Study||21||
48451521|NCT05105711|101439921|FG000|COMPLETED|Overall Study||19||
48660957|NCT02093520|101954665|FG000|NOT COMPLETED|Overall Study||6||
48660958|NCT02093520|101954666|FG001|NOT COMPLETED|Overall Study||22||
48660959|NCT03253627|101954667|FG000|STARTED|Overall Study||12||
48660960|NCT03253627|101954668|FG001|STARTED|Overall Study||11||
48660961|NCT03253627|101954667|FG000|Post-intervention|Overall Study||11||
48660962|NCT03253627|101954668|FG001|Post-intervention|Overall Study||9||
48660963|NCT03253627|101954667|FG000|COMPLETED|Overall Study||10||
48660964|NCT03253627|101954668|FG001|COMPLETED|Overall Study||7||
48660965|NCT03253627|101954667|FG000|NOT COMPLETED|Overall Study||2||
48660966|NCT03253627|101954668|FG001|NOT COMPLETED|Overall Study||4||
48660967|NCT02412436|101954669|FG000|STARTED|Overall Study||62||
48660968|NCT02412436|101954669|FG000|COMPLETED|Overall Study||44||
48660969|NCT02412436|101954669|FG000|NOT COMPLETED|Overall Study||18||
48660970|NCT05805150|101954670|FG000|STARTED|Period 1 (1 Week)||34||
48660971|NCT05805150|101954671|FG001|STARTED|Period 1 (1 Week)||35||
48660972|NCT05805150|101954670|FG000|COMPLETED|Period 1 (1 Week)||34||
48660973|NCT05805150|101954671|FG001|COMPLETED|Period 1 (1 Week)||35||
48660974|NCT05805150|101954670|FG000|NOT COMPLETED|Period 1 (1 Week)||0||
48660975|NCT05805150|101954671|FG001|NOT COMPLETED|Period 1 (1 Week)||0||
48660976|NCT05805150|101954670|FG000|STARTED|Period 2 (1 Week)||34||
48660977|NCT05805150|101954671|FG001|STARTED|Period 2 (1 Week)||35||
48660978|NCT05805150|101954670|FG000|COMPLETED|Period 2 (1 Week)||34||
48660979|NCT05805150|101954671|FG001|COMPLETED|Period 2 (1 Week)||34||
48660980|NCT05805150|101954670|FG000|NOT COMPLETED|Period 2 (1 Week)||0||
48660981|NCT05805150|101954671|FG001|NOT COMPLETED|Period 2 (1 Week)||1||
48660982|NCT02743312|101954672|FG000|STARTED|Overall Study||3||
48660983|NCT02743312|101954673|FG001|STARTED|Overall Study||2||
48660984|NCT02743312|101954672|FG000|COMPLETED|Overall Study||3||
48189162|NCT03176134|100786159|FG004|NOT COMPLETED|Overall Study||0||
48189163|NCT03176134|100786160|FG005|NOT COMPLETED|Overall Study||0||
48189164|NCT03176134|100786161|FG006|NOT COMPLETED|Overall Study||0||
48451522|NCT05105711|101439921|FG000|NOT COMPLETED|Overall Study||2||
48451523|NCT01201356|101439922|FG000|STARTED|Overall Study||4125|All enrolled patients|
48451524|NCT01201356|101439922|FG000|Safety Set|Overall Study||4083|At least one dose of fingolimod in any study and a post-baseline safety assessment|
48451525|NCT01201356|101439922|FG000|Fingolimod Full Analysis Set|Overall Study||4046||
48451526|NCT01201356|101439922|FG000|COMPLETED|Overall Study||3481||
48451527|NCT01201356|101439922|FG000|NOT COMPLETED|Overall Study||644||
48451528|NCT01375010|101439923|FG000|STARTED|Overall Study||43||
48451529|NCT01375010|101439924|FG001|STARTED|Overall Study||42||
48451530|NCT01375010|101439923|FG000|COMPLETED|Overall Study||31||
48451531|NCT01375010|101439924|FG001|COMPLETED|Overall Study||38||
48451532|NCT01375010|101439923|FG000|NOT COMPLETED|Overall Study||12||
48451533|NCT01375010|101439924|FG001|NOT COMPLETED|Overall Study||4||
48451534|NCT02236754|101439925|FG000|STARTED|Overall Study||15||
48451535|NCT02236754|101439926|FG001|STARTED|Overall Study||8||
48451536|NCT02236754|101439925|FG000|COMPLETED|Overall Study||14||
48451537|NCT02236754|101439926|FG001|COMPLETED|Overall Study||8||
48660985|NCT02743312|101954673|FG001|COMPLETED|Overall Study||2||
48660986|NCT02743312|101954672|FG000|NOT COMPLETED|Overall Study||0||
48660987|NCT02743312|101954673|FG001|NOT COMPLETED|Overall Study||0||
48660988|NCT03629678|101954674|FG000|STARTED|Overall Study||30||
48660989|NCT03629678|101954675|FG001|STARTED|Overall Study||37||
48660990|NCT03629678|101954674|FG000|COMPLETED|Overall Study||25||
48660991|NCT03629678|101954675|FG001|COMPLETED|Overall Study||31||
48660992|NCT03629678|101954674|FG000|NOT COMPLETED|Overall Study||5||
48660993|NCT03629678|101954675|FG001|NOT COMPLETED|Overall Study||6||
48660994|NCT01767987|101954676|FG000|STARTED|Overall Study||4||
48189165|NCT03176134|100786162|FG007|NOT COMPLETED|Overall Study||0||
48660995|NCT01767987|101954677|FG001|STARTED|Overall Study||2||
48660996|NCT01767987|101954676|FG000|COMPLETED|Overall Study||0||
48660997|NCT01767987|101954677|FG001|COMPLETED|Overall Study||1||
48660998|NCT01767987|101954676|FG000|NOT COMPLETED|Overall Study||4||
48660999|NCT01767987|101954677|FG001|NOT COMPLETED|Overall Study||1||
48661000|NCT00385515|101954678|FG000|STARTED|Overall Study||57||
48661001|NCT00385515|101954679|FG001|STARTED|Overall Study||24||
48661002|NCT00385515|101954678|FG000|COMPLETED|Overall Study||53||
48661003|NCT00385515|101954679|FG001|COMPLETED|Overall Study||21||
48661004|NCT00385515|101954678|FG000|NOT COMPLETED|Overall Study||4||
48661005|NCT00385515|101954679|FG001|NOT COMPLETED|Overall Study||3||
48661006|NCT03518060|101954680|FG000|STARTED|Overall Study||200||
48661007|NCT03518060|101954680|FG000|COMPLETED|Overall Study||124||
48661008|NCT03518060|101954680|FG000|NOT COMPLETED|Overall Study||76||
48661009|NCT00775671|101954681|FG000|STARTED|Overall Study||23||
48661010|NCT00775671|101954682|FG001|STARTED|Overall Study||23||
48661011|NCT00775671|101954681|FG000|COMPLETED|Overall Study||23||
48661012|NCT00775671|101954682|FG001|COMPLETED|Overall Study||23||
48661013|NCT00775671|101954681|FG000|NOT COMPLETED|Overall Study||0||
48661014|NCT00775671|101954682|FG001|NOT COMPLETED|Overall Study||0||
48661015|NCT03766906|101954683|FG000|STARTED|Overall Study||50||
48771997|NCT01746901|102229490|FG001|NOT COMPLETED|Treatment Phase: Sixth Intervention||0||
48771998|NCT01746901|102229491|FG002|NOT COMPLETED|Treatment Phase: Sixth Intervention||0||
48451538|NCT02236754|101439925|FG000|NOT COMPLETED|Overall Study||1||
48451539|NCT02236754|101439926|FG001|NOT COMPLETED|Overall Study||0||
48451540|NCT00678379|101439927|FG000|STARTED|Overall Study||40||
48451541|NCT00678379|101439928|FG001|STARTED|Overall Study||40||
48451542|NCT00678379|101439929|FG002|STARTED|Overall Study||40||
48451543|NCT00678379|101439927|FG000|COMPLETED|Overall Study||34||
48451544|NCT00678379|101439928|FG001|COMPLETED|Overall Study||37||
48451545|NCT00678379|101439929|FG002|COMPLETED|Overall Study||36||
48661016|NCT03766906|101954683|FG000|COMPLETED|Overall Study||44||
48661017|NCT03766906|101954683|FG000|NOT COMPLETED|Overall Study||6||
48661018|NCT03934684|101954684|FG000|STARTED|Overall Study||49||
48661019|NCT03934684|101954685|FG001|STARTED|Overall Study||52||
48661020|NCT03934684|101954684|FG000|COMPLETED|Overall Study||7||
48661021|NCT03934684|101954685|FG001|COMPLETED|Overall Study||3||
48661022|NCT03934684|101954684|FG000|NOT COMPLETED|Overall Study||42||
48661023|NCT03934684|101954685|FG001|NOT COMPLETED|Overall Study||49||
48661024|NCT01197300|101954686|FG000|STARTED|Overall Study||10|All enrolled patients were included in the Full Analysis Set (FAS) and Safety Set|
48661025|NCT01197300|101954687|FG001|STARTED|Overall Study||15|All enrolled patients were included in the Full Analysis Set (FAS) and Safety Set|
48661026|NCT01197300|101954686|FG000|COMPLETED|Overall Study||10||
48661027|NCT01197300|101954687|FG001|COMPLETED|Overall Study||13||
48661028|NCT01197300|101954686|FG000|NOT COMPLETED|Overall Study||0||
48661029|NCT01197300|101954687|FG001|NOT COMPLETED|Overall Study||2||
48661030|NCT03627468|101954688|FG000|STARTED|Overall Study||103||
48661031|NCT03627468|101954689|FG001|STARTED|Overall Study||197||
48661032|NCT03627468|101954688|FG000|COMPLETED|Overall Study||72||
48661033|NCT03627468|101954689|FG001|COMPLETED|Overall Study||118||
48661034|NCT03627468|101954688|FG000|NOT COMPLETED|Overall Study||31||
48661035|NCT03627468|101954689|FG001|NOT COMPLETED|Overall Study||79||
48661036|NCT01428713|101954690|FG000|STARTED|Overall Study||9||
48661037|NCT01428713|101954691|FG001|STARTED|Overall Study||8||
48661038|NCT01428713|101954690|FG000|COMPLETED|Overall Study||6||
48661039|NCT01428713|101954691|FG001|COMPLETED|Overall Study||3||
48661040|NCT01428713|101954690|FG000|NOT COMPLETED|Overall Study||3||
48661041|NCT01428713|101954691|FG001|NOT COMPLETED|Overall Study||5||
48661042|NCT03895476|101954692|FG000|STARTED|Overall Study||18||
48771999|NCT01746901|102229492|FG003|NOT COMPLETED|Treatment Phase: Sixth Intervention||0||
48451546|NCT00678379|101439927|FG000|NOT COMPLETED|Overall Study||6||
48451547|NCT00678379|101439928|FG001|NOT COMPLETED|Overall Study||3||
48661043|NCT03895476|101954693|FG001|STARTED|Overall Study||18||
48661044|NCT03895476|101954694|FG002|STARTED|Overall Study||18||
48772000|NCT01746901|102229493|FG004|NOT COMPLETED|Treatment Phase: Sixth Intervention||0||
48772001|NCT01746901|102229494|FG005|NOT COMPLETED|Treatment Phase: Sixth Intervention||0||
48772002|NCT01746901|102229495|FG006|NOT COMPLETED|Treatment Phase: Sixth Intervention||0||
48189166|NCT00487721|100786163|FG000|STARTED|Overall Study||6||
48451548|NCT00678379|101439929|FG002|NOT COMPLETED|Overall Study||4||
48451549|NCT02542150|101439930|FG000|STARTED|Overall Study||12||
48451550|NCT02542150|101439931|FG001|STARTED|Overall Study||12||
48661045|NCT03895476|101954695|FG003|STARTED|Overall Study||18||
48661046|NCT03895476|101954692|FG000|COMPLETED|Overall Study||18||
48661047|NCT03895476|101954693|FG001|COMPLETED|Overall Study||18||
48661048|NCT03895476|101954694|FG002|COMPLETED|Overall Study||18||
48661049|NCT03895476|101954695|FG003|COMPLETED|Overall Study||18||
48661050|NCT03895476|101954692|FG000|NOT COMPLETED|Overall Study||0||
48661051|NCT03895476|101954693|FG001|NOT COMPLETED|Overall Study||0||
48661052|NCT03895476|101954694|FG002|NOT COMPLETED|Overall Study||0||
48661053|NCT03895476|101954695|FG003|NOT COMPLETED|Overall Study||0||
48661054|NCT01475825|101954696|FG000|STARTED|Overall Study||104||
48661055|NCT01475825|101954697|FG001|STARTED|Overall Study||51||
48451551|NCT02542150|101439930|FG000|Completed Placebo|Overall Study||12||
48451552|NCT02542150|101439931|FG001|Completed Placebo|Overall Study||12||
48772003|NCT01746901|102229496|FG007|NOT COMPLETED|Treatment Phase: Sixth Intervention||0||
48772004|NCT01746901|102229497|FG008|NOT COMPLETED|Treatment Phase: Sixth Intervention||0||
48772005|NCT01298648|102229498|FG000|STARTED|Overall Study||1716||
48772006|NCT01298648|102229498|FG000|COMPLETED|Overall Study||1693||
48772007|NCT01298648|102229498|FG000|NOT COMPLETED|Overall Study||23||
48772008|NCT01821118|102229499|FG000|STARTED|Overall Study||24||
48772009|NCT01821118|102229500|FG001|STARTED|Overall Study||12||
48772010|NCT01821118|102229499|FG000|COMPLETED|Overall Study||24||
48772011|NCT01821118|102229500|FG001|COMPLETED|Overall Study||11||
48772012|NCT01821118|102229499|FG000|NOT COMPLETED|Overall Study||0||
48772013|NCT01821118|102229500|FG001|NOT COMPLETED|Overall Study||1||
48772014|NCT00225732|102229501|FG000|STARTED|Overall Study||153||
48451553|NCT02542150|101439930|FG000|Started Intervention|Overall Study||12||
48451554|NCT02542150|101439931|FG001|Started Intervention|Overall Study||12||
48451555|NCT02542150|101439930|FG000|COMPLETED|Overall Study||12||
48189167|NCT00487721|100786164|FG001|STARTED|Overall Study||6||
48451556|NCT02542150|101439931|FG001|COMPLETED|Overall Study||12||
48451557|NCT02542150|101439930|FG000|NOT COMPLETED|Overall Study||0||
48451558|NCT02542150|101439931|FG001|NOT COMPLETED|Overall Study||0||
48451559|NCT05149287|101439932|FG000|STARTED|Overall Study||3||
48451560|NCT05149287|101439933|FG001|STARTED|Overall Study||2||
48451561|NCT05149287|101439932|FG000|COMPLETED|Overall Study||3||
48451562|NCT05149287|101439933|FG001|COMPLETED|Overall Study||2||
48451563|NCT05149287|101439932|FG000|NOT COMPLETED|Overall Study||0||
48451564|NCT05149287|101439933|FG001|NOT COMPLETED|Overall Study||0||
48451565|NCT04582409|101439934|FG000|STARTED|Overall Study||7||
48451566|NCT04582409|101439935|FG001|STARTED|Overall Study||6||
48451567|NCT04582409|101439934|FG000|COMPLETED|Overall Study||7||
48451568|NCT04582409|101439935|FG001|COMPLETED|Overall Study||6||
48451569|NCT04582409|101439934|FG000|NOT COMPLETED|Overall Study||0||
48451570|NCT04582409|101439935|FG001|NOT COMPLETED|Overall Study||0||
48451571|NCT00389649|101439936|FG000|STARTED|Overall Study||2||
48451572|NCT00389649|101439937|FG001|STARTED|Overall Study||2||
48451573|NCT00389649|101439938|FG002|STARTED|Overall Study||3||
48451574|NCT00389649|101439939|FG003|STARTED|Overall Study||2||
48451575|NCT00389649|101439940|FG004|STARTED|Overall Study||2||
48451576|NCT00389649|101439941|FG005|STARTED|Overall Study||2||
48451577|NCT00389649|101439936|FG000|COMPLETED|Overall Study||2||
48451578|NCT00389649|101439937|FG001|COMPLETED|Overall Study||2||
48451579|NCT00389649|101439938|FG002|COMPLETED|Overall Study||3||
48451580|NCT00389649|101439939|FG003|COMPLETED|Overall Study||2||
48451581|NCT00389649|101439940|FG004|COMPLETED|Overall Study||2||
48451582|NCT00389649|101439941|FG005|COMPLETED|Overall Study||2||
48451583|NCT00389649|101439936|FG000|NOT COMPLETED|Overall Study||0||
48451584|NCT00389649|101439937|FG001|NOT COMPLETED|Overall Study||0||
48451585|NCT00389649|101439938|FG002|NOT COMPLETED|Overall Study||0||
48451586|NCT00389649|101439939|FG003|NOT COMPLETED|Overall Study||0||
48451587|NCT00389649|101439940|FG004|NOT COMPLETED|Overall Study||0||
48451588|NCT00389649|101439941|FG005|NOT COMPLETED|Overall Study||0||
48451589|NCT04071626|101439942|FG000|STARTED|Overall Study||5||
48451590|NCT04071626|101439943|FG001|STARTED|Overall Study||4||
48451591|NCT04071626|101439942|FG000|COMPLETED|Overall Study||4||
48451592|NCT04071626|101439943|FG001|COMPLETED|Overall Study||2||
48451593|NCT04071626|101439942|FG000|NOT COMPLETED|Overall Study||1||
48451594|NCT04071626|101439943|FG001|NOT COMPLETED|Overall Study||2||
48451595|NCT03812679|101439944|FG000|STARTED|Overall Study||22||
48451596|NCT03812679|101439944|FG000|COMPLETED|Overall Study||14||
48451597|NCT03812679|101439944|FG000|NOT COMPLETED|Overall Study||8||
48451598|NCT01375569|101439945|FG000|STARTED|Overall Study||11||
48451599|NCT01375569|101439945|FG000|COMPLETED|Overall Study||11||
48451600|NCT01375569|101439945|FG000|NOT COMPLETED|Overall Study||0||
48451601|NCT01964105|101439946|FG000|STARTED|Overall Study||15||
48451602|NCT01964105|101439947|FG001|STARTED|Overall Study||75||
48451603|NCT01964105|101439948|FG002|STARTED|Overall Study||10||
48451604|NCT01964105|101439946|FG000|COMPLETED|Overall Study||13||
48451605|NCT01964105|101439947|FG001|COMPLETED|Overall Study||62||
48451606|NCT01964105|101439948|FG002|COMPLETED|Overall Study||10||
48451607|NCT01964105|101439946|FG000|NOT COMPLETED|Overall Study||2||
48451608|NCT01964105|101439947|FG001|NOT COMPLETED|Overall Study||13||
48451609|NCT01964105|101439948|FG002|NOT COMPLETED|Overall Study||0||
48451610|NCT02462382|101439949|FG000|STARTED|Overall Study||24||
48451611|NCT02462382|101439950|FG001|STARTED|Overall Study||27||
48451612|NCT02462382|101439949|FG000|COMPLETED|Overall Study||24||
48451613|NCT02462382|101439950|FG001|COMPLETED|Overall Study||27||
48451614|NCT02462382|101439949|FG000|NOT COMPLETED|Overall Study||0||
48451615|NCT02462382|101439950|FG001|NOT COMPLETED|Overall Study||0||
48451616|NCT02400073|101439951|FG000|STARTED|Overall Study||122||
48451617|NCT02400073|101439951|FG000|COMPLETED|Overall Study||111||
48451618|NCT02400073|101439951|FG000|NOT COMPLETED|Overall Study||11||
48451619|NCT00690924|101439952|FG000|STARTED|Overall Study||16||
48451620|NCT00690924|101439952|FG000|COMPLETED|Overall Study||16||
48451621|NCT00690924|101439952|FG000|NOT COMPLETED|Overall Study||0||
48451622|NCT01241565|101439953|FG000|STARTED|Overall Study||50||
48772015|NCT00225732|102229502|FG001|STARTED|Overall Study||166||
48772016|NCT00225732|102229501|FG000|COMPLETED|Overall Study||153||
48661056|NCT01475825|101954698|FG002|STARTED|Overall Study||102||
48661057|NCT01475825|101954699|FG003|STARTED|Overall Study||52||
48661058|NCT01475825|101954696|FG000|Randomized and Treated|Overall Study||104||
48661059|NCT01475825|101954697|FG001|Randomized and Treated|Overall Study||51||
48661060|NCT01475825|101954698|FG002|Randomized and Treated|Overall Study||102||
48661061|NCT01475825|101954699|FG003|Randomized and Treated|Overall Study||52||
48661062|NCT01475825|101954696|FG000|Completed Blinded Treatment Period|Overall Study||60||
48661063|NCT01475825|101954697|FG001|Completed Blinded Treatment Period|Overall Study||42||
48661064|NCT01475825|101954698|FG002|Completed Blinded Treatment Period|Overall Study||59||
48661065|NCT01475825|101954699|FG003|Completed Blinded Treatment Period|Overall Study||40||
48661066|NCT01475825|101954696|FG000|Entered Open-Label Continuation|Overall Study||45||
48661067|NCT01475825|101954697|FG001|Entered Open-Label Continuation|Overall Study||31||
48661068|NCT01475825|101954698|FG002|Entered Open-Label Continuation|Overall Study||44||
48661069|NCT01475825|101954699|FG003|Entered Open-Label Continuation|Overall Study||29||
48661070|NCT01475825|101954696|FG000|Completed Open-Label Continuation|Overall Study||37||
48451623|NCT01241565|101439953|FG000|COMPLETED|Overall Study||50||
48451624|NCT01241565|101439953|FG000|NOT COMPLETED|Overall Study||0||
48451625|NCT00830388|101439954|FG000|STARTED|Overall Study||11||
48451626|NCT00830388|101439954|FG000|COMPLETED|Overall Study||11||
48451627|NCT00830388|101439954|FG000|NOT COMPLETED|Overall Study||0||
48451628|NCT04371419|101443450|FG000|STARTED|Overall Study||784||
48451629|NCT04371419|101443451|FG001|STARTED|Overall Study||791||
48451630|NCT04371419|101443452|FG002|STARTED|Overall Study||780||
48451631|NCT04371419|101443453|FG003|STARTED|Overall Study||778||
48451632|NCT04371419|101443454|FG004|STARTED|Overall Study||777||
48451633|NCT04371419|101443455|FG005|STARTED|Overall Study||788||
48451634|NCT04371419|101443456|FG006|STARTED|Overall Study||783||
48451635|NCT04371419|101443457|FG007|STARTED|Overall Study||788||
48451636|NCT04371419|101443458|FG008|STARTED|Overall Study||779||
48451637|NCT04371419|101443459|FG009|STARTED|Overall Study||780||
48451638|NCT04371419|101443460|FG010|STARTED|Overall Study||782||
48451639|NCT04371419|101443461|FG011|STARTED|Overall Study||790||
48451640|NCT04371419|101443462|FG012|STARTED|Overall Study||779||
48451641|NCT04371419|101443463|FG013|STARTED|Overall Study||786||
48451642|NCT04371419|101443464|FG014|STARTED|Overall Study||781||
48451643|NCT04371419|101443465|FG015|STARTED|Overall Study||781||
48451644|NCT04371419|101443466|FG016|STARTED|Overall Study||1617||
48451645|NCT04371419|101443450|FG000|Completed the Knowledge Questions|Overall Study||663|Participants who completed the knowledge questions and were included in the knowledge outcome analysis questions|
48451646|NCT04371419|101443451|FG001|Completed the Knowledge Questions|Overall Study||669|Participants who completed the knowledge questions and were included in the knowledge outcome analysis questions|
48451647|NCT04371419|101443452|FG002|Completed the Knowledge Questions|Overall Study||673|Participants who completed the knowledge questions and were included in the knowledge outcome analysis questions|
48661071|NCT01475825|101954697|FG001|Completed Open-Label Continuation|Overall Study||19||
48661072|NCT01475825|101954698|FG002|Completed Open-Label Continuation|Overall Study||38||
48661073|NCT01475825|101954699|FG003|Completed Open-Label Continuation|Overall Study||22||
48661074|NCT01475825|101954696|FG000|COMPLETED|Overall Study||37||
48661075|NCT01475825|101954697|FG001|COMPLETED|Overall Study||19||
48661076|NCT01475825|101954698|FG002|COMPLETED|Overall Study||38||
48661077|NCT01475825|101954699|FG003|COMPLETED|Overall Study||22||
48661078|NCT01475825|101954696|FG000|NOT COMPLETED|Overall Study||67||
48661079|NCT01475825|101954697|FG001|NOT COMPLETED|Overall Study||32||
48661080|NCT01475825|101954698|FG002|NOT COMPLETED|Overall Study||64||
48661081|NCT01475825|101954699|FG003|NOT COMPLETED|Overall Study||30||
48661082|NCT01946880|101954700|FG000|STARTED|Overall Study||50||
48661083|NCT01946880|101954701|FG001|STARTED|Overall Study||52||
48661084|NCT01946880|101954700|FG000|COMPLETED|Overall Study||43||
48661085|NCT01946880|101954701|FG001|COMPLETED|Overall Study||49||
48661086|NCT01946880|101954700|FG000|NOT COMPLETED|Overall Study||7||
48661087|NCT01946880|101954701|FG001|NOT COMPLETED|Overall Study||3||
48661088|NCT05130281|101954702|FG000|STARTED|Overall Study||18||
48661089|NCT05130281|101954703|FG001|STARTED|Overall Study||30||
48661090|NCT05130281|101954704|FG002|STARTED|Overall Study||11||
48661091|NCT05130281|101954702|FG000|COMPLETED|Overall Study||18||
48661092|NCT05130281|101954703|FG001|COMPLETED|Overall Study||30||
48661093|NCT05130281|101954704|FG002|COMPLETED|Overall Study||10||
48661094|NCT05130281|101954702|FG000|NOT COMPLETED|Overall Study||0||
48661095|NCT05130281|101954703|FG001|NOT COMPLETED|Overall Study||0||
48661096|NCT05130281|101954704|FG002|NOT COMPLETED|Overall Study||1||
48661097|NCT02076009|101954705|FG000|STARTED|Overall Study||283||
48661098|NCT02076009|101954706|FG001|STARTED|Overall Study||286||
48661099|NCT02076009|101954705|FG000|Treated (Safety Population)|Overall Study||281||
48661100|NCT02076009|101954706|FG001|Treated (Safety Population)|Overall Study||283||
48661101|NCT02076009|101954705|FG000|COMPLETED|Overall Study||0||
48661102|NCT02076009|101954706|FG001|COMPLETED|Overall Study||0||
48772017|NCT00225732|102229502|FG001|COMPLETED|Overall Study||166||
48661103|NCT02076009|101954705|FG000|NOT COMPLETED|Overall Study||283||
48661104|NCT02076009|101954706|FG001|NOT COMPLETED|Overall Study||286||
48661105|NCT02462057|101954707|FG000|STARTED|Overall Study||791||
48661106|NCT02462057|101954708|FG001|STARTED|Overall Study||793||
48661107|NCT02462057|101954709|FG002|STARTED|Overall Study||812||
48451648|NCT04371419|101443453|FG003|Completed the Knowledge Questions|Overall Study||664|Participants who completed the knowledge questions and were included in the knowledge outcome analysis questions|
48451649|NCT04371419|101443454|FG004|Completed the Knowledge Questions|Overall Study||666|Participants who completed the knowledge questions and were included in the knowledge outcome analysis questions|
48451650|NCT04371419|101443455|FG005|Completed the Knowledge Questions|Overall Study||683|Participants who completed the knowledge questions and were included in the knowledge outcome analysis questions|
48451651|NCT04371419|101443456|FG006|Completed the Knowledge Questions|Overall Study||664|Participants who completed the knowledge questions and were included in the knowledge outcome analysis questions|
48451652|NCT04371419|101443457|FG007|Completed the Knowledge Questions|Overall Study||679|Participants who completed the knowledge questions and were included in the knowledge outcome analysis questions|
48451653|NCT04371419|101443458|FG008|Completed the Knowledge Questions|Overall Study||670|Participants who completed the knowledge questions and were included in the knowledge outcome analysis questions|
48451654|NCT04371419|101443459|FG009|Completed the Knowledge Questions|Overall Study||655|Participants who completed the knowledge questions and were included in the knowledge outcome analysis questions|
48451655|NCT04371419|101443460|FG010|Completed the Knowledge Questions|Overall Study||656|Participants who completed the knowledge questions and were included in the knowledge outcome analysis questions|
48451656|NCT04371419|101443461|FG011|Completed the Knowledge Questions|Overall Study||692|Participants who completed the knowledge questions and were included in the knowledge outcome analysis questions|
48451657|NCT04371419|101443462|FG012|Completed the Knowledge Questions|Overall Study||664|Participants who completed the knowledge questions and were included in the knowledge outcome analysis questions|
48772018|NCT00225732|102229501|FG000|NOT COMPLETED|Overall Study||0||
48772019|NCT00225732|102229502|FG001|NOT COMPLETED|Overall Study||0||
48772020|NCT00993967|102229503|FG000|STARTED|Overall Study||200||
48772021|NCT00993967|102229503|FG000|COMPLETED|Overall Study||139||
48772022|NCT00993967|102229503|FG000|NOT COMPLETED|Overall Study||61||
48772023|NCT02109497|102229504|FG000|STARTED|Overall Study||18||
48772024|NCT02109497|102229504|FG000|COMPLETED|Overall Study||17||
48772025|NCT02109497|102229504|FG000|NOT COMPLETED|Overall Study||1||
48772026|NCT02754440|102229505|FG000|STARTED|Overall Study||99||
48772027|NCT02754440|102229506|FG001|STARTED|Overall Study||101||
48772028|NCT02754440|102229507|FG002|STARTED|Overall Study||100||
48772029|NCT02754440|102229508|FG003|STARTED|Overall Study||35||
48772030|NCT02754440|102229505|FG000|COMPLETED|Overall Study||93||
48772031|NCT02754440|102229506|FG001|COMPLETED|Overall Study||93||
48772032|NCT02754440|102229507|FG002|COMPLETED|Overall Study||93||
48772033|NCT02754440|102229508|FG003|COMPLETED|Overall Study||0||
48772034|NCT02754440|102229505|FG000|NOT COMPLETED|Overall Study||6||
48772035|NCT02754440|102229506|FG001|NOT COMPLETED|Overall Study||8||
48772036|NCT02754440|102229507|FG002|NOT COMPLETED|Overall Study||7||
48772037|NCT02754440|102229508|FG003|NOT COMPLETED|Overall Study||35||
48772038|NCT04540913|102229509|FG000|STARTED|Overall Study||153||
48772039|NCT04540913|102229510|FG001|STARTED|Overall Study||49||
48772040|NCT04540913|102229509|FG000|ITT Population|Overall Study||148||
48772041|NCT04540913|102229510|FG001|ITT Population|Overall Study||48||
48772042|NCT04540913|102229509|FG000|mITT Population|Overall Study||137||
48451658|NCT04371419|101443463|FG013|Completed the Knowledge Questions|Overall Study||687|Participants who completed the knowledge questions and were included in the knowledge outcome analysis questions|
48451659|NCT04371419|101443464|FG014|Completed the Knowledge Questions|Overall Study||652|Participants who completed the knowledge questions and were included in the knowledge outcome analysis questions|
48661108|NCT02462057|101954710|FG003|STARTED|Overall Study||752||
48661109|NCT02462057|101954711|FG004|STARTED|Overall Study||758||
48772043|NCT04540913|102229510|FG001|mITT Population|Overall Study||44||
48772044|NCT04540913|102229509|FG000|PP Population|Overall Study||127||
48772045|NCT04540913|102229510|FG001|PP Population|Overall Study||42||
48772046|NCT04540913|102229509|FG000|COMPLETED|Overall Study||139||
48772047|NCT04540913|102229510|FG001|COMPLETED|Overall Study||46||
48772048|NCT04540913|102229509|FG000|NOT COMPLETED|Overall Study||14||
48772049|NCT04540913|102229510|FG001|NOT COMPLETED|Overall Study||3||
48772050|NCT00345358|102232642|FG000|STARTED|Primary Vaccination Phase||150||
48772051|NCT00345358|102232643|FG001|STARTED|Primary Vaccination Phase||150||
48772052|NCT00345358|102232644|FG002|STARTED|Primary Vaccination Phase||150||
48772053|NCT00345358|102232645|FG003|STARTED|Primary Vaccination Phase||150||
48772054|NCT00345358|102232642|FG000|COMPLETED|Primary Vaccination Phase||145||
48772055|NCT00345358|102232643|FG001|COMPLETED|Primary Vaccination Phase||146||
48772056|NCT00345358|102232644|FG002|COMPLETED|Primary Vaccination Phase||142||
48772057|NCT00345358|102232645|FG003|COMPLETED|Primary Vaccination Phase||148||
48772058|NCT00345358|102232642|FG000|NOT COMPLETED|Primary Vaccination Phase||5||
48772059|NCT00345358|102232643|FG001|NOT COMPLETED|Primary Vaccination Phase||4||
48772060|NCT00345358|102232644|FG002|NOT COMPLETED|Primary Vaccination Phase||8||
48772061|NCT00345358|102232645|FG003|NOT COMPLETED|Primary Vaccination Phase||2||
48772062|NCT00345358|102232642|FG000|STARTED|Booster Vaccination Phase||145||
48772063|NCT00345358|102232643|FG001|STARTED|Booster Vaccination Phase||145||
48772064|NCT00345358|102232644|FG002|STARTED|Booster Vaccination Phase||0||
48772065|NCT00345358|102232645|FG003|STARTED|Booster Vaccination Phase||0||
48772066|NCT00345358|102232642|FG000|COMPLETED|Booster Vaccination Phase||141||
48772067|NCT00345358|102232643|FG001|COMPLETED|Booster Vaccination Phase||145||
48772068|NCT00345358|102232644|FG002|COMPLETED|Booster Vaccination Phase||0||
48661110|NCT02462057|101954707|FG000|COMPLETED|Overall Study||737||
48661111|NCT02462057|101954708|FG001|COMPLETED|Overall Study||753||
48661112|NCT02462057|101954709|FG002|COMPLETED|Overall Study||766||
48661113|NCT02462057|101954710|FG003|COMPLETED|Overall Study||701||
48661114|NCT02462057|101954711|FG004|COMPLETED|Overall Study||708||
48661115|NCT02462057|101954707|FG000|NOT COMPLETED|Overall Study||54||
48661116|NCT02462057|101954708|FG001|NOT COMPLETED|Overall Study||40||
48661117|NCT02462057|101954709|FG002|NOT COMPLETED|Overall Study||46||
48661118|NCT02462057|101954710|FG003|NOT COMPLETED|Overall Study||51||
48661119|NCT02462057|101954711|FG004|NOT COMPLETED|Overall Study||50||
48661120|NCT00087672|101954712|FG000|STARTED|Overall Study||41||
48661121|NCT00087672|101954712|FG000|COMPLETED|Overall Study||41||
48661122|NCT00087672|101954712|FG000|NOT COMPLETED|Overall Study||0||
48661123|NCT03492385|101954713|FG000|STARTED|Overall Study||3||
48661124|NCT03492385|101954714|FG001|STARTED|Overall Study||3||
48661125|NCT03492385|101954715|FG002|STARTED|Overall Study||3||
48772069|NCT00345358|102232645|FG003|COMPLETED|Booster Vaccination Phase||0||
48772070|NCT00345358|102232642|FG000|NOT COMPLETED|Booster Vaccination Phase||4||
48772071|NCT00345358|102232643|FG001|NOT COMPLETED|Booster Vaccination Phase||0||
48772072|NCT00345358|102232644|FG002|NOT COMPLETED|Booster Vaccination Phase||0||
48772073|NCT00345358|102232645|FG003|NOT COMPLETED|Booster Vaccination Phase||0||
48772074|NCT02494323|102232646|FG000|STARTED|Overall Study||70||
48772075|NCT02494323|102232646|FG000|COMPLETED|Overall Study||70||
48772076|NCT02494323|102232646|FG000|NOT COMPLETED|Overall Study||0||
48772077|NCT00214890|102232647|FG000|STARTED|Overall Study||10||
48772078|NCT00214890|102232648|FG001|STARTED|Overall Study||11||
48772079|NCT00214890|102232647|FG000|COMPLETED|Overall Study||10||
48772080|NCT00214890|102232648|FG001|COMPLETED|Overall Study||11||
48772081|NCT00214890|102232647|FG000|NOT COMPLETED|Overall Study||0||
48772082|NCT00214890|102232648|FG001|NOT COMPLETED|Overall Study||0||
48772083|NCT00478023|102232649|FG000|STARTED|Overall Study||170||
48772084|NCT00478023|102232650|FG001|STARTED|Overall Study||168||
48772085|NCT00478023|102232651|FG002|STARTED|Overall Study||171||
48772086|NCT00478023|102232652|FG003|STARTED|Overall Study||176||
48772087|NCT00478023|102232653|FG004|STARTED|Overall Study||169||
48772088|NCT00478023|102232649|FG000|COMPLETED|Overall Study||135||
48772089|NCT00478023|102232650|FG001|COMPLETED|Overall Study||144||
48772090|NCT00478023|102232651|FG002|COMPLETED|Overall Study||151||
48772091|NCT00478023|102232652|FG003|COMPLETED|Overall Study||146||
48772092|NCT00478023|102232653|FG004|COMPLETED|Overall Study||114||
48772093|NCT00478023|102232649|FG000|NOT COMPLETED|Overall Study||35||
48772094|NCT00478023|102232650|FG001|NOT COMPLETED|Overall Study||24||
48772095|NCT00478023|102232651|FG002|NOT COMPLETED|Overall Study||20||
48772096|NCT00478023|102232652|FG003|NOT COMPLETED|Overall Study||30||
48772097|NCT00478023|102232653|FG004|NOT COMPLETED|Overall Study||55||
48772098|NCT00396253|102232654|FG000|STARTED|Overall Study||223||
48772099|NCT00396253|102232654|FG000|COMPLETED|Overall Study||210||
48772100|NCT00396253|102232654|FG000|NOT COMPLETED|Overall Study||13||
48772101|NCT01054885|102232655|FG000|STARTED|2-week, Single-blind Run-In Period||1577||
48772102|NCT01054885|102232656|FG001|STARTED|2-week, Single-blind Run-In Period||0||
48772103|NCT01054885|102232657|FG002|STARTED|2-week, Single-blind Run-In Period||0||
48772104|NCT01054885|102232658|FG003|STARTED|2-week, Single-blind Run-In Period||0||
48772105|NCT01054885|102232659|FG004|STARTED|2-week, Single-blind Run-In Period||0||
48772106|NCT01054885|102232660|FG005|STARTED|2-week, Single-blind Run-In Period||0||
48772107|NCT01054885|102232661|FG006|STARTED|2-week, Single-blind Run-In Period||0||
48772108|NCT01054885|102232655|FG000|COMPLETED|2-week, Single-blind Run-In Period||1226||
48772109|NCT01054885|102232656|FG001|COMPLETED|2-week, Single-blind Run-In Period||0||
48772110|NCT01054885|102232657|FG002|COMPLETED|2-week, Single-blind Run-In Period||0||
48772111|NCT01054885|102232658|FG003|COMPLETED|2-week, Single-blind Run-In Period||0||
48772112|NCT01054885|102232659|FG004|COMPLETED|2-week, Single-blind Run-In Period||0||
48772113|NCT01054885|102232660|FG005|COMPLETED|2-week, Single-blind Run-In Period||0||
48772114|NCT01054885|102232661|FG006|COMPLETED|2-week, Single-blind Run-In Period||0||
48661126|NCT03492385|101954716|FG003|STARTED|Overall Study||3||
48661127|NCT03492385|101954717|FG004|STARTED|Overall Study||6||
48661128|NCT03492385|101954718|FG005|STARTED|Overall Study||6||
48661129|NCT03492385|101954719|FG006|STARTED|Overall Study||6||
48661130|NCT03492385|101954720|FG007|STARTED|Overall Study||6||
48661131|NCT03492385|101954721|FG008|STARTED|Overall Study||6||
48661132|NCT03492385|101954722|FG009|STARTED|Overall Study||6||
48661133|NCT03492385|101954723|FG010|STARTED|Overall Study||3||
48661134|NCT03492385|101954724|FG011|STARTED|Overall Study||6||
48661135|NCT03492385|101954725|FG012|STARTED|Overall Study||7||
48661136|NCT03492385|101954713|FG000|COMPLETED|Overall Study||3||
48661137|NCT03492385|101954714|FG001|COMPLETED|Overall Study||3||
48661138|NCT03492385|101954715|FG002|COMPLETED|Overall Study||3||
48661139|NCT03492385|101954716|FG003|COMPLETED|Overall Study||3||
48661140|NCT03492385|101954717|FG004|COMPLETED|Overall Study||6||
48661141|NCT03492385|101954718|FG005|COMPLETED|Overall Study||6||
48772115|NCT01054885|102232655|FG000|NOT COMPLETED|2-week, Single-blind Run-In Period||351||
48772116|NCT01054885|102232656|FG001|NOT COMPLETED|2-week, Single-blind Run-In Period||0||
48772117|NCT01054885|102232657|FG002|NOT COMPLETED|2-week, Single-blind Run-In Period||0||
48189168|NCT00487721|100786163|FG000|COMPLETED|Overall Study||6||
48189169|NCT00487721|100786164|FG001|COMPLETED|Overall Study||6||
48189170|NCT00487721|100786163|FG000|NOT COMPLETED|Overall Study||0||
48451660|NCT04371419|101443465|FG015|Completed the Knowledge Questions|Overall Study||652|Participants who completed the knowledge questions and were included in the knowledge outcome analysis questions|
48451661|NCT04371419|101443466|FG016|Completed the Knowledge Questions|Overall Study||1526|Participants who completed the knowledge questions and were included in the knowledge outcome analysis questions|
48451662|NCT04371419|101443450|FG000|COMPLETED|Overall Study||641|Participants completed the survey and were included in all analyses.|
48451663|NCT04371419|101443451|FG001|COMPLETED|Overall Study||636|Participants completed the survey and were included in all analyses.|
48451664|NCT04371419|101443452|FG002|COMPLETED|Overall Study||639|Participants completed the survey and were included in all analyses.|
48451665|NCT04371419|101443453|FG003|COMPLETED|Overall Study||631|Participants completed the survey and were included in all analyses.|
48451666|NCT04371419|101443454|FG004|COMPLETED|Overall Study||644|Participants completed the survey and were included in all analyses.|
48451667|NCT04371419|101443455|FG005|COMPLETED|Overall Study||654|Participants completed the survey and were included in all analyses.|
48451668|NCT04371419|101443456|FG006|COMPLETED|Overall Study||639|Participants completed the survey and were included in all analyses.|
48451669|NCT04371419|101443457|FG007|COMPLETED|Overall Study||658|Participants completed the survey and were included in all analyses.|
48451670|NCT04371419|101443458|FG008|COMPLETED|Overall Study||649|Participants completed the survey and were included in all analyses.|
48451671|NCT04371419|101443459|FG009|COMPLETED|Overall Study||621|Participants completed the survey and were included in all analyses.|
48451672|NCT04371419|101443460|FG010|COMPLETED|Overall Study||626|Participants completed the survey and were included in all analyses.|
48451673|NCT04371419|101443461|FG011|COMPLETED|Overall Study||662|Participants completed the survey and were included in all analyses.|
48451674|NCT04371419|101443462|FG012|COMPLETED|Overall Study||633|Participants completed the survey and were included in all analyses.|
48451675|NCT04371419|101443463|FG013|COMPLETED|Overall Study||660|Participants completed the survey and were included in all analyses.|
48451676|NCT04371419|101443464|FG014|COMPLETED|Overall Study||626|Participants completed the survey and were included in all analyses.|
48451677|NCT04371419|101443465|FG015|COMPLETED|Overall Study||625|Participants completed the survey and were included in all analyses.|
48451678|NCT04371419|101443466|FG016|COMPLETED|Overall Study||1450|Participants completed the survey and were included in all analyses.|
48451679|NCT04371419|101443450|FG000|NOT COMPLETED|Overall Study||143||
48451680|NCT04371419|101443451|FG001|NOT COMPLETED|Overall Study||155||
48661142|NCT03492385|101954719|FG006|COMPLETED|Overall Study||6||
48661143|NCT03492385|101954720|FG007|COMPLETED|Overall Study||6||
48661144|NCT03492385|101954721|FG008|COMPLETED|Overall Study||6||
48661145|NCT03492385|101954722|FG009|COMPLETED|Overall Study||6||
48661146|NCT03492385|101954723|FG010|COMPLETED|Overall Study||3||
48661147|NCT03492385|101954724|FG011|COMPLETED|Overall Study||6||
48661148|NCT03492385|101954725|FG012|COMPLETED|Overall Study||7||
48661149|NCT03492385|101954713|FG000|NOT COMPLETED|Overall Study||0||
48661150|NCT03492385|101954714|FG001|NOT COMPLETED|Overall Study||0||
48661151|NCT03492385|101954715|FG002|NOT COMPLETED|Overall Study||0||
48661152|NCT03492385|101954716|FG003|NOT COMPLETED|Overall Study||0||
48661153|NCT03492385|101954717|FG004|NOT COMPLETED|Overall Study||0||
48661154|NCT03492385|101954718|FG005|NOT COMPLETED|Overall Study||0||
48661155|NCT03492385|101954719|FG006|NOT COMPLETED|Overall Study||0||
48661156|NCT03492385|101954720|FG007|NOT COMPLETED|Overall Study||0||
48661157|NCT03492385|101954721|FG008|NOT COMPLETED|Overall Study||0||
48661158|NCT03492385|101954722|FG009|NOT COMPLETED|Overall Study||0||
48661159|NCT03492385|101954723|FG010|NOT COMPLETED|Overall Study||0||
48661160|NCT03492385|101954724|FG011|NOT COMPLETED|Overall Study||0||
48661161|NCT03492385|101954725|FG012|NOT COMPLETED|Overall Study||0||
48661162|NCT03338790|101954726|FG000|STARTED|Overall Study||88|Started = Treated|
48661163|NCT03338790|101954727|FG001|STARTED|Overall Study||71|Started = Treated|
48661164|NCT03338790|101954728|FG002|STARTED|Overall Study||84|Started = Treated|
48661165|NCT03338790|101954729|FG003|STARTED|Overall Study||49|Started = Treated|
48661166|NCT03338790|101954726|FG000|COMPLETED|Overall Study||4|Completed = Continuing treatment|
48661167|NCT03338790|101954727|FG001|COMPLETED|Overall Study||4|Completed = Continuing treatment|
48189171|NCT00487721|100786164|FG001|NOT COMPLETED|Overall Study||0||
48451681|NCT04371419|101443452|FG002|NOT COMPLETED|Overall Study||141||
48451682|NCT04371419|101443453|FG003|NOT COMPLETED|Overall Study||147||
48451683|NCT04371419|101443454|FG004|NOT COMPLETED|Overall Study||133||
48451684|NCT04371419|101443455|FG005|NOT COMPLETED|Overall Study||134||
48451685|NCT04371419|101443456|FG006|NOT COMPLETED|Overall Study||144||
48451686|NCT04371419|101443457|FG007|NOT COMPLETED|Overall Study||130||
48451687|NCT04371419|101443458|FG008|NOT COMPLETED|Overall Study||130||
48451688|NCT04371419|101443459|FG009|NOT COMPLETED|Overall Study||159||
48451689|NCT04371419|101443460|FG010|NOT COMPLETED|Overall Study||156||
48451690|NCT04371419|101443461|FG011|NOT COMPLETED|Overall Study||128||
48451691|NCT04371419|101443462|FG012|NOT COMPLETED|Overall Study||146||
48451692|NCT04371419|101443463|FG013|NOT COMPLETED|Overall Study||126||
48451693|NCT04371419|101443464|FG014|NOT COMPLETED|Overall Study||155||
48451694|NCT04371419|101443465|FG015|NOT COMPLETED|Overall Study||156||
48451695|NCT04371419|101443466|FG016|NOT COMPLETED|Overall Study||167||
48451696|NCT00811070|101443467|FG000|STARTED|Overall Study||7||
48451697|NCT00811070|101443468|FG001|STARTED|Overall Study||7||
48451698|NCT00811070|101443469|FG002|STARTED|Overall Study||3||
48451699|NCT00811070|101443470|FG003|STARTED|Overall Study||28||
48451700|NCT00811070|101443471|FG004|STARTED|Overall Study||7||
48451701|NCT00811070|101443472|FG005|STARTED|Overall Study||11||
48451702|NCT00811070|101443467|FG000|COMPLETED|Overall Study||6||
48451703|NCT00811070|101443468|FG001|COMPLETED|Overall Study||6||
48451704|NCT00811070|101443469|FG002|COMPLETED|Overall Study||3||
48451705|NCT00811070|101443470|FG003|COMPLETED|Overall Study||26||
48451706|NCT00811070|101443471|FG004|COMPLETED|Overall Study||2||
48451707|NCT00811070|101443472|FG005|COMPLETED|Overall Study||10||
48451708|NCT00811070|101443467|FG000|NOT COMPLETED|Overall Study||1||
48451709|NCT00811070|101443468|FG001|NOT COMPLETED|Overall Study||1||
48451710|NCT00811070|101443469|FG002|NOT COMPLETED|Overall Study||0||
48451711|NCT00811070|101443470|FG003|NOT COMPLETED|Overall Study||2||
48451712|NCT00811070|101443471|FG004|NOT COMPLETED|Overall Study||5||
48451713|NCT00811070|101443472|FG005|NOT COMPLETED|Overall Study||1||
48451714|NCT04428502|101443473|FG000|STARTED|Overall Study||127||
48451715|NCT04428502|101443473|FG000|COMPLETED|Overall Study||113||
48451716|NCT04428502|101443473|FG000|NOT COMPLETED|Overall Study||14||
48451717|NCT00529568|101443474|FG000|STARTED|Open-label Pre-Antiviral Treatment Phase||805||
48451718|NCT00529568|101443475|FG001|STARTED|Open-label Pre-Antiviral Treatment Phase||0||
48451719|NCT00529568|101443476|FG002|STARTED|Open-label Pre-Antiviral Treatment Phase||0||
48451720|NCT00529568|101443474|FG000|COMPLETED|Open-label Pre-Antiviral Treatment Phase||759||
48451721|NCT00529568|101443475|FG001|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0||
48451722|NCT00529568|101443476|FG002|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0||
48451723|NCT00529568|101443474|FG000|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||46||
48451724|NCT00529568|101443475|FG001|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0||
48451725|NCT00529568|101443476|FG002|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0||
48451726|NCT00529568|101443474|FG000|STARTED|Double-bilnd Antiviral Treatment Phase||0||
48451727|NCT00529568|101443475|FG001|STARTED|Double-bilnd Antiviral Treatment Phase||253||
48451728|NCT00529568|101443476|FG002|STARTED|Double-bilnd Antiviral Treatment Phase||506||
48451729|NCT00529568|101443474|FG000|COMPLETED|Double-bilnd Antiviral Treatment Phase||0||
48451730|NCT00529568|101443475|FG001|COMPLETED|Double-bilnd Antiviral Treatment Phase||205||
48451731|NCT00529568|101443476|FG002|COMPLETED|Double-bilnd Antiviral Treatment Phase||404||
48451732|NCT00529568|101443474|FG000|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||0||
48451733|NCT00529568|101443475|FG001|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||48||
48451734|NCT00529568|101443476|FG002|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||102||
48451735|NCT03548207|101443477|FG000|STARTED|Overall Study||35||
48451736|NCT03548207|101443478|FG001|STARTED|Overall Study||78||
48451737|NCT03548207|101443479|FG002|STARTED|Overall Study||13||
48451738|NCT03548207|101443477|FG000|Treated|Overall Study||29||
48451739|NCT03548207|101443478|FG001|Treated|Overall Study||68||
48451740|NCT03548207|101443479|FG002|Treated|Overall Study||9||
48451741|NCT03548207|101443477|FG000|COMPLETED|Overall Study||0||
48451742|NCT03548207|101443478|FG001|COMPLETED|Overall Study||0||
48451743|NCT03548207|101443479|FG002|COMPLETED|Overall Study||0||
48451744|NCT03548207|101443477|FG000|NOT COMPLETED|Overall Study||35||
48451745|NCT03548207|101443478|FG001|NOT COMPLETED|Overall Study||78||
48451746|NCT03548207|101443479|FG002|NOT COMPLETED|Overall Study||13||
48451747|NCT00328042|101443480|FG000|STARTED|Overall Study||69||
48451748|NCT00328042|101443481|FG001|STARTED|Overall Study||65||
48451749|NCT00328042|101443480|FG000|COMPLETED|Overall Study||69||
48451750|NCT00328042|101443481|FG001|COMPLETED|Overall Study||63||
48451751|NCT00328042|101443480|FG000|NOT COMPLETED|Overall Study||0||
48451752|NCT00328042|101443481|FG001|NOT COMPLETED|Overall Study||2||
48451753|NCT02657356|101443482|FG000|STARTED|Overall Study||102||
48451754|NCT02657356|101443483|FG001|STARTED|Overall Study||100||
48451755|NCT02657356|101443482|FG000|COMPLETED|Overall Study||82||
48451756|NCT02657356|101443483|FG001|COMPLETED|Overall Study||85||
48451757|NCT02657356|101443482|FG000|NOT COMPLETED|Overall Study||20||
48451758|NCT02657356|101443483|FG001|NOT COMPLETED|Overall Study||15||
48451759|NCT00950599|101443484|FG000|STARTED|Double-Blind Treatment Period||55||
48451760|NCT00950599|101443485|FG001|STARTED|Double-Blind Treatment Period||47||
48451761|NCT00950599|101443486|FG002|STARTED|Double-Blind Treatment Period||63||
48451762|NCT00950599|101443487|FG003|STARTED|Double-Blind Treatment Period||54||
48451763|NCT00950599|101443488|FG004|STARTED|Double-Blind Treatment Period||52||
48451764|NCT00950599|101443489|FG005|STARTED|Double-Blind Treatment Period||67||
48451765|NCT00950599|101443490|FG006|STARTED|Double-Blind Treatment Period||44||
48451766|NCT00950599|101443491|FG007|STARTED|Double-Blind Treatment Period||41||
48451767|NCT00950599|101443492|FG008|STARTED|Double-Blind Treatment Period||0||
48451768|NCT00950599|101443493|FG009|STARTED|Double-Blind Treatment Period||0||
48451769|NCT00950599|101443484|FG000|COMPLETED|Double-Blind Treatment Period||48||
48451770|NCT00950599|101443485|FG001|COMPLETED|Double-Blind Treatment Period||37||
48451771|NCT00950599|101443486|FG002|COMPLETED|Double-Blind Treatment Period||54||
48661168|NCT03338790|101954728|FG002|COMPLETED|Overall Study||8|Completed = Continuing treatment|
48661169|NCT03338790|101954729|FG003|COMPLETED|Overall Study||4|Completed = Continuing treatment|
48661170|NCT03338790|101954726|FG000|NOT COMPLETED|Overall Study||84||
48661171|NCT03338790|101954727|FG001|NOT COMPLETED|Overall Study||67||
48661172|NCT03338790|101954728|FG002|NOT COMPLETED|Overall Study||76||
48661173|NCT03338790|101954729|FG003|NOT COMPLETED|Overall Study||45||
48661174|NCT05155085|101954730|FG000|STARTED|Main Study||65||
48661175|NCT05155085|101954731|FG001|STARTED|Main Study||65||
48661176|NCT05155085|101954730|FG000|COMPLETED|Main Study||57||
48661177|NCT05155085|101954731|FG001|COMPLETED|Main Study||58||
48661178|NCT05155085|101954730|FG000|NOT COMPLETED|Main Study||8||
48661179|NCT05155085|101954731|FG001|NOT COMPLETED|Main Study||7||
48661180|NCT05155085|101954730|FG000|STARTED|Open-Label Extension||55||
48661181|NCT05155085|101954731|FG001|STARTED|Open-Label Extension||57||
48661182|NCT05155085|101954730|FG000|COMPLETED|Open-Label Extension||32||
48661183|NCT05155085|101954731|FG001|COMPLETED|Open-Label Extension||36||
48661184|NCT05155085|101954730|FG000|NOT COMPLETED|Open-Label Extension||23||
48661185|NCT05155085|101954731|FG001|NOT COMPLETED|Open-Label Extension||21||
48661186|NCT00090064|101954732|FG000|STARTED|Overall Study||15||
48661187|NCT00090064|101954733|FG001|STARTED|Overall Study||8||
48661188|NCT00090064|101954732|FG000|COMPLETED|Overall Study||13||
48661189|NCT00090064|101954733|FG001|COMPLETED|Overall Study||8||
48661190|NCT00090064|101954732|FG000|NOT COMPLETED|Overall Study||2||
48661191|NCT00090064|101954733|FG001|NOT COMPLETED|Overall Study||0||
48661192|NCT02016885|101954734|FG000|STARTED|Overall Study||38||
48661193|NCT02016885|101954735|FG001|STARTED|Overall Study||40||
48661194|NCT02016885|101954736|FG002|STARTED|Overall Study||40||
48661195|NCT02016885|101954737|FG003|STARTED|Overall Study||40||
48661196|NCT02016885|101954738|FG004|STARTED|Overall Study||40||
48661197|NCT02016885|101954734|FG000|COMPLETED|Overall Study||34||
48661198|NCT02016885|101954735|FG001|COMPLETED|Overall Study||36||
48661199|NCT02016885|101954736|FG002|COMPLETED|Overall Study||39||
48661200|NCT02016885|101954737|FG003|COMPLETED|Overall Study||30||
48661201|NCT02016885|101954738|FG004|COMPLETED|Overall Study||39||
48661202|NCT02016885|101954734|FG000|NOT COMPLETED|Overall Study||4||
48661203|NCT02016885|101954735|FG001|NOT COMPLETED|Overall Study||4||
48661204|NCT02016885|101954736|FG002|NOT COMPLETED|Overall Study||1||
48661205|NCT02016885|101954737|FG003|NOT COMPLETED|Overall Study||10||
48661206|NCT02016885|101954738|FG004|NOT COMPLETED|Overall Study||1||
48661207|NCT00353119|101954739|FG000|STARTED|First Intervention Day 0 to Week 12||5||
48451772|NCT00950599|101443487|FG003|COMPLETED|Double-Blind Treatment Period||43||
48451773|NCT00950599|101443488|FG004|COMPLETED|Double-Blind Treatment Period||45||
48451774|NCT00950599|101443489|FG005|COMPLETED|Double-Blind Treatment Period||55||
48451775|NCT00950599|101443490|FG006|COMPLETED|Double-Blind Treatment Period||44||
48451776|NCT00950599|101443491|FG007|COMPLETED|Double-Blind Treatment Period||35||
48451777|NCT00950599|101443492|FG008|COMPLETED|Double-Blind Treatment Period||0||
48451778|NCT00950599|101443493|FG009|COMPLETED|Double-Blind Treatment Period||0||
48451779|NCT00950599|101443484|FG000|NOT COMPLETED|Double-Blind Treatment Period||7||
48451780|NCT00950599|101443485|FG001|NOT COMPLETED|Double-Blind Treatment Period||10||
48451781|NCT00950599|101443486|FG002|NOT COMPLETED|Double-Blind Treatment Period||9||
48451782|NCT00950599|101443487|FG003|NOT COMPLETED|Double-Blind Treatment Period||11||
48451783|NCT00950599|101443488|FG004|NOT COMPLETED|Double-Blind Treatment Period||7||
48451784|NCT00950599|101443489|FG005|NOT COMPLETED|Double-Blind Treatment Period||12||
48451785|NCT00950599|101443490|FG006|NOT COMPLETED|Double-Blind Treatment Period||0||
48451786|NCT00950599|101443491|FG007|NOT COMPLETED|Double-Blind Treatment Period||6||
48451787|NCT00950599|101443492|FG008|NOT COMPLETED|Double-Blind Treatment Period||0||
48661208|NCT00353119|101954740|FG001|STARTED|First Intervention Day 0 to Week 12||10||
48661209|NCT00353119|101954739|FG000|COMPLETED|First Intervention Day 0 to Week 12||5||
48661210|NCT00353119|101954740|FG001|COMPLETED|First Intervention Day 0 to Week 12||10||
48661211|NCT00353119|101954739|FG000|NOT COMPLETED|First Intervention Day 0 to Week 12||0||
48661212|NCT00353119|101954740|FG001|NOT COMPLETED|First Intervention Day 0 to Week 12||0||
48661213|NCT00353119|101954739|FG000|STARTED|Second Intervention Week 12 to Week 28||5||
48661214|NCT00353119|101954740|FG001|STARTED|Second Intervention Week 12 to Week 28||10||
48661215|NCT00353119|101954739|FG000|COMPLETED|Second Intervention Week 12 to Week 28||5||
48661216|NCT00353119|101954740|FG001|COMPLETED|Second Intervention Week 12 to Week 28||10||
48670047|NCT05757193|101974878|FG001|STARTED|Overall Study||10||
48451788|NCT00950599|101443493|FG009|NOT COMPLETED|Double-Blind Treatment Period||0||
48451789|NCT00950599|101443484|FG000|STARTED|Follow-Up Period||0||
48451790|NCT00950599|101443485|FG001|STARTED|Follow-Up Period||0||
48451791|NCT00950599|101443486|FG002|STARTED|Follow-Up Period||0||
48451792|NCT00950599|101443487|FG003|STARTED|Follow-Up Period||0||
48451793|NCT00950599|101443488|FG004|STARTED|Follow-Up Period||0||
48451794|NCT00950599|101443489|FG005|STARTED|Follow-Up Period||0||
48451795|NCT00950599|101443490|FG006|STARTED|Follow-Up Period||0||
48451796|NCT00950599|101443491|FG007|STARTED|Follow-Up Period||0||
48451797|NCT00950599|101443492|FG008|STARTED|Follow-Up Period||309||
48451798|NCT00950599|101443493|FG009|STARTED|Follow-Up Period||80||
48451799|NCT00950599|101443484|FG000|COMPLETED|Follow-Up Period||0||
48451800|NCT00950599|101443485|FG001|COMPLETED|Follow-Up Period||0||
48451801|NCT00950599|101443486|FG002|COMPLETED|Follow-Up Period||0||
48451802|NCT00950599|101443487|FG003|COMPLETED|Follow-Up Period||0||
48451803|NCT00950599|101443488|FG004|COMPLETED|Follow-Up Period||0||
48451804|NCT00950599|101443489|FG005|COMPLETED|Follow-Up Period||0||
48451805|NCT00950599|101443490|FG006|COMPLETED|Follow-Up Period||0||
48451806|NCT00950599|101443491|FG007|COMPLETED|Follow-Up Period||0||
48451807|NCT00950599|101443492|FG008|COMPLETED|Follow-Up Period||296||
48451808|NCT00950599|101443493|FG009|COMPLETED|Follow-Up Period||78||
48451809|NCT00950599|101443484|FG000|NOT COMPLETED|Follow-Up Period||0||
48451810|NCT00950599|101443485|FG001|NOT COMPLETED|Follow-Up Period||0||
48451811|NCT00950599|101443486|FG002|NOT COMPLETED|Follow-Up Period||0||
48451812|NCT00950599|101443487|FG003|NOT COMPLETED|Follow-Up Period||0||
48451813|NCT00950599|101443488|FG004|NOT COMPLETED|Follow-Up Period||0||
48451814|NCT00950599|101443489|FG005|NOT COMPLETED|Follow-Up Period||0||
48451815|NCT00950599|101443490|FG006|NOT COMPLETED|Follow-Up Period||0||
48451816|NCT00950599|101443491|FG007|NOT COMPLETED|Follow-Up Period||0||
48451817|NCT00950599|101443492|FG008|NOT COMPLETED|Follow-Up Period||13||
48451818|NCT00950599|101443493|FG009|NOT COMPLETED|Follow-Up Period||2||
48451819|NCT00606801|101443494|FG000|STARTED|Adaptation||17||
48451820|NCT00606801|101443495|FG001|STARTED|Adaptation||17||
48451821|NCT00606801|101443494|FG000|COMPLETED|Adaptation||17||
48451822|NCT00606801|101443495|FG001|COMPLETED|Adaptation||17||
48451823|NCT00606801|101443494|FG000|NOT COMPLETED|Adaptation||0||
48451824|NCT00606801|101443495|FG001|NOT COMPLETED|Adaptation||0||
48451825|NCT00606801|101443494|FG000|STARTED|Intervention||17||
48451826|NCT00606801|101443495|FG001|STARTED|Intervention||17||
48451827|NCT00606801|101443494|FG000|COMPLETED|Intervention||14||
48451828|NCT00606801|101443495|FG001|COMPLETED|Intervention||14||
48451829|NCT00606801|101443494|FG000|NOT COMPLETED|Intervention||3||
48661217|NCT00353119|101954739|FG000|NOT COMPLETED|Second Intervention Week 12 to Week 28||0||
48661218|NCT00353119|101954740|FG001|NOT COMPLETED|Second Intervention Week 12 to Week 28||0||
48661219|NCT05181085|101954741|FG000|STARTED|Overall Study||10||
48661220|NCT05181085|101954742|FG001|STARTED|Overall Study||6||
48661221|NCT05181085|101954743|FG002|STARTED|Overall Study||6||
48661222|NCT05181085|101954744|FG003|STARTED|Overall Study||6||
48661223|NCT05181085|101954745|FG004|STARTED|Overall Study||6||
48661224|NCT05181085|101954746|FG005|STARTED|Overall Study||6||
48661225|NCT05181085|101954747|FG006|STARTED|Overall Study||6||
48661226|NCT05181085|101954748|FG007|STARTED|Overall Study||8||
48661227|NCT05181085|101954749|FG008|STARTED|Overall Study||8||
48661228|NCT05181085|101954750|FG009|STARTED|Overall Study||8||
48661229|NCT05181085|101954741|FG000|COMPLETED|Overall Study||10||
48661230|NCT05181085|101954742|FG001|COMPLETED|Overall Study||6||
48772118|NCT01054885|102232658|FG003|NOT COMPLETED|2-week, Single-blind Run-In Period||0||
48772119|NCT01054885|102232659|FG004|NOT COMPLETED|2-week, Single-blind Run-In Period||0||
48451830|NCT00606801|101443495|FG001|NOT COMPLETED|Intervention||3||
48451831|NCT00543439|101443496|FG000|STARTED|Period 1||10||
48451832|NCT00543439|101443497|FG001|STARTED|Period 1||29||
48451833|NCT00543439|101443498|FG002|STARTED|Period 1||27||
48451834|NCT00543439|101443496|FG000|Treated|Period 1||9||
48451835|NCT00543439|101443497|FG001|Treated|Period 1||29||
48451836|NCT00543439|101443498|FG002|Treated|Period 1||27||
48451837|NCT00543439|101443496|FG000|COMPLETED|Period 1||9||
48451838|NCT00543439|101443497|FG001|COMPLETED|Period 1||26||
48451839|NCT00543439|101443498|FG002|COMPLETED|Period 1||25||
48451840|NCT00543439|101443496|FG000|NOT COMPLETED|Period 1||1||
48451841|NCT00543439|101443497|FG001|NOT COMPLETED|Period 1||3||
48451842|NCT00543439|101443498|FG002|NOT COMPLETED|Period 1||2||
48451843|NCT00543439|101443496|FG000|STARTED|Period 2||9||
48451844|NCT00543439|101443497|FG001|STARTED|Period 2||26||
48451845|NCT00543439|101443498|FG002|STARTED|Period 2||25||
48451846|NCT00543439|101443496|FG000|COMPLETED|Period 2||8||
48451847|NCT00543439|101443497|FG001|COMPLETED|Period 2||25||
48451848|NCT00543439|101443498|FG002|COMPLETED|Period 2||23||
48451849|NCT00543439|101443496|FG000|NOT COMPLETED|Period 2||1||
48661231|NCT05181085|101954743|FG002|COMPLETED|Overall Study||6||
48661232|NCT05181085|101954744|FG003|COMPLETED|Overall Study||6||
48661233|NCT05181085|101954745|FG004|COMPLETED|Overall Study||6||
48661234|NCT05181085|101954746|FG005|COMPLETED|Overall Study||6||
48451850|NCT00543439|101443497|FG001|NOT COMPLETED|Period 2||1||
48451851|NCT00543439|101443498|FG002|NOT COMPLETED|Period 2||2||
48661235|NCT05181085|101954747|FG006|COMPLETED|Overall Study||6||
48451852|NCT01169987|101443499|FG000|STARTED|Overall Study||191||
48451853|NCT01169987|101443499|FG000|COMPLETED|Overall Study||160||
48451854|NCT01169987|101443499|FG000|NOT COMPLETED|Overall Study||31||
48451855|NCT03398928|101443500|FG000|STARTED|Overall Study||50||
48451856|NCT03398928|101443501|FG001|STARTED|Overall Study||31||
48451857|NCT03398928|101443500|FG000|COMPLETED|Overall Study||50||
48451858|NCT03398928|101443501|FG001|COMPLETED|Overall Study||31||
48451859|NCT03398928|101443500|FG000|NOT COMPLETED|Overall Study||0||
48451860|NCT03398928|101443501|FG001|NOT COMPLETED|Overall Study||0||
48451861|NCT01476345|101443502|FG000|STARTED|Period 1||40||
48451862|NCT01476345|101443503|FG001|STARTED|Period 1||40||
48451863|NCT01476345|101443502|FG000|Received at Least 1 Dose of Study Drug|Period 1||40||
48451864|NCT01476345|101443503|FG001|Received at Least 1 Dose of Study Drug|Period 1||40||
48451865|NCT01476345|101443502|FG000|COMPLETED|Period 1||40||
48451866|NCT01476345|101443503|FG001|COMPLETED|Period 1||40||
48451867|NCT01476345|101443502|FG000|NOT COMPLETED|Period 1||0||
48451868|NCT01476345|101443503|FG001|NOT COMPLETED|Period 1||0||
48451869|NCT01476345|101443502|FG000|STARTED|Period 2||40||
48451870|NCT01476345|101443503|FG001|STARTED|Period 2||40||
48451871|NCT01476345|101443502|FG000|COMPLETED|Period 2||40||
48451872|NCT01476345|101443503|FG001|COMPLETED|Period 2||40||
48451873|NCT01476345|101443502|FG000|NOT COMPLETED|Period 2||0||
48451874|NCT01476345|101443503|FG001|NOT COMPLETED|Period 2||0||
48451875|NCT01476345|101443502|FG000|STARTED|Period 3||39||
48451876|NCT01476345|101443503|FG001|STARTED|Period 3||39||
48451877|NCT01476345|101443502|FG000|COMPLETED|Period 3||39||
48451878|NCT01476345|101443503|FG001|COMPLETED|Period 3||39||
48451879|NCT01476345|101443502|FG000|NOT COMPLETED|Period 3||0||
48451880|NCT01476345|101443503|FG001|NOT COMPLETED|Period 3||0||
48451881|NCT01476345|101443502|FG000|STARTED|Period 4||39||
48451882|NCT01476345|101443503|FG001|STARTED|Period 4||39||
48451883|NCT01476345|101443502|FG000|COMPLETED|Period 4||39||
48451884|NCT01476345|101443503|FG001|COMPLETED|Period 4||39||
48451885|NCT01476345|101443502|FG000|NOT COMPLETED|Period 4||0||
48451886|NCT01476345|101443503|FG001|NOT COMPLETED|Period 4||0||
48451887|NCT04643782|101443504|FG000|STARTED|Overall Study||287||
48451888|NCT04643782|101443504|FG000|COMPLETED|Overall Study||225||
48451889|NCT04643782|101443504|FG000|NOT COMPLETED|Overall Study||62||
48451890|NCT00961051|101443505|FG000|STARTED|Overall Study||177||
48451891|NCT00961051|101443506|FG001|STARTED|Overall Study||93||
48451892|NCT00961051|101443505|FG000|COMPLETED|Overall Study||165||
48451893|NCT00961051|101443506|FG001|COMPLETED|Overall Study||79||
48451894|NCT00961051|101443505|FG000|NOT COMPLETED|Overall Study||12||
48451895|NCT00961051|101443506|FG001|NOT COMPLETED|Overall Study||14||
48451896|NCT01407575|101443507|FG000|STARTED|Overall Study||7||
48451897|NCT01407575|101443508|FG001|STARTED|Overall Study||6||
48451898|NCT01407575|101443507|FG000|COMPLETED|Overall Study||5||
48451899|NCT01407575|101443508|FG001|COMPLETED|Overall Study||5||
48189172|NCT03796689|100786165|FG000|STARTED|Overall Study||1051||
48451900|NCT01407575|101443507|FG000|NOT COMPLETED|Overall Study||2||
48451901|NCT01407575|101443508|FG001|NOT COMPLETED|Overall Study||1||
48451902|NCT00204932|101443509|FG000|STARTED|Overall Study||24||
48451903|NCT00204932|101443510|FG001|STARTED|Overall Study||24||
48451904|NCT00204932|101443509|FG000|COMPLETED|Overall Study||22||
48451905|NCT00204932|101443510|FG001|COMPLETED|Overall Study||18||
48451906|NCT00204932|101443509|FG000|NOT COMPLETED|Overall Study||2||
48451907|NCT00204932|101443510|FG001|NOT COMPLETED|Overall Study||6||
48451908|NCT00065065|101443511|FG000|STARTED|Overall Study||52||
48451909|NCT00065065|101443512|FG001|STARTED|Overall Study||53||
48451910|NCT00065065|101443511|FG000|COMPLETED|Overall Study||42||
48451911|NCT00065065|101443512|FG001|COMPLETED|Overall Study||33||
48451912|NCT00065065|101443511|FG000|NOT COMPLETED|Overall Study||10||
48451913|NCT00065065|101443512|FG001|NOT COMPLETED|Overall Study||20||
48451914|NCT00420290|101443513|FG000|STARTED|Overall Study||11||
48451915|NCT00420290|101443514|FG001|STARTED|Overall Study||11||
48451916|NCT00420290|101443513|FG000|COMPLETED|Overall Study||7||
48451917|NCT00420290|101443514|FG001|COMPLETED|Overall Study||7||
48189173|NCT03796689|100786166|FG001|STARTED|Overall Study||1050||
48189174|NCT03796689|100786165|FG000|COMPLETED|Overall Study||1051||
48189175|NCT03796689|100786166|FG001|COMPLETED|Overall Study||1050||
48189176|NCT03796689|100786165|FG000|NOT COMPLETED|Overall Study||0||
48189177|NCT03796689|100786166|FG001|NOT COMPLETED|Overall Study||0||
48189178|NCT00859014|100786167|FG000|STARTED|Overall Study||25||
48451918|NCT00420290|101443513|FG000|NOT COMPLETED|Overall Study||4||
48451919|NCT00420290|101443514|FG001|NOT COMPLETED|Overall Study||4||
48451920|NCT02063698|101443515|FG000|STARTED|Overall Study||15||
48451921|NCT02063698|101443516|FG001|STARTED|Overall Study||15||
48451922|NCT02063698|101443515|FG000|COMPLETED|Overall Study||14||
48451923|NCT02063698|101443516|FG001|COMPLETED|Overall Study||13||
48451924|NCT02063698|101443515|FG000|NOT COMPLETED|Overall Study||1||
48451925|NCT02063698|101443516|FG001|NOT COMPLETED|Overall Study||2||
48451926|NCT01284244|101443517|FG000|STARTED|Overall Study||18||
48451927|NCT01284244|101443518|FG001|STARTED|Overall Study||18||
48451928|NCT01284244|101443517|FG000|COMPLETED|Overall Study||18||
48451929|NCT01284244|101443518|FG001|COMPLETED|Overall Study||18||
48451930|NCT01284244|101443517|FG000|NOT COMPLETED|Overall Study||0||
48451931|NCT01284244|101443518|FG001|NOT COMPLETED|Overall Study||0||
48772120|NCT01054885|102232660|FG005|NOT COMPLETED|2-week, Single-blind Run-In Period||0||
48772121|NCT01054885|102232661|FG006|NOT COMPLETED|2-week, Single-blind Run-In Period||0||
48772122|NCT01054885|102232655|FG000|STARTED|24-week, Double-blind Treatment Period||0||
48772123|NCT01054885|102232656|FG001|STARTED|24-week, Double-blind Treatment Period||205||
48772124|NCT01054885|102232657|FG002|STARTED|24-week, Double-blind Treatment Period||204||
48772125|NCT01054885|102232658|FG003|STARTED|24-week, Double-blind Treatment Period||203||
48772126|NCT01054885|102232659|FG004|STARTED|24-week, Double-blind Treatment Period||203||
48772127|NCT01054885|102232660|FG005|STARTED|24-week, Double-blind Treatment Period||204||
48772128|NCT01054885|102232661|FG006|STARTED|24-week, Double-blind Treatment Period||205||
48772129|NCT01054885|102232655|FG000|COMPLETED|24-week, Double-blind Treatment Period||0||
48772130|NCT01054885|102232656|FG001|COMPLETED|24-week, Double-blind Treatment Period||146||
48772131|NCT01054885|102232657|FG002|COMPLETED|24-week, Double-blind Treatment Period||155||
48772132|NCT01054885|102232658|FG003|COMPLETED|24-week, Double-blind Treatment Period||160||
48772133|NCT01054885|102232659|FG004|COMPLETED|24-week, Double-blind Treatment Period||161||
48772134|NCT01054885|102232660|FG005|COMPLETED|24-week, Double-blind Treatment Period||144||
48772135|NCT01054885|102232661|FG006|COMPLETED|24-week, Double-blind Treatment Period||158||
48772136|NCT01054885|102232655|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0||
48772137|NCT01054885|102232656|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||59||
48772138|NCT01054885|102232657|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||49||
48772139|NCT01054885|102232658|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||43||
48772140|NCT01054885|102232659|FG004|NOT COMPLETED|24-week, Double-blind Treatment Period||42||
48772141|NCT01054885|102232660|FG005|NOT COMPLETED|24-week, Double-blind Treatment Period||60||
48772142|NCT01054885|102232661|FG006|NOT COMPLETED|24-week, Double-blind Treatment Period||47||
48772143|NCT04857320|102232662|FG000|STARTED|Overall Study||7||
48772144|NCT04857320|102232662|FG000|COMPLETED|Overall Study||5||
48772145|NCT04857320|102232662|FG000|NOT COMPLETED|Overall Study||2||
48772146|NCT01003769|102232663|FG000|STARTED|Overall Study||5||
48772147|NCT01003769|102232663|FG000|COMPLETED|Overall Study||5||
48772148|NCT01003769|102232663|FG000|NOT COMPLETED|Overall Study||0||
48772149|NCT03714672|102232664|FG000|STARTED|Overall Study||209||
48772150|NCT03714672|102232665|FG001|STARTED|Overall Study||206||
48772151|NCT03714672|102232666|FG002|STARTED|Overall Study||206||
48772152|NCT03714672|102232667|FG003|STARTED|Overall Study||208||
48772153|NCT03714672|102232664|FG000|Safety Set|Overall Study||208||
48772154|NCT03714672|102232665|FG001|Safety Set|Overall Study||205||
48772155|NCT03714672|102232666|FG002|Safety Set|Overall Study||206||
48772156|NCT03714672|102232667|FG003|Safety Set|Overall Study||207||
48772157|NCT03714672|102232664|FG000|COMPLETED|Overall Study||207||
48772158|NCT03714672|102232665|FG001|COMPLETED|Overall Study||202||
48772159|NCT03714672|102232666|FG002|COMPLETED|Overall Study||202||
48772160|NCT03714672|102232667|FG003|COMPLETED|Overall Study||207||
48772161|NCT03714672|102232664|FG000|NOT COMPLETED|Overall Study||2||
48772162|NCT03714672|102232665|FG001|NOT COMPLETED|Overall Study||4||
48772163|NCT03714672|102232666|FG002|NOT COMPLETED|Overall Study||4||
48772164|NCT03714672|102232667|FG003|NOT COMPLETED|Overall Study||1||
48772165|NCT01394003|102232668|FG000|STARTED|Overall Study||3||
48772166|NCT01394003|102232669|FG001|STARTED|Overall Study||8||
48772167|NCT01394003|102232670|FG002|STARTED|Overall Study||3||
48772168|NCT01394003|102232671|FG003|STARTED|Overall Study||6||
48772169|NCT01394003|102232672|FG004|STARTED|Overall Study||3||
48772170|NCT01394003|102232673|FG005|STARTED|Overall Study||3||
48772171|NCT01394003|102232674|FG006|STARTED|Overall Study||6||
48772172|NCT01394003|102232675|FG007|STARTED|Overall Study||2||
48772173|NCT01394003|102232668|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
48772174|NCT01394003|102232669|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8||
48772175|NCT01394003|102232670|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
48772176|NCT01394003|102232671|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6||
48772177|NCT01394003|102232672|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3||
48772178|NCT01394003|102232673|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3||
48189179|NCT00859014|100786167|FG000|COMPLETED|Overall Study||20||
48451932|NCT03262233|101443519|FG000|STARTED|Overall Study||53||
48451933|NCT03262233|101443520|FG001|STARTED|Overall Study||53||
48772179|NCT01394003|102232674|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6||
48772180|NCT01394003|102232675|FG007|Received at Least 1 Dose of Study Drug|Overall Study||2||
48772181|NCT01394003|102232668|FG000|COMPLETED|Overall Study||3||
48772182|NCT01394003|102232669|FG001|COMPLETED|Overall Study||8||
48772183|NCT01394003|102232670|FG002|COMPLETED|Overall Study||3||
48772184|NCT01394003|102232671|FG003|COMPLETED|Overall Study||6||
48772185|NCT01394003|102232672|FG004|COMPLETED|Overall Study||3||
48189180|NCT00859014|100786167|FG000|NOT COMPLETED|Overall Study||5||
48772186|NCT01394003|102232673|FG005|COMPLETED|Overall Study||3||
48772187|NCT01394003|102232674|FG006|COMPLETED|Overall Study||6||
48772188|NCT01394003|102232675|FG007|COMPLETED|Overall Study||2||
48772189|NCT01394003|102232668|FG000|NOT COMPLETED|Overall Study||0||
48189181|NCT00308061|100786168|FG000|STARTED|Overall Study||20||
48189182|NCT00308061|100786169|FG001|STARTED|Overall Study||20||
48451934|NCT03262233|101443521|FG002|STARTED|Overall Study||59||
48451935|NCT03262233|101443522|FG003|STARTED|Overall Study||61||
48772190|NCT01394003|102232669|FG001|NOT COMPLETED|Overall Study||0||
48772191|NCT01394003|102232670|FG002|NOT COMPLETED|Overall Study||0||
48772192|NCT01394003|102232671|FG003|NOT COMPLETED|Overall Study||0||
48772193|NCT01394003|102232672|FG004|NOT COMPLETED|Overall Study||0||
48772194|NCT01394003|102232673|FG005|NOT COMPLETED|Overall Study||0||
48451936|NCT03262233|101443519|FG000|COMPLETED|Overall Study||35||
48451937|NCT03262233|101443520|FG001|COMPLETED|Overall Study||32||
48451938|NCT03262233|101443521|FG002|COMPLETED|Overall Study||34||
48451939|NCT03262233|101443522|FG003|COMPLETED|Overall Study||32||
48661236|NCT05181085|101954748|FG007|COMPLETED|Overall Study||8||
48661237|NCT05181085|101954749|FG008|COMPLETED|Overall Study||8||
48661238|NCT05181085|101954750|FG009|COMPLETED|Overall Study||8||
48661239|NCT05181085|101954741|FG000|NOT COMPLETED|Overall Study||0||
48661240|NCT05181085|101954742|FG001|NOT COMPLETED|Overall Study||0||
48661241|NCT05181085|101954743|FG002|NOT COMPLETED|Overall Study||0||
48661242|NCT05181085|101954744|FG003|NOT COMPLETED|Overall Study||0||
48661243|NCT05181085|101954745|FG004|NOT COMPLETED|Overall Study||0||
48661244|NCT05181085|101954746|FG005|NOT COMPLETED|Overall Study||0||
48661245|NCT05181085|101954747|FG006|NOT COMPLETED|Overall Study||0||
48661246|NCT05181085|101954748|FG007|NOT COMPLETED|Overall Study||0||
48661247|NCT05181085|101954749|FG008|NOT COMPLETED|Overall Study||0||
48661248|NCT05181085|101954750|FG009|NOT COMPLETED|Overall Study||0||
48661249|NCT01346592|101954751|FG000|STARTED|Overall Study||3136||
48661250|NCT01346592|101954752|FG001|STARTED|Overall Study||1478||
48661251|NCT01346592|101954753|FG002|STARTED|Overall Study||1486||
48661252|NCT01346592|101954751|FG000|COMPLETED|Overall Study||2983||
48661253|NCT01346592|101954752|FG001|COMPLETED|Overall Study||1389||
48661254|NCT01346592|101954753|FG002|COMPLETED|Overall Study||1408||
48661255|NCT01346592|101954751|FG000|NOT COMPLETED|Overall Study||153||
48661256|NCT01346592|101954752|FG001|NOT COMPLETED|Overall Study||89||
48661257|NCT01346592|101954753|FG002|NOT COMPLETED|Overall Study||78||
48661258|NCT01697501|101954754|FG000|STARTED|Overall Study||88||
48661259|NCT01697501|101954754|FG000|COMPLETED|Overall Study||86||
48661260|NCT01697501|101954754|FG000|NOT COMPLETED|Overall Study||2||
48661261|NCT04498273|101954755|FG000|STARTED|Overall Study||165||
48661262|NCT04498273|101954756|FG001|STARTED|Overall Study||164||
48661263|NCT04498273|101954757|FG002|STARTED|Overall Study||164||
48661264|NCT04498273|101954758|FG003|STARTED|Overall Study||164||
48661265|NCT04498273|101954755|FG000|COMPLETED|Overall Study||134||
48661266|NCT04498273|101954756|FG001|COMPLETED|Overall Study||140||
48661267|NCT04498273|101954757|FG002|COMPLETED|Overall Study||143||
48661268|NCT04498273|101954758|FG003|COMPLETED|Overall Study||133||
48661269|NCT04498273|101954755|FG000|NOT COMPLETED|Overall Study||31||
48661270|NCT04498273|101954756|FG001|NOT COMPLETED|Overall Study||24||
48661271|NCT04498273|101954757|FG002|NOT COMPLETED|Overall Study||21||
48661272|NCT04498273|101954758|FG003|NOT COMPLETED|Overall Study||31||
48772195|NCT01394003|102232674|FG006|NOT COMPLETED|Overall Study||0||
48772196|NCT01394003|102232675|FG007|NOT COMPLETED|Overall Study||0||
48772197|NCT02858362|102232676|FG000|STARTED|Overall Study||30||
48772198|NCT02858362|102232677|FG001|STARTED|Overall Study||10||
48772199|NCT02858362|102232678|FG002|STARTED|Overall Study||3||
48772200|NCT02858362|102232676|FG000|Did Not Enter Extension Phase|Overall Study||1|Completed the study (Week 48 treatment visit) but did not enter the optional extension phase.|
48772201|NCT02858362|102232677|FG001|Did Not Enter Extension Phase|Overall Study||2|Completed the study (Week 48 treatment visit) but did not enter the optional extension phase.|
48772202|NCT02858362|102232678|FG002|Did Not Enter Extension Phase|Overall Study||0|Completed the study (Week 48 treatment visit) but did not enter the optional extension phase.|
48772203|NCT02858362|102232676|FG000|COMPLETED|Overall Study||28||
48772204|NCT02858362|102232677|FG001|COMPLETED|Overall Study||9||
48772205|NCT02858362|102232678|FG002|COMPLETED|Overall Study||0||
48772206|NCT02858362|102232676|FG000|NOT COMPLETED|Overall Study||2||
48772207|NCT02858362|102232677|FG001|NOT COMPLETED|Overall Study||1||
48772208|NCT02858362|102232678|FG002|NOT COMPLETED|Overall Study||3||
48661273|NCT03338920|101954759|FG000|STARTED|Overall Study||79||
48661274|NCT03338920|101954760|FG001|STARTED|Overall Study||80||
48661275|NCT03338920|101954759|FG000|COMPLETED|Overall Study||75||
48661276|NCT03338920|101954760|FG001|COMPLETED|Overall Study||74||
48661277|NCT03338920|101954759|FG000|NOT COMPLETED|Overall Study||4||
48661278|NCT03338920|101954760|FG001|NOT COMPLETED|Overall Study||6||
48772209|NCT05375760|102232679|FG000|STARTED|Overall Study||125||
48772210|NCT05375760|102232680|FG001|STARTED|Overall Study||126||
48772211|NCT05375760|102232679|FG000|Treated|Overall Study||124||
48772212|NCT05375760|102232680|FG001|Treated|Overall Study||124||
48772213|NCT05375760|102232679|FG000|COMPLETED|Overall Study||0||
48772214|NCT05375760|102232680|FG001|COMPLETED|Overall Study||0||
48772215|NCT05375760|102232679|FG000|NOT COMPLETED|Overall Study||125||
48661279|NCT03523585|101954761|FG000|STARTED|Overall Study||406||
48661280|NCT03523585|101954762|FG001|STARTED|Overall Study||91||
48772216|NCT05375760|102232680|FG001|NOT COMPLETED|Overall Study||126||
48772217|NCT03224819|102232681|FG000|STARTED|Overall Study||1||
48451940|NCT03262233|101443519|FG000|NOT COMPLETED|Overall Study||18||
48772218|NCT03224819|102232682|FG001|STARTED|Overall Study||1||
48451941|NCT03262233|101443520|FG001|NOT COMPLETED|Overall Study||21||
48661281|NCT03523585|101954763|FG002|STARTED|Overall Study||111||
48661282|NCT03523585|101954761|FG000|Randomized|Overall Study||406||
48661283|NCT03523585|101954762|FG001|Randomized|Overall Study||91||
48661284|NCT03523585|101954763|FG002|Randomized|Overall Study||111||
48451942|NCT03262233|101443521|FG002|NOT COMPLETED|Overall Study||25||
48451943|NCT03262233|101443522|FG003|NOT COMPLETED|Overall Study||29||
48451944|NCT01893983|101443523|FG000|STARTED|Overall Study||140||
48451945|NCT01893983|101443524|FG001|STARTED|Overall Study||140||
48451946|NCT01893983|101443523|FG000|COMPLETED|Overall Study||130||
48451947|NCT01893983|101443524|FG001|COMPLETED|Overall Study||134||
48451948|NCT01893983|101443523|FG000|NOT COMPLETED|Overall Study||10||
48451949|NCT01893983|101443524|FG001|NOT COMPLETED|Overall Study||6||
48451950|NCT03456726|101443525|FG000|STARTED|Overall Study||17||
48451951|NCT03456726|101443526|FG001|STARTED|Overall Study||3||
48451952|NCT03456726|101443525|FG000|COMPLETED|Overall Study||0||
48451953|NCT03456726|101443526|FG001|COMPLETED|Overall Study||0||
48451954|NCT03456726|101443525|FG000|NOT COMPLETED|Overall Study||17||
48451955|NCT03456726|101443526|FG001|NOT COMPLETED|Overall Study||3||
48451956|NCT01362959|101443527|FG000|STARTED|Overall Study||21||
48451957|NCT01362959|101443528|FG001|STARTED|Overall Study||26||
48451958|NCT01362959|101443527|FG000|COMPLETED|Overall Study||21||
48451959|NCT01362959|101443528|FG001|COMPLETED|Overall Study||26||
48451960|NCT01362959|101443527|FG000|NOT COMPLETED|Overall Study||0||
48451961|NCT01362959|101443528|FG001|NOT COMPLETED|Overall Study||0||
48451962|NCT02649608|101443529|FG000|STARTED|Overall Study||2||
48451963|NCT02649608|101443530|FG001|STARTED|Overall Study||1||
48451964|NCT02649608|101443531|FG002|STARTED|Overall Study||3||
48451965|NCT02649608|101443532|FG003|STARTED|Overall Study||3||
48451966|NCT02649608|101443533|FG004|STARTED|Overall Study||3||
48451967|NCT02649608|101443534|FG005|STARTED|Overall Study||2||
48451968|NCT02649608|101443535|FG006|STARTED|Overall Study||1||
48451969|NCT02649608|101443529|FG000|COMPLETED|Overall Study||2||
48451970|NCT02649608|101443530|FG001|COMPLETED|Overall Study||1||
48451971|NCT02649608|101443531|FG002|COMPLETED|Overall Study||3||
48451972|NCT02649608|101443532|FG003|COMPLETED|Overall Study||3||
48451973|NCT02649608|101443533|FG004|COMPLETED|Overall Study||3||
48451974|NCT02649608|101443534|FG005|COMPLETED|Overall Study||2||
48451975|NCT02649608|101443535|FG006|COMPLETED|Overall Study||1||
48451976|NCT02649608|101443529|FG000|NOT COMPLETED|Overall Study||0||
48451977|NCT02649608|101443530|FG001|NOT COMPLETED|Overall Study||0||
48451978|NCT02649608|101443531|FG002|NOT COMPLETED|Overall Study||0||
48451979|NCT02649608|101443532|FG003|NOT COMPLETED|Overall Study||0||
48451980|NCT02649608|101443533|FG004|NOT COMPLETED|Overall Study||0||
48451981|NCT02649608|101443534|FG005|NOT COMPLETED|Overall Study||0||
48451982|NCT02649608|101443535|FG006|NOT COMPLETED|Overall Study||0||
48451983|NCT00821041|101443536|FG000|STARTED|Overall Study||59||
48451984|NCT00821041|101443537|FG001|STARTED|Overall Study||59||
48451985|NCT00821041|101443536|FG000|COMPLETED|Overall Study||59||
48451986|NCT00821041|101443537|FG001|COMPLETED|Overall Study||59||
48451987|NCT00821041|101443536|FG000|NOT COMPLETED|Overall Study||0||
48451988|NCT00821041|101443537|FG001|NOT COMPLETED|Overall Study||0||
48451989|NCT03233737|101443538|FG000|STARTED|Overall Study||10||
48451990|NCT03233737|101443539|FG001|STARTED|Overall Study||10||
48451991|NCT03233737|101443540|FG002|STARTED|Overall Study||5||
48451992|NCT03233737|101443541|FG003|STARTED|Overall Study||24||
48451993|NCT03233737|101443542|FG004|STARTED|Overall Study||26||
48451994|NCT03233737|101443538|FG000|COMPLETED|Overall Study||10||
48451995|NCT03233737|101443539|FG001|COMPLETED|Overall Study||10||
48451996|NCT03233737|101443540|FG002|COMPLETED|Overall Study||5||
48451997|NCT03233737|101443541|FG003|COMPLETED|Overall Study||24||
48451998|NCT03233737|101443542|FG004|COMPLETED|Overall Study||26||
48451999|NCT03233737|101443538|FG000|NOT COMPLETED|Overall Study||0||
48452000|NCT03233737|101443539|FG001|NOT COMPLETED|Overall Study||0||
48452001|NCT03233737|101443540|FG002|NOT COMPLETED|Overall Study||0||
48452002|NCT03233737|101443541|FG003|NOT COMPLETED|Overall Study||0||
48452003|NCT03233737|101443542|FG004|NOT COMPLETED|Overall Study||0||
48452004|NCT02082262|101443543|FG000|STARTED|Overall Study||140||
48661285|NCT03523585|101954761|FG000|Randomized But Not Treated|Overall Study||2||
48661286|NCT03523585|101954762|FG001|Randomized But Not Treated|Overall Study||4||
48661287|NCT03523585|101954763|FG002|Randomized But Not Treated|Overall Study||3||
48772219|NCT03224819|102232683|FG002|STARTED|Overall Study||3||
48670048|NCT05757193|101974877|FG000|COMPLETED|Overall Study||10||
48452005|NCT02082262|101443543|FG000|COMPLETED|Overall Study||89||
48452006|NCT02082262|101443543|FG000|NOT COMPLETED|Overall Study||51||
48452007|NCT01416142|101443544|FG000|STARTED|Cross Over at Movie Intermission||32||
48452008|NCT01416142|101443545|FG001|STARTED|Cross Over at Movie Intermission||31||
48452009|NCT01416142|101443546|FG002|STARTED|Cross Over at Movie Intermission||0||
48772220|NCT03224819|102232684|FG003|STARTED|Overall Study||3||
48772221|NCT03224819|102232685|FG004|STARTED|Overall Study||3||
48452010|NCT01416142|101443544|FG000|COMPLETED|Cross Over at Movie Intermission||32||
48452011|NCT01416142|101443545|FG001|COMPLETED|Cross Over at Movie Intermission||31||
48452012|NCT01416142|101443546|FG002|COMPLETED|Cross Over at Movie Intermission||0||
48452013|NCT01416142|101443544|FG000|NOT COMPLETED|Cross Over at Movie Intermission||0||
48452014|NCT01416142|101443545|FG001|NOT COMPLETED|Cross Over at Movie Intermission||0||
48452015|NCT01416142|101443546|FG002|NOT COMPLETED|Cross Over at Movie Intermission||0||
48452016|NCT01416142|101443544|FG000|STARTED|PureVision2 HD||0||
48452017|NCT01416142|101443545|FG001|STARTED|PureVision2 HD||0||
48772222|NCT03224819|102232686|FG005|STARTED|Overall Study||3||
48772223|NCT03224819|102232687|FG006|STARTED|Overall Study||3||
48772224|NCT03224819|102232688|FG007|STARTED|Overall Study||3||
48772225|NCT03224819|102232689|FG008|STARTED|Overall Study||4||
48772226|NCT03224819|102232690|FG009|STARTED|Overall Study||6||
48772227|NCT03224819|102232691|FG010|STARTED|Overall Study||4||
48772228|NCT03224819|102232692|FG011|STARTED|Overall Study||4||
48772229|NCT03224819|102232693|FG012|STARTED|Overall Study||5||
48772230|NCT03224819|102232694|FG013|STARTED|Overall Study||3||
48772231|NCT03224819|102232681|FG000|COMPLETED|Overall Study||1||
48772232|NCT03224819|102232682|FG001|COMPLETED|Overall Study||0||
48772233|NCT03224819|102232683|FG002|COMPLETED|Overall Study||3||
48772234|NCT03224819|102232684|FG003|COMPLETED|Overall Study||2||
48772235|NCT03224819|102232685|FG004|COMPLETED|Overall Study||2||
48772236|NCT03224819|102232686|FG005|COMPLETED|Overall Study||1||
48772237|NCT03224819|102232687|FG006|COMPLETED|Overall Study||2||
48189183|NCT00308061|100786168|FG000|COMPLETED|Overall Study||20||
48452018|NCT01416142|101443546|FG002|STARTED|PureVision2 HD||63||
48452019|NCT01416142|101443544|FG000|COMPLETED|PureVision2 HD||0||
48452020|NCT01416142|101443545|FG001|COMPLETED|PureVision2 HD||0||
48452021|NCT01416142|101443546|FG002|COMPLETED|PureVision2 HD||62||
48452022|NCT01416142|101443544|FG000|NOT COMPLETED|PureVision2 HD||0||
48452023|NCT01416142|101443545|FG001|NOT COMPLETED|PureVision2 HD||0||
48452024|NCT01416142|101443546|FG002|NOT COMPLETED|PureVision2 HD||1||
48452025|NCT01580020|101443547|FG000|STARTED|Overall Study||52||
48452026|NCT01580020|101443548|FG001|STARTED|Overall Study||40||
48452027|NCT01580020|101443549|FG002|STARTED|Overall Study||61||
48452028|NCT01580020|101443550|FG003|STARTED|Overall Study||22||
48452029|NCT01580020|101443547|FG000|COMPLETED|Overall Study||51||
48452030|NCT01580020|101443548|FG001|COMPLETED|Overall Study||33||
48452031|NCT01580020|101443549|FG002|COMPLETED|Overall Study||57||
48452032|NCT01580020|101443550|FG003|COMPLETED|Overall Study||20||
48452033|NCT01580020|101443547|FG000|NOT COMPLETED|Overall Study||1||
48452034|NCT01580020|101443548|FG001|NOT COMPLETED|Overall Study||7||
48452035|NCT01580020|101443549|FG002|NOT COMPLETED|Overall Study||4||
48452036|NCT01580020|101443550|FG003|NOT COMPLETED|Overall Study||2||
48452037|NCT03835975|101443551|FG000|STARTED|Overall Study||253||
48452038|NCT03835975|101443552|FG001|STARTED|Overall Study||122||
48452039|NCT03835975|101443553|FG002|STARTED|Overall Study||248||
48452040|NCT03835975|101443554|FG003|STARTED|Overall Study||127||
48452041|NCT03835975|101443555|FG004|STARTED|Overall Study||125||
48452042|NCT03835975|101443551|FG000|Vaccinated|Overall Study||253||
48452043|NCT03835975|101443552|FG001|Vaccinated|Overall Study||122||
48452044|NCT03835975|101443553|FG002|Vaccinated|Overall Study||246||
48452045|NCT03835975|101443554|FG003|Vaccinated|Overall Study||127||
48452046|NCT03835975|101443555|FG004|Vaccinated|Overall Study||125||
48452047|NCT03835975|101443551|FG000|Safety Population|Overall Study||253||
48452048|NCT03835975|101443552|FG001|Safety Population|Overall Study||122||
48452049|NCT03835975|101443553|FG002|Safety Population|Overall Study||246||
48452050|NCT03835975|101443554|FG003|Safety Population|Overall Study||127||
48452051|NCT03835975|101443555|FG004|Safety Population|Overall Study||125||
48452052|NCT03835975|101443551|FG000|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||247||
48452053|NCT03835975|101443552|FG001|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||0||
48452054|NCT03835975|101443553|FG002|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||243||
48452055|NCT03835975|101443554|FG003|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||0||
48452056|NCT03835975|101443555|FG004|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||121||
48452057|NCT03835975|101443551|FG000|COMPLETED|Overall Study||250||
48452058|NCT03835975|101443552|FG001|COMPLETED|Overall Study||119||
48452059|NCT03835975|101443553|FG002|COMPLETED|Overall Study||245||
48452060|NCT03835975|101443554|FG003|COMPLETED|Overall Study||126||
48452061|NCT03835975|101443555|FG004|COMPLETED|Overall Study||125||
48452062|NCT03835975|101443551|FG000|NOT COMPLETED|Overall Study||3||
48452063|NCT03835975|101443552|FG001|NOT COMPLETED|Overall Study||3||
48452064|NCT03835975|101443553|FG002|NOT COMPLETED|Overall Study||3||
48661288|NCT03523585|101954761|FG000|COMPLETED|Overall Study||94|Completed = Participants who are on-going study treatment as of 30 Jun 22, Not Completed = Participants who discontinued treatment and participants randomized but not treated.|
48772238|NCT03224819|102232688|FG007|COMPLETED|Overall Study||1||
48772239|NCT03224819|102232689|FG008|COMPLETED|Overall Study||2||
48772240|NCT03224819|102232690|FG009|COMPLETED|Overall Study||4||
48772241|NCT03224819|102232691|FG010|COMPLETED|Overall Study||3||
48189184|NCT00308061|100786169|FG001|COMPLETED|Overall Study||20||
48189185|NCT00308061|100786168|FG000|NOT COMPLETED|Overall Study||0||
48452065|NCT03835975|101443554|FG003|NOT COMPLETED|Overall Study||1||
48189186|NCT00308061|100786169|FG001|NOT COMPLETED|Overall Study||0||
48452066|NCT03835975|101443555|FG004|NOT COMPLETED|Overall Study||0||
48452067|NCT01222715|101443556|FG000|STARTED|Overall Study||44||
48452068|NCT01222715|101443557|FG001|STARTED|Overall Study||43||
48452069|NCT01222715|101443556|FG000|COMPLETED|Overall Study||8||
48452070|NCT01222715|101443557|FG001|COMPLETED|Overall Study||16||
48452071|NCT01222715|101443556|FG000|NOT COMPLETED|Overall Study||36||
48772242|NCT03224819|102232692|FG011|COMPLETED|Overall Study||2||
48452072|NCT01222715|101443557|FG001|NOT COMPLETED|Overall Study||27||
48452073|NCT00267293|101443558|FG000|STARTED|Overall Study||20||
48452074|NCT00267293|101443559|FG001|STARTED|Overall Study||20||
48452075|NCT00267293|101443560|FG002|STARTED|Overall Study||20||
48452076|NCT00267293|101443558|FG000|COMPLETED|Overall Study||20||
48452077|NCT00267293|101443559|FG001|COMPLETED|Overall Study||20||
48452078|NCT00267293|101443560|FG002|COMPLETED|Overall Study||20||
48452079|NCT00267293|101443558|FG000|NOT COMPLETED|Overall Study||0||
48452080|NCT00267293|101443559|FG001|NOT COMPLETED|Overall Study||0||
48452081|NCT00267293|101443560|FG002|NOT COMPLETED|Overall Study||0||
48452082|NCT02598622|101443561|FG000|STARTED|Overall Study||8||
48452083|NCT02598622|101443562|FG001|STARTED|Overall Study||0||
48452084|NCT02598622|101443561|FG000|COMPLETED|Overall Study||2||
48452085|NCT02598622|101443562|FG001|COMPLETED|Overall Study||0||
48452086|NCT02598622|101443561|FG000|NOT COMPLETED|Overall Study||6||
48452087|NCT02598622|101443562|FG001|NOT COMPLETED|Overall Study||0||
48452088|NCT00265083|101443563|FG000|STARTED|Overall Study||78||
48452089|NCT00265083|101443564|FG001|STARTED|Overall Study||138||
48452090|NCT00265083|101443565|FG002|STARTED|Overall Study||140||
48452091|NCT00265083|101443563|FG000|COMPLETED|Overall Study||61||
48452092|NCT00265083|101443564|FG001|COMPLETED|Overall Study||96||
48452093|NCT00265083|101443565|FG002|COMPLETED|Overall Study||98||
48452094|NCT00265083|101443563|FG000|NOT COMPLETED|Overall Study||17||
48452095|NCT00265083|101443564|FG001|NOT COMPLETED|Overall Study||42||
48452096|NCT00265083|101443565|FG002|NOT COMPLETED|Overall Study||42||
48452097|NCT00117585|101443566|FG000|STARTED|Overall Study||341||
48452098|NCT00117585|101443566|FG000|COMPLETED|Overall Study||341||
48452099|NCT00117585|101443566|FG000|NOT COMPLETED|Overall Study||0||
48452100|NCT01726335|101443567|FG000|STARTED|Overall Study||53||
48452101|NCT01726335|101443567|FG000|COMPLETED|Overall Study||29||
48452102|NCT01726335|101443567|FG000|NOT COMPLETED|Overall Study||24||
48452103|NCT01205529|101443568|FG000|STARTED|Overall Study||161||
48452104|NCT01205529|101443568|FG000|COMPLETED|Overall Study||106||
48452105|NCT01205529|101443568|FG000|NOT COMPLETED|Overall Study||55||
48452106|NCT02230085|101443569|FG000|STARTED|Overall Study||110||
48661289|NCT03523585|101954762|FG001|COMPLETED|Overall Study||1|Completed = Participants who are on-going study treatment as of 30 Jun 22, Not Completed = Participants who discontinued treatment and participants randomized but not treated.|
48661290|NCT03523585|101954763|FG002|COMPLETED|Overall Study||4|Completed = Participants who are on-going study treatment as of 30 Jun 22, Not Completed = Participants who discontinued treatment and participants randomized but not treated.|
48661291|NCT03523585|101954761|FG000|NOT COMPLETED|Overall Study||312||
48661292|NCT03523585|101954762|FG001|NOT COMPLETED|Overall Study||90||
48661293|NCT03523585|101954763|FG002|NOT COMPLETED|Overall Study||107||
48661294|NCT02134808|101954764|FG000|STARTED|Overall Study||28||
48661295|NCT02134808|101954765|FG001|STARTED|Overall Study||23||
48661296|NCT02134808|101954766|FG002|STARTED|Overall Study||20||
48661297|NCT02134808|101954764|FG000|COMPLETED|Overall Study||24||
48661298|NCT02134808|101954765|FG001|COMPLETED|Overall Study||19||
48661299|NCT02134808|101954766|FG002|COMPLETED|Overall Study||20||
48661300|NCT02134808|101954764|FG000|NOT COMPLETED|Overall Study||4||
48661301|NCT02134808|101954765|FG001|NOT COMPLETED|Overall Study||4||
48661302|NCT02134808|101954766|FG002|NOT COMPLETED|Overall Study||0||
48661303|NCT03453515|101954767|FG000|STARTED|Overall Study||113||
48661304|NCT03453515|101954768|FG001|STARTED|Overall Study||113||
48661305|NCT03453515|101954767|FG000|COMPLETED|Overall Study||107||
48661306|NCT03453515|101954768|FG001|COMPLETED|Overall Study||100||
48661307|NCT03453515|101954767|FG000|NOT COMPLETED|Overall Study||6||
48661308|NCT03453515|101954768|FG001|NOT COMPLETED|Overall Study||13||
48661309|NCT04629521|101954769|FG000|STARTED|Overall Study||54||
48661310|NCT04629521|101954769|FG000|COMPLETED|Overall Study||46||
48661311|NCT04629521|101954769|FG000|NOT COMPLETED|Overall Study||8||
48661312|NCT01299961|101954770|FG000|STARTED|Overall Study||25||
48661313|NCT01299961|101954770|FG000|COMPLETED|Overall Study||19||
48661314|NCT01299961|101954770|FG000|NOT COMPLETED|Overall Study||6||
48661315|NCT02579057|101954771|FG000|STARTED|Overall Study||19||
48661316|NCT02579057|101954772|FG001|STARTED|Overall Study||21||
48661317|NCT02579057|101954771|FG000|COMPLETED|Overall Study||19||
48661318|NCT02579057|101954772|FG001|COMPLETED|Overall Study||21||
48452107|NCT02230085|101443569|FG000|COMPLETED|Overall Study||106||
48452108|NCT02230085|101443569|FG000|NOT COMPLETED|Overall Study||4||
48452109|NCT04060654|101443570|FG000|STARTED|Overall Study||17||
48452110|NCT04060654|101443570|FG000|COMPLETED|Overall Study||11||
48452111|NCT04060654|101443570|FG000|NOT COMPLETED|Overall Study||6||
48452112|NCT00363129|101443571|FG000|STARTED|Overall Study||96||
48452113|NCT00363129|101443572|FG001|STARTED|Overall Study||93||
48452114|NCT00363129|101443571|FG000|COMPLETED|Overall Study||67||
48452115|NCT00363129|101443572|FG001|COMPLETED|Overall Study||60||
48452116|NCT00363129|101443571|FG000|NOT COMPLETED|Overall Study||29||
48452117|NCT00363129|101443572|FG001|NOT COMPLETED|Overall Study||33||
48452118|NCT04603937|101443573|FG000|STARTED|Overall Study||229||
48452119|NCT04603937|101443574|FG001|STARTED|Overall Study||228||
48452120|NCT04603937|101443573|FG000|COMPLETED|Overall Study||208|Completed is defined as participants who completed treatment through Week 64.|
48452121|NCT04603937|101443574|FG001|COMPLETED|Overall Study||204|Completed is defined as participants who completed treatment through Week 64.|
48661319|NCT02579057|101954771|FG000|NOT COMPLETED|Overall Study||0||
48661320|NCT02579057|101954772|FG001|NOT COMPLETED|Overall Study||0||
48661321|NCT02685436|101954773|FG000|STARTED|Overall Study||52||
48661322|NCT02685436|101954773|FG000|COMPLETED|Overall Study||38||
48661323|NCT02685436|101954773|FG000|NOT COMPLETED|Overall Study||14||
48661324|NCT02743221|101956870|FG000|STARTED|Overall Study||77||
48661325|NCT02743221|101956871|FG001|STARTED|Overall Study||77||
48661326|NCT02743221|101956870|FG000|COMPLETED|Overall Study||21|Of note, these patients were still under treatment at the primary completion date (cut-off date).|
48661327|NCT02743221|101956871|FG001|COMPLETED|Overall Study||17|Of note, these patients were still under treatment at the primary completion date (cut-off date).|
48661328|NCT02743221|101956870|FG000|NOT COMPLETED|Overall Study||56||
48661329|NCT02743221|101956871|FG001|NOT COMPLETED|Overall Study||60||
48661330|NCT02150863|101956872|FG000|STARTED|Overall Study||0||
48661331|NCT02150863|101956873|FG001|STARTED|Overall Study||1||
48661332|NCT02150863|101956874|FG002|STARTED|Overall Study||0||
48661333|NCT02150863|101956872|FG000|COMPLETED|Overall Study||0||
48661334|NCT02150863|101956873|FG001|COMPLETED|Overall Study||0||
48661335|NCT02150863|101956874|FG002|COMPLETED|Overall Study||0||
48661336|NCT02150863|101956872|FG000|NOT COMPLETED|Overall Study||0||
48661337|NCT02150863|101956873|FG001|NOT COMPLETED|Overall Study||1||
48661338|NCT02150863|101956874|FG002|NOT COMPLETED|Overall Study||0||
48661339|NCT01892189|101956875|FG000|STARTED|First Intervention Period (1 Day)||3||
48661340|NCT01892189|101956876|FG001|STARTED|First Intervention Period (1 Day)||3||
48661341|NCT01892189|101956877|FG002|STARTED|First Intervention Period (1 Day)||3||
48661342|NCT01892189|101956878|FG003|STARTED|First Intervention Period (1 Day)||3||
48661343|NCT01892189|101956879|FG004|STARTED|First Intervention Period (1 Day)||3||
48661344|NCT01892189|101956880|FG005|STARTED|First Intervention Period (1 Day)||3||
48661345|NCT01892189|101956881|FG006|STARTED|First Intervention Period (1 Day)||3||
48369434|NCT01103349|101232771|FG002|COMPLETED|Overall Study||63||
48369435|NCT01103349|101232769|FG000|NOT COMPLETED|Overall Study||11||
48369436|NCT01103349|101232770|FG001|NOT COMPLETED|Overall Study||7||
48369437|NCT01103349|101232771|FG002|NOT COMPLETED|Overall Study||4||
48369438|NCT02234583|101232772|FG000|STARTED|Overall Study||847||
48661346|NCT01892189|101956882|FG007|STARTED|First Intervention Period (1 Day)||3||
48661347|NCT01892189|101956883|FG008|STARTED|First Intervention Period (1 Day)||3||
48661348|NCT01892189|101956875|FG000|COMPLETED|First Intervention Period (1 Day)||3||
48661349|NCT01892189|101956876|FG001|COMPLETED|First Intervention Period (1 Day)||3||
48661350|NCT01892189|101956877|FG002|COMPLETED|First Intervention Period (1 Day)||3||
48772243|NCT03224819|102232693|FG012|COMPLETED|Overall Study||3||
48772244|NCT03224819|102232694|FG013|COMPLETED|Overall Study||3||
48772245|NCT03224819|102232681|FG000|NOT COMPLETED|Overall Study||0||
48772246|NCT03224819|102232682|FG001|NOT COMPLETED|Overall Study||1||
48772247|NCT03224819|102232683|FG002|NOT COMPLETED|Overall Study||0||
48772248|NCT03224819|102232684|FG003|NOT COMPLETED|Overall Study||1||
48772249|NCT03224819|102232685|FG004|NOT COMPLETED|Overall Study||1||
48772250|NCT03224819|102232686|FG005|NOT COMPLETED|Overall Study||2||
48772251|NCT03224819|102232687|FG006|NOT COMPLETED|Overall Study||1||
48772252|NCT03224819|102232688|FG007|NOT COMPLETED|Overall Study||2||
48772253|NCT03224819|102232689|FG008|NOT COMPLETED|Overall Study||2||
48772254|NCT03224819|102232690|FG009|NOT COMPLETED|Overall Study||2||
48772255|NCT03224819|102232691|FG010|NOT COMPLETED|Overall Study||1||
48772256|NCT03224819|102232692|FG011|NOT COMPLETED|Overall Study||2||
48772257|NCT03224819|102232693|FG012|NOT COMPLETED|Overall Study||2||
48772258|NCT03224819|102232694|FG013|NOT COMPLETED|Overall Study||0||
48772259|NCT00811018|102232695|FG000|STARTED|Overall Study||1192||
48772260|NCT00811018|102232695|FG000|COMPLETED|Overall Study||224||
48772261|NCT00811018|102232695|FG000|NOT COMPLETED|Overall Study||968||
48772262|NCT01803607|102232696|FG000|STARTED|Overall Study||68||
48772263|NCT01803607|102232697|FG001|STARTED|Overall Study||67||
48772264|NCT01803607|102232696|FG000|COMPLETED|Overall Study||0||
48772265|NCT01803607|102232697|FG001|COMPLETED|Overall Study||0||
48772266|NCT01803607|102232696|FG000|NOT COMPLETED|Overall Study||68||
48772267|NCT01803607|102232697|FG001|NOT COMPLETED|Overall Study||67||
48772268|NCT02367833|102232698|FG000|STARTED|Overall Study||9||
48772269|NCT02367833|102232699|FG001|STARTED|Overall Study||9||
48772270|NCT02367833|102232700|FG002|STARTED|Overall Study||8||
48772271|NCT02367833|102232698|FG000|COMPLETED|Overall Study||8||
48661351|NCT01892189|101956878|FG003|COMPLETED|First Intervention Period (1 Day)||3||
48772272|NCT02367833|102232699|FG001|COMPLETED|Overall Study||8||
48772273|NCT02367833|102232700|FG002|COMPLETED|Overall Study||8||
48772274|NCT02367833|102232698|FG000|NOT COMPLETED|Overall Study||1||
48772275|NCT02367833|102232699|FG001|NOT COMPLETED|Overall Study||1||
48369439|NCT02234583|101232773|FG001|STARTED|Overall Study||1241||
48772276|NCT02367833|102232700|FG002|NOT COMPLETED|Overall Study||0||
48772277|NCT02892448|102232701|FG000|STARTED|Overall Study||12||
48772278|NCT02892448|102232702|FG001|STARTED|Overall Study||12||
48772279|NCT02892448|102232703|FG002|STARTED|Overall Study||11||
48772280|NCT02892448|102232701|FG000|COMPLETED|Overall Study||10||
48772281|NCT02892448|102232702|FG001|COMPLETED|Overall Study||10||
48772282|NCT02892448|102232703|FG002|COMPLETED|Overall Study||10||
48772283|NCT02892448|102232701|FG000|NOT COMPLETED|Overall Study||2||
48772284|NCT02892448|102232702|FG001|NOT COMPLETED|Overall Study||2||
48661352|NCT01892189|101956879|FG004|COMPLETED|First Intervention Period (1 Day)||3||
48661353|NCT01892189|101956880|FG005|COMPLETED|First Intervention Period (1 Day)||3||
48661354|NCT01892189|101956881|FG006|COMPLETED|First Intervention Period (1 Day)||3||
48661355|NCT01892189|101956882|FG007|COMPLETED|First Intervention Period (1 Day)||3||
48661356|NCT01892189|101956883|FG008|COMPLETED|First Intervention Period (1 Day)||3||
48661357|NCT01892189|101956875|FG000|NOT COMPLETED|First Intervention Period (1 Day)||0||
48661358|NCT01892189|101956876|FG001|NOT COMPLETED|First Intervention Period (1 Day)||0||
48661359|NCT01892189|101956877|FG002|NOT COMPLETED|First Intervention Period (1 Day)||0||
48661360|NCT01892189|101956878|FG003|NOT COMPLETED|First Intervention Period (1 Day)||0||
48661361|NCT01892189|101956879|FG004|NOT COMPLETED|First Intervention Period (1 Day)||0||
48772285|NCT02892448|102232703|FG002|NOT COMPLETED|Overall Study||1||
48772286|NCT02284243|102232704|FG000|STARTED|Overall Study||84||
48772287|NCT02284243|102232705|FG001|STARTED|Overall Study||84||
48772288|NCT02284243|102232704|FG000|COMPLETED|Overall Study||80||
48452122|NCT04603937|101443573|FG000|NOT COMPLETED|Overall Study||21||
48452123|NCT04603937|101443574|FG001|NOT COMPLETED|Overall Study||24||
48452124|NCT01430104|101443575|FG000|STARTED|14-Day Lead-In Period||30||
48452125|NCT01430104|101443575|FG000|COMPLETED|14-Day Lead-In Period||30||
48452126|NCT01430104|101443575|FG000|NOT COMPLETED|14-Day Lead-In Period||0||
48452127|NCT01430104|101443575|FG000|STARTED|28-Day Teriparatide Treatment Period||29||
48452128|NCT01430104|101443575|FG000|Received at Least 1 Dose of Teriparatide|28-Day Teriparatide Treatment Period||29||
48452129|NCT01430104|101443575|FG000|COMPLETED|28-Day Teriparatide Treatment Period||28||
48452130|NCT01430104|101443575|FG000|NOT COMPLETED|28-Day Teriparatide Treatment Period||1||
48452131|NCT01990898|101443576|FG000|STARTED|Overall Study||26||
48452132|NCT01990898|101443576|FG000|3 Months|Overall Study||22||
48452133|NCT01990898|101443576|FG000|COMPLETED|Overall Study||22||
48772289|NCT02284243|102232705|FG001|COMPLETED|Overall Study||81||
48772290|NCT02284243|102232704|FG000|NOT COMPLETED|Overall Study||4||
48772291|NCT02284243|102232705|FG001|NOT COMPLETED|Overall Study||3||
48772292|NCT04543279|102232706|FG000|STARTED|Overall Study||3||
48772293|NCT04543279|102232707|FG001|STARTED|Overall Study||0||
48772294|NCT04543279|102232706|FG000|COMPLETED|Overall Study||0||
48452134|NCT01990898|101443576|FG000|NOT COMPLETED|Overall Study||4||
48452135|NCT02762877|101443577|FG000|STARTED|Overall Study||121||
48452136|NCT02762877|101443578|FG001|STARTED|Overall Study||19||
48452137|NCT02762877|101443577|FG000|COMPLETED|Overall Study||121||
48452138|NCT02762877|101443578|FG001|COMPLETED|Overall Study||19||
48452139|NCT02762877|101443577|FG000|NOT COMPLETED|Overall Study||0||
48452140|NCT02762877|101443578|FG001|NOT COMPLETED|Overall Study||0||
48452141|NCT02755545|101443579|FG000|STARTED|Overall Study||62||
48452142|NCT02755545|101443580|FG001|STARTED|Overall Study||65||
48452143|NCT02755545|101443579|FG000|COMPLETED|Overall Study||43||
48452144|NCT02755545|101443580|FG001|COMPLETED|Overall Study||44||
48452145|NCT02755545|101443579|FG000|NOT COMPLETED|Overall Study||19||
48452146|NCT02755545|101443580|FG001|NOT COMPLETED|Overall Study||21||
48452147|NCT01289431|101443581|FG000|STARTED|Overall Study||34||
48452148|NCT01289431|101443582|FG001|STARTED|Overall Study||34||
48452149|NCT01289431|101443583|FG002|STARTED|Overall Study||34||
48452150|NCT01289431|101443584|FG003|STARTED|Overall Study||33||
48452151|NCT01289431|101443585|FG004|STARTED|Overall Study||34||
48452152|NCT01289431|101443586|FG005|STARTED|Overall Study||33||
48452153|NCT01289431|101443587|FG006|STARTED|Overall Study||34||
48452154|NCT01289431|101443581|FG000|COMPLETED|Overall Study||29||
48452155|NCT01289431|101443582|FG001|COMPLETED|Overall Study||32||
48452156|NCT01289431|101443583|FG002|COMPLETED|Overall Study||30||
48452157|NCT01289431|101443584|FG003|COMPLETED|Overall Study||28||
48452158|NCT01289431|101443585|FG004|COMPLETED|Overall Study||32||
48452159|NCT01289431|101443586|FG005|COMPLETED|Overall Study||31||
48452160|NCT01289431|101443587|FG006|COMPLETED|Overall Study||33||
48452161|NCT01289431|101443581|FG000|NOT COMPLETED|Overall Study||5||
48452162|NCT01289431|101443582|FG001|NOT COMPLETED|Overall Study||2||
48452163|NCT01289431|101443583|FG002|NOT COMPLETED|Overall Study||4||
48452164|NCT01289431|101443584|FG003|NOT COMPLETED|Overall Study||5||
48772295|NCT04543279|102232707|FG001|COMPLETED|Overall Study||0||
48772296|NCT04543279|102232706|FG000|NOT COMPLETED|Overall Study||3||
48772297|NCT04543279|102232707|FG001|NOT COMPLETED|Overall Study||0||
48772298|NCT01265537|102232708|FG000|STARTED|Overall Study||15||
48772299|NCT01265537|102232709|FG001|STARTED|Overall Study||15||
48189187|NCT02368886|100786170|FG000|STARTED|Overall Study||29||
48189188|NCT02368886|100786171|FG001|STARTED|Overall Study||27||
48189189|NCT02368886|100786172|FG002|STARTED|Overall Study||34||
48189190|NCT02368886|100786173|FG003|STARTED|Overall Study||33||
48452165|NCT01289431|101443585|FG004|NOT COMPLETED|Overall Study||2||
48452166|NCT01289431|101443586|FG005|NOT COMPLETED|Overall Study||2||
48452167|NCT01289431|101443587|FG006|NOT COMPLETED|Overall Study||1||
48452168|NCT02444182|101443588|FG000|STARTED|Overall Study||54||
48772300|NCT01265537|102232708|FG000|COMPLETED|Overall Study||13||
48452169|NCT02444182|101443589|FG001|STARTED|Overall Study||54||
48772301|NCT01265537|102232709|FG001|COMPLETED|Overall Study||13||
48189191|NCT02368886|100786170|FG000|COMPLETED|Overall Study||28||
48189192|NCT02368886|100786171|FG001|COMPLETED|Overall Study||26||
48189193|NCT02368886|100786172|FG002|COMPLETED|Overall Study||33||
48661362|NCT01892189|101956880|FG005|NOT COMPLETED|First Intervention Period (1 Day)||0||
48661363|NCT01892189|101956881|FG006|NOT COMPLETED|First Intervention Period (1 Day)||0||
48661364|NCT01892189|101956882|FG007|NOT COMPLETED|First Intervention Period (1 Day)||0||
48661365|NCT01892189|101956883|FG008|NOT COMPLETED|First Intervention Period (1 Day)||0||
48661366|NCT01892189|101956875|FG000|STARTED|Washout Period 1 (7 Days)||3||
48661367|NCT01892189|101956876|FG001|STARTED|Washout Period 1 (7 Days)||3||
48661368|NCT01892189|101956877|FG002|STARTED|Washout Period 1 (7 Days)||3||
48661369|NCT01892189|101956878|FG003|STARTED|Washout Period 1 (7 Days)||3||
48661370|NCT01892189|101956879|FG004|STARTED|Washout Period 1 (7 Days)||3||
48661371|NCT01892189|101956880|FG005|STARTED|Washout Period 1 (7 Days)||3||
48661372|NCT01892189|101956881|FG006|STARTED|Washout Period 1 (7 Days)||3||
48661373|NCT01892189|101956882|FG007|STARTED|Washout Period 1 (7 Days)||3||
48661374|NCT01892189|101956883|FG008|STARTED|Washout Period 1 (7 Days)||3||
48661375|NCT01892189|101956875|FG000|COMPLETED|Washout Period 1 (7 Days)||3||
48661376|NCT01892189|101956876|FG001|COMPLETED|Washout Period 1 (7 Days)||3||
48661377|NCT01892189|101956877|FG002|COMPLETED|Washout Period 1 (7 Days)||1||
48661378|NCT01892189|101956878|FG003|COMPLETED|Washout Period 1 (7 Days)||2||
48661379|NCT01892189|101956879|FG004|COMPLETED|Washout Period 1 (7 Days)||3||
48661380|NCT01892189|101956880|FG005|COMPLETED|Washout Period 1 (7 Days)||2||
48661381|NCT01892189|101956881|FG006|COMPLETED|Washout Period 1 (7 Days)||2||
48661382|NCT01892189|101956882|FG007|COMPLETED|Washout Period 1 (7 Days)||3||
48661383|NCT01892189|101956883|FG008|COMPLETED|Washout Period 1 (7 Days)||1||
48661384|NCT01892189|101956875|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48661385|NCT01892189|101956876|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48661386|NCT01892189|101956877|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||2||
48661387|NCT01892189|101956878|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1||
48661388|NCT01892189|101956879|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48661389|NCT01892189|101956880|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||1||
48661390|NCT01892189|101956881|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||1||
48661391|NCT01892189|101956882|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48661392|NCT01892189|101956883|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||2||
48661393|NCT01892189|101956875|FG000|STARTED|Second Intervention Period (1 Day)||3||
48661394|NCT01892189|101956876|FG001|STARTED|Second Intervention Period (1 Day)||3||
48661395|NCT01892189|101956877|FG002|STARTED|Second Intervention Period (1 Day)||1||
48661396|NCT01892189|101956878|FG003|STARTED|Second Intervention Period (1 Day)||2||
48661397|NCT01892189|101956879|FG004|STARTED|Second Intervention Period (1 Day)||3||
48661398|NCT01892189|101956880|FG005|STARTED|Second Intervention Period (1 Day)||2||
48772302|NCT01265537|102232708|FG000|NOT COMPLETED|Overall Study||2||
48661399|NCT01892189|101956881|FG006|STARTED|Second Intervention Period (1 Day)||2||
48661400|NCT01892189|101956882|FG007|STARTED|Second Intervention Period (1 Day)||3||
48661401|NCT01892189|101956883|FG008|STARTED|Second Intervention Period (1 Day)||1||
48661402|NCT01892189|101956875|FG000|COMPLETED|Second Intervention Period (1 Day)||3||
48661403|NCT01892189|101956876|FG001|COMPLETED|Second Intervention Period (1 Day)||3||
48661404|NCT01892189|101956877|FG002|COMPLETED|Second Intervention Period (1 Day)||1||
48661405|NCT01892189|101956878|FG003|COMPLETED|Second Intervention Period (1 Day)||2||
48661406|NCT01892189|101956879|FG004|COMPLETED|Second Intervention Period (1 Day)||3||
48661407|NCT01892189|101956880|FG005|COMPLETED|Second Intervention Period (1 Day)||2||
48661408|NCT01892189|101956881|FG006|COMPLETED|Second Intervention Period (1 Day)||2||
48661409|NCT01892189|101956882|FG007|COMPLETED|Second Intervention Period (1 Day)||3||
48661410|NCT01892189|101956883|FG008|COMPLETED|Second Intervention Period (1 Day)||1||
48661411|NCT01892189|101956875|FG000|NOT COMPLETED|Second Intervention Period (1 Day)||0||
48661412|NCT01892189|101956876|FG001|NOT COMPLETED|Second Intervention Period (1 Day)||0||
48661413|NCT01892189|101956877|FG002|NOT COMPLETED|Second Intervention Period (1 Day)||0||
48661414|NCT01892189|101956878|FG003|NOT COMPLETED|Second Intervention Period (1 Day)||0||
48661415|NCT01892189|101956879|FG004|NOT COMPLETED|Second Intervention Period (1 Day)||0||
48661416|NCT01892189|101956880|FG005|NOT COMPLETED|Second Intervention Period (1 Day)||0||
48661417|NCT01892189|101956881|FG006|NOT COMPLETED|Second Intervention Period (1 Day)||0||
48661418|NCT01892189|101956882|FG007|NOT COMPLETED|Second Intervention Period (1 Day)||0||
48661419|NCT01892189|101956883|FG008|NOT COMPLETED|Second Intervention Period (1 Day)||0||
48661420|NCT01892189|101956875|FG000|STARTED|Washout Period 2 (7 Days)||3||
48661421|NCT01892189|101956876|FG001|STARTED|Washout Period 2 (7 Days)||3||
48661422|NCT01892189|101956877|FG002|STARTED|Washout Period 2 (7 Days)||1||
48661423|NCT01892189|101956878|FG003|STARTED|Washout Period 2 (7 Days)||2||
48661424|NCT01892189|101956879|FG004|STARTED|Washout Period 2 (7 Days)||3||
48661425|NCT01892189|101956880|FG005|STARTED|Washout Period 2 (7 Days)||2||
48661426|NCT01892189|101956881|FG006|STARTED|Washout Period 2 (7 Days)||2||
48661427|NCT01892189|101956882|FG007|STARTED|Washout Period 2 (7 Days)||3||
48661428|NCT01892189|101956883|FG008|STARTED|Washout Period 2 (7 Days)||1||
48661429|NCT01892189|101956875|FG000|COMPLETED|Washout Period 2 (7 Days)||3||
48661430|NCT01892189|101956876|FG001|COMPLETED|Washout Period 2 (7 Days)||3||
48661431|NCT01892189|101956877|FG002|COMPLETED|Washout Period 2 (7 Days)||1||
48661432|NCT01892189|101956878|FG003|COMPLETED|Washout Period 2 (7 Days)||2||
48661433|NCT01892189|101956879|FG004|COMPLETED|Washout Period 2 (7 Days)||3||
48661434|NCT01892189|101956880|FG005|COMPLETED|Washout Period 2 (7 Days)||2||
48661435|NCT01892189|101956881|FG006|COMPLETED|Washout Period 2 (7 Days)||2||
48661436|NCT01892189|101956882|FG007|COMPLETED|Washout Period 2 (7 Days)||3||
48661437|NCT01892189|101956883|FG008|COMPLETED|Washout Period 2 (7 Days)||1||
48661438|NCT01892189|101956875|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48661439|NCT01892189|101956876|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48661440|NCT01892189|101956877|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48661441|NCT01892189|101956878|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48661442|NCT01892189|101956879|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48772303|NCT01265537|102232709|FG001|NOT COMPLETED|Overall Study||2||
48772304|NCT01526733|102232710|FG000|STARTED|Phase 1||12||
48189194|NCT02368886|100786173|FG003|COMPLETED|Overall Study||29||
48189195|NCT02368886|100786170|FG000|NOT COMPLETED|Overall Study||1||
48369440|NCT02234583|101232772|FG000|COMPLETED|Overall Study||434||
48369441|NCT02234583|101232773|FG001|COMPLETED|Overall Study||685||
48369442|NCT02234583|101232772|FG000|NOT COMPLETED|Overall Study||413||
48369443|NCT02234583|101232773|FG001|NOT COMPLETED|Overall Study||556||
48369444|NCT00705224|101232774|FG000|STARTED|Overall Study||250||
48369445|NCT00705224|101232774|FG000|COMPLETED|Overall Study||239||
48369446|NCT00705224|101232774|FG000|NOT COMPLETED|Overall Study||11||
48369447|NCT02817555|101232775|FG000|STARTED|Overall Study||24||
48369448|NCT02817555|101232776|FG001|STARTED|Overall Study||26||
48452170|NCT02444182|101443588|FG000|COMPLETED|Overall Study||52||
48452171|NCT02444182|101443589|FG001|COMPLETED|Overall Study||49||
48452172|NCT02444182|101443588|FG000|NOT COMPLETED|Overall Study||2||
48452173|NCT02444182|101443589|FG001|NOT COMPLETED|Overall Study||5||
48452174|NCT02282111|101443590|FG000|STARTED|Overall Study||26||
48452175|NCT02282111|101443591|FG001|STARTED|Overall Study||30||
48452176|NCT02282111|101443590|FG000|COMPLETED|Overall Study||19||
48452177|NCT02282111|101443591|FG001|COMPLETED|Overall Study||22||
48452178|NCT02282111|101443590|FG000|NOT COMPLETED|Overall Study||7||
48452179|NCT02282111|101443591|FG001|NOT COMPLETED|Overall Study||8||
48452180|NCT02372682|101443592|FG000|STARTED|Overall Study||78||
48452181|NCT02372682|101443593|FG001|STARTED|Overall Study||93||
48452182|NCT02372682|101443592|FG000|COMPLETED|Overall Study||70||
48452183|NCT02372682|101443593|FG001|COMPLETED|Overall Study||79||
48452184|NCT02372682|101443592|FG000|NOT COMPLETED|Overall Study||8||
48452185|NCT02372682|101443593|FG001|NOT COMPLETED|Overall Study||14||
48452186|NCT03836729|101443594|FG000|STARTED|Treatment Period 1 (Up to Day 14)||16||
48452187|NCT03836729|101443594|FG000|COMPLETED|Treatment Period 1 (Up to Day 14)||16||
48452188|NCT03836729|101443594|FG000|NOT COMPLETED|Treatment Period 1 (Up to Day 14)||0||
48452189|NCT03836729|101443594|FG000|STARTED|Treatment Period 2 (Up to Day 7)||16||
48452190|NCT03836729|101443594|FG000|COMPLETED|Treatment Period 2 (Up to Day 7)||15||
48452191|NCT03836729|101443594|FG000|NOT COMPLETED|Treatment Period 2 (Up to Day 7)||1||
48452192|NCT02209454|101443595|FG000|STARTED|First Period||13||
48452193|NCT02209454|101443596|FG001|STARTED|First Period||13||
48452194|NCT02209454|101443595|FG000|COMPLETED|First Period||13||
48452195|NCT02209454|101443596|FG001|COMPLETED|First Period||13||
48452196|NCT02209454|101443595|FG000|NOT COMPLETED|First Period||0||
48452197|NCT02209454|101443596|FG001|NOT COMPLETED|First Period||0||
48452198|NCT02209454|101443595|FG000|STARTED|Washout Period a Minimum of a 7 Day||13||
48661443|NCT01892189|101956880|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48661444|NCT01892189|101956881|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48661445|NCT01892189|101956882|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48661446|NCT01892189|101956883|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48661447|NCT01892189|101956875|FG000|STARTED|Third Intervention Period (1 Day)||3||
48661448|NCT01892189|101956876|FG001|STARTED|Third Intervention Period (1 Day)||3||
48661449|NCT01892189|101956877|FG002|STARTED|Third Intervention Period (1 Day)||1||
48661450|NCT01892189|101956878|FG003|STARTED|Third Intervention Period (1 Day)||2||
48661451|NCT01892189|101956879|FG004|STARTED|Third Intervention Period (1 Day)||3||
48661452|NCT01892189|101956880|FG005|STARTED|Third Intervention Period (1 Day)||2||
48661453|NCT01892189|101956881|FG006|STARTED|Third Intervention Period (1 Day)||2||
48661454|NCT01892189|101956882|FG007|STARTED|Third Intervention Period (1 Day)||3||
48661455|NCT01892189|101956883|FG008|STARTED|Third Intervention Period (1 Day)||1||
48661456|NCT01892189|101956875|FG000|COMPLETED|Third Intervention Period (1 Day)||3||
48661457|NCT01892189|101956876|FG001|COMPLETED|Third Intervention Period (1 Day)||3||
48661458|NCT01892189|101956877|FG002|COMPLETED|Third Intervention Period (1 Day)||1||
48661459|NCT01892189|101956878|FG003|COMPLETED|Third Intervention Period (1 Day)||2||
48661460|NCT01892189|101956879|FG004|COMPLETED|Third Intervention Period (1 Day)||3||
48661461|NCT01892189|101956880|FG005|COMPLETED|Third Intervention Period (1 Day)||2||
48661462|NCT01892189|101956881|FG006|COMPLETED|Third Intervention Period (1 Day)||2||
48661463|NCT01892189|101956882|FG007|COMPLETED|Third Intervention Period (1 Day)||3||
48661464|NCT01892189|101956883|FG008|COMPLETED|Third Intervention Period (1 Day)||1||
48661465|NCT01892189|101956875|FG000|NOT COMPLETED|Third Intervention Period (1 Day)||0||
48661466|NCT01892189|101956876|FG001|NOT COMPLETED|Third Intervention Period (1 Day)||0||
48661467|NCT01892189|101956877|FG002|NOT COMPLETED|Third Intervention Period (1 Day)||0||
48661468|NCT01892189|101956878|FG003|NOT COMPLETED|Third Intervention Period (1 Day)||0||
48661469|NCT01892189|101956879|FG004|NOT COMPLETED|Third Intervention Period (1 Day)||0||
48661470|NCT01892189|101956880|FG005|NOT COMPLETED|Third Intervention Period (1 Day)||0||
48452199|NCT02209454|101443596|FG001|STARTED|Washout Period a Minimum of a 7 Day||13||
48452200|NCT02209454|101443595|FG000|COMPLETED|Washout Period a Minimum of a 7 Day||13||
48452201|NCT02209454|101443596|FG001|COMPLETED|Washout Period a Minimum of a 7 Day||13||
48452202|NCT02209454|101443595|FG000|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0||
48452203|NCT02209454|101443596|FG001|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0||
48452204|NCT02209454|101443595|FG000|STARTED|Second Period||13||
48452205|NCT02209454|101443596|FG001|STARTED|Second Period||13||
48452206|NCT02209454|101443595|FG000|COMPLETED|Second Period||12||
48452207|NCT02209454|101443596|FG001|COMPLETED|Second Period||13||
48452208|NCT02209454|101443595|FG000|NOT COMPLETED|Second Period||1||
48452209|NCT02209454|101443596|FG001|NOT COMPLETED|Second Period||0||
48452210|NCT01271933|101443597|FG000|STARTED|Single-Blind Phase||441||
48452211|NCT01271933|101443598|FG001|STARTED|Single-Blind Phase||0||
48452212|NCT01271933|101443599|FG002|STARTED|Single-Blind Phase||0||
48452213|NCT01271933|101443597|FG000|COMPLETED|Single-Blind Phase||320||
48452214|NCT01271933|101443598|FG001|COMPLETED|Single-Blind Phase||0||
48452215|NCT01271933|101443599|FG002|COMPLETED|Single-Blind Phase||0||
48452216|NCT01271933|101443597|FG000|NOT COMPLETED|Single-Blind Phase||121||
48452217|NCT01271933|101443598|FG001|NOT COMPLETED|Single-Blind Phase||0||
48452218|NCT01271933|101443599|FG002|NOT COMPLETED|Single-Blind Phase||0||
48452219|NCT01271933|101443597|FG000|STARTED|Double-Blind Phase||0|198 participants completed SB phase but not randomized in DB phase|
48452220|NCT01271933|101443598|FG001|STARTED|Double-Blind Phase||63|198 participants completed SB phase but not randomized in DB phase|
48452221|NCT01271933|101443599|FG002|STARTED|Double-Blind Phase||59|198 participants completed SB phase but not randomized in DB phase|
48452222|NCT01271933|101443597|FG000|Treated|Double-Blind Phase||0||
48452223|NCT01271933|101443598|FG001|Treated|Double-Blind Phase||63||
48452224|NCT01271933|101443599|FG002|Treated|Double-Blind Phase||58||
48452225|NCT01271933|101443597|FG000|COMPLETED|Double-Blind Phase||0||
48452226|NCT01271933|101443598|FG001|COMPLETED|Double-Blind Phase||46||
48452227|NCT01271933|101443599|FG002|COMPLETED|Double-Blind Phase||47||
48452228|NCT01271933|101443597|FG000|NOT COMPLETED|Double-Blind Phase||0||
48452229|NCT01271933|101443598|FG001|NOT COMPLETED|Double-Blind Phase||17||
48452230|NCT01271933|101443599|FG002|NOT COMPLETED|Double-Blind Phase||12||
48661471|NCT01892189|101956881|FG006|NOT COMPLETED|Third Intervention Period (1 Day)||0||
48452231|NCT03255031|101443600|FG000|STARTED|Overall Study||33||
48189196|NCT02368886|100786171|FG001|NOT COMPLETED|Overall Study||1||
48189197|NCT02368886|100786172|FG002|NOT COMPLETED|Overall Study||1||
48189198|NCT02368886|100786173|FG003|NOT COMPLETED|Overall Study||4||
48452232|NCT03255031|101443601|FG001|STARTED|Overall Study||20||
48452233|NCT03255031|101443600|FG000|COMPLETED|Overall Study||17||
48452234|NCT03255031|101443601|FG001|COMPLETED|Overall Study||13||
48452235|NCT03255031|101443600|FG000|NOT COMPLETED|Overall Study||16||
48452236|NCT03255031|101443601|FG001|NOT COMPLETED|Overall Study||7||
48452237|NCT01309828|101443602|FG000|STARTED|Overall Study||77||
48452238|NCT01309828|101443603|FG001|STARTED|Overall Study||76||
48452239|NCT01309828|101443602|FG000|COMPLETED|Overall Study||61||
48452240|NCT01309828|101443603|FG001|COMPLETED|Overall Study||60||
48452241|NCT01309828|101443602|FG000|NOT COMPLETED|Overall Study||16||
48452242|NCT01309828|101443603|FG001|NOT COMPLETED|Overall Study||16||
48452243|NCT00304954|101443604|FG000|STARTED|Overall Study||4||
48452244|NCT00304954|101443605|FG001|STARTED|Overall Study||3||
48452245|NCT00304954|101443606|FG002|STARTED|Overall Study||3||
48452246|NCT00304954|101443607|FG003|STARTED|Overall Study||3||
48452247|NCT00304954|101443604|FG000|COMPLETED|Overall Study||3||
48452248|NCT00304954|101443605|FG001|COMPLETED|Overall Study||3||
48452249|NCT00304954|101443606|FG002|COMPLETED|Overall Study||2||
48452250|NCT00304954|101443607|FG003|COMPLETED|Overall Study||3||
48452251|NCT00304954|101443604|FG000|NOT COMPLETED|Overall Study||1||
48452252|NCT00304954|101443605|FG001|NOT COMPLETED|Overall Study||0||
48452253|NCT00304954|101443606|FG002|NOT COMPLETED|Overall Study||1||
48452254|NCT00304954|101443607|FG003|NOT COMPLETED|Overall Study||0||
48452255|NCT03724916|101443608|FG000|STARTED|Overall Study||6||
48452256|NCT03724916|101443609|FG001|STARTED|Overall Study||6||
48452257|NCT03724916|101443610|FG002|STARTED|Overall Study||6||
48452258|NCT03724916|101443611|FG003|STARTED|Overall Study||5||
48452259|NCT03724916|101443608|FG000|Safety Analysis Set|Overall Study||5|Safety analysis set included all participants who were enrolled and received at least 1 dose of study drug.|
48452260|NCT03724916|101443609|FG001|Safety Analysis Set|Overall Study||6|Safety analysis set included all participants who were enrolled and received at least 1 dose of study drug.|
48452261|NCT03724916|101443610|FG002|Safety Analysis Set|Overall Study||6|Safety analysis set included all participants who were enrolled and received at least 1 dose of study drug.|
48661472|NCT01892189|101956882|FG007|NOT COMPLETED|Third Intervention Period (1 Day)||0||
48661473|NCT01892189|101956883|FG008|NOT COMPLETED|Third Intervention Period (1 Day)||0||
48661474|NCT02592655|101956884|FG000|STARTED|First Tourniquet, Left Thigh.||19||
48661475|NCT02592655|101956884|FG000|ATS (Pneumatic)|First Tourniquet, Left Thigh.||5||
48452262|NCT03724916|101443611|FG003|Safety Analysis Set|Overall Study||5|Safety analysis set included all participants who were enrolled and received at least 1 dose of study drug.|
48452263|NCT03724916|101443608|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||0|PK analysis set included all participants who received study drug and had at least 1 measurable serum concentration.|
48452264|NCT03724916|101443609|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||6|PK analysis set included all participants who received study drug and had at least 1 measurable serum concentration.|
48452265|NCT03724916|101443610|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||6|PK analysis set included all participants who received study drug and had at least 1 measurable serum concentration.|
48452266|NCT03724916|101443611|FG003|Pharmacokinetic (PK) Analysis Set|Overall Study||5|PK analysis set included all participants who received study drug and had at least 1 measurable serum concentration.|
48452267|NCT03724916|101443608|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||5|PD analysis set included all participants who received study drug and had at least 1 postdose PD measurement.|
48452268|NCT03724916|101443609|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||6|PD analysis set included all participants who received study drug and had at least 1 postdose PD measurement.|
48452269|NCT03724916|101443610|FG002|Pharmacodynamic (PD) Analysis Set|Overall Study||6|PD analysis set included all participants who received study drug and had at least 1 postdose PD measurement.|
48452270|NCT03724916|101443611|FG003|Pharmacodynamic (PD) Analysis Set|Overall Study||5|PD analysis set included all participants who received study drug and had at least 1 postdose PD measurement.|
48452271|NCT03724916|101443608|FG000|Immunogenicity Analysis Set|Overall Study||5|Immunogenicity analysis set consisted of all participants who received study drug and had a baseline and at least 1 postbaseline immunogenicity sample assessment.|
48452272|NCT03724916|101443609|FG001|Immunogenicity Analysis Set|Overall Study||6|Immunogenicity analysis set consisted of all participants who received study drug and had a baseline and at least 1 postbaseline immunogenicity sample assessment.|
48452273|NCT03724916|101443610|FG002|Immunogenicity Analysis Set|Overall Study||5|Immunogenicity analysis set consisted of all participants who received study drug and had a baseline and at least 1 postbaseline immunogenicity sample assessment.|
48452274|NCT03724916|101443611|FG003|Immunogenicity Analysis Set|Overall Study||5|Immunogenicity analysis set consisted of all participants who received study drug and had a baseline and at least 1 postbaseline immunogenicity sample assessment.|
48452275|NCT03724916|101443608|FG000|COMPLETED|Overall Study||5||
48452276|NCT03724916|101443609|FG001|COMPLETED|Overall Study||5||
48452277|NCT03724916|101443610|FG002|COMPLETED|Overall Study||5||
48661476|NCT02592655|101956884|FG000|Windlass Tourniquet|First Tourniquet, Left Thigh.||7||
48661477|NCT02592655|101956884|FG000|Tourniquet Tape 10 cm Width|First Tourniquet, Left Thigh.||5||
48661478|NCT02592655|101956884|FG000|Tourniquet Tape 5 cm Width|First Tourniquet, Left Thigh.||2||
48661479|NCT02592655|101956884|FG000|COMPLETED|First Tourniquet, Left Thigh.||19||
48661480|NCT02592655|101956884|FG000|NOT COMPLETED|First Tourniquet, Left Thigh.||0||
48661481|NCT02592655|101956884|FG000|STARTED|Second Tourniquet Right Thigh.||19|Participants switch to different interventions each period.|
48661482|NCT02592655|101956884|FG000|ATS (Pneumatic)|Second Tourniquet Right Thigh.||5||
48661483|NCT02592655|101956884|FG000|Windlass Tourniquet|Second Tourniquet Right Thigh.||8||
48772305|NCT01526733|102232711|FG001|STARTED|Phase 1||13||
48772306|NCT01526733|102232710|FG000|Received at Least 1 Dose of Study Drug|Phase 1||12||
48452278|NCT03724916|101443611|FG003|COMPLETED|Overall Study||3||
48452279|NCT03724916|101443608|FG000|NOT COMPLETED|Overall Study||1||
48452280|NCT03724916|101443609|FG001|NOT COMPLETED|Overall Study||1||
48452281|NCT03724916|101443610|FG002|NOT COMPLETED|Overall Study||1||
48661484|NCT02592655|101956884|FG000|Tourniquet Tape 10 cm Width|Second Tourniquet Right Thigh.||5||
48661485|NCT02592655|101956884|FG000|Tourniquet Tape 5 cm Width|Second Tourniquet Right Thigh.||1||
48661486|NCT02592655|101956884|FG000|COMPLETED|Second Tourniquet Right Thigh.||19||
48661487|NCT02592655|101956884|FG000|NOT COMPLETED|Second Tourniquet Right Thigh.||0||
48661488|NCT02592655|101956884|FG000|STARTED|Third Tourniquet, Left Thigh.||19|Participants switch to different interventions each period.|
48661489|NCT02592655|101956884|FG000|ATS (Pneumatic)|Third Tourniquet, Left Thigh.||8||
48661490|NCT02592655|101956884|FG000|Windlass Tourniquet|Third Tourniquet, Left Thigh.||4||
48661491|NCT02592655|101956884|FG000|Tourniquet Tape 10 cm Width|Third Tourniquet, Left Thigh.||6||
48661492|NCT02592655|101956884|FG000|Tourniquet Tape 5 cm Width|Third Tourniquet, Left Thigh.||1||
48661493|NCT02592655|101956884|FG000|COMPLETED|Third Tourniquet, Left Thigh.||19||
48661494|NCT02592655|101956884|FG000|NOT COMPLETED|Third Tourniquet, Left Thigh.||0||
48661495|NCT02592655|101956884|FG000|STARTED|Fourth Tourniquet Right Thigh.||4|Investigator decided to discontinue the 5 cm Tourniquet Tape after the 4th participant.|
48661496|NCT02592655|101956884|FG000|ATS (Pneumatic)|Fourth Tourniquet Right Thigh.||1||
48661497|NCT02592655|101956884|FG000|Windlass Tourniquet|Fourth Tourniquet Right Thigh.||0||
48661498|NCT02592655|101956884|FG000|Tourniquet Tape 10 cm Width|Fourth Tourniquet Right Thigh.||3||
48661499|NCT02592655|101956884|FG000|Tourniquet Tape 5 cm Width|Fourth Tourniquet Right Thigh.||0||
48661500|NCT02592655|101956884|FG000|COMPLETED|Fourth Tourniquet Right Thigh.||4||
48661501|NCT02592655|101956884|FG000|NOT COMPLETED|Fourth Tourniquet Right Thigh.||0||
48661502|NCT04193176|101956885|FG000|STARTED|Overall Study||190||
48661503|NCT04193176|101956886|FG001|STARTED|Overall Study||186||
48661504|NCT04193176|101956885|FG000|Treated|Overall Study||190||
48661505|NCT04193176|101956886|FG001|Treated|Overall Study||185||
48661506|NCT04193176|101956885|FG000|COMPLETED|Overall Study||184||
48661507|NCT04193176|101956886|FG001|COMPLETED|Overall Study||176||
48661508|NCT04193176|101956885|FG000|NOT COMPLETED|Overall Study||6||
48661509|NCT04193176|101956886|FG001|NOT COMPLETED|Overall Study||10||
48452282|NCT03724916|101443611|FG003|NOT COMPLETED|Overall Study||2||
48452283|NCT02492295|101443612|FG000|STARTED|Overall Study||0||
48661510|NCT01838226|101956887|FG000|STARTED|Overall Study||202||
48661511|NCT01838226|101956888|FG001|STARTED|Overall Study||199||
48661512|NCT01838226|101956887|FG000|COMPLETED|Overall Study||126||
48661513|NCT01838226|101956888|FG001|COMPLETED|Overall Study||128||
48661514|NCT01838226|101956887|FG000|NOT COMPLETED|Overall Study||76||
48772307|NCT01526733|102232711|FG001|Received at Least 1 Dose of Study Drug|Phase 1||13||
48772308|NCT01526733|102232710|FG000|COMPLETED|Phase 1||10||
48452284|NCT02492295|101443612|FG000|COMPLETED|Overall Study||0||
48452285|NCT02492295|101443612|FG000|NOT COMPLETED|Overall Study||0||
48452286|NCT01491490|101443613|FG000|STARTED|Overall Study||1||
48452287|NCT01491490|101443614|FG001|STARTED|Overall Study||1||
48452288|NCT01491490|101443613|FG000|COMPLETED|Overall Study||1||
48452289|NCT01491490|101443614|FG001|COMPLETED|Overall Study||1||
48452290|NCT01491490|101443613|FG000|NOT COMPLETED|Overall Study||0||
48452291|NCT01491490|101443614|FG001|NOT COMPLETED|Overall Study||0||
48452292|NCT00736333|101443615|FG000|STARTED|Overall Study||167||
48452293|NCT00736333|101443615|FG000|COMPLETED|Overall Study||56||
48452294|NCT00736333|101443615|FG000|NOT COMPLETED|Overall Study||111||
48452295|NCT01986790|101443616|FG000|STARTED|Overall Study||91||
48452296|NCT01986790|101443617|FG001|STARTED|Overall Study||154||
48452297|NCT01986790|101443618|FG002|STARTED|Overall Study||98||
48452298|NCT01986790|101443616|FG000|COMPLETED|Overall Study||91||
48452299|NCT01986790|101443617|FG001|COMPLETED|Overall Study||154||
48452300|NCT01986790|101443618|FG002|COMPLETED|Overall Study||98||
48452301|NCT01986790|101443616|FG000|NOT COMPLETED|Overall Study||0||
48452302|NCT01986790|101443617|FG001|NOT COMPLETED|Overall Study||0||
48452303|NCT01986790|101443618|FG002|NOT COMPLETED|Overall Study||0||
48452304|NCT01783730|101443619|FG000|STARTED|Overall Study||163||
48452305|NCT01783730|101443619|FG000|COMPLETED|Overall Study||157||
48452306|NCT01783730|101443619|FG000|NOT COMPLETED|Overall Study||6||
48452307|NCT00305110|101443620|FG000|STARTED|Overall Study||298||
48452308|NCT00305110|101443620|FG000|All Necessary Data Collected|Overall Study||269||
48452309|NCT00305110|101443620|FG000|COMPLETED|Overall Study||269||
48452310|NCT00305110|101443620|FG000|NOT COMPLETED|Overall Study||29||
48452311|NCT01236053|101443621|FG000|STARTED|Overall Study||179138||
48452312|NCT01236053|101443622|FG001|STARTED|Overall Study||1710950||
48452313|NCT01236053|101443623|FG002|STARTED|Overall Study||1877||
48452314|NCT01236053|101443624|FG003|STARTED|Overall Study||17853||
48452315|NCT01236053|101443625|FG004|STARTED|Overall Study||212||
48452316|NCT01236053|101443626|FG005|STARTED|Overall Study||2067||
48452317|NCT01236053|101443627|FG006|STARTED|Overall Study||10855||
48452318|NCT01236053|101443628|FG007|STARTED|Overall Study||102836||
48452319|NCT01236053|101443629|FG008|STARTED|Overall Study||300||
48452320|NCT01236053|101443630|FG009|STARTED|Overall Study||2935||
48452321|NCT01236053|101443631|FG010|STARTED|Overall Study||19564||
48452322|NCT01236053|101443632|FG011|STARTED|Overall Study||188924||
48452323|NCT01236053|101443633|FG012|STARTED|Overall Study||148||
48452324|NCT01236053|101443634|FG013|STARTED|Overall Study||1396||
48452325|NCT01236053|101443635|FG014|STARTED|Overall Study||4600||
48452326|NCT01236053|101443636|FG015|STARTED|Overall Study||43559||
48452327|NCT01236053|101443637|FG016|STARTED|Overall Study||38||
48452328|NCT01236053|101443638|FG017|STARTED|Overall Study||380||
48452329|NCT01236053|101443639|FG018|STARTED|Overall Study||2155||
48452330|NCT01236053|101443640|FG019|STARTED|Overall Study||20382||
48452331|NCT01236053|101443641|FG020|STARTED|Overall Study||1272||
48452332|NCT01236053|101443642|FG021|STARTED|Overall Study||12167||
48452333|NCT01236053|101443621|FG000|COMPLETED|Overall Study||179138||
48452334|NCT01236053|101443622|FG001|COMPLETED|Overall Study||1710950||
48452335|NCT01236053|101443623|FG002|COMPLETED|Overall Study||1877||
48452336|NCT01236053|101443624|FG003|COMPLETED|Overall Study||17853||
48452337|NCT01236053|101443625|FG004|COMPLETED|Overall Study||212||
48452338|NCT01236053|101443626|FG005|COMPLETED|Overall Study||2067||
48452339|NCT01236053|101443627|FG006|COMPLETED|Overall Study||10855||
48452340|NCT01236053|101443628|FG007|COMPLETED|Overall Study||102836||
48452341|NCT01236053|101443629|FG008|COMPLETED|Overall Study||300||
48452342|NCT01236053|101443630|FG009|COMPLETED|Overall Study||2935||
48452343|NCT01236053|101443631|FG010|COMPLETED|Overall Study||19564||
48661515|NCT01838226|101956888|FG001|NOT COMPLETED|Overall Study||71||
48661516|NCT03984188|101956889|FG000|STARTED|Overall Study||50||
48661517|NCT03984188|101956890|FG001|STARTED|Overall Study||49||
48661518|NCT03984188|101956889|FG000|6 Months|Overall Study||42||
48661519|NCT03984188|101956890|FG001|6 Months|Overall Study||47||
48661520|NCT03984188|101956889|FG000|COMPLETED|Overall Study||39||
48661521|NCT03984188|101956890|FG001|COMPLETED|Overall Study||41||
48661522|NCT03984188|101956889|FG000|NOT COMPLETED|Overall Study||11||
48661523|NCT03984188|101956890|FG001|NOT COMPLETED|Overall Study||8||
48661524|NCT00567229|101956891|FG000|STARTED|Overall Study||3||
48661525|NCT00567229|101956891|FG000|COMPLETED|Overall Study||3||
48661526|NCT00567229|101956891|FG000|NOT COMPLETED|Overall Study||0||
48661527|NCT02904096|101956892|FG000|STARTED|Overall Study||130||
48661528|NCT02904096|101956893|FG001|STARTED|Overall Study||126||
48661529|NCT02904096|101956892|FG000|COMPLETED|Overall Study||111||
48661530|NCT02904096|101956893|FG001|COMPLETED|Overall Study||105||
48661531|NCT02904096|101956892|FG000|NOT COMPLETED|Overall Study||19||
48772309|NCT01526733|102232711|FG001|COMPLETED|Phase 1||12||
48452344|NCT01236053|101443632|FG011|COMPLETED|Overall Study||188924||
48452345|NCT01236053|101443633|FG012|COMPLETED|Overall Study||148||
48452346|NCT01236053|101443634|FG013|COMPLETED|Overall Study||1396||
48452347|NCT01236053|101443635|FG014|COMPLETED|Overall Study||4600||
48452348|NCT01236053|101443636|FG015|COMPLETED|Overall Study||43559||
48452349|NCT01236053|101443637|FG016|COMPLETED|Overall Study||38||
48452350|NCT01236053|101443638|FG017|COMPLETED|Overall Study||380||
48452351|NCT01236053|101443639|FG018|COMPLETED|Overall Study||2155||
48452352|NCT01236053|101443640|FG019|COMPLETED|Overall Study||20382||
48452353|NCT01236053|101443641|FG020|COMPLETED|Overall Study||1272||
48452354|NCT01236053|101443642|FG021|COMPLETED|Overall Study||12167||
48452355|NCT01236053|101443621|FG000|NOT COMPLETED|Overall Study||0||
48452356|NCT01236053|101443622|FG001|NOT COMPLETED|Overall Study||0||
48452357|NCT01236053|101443623|FG002|NOT COMPLETED|Overall Study||0||
48452358|NCT01236053|101443624|FG003|NOT COMPLETED|Overall Study||0||
48452359|NCT01236053|101443625|FG004|NOT COMPLETED|Overall Study||0||
48452360|NCT01236053|101443626|FG005|NOT COMPLETED|Overall Study||0||
48452361|NCT01236053|101443627|FG006|NOT COMPLETED|Overall Study||0||
48452362|NCT01236053|101443628|FG007|NOT COMPLETED|Overall Study||0||
48452363|NCT01236053|101443629|FG008|NOT COMPLETED|Overall Study||0||
48452364|NCT01236053|101443630|FG009|NOT COMPLETED|Overall Study||0||
48452365|NCT01236053|101443631|FG010|NOT COMPLETED|Overall Study||0||
48452366|NCT01236053|101443632|FG011|NOT COMPLETED|Overall Study||0||
48452367|NCT01236053|101443633|FG012|NOT COMPLETED|Overall Study||0||
48452368|NCT01236053|101443634|FG013|NOT COMPLETED|Overall Study||0||
48452369|NCT01236053|101443635|FG014|NOT COMPLETED|Overall Study||0||
48452370|NCT01236053|101443636|FG015|NOT COMPLETED|Overall Study||0||
48452371|NCT01236053|101443637|FG016|NOT COMPLETED|Overall Study||0||
48452372|NCT01236053|101443638|FG017|NOT COMPLETED|Overall Study||0||
48452373|NCT01236053|101443639|FG018|NOT COMPLETED|Overall Study||0||
48452374|NCT01236053|101443640|FG019|NOT COMPLETED|Overall Study||0||
48452375|NCT01236053|101443641|FG020|NOT COMPLETED|Overall Study||0||
48452376|NCT01236053|101443642|FG021|NOT COMPLETED|Overall Study||0||
48452377|NCT00722111|101443643|FG000|STARTED|Overall Study||11||
48452378|NCT00722111|101443644|FG001|STARTED|Overall Study||72||
48452379|NCT00722111|101443643|FG000|COMPLETED|Overall Study||11||
48452380|NCT00722111|101443644|FG001|COMPLETED|Overall Study||72||
48452381|NCT00722111|101443643|FG000|NOT COMPLETED|Overall Study||0||
48452382|NCT00722111|101443644|FG001|NOT COMPLETED|Overall Study||0||
48452383|NCT02981602|101443645|FG000|STARTED|Overall Study||6||
48452384|NCT02981602|101443646|FG001|STARTED|Overall Study||12||
48452385|NCT02981602|101443647|FG002|STARTED|Overall Study||6||
48452386|NCT02981602|101443648|FG003|STARTED|Overall Study||5||
48452387|NCT02981602|101443649|FG004|STARTED|Overall Study||2||
48452388|NCT02981602|101443645|FG000|COMPLETED|Overall Study||6||
48452389|NCT02981602|101443646|FG001|COMPLETED|Overall Study||12||
48452390|NCT02981602|101443647|FG002|COMPLETED|Overall Study||6||
48452391|NCT02981602|101443648|FG003|COMPLETED|Overall Study||4||
48452392|NCT02981602|101443649|FG004|COMPLETED|Overall Study||2||
48452393|NCT02981602|101443645|FG000|NOT COMPLETED|Overall Study||0||
48452394|NCT02981602|101443646|FG001|NOT COMPLETED|Overall Study||0||
48452395|NCT02981602|101443647|FG002|NOT COMPLETED|Overall Study||0||
48452396|NCT02981602|101443648|FG003|NOT COMPLETED|Overall Study||1||
48452397|NCT02981602|101443649|FG004|NOT COMPLETED|Overall Study||0||
48452398|NCT00580333|101443650|FG000|STARTED|Overall Study||51||
48452399|NCT00580333|101443650|FG000|COMPLETED|Overall Study||51||
48772310|NCT01526733|102232710|FG000|NOT COMPLETED|Phase 1||2||
48772311|NCT01526733|102232711|FG001|NOT COMPLETED|Phase 1||1||
48772312|NCT01526733|102232710|FG000|STARTED|Washout Period of 5 to 21 Days||10||
48452400|NCT00580333|101443650|FG000|NOT COMPLETED|Overall Study||0||
48452401|NCT03012815|101443651|FG000|STARTED|Overall Study||46||
48452402|NCT03012815|101443652|FG001|STARTED|Overall Study||42||
48452403|NCT03012815|101443651|FG000|COMPLETED|Overall Study||41||
48452404|NCT03012815|101443652|FG001|COMPLETED|Overall Study||40||
48452405|NCT03012815|101443651|FG000|NOT COMPLETED|Overall Study||5||
48452406|NCT03012815|101443652|FG001|NOT COMPLETED|Overall Study||2||
48452407|NCT00766506|101443653|FG000|STARTED|Overall Study||58||
48452408|NCT00766506|101443654|FG001|STARTED|Overall Study||50||
48452409|NCT00766506|101443653|FG000|COMPLETED|Overall Study||53||
48452410|NCT00766506|101443654|FG001|COMPLETED|Overall Study||48||
48772313|NCT01526733|102232711|FG001|STARTED|Washout Period of 5 to 21 Days||12||
48772314|NCT01526733|102232710|FG000|COMPLETED|Washout Period of 5 to 21 Days||10||
48452411|NCT00766506|101443653|FG000|NOT COMPLETED|Overall Study||5||
48452412|NCT00766506|101443654|FG001|NOT COMPLETED|Overall Study||2||
48452413|NCT00676026|101443655|FG000|STARTED|Overall Study||8||
48452414|NCT00676026|101443655|FG000|COMPLETED|Overall Study||8||
48452415|NCT00676026|101443655|FG000|NOT COMPLETED|Overall Study||0||
48452416|NCT01571635|101443656|FG000|STARTED|Overall Study||8||
48452417|NCT01571635|101443657|FG001|STARTED|Overall Study||9||
48452418|NCT01571635|101443658|FG002|STARTED|Overall Study||8||
48772315|NCT01526733|102232711|FG001|COMPLETED|Washout Period of 5 to 21 Days||12||
48772316|NCT01526733|102232710|FG000|NOT COMPLETED|Washout Period of 5 to 21 Days||0||
48772317|NCT01526733|102232711|FG001|NOT COMPLETED|Washout Period of 5 to 21 Days||0||
48772318|NCT01526733|102232710|FG000|STARTED|Phase 2||10||
48452419|NCT01571635|101443659|FG003|STARTED|Overall Study||12||
48661532|NCT02904096|101956893|FG001|NOT COMPLETED|Overall Study||21||
48661533|NCT04620668|101956894|FG000|STARTED|Overall Study||41||
48661534|NCT04620668|101956895|FG001|STARTED|Overall Study||38||
48661535|NCT04620668|101956894|FG000|COMPLETED|Overall Study||34||
48661536|NCT04620668|101956895|FG001|COMPLETED|Overall Study||34||
48661537|NCT04620668|101956894|FG000|NOT COMPLETED|Overall Study||7||
48661538|NCT04620668|101956895|FG001|NOT COMPLETED|Overall Study||4||
48661539|NCT02244957|101956896|FG000|STARTED|Overall Study||7||
48661540|NCT02244957|101956897|FG001|STARTED|Overall Study||16||
48661541|NCT02244957|101956896|FG000|COMPLETED|Overall Study||6||
48661542|NCT02244957|101956897|FG001|COMPLETED|Overall Study||16||
48661543|NCT02244957|101956896|FG000|NOT COMPLETED|Overall Study||1||
48661544|NCT02244957|101956897|FG001|NOT COMPLETED|Overall Study||0||
48661545|NCT00908908|101956898|FG000|STARTED|Overall Study||6||
48661546|NCT00908908|101956898|FG000|Adverse Event|Overall Study||0||
48661547|NCT00908908|101956898|FG000|Withdrawl by Subject|Overall Study||0||
48661548|NCT00908908|101956898|FG000|Administrative/Other|Overall Study||0||
48661549|NCT00908908|101956898|FG000|Physician Decision|Overall Study||0||
48661550|NCT00908908|101956898|FG000|COMPLETED|Overall Study||6||
48772319|NCT01526733|102232711|FG001|STARTED|Phase 2||12||
48772320|NCT01526733|102232710|FG000|COMPLETED|Phase 2||10||
48452420|NCT01571635|101443660|FG004|STARTED|Overall Study||9||
48661551|NCT00908908|101956898|FG000|NOT COMPLETED|Overall Study||0||
48661552|NCT00456365|101956899|FG000|STARTED|Overall Study||56||
48661553|NCT00456365|101956900|FG001|STARTED|Overall Study||54||
48661554|NCT00456365|101956899|FG000|COMPLETED|Overall Study||49||
48661555|NCT00456365|101956900|FG001|COMPLETED|Overall Study||42||
48661556|NCT00456365|101956899|FG000|NOT COMPLETED|Overall Study||7||
48661557|NCT00456365|101956900|FG001|NOT COMPLETED|Overall Study||12||
48661558|NCT05486065|101956901|FG000|STARTED|Overall Study||61||
48661559|NCT05486065|101956902|FG001|STARTED|Overall Study||62||
48661560|NCT05486065|101956903|FG002|STARTED|Overall Study||62||
48661561|NCT05486065|101956904|FG003|STARTED|Overall Study||60||
48661562|NCT05486065|101956901|FG000|Full Analysis Set|Overall Study||61||
48661563|NCT05486065|101956902|FG001|Full Analysis Set|Overall Study||62||
48661564|NCT05486065|101956903|FG002|Full Analysis Set|Overall Study||62||
48661565|NCT05486065|101956904|FG003|Full Analysis Set|Overall Study||60||
48661566|NCT05486065|101956901|FG000|Safety Analysis Set|Overall Study||60||
48661567|NCT05486065|101956902|FG001|Safety Analysis Set|Overall Study||60||
48661568|NCT05486065|101956903|FG002|Safety Analysis Set|Overall Study||62||
48772321|NCT01526733|102232711|FG001|COMPLETED|Phase 2||12||
48772322|NCT01526733|102232710|FG000|NOT COMPLETED|Phase 2||0||
48772323|NCT01526733|102232711|FG001|NOT COMPLETED|Phase 2||0||
48772324|NCT05036733|102232712|FG000|STARTED|Overall Study||15||
48772325|NCT05036733|102232712|FG000|COMPLETED|Overall Study||15||
48661569|NCT05486065|101956904|FG003|Safety Analysis Set|Overall Study||59||
48661570|NCT05486065|101956901|FG000|COMPLETED|Overall Study||56||
48661571|NCT05486065|101956902|FG001|COMPLETED|Overall Study||54||
48661572|NCT05486065|101956903|FG002|COMPLETED|Overall Study||55||
48661573|NCT05486065|101956904|FG003|COMPLETED|Overall Study||54||
48661574|NCT05486065|101956901|FG000|NOT COMPLETED|Overall Study||5||
48661575|NCT05486065|101956902|FG001|NOT COMPLETED|Overall Study||8||
48661576|NCT05486065|101956903|FG002|NOT COMPLETED|Overall Study||7||
48661577|NCT05486065|101956904|FG003|NOT COMPLETED|Overall Study||6||
48661578|NCT00661687|101956905|FG000|STARTED|Overall Study||204||
48661579|NCT00661687|101956905|FG000|COMPLETED|Overall Study||189||
48661580|NCT00661687|101956905|FG000|NOT COMPLETED|Overall Study||15||
48661581|NCT01730729|101956906|FG000|STARTED|Overall Study||20||
48661582|NCT01730729|101956906|FG000|Completed 2 Cycles/Reached 1st Response|Overall Study||18||
48661583|NCT01730729|101956906|FG000|Treated Cycle 3 and Beyond|Overall Study||6||
48661584|NCT01730729|101956906|FG000|COMPLETED|Overall Study||6|Patients treated until progressive disease, unacceptable toxicity, or withdrawal from study|
48661585|NCT01730729|101956906|FG000|NOT COMPLETED|Overall Study||14||
48661586|NCT01586897|101956907|FG000|STARTED|Overall Study||26||
48661587|NCT01586897|101956908|FG001|STARTED|Overall Study||26||
48661588|NCT01586897|101956907|FG000|COMPLETED|Overall Study||26||
48661589|NCT01586897|101956908|FG001|COMPLETED|Overall Study||26||
48661590|NCT01586897|101956907|FG000|NOT COMPLETED|Overall Study||0||
48661591|NCT01586897|101956908|FG001|NOT COMPLETED|Overall Study||0||
48661592|NCT02193347|101956909|FG000|STARTED|Overall Study||24||
48661593|NCT02193347|101956909|FG000|COMPLETED|Overall Study||24||
48661594|NCT02193347|101956909|FG000|NOT COMPLETED|Overall Study||0||
48661595|NCT03464461|101956910|FG000|STARTED|Overall Study||83||
48661596|NCT03464461|101956911|FG001|STARTED|Overall Study||92||
48661597|NCT03464461|101956912|FG002|STARTED|Overall Study||83||
48661598|NCT03464461|101956910|FG000|COMPLETED|Overall Study||82||
48661599|NCT03464461|101956911|FG001|COMPLETED|Overall Study||89||
48661600|NCT03464461|101956912|FG002|COMPLETED|Overall Study||83||
48661601|NCT03464461|101956910|FG000|NOT COMPLETED|Overall Study||1||
48661602|NCT03464461|101956911|FG001|NOT COMPLETED|Overall Study||3||
48661603|NCT03464461|101956912|FG002|NOT COMPLETED|Overall Study||0||
48661604|NCT04665765|101956913|FG000|STARTED|Overall Study||6||
48661605|NCT04665765|101956914|FG001|STARTED|Overall Study||35||
48661606|NCT04665765|101956913|FG000|COMPLETED|Overall Study||6||
48661607|NCT04665765|101956914|FG001|COMPLETED|Overall Study||35||
48772326|NCT05036733|102232712|FG000|NOT COMPLETED|Overall Study||0||
48772327|NCT01459497|102232713|FG000|STARTED|Overall Study||52||
48772328|NCT01459497|102232714|FG001|STARTED|Overall Study||51||
48772329|NCT01459497|102232713|FG000|COMPLETED|Overall Study||50||
48452421|NCT01571635|101443656|FG000|COMPLETED|Overall Study||2||
48452422|NCT01571635|101443657|FG001|COMPLETED|Overall Study||1||
48452423|NCT01571635|101443658|FG002|COMPLETED|Overall Study||1||
48452424|NCT01571635|101443659|FG003|COMPLETED|Overall Study||0||
48452425|NCT01571635|101443660|FG004|COMPLETED|Overall Study||0||
48452426|NCT01571635|101443656|FG000|NOT COMPLETED|Overall Study||6||
48452427|NCT01571635|101443657|FG001|NOT COMPLETED|Overall Study||8||
48452428|NCT01571635|101443658|FG002|NOT COMPLETED|Overall Study||7||
48452429|NCT01571635|101443659|FG003|NOT COMPLETED|Overall Study||12||
48452430|NCT01571635|101443660|FG004|NOT COMPLETED|Overall Study||9||
48452431|NCT01406873|101443661|FG000|STARTED|Overall Study||21||
48452432|NCT01406873|101443662|FG001|STARTED|Overall Study||21||
48452433|NCT01406873|101443661|FG000|COMPLETED|Overall Study||20||
48452434|NCT01406873|101443662|FG001|COMPLETED|Overall Study||20||
48452435|NCT01406873|101443661|FG000|NOT COMPLETED|Overall Study||1||
48452436|NCT01406873|101443662|FG001|NOT COMPLETED|Overall Study||1||
48452437|NCT00894465|101443663|FG000|STARTED|Overall Study||22||
48452438|NCT00894465|101443664|FG001|STARTED|Overall Study||22||
48452439|NCT00894465|101443663|FG000|COMPLETED|Overall Study||22||
48452440|NCT00894465|101443664|FG001|COMPLETED|Overall Study||22||
48452441|NCT00894465|101443663|FG000|NOT COMPLETED|Overall Study||0||
48452442|NCT00894465|101443664|FG001|NOT COMPLETED|Overall Study||0||
48452443|NCT01245595|101443665|FG000|STARTED|Overall Study||72||
48452444|NCT01245595|101443666|FG001|STARTED|Overall Study||72||
48452445|NCT01245595|101443665|FG000|Completed Full Course of Study Drug|Overall Study||57||
48452446|NCT01245595|101443666|FG001|Completed Full Course of Study Drug|Overall Study||61||
48452447|NCT01245595|101443665|FG000|COMPLETED|Overall Study||72||
48452448|NCT01245595|101443666|FG001|COMPLETED|Overall Study||72||
48452449|NCT01245595|101443665|FG000|NOT COMPLETED|Overall Study||0||
48452450|NCT01245595|101443666|FG001|NOT COMPLETED|Overall Study||0||
48452451|NCT00771901|101443667|FG000|STARTED|Overall Study||10||
48452452|NCT00771901|101443668|FG001|STARTED|Overall Study||10||
48452453|NCT00771901|101443669|FG002|STARTED|Overall Study||10||
48452454|NCT00771901|101443667|FG000|COMPLETED|Overall Study||10||
48452455|NCT00771901|101443668|FG001|COMPLETED|Overall Study||10||
48452456|NCT00771901|101443669|FG002|COMPLETED|Overall Study||6||
48452457|NCT00771901|101443667|FG000|NOT COMPLETED|Overall Study||0||
48452458|NCT00771901|101443668|FG001|NOT COMPLETED|Overall Study||0||
48452459|NCT00771901|101443669|FG002|NOT COMPLETED|Overall Study||4||
48452460|NCT01200394|101443670|FG000|STARTED|Overall Study||64||
48452461|NCT01200394|101443671|FG001|STARTED|Overall Study||192||
48772330|NCT01459497|102232714|FG001|COMPLETED|Overall Study||46||
48772331|NCT01459497|102232713|FG000|NOT COMPLETED|Overall Study||2||
48772332|NCT01459497|102232714|FG001|NOT COMPLETED|Overall Study||5||
48772333|NCT04032093|102232715|FG000|STARTED|Overall Study||116||
48772334|NCT04032093|102232716|FG001|STARTED|Overall Study||117||
48772335|NCT04032093|102232717|FG002|STARTED|Overall Study||116||
48772336|NCT04032093|102232718|FG003|STARTED|Overall Study||115||
48772337|NCT04032093|102232719|FG004|STARTED|Overall Study||117||
48189199|NCT03049111|100786174|FG000|STARTED|Overall Study||14||
48452462|NCT01200394|101443670|FG000|COMPLETED|Overall Study||62||
48452463|NCT01200394|101443671|FG001|COMPLETED|Overall Study||164||
48452464|NCT01200394|101443670|FG000|NOT COMPLETED|Overall Study||2||
48452465|NCT01200394|101443671|FG001|NOT COMPLETED|Overall Study||28||
48452466|NCT02626182|101443672|FG000|STARTED|Overall Study||11||
48452467|NCT02626182|101443673|FG001|STARTED|Overall Study||3||
48452468|NCT02626182|101443672|FG000|COMPLETED|Overall Study||9||
48452469|NCT02626182|101443673|FG001|COMPLETED|Overall Study||3||
48452470|NCT02626182|101443672|FG000|NOT COMPLETED|Overall Study||2||
48452471|NCT02626182|101443673|FG001|NOT COMPLETED|Overall Study||0||
48452472|NCT04126733|101443674|FG000|STARTED|Treatment Period||70||
48452473|NCT04126733|101443674|FG000|COMPLETED|Treatment Period||0||
48452474|NCT04126733|101443674|FG000|NOT COMPLETED|Treatment Period||70||
48452475|NCT04126733|101443674|FG000|STARTED|Active Follow-up Period||39||
48452476|NCT04126733|101443674|FG000|COMPLETED|Active Follow-up Period||19||
48452477|NCT04126733|101443674|FG000|NOT COMPLETED|Active Follow-up Period||20||
48452478|NCT04126733|101443674|FG000|STARTED|Long-term Follow-up Period||29||
48452479|NCT04126733|101443674|FG000|COMPLETED|Long-term Follow-up Period||0||
48661608|NCT04665765|101956913|FG000|NOT COMPLETED|Overall Study||0||
48661609|NCT04665765|101956914|FG001|NOT COMPLETED|Overall Study||0||
48661610|NCT04909801|101956915|FG000|STARTED|Overall Study||169|Started=Treated during Single-Blind Treatment|
48661611|NCT04909801|101956916|FG001|STARTED|Overall Study||169|Started=Treated during Single-Blind Treatment|
48661612|NCT04909801|101956915|FG000|Treated in Open-Label|Overall Study||160|At week 24, all participants ongoing in the OL self-administered abatacept 125 mg subcutaneous weekly up to and including Week 103 (Day 722)|
48661613|NCT04909801|101956916|FG001|Treated in Open-Label|Overall Study||161|At week 24, all participants ongoing in the OL self-administered abatacept 125 mg subcutaneous weekly up to and including Week 103 (Day 722)|
48670049|NCT05757193|101974878|FG001|COMPLETED|Overall Study||10||
48661614|NCT04909801|101956915|FG000|COMPLETED|Overall Study||162|Completed=Completed Single-Blind Treatment|
48661615|NCT04909801|101956916|FG001|COMPLETED|Overall Study||162|Completed=Completed Single-Blind Treatment|
48661616|NCT04909801|101956915|FG000|NOT COMPLETED|Overall Study||7||
48661617|NCT04909801|101956916|FG001|NOT COMPLETED|Overall Study||7||
48661618|NCT02826681|101956917|FG000|STARTED|Overall Study||35||
48772338|NCT04032093|102232720|FG005|STARTED|Overall Study||114||
48772339|NCT04032093|102232721|FG006|STARTED|Overall Study||117||
48772340|NCT04032093|102232722|FG007|STARTED|Overall Study||113||
48772341|NCT04032093|102232723|FG008|STARTED|Overall Study||112||
48772342|NCT04032093|102232724|FG009|STARTED|Overall Study||116||
48772343|NCT04032093|102232715|FG000|Safety Set|Overall Study||115||
48772344|NCT04032093|102232716|FG001|Safety Set|Overall Study||117||
48772345|NCT04032093|102232717|FG002|Safety Set|Overall Study||116||
48772346|NCT04032093|102232718|FG003|Safety Set|Overall Study||114||
48772347|NCT04032093|102232719|FG004|Safety Set|Overall Study||117||
48772348|NCT04032093|102232720|FG005|Safety Set|Overall Study||114||
48772349|NCT04032093|102232721|FG006|Safety Set|Overall Study||117||
48772350|NCT04032093|102232722|FG007|Safety Set|Overall Study||113||
48772351|NCT04032093|102232723|FG008|Safety Set|Overall Study||112||
48452480|NCT04126733|101443674|FG000|NOT COMPLETED|Long-term Follow-up Period||29||
48452481|NCT02957682|101443675|FG000|STARTED|Overall Study||1088|Randomized|
48452482|NCT02957682|101443676|FG001|STARTED|Overall Study||1088|Randomized|
48452483|NCT02957682|101443675|FG000|Randomized and Treated|Overall Study||1085||
48452484|NCT02957682|101443676|FG001|Randomized and Treated|Overall Study||1086||
48452485|NCT02957682|101443675|FG000|COMPLETED|Overall Study||890|Completed 96-week study treatment period|
48452486|NCT02957682|101443676|FG001|COMPLETED|Overall Study||919|Completed 96-week study treatment period|
48452487|NCT02957682|101443675|FG000|NOT COMPLETED|Overall Study||198||
48452488|NCT02957682|101443676|FG001|NOT COMPLETED|Overall Study||169||
48452489|NCT01440595|101443677|FG000|STARTED|Overall Study||1||
48452490|NCT01440595|101443678|FG001|STARTED|Overall Study||3||
48772352|NCT04032093|102232724|FG009|Safety Set|Overall Study||116||
48772353|NCT04032093|102232715|FG000|COMPLETED|Overall Study||107||
48772354|NCT04032093|102232716|FG001|COMPLETED|Overall Study||107||
48772355|NCT04032093|102232717|FG002|COMPLETED|Overall Study||108||
48772356|NCT04032093|102232718|FG003|COMPLETED|Overall Study||100||
48452491|NCT01440595|101443679|FG002|STARTED|Overall Study||1||
48452492|NCT01440595|101443677|FG000|COMPLETED|Overall Study||0||
48452493|NCT01440595|101443678|FG001|COMPLETED|Overall Study||0||
48452494|NCT01440595|101443679|FG002|COMPLETED|Overall Study||0||
48452495|NCT01440595|101443677|FG000|NOT COMPLETED|Overall Study||1||
48452496|NCT01440595|101443678|FG001|NOT COMPLETED|Overall Study||3||
48452497|NCT01440595|101443679|FG002|NOT COMPLETED|Overall Study||1||
48452498|NCT03451331|101443680|FG000|STARTED|Overall Study||25||
48452499|NCT03451331|101443681|FG001|STARTED|Overall Study||24||
48452500|NCT03451331|101443680|FG000|COMPLETED|Overall Study||23||
48452501|NCT03451331|101443681|FG001|COMPLETED|Overall Study||23||
48452502|NCT03451331|101443680|FG000|NOT COMPLETED|Overall Study||2||
48452503|NCT03451331|101443681|FG001|NOT COMPLETED|Overall Study||1||
48452504|NCT05288673|101443682|FG000|STARTED|Overall Study||6||
48452505|NCT05288673|101443683|FG001|STARTED|Overall Study||6||
48452506|NCT05288673|101443684|FG002|STARTED|Overall Study||4||
48452507|NCT05288673|101443682|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||6||
48452508|NCT05288673|101443683|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||6||
48452509|NCT05288673|101443684|FG002|Received At Least 1 Dose Of Study Drug|Overall Study||4||
48452510|NCT05288673|101443682|FG000|COMPLETED|Overall Study||6||
48452511|NCT05288673|101443683|FG001|COMPLETED|Overall Study||6||
48661619|NCT02826681|101956918|FG001|STARTED|Overall Study||35||
48661620|NCT02826681|101956917|FG000|COMPLETED|Overall Study||12||
48661621|NCT02826681|101956918|FG001|COMPLETED|Overall Study||13||
48661622|NCT02826681|101956917|FG000|NOT COMPLETED|Overall Study||23||
48661623|NCT02826681|101956918|FG001|NOT COMPLETED|Overall Study||22||
48661624|NCT01959919|101956919|FG000|STARTED|Overall Study||86||
48661625|NCT01959919|101956919|FG000|COMPLETED|Overall Study||84||
48661626|NCT01959919|101956919|FG000|NOT COMPLETED|Overall Study||2||
48661627|NCT02363283|101956920|FG000|STARTED|Overall Study||37||
48661628|NCT02363283|101956920|FG000|COMPLETED|Overall Study||35||
48661629|NCT02363283|101956920|FG000|NOT COMPLETED|Overall Study||2||
48661630|NCT01143636|101956921|FG000|STARTED|Overall Study||6||
48661631|NCT01143636|101956922|FG001|STARTED|Overall Study||5||
48661632|NCT01143636|101956923|FG002|STARTED|Overall Study||8||
48661633|NCT01143636|101956924|FG003|STARTED|Overall Study||7||
48661634|NCT01143636|101956921|FG000|COMPLETED|Overall Study||5||
48661635|NCT01143636|101956922|FG001|COMPLETED|Overall Study||4||
48661636|NCT01143636|101956923|FG002|COMPLETED|Overall Study||8||
48661637|NCT01143636|101956924|FG003|COMPLETED|Overall Study||7||
48661638|NCT01143636|101956921|FG000|NOT COMPLETED|Overall Study||1||
48661639|NCT01143636|101956922|FG001|NOT COMPLETED|Overall Study||1||
48661640|NCT01143636|101956923|FG002|NOT COMPLETED|Overall Study||0||
48661641|NCT01143636|101956924|FG003|NOT COMPLETED|Overall Study||0||
48661642|NCT04439357|101956925|FG000|STARTED|Overall Study||4||
48661643|NCT04439357|101956925|FG000|Eligible and Started Protocol Therapy|Overall Study||4|This is the primary analysis population.|
48661644|NCT04439357|101956925|FG000|COMPLETED|Overall Study||0||
48452512|NCT05288673|101443684|FG002|COMPLETED|Overall Study||3||
48452513|NCT05288673|101443682|FG000|NOT COMPLETED|Overall Study||0||
48452514|NCT05288673|101443683|FG001|NOT COMPLETED|Overall Study||0||
48452515|NCT05288673|101443684|FG002|NOT COMPLETED|Overall Study||1||
48452516|NCT03559010|101443685|FG000|STARTED|Overall Study||189||
48452517|NCT03559010|101443685|FG000|Purchaser Population|Overall Study||113||
48452518|NCT03559010|101443685|FG000|Use Phase Norgestrel 0.075 mg|Overall Study||109||
48452519|NCT03559010|101443685|FG000|COMPLETED|Overall Study||189||
48452520|NCT03559010|101443685|FG000|NOT COMPLETED|Overall Study||0||
48452521|NCT02683187|101443686|FG000|STARTED|Overall Study||40||
48452522|NCT02683187|101443686|FG000|COMPLETED|Overall Study||32||
48452523|NCT02683187|101443686|FG000|NOT COMPLETED|Overall Study||8||
48452524|NCT00769015|101443687|FG000|STARTED|Overall Study||96||
48452525|NCT00769015|101443688|FG001|STARTED|Overall Study||92||
48452526|NCT00769015|101443687|FG000|COMPLETED|Overall Study||87||
48452527|NCT00769015|101443688|FG001|COMPLETED|Overall Study||76||
48452528|NCT00769015|101443687|FG000|NOT COMPLETED|Overall Study||9||
48452529|NCT00769015|101443688|FG001|NOT COMPLETED|Overall Study||16||
48452530|NCT01463683|101443689|FG000|STARTED|Overall Study||309||
48452531|NCT01463683|101443690|FG001|STARTED|Overall Study||309||
48452532|NCT01463683|101443691|FG002|STARTED|Overall Study||104||
48452533|NCT01463683|101443689|FG000|Received Vaccination 1 (Day 1)|Overall Study||309||
48452534|NCT01463683|101443690|FG001|Received Vaccination 1 (Day 1)|Overall Study||308||
48452535|NCT01463683|101443691|FG002|Received Vaccination 1 (Day 1)|Overall Study||104||
48452536|NCT01463683|101443689|FG000|Received Vaccination 2 (Month 1)|Overall Study||302||
48452537|NCT01463683|101443690|FG001|Received Vaccination 2 (Month 1)|Overall Study||300||
48452538|NCT01463683|101443691|FG002|Received Vaccination 2 (Month 1)|Overall Study||103||
48452539|NCT01463683|101443689|FG000|Received Vaccination 3 (Month 6)|Overall Study||290||
48452540|NCT01463683|101443690|FG001|Received Vaccination 3 (Month 6)|Overall Study||281||
48452541|NCT01463683|101443691|FG002|Received Vaccination 3 (Month 6)|Overall Study||93||
48452542|NCT01463683|101443689|FG000|COMPLETED|Overall Study||290||
48452543|NCT01463683|101443690|FG001|COMPLETED|Overall Study||278||
48452544|NCT01463683|101443691|FG002|COMPLETED|Overall Study||93||
48452545|NCT01463683|101443689|FG000|NOT COMPLETED|Overall Study||19||
48452546|NCT01463683|101443690|FG001|NOT COMPLETED|Overall Study||31||
48452547|NCT01463683|101443691|FG002|NOT COMPLETED|Overall Study||11||
48452548|NCT04130919|101443692|FG000|STARTED|Blinded Treatment Phase||7||
48452549|NCT04130919|101443693|FG001|STARTED|Blinded Treatment Phase||6||
48452550|NCT04130919|101443694|FG002|STARTED|Blinded Treatment Phase||6||
48452551|NCT04130919|101443695|FG003|STARTED|Blinded Treatment Phase||0||
48452552|NCT04130919|101443696|FG004|STARTED|Blinded Treatment Phase||0||
48452553|NCT04130919|101443697|FG005|STARTED|Blinded Treatment Phase||0||
48452554|NCT04130919|101443692|FG000|COMPLETED|Blinded Treatment Phase||5||
48452555|NCT04130919|101443693|FG001|COMPLETED|Blinded Treatment Phase||4||
48452556|NCT04130919|101443694|FG002|COMPLETED|Blinded Treatment Phase||3||
48452557|NCT04130919|101443695|FG003|COMPLETED|Blinded Treatment Phase||0||
48452558|NCT04130919|101443696|FG004|COMPLETED|Blinded Treatment Phase||0||
48452559|NCT04130919|101443697|FG005|COMPLETED|Blinded Treatment Phase||0||
48452560|NCT04130919|101443692|FG000|NOT COMPLETED|Blinded Treatment Phase||2||
48452561|NCT04130919|101443693|FG001|NOT COMPLETED|Blinded Treatment Phase||2||
48452562|NCT04130919|101443694|FG002|NOT COMPLETED|Blinded Treatment Phase||3||
48452563|NCT04130919|101443695|FG003|NOT COMPLETED|Blinded Treatment Phase||0||
48772357|NCT04032093|102232719|FG004|COMPLETED|Overall Study||99||
48772358|NCT04032093|102232720|FG005|COMPLETED|Overall Study||106||
48772359|NCT04032093|102232721|FG006|COMPLETED|Overall Study||107||
48452564|NCT04130919|101443696|FG004|NOT COMPLETED|Blinded Treatment Phase||0||
48452565|NCT04130919|101443697|FG005|NOT COMPLETED|Blinded Treatment Phase||0||
48452566|NCT04130919|101443692|FG000|STARTED|Open-label Treatment Phase||0||
48452567|NCT04130919|101443693|FG001|STARTED|Open-label Treatment Phase||0||
48452568|NCT04130919|101443694|FG002|STARTED|Open-label Treatment Phase||0||
48452569|NCT04130919|101443695|FG003|STARTED|Open-label Treatment Phase||4||
48452570|NCT04130919|101443696|FG004|STARTED|Open-label Treatment Phase||3||
48452571|NCT04130919|101443697|FG005|STARTED|Open-label Treatment Phase||3||
48452572|NCT04130919|101443692|FG000|COMPLETED|Open-label Treatment Phase||0||
48452573|NCT04130919|101443693|FG001|COMPLETED|Open-label Treatment Phase||0||
48452574|NCT04130919|101443694|FG002|COMPLETED|Open-label Treatment Phase||0||
48452575|NCT04130919|101443695|FG003|COMPLETED|Open-label Treatment Phase||1||
48452576|NCT04130919|101443696|FG004|COMPLETED|Open-label Treatment Phase||1||
48452577|NCT04130919|101443697|FG005|COMPLETED|Open-label Treatment Phase||0||
48452578|NCT04130919|101443692|FG000|NOT COMPLETED|Open-label Treatment Phase||0||
48452579|NCT04130919|101443693|FG001|NOT COMPLETED|Open-label Treatment Phase||0||
48452580|NCT04130919|101443694|FG002|NOT COMPLETED|Open-label Treatment Phase||0||
48452581|NCT04130919|101443695|FG003|NOT COMPLETED|Open-label Treatment Phase||3||
48452582|NCT04130919|101443696|FG004|NOT COMPLETED|Open-label Treatment Phase||2||
48452583|NCT04130919|101443697|FG005|NOT COMPLETED|Open-label Treatment Phase||3||
48452584|NCT02316678|101443698|FG000|STARTED|Overall Study||1879||
48452585|NCT02316678|101443699|FG001|STARTED|Overall Study||7694||
48452586|NCT02316678|101443698|FG000|COMPLETED|Overall Study||1879||
48452587|NCT02316678|101443699|FG001|COMPLETED|Overall Study||7694||
48452588|NCT02316678|101443698|FG000|NOT COMPLETED|Overall Study||0||
48452589|NCT02316678|101443699|FG001|NOT COMPLETED|Overall Study||0||
48452590|NCT03202511|101443700|FG000|STARTED|Overall Study||8||
48452591|NCT03202511|101443701|FG001|STARTED|Overall Study||7||
48452592|NCT03202511|101443700|FG000|COMPLETED|Overall Study||7||
48452593|NCT03202511|101443701|FG001|COMPLETED|Overall Study||7||
48452594|NCT03202511|101443700|FG000|NOT COMPLETED|Overall Study||1||
48452595|NCT03202511|101443701|FG001|NOT COMPLETED|Overall Study||0||
48452596|NCT03053622|101443702|FG000|STARTED|Overall Study||17||
48452597|NCT03053622|101443703|FG001|STARTED|Overall Study||16||
48452598|NCT03053622|101443704|FG002|STARTED|Overall Study||17||
48452599|NCT03053622|101443705|FG003|STARTED|Overall Study||17||
48452600|NCT03053622|101443702|FG000|Received at Least One Dose of Study Drug|Overall Study||17||
48452601|NCT03053622|101443703|FG001|Received at Least One Dose of Study Drug|Overall Study||16||
48452602|NCT03053622|101443704|FG002|Received at Least One Dose of Study Drug|Overall Study||17||
48452603|NCT03053622|101443705|FG003|Received at Least One Dose of Study Drug|Overall Study||17||
48452604|NCT03053622|101443702|FG000|COMPLETED|Overall Study||17||
48452605|NCT03053622|101443703|FG001|COMPLETED|Overall Study||16||
48452606|NCT03053622|101443704|FG002|COMPLETED|Overall Study||17||
48452607|NCT03053622|101443705|FG003|COMPLETED|Overall Study||16||
48452608|NCT03053622|101443702|FG000|NOT COMPLETED|Overall Study||0||
48452609|NCT03053622|101443703|FG001|NOT COMPLETED|Overall Study||0||
48452610|NCT03053622|101443704|FG002|NOT COMPLETED|Overall Study||0||
48452611|NCT03053622|101443705|FG003|NOT COMPLETED|Overall Study||1||
48452612|NCT02662608|101443706|FG000|STARTED|Overall Study||1||
48452613|NCT02662608|101443706|FG000|COMPLETED|Overall Study||1||
48452614|NCT02662608|101443706|FG000|NOT COMPLETED|Overall Study||0||
48452615|NCT01328054|101443707|FG000|STARTED|Placebo on Day 1 and Day 2 (2 Days)||57||
48452616|NCT01328054|101443708|FG001|STARTED|Placebo on Day 1 and Day 2 (2 Days)||0||
48452617|NCT01328054|101443707|FG000|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||57||
48452618|NCT01328054|101443708|FG001|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0||
48452619|NCT01328054|101443707|FG000|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0||
48452620|NCT01328054|101443708|FG001|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0||
48452621|NCT01328054|101443707|FG000|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)||0||
48452622|NCT01328054|101443708|FG001|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)||58||
48189200|NCT03049111|100786174|FG000|COMPLETED|Overall Study||14||
48189201|NCT03049111|100786174|FG000|NOT COMPLETED|Overall Study||0||
48189202|NCT01140347|100786175|FG000|STARTED|Overall Study||283||
48452623|NCT01328054|101443707|FG000|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0||
48452624|NCT01328054|101443708|FG001|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||53||
48452625|NCT01328054|101443707|FG000|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0||
48452626|NCT01328054|101443708|FG001|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||5||
48452627|NCT01883999|101443709|FG000|STARTED|Overall Study||64||
48452628|NCT01883999|101443709|FG000|COMPLETED|Overall Study||61||
48452629|NCT01883999|101443709|FG000|NOT COMPLETED|Overall Study||3||
48452630|NCT00616928|101443710|FG000|STARTED|Overall Study||2304||
48452631|NCT00616928|101443711|FG001|STARTED|Overall Study||768||
48452632|NCT00616928|101443712|FG002|STARTED|Overall Study||1118||
48452633|NCT00616928|101443713|FG003|STARTED|Overall Study||371||
48452634|NCT00616928|101443710|FG000|COMPLETED|Overall Study||2242||
48452635|NCT00616928|101443711|FG001|COMPLETED|Overall Study||750||
48452636|NCT00616928|101443712|FG002|COMPLETED|Overall Study||1101||
48452637|NCT00616928|101443713|FG003|COMPLETED|Overall Study||364||
48452638|NCT00616928|101443710|FG000|NOT COMPLETED|Overall Study||62||
48772360|NCT04032093|102232722|FG007|COMPLETED|Overall Study||108||
48452639|NCT00616928|101443711|FG001|NOT COMPLETED|Overall Study||18||
48772361|NCT04032093|102232723|FG008|COMPLETED|Overall Study||100||
48772362|NCT04032093|102232724|FG009|COMPLETED|Overall Study||98||
48452640|NCT00616928|101443712|FG002|NOT COMPLETED|Overall Study||17||
48452641|NCT00616928|101443713|FG003|NOT COMPLETED|Overall Study||7||
48452642|NCT01664494|101443714|FG000|STARTED|Overall Study||563||
48452643|NCT01664494|101443714|FG000|COMPLETED|Overall Study||370||
48452644|NCT01664494|101443714|FG000|NOT COMPLETED|Overall Study||193||
48452645|NCT04470622|101443715|FG000|STARTED|Overall Study||12||
48452646|NCT04470622|101443716|FG001|STARTED|Overall Study||14||
48772363|NCT04032093|102232715|FG000|NOT COMPLETED|Overall Study||9||
48189203|NCT01140347|100786176|FG001|STARTED|Overall Study||282||
48452647|NCT04470622|101443715|FG000|COMPLETED|Overall Study||12||
48452648|NCT04470622|101443716|FG001|COMPLETED|Overall Study||11||
48452649|NCT04470622|101443715|FG000|NOT COMPLETED|Overall Study||0||
48452650|NCT04470622|101443716|FG001|NOT COMPLETED|Overall Study||3||
48452651|NCT02556632|101443717|FG000|STARTED|Overall Study||64||
48452652|NCT02556632|101443718|FG001|STARTED|Overall Study||65||
48452653|NCT02556632|101443719|FG002|STARTED|Overall Study||62||
48452654|NCT02556632|101443717|FG000|COMPLETED|Overall Study||59||
48452655|NCT02556632|101443718|FG001|COMPLETED|Overall Study||59||
48452656|NCT02556632|101443719|FG002|COMPLETED|Overall Study||53||
48452657|NCT02556632|101443717|FG000|NOT COMPLETED|Overall Study||5||
48452658|NCT02556632|101443718|FG001|NOT COMPLETED|Overall Study||6||
48452659|NCT02556632|101443719|FG002|NOT COMPLETED|Overall Study||9||
48452660|NCT00700310|101443720|FG000|STARTED|Overall Study||187||
48452661|NCT00700310|101443721|FG001|STARTED|Overall Study||180||
48452662|NCT00700310|101443722|FG002|STARTED|Overall Study||174||
48452663|NCT00700310|101443723|FG003|STARTED|Overall Study||171||
48452664|NCT00700310|101443720|FG000|COMPLETED|Overall Study||166||
48452665|NCT00700310|101443721|FG001|COMPLETED|Overall Study||154||
48452666|NCT00700310|101443722|FG002|COMPLETED|Overall Study||158||
48452667|NCT00700310|101443723|FG003|COMPLETED|Overall Study||145||
48452668|NCT00700310|101443720|FG000|NOT COMPLETED|Overall Study||21||
48452669|NCT00700310|101443721|FG001|NOT COMPLETED|Overall Study||26||
48452670|NCT00700310|101443722|FG002|NOT COMPLETED|Overall Study||16||
48452671|NCT00700310|101443723|FG003|NOT COMPLETED|Overall Study||26||
48452672|NCT00527397|101443724|FG000|STARTED|Overall Study||24||
48452673|NCT00527397|101443724|FG000|COMPLETED|Overall Study||0||
48452674|NCT00527397|101443724|FG000|NOT COMPLETED|Overall Study||24||
48452675|NCT01347879|101443725|FG000|STARTED|Overall Study||53||
48452676|NCT01347879|101443726|FG001|STARTED|Overall Study||100||
48452677|NCT01347879|101443725|FG000|COMPLETED|Overall Study||46||
48452678|NCT01347879|101443726|FG001|COMPLETED|Overall Study||83||
48452679|NCT01347879|101443725|FG000|NOT COMPLETED|Overall Study||7||
48452680|NCT01347879|101443726|FG001|NOT COMPLETED|Overall Study||17||
48452681|NCT00069160|101443727|FG000|STARTED|Overall Study||23||
48452682|NCT00069160|101443728|FG001|STARTED|Overall Study||25||
48452683|NCT00069160|101443727|FG000|COMPLETED|Overall Study||23||
48452684|NCT00069160|101443728|FG001|COMPLETED|Overall Study||25||
48452685|NCT00069160|101443727|FG000|NOT COMPLETED|Overall Study||0||
48452686|NCT00069160|101443728|FG001|NOT COMPLETED|Overall Study||0||
48452687|NCT03712228|101443729|FG000|STARTED|Treatment Period 1||8||
48452688|NCT03712228|101443730|FG001|STARTED|Treatment Period 1||9||
48452689|NCT03712228|101443731|FG002|STARTED|Treatment Period 1||8||
48452690|NCT03712228|101443732|FG003|STARTED|Treatment Period 1||7||
48452691|NCT03712228|101443733|FG004|STARTED|Treatment Period 1||6||
48452692|NCT03712228|101443734|FG005|STARTED|Treatment Period 1||6||
48452693|NCT03712228|101443729|FG000|COMPLETED|Treatment Period 1||8||
48452694|NCT03712228|101443730|FG001|COMPLETED|Treatment Period 1||9||
48452695|NCT03712228|101443731|FG002|COMPLETED|Treatment Period 1||8||
48452696|NCT03712228|101443732|FG003|COMPLETED|Treatment Period 1||7||
48452697|NCT03712228|101443733|FG004|COMPLETED|Treatment Period 1||6||
48452698|NCT03712228|101443734|FG005|COMPLETED|Treatment Period 1||5||
48452699|NCT03712228|101443729|FG000|NOT COMPLETED|Treatment Period 1||0||
48452700|NCT03712228|101443730|FG001|NOT COMPLETED|Treatment Period 1||0||
48452701|NCT03712228|101443731|FG002|NOT COMPLETED|Treatment Period 1||0||
48452702|NCT03712228|101443732|FG003|NOT COMPLETED|Treatment Period 1||0||
48452703|NCT03712228|101443733|FG004|NOT COMPLETED|Treatment Period 1||0||
48772364|NCT04032093|102232716|FG001|NOT COMPLETED|Overall Study||10||
48772365|NCT04032093|102232717|FG002|NOT COMPLETED|Overall Study||8||
48772366|NCT04032093|102232718|FG003|NOT COMPLETED|Overall Study||15||
48772367|NCT04032093|102232719|FG004|NOT COMPLETED|Overall Study||18||
48452704|NCT03712228|101443734|FG005|NOT COMPLETED|Treatment Period 1||1||
48452705|NCT03712228|101443729|FG000|STARTED|Treatment Period 2||0||
48452706|NCT03712228|101443730|FG001|STARTED|Treatment Period 2||0||
48452707|NCT03712228|101443731|FG002|STARTED|Treatment Period 2||20||
48452708|NCT03712228|101443732|FG003|STARTED|Treatment Period 2||18||
48452709|NCT03712228|101443733|FG004|STARTED|Treatment Period 2||0||
48452710|NCT03712228|101443734|FG005|STARTED|Treatment Period 2||2||
48452711|NCT03712228|101443729|FG000|COMPLETED|Treatment Period 2||0||
48452712|NCT03712228|101443730|FG001|COMPLETED|Treatment Period 2||0||
48452713|NCT03712228|101443731|FG002|COMPLETED|Treatment Period 2||20||
48452714|NCT03712228|101443732|FG003|COMPLETED|Treatment Period 2||16||
48452715|NCT03712228|101443733|FG004|COMPLETED|Treatment Period 2||0||
48452716|NCT03712228|101443734|FG005|COMPLETED|Treatment Period 2||2||
48452717|NCT03712228|101443729|FG000|NOT COMPLETED|Treatment Period 2||0||
48452718|NCT03712228|101443730|FG001|NOT COMPLETED|Treatment Period 2||0||
48452719|NCT03712228|101443731|FG002|NOT COMPLETED|Treatment Period 2||0||
48452720|NCT03712228|101443732|FG003|NOT COMPLETED|Treatment Period 2||2||
48452721|NCT03712228|101443733|FG004|NOT COMPLETED|Treatment Period 2||0||
48452722|NCT03712228|101443734|FG005|NOT COMPLETED|Treatment Period 2||0||
48452723|NCT02267850|101443735|FG000|STARTED|Overall Study||15||
48452724|NCT02267850|101443736|FG001|STARTED|Overall Study||14||
48452725|NCT02267850|101443735|FG000|COMPLETED|Overall Study||14||
48452726|NCT02267850|101443736|FG001|COMPLETED|Overall Study||12||
48452727|NCT02267850|101443735|FG000|NOT COMPLETED|Overall Study||1||
48452728|NCT02267850|101443736|FG001|NOT COMPLETED|Overall Study||2||
48452729|NCT00751972|101443737|FG000|STARTED|Overall Study||140||
48452730|NCT00751972|101443738|FG001|STARTED|Overall Study||499||
48452731|NCT00751972|101443737|FG000|COMPLETED|Overall Study||140||
48452732|NCT00751972|101443738|FG001|COMPLETED|Overall Study||499||
48452733|NCT00751972|101443737|FG000|NOT COMPLETED|Overall Study||0||
48452734|NCT00751972|101443738|FG001|NOT COMPLETED|Overall Study||0||
48452735|NCT00860574|101443739|FG000|STARTED|Overall Study||96||
48452736|NCT00860574|101443739|FG000|COMPLETED|Overall Study||93||
48452737|NCT00860574|101443739|FG000|NOT COMPLETED|Overall Study||3||
48452738|NCT01408576|101443740|FG000|STARTED|Overall Study||244||
48452739|NCT01408576|101443741|FG001|STARTED|Overall Study||498||
48452740|NCT01408576|101443742|FG002|STARTED|Overall Study||508||
48452741|NCT01408576|101443740|FG000|COMPLETED|Overall Study||56||
48452742|NCT01408576|101443741|FG001|COMPLETED|Overall Study||0||
48452743|NCT01408576|101443742|FG002|COMPLETED|Overall Study||0||
48452744|NCT01408576|101443740|FG000|NOT COMPLETED|Overall Study||188||
48452745|NCT01408576|101443741|FG001|NOT COMPLETED|Overall Study||498||
48452746|NCT01408576|101443742|FG002|NOT COMPLETED|Overall Study||508||
48452747|NCT00459381|101443743|FG000|STARTED|Overall Study||35||
48452748|NCT00459381|101443743|FG000|COMPLETED|Overall Study||35||
48452749|NCT00459381|101443743|FG000|NOT COMPLETED|Overall Study||0||
48661645|NCT04439357|101956925|FG000|NOT COMPLETED|Overall Study||4||
48452750|NCT03877237|101443744|FG000|STARTED|Overall Study||156||
48452751|NCT03877237|101443745|FG001|STARTED|Overall Study||157||
48661646|NCT02579759|101956926|FG000|STARTED|Overall Study||109||
48661647|NCT02579759|101956927|FG001|STARTED|Overall Study||113||
48772368|NCT04032093|102232720|FG005|NOT COMPLETED|Overall Study||8||
48772369|NCT04032093|102232721|FG006|NOT COMPLETED|Overall Study||10||
48772370|NCT04032093|102232722|FG007|NOT COMPLETED|Overall Study||5||
48772371|NCT04032093|102232723|FG008|NOT COMPLETED|Overall Study||12||
48772372|NCT04032093|102232724|FG009|NOT COMPLETED|Overall Study||18||
48772373|NCT01064947|102232725|FG000|STARTED|Overall Study||70||
48452752|NCT03877237|101443744|FG000|Treated|Overall Study||156||
48452753|NCT03877237|101443745|FG001|Treated|Overall Study||157||
48452754|NCT03877237|101443744|FG000|COMPLETED|Overall Study||151||
48452755|NCT03877237|101443745|FG001|COMPLETED|Overall Study||151||
48452756|NCT03877237|101443744|FG000|NOT COMPLETED|Overall Study||5||
48452757|NCT03877237|101443745|FG001|NOT COMPLETED|Overall Study||6||
48452758|NCT00345683|101443746|FG000|STARTED|Overall Study||3010||
48452759|NCT00345683|101443747|FG001|STARTED|Overall Study||1010||
48452760|NCT00345683|101443746|FG000|COMPLETED|Overall Study||2985||
48772374|NCT01064947|102232725|FG000|COMPLETED|Overall Study||29||
48772375|NCT01064947|102232725|FG000|NOT COMPLETED|Overall Study||41||
48772376|NCT00976404|102232726|FG000|STARTED|Overall Study||14||
48772377|NCT00976404|102232727|FG001|STARTED|Overall Study||14||
48772378|NCT00976404|102232726|FG000|COMPLETED|Overall Study||14||
48772379|NCT00976404|102232727|FG001|COMPLETED|Overall Study||14||
48772380|NCT00976404|102232726|FG000|NOT COMPLETED|Overall Study||0||
48772381|NCT00976404|102232727|FG001|NOT COMPLETED|Overall Study||0||
48772382|NCT04294680|102232728|FG000|STARTED|Overall Study||39||
48772383|NCT04294680|102232729|FG001|STARTED|Overall Study||43||
48772384|NCT04294680|102232728|FG000|Received Allocated Intervention|Overall Study||37||
48772385|NCT04294680|102232729|FG001|Received Allocated Intervention|Overall Study||42||
48772386|NCT04294680|102232728|FG000|COMPLETED|Overall Study||36||
48452761|NCT00345683|101443747|FG001|COMPLETED|Overall Study||1001||
48452762|NCT00345683|101443746|FG000|NOT COMPLETED|Overall Study||25||
48452763|NCT00345683|101443747|FG001|NOT COMPLETED|Overall Study||9||
48452764|NCT01335464|101443748|FG000|STARTED|Overall Study||206||
48452765|NCT01335464|101443749|FG001|STARTED|Overall Study||309||
48452766|NCT01335464|101443748|FG000|COMPLETED|Overall Study||174||
48452767|NCT01335464|101443749|FG001|COMPLETED|Overall Study||260||
48452768|NCT01335464|101443748|FG000|NOT COMPLETED|Overall Study||32||
48452769|NCT01335464|101443749|FG001|NOT COMPLETED|Overall Study||49||
48452770|NCT01440647|101443750|FG000|STARTED|Overall Study||16||
48452771|NCT01440647|101443751|FG001|STARTED|Overall Study||18||
48452772|NCT01440647|101443750|FG000|COMPLETED|Overall Study||14||
48661648|NCT02579759|101956928|FG002|STARTED|Overall Study||101||
48661649|NCT02579759|101956926|FG000|COMPLETED|Overall Study||85|Completed at 12 months|
48661650|NCT02579759|101956927|FG001|COMPLETED|Overall Study||49|Completed at 12 months|
48661651|NCT02579759|101956928|FG002|COMPLETED|Overall Study||80|Completed at 12 months|
48661652|NCT02579759|101956926|FG000|NOT COMPLETED|Overall Study||24||
48661653|NCT02579759|101956927|FG001|NOT COMPLETED|Overall Study||64||
48661654|NCT02579759|101956928|FG002|NOT COMPLETED|Overall Study||21||
48661655|NCT02202577|101956929|FG000|STARTED|Overall Study||461||
48661656|NCT02202577|101956930|FG001|STARTED|Overall Study||471||
48661657|NCT02202577|101956929|FG000|COMPLETED|Overall Study||448||
48661658|NCT02202577|101956930|FG001|COMPLETED|Overall Study||452||
48661659|NCT02202577|101956929|FG000|NOT COMPLETED|Overall Study||13||
48661660|NCT02202577|101956930|FG001|NOT COMPLETED|Overall Study||19||
48661661|NCT00967486|101956931|FG000|STARTED|Overall Study||98||
48661662|NCT00967486|101956932|FG001|STARTED|Overall Study||102||
48661663|NCT00967486|101956931|FG000|COMPLETED|Overall Study||98||
48661664|NCT00967486|101956932|FG001|COMPLETED|Overall Study||102||
48772387|NCT04294680|102232729|FG001|COMPLETED|Overall Study||42||
48772388|NCT04294680|102232728|FG000|NOT COMPLETED|Overall Study||3||
48369449|NCT02817555|101232775|FG000|COMPLETED|Overall Study||21||
48369450|NCT02817555|101232776|FG001|COMPLETED|Overall Study||21||
48369451|NCT02817555|101232775|FG000|NOT COMPLETED|Overall Study||3||
48369452|NCT02817555|101232776|FG001|NOT COMPLETED|Overall Study||5||
48369453|NCT04415489|101232777|FG000|STARTED|Overall Study||50||
48369454|NCT04415489|101232778|FG001|STARTED|Overall Study||50||
48369455|NCT04415489|101232777|FG000|COMPLETED|Overall Study||50||
48369456|NCT04415489|101232778|FG001|COMPLETED|Overall Study||50||
48369457|NCT04415489|101232777|FG000|NOT COMPLETED|Overall Study||0||
48369458|NCT04415489|101232778|FG001|NOT COMPLETED|Overall Study||0||
48369459|NCT04105543|101232779|FG000|STARTED|CLR Dose Level 1: 15.6mCi||4||
48369460|NCT04105543|101232779|FG000|Participants With Dose Limiting Toxicities|CLR Dose Level 1: 15.6mCi||1||
48369461|NCT04105543|101232779|FG000|COMPLETED|CLR Dose Level 1: 15.6mCi||4||
48369462|NCT04105543|101232779|FG000|NOT COMPLETED|CLR Dose Level 1: 15.6mCi||0||
48452773|NCT01440647|101443751|FG001|COMPLETED|Overall Study||15||
48452774|NCT01440647|101443750|FG000|NOT COMPLETED|Overall Study||2||
48452775|NCT01440647|101443751|FG001|NOT COMPLETED|Overall Study||3||
48452776|NCT01331083|101443752|FG000|STARTED|Overall Study||43||
48452777|NCT01331083|101443753|FG001|STARTED|Overall Study||25||
48452778|NCT01331083|101443752|FG000|COMPLETED|Overall Study||43||
48452779|NCT01331083|101443753|FG001|COMPLETED|Overall Study||25||
48452780|NCT01331083|101443752|FG000|NOT COMPLETED|Overall Study||0||
48452781|NCT01331083|101443753|FG001|NOT COMPLETED|Overall Study||0||
48452782|NCT00947765|101443754|FG000|STARTED|Overall Study||30||
48452783|NCT00947765|101443755|FG001|STARTED|Overall Study||30||
48452784|NCT00947765|101443754|FG000|COMPLETED|Overall Study||30||
48452785|NCT00947765|101443755|FG001|COMPLETED|Overall Study||30||
48452786|NCT00947765|101443754|FG000|NOT COMPLETED|Overall Study||0||
48452787|NCT00947765|101443755|FG001|NOT COMPLETED|Overall Study||0||
48452788|NCT03565666|101443756|FG000|STARTED|Overall Study||12||
48452789|NCT03565666|101443757|FG001|STARTED|Overall Study||12||
48452790|NCT03565666|101443758|FG002|STARTED|Overall Study||12||
48452791|NCT03565666|101443756|FG000|COMPLETED|Overall Study||12||
48452792|NCT03565666|101443757|FG001|COMPLETED|Overall Study||12||
48452793|NCT03565666|101443758|FG002|COMPLETED|Overall Study||11||
48452794|NCT03565666|101443756|FG000|NOT COMPLETED|Overall Study||0||
48452795|NCT03565666|101443757|FG001|NOT COMPLETED|Overall Study||0||
48452796|NCT03565666|101443758|FG002|NOT COMPLETED|Overall Study||1||
48452797|NCT02323295|101443759|FG000|STARTED|Overall Study||2||
48452798|NCT02323295|101443760|FG001|STARTED|Overall Study||10||
48452799|NCT02323295|101443759|FG000|COMPLETED|Overall Study||2||
48452800|NCT02323295|101443760|FG001|COMPLETED|Overall Study||7||
48452801|NCT02323295|101443759|FG000|NOT COMPLETED|Overall Study||0||
48452802|NCT02323295|101443760|FG001|NOT COMPLETED|Overall Study||3||
48452803|NCT01632683|101443761|FG000|STARTED|Overall Study||548||
48452804|NCT01632683|101443762|FG001|STARTED|Overall Study||552||
48452805|NCT01632683|101443761|FG000|COMPLETED|Overall Study||548||
48452806|NCT01632683|101443762|FG001|COMPLETED|Overall Study||552||
48452807|NCT01632683|101443761|FG000|NOT COMPLETED|Overall Study||0||
48452808|NCT01632683|101443762|FG001|NOT COMPLETED|Overall Study||0||
48452809|NCT05113901|101443763|FG000|STARTED|Overall Study||4||
48452810|NCT05113901|101443764|FG001|STARTED|Overall Study||0||
48452811|NCT05113901|101443763|FG000|COMPLETED|Overall Study||3||
48452812|NCT05113901|101443764|FG001|COMPLETED|Overall Study||0||
48452813|NCT05113901|101443763|FG000|NOT COMPLETED|Overall Study||1||
48452814|NCT05113901|101443764|FG001|NOT COMPLETED|Overall Study||0||
48452815|NCT03232749|101443765|FG000|STARTED|Overall Study||25||
48452816|NCT03232749|101443765|FG000|COMPLETED|Overall Study||21||
48772389|NCT04294680|102232729|FG001|NOT COMPLETED|Overall Study||1||
48772390|NCT00737672|102232730|FG000|STARTED|Overall Study||145||
48772391|NCT00737672|102232731|FG001|STARTED|Overall Study||148||
48772392|NCT00737672|102232730|FG000|Exclusions Due to Protocol Deviations|Overall Study||14||
48772393|NCT00737672|102232731|FG001|Exclusions Due to Protocol Deviations|Overall Study||10||
48772394|NCT00737672|102232730|FG000|Per Protocol Population|Overall Study||131||
48772395|NCT00737672|102232731|FG001|Per Protocol Population|Overall Study||138||
48772396|NCT00737672|102232730|FG000|COMPLETED|Overall Study||65||
48772397|NCT00737672|102232731|FG001|COMPLETED|Overall Study||65||
48772398|NCT00737672|102232730|FG000|NOT COMPLETED|Overall Study||80||
48772399|NCT00737672|102232731|FG001|NOT COMPLETED|Overall Study||83||
48452817|NCT03232749|101443765|FG000|NOT COMPLETED|Overall Study||4||
48452818|NCT03636542|101446310|FG000|STARTED|Overall Study||12||
48452819|NCT03636542|101446311|FG001|STARTED|Overall Study||14||
48452820|NCT03636542|101446310|FG000|COMPLETED|Overall Study||10||
48452821|NCT03636542|101446311|FG001|COMPLETED|Overall Study||12||
48452822|NCT03636542|101446310|FG000|NOT COMPLETED|Overall Study||2||
48661665|NCT00967486|101956931|FG000|NOT COMPLETED|Overall Study||0||
48661666|NCT00967486|101956932|FG001|NOT COMPLETED|Overall Study||0||
48661667|NCT02120261|101956933|FG000|STARTED|Overall Study||23||
48661668|NCT02120261|101956934|FG001|STARTED|Overall Study||25||
48661669|NCT02120261|101956933|FG000|COMPLETED|Overall Study||23||
48661670|NCT02120261|101956934|FG001|COMPLETED|Overall Study||25||
48452823|NCT03636542|101446311|FG001|NOT COMPLETED|Overall Study||2||
48452824|NCT02661282|101446312|FG000|STARTED|Overall Study||3||
48452825|NCT02661282|101446313|FG001|STARTED|Overall Study||3||
48452826|NCT02661282|101446314|FG002|STARTED|Overall Study||3||
48452827|NCT02661282|101446315|FG003|STARTED|Overall Study||7||
48452828|NCT02661282|101446316|FG004|STARTED|Overall Study||3||
48452829|NCT02661282|101446317|FG005|STARTED|Overall Study||1||
48452830|NCT02661282|101446312|FG000|COMPLETED|Overall Study||3||
48452831|NCT02661282|101446313|FG001|COMPLETED|Overall Study||3||
48452832|NCT02661282|101446314|FG002|COMPLETED|Overall Study||3||
48452833|NCT02661282|101446315|FG003|COMPLETED|Overall Study||7||
48452834|NCT02661282|101446316|FG004|COMPLETED|Overall Study||3||
48452835|NCT02661282|101446317|FG005|COMPLETED|Overall Study||1||
48452836|NCT02661282|101446312|FG000|NOT COMPLETED|Overall Study||0||
48452837|NCT02661282|101446313|FG001|NOT COMPLETED|Overall Study||0||
48452838|NCT02661282|101446314|FG002|NOT COMPLETED|Overall Study||0||
48452839|NCT02661282|101446315|FG003|NOT COMPLETED|Overall Study||0||
48452840|NCT02661282|101446316|FG004|NOT COMPLETED|Overall Study||0||
48452841|NCT02661282|101446317|FG005|NOT COMPLETED|Overall Study||0||
48452842|NCT04221087|101446318|FG000|STARTED|Overall Study||2||
48452843|NCT04221087|101446319|FG001|STARTED|Overall Study||1||
48452844|NCT04221087|101446318|FG000|COMPLETED|Overall Study||2||
48452845|NCT04221087|101446319|FG001|COMPLETED|Overall Study||0||
48452846|NCT04221087|101446318|FG000|NOT COMPLETED|Overall Study||0||
48452847|NCT04221087|101446319|FG001|NOT COMPLETED|Overall Study||1||
48452848|NCT01637961|101446320|FG000|STARTED|Overall Study||23||
48452849|NCT01637961|101446320|FG000|COMPLETED|Overall Study||21||
48452850|NCT01637961|101446320|FG000|NOT COMPLETED|Overall Study||2||
48452851|NCT00558519|101446321|FG000|STARTED|Overall Study||318||
48452852|NCT00558519|101446321|FG000|COMPLETED|Overall Study||295||
48452853|NCT00558519|101446321|FG000|NOT COMPLETED|Overall Study||23||
48452854|NCT01068873|101446322|FG000|STARTED|Overall Study||1||
48452855|NCT01068873|101446322|FG000|COMPLETED|Overall Study||1||
48452856|NCT01068873|101446322|FG000|NOT COMPLETED|Overall Study||0||
48452857|NCT05105477|101446323|FG000|STARTED|Overall Study||187||
48452858|NCT05105477|101446324|FG001|STARTED|Overall Study||182||
48452859|NCT05105477|101446323|FG000|COMPLETED|Overall Study||157||
48452860|NCT05105477|101446324|FG001|COMPLETED|Overall Study||159||
48452861|NCT05105477|101446323|FG000|NOT COMPLETED|Overall Study||30||
48452862|NCT05105477|101446324|FG001|NOT COMPLETED|Overall Study||23||
48452863|NCT02133352|101446325|FG000|STARTED|Main Study (180 Day)||10||
48452864|NCT02133352|101446325|FG000|COMPLETED|Main Study (180 Day)||10||
48452865|NCT02133352|101446325|FG000|NOT COMPLETED|Main Study (180 Day)||0||
48452866|NCT02133352|101446325|FG000|STARTED|Longer Term Extension||10||
48452867|NCT02133352|101446325|FG000|COMPLETED|Longer Term Extension||4|4 of the initial 10 subjects agreed/consented to participate in the longer term extension|
48452868|NCT02133352|101446325|FG000|NOT COMPLETED|Longer Term Extension||6||
48452869|NCT00382291|101446326|FG000|STARTED|Overall Study||18||
48452870|NCT00382291|101446327|FG001|STARTED|Overall Study||17||
48452871|NCT00382291|101446328|FG002|STARTED|Overall Study||21||
48452872|NCT00382291|101446326|FG000|COMPLETED|Overall Study||14||
48452873|NCT00382291|101446327|FG001|COMPLETED|Overall Study||10||
48452874|NCT00382291|101446328|FG002|COMPLETED|Overall Study||13||
48452875|NCT00382291|101446326|FG000|NOT COMPLETED|Overall Study||4||
48452876|NCT00382291|101446327|FG001|NOT COMPLETED|Overall Study||7||
48452877|NCT00382291|101446328|FG002|NOT COMPLETED|Overall Study||8||
48452878|NCT01537549|101446329|FG000|STARTED|Overall Study||11||
48452879|NCT01537549|101446329|FG000|COMPLETED|Overall Study||8||
48452880|NCT01537549|101446329|FG000|NOT COMPLETED|Overall Study||3||
48452881|NCT01785186|101446330|FG000|STARTED|Overall Study||59||
48452882|NCT01785186|101446331|FG001|STARTED|Overall Study||63||
48452883|NCT01785186|101446332|FG002|STARTED|Overall Study||57||
48189204|NCT01140347|100786175|FG000|Received at Least 1 Dose of Study Drug|Overall Study||277||
48452884|NCT01785186|101446333|FG003|STARTED|Overall Study||63||
48452885|NCT01785186|101446334|FG004|STARTED|Overall Study||123||
48452886|NCT01785186|101446330|FG000|COMPLETED|Overall Study||53||
48452887|NCT01785186|101446331|FG001|COMPLETED|Overall Study||57||
48452888|NCT01785186|101446332|FG002|COMPLETED|Overall Study||52||
48189205|NCT01140347|100786176|FG001|Received at Least 1 Dose of Study Drug|Overall Study||276||
48452889|NCT01785186|101446333|FG003|COMPLETED|Overall Study||58||
48452890|NCT01785186|101446334|FG004|COMPLETED|Overall Study||117||
48452891|NCT01785186|101446330|FG000|NOT COMPLETED|Overall Study||6||
48452892|NCT01785186|101446331|FG001|NOT COMPLETED|Overall Study||6||
48452893|NCT01785186|101446332|FG002|NOT COMPLETED|Overall Study||5||
48452894|NCT01785186|101446333|FG003|NOT COMPLETED|Overall Study||5||
48189206|NCT01140347|100786175|FG000|COMPLETED|Overall Study||265||
48452895|NCT01785186|101446334|FG004|NOT COMPLETED|Overall Study||6||
48452896|NCT01532349|101446335|FG000|STARTED|Overall Study||17||
48452897|NCT01532349|101446336|FG001|STARTED|Overall Study||17||
48452898|NCT01532349|101446335|FG000|COMPLETED|Overall Study||15||
48452899|NCT01532349|101446336|FG001|COMPLETED|Overall Study||12||
48452900|NCT01532349|101446335|FG000|NOT COMPLETED|Overall Study||2||
48452901|NCT01532349|101446336|FG001|NOT COMPLETED|Overall Study||5||
48452902|NCT01363401|101446337|FG000|STARTED|Overall Study||41||
48452903|NCT01363401|101446338|FG001|STARTED|Overall Study||31||
48452904|NCT01363401|101446337|FG000|COMPLETED|Overall Study||39||
48452905|NCT01363401|101446338|FG001|COMPLETED|Overall Study||27||
48452906|NCT01363401|101446337|FG000|NOT COMPLETED|Overall Study||2||
48452907|NCT01363401|101446338|FG001|NOT COMPLETED|Overall Study||4||
48452908|NCT06156969|101446339|FG000|STARTED|Overall Study||19||
48452909|NCT06156969|101446339|FG000|COMPLETED|Overall Study||13||
48452910|NCT06156969|101446339|FG000|NOT COMPLETED|Overall Study||6||
48452911|NCT00990561|101446340|FG000|STARTED|Period 1||20||
48452912|NCT00990561|101446341|FG001|STARTED|Period 1||20||
48452913|NCT00990561|101446342|FG002|STARTED|Period 1||0||
48452914|NCT00990561|101446343|FG003|STARTED|Period 1||0||
48452915|NCT00990561|101446340|FG000|COMPLETED|Period 1||20||
48452916|NCT00990561|101446341|FG001|COMPLETED|Period 1||19||
48452917|NCT00990561|101446342|FG002|COMPLETED|Period 1||0||
48452918|NCT00990561|101446343|FG003|COMPLETED|Period 1||0||
48452919|NCT00990561|101446340|FG000|NOT COMPLETED|Period 1||0||
48452920|NCT00990561|101446341|FG001|NOT COMPLETED|Period 1||1||
48452921|NCT00990561|101446342|FG002|NOT COMPLETED|Period 1||0||
48452922|NCT00990561|101446343|FG003|NOT COMPLETED|Period 1||0||
48452923|NCT00990561|101446340|FG000|STARTED|Period 2||0||
48452924|NCT00990561|101446341|FG001|STARTED|Period 2||0||
48452925|NCT00990561|101446342|FG002|STARTED|Period 2||20||
48452926|NCT00990561|101446343|FG003|STARTED|Period 2||19||
48452927|NCT00990561|101446340|FG000|COMPLETED|Period 2||0||
48452928|NCT00990561|101446341|FG001|COMPLETED|Period 2||0||
48452929|NCT00990561|101446342|FG002|COMPLETED|Period 2||20||
48452930|NCT00990561|101446343|FG003|COMPLETED|Period 2||17||
48452931|NCT00990561|101446340|FG000|NOT COMPLETED|Period 2||0||
48452932|NCT00990561|101446341|FG001|NOT COMPLETED|Period 2||0||
48452933|NCT00990561|101446342|FG002|NOT COMPLETED|Period 2||0||
48452934|NCT00990561|101446343|FG003|NOT COMPLETED|Period 2||2||
48661671|NCT02120261|101956933|FG000|NOT COMPLETED|Overall Study||0||
48661672|NCT02120261|101956934|FG001|NOT COMPLETED|Overall Study||0||
48661673|NCT02180672|101956935|FG000|STARTED|Overall Study||91||
48661674|NCT02180672|101956936|FG001|STARTED|Overall Study||43||
48661675|NCT02180672|101956935|FG000|COMPLETED|Overall Study||86||
48772400|NCT03710161|102232732|FG000|STARTED|Overall Study||3||
48189207|NCT01140347|100786176|FG001|COMPLETED|Overall Study||268||
48452935|NCT02629965|101446344|FG000|STARTED|Period 1||92||
48452936|NCT02629965|101446345|FG001|STARTED|Period 1||92||
48452937|NCT02629965|101446344|FG000|COMPLETED|Period 1||88||
48452938|NCT02629965|101446345|FG001|COMPLETED|Period 1||90||
48452939|NCT02629965|101446344|FG000|NOT COMPLETED|Period 1||4||
48452940|NCT02629965|101446345|FG001|NOT COMPLETED|Period 1||2||
48452941|NCT02629965|101446344|FG000|STARTED|Period 2||88||
48452942|NCT02629965|101446345|FG001|STARTED|Period 2||90||
48452943|NCT02629965|101446344|FG000|COMPLETED|Period 2||87||
48452944|NCT02629965|101446345|FG001|COMPLETED|Period 2||90||
48452945|NCT02629965|101446344|FG000|NOT COMPLETED|Period 2||1||
48452946|NCT02629965|101446345|FG001|NOT COMPLETED|Period 2||0||
48452947|NCT04006847|101446346|FG000|STARTED|Overall Study||1||
48452948|NCT04006847|101446346|FG000|COMPLETED|Overall Study||0||
48452949|NCT04006847|101446346|FG000|NOT COMPLETED|Overall Study||1||
48452950|NCT03818919|101446347|FG000|STARTED|Overall Study||35||
48452951|NCT03818919|101446348|FG001|STARTED|Overall Study||35||
48452952|NCT03818919|101446347|FG000|COMPLETED|Overall Study||17||
48452953|NCT03818919|101446348|FG001|COMPLETED|Overall Study||23||
48452954|NCT03818919|101446347|FG000|NOT COMPLETED|Overall Study||18||
48452955|NCT03818919|101446348|FG001|NOT COMPLETED|Overall Study||12||
48452956|NCT00328783|101446349|FG000|STARTED|Overall Study||112||
48452957|NCT00328783|101446349|FG000|COMPLETED|Overall Study||86||
48452958|NCT00328783|101446349|FG000|NOT COMPLETED|Overall Study||26||
48661676|NCT02180672|101956936|FG001|COMPLETED|Overall Study||36||
48661677|NCT02180672|101956935|FG000|NOT COMPLETED|Overall Study||5||
48661678|NCT02180672|101956936|FG001|NOT COMPLETED|Overall Study||7||
48661679|NCT01881932|101956937|FG000|STARTED|Overall Study||2||
48661680|NCT01881932|101956938|FG001|STARTED|Overall Study||4||
48661681|NCT01881932|101956939|FG002|STARTED|Overall Study||13||
48661682|NCT01881932|101956937|FG000|COMPLETED|Overall Study||2||
48661683|NCT01881932|101956938|FG001|COMPLETED|Overall Study||4||
48661684|NCT01881932|101956939|FG002|COMPLETED|Overall Study||13||
48661685|NCT01881932|101956937|FG000|NOT COMPLETED|Overall Study||0||
48661686|NCT01881932|101956938|FG001|NOT COMPLETED|Overall Study||0||
48661687|NCT01881932|101956939|FG002|NOT COMPLETED|Overall Study||0||
48661688|NCT04622267|101956940|FG000|STARTED|Overall Study||113||
48661689|NCT04622267|101956941|FG001|STARTED|Overall Study||113||
48661690|NCT04622267|101956940|FG000|COMPLETED|Overall Study||113||
48661691|NCT04622267|101956941|FG001|COMPLETED|Overall Study||113||
48661692|NCT04622267|101956940|FG000|NOT COMPLETED|Overall Study||0||
48661693|NCT04622267|101956941|FG001|NOT COMPLETED|Overall Study||0||
48661694|NCT01903863|101956942|FG000|STARTED|Overall Study||15||
48661695|NCT01903863|101956943|FG001|STARTED|Overall Study||16||
48661696|NCT01903863|101956942|FG000|COMPLETED|Overall Study||13||
48661697|NCT01903863|101956943|FG001|COMPLETED|Overall Study||16||
48661698|NCT01903863|101956942|FG000|NOT COMPLETED|Overall Study||2||
48661699|NCT01903863|101956943|FG001|NOT COMPLETED|Overall Study||0||
48661700|NCT03721367|101956944|FG000|STARTED|Overall Study||28||
48661701|NCT03721367|101956944|FG000|COMPLETED|Overall Study||28||
48452959|NCT01225991|101446350|FG000|STARTED|Overall Study||18||
48452960|NCT01225991|101446350|FG000|COMPLETED|Overall Study||12||
48452961|NCT01225991|101446350|FG000|NOT COMPLETED|Overall Study||6||
48452962|NCT00634283|101446351|FG000|STARTED|Overall Study||6||
48452963|NCT00634283|101446351|FG000|COMPLETED|Overall Study||6||
48452964|NCT00634283|101446351|FG000|NOT COMPLETED|Overall Study||0||
48452965|NCT01318733|101446352|FG000|STARTED|Overall Study||449||
48452966|NCT01318733|101446352|FG000|COMPLETED|Overall Study||279||
48452967|NCT01318733|101446352|FG000|NOT COMPLETED|Overall Study||170||
48452968|NCT00217971|101446353|FG000|STARTED|Overall Study||79||
48189208|NCT01140347|100786175|FG000|NOT COMPLETED|Overall Study||18||
48452969|NCT00217971|101446354|FG001|STARTED|Overall Study||77||
48452970|NCT00217971|101446353|FG000|COMPLETED|Overall Study||55||
48452971|NCT00217971|101446354|FG001|COMPLETED|Overall Study||44||
48452972|NCT00217971|101446353|FG000|NOT COMPLETED|Overall Study||24||
48452973|NCT00217971|101446354|FG001|NOT COMPLETED|Overall Study||33||
48452974|NCT01827371|101446355|FG000|STARTED|Overall Study||115||
48452975|NCT01827371|101446356|FG001|STARTED|Overall Study||96||
48452976|NCT01827371|101446357|FG002|STARTED|Overall Study||104||
48452977|NCT01827371|101446358|FG003|STARTED|Overall Study||120||
48452978|NCT01827371|101446355|FG000|COMPLETED|Overall Study||102||
48452979|NCT01827371|101446356|FG001|COMPLETED|Overall Study||89||
48452980|NCT01827371|101446357|FG002|COMPLETED|Overall Study||93||
48452981|NCT01827371|101446358|FG003|COMPLETED|Overall Study||97||
48452982|NCT01827371|101446355|FG000|NOT COMPLETED|Overall Study||13||
48452983|NCT01827371|101446356|FG001|NOT COMPLETED|Overall Study||7||
48452984|NCT01827371|101446357|FG002|NOT COMPLETED|Overall Study||11||
48452985|NCT01827371|101446358|FG003|NOT COMPLETED|Overall Study||23||
48452986|NCT01484028|101446359|FG000|STARTED|Period 1||66||
48452987|NCT01484028|101446360|FG001|STARTED|Period 1||70||
48452988|NCT01484028|101446361|FG002|STARTED|Period 1||64||
48452989|NCT01484028|101446362|FG003|STARTED|Period 1||67||
48452990|NCT01484028|101446359|FG000|COMPLETED|Period 1||66||
48452991|NCT01484028|101446360|FG001|COMPLETED|Period 1||67||
48452992|NCT01484028|101446361|FG002|COMPLETED|Period 1||64||
48452993|NCT01484028|101446362|FG003|COMPLETED|Period 1||66||
48452994|NCT01484028|101446359|FG000|NOT COMPLETED|Period 1||0||
48452995|NCT01484028|101446360|FG001|NOT COMPLETED|Period 1||3||
48452996|NCT01484028|101446361|FG002|NOT COMPLETED|Period 1||0||
48452997|NCT01484028|101446362|FG003|NOT COMPLETED|Period 1||1||
48452998|NCT01484028|101446359|FG000|STARTED|Period 2||66||
48452999|NCT01484028|101446360|FG001|STARTED|Period 2||67||
48453000|NCT01484028|101446361|FG002|STARTED|Period 2||64||
48453001|NCT01484028|101446362|FG003|STARTED|Period 2||66||
48453002|NCT01484028|101446359|FG000|COMPLETED|Period 2||66||
48453003|NCT01484028|101446360|FG001|COMPLETED|Period 2||67||
48453004|NCT01484028|101446361|FG002|COMPLETED|Period 2||64||
48453005|NCT01484028|101446362|FG003|COMPLETED|Period 2||66||
48453006|NCT01484028|101446359|FG000|NOT COMPLETED|Period 2||0||
48453007|NCT01484028|101446360|FG001|NOT COMPLETED|Period 2||0||
48189209|NCT01140347|100786176|FG001|NOT COMPLETED|Overall Study||14||
48189210|NCT03582137|100786177|FG000|STARTED|Overall Study||31||
48189211|NCT03582137|100786178|FG001|STARTED|Overall Study||30||
48453008|NCT01484028|101446361|FG002|NOT COMPLETED|Period 2||0||
48453009|NCT01484028|101446362|FG003|NOT COMPLETED|Period 2||0||
48453010|NCT03536819|101446363|FG000|STARTED|Overall Study||20||
48453011|NCT03536819|101446363|FG000|COMPLETED|Overall Study||15||
48453012|NCT03536819|101446363|FG000|NOT COMPLETED|Overall Study||5||
48453013|NCT02082912|101446364|FG000|STARTED|Overall Study||7||
48453014|NCT02082912|101446365|FG001|STARTED|Overall Study||7||
48453015|NCT02082912|101446364|FG000|COMPLETED|Overall Study||7||
48453016|NCT02082912|101446365|FG001|COMPLETED|Overall Study||6||
48453017|NCT02082912|101446364|FG000|NOT COMPLETED|Overall Study||0||
48453018|NCT02082912|101446365|FG001|NOT COMPLETED|Overall Study||1||
48453019|NCT01207401|101446366|FG000|STARTED|Overall Study||26||
48453020|NCT01207401|101446367|FG001|STARTED|Overall Study||24||
48453021|NCT01207401|101446366|FG000|COMPLETED|Overall Study||26||
48453022|NCT01207401|101446367|FG001|COMPLETED|Overall Study||24||
48453023|NCT01207401|101446366|FG000|NOT COMPLETED|Overall Study||0||
48453024|NCT01207401|101446367|FG001|NOT COMPLETED|Overall Study||0||
48453025|NCT01392859|101446368|FG000|STARTED|Overall Study||15||
48189212|NCT03582137|100786177|FG000|COMPLETED|Overall Study||30||
48189213|NCT03582137|100786178|FG001|COMPLETED|Overall Study||30||
48453026|NCT01392859|101446369|FG001|STARTED|Overall Study||13||
48453027|NCT01392859|101446370|FG002|STARTED|Overall Study||183||
48453028|NCT01392859|101446368|FG000|Wash Out 3-7 Days|Overall Study||15||
48453029|NCT01392859|101446369|FG001|Wash Out 3-7 Days|Overall Study||13||
48453030|NCT01392859|101446370|FG002|Wash Out 3-7 Days|Overall Study||0||
48453031|NCT01392859|101446368|FG000|COMPLETED|Overall Study||13||
48453032|NCT01392859|101446369|FG001|COMPLETED|Overall Study||13||
48453033|NCT01392859|101446370|FG002|COMPLETED|Overall Study||183||
48453034|NCT01392859|101446368|FG000|NOT COMPLETED|Overall Study||2||
48453035|NCT01392859|101446369|FG001|NOT COMPLETED|Overall Study||0||
48453036|NCT01392859|101446370|FG002|NOT COMPLETED|Overall Study||0||
48453037|NCT01208922|101446371|FG000|STARTED|Overall Study||420||
48453038|NCT01208922|101446372|FG001|STARTED|Overall Study||415||
48453039|NCT01208922|101446371|FG000|COMPLETED|Overall Study||409||
48453040|NCT01208922|101446372|FG001|COMPLETED|Overall Study||405||
48453041|NCT01208922|101446371|FG000|NOT COMPLETED|Overall Study||11||
48453042|NCT01208922|101446372|FG001|NOT COMPLETED|Overall Study||10||
48453043|NCT00707915|101446373|FG000|STARTED|Overall Study||30||
48453044|NCT00707915|101446373|FG000|Effects of Discontinuing Benzodiazepine|Overall Study||30||
48453045|NCT00707915|101446373|FG000|COMPLETED|Overall Study||30||
48453046|NCT00707915|101446373|FG000|NOT COMPLETED|Overall Study||0||
48453047|NCT01735877|101446374|FG000|STARTED|Overall Study||27||
48453048|NCT01735877|101446375|FG001|STARTED|Overall Study||21||
48453049|NCT01735877|101446374|FG000|COMPLETED|Overall Study||26||
48453050|NCT01735877|101446375|FG001|COMPLETED|Overall Study||21||
48453051|NCT01735877|101446374|FG000|NOT COMPLETED|Overall Study||1||
48453052|NCT01735877|101446375|FG001|NOT COMPLETED|Overall Study||0||
48453053|NCT00591253|101446376|FG000|STARTED|Overall Study||140||
48453054|NCT00591253|101446377|FG001|STARTED|Overall Study||137||
48453055|NCT00591253|101446378|FG002|STARTED|Overall Study||138||
48453056|NCT00591253|101446376|FG000|COMPLETED|Overall Study||126||
48453057|NCT00591253|101446377|FG001|COMPLETED|Overall Study||116||
48453058|NCT00591253|101446378|FG002|COMPLETED|Overall Study||123||
48453059|NCT00591253|101446376|FG000|NOT COMPLETED|Overall Study||14||
48453060|NCT00591253|101446377|FG001|NOT COMPLETED|Overall Study||21||
48453061|NCT00591253|101446378|FG002|NOT COMPLETED|Overall Study||15||
48453062|NCT01389024|101446379|FG000|STARTED|Overall Study||6||
48453063|NCT01389024|101446380|FG001|STARTED|Overall Study||6||
48453064|NCT01389024|101446379|FG000|COMPLETED|Overall Study||5||
48453065|NCT01389024|101446380|FG001|COMPLETED|Overall Study||5||
48453066|NCT01389024|101446379|FG000|NOT COMPLETED|Overall Study||1||
48453067|NCT01389024|101446380|FG001|NOT COMPLETED|Overall Study||1||
48453068|NCT02555618|101446381|FG000|STARTED|Overall Study||200||
48453069|NCT02555618|101446382|FG001|STARTED|Overall Study||200||
48453070|NCT02555618|101446381|FG000|COMPLETED|Overall Study||199||
48453071|NCT02555618|101446382|FG001|COMPLETED|Overall Study||200||
48453072|NCT02555618|101446381|FG000|NOT COMPLETED|Overall Study||1||
48453073|NCT02555618|101446382|FG001|NOT COMPLETED|Overall Study||0||
48453074|NCT02450760|101446383|FG000|STARTED|Overall Study||15||
48453075|NCT02450760|101446384|FG001|STARTED|Overall Study||18||
48453076|NCT02450760|101446383|FG000|COMPLETED|Overall Study||15||
48453077|NCT02450760|101446384|FG001|COMPLETED|Overall Study||18||
48453078|NCT02450760|101446383|FG000|NOT COMPLETED|Overall Study||0||
48453079|NCT02450760|101446384|FG001|NOT COMPLETED|Overall Study||0||
48453080|NCT00962949|101446385|FG000|STARTED|Overall Study||13||
48453081|NCT00962949|101446386|FG001|STARTED|Overall Study||15||
48453082|NCT00962949|101446385|FG000|COMPLETED|Overall Study||13||
48453083|NCT00962949|101446386|FG001|COMPLETED|Overall Study||15||
48453084|NCT00962949|101446385|FG000|NOT COMPLETED|Overall Study||0||
48453085|NCT00962949|101446386|FG001|NOT COMPLETED|Overall Study||0||
48453086|NCT00080288|101446387|FG000|STARTED|Overall Study||127||
48453087|NCT00080288|101446388|FG001|STARTED|Overall Study||127||
48453088|NCT00080288|101446387|FG000|COMPLETED|Overall Study||97||
48453089|NCT00080288|101446388|FG001|COMPLETED|Overall Study||89||
48453090|NCT00080288|101446387|FG000|NOT COMPLETED|Overall Study||30||
48453091|NCT00080288|101446388|FG001|NOT COMPLETED|Overall Study||38||
48453092|NCT04292171|101446389|FG000|STARTED|Overall Study||109||
48453093|NCT04292171|101446390|FG001|STARTED|Overall Study||110||
48453094|NCT04292171|101446389|FG000|COMPLETED|Overall Study||107||
48453095|NCT04292171|101446390|FG001|COMPLETED|Overall Study||109||
48453096|NCT04292171|101446389|FG000|NOT COMPLETED|Overall Study||2||
48453097|NCT04292171|101446390|FG001|NOT COMPLETED|Overall Study||1||
48453098|NCT02414854|101446391|FG000|STARTED|Overall Study||317|Randomized|
48772401|NCT03710161|102232733|FG001|STARTED|Overall Study||2||
48772402|NCT03710161|102232732|FG000|COMPLETED|Overall Study||0||
48453099|NCT02414854|101446392|FG001|STARTED|Overall Study||631|Randomized|
48772403|NCT03710161|102232733|FG001|COMPLETED|Overall Study||0||
48772404|NCT03710161|102232732|FG000|NOT COMPLETED|Overall Study||3||
48772405|NCT03710161|102232733|FG001|NOT COMPLETED|Overall Study||2||
48772406|NCT01077076|102232734|FG000|STARTED|First Intervention||5||
48772407|NCT01077076|102232735|FG001|STARTED|First Intervention||5||
48772408|NCT01077076|102232736|FG002|STARTED|First Intervention||5||
48772409|NCT01077076|102232737|FG003|STARTED|First Intervention||5||
48772410|NCT01077076|102232738|FG004|STARTED|First Intervention||5||
48772411|NCT01077076|102232739|FG005|STARTED|First Intervention||5||
48772412|NCT01077076|102232734|FG000|COMPLETED|First Intervention||4||
48772413|NCT01077076|102232735|FG001|COMPLETED|First Intervention||5||
48453100|NCT02414854|101446393|FG002|STARTED|Overall Study||321|Randomized|
48453101|NCT02414854|101446394|FG003|STARTED|Overall Study||633|Randomized|
48453102|NCT02414854|101446391|FG000|Treated|Overall Study||315|Randomized|
48453103|NCT02414854|101446392|FG001|Treated|Overall Study||629|Randomized|
48453104|NCT02414854|101446393|FG002|Treated|Overall Study||321|Randomized|
48453105|NCT02414854|101446394|FG003|Treated|Overall Study||632|Randomized|
48453106|NCT02414854|101446391|FG000|COMPLETED|Overall Study||295||
48453107|NCT02414854|101446392|FG001|COMPLETED|Overall Study||586||
48453108|NCT02414854|101446393|FG002|COMPLETED|Overall Study||301||
48453109|NCT02414854|101446394|FG003|COMPLETED|Overall Study||582||
48453110|NCT02414854|101446391|FG000|NOT COMPLETED|Overall Study||22||
48453111|NCT02414854|101446392|FG001|NOT COMPLETED|Overall Study||45||
48453112|NCT02414854|101446393|FG002|NOT COMPLETED|Overall Study||20||
48453113|NCT02414854|101446394|FG003|NOT COMPLETED|Overall Study||51||
48453114|NCT03263819|101446395|FG000|STARTED|Overall Study||13||
48453115|NCT03263819|101446396|FG001|STARTED|Overall Study||13||
48453116|NCT03263819|101446395|FG000|COMPLETED|Overall Study||12||
48453117|NCT03263819|101446396|FG001|COMPLETED|Overall Study||13||
48453118|NCT03263819|101446395|FG000|NOT COMPLETED|Overall Study||1||
48453119|NCT03263819|101446396|FG001|NOT COMPLETED|Overall Study||0||
48453120|NCT00597584|101446397|FG000|STARTED|Overall Study||549||
48453121|NCT00597584|101446398|FG001|STARTED|Overall Study||274||
48453122|NCT00597584|101446397|FG000|COMPLETED|Overall Study||421||
48453123|NCT00597584|101446398|FG001|COMPLETED|Overall Study||211||
48453124|NCT00597584|101446397|FG000|NOT COMPLETED|Overall Study||128||
48453125|NCT00597584|101446398|FG001|NOT COMPLETED|Overall Study||63||
48453126|NCT01796860|101446399|FG000|STARTED|Overall Study||10||
48453127|NCT01796860|101446399|FG000|COMPLETED|Overall Study||7||
48453128|NCT01796860|101446399|FG000|NOT COMPLETED|Overall Study||3||
48453129|NCT00926289|101446400|FG000|STARTED|Overall Study||294||
48453130|NCT00926289|101446401|FG001|STARTED|Overall Study||594||
48453131|NCT00926289|101446400|FG000|COMPLETED|Overall Study||269||
48453132|NCT00926289|101446401|FG001|COMPLETED|Overall Study||558||
48453133|NCT00926289|101446400|FG000|NOT COMPLETED|Overall Study||25||
48453134|NCT00926289|101446401|FG001|NOT COMPLETED|Overall Study||36||
48453135|NCT02217345|101446402|FG000|STARTED|Overall Study||27||
48772414|NCT01077076|102232736|FG002|COMPLETED|First Intervention||5||
48772415|NCT01077076|102232737|FG003|COMPLETED|First Intervention||5||
48453136|NCT02217345|101446403|FG001|STARTED|Overall Study||26||
48453137|NCT02217345|101446402|FG000|Baseline Data Available|Overall Study||26||
48453138|NCT02217345|101446403|FG001|Baseline Data Available|Overall Study||26||
48453139|NCT02217345|101446402|FG000|COMPLETED|Overall Study||20||
48453140|NCT02217345|101446403|FG001|COMPLETED|Overall Study||21||
48453141|NCT02217345|101446402|FG000|NOT COMPLETED|Overall Study||7||
48453142|NCT02217345|101446403|FG001|NOT COMPLETED|Overall Study||5||
48453143|NCT04071366|101446404|FG000|STARTED|Part 1: Open-label (29 Days)||16||
48453144|NCT04071366|101446405|FG001|STARTED|Part 1: Open-label (29 Days)||12||
48453145|NCT04071366|101446406|FG002|STARTED|Part 1: Open-label (29 Days)||35||
48453146|NCT04071366|101446407|FG003|STARTED|Part 1: Open-label (29 Days)||0||
48453147|NCT04071366|101446408|FG004|STARTED|Part 1: Open-label (29 Days)||0||
48453148|NCT04071366|101446404|FG000|COMPLETED|Part 1: Open-label (29 Days)||11||
48453149|NCT04071366|101446405|FG001|COMPLETED|Part 1: Open-label (29 Days)||10||
48453150|NCT04071366|101446406|FG002|COMPLETED|Part 1: Open-label (29 Days)||22||
48453151|NCT04071366|101446407|FG003|COMPLETED|Part 1: Open-label (29 Days)||0||
48453152|NCT04071366|101446408|FG004|COMPLETED|Part 1: Open-label (29 Days)||0||
48453153|NCT04071366|101446404|FG000|NOT COMPLETED|Part 1: Open-label (29 Days)||5||
48453154|NCT04071366|101446405|FG001|NOT COMPLETED|Part 1: Open-label (29 Days)||2||
48453155|NCT04071366|101446406|FG002|NOT COMPLETED|Part 1: Open-label (29 Days)||13||
48453156|NCT04071366|101446407|FG003|NOT COMPLETED|Part 1: Open-label (29 Days)||0||
48453157|NCT04071366|101446408|FG004|NOT COMPLETED|Part 1: Open-label (29 Days)||0||
48453158|NCT04071366|101446404|FG000|STARTED|Part 2: Randomized (29 Days)||0||
48453159|NCT04071366|101446405|FG001|STARTED|Part 2: Randomized (29 Days)||0||
48453160|NCT04071366|101446406|FG002|STARTED|Part 2: Randomized (29 Days)||0||
48453161|NCT04071366|101446407|FG003|STARTED|Part 2: Randomized (29 Days)||23||
48453162|NCT04071366|101446408|FG004|STARTED|Part 2: Randomized (29 Days)||24||
48453163|NCT04071366|101446404|FG000|COMPLETED|Part 2: Randomized (29 Days)||0||
48453164|NCT04071366|101446405|FG001|COMPLETED|Part 2: Randomized (29 Days)||0||
48453165|NCT04071366|101446406|FG002|COMPLETED|Part 2: Randomized (29 Days)||0||
48453166|NCT04071366|101446407|FG003|COMPLETED|Part 2: Randomized (29 Days)||17||
48453167|NCT04071366|101446408|FG004|COMPLETED|Part 2: Randomized (29 Days)||15||
48453168|NCT04071366|101446404|FG000|NOT COMPLETED|Part 2: Randomized (29 Days)||0||
48453169|NCT04071366|101446405|FG001|NOT COMPLETED|Part 2: Randomized (29 Days)||0||
48453170|NCT04071366|101446406|FG002|NOT COMPLETED|Part 2: Randomized (29 Days)||0||
48453171|NCT04071366|101446407|FG003|NOT COMPLETED|Part 2: Randomized (29 Days)||6||
48453172|NCT04071366|101446408|FG004|NOT COMPLETED|Part 2: Randomized (29 Days)||9||
48453173|NCT00320593|101446409|FG000|STARTED|Overall Study||59||
48453174|NCT00320593|101446410|FG001|STARTED|Overall Study||59||
48453175|NCT00320593|101446409|FG000|COMPLETED|Overall Study||52||
48453176|NCT00320593|101446410|FG001|COMPLETED|Overall Study||58||
48453177|NCT00320593|101446409|FG000|NOT COMPLETED|Overall Study||7||
48453178|NCT00320593|101446410|FG001|NOT COMPLETED|Overall Study||1||
48453179|NCT02746705|101446411|FG000|STARTED|Overall Study||17||
48453180|NCT02746705|101446412|FG001|STARTED|Overall Study||14||
48453181|NCT02746705|101446411|FG000|COMPLETED|Overall Study||15||
48453182|NCT02746705|101446412|FG001|COMPLETED|Overall Study||12||
48453183|NCT02746705|101446411|FG000|NOT COMPLETED|Overall Study||2||
48453184|NCT02746705|101446412|FG001|NOT COMPLETED|Overall Study||2||
48453185|NCT03070431|101446413|FG000|STARTED|Overall Study||44||
48453186|NCT03070431|101446413|FG000|COMPLETED|Overall Study||40||
48453187|NCT03070431|101446413|FG000|NOT COMPLETED|Overall Study||4||
48453188|NCT01572428|101446414|FG000|STARTED|Overall Study||402||
48453189|NCT01572428|101446415|FG001|STARTED|Overall Study||402||
48453190|NCT01572428|101446414|FG000|COMPLETED|Overall Study||399||
48453191|NCT01572428|101446415|FG001|COMPLETED|Overall Study||401||
48453192|NCT01572428|101446414|FG000|NOT COMPLETED|Overall Study||3||
48453193|NCT01572428|101446415|FG001|NOT COMPLETED|Overall Study||1||
48453194|NCT01190098|101446416|FG000|STARTED|Overall Study||42||
48453195|NCT01190098|101446417|FG001|STARTED|Overall Study||10||
48453196|NCT01190098|101446416|FG000|COMPLETED|Overall Study||39||
48453197|NCT01190098|101446417|FG001|COMPLETED|Overall Study||8||
48453198|NCT01190098|101446416|FG000|NOT COMPLETED|Overall Study||3||
48661702|NCT03721367|101956944|FG000|NOT COMPLETED|Overall Study||0||
48661703|NCT02943499|101956945|FG000|STARTED|Overall Study||41||
48661704|NCT02943499|101956946|FG001|STARTED|Overall Study||39||
48661705|NCT02943499|101956945|FG000|COMPLETED|Overall Study||34||
48661706|NCT02943499|101956946|FG001|COMPLETED|Overall Study||34||
48661707|NCT02943499|101956945|FG000|NOT COMPLETED|Overall Study||7||
48772416|NCT01077076|102232738|FG004|COMPLETED|First Intervention||5||
48772417|NCT01077076|102232739|FG005|COMPLETED|First Intervention||5||
48772418|NCT01077076|102232734|FG000|NOT COMPLETED|First Intervention||1||
48772419|NCT01077076|102232735|FG001|NOT COMPLETED|First Intervention||0||
48772420|NCT01077076|102232736|FG002|NOT COMPLETED|First Intervention||0||
48189214|NCT03582137|100786177|FG000|NOT COMPLETED|Overall Study||1||
48453199|NCT01190098|101446417|FG001|NOT COMPLETED|Overall Study||2||
48453200|NCT00370396|101446418|FG000|STARTED|Overall Study||737|1112 subjects were vaccinated in current study out of 1200 who received at least 1 dose of Prevenar|
48453201|NCT00370396|101446419|FG001|STARTED|Overall Study||92|1112 subjects were vaccinated in current study out of 1200 who received at least 1 dose of Prevenar|
48453202|NCT00370396|101446420|FG002|STARTED|Overall Study||283|1112 subjects were vaccinated in current study out of 1200 who received at least 1 dose of Prevenar|
48453203|NCT00370396|101446418|FG000|COMPLETED|Overall Study||726||
48453204|NCT00370396|101446419|FG001|COMPLETED|Overall Study||91||
48453205|NCT00370396|101446420|FG002|COMPLETED|Overall Study||282||
48453206|NCT00370396|101446418|FG000|NOT COMPLETED|Overall Study||11||
48453207|NCT00370396|101446419|FG001|NOT COMPLETED|Overall Study||1||
48453208|NCT00370396|101446420|FG002|NOT COMPLETED|Overall Study||1||
48453209|NCT00566098|101446421|FG000|STARTED|Collection of MILs||25||
48453210|NCT00566098|101446421|FG000|COMPLETED|Collection of MILs||23||
48453211|NCT00566098|101446421|FG000|NOT COMPLETED|Collection of MILs||2||
48453212|NCT00566098|101446421|FG000|STARTED|Generation of MILs Product||23||
48453213|NCT00566098|101446421|FG000|COMPLETED|Generation of MILs Product||22||
48453214|NCT00566098|101446421|FG000|NOT COMPLETED|Generation of MILs Product||1||
48453215|NCT00566098|101446421|FG000|STARTED|Administration of ASCT+MILs||22||
48453216|NCT00566098|101446421|FG000|COMPLETED|Administration of ASCT+MILs||4||
48661708|NCT02943499|101956946|FG001|NOT COMPLETED|Overall Study||5||
48661709|NCT00836901|101956947|FG000|STARTED|First Intervention||24||
48661710|NCT00836901|101956948|FG001|STARTED|First Intervention||28||
48661711|NCT00836901|101956947|FG000|COMPLETED|First Intervention||23||
48661712|NCT00836901|101956948|FG001|COMPLETED|First Intervention||28||
48661713|NCT00836901|101956947|FG000|NOT COMPLETED|First Intervention||1||
48661714|NCT00836901|101956948|FG001|NOT COMPLETED|First Intervention||0||
48661715|NCT00836901|101956947|FG000|STARTED|Second Intervention||23||
48661716|NCT00836901|101956948|FG001|STARTED|Second Intervention||28||
48661717|NCT00836901|101956947|FG000|COMPLETED|Second Intervention||23||
48661718|NCT00836901|101956948|FG001|COMPLETED|Second Intervention||28||
48661719|NCT00836901|101956947|FG000|NOT COMPLETED|Second Intervention||0||
48661720|NCT00836901|101956948|FG001|NOT COMPLETED|Second Intervention||0||
48661721|NCT00468546|101956949|FG000|STARTED|Week 24 Analysis||208||
48661722|NCT00468546|101956950|FG001|STARTED|Week 24 Analysis||308||
48661723|NCT00468546|101956949|FG000|COMPLETED|Week 24 Analysis||111||
48661724|NCT00468546|101956950|FG001|COMPLETED|Week 24 Analysis||253||
48661725|NCT00468546|101956949|FG000|NOT COMPLETED|Week 24 Analysis||97||
48661726|NCT00468546|101956950|FG001|NOT COMPLETED|Week 24 Analysis||55||
48661727|NCT00468546|101956949|FG000|STARTED|Week 24 to Week 104 Analysis||208||
48661728|NCT00468546|101956950|FG001|STARTED|Week 24 to Week 104 Analysis||308||
48661729|NCT00468546|101956949|FG000|COMPLETED|Week 24 to Week 104 Analysis||103||
48661730|NCT00468546|101956950|FG001|COMPLETED|Week 24 to Week 104 Analysis||83||
48661731|NCT00468546|101956949|FG000|NOT COMPLETED|Week 24 to Week 104 Analysis||105||
48661732|NCT00468546|101956950|FG001|NOT COMPLETED|Week 24 to Week 104 Analysis||225||
48661733|NCT02913326|101956951|FG000|STARTED|Overall Study||60||
48661734|NCT02913326|101956952|FG001|STARTED|Overall Study||60||
48661735|NCT02913326|101956951|FG000|COMPLETED|Overall Study||59||
48661736|NCT02913326|101956952|FG001|COMPLETED|Overall Study||58||
48453217|NCT00566098|101446421|FG000|NOT COMPLETED|Administration of ASCT+MILs||18||
48453218|NCT01076166|101446422|FG000|STARTED|Overall Study||337||
48453219|NCT01076166|101446422|FG000|COMPLETED|Overall Study||328||
48453220|NCT01076166|101446422|FG000|NOT COMPLETED|Overall Study||9||
48453221|NCT00399490|101446423|FG000|STARTED|Overall Study||281||
48453222|NCT00399490|101446423|FG000|COMPLETED|Overall Study||183||
48453223|NCT00399490|101446423|FG000|NOT COMPLETED|Overall Study||98||
48453224|NCT01528878|101446424|FG000|STARTED|Overall Study||30||
48453225|NCT01528878|101446424|FG000|COMPLETED|Overall Study||30||
48453226|NCT01528878|101446424|FG000|NOT COMPLETED|Overall Study||0||
48453227|NCT00361257|101446425|FG000|STARTED|Step 1: Minocycline vs. Placebo||52||
48453228|NCT00361257|101446426|FG001|STARTED|Step 1: Minocycline vs. Placebo||55||
48453229|NCT00361257|101446425|FG000|COMPLETED|Step 1: Minocycline vs. Placebo||40||
48453230|NCT00361257|101446426|FG001|COMPLETED|Step 1: Minocycline vs. Placebo||43||
48453231|NCT00361257|101446425|FG000|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12||
48453232|NCT00361257|101446426|FG001|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12||
48453233|NCT00361257|101446425|FG000|STARTED|Step 2: Minocycline(Open Label) for All||28||
48453234|NCT00361257|101446426|FG001|STARTED|Step 2: Minocycline(Open Label) for All||34||
48453235|NCT00361257|101446425|FG000|COMPLETED|Step 2: Minocycline(Open Label) for All||13||
48453236|NCT00361257|101446426|FG001|COMPLETED|Step 2: Minocycline(Open Label) for All||19||
48453237|NCT00361257|101446425|FG000|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15||
48453238|NCT00361257|101446426|FG001|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15||
48453239|NCT01092702|101446427|FG000|STARTED|Overall Study||32||
48453240|NCT01092702|101446427|FG000|COMPLETED|Overall Study||23||
48453241|NCT01092702|101446427|FG000|NOT COMPLETED|Overall Study||9||
48453242|NCT00323609|101446428|FG000|STARTED|Overall Study||191||
48453243|NCT00323609|101446429|FG001|STARTED|Overall Study||190||
48661737|NCT02913326|101956951|FG000|NOT COMPLETED|Overall Study||1||
48772421|NCT01077076|102232737|FG003|NOT COMPLETED|First Intervention||0||
48772422|NCT01077076|102232738|FG004|NOT COMPLETED|First Intervention||0||
48189215|NCT03582137|100786178|FG001|NOT COMPLETED|Overall Study||0||
48189216|NCT01341080|100786179|FG000|STARTED|Overall Study||18||
48453244|NCT00323609|101446430|FG002|STARTED|Overall Study||8||
48453245|NCT00323609|101446431|FG003|STARTED|Overall Study||15||
48772423|NCT01077076|102232739|FG005|NOT COMPLETED|First Intervention||0||
48772424|NCT01077076|102232734|FG000|STARTED|Washout Period of 2 Weeks||4||
48453246|NCT00323609|101446428|FG000|COMPLETED|Overall Study||100||
48453247|NCT00323609|101446429|FG001|COMPLETED|Overall Study||91||
48453248|NCT00323609|101446430|FG002|COMPLETED|Overall Study||0||
48453249|NCT00323609|101446431|FG003|COMPLETED|Overall Study||0||
48453250|NCT00323609|101446428|FG000|NOT COMPLETED|Overall Study||91||
48453251|NCT00323609|101446429|FG001|NOT COMPLETED|Overall Study||99||
48453252|NCT00323609|101446430|FG002|NOT COMPLETED|Overall Study||8||
48453253|NCT00323609|101446431|FG003|NOT COMPLETED|Overall Study||15||
48453254|NCT00711867|101446432|FG000|STARTED|Overall Study||30||
48453255|NCT00711867|101446433|FG001|STARTED|Overall Study||25||
48453256|NCT00711867|101446432|FG000|COMPLETED|Overall Study||25||
48453257|NCT00711867|101446433|FG001|COMPLETED|Overall Study||21||
48453258|NCT00711867|101446432|FG000|NOT COMPLETED|Overall Study||5||
48453259|NCT00711867|101446433|FG001|NOT COMPLETED|Overall Study||4||
48453260|NCT01901211|101446434|FG000|STARTED|First Ten-week Period||6||
48453261|NCT01901211|101446435|FG001|STARTED|First Ten-week Period||5||
48661738|NCT02913326|101956952|FG001|NOT COMPLETED|Overall Study||2||
48661739|NCT02513641|101956953|FG000|STARTED|Overall Study||8||
48661740|NCT02513641|101956953|FG000|COMPLETED|Overall Study||8||
48661741|NCT02513641|101956953|FG000|NOT COMPLETED|Overall Study||0||
48661742|NCT01044459|101956954|FG000|STARTED|Overall Study||312||
48453262|NCT01901211|101446434|FG000|COMPLETED|First Ten-week Period||6||
48453263|NCT01901211|101446435|FG001|COMPLETED|First Ten-week Period||5||
48453264|NCT01901211|101446434|FG000|NOT COMPLETED|First Ten-week Period||0||
48453265|NCT01901211|101446435|FG001|NOT COMPLETED|First Ten-week Period||0||
48661743|NCT01044459|101956955|FG001|STARTED|Overall Study||293||
48661744|NCT01044459|101956954|FG000|COMPLETED|Overall Study||179||
48661745|NCT01044459|101956955|FG001|COMPLETED|Overall Study||162||
48661746|NCT01044459|101956954|FG000|NOT COMPLETED|Overall Study||133||
48661747|NCT01044459|101956955|FG001|NOT COMPLETED|Overall Study||131||
48661748|NCT02038647|101956956|FG000|STARTED|Overall Study||89||
48661749|NCT02038647|101956957|FG001|STARTED|Overall Study||89||
48661750|NCT02038647|101956956|FG000|COMPLETED|Overall Study||0||
48661751|NCT02038647|101956957|FG001|COMPLETED|Overall Study||0||
48661752|NCT02038647|101956956|FG000|NOT COMPLETED|Overall Study||89||
48661753|NCT02038647|101956957|FG001|NOT COMPLETED|Overall Study||89||
48661754|NCT00003907|101956958|FG000|STARTED|Overall Study||19||
48661755|NCT00003907|101956959|FG001|STARTED|Overall Study||31||
48661756|NCT00003907|101956958|FG000|Eligible|Overall Study||18||
48661757|NCT00003907|101956959|FG001|Eligible|Overall Study||29||
48661758|NCT00003907|101956958|FG000|Received Protocol Therapy (Treated)|Overall Study||18||
48661759|NCT00003907|101956959|FG001|Received Protocol Therapy (Treated)|Overall Study||31||
48661760|NCT00003907|101956958|FG000|Eligible and Treated|Overall Study||17||
48661761|NCT00003907|101956959|FG001|Eligible and Treated|Overall Study||29||
48661762|NCT00003907|101956958|FG000|COMPLETED|Overall Study||6||
48661763|NCT00003907|101956959|FG001|COMPLETED|Overall Study||8||
48661764|NCT00003907|101956958|FG000|NOT COMPLETED|Overall Study||13||
48661765|NCT00003907|101956959|FG001|NOT COMPLETED|Overall Study||23||
48661766|NCT05252702|101956960|FG000|STARTED|Overall Study||464|Enrolled subjects|
48661767|NCT05252702|101956960|FG000|Attempted Implant|Overall Study||452||
48453266|NCT01901211|101446434|FG000|STARTED|Washout (6 Weeks)||6||
48453267|NCT01901211|101446435|FG001|STARTED|Washout (6 Weeks)||5||
48453268|NCT01901211|101446434|FG000|COMPLETED|Washout (6 Weeks)||6||
48453269|NCT01901211|101446435|FG001|COMPLETED|Washout (6 Weeks)||5||
48453270|NCT01901211|101446434|FG000|NOT COMPLETED|Washout (6 Weeks)||0||
48453271|NCT01901211|101446435|FG001|NOT COMPLETED|Washout (6 Weeks)||0||
48661768|NCT05252702|101956960|FG000|Predischarge Visit|Overall Study||450||
48661769|NCT05252702|101956960|FG000|1-month Visit|Overall Study||443||
48453272|NCT01901211|101446434|FG000|STARTED|Second Ten-week Period||6||
48453273|NCT01901211|101446435|FG001|STARTED|Second Ten-week Period||5||
48453274|NCT01901211|101446434|FG000|COMPLETED|Second Ten-week Period||6||
48453275|NCT01901211|101446435|FG001|COMPLETED|Second Ten-week Period||5||
48453276|NCT01901211|101446434|FG000|NOT COMPLETED|Second Ten-week Period||0||
48453277|NCT01901211|101446435|FG001|NOT COMPLETED|Second Ten-week Period||0||
48453278|NCT00066807|101446436|FG000|STARTED|Overall Study||14||
48453279|NCT00066807|101446437|FG001|STARTED|Overall Study||15||
48453280|NCT00066807|101446436|FG000|COMPLETED|Overall Study||0||
48453281|NCT00066807|101446437|FG001|COMPLETED|Overall Study||0||
48453282|NCT00066807|101446436|FG000|NOT COMPLETED|Overall Study||14||
48453283|NCT00066807|101446437|FG001|NOT COMPLETED|Overall Study||15||
48453284|NCT03734679|101446438|FG000|STARTED|Overall Study||12||
48453285|NCT03734679|101446438|FG000|COMPLETED|Overall Study||11||
48453286|NCT03734679|101446438|FG000|NOT COMPLETED|Overall Study||1||
48453287|NCT02328807|101446439|FG000|STARTED|Overall Study||6||
48453288|NCT02328807|101446439|FG000|COMPLETED|Overall Study||6||
48453289|NCT02328807|101446439|FG000|NOT COMPLETED|Overall Study||0||
48453290|NCT00350519|101446440|FG000|STARTED|Overall Study||18||
48453291|NCT00350519|101446441|FG001|STARTED|Overall Study||19||
48453292|NCT00350519|101446440|FG000|COMPLETED|Overall Study||14||
48453293|NCT00350519|101446441|FG001|COMPLETED|Overall Study||13||
48661770|NCT05252702|101956960|FG000|3-month Visit|Overall Study||442||
48661771|NCT05252702|101956960|FG000|6-month Visit|Overall Study||435||
48661772|NCT05252702|101956960|FG000|12-month Visit|Overall Study||360||
48661773|NCT05252702|101956960|FG000|18-month Visit|Overall Study||100||
48661774|NCT05252702|101956960|FG000|COMPLETED|Overall Study||30|24-month Visit|
48661775|NCT05252702|101956960|FG000|NOT COMPLETED|Overall Study||434||
48661776|NCT02389738|101956961|FG000|STARTED|Overall Study||6||
48661777|NCT02389738|101956961|FG000|COMPLETED|Overall Study||5||
48661778|NCT02389738|101956961|FG000|NOT COMPLETED|Overall Study||1||
48661779|NCT03008213|101956962|FG000|STARTED|Overall Study||1||
48661780|NCT03008213|101956962|FG000|COMPLETED|Overall Study||1||
48661781|NCT03008213|101956962|FG000|NOT COMPLETED|Overall Study||0||
48661782|NCT03211858|101956963|FG000|STARTED|Overall Study||301||
48661783|NCT03211858|101956964|FG001|STARTED|Overall Study||296||
48661784|NCT03211858|101956963|FG000|Treated|Overall Study||301||
48661785|NCT03211858|101956964|FG001|Treated|Overall Study||296||
48661786|NCT03211858|101956963|FG000|COMPLETED|Overall Study||264|Completed 12-month on treatment period.|
48661787|NCT03211858|101956964|FG001|COMPLETED|Overall Study||263|Completed 12-month on treatment period.|
48661788|NCT03211858|101956963|FG000|NOT COMPLETED|Overall Study||37||
48661789|NCT03211858|101956964|FG001|NOT COMPLETED|Overall Study||33||
48661790|NCT01840072|101956965|FG000|STARTED|Overall Study||2038||
48661791|NCT01840072|101956966|FG001|STARTED|Overall Study||2033||
48661792|NCT01840072|101956965|FG000|COMPLETED|Overall Study||2031||
48661793|NCT01840072|101956966|FG001|COMPLETED|Overall Study||1986||
48661794|NCT01840072|101956965|FG000|NOT COMPLETED|Overall Study||7||
48661795|NCT01840072|101956966|FG001|NOT COMPLETED|Overall Study||47||
48661796|NCT01397591|101956967|FG000|STARTED|Overall Study||2||
48661797|NCT01397591|101956967|FG000|COMPLETED|Overall Study||2||
48661798|NCT01397591|101956967|FG000|NOT COMPLETED|Overall Study||0||
48661799|NCT00814983|101956968|FG000|STARTED|Overall Study||15||
48661800|NCT00814983|101956969|FG001|STARTED|Overall Study||0||
48661801|NCT00814983|101956968|FG000|COMPLETED|Overall Study||12||
48661802|NCT00814983|101956969|FG001|COMPLETED|Overall Study||0||
48661803|NCT00814983|101956968|FG000|NOT COMPLETED|Overall Study||3||
48661804|NCT00814983|101956969|FG001|NOT COMPLETED|Overall Study||0||
48661805|NCT03411044|101956970|FG000|STARTED|Overall Study||420||
48661806|NCT03411044|101956970|FG000|COMPLETED|Overall Study||230||
48661807|NCT03411044|101956970|FG000|NOT COMPLETED|Overall Study||190||
48661808|NCT00298155|101956971|FG000|STARTED|Overall Study||12||
48661809|NCT00298155|101956972|FG001|STARTED|Overall Study||10||
48661810|NCT00298155|101956973|FG002|STARTED|Overall Study||13||
48661811|NCT00298155|101956971|FG000|COMPLETED|Overall Study||12||
48661812|NCT00298155|101956972|FG001|COMPLETED|Overall Study||10||
48661813|NCT00298155|101956973|FG002|COMPLETED|Overall Study||13||
48772425|NCT01077076|102232735|FG001|STARTED|Washout Period of 2 Weeks||5||
48772426|NCT01077076|102232736|FG002|STARTED|Washout Period of 2 Weeks||5||
48772427|NCT01077076|102232737|FG003|STARTED|Washout Period of 2 Weeks||5||
48772428|NCT01077076|102232738|FG004|STARTED|Washout Period of 2 Weeks||5||
48772429|NCT01077076|102232739|FG005|STARTED|Washout Period of 2 Weeks||5||
48772430|NCT01077076|102232734|FG000|COMPLETED|Washout Period of 2 Weeks||4||
48772431|NCT01077076|102232735|FG001|COMPLETED|Washout Period of 2 Weeks||5||
48772432|NCT01077076|102232736|FG002|COMPLETED|Washout Period of 2 Weeks||5||
48772433|NCT01077076|102232737|FG003|COMPLETED|Washout Period of 2 Weeks||5||
48772434|NCT01077076|102232738|FG004|COMPLETED|Washout Period of 2 Weeks||5||
48772435|NCT01077076|102232739|FG005|COMPLETED|Washout Period of 2 Weeks||5||
48772436|NCT01077076|102232734|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0||
48772437|NCT01077076|102232735|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0||
48453294|NCT00350519|101446440|FG000|NOT COMPLETED|Overall Study||4||
48453295|NCT00350519|101446441|FG001|NOT COMPLETED|Overall Study||6||
48453296|NCT00854620|101446442|FG000|STARTED|Overall Study||9||
48453297|NCT00854620|101446442|FG000|COMPLETED|Overall Study||8||
48453298|NCT00854620|101446442|FG000|NOT COMPLETED|Overall Study||1||
48453299|NCT00409188|101446443|FG000|STARTED|Overall Study||1006||
48453300|NCT00409188|101446444|FG001|STARTED|Overall Study||507||
48453301|NCT00409188|101446443|FG000|COMPLETED|Overall Study||623||
48453302|NCT00409188|101446444|FG001|COMPLETED|Overall Study||332||
48453303|NCT00409188|101446443|FG000|NOT COMPLETED|Overall Study||383||
48453304|NCT00409188|101446444|FG001|NOT COMPLETED|Overall Study||175||
48453305|NCT01999231|101446445|FG000|STARTED|Overall Study||6||
48453306|NCT01999231|101446446|FG001|STARTED|Overall Study||6||
48453307|NCT01999231|101446447|FG002|STARTED|Overall Study||6||
48661814|NCT00298155|101956971|FG000|NOT COMPLETED|Overall Study||0||
48661815|NCT00298155|101956972|FG001|NOT COMPLETED|Overall Study||0||
48661816|NCT00298155|101956973|FG002|NOT COMPLETED|Overall Study||0||
48661817|NCT04349098|101956974|FG000|STARTED|Overall Study||103||
48661818|NCT04349098|101956975|FG001|STARTED|Overall Study||87||
48772438|NCT01077076|102232736|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0||
48772439|NCT01077076|102232737|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0||
48772440|NCT01077076|102232738|FG004|NOT COMPLETED|Washout Period of 2 Weeks||0||
48772441|NCT01077076|102232739|FG005|NOT COMPLETED|Washout Period of 2 Weeks||0||
48772442|NCT01077076|102232734|FG000|STARTED|Second Intervention||4||
48772443|NCT01077076|102232735|FG001|STARTED|Second Intervention||5||
48772444|NCT01077076|102232736|FG002|STARTED|Second Intervention||5||
48772445|NCT01077076|102232737|FG003|STARTED|Second Intervention||5||
48772446|NCT01077076|102232738|FG004|STARTED|Second Intervention||5||
48772447|NCT01077076|102232739|FG005|STARTED|Second Intervention||5||
48772448|NCT01077076|102232734|FG000|COMPLETED|Second Intervention||4||
48772449|NCT01077076|102232735|FG001|COMPLETED|Second Intervention||5||
48772450|NCT01077076|102232736|FG002|COMPLETED|Second Intervention||5||
48772451|NCT01077076|102232737|FG003|COMPLETED|Second Intervention||5||
48772452|NCT01077076|102232738|FG004|COMPLETED|Second Intervention||5||
48453308|NCT01999231|101446448|FG003|STARTED|Overall Study||6||
48661819|NCT04349098|101956974|FG000|Treated|Overall Study||102||
48661820|NCT04349098|101956975|FG001|Treated|Overall Study||86||
48661821|NCT04349098|101956974|FG000|COMPLETED|Overall Study||65||
48661822|NCT04349098|101956975|FG001|COMPLETED|Overall Study||61||
48772453|NCT01077076|102232739|FG005|COMPLETED|Second Intervention||5||
48772454|NCT01077076|102232734|FG000|NOT COMPLETED|Second Intervention||0||
48453309|NCT01999231|101446445|FG000|COMPLETED|Overall Study||6||
48453310|NCT01999231|101446446|FG001|COMPLETED|Overall Study||6||
48453311|NCT01999231|101446447|FG002|COMPLETED|Overall Study||6||
48453312|NCT01999231|101446448|FG003|COMPLETED|Overall Study||6||
48453313|NCT01999231|101446445|FG000|NOT COMPLETED|Overall Study||0||
48453314|NCT01999231|101446446|FG001|NOT COMPLETED|Overall Study||0||
48453315|NCT01999231|101446447|FG002|NOT COMPLETED|Overall Study||0||
48453316|NCT01999231|101446448|FG003|NOT COMPLETED|Overall Study||0||
48661823|NCT04349098|101956974|FG000|NOT COMPLETED|Overall Study||38||
48453317|NCT03712137|101446449|FG000|STARTED|Control Period||49||
48453318|NCT03712137|101446450|FG001|STARTED|Control Period||157||
48453319|NCT03712137|101446449|FG000|Participants Treated as Randomized|Control Period||49||
48453320|NCT03712137|101446450|FG001|Participants Treated as Randomized|Control Period||156||
48453321|NCT03712137|101446449|FG000|Participants Not Treated as Randomized|Control Period||0|Participant was randomized to the treatment group (VOLUX XC) but subsequently found to not meet inclusion criteria and was discontinued at randomization without receiving treatment.|
48453322|NCT03712137|101446450|FG001|Participants Not Treated as Randomized|Control Period||1|Participant was randomized to the treatment group (VOLUX XC) but subsequently found to not meet inclusion criteria and was discontinued at randomization without receiving treatment.|
48661824|NCT04349098|101956975|FG001|NOT COMPLETED|Overall Study||26||
48661825|NCT04248153|101956976|FG000|STARTED|Overall Study||3||
48661826|NCT04248153|101956977|FG001|STARTED|Overall Study||0||
48661827|NCT04248153|101956978|FG002|STARTED|Overall Study||0||
48661828|NCT04248153|101956976|FG000|COMPLETED|Overall Study||3||
48661829|NCT04248153|101956977|FG001|COMPLETED|Overall Study||0||
48661830|NCT04248153|101956978|FG002|COMPLETED|Overall Study||0||
48661831|NCT04248153|101956976|FG000|NOT COMPLETED|Overall Study||0||
48661832|NCT04248153|101956977|FG001|NOT COMPLETED|Overall Study||0||
48661833|NCT04248153|101956978|FG002|NOT COMPLETED|Overall Study||0||
48661834|NCT03579719|101956979|FG000|STARTED|Overall Study||15||
48661835|NCT03579719|101956979|FG000|COMPLETED|Overall Study||14||
48661836|NCT03579719|101956979|FG000|NOT COMPLETED|Overall Study||1||
48661837|NCT00607477|101956980|FG000|STARTED|Overall Study||0||
48661838|NCT00607477|101956981|FG001|STARTED|Overall Study||2||
48661839|NCT00607477|101956980|FG000|COMPLETED|Overall Study||0||
48661840|NCT00607477|101956981|FG001|COMPLETED|Overall Study||2||
48661841|NCT00607477|101956980|FG000|NOT COMPLETED|Overall Study||0||
48661842|NCT00607477|101956981|FG001|NOT COMPLETED|Overall Study||0||
48661843|NCT01291160|101956982|FG000|STARTED|Overall Study||66||
48661844|NCT01291160|101956983|FG001|STARTED|Overall Study||64||
48661845|NCT01291160|101956982|FG000|COMPLETED|Overall Study||48||
48661846|NCT01291160|101956983|FG001|COMPLETED|Overall Study||48||
48661847|NCT01291160|101956982|FG000|NOT COMPLETED|Overall Study||18||
48661848|NCT01291160|101956983|FG001|NOT COMPLETED|Overall Study||16||
48661849|NCT02088554|101956984|FG000|STARTED|Overall Study||1312||
48661850|NCT02088554|101956984|FG000|Implanted|Overall Study||1132||
48661851|NCT02088554|101956984|FG000|1 Year Completion|Overall Study||1050|Primary outcome milestone (a minimum of 15 participants per valve size completes 1 year follow-up)|
48661852|NCT02088554|101956984|FG000|COMPLETED|Overall Study||268|Participants who have completed 5 year follow-up|
48661853|NCT02088554|101956984|FG000|NOT COMPLETED|Overall Study||1044||
48661854|NCT04601493|101956985|FG000|STARTED|Overall Study||126||10
48661855|NCT04601493|101956986|FG001|STARTED|Overall Study||112||11
48661856|NCT04601493|101956987|FG002|STARTED|Overall Study||104||9
48661857|NCT04601493|101956988|FG003|STARTED|Overall Study||131||11
48661858|NCT04601493|101956985|FG000|COMPLETED|Overall Study||126||10
48661859|NCT04601493|101956986|FG001|COMPLETED|Overall Study||112||11
48661860|NCT04601493|101956987|FG002|COMPLETED|Overall Study||104||9
48661861|NCT04601493|101956988|FG003|COMPLETED|Overall Study||131||11
48661862|NCT04601493|101956985|FG000|NOT COMPLETED|Overall Study||0||0
48661863|NCT04601493|101956986|FG001|NOT COMPLETED|Overall Study||0||0
48661864|NCT04601493|101956987|FG002|NOT COMPLETED|Overall Study||0||0
48661865|NCT04601493|101956988|FG003|NOT COMPLETED|Overall Study||0||0
48661866|NCT00131885|101956989|FG000|STARTED|Time 1: First Intervention||9||
48661867|NCT00131885|101956990|FG001|STARTED|Time 1: First Intervention||9||
48661868|NCT00131885|101956991|FG002|STARTED|Time 1: First Intervention||9||
48661869|NCT00131885|101956992|FG003|STARTED|Time 1: First Intervention||9||
48453323|NCT03712137|101446449|FG000|COMPLETED|Control Period||47||
48453324|NCT03712137|101446450|FG001|COMPLETED|Control Period||149||
48453325|NCT03712137|101446449|FG000|NOT COMPLETED|Control Period||2||
48453326|NCT03712137|101446450|FG001|NOT COMPLETED|Control Period||8||
48453327|NCT03712137|101446449|FG000|STARTED|Opt VOLUX Treatment Follow Up Period||42|Participants that were randomized to the No-Treatment Control arm that received optional VOLUX treatment after the Control Period|
48453328|NCT03712137|101446450|FG001|STARTED|Opt VOLUX Treatment Follow Up Period||0|Participants that were randomized to the No-Treatment Control arm that received optional VOLUX treatment after the Control Period|
48453329|NCT03712137|101446449|FG000|COMPLETED|Opt VOLUX Treatment Follow Up Period||35||
48453330|NCT03712137|101446450|FG001|COMPLETED|Opt VOLUX Treatment Follow Up Period||0||
48453331|NCT03712137|101446449|FG000|NOT COMPLETED|Opt VOLUX Treatment Follow Up Period||7||
48661870|NCT00131885|101956989|FG000|COMPLETED|Time 1: First Intervention||9||
48661871|NCT00131885|101956990|FG001|COMPLETED|Time 1: First Intervention||9||
48661872|NCT00131885|101956991|FG002|COMPLETED|Time 1: First Intervention||9||
48661873|NCT00131885|101956992|FG003|COMPLETED|Time 1: First Intervention||9||
48661874|NCT00131885|101956989|FG000|NOT COMPLETED|Time 1: First Intervention||0||
48661875|NCT00131885|101956990|FG001|NOT COMPLETED|Time 1: First Intervention||0||
48661876|NCT00131885|101956991|FG002|NOT COMPLETED|Time 1: First Intervention||0||
48661877|NCT00131885|101956992|FG003|NOT COMPLETED|Time 1: First Intervention||0||
48661878|NCT00131885|101956989|FG000|STARTED|Time 2: Second Intervention||9||
48661879|NCT00131885|101956990|FG001|STARTED|Time 2: Second Intervention||9||
48661880|NCT00131885|101956991|FG002|STARTED|Time 2: Second Intervention||9||
48661881|NCT00131885|101956992|FG003|STARTED|Time 2: Second Intervention||9||
48661882|NCT00131885|101956989|FG000|COMPLETED|Time 2: Second Intervention||9||
48661883|NCT00131885|101956990|FG001|COMPLETED|Time 2: Second Intervention||9||
48661884|NCT00131885|101956991|FG002|COMPLETED|Time 2: Second Intervention||9||
48453332|NCT03712137|101446450|FG001|NOT COMPLETED|Opt VOLUX Treatment Follow Up Period||0||
48453333|NCT03712137|101446449|FG000|STARTED|VOLUX Maintenance Treatment Period||0|Participants in the VOLUX XC treatment population who received VOLUX maintenance treatment|
48453334|NCT03712137|101446450|FG001|STARTED|VOLUX Maintenance Treatment Period||87|Participants in the VOLUX XC treatment population who received VOLUX maintenance treatment|
48453335|NCT03712137|101446449|FG000|COMPLETED|VOLUX Maintenance Treatment Period||0||
48453336|NCT03712137|101446450|FG001|COMPLETED|VOLUX Maintenance Treatment Period||85||
48453337|NCT03712137|101446449|FG000|NOT COMPLETED|VOLUX Maintenance Treatment Period||0||
48453338|NCT03712137|101446450|FG001|NOT COMPLETED|VOLUX Maintenance Treatment Period||2||
48453339|NCT01504867|101446451|FG000|STARTED|Overall Study||202||
48453340|NCT01504867|101446452|FG001|STARTED|Overall Study||198||
48453341|NCT01504867|101446451|FG000|COMPLETED|Overall Study||195||
48453342|NCT01504867|101446452|FG001|COMPLETED|Overall Study||195||
48453343|NCT01504867|101446451|FG000|NOT COMPLETED|Overall Study||7||
48453344|NCT01504867|101446452|FG001|NOT COMPLETED|Overall Study||3||
48453345|NCT03439293|101446453|FG000|STARTED|Overall Study||61||
48453346|NCT03439293|101446453|FG000|Response-evaluable Population|Overall Study||59|Response-evaluable population was defined as participants who received at least 1 dose of ixazomib, had measurable disease either during screening or before the first dose of study drug, and had a baseline and at least 1 postbaseline disease assessment.|
48453347|NCT03439293|101446453|FG000|COMPLETED|Overall Study||0||
48453348|NCT03439293|101446453|FG000|NOT COMPLETED|Overall Study||61||
48453349|NCT00923195|101446454|FG000|STARTED|Overall Study||2||
48453350|NCT00923195|101446455|FG001|STARTED|Overall Study||2||
48453351|NCT00923195|101446454|FG000|COMPLETED|Overall Study||2||
48453352|NCT00923195|101446455|FG001|COMPLETED|Overall Study||1||
48453353|NCT00923195|101446454|FG000|NOT COMPLETED|Overall Study||0||
48453354|NCT00923195|101446455|FG001|NOT COMPLETED|Overall Study||1||
48453355|NCT02769000|101446456|FG000|STARTED|Overall Study||5||
48453356|NCT02769000|101446457|FG001|STARTED|Overall Study||0||
48453357|NCT02769000|101446456|FG000|COMPLETED|Overall Study||5||
48453358|NCT02769000|101446457|FG001|COMPLETED|Overall Study||0||
48453359|NCT02769000|101446456|FG000|NOT COMPLETED|Overall Study||0||
48453360|NCT02769000|101446457|FG001|NOT COMPLETED|Overall Study||0||
48453361|NCT02577042|101446458|FG000|STARTED|Overall Study||20||
48453362|NCT02577042|101446459|FG001|STARTED|Overall Study||22||
48453363|NCT02577042|101446458|FG000|COMPLETED|Overall Study||15||
48453364|NCT02577042|101446459|FG001|COMPLETED|Overall Study||19||
48453365|NCT02577042|101446458|FG000|NOT COMPLETED|Overall Study||5||
48453366|NCT02577042|101446459|FG001|NOT COMPLETED|Overall Study||3||
48453367|NCT02580188|101446460|FG000|STARTED|Overall Study||35||
48453368|NCT02580188|101446461|FG001|STARTED|Overall Study||35||
48453369|NCT02580188|101446460|FG000|COMPLETED|Overall Study||32||
48453370|NCT02580188|101446461|FG001|COMPLETED|Overall Study||32||
48453371|NCT02580188|101446460|FG000|NOT COMPLETED|Overall Study||3||
48453372|NCT02580188|101446461|FG001|NOT COMPLETED|Overall Study||3||
48453373|NCT01706770|101446462|FG000|STARTED|Overall Study||33||
48453374|NCT01706770|101446463|FG001|STARTED|Overall Study||17||
48453375|NCT01706770|101446462|FG000|COMPLETED|Overall Study||31||
48453376|NCT01706770|101446463|FG001|COMPLETED|Overall Study||17||
48661885|NCT00131885|101956992|FG003|COMPLETED|Time 2: Second Intervention||9||
48661886|NCT00131885|101956989|FG000|NOT COMPLETED|Time 2: Second Intervention||0||
48661887|NCT00131885|101956990|FG001|NOT COMPLETED|Time 2: Second Intervention||0||
48772455|NCT01077076|102232735|FG001|NOT COMPLETED|Second Intervention||0||
48772456|NCT01077076|102232736|FG002|NOT COMPLETED|Second Intervention||0||
48772457|NCT01077076|102232737|FG003|NOT COMPLETED|Second Intervention||0||
48772458|NCT01077076|102232738|FG004|NOT COMPLETED|Second Intervention||0||
48772459|NCT01077076|102232739|FG005|NOT COMPLETED|Second Intervention||0||
48772460|NCT01077076|102232734|FG000|STARTED|Washout Period of 2 Weeks||4||
48661888|NCT00131885|101956991|FG002|NOT COMPLETED|Time 2: Second Intervention||0||
48661889|NCT00131885|101956992|FG003|NOT COMPLETED|Time 2: Second Intervention||0||
48661890|NCT02062008|101956993|FG000|STARTED|Overall Study||2||
48661891|NCT02062008|101956993|FG000|COMPLETED|Overall Study||2||
48772461|NCT01077076|102232735|FG001|STARTED|Washout Period of 2 Weeks||5||
48772462|NCT01077076|102232736|FG002|STARTED|Washout Period of 2 Weeks||5||
48453377|NCT01706770|101446462|FG000|NOT COMPLETED|Overall Study||2||
48453378|NCT01706770|101446463|FG001|NOT COMPLETED|Overall Study||0||
48453379|NCT03670537|101446464|FG000|STARTED|Overall Study||102||
48453380|NCT03670537|101446464|FG000|COMPLETED|Overall Study||101||
48453381|NCT03670537|101446464|FG000|NOT COMPLETED|Overall Study||1||
48661892|NCT02062008|101956993|FG000|NOT COMPLETED|Overall Study||0||
48661893|NCT01443026|101956994|FG000|STARTED|Overall Study||29||
48772463|NCT01077076|102232737|FG003|STARTED|Washout Period of 2 Weeks||5||
48772464|NCT01077076|102232738|FG004|STARTED|Washout Period of 2 Weeks||5||
48772465|NCT01077076|102232739|FG005|STARTED|Washout Period of 2 Weeks||5||
48772466|NCT01077076|102232734|FG000|COMPLETED|Washout Period of 2 Weeks||4||
48772467|NCT01077076|102232735|FG001|COMPLETED|Washout Period of 2 Weeks||5||
48772468|NCT01077076|102232736|FG002|COMPLETED|Washout Period of 2 Weeks||5||
48772469|NCT01077076|102232737|FG003|COMPLETED|Washout Period of 2 Weeks||5||
48453382|NCT01613131|101446465|FG000|STARTED|Overall Study||20||
48453383|NCT01613131|101446466|FG001|STARTED|Overall Study||18||
48453384|NCT01613131|101446465|FG000|COMPLETED|Overall Study||17||
48453385|NCT01613131|101446466|FG001|COMPLETED|Overall Study||13||
48453386|NCT01613131|101446465|FG000|NOT COMPLETED|Overall Study||3||
48453387|NCT01613131|101446466|FG001|NOT COMPLETED|Overall Study||5||
48453388|NCT03151499|101446467|FG000|STARTED|Period 1 (R)||15||
48453389|NCT03151499|101446467|FG000|COMPLETED|Period 1 (R)||15||
48453390|NCT03151499|101446467|FG000|NOT COMPLETED|Period 1 (R)||0||
48453391|NCT03151499|101446467|FG000|STARTED|Period 2 (T)||15||
48453392|NCT03151499|101446467|FG000|COMPLETED|Period 2 (T)||15||
48453393|NCT03151499|101446467|FG000|NOT COMPLETED|Period 2 (T)||0||
48453394|NCT03627195|101446468|FG000|STARTED|Overall Study||6||
48453395|NCT03627195|101446469|FG001|STARTED|Overall Study||6||
48453396|NCT03627195|101446470|FG002|STARTED|Overall Study||6||
48453397|NCT03627195|101446471|FG003|STARTED|Overall Study||6||
48453398|NCT03627195|101446472|FG004|STARTED|Overall Study||6||
48453399|NCT03627195|101446473|FG005|STARTED|Overall Study||10||
48453400|NCT03627195|101446468|FG000|COMPLETED|Overall Study||5||
48453401|NCT03627195|101446469|FG001|COMPLETED|Overall Study||6||
48453402|NCT03627195|101446470|FG002|COMPLETED|Overall Study||6||
48453403|NCT03627195|101446471|FG003|COMPLETED|Overall Study||6||
48453404|NCT03627195|101446472|FG004|COMPLETED|Overall Study||6||
48453405|NCT03627195|101446473|FG005|COMPLETED|Overall Study||10||
48453406|NCT03627195|101446468|FG000|NOT COMPLETED|Overall Study||1||
48453407|NCT03627195|101446469|FG001|NOT COMPLETED|Overall Study||0||
48453408|NCT03627195|101446470|FG002|NOT COMPLETED|Overall Study||0||
48453409|NCT03627195|101446471|FG003|NOT COMPLETED|Overall Study||0||
48453410|NCT03627195|101446472|FG004|NOT COMPLETED|Overall Study||0||
48453411|NCT03627195|101446473|FG005|NOT COMPLETED|Overall Study||0||
48453412|NCT00686790|101446474|FG000|STARTED|Overall Study||48||
48453413|NCT00686790|101446474|FG000|COMPLETED|Overall Study||32||
48453414|NCT00686790|101446474|FG000|NOT COMPLETED|Overall Study||16||
48453415|NCT02328547|101446475|FG000|STARTED|First Intervention (12 Weeks)||25||
48453416|NCT02328547|101446476|FG001|STARTED|First Intervention (12 Weeks)||23||
48453417|NCT02328547|101446475|FG000|COMPLETED|First Intervention (12 Weeks)||22||
48453418|NCT02328547|101446476|FG001|COMPLETED|First Intervention (12 Weeks)||23||
48453419|NCT02328547|101446475|FG000|NOT COMPLETED|First Intervention (12 Weeks)||3||
48453420|NCT02328547|101446476|FG001|NOT COMPLETED|First Intervention (12 Weeks)||0||
48453421|NCT02328547|101446475|FG000|STARTED|Second Intervention (12 Weeks)||22||
48453422|NCT02328547|101446476|FG001|STARTED|Second Intervention (12 Weeks)||23||
48453423|NCT02328547|101446475|FG000|COMPLETED|Second Intervention (12 Weeks)||22||
48453424|NCT02328547|101446476|FG001|COMPLETED|Second Intervention (12 Weeks)||23||
48453425|NCT02328547|101446475|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0||
48453426|NCT02328547|101446476|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0||
48453427|NCT00528879|101446477|FG000|STARTED|Short-term Period (Day 1 to Week 24)||137||
48453428|NCT00528879|101446478|FG001|STARTED|Short-term Period (Day 1 to Week 24)||137||
48453429|NCT00528879|101446479|FG002|STARTED|Short-term Period (Day 1 to Week 24)||137||
48453430|NCT00528879|101446480|FG003|STARTED|Short-term Period (Day 1 to Week 24)||135||
48453431|NCT00528879|101446477|FG000|Completed the Period|Short-term Period (Day 1 to Week 24)||119||
48453432|NCT00528879|101446478|FG001|Completed the Period|Short-term Period (Day 1 to Week 24)||121||
48453433|NCT00528879|101446479|FG002|Completed the Period|Short-term Period (Day 1 to Week 24)||122||
48453434|NCT00528879|101446480|FG003|Completed the Period|Short-term Period (Day 1 to Week 24)||121||
48453435|NCT00528879|101446477|FG000|COMPLETED|Short-term Period (Day 1 to Week 24)||115||
48453436|NCT00528879|101446478|FG001|COMPLETED|Short-term Period (Day 1 to Week 24)||120||
48453437|NCT00528879|101446479|FG002|COMPLETED|Short-term Period (Day 1 to Week 24)||122||
48453438|NCT00528879|101446480|FG003|COMPLETED|Short-term Period (Day 1 to Week 24)||119||
48453439|NCT00528879|101446477|FG000|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||22||
48453440|NCT00528879|101446478|FG001|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||17||
48453441|NCT00528879|101446479|FG002|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||15||
48453442|NCT00528879|101446480|FG003|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||16||
48453443|NCT00528879|101446477|FG000|STARTED|Long-term Period (Weeks 24 to 102)||115||
48453444|NCT00528879|101446478|FG001|STARTED|Long-term Period (Weeks 24 to 102)||120||
48453445|NCT00528879|101446479|FG002|STARTED|Long-term Period (Weeks 24 to 102)||122||
48453446|NCT00528879|101446480|FG003|STARTED|Long-term Period (Weeks 24 to 102)||119||
48453447|NCT00528879|101446477|FG000|COMPLETED|Long-term Period (Weeks 24 to 102)||73||
48453448|NCT00528879|101446478|FG001|COMPLETED|Long-term Period (Weeks 24 to 102)||82||
48453449|NCT00528879|101446479|FG002|COMPLETED|Long-term Period (Weeks 24 to 102)||89||
48453450|NCT00528879|101446480|FG003|COMPLETED|Long-term Period (Weeks 24 to 102)||95||
48453451|NCT00528879|101446477|FG000|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||42||
48453452|NCT00528879|101446478|FG001|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||38||
48453453|NCT00528879|101446479|FG002|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||33||
48453454|NCT00528879|101446480|FG003|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||24||
48772470|NCT01077076|102232738|FG004|COMPLETED|Washout Period of 2 Weeks||5||
48661894|NCT01443026|101956995|FG001|STARTED|Overall Study||37||
48661895|NCT01443026|101956994|FG000|COMPLETED|Overall Study||26||
48661896|NCT01443026|101956995|FG001|COMPLETED|Overall Study||32||
48661897|NCT01443026|101956994|FG000|NOT COMPLETED|Overall Study||3||
48661898|NCT01443026|101956995|FG001|NOT COMPLETED|Overall Study||5||
48661899|NCT01472185|101956996|FG000|STARTED|Overall Study||232||
48661900|NCT01472185|101956997|FG001|STARTED|Overall Study||233||
48661901|NCT01472185|101956996|FG000|COMPLETED|Overall Study||198||
48661902|NCT01472185|101956997|FG001|COMPLETED|Overall Study||199||
48661903|NCT01472185|101956996|FG000|NOT COMPLETED|Overall Study||34||
48661904|NCT01472185|101956997|FG001|NOT COMPLETED|Overall Study||34||
48661905|NCT01837550|101956998|FG000|STARTED|T0-T1, 5 Weeks||37||
48661906|NCT01837550|101956999|FG001|STARTED|T0-T1, 5 Weeks||37||
48661907|NCT01837550|101956998|FG000|COMPLETED|T0-T1, 5 Weeks||37||
48661908|NCT01837550|101956999|FG001|COMPLETED|T0-T1, 5 Weeks||37||
48661909|NCT01837550|101956998|FG000|NOT COMPLETED|T0-T1, 5 Weeks||0||
48661910|NCT01837550|101956999|FG001|NOT COMPLETED|T0-T1, 5 Weeks||0||
48661911|NCT01837550|101956998|FG000|STARTED|T0-T2, 6 Months Follow-up||37||
48661912|NCT01837550|101956999|FG001|STARTED|T0-T2, 6 Months Follow-up||37||
48661913|NCT01837550|101956998|FG000|COMPLETED|T0-T2, 6 Months Follow-up||37||
48661914|NCT01837550|101956999|FG001|COMPLETED|T0-T2, 6 Months Follow-up||37||
48661915|NCT01837550|101956998|FG000|NOT COMPLETED|T0-T2, 6 Months Follow-up||0||
48661916|NCT01837550|101956999|FG001|NOT COMPLETED|T0-T2, 6 Months Follow-up||0||
48661917|NCT02776735|101957000|FG000|STARTED|Overall Study||7||
48661918|NCT02776735|101957001|FG001|STARTED|Overall Study||6||
48661919|NCT02776735|101957002|FG002|STARTED|Overall Study||43||
48661920|NCT02776735|101957003|FG003|STARTED|Overall Study||31||
48661921|NCT02776735|101957004|FG004|STARTED|Overall Study||6||
48661922|NCT02776735|101957005|FG005|STARTED|Overall Study||9||
48661923|NCT02776735|101957000|FG000|Treated|Overall Study||7||
48661924|NCT02776735|101957001|FG001|Treated|Overall Study||6||
48661925|NCT02776735|101957002|FG002|Treated|Overall Study||42||
48661926|NCT02776735|101957003|FG003|Treated|Overall Study||31||
48661927|NCT02776735|101957004|FG004|Treated|Overall Study||6||
48661928|NCT02776735|101957005|FG005|Treated|Overall Study||9||
48661929|NCT02776735|101957000|FG000|COMPLETED|Overall Study||6||
48661930|NCT02776735|101957001|FG001|COMPLETED|Overall Study||6||
48661931|NCT02776735|101957002|FG002|COMPLETED|Overall Study||38||
48661932|NCT02776735|101957003|FG003|COMPLETED|Overall Study||27||
48661933|NCT02776735|101957004|FG004|COMPLETED|Overall Study||6||
48661934|NCT02776735|101957005|FG005|COMPLETED|Overall Study||7||
48661935|NCT02776735|101957000|FG000|NOT COMPLETED|Overall Study||1||
48661936|NCT02776735|101957001|FG001|NOT COMPLETED|Overall Study||0||
48661937|NCT02776735|101957002|FG002|NOT COMPLETED|Overall Study||5||
48661938|NCT02776735|101957003|FG003|NOT COMPLETED|Overall Study||4||
48661939|NCT02776735|101957004|FG004|NOT COMPLETED|Overall Study||0||
48661940|NCT02776735|101957005|FG005|NOT COMPLETED|Overall Study||2||
48661941|NCT03443401|101957006|FG000|STARTED|Overall Study||43||
48661942|NCT03443401|101957006|FG000|COMPLETED|Overall Study||29||
48661943|NCT03443401|101957006|FG000|NOT COMPLETED|Overall Study||14||
48661944|NCT02607722|101957007|FG000|STARTED|Overall Study||10117|registered patients|
48661945|NCT02607722|101957007|FG000|Treated|Overall Study||5753||
48661946|NCT02607722|101957007|FG000|COMPLETED|Overall Study||1535||
48661947|NCT02607722|101957007|FG000|NOT COMPLETED|Overall Study||8582||
48661948|NCT04976855|101957008|FG000|STARTED|Part I||9||
48661949|NCT04976855|101957009|FG001|STARTED|Part I||9||
48661950|NCT04976855|101957010|FG002|STARTED|Part I||6||
48661951|NCT04976855|101957011|FG003|STARTED|Part I||0||
48661952|NCT04976855|101957012|FG004|STARTED|Part I||0||
48661953|NCT04976855|101957013|FG005|STARTED|Part I||0||
48661954|NCT04976855|101957014|FG006|STARTED|Part I||0||
48661955|NCT04976855|101957008|FG000|COMPLETED|Part I||9||
48661956|NCT04976855|101957009|FG001|COMPLETED|Part I||8||
48661957|NCT04976855|101957010|FG002|COMPLETED|Part I||6||
48661958|NCT04976855|101957011|FG003|COMPLETED|Part I||0||
48661959|NCT04976855|101957012|FG004|COMPLETED|Part I||0||
48661960|NCT04976855|101957013|FG005|COMPLETED|Part I||0||
48661961|NCT04976855|101957014|FG006|COMPLETED|Part I||0||
48661962|NCT04976855|101957008|FG000|NOT COMPLETED|Part I||0||
48661963|NCT04976855|101957009|FG001|NOT COMPLETED|Part I||1||
48661964|NCT04976855|101957010|FG002|NOT COMPLETED|Part I||0||
48661965|NCT04976855|101957011|FG003|NOT COMPLETED|Part I||0||
48772471|NCT01077076|102232739|FG005|COMPLETED|Washout Period of 2 Weeks||5||
48661966|NCT04976855|101957012|FG004|NOT COMPLETED|Part I||0||
48661967|NCT04976855|101957013|FG005|NOT COMPLETED|Part I||0||
48661968|NCT04976855|101957014|FG006|NOT COMPLETED|Part I||0||
48661969|NCT04976855|101957008|FG000|STARTED|Part II||0||
48661970|NCT04976855|101957009|FG001|STARTED|Part II||0||
48661971|NCT04976855|101957010|FG002|STARTED|Part II||0||
48661972|NCT04976855|101957011|FG003|STARTED|Part II||9||
48661973|NCT04976855|101957012|FG004|STARTED|Part II||9||
48661974|NCT04976855|101957013|FG005|STARTED|Part II||6||
48661975|NCT04976855|101957014|FG006|STARTED|Part II||0||
48661976|NCT04976855|101957008|FG000|COMPLETED|Part II||0||
48661977|NCT04976855|101957009|FG001|COMPLETED|Part II||0||
48661978|NCT04976855|101957010|FG002|COMPLETED|Part II||0||
48661979|NCT04976855|101957011|FG003|COMPLETED|Part II||8||
48661980|NCT04976855|101957012|FG004|COMPLETED|Part II||8||
48661981|NCT04976855|101957013|FG005|COMPLETED|Part II||5||
48661982|NCT04976855|101957014|FG006|COMPLETED|Part II||0||
48661983|NCT04976855|101957008|FG000|NOT COMPLETED|Part II||0||
48661984|NCT04976855|101957009|FG001|NOT COMPLETED|Part II||0||
48661985|NCT04976855|101957010|FG002|NOT COMPLETED|Part II||0||
48661986|NCT04976855|101957011|FG003|NOT COMPLETED|Part II||1||
48661987|NCT04976855|101957012|FG004|NOT COMPLETED|Part II||1||
48661988|NCT04976855|101957013|FG005|NOT COMPLETED|Part II||1||
48661989|NCT04976855|101957014|FG006|NOT COMPLETED|Part II||0||
48661990|NCT04976855|101957008|FG000|STARTED|Part III: Run-in Period (6 Days)||0||
48661991|NCT04976855|101957009|FG001|STARTED|Part III: Run-in Period (6 Days)||0||
48661992|NCT04976855|101957010|FG002|STARTED|Part III: Run-in Period (6 Days)||0||
48661993|NCT04976855|101957011|FG003|STARTED|Part III: Run-in Period (6 Days)||0||
48661994|NCT04976855|101957012|FG004|STARTED|Part III: Run-in Period (6 Days)||0||
48661995|NCT04976855|101957013|FG005|STARTED|Part III: Run-in Period (6 Days)||0||
48661996|NCT04976855|101957014|FG006|STARTED|Part III: Run-in Period (6 Days)||16||
48661997|NCT04976855|101957008|FG000|COMPLETED|Part III: Run-in Period (6 Days)||0||
48661998|NCT04976855|101957009|FG001|COMPLETED|Part III: Run-in Period (6 Days)||0||
48661999|NCT04976855|101957010|FG002|COMPLETED|Part III: Run-in Period (6 Days)||0||
48662000|NCT04976855|101957011|FG003|COMPLETED|Part III: Run-in Period (6 Days)||0||
48662001|NCT04976855|101957012|FG004|COMPLETED|Part III: Run-in Period (6 Days)||0||
48662002|NCT04976855|101957013|FG005|COMPLETED|Part III: Run-in Period (6 Days)||0||
48662003|NCT04976855|101957014|FG006|COMPLETED|Part III: Run-in Period (6 Days)||16||
48662004|NCT04976855|101957008|FG000|NOT COMPLETED|Part III: Run-in Period (6 Days)||0||
48662005|NCT04976855|101957009|FG001|NOT COMPLETED|Part III: Run-in Period (6 Days)||0||
48662006|NCT04976855|101957010|FG002|NOT COMPLETED|Part III: Run-in Period (6 Days)||0||
48662007|NCT04976855|101957011|FG003|NOT COMPLETED|Part III: Run-in Period (6 Days)||0||
48662008|NCT04976855|101957012|FG004|NOT COMPLETED|Part III: Run-in Period (6 Days)||0||
48662009|NCT04976855|101957013|FG005|NOT COMPLETED|Part III: Run-in Period (6 Days)||0||
48662010|NCT04976855|101957014|FG006|NOT COMPLETED|Part III: Run-in Period (6 Days)||0||
48662011|NCT04976855|101957008|FG000|STARTED|Part III: Treatment Period (14 Days)||0||
48662012|NCT04976855|101957009|FG001|STARTED|Part III: Treatment Period (14 Days)||0||
48662013|NCT04976855|101957010|FG002|STARTED|Part III: Treatment Period (14 Days)||0||
48662014|NCT04976855|101957011|FG003|STARTED|Part III: Treatment Period (14 Days)||0||
48662015|NCT04976855|101957012|FG004|STARTED|Part III: Treatment Period (14 Days)||0||
48662016|NCT04976855|101957013|FG005|STARTED|Part III: Treatment Period (14 Days)||0||
48453455|NCT00168337|101446481|FG000|STARTED|Overall Study||188||
48453456|NCT00168337|101446482|FG001|STARTED|Overall Study||181||
48453457|NCT00168337|101446483|FG002|STARTED|Overall Study||185||
48453458|NCT00168337|101446481|FG000|COMPLETED|Overall Study||118||
48453459|NCT00168337|101446482|FG001|COMPLETED|Overall Study||112||
48453460|NCT00168337|101446483|FG002|COMPLETED|Overall Study||82||
48453461|NCT00168337|101446481|FG000|NOT COMPLETED|Overall Study||70||
48662017|NCT04976855|101957014|FG006|STARTED|Part III: Treatment Period (14 Days)||16||
48662018|NCT04976855|101957008|FG000|COMPLETED|Part III: Treatment Period (14 Days)||0||
48662019|NCT04976855|101957009|FG001|COMPLETED|Part III: Treatment Period (14 Days)||0||
48662020|NCT04976855|101957010|FG002|COMPLETED|Part III: Treatment Period (14 Days)||0||
48662021|NCT04976855|101957011|FG003|COMPLETED|Part III: Treatment Period (14 Days)||0||
48662022|NCT04976855|101957012|FG004|COMPLETED|Part III: Treatment Period (14 Days)||0||
48662023|NCT04976855|101957013|FG005|COMPLETED|Part III: Treatment Period (14 Days)||0||
48662024|NCT04976855|101957014|FG006|COMPLETED|Part III: Treatment Period (14 Days)||16||
48662025|NCT04976855|101957008|FG000|NOT COMPLETED|Part III: Treatment Period (14 Days)||0||
48662026|NCT04976855|101957009|FG001|NOT COMPLETED|Part III: Treatment Period (14 Days)||0||
48662027|NCT04976855|101957010|FG002|NOT COMPLETED|Part III: Treatment Period (14 Days)||0||
48662028|NCT04976855|101957011|FG003|NOT COMPLETED|Part III: Treatment Period (14 Days)||0||
48662029|NCT04976855|101957012|FG004|NOT COMPLETED|Part III: Treatment Period (14 Days)||0||
48662030|NCT04976855|101957013|FG005|NOT COMPLETED|Part III: Treatment Period (14 Days)||0||
48662031|NCT04976855|101957014|FG006|NOT COMPLETED|Part III: Treatment Period (14 Days)||0||
48662032|NCT04918771|101957015|FG000|STARTED|Overall Study||206||
48662033|NCT04918771|101957016|FG001|STARTED|Overall Study||214||
48662034|NCT04918771|101957015|FG000|COMPLETED|Overall Study||199||
48662035|NCT04918771|101957016|FG001|COMPLETED|Overall Study||205||
48662036|NCT04918771|101957015|FG000|NOT COMPLETED|Overall Study||7||
48662037|NCT04918771|101957016|FG001|NOT COMPLETED|Overall Study||9||
48662038|NCT05654181|101957017|FG000|STARTED|Overall Study||3||
48662039|NCT05654181|101957018|FG001|STARTED|Overall Study||2||
48453462|NCT00168337|101446482|FG001|NOT COMPLETED|Overall Study||69||
48453463|NCT00168337|101446483|FG002|NOT COMPLETED|Overall Study||103||
48453464|NCT02024698|101446484|FG000|STARTED|First Intervention (7 Days)||16||
48453465|NCT02024698|101446485|FG001|STARTED|First Intervention (7 Days)||27||
48453466|NCT02024698|101446484|FG000|COMPLETED|First Intervention (7 Days)||16||
48453467|NCT02024698|101446485|FG001|COMPLETED|First Intervention (7 Days)||26||
48662040|NCT05654181|101957019|FG002|STARTED|Overall Study||2||
48662041|NCT05654181|101957020|FG003|STARTED|Overall Study||2||
48662042|NCT05654181|101957021|FG004|STARTED|Overall Study||1||
48662043|NCT05654181|101957022|FG005|STARTED|Overall Study||1||
48662044|NCT05654181|101957023|FG006|STARTED|Overall Study||2||
48453468|NCT02024698|101446484|FG000|NOT COMPLETED|First Intervention (7 Days)||0||
48453469|NCT02024698|101446485|FG001|NOT COMPLETED|First Intervention (7 Days)||1||
48453470|NCT02024698|101446484|FG000|STARTED|Second Intervention (7 Days)||16||
48453471|NCT02024698|101446485|FG001|STARTED|Second Intervention (7 Days)||26||
48453472|NCT02024698|101446484|FG000|Received Etafilcon A Twice|Second Intervention (7 Days)||1||
48453473|NCT02024698|101446485|FG001|Received Etafilcon A Twice|Second Intervention (7 Days)||0||
48453474|NCT02024698|101446484|FG000|COMPLETED|Second Intervention (7 Days)||16||
48453475|NCT02024698|101446485|FG001|COMPLETED|Second Intervention (7 Days)||26||
48453476|NCT02024698|101446484|FG000|NOT COMPLETED|Second Intervention (7 Days)||0||
48453477|NCT02024698|101446485|FG001|NOT COMPLETED|Second Intervention (7 Days)||0||
48662045|NCT05654181|101957024|FG007|STARTED|Overall Study||3||
48662046|NCT05654181|101957025|FG008|STARTED|Overall Study||2||
48662047|NCT05654181|101957026|FG009|STARTED|Overall Study||2||
48662048|NCT05654181|101957017|FG000|COMPLETED|Overall Study||2||
48662049|NCT05654181|101957018|FG001|COMPLETED|Overall Study||2||
48662050|NCT05654181|101957019|FG002|COMPLETED|Overall Study||2||
48662051|NCT05654181|101957020|FG003|COMPLETED|Overall Study||2||
48662052|NCT05654181|101957021|FG004|COMPLETED|Overall Study||0||
48662053|NCT05654181|101957022|FG005|COMPLETED|Overall Study||0||
48662054|NCT05654181|101957023|FG006|COMPLETED|Overall Study||2||
48662055|NCT05654181|101957024|FG007|COMPLETED|Overall Study||1||
48662056|NCT05654181|101957025|FG008|COMPLETED|Overall Study||2||
48662057|NCT05654181|101957026|FG009|COMPLETED|Overall Study||2||
48662058|NCT05654181|101957017|FG000|NOT COMPLETED|Overall Study||1||
48772472|NCT01077076|102232734|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0||
48772473|NCT01077076|102232735|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0||
48772474|NCT01077076|102232736|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0||
48772475|NCT01077076|102232737|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0||
48772476|NCT01077076|102232738|FG004|NOT COMPLETED|Washout Period of 2 Weeks||0||
48772477|NCT01077076|102232739|FG005|NOT COMPLETED|Washout Period of 2 Weeks||0||
48772478|NCT01077076|102232734|FG000|STARTED|Third Intervention||4||
48772479|NCT01077076|102232735|FG001|STARTED|Third Intervention||5||
48772480|NCT01077076|102232736|FG002|STARTED|Third Intervention||5||
48772481|NCT01077076|102232737|FG003|STARTED|Third Intervention||5||
48772482|NCT01077076|102232738|FG004|STARTED|Third Intervention||5||
48772483|NCT01077076|102232739|FG005|STARTED|Third Intervention||5||
48772484|NCT01077076|102232734|FG000|COMPLETED|Third Intervention||4||
48662059|NCT05654181|101957018|FG001|NOT COMPLETED|Overall Study||0||
48772485|NCT01077076|102232735|FG001|COMPLETED|Third Intervention||5||
48772486|NCT01077076|102232736|FG002|COMPLETED|Third Intervention||5||
48772487|NCT01077076|102232737|FG003|COMPLETED|Third Intervention||5||
48453478|NCT02995837|101446486|FG000|STARTED|Overall Study||19||
48453479|NCT02995837|101446487|FG001|STARTED|Overall Study||15||
48453480|NCT02995837|101446486|FG000|COMPLETED|Overall Study||10||
48453481|NCT02995837|101446487|FG001|COMPLETED|Overall Study||7||
48453482|NCT02995837|101446486|FG000|NOT COMPLETED|Overall Study||9||
48453483|NCT02995837|101446487|FG001|NOT COMPLETED|Overall Study||8||
48453484|NCT00545181|101446488|FG000|STARTED|Overall Study||29||
48453485|NCT00545181|101446489|FG001|STARTED|Overall Study||25||
48453486|NCT00545181|101446488|FG000|COMPLETED|Overall Study||29||
48453487|NCT00545181|101446489|FG001|COMPLETED|Overall Study||25||
48453488|NCT00545181|101446488|FG000|NOT COMPLETED|Overall Study||0||
48453489|NCT00545181|101446489|FG001|NOT COMPLETED|Overall Study||0||
48453490|NCT01965535|101446490|FG000|STARTED|Overall Study||78||
48453491|NCT01965535|101446491|FG001|STARTED|Overall Study||77||
48453492|NCT01965535|101446490|FG000|COMPLETED|Overall Study||76||
48453493|NCT01965535|101446491|FG001|COMPLETED|Overall Study||76||
48453494|NCT01965535|101446490|FG000|NOT COMPLETED|Overall Study||2||
48453495|NCT01965535|101446491|FG001|NOT COMPLETED|Overall Study||1||
48453496|NCT02065791|101446492|FG000|STARTED|Overall Study||2199||
48453497|NCT02065791|101446493|FG001|STARTED|Overall Study||2202||
48453498|NCT02065791|101446492|FG000|Treated|Overall Study||2197||
48453499|NCT02065791|101446493|FG001|Treated|Overall Study||2200||
48453500|NCT02065791|101446492|FG000|COMPLETED|Overall Study||2174||
48453501|NCT02065791|101446493|FG001|COMPLETED|Overall Study||2187||
48453502|NCT02065791|101446492|FG000|NOT COMPLETED|Overall Study||25||
48453503|NCT02065791|101446493|FG001|NOT COMPLETED|Overall Study||15||
48662060|NCT05654181|101957019|FG002|NOT COMPLETED|Overall Study||0||
48662061|NCT05654181|101957020|FG003|NOT COMPLETED|Overall Study||0||
48662062|NCT05654181|101957021|FG004|NOT COMPLETED|Overall Study||1||
48453504|NCT00297479|101446494|FG000|STARTED|Overall Study||103||
48662063|NCT05654181|101957022|FG005|NOT COMPLETED|Overall Study||1||
48662064|NCT05654181|101957023|FG006|NOT COMPLETED|Overall Study||0||
48662065|NCT05654181|101957024|FG007|NOT COMPLETED|Overall Study||2||
48453505|NCT00297479|101446495|FG001|STARTED|Overall Study||155||
48453506|NCT00297479|101446496|FG002|STARTED|Overall Study||154||
48453507|NCT00297479|101446494|FG000|4-Week Follow Up|Overall Study||78||
48662066|NCT05654181|101957025|FG008|NOT COMPLETED|Overall Study||0||
48662067|NCT05654181|101957026|FG009|NOT COMPLETED|Overall Study||0||
48662068|NCT05787782|101957027|FG000|STARTED|Overall Study||60||
48662069|NCT05787782|101957027|FG000|COMPLETED|Overall Study||60||
48662070|NCT05787782|101957027|FG000|NOT COMPLETED|Overall Study||0||
48662071|NCT01813357|101957028|FG000|STARTED|Overall Study||40||
48662072|NCT01813357|101957029|FG001|STARTED|Overall Study||44||
48662073|NCT01813357|101957028|FG000|COMPLETED|Overall Study||35||
48662074|NCT01813357|101957029|FG001|COMPLETED|Overall Study||38||
48453508|NCT00297479|101446495|FG001|4-Week Follow Up|Overall Study||132||
48453509|NCT00297479|101446496|FG002|4-Week Follow Up|Overall Study||128||
48453510|NCT00297479|101446494|FG000|26- Week Follow Up|Overall Study||66||
48453511|NCT00297479|101446495|FG001|26- Week Follow Up|Overall Study||101||
48453512|NCT00297479|101446496|FG002|26- Week Follow Up|Overall Study||103||
48453513|NCT00297479|101446494|FG000|COMPLETED|Overall Study||66||
48453514|NCT00297479|101446495|FG001|COMPLETED|Overall Study||101||
48453515|NCT00297479|101446496|FG002|COMPLETED|Overall Study||103||
48453516|NCT00297479|101446494|FG000|NOT COMPLETED|Overall Study||37||
48453517|NCT00297479|101446495|FG001|NOT COMPLETED|Overall Study||54||
48453518|NCT00297479|101446496|FG002|NOT COMPLETED|Overall Study||51||
48453519|NCT01017029|101446497|FG000|STARTED|Overall Study||89||
48453520|NCT01017029|101446498|FG001|STARTED|Overall Study||92||
48662075|NCT01813357|101957028|FG000|NOT COMPLETED|Overall Study||5||
48662076|NCT01813357|101957029|FG001|NOT COMPLETED|Overall Study||6||
48662077|NCT01648322|101957030|FG000|STARTED|Overall Study||35||
48772488|NCT01077076|102232738|FG004|COMPLETED|Third Intervention||5||
48772489|NCT01077076|102232739|FG005|COMPLETED|Third Intervention||4||
48772490|NCT01077076|102232734|FG000|NOT COMPLETED|Third Intervention||0||
48772491|NCT01077076|102232735|FG001|NOT COMPLETED|Third Intervention||0||
48453521|NCT01017029|101446497|FG000|COMPLETED|Overall Study||85||
48453522|NCT01017029|101446498|FG001|COMPLETED|Overall Study||90||
48453523|NCT01017029|101446497|FG000|NOT COMPLETED|Overall Study||4||
48453524|NCT01017029|101446498|FG001|NOT COMPLETED|Overall Study||2||
48453525|NCT02483481|101446499|FG000|STARTED|Overall Study||45||
48453526|NCT02483481|101446499|FG000|COMPLETED|Overall Study||45||
48453527|NCT02483481|101446499|FG000|NOT COMPLETED|Overall Study||0||
48453528|NCT00455533|101446500|FG000|STARTED|Period One: Initial Chemotherapy||313||
48453529|NCT00455533|101446501|FG001|STARTED|Period One: Initial Chemotherapy||0||
48453530|NCT00455533|101446502|FG002|STARTED|Period One: Initial Chemotherapy||0||
48453531|NCT00455533|101446500|FG000|COMPLETED|Period One: Initial Chemotherapy||295||
48453532|NCT00455533|101446501|FG001|COMPLETED|Period One: Initial Chemotherapy||0||
48772492|NCT01077076|102232736|FG002|NOT COMPLETED|Third Intervention||0||
48772493|NCT01077076|102232737|FG003|NOT COMPLETED|Third Intervention||0||
48772494|NCT01077076|102232738|FG004|NOT COMPLETED|Third Intervention||0||
48772495|NCT01077076|102232739|FG005|NOT COMPLETED|Third Intervention||1||
48772496|NCT01671319|102232740|FG000|STARTED|Overall Study||42||
48772497|NCT01671319|102232740|FG000|COMPLETED|Overall Study||41||
48453533|NCT00455533|101446502|FG002|COMPLETED|Period One: Initial Chemotherapy||0||
48453534|NCT00455533|101446500|FG000|NOT COMPLETED|Period One: Initial Chemotherapy||18||
48453535|NCT00455533|101446501|FG001|NOT COMPLETED|Period One: Initial Chemotherapy||0||
48453536|NCT00455533|101446502|FG002|NOT COMPLETED|Period One: Initial Chemotherapy||0||
48453537|NCT00455533|101446500|FG000|STARTED|Period Two: Randomized Period||0||
48453538|NCT00455533|101446501|FG001|STARTED|Period Two: Randomized Period||145||
48453539|NCT00455533|101446502|FG002|STARTED|Period Two: Randomized Period||144||
48453540|NCT00455533|101446500|FG000|COMPLETED|Period Two: Randomized Period||0||
48453541|NCT00455533|101446501|FG001|COMPLETED|Period Two: Randomized Period||139||
48453542|NCT00455533|101446502|FG002|COMPLETED|Period Two: Randomized Period||138||
48453543|NCT00455533|101446500|FG000|NOT COMPLETED|Period Two: Randomized Period||0||
48453544|NCT00455533|101446501|FG001|NOT COMPLETED|Period Two: Randomized Period||6||
48453545|NCT00455533|101446502|FG002|NOT COMPLETED|Period Two: Randomized Period||6||
48453546|NCT03615079|101446503|FG000|STARTED|Overall Study||28||
48453547|NCT03615079|101446503|FG000|COMPLETED|Overall Study||11||
48453548|NCT03615079|101446503|FG000|NOT COMPLETED|Overall Study||17||
48453549|NCT02340078|101446504|FG000|STARTED|Overall Study||62||
48453550|NCT02340078|101446504|FG000|COMPLETED|Overall Study||61||
48772498|NCT01671319|102232740|FG000|NOT COMPLETED|Overall Study||1||
48453551|NCT02340078|101446504|FG000|NOT COMPLETED|Overall Study||1||
48453552|NCT01298596|101446505|FG000|STARTED|Overall Study||200||
48453553|NCT01298596|101446506|FG001|STARTED|Overall Study||200||
48453554|NCT01298596|101446505|FG000|COMPLETED|Overall Study||172||
48453555|NCT01298596|101446506|FG001|COMPLETED|Overall Study||167||
48662078|NCT01648322|101957031|FG001|STARTED|Overall Study||67||
48662079|NCT01648322|101957032|FG002|STARTED|Overall Study||65||
48662080|NCT01648322|101957033|FG003|STARTED|Overall Study||65||
48662081|NCT01648322|101957030|FG000|COMPLETED|Overall Study||33||
48453556|NCT01298596|101446505|FG000|NOT COMPLETED|Overall Study||28||
48453557|NCT01298596|101446506|FG001|NOT COMPLETED|Overall Study||33||
48453558|NCT02437890|101446507|FG000|STARTED|Overall Study||62||
48453559|NCT02437890|101446508|FG001|STARTED|Overall Study||64||
48453560|NCT02437890|101446509|FG002|STARTED|Overall Study||62||
48453561|NCT02437890|101446510|FG003|STARTED|Overall Study||62||
48453562|NCT02437890|101446511|FG004|STARTED|Overall Study||62||
48453563|NCT02437890|101446507|FG000|COMPLETED|Overall Study||54||
48453564|NCT02437890|101446508|FG001|COMPLETED|Overall Study||48||
48453565|NCT02437890|101446509|FG002|COMPLETED|Overall Study||47||
48453566|NCT02437890|101446510|FG003|COMPLETED|Overall Study||40||
48453567|NCT02437890|101446511|FG004|COMPLETED|Overall Study||46||
48453568|NCT02437890|101446507|FG000|NOT COMPLETED|Overall Study||8||
48453569|NCT02437890|101446508|FG001|NOT COMPLETED|Overall Study||16||
48453570|NCT02437890|101446509|FG002|NOT COMPLETED|Overall Study||15||
48453571|NCT02437890|101446510|FG003|NOT COMPLETED|Overall Study||22||
48453572|NCT02437890|101446511|FG004|NOT COMPLETED|Overall Study||16||
48453573|NCT03101293|101446512|FG000|STARTED|Intervention Period 1||7||
48453574|NCT03101293|101446513|FG001|STARTED|Intervention Period 1||8||
48453575|NCT03101293|101446512|FG000|COMPLETED|Intervention Period 1||7||
48453576|NCT03101293|101446513|FG001|COMPLETED|Intervention Period 1||8||
48453577|NCT03101293|101446512|FG000|NOT COMPLETED|Intervention Period 1||0||
48453578|NCT03101293|101446513|FG001|NOT COMPLETED|Intervention Period 1||0||
48453579|NCT03101293|101446512|FG000|STARTED|Washout Period (at Least 7 Days)||7||
48453580|NCT03101293|101446513|FG001|STARTED|Washout Period (at Least 7 Days)||8||
48453581|NCT03101293|101446512|FG000|COMPLETED|Washout Period (at Least 7 Days)||6||
48453582|NCT03101293|101446513|FG001|COMPLETED|Washout Period (at Least 7 Days)||8||
48662082|NCT01648322|101957031|FG001|COMPLETED|Overall Study||62||
48662083|NCT01648322|101957032|FG002|COMPLETED|Overall Study||60||
48772499|NCT00472030|102232741|FG000|STARTED|Overall Study||2||
48453583|NCT03101293|101446512|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||1||
48453584|NCT03101293|101446513|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48453585|NCT03101293|101446512|FG000|STARTED|Intervention Period 2||6||
48453586|NCT03101293|101446513|FG001|STARTED|Intervention Period 2||8||
48453587|NCT03101293|101446512|FG000|COMPLETED|Intervention Period 2||6||
48453588|NCT03101293|101446513|FG001|COMPLETED|Intervention Period 2||8||
48453589|NCT03101293|101446512|FG000|NOT COMPLETED|Intervention Period 2||0||
48453590|NCT03101293|101446513|FG001|NOT COMPLETED|Intervention Period 2||0||
48453591|NCT01272193|101446514|FG000|STARTED|Overall Study||147||
48453592|NCT01272193|101446515|FG001|STARTED|Overall Study||149||
48453593|NCT01272193|101446514|FG000|COMPLETED|Overall Study||137||
48453594|NCT01272193|101446515|FG001|COMPLETED|Overall Study||137||
48453595|NCT01272193|101446514|FG000|NOT COMPLETED|Overall Study||10||
48453596|NCT01272193|101446515|FG001|NOT COMPLETED|Overall Study||12||
48453597|NCT01377233|101446516|FG000|STARTED|Open-label||46||
48453598|NCT01377233|101446517|FG001|STARTED|Open-label||0||
48453599|NCT01377233|101446518|FG002|STARTED|Open-label||0||
48453600|NCT01377233|101446519|FG003|STARTED|Open-label||0||
48453601|NCT01377233|101446520|FG004|STARTED|Open-label||0||
48453602|NCT01377233|101446516|FG000|COMPLETED|Open-label||42||
48453603|NCT01377233|101446517|FG001|COMPLETED|Open-label||0||
48453604|NCT01377233|101446518|FG002|COMPLETED|Open-label||0||
48453605|NCT01377233|101446519|FG003|COMPLETED|Open-label||0||
48453606|NCT01377233|101446520|FG004|COMPLETED|Open-label||0||
48453607|NCT01377233|101446516|FG000|NOT COMPLETED|Open-label||4||
48453608|NCT01377233|101446517|FG001|NOT COMPLETED|Open-label||0||
48453609|NCT01377233|101446518|FG002|NOT COMPLETED|Open-label||0||
48453610|NCT01377233|101446519|FG003|NOT COMPLETED|Open-label||0||
48453611|NCT01377233|101446520|FG004|NOT COMPLETED|Open-label||0||
48453612|NCT01377233|101446516|FG000|STARTED|Double-blind||0||
48453613|NCT01377233|101446517|FG001|STARTED|Double-blind||11||
48453614|NCT01377233|101446518|FG002|STARTED|Double-blind||10||
48453615|NCT01377233|101446519|FG003|STARTED|Double-blind||11||
48453616|NCT01377233|101446520|FG004|STARTED|Double-blind||10||
48453617|NCT01377233|101446516|FG000|COMPLETED|Double-blind||0||
48453618|NCT01377233|101446517|FG001|COMPLETED|Double-blind||10||
48453619|NCT01377233|101446518|FG002|COMPLETED|Double-blind||8||
48453620|NCT01377233|101446519|FG003|COMPLETED|Double-blind||7||
48453621|NCT01377233|101446520|FG004|COMPLETED|Double-blind||8||
48453622|NCT01377233|101446516|FG000|NOT COMPLETED|Double-blind||0||
48453623|NCT01377233|101446517|FG001|NOT COMPLETED|Double-blind||1||
48662084|NCT01648322|101957033|FG003|COMPLETED|Overall Study||61||
48662085|NCT01648322|101957030|FG000|NOT COMPLETED|Overall Study||2||
48662086|NCT01648322|101957031|FG001|NOT COMPLETED|Overall Study||5||
48662087|NCT01648322|101957032|FG002|NOT COMPLETED|Overall Study||5||
48453624|NCT01377233|101446518|FG002|NOT COMPLETED|Double-blind||2||
48453625|NCT01377233|101446519|FG003|NOT COMPLETED|Double-blind||4||
48453626|NCT01377233|101446520|FG004|NOT COMPLETED|Double-blind||2||
48453627|NCT02348619|101446521|FG000|STARTED|Titration Phase||174||
48453628|NCT02348619|101446522|FG001|STARTED|Titration Phase||0||
48453629|NCT02348619|101446521|FG000|COMPLETED|Titration Phase||157||
48453630|NCT02348619|101446522|FG001|COMPLETED|Titration Phase||0||
48662088|NCT01648322|101957033|FG003|NOT COMPLETED|Overall Study||4||
48453631|NCT02348619|101446521|FG000|NOT COMPLETED|Titration Phase||17||
48453632|NCT02348619|101446522|FG001|NOT COMPLETED|Titration Phase||0||
48453633|NCT02348619|101446521|FG000|STARTED|Stable-Dose Phase||157||
48453634|NCT02348619|101446522|FG001|STARTED|Stable-Dose Phase||0||
48453635|NCT02348619|101446521|FG000|COMPLETED|Stable-Dose Phase||124||
48453636|NCT02348619|101446522|FG001|COMPLETED|Stable-Dose Phase||0||
48453637|NCT02348619|101446521|FG000|NOT COMPLETED|Stable-Dose Phase||33||
48453638|NCT02348619|101446522|FG001|NOT COMPLETED|Stable-Dose Phase||0||
48453639|NCT02348619|101446521|FG000|STARTED|Double-Blind Withdrawal Phase||62||
48453640|NCT02348619|101446522|FG001|STARTED|Double-Blind Withdrawal Phase||62||
48453641|NCT02348619|101446521|FG000|COMPLETED|Double-Blind Withdrawal Phase||60||
48453642|NCT02348619|101446522|FG001|COMPLETED|Double-Blind Withdrawal Phase||62||
48453643|NCT02348619|101446521|FG000|NOT COMPLETED|Double-Blind Withdrawal Phase||2||
48453644|NCT02348619|101446522|FG001|NOT COMPLETED|Double-Blind Withdrawal Phase||0||
48453645|NCT00185211|101446523|FG000|STARTED|Placebo-controlled Study (92012)||292||
48453646|NCT00185211|101446524|FG001|STARTED|Placebo-controlled Study (92012)||176||
48453647|NCT00185211|101446523|FG000|COMPLETED|Placebo-controlled Study (92012)||271||
48453648|NCT00185211|101446524|FG001|COMPLETED|Placebo-controlled Study (92012)||166||
48453649|NCT00185211|101446523|FG000|NOT COMPLETED|Placebo-controlled Study (92012)||21||
48453650|NCT00185211|101446524|FG001|NOT COMPLETED|Placebo-controlled Study (92012)||10||
48453651|NCT00185211|101446523|FG000|STARTED|Follow-up Study (91031 - This Study)||261||
48453652|NCT00185211|101446524|FG001|STARTED|Follow-up Study (91031 - This Study)||157||
48453653|NCT00185211|101446523|FG000|COMPLETED|Follow-up Study (91031 - This Study)||235||
48453654|NCT00185211|101446524|FG001|COMPLETED|Follow-up Study (91031 - This Study)||123||
48453655|NCT00185211|101446523|FG000|NOT COMPLETED|Follow-up Study (91031 - This Study)||26||
48453656|NCT00185211|101446524|FG001|NOT COMPLETED|Follow-up Study (91031 - This Study)||34||
48453657|NCT01098240|101446525|FG000|STARTED|Open-Label Phase||297||
48453658|NCT01098240|101446526|FG001|STARTED|Open-Label Phase||0||
48453659|NCT01098240|101446527|FG002|STARTED|Open-Label Phase||0||
48453660|NCT01098240|101446525|FG000|COMPLETED|Open-Label Phase||162||
48453661|NCT01098240|101446526|FG001|COMPLETED|Open-Label Phase||0||
48453662|NCT01098240|101446527|FG002|COMPLETED|Open-Label Phase||0||
48662089|NCT00619918|101957034|FG000|STARTED|Overall Study||230||
48662090|NCT00619918|101957035|FG001|STARTED|Overall Study||217||
48662091|NCT00619918|101957034|FG000|COMPLETED|Overall Study||210||
48662092|NCT00619918|101957035|FG001|COMPLETED|Overall Study||195||
48662093|NCT00619918|101957034|FG000|NOT COMPLETED|Overall Study||20||
48662094|NCT00619918|101957035|FG001|NOT COMPLETED|Overall Study||22||
48662095|NCT01308788|101957036|FG000|STARTED|6-month Treatment||14||
48662096|NCT01308788|101957037|FG001|STARTED|6-month Treatment||21||
48662097|NCT01308788|101957036|FG000|COMPLETED|6-month Treatment||14||
48662098|NCT01308788|101957037|FG001|COMPLETED|6-month Treatment||21||
48662099|NCT01308788|101957036|FG000|NOT COMPLETED|6-month Treatment||0||
48662100|NCT01308788|101957037|FG001|NOT COMPLETED|6-month Treatment||0||
48662101|NCT01308788|101957036|FG000|STARTED|2-year Treatment||14||
48662102|NCT01308788|101957037|FG001|STARTED|2-year Treatment||21||
48662103|NCT01308788|101957036|FG000|COMPLETED|2-year Treatment||10||
48662104|NCT01308788|101957037|FG001|COMPLETED|2-year Treatment||10||
48662105|NCT01308788|101957036|FG000|NOT COMPLETED|2-year Treatment||4||
48662106|NCT01308788|101957037|FG001|NOT COMPLETED|2-year Treatment||11||
48662107|NCT01469156|101957038|FG000|STARTED|Overall Study||15||
48662108|NCT01469156|101957039|FG001|STARTED|Overall Study||5||
48662109|NCT01469156|101957038|FG000|COMPLETED|Overall Study||15||
48662110|NCT01469156|101957039|FG001|COMPLETED|Overall Study||5||
48662111|NCT01469156|101957038|FG000|NOT COMPLETED|Overall Study||0||
48662112|NCT01469156|101957039|FG001|NOT COMPLETED|Overall Study||0||
48662113|NCT02951819|101957040|FG000|STARTED|Overall Study||87||
48662114|NCT02951819|101957041|FG001|STARTED|Overall Study||14||
48662115|NCT02951819|101957040|FG000|Treated|Overall Study||86||
48662116|NCT02951819|101957041|FG001|Treated|Overall Study||14||
48662117|NCT02951819|101957040|FG000|COMPLETED|Overall Study||59||
48662118|NCT02951819|101957041|FG001|COMPLETED|Overall Study||7||
48662119|NCT02951819|101957040|FG000|NOT COMPLETED|Overall Study||28||
48662120|NCT02951819|101957041|FG001|NOT COMPLETED|Overall Study||7||
48662121|NCT01491919|101957042|FG000|STARTED|Overall Study||13||
48662122|NCT01491919|101957043|FG001|STARTED|Overall Study||10||
48662123|NCT01491919|101957044|FG002|STARTED|Overall Study||3||
48662124|NCT01491919|101957042|FG000|COMPLETED|Overall Study||12||
48662125|NCT01491919|101957043|FG001|COMPLETED|Overall Study||8||
48662126|NCT01491919|101957044|FG002|COMPLETED|Overall Study||2||
48453663|NCT01098240|101446525|FG000|NOT COMPLETED|Open-Label Phase||135||
48662127|NCT01491919|101957042|FG000|NOT COMPLETED|Overall Study||1||
48662128|NCT01491919|101957043|FG001|NOT COMPLETED|Overall Study||2||
48772500|NCT00472030|102232742|FG001|STARTED|Overall Study||0||
48453664|NCT01098240|101446526|FG001|NOT COMPLETED|Open-Label Phase||0||
48453665|NCT01098240|101446527|FG002|NOT COMPLETED|Open-Label Phase||0||
48453666|NCT01098240|101446525|FG000|STARTED|Double-Blind Phase||0||
48453667|NCT01098240|101446526|FG001|STARTED|Double-Blind Phase||77||
48453668|NCT01098240|101446527|FG002|STARTED|Double-Blind Phase||85||
48662129|NCT01491919|101957044|FG002|NOT COMPLETED|Overall Study||1||
48662130|NCT01799135|101957045|FG000|STARTED|Overall Study||6||
48662131|NCT01799135|101957045|FG000|COMPLETED|Overall Study||6||
48662132|NCT01799135|101957045|FG000|NOT COMPLETED|Overall Study||0||
48662133|NCT05218434|101957046|FG000|STARTED|Overall Study||6||
48453669|NCT01098240|101446525|FG000|COMPLETED|Double-Blind Phase||0||
48453670|NCT01098240|101446526|FG001|COMPLETED|Double-Blind Phase||60||
48453671|NCT01098240|101446527|FG002|COMPLETED|Double-Blind Phase||63||
48453672|NCT01098240|101446525|FG000|NOT COMPLETED|Double-Blind Phase||0||
48453673|NCT01098240|101446526|FG001|NOT COMPLETED|Double-Blind Phase||17||
48453674|NCT01098240|101446527|FG002|NOT COMPLETED|Double-Blind Phase||22||
48453675|NCT01689974|101446528|FG000|STARTED|Overall Study||5||
48453676|NCT01689974|101446529|FG001|STARTED|Overall Study||5||
48453677|NCT01689974|101446528|FG000|COMPLETED|Overall Study||0||
48453678|NCT01689974|101446529|FG001|COMPLETED|Overall Study||0||
48453679|NCT01689974|101446528|FG000|NOT COMPLETED|Overall Study||5||
48453680|NCT01689974|101446529|FG001|NOT COMPLETED|Overall Study||5||
48453681|NCT03558997|101446530|FG000|STARTED|Overall Study||25||
48453682|NCT03558997|101446531|FG001|STARTED|Overall Study||26||
48453683|NCT03558997|101446532|FG002|STARTED|Overall Study||26||
48453684|NCT03558997|101446533|FG003|STARTED|Overall Study||26||
48453685|NCT03558997|101446530|FG000|COMPLETED|Overall Study||24||
48453686|NCT03558997|101446531|FG001|COMPLETED|Overall Study||24||
48453687|NCT03558997|101446532|FG002|COMPLETED|Overall Study||18||
48453688|NCT03558997|101446533|FG003|COMPLETED|Overall Study||24||
48453689|NCT03558997|101446530|FG000|NOT COMPLETED|Overall Study||1||
48453690|NCT03558997|101446531|FG001|NOT COMPLETED|Overall Study||2||
48453691|NCT03558997|101446532|FG002|NOT COMPLETED|Overall Study||8||
48453692|NCT03558997|101446533|FG003|NOT COMPLETED|Overall Study||2||
48453693|NCT01458119|101446534|FG000|STARTED|Overall Study||85||
48453694|NCT01458119|101446534|FG000|Received at Least 1 Dose of Study Drug|Overall Study||85||
48453695|NCT01458119|101446534|FG000|Safety Population|Overall Study||85||
48453696|NCT01458119|101446534|FG000|Intent to Treat (ITT) Population|Overall Study||85|Received at least 1 dose of study drug.|
48453697|NCT01458119|101446534|FG000|ITT-Amenable Population|Overall Study||68|Amenable mutations based on Good Laboratory Practice (GLP) Human Embryonic Kidney (HEK) assay.|
48453698|NCT01458119|101446534|FG000|COMPLETED|Overall Study||65||
48453699|NCT01458119|101446534|FG000|NOT COMPLETED|Overall Study||20||
48453700|NCT03940326|101446535|FG000|STARTED|Overall Study||45||
48453701|NCT03940326|101446536|FG001|STARTED|Overall Study||58||
48453702|NCT03940326|101446535|FG000|COMPLETED|Overall Study||45||
48453703|NCT03940326|101446536|FG001|COMPLETED|Overall Study||58||
48453704|NCT03940326|101446535|FG000|NOT COMPLETED|Overall Study||0||
48453705|NCT03940326|101446536|FG001|NOT COMPLETED|Overall Study||0||
48453706|NCT02868281|101446537|FG000|STARTED|Overall Study||252||
48453707|NCT02868281|101446538|FG001|STARTED|Overall Study||278||
48453708|NCT02868281|101446537|FG000|COMPLETED|Overall Study||209||
48453709|NCT02868281|101446538|FG001|COMPLETED|Overall Study||234||
48453710|NCT02868281|101446537|FG000|NOT COMPLETED|Overall Study||43||
48453711|NCT02868281|101446538|FG001|NOT COMPLETED|Overall Study||44||
48453712|NCT01722266|101446539|FG000|STARTED|Overall Study||18||
48453713|NCT01722266|101446540|FG001|STARTED|Overall Study||18||
48453714|NCT01722266|101446541|FG002|STARTED|Overall Study||18||
48453715|NCT01722266|101446542|FG003|STARTED|Overall Study||18||
48453716|NCT01722266|101446539|FG000|COMPLETED|Overall Study||17||
48453717|NCT01722266|101446540|FG001|COMPLETED|Overall Study||15||
48453718|NCT01722266|101446541|FG002|COMPLETED|Overall Study||13||
48453719|NCT01722266|101446542|FG003|COMPLETED|Overall Study||18||
48453720|NCT01722266|101446539|FG000|NOT COMPLETED|Overall Study||1||
48453721|NCT01722266|101446540|FG001|NOT COMPLETED|Overall Study||3||
48453722|NCT01722266|101446541|FG002|NOT COMPLETED|Overall Study||5||
48453723|NCT01722266|101446542|FG003|NOT COMPLETED|Overall Study||0||
48453724|NCT03555890|101446543|FG000|STARTED|Part 1:Treatment Period 1 (3 Days)||12||
48453725|NCT03555890|101446544|FG001|STARTED|Part 1:Treatment Period 1 (3 Days)||12||
48453726|NCT03555890|101446545|FG002|STARTED|Part 1:Treatment Period 1 (3 Days)||0||
48453727|NCT03555890|101446546|FG003|STARTED|Part 1:Treatment Period 1 (3 Days)||0||
48453728|NCT03555890|101446543|FG000|COMPLETED|Part 1:Treatment Period 1 (3 Days)||12||
48453729|NCT03555890|101446544|FG001|COMPLETED|Part 1:Treatment Period 1 (3 Days)||12||
48453730|NCT03555890|101446545|FG002|COMPLETED|Part 1:Treatment Period 1 (3 Days)||0||
48453731|NCT03555890|101446546|FG003|COMPLETED|Part 1:Treatment Period 1 (3 Days)||0||
48453732|NCT03555890|101446543|FG000|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0||
48453733|NCT03555890|101446544|FG001|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0||
48453734|NCT03555890|101446545|FG002|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0||
48453735|NCT03555890|101446546|FG003|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0||
48453736|NCT03555890|101446543|FG000|STARTED|Part 1:Washout Period (at Least 5 Days)||12||
48453737|NCT03555890|101446544|FG001|STARTED|Part 1:Washout Period (at Least 5 Days)||12||
48453738|NCT03555890|101446545|FG002|STARTED|Part 1:Washout Period (at Least 5 Days)||0||
48453739|NCT03555890|101446546|FG003|STARTED|Part 1:Washout Period (at Least 5 Days)||0||
48453740|NCT03555890|101446543|FG000|COMPLETED|Part 1:Washout Period (at Least 5 Days)||12||
48453741|NCT03555890|101446544|FG001|COMPLETED|Part 1:Washout Period (at Least 5 Days)||12||
48453742|NCT03555890|101446545|FG002|COMPLETED|Part 1:Washout Period (at Least 5 Days)||0||
48453743|NCT03555890|101446546|FG003|COMPLETED|Part 1:Washout Period (at Least 5 Days)||0||
48453744|NCT03555890|101446543|FG000|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0||
48453745|NCT03555890|101446544|FG001|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0||
48453746|NCT03555890|101446545|FG002|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0||
48453747|NCT03555890|101446546|FG003|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0||
48453748|NCT03555890|101446543|FG000|STARTED|Part 1:Treatment Period 2 (10 Days)||12||
48453749|NCT03555890|101446544|FG001|STARTED|Part 1:Treatment Period 2 (10 Days)||12||
48453750|NCT03555890|101446545|FG002|STARTED|Part 1:Treatment Period 2 (10 Days)||0||
48453751|NCT03555890|101446546|FG003|STARTED|Part 1:Treatment Period 2 (10 Days)||0||
48453752|NCT03555890|101446543|FG000|COMPLETED|Part 1:Treatment Period 2 (10 Days)||12||
48453753|NCT03555890|101446544|FG001|COMPLETED|Part 1:Treatment Period 2 (10 Days)||12||
48453754|NCT03555890|101446545|FG002|COMPLETED|Part 1:Treatment Period 2 (10 Days)||0||
48453755|NCT03555890|101446546|FG003|COMPLETED|Part 1:Treatment Period 2 (10 Days)||0||
48453756|NCT03555890|101446543|FG000|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0||
48453757|NCT03555890|101446544|FG001|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0||
48453758|NCT03555890|101446545|FG002|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0||
48453759|NCT03555890|101446546|FG003|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0||
48453760|NCT03555890|101446543|FG000|STARTED|Part 2:Treatment Period 1 (3 Days)||0||
48453761|NCT03555890|101446544|FG001|STARTED|Part 2:Treatment Period 1 (3 Days)||0||
48453762|NCT03555890|101446545|FG002|STARTED|Part 2:Treatment Period 1 (3 Days)||24||
48453763|NCT03555890|101446546|FG003|STARTED|Part 2:Treatment Period 1 (3 Days)||24||
48453764|NCT03555890|101446543|FG000|COMPLETED|Part 2:Treatment Period 1 (3 Days)||0||
48453765|NCT03555890|101446544|FG001|COMPLETED|Part 2:Treatment Period 1 (3 Days)||0||
48453766|NCT03555890|101446545|FG002|COMPLETED|Part 2:Treatment Period 1 (3 Days)||24||
48453767|NCT03555890|101446546|FG003|COMPLETED|Part 2:Treatment Period 1 (3 Days)||24||
48453768|NCT03555890|101446543|FG000|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0||
48453769|NCT03555890|101446544|FG001|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0||
48453770|NCT03555890|101446545|FG002|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0||
48453771|NCT03555890|101446546|FG003|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0||
48453772|NCT03555890|101446543|FG000|STARTED|Part 2:Washout Period (at Least 5 Days)||0||
48453773|NCT03555890|101446544|FG001|STARTED|Part 2:Washout Period (at Least 5 Days)||0||
48453774|NCT03555890|101446545|FG002|STARTED|Part 2:Washout Period (at Least 5 Days)||24||
48453775|NCT03555890|101446546|FG003|STARTED|Part 2:Washout Period (at Least 5 Days)||24||
48453776|NCT03555890|101446543|FG000|COMPLETED|Part 2:Washout Period (at Least 5 Days)||0||
48453777|NCT03555890|101446544|FG001|COMPLETED|Part 2:Washout Period (at Least 5 Days)||0||
48453778|NCT03555890|101446545|FG002|COMPLETED|Part 2:Washout Period (at Least 5 Days)||24||
48453779|NCT03555890|101446546|FG003|COMPLETED|Part 2:Washout Period (at Least 5 Days)||23||
48453780|NCT03555890|101446543|FG000|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0||
48453781|NCT03555890|101446544|FG001|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0||
48453782|NCT03555890|101446545|FG002|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0||
48453783|NCT03555890|101446546|FG003|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||1||
48453784|NCT03555890|101446543|FG000|STARTED|Part 2:Treatment Period 2 (10 Days)||0||
48453785|NCT03555890|101446544|FG001|STARTED|Part 2:Treatment Period 2 (10 Days)||0||
48453786|NCT03555890|101446545|FG002|STARTED|Part 2:Treatment Period 2 (10 Days)||24||
48453787|NCT03555890|101446546|FG003|STARTED|Part 2:Treatment Period 2 (10 Days)||23||
48453788|NCT03555890|101446543|FG000|COMPLETED|Part 2:Treatment Period 2 (10 Days)||0||
48453789|NCT03555890|101446544|FG001|COMPLETED|Part 2:Treatment Period 2 (10 Days)||0||
48453790|NCT03555890|101446545|FG002|COMPLETED|Part 2:Treatment Period 2 (10 Days)||24||
48453791|NCT03555890|101446546|FG003|COMPLETED|Part 2:Treatment Period 2 (10 Days)||23||
48453792|NCT03555890|101446543|FG000|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0||
48453793|NCT03555890|101446544|FG001|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0||
48453794|NCT03555890|101446545|FG002|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0||
48453795|NCT03555890|101446546|FG003|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0||
48453796|NCT04149899|101446547|FG000|STARTED|Overall Study||6||
48453797|NCT04149899|101446548|FG001|STARTED|Overall Study||6||
48453798|NCT04149899|101446549|FG002|STARTED|Overall Study||6||
48453799|NCT04149899|101446550|FG003|STARTED|Overall Study||23||
48453800|NCT04149899|101446551|FG004|STARTED|Overall Study||24||
48453801|NCT04149899|101446552|FG005|STARTED|Overall Study||12||
48453802|NCT04149899|101446547|FG000|COMPLETED|Overall Study||6||
48453803|NCT04149899|101446548|FG001|COMPLETED|Overall Study||6||
48453804|NCT04149899|101446549|FG002|COMPLETED|Overall Study||6||
48453805|NCT04149899|101446550|FG003|COMPLETED|Overall Study||23||
48453806|NCT04149899|101446551|FG004|COMPLETED|Overall Study||24||
48453807|NCT04149899|101446552|FG005|COMPLETED|Overall Study||12||
48453808|NCT04149899|101446547|FG000|NOT COMPLETED|Overall Study||0||
48453809|NCT04149899|101446548|FG001|NOT COMPLETED|Overall Study||0||
48453810|NCT04149899|101446549|FG002|NOT COMPLETED|Overall Study||0||
48453811|NCT04149899|101446550|FG003|NOT COMPLETED|Overall Study||0||
48453812|NCT04149899|101446551|FG004|NOT COMPLETED|Overall Study||0||
48453813|NCT04149899|101446552|FG005|NOT COMPLETED|Overall Study||0||
48453814|NCT02077192|101446553|FG000|STARTED|Overall Study||123||
48453815|NCT02077192|101446553|FG000|COMPLETED|Overall Study||29||
48453816|NCT02077192|101446553|FG000|NOT COMPLETED|Overall Study||94||
48453817|NCT02354976|101446554|FG000|STARTED|Overall Study||25||
48453818|NCT02354976|101446555|FG001|STARTED|Overall Study||27||
48772501|NCT00472030|102232741|FG000|COMPLETED|Overall Study||1||
48772502|NCT00472030|102232742|FG001|COMPLETED|Overall Study||0||
48453819|NCT02354976|101446556|FG002|STARTED|Overall Study||26||
48453820|NCT02354976|101446554|FG000|COMPLETED|Overall Study||23||
48662134|NCT05218434|101957047|FG001|STARTED|Overall Study||5||
48662135|NCT05218434|101957048|FG002|STARTED|Overall Study||4||
48662136|NCT05218434|101957049|FG003|STARTED|Overall Study||4||
48662137|NCT05218434|101957050|FG004|STARTED|Overall Study||6||
48453821|NCT02354976|101446555|FG001|COMPLETED|Overall Study||26||
48453822|NCT02354976|101446556|FG002|COMPLETED|Overall Study||23||
48453823|NCT02354976|101446554|FG000|NOT COMPLETED|Overall Study||2||
48453824|NCT02354976|101446555|FG001|NOT COMPLETED|Overall Study||1||
48453825|NCT02354976|101446556|FG002|NOT COMPLETED|Overall Study||3||
48453826|NCT03596918|101446557|FG000|STARTED|Overall Study||10||
48453827|NCT03596918|101446557|FG000|COMPLETED|Overall Study||10||
48453828|NCT03596918|101446557|FG000|NOT COMPLETED|Overall Study||0||
48453829|NCT03077828|101446558|FG000|STARTED|Treatment Cycles||43||
48453830|NCT03077828|101446558|FG000|Cycle 1|Treatment Cycles||42||
48453831|NCT03077828|101446558|FG000|Cycle 2|Treatment Cycles||39||
48453832|NCT03077828|101446558|FG000|Cycle 3|Treatment Cycles||39||
48453833|NCT03077828|101446558|FG000|Optional Cycle 4|Treatment Cycles||5|Cycle #4 is not required on the study protocol. Patients with a Deauville score ≤3 may proceed directly to AHSCT per provider discretion if the procedure can be arranged within 21-35 days after cycle #3. Alternatively, if the patient's FDG-PET/CT has a Deauville score \>3, they will come off protocol, receive no further study agent, and be treated per investigator discretion.|
48453834|NCT03077828|101446558|FG000|COMPLETED|Treatment Cycles||39||
48453835|NCT03077828|101446558|FG000|NOT COMPLETED|Treatment Cycles||4||
48453836|NCT03077828|101446558|FG000|STARTED|Autologous Stem Cell Transplant||42|Autologous Stem Cell Transplant will took place 21-42 days after the final study regimen pembrolizumab dose (optional pembro-ICE combination or otherwise, per provider discretion). Transplant visit parameters were obtained on the initial day of induction chemotherapy or within 21-42 days following final study regimen but prior to the autologous stem cell transplant procedure.|
48453837|NCT03077828|101446558|FG000|COMPLETED|Autologous Stem Cell Transplant||38||
48453838|NCT03077828|101446558|FG000|NOT COMPLETED|Autologous Stem Cell Transplant||4||
48453839|NCT03077828|101446558|FG000|STARTED|Follow-up||39||
48453840|NCT03077828|101446558|FG000|COMPLETED|Follow-up||24||
48453841|NCT03077828|101446558|FG000|NOT COMPLETED|Follow-up||15||
48453842|NCT01149616|101446559|FG000|STARTED|Overall Study||41||
48453843|NCT01149616|101446560|FG001|STARTED|Overall Study||41||
48662138|NCT05218434|101957051|FG005|STARTED|Overall Study||9||
48662139|NCT05218434|101957052|FG006|STARTED|Overall Study||8||
48662140|NCT05218434|101957053|FG007|STARTED|Overall Study||6||
48662141|NCT05218434|101957054|FG008|STARTED|Overall Study||5||
48662142|NCT05218434|101957055|FG009|STARTED|Overall Study||6||
48662143|NCT05218434|101957056|FG010|STARTED|Overall Study||5||
48662144|NCT05218434|101957046|FG000|COMPLETED|Overall Study||6||
48662145|NCT05218434|101957047|FG001|COMPLETED|Overall Study||5||
48662146|NCT05218434|101957048|FG002|COMPLETED|Overall Study||4||
48662147|NCT05218434|101957049|FG003|COMPLETED|Overall Study||4||
48662148|NCT05218434|101957050|FG004|COMPLETED|Overall Study||6||
48662149|NCT05218434|101957051|FG005|COMPLETED|Overall Study||9||
48662150|NCT05218434|101957052|FG006|COMPLETED|Overall Study||8||
48772503|NCT00472030|102232741|FG000|NOT COMPLETED|Overall Study||1||
48453844|NCT01149616|101446559|FG000|COMPLETED|Overall Study||41||
48453845|NCT01149616|101446560|FG001|COMPLETED|Overall Study||41||
48453846|NCT01149616|101446559|FG000|NOT COMPLETED|Overall Study||0||
48453847|NCT01149616|101446560|FG001|NOT COMPLETED|Overall Study||0||
48453848|NCT04575038|101446561|FG000|STARTED|Overall Study||56||
48453849|NCT04575038|101446562|FG001|STARTED|Overall Study||59||
48453850|NCT04575038|101446561|FG000|COMPLETED|Overall Study||55||
48453851|NCT04575038|101446562|FG001|COMPLETED|Overall Study||58||
48453852|NCT04575038|101446561|FG000|NOT COMPLETED|Overall Study||1||
48453853|NCT04575038|101446562|FG001|NOT COMPLETED|Overall Study||1||
48453854|NCT01462695|101446563|FG000|STARTED|Overall Study||17||
48453855|NCT01462695|101446564|FG001|STARTED|Overall Study||13||
48453856|NCT01462695|101446563|FG000|COMPLETED|Overall Study||0||
48453857|NCT01462695|101446564|FG001|COMPLETED|Overall Study||0||
48453858|NCT01462695|101446563|FG000|NOT COMPLETED|Overall Study||17||
48453859|NCT01462695|101446564|FG001|NOT COMPLETED|Overall Study||13||
48453860|NCT00068237|101446565|FG000|STARTED|Overall Study||49||
48453861|NCT00068237|101446565|FG000|COMPLETED|Overall Study||44||
48453862|NCT00068237|101446565|FG000|NOT COMPLETED|Overall Study||5||
48453863|NCT00845026|101446566|FG000|STARTED|Study Period III||130||
48453864|NCT00845026|101446567|FG001|STARTED|Study Period III||131||
48453865|NCT00845026|101446566|FG000|COMPLETED|Study Period III||35||
48453866|NCT00845026|101446567|FG001|COMPLETED|Study Period III||59||
48453867|NCT00845026|101446566|FG000|NOT COMPLETED|Study Period III||95||
48453868|NCT00845026|101446567|FG001|NOT COMPLETED|Study Period III||72||
48453869|NCT00845026|101446566|FG000|STARTED|Study Period IV||28||
48453870|NCT00845026|101446567|FG001|STARTED|Study Period IV||50||
48453871|NCT00845026|101446566|FG000|COMPLETED|Study Period IV||12||
48662151|NCT05218434|101957053|FG007|COMPLETED|Overall Study||6||
48662152|NCT05218434|101957054|FG008|COMPLETED|Overall Study||5||
48662153|NCT05218434|101957055|FG009|COMPLETED|Overall Study||6||
48662154|NCT05218434|101957056|FG010|COMPLETED|Overall Study||5||
48662155|NCT05218434|101957046|FG000|NOT COMPLETED|Overall Study||0||
48662156|NCT05218434|101957047|FG001|NOT COMPLETED|Overall Study||0||
48772504|NCT00472030|102232742|FG001|NOT COMPLETED|Overall Study||0||
48772505|NCT00357903|102232743|FG000|STARTED|Overall Study||581||
48772506|NCT00357903|102232744|FG001|STARTED|Overall Study||58||
48772507|NCT00357903|102232743|FG000|COMPLETED|Overall Study||218||
48772508|NCT00357903|102232744|FG001|COMPLETED|Overall Study||15||
48453872|NCT00845026|101446567|FG001|COMPLETED|Study Period IV||46||
48453873|NCT00845026|101446566|FG000|NOT COMPLETED|Study Period IV||16||
48453874|NCT00845026|101446567|FG001|NOT COMPLETED|Study Period IV||4||
48453875|NCT03769181|101449484|FG000|STARTED|Overall Study||18||
48453876|NCT03769181|101449485|FG001|STARTED|Overall Study||12||
48453877|NCT03769181|101449486|FG002|STARTED|Overall Study||17||
48453878|NCT03769181|101449487|FG003|STARTED|Overall Study||11||
48453879|NCT03769181|101449484|FG000|COMPLETED|Overall Study||5|Participants who completed study treatment.|
48453880|NCT03769181|101449485|FG001|COMPLETED|Overall Study||4|Participants who completed study treatment.|
48453881|NCT03769181|101449486|FG002|COMPLETED|Overall Study||0|Participants who completed study treatment.|
48453882|NCT03769181|101449487|FG003|COMPLETED|Overall Study||0|Participants who completed study treatment.|
48453883|NCT03769181|101449484|FG000|NOT COMPLETED|Overall Study||13||
48453884|NCT03769181|101449485|FG001|NOT COMPLETED|Overall Study||8||
48453885|NCT03769181|101449486|FG002|NOT COMPLETED|Overall Study||17||
48453886|NCT03769181|101449487|FG003|NOT COMPLETED|Overall Study||11||
48453887|NCT02128867|101449488|FG000|STARTED|Overall Study||53||
48453888|NCT02128867|101449489|FG001|STARTED|Overall Study||52||
48453889|NCT02128867|101449490|FG002|STARTED|Overall Study||54||
48453890|NCT02128867|101449488|FG000|COMPLETED|Overall Study||50||
48453891|NCT02128867|101449489|FG001|COMPLETED|Overall Study||50||
48453892|NCT02128867|101449490|FG002|COMPLETED|Overall Study||50||
48453893|NCT02128867|101449488|FG000|NOT COMPLETED|Overall Study||3||
48453894|NCT02128867|101449489|FG001|NOT COMPLETED|Overall Study||2||
48453895|NCT02128867|101449490|FG002|NOT COMPLETED|Overall Study||4||
48453896|NCT01021137|101449491|FG000|STARTED|Overall Study||62||
48453897|NCT01021137|101449492|FG001|STARTED|Overall Study||20||
48453898|NCT01021137|101449493|FG002|STARTED|Overall Study||11||
48453899|NCT01021137|101449494|FG003|STARTED|Overall Study||41||
48453900|NCT01021137|101449491|FG000|COMPLETED|Overall Study||52||
48453901|NCT01021137|101449492|FG001|COMPLETED|Overall Study||16||
48453902|NCT01021137|101449493|FG002|COMPLETED|Overall Study||9||
48453903|NCT01021137|101449494|FG003|COMPLETED|Overall Study||32||
48453904|NCT01021137|101449491|FG000|NOT COMPLETED|Overall Study||10||
48453905|NCT01021137|101449492|FG001|NOT COMPLETED|Overall Study||4||
48453906|NCT01021137|101449493|FG002|NOT COMPLETED|Overall Study||2||
48453907|NCT01021137|101449494|FG003|NOT COMPLETED|Overall Study||9||
48453908|NCT02883673|101449495|FG000|STARTED|Overall Study||107||
48453909|NCT02883673|101449495|FG000|COMPLETED|Overall Study||107||
48453910|NCT02883673|101449495|FG000|NOT COMPLETED|Overall Study||0||
48453911|NCT03872700|101449496|FG000|STARTED|Overall Study||24||
48453912|NCT03872700|101449497|FG001|STARTED|Overall Study||25||
48453913|NCT03872700|101449496|FG000|COMPLETED|Overall Study||24||
48453914|NCT03872700|101449497|FG001|COMPLETED|Overall Study||25||
48453915|NCT03872700|101449496|FG000|NOT COMPLETED|Overall Study||0||
48453916|NCT03872700|101449497|FG001|NOT COMPLETED|Overall Study||0||
48453917|NCT02535000|101449498|FG000|STARTED|Overall Study||30||
48453918|NCT02535000|101449499|FG001|STARTED|Overall Study||30||
48453919|NCT02535000|101449498|FG000|COMPLETED|Overall Study||29||
48453920|NCT02535000|101449499|FG001|COMPLETED|Overall Study||28||
48453921|NCT02535000|101449498|FG000|NOT COMPLETED|Overall Study||1||
48453922|NCT02535000|101449499|FG001|NOT COMPLETED|Overall Study||2||
48453923|NCT05483920|101449500|FG000|STARTED|Overall Study||15||
48453924|NCT05483920|101449501|FG001|STARTED|Overall Study||15||
48453925|NCT05483920|101449500|FG000|COMPLETED|Overall Study||15||
48772509|NCT00357903|102232743|FG000|NOT COMPLETED|Overall Study||363||
48772510|NCT00357903|102232744|FG001|NOT COMPLETED|Overall Study||43||
48772511|NCT02058303|102232745|FG000|STARTED|Overall Study||16||
48453926|NCT05483920|101449501|FG001|COMPLETED|Overall Study||15||
48453927|NCT05483920|101449500|FG000|NOT COMPLETED|Overall Study||0||
48453928|NCT05483920|101449501|FG001|NOT COMPLETED|Overall Study||0||
48453929|NCT02931565|101449502|FG000|STARTED|Overall Study||2||
48453930|NCT02931565|101449503|FG001|STARTED|Overall Study||7||
48453931|NCT02931565|101449502|FG000|COMPLETED|Overall Study||2||
48453932|NCT02931565|101449503|FG001|COMPLETED|Overall Study||7||
48453933|NCT02931565|101449502|FG000|NOT COMPLETED|Overall Study||0||
48453934|NCT02931565|101449503|FG001|NOT COMPLETED|Overall Study||0||
48453935|NCT04741503|101449504|FG000|STARTED|Initial Enrollment||160||
48453936|NCT04741503|101449505|FG001|STARTED|Initial Enrollment||164||
48772512|NCT02058303|102232746|FG001|STARTED|Overall Study||21||
48772513|NCT02058303|102232745|FG000|COMPLETED|Overall Study||16||
48453937|NCT04741503|101449506|FG002|STARTED|Initial Enrollment||953||
48453938|NCT04741503|101449504|FG000|COMPLETED|Initial Enrollment||160||
48453939|NCT04741503|101449505|FG001|COMPLETED|Initial Enrollment||164||
48453940|NCT04741503|101449506|FG002|COMPLETED|Initial Enrollment||0||
48453941|NCT04741503|101449504|FG000|NOT COMPLETED|Initial Enrollment||0||
48772514|NCT02058303|102232746|FG001|COMPLETED|Overall Study||21||
48772515|NCT02058303|102232745|FG000|NOT COMPLETED|Overall Study||0||
48772516|NCT02058303|102232746|FG001|NOT COMPLETED|Overall Study||0||
48662157|NCT05218434|101957048|FG002|NOT COMPLETED|Overall Study||0||
48662158|NCT05218434|101957049|FG003|NOT COMPLETED|Overall Study||0||
48662159|NCT05218434|101957050|FG004|NOT COMPLETED|Overall Study||0||
48662160|NCT05218434|101957051|FG005|NOT COMPLETED|Overall Study||0||
48662161|NCT05218434|101957052|FG006|NOT COMPLETED|Overall Study||0||
48662162|NCT05218434|101957053|FG007|NOT COMPLETED|Overall Study||0||
48662163|NCT05218434|101957054|FG008|NOT COMPLETED|Overall Study||0||
48662164|NCT05218434|101957055|FG009|NOT COMPLETED|Overall Study||0||
48662165|NCT05218434|101957056|FG010|NOT COMPLETED|Overall Study||0||
48662166|NCT05201495|101957057|FG000|STARTED|Overall Study||322||
48662167|NCT05201495|101957057|FG000|COMPLETED|Overall Study||314||
48662168|NCT05201495|101957057|FG000|NOT COMPLETED|Overall Study||8||
48662169|NCT03735121|101957058|FG000|STARTED|Overall Study||13||
48662170|NCT03735121|101957059|FG001|STARTED|Overall Study||15||
48662171|NCT03735121|101957060|FG002|STARTED|Overall Study||39||
48662172|NCT03735121|101957061|FG003|STARTED|Overall Study||124||
48662173|NCT03735121|101957062|FG004|STARTED|Overall Study||247||
48662174|NCT03735121|101957058|FG000|COMPLETED|Overall Study||6||
48662175|NCT03735121|101957059|FG001|COMPLETED|Overall Study||5||
48662176|NCT03735121|101957060|FG002|COMPLETED|Overall Study||1||
48662177|NCT03735121|101957061|FG003|COMPLETED|Overall Study||0||
48662178|NCT03735121|101957062|FG004|COMPLETED|Overall Study||0||
48662179|NCT03735121|101957058|FG000|NOT COMPLETED|Overall Study||7||
48662180|NCT03735121|101957059|FG001|NOT COMPLETED|Overall Study||10||
48662181|NCT03735121|101957060|FG002|NOT COMPLETED|Overall Study||38||
48662182|NCT03735121|101957061|FG003|NOT COMPLETED|Overall Study||124||
48662183|NCT03735121|101957062|FG004|NOT COMPLETED|Overall Study||247||
48662184|NCT02500836|101957063|FG000|STARTED|Overall Study||259||
48453942|NCT04741503|101449505|FG001|NOT COMPLETED|Initial Enrollment||0||
48453943|NCT04741503|101449506|FG002|NOT COMPLETED|Initial Enrollment||953||
48453944|NCT04741503|101449504|FG000|STARTED|Met Protocol Criteria for Data Inclusion||160||
48662185|NCT02500836|101957064|FG001|STARTED|Overall Study||259||
48662186|NCT02500836|101957065|FG002|STARTED|Overall Study||128||
48662187|NCT02500836|101957063|FG000|COMPLETED|Overall Study||256||
48662188|NCT02500836|101957064|FG001|COMPLETED|Overall Study||254||
48662189|NCT02500836|101957065|FG002|COMPLETED|Overall Study||127||
48662190|NCT02500836|101957063|FG000|NOT COMPLETED|Overall Study||3||
48662191|NCT02500836|101957064|FG001|NOT COMPLETED|Overall Study||5||
48662192|NCT02500836|101957065|FG002|NOT COMPLETED|Overall Study||1||
48662193|NCT00267488|101957066|FG000|STARTED|Overall Study||37||
48662194|NCT00267488|101957066|FG000|COMPLETED|Overall Study||26||
48662195|NCT00267488|101957066|FG000|NOT COMPLETED|Overall Study||11||
48662196|NCT00944645|101957067|FG000|STARTED|Period 1||94||
48662197|NCT00944645|101957068|FG001|STARTED|Period 1||94||
48662198|NCT00944645|101957067|FG000|COMPLETED|Period 1||94||
48662199|NCT00944645|101957068|FG001|COMPLETED|Period 1||94||
48662200|NCT00944645|101957067|FG000|NOT COMPLETED|Period 1||0||
48662201|NCT00944645|101957068|FG001|NOT COMPLETED|Period 1||0||
48662202|NCT00944645|101957067|FG000|STARTED|Period 2||94||
48662203|NCT00944645|101957068|FG001|STARTED|Period 2||94||
48662204|NCT00944645|101957067|FG000|COMPLETED|Period 2||86||
48662205|NCT00944645|101957068|FG001|COMPLETED|Period 2||85||
48662206|NCT00944645|101957067|FG000|NOT COMPLETED|Period 2||8||
48662207|NCT00944645|101957068|FG001|NOT COMPLETED|Period 2||9||
48662208|NCT01950039|101957069|FG000|STARTED|Overall Study||15||
48662209|NCT01950039|101957070|FG001|STARTED|Overall Study||13||
48662210|NCT01950039|101957069|FG000|Study Drug Initiated|Overall Study||14||
48662211|NCT01950039|101957070|FG001|Study Drug Initiated|Overall Study||13||
48662212|NCT01950039|101957069|FG000|Completed Clamp|Overall Study||13||
48662213|NCT01950039|101957070|FG001|Completed Clamp|Overall Study||12||
48662214|NCT01950039|101957069|FG000|Completed MRI|Overall Study||13||
48662215|NCT01950039|101957070|FG001|Completed MRI|Overall Study||12||
48662216|NCT01950039|101957069|FG000|Completed Endothelial Evaluation|Overall Study||14||
48662217|NCT01950039|101957070|FG001|Completed Endothelial Evaluation|Overall Study||12||
48662218|NCT01950039|101957069|FG000|COMPLETED|Overall Study||14||
48662219|NCT01950039|101957070|FG001|COMPLETED|Overall Study||13||
48662220|NCT01950039|101957069|FG000|NOT COMPLETED|Overall Study||1||
48662221|NCT01950039|101957070|FG001|NOT COMPLETED|Overall Study||0||
48662222|NCT02609503|101957071|FG000|STARTED|Overall Study||29||
48453945|NCT04741503|101449505|FG001|STARTED|Met Protocol Criteria for Data Inclusion||164||
48453946|NCT04741503|101449506|FG002|STARTED|Met Protocol Criteria for Data Inclusion||0||
48662223|NCT02609503|101957071|FG000|COMPLETED|Overall Study||25||
48662224|NCT02609503|101957071|FG000|NOT COMPLETED|Overall Study||4||
48662225|NCT00911157|101957072|FG000|STARTED|Overall Study||29||
48662226|NCT00911157|101957073|FG001|STARTED|Overall Study||10||
48662227|NCT00911157|101957072|FG000|COMPLETED|Overall Study||22||
48662228|NCT00911157|101957073|FG001|COMPLETED|Overall Study||8||
48662229|NCT00911157|101957072|FG000|NOT COMPLETED|Overall Study||7||
48662230|NCT00911157|101957073|FG001|NOT COMPLETED|Overall Study||2||
48662231|NCT03510715|101957074|FG000|STARTED|Overall Study||9||
48662232|NCT03510715|101957075|FG001|STARTED|Overall Study||9||
48662233|NCT03510715|101957074|FG000|COMPLETED|Overall Study||8||
48662234|NCT03510715|101957075|FG001|COMPLETED|Overall Study||9||
48662235|NCT03510715|101957074|FG000|NOT COMPLETED|Overall Study||1||
48453947|NCT04741503|101449504|FG000|COMPLETED|Met Protocol Criteria for Data Inclusion||137||
48453948|NCT04741503|101449505|FG001|COMPLETED|Met Protocol Criteria for Data Inclusion||147||
48453949|NCT04741503|101449506|FG002|COMPLETED|Met Protocol Criteria for Data Inclusion||0||
48453950|NCT04741503|101449504|FG000|NOT COMPLETED|Met Protocol Criteria for Data Inclusion||23||
48453951|NCT04741503|101449505|FG001|NOT COMPLETED|Met Protocol Criteria for Data Inclusion||17||
48453952|NCT04741503|101449506|FG002|NOT COMPLETED|Met Protocol Criteria for Data Inclusion||0||
48453953|NCT03112993|101449507|FG000|STARTED|Overall Study||19||
48453954|NCT03112993|101449508|FG001|STARTED|Overall Study||21||
48453955|NCT03112993|101449507|FG000|COMPLETED|Overall Study||19||
48453956|NCT03112993|101449508|FG001|COMPLETED|Overall Study||21||
48453957|NCT03112993|101449507|FG000|NOT COMPLETED|Overall Study||0||
48453958|NCT03112993|101449508|FG001|NOT COMPLETED|Overall Study||0||
48453959|NCT01015612|101449509|FG000|STARTED|Overall Study||634||
48453960|NCT01015612|101449509|FG000|COMPLETED|Overall Study||481||
48453961|NCT01015612|101449509|FG000|NOT COMPLETED|Overall Study||153||
48453962|NCT03208933|101449510|FG000|STARTED|Overall Study||60||
48453963|NCT03208933|101449510|FG000|COMPLETED|Overall Study||47||
48453964|NCT03208933|101449510|FG000|NOT COMPLETED|Overall Study||13||
48453965|NCT00095199|101449511|FG000|STARTED|Overall Study||302||
48453966|NCT00095199|101449512|FG001|STARTED|Overall Study||304||
48453967|NCT00095199|101449513|FG002|STARTED|Overall Study||167||
48662236|NCT03510715|101957075|FG001|NOT COMPLETED|Overall Study||0||
48453968|NCT00095199|101449514|FG003|STARTED|Overall Study||166||
48453969|NCT00095199|101449511|FG000|COMPLETED|Overall Study||6||
48453970|NCT00095199|101449512|FG001|COMPLETED|Overall Study||62||
48453971|NCT00095199|101449513|FG002|COMPLETED|Overall Study||7||
48453972|NCT00095199|101449514|FG003|COMPLETED|Overall Study||23||
48453973|NCT00095199|101449511|FG000|NOT COMPLETED|Overall Study||296||
48453974|NCT00095199|101449512|FG001|NOT COMPLETED|Overall Study||242||
48453975|NCT00095199|101449513|FG002|NOT COMPLETED|Overall Study||160||
48453976|NCT00095199|101449514|FG003|NOT COMPLETED|Overall Study||143||
48453977|NCT03066440|101449515|FG000|STARTED|Overall Study||26||
48453978|NCT03066440|101449516|FG001|STARTED|Overall Study||27||
48453979|NCT03066440|101449515|FG000|COMPLETED|Overall Study||25||
48453980|NCT03066440|101449516|FG001|COMPLETED|Overall Study||24||
48453981|NCT03066440|101449515|FG000|NOT COMPLETED|Overall Study||1||
48453982|NCT03066440|101449516|FG001|NOT COMPLETED|Overall Study||3||
48453983|NCT03578276|101449517|FG000|STARTED|Overall Study||35||35
48453984|NCT03578276|101449518|FG001|STARTED|Overall Study||35||35
48453985|NCT03578276|101449517|FG000|COMPLETED|Overall Study||33||33
48453986|NCT03578276|101449518|FG001|COMPLETED|Overall Study||33||33
48453987|NCT03578276|101449517|FG000|NOT COMPLETED|Overall Study||2||2
48453988|NCT03578276|101449518|FG001|NOT COMPLETED|Overall Study||2||2
48453989|NCT00125931|101449519|FG000|STARTED|Overall Study||10||
48453990|NCT00125931|101449519|FG000|COMPLETED|Overall Study||10||
48453991|NCT00125931|101449519|FG000|NOT COMPLETED|Overall Study||0||
48453992|NCT00515073|101449520|FG000|STARTED|Overall Study||30||
48453993|NCT00515073|101449520|FG000|COMPLETED|Overall Study||28||
48453994|NCT00515073|101449520|FG000|NOT COMPLETED|Overall Study||2||
48453995|NCT03621085|101449521|FG000|STARTED|Enrollment||22||
48453996|NCT03621085|101449522|FG001|STARTED|Enrollment||21||
48453997|NCT03621085|101449521|FG000|COMPLETED|Enrollment||16||
48453998|NCT03621085|101449522|FG001|COMPLETED|Enrollment||14||
48453999|NCT03621085|101449521|FG000|NOT COMPLETED|Enrollment||6||
48454000|NCT03621085|101449522|FG001|NOT COMPLETED|Enrollment||7||
48454001|NCT03621085|101449521|FG000|STARTED|First Visit||16||
48454002|NCT03621085|101449522|FG001|STARTED|First Visit||14||
48454003|NCT03621085|101449521|FG000|COMPLETED|First Visit||16||
48454004|NCT03621085|101449522|FG001|COMPLETED|First Visit||14||
48454005|NCT03621085|101449521|FG000|NOT COMPLETED|First Visit||0||
48662237|NCT02457793|101957076|FG000|STARTED|Overall Study||1||
48454006|NCT03621085|101449522|FG001|NOT COMPLETED|First Visit||0||
48454007|NCT03621085|101449521|FG000|STARTED|Washout (at Least 48 Hours)||16||
48454008|NCT03621085|101449522|FG001|STARTED|Washout (at Least 48 Hours)||14||
48454009|NCT03621085|101449521|FG000|COMPLETED|Washout (at Least 48 Hours)||16||
48454010|NCT03621085|101449522|FG001|COMPLETED|Washout (at Least 48 Hours)||14||
48454011|NCT03621085|101449521|FG000|NOT COMPLETED|Washout (at Least 48 Hours)||0||
48454012|NCT03621085|101449522|FG001|NOT COMPLETED|Washout (at Least 48 Hours)||0||
48454013|NCT03621085|101449521|FG000|STARTED|Second Visit||16||
48454014|NCT03621085|101449522|FG001|STARTED|Second Visit||14||
48454015|NCT03621085|101449521|FG000|COMPLETED|Second Visit||16||
48454016|NCT03621085|101449522|FG001|COMPLETED|Second Visit||14||
48454017|NCT03621085|101449521|FG000|NOT COMPLETED|Second Visit||0||
48454018|NCT03621085|101449522|FG001|NOT COMPLETED|Second Visit||0||
48454019|NCT02191579|101449523|FG000|STARTED|Treatment 1||140||
48454020|NCT02191579|101449524|FG001|STARTED|Treatment 1||142||
48454021|NCT02191579|101449523|FG000|COMPLETED|Treatment 1||113||
48454022|NCT02191579|101449524|FG001|COMPLETED|Treatment 1||84||
48454023|NCT02191579|101449523|FG000|NOT COMPLETED|Treatment 1||27||
48454024|NCT02191579|101449524|FG001|NOT COMPLETED|Treatment 1||58||
48454025|NCT02191579|101449523|FG000|STARTED|Treatment 2||0||
48454026|NCT02191579|101449524|FG001|STARTED|Treatment 2||80||
48454027|NCT02191579|101449523|FG000|COMPLETED|Treatment 2||0||
48454028|NCT02191579|101449524|FG001|COMPLETED|Treatment 2||55||
48454029|NCT02191579|101449523|FG000|NOT COMPLETED|Treatment 2||0||
48454030|NCT02191579|101449524|FG001|NOT COMPLETED|Treatment 2||25||
48454031|NCT01427803|101449525|FG000|STARTED|Overall Study||526||
48454032|NCT01427803|101449526|FG001|STARTED|Overall Study||252||
48454033|NCT01427803|101449525|FG000|Purchased Product|Overall Study||525||
48454034|NCT01427803|101449526|FG001|Purchased Product|Overall Study||252||
48454035|NCT01427803|101449525|FG000|Baseline Assessment|Overall Study||516||
48454036|NCT01427803|101449526|FG001|Baseline Assessment|Overall Study||130||
48454037|NCT01427803|101449525|FG000|Took Product|Overall Study||508||
48454038|NCT01427803|101449526|FG001|Took Product|Overall Study||237||
48454039|NCT01427803|101449525|FG000|COMPLETED|Overall Study||463||
48454040|NCT01427803|101449526|FG001|COMPLETED|Overall Study||226||
48454041|NCT01427803|101449525|FG000|NOT COMPLETED|Overall Study||63||
48454042|NCT01427803|101449526|FG001|NOT COMPLETED|Overall Study||26||
48454043|NCT00780715|101449527|FG000|STARTED|Overall Study||6||
48454044|NCT00780715|101449528|FG001|STARTED|Overall Study||6||
48454045|NCT00780715|101449529|FG002|STARTED|Overall Study||6||
48454046|NCT00780715|101449530|FG003|STARTED|Overall Study||11||
48454047|NCT00780715|101449527|FG000|COMPLETED|Overall Study||6||
48454048|NCT00780715|101449528|FG001|COMPLETED|Overall Study||6||
48454049|NCT00780715|101449529|FG002|COMPLETED|Overall Study||6||
48454050|NCT00780715|101449530|FG003|COMPLETED|Overall Study||11||
48454051|NCT00780715|101449527|FG000|NOT COMPLETED|Overall Study||0||
48454052|NCT00780715|101449528|FG001|NOT COMPLETED|Overall Study||0||
48662238|NCT02457793|101957077|FG001|STARTED|Overall Study||5||
48662239|NCT02457793|101957078|FG002|STARTED|Overall Study||3||
48662240|NCT02457793|101957079|FG003|STARTED|Overall Study||5||
48662241|NCT02457793|101957080|FG004|STARTED|Overall Study||4||
48662242|NCT02457793|101957081|FG005|STARTED|Overall Study||6||
48662243|NCT02457793|101957076|FG000|COMPLETED|Overall Study||0||
48662244|NCT02457793|101957077|FG001|COMPLETED|Overall Study||1||
48662245|NCT02457793|101957078|FG002|COMPLETED|Overall Study||0||
48662246|NCT02457793|101957079|FG003|COMPLETED|Overall Study||0||
48454053|NCT00780715|101449529|FG002|NOT COMPLETED|Overall Study||0||
48454054|NCT00780715|101449530|FG003|NOT COMPLETED|Overall Study||0||
48454055|NCT00948025|101449531|FG000|STARTED|Phase 1 (Pilot Phase)||14||
48454056|NCT00948025|101449532|FG001|STARTED|Phase 1 (Pilot Phase)||9||
48454057|NCT00948025|101449531|FG000|COMPLETED|Phase 1 (Pilot Phase)||5||
48454058|NCT00948025|101449532|FG001|COMPLETED|Phase 1 (Pilot Phase)||6||
48454059|NCT00948025|101449531|FG000|NOT COMPLETED|Phase 1 (Pilot Phase)||9||
48454060|NCT00948025|101449532|FG001|NOT COMPLETED|Phase 1 (Pilot Phase)||3||
48662247|NCT02457793|101957080|FG004|COMPLETED|Overall Study||0||
48662248|NCT02457793|101957081|FG005|COMPLETED|Overall Study||0||
48662249|NCT02457793|101957076|FG000|NOT COMPLETED|Overall Study||1||
48662250|NCT02457793|101957077|FG001|NOT COMPLETED|Overall Study||4||
48662251|NCT02457793|101957078|FG002|NOT COMPLETED|Overall Study||3||
48662252|NCT02457793|101957079|FG003|NOT COMPLETED|Overall Study||5||
48662253|NCT02457793|101957080|FG004|NOT COMPLETED|Overall Study||4||
48662254|NCT02457793|101957081|FG005|NOT COMPLETED|Overall Study||6||
48662255|NCT05073432|101957082|FG000|STARTED|Overall Study||10||
48662256|NCT05073432|101957082|FG000|COMPLETED|Overall Study||10||
48662257|NCT05073432|101957082|FG000|NOT COMPLETED|Overall Study||0||
48662258|NCT02144337|101957083|FG000|STARTED|Baseline 0 Months||8||
48662259|NCT02144337|101957084|FG001|STARTED|Baseline 0 Months||5||
48454061|NCT00948025|101449531|FG000|STARTED|Phase 2 (Comparative Phase)||0||
48454062|NCT00948025|101449532|FG001|STARTED|Phase 2 (Comparative Phase)||0||
48454063|NCT00948025|101449531|FG000|COMPLETED|Phase 2 (Comparative Phase)||0||
48662260|NCT02144337|101957083|FG000|COMPLETED|Baseline 0 Months||8||
48662261|NCT02144337|101957084|FG001|COMPLETED|Baseline 0 Months||5||
48662262|NCT02144337|101957083|FG000|NOT COMPLETED|Baseline 0 Months||0||
48662263|NCT02144337|101957084|FG001|NOT COMPLETED|Baseline 0 Months||0||
48662264|NCT02144337|101957083|FG000|STARTED|T2 Follow-up (Post-intervention)||8||
48662265|NCT02144337|101957084|FG001|STARTED|T2 Follow-up (Post-intervention)||5||
48662266|NCT02144337|101957083|FG000|COMPLETED|T2 Follow-up (Post-intervention)||4||
48662267|NCT02144337|101957084|FG001|COMPLETED|T2 Follow-up (Post-intervention)||4||
48454064|NCT00948025|101449532|FG001|COMPLETED|Phase 2 (Comparative Phase)||0||
48454065|NCT00948025|101449531|FG000|NOT COMPLETED|Phase 2 (Comparative Phase)||0||
48454066|NCT00948025|101449532|FG001|NOT COMPLETED|Phase 2 (Comparative Phase)||0||
48454067|NCT01360632|101449533|FG000|STARTED|Phase A (8 Weeks)||1532||
48454068|NCT01360632|101449534|FG001|STARTED|Phase A (8 Weeks)||0||
48454069|NCT01360632|101449535|FG002|STARTED|Phase A (8 Weeks)||0||
48454070|NCT01360632|101449536|FG003|STARTED|Phase A (8 Weeks)||0||
48454071|NCT01360632|101449537|FG004|STARTED|Phase A (8 Weeks)||0||
48454072|NCT01360632|101449533|FG000|COMPLETED|Phase A (8 Weeks)||1277||
48662268|NCT02144337|101957083|FG000|NOT COMPLETED|T2 Follow-up (Post-intervention)||4||
48662269|NCT02144337|101957084|FG001|NOT COMPLETED|T2 Follow-up (Post-intervention)||1||
48662270|NCT02144337|101957083|FG000|STARTED|T3 Follow-up (3 Month Post-intervention)||8||
48772517|NCT05887388|102232747|FG000|STARTED|Overall Study||38||
48454073|NCT01360632|101449534|FG001|COMPLETED|Phase A (8 Weeks)||0||
48454074|NCT01360632|101449535|FG002|COMPLETED|Phase A (8 Weeks)||0||
48454075|NCT01360632|101449536|FG003|COMPLETED|Phase A (8 Weeks)||0||
48454076|NCT01360632|101449537|FG004|COMPLETED|Phase A (8 Weeks)||0||
48454077|NCT01360632|101449533|FG000|NOT COMPLETED|Phase A (8 Weeks)||255||
48454078|NCT01360632|101449534|FG001|NOT COMPLETED|Phase A (8 Weeks)||0||
48454079|NCT01360632|101449535|FG002|NOT COMPLETED|Phase A (8 Weeks)||0||
48454080|NCT01360632|101449536|FG003|NOT COMPLETED|Phase A (8 Weeks)||0||
48454081|NCT01360632|101449537|FG004|NOT COMPLETED|Phase A (8 Weeks)||0||
48454082|NCT01360632|101449533|FG000|STARTED|Phase B (6 Weeks)||0||
48454083|NCT01360632|101449534|FG001|STARTED|Phase B (6 Weeks)||226||
48454084|NCT01360632|101449535|FG002|STARTED|Phase B (6 Weeks)||230||
48454085|NCT01360632|101449536|FG003|STARTED|Phase B (6 Weeks)||221||
48454086|NCT01360632|101449537|FG004|STARTED|Phase B (6 Weeks)||0||
48454087|NCT01360632|101449533|FG000|COMPLETED|Phase B (6 Weeks)||0||
48454088|NCT01360632|101449534|FG001|COMPLETED|Phase B (6 Weeks)||216||
48454089|NCT01360632|101449535|FG002|COMPLETED|Phase B (6 Weeks)||210||
48454090|NCT01360632|101449536|FG003|COMPLETED|Phase B (6 Weeks)||208||
48454091|NCT01360632|101449537|FG004|COMPLETED|Phase B (6 Weeks)||0||
48454092|NCT01360632|101449533|FG000|NOT COMPLETED|Phase B (6 Weeks)||0||
48662271|NCT02144337|101957084|FG001|STARTED|T3 Follow-up (3 Month Post-intervention)||5||
48662272|NCT02144337|101957083|FG000|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5||
48662273|NCT02144337|101957084|FG001|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5||
48772518|NCT05887388|102232747|FG000|Patients Started|Overall Study||19||
48772519|NCT05887388|102232747|FG000|Caregivers Started|Overall Study||19||
48454093|NCT01360632|101449534|FG001|NOT COMPLETED|Phase B (6 Weeks)||10||
48454094|NCT01360632|101449535|FG002|NOT COMPLETED|Phase B (6 Weeks)||20||
48454095|NCT01360632|101449536|FG003|NOT COMPLETED|Phase B (6 Weeks)||13||
48454096|NCT01360632|101449537|FG004|NOT COMPLETED|Phase B (6 Weeks)||0||
48454097|NCT01360632|101449533|FG000|STARTED|Phase A+||0||
48454098|NCT01360632|101449534|FG001|STARTED|Phase A+||0||
48454099|NCT01360632|101449535|FG002|STARTED|Phase A+||0||
48454100|NCT01360632|101449536|FG003|STARTED|Phase A+||0||
48454101|NCT01360632|101449537|FG004|STARTED|Phase A+||600||
48454102|NCT01360632|101449533|FG000|COMPLETED|Phase A+||0||
48454103|NCT01360632|101449534|FG001|COMPLETED|Phase A+||0||
48454104|NCT01360632|101449535|FG002|COMPLETED|Phase A+||0||
48454105|NCT01360632|101449536|FG003|COMPLETED|Phase A+||0||
48454106|NCT01360632|101449537|FG004|COMPLETED|Phase A+||575||
48454107|NCT01360632|101449533|FG000|NOT COMPLETED|Phase A+||0||
48454108|NCT01360632|101449534|FG001|NOT COMPLETED|Phase A+||0||
48454109|NCT01360632|101449535|FG002|NOT COMPLETED|Phase A+||0||
48454110|NCT01360632|101449536|FG003|NOT COMPLETED|Phase A+||0||
48454111|NCT01360632|101449537|FG004|NOT COMPLETED|Phase A+||25||
48454112|NCT00947518|101449538|FG000|STARTED|Overall Study||20||
48454113|NCT00947518|101449539|FG001|STARTED|Overall Study||20||
48454114|NCT00947518|101449540|FG002|STARTED|Overall Study||20||
48454115|NCT00947518|101449538|FG000|COMPLETED|Overall Study||20||
48454116|NCT00947518|101449539|FG001|COMPLETED|Overall Study||20||
48454117|NCT00947518|101449540|FG002|COMPLETED|Overall Study||20||
48454118|NCT00947518|101449538|FG000|NOT COMPLETED|Overall Study||0||
48454119|NCT00947518|101449539|FG001|NOT COMPLETED|Overall Study||0||
48454120|NCT00947518|101449540|FG002|NOT COMPLETED|Overall Study||0||
48454121|NCT01086215|101449541|FG000|STARTED|Overall Study||212||
48454122|NCT01086215|101449542|FG001|STARTED|Overall Study||201||
48454123|NCT01086215|101449543|FG002|STARTED|Overall Study||73||
48454124|NCT01086215|101449544|FG003|STARTED|Overall Study||14||
48454125|NCT01086215|101449541|FG000|3 Month Follow Up|Overall Study||201||
48454126|NCT01086215|101449542|FG001|3 Month Follow Up|Overall Study||187||
48454127|NCT01086215|101449543|FG002|3 Month Follow Up|Overall Study||64||
48454128|NCT01086215|101449544|FG003|3 Month Follow Up|Overall Study||13||
48454129|NCT01086215|101449541|FG000|6 Month Follow Up|Overall Study||192||
48772520|NCT05887388|102232747|FG000|COMPLETED|Overall Study||38||
48772521|NCT05887388|102232747|FG000|NOT COMPLETED|Overall Study||0||
48772522|NCT02566369|102232748|FG000|STARTED|Overall Study||612||
48454130|NCT01086215|101449542|FG001|6 Month Follow Up|Overall Study||172||
48454131|NCT01086215|101449543|FG002|6 Month Follow Up|Overall Study||60||
48670050|NCT05757193|101974877|FG000|NOT COMPLETED|Overall Study||0||
48454132|NCT01086215|101449544|FG003|6 Month Follow Up|Overall Study||12||
48454133|NCT01086215|101449541|FG000|12 Month Follow Up|Overall Study||176||
48454134|NCT01086215|101449542|FG001|12 Month Follow Up|Overall Study||154||
48454135|NCT01086215|101449543|FG002|12 Month Follow Up|Overall Study||47||
48454136|NCT01086215|101449544|FG003|12 Month Follow Up|Overall Study||11||
48454137|NCT01086215|101449541|FG000|COMPLETED|Overall Study||176||
48454138|NCT01086215|101449542|FG001|COMPLETED|Overall Study||154||
48454139|NCT01086215|101449543|FG002|COMPLETED|Overall Study||47||
48454140|NCT01086215|101449544|FG003|COMPLETED|Overall Study||11||
48454141|NCT01086215|101449541|FG000|NOT COMPLETED|Overall Study||36||
48454142|NCT01086215|101449542|FG001|NOT COMPLETED|Overall Study||47||
48454143|NCT01086215|101449543|FG002|NOT COMPLETED|Overall Study||26||
48454144|NCT01086215|101449544|FG003|NOT COMPLETED|Overall Study||3||
48454145|NCT00634582|101449545|FG000|STARTED|Overall Study||2||
48772523|NCT02566369|102232749|FG001|STARTED|Overall Study||596||
48454146|NCT00634582|101449545|FG000|COMPLETED|Overall Study||2||
48454147|NCT00634582|101449545|FG000|NOT COMPLETED|Overall Study||0||
48454148|NCT00565370|101449546|FG000|STARTED|Overall Study||21||
48454149|NCT00565370|101449546|FG000|COMPLETED|Overall Study||21||
48662274|NCT02144337|101957083|FG000|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||3||
48662275|NCT02144337|101957084|FG001|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||0||
48662276|NCT02414841|101957085|FG000|STARTED|Overall Study||405||
48662277|NCT02414841|101957086|FG001|STARTED|Overall Study||208||
48662278|NCT02414841|101957085|FG000|COMPLETED|Overall Study||349||
48662279|NCT02414841|101957086|FG001|COMPLETED|Overall Study||175||
48662280|NCT02414841|101957085|FG000|NOT COMPLETED|Overall Study||56||
48662281|NCT02414841|101957086|FG001|NOT COMPLETED|Overall Study||33||
48662282|NCT02598973|101957087|FG000|STARTED|Overall Study||5||
48662283|NCT02598973|101957088|FG001|STARTED|Overall Study||4||
48662284|NCT02598973|101957087|FG000|COMPLETED|Overall Study||3||
48772524|NCT02566369|102232748|FG000|COMPLETED|Overall Study||540||
48454150|NCT00565370|101449546|FG000|NOT COMPLETED|Overall Study||0||
48454151|NCT03216200|101449547|FG000|STARTED|Overall Study||5||
48454152|NCT03216200|101449547|FG000|COMPLETED|Overall Study||5||
48454153|NCT03216200|101449547|FG000|NOT COMPLETED|Overall Study||0||
48454154|NCT01878656|101449548|FG000|STARTED|Overall Study||72||
48454155|NCT01878656|101449549|FG001|STARTED|Overall Study||72||
48454156|NCT01878656|101449548|FG000|COMPLETED|Overall Study||72||
48454157|NCT01878656|101449549|FG001|COMPLETED|Overall Study||72||
48454158|NCT01878656|101449548|FG000|NOT COMPLETED|Overall Study||0||
48454159|NCT01878656|101449549|FG001|NOT COMPLETED|Overall Study||0||
48454160|NCT00409578|101449550|FG000|STARTED|Overall Study||280||
48454161|NCT00409578|101449551|FG001|STARTED|Overall Study||271||
48454162|NCT00409578|101449552|FG002|STARTED|Overall Study||269||
48454163|NCT00409578|101449553|FG003|STARTED|Overall Study||281||
48454164|NCT00409578|101449550|FG000|COMPLETED|Overall Study||228||
48454165|NCT00409578|101449551|FG001|COMPLETED|Overall Study||201||
48454166|NCT00409578|101449552|FG002|COMPLETED|Overall Study||215||
48454167|NCT00409578|101449553|FG003|COMPLETED|Overall Study||214||
48454168|NCT00409578|101449550|FG000|NOT COMPLETED|Overall Study||52||
48454169|NCT00409578|101449551|FG001|NOT COMPLETED|Overall Study||70||
48454170|NCT00409578|101449552|FG002|NOT COMPLETED|Overall Study||54||
48454171|NCT00409578|101449553|FG003|NOT COMPLETED|Overall Study||67||
48454172|NCT03083132|101449554|FG000|STARTED|First 12 Weeks (Placebo vs Modafinil)||12||
48454173|NCT03083132|101449555|FG001|STARTED|First 12 Weeks (Placebo vs Modafinil)||9||
48662285|NCT02598973|101957088|FG001|COMPLETED|Overall Study||3||
48662286|NCT02598973|101957087|FG000|NOT COMPLETED|Overall Study||2||
48662287|NCT02598973|101957088|FG001|NOT COMPLETED|Overall Study||1||
48662288|NCT01416831|101959420|FG000|STARTED|Cycles 1 & 2 (Weeks 1-14)||20||
48662289|NCT01416831|101959421|FG001|STARTED|Cycles 1 & 2 (Weeks 1-14)||24||
48662290|NCT01416831|101959420|FG000|COMPLETED|Cycles 1 & 2 (Weeks 1-14)||19||
48662291|NCT01416831|101959421|FG001|COMPLETED|Cycles 1 & 2 (Weeks 1-14)||22||
48662292|NCT01416831|101959420|FG000|NOT COMPLETED|Cycles 1 & 2 (Weeks 1-14)||1||
48662293|NCT01416831|101959421|FG001|NOT COMPLETED|Cycles 1 & 2 (Weeks 1-14)||2||
48662294|NCT01416831|101959420|FG000|STARTED|SBRT Crossover Period||7|Of the 8 patients enrolled into Arm A whose melanoma progressed after the first imaging, 7 agreed to participate in the crossover portion of the study after completion of Cycle 2.|
48662295|NCT01416831|101959421|FG001|STARTED|SBRT Crossover Period||0|Of the 8 patients enrolled into Arm A whose melanoma progressed after the first imaging, 7 agreed to participate in the crossover portion of the study after completion of Cycle 2.|
48662296|NCT01416831|101959420|FG000|COMPLETED|SBRT Crossover Period||7||
48662297|NCT01416831|101959421|FG001|COMPLETED|SBRT Crossover Period||0||
48662298|NCT01416831|101959420|FG000|NOT COMPLETED|SBRT Crossover Period||0||
48662299|NCT01416831|101959421|FG001|NOT COMPLETED|SBRT Crossover Period||0||
48662300|NCT04635280|101959422|FG000|STARTED|Overall Study||35||
48772525|NCT02566369|102232749|FG001|COMPLETED|Overall Study||535||
48772526|NCT02566369|102232748|FG000|NOT COMPLETED|Overall Study||72||
48772527|NCT02566369|102232749|FG001|NOT COMPLETED|Overall Study||61||
48772528|NCT02745119|102232750|FG000|STARTED|Overall Study||145||
48454174|NCT03083132|101449554|FG000|COMPLETED|First 12 Weeks (Placebo vs Modafinil)||12||
48454175|NCT03083132|101449555|FG001|COMPLETED|First 12 Weeks (Placebo vs Modafinil)||7||
48454176|NCT03083132|101449554|FG000|NOT COMPLETED|First 12 Weeks (Placebo vs Modafinil)||0||
48454177|NCT03083132|101449555|FG001|NOT COMPLETED|First 12 Weeks (Placebo vs Modafinil)||2||
48454178|NCT03083132|101449554|FG000|STARTED|Last 12 Weeks (Drug for All Subjects)||12||
48662301|NCT04635280|101959422|FG000|COMPLETED|Overall Study||35||
48662302|NCT04635280|101959422|FG000|NOT COMPLETED|Overall Study||0||
48662303|NCT00322218|101959423|FG000|STARTED|Overall Study||34||
48662304|NCT00322218|101959424|FG001|STARTED|Overall Study||34||
48662305|NCT00322218|101959423|FG000|Per-Protocol Set|Overall Study||33||
48662306|NCT00322218|101959424|FG001|Per-Protocol Set|Overall Study||32||
48662307|NCT00322218|101959423|FG000|COMPLETED|Overall Study||31||
48662308|NCT00322218|101959424|FG001|COMPLETED|Overall Study||28||
48662309|NCT00322218|101959423|FG000|NOT COMPLETED|Overall Study||3||
48662310|NCT00322218|101959424|FG001|NOT COMPLETED|Overall Study||6||
48662311|NCT01586910|101959425|FG000|STARTED|Overall Study||879||
48662312|NCT01586910|101959426|FG001|STARTED|Overall Study||867||
48772529|NCT02745119|102232751|FG001|STARTED|Overall Study||274||
48662313|NCT01586910|101959425|FG000|COMPLETED|Overall Study||864||
48662314|NCT01586910|101959426|FG001|COMPLETED|Overall Study||796||
48662315|NCT01586910|101959425|FG000|NOT COMPLETED|Overall Study||15||
48662316|NCT01586910|101959426|FG001|NOT COMPLETED|Overall Study||71||
48662317|NCT04650893|101959427|FG000|STARTED|Overall Study||11||
48662318|NCT04650893|101959428|FG001|STARTED|Overall Study||10||
48662319|NCT04650893|101959429|FG002|STARTED|Overall Study||12||
48454179|NCT03083132|101449555|FG001|STARTED|Last 12 Weeks (Drug for All Subjects)||7||
48454180|NCT03083132|101449554|FG000|COMPLETED|Last 12 Weeks (Drug for All Subjects)||11||
48454181|NCT03083132|101449555|FG001|COMPLETED|Last 12 Weeks (Drug for All Subjects)||6||
48454182|NCT03083132|101449554|FG000|NOT COMPLETED|Last 12 Weeks (Drug for All Subjects)||1||
48454183|NCT03083132|101449555|FG001|NOT COMPLETED|Last 12 Weeks (Drug for All Subjects)||1||
48454184|NCT02729194|101449556|FG000|STARTED|Overall Study||16||
48454185|NCT02729194|101449556|FG000|COMPLETED|Overall Study||13||
48454186|NCT02729194|101449556|FG000|NOT COMPLETED|Overall Study||3||
48454187|NCT00299728|101449557|FG000|STARTED|Overall Study||11||
48454188|NCT00299728|101449558|FG001|STARTED|Overall Study||11||
48454189|NCT00299728|101449557|FG000|COMPLETED|Overall Study||11||
48454190|NCT00299728|101449558|FG001|COMPLETED|Overall Study||8||
48454191|NCT00299728|101449557|FG000|NOT COMPLETED|Overall Study||0||
48454192|NCT00299728|101449558|FG001|NOT COMPLETED|Overall Study||3||
48454193|NCT02199652|101449559|FG000|STARTED|Overall Study||10||
48454194|NCT02199652|101449560|FG001|STARTED|Overall Study||10||
48454195|NCT02199652|101449559|FG000|COMPLETED|Overall Study||3||
48454196|NCT02199652|101449560|FG001|COMPLETED|Overall Study||3||
48454197|NCT02199652|101449559|FG000|NOT COMPLETED|Overall Study||7||
48454198|NCT02199652|101449560|FG001|NOT COMPLETED|Overall Study||7||
48454199|NCT01880099|101449561|FG000|STARTED|Overall Study||17||
48454200|NCT01880099|101449562|FG001|STARTED|Overall Study||21||
48454201|NCT01880099|101449563|FG002|STARTED|Overall Study||22||
48454202|NCT01880099|101449561|FG000|COMPLETED|Overall Study||9||
48454203|NCT01880099|101449562|FG001|COMPLETED|Overall Study||11||
48454204|NCT01880099|101449563|FG002|COMPLETED|Overall Study||15||
48454205|NCT01880099|101449561|FG000|NOT COMPLETED|Overall Study||8||
48454206|NCT01880099|101449562|FG001|NOT COMPLETED|Overall Study||10||
48454207|NCT01880099|101449563|FG002|NOT COMPLETED|Overall Study||7||
48662320|NCT04650893|101959427|FG000|COMPLETED|Overall Study||0||
48662321|NCT04650893|101959428|FG001|COMPLETED|Overall Study||0||
48662322|NCT04650893|101959429|FG002|COMPLETED|Overall Study||1||
48662323|NCT04650893|101959427|FG000|NOT COMPLETED|Overall Study||11||
48662324|NCT04650893|101959428|FG001|NOT COMPLETED|Overall Study||10||
48662325|NCT04650893|101959429|FG002|NOT COMPLETED|Overall Study||11||
48662326|NCT03093415|101959430|FG000|STARTED|Assessed for Eligibility --> Enrollment||165||
48662327|NCT03093415|101959431|FG001|STARTED|Assessed for Eligibility --> Enrollment||135||
48662328|NCT03093415|101959432|FG002|STARTED|Assessed for Eligibility --> Enrollment||50||
48662329|NCT03093415|101959430|FG000|COMPLETED|Assessed for Eligibility --> Enrollment||25||
48662330|NCT03093415|101959431|FG001|COMPLETED|Assessed for Eligibility --> Enrollment||25||
48662331|NCT03093415|101959432|FG002|COMPLETED|Assessed for Eligibility --> Enrollment||50||
48662332|NCT03093415|101959430|FG000|NOT COMPLETED|Assessed for Eligibility --> Enrollment||140||
48454208|NCT01473758|101449564|FG000|STARTED|Cycle 1||38||
48454209|NCT01473758|101449565|FG001|STARTED|Cycle 1||43||
48454210|NCT01473758|101449566|FG002|STARTED|Cycle 1||0||
48454211|NCT01473758|101449567|FG003|STARTED|Cycle 1||0||
48454212|NCT01473758|101449564|FG000|COMPLETED|Cycle 1||27||
48454213|NCT01473758|101449565|FG001|COMPLETED|Cycle 1||40||
48662333|NCT03093415|101959431|FG001|NOT COMPLETED|Assessed for Eligibility --> Enrollment||110||
48662334|NCT03093415|101959432|FG002|NOT COMPLETED|Assessed for Eligibility --> Enrollment||0||
48772530|NCT02745119|102232752|FG002|STARTED|Overall Study||146||
48772531|NCT02745119|102232753|FG003|STARTED|Overall Study||277||
48454214|NCT01473758|101449566|FG002|COMPLETED|Cycle 1||0||
48454215|NCT01473758|101449567|FG003|COMPLETED|Cycle 1||0||
48454216|NCT01473758|101449564|FG000|NOT COMPLETED|Cycle 1||11||
48454217|NCT01473758|101449565|FG001|NOT COMPLETED|Cycle 1||3||
48454218|NCT01473758|101449566|FG002|NOT COMPLETED|Cycle 1||0||
48454219|NCT01473758|101449567|FG003|NOT COMPLETED|Cycle 1||0||
48454220|NCT01473758|101449564|FG000|STARTED|Cycle 2||0||
48454221|NCT01473758|101449565|FG001|STARTED|Cycle 2||0||
48454222|NCT01473758|101449566|FG002|STARTED|Cycle 2||10||
48454223|NCT01473758|101449567|FG003|STARTED|Cycle 2||4||
48454224|NCT01473758|101449564|FG000|COMPLETED|Cycle 2||0||
48662335|NCT03093415|101959430|FG000|STARTED|Enrollment to SVR12 Results||25||
48662336|NCT03093415|101959431|FG001|STARTED|Enrollment to SVR12 Results||25||
48662337|NCT03093415|101959432|FG002|STARTED|Enrollment to SVR12 Results||50||
48662338|NCT03093415|101959430|FG000|COMPLETED|Enrollment to SVR12 Results||24||
48662339|NCT03093415|101959431|FG001|COMPLETED|Enrollment to SVR12 Results||17||
48662340|NCT03093415|101959432|FG002|COMPLETED|Enrollment to SVR12 Results||47||
48662341|NCT03093415|101959430|FG000|NOT COMPLETED|Enrollment to SVR12 Results||1||
48662342|NCT03093415|101959431|FG001|NOT COMPLETED|Enrollment to SVR12 Results||8||
48662343|NCT03093415|101959432|FG002|NOT COMPLETED|Enrollment to SVR12 Results||3||
48662344|NCT02302222|101959433|FG000|STARTED|Overall Study||34||
48662345|NCT02302222|101959434|FG001|STARTED|Overall Study||37||
48662346|NCT02302222|101959433|FG000|COMPLETED|Overall Study||33||
48662347|NCT02302222|101959434|FG001|COMPLETED|Overall Study||31||
48454225|NCT01473758|101449565|FG001|COMPLETED|Cycle 2||0||
48454226|NCT01473758|101449566|FG002|COMPLETED|Cycle 2||5||
48454227|NCT01473758|101449567|FG003|COMPLETED|Cycle 2||4||
48454228|NCT01473758|101449564|FG000|NOT COMPLETED|Cycle 2||0||
48454229|NCT01473758|101449565|FG001|NOT COMPLETED|Cycle 2||0||
48454230|NCT01473758|101449566|FG002|NOT COMPLETED|Cycle 2||5||
48454231|NCT01473758|101449567|FG003|NOT COMPLETED|Cycle 2||0||
48454232|NCT01386879|101449568|FG000|STARTED|Overall Study||17||
48454233|NCT01386879|101449569|FG001|STARTED|Overall Study||17||
48454234|NCT01386879|101449570|FG002|STARTED|Overall Study||16||
48454235|NCT01386879|101449568|FG000|COMPLETED|Overall Study||17||
48454236|NCT01386879|101449569|FG001|COMPLETED|Overall Study||17||
48454237|NCT01386879|101449570|FG002|COMPLETED|Overall Study||16||
48454238|NCT01386879|101449568|FG000|NOT COMPLETED|Overall Study||0||
48454239|NCT01386879|101449569|FG001|NOT COMPLETED|Overall Study||0||
48454240|NCT01386879|101449570|FG002|NOT COMPLETED|Overall Study||0||
48454241|NCT00534092|101449571|FG000|STARTED|Overall Study||55||
48454242|NCT00534092|101449572|FG001|STARTED|Overall Study||14||
48454243|NCT00534092|101449571|FG000|COMPLETED|Overall Study||53||
48454244|NCT00534092|101449572|FG001|COMPLETED|Overall Study||14||
48454245|NCT00534092|101449571|FG000|NOT COMPLETED|Overall Study||2||
48454246|NCT00534092|101449572|FG001|NOT COMPLETED|Overall Study||0||
48454247|NCT04023994|101449573|FG000|STARTED|Overall Study||10||
48454248|NCT04023994|101449574|FG001|STARTED|Overall Study||4||
48454249|NCT04023994|101449575|FG002|STARTED|Overall Study||4||
48454250|NCT04023994|101449576|FG003|STARTED|Overall Study||6||
48454251|NCT04023994|101449577|FG004|STARTED|Overall Study||6||
48454252|NCT04023994|101449578|FG005|STARTED|Overall Study||6||
48454253|NCT04023994|101449573|FG000|COMPLETED|Overall Study||10||
48454254|NCT04023994|101449574|FG001|COMPLETED|Overall Study||3||
48454255|NCT04023994|101449575|FG002|COMPLETED|Overall Study||2||
48454256|NCT04023994|101449576|FG003|COMPLETED|Overall Study||5||
48454257|NCT04023994|101449577|FG004|COMPLETED|Overall Study||6||
48454258|NCT04023994|101449578|FG005|COMPLETED|Overall Study||6||
48454259|NCT04023994|101449573|FG000|NOT COMPLETED|Overall Study||0||
48454260|NCT04023994|101449574|FG001|NOT COMPLETED|Overall Study||1||
48454261|NCT04023994|101449575|FG002|NOT COMPLETED|Overall Study||2||
48454262|NCT04023994|101449576|FG003|NOT COMPLETED|Overall Study||1||
48454263|NCT04023994|101449577|FG004|NOT COMPLETED|Overall Study||0||
48454264|NCT04023994|101449578|FG005|NOT COMPLETED|Overall Study||0||
48454265|NCT04525157|101449579|FG000|STARTED|Overall Study||18||
48454266|NCT04525157|101449579|FG000|COMPLETED|Overall Study||15||
48454267|NCT04525157|101449579|FG000|NOT COMPLETED|Overall Study||3||
48454268|NCT02731833|101449580|FG000|STARTED|Overall Study||111||
48454269|NCT02731833|101449581|FG001|STARTED|Overall Study||111||
48454270|NCT02731833|101449580|FG000|COMPLETED|Overall Study||111||
48454271|NCT02731833|101449581|FG001|COMPLETED|Overall Study||111||
48454272|NCT02731833|101449580|FG000|NOT COMPLETED|Overall Study||0||
48454273|NCT02731833|101449581|FG001|NOT COMPLETED|Overall Study||0||
48454274|NCT00124176|101449582|FG000|STARTED|Overall Study||40||
48454275|NCT00124176|101449583|FG001|STARTED|Overall Study||41||
48454276|NCT00124176|101449582|FG000|Received Study Drug|Overall Study||37||
48454277|NCT00124176|101449583|FG001|Received Study Drug|Overall Study||41||
48454278|NCT00124176|101449582|FG000|COMPLETED|Overall Study||40||
48454279|NCT00124176|101449583|FG001|COMPLETED|Overall Study||41||
48454280|NCT00124176|101449582|FG000|NOT COMPLETED|Overall Study||0||
48454281|NCT00124176|101449583|FG001|NOT COMPLETED|Overall Study||0||
48454282|NCT00235833|101449584|FG000|STARTED|Overall Study||25||
48454283|NCT00235833|101449584|FG000|COMPLETED|Overall Study||9||
48454284|NCT00235833|101449584|FG000|NOT COMPLETED|Overall Study||16||
48454285|NCT02378506|101449585|FG000|STARTED|Overall Study||188||
48454286|NCT02378506|101449585|FG000|Treated|Overall Study||187||
48454287|NCT02378506|101449585|FG000|COMPLETED|Overall Study||163||
48454288|NCT02378506|101449585|FG000|NOT COMPLETED|Overall Study||25||
48454289|NCT00219557|101449586|FG000|STARTED|Phase 1||8||
48454290|NCT00219557|101449587|FG001|STARTED|Phase 1||0||
48454291|NCT00219557|101449588|FG002|STARTED|Phase 1||0||
48454292|NCT00219557|101449586|FG000|COMPLETED|Phase 1||1||
48454293|NCT00219557|101449587|FG001|COMPLETED|Phase 1||0||
48454294|NCT00219557|101449588|FG002|COMPLETED|Phase 1||0||
48454295|NCT00219557|101449586|FG000|NOT COMPLETED|Phase 1||7||
48454296|NCT00219557|101449587|FG001|NOT COMPLETED|Phase 1||0||
48454297|NCT00219557|101449588|FG002|NOT COMPLETED|Phase 1||0||
48454298|NCT00219557|101449586|FG000|STARTED|Phase 2||0||
48454299|NCT00219557|101449587|FG001|STARTED|Phase 2||69||
48454300|NCT00219557|101449588|FG002|STARTED|Phase 2||34||
48454301|NCT00219557|101449586|FG000|Treated|Phase 2||0||
48454302|NCT00219557|101449587|FG001|Treated|Phase 2||68||
48454303|NCT00219557|101449588|FG002|Treated|Phase 2||31||
48454304|NCT00219557|101449586|FG000|COMPLETED|Phase 2||0||
48454305|NCT00219557|101449587|FG001|COMPLETED|Phase 2||0||
48454306|NCT00219557|101449588|FG002|COMPLETED|Phase 2||1||
48454307|NCT00219557|101449586|FG000|NOT COMPLETED|Phase 2||0||
48454308|NCT00219557|101449587|FG001|NOT COMPLETED|Phase 2||69||
48454309|NCT00219557|101449588|FG002|NOT COMPLETED|Phase 2||33||
48454310|NCT01348542|101449589|FG000|STARTED|Overall Study||13||
48454311|NCT01348542|101449590|FG001|STARTED|Overall Study||11||
48454312|NCT01348542|101449589|FG000|COMPLETED|Overall Study||10||
48454313|NCT01348542|101449590|FG001|COMPLETED|Overall Study||11||
48454314|NCT01348542|101449589|FG000|NOT COMPLETED|Overall Study||3||
48454315|NCT01348542|101449590|FG001|NOT COMPLETED|Overall Study||0||
48454316|NCT02609737|101449591|FG000|STARTED|Overall Study||20||
48454317|NCT02609737|101449591|FG000|COMPLETED|Overall Study||20||
48454318|NCT02609737|101449591|FG000|NOT COMPLETED|Overall Study||0||
48454319|NCT04313283|101449592|FG000|STARTED|Overall Study||19||
48454320|NCT04313283|101449592|FG000|COMPLETED|Overall Study||15||
48454321|NCT04313283|101449592|FG000|NOT COMPLETED|Overall Study||4||
48454322|NCT02278952|101449593|FG000|STARTED|Overall Study||50||225
48454323|NCT02278952|101449593|FG000|COMPLETED|Overall Study||44||117
48454324|NCT02278952|101449593|FG000|NOT COMPLETED|Overall Study||6||108
48454325|NCT03586830|101449594|FG000|STARTED|Overall Study||50||
48454326|NCT03586830|101449595|FG001|STARTED|Overall Study||48||
48454327|NCT03586830|101449596|FG002|STARTED|Overall Study||49||
48454328|NCT03586830|101449597|FG003|STARTED|Overall Study||49||
48454329|NCT03586830|101449594|FG000|Treated|Overall Study||49||
48454330|NCT03586830|101449595|FG001|Treated|Overall Study||48||
48454331|NCT03586830|101449596|FG002|Treated|Overall Study||49||
48454332|NCT03586830|101449597|FG003|Treated|Overall Study||49||
48454333|NCT03586830|101449594|FG000|COMPLETED|Overall Study||48||
48454334|NCT03586830|101449595|FG001|COMPLETED|Overall Study||42||
48454335|NCT03586830|101449596|FG002|COMPLETED|Overall Study||41||
48454336|NCT03586830|101449597|FG003|COMPLETED|Overall Study||44||
48454337|NCT03586830|101449594|FG000|NOT COMPLETED|Overall Study||2||
48454338|NCT03586830|101449595|FG001|NOT COMPLETED|Overall Study||6||
48454339|NCT03586830|101449596|FG002|NOT COMPLETED|Overall Study||8||
48454340|NCT03586830|101449597|FG003|NOT COMPLETED|Overall Study||5||
48454341|NCT01712230|101449598|FG000|STARTED|Overall Study||11||
48454342|NCT01712230|101449599|FG001|STARTED|Overall Study||18||
48454343|NCT01712230|101449600|FG002|STARTED|Overall Study||18||
48454344|NCT01712230|101449598|FG000|COMPLETED|Overall Study||9||
48454345|NCT01712230|101449599|FG001|COMPLETED|Overall Study||14||
48454346|NCT01712230|101449600|FG002|COMPLETED|Overall Study||11||
48454347|NCT01712230|101449598|FG000|NOT COMPLETED|Overall Study||2||
48454348|NCT01712230|101449599|FG001|NOT COMPLETED|Overall Study||4||
48454349|NCT01712230|101449600|FG002|NOT COMPLETED|Overall Study||7||
48454350|NCT01222871|101449601|FG000|STARTED|Overall Study||0||
48454351|NCT01222871|101449602|FG001|STARTED|Overall Study||0||
48454352|NCT01222871|101449601|FG000|COMPLETED|Overall Study||0||
48454353|NCT01222871|101449602|FG001|COMPLETED|Overall Study||0||
48454354|NCT01222871|101449601|FG000|NOT COMPLETED|Overall Study||0||
48454355|NCT01222871|101449602|FG001|NOT COMPLETED|Overall Study||0||
48454356|NCT01110499|101449603|FG000|STARTED|Overall Study||14||
48454357|NCT01110499|101449604|FG001|STARTED|Overall Study||14||
48454358|NCT01110499|101449605|FG002|STARTED|Overall Study||14||
48454359|NCT01110499|101449606|FG003|STARTED|Overall Study||14||
48454360|NCT01110499|101449607|FG004|STARTED|Overall Study||14||
48454361|NCT01110499|101449608|FG005|STARTED|Overall Study||14||
48454362|NCT01110499|101449609|FG006|STARTED|Overall Study||39||
48454363|NCT01110499|101449610|FG007|STARTED|Overall Study||40||
48662348|NCT02302222|101959433|FG000|NOT COMPLETED|Overall Study||1||
48189217|NCT01341080|100786180|FG001|STARTED|Overall Study||18||
48454364|NCT01110499|101449603|FG000|COMPLETED|Overall Study||14||
48454365|NCT01110499|101449604|FG001|COMPLETED|Overall Study||14||
48454366|NCT01110499|101449605|FG002|COMPLETED|Overall Study||14||
48454367|NCT01110499|101449606|FG003|COMPLETED|Overall Study||14||
48454368|NCT01110499|101449607|FG004|COMPLETED|Overall Study||14||
48454369|NCT01110499|101449608|FG005|COMPLETED|Overall Study||14||
48454370|NCT01110499|101449609|FG006|COMPLETED|Overall Study||39||
48454371|NCT01110499|101449610|FG007|COMPLETED|Overall Study||40||
48454372|NCT01110499|101449603|FG000|NOT COMPLETED|Overall Study||0||
48454373|NCT01110499|101449604|FG001|NOT COMPLETED|Overall Study||0||
48454374|NCT01110499|101449605|FG002|NOT COMPLETED|Overall Study||0||
48662349|NCT02302222|101959434|FG001|NOT COMPLETED|Overall Study||6||
48772532|NCT02745119|102232750|FG000|COMPLETED|Overall Study||0||
48454375|NCT01110499|101449606|FG003|NOT COMPLETED|Overall Study||0||
48454376|NCT01110499|101449607|FG004|NOT COMPLETED|Overall Study||0||
48454377|NCT01110499|101449608|FG005|NOT COMPLETED|Overall Study||0||
48454378|NCT01110499|101449609|FG006|NOT COMPLETED|Overall Study||0||
48454379|NCT01110499|101449610|FG007|NOT COMPLETED|Overall Study||0||
48454380|NCT04356573|101449611|FG000|STARTED|Overall Study||7||
48454381|NCT04356573|101449612|FG001|STARTED|Overall Study||6||
48454382|NCT04356573|101449611|FG000|COMPLETED|Overall Study||6||
48454383|NCT04356573|101449612|FG001|COMPLETED|Overall Study||6||
48454384|NCT04356573|101449611|FG000|NOT COMPLETED|Overall Study||1||
48454385|NCT04356573|101449612|FG001|NOT COMPLETED|Overall Study||0||
48454386|NCT00478361|101449613|FG000|STARTED|Overall Study||39||
48454387|NCT00478361|101449613|FG000|COMPLETED|Overall Study||39||
48454388|NCT00478361|101449613|FG000|NOT COMPLETED|Overall Study||0||
48454389|NCT02598193|101449614|FG000|STARTED|Overall Study||89||
48454390|NCT02598193|101449614|FG000|COMPLETED|Overall Study||73||
48454391|NCT02598193|101449614|FG000|NOT COMPLETED|Overall Study||16||
48662350|NCT05543174|101959435|FG000|STARTED|Overall Study||7||
48662351|NCT05543174|101959435|FG000|Dosed TAK-625 200 mcg/kg|Overall Study||7|TAK-625 orally, QD for 1 week in Dose Escalation Period.|
48662352|NCT05543174|101959435|FG000|Dosed TAK-625 400 mcg/kg|Overall Study||7|TAK-625 orally, QD for 1 week in Dose Escalation Period and for up to 20 weeks after Dose Escalation Period.|
48662353|NCT05543174|101959435|FG000|COMPLETED|Overall Study||0||
48662354|NCT05543174|101959435|FG000|NOT COMPLETED|Overall Study||7||
48662355|NCT03412591|101959436|FG000|STARTED|Overall Study||6||
48662356|NCT03412591|101959437|FG001|STARTED|Overall Study||22||
48662357|NCT03412591|101959436|FG000|COMPLETED|Overall Study||5||
48662358|NCT03412591|101959437|FG001|COMPLETED|Overall Study||13||
48662359|NCT03412591|101959436|FG000|NOT COMPLETED|Overall Study||1||
48454392|NCT02457728|101449615|FG000|STARTED|Overall Study||34||
48454393|NCT02457728|101449615|FG000|COMPLETED|Overall Study||34||
48454394|NCT02457728|101449615|FG000|NOT COMPLETED|Overall Study||0||
48454395|NCT00693784|101449616|FG000|STARTED|Overall Study||15||
48454396|NCT00693784|101449616|FG000|26-Week Primary Endpoint|Overall Study||15||
48454397|NCT00693784|101449616|FG000|52-week Extended Follow-up|Overall Study||13||
48454398|NCT00693784|101449616|FG000|104-week Extended Follow-up|Overall Study||11||
48454399|NCT00693784|101449616|FG000|COMPLETED|Overall Study||11||
48454400|NCT00693784|101449616|FG000|NOT COMPLETED|Overall Study||4||
48454401|NCT00971204|101449617|FG000|STARTED|Overall Study||100||
48454402|NCT00971204|101449617|FG000|Treated|Overall Study||86||
48454403|NCT00971204|101449617|FG000|COMPLETED|Overall Study||76||
48454404|NCT00971204|101449617|FG000|NOT COMPLETED|Overall Study||24||
48454405|NCT01967888|101449618|FG000|STARTED|Overall Study||52||
48454406|NCT01967888|101449619|FG001|STARTED|Overall Study||52||
48454407|NCT01967888|101449618|FG000|COMPLETED|Overall Study||42||
48454408|NCT01967888|101449619|FG001|COMPLETED|Overall Study||45||
48454409|NCT01967888|101449618|FG000|NOT COMPLETED|Overall Study||10||
48454410|NCT01967888|101449619|FG001|NOT COMPLETED|Overall Study||7||
48454411|NCT00876733|101449620|FG000|STARTED|Overall Study||288||
48454412|NCT00876733|101449621|FG001|STARTED|Overall Study||203||
48454413|NCT00876733|101449622|FG002|STARTED|Overall Study||93||
48662360|NCT03412591|101959437|FG001|NOT COMPLETED|Overall Study||9||
48662361|NCT04347538|101959438|FG000|STARTED|Overall Study||28||
48662362|NCT04347538|101959439|FG001|STARTED|Overall Study||29||
48662363|NCT04347538|101959440|FG002|STARTED|Overall Study||31||
48662364|NCT04347538|101959438|FG000|COMPLETED|Overall Study||24||
48662365|NCT04347538|101959439|FG001|COMPLETED|Overall Study||24||
48662366|NCT04347538|101959440|FG002|COMPLETED|Overall Study||24||
48662367|NCT04347538|101959438|FG000|NOT COMPLETED|Overall Study||4||
48662368|NCT04347538|101959439|FG001|NOT COMPLETED|Overall Study||5||
48662369|NCT04347538|101959440|FG002|NOT COMPLETED|Overall Study||7||
48454414|NCT00876733|101449623|FG003|STARTED|Overall Study||21||
48454415|NCT00876733|101449620|FG000|COMPLETED|Overall Study||197||
48454416|NCT00876733|101449621|FG001|COMPLETED|Overall Study||161||
48454417|NCT00876733|101449622|FG002|COMPLETED|Overall Study||63||
48454418|NCT00876733|101449623|FG003|COMPLETED|Overall Study||14||
48454419|NCT00876733|101449620|FG000|NOT COMPLETED|Overall Study||91||
48454420|NCT00876733|101449621|FG001|NOT COMPLETED|Overall Study||42||
48454421|NCT00876733|101449622|FG002|NOT COMPLETED|Overall Study||30||
48454422|NCT00876733|101449623|FG003|NOT COMPLETED|Overall Study||7||
48454423|NCT01401478|101449624|FG000|STARTED|Overall Study||86||
48454424|NCT01401478|101449624|FG000|COMPLETED|Overall Study||55||
48454425|NCT01401478|101449624|FG000|NOT COMPLETED|Overall Study||31||
48454426|NCT02464878|101449625|FG000|STARTED|Overall Study||2||
48454427|NCT02464878|101449625|FG000|COMPLETED|Overall Study||2||
48454428|NCT02464878|101449625|FG000|NOT COMPLETED|Overall Study||0||
48454429|NCT02390219|101449626|FG000|STARTED|Overall Study||46||
48454430|NCT02390219|101449626|FG000|COMPLETED|Overall Study||33||
48454431|NCT02390219|101449626|FG000|NOT COMPLETED|Overall Study||13||
48454432|NCT02094937|101449627|FG000|STARTED|8 Weeks in Period 1||430||
48454433|NCT02094937|101449628|FG001|STARTED|8 Weeks in Period 1||0||
48454434|NCT02094937|101449629|FG002|STARTED|8 Weeks in Period 1||0||
48454435|NCT02094937|101449630|FG003|STARTED|8 Weeks in Period 1||0||
48454436|NCT02094937|101449627|FG000|COMPLETED|8 Weeks in Period 1||370||
48454437|NCT02094937|101449628|FG001|COMPLETED|8 Weeks in Period 1||0||
48454438|NCT02094937|101449629|FG002|COMPLETED|8 Weeks in Period 1||0||
48454439|NCT02094937|101449630|FG003|COMPLETED|8 Weeks in Period 1||0||
48454440|NCT02094937|101449627|FG000|NOT COMPLETED|8 Weeks in Period 1||60||
48454441|NCT02094937|101449628|FG001|NOT COMPLETED|8 Weeks in Period 1||0||
48454442|NCT02094937|101449629|FG002|NOT COMPLETED|8 Weeks in Period 1||0||
48454443|NCT02094937|101449630|FG003|NOT COMPLETED|8 Weeks in Period 1||0||
48454444|NCT02094937|101449627|FG000|STARTED|12 Weeks in Period 2||0||
48662370|NCT03676270|101959441|FG000|STARTED|Overall Study||6915||224
48662371|NCT03676270|101959441|FG000|COMPLETED|Overall Study||6915||224
48662372|NCT03676270|101959441|FG000|NOT COMPLETED|Overall Study||0||0
48662373|NCT02034565|101959442|FG000|STARTED|Overall Study||7||
48662374|NCT02034565|101959443|FG001|STARTED|Overall Study||7||
48662375|NCT02034565|101959442|FG000|COMPLETED|Overall Study||6||
48662376|NCT02034565|101959443|FG001|COMPLETED|Overall Study||7||
48662377|NCT02034565|101959442|FG000|NOT COMPLETED|Overall Study||1||
48662378|NCT02034565|101959443|FG001|NOT COMPLETED|Overall Study||0||
48662379|NCT01854762|101959444|FG000|STARTED|Overall Study||17||
48662380|NCT01854762|101959445|FG001|STARTED|Overall Study||16||
48662381|NCT01854762|101959444|FG000|COMPLETED|Overall Study||17||
48454445|NCT02094937|101449628|FG001|STARTED|12 Weeks in Period 2||123||
48454446|NCT02094937|101449629|FG002|STARTED|12 Weeks in Period 2||124||
48454447|NCT02094937|101449630|FG003|STARTED|12 Weeks in Period 2||124||
48454448|NCT02094937|101449627|FG000|COMPLETED|12 Weeks in Period 2||0||
48454449|NCT02094937|101449628|FG001|COMPLETED|12 Weeks in Period 2||112||
48454450|NCT02094937|101449629|FG002|COMPLETED|12 Weeks in Period 2||112||
48454451|NCT02094937|101449630|FG003|COMPLETED|12 Weeks in Period 2||112||
48454452|NCT02094937|101449627|FG000|NOT COMPLETED|12 Weeks in Period 2||0||
48454453|NCT02094937|101449628|FG001|NOT COMPLETED|12 Weeks in Period 2||11||
48454454|NCT02094937|101449629|FG002|NOT COMPLETED|12 Weeks in Period 2||12||
48454455|NCT02094937|101449630|FG003|NOT COMPLETED|12 Weeks in Period 2||12||
48454456|NCT03411642|101449631|FG000|STARTED|Overall Study||494||
48454457|NCT03411642|101449631|FG000|Participants Who Received TTE|Overall Study||492||
48454458|NCT03411642|101449631|FG000|Participants Who Received TEE|Overall Study||454||
48454459|NCT03411642|101449631|FG000|COMPLETED|Overall Study||454||
48454460|NCT03411642|101449631|FG000|NOT COMPLETED|Overall Study||40||
48454461|NCT00936884|101449632|FG000|STARTED|Double-blind||25||
48454462|NCT00936884|101449633|FG001|STARTED|Double-blind||25||
48454463|NCT00936884|101449634|FG002|STARTED|Double-blind||0||
48454464|NCT00936884|101449632|FG000|COMPLETED|Double-blind||13||
48454465|NCT00936884|101449633|FG001|COMPLETED|Double-blind||18||
48454466|NCT00936884|101449634|FG002|COMPLETED|Double-blind||0||
48454467|NCT00936884|101449632|FG000|NOT COMPLETED|Double-blind||12||
48454468|NCT00936884|101449633|FG001|NOT COMPLETED|Double-blind||7||
48454469|NCT00936884|101449634|FG002|NOT COMPLETED|Double-blind||0||
48454470|NCT00936884|101449632|FG000|STARTED|Open-label||0|Thirteen subjects from the MNTX group and 18 from the placebo group entered the 12-week extension.|
48772533|NCT02745119|102232751|FG001|COMPLETED|Overall Study||0||
48772534|NCT02745119|102232752|FG002|COMPLETED|Overall Study||0||
48772535|NCT02745119|102232753|FG003|COMPLETED|Overall Study||0||
48772536|NCT02745119|102232750|FG000|NOT COMPLETED|Overall Study||145||
48772537|NCT02745119|102232751|FG001|NOT COMPLETED|Overall Study||274||
48772538|NCT02745119|102232752|FG002|NOT COMPLETED|Overall Study||146||
48772539|NCT02745119|102232753|FG003|NOT COMPLETED|Overall Study||277||
48772540|NCT01216189|102232754|FG000|STARTED|Overall Study||110||
48772541|NCT01216189|102232755|FG001|STARTED|Overall Study||32||
48772542|NCT01216189|102232754|FG000|COMPLETED|Overall Study||85||
48772543|NCT01216189|102232755|FG001|COMPLETED|Overall Study||27||
48772544|NCT01216189|102232754|FG000|NOT COMPLETED|Overall Study||25||
48454471|NCT00936884|101449633|FG001|STARTED|Open-label||0|Thirteen subjects from the MNTX group and 18 from the placebo group entered the 12-week extension.|
48454472|NCT00936884|101449634|FG002|STARTED|Open-label||31|Thirteen subjects from the MNTX group and 18 from the placebo group entered the 12-week extension.|
48454473|NCT00936884|101449632|FG000|COMPLETED|Open-label||0||
48454474|NCT00936884|101449633|FG001|COMPLETED|Open-label||0||
48454475|NCT00936884|101449634|FG002|COMPLETED|Open-label||12||
48454476|NCT00936884|101449632|FG000|NOT COMPLETED|Open-label||0||
48454477|NCT00936884|101449633|FG001|NOT COMPLETED|Open-label||0||
48454478|NCT00936884|101449634|FG002|NOT COMPLETED|Open-label||19||
48454479|NCT00856778|101449635|FG000|STARTED|Overall Study||98||
48454480|NCT00856778|101449635|FG000|COMPLETED|Overall Study||74||
48454481|NCT00856778|101449635|FG000|NOT COMPLETED|Overall Study||24||
48454482|NCT01326702|101449636|FG000|STARTED|Overall Study||3||
48454483|NCT01326702|101449637|FG001|STARTED|Overall Study||3||
48454484|NCT01326702|101449638|FG002|STARTED|Overall Study||6||
48454485|NCT01326702|101449639|FG003|STARTED|Overall Study||4||
48454486|NCT01326702|101449640|FG004|STARTED|Overall Study||5||
48662382|NCT01854762|101959445|FG001|COMPLETED|Overall Study||16||
48662383|NCT01854762|101959444|FG000|NOT COMPLETED|Overall Study||0||
48662384|NCT01854762|101959445|FG001|NOT COMPLETED|Overall Study||0||
48662385|NCT02624687|101959446|FG000|STARTED|Overall Study||13||
48772545|NCT01216189|102232755|FG001|NOT COMPLETED|Overall Study||5||
48772546|NCT03077412|102232756|FG000|STARTED|Overall Study||17||
48772547|NCT03077412|102232757|FG001|STARTED|Overall Study||25||
48772548|NCT03077412|102232758|FG002|STARTED|Overall Study||15||
48772549|NCT03077412|102232756|FG000|COMPLETED|Overall Study||14||
48772550|NCT03077412|102232757|FG001|COMPLETED|Overall Study||12||
48772551|NCT03077412|102232758|FG002|COMPLETED|Overall Study||6||
48772552|NCT03077412|102232756|FG000|NOT COMPLETED|Overall Study||3||
48772553|NCT03077412|102232757|FG001|NOT COMPLETED|Overall Study||13||
48454487|NCT01326702|101449641|FG005|STARTED|Overall Study||15||
48454488|NCT01326702|101449642|FG006|STARTED|Overall Study||7||
48454489|NCT01326702|101449636|FG000|COMPLETED|Overall Study||1||
48454490|NCT01326702|101449637|FG001|COMPLETED|Overall Study||1||
48454491|NCT01326702|101449638|FG002|COMPLETED|Overall Study||1||
48454492|NCT01326702|101449639|FG003|COMPLETED|Overall Study||1||
48662386|NCT02624687|101959447|FG001|STARTED|Overall Study||14||
48662387|NCT02624687|101959446|FG000|COMPLETED|Overall Study||12||
48662388|NCT02624687|101959447|FG001|COMPLETED|Overall Study||12||
48772554|NCT03077412|102232758|FG002|NOT COMPLETED|Overall Study||9||
48772555|NCT04161157|102232759|FG000|STARTED|Overall Study||53||
48772556|NCT04161157|102232759|FG000|COMPLETED|Overall Study||40||
48772557|NCT04161157|102232759|FG000|NOT COMPLETED|Overall Study||13||
48772558|NCT00622440|102232760|FG000|STARTED|Baseline - Week 12 (Treatment)||35||
48772559|NCT00622440|102232761|FG001|STARTED|Baseline - Week 12 (Treatment)||35||
48454493|NCT01326702|101449640|FG004|COMPLETED|Overall Study||1||
48454494|NCT01326702|101449641|FG005|COMPLETED|Overall Study||7||
48454495|NCT01326702|101449642|FG006|COMPLETED|Overall Study||0||
48454496|NCT01326702|101449636|FG000|NOT COMPLETED|Overall Study||2||
48454497|NCT01326702|101449637|FG001|NOT COMPLETED|Overall Study||2||
48454498|NCT01326702|101449638|FG002|NOT COMPLETED|Overall Study||5||
48454499|NCT01326702|101449639|FG003|NOT COMPLETED|Overall Study||3||
48454500|NCT01326702|101449640|FG004|NOT COMPLETED|Overall Study||4||
48454501|NCT01326702|101449641|FG005|NOT COMPLETED|Overall Study||8||
48454502|NCT01326702|101449642|FG006|NOT COMPLETED|Overall Study||7||
48454503|NCT02092961|101449643|FG000|STARTED|Overall Study||33||
48454504|NCT02092961|101449644|FG001|STARTED|Overall Study||28||
48454505|NCT02092961|101449645|FG002|STARTED|Overall Study||29||
48454506|NCT02092961|101449643|FG000|Randomised But Did Not Receive Treatment|Overall Study||1||
48454507|NCT02092961|101449644|FG001|Randomised But Did Not Receive Treatment|Overall Study||5||
48454508|NCT02092961|101449645|FG002|Randomised But Did Not Receive Treatment|Overall Study||1||
48454509|NCT02092961|101449643|FG000|COMPLETED|Overall Study||12||
48454510|NCT02092961|101449644|FG001|COMPLETED|Overall Study||14||
48454511|NCT02092961|101449645|FG002|COMPLETED|Overall Study||13||
48454512|NCT02092961|101449643|FG000|NOT COMPLETED|Overall Study||21||
48454513|NCT02092961|101449644|FG001|NOT COMPLETED|Overall Study||14||
48454514|NCT02092961|101449645|FG002|NOT COMPLETED|Overall Study||16||
48454515|NCT01447329|101449646|FG000|STARTED|Overall Study||24||
48454516|NCT01447329|101449647|FG001|STARTED|Overall Study||25||
48454517|NCT01447329|101449646|FG000|COMPLETED|Overall Study||18||
48454518|NCT01447329|101449647|FG001|COMPLETED|Overall Study||16||
48454519|NCT01447329|101449646|FG000|NOT COMPLETED|Overall Study||6||
48454520|NCT01447329|101449647|FG001|NOT COMPLETED|Overall Study||9||
48454521|NCT01252238|101449648|FG000|STARTED|Overall Study||8||
48454522|NCT01252238|101449649|FG001|STARTED|Overall Study||8||
48454523|NCT01252238|101449650|FG002|STARTED|Overall Study||8||
48454524|NCT01252238|101449648|FG000|COMPLETED|Overall Study||4||
48454525|NCT01252238|101449649|FG001|COMPLETED|Overall Study||4||
48454526|NCT01252238|101449650|FG002|COMPLETED|Overall Study||4||
48454527|NCT01252238|101449648|FG000|NOT COMPLETED|Overall Study||4||
48454528|NCT01252238|101449649|FG001|NOT COMPLETED|Overall Study||4||
48454529|NCT01252238|101449650|FG002|NOT COMPLETED|Overall Study||4||
48454530|NCT01361607|101449651|FG000|STARTED|Overall Study||200||
48454531|NCT01361607|101449652|FG001|STARTED|Overall Study||199||
48454532|NCT01361607|101449651|FG000|Received at Least 1 Dose of Study Drug|Overall Study||198||
48454533|NCT01361607|101449652|FG001|Received at Least 1 Dose of Study Drug|Overall Study||199||
48454534|NCT01361607|101449651|FG000|Safety Population|Overall Study||199||
48454535|NCT01361607|101449652|FG001|Safety Population|Overall Study||198||
48454536|NCT01361607|101449651|FG000|ITT Population|Overall Study||198||
48454537|NCT01361607|101449652|FG001|ITT Population|Overall Study||199||
48454538|NCT01361607|101449651|FG000|COMPLETED|Overall Study||136||
48454539|NCT01361607|101449652|FG001|COMPLETED|Overall Study||158||
48454540|NCT01361607|101449651|FG000|NOT COMPLETED|Overall Study||64||
48454541|NCT01361607|101449652|FG001|NOT COMPLETED|Overall Study||41||
48454542|NCT01325532|101449653|FG000|STARTED|Overall Study||17||
48454543|NCT01325532|101449654|FG001|STARTED|Overall Study||13||
48454544|NCT01325532|101449653|FG000|COMPLETED|Overall Study||15||
48454545|NCT01325532|101449654|FG001|COMPLETED|Overall Study||13||
48454546|NCT01325532|101449653|FG000|NOT COMPLETED|Overall Study||2||
48454547|NCT01325532|101449654|FG001|NOT COMPLETED|Overall Study||0||
48454548|NCT03210259|101449655|FG000|STARTED|12-Week Run-in Period||21|Enrolled|
48454549|NCT03210259|101449656|FG001|STARTED|12-Week Run-in Period||118|Enrolled|
48454550|NCT03210259|101449657|FG002|STARTED|12-Week Run-in Period||120|Enrolled|
48454551|NCT03210259|101449655|FG000|COMPLETED|12-Week Run-in Period||0|Completed the run-in period|
48454552|NCT03210259|101449656|FG001|COMPLETED|12-Week Run-in Period||118|Completed the run-in period|
48454553|NCT03210259|101449657|FG002|COMPLETED|12-Week Run-in Period||120|Completed the run-in period|
48454554|NCT03210259|101449655|FG000|NOT COMPLETED|12-Week Run-in Period||21||
48454555|NCT03210259|101449656|FG001|NOT COMPLETED|12-Week Run-in Period||0||
48454556|NCT03210259|101449657|FG002|NOT COMPLETED|12-Week Run-in Period||0||
48454557|NCT03210259|101449655|FG000|STARTED|48-Week Randomized Responder Period||0|Randomization|
48454558|NCT03210259|101449656|FG001|STARTED|48-Week Randomized Responder Period||118|Randomization|
48454559|NCT03210259|101449657|FG002|STARTED|48-Week Randomized Responder Period||120|Randomization|
48454560|NCT03210259|101449655|FG000|COMPLETED|48-Week Randomized Responder Period||0|Completed the trial|
48454561|NCT03210259|101449656|FG001|COMPLETED|48-Week Randomized Responder Period||107|Completed the trial|
48454562|NCT03210259|101449657|FG002|COMPLETED|48-Week Randomized Responder Period||91|Completed the trial|
48454563|NCT03210259|101449655|FG000|NOT COMPLETED|48-Week Randomized Responder Period||0||
48454564|NCT03210259|101449656|FG001|NOT COMPLETED|48-Week Randomized Responder Period||11||
48454565|NCT03210259|101449657|FG002|NOT COMPLETED|48-Week Randomized Responder Period||29||
48454566|NCT00770315|101449658|FG000|STARTED|Overall Study||197||
48454567|NCT00770315|101449659|FG001|STARTED|Overall Study||195||
48454568|NCT00770315|101449660|FG002|STARTED|Overall Study||194||
48454569|NCT00770315|101449661|FG003|STARTED|Overall Study||198||
48454570|NCT00770315|101449658|FG000|COMPLETED|Overall Study||157||
48454571|NCT00770315|101449659|FG001|COMPLETED|Overall Study||152||
48454572|NCT00770315|101449660|FG002|COMPLETED|Overall Study||137||
48454573|NCT00770315|101449661|FG003|COMPLETED|Overall Study||160||
48454574|NCT00770315|101449658|FG000|NOT COMPLETED|Overall Study||40||
48454575|NCT00770315|101449659|FG001|NOT COMPLETED|Overall Study||43||
48454576|NCT00770315|101449660|FG002|NOT COMPLETED|Overall Study||57||
48454577|NCT00770315|101449661|FG003|NOT COMPLETED|Overall Study||38||
48454578|NCT01203319|101449662|FG000|STARTED|Overall Study||434||
48454579|NCT01203319|101449663|FG001|STARTED|Overall Study||435||
48454580|NCT01203319|101449664|FG002|STARTED|Overall Study||222||
48454581|NCT01203319|101449662|FG000|COMPLETED|Overall Study||428||
48454582|NCT01203319|101449663|FG001|COMPLETED|Overall Study||426||
48454583|NCT01203319|101449664|FG002|COMPLETED|Overall Study||217||
48454584|NCT01203319|101449662|FG000|NOT COMPLETED|Overall Study||6||
48454585|NCT01203319|101449663|FG001|NOT COMPLETED|Overall Study||9||
48454586|NCT01203319|101449664|FG002|NOT COMPLETED|Overall Study||5||
48454587|NCT04242186|101449665|FG000|STARTED|Overall Study||140||
48662389|NCT02624687|101959446|FG000|NOT COMPLETED|Overall Study||1||
48662390|NCT02624687|101959447|FG001|NOT COMPLETED|Overall Study||2||
48454588|NCT04242186|101449665|FG000|Qualitative Interview Participants|Overall Study||28||
48454589|NCT04242186|101449665|FG000|Nursing Home Residents|Overall Study||46||
48454590|NCT04242186|101449665|FG000|Facility Staff Members|Overall Study||66||
48454591|NCT04242186|101449665|FG000|COMPLETED|Overall Study||135||
48454592|NCT04242186|101449665|FG000|NOT COMPLETED|Overall Study||5||
48454593|NCT04080882|101449666|FG000|STARTED|Overall Study||20||
48454594|NCT04080882|101449667|FG001|STARTED|Overall Study||60||
48454595|NCT04080882|101449666|FG000|COMPLETED|Overall Study||18||
48454596|NCT04080882|101449667|FG001|COMPLETED|Overall Study||58||
48454597|NCT04080882|101449666|FG000|NOT COMPLETED|Overall Study||2||
48454598|NCT04080882|101449667|FG001|NOT COMPLETED|Overall Study||2||
48454599|NCT03198988|101449668|FG000|STARTED|Overall Study||10||
48454600|NCT03198988|101449668|FG000|COMPLETED|Overall Study||10||
48454601|NCT03198988|101449668|FG000|NOT COMPLETED|Overall Study||0||
48454602|NCT04535583|101449669|FG000|STARTED|Overall Study||65||
48454603|NCT04535583|101449669|FG000|COMPLETED|Overall Study||62||
48454604|NCT04535583|101449669|FG000|NOT COMPLETED|Overall Study||3||
48454605|NCT01270841|101449670|FG000|STARTED|Overall Study||29||
48454606|NCT01270841|101449671|FG001|STARTED|Overall Study||33||
48454607|NCT01270841|101449672|FG002|STARTED|Overall Study||29||
48454608|NCT01270841|101449673|FG003|STARTED|Overall Study||33||
48454609|NCT01270841|101449670|FG000|COMPLETED|Overall Study||16||
48454610|NCT01270841|101449671|FG001|COMPLETED|Overall Study||19||
48454611|NCT01270841|101449672|FG002|COMPLETED|Overall Study||18||
48454612|NCT01270841|101449673|FG003|COMPLETED|Overall Study||20||
48454613|NCT01270841|101449670|FG000|NOT COMPLETED|Overall Study||13||
48454614|NCT01270841|101449671|FG001|NOT COMPLETED|Overall Study||14||
48454615|NCT01270841|101449672|FG002|NOT COMPLETED|Overall Study||11||
48454616|NCT01270841|101449673|FG003|NOT COMPLETED|Overall Study||13||
48454617|NCT00124449|101449674|FG000|STARTED|6-month Double-Blind Treatment Period||28||
48454618|NCT00124449|101449675|FG001|STARTED|6-month Double-Blind Treatment Period||28||
48454619|NCT00124449|101449674|FG000|COMPLETED|6-month Double-Blind Treatment Period||22||
48454620|NCT00124449|101449675|FG001|COMPLETED|6-month Double-Blind Treatment Period||17||
48454621|NCT00124449|101449674|FG000|NOT COMPLETED|6-month Double-Blind Treatment Period||6||
48454622|NCT00124449|101449675|FG001|NOT COMPLETED|6-month Double-Blind Treatment Period||11||
48454623|NCT00124449|101449674|FG000|STARTED|18-Month Untreated Observation Period||22||
48454624|NCT00124449|101449675|FG001|STARTED|18-Month Untreated Observation Period||17||
48454625|NCT00124449|101449674|FG000|Completed Year 1 of Study|18-Month Untreated Observation Period||14||
48454626|NCT00124449|101449675|FG001|Completed Year 1 of Study|18-Month Untreated Observation Period||9||
48454627|NCT00124449|101449674|FG000|COMPLETED|18-Month Untreated Observation Period||7||
48454628|NCT00124449|101449675|FG001|COMPLETED|18-Month Untreated Observation Period||4||
48454629|NCT00124449|101449674|FG000|NOT COMPLETED|18-Month Untreated Observation Period||15||
48454630|NCT00124449|101449675|FG001|NOT COMPLETED|18-Month Untreated Observation Period||13||
48454631|NCT03568500|101449676|FG000|STARTED|Overall Study||18||
48454632|NCT03568500|101449677|FG001|STARTED|Overall Study||20||
48454633|NCT03568500|101449678|FG002|STARTED|Overall Study||6||
48454634|NCT03568500|101449676|FG000|Received At Least 1 Dose of Study Drug|Overall Study||18|Safety Population: All participants who entered the trial and used the DMS.|
48454635|NCT03568500|101449677|FG001|Received At Least 1 Dose of Study Drug|Overall Study||19|Safety Population: All participants who entered the trial and used the DMS.|
48662391|NCT03135067|101959448|FG000|STARTED|Overall Study||1063||33
48772560|NCT00622440|102232760|FG000|COMPLETED|Baseline - Week 12 (Treatment)||31||
48772561|NCT00622440|102232761|FG001|COMPLETED|Baseline - Week 12 (Treatment)||34||
48454636|NCT03568500|101449678|FG002|Received At Least 1 Dose of Study Drug|Overall Study||6|Safety Population: All participants who entered the trial and used the DMS.|
48454637|NCT03568500|101449676|FG000|COMPLETED|Overall Study||8||
48454638|NCT03568500|101449677|FG001|COMPLETED|Overall Study||14||
48662392|NCT03135067|101959449|FG001|STARTED|Overall Study||1039||33
48662393|NCT03135067|101959448|FG000|COMPLETED|Overall Study||1019||33
48662394|NCT03135067|101959449|FG001|COMPLETED|Overall Study||991||33
48662395|NCT03135067|101959448|FG000|NOT COMPLETED|Overall Study||44||0
48454639|NCT03568500|101449678|FG002|COMPLETED|Overall Study||2||
48454640|NCT03568500|101449676|FG000|NOT COMPLETED|Overall Study||10||
48454641|NCT03568500|101449677|FG001|NOT COMPLETED|Overall Study||6||
48454642|NCT03568500|101449678|FG002|NOT COMPLETED|Overall Study||4||
48454643|NCT02460874|101449679|FG000|STARTED|Overall Study||1||
48454644|NCT02460874|101449680|FG001|STARTED|Overall Study||0||
48454645|NCT02460874|101449679|FG000|COMPLETED|Overall Study||1||
48454646|NCT02460874|101449680|FG001|COMPLETED|Overall Study||0||
48454647|NCT02460874|101449679|FG000|NOT COMPLETED|Overall Study||0||
48454648|NCT02460874|101449680|FG001|NOT COMPLETED|Overall Study||0||
48454649|NCT04894994|101449681|FG000|STARTED|Overall Study||6||
48454650|NCT04894994|101449681|FG000|COMPLETED|Overall Study||6||
48454651|NCT04894994|101449681|FG000|NOT COMPLETED|Overall Study||0||
48454652|NCT00353938|101449682|FG000|STARTED|Overall Study||9||
48454653|NCT00353938|101449683|FG001|STARTED|Overall Study||5||
48454654|NCT00353938|101449684|FG002|STARTED|Overall Study||0||
48454655|NCT00353938|101449685|FG003|STARTED|Overall Study||0||
48454656|NCT00353938|101449682|FG000|Completed Stage 2|Overall Study||0||
48454657|NCT00353938|101449683|FG001|Completed Stage 2|Overall Study||0||
48454658|NCT00353938|101449684|FG002|Completed Stage 2|Overall Study||4||
48454659|NCT00353938|101449685|FG003|Completed Stage 2|Overall Study||0||
48454660|NCT00353938|101449682|FG000|Completed Stage 3|Overall Study||0||
48454661|NCT00353938|101449683|FG001|Completed Stage 3|Overall Study||0||
48454662|NCT00353938|101449684|FG002|Completed Stage 3|Overall Study||0||
48454663|NCT00353938|101449685|FG003|Completed Stage 3|Overall Study||3||
48454664|NCT00353938|101449682|FG000|COMPLETED|Overall Study||8|Completed Stage 1|
48454665|NCT00353938|101449683|FG001|COMPLETED|Overall Study||5|Completed Stage 1|
48454666|NCT00353938|101449684|FG002|COMPLETED|Overall Study||0|Completed Stage 1|
48454667|NCT00353938|101449685|FG003|COMPLETED|Overall Study||0|Completed Stage 1|
48454668|NCT00353938|101449682|FG000|NOT COMPLETED|Overall Study||1||
48454669|NCT00353938|101449683|FG001|NOT COMPLETED|Overall Study||0||
48454670|NCT00353938|101449684|FG002|NOT COMPLETED|Overall Study||0||
48454671|NCT00353938|101449685|FG003|NOT COMPLETED|Overall Study||0||
48454672|NCT00446264|101449686|FG000|STARTED|Overall Study||14||
48454673|NCT00446264|101449686|FG000|COMPLETED|Overall Study||14||
48454674|NCT00446264|101449686|FG000|NOT COMPLETED|Overall Study||0||
48454675|NCT00804349|101449687|FG000|STARTED|Overall Study||0||
48454676|NCT00804349|101449688|FG001|STARTED|Overall Study||0||
48454677|NCT00804349|101449687|FG000|COMPLETED|Overall Study||0||
48454678|NCT00804349|101449688|FG001|COMPLETED|Overall Study||0||
48454679|NCT00804349|101449687|FG000|NOT COMPLETED|Overall Study||0||
48454680|NCT00804349|101449688|FG001|NOT COMPLETED|Overall Study||0||
48454681|NCT02270983|101449689|FG000|STARTED|Overall Study||79||
48454682|NCT02270983|101449690|FG001|STARTED|Overall Study||87||
48454683|NCT02270983|101449691|FG002|STARTED|Overall Study||88||
48454684|NCT02270983|101449689|FG000|COMPLETED|Overall Study||70||
48454685|NCT02270983|101449690|FG001|COMPLETED|Overall Study||80||
48772562|NCT00622440|102232760|FG000|NOT COMPLETED|Baseline - Week 12 (Treatment)||4||
48772563|NCT00622440|102232761|FG001|NOT COMPLETED|Baseline - Week 12 (Treatment)||1||
48772564|NCT00622440|102232760|FG000|STARTED|Week 12 - Week 48 (Treatment)||31||
48772565|NCT00622440|102232761|FG001|STARTED|Week 12 - Week 48 (Treatment)||34||
48772566|NCT00622440|102232760|FG000|COMPLETED|Week 12 - Week 48 (Treatment)||28||
48772567|NCT00622440|102232761|FG001|COMPLETED|Week 12 - Week 48 (Treatment)||28||
48772568|NCT00622440|102232760|FG000|NOT COMPLETED|Week 12 - Week 48 (Treatment)||3||
48772569|NCT00622440|102232761|FG001|NOT COMPLETED|Week 12 - Week 48 (Treatment)||6||
48772570|NCT00622440|102232760|FG000|STARTED|Week 60 (Post-treatment Follow-up Visit)||28||
48454686|NCT02270983|101449691|FG002|COMPLETED|Overall Study||76||
48454687|NCT02270983|101449689|FG000|NOT COMPLETED|Overall Study||9||
48454688|NCT02270983|101449690|FG001|NOT COMPLETED|Overall Study||7||
48454689|NCT02270983|101449691|FG002|NOT COMPLETED|Overall Study||12||
48454690|NCT01033864|101449692|FG000|STARTED|Overall Study||12||
48454691|NCT01033864|101449693|FG001|STARTED|Overall Study||11||
48454692|NCT01033864|101449692|FG000|COMPLETED|Overall Study||12||
48454693|NCT01033864|101449693|FG001|COMPLETED|Overall Study||11||
48454694|NCT01033864|101449692|FG000|NOT COMPLETED|Overall Study||0||
48454695|NCT01033864|101449693|FG001|NOT COMPLETED|Overall Study||0||
48454696|NCT01902134|101449694|FG000|STARTED|Overall Study||159||
48454697|NCT01902134|101449695|FG001|STARTED|Overall Study||161||
48454698|NCT01902134|101449696|FG002|STARTED|Overall Study||160||
48454699|NCT01902134|101449697|FG003|STARTED|Overall Study||54||
48454700|NCT01902134|101449698|FG004|STARTED|Overall Study||53||
48454701|NCT01902134|101449699|FG005|STARTED|Overall Study||54||
48454702|NCT01902134|101449694|FG000|Single-dose Phase|Overall Study||159||
48454703|NCT01902134|101449695|FG001|Single-dose Phase|Overall Study||161||
48454704|NCT01902134|101449696|FG002|Single-dose Phase|Overall Study||160||
48454705|NCT01902134|101449697|FG003|Single-dose Phase|Overall Study||54||
48454706|NCT01902134|101449698|FG004|Single-dose Phase|Overall Study||53||
48454707|NCT01902134|101449699|FG005|Single-dose Phase|Overall Study||54||
48454708|NCT01902134|101449694|FG000|Multiple-dose Phase|Overall Study||159||
48454709|NCT01902134|101449695|FG001|Multiple-dose Phase|Overall Study||160||
48454710|NCT01902134|101449696|FG002|Multiple-dose Phase|Overall Study||160||
48454711|NCT01902134|101449697|FG003|Multiple-dose Phase|Overall Study||54||
48662396|NCT03135067|101959449|FG001|NOT COMPLETED|Overall Study||48||0
48662397|NCT02367885|101959450|FG000|STARTED|Overall Study||33||
48662398|NCT02367885|101959451|FG001|STARTED|Overall Study||33||
48662399|NCT02367885|101959452|FG002|STARTED|Overall Study||33||
48662400|NCT02367885|101959450|FG000|COMPLETED|Overall Study||31||
48662401|NCT02367885|101959451|FG001|COMPLETED|Overall Study||33||
48662402|NCT02367885|101959452|FG002|COMPLETED|Overall Study||33||
48662403|NCT02367885|101959450|FG000|NOT COMPLETED|Overall Study||2||
48662404|NCT02367885|101959451|FG001|NOT COMPLETED|Overall Study||0||
48662405|NCT02367885|101959452|FG002|NOT COMPLETED|Overall Study||0||
48662406|NCT01450631|101959453|FG000|STARTED|Overall Study||46||
48662407|NCT01450631|101959454|FG001|STARTED|Overall Study||46||
48662408|NCT01450631|101959453|FG000|COMPLETED|Overall Study||43||
48662409|NCT01450631|101959454|FG001|COMPLETED|Overall Study||42||
48662410|NCT01450631|101959453|FG000|NOT COMPLETED|Overall Study||3||
48662411|NCT01450631|101959454|FG001|NOT COMPLETED|Overall Study||4||
48662412|NCT03792737|101959455|FG000|STARTED|Overall Study||166|Participated in randomization|
48662413|NCT03792737|101959456|FG001|STARTED|Overall Study||167|Participated in randomization|
48662414|NCT03792737|101959457|FG002|STARTED|Overall Study||167|Participated in randomization|
48662415|NCT03792737|101959455|FG000|Safety Analysis Set|Overall Study||162|subjects who received investigational product treatment and had post-baseline follow-up data|
48662416|NCT03792737|101959456|FG001|Safety Analysis Set|Overall Study||161|subjects who received investigational product treatment and had post-baseline follow-up data|
48772571|NCT00622440|102232761|FG001|STARTED|Week 60 (Post-treatment Follow-up Visit)||28||
48772572|NCT00622440|102232760|FG000|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||28||
48454712|NCT01902134|101449698|FG004|Multiple-dose Phase|Overall Study||53||
48454713|NCT01902134|101449699|FG005|Multiple-dose Phase|Overall Study||52||
48454714|NCT01902134|101449694|FG000|COMPLETED|Overall Study||151||
48454715|NCT01902134|101449695|FG001|COMPLETED|Overall Study||150||
48454716|NCT01902134|101449696|FG002|COMPLETED|Overall Study||145||
48454717|NCT01902134|101449697|FG003|COMPLETED|Overall Study||52||
48454718|NCT01902134|101449698|FG004|COMPLETED|Overall Study||46||
48454719|NCT01902134|101449699|FG005|COMPLETED|Overall Study||45||
48454720|NCT01902134|101449694|FG000|NOT COMPLETED|Overall Study||8||
48454721|NCT01902134|101449695|FG001|NOT COMPLETED|Overall Study||11||
48454722|NCT01902134|101449696|FG002|NOT COMPLETED|Overall Study||15||
48454723|NCT01902134|101449697|FG003|NOT COMPLETED|Overall Study||2||
48454724|NCT01902134|101449698|FG004|NOT COMPLETED|Overall Study||7||
48454725|NCT01902134|101449699|FG005|NOT COMPLETED|Overall Study||9||
48454726|NCT02314520|101449700|FG000|STARTED|Overall Study||72||
48454727|NCT02314520|101449701|FG001|STARTED|Overall Study||80||
48454728|NCT02314520|101449700|FG000|COMPLETED|Overall Study||72||
48454729|NCT02314520|101449701|FG001|COMPLETED|Overall Study||80||
48454730|NCT02314520|101449700|FG000|NOT COMPLETED|Overall Study||0||
48454731|NCT02314520|101449701|FG001|NOT COMPLETED|Overall Study||0||
48772573|NCT00622440|102232761|FG001|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||27||
48772574|NCT00622440|102232760|FG000|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||0||
48454732|NCT02117479|101449702|FG000|STARTED|Overall Study||161||
48454733|NCT02117479|101449703|FG001|STARTED|Overall Study||160||
48454734|NCT02117479|101449702|FG000|COMPLETED|Overall Study||5||
48454735|NCT02117479|101449703|FG001|COMPLETED|Overall Study||4||
48454736|NCT02117479|101449702|FG000|NOT COMPLETED|Overall Study||156||
48454737|NCT02117479|101449703|FG001|NOT COMPLETED|Overall Study||156||
48454738|NCT02984683|101449704|FG000|STARTED|Overall Study||11||
48454739|NCT02984683|101449705|FG001|STARTED|Overall Study||12||
48454740|NCT02984683|101449704|FG000|COMPLETED|Overall Study||0||
48454741|NCT02984683|101449705|FG001|COMPLETED|Overall Study||0||
48454742|NCT02984683|101449704|FG000|NOT COMPLETED|Overall Study||11||
48454743|NCT02984683|101449705|FG001|NOT COMPLETED|Overall Study||12||
48454744|NCT00303316|101449706|FG000|STARTED|Overall Study||232||
48454745|NCT00303316|101449707|FG001|STARTED|Overall Study||226||
48454746|NCT00303316|101449706|FG000|COMPLETED|Overall Study||230||
48454747|NCT00303316|101449707|FG001|COMPLETED|Overall Study||223||
48454748|NCT00303316|101449706|FG000|NOT COMPLETED|Overall Study||2||
48662417|NCT03792737|101959457|FG002|Safety Analysis Set|Overall Study||162|subjects who received investigational product treatment and had post-baseline follow-up data|
48662418|NCT03792737|101959455|FG000|Full Analysis Set|Overall Study||162|Subjects who were randomized and received corresponding investigational product(IP) treatment, with at least one data to evaluate the post-baseline effectiveness.|
48662419|NCT03792737|101959456|FG001|Full Analysis Set|Overall Study||160|Subjects who were randomized and received corresponding investigational product(IP) treatment, with at least one data to evaluate the post-baseline effectiveness.|
48662420|NCT03792737|101959457|FG002|Full Analysis Set|Overall Study||162|Subjects who were randomized and received corresponding investigational product(IP) treatment, with at least one data to evaluate the post-baseline effectiveness.|
48662421|NCT03792737|101959455|FG000|COMPLETED|Overall Study||160|Completed all the study visits|
48662422|NCT03792737|101959456|FG001|COMPLETED|Overall Study||159|Completed all the study visits|
48454749|NCT00303316|101449707|FG001|NOT COMPLETED|Overall Study||3||
48454750|NCT01488019|101449708|FG000|STARTED|Overall Study||541||
48454751|NCT01488019|101449709|FG001|STARTED|Overall Study||530||
48454752|NCT01488019|101449708|FG000|COMPLETED|Overall Study||294||
48454753|NCT01488019|101449709|FG001|COMPLETED|Overall Study||226||
48454754|NCT01488019|101449708|FG000|NOT COMPLETED|Overall Study||247||
48454755|NCT01488019|101449709|FG001|NOT COMPLETED|Overall Study||304||
48454756|NCT01208402|101449710|FG000|STARTED|Overall Study||31||
48454757|NCT01208402|101449711|FG001|STARTED|Overall Study||28||
48454758|NCT01208402|101449710|FG000|COMPLETED|Overall Study||30||
48454759|NCT01208402|101449711|FG001|COMPLETED|Overall Study||28||
48454760|NCT01208402|101449710|FG000|NOT COMPLETED|Overall Study||1||
48454761|NCT01208402|101449711|FG001|NOT COMPLETED|Overall Study||0||
48454762|NCT00379587|101449712|FG000|STARTED|Overall Study||65||
48454763|NCT00379587|101449712|FG000|COMPLETED|Overall Study||63||
48454764|NCT00379587|101449712|FG000|NOT COMPLETED|Overall Study||2||
48454765|NCT01155063|101449713|FG000|STARTED|Overall Study||89||
48454766|NCT01155063|101449713|FG000|COMPLETED|Overall Study||0||
48454767|NCT01155063|101449713|FG000|NOT COMPLETED|Overall Study||89||
48454768|NCT01814137|101449714|FG000|STARTED|Overall Study||20||
48454769|NCT01814137|101449715|FG001|STARTED|Overall Study||20||
48454770|NCT01814137|101449714|FG000|COMPLETED|Overall Study||15||
48454771|NCT01814137|101449715|FG001|COMPLETED|Overall Study||15||
48454772|NCT01814137|101449714|FG000|NOT COMPLETED|Overall Study||5||
48454773|NCT01814137|101449715|FG001|NOT COMPLETED|Overall Study||5||
48454774|NCT02879747|101449716|FG000|STARTED|Overall Study||27|observe that 33 more Children were included in the fix-arm (not randomized).|
48454775|NCT02879747|101449717|FG001|STARTED|Overall Study||38|observe that 33 more Children were included in the fix-arm (not randomized).|
48454776|NCT02879747|101449718|FG002|STARTED|Overall Study||33|observe that 33 more Children were included in the fix-arm (not randomized).|
48454777|NCT02879747|101449716|FG000|COMPLETED|Overall Study||23||
48454778|NCT02879747|101449717|FG001|COMPLETED|Overall Study||32||
48454779|NCT02879747|101449718|FG002|COMPLETED|Overall Study||31||
48454780|NCT02879747|101449716|FG000|NOT COMPLETED|Overall Study||4||
48454781|NCT02879747|101449717|FG001|NOT COMPLETED|Overall Study||6||
48454782|NCT02879747|101449718|FG002|NOT COMPLETED|Overall Study||2||
48454783|NCT02611206|101449719|FG000|STARTED|Overall Study||7||
48454784|NCT02611206|101449720|FG001|STARTED|Overall Study||3||
48454785|NCT02611206|101449721|FG002|STARTED|Overall Study||14||
48454786|NCT02611206|101449719|FG000|COMPLETED|Overall Study||3||
48454787|NCT02611206|101449720|FG001|COMPLETED|Overall Study||3||
48454788|NCT02611206|101449721|FG002|COMPLETED|Overall Study||8||
48454789|NCT02611206|101449719|FG000|NOT COMPLETED|Overall Study||4||
48454790|NCT02611206|101449720|FG001|NOT COMPLETED|Overall Study||0||
48454791|NCT02611206|101449721|FG002|NOT COMPLETED|Overall Study||6||
48454792|NCT02360397|101449722|FG000|STARTED|Overall Study||6||
48454793|NCT02360397|101449722|FG000|COMPLETED|Overall Study||2||
48454794|NCT02360397|101449722|FG000|NOT COMPLETED|Overall Study||4||
48454795|NCT01690520|101449723|FG000|STARTED|Overall Study||78||
48454796|NCT01690520|101449724|FG001|STARTED|Overall Study||82||
48454797|NCT01690520|101449723|FG000|Modified Intent to Treat (mITT)|Overall Study||78||
48454798|NCT01690520|101449724|FG001|Modified Intent to Treat (mITT)|Overall Study||80||
48454799|NCT01690520|101449723|FG000|COMPLETED|Overall Study||27||
48772575|NCT00622440|102232761|FG001|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||1||
48454800|NCT01690520|101449724|FG001|COMPLETED|Overall Study||35||
48454801|NCT01690520|101449723|FG000|NOT COMPLETED|Overall Study||51||
48454802|NCT01690520|101449724|FG001|NOT COMPLETED|Overall Study||47||
48454803|NCT01684722|101449725|FG000|STARTED|Overall Study||333||
48454804|NCT01684722|101449726|FG001|STARTED|Overall Study||289||
48454805|NCT01684722|101449727|FG002|STARTED|Overall Study||320||
48454806|NCT01684722|101449728|FG003|STARTED|Overall Study||370||
48454807|NCT01684722|101449725|FG000|COMPLETED|Overall Study||236||
48454808|NCT01684722|101449726|FG001|COMPLETED|Overall Study||212||
48454809|NCT01684722|101449727|FG002|COMPLETED|Overall Study||226||
48772576|NCT01554241|102232762|FG000|STARTED|Overall Study||23||
48772577|NCT01554241|102232763|FG001|STARTED|Overall Study||20||
48772578|NCT01554241|102232764|FG002|STARTED|Overall Study||24||
48772579|NCT01554241|102232765|FG003|STARTED|Overall Study||14||
48772580|NCT01554241|102232762|FG000|COMPLETED|Overall Study||20||
48772581|NCT01554241|102232763|FG001|COMPLETED|Overall Study||19||
48772582|NCT01554241|102232764|FG002|COMPLETED|Overall Study||20||
48772583|NCT01554241|102232765|FG003|COMPLETED|Overall Study||13||
48772584|NCT01554241|102232762|FG000|NOT COMPLETED|Overall Study||3||
48772585|NCT01554241|102232763|FG001|NOT COMPLETED|Overall Study||1||
48772586|NCT01554241|102232764|FG002|NOT COMPLETED|Overall Study||4||
48454810|NCT01684722|101449728|FG003|COMPLETED|Overall Study||260||
48454811|NCT01684722|101449725|FG000|NOT COMPLETED|Overall Study||97||
48454812|NCT01684722|101449726|FG001|NOT COMPLETED|Overall Study||77||
48454813|NCT01684722|101449727|FG002|NOT COMPLETED|Overall Study||94||
48454814|NCT01684722|101449728|FG003|NOT COMPLETED|Overall Study||110||
48454815|NCT01625845|101449729|FG000|STARTED|Overall Study||10||
48454816|NCT01625845|101449730|FG001|STARTED|Overall Study||6||
48454817|NCT01625845|101449729|FG000|COMPLETED|Overall Study||5||
48772587|NCT01554241|102232765|FG003|NOT COMPLETED|Overall Study||1||
48772588|NCT04816552|102232766|FG000|STARTED|Overall Study||138||39
48454818|NCT01625845|101449730|FG001|COMPLETED|Overall Study||3||
48454819|NCT01625845|101449729|FG000|NOT COMPLETED|Overall Study||5||
48454820|NCT01625845|101449730|FG001|NOT COMPLETED|Overall Study||3||
48662423|NCT03792737|101959457|FG002|COMPLETED|Overall Study||158|Completed all the study visits|
48662424|NCT03792737|101959455|FG000|NOT COMPLETED|Overall Study||6||
48662425|NCT03792737|101959456|FG001|NOT COMPLETED|Overall Study||8||
48662426|NCT03792737|101959457|FG002|NOT COMPLETED|Overall Study||9||
48662427|NCT06582732|101959458|FG000|STARTED|Initial Study Period||30||30
48662428|NCT06582732|101959459|FG001|STARTED|Initial Study Period||30||30
48662429|NCT06582732|101959460|FG002|STARTED|Initial Study Period||30||30
48662430|NCT06582732|101959461|FG003|STARTED|Initial Study Period||30||30
48662431|NCT06582732|101959462|FG004|STARTED|Initial Study Period||30||30
48662432|NCT06582732|101959463|FG005|STARTED|Initial Study Period||30||30
48662433|NCT06582732|101959464|FG006|STARTED|Initial Study Period||30||30
48662434|NCT06582732|101959458|FG000|COMPLETED|Initial Study Period||29||29
48662435|NCT06582732|101959459|FG001|COMPLETED|Initial Study Period||29||29
48662436|NCT06582732|101959460|FG002|COMPLETED|Initial Study Period||28||28
48662437|NCT06582732|101959461|FG003|COMPLETED|Initial Study Period||27||27
48772589|NCT04816552|102232767|FG001|STARTED|Overall Study||146||34
48772590|NCT04816552|102232766|FG000|COMPLETED|Overall Study||138||39
48772591|NCT04816552|102232767|FG001|COMPLETED|Overall Study||146||34
48772592|NCT04816552|102232766|FG000|NOT COMPLETED|Overall Study||0||0
48772593|NCT04816552|102232767|FG001|NOT COMPLETED|Overall Study||0||0
48772594|NCT02035267|102232768|FG000|STARTED|Overall Study||31||
48772595|NCT02035267|102232769|FG001|STARTED|Overall Study||16||
48772596|NCT02035267|102232770|FG002|STARTED|Overall Study||30||
48772597|NCT02035267|102232771|FG003|STARTED|Overall Study||16||
48772598|NCT02035267|102232768|FG000|COMPLETED|Overall Study||31||
48772599|NCT02035267|102232769|FG001|COMPLETED|Overall Study||15||
48772600|NCT02035267|102232770|FG002|COMPLETED|Overall Study||28||
48772601|NCT02035267|102232771|FG003|COMPLETED|Overall Study||15||
48772602|NCT02035267|102232768|FG000|NOT COMPLETED|Overall Study||0||
48772603|NCT02035267|102232769|FG001|NOT COMPLETED|Overall Study||1||
48772604|NCT02035267|102232770|FG002|NOT COMPLETED|Overall Study||2||
48772605|NCT02035267|102232771|FG003|NOT COMPLETED|Overall Study||1||
48772606|NCT00986856|102232772|FG000|STARTED|Overall Study||42||
48454821|NCT01663714|101449731|FG000|STARTED|Dosimetric and Therapeutic Treatment||30||
48454822|NCT01663714|101449731|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0||
48454823|NCT01663714|101449731|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||30||
48454824|NCT01663714|101449731|FG000|STARTED|Long-Term Follow-Up||22||
48454825|NCT01663714|101449731|FG000|COMPLETED|Long-Term Follow-Up||16||
48454826|NCT01663714|101449731|FG000|NOT COMPLETED|Long-Term Follow-Up||6||
48662438|NCT06582732|101959462|FG004|COMPLETED|Initial Study Period||25||25
48662439|NCT06582732|101959463|FG005|COMPLETED|Initial Study Period||29||29
48662440|NCT06582732|101959464|FG006|COMPLETED|Initial Study Period||28||28
48662441|NCT06582732|101959458|FG000|NOT COMPLETED|Initial Study Period||1||1
48662442|NCT06582732|101959459|FG001|NOT COMPLETED|Initial Study Period||1||1
48662443|NCT06582732|101959460|FG002|NOT COMPLETED|Initial Study Period||2||2
48662444|NCT06582732|101959461|FG003|NOT COMPLETED|Initial Study Period||3||3
48662445|NCT06582732|101959462|FG004|NOT COMPLETED|Initial Study Period||5||5
48662446|NCT06582732|101959463|FG005|NOT COMPLETED|Initial Study Period||1||1
48662447|NCT06582732|101959464|FG006|NOT COMPLETED|Initial Study Period||2||2
48662448|NCT06582732|101959458|FG000|STARTED|Post-exchange Study Period||29||29
48662449|NCT06582732|101959459|FG001|STARTED|Post-exchange Study Period||29||29
48662450|NCT06582732|101959460|FG002|STARTED|Post-exchange Study Period||28||28
48662451|NCT06582732|101959461|FG003|STARTED|Post-exchange Study Period||27||27
48662452|NCT06582732|101959462|FG004|STARTED|Post-exchange Study Period||25||25
48662453|NCT06582732|101959463|FG005|STARTED|Post-exchange Study Period||29||29
48662454|NCT06582732|101959464|FG006|STARTED|Post-exchange Study Period||28||28
48662455|NCT06582732|101959458|FG000|COMPLETED|Post-exchange Study Period||29||29
48662456|NCT06582732|101959459|FG001|COMPLETED|Post-exchange Study Period||29||29
48662457|NCT06582732|101959460|FG002|COMPLETED|Post-exchange Study Period||28||28
48662458|NCT06582732|101959461|FG003|COMPLETED|Post-exchange Study Period||27||27
48662459|NCT06582732|101959462|FG004|COMPLETED|Post-exchange Study Period||25||25
48662460|NCT06582732|101959463|FG005|COMPLETED|Post-exchange Study Period||29||29
48662461|NCT06582732|101959464|FG006|COMPLETED|Post-exchange Study Period||28||28
48662462|NCT06582732|101959458|FG000|NOT COMPLETED|Post-exchange Study Period||0||0
48662463|NCT06582732|101959459|FG001|NOT COMPLETED|Post-exchange Study Period||0||0
48662464|NCT06582732|101959460|FG002|NOT COMPLETED|Post-exchange Study Period||0||0
48772607|NCT00986856|102232773|FG001|STARTED|Overall Study||16||
48772608|NCT00986856|102232772|FG000|COMPLETED|Overall Study||42||
48772609|NCT00986856|102232773|FG001|COMPLETED|Overall Study||16||
48772610|NCT00986856|102232772|FG000|NOT COMPLETED|Overall Study||0||
48772611|NCT00986856|102232773|FG001|NOT COMPLETED|Overall Study||0||
48772612|NCT04041414|102232774|FG000|STARTED|Overall Study||27||
48772613|NCT04041414|102232775|FG001|STARTED|Overall Study||20||
48772614|NCT04041414|102232774|FG000|COMPLETED|Overall Study||26||
48772615|NCT04041414|102232775|FG001|COMPLETED|Overall Study||18||
48772616|NCT04041414|102232774|FG000|NOT COMPLETED|Overall Study||1||
48662465|NCT06582732|101959461|FG003|NOT COMPLETED|Post-exchange Study Period||0||0
48662466|NCT06582732|101959462|FG004|NOT COMPLETED|Post-exchange Study Period||0||0
48662467|NCT06582732|101959463|FG005|NOT COMPLETED|Post-exchange Study Period||0||0
48662468|NCT06582732|101959464|FG006|NOT COMPLETED|Post-exchange Study Period||0||0
48662469|NCT05535972|101959465|FG000|STARTED|Overall Study||463|Enrolled|
48662470|NCT05535972|101959465|FG000|Full Analysis Set|Overall Study||460||
48662471|NCT05535972|101959465|FG000|COMPLETED|Overall Study||419||
48662472|NCT05535972|101959465|FG000|NOT COMPLETED|Overall Study||44||
48772617|NCT04041414|102232775|FG001|NOT COMPLETED|Overall Study||2||
48772618|NCT00417417|102232776|FG000|STARTED|Overall Study||4||
48772619|NCT00417417|102232777|FG001|STARTED|Overall Study||6||
48772620|NCT00417417|102232776|FG000|COMPLETED|Overall Study||4||
48772621|NCT00417417|102232777|FG001|COMPLETED|Overall Study||6||
48772622|NCT00417417|102232776|FG000|NOT COMPLETED|Overall Study||0||
48772623|NCT00417417|102232777|FG001|NOT COMPLETED|Overall Study||0||
48772624|NCT00670748|102232778|FG000|STARTED|Overall Study||17||
48772625|NCT00670748|102232779|FG001|STARTED|Overall Study||16||
48772626|NCT00670748|102232780|FG002|STARTED|Overall Study||7||
48772627|NCT00670748|102232781|FG003|STARTED|Overall Study||5||
48772628|NCT00670748|102232778|FG000|COMPLETED|Overall Study||14||
48772629|NCT00670748|102232779|FG001|COMPLETED|Overall Study||14||
48772630|NCT00670748|102232780|FG002|COMPLETED|Overall Study||5||
48772631|NCT00670748|102232781|FG003|COMPLETED|Overall Study||4||
48772632|NCT00670748|102232778|FG000|NOT COMPLETED|Overall Study||3||
48772633|NCT00670748|102232779|FG001|NOT COMPLETED|Overall Study||2||
48772634|NCT00670748|102232780|FG002|NOT COMPLETED|Overall Study||2||
48772635|NCT00670748|102232781|FG003|NOT COMPLETED|Overall Study||1||
48772636|NCT04103749|102232782|FG000|STARTED|Overall Study||551||
48772637|NCT04103749|102232782|FG000|COMPLETED|Overall Study||495||
48772638|NCT04103749|102232782|FG000|NOT COMPLETED|Overall Study||56||
48772639|NCT00996333|102232783|FG000|STARTED|Overall Study||46||
48772640|NCT00996333|102232783|FG000|COMPLETED|Overall Study||33||
48772641|NCT00996333|102232783|FG000|NOT COMPLETED|Overall Study||13||
48772642|NCT03762993|102232784|FG000|STARTED|Overall Study||21||
48772643|NCT03762993|102232785|FG001|STARTED|Overall Study||10||
48772644|NCT03762993|102232784|FG000|COMPLETED|Overall Study||21||
48772645|NCT03762993|102232785|FG001|COMPLETED|Overall Study||10||
48772646|NCT03762993|102232784|FG000|NOT COMPLETED|Overall Study||0||
48772647|NCT03762993|102232785|FG001|NOT COMPLETED|Overall Study||0||
48454827|NCT01265966|101449732|FG000|STARTED|Overall Study||47||
48454828|NCT01265966|101449733|FG001|STARTED|Overall Study||41||
48454829|NCT01265966|101449734|FG002|STARTED|Overall Study||29||
48454830|NCT01265966|101449732|FG000|Analyzed Separately|Overall Study||3||
48454831|NCT01265966|101449733|FG001|Analyzed Separately|Overall Study||2||
48454832|NCT01265966|101449734|FG002|Analyzed Separately|Overall Study||2||
48454833|NCT01265966|101449732|FG000|COMPLETED|Overall Study||44||
48454834|NCT01265966|101449733|FG001|COMPLETED|Overall Study||39||
48454835|NCT01265966|101449734|FG002|COMPLETED|Overall Study||27||
48454836|NCT01265966|101449732|FG000|NOT COMPLETED|Overall Study||3||
48454837|NCT01265966|101449733|FG001|NOT COMPLETED|Overall Study||2||
48454838|NCT01265966|101449734|FG002|NOT COMPLETED|Overall Study||2||
48454839|NCT04133519|101449735|FG000|STARTED|Overall Study||188||
48454840|NCT04133519|101449736|FG001|STARTED|Overall Study||190||
48772648|NCT03530124|102232786|FG000|STARTED|Overall Study||107||
48772649|NCT03530124|102232787|FG001|STARTED|Overall Study||116||
48772650|NCT03530124|102232786|FG000|COMPLETED|Overall Study||105||
48454841|NCT04133519|101449735|FG000|COMPLETED|Overall Study||182||
48454842|NCT04133519|101449736|FG001|COMPLETED|Overall Study||184||
48772651|NCT03530124|102232787|FG001|COMPLETED|Overall Study||115||
48772652|NCT03530124|102232786|FG000|NOT COMPLETED|Overall Study||2||
48772653|NCT03530124|102232787|FG001|NOT COMPLETED|Overall Study||1||
48772654|NCT04596384|102232788|FG000|STARTED|Overall Study||189||
48772655|NCT04596384|102232789|FG001|STARTED|Overall Study||193||
48772656|NCT04596384|102232788|FG000|COMPLETED|Overall Study||164||
48772657|NCT04596384|102232789|FG001|COMPLETED|Overall Study||145||
48772658|NCT04596384|102232788|FG000|NOT COMPLETED|Overall Study||25||
48772659|NCT04596384|102232789|FG001|NOT COMPLETED|Overall Study||48||
48772660|NCT03895840|102232790|FG000|STARTED|Overall Study||70||
48772661|NCT03895840|102232790|FG000|6-Week Follow-Up|Overall Study||70||
48454843|NCT04133519|101449735|FG000|NOT COMPLETED|Overall Study||6||
48454844|NCT04133519|101449736|FG001|NOT COMPLETED|Overall Study||6||
48454845|NCT03379246|101449737|FG000|STARTED|Overall Study||236||
48662473|NCT03777020|101959466|FG000|STARTED|Overall Study||30||
48772662|NCT03895840|102232790|FG000|12-Week Follow-Up|Overall Study||65||
48772663|NCT03895840|102232790|FG000|24-Week Follow-Up|Overall Study||49||
48772664|NCT03895840|102232790|FG000|COMPLETED|Overall Study||49|Primary outcome measures were a priori defined at the 12-week follow-up, while 24-week measurements were included for extended follow-up|
48772665|NCT03895840|102232790|FG000|NOT COMPLETED|Overall Study||21||
48772666|NCT04411667|102232791|FG000|STARTED|Overall Study||17||
48772667|NCT04411667|102232792|FG001|STARTED|Overall Study||17||
48772668|NCT04411667|102232791|FG000|COMPLETED|Overall Study||16||
48772669|NCT04411667|102232792|FG001|COMPLETED|Overall Study||17||
48454846|NCT03379246|101449737|FG000|COMPLETED|Overall Study||236||
48454847|NCT03379246|101449737|FG000|NOT COMPLETED|Overall Study||0||
48454848|NCT01764854|101449738|FG000|STARTED|Overall Study||8||
48454849|NCT01764854|101449739|FG001|STARTED|Overall Study||8||
48454850|NCT01764854|101449740|FG002|STARTED|Overall Study||37||
48454851|NCT01764854|101449741|FG003|STARTED|Overall Study||35||
48454852|NCT01764854|101449738|FG000|COMPLETED|Overall Study||8||
48454853|NCT01764854|101449739|FG001|COMPLETED|Overall Study||8||
48454854|NCT01764854|101449740|FG002|COMPLETED|Overall Study||31||
48454855|NCT01764854|101449741|FG003|COMPLETED|Overall Study||33||
48454856|NCT01764854|101449738|FG000|NOT COMPLETED|Overall Study||0||
48454857|NCT01764854|101449739|FG001|NOT COMPLETED|Overall Study||0||
48454858|NCT01764854|101449740|FG002|NOT COMPLETED|Overall Study||6||
48454859|NCT01764854|101449741|FG003|NOT COMPLETED|Overall Study||2||
48662474|NCT03777020|101959467|FG001|STARTED|Overall Study||30||
48662475|NCT03777020|101959466|FG000|COMPLETED|Overall Study||26||
48662476|NCT03777020|101959467|FG001|COMPLETED|Overall Study||25||
48662477|NCT03777020|101959466|FG000|NOT COMPLETED|Overall Study||4||
48662478|NCT03777020|101959467|FG001|NOT COMPLETED|Overall Study||5||
48662479|NCT02255656|101959468|FG000|STARTED|Overall Study||1062||
48662480|NCT02255656|101959468|FG000|COMPLETED|Overall Study||592||
48662481|NCT02255656|101959468|FG000|NOT COMPLETED|Overall Study||470||
48662482|NCT00373360|101959469|FG000|STARTED|Overall Study||10||
48662483|NCT00373360|101959469|FG000|COMPLETED|Overall Study||10||
48662484|NCT00373360|101959469|FG000|NOT COMPLETED|Overall Study||0||
48662485|NCT02412982|101959470|FG000|STARTED|Primary Endpoint||51||
48662486|NCT02412982|101959471|FG001|STARTED|Primary Endpoint||52||
48662487|NCT02412982|101959470|FG000|COMPLETED|Primary Endpoint||47||
48662488|NCT02412982|101959471|FG001|COMPLETED|Primary Endpoint||49||
48662489|NCT02412982|101959470|FG000|NOT COMPLETED|Primary Endpoint||4||
48662490|NCT02412982|101959471|FG001|NOT COMPLETED|Primary Endpoint||3||
48662491|NCT02412982|101959470|FG000|STARTED|Intervention Group: Randomization||0||
48662492|NCT02412982|101959471|FG001|STARTED|Intervention Group: Randomization||52||
48662493|NCT02412982|101959470|FG000|COMPLETED|Intervention Group: Randomization||0||
48662494|NCT02412982|101959471|FG001|COMPLETED|Intervention Group: Randomization||51||
48662495|NCT02412982|101959470|FG000|NOT COMPLETED|Intervention Group: Randomization||0||
48662496|NCT02412982|101959471|FG001|NOT COMPLETED|Intervention Group: Randomization||1||
48662497|NCT05788991|101959472|FG000|STARTED|Overall Study||73|Randomized|
48662498|NCT05788991|101959473|FG001|STARTED|Overall Study||78|Randomized|
48662499|NCT05788991|101959472|FG000|COMPLETED|Overall Study||70|Completed 1 month follow up|
48662500|NCT05788991|101959473|FG001|COMPLETED|Overall Study||72|Completed 1 month follow up|
48662501|NCT05788991|101959472|FG000|NOT COMPLETED|Overall Study||3||
48662502|NCT05788991|101959473|FG001|NOT COMPLETED|Overall Study||6||
48662503|NCT02298946|101959474|FG000|STARTED|Overall Study||8||
48662504|NCT02298946|101959475|FG001|STARTED|Overall Study||9||
48662505|NCT02298946|101959474|FG000|COMPLETED|Overall Study||4||
48662506|NCT02298946|101959475|FG001|COMPLETED|Overall Study||8||
48662507|NCT02298946|101959474|FG000|NOT COMPLETED|Overall Study||4||
48662508|NCT02298946|101959475|FG001|NOT COMPLETED|Overall Study||1||
48662509|NCT01854775|101959476|FG000|STARTED|Treatment Phase (48 Weeks)||50||
48662510|NCT01854775|101959477|FG001|STARTED|Treatment Phase (48 Weeks)||52||
48662511|NCT01854775|101959478|FG002|STARTED|Treatment Phase (48 Weeks)||27||
48189218|NCT01341080|100786179|FG000|COMPLETED|Overall Study||15||
48454860|NCT02707432|101449742|FG000|STARTED|Overall Study||72||
48454861|NCT02707432|101449743|FG001|STARTED|Overall Study||71||
48454862|NCT02707432|101449742|FG000|COMPLETED|Overall Study||57||
48454863|NCT02707432|101449743|FG001|COMPLETED|Overall Study||51||
48454864|NCT02707432|101449742|FG000|NOT COMPLETED|Overall Study||15||
48454865|NCT02707432|101449743|FG001|NOT COMPLETED|Overall Study||20||
48454866|NCT05476679|101449744|FG000|STARTED|Overall Study||8||
48454867|NCT05476679|101449745|FG001|STARTED|Overall Study||10||
48454868|NCT05476679|101449746|FG002|STARTED|Overall Study||9||
48454869|NCT05476679|101449747|FG003|STARTED|Overall Study||11||
48454870|NCT05476679|101449748|FG004|STARTED|Overall Study||10||
48454871|NCT05476679|101449744|FG000|COMPLETED|Overall Study||8||
48454872|NCT05476679|101449745|FG001|COMPLETED|Overall Study||10||
48454873|NCT05476679|101449746|FG002|COMPLETED|Overall Study||9||
48454874|NCT05476679|101449747|FG003|COMPLETED|Overall Study||9||
48454875|NCT05476679|101449748|FG004|COMPLETED|Overall Study||10||
48454876|NCT05476679|101449744|FG000|NOT COMPLETED|Overall Study||0||
48454877|NCT05476679|101449745|FG001|NOT COMPLETED|Overall Study||0||
48454878|NCT05476679|101449746|FG002|NOT COMPLETED|Overall Study||0||
48454879|NCT05476679|101449747|FG003|NOT COMPLETED|Overall Study||2||
48454880|NCT05476679|101449748|FG004|NOT COMPLETED|Overall Study||0||
48662512|NCT01854775|101959476|FG000|COMPLETED|Treatment Phase (48 Weeks)||48||
48662513|NCT01854775|101959477|FG001|COMPLETED|Treatment Phase (48 Weeks)||51||
48662514|NCT01854775|101959478|FG002|COMPLETED|Treatment Phase (48 Weeks)||18||
48454881|NCT00096382|101449749|FG000|STARTED|Overall Study||23||
48454882|NCT00096382|101449750|FG001|STARTED|Overall Study||3||
48454883|NCT00096382|101449749|FG000|COMPLETED|Overall Study||21||
48454884|NCT00096382|101449750|FG001|COMPLETED|Overall Study||3||
48454885|NCT00096382|101449749|FG000|NOT COMPLETED|Overall Study||2||
48454886|NCT00096382|101449750|FG001|NOT COMPLETED|Overall Study||0||
48662515|NCT01854775|101959476|FG000|NOT COMPLETED|Treatment Phase (48 Weeks)||2||
48662516|NCT01854775|101959477|FG001|NOT COMPLETED|Treatment Phase (48 Weeks)||1||
48662517|NCT01854775|101959478|FG002|NOT COMPLETED|Treatment Phase (48 Weeks)||9||
48662518|NCT01854775|101959476|FG000|STARTED|Extension Phase||48||
48662519|NCT01854775|101959477|FG001|STARTED|Extension Phase||50||
48662520|NCT01854775|101959478|FG002|STARTED|Extension Phase||18||
48662521|NCT01854775|101959476|FG000|COMPLETED|Extension Phase||9||
48662522|NCT01854775|101959477|FG001|COMPLETED|Extension Phase||3||
48662523|NCT01854775|101959478|FG002|COMPLETED|Extension Phase||0||
48662524|NCT01854775|101959476|FG000|NOT COMPLETED|Extension Phase||39||
48662525|NCT01854775|101959477|FG001|NOT COMPLETED|Extension Phase||47||
48662526|NCT01854775|101959478|FG002|NOT COMPLETED|Extension Phase||18||
48662527|NCT00802503|101959479|FG000|STARTED|Overall Study||152||
48662528|NCT00802503|101959480|FG001|STARTED|Overall Study||153||
48662529|NCT00802503|101959479|FG000|COMPLETED|Overall Study||142||
48662530|NCT00802503|101959480|FG001|COMPLETED|Overall Study||133||
48662531|NCT00802503|101959479|FG000|NOT COMPLETED|Overall Study||10||
48662532|NCT00802503|101959480|FG001|NOT COMPLETED|Overall Study||20||
48662533|NCT03977155|101959481|FG000|STARTED|Overall Study||43||
48662534|NCT03977155|101959482|FG001|STARTED|Overall Study||48||
48662535|NCT03977155|101959483|FG002|STARTED|Overall Study||42||
48662536|NCT03977155|101959481|FG000|COMPLETED|Overall Study||38||
48662537|NCT03977155|101959482|FG001|COMPLETED|Overall Study||46||
48662538|NCT03977155|101959483|FG002|COMPLETED|Overall Study||40||
48662539|NCT03977155|101959481|FG000|NOT COMPLETED|Overall Study||5||
48662540|NCT03977155|101959482|FG001|NOT COMPLETED|Overall Study||2||
48662541|NCT03977155|101959483|FG002|NOT COMPLETED|Overall Study||2||
48662542|NCT03906071|101959484|FG000|STARTED|Overall Study||284|The intent-to-treat (ITT) population is defined as all patients who are randomized into this study.|
48662543|NCT03906071|101959485|FG001|STARTED|Overall Study||293|The intent-to-treat (ITT) population is defined as all patients who are randomized into this study.|
48662544|NCT03906071|101959484|FG000|Safety Population|Overall Study||281|The Safety Population is defined as all patients who received any dose of study medication (i.e., sitravatinib, nivolumab or docetaxel).|
48662545|NCT03906071|101959485|FG001|Safety Population|Overall Study||273|The Safety Population is defined as all patients who received any dose of study medication (i.e., sitravatinib, nivolumab or docetaxel).|
48662546|NCT03906071|101959484|FG000|COMPLETED|Overall Study||84|Continuing in the study.|
48662547|NCT03906071|101959485|FG001|COMPLETED|Overall Study||77|Continuing in the study.|
48662548|NCT03906071|101959484|FG000|NOT COMPLETED|Overall Study||200||
48662549|NCT03906071|101959485|FG001|NOT COMPLETED|Overall Study||216||
48662550|NCT03992872|101959486|FG000|STARTED|Overall Study||30||
48662551|NCT03992872|101959487|FG001|STARTED|Overall Study||30||
48662552|NCT03992872|101959486|FG000|Exposed|Overall Study||30|Screened subjects who received study vaccination.|
48662553|NCT03992872|101959487|FG001|Exposed|Overall Study||30|Screened subjects who received study vaccination.|
48662554|NCT03992872|101959486|FG000|Safety|Overall Study||30|Subjects who received study vaccination and provided safety assessment data.|
48662555|NCT03992872|101959487|FG001|Safety|Overall Study||30|Subjects who received study vaccination and provided safety assessment data.|
48662556|NCT03992872|101959486|FG000|mITT|Overall Study||30|Exposed subjects who had evaluable results from both Day 1 and at least one later on-study sample.|
48662557|NCT03992872|101959487|FG001|mITT|Overall Study||30|Exposed subjects who had evaluable results from both Day 1 and at least one later on-study sample.|
48662558|NCT03992872|101959486|FG000|Immunogenicity Evaluable|Overall Study||30|Exposed subjects who met the IEP criteria as detailed in the SAP.|
48662559|NCT03992872|101959487|FG001|Immunogenicity Evaluable|Overall Study||30|Exposed subjects who met the IEP criteria as detailed in the SAP.|
48662560|NCT03992872|101959486|FG000|COMPLETED|Overall Study||30||
48662561|NCT03992872|101959487|FG001|COMPLETED|Overall Study||30||
48662562|NCT03992872|101959486|FG000|NOT COMPLETED|Overall Study||0||
48662563|NCT03992872|101959487|FG001|NOT COMPLETED|Overall Study||0||
48662564|NCT04330859|101959488|FG000|STARTED|Overall Study||36||
48662565|NCT04330859|101959489|FG001|STARTED|Overall Study||34||
48662566|NCT04330859|101959488|FG000|COMPLETED|Overall Study||25||
48662567|NCT04330859|101959489|FG001|COMPLETED|Overall Study||26||
48662568|NCT04330859|101959488|FG000|NOT COMPLETED|Overall Study||11||
48662569|NCT04330859|101959489|FG001|NOT COMPLETED|Overall Study||8||
48662570|NCT03345550|101959490|FG000|STARTED|Overall Study||22||
48662571|NCT03345550|101959491|FG001|STARTED|Overall Study||22||
48662572|NCT03345550|101959490|FG000|First Received Drug|Overall Study||22||
48662573|NCT03345550|101959491|FG001|First Received Drug|Overall Study||22||
48662574|NCT03345550|101959490|FG000|COMPLETED|Overall Study||17||
48662575|NCT03345550|101959491|FG001|COMPLETED|Overall Study||17||
48662576|NCT03345550|101959490|FG000|NOT COMPLETED|Overall Study||5||
48662577|NCT03345550|101959491|FG001|NOT COMPLETED|Overall Study||5||
48662578|NCT02113878|101959492|FG000|STARTED|Overall Study||17||
48662579|NCT02113878|101959493|FG001|STARTED|Overall Study||6||
48662580|NCT02113878|101959492|FG000|COMPLETED|Overall Study||14||
48662581|NCT02113878|101959493|FG001|COMPLETED|Overall Study||6||
48662582|NCT02113878|101959492|FG000|NOT COMPLETED|Overall Study||3||
48662583|NCT02113878|101959493|FG001|NOT COMPLETED|Overall Study||0||
48662584|NCT00847730|101959494|FG000|STARTED|Overall Study||33||
48662585|NCT00847730|101959494|FG000|COMPLETED|Overall Study||25||
48662586|NCT00847730|101959494|FG000|NOT COMPLETED|Overall Study||8||
48772670|NCT04411667|102232791|FG000|NOT COMPLETED|Overall Study||1||
48662587|NCT00800345|101959495|FG000|STARTED|Overall Study||33||
48662588|NCT00800345|101959495|FG000|COMPLETED|Overall Study||33||
48662589|NCT00800345|101959495|FG000|NOT COMPLETED|Overall Study||0||
48662590|NCT02069847|101959496|FG000|STARTED|Overall Study||22||
48662591|NCT02069847|101959497|FG001|STARTED|Overall Study||68||
48662592|NCT02069847|101959496|FG000|COMPLETED|Overall Study||22||
48454887|NCT00628394|101449751|FG000|STARTED|Overall Study||14|Participants that made it past Randomization and one session of CR/Control.|
48454888|NCT00628394|101449752|FG001|STARTED|Overall Study||13|Participants that made it past Randomization and one session of CR/Control.|
48454889|NCT00628394|101449753|FG002|STARTED|Overall Study||13|Participants that made it past Randomization and one session of CR/Control.|
48454890|NCT00628394|101449754|FG003|STARTED|Overall Study||13|Participants that made it past Randomization and one session of CR/Control.|
48454891|NCT00628394|101449751|FG000|COMPLETED|Overall Study||10||
48454892|NCT00628394|101449752|FG001|COMPLETED|Overall Study||9||
48454893|NCT00628394|101449753|FG002|COMPLETED|Overall Study||11||
48454894|NCT00628394|101449754|FG003|COMPLETED|Overall Study||10||
48454895|NCT00628394|101449751|FG000|NOT COMPLETED|Overall Study||4||
48454896|NCT00628394|101449752|FG001|NOT COMPLETED|Overall Study||4||
48454897|NCT00628394|101449753|FG002|NOT COMPLETED|Overall Study||2||
48454898|NCT00628394|101449754|FG003|NOT COMPLETED|Overall Study||3||
48454899|NCT03016078|101449755|FG000|STARTED|Overall Study||21||
48454900|NCT03016078|101449755|FG000|COMPLETED|Overall Study||19||
48454901|NCT03016078|101449755|FG000|NOT COMPLETED|Overall Study||2||
48454902|NCT00446654|101449756|FG000|STARTED|Overall Study||21||
48454903|NCT00446654|101449757|FG001|STARTED|Overall Study||22||
48454904|NCT00446654|101449756|FG000|COMPLETED|Overall Study||19||
48454905|NCT00446654|101449757|FG001|COMPLETED|Overall Study||22||
48454906|NCT00446654|101449756|FG000|NOT COMPLETED|Overall Study||2||
48454907|NCT00446654|101449757|FG001|NOT COMPLETED|Overall Study||0||
48454908|NCT00448682|101449758|FG000|STARTED|Overall Study||25||
48454909|NCT00448682|101449758|FG000|COMPLETED|Overall Study||25||
48454910|NCT00448682|101449758|FG000|NOT COMPLETED|Overall Study||0||
48454911|NCT01489956|101449759|FG000|STARTED|Overall Study||13||
48454912|NCT01489956|101449760|FG001|STARTED|Overall Study||0||
48454913|NCT01489956|101449761|FG002|STARTED|Overall Study||6||
48454914|NCT01489956|101449759|FG000|COMPLETED|Overall Study||12||
48454915|NCT01489956|101449760|FG001|COMPLETED|Overall Study||0||
48454916|NCT01489956|101449761|FG002|COMPLETED|Overall Study||5||
48454917|NCT01489956|101449759|FG000|NOT COMPLETED|Overall Study||1||
48454918|NCT01489956|101449760|FG001|NOT COMPLETED|Overall Study||0||
48454919|NCT01489956|101449761|FG002|NOT COMPLETED|Overall Study||1||
48454920|NCT03372369|101449762|FG000|STARTED|Qualification Period||495||
48454921|NCT03372369|101449763|FG001|STARTED|Qualification Period||495||
48454922|NCT03372369|101449762|FG000|COMPLETED|Qualification Period||469||
48454923|NCT03372369|101449763|FG001|COMPLETED|Qualification Period||473||
48454924|NCT03372369|101449762|FG000|NOT COMPLETED|Qualification Period||26||
48454925|NCT03372369|101449763|FG001|NOT COMPLETED|Qualification Period||22||
48454926|NCT03372369|101449762|FG000|STARTED|Intervention and Follow-Up Period||469||
48662593|NCT02069847|101959497|FG001|COMPLETED|Overall Study||68||
48662594|NCT02069847|101959496|FG000|NOT COMPLETED|Overall Study||0||
48662595|NCT02069847|101959497|FG001|NOT COMPLETED|Overall Study||0||
48662596|NCT03689179|101959498|FG000|STARTED|Overall Study||83||
48662597|NCT03689179|101959499|FG001|STARTED|Overall Study||83||
48662598|NCT03689179|101959498|FG000|COMPLETED|Overall Study||69||
48662599|NCT03689179|101959499|FG001|COMPLETED|Overall Study||67||
48662600|NCT03689179|101959498|FG000|NOT COMPLETED|Overall Study||14||
48772671|NCT04411667|102232792|FG001|NOT COMPLETED|Overall Study||0||
48772672|NCT00790842|102232793|FG000|STARTED|Dose Level 1||6||
48772673|NCT00790842|102232794|FG001|STARTED|Dose Level 1||0||
48662601|NCT03689179|101959499|FG001|NOT COMPLETED|Overall Study||16||
48662602|NCT01400412|101959500|FG000|STARTED|Overall Study||130||
48662603|NCT01400412|101959501|FG001|STARTED|Overall Study||132||
48662604|NCT01400412|101959500|FG000|COMPLETED|Overall Study||120||
48662605|NCT01400412|101959501|FG001|COMPLETED|Overall Study||115||
48662606|NCT01400412|101959500|FG000|NOT COMPLETED|Overall Study||10||
48662607|NCT01400412|101959501|FG001|NOT COMPLETED|Overall Study||17||
48772674|NCT00790842|102232795|FG002|STARTED|Dose Level 1||0||
48772675|NCT00790842|102232796|FG003|STARTED|Dose Level 1||3||
48189219|NCT01341080|100786180|FG001|COMPLETED|Overall Study||17||
48454927|NCT03372369|101449763|FG001|STARTED|Intervention and Follow-Up Period||473||
48454928|NCT03372369|101449762|FG000|COMPLETED|Intervention and Follow-Up Period||466||
48454929|NCT03372369|101449763|FG001|COMPLETED|Intervention and Follow-Up Period||470||
48454930|NCT03372369|101449762|FG000|NOT COMPLETED|Intervention and Follow-Up Period||3||
48454931|NCT03372369|101449763|FG001|NOT COMPLETED|Intervention and Follow-Up Period||3||
48454932|NCT01551550|101449764|FG000|STARTED|Overall Study||41||
48454933|NCT01551550|101449765|FG001|STARTED|Overall Study||41||
48454934|NCT01551550|101449764|FG000|COMPLETED|Overall Study||41||
48454935|NCT01551550|101449765|FG001|COMPLETED|Overall Study||40||
48662608|NCT03926247|101959502|FG000|STARTED|Overall Study||56||
48454936|NCT01551550|101449764|FG000|NOT COMPLETED|Overall Study||0||
48454937|NCT01551550|101449765|FG001|NOT COMPLETED|Overall Study||1||
48454938|NCT04942379|101449766|FG000|STARTED|Overall Study||31||
48454939|NCT04942379|101449767|FG001|STARTED|Overall Study||35||
48454940|NCT04942379|101449766|FG000|3 Months|Overall Study||29||
48454941|NCT04942379|101449767|FG001|3 Months|Overall Study||34||
48454942|NCT04942379|101449766|FG000|6 Months|Overall Study||28||
48454943|NCT04942379|101449767|FG001|6 Months|Overall Study||32||
48454944|NCT04942379|101449766|FG000|COMPLETED|Overall Study||27|12 months|
48454945|NCT04942379|101449767|FG001|COMPLETED|Overall Study||32|12 months|
48454946|NCT04942379|101449766|FG000|NOT COMPLETED|Overall Study||4||
48454947|NCT04942379|101449767|FG001|NOT COMPLETED|Overall Study||3||
48454948|NCT00879970|101449768|FG000|STARTED|Period 1 TZD Randomization||541||
48454949|NCT00879970|101449769|FG001|STARTED|Period 1 TZD Randomization||392||
48454950|NCT00879970|101449770|FG002|STARTED|Period 1 TZD Randomization||399||
48454951|NCT00879970|101449771|FG003|STARTED|Period 1 TZD Randomization||0||
48454952|NCT00879970|101449772|FG004|STARTED|Period 1 TZD Randomization||0||
48454953|NCT00879970|101449768|FG000|COMPLETED|Period 1 TZD Randomization||533||
48454954|NCT00879970|101449769|FG001|COMPLETED|Period 1 TZD Randomization||388||
48454955|NCT00879970|101449770|FG002|COMPLETED|Period 1 TZD Randomization||393||
48454956|NCT00879970|101449771|FG003|COMPLETED|Period 1 TZD Randomization||0||
48454957|NCT00879970|101449772|FG004|COMPLETED|Period 1 TZD Randomization||0||
48454958|NCT00879970|101449768|FG000|NOT COMPLETED|Period 1 TZD Randomization||8||
48454959|NCT00879970|101449769|FG001|NOT COMPLETED|Period 1 TZD Randomization||4||
48454960|NCT00879970|101449770|FG002|NOT COMPLETED|Period 1 TZD Randomization||6||
48454961|NCT00879970|101449771|FG003|NOT COMPLETED|Period 1 TZD Randomization||0||
48454962|NCT00879970|101449772|FG004|NOT COMPLETED|Period 1 TZD Randomization||0||
48454963|NCT00879970|101449768|FG000|STARTED|Period 2 Vitamin D Randomization||0||
48454964|NCT00879970|101449769|FG001|STARTED|Period 2 Vitamin D Randomization||0||
48454965|NCT00879970|101449770|FG002|STARTED|Period 2 Vitamin D Randomization||0||
48454966|NCT00879970|101449771|FG003|STARTED|Period 2 Vitamin D Randomization||614||
48454967|NCT00879970|101449772|FG004|STARTED|Period 2 Vitamin D Randomization||607||
48454968|NCT00879970|101449768|FG000|COMPLETED|Period 2 Vitamin D Randomization||0||
48662609|NCT03926247|101959502|FG000|COMPLETED|Overall Study||31||
48772676|NCT00790842|102232797|FG004|STARTED|Dose Level 1||0||
48189220|NCT01341080|100786179|FG000|NOT COMPLETED|Overall Study||3||
48189221|NCT01341080|100786180|FG001|NOT COMPLETED|Overall Study||1||
48189222|NCT02395185|100786181|FG000|STARTED|Overall Study||33||
48454969|NCT00879970|101449769|FG001|COMPLETED|Period 2 Vitamin D Randomization||0||
48454970|NCT00879970|101449770|FG002|COMPLETED|Period 2 Vitamin D Randomization||0||
48454971|NCT00879970|101449771|FG003|COMPLETED|Period 2 Vitamin D Randomization||610||
48454972|NCT00879970|101449772|FG004|COMPLETED|Period 2 Vitamin D Randomization||600||
48454973|NCT00879970|101449768|FG000|NOT COMPLETED|Period 2 Vitamin D Randomization||0||
48454974|NCT00879970|101449769|FG001|NOT COMPLETED|Period 2 Vitamin D Randomization||0||
48454975|NCT00879970|101449770|FG002|NOT COMPLETED|Period 2 Vitamin D Randomization||0||
48454976|NCT00879970|101449771|FG003|NOT COMPLETED|Period 2 Vitamin D Randomization||4||
48454977|NCT00879970|101449772|FG004|NOT COMPLETED|Period 2 Vitamin D Randomization||7||
48454978|NCT02525029|101449773|FG000|STARTED|Overall Study||0||
48454979|NCT02525029|101449774|FG001|STARTED|Overall Study||0||
48454980|NCT02525029|101449775|FG002|STARTED|Overall Study||0||
48454981|NCT02525029|101449776|FG003|STARTED|Overall Study||0||
48454982|NCT02525029|101449777|FG004|STARTED|Overall Study||2||
48454983|NCT02525029|101449778|FG005|STARTED|Overall Study||0||
48454984|NCT02525029|101449779|FG006|STARTED|Overall Study||2||
48454985|NCT02525029|101449780|FG007|STARTED|Overall Study||0||
48454986|NCT02525029|101449781|FG008|STARTED|Overall Study||9||
48662610|NCT03926247|101959502|FG000|NOT COMPLETED|Overall Study||25||
48189223|NCT02395185|100786181|FG000|Sequence 1 (s,s,m,m,w,w)|Overall Study||2||
48454987|NCT02525029|101449782|FG009|STARTED|Overall Study||13||
48454988|NCT02525029|101449783|FG010|STARTED|Overall Study||0||
48454989|NCT02525029|101449784|FG011|STARTED|Overall Study||0||
48454990|NCT02525029|101449785|FG012|STARTED|Overall Study||0||
48454991|NCT02525029|101449786|FG013|STARTED|Overall Study||0||
48454992|NCT02525029|101449787|FG014|STARTED|Overall Study||0||
48454993|NCT02525029|101449788|FG015|STARTED|Overall Study||0||
48454994|NCT02525029|101449789|FG016|STARTED|Overall Study||1||
48454995|NCT02525029|101449790|FG017|STARTED|Overall Study||0||
48772677|NCT00790842|102232798|FG005|STARTED|Dose Level 1||0||
48772678|NCT00790842|102232799|FG006|STARTED|Dose Level 1||0||
48454996|NCT02525029|101449791|FG018|STARTED|Overall Study||4||
48454997|NCT02525029|101449792|FG019|STARTED|Overall Study||8||
48454998|NCT02525029|101449793|FG020|STARTED|Overall Study||0||
48454999|NCT02525029|101449794|FG021|STARTED|Overall Study||0||
48455000|NCT02525029|101449795|FG022|STARTED|Overall Study||0||
48455001|NCT02525029|101449796|FG023|STARTED|Overall Study||0||
48455002|NCT02525029|101449797|FG024|STARTED|Overall Study||2||
48455003|NCT02525029|101449798|FG025|STARTED|Overall Study||0||
48455004|NCT02525029|101449799|FG026|STARTED|Overall Study||1||
48455005|NCT02525029|101449800|FG027|STARTED|Overall Study||0||
48455006|NCT02525029|101449801|FG028|STARTED|Overall Study||5||
48662611|NCT03766399|101959503|FG000|STARTED|Part 1a: SAD (Nebulized Inhalation)||12||
48772679|NCT00790842|102232800|FG007|STARTED|Dose Level 1||3||
48189224|NCT02395185|100786181|FG000|Sequence 2 (w,s,s,m,m,w)|Overall Study||2||
48455007|NCT02525029|101449802|FG029|STARTED|Overall Study||1||
48455008|NCT02525029|101449803|FG030|STARTED|Overall Study||2||
48455009|NCT02525029|101449804|FG031|STARTED|Overall Study||0||
48455010|NCT02525029|101449805|FG032|STARTED|Overall Study||3||
48455011|NCT02525029|101449806|FG033|STARTED|Overall Study||0||
48455012|NCT02525029|101449773|FG000|COMPLETED|Overall Study||0||
48455013|NCT02525029|101449774|FG001|COMPLETED|Overall Study||0||
48455014|NCT02525029|101449775|FG002|COMPLETED|Overall Study||0||
48455015|NCT02525029|101449776|FG003|COMPLETED|Overall Study||0||
48455016|NCT02525029|101449777|FG004|COMPLETED|Overall Study||2||
48455017|NCT02525029|101449778|FG005|COMPLETED|Overall Study||0||
48455018|NCT02525029|101449779|FG006|COMPLETED|Overall Study||2||
48455019|NCT02525029|101449780|FG007|COMPLETED|Overall Study||0||
48455020|NCT02525029|101449781|FG008|COMPLETED|Overall Study||9||
48455021|NCT02525029|101449782|FG009|COMPLETED|Overall Study||13||
48455022|NCT02525029|101449783|FG010|COMPLETED|Overall Study||0||
48455023|NCT02525029|101449784|FG011|COMPLETED|Overall Study||0||
48455024|NCT02525029|101449785|FG012|COMPLETED|Overall Study||0||
48455025|NCT02525029|101449786|FG013|COMPLETED|Overall Study||0||
48455026|NCT02525029|101449787|FG014|COMPLETED|Overall Study||0||
48455027|NCT02525029|101449788|FG015|COMPLETED|Overall Study||0||
48455028|NCT02525029|101449789|FG016|COMPLETED|Overall Study||1||
48455029|NCT02525029|101449790|FG017|COMPLETED|Overall Study||0||
48455030|NCT02525029|101449791|FG018|COMPLETED|Overall Study||4||
48662612|NCT03766399|101959504|FG001|STARTED|Part 1a: SAD (Nebulized Inhalation)||6||
48662613|NCT03766399|101959505|FG002|STARTED|Part 1a: SAD (Nebulized Inhalation)||6||
48455031|NCT02525029|101449792|FG019|COMPLETED|Overall Study||8||
48455032|NCT02525029|101449793|FG020|COMPLETED|Overall Study||0||
48455033|NCT02525029|101449794|FG021|COMPLETED|Overall Study||0||
48455034|NCT02525029|101449795|FG022|COMPLETED|Overall Study||0||
48455035|NCT02525029|101449796|FG023|COMPLETED|Overall Study||0||
48455036|NCT02525029|101449797|FG024|COMPLETED|Overall Study||1||
48455037|NCT02525029|101449798|FG025|COMPLETED|Overall Study||0||
48455038|NCT02525029|101449799|FG026|COMPLETED|Overall Study||1||
48455039|NCT02525029|101449800|FG027|COMPLETED|Overall Study||0||
48455040|NCT02525029|101449801|FG028|COMPLETED|Overall Study||5||
48455041|NCT02525029|101449802|FG029|COMPLETED|Overall Study||1||
48455042|NCT02525029|101449803|FG030|COMPLETED|Overall Study||2||
48455043|NCT02525029|101449804|FG031|COMPLETED|Overall Study||0||
48455044|NCT02525029|101449805|FG032|COMPLETED|Overall Study||3||
48455045|NCT02525029|101449806|FG033|COMPLETED|Overall Study||0||
48455046|NCT02525029|101449773|FG000|NOT COMPLETED|Overall Study||0||
48455047|NCT02525029|101449774|FG001|NOT COMPLETED|Overall Study||0||
48455048|NCT02525029|101449775|FG002|NOT COMPLETED|Overall Study||0||
48455049|NCT02525029|101449776|FG003|NOT COMPLETED|Overall Study||0||
48455050|NCT02525029|101449777|FG004|NOT COMPLETED|Overall Study||0||
48455051|NCT02525029|101449778|FG005|NOT COMPLETED|Overall Study||0||
48455052|NCT02525029|101449779|FG006|NOT COMPLETED|Overall Study||0||
48455053|NCT02525029|101449780|FG007|NOT COMPLETED|Overall Study||0||
48455054|NCT02525029|101449781|FG008|NOT COMPLETED|Overall Study||0||
48455055|NCT02525029|101449782|FG009|NOT COMPLETED|Overall Study||0||
48455056|NCT02525029|101449783|FG010|NOT COMPLETED|Overall Study||0||
48455057|NCT02525029|101449784|FG011|NOT COMPLETED|Overall Study||0||
48455058|NCT02525029|101449785|FG012|NOT COMPLETED|Overall Study||0||
48455059|NCT02525029|101449786|FG013|NOT COMPLETED|Overall Study||0||
48455060|NCT02525029|101449787|FG014|NOT COMPLETED|Overall Study||0||
48455061|NCT02525029|101449788|FG015|NOT COMPLETED|Overall Study||0||
48455062|NCT02525029|101449789|FG016|NOT COMPLETED|Overall Study||0||
48455063|NCT02525029|101449790|FG017|NOT COMPLETED|Overall Study||0||
48455064|NCT02525029|101449791|FG018|NOT COMPLETED|Overall Study||0||
48455065|NCT02525029|101449792|FG019|NOT COMPLETED|Overall Study||0||
48455066|NCT02525029|101449793|FG020|NOT COMPLETED|Overall Study||0||
48455067|NCT02525029|101449794|FG021|NOT COMPLETED|Overall Study||0||
48455068|NCT02525029|101449795|FG022|NOT COMPLETED|Overall Study||0||
48455069|NCT02525029|101449796|FG023|NOT COMPLETED|Overall Study||0||
48662614|NCT03766399|101959506|FG003|STARTED|Part 1a: SAD (Nebulized Inhalation)||6||
48662615|NCT03766399|101959507|FG004|STARTED|Part 1a: SAD (Nebulized Inhalation)||6||
48662616|NCT03766399|101959508|FG005|STARTED|Part 1a: SAD (Nebulized Inhalation)||6||
48662617|NCT03766399|101959509|FG006|STARTED|Part 1a: SAD (Nebulized Inhalation)||6||
48662618|NCT03766399|101959510|FG007|STARTED|Part 1a: SAD (Nebulized Inhalation)||0||
48662619|NCT03766399|101959511|FG008|STARTED|Part 1a: SAD (Nebulized Inhalation)||0||
48662620|NCT03766399|101959512|FG009|STARTED|Part 1a: SAD (Nebulized Inhalation)||0||
48662621|NCT03766399|101959513|FG010|STARTED|Part 1a: SAD (Nebulized Inhalation)||0||
48662622|NCT03766399|101959514|FG011|STARTED|Part 1a: SAD (Nebulized Inhalation)||0||
48662623|NCT03766399|101959515|FG012|STARTED|Part 1a: SAD (Nebulized Inhalation)||0||
48662624|NCT03766399|101959516|FG013|STARTED|Part 1a: SAD (Nebulized Inhalation)||0||
48662625|NCT03766399|101959517|FG014|STARTED|Part 1a: SAD (Nebulized Inhalation)||0||
48662626|NCT03766399|101959518|FG015|STARTED|Part 1a: SAD (Nebulized Inhalation)||0||
48662627|NCT03766399|101959519|FG016|STARTED|Part 1a: SAD (Nebulized Inhalation)||0||
48662628|NCT03766399|101959520|FG017|STARTED|Part 1a: SAD (Nebulized Inhalation)||0||
48662629|NCT03766399|101959503|FG000|COMPLETED|Part 1a: SAD (Nebulized Inhalation)||12||
48662630|NCT03766399|101959504|FG001|COMPLETED|Part 1a: SAD (Nebulized Inhalation)||6||
48662631|NCT03766399|101959505|FG002|COMPLETED|Part 1a: SAD (Nebulized Inhalation)||6||
48662632|NCT03766399|101959506|FG003|COMPLETED|Part 1a: SAD (Nebulized Inhalation)||6||
48662633|NCT03766399|101959507|FG004|COMPLETED|Part 1a: SAD (Nebulized Inhalation)||6||
48662634|NCT03766399|101959508|FG005|COMPLETED|Part 1a: SAD (Nebulized Inhalation)||6||
48369463|NCT04105543|101232779|FG000|STARTED|Dose Held at Dose Level 1: 15.6mCi||12|Investigators held dose at 15.6mCi as 1 participant had a dose limiting toxicity. N=12 includes the 4 participants initially enrolled into this dose level.|
48369464|NCT04105543|101232779|FG000|Completed Treatment|Dose Held at Dose Level 1: 15.6mCi||12||
48662635|NCT03766399|101959509|FG006|COMPLETED|Part 1a: SAD (Nebulized Inhalation)||6||
48662636|NCT03766399|101959510|FG007|COMPLETED|Part 1a: SAD (Nebulized Inhalation)||0||
48662637|NCT03766399|101959511|FG008|COMPLETED|Part 1a: SAD (Nebulized Inhalation)||0||
48369465|NCT04105543|101232779|FG000|Primary Analysis Population|Dose Held at Dose Level 1: 15.6mCi||12||
48369466|NCT04105543|101232779|FG000|Overall Response Rate Analysis Population|Dose Held at Dose Level 1: 15.6mCi||11||
48662638|NCT03766399|101959512|FG009|COMPLETED|Part 1a: SAD (Nebulized Inhalation)||0||
48662639|NCT03766399|101959513|FG010|COMPLETED|Part 1a: SAD (Nebulized Inhalation)||0||
48662640|NCT03766399|101959514|FG011|COMPLETED|Part 1a: SAD (Nebulized Inhalation)||0||
48662641|NCT03766399|101959515|FG012|COMPLETED|Part 1a: SAD (Nebulized Inhalation)||0||
48662642|NCT03766399|101959516|FG013|COMPLETED|Part 1a: SAD (Nebulized Inhalation)||0||
48662643|NCT03766399|101959517|FG014|COMPLETED|Part 1a: SAD (Nebulized Inhalation)||0||
48662644|NCT03766399|101959518|FG015|COMPLETED|Part 1a: SAD (Nebulized Inhalation)||0||
48662645|NCT03766399|101959519|FG016|COMPLETED|Part 1a: SAD (Nebulized Inhalation)||0||
48662646|NCT03766399|101959520|FG017|COMPLETED|Part 1a: SAD (Nebulized Inhalation)||0||
48662647|NCT03766399|101959503|FG000|NOT COMPLETED|Part 1a: SAD (Nebulized Inhalation)||0||
48662648|NCT03766399|101959504|FG001|NOT COMPLETED|Part 1a: SAD (Nebulized Inhalation)||0||
48662649|NCT03766399|101959505|FG002|NOT COMPLETED|Part 1a: SAD (Nebulized Inhalation)||0||
48662650|NCT03766399|101959506|FG003|NOT COMPLETED|Part 1a: SAD (Nebulized Inhalation)||0||
48662651|NCT03766399|101959507|FG004|NOT COMPLETED|Part 1a: SAD (Nebulized Inhalation)||0||
48662652|NCT03766399|101959508|FG005|NOT COMPLETED|Part 1a: SAD (Nebulized Inhalation)||0||
48662653|NCT03766399|101959509|FG006|NOT COMPLETED|Part 1a: SAD (Nebulized Inhalation)||0||
48662654|NCT03766399|101959510|FG007|NOT COMPLETED|Part 1a: SAD (Nebulized Inhalation)||0||
48662655|NCT03766399|101959511|FG008|NOT COMPLETED|Part 1a: SAD (Nebulized Inhalation)||0||
48662656|NCT03766399|101959512|FG009|NOT COMPLETED|Part 1a: SAD (Nebulized Inhalation)||0||
48662657|NCT03766399|101959513|FG010|NOT COMPLETED|Part 1a: SAD (Nebulized Inhalation)||0||
48662658|NCT03766399|101959514|FG011|NOT COMPLETED|Part 1a: SAD (Nebulized Inhalation)||0||
48662659|NCT03766399|101959515|FG012|NOT COMPLETED|Part 1a: SAD (Nebulized Inhalation)||0||
48662660|NCT03766399|101959516|FG013|NOT COMPLETED|Part 1a: SAD (Nebulized Inhalation)||0||
48662661|NCT03766399|101959517|FG014|NOT COMPLETED|Part 1a: SAD (Nebulized Inhalation)||0||
48662662|NCT03766399|101959518|FG015|NOT COMPLETED|Part 1a: SAD (Nebulized Inhalation)||0||
48662663|NCT03766399|101959519|FG016|NOT COMPLETED|Part 1a: SAD (Nebulized Inhalation)||0||
48662664|NCT03766399|101959520|FG017|NOT COMPLETED|Part 1a: SAD (Nebulized Inhalation)||0||
48662665|NCT03766399|101959503|FG000|STARTED|Part 1b: SAD (Intravenous Dosing)||0||
48662666|NCT03766399|101959504|FG001|STARTED|Part 1b: SAD (Intravenous Dosing)||0||
48662667|NCT03766399|101959505|FG002|STARTED|Part 1b: SAD (Intravenous Dosing)||0||
48662668|NCT03766399|101959506|FG003|STARTED|Part 1b: SAD (Intravenous Dosing)||0||
48662669|NCT03766399|101959507|FG004|STARTED|Part 1b: SAD (Intravenous Dosing)||0||
48662670|NCT03766399|101959508|FG005|STARTED|Part 1b: SAD (Intravenous Dosing)||0||
48662671|NCT03766399|101959509|FG006|STARTED|Part 1b: SAD (Intravenous Dosing)||0||
48662672|NCT03766399|101959510|FG007|STARTED|Part 1b: SAD (Intravenous Dosing)||6||
48662673|NCT03766399|101959511|FG008|STARTED|Part 1b: SAD (Intravenous Dosing)||6||
48662674|NCT03766399|101959512|FG009|STARTED|Part 1b: SAD (Intravenous Dosing)||0||
48662675|NCT03766399|101959513|FG010|STARTED|Part 1b: SAD (Intravenous Dosing)||0||
48662676|NCT03766399|101959514|FG011|STARTED|Part 1b: SAD (Intravenous Dosing)||0||
48662677|NCT03766399|101959515|FG012|STARTED|Part 1b: SAD (Intravenous Dosing)||0||
48662678|NCT03766399|101959516|FG013|STARTED|Part 1b: SAD (Intravenous Dosing)||0||
48662679|NCT03766399|101959517|FG014|STARTED|Part 1b: SAD (Intravenous Dosing)||0||
48662680|NCT03766399|101959518|FG015|STARTED|Part 1b: SAD (Intravenous Dosing)||0||
48455070|NCT02525029|101449797|FG024|NOT COMPLETED|Overall Study||1||
48455071|NCT02525029|101449798|FG025|NOT COMPLETED|Overall Study||0||
48455072|NCT02525029|101449799|FG026|NOT COMPLETED|Overall Study||0||
48455073|NCT02525029|101449800|FG027|NOT COMPLETED|Overall Study||0||
48455074|NCT02525029|101449801|FG028|NOT COMPLETED|Overall Study||0||
48455075|NCT02525029|101449802|FG029|NOT COMPLETED|Overall Study||0||
48455076|NCT02525029|101449803|FG030|NOT COMPLETED|Overall Study||0||
48455077|NCT02525029|101449804|FG031|NOT COMPLETED|Overall Study||0||
48455078|NCT02525029|101449805|FG032|NOT COMPLETED|Overall Study||0||
48455079|NCT02525029|101449806|FG033|NOT COMPLETED|Overall Study||0||
48455080|NCT03723590|101449807|FG000|STARTED|Overall Study||5||
48455081|NCT03723590|101449807|FG000|COMPLETED|Overall Study||0||
48662681|NCT03766399|101959519|FG016|STARTED|Part 1b: SAD (Intravenous Dosing)||0||
48662682|NCT03766399|101959520|FG017|STARTED|Part 1b: SAD (Intravenous Dosing)||0||
48662683|NCT03766399|101959503|FG000|COMPLETED|Part 1b: SAD (Intravenous Dosing)||0||
48662684|NCT03766399|101959504|FG001|COMPLETED|Part 1b: SAD (Intravenous Dosing)||0||
48662685|NCT03766399|101959505|FG002|COMPLETED|Part 1b: SAD (Intravenous Dosing)||0||
48662686|NCT03766399|101959506|FG003|COMPLETED|Part 1b: SAD (Intravenous Dosing)||0||
48662687|NCT03766399|101959507|FG004|COMPLETED|Part 1b: SAD (Intravenous Dosing)||0||
48662688|NCT03766399|101959508|FG005|COMPLETED|Part 1b: SAD (Intravenous Dosing)||0||
48662689|NCT03766399|101959509|FG006|COMPLETED|Part 1b: SAD (Intravenous Dosing)||0||
48662690|NCT03766399|101959510|FG007|COMPLETED|Part 1b: SAD (Intravenous Dosing)||6||
48662691|NCT03766399|101959511|FG008|COMPLETED|Part 1b: SAD (Intravenous Dosing)||6||
48662692|NCT03766399|101959512|FG009|COMPLETED|Part 1b: SAD (Intravenous Dosing)||0||
48662693|NCT03766399|101959513|FG010|COMPLETED|Part 1b: SAD (Intravenous Dosing)||0||
48662694|NCT03766399|101959514|FG011|COMPLETED|Part 1b: SAD (Intravenous Dosing)||0||
48772680|NCT00790842|102232801|FG008|STARTED|Dose Level 1||0||
48772681|NCT00790842|102232802|FG009|STARTED|Dose Level 1||0||
48772682|NCT00790842|102232803|FG010|STARTED|Dose Level 1||0||
48772683|NCT00790842|102232793|FG000|Began Treatment|Dose Level 1||6||
48772684|NCT00790842|102232794|FG001|Began Treatment|Dose Level 1||0||
48772685|NCT00790842|102232795|FG002|Began Treatment|Dose Level 1||0||
48189225|NCT02395185|100786181|FG000|Sequence 3 (w,w,s,s,m,m)|Overall Study||2||
48455082|NCT03723590|101449807|FG000|NOT COMPLETED|Overall Study||5||
48455083|NCT00677924|101449808|FG000|STARTED|Overall Study||3||
48455084|NCT00677924|101449809|FG001|STARTED|Overall Study||6||
48455085|NCT00677924|101449808|FG000|COMPLETED|Overall Study||3||
48455086|NCT00677924|101449809|FG001|COMPLETED|Overall Study||6||
48455087|NCT00677924|101449808|FG000|NOT COMPLETED|Overall Study||0||
48455088|NCT00677924|101449809|FG001|NOT COMPLETED|Overall Study||0||
48455089|NCT01565382|101449810|FG000|STARTED|Overall Study||40||
48455090|NCT01565382|101449810|FG000|COMPLETED|Overall Study||40||
48455091|NCT01565382|101449810|FG000|NOT COMPLETED|Overall Study||0||
48455092|NCT01714505|101449811|FG000|STARTED|Admission 1 (40 Hours)||10||
48455093|NCT01714505|101449812|FG001|STARTED|Admission 1 (40 Hours)||10||
48455094|NCT01714505|101449811|FG000|COMPLETED|Admission 1 (40 Hours)||9||
48455095|NCT01714505|101449812|FG001|COMPLETED|Admission 1 (40 Hours)||9||
48455096|NCT01714505|101449811|FG000|NOT COMPLETED|Admission 1 (40 Hours)||1||
48455097|NCT01714505|101449812|FG001|NOT COMPLETED|Admission 1 (40 Hours)||1||
48455098|NCT01714505|101449811|FG000|STARTED|Admission 2 (40 Hours)||9||
48455099|NCT01714505|101449812|FG001|STARTED|Admission 2 (40 Hours)||9||
48455100|NCT01714505|101449811|FG000|COMPLETED|Admission 2 (40 Hours)||9||
48455101|NCT01714505|101449812|FG001|COMPLETED|Admission 2 (40 Hours)||9||
48455102|NCT01714505|101449811|FG000|NOT COMPLETED|Admission 2 (40 Hours)||0||
48455103|NCT01714505|101449812|FG001|NOT COMPLETED|Admission 2 (40 Hours)||0||
48455104|NCT01710306|101449813|FG000|STARTED|Overall Study||86||
48455105|NCT01710306|101449814|FG001|STARTED|Overall Study||85||
48455106|NCT01710306|101449813|FG000|COMPLETED|Overall Study||68||
48455107|NCT01710306|101449814|FG001|COMPLETED|Overall Study||55||
48662695|NCT03766399|101959515|FG012|COMPLETED|Part 1b: SAD (Intravenous Dosing)||0||
48662696|NCT03766399|101959516|FG013|COMPLETED|Part 1b: SAD (Intravenous Dosing)||0||
48662697|NCT03766399|101959517|FG014|COMPLETED|Part 1b: SAD (Intravenous Dosing)||0||
48662698|NCT03766399|101959518|FG015|COMPLETED|Part 1b: SAD (Intravenous Dosing)||0||
48662699|NCT03766399|101959519|FG016|COMPLETED|Part 1b: SAD (Intravenous Dosing)||0||
48662700|NCT03766399|101959520|FG017|COMPLETED|Part 1b: SAD (Intravenous Dosing)||0||
48662701|NCT03766399|101959503|FG000|NOT COMPLETED|Part 1b: SAD (Intravenous Dosing)||0||
48662702|NCT03766399|101959504|FG001|NOT COMPLETED|Part 1b: SAD (Intravenous Dosing)||0||
48662703|NCT03766399|101959505|FG002|NOT COMPLETED|Part 1b: SAD (Intravenous Dosing)||0||
48662704|NCT03766399|101959506|FG003|NOT COMPLETED|Part 1b: SAD (Intravenous Dosing)||0||
48662705|NCT03766399|101959507|FG004|NOT COMPLETED|Part 1b: SAD (Intravenous Dosing)||0||
48662706|NCT03766399|101959508|FG005|NOT COMPLETED|Part 1b: SAD (Intravenous Dosing)||0||
48662707|NCT03766399|101959509|FG006|NOT COMPLETED|Part 1b: SAD (Intravenous Dosing)||0||
48662708|NCT03766399|101959510|FG007|NOT COMPLETED|Part 1b: SAD (Intravenous Dosing)||0||
48662709|NCT03766399|101959511|FG008|NOT COMPLETED|Part 1b: SAD (Intravenous Dosing)||0||
48662710|NCT03766399|101959512|FG009|NOT COMPLETED|Part 1b: SAD (Intravenous Dosing)||0||
48662711|NCT03766399|101959513|FG010|NOT COMPLETED|Part 1b: SAD (Intravenous Dosing)||0||
48662712|NCT03766399|101959514|FG011|NOT COMPLETED|Part 1b: SAD (Intravenous Dosing)||0||
48662713|NCT03766399|101959515|FG012|NOT COMPLETED|Part 1b: SAD (Intravenous Dosing)||0||
48662714|NCT03766399|101959516|FG013|NOT COMPLETED|Part 1b: SAD (Intravenous Dosing)||0||
48662715|NCT03766399|101959517|FG014|NOT COMPLETED|Part 1b: SAD (Intravenous Dosing)||0||
48662716|NCT03766399|101959518|FG015|NOT COMPLETED|Part 1b: SAD (Intravenous Dosing)||0||
48662717|NCT03766399|101959519|FG016|NOT COMPLETED|Part 1b: SAD (Intravenous Dosing)||0||
48662718|NCT03766399|101959520|FG017|NOT COMPLETED|Part 1b: SAD (Intravenous Dosing)||0||
48662719|NCT03766399|101959503|FG000|STARTED|Part 2a: MAD (Nebulized Inhalation)||0||
48662720|NCT03766399|101959504|FG001|STARTED|Part 2a: MAD (Nebulized Inhalation)||0||
48662721|NCT03766399|101959505|FG002|STARTED|Part 2a: MAD (Nebulized Inhalation)||0||
48662722|NCT03766399|101959506|FG003|STARTED|Part 2a: MAD (Nebulized Inhalation)||0||
48662723|NCT03766399|101959507|FG004|STARTED|Part 2a: MAD (Nebulized Inhalation)||0||
48662724|NCT03766399|101959508|FG005|STARTED|Part 2a: MAD (Nebulized Inhalation)||0||
48662725|NCT03766399|101959509|FG006|STARTED|Part 2a: MAD (Nebulized Inhalation)||0||
48662726|NCT03766399|101959510|FG007|STARTED|Part 2a: MAD (Nebulized Inhalation)||0||
48772686|NCT00790842|102232796|FG003|Began Treatment|Dose Level 1||3||
48455108|NCT01710306|101449813|FG000|NOT COMPLETED|Overall Study||18||
48455109|NCT01710306|101449814|FG001|NOT COMPLETED|Overall Study||30||
48455110|NCT00525031|101449815|FG000|STARTED|Overall Study||27||
48455111|NCT00525031|101449816|FG001|STARTED|Overall Study||25||
48455112|NCT00525031|101449815|FG000|COMPLETED|Overall Study||26||
48455113|NCT00525031|101449816|FG001|COMPLETED|Overall Study||24||
48455114|NCT00525031|101449815|FG000|NOT COMPLETED|Overall Study||1||
48455115|NCT00525031|101449816|FG001|NOT COMPLETED|Overall Study||1||
48455116|NCT01975090|101449817|FG000|STARTED|Overall Study||129||
48455117|NCT01975090|101449817|FG000|6-month Follow-up|Overall Study||117||
48455118|NCT01975090|101449817|FG000|COMPLETED|Overall Study||117||
48455119|NCT01975090|101449817|FG000|NOT COMPLETED|Overall Study||12||
48455120|NCT03469271|101449818|FG000|STARTED|Overall Study||16||
48455121|NCT03469271|101449819|FG001|STARTED|Overall Study||15||
48455122|NCT03469271|101449820|FG002|STARTED|Overall Study||15||
48455123|NCT03469271|101449821|FG003|STARTED|Overall Study||17||
48455124|NCT03469271|101449818|FG000|COMPLETED|Overall Study||14||
48772687|NCT00790842|102232797|FG004|Began Treatment|Dose Level 1||0||
48772688|NCT00790842|102232798|FG005|Began Treatment|Dose Level 1||0||
48772689|NCT00790842|102232799|FG006|Began Treatment|Dose Level 1||0||
48772690|NCT00790842|102232800|FG007|Began Treatment|Dose Level 1||3||
48772691|NCT00790842|102232801|FG008|Began Treatment|Dose Level 1||0||
48455125|NCT03469271|101449819|FG001|COMPLETED|Overall Study||15||
48455126|NCT03469271|101449820|FG002|COMPLETED|Overall Study||15||
48455127|NCT03469271|101449821|FG003|COMPLETED|Overall Study||16||
48455128|NCT03469271|101449818|FG000|NOT COMPLETED|Overall Study||2||
48662727|NCT03766399|101959511|FG008|STARTED|Part 2a: MAD (Nebulized Inhalation)||0||
48662728|NCT03766399|101959512|FG009|STARTED|Part 2a: MAD (Nebulized Inhalation)||6||
48662729|NCT03766399|101959513|FG010|STARTED|Part 2a: MAD (Nebulized Inhalation)||6||
48772692|NCT00790842|102232802|FG009|Began Treatment|Dose Level 1||0||
48772693|NCT00790842|102232803|FG010|Began Treatment|Dose Level 1||0||
48772694|NCT00790842|102232793|FG000|COMPLETED|Dose Level 1||3|Treated until disease progression|
48455129|NCT03469271|101449819|FG001|NOT COMPLETED|Overall Study||0||
48455130|NCT03469271|101449820|FG002|NOT COMPLETED|Overall Study||0||
48455131|NCT03469271|101449821|FG003|NOT COMPLETED|Overall Study||1||
48455132|NCT01792284|101449822|FG000|STARTED|Lead-in Period||212||
48455133|NCT01792284|101449823|FG001|STARTED|Lead-in Period||0||
48455134|NCT01792284|101449824|FG002|STARTED|Lead-in Period||0||
48455135|NCT01792284|101449822|FG000|COMPLETED|Lead-in Period||182||
48662730|NCT03766399|101959514|FG011|STARTED|Part 2a: MAD (Nebulized Inhalation)||6||
48662731|NCT03766399|101959515|FG012|STARTED|Part 2a: MAD (Nebulized Inhalation)||0||
48662732|NCT03766399|101959516|FG013|STARTED|Part 2a: MAD (Nebulized Inhalation)||0||
48662733|NCT03766399|101959517|FG014|STARTED|Part 2a: MAD (Nebulized Inhalation)||0||
48662734|NCT03766399|101959518|FG015|STARTED|Part 2a: MAD (Nebulized Inhalation)||0||
48662735|NCT03766399|101959519|FG016|STARTED|Part 2a: MAD (Nebulized Inhalation)||0||
48662736|NCT03766399|101959520|FG017|STARTED|Part 2a: MAD (Nebulized Inhalation)||0||
48662737|NCT03766399|101959503|FG000|COMPLETED|Part 2a: MAD (Nebulized Inhalation)||0||
48662738|NCT03766399|101959504|FG001|COMPLETED|Part 2a: MAD (Nebulized Inhalation)||0||
48662739|NCT03766399|101959505|FG002|COMPLETED|Part 2a: MAD (Nebulized Inhalation)||0||
48662740|NCT03766399|101959506|FG003|COMPLETED|Part 2a: MAD (Nebulized Inhalation)||0||
48455136|NCT01792284|101449823|FG001|COMPLETED|Lead-in Period||0||
48455137|NCT01792284|101449824|FG002|COMPLETED|Lead-in Period||0||
48455138|NCT01792284|101449822|FG000|NOT COMPLETED|Lead-in Period||30||
48455139|NCT01792284|101449823|FG001|NOT COMPLETED|Lead-in Period||0||
48455140|NCT01792284|101449824|FG002|NOT COMPLETED|Lead-in Period||0||
48455141|NCT01792284|101449822|FG000|STARTED|Randomization Period 1||0||
48455142|NCT01792284|101449823|FG001|STARTED|Randomization Period 1||92||
48455143|NCT01792284|101449824|FG002|STARTED|Randomization Period 1||90||
48455144|NCT01792284|101449822|FG000|Received at Least 1 Dose of Study Drug|Randomization Period 1||0||
48455145|NCT01792284|101449823|FG001|Received at Least 1 Dose of Study Drug|Randomization Period 1||92||
48455146|NCT01792284|101449824|FG002|Received at Least 1 Dose of Study Drug|Randomization Period 1||90||
48455147|NCT01792284|101449822|FG000|COMPLETED|Randomization Period 1||0||
48662741|NCT03766399|101959507|FG004|COMPLETED|Part 2a: MAD (Nebulized Inhalation)||0||
48662742|NCT03766399|101959508|FG005|COMPLETED|Part 2a: MAD (Nebulized Inhalation)||0||
48662743|NCT03766399|101959509|FG006|COMPLETED|Part 2a: MAD (Nebulized Inhalation)||0||
48662744|NCT03766399|101959510|FG007|COMPLETED|Part 2a: MAD (Nebulized Inhalation)||0||
48662745|NCT03766399|101959511|FG008|COMPLETED|Part 2a: MAD (Nebulized Inhalation)||0||
48662746|NCT03766399|101959512|FG009|COMPLETED|Part 2a: MAD (Nebulized Inhalation)||0||
48455148|NCT01792284|101449823|FG001|COMPLETED|Randomization Period 1||90||
48455149|NCT01792284|101449824|FG002|COMPLETED|Randomization Period 1||85||
48455150|NCT01792284|101449822|FG000|NOT COMPLETED|Randomization Period 1||0||
48455151|NCT01792284|101449823|FG001|NOT COMPLETED|Randomization Period 1||2||
48455152|NCT01792284|101449824|FG002|NOT COMPLETED|Randomization Period 1||5||
48455153|NCT01792284|101449822|FG000|STARTED|Randomization Period 2||0||
48455154|NCT01792284|101449823|FG001|STARTED|Randomization Period 2||90||
48455155|NCT01792284|101449824|FG002|STARTED|Randomization Period 2||85||
48455156|NCT01792284|101449822|FG000|Received at Least 1 Dose of Study Drug|Randomization Period 2||0||
48455157|NCT01792284|101449823|FG001|Received at Least 1 Dose of Study Drug|Randomization Period 2||90||
48455158|NCT01792284|101449824|FG002|Received at Least 1 Dose of Study Drug|Randomization Period 2||85||
48455159|NCT01792284|101449822|FG000|COMPLETED|Randomization Period 2||0||
48455160|NCT01792284|101449823|FG001|COMPLETED|Randomization Period 2||87||
48455161|NCT01792284|101449824|FG002|COMPLETED|Randomization Period 2||85||
48455162|NCT01792284|101449822|FG000|NOT COMPLETED|Randomization Period 2||0||
48455163|NCT01792284|101449823|FG001|NOT COMPLETED|Randomization Period 2||3||
48455164|NCT01792284|101449824|FG002|NOT COMPLETED|Randomization Period 2||0||
48662747|NCT03766399|101959513|FG010|COMPLETED|Part 2a: MAD (Nebulized Inhalation)||0||
48662748|NCT03766399|101959514|FG011|COMPLETED|Part 2a: MAD (Nebulized Inhalation)||0||
48662749|NCT03766399|101959515|FG012|COMPLETED|Part 2a: MAD (Nebulized Inhalation)||0||
48662750|NCT03766399|101959516|FG013|COMPLETED|Part 2a: MAD (Nebulized Inhalation)||0||
48662751|NCT03766399|101959517|FG014|COMPLETED|Part 2a: MAD (Nebulized Inhalation)||0||
48662752|NCT03766399|101959518|FG015|COMPLETED|Part 2a: MAD (Nebulized Inhalation)||0||
48662753|NCT03766399|101959519|FG016|COMPLETED|Part 2a: MAD (Nebulized Inhalation)||0||
48662754|NCT03766399|101959520|FG017|COMPLETED|Part 2a: MAD (Nebulized Inhalation)||0||
48662755|NCT03766399|101959503|FG000|NOT COMPLETED|Part 2a: MAD (Nebulized Inhalation)||0||
48772695|NCT00790842|102232794|FG001|COMPLETED|Dose Level 1||0|Treated until disease progression|
48455165|NCT03119064|101449825|FG000|STARTED|Overall Study||9||
48455166|NCT03119064|101449826|FG001|STARTED|Overall Study||3||
48455167|NCT03119064|101449827|FG002|STARTED|Overall Study||0||
48455168|NCT03119064|101449825|FG000|COMPLETED|Overall Study||9||
48455169|NCT03119064|101449826|FG001|COMPLETED|Overall Study||3||
48455170|NCT03119064|101449827|FG002|COMPLETED|Overall Study||0||
48455171|NCT03119064|101449825|FG000|NOT COMPLETED|Overall Study||0||
48455172|NCT03119064|101449826|FG001|NOT COMPLETED|Overall Study||0||
48455173|NCT03119064|101449827|FG002|NOT COMPLETED|Overall Study||0||
48455174|NCT00707174|101449828|FG000|STARTED|Overall Study||46||
48455175|NCT00707174|101449829|FG001|STARTED|Overall Study||44||
48662756|NCT03766399|101959504|FG001|NOT COMPLETED|Part 2a: MAD (Nebulized Inhalation)||0||
48662757|NCT03766399|101959505|FG002|NOT COMPLETED|Part 2a: MAD (Nebulized Inhalation)||0||
48662758|NCT03766399|101959506|FG003|NOT COMPLETED|Part 2a: MAD (Nebulized Inhalation)||0||
48662759|NCT03766399|101959507|FG004|NOT COMPLETED|Part 2a: MAD (Nebulized Inhalation)||0||
48662760|NCT03766399|101959508|FG005|NOT COMPLETED|Part 2a: MAD (Nebulized Inhalation)||0||
48662761|NCT03766399|101959509|FG006|NOT COMPLETED|Part 2a: MAD (Nebulized Inhalation)||0||
48662762|NCT03766399|101959510|FG007|NOT COMPLETED|Part 2a: MAD (Nebulized Inhalation)||0||
48662763|NCT03766399|101959511|FG008|NOT COMPLETED|Part 2a: MAD (Nebulized Inhalation)||0||
48455176|NCT00707174|101449828|FG000|COMPLETED|Overall Study||41||
48455177|NCT00707174|101449829|FG001|COMPLETED|Overall Study||37||
48455178|NCT00707174|101449828|FG000|NOT COMPLETED|Overall Study||5||
48455179|NCT00707174|101449829|FG001|NOT COMPLETED|Overall Study||7||
48455180|NCT01716754|101449830|FG000|STARTED|Overall Study||199||
48455181|NCT01716754|101449831|FG001|STARTED|Overall Study||40||
48455182|NCT01716754|101449832|FG002|STARTED|Overall Study||135||
48455183|NCT01716754|101449833|FG003|STARTED|Overall Study||97||
48455184|NCT01716754|101449830|FG000|FAS|Overall Study||199||
48455185|NCT01716754|101449831|FG001|FAS|Overall Study||40||
48455186|NCT01716754|101449832|FG002|FAS|Overall Study||131||
48455187|NCT01716754|101449833|FG003|FAS|Overall Study||96||
48455188|NCT01716754|101449830|FG000|Safety Set|Overall Study||199||
48455189|NCT01716754|101449831|FG001|Safety Set|Overall Study||40||
48455190|NCT01716754|101449832|FG002|Safety Set|Overall Study||131||
48455191|NCT01716754|101449833|FG003|Safety Set|Overall Study||96||
48455192|NCT01716754|101449830|FG000|COMPLETED|Overall Study||188||
48455193|NCT01716754|101449831|FG001|COMPLETED|Overall Study||36||
48455194|NCT01716754|101449832|FG002|COMPLETED|Overall Study||121||
48455195|NCT01716754|101449833|FG003|COMPLETED|Overall Study||89||
48455196|NCT01716754|101449830|FG000|NOT COMPLETED|Overall Study||11||
48455197|NCT01716754|101449831|FG001|NOT COMPLETED|Overall Study||4||
48455198|NCT01716754|101449832|FG002|NOT COMPLETED|Overall Study||14||
48455199|NCT01716754|101449833|FG003|NOT COMPLETED|Overall Study||8||
48455200|NCT04304950|101449834|FG000|STARTED|Overall Study||19||
48455201|NCT04304950|101449835|FG001|STARTED|Overall Study||9||
48455202|NCT04304950|101449834|FG000|COMPLETED|Overall Study||18||
48455203|NCT04304950|101449835|FG001|COMPLETED|Overall Study||8||
48455204|NCT04304950|101449834|FG000|NOT COMPLETED|Overall Study||1||
48455205|NCT04304950|101449835|FG001|NOT COMPLETED|Overall Study||1||
48455206|NCT02196506|101449836|FG000|STARTED|Phase A||837||
48455207|NCT02196506|101449837|FG001|STARTED|Phase A||0||
48662764|NCT03766399|101959512|FG009|NOT COMPLETED|Part 2a: MAD (Nebulized Inhalation)||6||
48189226|NCT02395185|100786181|FG000|Sequence 4 (m,w,w,s,s,m)|Overall Study||2||
48455208|NCT02196506|101449838|FG002|STARTED|Phase A||0||
48455209|NCT02196506|101449839|FG003|STARTED|Phase A||0||
48455210|NCT02196506|101449836|FG000|COMPLETED|Phase A||716||
48455211|NCT02196506|101449837|FG001|COMPLETED|Phase A||0||
48455212|NCT02196506|101449838|FG002|COMPLETED|Phase A||0||
48455213|NCT02196506|101449839|FG003|COMPLETED|Phase A||0||
48455214|NCT02196506|101449836|FG000|NOT COMPLETED|Phase A||121||
48455215|NCT02196506|101449837|FG001|NOT COMPLETED|Phase A||0||
48455216|NCT02196506|101449838|FG002|NOT COMPLETED|Phase A||0||
48455217|NCT02196506|101449839|FG003|NOT COMPLETED|Phase A||0||
48455218|NCT02196506|101449836|FG000|STARTED|Phase B||0||
48455219|NCT02196506|101449837|FG001|STARTED|Phase B||192||
48455220|NCT02196506|101449838|FG002|STARTED|Phase B||202||
48455221|NCT02196506|101449839|FG003|STARTED|Phase B||0||
48455222|NCT02196506|101449836|FG000|COMPLETED|Phase B||0||
48455223|NCT02196506|101449837|FG001|COMPLETED|Phase B||177||
48455224|NCT02196506|101449838|FG002|COMPLETED|Phase B||196||
48455225|NCT02196506|101449839|FG003|COMPLETED|Phase B||0||
48455226|NCT02196506|101449836|FG000|NOT COMPLETED|Phase B||0||
48455227|NCT02196506|101449837|FG001|NOT COMPLETED|Phase B||15||
48455228|NCT02196506|101449838|FG002|NOT COMPLETED|Phase B||6||
48455229|NCT02196506|101449839|FG003|NOT COMPLETED|Phase B||0||
48455230|NCT02196506|101449836|FG000|STARTED|Phase A+||0||
48455231|NCT02196506|101449837|FG001|STARTED|Phase A+||0||
48455232|NCT02196506|101449838|FG002|STARTED|Phase A+||0||
48455233|NCT02196506|101449839|FG003|STARTED|Phase A+||322||
48455234|NCT02196506|101449836|FG000|COMPLETED|Phase A+||0||
48455235|NCT02196506|101449837|FG001|COMPLETED|Phase A+||0||
48455236|NCT02196506|101449838|FG002|COMPLETED|Phase A+||0||
48455237|NCT02196506|101449839|FG003|COMPLETED|Phase A+||308||
48455238|NCT02196506|101449836|FG000|NOT COMPLETED|Phase A+||0||
48455239|NCT02196506|101449837|FG001|NOT COMPLETED|Phase A+||0||
48455240|NCT02196506|101449838|FG002|NOT COMPLETED|Phase A+||0||
48455241|NCT02196506|101449839|FG003|NOT COMPLETED|Phase A+||14||
48455242|NCT01965652|101449840|FG000|STARTED|Overall Study||623||
48455243|NCT01965652|101449841|FG001|STARTED|Overall Study||623||
48455244|NCT01965652|101449840|FG000|Received Treatment|Overall Study||622||
48455245|NCT01965652|101449841|FG001|Received Treatment|Overall Study||623||
48455246|NCT01965652|101449840|FG000|COMPLETED|Overall Study||413||
48455247|NCT01965652|101449841|FG001|COMPLETED|Overall Study||413||
48455248|NCT01965652|101449840|FG000|NOT COMPLETED|Overall Study||210||
48455249|NCT01965652|101449841|FG001|NOT COMPLETED|Overall Study||210||
48455250|NCT01042496|101449842|FG000|STARTED|Overall Study||29||
48455251|NCT01042496|101449843|FG001|STARTED|Overall Study||33||
48662765|NCT03766399|101959513|FG010|NOT COMPLETED|Part 2a: MAD (Nebulized Inhalation)||6||
48662766|NCT03766399|101959514|FG011|NOT COMPLETED|Part 2a: MAD (Nebulized Inhalation)||6||
48455252|NCT01042496|101449842|FG000|COMPLETED|Overall Study||29||
48455253|NCT01042496|101449843|FG001|COMPLETED|Overall Study||33||
48455254|NCT01042496|101449842|FG000|NOT COMPLETED|Overall Study||0||
48455255|NCT01042496|101449843|FG001|NOT COMPLETED|Overall Study||0||
48455256|NCT02102490|101449844|FG000|STARTED|Overall Study||132||
48455257|NCT02102490|101449844|FG000|Received at Least 1 Dose of Study Drug|Overall Study||132||
48455258|NCT02102490|101449844|FG000|COMPLETED|Overall Study||125||
48455259|NCT02102490|101449844|FG000|NOT COMPLETED|Overall Study||7||
48455260|NCT02033876|101449845|FG000|STARTED|Overall Study||12||
48455261|NCT02033876|101449846|FG001|STARTED|Overall Study||12||
48455262|NCT02033876|101449845|FG000|COMPLETED|Overall Study||12||
48455263|NCT02033876|101449846|FG001|COMPLETED|Overall Study||12||
48455264|NCT02033876|101449845|FG000|NOT COMPLETED|Overall Study||0||
48455265|NCT02033876|101449846|FG001|NOT COMPLETED|Overall Study||0||
48455266|NCT01872689|101449847|FG000|STARTED|Double-Blind/Placebo-Controlled Period||76||
48455267|NCT01872689|101449848|FG001|STARTED|Double-Blind/Placebo-Controlled Period||78||
48455268|NCT01872689|101449849|FG002|STARTED|Double-Blind/Placebo-Controlled Period||177||
48455269|NCT01872689|101449850|FG003|STARTED|Double-Blind/Placebo-Controlled Period||174||
48455270|NCT01872689|101449847|FG000|COMPLETED|Double-Blind/Placebo-Controlled Period||56||
48455271|NCT01872689|101449848|FG001|COMPLETED|Double-Blind/Placebo-Controlled Period||58||
48455272|NCT01872689|101449849|FG002|COMPLETED|Double-Blind/Placebo-Controlled Period||129||
48455273|NCT01872689|101449850|FG003|COMPLETED|Double-Blind/Placebo-Controlled Period||136||
48455274|NCT01872689|101449847|FG000|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||20||
48455275|NCT01872689|101449848|FG001|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||20||
48455276|NCT01872689|101449849|FG002|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||48||
48455277|NCT01872689|101449850|FG003|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||38||
48455278|NCT01872689|101449847|FG000|STARTED|Open-Label Period (Only For Monotherapy)||52||
48455279|NCT01872689|101449848|FG001|STARTED|Open-Label Period (Only For Monotherapy)||56||
48772696|NCT00790842|102232795|FG002|COMPLETED|Dose Level 1||0|Treated until disease progression|
48772697|NCT00790842|102232796|FG003|COMPLETED|Dose Level 1||1|Treated until disease progression|
48772698|NCT00790842|102232797|FG004|COMPLETED|Dose Level 1||0|Treated until disease progression|
48772699|NCT00790842|102232798|FG005|COMPLETED|Dose Level 1||0|Treated until disease progression|
48772700|NCT00790842|102232799|FG006|COMPLETED|Dose Level 1||0|Treated until disease progression|
48455280|NCT01872689|101449849|FG002|STARTED|Open-Label Period (Only For Monotherapy)||0||
48455281|NCT01872689|101449850|FG003|STARTED|Open-Label Period (Only For Monotherapy)||0||
48455282|NCT01872689|101449847|FG000|COMPLETED|Open-Label Period (Only For Monotherapy)||31||
48455283|NCT01872689|101449848|FG001|COMPLETED|Open-Label Period (Only For Monotherapy)||33||
48455284|NCT01872689|101449849|FG002|COMPLETED|Open-Label Period (Only For Monotherapy)||0||
48455285|NCT01872689|101449850|FG003|COMPLETED|Open-Label Period (Only For Monotherapy)||0||
48455286|NCT01872689|101449847|FG000|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||21||
48455287|NCT01872689|101449848|FG001|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||23||
48455288|NCT01872689|101449849|FG002|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||0||
48455289|NCT01872689|101449850|FG003|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||0||
48455290|NCT05723822|101449851|FG000|STARTED|Overall Study||12||
48455291|NCT05723822|101449851|FG000|COMPLETED|Overall Study||12||
48455292|NCT05723822|101449851|FG000|NOT COMPLETED|Overall Study||0||
48455293|NCT02151461|101453526|FG000|STARTED|Overall Study||24||
48455294|NCT02151461|101453527|FG001|STARTED|Overall Study||25||
48455295|NCT02151461|101453528|FG002|STARTED|Overall Study||24||
48455296|NCT02151461|101453529|FG003|STARTED|Overall Study||23||
48455297|NCT02151461|101453526|FG000|COMPLETED|Overall Study||18||
48455298|NCT02151461|101453527|FG001|COMPLETED|Overall Study||24||
48455299|NCT02151461|101453528|FG002|COMPLETED|Overall Study||21||
48455300|NCT02151461|101453529|FG003|COMPLETED|Overall Study||19||
48455301|NCT02151461|101453526|FG000|NOT COMPLETED|Overall Study||6||
48455302|NCT02151461|101453527|FG001|NOT COMPLETED|Overall Study||1||
48455303|NCT02151461|101453528|FG002|NOT COMPLETED|Overall Study||3||
48455304|NCT02151461|101453529|FG003|NOT COMPLETED|Overall Study||4||
48455305|NCT02273206|101453530|FG000|STARTED|Overall Study||378||
48455306|NCT02273206|101453531|FG001|STARTED|Overall Study||379||
48455307|NCT02273206|101453530|FG000|COMPLETED|Overall Study||353||
48455308|NCT02273206|101453531|FG001|COMPLETED|Overall Study||337||
48455309|NCT02273206|101453530|FG000|NOT COMPLETED|Overall Study||25||
48455310|NCT02273206|101453531|FG001|NOT COMPLETED|Overall Study||42||
48455311|NCT04214951|101453532|FG000|STARTED|Overall Study||50||
48455312|NCT04214951|101453533|FG001|STARTED|Overall Study||50||
48455313|NCT04214951|101453532|FG000|COMPLETED|Overall Study||10||
48455314|NCT04214951|101453533|FG001|COMPLETED|Overall Study||10||
48455315|NCT04214951|101453532|FG000|NOT COMPLETED|Overall Study||40||
48455316|NCT04214951|101453533|FG001|NOT COMPLETED|Overall Study||40||
48455317|NCT02685956|101453534|FG000|STARTED|Overall Study||317||
48455318|NCT02685956|101453535|FG001|STARTED|Overall Study||1978||
48455319|NCT02685956|101453534|FG000|COMPLETED|Overall Study||317||
48455320|NCT02685956|101453535|FG001|COMPLETED|Overall Study||1978||
48455321|NCT02685956|101453534|FG000|NOT COMPLETED|Overall Study||0||
48455322|NCT02685956|101453535|FG001|NOT COMPLETED|Overall Study||0||
48455323|NCT01170260|101453536|FG000|STARTED|Overall Study||143||
48455324|NCT01170260|101453537|FG001|STARTED|Overall Study||155||
48455325|NCT01170260|101453538|FG002|STARTED|Overall Study||162||
48455326|NCT01170260|101453536|FG000|COMPLETED|Overall Study||143||
48455327|NCT01170260|101453537|FG001|COMPLETED|Overall Study||155||
48455328|NCT01170260|101453538|FG002|COMPLETED|Overall Study||162||
48455329|NCT01170260|101453536|FG000|NOT COMPLETED|Overall Study||0||
48455330|NCT01170260|101453537|FG001|NOT COMPLETED|Overall Study||0||
48455331|NCT01170260|101453538|FG002|NOT COMPLETED|Overall Study||0||
48455332|NCT02629133|101453539|FG000|STARTED|Overall Study||25||
48455333|NCT02629133|101453540|FG001|STARTED|Overall Study||25||
48455334|NCT02629133|101453539|FG000|COMPLETED|Overall Study||21||
48662767|NCT03766399|101959515|FG012|NOT COMPLETED|Part 2a: MAD (Nebulized Inhalation)||0||
48662768|NCT03766399|101959516|FG013|NOT COMPLETED|Part 2a: MAD (Nebulized Inhalation)||0||
48662769|NCT03766399|101959517|FG014|NOT COMPLETED|Part 2a: MAD (Nebulized Inhalation)||0||
48772701|NCT00790842|102232800|FG007|COMPLETED|Dose Level 1||1|Treated until disease progression|
48772702|NCT00790842|102232801|FG008|COMPLETED|Dose Level 1||0|Treated until disease progression|
48772703|NCT00790842|102232802|FG009|COMPLETED|Dose Level 1||0|Treated until disease progression|
48772704|NCT00790842|102232803|FG010|COMPLETED|Dose Level 1||0|Treated until disease progression|
48772705|NCT00790842|102232793|FG000|NOT COMPLETED|Dose Level 1||3||
48772706|NCT00790842|102232794|FG001|NOT COMPLETED|Dose Level 1||0||
48772707|NCT00790842|102232795|FG002|NOT COMPLETED|Dose Level 1||0||
48772708|NCT00790842|102232796|FG003|NOT COMPLETED|Dose Level 1||2||
48772709|NCT00790842|102232797|FG004|NOT COMPLETED|Dose Level 1||0||
48772710|NCT00790842|102232798|FG005|NOT COMPLETED|Dose Level 1||0||
48772711|NCT00790842|102232799|FG006|NOT COMPLETED|Dose Level 1||0||
48772712|NCT00790842|102232800|FG007|NOT COMPLETED|Dose Level 1||2||
48772713|NCT00790842|102232801|FG008|NOT COMPLETED|Dose Level 1||0||
48772714|NCT00790842|102232802|FG009|NOT COMPLETED|Dose Level 1||0||
48772715|NCT00790842|102232803|FG010|NOT COMPLETED|Dose Level 1||0||
48772716|NCT00790842|102232793|FG000|STARTED|Dose Level 2||0||
48772717|NCT00790842|102232794|FG001|STARTED|Dose Level 2||3||
48772718|NCT00790842|102232795|FG002|STARTED|Dose Level 2||0||
48772719|NCT00790842|102232796|FG003|STARTED|Dose Level 2||0||
48772720|NCT00790842|102232797|FG004|STARTED|Dose Level 2||3||
48772721|NCT00790842|102232798|FG005|STARTED|Dose Level 2||0||
48772722|NCT00790842|102232799|FG006|STARTED|Dose Level 2||0||
48772723|NCT00790842|102232800|FG007|STARTED|Dose Level 2||0||
48772724|NCT00790842|102232801|FG008|STARTED|Dose Level 2||3||
48772725|NCT00790842|102232802|FG009|STARTED|Dose Level 2||0||
48772726|NCT00790842|102232803|FG010|STARTED|Dose Level 2||0||
48772727|NCT00790842|102232793|FG000|Began Treatment|Dose Level 2||0||
48772728|NCT00790842|102232794|FG001|Began Treatment|Dose Level 2||3||
48772729|NCT00790842|102232795|FG002|Began Treatment|Dose Level 2||0||
48772730|NCT00790842|102232796|FG003|Began Treatment|Dose Level 2||0||
48772731|NCT00790842|102232797|FG004|Began Treatment|Dose Level 2||3||
48772732|NCT00790842|102232798|FG005|Began Treatment|Dose Level 2||0||
48455335|NCT02629133|101453540|FG001|COMPLETED|Overall Study||23||
48455336|NCT02629133|101453539|FG000|NOT COMPLETED|Overall Study||4||
48455337|NCT02629133|101453540|FG001|NOT COMPLETED|Overall Study||2||
48455338|NCT03563027|101453541|FG000|STARTED|Overall Study||60||
48455339|NCT03563027|101453542|FG001|STARTED|Overall Study||60||
48455340|NCT03563027|101453543|FG002|STARTED|Overall Study||60||
48455341|NCT03563027|101453541|FG000|COMPLETED|Overall Study||60||
48455342|NCT03563027|101453542|FG001|COMPLETED|Overall Study||60||
48455343|NCT03563027|101453543|FG002|COMPLETED|Overall Study||58||
48455344|NCT03563027|101453541|FG000|NOT COMPLETED|Overall Study||0||
48455345|NCT03563027|101453542|FG001|NOT COMPLETED|Overall Study||0||
48455346|NCT03563027|101453543|FG002|NOT COMPLETED|Overall Study||2||
48455347|NCT01862328|101453544|FG000|STARTED|Overall Study||4||
48455348|NCT01862328|101453545|FG001|STARTED|Overall Study||18||
48455349|NCT01862328|101453546|FG002|STARTED|Overall Study||6||
48772733|NCT00790842|102232799|FG006|Began Treatment|Dose Level 2||0||
48772734|NCT00790842|102232800|FG007|Began Treatment|Dose Level 2||0||
48772735|NCT00790842|102232801|FG008|Began Treatment|Dose Level 2||3||
48772736|NCT00790842|102232802|FG009|Began Treatment|Dose Level 2||0||
48772737|NCT00790842|102232803|FG010|Began Treatment|Dose Level 2||0||
48772738|NCT00790842|102232793|FG000|COMPLETED|Dose Level 2||0||
48772739|NCT00790842|102232794|FG001|COMPLETED|Dose Level 2||0||
48455350|NCT01862328|101453547|FG003|STARTED|Overall Study||7||
48455351|NCT01862328|101453548|FG004|STARTED|Overall Study||12||
48455352|NCT01862328|101453549|FG005|STARTED|Overall Study||7||
48455353|NCT01862328|101453550|FG006|STARTED|Overall Study||10||
48455354|NCT01862328|101453544|FG000|COMPLETED|Overall Study||0||
48455355|NCT01862328|101453545|FG001|COMPLETED|Overall Study||0||
48455356|NCT01862328|101453546|FG002|COMPLETED|Overall Study||0||
48772740|NCT00790842|102232795|FG002|COMPLETED|Dose Level 2||0||
48455357|NCT01862328|101453547|FG003|COMPLETED|Overall Study||0||
48455358|NCT01862328|101453548|FG004|COMPLETED|Overall Study||0||
48455359|NCT01862328|101453549|FG005|COMPLETED|Overall Study||0||
48455360|NCT01862328|101453550|FG006|COMPLETED|Overall Study||0||
48662770|NCT03766399|101959518|FG015|NOT COMPLETED|Part 2a: MAD (Nebulized Inhalation)||0||
48662771|NCT03766399|101959519|FG016|NOT COMPLETED|Part 2a: MAD (Nebulized Inhalation)||0||
48662772|NCT03766399|101959520|FG017|NOT COMPLETED|Part 2a: MAD (Nebulized Inhalation)||0||
48662773|NCT03766399|101959503|FG000|STARTED|Part 2b: MAD (Nebulized Inhalation)||0||
48662774|NCT03766399|101959504|FG001|STARTED|Part 2b: MAD (Nebulized Inhalation)||0||
48772741|NCT00790842|102232796|FG003|COMPLETED|Dose Level 2||0||
48772742|NCT00790842|102232797|FG004|COMPLETED|Dose Level 2||2||
48772743|NCT00790842|102232798|FG005|COMPLETED|Dose Level 2||0||
48455361|NCT01862328|101453544|FG000|NOT COMPLETED|Overall Study||4||
48455362|NCT01862328|101453545|FG001|NOT COMPLETED|Overall Study||18||
48455363|NCT01862328|101453546|FG002|NOT COMPLETED|Overall Study||6||
48455364|NCT01862328|101453547|FG003|NOT COMPLETED|Overall Study||7||
48455365|NCT01862328|101453548|FG004|NOT COMPLETED|Overall Study||12||
48455366|NCT01862328|101453549|FG005|NOT COMPLETED|Overall Study||7||
48455367|NCT01862328|101453550|FG006|NOT COMPLETED|Overall Study||10||
48455368|NCT04363736|101453551|FG000|STARTED|Overall Study||49||
48455369|NCT04363736|101453552|FG001|STARTED|Overall Study||48||
48455370|NCT04363736|101453551|FG000|COMPLETED|Overall Study||30||
48455371|NCT04363736|101453552|FG001|COMPLETED|Overall Study||35||
48455372|NCT04363736|101453551|FG000|NOT COMPLETED|Overall Study||19||
48455373|NCT04363736|101453552|FG001|NOT COMPLETED|Overall Study||13||
48455374|NCT02418910|101453553|FG000|STARTED|Overall Study||50||
48455375|NCT02418910|101453553|FG000|COMPLETED|Overall Study||43||
48455376|NCT02418910|101453553|FG000|NOT COMPLETED|Overall Study||7||
48455377|NCT00580983|101453554|FG000|STARTED|Overall Study||80||
48455378|NCT00580983|101453554|FG000|COMPLETED|Overall Study||73||
48455379|NCT00580983|101453554|FG000|NOT COMPLETED|Overall Study||7||
48455380|NCT02791659|101453555|FG000|STARTED|Overall Study||27||
48455381|NCT02791659|101453556|FG001|STARTED|Overall Study||28||
48455382|NCT02791659|101453555|FG000|COMPLETED|Overall Study||27||
48455383|NCT02791659|101453556|FG001|COMPLETED|Overall Study||27||
48455384|NCT02791659|101453555|FG000|NOT COMPLETED|Overall Study||0||
48455385|NCT02791659|101453556|FG001|NOT COMPLETED|Overall Study||1||
48455386|NCT00660790|101453557|FG000|STARTED|Baseline to 3 Months||97||
48455387|NCT00660790|101453557|FG000|COMPLETED|Baseline to 3 Months||94||
48455388|NCT00660790|101453557|FG000|NOT COMPLETED|Baseline to 3 Months||3||
48455389|NCT00660790|101453557|FG000|STARTED|3 Months to 2 Years||94||
48455390|NCT00660790|101453557|FG000|COMPLETED|3 Months to 2 Years||77||
48455391|NCT00660790|101453557|FG000|NOT COMPLETED|3 Months to 2 Years||17||
48455392|NCT00830063|101453558|FG000|STARTED|Overall Study||208||
48455393|NCT00830063|101453559|FG001|STARTED|Overall Study||208||
48455394|NCT00830063|101453560|FG002|STARTED|Overall Study||208||
48455395|NCT00830063|101453561|FG003|STARTED|Overall Study||208||
48455396|NCT00830063|101453558|FG000|Treated|Overall Study||208||
48455397|NCT00830063|101453559|FG001|Treated|Overall Study||206||
48455398|NCT00830063|101453560|FG002|Treated|Overall Study||208||
48455399|NCT00830063|101453561|FG003|Treated|Overall Study||206||
48455400|NCT00830063|101453558|FG000|COMPLETED|Overall Study||8||
48455401|NCT00830063|101453559|FG001|COMPLETED|Overall Study||16||
48455402|NCT00830063|101453560|FG002|COMPLETED|Overall Study||10||
48455403|NCT00830063|101453561|FG003|COMPLETED|Overall Study||13||
48455404|NCT00830063|101453558|FG000|NOT COMPLETED|Overall Study||200||
48455405|NCT00830063|101453559|FG001|NOT COMPLETED|Overall Study||192||
48455406|NCT00830063|101453560|FG002|NOT COMPLETED|Overall Study||198||
48455407|NCT00830063|101453561|FG003|NOT COMPLETED|Overall Study||195||
48455408|NCT02971605|101453562|FG000|STARTED|Overall Study||13||
48455409|NCT02971605|101453562|FG000|COMPLETED|Overall Study||12||
48455410|NCT02971605|101453562|FG000|NOT COMPLETED|Overall Study||1||
48455411|NCT04409002|101453563|FG000|STARTED|Overall Study||18||
48455412|NCT04409002|101453563|FG000|COMPLETED|Overall Study||15||
48455413|NCT04409002|101453563|FG000|NOT COMPLETED|Overall Study||3||
48455414|NCT00461500|101453564|FG000|STARTED|Overall Study||37||
48455415|NCT00461500|101453565|FG001|STARTED|Overall Study||44||
48455416|NCT00461500|101453564|FG000|COMPLETED|Overall Study||30||
48455417|NCT00461500|101453565|FG001|COMPLETED|Overall Study||38||
48455418|NCT00461500|101453564|FG000|NOT COMPLETED|Overall Study||7||
48455419|NCT00461500|101453565|FG001|NOT COMPLETED|Overall Study||6||
48455420|NCT01614613|101453566|FG000|STARTED|Overall Study||146||
48455421|NCT01614613|101453566|FG000|COMPLETED|Overall Study||146||
48455422|NCT01614613|101453566|FG000|NOT COMPLETED|Overall Study||0||
48455423|NCT02370784|101453567|FG000|STARTED|Overall Study||10||
48455424|NCT02370784|101453568|FG001|STARTED|Overall Study||14||
48455425|NCT02370784|101453567|FG000|COMPLETED|Overall Study||10||
48455426|NCT02370784|101453568|FG001|COMPLETED|Overall Study||13||
48455427|NCT02370784|101453567|FG000|NOT COMPLETED|Overall Study||0||
48455428|NCT02370784|101453568|FG001|NOT COMPLETED|Overall Study||1||
48455429|NCT01698320|101453569|FG000|STARTED|Run-In Period (Week -1 to Day 0)||364||
48455430|NCT01698320|101453570|FG001|STARTED|Run-In Period (Week -1 to Day 0)||0||
48455431|NCT01698320|101453571|FG002|STARTED|Run-In Period (Week -1 to Day 0)||0||
48772744|NCT00790842|102232799|FG006|COMPLETED|Dose Level 2||0||
48455432|NCT01698320|101453569|FG000|COMPLETED|Run-In Period (Week -1 to Day 0)||337||
48455433|NCT01698320|101453570|FG001|COMPLETED|Run-In Period (Week -1 to Day 0)||0||
48455434|NCT01698320|101453571|FG002|COMPLETED|Run-In Period (Week -1 to Day 0)||0||
48455435|NCT01698320|101453569|FG000|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||27||
48455436|NCT01698320|101453570|FG001|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0||
48455437|NCT01698320|101453571|FG002|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0||
48455438|NCT01698320|101453569|FG000|STARTED|12-Week Double-Blind Period||0||
48455439|NCT01698320|101453570|FG001|STARTED|12-Week Double-Blind Period||169||
48455440|NCT01698320|101453571|FG002|STARTED|12-Week Double-Blind Period||168||
48455441|NCT01698320|101453569|FG000|Safety Population|12-Week Double-Blind Period||0||
48455442|NCT01698320|101453570|FG001|Safety Population|12-Week Double-Blind Period||170||
48455443|NCT01698320|101453571|FG002|Safety Population|12-Week Double-Blind Period||168||
48455444|NCT01698320|101453569|FG000|COMPLETED|12-Week Double-Blind Period||0||
48455445|NCT01698320|101453570|FG001|COMPLETED|12-Week Double-Blind Period||165||
48455446|NCT01698320|101453571|FG002|COMPLETED|12-Week Double-Blind Period||156||
48455447|NCT01698320|101453569|FG000|NOT COMPLETED|12-Week Double-Blind Period||0||
48455448|NCT01698320|101453570|FG001|NOT COMPLETED|12-Week Double-Blind Period||4||
48455449|NCT01698320|101453571|FG002|NOT COMPLETED|12-Week Double-Blind Period||12||
48455450|NCT01698320|101453569|FG000|STARTED|40-Week Open-Label Period||0||
48455451|NCT01698320|101453570|FG001|STARTED|40-Week Open-Label Period||165||
48455452|NCT01698320|101453571|FG002|STARTED|40-Week Open-Label Period||156||
48455453|NCT01698320|101453569|FG000|COMPLETED|40-Week Open-Label Period||0||
48455454|NCT01698320|101453570|FG001|COMPLETED|40-Week Open-Label Period||146||
48455455|NCT01698320|101453571|FG002|COMPLETED|40-Week Open-Label Period||146||
48455456|NCT01698320|101453569|FG000|NOT COMPLETED|40-Week Open-Label Period||0||
48455457|NCT01698320|101453570|FG001|NOT COMPLETED|40-Week Open-Label Period||19||
48455458|NCT01698320|101453571|FG002|NOT COMPLETED|40-Week Open-Label Period||10||
48455459|NCT00686374|101453572|FG000|STARTED|Overall Study||100||
48455460|NCT00686374|101453572|FG000|COMPLETED|Overall Study||39||
48455461|NCT00686374|101453572|FG000|NOT COMPLETED|Overall Study||61||
48455462|NCT01956279|101453573|FG000|STARTED|Overall Study||82||
48455463|NCT01956279|101453574|FG001|STARTED|Overall Study||88||
48455464|NCT01956279|101453573|FG000|COMPLETED|Overall Study||68||
48455465|NCT01956279|101453574|FG001|COMPLETED|Overall Study||74||
48455466|NCT01956279|101453573|FG000|NOT COMPLETED|Overall Study||14||
48455467|NCT01956279|101453574|FG001|NOT COMPLETED|Overall Study||14||
48455468|NCT00401882|101453575|FG000|STARTED|Overall Study||2||
48455469|NCT00401882|101453576|FG001|STARTED|Overall Study||5||
48455470|NCT00401882|101453575|FG000|COMPLETED|Overall Study||2||
48455471|NCT00401882|101453576|FG001|COMPLETED|Overall Study||5||
48455472|NCT00401882|101453575|FG000|NOT COMPLETED|Overall Study||0||
48455473|NCT00401882|101453576|FG001|NOT COMPLETED|Overall Study||0||
48455474|NCT00437281|101453577|FG000|STARTED|Overall Study||3||
48455475|NCT00437281|101453578|FG001|STARTED|Overall Study||3||
48455476|NCT00437281|101453579|FG002|STARTED|Overall Study||3||
48455477|NCT00437281|101453580|FG003|STARTED|Overall Study||3||
48455478|NCT00437281|101453581|FG004|STARTED|Overall Study||4||
48455479|NCT00437281|101453582|FG005|STARTED|Overall Study||4||
48455480|NCT00437281|101453583|FG006|STARTED|Overall Study||3||
48455481|NCT00437281|101453584|FG007|STARTED|Overall Study||3||
48455482|NCT00437281|101453585|FG008|STARTED|Overall Study||3||
48455483|NCT00437281|101453586|FG009|STARTED|Overall Study||5||
48455484|NCT00437281|101453587|FG010|STARTED|Overall Study||3||
48455485|NCT00437281|101453588|FG011|STARTED|Overall Study||3||
48455486|NCT00437281|101453589|FG012|STARTED|Overall Study||2||
48455487|NCT00437281|101453590|FG013|STARTED|Overall Study||3||
48455488|NCT00437281|101453591|FG014|STARTED|Overall Study||5||
48455489|NCT00437281|101453592|FG015|STARTED|Overall Study||3||
48455490|NCT00437281|101453593|FG016|STARTED|Overall Study||3||
48662775|NCT03766399|101959505|FG002|STARTED|Part 2b: MAD (Nebulized Inhalation)||0||
48662776|NCT03766399|101959506|FG003|STARTED|Part 2b: MAD (Nebulized Inhalation)||0||
48662777|NCT03766399|101959507|FG004|STARTED|Part 2b: MAD (Nebulized Inhalation)||0||
48662778|NCT03766399|101959508|FG005|STARTED|Part 2b: MAD (Nebulized Inhalation)||0||
48662779|NCT03766399|101959509|FG006|STARTED|Part 2b: MAD (Nebulized Inhalation)||0||
48662780|NCT03766399|101959510|FG007|STARTED|Part 2b: MAD (Nebulized Inhalation)||0||
48662781|NCT03766399|101959511|FG008|STARTED|Part 2b: MAD (Nebulized Inhalation)||0||
48662782|NCT03766399|101959512|FG009|STARTED|Part 2b: MAD (Nebulized Inhalation)||0||
48662783|NCT03766399|101959513|FG010|STARTED|Part 2b: MAD (Nebulized Inhalation)||0||
48662784|NCT03766399|101959514|FG011|STARTED|Part 2b: MAD (Nebulized Inhalation)||0||
48772745|NCT00790842|102232800|FG007|COMPLETED|Dose Level 2||0||
48772746|NCT00790842|102232801|FG008|COMPLETED|Dose Level 2||1||
48772747|NCT00790842|102232802|FG009|COMPLETED|Dose Level 2||0||
48455491|NCT00437281|101453594|FG017|STARTED|Overall Study||4||
48455492|NCT00437281|101453595|FG018|STARTED|Overall Study||2||
48455493|NCT00437281|101453596|FG019|STARTED|Overall Study||3||
48455494|NCT00437281|101453577|FG000|COMPLETED|Overall Study||3||
48455495|NCT00437281|101453578|FG001|COMPLETED|Overall Study||3||
48662785|NCT03766399|101959515|FG012|STARTED|Part 2b: MAD (Nebulized Inhalation)||2||
48662786|NCT03766399|101959516|FG013|STARTED|Part 2b: MAD (Nebulized Inhalation)||7||
48662787|NCT03766399|101959517|FG014|STARTED|Part 2b: MAD (Nebulized Inhalation)||0||
48662788|NCT03766399|101959518|FG015|STARTED|Part 2b: MAD (Nebulized Inhalation)||0||
48662789|NCT03766399|101959519|FG016|STARTED|Part 2b: MAD (Nebulized Inhalation)||0||
48662790|NCT03766399|101959520|FG017|STARTED|Part 2b: MAD (Nebulized Inhalation)||0||
48670051|NCT05757193|101974878|FG001|NOT COMPLETED|Overall Study||0||
48455496|NCT00437281|101453579|FG002|COMPLETED|Overall Study||3||
48455497|NCT00437281|101453580|FG003|COMPLETED|Overall Study||2||
48455498|NCT00437281|101453581|FG004|COMPLETED|Overall Study||4||
48455499|NCT00437281|101453582|FG005|COMPLETED|Overall Study||3||
48455500|NCT00437281|101453583|FG006|COMPLETED|Overall Study||3||
48455501|NCT00437281|101453584|FG007|COMPLETED|Overall Study||3||
48455502|NCT00437281|101453585|FG008|COMPLETED|Overall Study||3||
48455503|NCT00437281|101453586|FG009|COMPLETED|Overall Study||4||
48455504|NCT00437281|101453587|FG010|COMPLETED|Overall Study||3||
48455505|NCT00437281|101453588|FG011|COMPLETED|Overall Study||3||
48455506|NCT00437281|101453589|FG012|COMPLETED|Overall Study||2||
48455507|NCT00437281|101453590|FG013|COMPLETED|Overall Study||2||
48455508|NCT00437281|101453591|FG014|COMPLETED|Overall Study||4||
48662791|NCT03766399|101959503|FG000|COMPLETED|Part 2b: MAD (Nebulized Inhalation)||0||
48662792|NCT03766399|101959504|FG001|COMPLETED|Part 2b: MAD (Nebulized Inhalation)||0||
48662793|NCT03766399|101959505|FG002|COMPLETED|Part 2b: MAD (Nebulized Inhalation)||0||
48662794|NCT03766399|101959506|FG003|COMPLETED|Part 2b: MAD (Nebulized Inhalation)||0||
48662795|NCT03766399|101959507|FG004|COMPLETED|Part 2b: MAD (Nebulized Inhalation)||0||
48662796|NCT03766399|101959508|FG005|COMPLETED|Part 2b: MAD (Nebulized Inhalation)||0||
48662797|NCT03766399|101959509|FG006|COMPLETED|Part 2b: MAD (Nebulized Inhalation)||0||
48662798|NCT03766399|101959510|FG007|COMPLETED|Part 2b: MAD (Nebulized Inhalation)||0||
48455509|NCT00437281|101453592|FG015|COMPLETED|Overall Study||3||
48455510|NCT00437281|101453593|FG016|COMPLETED|Overall Study||3||
48455511|NCT00437281|101453594|FG017|COMPLETED|Overall Study||4||
48455512|NCT00437281|101453595|FG018|COMPLETED|Overall Study||1||
48455513|NCT00437281|101453596|FG019|COMPLETED|Overall Study||2||
48455514|NCT00437281|101453577|FG000|NOT COMPLETED|Overall Study||0||
48455515|NCT00437281|101453578|FG001|NOT COMPLETED|Overall Study||0||
48455516|NCT00437281|101453579|FG002|NOT COMPLETED|Overall Study||0||
48455517|NCT00437281|101453580|FG003|NOT COMPLETED|Overall Study||1||
48455518|NCT00437281|101453581|FG004|NOT COMPLETED|Overall Study||0||
48455519|NCT00437281|101453582|FG005|NOT COMPLETED|Overall Study||1||
48455520|NCT00437281|101453583|FG006|NOT COMPLETED|Overall Study||0||
48455521|NCT00437281|101453584|FG007|NOT COMPLETED|Overall Study||0||
48455522|NCT00437281|101453585|FG008|NOT COMPLETED|Overall Study||0||
48455523|NCT00437281|101453586|FG009|NOT COMPLETED|Overall Study||1||
48455524|NCT00437281|101453587|FG010|NOT COMPLETED|Overall Study||0||
48455525|NCT00437281|101453588|FG011|NOT COMPLETED|Overall Study||0||
48455526|NCT00437281|101453589|FG012|NOT COMPLETED|Overall Study||0||
48455527|NCT00437281|101453590|FG013|NOT COMPLETED|Overall Study||1||
48455528|NCT00437281|101453591|FG014|NOT COMPLETED|Overall Study||1||
48455529|NCT00437281|101453592|FG015|NOT COMPLETED|Overall Study||0||
48455530|NCT00437281|101453593|FG016|NOT COMPLETED|Overall Study||0||
48455531|NCT00437281|101453594|FG017|NOT COMPLETED|Overall Study||0||
48455532|NCT00437281|101453595|FG018|NOT COMPLETED|Overall Study||1||
48455533|NCT00437281|101453596|FG019|NOT COMPLETED|Overall Study||1||
48455534|NCT00475852|101453597|FG000|STARTED|Overall Study||3564||
48662799|NCT03766399|101959511|FG008|COMPLETED|Part 2b: MAD (Nebulized Inhalation)||0||
48662800|NCT03766399|101959512|FG009|COMPLETED|Part 2b: MAD (Nebulized Inhalation)||0||
48662801|NCT03766399|101959513|FG010|COMPLETED|Part 2b: MAD (Nebulized Inhalation)||0||
48662802|NCT03766399|101959514|FG011|COMPLETED|Part 2b: MAD (Nebulized Inhalation)||0||
48662803|NCT03766399|101959515|FG012|COMPLETED|Part 2b: MAD (Nebulized Inhalation)||2||
48662804|NCT03766399|101959516|FG013|COMPLETED|Part 2b: MAD (Nebulized Inhalation)||6||
48662805|NCT03766399|101959517|FG014|COMPLETED|Part 2b: MAD (Nebulized Inhalation)||0||
48662806|NCT03766399|101959518|FG015|COMPLETED|Part 2b: MAD (Nebulized Inhalation)||0||
48662807|NCT03766399|101959519|FG016|COMPLETED|Part 2b: MAD (Nebulized Inhalation)||0||
48662808|NCT03766399|101959520|FG017|COMPLETED|Part 2b: MAD (Nebulized Inhalation)||0||
48662809|NCT03766399|101959503|FG000|NOT COMPLETED|Part 2b: MAD (Nebulized Inhalation)||0||
48662810|NCT03766399|101959504|FG001|NOT COMPLETED|Part 2b: MAD (Nebulized Inhalation)||0||
48662811|NCT03766399|101959505|FG002|NOT COMPLETED|Part 2b: MAD (Nebulized Inhalation)||0||
48662812|NCT03766399|101959506|FG003|NOT COMPLETED|Part 2b: MAD (Nebulized Inhalation)||0||
48662813|NCT03766399|101959507|FG004|NOT COMPLETED|Part 2b: MAD (Nebulized Inhalation)||0||
48662814|NCT03766399|101959508|FG005|NOT COMPLETED|Part 2b: MAD (Nebulized Inhalation)||0||
48662815|NCT03766399|101959509|FG006|NOT COMPLETED|Part 2b: MAD (Nebulized Inhalation)||0||
48662816|NCT03766399|101959510|FG007|NOT COMPLETED|Part 2b: MAD (Nebulized Inhalation)||0||
48662817|NCT03766399|101959511|FG008|NOT COMPLETED|Part 2b: MAD (Nebulized Inhalation)||0||
48662818|NCT03766399|101959512|FG009|NOT COMPLETED|Part 2b: MAD (Nebulized Inhalation)||0||
48189227|NCT02395185|100786181|FG000|Sequence 5 (m,m,w,w,s,s)|Overall Study||2||
48189228|NCT02395185|100786181|FG000|Sequence 6 (s,m,m,w,w,s)|Overall Study||2||
48455535|NCT00475852|101453598|FG001|STARTED|Overall Study||3577||
48455536|NCT00475852|101453597|FG000|COMPLETED|Overall Study||3047||
48455537|NCT00475852|101453598|FG001|COMPLETED|Overall Study||3029||
48455538|NCT00475852|101453597|FG000|NOT COMPLETED|Overall Study||517||
48455539|NCT00475852|101453598|FG001|NOT COMPLETED|Overall Study||548||
48455540|NCT05017493|101453599|FG000|STARTED|Overall Study||483|483 patients enrolled in treatment arm|
48455541|NCT05017493|101453600|FG001|STARTED|Overall Study||178|483 patients enrolled in treatment arm|
48455542|NCT05017493|101453599|FG000|Treatment & Care|Overall Study||483|483 patients received Xagrotin|
48662819|NCT03766399|101959513|FG010|NOT COMPLETED|Part 2b: MAD (Nebulized Inhalation)||0||
48662820|NCT03766399|101959514|FG011|NOT COMPLETED|Part 2b: MAD (Nebulized Inhalation)||0||
48662821|NCT03766399|101959515|FG012|NOT COMPLETED|Part 2b: MAD (Nebulized Inhalation)||0||
48662822|NCT03766399|101959516|FG013|NOT COMPLETED|Part 2b: MAD (Nebulized Inhalation)||1||
48189229|NCT02395185|100786181|FG000|Sequence 7 (s,s,w,w,m,m)|Overall Study||2||
48455543|NCT05017493|101453600|FG001|Treatment & Care|Overall Study||178|483 patients received Xagrotin|
48455544|NCT05017493|101453599|FG000|Follow up|Overall Study||483|483 patients were followed up|
48455545|NCT05017493|101453600|FG001|Follow up|Overall Study||178|483 patients were followed up|
48455546|NCT05017493|101453599|FG000|Mortality Check|Overall Study||483|483 patients were checked for mortality|
48455547|NCT05017493|101453600|FG001|Mortality Check|Overall Study||178|483 patients were checked for mortality|
48455548|NCT05017493|101453599|FG000|COMPLETED|Overall Study||361|361 patients completed pr protocol|
48455549|NCT05017493|101453600|FG001|COMPLETED|Overall Study||178|361 patients completed pr protocol|
48455550|NCT05017493|101453599|FG000|NOT COMPLETED|Overall Study||122||
48455551|NCT05017493|101453600|FG001|NOT COMPLETED|Overall Study||0||
48455552|NCT00911859|101453601|FG000|STARTED|Treatment Period||12||
48455553|NCT00911859|101453602|FG001|STARTED|Treatment Period||54||
48455554|NCT00911859|101453603|FG002|STARTED|Treatment Period||52||
48455555|NCT00911859|101453601|FG000|Received Treatment|Treatment Period||12||
48455556|NCT00911859|101453602|FG001|Received Treatment|Treatment Period||53||
48455557|NCT00911859|101453603|FG002|Received Treatment|Treatment Period||52||
48455558|NCT00911859|101453601|FG000|COMPLETED|Treatment Period||4||
48455559|NCT00911859|101453602|FG001|COMPLETED|Treatment Period||33||
48455560|NCT00911859|101453603|FG002|COMPLETED|Treatment Period||27||
48455561|NCT00911859|101453601|FG000|NOT COMPLETED|Treatment Period||8||
48455562|NCT00911859|101453602|FG001|NOT COMPLETED|Treatment Period||21||
48455563|NCT00911859|101453603|FG002|NOT COMPLETED|Treatment Period||25||
48455564|NCT00911859|101453601|FG000|STARTED|Maintainance Period||0||
48455565|NCT00911859|101453602|FG001|STARTED|Maintainance Period||0||
48455566|NCT00911859|101453603|FG002|STARTED|Maintainance Period||21||
48455567|NCT00911859|101453601|FG000|COMPLETED|Maintainance Period||0||
48455568|NCT00911859|101453602|FG001|COMPLETED|Maintainance Period||0||
48455569|NCT00911859|101453603|FG002|COMPLETED|Maintainance Period||0||
48455570|NCT00911859|101453601|FG000|NOT COMPLETED|Maintainance Period||0||
48455571|NCT00911859|101453602|FG001|NOT COMPLETED|Maintainance Period||0||
48455572|NCT00911859|101453603|FG002|NOT COMPLETED|Maintainance Period||21||
48455573|NCT00911859|101453601|FG000|STARTED|Follow-up Period||12||
48455574|NCT00911859|101453602|FG001|STARTED|Follow-up Period||53||
48455575|NCT00911859|101453603|FG002|STARTED|Follow-up Period||52||
48455576|NCT00911859|101453601|FG000|COMPLETED|Follow-up Period||1||
48455577|NCT00911859|101453602|FG001|COMPLETED|Follow-up Period||7||
48455578|NCT00911859|101453603|FG002|COMPLETED|Follow-up Period||11||
48455579|NCT00911859|101453601|FG000|NOT COMPLETED|Follow-up Period||11||
48455580|NCT00911859|101453602|FG001|NOT COMPLETED|Follow-up Period||46||
48455581|NCT00911859|101453603|FG002|NOT COMPLETED|Follow-up Period||41||
48455582|NCT01991977|101453604|FG000|STARTED|Overall Study||91|Enrolled|
48455583|NCT01991977|101453604|FG000|Received PET Tracer|Overall Study||84|Received the experimental FDOPA PET tracer; evaluable for AEs|
48455584|NCT01991977|101453604|FG000|Received IMRT Treatment|Overall Study||79|Received IMRT treatment based on the FDOPA imaging results|
48455585|NCT01991977|101453604|FG000|Evaluable for the Primary Outcome|Overall Study||39|Grade IV MGMT un-methylated glioma patients after radiation therapy|
48455586|NCT01991977|101453604|FG000|COMPLETED|Overall Study||79|Received standard of care CT simulation and received treatment|
48455587|NCT01991977|101453604|FG000|NOT COMPLETED|Overall Study||12||
48455588|NCT02292433|101453605|FG000|STARTED|First Intervention Period (7 Days)||4||
48455589|NCT02292433|101453606|FG001|STARTED|First Intervention Period (7 Days)||4||
48455590|NCT02292433|101453607|FG002|STARTED|First Intervention Period (7 Days)||4||
48455591|NCT02292433|101453605|FG000|COMPLETED|First Intervention Period (7 Days)||4||
48455592|NCT02292433|101453606|FG001|COMPLETED|First Intervention Period (7 Days)||4||
48455593|NCT02292433|101453607|FG002|COMPLETED|First Intervention Period (7 Days)||4||
48455594|NCT02292433|101453605|FG000|NOT COMPLETED|First Intervention Period (7 Days)||0||
48455595|NCT02292433|101453606|FG001|NOT COMPLETED|First Intervention Period (7 Days)||0||
48455596|NCT02292433|101453607|FG002|NOT COMPLETED|First Intervention Period (7 Days)||0||
48455597|NCT02292433|101453605|FG000|STARTED|First Washout Period (7 to 14 Days)||4||
48455598|NCT02292433|101453606|FG001|STARTED|First Washout Period (7 to 14 Days)||4||
48455599|NCT02292433|101453607|FG002|STARTED|First Washout Period (7 to 14 Days)||4||
48455600|NCT02292433|101453605|FG000|COMPLETED|First Washout Period (7 to 14 Days)||4||
48455601|NCT02292433|101453606|FG001|COMPLETED|First Washout Period (7 to 14 Days)||4||
48455602|NCT02292433|101453607|FG002|COMPLETED|First Washout Period (7 to 14 Days)||4||
48455603|NCT02292433|101453605|FG000|NOT COMPLETED|First Washout Period (7 to 14 Days)||0||
48455604|NCT02292433|101453606|FG001|NOT COMPLETED|First Washout Period (7 to 14 Days)||0||
48455605|NCT02292433|101453607|FG002|NOT COMPLETED|First Washout Period (7 to 14 Days)||0||
48455606|NCT02292433|101453605|FG000|STARTED|Second Intervention Period (7 Days)||4||
48455607|NCT02292433|101453606|FG001|STARTED|Second Intervention Period (7 Days)||4||
48662823|NCT03766399|101959517|FG014|NOT COMPLETED|Part 2b: MAD (Nebulized Inhalation)||0||
48662824|NCT03766399|101959518|FG015|NOT COMPLETED|Part 2b: MAD (Nebulized Inhalation)||0||
48455608|NCT02292433|101453607|FG002|STARTED|Second Intervention Period (7 Days)||4||
48455609|NCT02292433|101453605|FG000|COMPLETED|Second Intervention Period (7 Days)||4||
48455610|NCT02292433|101453606|FG001|COMPLETED|Second Intervention Period (7 Days)||4||
48455611|NCT02292433|101453607|FG002|COMPLETED|Second Intervention Period (7 Days)||4||
48455612|NCT02292433|101453605|FG000|NOT COMPLETED|Second Intervention Period (7 Days)||0||
48455613|NCT02292433|101453606|FG001|NOT COMPLETED|Second Intervention Period (7 Days)||0||
48455614|NCT02292433|101453607|FG002|NOT COMPLETED|Second Intervention Period (7 Days)||0||
48455615|NCT02292433|101453605|FG000|STARTED|Second Washout Period (7 to 14 Days)||4||
48455616|NCT02292433|101453606|FG001|STARTED|Second Washout Period (7 to 14 Days)||4||
48455617|NCT02292433|101453607|FG002|STARTED|Second Washout Period (7 to 14 Days)||4||
48455618|NCT02292433|101453605|FG000|COMPLETED|Second Washout Period (7 to 14 Days)||4||
48455619|NCT02292433|101453606|FG001|COMPLETED|Second Washout Period (7 to 14 Days)||4||
48662825|NCT03766399|101959519|FG016|NOT COMPLETED|Part 2b: MAD (Nebulized Inhalation)||0||
48662826|NCT03766399|101959520|FG017|NOT COMPLETED|Part 2b: MAD (Nebulized Inhalation)||0||
48662827|NCT03766399|101959503|FG000|STARTED|Part 3a: Asthma Patients (DPI)||0||
48662828|NCT03766399|101959504|FG001|STARTED|Part 3a: Asthma Patients (DPI)||0||
48662829|NCT03766399|101959505|FG002|STARTED|Part 3a: Asthma Patients (DPI)||0||
48662830|NCT03766399|101959506|FG003|STARTED|Part 3a: Asthma Patients (DPI)||0||
48662831|NCT03766399|101959507|FG004|STARTED|Part 3a: Asthma Patients (DPI)||0||
48662832|NCT03766399|101959508|FG005|STARTED|Part 3a: Asthma Patients (DPI)||0||
48662833|NCT03766399|101959509|FG006|STARTED|Part 3a: Asthma Patients (DPI)||0||
48662834|NCT03766399|101959510|FG007|STARTED|Part 3a: Asthma Patients (DPI)||0||
48662835|NCT03766399|101959511|FG008|STARTED|Part 3a: Asthma Patients (DPI)||0||
48772748|NCT00790842|102232803|FG010|COMPLETED|Dose Level 2||0||
48772749|NCT00790842|102232793|FG000|NOT COMPLETED|Dose Level 2||0||
48772750|NCT00790842|102232794|FG001|NOT COMPLETED|Dose Level 2||3||
48772751|NCT00790842|102232795|FG002|NOT COMPLETED|Dose Level 2||0||
48772752|NCT00790842|102232796|FG003|NOT COMPLETED|Dose Level 2||0||
48772753|NCT00790842|102232797|FG004|NOT COMPLETED|Dose Level 2||1||
48772754|NCT00790842|102232798|FG005|NOT COMPLETED|Dose Level 2||0||
48772755|NCT00790842|102232799|FG006|NOT COMPLETED|Dose Level 2||0||
48772756|NCT00790842|102232800|FG007|NOT COMPLETED|Dose Level 2||0||
48772757|NCT00790842|102232801|FG008|NOT COMPLETED|Dose Level 2||2||
48455620|NCT02292433|101453607|FG002|COMPLETED|Second Washout Period (7 to 14 Days)||4||
48455621|NCT02292433|101453605|FG000|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0||
48455622|NCT02292433|101453606|FG001|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0||
48455623|NCT02292433|101453607|FG002|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0||
48455624|NCT02292433|101453605|FG000|STARTED|Third Intervention Period (7 Days)||4||
48455625|NCT02292433|101453606|FG001|STARTED|Third Intervention Period (7 Days)||4||
48455626|NCT02292433|101453607|FG002|STARTED|Third Intervention Period (7 Days)||4||
48455627|NCT02292433|101453605|FG000|COMPLETED|Third Intervention Period (7 Days)||4||
48455628|NCT02292433|101453606|FG001|COMPLETED|Third Intervention Period (7 Days)||4||
48455629|NCT02292433|101453607|FG002|COMPLETED|Third Intervention Period (7 Days)||4||
48455630|NCT02292433|101453605|FG000|NOT COMPLETED|Third Intervention Period (7 Days)||0||
48455631|NCT02292433|101453606|FG001|NOT COMPLETED|Third Intervention Period (7 Days)||0||
48455632|NCT02292433|101453607|FG002|NOT COMPLETED|Third Intervention Period (7 Days)||0||
48455633|NCT02725671|101453608|FG000|STARTED|Overall Study||2||
48455634|NCT02725671|101453608|FG000|COMPLETED|Overall Study||1||
48455635|NCT02725671|101453608|FG000|NOT COMPLETED|Overall Study||1||
48662836|NCT03766399|101959512|FG009|STARTED|Part 3a: Asthma Patients (DPI)||0||
48662837|NCT03766399|101959513|FG010|STARTED|Part 3a: Asthma Patients (DPI)||0||
48662838|NCT03766399|101959514|FG011|STARTED|Part 3a: Asthma Patients (DPI)||0||
48662839|NCT03766399|101959515|FG012|STARTED|Part 3a: Asthma Patients (DPI)||0||
48662840|NCT03766399|101959516|FG013|STARTED|Part 3a: Asthma Patients (DPI)||0||
48662841|NCT03766399|101959517|FG014|STARTED|Part 3a: Asthma Patients (DPI)||18||
48662842|NCT03766399|101959518|FG015|STARTED|Part 3a: Asthma Patients (DPI)||18||
48772758|NCT00790842|102232802|FG009|NOT COMPLETED|Dose Level 2||0||
48772759|NCT00790842|102232803|FG010|NOT COMPLETED|Dose Level 2||0||
48772760|NCT00790842|102232793|FG000|STARTED|Dose Level 3||0||
48772761|NCT00790842|102232794|FG001|STARTED|Dose Level 3||0||
48772762|NCT00790842|102232795|FG002|STARTED|Dose Level 3||7||
48772763|NCT00790842|102232796|FG003|STARTED|Dose Level 3||0||
48772764|NCT00790842|102232797|FG004|STARTED|Dose Level 3||0||
48772765|NCT00790842|102232798|FG005|STARTED|Dose Level 3||3||
48772766|NCT00790842|102232799|FG006|STARTED|Dose Level 3||0||
48772767|NCT00790842|102232800|FG007|STARTED|Dose Level 3||0||
48772768|NCT00790842|102232801|FG008|STARTED|Dose Level 3||0||
48772769|NCT00790842|102232802|FG009|STARTED|Dose Level 3||3||
48772770|NCT00790842|102232803|FG010|STARTED|Dose Level 3||0||
48772771|NCT00790842|102232793|FG000|Began Treatment|Dose Level 3||0||
48772772|NCT00790842|102232794|FG001|Began Treatment|Dose Level 3||0||
48772773|NCT00790842|102232795|FG002|Began Treatment|Dose Level 3||6||
48772774|NCT00790842|102232796|FG003|Began Treatment|Dose Level 3||0||
48772775|NCT00790842|102232797|FG004|Began Treatment|Dose Level 3||0||
48772776|NCT00790842|102232798|FG005|Began Treatment|Dose Level 3||3||
48772777|NCT00790842|102232799|FG006|Began Treatment|Dose Level 3||0||
48455636|NCT02962882|101453609|FG000|STARTED|Overall Study||50||
48455637|NCT02962882|101453609|FG000|COMPLETED|Overall Study||14||
48455638|NCT02962882|101453609|FG000|NOT COMPLETED|Overall Study||36||
48455639|NCT02145403|101453610|FG000|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||3|Started carfilzomib|
48455640|NCT02145403|101453611|FG001|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0|Started carfilzomib|
48455641|NCT02145403|101453612|FG002|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0|Started carfilzomib|
48455642|NCT02145403|101453613|FG003|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0|Started carfilzomib|
48455643|NCT02145403|101453610|FG000|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||3|Completed all 4 doses of Carfilzomib|
48455644|NCT02145403|101453611|FG001|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0|Completed all 4 doses of Carfilzomib|
48455645|NCT02145403|101453612|FG002|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0|Completed all 4 doses of Carfilzomib|
48455646|NCT02145403|101453613|FG003|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0|Completed all 4 doses of Carfilzomib|
48455647|NCT02145403|101453610|FG000|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0||
48455648|NCT02145403|101453611|FG001|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0||
48662843|NCT03766399|101959519|FG016|STARTED|Part 3a: Asthma Patients (DPI)||0||
48662844|NCT03766399|101959520|FG017|STARTED|Part 3a: Asthma Patients (DPI)||0||
48772778|NCT00790842|102232800|FG007|Began Treatment|Dose Level 3||0||
48189230|NCT02395185|100786181|FG000|Sequence 8 (m,s,s,w,w,m)|Overall Study||2||
48189231|NCT02395185|100786181|FG000|Sequence 9 (m,m,s,s,w,w)|Overall Study||2||
48189232|NCT02395185|100786181|FG000|Sequence 10 (w,m,m,s,s,w)|Overall Study||2||
48189233|NCT02395185|100786181|FG000|Sequence 11 (w,w,m,m,s,s)|Overall Study||2||
48455649|NCT02145403|101453612|FG002|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0||
48455650|NCT02145403|101453613|FG003|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0||
48455651|NCT02145403|101453610|FG000|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0||
48455652|NCT02145403|101453611|FG001|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||3||
48455653|NCT02145403|101453612|FG002|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0||
48455654|NCT02145403|101453613|FG003|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0||
48455655|NCT02145403|101453610|FG000|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0||
48455656|NCT02145403|101453611|FG001|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||3||
48455657|NCT02145403|101453612|FG002|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0||
48455658|NCT02145403|101453613|FG003|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0||
48455659|NCT02145403|101453610|FG000|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0||
48455660|NCT02145403|101453611|FG001|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0||
48455661|NCT02145403|101453612|FG002|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0||
48455662|NCT02145403|101453613|FG003|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0||
48455663|NCT02145403|101453610|FG000|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0||
48455664|NCT02145403|101453611|FG001|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0||
48455665|NCT02145403|101453612|FG002|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||4||
48455666|NCT02145403|101453613|FG003|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0||
48455667|NCT02145403|101453610|FG000|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0||
48455668|NCT02145403|101453611|FG001|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0||
48455669|NCT02145403|101453612|FG002|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||3||
48455670|NCT02145403|101453613|FG003|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0||
48455671|NCT02145403|101453610|FG000|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0||
48455672|NCT02145403|101453611|FG001|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0||
48455673|NCT02145403|101453612|FG002|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||1||
48455674|NCT02145403|101453613|FG003|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0||
48455675|NCT02145403|101453610|FG000|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0||
48455676|NCT02145403|101453611|FG001|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0||
48455677|NCT02145403|101453612|FG002|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0||
48455678|NCT02145403|101453613|FG003|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||4||
48455679|NCT02145403|101453610|FG000|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0||
48455680|NCT02145403|101453611|FG001|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0||
48455681|NCT02145403|101453612|FG002|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0||
48455682|NCT02145403|101453613|FG003|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||2||
48455683|NCT02145403|101453610|FG000|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0||
48455684|NCT02145403|101453611|FG001|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0||
48455685|NCT02145403|101453612|FG002|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0||
48455686|NCT02145403|101453613|FG003|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||2||
48455687|NCT02145403|101453610|FG000|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0||
48455688|NCT02145403|101453611|FG001|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0||
48455689|NCT02145403|101453612|FG002|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||37||
48455690|NCT02145403|101453613|FG003|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0||
48455691|NCT02145403|101453610|FG000|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0||
48455692|NCT02145403|101453611|FG001|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0||
48455693|NCT02145403|101453612|FG002|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||36||
48662845|NCT03766399|101959503|FG000|COMPLETED|Part 3a: Asthma Patients (DPI)||0||
48662846|NCT03766399|101959504|FG001|COMPLETED|Part 3a: Asthma Patients (DPI)||0||
48662847|NCT03766399|101959505|FG002|COMPLETED|Part 3a: Asthma Patients (DPI)||0||
48455694|NCT02145403|101453613|FG003|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0||
48455695|NCT02145403|101453610|FG000|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0||
48455696|NCT02145403|101453611|FG001|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0||
48455697|NCT02145403|101453612|FG002|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||1||
48455698|NCT02145403|101453613|FG003|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0||
48455699|NCT03065283|101453614|FG000|STARTED|Overall Study||50||
48455700|NCT03065283|101453615|FG001|STARTED|Overall Study||25||
48455701|NCT03065283|101453614|FG000|COMPLETED|Overall Study||50|Outcomes were measured at baseline and after intervention. There was no dropoput of sample.|
48662848|NCT03766399|101959506|FG003|COMPLETED|Part 3a: Asthma Patients (DPI)||0||
48662849|NCT03766399|101959507|FG004|COMPLETED|Part 3a: Asthma Patients (DPI)||0||
48772779|NCT00790842|102232801|FG008|Began Treatment|Dose Level 3||0||
48455702|NCT03065283|101453615|FG001|COMPLETED|Overall Study||25|Outcomes were measured at baseline and after intervention. There was no dropoput of sample.|
48455703|NCT03065283|101453614|FG000|NOT COMPLETED|Overall Study||0||
48455704|NCT03065283|101453615|FG001|NOT COMPLETED|Overall Study||0||
48455705|NCT00955747|101453616|FG000|STARTED|Overall Study||253||
48455706|NCT00955747|101453617|FG001|STARTED|Overall Study||241||
48455707|NCT00955747|101453616|FG000|COMPLETED|Overall Study||184||
48455708|NCT00955747|101453617|FG001|COMPLETED|Overall Study||172||
48455709|NCT00955747|101453616|FG000|NOT COMPLETED|Overall Study||69||
48455710|NCT00955747|101453617|FG001|NOT COMPLETED|Overall Study||69||
48455711|NCT00544557|101453618|FG000|STARTED|Overall Study||1685||
48455712|NCT00544557|101453618|FG000|COMPLETED|Overall Study||1251||
48455713|NCT00544557|101453618|FG000|NOT COMPLETED|Overall Study||434||
48455714|NCT01020305|101453619|FG000|STARTED|Overall Study||5||
48455715|NCT01020305|101453619|FG000|COMPLETED|Overall Study||3||
48455716|NCT01020305|101453619|FG000|NOT COMPLETED|Overall Study||2||
48455717|NCT00443352|101453620|FG000|STARTED|Overall Study||27||
48455718|NCT00443352|101453620|FG000|COMPLETED|Overall Study||22||
48455719|NCT00443352|101453620|FG000|NOT COMPLETED|Overall Study||5||
48455720|NCT01512979|101453621|FG000|STARTED|Overall Study||159||
48455721|NCT01512979|101453622|FG001|STARTED|Overall Study||157||
48455722|NCT01512979|101453621|FG000|COMPLETED|Overall Study||140||
48455723|NCT01512979|101453622|FG001|COMPLETED|Overall Study||135||
48455724|NCT01512979|101453621|FG000|NOT COMPLETED|Overall Study||19||
48455725|NCT01512979|101453622|FG001|NOT COMPLETED|Overall Study||22||
48455726|NCT01588106|101453623|FG000|STARTED|Overall Study||78||
48455727|NCT01588106|101453624|FG001|STARTED|Overall Study||76||
48455728|NCT01588106|101453623|FG000|COMPLETED|Overall Study||73||
48455729|NCT01588106|101453624|FG001|COMPLETED|Overall Study||72||
48455730|NCT01588106|101453623|FG000|NOT COMPLETED|Overall Study||5||
48455731|NCT01588106|101453624|FG001|NOT COMPLETED|Overall Study||4||
48455732|NCT02675426|101453625|FG000|STARTED|Period 1: Week 1 to Week 12||110||
48455733|NCT02675426|101453626|FG001|STARTED|Period 1: Week 1 to Week 12||111||
48455734|NCT02675426|101453627|FG002|STARTED|Period 1: Week 1 to Week 12||221||
48455735|NCT02675426|101453628|FG003|STARTED|Period 1: Week 1 to Week 12||219||
48455736|NCT02675426|101453625|FG000|Received Study Drug|Period 1: Week 1 to Week 12||110||
48455737|NCT02675426|101453626|FG001|Received Study Drug|Period 1: Week 1 to Week 12||111||
48455738|NCT02675426|101453627|FG002|Received Study Drug|Period 1: Week 1 to Week 12||221||
48455739|NCT02675426|101453628|FG003|Received Study Drug|Period 1: Week 1 to Week 12||219||
48455740|NCT02675426|101453625|FG000|COMPLETED|Period 1: Week 1 to Week 12||104||
48455741|NCT02675426|101453626|FG001|COMPLETED|Period 1: Week 1 to Week 12||104||
48455742|NCT02675426|101453627|FG002|COMPLETED|Period 1: Week 1 to Week 12||213||
48455743|NCT02675426|101453628|FG003|COMPLETED|Period 1: Week 1 to Week 12||201||
48455744|NCT02675426|101453625|FG000|NOT COMPLETED|Period 1: Week 1 to Week 12||6||
48455745|NCT02675426|101453626|FG001|NOT COMPLETED|Period 1: Week 1 to Week 12||7||
48455746|NCT02675426|101453627|FG002|NOT COMPLETED|Period 1: Week 1 to Week 12||8||
48455747|NCT02675426|101453628|FG003|NOT COMPLETED|Period 1: Week 1 to Week 12||18||
48455748|NCT02675426|101453625|FG000|STARTED|Period 2: Week 12 to Week 260||103|Four participants completed the Week 12 visit but did not continue into Period 2.|
48455749|NCT02675426|101453626|FG001|STARTED|Period 2: Week 12 to Week 260||103|Four participants completed the Week 12 visit but did not continue into Period 2.|
48455750|NCT02675426|101453627|FG002|STARTED|Period 2: Week 12 to Week 260||212|Four participants completed the Week 12 visit but did not continue into Period 2.|
48455751|NCT02675426|101453628|FG003|STARTED|Period 2: Week 12 to Week 260||200|Four participants completed the Week 12 visit but did not continue into Period 2.|
48455752|NCT02675426|101453625|FG000|Received Study Drug|Period 2: Week 12 to Week 260||103||
48455753|NCT02675426|101453626|FG001|Received Study Drug|Period 2: Week 12 to Week 260||102||
48455754|NCT02675426|101453627|FG002|Received Study Drug|Period 2: Week 12 to Week 260||207||
48455755|NCT02675426|101453628|FG003|Received Study Drug|Period 2: Week 12 to Week 260||199||
48455756|NCT02675426|101453625|FG000|Switched to Upadacitinib 15 mg After Protocol Amendment 6|Period 2: Week 12 to Week 260||0||
48455757|NCT02675426|101453626|FG001|Switched to Upadacitinib 15 mg After Protocol Amendment 6|Period 2: Week 12 to Week 260||53||
48455758|NCT02675426|101453627|FG002|Switched to Upadacitinib 15 mg After Protocol Amendment 6|Period 2: Week 12 to Week 260||0||
48455759|NCT02675426|101453628|FG003|Switched to Upadacitinib 15 mg After Protocol Amendment 6|Period 2: Week 12 to Week 260||126||
48455760|NCT02675426|101453625|FG000|COMPLETED|Period 2: Week 12 to Week 260||61||
48455761|NCT02675426|101453626|FG001|COMPLETED|Period 2: Week 12 to Week 260||49||
48455762|NCT02675426|101453627|FG002|COMPLETED|Period 2: Week 12 to Week 260||130||
48455763|NCT02675426|101453628|FG003|COMPLETED|Period 2: Week 12 to Week 260||120||
48455764|NCT02675426|101453625|FG000|NOT COMPLETED|Period 2: Week 12 to Week 260||42||
48455765|NCT02675426|101453626|FG001|NOT COMPLETED|Period 2: Week 12 to Week 260||54||
48455766|NCT02675426|101453627|FG002|NOT COMPLETED|Period 2: Week 12 to Week 260||82||
48455767|NCT02675426|101453628|FG003|NOT COMPLETED|Period 2: Week 12 to Week 260||80||
48455768|NCT01050231|101453629|FG000|STARTED|Overall Study||10||
48455769|NCT01050231|101453630|FG001|STARTED|Overall Study||10||
48455770|NCT01050231|101453629|FG000|COMPLETED|Overall Study||10||
48455771|NCT01050231|101453630|FG001|COMPLETED|Overall Study||10||
48455772|NCT01050231|101453629|FG000|NOT COMPLETED|Overall Study||0||
48455773|NCT01050231|101453630|FG001|NOT COMPLETED|Overall Study||0||
48455774|NCT00775983|101453631|FG000|STARTED|Overall Study||36||
48455775|NCT00775983|101453632|FG001|STARTED|Overall Study||36||
48455776|NCT00775983|101453631|FG000|COMPLETED|Overall Study||35||
48455777|NCT00775983|101453632|FG001|COMPLETED|Overall Study||34||
48455778|NCT00775983|101453631|FG000|NOT COMPLETED|Overall Study||1||
48455779|NCT00775983|101453632|FG001|NOT COMPLETED|Overall Study||2||
48455780|NCT01165242|101453633|FG000|STARTED|Overall Study||337||
48455781|NCT01165242|101453634|FG001|STARTED|Overall Study||336||
48455782|NCT01165242|101453635|FG002|STARTED|Overall Study||338||
48455783|NCT01165242|101453633|FG000|COMPLETED|Overall Study||327||
48455784|NCT01165242|101453634|FG001|COMPLETED|Overall Study||326||
48455785|NCT01165242|101453635|FG002|COMPLETED|Overall Study||324||
48455786|NCT01165242|101453633|FG000|NOT COMPLETED|Overall Study||10||
48455787|NCT01165242|101453634|FG001|NOT COMPLETED|Overall Study||10||
48455788|NCT01165242|101453635|FG002|NOT COMPLETED|Overall Study||14||
48455789|NCT01859702|101453636|FG000|STARTED|Overall Study||36||
48455790|NCT01859702|101453636|FG000|COMPLETED|Overall Study||31||
48455791|NCT01859702|101453636|FG000|NOT COMPLETED|Overall Study||5||
48455792|NCT01841359|101453637|FG000|STARTED|Overall Study||22||
48455793|NCT01841359|101453637|FG000|COMPLETED|Overall Study||14||
48455794|NCT01841359|101453637|FG000|NOT COMPLETED|Overall Study||8||
48455795|NCT01188928|101453638|FG000|STARTED|Overall Study||482||
48455796|NCT01188928|101453639|FG001|STARTED|Overall Study||479||
48455797|NCT01188928|101453640|FG002|STARTED|Overall Study||96||
48455798|NCT01188928|101453641|FG003|STARTED|Overall Study||95||
48455799|NCT01188928|101453638|FG000|COMPLETED|Overall Study||444||
48455800|NCT01188928|101453639|FG001|COMPLETED|Overall Study||417||
48455801|NCT01188928|101453640|FG002|COMPLETED|Overall Study||82||
48455802|NCT01188928|101453641|FG003|COMPLETED|Overall Study||77||
48455803|NCT01188928|101453638|FG000|NOT COMPLETED|Overall Study||38||
48455804|NCT01188928|101453639|FG001|NOT COMPLETED|Overall Study||62||
48455805|NCT01188928|101453640|FG002|NOT COMPLETED|Overall Study||14||
48455806|NCT01188928|101453641|FG003|NOT COMPLETED|Overall Study||18||
48455807|NCT01507831|101453642|FG000|STARTED|Overall Study||788||
48455808|NCT01507831|101453643|FG001|STARTED|Overall Study||1553||
48455809|NCT01507831|101453642|FG000|Treated|Overall Study||788||
48455810|NCT01507831|101453643|FG001|Treated|Overall Study||1550||
48455811|NCT01507831|101453642|FG000|COMPLETED|Overall Study||595||
48455812|NCT01507831|101453643|FG001|COMPLETED|Overall Study||1113||
48455813|NCT01507831|101453642|FG000|NOT COMPLETED|Overall Study||193||
48455814|NCT01507831|101453643|FG001|NOT COMPLETED|Overall Study||440||
48455815|NCT00927888|101453644|FG000|STARTED|Overall Study||29||
48455816|NCT00927888|101453645|FG001|STARTED|Overall Study||27||
48455817|NCT00927888|101453644|FG000|COMPLETED|Overall Study||29||
48455818|NCT00927888|101453645|FG001|COMPLETED|Overall Study||27||
48455819|NCT00927888|101453644|FG000|NOT COMPLETED|Overall Study||0||
48455820|NCT00927888|101453645|FG001|NOT COMPLETED|Overall Study||0||
48455821|NCT03974152|101453646|FG000|STARTED|Overall Study||1||
48455822|NCT03974152|101453647|FG001|STARTED|Overall Study||3||
48455823|NCT03974152|101453648|FG002|STARTED|Overall Study||1||
48455824|NCT03974152|101453649|FG003|STARTED|Overall Study||1||
48455825|NCT03974152|101453650|FG004|STARTED|Overall Study||1||
48455826|NCT03974152|101453651|FG005|STARTED|Overall Study||4||
48455827|NCT03974152|101453646|FG000|COMPLETED|Overall Study||1||
48455828|NCT03974152|101453647|FG001|COMPLETED|Overall Study||1||
48455829|NCT03974152|101453648|FG002|COMPLETED|Overall Study||1||
48189234|NCT02395185|100786181|FG000|Sequence 12 (s,w,w,m,m,s)|Overall Study||2||
48455830|NCT03974152|101453649|FG003|COMPLETED|Overall Study||1||
48455831|NCT03974152|101453650|FG004|COMPLETED|Overall Study||1||
48455832|NCT03974152|101453651|FG005|COMPLETED|Overall Study||0||
48455833|NCT03974152|101453646|FG000|NOT COMPLETED|Overall Study||0||
48455834|NCT03974152|101453647|FG001|NOT COMPLETED|Overall Study||2||
48455835|NCT03974152|101453648|FG002|NOT COMPLETED|Overall Study||0||
48455836|NCT03974152|101453649|FG003|NOT COMPLETED|Overall Study||0||
48455837|NCT03974152|101453650|FG004|NOT COMPLETED|Overall Study||0||
48455838|NCT03974152|101453651|FG005|NOT COMPLETED|Overall Study||4||
48455839|NCT02922959|101453652|FG000|STARTED|Overall Study||40||
48455840|NCT02922959|101453653|FG001|STARTED|Overall Study||40||
48455841|NCT02922959|101453652|FG000|3 Weeks|Overall Study||38||
48455842|NCT02922959|101453653|FG001|3 Weeks|Overall Study||36||
48455843|NCT02922959|101453652|FG000|3 Months|Overall Study||35||
48455844|NCT02922959|101453653|FG001|3 Months|Overall Study||31||
48455845|NCT02922959|101453652|FG000|6 Months|Overall Study||28||
48455846|NCT02922959|101453653|FG001|6 Months|Overall Study||30||
48455847|NCT02922959|101453652|FG000|12 Months|Overall Study||21||
48455848|NCT02922959|101453653|FG001|12 Months|Overall Study||23||
48455849|NCT02922959|101453652|FG000|COMPLETED|Overall Study||21||
48455850|NCT02922959|101453653|FG001|COMPLETED|Overall Study||23||
48455851|NCT02922959|101453652|FG000|NOT COMPLETED|Overall Study||19||
48455852|NCT02922959|101453653|FG001|NOT COMPLETED|Overall Study||17||
48455853|NCT00520351|101453654|FG000|STARTED|First Intervention||15||
48455854|NCT00520351|101453655|FG001|STARTED|First Intervention||15||
48455855|NCT00520351|101453654|FG000|COMPLETED|First Intervention||14||
48455856|NCT00520351|101453655|FG001|COMPLETED|First Intervention||14||
48455857|NCT00520351|101453654|FG000|NOT COMPLETED|First Intervention||1||
48455858|NCT00520351|101453655|FG001|NOT COMPLETED|First Intervention||1||
48455859|NCT00520351|101453654|FG000|STARTED|Second Intervention||14||
48455860|NCT00520351|101453655|FG001|STARTED|Second Intervention||14||
48455861|NCT00520351|101453654|FG000|COMPLETED|Second Intervention||14||
48455862|NCT00520351|101453655|FG001|COMPLETED|Second Intervention||14||
48455863|NCT00520351|101453654|FG000|NOT COMPLETED|Second Intervention||0||
48455864|NCT00520351|101453655|FG001|NOT COMPLETED|Second Intervention||0||
48455865|NCT03760510|101453656|FG000|STARTED|Overall Study||250||
48455866|NCT03760510|101453657|FG001|STARTED|Overall Study||250||
48455867|NCT03760510|101453656|FG000|COMPLETED|Overall Study||145||
48455868|NCT03760510|101453657|FG001|COMPLETED|Overall Study||153||
48455869|NCT03760510|101453656|FG000|NOT COMPLETED|Overall Study||105||
48455870|NCT03760510|101453657|FG001|NOT COMPLETED|Overall Study||97||
48455871|NCT02238977|101453658|FG000|STARTED|Overall Study||0||
48455872|NCT02238977|101453659|FG001|STARTED|Overall Study||1||
48455873|NCT02238977|101453658|FG000|COMPLETED|Overall Study||0||
48455874|NCT02238977|101453659|FG001|COMPLETED|Overall Study||1||
48455875|NCT02238977|101453658|FG000|NOT COMPLETED|Overall Study||0||
48455876|NCT02238977|101453659|FG001|NOT COMPLETED|Overall Study||0||
48455877|NCT02280421|101453660|FG000|STARTED|First Intervention(2 Weeks)||12||
48455878|NCT02280421|101453661|FG001|STARTED|First Intervention(2 Weeks)||12||
48455879|NCT02280421|101453660|FG000|Received Intervention|First Intervention(2 Weeks)||12||
48455880|NCT02280421|101453661|FG001|Received Intervention|First Intervention(2 Weeks)||12||
48455881|NCT02280421|101453660|FG000|COMPLETED|First Intervention(2 Weeks)||12||
48455882|NCT02280421|101453661|FG001|COMPLETED|First Intervention(2 Weeks)||12||
48455883|NCT02280421|101453660|FG000|NOT COMPLETED|First Intervention(2 Weeks)||0||
48455884|NCT02280421|101453661|FG001|NOT COMPLETED|First Intervention(2 Weeks)||0||
48455885|NCT02280421|101453660|FG000|STARTED|Washout (2 Weeks)||12||
48455886|NCT02280421|101453661|FG001|STARTED|Washout (2 Weeks)||12||
48455887|NCT02280421|101453660|FG000|COMPLETED|Washout (2 Weeks)||11||
48189235|NCT02395185|100786181|FG000|Sequence 13 (s,m,w,m,s,w)|Overall Study||2||
48189236|NCT02395185|100786181|FG000|Sequence 14 (w,s,m,w,m,s)|Overall Study||2||
48189237|NCT02395185|100786181|FG000|Sequence 15 (s,w,s,m,w,m)|Overall Study||2||
48455888|NCT02280421|101453661|FG001|COMPLETED|Washout (2 Weeks)||11||
48455889|NCT02280421|101453660|FG000|NOT COMPLETED|Washout (2 Weeks)||1||
48455890|NCT02280421|101453661|FG001|NOT COMPLETED|Washout (2 Weeks)||1||
48455891|NCT02280421|101453660|FG000|STARTED|Second Intervention(2 Weeks)||12||
48455892|NCT02280421|101453661|FG001|STARTED|Second Intervention(2 Weeks)||12||
48455893|NCT02280421|101453660|FG000|Received Intervention|Second Intervention(2 Weeks)||12||
48455894|NCT02280421|101453661|FG001|Received Intervention|Second Intervention(2 Weeks)||12||
48455895|NCT02280421|101453660|FG000|COMPLETED|Second Intervention(2 Weeks)||12||
48455896|NCT02280421|101453661|FG001|COMPLETED|Second Intervention(2 Weeks)||12||
48455897|NCT02280421|101453660|FG000|NOT COMPLETED|Second Intervention(2 Weeks)||0||
48455898|NCT02280421|101453661|FG001|NOT COMPLETED|Second Intervention(2 Weeks)||0||
48455899|NCT00789802|101453662|FG000|STARTED|Overall Study||44||
48455900|NCT00789802|101453663|FG001|STARTED|Overall Study||42||
48455901|NCT00789802|101453664|FG002|STARTED|Overall Study||43||
48455902|NCT00789802|101453662|FG000|COMPLETED|Overall Study||34||
48455903|NCT00789802|101453663|FG001|COMPLETED|Overall Study||35||
48455904|NCT00789802|101453664|FG002|COMPLETED|Overall Study||37||
48455905|NCT00789802|101453662|FG000|NOT COMPLETED|Overall Study||10||
48455906|NCT00789802|101453663|FG001|NOT COMPLETED|Overall Study||7||
48455907|NCT00789802|101453664|FG002|NOT COMPLETED|Overall Study||6||
48455908|NCT03652961|101453665|FG000|STARTED|Overall Study||25||
48455909|NCT03652961|101453665|FG000|COMPLETED|Overall Study||21||
48455910|NCT03652961|101453665|FG000|NOT COMPLETED|Overall Study||4||
48189238|NCT02395185|100786181|FG000|Sequence 16 (m,s,w,s,m,w)|Overall Study||1||
48455911|NCT01816971|101453666|FG000|STARTED|Overall Study||76||
48455912|NCT01816971|101453666|FG000|COMPLETED|Overall Study||64||
48455913|NCT01816971|101453666|FG000|NOT COMPLETED|Overall Study||12||
48455914|NCT01070394|101453667|FG000|STARTED|Overall Study||40||
48189239|NCT02395185|100786181|FG000|Sequence 17 (w,m,s,w,s,m)|Overall Study||1||
48189240|NCT02395185|100786181|FG000|Sequence 18 (m,w,m,s,w,s)|Overall Study||1||
48455915|NCT01070394|101453667|FG000|COMPLETED|Overall Study||33||
48455916|NCT01070394|101453667|FG000|NOT COMPLETED|Overall Study||7||
48455917|NCT03989115|101453668|FG000|STARTED|Overall Study||8||
48455918|NCT03989115|101453669|FG001|STARTED|Overall Study||6||
48189241|NCT02395185|100786181|FG000|COMPLETED|Overall Study||33||
48455919|NCT03989115|101453670|FG002|STARTED|Overall Study||12||
48455920|NCT03989115|101453671|FG003|STARTED|Overall Study||7||
48455921|NCT03989115|101453672|FG004|STARTED|Overall Study||65||
48455922|NCT03989115|101453673|FG005|STARTED|Overall Study||7||
48455923|NCT03989115|101453674|FG006|STARTED|Overall Study||4||
48455924|NCT03989115|101453675|FG007|STARTED|Overall Study||4||
48455925|NCT03989115|101453668|FG000|COMPLETED|Overall Study||0||
48455926|NCT03989115|101453669|FG001|COMPLETED|Overall Study||0||
48455927|NCT03989115|101453670|FG002|COMPLETED|Overall Study||0||
48455928|NCT03989115|101453671|FG003|COMPLETED|Overall Study||0||
48455929|NCT03989115|101453672|FG004|COMPLETED|Overall Study||0||
48455930|NCT03989115|101453673|FG005|COMPLETED|Overall Study||0||
48455931|NCT03989115|101453674|FG006|COMPLETED|Overall Study||0||
48455932|NCT03989115|101453675|FG007|COMPLETED|Overall Study||0||
48455933|NCT03989115|101453668|FG000|NOT COMPLETED|Overall Study||8||
48455934|NCT03989115|101453669|FG001|NOT COMPLETED|Overall Study||6||
48455935|NCT03989115|101453670|FG002|NOT COMPLETED|Overall Study||12||
48455936|NCT03989115|101453671|FG003|NOT COMPLETED|Overall Study||7||
48455937|NCT03989115|101453672|FG004|NOT COMPLETED|Overall Study||65||
48455938|NCT03989115|101453673|FG005|NOT COMPLETED|Overall Study||7||
48455939|NCT03989115|101453674|FG006|NOT COMPLETED|Overall Study||4||
48455940|NCT03989115|101453675|FG007|NOT COMPLETED|Overall Study||4||
48455941|NCT01456052|101453676|FG000|STARTED|Overall Study||10||
48455942|NCT01456052|101453677|FG001|STARTED|Overall Study||25||
48455943|NCT01456052|101453678|FG002|STARTED|Overall Study||24||
48455944|NCT01456052|101453676|FG000|COMPLETED|Overall Study||8||
48455945|NCT01456052|101453677|FG001|COMPLETED|Overall Study||20||
48455946|NCT01456052|101453678|FG002|COMPLETED|Overall Study||19||
48455947|NCT01456052|101453676|FG000|NOT COMPLETED|Overall Study||2||
48455948|NCT01456052|101453677|FG001|NOT COMPLETED|Overall Study||5||
48455949|NCT01456052|101453678|FG002|NOT COMPLETED|Overall Study||5||
48455950|NCT01259401|101453679|FG000|STARTED|End of 4-week Intervention||21||
48455951|NCT01259401|101453680|FG001|STARTED|End of 4-week Intervention||21||
48455952|NCT01259401|101453679|FG000|COMPLETED|End of 4-week Intervention||21||
48455953|NCT01259401|101453680|FG001|COMPLETED|End of 4-week Intervention||21||
48455954|NCT01259401|101453679|FG000|NOT COMPLETED|End of 4-week Intervention||0||
48455955|NCT01259401|101453680|FG001|NOT COMPLETED|End of 4-week Intervention||0||
48455956|NCT01259401|101453679|FG000|STARTED|4-month Follow-up||21||
48455957|NCT01259401|101453680|FG001|STARTED|4-month Follow-up||21||
48455958|NCT01259401|101453679|FG000|COMPLETED|4-month Follow-up||21||
48455959|NCT01259401|101453680|FG001|COMPLETED|4-month Follow-up||19||
48455960|NCT01259401|101453679|FG000|NOT COMPLETED|4-month Follow-up||0||
48455961|NCT01259401|101453680|FG001|NOT COMPLETED|4-month Follow-up||2||
48455962|NCT02565485|101453681|FG000|STARTED|Overall Study||139||
48455963|NCT02565485|101453682|FG001|STARTED|Overall Study||137||
48455964|NCT02565485|101453681|FG000|COMPLETED|Overall Study||139||
48455965|NCT02565485|101453682|FG001|COMPLETED|Overall Study||137||
48455966|NCT02565485|101453681|FG000|NOT COMPLETED|Overall Study||0||
48455967|NCT02565485|101453682|FG001|NOT COMPLETED|Overall Study||0||
48455968|NCT01498419|101453683|FG000|STARTED|Overall Study||60||
48455969|NCT01498419|101453684|FG001|STARTED|Overall Study||62||
48455970|NCT01498419|101453685|FG002|STARTED|Overall Study||59||
48455971|NCT01498419|101453686|FG003|STARTED|Overall Study||26||
48455972|NCT01498419|101453683|FG000|COMPLETED|Overall Study||42||
48455973|NCT01498419|101453684|FG001|COMPLETED|Overall Study||39||
48455974|NCT01498419|101453685|FG002|COMPLETED|Overall Study||41||
48455975|NCT01498419|101453686|FG003|COMPLETED|Overall Study||7||
48455976|NCT01498419|101453683|FG000|NOT COMPLETED|Overall Study||18||
48455977|NCT01498419|101453684|FG001|NOT COMPLETED|Overall Study||23||
48455978|NCT01498419|101453685|FG002|NOT COMPLETED|Overall Study||18||
48455979|NCT01498419|101453686|FG003|NOT COMPLETED|Overall Study||19||
48455980|NCT02163811|101453687|FG000|STARTED|Overall Study||71||
48455981|NCT02163811|101453688|FG001|STARTED|Overall Study||76||
48455982|NCT02163811|101453687|FG000|COMPLETED|Overall Study||35||
48455983|NCT02163811|101453688|FG001|COMPLETED|Overall Study||60||
48455984|NCT02163811|101453687|FG000|NOT COMPLETED|Overall Study||36||
48455985|NCT02163811|101453688|FG001|NOT COMPLETED|Overall Study||16||
48455986|NCT01623830|101453689|FG000|STARTED|Overall Study||45||
48455987|NCT01623830|101453690|FG001|STARTED|Overall Study||44||
48455988|NCT01623830|101453689|FG000|COMPLETED|Overall Study||38||
48455989|NCT01623830|101453690|FG001|COMPLETED|Overall Study||35||
48455990|NCT01623830|101453689|FG000|NOT COMPLETED|Overall Study||7||
48455991|NCT01623830|101453690|FG001|NOT COMPLETED|Overall Study||9||
48455992|NCT00871169|101453691|FG000|STARTED|Overall Study||61||
48455993|NCT00871169|101453691|FG000|COMPLETED|Overall Study||58||
48455994|NCT00871169|101453691|FG000|NOT COMPLETED|Overall Study||3||
48455995|NCT03254719|101453692|FG000|STARTED|Overall Study||40||
48455996|NCT03254719|101453692|FG000|COMPLETED|Overall Study||40||
48455997|NCT03254719|101453692|FG000|NOT COMPLETED|Overall Study||0||
48455998|NCT04364165|101453693|FG000|STARTED|Overall Study||544||20
48455999|NCT04364165|101453694|FG001|STARTED|Overall Study||504||20
48456000|NCT04364165|101453693|FG000|COMPLETED|Overall Study||68||5
48456001|NCT04364165|101453694|FG001|COMPLETED|Overall Study||112||7
48456002|NCT04364165|101453693|FG000|NOT COMPLETED|Overall Study||476||15
48456003|NCT04364165|101453694|FG001|NOT COMPLETED|Overall Study||392||13
48456004|NCT04229303|101453695|FG000|STARTED|Overall Study||6||
48456005|NCT04229303|101453696|FG001|STARTED|Overall Study||6||
48456006|NCT04229303|101453697|FG002|STARTED|Overall Study||6||
48456007|NCT04229303|101453698|FG003|STARTED|Overall Study||6||
48456008|NCT04229303|101453699|FG004|STARTED|Overall Study||6||
48456009|NCT04229303|101453700|FG005|STARTED|Overall Study||6||
48456010|NCT04229303|101453701|FG006|STARTED|Overall Study||6||
48456011|NCT04229303|101453702|FG007|STARTED|Overall Study||8||
48456012|NCT04229303|101453703|FG008|STARTED|Overall Study||8||
48456013|NCT04229303|101453695|FG000|COMPLETED|Overall Study||6||
48456014|NCT04229303|101453696|FG001|COMPLETED|Overall Study||6||
48456015|NCT04229303|101453697|FG002|COMPLETED|Overall Study||6||
48456016|NCT04229303|101453698|FG003|COMPLETED|Overall Study||6||
48456017|NCT04229303|101453699|FG004|COMPLETED|Overall Study||6||
48456018|NCT04229303|101453700|FG005|COMPLETED|Overall Study||6||
48456019|NCT04229303|101453701|FG006|COMPLETED|Overall Study||6||
48456020|NCT04229303|101453702|FG007|COMPLETED|Overall Study||8||
48456021|NCT04229303|101453703|FG008|COMPLETED|Overall Study||8||
48456022|NCT04229303|101453695|FG000|NOT COMPLETED|Overall Study||0||
48456023|NCT04229303|101453696|FG001|NOT COMPLETED|Overall Study||0||
48456024|NCT04229303|101453697|FG002|NOT COMPLETED|Overall Study||0||
48456025|NCT04229303|101453698|FG003|NOT COMPLETED|Overall Study||0||
48456026|NCT04229303|101453699|FG004|NOT COMPLETED|Overall Study||0||
48456027|NCT04229303|101453700|FG005|NOT COMPLETED|Overall Study||0||
48456028|NCT04229303|101453701|FG006|NOT COMPLETED|Overall Study||0||
48456029|NCT04229303|101453702|FG007|NOT COMPLETED|Overall Study||0||
48456030|NCT04229303|101453703|FG008|NOT COMPLETED|Overall Study||0||
48456031|NCT03751020|101453704|FG000|STARTED|Overall Study||36||
48456032|NCT03751020|101453705|FG001|STARTED|Overall Study||36||
48456033|NCT03751020|101453706|FG002|STARTED|Overall Study||36||
48456034|NCT03751020|101453704|FG000|Post Intervention|Overall Study||33||
48456035|NCT03751020|101453705|FG001|Post Intervention|Overall Study||33||
48456036|NCT03751020|101453706|FG002|Post Intervention|Overall Study||30||
48456037|NCT03751020|101453704|FG000|3 Month Follow Up|Overall Study||27||
48456038|NCT03751020|101453705|FG001|3 Month Follow Up|Overall Study||32||
48456039|NCT03751020|101453706|FG002|3 Month Follow Up|Overall Study||26||
48456040|NCT03751020|101453704|FG000|COMPLETED|Overall Study||27||
48456041|NCT03751020|101453705|FG001|COMPLETED|Overall Study||32||
48456042|NCT03751020|101453706|FG002|COMPLETED|Overall Study||26||
48456043|NCT03751020|101453704|FG000|NOT COMPLETED|Overall Study||9||
48456044|NCT03751020|101453705|FG001|NOT COMPLETED|Overall Study||4||
48456045|NCT03751020|101453706|FG002|NOT COMPLETED|Overall Study||10||
48456046|NCT04335110|101453707|FG000|STARTED|Overall Study||14|Care partners were enrolled in Spring of 2021, completing in Spring 2023|
48456047|NCT04335110|101453708|FG001|STARTED|Overall Study||14|Care partners were enrolled in Spring of 2021, completing in Spring 2023|
48456048|NCT04335110|101453707|FG000|COMPLETED|Overall Study||13||
48456049|NCT04335110|101453708|FG001|COMPLETED|Overall Study||12||
48456050|NCT04335110|101453707|FG000|NOT COMPLETED|Overall Study||1||
48456051|NCT04335110|101453708|FG001|NOT COMPLETED|Overall Study||2||
48456052|NCT02451670|101453709|FG000|STARTED|Overall Study||5264||47
48456053|NCT02451670|101453710|FG001|STARTED|Overall Study||5083||38
48456054|NCT02451670|101453709|FG000|COMPLETED|Overall Study||4550||47
48456055|NCT02451670|101453710|FG001|COMPLETED|Overall Study||4387||38
48456056|NCT02451670|101453709|FG000|NOT COMPLETED|Overall Study||714||0
48189242|NCT02395185|100786181|FG000|NOT COMPLETED|Overall Study||0||
48189243|NCT03392532|100786182|FG000|STARTED|Period 1, FIrst 30 Minutes of Wear||18|As randomized|
48189244|NCT03392532|100786183|FG001|STARTED|Period 1, FIrst 30 Minutes of Wear||18|As randomized|
48456057|NCT02451670|101453710|FG001|NOT COMPLETED|Overall Study||696||0
48189245|NCT03392532|100786182|FG000|COMPLETED|Period 1, FIrst 30 Minutes of Wear||18||
48189246|NCT03392532|100786183|FG001|COMPLETED|Period 1, FIrst 30 Minutes of Wear||18||
48189247|NCT03392532|100786182|FG000|NOT COMPLETED|Period 1, FIrst 30 Minutes of Wear||0||
48189248|NCT03392532|100786183|FG001|NOT COMPLETED|Period 1, FIrst 30 Minutes of Wear||0||
48189249|NCT03392532|100786182|FG000|STARTED|Period 2, Second 30 Minutes of Wear||18|As randomized|
48189250|NCT03392532|100786183|FG001|STARTED|Period 2, Second 30 Minutes of Wear||18|As randomized|
48189251|NCT03392532|100786182|FG000|COMPLETED|Period 2, Second 30 Minutes of Wear||18||
48189252|NCT03392532|100786183|FG001|COMPLETED|Period 2, Second 30 Minutes of Wear||18||
48456058|NCT02410837|101453711|FG000|STARTED|Overall Study||1388||
48456059|NCT02410837|101453711|FG000|Procedure|Overall Study||1388||
48456060|NCT02410837|101453711|FG000|1-Month|Overall Study||1374||
48456061|NCT02410837|101453711|FG000|12-Month|Overall Study||1121||
48456062|NCT02410837|101453711|FG000|24-Month|Overall Study||900||
48456063|NCT02410837|101453711|FG000|COMPLETED|Overall Study||900||
48456064|NCT02410837|101453711|FG000|NOT COMPLETED|Overall Study||488||
48456065|NCT01557452|101453712|FG000|STARTED|Overall Study||1||
48456066|NCT01557452|101453712|FG000|COMPLETED|Overall Study||1||
48456067|NCT01557452|101453712|FG000|NOT COMPLETED|Overall Study||0||
48456068|NCT03990389|101453713|FG000|STARTED|Overall Study||15||
48456069|NCT03990389|101453714|FG001|STARTED|Overall Study||16||
48456070|NCT03990389|101453713|FG000|COMPLETED|Overall Study||12||
48456071|NCT03990389|101453714|FG001|COMPLETED|Overall Study||16||
48456072|NCT03990389|101453713|FG000|NOT COMPLETED|Overall Study||3||
48456073|NCT03990389|101453714|FG001|NOT COMPLETED|Overall Study||0||
48456074|NCT00947011|101453715|FG000|STARTED|Overall Study||12||
48456075|NCT00947011|101453715|FG000|COMPLETED|Overall Study||0||
48189253|NCT03392532|100786182|FG000|NOT COMPLETED|Period 2, Second 30 Minutes of Wear||0||
48189254|NCT03392532|100786183|FG001|NOT COMPLETED|Period 2, Second 30 Minutes of Wear||0||
48189255|NCT05750745|100786184|FG000|STARTED|Overall Study||97||
48189256|NCT05750745|100786185|FG001|STARTED|Overall Study||50||
48189257|NCT05750745|100786186|FG002|STARTED|Overall Study||96||
48189258|NCT05750745|100786184|FG000|COMPLETED|Overall Study||95||
48189259|NCT05750745|100786185|FG001|COMPLETED|Overall Study||49||
48189260|NCT05750745|100786186|FG002|COMPLETED|Overall Study||96||
48189261|NCT05750745|100786184|FG000|NOT COMPLETED|Overall Study||2||
48189262|NCT05750745|100786185|FG001|NOT COMPLETED|Overall Study||1||
48189263|NCT05750745|100786186|FG002|NOT COMPLETED|Overall Study||0||
48189264|NCT01522339|100786187|FG000|STARTED|Overall Study||15||
48189265|NCT01522339|100786187|FG000|COMPLETED|Overall Study||15||
48369467|NCT04105543|101232779|FG000|Completed Baseline Salivary Measures|Dose Held at Dose Level 1: 15.6mCi||10||
48369468|NCT04105543|101232779|FG000|Completed 3 Months Post EBRT Salivary Measures|Dose Held at Dose Level 1: 15.6mCi||9||
48456076|NCT00947011|101453715|FG000|NOT COMPLETED|Overall Study||12||
48456077|NCT01783496|101453716|FG000|STARTED|Overall Study||10||
48662850|NCT03766399|101959508|FG005|COMPLETED|Part 3a: Asthma Patients (DPI)||0||
48662851|NCT03766399|101959509|FG006|COMPLETED|Part 3a: Asthma Patients (DPI)||0||
48662852|NCT03766399|101959510|FG007|COMPLETED|Part 3a: Asthma Patients (DPI)||0||
48662853|NCT03766399|101959511|FG008|COMPLETED|Part 3a: Asthma Patients (DPI)||0||
48662854|NCT03766399|101959512|FG009|COMPLETED|Part 3a: Asthma Patients (DPI)||0||
48662855|NCT03766399|101959513|FG010|COMPLETED|Part 3a: Asthma Patients (DPI)||0||
48662856|NCT03766399|101959514|FG011|COMPLETED|Part 3a: Asthma Patients (DPI)||0||
48662857|NCT03766399|101959515|FG012|COMPLETED|Part 3a: Asthma Patients (DPI)||0||
48662858|NCT03766399|101959516|FG013|COMPLETED|Part 3a: Asthma Patients (DPI)||0||
48662859|NCT03766399|101959517|FG014|COMPLETED|Part 3a: Asthma Patients (DPI)||18||
48662860|NCT03766399|101959518|FG015|COMPLETED|Part 3a: Asthma Patients (DPI)||18||
48662861|NCT03766399|101959519|FG016|COMPLETED|Part 3a: Asthma Patients (DPI)||0||
48662862|NCT03766399|101959520|FG017|COMPLETED|Part 3a: Asthma Patients (DPI)||0||
48662863|NCT03766399|101959503|FG000|NOT COMPLETED|Part 3a: Asthma Patients (DPI)||0||
48662864|NCT03766399|101959504|FG001|NOT COMPLETED|Part 3a: Asthma Patients (DPI)||0||
48662865|NCT03766399|101959505|FG002|NOT COMPLETED|Part 3a: Asthma Patients (DPI)||0||
48662866|NCT03766399|101959506|FG003|NOT COMPLETED|Part 3a: Asthma Patients (DPI)||0||
48662867|NCT03766399|101959507|FG004|NOT COMPLETED|Part 3a: Asthma Patients (DPI)||0||
48662868|NCT03766399|101959508|FG005|NOT COMPLETED|Part 3a: Asthma Patients (DPI)||0||
48662869|NCT03766399|101959509|FG006|NOT COMPLETED|Part 3a: Asthma Patients (DPI)||0||
48662870|NCT03766399|101959510|FG007|NOT COMPLETED|Part 3a: Asthma Patients (DPI)||0||
48662871|NCT03766399|101959511|FG008|NOT COMPLETED|Part 3a: Asthma Patients (DPI)||0||
48662872|NCT03766399|101959512|FG009|NOT COMPLETED|Part 3a: Asthma Patients (DPI)||0||
48662873|NCT03766399|101959513|FG010|NOT COMPLETED|Part 3a: Asthma Patients (DPI)||0||
48662874|NCT03766399|101959514|FG011|NOT COMPLETED|Part 3a: Asthma Patients (DPI)||0||
48662875|NCT03766399|101959515|FG012|NOT COMPLETED|Part 3a: Asthma Patients (DPI)||0||
48662876|NCT03766399|101959516|FG013|NOT COMPLETED|Part 3a: Asthma Patients (DPI)||0||
48662877|NCT03766399|101959517|FG014|NOT COMPLETED|Part 3a: Asthma Patients (DPI)||0||
48662878|NCT03766399|101959518|FG015|NOT COMPLETED|Part 3a: Asthma Patients (DPI)||0||
48662879|NCT03766399|101959519|FG016|NOT COMPLETED|Part 3a: Asthma Patients (DPI)||0||
48662880|NCT03766399|101959520|FG017|NOT COMPLETED|Part 3a: Asthma Patients (DPI)||0||
48662881|NCT03766399|101959503|FG000|STARTED|Part 3b: Healthy Participants (DPI)||0||
48662882|NCT03766399|101959504|FG001|STARTED|Part 3b: Healthy Participants (DPI)||0||
48662883|NCT03766399|101959505|FG002|STARTED|Part 3b: Healthy Participants (DPI)||0||
48662884|NCT03766399|101959506|FG003|STARTED|Part 3b: Healthy Participants (DPI)||0||
48662885|NCT03766399|101959507|FG004|STARTED|Part 3b: Healthy Participants (DPI)||0||
48662886|NCT03766399|101959508|FG005|STARTED|Part 3b: Healthy Participants (DPI)||0||
48662887|NCT03766399|101959509|FG006|STARTED|Part 3b: Healthy Participants (DPI)||0||
48662888|NCT03766399|101959510|FG007|STARTED|Part 3b: Healthy Participants (DPI)||0||
48662889|NCT03766399|101959511|FG008|STARTED|Part 3b: Healthy Participants (DPI)||0||
48662890|NCT03766399|101959512|FG009|STARTED|Part 3b: Healthy Participants (DPI)||0||
48662891|NCT03766399|101959513|FG010|STARTED|Part 3b: Healthy Participants (DPI)||0||
48662892|NCT03766399|101959514|FG011|STARTED|Part 3b: Healthy Participants (DPI)||0||
48662893|NCT03766399|101959515|FG012|STARTED|Part 3b: Healthy Participants (DPI)||0||
48662894|NCT03766399|101959516|FG013|STARTED|Part 3b: Healthy Participants (DPI)||0||
48662895|NCT03766399|101959517|FG014|STARTED|Part 3b: Healthy Participants (DPI)||0||
48662896|NCT03766399|101959518|FG015|STARTED|Part 3b: Healthy Participants (DPI)||0||
48662897|NCT03766399|101959519|FG016|STARTED|Part 3b: Healthy Participants (DPI)||2||
48662898|NCT03766399|101959520|FG017|STARTED|Part 3b: Healthy Participants (DPI)||6||
48369469|NCT04105543|101232779|FG000|Completed 6 Months Post EBRT Salivary Measures|Dose Held at Dose Level 1: 15.6mCi||5||
48456078|NCT01783496|101453717|FG001|STARTED|Overall Study||10||
48456079|NCT01783496|101453718|FG002|STARTED|Overall Study||10||
48189266|NCT01522339|100786187|FG000|NOT COMPLETED|Overall Study||0||
48189267|NCT03168438|100786188|FG000|STARTED|Overall Study||3||
48456080|NCT01783496|101453719|FG003|STARTED|Overall Study||10||
48456081|NCT01783496|101453720|FG004|STARTED|Overall Study||5||
48456082|NCT01783496|101453721|FG005|STARTED|Overall Study||5||
48456083|NCT01783496|101453716|FG000|COMPLETED|Overall Study||9||
48456084|NCT01783496|101453717|FG001|COMPLETED|Overall Study||10||
48456085|NCT01783496|101453718|FG002|COMPLETED|Overall Study||10||
48456086|NCT01783496|101453719|FG003|COMPLETED|Overall Study||8||
48456087|NCT01783496|101453720|FG004|COMPLETED|Overall Study||5||
48456088|NCT01783496|101453721|FG005|COMPLETED|Overall Study||4||
48456089|NCT01783496|101453716|FG000|NOT COMPLETED|Overall Study||1||
48456090|NCT01783496|101453717|FG001|NOT COMPLETED|Overall Study||0||
48456091|NCT01783496|101453718|FG002|NOT COMPLETED|Overall Study||0||
48456092|NCT01783496|101453719|FG003|NOT COMPLETED|Overall Study||2||
48456093|NCT01783496|101453720|FG004|NOT COMPLETED|Overall Study||0||
48662899|NCT03766399|101959503|FG000|COMPLETED|Part 3b: Healthy Participants (DPI)||0||
48456094|NCT01783496|101453721|FG005|NOT COMPLETED|Overall Study||1||
48456095|NCT03862625|101453722|FG000|STARTED|Overall Study||15||
48456096|NCT03862625|101453723|FG001|STARTED|Overall Study||15||
48456097|NCT03862625|101453722|FG000|COMPLETED|Overall Study||15||
48456098|NCT03862625|101453723|FG001|COMPLETED|Overall Study||14||
48456099|NCT03862625|101453722|FG000|NOT COMPLETED|Overall Study||0||
48456100|NCT03862625|101453723|FG001|NOT COMPLETED|Overall Study||1||
48456101|NCT03361956|101453724|FG000|STARTED|Overall Study||43||
48456102|NCT03361956|101453725|FG001|STARTED|Overall Study||28||
48456103|NCT03361956|101453726|FG002|STARTED|Overall Study||66||
48456104|NCT03361956|101453727|FG003|STARTED|Overall Study||32||
48456105|NCT03361956|101453728|FG004|STARTED|Overall Study||63||
48456106|NCT03361956|101453724|FG000|Currently Not Treated|Overall Study||22||
48456107|NCT03361956|101453725|FG001|Currently Not Treated|Overall Study||28||
48456108|NCT03361956|101453726|FG002|Currently Not Treated|Overall Study||33||
48456109|NCT03361956|101453727|FG003|Currently Not Treated|Overall Study||32||
48456110|NCT03361956|101453728|FG004|Currently Not Treated|Overall Study||33||
48456111|NCT03361956|101453724|FG000|Virologically Suppressed|Overall Study||21||
48456112|NCT03361956|101453725|FG001|Virologically Suppressed|Overall Study||0||
48456113|NCT03361956|101453726|FG002|Virologically Suppressed|Overall Study||33||
48456114|NCT03361956|101453727|FG003|Virologically Suppressed|Overall Study||0||
48456115|NCT03361956|101453728|FG004|Virologically Suppressed|Overall Study||30||
48456116|NCT03361956|101453724|FG000|COMPLETED|Overall Study||40||
48456117|NCT03361956|101453725|FG001|COMPLETED|Overall Study||24||
48456118|NCT03361956|101453726|FG002|COMPLETED|Overall Study||61||
48456119|NCT03361956|101453727|FG003|COMPLETED|Overall Study||28||
48662900|NCT03766399|101959504|FG001|COMPLETED|Part 3b: Healthy Participants (DPI)||0||
48456120|NCT03361956|101453728|FG004|COMPLETED|Overall Study||58||
48456121|NCT03361956|101453724|FG000|NOT COMPLETED|Overall Study||3||
48456122|NCT03361956|101453725|FG001|NOT COMPLETED|Overall Study||4||
48456123|NCT03361956|101453726|FG002|NOT COMPLETED|Overall Study||5||
48456124|NCT03361956|101453727|FG003|NOT COMPLETED|Overall Study||4||
48456125|NCT03361956|101453728|FG004|NOT COMPLETED|Overall Study||5||
48456126|NCT00814658|101453729|FG000|STARTED|Overall Study||9||
48456127|NCT00814658|101453730|FG001|STARTED|Overall Study||12||
48456128|NCT00814658|101453729|FG000|COMPLETED|Overall Study||5||
48456129|NCT00814658|101453730|FG001|COMPLETED|Overall Study||8||
48456130|NCT00814658|101453729|FG000|NOT COMPLETED|Overall Study||4||
48456131|NCT00814658|101453730|FG001|NOT COMPLETED|Overall Study||4||
48456132|NCT03705169|101453731|FG000|STARTED|Overall Study||4||
48456133|NCT03705169|101453732|FG001|STARTED|Overall Study||4||
48456134|NCT03705169|101453733|FG002|STARTED|Overall Study||4||
48456135|NCT03705169|101453734|FG003|STARTED|Overall Study||11||
48456136|NCT03705169|101453735|FG004|STARTED|Overall Study||10||
48456137|NCT03705169|101453736|FG005|STARTED|Overall Study||5||
48456138|NCT03705169|101453737|FG006|STARTED|Overall Study||2||
48456139|NCT03705169|101453738|FG007|STARTED|Overall Study||4||
48456140|NCT03705169|101453739|FG008|STARTED|Overall Study||4||
48456141|NCT03705169|101453740|FG009|STARTED|Overall Study||4||
48456142|NCT03705169|101453731|FG000|Participants Receiving First Dose|Overall Study||4||
48456143|NCT03705169|101453732|FG001|Participants Receiving First Dose|Overall Study||4||
48456144|NCT03705169|101453733|FG002|Participants Receiving First Dose|Overall Study||4||
48456145|NCT03705169|101453734|FG003|Participants Receiving First Dose|Overall Study||10||
48456146|NCT03705169|101453735|FG004|Participants Receiving First Dose|Overall Study||10||
48456147|NCT03705169|101453736|FG005|Participants Receiving First Dose|Overall Study||5||
48456148|NCT03705169|101453737|FG006|Participants Receiving First Dose|Overall Study||2||
48456149|NCT03705169|101453738|FG007|Participants Receiving First Dose|Overall Study||4||
48456150|NCT03705169|101453739|FG008|Participants Receiving First Dose|Overall Study||4||
48456151|NCT03705169|101453740|FG009|Participants Receiving First Dose|Overall Study||4||
48456152|NCT03705169|101453731|FG000|COMPLETED|Overall Study||4||
48456153|NCT03705169|101453732|FG001|COMPLETED|Overall Study||4||
48456154|NCT03705169|101453733|FG002|COMPLETED|Overall Study||4||
48456155|NCT03705169|101453734|FG003|COMPLETED|Overall Study||5||
48456156|NCT03705169|101453735|FG004|COMPLETED|Overall Study||10||
48456157|NCT03705169|101453736|FG005|COMPLETED|Overall Study||3||
48456158|NCT03705169|101453737|FG006|COMPLETED|Overall Study||1||
48456159|NCT03705169|101453738|FG007|COMPLETED|Overall Study||4||
48456160|NCT03705169|101453739|FG008|COMPLETED|Overall Study||4||
48456161|NCT03705169|101453740|FG009|COMPLETED|Overall Study||3||
48456162|NCT03705169|101453731|FG000|NOT COMPLETED|Overall Study||0||
48456163|NCT03705169|101453732|FG001|NOT COMPLETED|Overall Study||0||
48456164|NCT03705169|101453733|FG002|NOT COMPLETED|Overall Study||0||
48456165|NCT03705169|101453734|FG003|NOT COMPLETED|Overall Study||6||
48456166|NCT03705169|101453735|FG004|NOT COMPLETED|Overall Study||0||
48456167|NCT03705169|101453736|FG005|NOT COMPLETED|Overall Study||2||
48456168|NCT03705169|101453737|FG006|NOT COMPLETED|Overall Study||1||
48456169|NCT03705169|101453738|FG007|NOT COMPLETED|Overall Study||0||
48456170|NCT03705169|101453739|FG008|NOT COMPLETED|Overall Study||0||
48456171|NCT03705169|101453740|FG009|NOT COMPLETED|Overall Study||1||
48456172|NCT00787566|101453741|FG000|STARTED|Overall Study||21||
48456173|NCT00787566|101453742|FG001|STARTED|Overall Study||25||
48456174|NCT00787566|101453743|FG002|STARTED|Overall Study||22||
48456175|NCT00787566|101453741|FG000|COMPLETED|Overall Study||21||
48662901|NCT03766399|101959505|FG002|COMPLETED|Part 3b: Healthy Participants (DPI)||0||
48662902|NCT03766399|101959506|FG003|COMPLETED|Part 3b: Healthy Participants (DPI)||0||
48662903|NCT03766399|101959507|FG004|COMPLETED|Part 3b: Healthy Participants (DPI)||0||
48662904|NCT03766399|101959508|FG005|COMPLETED|Part 3b: Healthy Participants (DPI)||0||
48662905|NCT03766399|101959509|FG006|COMPLETED|Part 3b: Healthy Participants (DPI)||0||
48772780|NCT00790842|102232802|FG009|Began Treatment|Dose Level 3||3||
48456176|NCT00787566|101453742|FG001|COMPLETED|Overall Study||24||
48456177|NCT00787566|101453743|FG002|COMPLETED|Overall Study||22||
48456178|NCT00787566|101453741|FG000|NOT COMPLETED|Overall Study||0||
48456179|NCT00787566|101453742|FG001|NOT COMPLETED|Overall Study||1||
48456180|NCT00787566|101453743|FG002|NOT COMPLETED|Overall Study||0||
48456181|NCT00003782|101453744|FG000|STARTED|Overall Study||1783||
48456182|NCT00003782|101453745|FG001|STARTED|Overall Study||1784||
48456183|NCT00003782|101453746|FG002|STARTED|Overall Study||1784||
48662906|NCT03766399|101959510|FG007|COMPLETED|Part 3b: Healthy Participants (DPI)||0||
48662907|NCT03766399|101959511|FG008|COMPLETED|Part 3b: Healthy Participants (DPI)||0||
48662908|NCT03766399|101959512|FG009|COMPLETED|Part 3b: Healthy Participants (DPI)||0||
48662909|NCT03766399|101959513|FG010|COMPLETED|Part 3b: Healthy Participants (DPI)||0||
48662910|NCT03766399|101959514|FG011|COMPLETED|Part 3b: Healthy Participants (DPI)||0||
48662911|NCT03766399|101959515|FG012|COMPLETED|Part 3b: Healthy Participants (DPI)||0||
48662912|NCT03766399|101959516|FG013|COMPLETED|Part 3b: Healthy Participants (DPI)||0||
48662913|NCT03766399|101959517|FG014|COMPLETED|Part 3b: Healthy Participants (DPI)||0||
48456184|NCT00003782|101453744|FG000|COMPLETED|Overall Study||1753||
48456185|NCT00003782|101453745|FG001|COMPLETED|Overall Study||1753||
48456186|NCT00003782|101453746|FG002|COMPLETED|Overall Study||1758||
48456187|NCT00003782|101453744|FG000|NOT COMPLETED|Overall Study||30||
48662914|NCT03766399|101959518|FG015|COMPLETED|Part 3b: Healthy Participants (DPI)||0||
48662915|NCT03766399|101959519|FG016|COMPLETED|Part 3b: Healthy Participants (DPI)||2||
48662916|NCT03766399|101959520|FG017|COMPLETED|Part 3b: Healthy Participants (DPI)||6||
48772781|NCT00790842|102232803|FG010|Began Treatment|Dose Level 3||0||
48772782|NCT00790842|102232793|FG000|COMPLETED|Dose Level 3||0||
48772783|NCT00790842|102232794|FG001|COMPLETED|Dose Level 3||0||
48772784|NCT00790842|102232795|FG002|COMPLETED|Dose Level 3||2||
48772785|NCT00790842|102232796|FG003|COMPLETED|Dose Level 3||0||
48772786|NCT00790842|102232797|FG004|COMPLETED|Dose Level 3||0||
48772787|NCT00790842|102232798|FG005|COMPLETED|Dose Level 3||2||
48772788|NCT00790842|102232799|FG006|COMPLETED|Dose Level 3||0||
48772789|NCT00790842|102232800|FG007|COMPLETED|Dose Level 3||0||
48662917|NCT03766399|101959503|FG000|NOT COMPLETED|Part 3b: Healthy Participants (DPI)||0||
48662918|NCT03766399|101959504|FG001|NOT COMPLETED|Part 3b: Healthy Participants (DPI)||0||
48662919|NCT03766399|101959505|FG002|NOT COMPLETED|Part 3b: Healthy Participants (DPI)||0||
48662920|NCT03766399|101959506|FG003|NOT COMPLETED|Part 3b: Healthy Participants (DPI)||0||
48662921|NCT03766399|101959507|FG004|NOT COMPLETED|Part 3b: Healthy Participants (DPI)||0||
48662922|NCT03766399|101959508|FG005|NOT COMPLETED|Part 3b: Healthy Participants (DPI)||0||
48662923|NCT03766399|101959509|FG006|NOT COMPLETED|Part 3b: Healthy Participants (DPI)||0||
48662924|NCT03766399|101959510|FG007|NOT COMPLETED|Part 3b: Healthy Participants (DPI)||0||
48662925|NCT03766399|101959511|FG008|NOT COMPLETED|Part 3b: Healthy Participants (DPI)||0||
48662926|NCT03766399|101959512|FG009|NOT COMPLETED|Part 3b: Healthy Participants (DPI)||0||
48772790|NCT00790842|102232801|FG008|COMPLETED|Dose Level 3||0||
48772791|NCT00790842|102232802|FG009|COMPLETED|Dose Level 3||1||
48456188|NCT00003782|101453745|FG001|NOT COMPLETED|Overall Study||31||
48662927|NCT03766399|101959513|FG010|NOT COMPLETED|Part 3b: Healthy Participants (DPI)||0||
48772792|NCT00790842|102232803|FG010|COMPLETED|Dose Level 3||0||
48772793|NCT00790842|102232793|FG000|NOT COMPLETED|Dose Level 3||0||
48772794|NCT00790842|102232794|FG001|NOT COMPLETED|Dose Level 3||0||
48456189|NCT00003782|101453746|FG002|NOT COMPLETED|Overall Study||26||
48456190|NCT01154153|101453747|FG000|STARTED|Overall Study||71||
48456191|NCT01154153|101453748|FG001|STARTED|Overall Study||69||
48662928|NCT03766399|101959514|FG011|NOT COMPLETED|Part 3b: Healthy Participants (DPI)||0||
48662929|NCT03766399|101959515|FG012|NOT COMPLETED|Part 3b: Healthy Participants (DPI)||0||
48662930|NCT03766399|101959516|FG013|NOT COMPLETED|Part 3b: Healthy Participants (DPI)||0||
48662931|NCT03766399|101959517|FG014|NOT COMPLETED|Part 3b: Healthy Participants (DPI)||0||
48662932|NCT03766399|101959518|FG015|NOT COMPLETED|Part 3b: Healthy Participants (DPI)||0||
48662933|NCT03766399|101959519|FG016|NOT COMPLETED|Part 3b: Healthy Participants (DPI)||0||
48662934|NCT03766399|101959520|FG017|NOT COMPLETED|Part 3b: Healthy Participants (DPI)||0||
48662935|NCT03312543|101959521|FG000|STARTED|Before Treatment (Screening to Baseline)||61||
48662936|NCT03312543|101959522|FG001|STARTED|Before Treatment (Screening to Baseline)||63||
48662937|NCT03312543|101959521|FG000|COMPLETED|Before Treatment (Screening to Baseline)||60||
48662938|NCT03312543|101959522|FG001|COMPLETED|Before Treatment (Screening to Baseline)||59||
48662939|NCT03312543|101959521|FG000|NOT COMPLETED|Before Treatment (Screening to Baseline)||1||
48662940|NCT03312543|101959522|FG001|NOT COMPLETED|Before Treatment (Screening to Baseline)||4||
48662941|NCT03312543|101959521|FG000|STARTED|Treatment (Baseline to Week 12)||60||
48662942|NCT03312543|101959522|FG001|STARTED|Treatment (Baseline to Week 12)||59||
48662943|NCT03312543|101959521|FG000|COMPLETED|Treatment (Baseline to Week 12)||56||
48662944|NCT03312543|101959522|FG001|COMPLETED|Treatment (Baseline to Week 12)||54||
48662945|NCT03312543|101959521|FG000|NOT COMPLETED|Treatment (Baseline to Week 12)||4||
48662946|NCT03312543|101959522|FG001|NOT COMPLETED|Treatment (Baseline to Week 12)||5||
48662947|NCT03312543|101959521|FG000|STARTED|Regression (Week 12 to Week 24)||56||
48662948|NCT03312543|101959522|FG001|STARTED|Regression (Week 12 to Week 24)||54||
48662949|NCT03312543|101959521|FG000|COMPLETED|Regression (Week 12 to Week 24)||55||
48662950|NCT03312543|101959522|FG001|COMPLETED|Regression (Week 12 to Week 24)||52||
48662951|NCT03312543|101959521|FG000|NOT COMPLETED|Regression (Week 12 to Week 24)||1||
48662952|NCT03312543|101959522|FG001|NOT COMPLETED|Regression (Week 12 to Week 24)||2||
48662953|NCT04681885|101959523|FG000|STARTED|First Intervention (1 Week)||4||
48662954|NCT04681885|101959524|FG001|STARTED|First Intervention (1 Week)||3||
48772795|NCT00790842|102232795|FG002|NOT COMPLETED|Dose Level 3||5||
48772796|NCT00790842|102232796|FG003|NOT COMPLETED|Dose Level 3||0||
48772797|NCT00790842|102232797|FG004|NOT COMPLETED|Dose Level 3||0||
48772798|NCT00790842|102232798|FG005|NOT COMPLETED|Dose Level 3||1||
48772799|NCT00790842|102232799|FG006|NOT COMPLETED|Dose Level 3||0||
48772800|NCT00790842|102232800|FG007|NOT COMPLETED|Dose Level 3||0||
48456192|NCT01154153|101453747|FG000|COMPLETED|Overall Study||66||
48456193|NCT01154153|101453748|FG001|COMPLETED|Overall Study||66||
48456194|NCT01154153|101453747|FG000|NOT COMPLETED|Overall Study||5||
48456195|NCT01154153|101453748|FG001|NOT COMPLETED|Overall Study||3||
48456196|NCT02308111|101453749|FG000|STARTED|Overall Study||168||
48456197|NCT02308111|101453750|FG001|STARTED|Overall Study||166||
48456198|NCT02308111|101453749|FG000|Received at Least 1 Dose of Study Drug|Overall Study||168||
48456199|NCT02308111|101453750|FG001|Received at Least 1 Dose of Study Drug|Overall Study||166||
48456200|NCT02308111|101453749|FG000|COMPLETED|Overall Study||0|The discontinuation reasons from here onward reflect discontinuation for withdrawal from study visits only. Reasons for discontinuation from study IP and reasons for discontinuation from study follow-up (phone call / medical record review) were also collected but are not reported here.|
48456201|NCT02308111|101453750|FG001|COMPLETED|Overall Study||0|The discontinuation reasons from here onward reflect discontinuation for withdrawal from study visits only. Reasons for discontinuation from study IP and reasons for discontinuation from study follow-up (phone call / medical record review) were also collected but are not reported here.|
48456202|NCT02308111|101453749|FG000|NOT COMPLETED|Overall Study||168||
48456203|NCT02308111|101453750|FG001|NOT COMPLETED|Overall Study||166||
48456204|NCT01681771|101453751|FG000|STARTED|Overall Study||25||
48456205|NCT01681771|101453752|FG001|STARTED|Overall Study||25||
48456206|NCT01681771|101453751|FG000|COMPLETED|Overall Study||21||
48670052|NCT02052882|101974879|FG000|STARTED|Overall Study||60||
48772801|NCT00790842|102232801|FG008|NOT COMPLETED|Dose Level 3||0||
48772802|NCT00790842|102232802|FG009|NOT COMPLETED|Dose Level 3||2||
48772803|NCT00790842|102232803|FG010|NOT COMPLETED|Dose Level 3||0||
48772804|NCT00790842|102232793|FG000|STARTED|Dose Level 4||0||
48772805|NCT00790842|102232794|FG001|STARTED|Dose Level 4||0||
48456207|NCT01681771|101453752|FG001|COMPLETED|Overall Study||23||
48456208|NCT01681771|101453751|FG000|NOT COMPLETED|Overall Study||4||
48456209|NCT01681771|101453752|FG001|NOT COMPLETED|Overall Study||2||
48456210|NCT00863057|101453753|FG000|STARTED|Milestones Period 1 (Weeks 0-5)||4||
48456211|NCT00863057|101453754|FG001|STARTED|Milestones Period 1 (Weeks 0-5)||4||
48456212|NCT00863057|101453755|FG002|STARTED|Milestones Period 1 (Weeks 0-5)||3||
48456213|NCT00863057|101453756|FG003|STARTED|Milestones Period 1 (Weeks 0-5)||4||
48456214|NCT00863057|101453753|FG000|COMPLETED|Milestones Period 1 (Weeks 0-5)||3||
48456215|NCT00863057|101453754|FG001|COMPLETED|Milestones Period 1 (Weeks 0-5)||2||
48456216|NCT00863057|101453755|FG002|COMPLETED|Milestones Period 1 (Weeks 0-5)||3||
48456217|NCT00863057|101453756|FG003|COMPLETED|Milestones Period 1 (Weeks 0-5)||3||
48456218|NCT00863057|101453753|FG000|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1||
48456219|NCT00863057|101453754|FG001|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||2||
48456220|NCT00863057|101453755|FG002|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||0||
48456221|NCT00863057|101453756|FG003|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1||
48456222|NCT00863057|101453753|FG000|STARTED|Period 2 (Weeks 6-10)||3||
48456223|NCT00863057|101453754|FG001|STARTED|Period 2 (Weeks 6-10)||2||
48456224|NCT00863057|101453755|FG002|STARTED|Period 2 (Weeks 6-10)||3||
48456225|NCT00863057|101453756|FG003|STARTED|Period 2 (Weeks 6-10)||3||
48456226|NCT00863057|101453753|FG000|COMPLETED|Period 2 (Weeks 6-10)||3||
48456227|NCT00863057|101453754|FG001|COMPLETED|Period 2 (Weeks 6-10)||1||
48456228|NCT00863057|101453755|FG002|COMPLETED|Period 2 (Weeks 6-10)||2||
48456229|NCT00863057|101453756|FG003|COMPLETED|Period 2 (Weeks 6-10)||2||
48456230|NCT00863057|101453753|FG000|NOT COMPLETED|Period 2 (Weeks 6-10)||0||
48456231|NCT00863057|101453754|FG001|NOT COMPLETED|Period 2 (Weeks 6-10)||1||
48456232|NCT00863057|101453755|FG002|NOT COMPLETED|Period 2 (Weeks 6-10)||1||
48456233|NCT00863057|101453756|FG003|NOT COMPLETED|Period 2 (Weeks 6-10)||1||
48456234|NCT00863057|101453753|FG000|STARTED|Period 3 (Weeks 11-15)||3||
48662955|NCT04681885|101959525|FG002|STARTED|First Intervention (1 Week)||3||
48662956|NCT04681885|101959523|FG000|COMPLETED|First Intervention (1 Week)||4||
48662957|NCT04681885|101959524|FG001|COMPLETED|First Intervention (1 Week)||3||
48662958|NCT04681885|101959525|FG002|COMPLETED|First Intervention (1 Week)||3||
48662959|NCT04681885|101959523|FG000|NOT COMPLETED|First Intervention (1 Week)||0||
48662960|NCT04681885|101959524|FG001|NOT COMPLETED|First Intervention (1 Week)||0||
48662961|NCT04681885|101959525|FG002|NOT COMPLETED|First Intervention (1 Week)||0||
48662962|NCT04681885|101959523|FG000|STARTED|Washout (1 Week)||4||
48662963|NCT04681885|101959524|FG001|STARTED|Washout (1 Week)||3||
48662964|NCT04681885|101959525|FG002|STARTED|Washout (1 Week)||3||
48662965|NCT04681885|101959523|FG000|COMPLETED|Washout (1 Week)||4||
48662966|NCT04681885|101959524|FG001|COMPLETED|Washout (1 Week)||3||
48662967|NCT04681885|101959525|FG002|COMPLETED|Washout (1 Week)||3||
48662968|NCT04681885|101959523|FG000|NOT COMPLETED|Washout (1 Week)||0||
48662969|NCT04681885|101959524|FG001|NOT COMPLETED|Washout (1 Week)||0||
48662970|NCT04681885|101959525|FG002|NOT COMPLETED|Washout (1 Week)||0||
48662971|NCT04681885|101959523|FG000|STARTED|Second Intervention (1 Week)||4||
48662972|NCT04681885|101959524|FG001|STARTED|Second Intervention (1 Week)||3||
48662973|NCT04681885|101959525|FG002|STARTED|Second Intervention (1 Week)||3||
48662974|NCT04681885|101959523|FG000|COMPLETED|Second Intervention (1 Week)||4||
48662975|NCT04681885|101959524|FG001|COMPLETED|Second Intervention (1 Week)||3||
48662976|NCT04681885|101959525|FG002|COMPLETED|Second Intervention (1 Week)||3||
48662977|NCT04681885|101959523|FG000|NOT COMPLETED|Second Intervention (1 Week)||0||
48662978|NCT04681885|101959524|FG001|NOT COMPLETED|Second Intervention (1 Week)||0||
48662979|NCT04681885|101959525|FG002|NOT COMPLETED|Second Intervention (1 Week)||0||
48662980|NCT04681885|101959523|FG000|STARTED|Washout (1 Week)||4||
48662981|NCT04681885|101959524|FG001|STARTED|Washout (1 Week)||3||
48662982|NCT04681885|101959525|FG002|STARTED|Washout (1 Week)||3||
48662983|NCT04681885|101959523|FG000|COMPLETED|Washout (1 Week)||4||
48662984|NCT04681885|101959524|FG001|COMPLETED|Washout (1 Week)||3||
48456235|NCT00863057|101453754|FG001|STARTED|Period 3 (Weeks 11-15)||1||
48456236|NCT00863057|101453755|FG002|STARTED|Period 3 (Weeks 11-15)||2||
48456237|NCT00863057|101453756|FG003|STARTED|Period 3 (Weeks 11-15)||2||
48456238|NCT00863057|101453753|FG000|COMPLETED|Period 3 (Weeks 11-15)||3||
48662985|NCT04681885|101959525|FG002|COMPLETED|Washout (1 Week)||3||
48662986|NCT04681885|101959523|FG000|NOT COMPLETED|Washout (1 Week)||0||
48662987|NCT04681885|101959524|FG001|NOT COMPLETED|Washout (1 Week)||0||
48662988|NCT04681885|101959525|FG002|NOT COMPLETED|Washout (1 Week)||0||
48662989|NCT04681885|101959523|FG000|STARTED|Third Intervention (1 Week)||4||
48662990|NCT04681885|101959524|FG001|STARTED|Third Intervention (1 Week)||3||
48772806|NCT00790842|102232795|FG002|STARTED|Dose Level 4||0||
48772807|NCT00790842|102232796|FG003|STARTED|Dose Level 4||0||
48772808|NCT00790842|102232797|FG004|STARTED|Dose Level 4||0||
48772809|NCT00790842|102232798|FG005|STARTED|Dose Level 4||0||
48772810|NCT00790842|102232799|FG006|STARTED|Dose Level 4||8||
48456239|NCT00863057|101453754|FG001|COMPLETED|Period 3 (Weeks 11-15)||1||
48456240|NCT00863057|101453755|FG002|COMPLETED|Period 3 (Weeks 11-15)||2||
48456241|NCT00863057|101453756|FG003|COMPLETED|Period 3 (Weeks 11-15)||2||
48456242|NCT00863057|101453753|FG000|NOT COMPLETED|Period 3 (Weeks 11-15)||0||
48456243|NCT00863057|101453754|FG001|NOT COMPLETED|Period 3 (Weeks 11-15)||0||
48662991|NCT04681885|101959525|FG002|STARTED|Third Intervention (1 Week)||3||
48662992|NCT04681885|101959523|FG000|COMPLETED|Third Intervention (1 Week)||4||
48772811|NCT00790842|102232800|FG007|STARTED|Dose Level 4||0||
48662993|NCT04681885|101959524|FG001|COMPLETED|Third Intervention (1 Week)||3||
48662994|NCT04681885|101959525|FG002|COMPLETED|Third Intervention (1 Week)||3||
48662995|NCT04681885|101959523|FG000|NOT COMPLETED|Third Intervention (1 Week)||0||
48456244|NCT00863057|101453755|FG002|NOT COMPLETED|Period 3 (Weeks 11-15)||0||
48456245|NCT00863057|101453756|FG003|NOT COMPLETED|Period 3 (Weeks 11-15)||0||
48456246|NCT00863057|101453753|FG000|STARTED|Period 4 (Weeks 16-20)||3||
48456247|NCT00863057|101453754|FG001|STARTED|Period 4 (Weeks 16-20)||1||
48456248|NCT00863057|101453755|FG002|STARTED|Period 4 (Weeks 16-20)||2||
48456249|NCT00863057|101453756|FG003|STARTED|Period 4 (Weeks 16-20)||2||
48456250|NCT00863057|101453753|FG000|COMPLETED|Period 4 (Weeks 16-20)||3||
48456251|NCT00863057|101453754|FG001|COMPLETED|Period 4 (Weeks 16-20)||1||
48456252|NCT00863057|101453755|FG002|COMPLETED|Period 4 (Weeks 16-20)||2||
48456253|NCT00863057|101453756|FG003|COMPLETED|Period 4 (Weeks 16-20)||2||
48456254|NCT00863057|101453753|FG000|NOT COMPLETED|Period 4 (Weeks 16-20)||0||
48456255|NCT00863057|101453754|FG001|NOT COMPLETED|Period 4 (Weeks 16-20)||0||
48456256|NCT00863057|101453755|FG002|NOT COMPLETED|Period 4 (Weeks 16-20)||0||
48456257|NCT00863057|101453756|FG003|NOT COMPLETED|Period 4 (Weeks 16-20)||0||
48456258|NCT00006721|101453757|FG000|STARTED|Overall Study||17||
48456259|NCT00006721|101453758|FG001|STARTED|Overall Study||279||
48456260|NCT00006721|101453759|FG002|STARTED|Overall Study||275||
48456261|NCT00006721|101453757|FG000|Eligible|Overall Study||15||
48456262|NCT00006721|101453758|FG001|Eligible|Overall Study||267||
48456263|NCT00006721|101453759|FG002|Eligible|Overall Study||265||
48456264|NCT00006721|101453757|FG000|Eligible and Began Protocol Therapy|Overall Study||14||
48456265|NCT00006721|101453758|FG001|Eligible and Began Protocol Therapy|Overall Study||267||
48456266|NCT00006721|101453759|FG002|Eligible and Began Protocol Therapy|Overall Study||265||
48456267|NCT00006721|101453757|FG000|COMPLETED|Overall Study||13||
48456268|NCT00006721|101453758|FG001|COMPLETED|Overall Study||254||
48456269|NCT00006721|101453759|FG002|COMPLETED|Overall Study||242||
48456270|NCT00006721|101453757|FG000|NOT COMPLETED|Overall Study||4||
48456271|NCT00006721|101453758|FG001|NOT COMPLETED|Overall Study||25||
48456272|NCT00006721|101453759|FG002|NOT COMPLETED|Overall Study||33||
48456273|NCT02967133|101453760|FG000|STARTED|Overall Study||3||
48456274|NCT02967133|101453761|FG001|STARTED|Overall Study||4||
48456275|NCT02967133|101453760|FG000|COMPLETED|Overall Study||3||
48456276|NCT02967133|101453761|FG001|COMPLETED|Overall Study||4||
48456277|NCT02967133|101453760|FG000|NOT COMPLETED|Overall Study||0||
48456278|NCT02967133|101453761|FG001|NOT COMPLETED|Overall Study||0||
48456279|NCT01072032|101453762|FG000|STARTED|Overall Study||13||
48456280|NCT01072032|101453763|FG001|STARTED|Overall Study||14||
48456281|NCT01072032|101453762|FG000|COMPLETED|Overall Study||5||
48456282|NCT01072032|101453763|FG001|COMPLETED|Overall Study||5||
48456283|NCT01072032|101453762|FG000|NOT COMPLETED|Overall Study||8||
48456284|NCT01072032|101453763|FG001|NOT COMPLETED|Overall Study||9||
48456285|NCT01078623|101453764|FG000|STARTED|Treatment Period 1||6||
48456286|NCT01078623|101453765|FG001|STARTED|Treatment Period 1||6||
48456287|NCT01078623|101453766|FG002|STARTED|Treatment Period 1||7||
48456288|NCT01078623|101453767|FG003|STARTED|Treatment Period 1||6||
48456289|NCT01078623|101453768|FG004|STARTED|Treatment Period 1||7||
48456290|NCT01078623|101453769|FG005|STARTED|Treatment Period 1||6||
48456291|NCT01078623|101453770|FG006|STARTED|Treatment Period 1||7||
48456292|NCT01078623|101453771|FG007|STARTED|Treatment Period 1||7||
48456293|NCT01078623|101453772|FG008|STARTED|Treatment Period 1||6||
48456294|NCT01078623|101453773|FG009|STARTED|Treatment Period 1||7||
48456295|NCT01078623|101453774|FG010|STARTED|Treatment Period 1||7||
48456296|NCT01078623|101453775|FG011|STARTED|Treatment Period 1||7||
48456297|NCT01078623|101453776|FG012|STARTED|Treatment Period 1||7||
48456298|NCT01078623|101453777|FG013|STARTED|Treatment Period 1||7||
48456299|NCT01078623|101453778|FG014|STARTED|Treatment Period 1||7||
48456300|NCT01078623|101453779|FG015|STARTED|Treatment Period 1||7||
48456301|NCT01078623|101453780|FG016|STARTED|Treatment Period 1||7||
48456302|NCT01078623|101453781|FG017|STARTED|Treatment Period 1||7||
48456303|NCT01078623|101453782|FG018|STARTED|Treatment Period 1||7||
48456304|NCT01078623|101453783|FG019|STARTED|Treatment Period 1||7||
48456305|NCT01078623|101453764|FG000|COMPLETED|Treatment Period 1||5||
48456306|NCT01078623|101453765|FG001|COMPLETED|Treatment Period 1||5||
48456307|NCT01078623|101453766|FG002|COMPLETED|Treatment Period 1||6||
48456308|NCT01078623|101453767|FG003|COMPLETED|Treatment Period 1||6||
48456309|NCT01078623|101453768|FG004|COMPLETED|Treatment Period 1||7||
48456310|NCT01078623|101453769|FG005|COMPLETED|Treatment Period 1||5||
48456311|NCT01078623|101453770|FG006|COMPLETED|Treatment Period 1||6||
48456312|NCT01078623|101453771|FG007|COMPLETED|Treatment Period 1||6||
48662996|NCT04681885|101959524|FG001|NOT COMPLETED|Third Intervention (1 Week)||0||
48662997|NCT04681885|101959525|FG002|NOT COMPLETED|Third Intervention (1 Week)||0||
48456313|NCT01078623|101453772|FG008|COMPLETED|Treatment Period 1||5||
48456314|NCT01078623|101453773|FG009|COMPLETED|Treatment Period 1||6||
48456315|NCT01078623|101453774|FG010|COMPLETED|Treatment Period 1||6||
48456316|NCT01078623|101453775|FG011|COMPLETED|Treatment Period 1||7||
48456317|NCT01078623|101453776|FG012|COMPLETED|Treatment Period 1||7||
48456318|NCT01078623|101453777|FG013|COMPLETED|Treatment Period 1||7||
48456319|NCT01078623|101453778|FG014|COMPLETED|Treatment Period 1||7||
48456320|NCT01078623|101453779|FG015|COMPLETED|Treatment Period 1||7||
48456321|NCT01078623|101453780|FG016|COMPLETED|Treatment Period 1||7||
48456322|NCT01078623|101453781|FG017|COMPLETED|Treatment Period 1||7||
48456323|NCT01078623|101453782|FG018|COMPLETED|Treatment Period 1||7||
48456324|NCT01078623|101453783|FG019|COMPLETED|Treatment Period 1||7||
48456325|NCT01078623|101453764|FG000|NOT COMPLETED|Treatment Period 1||1||
48456326|NCT01078623|101453765|FG001|NOT COMPLETED|Treatment Period 1||1||
48456327|NCT01078623|101453766|FG002|NOT COMPLETED|Treatment Period 1||1||
48456328|NCT01078623|101453767|FG003|NOT COMPLETED|Treatment Period 1||0||
48456329|NCT01078623|101453768|FG004|NOT COMPLETED|Treatment Period 1||0||
48456330|NCT01078623|101453769|FG005|NOT COMPLETED|Treatment Period 1||1||
48456331|NCT01078623|101453770|FG006|NOT COMPLETED|Treatment Period 1||1||
48456332|NCT01078623|101453771|FG007|NOT COMPLETED|Treatment Period 1||1||
48456333|NCT01078623|101453772|FG008|NOT COMPLETED|Treatment Period 1||1||
48456334|NCT01078623|101453773|FG009|NOT COMPLETED|Treatment Period 1||1||
48456335|NCT01078623|101453774|FG010|NOT COMPLETED|Treatment Period 1||1||
48456336|NCT01078623|101453775|FG011|NOT COMPLETED|Treatment Period 1||0||
48456337|NCT01078623|101453776|FG012|NOT COMPLETED|Treatment Period 1||0||
48456338|NCT01078623|101453777|FG013|NOT COMPLETED|Treatment Period 1||0||
48456339|NCT01078623|101453778|FG014|NOT COMPLETED|Treatment Period 1||0||
48456340|NCT01078623|101453779|FG015|NOT COMPLETED|Treatment Period 1||0||
48456341|NCT01078623|101453780|FG016|NOT COMPLETED|Treatment Period 1||0||
48456342|NCT01078623|101453781|FG017|NOT COMPLETED|Treatment Period 1||0||
48456343|NCT01078623|101453782|FG018|NOT COMPLETED|Treatment Period 1||0||
48456344|NCT01078623|101453783|FG019|NOT COMPLETED|Treatment Period 1||0||
48456345|NCT01078623|101453764|FG000|STARTED|Treatment Period 2||5||
48456346|NCT01078623|101453765|FG001|STARTED|Treatment Period 2||5||
48456347|NCT01078623|101453766|FG002|STARTED|Treatment Period 2||6||
48456348|NCT01078623|101453767|FG003|STARTED|Treatment Period 2||6||
48456349|NCT01078623|101453768|FG004|STARTED|Treatment Period 2||7||
48456350|NCT01078623|101453769|FG005|STARTED|Treatment Period 2||5||
48456351|NCT01078623|101453770|FG006|STARTED|Treatment Period 2||6||
48456352|NCT01078623|101453771|FG007|STARTED|Treatment Period 2||6||
48456353|NCT01078623|101453772|FG008|STARTED|Treatment Period 2||5||
48456354|NCT01078623|101453773|FG009|STARTED|Treatment Period 2||6||
48456355|NCT01078623|101453774|FG010|STARTED|Treatment Period 2||6||
48456356|NCT01078623|101453775|FG011|STARTED|Treatment Period 2||7||
48456357|NCT01078623|101453776|FG012|STARTED|Treatment Period 2||7||
48456358|NCT01078623|101453777|FG013|STARTED|Treatment Period 2||7||
48456359|NCT01078623|101453778|FG014|STARTED|Treatment Period 2||7||
48456360|NCT01078623|101453779|FG015|STARTED|Treatment Period 2||7||
48456361|NCT01078623|101453780|FG016|STARTED|Treatment Period 2||7||
48456362|NCT01078623|101453781|FG017|STARTED|Treatment Period 2||7||
48456363|NCT01078623|101453782|FG018|STARTED|Treatment Period 2||7||
48456364|NCT01078623|101453783|FG019|STARTED|Treatment Period 2||7||
48456365|NCT01078623|101453764|FG000|COMPLETED|Treatment Period 2||5||
48456366|NCT01078623|101453765|FG001|COMPLETED|Treatment Period 2||5||
48456367|NCT01078623|101453766|FG002|COMPLETED|Treatment Period 2||6||
48456368|NCT01078623|101453767|FG003|COMPLETED|Treatment Period 2||6||
48456369|NCT01078623|101453768|FG004|COMPLETED|Treatment Period 2||7||
48456370|NCT01078623|101453769|FG005|COMPLETED|Treatment Period 2||4||
48456371|NCT01078623|101453770|FG006|COMPLETED|Treatment Period 2||5||
48456372|NCT01078623|101453771|FG007|COMPLETED|Treatment Period 2||6||
48456373|NCT01078623|101453772|FG008|COMPLETED|Treatment Period 2||5||
48456374|NCT01078623|101453773|FG009|COMPLETED|Treatment Period 2||6||
48456375|NCT01078623|101453774|FG010|COMPLETED|Treatment Period 2||6||
48456376|NCT01078623|101453775|FG011|COMPLETED|Treatment Period 2||7||
48456377|NCT01078623|101453776|FG012|COMPLETED|Treatment Period 2||7||
48456378|NCT01078623|101453777|FG013|COMPLETED|Treatment Period 2||7||
48456379|NCT01078623|101453778|FG014|COMPLETED|Treatment Period 2||7||
48456380|NCT01078623|101453779|FG015|COMPLETED|Treatment Period 2||7||
48456381|NCT01078623|101453780|FG016|COMPLETED|Treatment Period 2||7||
48456382|NCT01078623|101453781|FG017|COMPLETED|Treatment Period 2||7||
48456383|NCT01078623|101453782|FG018|COMPLETED|Treatment Period 2||6||
48456384|NCT01078623|101453783|FG019|COMPLETED|Treatment Period 2||7||
48456385|NCT01078623|101453764|FG000|NOT COMPLETED|Treatment Period 2||0||
48456386|NCT01078623|101453765|FG001|NOT COMPLETED|Treatment Period 2||0||
48456387|NCT01078623|101453766|FG002|NOT COMPLETED|Treatment Period 2||0||
48456388|NCT01078623|101453767|FG003|NOT COMPLETED|Treatment Period 2||0||
48456389|NCT01078623|101453768|FG004|NOT COMPLETED|Treatment Period 2||0||
48456390|NCT01078623|101453769|FG005|NOT COMPLETED|Treatment Period 2||1||
48456391|NCT01078623|101453770|FG006|NOT COMPLETED|Treatment Period 2||1||
48456392|NCT01078623|101453771|FG007|NOT COMPLETED|Treatment Period 2||0||
48456393|NCT01078623|101453772|FG008|NOT COMPLETED|Treatment Period 2||0||
48456394|NCT01078623|101453773|FG009|NOT COMPLETED|Treatment Period 2||0||
48456395|NCT01078623|101453774|FG010|NOT COMPLETED|Treatment Period 2||0||
48456396|NCT01078623|101453775|FG011|NOT COMPLETED|Treatment Period 2||0||
48456397|NCT01078623|101453776|FG012|NOT COMPLETED|Treatment Period 2||0||
48456398|NCT01078623|101453777|FG013|NOT COMPLETED|Treatment Period 2||0||
48456399|NCT01078623|101453778|FG014|NOT COMPLETED|Treatment Period 2||0||
48456400|NCT01078623|101453779|FG015|NOT COMPLETED|Treatment Period 2||0||
48456401|NCT01078623|101453780|FG016|NOT COMPLETED|Treatment Period 2||0||
48456402|NCT01078623|101453781|FG017|NOT COMPLETED|Treatment Period 2||0||
48456403|NCT01078623|101453782|FG018|NOT COMPLETED|Treatment Period 2||1||
48456404|NCT01078623|101453783|FG019|NOT COMPLETED|Treatment Period 2||0||
48456405|NCT01078623|101453764|FG000|STARTED|Treatment Period 3||5||
48456406|NCT01078623|101453765|FG001|STARTED|Treatment Period 3||5||
48456407|NCT01078623|101453766|FG002|STARTED|Treatment Period 3||6||
48456408|NCT01078623|101453767|FG003|STARTED|Treatment Period 3||6||
48456409|NCT01078623|101453768|FG004|STARTED|Treatment Period 3||7||
48456410|NCT01078623|101453769|FG005|STARTED|Treatment Period 3||4||
48456411|NCT01078623|101453770|FG006|STARTED|Treatment Period 3||5||
48456412|NCT01078623|101453771|FG007|STARTED|Treatment Period 3||6||
48456413|NCT01078623|101453772|FG008|STARTED|Treatment Period 3||5||
48456414|NCT01078623|101453773|FG009|STARTED|Treatment Period 3||6||
48456415|NCT01078623|101453774|FG010|STARTED|Treatment Period 3||6||
48456416|NCT01078623|101453775|FG011|STARTED|Treatment Period 3||7||
48456417|NCT01078623|101453776|FG012|STARTED|Treatment Period 3||7||
48456418|NCT01078623|101453777|FG013|STARTED|Treatment Period 3||7||
48456419|NCT01078623|101453778|FG014|STARTED|Treatment Period 3||7||
48456420|NCT01078623|101453779|FG015|STARTED|Treatment Period 3||7||
48456421|NCT01078623|101453780|FG016|STARTED|Treatment Period 3||7||
48456422|NCT01078623|101453781|FG017|STARTED|Treatment Period 3||7||
48456423|NCT01078623|101453782|FG018|STARTED|Treatment Period 3||6||
48456424|NCT01078623|101453783|FG019|STARTED|Treatment Period 3||7||
48456425|NCT01078623|101453764|FG000|COMPLETED|Treatment Period 3||5||
48456426|NCT01078623|101453765|FG001|COMPLETED|Treatment Period 3||5||
48456427|NCT01078623|101453766|FG002|COMPLETED|Treatment Period 3||6||
48456428|NCT01078623|101453767|FG003|COMPLETED|Treatment Period 3||6||
48456429|NCT01078623|101453768|FG004|COMPLETED|Treatment Period 3||6||
48456430|NCT01078623|101453769|FG005|COMPLETED|Treatment Period 3||4||
48772812|NCT00790842|102232801|FG008|STARTED|Dose Level 4||0||
48772813|NCT00790842|102232802|FG009|STARTED|Dose Level 4||0||
48772814|NCT00790842|102232803|FG010|STARTED|Dose Level 4||5||
48772815|NCT00790842|102232793|FG000|Began Treatment|Dose Level 4||0||
48772816|NCT00790842|102232794|FG001|Began Treatment|Dose Level 4||0||
48772817|NCT00790842|102232795|FG002|Began Treatment|Dose Level 4||0||
48456431|NCT01078623|101453770|FG006|COMPLETED|Treatment Period 3||5||
48456432|NCT01078623|101453771|FG007|COMPLETED|Treatment Period 3||6||
48456433|NCT01078623|101453772|FG008|COMPLETED|Treatment Period 3||5||
48456434|NCT01078623|101453773|FG009|COMPLETED|Treatment Period 3||6||
48456435|NCT01078623|101453774|FG010|COMPLETED|Treatment Period 3||6||
48456436|NCT01078623|101453775|FG011|COMPLETED|Treatment Period 3||7||
48456437|NCT01078623|101453776|FG012|COMPLETED|Treatment Period 3||7||
48456438|NCT01078623|101453777|FG013|COMPLETED|Treatment Period 3||6||
48456439|NCT01078623|101453778|FG014|COMPLETED|Treatment Period 3||7||
48456440|NCT01078623|101453779|FG015|COMPLETED|Treatment Period 3||7||
48456441|NCT01078623|101453780|FG016|COMPLETED|Treatment Period 3||7||
48456442|NCT01078623|101453781|FG017|COMPLETED|Treatment Period 3||7||
48456443|NCT01078623|101453782|FG018|COMPLETED|Treatment Period 3||6||
48456444|NCT01078623|101453783|FG019|COMPLETED|Treatment Period 3||7||
48456445|NCT01078623|101453764|FG000|NOT COMPLETED|Treatment Period 3||0||
48456446|NCT01078623|101453765|FG001|NOT COMPLETED|Treatment Period 3||0||
48662998|NCT00265122|101959526|FG000|STARTED|Intervention Period 1 (Weeks 0 to 8):||26||
48772818|NCT00790842|102232796|FG003|Began Treatment|Dose Level 4||0||
48772819|NCT00790842|102232797|FG004|Began Treatment|Dose Level 4||0||
48772820|NCT00790842|102232798|FG005|Began Treatment|Dose Level 4||0||
48772821|NCT00790842|102232799|FG006|Began Treatment|Dose Level 4||8||
48456447|NCT01078623|101453766|FG002|NOT COMPLETED|Treatment Period 3||0||
48456448|NCT01078623|101453767|FG003|NOT COMPLETED|Treatment Period 3||0||
48456449|NCT01078623|101453768|FG004|NOT COMPLETED|Treatment Period 3||1||
48456450|NCT01078623|101453769|FG005|NOT COMPLETED|Treatment Period 3||0||
48456451|NCT01078623|101453770|FG006|NOT COMPLETED|Treatment Period 3||0||
48456452|NCT01078623|101453771|FG007|NOT COMPLETED|Treatment Period 3||0||
48456453|NCT01078623|101453772|FG008|NOT COMPLETED|Treatment Period 3||0||
48456454|NCT01078623|101453773|FG009|NOT COMPLETED|Treatment Period 3||0||
48456455|NCT01078623|101453774|FG010|NOT COMPLETED|Treatment Period 3||0||
48456456|NCT01078623|101453775|FG011|NOT COMPLETED|Treatment Period 3||0||
48456457|NCT01078623|101453776|FG012|NOT COMPLETED|Treatment Period 3||0||
48456458|NCT01078623|101453777|FG013|NOT COMPLETED|Treatment Period 3||1||
48456459|NCT01078623|101453778|FG014|NOT COMPLETED|Treatment Period 3||0||
48456460|NCT01078623|101453779|FG015|NOT COMPLETED|Treatment Period 3||0||
48456461|NCT01078623|101453780|FG016|NOT COMPLETED|Treatment Period 3||0||
48456462|NCT01078623|101453781|FG017|NOT COMPLETED|Treatment Period 3||0||
48456463|NCT01078623|101453782|FG018|NOT COMPLETED|Treatment Period 3||0||
48456464|NCT01078623|101453783|FG019|NOT COMPLETED|Treatment Period 3||0||
48456465|NCT01078623|101453764|FG000|STARTED|Treatment Period 4||5||
48456466|NCT01078623|101453765|FG001|STARTED|Treatment Period 4||5||
48456467|NCT01078623|101453766|FG002|STARTED|Treatment Period 4||6||
48456468|NCT01078623|101453767|FG003|STARTED|Treatment Period 4||6||
48456469|NCT01078623|101453768|FG004|STARTED|Treatment Period 4||6||
48456470|NCT01078623|101453769|FG005|STARTED|Treatment Period 4||4||
48456471|NCT01078623|101453770|FG006|STARTED|Treatment Period 4||5||
48456472|NCT01078623|101453771|FG007|STARTED|Treatment Period 4||6||
48456473|NCT01078623|101453772|FG008|STARTED|Treatment Period 4||5||
48456474|NCT01078623|101453773|FG009|STARTED|Treatment Period 4||6||
48456475|NCT01078623|101453774|FG010|STARTED|Treatment Period 4||6||
48456476|NCT01078623|101453775|FG011|STARTED|Treatment Period 4||7||
48456477|NCT01078623|101453776|FG012|STARTED|Treatment Period 4||7||
48456478|NCT01078623|101453777|FG013|STARTED|Treatment Period 4||6||
48456479|NCT01078623|101453778|FG014|STARTED|Treatment Period 4||7||
48456480|NCT01078623|101453779|FG015|STARTED|Treatment Period 4||7||
48456481|NCT01078623|101453780|FG016|STARTED|Treatment Period 4||7||
48456482|NCT01078623|101453781|FG017|STARTED|Treatment Period 4||7||
48456483|NCT01078623|101453782|FG018|STARTED|Treatment Period 4||6||
48456484|NCT01078623|101453783|FG019|STARTED|Treatment Period 4||7||
48456485|NCT01078623|101453764|FG000|COMPLETED|Treatment Period 4||5||
48456486|NCT01078623|101453765|FG001|COMPLETED|Treatment Period 4||5||
48456487|NCT01078623|101453766|FG002|COMPLETED|Treatment Period 4||5||
48456488|NCT01078623|101453767|FG003|COMPLETED|Treatment Period 4||6||
48456489|NCT01078623|101453768|FG004|COMPLETED|Treatment Period 4||6||
48456490|NCT01078623|101453769|FG005|COMPLETED|Treatment Period 4||4||
48456491|NCT01078623|101453770|FG006|COMPLETED|Treatment Period 4||5||
48456492|NCT01078623|101453771|FG007|COMPLETED|Treatment Period 4||6||
48456493|NCT01078623|101453772|FG008|COMPLETED|Treatment Period 4||5||
48662999|NCT00265122|101959527|FG001|STARTED|Intervention Period 1 (Weeks 0 to 8):||25||
48663000|NCT00265122|101959528|FG002|STARTED|Intervention Period 1 (Weeks 0 to 8):||27||
48663001|NCT00265122|101959529|FG003|STARTED|Intervention Period 1 (Weeks 0 to 8):||26||
48663002|NCT00265122|101959530|FG004|STARTED|Intervention Period 1 (Weeks 0 to 8):||14||
48663003|NCT00265122|101959531|FG005|STARTED|Intervention Period 1 (Weeks 0 to 8):||13||
48663004|NCT00265122|101959526|FG000|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24||
48663005|NCT00265122|101959527|FG001|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||23||
48663006|NCT00265122|101959528|FG002|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||22||
48663007|NCT00265122|101959529|FG003|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24||
48663008|NCT00265122|101959530|FG004|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13||
48663009|NCT00265122|101959531|FG005|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13||
48663010|NCT00265122|101959526|FG000|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2||
48663011|NCT00265122|101959527|FG001|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2||
48663012|NCT00265122|101959528|FG002|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||5||
48772822|NCT00790842|102232800|FG007|Began Treatment|Dose Level 4||0||
48772823|NCT00790842|102232801|FG008|Began Treatment|Dose Level 4||0||
48772824|NCT00790842|102232802|FG009|Began Treatment|Dose Level 4||0||
48772825|NCT00790842|102232803|FG010|Began Treatment|Dose Level 4||5||
48772826|NCT00790842|102232793|FG000|COMPLETED|Dose Level 4||0||
48772827|NCT00790842|102232794|FG001|COMPLETED|Dose Level 4||0||
48772828|NCT00790842|102232795|FG002|COMPLETED|Dose Level 4||0||
48772829|NCT00790842|102232796|FG003|COMPLETED|Dose Level 4||0||
48772830|NCT00790842|102232797|FG004|COMPLETED|Dose Level 4||0||
48772831|NCT00790842|102232798|FG005|COMPLETED|Dose Level 4||0||
48772832|NCT00790842|102232799|FG006|COMPLETED|Dose Level 4||6||
48772833|NCT00790842|102232800|FG007|COMPLETED|Dose Level 4||0||
48772834|NCT00790842|102232801|FG008|COMPLETED|Dose Level 4||0||
48772835|NCT00790842|102232802|FG009|COMPLETED|Dose Level 4||0||
48772836|NCT00790842|102232803|FG010|COMPLETED|Dose Level 4||3||
48772837|NCT00790842|102232793|FG000|NOT COMPLETED|Dose Level 4||0||
48772838|NCT00790842|102232794|FG001|NOT COMPLETED|Dose Level 4||0||
48772839|NCT00790842|102232795|FG002|NOT COMPLETED|Dose Level 4||0||
48772840|NCT00790842|102232796|FG003|NOT COMPLETED|Dose Level 4||0||
48772841|NCT00790842|102232797|FG004|NOT COMPLETED|Dose Level 4||0||
48772842|NCT00790842|102232798|FG005|NOT COMPLETED|Dose Level 4||0||
48456494|NCT01078623|101453773|FG009|COMPLETED|Treatment Period 4||6||
48456495|NCT01078623|101453774|FG010|COMPLETED|Treatment Period 4||6||
48456496|NCT01078623|101453775|FG011|COMPLETED|Treatment Period 4||7||
48456497|NCT01078623|101453776|FG012|COMPLETED|Treatment Period 4||7||
48456498|NCT01078623|101453777|FG013|COMPLETED|Treatment Period 4||6||
48456499|NCT01078623|101453778|FG014|COMPLETED|Treatment Period 4||7||
48456500|NCT01078623|101453779|FG015|COMPLETED|Treatment Period 4||6||
48456501|NCT01078623|101453780|FG016|COMPLETED|Treatment Period 4||7||
48456502|NCT01078623|101453781|FG017|COMPLETED|Treatment Period 4||7||
48456503|NCT01078623|101453782|FG018|COMPLETED|Treatment Period 4||6||
48456504|NCT01078623|101453783|FG019|COMPLETED|Treatment Period 4||7||
48456505|NCT01078623|101453764|FG000|NOT COMPLETED|Treatment Period 4||0||
48456506|NCT01078623|101453765|FG001|NOT COMPLETED|Treatment Period 4||0||
48456507|NCT01078623|101453766|FG002|NOT COMPLETED|Treatment Period 4||1||
48456508|NCT01078623|101453767|FG003|NOT COMPLETED|Treatment Period 4||0||
48456509|NCT01078623|101453768|FG004|NOT COMPLETED|Treatment Period 4||0||
48456510|NCT01078623|101453769|FG005|NOT COMPLETED|Treatment Period 4||0||
48456511|NCT01078623|101453770|FG006|NOT COMPLETED|Treatment Period 4||0||
48456512|NCT01078623|101453771|FG007|NOT COMPLETED|Treatment Period 4||0||
48772843|NCT00790842|102232799|FG006|NOT COMPLETED|Dose Level 4||2||
48772844|NCT00790842|102232800|FG007|NOT COMPLETED|Dose Level 4||0||
48772845|NCT00790842|102232801|FG008|NOT COMPLETED|Dose Level 4||0||
48772846|NCT00790842|102232802|FG009|NOT COMPLETED|Dose Level 4||0||
48772847|NCT00790842|102232803|FG010|NOT COMPLETED|Dose Level 4||2||
48456513|NCT01078623|101453772|FG008|NOT COMPLETED|Treatment Period 4||0||
48456514|NCT01078623|101453773|FG009|NOT COMPLETED|Treatment Period 4||0||
48456515|NCT01078623|101453774|FG010|NOT COMPLETED|Treatment Period 4||0||
48456516|NCT01078623|101453775|FG011|NOT COMPLETED|Treatment Period 4||0||
48456517|NCT01078623|101453776|FG012|NOT COMPLETED|Treatment Period 4||0||
48456518|NCT01078623|101453777|FG013|NOT COMPLETED|Treatment Period 4||0||
48456519|NCT01078623|101453778|FG014|NOT COMPLETED|Treatment Period 4||0||
48456520|NCT01078623|101453779|FG015|NOT COMPLETED|Treatment Period 4||1||
48456521|NCT01078623|101453780|FG016|NOT COMPLETED|Treatment Period 4||0||
48772848|NCT00790842|102232793|FG000|STARTED|Expansion Cohort||0||
48456522|NCT01078623|101453781|FG017|NOT COMPLETED|Treatment Period 4||0||
48456523|NCT01078623|101453782|FG018|NOT COMPLETED|Treatment Period 4||0||
48456524|NCT01078623|101453783|FG019|NOT COMPLETED|Treatment Period 4||0||
48456525|NCT02005354|101453784|FG000|STARTED|Overall Study||35||
48456526|NCT02005354|101453785|FG001|STARTED|Overall Study||35||
48456527|NCT02005354|101453784|FG000|COMPLETED|Overall Study||35||
48456528|NCT02005354|101453785|FG001|COMPLETED|Overall Study||35||
48456529|NCT02005354|101453784|FG000|NOT COMPLETED|Overall Study||0||
48456530|NCT02005354|101453785|FG001|NOT COMPLETED|Overall Study||0||
48456531|NCT01428024|101453786|FG000|STARTED|Overall Study||30||
48456532|NCT01428024|101453787|FG001|STARTED|Overall Study||30||
48456533|NCT01428024|101453786|FG000|COMPLETED|Overall Study||29||
48456534|NCT01428024|101453787|FG001|COMPLETED|Overall Study||29||
48456535|NCT01428024|101453786|FG000|NOT COMPLETED|Overall Study||1||
48456536|NCT01428024|101453787|FG001|NOT COMPLETED|Overall Study||1||
48456537|NCT01306253|101453788|FG000|STARTED|Overall Study||57||
48456538|NCT01306253|101453789|FG001|STARTED|Overall Study||57||
48456539|NCT01306253|101453788|FG000|COMPLETED|Overall Study||56||
48456540|NCT01306253|101453789|FG001|COMPLETED|Overall Study||56||
48456541|NCT01306253|101453788|FG000|NOT COMPLETED|Overall Study||1||
48456542|NCT01306253|101453789|FG001|NOT COMPLETED|Overall Study||1||
48456543|NCT01034137|101453790|FG000|STARTED|Overall Study||106||
48456544|NCT01034137|101453791|FG001|STARTED|Overall Study||103||
48456545|NCT01034137|101453792|FG002|STARTED|Overall Study||108||
48456546|NCT01034137|101453790|FG000|COMPLETED|Overall Study||78||
48456547|NCT01034137|101453791|FG001|COMPLETED|Overall Study||81||
48456548|NCT01034137|101453792|FG002|COMPLETED|Overall Study||78||
48456549|NCT01034137|101453790|FG000|NOT COMPLETED|Overall Study||28||
48663013|NCT00265122|101959529|FG003|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2||
48663014|NCT00265122|101959530|FG004|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||1||
48663015|NCT00265122|101959531|FG005|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||0||
48663016|NCT00265122|101959526|FG000|STARTED|Intervention Period 2 (Weeks 8 to 28):||24||
48663017|NCT00265122|101959527|FG001|STARTED|Intervention Period 2 (Weeks 8 to 28):||23||
48456550|NCT01034137|101453791|FG001|NOT COMPLETED|Overall Study||22||
48456551|NCT01034137|101453792|FG002|NOT COMPLETED|Overall Study||30||
48772849|NCT00790842|102232794|FG001|STARTED|Expansion Cohort||0||
48772850|NCT00790842|102232795|FG002|STARTED|Expansion Cohort||14||
48456552|NCT01323998|101453793|FG000|STARTED|Overall Study||200631||
48456553|NCT01323998|101453794|FG001|STARTED|Overall Study||18681||
48456554|NCT01323998|101453795|FG002|STARTED|Overall Study||10294||
48456555|NCT01323998|101453796|FG003|STARTED|Overall Study||12052||
48456556|NCT01323998|101453797|FG004|STARTED|Overall Study||6735||
48456557|NCT01323998|101453793|FG000|COMPLETED|Overall Study||200631||
48456558|NCT01323998|101453794|FG001|COMPLETED|Overall Study||18681||
48456559|NCT01323998|101453795|FG002|COMPLETED|Overall Study||10294||
48456560|NCT01323998|101453796|FG003|COMPLETED|Overall Study||12052||
48456561|NCT01323998|101453797|FG004|COMPLETED|Overall Study||6735||
48456562|NCT01323998|101453793|FG000|NOT COMPLETED|Overall Study||0||
48456563|NCT01323998|101453794|FG001|NOT COMPLETED|Overall Study||0||
48456564|NCT01323998|101453795|FG002|NOT COMPLETED|Overall Study||0||
48456565|NCT01323998|101453796|FG003|NOT COMPLETED|Overall Study||0||
48456566|NCT01323998|101453797|FG004|NOT COMPLETED|Overall Study||0||
48456567|NCT02557672|101453798|FG000|STARTED|Overall Study||53||
48456568|NCT02557672|101453799|FG001|STARTED|Overall Study||53||
48456569|NCT02557672|101453798|FG000|COMPLETED|Overall Study||49||
48456570|NCT02557672|101453799|FG001|COMPLETED|Overall Study||51||
48456571|NCT02557672|101453798|FG000|NOT COMPLETED|Overall Study||4||
48663018|NCT00265122|101959528|FG002|STARTED|Intervention Period 2 (Weeks 8 to 28):||22||
48456572|NCT02557672|101453799|FG001|NOT COMPLETED|Overall Study||2||
48663019|NCT00265122|101959529|FG003|STARTED|Intervention Period 2 (Weeks 8 to 28):||24||
48772851|NCT00790842|102232796|FG003|STARTED|Expansion Cohort||0||
48456573|NCT01159769|101453800|FG000|STARTED|Overall Study||215||
48456574|NCT01159769|101453800|FG000|COMPLETED|Overall Study||214||
48456575|NCT01159769|101453800|FG000|NOT COMPLETED|Overall Study||1||
48456576|NCT02110706|101453801|FG000|STARTED|Overall Study||25||
48456577|NCT02110706|101453802|FG001|STARTED|Overall Study||27||
48456578|NCT02110706|101453801|FG000|No. Completing Study Through Week 52|Overall Study||23||
48456579|NCT02110706|101453802|FG001|No. Completing Study Through Week 52|Overall Study||24||
48456580|NCT02110706|101453801|FG000|COMPLETED|Overall Study||20|No. of participants who completed two-cycle rituximab/placebo treatment|
48456581|NCT02110706|101453802|FG001|COMPLETED|Overall Study||23|No. of participants who completed two-cycle rituximab/placebo treatment|
48456582|NCT02110706|101453801|FG000|NOT COMPLETED|Overall Study||5||
48456583|NCT02110706|101453802|FG001|NOT COMPLETED|Overall Study||4||
48456584|NCT04908722|101453803|FG000|STARTED|Overall Study||291|Randomized Participants|
48456585|NCT04908722|101453804|FG001|STARTED|Overall Study||222|Randomized Participants|
48456586|NCT04908722|101453805|FG002|STARTED|Overall Study||293|Randomized Participants|
48456587|NCT04908722|101453806|FG003|STARTED|Overall Study||222|Randomized Participants|
48456588|NCT04908722|101453807|FG004|STARTED|Overall Study||291|Randomized Participants|
48456589|NCT04908722|101453808|FG005|STARTED|Overall Study||289|Randomized Participants|
48456590|NCT04908722|101453803|FG000|Main Study|Overall Study||222||
48456591|NCT04908722|101453804|FG001|Main Study|Overall Study||222||
48456592|NCT04908722|101453805|FG002|Main Study|Overall Study||223||
48456593|NCT04908722|101453806|FG003|Main Study|Overall Study||222||
48456594|NCT04908722|101453807|FG004|Main Study|Overall Study||222||
48456595|NCT04908722|101453808|FG005|Main Study|Overall Study||221||
48456596|NCT04908722|101453803|FG000|Sub Study|Overall Study||69||
48456597|NCT04908722|101453804|FG001|Sub Study|Overall Study||0||
48456598|NCT04908722|101453805|FG002|Sub Study|Overall Study||70||
48456599|NCT04908722|101453806|FG003|Sub Study|Overall Study||0||
48456600|NCT04908722|101453807|FG004|Sub Study|Overall Study||69||
48456601|NCT04908722|101453808|FG005|Sub Study|Overall Study||68||
48456602|NCT04908722|101453803|FG000|Treated|Overall Study||288|Vaccinated Participants|
48456603|NCT04908722|101453804|FG001|Treated|Overall Study||221|Vaccinated Participants|
48456604|NCT04908722|101453805|FG002|Treated|Overall Study||291|Vaccinated Participants|
48456605|NCT04908722|101453806|FG003|Treated|Overall Study||220|Vaccinated Participants|
48456606|NCT04908722|101453807|FG004|Treated|Overall Study||288|Vaccinated Participants|
48456607|NCT04908722|101453808|FG005|Treated|Overall Study||285|Vaccinated Participants|
48456608|NCT04908722|101453803|FG000|Per Protocol Immunogenicity Set|Overall Study||276||
48456609|NCT04908722|101453804|FG001|Per Protocol Immunogenicity Set|Overall Study||212||
48456610|NCT04908722|101453805|FG002|Per Protocol Immunogenicity Set|Overall Study||282||
48456611|NCT04908722|101453806|FG003|Per Protocol Immunogenicity Set|Overall Study||212||
48456612|NCT04908722|101453807|FG004|Per Protocol Immunogenicity Set|Overall Study||277||
48456613|NCT04908722|101453808|FG005|Per Protocol Immunogenicity Set|Overall Study||271||
48772852|NCT00790842|102232797|FG004|STARTED|Expansion Cohort||0||
48456614|NCT04908722|101453803|FG000|COMPLETED|Overall Study||237||
48456615|NCT04908722|101453804|FG001|COMPLETED|Overall Study||178||
48456616|NCT04908722|101453805|FG002|COMPLETED|Overall Study||244||
48456617|NCT04908722|101453806|FG003|COMPLETED|Overall Study||179||
48456618|NCT04908722|101453807|FG004|COMPLETED|Overall Study||240||
48456619|NCT04908722|101453808|FG005|COMPLETED|Overall Study||233||
48456620|NCT04908722|101453803|FG000|NOT COMPLETED|Overall Study||54||
48456621|NCT04908722|101453804|FG001|NOT COMPLETED|Overall Study||44||
48456622|NCT04908722|101453805|FG002|NOT COMPLETED|Overall Study||49||
48456623|NCT04908722|101453806|FG003|NOT COMPLETED|Overall Study||43||
48456624|NCT04908722|101453807|FG004|NOT COMPLETED|Overall Study||51||
48456625|NCT04908722|101453808|FG005|NOT COMPLETED|Overall Study||56||
48456626|NCT01261325|101453809|FG000|STARTED|Overall Study||263||
48456627|NCT01261325|101453810|FG001|STARTED|Overall Study||254||
48456628|NCT01261325|101453811|FG002|STARTED|Overall Study||251||
48456629|NCT01261325|101453809|FG000|COMPLETED|Overall Study||246||
48456630|NCT01261325|101453810|FG001|COMPLETED|Overall Study||225||
48456631|NCT01261325|101453811|FG002|COMPLETED|Overall Study||225||
48456632|NCT01261325|101453809|FG000|NOT COMPLETED|Overall Study||17||
48456633|NCT01261325|101453810|FG001|NOT COMPLETED|Overall Study||29||
48456634|NCT01261325|101453811|FG002|NOT COMPLETED|Overall Study||26||
48456635|NCT00661674|101453812|FG000|STARTED|Overall Study||2|Only 1 intervention per sequence was given each week based on sequence assignment|
48456636|NCT00661674|101453813|FG001|STARTED|Overall Study||2|Only 1 intervention per sequence was given each week based on sequence assignment|
48456637|NCT00661674|101453814|FG002|STARTED|Overall Study||2|Only 1 intervention per sequence was given each week based on sequence assignment|
48456638|NCT00661674|101453815|FG003|STARTED|Overall Study||1|Only 1 intervention per sequence was given each week based on sequence assignment|
48456639|NCT00661674|101453816|FG004|STARTED|Overall Study||2|Only 1 intervention per sequence was given each week based on sequence assignment|
48772853|NCT00790842|102232798|FG005|STARTED|Expansion Cohort||0||
48772854|NCT00790842|102232799|FG006|STARTED|Expansion Cohort||2||
48772855|NCT00790842|102232800|FG007|STARTED|Expansion Cohort||0||
48772856|NCT00790842|102232801|FG008|STARTED|Expansion Cohort||0||
48772857|NCT00790842|102232802|FG009|STARTED|Expansion Cohort||0||
48456640|NCT00661674|101453817|FG005|STARTED|Overall Study||1|Only 1 intervention per sequence was given each week based on sequence assignment|
48456641|NCT00661674|101453812|FG000|COMPLETED|Overall Study||2||
48456642|NCT00661674|101453813|FG001|COMPLETED|Overall Study||2||
48456643|NCT00661674|101453814|FG002|COMPLETED|Overall Study||2||
48456644|NCT00661674|101453815|FG003|COMPLETED|Overall Study||1||
48456645|NCT00661674|101453816|FG004|COMPLETED|Overall Study||2||
48456646|NCT00661674|101453817|FG005|COMPLETED|Overall Study||1||
48456647|NCT00661674|101453812|FG000|NOT COMPLETED|Overall Study||0||
48456648|NCT00661674|101453813|FG001|NOT COMPLETED|Overall Study||0||
48456649|NCT00661674|101453814|FG002|NOT COMPLETED|Overall Study||0||
48456650|NCT00661674|101453815|FG003|NOT COMPLETED|Overall Study||0||
48456651|NCT00661674|101453816|FG004|NOT COMPLETED|Overall Study||0||
48456652|NCT00661674|101453817|FG005|NOT COMPLETED|Overall Study||0||
48456653|NCT01312779|101453818|FG000|STARTED|Overall Study||39||
48456654|NCT01312779|101453818|FG000|Implanted With Device|Overall Study||12||
48456655|NCT01312779|101453818|FG000|COMPLETED|Overall Study||7||
48456656|NCT01312779|101453818|FG000|NOT COMPLETED|Overall Study||32||
48456657|NCT02624518|101453819|FG000|STARTED|Overall Study||122||
48663020|NCT00265122|101959530|FG004|STARTED|Intervention Period 2 (Weeks 8 to 28):||13||
48663021|NCT00265122|101959531|FG005|STARTED|Intervention Period 2 (Weeks 8 to 28):||13||
48663022|NCT00265122|101959526|FG000|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||17||
48663023|NCT00265122|101959527|FG001|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||22||
48456658|NCT02624518|101453819|FG000|COMPLETED|Overall Study||121||
48456659|NCT02624518|101453819|FG000|NOT COMPLETED|Overall Study||1||
48456660|NCT00706706|101453820|FG000|STARTED|Overall Study||105||
48456661|NCT00706706|101453820|FG000|COMPLETED|Overall Study||0||
48456662|NCT00706706|101453820|FG000|NOT COMPLETED|Overall Study||105||
48456663|NCT02544633|101453821|FG000|STARTED|Treatment Period||28||
48456664|NCT02544633|101453822|FG001|STARTED|Treatment Period||20||
48456665|NCT02544633|101453823|FG002|STARTED|Treatment Period||8||
48456666|NCT02544633|101453824|FG003|STARTED|Treatment Period||12||
48456667|NCT02544633|101453821|FG000|COMPLETED|Treatment Period||0||
48456668|NCT02544633|101453822|FG001|COMPLETED|Treatment Period||0||
48456669|NCT02544633|101453823|FG002|COMPLETED|Treatment Period||0||
48456670|NCT02544633|101453824|FG003|COMPLETED|Treatment Period||0||
48456671|NCT02544633|101453821|FG000|NOT COMPLETED|Treatment Period||28||
48456672|NCT02544633|101453822|FG001|NOT COMPLETED|Treatment Period||20||
48456673|NCT02544633|101453823|FG002|NOT COMPLETED|Treatment Period||8||
48456674|NCT02544633|101453824|FG003|NOT COMPLETED|Treatment Period||12||
48456675|NCT02544633|101453821|FG000|STARTED|Survival Follow-up Period||28|2 patients on treatment at the time of primary report date|
48456676|NCT02544633|101453822|FG001|STARTED|Survival Follow-up Period||19|2 patients on treatment at the time of primary report date|
48456677|NCT02544633|101453823|FG002|STARTED|Survival Follow-up Period||7|2 patients on treatment at the time of primary report date|
48456678|NCT02544633|101453824|FG003|STARTED|Survival Follow-up Period||12|2 patients on treatment at the time of primary report date|
48456679|NCT02544633|101453821|FG000|COMPLETED|Survival Follow-up Period||0||
48456680|NCT02544633|101453822|FG001|COMPLETED|Survival Follow-up Period||0||
48456681|NCT02544633|101453823|FG002|COMPLETED|Survival Follow-up Period||0||
48456682|NCT02544633|101453824|FG003|COMPLETED|Survival Follow-up Period||0||
48456683|NCT02544633|101453821|FG000|NOT COMPLETED|Survival Follow-up Period||28||
48663024|NCT00265122|101959528|FG002|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||18||
48663025|NCT00265122|101959529|FG003|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||20||
48772858|NCT00790842|102232803|FG010|STARTED|Expansion Cohort||0||
48772859|NCT00790842|102232793|FG000|Began Treatment|Expansion Cohort||0||
48772860|NCT00790842|102232794|FG001|Began Treatment|Expansion Cohort||0||
48772861|NCT00790842|102232795|FG002|Began Treatment|Expansion Cohort||14||
48772862|NCT00790842|102232796|FG003|Began Treatment|Expansion Cohort||0||
48772863|NCT00790842|102232797|FG004|Began Treatment|Expansion Cohort||0||
48772864|NCT00790842|102232798|FG005|Began Treatment|Expansion Cohort||0||
48772865|NCT00790842|102232799|FG006|Began Treatment|Expansion Cohort||2||
48456684|NCT02544633|101453822|FG001|NOT COMPLETED|Survival Follow-up Period||19||
48772866|NCT00790842|102232800|FG007|Began Treatment|Expansion Cohort||0||
48772867|NCT00790842|102232801|FG008|Began Treatment|Expansion Cohort||0||
48772868|NCT00790842|102232802|FG009|Began Treatment|Expansion Cohort||0||
48772869|NCT00790842|102232803|FG010|Began Treatment|Expansion Cohort||0||
48772870|NCT00790842|102232793|FG000|COMPLETED|Expansion Cohort||0||
48772871|NCT00790842|102232794|FG001|COMPLETED|Expansion Cohort||0||
48772872|NCT00790842|102232795|FG002|COMPLETED|Expansion Cohort||7||
48772873|NCT00790842|102232796|FG003|COMPLETED|Expansion Cohort||0||
48772874|NCT00790842|102232797|FG004|COMPLETED|Expansion Cohort||0||
48772875|NCT00790842|102232798|FG005|COMPLETED|Expansion Cohort||0||
48772876|NCT00790842|102232799|FG006|COMPLETED|Expansion Cohort||1||
48772877|NCT00790842|102232800|FG007|COMPLETED|Expansion Cohort||0||
48663026|NCT00265122|101959530|FG004|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||8||
48456685|NCT02544633|101453823|FG002|NOT COMPLETED|Survival Follow-up Period||7||
48456686|NCT02544633|101453824|FG003|NOT COMPLETED|Survival Follow-up Period||12||
48456687|NCT01121900|101453825|FG000|STARTED|First Intervention Period||13||
48456688|NCT01121900|101453826|FG001|STARTED|First Intervention Period||13||
48456689|NCT01121900|101453825|FG000|COMPLETED|First Intervention Period||12||
48456690|NCT01121900|101453826|FG001|COMPLETED|First Intervention Period||12||
48456691|NCT01121900|101453825|FG000|NOT COMPLETED|First Intervention Period||1||
48456692|NCT01121900|101453826|FG001|NOT COMPLETED|First Intervention Period||1||
48456693|NCT01121900|101453825|FG000|STARTED|Washout Period of 7 Days||12||
48456694|NCT01121900|101453826|FG001|STARTED|Washout Period of 7 Days||12||
48456695|NCT01121900|101453825|FG000|COMPLETED|Washout Period of 7 Days||12||
48456696|NCT01121900|101453826|FG001|COMPLETED|Washout Period of 7 Days||11||
48456697|NCT01121900|101453825|FG000|NOT COMPLETED|Washout Period of 7 Days||0||
48456698|NCT01121900|101453826|FG001|NOT COMPLETED|Washout Period of 7 Days||1||
48456699|NCT01121900|101453825|FG000|STARTED|Second Intervention Period||12||
48456700|NCT01121900|101453826|FG001|STARTED|Second Intervention Period||11||
48456701|NCT01121900|101453825|FG000|COMPLETED|Second Intervention Period||12||
48456702|NCT01121900|101453826|FG001|COMPLETED|Second Intervention Period||11||
48456703|NCT01121900|101453825|FG000|NOT COMPLETED|Second Intervention Period||0||
48456704|NCT01121900|101453826|FG001|NOT COMPLETED|Second Intervention Period||0||
48456705|NCT03493698|101453827|FG000|STARTED|Treatment Period A||17||
48456706|NCT03493698|101453827|FG000|COMPLETED|Treatment Period A||17||
48456707|NCT03493698|101453827|FG000|NOT COMPLETED|Treatment Period A||0||
48456708|NCT03493698|101453827|FG000|STARTED|Treatment Period B||17||
48456709|NCT03493698|101453827|FG000|COMPLETED|Treatment Period B||17||
48456710|NCT03493698|101453827|FG000|NOT COMPLETED|Treatment Period B||0||
48456711|NCT03493698|101453827|FG000|STARTED|Treatment Period C||17||
48456712|NCT03493698|101453827|FG000|COMPLETED|Treatment Period C||15|One subject withdrawn from the study on Day 9 and was replaced|
48456713|NCT03493698|101453827|FG000|NOT COMPLETED|Treatment Period C||2||
48456714|NCT03493698|101453827|FG000|STARTED|Treatment Period D||15||
48456715|NCT03493698|101453827|FG000|COMPLETED|Treatment Period D||15||
48456716|NCT03493698|101453827|FG000|NOT COMPLETED|Treatment Period D||0||
48456717|NCT01724359|101453828|FG000|STARTED|Overall Study||95||
48456718|NCT01724359|101453828|FG000|COMPLETED|Overall Study||64||
48456719|NCT01724359|101453828|FG000|NOT COMPLETED|Overall Study||31||
48456720|NCT02436135|101453829|FG000|STARTED|Overall Study||6||
48456721|NCT02436135|101453830|FG001|STARTED|Overall Study||4||
48456722|NCT02436135|101453829|FG000|COMPLETED|Overall Study||0||
48456723|NCT02436135|101453830|FG001|COMPLETED|Overall Study||0||
48456724|NCT02436135|101453829|FG000|NOT COMPLETED|Overall Study||6||
48456725|NCT02436135|101453830|FG001|NOT COMPLETED|Overall Study||4||
48456726|NCT00686803|101453831|FG000|STARTED|Overall Study||6||
48456727|NCT00686803|101453832|FG001|STARTED|Overall Study||12||
48456728|NCT00686803|101453833|FG002|STARTED|Overall Study||3||
48456729|NCT00686803|101453831|FG000|COMPLETED|Overall Study||6||
48456730|NCT00686803|101453832|FG001|COMPLETED|Overall Study||12||
48456731|NCT00686803|101453833|FG002|COMPLETED|Overall Study||3||
48456732|NCT00686803|101453831|FG000|NOT COMPLETED|Overall Study||0||
48456733|NCT00686803|101453832|FG001|NOT COMPLETED|Overall Study||0||
48456734|NCT00686803|101453833|FG002|NOT COMPLETED|Overall Study||0||
48456735|NCT00747747|101453834|FG000|STARTED|Overall Study||14||
48456736|NCT00747747|101453835|FG001|STARTED|Overall Study||14||
48456737|NCT00747747|101453836|FG002|STARTED|Overall Study||21||
48456738|NCT00747747|101453834|FG000|COMPLETED|Overall Study||14||
48456739|NCT00747747|101453835|FG001|COMPLETED|Overall Study||14||
48456740|NCT00747747|101453836|FG002|COMPLETED|Overall Study||21||
48456741|NCT00747747|101453834|FG000|NOT COMPLETED|Overall Study||0||
48456742|NCT00747747|101453835|FG001|NOT COMPLETED|Overall Study||0||
48456743|NCT00747747|101453836|FG002|NOT COMPLETED|Overall Study||0||
48456744|NCT02513459|101453837|FG000|STARTED|Overall Study||65||
48456745|NCT02513459|101453837|FG000|COMPLETED|Overall Study||44||
48456746|NCT02513459|101453837|FG000|NOT COMPLETED|Overall Study||21||
48456747|NCT01785875|101453838|FG000|STARTED|Overall Study||384||
48456748|NCT01785875|101453839|FG001|STARTED|Overall Study||384||
48456749|NCT01785875|101453840|FG002|STARTED|Overall Study||123||
48456750|NCT01785875|101453838|FG000|Received Etelcalcetide|Overall Study||383||
48456751|NCT01785875|101453839|FG001|Received Etelcalcetide|Overall Study||384||
48456752|NCT01785875|101453840|FG002|Received Etelcalcetide|Overall Study||123||
48456753|NCT01785875|101453838|FG000|COMPLETED|Overall Study||90||
48456754|NCT01785875|101453839|FG001|COMPLETED|Overall Study||95||
48456755|NCT01785875|101453840|FG002|COMPLETED|Overall Study||16||
48456756|NCT01785875|101453838|FG000|NOT COMPLETED|Overall Study||294||
48456757|NCT01785875|101453839|FG001|NOT COMPLETED|Overall Study||289||
48456758|NCT01785875|101453840|FG002|NOT COMPLETED|Overall Study||107||
48663027|NCT00265122|101959531|FG005|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||12||
48663028|NCT00265122|101959526|FG000|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||7||
48456759|NCT03944785|101453841|FG000|STARTED|2 Month Study Completion||2|Participants were prospectively followed for 2 months.|
48456760|NCT03944785|101453842|FG001|STARTED|2 Month Study Completion||34|Participants were prospectively followed for 2 months.|
48456761|NCT03944785|101453843|FG002|STARTED|2 Month Study Completion||128|Participants were prospectively followed for 2 months.|
48456762|NCT03944785|101453841|FG000|COMPLETED|2 Month Study Completion||2||
48456763|NCT03944785|101453842|FG001|COMPLETED|2 Month Study Completion||30||
48456764|NCT03944785|101453843|FG002|COMPLETED|2 Month Study Completion||123||
48456765|NCT03944785|101453841|FG000|NOT COMPLETED|2 Month Study Completion||0||
48456766|NCT03944785|101453842|FG001|NOT COMPLETED|2 Month Study Completion||4||
48456767|NCT03944785|101453843|FG002|NOT COMPLETED|2 Month Study Completion||5||
48456768|NCT03944785|101453841|FG000|STARTED|4 Month Study Optional Extension||1|Continued participation for 4 additional months as an optional extension to the original 2 months.|
48456769|NCT03944785|101453842|FG001|STARTED|4 Month Study Optional Extension||10|Continued participation for 4 additional months as an optional extension to the original 2 months.|
48456770|NCT03944785|101453843|FG002|STARTED|4 Month Study Optional Extension||64|Continued participation for 4 additional months as an optional extension to the original 2 months.|
48456771|NCT03944785|101453841|FG000|COMPLETED|4 Month Study Optional Extension||0||
48456772|NCT03944785|101453842|FG001|COMPLETED|4 Month Study Optional Extension||8||
48456773|NCT03944785|101453843|FG002|COMPLETED|4 Month Study Optional Extension||41||
48456774|NCT03944785|101453841|FG000|NOT COMPLETED|4 Month Study Optional Extension||1||
48456775|NCT03944785|101453842|FG001|NOT COMPLETED|4 Month Study Optional Extension||2||
48456776|NCT03944785|101453843|FG002|NOT COMPLETED|4 Month Study Optional Extension||23||
48456777|NCT03280537|101453844|FG000|STARTED|Overall Study||65||
48456778|NCT03280537|101453845|FG001|STARTED|Overall Study||62||
48456779|NCT03280537|101453844|FG000|COMPLETED|Overall Study||63||
48456780|NCT03280537|101453845|FG001|COMPLETED|Overall Study||58||
48456781|NCT03280537|101453844|FG000|NOT COMPLETED|Overall Study||2||
48456782|NCT03280537|101453845|FG001|NOT COMPLETED|Overall Study||4||
48456783|NCT04549259|101453846|FG000|STARTED|Overall Study||4||
48456784|NCT04549259|101453847|FG001|STARTED|Overall Study||4||
48456785|NCT04549259|101453848|FG002|STARTED|Overall Study||3||
48456786|NCT04549259|101453849|FG003|STARTED|Overall Study||3||
48456787|NCT04549259|101453850|FG004|STARTED|Overall Study||4||
48456788|NCT04549259|101453851|FG005|STARTED|Overall Study||4||
48456789|NCT04549259|101453852|FG006|STARTED|Overall Study||4||
48456790|NCT04549259|101453853|FG007|STARTED|Overall Study||4||
48456791|NCT04549259|101453854|FG008|STARTED|Overall Study||4||
48456792|NCT04549259|101453855|FG009|STARTED|Overall Study||3||
48456793|NCT04549259|101453856|FG010|STARTED|Overall Study||4||
48456794|NCT04549259|101453857|FG011|STARTED|Overall Study||4||
48456795|NCT04549259|101453858|FG012|STARTED|Overall Study||4||
48456796|NCT04549259|101453859|FG013|STARTED|Overall Study||4||
48456797|NCT04549259|101453860|FG014|STARTED|Overall Study||4||
48456798|NCT04549259|101453861|FG015|STARTED|Overall Study||4||
48456799|NCT04549259|101453846|FG000|COMPLETED|Overall Study||4||
48456800|NCT04549259|101453847|FG001|COMPLETED|Overall Study||4||
48456801|NCT04549259|101453848|FG002|COMPLETED|Overall Study||3||
48456802|NCT04549259|101453849|FG003|COMPLETED|Overall Study||2||
48456803|NCT04549259|101453850|FG004|COMPLETED|Overall Study||4||
48456804|NCT04549259|101453851|FG005|COMPLETED|Overall Study||2||
48456805|NCT04549259|101453852|FG006|COMPLETED|Overall Study||3||
48456806|NCT04549259|101453853|FG007|COMPLETED|Overall Study||2||
48456807|NCT04549259|101453854|FG008|COMPLETED|Overall Study||3||
48456808|NCT04549259|101453855|FG009|COMPLETED|Overall Study||3||
48456809|NCT04549259|101453856|FG010|COMPLETED|Overall Study||4||
48456810|NCT04549259|101453857|FG011|COMPLETED|Overall Study||3||
48456811|NCT04549259|101453858|FG012|COMPLETED|Overall Study||3||
48456812|NCT04549259|101453859|FG013|COMPLETED|Overall Study||3||
48456813|NCT04549259|101453860|FG014|COMPLETED|Overall Study||4||
48456814|NCT04549259|101453861|FG015|COMPLETED|Overall Study||4||
48456815|NCT04549259|101453846|FG000|NOT COMPLETED|Overall Study||0||
48456816|NCT04549259|101453847|FG001|NOT COMPLETED|Overall Study||0||
48456817|NCT04549259|101453848|FG002|NOT COMPLETED|Overall Study||0||
48456818|NCT04549259|101453849|FG003|NOT COMPLETED|Overall Study||1||
48456819|NCT04549259|101453850|FG004|NOT COMPLETED|Overall Study||0||
48456820|NCT04549259|101453851|FG005|NOT COMPLETED|Overall Study||2||
48456821|NCT04549259|101453852|FG006|NOT COMPLETED|Overall Study||1||
48456822|NCT04549259|101453853|FG007|NOT COMPLETED|Overall Study||2||
48456823|NCT04549259|101453854|FG008|NOT COMPLETED|Overall Study||1||
48456824|NCT04549259|101453855|FG009|NOT COMPLETED|Overall Study||0||
48456825|NCT04549259|101453856|FG010|NOT COMPLETED|Overall Study||0||
48456826|NCT04549259|101453857|FG011|NOT COMPLETED|Overall Study||1||
48456827|NCT04549259|101453858|FG012|NOT COMPLETED|Overall Study||1||
48456828|NCT04549259|101453859|FG013|NOT COMPLETED|Overall Study||1||
48456829|NCT04549259|101453860|FG014|NOT COMPLETED|Overall Study||0||
48456830|NCT04549259|101453861|FG015|NOT COMPLETED|Overall Study||0||
48456831|NCT02521948|101453862|FG000|STARTED|Overall Study||50||
48456832|NCT02521948|101453862|FG000|COMPLETED|Overall Study||37||
48456833|NCT02521948|101453862|FG000|NOT COMPLETED|Overall Study||13||
48456834|NCT01169649|101453863|FG000|STARTED|Overall Study||11||
48456835|NCT01169649|101453863|FG000|COMPLETED|Overall Study||8||
48456836|NCT01169649|101453863|FG000|NOT COMPLETED|Overall Study||3||
48456837|NCT01365845|101453864|FG000|STARTED|Induction Phase||18||
48456838|NCT01365845|101453865|FG001|STARTED|Induction Phase||0||
48456839|NCT01365845|101453866|FG002|STARTED|Induction Phase||0||
48456840|NCT01365845|101453864|FG000|COMPLETED|Induction Phase||18||
48456841|NCT01365845|101453865|FG001|COMPLETED|Induction Phase||0||
48456842|NCT01365845|101453866|FG002|COMPLETED|Induction Phase||0||
48456843|NCT01365845|101453864|FG000|NOT COMPLETED|Induction Phase||0||
48456844|NCT01365845|101453865|FG001|NOT COMPLETED|Induction Phase||0||
48456845|NCT01365845|101453866|FG002|NOT COMPLETED|Induction Phase||0||
48456846|NCT01365845|101453864|FG000|STARTED|Treatment Phase||0||
48456847|NCT01365845|101453865|FG001|STARTED|Treatment Phase||0||
48456848|NCT01365845|101453866|FG002|STARTED|Treatment Phase||18||
48456849|NCT01365845|101453864|FG000|COMPLETED|Treatment Phase||0||
48456850|NCT01365845|101453865|FG001|COMPLETED|Treatment Phase||0||
48456851|NCT01365845|101453866|FG002|COMPLETED|Treatment Phase||18||
48456852|NCT01365845|101453864|FG000|NOT COMPLETED|Treatment Phase||0||
48456853|NCT01365845|101453865|FG001|NOT COMPLETED|Treatment Phase||0||
48456854|NCT01365845|101453866|FG002|NOT COMPLETED|Treatment Phase||0||
48456855|NCT01783483|101453867|FG000|STARTED|Overall Study||120||
48456856|NCT01783483|101453868|FG001|STARTED|Overall Study||116||
48456857|NCT01783483|101453867|FG000|COMPLETED|Overall Study||100||
48456858|NCT01783483|101453868|FG001|COMPLETED|Overall Study||101||
48456859|NCT01783483|101453867|FG000|NOT COMPLETED|Overall Study||20||
48456860|NCT01783483|101453868|FG001|NOT COMPLETED|Overall Study||15||
48456861|NCT01189240|101453869|FG000|STARTED|Overall Study||4||
48456862|NCT01189240|101453870|FG001|STARTED|Overall Study||6||
48456863|NCT01189240|101453871|FG002|STARTED|Overall Study||3||
48456864|NCT01189240|101453869|FG000|COMPLETED|Overall Study||4||
48456865|NCT01189240|101453870|FG001|COMPLETED|Overall Study||6||
48456866|NCT01189240|101453871|FG002|COMPLETED|Overall Study||3||
48456867|NCT01189240|101453869|FG000|NOT COMPLETED|Overall Study||0||
48456868|NCT01189240|101453870|FG001|NOT COMPLETED|Overall Study||0||
48456869|NCT01189240|101453871|FG002|NOT COMPLETED|Overall Study||0||
48456870|NCT01567371|101456996|FG000|STARTED|Overall Study||30||
48456871|NCT01567371|101456996|FG000|COMPLETED|Overall Study||30||
48456872|NCT01567371|101456996|FG000|NOT COMPLETED|Overall Study||0||
48456873|NCT01203774|101456997|FG000|STARTED|Overall Study||21||
48456874|NCT01203774|101456998|FG001|STARTED|Overall Study||10||
48456875|NCT01203774|101456997|FG000|COMPLETED|Overall Study||21||
48456876|NCT01203774|101456998|FG001|COMPLETED|Overall Study||10||
48456877|NCT01203774|101456997|FG000|NOT COMPLETED|Overall Study||0||
48456878|NCT01203774|101456998|FG001|NOT COMPLETED|Overall Study||0||
48456879|NCT00287287|101456999|FG000|STARTED|Overall Study||25||
48456880|NCT00287287|101456999|FG000|COMPLETED|Overall Study||25||
48456881|NCT00287287|101456999|FG000|NOT COMPLETED|Overall Study||0||
48456882|NCT00955032|101457000|FG000|STARTED|Overall Study||16||
48456883|NCT00955032|101457001|FG001|STARTED|Overall Study||8||
48456884|NCT00955032|101457000|FG000|COMPLETED|Overall Study||16||
48456885|NCT00955032|101457001|FG001|COMPLETED|Overall Study||8||
48456886|NCT00955032|101457000|FG000|NOT COMPLETED|Overall Study||0||
48456887|NCT00955032|101457001|FG001|NOT COMPLETED|Overall Study||0||
48456888|NCT00824460|101457002|FG000|STARTED|Overall Study||26||
48456889|NCT00824460|101457003|FG001|STARTED|Overall Study||26||
48456890|NCT00824460|101457004|FG002|STARTED|Overall Study||25||
48456891|NCT00824460|101457005|FG003|STARTED|Overall Study||27||
48456892|NCT00824460|101457006|FG004|STARTED|Overall Study||24||
48456893|NCT00824460|101457007|FG005|STARTED|Overall Study||26||
48456894|NCT00824460|101457002|FG000|COMPLETED|Overall Study||18||
48456895|NCT00824460|101457003|FG001|COMPLETED|Overall Study||17||
48456896|NCT00824460|101457004|FG002|COMPLETED|Overall Study||20||
48456897|NCT00824460|101457005|FG003|COMPLETED|Overall Study||15||
48456898|NCT00824460|101457006|FG004|COMPLETED|Overall Study||15||
48456899|NCT00824460|101457007|FG005|COMPLETED|Overall Study||18||
48456900|NCT00824460|101457002|FG000|NOT COMPLETED|Overall Study||8||
48456901|NCT00824460|101457003|FG001|NOT COMPLETED|Overall Study||9||
48456902|NCT00824460|101457004|FG002|NOT COMPLETED|Overall Study||5||
48456903|NCT00824460|101457005|FG003|NOT COMPLETED|Overall Study||12||
48456904|NCT00824460|101457006|FG004|NOT COMPLETED|Overall Study||9||
48456905|NCT00824460|101457007|FG005|NOT COMPLETED|Overall Study||8||
48456906|NCT02708290|101457008|FG000|STARTED|Overall Study||1009||
48456907|NCT02708290|101457009|FG001|STARTED|Overall Study||1009||
48456908|NCT02708290|101457008|FG000|COMPLETED|Overall Study||1009||
48456909|NCT02708290|101457009|FG001|COMPLETED|Overall Study||1009||
48456910|NCT02708290|101457008|FG000|NOT COMPLETED|Overall Study||0||
48772878|NCT00790842|102232801|FG008|COMPLETED|Expansion Cohort||0||
48772879|NCT00790842|102232802|FG009|COMPLETED|Expansion Cohort||0||
48456911|NCT02708290|101457009|FG001|NOT COMPLETED|Overall Study||0||
48456912|NCT02762565|101457010|FG000|STARTED|Overall Study||89||
48456913|NCT02762565|101457010|FG000|COMPLETED|Overall Study||78||
48456914|NCT02762565|101457010|FG000|NOT COMPLETED|Overall Study||11||
48456915|NCT04036227|101457011|FG000|STARTED|Part I (SAD): 1 mg||6||
48456916|NCT04036227|101457012|FG001|STARTED|Part I (SAD): 1 mg||0||
48456917|NCT04036227|101457013|FG002|STARTED|Part I (SAD): 1 mg||0||
48456918|NCT04036227|101457014|FG003|STARTED|Part I (SAD): 1 mg||0||
48456919|NCT04036227|101457015|FG004|STARTED|Part I (SAD): 1 mg||0||
48456920|NCT04036227|101457016|FG005|STARTED|Part I (SAD): 1 mg||0||
48456921|NCT04036227|101457017|FG006|STARTED|Part I (SAD): 1 mg||0||
48663029|NCT00265122|101959527|FG001|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1||
48663030|NCT00265122|101959528|FG002|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4||
48772880|NCT00790842|102232803|FG010|COMPLETED|Expansion Cohort||0||
48772881|NCT00790842|102232793|FG000|NOT COMPLETED|Expansion Cohort||0||
48772882|NCT00790842|102232794|FG001|NOT COMPLETED|Expansion Cohort||0||
48772883|NCT00790842|102232795|FG002|NOT COMPLETED|Expansion Cohort||7||
48772884|NCT00790842|102232796|FG003|NOT COMPLETED|Expansion Cohort||0||
48772885|NCT00790842|102232797|FG004|NOT COMPLETED|Expansion Cohort||0||
48772886|NCT00790842|102232798|FG005|NOT COMPLETED|Expansion Cohort||0||
48772887|NCT00790842|102232799|FG006|NOT COMPLETED|Expansion Cohort||1||
48772888|NCT00790842|102232800|FG007|NOT COMPLETED|Expansion Cohort||0||
48189268|NCT03168438|100786189|FG001|STARTED|Overall Study||3||
48369470|NCT04105543|101232779|FG000|Completed 12 Months Post EBRT QoL Measures|Dose Held at Dose Level 1: 15.6mCi||0||
48369471|NCT04105543|101232779|FG000|Died While on Study|Dose Held at Dose Level 1: 15.6mCi||8||
48369472|NCT04105543|101232779|FG000|COMPLETED|Dose Held at Dose Level 1: 15.6mCi||12||
48369473|NCT04105543|101232779|FG000|NOT COMPLETED|Dose Held at Dose Level 1: 15.6mCi||0||
48369474|NCT05022004|101232780|FG000|STARTED|Overall Study||297||
48369475|NCT05022004|101232781|FG001|STARTED|Overall Study||300||
48369476|NCT05022004|101232780|FG000|COMPLETED|Overall Study||287||
48369477|NCT05022004|101232781|FG001|COMPLETED|Overall Study||289||
48369478|NCT05022004|101232780|FG000|NOT COMPLETED|Overall Study||10||
48369479|NCT05022004|101232781|FG001|NOT COMPLETED|Overall Study||11||
48369480|NCT00850759|101232782|FG000|STARTED|Overall Study||59||
48369481|NCT00850759|101232783|FG001|STARTED|Overall Study||57||
48369482|NCT00850759|101232784|FG002|STARTED|Overall Study||57||
48369483|NCT00850759|101232785|FG003|STARTED|Overall Study||58||
48369484|NCT00850759|101232782|FG000|COMPLETED|Overall Study||52||
48369485|NCT00850759|101232783|FG001|COMPLETED|Overall Study||52||
48369486|NCT00850759|101232784|FG002|COMPLETED|Overall Study||52||
48369487|NCT00850759|101232785|FG003|COMPLETED|Overall Study||55||
48369488|NCT00850759|101232782|FG000|NOT COMPLETED|Overall Study||7||
48369489|NCT00850759|101232783|FG001|NOT COMPLETED|Overall Study||5||
48369490|NCT00850759|101232784|FG002|NOT COMPLETED|Overall Study||5||
48369491|NCT00850759|101232785|FG003|NOT COMPLETED|Overall Study||3||
48369492|NCT02300077|101232786|FG000|STARTED|Overall Study||21||
48369493|NCT02300077|101232787|FG001|STARTED|Overall Study||18||
48369494|NCT02300077|101232788|FG002|STARTED|Overall Study||21||
48369495|NCT02300077|101232786|FG000|COMPLETED|Overall Study||21||
48369496|NCT02300077|101232787|FG001|COMPLETED|Overall Study||18||
48369497|NCT02300077|101232788|FG002|COMPLETED|Overall Study||21||
48369498|NCT02300077|101232786|FG000|NOT COMPLETED|Overall Study||0||
48369499|NCT02300077|101232787|FG001|NOT COMPLETED|Overall Study||0||
48369500|NCT02300077|101232788|FG002|NOT COMPLETED|Overall Study||0||
48369501|NCT03552549|101232789|FG000|STARTED|Overall Study||63||
48369502|NCT03552549|101232790|FG001|STARTED|Overall Study||63||
48369503|NCT03552549|101232789|FG000|Treated|Overall Study||62||
48369504|NCT03552549|101232790|FG001|Treated|Overall Study||62||
48369505|NCT03552549|101232789|FG000|COMPLETED|Overall Study||10||
48369506|NCT03552549|101232790|FG001|COMPLETED|Overall Study||11||
48369507|NCT03552549|101232789|FG000|NOT COMPLETED|Overall Study||53||
48369508|NCT03552549|101232790|FG001|NOT COMPLETED|Overall Study||52||
48369509|NCT02043301|101232791|FG000|STARTED|Overall Study||25||
48369510|NCT02043301|101232792|FG001|STARTED|Overall Study||25||
48369511|NCT02043301|101232793|FG002|STARTED|Overall Study||25||
48369512|NCT02043301|101232791|FG000|COMPLETED|Overall Study||25||
48369513|NCT02043301|101232792|FG001|COMPLETED|Overall Study||24||
48369514|NCT02043301|101232793|FG002|COMPLETED|Overall Study||25||
48369515|NCT02043301|101232791|FG000|NOT COMPLETED|Overall Study||0||
48369516|NCT02043301|101232792|FG001|NOT COMPLETED|Overall Study||1||
48369517|NCT02043301|101232793|FG002|NOT COMPLETED|Overall Study||0||
48369518|NCT02619253|101232794|FG000|STARTED|Overall Study||4||
48369519|NCT02619253|101232795|FG001|STARTED|Overall Study||4||
48369520|NCT02619253|101232796|FG002|STARTED|Overall Study||15||
48369521|NCT02619253|101232797|FG003|STARTED|Overall Study||14||
48369522|NCT02619253|101232798|FG004|STARTED|Overall Study||15||
48369523|NCT02619253|101232794|FG000|COMPLETED|Overall Study||0||
48369524|NCT02619253|101232795|FG001|COMPLETED|Overall Study||0||
48369525|NCT02619253|101232796|FG002|COMPLETED|Overall Study||1||
48369526|NCT02619253|101232797|FG003|COMPLETED|Overall Study||0||
48369527|NCT02619253|101232798|FG004|COMPLETED|Overall Study||0||
48369528|NCT02619253|101232794|FG000|NOT COMPLETED|Overall Study||4||
48369529|NCT02619253|101232795|FG001|NOT COMPLETED|Overall Study||4||
48663031|NCT00265122|101959529|FG003|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4||
48663032|NCT00265122|101959530|FG004|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||5||
48663033|NCT00265122|101959531|FG005|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1||
48663034|NCT00085839|101959532|FG000|STARTED|Overall Study||52||
48663035|NCT00085839|101959533|FG001|STARTED|Overall Study||51||
48663036|NCT00085839|101959532|FG000|COMPLETED|Overall Study||52||
48663037|NCT00085839|101959533|FG001|COMPLETED|Overall Study||51||
48663038|NCT00085839|101959532|FG000|NOT COMPLETED|Overall Study||0||
48663039|NCT00085839|101959533|FG001|NOT COMPLETED|Overall Study||0||
48663040|NCT01832038|101959534|FG000|STARTED|Overall Study||473||
48663041|NCT01832038|101959534|FG000|COMPLETED|Overall Study||238||
48663042|NCT01832038|101959534|FG000|NOT COMPLETED|Overall Study||235||
48663043|NCT02402647|101959535|FG000|STARTED|Overall Study||59||
48663044|NCT02402647|101959536|FG001|STARTED|Overall Study||56||
48663045|NCT02402647|101959535|FG000|COMPLETED|Overall Study||34||
48663046|NCT02402647|101959536|FG001|COMPLETED|Overall Study||42||
48663047|NCT02402647|101959535|FG000|NOT COMPLETED|Overall Study||25||
48663048|NCT02402647|101959536|FG001|NOT COMPLETED|Overall Study||14||
48663049|NCT03658304|101959537|FG000|STARTED|Overall Study||29||
48456922|NCT04036227|101457018|FG007|STARTED|Part I (SAD): 1 mg||0||
48456923|NCT04036227|101457019|FG008|STARTED|Part I (SAD): 1 mg||0||
48456924|NCT04036227|101457020|FG009|STARTED|Part I (SAD): 1 mg||0||
48456925|NCT04036227|101457021|FG010|STARTED|Part I (SAD): 1 mg||0||
48456926|NCT04036227|101457011|FG000|COMPLETED|Part I (SAD): 1 mg||6||
48456927|NCT04036227|101457012|FG001|COMPLETED|Part I (SAD): 1 mg||0||
48456928|NCT04036227|101457013|FG002|COMPLETED|Part I (SAD): 1 mg||0||
48456929|NCT04036227|101457014|FG003|COMPLETED|Part I (SAD): 1 mg||0||
48456930|NCT04036227|101457015|FG004|COMPLETED|Part I (SAD): 1 mg||0||
48456931|NCT04036227|101457016|FG005|COMPLETED|Part I (SAD): 1 mg||0||
48456932|NCT04036227|101457017|FG006|COMPLETED|Part I (SAD): 1 mg||0||
48456933|NCT04036227|101457018|FG007|COMPLETED|Part I (SAD): 1 mg||0||
48772889|NCT00790842|102232801|FG008|NOT COMPLETED|Expansion Cohort||0||
48772890|NCT00790842|102232802|FG009|NOT COMPLETED|Expansion Cohort||0||
48772891|NCT00790842|102232803|FG010|NOT COMPLETED|Expansion Cohort||0||
48772892|NCT03193593|102232804|FG000|STARTED|Overall Study||18||
48772893|NCT03193593|102232805|FG001|STARTED|Overall Study||4||
48456934|NCT04036227|101457019|FG008|COMPLETED|Part I (SAD): 1 mg||0||
48456935|NCT04036227|101457020|FG009|COMPLETED|Part I (SAD): 1 mg||0||
48456936|NCT04036227|101457021|FG010|COMPLETED|Part I (SAD): 1 mg||0||
48456937|NCT04036227|101457011|FG000|NOT COMPLETED|Part I (SAD): 1 mg||0||
48456938|NCT04036227|101457012|FG001|NOT COMPLETED|Part I (SAD): 1 mg||0||
48456939|NCT04036227|101457013|FG002|NOT COMPLETED|Part I (SAD): 1 mg||0||
48456940|NCT04036227|101457014|FG003|NOT COMPLETED|Part I (SAD): 1 mg||0||
48456941|NCT04036227|101457015|FG004|NOT COMPLETED|Part I (SAD): 1 mg||0||
48663050|NCT03658304|101959537|FG000|COMPLETED|Overall Study||29||
48663051|NCT03658304|101959537|FG000|NOT COMPLETED|Overall Study||0||
48663052|NCT02971137|101959538|FG000|STARTED|Overall Study||189||
48772894|NCT03193593|102232806|FG002|STARTED|Overall Study||4||
48772895|NCT03193593|102232807|FG003|STARTED|Overall Study||4||
48772896|NCT03193593|102232808|FG004|STARTED|Overall Study||8||
48772897|NCT03193593|102232809|FG005|STARTED|Overall Study||16||
48772898|NCT03193593|102232810|FG006|STARTED|Overall Study||12||
48772899|NCT03193593|102232804|FG000|COMPLETED|Overall Study||14||
48772900|NCT03193593|102232805|FG001|COMPLETED|Overall Study||3||
48772901|NCT03193593|102232806|FG002|COMPLETED|Overall Study||3||
48772902|NCT03193593|102232807|FG003|COMPLETED|Overall Study||4||
48772903|NCT03193593|102232808|FG004|COMPLETED|Overall Study||7||
48772904|NCT03193593|102232809|FG005|COMPLETED|Overall Study||13||
48772905|NCT03193593|102232810|FG006|COMPLETED|Overall Study||8||
48772906|NCT03193593|102232804|FG000|NOT COMPLETED|Overall Study||4||
48772907|NCT03193593|102232805|FG001|NOT COMPLETED|Overall Study||1||
48772908|NCT03193593|102232806|FG002|NOT COMPLETED|Overall Study||1||
48772909|NCT03193593|102232807|FG003|NOT COMPLETED|Overall Study||0||
48772910|NCT03193593|102232808|FG004|NOT COMPLETED|Overall Study||1||
48772911|NCT03193593|102232809|FG005|NOT COMPLETED|Overall Study||3||
48772912|NCT03193593|102232810|FG006|NOT COMPLETED|Overall Study||4||
48772913|NCT03710577|102232811|FG000|STARTED|First Intervention||8||
48772914|NCT03710577|102232812|FG001|STARTED|First Intervention||4||
48772915|NCT03710577|102232811|FG000|COMPLETED|First Intervention||8||
48772916|NCT03710577|102232812|FG001|COMPLETED|First Intervention||4||
48772917|NCT03710577|102232811|FG000|NOT COMPLETED|First Intervention||0||
48772918|NCT03710577|102232812|FG001|NOT COMPLETED|First Intervention||0||
48772919|NCT03710577|102232811|FG000|STARTED|Time Between Sessions (2-5 Days)||8||
48772920|NCT03710577|102232812|FG001|STARTED|Time Between Sessions (2-5 Days)||4||
48772921|NCT03710577|102232811|FG000|COMPLETED|Time Between Sessions (2-5 Days)||8||
48772922|NCT03710577|102232812|FG001|COMPLETED|Time Between Sessions (2-5 Days)||4||
48772923|NCT03710577|102232811|FG000|NOT COMPLETED|Time Between Sessions (2-5 Days)||0||
48772924|NCT03710577|102232812|FG001|NOT COMPLETED|Time Between Sessions (2-5 Days)||0||
48772925|NCT03710577|102232811|FG000|STARTED|Second Intervention||8||
48772926|NCT03710577|102232812|FG001|STARTED|Second Intervention||4||
48456942|NCT04036227|101457016|FG005|NOT COMPLETED|Part I (SAD): 1 mg||0||
48456943|NCT04036227|101457017|FG006|NOT COMPLETED|Part I (SAD): 1 mg||0||
48456944|NCT04036227|101457018|FG007|NOT COMPLETED|Part I (SAD): 1 mg||0||
48456945|NCT04036227|101457019|FG008|NOT COMPLETED|Part I (SAD): 1 mg||0||
48456946|NCT04036227|101457020|FG009|NOT COMPLETED|Part I (SAD): 1 mg||0||
48456947|NCT04036227|101457021|FG010|NOT COMPLETED|Part I (SAD): 1 mg||0||
48456948|NCT04036227|101457011|FG000|STARTED|Part I (SAD): 5 mg||0||
48456949|NCT04036227|101457012|FG001|STARTED|Part I (SAD): 5 mg||6||
48456950|NCT04036227|101457013|FG002|STARTED|Part I (SAD): 5 mg||0||
48456951|NCT04036227|101457014|FG003|STARTED|Part I (SAD): 5 mg||0||
48456952|NCT04036227|101457015|FG004|STARTED|Part I (SAD): 5 mg||0||
48456953|NCT04036227|101457016|FG005|STARTED|Part I (SAD): 5 mg||0||
48456954|NCT04036227|101457017|FG006|STARTED|Part I (SAD): 5 mg||0||
48456955|NCT04036227|101457018|FG007|STARTED|Part I (SAD): 5 mg||0||
48663053|NCT02971137|101959539|FG001|STARTED|Overall Study||182||
48663054|NCT02971137|101959538|FG000|COMPLETED|Overall Study||145||
48663055|NCT02971137|101959539|FG001|COMPLETED|Overall Study||126||
48663056|NCT02971137|101959538|FG000|NOT COMPLETED|Overall Study||44||
48663057|NCT02971137|101959539|FG001|NOT COMPLETED|Overall Study||56||
48663058|NCT00959049|101959540|FG000|STARTED|Overall Study||231||
48663059|NCT00959049|101959541|FG001|STARTED|Overall Study||254||
48663060|NCT00959049|101959542|FG002|STARTED|Overall Study||254||
48663061|NCT00959049|101959543|FG003|STARTED|Overall Study||228||
48663062|NCT00959049|101959544|FG004|STARTED|Overall Study||257||
48663063|NCT00959049|101959545|FG005|STARTED|Overall Study||250||
48663064|NCT00959049|101959540|FG000|COMPLETED|Overall Study||213||
48663065|NCT00959049|101959541|FG001|COMPLETED|Overall Study||247||
48663066|NCT00959049|101959542|FG002|COMPLETED|Overall Study||253||
48663067|NCT00959049|101959543|FG003|COMPLETED|Overall Study||217||
48663068|NCT00959049|101959544|FG004|COMPLETED|Overall Study||248||
48663069|NCT00959049|101959545|FG005|COMPLETED|Overall Study||249||
48456956|NCT04036227|101457019|FG008|STARTED|Part I (SAD): 5 mg||0||
48456957|NCT04036227|101457020|FG009|STARTED|Part I (SAD): 5 mg||0||
48456958|NCT04036227|101457021|FG010|STARTED|Part I (SAD): 5 mg||0||
48456959|NCT04036227|101457011|FG000|COMPLETED|Part I (SAD): 5 mg||0||
48456960|NCT04036227|101457012|FG001|COMPLETED|Part I (SAD): 5 mg||6||
48456961|NCT04036227|101457013|FG002|COMPLETED|Part I (SAD): 5 mg||0||
48456962|NCT04036227|101457014|FG003|COMPLETED|Part I (SAD): 5 mg||0||
48456963|NCT04036227|101457015|FG004|COMPLETED|Part I (SAD): 5 mg||0||
48456964|NCT04036227|101457016|FG005|COMPLETED|Part I (SAD): 5 mg||0||
48456965|NCT04036227|101457017|FG006|COMPLETED|Part I (SAD): 5 mg||0||
48456966|NCT04036227|101457018|FG007|COMPLETED|Part I (SAD): 5 mg||0||
48456967|NCT04036227|101457019|FG008|COMPLETED|Part I (SAD): 5 mg||0||
48456968|NCT04036227|101457020|FG009|COMPLETED|Part I (SAD): 5 mg||0||
48456969|NCT04036227|101457021|FG010|COMPLETED|Part I (SAD): 5 mg||0||
48456970|NCT04036227|101457011|FG000|NOT COMPLETED|Part I (SAD): 5 mg||0||
48456971|NCT04036227|101457012|FG001|NOT COMPLETED|Part I (SAD): 5 mg||0||
48456972|NCT04036227|101457013|FG002|NOT COMPLETED|Part I (SAD): 5 mg||0||
48456973|NCT04036227|101457014|FG003|NOT COMPLETED|Part I (SAD): 5 mg||0||
48456974|NCT04036227|101457015|FG004|NOT COMPLETED|Part I (SAD): 5 mg||0||
48456975|NCT04036227|101457016|FG005|NOT COMPLETED|Part I (SAD): 5 mg||0||
48456976|NCT04036227|101457017|FG006|NOT COMPLETED|Part I (SAD): 5 mg||0||
48456977|NCT04036227|101457018|FG007|NOT COMPLETED|Part I (SAD): 5 mg||0||
48456978|NCT04036227|101457019|FG008|NOT COMPLETED|Part I (SAD): 5 mg||0||
48456979|NCT04036227|101457020|FG009|NOT COMPLETED|Part I (SAD): 5 mg||0||
48456980|NCT04036227|101457021|FG010|NOT COMPLETED|Part I (SAD): 5 mg||0||
48456981|NCT04036227|101457011|FG000|STARTED|Part I (SAD): 8 mg||0||
48456982|NCT04036227|101457012|FG001|STARTED|Part I (SAD): 8 mg||0||
48456983|NCT04036227|101457013|FG002|STARTED|Part I (SAD): 8 mg||6||
48456984|NCT04036227|101457014|FG003|STARTED|Part I (SAD): 8 mg||0||
48456985|NCT04036227|101457015|FG004|STARTED|Part I (SAD): 8 mg||0||
48456986|NCT04036227|101457016|FG005|STARTED|Part I (SAD): 8 mg||0||
48456987|NCT04036227|101457017|FG006|STARTED|Part I (SAD): 8 mg||0||
48456988|NCT04036227|101457018|FG007|STARTED|Part I (SAD): 8 mg||0||
48456989|NCT04036227|101457019|FG008|STARTED|Part I (SAD): 8 mg||0||
48456990|NCT04036227|101457020|FG009|STARTED|Part I (SAD): 8 mg||0||
48663070|NCT00959049|101959540|FG000|NOT COMPLETED|Overall Study||18||
48663071|NCT00959049|101959541|FG001|NOT COMPLETED|Overall Study||7||
48663072|NCT00959049|101959542|FG002|NOT COMPLETED|Overall Study||1||
48456991|NCT04036227|101457021|FG010|STARTED|Part I (SAD): 8 mg||0||
48456992|NCT04036227|101457011|FG000|COMPLETED|Part I (SAD): 8 mg||0||
48456993|NCT04036227|101457012|FG001|COMPLETED|Part I (SAD): 8 mg||0||
48456994|NCT04036227|101457013|FG002|COMPLETED|Part I (SAD): 8 mg||6||
48456995|NCT04036227|101457014|FG003|COMPLETED|Part I (SAD): 8 mg||0||
48663073|NCT00959049|101959543|FG003|NOT COMPLETED|Overall Study||11||
48663074|NCT00959049|101959544|FG004|NOT COMPLETED|Overall Study||9||
48663075|NCT00959049|101959545|FG005|NOT COMPLETED|Overall Study||1||
48663076|NCT04034927|101959546|FG000|STARTED|Overall Study||30||
48663077|NCT04034927|101959547|FG001|STARTED|Overall Study||31||
48663078|NCT04034927|101959546|FG000|COMPLETED|Overall Study||23||
48663079|NCT04034927|101959547|FG001|COMPLETED|Overall Study||16||
48663080|NCT04034927|101959546|FG000|NOT COMPLETED|Overall Study||7||
48663081|NCT04034927|101959547|FG001|NOT COMPLETED|Overall Study||15||
48663082|NCT02014103|101959548|FG000|STARTED|Overall Study||35||
48663083|NCT02014103|101959549|FG001|STARTED|Overall Study||36||
48663084|NCT02014103|101959548|FG000|Did Receive Allocated Intervention|Overall Study||34|One patient did not receive intervention due to elevated SrCr at baseline|
48663085|NCT02014103|101959549|FG001|Did Receive Allocated Intervention|Overall Study||36|One patient did not receive intervention due to elevated SrCr at baseline|
48663086|NCT02014103|101959548|FG000|Discontinued Intervention|Overall Study||6||
48663087|NCT02014103|101959549|FG001|Discontinued Intervention|Overall Study||5||
48663088|NCT02014103|101959548|FG000|Number Subjects Receiving Accord|Overall Study||34|Subjects were randomized to a sequence of formulation administration for each period. Subjects were withdrawn or dropped out at various periods of the study. The subjects who received identified formulation during the study period of participation are counted.|
48663089|NCT02014103|101959549|FG001|Number Subjects Receiving Accord|Overall Study||34|Subjects were randomized to a sequence of formulation administration for each period. Subjects were withdrawn or dropped out at various periods of the study. The subjects who received identified formulation during the study period of participation are counted.|
48663090|NCT02014103|101959548|FG000|Number Subjects Receiving Astellas|Overall Study||32|Subjects were randomized to a sequence of formulation administration for each period. Subjects were withdrawn or dropped out at various periods of the study. The subjects who received identified formulation during the study period of participation are counted.|
48663091|NCT02014103|101959549|FG001|Number Subjects Receiving Astellas|Overall Study||33|Subjects were randomized to a sequence of formulation administration for each period. Subjects were withdrawn or dropped out at various periods of the study. The subjects who received identified formulation during the study period of participation are counted.|
48670053|NCT02052882|101974879|FG000|COMPLETED|Overall Study||47||
48670054|NCT02052882|101974879|FG000|NOT COMPLETED|Overall Study||13||
48772927|NCT03710577|102232811|FG000|COMPLETED|Second Intervention||8||
48772928|NCT03710577|102232812|FG001|COMPLETED|Second Intervention||4||
48772929|NCT03710577|102232811|FG000|NOT COMPLETED|Second Intervention||0||
48772930|NCT03710577|102232812|FG001|NOT COMPLETED|Second Intervention||0||
48369530|NCT02619253|101232796|FG002|NOT COMPLETED|Overall Study||14||
48369531|NCT02619253|101232797|FG003|NOT COMPLETED|Overall Study||14||
48369532|NCT02619253|101232798|FG004|NOT COMPLETED|Overall Study||15||
48772931|NCT01287741|102232813|FG000|STARTED|Overall Study||712||
48772932|NCT01287741|102232814|FG001|STARTED|Overall Study||706||
48772933|NCT01287741|102232813|FG000|COMPLETED|Overall Study||86||
48772934|NCT01287741|102232814|FG001|COMPLETED|Overall Study||91||
48772935|NCT01287741|102232813|FG000|NOT COMPLETED|Overall Study||626||
48772936|NCT01287741|102232814|FG001|NOT COMPLETED|Overall Study||615||
48772937|NCT03613519|102232815|FG000|STARTED|Baseline||115||
48772938|NCT03613519|102232816|FG001|STARTED|Baseline||108||
48772939|NCT03613519|102232817|FG002|STARTED|Baseline||110||
48772940|NCT03613519|102232815|FG000|COMPLETED|Baseline||113||
48772941|NCT03613519|102232816|FG001|COMPLETED|Baseline||85||
48772942|NCT03613519|102232817|FG002|COMPLETED|Baseline||100||
48772943|NCT03613519|102232815|FG000|NOT COMPLETED|Baseline||2||
48772944|NCT03613519|102232816|FG001|NOT COMPLETED|Baseline||23||
48772945|NCT03613519|102232817|FG002|NOT COMPLETED|Baseline||10||
48772946|NCT03613519|102232815|FG000|STARTED|Post -Intervention (9 Weeks)||113||
48772947|NCT03613519|102232816|FG001|STARTED|Post -Intervention (9 Weeks)||85||
48772948|NCT03613519|102232817|FG002|STARTED|Post -Intervention (9 Weeks)||100||
48772949|NCT03613519|102232815|FG000|COMPLETED|Post -Intervention (9 Weeks)||112||
48772950|NCT03613519|102232816|FG001|COMPLETED|Post -Intervention (9 Weeks)||79||
48369533|NCT04230486|101232799|FG000|STARTED|Overall Study||6||
48663092|NCT02014103|101959548|FG000|Number Subjects Receiving Dr. Reddy|Overall Study||34|Subjects were randomized to a sequence of formulation administration for each period. Subjects were withdrawn or dropped out at various periods of the study. The subjects who received identified formulation during the study period of participation are counted.|
48663093|NCT02014103|101959549|FG001|Number Subjects Receiving Dr. Reddy|Overall Study||33|Subjects were randomized to a sequence of formulation administration for each period. Subjects were withdrawn or dropped out at various periods of the study. The subjects who received identified formulation during the study period of participation are counted.|
48663094|NCT02014103|101959548|FG000|Number Subjects Receiving Mylan|Overall Study||32|Subjects were randomized to a sequence of formulation administration for each period. Subjects were withdrawn or dropped out at various periods of the study. The subjects who received identified formulation during the study period of participation are counted.|
48189269|NCT03168438|100786188|FG000|COMPLETED|Overall Study||3||
48189270|NCT03168438|100786189|FG001|COMPLETED|Overall Study||2||
48189271|NCT03168438|100786188|FG000|NOT COMPLETED|Overall Study||0||
48189272|NCT03168438|100786189|FG001|NOT COMPLETED|Overall Study||1||
48189273|NCT00451698|100786190|FG000|STARTED|Overall Study||3||
48189274|NCT00451698|100786191|FG001|STARTED|Overall Study||6||
48189275|NCT00451698|100786190|FG000|COMPLETED|Overall Study||3||
48189276|NCT00451698|100786191|FG001|COMPLETED|Overall Study||6||
48189277|NCT00451698|100786190|FG000|NOT COMPLETED|Overall Study||0||
48772951|NCT03613519|102232817|FG002|COMPLETED|Post -Intervention (9 Weeks)||93||
48772952|NCT03613519|102232815|FG000|NOT COMPLETED|Post -Intervention (9 Weeks)||1||
48772953|NCT03613519|102232816|FG001|NOT COMPLETED|Post -Intervention (9 Weeks)||6||
48772954|NCT03613519|102232817|FG002|NOT COMPLETED|Post -Intervention (9 Weeks)||7||
48772955|NCT03613519|102232815|FG000|STARTED|Long-term Follow-up (6 Months)||112||
48189278|NCT00451698|100786191|FG001|NOT COMPLETED|Overall Study||0||
48189279|NCT00798265|100786192|FG000|STARTED|Overall Study||8||
48189280|NCT00798265|100786193|FG001|STARTED|Overall Study||18||
48189281|NCT00798265|100786192|FG000|COMPLETED|Overall Study||0||
48189282|NCT00798265|100786193|FG001|COMPLETED|Overall Study||0||
48189283|NCT00798265|100786192|FG000|NOT COMPLETED|Overall Study||8||
48189284|NCT00798265|100786193|FG001|NOT COMPLETED|Overall Study||18||
48189285|NCT05177848|100786194|FG000|STARTED|Overall Study||29||
48189286|NCT05177848|100786195|FG001|STARTED|Overall Study||31||
48189287|NCT05177848|100786194|FG000|COMPLETED|Overall Study||26||
48189288|NCT05177848|100786195|FG001|COMPLETED|Overall Study||26||
48189289|NCT05177848|100786194|FG000|NOT COMPLETED|Overall Study||3||
48189290|NCT05177848|100786195|FG001|NOT COMPLETED|Overall Study||5||
48189291|NCT04731714|100786196|FG000|STARTED|Overall Study||16||
48189292|NCT04731714|100786197|FG001|STARTED|Overall Study||16||
48189293|NCT04731714|100786196|FG000|Completed Study Visit 1|Overall Study||16||
48189294|NCT04731714|100786197|FG001|Completed Study Visit 1|Overall Study||16||
48189295|NCT04731714|100786196|FG000|Completed Study Visit 2|Overall Study||16||
48189296|NCT04731714|100786197|FG001|Completed Study Visit 2|Overall Study||16||
48189297|NCT04731714|100786196|FG000|COMPLETED|Overall Study||16||
48189298|NCT04731714|100786197|FG001|COMPLETED|Overall Study||16||
48189299|NCT04731714|100786196|FG000|NOT COMPLETED|Overall Study||0||
48189300|NCT04731714|100786197|FG001|NOT COMPLETED|Overall Study||0||
48189301|NCT01613118|100786198|FG000|STARTED|Double-blind||13||
48189302|NCT01613118|100786199|FG001|STARTED|Double-blind||26||
48189303|NCT01613118|100786200|FG002|STARTED|Double-blind||34||
48189304|NCT01613118|100786201|FG003|STARTED|Double-blind||36||
48189305|NCT01613118|100786198|FG000|COMPLETED|Double-blind||13||
48663095|NCT02014103|101959549|FG001|Number Subjects Receiving Mylan|Overall Study||34|Subjects were randomized to a sequence of formulation administration for each period. Subjects were withdrawn or dropped out at various periods of the study. The subjects who received identified formulation during the study period of participation are counted.|
48670055|NCT02828358|101974880|FG000|STARTED|Overall Study||56||
48772956|NCT03613519|102232816|FG001|STARTED|Long-term Follow-up (6 Months)||79||
48772957|NCT03613519|102232817|FG002|STARTED|Long-term Follow-up (6 Months)||93||
48772958|NCT03613519|102232815|FG000|COMPLETED|Long-term Follow-up (6 Months)||112||
48772959|NCT03613519|102232816|FG001|COMPLETED|Long-term Follow-up (6 Months)||79||
48772960|NCT03613519|102232817|FG002|COMPLETED|Long-term Follow-up (6 Months)||93||
48772961|NCT03613519|102232815|FG000|NOT COMPLETED|Long-term Follow-up (6 Months)||0||
48772962|NCT03613519|102232816|FG001|NOT COMPLETED|Long-term Follow-up (6 Months)||0||
48772963|NCT03613519|102232817|FG002|NOT COMPLETED|Long-term Follow-up (6 Months)||0||
48772964|NCT02289157|102232818|FG000|STARTED|Overall Study||222||
48772965|NCT02289157|102232819|FG001|STARTED|Overall Study||219||
48772966|NCT02289157|102232818|FG000|No Post op Check or Follow up Phone Call|Overall Study||2||
48189306|NCT01613118|100786199|FG001|COMPLETED|Double-blind||23||
48189307|NCT01613118|100786200|FG002|COMPLETED|Double-blind||32||
48189308|NCT01613118|100786201|FG003|COMPLETED|Double-blind||35||
48189309|NCT01613118|100786198|FG000|NOT COMPLETED|Double-blind||0||
48189310|NCT01613118|100786199|FG001|NOT COMPLETED|Double-blind||3||
48189311|NCT01613118|100786200|FG002|NOT COMPLETED|Double-blind||2||
48189312|NCT01613118|100786201|FG003|NOT COMPLETED|Double-blind||1||
48369534|NCT04230486|101232799|FG000|COMPLETED|Overall Study||5||
48189313|NCT01613118|100786198|FG000|STARTED|Open-label Extension||21||
48189314|NCT01613118|100786199|FG001|STARTED|Open-label Extension||42||
48189315|NCT01613118|100786200|FG002|STARTED|Open-label Extension||40||
48189316|NCT01613118|100786201|FG003|STARTED|Open-label Extension||0||
48189317|NCT01613118|100786198|FG000|COMPLETED|Open-label Extension||0||
48189318|NCT01613118|100786199|FG001|COMPLETED|Open-label Extension||0||
48189319|NCT01613118|100786200|FG002|COMPLETED|Open-label Extension||0||
48189320|NCT01613118|100786201|FG003|COMPLETED|Open-label Extension||0||
48189321|NCT01613118|100786198|FG000|NOT COMPLETED|Open-label Extension||21||
48189322|NCT01613118|100786199|FG001|NOT COMPLETED|Open-label Extension||42||
48189323|NCT01613118|100786200|FG002|NOT COMPLETED|Open-label Extension||40||
48189324|NCT01613118|100786201|FG003|NOT COMPLETED|Open-label Extension||0||
48189325|NCT05008224|100786202|FG000|STARTED|Overall Study||146||
48189326|NCT05008224|100786202|FG000|Received ≥1 Dose of Pembrolizumab|Overall Study||146||
48189327|NCT05008224|100786202|FG000|Received at ≥1 Dose of AVD Chemotherapy|Overall Study||136||
48189328|NCT05008224|100786202|FG000|Received at ≥1 Dose of escBEACOPP Chemotherapy|Overall Study||17||
48189329|NCT05008224|100786202|FG000|COMPLETED|Overall Study||0||
48189330|NCT05008224|100786202|FG000|NOT COMPLETED|Overall Study||146||
48189331|NCT01556243|100786203|FG000|STARTED|Overall Study||270||
48189332|NCT01556243|100786203|FG000|COMPLETED|Overall Study||204||
48189333|NCT01556243|100786203|FG000|NOT COMPLETED|Overall Study||66||
48189334|NCT04794179|100786204|FG000|STARTED|Overall Study||8||
48189335|NCT04794179|100786205|FG001|STARTED|Overall Study||7||
48189336|NCT04794179|100786204|FG000|COMPLETED|Overall Study||7||
48189337|NCT04794179|100786205|FG001|COMPLETED|Overall Study||7||
48189338|NCT04794179|100786204|FG000|NOT COMPLETED|Overall Study||1||
48189339|NCT04794179|100786205|FG001|NOT COMPLETED|Overall Study||0||
48189340|NCT01764386|100786206|FG000|STARTED|Controlled Treatment Period (CTP)||153||
48189341|NCT01764386|100786207|FG001|STARTED|Controlled Treatment Period (CTP)||89||
48189342|NCT01764386|100786206|FG000|COMPLETED|Controlled Treatment Period (CTP)||71||
48189343|NCT01764386|100786207|FG001|COMPLETED|Controlled Treatment Period (CTP)||82||
48189344|NCT01764386|100786206|FG000|NOT COMPLETED|Controlled Treatment Period (CTP)||82||
48189345|NCT01764386|100786207|FG001|NOT COMPLETED|Controlled Treatment Period (CTP)||7||
48189346|NCT01764386|100786206|FG000|STARTED|Uncontrolled Treatment Period (UTP)||71||
48189347|NCT01764386|100786207|FG001|STARTED|Uncontrolled Treatment Period (UTP)||81||
48189348|NCT01764386|100786206|FG000|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||61||
48189349|NCT01764386|100786207|FG001|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||35||
48189350|NCT01764386|100786206|FG000|COMPLETED|Uncontrolled Treatment Period (UTP)||55||
48189351|NCT01764386|100786207|FG001|COMPLETED|Uncontrolled Treatment Period (UTP)||28||
48189352|NCT01764386|100786206|FG000|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||16||
48189353|NCT01764386|100786207|FG001|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||53||
48189354|NCT00980278|100786208|FG000|STARTED|Overall Study||13||
48189355|NCT00980278|100786209|FG001|STARTED|Overall Study||13||
48663096|NCT02014103|101959548|FG000|Number Subjects Receiving Panacea|Overall Study||33|Subjects were randomized to a sequence of formulation administration for each period. Subjects were withdrawn or dropped out at various periods of the study. The subjects who received identified formulation during the study period of participation are counted.|
48663097|NCT02014103|101959549|FG001|Number Subjects Receiving Panacea|Overall Study||33|Subjects were randomized to a sequence of formulation administration for each period. Subjects were withdrawn or dropped out at various periods of the study. The subjects who received identified formulation during the study period of participation are counted.|
48663098|NCT02014103|101959548|FG000|Number Subjects Receiving Sandoz|Overall Study||34|Subjects were randomized to a sequence of formulation administration for each period. Subjects were withdrawn or dropped out at various periods of the study. The subjects who received identified formulation during the study period of participation are counted.|
48670056|NCT02828358|101974881|FG001|STARTED|Overall Study||22||
48670057|NCT02828358|101974880|FG000|COMPLETED|Overall Study||11||
48772967|NCT02289157|102232819|FG001|No Post op Check or Follow up Phone Call|Overall Study||4||
48772968|NCT02289157|102232818|FG000|COMPLETED|Overall Study||222||
48772969|NCT02289157|102232819|FG001|COMPLETED|Overall Study||219||
48772970|NCT02289157|102232818|FG000|NOT COMPLETED|Overall Study||0||
48772971|NCT02289157|102232819|FG001|NOT COMPLETED|Overall Study||0||
48772972|NCT01181349|102232820|FG000|STARTED|Overall Study||350||
48189356|NCT00980278|100786208|FG000|COMPLETED|Overall Study||11||
48189357|NCT00980278|100786209|FG001|COMPLETED|Overall Study||13||
48189358|NCT00980278|100786208|FG000|NOT COMPLETED|Overall Study||2||
48189359|NCT00980278|100786209|FG001|NOT COMPLETED|Overall Study||0||
48189360|NCT01167023|100786210|FG000|STARTED|Overall Study||0||
48189361|NCT01167023|100786211|FG001|STARTED|Overall Study||21||
48189362|NCT01167023|100786212|FG002|STARTED|Overall Study||41||
48189363|NCT01167023|100786210|FG000|Received at Least 1 Dose of Study Drug|Overall Study||0||
48189364|NCT01167023|100786211|FG001|Received at Least 1 Dose of Study Drug|Overall Study||19||
48772973|NCT01181349|102232820|FG000|COMPLETED|Overall Study||350||
48772974|NCT01181349|102232820|FG000|NOT COMPLETED|Overall Study||0||
48772975|NCT00753649|102232821|FG000|STARTED|Overall Study||112||
48772976|NCT00753649|102232822|FG001|STARTED|Overall Study||112||
48772977|NCT00753649|102232821|FG000|COMPLETED|Overall Study||105||
48189365|NCT01167023|100786212|FG002|Received at Least 1 Dose of Study Drug|Overall Study||41||
48189366|NCT01167023|100786210|FG000|COMPLETED|Overall Study||0||
48189367|NCT01167023|100786211|FG001|COMPLETED|Overall Study||18||
48189368|NCT01167023|100786212|FG002|COMPLETED|Overall Study||39||
48189369|NCT01167023|100786210|FG000|NOT COMPLETED|Overall Study||0||
48189370|NCT01167023|100786211|FG001|NOT COMPLETED|Overall Study||3||
48772978|NCT00753649|102232822|FG001|COMPLETED|Overall Study||112||
48772979|NCT00753649|102232821|FG000|NOT COMPLETED|Overall Study||7||
48772980|NCT00753649|102232822|FG001|NOT COMPLETED|Overall Study||0||
48663099|NCT02014103|101959549|FG001|Number Subjects Receiving Sandoz|Overall Study||32|Subjects were randomized to a sequence of formulation administration for each period. Subjects were withdrawn or dropped out at various periods of the study. The subjects who received identified formulation during the study period of participation are counted.|
48663100|NCT02014103|101959548|FG000|Excluded From Analysis|Overall Study||2||
48663101|NCT02014103|101959549|FG001|Excluded From Analysis|Overall Study||4||
48663102|NCT02014103|101959548|FG000|COMPLETED|Overall Study||26||
48663103|NCT02014103|101959549|FG001|COMPLETED|Overall Study||27||
48663104|NCT02014103|101959548|FG000|NOT COMPLETED|Overall Study||9||
48663105|NCT02014103|101959549|FG001|NOT COMPLETED|Overall Study||9||
48663106|NCT05375929|101959550|FG000|STARTED|Main Study: Treatment Phase (12 Weeks)||99||
48663107|NCT05375929|101959551|FG001|STARTED|Main Study: Treatment Phase (12 Weeks)||101||
48663108|NCT05375929|101959552|FG002|STARTED|Main Study: Treatment Phase (12 Weeks)||0||
48663109|NCT05375929|101959553|FG003|STARTED|Main Study: Treatment Phase (12 Weeks)||0||
48663110|NCT05375929|101959550|FG000|Safety Analysis Set|Main Study: Treatment Phase (12 Weeks)||99|According to actual treatment that participants received.|
48663111|NCT05375929|101959551|FG001|Safety Analysis Set|Main Study: Treatment Phase (12 Weeks)||101|According to actual treatment that participants received.|
48772981|NCT01165216|102232823|FG000|STARTED|Overall Study||8||
48772982|NCT01165216|102232824|FG001|STARTED|Overall Study||7||
48189371|NCT01167023|100786212|FG002|NOT COMPLETED|Overall Study||2||
48189372|NCT04283123|100786213|FG000|STARTED|Overall Study||5||
48189373|NCT04283123|100786214|FG001|STARTED|Overall Study||5||
48663112|NCT05375929|101959552|FG002|Safety Analysis Set|Main Study: Treatment Phase (12 Weeks)||0|According to actual treatment that participants received.|
48772983|NCT01165216|102232823|FG000|Received at Least 1 Dose of Ipilimumab|Overall Study||6||
48772984|NCT01165216|102232824|FG001|Received at Least 1 Dose of Ipilimumab|Overall Study||6||
48772985|NCT01165216|102232823|FG000|COMPLETED|Overall Study||0||
48772986|NCT01165216|102232824|FG001|COMPLETED|Overall Study||0||
48772987|NCT01165216|102232823|FG000|NOT COMPLETED|Overall Study||8||
48772988|NCT01165216|102232824|FG001|NOT COMPLETED|Overall Study||7||
48772989|NCT01467960|102232825|FG000|STARTED|Overall Study||30||
48772990|NCT01467960|102232826|FG001|STARTED|Overall Study||30||
48772991|NCT01467960|102232827|FG002|STARTED|Overall Study||30||
48663113|NCT05375929|101959553|FG003|Safety Analysis Set|Main Study: Treatment Phase (12 Weeks)||0|According to actual treatment that participants received.|
48663114|NCT05375929|101959550|FG000|Full Analysis Set|Main Study: Treatment Phase (12 Weeks)||100|According to the treatment arm participants were randomized to.|
48663115|NCT05375929|101959551|FG001|Full Analysis Set|Main Study: Treatment Phase (12 Weeks)||100|According to the treatment arm participants were randomized to.|
48663116|NCT05375929|101959552|FG002|Full Analysis Set|Main Study: Treatment Phase (12 Weeks)||0|According to the treatment arm participants were randomized to.|
48663117|NCT05375929|101959553|FG003|Full Analysis Set|Main Study: Treatment Phase (12 Weeks)||0|According to the treatment arm participants were randomized to.|
48663118|NCT05375929|101959550|FG000|COMPLETED|Main Study: Treatment Phase (12 Weeks)||91||
48663119|NCT05375929|101959551|FG001|COMPLETED|Main Study: Treatment Phase (12 Weeks)||94||
48663120|NCT05375929|101959552|FG002|COMPLETED|Main Study: Treatment Phase (12 Weeks)||0||
48663121|NCT05375929|101959553|FG003|COMPLETED|Main Study: Treatment Phase (12 Weeks)||0||
48663122|NCT05375929|101959550|FG000|NOT COMPLETED|Main Study: Treatment Phase (12 Weeks)||8||
48663123|NCT05375929|101959551|FG001|NOT COMPLETED|Main Study: Treatment Phase (12 Weeks)||7||
48663124|NCT05375929|101959552|FG002|NOT COMPLETED|Main Study: Treatment Phase (12 Weeks)||0||
48663125|NCT05375929|101959553|FG003|NOT COMPLETED|Main Study: Treatment Phase (12 Weeks)||0||
48189374|NCT04283123|100786213|FG000|COMPLETED|Overall Study||5||
48663126|NCT05375929|101959550|FG000|STARTED|Main Study: Follow-up (4 Weeks)||91||
48663127|NCT05375929|101959551|FG001|STARTED|Main Study: Follow-up (4 Weeks)||94||
48663128|NCT05375929|101959552|FG002|STARTED|Main Study: Follow-up (4 Weeks)||0||
48663129|NCT05375929|101959553|FG003|STARTED|Main Study: Follow-up (4 Weeks)||0||
48663130|NCT05375929|101959550|FG000|COMPLETED|Main Study: Follow-up (4 Weeks)||90||
48663131|NCT05375929|101959551|FG001|COMPLETED|Main Study: Follow-up (4 Weeks)||93||
48663132|NCT05375929|101959552|FG002|COMPLETED|Main Study: Follow-up (4 Weeks)||0||
48663133|NCT05375929|101959553|FG003|COMPLETED|Main Study: Follow-up (4 Weeks)||0||
48663134|NCT05375929|101959550|FG000|NOT COMPLETED|Main Study: Follow-up (4 Weeks)||1||
48663135|NCT05375929|101959551|FG001|NOT COMPLETED|Main Study: Follow-up (4 Weeks)||1||
48663136|NCT05375929|101959552|FG002|NOT COMPLETED|Main Study: Follow-up (4 Weeks)||0||
48663137|NCT05375929|101959553|FG003|NOT COMPLETED|Main Study: Follow-up (4 Weeks)||0||
48663138|NCT05375929|101959550|FG000|STARTED|Substudy: Treatment Phase (1 Year)||0||
48663139|NCT05375929|101959551|FG001|STARTED|Substudy: Treatment Phase (1 Year)||0||
48663140|NCT05375929|101959552|FG002|STARTED|Substudy: Treatment Phase (1 Year)||19||
48663141|NCT05375929|101959553|FG003|STARTED|Substudy: Treatment Phase (1 Year)||16||
48663142|NCT05375929|101959550|FG000|COMPLETED|Substudy: Treatment Phase (1 Year)||0||
48663143|NCT05375929|101959551|FG001|COMPLETED|Substudy: Treatment Phase (1 Year)||0||
48663144|NCT05375929|101959552|FG002|COMPLETED|Substudy: Treatment Phase (1 Year)||12||
48663145|NCT05375929|101959553|FG003|COMPLETED|Substudy: Treatment Phase (1 Year)||15||
48663146|NCT05375929|101959550|FG000|NOT COMPLETED|Substudy: Treatment Phase (1 Year)||0||
48663147|NCT05375929|101959551|FG001|NOT COMPLETED|Substudy: Treatment Phase (1 Year)||0||
48663148|NCT05375929|101959552|FG002|NOT COMPLETED|Substudy: Treatment Phase (1 Year)||7||
48663149|NCT05375929|101959553|FG003|NOT COMPLETED|Substudy: Treatment Phase (1 Year)||1||
48663150|NCT05375929|101959550|FG000|STARTED|Substudy: Follow-up (4 Weeks)||0||
48663151|NCT05375929|101959551|FG001|STARTED|Substudy: Follow-up (4 Weeks)||0||
48663152|NCT05375929|101959552|FG002|STARTED|Substudy: Follow-up (4 Weeks)||17||
48663153|NCT05375929|101959553|FG003|STARTED|Substudy: Follow-up (4 Weeks)||15||
48663154|NCT05375929|101959550|FG000|COMPLETED|Substudy: Follow-up (4 Weeks)||0||
48663155|NCT05375929|101959551|FG001|COMPLETED|Substudy: Follow-up (4 Weeks)||0||
48663156|NCT05375929|101959552|FG002|COMPLETED|Substudy: Follow-up (4 Weeks)||17||
48663157|NCT05375929|101959553|FG003|COMPLETED|Substudy: Follow-up (4 Weeks)||15||
48663158|NCT05375929|101959550|FG000|NOT COMPLETED|Substudy: Follow-up (4 Weeks)||0||
48663159|NCT05375929|101959551|FG001|NOT COMPLETED|Substudy: Follow-up (4 Weeks)||0||
48663160|NCT05375929|101959552|FG002|NOT COMPLETED|Substudy: Follow-up (4 Weeks)||0||
48663161|NCT05375929|101959553|FG003|NOT COMPLETED|Substudy: Follow-up (4 Weeks)||0||
48663162|NCT02722330|101959554|FG000|STARTED|Overall Study||23||
48663163|NCT02722330|101959554|FG000|COMPLETED|Overall Study||23||
48663164|NCT02722330|101959554|FG000|NOT COMPLETED|Overall Study||0||
48663165|NCT05807945|101959555|FG000|STARTED|Overall Study||36||
48663166|NCT05807945|101959556|FG001|STARTED|Overall Study||34||
48663167|NCT05807945|101959555|FG000|COMPLETED|Overall Study||36||
48663168|NCT05807945|101959556|FG001|COMPLETED|Overall Study||34||
48663169|NCT05807945|101959555|FG000|NOT COMPLETED|Overall Study||0||
48663170|NCT05807945|101959556|FG001|NOT COMPLETED|Overall Study||0||
48663171|NCT03574363|101959557|FG000|STARTED|Overall Study||51||
48663172|NCT03574363|101959558|FG001|STARTED|Overall Study||54||
48189375|NCT04283123|100786214|FG001|COMPLETED|Overall Study||5||
48189376|NCT04283123|100786213|FG000|NOT COMPLETED|Overall Study||0||
48189377|NCT04283123|100786214|FG001|NOT COMPLETED|Overall Study||0||
48189378|NCT03432533|100786215|FG000|STARTED|Overall Study||141||
48663173|NCT03574363|101959559|FG002|STARTED|Overall Study||57||
48663174|NCT03574363|101959557|FG000|COMPLETED|Overall Study||47||
48663175|NCT03574363|101959558|FG001|COMPLETED|Overall Study||44||
48663176|NCT03574363|101959559|FG002|COMPLETED|Overall Study||47||
48663177|NCT03574363|101959557|FG000|NOT COMPLETED|Overall Study||4||
48663178|NCT03574363|101959558|FG001|NOT COMPLETED|Overall Study||10||
48663179|NCT03574363|101959559|FG002|NOT COMPLETED|Overall Study||10||
48663180|NCT05468918|101959560|FG000|STARTED|Overall Study||7||
48663181|NCT05468918|101959561|FG001|STARTED|Overall Study||7||
48663182|NCT05468918|101959560|FG000|COMPLETED|Overall Study||7||
48663183|NCT05468918|101959561|FG001|COMPLETED|Overall Study||7||
48663184|NCT05468918|101959560|FG000|NOT COMPLETED|Overall Study||0||
48663185|NCT05468918|101959561|FG001|NOT COMPLETED|Overall Study||0||
48189379|NCT03432533|100786216|FG001|STARTED|Overall Study||142||
48189380|NCT03432533|100786215|FG000|Completed 6-Month Treatment Period|Overall Study||136||
48189381|NCT03432533|100786216|FG001|Completed 6-Month Treatment Period|Overall Study||137||
48189382|NCT03432533|100786215|FG000|COMPLETED|Overall Study||126|Completed 9-Month Study Period|
48189383|NCT03432533|100786216|FG001|COMPLETED|Overall Study||131|Completed 9-Month Study Period|
48189384|NCT03432533|100786215|FG000|NOT COMPLETED|Overall Study||15||
48189385|NCT03432533|100786216|FG001|NOT COMPLETED|Overall Study||11||
48189386|NCT01094171|100786217|FG000|STARTED|Overall Study||400||
48189387|NCT01094171|100786217|FG000|COMPLETED|Overall Study||390||
48189388|NCT01094171|100786217|FG000|NOT COMPLETED|Overall Study||10||
48189389|NCT02427737|100786218|FG000|STARTED|OSU Baseline Q4FY15||4158||4754
48189390|NCT02427737|100786219|FG001|STARTED|OSU Baseline Q4FY15||3446||4219
48189391|NCT02427737|100786218|FG000|COMPLETED|OSU Baseline Q4FY15||3940||4754
48189392|NCT02427737|100786219|FG001|COMPLETED|OSU Baseline Q4FY15||3230||4219
48189393|NCT02427737|100786218|FG000|NOT COMPLETED|OSU Baseline Q4FY15||218||0
48189394|NCT02427737|100786219|FG001|NOT COMPLETED|OSU Baseline Q4FY15||216||0
48189395|NCT02427737|100786218|FG000|STARTED|OSU Q1FY16 (First Post-Training Quarter)||4030||4583
48189396|NCT02427737|100786219|FG001|STARTED|OSU Q1FY16 (First Post-Training Quarter)||3246||4144
48663186|NCT00112385|101959562|FG000|STARTED|Overall Study||11||
48663187|NCT00112385|101959563|FG001|STARTED|Overall Study||5||
48663188|NCT00112385|101959562|FG000|COMPLETED|Overall Study||10||
48663189|NCT00112385|101959563|FG001|COMPLETED|Overall Study||4||
48663190|NCT00112385|101959562|FG000|NOT COMPLETED|Overall Study||1||
48663191|NCT00112385|101959563|FG001|NOT COMPLETED|Overall Study||1||
48663192|NCT00553969|101959564|FG000|STARTED|Overall Study||31||
48663193|NCT00553969|101959565|FG001|STARTED|Overall Study||24||
48663194|NCT00553969|101959566|FG002|STARTED|Overall Study||22||
48663195|NCT00553969|101959567|FG003|STARTED|Overall Study||24||
48663196|NCT00553969|101959564|FG000|COMPLETED|Overall Study||23||
48663197|NCT00553969|101959565|FG001|COMPLETED|Overall Study||24||
48189397|NCT02427737|100786218|FG000|COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||3815||4583
48189398|NCT02427737|100786219|FG001|COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||3032||4144
48189399|NCT02427737|100786218|FG000|NOT COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||215||0
48189400|NCT02427737|100786219|FG001|NOT COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||214||0
48189401|NCT02427737|100786218|FG000|STARTED|OSU Q2FY16(Second Post Training Quarter)||4121||4659
48189402|NCT02427737|100786219|FG001|STARTED|OSU Q2FY16(Second Post Training Quarter)||3070||4204
48772992|NCT01467960|102232828|FG003|STARTED|Overall Study||30||
48772993|NCT01467960|102232829|FG004|STARTED|Overall Study||30||
48772994|NCT01467960|102232830|FG005|STARTED|Overall Study||30||
48772995|NCT01467960|102232825|FG000|COMPLETED|Overall Study||30||
48189403|NCT02427737|100786218|FG000|COMPLETED|OSU Q2FY16(Second Post Training Quarter)||3907||4659
48189404|NCT02427737|100786219|FG001|COMPLETED|OSU Q2FY16(Second Post Training Quarter)||2857||4204
48189405|NCT02427737|100786218|FG000|NOT COMPLETED|OSU Q2FY16(Second Post Training Quarter)||214||0
48189406|NCT02427737|100786219|FG001|NOT COMPLETED|OSU Q2FY16(Second Post Training Quarter)||213||0
48189407|NCT02427737|100786218|FG000|STARTED|OSU Q3FY16 (Third Post Training Quarter)||4148||4647
48189408|NCT02427737|100786219|FG001|STARTED|OSU Q3FY16 (Third Post Training Quarter)||2931||4199
48189409|NCT02427737|100786218|FG000|COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||3928||4647
48189410|NCT02427737|100786219|FG001|COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||2716||4199
48189411|NCT02427737|100786218|FG000|NOT COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||220||0
48663198|NCT00553969|101959566|FG002|COMPLETED|Overall Study||21||
48663199|NCT00553969|101959567|FG003|COMPLETED|Overall Study||23||
48663200|NCT00553969|101959564|FG000|NOT COMPLETED|Overall Study||8||
48772996|NCT01467960|102232826|FG001|COMPLETED|Overall Study||30||
48772997|NCT01467960|102232827|FG002|COMPLETED|Overall Study||30||
48772998|NCT01467960|102232828|FG003|COMPLETED|Overall Study||0||
48663201|NCT00553969|101959565|FG001|NOT COMPLETED|Overall Study||0||
48663202|NCT00553969|101959566|FG002|NOT COMPLETED|Overall Study||1||
48772999|NCT01467960|102232829|FG004|COMPLETED|Overall Study||0||
48773000|NCT01467960|102232830|FG005|COMPLETED|Overall Study||0||
48663203|NCT00553969|101959567|FG003|NOT COMPLETED|Overall Study||1||
48663204|NCT05781685|101959568|FG000|STARTED|First Period of Intervention (Day 1)||10||
48663205|NCT05781685|101959569|FG001|STARTED|First Period of Intervention (Day 1)||10||
48663206|NCT05781685|101959568|FG000|COMPLETED|First Period of Intervention (Day 1)||10||
48663207|NCT05781685|101959569|FG001|COMPLETED|First Period of Intervention (Day 1)||10||
48663208|NCT05781685|101959568|FG000|NOT COMPLETED|First Period of Intervention (Day 1)||0||
48663209|NCT05781685|101959569|FG001|NOT COMPLETED|First Period of Intervention (Day 1)||0||
48663210|NCT05781685|101959568|FG000|STARTED|Second Period of Intervention (Day 4)||10||
48663211|NCT05781685|101959569|FG001|STARTED|Second Period of Intervention (Day 4)||10||
48663212|NCT05781685|101959568|FG000|COMPLETED|Second Period of Intervention (Day 4)||10||
48663213|NCT05781685|101959569|FG001|COMPLETED|Second Period of Intervention (Day 4)||10||
48663214|NCT05781685|101959568|FG000|NOT COMPLETED|Second Period of Intervention (Day 4)||0||
48663215|NCT05781685|101959569|FG001|NOT COMPLETED|Second Period of Intervention (Day 4)||0||
48663216|NCT00979407|101959570|FG000|STARTED|Overall Study||167||
48663217|NCT00979407|101959571|FG001|STARTED|Overall Study||167||
48663218|NCT00979407|101959570|FG000|COMPLETED|Overall Study||161||
48663219|NCT00979407|101959571|FG001|COMPLETED|Overall Study||160||
48663220|NCT00979407|101959570|FG000|NOT COMPLETED|Overall Study||6||
48663221|NCT00979407|101959571|FG001|NOT COMPLETED|Overall Study||7||
48663222|NCT03436732|101959572|FG000|STARTED|Overall Study||4||
48663223|NCT03436732|101959573|FG001|STARTED|Overall Study||1||
48189412|NCT02427737|100786219|FG001|NOT COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||215||0
48189413|NCT02427737|100786218|FG000|STARTED|Duke Pre- and Post-Training Groups||9658||9658
48189414|NCT02427737|100786219|FG001|STARTED|Duke Pre- and Post-Training Groups||4446||4446
48189415|NCT02427737|100786218|FG000|COMPLETED|Duke Pre- and Post-Training Groups||8879||9658
48189416|NCT02427737|100786219|FG001|COMPLETED|Duke Pre- and Post-Training Groups||4051||4446
48189417|NCT02427737|100786218|FG000|NOT COMPLETED|Duke Pre- and Post-Training Groups||779||0
48189418|NCT02427737|100786219|FG001|NOT COMPLETED|Duke Pre- and Post-Training Groups||395||0
48189419|NCT03568461|100786220|FG000|STARTED|Overall Study||98|Started = enrolled and entered pre-treatment phase|
48189420|NCT03568461|100786220|FG000|Treated|Overall Study||97|Treated = infused with tisagenlecleucel|
48189421|NCT03568461|100786220|FG000|Discontinued Prior to Infusion With Tisagenlecleucel|Overall Study||1||
48189422|NCT03568461|100786220|FG000|COMPLETED|Overall Study||80|Completed = Ongoing/in follow-up|
48189423|NCT03568461|100786220|FG000|NOT COMPLETED|Overall Study||18||
48189424|NCT05812794|100786221|FG000|STARTED|Overall Study||5||
48189425|NCT05812794|100786221|FG000|COMPLETED|Overall Study||5||
48189426|NCT05812794|100786221|FG000|NOT COMPLETED|Overall Study||0||
48189427|NCT01687270|100786222|FG000|STARTED|Overall Study||40||
48189428|NCT01687270|100786222|FG000|COMPLETED|Overall Study||28||
48189429|NCT01687270|100786222|FG000|NOT COMPLETED|Overall Study||12||
48189430|NCT01575860|100786223|FG000|STARTED|Overall Study||8||
48189431|NCT01575860|100786223|FG000|COMPLETED|Overall Study||6||
48189432|NCT01575860|100786223|FG000|NOT COMPLETED|Overall Study||2||
48189433|NCT01890967|100786224|FG000|STARTED|Overall Study||88||
48189434|NCT01890967|100786225|FG001|STARTED|Overall Study||88||
48189435|NCT01890967|100786226|FG002|STARTED|Overall Study||88||
48189436|NCT01890967|100786227|FG003|STARTED|Overall Study||88||
48189437|NCT01890967|100786228|FG004|STARTED|Overall Study||87||
48189438|NCT01890967|100786229|FG005|STARTED|Overall Study||88||
48189439|NCT01890967|100786224|FG000|Received at Least One Dose of Study Drug|Overall Study||87||
48189440|NCT01890967|100786225|FG001|Received at Least One Dose of Study Drug|Overall Study||87||
48189441|NCT01890967|100786226|FG002|Received at Least One Dose of Study Drug|Overall Study||86||
48189442|NCT01890967|100786227|FG003|Received at Least One Dose of Study Drug|Overall Study||86||
48189443|NCT01890967|100786228|FG004|Received at Least One Dose of Study Drug|Overall Study||86||
48189444|NCT01890967|100786229|FG005|Received at Least One Dose of Study Drug|Overall Study||87||
48189445|NCT01890967|100786224|FG000|COMPLETED|Overall Study||78||
48189446|NCT01890967|100786225|FG001|COMPLETED|Overall Study||77||
48189447|NCT01890967|100786226|FG002|COMPLETED|Overall Study||78||
48189448|NCT01890967|100786227|FG003|COMPLETED|Overall Study||77||
48189449|NCT01890967|100786228|FG004|COMPLETED|Overall Study||77||
48663224|NCT03436732|101959572|FG000|COMPLETED|Overall Study||0||
48189450|NCT01890967|100786229|FG005|COMPLETED|Overall Study||75||
48189451|NCT01890967|100786224|FG000|NOT COMPLETED|Overall Study||10||
48189452|NCT01890967|100786225|FG001|NOT COMPLETED|Overall Study||11||
48189453|NCT01890967|100786226|FG002|NOT COMPLETED|Overall Study||10||
48189454|NCT01890967|100786227|FG003|NOT COMPLETED|Overall Study||11||
48189455|NCT01890967|100786228|FG004|NOT COMPLETED|Overall Study||10||
48189456|NCT01890967|100786229|FG005|NOT COMPLETED|Overall Study||13||
48189457|NCT04541186|100786230|FG000|STARTED|Main Study||16|Randomization set summarized based on planned treatment.|
48189458|NCT04541186|100786231|FG001|STARTED|Main Study||17|Randomization set summarized based on planned treatment.|
48189459|NCT04541186|100786232|FG002|STARTED|Main Study||16|Randomization set summarized based on planned treatment.|
48189460|NCT04541186|100786233|FG003|STARTED|Main Study||16|Randomization set summarized based on planned treatment.|
48189461|NCT04541186|100786234|FG004|STARTED|Main Study||15|Randomization set summarized based on planned treatment.|
48369535|NCT04230486|101232799|FG000|NOT COMPLETED|Overall Study||1||
48663225|NCT03436732|101959573|FG001|COMPLETED|Overall Study||0||
48189462|NCT04541186|100786230|FG000|Safety Analysis Set|Main Study||12|Participants who received at least 1 dose of study drug. Safety Analysis Set is summarized based treatment received.|
48189463|NCT04541186|100786231|FG001|Safety Analysis Set|Main Study||21|Participants who received at least 1 dose of study drug. Safety Analysis Set is summarized based treatment received.|
48189464|NCT04541186|100786232|FG002|Safety Analysis Set|Main Study||15|Participants who received at least 1 dose of study drug. Safety Analysis Set is summarized based treatment received.|
48189465|NCT04541186|100786233|FG003|Safety Analysis Set|Main Study||16|Participants who received at least 1 dose of study drug. Safety Analysis Set is summarized based treatment received.|
48189466|NCT04541186|100786234|FG004|Safety Analysis Set|Main Study||15|Participants who received at least 1 dose of study drug. Safety Analysis Set is summarized based treatment received.|
48189467|NCT04541186|100786230|FG000|Full Analysis Set (FAS)|Main Study||16|Participants who received at least 1 dose of study drug, had a baseline, and at least 1 post-baseline triglyceride measurement not including end of study (EOS) visit.|
48189468|NCT04541186|100786231|FG001|Full Analysis Set (FAS)|Main Study||17|Participants who received at least 1 dose of study drug, had a baseline, and at least 1 post-baseline triglyceride measurement not including end of study (EOS) visit.|
48189469|NCT04541186|100786232|FG002|Full Analysis Set (FAS)|Main Study||13|Participants who received at least 1 dose of study drug, had a baseline, and at least 1 post-baseline triglyceride measurement not including end of study (EOS) visit.|
48189470|NCT04541186|100786233|FG003|Full Analysis Set (FAS)|Main Study||16|Participants who received at least 1 dose of study drug, had a baseline, and at least 1 post-baseline triglyceride measurement not including end of study (EOS) visit.|
48189471|NCT04541186|100786234|FG004|Full Analysis Set (FAS)|Main Study||14|Participants who received at least 1 dose of study drug, had a baseline, and at least 1 post-baseline triglyceride measurement not including end of study (EOS) visit.|
48189472|NCT04541186|100786230|FG000|COMPLETED|Main Study||15||
48189473|NCT04541186|100786231|FG001|COMPLETED|Main Study||16||
48189474|NCT04541186|100786232|FG002|COMPLETED|Main Study||10||
48189475|NCT04541186|100786233|FG003|COMPLETED|Main Study||15||
48189476|NCT04541186|100786234|FG004|COMPLETED|Main Study||14||
48189477|NCT04541186|100786230|FG000|NOT COMPLETED|Main Study||1||
48189478|NCT04541186|100786231|FG001|NOT COMPLETED|Main Study||1||
48189479|NCT04541186|100786232|FG002|NOT COMPLETED|Main Study||6||
48189480|NCT04541186|100786233|FG003|NOT COMPLETED|Main Study||1||
48189481|NCT04541186|100786234|FG004|NOT COMPLETED|Main Study||1||
48189482|NCT04541186|100786230|FG000|STARTED|Fibrate Expansion Study||0||
48189483|NCT04541186|100786231|FG001|STARTED|Fibrate Expansion Study||0||
48189484|NCT04541186|100786232|FG002|STARTED|Fibrate Expansion Study||3||
48189485|NCT04541186|100786233|FG003|STARTED|Fibrate Expansion Study||0||
48189486|NCT04541186|100786234|FG004|STARTED|Fibrate Expansion Study||3||
48189487|NCT04541186|100786230|FG000|Received at Least 1 Dose of Study Drug|Fibrate Expansion Study||0||
48189488|NCT04541186|100786231|FG001|Received at Least 1 Dose of Study Drug|Fibrate Expansion Study||0||
48189489|NCT04541186|100786232|FG002|Received at Least 1 Dose of Study Drug|Fibrate Expansion Study||3||
48189490|NCT04541186|100786233|FG003|Received at Least 1 Dose of Study Drug|Fibrate Expansion Study||0||
48189491|NCT04541186|100786234|FG004|Received at Least 1 Dose of Study Drug|Fibrate Expansion Study||3||
48189492|NCT04541186|100786230|FG000|Full Analysis Set|Fibrate Expansion Study||0|Participants who received at least 1 dose of study drug, had a baseline, and at least 1 post-baseline TG measurement not including EOS visit.|
48189493|NCT04541186|100786231|FG001|Full Analysis Set|Fibrate Expansion Study||0|Participants who received at least 1 dose of study drug, had a baseline, and at least 1 post-baseline TG measurement not including EOS visit.|
48189494|NCT04541186|100786232|FG002|Full Analysis Set|Fibrate Expansion Study||3|Participants who received at least 1 dose of study drug, had a baseline, and at least 1 post-baseline TG measurement not including EOS visit.|
48189495|NCT04541186|100786233|FG003|Full Analysis Set|Fibrate Expansion Study||0|Participants who received at least 1 dose of study drug, had a baseline, and at least 1 post-baseline TG measurement not including EOS visit.|
48189496|NCT04541186|100786234|FG004|Full Analysis Set|Fibrate Expansion Study||3|Participants who received at least 1 dose of study drug, had a baseline, and at least 1 post-baseline TG measurement not including EOS visit.|
48189497|NCT04541186|100786230|FG000|COMPLETED|Fibrate Expansion Study||0||
48663226|NCT03436732|101959572|FG000|NOT COMPLETED|Overall Study||4||
48663227|NCT03436732|101959573|FG001|NOT COMPLETED|Overall Study||1||
48663228|NCT04732468|101959574|FG000|STARTED|Overall Study||4||
48663229|NCT04732468|101959575|FG001|STARTED|Overall Study||10||
48663230|NCT04732468|101959576|FG002|STARTED|Overall Study||10||
48773001|NCT01467960|102232825|FG000|NOT COMPLETED|Overall Study||0||
48773002|NCT01467960|102232826|FG001|NOT COMPLETED|Overall Study||0||
48773003|NCT01467960|102232827|FG002|NOT COMPLETED|Overall Study||0||
48663231|NCT04732468|101959577|FG003|STARTED|Overall Study||4||
48663232|NCT04732468|101959574|FG000|COMPLETED|Overall Study||1||
48663233|NCT04732468|101959575|FG001|COMPLETED|Overall Study||10||
48663234|NCT04732468|101959576|FG002|COMPLETED|Overall Study||10||
48663235|NCT04732468|101959577|FG003|COMPLETED|Overall Study||4||
48663236|NCT04732468|101959574|FG000|NOT COMPLETED|Overall Study||3||
48663237|NCT04732468|101959575|FG001|NOT COMPLETED|Overall Study||0||
48663238|NCT04732468|101959576|FG002|NOT COMPLETED|Overall Study||0||
48773004|NCT01467960|102232828|FG003|NOT COMPLETED|Overall Study||30||
48773005|NCT01467960|102232829|FG004|NOT COMPLETED|Overall Study||30||
48773006|NCT01467960|102232830|FG005|NOT COMPLETED|Overall Study||30||
48773007|NCT02812342|102232831|FG000|STARTED|Overall Study||10||
48773008|NCT02812342|102232831|FG000|COMPLETED|Overall Study||10||
48773009|NCT02812342|102232831|FG000|NOT COMPLETED|Overall Study||0||
48189498|NCT04541186|100786231|FG001|COMPLETED|Fibrate Expansion Study||0||
48189499|NCT04541186|100786232|FG002|COMPLETED|Fibrate Expansion Study||3||
48189500|NCT04541186|100786233|FG003|COMPLETED|Fibrate Expansion Study||0||
48189501|NCT04541186|100786234|FG004|COMPLETED|Fibrate Expansion Study||2||
48189502|NCT04541186|100786230|FG000|NOT COMPLETED|Fibrate Expansion Study||0||
48189503|NCT04541186|100786231|FG001|NOT COMPLETED|Fibrate Expansion Study||0||
48189504|NCT04541186|100786232|FG002|NOT COMPLETED|Fibrate Expansion Study||0||
48189505|NCT04541186|100786233|FG003|NOT COMPLETED|Fibrate Expansion Study||0||
48189506|NCT04541186|100786234|FG004|NOT COMPLETED|Fibrate Expansion Study||1||
48189507|NCT01245413|100786235|FG000|STARTED|Sensura First,||16||
48189508|NCT01245413|100786236|FG001|STARTED|Sensura First,||16||
48189509|NCT01245413|100786235|FG000|COMPLETED|Sensura First,||16||
48189510|NCT01245413|100786236|FG001|COMPLETED|Sensura First,||16||
48189511|NCT01245413|100786235|FG000|NOT COMPLETED|Sensura First,||0||
48189512|NCT01245413|100786236|FG001|NOT COMPLETED|Sensura First,||0||
48189513|NCT01245413|100786235|FG000|STARTED|Athena First,||16||
48189514|NCT01245413|100786236|FG001|STARTED|Athena First,||16||
48189515|NCT01245413|100786235|FG000|COMPLETED|Athena First,||16||
48189516|NCT01245413|100786236|FG001|COMPLETED|Athena First,||16||
48189517|NCT01245413|100786235|FG000|NOT COMPLETED|Athena First,||0||
48189518|NCT01245413|100786236|FG001|NOT COMPLETED|Athena First,||0||
48189519|NCT01388543|100786237|FG000|STARTED|Day 7, Primary End Point||15||
48189520|NCT01388543|100786238|FG001|STARTED|Day 7, Primary End Point||16||
48189521|NCT01388543|100786237|FG000|COMPLETED|Day 7, Primary End Point||15||
48189522|NCT01388543|100786238|FG001|COMPLETED|Day 7, Primary End Point||16||
48189523|NCT01388543|100786237|FG000|NOT COMPLETED|Day 7, Primary End Point||0||
48189524|NCT01388543|100786238|FG001|NOT COMPLETED|Day 7, Primary End Point||0||
48189525|NCT01388543|100786237|FG000|STARTED|Day 14||15||
48189526|NCT01388543|100786238|FG001|STARTED|Day 14||16||
48189527|NCT01388543|100786237|FG000|COMPLETED|Day 14||14||
48369536|NCT00748826|101232800|FG000|STARTED|Overall Study||508||
48189528|NCT01388543|100786238|FG001|COMPLETED|Day 14||12||
48189529|NCT01388543|100786237|FG000|NOT COMPLETED|Day 14||1||
48189530|NCT01388543|100786238|FG001|NOT COMPLETED|Day 14||4||
48189531|NCT00335153|100786239|FG000|STARTED|Nasojejunal (NJ) Test Period||354||
48663239|NCT04732468|101959577|FG003|NOT COMPLETED|Overall Study||0||
48663240|NCT02936323|101959578|FG000|STARTED|Phase 1 Dose Escalation||2||
48663241|NCT02936323|101959579|FG001|STARTED|Phase 1 Dose Escalation||3||
48663242|NCT02936323|101959580|FG002|STARTED|Phase 1 Dose Escalation||3||
48663243|NCT02936323|101959581|FG003|STARTED|Phase 1 Dose Escalation||3||
48663244|NCT02936323|101959582|FG004|STARTED|Phase 1 Dose Escalation||3||
48663245|NCT02936323|101959583|FG005|STARTED|Phase 1 Dose Escalation||6||
48456996|NCT04036227|101457015|FG004|COMPLETED|Part I (SAD): 8 mg||0||
48663246|NCT02936323|101959584|FG006|STARTED|Phase 1 Dose Escalation||3||
48663247|NCT02936323|101959585|FG007|STARTED|Phase 1 Dose Escalation||0||
48663248|NCT02936323|101959586|FG008|STARTED|Phase 1 Dose Escalation||0||
48663249|NCT02936323|101959587|FG009|STARTED|Phase 1 Dose Escalation||0||
48663250|NCT02936323|101959578|FG000|COMPLETED|Phase 1 Dose Escalation||0|Participants in the follow-up period of Phase 1 study as of data cut-off date 31 Jul 2020.|
48663251|NCT02936323|101959579|FG001|COMPLETED|Phase 1 Dose Escalation||1|Participants in the follow-up period of Phase 1 study as of data cut-off date 31 Jul 2020.|
48663252|NCT02936323|101959580|FG002|COMPLETED|Phase 1 Dose Escalation||0|Participants in the follow-up period of Phase 1 study as of data cut-off date 31 Jul 2020.|
48663253|NCT02936323|101959581|FG003|COMPLETED|Phase 1 Dose Escalation||1|Participants in the follow-up period of Phase 1 study as of data cut-off date 31 Jul 2020.|
48663254|NCT02936323|101959582|FG004|COMPLETED|Phase 1 Dose Escalation||0|Participants in the follow-up period of Phase 1 study as of data cut-off date 31 Jul 2020.|
48663255|NCT02936323|101959583|FG005|COMPLETED|Phase 1 Dose Escalation||1|Participants in the follow-up period of Phase 1 study as of data cut-off date 31 Jul 2020.|
48663256|NCT02936323|101959584|FG006|COMPLETED|Phase 1 Dose Escalation||0|Participants in the follow-up period of Phase 1 study as of data cut-off date 31 Jul 2020.|
48663257|NCT02936323|101959585|FG007|COMPLETED|Phase 1 Dose Escalation||0|Participants in the follow-up period of Phase 1 study as of data cut-off date 31 Jul 2020.|
48663258|NCT02936323|101959586|FG008|COMPLETED|Phase 1 Dose Escalation||0|Participants in the follow-up period of Phase 1 study as of data cut-off date 31 Jul 2020.|
48663259|NCT02936323|101959587|FG009|COMPLETED|Phase 1 Dose Escalation||0|Participants in the follow-up period of Phase 1 study as of data cut-off date 31 Jul 2020.|
48663260|NCT02936323|101959578|FG000|NOT COMPLETED|Phase 1 Dose Escalation||2||
48663261|NCT02936323|101959579|FG001|NOT COMPLETED|Phase 1 Dose Escalation||2||
48663262|NCT02936323|101959580|FG002|NOT COMPLETED|Phase 1 Dose Escalation||3||
48663263|NCT02936323|101959581|FG003|NOT COMPLETED|Phase 1 Dose Escalation||2||
48663264|NCT02936323|101959582|FG004|NOT COMPLETED|Phase 1 Dose Escalation||3||
48663265|NCT02936323|101959583|FG005|NOT COMPLETED|Phase 1 Dose Escalation||5||
48663266|NCT02936323|101959584|FG006|NOT COMPLETED|Phase 1 Dose Escalation||3||
48663267|NCT02936323|101959585|FG007|NOT COMPLETED|Phase 1 Dose Escalation||0||
48663268|NCT02936323|101959586|FG008|NOT COMPLETED|Phase 1 Dose Escalation||0||
48663269|NCT02936323|101959587|FG009|NOT COMPLETED|Phase 1 Dose Escalation||0||
48670058|NCT02828358|101974881|FG001|COMPLETED|Overall Study||0||
48670059|NCT02828358|101974880|FG000|NOT COMPLETED|Overall Study||45||
48670060|NCT02828358|101974881|FG001|NOT COMPLETED|Overall Study||22||
48773010|NCT00256997|102232832|FG000|STARTED|Overall Study||81||
48773011|NCT00256997|102232833|FG001|STARTED|Overall Study||86||
48773012|NCT00256997|102232832|FG000|Treated|Overall Study||79||
48773013|NCT00256997|102232833|FG001|Treated|Overall Study||86||
48773014|NCT00256997|102232832|FG000|COMPLETED|Overall Study||33||
48773015|NCT00256997|102232833|FG001|COMPLETED|Overall Study||31||
48773016|NCT00256997|102232832|FG000|NOT COMPLETED|Overall Study||48||
48773017|NCT00256997|102232833|FG001|NOT COMPLETED|Overall Study||55||
48773018|NCT01647217|102232834|FG000|STARTED|Overall Study||8||
48773019|NCT01647217|102232835|FG001|STARTED|Overall Study||9||
48773020|NCT01647217|102232834|FG000|COMPLETED|Overall Study||7||
48773021|NCT01647217|102232835|FG001|COMPLETED|Overall Study||8||
48773022|NCT01647217|102232834|FG000|NOT COMPLETED|Overall Study||1||
48773023|NCT01647217|102232835|FG001|NOT COMPLETED|Overall Study||1||
48773024|NCT02106390|102232836|FG000|STARTED|Overall Study||252||
48456997|NCT04036227|101457016|FG005|COMPLETED|Part I (SAD): 8 mg||0||
48456998|NCT04036227|101457017|FG006|COMPLETED|Part I (SAD): 8 mg||0||
48773025|NCT02106390|102232837|FG001|STARTED|Overall Study||250||
48773026|NCT02106390|102232838|FG002|STARTED|Overall Study||248||
48773027|NCT02106390|102232836|FG000|COMPLETED|Overall Study||203||
48773028|NCT02106390|102232837|FG001|COMPLETED|Overall Study||202||
48773029|NCT02106390|102232838|FG002|COMPLETED|Overall Study||205||
48773030|NCT02106390|102232836|FG000|NOT COMPLETED|Overall Study||49||
48773031|NCT02106390|102232837|FG001|NOT COMPLETED|Overall Study||48||
48456999|NCT04036227|101457018|FG007|COMPLETED|Part I (SAD): 8 mg||0||
48189532|NCT00335153|100786239|FG000|COMPLETED|Nasojejunal (NJ) Test Period||324||
48189533|NCT00335153|100786239|FG000|NOT COMPLETED|Nasojejunal (NJ) Test Period||30||
48189534|NCT00335153|100786239|FG000|STARTED|Post-PEG-J Long-Term Treatment Period||324||
48189535|NCT00335153|100786239|FG000|COMPLETED|Post-PEG-J Long-Term Treatment Period||272||
48189536|NCT00335153|100786239|FG000|NOT COMPLETED|Post-PEG-J Long-Term Treatment Period||52||
48189537|NCT03289455|100786240|FG000|STARTED|Overall Study||4||
48189538|NCT03289455|100786241|FG001|STARTED|Overall Study||5||
48189539|NCT03289455|100786242|FG002|STARTED|Overall Study||6||
48189540|NCT03289455|100786240|FG000|COMPLETED|Overall Study||0||
48189541|NCT03289455|100786241|FG001|COMPLETED|Overall Study||0||
48189542|NCT03289455|100786242|FG002|COMPLETED|Overall Study||0||
48189543|NCT03289455|100786240|FG000|NOT COMPLETED|Overall Study||4||
48189544|NCT03289455|100786241|FG001|NOT COMPLETED|Overall Study||5||
48189545|NCT03289455|100786242|FG002|NOT COMPLETED|Overall Study||6||
48189546|NCT00827944|100786243|FG000|STARTED|Overall Study||304||
48189547|NCT00827944|100786244|FG001|STARTED|Overall Study||299||
48189548|NCT00827944|100786243|FG000|COMPLETED|Overall Study||241||
48189549|NCT00827944|100786244|FG001|COMPLETED|Overall Study||240||
48189550|NCT00827944|100786243|FG000|NOT COMPLETED|Overall Study||63||
48189551|NCT00827944|100786244|FG001|NOT COMPLETED|Overall Study||59||
48189552|NCT01805323|100786245|FG000|STARTED|Overall Study||101||
48189553|NCT01805323|100786245|FG000|COMPLETED|Overall Study||101||
48189554|NCT01805323|100786245|FG000|NOT COMPLETED|Overall Study||0||
48189555|NCT00953160|100786246|FG000|STARTED|Overall Study||76||
48189556|NCT00953160|100786246|FG000|COMPLETED|Overall Study||49||
48189557|NCT00953160|100786246|FG000|NOT COMPLETED|Overall Study||27||
48189558|NCT00814489|100786247|FG000|STARTED|Overall Study||15||
48189559|NCT00814489|100786248|FG001|STARTED|Overall Study||17||
48189560|NCT00814489|100786249|FG002|STARTED|Overall Study||8||
48189561|NCT00814489|100786247|FG000|COMPLETED|Overall Study||13||
48189562|NCT00814489|100786248|FG001|COMPLETED|Overall Study||17||
48189563|NCT00814489|100786249|FG002|COMPLETED|Overall Study||7||
48189564|NCT00814489|100786247|FG000|NOT COMPLETED|Overall Study||2||
48189565|NCT00814489|100786248|FG001|NOT COMPLETED|Overall Study||0||
48189566|NCT00814489|100786249|FG002|NOT COMPLETED|Overall Study||1||
48189567|NCT01819415|100786250|FG000|STARTED|Overall Study||10||
48189568|NCT01819415|100786251|FG001|STARTED|Overall Study||10||
48457000|NCT04036227|101457019|FG008|COMPLETED|Part I (SAD): 8 mg||0||
48670061|NCT02626533|101974882|FG000|STARTED|Overall Study||179||
48189569|NCT01819415|100786252|FG002|STARTED|Overall Study||10||
48189570|NCT01819415|100786253|FG003|STARTED|Overall Study||10||
48189571|NCT01819415|100786250|FG000|COMPLETED|Overall Study||7||
48189572|NCT01819415|100786251|FG001|COMPLETED|Overall Study||6||
48189573|NCT01819415|100786252|FG002|COMPLETED|Overall Study||9||
48189574|NCT01819415|100786253|FG003|COMPLETED|Overall Study||8||
48189575|NCT01819415|100786250|FG000|NOT COMPLETED|Overall Study||3||
48189576|NCT01819415|100786251|FG001|NOT COMPLETED|Overall Study||4||
48189577|NCT01819415|100786252|FG002|NOT COMPLETED|Overall Study||1||
48189578|NCT01819415|100786253|FG003|NOT COMPLETED|Overall Study||2||
48189579|NCT03587194|100786254|FG000|STARTED|Overall Study||50||
48189580|NCT03587194|100786254|FG000|COMPLETED|Overall Study||23||
48189581|NCT03587194|100786254|FG000|NOT COMPLETED|Overall Study||27||
48189582|NCT01642186|100786255|FG000|STARTED|Overall Study||9||
48189583|NCT01642186|100786256|FG001|STARTED|Overall Study||9||
48457001|NCT04036227|101457020|FG009|COMPLETED|Part I (SAD): 8 mg||0||
48457002|NCT04036227|101457021|FG010|COMPLETED|Part I (SAD): 8 mg||0||
48457003|NCT04036227|101457011|FG000|NOT COMPLETED|Part I (SAD): 8 mg||0||
48457004|NCT04036227|101457012|FG001|NOT COMPLETED|Part I (SAD): 8 mg||0||
48670062|NCT02626533|101974882|FG000|POD 1 Follow up|Overall Study||162|Participants who were successfully contacted for Post-operative day 1 follow up.|
48670063|NCT02626533|101974882|FG000|POD 2 Follow up|Overall Study||162|Participants who were successfully contacted for post-operative day 2 follow up.|
48189584|NCT01642186|100786257|FG002|STARTED|Overall Study||10||
48189585|NCT01642186|100786255|FG000|COMPLETED|Overall Study||9||
48189586|NCT01642186|100786256|FG001|COMPLETED|Overall Study||7||
48189587|NCT01642186|100786257|FG002|COMPLETED|Overall Study||7||
48189588|NCT01642186|100786255|FG000|NOT COMPLETED|Overall Study||0||
48189589|NCT01642186|100786256|FG001|NOT COMPLETED|Overall Study||2||
48189590|NCT01642186|100786257|FG002|NOT COMPLETED|Overall Study||3||
48189591|NCT00662909|100786258|FG000|STARTED|Overall Study||454||
48369537|NCT00748826|101232800|FG000|COMPLETED|Overall Study||207||
48369538|NCT00748826|101232800|FG000|NOT COMPLETED|Overall Study||301||
48189592|NCT00662909|100786259|FG001|STARTED|Overall Study||442||
48189593|NCT00662909|100786260|FG002|STARTED|Overall Study||433||
48189594|NCT00662909|100786258|FG000|Safety Analysis Set (SAF)|Overall Study||453||
48189595|NCT00662909|100786259|FG001|Safety Analysis Set (SAF)|Overall Study||442||
48189596|NCT00662909|100786260|FG002|Safety Analysis Set (SAF)|Overall Study||433||
48189597|NCT00662909|100786258|FG000|Full Analysis Set (FAS)|Overall Study||433||
48189598|NCT00662909|100786259|FG001|Full Analysis Set (FAS)|Overall Study||425||
48189599|NCT00662909|100786260|FG002|Full Analysis Set (FAS)|Overall Study||412||
48189600|NCT00662909|100786258|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study||325||
48189601|NCT00662909|100786259|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study||312||
48457005|NCT04036227|101457013|FG002|NOT COMPLETED|Part I (SAD): 8 mg||0||
48457006|NCT04036227|101457014|FG003|NOT COMPLETED|Part I (SAD): 8 mg||0||
48457007|NCT04036227|101457015|FG004|NOT COMPLETED|Part I (SAD): 8 mg||0||
48457008|NCT04036227|101457016|FG005|NOT COMPLETED|Part I (SAD): 8 mg||0||
48457009|NCT04036227|101457017|FG006|NOT COMPLETED|Part I (SAD): 8 mg||0||
48457010|NCT04036227|101457018|FG007|NOT COMPLETED|Part I (SAD): 8 mg||0||
48457011|NCT04036227|101457019|FG008|NOT COMPLETED|Part I (SAD): 8 mg||0||
48457012|NCT04036227|101457020|FG009|NOT COMPLETED|Part I (SAD): 8 mg||0||
48457013|NCT04036227|101457021|FG010|NOT COMPLETED|Part I (SAD): 8 mg||0||
48457014|NCT04036227|101457011|FG000|STARTED|Part I (SAD): 40 mg||0||
48457015|NCT04036227|101457012|FG001|STARTED|Part I (SAD): 40 mg||0||
48457016|NCT04036227|101457013|FG002|STARTED|Part I (SAD): 40 mg||0||
48457017|NCT04036227|101457014|FG003|STARTED|Part I (SAD): 40 mg||6||
48457018|NCT04036227|101457015|FG004|STARTED|Part I (SAD): 40 mg||0||
48457019|NCT04036227|101457016|FG005|STARTED|Part I (SAD): 40 mg||0||
48457020|NCT04036227|101457017|FG006|STARTED|Part I (SAD): 40 mg||0||
48457021|NCT04036227|101457018|FG007|STARTED|Part I (SAD): 40 mg||0||
48457022|NCT04036227|101457019|FG008|STARTED|Part I (SAD): 40 mg||0||
48457023|NCT04036227|101457020|FG009|STARTED|Part I (SAD): 40 mg||0||
48663270|NCT02936323|101959578|FG000|STARTED|Phase 2a Dose Expansion||0|Initial Phase 2a PEN-221 start dose at Phase 1 MTD and RP2D of 18 mg flat dose. After review of 19 Phase 2a participants, SRC decreased start dose from 18 mg to 15 mg flat dose due to higher-than-expected treatment discontinuation rate. After review of all Phase 1 and 31 Phase 2a participants, SRC changed 15 mg flat dose to Body Surface Area (BSA) based PEN-221 dose of 8.8 mg/m\^2 due to correlation between BSA and drug exposure (AUC) associated with higher rate of participant discontinuation.|
48663271|NCT02936323|101959579|FG001|STARTED|Phase 2a Dose Expansion||0|Initial Phase 2a PEN-221 start dose at Phase 1 MTD and RP2D of 18 mg flat dose. After review of 19 Phase 2a participants, SRC decreased start dose from 18 mg to 15 mg flat dose due to higher-than-expected treatment discontinuation rate. After review of all Phase 1 and 31 Phase 2a participants, SRC changed 15 mg flat dose to Body Surface Area (BSA) based PEN-221 dose of 8.8 mg/m\^2 due to correlation between BSA and drug exposure (AUC) associated with higher rate of participant discontinuation.|
48663272|NCT02936323|101959580|FG002|STARTED|Phase 2a Dose Expansion||0|Initial Phase 2a PEN-221 start dose at Phase 1 MTD and RP2D of 18 mg flat dose. After review of 19 Phase 2a participants, SRC decreased start dose from 18 mg to 15 mg flat dose due to higher-than-expected treatment discontinuation rate. After review of all Phase 1 and 31 Phase 2a participants, SRC changed 15 mg flat dose to Body Surface Area (BSA) based PEN-221 dose of 8.8 mg/m\^2 due to correlation between BSA and drug exposure (AUC) associated with higher rate of participant discontinuation.|
48663273|NCT02936323|101959581|FG003|STARTED|Phase 2a Dose Expansion||0|Initial Phase 2a PEN-221 start dose at Phase 1 MTD and RP2D of 18 mg flat dose. After review of 19 Phase 2a participants, SRC decreased start dose from 18 mg to 15 mg flat dose due to higher-than-expected treatment discontinuation rate. After review of all Phase 1 and 31 Phase 2a participants, SRC changed 15 mg flat dose to Body Surface Area (BSA) based PEN-221 dose of 8.8 mg/m\^2 due to correlation between BSA and drug exposure (AUC) associated with higher rate of participant discontinuation.|
48457024|NCT04036227|101457021|FG010|STARTED|Part I (SAD): 40 mg||0||
48457025|NCT04036227|101457011|FG000|COMPLETED|Part I (SAD): 40 mg||0||
48457026|NCT04036227|101457012|FG001|COMPLETED|Part I (SAD): 40 mg||0||
48457027|NCT04036227|101457013|FG002|COMPLETED|Part I (SAD): 40 mg||0||
48457028|NCT04036227|101457014|FG003|COMPLETED|Part I (SAD): 40 mg||6||
48457029|NCT04036227|101457015|FG004|COMPLETED|Part I (SAD): 40 mg||0||
48457030|NCT04036227|101457016|FG005|COMPLETED|Part I (SAD): 40 mg||0||
48457031|NCT04036227|101457017|FG006|COMPLETED|Part I (SAD): 40 mg||0||
48457032|NCT04036227|101457018|FG007|COMPLETED|Part I (SAD): 40 mg||0||
48457033|NCT04036227|101457019|FG008|COMPLETED|Part I (SAD): 40 mg||0||
48457034|NCT04036227|101457020|FG009|COMPLETED|Part I (SAD): 40 mg||0||
48457035|NCT04036227|101457021|FG010|COMPLETED|Part I (SAD): 40 mg||0||
48457036|NCT04036227|101457011|FG000|NOT COMPLETED|Part I (SAD): 40 mg||0||
48457037|NCT04036227|101457012|FG001|NOT COMPLETED|Part I (SAD): 40 mg||0||
48457038|NCT04036227|101457013|FG002|NOT COMPLETED|Part I (SAD): 40 mg||0||
48457039|NCT04036227|101457014|FG003|NOT COMPLETED|Part I (SAD): 40 mg||0||
48457040|NCT04036227|101457015|FG004|NOT COMPLETED|Part I (SAD): 40 mg||0||
48457041|NCT04036227|101457016|FG005|NOT COMPLETED|Part I (SAD): 40 mg||0||
48457042|NCT04036227|101457017|FG006|NOT COMPLETED|Part I (SAD): 40 mg||0||
48457043|NCT04036227|101457018|FG007|NOT COMPLETED|Part I (SAD): 40 mg||0||
48457044|NCT04036227|101457019|FG008|NOT COMPLETED|Part I (SAD): 40 mg||0||
48457045|NCT04036227|101457020|FG009|NOT COMPLETED|Part I (SAD): 40 mg||0||
48457046|NCT04036227|101457021|FG010|NOT COMPLETED|Part I (SAD): 40 mg||0||
48457047|NCT04036227|101457011|FG000|STARTED|Part I (SAD): 100 mg||0||
48457048|NCT04036227|101457012|FG001|STARTED|Part I (SAD): 100 mg||0||
48457049|NCT04036227|101457013|FG002|STARTED|Part I (SAD): 100 mg||0||
48457050|NCT04036227|101457014|FG003|STARTED|Part I (SAD): 100 mg||0||
48457051|NCT04036227|101457015|FG004|STARTED|Part I (SAD): 100 mg||6||
48457052|NCT04036227|101457016|FG005|STARTED|Part I (SAD): 100 mg||0||
48457053|NCT04036227|101457017|FG006|STARTED|Part I (SAD): 100 mg||0||
48457054|NCT04036227|101457018|FG007|STARTED|Part I (SAD): 100 mg||0||
48457055|NCT04036227|101457019|FG008|STARTED|Part I (SAD): 100 mg||0||
48457056|NCT04036227|101457020|FG009|STARTED|Part I (SAD): 100 mg||0||
48457057|NCT04036227|101457021|FG010|STARTED|Part I (SAD): 100 mg||0||
48457058|NCT04036227|101457011|FG000|COMPLETED|Part I (SAD): 100 mg||0||
48457059|NCT04036227|101457012|FG001|COMPLETED|Part I (SAD): 100 mg||0||
48457060|NCT04036227|101457013|FG002|COMPLETED|Part I (SAD): 100 mg||0||
48457061|NCT04036227|101457014|FG003|COMPLETED|Part I (SAD): 100 mg||0||
48369539|NCT01318083|101232801|FG000|STARTED|Overall Study||105||
48369540|NCT01318083|101232802|FG001|STARTED|Overall Study||104||
48369541|NCT01318083|101232803|FG002|STARTED|Overall Study||103||
48457062|NCT04036227|101457015|FG004|COMPLETED|Part I (SAD): 100 mg||6||
48457063|NCT04036227|101457016|FG005|COMPLETED|Part I (SAD): 100 mg||0||
48457064|NCT04036227|101457017|FG006|COMPLETED|Part I (SAD): 100 mg||0||
48457065|NCT04036227|101457018|FG007|COMPLETED|Part I (SAD): 100 mg||0||
48457066|NCT04036227|101457019|FG008|COMPLETED|Part I (SAD): 100 mg||0||
48457067|NCT04036227|101457020|FG009|COMPLETED|Part I (SAD): 100 mg||0||
48457068|NCT04036227|101457021|FG010|COMPLETED|Part I (SAD): 100 mg||0||
48457069|NCT04036227|101457011|FG000|NOT COMPLETED|Part I (SAD): 100 mg||0||
48457070|NCT04036227|101457012|FG001|NOT COMPLETED|Part I (SAD): 100 mg||0||
48457071|NCT04036227|101457013|FG002|NOT COMPLETED|Part I (SAD): 100 mg||0||
48457072|NCT04036227|101457014|FG003|NOT COMPLETED|Part I (SAD): 100 mg||0||
48457073|NCT04036227|101457015|FG004|NOT COMPLETED|Part I (SAD): 100 mg||0||
48457074|NCT04036227|101457016|FG005|NOT COMPLETED|Part I (SAD): 100 mg||0||
48457075|NCT04036227|101457017|FG006|NOT COMPLETED|Part I (SAD): 100 mg||0||
48457076|NCT04036227|101457018|FG007|NOT COMPLETED|Part I (SAD): 100 mg||0||
48457077|NCT04036227|101457019|FG008|NOT COMPLETED|Part I (SAD): 100 mg||0||
48457078|NCT04036227|101457020|FG009|NOT COMPLETED|Part I (SAD): 100 mg||0||
48457079|NCT04036227|101457021|FG010|NOT COMPLETED|Part I (SAD): 100 mg||0||
48457080|NCT04036227|101457011|FG000|STARTED|Part I (SAD): 300 mg||0||
48457081|NCT04036227|101457012|FG001|STARTED|Part I (SAD): 300 mg||0||
48457082|NCT04036227|101457013|FG002|STARTED|Part I (SAD): 300 mg||0||
48457083|NCT04036227|101457014|FG003|STARTED|Part I (SAD): 300 mg||0||
48457084|NCT04036227|101457015|FG004|STARTED|Part I (SAD): 300 mg||0||
48457085|NCT04036227|101457016|FG005|STARTED|Part I (SAD): 300 mg||6||
48457086|NCT04036227|101457017|FG006|STARTED|Part I (SAD): 300 mg||0||
48457087|NCT04036227|101457018|FG007|STARTED|Part I (SAD): 300 mg||0||
48457088|NCT04036227|101457019|FG008|STARTED|Part I (SAD): 300 mg||0||
48457089|NCT04036227|101457020|FG009|STARTED|Part I (SAD): 300 mg||0||
48457090|NCT04036227|101457021|FG010|STARTED|Part I (SAD): 300 mg||0||
48457091|NCT04036227|101457011|FG000|COMPLETED|Part I (SAD): 300 mg||0||
48457092|NCT04036227|101457012|FG001|COMPLETED|Part I (SAD): 300 mg||0||
48457093|NCT04036227|101457013|FG002|COMPLETED|Part I (SAD): 300 mg||0||
48457094|NCT04036227|101457014|FG003|COMPLETED|Part I (SAD): 300 mg||0||
48457095|NCT04036227|101457015|FG004|COMPLETED|Part I (SAD): 300 mg||0||
48457096|NCT04036227|101457016|FG005|COMPLETED|Part I (SAD): 300 mg||6||
48457097|NCT04036227|101457017|FG006|COMPLETED|Part I (SAD): 300 mg||0||
48457098|NCT04036227|101457018|FG007|COMPLETED|Part I (SAD): 300 mg||0||
48457099|NCT04036227|101457019|FG008|COMPLETED|Part I (SAD): 300 mg||0||
48457100|NCT04036227|101457020|FG009|COMPLETED|Part I (SAD): 300 mg||0||
48457101|NCT04036227|101457021|FG010|COMPLETED|Part I (SAD): 300 mg||0||
48457102|NCT04036227|101457011|FG000|NOT COMPLETED|Part I (SAD): 300 mg||0||
48457103|NCT04036227|101457012|FG001|NOT COMPLETED|Part I (SAD): 300 mg||0||
48369542|NCT01318083|101232801|FG000|COMPLETED|Overall Study||99||
48369543|NCT01318083|101232802|FG001|COMPLETED|Overall Study||102||
48369544|NCT01318083|101232803|FG002|COMPLETED|Overall Study||98||
48369545|NCT01318083|101232801|FG000|NOT COMPLETED|Overall Study||6||
48369546|NCT01318083|101232802|FG001|NOT COMPLETED|Overall Study||2||
48369547|NCT01318083|101232803|FG002|NOT COMPLETED|Overall Study||5||
48369548|NCT02065869|101232804|FG000|STARTED|Overall Study||184|Patients receiving HSCT graft (HSCT Safety population)|
48369549|NCT02065869|101232804|FG000|Patients Receiving Rivogenlecleucel (BPX-501 Safety Population)|Overall Study||171||
48369550|NCT02065869|101232804|FG000|ITT Population|Overall Study||142||
48369551|NCT02065869|101232804|FG000|Patients Receiving at Least 1 Dose of Rimiducid|Overall Study||16||
48369552|NCT02065869|101232804|FG000|COMPLETED|Overall Study||149||
48369553|NCT02065869|101232804|FG000|NOT COMPLETED|Overall Study||35||
48369554|NCT01849250|101232805|FG000|STARTED|Overall Study||32||
48369555|NCT01849250|101232806|FG001|STARTED|Overall Study||32||
48369556|NCT01849250|101232805|FG000|COMPLETED|Overall Study||25||
48369557|NCT01849250|101232806|FG001|COMPLETED|Overall Study||29||
48369558|NCT01849250|101232805|FG000|NOT COMPLETED|Overall Study||7||
48369559|NCT01849250|101232806|FG001|NOT COMPLETED|Overall Study||3||
48369560|NCT02191917|101232807|FG000|STARTED|Overall Study||8||
48369561|NCT02191917|101232807|FG000|COMPLETED|Overall Study||7||
48369562|NCT02191917|101232807|FG000|NOT COMPLETED|Overall Study||1||
48369563|NCT00540969|101232808|FG000|STARTED|Overall Study||2||
48369564|NCT00540969|101232809|FG001|STARTED|Overall Study||1||
48369565|NCT00540969|101232808|FG000|COMPLETED|Overall Study||2||
48369566|NCT00540969|101232809|FG001|COMPLETED|Overall Study||1||
48457104|NCT04036227|101457013|FG002|NOT COMPLETED|Part I (SAD): 300 mg||0||
48457105|NCT04036227|101457014|FG003|NOT COMPLETED|Part I (SAD): 300 mg||0||
48457106|NCT04036227|101457015|FG004|NOT COMPLETED|Part I (SAD): 300 mg||0||
48457107|NCT04036227|101457016|FG005|NOT COMPLETED|Part I (SAD): 300 mg||0||
48457108|NCT04036227|101457017|FG006|NOT COMPLETED|Part I (SAD): 300 mg||0||
48457109|NCT04036227|101457018|FG007|NOT COMPLETED|Part I (SAD): 300 mg||0||
48457110|NCT04036227|101457019|FG008|NOT COMPLETED|Part I (SAD): 300 mg||0||
48457111|NCT04036227|101457020|FG009|NOT COMPLETED|Part I (SAD): 300 mg||0||
48457112|NCT04036227|101457021|FG010|NOT COMPLETED|Part I (SAD): 300 mg||0||
48457113|NCT04036227|101457011|FG000|STARTED|Part I (SAD): Placebo||0||
48457114|NCT04036227|101457012|FG001|STARTED|Part I (SAD): Placebo||0||
48457115|NCT04036227|101457013|FG002|STARTED|Part I (SAD): Placebo||0||
48457116|NCT04036227|101457014|FG003|STARTED|Part I (SAD): Placebo||0||
48457117|NCT04036227|101457015|FG004|STARTED|Part I (SAD): Placebo||0||
48457118|NCT04036227|101457016|FG005|STARTED|Part I (SAD): Placebo||0||
48457119|NCT04036227|101457017|FG006|STARTED|Part I (SAD): Placebo||12||
48457120|NCT04036227|101457018|FG007|STARTED|Part I (SAD): Placebo||0||
48457121|NCT04036227|101457019|FG008|STARTED|Part I (SAD): Placebo||0||
48457122|NCT04036227|101457020|FG009|STARTED|Part I (SAD): Placebo||0||
48457123|NCT04036227|101457021|FG010|STARTED|Part I (SAD): Placebo||0||
48457124|NCT04036227|101457011|FG000|COMPLETED|Part I (SAD): Placebo||0||
48457125|NCT04036227|101457012|FG001|COMPLETED|Part I (SAD): Placebo||0||
48457126|NCT04036227|101457013|FG002|COMPLETED|Part I (SAD): Placebo||0||
48457127|NCT04036227|101457014|FG003|COMPLETED|Part I (SAD): Placebo||0||
48457128|NCT04036227|101457015|FG004|COMPLETED|Part I (SAD): Placebo||0||
48457129|NCT04036227|101457016|FG005|COMPLETED|Part I (SAD): Placebo||0||
48457130|NCT04036227|101457017|FG006|COMPLETED|Part I (SAD): Placebo||12||
48457131|NCT04036227|101457018|FG007|COMPLETED|Part I (SAD): Placebo||0||
48457132|NCT04036227|101457019|FG008|COMPLETED|Part I (SAD): Placebo||0||
48457133|NCT04036227|101457020|FG009|COMPLETED|Part I (SAD): Placebo||0||
48457134|NCT04036227|101457021|FG010|COMPLETED|Part I (SAD): Placebo||0||
48457135|NCT04036227|101457011|FG000|NOT COMPLETED|Part I (SAD): Placebo||0||
48457136|NCT04036227|101457012|FG001|NOT COMPLETED|Part I (SAD): Placebo||0||
48457137|NCT04036227|101457013|FG002|NOT COMPLETED|Part I (SAD): Placebo||0||
48457138|NCT04036227|101457014|FG003|NOT COMPLETED|Part I (SAD): Placebo||0||
48457139|NCT04036227|101457015|FG004|NOT COMPLETED|Part I (SAD): Placebo||0||
48457140|NCT04036227|101457016|FG005|NOT COMPLETED|Part I (SAD): Placebo||0||
48457141|NCT04036227|101457017|FG006|NOT COMPLETED|Part I (SAD): Placebo||0||
48457142|NCT04036227|101457018|FG007|NOT COMPLETED|Part I (SAD): Placebo||0||
48457143|NCT04036227|101457019|FG008|NOT COMPLETED|Part I (SAD): Placebo||0||
48457144|NCT04036227|101457020|FG009|NOT COMPLETED|Part I (SAD): Placebo||0||
48457145|NCT04036227|101457021|FG010|NOT COMPLETED|Part I (SAD): Placebo||0||
48457146|NCT04036227|101457011|FG000|STARTED|Part II (MAD): 20 mg||0||
48457147|NCT04036227|101457012|FG001|STARTED|Part II (MAD): 20 mg||0||
48457148|NCT04036227|101457013|FG002|STARTED|Part II (MAD): 20 mg||0||
48457149|NCT04036227|101457014|FG003|STARTED|Part II (MAD): 20 mg||0||
48457150|NCT04036227|101457015|FG004|STARTED|Part II (MAD): 20 mg||0||
48457151|NCT04036227|101457016|FG005|STARTED|Part II (MAD): 20 mg||0||
48457152|NCT04036227|101457017|FG006|STARTED|Part II (MAD): 20 mg||0||
48457153|NCT04036227|101457018|FG007|STARTED|Part II (MAD): 20 mg||6||
48457154|NCT04036227|101457019|FG008|STARTED|Part II (MAD): 20 mg||0||
48457155|NCT04036227|101457020|FG009|STARTED|Part II (MAD): 20 mg||0||
48457156|NCT04036227|101457021|FG010|STARTED|Part II (MAD): 20 mg||0||
48457157|NCT04036227|101457011|FG000|COMPLETED|Part II (MAD): 20 mg||0||
48457158|NCT04036227|101457012|FG001|COMPLETED|Part II (MAD): 20 mg||0||
48457159|NCT04036227|101457013|FG002|COMPLETED|Part II (MAD): 20 mg||0||
48457160|NCT04036227|101457014|FG003|COMPLETED|Part II (MAD): 20 mg||0||
48457161|NCT04036227|101457015|FG004|COMPLETED|Part II (MAD): 20 mg||0||
48457162|NCT04036227|101457016|FG005|COMPLETED|Part II (MAD): 20 mg||0||
48457163|NCT04036227|101457017|FG006|COMPLETED|Part II (MAD): 20 mg||0||
48457164|NCT04036227|101457018|FG007|COMPLETED|Part II (MAD): 20 mg||6||
48457165|NCT04036227|101457019|FG008|COMPLETED|Part II (MAD): 20 mg||0||
48457166|NCT04036227|101457020|FG009|COMPLETED|Part II (MAD): 20 mg||0||
48457167|NCT04036227|101457021|FG010|COMPLETED|Part II (MAD): 20 mg||0||
48457168|NCT04036227|101457011|FG000|NOT COMPLETED|Part II (MAD): 20 mg||0||
48457169|NCT04036227|101457012|FG001|NOT COMPLETED|Part II (MAD): 20 mg||0||
48457170|NCT04036227|101457013|FG002|NOT COMPLETED|Part II (MAD): 20 mg||0||
48457171|NCT04036227|101457014|FG003|NOT COMPLETED|Part II (MAD): 20 mg||0||
48457172|NCT04036227|101457015|FG004|NOT COMPLETED|Part II (MAD): 20 mg||0||
48457173|NCT04036227|101457016|FG005|NOT COMPLETED|Part II (MAD): 20 mg||0||
48457174|NCT04036227|101457017|FG006|NOT COMPLETED|Part II (MAD): 20 mg||0||
48369567|NCT00540969|101232808|FG000|NOT COMPLETED|Overall Study||0||
48457175|NCT04036227|101457018|FG007|NOT COMPLETED|Part II (MAD): 20 mg||0||
48457176|NCT04036227|101457019|FG008|NOT COMPLETED|Part II (MAD): 20 mg||0||
48457177|NCT04036227|101457020|FG009|NOT COMPLETED|Part II (MAD): 20 mg||0||
48457178|NCT04036227|101457021|FG010|NOT COMPLETED|Part II (MAD): 20 mg||0||
48457179|NCT04036227|101457011|FG000|STARTED|Part II (MAD): 60 mg||0||
48457180|NCT04036227|101457012|FG001|STARTED|Part II (MAD): 60 mg||0||
48457181|NCT04036227|101457013|FG002|STARTED|Part II (MAD): 60 mg||0||
48457182|NCT04036227|101457014|FG003|STARTED|Part II (MAD): 60 mg||0||
48457183|NCT04036227|101457015|FG004|STARTED|Part II (MAD): 60 mg||0||
48457184|NCT04036227|101457016|FG005|STARTED|Part II (MAD): 60 mg||0||
48457185|NCT04036227|101457017|FG006|STARTED|Part II (MAD): 60 mg||0||
48457186|NCT04036227|101457018|FG007|STARTED|Part II (MAD): 60 mg||0||
48457187|NCT04036227|101457019|FG008|STARTED|Part II (MAD): 60 mg||6||
48457188|NCT04036227|101457020|FG009|STARTED|Part II (MAD): 60 mg||0||
48457189|NCT04036227|101457021|FG010|STARTED|Part II (MAD): 60 mg||0||
48457190|NCT04036227|101457011|FG000|COMPLETED|Part II (MAD): 60 mg||0||
48457191|NCT04036227|101457012|FG001|COMPLETED|Part II (MAD): 60 mg||0||
48457192|NCT04036227|101457013|FG002|COMPLETED|Part II (MAD): 60 mg||0||
48457193|NCT04036227|101457014|FG003|COMPLETED|Part II (MAD): 60 mg||0||
48457194|NCT04036227|101457015|FG004|COMPLETED|Part II (MAD): 60 mg||0||
48457195|NCT04036227|101457016|FG005|COMPLETED|Part II (MAD): 60 mg||0||
48457196|NCT04036227|101457017|FG006|COMPLETED|Part II (MAD): 60 mg||0||
48457197|NCT04036227|101457018|FG007|COMPLETED|Part II (MAD): 60 mg||0||
48457198|NCT04036227|101457019|FG008|COMPLETED|Part II (MAD): 60 mg||6||
48457199|NCT04036227|101457020|FG009|COMPLETED|Part II (MAD): 60 mg||0||
48457200|NCT04036227|101457021|FG010|COMPLETED|Part II (MAD): 60 mg||0||
48457201|NCT04036227|101457011|FG000|NOT COMPLETED|Part II (MAD): 60 mg||0||
48457202|NCT04036227|101457012|FG001|NOT COMPLETED|Part II (MAD): 60 mg||0||
48457203|NCT04036227|101457013|FG002|NOT COMPLETED|Part II (MAD): 60 mg||0||
48457204|NCT04036227|101457014|FG003|NOT COMPLETED|Part II (MAD): 60 mg||0||
48457205|NCT04036227|101457015|FG004|NOT COMPLETED|Part II (MAD): 60 mg||0||
48457206|NCT04036227|101457016|FG005|NOT COMPLETED|Part II (MAD): 60 mg||0||
48457207|NCT04036227|101457017|FG006|NOT COMPLETED|Part II (MAD): 60 mg||0||
48457208|NCT04036227|101457018|FG007|NOT COMPLETED|Part II (MAD): 60 mg||0||
48457209|NCT04036227|101457019|FG008|NOT COMPLETED|Part II (MAD): 60 mg||0||
48457210|NCT04036227|101457020|FG009|NOT COMPLETED|Part II (MAD): 60 mg||0||
48457211|NCT04036227|101457021|FG010|NOT COMPLETED|Part II (MAD): 60 mg||0||
48457212|NCT04036227|101457011|FG000|STARTED|Part II (MAD): 180 mg||0||
48457213|NCT04036227|101457012|FG001|STARTED|Part II (MAD): 180 mg||0||
48457214|NCT04036227|101457013|FG002|STARTED|Part II (MAD): 180 mg||0||
48457215|NCT04036227|101457014|FG003|STARTED|Part II (MAD): 180 mg||0||
48457216|NCT04036227|101457015|FG004|STARTED|Part II (MAD): 180 mg||0||
48457217|NCT04036227|101457016|FG005|STARTED|Part II (MAD): 180 mg||0||
48189602|NCT00662909|100786260|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study||296||
48457218|NCT04036227|101457017|FG006|STARTED|Part II (MAD): 180 mg||0||
48457219|NCT04036227|101457018|FG007|STARTED|Part II (MAD): 180 mg||0||
48457220|NCT04036227|101457019|FG008|STARTED|Part II (MAD): 180 mg||0||
48457221|NCT04036227|101457020|FG009|STARTED|Part II (MAD): 180 mg||6||
48457222|NCT04036227|101457021|FG010|STARTED|Part II (MAD): 180 mg||0||
48457223|NCT04036227|101457011|FG000|COMPLETED|Part II (MAD): 180 mg||0||
48457224|NCT04036227|101457012|FG001|COMPLETED|Part II (MAD): 180 mg||0||
48457225|NCT04036227|101457013|FG002|COMPLETED|Part II (MAD): 180 mg||0||
48457226|NCT04036227|101457014|FG003|COMPLETED|Part II (MAD): 180 mg||0||
48457227|NCT04036227|101457015|FG004|COMPLETED|Part II (MAD): 180 mg||0||
48457228|NCT04036227|101457016|FG005|COMPLETED|Part II (MAD): 180 mg||0||
48457229|NCT04036227|101457017|FG006|COMPLETED|Part II (MAD): 180 mg||0||
48457230|NCT04036227|101457018|FG007|COMPLETED|Part II (MAD): 180 mg||0||
48457231|NCT04036227|101457019|FG008|COMPLETED|Part II (MAD): 180 mg||0||
48457232|NCT04036227|101457020|FG009|COMPLETED|Part II (MAD): 180 mg||5||
48457233|NCT04036227|101457021|FG010|COMPLETED|Part II (MAD): 180 mg||0||
48457234|NCT04036227|101457011|FG000|NOT COMPLETED|Part II (MAD): 180 mg||0||
48457235|NCT04036227|101457012|FG001|NOT COMPLETED|Part II (MAD): 180 mg||0||
48457236|NCT04036227|101457013|FG002|NOT COMPLETED|Part II (MAD): 180 mg||0||
48457237|NCT04036227|101457014|FG003|NOT COMPLETED|Part II (MAD): 180 mg||0||
48457238|NCT04036227|101457015|FG004|NOT COMPLETED|Part II (MAD): 180 mg||0||
48457239|NCT04036227|101457016|FG005|NOT COMPLETED|Part II (MAD): 180 mg||0||
48457240|NCT04036227|101457017|FG006|NOT COMPLETED|Part II (MAD): 180 mg||0||
48457241|NCT04036227|101457018|FG007|NOT COMPLETED|Part II (MAD): 180 mg||0||
48457242|NCT04036227|101457019|FG008|NOT COMPLETED|Part II (MAD): 180 mg||0||
48457243|NCT04036227|101457020|FG009|NOT COMPLETED|Part II (MAD): 180 mg||1||
48457244|NCT04036227|101457021|FG010|NOT COMPLETED|Part II (MAD): 180 mg||0||
48457245|NCT04036227|101457011|FG000|STARTED|Part II (MAD): Placebo||0||
48457246|NCT04036227|101457012|FG001|STARTED|Part II (MAD): Placebo||0||
48457247|NCT04036227|101457013|FG002|STARTED|Part II (MAD): Placebo||0||
48457248|NCT04036227|101457014|FG003|STARTED|Part II (MAD): Placebo||0||
48457249|NCT04036227|101457015|FG004|STARTED|Part II (MAD): Placebo||0||
48457250|NCT04036227|101457016|FG005|STARTED|Part II (MAD): Placebo||0||
48457251|NCT04036227|101457017|FG006|STARTED|Part II (MAD): Placebo||0||
48457252|NCT04036227|101457018|FG007|STARTED|Part II (MAD): Placebo||0||
48457253|NCT04036227|101457019|FG008|STARTED|Part II (MAD): Placebo||0||
48457254|NCT04036227|101457020|FG009|STARTED|Part II (MAD): Placebo||0||
48457255|NCT04036227|101457021|FG010|STARTED|Part II (MAD): Placebo||6||
48457256|NCT04036227|101457011|FG000|COMPLETED|Part II (MAD): Placebo||0||
48457257|NCT04036227|101457012|FG001|COMPLETED|Part II (MAD): Placebo||0||
48457258|NCT04036227|101457013|FG002|COMPLETED|Part II (MAD): Placebo||0||
48457259|NCT04036227|101457014|FG003|COMPLETED|Part II (MAD): Placebo||0||
48457260|NCT04036227|101457015|FG004|COMPLETED|Part II (MAD): Placebo||0||
48457261|NCT04036227|101457016|FG005|COMPLETED|Part II (MAD): Placebo||0||
48457262|NCT04036227|101457017|FG006|COMPLETED|Part II (MAD): Placebo||0||
48457263|NCT04036227|101457018|FG007|COMPLETED|Part II (MAD): Placebo||0||
48457264|NCT04036227|101457019|FG008|COMPLETED|Part II (MAD): Placebo||0||
48457265|NCT04036227|101457020|FG009|COMPLETED|Part II (MAD): Placebo||0||
48457266|NCT04036227|101457021|FG010|COMPLETED|Part II (MAD): Placebo||6||
48457267|NCT04036227|101457011|FG000|NOT COMPLETED|Part II (MAD): Placebo||0||
48457268|NCT04036227|101457012|FG001|NOT COMPLETED|Part II (MAD): Placebo||0||
48457269|NCT04036227|101457013|FG002|NOT COMPLETED|Part II (MAD): Placebo||0||
48457270|NCT04036227|101457014|FG003|NOT COMPLETED|Part II (MAD): Placebo||0||
48457271|NCT04036227|101457015|FG004|NOT COMPLETED|Part II (MAD): Placebo||0||
48457272|NCT04036227|101457016|FG005|NOT COMPLETED|Part II (MAD): Placebo||0||
48457273|NCT04036227|101457017|FG006|NOT COMPLETED|Part II (MAD): Placebo||0||
48457274|NCT04036227|101457018|FG007|NOT COMPLETED|Part II (MAD): Placebo||0||
48457275|NCT04036227|101457019|FG008|NOT COMPLETED|Part II (MAD): Placebo||0||
48457276|NCT04036227|101457020|FG009|NOT COMPLETED|Part II (MAD): Placebo||0||
48457277|NCT04036227|101457021|FG010|NOT COMPLETED|Part II (MAD): Placebo||0||
48457278|NCT00254397|101457022|FG000|STARTED|Overall Study||10||
48457279|NCT00254397|101457023|FG001|STARTED|Overall Study||6||
48457280|NCT00254397|101457024|FG002|STARTED|Overall Study||37||
48457281|NCT00254397|101457025|FG003|STARTED|Overall Study||45||
48457282|NCT00254397|101457022|FG000|COMPLETED|Overall Study||4||
48457283|NCT00254397|101457023|FG001|COMPLETED|Overall Study||5||
48457284|NCT00254397|101457024|FG002|COMPLETED|Overall Study||18||
48457285|NCT00254397|101457025|FG003|COMPLETED|Overall Study||20||
48457286|NCT00254397|101457022|FG000|NOT COMPLETED|Overall Study||6||
48457287|NCT00254397|101457023|FG001|NOT COMPLETED|Overall Study||1||
48457288|NCT00254397|101457024|FG002|NOT COMPLETED|Overall Study||19||
48457289|NCT00254397|101457025|FG003|NOT COMPLETED|Overall Study||25||
48457290|NCT01102777|101457026|FG000|STARTED|Overall Study||84||
48457291|NCT01102777|101457027|FG001|STARTED|Overall Study||155||
48457292|NCT01102777|101457026|FG000|COMPLETED|Overall Study||75||
48457293|NCT01102777|101457027|FG001|COMPLETED|Overall Study||139||
48457294|NCT01102777|101457026|FG000|NOT COMPLETED|Overall Study||9||
48369568|NCT00540969|101232809|FG001|NOT COMPLETED|Overall Study||0||
48369569|NCT00540722|101232810|FG000|STARTED|Overall Study||56||
48369570|NCT00540722|101232810|FG000|COMPLETED|Overall Study||56||
48369571|NCT00540722|101232810|FG000|NOT COMPLETED|Overall Study||0||
48369572|NCT00073333|101232811|FG000|STARTED|Overall Study||46||
48369573|NCT00073333|101232812|FG001|STARTED|Overall Study||41||
48369574|NCT00073333|101232813|FG002|STARTED|Overall Study||19||
48369575|NCT00073333|101232811|FG000|COMPLETED|Overall Study||32||
48369576|NCT00073333|101232812|FG001|COMPLETED|Overall Study||27||
48369577|NCT00073333|101232813|FG002|COMPLETED|Overall Study||19||
48369578|NCT00073333|101232811|FG000|NOT COMPLETED|Overall Study||14||
48369579|NCT00073333|101232812|FG001|NOT COMPLETED|Overall Study||14||
48369580|NCT00073333|101232813|FG002|NOT COMPLETED|Overall Study||0||
48369581|NCT00797459|101232814|FG000|STARTED|Overall Study||60||
48369582|NCT00797459|101232814|FG000|COMPLETED|Overall Study||60||
48369583|NCT00797459|101232814|FG000|NOT COMPLETED|Overall Study||0||
48369584|NCT03074162|101232815|FG000|STARTED|Period 1 Including Washout 1||8||
48369585|NCT03074162|101232816|FG001|STARTED|Period 1 Including Washout 1||8||
48369586|NCT03074162|101232817|FG002|STARTED|Period 1 Including Washout 1||8||
48369587|NCT03074162|101232818|FG003|STARTED|Period 1 Including Washout 1||8||
48369588|NCT03074162|101232819|FG004|STARTED|Period 1 Including Washout 1||8||
48457295|NCT01102777|101457027|FG001|NOT COMPLETED|Overall Study||16||
48457296|NCT03031899|101457028|FG000|STARTED|Overall Study||27||41
48457297|NCT03031899|101457028|FG000|COMPLETED|Overall Study||25|one patient had not quit the habit, another lesion disappeared 2 patients (3 lesions) were excluded|38
48457298|NCT03031899|101457028|FG000|NOT COMPLETED|Overall Study||2||3
48457299|NCT01835132|101457029|FG000|STARTED|Initial Phase||8||
48369589|NCT03074162|101232820|FG005|STARTED|Period 1 Including Washout 1||8||
48369590|NCT03074162|101232815|FG000|COMPLETED|Period 1 Including Washout 1||8||
48369591|NCT03074162|101232816|FG001|COMPLETED|Period 1 Including Washout 1||8||
48369592|NCT03074162|101232817|FG002|COMPLETED|Period 1 Including Washout 1||7||
48369593|NCT03074162|101232818|FG003|COMPLETED|Period 1 Including Washout 1||8||
48457300|NCT01835132|101457029|FG000|COMPLETED|Initial Phase||6||
48457301|NCT01835132|101457029|FG000|NOT COMPLETED|Initial Phase||2||
48457302|NCT01835132|101457029|FG000|STARTED|1st Extension Phase||6||
48457303|NCT01835132|101457029|FG000|COMPLETED|1st Extension Phase||6||
48457304|NCT01835132|101457029|FG000|NOT COMPLETED|1st Extension Phase||0||
48457305|NCT01835132|101457029|FG000|STARTED|2nd Extension Phase - As Needed (PRN)||3||
48457306|NCT01835132|101457029|FG000|COMPLETED|2nd Extension Phase - As Needed (PRN)||3||
48457307|NCT01835132|101457029|FG000|NOT COMPLETED|2nd Extension Phase - As Needed (PRN)||0||
48457308|NCT03124381|101457030|FG000|STARTED|Overall Study||65||
48457309|NCT03124381|101457031|FG001|STARTED|Overall Study||61||
48457310|NCT03124381|101457030|FG000|COMPLETED|Overall Study||56||
48457311|NCT03124381|101457031|FG001|COMPLETED|Overall Study||55||
48457312|NCT03124381|101457030|FG000|NOT COMPLETED|Overall Study||9||
48457313|NCT03124381|101457031|FG001|NOT COMPLETED|Overall Study||6||
48457314|NCT02400710|101457032|FG000|STARTED|Overall Study||10||
48457315|NCT02400710|101457033|FG001|STARTED|Overall Study||10||
48457316|NCT02400710|101457032|FG000|COMPLETED|Overall Study||10||
48457317|NCT02400710|101457033|FG001|COMPLETED|Overall Study||10||
48457318|NCT02400710|101457032|FG000|NOT COMPLETED|Overall Study||0||
48457319|NCT02400710|101457033|FG001|NOT COMPLETED|Overall Study||0||
48457320|NCT00006170|101457034|FG000|STARTED|Overall Study||106||
48457321|NCT00006170|101457035|FG001|STARTED|Overall Study||87||
48457322|NCT00006170|101457036|FG002|STARTED|Overall Study||89||
48457323|NCT00006170|101457037|FG003|STARTED|Overall Study||67||
48457324|NCT00006170|101457034|FG000|COMPLETED|Overall Study||57||
48457325|NCT00006170|101457035|FG001|COMPLETED|Overall Study||37||
48457326|NCT00006170|101457036|FG002|COMPLETED|Overall Study||46||
48457327|NCT00006170|101457037|FG003|COMPLETED|Overall Study||28||
48457328|NCT00006170|101457034|FG000|NOT COMPLETED|Overall Study||49||
48457329|NCT00006170|101457035|FG001|NOT COMPLETED|Overall Study||50||
48457330|NCT00006170|101457036|FG002|NOT COMPLETED|Overall Study||43||
48457331|NCT00006170|101457037|FG003|NOT COMPLETED|Overall Study||39||
48457332|NCT02660385|101457038|FG000|STARTED|Overall Study||100||
48457333|NCT02660385|101457039|FG001|STARTED|Overall Study||89||
48457334|NCT02660385|101457038|FG000|COMPLETED|Overall Study||91||
48457335|NCT02660385|101457039|FG001|COMPLETED|Overall Study||84||
48457336|NCT02660385|101457038|FG000|NOT COMPLETED|Overall Study||9||
48457337|NCT02660385|101457039|FG001|NOT COMPLETED|Overall Study||5||
48457338|NCT01084603|101457040|FG000|STARTED|Baseline||45||
48457339|NCT01084603|101457040|FG000|COMPLETED|Baseline||43||
48457340|NCT01084603|101457040|FG000|NOT COMPLETED|Baseline||2||
48457341|NCT01084603|101457040|FG000|STARTED|NiQuitinTM Lozenge||43||
48457342|NCT01084603|101457040|FG000|COMPLETED|NiQuitinTM Lozenge||42||
48457343|NCT01084603|101457040|FG000|NOT COMPLETED|NiQuitinTM Lozenge||1||
48457344|NCT01084603|101457040|FG000|STARTED|Washout Period 1||42||
48457345|NCT01084603|101457040|FG000|COMPLETED|Washout Period 1||42||
48457346|NCT01084603|101457040|FG000|NOT COMPLETED|Washout Period 1||0||
48457347|NCT01084603|101457040|FG000|STARTED|Nicorette® Gum||42||
48457348|NCT01084603|101457040|FG000|COMPLETED|Nicorette® Gum||41||
48457349|NCT01084603|101457040|FG000|NOT COMPLETED|Nicorette® Gum||1||
48457350|NCT01084603|101457040|FG000|STARTED|Washout Period 2||41||
48457351|NCT01084603|101457040|FG000|COMPLETED|Washout Period 2||41||
48457352|NCT01084603|101457040|FG000|NOT COMPLETED|Washout Period 2||0||
48457353|NCT01084603|101457040|FG000|STARTED|Oral Nicotine 1||41||
48457354|NCT01084603|101457040|FG000|COMPLETED|Oral Nicotine 1||40||
48457355|NCT01084603|101457040|FG000|NOT COMPLETED|Oral Nicotine 1||1||
48457356|NCT01084603|101457040|FG000|STARTED|Washout Period 3||40||
48457357|NCT01084603|101457040|FG000|COMPLETED|Washout Period 3||40||
48457358|NCT01084603|101457040|FG000|NOT COMPLETED|Washout Period 3||0||
48457359|NCT01084603|101457040|FG000|STARTED|Oral Nicotine 2||40||
48457360|NCT01084603|101457040|FG000|COMPLETED|Oral Nicotine 2||40||
48457361|NCT01084603|101457040|FG000|NOT COMPLETED|Oral Nicotine 2||0||
48457362|NCT01084603|101457040|FG000|STARTED|Washout Period 4||40||
48457363|NCT01084603|101457040|FG000|COMPLETED|Washout Period 4||39||
48457364|NCT01084603|101457040|FG000|NOT COMPLETED|Washout Period 4||1||
48457365|NCT01084603|101457040|FG000|STARTED|Oral Nicotine 4||39||
48457366|NCT01084603|101457040|FG000|COMPLETED|Oral Nicotine 4||39||
48457367|NCT01084603|101457040|FG000|NOT COMPLETED|Oral Nicotine 4||0||
48457368|NCT00481247|101457041|FG000|STARTED|Overall Study||259||
48457369|NCT00481247|101457042|FG001|STARTED|Overall Study||260||
48457370|NCT00481247|101457041|FG000|Received Treatment|Overall Study||258||
48457371|NCT00481247|101457042|FG001|Received Treatment|Overall Study||258||
48457372|NCT00481247|101457041|FG000|COMPLETED|Overall Study||0||
48457373|NCT00481247|101457042|FG001|COMPLETED|Overall Study||0||
48457374|NCT00481247|101457041|FG000|NOT COMPLETED|Overall Study||259||
48457375|NCT00481247|101457042|FG001|NOT COMPLETED|Overall Study||260||
48457376|NCT01605461|101457043|FG000|STARTED|Overall Study||12||
48457377|NCT01605461|101457043|FG000|COMPLETED|Overall Study||8||
48457378|NCT01605461|101457043|FG000|NOT COMPLETED|Overall Study||4||
48457379|NCT02741271|101457044|FG000|STARTED|Overall Study||91||
48457380|NCT02741271|101457045|FG001|STARTED|Overall Study||90||
48457381|NCT02741271|101457044|FG000|COMPLETED|Overall Study||89||
48457382|NCT02741271|101457045|FG001|COMPLETED|Overall Study||88||
48457383|NCT02741271|101457044|FG000|NOT COMPLETED|Overall Study||2||
48457384|NCT02741271|101457045|FG001|NOT COMPLETED|Overall Study||2||
48457385|NCT01879800|101457046|FG000|STARTED|Overall Study||14||
48457386|NCT01879800|101457047|FG001|STARTED|Overall Study||30||
48457387|NCT01879800|101457046|FG000|COMPLETED|Overall Study||14||
48457388|NCT01879800|101457047|FG001|COMPLETED|Overall Study||26||
48457389|NCT01879800|101457046|FG000|NOT COMPLETED|Overall Study||0||
48457390|NCT01879800|101457047|FG001|NOT COMPLETED|Overall Study||4||
48457391|NCT01612156|101457048|FG000|STARTED|Overall Study||42||
48457392|NCT01612156|101457049|FG001|STARTED|Overall Study||48||
48189603|NCT00662909|100786258|FG000|COMPLETED|Overall Study||385||
48189604|NCT00662909|100786259|FG001|COMPLETED|Overall Study||383||
48189605|NCT00662909|100786260|FG002|COMPLETED|Overall Study||380||
48773032|NCT02106390|102232838|FG002|NOT COMPLETED|Overall Study||43||
48773033|NCT00829504|102232839|FG000|STARTED|First Intervention||22||
48773034|NCT00829504|102232840|FG001|STARTED|First Intervention||22||
48369594|NCT03074162|101232819|FG004|COMPLETED|Period 1 Including Washout 1||8||
48457393|NCT01612156|101457048|FG000|COMPLETED|Overall Study||40||
48457394|NCT01612156|101457049|FG001|COMPLETED|Overall Study||48||
48457395|NCT01612156|101457048|FG000|NOT COMPLETED|Overall Study||2||
48457396|NCT01612156|101457049|FG001|NOT COMPLETED|Overall Study||0||
48663274|NCT02936323|101959582|FG004|STARTED|Phase 2a Dose Expansion||0|Initial Phase 2a PEN-221 start dose at Phase 1 MTD and RP2D of 18 mg flat dose. After review of 19 Phase 2a participants, SRC decreased start dose from 18 mg to 15 mg flat dose due to higher-than-expected treatment discontinuation rate. After review of all Phase 1 and 31 Phase 2a participants, SRC changed 15 mg flat dose to Body Surface Area (BSA) based PEN-221 dose of 8.8 mg/m\^2 due to correlation between BSA and drug exposure (AUC) associated with higher rate of participant discontinuation.|
48663275|NCT02936323|101959583|FG005|STARTED|Phase 2a Dose Expansion||0|Initial Phase 2a PEN-221 start dose at Phase 1 MTD and RP2D of 18 mg flat dose. After review of 19 Phase 2a participants, SRC decreased start dose from 18 mg to 15 mg flat dose due to higher-than-expected treatment discontinuation rate. After review of all Phase 1 and 31 Phase 2a participants, SRC changed 15 mg flat dose to Body Surface Area (BSA) based PEN-221 dose of 8.8 mg/m\^2 due to correlation between BSA and drug exposure (AUC) associated with higher rate of participant discontinuation.|
48663276|NCT02936323|101959584|FG006|STARTED|Phase 2a Dose Expansion||0|Initial Phase 2a PEN-221 start dose at Phase 1 MTD and RP2D of 18 mg flat dose. After review of 19 Phase 2a participants, SRC decreased start dose from 18 mg to 15 mg flat dose due to higher-than-expected treatment discontinuation rate. After review of all Phase 1 and 31 Phase 2a participants, SRC changed 15 mg flat dose to Body Surface Area (BSA) based PEN-221 dose of 8.8 mg/m\^2 due to correlation between BSA and drug exposure (AUC) associated with higher rate of participant discontinuation.|
48663277|NCT02936323|101959585|FG007|STARTED|Phase 2a Dose Expansion||32|Initial Phase 2a PEN-221 start dose at Phase 1 MTD and RP2D of 18 mg flat dose. After review of 19 Phase 2a participants, SRC decreased start dose from 18 mg to 15 mg flat dose due to higher-than-expected treatment discontinuation rate. After review of all Phase 1 and 31 Phase 2a participants, SRC changed 15 mg flat dose to Body Surface Area (BSA) based PEN-221 dose of 8.8 mg/m\^2 due to correlation between BSA and drug exposure (AUC) associated with higher rate of participant discontinuation.|
48663278|NCT02936323|101959586|FG008|STARTED|Phase 2a Dose Expansion||15|Initial Phase 2a PEN-221 start dose at Phase 1 MTD and RP2D of 18 mg flat dose. After review of 19 Phase 2a participants, SRC decreased start dose from 18 mg to 15 mg flat dose due to higher-than-expected treatment discontinuation rate. After review of all Phase 1 and 31 Phase 2a participants, SRC changed 15 mg flat dose to Body Surface Area (BSA) based PEN-221 dose of 8.8 mg/m\^2 due to correlation between BSA and drug exposure (AUC) associated with higher rate of participant discontinuation.|
48663279|NCT02936323|101959587|FG009|STARTED|Phase 2a Dose Expansion||19|Initial Phase 2a PEN-221 start dose at Phase 1 MTD and RP2D of 18 mg flat dose. After review of 19 Phase 2a participants, SRC decreased start dose from 18 mg to 15 mg flat dose due to higher-than-expected treatment discontinuation rate. After review of all Phase 1 and 31 Phase 2a participants, SRC changed 15 mg flat dose to Body Surface Area (BSA) based PEN-221 dose of 8.8 mg/m\^2 due to correlation between BSA and drug exposure (AUC) associated with higher rate of participant discontinuation.|
48670216|NCT05281562|101974913|FG000|STARTED|Overall Study||1||
48670217|NCT05281562|101974914|FG001|STARTED|Overall Study||0||
48773035|NCT00829504|102232839|FG000|COMPLETED|First Intervention||21||
48773036|NCT00829504|102232840|FG001|COMPLETED|First Intervention||22||
48773037|NCT00829504|102232839|FG000|NOT COMPLETED|First Intervention||1||
48773038|NCT00829504|102232840|FG001|NOT COMPLETED|First Intervention||0||
48773039|NCT00829504|102232839|FG000|STARTED|Washout of 7 Days||21||
48773040|NCT00829504|102232840|FG001|STARTED|Washout of 7 Days||22||
48773041|NCT00829504|102232839|FG000|COMPLETED|Washout of 7 Days||20||
48773042|NCT00829504|102232840|FG001|COMPLETED|Washout of 7 Days||22||
48773043|NCT00829504|102232839|FG000|NOT COMPLETED|Washout of 7 Days||1||
48773044|NCT00829504|102232840|FG001|NOT COMPLETED|Washout of 7 Days||0||
48773045|NCT00829504|102232839|FG000|STARTED|Second Intervention||20||
48773046|NCT00829504|102232840|FG001|STARTED|Second Intervention||22||
48773047|NCT00829504|102232839|FG000|COMPLETED|Second Intervention||19||
48457397|NCT00140556|101457050|FG000|STARTED|Pre Radiation Period: Avastin / Tarceva||28||
48457398|NCT00140556|101457050|FG000|COMPLETED|Pre Radiation Period: Avastin / Tarceva||28||
48457399|NCT00140556|101457050|FG000|NOT COMPLETED|Pre Radiation Period: Avastin / Tarceva||0||
48457400|NCT00140556|101457050|FG000|STARTED|Chemoradiotherapy Period||28||
48773048|NCT00829504|102232840|FG001|COMPLETED|Second Intervention||22||
48773049|NCT00829504|102232839|FG000|NOT COMPLETED|Second Intervention||1||
48773050|NCT00829504|102232840|FG001|NOT COMPLETED|Second Intervention||0||
48773051|NCT01559857|102232841|FG000|STARTED|Overall Study||19||
48773052|NCT01559857|102232842|FG001|STARTED|Overall Study||18||
48773053|NCT01559857|102232841|FG000|COMPLETED|Overall Study||19||
48773054|NCT01559857|102232842|FG001|COMPLETED|Overall Study||18||
48773055|NCT01559857|102232841|FG000|NOT COMPLETED|Overall Study||0||
48773056|NCT01559857|102232842|FG001|NOT COMPLETED|Overall Study||0||
48773057|NCT03089281|102232843|FG000|STARTED|Overall Study||225||
48773058|NCT03089281|102232844|FG001|STARTED|Overall Study||215||
48773059|NCT03089281|102232843|FG000|COMPLETED|Overall Study||197||
48773060|NCT03089281|102232844|FG001|COMPLETED|Overall Study||198||
48773061|NCT03089281|102232843|FG000|NOT COMPLETED|Overall Study||28||
48773062|NCT03089281|102232844|FG001|NOT COMPLETED|Overall Study||17||
48773063|NCT02395471|102232845|FG000|STARTED|Overall Study||129||
48773064|NCT02395471|102232846|FG001|STARTED|Overall Study||62||
48773065|NCT02395471|102232845|FG000|COMPLETED|Overall Study||122||
48773066|NCT02395471|102232846|FG001|COMPLETED|Overall Study||59||
48773067|NCT02395471|102232845|FG000|NOT COMPLETED|Overall Study||7||
48773068|NCT02395471|102232846|FG001|NOT COMPLETED|Overall Study||3||
48773069|NCT02369796|102232847|FG000|STARTED|Overall Study||3||
48773070|NCT02369796|102232848|FG001|STARTED|Overall Study||3||
48773071|NCT02369796|102232849|FG002|STARTED|Overall Study||3||
48773072|NCT02369796|102232850|FG003|STARTED|Overall Study||3||
48773073|NCT02369796|102232851|FG004|STARTED|Overall Study||3||
48773074|NCT02369796|102232847|FG000|COMPLETED|Overall Study||3||
48773075|NCT02369796|102232848|FG001|COMPLETED|Overall Study||3||
48773076|NCT02369796|102232849|FG002|COMPLETED|Overall Study||3||
48773077|NCT02369796|102232850|FG003|COMPLETED|Overall Study||3||
48773078|NCT02369796|102232851|FG004|COMPLETED|Overall Study||3||
48773079|NCT02369796|102232847|FG000|NOT COMPLETED|Overall Study||0||
48773080|NCT02369796|102232848|FG001|NOT COMPLETED|Overall Study||0||
48773081|NCT02369796|102232849|FG002|NOT COMPLETED|Overall Study||0||
48773082|NCT02369796|102232850|FG003|NOT COMPLETED|Overall Study||0||
48773083|NCT02369796|102232851|FG004|NOT COMPLETED|Overall Study||0||
48773084|NCT00802945|102232852|FG000|STARTED|Overall Study||35||
48773085|NCT00802945|102232853|FG001|STARTED|Overall Study||35||
48773086|NCT00802945|102232852|FG000|COMPLETED|Overall Study||0||
48773087|NCT00802945|102232853|FG001|COMPLETED|Overall Study||0||
48773088|NCT00802945|102232852|FG000|NOT COMPLETED|Overall Study||35||
48773089|NCT00802945|102232853|FG001|NOT COMPLETED|Overall Study||35||
48773090|NCT01442103|102232854|FG000|STARTED|Overall Study||10||
48773091|NCT01442103|102232854|FG000|COMPLETED|Overall Study||8||
48773092|NCT01442103|102232854|FG000|NOT COMPLETED|Overall Study||2||
48773093|NCT02840461|102232855|FG000|STARTED|Overall Study||259||
48773094|NCT02840461|102232856|FG001|STARTED|Overall Study||257||
48773095|NCT02840461|102232857|FG002|STARTED|Overall Study||114||
48457401|NCT00140556|101457050|FG000|COMPLETED|Chemoradiotherapy Period||28||
48457402|NCT00140556|101457050|FG000|NOT COMPLETED|Chemoradiotherapy Period||0||
48457403|NCT01455545|101457051|FG000|STARTED|Overall Study||55||
48457404|NCT01455545|101457052|FG001|STARTED|Overall Study||45||
48457405|NCT01455545|101457051|FG000|COMPLETED|Overall Study||55||
48457406|NCT01455545|101457052|FG001|COMPLETED|Overall Study||45||
48457407|NCT01455545|101457051|FG000|NOT COMPLETED|Overall Study||0||
48457408|NCT01455545|101457052|FG001|NOT COMPLETED|Overall Study||0||
48457409|NCT03237611|101457053|FG000|STARTED|Overall Study||15||
48457410|NCT03237611|101457053|FG000|COMPLETED|Overall Study||13||
48457411|NCT03237611|101457053|FG000|NOT COMPLETED|Overall Study||2||
48457412|NCT01847196|101457054|FG000|STARTED|Overall Study||5||
48457413|NCT01847196|101457054|FG000|COMPLETED|Overall Study||5||
48457414|NCT01847196|101457054|FG000|NOT COMPLETED|Overall Study||0||
48457415|NCT02257632|101457055|FG000|STARTED|Overall Study||19|All randomized patients|
48457416|NCT02257632|101457056|FG001|STARTED|Overall Study||22|All randomized patients|
48457417|NCT02257632|101457055|FG000|Full Analysis Set (FAS)|Overall Study||19|all randomized patients who received study treatment and had ≥ 1 primary efficacy assessment|
48457418|NCT02257632|101457056|FG001|Full Analysis Set (FAS)|Overall Study||21|all randomized patients who received study treatment and had ≥ 1 primary efficacy assessment|
48457419|NCT02257632|101457055|FG000|Safety Set (SAF)|Overall Study||19|all patients who received study treatment and had ≥ 1 post-baseline safety assessment.|
48457420|NCT02257632|101457056|FG001|Safety Set (SAF)|Overall Study||21|all patients who received study treatment and had ≥ 1 post-baseline safety assessment.|
48457421|NCT02257632|101457055|FG000|Per-Protocol Set (PPS)|Overall Study||17|all patients in the FAS who did not have any major protocol deviations|
48457422|NCT02257632|101457056|FG001|Per-Protocol Set (PPS)|Overall Study||20|all patients in the FAS who did not have any major protocol deviations|
48457423|NCT02257632|101457055|FG000|COMPLETED|Overall Study||18||
48457424|NCT02257632|101457056|FG001|COMPLETED|Overall Study||19||
48457425|NCT02257632|101457055|FG000|NOT COMPLETED|Overall Study||1||
48457426|NCT02257632|101457056|FG001|NOT COMPLETED|Overall Study||3||
48773096|NCT02840461|102232855|FG000|COMPLETED|Overall Study||236||
48773097|NCT02840461|102232856|FG001|COMPLETED|Overall Study||235||
48773098|NCT02840461|102232857|FG002|COMPLETED|Overall Study||100||
48773099|NCT02840461|102232855|FG000|NOT COMPLETED|Overall Study||23||
48773100|NCT02840461|102232856|FG001|NOT COMPLETED|Overall Study||22||
48457427|NCT03196791|101457057|FG000|STARTED|Overall Study||98||
48457428|NCT03196791|101457058|FG001|STARTED|Overall Study||98||
48457429|NCT03196791|101457057|FG000|COMPLETED|Overall Study||88||
48457430|NCT03196791|101457058|FG001|COMPLETED|Overall Study||93||
48457431|NCT03196791|101457057|FG000|NOT COMPLETED|Overall Study||10||
48457432|NCT03196791|101457058|FG001|NOT COMPLETED|Overall Study||5||
48457433|NCT02622074|101457059|FG000|STARTED|Overall Study||10||
48457434|NCT02622074|101457060|FG001|STARTED|Overall Study||10||
48457435|NCT02622074|101457061|FG002|STARTED|Overall Study||10||
48457436|NCT02622074|101457062|FG003|STARTED|Overall Study||10||
48457437|NCT02622074|101457063|FG004|STARTED|Overall Study||10||
48457438|NCT02622074|101457064|FG005|STARTED|Overall Study||10||
48457439|NCT02622074|101457059|FG000|COMPLETED|Overall Study||6||
48457440|NCT02622074|101457060|FG001|COMPLETED|Overall Study||9||
48457441|NCT02622074|101457061|FG002|COMPLETED|Overall Study||10||
48457442|NCT02622074|101457062|FG003|COMPLETED|Overall Study||9||
48457443|NCT02622074|101457063|FG004|COMPLETED|Overall Study||9||
48457444|NCT02622074|101457064|FG005|COMPLETED|Overall Study||10||
48457445|NCT02622074|101457059|FG000|NOT COMPLETED|Overall Study||4||
48457446|NCT02622074|101457060|FG001|NOT COMPLETED|Overall Study||1||
48457447|NCT02622074|101457061|FG002|NOT COMPLETED|Overall Study||0||
48457448|NCT02622074|101457062|FG003|NOT COMPLETED|Overall Study||1||
48773101|NCT02840461|102232857|FG002|NOT COMPLETED|Overall Study||14||
48773102|NCT04085289|102232858|FG000|STARTED|Overall Study||6||
48773103|NCT04085289|102232859|FG001|STARTED|Overall Study||12||
48773104|NCT04085289|102232860|FG002|STARTED|Overall Study||12||
48773105|NCT04085289|102232858|FG000|Received at Least One Dose of Study Drug|Overall Study||6||
48773106|NCT04085289|102232859|FG001|Received at Least One Dose of Study Drug|Overall Study||12||
48773107|NCT04085289|102232860|FG002|Received at Least One Dose of Study Drug|Overall Study||12||
48773108|NCT04085289|102232858|FG000|COMPLETED|Overall Study||6||
48773109|NCT04085289|102232859|FG001|COMPLETED|Overall Study||12||
48773110|NCT04085289|102232860|FG002|COMPLETED|Overall Study||11||
48773111|NCT04085289|102232858|FG000|NOT COMPLETED|Overall Study||0||
48773112|NCT04085289|102232859|FG001|NOT COMPLETED|Overall Study||0||
48773113|NCT04085289|102232860|FG002|NOT COMPLETED|Overall Study||1||
48773114|NCT02675634|102232861|FG000|STARTED|Test Period 1||10||
48773115|NCT02675634|102232862|FG001|STARTED|Test Period 1||8||
48773116|NCT02675634|102232863|FG002|STARTED|Test Period 1||9||
48773117|NCT02675634|102232864|FG003|STARTED|Test Period 1||9||
48773118|NCT02675634|102232865|FG004|STARTED|Test Period 1||10||
48773119|NCT02675634|102232866|FG005|STARTED|Test Period 1||9||
48773120|NCT02675634|102232861|FG000|COMPLETED|Test Period 1||10||
48773121|NCT02675634|102232862|FG001|COMPLETED|Test Period 1||7||
48773122|NCT02675634|102232863|FG002|COMPLETED|Test Period 1||8||
48773123|NCT02675634|102232864|FG003|COMPLETED|Test Period 1||8||
48773124|NCT02675634|102232865|FG004|COMPLETED|Test Period 1||10||
48773125|NCT02675634|102232866|FG005|COMPLETED|Test Period 1||9||
48773126|NCT02675634|102232861|FG000|NOT COMPLETED|Test Period 1||0||
48773127|NCT02675634|102232862|FG001|NOT COMPLETED|Test Period 1||1||
48773128|NCT02675634|102232863|FG002|NOT COMPLETED|Test Period 1||1||
48773129|NCT02675634|102232864|FG003|NOT COMPLETED|Test Period 1||1||
48773130|NCT02675634|102232865|FG004|NOT COMPLETED|Test Period 1||0||
48773131|NCT02675634|102232866|FG005|NOT COMPLETED|Test Period 1||0||
48189606|NCT00662909|100786258|FG000|NOT COMPLETED|Overall Study||69||
48663280|NCT02936323|101959578|FG000|COMPLETED|Phase 2a Dose Expansion||0|Participants in the follow-up period of Phase 2a study as of data cut-off date 31 Jul 2020.|
48663281|NCT02936323|101959579|FG001|COMPLETED|Phase 2a Dose Expansion||0|Participants in the follow-up period of Phase 2a study as of data cut-off date 31 Jul 2020.|
48773132|NCT02675634|102232861|FG000|STARTED|Test Period 2||10||
48773133|NCT02675634|102232862|FG001|STARTED|Test Period 2||7||
48773134|NCT02675634|102232863|FG002|STARTED|Test Period 2||8||
48773135|NCT02675634|102232864|FG003|STARTED|Test Period 2||8||
48773136|NCT02675634|102232865|FG004|STARTED|Test Period 2||10||
48773137|NCT02675634|102232866|FG005|STARTED|Test Period 2||9||
48773138|NCT02675634|102232861|FG000|COMPLETED|Test Period 2||9||
48773139|NCT02675634|102232862|FG001|COMPLETED|Test Period 2||7||
48773140|NCT02675634|102232863|FG002|COMPLETED|Test Period 2||8||
48773141|NCT02675634|102232864|FG003|COMPLETED|Test Period 2||8||
48773142|NCT02675634|102232865|FG004|COMPLETED|Test Period 2||10||
48773143|NCT02675634|102232866|FG005|COMPLETED|Test Period 2||8||
48773144|NCT02675634|102232861|FG000|NOT COMPLETED|Test Period 2||1||
48773145|NCT02675634|102232862|FG001|NOT COMPLETED|Test Period 2||0||
48773146|NCT02675634|102232863|FG002|NOT COMPLETED|Test Period 2||0||
48773147|NCT02675634|102232864|FG003|NOT COMPLETED|Test Period 2||0||
48189607|NCT00662909|100786259|FG001|NOT COMPLETED|Overall Study||59||
48189608|NCT00662909|100786260|FG002|NOT COMPLETED|Overall Study||53||
48457449|NCT02622074|101457063|FG004|NOT COMPLETED|Overall Study||1||
48670218|NCT05281562|101974913|FG000|COMPLETED|Overall Study||0||
48773148|NCT02675634|102232865|FG004|NOT COMPLETED|Test Period 2||0||
48457450|NCT02622074|101457064|FG005|NOT COMPLETED|Overall Study||0||
48457451|NCT02732587|101457065|FG000|STARTED|Overall Study||5||
48457452|NCT02732587|101457065|FG000|COMPLETED|Overall Study||5||
48457453|NCT02732587|101457065|FG000|NOT COMPLETED|Overall Study||0||
48773149|NCT02675634|102232866|FG005|NOT COMPLETED|Test Period 2||1||
48773150|NCT02675634|102232861|FG000|STARTED|Test Period 3||9||
48457454|NCT03111147|101457066|FG000|STARTED|Overall Study||42||
48457455|NCT03111147|101457067|FG001|STARTED|Overall Study||43||
48457456|NCT03111147|101457066|FG000|COMPLETED|Overall Study||33||
48457457|NCT03111147|101457067|FG001|COMPLETED|Overall Study||33||
48457458|NCT03111147|101457066|FG000|NOT COMPLETED|Overall Study||9||
48457459|NCT03111147|101457067|FG001|NOT COMPLETED|Overall Study||10||
48457460|NCT01430182|101457068|FG000|STARTED|Overall Study||9||
48457461|NCT01430182|101457069|FG001|STARTED|Overall Study||8||
48457462|NCT01430182|101457068|FG000|COMPLETED|Overall Study||9||
48457463|NCT01430182|101457069|FG001|COMPLETED|Overall Study||8||
48457464|NCT01430182|101457068|FG000|NOT COMPLETED|Overall Study||0||
48457465|NCT01430182|101457069|FG001|NOT COMPLETED|Overall Study||0||
48457466|NCT01606137|101457070|FG000|STARTED|Overall Study||507||
48457467|NCT01606137|101457070|FG000|COMPLETED|Overall Study||245||
48457468|NCT01606137|101457070|FG000|NOT COMPLETED|Overall Study||262||
48457469|NCT01677910|101457071|FG000|STARTED|Double-Blind Treatment Period||45||
48457470|NCT01677910|101457072|FG001|STARTED|Double-Blind Treatment Period||45||
48457471|NCT01677910|101457073|FG002|STARTED|Double-Blind Treatment Period||45||
48457472|NCT01677910|101457074|FG003|STARTED|Double-Blind Treatment Period||0||
48457473|NCT01677910|101457071|FG000|COMPLETED|Double-Blind Treatment Period||38||
48457474|NCT01677910|101457072|FG001|COMPLETED|Double-Blind Treatment Period||42||
48457475|NCT01677910|101457073|FG002|COMPLETED|Double-Blind Treatment Period||38||
48457476|NCT01677910|101457074|FG003|COMPLETED|Double-Blind Treatment Period||0||
48457477|NCT01677910|101457071|FG000|NOT COMPLETED|Double-Blind Treatment Period||7||
48457478|NCT01677910|101457072|FG001|NOT COMPLETED|Double-Blind Treatment Period||3||
48457479|NCT01677910|101457073|FG002|NOT COMPLETED|Double-Blind Treatment Period||7||
48457480|NCT01677910|101457074|FG003|NOT COMPLETED|Double-Blind Treatment Period||0||
48457481|NCT01677910|101457071|FG000|STARTED|Open-Label Extension Period (OLE)||0||
48457482|NCT01677910|101457072|FG001|STARTED|Open-Label Extension Period (OLE)||0||
48457483|NCT01677910|101457073|FG002|STARTED|Open-Label Extension Period (OLE)||0||
48457484|NCT01677910|101457074|FG003|STARTED|Open-Label Extension Period (OLE)||115||
48457485|NCT01677910|101457071|FG000|COMPLETED|Open-Label Extension Period (OLE)||0||
48663282|NCT02936323|101959580|FG002|COMPLETED|Phase 2a Dose Expansion||0|Participants in the follow-up period of Phase 2a study as of data cut-off date 31 Jul 2020.|
48663283|NCT02936323|101959581|FG003|COMPLETED|Phase 2a Dose Expansion||0|Participants in the follow-up period of Phase 2a study as of data cut-off date 31 Jul 2020.|
48663284|NCT02936323|101959582|FG004|COMPLETED|Phase 2a Dose Expansion||0|Participants in the follow-up period of Phase 2a study as of data cut-off date 31 Jul 2020.|
48663285|NCT02936323|101959583|FG005|COMPLETED|Phase 2a Dose Expansion||0|Participants in the follow-up period of Phase 2a study as of data cut-off date 31 Jul 2020.|
48663286|NCT02936323|101959584|FG006|COMPLETED|Phase 2a Dose Expansion||0|Participants in the follow-up period of Phase 2a study as of data cut-off date 31 Jul 2020.|
48663287|NCT02936323|101959585|FG007|COMPLETED|Phase 2a Dose Expansion||15|Participants in the follow-up period of Phase 2a study as of data cut-off date 31 Jul 2020.|
48663288|NCT02936323|101959586|FG008|COMPLETED|Phase 2a Dose Expansion||2|Participants in the follow-up period of Phase 2a study as of data cut-off date 31 Jul 2020.|
48663289|NCT02936323|101959587|FG009|COMPLETED|Phase 2a Dose Expansion||5|Participants in the follow-up period of Phase 2a study as of data cut-off date 31 Jul 2020.|
48663290|NCT02936323|101959578|FG000|NOT COMPLETED|Phase 2a Dose Expansion||0||
48663291|NCT02936323|101959579|FG001|NOT COMPLETED|Phase 2a Dose Expansion||0||
48663292|NCT02936323|101959580|FG002|NOT COMPLETED|Phase 2a Dose Expansion||0||
48663293|NCT02936323|101959581|FG003|NOT COMPLETED|Phase 2a Dose Expansion||0||
48663294|NCT02936323|101959582|FG004|NOT COMPLETED|Phase 2a Dose Expansion||0||
48663295|NCT02936323|101959583|FG005|NOT COMPLETED|Phase 2a Dose Expansion||0||
48663296|NCT02936323|101959584|FG006|NOT COMPLETED|Phase 2a Dose Expansion||0||
48663297|NCT02936323|101959585|FG007|NOT COMPLETED|Phase 2a Dose Expansion||17||
48663298|NCT02936323|101959586|FG008|NOT COMPLETED|Phase 2a Dose Expansion||13||
48663299|NCT02936323|101959587|FG009|NOT COMPLETED|Phase 2a Dose Expansion||14||
48663300|NCT01817777|101959588|FG000|STARTED|Observational Phase (8 Weeks)||36||
48663301|NCT01817777|101959589|FG001|STARTED|Observational Phase (8 Weeks)||0||
48663302|NCT01817777|101959590|FG002|STARTED|Observational Phase (8 Weeks)||0||
48663303|NCT01817777|101959588|FG000|COMPLETED|Observational Phase (8 Weeks)||31||
48663304|NCT01817777|101959589|FG001|COMPLETED|Observational Phase (8 Weeks)||0||
48457486|NCT01677910|101457072|FG001|COMPLETED|Open-Label Extension Period (OLE)||0||
48457487|NCT01677910|101457073|FG002|COMPLETED|Open-Label Extension Period (OLE)||0||
48457488|NCT01677910|101457074|FG003|COMPLETED|Open-Label Extension Period (OLE)||79||
48457489|NCT01677910|101457071|FG000|NOT COMPLETED|Open-Label Extension Period (OLE)||0||
48457490|NCT01677910|101457072|FG001|NOT COMPLETED|Open-Label Extension Period (OLE)||0||
48457491|NCT01677910|101457073|FG002|NOT COMPLETED|Open-Label Extension Period (OLE)||0||
48457492|NCT01677910|101457074|FG003|NOT COMPLETED|Open-Label Extension Period (OLE)||36||
48457493|NCT04177810|101457075|FG000|STARTED|Overall Study||21|Started = enrolled and received at least one dose of study drug|
48457494|NCT04177810|101457075|FG000|COMPLETED|Overall Study||20||
48457495|NCT04177810|101457075|FG000|NOT COMPLETED|Overall Study||1||
48457496|NCT01875445|101457076|FG000|STARTED|Overall Study||19||
48457497|NCT01875445|101457077|FG001|STARTED|Overall Study||19||
48457498|NCT01875445|101457076|FG000|COMPLETED|Overall Study||12||
48457499|NCT01875445|101457077|FG001|COMPLETED|Overall Study||19||
48457500|NCT01875445|101457076|FG000|NOT COMPLETED|Overall Study||7||
48457501|NCT01875445|101457077|FG001|NOT COMPLETED|Overall Study||0||
48663305|NCT01817777|101959590|FG002|COMPLETED|Observational Phase (8 Weeks)||0||
48663306|NCT01817777|101959588|FG000|NOT COMPLETED|Observational Phase (8 Weeks)||5||
48663307|NCT01817777|101959589|FG001|NOT COMPLETED|Observational Phase (8 Weeks)||0||
48663308|NCT01817777|101959590|FG002|NOT COMPLETED|Observational Phase (8 Weeks)||0||
48663309|NCT01817777|101959588|FG000|STARTED|Interventional Phase (20 Weeks)||0||
48663310|NCT01817777|101959589|FG001|STARTED|Interventional Phase (20 Weeks)||16||
48663311|NCT01817777|101959590|FG002|STARTED|Interventional Phase (20 Weeks)||15||
48189609|NCT04011384|100786261|FG000|STARTED|Overall Study||111||
48369595|NCT03074162|101232820|FG005|COMPLETED|Period 1 Including Washout 1||8||
48663312|NCT01817777|101959588|FG000|COMPLETED|Interventional Phase (20 Weeks)||0||
48663313|NCT01817777|101959589|FG001|COMPLETED|Interventional Phase (20 Weeks)||11||
48663314|NCT01817777|101959590|FG002|COMPLETED|Interventional Phase (20 Weeks)||10||
48663315|NCT01817777|101959588|FG000|NOT COMPLETED|Interventional Phase (20 Weeks)||0||
48663316|NCT01817777|101959589|FG001|NOT COMPLETED|Interventional Phase (20 Weeks)||5||
48663317|NCT01817777|101959590|FG002|NOT COMPLETED|Interventional Phase (20 Weeks)||5||
48663318|NCT04526925|101959591|FG000|STARTED|First Intervention||4||
48663319|NCT04526925|101959592|FG001|STARTED|First Intervention||6||
48663320|NCT04526925|101959591|FG000|COMPLETED|First Intervention||4||
48773151|NCT02675634|102232862|FG001|STARTED|Test Period 3||7||
48773152|NCT02675634|102232863|FG002|STARTED|Test Period 3||8||
48773153|NCT02675634|102232864|FG003|STARTED|Test Period 3||8||
48773154|NCT02675634|102232865|FG004|STARTED|Test Period 3||10||
48773155|NCT02675634|102232866|FG005|STARTED|Test Period 3||8||
48773156|NCT02675634|102232861|FG000|COMPLETED|Test Period 3||9||
48773157|NCT02675634|102232862|FG001|COMPLETED|Test Period 3||7||
48773158|NCT02675634|102232863|FG002|COMPLETED|Test Period 3||8||
48773159|NCT02675634|102232864|FG003|COMPLETED|Test Period 3||8||
48773160|NCT02675634|102232865|FG004|COMPLETED|Test Period 3||10||
48773161|NCT02675634|102232866|FG005|COMPLETED|Test Period 3||8||
48773162|NCT02675634|102232861|FG000|NOT COMPLETED|Test Period 3||0||
48773163|NCT02675634|102232862|FG001|NOT COMPLETED|Test Period 3||0||
48773164|NCT02675634|102232863|FG002|NOT COMPLETED|Test Period 3||0||
48773165|NCT02675634|102232864|FG003|NOT COMPLETED|Test Period 3||0||
48773166|NCT02675634|102232865|FG004|NOT COMPLETED|Test Period 3||0||
48773167|NCT02675634|102232866|FG005|NOT COMPLETED|Test Period 3||0||
48773168|NCT00721968|102232867|FG000|STARTED|Overall Study||27||
48189610|NCT04011384|100786262|FG001|STARTED|Overall Study||124||
48369596|NCT03074162|101232815|FG000|NOT COMPLETED|Period 1 Including Washout 1||0||
48369597|NCT03074162|101232816|FG001|NOT COMPLETED|Period 1 Including Washout 1||0||
48369598|NCT03074162|101232817|FG002|NOT COMPLETED|Period 1 Including Washout 1||1||
48369599|NCT03074162|101232818|FG003|NOT COMPLETED|Period 1 Including Washout 1||0||
48369600|NCT03074162|101232819|FG004|NOT COMPLETED|Period 1 Including Washout 1||0||
48369601|NCT03074162|101232820|FG005|NOT COMPLETED|Period 1 Including Washout 1||0||
48369602|NCT03074162|101232815|FG000|STARTED|Period 2 Including Washout 2||8||
48369603|NCT03074162|101232816|FG001|STARTED|Period 2 Including Washout 2||8||
48369604|NCT03074162|101232817|FG002|STARTED|Period 2 Including Washout 2||7||
48369605|NCT03074162|101232818|FG003|STARTED|Period 2 Including Washout 2||8||
48369606|NCT03074162|101232819|FG004|STARTED|Period 2 Including Washout 2||8||
48369607|NCT03074162|101232820|FG005|STARTED|Period 2 Including Washout 2||8||
48369608|NCT03074162|101232815|FG000|COMPLETED|Period 2 Including Washout 2||8||
48369609|NCT03074162|101232816|FG001|COMPLETED|Period 2 Including Washout 2||8||
48369610|NCT03074162|101232817|FG002|COMPLETED|Period 2 Including Washout 2||6||
48369611|NCT03074162|101232818|FG003|COMPLETED|Period 2 Including Washout 2||8||
48369612|NCT03074162|101232819|FG004|COMPLETED|Period 2 Including Washout 2||8||
48369613|NCT03074162|101232820|FG005|COMPLETED|Period 2 Including Washout 2||7||
48369614|NCT03074162|101232815|FG000|NOT COMPLETED|Period 2 Including Washout 2||0||
48369615|NCT03074162|101232816|FG001|NOT COMPLETED|Period 2 Including Washout 2||0||
48369616|NCT03074162|101232817|FG002|NOT COMPLETED|Period 2 Including Washout 2||1||
48369617|NCT03074162|101232818|FG003|NOT COMPLETED|Period 2 Including Washout 2||0||
48369618|NCT03074162|101232819|FG004|NOT COMPLETED|Period 2 Including Washout 2||0||
48369619|NCT03074162|101232820|FG005|NOT COMPLETED|Period 2 Including Washout 2||1||
48369620|NCT03074162|101232815|FG000|STARTED|Period 3||8||
48369621|NCT03074162|101232816|FG001|STARTED|Period 3||8||
48369622|NCT03074162|101232817|FG002|STARTED|Period 3||6||
48369623|NCT03074162|101232818|FG003|STARTED|Period 3||8||
48369624|NCT03074162|101232819|FG004|STARTED|Period 3||8||
48369625|NCT03074162|101232820|FG005|STARTED|Period 3||7||
48663321|NCT04526925|101959592|FG001|COMPLETED|First Intervention||6||
48663322|NCT04526925|101959591|FG000|NOT COMPLETED|First Intervention||0||
48663323|NCT04526925|101959592|FG001|NOT COMPLETED|First Intervention||0||
48663324|NCT04526925|101959591|FG000|STARTED|Second Intervention||4||
48773169|NCT00721968|102232868|FG001|STARTED|Overall Study||17||
48773170|NCT00721968|102232867|FG000|COMPLETED|Overall Study||25||
48773171|NCT00721968|102232868|FG001|COMPLETED|Overall Study||17||
48369626|NCT03074162|101232815|FG000|COMPLETED|Period 3||7||
48369627|NCT03074162|101232816|FG001|COMPLETED|Period 3||8||
48369628|NCT03074162|101232817|FG002|COMPLETED|Period 3||6||
48369629|NCT03074162|101232818|FG003|COMPLETED|Period 3||8||
48663325|NCT04526925|101959592|FG001|STARTED|Second Intervention||6||
48189611|NCT04011384|100786261|FG000|COMPLETED|Overall Study||109||
48189612|NCT04011384|100786262|FG001|COMPLETED|Overall Study||124||
48457502|NCT02454972|101457078|FG000|STARTED|Overall Study||19||
48457503|NCT02454972|101457079|FG001|STARTED|Overall Study||19||
48457504|NCT02454972|101457080|FG002|STARTED|Overall Study||76||
48189613|NCT04011384|100786261|FG000|NOT COMPLETED|Overall Study||2||
48457505|NCT02454972|101457081|FG003|STARTED|Overall Study||29||
48457506|NCT02454972|101457082|FG004|STARTED|Overall Study||24||
48457507|NCT02454972|101457083|FG005|STARTED|Overall Study||15||
48663326|NCT04526925|101959591|FG000|COMPLETED|Second Intervention||4||
48663327|NCT04526925|101959592|FG001|COMPLETED|Second Intervention||6||
48663328|NCT04526925|101959591|FG000|NOT COMPLETED|Second Intervention||0||
48663329|NCT04526925|101959592|FG001|NOT COMPLETED|Second Intervention||0||
48663330|NCT03709472|101959593|FG000|STARTED|Baseline||84||
48663331|NCT03709472|101959594|FG001|STARTED|Baseline||84||
48663332|NCT03709472|101959593|FG000|Adolescent|Baseline||42||
48663333|NCT03709472|101959594|FG001|Adolescent|Baseline||42||
48663334|NCT03709472|101959593|FG000|Caregiver|Baseline||42||
48663335|NCT03709472|101959594|FG001|Caregiver|Baseline||42||
48663336|NCT03709472|101959593|FG000|COMPLETED|Baseline||84||
48663337|NCT03709472|101959594|FG001|COMPLETED|Baseline||84||
48663338|NCT03709472|101959593|FG000|NOT COMPLETED|Baseline||0||
48663339|NCT03709472|101959594|FG001|NOT COMPLETED|Baseline||0||
48663340|NCT03709472|101959593|FG000|STARTED|4 Month Assessment (Post Treatment)||84||
48663341|NCT03709472|101959594|FG001|STARTED|4 Month Assessment (Post Treatment)||84||
48457508|NCT02454972|101457084|FG006|STARTED|Overall Study||21||
48457509|NCT02454972|101457085|FG007|STARTED|Overall Study||32||
48457510|NCT02454972|101457086|FG008|STARTED|Overall Study||110||
48457511|NCT02454972|101457078|FG000|Treated|Overall Study||19||
48457512|NCT02454972|101457079|FG001|Treated|Overall Study||19||
48457513|NCT02454972|101457080|FG002|Treated|Overall Study||73||
48457514|NCT02454972|101457081|FG003|Treated|Overall Study||28||
48457515|NCT02454972|101457082|FG004|Treated|Overall Study||23||
48457516|NCT02454972|101457083|FG005|Treated|Overall Study||15||
48457517|NCT02454972|101457084|FG006|Treated|Overall Study||21||
48457518|NCT02454972|101457085|FG007|Treated|Overall Study||32||
48457519|NCT02454972|101457086|FG008|Treated|Overall Study||105||
48457520|NCT02454972|101457078|FG000|COMPLETED|Overall Study||0||
48457521|NCT02454972|101457079|FG001|COMPLETED|Overall Study||0||
48457522|NCT02454972|101457080|FG002|COMPLETED|Overall Study||0||
48457523|NCT02454972|101457081|FG003|COMPLETED|Overall Study||0||
48457524|NCT02454972|101457082|FG004|COMPLETED|Overall Study||0||
48457525|NCT02454972|101457083|FG005|COMPLETED|Overall Study||0||
48457526|NCT02454972|101457084|FG006|COMPLETED|Overall Study||0||
48457527|NCT02454972|101457085|FG007|COMPLETED|Overall Study||0||
48457528|NCT02454972|101457086|FG008|COMPLETED|Overall Study||0||
48457529|NCT02454972|101457078|FG000|NOT COMPLETED|Overall Study||19||
48457530|NCT02454972|101457079|FG001|NOT COMPLETED|Overall Study||19||
48457531|NCT02454972|101457080|FG002|NOT COMPLETED|Overall Study||76||
48457532|NCT02454972|101457081|FG003|NOT COMPLETED|Overall Study||29||
48457533|NCT02454972|101457082|FG004|NOT COMPLETED|Overall Study||24||
48457534|NCT02454972|101457083|FG005|NOT COMPLETED|Overall Study||15||
48457535|NCT02454972|101457084|FG006|NOT COMPLETED|Overall Study||21||
48457536|NCT02454972|101457085|FG007|NOT COMPLETED|Overall Study||32||
48457537|NCT02454972|101457086|FG008|NOT COMPLETED|Overall Study||110||
48457538|NCT00752856|101457087|FG000|STARTED|Overall Study||26||
48457539|NCT00752856|101457088|FG001|STARTED|Overall Study||25||
48457540|NCT00752856|101457087|FG000|COMPLETED|Overall Study||26||
48457541|NCT00752856|101457088|FG001|COMPLETED|Overall Study||24||
48457542|NCT00752856|101457087|FG000|NOT COMPLETED|Overall Study||0||
48457543|NCT00752856|101457088|FG001|NOT COMPLETED|Overall Study||1||
48457544|NCT01402115|101457089|FG000|STARTED|Overall Study||30||
48457545|NCT01402115|101457090|FG001|STARTED|Overall Study||30||
48457546|NCT01402115|101457089|FG000|COMPLETED|Overall Study||29||
48457547|NCT01402115|101457090|FG001|COMPLETED|Overall Study||29||
48457548|NCT01402115|101457089|FG000|NOT COMPLETED|Overall Study||1||
48457549|NCT01402115|101457090|FG001|NOT COMPLETED|Overall Study||1||
48457550|NCT03763331|101457091|FG000|STARTED|Overall Study||16||
48457551|NCT03763331|101457092|FG001|STARTED|Overall Study||18||
48457552|NCT03763331|101457091|FG000|COMPLETED|Overall Study||14||
48457553|NCT03763331|101457092|FG001|COMPLETED|Overall Study||15||
48457554|NCT03763331|101457091|FG000|NOT COMPLETED|Overall Study||2||
48663342|NCT03709472|101959593|FG000|Adolescent|4 Month Assessment (Post Treatment)||38||
48663343|NCT03709472|101959594|FG001|Adolescent|4 Month Assessment (Post Treatment)||27||
48663344|NCT03709472|101959593|FG000|Caregiver|4 Month Assessment (Post Treatment)||38||
48663345|NCT03709472|101959594|FG001|Caregiver|4 Month Assessment (Post Treatment)||27||
48670219|NCT05281562|101974914|FG001|COMPLETED|Overall Study||0||
48457555|NCT03763331|101457092|FG001|NOT COMPLETED|Overall Study||3||
48457556|NCT02123459|101457093|FG000|STARTED|Period 1 (7 Days)||14||
48457557|NCT02123459|101457094|FG001|STARTED|Period 1 (7 Days)||14||
48457558|NCT02123459|101457093|FG000|COMPLETED|Period 1 (7 Days)||14||
48457559|NCT02123459|101457094|FG001|COMPLETED|Period 1 (7 Days)||14||
48457560|NCT02123459|101457093|FG000|NOT COMPLETED|Period 1 (7 Days)||0||
48457561|NCT02123459|101457094|FG001|NOT COMPLETED|Period 1 (7 Days)||0||
48457562|NCT02123459|101457093|FG000|STARTED|Washout Period (1 Day)||14||
48663346|NCT03709472|101959593|FG000|COMPLETED|4 Month Assessment (Post Treatment)||76||
48663347|NCT03709472|101959594|FG001|COMPLETED|4 Month Assessment (Post Treatment)||54||
48663348|NCT03709472|101959593|FG000|NOT COMPLETED|4 Month Assessment (Post Treatment)||8||
48663349|NCT03709472|101959594|FG001|NOT COMPLETED|4 Month Assessment (Post Treatment)||30||
48663350|NCT03709472|101959593|FG000|STARTED|Assessment (12-month Post Baseline)||84|For each assessment time point, the 4-month post treatment assessment and the 12-month assessment, all participants were invited to complete the assessment even if they did not complete the previous time period. For this reason, the number of participants at the start of each arm is 84.|
48663351|NCT03709472|101959594|FG001|STARTED|Assessment (12-month Post Baseline)||84|For each assessment time point, the 4-month post treatment assessment and the 12-month assessment, all participants were invited to complete the assessment even if they did not complete the previous time period. For this reason, the number of participants at the start of each arm is 84.|
48663352|NCT03709472|101959593|FG000|Adolescent|Assessment (12-month Post Baseline)||36||
48663353|NCT03709472|101959594|FG001|Adolescent|Assessment (12-month Post Baseline)||19||
48663354|NCT03709472|101959593|FG000|Caregiver|Assessment (12-month Post Baseline)||36||
48773172|NCT00721968|102232867|FG000|NOT COMPLETED|Overall Study||2||
48773173|NCT00721968|102232868|FG001|NOT COMPLETED|Overall Study||0||
48773174|NCT01012440|102232869|FG000|STARTED|Overall Study||5||
48773175|NCT01012440|102232869|FG000|COMPLETED|Overall Study||3||
48773176|NCT01012440|102232869|FG000|NOT COMPLETED|Overall Study||2||
48773177|NCT02379091|102232870|FG000|STARTED|Overall Study||27||
48773178|NCT02379091|102232871|FG001|STARTED|Overall Study||28||
48773179|NCT02379091|102232872|FG002|STARTED|Overall Study||25||
48773180|NCT02379091|102232873|FG003|STARTED|Overall Study||28||
48773181|NCT02379091|102232870|FG000|Full Analysis Set|Overall Study||26||
48773182|NCT02379091|102232871|FG001|Full Analysis Set|Overall Study||28||
48773183|NCT02379091|102232872|FG002|Full Analysis Set|Overall Study||24||
48773184|NCT02379091|102232873|FG003|Full Analysis Set|Overall Study||28||
48773185|NCT02379091|102232870|FG000|COMPLETED|Overall Study||15||
48773186|NCT02379091|102232871|FG001|COMPLETED|Overall Study||18||
48773187|NCT02379091|102232872|FG002|COMPLETED|Overall Study||18||
48773188|NCT02379091|102232873|FG003|COMPLETED|Overall Study||14||
48773189|NCT02379091|102232870|FG000|NOT COMPLETED|Overall Study||12||
48773190|NCT02379091|102232871|FG001|NOT COMPLETED|Overall Study||10||
48773191|NCT02379091|102232872|FG002|NOT COMPLETED|Overall Study||7||
48773192|NCT02379091|102232873|FG003|NOT COMPLETED|Overall Study||14||
48773193|NCT02302339|102232874|FG000|STARTED|Overall Study||62||
48773194|NCT02302339|102232875|FG001|STARTED|Overall Study||34||
48773195|NCT02302339|102232876|FG002|STARTED|Overall Study||29||
48773196|NCT02302339|102232877|FG003|STARTED|Overall Study||7||
48773197|NCT02302339|102232874|FG000|COMPLETED|Overall Study||61||
48773198|NCT02302339|102232875|FG001|COMPLETED|Overall Study||32||
48773199|NCT02302339|102232876|FG002|COMPLETED|Overall Study||28||
48773200|NCT02302339|102232877|FG003|COMPLETED|Overall Study||7||
48773201|NCT02302339|102232874|FG000|NOT COMPLETED|Overall Study||1||
48773202|NCT02302339|102232875|FG001|NOT COMPLETED|Overall Study||2||
48773203|NCT02302339|102232876|FG002|NOT COMPLETED|Overall Study||1||
48773204|NCT02302339|102232877|FG003|NOT COMPLETED|Overall Study||0||
48773205|NCT03060096|102232878|FG000|STARTED|Overall Study||19||
48773206|NCT03060096|102232879|FG001|STARTED|Overall Study||15||
48773207|NCT03060096|102232880|FG002|STARTED|Overall Study||34||
48773208|NCT03060096|102232878|FG000|COMPLETED|Overall Study||16||
48773209|NCT03060096|102232879|FG001|COMPLETED|Overall Study||12||
48773210|NCT03060096|102232880|FG002|COMPLETED|Overall Study||32||
48773211|NCT03060096|102232878|FG000|NOT COMPLETED|Overall Study||3||
48773212|NCT03060096|102232879|FG001|NOT COMPLETED|Overall Study||3||
48773213|NCT03060096|102232880|FG002|NOT COMPLETED|Overall Study||2||
48773214|NCT02282514|102232881|FG000|STARTED|Overall Study||23||
48773215|NCT02282514|102232881|FG000|COMPLETED|Overall Study||23|Conditioning Regimen|
48457563|NCT02123459|101457094|FG001|STARTED|Washout Period (1 Day)||14||
48457564|NCT02123459|101457093|FG000|COMPLETED|Washout Period (1 Day)||13||
48457565|NCT02123459|101457094|FG001|COMPLETED|Washout Period (1 Day)||14||
48457566|NCT02123459|101457093|FG000|NOT COMPLETED|Washout Period (1 Day)||1||
48457567|NCT02123459|101457094|FG001|NOT COMPLETED|Washout Period (1 Day)||0||
48457568|NCT02123459|101457093|FG000|STARTED|Period 2 (7 Days)||13||
48457569|NCT02123459|101457094|FG001|STARTED|Period 2 (7 Days)||14||
48457570|NCT02123459|101457093|FG000|COMPLETED|Period 2 (7 Days)||13||
48457571|NCT02123459|101457094|FG001|COMPLETED|Period 2 (7 Days)||14||
48457572|NCT02123459|101457093|FG000|NOT COMPLETED|Period 2 (7 Days)||0||
48457573|NCT02123459|101457094|FG001|NOT COMPLETED|Period 2 (7 Days)||0||
48457574|NCT01025193|101457095|FG000|STARTED|Overall Study||8||
48457575|NCT01025193|101457095|FG000|COMPLETED|Overall Study||4||
48457576|NCT01025193|101457095|FG000|NOT COMPLETED|Overall Study||4||
48457577|NCT00003102|101457096|FG000|STARTED|Overall Study||3||
48457578|NCT00003102|101457097|FG001|STARTED|Overall Study||9||
48457579|NCT00003102|101457098|FG002|STARTED|Overall Study||3||
48773216|NCT02282514|102232881|FG000|NOT COMPLETED|Overall Study||0||
48457580|NCT00003102|101457096|FG000|COMPLETED|Overall Study||2||
48457581|NCT00003102|101457097|FG001|COMPLETED|Overall Study||6||
48457582|NCT00003102|101457098|FG002|COMPLETED|Overall Study||1||
48457583|NCT00003102|101457096|FG000|NOT COMPLETED|Overall Study||1||
48457584|NCT00003102|101457097|FG001|NOT COMPLETED|Overall Study||3||
48457585|NCT00003102|101457098|FG002|NOT COMPLETED|Overall Study||2||
48457586|NCT03521999|101457099|FG000|STARTED|Completed 1 Month Up||165||
48457587|NCT03521999|101457100|FG001|STARTED|Completed 1 Month Up||165||
48457588|NCT03521999|101457099|FG000|COMPLETED|Completed 1 Month Up||106||
48457589|NCT03521999|101457100|FG001|COMPLETED|Completed 1 Month Up||107||
48457590|NCT03521999|101457099|FG000|NOT COMPLETED|Completed 1 Month Up||59||
48457591|NCT03521999|101457100|FG001|NOT COMPLETED|Completed 1 Month Up||58||
48457592|NCT03521999|101457099|FG000|STARTED|Completed 3 Month Follow up||165||
48457593|NCT03521999|101457100|FG001|STARTED|Completed 3 Month Follow up||165||
48457594|NCT03521999|101457099|FG000|COMPLETED|Completed 3 Month Follow up||101||
48457595|NCT03521999|101457100|FG001|COMPLETED|Completed 3 Month Follow up||105||
48457596|NCT03521999|101457099|FG000|NOT COMPLETED|Completed 3 Month Follow up||64||
48457597|NCT03521999|101457100|FG001|NOT COMPLETED|Completed 3 Month Follow up||60||
48457598|NCT03521999|101457099|FG000|STARTED|Completed 6 Month Follow||165||
48457599|NCT03521999|101457100|FG001|STARTED|Completed 6 Month Follow||164||
48457600|NCT03521999|101457099|FG000|COMPLETED|Completed 6 Month Follow||99||
48457601|NCT03521999|101457100|FG001|COMPLETED|Completed 6 Month Follow||94||
48457602|NCT03521999|101457099|FG000|NOT COMPLETED|Completed 6 Month Follow||66||
48457603|NCT03521999|101457100|FG001|NOT COMPLETED|Completed 6 Month Follow||70||
48457604|NCT01223196|101457101|FG000|STARTED|Overall Study||13||
48457605|NCT01223196|101457102|FG001|STARTED|Overall Study||11||
48457606|NCT01223196|101457101|FG000|COMPLETED|Overall Study||9||
48457607|NCT01223196|101457102|FG001|COMPLETED|Overall Study||11||
48457608|NCT01223196|101457101|FG000|NOT COMPLETED|Overall Study||4||
48457609|NCT01223196|101457102|FG001|NOT COMPLETED|Overall Study||0||
48457610|NCT01577537|101457103|FG000|STARTED|Overall Study||128||
48457611|NCT01577537|101457104|FG001|STARTED|Overall Study||123||
48457612|NCT01577537|101457103|FG000|COMPLETED|Overall Study||120||
48457613|NCT01577537|101457104|FG001|COMPLETED|Overall Study||116||
48457614|NCT01577537|101457103|FG000|NOT COMPLETED|Overall Study||8||
48457615|NCT01577537|101457104|FG001|NOT COMPLETED|Overall Study||7||
48457616|NCT00583596|101457105|FG000|STARTED|Overall Study||436||
48457617|NCT00583596|101457105|FG000|COMPLETED|Overall Study||152||
48457618|NCT00583596|101457105|FG000|NOT COMPLETED|Overall Study||284||
48663355|NCT03709472|101959594|FG001|Caregiver|Assessment (12-month Post Baseline)||19||
48663356|NCT03709472|101959593|FG000|COMPLETED|Assessment (12-month Post Baseline)||72||
48663357|NCT03709472|101959594|FG001|COMPLETED|Assessment (12-month Post Baseline)||38||
48189614|NCT04011384|100786262|FG001|NOT COMPLETED|Overall Study||0||
48189615|NCT03888365|100786263|FG000|STARTED|Cohort A Peak Level/Cohort B Period 1||20|All Participants: Participants who consented to the study protocol.|
48189616|NCT03888365|100786264|FG001|STARTED|Cohort A Peak Level/Cohort B Period 1||23|All Participants: Participants who consented to the study protocol.|
48369630|NCT03074162|101232819|FG004|COMPLETED|Period 3||7||
48457619|NCT03821324|101457106|FG000|STARTED|6 Weeks After Treatment||14||28
48457620|NCT03821324|101457106|FG000|COMPLETED|6 Weeks After Treatment||9||18
48457621|NCT03821324|101457106|FG000|NOT COMPLETED|6 Weeks After Treatment||5||10
48457622|NCT03821324|101457106|FG000|STARTED|12 Weeks After Treatment||9||18
48457623|NCT03821324|101457106|FG000|COMPLETED|12 Weeks After Treatment||9||18
48457624|NCT03821324|101457106|FG000|NOT COMPLETED|12 Weeks After Treatment||0||0
48457625|NCT00373685|101457107|FG000|STARTED|Overall Study||4035||
48457626|NCT00373685|101457108|FG001|STARTED|Overall Study||4032||
48457627|NCT00373685|101457107|FG000|Treated|Overall Study||3984||
48457628|NCT00373685|101457108|FG001|Treated|Overall Study||3955||
48457629|NCT00373685|101457107|FG000|COMPLETED|Overall Study||2596||
48457630|NCT00373685|101457108|FG001|COMPLETED|Overall Study||2611||
48457631|NCT00373685|101457107|FG000|NOT COMPLETED|Overall Study||1439||
48457632|NCT00373685|101457108|FG001|NOT COMPLETED|Overall Study||1421||
48457633|NCT03840811|101457109|FG000|STARTED|Overall Study||9||
48457634|NCT03840811|101457110|FG001|STARTED|Overall Study||6||
48457635|NCT03840811|101457111|FG002|STARTED|Overall Study||12||
48457636|NCT03840811|101457109|FG000|COMPLETED|Overall Study||9||
48457637|NCT03840811|101457110|FG001|COMPLETED|Overall Study||6||
48663358|NCT03709472|101959593|FG000|NOT COMPLETED|Assessment (12-month Post Baseline)||12||
48663359|NCT03709472|101959594|FG001|NOT COMPLETED|Assessment (12-month Post Baseline)||46||
48457638|NCT03840811|101457111|FG002|COMPLETED|Overall Study||11||
48457639|NCT03840811|101457109|FG000|NOT COMPLETED|Overall Study||0||
48457640|NCT03840811|101457110|FG001|NOT COMPLETED|Overall Study||0||
48457641|NCT03840811|101457111|FG002|NOT COMPLETED|Overall Study||1||
48457642|NCT01806597|101457112|FG000|STARTED|Period 1 (Baseline to Week 16)||68||
48457643|NCT01806597|101457113|FG001|STARTED|Period 1 (Baseline to Week 16)||69||
48457644|NCT01806597|101457114|FG002|STARTED|Period 1 (Baseline to Week 16)||0||
48457645|NCT01806597|101457115|FG003|STARTED|Period 1 (Baseline to Week 16)||0||
48457646|NCT01806597|101457116|FG004|STARTED|Period 1 (Baseline to Week 16)||68||
48457647|NCT01806597|101457117|FG005|STARTED|Period 1 (Baseline to Week 16)||0||
48457648|NCT01806597|101457112|FG000|COMPLETED|Period 1 (Baseline to Week 16)||63||
48457649|NCT01806597|101457113|FG001|COMPLETED|Period 1 (Baseline to Week 16)||64||
48457650|NCT01806597|101457114|FG002|COMPLETED|Period 1 (Baseline to Week 16)||0||
48457651|NCT01806597|101457115|FG003|COMPLETED|Period 1 (Baseline to Week 16)||0||
48457652|NCT01806597|101457116|FG004|COMPLETED|Period 1 (Baseline to Week 16)||63||
48457653|NCT01806597|101457117|FG005|COMPLETED|Period 1 (Baseline to Week 16)||0||
48457654|NCT01806597|101457112|FG000|NOT COMPLETED|Period 1 (Baseline to Week 16)||5||
48457655|NCT01806597|101457113|FG001|NOT COMPLETED|Period 1 (Baseline to Week 16)||5||
48457656|NCT01806597|101457114|FG002|NOT COMPLETED|Period 1 (Baseline to Week 16)||0||
48457657|NCT01806597|101457115|FG003|NOT COMPLETED|Period 1 (Baseline to Week 16)||0||
48457658|NCT01806597|101457116|FG004|NOT COMPLETED|Period 1 (Baseline to Week 16)||5||
48457659|NCT01806597|101457117|FG005|NOT COMPLETED|Period 1 (Baseline to Week 16)||0||
48457660|NCT01806597|101457112|FG000|STARTED|Treatment Period 2 (Week 16 to Week 132)||63||
48457661|NCT01806597|101457113|FG001|STARTED|Treatment Period 2 (Week 16 to Week 132)||64||
48457662|NCT01806597|101457114|FG002|STARTED|Treatment Period 2 (Week 16 to Week 132)||31||
48457663|NCT01806597|101457115|FG003|STARTED|Treatment Period 2 (Week 16 to Week 132)||31||
48457664|NCT01806597|101457116|FG004|STARTED|Treatment Period 2 (Week 16 to Week 132)||1||
48457665|NCT01806597|101457117|FG005|STARTED|Treatment Period 2 (Week 16 to Week 132)||0||
48457666|NCT01806597|101457112|FG000|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||24||
48457667|NCT01806597|101457113|FG001|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||44||
48457668|NCT01806597|101457114|FG002|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||17||
48457669|NCT01806597|101457115|FG003|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20||
48457670|NCT01806597|101457116|FG004|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0||
48457671|NCT01806597|101457117|FG005|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0||
48457672|NCT01806597|101457112|FG000|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||39||
48457673|NCT01806597|101457113|FG001|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20||
48457674|NCT01806597|101457114|FG002|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||14||
48457675|NCT01806597|101457115|FG003|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||11||
48457676|NCT01806597|101457116|FG004|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||1||
48457677|NCT01806597|101457117|FG005|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0||
48457678|NCT01806597|101457112|FG000|STARTED|Follow-up Period (Week 132 to Week 140)||0||
48457679|NCT01806597|101457113|FG001|STARTED|Follow-up Period (Week 132 to Week 140)||0||
48457680|NCT01806597|101457114|FG002|STARTED|Follow-up Period (Week 132 to Week 140)||0||
48457681|NCT01806597|101457115|FG003|STARTED|Follow-up Period (Week 132 to Week 140)||0||
48457682|NCT01806597|101457116|FG004|STARTED|Follow-up Period (Week 132 to Week 140)||3||
48457683|NCT01806597|101457117|FG005|STARTED|Follow-up Period (Week 132 to Week 140)||161||
48457684|NCT01806597|101457112|FG000|COMPLETED|Follow-up Period (Week 132 to Week 140)||0||
48457685|NCT01806597|101457113|FG001|COMPLETED|Follow-up Period (Week 132 to Week 140)||0||
48457686|NCT01806597|101457114|FG002|COMPLETED|Follow-up Period (Week 132 to Week 140)||0||
48457687|NCT01806597|101457115|FG003|COMPLETED|Follow-up Period (Week 132 to Week 140)||0||
48457688|NCT01806597|101457116|FG004|COMPLETED|Follow-up Period (Week 132 to Week 140)||3||
48457689|NCT01806597|101457117|FG005|COMPLETED|Follow-up Period (Week 132 to Week 140)||149||
48457690|NCT01806597|101457112|FG000|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0||
48457691|NCT01806597|101457113|FG001|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0||
48457692|NCT01806597|101457114|FG002|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0||
48457693|NCT01806597|101457115|FG003|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0||
48457694|NCT01806597|101457116|FG004|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0||
48457695|NCT01806597|101457117|FG005|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||12||
48457696|NCT02499354|101457118|FG000|STARTED|Overall Study||46||
48457697|NCT02499354|101457119|FG001|STARTED|Overall Study||47||
48457698|NCT02499354|101457118|FG000|COMPLETED|Overall Study||45||
48457699|NCT02499354|101457119|FG001|COMPLETED|Overall Study||47||
48457700|NCT02499354|101457118|FG000|NOT COMPLETED|Overall Study||1||
48457701|NCT02499354|101457119|FG001|NOT COMPLETED|Overall Study||0||
48457702|NCT02159859|101457120|FG000|STARTED|Overall Study||7||
48457703|NCT02159859|101457120|FG000|COMPLETED|Overall Study||7||
48457704|NCT02159859|101457120|FG000|NOT COMPLETED|Overall Study||0||
48457705|NCT04274192|101457121|FG000|STARTED|Overall Study||1||
48457706|NCT04274192|101457122|FG001|STARTED|Overall Study||0||
48457707|NCT04274192|101457121|FG000|COMPLETED|Overall Study||0|"Using the equipment available, we were unable to administer the 6 LPM (per the protocol), so this subject did not receive all of the interventions and therefore did not complete the study.~We subsequently terminated the study due to lack of protocol feasibility and the departure of the original PI."|
48457708|NCT04274192|101457122|FG001|COMPLETED|Overall Study||0|"Using the equipment available, we were unable to administer the 6 LPM (per the protocol), so this subject did not receive all of the interventions and therefore did not complete the study.~We subsequently terminated the study due to lack of protocol feasibility and the departure of the original PI."|
48457709|NCT04274192|101457121|FG000|NOT COMPLETED|Overall Study||1||
48663360|NCT04642976|101959595|FG000|STARTED|Overall Study||30||
48663361|NCT04642976|101959595|FG000|COMPLETED|Overall Study||30||
48663362|NCT04642976|101959595|FG000|NOT COMPLETED|Overall Study||0||
48663363|NCT04857281|101959596|FG000|STARTED|Baseline||49||
48663364|NCT04857281|101959596|FG000|COMPLETED|Baseline||41||
48663365|NCT04857281|101959596|FG000|NOT COMPLETED|Baseline||8||
48773217|NCT01550224|102232882|FG000|STARTED|Overall Study||3||
48773218|NCT01550224|102232883|FG001|STARTED|Overall Study||20||
48457710|NCT04274192|101457122|FG001|NOT COMPLETED|Overall Study||0||
48457711|NCT00950833|101457123|FG000|STARTED|Overall Study||112||
48457712|NCT00950833|101457124|FG001|STARTED|Overall Study||108||
48457713|NCT00950833|101457125|FG002|STARTED|Overall Study||223||
48457714|NCT00950833|101457123|FG000|COMPLETED|Overall Study||112||
48457715|NCT00950833|101457124|FG001|COMPLETED|Overall Study||108||
48663366|NCT04857281|101959596|FG000|STARTED|First Intervention - 4 Weeks||41||
48663367|NCT04857281|101959596|FG000|COMPLETED|First Intervention - 4 Weeks||41||
48663368|NCT04857281|101959596|FG000|NOT COMPLETED|First Intervention - 4 Weeks||0||
48663369|NCT04857281|101959596|FG000|STARTED|First Washout - 2 Weeks||41||
48663370|NCT04857281|101959596|FG000|COMPLETED|First Washout - 2 Weeks||41||
48663371|NCT04857281|101959596|FG000|NOT COMPLETED|First Washout - 2 Weeks||0||
48663372|NCT04857281|101959596|FG000|STARTED|Second Intervention - 4 Weeks||41||
48663373|NCT04857281|101959596|FG000|COMPLETED|Second Intervention - 4 Weeks||41||
48663374|NCT04857281|101959596|FG000|NOT COMPLETED|Second Intervention - 4 Weeks||0||
48663375|NCT04857281|101959596|FG000|STARTED|Second Washout - 2 Weeks||41||
48663376|NCT04857281|101959596|FG000|COMPLETED|Second Washout - 2 Weeks||41||
48189617|NCT03888365|100786263|FG000|Safety Population|Cohort A Peak Level/Cohort B Period 1||20|All participants who initiated an ISWT at Screening.|
48369631|NCT03074162|101232820|FG005|COMPLETED|Period 3||7||
48663377|NCT04857281|101959596|FG000|NOT COMPLETED|Second Washout - 2 Weeks||0||
48663378|NCT00721110|101959597|FG000|STARTED|Overall Study||16||
48663379|NCT00721110|101959598|FG001|STARTED|Overall Study||16||
48663380|NCT00721110|101959599|FG002|STARTED|Overall Study||16||
48663381|NCT00721110|101959600|FG003|STARTED|Overall Study||16||
48663382|NCT00721110|101959597|FG000|COMPLETED|Overall Study||15||
48663383|NCT00721110|101959598|FG001|COMPLETED|Overall Study||16||
48663384|NCT00721110|101959599|FG002|COMPLETED|Overall Study||15||
48663385|NCT00721110|101959600|FG003|COMPLETED|Overall Study||16||
48663386|NCT00721110|101959597|FG000|NOT COMPLETED|Overall Study||1||
48663387|NCT00721110|101959598|FG001|NOT COMPLETED|Overall Study||0||
48663388|NCT00721110|101959599|FG002|NOT COMPLETED|Overall Study||1||
48663389|NCT00721110|101959600|FG003|NOT COMPLETED|Overall Study||0||
48663390|NCT02960893|101959601|FG000|STARTED|Randomization Phase (8-week)||71||
48663391|NCT02960893|101959602|FG001|STARTED|Randomization Phase (8-week)||70||
48663392|NCT02960893|101959601|FG000|COMPLETED|Randomization Phase (8-week)||64|Completed the Randomization Phase|
48663393|NCT02960893|101959602|FG001|COMPLETED|Randomization Phase (8-week)||68|Completed the Randomization Phase|
48663394|NCT02960893|101959601|FG000|NOT COMPLETED|Randomization Phase (8-week)||7||
48663395|NCT02960893|101959602|FG001|NOT COMPLETED|Randomization Phase (8-week)||2||
48663396|NCT02960893|101959601|FG000|STARTED|Extension Phase (48-week)||64||
48663397|NCT02960893|101959602|FG001|STARTED|Extension Phase (48-week)||67||
48663398|NCT02960893|101959601|FG000|COMPLETED|Extension Phase (48-week)||50|Completed the 48-week Extension Phase|
48663399|NCT02960893|101959602|FG001|COMPLETED|Extension Phase (48-week)||54|Completed the 48-week Extension Phase|
48663400|NCT02960893|101959601|FG000|NOT COMPLETED|Extension Phase (48-week)||14||
48663401|NCT02960893|101959602|FG001|NOT COMPLETED|Extension Phase (48-week)||13||
48663402|NCT03439072|101959603|FG000|STARTED|Overall Study||41||
48663403|NCT03439072|101959604|FG001|STARTED|Overall Study||40||
48663404|NCT03439072|101959603|FG000|COMPLETED|Overall Study||39||
48663405|NCT03439072|101959604|FG001|COMPLETED|Overall Study||36||
48663406|NCT03439072|101959603|FG000|NOT COMPLETED|Overall Study||2||
48663407|NCT03439072|101959604|FG001|NOT COMPLETED|Overall Study||4||
48663408|NCT03863574|101959605|FG000|STARTED|Overall Study||6||
48663409|NCT03863574|101959606|FG001|STARTED|Overall Study||7||
48663410|NCT03863574|101959607|FG002|STARTED|Overall Study||3||
48663411|NCT03863574|101959605|FG000|COMPLETED|Overall Study||6||
48663412|NCT03863574|101959606|FG001|COMPLETED|Overall Study||7||
48663413|NCT03863574|101959607|FG002|COMPLETED|Overall Study||3||
48663414|NCT03863574|101959605|FG000|NOT COMPLETED|Overall Study||0||
48663415|NCT03863574|101959606|FG001|NOT COMPLETED|Overall Study||0||
48773219|NCT01550224|102232882|FG000|COMPLETED|Overall Study||3||
48773220|NCT01550224|102232883|FG001|COMPLETED|Overall Study||20||
48773221|NCT01550224|102232882|FG000|NOT COMPLETED|Overall Study||0||
48773222|NCT01550224|102232883|FG001|NOT COMPLETED|Overall Study||0||
48773223|NCT00060840|102232884|FG000|STARTED|Overall Study||73||
48773224|NCT00060840|102232885|FG001|STARTED|Overall Study||77||
48773225|NCT00060840|102232884|FG000|COMPLETED|Overall Study||69||
48773226|NCT00060840|102232885|FG001|COMPLETED|Overall Study||68||
48773227|NCT00060840|102232884|FG000|NOT COMPLETED|Overall Study||4||
48773228|NCT00060840|102232885|FG001|NOT COMPLETED|Overall Study||9||
48773229|NCT01695304|102232886|FG000|STARTED|Overall Study||120||
48773230|NCT01695304|102232887|FG001|STARTED|Overall Study||120||
48773231|NCT01695304|102232886|FG000|COMPLETED|Overall Study||120||
48773232|NCT01695304|102232887|FG001|COMPLETED|Overall Study||120||
48773233|NCT01695304|102232886|FG000|NOT COMPLETED|Overall Study||0||
48773234|NCT01695304|102232887|FG001|NOT COMPLETED|Overall Study||0||
48773235|NCT00865566|102232888|FG000|STARTED|Overall Study||1253|Enrollment is defined as receiving the first vaccination.|
48773236|NCT00865566|102232889|FG001|STARTED|Overall Study||1251|Enrollment is defined as receiving the first vaccination.|
48773237|NCT00865566|102232888|FG000|Modified Intent-to-Treat Population|Overall Study||1251|Participants excluded from MITT if HIV-1 positive at first vaccination (retrospective testing)|
48773238|NCT00865566|102232889|FG001|Modified Intent-to-Treat Population|Overall Study||1245|Participants excluded from MITT if HIV-1 positive at first vaccination (retrospective testing)|
48773239|NCT00865566|102232888|FG000|COMPLETED|Overall Study||629|Completed if attended all visits. Note dropout endpoint does NOT include all visits.|
48773240|NCT00865566|102232889|FG001|COMPLETED|Overall Study||564|Completed if attended all visits. Note dropout endpoint does NOT include all visits.|
48773241|NCT00865566|102232888|FG000|NOT COMPLETED|Overall Study||624||
48457716|NCT00950833|101457125|FG002|COMPLETED|Overall Study||223||
48457717|NCT00950833|101457123|FG000|NOT COMPLETED|Overall Study||0||
48457718|NCT00950833|101457124|FG001|NOT COMPLETED|Overall Study||0||
48457719|NCT00950833|101457125|FG002|NOT COMPLETED|Overall Study||0||
48457720|NCT02770716|101457126|FG000|STARTED|Overall Study||199||
48457721|NCT02770716|101457127|FG001|STARTED|Overall Study||101||
48457722|NCT02770716|101457126|FG000|Intent to Treat (ITT)|Overall Study||199||
48457723|NCT02770716|101457127|FG001|Intent to Treat (ITT)|Overall Study||101||
48457724|NCT02770716|101457126|FG000|Safety Analysis Set (SAS)|Overall Study||200||
48457725|NCT02770716|101457127|FG001|Safety Analysis Set (SAS)|Overall Study||99||
48457726|NCT02770716|101457126|FG000|Systemic Inflammatory Response Syndrome (SIRS) Subgroup|Overall Study||84|SIRS subgroup included all participants from the ITT population who met the SIRS criteria.|
48457727|NCT02770716|101457127|FG001|Systemic Inflammatory Response Syndrome (SIRS) Subgroup|Overall Study||48|SIRS subgroup included all participants from the ITT population who met the SIRS criteria.|
48457728|NCT02770716|101457126|FG000|COMPLETED|Overall Study||87||
48457729|NCT02770716|101457127|FG001|COMPLETED|Overall Study||52||
48457730|NCT02770716|101457126|FG000|NOT COMPLETED|Overall Study||112||
48457731|NCT02770716|101457127|FG001|NOT COMPLETED|Overall Study||49||
48773242|NCT00865566|102232889|FG001|NOT COMPLETED|Overall Study||687||
48457732|NCT02040428|101457128|FG000|STARTED|Overall Study||75||
48457733|NCT02040428|101457129|FG001|STARTED|Overall Study||81||
48457734|NCT02040428|101457128|FG000|Intent to Treat (Randomized Subjects)|Overall Study||76||
48457735|NCT02040428|101457129|FG001|Intent to Treat (Randomized Subjects)|Overall Study||80||
48457736|NCT02040428|101457128|FG000|COMPLETED|Overall Study||70||
48457737|NCT02040428|101457129|FG001|COMPLETED|Overall Study||77||
48457738|NCT02040428|101457128|FG000|NOT COMPLETED|Overall Study||5||
48457739|NCT02040428|101457129|FG001|NOT COMPLETED|Overall Study||4||
48457740|NCT01360450|101457130|FG000|STARTED|Overall Study||6||
48457741|NCT01360450|101457131|FG001|STARTED|Overall Study||6||
48457742|NCT01360450|101457130|FG000|Completed Treatment|Overall Study||6||
48457743|NCT01360450|101457131|FG001|Completed Treatment|Overall Study||6||
48457744|NCT01360450|101457130|FG000|COMPLETED|Overall Study||6||
48457745|NCT01360450|101457131|FG001|COMPLETED|Overall Study||6||
48457746|NCT01360450|101457130|FG000|NOT COMPLETED|Overall Study||0||
48457747|NCT01360450|101457131|FG001|NOT COMPLETED|Overall Study||0||
48457748|NCT02468557|101457132|FG000|STARTED|Overall Study||16||
48457749|NCT02468557|101457132|FG000|COMPLETED|Overall Study||0||
48457750|NCT02468557|101457132|FG000|NOT COMPLETED|Overall Study||16||
48457751|NCT01907737|101457133|FG000|STARTED|Overall Study||22||
48457752|NCT01907737|101457133|FG000|COMPLETED|Overall Study||21||
48457753|NCT01907737|101457133|FG000|NOT COMPLETED|Overall Study||1||
48457754|NCT00571922|101457134|FG000|STARTED|Overall Study||36||
48457755|NCT00571922|101457135|FG001|STARTED|Overall Study||36||
48457756|NCT00571922|101457134|FG000|COMPLETED|Overall Study||0||
48457757|NCT00571922|101457135|FG001|COMPLETED|Overall Study||0||
48457758|NCT00571922|101457134|FG000|NOT COMPLETED|Overall Study||36||
48457759|NCT00571922|101457135|FG001|NOT COMPLETED|Overall Study||36||
48457760|NCT02763579|101457136|FG000|STARTED|Global Period||202||
48457761|NCT02763579|101457137|FG001|STARTED|Global Period||201||
48457762|NCT02763579|101457138|FG002|STARTED|Global Period||0||
48457763|NCT02763579|101457139|FG003|STARTED|Global Period||0||
48457764|NCT02763579|101457136|FG000|COMPLETED|Global Period||0||
48457765|NCT02763579|101457137|FG001|COMPLETED|Global Period||0||
48457766|NCT02763579|101457138|FG002|COMPLETED|Global Period||0||
48457767|NCT02763579|101457139|FG003|COMPLETED|Global Period||0||
48457768|NCT02763579|101457136|FG000|NOT COMPLETED|Global Period||202||
48457769|NCT02763579|101457137|FG001|NOT COMPLETED|Global Period||201||
48457770|NCT02763579|101457138|FG002|NOT COMPLETED|Global Period||0||
48457771|NCT02763579|101457139|FG003|NOT COMPLETED|Global Period||0||
48457772|NCT02763579|101457136|FG000|STARTED|China Period||0||
48457773|NCT02763579|101457137|FG001|STARTED|China Period||0||
48457774|NCT02763579|101457138|FG002|STARTED|China Period||53||
48457775|NCT02763579|101457139|FG003|STARTED|China Period||57||
48457776|NCT02763579|101457136|FG000|COMPLETED|China Period||0||
48457777|NCT02763579|101457137|FG001|COMPLETED|China Period||0||
48457778|NCT02763579|101457138|FG002|COMPLETED|China Period||0||
48457779|NCT02763579|101457139|FG003|COMPLETED|China Period||0||
48457780|NCT02763579|101457136|FG000|NOT COMPLETED|China Period||0||
48457781|NCT02763579|101457137|FG001|NOT COMPLETED|China Period||0||
48773243|NCT01424072|102232890|FG000|STARTED|Overall Study||27||
48773244|NCT01424072|102232891|FG001|STARTED|Overall Study||26||
48773245|NCT01424072|102232892|FG002|STARTED|Overall Study||22||
48773246|NCT01424072|102232890|FG000|COMPLETED|Overall Study||27||
48773247|NCT01424072|102232891|FG001|COMPLETED|Overall Study||26||
48773248|NCT01424072|102232892|FG002|COMPLETED|Overall Study||22||
48773249|NCT01424072|102232890|FG000|NOT COMPLETED|Overall Study||0||
48773250|NCT01424072|102232891|FG001|NOT COMPLETED|Overall Study||0||
48773251|NCT01424072|102232892|FG002|NOT COMPLETED|Overall Study||0||
48773252|NCT04674761|102232893|FG000|STARTED|Overall Study||35||
48773253|NCT04674761|102232894|FG001|STARTED|Overall Study||17||
48773254|NCT04674761|102232893|FG000|COMPLETED|Overall Study||35||
48773255|NCT04674761|102232894|FG001|COMPLETED|Overall Study||17||
48773256|NCT04674761|102232893|FG000|NOT COMPLETED|Overall Study||0||
48773257|NCT04674761|102232894|FG001|NOT COMPLETED|Overall Study||0||
48773258|NCT00048074|102232895|FG000|STARTED|Overall Study||465||
48773259|NCT00048074|102232896|FG001|STARTED|Overall Study||448||
48773260|NCT00048074|102232897|FG002|STARTED|Overall Study||469||
48773261|NCT00048074|102232895|FG000|COMPLETED|Overall Study||384||
48773262|NCT00048074|102232896|FG001|COMPLETED|Overall Study||361||
48773263|NCT00048074|102232897|FG002|COMPLETED|Overall Study||372||
48773264|NCT00048074|102232895|FG000|NOT COMPLETED|Overall Study||81||
48773265|NCT00048074|102232896|FG001|NOT COMPLETED|Overall Study||87||
48773266|NCT00048074|102232897|FG002|NOT COMPLETED|Overall Study||97||
48773267|NCT01342211|102232898|FG000|STARTED|Overall Study||19||
48773268|NCT01342211|102232899|FG001|STARTED|Overall Study||19||
48773269|NCT01342211|102232900|FG002|STARTED|Overall Study||18||
48773270|NCT01342211|102232901|FG003|STARTED|Overall Study||19||
48773271|NCT01342211|102232902|FG004|STARTED|Overall Study||18||
48773272|NCT01342211|102232898|FG000|Treated|Overall Study||19||
48773273|NCT01342211|102232899|FG001|Treated|Overall Study||17||
48773274|NCT01342211|102232900|FG002|Treated|Overall Study||18||
48773275|NCT01342211|102232901|FG003|Treated|Overall Study||19||
48773276|NCT01342211|102232902|FG004|Treated|Overall Study||17||
48773277|NCT01342211|102232898|FG000|COMPLETED|Overall Study||19||
48773278|NCT01342211|102232899|FG001|COMPLETED|Overall Study||17||
48773279|NCT01342211|102232900|FG002|COMPLETED|Overall Study||18||
48773280|NCT01342211|102232901|FG003|COMPLETED|Overall Study||17||
48773281|NCT01342211|102232902|FG004|COMPLETED|Overall Study||16||
48773282|NCT01342211|102232898|FG000|NOT COMPLETED|Overall Study||0||
48773283|NCT01342211|102232899|FG001|NOT COMPLETED|Overall Study||2||
48773284|NCT01342211|102232900|FG002|NOT COMPLETED|Overall Study||0||
48773285|NCT01342211|102232901|FG003|NOT COMPLETED|Overall Study||2||
48773286|NCT01342211|102232902|FG004|NOT COMPLETED|Overall Study||2||
48773287|NCT00346697|102232903|FG000|STARTED|Overall Study||24||
48773288|NCT00346697|102232904|FG001|STARTED|Overall Study||24||
48457782|NCT02763579|101457138|FG002|NOT COMPLETED|China Period||53||
48457783|NCT02763579|101457139|FG003|NOT COMPLETED|China Period||57||
48457784|NCT01190306|101457140|FG000|STARTED|Overall Study||61||
48457785|NCT01190306|101457141|FG001|STARTED|Overall Study||66||
48457786|NCT01190306|101457140|FG000|COMPLETED|Overall Study||61||
48457787|NCT01190306|101457141|FG001|COMPLETED|Overall Study||66||
48457788|NCT01190306|101457140|FG000|NOT COMPLETED|Overall Study||0||
48457789|NCT01190306|101457141|FG001|NOT COMPLETED|Overall Study||0||
48457790|NCT03202628|101457142|FG000|STARTED|Overall Study||8||
48457791|NCT03202628|101457142|FG000|COMPLETED|Overall Study||8||
48457792|NCT03202628|101457142|FG000|NOT COMPLETED|Overall Study||0||
48457793|NCT03740100|101457143|FG000|STARTED|Overall Study||8||
48457794|NCT03740100|101457143|FG000|Confirmed Partial Response|Overall Study||1||
48457795|NCT03740100|101457143|FG000|COMPLETED|Overall Study||6||
48457796|NCT03740100|101457143|FG000|NOT COMPLETED|Overall Study||2||
48457797|NCT01357356|101457144|FG000|STARTED|Overall Study||188||
48457798|NCT01357356|101457145|FG001|STARTED|Overall Study||188||
48457799|NCT01357356|101457146|FG002|STARTED|Overall Study||186||
48457800|NCT01357356|101457147|FG003|STARTED|Overall Study||188||
48457801|NCT01357356|101457144|FG000|COMPLETED|Overall Study||166||
48457802|NCT01357356|101457145|FG001|COMPLETED|Overall Study||163||
48457803|NCT01357356|101457146|FG002|COMPLETED|Overall Study||158||
48457804|NCT01357356|101457147|FG003|COMPLETED|Overall Study||171||
48773289|NCT00346697|102232903|FG000|COMPLETED|Overall Study||24||
48773290|NCT00346697|102232904|FG001|COMPLETED|Overall Study||23||
48773291|NCT00346697|102232903|FG000|NOT COMPLETED|Overall Study||0||
48773292|NCT00346697|102232904|FG001|NOT COMPLETED|Overall Study||1||
48773293|NCT04454918|102232905|FG000|STARTED|Treatment Period 1 (Day 1)||6||
48773294|NCT04454918|102232905|FG000|COMPLETED|Treatment Period 1 (Day 1)||6||
48773295|NCT04454918|102232905|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48773296|NCT04454918|102232905|FG000|STARTED|Washout Period (Day 2 to 8)||6||
48369632|NCT03074162|101232815|FG000|NOT COMPLETED|Period 3||1||
48457805|NCT01357356|101457144|FG000|NOT COMPLETED|Overall Study||22||
48457806|NCT01357356|101457145|FG001|NOT COMPLETED|Overall Study||25||
48773297|NCT04454918|102232905|FG000|COMPLETED|Washout Period (Day 2 to 8)||6||
48773298|NCT04454918|102232905|FG000|NOT COMPLETED|Washout Period (Day 2 to 8)||0||
48773299|NCT04454918|102232905|FG000|STARTED|Treatment Period 2(Day9[Day1of Period2])||6||
48457807|NCT01357356|101457146|FG002|NOT COMPLETED|Overall Study||28||
48457808|NCT01357356|101457147|FG003|NOT COMPLETED|Overall Study||17||
48773300|NCT04454918|102232905|FG000|COMPLETED|Treatment Period 2(Day9[Day1of Period2])||6||
48773301|NCT04454918|102232905|FG000|NOT COMPLETED|Treatment Period 2(Day9[Day1of Period2])||0||
48773302|NCT03941288|102232906|FG000|STARTED|Overall Study||25||
48773303|NCT03941288|102232907|FG001|STARTED|Overall Study||23||
48773304|NCT03941288|102232908|FG002|STARTED|Overall Study||21||
48773305|NCT03941288|102232909|FG003|STARTED|Overall Study||23||
48773306|NCT03941288|102232906|FG000|COMPLETED|Overall Study||22||
48773307|NCT03941288|102232907|FG001|COMPLETED|Overall Study||21||
48773308|NCT03941288|102232908|FG002|COMPLETED|Overall Study||20||
48773309|NCT03941288|102232909|FG003|COMPLETED|Overall Study||22||
48773310|NCT03941288|102232906|FG000|NOT COMPLETED|Overall Study||3||
48773311|NCT03941288|102232907|FG001|NOT COMPLETED|Overall Study||2||
48773312|NCT03941288|102232908|FG002|NOT COMPLETED|Overall Study||1||
48773313|NCT03941288|102232909|FG003|NOT COMPLETED|Overall Study||1||
48773314|NCT01004991|102232910|FG000|STARTED|Overall Study||12||
48773315|NCT01004991|102232910|FG000|COMPLETED|Overall Study||12||
48773316|NCT01004991|102232910|FG000|NOT COMPLETED|Overall Study||0||
48773317|NCT02357368|102232911|FG000|STARTED|Overall Study||19||
48773318|NCT02357368|102232912|FG001|STARTED|Overall Study||18||
48773319|NCT02357368|102232913|FG002|STARTED|Overall Study||14||
48773320|NCT02357368|102232914|FG003|STARTED|Overall Study||8||
48773321|NCT02357368|102232911|FG000|COMPLETED|Overall Study||13||
48773322|NCT02357368|102232912|FG001|COMPLETED|Overall Study||15||
48773323|NCT02357368|102232913|FG002|COMPLETED|Overall Study||13||
48773324|NCT02357368|102232914|FG003|COMPLETED|Overall Study||5||
48773325|NCT02357368|102232911|FG000|NOT COMPLETED|Overall Study||6||
48773326|NCT02357368|102232912|FG001|NOT COMPLETED|Overall Study||3||
48773327|NCT02357368|102232913|FG002|NOT COMPLETED|Overall Study||1||
48773328|NCT02357368|102232914|FG003|NOT COMPLETED|Overall Study||3||
48773329|NCT02038933|102232915|FG000|STARTED|Overall Study||121||
48773330|NCT02038933|102232915|FG000|COMPLETED|Overall Study||0||
48773331|NCT02038933|102232915|FG000|NOT COMPLETED|Overall Study||121||
48773332|NCT00298558|102232916|FG000|STARTED|Baseline||711||
48773333|NCT00298558|102232917|FG001|STARTED|Baseline||705||
48773334|NCT00298558|102232918|FG002|STARTED|Baseline||712||
48773335|NCT00298558|102232919|FG003|STARTED|Baseline||704||
48773336|NCT00298558|102232916|FG000|COMPLETED|Baseline||711||
48773337|NCT00298558|102232917|FG001|COMPLETED|Baseline||705||
48773338|NCT00298558|102232918|FG002|COMPLETED|Baseline||712||
48773339|NCT00298558|102232919|FG003|COMPLETED|Baseline||704||
48189618|NCT03888365|100786264|FG001|Safety Population|Cohort A Peak Level/Cohort B Period 1||23|All participants who initiated an ISWT at Screening.|
48457809|NCT01244815|101457148|FG000|STARTED|Overall Study||101||
48457810|NCT01244815|101457149|FG001|STARTED|Overall Study||105||
48457811|NCT01244815|101457150|FG002|STARTED|Overall Study||99||
48457812|NCT01244815|101457151|FG003|STARTED|Overall Study||99||
48457813|NCT01244815|101457148|FG000|Treated|Overall Study||101||
48457814|NCT01244815|101457149|FG001|Treated|Overall Study||104||
48457815|NCT01244815|101457150|FG002|Treated|Overall Study||99||
48457816|NCT01244815|101457151|FG003|Treated|Overall Study||99||
48457817|NCT01244815|101457148|FG000|COMPLETED|Overall Study||87||
48457818|NCT01244815|101457149|FG001|COMPLETED|Overall Study||88||
48457819|NCT01244815|101457150|FG002|COMPLETED|Overall Study||88||
48457820|NCT01244815|101457151|FG003|COMPLETED|Overall Study||87||
48457821|NCT01244815|101457148|FG000|NOT COMPLETED|Overall Study||14||
48457822|NCT01244815|101457149|FG001|NOT COMPLETED|Overall Study||17||
48457823|NCT01244815|101457150|FG002|NOT COMPLETED|Overall Study||11||
48457824|NCT01244815|101457151|FG003|NOT COMPLETED|Overall Study||12||
48457825|NCT01741480|101457152|FG000|STARTED|Overall Study||285||
48457826|NCT01741480|101457153|FG001|STARTED|Overall Study||286||
48457827|NCT01741480|101457152|FG000|COMPLETED|Overall Study||285||
48457828|NCT01741480|101457153|FG001|COMPLETED|Overall Study||286||
48457829|NCT01741480|101457152|FG000|NOT COMPLETED|Overall Study||0||
48457830|NCT01741480|101457153|FG001|NOT COMPLETED|Overall Study||0||
48457831|NCT03154333|101457154|FG000|STARTED|Overall Study||28||
48457832|NCT03154333|101457155|FG001|STARTED|Overall Study||26||
48457833|NCT03154333|101457154|FG000|COMPLETED|Overall Study||21||
48457834|NCT03154333|101457155|FG001|COMPLETED|Overall Study||21||
48457835|NCT03154333|101457154|FG000|NOT COMPLETED|Overall Study||7||
48457836|NCT03154333|101457155|FG001|NOT COMPLETED|Overall Study||5||
48457837|NCT04756141|101457156|FG000|STARTED|Overall Study||20||
48457838|NCT04756141|101457156|FG000|COMPLETED|Overall Study||20||
48457839|NCT04756141|101457156|FG000|NOT COMPLETED|Overall Study||0||
48457840|NCT01042977|101457157|FG000|STARTED|Overall Study||482||
48773340|NCT00298558|102232916|FG000|NOT COMPLETED|Baseline||0||
48773341|NCT00298558|102232917|FG001|NOT COMPLETED|Baseline||0||
48773342|NCT00298558|102232918|FG002|NOT COMPLETED|Baseline||0||
48773343|NCT00298558|102232919|FG003|NOT COMPLETED|Baseline||0||
48773344|NCT00298558|102232916|FG000|STARTED|Intervention||711||
48773345|NCT00298558|102232917|FG001|STARTED|Intervention||705||
48457841|NCT01042977|101457158|FG001|STARTED|Overall Study||483||
48457842|NCT01042977|101457157|FG000|COMPLETED|Overall Study||441||
48457843|NCT01042977|101457158|FG001|COMPLETED|Overall Study||428||
48773346|NCT00298558|102232918|FG002|STARTED|Intervention||712||
48773347|NCT00298558|102232919|FG003|STARTED|Intervention||704||
48773348|NCT00298558|102232916|FG000|COMPLETED|Intervention||620||
48773349|NCT00298558|102232917|FG001|COMPLETED|Intervention||627||
48773350|NCT00298558|102232918|FG002|COMPLETED|Intervention||637||
48773351|NCT00298558|102232919|FG003|COMPLETED|Intervention||285||
48773352|NCT00298558|102232916|FG000|NOT COMPLETED|Intervention||91||
48773353|NCT00298558|102232917|FG001|NOT COMPLETED|Intervention||78||
48773354|NCT00298558|102232918|FG002|NOT COMPLETED|Intervention||75||
48773355|NCT00298558|102232919|FG003|NOT COMPLETED|Intervention||419||
48773356|NCT00298558|102232916|FG000|STARTED|Immediate Post Test||711||
48773357|NCT00298558|102232917|FG001|STARTED|Immediate Post Test||705||
48773358|NCT00298558|102232918|FG002|STARTED|Immediate Post Test||712||
48773359|NCT00298558|102232919|FG003|STARTED|Immediate Post Test||704||
48773360|NCT00298558|102232916|FG000|COMPLETED|Immediate Post Test||640||
48773361|NCT00298558|102232917|FG001|COMPLETED|Immediate Post Test||629||
48773362|NCT00298558|102232918|FG002|COMPLETED|Immediate Post Test||653||
48773363|NCT00298558|102232919|FG003|COMPLETED|Immediate Post Test||639||
48773364|NCT00298558|102232916|FG000|NOT COMPLETED|Immediate Post Test||71||
48773365|NCT00298558|102232917|FG001|NOT COMPLETED|Immediate Post Test||76||
48773366|NCT00298558|102232918|FG002|NOT COMPLETED|Immediate Post Test||59||
48773367|NCT00298558|102232919|FG003|NOT COMPLETED|Immediate Post Test||65||
48773368|NCT00298558|102232916|FG000|STARTED|Booster||372||
48773369|NCT00298558|102232917|FG001|STARTED|Booster||371||
48773370|NCT00298558|102232918|FG002|STARTED|Booster||370||
48773371|NCT00298558|102232919|FG003|STARTED|Booster||0||
48773372|NCT00298558|102232916|FG000|COMPLETED|Booster||283||
48773373|NCT00298558|102232917|FG001|COMPLETED|Booster||301||
48773374|NCT00298558|102232918|FG002|COMPLETED|Booster||295||
48773375|NCT00298558|102232919|FG003|COMPLETED|Booster||0||
48773376|NCT00298558|102232916|FG000|NOT COMPLETED|Booster||89||
48773377|NCT00298558|102232917|FG001|NOT COMPLETED|Booster||70||
48773378|NCT00298558|102232918|FG002|NOT COMPLETED|Booster||75||
48773379|NCT00298558|102232919|FG003|NOT COMPLETED|Booster||0||
48773380|NCT00298558|102232916|FG000|STARTED|1st Annual (A1)||640||
48773381|NCT00298558|102232917|FG001|STARTED|1st Annual (A1)||629||
48773382|NCT00298558|102232918|FG002|STARTED|1st Annual (A1)||653||
48773383|NCT00298558|102232919|FG003|STARTED|1st Annual (A1)||639||
48773384|NCT00298558|102232916|FG000|COMPLETED|1st Annual (A1)||585||
48773385|NCT00298558|102232917|FG001|COMPLETED|1st Annual (A1)||566||
48773386|NCT00298558|102232918|FG002|COMPLETED|1st Annual (A1)||601||
48773387|NCT00298558|102232919|FG003|COMPLETED|1st Annual (A1)||584||
48773388|NCT00298558|102232916|FG000|NOT COMPLETED|1st Annual (A1)||55||
48773389|NCT00298558|102232917|FG001|NOT COMPLETED|1st Annual (A1)||63||
48457844|NCT01042977|101457157|FG000|NOT COMPLETED|Overall Study||41||
48457845|NCT01042977|101457158|FG001|NOT COMPLETED|Overall Study||55||
48773390|NCT00298558|102232918|FG002|NOT COMPLETED|1st Annual (A1)||52||
48773391|NCT00298558|102232919|FG003|NOT COMPLETED|1st Annual (A1)||55||
48773392|NCT00298558|102232916|FG000|STARTED|2nd Annual (A2)||585||
48773393|NCT00298558|102232917|FG001|STARTED|2nd Annual (A2)||566||
48773394|NCT00298558|102232918|FG002|STARTED|2nd Annual (A2)||601||
48773395|NCT00298558|102232919|FG003|STARTED|2nd Annual (A2)||584||
48773396|NCT00298558|102232916|FG000|COMPLETED|2nd Annual (A2)||563||
48773397|NCT00298558|102232917|FG001|COMPLETED|2nd Annual (A2)||555||
48773398|NCT00298558|102232918|FG002|COMPLETED|2nd Annual (A2)||574||
48773399|NCT00298558|102232919|FG003|COMPLETED|2nd Annual (A2)||552||
48773400|NCT00298558|102232916|FG000|NOT COMPLETED|2nd Annual (A2)||22||
48773401|NCT00298558|102232917|FG001|NOT COMPLETED|2nd Annual (A2)||11||
48773402|NCT00298558|102232918|FG002|NOT COMPLETED|2nd Annual (A2)||27||
48773403|NCT00298558|102232919|FG003|NOT COMPLETED|2nd Annual (A2)||32||
48773404|NCT00298558|102232916|FG000|STARTED|3rd Annual Booster||372||
48773405|NCT00298558|102232917|FG001|STARTED|3rd Annual Booster||371||
48773406|NCT00298558|102232918|FG002|STARTED|3rd Annual Booster||370||
48773407|NCT00298558|102232919|FG003|STARTED|3rd Annual Booster||0||
48773408|NCT00298558|102232916|FG000|COMPLETED|3rd Annual Booster||250||
48773409|NCT00298558|102232917|FG001|COMPLETED|3rd Annual Booster||243||
48773410|NCT00298558|102232918|FG002|COMPLETED|3rd Annual Booster||230||
48773411|NCT00298558|102232919|FG003|COMPLETED|3rd Annual Booster||0||
48773412|NCT00298558|102232916|FG000|NOT COMPLETED|3rd Annual Booster||122||
48773413|NCT00298558|102232917|FG001|NOT COMPLETED|3rd Annual Booster||128||
48773414|NCT00298558|102232918|FG002|NOT COMPLETED|3rd Annual Booster||140||
48773415|NCT00298558|102232919|FG003|NOT COMPLETED|3rd Annual Booster||0||
48773416|NCT00298558|102232916|FG000|STARTED|3rd Annual (A3) and 5th Annual (A5)||563||
48773417|NCT00298558|102232917|FG001|STARTED|3rd Annual (A3) and 5th Annual (A5)||555||
48773418|NCT00298558|102232918|FG002|STARTED|3rd Annual (A3) and 5th Annual (A5)||574||
48773419|NCT00298558|102232919|FG003|STARTED|3rd Annual (A3) and 5th Annual (A5)||552||
48773420|NCT00298558|102232916|FG000|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||472||
48773421|NCT00298558|102232917|FG001|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||469||
48457846|NCT04317781|101457159|FG000|STARTED|Overall Study||3||
48457847|NCT04317781|101457159|FG000|COMPLETED|Overall Study||0||
48457848|NCT04317781|101457159|FG000|NOT COMPLETED|Overall Study||3||
48773422|NCT00298558|102232918|FG002|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||490||
48773423|NCT00298558|102232919|FG003|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||448||
48773424|NCT00298558|102232916|FG000|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||91||
48773425|NCT00298558|102232917|FG001|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||86||
48773426|NCT00298558|102232918|FG002|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||84||
48457849|NCT01224210|101457160|FG000|STARTED|Overall Study||30||
48457850|NCT01224210|101457160|FG000|COMPLETED|Overall Study||23||
48773427|NCT00298558|102232919|FG003|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||104||
48773428|NCT00298558|102232916|FG000|STARTED|10th Annual (A10)||472||
48773429|NCT00298558|102232917|FG001|STARTED|10th Annual (A10)||469||
48773430|NCT00298558|102232918|FG002|STARTED|10th Annual (A10)||490||
48773431|NCT00298558|102232919|FG003|STARTED|10th Annual (A10)||448||
48773432|NCT00298558|102232916|FG000|COMPLETED|10th Annual (A10)||300||
48773433|NCT00298558|102232917|FG001|COMPLETED|10th Annual (A10)||316||
48773434|NCT00298558|102232918|FG002|COMPLETED|10th Annual (A10)||319||
48773435|NCT00298558|102232919|FG003|COMPLETED|10th Annual (A10)||285||
48773436|NCT00298558|102232916|FG000|NOT COMPLETED|10th Annual (A10)||172||
48773437|NCT00298558|102232917|FG001|NOT COMPLETED|10th Annual (A10)||153||
48773438|NCT00298558|102232918|FG002|NOT COMPLETED|10th Annual (A10)||171||
48773439|NCT00298558|102232919|FG003|NOT COMPLETED|10th Annual (A10)||163||
48773440|NCT01301027|102232920|FG000|STARTED|Overall Study||48||
48773441|NCT01301027|102232921|FG001|STARTED|Overall Study||47||
48773442|NCT01301027|102232920|FG000|COMPLETED|Overall Study||40||
48773443|NCT01301027|102232921|FG001|COMPLETED|Overall Study||37||
48773444|NCT01301027|102232920|FG000|NOT COMPLETED|Overall Study||8||
48773445|NCT01301027|102232921|FG001|NOT COMPLETED|Overall Study||10||
48773446|NCT02351856|102232922|FG000|STARTED|Overall Study||8||
48773447|NCT02351856|102232922|FG000|COMPLETED|Overall Study||0||
48773448|NCT02351856|102232922|FG000|NOT COMPLETED|Overall Study||8||
48773449|NCT04843007|102232923|FG000|STARTED|Overall Study||199||
48773450|NCT04843007|102232923|FG000|COMPLETED|Overall Study||198||
48773451|NCT04843007|102232923|FG000|NOT COMPLETED|Overall Study||1||
48773452|NCT01072643|102232924|FG000|STARTED|Overall Study||4||
48773453|NCT01072643|102232924|FG000|COMPLETED|Overall Study||4||
48773454|NCT01072643|102232924|FG000|NOT COMPLETED|Overall Study||0||
48773455|NCT02999672|102232925|FG000|STARTED|Overall Study||13||
48773456|NCT02999672|102232926|FG001|STARTED|Overall Study||7||
48773457|NCT02999672|102232925|FG000|COMPLETED|Overall Study||0||
48773458|NCT02999672|102232926|FG001|COMPLETED|Overall Study||0||
48773459|NCT02999672|102232925|FG000|NOT COMPLETED|Overall Study||13||
48773460|NCT02999672|102232926|FG001|NOT COMPLETED|Overall Study||7||
48773461|NCT00912795|102232927|FG000|STARTED|Overall Study||76||
48773462|NCT00912795|102232928|FG001|STARTED|Overall Study||75||
48773463|NCT00912795|102232927|FG000|COMPLETED|Overall Study||29||
48773464|NCT00912795|102232928|FG001|COMPLETED|Overall Study||17||
48773465|NCT00912795|102232927|FG000|NOT COMPLETED|Overall Study||47||
48773466|NCT00912795|102232928|FG001|NOT COMPLETED|Overall Study||58||
48773467|NCT04539795|102232929|FG000|STARTED|Overall Study||7||
48773468|NCT04539795|102232930|FG001|STARTED|Overall Study||8||
48773469|NCT04539795|102232929|FG000|COMPLETED|Overall Study||7||
48773470|NCT04539795|102232930|FG001|COMPLETED|Overall Study||8||
48773471|NCT04539795|102232929|FG000|NOT COMPLETED|Overall Study||0||
48189619|NCT03888365|100786263|FG000|COMPLETED|Cohort A Peak Level/Cohort B Period 1||20||
48189620|NCT03888365|100786264|FG001|COMPLETED|Cohort A Peak Level/Cohort B Period 1||23||
48189621|NCT03888365|100786263|FG000|NOT COMPLETED|Cohort A Peak Level/Cohort B Period 1||0||
48189622|NCT03888365|100786264|FG001|NOT COMPLETED|Cohort A Peak Level/Cohort B Period 1||0||
48457851|NCT01224210|101457160|FG000|NOT COMPLETED|Overall Study||7||
48457852|NCT02424565|101457161|FG000|STARTED|Period 1 (D0)||8||
48457853|NCT02424565|101457162|FG001|STARTED|Period 1 (D0)||7||
48773472|NCT04539795|102232930|FG001|NOT COMPLETED|Overall Study||0||
48773473|NCT00953056|102232931|FG000|STARTED|Overall Study||24||
48773474|NCT00953056|102232932|FG001|STARTED|Overall Study||24||
48773475|NCT00953056|102232933|FG002|STARTED|Overall Study||24||
48773476|NCT00953056|102232934|FG003|STARTED|Overall Study||24||
48773477|NCT00953056|102232935|FG004|STARTED|Overall Study||24||
48773478|NCT00953056|102232936|FG005|STARTED|Overall Study||24||
48773479|NCT00953056|102232931|FG000|COMPLETED|Overall Study||24||
48773480|NCT00953056|102232932|FG001|COMPLETED|Overall Study||24||
48773481|NCT00953056|102232933|FG002|COMPLETED|Overall Study||24||
48773482|NCT00953056|102232934|FG003|COMPLETED|Overall Study||24||
48773483|NCT00953056|102232935|FG004|COMPLETED|Overall Study||22||
48773484|NCT00953056|102232936|FG005|COMPLETED|Overall Study||20||
48773485|NCT00953056|102232931|FG000|NOT COMPLETED|Overall Study||0||
48773486|NCT00953056|102232932|FG001|NOT COMPLETED|Overall Study||0||
48773487|NCT00953056|102232933|FG002|NOT COMPLETED|Overall Study||0||
48773488|NCT00953056|102232934|FG003|NOT COMPLETED|Overall Study||0||
48773489|NCT00953056|102232935|FG004|NOT COMPLETED|Overall Study||2||
48773490|NCT00953056|102232936|FG005|NOT COMPLETED|Overall Study||4||
48773491|NCT00659789|102232937|FG000|STARTED|Overall Study||93||
48773492|NCT00659789|102232938|FG001|STARTED|Overall Study||43||
48773493|NCT00659789|102232937|FG000|COMPLETED|Overall Study||86||
48773494|NCT00659789|102232938|FG001|COMPLETED|Overall Study||36||
48773495|NCT00659789|102232937|FG000|NOT COMPLETED|Overall Study||7||
48773496|NCT00659789|102232938|FG001|NOT COMPLETED|Overall Study||7||
48773497|NCT01668589|102232939|FG000|STARTED|Overall Study||600||
48773498|NCT01668589|102232940|FG001|STARTED|Overall Study||300||
48773499|NCT01668589|102232941|FG002|STARTED|Overall Study||300||
48773500|NCT01668589|102232942|FG003|STARTED|Overall Study||301||
48773501|NCT01668589|102232939|FG000|Received Denosumab|Overall Study||599||
48773502|NCT01668589|102232940|FG001|Received Denosumab|Overall Study||300||
48773503|NCT01668589|102232941|FG002|Received Denosumab|Overall Study||300||
48773504|NCT01668589|102232942|FG003|Received Denosumab|Overall Study||301||
48773505|NCT01668589|102232939|FG000|COMPLETED|Overall Study||461||
48773506|NCT01668589|102232940|FG001|COMPLETED|Overall Study||242||
48773507|NCT01668589|102232941|FG002|COMPLETED|Overall Study||265||
48773508|NCT01668589|102232942|FG003|COMPLETED|Overall Study||266||
48773509|NCT01668589|102232939|FG000|NOT COMPLETED|Overall Study||139||
48773510|NCT01668589|102232940|FG001|NOT COMPLETED|Overall Study||58||
48773511|NCT01668589|102232941|FG002|NOT COMPLETED|Overall Study||35||
48773512|NCT01668589|102232942|FG003|NOT COMPLETED|Overall Study||35||
48773513|NCT02350296|102232943|FG000|STARTED|First Treatment Period||15||
48773514|NCT02350296|102232944|FG001|STARTED|First Treatment Period||15||
48773515|NCT02350296|102232943|FG000|COMPLETED|First Treatment Period||15||
48773516|NCT02350296|102232944|FG001|COMPLETED|First Treatment Period||15||
48773517|NCT02350296|102232943|FG000|NOT COMPLETED|First Treatment Period||0||
48773518|NCT02350296|102232944|FG001|NOT COMPLETED|First Treatment Period||0||
48663416|NCT03863574|101959607|FG002|NOT COMPLETED|Overall Study||0||
48663417|NCT03026777|101959608|FG000|STARTED|Overall Study||168||
48663418|NCT03026777|101959609|FG001|STARTED|Overall Study||169||
48663419|NCT03026777|101959608|FG000|COMPLETED|Overall Study||168||
48773519|NCT02350296|102232943|FG000|STARTED|Washout Period (at Least 4 Days)||15||
48773520|NCT02350296|102232944|FG001|STARTED|Washout Period (at Least 4 Days)||15||
48773521|NCT02350296|102232943|FG000|COMPLETED|Washout Period (at Least 4 Days)||15||
48773522|NCT02350296|102232944|FG001|COMPLETED|Washout Period (at Least 4 Days)||15||
48773523|NCT02350296|102232943|FG000|NOT COMPLETED|Washout Period (at Least 4 Days)||0||
48773524|NCT02350296|102232944|FG001|NOT COMPLETED|Washout Period (at Least 4 Days)||0||
48773525|NCT02350296|102232943|FG000|STARTED|Second Treatment Period||15||
48773526|NCT02350296|102232944|FG001|STARTED|Second Treatment Period||15||
48773527|NCT02350296|102232943|FG000|COMPLETED|Second Treatment Period||15||
48773528|NCT02350296|102232944|FG001|COMPLETED|Second Treatment Period||15||
48773529|NCT02350296|102232943|FG000|NOT COMPLETED|Second Treatment Period||0||
48773530|NCT02350296|102232944|FG001|NOT COMPLETED|Second Treatment Period||0||
48773531|NCT01470326|102232945|FG000|STARTED|Overall Study||3187||
48457854|NCT02424565|101457161|FG000|COMPLETED|Period 1 (D0)||8||
48457855|NCT02424565|101457162|FG001|COMPLETED|Period 1 (D0)||6||
48457856|NCT02424565|101457161|FG000|NOT COMPLETED|Period 1 (D0)||0||
48457857|NCT02424565|101457162|FG001|NOT COMPLETED|Period 1 (D0)||1||
48457858|NCT02424565|101457161|FG000|STARTED|Washout Period||8||
48457859|NCT02424565|101457162|FG001|STARTED|Washout Period||6||
48457860|NCT02424565|101457161|FG000|COMPLETED|Washout Period||8||
48457861|NCT02424565|101457162|FG001|COMPLETED|Washout Period||6||
48457862|NCT02424565|101457161|FG000|NOT COMPLETED|Washout Period||0||
48457863|NCT02424565|101457162|FG001|NOT COMPLETED|Washout Period||0||
48457864|NCT02424565|101457161|FG000|STARTED|Period 2 (D3)||8||
48457865|NCT02424565|101457162|FG001|STARTED|Period 2 (D3)||6||
48457866|NCT02424565|101457161|FG000|COMPLETED|Period 2 (D3)||8||
48457867|NCT02424565|101457162|FG001|COMPLETED|Period 2 (D3)||6||
48457868|NCT02424565|101457161|FG000|NOT COMPLETED|Period 2 (D3)||0||
48663420|NCT03026777|101959609|FG001|COMPLETED|Overall Study||169||
48663421|NCT03026777|101959608|FG000|NOT COMPLETED|Overall Study||0||
48663422|NCT03026777|101959609|FG001|NOT COMPLETED|Overall Study||0||
48663423|NCT03502200|101959610|FG000|STARTED|Overall Study||175||
48663424|NCT03502200|101959611|FG001|STARTED|Overall Study||175||
48663425|NCT03502200|101959610|FG000|COMPLETED|Overall Study||132||
48663426|NCT03502200|101959611|FG001|COMPLETED|Overall Study||127||
48663427|NCT03502200|101959610|FG000|NOT COMPLETED|Overall Study||43||
48663428|NCT03502200|101959611|FG001|NOT COMPLETED|Overall Study||48||
48663429|NCT04818229|101959612|FG000|STARTED|Overall Study||55||
48663430|NCT04818229|101959613|FG001|STARTED|Overall Study||28||
48189623|NCT03888365|100786263|FG000|STARTED|Rest - At Least 1 h||20||
48457869|NCT02424565|101457162|FG001|NOT COMPLETED|Period 2 (D3)||0||
48457870|NCT00326885|101457163|FG000|STARTED|Overall Study||32||
48457871|NCT00326885|101457163|FG000|COMPLETED|Overall Study||25||
48457872|NCT00326885|101457163|FG000|NOT COMPLETED|Overall Study||7||
48457873|NCT02625766|101457164|FG000|STARTED|Overall Study||47||
48457874|NCT02625766|101457165|FG001|STARTED|Overall Study||48||
48457875|NCT02625766|101457164|FG000|COMPLETED|Overall Study||47||
48457876|NCT02625766|101457165|FG001|COMPLETED|Overall Study||48||
48457877|NCT02625766|101457164|FG000|NOT COMPLETED|Overall Study||0||
48663431|NCT04818229|101959614|FG002|STARTED|Overall Study||29||
48663432|NCT04818229|101959612|FG000|COMPLETED|Overall Study||32||
48663433|NCT04818229|101959613|FG001|COMPLETED|Overall Study||17||
48663434|NCT04818229|101959614|FG002|COMPLETED|Overall Study||15||
48663435|NCT04818229|101959612|FG000|NOT COMPLETED|Overall Study||23||
48773532|NCT01470326|102232945|FG000|COMPLETED|Overall Study||3034||
48773533|NCT01470326|102232945|FG000|NOT COMPLETED|Overall Study||153||
48773534|NCT01092546|102232946|FG000|STARTED|Overall Study||16||
48773535|NCT01092546|102232946|FG000|COMPLETED|Overall Study||12||
48773536|NCT01092546|102232946|FG000|NOT COMPLETED|Overall Study||4||
48773537|NCT00515619|102232947|FG000|STARTED|Overall Study||376||
48773538|NCT00515619|102232947|FG000|Safety Set|Overall Study||376||
48773539|NCT00515619|102232947|FG000|COMPLETED|Overall Study||160||
48457878|NCT02625766|101457165|FG001|NOT COMPLETED|Overall Study||0||
48457879|NCT03705351|101457166|FG000|STARTED|Overall Study||7||
48457880|NCT03705351|101457166|FG000|COMPLETED|Overall Study||0||
48457881|NCT03705351|101457166|FG000|NOT COMPLETED|Overall Study||7||
48457882|NCT01142297|101457167|FG000|STARTED|Overall Study||24||
48457883|NCT01142297|101457167|FG000|COMPLETED|Overall Study||18||
48457884|NCT01142297|101457167|FG000|NOT COMPLETED|Overall Study||6||
48457885|NCT00676585|101457168|FG000|STARTED|Overall Study||25||
48457886|NCT00676585|101457169|FG001|STARTED|Overall Study||25||
48457887|NCT00676585|101457168|FG000|COMPLETED|Overall Study||25||
48457888|NCT00676585|101457169|FG001|COMPLETED|Overall Study||25||
48457889|NCT00676585|101457168|FG000|NOT COMPLETED|Overall Study||0||
48457890|NCT00676585|101457169|FG001|NOT COMPLETED|Overall Study||0||
48457891|NCT02186808|101457170|FG000|STARTED|Overall Study||80||
48457892|NCT02186808|101457170|FG000|COMPLETED|Overall Study||67||
48457893|NCT02186808|101457170|FG000|NOT COMPLETED|Overall Study||13||
48457894|NCT01294592|101457171|FG000|STARTED|Overall Study||369||
48457895|NCT01294592|101457172|FG001|STARTED|Overall Study||373||
48457896|NCT01294592|101457171|FG000|COMPLETED|Overall Study||292||
48457897|NCT01294592|101457172|FG001|COMPLETED|Overall Study||300||
48457898|NCT01294592|101457171|FG000|NOT COMPLETED|Overall Study||77||
48457899|NCT01294592|101457172|FG001|NOT COMPLETED|Overall Study||73||
48457900|NCT00593333|101457173|FG000|STARTED|Overall Study||54||
48457901|NCT00593333|101457174|FG001|STARTED|Overall Study||56||
48457902|NCT00593333|101457173|FG000|COMPLETED|Overall Study||44||
48457903|NCT00593333|101457174|FG001|COMPLETED|Overall Study||45||
48457904|NCT00593333|101457173|FG000|NOT COMPLETED|Overall Study||10||
48457905|NCT00593333|101457174|FG001|NOT COMPLETED|Overall Study||11||
48457906|NCT02265952|101457175|FG000|STARTED|Main Study Period||9||
48189624|NCT03888365|100786264|FG001|STARTED|Rest - At Least 1 h||23||
48457907|NCT02265952|101457176|FG001|STARTED|Main Study Period||0||
48457908|NCT02265952|101457175|FG000|COMPLETED|Main Study Period||9||
48457909|NCT02265952|101457176|FG001|COMPLETED|Main Study Period||0||
48457910|NCT02265952|101457175|FG000|NOT COMPLETED|Main Study Period||0||
48457911|NCT02265952|101457176|FG001|NOT COMPLETED|Main Study Period||0||
48457912|NCT02265952|101457175|FG000|STARTED|Open Label Extension (OLE) Period||0||
48457913|NCT02265952|101457176|FG001|STARTED|Open Label Extension (OLE) Period||8||
48457914|NCT02265952|101457175|FG000|COMPLETED|Open Label Extension (OLE) Period||0||
48457915|NCT02265952|101457176|FG001|COMPLETED|Open Label Extension (OLE) Period||0||
48457916|NCT02265952|101457175|FG000|NOT COMPLETED|Open Label Extension (OLE) Period||0||
48457917|NCT02265952|101457176|FG001|NOT COMPLETED|Open Label Extension (OLE) Period||8||
48457918|NCT01777425|101457177|FG000|STARTED|Overall Study||389||
48457919|NCT01777425|101457177|FG000|COMPLETED|Overall Study||389||
48457920|NCT01777425|101457177|FG000|NOT COMPLETED|Overall Study||0||
48457921|NCT01446913|101457178|FG000|STARTED|Overall Study||86||
48457922|NCT01446913|101457179|FG001|STARTED|Overall Study||82||
48457923|NCT01446913|101457180|FG002|STARTED|Overall Study||84||
48457924|NCT01446913|101457178|FG000|Patients With Sleep Study|Overall Study||53|A sub sample of patients had a valid sleep study conducted.|
48457925|NCT01446913|101457179|FG001|Patients With Sleep Study|Overall Study||56|A sub sample of patients had a valid sleep study conducted.|
48457926|NCT01446913|101457180|FG002|Patients With Sleep Study|Overall Study||29|A sub sample of patients had a valid sleep study conducted.|
48457927|NCT01446913|101457178|FG000|Patients With Sleep Apnea|Overall Study||39|A sub sample of patients with sleep apnea were studied.|
48457928|NCT01446913|101457179|FG001|Patients With Sleep Apnea|Overall Study||45|A sub sample of patients with sleep apnea were studied.|
48457929|NCT01446913|101457180|FG002|Patients With Sleep Apnea|Overall Study||21|A sub sample of patients with sleep apnea were studied.|
48457930|NCT01446913|101457178|FG000|COMPLETED|Overall Study||77||
48663436|NCT04818229|101959613|FG001|NOT COMPLETED|Overall Study||11||
48663437|NCT04818229|101959614|FG002|NOT COMPLETED|Overall Study||14||
48663438|NCT02781558|101959615|FG000|STARTED|Overall Study||101||
48663439|NCT02781558|101959616|FG001|STARTED|Overall Study||103||
48663440|NCT02781558|101959615|FG000|COMPLETED|Overall Study||98||
48663441|NCT02781558|101959616|FG001|COMPLETED|Overall Study||101||
48663442|NCT02781558|101959615|FG000|NOT COMPLETED|Overall Study||3||
48773540|NCT00515619|102232947|FG000|NOT COMPLETED|Overall Study||216||
48457931|NCT01446913|101457179|FG001|COMPLETED|Overall Study||73||
48457932|NCT01446913|101457180|FG002|COMPLETED|Overall Study||73||
48457933|NCT01446913|101457178|FG000|NOT COMPLETED|Overall Study||9||
48457934|NCT01446913|101457179|FG001|NOT COMPLETED|Overall Study||9||
48663443|NCT02781558|101959616|FG001|NOT COMPLETED|Overall Study||2||
48773541|NCT00714870|102232948|FG000|STARTED|Overall Study||49||
48773542|NCT00714870|102232949|FG001|STARTED|Overall Study||27||
48773543|NCT00714870|102232948|FG000|COMPLETED|Overall Study||22||
48773544|NCT00714870|102232949|FG001|COMPLETED|Overall Study||22||
48773545|NCT00714870|102232948|FG000|NOT COMPLETED|Overall Study||27||
48773546|NCT00714870|102232949|FG001|NOT COMPLETED|Overall Study||5||
48773547|NCT02362282|102232950|FG000|STARTED|Overall Study||5||
48773548|NCT02362282|102232951|FG001|STARTED|Overall Study||7||
48189625|NCT03888365|100786263|FG000|COMPLETED|Rest - At Least 1 h||20||
48189626|NCT03888365|100786264|FG001|COMPLETED|Rest - At Least 1 h||23||
48773549|NCT02362282|102232950|FG000|COMPLETED|Overall Study||4||
48189627|NCT03888365|100786263|FG000|NOT COMPLETED|Rest - At Least 1 h||0||
48457935|NCT01446913|101457180|FG002|NOT COMPLETED|Overall Study||11||
48773550|NCT02362282|102232951|FG001|COMPLETED|Overall Study||7||
48773551|NCT02362282|102232950|FG000|NOT COMPLETED|Overall Study||1||
48773552|NCT02362282|102232951|FG001|NOT COMPLETED|Overall Study||0||
48773553|NCT00885534|102232952|FG000|STARTED|Overall Study||7||
48773554|NCT00885534|102232952|FG000|COMPLETED|Overall Study||6||
48773555|NCT00885534|102232952|FG000|NOT COMPLETED|Overall Study||1||
48773556|NCT01237197|102232953|FG000|STARTED|Randomization Period||13||
48773557|NCT01237197|102232954|FG001|STARTED|Randomization Period||13||
48773558|NCT01237197|102232953|FG000|COMPLETED|Randomization Period||12||
48773559|NCT01237197|102232954|FG001|COMPLETED|Randomization Period||10||
48773560|NCT01237197|102232953|FG000|NOT COMPLETED|Randomization Period||1||
48773561|NCT01237197|102232954|FG001|NOT COMPLETED|Randomization Period||3||
48773562|NCT01237197|102232953|FG000|STARTED|Open Label Period||12||
48773563|NCT01237197|102232954|FG001|STARTED|Open Label Period||10||
48773564|NCT01237197|102232953|FG000|COMPLETED|Open Label Period||12||
48773565|NCT01237197|102232954|FG001|COMPLETED|Open Label Period||10||
48773566|NCT01237197|102232953|FG000|NOT COMPLETED|Open Label Period||0||
48773567|NCT01237197|102232954|FG001|NOT COMPLETED|Open Label Period||0||
48773568|NCT00706238|102232955|FG000|STARTED|Overall Study||5||
48773569|NCT00706238|102232955|FG000|COMPLETED|Overall Study||0||
48457936|NCT02175966|101457181|FG000|STARTED|Treatment Period||14||
48457937|NCT02175966|101457182|FG001|STARTED|Treatment Period||14||
48457938|NCT02175966|101457181|FG000|COMPLETED|Treatment Period||14||
48457939|NCT02175966|101457182|FG001|COMPLETED|Treatment Period||14||
48663444|NCT05677347|101959617|FG000|STARTED|Treatment Period 1 (3 Days)||3||
48663445|NCT05677347|101959618|FG001|STARTED|Treatment Period 1 (3 Days)||3||
48663446|NCT05677347|101959619|FG002|STARTED|Treatment Period 1 (3 Days)||3||
48663447|NCT05677347|101959620|FG003|STARTED|Treatment Period 1 (3 Days)||3||
48663448|NCT05677347|101959617|FG000|COMPLETED|Treatment Period 1 (3 Days)||3||
48663449|NCT05677347|101959618|FG001|COMPLETED|Treatment Period 1 (3 Days)||3||
48663450|NCT05677347|101959619|FG002|COMPLETED|Treatment Period 1 (3 Days)||3||
48663451|NCT05677347|101959620|FG003|COMPLETED|Treatment Period 1 (3 Days)||3||
48663452|NCT05677347|101959617|FG000|NOT COMPLETED|Treatment Period 1 (3 Days)||0||
48189628|NCT03888365|100786264|FG001|NOT COMPLETED|Rest - At Least 1 h||0||
48189629|NCT03888365|100786263|FG000|STARTED|Cohort A Trough Level/Cohort B Period 2||20||
48189630|NCT03888365|100786264|FG001|STARTED|Cohort A Trough Level/Cohort B Period 2||23||
48189631|NCT03888365|100786263|FG000|COMPLETED|Cohort A Trough Level/Cohort B Period 2||20||
48189632|NCT03888365|100786264|FG001|COMPLETED|Cohort A Trough Level/Cohort B Period 2||23||
48457940|NCT02175966|101457181|FG000|NOT COMPLETED|Treatment Period||0||
48457941|NCT02175966|101457182|FG001|NOT COMPLETED|Treatment Period||0||
48457942|NCT02175966|101457181|FG000|STARTED|Follow-up Period||14||
48457943|NCT02175966|101457182|FG001|STARTED|Follow-up Period||14||
48457944|NCT02175966|101457181|FG000|COMPLETED|Follow-up Period||4||
48457945|NCT02175966|101457182|FG001|COMPLETED|Follow-up Period||8||
48457946|NCT02175966|101457181|FG000|NOT COMPLETED|Follow-up Period||10||
48457947|NCT02175966|101457182|FG001|NOT COMPLETED|Follow-up Period||6||
48457948|NCT03063632|101457183|FG000|STARTED|Overall Study||16||
48457949|NCT03063632|101457184|FG001|STARTED|Overall Study||12||
48457950|NCT03063632|101457183|FG000|COMPLETED|Overall Study||9||
48457951|NCT03063632|101457184|FG001|COMPLETED|Overall Study||2||
48457952|NCT03063632|101457183|FG000|NOT COMPLETED|Overall Study||7||
48457953|NCT03063632|101457184|FG001|NOT COMPLETED|Overall Study||10||
48457954|NCT02904200|101457185|FG000|STARTED|Overall Study||2||
48457955|NCT02904200|101457186|FG001|STARTED|Overall Study||0||
48457956|NCT02904200|101457185|FG000|COMPLETED|Overall Study||1||
48457957|NCT02904200|101457186|FG001|COMPLETED|Overall Study||0||
48457958|NCT02904200|101457185|FG000|NOT COMPLETED|Overall Study||1||
48457959|NCT02904200|101457186|FG001|NOT COMPLETED|Overall Study||0||
48457960|NCT01113710|101457187|FG000|STARTED|Overall Study||687||
48663453|NCT05677347|101959618|FG001|NOT COMPLETED|Treatment Period 1 (3 Days)||0||
48663454|NCT05677347|101959619|FG002|NOT COMPLETED|Treatment Period 1 (3 Days)||0||
48773570|NCT00706238|102232955|FG000|NOT COMPLETED|Overall Study||5||
48773571|NCT03349034|102232956|FG000|STARTED|Overall Study||12||
48773572|NCT03349034|102232957|FG001|STARTED|Overall Study||12||
48773573|NCT03349034|102232956|FG000|COMPLETED|Overall Study||8||
48773574|NCT03349034|102232957|FG001|COMPLETED|Overall Study||10||
48773575|NCT03349034|102232956|FG000|NOT COMPLETED|Overall Study||4||
48773576|NCT03349034|102232957|FG001|NOT COMPLETED|Overall Study||2||
48457961|NCT01113710|101457187|FG000|COMPLETED|Overall Study||418||
48457962|NCT01113710|101457187|FG000|NOT COMPLETED|Overall Study||269||
48457963|NCT00770991|101457188|FG000|STARTED|Overall Study||12||
48457964|NCT00770991|101457189|FG001|STARTED|Overall Study||12||
48457965|NCT00770991|101457188|FG000|COMPLETED|Overall Study||7||
48457966|NCT00770991|101457189|FG001|COMPLETED|Overall Study||7||
48457967|NCT00770991|101457188|FG000|NOT COMPLETED|Overall Study||5||
48457968|NCT00770991|101457189|FG001|NOT COMPLETED|Overall Study||5||
48189633|NCT03888365|100786263|FG000|NOT COMPLETED|Cohort A Trough Level/Cohort B Period 2||0||
48663455|NCT05677347|101959620|FG003|NOT COMPLETED|Treatment Period 1 (3 Days)||0||
48663456|NCT05677347|101959617|FG000|STARTED|Washout Period 1 (up to 6 Days)||3||
48663457|NCT05677347|101959618|FG001|STARTED|Washout Period 1 (up to 6 Days)||3||
48663458|NCT05677347|101959619|FG002|STARTED|Washout Period 1 (up to 6 Days)||3||
48663459|NCT05677347|101959620|FG003|STARTED|Washout Period 1 (up to 6 Days)||3||
48663460|NCT05677347|101959617|FG000|COMPLETED|Washout Period 1 (up to 6 Days)||3||
48663461|NCT05677347|101959618|FG001|COMPLETED|Washout Period 1 (up to 6 Days)||3||
48663462|NCT05677347|101959619|FG002|COMPLETED|Washout Period 1 (up to 6 Days)||3||
48663463|NCT05677347|101959620|FG003|COMPLETED|Washout Period 1 (up to 6 Days)||3||
48663464|NCT05677347|101959617|FG000|NOT COMPLETED|Washout Period 1 (up to 6 Days)||0||
48663465|NCT05677347|101959618|FG001|NOT COMPLETED|Washout Period 1 (up to 6 Days)||0||
48663466|NCT05677347|101959619|FG002|NOT COMPLETED|Washout Period 1 (up to 6 Days)||0||
48663467|NCT05677347|101959620|FG003|NOT COMPLETED|Washout Period 1 (up to 6 Days)||0||
48663468|NCT05677347|101959617|FG000|STARTED|Treatment Period 2 (3 Days)||3||
48663469|NCT05677347|101959618|FG001|STARTED|Treatment Period 2 (3 Days)||3||
48663470|NCT05677347|101959619|FG002|STARTED|Treatment Period 2 (3 Days)||3||
48663471|NCT05677347|101959620|FG003|STARTED|Treatment Period 2 (3 Days)||3||
48663472|NCT05677347|101959617|FG000|COMPLETED|Treatment Period 2 (3 Days)||3||
48773577|NCT02248246|102232958|FG000|STARTED|Overall Study||40||
48457969|NCT02659202|101457190|FG000|STARTED|Overall Study||7||
48457970|NCT02659202|101457190|FG000|COMPLETED|Overall Study||3||
48663473|NCT05677347|101959618|FG001|COMPLETED|Treatment Period 2 (3 Days)||3||
48663474|NCT05677347|101959619|FG002|COMPLETED|Treatment Period 2 (3 Days)||3||
48663475|NCT05677347|101959620|FG003|COMPLETED|Treatment Period 2 (3 Days)||3||
48663476|NCT05677347|101959617|FG000|NOT COMPLETED|Treatment Period 2 (3 Days)||0||
48663477|NCT05677347|101959618|FG001|NOT COMPLETED|Treatment Period 2 (3 Days)||0||
48663478|NCT05677347|101959619|FG002|NOT COMPLETED|Treatment Period 2 (3 Days)||0||
48663479|NCT05677347|101959620|FG003|NOT COMPLETED|Treatment Period 2 (3 Days)||0||
48663480|NCT05677347|101959617|FG000|STARTED|Washout Period 2 (up to 6 Days)||3||
48663481|NCT05677347|101959618|FG001|STARTED|Washout Period 2 (up to 6 Days)||3||
48663482|NCT05677347|101959619|FG002|STARTED|Washout Period 2 (up to 6 Days)||3||
48663483|NCT05677347|101959620|FG003|STARTED|Washout Period 2 (up to 6 Days)||3||
48663484|NCT05677347|101959617|FG000|COMPLETED|Washout Period 2 (up to 6 Days)||3||
48663485|NCT05677347|101959618|FG001|COMPLETED|Washout Period 2 (up to 6 Days)||3||
48663486|NCT05677347|101959619|FG002|COMPLETED|Washout Period 2 (up to 6 Days)||3||
48663487|NCT05677347|101959620|FG003|COMPLETED|Washout Period 2 (up to 6 Days)||3||
48663488|NCT05677347|101959617|FG000|NOT COMPLETED|Washout Period 2 (up to 6 Days)||0||
48663489|NCT05677347|101959618|FG001|NOT COMPLETED|Washout Period 2 (up to 6 Days)||0||
48663490|NCT05677347|101959619|FG002|NOT COMPLETED|Washout Period 2 (up to 6 Days)||0||
48663491|NCT05677347|101959620|FG003|NOT COMPLETED|Washout Period 2 (up to 6 Days)||0||
48663492|NCT05677347|101959617|FG000|STARTED|Treatment Period 3 (up to 15 Days)||3||
48663493|NCT05677347|101959618|FG001|STARTED|Treatment Period 3 (up to 15 Days)||3||
48663494|NCT05677347|101959619|FG002|STARTED|Treatment Period 3 (up to 15 Days)||3||
48663495|NCT05677347|101959620|FG003|STARTED|Treatment Period 3 (up to 15 Days)||3||
48663496|NCT05677347|101959617|FG000|COMPLETED|Treatment Period 3 (up to 15 Days)||3||
48663497|NCT05677347|101959618|FG001|COMPLETED|Treatment Period 3 (up to 15 Days)||3||
48663498|NCT05677347|101959619|FG002|COMPLETED|Treatment Period 3 (up to 15 Days)||3||
48663499|NCT05677347|101959620|FG003|COMPLETED|Treatment Period 3 (up to 15 Days)||3||
48663500|NCT05677347|101959617|FG000|NOT COMPLETED|Treatment Period 3 (up to 15 Days)||0||
48663501|NCT05677347|101959618|FG001|NOT COMPLETED|Treatment Period 3 (up to 15 Days)||0||
48663502|NCT05677347|101959619|FG002|NOT COMPLETED|Treatment Period 3 (up to 15 Days)||0||
48663503|NCT05677347|101959620|FG003|NOT COMPLETED|Treatment Period 3 (up to 15 Days)||0||
48663504|NCT04556006|101959621|FG000|STARTED|Overall Study||28||
48663505|NCT04556006|101959622|FG001|STARTED|Overall Study||30||
48663506|NCT04556006|101959621|FG000|COMPLETED|Overall Study||28||
48773578|NCT02248246|102232958|FG000|COMPLETED|Overall Study||40||
48773579|NCT02248246|102232958|FG000|NOT COMPLETED|Overall Study||0||
48773580|NCT03108469|102232959|FG000|STARTED|Overall Study||15||
48773581|NCT03108469|102232960|FG001|STARTED|Overall Study||15||
48773582|NCT03108469|102232959|FG000|COMPLETED|Overall Study||11||
48189634|NCT03888365|100786264|FG001|NOT COMPLETED|Cohort A Trough Level/Cohort B Period 2||0||
48457971|NCT02659202|101457190|FG000|NOT COMPLETED|Overall Study||4||
48457972|NCT03404206|101457191|FG000|STARTED|Overall Study||166||
48457973|NCT03404206|101457192|FG001|STARTED|Overall Study||166||
48457974|NCT03404206|101457193|FG002|STARTED|Overall Study||55||
48457975|NCT03404206|101457191|FG000|COMPLETED|Overall Study||162||
48457976|NCT03404206|101457192|FG001|COMPLETED|Overall Study||164||
48773583|NCT03108469|102232960|FG001|COMPLETED|Overall Study||11||
48457977|NCT03404206|101457193|FG002|COMPLETED|Overall Study||55||
48457978|NCT03404206|101457191|FG000|NOT COMPLETED|Overall Study||4||
48457979|NCT03404206|101457192|FG001|NOT COMPLETED|Overall Study||2||
48457980|NCT03404206|101457193|FG002|NOT COMPLETED|Overall Study||0||
48457981|NCT02387814|101457194|FG000|STARTED|Overall Study||10||
48457982|NCT02387814|101457195|FG001|STARTED|Overall Study||9||
48457983|NCT02387814|101457196|FG002|STARTED|Overall Study||10||
48457984|NCT02387814|101457197|FG003|STARTED|Overall Study||6||
48457985|NCT02387814|101457194|FG000|Received Abemaciclib|Overall Study||10||
48457986|NCT02387814|101457195|FG001|Received Abemaciclib|Overall Study||9||
48457987|NCT02387814|101457196|FG002|Received Abemaciclib|Overall Study||10||
48457988|NCT02387814|101457197|FG003|Received Abemaciclib|Overall Study||6||
48457989|NCT02387814|101457194|FG000|COMPLETED|Overall Study||10||
48457990|NCT02387814|101457195|FG001|COMPLETED|Overall Study||9||
48457991|NCT02387814|101457196|FG002|COMPLETED|Overall Study||10||
48457992|NCT02387814|101457197|FG003|COMPLETED|Overall Study||6||
48457993|NCT02387814|101457194|FG000|NOT COMPLETED|Overall Study||0||
48457994|NCT02387814|101457195|FG001|NOT COMPLETED|Overall Study||0||
48457995|NCT02387814|101457196|FG002|NOT COMPLETED|Overall Study||0||
48457996|NCT02387814|101457197|FG003|NOT COMPLETED|Overall Study||0||
48773584|NCT03108469|102232959|FG000|NOT COMPLETED|Overall Study||4||
48457997|NCT01138150|101457198|FG000|STARTED|Overall Study||18||
48457998|NCT01138150|101457199|FG001|STARTED|Overall Study||18||
48457999|NCT01138150|101457198|FG000|COMPLETED|Overall Study||17||
48458000|NCT01138150|101457199|FG001|COMPLETED|Overall Study||17||
48458001|NCT01138150|101457198|FG000|NOT COMPLETED|Overall Study||1||
48458002|NCT01138150|101457199|FG001|NOT COMPLETED|Overall Study||1||
48458003|NCT02531022|101457200|FG000|STARTED|Overall Study||55||
48458004|NCT02531022|101457201|FG001|STARTED|Overall Study||50||
48458005|NCT02531022|101457200|FG000|COMPLETED|Overall Study||55||
48458006|NCT02531022|101457201|FG001|COMPLETED|Overall Study||48||
48458007|NCT02531022|101457200|FG000|NOT COMPLETED|Overall Study||0||
48458008|NCT02531022|101457201|FG001|NOT COMPLETED|Overall Study||2||
48458009|NCT00207714|101457202|FG000|STARTED|Overall Study||35||
48458010|NCT00207714|101457203|FG001|STARTED|Overall Study||35||
48458011|NCT00207714|101457204|FG002|STARTED|Overall Study||34||
48458012|NCT00207714|101457205|FG003|STARTED|Overall Study||34||
48458013|NCT00207714|101457206|FG004|STARTED|Overall Study||34||
48458014|NCT00207714|101457202|FG000|COMPLETED|Overall Study||21||
48458015|NCT00207714|101457203|FG001|COMPLETED|Overall Study||28||
48458016|NCT00207714|101457204|FG002|COMPLETED|Overall Study||24||
48458017|NCT00207714|101457205|FG003|COMPLETED|Overall Study||26||
48458018|NCT00207714|101457206|FG004|COMPLETED|Overall Study||29||
48458019|NCT00207714|101457202|FG000|NOT COMPLETED|Overall Study||14||
48458020|NCT00207714|101457203|FG001|NOT COMPLETED|Overall Study||7||
48458021|NCT00207714|101457204|FG002|NOT COMPLETED|Overall Study||10||
48458022|NCT00207714|101457205|FG003|NOT COMPLETED|Overall Study||8||
48458023|NCT00207714|101457206|FG004|NOT COMPLETED|Overall Study||5||
48458024|NCT00936975|101457207|FG000|STARTED|Overall Study||18||
48458025|NCT00936975|101457207|FG000|COMPLETED|Overall Study||12||
48458026|NCT00936975|101457207|FG000|NOT COMPLETED|Overall Study||6||
48458027|NCT03109873|101457208|FG000|STARTED|Overall Study||5||
48458028|NCT03109873|101457209|FG001|STARTED|Overall Study||4||
48458029|NCT03109873|101457208|FG000|COMPLETED|Overall Study||5||
48458030|NCT03109873|101457209|FG001|COMPLETED|Overall Study||4||
48458031|NCT03109873|101457208|FG000|NOT COMPLETED|Overall Study||0||
48458032|NCT03109873|101457209|FG001|NOT COMPLETED|Overall Study||0||
48458033|NCT01381900|101457210|FG000|STARTED|Overall Study||226||
48663507|NCT04556006|101959622|FG001|COMPLETED|Overall Study||30||
48663508|NCT04556006|101959621|FG000|NOT COMPLETED|Overall Study||0||
48663509|NCT04556006|101959622|FG001|NOT COMPLETED|Overall Study||0||
48663510|NCT04132427|101959623|FG000|STARTED|Overall Study||3||
48663511|NCT04132427|101959624|FG001|STARTED|Overall Study||3||
48663512|NCT04132427|101959623|FG000|COMPLETED|Overall Study||3||
48663513|NCT04132427|101959624|FG001|COMPLETED|Overall Study||3||
48663514|NCT04132427|101959623|FG000|NOT COMPLETED|Overall Study||0||
48663515|NCT04132427|101959624|FG001|NOT COMPLETED|Overall Study||0||
48663516|NCT01500135|101959625|FG000|STARTED|Overall Study||100||
48663517|NCT01500135|101959626|FG001|STARTED|Overall Study||50||
48663518|NCT01500135|101959625|FG000|COMPLETED|Overall Study||83||
48663519|NCT01500135|101959626|FG001|COMPLETED|Overall Study||39||
48663520|NCT01500135|101959625|FG000|NOT COMPLETED|Overall Study||17||
48663521|NCT01500135|101959626|FG001|NOT COMPLETED|Overall Study||11||
48663522|NCT04573881|101959627|FG000|STARTED|Overall Study||24||
48663523|NCT04573881|101959627|FG000|COMPLETED|Overall Study||0||
48663524|NCT04573881|101959627|FG000|NOT COMPLETED|Overall Study||24||
48663525|NCT00834197|101959628|FG000|STARTED|First Intervention||16||
48663526|NCT00834197|101959629|FG001|STARTED|First Intervention||16||
48663527|NCT00834197|101959628|FG000|COMPLETED|First Intervention||16||
48663528|NCT00834197|101959629|FG001|COMPLETED|First Intervention||16||
48663529|NCT00834197|101959628|FG000|NOT COMPLETED|First Intervention||0||
48663530|NCT00834197|101959629|FG001|NOT COMPLETED|First Intervention||0||
48458034|NCT01381900|101457211|FG001|STARTED|Overall Study||223||
48458035|NCT01381900|101457212|FG002|STARTED|Overall Study||227||
48458036|NCT01381900|101457210|FG000|COMPLETED|Overall Study||217||
48458037|NCT01381900|101457211|FG001|COMPLETED|Overall Study||214||
48458038|NCT01381900|101457212|FG002|COMPLETED|Overall Study||215||
48458039|NCT01381900|101457210|FG000|NOT COMPLETED|Overall Study||9||
48458040|NCT01381900|101457211|FG001|NOT COMPLETED|Overall Study||9||
48458041|NCT01381900|101457212|FG002|NOT COMPLETED|Overall Study||12||
48458042|NCT03549130|101457213|FG000|STARTED|Overall Study||64||
48663531|NCT00834197|101959628|FG000|STARTED|Washout of 14 Days||16||
48663532|NCT00834197|101959629|FG001|STARTED|Washout of 14 Days||16||
48663533|NCT00834197|101959628|FG000|COMPLETED|Washout of 14 Days||16||
48663534|NCT00834197|101959629|FG001|COMPLETED|Washout of 14 Days||16||
48663535|NCT00834197|101959628|FG000|NOT COMPLETED|Washout of 14 Days||0||
48663536|NCT00834197|101959629|FG001|NOT COMPLETED|Washout of 14 Days||0||
48663537|NCT00834197|101959628|FG000|STARTED|Second Intervention||16||
48663538|NCT00834197|101959629|FG001|STARTED|Second Intervention||16||
48663539|NCT00834197|101959628|FG000|COMPLETED|Second Intervention||16||
48663540|NCT00834197|101959629|FG001|COMPLETED|Second Intervention||16||
48458043|NCT03549130|101457214|FG001|STARTED|Overall Study||66||
48458044|NCT03549130|101457213|FG000|COMPLETED|Overall Study||64||
48458045|NCT03549130|101457214|FG001|COMPLETED|Overall Study||64||
48458046|NCT03549130|101457213|FG000|NOT COMPLETED|Overall Study||0||
48458047|NCT03549130|101457214|FG001|NOT COMPLETED|Overall Study||2||
48458048|NCT02524106|101457215|FG000|STARTED|Overall Study||6||
48458049|NCT02524106|101457216|FG001|STARTED|Overall Study||5||
48458050|NCT02524106|101457215|FG000|COMPLETED|Overall Study||6||
48458051|NCT02524106|101457216|FG001|COMPLETED|Overall Study||5||
48663541|NCT00834197|101959628|FG000|NOT COMPLETED|Second Intervention||0||
48663542|NCT00834197|101959629|FG001|NOT COMPLETED|Second Intervention||0||
48458052|NCT02524106|101457215|FG000|NOT COMPLETED|Overall Study||0||
48458053|NCT02524106|101457216|FG001|NOT COMPLETED|Overall Study||0||
48458054|NCT04303845|101457217|FG000|STARTED|Overall Study||2||
48458055|NCT04303845|101457217|FG000|COMPLETED|Overall Study||2||
48458056|NCT04303845|101457217|FG000|NOT COMPLETED|Overall Study||0||
48458057|NCT01166971|101457218|FG000|STARTED|Overall Study||33||
48458058|NCT01166971|101457219|FG001|STARTED|Overall Study||31||
48458059|NCT01166971|101457218|FG000|COMPLETED|Overall Study||32||
48458060|NCT01166971|101457219|FG001|COMPLETED|Overall Study||30||
48458061|NCT01166971|101457218|FG000|NOT COMPLETED|Overall Study||1||
48458062|NCT01166971|101457219|FG001|NOT COMPLETED|Overall Study||1||
48458063|NCT01590433|101457220|FG000|STARTED|Overall Study||127||
48458064|NCT01590433|101457221|FG001|STARTED|Overall Study||55||
48458065|NCT01590433|101457220|FG000|COMPLETED|Overall Study||75||
48458066|NCT01590433|101457221|FG001|COMPLETED|Overall Study||33||
48458067|NCT01590433|101457220|FG000|NOT COMPLETED|Overall Study||52||
48458068|NCT01590433|101457221|FG001|NOT COMPLETED|Overall Study||22||
48458069|NCT04980521|101457222|FG000|STARTED|Overall Study||68||
48458070|NCT04980521|101457223|FG001|STARTED|Overall Study||70||
48458071|NCT04980521|101457222|FG000|COMPLETED|Overall Study||50||
48458072|NCT04980521|101457223|FG001|COMPLETED|Overall Study||57||
48458073|NCT04980521|101457222|FG000|NOT COMPLETED|Overall Study||18||
48458074|NCT04980521|101457223|FG001|NOT COMPLETED|Overall Study||13||
48458075|NCT00618774|101457224|FG000|STARTED|Overall Study||211||
48458076|NCT00618774|101457225|FG001|STARTED|Overall Study||48||
48458077|NCT00618774|101457224|FG000|COMPLETED|Overall Study||205||
48458078|NCT00618774|101457225|FG001|COMPLETED|Overall Study||45||
48458079|NCT00618774|101457224|FG000|NOT COMPLETED|Overall Study||6||
48458080|NCT00618774|101457225|FG001|NOT COMPLETED|Overall Study||3||
48458081|NCT00910858|101457226|FG000|STARTED|Pharmacokinetic Phase||9||
48458082|NCT00910858|101457227|FG001|STARTED|Pharmacokinetic Phase||0||
48458083|NCT00910858|101457228|FG002|STARTED|Pharmacokinetic Phase||3||
48458084|NCT00910858|101457226|FG000|COMPLETED|Pharmacokinetic Phase||8||
48458085|NCT00910858|101457227|FG001|COMPLETED|Pharmacokinetic Phase||0||
48458086|NCT00910858|101457228|FG002|COMPLETED|Pharmacokinetic Phase||3||
48458087|NCT00910858|101457226|FG000|NOT COMPLETED|Pharmacokinetic Phase||1||
48458088|NCT00910858|101457227|FG001|NOT COMPLETED|Pharmacokinetic Phase||0||
48458089|NCT00910858|101457228|FG002|NOT COMPLETED|Pharmacokinetic Phase||0||
48458090|NCT00910858|101457226|FG000|STARTED|Monotherapy Phase||17||
48663543|NCT02268656|101959630|FG000|STARTED|Overall Study||20||
48458091|NCT00910858|101457227|FG001|STARTED|Monotherapy Phase||15||
48458092|NCT00910858|101457228|FG002|STARTED|Monotherapy Phase||7||
48458093|NCT00910858|101457226|FG000|Safety Population|Monotherapy Phase||17||
48458094|NCT00910858|101457227|FG001|Safety Population|Monotherapy Phase||15||
48663544|NCT02268656|101959631|FG001|STARTED|Overall Study||20||
48663545|NCT02268656|101959630|FG000|COMPLETED|Overall Study||20||
48663546|NCT02268656|101959631|FG001|COMPLETED|Overall Study||20||
48663547|NCT02268656|101959630|FG000|NOT COMPLETED|Overall Study||0||
48663548|NCT02268656|101959631|FG001|NOT COMPLETED|Overall Study||0||
48663549|NCT04629196|101959632|FG000|STARTED|Overall Study||6||
48663550|NCT04629196|101959633|FG001|STARTED|Overall Study||6||
48663551|NCT04629196|101959632|FG000|COMPLETED|Overall Study||3||
48663552|NCT04629196|101959633|FG001|COMPLETED|Overall Study||3||
48773585|NCT03108469|102232960|FG001|NOT COMPLETED|Overall Study||4||
48773586|NCT03345784|102232961|FG000|STARTED|Overall Study||5||
48458095|NCT00910858|101457228|FG002|Safety Population|Monotherapy Phase||7||
48773587|NCT03345784|102232962|FG001|STARTED|Overall Study||5||
48773588|NCT03345784|102232961|FG000|COMPLETED|Overall Study||3||
48773589|NCT03345784|102232962|FG001|COMPLETED|Overall Study||4||
48773590|NCT03345784|102232961|FG000|NOT COMPLETED|Overall Study||2||
48773591|NCT03345784|102232962|FG001|NOT COMPLETED|Overall Study||1||
48773592|NCT01584440|102232963|FG000|STARTED|Stage 1 (5 Weeks)||93||
48773593|NCT01584440|102232964|FG001|STARTED|Stage 1 (5 Weeks)||127||
48773594|NCT01584440|102232965|FG002|STARTED|Stage 1 (5 Weeks)||0||
48773595|NCT01584440|102232966|FG003|STARTED|Stage 1 (5 Weeks)||0||
48773596|NCT01584440|102232967|FG004|STARTED|Stage 1 (5 Weeks)||0||
48773597|NCT01584440|102232963|FG000|COMPLETED|Stage 1 (5 Weeks)||83||
48773598|NCT01584440|102232964|FG001|COMPLETED|Stage 1 (5 Weeks)||119||
48773599|NCT01584440|102232965|FG002|COMPLETED|Stage 1 (5 Weeks)||0||
48773600|NCT01584440|102232966|FG003|COMPLETED|Stage 1 (5 Weeks)||0||
48773601|NCT01584440|102232967|FG004|COMPLETED|Stage 1 (5 Weeks)||0||
48773602|NCT01584440|102232963|FG000|NOT COMPLETED|Stage 1 (5 Weeks)||10||
48773603|NCT01584440|102232964|FG001|NOT COMPLETED|Stage 1 (5 Weeks)||8||
48458096|NCT00910858|101457226|FG000|Pharmacokinetic Population|Monotherapy Phase||17||
48458097|NCT00910858|101457227|FG001|Pharmacokinetic Population|Monotherapy Phase||0||
48458098|NCT00910858|101457228|FG002|Pharmacokinetic Population|Monotherapy Phase||7||
48458099|NCT00910858|101457226|FG000|COMPLETED|Monotherapy Phase||0||
48458100|NCT00910858|101457227|FG001|COMPLETED|Monotherapy Phase||0||
48458101|NCT00910858|101457228|FG002|COMPLETED|Monotherapy Phase||0||
48458102|NCT00910858|101457226|FG000|NOT COMPLETED|Monotherapy Phase||17||
48663553|NCT04629196|101959632|FG000|NOT COMPLETED|Overall Study||3||
48458103|NCT00910858|101457227|FG001|NOT COMPLETED|Monotherapy Phase||15||
48458104|NCT00910858|101457228|FG002|NOT COMPLETED|Monotherapy Phase||7||
48458105|NCT00910858|101457226|FG000|STARTED|Combined Treatment Phase||9||
48458106|NCT00910858|101457227|FG001|STARTED|Combined Treatment Phase||10||
48458107|NCT00910858|101457228|FG002|STARTED|Combined Treatment Phase||4||
48458108|NCT00910858|101457226|FG000|COMPLETED|Combined Treatment Phase||0||
48458109|NCT00910858|101457227|FG001|COMPLETED|Combined Treatment Phase||0||
48458110|NCT00910858|101457228|FG002|COMPLETED|Combined Treatment Phase||0||
48458111|NCT00910858|101457226|FG000|NOT COMPLETED|Combined Treatment Phase||9||
48458112|NCT00910858|101457227|FG001|NOT COMPLETED|Combined Treatment Phase||10||
48458113|NCT00910858|101457228|FG002|NOT COMPLETED|Combined Treatment Phase||4||
48458114|NCT00939705|101457229|FG000|STARTED|Period 1 - First Intervention - 5 Days||9||
48458115|NCT00939705|101457230|FG001|STARTED|Period 1 - First Intervention - 5 Days||9||
48458116|NCT00939705|101457229|FG000|COMPLETED|Period 1 - First Intervention - 5 Days||9||
48458117|NCT00939705|101457230|FG001|COMPLETED|Period 1 - First Intervention - 5 Days||9||
48458118|NCT00939705|101457229|FG000|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0||
48458119|NCT00939705|101457230|FG001|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0||
48458120|NCT00939705|101457229|FG000|STARTED|Period 2 - Washout Period - 21 Days||9||
48458121|NCT00939705|101457230|FG001|STARTED|Period 2 - Washout Period - 21 Days||9||
48458122|NCT00939705|101457229|FG000|COMPLETED|Period 2 - Washout Period - 21 Days||9||
48458123|NCT00939705|101457230|FG001|COMPLETED|Period 2 - Washout Period - 21 Days||9||
48458124|NCT00939705|101457229|FG000|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0||
48458125|NCT00939705|101457230|FG001|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0||
48458126|NCT00939705|101457229|FG000|STARTED|Period 3 - Second Intervent - 5 Days||9||
48458127|NCT00939705|101457230|FG001|STARTED|Period 3 - Second Intervent - 5 Days||9||
48458128|NCT00939705|101457229|FG000|COMPLETED|Period 3 - Second Intervent - 5 Days||9||
48458129|NCT00939705|101457230|FG001|COMPLETED|Period 3 - Second Intervent - 5 Days||9||
48458130|NCT00939705|101457229|FG000|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0||
48458131|NCT00939705|101457230|FG001|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0||
48458132|NCT02266706|101457231|FG000|STARTED|Overall Study||6||
48458133|NCT02266706|101457232|FG001|STARTED|Overall Study||7||
48458134|NCT02266706|101457233|FG002|STARTED|Overall Study||4||
48458135|NCT02266706|101457234|FG003|STARTED|Overall Study||4||
48458136|NCT02266706|101457235|FG004|STARTED|Overall Study||1||
48458137|NCT02266706|101457236|FG005|STARTED|Overall Study||7||
48458138|NCT02266706|101457237|FG006|STARTED|Overall Study||8||
48458139|NCT02266706|101457238|FG007|STARTED|Overall Study||2||
48458140|NCT02266706|101457239|FG008|STARTED|Overall Study||4||
48458141|NCT02266706|101457231|FG000|Treated|Overall Study||6||
48458142|NCT02266706|101457232|FG001|Treated|Overall Study||6||
48458143|NCT02266706|101457233|FG002|Treated|Overall Study||3||
48458144|NCT02266706|101457234|FG003|Treated|Overall Study||3||
48458145|NCT02266706|101457235|FG004|Treated|Overall Study||1||
48458146|NCT02266706|101457236|FG005|Treated|Overall Study||5||
48458147|NCT02266706|101457237|FG006|Treated|Overall Study||7||
48458148|NCT02266706|101457238|FG007|Treated|Overall Study||2||
48458149|NCT02266706|101457239|FG008|Treated|Overall Study||4||
48458150|NCT02266706|101457231|FG000|COMPLETED|Overall Study||6||
48458151|NCT02266706|101457232|FG001|COMPLETED|Overall Study||6||
48458152|NCT02266706|101457233|FG002|COMPLETED|Overall Study||3||
48458153|NCT02266706|101457234|FG003|COMPLETED|Overall Study||3||
48458154|NCT02266706|101457235|FG004|COMPLETED|Overall Study||1||
48458155|NCT02266706|101457236|FG005|COMPLETED|Overall Study||5||
48458156|NCT02266706|101457237|FG006|COMPLETED|Overall Study||7||
48458157|NCT02266706|101457238|FG007|COMPLETED|Overall Study||2||
48458158|NCT02266706|101457239|FG008|COMPLETED|Overall Study||4||
48458159|NCT02266706|101457231|FG000|NOT COMPLETED|Overall Study||0||
48458160|NCT02266706|101457232|FG001|NOT COMPLETED|Overall Study||1||
48458161|NCT02266706|101457233|FG002|NOT COMPLETED|Overall Study||1||
48458162|NCT02266706|101457234|FG003|NOT COMPLETED|Overall Study||1||
48458163|NCT02266706|101457235|FG004|NOT COMPLETED|Overall Study||0||
48458164|NCT02266706|101457236|FG005|NOT COMPLETED|Overall Study||2||
48458165|NCT02266706|101457237|FG006|NOT COMPLETED|Overall Study||1||
48458166|NCT02266706|101457238|FG007|NOT COMPLETED|Overall Study||0||
48458167|NCT02266706|101457239|FG008|NOT COMPLETED|Overall Study||0||
48458168|NCT01851590|101457240|FG000|STARTED|Overall Study||23||
48458169|NCT01851590|101457241|FG001|STARTED|Overall Study||25||
48458170|NCT01851590|101457242|FG002|STARTED|Overall Study||25||
48458171|NCT01851590|101457240|FG000|At 3 Month: End of Terbinafine Treatment|Overall Study||23||
48458172|NCT01851590|101457241|FG001|At 3 Month: End of Terbinafine Treatment|Overall Study||24||
48458173|NCT01851590|101457242|FG002|At 3 Month: End of Terbinafine Treatment|Overall Study||22||
48458174|NCT01851590|101457240|FG000|At 4 Month: Follow-up Visit and Control|Overall Study||23||
48458175|NCT01851590|101457241|FG001|At 4 Month: Follow-up Visit and Control|Overall Study||24||
48458176|NCT01851590|101457242|FG002|At 4 Month: Follow-up Visit and Control|Overall Study||22||
48458177|NCT01851590|101457240|FG000|At 9 Month: End of Topical Treatments|Overall Study||23||
48458178|NCT01851590|101457241|FG001|At 9 Month: End of Topical Treatments|Overall Study||24||
48458179|NCT01851590|101457242|FG002|At 9 Month: End of Topical Treatments|Overall Study||22||
48458180|NCT01851590|101457240|FG000|At 10 Month: Follow-up Visit and Control|Overall Study||23||
48458181|NCT01851590|101457241|FG001|At 10 Month: Follow-up Visit and Control|Overall Study||24||
48458182|NCT01851590|101457242|FG002|At 10 Month: Follow-up Visit and Control|Overall Study||22||
48458183|NCT01851590|101457240|FG000|COMPLETED|Overall Study||23||
48458184|NCT01851590|101457241|FG001|COMPLETED|Overall Study||24||
48458185|NCT01851590|101457242|FG002|COMPLETED|Overall Study||22||
48458186|NCT01851590|101457240|FG000|NOT COMPLETED|Overall Study||0||
48458187|NCT01851590|101457241|FG001|NOT COMPLETED|Overall Study||1||
48458188|NCT01851590|101457242|FG002|NOT COMPLETED|Overall Study||3||
48458189|NCT02642627|101457243|FG000|STARTED|Overall Study||42||
48458190|NCT02642627|101457243|FG000|COMPLETED|Overall Study||39||
48458191|NCT02642627|101457243|FG000|NOT COMPLETED|Overall Study||3||
48458192|NCT00408876|101457244|FG000|STARTED|Overall Study||59||
48458193|NCT00408876|101457245|FG001|STARTED|Overall Study||116||
48458194|NCT00408876|101457246|FG002|STARTED|Overall Study||112||
48458195|NCT00408876|101457247|FG003|STARTED|Overall Study||117||
48458196|NCT00408876|101457244|FG000|COMPLETED|Overall Study||43||
48458197|NCT00408876|101457245|FG001|COMPLETED|Overall Study||80||
48458198|NCT00408876|101457246|FG002|COMPLETED|Overall Study||62||
48458199|NCT00408876|101457247|FG003|COMPLETED|Overall Study||82||
48458200|NCT00408876|101457244|FG000|NOT COMPLETED|Overall Study||16||
48458201|NCT00408876|101457245|FG001|NOT COMPLETED|Overall Study||36||
48458202|NCT00408876|101457246|FG002|NOT COMPLETED|Overall Study||50||
48458203|NCT00408876|101457247|FG003|NOT COMPLETED|Overall Study||35||
48458204|NCT01743677|101457248|FG000|STARTED|First Intervention Period||10||
48458205|NCT01743677|101457249|FG001|STARTED|First Intervention Period||10||
48458206|NCT01743677|101457250|FG002|STARTED|First Intervention Period||10||
48458207|NCT01743677|101457251|FG003|STARTED|First Intervention Period||10||
48458208|NCT01743677|101457252|FG004|STARTED|First Intervention Period||10||
48458209|NCT01743677|101457253|FG005|STARTED|First Intervention Period||10||
48458210|NCT01743677|101457248|FG000|COMPLETED|First Intervention Period||10||
48458211|NCT01743677|101457249|FG001|COMPLETED|First Intervention Period||10||
48458212|NCT01743677|101457250|FG002|COMPLETED|First Intervention Period||10||
48458213|NCT01743677|101457251|FG003|COMPLETED|First Intervention Period||10||
48773604|NCT01584440|102232965|FG002|NOT COMPLETED|Stage 1 (5 Weeks)||0||
48773605|NCT01584440|102232966|FG003|NOT COMPLETED|Stage 1 (5 Weeks)||0||
48773606|NCT01584440|102232967|FG004|NOT COMPLETED|Stage 1 (5 Weeks)||0||
48458214|NCT01743677|101457252|FG004|COMPLETED|First Intervention Period||10||
48458215|NCT01743677|101457253|FG005|COMPLETED|First Intervention Period||10||
48458216|NCT01743677|101457248|FG000|NOT COMPLETED|First Intervention Period||0||
48458217|NCT01743677|101457249|FG001|NOT COMPLETED|First Intervention Period||0||
48458218|NCT01743677|101457250|FG002|NOT COMPLETED|First Intervention Period||0||
48458219|NCT01743677|101457251|FG003|NOT COMPLETED|First Intervention Period||0||
48458220|NCT01743677|101457252|FG004|NOT COMPLETED|First Intervention Period||0||
48458221|NCT01743677|101457253|FG005|NOT COMPLETED|First Intervention Period||0||
48458222|NCT01743677|101457248|FG000|STARTED|Washout Period 1 (at Least 7 Days)||10||
48458223|NCT01743677|101457249|FG001|STARTED|Washout Period 1 (at Least 7 Days)||10||
48773607|NCT01584440|102232963|FG000|STARTED|Stage 2 (5 Weeks)||0||
48773608|NCT01584440|102232964|FG001|STARTED|Stage 2 (5 Weeks)||0||
48773609|NCT01584440|102232965|FG002|STARTED|Stage 2 (5 Weeks)||83||
48773610|NCT01584440|102232966|FG003|STARTED|Stage 2 (5 Weeks)||59||
48773611|NCT01584440|102232967|FG004|STARTED|Stage 2 (5 Weeks)||60||
48773612|NCT01584440|102232963|FG000|COMPLETED|Stage 2 (5 Weeks)||0||
48773613|NCT01584440|102232964|FG001|COMPLETED|Stage 2 (5 Weeks)||0||
48773614|NCT01584440|102232965|FG002|COMPLETED|Stage 2 (5 Weeks)||80||
48773615|NCT01584440|102232966|FG003|COMPLETED|Stage 2 (5 Weeks)||55||
48773616|NCT01584440|102232967|FG004|COMPLETED|Stage 2 (5 Weeks)||59||
48773617|NCT01584440|102232963|FG000|NOT COMPLETED|Stage 2 (5 Weeks)||0||
48189635|NCT01598987|100786265|FG000|STARTED|Baseline to Month 12||56||
48458224|NCT01743677|101457250|FG002|STARTED|Washout Period 1 (at Least 7 Days)||10||
48458225|NCT01743677|101457251|FG003|STARTED|Washout Period 1 (at Least 7 Days)||10||
48458226|NCT01743677|101457252|FG004|STARTED|Washout Period 1 (at Least 7 Days)||10||
48458227|NCT01743677|101457253|FG005|STARTED|Washout Period 1 (at Least 7 Days)||10||
48458228|NCT01743677|101457248|FG000|COMPLETED|Washout Period 1 (at Least 7 Days)||10||
48458229|NCT01743677|101457249|FG001|COMPLETED|Washout Period 1 (at Least 7 Days)||10||
48773618|NCT01584440|102232964|FG001|NOT COMPLETED|Stage 2 (5 Weeks)||0||
48773619|NCT01584440|102232965|FG002|NOT COMPLETED|Stage 2 (5 Weeks)||3||
48773620|NCT01584440|102232966|FG003|NOT COMPLETED|Stage 2 (5 Weeks)||4||
48773621|NCT01584440|102232967|FG004|NOT COMPLETED|Stage 2 (5 Weeks)||1||
48458230|NCT01743677|101457250|FG002|COMPLETED|Washout Period 1 (at Least 7 Days)||10||
48458231|NCT01743677|101457251|FG003|COMPLETED|Washout Period 1 (at Least 7 Days)||10||
48458232|NCT01743677|101457252|FG004|COMPLETED|Washout Period 1 (at Least 7 Days)||10||
48458233|NCT01743677|101457253|FG005|COMPLETED|Washout Period 1 (at Least 7 Days)||10||
48458234|NCT01743677|101457248|FG000|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0||
48458235|NCT01743677|101457249|FG001|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0||
48458236|NCT01743677|101457250|FG002|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0||
48458237|NCT01743677|101457251|FG003|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0||
48458238|NCT01743677|101457252|FG004|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0||
48458239|NCT01743677|101457253|FG005|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0||
48458240|NCT01743677|101457248|FG000|STARTED|Second Intervention Period||10||
48458241|NCT01743677|101457249|FG001|STARTED|Second Intervention Period||10||
48458242|NCT01743677|101457250|FG002|STARTED|Second Intervention Period||10||
48458243|NCT01743677|101457251|FG003|STARTED|Second Intervention Period||10||
48458244|NCT01743677|101457252|FG004|STARTED|Second Intervention Period||10||
48458245|NCT01743677|101457253|FG005|STARTED|Second Intervention Period||10||
48458246|NCT01743677|101457248|FG000|COMPLETED|Second Intervention Period||10||
48458247|NCT01743677|101457249|FG001|COMPLETED|Second Intervention Period||10||
48458248|NCT01743677|101457250|FG002|COMPLETED|Second Intervention Period||10||
48458249|NCT01743677|101457251|FG003|COMPLETED|Second Intervention Period||10||
48458250|NCT01743677|101457252|FG004|COMPLETED|Second Intervention Period||10||
48458251|NCT01743677|101457253|FG005|COMPLETED|Second Intervention Period||10||
48458252|NCT01743677|101457248|FG000|NOT COMPLETED|Second Intervention Period||0||
48458253|NCT01743677|101457249|FG001|NOT COMPLETED|Second Intervention Period||0||
48458254|NCT01743677|101457250|FG002|NOT COMPLETED|Second Intervention Period||0||
48458255|NCT01743677|101457251|FG003|NOT COMPLETED|Second Intervention Period||0||
48458256|NCT01743677|101457252|FG004|NOT COMPLETED|Second Intervention Period||0||
48458257|NCT01743677|101457253|FG005|NOT COMPLETED|Second Intervention Period||0||
48458258|NCT01743677|101457248|FG000|STARTED|Washout Period 2 (at Least 7 Days)||10||
48458259|NCT01743677|101457249|FG001|STARTED|Washout Period 2 (at Least 7 Days)||10||
48458260|NCT01743677|101457250|FG002|STARTED|Washout Period 2 (at Least 7 Days)||10||
48458261|NCT01743677|101457251|FG003|STARTED|Washout Period 2 (at Least 7 Days)||10||
48458262|NCT01743677|101457252|FG004|STARTED|Washout Period 2 (at Least 7 Days)||10||
48458263|NCT01743677|101457253|FG005|STARTED|Washout Period 2 (at Least 7 Days)||10||
48458264|NCT01743677|101457248|FG000|COMPLETED|Washout Period 2 (at Least 7 Days)||10||
48458265|NCT01743677|101457249|FG001|COMPLETED|Washout Period 2 (at Least 7 Days)||10||
48458266|NCT01743677|101457250|FG002|COMPLETED|Washout Period 2 (at Least 7 Days)||10||
48458267|NCT01743677|101457251|FG003|COMPLETED|Washout Period 2 (at Least 7 Days)||10||
48458268|NCT01743677|101457252|FG004|COMPLETED|Washout Period 2 (at Least 7 Days)||10||
48458269|NCT01743677|101457253|FG005|COMPLETED|Washout Period 2 (at Least 7 Days)||10||
48458270|NCT01743677|101457248|FG000|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0||
48458271|NCT01743677|101457249|FG001|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0||
48458272|NCT01743677|101457250|FG002|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0||
48458273|NCT01743677|101457251|FG003|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0||
48458274|NCT01743677|101457252|FG004|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0||
48458275|NCT01743677|101457253|FG005|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0||
48458276|NCT01743677|101457248|FG000|STARTED|Third Intervention Period||10||
48458277|NCT01743677|101457249|FG001|STARTED|Third Intervention Period||10||
48458278|NCT01743677|101457250|FG002|STARTED|Third Intervention Period||10||
48458279|NCT01743677|101457251|FG003|STARTED|Third Intervention Period||10||
48458280|NCT01743677|101457252|FG004|STARTED|Third Intervention Period||10||
48458281|NCT01743677|101457253|FG005|STARTED|Third Intervention Period||10||
48458282|NCT01743677|101457248|FG000|COMPLETED|Third Intervention Period||10||
48458283|NCT01743677|101457249|FG001|COMPLETED|Third Intervention Period||10||
48458284|NCT01743677|101457250|FG002|COMPLETED|Third Intervention Period||10||
48458285|NCT01743677|101457251|FG003|COMPLETED|Third Intervention Period||10||
48458286|NCT01743677|101457252|FG004|COMPLETED|Third Intervention Period||10||
48458287|NCT01743677|101457253|FG005|COMPLETED|Third Intervention Period||10||
48458288|NCT01743677|101457248|FG000|NOT COMPLETED|Third Intervention Period||0||
48458289|NCT01743677|101457249|FG001|NOT COMPLETED|Third Intervention Period||0||
48458290|NCT01743677|101457250|FG002|NOT COMPLETED|Third Intervention Period||0||
48458291|NCT01743677|101457251|FG003|NOT COMPLETED|Third Intervention Period||0||
48458292|NCT01743677|101457252|FG004|NOT COMPLETED|Third Intervention Period||0||
48458293|NCT01743677|101457253|FG005|NOT COMPLETED|Third Intervention Period||0||
48458294|NCT00833781|101457254|FG000|STARTED|Overall Study||10||
48458295|NCT00833781|101457255|FG001|STARTED|Overall Study||5||
48458296|NCT00833781|101457254|FG000|COMPLETED|Overall Study||10||
48458297|NCT00833781|101457255|FG001|COMPLETED|Overall Study||5||
48458298|NCT00833781|101457254|FG000|NOT COMPLETED|Overall Study||0||
48458299|NCT00833781|101457255|FG001|NOT COMPLETED|Overall Study||0||
48458300|NCT00362401|101457256|FG000|STARTED|Overall Study||15||
48663554|NCT04629196|101959633|FG001|NOT COMPLETED|Overall Study||3||
48458301|NCT00362401|101457257|FG001|STARTED|Overall Study||29||
48458302|NCT00362401|101457258|FG002|STARTED|Overall Study||40||
48458303|NCT00362401|101457256|FG000|COMPLETED|Overall Study||15||
48458304|NCT00362401|101457257|FG001|COMPLETED|Overall Study||29||
48458305|NCT00362401|101457258|FG002|COMPLETED|Overall Study||40||
48458306|NCT00362401|101457256|FG000|NOT COMPLETED|Overall Study||0||
48458307|NCT00362401|101457257|FG001|NOT COMPLETED|Overall Study||0||
48458308|NCT00362401|101457258|FG002|NOT COMPLETED|Overall Study||0||
48458309|NCT02006147|101457259|FG000|STARTED|Overall Study||5||
48458310|NCT02006147|101457260|FG001|STARTED|Overall Study||9||
48458311|NCT02006147|101457261|FG002|STARTED|Overall Study||0||
48458312|NCT02006147|101457262|FG003|STARTED|Overall Study||0||
48458313|NCT02006147|101457259|FG000|COMPLETED|Overall Study||3||
48458314|NCT02006147|101457260|FG001|COMPLETED|Overall Study||7||
48458315|NCT02006147|101457261|FG002|COMPLETED|Overall Study||0||
48458316|NCT02006147|101457262|FG003|COMPLETED|Overall Study||0||
48458317|NCT02006147|101457259|FG000|NOT COMPLETED|Overall Study||2||
48458318|NCT02006147|101457260|FG001|NOT COMPLETED|Overall Study||2||
48458319|NCT02006147|101457261|FG002|NOT COMPLETED|Overall Study||0||
48458320|NCT02006147|101457262|FG003|NOT COMPLETED|Overall Study||0||
48458321|NCT01238822|101457263|FG000|STARTED|Overall Study||96||
48458322|NCT01238822|101457263|FG000|Received Placebo|Overall Study||93||
48458323|NCT01238822|101457263|FG000|Received Low Dosage|Overall Study||93||
48458324|NCT01238822|101457263|FG000|Received Medium Dosage|Overall Study||93||
48458325|NCT01238822|101457263|FG000|Received High Dosage|Overall Study||93||
48458326|NCT01238822|101457263|FG000|COMPLETED|Overall Study||93||
48458327|NCT01238822|101457263|FG000|NOT COMPLETED|Overall Study||3||
48458328|NCT02785172|101457264|FG000|STARTED|Overall Study||61||
48458329|NCT02785172|101457265|FG001|STARTED|Overall Study||63||
48458330|NCT02785172|101457266|FG002|STARTED|Overall Study||16||
48458331|NCT02785172|101457267|FG003|STARTED|Overall Study||14||
48458332|NCT02785172|101457264|FG000|COMPLETED|Overall Study||61||
48458333|NCT02785172|101457265|FG001|COMPLETED|Overall Study||62||
48458334|NCT02785172|101457266|FG002|COMPLETED|Overall Study||15||
48458335|NCT02785172|101457267|FG003|COMPLETED|Overall Study||14||
48458336|NCT02785172|101457264|FG000|NOT COMPLETED|Overall Study||0||
48458337|NCT02785172|101457265|FG001|NOT COMPLETED|Overall Study||1||
48458338|NCT02785172|101457266|FG002|NOT COMPLETED|Overall Study||1||
48458339|NCT02785172|101457267|FG003|NOT COMPLETED|Overall Study||0||
48458340|NCT04555525|101457268|FG000|STARTED|Overall Study||75||
48458341|NCT04555525|101457269|FG001|STARTED|Overall Study||25||
48458342|NCT04555525|101457268|FG000|COMPLETED|Overall Study||72||
48458343|NCT04555525|101457269|FG001|COMPLETED|Overall Study||25||
48458344|NCT04555525|101457268|FG000|NOT COMPLETED|Overall Study||3||
48458345|NCT04555525|101457269|FG001|NOT COMPLETED|Overall Study||0||
48458346|NCT01023269|101457270|FG000|STARTED|Overall Study||3||
48458347|NCT01023269|101457271|FG001|STARTED|Overall Study||2||
48458348|NCT01023269|101457270|FG000|COMPLETED|Overall Study||1||
48458349|NCT01023269|101457271|FG001|COMPLETED|Overall Study||2||
48458350|NCT01023269|101457270|FG000|NOT COMPLETED|Overall Study||2||
48458351|NCT01023269|101457271|FG001|NOT COMPLETED|Overall Study||0||
48458352|NCT00979628|101457272|FG000|STARTED|Overall Study||153||
48458353|NCT00979628|101457273|FG001|STARTED|Overall Study||142||
48458354|NCT00979628|101457274|FG002|STARTED|Overall Study||80||
48458355|NCT00979628|101457272|FG000|COMPLETED|Overall Study||144||
48458356|NCT00979628|101457273|FG001|COMPLETED|Overall Study||133||
48458357|NCT00979628|101457274|FG002|COMPLETED|Overall Study||74||
48663555|NCT05418426|101959634|FG000|STARTED|Overall Study||10||
48663556|NCT05418426|101959635|FG001|STARTED|Overall Study||12||
48663557|NCT05418426|101959636|FG002|STARTED|Overall Study||12||
48663558|NCT05418426|101959634|FG000|COMPLETED|Overall Study||10||
48663559|NCT05418426|101959635|FG001|COMPLETED|Overall Study||10||
48663560|NCT05418426|101959636|FG002|COMPLETED|Overall Study||11||
48663561|NCT05418426|101959634|FG000|NOT COMPLETED|Overall Study||0||
48663562|NCT05418426|101959635|FG001|NOT COMPLETED|Overall Study||2||
48773622|NCT02970162|102232968|FG000|STARTED|Overall Study||13||
48773623|NCT02970162|102232969|FG001|STARTED|Overall Study||13||
48773624|NCT02970162|102232968|FG000|COMPLETED|Overall Study||13||
48458358|NCT00979628|101457272|FG000|NOT COMPLETED|Overall Study||9||
48458359|NCT00979628|101457273|FG001|NOT COMPLETED|Overall Study||9||
48458360|NCT00979628|101457274|FG002|NOT COMPLETED|Overall Study||6||
48458361|NCT00549198|101457275|FG000|STARTED|Overall Study||195||
48458362|NCT00549198|101457276|FG001|STARTED|Overall Study||197||
48458363|NCT00549198|101457275|FG000|COMPLETED|Overall Study||115||
48458364|NCT00549198|101457276|FG001|COMPLETED|Overall Study||134||
48458365|NCT00549198|101457275|FG000|NOT COMPLETED|Overall Study||80||
48458366|NCT00549198|101457276|FG001|NOT COMPLETED|Overall Study||63||
48458367|NCT02139306|101457277|FG000|STARTED|Overall Study||140||
48458368|NCT02139306|101457278|FG001|STARTED|Overall Study||139||
48458369|NCT02139306|101457277|FG000|COMPLETED|Overall Study||127||
48458370|NCT02139306|101457278|FG001|COMPLETED|Overall Study||125||
48458371|NCT02139306|101457277|FG000|NOT COMPLETED|Overall Study||13||
48458372|NCT02139306|101457278|FG001|NOT COMPLETED|Overall Study||14||
48458373|NCT01832090|101457279|FG000|STARTED|Overall Study||89||
48458374|NCT01832090|101457280|FG001|STARTED|Overall Study||29||
48458375|NCT01832090|101457279|FG000|COMPLETED|Overall Study||83||
48458376|NCT01832090|101457280|FG001|COMPLETED|Overall Study||28||
48458377|NCT01832090|101457279|FG000|NOT COMPLETED|Overall Study||6||
48663563|NCT05418426|101959636|FG002|NOT COMPLETED|Overall Study||1||
48663564|NCT00928720|101959637|FG000|STARTED|Overall Study||19||
48458378|NCT01832090|101457280|FG001|NOT COMPLETED|Overall Study||1||
48458379|NCT02415166|101457281|FG000|STARTED|Overall Study||6||
48458380|NCT02415166|101457282|FG001|STARTED|Overall Study||0||
48458381|NCT02415166|101457283|FG002|STARTED|Overall Study||0||
48458382|NCT02415166|101457284|FG003|STARTED|Overall Study||0||
48773625|NCT02970162|102232969|FG001|COMPLETED|Overall Study||13||
48773626|NCT02970162|102232968|FG000|NOT COMPLETED|Overall Study||0||
48773627|NCT02970162|102232969|FG001|NOT COMPLETED|Overall Study||0||
48773628|NCT01421719|102232970|FG000|STARTED|Overall Study||20||
48773629|NCT01421719|102232970|FG000|COMPLETED|Overall Study||16||
48773630|NCT01421719|102232970|FG000|NOT COMPLETED|Overall Study||4||
48773631|NCT02453711|102232971|FG000|STARTED|Overall Study||103||
48773632|NCT02453711|102232972|FG001|STARTED|Overall Study||102||
48773633|NCT02453711|102232973|FG002|STARTED|Overall Study||103||
48773634|NCT02453711|102232974|FG003|STARTED|Overall Study||103||
48773635|NCT02453711|102232975|FG004|STARTED|Overall Study||102||
48773636|NCT02453711|102232976|FG005|STARTED|Overall Study||102||
48773637|NCT02453711|102232977|FG006|STARTED|Overall Study||103||
48773638|NCT02453711|102232978|FG007|STARTED|Overall Study||103||
48773639|NCT02453711|102232979|FG008|STARTED|Overall Study||136||
48773640|NCT02453711|102232971|FG000|Full Analysis Set|Overall Study||103||
48773641|NCT02453711|102232972|FG001|Full Analysis Set|Overall Study||102||
48773642|NCT02453711|102232973|FG002|Full Analysis Set|Overall Study||103||
48773643|NCT02453711|102232974|FG003|Full Analysis Set|Overall Study||103||
48773644|NCT02453711|102232975|FG004|Full Analysis Set|Overall Study||102||
48773645|NCT02453711|102232976|FG005|Full Analysis Set|Overall Study||102||
48773646|NCT02453711|102232977|FG006|Full Analysis Set|Overall Study||103||
48773647|NCT02453711|102232978|FG007|Full Analysis Set|Overall Study||103||
48773648|NCT02453711|102232979|FG008|Full Analysis Set|Overall Study||136||
48773649|NCT02453711|102232971|FG000|Safety Analysis Set|Overall Study||103||
48458383|NCT02415166|101457281|FG000|COMPLETED|Overall Study||6||
48458384|NCT02415166|101457282|FG001|COMPLETED|Overall Study||0||
48773650|NCT02453711|102232972|FG001|Safety Analysis Set|Overall Study||102||
48773651|NCT02453711|102232973|FG002|Safety Analysis Set|Overall Study||103||
48773652|NCT02453711|102232974|FG003|Safety Analysis Set|Overall Study||103||
48773653|NCT02453711|102232975|FG004|Safety Analysis Set|Overall Study||102||
48773654|NCT02453711|102232976|FG005|Safety Analysis Set|Overall Study||102||
48773655|NCT02453711|102232977|FG006|Safety Analysis Set|Overall Study||103||
48458385|NCT02415166|101457283|FG002|COMPLETED|Overall Study||0||
48458386|NCT02415166|101457284|FG003|COMPLETED|Overall Study||0||
48458387|NCT02415166|101457281|FG000|NOT COMPLETED|Overall Study||0||
48458388|NCT02415166|101457282|FG001|NOT COMPLETED|Overall Study||0||
48458389|NCT02415166|101457283|FG002|NOT COMPLETED|Overall Study||0||
48458390|NCT02415166|101457284|FG003|NOT COMPLETED|Overall Study||0||
48773656|NCT02453711|102232978|FG007|Safety Analysis Set|Overall Study||103||
48773657|NCT02453711|102232979|FG008|Safety Analysis Set|Overall Study||136||
48773658|NCT02453711|102232971|FG000|COMPLETED|Overall Study||92||
48773659|NCT02453711|102232972|FG001|COMPLETED|Overall Study||95||
48773660|NCT02453711|102232973|FG002|COMPLETED|Overall Study||94||
48773661|NCT02453711|102232974|FG003|COMPLETED|Overall Study||96||
48773662|NCT02453711|102232975|FG004|COMPLETED|Overall Study||100||
48773663|NCT02453711|102232976|FG005|COMPLETED|Overall Study||96||
48773664|NCT02453711|102232977|FG006|COMPLETED|Overall Study||100||
48773665|NCT02453711|102232978|FG007|COMPLETED|Overall Study||96||
48458391|NCT00528437|101457285|FG000|STARTED|Overall Study||46||
48458392|NCT00528437|101457285|FG000|COMPLETED|Overall Study||46||
48458393|NCT00528437|101457285|FG000|NOT COMPLETED|Overall Study||0||
48458394|NCT03501550|101457286|FG000|STARTED|Overall Study||12||
48458395|NCT03501550|101457286|FG000|COMPLETED|Overall Study||12||
48458396|NCT03501550|101457286|FG000|NOT COMPLETED|Overall Study||0||
48458397|NCT01314703|101457287|FG000|STARTED|Overall Study||35||
48458398|NCT01314703|101457287|FG000|Signed Informed Consent|Overall Study||35||
48458399|NCT01314703|101457287|FG000|Completed Screen Visit|Overall Study||33||
48458400|NCT01314703|101457287|FG000|Completed Treatment Visit|Overall Study||27||
48458401|NCT01314703|101457287|FG000|Completed Study|Overall Study||27||
48458402|NCT01314703|101457287|FG000|Excluded Prior to Screening Baseline|Overall Study||2||
48458403|NCT01314703|101457287|FG000|Non Qualified Bacterial Screening Counts|Overall Study||3||
48458404|NCT01314703|101457287|FG000|Discontinued When Enrollment Completed|Overall Study||3||
48458405|NCT01314703|101457287|FG000|COMPLETED|Overall Study||27||
48458406|NCT01314703|101457287|FG000|NOT COMPLETED|Overall Study||8||
48458407|NCT02184494|101457288|FG000|STARTED|Overall Study||13||
48458408|NCT02184494|101457289|FG001|STARTED|Overall Study||13||
48458409|NCT02184494|101457290|FG002|STARTED|Overall Study||8||
48458410|NCT02184494|101457288|FG000|COMPLETED|Overall Study||12||
48458411|NCT02184494|101457289|FG001|COMPLETED|Overall Study||11||
48458412|NCT02184494|101457290|FG002|COMPLETED|Overall Study||8||
48458413|NCT02184494|101457288|FG000|NOT COMPLETED|Overall Study||1||
48458414|NCT02184494|101457289|FG001|NOT COMPLETED|Overall Study||2||
48458415|NCT02184494|101457290|FG002|NOT COMPLETED|Overall Study||0||
48458416|NCT00950183|101457291|FG000|STARTED|Overall Study||36||
48458417|NCT00950183|101457291|FG000|COMPLETED|Overall Study||0||
48458418|NCT00950183|101457291|FG000|NOT COMPLETED|Overall Study||36||
48458419|NCT01907087|101457292|FG000|STARTED|Overall Study||24||
48458420|NCT01907087|101457292|FG000|COMPLETED|Overall Study||23||
48458421|NCT01907087|101457292|FG000|NOT COMPLETED|Overall Study||1||
48663565|NCT00928720|101959638|FG001|STARTED|Overall Study||20||
48773666|NCT02453711|102232979|FG008|COMPLETED|Overall Study||123||
48773667|NCT02453711|102232971|FG000|NOT COMPLETED|Overall Study||11||
48773668|NCT02453711|102232972|FG001|NOT COMPLETED|Overall Study||7||
48773669|NCT02453711|102232973|FG002|NOT COMPLETED|Overall Study||9||
48458422|NCT01859390|101457293|FG000|STARTED|Overall Study||36|Randomized|
48458423|NCT01859390|101457294|FG001|STARTED|Overall Study||37|Randomized|
48458424|NCT01859390|101457293|FG000|Withdrawals|Overall Study||2|Participants can withdraw anytime prior to their Week 18 follow-up visit.|
48773670|NCT02453711|102232974|FG003|NOT COMPLETED|Overall Study||7||
48773671|NCT02453711|102232975|FG004|NOT COMPLETED|Overall Study||2||
48773672|NCT02453711|102232976|FG005|NOT COMPLETED|Overall Study||6||
48773673|NCT02453711|102232977|FG006|NOT COMPLETED|Overall Study||3||
48773674|NCT02453711|102232978|FG007|NOT COMPLETED|Overall Study||7||
48773675|NCT02453711|102232979|FG008|NOT COMPLETED|Overall Study||13||
48773676|NCT03507569|102236391|FG000|STARTED|Overall Study||2||
48773677|NCT03507569|102236392|FG001|STARTED|Overall Study||1||
48773678|NCT03507569|102236393|FG002|STARTED|Overall Study||2||
48773679|NCT03507569|102236394|FG003|STARTED|Overall Study||1||
48773680|NCT03507569|102236391|FG000|COMPLETED|Overall Study||2||
48773681|NCT03507569|102236392|FG001|COMPLETED|Overall Study||1||
48773682|NCT03507569|102236393|FG002|COMPLETED|Overall Study||2||
48773683|NCT03507569|102236394|FG003|COMPLETED|Overall Study||1||
48773684|NCT03507569|102236391|FG000|NOT COMPLETED|Overall Study||0||
48773685|NCT03507569|102236392|FG001|NOT COMPLETED|Overall Study||0||
48773686|NCT03507569|102236393|FG002|NOT COMPLETED|Overall Study||0||
48773687|NCT03507569|102236394|FG003|NOT COMPLETED|Overall Study||0||
48773688|NCT00248040|102236395|FG000|STARTED|Overall Study||25||
48773689|NCT00248040|102236396|FG001|STARTED|Overall Study||23||
48773690|NCT00248040|102236397|FG002|STARTED|Overall Study||26||
48663566|NCT00928720|101959639|FG002|STARTED|Overall Study||18||
48663567|NCT00928720|101959637|FG000|COMPLETED|Overall Study||17||
48663568|NCT00928720|101959638|FG001|COMPLETED|Overall Study||14||
48663569|NCT00928720|101959639|FG002|COMPLETED|Overall Study||15||
48773691|NCT00248040|102236395|FG000|COMPLETED|Overall Study||22||
48773692|NCT00248040|102236396|FG001|COMPLETED|Overall Study||22||
48773693|NCT00248040|102236397|FG002|COMPLETED|Overall Study||22||
48773694|NCT00248040|102236395|FG000|NOT COMPLETED|Overall Study||3||
48773695|NCT00248040|102236396|FG001|NOT COMPLETED|Overall Study||1||
48773696|NCT00248040|102236397|FG002|NOT COMPLETED|Overall Study||4||
48773697|NCT01941186|102236398|FG000|STARTED|Randomization/Allocation to Study Group||31||
48773698|NCT01941186|102236399|FG001|STARTED|Randomization/Allocation to Study Group||33||
48773699|NCT01941186|102236398|FG000|COMPLETED|Randomization/Allocation to Study Group||31||
48773700|NCT01941186|102236399|FG001|COMPLETED|Randomization/Allocation to Study Group||33||
48773701|NCT01941186|102236398|FG000|NOT COMPLETED|Randomization/Allocation to Study Group||0||
48773702|NCT01941186|102236399|FG001|NOT COMPLETED|Randomization/Allocation to Study Group||0||
48773703|NCT01941186|102236398|FG000|STARTED|Follow-up||31||
48773704|NCT01941186|102236399|FG001|STARTED|Follow-up||33||
48773705|NCT01941186|102236398|FG000|COMPLETED|Follow-up||30||
48773706|NCT01941186|102236399|FG001|COMPLETED|Follow-up||33||
48458425|NCT01859390|101457294|FG001|Withdrawals|Overall Study||2|Participants can withdraw anytime prior to their Week 18 follow-up visit.|
48458426|NCT01859390|101457293|FG000|COMPLETED|Overall Study||35|Based on availability of Week 16 sputum myeloperoxidase (MPO) measurement (primary endpoint)|
48458427|NCT01859390|101457294|FG001|COMPLETED|Overall Study||30|Based on availability of Week 16 sputum myeloperoxidase (MPO) measurement (primary endpoint)|
48458428|NCT01859390|101457293|FG000|NOT COMPLETED|Overall Study||1||
48458429|NCT01859390|101457294|FG001|NOT COMPLETED|Overall Study||7||
48458430|NCT00272337|101457295|FG000|STARTED|Overall Study||8||
48663570|NCT00928720|101959637|FG000|NOT COMPLETED|Overall Study||2||
48663571|NCT00928720|101959638|FG001|NOT COMPLETED|Overall Study||6||
48663572|NCT00928720|101959639|FG002|NOT COMPLETED|Overall Study||3||
48663573|NCT01339091|101959640|FG000|STARTED|Overall Study||288||
48663574|NCT01339091|101959641|FG001|STARTED|Overall Study||285||
48773707|NCT01941186|102236398|FG000|NOT COMPLETED|Follow-up||1||
48773708|NCT01941186|102236399|FG001|NOT COMPLETED|Follow-up||0||
48773709|NCT00380367|102236400|FG000|STARTED|Overall Study||110||
48773710|NCT00380367|102236400|FG000|COMPLETED|Overall Study||108||
48773711|NCT00380367|102236400|FG000|NOT COMPLETED|Overall Study||2||
48773712|NCT03830307|102236401|FG000|STARTED|Overall Study||5||
48773713|NCT03830307|102236401|FG000|COMPLETED|Overall Study||5||
48773714|NCT03830307|102236401|FG000|NOT COMPLETED|Overall Study||0||
48773715|NCT00943618|102236402|FG000|STARTED|Overall Study||163||
48773716|NCT00943618|102236403|FG001|STARTED|Overall Study||166||
48773717|NCT00943618|102236404|FG002|STARTED|Overall Study||56||
48773718|NCT00943618|102236402|FG000|COMPLETED|Overall Study||108||
48773719|NCT00943618|102236403|FG001|COMPLETED|Overall Study||89||
48773720|NCT00943618|102236404|FG002|COMPLETED|Overall Study||25||
48773721|NCT00943618|102236402|FG000|NOT COMPLETED|Overall Study||55||
48773722|NCT00943618|102236403|FG001|NOT COMPLETED|Overall Study||77||
48773723|NCT00943618|102236404|FG002|NOT COMPLETED|Overall Study||31||
48663575|NCT01339091|101959640|FG000|Safety Population|Overall Study||284||
48663576|NCT01339091|101959641|FG001|Safety Population|Overall Study||284||
48663577|NCT01339091|101959640|FG000|COMPLETED|Overall Study||261||
48663578|NCT01339091|101959641|FG001|COMPLETED|Overall Study||257||
48663579|NCT01339091|101959640|FG000|NOT COMPLETED|Overall Study||27||
48663580|NCT01339091|101959641|FG001|NOT COMPLETED|Overall Study||28||
48773724|NCT02447302|102236405|FG000|STARTED|Overall Study||52||
48773725|NCT02447302|102236406|FG001|STARTED|Overall Study||50||
48773726|NCT02447302|102236407|FG002|STARTED|Overall Study||54||
48773727|NCT02447302|102236405|FG000|COMPLETED|Overall Study||47||
48773728|NCT02447302|102236406|FG001|COMPLETED|Overall Study||46||
48773729|NCT02447302|102236407|FG002|COMPLETED|Overall Study||48||
48773730|NCT02447302|102236405|FG000|NOT COMPLETED|Overall Study||5||
48773731|NCT02447302|102236406|FG001|NOT COMPLETED|Overall Study||4||
48773732|NCT02447302|102236407|FG002|NOT COMPLETED|Overall Study||6||
48773733|NCT02042274|102236408|FG000|STARTED|Overall Study||12||
48773734|NCT02042274|102236408|FG000|COMPLETED|Overall Study||12||
48773735|NCT02042274|102236408|FG000|NOT COMPLETED|Overall Study||0||
48773736|NCT03239106|102236409|FG000|STARTED|Overall Study||10||
48773737|NCT03239106|102236409|FG000|COMPLETED|Overall Study||3||
48773738|NCT03239106|102236409|FG000|NOT COMPLETED|Overall Study||7||
48773739|NCT02645019|102236410|FG000|STARTED|Overall Study||13||
48773740|NCT02645019|102236411|FG001|STARTED|Overall Study||15||
48773741|NCT02645019|102236412|FG002|STARTED|Overall Study||15||
48773742|NCT02645019|102236413|FG003|STARTED|Overall Study||33||
48773743|NCT02645019|102236414|FG004|STARTED|Overall Study||24||
48773744|NCT02645019|102236410|FG000|COMPLETED|Overall Study||13||
48773745|NCT02645019|102236411|FG001|COMPLETED|Overall Study||15||
48773746|NCT02645019|102236412|FG002|COMPLETED|Overall Study||15||
48773747|NCT02645019|102236413|FG003|COMPLETED|Overall Study||33||
48773748|NCT02645019|102236414|FG004|COMPLETED|Overall Study||24||
48773749|NCT02645019|102236410|FG000|NOT COMPLETED|Overall Study||0||
48773750|NCT02645019|102236411|FG001|NOT COMPLETED|Overall Study||0||
48773751|NCT02645019|102236412|FG002|NOT COMPLETED|Overall Study||0||
48773752|NCT02645019|102236413|FG003|NOT COMPLETED|Overall Study||0||
48773753|NCT02645019|102236414|FG004|NOT COMPLETED|Overall Study||0||
48773754|NCT01185080|102236415|FG000|STARTED|Overall Study||50||
48773755|NCT01185080|102236416|FG001|STARTED|Overall Study||16||
48773756|NCT01185080|102236417|FG002|STARTED|Overall Study||17||
48773757|NCT01185080|102236415|FG000|COMPLETED|Overall Study||49||
48773758|NCT01185080|102236416|FG001|COMPLETED|Overall Study||15||
48773759|NCT01185080|102236417|FG002|COMPLETED|Overall Study||16||
48773760|NCT01185080|102236415|FG000|NOT COMPLETED|Overall Study||1||
48773761|NCT01185080|102236416|FG001|NOT COMPLETED|Overall Study||1||
48773762|NCT01185080|102236417|FG002|NOT COMPLETED|Overall Study||1||
48773763|NCT01388335|102236418|FG000|STARTED|Period 1||13||
48773764|NCT01388335|102236418|FG000|Received at Least 1 Dose of Study Drug|Period 1||13||
48773765|NCT01388335|102236418|FG000|COMPLETED|Period 1||12||
48773766|NCT01388335|102236418|FG000|NOT COMPLETED|Period 1||1||
48773767|NCT01388335|102236418|FG000|STARTED|Period 2||12||
48773768|NCT01388335|102236418|FG000|Received at Least 1 Dose of Study Drug|Period 2||12||
48773769|NCT01388335|102236418|FG000|COMPLETED|Period 2||9||
48773770|NCT01388335|102236418|FG000|NOT COMPLETED|Period 2||3||
48773771|NCT01388335|102236418|FG000|STARTED|Safety Extension||7||
48773772|NCT01388335|102236418|FG000|COMPLETED|Safety Extension||0||
48773773|NCT01388335|102236418|FG000|NOT COMPLETED|Safety Extension||7||
48773774|NCT02758184|102236419|FG000|STARTED|Overall Study||11||
48773775|NCT02758184|102236420|FG001|STARTED|Overall Study||10||
48773776|NCT02758184|102236419|FG000|COMPLETED|Overall Study||11||
48773777|NCT02758184|102236420|FG001|COMPLETED|Overall Study||10||
48773778|NCT02758184|102236419|FG000|NOT COMPLETED|Overall Study||0||
48773779|NCT02758184|102236420|FG001|NOT COMPLETED|Overall Study||0||
48773780|NCT02245217|102236421|FG000|STARTED|Overall Study||9||
48773781|NCT02245217|102236421|FG000|COMPLETED|Overall Study||7||
48773782|NCT02245217|102236421|FG000|NOT COMPLETED|Overall Study||2||
48773783|NCT00357552|102236422|FG000|STARTED|Screening||207||
48773784|NCT00357552|102236422|FG000|COMPLETED|Screening||123||
48773785|NCT00357552|102236422|FG000|NOT COMPLETED|Screening||84||
48773786|NCT00357552|102236422|FG000|STARTED|Weeks 0 to 24||123||
48773787|NCT00357552|102236422|FG000|COMPLETED|Weeks 0 to 24||122||
48773788|NCT00357552|102236422|FG000|NOT COMPLETED|Weeks 0 to 24||1||
48773789|NCT00357552|102236422|FG000|STARTED|Weeks 24 to 104||122||
48773790|NCT00357552|102236422|FG000|COMPLETED|Weeks 24 to 104||117||
48773791|NCT00357552|102236422|FG000|NOT COMPLETED|Weeks 24 to 104||5||
48773792|NCT00214201|102236423|FG000|STARTED|Overall Study||20||
48773793|NCT00214201|102236424|FG001|STARTED|Overall Study||20||
48773794|NCT00214201|102236423|FG000|COMPLETED|Overall Study||18||
48773795|NCT00214201|102236424|FG001|COMPLETED|Overall Study||18||
48773796|NCT00214201|102236423|FG000|NOT COMPLETED|Overall Study||2||
48773797|NCT00214201|102236424|FG001|NOT COMPLETED|Overall Study||2||
48773798|NCT02983552|102236425|FG000|STARTED|Overall Study||69||
48773799|NCT02983552|102236426|FG001|STARTED|Overall Study||69||
48773800|NCT02983552|102236427|FG002|STARTED|Overall Study||92||
48773801|NCT02983552|102236428|FG003|STARTED|Overall Study||90||
48773802|NCT02983552|102236425|FG000|4 Week Visit|Overall Study||69||
48773803|NCT02983552|102236426|FG001|4 Week Visit|Overall Study||67||
48773804|NCT02983552|102236427|FG002|4 Week Visit|Overall Study||85||
48773805|NCT02983552|102236428|FG003|4 Week Visit|Overall Study||84||
48773806|NCT02983552|102236425|FG000|8 Week Visit|Overall Study||67||
48773807|NCT02983552|102236426|FG001|8 Week Visit|Overall Study||68||
48773808|NCT02983552|102236427|FG002|8 Week Visit|Overall Study||85||
48773809|NCT02983552|102236428|FG003|8 Week Visit|Overall Study||84||
48369633|NCT03074162|101232816|FG001|NOT COMPLETED|Period 3||0||
48369634|NCT03074162|101232817|FG002|NOT COMPLETED|Period 3||0||
48369635|NCT03074162|101232818|FG003|NOT COMPLETED|Period 3||0||
48369636|NCT03074162|101232819|FG004|NOT COMPLETED|Period 3||1||
48369637|NCT03074162|101232820|FG005|NOT COMPLETED|Period 3||0||
48369638|NCT01167595|101232821|FG000|STARTED|Overall Study||522||9
48369639|NCT01167595|101232822|FG001|STARTED|Overall Study||537||9
48369640|NCT01167595|101232821|FG000|COMPLETED|Overall Study||522||9
48458431|NCT00272337|101457296|FG001|STARTED|Overall Study||7||
48458432|NCT00272337|101457297|FG002|STARTED|Overall Study||7||
48458433|NCT00272337|101457298|FG003|STARTED|Overall Study||7||
48458434|NCT00272337|101457299|FG004|STARTED|Overall Study||8||
48458435|NCT00272337|101457295|FG000|COMPLETED|Overall Study||8||
48458436|NCT00272337|101457296|FG001|COMPLETED|Overall Study||7||
48458437|NCT00272337|101457297|FG002|COMPLETED|Overall Study||7||
48458438|NCT00272337|101457298|FG003|COMPLETED|Overall Study||7||
48458439|NCT00272337|101457299|FG004|COMPLETED|Overall Study||8||
48458440|NCT00272337|101457295|FG000|NOT COMPLETED|Overall Study||0||
48458441|NCT00272337|101457296|FG001|NOT COMPLETED|Overall Study||0||
48458442|NCT00272337|101457297|FG002|NOT COMPLETED|Overall Study||0||
48458443|NCT00272337|101457298|FG003|NOT COMPLETED|Overall Study||0||
48458444|NCT00272337|101457299|FG004|NOT COMPLETED|Overall Study||0||
48458445|NCT02833857|101457300|FG000|STARTED|Overall Study||11||
48458446|NCT02833857|101457300|FG000|COMPLETED|Overall Study||11||
48458447|NCT02833857|101457300|FG000|NOT COMPLETED|Overall Study||0||
48458448|NCT02533999|101457301|FG000|STARTED|Overall Study||38||
48458449|NCT02533999|101457302|FG001|STARTED|Overall Study||37||
48458450|NCT02533999|101457301|FG000|COMPLETED|Overall Study||32||
48458451|NCT02533999|101457302|FG001|COMPLETED|Overall Study||30||
48458452|NCT02533999|101457301|FG000|NOT COMPLETED|Overall Study||6||
48458453|NCT02533999|101457302|FG001|NOT COMPLETED|Overall Study||7||
48458454|NCT03947788|101457303|FG000|STARTED|Overall Study||69||
48458455|NCT03947788|101457304|FG001|STARTED|Overall Study||74||
48458456|NCT03947788|101457303|FG000|COMPLETED|Overall Study||69||
48458457|NCT03947788|101457304|FG001|COMPLETED|Overall Study||74||
48458458|NCT03947788|101457303|FG000|NOT COMPLETED|Overall Study||0||
48458459|NCT03947788|101457304|FG001|NOT COMPLETED|Overall Study||0||
48458460|NCT01084005|101459897|FG000|STARTED|Overall Study||79||
48458461|NCT01084005|101459898|FG001|STARTED|Overall Study||162||
48458462|NCT01084005|101459897|FG000|COMPLETED|Overall Study||74||
48663581|NCT02274675|101959642|FG000|STARTED|Overall Study||7||
48663582|NCT02274675|101959642|FG000|COMPLETED|Overall Study||7||
48663583|NCT02274675|101959642|FG000|NOT COMPLETED|Overall Study||0||
48663584|NCT05852340|101959643|FG000|STARTED|Period 1||3||
48663585|NCT05852340|101959644|FG001|STARTED|Period 1||3||
48663586|NCT05852340|101959645|FG002|STARTED|Period 1||3||
48663587|NCT05852340|101959646|FG003|STARTED|Period 1||3||
48663588|NCT05852340|101959643|FG000|COMPLETED|Period 1||3||
48663589|NCT05852340|101959644|FG001|COMPLETED|Period 1||3||
48663590|NCT05852340|101959645|FG002|COMPLETED|Period 1||3||
48663591|NCT05852340|101959646|FG003|COMPLETED|Period 1||3||
48663592|NCT05852340|101959643|FG000|NOT COMPLETED|Period 1||0||
48663593|NCT05852340|101959644|FG001|NOT COMPLETED|Period 1||0||
48663594|NCT05852340|101959645|FG002|NOT COMPLETED|Period 1||0||
48663595|NCT05852340|101959646|FG003|NOT COMPLETED|Period 1||0||
48663596|NCT05852340|101959643|FG000|STARTED|Period 2||3||
48663597|NCT05852340|101959644|FG001|STARTED|Period 2||3||
48663598|NCT05852340|101959645|FG002|STARTED|Period 2||3||
48663599|NCT05852340|101959646|FG003|STARTED|Period 2||3||
48663600|NCT05852340|101959643|FG000|COMPLETED|Period 2||3||
48663601|NCT05852340|101959644|FG001|COMPLETED|Period 2||3||
48663602|NCT05852340|101959645|FG002|COMPLETED|Period 2||3||
48369641|NCT01167595|101232822|FG001|COMPLETED|Overall Study||537||9
48369642|NCT01167595|101232821|FG000|NOT COMPLETED|Overall Study||0||0
48458463|NCT01084005|101459898|FG001|COMPLETED|Overall Study||146||
48458464|NCT01084005|101459897|FG000|NOT COMPLETED|Overall Study||5||
48458465|NCT01084005|101459898|FG001|NOT COMPLETED|Overall Study||16||
48458466|NCT02462070|101459899|FG000|STARTED|Overall Study||135||
48458467|NCT02462070|101459900|FG001|STARTED|Overall Study||68||
48458468|NCT02462070|101459899|FG000|COMPLETED|Overall Study||112||
48458469|NCT02462070|101459900|FG001|COMPLETED|Overall Study||57||
48458470|NCT02462070|101459899|FG000|NOT COMPLETED|Overall Study||23||
48663603|NCT05852340|101959646|FG003|COMPLETED|Period 2||3||
48663604|NCT05852340|101959643|FG000|NOT COMPLETED|Period 2||0||
48663605|NCT05852340|101959644|FG001|NOT COMPLETED|Period 2||0||
48663606|NCT05852340|101959645|FG002|NOT COMPLETED|Period 2||0||
48663607|NCT05852340|101959646|FG003|NOT COMPLETED|Period 2||0||
48663608|NCT05852340|101959643|FG000|STARTED|Period 3||3||
48663609|NCT05852340|101959644|FG001|STARTED|Period 3||3||
48369643|NCT01167595|101232822|FG001|NOT COMPLETED|Overall Study||0||0
48369644|NCT00859898|101232823|FG000|STARTED|Overall Study||211||
48458471|NCT02462070|101459900|FG001|NOT COMPLETED|Overall Study||11||
48663610|NCT05852340|101959645|FG002|STARTED|Period 3||3||
48663611|NCT05852340|101959646|FG003|STARTED|Period 3||3||
48458472|NCT00463866|101459901|FG000|STARTED|Overall Study||4008||
48458473|NCT00463866|101459902|FG001|STARTED|Overall Study||4045||
48458474|NCT00463866|101459901|FG000|COMPLETED|Overall Study||3699||
48458475|NCT00463866|101459902|FG001|COMPLETED|Overall Study||3705||
48458476|NCT00463866|101459901|FG000|NOT COMPLETED|Overall Study||309||
48458477|NCT00463866|101459902|FG001|NOT COMPLETED|Overall Study||340||
48458478|NCT02060461|101459903|FG000|STARTED|Overall Study||33||
48458479|NCT02060461|101459903|FG000|COMPLETED|Overall Study||33||
48458480|NCT02060461|101459903|FG000|NOT COMPLETED|Overall Study||0||
48458481|NCT01620489|101459904|FG000|STARTED|Overall Study||140||
48458482|NCT01620489|101459905|FG001|STARTED|Overall Study||139||
48458483|NCT01620489|101459904|FG000|Exposed|Overall Study||140||
48458484|NCT01620489|101459905|FG001|Exposed|Overall Study||137||
48458485|NCT01620489|101459904|FG000|COMPLETED|Overall Study||105||
48458486|NCT01620489|101459905|FG001|COMPLETED|Overall Study||105||
48458487|NCT01620489|101459904|FG000|NOT COMPLETED|Overall Study||35||
48458488|NCT01620489|101459905|FG001|NOT COMPLETED|Overall Study||34||
48458489|NCT01976390|101459906|FG000|STARTED|Overall Study||41||
48458490|NCT01976390|101459907|FG001|STARTED|Overall Study||19||
48458491|NCT01976390|101459906|FG000|COMPLETED|Overall Study||41||
48458492|NCT01976390|101459907|FG001|COMPLETED|Overall Study||19||
48663612|NCT05852340|101959643|FG000|COMPLETED|Period 3||3||
48663613|NCT05852340|101959644|FG001|COMPLETED|Period 3||3||
48663614|NCT05852340|101959645|FG002|COMPLETED|Period 3||3||
48663615|NCT05852340|101959646|FG003|COMPLETED|Period 3||3||
48663616|NCT05852340|101959643|FG000|NOT COMPLETED|Period 3||0||
48663617|NCT05852340|101959644|FG001|NOT COMPLETED|Period 3||0||
48663618|NCT05852340|101959645|FG002|NOT COMPLETED|Period 3||0||
48663619|NCT05852340|101959646|FG003|NOT COMPLETED|Period 3||0||
48663620|NCT05852340|101959643|FG000|STARTED|Period 4||3||
48663621|NCT05852340|101959644|FG001|STARTED|Period 4||3||
48663622|NCT05852340|101959645|FG002|STARTED|Period 4||3||
48663623|NCT05852340|101959646|FG003|STARTED|Period 4||3||
48663624|NCT05852340|101959643|FG000|COMPLETED|Period 4||3||
48663625|NCT05852340|101959644|FG001|COMPLETED|Period 4||3||
48663626|NCT05852340|101959645|FG002|COMPLETED|Period 4||3||
48663627|NCT05852340|101959646|FG003|COMPLETED|Period 4||3||
48663628|NCT05852340|101959643|FG000|NOT COMPLETED|Period 4||0||
48663629|NCT05852340|101959644|FG001|NOT COMPLETED|Period 4||0||
48773810|NCT02983552|102236425|FG000|16 Week Visit|Overall Study||0|The 16 week visit was elective for those who were originally assigned to continued spectacle correction. After completing 8 weeks of continued spectacle correction, participants were able to complete 8 weeks of binocular therapy. Values are not provided for the binocular computer game treatment cohorts as this visit was not applicable.|
48663630|NCT05852340|101959645|FG002|NOT COMPLETED|Period 4||0||
48663631|NCT05852340|101959646|FG003|NOT COMPLETED|Period 4||0||
48189636|NCT01598987|100786265|FG000|COMPLETED|Baseline to Month 12||50||
48458493|NCT01976390|101459906|FG000|NOT COMPLETED|Overall Study||0||
48458494|NCT01976390|101459907|FG001|NOT COMPLETED|Overall Study||0||
48458495|NCT03094806|101459908|FG000|STARTED|Overall Study||44||
48458496|NCT03094806|101459909|FG001|STARTED|Overall Study||47||
48458497|NCT03094806|101459908|FG000|COMPLETED|Overall Study||44||
48458498|NCT03094806|101459909|FG001|COMPLETED|Overall Study||47||
48458499|NCT03094806|101459908|FG000|NOT COMPLETED|Overall Study||0||
48458500|NCT03094806|101459909|FG001|NOT COMPLETED|Overall Study||0||
48458501|NCT02143947|101459910|FG000|STARTED|Overall Study||36||
48663632|NCT05852340|101959643|FG000|STARTED|Period 5||3||
48663633|NCT05852340|101959644|FG001|STARTED|Period 5||3||
48663634|NCT05852340|101959645|FG002|STARTED|Period 5||3||
48663635|NCT05852340|101959646|FG003|STARTED|Period 5||3||
48663636|NCT05852340|101959643|FG000|COMPLETED|Period 5||3||
48663637|NCT05852340|101959644|FG001|COMPLETED|Period 5||2||
48663638|NCT05852340|101959645|FG002|COMPLETED|Period 5||3||
48663639|NCT05852340|101959646|FG003|COMPLETED|Period 5||2||
48663640|NCT05852340|101959643|FG000|NOT COMPLETED|Period 5||0||
48663641|NCT05852340|101959644|FG001|NOT COMPLETED|Period 5||1||
48663642|NCT05852340|101959645|FG002|NOT COMPLETED|Period 5||0||
48663643|NCT05852340|101959646|FG003|NOT COMPLETED|Period 5||1||
48663644|NCT01145183|101959647|FG000|STARTED|Overall Study||21||
48663645|NCT01145183|101959648|FG001|STARTED|Overall Study||26||
48663646|NCT01145183|101959649|FG002|STARTED|Overall Study||19||
48663647|NCT01145183|101959650|FG003|STARTED|Overall Study||10||
48458502|NCT02143947|101459911|FG001|STARTED|Overall Study||44||
48458503|NCT02143947|101459910|FG000|COMPLETED|Overall Study||32||
48458504|NCT02143947|101459911|FG001|COMPLETED|Overall Study||42||
48458505|NCT02143947|101459910|FG000|NOT COMPLETED|Overall Study||4||
48458506|NCT02143947|101459911|FG001|NOT COMPLETED|Overall Study||2||
48458507|NCT02970669|101459912|FG000|STARTED|Double-blind Period||70|Randomized|
48458508|NCT02970669|101459913|FG001|STARTED|Double-blind Period||70|Randomized|
48458509|NCT02970669|101459912|FG000|COMPLETED|Double-blind Period||62||
48458510|NCT02970669|101459913|FG001|COMPLETED|Double-blind Period||64||
48458511|NCT02970669|101459912|FG000|NOT COMPLETED|Double-blind Period||8||
48663648|NCT01145183|101959647|FG000|COMPLETED|Overall Study||21||
48458512|NCT02970669|101459913|FG001|NOT COMPLETED|Double-blind Period||6||
48458513|NCT02970669|101459912|FG000|STARTED|Open-label Period||62||
48458514|NCT02970669|101459913|FG001|STARTED|Open-label Period||64||
48458515|NCT02970669|101459912|FG000|COMPLETED|Open-label Period||58||
48458516|NCT02970669|101459913|FG001|COMPLETED|Open-label Period||62||
48458517|NCT02970669|101459912|FG000|NOT COMPLETED|Open-label Period||4||
48458518|NCT02970669|101459913|FG001|NOT COMPLETED|Open-label Period||2||
48663649|NCT01145183|101959648|FG001|COMPLETED|Overall Study||26||
48663650|NCT01145183|101959649|FG002|COMPLETED|Overall Study||19||
48458519|NCT01155583|101459914|FG000|STARTED|Phase I||3||
48458520|NCT01155583|101459915|FG001|STARTED|Phase I||3||
48663651|NCT01145183|101959650|FG003|COMPLETED|Overall Study||10||
48663652|NCT01145183|101959647|FG000|NOT COMPLETED|Overall Study||0||
48663653|NCT01145183|101959648|FG001|NOT COMPLETED|Overall Study||0||
48663654|NCT01145183|101959649|FG002|NOT COMPLETED|Overall Study||0||
48663655|NCT01145183|101959650|FG003|NOT COMPLETED|Overall Study||0||
48663656|NCT01904279|101961844|FG000|STARTED|Overall Study||27||
48663657|NCT01904279|101961845|FG001|STARTED|Overall Study||25||
48663658|NCT01904279|101961844|FG000|COMPLETED|Overall Study||24||
48663659|NCT01904279|101961845|FG001|COMPLETED|Overall Study||22||
48663660|NCT01904279|101961844|FG000|NOT COMPLETED|Overall Study||3||
48663661|NCT01904279|101961845|FG001|NOT COMPLETED|Overall Study||3||
48663662|NCT05498870|101961846|FG000|STARTED|Overall Study||41||
48773811|NCT02983552|102236426|FG001|16 Week Visit|Overall Study||66|The 16 week visit was elective for those who were originally assigned to continued spectacle correction. After completing 8 weeks of continued spectacle correction, participants were able to complete 8 weeks of binocular therapy. Values are not provided for the binocular computer game treatment cohorts as this visit was not applicable.|
48773812|NCT02983552|102236427|FG002|16 Week Visit|Overall Study||0|The 16 week visit was elective for those who were originally assigned to continued spectacle correction. After completing 8 weeks of continued spectacle correction, participants were able to complete 8 weeks of binocular therapy. Values are not provided for the binocular computer game treatment cohorts as this visit was not applicable.|
48773813|NCT02983552|102236428|FG003|16 Week Visit|Overall Study||72|The 16 week visit was elective for those who were originally assigned to continued spectacle correction. After completing 8 weeks of continued spectacle correction, participants were able to complete 8 weeks of binocular therapy. Values are not provided for the binocular computer game treatment cohorts as this visit was not applicable.|
48773814|NCT02983552|102236425|FG000|COMPLETED|Overall Study||69||
48773815|NCT02983552|102236426|FG001|COMPLETED|Overall Study||67||
48773816|NCT02983552|102236427|FG002|COMPLETED|Overall Study||92||
48773817|NCT02983552|102236428|FG003|COMPLETED|Overall Study||90||
48773818|NCT02983552|102236425|FG000|NOT COMPLETED|Overall Study||0||
48773819|NCT02983552|102236426|FG001|NOT COMPLETED|Overall Study||2||
48773820|NCT02983552|102236427|FG002|NOT COMPLETED|Overall Study||0||
48773821|NCT02983552|102236428|FG003|NOT COMPLETED|Overall Study||0||
48773822|NCT00641667|102236429|FG000|STARTED|Overall Study||66||
48773823|NCT00641667|102236429|FG000|COMPLETED|Overall Study||60||
48773824|NCT00641667|102236429|FG000|NOT COMPLETED|Overall Study||6||
48773825|NCT03038880|102236430|FG000|STARTED|Overall Study||24||
48773826|NCT03038880|102236431|FG001|STARTED|Overall Study||31||
48773827|NCT03038880|102236432|FG002|STARTED|Overall Study||16||
48773828|NCT03038880|102236430|FG000|COMPLETED|Overall Study||21||
48773829|NCT03038880|102236431|FG001|COMPLETED|Overall Study||28||
48773830|NCT03038880|102236432|FG002|COMPLETED|Overall Study||16||
48773831|NCT03038880|102236430|FG000|NOT COMPLETED|Overall Study||3||
48773832|NCT03038880|102236431|FG001|NOT COMPLETED|Overall Study||3||
48773833|NCT03038880|102236432|FG002|NOT COMPLETED|Overall Study||0||
48773834|NCT01536886|102236433|FG000|STARTED|Overall Study||141||
48773835|NCT01536886|102236434|FG001|STARTED|Overall Study||135||
48773836|NCT01536886|102236435|FG002|STARTED|Overall Study||49||
48773837|NCT01536886|102236436|FG003|STARTED|Overall Study||51||
48773838|NCT01536886|102236433|FG000|COMPLETED|Overall Study||136||
48773839|NCT01536886|102236434|FG001|COMPLETED|Overall Study||127||
48773840|NCT01536886|102236435|FG002|COMPLETED|Overall Study||47||
48773841|NCT01536886|102236436|FG003|COMPLETED|Overall Study||48||
48773842|NCT01536886|102236433|FG000|NOT COMPLETED|Overall Study||5||
48773843|NCT01536886|102236434|FG001|NOT COMPLETED|Overall Study||8||
48773844|NCT01536886|102236435|FG002|NOT COMPLETED|Overall Study||2||
48663663|NCT05498870|101961847|FG001|STARTED|Overall Study||41||
48663664|NCT05498870|101961846|FG000|COMPLETED|Overall Study||34||
48663665|NCT05498870|101961847|FG001|COMPLETED|Overall Study||38||
48458521|NCT01155583|101459916|FG002|STARTED|Phase I||4||
48458522|NCT01155583|101459917|FG003|STARTED|Phase I||6||
48458523|NCT01155583|101459918|FG004|STARTED|Phase I||7||
48458524|NCT01155583|101459919|FG005|STARTED|Phase I||0||
48458525|NCT01155583|101459920|FG006|STARTED|Phase I||3||
48663666|NCT05498870|101961846|FG000|NOT COMPLETED|Overall Study||7||
48663667|NCT05498870|101961847|FG001|NOT COMPLETED|Overall Study||3||
48663668|NCT00581919|101961848|FG000|STARTED|Overall Study||32||
48663669|NCT00581919|101961848|FG000|COMPLETED|Overall Study||8||
48663670|NCT00581919|101961848|FG000|NOT COMPLETED|Overall Study||24||
48663671|NCT01381679|101961849|FG000|STARTED|Overall Study||1682||
48663672|NCT01381679|101961849|FG000|COMPLETED|Overall Study||794||
48663673|NCT01381679|101961849|FG000|NOT COMPLETED|Overall Study||888||
48663674|NCT02371187|101961850|FG000|STARTED|Overall Study||18||
48663675|NCT02371187|101961851|FG001|STARTED|Overall Study||19||
48663676|NCT02371187|101961850|FG000|COMPLETED|Overall Study||15||
48663677|NCT02371187|101961851|FG001|COMPLETED|Overall Study||15||
48663678|NCT02371187|101961850|FG000|NOT COMPLETED|Overall Study||3||
48663679|NCT02371187|101961851|FG001|NOT COMPLETED|Overall Study||4||
48663680|NCT05835323|101961852|FG000|STARTED|Overall Study||13||32
48663681|NCT05835323|101961852|FG000|COMPLETED|Overall Study||13||32
48663682|NCT05835323|101961852|FG000|NOT COMPLETED|Overall Study||0||0
48663683|NCT05078437|101961853|FG000|STARTED|Overall Study||16||
48773845|NCT01536886|102236436|FG003|NOT COMPLETED|Overall Study||3||
48773846|NCT00272311|102236437|FG000|STARTED|Overall Study||14||
48458526|NCT01155583|101459921|FG007|STARTED|Phase I||8||
48458527|NCT01155583|101459922|FG008|STARTED|Phase I||0||
48458528|NCT01155583|101459914|FG000|COMPLETED|Phase I||3||
48458529|NCT01155583|101459915|FG001|COMPLETED|Phase I||3||
48458530|NCT01155583|101459916|FG002|COMPLETED|Phase I||4||
48458531|NCT01155583|101459917|FG003|COMPLETED|Phase I||6||
48458532|NCT01155583|101459918|FG004|COMPLETED|Phase I||6||
48458533|NCT01155583|101459919|FG005|COMPLETED|Phase I||0||
48458534|NCT01155583|101459920|FG006|COMPLETED|Phase I||3||
48458535|NCT01155583|101459921|FG007|COMPLETED|Phase I||5||
48458536|NCT01155583|101459922|FG008|COMPLETED|Phase I||0||
48458537|NCT01155583|101459914|FG000|NOT COMPLETED|Phase I||0||
48458538|NCT01155583|101459915|FG001|NOT COMPLETED|Phase I||0||
48458539|NCT01155583|101459916|FG002|NOT COMPLETED|Phase I||0||
48458540|NCT01155583|101459917|FG003|NOT COMPLETED|Phase I||0||
48458541|NCT01155583|101459918|FG004|NOT COMPLETED|Phase I||1||
48458542|NCT01155583|101459919|FG005|NOT COMPLETED|Phase I||0||
48458543|NCT01155583|101459920|FG006|NOT COMPLETED|Phase I||0||
48458544|NCT01155583|101459921|FG007|NOT COMPLETED|Phase I||3||
48458545|NCT01155583|101459922|FG008|NOT COMPLETED|Phase I||0||
48458546|NCT01155583|101459914|FG000|STARTED|Phase II - Expansion Phase||0||
48458547|NCT01155583|101459915|FG001|STARTED|Phase II - Expansion Phase||0||
48458548|NCT01155583|101459916|FG002|STARTED|Phase II - Expansion Phase||0||
48458549|NCT01155583|101459917|FG003|STARTED|Phase II - Expansion Phase||0||
48458550|NCT01155583|101459918|FG004|STARTED|Phase II - Expansion Phase||0||
48458551|NCT01155583|101459919|FG005|STARTED|Phase II - Expansion Phase||0||
48458552|NCT01155583|101459920|FG006|STARTED|Phase II - Expansion Phase||0||
48458553|NCT01155583|101459921|FG007|STARTED|Phase II - Expansion Phase||0||
48458554|NCT01155583|101459922|FG008|STARTED|Phase II - Expansion Phase||11||
48458555|NCT01155583|101459914|FG000|COMPLETED|Phase II - Expansion Phase||0||
48458556|NCT01155583|101459915|FG001|COMPLETED|Phase II - Expansion Phase||0||
48458557|NCT01155583|101459916|FG002|COMPLETED|Phase II - Expansion Phase||0||
48458558|NCT01155583|101459917|FG003|COMPLETED|Phase II - Expansion Phase||0||
48458559|NCT01155583|101459918|FG004|COMPLETED|Phase II - Expansion Phase||0||
48458560|NCT01155583|101459919|FG005|COMPLETED|Phase II - Expansion Phase||0||
48458561|NCT01155583|101459920|FG006|COMPLETED|Phase II - Expansion Phase||0||
48458562|NCT01155583|101459921|FG007|COMPLETED|Phase II - Expansion Phase||0||
48458563|NCT01155583|101459922|FG008|COMPLETED|Phase II - Expansion Phase||11||
48458564|NCT01155583|101459914|FG000|NOT COMPLETED|Phase II - Expansion Phase||0||
48458565|NCT01155583|101459915|FG001|NOT COMPLETED|Phase II - Expansion Phase||0||
48458566|NCT01155583|101459916|FG002|NOT COMPLETED|Phase II - Expansion Phase||0||
48458567|NCT01155583|101459917|FG003|NOT COMPLETED|Phase II - Expansion Phase||0||
48458568|NCT01155583|101459918|FG004|NOT COMPLETED|Phase II - Expansion Phase||0||
48458569|NCT01155583|101459919|FG005|NOT COMPLETED|Phase II - Expansion Phase||0||
48663684|NCT05078437|101961853|FG000|COMPLETED|Overall Study||15||
48663685|NCT05078437|101961853|FG000|NOT COMPLETED|Overall Study||1||
48663686|NCT03163667|101961854|FG000|STARTED|Overall Study||23||
48663687|NCT03163667|101961855|FG001|STARTED|Overall Study||46||
48663688|NCT03163667|101961854|FG000|COMPLETED|Overall Study||0||
48663689|NCT03163667|101961855|FG001|COMPLETED|Overall Study||0||
48773847|NCT00272311|102236438|FG001|STARTED|Overall Study||14||
48773848|NCT00272311|102236439|FG002|STARTED|Overall Study||14||
48458570|NCT01155583|101459920|FG006|NOT COMPLETED|Phase II - Expansion Phase||0||
48458571|NCT01155583|101459921|FG007|NOT COMPLETED|Phase II - Expansion Phase||0||
48458572|NCT01155583|101459922|FG008|NOT COMPLETED|Phase II - Expansion Phase||0||
48663690|NCT03163667|101961854|FG000|NOT COMPLETED|Overall Study||23||
48458573|NCT04147715|101459923|FG000|STARTED|Overall Study||12||
48458574|NCT04147715|101459924|FG001|STARTED|Overall Study||6||
48458575|NCT04147715|101459925|FG002|STARTED|Overall Study||6||
48458576|NCT04147715|101459926|FG003|STARTED|Overall Study||8||
48458577|NCT04147715|101459927|FG004|STARTED|Overall Study||6||
48458578|NCT04147715|101459928|FG005|STARTED|Overall Study||6||
48663691|NCT03163667|101961855|FG001|NOT COMPLETED|Overall Study||46||
48670220|NCT05281562|101974913|FG000|NOT COMPLETED|Overall Study||1||
48458579|NCT04147715|101459929|FG006|STARTED|Overall Study||6||
48458580|NCT04147715|101459930|FG007|STARTED|Overall Study||4||
48458581|NCT04147715|101459931|FG008|STARTED|Overall Study||8||
48458582|NCT04147715|101459932|FG009|STARTED|Overall Study||8||
48458583|NCT04147715|101459933|FG010|STARTED|Overall Study||14||
48458584|NCT04147715|101459934|FG011|STARTED|Overall Study||14||
48458585|NCT04147715|101459923|FG000|COMPLETED|Overall Study||12||
48458586|NCT04147715|101459924|FG001|COMPLETED|Overall Study||6||
48458587|NCT04147715|101459925|FG002|COMPLETED|Overall Study||6||
48458588|NCT04147715|101459926|FG003|COMPLETED|Overall Study||8||
48458589|NCT04147715|101459927|FG004|COMPLETED|Overall Study||6||
48458590|NCT04147715|101459928|FG005|COMPLETED|Overall Study||6||
48458591|NCT04147715|101459929|FG006|COMPLETED|Overall Study||6||
48458592|NCT04147715|101459930|FG007|COMPLETED|Overall Study||2||
48458593|NCT04147715|101459931|FG008|COMPLETED|Overall Study||7||
48458594|NCT04147715|101459932|FG009|COMPLETED|Overall Study||8||
48458595|NCT04147715|101459933|FG010|COMPLETED|Overall Study||14||
48458596|NCT04147715|101459934|FG011|COMPLETED|Overall Study||14||
48458597|NCT04147715|101459923|FG000|NOT COMPLETED|Overall Study||0||
48458598|NCT04147715|101459924|FG001|NOT COMPLETED|Overall Study||0||
48458599|NCT04147715|101459925|FG002|NOT COMPLETED|Overall Study||0||
48458600|NCT04147715|101459926|FG003|NOT COMPLETED|Overall Study||0||
48458601|NCT04147715|101459927|FG004|NOT COMPLETED|Overall Study||0||
48458602|NCT04147715|101459928|FG005|NOT COMPLETED|Overall Study||0||
48458603|NCT04147715|101459929|FG006|NOT COMPLETED|Overall Study||0||
48458604|NCT04147715|101459930|FG007|NOT COMPLETED|Overall Study||2||
48458605|NCT04147715|101459931|FG008|NOT COMPLETED|Overall Study||1||
48458606|NCT04147715|101459932|FG009|NOT COMPLETED|Overall Study||0||
48458607|NCT04147715|101459933|FG010|NOT COMPLETED|Overall Study||0||
48458608|NCT04147715|101459934|FG011|NOT COMPLETED|Overall Study||0||
48458609|NCT00756964|101459935|FG000|STARTED|Overall Study||13||
48458610|NCT00756964|101459936|FG001|STARTED|Overall Study||13||
48458611|NCT00756964|101459935|FG000|COMPLETED|Overall Study||13||
48458612|NCT00756964|101459936|FG001|COMPLETED|Overall Study||13||
48458613|NCT00756964|101459935|FG000|NOT COMPLETED|Overall Study||0||
48458614|NCT00756964|101459936|FG001|NOT COMPLETED|Overall Study||0||
48458615|NCT06118359|101459937|FG000|STARTED|Overall Study||13|Unique providers identified to receive the survey.|13
48458616|NCT06118359|101459938|FG001|STARTED|Overall Study||12|Unique providers identified to receive the survey.|41
48458617|NCT06118359|101459937|FG000|Providers Enrolled in Intervention Training|Overall Study||0||0
48458618|NCT06118359|101459938|FG001|Providers Enrolled in Intervention Training|Overall Study||3||0
48458619|NCT06118359|101459937|FG000|COMPLETED|Overall Study||13|Unique providers who completed the survey.|13
48458620|NCT06118359|101459938|FG001|COMPLETED|Overall Study||12|Unique providers who completed the survey.|41
48458621|NCT06118359|101459937|FG000|NOT COMPLETED|Overall Study||0||0
48458622|NCT06118359|101459938|FG001|NOT COMPLETED|Overall Study||0||0
48458623|NCT03137082|101459939|FG000|STARTED|Overall Study||8||
48458624|NCT03137082|101459940|FG001|STARTED|Overall Study||7||
48458625|NCT03137082|101459939|FG000|COMPLETED|Overall Study||6||
48458626|NCT03137082|101459940|FG001|COMPLETED|Overall Study||6||
48458627|NCT03137082|101459939|FG000|NOT COMPLETED|Overall Study||2||
48458628|NCT03137082|101459940|FG001|NOT COMPLETED|Overall Study||1||
48458629|NCT00490061|101459941|FG000|STARTED|Overall Study||17||
48458630|NCT00490061|101459941|FG000|COMPLETED|Overall Study||16||
48458631|NCT00490061|101459941|FG000|NOT COMPLETED|Overall Study||1||
48458632|NCT05425966|101459942|FG000|STARTED|Overall Study||67||
48458633|NCT05425966|101459942|FG000|COMPLETED|Overall Study||67||
48458634|NCT05425966|101459942|FG000|NOT COMPLETED|Overall Study||0||
48458635|NCT01288833|101459943|FG000|STARTED|Overall Study||277||
48458636|NCT01288833|101459944|FG001|STARTED|Overall Study||281||
48773849|NCT00272311|102236440|FG003|STARTED|Overall Study||14||
48773850|NCT00272311|102236441|FG004|STARTED|Overall Study||14||
48773851|NCT00272311|102236437|FG000|COMPLETED|Overall Study||14||
48773852|NCT00272311|102236438|FG001|COMPLETED|Overall Study||14||
48773853|NCT00272311|102236439|FG002|COMPLETED|Overall Study||14||
48458637|NCT01288833|101459943|FG000|COMPLETED|Overall Study||277||
48458638|NCT01288833|101459944|FG001|COMPLETED|Overall Study||281||
48458639|NCT01288833|101459943|FG000|NOT COMPLETED|Overall Study||0||
48458640|NCT01288833|101459944|FG001|NOT COMPLETED|Overall Study||0||
48458641|NCT01952574|101459945|FG000|STARTED|Double-blind Treatment Phase||160||
48458642|NCT01952574|101459946|FG001|STARTED|Double-blind Treatment Phase||108||
48458643|NCT01952574|101459947|FG002|STARTED|Double-blind Treatment Phase||108||
48458644|NCT01952574|101459948|FG003|STARTED|Double-blind Treatment Phase||107||
48458645|NCT01952574|101459949|FG004|STARTED|Double-blind Treatment Phase||0||
48458646|NCT01952574|101459950|FG005|STARTED|Double-blind Treatment Phase||0||
48458647|NCT01952574|101459951|FG006|STARTED|Double-blind Treatment Phase||0||
48458648|NCT01952574|101459945|FG000|Received Study Drug|Double-blind Treatment Phase||153||
48458649|NCT01952574|101459946|FG001|Received Study Drug|Double-blind Treatment Phase||108||
48458650|NCT01952574|101459947|FG002|Received Study Drug|Double-blind Treatment Phase||105||
48458651|NCT01952574|101459948|FG003|Received Study Drug|Double-blind Treatment Phase||106||
48458652|NCT01952574|101459949|FG004|Received Study Drug|Double-blind Treatment Phase||0||
48458653|NCT01952574|101459950|FG005|Received Study Drug|Double-blind Treatment Phase||0||
48773854|NCT00272311|102236440|FG003|COMPLETED|Overall Study||14||
48773855|NCT00272311|102236441|FG004|COMPLETED|Overall Study||14||
48773856|NCT00272311|102236437|FG000|NOT COMPLETED|Overall Study||0||
48773857|NCT00272311|102236438|FG001|NOT COMPLETED|Overall Study||0||
48773858|NCT00272311|102236439|FG002|NOT COMPLETED|Overall Study||0||
48773859|NCT00272311|102236440|FG003|NOT COMPLETED|Overall Study||0||
48773860|NCT00272311|102236441|FG004|NOT COMPLETED|Overall Study||0||
48773861|NCT03847896|102236442|FG000|STARTED|Overall Study||197||
48773862|NCT03847896|102236443|FG001|STARTED|Overall Study||204||
48773863|NCT03847896|102236444|FG002|STARTED|Overall Study||200||
48773864|NCT03847896|102236445|FG003|STARTED|Overall Study||201||
48773865|NCT03847896|102236446|FG004|STARTED|Overall Study||199||
48773866|NCT03847896|102236442|FG000|COMPLETED|Overall Study||190||
48773867|NCT03847896|102236443|FG001|COMPLETED|Overall Study||188||
48773868|NCT03847896|102236444|FG002|COMPLETED|Overall Study||188||
48773869|NCT03847896|102236445|FG003|COMPLETED|Overall Study||184||
48773870|NCT03847896|102236446|FG004|COMPLETED|Overall Study||178||
48773871|NCT03847896|102236442|FG000|NOT COMPLETED|Overall Study||7||
48773872|NCT03847896|102236443|FG001|NOT COMPLETED|Overall Study||16||
48773873|NCT03847896|102236444|FG002|NOT COMPLETED|Overall Study||12||
48773874|NCT03847896|102236445|FG003|NOT COMPLETED|Overall Study||17||
48773875|NCT03847896|102236446|FG004|NOT COMPLETED|Overall Study||21||
48773876|NCT04163952|102236447|FG000|STARTED|Overall Study||5||
48773877|NCT04163952|102236447|FG000|COMPLETED|Overall Study||5||
48773878|NCT04163952|102236447|FG000|NOT COMPLETED|Overall Study||0||
48773879|NCT02492763|102236448|FG000|STARTED|Overall Study||46||
48773880|NCT02492763|102236449|FG001|STARTED|Overall Study||44||
48773881|NCT02492763|102236450|FG002|STARTED|Overall Study||43||
48773882|NCT02492763|102236451|FG003|STARTED|Overall Study||43||
48773883|NCT02492763|102236448|FG000|Treated|Overall Study||46||
48773884|NCT02492763|102236449|FG001|Treated|Overall Study||44||
48773885|NCT02492763|102236450|FG002|Treated|Overall Study||43||
48773886|NCT02492763|102236451|FG003|Treated|Overall Study||42||
48773887|NCT02492763|102236448|FG000|COMPLETED|Overall Study||30||
48773888|NCT02492763|102236449|FG001|COMPLETED|Overall Study||29||
48773889|NCT02492763|102236450|FG002|COMPLETED|Overall Study||33||
48773890|NCT02492763|102236451|FG003|COMPLETED|Overall Study||30||
48773891|NCT02492763|102236448|FG000|NOT COMPLETED|Overall Study||16||
48773892|NCT02492763|102236449|FG001|NOT COMPLETED|Overall Study||15||
48773893|NCT02492763|102236450|FG002|NOT COMPLETED|Overall Study||10||
48773894|NCT02492763|102236451|FG003|NOT COMPLETED|Overall Study||13||
48773895|NCT00670306|102236452|FG000|STARTED|Overall Study||528||
48773896|NCT00670306|102236452|FG000|COMPLETED|Overall Study||473||
48773897|NCT00670306|102236452|FG000|NOT COMPLETED|Overall Study||55||
48773898|NCT03682770|102236453|FG000|STARTED|Pre-AR101 Dosing Period (Day 1 - Week 4)||50||
48773899|NCT03682770|102236454|FG001|STARTED|Pre-AR101 Dosing Period (Day 1 - Week 4)||98||
48773900|NCT03682770|102236455|FG002|STARTED|Pre-AR101 Dosing Period (Day 1 - Week 4)||0||
48773901|NCT03682770|102236456|FG003|STARTED|Pre-AR101 Dosing Period (Day 1 - Week 4)||0||
48773902|NCT03682770|102236457|FG004|STARTED|Pre-AR101 Dosing Period (Day 1 - Week 4)||0||
48773903|NCT03682770|102236458|FG005|STARTED|Pre-AR101 Dosing Period (Day 1 - Week 4)||0||
48773904|NCT03682770|102236459|FG006|STARTED|Pre-AR101 Dosing Period (Day 1 - Week 4)||0||
48773905|NCT03682770|102236453|FG000|COMPLETED|Pre-AR101 Dosing Period (Day 1 - Week 4)||49|Completed = Progressed to Up-dosing period|
48773906|NCT03682770|102236454|FG001|COMPLETED|Pre-AR101 Dosing Period (Day 1 - Week 4)||96|Completed = Progressed to Up-dosing period|
48773907|NCT03682770|102236455|FG002|COMPLETED|Pre-AR101 Dosing Period (Day 1 - Week 4)||0|Completed = Progressed to Up-dosing period|
48773908|NCT03682770|102236456|FG003|COMPLETED|Pre-AR101 Dosing Period (Day 1 - Week 4)||0|Completed = Progressed to Up-dosing period|
48773909|NCT03682770|102236457|FG004|COMPLETED|Pre-AR101 Dosing Period (Day 1 - Week 4)||0|Completed = Progressed to Up-dosing period|
48773910|NCT03682770|102236458|FG005|COMPLETED|Pre-AR101 Dosing Period (Day 1 - Week 4)||0|Completed = Progressed to Up-dosing period|
48773911|NCT03682770|102236459|FG006|COMPLETED|Pre-AR101 Dosing Period (Day 1 - Week 4)||0|Completed = Progressed to Up-dosing period|
48773912|NCT03682770|102236453|FG000|NOT COMPLETED|Pre-AR101 Dosing Period (Day 1 - Week 4)||1||
48773913|NCT03682770|102236454|FG001|NOT COMPLETED|Pre-AR101 Dosing Period (Day 1 - Week 4)||2||
48773914|NCT03682770|102236455|FG002|NOT COMPLETED|Pre-AR101 Dosing Period (Day 1 - Week 4)||0||
48773915|NCT03682770|102236456|FG003|NOT COMPLETED|Pre-AR101 Dosing Period (Day 1 - Week 4)||0||
48773916|NCT03682770|102236457|FG004|NOT COMPLETED|Pre-AR101 Dosing Period (Day 1 - Week 4)||0||
48773917|NCT03682770|102236458|FG005|NOT COMPLETED|Pre-AR101 Dosing Period (Day 1 - Week 4)||0||
48773918|NCT03682770|102236459|FG006|NOT COMPLETED|Pre-AR101 Dosing Period (Day 1 - Week 4)||0||
48773919|NCT03682770|102236453|FG000|STARTED|AR101 Up-dosing Period (Week 28-40)||0||
48773920|NCT03682770|102236454|FG001|STARTED|AR101 Up-dosing Period (Week 28-40)||0||
48773921|NCT03682770|102236455|FG002|STARTED|AR101 Up-dosing Period (Week 28-40)||49||
48773922|NCT03682770|102236456|FG003|STARTED|AR101 Up-dosing Period (Week 28-40)||96||
48773923|NCT03682770|102236457|FG004|STARTED|AR101 Up-dosing Period (Week 28-40)||0||
48189637|NCT01598987|100786265|FG000|NOT COMPLETED|Baseline to Month 12||6||
48189638|NCT01598987|100786265|FG000|STARTED|Baseline to 24 Month||56||
48773924|NCT03682770|102236458|FG005|STARTED|AR101 Up-dosing Period (Week 28-40)||0||
48773925|NCT03682770|102236459|FG006|STARTED|AR101 Up-dosing Period (Week 28-40)||0||
48773926|NCT03682770|102236453|FG000|COMPLETED|AR101 Up-dosing Period (Week 28-40)||0|Completed = Progressed to Maintenance period|
48773927|NCT03682770|102236454|FG001|COMPLETED|AR101 Up-dosing Period (Week 28-40)||0|Completed = Progressed to Maintenance period|
48458654|NCT01952574|101459951|FG006|Received Study Drug|Double-blind Treatment Phase||0||
48458655|NCT01952574|101459945|FG000|COMPLETED|Double-blind Treatment Phase||143|Completed double-blind treatment phase|
48458656|NCT01952574|101459946|FG001|COMPLETED|Double-blind Treatment Phase||105|Completed double-blind treatment phase|
48773928|NCT03682770|102236455|FG002|COMPLETED|AR101 Up-dosing Period (Week 28-40)||39|Completed = Progressed to Maintenance period|
48773929|NCT03682770|102236456|FG003|COMPLETED|AR101 Up-dosing Period (Week 28-40)||88|Completed = Progressed to Maintenance period|
48773930|NCT03682770|102236457|FG004|COMPLETED|AR101 Up-dosing Period (Week 28-40)||0|Completed = Progressed to Maintenance period|
48773931|NCT03682770|102236458|FG005|COMPLETED|AR101 Up-dosing Period (Week 28-40)||0|Completed = Progressed to Maintenance period|
48773932|NCT03682770|102236459|FG006|COMPLETED|AR101 Up-dosing Period (Week 28-40)||0|Completed = Progressed to Maintenance period|
48773933|NCT03682770|102236453|FG000|NOT COMPLETED|AR101 Up-dosing Period (Week 28-40)||0||
48773934|NCT03682770|102236454|FG001|NOT COMPLETED|AR101 Up-dosing Period (Week 28-40)||0||
48773935|NCT03682770|102236455|FG002|NOT COMPLETED|AR101 Up-dosing Period (Week 28-40)||10||
48773936|NCT03682770|102236456|FG003|NOT COMPLETED|AR101 Up-dosing Period (Week 28-40)||8||
48773937|NCT03682770|102236457|FG004|NOT COMPLETED|AR101 Up-dosing Period (Week 28-40)||0||
48773938|NCT03682770|102236458|FG005|NOT COMPLETED|AR101 Up-dosing Period (Week 28-40)||0||
48773939|NCT03682770|102236459|FG006|NOT COMPLETED|AR101 Up-dosing Period (Week 28-40)||0||
48773940|NCT03682770|102236453|FG000|STARTED|AR101 Maintenance Period: (Week 52-64)||0|Randomized|
48773941|NCT03682770|102236454|FG001|STARTED|AR101 Maintenance Period: (Week 52-64)||0|Randomized|
48773942|NCT03682770|102236455|FG002|STARTED|AR101 Maintenance Period: (Week 52-64)||0|Randomized|
48773943|NCT03682770|102236456|FG003|STARTED|AR101 Maintenance Period: (Week 52-64)||0|Randomized|
48773944|NCT03682770|102236457|FG004|STARTED|AR101 Maintenance Period: (Week 52-64)||40|Randomized|
48773945|NCT03682770|102236458|FG005|STARTED|AR101 Maintenance Period: (Week 52-64)||44|Randomized|
48773946|NCT03682770|102236459|FG006|STARTED|AR101 Maintenance Period: (Week 52-64)||44|Randomized|
48773947|NCT03682770|102236453|FG000|Randomized and Treated|AR101 Maintenance Period: (Week 52-64)||0||
48773948|NCT03682770|102236454|FG001|Randomized and Treated|AR101 Maintenance Period: (Week 52-64)||0||
48773949|NCT03682770|102236455|FG002|Randomized and Treated|AR101 Maintenance Period: (Week 52-64)||0||
48773950|NCT03682770|102236456|FG003|Randomized and Treated|AR101 Maintenance Period: (Week 52-64)||0||
48773951|NCT03682770|102236457|FG004|Randomized and Treated|AR101 Maintenance Period: (Week 52-64)||40||
48773952|NCT03682770|102236458|FG005|Randomized and Treated|AR101 Maintenance Period: (Week 52-64)||43||
48773953|NCT03682770|102236459|FG006|Randomized and Treated|AR101 Maintenance Period: (Week 52-64)||42||
48773954|NCT03682770|102236453|FG000|COMPLETED|AR101 Maintenance Period: (Week 52-64)||0||
48773955|NCT03682770|102236454|FG001|COMPLETED|AR101 Maintenance Period: (Week 52-64)||0||
48773956|NCT03682770|102236455|FG002|COMPLETED|AR101 Maintenance Period: (Week 52-64)||0||
48773957|NCT03682770|102236456|FG003|COMPLETED|AR101 Maintenance Period: (Week 52-64)||0||
48773958|NCT03682770|102236457|FG004|COMPLETED|AR101 Maintenance Period: (Week 52-64)||36||
48773959|NCT03682770|102236458|FG005|COMPLETED|AR101 Maintenance Period: (Week 52-64)||41||
48773960|NCT03682770|102236459|FG006|COMPLETED|AR101 Maintenance Period: (Week 52-64)||41||
48773961|NCT03682770|102236453|FG000|NOT COMPLETED|AR101 Maintenance Period: (Week 52-64)||0||
48773962|NCT03682770|102236454|FG001|NOT COMPLETED|AR101 Maintenance Period: (Week 52-64)||0||
48773963|NCT03682770|102236455|FG002|NOT COMPLETED|AR101 Maintenance Period: (Week 52-64)||0||
48773964|NCT03682770|102236456|FG003|NOT COMPLETED|AR101 Maintenance Period: (Week 52-64)||0||
48773965|NCT03682770|102236457|FG004|NOT COMPLETED|AR101 Maintenance Period: (Week 52-64)||4||
48773966|NCT03682770|102236458|FG005|NOT COMPLETED|AR101 Maintenance Period: (Week 52-64)||3||
48773967|NCT03682770|102236459|FG006|NOT COMPLETED|AR101 Maintenance Period: (Week 52-64)||3||
48773968|NCT01413204|102236460|FG000|STARTED|Overall Study||90||
48773969|NCT01413204|102236461|FG001|STARTED|Overall Study||89||
48773970|NCT01413204|102236462|FG002|STARTED|Overall Study||93||
48773971|NCT01413204|102236460|FG000|COMPLETED|Overall Study||84||
48773972|NCT01413204|102236461|FG001|COMPLETED|Overall Study||83||
48458657|NCT01952574|101459947|FG002|COMPLETED|Double-blind Treatment Phase||99|Completed double-blind treatment phase|
48670221|NCT05281562|101974914|FG001|NOT COMPLETED|Overall Study||0||
48773973|NCT01413204|102236462|FG002|COMPLETED|Overall Study||74||
48773974|NCT01413204|102236460|FG000|NOT COMPLETED|Overall Study||6||
48773975|NCT01413204|102236461|FG001|NOT COMPLETED|Overall Study||6||
48773976|NCT01413204|102236462|FG002|NOT COMPLETED|Overall Study||19||
48773977|NCT01432730|102236463|FG000|STARTED|Period 1||12||
48773978|NCT01432730|102236464|FG001|STARTED|Period 1||12||
48773979|NCT01432730|102236463|FG000|COMPLETED|Period 1||10||
48773980|NCT01432730|102236464|FG001|COMPLETED|Period 1||12||
48773981|NCT01432730|102236463|FG000|NOT COMPLETED|Period 1||2||
48773982|NCT01432730|102236464|FG001|NOT COMPLETED|Period 1||0||
48773983|NCT01432730|102236463|FG000|STARTED|Period 2||10||
48773984|NCT01432730|102236464|FG001|STARTED|Period 2||12||
48773985|NCT01432730|102236463|FG000|COMPLETED|Period 2||10||
48773986|NCT01432730|102236464|FG001|COMPLETED|Period 2||8||
48773987|NCT01432730|102236463|FG000|NOT COMPLETED|Period 2||0||
48773988|NCT01432730|102236464|FG001|NOT COMPLETED|Period 2||4||
48773989|NCT03417154|102236465|FG000|STARTED|Overall Study||6||
48773990|NCT03417154|102236466|FG001|STARTED|Overall Study||6||
48189639|NCT01598987|100786265|FG000|COMPLETED|Baseline to 24 Month||48||
48189640|NCT01598987|100786265|FG000|NOT COMPLETED|Baseline to 24 Month||8||
48458658|NCT01952574|101459948|FG003|COMPLETED|Double-blind Treatment Phase||101|Completed double-blind treatment phase|
48458659|NCT01952574|101459949|FG004|COMPLETED|Double-blind Treatment Phase||0|Completed double-blind treatment phase|
48458660|NCT01952574|101459950|FG005|COMPLETED|Double-blind Treatment Phase||0|Completed double-blind treatment phase|
48458661|NCT01952574|101459951|FG006|COMPLETED|Double-blind Treatment Phase||0|Completed double-blind treatment phase|
48458662|NCT01952574|101459945|FG000|NOT COMPLETED|Double-blind Treatment Phase||17||
48458663|NCT01952574|101459946|FG001|NOT COMPLETED|Double-blind Treatment Phase||3||
48458664|NCT01952574|101459947|FG002|NOT COMPLETED|Double-blind Treatment Phase||9||
48458665|NCT01952574|101459948|FG003|NOT COMPLETED|Double-blind Treatment Phase||6||
48458666|NCT01952574|101459949|FG004|NOT COMPLETED|Double-blind Treatment Phase||0||
48458667|NCT01952574|101459950|FG005|NOT COMPLETED|Double-blind Treatment Phase||0||
48458668|NCT01952574|101459951|FG006|NOT COMPLETED|Double-blind Treatment Phase||0||
48458669|NCT01952574|101459945|FG000|STARTED|Open-label Treatment Phase||0|Participants enrolled in Norway did not participate in the OLTP. In addition 12 participants who completed the DBTP withdrew consent prior to entering the OLTP.|
48458670|NCT01952574|101459946|FG001|STARTED|Open-label Treatment Phase||0|Participants enrolled in Norway did not participate in the OLTP. In addition 12 participants who completed the DBTP withdrew consent prior to entering the OLTP.|
48458671|NCT01952574|101459947|FG002|STARTED|Open-label Treatment Phase||0|Participants enrolled in Norway did not participate in the OLTP. In addition 12 participants who completed the DBTP withdrew consent prior to entering the OLTP.|
48458672|NCT01952574|101459948|FG003|STARTED|Open-label Treatment Phase||0|Participants enrolled in Norway did not participate in the OLTP. In addition 12 participants who completed the DBTP withdrew consent prior to entering the OLTP.|
48458673|NCT01952574|101459949|FG004|STARTED|Open-label Treatment Phase||383|Participants enrolled in Norway did not participate in the OLTP. In addition 12 participants who completed the DBTP withdrew consent prior to entering the OLTP.|
48663692|NCT01198691|101961856|FG000|STARTED|Completed Surgery -Received Intervention||50||
48663693|NCT01198691|101961857|FG001|STARTED|Completed Surgery -Received Intervention||50||
48663694|NCT01198691|101961856|FG000|COMPLETED|Completed Surgery -Received Intervention||50||
48663695|NCT01198691|101961857|FG001|COMPLETED|Completed Surgery -Received Intervention||50||
48663696|NCT01198691|101961856|FG000|NOT COMPLETED|Completed Surgery -Received Intervention||0||
48663697|NCT01198691|101961857|FG001|NOT COMPLETED|Completed Surgery -Received Intervention||0||
48663698|NCT01198691|101961856|FG000|STARTED|Completed VAS Score Postop Day 1||50||
48663699|NCT01198691|101961857|FG001|STARTED|Completed VAS Score Postop Day 1||50||
48773991|NCT03417154|102236465|FG000|COMPLETED|Overall Study||0||
48773992|NCT03417154|102236466|FG001|COMPLETED|Overall Study||0||
48189641|NCT02963597|100786266|FG000|STARTED|Overall Study||10||
48189642|NCT02963597|100786267|FG001|STARTED|Overall Study||11||
48773993|NCT03417154|102236465|FG000|NOT COMPLETED|Overall Study||6||
48773994|NCT03417154|102236466|FG001|NOT COMPLETED|Overall Study||6||
48773995|NCT01472718|102236467|FG000|STARTED|Overall Study||104||
48458674|NCT01952574|101459950|FG005|STARTED|Open-label Treatment Phase||0|Participants enrolled in Norway did not participate in the OLTP. In addition 12 participants who completed the DBTP withdrew consent prior to entering the OLTP.|
48458675|NCT01952574|101459951|FG006|STARTED|Open-label Treatment Phase||0|Participants enrolled in Norway did not participate in the OLTP. In addition 12 participants who completed the DBTP withdrew consent prior to entering the OLTP.|
48189643|NCT02963597|100786266|FG000|COMPLETED|Overall Study||10||
48189644|NCT02963597|100786267|FG001|COMPLETED|Overall Study||11||
48458676|NCT01952574|101459945|FG000|Received 70 mg Erenumab|Open-label Treatment Phase||0||
48773996|NCT01472718|102236468|FG001|STARTED|Overall Study||104||
48458677|NCT01952574|101459946|FG001|Received 70 mg Erenumab|Open-label Treatment Phase||0||
48458678|NCT01952574|101459947|FG002|Received 70 mg Erenumab|Open-label Treatment Phase||0||
48458679|NCT01952574|101459948|FG003|Received 70 mg Erenumab|Open-label Treatment Phase||0||
48663700|NCT01198691|101961856|FG000|COMPLETED|Completed VAS Score Postop Day 1||47||
48663701|NCT01198691|101961857|FG001|COMPLETED|Completed VAS Score Postop Day 1||46||
48663702|NCT01198691|101961856|FG000|NOT COMPLETED|Completed VAS Score Postop Day 1||3||
48663703|NCT01198691|101961857|FG001|NOT COMPLETED|Completed VAS Score Postop Day 1||4||
48663704|NCT01198691|101961856|FG000|STARTED|Completed VAS Score at Discharge||50||
48663705|NCT01198691|101961857|FG001|STARTED|Completed VAS Score at Discharge||50||
48663706|NCT01198691|101961856|FG000|COMPLETED|Completed VAS Score at Discharge||45||
48663707|NCT01198691|101961857|FG001|COMPLETED|Completed VAS Score at Discharge||44||
48663708|NCT01198691|101961856|FG000|NOT COMPLETED|Completed VAS Score at Discharge||5||
48663709|NCT01198691|101961857|FG001|NOT COMPLETED|Completed VAS Score at Discharge||6||
48663710|NCT01198691|101961856|FG000|STARTED|Survey Prior to Discharge||50||
48663711|NCT01198691|101961857|FG001|STARTED|Survey Prior to Discharge||50||
48663712|NCT01198691|101961856|FG000|COMPLETED|Survey Prior to Discharge||18||
48663713|NCT01198691|101961857|FG001|COMPLETED|Survey Prior to Discharge||17||
48663714|NCT01198691|101961856|FG000|NOT COMPLETED|Survey Prior to Discharge||32||
48663715|NCT01198691|101961857|FG001|NOT COMPLETED|Survey Prior to Discharge||33||
48663716|NCT01198691|101961856|FG000|STARTED|6 Week Post-partum Survey||50||
48663717|NCT01198691|101961857|FG001|STARTED|6 Week Post-partum Survey||50||
48663718|NCT01198691|101961856|FG000|COMPLETED|6 Week Post-partum Survey||21||
48663719|NCT01198691|101961857|FG001|COMPLETED|6 Week Post-partum Survey||26||
48663720|NCT01198691|101961856|FG000|NOT COMPLETED|6 Week Post-partum Survey||29||
48663721|NCT01198691|101961857|FG001|NOT COMPLETED|6 Week Post-partum Survey||24||
48663722|NCT00530257|101961858|FG000|STARTED|Overall Study||31||
48663723|NCT00530257|101961858|FG000|COMPLETED|Overall Study||30||
48663724|NCT00530257|101961858|FG000|NOT COMPLETED|Overall Study||1||
48663725|NCT05715827|101961859|FG000|STARTED|Overall Study||20||
48663726|NCT05715827|101961860|FG001|STARTED|Overall Study||22||
48663727|NCT05715827|101961859|FG000|COMPLETED|Overall Study||20||
48663728|NCT05715827|101961860|FG001|COMPLETED|Overall Study||20||
48663729|NCT05715827|101961859|FG000|NOT COMPLETED|Overall Study||0||
48663730|NCT05715827|101961860|FG001|NOT COMPLETED|Overall Study||2||
48663731|NCT04543786|101961861|FG000|STARTED|Overall Study||3||
48663732|NCT04543786|101961861|FG000|COMPLETED|Overall Study||3||
48663733|NCT04543786|101961861|FG000|NOT COMPLETED|Overall Study||0||
48663734|NCT02679274|101961862|FG000|STARTED|Overall Study||2|One (1) subject withdrew after consent, and randomization but before study testing started.|
48663735|NCT02679274|101961863|FG001|STARTED|Overall Study||1|One (1) subject withdrew after consent, and randomization but before study testing started.|
48663736|NCT02679274|101961862|FG000|COMPLETED|Overall Study||1||
48663737|NCT02679274|101961863|FG001|COMPLETED|Overall Study||1||
48663738|NCT02679274|101961862|FG000|NOT COMPLETED|Overall Study||1||
48663739|NCT02679274|101961863|FG001|NOT COMPLETED|Overall Study||0||
48663740|NCT00855335|101961864|FG000|STARTED|Overall Study||18||
48663741|NCT00855335|101961865|FG001|STARTED|Overall Study||18||
48663742|NCT00855335|101961866|FG002|STARTED|Overall Study||15||
48663743|NCT00855335|101961867|FG003|STARTED|Overall Study||19||
48663744|NCT00855335|101961868|FG004|STARTED|Overall Study||7||
48663745|NCT00855335|101961864|FG000|COMPLETED|Overall Study||13||
48773997|NCT01472718|102236467|FG000|COMPLETED|Overall Study||98||
48773998|NCT01472718|102236468|FG001|COMPLETED|Overall Study||97||
48773999|NCT01472718|102236467|FG000|NOT COMPLETED|Overall Study||6||
48774000|NCT01472718|102236468|FG001|NOT COMPLETED|Overall Study||7||
48774001|NCT01273519|102236469|FG000|STARTED|Overall Study||78||
48774002|NCT01273519|102236470|FG001|STARTED|Overall Study||30||
48774003|NCT01273519|102236471|FG002|STARTED|Overall Study||47||
48774004|NCT01273519|102236469|FG000|COMPLETED|Overall Study||59||
48774005|NCT01273519|102236470|FG001|COMPLETED|Overall Study||25||
48774006|NCT01273519|102236471|FG002|COMPLETED|Overall Study||39||
48774007|NCT01273519|102236469|FG000|NOT COMPLETED|Overall Study||19||
48774008|NCT01273519|102236470|FG001|NOT COMPLETED|Overall Study||5||
48774009|NCT01273519|102236471|FG002|NOT COMPLETED|Overall Study||8||
48774010|NCT02598583|102236472|FG000|STARTED|Primary Evaluation Period||6||
48774011|NCT02598583|102236473|FG001|STARTED|Primary Evaluation Period||7||
48774012|NCT02598583|102236472|FG000|COMPLETED|Primary Evaluation Period||6|Completed 169-day Primary Evaluation Period.|
48774013|NCT02598583|102236473|FG001|COMPLETED|Primary Evaluation Period||7|Completed 169-day Primary Evaluation Period.|
48774014|NCT02598583|102236472|FG000|NOT COMPLETED|Primary Evaluation Period||0||
48774015|NCT02598583|102236473|FG001|NOT COMPLETED|Primary Evaluation Period||0||
48774016|NCT02598583|102236472|FG000|STARTED|Extension Period||6||
48774017|NCT02598583|102236473|FG001|STARTED|Extension Period||7||
48774018|NCT02598583|102236472|FG000|COMPLETED|Extension Period||5||
48774019|NCT02598583|102236473|FG001|COMPLETED|Extension Period||7||
48774020|NCT02598583|102236472|FG000|NOT COMPLETED|Extension Period||1||
48774021|NCT02598583|102236473|FG001|NOT COMPLETED|Extension Period||0||
48774022|NCT00606593|102236474|FG000|STARTED|Overall Study||11||
48774023|NCT00606593|102236475|FG001|STARTED|Overall Study||11||
48774024|NCT00606593|102236476|FG002|STARTED|Overall Study||11||
48774025|NCT00606593|102236477|FG003|STARTED|Overall Study||11||
48774026|NCT00606593|102236478|FG004|STARTED|Overall Study||12||
48774027|NCT00606593|102236479|FG005|STARTED|Overall Study||11||
48774028|NCT00606593|102236480|FG006|STARTED|Overall Study||11||
48774029|NCT00606593|102236481|FG007|STARTED|Overall Study||11||
48774030|NCT00606593|102236482|FG008|STARTED|Overall Study||12||
48774031|NCT00606593|102236483|FG009|STARTED|Overall Study||11||
48774032|NCT00606593|102236474|FG000|1st Double-blind Treatment|Overall Study||11||
48774033|NCT00606593|102236475|FG001|1st Double-blind Treatment|Overall Study||11||
48774034|NCT00606593|102236476|FG002|1st Double-blind Treatment|Overall Study||11||
48774035|NCT00606593|102236477|FG003|1st Double-blind Treatment|Overall Study||11||
48774036|NCT00606593|102236478|FG004|1st Double-blind Treatment|Overall Study||12||
48774037|NCT00606593|102236479|FG005|1st Double-blind Treatment|Overall Study||11||
48774038|NCT00606593|102236480|FG006|1st Double-blind Treatment|Overall Study||11||
48774039|NCT00606593|102236481|FG007|1st Double-blind Treatment|Overall Study||11||
48774040|NCT00606593|102236482|FG008|1st Double-blind Treatment|Overall Study||12||
48774041|NCT00606593|102236483|FG009|1st Double-blind Treatment|Overall Study||11||
48774042|NCT00606593|102236474|FG000|2nd Double-blind Treatment|Overall Study||11||
48774043|NCT00606593|102236475|FG001|2nd Double-blind Treatment|Overall Study||11||
48458680|NCT01952574|101459949|FG004|Received 70 mg Erenumab|Open-label Treatment Phase||383||
48458681|NCT01952574|101459950|FG005|Received 70 mg Erenumab|Open-label Treatment Phase||0||
48458682|NCT01952574|101459951|FG006|Received 70 mg Erenumab|Open-label Treatment Phase||0||
48663746|NCT00855335|101961865|FG001|COMPLETED|Overall Study||16||
48663747|NCT00855335|101961866|FG002|COMPLETED|Overall Study||10||
48663748|NCT00855335|101961867|FG003|COMPLETED|Overall Study||12||
48663749|NCT00855335|101961868|FG004|COMPLETED|Overall Study||6||
48774044|NCT00606593|102236476|FG002|2nd Double-blind Treatment|Overall Study||11||
48774045|NCT00606593|102236477|FG003|2nd Double-blind Treatment|Overall Study||10||
48774046|NCT00606593|102236478|FG004|2nd Double-blind Treatment|Overall Study||12||
48774047|NCT00606593|102236479|FG005|2nd Double-blind Treatment|Overall Study||11||
48774048|NCT00606593|102236480|FG006|2nd Double-blind Treatment|Overall Study||10||
48774049|NCT00606593|102236481|FG007|2nd Double-blind Treatment|Overall Study||9||
48774050|NCT00606593|102236482|FG008|2nd Double-blind Treatment|Overall Study||12||
48774051|NCT00606593|102236483|FG009|2nd Double-blind Treatment|Overall Study||11||
48774052|NCT00606593|102236474|FG000|3rd Double-blind Treatment|Overall Study||11||
48774053|NCT00606593|102236475|FG001|3rd Double-blind Treatment|Overall Study||11||
48774054|NCT00606593|102236476|FG002|3rd Double-blind Treatment|Overall Study||10||
48189645|NCT02963597|100786266|FG000|NOT COMPLETED|Overall Study||0||
48189646|NCT02963597|100786267|FG001|NOT COMPLETED|Overall Study||0||
48458683|NCT01952574|101459945|FG000|Received 140 mg Erenumab|Open-label Treatment Phase||0||
48458684|NCT01952574|101459946|FG001|Received 140 mg Erenumab|Open-label Treatment Phase||0||
48458685|NCT01952574|101459947|FG002|Received 140 mg Erenumab|Open-label Treatment Phase||0||
48458686|NCT01952574|101459948|FG003|Received 140 mg Erenumab|Open-label Treatment Phase||0||
48458687|NCT01952574|101459949|FG004|Received 140 mg Erenumab|Open-label Treatment Phase||250||
48458688|NCT01952574|101459950|FG005|Received 140 mg Erenumab|Open-label Treatment Phase||0||
48458689|NCT01952574|101459951|FG006|Received 140 mg Erenumab|Open-label Treatment Phase||0||
48458690|NCT01952574|101459945|FG000|COMPLETED|Open-label Treatment Phase||0||
48663750|NCT00855335|101961864|FG000|NOT COMPLETED|Overall Study||5||
48663751|NCT00855335|101961865|FG001|NOT COMPLETED|Overall Study||2||
48663752|NCT00855335|101961866|FG002|NOT COMPLETED|Overall Study||5||
48663753|NCT00855335|101961867|FG003|NOT COMPLETED|Overall Study||7||
48774055|NCT00606593|102236477|FG003|3rd Double-blind Treatment|Overall Study||10||
48774056|NCT00606593|102236478|FG004|3rd Double-blind Treatment|Overall Study||11||
48774057|NCT00606593|102236479|FG005|3rd Double-blind Treatment|Overall Study||11||
48189647|NCT03570255|100786268|FG000|STARTED|Overall Study||28||
48663754|NCT00855335|101961868|FG004|NOT COMPLETED|Overall Study||1||
48663755|NCT04280783|101961869|FG000|STARTED|Overall Study||15||
48663756|NCT04280783|101961870|FG001|STARTED|Overall Study||15||
48774058|NCT00606593|102236480|FG006|3rd Double-blind Treatment|Overall Study||10||
48774059|NCT00606593|102236481|FG007|3rd Double-blind Treatment|Overall Study||9||
48774060|NCT00606593|102236482|FG008|3rd Double-blind Treatment|Overall Study||12||
48774061|NCT00606593|102236483|FG009|3rd Double-blind Treatment|Overall Study||11||
48774062|NCT00606593|102236474|FG000|4th Double-blind Treatment|Overall Study||10||
48774063|NCT00606593|102236475|FG001|4th Double-blind Treatment|Overall Study||11||
48774064|NCT00606593|102236476|FG002|4th Double-blind Treatment|Overall Study||10||
48774065|NCT00606593|102236477|FG003|4th Double-blind Treatment|Overall Study||10||
48774066|NCT00606593|102236478|FG004|4th Double-blind Treatment|Overall Study||11||
48458691|NCT01952574|101459946|FG001|COMPLETED|Open-label Treatment Phase||0||
48458692|NCT01952574|101459947|FG002|COMPLETED|Open-label Treatment Phase||0||
48458693|NCT01952574|101459948|FG003|COMPLETED|Open-label Treatment Phase||0||
48458694|NCT01952574|101459949|FG004|COMPLETED|Open-label Treatment Phase||221||
48458695|NCT01952574|101459950|FG005|COMPLETED|Open-label Treatment Phase||0||
48458696|NCT01952574|101459951|FG006|COMPLETED|Open-label Treatment Phase||0||
48458697|NCT01952574|101459945|FG000|NOT COMPLETED|Open-label Treatment Phase||0||
48458698|NCT01952574|101459946|FG001|NOT COMPLETED|Open-label Treatment Phase||0||
48458699|NCT01952574|101459947|FG002|NOT COMPLETED|Open-label Treatment Phase||0||
48458700|NCT01952574|101459948|FG003|NOT COMPLETED|Open-label Treatment Phase||0||
48458701|NCT01952574|101459949|FG004|NOT COMPLETED|Open-label Treatment Phase||162||
48458702|NCT01952574|101459950|FG005|NOT COMPLETED|Open-label Treatment Phase||0||
48458703|NCT01952574|101459951|FG006|NOT COMPLETED|Open-label Treatment Phase||0||
48458704|NCT01952574|101459945|FG000|STARTED|Clinical Home Use Substudy||0||
48458705|NCT01952574|101459946|FG001|STARTED|Clinical Home Use Substudy||0||
48458706|NCT01952574|101459947|FG002|STARTED|Clinical Home Use Substudy||0||
48458707|NCT01952574|101459948|FG003|STARTED|Clinical Home Use Substudy||0||
48458708|NCT01952574|101459949|FG004|STARTED|Clinical Home Use Substudy||0||
48458709|NCT01952574|101459950|FG005|STARTED|Clinical Home Use Substudy||42||
48458710|NCT01952574|101459951|FG006|STARTED|Clinical Home Use Substudy||41||
48458711|NCT01952574|101459945|FG000|COMPLETED|Clinical Home Use Substudy||0||
48458712|NCT01952574|101459946|FG001|COMPLETED|Clinical Home Use Substudy||0||
48458713|NCT01952574|101459947|FG002|COMPLETED|Clinical Home Use Substudy||0||
48458714|NCT01952574|101459948|FG003|COMPLETED|Clinical Home Use Substudy||0||
48458715|NCT01952574|101459949|FG004|COMPLETED|Clinical Home Use Substudy||0||
48458716|NCT01952574|101459950|FG005|COMPLETED|Clinical Home Use Substudy||39||
48458717|NCT01952574|101459951|FG006|COMPLETED|Clinical Home Use Substudy||40||
48458718|NCT01952574|101459945|FG000|NOT COMPLETED|Clinical Home Use Substudy||0||
48458719|NCT01952574|101459946|FG001|NOT COMPLETED|Clinical Home Use Substudy||0||
48458720|NCT01952574|101459947|FG002|NOT COMPLETED|Clinical Home Use Substudy||0||
48458721|NCT01952574|101459948|FG003|NOT COMPLETED|Clinical Home Use Substudy||0||
48458722|NCT01952574|101459949|FG004|NOT COMPLETED|Clinical Home Use Substudy||0||
48458723|NCT01952574|101459950|FG005|NOT COMPLETED|Clinical Home Use Substudy||3||
48458724|NCT01952574|101459951|FG006|NOT COMPLETED|Clinical Home Use Substudy||1||
48458725|NCT00863369|101459952|FG000|STARTED|Overall Study||4||
48458726|NCT00863369|101459953|FG001|STARTED|Overall Study||5||
48458727|NCT00863369|101459954|FG002|STARTED|Overall Study||4||
48458728|NCT00863369|101459955|FG003|STARTED|Overall Study||3||
48458729|NCT00863369|101459956|FG004|STARTED|Overall Study||6||
48458730|NCT00863369|101459957|FG005|STARTED|Overall Study||11||
48458731|NCT00863369|101459952|FG000|COMPLETED|Overall Study||4||
48458732|NCT00863369|101459953|FG001|COMPLETED|Overall Study||5||
48458733|NCT00863369|101459954|FG002|COMPLETED|Overall Study||4||
48458734|NCT00863369|101459955|FG003|COMPLETED|Overall Study||3||
48458735|NCT00863369|101459956|FG004|COMPLETED|Overall Study||6||
48458736|NCT00863369|101459957|FG005|COMPLETED|Overall Study||11||
48458737|NCT00863369|101459952|FG000|NOT COMPLETED|Overall Study||0||
48458738|NCT00863369|101459953|FG001|NOT COMPLETED|Overall Study||0||
48458739|NCT00863369|101459954|FG002|NOT COMPLETED|Overall Study||0||
48663757|NCT04280783|101961869|FG000|COMPLETED|Overall Study||14||
48663758|NCT04280783|101961870|FG001|COMPLETED|Overall Study||14||
48663759|NCT04280783|101961869|FG000|NOT COMPLETED|Overall Study||1||
48663760|NCT04280783|101961870|FG001|NOT COMPLETED|Overall Study||1||
48663761|NCT05670756|101961871|FG000|STARTED|Overall Study||250||
48663762|NCT05670756|101961871|FG000|COMPLETED|Overall Study||250||
48663763|NCT05670756|101961871|FG000|NOT COMPLETED|Overall Study||0||
48663764|NCT02321514|101961872|FG000|STARTED|Overall Study||191||
48663765|NCT02321514|101961872|FG000|COMPLETED|Overall Study||166||
48663766|NCT02321514|101961872|FG000|NOT COMPLETED|Overall Study||25||
48774067|NCT00606593|102236479|FG005|4th Double-blind Treatment|Overall Study||11||
48774068|NCT00606593|102236480|FG006|4th Double-blind Treatment|Overall Study||10||
48774069|NCT00606593|102236481|FG007|4th Double-blind Treatment|Overall Study||9||
48774070|NCT00606593|102236482|FG008|4th Double-blind Treatment|Overall Study||11||
48774071|NCT00606593|102236483|FG009|4th Double-blind Treatment|Overall Study||11||
48774072|NCT00606593|102236474|FG000|5th Double-blind Treatment|Overall Study||10||
48774073|NCT00606593|102236475|FG001|5th Double-blind Treatment|Overall Study||11||
48774074|NCT00606593|102236476|FG002|5th Double-blind Treatment|Overall Study||9||
48458740|NCT00863369|101459955|FG003|NOT COMPLETED|Overall Study||0||
48458741|NCT00863369|101459956|FG004|NOT COMPLETED|Overall Study||0||
48458742|NCT00863369|101459957|FG005|NOT COMPLETED|Overall Study||0||
48458743|NCT03104205|101459958|FG000|STARTED|Overall Study||53||
48663767|NCT03988205|101961873|FG000|STARTED|Overall Study||3||
48663768|NCT03988205|101961873|FG000|COMPLETED|Overall Study||3||
48663769|NCT03988205|101961873|FG000|NOT COMPLETED|Overall Study||0||
48663770|NCT01380080|101961874|FG000|STARTED|Overall Study||424||
48774075|NCT00606593|102236477|FG003|5th Double-blind Treatment|Overall Study||10||
48774076|NCT00606593|102236478|FG004|5th Double-blind Treatment|Overall Study||11||
48774077|NCT00606593|102236479|FG005|5th Double-blind Treatment|Overall Study||11||
48774078|NCT00606593|102236480|FG006|5th Double-blind Treatment|Overall Study||10||
48774079|NCT00606593|102236481|FG007|5th Double-blind Treatment|Overall Study||9||
48774080|NCT00606593|102236482|FG008|5th Double-blind Treatment|Overall Study||11||
48774081|NCT00606593|102236483|FG009|5th Double-blind Treatment|Overall Study||11||
48774082|NCT00606593|102236474|FG000|COMPLETED|Overall Study||10||
48774083|NCT00606593|102236475|FG001|COMPLETED|Overall Study||11||
48774084|NCT00606593|102236476|FG002|COMPLETED|Overall Study||9||
48774085|NCT00606593|102236477|FG003|COMPLETED|Overall Study||10||
48774086|NCT00606593|102236478|FG004|COMPLETED|Overall Study||11||
48774087|NCT00606593|102236479|FG005|COMPLETED|Overall Study||11||
48774088|NCT00606593|102236480|FG006|COMPLETED|Overall Study||10||
48774089|NCT00606593|102236481|FG007|COMPLETED|Overall Study||9||
48774090|NCT00606593|102236482|FG008|COMPLETED|Overall Study||11||
48774091|NCT00606593|102236483|FG009|COMPLETED|Overall Study||11||
48774092|NCT00606593|102236474|FG000|NOT COMPLETED|Overall Study||1||
48774093|NCT00606593|102236475|FG001|NOT COMPLETED|Overall Study||0||
48774094|NCT00606593|102236476|FG002|NOT COMPLETED|Overall Study||2||
48774095|NCT00606593|102236477|FG003|NOT COMPLETED|Overall Study||1||
48774096|NCT00606593|102236478|FG004|NOT COMPLETED|Overall Study||1||
48774097|NCT00606593|102236479|FG005|NOT COMPLETED|Overall Study||0||
48774098|NCT00606593|102236480|FG006|NOT COMPLETED|Overall Study||1||
48774099|NCT00606593|102236481|FG007|NOT COMPLETED|Overall Study||2||
48774100|NCT00606593|102236482|FG008|NOT COMPLETED|Overall Study||1||
48774101|NCT00606593|102236483|FG009|NOT COMPLETED|Overall Study||0||
48774102|NCT03527732|102236484|FG000|STARTED|Overall Study||256||
48774103|NCT03527732|102236485|FG001|STARTED|Overall Study||255||
48774104|NCT03527732|102236486|FG002|STARTED|Overall Study||274||
48774105|NCT03527732|102236487|FG003|STARTED|Overall Study||275||
48774106|NCT03527732|102236488|FG004|STARTED|Overall Study||305||
48774107|NCT03527732|102236489|FG005|STARTED|Overall Study||308||
48774108|NCT03527732|102236484|FG000|COMPLETED|Overall Study||235||
48774109|NCT03527732|102236485|FG001|COMPLETED|Overall Study||232||
48774110|NCT03527732|102236486|FG002|COMPLETED|Overall Study||194||
48774111|NCT03527732|102236487|FG003|COMPLETED|Overall Study||213||
48774112|NCT03527732|102236488|FG004|COMPLETED|Overall Study||293||
48458744|NCT03104205|101459958|FG000|COMPLETED|Overall Study||44||
48458745|NCT03104205|101459958|FG000|NOT COMPLETED|Overall Study||9||
48458746|NCT00494806|101459959|FG000|STARTED|Overall Study||34||
48458747|NCT00494806|101459960|FG001|STARTED|Overall Study||32||
48774113|NCT03527732|102236489|FG005|COMPLETED|Overall Study||288||
48774114|NCT03527732|102236484|FG000|NOT COMPLETED|Overall Study||21||
48774115|NCT03527732|102236485|FG001|NOT COMPLETED|Overall Study||23||
48774116|NCT03527732|102236486|FG002|NOT COMPLETED|Overall Study||80||
48774117|NCT03527732|102236487|FG003|NOT COMPLETED|Overall Study||62||
48774118|NCT03527732|102236488|FG004|NOT COMPLETED|Overall Study||12||
48774119|NCT03527732|102236489|FG005|NOT COMPLETED|Overall Study||20||
48774120|NCT03761368|102236490|FG000|STARTED|Overall Study||50||
48774121|NCT03761368|102236491|FG001|STARTED|Overall Study||51||
48774122|NCT03761368|102236490|FG000|COMPLETED|Overall Study||50||
48774123|NCT03761368|102236491|FG001|COMPLETED|Overall Study||51||
48774124|NCT03761368|102236490|FG000|NOT COMPLETED|Overall Study||0||
48774125|NCT03761368|102236491|FG001|NOT COMPLETED|Overall Study||0||
48774126|NCT05844007|102236492|FG000|STARTED|Overall Study||22||
48774127|NCT05844007|102236493|FG001|STARTED|Overall Study||18||
48774128|NCT05844007|102236494|FG002|STARTED|Overall Study||43||
48774129|NCT05844007|102236492|FG000|COMPLETED|Overall Study||22||
48774130|NCT05844007|102236493|FG001|COMPLETED|Overall Study||18||
48774131|NCT05844007|102236494|FG002|COMPLETED|Overall Study||43||
48774132|NCT05844007|102236492|FG000|NOT COMPLETED|Overall Study||0||
48774133|NCT05844007|102236493|FG001|NOT COMPLETED|Overall Study||0||
48774134|NCT05844007|102236494|FG002|NOT COMPLETED|Overall Study||0||
48774135|NCT00487461|102236495|FG000|STARTED|Overall Study||2||
48774136|NCT00487461|102236496|FG001|STARTED|Overall Study||12||
48774137|NCT00487461|102236497|FG002|STARTED|Overall Study||11||
48189648|NCT03570255|100786268|FG000|COMPLETED|Overall Study||28||
48189649|NCT03570255|100786268|FG000|NOT COMPLETED|Overall Study||0||
48458748|NCT00494806|101459959|FG000|COMPLETED|Overall Study||34||
48458749|NCT00494806|101459960|FG001|COMPLETED|Overall Study||32||
48774138|NCT00487461|102236495|FG000|COMPLETED|Overall Study||2||
48774139|NCT00487461|102236496|FG001|COMPLETED|Overall Study||10||
48774140|NCT00487461|102236497|FG002|COMPLETED|Overall Study||7||
48774141|NCT00487461|102236495|FG000|NOT COMPLETED|Overall Study||0||
48774142|NCT00487461|102236496|FG001|NOT COMPLETED|Overall Study||2||
48774143|NCT00487461|102236497|FG002|NOT COMPLETED|Overall Study||4||
48774144|NCT01663103|102236498|FG000|STARTED|Overall Study||21||
48774145|NCT01663103|102236499|FG001|STARTED|Overall Study||21||
48774146|NCT01663103|102236498|FG000|COMPLETED|Overall Study||18||
48774147|NCT01663103|102236499|FG001|COMPLETED|Overall Study||19||
48774148|NCT01663103|102236498|FG000|NOT COMPLETED|Overall Study||3||
48774149|NCT01663103|102236499|FG001|NOT COMPLETED|Overall Study||2||
48774150|NCT01167504|102236500|FG000|STARTED|Overall Study||15||
48774151|NCT01167504|102236500|FG000|COMPLETED|Overall Study||12||
48774152|NCT01167504|102236500|FG000|NOT COMPLETED|Overall Study||3||
48458750|NCT00494806|101459959|FG000|NOT COMPLETED|Overall Study||0||
48458751|NCT00494806|101459960|FG001|NOT COMPLETED|Overall Study||0||
48458752|NCT01173159|101459961|FG000|STARTED|Overall Study||10||
48458753|NCT01173159|101459961|FG000|COMPLETED|Overall Study||10||
48458754|NCT01173159|101459961|FG000|NOT COMPLETED|Overall Study||0||
48458755|NCT01483872|101459962|FG000|STARTED|Overall Study||0||
48458756|NCT01483872|101459963|FG001|STARTED|Overall Study||1||
48458757|NCT01483872|101459962|FG000|COMPLETED|Overall Study||0||
48458758|NCT01483872|101459963|FG001|COMPLETED|Overall Study||1||
48458759|NCT01483872|101459962|FG000|NOT COMPLETED|Overall Study||0||
48458760|NCT01483872|101459963|FG001|NOT COMPLETED|Overall Study||0||
48458761|NCT00526890|101459964|FG000|STARTED|Overall Study||16||
48458762|NCT00526890|101459964|FG000|COMPLETED|Overall Study||14||
48458763|NCT00526890|101459964|FG000|NOT COMPLETED|Overall Study||2||
48458764|NCT03567057|101459965|FG000|STARTED|Overall Study||159||
48458765|NCT03567057|101459966|FG001|STARTED|Overall Study||151||
48458766|NCT03567057|101459967|FG002|STARTED|Overall Study||114||
48458767|NCT03567057|101459965|FG000|COMPLETED|Overall Study||64||
48458768|NCT03567057|101459966|FG001|COMPLETED|Overall Study||64||
48458769|NCT03567057|101459967|FG002|COMPLETED|Overall Study||68||
48458770|NCT03567057|101459965|FG000|NOT COMPLETED|Overall Study||95||
48458771|NCT03567057|101459966|FG001|NOT COMPLETED|Overall Study||87||
48458772|NCT03567057|101459967|FG002|NOT COMPLETED|Overall Study||46||
48458773|NCT02058628|101459968|FG000|STARTED|Overall Study||111||
48458774|NCT02058628|101459969|FG001|STARTED|Overall Study||110||
48458775|NCT02058628|101459968|FG000|COMPLETED|Overall Study||104||
48458776|NCT02058628|101459969|FG001|COMPLETED|Overall Study||102||
48458777|NCT02058628|101459968|FG000|NOT COMPLETED|Overall Study||7||
48458778|NCT02058628|101459969|FG001|NOT COMPLETED|Overall Study||8||
48458779|NCT01070966|101459970|FG000|STARTED|Participants for Safety Evaluation||2089||
48458780|NCT01070966|101459970|FG000|COMPLETED|Participants for Safety Evaluation||2011||
48458781|NCT01070966|101459970|FG000|NOT COMPLETED|Participants for Safety Evaluation||78||
48663771|NCT01380080|101961875|FG001|STARTED|Overall Study||426||
48663772|NCT01380080|101961874|FG000|COMPLETED|Overall Study||339||
48663773|NCT01380080|101961875|FG001|COMPLETED|Overall Study||343||
48663774|NCT01380080|101961874|FG000|NOT COMPLETED|Overall Study||85||
48663775|NCT01380080|101961875|FG001|NOT COMPLETED|Overall Study||83||
48663776|NCT03847519|101961876|FG000|STARTED|Overall Study||7||
48663777|NCT03847519|101961877|FG001|STARTED|Overall Study||14||
48663778|NCT03847519|101961878|FG002|STARTED|Overall Study||3||
48663779|NCT03847519|101961876|FG000|COMPLETED|Overall Study||1||
48663780|NCT03847519|101961877|FG001|COMPLETED|Overall Study||1||
48663781|NCT03847519|101961878|FG002|COMPLETED|Overall Study||0||
48663782|NCT03847519|101961876|FG000|NOT COMPLETED|Overall Study||6||
48663783|NCT03847519|101961877|FG001|NOT COMPLETED|Overall Study||13||
48663784|NCT03847519|101961878|FG002|NOT COMPLETED|Overall Study||3||
48663785|NCT05473715|101961879|FG000|STARTED|Overall Study||2||
48663786|NCT05473715|101961880|FG001|STARTED|Overall Study||1||
48663787|NCT05473715|101961879|FG000|COMPLETED|Overall Study||0||
48663788|NCT05473715|101961880|FG001|COMPLETED|Overall Study||0||
48663789|NCT05473715|101961879|FG000|NOT COMPLETED|Overall Study||2||
48189650|NCT01268059|100786269|FG000|STARTED|Overall Study||40||
48458782|NCT01070966|101459970|FG000|STARTED|Participants for Efficacy Evaluation||2011||
48458783|NCT01070966|101459970|FG000|COMPLETED|Participants for Efficacy Evaluation||1929||
48458784|NCT01070966|101459970|FG000|NOT COMPLETED|Participants for Efficacy Evaluation||82||
48458785|NCT01337050|101459971|FG000|STARTED|Overall Study||4||
48458786|NCT01337050|101459972|FG001|STARTED|Overall Study||13||
48458787|NCT01337050|101459973|FG002|STARTED|Overall Study||19||
48458788|NCT01337050|101459971|FG000|COMPLETED|Overall Study||0||
48458789|NCT01337050|101459972|FG001|COMPLETED|Overall Study||0||
48458790|NCT01337050|101459973|FG002|COMPLETED|Overall Study||0||
48458791|NCT01337050|101459971|FG000|NOT COMPLETED|Overall Study||4||
48458792|NCT01337050|101459972|FG001|NOT COMPLETED|Overall Study||13||
48458793|NCT01337050|101459973|FG002|NOT COMPLETED|Overall Study||19||
48458794|NCT01299038|101459974|FG000|STARTED|Overall Study||10||
48458795|NCT01299038|101459975|FG001|STARTED|Overall Study||10||
48458796|NCT01299038|101459974|FG000|COMPLETED|Overall Study||9||
48458797|NCT01299038|101459975|FG001|COMPLETED|Overall Study||10||
48458798|NCT01299038|101459974|FG000|NOT COMPLETED|Overall Study||1||
48458799|NCT01299038|101459975|FG001|NOT COMPLETED|Overall Study||0||
48458800|NCT00767325|101459976|FG000|STARTED|Overall Study||104||
48458801|NCT00767325|101459976|FG000|COMPLETED|Overall Study||89||
48458802|NCT00767325|101459976|FG000|NOT COMPLETED|Overall Study||15||
48458803|NCT01078090|101459977|FG000|STARTED|Overall Study||5745||
48458804|NCT01078090|101459977|FG000|COMPLETED|Overall Study||1152||
48458805|NCT01078090|101459977|FG000|NOT COMPLETED|Overall Study||4593||
48458806|NCT01193517|101459978|FG000|STARTED|Overall Study||3||
48458807|NCT01193517|101459979|FG001|STARTED|Overall Study||12||
48458808|NCT01193517|101459980|FG002|STARTED|Overall Study||11||
48663790|NCT05473715|101961880|FG001|NOT COMPLETED|Overall Study||1||
48663791|NCT00605189|101961881|FG000|STARTED|Overall Study||20||
48663792|NCT00605189|101961882|FG001|STARTED|Overall Study||21||
48663793|NCT00605189|101961883|FG002|STARTED|Overall Study||9||
48663794|NCT00605189|101961881|FG000|COMPLETED|Overall Study||17||
48458809|NCT01193517|101459978|FG000|COMPLETED|Overall Study||2||
48458810|NCT01193517|101459979|FG001|COMPLETED|Overall Study||12||
48458811|NCT01193517|101459980|FG002|COMPLETED|Overall Study||11||
48458812|NCT01193517|101459978|FG000|NOT COMPLETED|Overall Study||1||
48458813|NCT01193517|101459979|FG001|NOT COMPLETED|Overall Study||0||
48458814|NCT01193517|101459980|FG002|NOT COMPLETED|Overall Study||0||
48458815|NCT02452060|101459981|FG000|STARTED|Overall Study||46||
48458816|NCT02452060|101459982|FG001|STARTED|Overall Study||44||
48663795|NCT00605189|101961882|FG001|COMPLETED|Overall Study||19||
48663796|NCT00605189|101961883|FG002|COMPLETED|Overall Study||9||
48663797|NCT00605189|101961881|FG000|NOT COMPLETED|Overall Study||3||
48663798|NCT00605189|101961882|FG001|NOT COMPLETED|Overall Study||2||
48663799|NCT00605189|101961883|FG002|NOT COMPLETED|Overall Study||0||
48663800|NCT02730169|101961884|FG000|STARTED|Overall Study||67||
48663801|NCT02730169|101961885|FG001|STARTED|Overall Study||66||
48663802|NCT02730169|101961886|FG002|STARTED|Overall Study||67||
48663803|NCT02730169|101961887|FG003|STARTED|Overall Study||71||
48663804|NCT02730169|101961884|FG000|COMPLETED|Overall Study||53||
48663805|NCT02730169|101961885|FG001|COMPLETED|Overall Study||45||
48663806|NCT02730169|101961886|FG002|COMPLETED|Overall Study||50||
48663807|NCT02730169|101961887|FG003|COMPLETED|Overall Study||55||
48663808|NCT02730169|101961884|FG000|NOT COMPLETED|Overall Study||14||
48663809|NCT02730169|101961885|FG001|NOT COMPLETED|Overall Study||21||
48663810|NCT02730169|101961886|FG002|NOT COMPLETED|Overall Study||17||
48663811|NCT02730169|101961887|FG003|NOT COMPLETED|Overall Study||16||
48663812|NCT02457546|101961888|FG000|STARTED|Overall Study||114||
48663813|NCT02457546|101961889|FG001|STARTED|Overall Study||120||
48663814|NCT02457546|101961888|FG000|COMPLETED|Overall Study||105||
48663815|NCT02457546|101961889|FG001|COMPLETED|Overall Study||116||
48663816|NCT02457546|101961888|FG000|NOT COMPLETED|Overall Study||9||
48663817|NCT02457546|101961889|FG001|NOT COMPLETED|Overall Study||4||
48663818|NCT03408262|101961890|FG000|STARTED|Overall Study||15||
48663819|NCT03408262|101961891|FG001|STARTED|Overall Study||6||
48663820|NCT03408262|101961892|FG002|STARTED|Overall Study||6||
48663821|NCT03408262|101961893|FG003|STARTED|Overall Study||13||
48663822|NCT03408262|101961894|FG004|STARTED|Overall Study||6||
48663823|NCT03408262|101961895|FG005|STARTED|Overall Study||6||
48663824|NCT03408262|101961896|FG006|STARTED|Overall Study||9||
48663825|NCT03408262|101961897|FG007|STARTED|Overall Study||7||
48774153|NCT02282605|102236501|FG000|STARTED|Overall Study||27||
48458817|NCT02452060|101459981|FG000|COMPLETED|Overall Study||46||
48458818|NCT02452060|101459982|FG001|COMPLETED|Overall Study||44||
48458819|NCT02452060|101459981|FG000|NOT COMPLETED|Overall Study||0||
48458820|NCT02452060|101459982|FG001|NOT COMPLETED|Overall Study||0||
48458821|NCT00417027|101459983|FG000|STARTED|Overall Study||66||
48458822|NCT00417027|101459984|FG001|STARTED|Overall Study||65||
48458823|NCT00417027|101459985|FG002|STARTED|Overall Study||59||
48663826|NCT03408262|101961890|FG000|COMPLETED|Overall Study||11||
48663827|NCT03408262|101961891|FG001|COMPLETED|Overall Study||6||
48663828|NCT03408262|101961892|FG002|COMPLETED|Overall Study||6||
48663829|NCT03408262|101961893|FG003|COMPLETED|Overall Study||12||
48663830|NCT03408262|101961894|FG004|COMPLETED|Overall Study||6||
48663831|NCT03408262|101961895|FG005|COMPLETED|Overall Study||6||
48663832|NCT03408262|101961896|FG006|COMPLETED|Overall Study||6||
48663833|NCT03408262|101961897|FG007|COMPLETED|Overall Study||6||
48663834|NCT03408262|101961890|FG000|NOT COMPLETED|Overall Study||4||
48774154|NCT02282605|102236502|FG001|STARTED|Overall Study||12||
48458824|NCT00417027|101459983|FG000|COMPLETED|Overall Study||66||
48458825|NCT00417027|101459984|FG001|COMPLETED|Overall Study||60||
48458826|NCT00417027|101459985|FG002|COMPLETED|Overall Study||54||
48458827|NCT00417027|101459983|FG000|NOT COMPLETED|Overall Study||0||
48458828|NCT00417027|101459984|FG001|NOT COMPLETED|Overall Study||5||
48458829|NCT00417027|101459985|FG002|NOT COMPLETED|Overall Study||5||
48458830|NCT01904383|101459986|FG000|STARTED|Overall Study||4057|Started are registered|
48458831|NCT01904383|101459986|FG000|Treated|Overall Study||3940||
48458832|NCT01904383|101459986|FG000|COMPLETED|Overall Study||2283||
48458833|NCT01904383|101459986|FG000|NOT COMPLETED|Overall Study||1774||
48458834|NCT04523142|101459987|FG000|STARTED|Overall Study||202||
48663835|NCT03408262|101961891|FG001|NOT COMPLETED|Overall Study||0||
48663836|NCT03408262|101961892|FG002|NOT COMPLETED|Overall Study||0||
48663837|NCT03408262|101961893|FG003|NOT COMPLETED|Overall Study||1||
48663838|NCT03408262|101961894|FG004|NOT COMPLETED|Overall Study||0||
48663839|NCT03408262|101961895|FG005|NOT COMPLETED|Overall Study||0||
48663840|NCT03408262|101961896|FG006|NOT COMPLETED|Overall Study||3||
48663841|NCT03408262|101961897|FG007|NOT COMPLETED|Overall Study||1||
48663842|NCT03126630|101961898|FG000|STARTED|Overall Study||18||
48663843|NCT03126630|101961899|FG001|STARTED|Overall Study||18||
48663844|NCT03126630|101961900|FG002|STARTED|Overall Study||13||
48663845|NCT03126630|101961898|FG000|COMPLETED|Overall Study||18||
48663846|NCT03126630|101961899|FG001|COMPLETED|Overall Study||17||
48663847|NCT03126630|101961900|FG002|COMPLETED|Overall Study||13||
48663848|NCT03126630|101961898|FG000|NOT COMPLETED|Overall Study||0||
48663849|NCT03126630|101961899|FG001|NOT COMPLETED|Overall Study||1||
48663850|NCT03126630|101961900|FG002|NOT COMPLETED|Overall Study||0||
48774155|NCT02282605|102236503|FG002|STARTED|Overall Study||24||
48774156|NCT02282605|102236501|FG000|COMPLETED|Overall Study||24||
48774157|NCT02282605|102236502|FG001|COMPLETED|Overall Study||12||
48774158|NCT02282605|102236503|FG002|COMPLETED|Overall Study||24||
48774159|NCT02282605|102236501|FG000|NOT COMPLETED|Overall Study||3||
48774160|NCT02282605|102236502|FG001|NOT COMPLETED|Overall Study||0||
48774161|NCT02282605|102236503|FG002|NOT COMPLETED|Overall Study||0||
48774162|NCT03714880|102236504|FG000|STARTED|Overall Study||20||
48774163|NCT03714880|102236505|FG001|STARTED|Overall Study||24||
48774164|NCT03714880|102236504|FG000|COMPLETED|Overall Study||19||
48774165|NCT03714880|102236505|FG001|COMPLETED|Overall Study||22||
48774166|NCT03714880|102236504|FG000|NOT COMPLETED|Overall Study||1||
48774167|NCT03714880|102236505|FG001|NOT COMPLETED|Overall Study||2||
48774168|NCT02259088|102236506|FG000|STARTED|Overall Study||307|All randomized participants|
48774169|NCT02259088|102236507|FG001|STARTED|Overall Study||77|All randomized participants|
48774170|NCT02259088|102236506|FG000|Full Analysis Set|Overall Study||307||
48774171|NCT02259088|102236507|FG001|Full Analysis Set|Overall Study||77||
48774172|NCT02259088|102236506|FG000|Treated (Safety Analysis Set)|Overall Study||307||
48458835|NCT04523142|101459987|FG000|COMPLETED|Overall Study||175||
48458836|NCT04523142|101459987|FG000|NOT COMPLETED|Overall Study||27||
48458837|NCT03903640|101459988|FG000|STARTED|Overall Study||2||
48458838|NCT03903640|101459988|FG000|COMPLETED|Overall Study||2||
48458839|NCT03903640|101459988|FG000|NOT COMPLETED|Overall Study||0||
48458840|NCT02444533|101459989|FG000|STARTED|Overall Study||17||
48458841|NCT02444533|101459990|FG001|STARTED|Overall Study||22||
48458842|NCT02444533|101459989|FG000|COMPLETED|Overall Study||15||
48458843|NCT02444533|101459990|FG001|COMPLETED|Overall Study||18||
48458844|NCT02444533|101459989|FG000|NOT COMPLETED|Overall Study||2||
48458845|NCT02444533|101459990|FG001|NOT COMPLETED|Overall Study||4||
48458846|NCT02780661|101459991|FG000|STARTED|Period 1||10||
48458847|NCT02780661|101459992|FG001|STARTED|Period 1||9||
48458848|NCT02780661|101459991|FG000|COMPLETED|Period 1||10||
48458849|NCT02780661|101459992|FG001|COMPLETED|Period 1||9||
48458850|NCT02780661|101459991|FG000|NOT COMPLETED|Period 1||0||
48458851|NCT02780661|101459992|FG001|NOT COMPLETED|Period 1||0||
48458852|NCT02780661|101459991|FG000|STARTED|Wash Out Period||10||
48458853|NCT02780661|101459992|FG001|STARTED|Wash Out Period||9||
48458854|NCT02780661|101459991|FG000|COMPLETED|Wash Out Period||10||
48458855|NCT02780661|101459992|FG001|COMPLETED|Wash Out Period||9||
48774173|NCT02259088|102236507|FG001|Treated (Safety Analysis Set)|Overall Study||75||
48774174|NCT02259088|102236506|FG000|COMPLETED|Overall Study||279||
48774175|NCT02259088|102236507|FG001|COMPLETED|Overall Study||63||
48774176|NCT02259088|102236506|FG000|NOT COMPLETED|Overall Study||28||
48458856|NCT02780661|101459991|FG000|NOT COMPLETED|Wash Out Period||0||
48458857|NCT02780661|101459992|FG001|NOT COMPLETED|Wash Out Period||0||
48458858|NCT02780661|101459991|FG000|STARTED|Period 2||10||
48458859|NCT02780661|101459992|FG001|STARTED|Period 2||9||
48458860|NCT02780661|101459991|FG000|COMPLETED|Period 2||10||
48458861|NCT02780661|101459992|FG001|COMPLETED|Period 2||9||
48458862|NCT02780661|101459991|FG000|NOT COMPLETED|Period 2||0||
48458863|NCT02780661|101459992|FG001|NOT COMPLETED|Period 2||0||
48458864|NCT02057952|101459993|FG000|STARTED|Overall Study||51||
48458865|NCT02057952|101459994|FG001|STARTED|Overall Study||49||
48458866|NCT02057952|101459995|FG002|STARTED|Overall Study||50||
48458867|NCT02057952|101459993|FG000|COMPLETED|Overall Study||43||
48458868|NCT02057952|101459994|FG001|COMPLETED|Overall Study||39||
48458869|NCT02057952|101459995|FG002|COMPLETED|Overall Study||28||
48458870|NCT02057952|101459993|FG000|NOT COMPLETED|Overall Study||8||
48458871|NCT02057952|101459994|FG001|NOT COMPLETED|Overall Study||10||
48458872|NCT02057952|101459995|FG002|NOT COMPLETED|Overall Study||22||
48458873|NCT05321810|101459996|FG000|STARTED|Overall Study||57560||
48458874|NCT05321810|101459997|FG001|STARTED|Overall Study||90636||
48458875|NCT05321810|101459998|FG002|STARTED|Overall Study||18216||
48458876|NCT05321810|101459999|FG003|STARTED|Overall Study||27153||
48458877|NCT05321810|101459996|FG000|COMPLETED|Overall Study||57560||
48458878|NCT05321810|101459997|FG001|COMPLETED|Overall Study||90636||
48458879|NCT05321810|101459998|FG002|COMPLETED|Overall Study||18216||
48458880|NCT05321810|101459999|FG003|COMPLETED|Overall Study||27153||
48458881|NCT05321810|101459996|FG000|NOT COMPLETED|Overall Study||0||
48458882|NCT05321810|101459997|FG001|NOT COMPLETED|Overall Study||0||
48774177|NCT02259088|102236507|FG001|NOT COMPLETED|Overall Study||14||
48774178|NCT04518358|102236508|FG000|STARTED|Single Case Experimental Design (SCED) 1||4|Each ARM consisted of 4 instructors and 4 adult participants with ASD.|
48774179|NCT04518358|102236509|FG001|STARTED|Single Case Experimental Design (SCED) 1||0|Each ARM consisted of 4 instructors and 4 adult participants with ASD.|
48458883|NCT05321810|101459998|FG002|NOT COMPLETED|Overall Study||0||
48458884|NCT05321810|101459999|FG003|NOT COMPLETED|Overall Study||0||
48458885|NCT03944486|101460000|FG000|STARTED|Overall Study||24||
48774180|NCT04518358|102236508|FG000|COMPLETED|Single Case Experimental Design (SCED) 1||4||
48774181|NCT04518358|102236509|FG001|COMPLETED|Single Case Experimental Design (SCED) 1||0||
48774182|NCT04518358|102236508|FG000|NOT COMPLETED|Single Case Experimental Design (SCED) 1||0||
48458886|NCT03944486|101460000|FG000|COMPLETED|Overall Study||12||
48458887|NCT03944486|101460000|FG000|NOT COMPLETED|Overall Study||12||
48458888|NCT05085964|101460001|FG000|STARTED|Overall Study||21||
48458889|NCT05085964|101460002|FG001|STARTED|Overall Study||0||
48458890|NCT05085964|101460001|FG000|COMPLETED|Overall Study||0||
48458891|NCT05085964|101460002|FG001|COMPLETED|Overall Study||0||
48774183|NCT04518358|102236509|FG001|NOT COMPLETED|Single Case Experimental Design (SCED) 1||0||
48774184|NCT04518358|102236508|FG000|STARTED|SCED 2||0||
48774185|NCT04518358|102236509|FG001|STARTED|SCED 2||4||
48774186|NCT04518358|102236508|FG000|COMPLETED|SCED 2||0||
48774187|NCT04518358|102236509|FG001|COMPLETED|SCED 2||4||
48774188|NCT04518358|102236508|FG000|NOT COMPLETED|SCED 2||0||
48774189|NCT04518358|102236509|FG001|NOT COMPLETED|SCED 2||0||
48774190|NCT03524118|102236510|FG000|STARTED|Overall Study||8||
48774191|NCT03524118|102236511|FG001|STARTED|Overall Study||31||
48774192|NCT03524118|102236512|FG002|STARTED|Overall Study||41||
48774193|NCT03524118|102236513|FG003|STARTED|Overall Study||32||
48774194|NCT03524118|102236514|FG004|STARTED|Overall Study||33||
48774195|NCT03524118|102236515|FG005|STARTED|Overall Study||38||
48774196|NCT03524118|102236510|FG000|Treated|Overall Study||8||
48774197|NCT03524118|102236511|FG001|Treated|Overall Study||31||
48774198|NCT03524118|102236512|FG002|Treated|Overall Study||40||
48774199|NCT03524118|102236513|FG003|Treated|Overall Study||32||
48774200|NCT03524118|102236514|FG004|Treated|Overall Study||32||
48369645|NCT00859898|101232824|FG001|STARTED|Overall Study||219||
48369646|NCT00859898|101232825|FG002|STARTED|Overall Study||208||
48369647|NCT00859898|101232823|FG000|COMPLETED|Overall Study||183||
48369648|NCT00859898|101232824|FG001|COMPLETED|Overall Study||188||
48369649|NCT00859898|101232825|FG002|COMPLETED|Overall Study||181||
48369650|NCT00859898|101232823|FG000|NOT COMPLETED|Overall Study||28||
48369651|NCT00859898|101232824|FG001|NOT COMPLETED|Overall Study||31||
48369652|NCT00859898|101232825|FG002|NOT COMPLETED|Overall Study||27||
48369653|NCT01419249|101232826|FG000|STARTED|Overall Study||318||
48369654|NCT01419249|101232827|FG001|STARTED|Overall Study||140||
48369655|NCT01419249|101232826|FG000|COMPLETED|Overall Study||318||
48369656|NCT01419249|101232827|FG001|COMPLETED|Overall Study||140||
48369657|NCT01419249|101232826|FG000|NOT COMPLETED|Overall Study||0||
48369658|NCT01419249|101232827|FG001|NOT COMPLETED|Overall Study||0||
48369659|NCT01971476|101232828|FG000|STARTED|Cohort 1: 2 to <12 Years||3||
48369660|NCT01971476|101232829|FG001|STARTED|Cohort 1: 2 to <12 Years||3||
48369661|NCT01971476|101232830|FG002|STARTED|Cohort 1: 2 to <12 Years||6||
48369662|NCT01971476|101232828|FG000|COMPLETED|Cohort 1: 2 to <12 Years||0||
48369663|NCT01971476|101232829|FG001|COMPLETED|Cohort 1: 2 to <12 Years||0||
48369664|NCT01971476|101232830|FG002|COMPLETED|Cohort 1: 2 to <12 Years||0||
48369665|NCT01971476|101232828|FG000|NOT COMPLETED|Cohort 1: 2 to <12 Years||3||
48369666|NCT01971476|101232829|FG001|NOT COMPLETED|Cohort 1: 2 to <12 Years||3||
48369667|NCT01971476|101232830|FG002|NOT COMPLETED|Cohort 1: 2 to <12 Years||6||
48369668|NCT01971476|101232828|FG000|STARTED|Cohort 2: 12 to <18 Years||6||
48369669|NCT01971476|101232829|FG001|STARTED|Cohort 2: 12 to <18 Years||4||
48369670|NCT01971476|101232830|FG002|STARTED|Cohort 2: 12 to <18 Years||0||
48369671|NCT01971476|101232828|FG000|COMPLETED|Cohort 2: 12 to <18 Years||0||
48369672|NCT01971476|101232829|FG001|COMPLETED|Cohort 2: 12 to <18 Years||0||
48369673|NCT01971476|101232830|FG002|COMPLETED|Cohort 2: 12 to <18 Years||0||
48369674|NCT01971476|101232828|FG000|NOT COMPLETED|Cohort 2: 12 to <18 Years||6||
48369675|NCT01971476|101232829|FG001|NOT COMPLETED|Cohort 2: 12 to <18 Years||4||
48369676|NCT01971476|101232830|FG002|NOT COMPLETED|Cohort 2: 12 to <18 Years||0||
48369677|NCT05523362|101232831|FG000|STARTED|Phase 1- Blinded (10 Days)||56||
48369678|NCT05523362|101232831|FG000|COMPLETED|Phase 1- Blinded (10 Days)||47||
48369679|NCT05523362|101232831|FG000|NOT COMPLETED|Phase 1- Blinded (10 Days)||9||
48369680|NCT05523362|101232831|FG000|STARTED|Phase 2- Unblinded (3 Months)||47||
48369681|NCT05523362|101232831|FG000|COMPLETED|Phase 2- Unblinded (3 Months)||47||
48369682|NCT05523362|101232831|FG000|NOT COMPLETED|Phase 2- Unblinded (3 Months)||0||
48369683|NCT03283163|101232832|FG000|STARTED|Overall Study||23|23 participants total were recruited into the study|
48369684|NCT03283163|101232832|FG000|COMPLETED|Overall Study||12||
48369685|NCT03283163|101232832|FG000|NOT COMPLETED|Overall Study||11||
48369686|NCT01993329|101232833|FG000|STARTED|Period 1||3||
48369687|NCT01993329|101232834|FG001|STARTED|Period 1||4||
48369688|NCT01993329|101232835|FG002|STARTED|Period 1||3||
48369689|NCT01993329|101232836|FG003|STARTED|Period 1||3||
48369690|NCT01993329|101232837|FG004|STARTED|Period 1||3||
48369691|NCT01993329|101232838|FG005|STARTED|Period 1||4||
48458892|NCT05085964|101460001|FG000|NOT COMPLETED|Overall Study||21||
48369692|NCT01993329|101232833|FG000|COMPLETED|Period 1||3||
48369693|NCT01993329|101232834|FG001|COMPLETED|Period 1||4||
48369694|NCT01993329|101232835|FG002|COMPLETED|Period 1||3||
48369695|NCT01993329|101232836|FG003|COMPLETED|Period 1||3||
48774201|NCT03524118|102236515|FG005|Treated|Overall Study||38||
48774202|NCT03524118|102236510|FG000|Safety Analysis Population|Overall Study||6|Two participants who were randomized to the MK-1654 20 mg dose group actually received MK-1654 50 mg|
48774203|NCT03524118|102236511|FG001|Safety Analysis Population|Overall Study||33|Two participants who were randomized to the MK-1654 20 mg dose group actually received MK-1654 50 mg|
48458893|NCT05085964|101460002|FG001|NOT COMPLETED|Overall Study||0||
48458894|NCT01275313|101460003|FG000|STARTED|Overall Study||127||
48458895|NCT01275313|101460004|FG001|STARTED|Overall Study||131||
48458896|NCT01275313|101460003|FG000|COMPLETED|Overall Study||102||
48458897|NCT01275313|101460004|FG001|COMPLETED|Overall Study||79||
48458898|NCT01275313|101460003|FG000|NOT COMPLETED|Overall Study||25||
48458899|NCT01275313|101460004|FG001|NOT COMPLETED|Overall Study||52||
48458900|NCT00633152|101460005|FG000|STARTED|Overall Study||103||
48458901|NCT00633152|101460006|FG001|STARTED|Overall Study||47||
48458902|NCT00633152|101460005|FG000|MITT and Safety Population|Overall Study||98||
48458903|NCT00633152|101460006|FG001|MITT and Safety Population|Overall Study||45||
48458904|NCT00633152|101460005|FG000|Clinically Evaluable Population|Overall Study||86||
48458905|NCT00633152|101460006|FG001|Clinically Evaluable Population|Overall Study||39||
48458906|NCT00633152|101460005|FG000|COMPLETED|Overall Study||89||
48458907|NCT00633152|101460006|FG001|COMPLETED|Overall Study||41||
48458908|NCT00633152|101460005|FG000|NOT COMPLETED|Overall Study||14||
48458909|NCT00633152|101460006|FG001|NOT COMPLETED|Overall Study||6||
48458910|NCT03764059|101460007|FG000|STARTED|Overall Study||120||
48458911|NCT03764059|101460008|FG001|STARTED|Overall Study||120||
48458912|NCT03764059|101460007|FG000|COMPLETED|Overall Study||120||
48458913|NCT03764059|101460008|FG001|COMPLETED|Overall Study||120||
48458914|NCT03764059|101460007|FG000|NOT COMPLETED|Overall Study||0||
48458915|NCT03764059|101460008|FG001|NOT COMPLETED|Overall Study||0||
48458916|NCT01889862|101460009|FG000|STARTED|Part 1 (Up to 13 Weeks)||86|51 subjects out of 215 entered Part 4 directly, as they didn't receive target dose in study 165-301.|
48458917|NCT01889862|101460010|FG001|STARTED|Part 1 (Up to 13 Weeks)||0|51 subjects out of 215 entered Part 4 directly, as they didn't receive target dose in study 165-301.|
48663851|NCT03427619|101961901|FG000|STARTED|Overall Study||275||
48663852|NCT03427619|101961901|FG000|Safety Population|Overall Study||275||
48663853|NCT03427619|101961901|FG000|Modified Intention to Treat Population|Overall Study||143||
48663854|NCT03427619|101961901|FG000|COMPLETED|Overall Study||209||
48663855|NCT03427619|101961901|FG000|NOT COMPLETED|Overall Study||66||
48663856|NCT05472870|101961902|FG000|STARTED|Overall Study||30||
48774204|NCT03524118|102236512|FG002|Safety Analysis Population|Overall Study||40|Two participants who were randomized to the MK-1654 20 mg dose group actually received MK-1654 50 mg|
48774205|NCT03524118|102236513|FG003|Safety Analysis Population|Overall Study||32|Two participants who were randomized to the MK-1654 20 mg dose group actually received MK-1654 50 mg|
48774206|NCT03524118|102236514|FG004|Safety Analysis Population|Overall Study||32|Two participants who were randomized to the MK-1654 20 mg dose group actually received MK-1654 50 mg|
48774207|NCT03524118|102236515|FG005|Safety Analysis Population|Overall Study||38|Two participants who were randomized to the MK-1654 20 mg dose group actually received MK-1654 50 mg|
48774208|NCT03524118|102236510|FG000|COMPLETED|Overall Study||8||
48774209|NCT03524118|102236511|FG001|COMPLETED|Overall Study||29||
48774210|NCT03524118|102236512|FG002|COMPLETED|Overall Study||40||
48774211|NCT03524118|102236513|FG003|COMPLETED|Overall Study||31||
48774212|NCT03524118|102236514|FG004|COMPLETED|Overall Study||26||
48774213|NCT03524118|102236515|FG005|COMPLETED|Overall Study||37||
48774214|NCT03524118|102236510|FG000|NOT COMPLETED|Overall Study||0||
48774215|NCT03524118|102236511|FG001|NOT COMPLETED|Overall Study||2||
48774216|NCT03524118|102236512|FG002|NOT COMPLETED|Overall Study||1||
48774217|NCT03524118|102236513|FG003|NOT COMPLETED|Overall Study||1||
48774218|NCT03524118|102236514|FG004|NOT COMPLETED|Overall Study||7||
48774219|NCT03524118|102236515|FG005|NOT COMPLETED|Overall Study||1||
48774220|NCT02577718|102236516|FG000|STARTED|Overall Study||60||
48774221|NCT02577718|102236516|FG000|COMPLETED|Overall Study||52||
48774222|NCT02577718|102236516|FG000|NOT COMPLETED|Overall Study||8||
48663857|NCT05472870|101961902|FG000|COMPLETED|Overall Study||30||
48663858|NCT05472870|101961902|FG000|NOT COMPLETED|Overall Study||0||
48663859|NCT01287208|101961903|FG000|STARTED|Phase 1: Randomized Phase||52||
48663860|NCT01287208|101961904|FG001|STARTED|Phase 1: Randomized Phase||52||
48663861|NCT01287208|101961903|FG000|COMPLETED|Phase 1: Randomized Phase||50||
48663862|NCT01287208|101961904|FG001|COMPLETED|Phase 1: Randomized Phase||49||
48663863|NCT01287208|101961903|FG000|NOT COMPLETED|Phase 1: Randomized Phase||2||
48663864|NCT01287208|101961904|FG001|NOT COMPLETED|Phase 1: Randomized Phase||3||
48663865|NCT01287208|101961903|FG000|STARTED|Phase 2: Team Competition||50||
48663866|NCT01287208|101961904|FG001|STARTED|Phase 2: Team Competition||49||
48663867|NCT01287208|101961903|FG000|COMPLETED|Phase 2: Team Competition||50||
48663868|NCT01287208|101961904|FG001|COMPLETED|Phase 2: Team Competition||49||
48663869|NCT01287208|101961903|FG000|NOT COMPLETED|Phase 2: Team Competition||0||
48663870|NCT01287208|101961904|FG001|NOT COMPLETED|Phase 2: Team Competition||0||
48774223|NCT00196313|102236517|FG000|STARTED|Overall Study||47||
48774224|NCT00196313|102236518|FG001|STARTED|Overall Study||48||
48774225|NCT00196313|102236517|FG000|COMPLETED|Overall Study||36||
48663871|NCT03599713|101961905|FG000|STARTED|Overall Study||101||
48774226|NCT00196313|102236518|FG001|COMPLETED|Overall Study||40||
48774227|NCT00196313|102236517|FG000|NOT COMPLETED|Overall Study||11||
48774228|NCT00196313|102236518|FG001|NOT COMPLETED|Overall Study||8||
48774229|NCT01587924|102236519|FG000|STARTED|Overall Study||21||
48774230|NCT01587924|102236520|FG001|STARTED|Overall Study||21||
48663872|NCT03599713|101961906|FG001|STARTED|Overall Study||6||
48663873|NCT03599713|101961905|FG000|Safety Evaluable Population|Overall Study||101||
48774231|NCT01587924|102236521|FG002|STARTED|Overall Study||21||
48774232|NCT01587924|102236522|FG003|STARTED|Overall Study||20||
48774233|NCT01587924|102236519|FG000|COMPLETED|Overall Study||17||
48774234|NCT01587924|102236520|FG001|COMPLETED|Overall Study||17||
48774235|NCT01587924|102236521|FG002|COMPLETED|Overall Study||17||
48774236|NCT01587924|102236522|FG003|COMPLETED|Overall Study||19||
48774237|NCT01587924|102236519|FG000|NOT COMPLETED|Overall Study||4||
48774238|NCT01587924|102236520|FG001|NOT COMPLETED|Overall Study||4||
48774239|NCT01587924|102236521|FG002|NOT COMPLETED|Overall Study||4||
48774240|NCT01587924|102236522|FG003|NOT COMPLETED|Overall Study||1||
48774241|NCT01052701|102236523|FG000|STARTED|Overall Study||14||
48774242|NCT01052701|102236524|FG001|STARTED|Overall Study||12||
48774243|NCT01052701|102236523|FG000|COMPLETED|Overall Study||14||
48774244|NCT01052701|102236524|FG001|COMPLETED|Overall Study||12||
48458918|NCT01889862|101460011|FG002|STARTED|Part 1 (Up to 13 Weeks)||78|51 subjects out of 215 entered Part 4 directly, as they didn't receive target dose in study 165-301.|
48458919|NCT01889862|101460012|FG003|STARTED|Part 1 (Up to 13 Weeks)||0|51 subjects out of 215 entered Part 4 directly, as they didn't receive target dose in study 165-301.|
48458920|NCT01889862|101460013|FG004|STARTED|Part 1 (Up to 13 Weeks)||0|51 subjects out of 215 entered Part 4 directly, as they didn't receive target dose in study 165-301.|
48458921|NCT01889862|101460009|FG000|COMPLETED|Part 1 (Up to 13 Weeks)||74|57 Subjects out of 164 didn't meet Part 2 eligibility criterion, so transitioned directly to Part 4|
48458922|NCT01889862|101460010|FG001|COMPLETED|Part 1 (Up to 13 Weeks)||0|57 Subjects out of 164 didn't meet Part 2 eligibility criterion, so transitioned directly to Part 4|
48458923|NCT01889862|101460011|FG002|COMPLETED|Part 1 (Up to 13 Weeks)||78|57 Subjects out of 164 didn't meet Part 2 eligibility criterion, so transitioned directly to Part 4|
48458924|NCT01889862|101460012|FG003|COMPLETED|Part 1 (Up to 13 Weeks)||0|57 Subjects out of 164 didn't meet Part 2 eligibility criterion, so transitioned directly to Part 4|
48458925|NCT01889862|101460013|FG004|COMPLETED|Part 1 (Up to 13 Weeks)||0|57 Subjects out of 164 didn't meet Part 2 eligibility criterion, so transitioned directly to Part 4|
48458926|NCT01889862|101460009|FG000|NOT COMPLETED|Part 1 (Up to 13 Weeks)||12||
48458927|NCT01889862|101460010|FG001|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0||
48663874|NCT03599713|101961906|FG001|Safety Evaluable Population|Overall Study||6||
48663875|NCT03599713|101961905|FG000|Enrolled Population|Overall Study||101||
48663876|NCT03599713|101961906|FG001|Enrolled Population|Overall Study||6||
48663877|NCT03599713|101961905|FG000|Full Analysis Set|Overall Study||65||
48663878|NCT03599713|101961906|FG001|Full Analysis Set|Overall Study||6||
48663879|NCT03599713|101961905|FG000|COMPLETED|Overall Study||0||
48663880|NCT03599713|101961906|FG001|COMPLETED|Overall Study||0||
48663881|NCT03599713|101961905|FG000|NOT COMPLETED|Overall Study||101||
48663882|NCT03599713|101961906|FG001|NOT COMPLETED|Overall Study||6||
48369696|NCT01993329|101232837|FG004|COMPLETED|Period 1||3||
48663883|NCT00839930|101961907|FG000|STARTED|First Intervention||15||
48663884|NCT00839930|101961908|FG001|STARTED|First Intervention||15||
48663885|NCT00839930|101961907|FG000|COMPLETED|First Intervention||15||
48663886|NCT00839930|101961908|FG001|COMPLETED|First Intervention||15||
48663887|NCT00839930|101961907|FG000|NOT COMPLETED|First Intervention||0||
48663888|NCT00839930|101961908|FG001|NOT COMPLETED|First Intervention||0||
48663889|NCT00839930|101961907|FG000|STARTED|Washout: 7 Days||15||
48663890|NCT00839930|101961908|FG001|STARTED|Washout: 7 Days||15||
48663891|NCT00839930|101961907|FG000|COMPLETED|Washout: 7 Days||15||
48663892|NCT00839930|101961908|FG001|COMPLETED|Washout: 7 Days||15||
48663893|NCT00839930|101961907|FG000|NOT COMPLETED|Washout: 7 Days||0||
48663894|NCT00839930|101961908|FG001|NOT COMPLETED|Washout: 7 Days||0||
48663895|NCT00839930|101961907|FG000|STARTED|Second Intervention||15||
48663896|NCT00839930|101961908|FG001|STARTED|Second Intervention||15||
48663897|NCT00839930|101961907|FG000|COMPLETED|Second Intervention||15||
48663898|NCT00839930|101961908|FG001|COMPLETED|Second Intervention||15||
48663899|NCT00839930|101961907|FG000|NOT COMPLETED|Second Intervention||0||
48663900|NCT00839930|101961908|FG001|NOT COMPLETED|Second Intervention||0||
48663901|NCT03913130|101961909|FG000|STARTED|Overall Study||9||
48663902|NCT03913130|101961909|FG000|COMPLETED|Overall Study||8||
48663903|NCT03913130|101961909|FG000|NOT COMPLETED|Overall Study||1||
48663904|NCT01926509|101961910|FG000|STARTED|Overall Study||6||
48774245|NCT01052701|102236523|FG000|NOT COMPLETED|Overall Study||0||
48774246|NCT01052701|102236524|FG001|NOT COMPLETED|Overall Study||0||
48774247|NCT01168986|102236525|FG000|STARTED|Overall Study||20||
48774248|NCT01168986|102236526|FG001|STARTED|Overall Study||21||
48369697|NCT01993329|101232838|FG005|COMPLETED|Period 1||4||
48369698|NCT01993329|101232833|FG000|NOT COMPLETED|Period 1||0||
48369699|NCT01993329|101232834|FG001|NOT COMPLETED|Period 1||0||
48369700|NCT01993329|101232835|FG002|NOT COMPLETED|Period 1||0||
48369701|NCT01993329|101232836|FG003|NOT COMPLETED|Period 1||0||
48774249|NCT01168986|102236527|FG002|STARTED|Overall Study||21||
48774250|NCT01168986|102236525|FG000|COMPLETED|Overall Study||18||
48369702|NCT01993329|101232837|FG004|NOT COMPLETED|Period 1||0||
48458928|NCT01889862|101460011|FG002|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0||
48458929|NCT01889862|101460012|FG003|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0||
48458930|NCT01889862|101460013|FG004|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0||
48458931|NCT01889862|101460009|FG000|STARTED|Part 2 (8 Weeks)||34||
48774251|NCT01168986|102236526|FG001|COMPLETED|Overall Study||20||
48774252|NCT01168986|102236527|FG002|COMPLETED|Overall Study||21||
48774253|NCT01168986|102236525|FG000|NOT COMPLETED|Overall Study||2||
48774254|NCT01168986|102236526|FG001|NOT COMPLETED|Overall Study||1||
48774255|NCT01168986|102236527|FG002|NOT COMPLETED|Overall Study||0||
48774256|NCT01708902|102236528|FG000|STARTED|Overall Study||147||
48774257|NCT01708902|102236529|FG001|STARTED|Overall Study||145||
48774258|NCT01708902|102236530|FG002|STARTED|Overall Study||144||
48774259|NCT01708902|102236531|FG003|STARTED|Overall Study||147||
48774260|NCT01708902|102236532|FG004|STARTED|Overall Study||147||
48774261|NCT01708902|102236533|FG005|STARTED|Overall Study||71||
48774262|NCT01708902|102236534|FG006|STARTED|Overall Study||72||
48774263|NCT01708902|102236528|FG000|COMPLETED|Overall Study||130||
48774264|NCT01708902|102236529|FG001|COMPLETED|Overall Study||137||
48774265|NCT01708902|102236530|FG002|COMPLETED|Overall Study||127||
48774266|NCT01708902|102236531|FG003|COMPLETED|Overall Study||137||
48774267|NCT01708902|102236532|FG004|COMPLETED|Overall Study||131||
48774268|NCT01708902|102236533|FG005|COMPLETED|Overall Study||64||
48774269|NCT01708902|102236534|FG006|COMPLETED|Overall Study||65||
48774270|NCT01708902|102236528|FG000|NOT COMPLETED|Overall Study||17||
48774271|NCT01708902|102236529|FG001|NOT COMPLETED|Overall Study||8||
48774272|NCT01708902|102236530|FG002|NOT COMPLETED|Overall Study||17||
48774273|NCT01708902|102236531|FG003|NOT COMPLETED|Overall Study||10||
48774274|NCT01708902|102236532|FG004|NOT COMPLETED|Overall Study||16||
48774275|NCT01708902|102236533|FG005|NOT COMPLETED|Overall Study||7||
48774276|NCT01708902|102236534|FG006|NOT COMPLETED|Overall Study||7||
48774277|NCT00602472|102236535|FG000|STARTED|Overall Study||263||
48774278|NCT00602472|102236536|FG001|STARTED|Overall Study||792||
48774279|NCT00602472|102236535|FG000|COMPLETED|Overall Study||242||
48774280|NCT00602472|102236536|FG001|COMPLETED|Overall Study||734||
48774281|NCT00602472|102236535|FG000|NOT COMPLETED|Overall Study||21||
48774282|NCT00602472|102236536|FG001|NOT COMPLETED|Overall Study||58||
48774283|NCT02210039|102236537|FG000|STARTED|Overall Study||6||
48774284|NCT02210039|102236537|FG000|COMPLETED|Overall Study||6||
48774285|NCT02210039|102236537|FG000|NOT COMPLETED|Overall Study||0||
48774286|NCT00888940|102236538|FG000|STARTED|Overall Study||120||
48774287|NCT00888940|102236539|FG001|STARTED|Overall Study||122||
48774288|NCT00888940|102236538|FG000|Completed Therapy|Overall Study||107||
48774289|NCT00888940|102236539|FG001|Completed Therapy|Overall Study||106||
48774290|NCT00888940|102236538|FG000|COMPLETED|Overall Study||92||
48774291|NCT00888940|102236539|FG001|COMPLETED|Overall Study||101||
48774292|NCT00888940|102236538|FG000|NOT COMPLETED|Overall Study||28||
48774293|NCT00888940|102236539|FG001|NOT COMPLETED|Overall Study||21||
48774294|NCT02633020|102236540|FG000|STARTED|Overall Study||19||
48774295|NCT02633020|102236541|FG001|STARTED|Overall Study||9||
48774296|NCT02633020|102236540|FG000|COMPLETED|Overall Study||18||
48774297|NCT02633020|102236541|FG001|COMPLETED|Overall Study||9||
48774298|NCT02633020|102236540|FG000|NOT COMPLETED|Overall Study||1||
48774299|NCT02633020|102236541|FG001|NOT COMPLETED|Overall Study||0||
48774300|NCT03298035|102236542|FG000|STARTED|Overall Study||10||
48774301|NCT03298035|102236543|FG001|STARTED|Overall Study||9||
48774302|NCT03298035|102236542|FG000|Received Intervention|Overall Study||9||
48774303|NCT03298035|102236543|FG001|Received Intervention|Overall Study||7||
48774304|NCT03298035|102236542|FG000|COMPLETED|Overall Study||9||
48189651|NCT01268059|100786270|FG001|STARTED|Overall Study||45||
48774305|NCT03298035|102236543|FG001|COMPLETED|Overall Study||7||
48774306|NCT03298035|102236542|FG000|NOT COMPLETED|Overall Study||1||
48774307|NCT03298035|102236543|FG001|NOT COMPLETED|Overall Study||2||
48774308|NCT00684541|102236544|FG000|STARTED|Overall Study||23||
48189652|NCT01268059|100786271|FG002|STARTED|Overall Study||6||
48458932|NCT01889862|101460010|FG001|STARTED|Part 2 (8 Weeks)||15||
48458933|NCT01889862|101460011|FG002|STARTED|Part 2 (8 Weeks)||32||
48458934|NCT01889862|101460012|FG003|STARTED|Part 2 (8 Weeks)||14||
48458935|NCT01889862|101460013|FG004|STARTED|Part 2 (8 Weeks)||0||
48774309|NCT00684541|102236545|FG001|STARTED|Overall Study||26||
48774310|NCT00684541|102236544|FG000|COMPLETED|Overall Study||20||
48774311|NCT00684541|102236545|FG001|COMPLETED|Overall Study||23||
48774312|NCT00684541|102236544|FG000|NOT COMPLETED|Overall Study||3||
48774313|NCT00684541|102236545|FG001|NOT COMPLETED|Overall Study||3||
48774314|NCT03281200|102236546|FG000|STARTED|Overall Study||172|Started are the treated with entry criteria met|
48774315|NCT03281200|102236546|FG000|COMPLETED|Overall Study||172||
48774316|NCT03281200|102236546|FG000|NOT COMPLETED|Overall Study||0||
48774317|NCT01967576|102236547|FG000|STARTED|Overall Study||14||
48774318|NCT01967576|102236547|FG000|COMPLETED|Overall Study||7||
48774319|NCT01967576|102236547|FG000|NOT COMPLETED|Overall Study||7||
48774320|NCT01254422|102236548|FG000|STARTED|Overall Study||199||
48774321|NCT01254422|102236549|FG001|STARTED|Overall Study||51||
48774322|NCT01254422|102236548|FG000|COMPLETED|Overall Study||196||
48458936|NCT01889862|101460009|FG000|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||29|Subjects not included in mITT, if the last two consecutive blood Phe reduction of ≥ 20% in Part 1.|
48458937|NCT01889862|101460010|FG001|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||14|Subjects not included in mITT, if the last two consecutive blood Phe reduction of ≥ 20% in Part 1.|
48458938|NCT01889862|101460011|FG002|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||29|Subjects not included in mITT, if the last two consecutive blood Phe reduction of ≥ 20% in Part 1.|
48458939|NCT01889862|101460012|FG003|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||14|Subjects not included in mITT, if the last two consecutive blood Phe reduction of ≥ 20% in Part 1.|
48458940|NCT01889862|101460013|FG004|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||0|Subjects not included in mITT, if the last two consecutive blood Phe reduction of ≥ 20% in Part 1.|
48458941|NCT01889862|101460009|FG000|COMPLETED|Part 2 (8 Weeks)||34|5 subjects unable to complete Part 2 due to an Adverse Event transitioned directly into Part 4.|
48458942|NCT01889862|101460010|FG001|COMPLETED|Part 2 (8 Weeks)||15|5 subjects unable to complete Part 2 due to an Adverse Event transitioned directly into Part 4.|
48458943|NCT01889862|101460011|FG002|COMPLETED|Part 2 (8 Weeks)||31|5 subjects unable to complete Part 2 due to an Adverse Event transitioned directly into Part 4.|
48458944|NCT01889862|101460012|FG003|COMPLETED|Part 2 (8 Weeks)||14|5 subjects unable to complete Part 2 due to an Adverse Event transitioned directly into Part 4.|
48663905|NCT01926509|101961911|FG001|STARTED|Overall Study||6||
48663906|NCT01926509|101961912|FG002|STARTED|Overall Study||5||
48663907|NCT01926509|101961913|FG003|STARTED|Overall Study||6||
48663908|NCT01926509|101961910|FG000|COMPLETED|Overall Study||5||
48663909|NCT01926509|101961911|FG001|COMPLETED|Overall Study||6||
48663910|NCT01926509|101961912|FG002|COMPLETED|Overall Study||5||
48663911|NCT01926509|101961913|FG003|COMPLETED|Overall Study||6||
48663912|NCT01926509|101961910|FG000|NOT COMPLETED|Overall Study||1||
48663913|NCT01926509|101961911|FG001|NOT COMPLETED|Overall Study||0||
48663914|NCT01926509|101961912|FG002|NOT COMPLETED|Overall Study||0||
48663915|NCT01926509|101961913|FG003|NOT COMPLETED|Overall Study||0||
48663916|NCT02507934|101961914|FG000|STARTED|Overall Study||20||
48663917|NCT02507934|101961915|FG001|STARTED|Overall Study||20||
48663918|NCT02507934|101961914|FG000|Full Analysis Set Population (FAS)|Overall Study||19||
48663919|NCT02507934|101961915|FG001|Full Analysis Set Population (FAS)|Overall Study||20||
48663920|NCT02507934|101961914|FG000|Safety Population (SAF)|Overall Study||20||
48663921|NCT02507934|101961915|FG001|Safety Population (SAF)|Overall Study||20||
48663922|NCT02507934|101961914|FG000|COMPLETED|Overall Study||16||
48663923|NCT02507934|101961915|FG001|COMPLETED|Overall Study||20||
48663924|NCT02507934|101961914|FG000|NOT COMPLETED|Overall Study||4||
48663925|NCT02507934|101961915|FG001|NOT COMPLETED|Overall Study||0||
48663926|NCT01356940|101961916|FG000|STARTED|First Intervention (28 Days)||22||
48663927|NCT01356940|101961917|FG001|STARTED|First Intervention (28 Days)||21||
48663928|NCT01356940|101961916|FG000|COMPLETED|First Intervention (28 Days)||21||
48663929|NCT01356940|101961917|FG001|COMPLETED|First Intervention (28 Days)||21||
48663930|NCT01356940|101961916|FG000|NOT COMPLETED|First Intervention (28 Days)||1||
48774323|NCT01254422|102236549|FG001|COMPLETED|Overall Study||50||
48774324|NCT01254422|102236548|FG000|NOT COMPLETED|Overall Study||3||
48774325|NCT01254422|102236549|FG001|NOT COMPLETED|Overall Study||1||
48774326|NCT02281383|102236550|FG000|STARTED|Overall Study||80||
48774327|NCT02281383|102236550|FG000|COMPLETED|Overall Study||68||
48774328|NCT02281383|102236550|FG000|NOT COMPLETED|Overall Study||12||
48774329|NCT04646044|102236551|FG000|STARTED|Overall Study||5||
48774330|NCT04646044|102236552|FG001|STARTED|Overall Study||5||
48774331|NCT04646044|102236553|FG002|STARTED|Overall Study||5||
48774332|NCT04646044|102236554|FG003|STARTED|Overall Study||15||
48774333|NCT04646044|102236551|FG000|COMPLETED|Overall Study||5||
48774334|NCT04646044|102236552|FG001|COMPLETED|Overall Study||4||
48774335|NCT04646044|102236553|FG002|COMPLETED|Overall Study||4||
48774336|NCT04646044|102236554|FG003|COMPLETED|Overall Study||15||
48774337|NCT04646044|102236551|FG000|NOT COMPLETED|Overall Study||0||
48774338|NCT04646044|102236552|FG001|NOT COMPLETED|Overall Study||1||
48774339|NCT04646044|102236553|FG002|NOT COMPLETED|Overall Study||1||
48774340|NCT04646044|102236554|FG003|NOT COMPLETED|Overall Study||0||
48774341|NCT01134055|102236555|FG000|STARTED|Overall Study||73||
48774342|NCT01134055|102236556|FG001|STARTED|Overall Study||72||
48774343|NCT01134055|102236557|FG002|STARTED|Overall Study||74||
48774344|NCT01134055|102236558|FG003|STARTED|Overall Study||73||
48774345|NCT01134055|102236559|FG004|STARTED|Overall Study||73||
48774346|NCT01134055|102236560|FG005|STARTED|Overall Study||72||
48774347|NCT01134055|102236561|FG006|STARTED|Overall Study||73||
48774348|NCT01134055|102236555|FG000|COMPLETED|Overall Study||65||
48774349|NCT01134055|102236556|FG001|COMPLETED|Overall Study||66||
48663931|NCT01356940|101961917|FG001|NOT COMPLETED|First Intervention (28 Days)||0||
48663932|NCT01356940|101961916|FG000|STARTED|Washout (14 Days)||21||
48663933|NCT01356940|101961917|FG001|STARTED|Washout (14 Days)||21||
48663934|NCT01356940|101961916|FG000|COMPLETED|Washout (14 Days)||21||
48663935|NCT01356940|101961917|FG001|COMPLETED|Washout (14 Days)||21||
48663936|NCT01356940|101961916|FG000|NOT COMPLETED|Washout (14 Days)||0||
48663937|NCT01356940|101961917|FG001|NOT COMPLETED|Washout (14 Days)||0||
48458945|NCT01889862|101460013|FG004|COMPLETED|Part 2 (8 Weeks)||0|5 subjects unable to complete Part 2 due to an Adverse Event transitioned directly into Part 4.|
48458946|NCT01889862|101460009|FG000|NOT COMPLETED|Part 2 (8 Weeks)||0||
48458947|NCT01889862|101460010|FG001|NOT COMPLETED|Part 2 (8 Weeks)||0||
48458948|NCT01889862|101460011|FG002|NOT COMPLETED|Part 2 (8 Weeks)||1||
48458949|NCT01889862|101460012|FG003|NOT COMPLETED|Part 2 (8 Weeks)||0||
48458950|NCT01889862|101460013|FG004|NOT COMPLETED|Part 2 (8 Weeks)||0||
48663938|NCT01356940|101961916|FG000|STARTED|Second Intervention (28 Days)||21||
48663939|NCT01356940|101961917|FG001|STARTED|Second Intervention (28 Days)||21||
48663940|NCT01356940|101961916|FG000|COMPLETED|Second Intervention (28 Days)||20||
48663941|NCT01356940|101961917|FG001|COMPLETED|Second Intervention (28 Days)||21||
48663942|NCT01356940|101961916|FG000|NOT COMPLETED|Second Intervention (28 Days)||1||
48663943|NCT01356940|101961917|FG001|NOT COMPLETED|Second Intervention (28 Days)||0||
48663944|NCT03274466|101961918|FG000|STARTED|Overall Study||147||
48663945|NCT03274466|101961919|FG001|STARTED|Overall Study||147||
48663946|NCT03274466|101961918|FG000|COMPLETED|Overall Study||124||
48663947|NCT03274466|101961919|FG001|COMPLETED|Overall Study||118||
48663948|NCT03274466|101961918|FG000|NOT COMPLETED|Overall Study||23||
48663949|NCT03274466|101961919|FG001|NOT COMPLETED|Overall Study||29||
48663950|NCT01557244|101961920|FG000|STARTED|Active Comparator/Efficacy Phase:12Weeks||42||
48663951|NCT01557244|101961921|FG001|STARTED|Active Comparator/Efficacy Phase:12Weeks||42||
48663952|NCT01557244|101961922|FG002|STARTED|Active Comparator/Efficacy Phase:12Weeks||40||
48663953|NCT01557244|101961923|FG003|STARTED|Active Comparator/Efficacy Phase:12Weeks||0||
48663954|NCT01557244|101961924|FG004|STARTED|Active Comparator/Efficacy Phase:12Weeks||0||
48663955|NCT01557244|101961925|FG005|STARTED|Active Comparator/Efficacy Phase:12Weeks||28||
48663956|NCT01557244|101961926|FG006|STARTED|Active Comparator/Efficacy Phase:12Weeks||29||
48663957|NCT01557244|101961920|FG000|Treated|Active Comparator/Efficacy Phase:12Weeks||42||
48663958|NCT01557244|101961921|FG001|Treated|Active Comparator/Efficacy Phase:12Weeks||42||
48663959|NCT01557244|101961922|FG002|Treated|Active Comparator/Efficacy Phase:12Weeks||40||
48663960|NCT01557244|101961923|FG003|Treated|Active Comparator/Efficacy Phase:12Weeks||0||
48663961|NCT01557244|101961924|FG004|Treated|Active Comparator/Efficacy Phase:12Weeks||0||
48663962|NCT01557244|101961925|FG005|Treated|Active Comparator/Efficacy Phase:12Weeks||28||
48663963|NCT01557244|101961926|FG006|Treated|Active Comparator/Efficacy Phase:12Weeks||29||
48663964|NCT01557244|101961920|FG000|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||33||
48663965|NCT01557244|101961921|FG001|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||40||
48663966|NCT01557244|101961922|FG002|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||36||
48663967|NCT01557244|101961923|FG003|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0||
48663968|NCT01557244|101961924|FG004|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0||
48663969|NCT01557244|101961925|FG005|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||21||
48663970|NCT01557244|101961926|FG006|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||28||
48663971|NCT01557244|101961920|FG000|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||9||
48458951|NCT01889862|101460009|FG000|STARTED|Part 3A/B (6 Week)||48||
48458952|NCT01889862|101460010|FG001|STARTED|Part 3A/B (6 Week)||0||
48458953|NCT01889862|101460011|FG002|STARTED|Part 3A/B (6 Week)||41||
48458954|NCT01889862|101460012|FG003|STARTED|Part 3A/B (6 Week)||0||
48458955|NCT01889862|101460013|FG004|STARTED|Part 3A/B (6 Week)||0||
48458956|NCT01889862|101460009|FG000|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||34|58 of 89 subjects enrolled under Amendment #2 were included in the PK/PD analyses.|
48458957|NCT01889862|101460010|FG001|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||0|58 of 89 subjects enrolled under Amendment #2 were included in the PK/PD analyses.|
48458958|NCT01889862|101460011|FG002|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||26|58 of 89 subjects enrolled under Amendment #2 were included in the PK/PD analyses.|
48663972|NCT01557244|101961921|FG001|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||2||
48663973|NCT01557244|101961922|FG002|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||4||
48663974|NCT01557244|101961923|FG003|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0||
48663975|NCT01557244|101961924|FG004|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0||
48663976|NCT01557244|101961925|FG005|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||7||
48663977|NCT01557244|101961926|FG006|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||1||
48663978|NCT01557244|101961920|FG000|STARTED|Safety Extension Phase: 12 Weeks||33||
48663979|NCT01557244|101961921|FG001|STARTED|Safety Extension Phase: 12 Weeks||40||
48663980|NCT01557244|101961922|FG002|STARTED|Safety Extension Phase: 12 Weeks||0||
48663981|NCT01557244|101961923|FG003|STARTED|Safety Extension Phase: 12 Weeks||16||
48663982|NCT01557244|101961924|FG004|STARTED|Safety Extension Phase: 12 Weeks||20||
48663983|NCT01557244|101961925|FG005|STARTED|Safety Extension Phase: 12 Weeks||21||
48663984|NCT01557244|101961926|FG006|STARTED|Safety Extension Phase: 12 Weeks||28||
48663985|NCT01557244|101961920|FG000|Treated|Safety Extension Phase: 12 Weeks||30||
48663986|NCT01557244|101961921|FG001|Treated|Safety Extension Phase: 12 Weeks||37||
48774350|NCT01134055|102236557|FG002|COMPLETED|Overall Study||71||
48774351|NCT01134055|102236558|FG003|COMPLETED|Overall Study||67||
48774352|NCT01134055|102236559|FG004|COMPLETED|Overall Study||67||
48774353|NCT01134055|102236560|FG005|COMPLETED|Overall Study||65||
48774354|NCT01134055|102236561|FG006|COMPLETED|Overall Study||62||
48774355|NCT01134055|102236555|FG000|NOT COMPLETED|Overall Study||8||
48774356|NCT01134055|102236556|FG001|NOT COMPLETED|Overall Study||6||
48189653|NCT01268059|100786272|FG003|STARTED|Overall Study||8||
48458959|NCT01889862|101460012|FG003|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||0|58 of 89 subjects enrolled under Amendment #2 were included in the PK/PD analyses.|
48458960|NCT01889862|101460013|FG004|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||0|58 of 89 subjects enrolled under Amendment #2 were included in the PK/PD analyses.|
48458961|NCT01889862|101460009|FG000|COMPLETED|Part 3A/B (6 Week)||48||
48458962|NCT01889862|101460010|FG001|COMPLETED|Part 3A/B (6 Week)||0||
48458963|NCT01889862|101460011|FG002|COMPLETED|Part 3A/B (6 Week)||41||
48458964|NCT01889862|101460012|FG003|COMPLETED|Part 3A/B (6 Week)||0||
48458965|NCT01889862|101460013|FG004|COMPLETED|Part 3A/B (6 Week)||0||
48458966|NCT01889862|101460009|FG000|NOT COMPLETED|Part 3A/B (6 Week)||0||
48458967|NCT01889862|101460010|FG001|NOT COMPLETED|Part 3A/B (6 Week)||0||
48458968|NCT01889862|101460011|FG002|NOT COMPLETED|Part 3A/B (6 Week)||0||
48458969|NCT01889862|101460012|FG003|NOT COMPLETED|Part 3A/B (6 Week)||0||
48458970|NCT01889862|101460013|FG004|NOT COMPLETED|Part 3A/B (6 Week)||0||
48458971|NCT01889862|101460009|FG000|STARTED|Part 4 (Up to 274 Weeks)||0||
48458972|NCT01889862|101460010|FG001|STARTED|Part 4 (Up to 274 Weeks)||0||
48458973|NCT01889862|101460011|FG002|STARTED|Part 4 (Up to 274 Weeks)||0||
48458974|NCT01889862|101460012|FG003|STARTED|Part 4 (Up to 274 Weeks)||0||
48458975|NCT01889862|101460013|FG004|STARTED|Part 4 (Up to 274 Weeks)||202||
48458976|NCT01889862|101460009|FG000|COMPLETED|Part 4 (Up to 274 Weeks)||0||
48458977|NCT01889862|101460010|FG001|COMPLETED|Part 4 (Up to 274 Weeks)||0||
48458978|NCT01889862|101460011|FG002|COMPLETED|Part 4 (Up to 274 Weeks)||0||
48458979|NCT01889862|101460012|FG003|COMPLETED|Part 4 (Up to 274 Weeks)||0||
48458980|NCT01889862|101460013|FG004|COMPLETED|Part 4 (Up to 274 Weeks)||172||
48458981|NCT01889862|101460009|FG000|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0||
48458982|NCT01889862|101460010|FG001|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0||
48458983|NCT01889862|101460011|FG002|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0||
48458984|NCT01889862|101460012|FG003|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0||
48458985|NCT01889862|101460013|FG004|NOT COMPLETED|Part 4 (Up to 274 Weeks)||30||
48458986|NCT04132232|101460014|FG000|STARTED|Overall Study||37||
48458987|NCT04132232|101460015|FG001|STARTED|Overall Study||37||
48458988|NCT04132232|101460014|FG000|COMPLETED|Overall Study||30||
48458989|NCT04132232|101460015|FG001|COMPLETED|Overall Study||29||
48458990|NCT04132232|101460014|FG000|NOT COMPLETED|Overall Study||7||
48458991|NCT04132232|101460015|FG001|NOT COMPLETED|Overall Study||8||
48458992|NCT00924066|101460016|FG000|STARTED|Overall Study||41||
48774357|NCT01134055|102236557|FG002|NOT COMPLETED|Overall Study||3||
48774358|NCT01134055|102236558|FG003|NOT COMPLETED|Overall Study||6||
48774359|NCT01134055|102236559|FG004|NOT COMPLETED|Overall Study||6||
48774360|NCT01134055|102236560|FG005|NOT COMPLETED|Overall Study||7||
48774361|NCT01134055|102236561|FG006|NOT COMPLETED|Overall Study||11||
48774362|NCT00828204|102236562|FG000|STARTED|Main Study: Prior to Study Suspension||21||
48774363|NCT00828204|102236563|FG001|STARTED|Main Study: Prior to Study Suspension||0||
48774364|NCT00828204|102236562|FG000|Completed Manual Injection|Main Study: Prior to Study Suspension||21||
48774365|NCT00828204|102236563|FG001|Completed Manual Injection|Main Study: Prior to Study Suspension||0||
48774366|NCT00828204|102236562|FG000|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||19||
48774367|NCT00828204|102236563|FG001|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||0||
48774368|NCT00828204|102236562|FG000|COMPLETED|Main Study: Prior to Study Suspension||7||
48774369|NCT00828204|102236563|FG001|COMPLETED|Main Study: Prior to Study Suspension||0||
48774370|NCT00828204|102236562|FG000|NOT COMPLETED|Main Study: Prior to Study Suspension||14||
48774371|NCT00828204|102236563|FG001|NOT COMPLETED|Main Study: Prior to Study Suspension||0||
48774372|NCT00828204|102236562|FG000|STARTED|Main Study: After Study Restart||0||
48774373|NCT00828204|102236563|FG001|STARTED|Main Study: After Study Restart||74||
48774374|NCT00828204|102236562|FG000|Completed Manual Injection|Main Study: After Study Restart||0||
48774375|NCT00828204|102236563|FG001|Completed Manual Injection|Main Study: After Study Restart||74||
48774376|NCT00828204|102236562|FG000|Continued With Autoinjector Injections|Main Study: After Study Restart||0||
48774377|NCT00828204|102236563|FG001|Continued With Autoinjector Injections|Main Study: After Study Restart||72||
48774378|NCT00828204|102236562|FG000|COMPLETED|Main Study: After Study Restart||0||
48189654|NCT01268059|100786269|FG000|COMPLETED|Overall Study||12||
48189655|NCT01268059|100786270|FG001|COMPLETED|Overall Study||10||
48458993|NCT00924066|101460016|FG000|COMPLETED|Overall Study||41||
48458994|NCT00924066|101460016|FG000|NOT COMPLETED|Overall Study||0||
48458995|NCT00638157|101460017|FG000|STARTED|Overall Study||12||
48458996|NCT00638157|101460018|FG001|STARTED|Overall Study||12||
48458997|NCT00638157|101460017|FG000|Treated|Overall Study||10||
48458998|NCT00638157|101460018|FG001|Treated|Overall Study||12||
48458999|NCT00638157|101460017|FG000|COMPLETED|Overall Study||5||
48459000|NCT00638157|101460018|FG001|COMPLETED|Overall Study||8||
48774379|NCT00828204|102236563|FG001|COMPLETED|Main Study: After Study Restart||71||
48774380|NCT00828204|102236562|FG000|NOT COMPLETED|Main Study: After Study Restart||0||
48774381|NCT00828204|102236563|FG001|NOT COMPLETED|Main Study: After Study Restart||3||
48774382|NCT00828204|102236562|FG000|STARTED|Extension Study||0||
48774383|NCT00828204|102236563|FG001|STARTED|Extension Study||64||
48774384|NCT00828204|102236562|FG000|COMPLETED|Extension Study||0||
48774385|NCT00828204|102236563|FG001|COMPLETED|Extension Study||61||
48774386|NCT00828204|102236562|FG000|NOT COMPLETED|Extension Study||0||
48774387|NCT00828204|102236563|FG001|NOT COMPLETED|Extension Study||3||
48774388|NCT00356304|102236564|FG000|STARTED|Overall Study||26||
48774389|NCT00356304|102236565|FG001|STARTED|Overall Study||24||
48774390|NCT00356304|102236564|FG000|COMPLETED|Overall Study||24||
48774391|NCT00356304|102236565|FG001|COMPLETED|Overall Study||20||
48774392|NCT00356304|102236564|FG000|NOT COMPLETED|Overall Study||2||
48774393|NCT00356304|102236565|FG001|NOT COMPLETED|Overall Study||4||
48774394|NCT02141204|102236566|FG000|STARTED|Overall Study||224||
48774395|NCT02141204|102236567|FG001|STARTED|Overall Study||225||
48774396|NCT02141204|102236566|FG000|COMPLETED|Overall Study||209||
48774397|NCT02141204|102236567|FG001|COMPLETED|Overall Study||210||
48774398|NCT02141204|102236566|FG000|NOT COMPLETED|Overall Study||15||
48774399|NCT02141204|102236567|FG001|NOT COMPLETED|Overall Study||15||
48774400|NCT01760733|102236568|FG000|STARTED|Waiting List||289||
48774401|NCT01760733|102236568|FG000|COMPLETED|Waiting List||217||
48774402|NCT01760733|102236568|FG000|NOT COMPLETED|Waiting List||72||
48774403|NCT01760733|102236568|FG000|STARTED|Transplanted||217|By Sept 15 2019, 217 patients have received a kidney transplant|
48774404|NCT01760733|102236568|FG000|COMPLETED|Transplanted||0|By Sept 15 2019, 8 patients have died after kidney transplantation|
48774405|NCT01760733|102236568|FG000|NOT COMPLETED|Transplanted||217||
48774406|NCT04421027|102236569|FG000|STARTED|Treatment Period||761||
48774407|NCT04421027|102236570|FG001|STARTED|Treatment Period||764||
48774408|NCT04421027|102236571|FG002|STARTED|Treatment Period||0||
48774409|NCT04421027|102236572|FG003|STARTED|Treatment Period||0||
48774410|NCT04421027|102236569|FG000|Received at Least One Dose of Study Drug|Treatment Period||752||
48774411|NCT04421027|102236570|FG001|Received at Least One Dose of Study Drug|Treatment Period||750||
48774412|NCT04421027|102236571|FG002|Received at Least One Dose of Study Drug|Treatment Period||0||
48774413|NCT04421027|102236572|FG003|Received at Least One Dose of Study Drug|Treatment Period||0||
48774414|NCT04421027|102236569|FG000|COMPLETED|Treatment Period||604||
48774415|NCT04421027|102236570|FG001|COMPLETED|Treatment Period||644||
48774416|NCT04421027|102236571|FG002|COMPLETED|Treatment Period||0||
48774417|NCT04421027|102236572|FG003|COMPLETED|Treatment Period||0||
48774418|NCT04421027|102236569|FG000|NOT COMPLETED|Treatment Period||157||
48774419|NCT04421027|102236570|FG001|NOT COMPLETED|Treatment Period||120||
48774420|NCT04421027|102236571|FG002|NOT COMPLETED|Treatment Period||0||
48774421|NCT04421027|102236572|FG003|NOT COMPLETED|Treatment Period||0||
48774422|NCT04421027|102236569|FG000|STARTED|Follow-Up Period||0||
48774423|NCT04421027|102236570|FG001|STARTED|Follow-Up Period||0||
48774424|NCT04421027|102236571|FG002|STARTED|Follow-Up Period||613||
48774425|NCT04421027|102236572|FG003|STARTED|Follow-Up Period||645||
48774426|NCT04421027|102236569|FG000|COMPLETED|Follow-Up Period||0||
48774427|NCT04421027|102236570|FG001|COMPLETED|Follow-Up Period||0||
48774428|NCT04421027|102236571|FG002|COMPLETED|Follow-Up Period||588||
48774429|NCT04421027|102236572|FG003|COMPLETED|Follow-Up Period||615||
48774430|NCT04421027|102236569|FG000|NOT COMPLETED|Follow-Up Period||0||
48774431|NCT04421027|102236570|FG001|NOT COMPLETED|Follow-Up Period||0||
48774432|NCT04421027|102236571|FG002|NOT COMPLETED|Follow-Up Period||25||
48774433|NCT04421027|102236572|FG003|NOT COMPLETED|Follow-Up Period||30||
48774434|NCT03967444|102236573|FG000|STARTED|Overall Study||19||
48774435|NCT03967444|102236574|FG001|STARTED|Overall Study||40||
48774436|NCT03967444|102236573|FG000|COMPLETED|Overall Study||18||
48774437|NCT03967444|102236574|FG001|COMPLETED|Overall Study||38||
48774438|NCT03967444|102236573|FG000|NOT COMPLETED|Overall Study||1||
48774439|NCT03967444|102236574|FG001|NOT COMPLETED|Overall Study||2||
48189656|NCT01268059|100786271|FG002|COMPLETED|Overall Study||3||
48189657|NCT01268059|100786272|FG003|COMPLETED|Overall Study||3||
48774440|NCT02625909|102236575|FG000|STARTED|Overall Study||93||
48774441|NCT02625909|102236576|FG001|STARTED|Overall Study||95||
48774442|NCT02625909|102236575|FG000|COMPLETED|Overall Study||76||
48774443|NCT02625909|102236576|FG001|COMPLETED|Overall Study||86||
48774444|NCT02625909|102236575|FG000|NOT COMPLETED|Overall Study||17||
48189658|NCT01268059|100786269|FG000|NOT COMPLETED|Overall Study||28||
48189659|NCT01268059|100786270|FG001|NOT COMPLETED|Overall Study||35||
48774445|NCT02625909|102236576|FG001|NOT COMPLETED|Overall Study||9||
48774446|NCT01376804|102236577|FG000|STARTED|Treatment Period||57||
48774447|NCT01376804|102236577|FG000|Received Study Drug|Treatment Period||56||
48774448|NCT01376804|102236577|FG000|COMPLETED|Treatment Period||49||
48774449|NCT01376804|102236577|FG000|NOT COMPLETED|Treatment Period||8||
48774450|NCT01376804|102236577|FG000|STARTED|Follow-up Period||55||
48774451|NCT01376804|102236577|FG000|COMPLETED|Follow-up Period||55||
48774452|NCT01376804|102236577|FG000|NOT COMPLETED|Follow-up Period||0||
48774453|NCT02055118|102236578|FG000|STARTED|Overall Study||15||
48774454|NCT02055118|102236579|FG001|STARTED|Overall Study||34||
48774455|NCT02055118|102236580|FG002|STARTED|Overall Study||9||
48774456|NCT02055118|102236578|FG000|COMPLETED|Overall Study||15||
48774457|NCT02055118|102236579|FG001|COMPLETED|Overall Study||32||
48774458|NCT02055118|102236580|FG002|COMPLETED|Overall Study||9||
48774459|NCT02055118|102236578|FG000|NOT COMPLETED|Overall Study||0||
48774460|NCT02055118|102236579|FG001|NOT COMPLETED|Overall Study||2||
48774461|NCT02055118|102236580|FG002|NOT COMPLETED|Overall Study||0||
48774462|NCT02433366|102236581|FG000|STARTED|Overall Study||411||
48774463|NCT02433366|102236582|FG001|STARTED|Overall Study||802||
48774464|NCT02433366|102236581|FG000|COMPLETED|Overall Study||411||
48774465|NCT02433366|102236582|FG001|COMPLETED|Overall Study||802||
48774466|NCT02433366|102236581|FG000|NOT COMPLETED|Overall Study||0||
48774467|NCT02433366|102236582|FG001|NOT COMPLETED|Overall Study||0||
48774468|NCT01642589|102236583|FG000|STARTED|Overall Study||200||
48774469|NCT01642589|102236584|FG001|STARTED|Overall Study||100||
48774470|NCT01642589|102236583|FG000|COMPLETED|Overall Study||199||
48774471|NCT01642589|102236584|FG001|COMPLETED|Overall Study||99||
48774472|NCT01642589|102236583|FG000|NOT COMPLETED|Overall Study||1||
48774473|NCT01642589|102236584|FG001|NOT COMPLETED|Overall Study||1||
48774474|NCT01177397|102236585|FG000|STARTED|Overall Study||1||
48774475|NCT01177397|102236586|FG001|STARTED|Overall Study||2||
48774476|NCT01177397|102236587|FG002|STARTED|Overall Study||9||
48774477|NCT01177397|102236588|FG003|STARTED|Overall Study||9||
48774478|NCT01177397|102236589|FG004|STARTED|Overall Study||7||
48774479|NCT01177397|102236590|FG005|STARTED|Overall Study||26||
48774480|NCT01177397|102236591|FG006|STARTED|Overall Study||13||
48774481|NCT01177397|102236592|FG007|STARTED|Overall Study||53||
48774482|NCT01177397|102236593|FG008|STARTED|Overall Study||47||
48774483|NCT01177397|102236594|FG009|STARTED|Overall Study||28||
48774484|NCT01177397|102236595|FG010|STARTED|Overall Study||14||
48774485|NCT01177397|102236596|FG011|STARTED|Overall Study||17||
48774486|NCT01177397|102236585|FG000|COMPLETED|Overall Study||0||
48774487|NCT01177397|102236586|FG001|COMPLETED|Overall Study||0||
48189660|NCT01268059|100786271|FG002|NOT COMPLETED|Overall Study||3||
48459001|NCT00638157|101460017|FG000|NOT COMPLETED|Overall Study||7||
48459002|NCT00638157|101460018|FG001|NOT COMPLETED|Overall Study||4||
48459003|NCT02884206|101460019|FG000|STARTED|Valsartan Run-in Period||706|Valsartan run-in|
48459004|NCT02884206|101460020|FG001|STARTED|Valsartan Run-in Period||0|Valsartan run-in|
48459005|NCT02884206|101460021|FG002|STARTED|Valsartan Run-in Period||0|Valsartan run-in|
48459006|NCT02884206|101460019|FG000|COMPLETED|Valsartan Run-in Period||659||
48459007|NCT02884206|101460020|FG001|COMPLETED|Valsartan Run-in Period||0||
48459008|NCT02884206|101460021|FG002|COMPLETED|Valsartan Run-in Period||0||
48459009|NCT02884206|101460019|FG000|NOT COMPLETED|Valsartan Run-in Period||47||
48663987|NCT01557244|101961922|FG002|Treated|Safety Extension Phase: 12 Weeks||0||
48663988|NCT01557244|101961923|FG003|Treated|Safety Extension Phase: 12 Weeks||16||
48663989|NCT01557244|101961924|FG004|Treated|Safety Extension Phase: 12 Weeks||20||
48663990|NCT01557244|101961925|FG005|Treated|Safety Extension Phase: 12 Weeks||20||
48663991|NCT01557244|101961926|FG006|Treated|Safety Extension Phase: 12 Weeks||28||
48663992|NCT01557244|101961920|FG000|COMPLETED|Safety Extension Phase: 12 Weeks||30||
48663993|NCT01557244|101961921|FG001|COMPLETED|Safety Extension Phase: 12 Weeks||36||
48663994|NCT01557244|101961922|FG002|COMPLETED|Safety Extension Phase: 12 Weeks||0||
48663995|NCT01557244|101961923|FG003|COMPLETED|Safety Extension Phase: 12 Weeks||15||
48663996|NCT01557244|101961924|FG004|COMPLETED|Safety Extension Phase: 12 Weeks||20||
48663997|NCT01557244|101961925|FG005|COMPLETED|Safety Extension Phase: 12 Weeks||20||
48663998|NCT01557244|101961926|FG006|COMPLETED|Safety Extension Phase: 12 Weeks||28||
48663999|NCT01557244|101961920|FG000|NOT COMPLETED|Safety Extension Phase: 12 Weeks||3||
48774488|NCT01177397|102236587|FG002|COMPLETED|Overall Study||0||
48774489|NCT01177397|102236588|FG003|COMPLETED|Overall Study||0||
48774490|NCT01177397|102236589|FG004|COMPLETED|Overall Study||0||
48774491|NCT01177397|102236590|FG005|COMPLETED|Overall Study||0||
48774492|NCT01177397|102236591|FG006|COMPLETED|Overall Study||0||
48774493|NCT01177397|102236592|FG007|COMPLETED|Overall Study||0||
48774494|NCT01177397|102236593|FG008|COMPLETED|Overall Study||0||
48774495|NCT01177397|102236594|FG009|COMPLETED|Overall Study||0||
48774496|NCT01177397|102236595|FG010|COMPLETED|Overall Study||0||
48189661|NCT01268059|100786272|FG003|NOT COMPLETED|Overall Study||5||
48189662|NCT02537444|100786273|FG000|STARTED|Overall Study||39||
48664000|NCT01557244|101961921|FG001|NOT COMPLETED|Safety Extension Phase: 12 Weeks||4||
48664001|NCT01557244|101961922|FG002|NOT COMPLETED|Safety Extension Phase: 12 Weeks||0||
48664002|NCT01557244|101961923|FG003|NOT COMPLETED|Safety Extension Phase: 12 Weeks||1||
48774497|NCT01177397|102236596|FG011|COMPLETED|Overall Study||0||
48774498|NCT01177397|102236585|FG000|NOT COMPLETED|Overall Study||1||
48459010|NCT02884206|101460020|FG001|NOT COMPLETED|Valsartan Run-in Period||0||
48459011|NCT02884206|101460021|FG002|NOT COMPLETED|Valsartan Run-in Period||0||
48459012|NCT02884206|101460019|FG000|STARTED|LCZ696 Run-in Period||659||
48774499|NCT01177397|102236586|FG001|NOT COMPLETED|Overall Study||2||
48774500|NCT01177397|102236587|FG002|NOT COMPLETED|Overall Study||9||
48774501|NCT01177397|102236588|FG003|NOT COMPLETED|Overall Study||9||
48774502|NCT01177397|102236589|FG004|NOT COMPLETED|Overall Study||7||
48774503|NCT01177397|102236590|FG005|NOT COMPLETED|Overall Study||26||
48774504|NCT01177397|102236591|FG006|NOT COMPLETED|Overall Study||13||
48774505|NCT01177397|102236592|FG007|NOT COMPLETED|Overall Study||53||
48774506|NCT01177397|102236593|FG008|NOT COMPLETED|Overall Study||47||
48774507|NCT01177397|102236594|FG009|NOT COMPLETED|Overall Study||28||
48774508|NCT01177397|102236595|FG010|NOT COMPLETED|Overall Study||14||
48774509|NCT01177397|102236596|FG011|NOT COMPLETED|Overall Study||17||
48459013|NCT02884206|101460020|FG001|STARTED|LCZ696 Run-in Period||0||
48459014|NCT02884206|101460021|FG002|STARTED|LCZ696 Run-in Period||0||
48459015|NCT02884206|101460019|FG000|COMPLETED|LCZ696 Run-in Period||592||
48459016|NCT02884206|101460020|FG001|COMPLETED|LCZ696 Run-in Period||0||
48459017|NCT02884206|101460021|FG002|COMPLETED|LCZ696 Run-in Period||0||
48459018|NCT02884206|101460019|FG000|NOT COMPLETED|LCZ696 Run-in Period||67||
48459019|NCT02884206|101460020|FG001|NOT COMPLETED|LCZ696 Run-in Period||0||
48459020|NCT02884206|101460021|FG002|NOT COMPLETED|LCZ696 Run-in Period||0||
48459021|NCT02884206|101460019|FG000|STARTED|Double-Blind Period||0||
48459022|NCT02884206|101460020|FG001|STARTED|Double-Blind Period||295||
48459023|NCT02884206|101460021|FG002|STARTED|Double-Blind Period||297||
48459024|NCT02884206|101460019|FG000|Safety Set|Double-Blind Period||0||
48459025|NCT02884206|101460020|FG001|Safety Set|Double-Blind Period||295||
48459026|NCT02884206|101460021|FG002|Safety Set|Double-Blind Period||297||
48459027|NCT02884206|101460019|FG000|PET Substudy Set|Double-Blind Period||0||
48459028|NCT02884206|101460020|FG001|PET Substudy Set|Double-Blind Period||244||
48459029|NCT02884206|101460021|FG002|PET Substudy Set|Double-Blind Period||247||
48459030|NCT02884206|101460019|FG000|COMPLETED|Double-Blind Period||0||
48459031|NCT02884206|101460020|FG001|COMPLETED|Double-Blind Period||251||
48459032|NCT02884206|101460021|FG002|COMPLETED|Double-Blind Period||237||
48459033|NCT02884206|101460019|FG000|NOT COMPLETED|Double-Blind Period||0||
48459034|NCT02884206|101460020|FG001|NOT COMPLETED|Double-Blind Period||44||
48459035|NCT02884206|101460021|FG002|NOT COMPLETED|Double-Blind Period||60||
48459036|NCT00686920|101460022|FG000|STARTED|Overall Study||252||
48459037|NCT00686920|101460023|FG001|STARTED|Overall Study||70||
48459038|NCT00686920|101460022|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||252||
48774510|NCT01963078|102236597|FG000|STARTED|Overall Study||9||
48774511|NCT01963078|102236598|FG001|STARTED|Overall Study||10||
48774512|NCT01963078|102236599|FG002|STARTED|Overall Study||10||
48774513|NCT01963078|102236600|FG003|STARTED|Overall Study||9||
48774514|NCT01963078|102236597|FG000|COMPLETED|Overall Study||8||
48774515|NCT01963078|102236598|FG001|COMPLETED|Overall Study||9||
48774516|NCT01963078|102236599|FG002|COMPLETED|Overall Study||9||
48774517|NCT01963078|102236600|FG003|COMPLETED|Overall Study||7||
48774518|NCT01963078|102236597|FG000|NOT COMPLETED|Overall Study||1||
48774519|NCT01963078|102236598|FG001|NOT COMPLETED|Overall Study||1||
48774520|NCT01963078|102236599|FG002|NOT COMPLETED|Overall Study||1||
48774521|NCT01963078|102236600|FG003|NOT COMPLETED|Overall Study||2||
48774522|NCT02447003|102236601|FG000|STARTED|Overall Study||170||
48774523|NCT02447003|102236602|FG001|STARTED|Overall Study||84||
48774524|NCT02447003|102236601|FG000|COMPLETED|Overall Study||0||
48774525|NCT02447003|102236602|FG001|COMPLETED|Overall Study||0||
48774526|NCT02447003|102236601|FG000|NOT COMPLETED|Overall Study||170||
48774527|NCT02447003|102236602|FG001|NOT COMPLETED|Overall Study||84||
48774528|NCT03216226|102236603|FG000|STARTED|Overall Study||57|Randomized|
48774529|NCT03216226|102236604|FG001|STARTED|Overall Study||55|Randomized|
48774530|NCT03216226|102236603|FG000|Randomized and Treated|Overall Study||57||
48774531|NCT03216226|102236604|FG001|Randomized and Treated|Overall Study||54||
48774532|NCT03216226|102236603|FG000|COMPLETED|Overall Study||52||
48774533|NCT03216226|102236604|FG001|COMPLETED|Overall Study||50||
48774534|NCT03216226|102236603|FG000|NOT COMPLETED|Overall Study||5||
48774535|NCT03216226|102236604|FG001|NOT COMPLETED|Overall Study||5||
48774536|NCT01209689|102236605|FG000|STARTED|Overall Study||91||
48774537|NCT01209689|102236606|FG001|STARTED|Overall Study||22||
48774538|NCT01209689|102236605|FG000|COMPLETED|Overall Study||0||
48774539|NCT01209689|102236606|FG001|COMPLETED|Overall Study||0||
48774540|NCT01209689|102236605|FG000|NOT COMPLETED|Overall Study||91||
48774541|NCT01209689|102236606|FG001|NOT COMPLETED|Overall Study||22||
48774542|NCT00408200|102236607|FG000|STARTED|Overall Study||57||
48459039|NCT00686920|101460023|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||70||
48459040|NCT00686920|101460022|FG000|COMPLETED|Overall Study||120||
48459041|NCT00686920|101460023|FG001|COMPLETED|Overall Study||34||
48459042|NCT00686920|101460022|FG000|NOT COMPLETED|Overall Study||132||
48774543|NCT00408200|102236608|FG001|STARTED|Overall Study||53||
48774544|NCT00408200|102236607|FG000|COMPLETED|Overall Study||57||
48774545|NCT00408200|102236608|FG001|COMPLETED|Overall Study||53||
48459043|NCT00686920|101460023|FG001|NOT COMPLETED|Overall Study||36||
48459044|NCT02019979|101460024|FG000|STARTED|Overall Study||14||
48459045|NCT02019979|101460024|FG000|COMPLETED|Overall Study||0||
48459046|NCT02019979|101460024|FG000|NOT COMPLETED|Overall Study||14||
48459047|NCT00289458|101460025|FG000|STARTED|Overall Study||25||
48459048|NCT00289458|101460026|FG001|STARTED|Overall Study||26||
48774546|NCT00408200|102236607|FG000|NOT COMPLETED|Overall Study||0||
48774547|NCT00408200|102236608|FG001|NOT COMPLETED|Overall Study||0||
48774548|NCT00711191|102236609|FG000|STARTED|Overall Study||3||
48774549|NCT00711191|102236610|FG001|STARTED|Overall Study||6||
48774550|NCT00711191|102236611|FG002|STARTED|Overall Study||13||
48774551|NCT00711191|102236609|FG000|COMPLETED|Overall Study||0||
48774552|NCT00711191|102236610|FG001|COMPLETED|Overall Study||1||
48774553|NCT00711191|102236611|FG002|COMPLETED|Overall Study||1||
48774554|NCT00711191|102236609|FG000|NOT COMPLETED|Overall Study||3||
48774555|NCT00711191|102236610|FG001|NOT COMPLETED|Overall Study||5||
48774556|NCT00711191|102236611|FG002|NOT COMPLETED|Overall Study||12||
48774557|NCT03860259|102236612|FG000|STARTED|Overall Study||25||
48774558|NCT03860259|102236613|FG001|STARTED|Overall Study||25||
48774559|NCT03860259|102236612|FG000|COMPLETED|Overall Study||19||
48774560|NCT03860259|102236613|FG001|COMPLETED|Overall Study||20||
48774561|NCT03860259|102236612|FG000|NOT COMPLETED|Overall Study||6||
48774562|NCT03860259|102236613|FG001|NOT COMPLETED|Overall Study||5||
48774563|NCT00882557|102236614|FG000|STARTED|Overall Study||8||
48774564|NCT00882557|102236615|FG001|STARTED|Overall Study||8||
48774565|NCT00882557|102236614|FG000|Completed Dose 1|Overall Study||8||
48774566|NCT00882557|102236615|FG001|Completed Dose 1|Overall Study||7||
48774567|NCT00882557|102236614|FG000|Completed Dose 2|Overall Study||6||
48774568|NCT00882557|102236615|FG001|Completed Dose 2|Overall Study||7||
48774569|NCT00882557|102236614|FG000|COMPLETED|Overall Study||6||
48774570|NCT00882557|102236615|FG001|COMPLETED|Overall Study||7||
48774571|NCT00882557|102236614|FG000|NOT COMPLETED|Overall Study||2||
48774572|NCT00882557|102236615|FG001|NOT COMPLETED|Overall Study||1||
48774573|NCT02560558|102236616|FG000|STARTED|Overall Study||84||
48774574|NCT02560558|102236617|FG001|STARTED|Overall Study||82||
48189663|NCT02537444|100786274|FG001|STARTED|Overall Study||39||
48189664|NCT02537444|100786273|FG000|Enrolled|Overall Study||39||
48664003|NCT01557244|101961924|FG004|NOT COMPLETED|Safety Extension Phase: 12 Weeks||0||
48664004|NCT01557244|101961925|FG005|NOT COMPLETED|Safety Extension Phase: 12 Weeks||1||
48664005|NCT01557244|101961926|FG006|NOT COMPLETED|Safety Extension Phase: 12 Weeks||0||
48664006|NCT02800785|101961927|FG000|STARTED|Overall Study||776||
48664007|NCT02800785|101961928|FG001|STARTED|Overall Study||776||
48664008|NCT02800785|101961927|FG000|30 Day Follow up|Overall Study||702||
48664009|NCT02800785|101961928|FG001|30 Day Follow up|Overall Study||695||
48664010|NCT02800785|101961927|FG000|COMPLETED|Overall Study||676||
48664011|NCT02800785|101961928|FG001|COMPLETED|Overall Study||656||
48664012|NCT02800785|101961927|FG000|NOT COMPLETED|Overall Study||100||
48664013|NCT02800785|101961928|FG001|NOT COMPLETED|Overall Study||120||
48664014|NCT02276040|101961929|FG000|STARTED|Overall Study||26||
48664015|NCT02276040|101961929|FG000|COMPLETED|Overall Study||11|Patients with insufficient bleeding to allow for toxicology testing were withdrawn from the study.|
48664016|NCT02276040|101961929|FG000|NOT COMPLETED|Overall Study||15||
48664017|NCT00781898|101961930|FG000|STARTED|Overall Study||153||
48664018|NCT00781898|101961931|FG001|STARTED|Overall Study||155||
48664019|NCT00781898|101961930|FG000|COMPLETED|Overall Study||119||
48664020|NCT00781898|101961931|FG001|COMPLETED|Overall Study||126||
48664021|NCT00781898|101961930|FG000|NOT COMPLETED|Overall Study||34||
48664022|NCT00781898|101961931|FG001|NOT COMPLETED|Overall Study||29||
48664023|NCT03900650|101961932|FG000|STARTED|Overall Study||74||
48664024|NCT03900650|101961933|FG001|STARTED|Overall Study||75||
48664025|NCT03900650|101961934|FG002|STARTED|Overall Study||74||
48664026|NCT03900650|101961935|FG003|STARTED|Overall Study||70||
48664027|NCT03900650|101961932|FG000|COMPLETED|Overall Study||72||
48664028|NCT03900650|101961933|FG001|COMPLETED|Overall Study||74||
48664029|NCT03900650|101961934|FG002|COMPLETED|Overall Study||74||
48664030|NCT03900650|101961935|FG003|COMPLETED|Overall Study||70||
48189665|NCT02537444|100786274|FG001|Enrolled|Overall Study||39||
48664031|NCT03900650|101961932|FG000|NOT COMPLETED|Overall Study||2||
48664032|NCT03900650|101961933|FG001|NOT COMPLETED|Overall Study||1||
48774575|NCT02560558|102236616|FG000|COMPLETED|Overall Study||77||
48774576|NCT02560558|102236617|FG001|COMPLETED|Overall Study||76||
48774577|NCT02560558|102236616|FG000|NOT COMPLETED|Overall Study||7||
48664033|NCT03900650|101961934|FG002|NOT COMPLETED|Overall Study||0||
48664034|NCT03900650|101961935|FG003|NOT COMPLETED|Overall Study||0||
48664035|NCT01957384|101961936|FG000|STARTED|Test Period 1 (14 Days)||4||
48664036|NCT01957384|101961937|FG001|STARTED|Test Period 1 (14 Days)||4||
48664037|NCT01957384|101961938|FG002|STARTED|Test Period 1 (14 Days)||4||
48664038|NCT01957384|101961939|FG003|STARTED|Test Period 1 (14 Days)||4||
48664039|NCT01957384|101961940|FG004|STARTED|Test Period 1 (14 Days)||3||
48664040|NCT01957384|101961941|FG005|STARTED|Test Period 1 (14 Days)||3||
48664041|NCT01957384|101961936|FG000|COMPLETED|Test Period 1 (14 Days)||4||
48774578|NCT02560558|102236617|FG001|NOT COMPLETED|Overall Study||6||
48774579|NCT00804908|102236618|FG000|STARTED|Overall Study||115|Intent-to-treat (ITT) population defined as all randomized subjects.|
48774580|NCT00804908|102236619|FG001|STARTED|Overall Study||116|Intent-to-treat (ITT) population defined as all randomized subjects.|
48774581|NCT00804908|102236620|FG002|STARTED|Overall Study||115|Intent-to-treat (ITT) population defined as all randomized subjects.|
48774582|NCT00804908|102236618|FG000|COMPLETED|Overall Study||0||
48774583|NCT00804908|102236619|FG001|COMPLETED|Overall Study||0||
48774584|NCT00804908|102236620|FG002|COMPLETED|Overall Study||1||
48774585|NCT00804908|102236618|FG000|NOT COMPLETED|Overall Study||115||
48774586|NCT00804908|102236619|FG001|NOT COMPLETED|Overall Study||116||
48774587|NCT00804908|102236620|FG002|NOT COMPLETED|Overall Study||114||
48774588|NCT00526071|102236621|FG000|STARTED|Overall Study||23||
48774589|NCT00526071|102236621|FG000|Safety Population|Overall Study||23|All participants who received at least 1 dose of study drug|
48774590|NCT00526071|102236621|FG000|Pharmacodynamic (PD) Population|Overall Study||23|Received study drug and had a baseline measurement and at least 1 postbaseline PD measure|
48774591|NCT00526071|102236621|FG000|Amenable Population; Men|Overall Study||11|Amenable mutations based on the clinical trial (CT) Human Embryonic Kidney (HEK) assay|
48774592|NCT00526071|102236621|FG000|Amenable Population; Women|Overall Study||5|Amenable mutations based on the CT-HEK assay|
48774593|NCT00526071|102236621|FG000|Non-amenable Population; Men|Overall Study||3|Those without mutant forms of α-Gal A responsive to migalastat treatment based on the CT-HEK assay|
48774594|NCT00526071|102236621|FG000|Non-amenable Population; Women|Overall Study||4|Those without mutant forms of α-Gal A responsive to migalastat treatment based on the CT-HEK assay|
48774595|NCT00526071|102236621|FG000|COMPLETED|Overall Study||17||
48774596|NCT00526071|102236621|FG000|NOT COMPLETED|Overall Study||6||
48774597|NCT01833247|102236622|FG000|STARTED|Overall Study||12||
48774598|NCT01833247|102236622|FG000|COMPLETED|Overall Study||12||
48774599|NCT01833247|102236622|FG000|NOT COMPLETED|Overall Study||0||
48774600|NCT03163303|102236623|FG000|STARTED|Overall Study||85||
48774601|NCT03163303|102236624|FG001|STARTED|Overall Study||94||
48774602|NCT03163303|102236623|FG000|COMPLETED|Overall Study||85||
48774603|NCT03163303|102236624|FG001|COMPLETED|Overall Study||94||
48774604|NCT03163303|102236623|FG000|NOT COMPLETED|Overall Study||0||
48774605|NCT03163303|102236624|FG001|NOT COMPLETED|Overall Study||0||
48774606|NCT04555616|102236625|FG000|STARTED|Overall Study||10|All numbers in this table represent dyads. One dyad is patient and their caregiver (total participants = 2 per dyad).|
48774607|NCT04555616|102236626|FG001|STARTED|Overall Study||10|All numbers in this table represent dyads. One dyad is patient and their caregiver (total participants = 2 per dyad).|
48774608|NCT04555616|102236627|FG002|STARTED|Overall Study||10|All numbers in this table represent dyads. One dyad is patient and their caregiver (total participants = 2 per dyad).|
48774609|NCT04555616|102236625|FG000|COMPLETED|Overall Study||7|"2 deaths report patient death."|
48774610|NCT04555616|102236626|FG001|COMPLETED|Overall Study||9|"2 deaths report patient death."|
48774611|NCT04555616|102236627|FG002|COMPLETED|Overall Study||9|"2 deaths report patient death."|
48774612|NCT04555616|102236625|FG000|NOT COMPLETED|Overall Study||3||
48774613|NCT04555616|102236626|FG001|NOT COMPLETED|Overall Study||1||
48774614|NCT04555616|102236627|FG002|NOT COMPLETED|Overall Study||1||
48189666|NCT02537444|100786273|FG000|Received Study Medication|Overall Study||38||
48774615|NCT02136069|102236628|FG000|STARTED|Overall Study||199||
48774616|NCT02136069|102236629|FG001|STARTED|Overall Study||198||
48774617|NCT02136069|102236628|FG000|COMPLETED|Overall Study||165||
48774618|NCT02136069|102236629|FG001|COMPLETED|Overall Study||170||
48774619|NCT02136069|102236628|FG000|NOT COMPLETED|Overall Study||34||
48774620|NCT02136069|102236629|FG001|NOT COMPLETED|Overall Study||28||
48774621|NCT02047032|102236630|FG000|STARTED|Overall Study||250||
48774622|NCT02047032|102236631|FG001|STARTED|Overall Study||250||
48774623|NCT02047032|102236630|FG000|COMPLETED|Overall Study||245||
48774624|NCT02047032|102236631|FG001|COMPLETED|Overall Study||235||
48774625|NCT02047032|102236630|FG000|NOT COMPLETED|Overall Study||5||
48774626|NCT02047032|102236631|FG001|NOT COMPLETED|Overall Study||15||
48774627|NCT02817464|102236632|FG000|STARTED|Overall Study||6||
48774628|NCT02817464|102236633|FG001|STARTED|Overall Study||6||
48774629|NCT02817464|102236632|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
48774630|NCT02817464|102236633|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
48774631|NCT02817464|102236632|FG000|COMPLETED|Overall Study||4||
48774632|NCT02817464|102236633|FG001|COMPLETED|Overall Study||5||
48774633|NCT02817464|102236632|FG000|NOT COMPLETED|Overall Study||2||
48774634|NCT02817464|102236633|FG001|NOT COMPLETED|Overall Study||1||
48774635|NCT01399372|102236634|FG000|STARTED|Overall Study||47||
48774636|NCT01399372|102236635|FG001|STARTED|Overall Study||44||
48774637|NCT01399372|102236634|FG000|Eligible|Overall Study||44||
48774638|NCT01399372|102236635|FG001|Eligible|Overall Study||43||
48189667|NCT02537444|100786274|FG001|Received Study Medication|Overall Study||39||
48459049|NCT00289458|101460027|FG002|STARTED|Overall Study||28||
48459050|NCT00289458|101460025|FG000|COMPLETED|Overall Study||19||
48459051|NCT00289458|101460026|FG001|COMPLETED|Overall Study||20||
48459052|NCT00289458|101460027|FG002|COMPLETED|Overall Study||22||
48459053|NCT00289458|101460025|FG000|NOT COMPLETED|Overall Study||6||
48459054|NCT00289458|101460026|FG001|NOT COMPLETED|Overall Study||6||
48459055|NCT00289458|101460027|FG002|NOT COMPLETED|Overall Study||6||
48459056|NCT00374543|101460028|FG000|STARTED|Overall Study||2||
48459057|NCT00374543|101460029|FG001|STARTED|Overall Study||1||
48459058|NCT00374543|101460028|FG000|COMPLETED|Overall Study||2||
48459059|NCT00374543|101460029|FG001|COMPLETED|Overall Study||1||
48459060|NCT00374543|101460028|FG000|NOT COMPLETED|Overall Study||0||
48459061|NCT00374543|101460029|FG001|NOT COMPLETED|Overall Study||0||
48459062|NCT02049359|101460030|FG000|STARTED|Overall Study||95||
48459063|NCT02049359|101460031|FG001|STARTED|Overall Study||75||
48459064|NCT02049359|101460030|FG000|COMPLETED|Overall Study||69||
48459065|NCT02049359|101460031|FG001|COMPLETED|Overall Study||56||
48459066|NCT02049359|101460030|FG000|NOT COMPLETED|Overall Study||26||
48459067|NCT02049359|101460031|FG001|NOT COMPLETED|Overall Study||19||
48459068|NCT04345471|101460032|FG000|STARTED|Overall Study||204||
48459069|NCT04345471|101460033|FG001|STARTED|Overall Study||207||
48459070|NCT04345471|101460034|FG002|STARTED|Overall Study||204||
48459071|NCT04345471|101460032|FG000|Received Treatment|Overall Study||204||
48459072|NCT04345471|101460033|FG001|Received Treatment|Overall Study||206||
48459073|NCT04345471|101460034|FG002|Received Treatment|Overall Study||204||
48459074|NCT04345471|101460032|FG000|COMPLETED|Overall Study||185||
48459075|NCT04345471|101460033|FG001|COMPLETED|Overall Study||195||
48459076|NCT04345471|101460034|FG002|COMPLETED|Overall Study||186||
48459077|NCT04345471|101460032|FG000|NOT COMPLETED|Overall Study||19||
48189668|NCT02537444|100786273|FG000|Discontinued Study|Overall Study||39||
48664042|NCT01957384|101961937|FG001|COMPLETED|Test Period 1 (14 Days)||4||
48664043|NCT01957384|101961938|FG002|COMPLETED|Test Period 1 (14 Days)||4||
48664044|NCT01957384|101961939|FG003|COMPLETED|Test Period 1 (14 Days)||4||
48664045|NCT01957384|101961940|FG004|COMPLETED|Test Period 1 (14 Days)||3||
48664046|NCT01957384|101961941|FG005|COMPLETED|Test Period 1 (14 Days)||3||
48664047|NCT01957384|101961936|FG000|NOT COMPLETED|Test Period 1 (14 Days)||0||
48664048|NCT01957384|101961937|FG001|NOT COMPLETED|Test Period 1 (14 Days)||0||
48664049|NCT01957384|101961938|FG002|NOT COMPLETED|Test Period 1 (14 Days)||0||
48664050|NCT01957384|101961939|FG003|NOT COMPLETED|Test Period 1 (14 Days)||0||
48459078|NCT04345471|101460033|FG001|NOT COMPLETED|Overall Study||12||
48459079|NCT04345471|101460034|FG002|NOT COMPLETED|Overall Study||18||
48459080|NCT03277183|101460035|FG000|STARTED|Overall Study||3||
48459081|NCT03277183|101460036|FG001|STARTED|Overall Study||2||
48459082|NCT03277183|101460035|FG000|COMPLETED|Overall Study||0||
48459083|NCT03277183|101460036|FG001|COMPLETED|Overall Study||0||
48459084|NCT03277183|101460035|FG000|NOT COMPLETED|Overall Study||3||
48459085|NCT03277183|101460036|FG001|NOT COMPLETED|Overall Study||2||
48459086|NCT00626925|101460037|FG000|STARTED|Overall Study||67||
48459087|NCT00626925|101460038|FG001|STARTED|Overall Study||71||
48459088|NCT00626925|101460037|FG000|COMPLETED|Overall Study||55||
48664051|NCT01957384|101961940|FG004|NOT COMPLETED|Test Period 1 (14 Days)||0||
48664052|NCT01957384|101961941|FG005|NOT COMPLETED|Test Period 1 (14 Days)||0||
48664053|NCT01957384|101961936|FG000|STARTED|Test Period 2 (14 Days)||4||
48774639|NCT01399372|102236634|FG000|Eligible and Started Protocol Treatment|Overall Study||43||
48774640|NCT01399372|102236635|FG001|Eligible and Started Protocol Treatment|Overall Study||43||
48774641|NCT01399372|102236634|FG000|COMPLETED|Overall Study||44|Participants contributing data to results are considered to have completed the study|
48774642|NCT01399372|102236635|FG001|COMPLETED|Overall Study||43|Participants contributing data to results are considered to have completed the study|
48774643|NCT01399372|102236634|FG000|NOT COMPLETED|Overall Study||3||
48774644|NCT01399372|102236635|FG001|NOT COMPLETED|Overall Study||1||
48774645|NCT01908062|102236636|FG000|STARTED|Overall Study||26||
48774646|NCT01908062|102236637|FG001|STARTED|Overall Study||25||
48774647|NCT01908062|102236636|FG000|COMPLETED|Overall Study||24||
48774648|NCT01908062|102236637|FG001|COMPLETED|Overall Study||22||
48774649|NCT01908062|102236636|FG000|NOT COMPLETED|Overall Study||2||
48774650|NCT01908062|102236637|FG001|NOT COMPLETED|Overall Study||3||
48774651|NCT01189409|102236638|FG000|STARTED|First 3 Weeks||37||
48774652|NCT01189409|102236639|FG001|STARTED|First 3 Weeks||33||
48774653|NCT01189409|102236638|FG000|COMPLETED|First 3 Weeks||19||
48459089|NCT00626925|101460038|FG001|COMPLETED|Overall Study||62||
48459090|NCT00626925|101460037|FG000|NOT COMPLETED|Overall Study||12||
48459091|NCT00626925|101460038|FG001|NOT COMPLETED|Overall Study||9||
48459092|NCT00673790|101460039|FG000|STARTED|Overall Study||223||
48459093|NCT00673790|101460040|FG001|STARTED|Overall Study||212||
48664054|NCT01957384|101961937|FG001|STARTED|Test Period 2 (14 Days)||4||
48459094|NCT00673790|101460041|FG002|STARTED|Overall Study||102||
48459095|NCT00673790|101460039|FG000|COMPLETED|Overall Study||178||
48664055|NCT01957384|101961938|FG002|STARTED|Test Period 2 (14 Days)||4||
48664056|NCT01957384|101961939|FG003|STARTED|Test Period 2 (14 Days)||4||
48664057|NCT01957384|101961940|FG004|STARTED|Test Period 2 (14 Days)||3||
48664058|NCT01957384|101961941|FG005|STARTED|Test Period 2 (14 Days)||3||
48664059|NCT01957384|101961936|FG000|COMPLETED|Test Period 2 (14 Days)||4||
48664060|NCT01957384|101961937|FG001|COMPLETED|Test Period 2 (14 Days)||4||
48459096|NCT00673790|101460040|FG001|COMPLETED|Overall Study||174||
48459097|NCT00673790|101460041|FG002|COMPLETED|Overall Study||90||
48459098|NCT00673790|101460039|FG000|NOT COMPLETED|Overall Study||45||
48459099|NCT00673790|101460040|FG001|NOT COMPLETED|Overall Study||38||
48459100|NCT00673790|101460041|FG002|NOT COMPLETED|Overall Study||12||
48459101|NCT01564758|101460042|FG000|STARTED|Overall Study||99||
48459102|NCT01564758|101460042|FG000|COMPLETED|Overall Study||85||
48664061|NCT01957384|101961938|FG002|COMPLETED|Test Period 2 (14 Days)||4||
48664062|NCT01957384|101961939|FG003|COMPLETED|Test Period 2 (14 Days)||4||
48664063|NCT01957384|101961940|FG004|COMPLETED|Test Period 2 (14 Days)||3||
48664064|NCT01957384|101961941|FG005|COMPLETED|Test Period 2 (14 Days)||3||
48664065|NCT01957384|101961936|FG000|NOT COMPLETED|Test Period 2 (14 Days)||0||
48664066|NCT01957384|101961937|FG001|NOT COMPLETED|Test Period 2 (14 Days)||0||
48664067|NCT01957384|101961938|FG002|NOT COMPLETED|Test Period 2 (14 Days)||0||
48664068|NCT01957384|101961939|FG003|NOT COMPLETED|Test Period 2 (14 Days)||0||
48664069|NCT01957384|101961940|FG004|NOT COMPLETED|Test Period 2 (14 Days)||0||
48664070|NCT01957384|101961941|FG005|NOT COMPLETED|Test Period 2 (14 Days)||0||
48664071|NCT01957384|101961936|FG000|STARTED|Test Period 3 (14 Days)||4||
48664072|NCT01957384|101961937|FG001|STARTED|Test Period 3 (14 Days)||4||
48664073|NCT01957384|101961938|FG002|STARTED|Test Period 3 (14 Days)||4||
48664074|NCT01957384|101961939|FG003|STARTED|Test Period 3 (14 Days)||4||
48664075|NCT01957384|101961940|FG004|STARTED|Test Period 3 (14 Days)||3||
48664076|NCT01957384|101961941|FG005|STARTED|Test Period 3 (14 Days)||3||
48664077|NCT01957384|101961936|FG000|COMPLETED|Test Period 3 (14 Days)||4||
48664078|NCT01957384|101961937|FG001|COMPLETED|Test Period 3 (14 Days)||4||
48664079|NCT01957384|101961938|FG002|COMPLETED|Test Period 3 (14 Days)||4||
48664080|NCT01957384|101961939|FG003|COMPLETED|Test Period 3 (14 Days)||4||
48664081|NCT01957384|101961940|FG004|COMPLETED|Test Period 3 (14 Days)||3||
48664082|NCT01957384|101961941|FG005|COMPLETED|Test Period 3 (14 Days)||3||
48664083|NCT01957384|101961936|FG000|NOT COMPLETED|Test Period 3 (14 Days)||0||
48664084|NCT01957384|101961937|FG001|NOT COMPLETED|Test Period 3 (14 Days)||0||
48459103|NCT01564758|101460042|FG000|NOT COMPLETED|Overall Study||14||
48664085|NCT01957384|101961938|FG002|NOT COMPLETED|Test Period 3 (14 Days)||0||
48664086|NCT01957384|101961939|FG003|NOT COMPLETED|Test Period 3 (14 Days)||0||
48664087|NCT01957384|101961940|FG004|NOT COMPLETED|Test Period 3 (14 Days)||0||
48664088|NCT01957384|101961941|FG005|NOT COMPLETED|Test Period 3 (14 Days)||0||
48664089|NCT02249949|101961942|FG000|STARTED|Overall Study||13||
48664090|NCT02249949|101961942|FG000|COMPLETED|Overall Study||11||
48664091|NCT02249949|101961942|FG000|NOT COMPLETED|Overall Study||2||
48664092|NCT04548219|101961943|FG000|STARTED|Overall Study||10||
48664093|NCT04548219|101961944|FG001|STARTED|Overall Study||10||
48774654|NCT01189409|102236639|FG001|COMPLETED|First 3 Weeks||23||
48774655|NCT01189409|102236638|FG000|NOT COMPLETED|First 3 Weeks||18||
48664094|NCT04548219|101961945|FG002|STARTED|Overall Study||10||
48664095|NCT04548219|101961946|FG003|STARTED|Overall Study||10||
48664096|NCT04548219|101961947|FG004|STARTED|Overall Study||10||
48664097|NCT04548219|101961948|FG005|STARTED|Overall Study||10||
48664098|NCT04548219|101961943|FG000|Received at Least 1 Dose of Study Drug|Overall Study||10||
48664099|NCT04548219|101961944|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10||
48774656|NCT01189409|102236639|FG001|NOT COMPLETED|First 3 Weeks||10||
48774657|NCT01189409|102236638|FG000|STARTED|Second 3 Weeks (Switch to 2nd Treatment)||19||
48774658|NCT01189409|102236639|FG001|STARTED|Second 3 Weeks (Switch to 2nd Treatment)||23||
48774659|NCT01189409|102236638|FG000|COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||13||
48774660|NCT01189409|102236639|FG001|COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||15||
48774661|NCT01189409|102236638|FG000|NOT COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||6||
48189669|NCT02537444|100786274|FG001|Discontinued Study|Overall Study||39||
48664100|NCT04548219|101961945|FG002|Received at Least 1 Dose of Study Drug|Overall Study||10||
48664101|NCT04548219|101961946|FG003|Received at Least 1 Dose of Study Drug|Overall Study||10||
48774662|NCT01189409|102236639|FG001|NOT COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||8||
48774663|NCT03855059|102236640|FG000|STARTED|Overall Study||25||
48664102|NCT04548219|101961947|FG004|Received at Least 1 Dose of Study Drug|Overall Study||10||
48189670|NCT02537444|100786273|FG000|COMPLETED|Overall Study||0||
48664103|NCT04548219|101961948|FG005|Received at Least 1 Dose of Study Drug|Overall Study||10||
48774664|NCT03855059|102236641|FG001|STARTED|Overall Study||25||
48774665|NCT03855059|102236640|FG000|COMPLETED|Overall Study||23||
48774666|NCT03855059|102236641|FG001|COMPLETED|Overall Study||25||
48774667|NCT03855059|102236640|FG000|NOT COMPLETED|Overall Study||2||
48774668|NCT03855059|102236641|FG001|NOT COMPLETED|Overall Study||0||
48774669|NCT01573052|102236642|FG000|STARTED|Overall Study||9||
48774670|NCT01573052|102236643|FG001|STARTED|Overall Study||17||
48774671|NCT01573052|102236642|FG000|COMPLETED|Overall Study||6||
48774672|NCT01573052|102236643|FG001|COMPLETED|Overall Study||11||
48774673|NCT01573052|102236642|FG000|NOT COMPLETED|Overall Study||3||
48774674|NCT01573052|102236643|FG001|NOT COMPLETED|Overall Study||6||
48774675|NCT02622178|102236644|FG000|STARTED|Overall Study||42||
48774676|NCT02622178|102236645|FG001|STARTED|Overall Study||45||
48774677|NCT02622178|102236646|FG002|STARTED|Overall Study||49||
48774678|NCT02622178|102236644|FG000|COMPLETED|Overall Study||42||
48774679|NCT02622178|102236645|FG001|COMPLETED|Overall Study||45||
48774680|NCT02622178|102236646|FG002|COMPLETED|Overall Study||49||
48774681|NCT02622178|102236644|FG000|NOT COMPLETED|Overall Study||0||
48774682|NCT02622178|102236645|FG001|NOT COMPLETED|Overall Study||0||
48774683|NCT02622178|102236646|FG002|NOT COMPLETED|Overall Study||0||
48774684|NCT00577798|102236647|FG000|STARTED|Overall Study||10||
48774685|NCT00577798|102236647|FG000|COMPLETED|Overall Study||10||
48774686|NCT00577798|102236647|FG000|NOT COMPLETED|Overall Study||0||
48774687|NCT01106248|102236648|FG000|STARTED|Overall Study||26||
48774688|NCT01106248|102236648|FG000|COMPLETED|Overall Study||23||
48774689|NCT01106248|102236648|FG000|NOT COMPLETED|Overall Study||3||
48774690|NCT00508196|102236649|FG000|STARTED|Overall Study||11||
48774691|NCT00508196|102236650|FG001|STARTED|Overall Study||11||
48774692|NCT00508196|102236649|FG000|COMPLETED|Overall Study||11||
48774693|NCT00508196|102236650|FG001|COMPLETED|Overall Study||11||
48189671|NCT02537444|100786274|FG001|COMPLETED|Overall Study||0||
48459104|NCT02843074|101460043|FG000|STARTED|Overall Study||52||
48459105|NCT02843074|101460043|FG000|COMPLETED|Overall Study||35||
48459106|NCT02843074|101460043|FG000|NOT COMPLETED|Overall Study||17||
48459107|NCT01156571|101460044|FG000|STARTED|Overall Study||5581||
48459108|NCT01156571|101460045|FG001|STARTED|Overall Study||5564||
48774694|NCT00508196|102236649|FG000|NOT COMPLETED|Overall Study||0||
48774695|NCT00508196|102236650|FG001|NOT COMPLETED|Overall Study||0||
48774696|NCT03695367|102236651|FG000|STARTED|Overall Study||33||
48774697|NCT03695367|102236652|FG001|STARTED|Overall Study||30||
48774698|NCT03695367|102236651|FG000|COMPLETED|Overall Study||32||
48774699|NCT03695367|102236652|FG001|COMPLETED|Overall Study||26||
48774700|NCT03695367|102236651|FG000|NOT COMPLETED|Overall Study||1||
48774701|NCT03695367|102236652|FG001|NOT COMPLETED|Overall Study||4||
48774702|NCT04287517|102236653|FG000|STARTED|Overall Study||19||
48774703|NCT04287517|102236654|FG001|STARTED|Overall Study||19||
48774704|NCT04287517|102236653|FG000|COMPLETED|Overall Study||18||
48774705|NCT04287517|102236654|FG001|COMPLETED|Overall Study||18||
48774706|NCT04287517|102236653|FG000|NOT COMPLETED|Overall Study||1||
48774707|NCT04287517|102236654|FG001|NOT COMPLETED|Overall Study||1||
48774708|NCT00695097|102236655|FG000|STARTED|Overall Study||10||
48774709|NCT00695097|102236656|FG001|STARTED|Overall Study||5||
48189672|NCT02537444|100786273|FG000|NOT COMPLETED|Overall Study||39||
48189673|NCT02537444|100786274|FG001|NOT COMPLETED|Overall Study||39||
48459109|NCT01156571|101460044|FG000|COMPLETED|Overall Study||5564||
48459110|NCT01156571|101460045|FG001|COMPLETED|Overall Study||5545||
48774710|NCT00695097|102236655|FG000|COMPLETED|Overall Study||9||
48774711|NCT00695097|102236656|FG001|COMPLETED|Overall Study||5||
48774712|NCT00695097|102236655|FG000|NOT COMPLETED|Overall Study||1||
48774713|NCT00695097|102236656|FG001|NOT COMPLETED|Overall Study||0||
48774714|NCT01652534|102236657|FG000|STARTED|Overall Study||2||
48189674|NCT00550732|100786275|FG000|STARTED|Overall Study||40||
48774715|NCT01652534|102236658|FG001|STARTED|Overall Study||1||
48459111|NCT01156571|101460044|FG000|NOT COMPLETED|Overall Study||17||
48459112|NCT01156571|101460045|FG001|NOT COMPLETED|Overall Study||19||
48459113|NCT03467412|101460046|FG000|STARTED|Overall Study||25||25
48459114|NCT03467412|101460047|FG001|STARTED|Overall Study||25||25
48459115|NCT03467412|101460048|FG002|STARTED|Overall Study||25||25
48459116|NCT03467412|101460049|FG003|STARTED|Overall Study||25||25
48459117|NCT03467412|101460050|FG004|STARTED|Overall Study||20||20
48459118|NCT03467412|101460046|FG000|COMPLETED|Overall Study||22||22
48459119|NCT03467412|101460047|FG001|COMPLETED|Overall Study||24||24
48459120|NCT03467412|101460048|FG002|COMPLETED|Overall Study||20||20
48459121|NCT03467412|101460049|FG003|COMPLETED|Overall Study||23||23
48459122|NCT03467412|101460050|FG004|COMPLETED|Overall Study||17||17
48459123|NCT03467412|101460046|FG000|NOT COMPLETED|Overall Study||3||3
48459124|NCT03467412|101460047|FG001|NOT COMPLETED|Overall Study||1||1
48459125|NCT03467412|101460048|FG002|NOT COMPLETED|Overall Study||5||5
48459126|NCT03467412|101460049|FG003|NOT COMPLETED|Overall Study||2||2
48459127|NCT03467412|101460050|FG004|NOT COMPLETED|Overall Study||3||3
48459128|NCT02625545|101460051|FG000|STARTED|Overall Study||45||
48459129|NCT02625545|101460051|FG000|3 Month|Overall Study||45||
48459130|NCT02625545|101460051|FG000|6 Month|Overall Study||45||
48459131|NCT02625545|101460051|FG000|12 Month|Overall Study||45||
48459132|NCT02625545|101460051|FG000|COMPLETED|Overall Study||45||
48459133|NCT02625545|101460051|FG000|NOT COMPLETED|Overall Study||0||
48459134|NCT01186978|101460052|FG000|STARTED|Overall Study||63||
48459135|NCT01186978|101460052|FG000|COMPLETED|Overall Study||62||
48459136|NCT01186978|101460052|FG000|NOT COMPLETED|Overall Study||1||
48459137|NCT01736553|101460053|FG000|STARTED|Overall Study||26||
48459138|NCT01736553|101460054|FG001|STARTED|Overall Study||27||
48459139|NCT01736553|101460053|FG000|COMPLETED|Overall Study||7||
48459140|NCT01736553|101460054|FG001|COMPLETED|Overall Study||23||
48459141|NCT01736553|101460053|FG000|NOT COMPLETED|Overall Study||19||
48459142|NCT01736553|101460054|FG001|NOT COMPLETED|Overall Study||4||
48459143|NCT00740727|101460055|FG000|STARTED|Overall Study||18||
48459144|NCT00740727|101460055|FG000|COMPLETED|Overall Study||18||
48459145|NCT00740727|101460055|FG000|NOT COMPLETED|Overall Study||0||
48459146|NCT00576199|101460056|FG000|STARTED|Overall Study||30||
48459147|NCT00576199|101460056|FG000|COMPLETED|Overall Study||0||
48459148|NCT00576199|101460056|FG000|NOT COMPLETED|Overall Study||30||
48459149|NCT02268045|101460057|FG000|STARTED|Overall Study||136||
48459150|NCT02268045|101460058|FG001|STARTED|Overall Study||136||
48459151|NCT02268045|101460057|FG000|COMPLETED|Overall Study||120||
48459152|NCT02268045|101460058|FG001|COMPLETED|Overall Study||116||
48459153|NCT02268045|101460057|FG000|NOT COMPLETED|Overall Study||16||
48459154|NCT02268045|101460058|FG001|NOT COMPLETED|Overall Study||20||
48459155|NCT03387059|101460059|FG000|STARTED|Overall Study||5||
48459156|NCT03387059|101460060|FG001|STARTED|Overall Study||4||
48459157|NCT03387059|101460059|FG000|COMPLETED|Overall Study||0||
48459158|NCT03387059|101460060|FG001|COMPLETED|Overall Study||0||
48459159|NCT03387059|101460059|FG000|NOT COMPLETED|Overall Study||5||
48459160|NCT03387059|101460060|FG001|NOT COMPLETED|Overall Study||4||
48459161|NCT02340156|101460061|FG000|STARTED|Overall Study||1||
48459162|NCT02340156|101460061|FG000|COMPLETED|Overall Study||1||
48459163|NCT02340156|101460061|FG000|NOT COMPLETED|Overall Study||0||
48459164|NCT01759537|101460062|FG000|STARTED|Overall Study||48||48
48459165|NCT01759537|101460063|FG001|STARTED|Overall Study||48||48
48459166|NCT01759537|101460062|FG000|COMPLETED|Overall Study||35||35
48459167|NCT01759537|101460063|FG001|COMPLETED|Overall Study||35||35
48459168|NCT01759537|101460062|FG000|NOT COMPLETED|Overall Study||13||13
48459169|NCT01759537|101460063|FG001|NOT COMPLETED|Overall Study||13||13
48459170|NCT01388647|101460064|FG000|STARTED|Overall Study||6||
48459171|NCT01388647|101460065|FG001|STARTED|Overall Study||6||
48459172|NCT01388647|101460064|FG000|COMPLETED|Overall Study||5||
48459173|NCT01388647|101460065|FG001|COMPLETED|Overall Study||4||
48459174|NCT01388647|101460064|FG000|NOT COMPLETED|Overall Study||1||
48459175|NCT01388647|101460065|FG001|NOT COMPLETED|Overall Study||2||
48459176|NCT00669578|101460066|FG000|STARTED|Overall Study||12||
48459177|NCT00669578|101460067|FG001|STARTED|Overall Study||65||
48459178|NCT00669578|101460066|FG000|COMPLETED|Overall Study||12||
48459179|NCT00669578|101460067|FG001|COMPLETED|Overall Study||65||
48459180|NCT00669578|101460066|FG000|NOT COMPLETED|Overall Study||0||
48459181|NCT00669578|101460067|FG001|NOT COMPLETED|Overall Study||0||
48459182|NCT02400905|101460068|FG000|STARTED|Overall Study||271||
48459183|NCT02400905|101460068|FG000|30-Days Follow-up|Overall Study||268||
48459184|NCT02400905|101460068|FG000|12-Months Follow-up|Overall Study||256||
48459185|NCT02400905|101460068|FG000|24-Months Follow-up|Overall Study||225||
48459186|NCT02400905|101460068|FG000|36 Months-Follow-up|Overall Study||208||
48459187|NCT02400905|101460068|FG000|COMPLETED|Overall Study||208||
48459188|NCT02400905|101460068|FG000|NOT COMPLETED|Overall Study||63||
48459189|NCT02472977|101460069|FG000|STARTED|Overall Study||6||
48459190|NCT02472977|101460070|FG001|STARTED|Overall Study||27||
48459191|NCT02472977|101460071|FG002|STARTED|Overall Study||8||
48459192|NCT02472977|101460069|FG000|COMPLETED|Overall Study||0||
48459193|NCT02472977|101460070|FG001|COMPLETED|Overall Study||0||
48459194|NCT02472977|101460071|FG002|COMPLETED|Overall Study||0||
48459195|NCT02472977|101460069|FG000|NOT COMPLETED|Overall Study||6||
48459196|NCT02472977|101460070|FG001|NOT COMPLETED|Overall Study||27||
48459197|NCT02472977|101460071|FG002|NOT COMPLETED|Overall Study||8||
48459198|NCT02415959|101460072|FG000|STARTED|Overall Study||14||
48459199|NCT02415959|101460073|FG001|STARTED|Overall Study||14||
48459200|NCT02415959|101460074|FG002|STARTED|Overall Study||14||
48459201|NCT02415959|101460075|FG003|STARTED|Overall Study||14||
48459202|NCT02415959|101460076|FG004|STARTED|Overall Study||14||
48459203|NCT02415959|101460072|FG000|COMPLETED|Overall Study||14||
48459204|NCT02415959|101460073|FG001|COMPLETED|Overall Study||13||
48459205|NCT02415959|101460074|FG002|COMPLETED|Overall Study||14||
48459206|NCT02415959|101460075|FG003|COMPLETED|Overall Study||13||
48459207|NCT02415959|101460076|FG004|COMPLETED|Overall Study||14||
48459208|NCT02415959|101460072|FG000|NOT COMPLETED|Overall Study||0||
48459209|NCT02415959|101460073|FG001|NOT COMPLETED|Overall Study||1||
48459210|NCT02415959|101460074|FG002|NOT COMPLETED|Overall Study||0||
48459211|NCT02415959|101460075|FG003|NOT COMPLETED|Overall Study||1||
48459212|NCT02415959|101460076|FG004|NOT COMPLETED|Overall Study||0||
48459213|NCT00905489|101460077|FG000|STARTED|Pharmaco-kinetic (PK) Phase||85||
48459214|NCT00905489|101460077|FG000|COMPLETED|Pharmaco-kinetic (PK) Phase||80||
48459215|NCT00905489|101460077|FG000|NOT COMPLETED|Pharmaco-kinetic (PK) Phase||5||
48459216|NCT00905489|101460077|FG000|STARTED|Optional Extension Phase (OEP)||40||
48459217|NCT00905489|101460077|FG000|COMPLETED|Optional Extension Phase (OEP)||39||
48459218|NCT00905489|101460077|FG000|NOT COMPLETED|Optional Extension Phase (OEP)||1||
48459219|NCT00697112|101460078|FG000|STARTED|Overall Study||53||
48459220|NCT00697112|101460078|FG000|Met the Inclusion Criteria|Overall Study||52||
48459221|NCT00697112|101460078|FG000|COMPLETED|Overall Study||43||
48459222|NCT00697112|101460078|FG000|NOT COMPLETED|Overall Study||10||
48459223|NCT02873481|101460079|FG000|STARTED|Overall Study||15||
48369703|NCT01993329|101232838|FG005|NOT COMPLETED|Period 1||0||
48369704|NCT01993329|101232833|FG000|STARTED|Wash-out||3||
48369705|NCT01993329|101232834|FG001|STARTED|Wash-out||4||
48369706|NCT01993329|101232835|FG002|STARTED|Wash-out||3||
48369707|NCT01993329|101232836|FG003|STARTED|Wash-out||3||
48369708|NCT01993329|101232837|FG004|STARTED|Wash-out||3||
48369709|NCT01993329|101232838|FG005|STARTED|Wash-out||4||
48369710|NCT01993329|101232833|FG000|COMPLETED|Wash-out||3||
48369711|NCT01993329|101232834|FG001|COMPLETED|Wash-out||4||
48369712|NCT01993329|101232835|FG002|COMPLETED|Wash-out||3||
48369713|NCT01993329|101232836|FG003|COMPLETED|Wash-out||3||
48369714|NCT01993329|101232837|FG004|COMPLETED|Wash-out||3||
48369715|NCT01993329|101232838|FG005|COMPLETED|Wash-out||4||
48369716|NCT01993329|101232833|FG000|NOT COMPLETED|Wash-out||0||
48369717|NCT01993329|101232834|FG001|NOT COMPLETED|Wash-out||0||
48369718|NCT01993329|101232835|FG002|NOT COMPLETED|Wash-out||0||
48369719|NCT01993329|101232836|FG003|NOT COMPLETED|Wash-out||0||
48369720|NCT01993329|101232837|FG004|NOT COMPLETED|Wash-out||0||
48369721|NCT01993329|101232838|FG005|NOT COMPLETED|Wash-out||0||
48369722|NCT01993329|101232833|FG000|STARTED|Period 2||3||
48369723|NCT01993329|101232834|FG001|STARTED|Period 2||4||
48369724|NCT01993329|101232835|FG002|STARTED|Period 2||3||
48369725|NCT01993329|101232836|FG003|STARTED|Period 2||3||
48369726|NCT01993329|101232837|FG004|STARTED|Period 2||3||
48369727|NCT01993329|101232838|FG005|STARTED|Period 2||4||
48369728|NCT01993329|101232833|FG000|COMPLETED|Period 2||3||
48369729|NCT01993329|101232834|FG001|COMPLETED|Period 2||4||
48369730|NCT01993329|101232835|FG002|COMPLETED|Period 2||3||
48369731|NCT01993329|101232836|FG003|COMPLETED|Period 2||3||
48369732|NCT01993329|101232837|FG004|COMPLETED|Period 2||3||
48369733|NCT01993329|101232838|FG005|COMPLETED|Period 2||3||
48369734|NCT01993329|101232833|FG000|NOT COMPLETED|Period 2||0||
48369735|NCT01993329|101232834|FG001|NOT COMPLETED|Period 2||0||
48369736|NCT01993329|101232835|FG002|NOT COMPLETED|Period 2||0||
48369737|NCT01993329|101232836|FG003|NOT COMPLETED|Period 2||0||
48369738|NCT01993329|101232837|FG004|NOT COMPLETED|Period 2||0||
48369739|NCT01993329|101232838|FG005|NOT COMPLETED|Period 2||1||
48369740|NCT01993329|101232833|FG000|STARTED|Wash-out||3||
48369741|NCT01993329|101232834|FG001|STARTED|Wash-out||4||
48369742|NCT01993329|101232835|FG002|STARTED|Wash-out||3||
48369743|NCT01993329|101232836|FG003|STARTED|Wash-out||3||
48369744|NCT01993329|101232837|FG004|STARTED|Wash-out||3||
48369745|NCT01993329|101232838|FG005|STARTED|Wash-out||3||
48459224|NCT02873481|101460080|FG001|STARTED|Overall Study||17||
48459225|NCT02873481|101460079|FG000|COMPLETED|Overall Study||15||
48459226|NCT02873481|101460080|FG001|COMPLETED|Overall Study||17||
48459227|NCT02873481|101460079|FG000|NOT COMPLETED|Overall Study||0||
48369746|NCT01993329|101232833|FG000|COMPLETED|Wash-out||3||
48369747|NCT01993329|101232834|FG001|COMPLETED|Wash-out||3||
48369748|NCT01993329|101232835|FG002|COMPLETED|Wash-out||3||
48369749|NCT01993329|101232836|FG003|COMPLETED|Wash-out||3||
48369750|NCT01993329|101232837|FG004|COMPLETED|Wash-out||3||
48369751|NCT01993329|101232838|FG005|COMPLETED|Wash-out||3||
48369752|NCT01993329|101232833|FG000|NOT COMPLETED|Wash-out||0||
48369753|NCT01993329|101232834|FG001|NOT COMPLETED|Wash-out||1||
48369754|NCT01993329|101232835|FG002|NOT COMPLETED|Wash-out||0||
48369755|NCT01993329|101232836|FG003|NOT COMPLETED|Wash-out||0||
48369756|NCT01993329|101232837|FG004|NOT COMPLETED|Wash-out||0||
48369757|NCT01993329|101232838|FG005|NOT COMPLETED|Wash-out||0||
48774716|NCT01652534|102236657|FG000|COMPLETED|Overall Study||1||
48774717|NCT01652534|102236658|FG001|COMPLETED|Overall Study||1||
48774718|NCT01652534|102236657|FG000|NOT COMPLETED|Overall Study||1||
48774719|NCT01652534|102236658|FG001|NOT COMPLETED|Overall Study||0||
48774720|NCT03752567|102236659|FG000|STARTED|Overall Study||40||
48774721|NCT03752567|102236659|FG000|COMPLETED|Overall Study||40||
48774722|NCT03752567|102236659|FG000|NOT COMPLETED|Overall Study||0||
48774723|NCT01056016|102236660|FG000|STARTED|Overall Study||22||
48774724|NCT01056016|102236661|FG001|STARTED|Overall Study||27||
48774725|NCT01056016|102236660|FG000|COMPLETED|Overall Study||20||
48774726|NCT01056016|102236661|FG001|COMPLETED|Overall Study||26||
48774727|NCT01056016|102236660|FG000|NOT COMPLETED|Overall Study||2||
48774728|NCT01056016|102236661|FG001|NOT COMPLETED|Overall Study||1||
48774729|NCT02577445|102236662|FG000|STARTED|Overall Study||14||
48774730|NCT02577445|102236663|FG001|STARTED|Overall Study||17||
48774731|NCT02577445|102236662|FG000|COMPLETED|Overall Study||0||
48774732|NCT02577445|102236663|FG001|COMPLETED|Overall Study||0||
48774733|NCT02577445|102236662|FG000|NOT COMPLETED|Overall Study||14||
48774734|NCT02577445|102236663|FG001|NOT COMPLETED|Overall Study||17||
48774735|NCT02207088|102236664|FG000|STARTED|Overall Study||68||
48369758|NCT01993329|101232833|FG000|STARTED|Period 3||3||
48369759|NCT01993329|101232834|FG001|STARTED|Period 3||3||
48369760|NCT01993329|101232835|FG002|STARTED|Period 3||3||
48369761|NCT01993329|101232836|FG003|STARTED|Period 3||3||
48369762|NCT01993329|101232837|FG004|STARTED|Period 3||3||
48774736|NCT02207088|102236664|FG000|COMPLETED|Overall Study||66||
48774737|NCT02207088|102236664|FG000|NOT COMPLETED|Overall Study||2||
48774738|NCT00125164|102236665|FG000|STARTED|Overall Study||25||
48774739|NCT00125164|102236666|FG001|STARTED|Overall Study||16||
48774740|NCT00125164|102236667|FG002|STARTED|Overall Study||44||
48774741|NCT00125164|102236668|FG003|STARTED|Overall Study||51||
48774742|NCT00125164|102236665|FG000|COMPLETED|Overall Study||23||
48774743|NCT00125164|102236666|FG001|COMPLETED|Overall Study||16||
48774744|NCT00125164|102236667|FG002|COMPLETED|Overall Study||40||
48774745|NCT00125164|102236668|FG003|COMPLETED|Overall Study||45||
48774746|NCT00125164|102236665|FG000|NOT COMPLETED|Overall Study||2||
48774747|NCT00125164|102236666|FG001|NOT COMPLETED|Overall Study||0||
48774748|NCT00125164|102236667|FG002|NOT COMPLETED|Overall Study||4||
48774749|NCT00125164|102236668|FG003|NOT COMPLETED|Overall Study||6||
48774750|NCT00470275|102236669|FG000|STARTED|Overall Study||10||
48774751|NCT00470275|102236669|FG000|COMPLETED|Overall Study||0||
48774752|NCT00470275|102236669|FG000|NOT COMPLETED|Overall Study||10||
48774753|NCT02373683|102236670|FG000|STARTED|Overall Study||6||
48774754|NCT02373683|102236671|FG001|STARTED|Overall Study||4||
48774755|NCT02373683|102236670|FG000|COMPLETED|Overall Study||6||
48774756|NCT02373683|102236671|FG001|COMPLETED|Overall Study||4||
48774757|NCT02373683|102236670|FG000|NOT COMPLETED|Overall Study||0||
48774758|NCT02373683|102236671|FG001|NOT COMPLETED|Overall Study||0||
48774759|NCT02230995|102236672|FG000|STARTED|Period 1 + Washout||15||
48774760|NCT02230995|102236673|FG001|STARTED|Period 1 + Washout||15||
48774761|NCT02230995|102236672|FG000|COMPLETED|Period 1 + Washout||15||
48774762|NCT02230995|102236673|FG001|COMPLETED|Period 1 + Washout||15||
48774763|NCT02230995|102236672|FG000|NOT COMPLETED|Period 1 + Washout||0||
48774764|NCT02230995|102236673|FG001|NOT COMPLETED|Period 1 + Washout||0||
48774765|NCT02230995|102236672|FG000|STARTED|Period 2 + Washout||15||
48774766|NCT02230995|102236673|FG001|STARTED|Period 2 + Washout||15||
48774767|NCT02230995|102236672|FG000|COMPLETED|Period 2 + Washout||15||
48774768|NCT02230995|102236673|FG001|COMPLETED|Period 2 + Washout||15||
48774769|NCT02230995|102236672|FG000|NOT COMPLETED|Period 2 + Washout||0||
48774770|NCT02230995|102236673|FG001|NOT COMPLETED|Period 2 + Washout||0||
48774771|NCT03009396|102236674|FG000|STARTED|Overall Study||16||
48774772|NCT03009396|102236675|FG001|STARTED|Overall Study||38||
48774773|NCT03009396|102236674|FG000|COMPLETED|Overall Study||9||
48774774|NCT03009396|102236675|FG001|COMPLETED|Overall Study||21||
48774775|NCT03009396|102236674|FG000|NOT COMPLETED|Overall Study||7||
48774776|NCT03009396|102236675|FG001|NOT COMPLETED|Overall Study||17||
48774777|NCT02668393|102236676|FG000|STARTED|Overall Study||7||
48774778|NCT02668393|102236677|FG001|STARTED|Overall Study||7||
48774779|NCT02668393|102236676|FG000|COMPLETED|Overall Study||0||
48774780|NCT02668393|102236677|FG001|COMPLETED|Overall Study||1||
48369763|NCT01993329|101232838|FG005|STARTED|Period 3||3||
48369764|NCT01993329|101232833|FG000|COMPLETED|Period 3||3||
48774781|NCT02668393|102236676|FG000|NOT COMPLETED|Overall Study||7||
48774782|NCT02668393|102236677|FG001|NOT COMPLETED|Overall Study||6||
48774783|NCT00775190|102236678|FG000|STARTED|Overall Study||7||
48774784|NCT00775190|102236679|FG001|STARTED|Overall Study||5||
48774785|NCT00775190|102236678|FG000|COMPLETED|Overall Study||3||
48774786|NCT00775190|102236679|FG001|COMPLETED|Overall Study||0||
48774787|NCT00775190|102236678|FG000|NOT COMPLETED|Overall Study||4||
48774788|NCT00775190|102236679|FG001|NOT COMPLETED|Overall Study||5||
48774789|NCT00831480|102236680|FG000|STARTED|Overall Study||9||
48774790|NCT00831480|102236680|FG000|COMPLETED|Overall Study||7||
48774791|NCT00831480|102236680|FG000|NOT COMPLETED|Overall Study||2||
48774792|NCT05503823|102236681|FG000|STARTED|Overall Study||6||
48774793|NCT05503823|102236681|FG000|COMPLETED|Overall Study||6||
48774794|NCT05503823|102236681|FG000|NOT COMPLETED|Overall Study||0||
48774795|NCT01059435|102236682|FG000|STARTED|Overall Study||14||
48774796|NCT01059435|102236683|FG001|STARTED|Overall Study||6||
48774797|NCT01059435|102236684|FG002|STARTED|Overall Study||8||
48774798|NCT01059435|102236685|FG003|STARTED|Overall Study||9||
48774799|NCT01059435|102236686|FG004|STARTED|Overall Study||6||
48774800|NCT01059435|102236687|FG005|STARTED|Overall Study||9||
48774801|NCT01059435|102236688|FG006|STARTED|Overall Study||6||
48774802|NCT01059435|102236689|FG007|STARTED|Overall Study||4||
48774803|NCT01059435|102236690|FG008|STARTED|Overall Study||6||
48774804|NCT01059435|102236691|FG009|STARTED|Overall Study||6||
48774805|NCT01059435|102236682|FG000|Received Study Drug|Overall Study||14||
48774806|NCT01059435|102236683|FG001|Received Study Drug|Overall Study||6||
48774807|NCT01059435|102236684|FG002|Received Study Drug|Overall Study||6||
48774808|NCT01059435|102236685|FG003|Received Study Drug|Overall Study||9||
48774809|NCT01059435|102236686|FG004|Received Study Drug|Overall Study||6||
48774810|NCT01059435|102236687|FG005|Received Study Drug|Overall Study||9||
48774811|NCT01059435|102236688|FG006|Received Study Drug|Overall Study||6||
48774812|NCT01059435|102236689|FG007|Received Study Drug|Overall Study||4||
48774813|NCT01059435|102236690|FG008|Received Study Drug|Overall Study||6||
48774814|NCT01059435|102236691|FG009|Received Study Drug|Overall Study||6||
48774815|NCT01059435|102236682|FG000|COMPLETED|Overall Study||14||
48774816|NCT01059435|102236683|FG001|COMPLETED|Overall Study||6||
48774817|NCT01059435|102236684|FG002|COMPLETED|Overall Study||6||
48774818|NCT01059435|102236685|FG003|COMPLETED|Overall Study||9||
48774819|NCT01059435|102236686|FG004|COMPLETED|Overall Study||6||
48774820|NCT01059435|102236687|FG005|COMPLETED|Overall Study||9||
48774821|NCT01059435|102236688|FG006|COMPLETED|Overall Study||6||
48774822|NCT01059435|102236689|FG007|COMPLETED|Overall Study||4||
48774823|NCT01059435|102236690|FG008|COMPLETED|Overall Study||6||
48774824|NCT01059435|102236691|FG009|COMPLETED|Overall Study||6||
48774825|NCT01059435|102236682|FG000|NOT COMPLETED|Overall Study||0||
48774826|NCT01059435|102236683|FG001|NOT COMPLETED|Overall Study||0||
48774827|NCT01059435|102236684|FG002|NOT COMPLETED|Overall Study||2||
48774828|NCT01059435|102236685|FG003|NOT COMPLETED|Overall Study||0||
48774829|NCT01059435|102236686|FG004|NOT COMPLETED|Overall Study||0||
48774830|NCT01059435|102236687|FG005|NOT COMPLETED|Overall Study||0||
48774831|NCT01059435|102236688|FG006|NOT COMPLETED|Overall Study||0||
48774832|NCT01059435|102236689|FG007|NOT COMPLETED|Overall Study||0||
48774833|NCT01059435|102236690|FG008|NOT COMPLETED|Overall Study||0||
48774834|NCT01059435|102236691|FG009|NOT COMPLETED|Overall Study||0||
48774835|NCT02561832|102236692|FG000|STARTED|Overall Study||8||
48774836|NCT02561832|102236693|FG001|STARTED|Overall Study||7||
48774837|NCT02561832|102236692|FG000|INFORMED CONSENT OBTAINED|Overall Study||8||
48774838|NCT02561832|102236693|FG001|INFORMED CONSENT OBTAINED|Overall Study||7||
48774839|NCT02561832|102236692|FG000|COMPLETED|Overall Study||1|Subjects were still receiving study treatment when the study was terminated early by the Sponsor.|
48774840|NCT02561832|102236693|FG001|COMPLETED|Overall Study||3|Subjects were still receiving study treatment when the study was terminated early by the Sponsor.|
48774841|NCT02561832|102236692|FG000|NOT COMPLETED|Overall Study||7||
48774842|NCT02561832|102236693|FG001|NOT COMPLETED|Overall Study||4||
48774843|NCT01936870|102236694|FG000|STARTED|Overall Study||2492||
48774844|NCT01936870|102236694|FG000|COMPLETED|Overall Study||2303||
48774845|NCT01936870|102236694|FG000|NOT COMPLETED|Overall Study||189||
48774846|NCT01310075|102236695|FG000|STARTED|Overall Study||45||
48774847|NCT01310075|102236696|FG001|STARTED|Overall Study||45||
48774848|NCT01310075|102236695|FG000|COMPLETED|Overall Study||31||
48774849|NCT01310075|102236696|FG001|COMPLETED|Overall Study||35||
48774850|NCT01310075|102236695|FG000|NOT COMPLETED|Overall Study||14||
48774851|NCT01310075|102236696|FG001|NOT COMPLETED|Overall Study||10||
48774852|NCT00686686|102236697|FG000|STARTED|Overall Study||23||
48774853|NCT00686686|102236697|FG000|COMPLETED|Overall Study||17||
48774854|NCT00686686|102236697|FG000|NOT COMPLETED|Overall Study||6||
48774855|NCT01247272|102236698|FG000|STARTED|First Intervention||13||
48774856|NCT01247272|102236699|FG001|STARTED|First Intervention||13||
48774857|NCT01247272|102236698|FG000|COMPLETED|First Intervention||13||
48774858|NCT01247272|102236699|FG001|COMPLETED|First Intervention||13||
48774859|NCT01247272|102236698|FG000|NOT COMPLETED|First Intervention||0||
48774860|NCT01247272|102236699|FG001|NOT COMPLETED|First Intervention||0||
48774861|NCT01247272|102236698|FG000|STARTED|Washout of 28 Days||13||
48774862|NCT01247272|102236699|FG001|STARTED|Washout of 28 Days||13||
48774863|NCT01247272|102236698|FG000|COMPLETED|Washout of 28 Days||13||
48774864|NCT01247272|102236699|FG001|COMPLETED|Washout of 28 Days||13||
48774865|NCT01247272|102236698|FG000|NOT COMPLETED|Washout of 28 Days||0||
48774866|NCT01247272|102236699|FG001|NOT COMPLETED|Washout of 28 Days||0||
48774867|NCT01247272|102236698|FG000|STARTED|Second Intervention||13||
48774868|NCT01247272|102236699|FG001|STARTED|Second Intervention||13||
48774869|NCT01247272|102236698|FG000|COMPLETED|Second Intervention||13||
48774870|NCT01247272|102236699|FG001|COMPLETED|Second Intervention||13||
48774871|NCT01247272|102236698|FG000|NOT COMPLETED|Second Intervention||0||
48774872|NCT01247272|102236699|FG001|NOT COMPLETED|Second Intervention||0||
48774873|NCT02157883|102236700|FG000|STARTED|Part A: Day 1-5 (AZD9291 Alone)||39||
48774874|NCT02157883|102236700|FG000|COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||38||
48774875|NCT02157883|102236700|FG000|NOT COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||1||
48664104|NCT04548219|101961943|FG000|COMPLETED|Overall Study||10||
48664105|NCT04548219|101961944|FG001|COMPLETED|Overall Study||10||
48664106|NCT04548219|101961945|FG002|COMPLETED|Overall Study||10||
48664107|NCT04548219|101961946|FG003|COMPLETED|Overall Study||10||
48664108|NCT04548219|101961947|FG004|COMPLETED|Overall Study||10||
48664109|NCT04548219|101961948|FG005|COMPLETED|Overall Study||10||
48664110|NCT04548219|101961943|FG000|NOT COMPLETED|Overall Study||0||
48664111|NCT04548219|101961944|FG001|NOT COMPLETED|Overall Study||0||
48664112|NCT04548219|101961945|FG002|NOT COMPLETED|Overall Study||0||
48664113|NCT04548219|101961946|FG003|NOT COMPLETED|Overall Study||0||
48664114|NCT04548219|101961947|FG004|NOT COMPLETED|Overall Study||0||
48664115|NCT04548219|101961948|FG005|NOT COMPLETED|Overall Study||0||
48664116|NCT01435356|101961949|FG000|STARTED|Overall Study||48||
48664117|NCT01435356|101961950|FG001|STARTED|Overall Study||29||
48664118|NCT01435356|101961949|FG000|COMPLETED|Overall Study||16||
48664119|NCT01435356|101961950|FG001|COMPLETED|Overall Study||5||
48664120|NCT01435356|101961949|FG000|NOT COMPLETED|Overall Study||32||
48664121|NCT01435356|101961950|FG001|NOT COMPLETED|Overall Study||24||
48664122|NCT03140969|101961951|FG000|STARTED|Overall Study||6||
48664123|NCT03140969|101961952|FG001|STARTED|Overall Study||5||
48664124|NCT03140969|101961953|FG002|STARTED|Overall Study||0||
48664125|NCT03140969|101961951|FG000|COMPLETED|Overall Study||6||
48664126|NCT03140969|101961952|FG001|COMPLETED|Overall Study||5||
48664127|NCT03140969|101961953|FG002|COMPLETED|Overall Study||0||
48664128|NCT03140969|101961951|FG000|NOT COMPLETED|Overall Study||0||
48664129|NCT03140969|101961952|FG001|NOT COMPLETED|Overall Study||0||
48664130|NCT03140969|101961953|FG002|NOT COMPLETED|Overall Study||0||
48664131|NCT03701074|101961954|FG000|STARTED|Overall Study||1||
48664132|NCT03701074|101961955|FG001|STARTED|Overall Study||0||
48664133|NCT03701074|101961954|FG000|COMPLETED|Overall Study||0||
48664134|NCT03701074|101961955|FG001|COMPLETED|Overall Study||0||
48664135|NCT03701074|101961954|FG000|NOT COMPLETED|Overall Study||1||
48664136|NCT03701074|101961955|FG001|NOT COMPLETED|Overall Study||0||
48664137|NCT01166646|101961956|FG000|STARTED|Overall Study||21||
48664138|NCT01166646|101961957|FG001|STARTED|Overall Study||22||
48664139|NCT01166646|101961956|FG000|COMPLETED|Overall Study||20||
48664140|NCT01166646|101961957|FG001|COMPLETED|Overall Study||21||
48664141|NCT01166646|101961956|FG000|NOT COMPLETED|Overall Study||1||
48664142|NCT01166646|101961957|FG001|NOT COMPLETED|Overall Study||1||
48664143|NCT01275300|101961958|FG000|STARTED|1st Intervention (5 Days)||5||
48664144|NCT01275300|101961959|FG001|STARTED|1st Intervention (5 Days)||4||
48664145|NCT01275300|101961958|FG000|COMPLETED|1st Intervention (5 Days)||5||
48664146|NCT01275300|101961959|FG001|COMPLETED|1st Intervention (5 Days)||4||
48664147|NCT01275300|101961958|FG000|NOT COMPLETED|1st Intervention (5 Days)||0||
48774876|NCT02157883|102236700|FG000|STARTED|Part A: Day 6-18 (AZD9291+Itraconozole)||39||
48774877|NCT02157883|102236700|FG000|COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||38||
48774878|NCT02157883|102236700|FG000|NOT COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||1||
48774879|NCT02157883|102236700|FG000|STARTED|Part B: Day 19 to End Part B (AZD9291)||38||
48774880|NCT02157883|102236700|FG000|COMPLETED|Part B: Day 19 to End Part B (AZD9291)||16||
48774881|NCT02157883|102236700|FG000|NOT COMPLETED|Part B: Day 19 to End Part B (AZD9291)||22||
48774882|NCT00779155|102236701|FG000|STARTED|Overall Study||6||
48774883|NCT00779155|102236702|FG001|STARTED|Overall Study||6||
48774884|NCT00779155|102236701|FG000|COMPLETED|Overall Study||6||
48774885|NCT00779155|102236702|FG001|COMPLETED|Overall Study||6||
48774886|NCT00779155|102236701|FG000|NOT COMPLETED|Overall Study||0||
48774887|NCT00779155|102236702|FG001|NOT COMPLETED|Overall Study||0||
48774888|NCT01253577|102236703|FG000|STARTED|Overall Study||105||
48774889|NCT01253577|102236703|FG000|COMPLETED|Overall Study||102||
48774890|NCT01253577|102236703|FG000|NOT COMPLETED|Overall Study||3||
48774891|NCT01356277|102236704|FG000|STARTED|Run-in||81|Run-in|
48774892|NCT01356277|102236705|FG001|STARTED|Run-in||88|Run-in|
48774893|NCT01356277|102236704|FG000|COMPLETED|Run-in||76|run-in|
48774894|NCT01356277|102236705|FG001|COMPLETED|Run-in||88|run-in|
48774895|NCT01356277|102236704|FG000|NOT COMPLETED|Run-in||5||
48774896|NCT01356277|102236705|FG001|NOT COMPLETED|Run-in||0||
48774897|NCT01356277|102236704|FG000|STARTED|Intervention Interval||76||
48774898|NCT01356277|102236705|FG001|STARTED|Intervention Interval||88||
48774899|NCT01356277|102236704|FG000|COMPLETED|Intervention Interval||66||
48774900|NCT01356277|102236705|FG001|COMPLETED|Intervention Interval||81||
48774901|NCT01356277|102236704|FG000|NOT COMPLETED|Intervention Interval||10||
48774902|NCT01356277|102236705|FG001|NOT COMPLETED|Intervention Interval||7||
48774903|NCT02346721|102236706|FG000|STARTED|Overall Study||111||
48774904|NCT02346721|102236706|FG000|COMPLETED|Overall Study||107||
48664148|NCT01275300|101961959|FG001|NOT COMPLETED|1st Intervention (5 Days)||0||
48664149|NCT01275300|101961958|FG000|STARTED|Washout (14 Days)||5||
48664150|NCT01275300|101961959|FG001|STARTED|Washout (14 Days)||4||
48664151|NCT01275300|101961958|FG000|COMPLETED|Washout (14 Days)||5||
48664152|NCT01275300|101961959|FG001|COMPLETED|Washout (14 Days)||4||
48774905|NCT02346721|102236706|FG000|NOT COMPLETED|Overall Study||4||
48774906|NCT03252925|102236707|FG000|STARTED|Overall Study||80||
48774907|NCT03252925|102236708|FG001|STARTED|Overall Study||80||
48774908|NCT03252925|102236707|FG000|COMPLETED|Overall Study||66||
48774909|NCT03252925|102236708|FG001|COMPLETED|Overall Study||74||
48774910|NCT03252925|102236707|FG000|NOT COMPLETED|Overall Study||14||
48774911|NCT03252925|102236708|FG001|NOT COMPLETED|Overall Study||6||
48774912|NCT01357525|102236709|FG000|STARTED|Overall Study||50||
48774913|NCT01357525|102236709|FG000|COMPLETED|Overall Study||49|Participant underwent surgery but did not receive SBRT.|
48774914|NCT01357525|102236709|FG000|NOT COMPLETED|Overall Study||1||
48774915|NCT00755183|102236710|FG000|STARTED|Overall Study||30||
48774916|NCT00755183|102236711|FG001|STARTED|Overall Study||30||
48774917|NCT00755183|102236710|FG000|COMPLETED|Overall Study||23||
48774918|NCT00755183|102236711|FG001|COMPLETED|Overall Study||24||
48774919|NCT00755183|102236710|FG000|NOT COMPLETED|Overall Study||7||
48774920|NCT00755183|102236711|FG001|NOT COMPLETED|Overall Study||6||
48459228|NCT02873481|101460080|FG001|NOT COMPLETED|Overall Study||0||
48459229|NCT02532010|101460081|FG000|STARTED|Overall Study||9||
48459230|NCT02532010|101460082|FG001|STARTED|Overall Study||4||
48459231|NCT02532010|101460081|FG000|COMPLETED|Overall Study||0||
48459232|NCT02532010|101460082|FG001|COMPLETED|Overall Study||0||
48664153|NCT01275300|101961958|FG000|NOT COMPLETED|Washout (14 Days)||0||
48664154|NCT01275300|101961959|FG001|NOT COMPLETED|Washout (14 Days)||0||
48664155|NCT01275300|101961958|FG000|STARTED|2nd Intervention(5 Days)||5||
48664156|NCT01275300|101961959|FG001|STARTED|2nd Intervention(5 Days)||4||
48664157|NCT01275300|101961958|FG000|COMPLETED|2nd Intervention(5 Days)||5||
48664158|NCT01275300|101961959|FG001|COMPLETED|2nd Intervention(5 Days)||4||
48664159|NCT01275300|101961958|FG000|NOT COMPLETED|2nd Intervention(5 Days)||0||
48664160|NCT01275300|101961959|FG001|NOT COMPLETED|2nd Intervention(5 Days)||0||
48664161|NCT01275300|101961958|FG000|STARTED|Washout (14 Days)||5||
48664162|NCT01275300|101961959|FG001|STARTED|Washout (14 Days)||4||
48664163|NCT01275300|101961958|FG000|COMPLETED|Washout (14 Days)||5||
48774921|NCT00354978|102236712|FG000|STARTED|Overall Study||43||
48774922|NCT00354978|102236712|FG000|COMPLETED|Overall Study||43||
48459233|NCT02532010|101460081|FG000|NOT COMPLETED|Overall Study||9||
48459234|NCT02532010|101460082|FG001|NOT COMPLETED|Overall Study||4||
48459235|NCT01191255|101460083|FG000|STARTED|Safety Assessment Period||149||
48459236|NCT01191255|101460084|FG001|STARTED|Safety Assessment Period||292||
48459237|NCT01191255|101460085|FG002|STARTED|Safety Assessment Period||0||
48459238|NCT01191255|101460086|FG003|STARTED|Safety Assessment Period||0||
48459239|NCT01191255|101460083|FG000|Safety Population|Safety Assessment Period||149||
48459240|NCT01191255|101460084|FG001|Safety Population|Safety Assessment Period||289||
48459241|NCT01191255|101460085|FG002|Safety Population|Safety Assessment Period||0||
48459242|NCT01191255|101460086|FG003|Safety Population|Safety Assessment Period||0||
48459243|NCT01191255|101460083|FG000|COMPLETED|Safety Assessment Period||111||
48459244|NCT01191255|101460084|FG001|COMPLETED|Safety Assessment Period||193||
48459245|NCT01191255|101460085|FG002|COMPLETED|Safety Assessment Period||0||
48459246|NCT01191255|101460086|FG003|COMPLETED|Safety Assessment Period||0||
48459247|NCT01191255|101460083|FG000|NOT COMPLETED|Safety Assessment Period||38||
48459248|NCT01191255|101460084|FG001|NOT COMPLETED|Safety Assessment Period||99||
48459249|NCT01191255|101460085|FG002|NOT COMPLETED|Safety Assessment Period||0||
48459250|NCT01191255|101460086|FG003|NOT COMPLETED|Safety Assessment Period||0||
48459251|NCT01191255|101460083|FG000|STARTED|Efficacy Assessment Period||0||
48459252|NCT01191255|101460084|FG001|STARTED|Efficacy Assessment Period||0||
48459253|NCT01191255|101460085|FG002|STARTED|Efficacy Assessment Period||96||
48459254|NCT01191255|101460086|FG003|STARTED|Efficacy Assessment Period||96||
48459255|NCT01191255|101460083|FG000|COMPLETED|Efficacy Assessment Period||0||
48459256|NCT01191255|101460084|FG001|COMPLETED|Efficacy Assessment Period||0||
48459257|NCT01191255|101460085|FG002|COMPLETED|Efficacy Assessment Period||70||
48459258|NCT01191255|101460086|FG003|COMPLETED|Efficacy Assessment Period||90||
48459259|NCT01191255|101460083|FG000|NOT COMPLETED|Efficacy Assessment Period||0||
48459260|NCT01191255|101460084|FG001|NOT COMPLETED|Efficacy Assessment Period||0||
48459261|NCT01191255|101460085|FG002|NOT COMPLETED|Efficacy Assessment Period||26||
48459262|NCT01191255|101460086|FG003|NOT COMPLETED|Efficacy Assessment Period||6||
48664164|NCT01275300|101961959|FG001|COMPLETED|Washout (14 Days)||4||
48774923|NCT00354978|102236712|FG000|NOT COMPLETED|Overall Study||0||
48774924|NCT02736578|102236713|FG000|STARTED|Overall Study||6||
48774925|NCT02736578|102236714|FG001|STARTED|Overall Study||2||
48774926|NCT02736578|102236713|FG000|COMPLETED|Overall Study||5||
48774927|NCT02736578|102236714|FG001|COMPLETED|Overall Study||2||
48774928|NCT02736578|102236713|FG000|NOT COMPLETED|Overall Study||1||
48774929|NCT02736578|102236714|FG001|NOT COMPLETED|Overall Study||0||
48774930|NCT03636893|102236715|FG000|STARTED|Overall Study||40||
48774931|NCT03636893|102236716|FG001|STARTED|Overall Study||34||
48774932|NCT03636893|102236715|FG000|COMPLETED|Overall Study||31||
48774933|NCT03636893|102236716|FG001|COMPLETED|Overall Study||24||
48774934|NCT03636893|102236715|FG000|NOT COMPLETED|Overall Study||9||
48774935|NCT03636893|102236716|FG001|NOT COMPLETED|Overall Study||10||
48774936|NCT02708186|102236717|FG000|STARTED|Overall Study||16||
48774937|NCT02708186|102236718|FG001|STARTED|Overall Study||18||
48774938|NCT02708186|102236717|FG000|COMPLETED|Overall Study||14||
48774939|NCT02708186|102236718|FG001|COMPLETED|Overall Study||16||
48774940|NCT02708186|102236717|FG000|NOT COMPLETED|Overall Study||2||
48459263|NCT02742181|101460087|FG000|STARTED|Overall Study||6||
48459264|NCT02742181|101460088|FG001|STARTED|Overall Study||8||
48459265|NCT02742181|101460087|FG000|COMPLETED|Overall Study||5||
48459266|NCT02742181|101460088|FG001|COMPLETED|Overall Study||8||
48459267|NCT02742181|101460087|FG000|NOT COMPLETED|Overall Study||1||
48459268|NCT02742181|101460088|FG001|NOT COMPLETED|Overall Study||0||
48459269|NCT02449291|101460089|FG000|STARTED|Overall Study||191||
48459270|NCT02449291|101460090|FG001|STARTED|Overall Study||188||
48459271|NCT02449291|101460091|FG002|STARTED|Overall Study||181||
48664165|NCT01275300|101961958|FG000|NOT COMPLETED|Washout (14 Days)||0||
48664166|NCT01275300|101961959|FG001|NOT COMPLETED|Washout (14 Days)||0||
48664167|NCT01275300|101961958|FG000|STARTED|Phase 2: Open-label 6days)||5||
48664168|NCT01275300|101961959|FG001|STARTED|Phase 2: Open-label 6days)||4||
48664169|NCT01275300|101961958|FG000|COMPLETED|Phase 2: Open-label 6days)||5||
48664170|NCT01275300|101961959|FG001|COMPLETED|Phase 2: Open-label 6days)||4||
48664171|NCT01275300|101961958|FG000|NOT COMPLETED|Phase 2: Open-label 6days)||0||
48774941|NCT02708186|102236718|FG001|NOT COMPLETED|Overall Study||2||
48774942|NCT01918306|102236719|FG000|STARTED|Overall Study||6|11 total patients. 2 pts received Cisplatin alone. 9 pts started Cisplatin and GDC-0941.|
48774943|NCT01918306|102236720|FG001|STARTED|Overall Study||0|11 total patients. 2 pts received Cisplatin alone. 9 pts started Cisplatin and GDC-0941.|
48459272|NCT02449291|101460089|FG000|COMPLETED|Overall Study||186||
48664172|NCT01275300|101961959|FG001|NOT COMPLETED|Phase 2: Open-label 6days)||0||
48664173|NCT02185768|101961960|FG000|STARTED|Overall Study||46||
48664174|NCT02185768|101961960|FG000|COMPLETED|Overall Study||44||
48664175|NCT02185768|101961960|FG000|NOT COMPLETED|Overall Study||2||
48664176|NCT01879826|101961961|FG000|STARTED|Overall Study||41||
48664177|NCT01879826|101961962|FG001|STARTED|Overall Study||40||
48664178|NCT01879826|101961961|FG000|COMPLETED|Overall Study||41||
48664179|NCT01879826|101961962|FG001|COMPLETED|Overall Study||40||
48664180|NCT01879826|101961961|FG000|NOT COMPLETED|Overall Study||0||
48664181|NCT01879826|101961962|FG001|NOT COMPLETED|Overall Study||0||
48664182|NCT03757715|101961963|FG000|STARTED|Overall Study||21||
48664183|NCT03757715|101961964|FG001|STARTED|Overall Study||25||
48664184|NCT03757715|101961963|FG000|COMPLETED|Overall Study||16||
48664185|NCT03757715|101961964|FG001|COMPLETED|Overall Study||15||
48664186|NCT03757715|101961963|FG000|NOT COMPLETED|Overall Study||5||
48664187|NCT03757715|101961964|FG001|NOT COMPLETED|Overall Study||10||
48664188|NCT04893811|101961965|FG000|STARTED|Vaccination Phase||53||
48664189|NCT04893811|101961966|FG001|STARTED|Vaccination Phase||51||
48664190|NCT04893811|101961965|FG000|Vaccination 1|Vaccination Phase||53||
48664191|NCT04893811|101961966|FG001|Vaccination 1|Vaccination Phase||51||
48664192|NCT04893811|101961965|FG000|Vaccination 2|Vaccination Phase||47||
48664193|NCT04893811|101961966|FG001|Vaccination 2|Vaccination Phase||47||
48774944|NCT01918306|102236721|FG002|STARTED|Overall Study||2|11 total patients. 2 pts received Cisplatin alone. 9 pts started Cisplatin and GDC-0941.|
48774945|NCT01918306|102236722|FG003|STARTED|Overall Study||3|11 total patients. 2 pts received Cisplatin alone. 9 pts started Cisplatin and GDC-0941.|
48774946|NCT01918306|102236719|FG000|COMPLETED|Overall Study||0||
48774947|NCT01918306|102236720|FG001|COMPLETED|Overall Study||0||
48774948|NCT01918306|102236721|FG002|COMPLETED|Overall Study||0||
48774949|NCT01918306|102236722|FG003|COMPLETED|Overall Study||0||
48774950|NCT01918306|102236719|FG000|NOT COMPLETED|Overall Study||6||
48774951|NCT01918306|102236720|FG001|NOT COMPLETED|Overall Study||0||
48459273|NCT02449291|101460090|FG001|COMPLETED|Overall Study||186||
48459274|NCT02449291|101460091|FG002|COMPLETED|Overall Study||180||
48459275|NCT02449291|101460089|FG000|NOT COMPLETED|Overall Study||5||
48459276|NCT02449291|101460090|FG001|NOT COMPLETED|Overall Study||2||
48459277|NCT02449291|101460091|FG002|NOT COMPLETED|Overall Study||1||
48459278|NCT01789281|101460092|FG000|STARTED|Overall Study||22||
48459279|NCT01789281|101460093|FG001|STARTED|Overall Study||12||
48459280|NCT01789281|101460092|FG000|COMPLETED|Overall Study||0||
48459281|NCT01789281|101460093|FG001|COMPLETED|Overall Study||2||
48459282|NCT01789281|101460092|FG000|NOT COMPLETED|Overall Study||22||
48459283|NCT01789281|101460093|FG001|NOT COMPLETED|Overall Study||10||
48664194|NCT04893811|101961965|FG000|COMPLETED|Vaccination Phase||47||
48664195|NCT04893811|101961966|FG001|COMPLETED|Vaccination Phase||47||
48664196|NCT04893811|101961965|FG000|NOT COMPLETED|Vaccination Phase||6||
48664197|NCT04893811|101961966|FG001|NOT COMPLETED|Vaccination Phase||4||
48664198|NCT04893811|101961965|FG000|STARTED|Follow-up Phase||47||
48774952|NCT01918306|102236721|FG002|NOT COMPLETED|Overall Study||2||
48774953|NCT01918306|102236722|FG003|NOT COMPLETED|Overall Study||3||
48774954|NCT01626872|102240040|FG000|STARTED|Overall Study||81||
48774955|NCT01626872|102240041|FG001|STARTED|Overall Study||109||
48774956|NCT01626872|102240042|FG002|STARTED|Overall Study||58||
48774957|NCT01626872|102240040|FG000|COMPLETED|Overall Study||29||
48774958|NCT01626872|102240041|FG001|COMPLETED|Overall Study||43||
48774959|NCT01626872|102240042|FG002|COMPLETED|Overall Study||34||
48369765|NCT01993329|101232834|FG001|COMPLETED|Period 3||3||
48459284|NCT02109133|101460094|FG000|STARTED|Overall Study||33||
48459285|NCT02109133|101460095|FG001|STARTED|Overall Study||34||
48459286|NCT02109133|101460094|FG000|COMPLETED|Overall Study||32||
48459287|NCT02109133|101460095|FG001|COMPLETED|Overall Study||34||
48459288|NCT02109133|101460094|FG000|NOT COMPLETED|Overall Study||1||
48459289|NCT02109133|101460095|FG001|NOT COMPLETED|Overall Study||0||
48459290|NCT03043274|101460096|FG000|STARTED|Overall Study||13||
48459291|NCT03043274|101460097|FG001|STARTED|Overall Study||10||
48459292|NCT03043274|101460096|FG000|COMPLETED|Overall Study||13||
48459293|NCT03043274|101460097|FG001|COMPLETED|Overall Study||9||
48459294|NCT03043274|101460096|FG000|NOT COMPLETED|Overall Study||0||
48459295|NCT03043274|101460097|FG001|NOT COMPLETED|Overall Study||1||
48459296|NCT02614703|101460098|FG000|STARTED|Overall Study||31||
48459297|NCT02614703|101460099|FG001|STARTED|Overall Study||29||
48459298|NCT02614703|101460098|FG000|COMPLETED|Overall Study||24||
48459299|NCT02614703|101460099|FG001|COMPLETED|Overall Study||28||
48459300|NCT02614703|101460098|FG000|NOT COMPLETED|Overall Study||7||
48459301|NCT02614703|101460099|FG001|NOT COMPLETED|Overall Study||1||
48459302|NCT00947856|101460100|FG000|STARTED|Treatment Period||78||
48459303|NCT00947856|101460101|FG001|STARTED|Treatment Period||32||
48459304|NCT00947856|101460100|FG000|COMPLETED|Treatment Period||0||
48459305|NCT00947856|101460101|FG001|COMPLETED|Treatment Period||0||
48459306|NCT00947856|101460100|FG000|NOT COMPLETED|Treatment Period||78||
48459307|NCT00947856|101460101|FG001|NOT COMPLETED|Treatment Period||32||
48459308|NCT00947856|101460100|FG000|STARTED|Follow-up Period||78||
48664199|NCT04893811|101961966|FG001|STARTED|Follow-up Phase||47||
48664200|NCT04893811|101961965|FG000|Follow-up Safety Set|Follow-up Phase||44|B1971060: Follow-up safety set included all participants who received at least 1 dose of study intervention and for whom safety information was available from after Visit 4 up to and including Visit 5. B1971057: Historical data of the age- and sex-matched healthy participants (selected randomly) as reference for current study.|
48664201|NCT04893811|101961966|FG001|Follow-up Safety Set|Follow-up Phase||48|B1971060: Follow-up safety set included all participants who received at least 1 dose of study intervention and for whom safety information was available from after Visit 4 up to and including Visit 5. B1971057: Historical data of the age- and sex-matched healthy participants (selected randomly) as reference for current study.|
48664202|NCT04893811|101961965|FG000|COMPLETED|Follow-up Phase||47||
48664203|NCT04893811|101961966|FG001|COMPLETED|Follow-up Phase||46||
48664204|NCT04893811|101961965|FG000|NOT COMPLETED|Follow-up Phase||0||
48664205|NCT04893811|101961966|FG001|NOT COMPLETED|Follow-up Phase||1||
48664206|NCT03312114|101961967|FG000|STARTED|Overall Study||5||
48664207|NCT03312114|101961967|FG000|COMPLETED|Overall Study||0||
48664208|NCT03312114|101961967|FG000|NOT COMPLETED|Overall Study||5||
48664209|NCT02918942|101961968|FG000|STARTED|Overall Study||25||
48774960|NCT01626872|102240040|FG000|NOT COMPLETED|Overall Study||52||
48774961|NCT01626872|102240041|FG001|NOT COMPLETED|Overall Study||66||
48774962|NCT01626872|102240042|FG002|NOT COMPLETED|Overall Study||24||
48774963|NCT01605799|102240043|FG000|STARTED|Overall Study||17||
48774964|NCT01605799|102240044|FG001|STARTED|Overall Study||16||
48774965|NCT01605799|102240043|FG000|COMPLETED|Overall Study||15||
48369766|NCT01993329|101232835|FG002|COMPLETED|Period 3||3||
48369767|NCT01993329|101232836|FG003|COMPLETED|Period 3||3||
48369768|NCT01993329|101232837|FG004|COMPLETED|Period 3||3||
48369769|NCT01993329|101232838|FG005|COMPLETED|Period 3||3||
48369770|NCT01993329|101232833|FG000|NOT COMPLETED|Period 3||0||
48369771|NCT01993329|101232834|FG001|NOT COMPLETED|Period 3||0||
48369772|NCT01993329|101232835|FG002|NOT COMPLETED|Period 3||0||
48369773|NCT01993329|101232836|FG003|NOT COMPLETED|Period 3||0||
48369774|NCT01993329|101232837|FG004|NOT COMPLETED|Period 3||0||
48369775|NCT01993329|101232838|FG005|NOT COMPLETED|Period 3||0||
48369776|NCT02371759|101232839|FG000|STARTED|Overall Study||32||
48369777|NCT02371759|101232840|FG001|STARTED|Overall Study||31||
48369778|NCT02371759|101232841|FG002|STARTED|Overall Study||33||
48369779|NCT02371759|101232842|FG003|STARTED|Overall Study||31||
48369780|NCT02371759|101232843|FG004|STARTED|Overall Study||27||
48369781|NCT02371759|101232844|FG005|STARTED|Overall Study||26||
48369782|NCT02371759|101232845|FG006|STARTED|Overall Study||25||
48369783|NCT02371759|101232846|FG007|STARTED|Overall Study||28||
48369784|NCT02371759|101232839|FG000|COMPLETED|Overall Study||29||
48369785|NCT02371759|101232840|FG001|COMPLETED|Overall Study||30||
48369786|NCT02371759|101232841|FG002|COMPLETED|Overall Study||32||
48459309|NCT00947856|101460101|FG001|STARTED|Follow-up Period||32||
48459310|NCT00947856|101460100|FG000|COMPLETED|Follow-up Period||27||
48369787|NCT02371759|101232842|FG003|COMPLETED|Overall Study||31||
48369788|NCT02371759|101232843|FG004|COMPLETED|Overall Study||24||
48459311|NCT00947856|101460101|FG001|COMPLETED|Follow-up Period||9||
48459312|NCT00947856|101460100|FG000|NOT COMPLETED|Follow-up Period||51||
48459313|NCT00947856|101460101|FG001|NOT COMPLETED|Follow-up Period||23||
48774966|NCT01605799|102240044|FG001|COMPLETED|Overall Study||15||
48774967|NCT01605799|102240043|FG000|NOT COMPLETED|Overall Study||2||
48774968|NCT01605799|102240044|FG001|NOT COMPLETED|Overall Study||1||
48459314|NCT02826603|101460102|FG000|STARTED|Overall Study||550||
48459315|NCT02826603|101460103|FG001|STARTED|Overall Study||552||
48459316|NCT02826603|101460102|FG000|COMPLETED|Overall Study||489||
48774969|NCT00420771|102240045|FG000|STARTED|Overall Study||8||
48774970|NCT00420771|102240046|FG001|STARTED|Overall Study||11||
48774971|NCT00420771|102240045|FG000|COMPLETED|Overall Study||5||
48774972|NCT00420771|102240046|FG001|COMPLETED|Overall Study||7||
48774973|NCT00420771|102240045|FG000|NOT COMPLETED|Overall Study||3||
48774974|NCT00420771|102240046|FG001|NOT COMPLETED|Overall Study||4||
48459317|NCT02826603|101460103|FG001|COMPLETED|Overall Study||488||
48459318|NCT02826603|101460102|FG000|NOT COMPLETED|Overall Study||61||
48459319|NCT02826603|101460103|FG001|NOT COMPLETED|Overall Study||64||
48459320|NCT03421652|101460104|FG000|STARTED|Overall Study||20||
48459321|NCT03421652|101460104|FG000|COMPLETED|Overall Study||20||
48459322|NCT03421652|101460104|FG000|NOT COMPLETED|Overall Study||0||
48459323|NCT00669955|101460105|FG000|STARTED|Overall Study||218||
48459324|NCT00669955|101460106|FG001|STARTED|Overall Study||222||
48459325|NCT00669955|101460105|FG000|COMPLETED|Overall Study||204||
48459326|NCT00669955|101460106|FG001|COMPLETED|Overall Study||195||
48459327|NCT00669955|101460105|FG000|NOT COMPLETED|Overall Study||14||
48664210|NCT02918942|101961968|FG000|COMPLETED|Overall Study||25||
48664211|NCT02918942|101961968|FG000|NOT COMPLETED|Overall Study||0||
48664212|NCT00330733|101961969|FG000|STARTED|Overall Study||37||
48664213|NCT00330733|101961970|FG001|STARTED|Overall Study||34||
48664214|NCT00330733|101961969|FG000|Received Study Medication|Overall Study||36||
48664215|NCT00330733|101961970|FG001|Received Study Medication|Overall Study||34||
48664216|NCT00330733|101961969|FG000|COMPLETED|Overall Study||30||
48664217|NCT00330733|101961970|FG001|COMPLETED|Overall Study||29||
48664218|NCT00330733|101961969|FG000|NOT COMPLETED|Overall Study||7||
48664219|NCT00330733|101961970|FG001|NOT COMPLETED|Overall Study||5||
48774975|NCT03241368|102240047|FG000|STARTED|Overall Study||158||
48774976|NCT03241368|102240047|FG000|COMPLETED|Overall Study||119||
48774977|NCT03241368|102240047|FG000|NOT COMPLETED|Overall Study||39||
48774978|NCT00857714|102240048|FG000|STARTED|Overall Study||1||
48774979|NCT00857714|102240048|FG000|COMPLETED|Overall Study||1||
48774980|NCT00857714|102240048|FG000|NOT COMPLETED|Overall Study||0||
48774981|NCT00659737|102240049|FG000|STARTED|Overall Study||57||
48774982|NCT00659737|102240050|FG001|STARTED|Overall Study||58||
48774983|NCT00659737|102240049|FG000|COMPLETED|Overall Study||57||
48664220|NCT03435107|101961971|FG000|STARTED|Overall Study||33||
48664221|NCT03435107|101961971|FG000|COMPLETED|Overall Study||32||
48774984|NCT00659737|102240050|FG001|COMPLETED|Overall Study||58||
48774985|NCT00659737|102240049|FG000|NOT COMPLETED|Overall Study||0||
48774986|NCT00659737|102240050|FG001|NOT COMPLETED|Overall Study||0||
48774987|NCT01528969|102240051|FG000|STARTED|Overall Study||37||
48774988|NCT01528969|102240052|FG001|STARTED|Overall Study||38||
48774989|NCT01528969|102240051|FG000|COMPLETED|Overall Study||35||
48774990|NCT01528969|102240052|FG001|COMPLETED|Overall Study||38||
48459328|NCT00669955|101460106|FG001|NOT COMPLETED|Overall Study||27||
48459329|NCT02100956|101460107|FG000|STARTED|First Injection||3||
48459330|NCT02100956|101460108|FG001|STARTED|First Injection||3||
48459331|NCT02100956|101460107|FG000|COMPLETED|First Injection||3||
48459332|NCT02100956|101460108|FG001|COMPLETED|First Injection||3||
48459333|NCT02100956|101460107|FG000|NOT COMPLETED|First Injection||0||
48459334|NCT02100956|101460108|FG001|NOT COMPLETED|First Injection||0||
48459335|NCT02100956|101460107|FG000|STARTED|At Least One Week Between Injections||3||
48459336|NCT02100956|101460108|FG001|STARTED|At Least One Week Between Injections||3||
48459337|NCT02100956|101460107|FG000|COMPLETED|At Least One Week Between Injections||3||
48664222|NCT03435107|101961971|FG000|NOT COMPLETED|Overall Study||1||
48664223|NCT05395338|101961972|FG000|STARTED|Overall Study||8014||
48664224|NCT05395338|101961973|FG001|STARTED|Overall Study||4537||
48664225|NCT05395338|101961972|FG000|Propensity Score Matched Patients|Overall Study||3247||
48664226|NCT05395338|101961973|FG001|Propensity Score Matched Patients|Overall Study||3247||
48664227|NCT05395338|101961972|FG000|COMPLETED|Overall Study||8014||
48664228|NCT05395338|101961973|FG001|COMPLETED|Overall Study||4537||
48664229|NCT05395338|101961972|FG000|NOT COMPLETED|Overall Study||0||
48664230|NCT05395338|101961973|FG001|NOT COMPLETED|Overall Study||0||
48774991|NCT01528969|102240051|FG000|NOT COMPLETED|Overall Study||2||
48774992|NCT01528969|102240052|FG001|NOT COMPLETED|Overall Study||0||
48774993|NCT01276054|102240053|FG000|STARTED|Overall Study||2||
48774994|NCT01276054|102240054|FG001|STARTED|Overall Study||2||
48189675|NCT00550732|100786275|FG000|COMPLETED|Overall Study||29||
48459338|NCT02100956|101460108|FG001|COMPLETED|At Least One Week Between Injections||2||
48774995|NCT01276054|102240053|FG000|COMPLETED|Overall Study||0||
48459339|NCT02100956|101460107|FG000|NOT COMPLETED|At Least One Week Between Injections||0||
48459340|NCT02100956|101460108|FG001|NOT COMPLETED|At Least One Week Between Injections||1||
48459341|NCT02100956|101460107|FG000|STARTED|Second Injection||3||
48459342|NCT02100956|101460108|FG001|STARTED|Second Injection||2||
48459343|NCT02100956|101460107|FG000|COMPLETED|Second Injection||3||
48459344|NCT02100956|101460108|FG001|COMPLETED|Second Injection||2||
48459345|NCT02100956|101460107|FG000|NOT COMPLETED|Second Injection||0||
48459346|NCT02100956|101460108|FG001|NOT COMPLETED|Second Injection||0||
48459347|NCT02917447|101460109|FG000|STARTED|Overall Study||51||
48459348|NCT02917447|101460110|FG001|STARTED|Overall Study||51||
48459349|NCT02917447|101460109|FG000|COMPLETED|Overall Study||44||
48459350|NCT02917447|101460110|FG001|COMPLETED|Overall Study||48||
48774996|NCT01276054|102240054|FG001|COMPLETED|Overall Study||0||
48459351|NCT02917447|101460109|FG000|NOT COMPLETED|Overall Study||7||
48459352|NCT02917447|101460110|FG001|NOT COMPLETED|Overall Study||3||
48459353|NCT03263195|101460111|FG000|STARTED|Overall Study||174||
48459354|NCT03263195|101460112|FG001|STARTED|Overall Study||0||
48459355|NCT03263195|101460113|FG002|STARTED|Overall Study||0||
48459356|NCT03263195|101460114|FG003|STARTED|Overall Study||26||
48459357|NCT03263195|101460115|FG004|STARTED|Overall Study||170||
48459358|NCT03263195|101460116|FG005|STARTED|Overall Study||0||
48459359|NCT03263195|101460117|FG006|STARTED|Overall Study||0||
48459360|NCT03263195|101460118|FG007|STARTED|Overall Study||25||
48459361|NCT03263195|101460111|FG000|COMPLETED|Overall Study||168||
48459362|NCT03263195|101460112|FG001|COMPLETED|Overall Study||0||
48459363|NCT03263195|101460113|FG002|COMPLETED|Overall Study||0||
48459364|NCT03263195|101460114|FG003|COMPLETED|Overall Study||23||
48459365|NCT03263195|101460115|FG004|COMPLETED|Overall Study||155||
48459366|NCT03263195|101460116|FG005|COMPLETED|Overall Study||0||
48459367|NCT03263195|101460117|FG006|COMPLETED|Overall Study||0||
48459368|NCT03263195|101460118|FG007|COMPLETED|Overall Study||19||
48459369|NCT03263195|101460111|FG000|NOT COMPLETED|Overall Study||6||
48459370|NCT03263195|101460112|FG001|NOT COMPLETED|Overall Study||0||
48459371|NCT03263195|101460113|FG002|NOT COMPLETED|Overall Study||0||
48459372|NCT03263195|101460114|FG003|NOT COMPLETED|Overall Study||3||
48459373|NCT03263195|101460115|FG004|NOT COMPLETED|Overall Study||15||
48459374|NCT03263195|101460116|FG005|NOT COMPLETED|Overall Study||0||
48459375|NCT03263195|101460117|FG006|NOT COMPLETED|Overall Study||0||
48459376|NCT03263195|101460118|FG007|NOT COMPLETED|Overall Study||6||
48459377|NCT03979677|101460119|FG000|STARTED|Overall Study||41||
48459378|NCT03979677|101460119|FG000|COMPLETED|Overall Study||28||
48459379|NCT03979677|101460119|FG000|NOT COMPLETED|Overall Study||13||
48459380|NCT03182920|101460120|FG000|STARTED|Period 1||9||
48459381|NCT03182920|101460121|FG001|STARTED|Period 1||9||
48459382|NCT03182920|101460122|FG002|STARTED|Period 1||17||
48459383|NCT03182920|101460120|FG000|COMPLETED|Period 1||9||
48459384|NCT03182920|101460121|FG001|COMPLETED|Period 1||9||
48459385|NCT03182920|101460122|FG002|COMPLETED|Period 1||17||
48459386|NCT03182920|101460120|FG000|NOT COMPLETED|Period 1||0||
48459387|NCT03182920|101460121|FG001|NOT COMPLETED|Period 1||0||
48459388|NCT03182920|101460122|FG002|NOT COMPLETED|Period 1||0||
48459389|NCT03182920|101460120|FG000|STARTED|Washout Period||9||
48459390|NCT03182920|101460121|FG001|STARTED|Washout Period||9||
48459391|NCT03182920|101460122|FG002|STARTED|Washout Period||0||
48459392|NCT03182920|101460120|FG000|COMPLETED|Washout Period||9||
48459393|NCT03182920|101460121|FG001|COMPLETED|Washout Period||9||
48459394|NCT03182920|101460122|FG002|COMPLETED|Washout Period||0||
48459395|NCT03182920|101460120|FG000|NOT COMPLETED|Washout Period||0||
48459396|NCT03182920|101460121|FG001|NOT COMPLETED|Washout Period||0||
48459397|NCT03182920|101460122|FG002|NOT COMPLETED|Washout Period||0||
48459398|NCT03182920|101460120|FG000|STARTED|Period 2||9||
48774997|NCT01276054|102240053|FG000|NOT COMPLETED|Overall Study||2||
48774998|NCT01276054|102240054|FG001|NOT COMPLETED|Overall Study||2||
48774999|NCT00993148|102240055|FG000|STARTED|Overall Study||25||
48775000|NCT00993148|102240055|FG000|COMPLETED|Overall Study||22||
48459399|NCT03182920|101460121|FG001|STARTED|Period 2||9||
48459400|NCT03182920|101460122|FG002|STARTED|Period 2||0||
48459401|NCT03182920|101460120|FG000|COMPLETED|Period 2||9||
48459402|NCT03182920|101460121|FG001|COMPLETED|Period 2||9||
48459403|NCT03182920|101460122|FG002|COMPLETED|Period 2||0||
48459404|NCT03182920|101460120|FG000|NOT COMPLETED|Period 2||0||
48459405|NCT03182920|101460121|FG001|NOT COMPLETED|Period 2||0||
48459406|NCT03182920|101460122|FG002|NOT COMPLETED|Period 2||0||
48459407|NCT02099266|101460123|FG000|STARTED|Overall Study||15||
48459408|NCT02099266|101460123|FG000|COMPLETED|Overall Study||15||
48459409|NCT02099266|101460123|FG000|NOT COMPLETED|Overall Study||0||
48775001|NCT00993148|102240055|FG000|NOT COMPLETED|Overall Study||3||
48775002|NCT00523302|102240056|FG000|STARTED|Overall Study||10||
48775003|NCT00523302|102240057|FG001|STARTED|Overall Study||10||
48459410|NCT02965820|101460124|FG000|STARTED|Period 1, First 30 Days||59||
48459411|NCT02965820|101460125|FG001|STARTED|Period 1, First 30 Days||62||
48459412|NCT02965820|101460124|FG000|COMPLETED|Period 1, First 30 Days||59||
48459413|NCT02965820|101460125|FG001|COMPLETED|Period 1, First 30 Days||62||
48459414|NCT02965820|101460124|FG000|NOT COMPLETED|Period 1, First 30 Days||0||
48459415|NCT02965820|101460125|FG001|NOT COMPLETED|Period 1, First 30 Days||0||
48775004|NCT00523302|102240056|FG000|COMPLETED|Overall Study||10||
48459416|NCT02965820|101460124|FG000|STARTED|Period 2, Second 30 Days||58||
48459417|NCT02965820|101460125|FG001|STARTED|Period 2, Second 30 Days||62||
48459418|NCT02965820|101460124|FG000|COMPLETED|Period 2, Second 30 Days||57||
48459419|NCT02965820|101460125|FG001|COMPLETED|Period 2, Second 30 Days||61||
48459420|NCT02965820|101460124|FG000|NOT COMPLETED|Period 2, Second 30 Days||1||
48459421|NCT02965820|101460125|FG001|NOT COMPLETED|Period 2, Second 30 Days||1||
48459422|NCT00415532|101460126|FG000|STARTED|Treatment Period||77||
48459423|NCT00415532|101460127|FG001|STARTED|Treatment Period||157||
48459424|NCT00415532|101460126|FG000|Received Treatment|Treatment Period||75||
48459425|NCT00415532|101460127|FG001|Received Treatment|Treatment Period||154||
48459426|NCT00415532|101460126|FG000|Switched to Romiplostim Group|Treatment Period||2||
48459427|NCT00415532|101460127|FG001|Switched to Romiplostim Group|Treatment Period||0||
48459428|NCT00415532|101460126|FG000|COMPLETED|Treatment Period||60||
48459429|NCT00415532|101460127|FG001|COMPLETED|Treatment Period||142||
48459430|NCT00415532|101460126|FG000|NOT COMPLETED|Treatment Period||17||
48459431|NCT00415532|101460127|FG001|NOT COMPLETED|Treatment Period||15||
48459432|NCT00415532|101460126|FG000|STARTED|Safety Follow Up Period||43||
48459433|NCT00415532|101460127|FG001|STARTED|Safety Follow Up Period||30||
48459434|NCT00415532|101460126|FG000|COMPLETED|Safety Follow Up Period||34||
48459435|NCT00415532|101460127|FG001|COMPLETED|Safety Follow Up Period||18||
48459436|NCT00415532|101460126|FG000|NOT COMPLETED|Safety Follow Up Period||9||
48459437|NCT00415532|101460127|FG001|NOT COMPLETED|Safety Follow Up Period||12||
48459438|NCT00423800|101460128|FG000|STARTED|Overall Study||3||
48459439|NCT00423800|101460129|FG001|STARTED|Overall Study||2||
48459440|NCT00423800|101460128|FG000|COMPLETED|Overall Study||3||
48459441|NCT00423800|101460129|FG001|COMPLETED|Overall Study||1||
48459442|NCT00423800|101460128|FG000|NOT COMPLETED|Overall Study||0||
48775005|NCT00523302|102240057|FG001|COMPLETED|Overall Study||10||
48775006|NCT00523302|102240056|FG000|NOT COMPLETED|Overall Study||0||
48775007|NCT00523302|102240057|FG001|NOT COMPLETED|Overall Study||0||
48775008|NCT04375085|102240058|FG000|STARTED|Overall Study||49||
48775009|NCT04375085|102240058|FG000|COMPLETED|Overall Study||49||
48459443|NCT00423800|101460129|FG001|NOT COMPLETED|Overall Study||1||
48459444|NCT02042911|101460130|FG000|STARTED|Overall Study||10||
48459445|NCT02042911|101460130|FG000|COMPLETED|Overall Study||9||
48459446|NCT02042911|101460130|FG000|NOT COMPLETED|Overall Study||1||
48459447|NCT00306384|101460131|FG000|STARTED|Overall Study||1396||
48459448|NCT00306384|101460132|FG001|STARTED|Overall Study||1399||
48459449|NCT00306384|101460133|FG002|STARTED|Overall Study||528||
48459450|NCT00306384|101460131|FG000|Safety Set|Overall Study||1395||
48459451|NCT00306384|101460132|FG001|Safety Set|Overall Study||1398||
48459452|NCT00306384|101460133|FG002|Safety Set|Overall Study||527||
48664231|NCT04938427|101961974|FG000|STARTED|Overall Study||136||
48664232|NCT04938427|101961975|FG001|STARTED|Overall Study||134||
48664233|NCT04938427|101961974|FG000|COMPLETED|Overall Study||126||
48664234|NCT04938427|101961975|FG001|COMPLETED|Overall Study||114||
48664235|NCT04938427|101961974|FG000|NOT COMPLETED|Overall Study||10||
48664236|NCT04938427|101961975|FG001|NOT COMPLETED|Overall Study||20||
48664237|NCT03034044|101961976|FG000|STARTED|Overall Study||106||
48664238|NCT03034044|101961976|FG000|Received Xyntha|Overall Study||105||
48664239|NCT03034044|101961976|FG000|COMPLETED|Overall Study||105||
48664240|NCT03034044|101961976|FG000|NOT COMPLETED|Overall Study||1||
48664241|NCT00934180|101961977|FG000|STARTED|First Intervention||12||
48664242|NCT00934180|101961978|FG001|STARTED|First Intervention||12||
48775010|NCT04375085|102240058|FG000|NOT COMPLETED|Overall Study||0||
48189676|NCT00550732|100786275|FG000|NOT COMPLETED|Overall Study||11||
48459453|NCT00306384|101460131|FG000|COMPLETED|Overall Study||854||
48459454|NCT00306384|101460132|FG001|COMPLETED|Overall Study||891||
48664243|NCT00934180|101961977|FG000|COMPLETED|First Intervention||12||
48664244|NCT00934180|101961978|FG001|COMPLETED|First Intervention||12||
48775011|NCT01716052|102240059|FG000|STARTED|Overall Study||1||
48775012|NCT01716052|102240060|FG001|STARTED|Overall Study||1||
48775013|NCT01716052|102240059|FG000|COMPLETED|Overall Study||0||
48459455|NCT00306384|101460133|FG002|COMPLETED|Overall Study||251||
48664245|NCT00934180|101961977|FG000|NOT COMPLETED|First Intervention||0||
48664246|NCT00934180|101961978|FG001|NOT COMPLETED|First Intervention||0||
48459456|NCT00306384|101460131|FG000|NOT COMPLETED|Overall Study||542||
48459457|NCT00306384|101460132|FG001|NOT COMPLETED|Overall Study||508||
48664247|NCT00934180|101961977|FG000|STARTED|Second Intervention||12||
48775014|NCT01716052|102240060|FG001|COMPLETED|Overall Study||0||
48459458|NCT00306384|101460133|FG002|NOT COMPLETED|Overall Study||277||
48459459|NCT04378010|101460134|FG000|STARTED|Overall Study||32||
48459460|NCT04378010|101460135|FG001|STARTED|Overall Study||34||
48459461|NCT04378010|101460136|FG002|STARTED|Overall Study||32||
48664248|NCT00934180|101961978|FG001|STARTED|Second Intervention||12||
48775015|NCT01716052|102240059|FG000|NOT COMPLETED|Overall Study||1||
48459462|NCT04378010|101460134|FG000|COMPLETED|Overall Study||0||
48459463|NCT04378010|101460135|FG001|COMPLETED|Overall Study||0||
48459464|NCT04378010|101460136|FG002|COMPLETED|Overall Study||0||
48459465|NCT04378010|101460134|FG000|NOT COMPLETED|Overall Study||32||
48459466|NCT04378010|101460135|FG001|NOT COMPLETED|Overall Study||34||
48459467|NCT04378010|101460136|FG002|NOT COMPLETED|Overall Study||32||
48459468|NCT00539539|101460137|FG000|STARTED|Overall Study||815||
48459469|NCT00539539|101460138|FG001|STARTED|Overall Study||771||
48459470|NCT00539539|101460137|FG000|COMPLETED|Overall Study||815||
48459471|NCT00539539|101460138|FG001|COMPLETED|Overall Study||771||
48459472|NCT00539539|101460137|FG000|NOT COMPLETED|Overall Study||0||
48775016|NCT01716052|102240060|FG001|NOT COMPLETED|Overall Study||1||
48775017|NCT02223858|102240061|FG000|STARTED|Overall Study||180||
48775018|NCT02223858|102240062|FG001|STARTED|Overall Study||180||
48775019|NCT02223858|102240061|FG000|1-month Follow-up|Overall Study||156||
48775020|NCT02223858|102240062|FG001|1-month Follow-up|Overall Study||150||
48775021|NCT02223858|102240061|FG000|3-month Follow-up|Overall Study||155||
48775022|NCT02223858|102240062|FG001|3-month Follow-up|Overall Study||154||
48775023|NCT02223858|102240061|FG000|6-month Follow-up|Overall Study||156||
48459473|NCT00539539|101460138|FG001|NOT COMPLETED|Overall Study||0||
48459474|NCT01199601|101460139|FG000|STARTED|Overall Study||422||
48459475|NCT01199601|101460140|FG001|STARTED|Overall Study||422||
48459476|NCT01199601|101460139|FG000|COMPLETED|Overall Study||353||
48459477|NCT01199601|101460140|FG001|COMPLETED|Overall Study||344||
48459478|NCT01199601|101460139|FG000|NOT COMPLETED|Overall Study||69||
48459479|NCT01199601|101460140|FG001|NOT COMPLETED|Overall Study||78||
48459480|NCT01162499|101460141|FG000|STARTED|Intervention 1 (4 Hours)||3||
48459481|NCT01162499|101460142|FG001|STARTED|Intervention 1 (4 Hours)||4||
48459482|NCT01162499|101460141|FG000|Received Intervention|Intervention 1 (4 Hours)||3||
48459483|NCT01162499|101460142|FG001|Received Intervention|Intervention 1 (4 Hours)||3||
48459484|NCT01162499|101460141|FG000|COMPLETED|Intervention 1 (4 Hours)||3||
48459485|NCT01162499|101460142|FG001|COMPLETED|Intervention 1 (4 Hours)||3||
48459486|NCT01162499|101460141|FG000|NOT COMPLETED|Intervention 1 (4 Hours)||0||
48459487|NCT01162499|101460142|FG001|NOT COMPLETED|Intervention 1 (4 Hours)||1||
48459488|NCT01162499|101460141|FG000|STARTED|Intervention 2 (4 Hours)||3||
48459489|NCT01162499|101460142|FG001|STARTED|Intervention 2 (4 Hours)||3||
48459490|NCT01162499|101460141|FG000|COMPLETED|Intervention 2 (4 Hours)||3||
48459491|NCT01162499|101460142|FG001|COMPLETED|Intervention 2 (4 Hours)||3||
48459492|NCT01162499|101460141|FG000|NOT COMPLETED|Intervention 2 (4 Hours)||0||
48459493|NCT01162499|101460142|FG001|NOT COMPLETED|Intervention 2 (4 Hours)||0||
48459494|NCT02797964|101460143|FG000|STARTED|Overall Study||32||
48459495|NCT02797964|101460144|FG001|STARTED|Overall Study||37||
48459496|NCT02797964|101460145|FG002|STARTED|Overall Study||10||
48459497|NCT02797964|101460146|FG003|STARTED|Overall Study||16||
48459498|NCT02797964|101460147|FG004|STARTED|Overall Study||4||
48459499|NCT02797964|101460148|FG005|STARTED|Overall Study||8||
48459500|NCT02797964|101460143|FG000|COMPLETED|Overall Study||32||
48459501|NCT02797964|101460144|FG001|COMPLETED|Overall Study||37||
48459502|NCT02797964|101460145|FG002|COMPLETED|Overall Study||10||
48459503|NCT02797964|101460146|FG003|COMPLETED|Overall Study||16||
48459504|NCT02797964|101460147|FG004|COMPLETED|Overall Study||4||
48459505|NCT02797964|101460148|FG005|COMPLETED|Overall Study||8||
48459506|NCT02797964|101460143|FG000|NOT COMPLETED|Overall Study||0||
48459507|NCT02797964|101460144|FG001|NOT COMPLETED|Overall Study||0||
48459508|NCT02797964|101460145|FG002|NOT COMPLETED|Overall Study||0||
48459509|NCT02797964|101460146|FG003|NOT COMPLETED|Overall Study||0||
48459510|NCT02797964|101460147|FG004|NOT COMPLETED|Overall Study||0||
48459511|NCT02797964|101460148|FG005|NOT COMPLETED|Overall Study||0||
48775024|NCT02223858|102240062|FG001|6-month Follow-up|Overall Study||154||
48775025|NCT02223858|102240061|FG000|COMPLETED|Overall Study||156||
48775026|NCT02223858|102240062|FG001|COMPLETED|Overall Study||154||
48775027|NCT02223858|102240061|FG000|NOT COMPLETED|Overall Study||24||
48775028|NCT02223858|102240062|FG001|NOT COMPLETED|Overall Study||26||
48775029|NCT02379637|102240063|FG000|STARTED|Overall Study||35||
48775030|NCT02379637|102240064|FG001|STARTED|Overall Study||35||
48775031|NCT02379637|102240063|FG000|COMPLETED|Overall Study||33||
48459512|NCT01772368|101460149|FG000|STARTED|Overall Study||72||
48775032|NCT02379637|102240064|FG001|COMPLETED|Overall Study||34||
48775033|NCT02379637|102240063|FG000|NOT COMPLETED|Overall Study||2||
48775034|NCT02379637|102240064|FG001|NOT COMPLETED|Overall Study||1||
48775035|NCT03599089|102240065|FG000|STARTED|Overall Study||36||
48459513|NCT01772368|101460149|FG000|Received Fp MDPI 100 mcg|Overall Study||67||
48459514|NCT01772368|101460149|FG000|Received FS MDPI 100/6.25 mcg|Overall Study||68||
48459515|NCT01772368|101460149|FG000|Received FS MDPI 100/12.5mcg|Overall Study||69||
48459516|NCT01772368|101460149|FG000|Received FS MDPI 100/25 mcg|Overall Study||67||
48459517|NCT01772368|101460149|FG000|Received FS MDPI 100/50 mcg|Overall Study||68||
48459518|NCT01772368|101460149|FG000|Received Advair Diskus 100/50 mcg|Overall Study||66||
48775036|NCT03599089|102240066|FG001|STARTED|Overall Study||36||
48775037|NCT03599089|102240067|FG002|STARTED|Overall Study||38||
48189677|NCT02923895|100786276|FG000|STARTED|Overall Study||97||
48459519|NCT01772368|101460149|FG000|COMPLETED|Overall Study||65||
48459520|NCT01772368|101460149|FG000|NOT COMPLETED|Overall Study||7||
48459521|NCT01798485|101460150|FG000|STARTED|Overall Study||347||
48459522|NCT01798485|101460151|FG001|STARTED|Overall Study||349||
48459523|NCT01798485|101460150|FG000|Safety Population as of 23 Dec 2015|Overall Study||338||
48459524|NCT01798485|101460151|FG001|Safety Population as of 23 Dec 2015|Overall Study||342||
48459525|NCT01798485|101460150|FG000|Randomized as of 19 October 2015|Overall Study||335||
48459526|NCT01798485|101460151|FG001|Randomized as of 19 October 2015|Overall Study||337||
48459527|NCT01798485|101460150|FG000|COMPLETED|Overall Study||1||
48459528|NCT01798485|101460151|FG001|COMPLETED|Overall Study||59||
48459529|NCT01798485|101460150|FG000|NOT COMPLETED|Overall Study||346||
48459530|NCT01798485|101460151|FG001|NOT COMPLETED|Overall Study||290||
48459531|NCT02611752|101460152|FG000|STARTED|Overall Study||22||
48459532|NCT02611752|101460153|FG001|STARTED|Overall Study||25||
48459533|NCT02611752|101460152|FG000|Day 1-3 Hydromorphone Challenge Injs|Overall Study||22||
48459534|NCT02611752|101460153|FG001|Day 1-3 Hydromorphone Challenge Injs|Overall Study||25||
48459535|NCT02611752|101460152|FG000|Day 4-6 Hydromorphone Challenge Injs|Overall Study||22||
48459536|NCT02611752|101460153|FG001|Day 4-6 Hydromorphone Challenge Injs|Overall Study||24||
48459537|NCT02611752|101460152|FG000|Day 8-10 Hydromorphone Challenge Injs|Overall Study||22||
48459538|NCT02611752|101460153|FG001|Day 8-10 Hydromorphone Challenge Injs|Overall Study||24||
48459539|NCT02611752|101460152|FG000|Day11-13 Hydromorphone Challenge Injs|Overall Study||22||
48459540|NCT02611752|101460153|FG001|Day11-13 Hydromorphone Challenge Injs|Overall Study||24||
48459541|NCT02611752|101460152|FG000|COMPLETED|Overall Study||22||
48459542|NCT02611752|101460153|FG001|COMPLETED|Overall Study||24||
48459543|NCT02611752|101460152|FG000|NOT COMPLETED|Overall Study||0||
48459544|NCT02611752|101460153|FG001|NOT COMPLETED|Overall Study||1||
48459545|NCT01007916|101460154|FG000|STARTED|Period 1, 4 Weeks of Wear||23||
48459546|NCT01007916|101460155|FG001|STARTED|Period 1, 4 Weeks of Wear||26||
48459547|NCT01007916|101460154|FG000|COMPLETED|Period 1, 4 Weeks of Wear||22||
48459548|NCT01007916|101460155|FG001|COMPLETED|Period 1, 4 Weeks of Wear||26||
48459549|NCT01007916|101460154|FG000|NOT COMPLETED|Period 1, 4 Weeks of Wear||1||
48459550|NCT01007916|101460155|FG001|NOT COMPLETED|Period 1, 4 Weeks of Wear||0||
48459551|NCT01007916|101460154|FG000|STARTED|Period 2, 4 Weeks of Wear||22||
48459552|NCT01007916|101460155|FG001|STARTED|Period 2, 4 Weeks of Wear||25||
48459553|NCT01007916|101460154|FG000|COMPLETED|Period 2, 4 Weeks of Wear||21||
48459554|NCT01007916|101460155|FG001|COMPLETED|Period 2, 4 Weeks of Wear||25||
48459555|NCT01007916|101460154|FG000|NOT COMPLETED|Period 2, 4 Weeks of Wear||1||
48459556|NCT01007916|101460155|FG001|NOT COMPLETED|Period 2, 4 Weeks of Wear||0||
48459557|NCT01534975|101460156|FG000|STARTED|Overall Study||136||
48459558|NCT01534975|101460157|FG001|STARTED|Overall Study||133||
48459559|NCT01534975|101460158|FG002|STARTED|Overall Study||160||
48459560|NCT01534975|101460159|FG003|STARTED|Overall Study||84||
48459561|NCT01534975|101460156|FG000|COMPLETED|Overall Study||136||
48459562|NCT01534975|101460157|FG001|COMPLETED|Overall Study||133||
48459563|NCT01534975|101460158|FG002|COMPLETED|Overall Study||160||
48459564|NCT01534975|101460159|FG003|COMPLETED|Overall Study||84||
48459565|NCT01534975|101460156|FG000|NOT COMPLETED|Overall Study||0||
48459566|NCT01534975|101460157|FG001|NOT COMPLETED|Overall Study||0||
48459567|NCT01534975|101460158|FG002|NOT COMPLETED|Overall Study||0||
48459568|NCT01534975|101460159|FG003|NOT COMPLETED|Overall Study||0||
48459569|NCT00772577|101460160|FG000|STARTED|Overall Study||193||
48459570|NCT00772577|101460161|FG001|STARTED|Overall Study||193||
48459571|NCT00772577|101460160|FG000|COMPLETED|Overall Study||170||
48459572|NCT00772577|101460161|FG001|COMPLETED|Overall Study||170||
48459573|NCT00772577|101460160|FG000|NOT COMPLETED|Overall Study||23||
48459574|NCT00772577|101460161|FG001|NOT COMPLETED|Overall Study||23||
48459575|NCT04749524|101460162|FG000|STARTED|Overall Study||166||
48459576|NCT04749524|101460163|FG001|STARTED|Overall Study||22||
48664249|NCT00934180|101961977|FG000|COMPLETED|Second Intervention||12||
48664250|NCT00934180|101961978|FG001|COMPLETED|Second Intervention||12||
48664251|NCT00934180|101961977|FG000|NOT COMPLETED|Second Intervention||0||
48459577|NCT04749524|101460164|FG002|STARTED|Overall Study||45||
48459578|NCT04749524|101460165|FG003|STARTED|Overall Study||3||
48664252|NCT00934180|101961978|FG001|NOT COMPLETED|Second Intervention||0||
48664253|NCT02097225|101961979|FG000|STARTED|Dose Level 1||0||
48459579|NCT04749524|101460162|FG000|COMPLETED|Overall Study||166||
48459580|NCT04749524|101460163|FG001|COMPLETED|Overall Study||22||
48459581|NCT04749524|101460164|FG002|COMPLETED|Overall Study||45||
48459582|NCT04749524|101460165|FG003|COMPLETED|Overall Study||3||
48459583|NCT04749524|101460162|FG000|NOT COMPLETED|Overall Study||0||
48459584|NCT04749524|101460163|FG001|NOT COMPLETED|Overall Study||0||
48459585|NCT04749524|101460164|FG002|NOT COMPLETED|Overall Study||0||
48664254|NCT02097225|101961980|FG001|STARTED|Dose Level 1||3||
48189678|NCT02923895|100786277|FG001|STARTED|Overall Study||95||
48664255|NCT02097225|101961981|FG002|STARTED|Dose Level 1||0||
48664256|NCT02097225|101961982|FG003|STARTED|Dose Level 1||0||
48664257|NCT02097225|101961983|FG004|STARTED|Dose Level 1||0||
48664258|NCT02097225|101961979|FG000|COMPLETED|Dose Level 1||0||
48664259|NCT02097225|101961980|FG001|COMPLETED|Dose Level 1||3||
48664260|NCT02097225|101961981|FG002|COMPLETED|Dose Level 1||0||
48664261|NCT02097225|101961982|FG003|COMPLETED|Dose Level 1||0||
48459586|NCT04749524|101460165|FG003|NOT COMPLETED|Overall Study||0||
48459587|NCT03035227|101460166|FG000|STARTED|Overall Study||1||
48459588|NCT03035227|101460167|FG001|STARTED|Overall Study||1||
48459589|NCT03035227|101460166|FG000|COMPLETED|Overall Study||0||
48459590|NCT03035227|101460167|FG001|COMPLETED|Overall Study||0||
48459591|NCT03035227|101460166|FG000|NOT COMPLETED|Overall Study||1||
48459592|NCT03035227|101460167|FG001|NOT COMPLETED|Overall Study||1||
48459593|NCT02243020|101460168|FG000|STARTED|Overall Study||8||
48459594|NCT02243020|101460169|FG001|STARTED|Overall Study||9||
48189679|NCT02923895|100786276|FG000|COMPLETED|Overall Study||97||
48459595|NCT02243020|101460168|FG000|COMPLETED|Overall Study||8||
48459596|NCT02243020|101460169|FG001|COMPLETED|Overall Study||9||
48459597|NCT02243020|101460168|FG000|NOT COMPLETED|Overall Study||0||
48459598|NCT02243020|101460169|FG001|NOT COMPLETED|Overall Study||0||
48775038|NCT03599089|102240068|FG003|STARTED|Overall Study||37||
48775039|NCT03599089|102240065|FG000|COMPLETED|Overall Study||33||
48775040|NCT03599089|102240066|FG001|COMPLETED|Overall Study||35||
48775041|NCT03599089|102240067|FG002|COMPLETED|Overall Study||37||
48775042|NCT03599089|102240068|FG003|COMPLETED|Overall Study||35||
48775043|NCT03599089|102240065|FG000|NOT COMPLETED|Overall Study||3||
48775044|NCT03599089|102240066|FG001|NOT COMPLETED|Overall Study||1||
48775045|NCT03599089|102240067|FG002|NOT COMPLETED|Overall Study||1||
48775046|NCT03599089|102240068|FG003|NOT COMPLETED|Overall Study||2||
48775047|NCT01011309|102240069|FG000|STARTED|Overall Study||14||
48775048|NCT01011309|102240070|FG001|STARTED|Overall Study||10||
48775049|NCT01011309|102240071|FG002|STARTED|Overall Study||21||
48775050|NCT01011309|102240069|FG000|COMPLETED|Overall Study||12||
48775051|NCT01011309|102240070|FG001|COMPLETED|Overall Study||7||
48775052|NCT01011309|102240071|FG002|COMPLETED|Overall Study||16||
48775053|NCT01011309|102240069|FG000|NOT COMPLETED|Overall Study||2||
48775054|NCT01011309|102240070|FG001|NOT COMPLETED|Overall Study||3||
48775055|NCT01011309|102240071|FG002|NOT COMPLETED|Overall Study||5||
48775056|NCT02904954|102240072|FG000|STARTED|Neoadjuvant (Preoperative) to Surgery||30||
48775057|NCT02904954|102240073|FG001|STARTED|Neoadjuvant (Preoperative) to Surgery||30||
48775058|NCT02904954|102240072|FG000|COMPLETED|Neoadjuvant (Preoperative) to Surgery||26||
48775059|NCT02904954|102240073|FG001|COMPLETED|Neoadjuvant (Preoperative) to Surgery||26||
48775060|NCT02904954|102240072|FG000|NOT COMPLETED|Neoadjuvant (Preoperative) to Surgery||4||
48459599|NCT00827827|101460170|FG000|STARTED|Overall Study||22||
48459600|NCT00827827|101460171|FG001|STARTED|Overall Study||16||
48459601|NCT00827827|101460170|FG000|COMPLETED|Overall Study||14||
48459602|NCT00827827|101460171|FG001|COMPLETED|Overall Study||16||
48459603|NCT00827827|101460170|FG000|NOT COMPLETED|Overall Study||8||
48459604|NCT00827827|101460171|FG001|NOT COMPLETED|Overall Study||0||
48459605|NCT02961920|101460172|FG000|STARTED|Overall Study||25||
48459606|NCT02961920|101460173|FG001|STARTED|Overall Study||25||
48775061|NCT02904954|102240073|FG001|NOT COMPLETED|Neoadjuvant (Preoperative) to Surgery||4||
48459607|NCT02961920|101460172|FG000|COMPLETED|Overall Study||24||
48459608|NCT02961920|101460173|FG001|COMPLETED|Overall Study||24||
48459609|NCT02961920|101460172|FG000|NOT COMPLETED|Overall Study||1||
48459610|NCT02961920|101460173|FG001|NOT COMPLETED|Overall Study||1||
48459611|NCT01427920|101460174|FG000|STARTED|Overall Study||174||
48459612|NCT01427920|101460175|FG001|STARTED|Overall Study||174||
48459613|NCT01427920|101460174|FG000|Exposed|Overall Study||174||
48459614|NCT01427920|101460175|FG001|Exposed|Overall Study||173||
48459615|NCT01427920|101460174|FG000|COMPLETED|Overall Study||165||
48459616|NCT01427920|101460175|FG001|COMPLETED|Overall Study||157||
48459617|NCT01427920|101460174|FG000|NOT COMPLETED|Overall Study||9||
48459618|NCT01427920|101460175|FG001|NOT COMPLETED|Overall Study||17||
48775062|NCT02904954|102240072|FG000|STARTED|Adjuvant Durvalumab||26||
48775063|NCT02904954|102240073|FG001|STARTED|Adjuvant Durvalumab||26||
48775064|NCT02904954|102240072|FG000|COMPLETED|Adjuvant Durvalumab||6||
48775065|NCT02904954|102240073|FG001|COMPLETED|Adjuvant Durvalumab||11||
48775066|NCT02904954|102240072|FG000|NOT COMPLETED|Adjuvant Durvalumab||20||
48775067|NCT02904954|102240073|FG001|NOT COMPLETED|Adjuvant Durvalumab||15||
48775068|NCT03249116|102240074|FG000|STARTED|Overall Study||25||
48775069|NCT03249116|102240075|FG001|STARTED|Overall Study||25||
48775070|NCT03249116|102240076|FG002|STARTED|Overall Study||25||
48775071|NCT03249116|102240074|FG000|COMPLETED|Overall Study||25||
48775072|NCT03249116|102240075|FG001|COMPLETED|Overall Study||25||
48775073|NCT03249116|102240076|FG002|COMPLETED|Overall Study||25||
48775074|NCT03249116|102240074|FG000|NOT COMPLETED|Overall Study||0||
48189680|NCT02923895|100786277|FG001|COMPLETED|Overall Study||95||
48459619|NCT00441584|101460176|FG000|STARTED|Overall Study||117||
48459620|NCT00441584|101460176|FG000|COMPLETED|Overall Study||12||
48459621|NCT00441584|101460176|FG000|NOT COMPLETED|Overall Study||105||
48459622|NCT03770000|101460177|FG000|STARTED|Overall Study||3||
48459623|NCT03770000|101460178|FG001|STARTED|Overall Study||3||
48459624|NCT03770000|101460179|FG002|STARTED|Overall Study||3||
48459625|NCT03770000|101460180|FG003|STARTED|Overall Study||12||
48459626|NCT03770000|101460181|FG004|STARTED|Overall Study||12||
48459627|NCT03770000|101460177|FG000|COMPLETED|Overall Study||3||
48459628|NCT03770000|101460178|FG001|COMPLETED|Overall Study||3||
48459629|NCT03770000|101460179|FG002|COMPLETED|Overall Study||2||
48459630|NCT03770000|101460180|FG003|COMPLETED|Overall Study||9||
48459631|NCT03770000|101460181|FG004|COMPLETED|Overall Study||10||
48459632|NCT03770000|101460177|FG000|NOT COMPLETED|Overall Study||0||
48459633|NCT03770000|101460178|FG001|NOT COMPLETED|Overall Study||0||
48459634|NCT03770000|101460179|FG002|NOT COMPLETED|Overall Study||1||
48459635|NCT03770000|101460180|FG003|NOT COMPLETED|Overall Study||3||
48459636|NCT03770000|101460181|FG004|NOT COMPLETED|Overall Study||2||
48459637|NCT00757666|101460182|FG000|STARTED|Overall Study||34|566 subjects enrolled, of which 68 had all visits completed at the time of study termination.|
48459638|NCT00757666|101460183|FG001|STARTED|Overall Study||34|566 subjects enrolled, of which 68 had all visits completed at the time of study termination.|
48459639|NCT00757666|101460182|FG000|COMPLETED|Overall Study||12||
48459640|NCT00757666|101460183|FG001|COMPLETED|Overall Study||11||
48459641|NCT00757666|101460182|FG000|NOT COMPLETED|Overall Study||22||
48459642|NCT00757666|101460183|FG001|NOT COMPLETED|Overall Study||23||
48459643|NCT03740698|101463260|FG000|STARTED|Overall Study||0||
48459644|NCT03740698|101463261|FG001|STARTED|Overall Study||1||
48459645|NCT03740698|101463262|FG002|STARTED|Overall Study||1||
48459646|NCT03740698|101463260|FG000|COMPLETED|Overall Study||0||
48459647|NCT03740698|101463261|FG001|COMPLETED|Overall Study||0||
48459648|NCT03740698|101463262|FG002|COMPLETED|Overall Study||0||
48459649|NCT03740698|101463260|FG000|NOT COMPLETED|Overall Study||0||
48459650|NCT03740698|101463261|FG001|NOT COMPLETED|Overall Study||1||
48459651|NCT03740698|101463262|FG002|NOT COMPLETED|Overall Study||1||
48459652|NCT03522584|101463263|FG000|STARTED|Overall Study||6||
48459653|NCT03522584|101463263|FG000|COMPLETED|Overall Study||6||
48459654|NCT03522584|101463263|FG000|NOT COMPLETED|Overall Study||0||
48775075|NCT03249116|102240075|FG001|NOT COMPLETED|Overall Study||0||
48775076|NCT03249116|102240076|FG002|NOT COMPLETED|Overall Study||0||
48775077|NCT01614392|102240077|FG000|STARTED|Overall Study||25||
48775078|NCT01614392|102240078|FG001|STARTED|Overall Study||27||
48775079|NCT01614392|102240077|FG000|COMPLETED|Overall Study||24||
48775080|NCT01614392|102240078|FG001|COMPLETED|Overall Study||24||
48775081|NCT01614392|102240077|FG000|NOT COMPLETED|Overall Study||1||
48775082|NCT01614392|102240078|FG001|NOT COMPLETED|Overall Study||3||
48459655|NCT02482805|101463264|FG000|STARTED|Overall Study||26||
48459656|NCT02482805|101463265|FG001|STARTED|Overall Study||27||
48459657|NCT02482805|101463266|FG002|STARTED|Overall Study||20||
48459658|NCT02482805|101463264|FG000|COMPLETED|Overall Study||22||
48459659|NCT02482805|101463265|FG001|COMPLETED|Overall Study||23||
48775083|NCT02998268|102240079|FG000|STARTED|Overall Study||20||
48775084|NCT02998268|102240080|FG001|STARTED|Overall Study||22||
48459660|NCT02482805|101463266|FG002|COMPLETED|Overall Study||20||
48459661|NCT02482805|101463264|FG000|NOT COMPLETED|Overall Study||4||
48459662|NCT02482805|101463265|FG001|NOT COMPLETED|Overall Study||4||
48459663|NCT02482805|101463266|FG002|NOT COMPLETED|Overall Study||0||
48459664|NCT00832078|101463267|FG000|STARTED|Test Day 1- 1 Period||13||
48459665|NCT00832078|101463268|FG001|STARTED|Test Day 1- 1 Period||12||
48459666|NCT00832078|101463267|FG000|COMPLETED|Test Day 1- 1 Period||13||
48459667|NCT00832078|101463268|FG001|COMPLETED|Test Day 1- 1 Period||12||
48459668|NCT00832078|101463267|FG000|NOT COMPLETED|Test Day 1- 1 Period||0||
48459669|NCT00832078|101463268|FG001|NOT COMPLETED|Test Day 1- 1 Period||0||
48459670|NCT00832078|101463267|FG000|STARTED|Test Day 1-2 Period||13||
48459671|NCT00832078|101463268|FG001|STARTED|Test Day 1-2 Period||12||
48459672|NCT00832078|101463267|FG000|COMPLETED|Test Day 1-2 Period||13||
48459673|NCT00832078|101463268|FG001|COMPLETED|Test Day 1-2 Period||10||
48459674|NCT00832078|101463267|FG000|NOT COMPLETED|Test Day 1-2 Period||0||
48459675|NCT00832078|101463268|FG001|NOT COMPLETED|Test Day 1-2 Period||2||
48459676|NCT00832078|101463267|FG000|STARTED|Test Day 2 - 1 Period||13||
48459677|NCT00832078|101463268|FG001|STARTED|Test Day 2 - 1 Period||10||
48459678|NCT00832078|101463267|FG000|COMPLETED|Test Day 2 - 1 Period||13||
48459679|NCT00832078|101463268|FG001|COMPLETED|Test Day 2 - 1 Period||10||
48459680|NCT00832078|101463267|FG000|NOT COMPLETED|Test Day 2 - 1 Period||0||
48459681|NCT00832078|101463268|FG001|NOT COMPLETED|Test Day 2 - 1 Period||0||
48459682|NCT00832078|101463267|FG000|STARTED|Test Day 2 - 2 Period||13||
48459683|NCT00832078|101463268|FG001|STARTED|Test Day 2 - 2 Period||10||
48459684|NCT00832078|101463267|FG000|COMPLETED|Test Day 2 - 2 Period||12||
48459685|NCT00832078|101463268|FG001|COMPLETED|Test Day 2 - 2 Period||10||
48459686|NCT00832078|101463267|FG000|NOT COMPLETED|Test Day 2 - 2 Period||1||
48459687|NCT00832078|101463268|FG001|NOT COMPLETED|Test Day 2 - 2 Period||0||
48459688|NCT02666430|101463269|FG000|STARTED|Baseline||64||
48459689|NCT02666430|101463270|FG001|STARTED|Baseline||63||
48459690|NCT02666430|101463269|FG000|COMPLETED|Baseline||64||
48459691|NCT02666430|101463270|FG001|COMPLETED|Baseline||63||
48459692|NCT02666430|101463269|FG000|NOT COMPLETED|Baseline||0||
48459693|NCT02666430|101463270|FG001|NOT COMPLETED|Baseline||0||
48459694|NCT02666430|101463269|FG000|STARTED|Period 1||64||
48459695|NCT02666430|101463270|FG001|STARTED|Period 1||63||
48459696|NCT02666430|101463269|FG000|COMPLETED|Period 1||63||
48459697|NCT02666430|101463270|FG001|COMPLETED|Period 1||62||
48459698|NCT02666430|101463269|FG000|NOT COMPLETED|Period 1||1||
48459699|NCT02666430|101463270|FG001|NOT COMPLETED|Period 1||1||
48459700|NCT02666430|101463269|FG000|STARTED|Period 2||63||
48459701|NCT02666430|101463270|FG001|STARTED|Period 2||62||
48459702|NCT02666430|101463269|FG000|COMPLETED|Period 2||62||
48459703|NCT02666430|101463270|FG001|COMPLETED|Period 2||58||
48459704|NCT02666430|101463269|FG000|NOT COMPLETED|Period 2||1||
48459705|NCT02666430|101463270|FG001|NOT COMPLETED|Period 2||4||
48459706|NCT02666430|101463269|FG000|STARTED|Period 3||62||
48459707|NCT02666430|101463270|FG001|STARTED|Period 3||58||
48459708|NCT02666430|101463269|FG000|COMPLETED|Period 3||61||
48459709|NCT02666430|101463270|FG001|COMPLETED|Period 3||58||
48459710|NCT02666430|101463269|FG000|NOT COMPLETED|Period 3||1||
48459711|NCT02666430|101463270|FG001|NOT COMPLETED|Period 3||0||
48459712|NCT03135379|101463271|FG000|STARTED|Overall Study||62||
48459713|NCT03135379|101463272|FG001|STARTED|Overall Study||62||
48459714|NCT03135379|101463271|FG000|COMPLETED|Overall Study||61||
48459715|NCT03135379|101463272|FG001|COMPLETED|Overall Study||59||
48459716|NCT03135379|101463271|FG000|NOT COMPLETED|Overall Study||1||
48459717|NCT03135379|101463272|FG001|NOT COMPLETED|Overall Study||3||
48459718|NCT00419926|101463273|FG000|STARTED|Overall Study||155||
48459719|NCT00419926|101463274|FG001|STARTED|Overall Study||158||
48459720|NCT00419926|101463273|FG000|COMPLETED|Overall Study||141||
48459721|NCT00419926|101463274|FG001|COMPLETED|Overall Study||148||
48459722|NCT00419926|101463273|FG000|NOT COMPLETED|Overall Study||14||
48459723|NCT00419926|101463274|FG001|NOT COMPLETED|Overall Study||10||
48459724|NCT00746668|101463275|FG000|STARTED|Overall Study||6||
48459725|NCT00746668|101463276|FG001|STARTED|Overall Study||5||
48459726|NCT00746668|101463277|FG002|STARTED|Overall Study||5||
48459727|NCT00746668|101463278|FG003|STARTED|Overall Study||5||
48459728|NCT00746668|101463279|FG004|STARTED|Overall Study||5||
48459729|NCT00746668|101463280|FG005|STARTED|Overall Study||5||
48459730|NCT00746668|101463281|FG006|STARTED|Overall Study||5||
48459731|NCT00746668|101463275|FG000|COMPLETED|Overall Study||6||
48459732|NCT00746668|101463276|FG001|COMPLETED|Overall Study||5||
48459733|NCT00746668|101463277|FG002|COMPLETED|Overall Study||5||
48459734|NCT00746668|101463278|FG003|COMPLETED|Overall Study||5||
48459735|NCT00746668|101463279|FG004|COMPLETED|Overall Study||5||
48459736|NCT00746668|101463280|FG005|COMPLETED|Overall Study||5||
48459737|NCT00746668|101463281|FG006|COMPLETED|Overall Study||5||
48459738|NCT00746668|101463275|FG000|NOT COMPLETED|Overall Study||0||
48459739|NCT00746668|101463276|FG001|NOT COMPLETED|Overall Study||0||
48459740|NCT00746668|101463277|FG002|NOT COMPLETED|Overall Study||0||
48459741|NCT00746668|101463278|FG003|NOT COMPLETED|Overall Study||0||
48459742|NCT00746668|101463279|FG004|NOT COMPLETED|Overall Study||0||
48459743|NCT00746668|101463280|FG005|NOT COMPLETED|Overall Study||0||
48459744|NCT00746668|101463281|FG006|NOT COMPLETED|Overall Study||0||
48459745|NCT00809809|101463282|FG000|STARTED|Overall Study||78||
48459746|NCT00809809|101463283|FG001|STARTED|Overall Study||79||
48459747|NCT00809809|101463282|FG000|COMPLETED|Overall Study||75||
48459748|NCT00809809|101463283|FG001|COMPLETED|Overall Study||77||
48459749|NCT00809809|101463282|FG000|NOT COMPLETED|Overall Study||3||
48459750|NCT00809809|101463283|FG001|NOT COMPLETED|Overall Study||2||
48459751|NCT05267574|101463284|FG000|STARTED|Overall Study||155||
48459752|NCT05267574|101463284|FG000|COMPLETED|Overall Study||0||
48459753|NCT05267574|101463284|FG000|NOT COMPLETED|Overall Study||155||
48459754|NCT03131999|101463285|FG000|STARTED|Overall Study||8||
48459755|NCT03131999|101463286|FG001|STARTED|Overall Study||8||
48459756|NCT03131999|101463285|FG000|COMPLETED|Overall Study||8||
48459757|NCT03131999|101463286|FG001|COMPLETED|Overall Study||7||
48459758|NCT03131999|101463285|FG000|NOT COMPLETED|Overall Study||0||
48459759|NCT03131999|101463286|FG001|NOT COMPLETED|Overall Study||1||
48459760|NCT02480010|101463287|FG000|STARTED|Overall Study||35||
48459761|NCT02480010|101463288|FG001|STARTED|Overall Study||33||
48459762|NCT02480010|101463287|FG000|COMPLETED|Overall Study||0||
48459763|NCT02480010|101463288|FG001|COMPLETED|Overall Study||0||
48459764|NCT02480010|101463287|FG000|NOT COMPLETED|Overall Study||35||
48459765|NCT02480010|101463288|FG001|NOT COMPLETED|Overall Study||33||
48459766|NCT00788957|101463289|FG000|STARTED|Part 1||11||
48459767|NCT00788957|101463290|FG001|STARTED|Part 1||0||
48459768|NCT00788957|101463291|FG002|STARTED|Part 1||0||
48459769|NCT00788957|101463292|FG003|STARTED|Part 1||0||
48459770|NCT00788957|101463293|FG004|STARTED|Part 1||0||
48459771|NCT00788957|101463294|FG005|STARTED|Part 1||0||
48459772|NCT00788957|101463289|FG000|COMPLETED|Part 1||2||
48459773|NCT00788957|101463290|FG001|COMPLETED|Part 1||0||
48459774|NCT00788957|101463291|FG002|COMPLETED|Part 1||0||
48459775|NCT00788957|101463292|FG003|COMPLETED|Part 1||0||
48459776|NCT00788957|101463293|FG004|COMPLETED|Part 1||0||
48459777|NCT00788957|101463294|FG005|COMPLETED|Part 1||0||
48459778|NCT00788957|101463289|FG000|NOT COMPLETED|Part 1||9||
48459779|NCT00788957|101463290|FG001|NOT COMPLETED|Part 1||0||
48459780|NCT00788957|101463291|FG002|NOT COMPLETED|Part 1||0||
48459781|NCT00788957|101463292|FG003|NOT COMPLETED|Part 1||0||
48459782|NCT00788957|101463293|FG004|NOT COMPLETED|Part 1||0||
48459783|NCT00788957|101463294|FG005|NOT COMPLETED|Part 1||0||
48459784|NCT00788957|101463289|FG000|STARTED|Part 2||0||
48459785|NCT00788957|101463290|FG001|STARTED|Part 2||48||
48459786|NCT00788957|101463291|FG002|STARTED|Part 2||48||
48459787|NCT00788957|101463292|FG003|STARTED|Part 2||46||
48459788|NCT00788957|101463293|FG004|STARTED|Part 2||0||
48459789|NCT00788957|101463294|FG005|STARTED|Part 2||0||
48459790|NCT00788957|101463289|FG000|COMPLETED|Part 2||0||
48459791|NCT00788957|101463290|FG001|COMPLETED|Part 2||6||
48459792|NCT00788957|101463291|FG002|COMPLETED|Part 2||4||
48459793|NCT00788957|101463292|FG003|COMPLETED|Part 2||5||
48459794|NCT00788957|101463293|FG004|COMPLETED|Part 2||0||
48459795|NCT00788957|101463294|FG005|COMPLETED|Part 2||0||
48459796|NCT00788957|101463289|FG000|NOT COMPLETED|Part 2||0||
48459797|NCT00788957|101463290|FG001|NOT COMPLETED|Part 2||42||
48459798|NCT00788957|101463291|FG002|NOT COMPLETED|Part 2||44||
48459799|NCT00788957|101463292|FG003|NOT COMPLETED|Part 2||41||
48459800|NCT00788957|101463293|FG004|NOT COMPLETED|Part 2||0||
48459801|NCT00788957|101463294|FG005|NOT COMPLETED|Part 2||0||
48459802|NCT00788957|101463289|FG000|STARTED|Part 3||0||
48459803|NCT00788957|101463290|FG001|STARTED|Part 3||0||
48459804|NCT00788957|101463291|FG002|STARTED|Part 3||0||
48459805|NCT00788957|101463292|FG003|STARTED|Part 3||0||
48459806|NCT00788957|101463293|FG004|STARTED|Part 3||13||
48459807|NCT00788957|101463294|FG005|STARTED|Part 3||11||
48459808|NCT00788957|101463289|FG000|COMPLETED|Part 3||0||
48664262|NCT02097225|101961983|FG004|COMPLETED|Dose Level 1||0||
48664263|NCT02097225|101961979|FG000|NOT COMPLETED|Dose Level 1||0||
48775085|NCT02998268|102240079|FG000|COMPLETED|Overall Study||20||
48459809|NCT00788957|101463290|FG001|COMPLETED|Part 3||0||
48459810|NCT00788957|101463291|FG002|COMPLETED|Part 3||0||
48459811|NCT00788957|101463292|FG003|COMPLETED|Part 3||0||
48459812|NCT00788957|101463293|FG004|COMPLETED|Part 3||4||
48459813|NCT00788957|101463294|FG005|COMPLETED|Part 3||1||
48459814|NCT00788957|101463289|FG000|NOT COMPLETED|Part 3||0||
48664264|NCT02097225|101961980|FG001|NOT COMPLETED|Dose Level 1||0||
48664265|NCT02097225|101961981|FG002|NOT COMPLETED|Dose Level 1||0||
48664266|NCT02097225|101961982|FG003|NOT COMPLETED|Dose Level 1||0||
48664267|NCT02097225|101961983|FG004|NOT COMPLETED|Dose Level 1||0||
48664268|NCT02097225|101961979|FG000|STARTED|Dose Level 2||0||
48664269|NCT02097225|101961980|FG001|STARTED|Dose Level 2||0||
48664270|NCT02097225|101961981|FG002|STARTED|Dose Level 2||4||
48775086|NCT02998268|102240080|FG001|COMPLETED|Overall Study||19||
48459815|NCT00788957|101463290|FG001|NOT COMPLETED|Part 3||0||
48459816|NCT00788957|101463291|FG002|NOT COMPLETED|Part 3||0||
48459817|NCT00788957|101463292|FG003|NOT COMPLETED|Part 3||0||
48459818|NCT00788957|101463293|FG004|NOT COMPLETED|Part 3||9||
48459819|NCT00788957|101463294|FG005|NOT COMPLETED|Part 3||10||
48459820|NCT01133392|101463295|FG000|STARTED|First Intervention (1 Day )||20||
48459821|NCT01133392|101463296|FG001|STARTED|First Intervention (1 Day )||18||
48459822|NCT01133392|101463295|FG000|COMPLETED|First Intervention (1 Day )||20||
48459823|NCT01133392|101463296|FG001|COMPLETED|First Intervention (1 Day )||18||
48459824|NCT01133392|101463295|FG000|NOT COMPLETED|First Intervention (1 Day )||0||
48459825|NCT01133392|101463296|FG001|NOT COMPLETED|First Intervention (1 Day )||0||
48459826|NCT01133392|101463295|FG000|STARTED|Interval Between Dosing (4-7 Days)||20||
48459827|NCT01133392|101463296|FG001|STARTED|Interval Between Dosing (4-7 Days)||18||
48459828|NCT01133392|101463295|FG000|COMPLETED|Interval Between Dosing (4-7 Days)||20||
48459829|NCT01133392|101463296|FG001|COMPLETED|Interval Between Dosing (4-7 Days)||17||
48459830|NCT01133392|101463295|FG000|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0||
48459831|NCT01133392|101463296|FG001|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1||
48459832|NCT01133392|101463295|FG000|STARTED|Second Intervention (1 Day)||20||
48459833|NCT01133392|101463296|FG001|STARTED|Second Intervention (1 Day)||17||
48459834|NCT01133392|101463295|FG000|COMPLETED|Second Intervention (1 Day)||20||
48459835|NCT01133392|101463296|FG001|COMPLETED|Second Intervention (1 Day)||17||
48459836|NCT01133392|101463295|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48459837|NCT01133392|101463296|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48459838|NCT01133392|101463295|FG000|STARTED|Interval Between Dosing (4-7 Days)||20||
48459839|NCT01133392|101463296|FG001|STARTED|Interval Between Dosing (4-7 Days)||17||
48459840|NCT01133392|101463295|FG000|COMPLETED|Interval Between Dosing (4-7 Days)||20||
48459841|NCT01133392|101463296|FG001|COMPLETED|Interval Between Dosing (4-7 Days)||17||
48459842|NCT01133392|101463295|FG000|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0||
48459843|NCT01133392|101463296|FG001|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0||
48459844|NCT01133392|101463295|FG000|STARTED|Third Intervention (1 Day)||20||
48459845|NCT01133392|101463296|FG001|STARTED|Third Intervention (1 Day)||17||
48459846|NCT01133392|101463295|FG000|COMPLETED|Third Intervention (1 Day)||20||
48459847|NCT01133392|101463296|FG001|COMPLETED|Third Intervention (1 Day)||17||
48459848|NCT01133392|101463295|FG000|NOT COMPLETED|Third Intervention (1 Day)||0||
48459849|NCT01133392|101463296|FG001|NOT COMPLETED|Third Intervention (1 Day)||0||
48459850|NCT01133392|101463295|FG000|STARTED|Interval Between Dosing (4-7 Days)||20||
48459851|NCT01133392|101463296|FG001|STARTED|Interval Between Dosing (4-7 Days)||17||
48459852|NCT01133392|101463295|FG000|COMPLETED|Interval Between Dosing (4-7 Days)||20||
48459853|NCT01133392|101463296|FG001|COMPLETED|Interval Between Dosing (4-7 Days)||16||
48459854|NCT01133392|101463295|FG000|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0||
48459855|NCT01133392|101463296|FG001|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1||
48459856|NCT01133392|101463295|FG000|STARTED|Fourth Intervention (1 Day)||20||
48459857|NCT01133392|101463296|FG001|STARTED|Fourth Intervention (1 Day)||16||
48459858|NCT01133392|101463295|FG000|COMPLETED|Fourth Intervention (1 Day)||20||
48459859|NCT01133392|101463296|FG001|COMPLETED|Fourth Intervention (1 Day)||16||
48459860|NCT01133392|101463295|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0||
48459861|NCT01133392|101463296|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0||
48459862|NCT01664052|101463297|FG000|STARTED|Phase 1||31||
48459863|NCT01664052|101463298|FG001|STARTED|Phase 1||0||
48459864|NCT01664052|101463297|FG000|Insert Placed in at Least One Tube|Phase 1||25||
48459865|NCT01664052|101463298|FG001|Insert Placed in at Least One Tube|Phase 1||0||
48459866|NCT01664052|101463297|FG000|HSG 1 Hour Post Placement|Phase 1||24||
48459867|NCT01664052|101463298|FG001|HSG 1 Hour Post Placement|Phase 1||0||
48459868|NCT01664052|101463297|FG000|Repeat HSG and Hysterectomy at 30 Days|Phase 1||9||
48459869|NCT01664052|101463298|FG001|Repeat HSG and Hysterectomy at 30 Days|Phase 1||0||
48459870|NCT01664052|101463297|FG000|Repeat HSG and Hysterectomy at 60 Days|Phase 1||8||
48459871|NCT01664052|101463298|FG001|Repeat HSG and Hysterectomy at 60 Days|Phase 1||0||
48459872|NCT01664052|101463297|FG000|Repeat HSG and Hysterectomy at 90 Days|Phase 1||7||
48459873|NCT01664052|101463298|FG001|Repeat HSG and Hysterectomy at 90 Days|Phase 1||0||
48459874|NCT01664052|101463297|FG000|COMPLETED|Phase 1||24||
48459875|NCT01664052|101463298|FG001|COMPLETED|Phase 1||0||
48459876|NCT01664052|101463297|FG000|NOT COMPLETED|Phase 1||7||
48459877|NCT01664052|101463298|FG001|NOT COMPLETED|Phase 1||0||
48459878|NCT01664052|101463297|FG000|STARTED|Phase 2||0||
48459879|NCT01664052|101463298|FG001|STARTED|Phase 2||35||
48459880|NCT01664052|101463297|FG000|Insert Placed|Phase 2||0||
48459881|NCT01664052|101463298|FG001|Insert Placed|Phase 2||31||
48459882|NCT01664052|101463297|FG000|HSG 1 Hour Post Placement|Phase 2||0||
48459883|NCT01664052|101463298|FG001|HSG 1 Hour Post Placement|Phase 2||31||
48459884|NCT01664052|101463297|FG000|Repeat HSG and Hysterectomy at 30 Days|Phase 2||0||
48459885|NCT01664052|101463298|FG001|Repeat HSG and Hysterectomy at 30 Days|Phase 2||10||
48459886|NCT01664052|101463297|FG000|Repeat HSG and Hysterectomy at 60 Days|Phase 2||0||
48459887|NCT01664052|101463298|FG001|Repeat HSG and Hysterectomy at 60 Days|Phase 2||10||
48459888|NCT01664052|101463297|FG000|Repeat HSG and Hysterectomy at 90 Days|Phase 2||0||
48459889|NCT01664052|101463298|FG001|Repeat HSG and Hysterectomy at 90 Days|Phase 2||10||
48459890|NCT01664052|101463297|FG000|COMPLETED|Phase 2||0||
48459891|NCT01664052|101463298|FG001|COMPLETED|Phase 2||31||
48459892|NCT01664052|101463297|FG000|NOT COMPLETED|Phase 2||0||
48459893|NCT01664052|101463298|FG001|NOT COMPLETED|Phase 2||4||
48459894|NCT01688037|101463299|FG000|STARTED|Double-Blind Period (Week 0 to 6)||54||
48459895|NCT01688037|101463300|FG001|STARTED|Double-Blind Period (Week 0 to 6)||28||
48459896|NCT01688037|101463301|FG002|STARTED|Double-Blind Period (Week 0 to 6)||27||
48459897|NCT01688037|101463299|FG000|COMPLETED|Double-Blind Period (Week 0 to 6)||47||
48459898|NCT01688037|101463300|FG001|COMPLETED|Double-Blind Period (Week 0 to 6)||25||
48189681|NCT02923895|100786276|FG000|NOT COMPLETED|Overall Study||0||
48459899|NCT01688037|101463301|FG002|COMPLETED|Double-Blind Period (Week 0 to 6)||21||
48459900|NCT01688037|101463299|FG000|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7||
48459901|NCT01688037|101463300|FG001|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||3||
48459902|NCT01688037|101463301|FG002|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||6||
48459903|NCT01688037|101463299|FG000|STARTED|Open-Label Period (Week 6 to 12)||47||
48459904|NCT01688037|101463300|FG001|STARTED|Open-Label Period (Week 6 to 12)||25||
48459905|NCT01688037|101463301|FG002|STARTED|Open-Label Period (Week 6 to 12)||21||
48459906|NCT01688037|101463299|FG000|COMPLETED|Open-Label Period (Week 6 to 12)||42||
48459907|NCT01688037|101463300|FG001|COMPLETED|Open-Label Period (Week 6 to 12)||22||
48459908|NCT01688037|101463301|FG002|COMPLETED|Open-Label Period (Week 6 to 12)||17||
48459909|NCT01688037|101463299|FG000|NOT COMPLETED|Open-Label Period (Week 6 to 12)||5||
48459910|NCT01688037|101463300|FG001|NOT COMPLETED|Open-Label Period (Week 6 to 12)||3||
48459911|NCT01688037|101463301|FG002|NOT COMPLETED|Open-Label Period (Week 6 to 12)||4||
48459912|NCT01688037|101463299|FG000|STARTED|Follow-up Period (Week 12 to 16)||42||
48459913|NCT01688037|101463300|FG001|STARTED|Follow-up Period (Week 12 to 16)||22||
48459914|NCT01688037|101463301|FG002|STARTED|Follow-up Period (Week 12 to 16)||17||
48459915|NCT01688037|101463299|FG000|COMPLETED|Follow-up Period (Week 12 to 16)||42||
48459916|NCT01688037|101463300|FG001|COMPLETED|Follow-up Period (Week 12 to 16)||21||
48459917|NCT01688037|101463301|FG002|COMPLETED|Follow-up Period (Week 12 to 16)||17||
48459918|NCT01688037|101463299|FG000|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0||
48459919|NCT01688037|101463300|FG001|NOT COMPLETED|Follow-up Period (Week 12 to 16)||1||
48459920|NCT01688037|101463301|FG002|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0||
48459921|NCT00130520|101463302|FG000|STARTED|Overall Study||40||
48459922|NCT00130520|101463302|FG000|Completion of at Least One Cycle|Overall Study||39||
48459923|NCT00130520|101463302|FG000|COMPLETED|Overall Study||1||
48459924|NCT00130520|101463302|FG000|NOT COMPLETED|Overall Study||39||
48459925|NCT01618305|101463303|FG000|STARTED|Overall Study||202||
48459926|NCT01618305|101463304|FG001|STARTED|Overall Study||206||
48459927|NCT01618305|101463303|FG000|COMPLETED|Overall Study||187||
48459928|NCT01618305|101463304|FG001|COMPLETED|Overall Study||196||
48459929|NCT01618305|101463303|FG000|NOT COMPLETED|Overall Study||15||
48459930|NCT01618305|101463304|FG001|NOT COMPLETED|Overall Study||10||
48459931|NCT02300025|101463305|FG000|STARTED|Overall Study||10||
48459932|NCT02300025|101463306|FG001|STARTED|Overall Study||6||
48459933|NCT02300025|101463307|FG002|STARTED|Overall Study||6||
48459934|NCT02300025|101463308|FG003|STARTED|Overall Study||6||
48459935|NCT02300025|101463305|FG000|COMPLETED|Overall Study||10||
48459936|NCT02300025|101463306|FG001|COMPLETED|Overall Study||6||
48459937|NCT02300025|101463307|FG002|COMPLETED|Overall Study||6||
48459938|NCT02300025|101463308|FG003|COMPLETED|Overall Study||6||
48459939|NCT02300025|101463305|FG000|NOT COMPLETED|Overall Study||0||
48459940|NCT02300025|101463306|FG001|NOT COMPLETED|Overall Study||0||
48459941|NCT02300025|101463307|FG002|NOT COMPLETED|Overall Study||0||
48459942|NCT02300025|101463308|FG003|NOT COMPLETED|Overall Study||0||
48459943|NCT01847313|101463309|FG000|STARTED|Overall Study||10||
48459944|NCT01847313|101463310|FG001|STARTED|Overall Study||10||
48459945|NCT01847313|101463309|FG000|COMPLETED|Overall Study||10||
48459946|NCT01847313|101463310|FG001|COMPLETED|Overall Study||8||
48459947|NCT01847313|101463309|FG000|NOT COMPLETED|Overall Study||0||
48459948|NCT01847313|101463310|FG001|NOT COMPLETED|Overall Study||2||
48459949|NCT02207621|101463311|FG000|STARTED|Overall Study||251||
48459950|NCT02207621|101463312|FG001|STARTED|Overall Study||251||
48459951|NCT02207621|101463313|FG002|STARTED|Overall Study||254||
48459952|NCT02207621|101463311|FG000|COMPLETED|Overall Study||146||
48459953|NCT02207621|101463312|FG001|COMPLETED|Overall Study||204||
48459954|NCT02207621|101463313|FG002|COMPLETED|Overall Study||86||
48459955|NCT02207621|101463311|FG000|NOT COMPLETED|Overall Study||105||
48459956|NCT02207621|101463312|FG001|NOT COMPLETED|Overall Study||47||
48459957|NCT02207621|101463313|FG002|NOT COMPLETED|Overall Study||168||
48459958|NCT00439608|101463314|FG000|STARTED|Overall Study||60||
48459959|NCT00439608|101463314|FG000|COMPLETED|Overall Study||60||
48459960|NCT00439608|101463314|FG000|NOT COMPLETED|Overall Study||0||
48459961|NCT00621179|101463315|FG000|STARTED|Overall Study||12||
48459962|NCT00621179|101463316|FG001|STARTED|Overall Study||8||
48459963|NCT00621179|101463317|FG002|STARTED|Overall Study||7||
48459964|NCT00621179|101463318|FG003|STARTED|Overall Study||10||
48459965|NCT00621179|101463315|FG000|COMPLETED|Overall Study||12||
48459966|NCT00621179|101463316|FG001|COMPLETED|Overall Study||8||
48459967|NCT00621179|101463317|FG002|COMPLETED|Overall Study||6||
48459968|NCT00621179|101463318|FG003|COMPLETED|Overall Study||9||
48459969|NCT00621179|101463315|FG000|NOT COMPLETED|Overall Study||0||
48459970|NCT00621179|101463316|FG001|NOT COMPLETED|Overall Study||0||
48459971|NCT00621179|101463317|FG002|NOT COMPLETED|Overall Study||1||
48459972|NCT00621179|101463318|FG003|NOT COMPLETED|Overall Study||1||
48459973|NCT02260492|101463319|FG000|STARTED|Overall Study||418||
48459974|NCT02260492|101463320|FG001|STARTED|Overall Study||419||
48459975|NCT02260492|101463321|FG002|STARTED|Overall Study||42||
48459976|NCT02260492|101463319|FG000|Completed Day 1|Overall Study||418||
48459977|NCT02260492|101463320|FG001|Completed Day 1|Overall Study||419||
48459978|NCT02260492|101463321|FG002|Completed Day 1|Overall Study||42||
48459979|NCT02260492|101463319|FG000|COMPLETED|Overall Study||395||
48459980|NCT02260492|101463320|FG001|COMPLETED|Overall Study||406||
48459981|NCT02260492|101463321|FG002|COMPLETED|Overall Study||37||
48459982|NCT02260492|101463319|FG000|NOT COMPLETED|Overall Study||23||
48459983|NCT02260492|101463320|FG001|NOT COMPLETED|Overall Study||13||
48459984|NCT02260492|101463321|FG002|NOT COMPLETED|Overall Study||5||
48459985|NCT00903383|101463322|FG000|STARTED|Overall Study||55||
48459986|NCT00903383|101463323|FG001|STARTED|Overall Study||54||
48459987|NCT00903383|101463324|FG002|STARTED|Overall Study||50||
48459988|NCT00903383|101463325|FG003|STARTED|Overall Study||49||
48459989|NCT00903383|101463322|FG000|COMPLETED|Overall Study||48||
48459990|NCT00903383|101463323|FG001|COMPLETED|Overall Study||48||
48459991|NCT00903383|101463324|FG002|COMPLETED|Overall Study||47||
48459992|NCT00903383|101463325|FG003|COMPLETED|Overall Study||44||
48459993|NCT00903383|101463322|FG000|NOT COMPLETED|Overall Study||7||
48459994|NCT00903383|101463323|FG001|NOT COMPLETED|Overall Study||6||
48459995|NCT00903383|101463324|FG002|NOT COMPLETED|Overall Study||3||
48459996|NCT00903383|101463325|FG003|NOT COMPLETED|Overall Study||5||
48459997|NCT03433001|101463326|FG000|STARTED|Overall Study||295||
48459998|NCT03433001|101463326|FG000|COMPLETED|Overall Study||66||
48459999|NCT03433001|101463326|FG000|NOT COMPLETED|Overall Study||229||
48460000|NCT03896490|101463327|FG000|STARTED|Overall Study||6||
48460001|NCT03896490|101463328|FG001|STARTED|Overall Study||6||
48460002|NCT03896490|101463327|FG000|COMPLETED|Overall Study||5||
48460003|NCT03896490|101463328|FG001|COMPLETED|Overall Study||5||
48460004|NCT03896490|101463327|FG000|NOT COMPLETED|Overall Study||1||
48460005|NCT03896490|101463328|FG001|NOT COMPLETED|Overall Study||1||
48460006|NCT03877055|101463329|FG000|STARTED|Overall Study||6||
48460007|NCT03877055|101463330|FG001|STARTED|Overall Study||2||
48460008|NCT03877055|101463329|FG000|COMPLETED|Overall Study||6||
48460009|NCT03877055|101463330|FG001|COMPLETED|Overall Study||2||
48460010|NCT03877055|101463329|FG000|NOT COMPLETED|Overall Study||0||
48460011|NCT03877055|101463330|FG001|NOT COMPLETED|Overall Study||0||
48460012|NCT01868009|101463331|FG000|STARTED|Period 1 (5-9 Days)||143||
48460013|NCT01868009|101463332|FG001|STARTED|Period 1 (5-9 Days)||144||
48460014|NCT01868009|101463331|FG000|COMPLETED|Period 1 (5-9 Days)||143||
48460015|NCT01868009|101463332|FG001|COMPLETED|Period 1 (5-9 Days)||142||
48460016|NCT01868009|101463331|FG000|NOT COMPLETED|Period 1 (5-9 Days)||0||
48460017|NCT01868009|101463332|FG001|NOT COMPLETED|Period 1 (5-9 Days)||2||
48460018|NCT01868009|101463331|FG000|STARTED|Period 2 (5-9 Days)||143||
48460019|NCT01868009|101463332|FG001|STARTED|Period 2 (5-9 Days)||142||
48460020|NCT01868009|101463331|FG000|COMPLETED|Period 2 (5-9 Days)||141||
48460021|NCT01868009|101463332|FG001|COMPLETED|Period 2 (5-9 Days)||142||
48460022|NCT01868009|101463331|FG000|NOT COMPLETED|Period 2 (5-9 Days)||2||
48460023|NCT01868009|101463332|FG001|NOT COMPLETED|Period 2 (5-9 Days)||0||
48460024|NCT01814761|101463333|FG000|STARTED|Overall Study||42||
48460025|NCT01814761|101463334|FG001|STARTED|Overall Study||270||
48460026|NCT01814761|101463333|FG000|COMPLETED|Overall Study||34||
48460027|NCT01814761|101463334|FG001|COMPLETED|Overall Study||240||
48460028|NCT01814761|101463333|FG000|NOT COMPLETED|Overall Study||8||
48460029|NCT01814761|101463334|FG001|NOT COMPLETED|Overall Study||30||
48460030|NCT02168270|101463335|FG000|STARTED|Overall Study||4||
48460031|NCT02168270|101463335|FG000|COMPLETED|Overall Study||0||
48460032|NCT02168270|101463335|FG000|NOT COMPLETED|Overall Study||4||
48460033|NCT01943461|101463336|FG000|STARTED|Overall Study||5||
48460034|NCT01943461|101463337|FG001|STARTED|Overall Study||6||
48460035|NCT01943461|101463338|FG002|STARTED|Overall Study||6||
48460036|NCT01943461|101463339|FG003|STARTED|Overall Study||40||
48460037|NCT01943461|101463336|FG000|COMPLETED|Overall Study||5||
48460038|NCT01943461|101463337|FG001|COMPLETED|Overall Study||6||
48460039|NCT01943461|101463338|FG002|COMPLETED|Overall Study||6||
48460040|NCT01943461|101463339|FG003|COMPLETED|Overall Study||40||
48460041|NCT01943461|101463336|FG000|NOT COMPLETED|Overall Study||0||
48460042|NCT01943461|101463337|FG001|NOT COMPLETED|Overall Study||0||
48460043|NCT01943461|101463338|FG002|NOT COMPLETED|Overall Study||0||
48460044|NCT01943461|101463339|FG003|NOT COMPLETED|Overall Study||0||
48460045|NCT02144259|101463340|FG000|STARTED|Overall Study||33||
48460046|NCT02144259|101463341|FG001|STARTED|Overall Study||33||
48460047|NCT02144259|101463342|FG002|STARTED|Overall Study||34||
48460048|NCT02144259|101463340|FG000|COMPLETED|Overall Study||23||
48460049|NCT02144259|101463341|FG001|COMPLETED|Overall Study||28||
48460050|NCT02144259|101463342|FG002|COMPLETED|Overall Study||16||
48460051|NCT02144259|101463340|FG000|NOT COMPLETED|Overall Study||10||
48460052|NCT02144259|101463341|FG001|NOT COMPLETED|Overall Study||5||
48460053|NCT02144259|101463342|FG002|NOT COMPLETED|Overall Study||18||
48460054|NCT02789111|101463343|FG000|STARTED|Overall Study||24||
48460055|NCT02789111|101463344|FG001|STARTED|Overall Study||25||
48460056|NCT02789111|101463343|FG000|COMPLETED|Overall Study||23||
48460057|NCT02789111|101463344|FG001|COMPLETED|Overall Study||21||
48460058|NCT02789111|101463343|FG000|NOT COMPLETED|Overall Study||1||
48460059|NCT02789111|101463344|FG001|NOT COMPLETED|Overall Study||4||
48460060|NCT01507896|101463345|FG000|STARTED|Overall Study||30||
48460061|NCT01507896|101463345|FG000|COMPLETED|Overall Study||28||
48460062|NCT01507896|101463345|FG000|NOT COMPLETED|Overall Study||2||
48460063|NCT02345486|101463346|FG000|STARTED|Overall Study||454||
48460064|NCT02345486|101463347|FG001|STARTED|Overall Study||520||
48460065|NCT02345486|101463346|FG000|COMPLETED|Overall Study||454||
48460066|NCT02345486|101463347|FG001|COMPLETED|Overall Study||520||
48460067|NCT02345486|101463346|FG000|NOT COMPLETED|Overall Study||0||
48460068|NCT02345486|101463347|FG001|NOT COMPLETED|Overall Study||0||
48460069|NCT02296606|101463348|FG000|STARTED|Overall Study||127||
48460070|NCT02296606|101463348|FG000|COMPLETED|Overall Study||127||
48460071|NCT02296606|101463348|FG000|NOT COMPLETED|Overall Study||0||
48460072|NCT01254045|101463349|FG000|STARTED|First/Baseline (1 Day at Week 1 )||2||
48460073|NCT01254045|101463350|FG001|STARTED|First/Baseline (1 Day at Week 1 )||2||
48460074|NCT01254045|101463351|FG002|STARTED|First/Baseline (1 Day at Week 1 )||2||
48460075|NCT01254045|101463352|FG003|STARTED|First/Baseline (1 Day at Week 1 )||1||
48460076|NCT01254045|101463353|FG004|STARTED|First/Baseline (1 Day at Week 1 )||1||
48460077|NCT01254045|101463354|FG005|STARTED|First/Baseline (1 Day at Week 1 )||1||
48460078|NCT01254045|101463349|FG000|COMPLETED|First/Baseline (1 Day at Week 1 )||1||
48460079|NCT01254045|101463350|FG001|COMPLETED|First/Baseline (1 Day at Week 1 )||2||
48460080|NCT01254045|101463351|FG002|COMPLETED|First/Baseline (1 Day at Week 1 )||2||
48460081|NCT01254045|101463352|FG003|COMPLETED|First/Baseline (1 Day at Week 1 )||1||
48460082|NCT01254045|101463353|FG004|COMPLETED|First/Baseline (1 Day at Week 1 )||1||
48460083|NCT01254045|101463354|FG005|COMPLETED|First/Baseline (1 Day at Week 1 )||1||
48460084|NCT01254045|101463349|FG000|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||1||
48460085|NCT01254045|101463350|FG001|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0||
48460086|NCT01254045|101463351|FG002|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0||
48460087|NCT01254045|101463352|FG003|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0||
48460088|NCT01254045|101463353|FG004|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0||
48460089|NCT01254045|101463354|FG005|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0||
48460090|NCT01254045|101463349|FG000|STARTED|Second/Time 2 (1 Day at Week 2)||1||
48460091|NCT01254045|101463350|FG001|STARTED|Second/Time 2 (1 Day at Week 2)||2||
48460092|NCT01254045|101463351|FG002|STARTED|Second/Time 2 (1 Day at Week 2)||2||
48460093|NCT01254045|101463352|FG003|STARTED|Second/Time 2 (1 Day at Week 2)||1||
48460094|NCT01254045|101463353|FG004|STARTED|Second/Time 2 (1 Day at Week 2)||1||
48460095|NCT01254045|101463354|FG005|STARTED|Second/Time 2 (1 Day at Week 2)||1||
48460096|NCT01254045|101463349|FG000|COMPLETED|Second/Time 2 (1 Day at Week 2)||1||
48460097|NCT01254045|101463350|FG001|COMPLETED|Second/Time 2 (1 Day at Week 2)||2||
48460098|NCT01254045|101463351|FG002|COMPLETED|Second/Time 2 (1 Day at Week 2)||2||
48460099|NCT01254045|101463352|FG003|COMPLETED|Second/Time 2 (1 Day at Week 2)||1||
48460100|NCT01254045|101463353|FG004|COMPLETED|Second/Time 2 (1 Day at Week 2)||1||
48460101|NCT01254045|101463354|FG005|COMPLETED|Second/Time 2 (1 Day at Week 2)||1||
48460102|NCT01254045|101463349|FG000|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0||
48460103|NCT01254045|101463350|FG001|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0||
48460104|NCT01254045|101463351|FG002|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0||
48460105|NCT01254045|101463352|FG003|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0||
48460106|NCT01254045|101463353|FG004|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0||
48460107|NCT01254045|101463354|FG005|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0||
48460108|NCT01254045|101463349|FG000|STARTED|Third/Time 3 (1 Day at Week 3)||1||
48460109|NCT01254045|101463350|FG001|STARTED|Third/Time 3 (1 Day at Week 3)||2||
48460110|NCT01254045|101463351|FG002|STARTED|Third/Time 3 (1 Day at Week 3)||2||
48460111|NCT01254045|101463352|FG003|STARTED|Third/Time 3 (1 Day at Week 3)||1||
48460112|NCT01254045|101463353|FG004|STARTED|Third/Time 3 (1 Day at Week 3)||1||
48460113|NCT01254045|101463354|FG005|STARTED|Third/Time 3 (1 Day at Week 3)||1||
48460114|NCT01254045|101463349|FG000|COMPLETED|Third/Time 3 (1 Day at Week 3)||1||
48460115|NCT01254045|101463350|FG001|COMPLETED|Third/Time 3 (1 Day at Week 3)||2||
48460116|NCT01254045|101463351|FG002|COMPLETED|Third/Time 3 (1 Day at Week 3)||2||
48460117|NCT01254045|101463352|FG003|COMPLETED|Third/Time 3 (1 Day at Week 3)||1||
48460118|NCT01254045|101463353|FG004|COMPLETED|Third/Time 3 (1 Day at Week 3)||1||
48460119|NCT01254045|101463354|FG005|COMPLETED|Third/Time 3 (1 Day at Week 3)||1||
48460120|NCT01254045|101463349|FG000|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0||
48460121|NCT01254045|101463350|FG001|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0||
48460122|NCT01254045|101463351|FG002|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0||
48460123|NCT01254045|101463352|FG003|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0||
48460124|NCT01254045|101463353|FG004|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0||
48460125|NCT01254045|101463354|FG005|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0||
48460126|NCT02570165|101463355|FG000|STARTED|Overall Study||46||
48460127|NCT02570165|101463356|FG001|STARTED|Overall Study||46||
48460128|NCT02570165|101463357|FG002|STARTED|Overall Study||46||
48460129|NCT02570165|101463358|FG003|STARTED|Overall Study||45||
48460130|NCT02570165|101463359|FG004|STARTED|Overall Study||47||
48460131|NCT02570165|101463360|FG005|STARTED|Overall Study||46||
48460132|NCT02570165|101463361|FG006|STARTED|Overall Study||47||
48460133|NCT02570165|101463355|FG000|COMPLETED|Overall Study||44||
48460134|NCT02570165|101463356|FG001|COMPLETED|Overall Study||43||
48460135|NCT02570165|101463357|FG002|COMPLETED|Overall Study||41||
48460136|NCT02570165|101463358|FG003|COMPLETED|Overall Study||40||
48460137|NCT02570165|101463359|FG004|COMPLETED|Overall Study||41||
48460138|NCT02570165|101463360|FG005|COMPLETED|Overall Study||44||
48460139|NCT02570165|101463361|FG006|COMPLETED|Overall Study||47||
48460140|NCT02570165|101463355|FG000|NOT COMPLETED|Overall Study||2||
48460141|NCT02570165|101463356|FG001|NOT COMPLETED|Overall Study||3||
48460142|NCT02570165|101463357|FG002|NOT COMPLETED|Overall Study||5||
48460143|NCT02570165|101463358|FG003|NOT COMPLETED|Overall Study||5||
48460144|NCT02570165|101463359|FG004|NOT COMPLETED|Overall Study||6||
48460145|NCT02570165|101463360|FG005|NOT COMPLETED|Overall Study||2||
48460146|NCT02570165|101463361|FG006|NOT COMPLETED|Overall Study||0||
48460147|NCT01004770|101463362|FG000|STARTED|Overall Study||10||
48460148|NCT01004770|101463363|FG001|STARTED|Overall Study||10||
48460149|NCT01004770|101463364|FG002|STARTED|Overall Study||10||
48460150|NCT01004770|101463365|FG003|STARTED|Overall Study||10||
48460151|NCT01004770|101463366|FG004|STARTED|Overall Study||10||
48460152|NCT01004770|101463362|FG000|COMPLETED|Overall Study||10||
48460153|NCT01004770|101463363|FG001|COMPLETED|Overall Study||10||
48460154|NCT01004770|101463364|FG002|COMPLETED|Overall Study||10||
48460155|NCT01004770|101463365|FG003|COMPLETED|Overall Study||10||
48460156|NCT01004770|101463366|FG004|COMPLETED|Overall Study||10||
48460157|NCT01004770|101463362|FG000|NOT COMPLETED|Overall Study||0||
48460158|NCT01004770|101463363|FG001|NOT COMPLETED|Overall Study||0||
48460159|NCT01004770|101463364|FG002|NOT COMPLETED|Overall Study||0||
48460160|NCT01004770|101463365|FG003|NOT COMPLETED|Overall Study||0||
48460161|NCT01004770|101463366|FG004|NOT COMPLETED|Overall Study||0||
48460162|NCT04079842|101463367|FG000|STARTED|Overall Study||29||
48460163|NCT04079842|101463367|FG000|COMPLETED|Overall Study||26||
48460164|NCT04079842|101463367|FG000|NOT COMPLETED|Overall Study||3||
48460165|NCT01859325|101463368|FG000|STARTED|Overall Study||15||
48460166|NCT01859325|101463369|FG001|STARTED|Overall Study||16||
48460167|NCT01859325|101463370|FG002|STARTED|Overall Study||2||
48460168|NCT01859325|101463368|FG000|COMPLETED|Overall Study||12||
48460169|NCT01859325|101463369|FG001|COMPLETED|Overall Study||12||
48460170|NCT01859325|101463370|FG002|COMPLETED|Overall Study||2||
48460171|NCT01859325|101463368|FG000|NOT COMPLETED|Overall Study||3||
48460172|NCT01859325|101463369|FG001|NOT COMPLETED|Overall Study||4||
48460173|NCT01859325|101463370|FG002|NOT COMPLETED|Overall Study||0||
48460174|NCT04228302|101463371|FG000|STARTED|Overall Study||6||
48460175|NCT04228302|101463372|FG001|STARTED|Overall Study||6||
48460176|NCT04228302|101463373|FG002|STARTED|Overall Study||6||
48460177|NCT04228302|101463374|FG003|STARTED|Overall Study||6||
48460178|NCT04228302|101463375|FG004|STARTED|Overall Study||6||
48460179|NCT04228302|101463376|FG005|STARTED|Overall Study||10||
48460180|NCT04228302|101463371|FG000|COMPLETED|Overall Study||6||
48460181|NCT04228302|101463372|FG001|COMPLETED|Overall Study||6||
48460182|NCT04228302|101463373|FG002|COMPLETED|Overall Study||6||
48460183|NCT04228302|101463374|FG003|COMPLETED|Overall Study||6||
48460184|NCT04228302|101463375|FG004|COMPLETED|Overall Study||5||
48460185|NCT04228302|101463376|FG005|COMPLETED|Overall Study||10||
48460186|NCT04228302|101463371|FG000|NOT COMPLETED|Overall Study||0||
48460187|NCT04228302|101463372|FG001|NOT COMPLETED|Overall Study||0||
48460188|NCT04228302|101463373|FG002|NOT COMPLETED|Overall Study||0||
48460189|NCT04228302|101463374|FG003|NOT COMPLETED|Overall Study||0||
48460190|NCT04228302|101463375|FG004|NOT COMPLETED|Overall Study||1||
48460191|NCT04228302|101463376|FG005|NOT COMPLETED|Overall Study||0||
48460192|NCT03369756|101463377|FG000|STARTED|Overall Study||43||
48460193|NCT03369756|101463377|FG000|COMPLETED|Overall Study||36||
48460194|NCT03369756|101463377|FG000|NOT COMPLETED|Overall Study||7||
48460195|NCT01706198|101463378|FG000|STARTED|Overall Study||2119||
48460196|NCT01706198|101463379|FG001|STARTED|Overall Study||2114||
48460197|NCT01706198|101463378|FG000|COMPLETED|Overall Study||1946||
48460198|NCT01706198|101463379|FG001|COMPLETED|Overall Study||1920||
48460199|NCT01706198|101463378|FG000|NOT COMPLETED|Overall Study||173||
48460200|NCT01706198|101463379|FG001|NOT COMPLETED|Overall Study||194||
48460201|NCT00881959|101463380|FG000|STARTED|Overall Study||38||
48460202|NCT00881959|101463381|FG001|STARTED|Overall Study||42||
48664271|NCT02097225|101961982|FG003|STARTED|Dose Level 2||0||
48664272|NCT02097225|101961983|FG004|STARTED|Dose Level 2||0||
48664273|NCT02097225|101961979|FG000|COMPLETED|Dose Level 2||0||
48664274|NCT02097225|101961980|FG001|COMPLETED|Dose Level 2||0||
48664275|NCT02097225|101961981|FG002|COMPLETED|Dose Level 2||4||
48664276|NCT02097225|101961982|FG003|COMPLETED|Dose Level 2||0||
48664277|NCT02097225|101961983|FG004|COMPLETED|Dose Level 2||0||
48664278|NCT02097225|101961979|FG000|NOT COMPLETED|Dose Level 2||0||
48664279|NCT02097225|101961980|FG001|NOT COMPLETED|Dose Level 2||0||
48664280|NCT02097225|101961981|FG002|NOT COMPLETED|Dose Level 2||0||
48664281|NCT02097225|101961982|FG003|NOT COMPLETED|Dose Level 2||0||
48664282|NCT02097225|101961983|FG004|NOT COMPLETED|Dose Level 2||0||
48775087|NCT02998268|102240079|FG000|NOT COMPLETED|Overall Study||0||
48460203|NCT00881959|101463380|FG000|COMPLETED|Overall Study||36||
48460204|NCT00881959|101463381|FG001|COMPLETED|Overall Study||38||
48460205|NCT00881959|101463380|FG000|NOT COMPLETED|Overall Study||2||
48460206|NCT00881959|101463381|FG001|NOT COMPLETED|Overall Study||4||
48460207|NCT00891774|101463382|FG000|STARTED|Overall Study||172||
48460208|NCT00891774|101463382|FG000|COMPLETED|Overall Study||158||
48460209|NCT00891774|101463382|FG000|NOT COMPLETED|Overall Study||14||
48460210|NCT00621686|101463383|FG000|STARTED|Overall Study||19||
48460211|NCT00621686|101463384|FG001|STARTED|Overall Study||35||
48460212|NCT00621686|101463383|FG000|COMPLETED|Overall Study||19||
48460213|NCT00621686|101463384|FG001|COMPLETED|Overall Study||35||
48460214|NCT00621686|101463383|FG000|NOT COMPLETED|Overall Study||0||
48460215|NCT00621686|101463384|FG001|NOT COMPLETED|Overall Study||0||
48460216|NCT01227668|101463385|FG000|STARTED|Phase 1 (Stabilization Phase)||157||
48460217|NCT01227668|101463386|FG001|STARTED|Phase 1 (Stabilization Phase)||0||
48460218|NCT01227668|101463385|FG000|Received Treatment|Phase 1 (Stabilization Phase)||155||
48460219|NCT01227668|101463386|FG001|Received Treatment|Phase 1 (Stabilization Phase)||0||
48460220|NCT01227668|101463385|FG000|COMPLETED|Phase 1 (Stabilization Phase)||85||
48460221|NCT01227668|101463386|FG001|COMPLETED|Phase 1 (Stabilization Phase)||0||
48460222|NCT01227668|101463385|FG000|NOT COMPLETED|Phase 1 (Stabilization Phase)||72||
48460223|NCT01227668|101463386|FG001|NOT COMPLETED|Phase 1 (Stabilization Phase)||0||
48460224|NCT01227668|101463385|FG000|STARTED|Phase 2 (Randomization Phase)||41||
48460225|NCT01227668|101463386|FG001|STARTED|Phase 2 (Randomization Phase)||44||
48460226|NCT01227668|101463385|FG000|Received Treatment|Phase 2 (Randomization Phase)||39||
48460227|NCT01227668|101463386|FG001|Received Treatment|Phase 2 (Randomization Phase)||43||
48460228|NCT01227668|101463385|FG000|COMPLETED|Phase 2 (Randomization Phase)||22||
48460229|NCT01227668|101463386|FG001|COMPLETED|Phase 2 (Randomization Phase)||19||
48460230|NCT01227668|101463385|FG000|NOT COMPLETED|Phase 2 (Randomization Phase)||19||
48664283|NCT02097225|101961979|FG000|STARTED|Dose Level 3||0||
48189682|NCT02923895|100786277|FG001|NOT COMPLETED|Overall Study||0||
48189683|NCT00427973|100786278|FG000|STARTED|Overall Study||17||
48189684|NCT00427973|100786278|FG000|COMPLETED|Overall Study||17||
48189685|NCT00427973|100786278|FG000|NOT COMPLETED|Overall Study||0||
48460231|NCT01227668|101463386|FG001|NOT COMPLETED|Phase 2 (Randomization Phase)||25||
48460232|NCT03929224|101463387|FG000|STARTED|Overall Study||8||
48460233|NCT03929224|101463388|FG001|STARTED|Overall Study||9||
48460234|NCT03929224|101463387|FG000|COMPLETED|Overall Study||8||
48460235|NCT03929224|101463388|FG001|COMPLETED|Overall Study||9||
48460236|NCT03929224|101463387|FG000|NOT COMPLETED|Overall Study||0||
48460237|NCT03929224|101463388|FG001|NOT COMPLETED|Overall Study||0||
48460238|NCT01809314|101463389|FG000|STARTED|Overall Study||1167||
48460239|NCT01809314|101463389|FG000|COMPLETED|Overall Study||422||
48460240|NCT01809314|101463389|FG000|NOT COMPLETED|Overall Study||745||
48460241|NCT04014959|101463390|FG000|STARTED|Baseline MRI and Assessments||41||
48460242|NCT04014959|101463390|FG000|COMPLETED|Baseline MRI and Assessments||39||
48460243|NCT04014959|101463390|FG000|NOT COMPLETED|Baseline MRI and Assessments||2||
48460244|NCT04014959|101463390|FG000|STARTED|Targeting TMS Scan||39||
48460245|NCT04014959|101463390|FG000|COMPLETED|Targeting TMS Scan||38||
48460246|NCT04014959|101463390|FG000|NOT COMPLETED|Targeting TMS Scan||1||
48664284|NCT02097225|101961980|FG001|STARTED|Dose Level 3||0||
48664285|NCT02097225|101961981|FG002|STARTED|Dose Level 3||0||
48664286|NCT02097225|101961982|FG003|STARTED|Dose Level 3||6||
48664287|NCT02097225|101961983|FG004|STARTED|Dose Level 3||0||
48664288|NCT02097225|101961979|FG000|COMPLETED|Dose Level 3||0||
48664289|NCT02097225|101961980|FG001|COMPLETED|Dose Level 3||0||
48664290|NCT02097225|101961981|FG002|COMPLETED|Dose Level 3||0||
48664291|NCT02097225|101961982|FG003|COMPLETED|Dose Level 3||6||
48664292|NCT02097225|101961983|FG004|COMPLETED|Dose Level 3||0||
48664293|NCT02097225|101961979|FG000|NOT COMPLETED|Dose Level 3||0||
48664294|NCT02097225|101961980|FG001|NOT COMPLETED|Dose Level 3||0||
48664295|NCT02097225|101961981|FG002|NOT COMPLETED|Dose Level 3||0||
48664296|NCT02097225|101961982|FG003|NOT COMPLETED|Dose Level 3||0||
48664297|NCT02097225|101961983|FG004|NOT COMPLETED|Dose Level 3||0||
48664298|NCT02097225|101961979|FG000|STARTED|Dose Level 4||0||
48664299|NCT02097225|101961980|FG001|STARTED|Dose Level 4||0||
48664300|NCT02097225|101961981|FG002|STARTED|Dose Level 4||0||
48664301|NCT02097225|101961982|FG003|STARTED|Dose Level 4||0||
48664302|NCT02097225|101961983|FG004|STARTED|Dose Level 4||9||
48664303|NCT02097225|101961979|FG000|COMPLETED|Dose Level 4||0||
48460247|NCT04014959|101463390|FG000|STARTED|TMS + fMRI Scan #1||38||
48460248|NCT04014959|101463390|FG000|COMPLETED|TMS + fMRI Scan #1||38||
48460249|NCT04014959|101463390|FG000|NOT COMPLETED|TMS + fMRI Scan #1||0||
48460250|NCT04014959|101463390|FG000|STARTED|Mini TMS Sessions (3 Visits)||38||
48460251|NCT04014959|101463390|FG000|COMPLETED|Mini TMS Sessions (3 Visits)||37||
48460252|NCT04014959|101463390|FG000|NOT COMPLETED|Mini TMS Sessions (3 Visits)||1||
48460253|NCT04014959|101463390|FG000|STARTED|TMS + fMRI Scan #2||37||
48460254|NCT04014959|101463390|FG000|COMPLETED|TMS + fMRI Scan #2||37||
48460255|NCT04014959|101463390|FG000|NOT COMPLETED|TMS + fMRI Scan #2||0||
48460256|NCT01464359|101463391|FG000|STARTED|Overall Study||3||
48460257|NCT01464359|101463391|FG000|COMPLETED|Overall Study||3||
48460258|NCT01464359|101463391|FG000|NOT COMPLETED|Overall Study||0||
48460259|NCT02743442|101463392|FG000|STARTED|Overall Study||8||
48460260|NCT02743442|101463392|FG000|COMPLETED|Overall Study||8||
48460261|NCT02743442|101463392|FG000|NOT COMPLETED|Overall Study||0||
48460262|NCT00717977|101463393|FG000|STARTED|Overall Study||74||
48460263|NCT00717977|101463393|FG000|COMPLETED|Overall Study||74||
48460264|NCT00717977|101463393|FG000|NOT COMPLETED|Overall Study||0||
48460265|NCT02099461|101463394|FG000|STARTED|Overall Study||27||
48460266|NCT02099461|101463395|FG001|STARTED|Overall Study||27||
48460267|NCT02099461|101463396|FG002|STARTED|Overall Study||28||
48460268|NCT02099461|101463394|FG000|COMPLETED|Overall Study||27||
48664304|NCT02097225|101961980|FG001|COMPLETED|Dose Level 4||0||
48460269|NCT02099461|101463395|FG001|COMPLETED|Overall Study||27||
48460270|NCT02099461|101463396|FG002|COMPLETED|Overall Study||28||
48460271|NCT02099461|101463394|FG000|NOT COMPLETED|Overall Study||0||
48460272|NCT02099461|101463395|FG001|NOT COMPLETED|Overall Study||0||
48460273|NCT02099461|101463396|FG002|NOT COMPLETED|Overall Study||0||
48460274|NCT00410410|101463397|FG000|STARTED|Induction Period (IP)||141||
48460275|NCT00410410|101463398|FG001|STARTED|Induction Period (IP)||139||
48460276|NCT00410410|101463399|FG002|STARTED|Induction Period (IP)||70||
48460277|NCT00410410|101463400|FG003|STARTED|Induction Period (IP)||140||
48460278|NCT00410410|101463401|FG004|STARTED|Induction Period (IP)||51||
48460279|NCT00410410|101463402|FG005|STARTED|Induction Period (IP)||50||
48460280|NCT00410410|101463403|FG006|STARTED|Induction Period (IP)||0||
48460281|NCT00410410|101463404|FG007|STARTED|Induction Period (IP)||0||
48460282|NCT00410410|101463405|FG008|STARTED|Induction Period (IP)||0||
48460283|NCT00410410|101463397|FG000|COMPLETED|Induction Period (IP)||106||
48460284|NCT00410410|101463398|FG001|COMPLETED|Induction Period (IP)||104||
48460285|NCT00410410|101463399|FG002|COMPLETED|Induction Period (IP)||53||
48664305|NCT02097225|101961981|FG002|COMPLETED|Dose Level 4||0||
48664306|NCT02097225|101961982|FG003|COMPLETED|Dose Level 4||0||
48664307|NCT02097225|101961983|FG004|COMPLETED|Dose Level 4||8||
48664308|NCT02097225|101961979|FG000|NOT COMPLETED|Dose Level 4||0||
48664309|NCT02097225|101961980|FG001|NOT COMPLETED|Dose Level 4||0||
48664310|NCT02097225|101961981|FG002|NOT COMPLETED|Dose Level 4||0||
48775088|NCT02998268|102240080|FG001|NOT COMPLETED|Overall Study||3||
48775089|NCT02505919|102240081|FG000|STARTED|Treatment||116||
48775090|NCT02505919|102240082|FG001|STARTED|Treatment||65||
48775091|NCT02505919|102240081|FG000|COMPLETED|Treatment||116||
48775092|NCT02505919|102240082|FG001|COMPLETED|Treatment||65||
48460286|NCT00410410|101463400|FG003|COMPLETED|Induction Period (IP)||120||
48460287|NCT00410410|101463401|FG004|COMPLETED|Induction Period (IP)||19||
48460288|NCT00410410|101463402|FG005|COMPLETED|Induction Period (IP)||21||
48460289|NCT00410410|101463403|FG006|COMPLETED|Induction Period (IP)||0||
48460290|NCT00410410|101463404|FG007|COMPLETED|Induction Period (IP)||0||
48460291|NCT00410410|101463405|FG008|COMPLETED|Induction Period (IP)||0||
48460292|NCT00410410|101463397|FG000|NOT COMPLETED|Induction Period (IP)||35||
48460293|NCT00410410|101463398|FG001|NOT COMPLETED|Induction Period (IP)||35||
48460294|NCT00410410|101463399|FG002|NOT COMPLETED|Induction Period (IP)||17||
48460295|NCT00410410|101463400|FG003|NOT COMPLETED|Induction Period (IP)||20||
48460296|NCT00410410|101463401|FG004|NOT COMPLETED|Induction Period (IP)||32||
48460297|NCT00410410|101463402|FG005|NOT COMPLETED|Induction Period (IP)||29||
48460298|NCT00410410|101463403|FG006|NOT COMPLETED|Induction Period (IP)||0||
48460299|NCT00410410|101463404|FG007|NOT COMPLETED|Induction Period (IP)||0||
48460300|NCT00410410|101463405|FG008|NOT COMPLETED|Induction Period (IP)||0||
48460301|NCT00410410|101463397|FG000|STARTED|Maintenance Period (MP)||0||
48460302|NCT00410410|101463398|FG001|STARTED|Maintenance Period (MP)||0||
48460303|NCT00410410|101463399|FG002|STARTED|Maintenance Period (MP)||0||
48460304|NCT00410410|101463400|FG003|STARTED|Maintenance Period (MP)||0||
48460305|NCT00410410|101463401|FG004|STARTED|Maintenance Period (MP)||0||
48460306|NCT00410410|101463402|FG005|STARTED|Maintenance Period (MP)||0||
48460307|NCT00410410|101463403|FG006|STARTED|Maintenance Period (MP)||65||
48460308|NCT00410410|101463404|FG007|STARTED|Maintenance Period (MP)||66||
48460309|NCT00410410|101463405|FG008|STARTED|Maintenance Period (MP)||0||
48460310|NCT00410410|101463397|FG000|COMPLETED|Maintenance Period (MP)||0||
48460311|NCT00410410|101463398|FG001|COMPLETED|Maintenance Period (MP)||0||
48460312|NCT00410410|101463399|FG002|COMPLETED|Maintenance Period (MP)||0||
48460313|NCT00410410|101463400|FG003|COMPLETED|Maintenance Period (MP)||0||
48460314|NCT00410410|101463401|FG004|COMPLETED|Maintenance Period (MP)||0||
48460315|NCT00410410|101463402|FG005|COMPLETED|Maintenance Period (MP)||0||
48460316|NCT00410410|101463403|FG006|COMPLETED|Maintenance Period (MP)||15||
48460317|NCT00410410|101463404|FG007|COMPLETED|Maintenance Period (MP)||11||
48460318|NCT00410410|101463405|FG008|COMPLETED|Maintenance Period (MP)||0||
48460319|NCT00410410|101463397|FG000|NOT COMPLETED|Maintenance Period (MP)||0||
48460320|NCT00410410|101463398|FG001|NOT COMPLETED|Maintenance Period (MP)||0||
48460321|NCT00410410|101463399|FG002|NOT COMPLETED|Maintenance Period (MP)||0||
48460322|NCT00410410|101463400|FG003|NOT COMPLETED|Maintenance Period (MP)||0||
48664311|NCT02097225|101961982|FG003|NOT COMPLETED|Dose Level 4||0||
48664312|NCT02097225|101961983|FG004|NOT COMPLETED|Dose Level 4||1||
48664313|NCT03559556|101961984|FG000|STARTED|Overall Study||14||
48664314|NCT03559556|101961984|FG000|COMPLETED|Overall Study||13||
48664315|NCT03559556|101961984|FG000|NOT COMPLETED|Overall Study||1||
48664316|NCT00088699|101961985|FG000|STARTED|Infusion 1||23||
48775093|NCT02505919|102240081|FG000|NOT COMPLETED|Treatment||0||
48775094|NCT02505919|102240082|FG001|NOT COMPLETED|Treatment||0||
48460323|NCT00410410|101463401|FG004|NOT COMPLETED|Maintenance Period (MP)||0||
48460324|NCT00410410|101463402|FG005|NOT COMPLETED|Maintenance Period (MP)||0||
48460325|NCT00410410|101463403|FG006|NOT COMPLETED|Maintenance Period (MP)||50||
48460326|NCT00410410|101463404|FG007|NOT COMPLETED|Maintenance Period (MP)||55||
48775095|NCT02505919|102240081|FG000|STARTED|1 Week Follow-Up||116||
48460327|NCT00410410|101463405|FG008|NOT COMPLETED|Maintenance Period (MP)||0||
48460328|NCT00410410|101463397|FG000|STARTED|Open-Label Period (OL)||0||
48775096|NCT02505919|102240082|FG001|STARTED|1 Week Follow-Up||65||
48460329|NCT00410410|101463398|FG001|STARTED|Open-Label Period (OL)||0||
48460330|NCT00410410|101463399|FG002|STARTED|Open-Label Period (OL)||0||
48460331|NCT00410410|101463400|FG003|STARTED|Open-Label Period (OL)||0||
48460332|NCT00410410|101463401|FG004|STARTED|Open-Label Period (OL)||0||
48460333|NCT00410410|101463402|FG005|STARTED|Open-Label Period (OL)||0||
48460334|NCT00410410|101463403|FG006|STARTED|Open-Label Period (OL)||0||
48460335|NCT00410410|101463404|FG007|STARTED|Open-Label Period (OL)||0||
48460336|NCT00410410|101463405|FG008|STARTED|Open-Label Period (OL)||349||
48460337|NCT00410410|101463397|FG000|COMPLETED|Open-Label Period (OL)||0||
48460338|NCT00410410|101463398|FG001|COMPLETED|Open-Label Period (OL)||0||
48460339|NCT00410410|101463399|FG002|COMPLETED|Open-Label Period (OL)||0||
48460340|NCT00410410|101463400|FG003|COMPLETED|Open-Label Period (OL)||0||
48460341|NCT00410410|101463401|FG004|COMPLETED|Open-Label Period (OL)||0||
48460342|NCT00410410|101463402|FG005|COMPLETED|Open-Label Period (OL)||0||
48460343|NCT00410410|101463403|FG006|COMPLETED|Open-Label Period (OL)||0||
48460344|NCT00410410|101463404|FG007|COMPLETED|Open-Label Period (OL)||0||
48460345|NCT00410410|101463405|FG008|COMPLETED|Open-Label Period (OL)||0||
48460346|NCT00410410|101463397|FG000|NOT COMPLETED|Open-Label Period (OL)||0||
48460347|NCT00410410|101463398|FG001|NOT COMPLETED|Open-Label Period (OL)||0||
48460348|NCT00410410|101463399|FG002|NOT COMPLETED|Open-Label Period (OL)||0||
48460349|NCT00410410|101463400|FG003|NOT COMPLETED|Open-Label Period (OL)||0||
48460350|NCT00410410|101463401|FG004|NOT COMPLETED|Open-Label Period (OL)||0||
48460351|NCT00410410|101463402|FG005|NOT COMPLETED|Open-Label Period (OL)||0||
48460352|NCT00410410|101463403|FG006|NOT COMPLETED|Open-Label Period (OL)||0||
48460353|NCT00410410|101463404|FG007|NOT COMPLETED|Open-Label Period (OL)||0||
48460354|NCT00410410|101463405|FG008|NOT COMPLETED|Open-Label Period (OL)||349||
48460355|NCT01347710|101463406|FG000|STARTED|Overall Study||795||
48460356|NCT01347710|101463406|FG000|COMPLETED|Overall Study||764||
48460357|NCT01347710|101463406|FG000|NOT COMPLETED|Overall Study||31||
48460358|NCT00386724|101463407|FG000|STARTED|Overall Study||8||
48460359|NCT00386724|101463407|FG000|3 Months Post-activation|Overall Study||4||
48460360|NCT00386724|101463407|FG000|COMPLETED|Overall Study||3||
48460361|NCT00386724|101463407|FG000|NOT COMPLETED|Overall Study||5||
48460362|NCT00146770|101463408|FG000|STARTED|Overall Study||23||
48460363|NCT00146770|101463409|FG001|STARTED|Overall Study||22||
48460364|NCT00146770|101463408|FG000|COMPLETED|Overall Study||18||
48460365|NCT00146770|101463409|FG001|COMPLETED|Overall Study||22||
48460366|NCT00146770|101463408|FG000|NOT COMPLETED|Overall Study||5||
48460367|NCT00146770|101463409|FG001|NOT COMPLETED|Overall Study||0||
48460368|NCT01211769|101463410|FG000|STARTED|Overall Study||20||
48460369|NCT01211769|101463411|FG001|STARTED|Overall Study||20||
48460370|NCT01211769|101463412|FG002|STARTED|Overall Study||20||
48664317|NCT00088699|101961986|FG001|STARTED|Infusion 1||19||
48189686|NCT01027871|100786279|FG000|STARTED|Overall Study||93||
48189687|NCT01027871|100786280|FG001|STARTED|Overall Study||98||
48460371|NCT01211769|101463413|FG003|STARTED|Overall Study||20||
48460372|NCT01211769|101463410|FG000|Participants/Group|Overall Study||20||
48460373|NCT01211769|101463411|FG001|Participants/Group|Overall Study||20||
48460374|NCT01211769|101463412|FG002|Participants/Group|Overall Study||20||
48460375|NCT01211769|101463413|FG003|Participants/Group|Overall Study||20||
48460376|NCT01211769|101463410|FG000|COMPLETED|Overall Study||11||
48664318|NCT00088699|101961987|FG002|STARTED|Infusion 1||13||
48664319|NCT00088699|101961988|FG003|STARTED|Infusion 1||12||
48664320|NCT00088699|101961985|FG000|COMPLETED|Infusion 1||22||
48664321|NCT00088699|101961986|FG001|COMPLETED|Infusion 1||19||
48664322|NCT00088699|101961987|FG002|COMPLETED|Infusion 1||12||
48664323|NCT00088699|101961988|FG003|COMPLETED|Infusion 1||10||
48775097|NCT02505919|102240081|FG000|COMPLETED|1 Week Follow-Up||116||
48775098|NCT02505919|102240082|FG001|COMPLETED|1 Week Follow-Up||65||
48775099|NCT02505919|102240081|FG000|NOT COMPLETED|1 Week Follow-Up||0||
48775100|NCT02505919|102240082|FG001|NOT COMPLETED|1 Week Follow-Up||0||
48189688|NCT01027871|100786281|FG002|STARTED|Overall Study||98||
48460377|NCT01211769|101463411|FG001|COMPLETED|Overall Study||10||
48460378|NCT01211769|101463412|FG002|COMPLETED|Overall Study||12||
48460379|NCT01211769|101463413|FG003|COMPLETED|Overall Study||9||
48460380|NCT01211769|101463410|FG000|NOT COMPLETED|Overall Study||9||
48460381|NCT01211769|101463411|FG001|NOT COMPLETED|Overall Study||10||
48460382|NCT01211769|101463412|FG002|NOT COMPLETED|Overall Study||8||
48460383|NCT01211769|101463413|FG003|NOT COMPLETED|Overall Study||11||
48460384|NCT01467063|101463414|FG000|STARTED|Overall Study||6||
48460385|NCT01467063|101463415|FG001|STARTED|Overall Study||7||
48460386|NCT01467063|101463414|FG000|COMPLETED|Overall Study||5||
48460387|NCT01467063|101463415|FG001|COMPLETED|Overall Study||7||
48460388|NCT01467063|101463414|FG000|NOT COMPLETED|Overall Study||1||
48460389|NCT01467063|101463415|FG001|NOT COMPLETED|Overall Study||0||
48460390|NCT00634179|101463416|FG000|STARTED|Phase I: Induction||19||
48460391|NCT00634179|101463416|FG000|COMPLETED|Phase I: Induction||19||
48460392|NCT00634179|101463416|FG000|NOT COMPLETED|Phase I: Induction||0||
48460393|NCT00634179|101463416|FG000|STARTED|Phase II: Maintenance||30||
48460394|NCT00634179|101463416|FG000|COMPLETED|Phase II: Maintenance||29||
48460395|NCT00634179|101463416|FG000|NOT COMPLETED|Phase II: Maintenance||1||
48664324|NCT00088699|101961985|FG000|NOT COMPLETED|Infusion 1||1||
48664325|NCT00088699|101961986|FG001|NOT COMPLETED|Infusion 1||0||
48460396|NCT01452529|101463417|FG000|STARTED|Run-in Period||905||
48460397|NCT01452529|101463418|FG001|STARTED|Run-in Period||0||
48460398|NCT01452529|101463419|FG002|STARTED|Run-in Period||0||
48460399|NCT01452529|101463417|FG000|COMPLETED|Run-in Period||592||
48460400|NCT01452529|101463418|FG001|COMPLETED|Run-in Period||0||
48460401|NCT01452529|101463419|FG002|COMPLETED|Run-in Period||0||
48460402|NCT01452529|101463417|FG000|NOT COMPLETED|Run-in Period||313||
48460403|NCT01452529|101463418|FG001|NOT COMPLETED|Run-in Period||0||
48460404|NCT01452529|101463419|FG002|NOT COMPLETED|Run-in Period||0||
48460405|NCT01452529|101463417|FG000|STARTED|Double-blind (DB) Period||0||
48460406|NCT01452529|101463418|FG001|STARTED|Double-blind (DB) Period||296||
48460407|NCT01452529|101463419|FG002|STARTED|Double-blind (DB) Period||292||
48460408|NCT01452529|101463417|FG000|COMPLETED|Double-blind (DB) Period||0||
48460409|NCT01452529|101463418|FG001|COMPLETED|Double-blind (DB) Period||229||
48460410|NCT01452529|101463419|FG002|COMPLETED|Double-blind (DB) Period||210||
48460411|NCT01452529|101463417|FG000|NOT COMPLETED|Double-blind (DB) Period||0||
48460412|NCT01452529|101463418|FG001|NOT COMPLETED|Double-blind (DB) Period||67||
48460413|NCT01452529|101463419|FG002|NOT COMPLETED|Double-blind (DB) Period||82||
48460414|NCT01073020|101463420|FG000|STARTED|Overall Study||23||
48460415|NCT01073020|101463421|FG001|STARTED|Overall Study||22||
48460416|NCT01073020|101463422|FG002|STARTED|Overall Study||22||
48460417|NCT01073020|101463423|FG003|STARTED|Overall Study||21||
48460418|NCT01073020|101463420|FG000|COMPLETED|Overall Study||16||
48460419|NCT01073020|101463421|FG001|COMPLETED|Overall Study||17||
48460420|NCT01073020|101463422|FG002|COMPLETED|Overall Study||19||
48460421|NCT01073020|101463423|FG003|COMPLETED|Overall Study||19||
48460422|NCT01073020|101463420|FG000|NOT COMPLETED|Overall Study||7||
48460423|NCT01073020|101463421|FG001|NOT COMPLETED|Overall Study||5||
48460424|NCT01073020|101463422|FG002|NOT COMPLETED|Overall Study||3||
48460425|NCT01073020|101463423|FG003|NOT COMPLETED|Overall Study||2||
48460426|NCT00319449|101463424|FG000|STARTED|Overall Study||10||
48460427|NCT00319449|101463425|FG001|STARTED|Overall Study||12||
48460428|NCT00319449|101463424|FG000|COMPLETED|Overall Study||8||
48460429|NCT00319449|101463425|FG001|COMPLETED|Overall Study||12||
48460430|NCT00319449|101463424|FG000|NOT COMPLETED|Overall Study||2||
48460431|NCT00319449|101463425|FG001|NOT COMPLETED|Overall Study||0||
48460432|NCT01592799|101463426|FG000|STARTED|Overall Study||501||
48460433|NCT01592799|101463426|FG000|COMPLETED|Overall Study||501||
48460434|NCT01592799|101463426|FG000|NOT COMPLETED|Overall Study||0||
48460435|NCT00698022|101463427|FG000|STARTED|Overall Study||30||
48460436|NCT00698022|101463428|FG001|STARTED|Overall Study||30||
48460437|NCT00698022|101463429|FG002|STARTED|Overall Study||16||
48460438|NCT00698022|101463427|FG000|COMPLETED|Overall Study||14||
48460439|NCT00698022|101463428|FG001|COMPLETED|Overall Study||20||
48460440|NCT00698022|101463429|FG002|COMPLETED|Overall Study||14||
48460441|NCT00698022|101463427|FG000|NOT COMPLETED|Overall Study||16||
48460442|NCT00698022|101463428|FG001|NOT COMPLETED|Overall Study||10||
48460443|NCT00698022|101463429|FG002|NOT COMPLETED|Overall Study||2||
48460444|NCT00943800|101463430|FG000|STARTED|Overall Study||87||
48460445|NCT00943800|101463430|FG000|COMPLETED|Overall Study||87||
48460446|NCT00943800|101463430|FG000|NOT COMPLETED|Overall Study||0||
48460447|NCT01768000|101463431|FG000|STARTED|Overall Study||10||
48460448|NCT01768000|101463432|FG001|STARTED|Overall Study||10||
48460449|NCT01768000|101463433|FG002|STARTED|Overall Study||10||
48460450|NCT01768000|101463434|FG003|STARTED|Overall Study||10||
48460451|NCT01768000|101463431|FG000|COMPLETED|Overall Study||9||
48460452|NCT01768000|101463432|FG001|COMPLETED|Overall Study||8||
48460453|NCT01768000|101463433|FG002|COMPLETED|Overall Study||9||
48460454|NCT01768000|101463434|FG003|COMPLETED|Overall Study||8||
48460455|NCT01768000|101463431|FG000|NOT COMPLETED|Overall Study||1||
48460456|NCT01768000|101463432|FG001|NOT COMPLETED|Overall Study||2||
48664326|NCT00088699|101961987|FG002|NOT COMPLETED|Infusion 1||1||
48664327|NCT00088699|101961988|FG003|NOT COMPLETED|Infusion 1||2||
48664328|NCT00088699|101961985|FG000|STARTED|Infusion 2||19||
48775101|NCT02505919|102240081|FG000|STARTED|1 Month Follow-Up||116||
48775102|NCT02505919|102240082|FG001|STARTED|1 Month Follow-Up||65||
48775103|NCT02505919|102240081|FG000|COMPLETED|1 Month Follow-Up||116||
48775104|NCT02505919|102240082|FG001|COMPLETED|1 Month Follow-Up||65||
48775105|NCT02505919|102240081|FG000|NOT COMPLETED|1 Month Follow-Up||0||
48775106|NCT02505919|102240082|FG001|NOT COMPLETED|1 Month Follow-Up||0||
48775107|NCT02505919|102240081|FG000|STARTED|3 Months Follow-Up||116||
48775108|NCT02505919|102240082|FG001|STARTED|3 Months Follow-Up||65||
48460457|NCT01768000|101463433|FG002|NOT COMPLETED|Overall Study||1||
48460458|NCT01768000|101463434|FG003|NOT COMPLETED|Overall Study||2||
48460459|NCT02739984|101463435|FG000|STARTED|Overall Study||143||
48460460|NCT02739984|101463436|FG001|STARTED|Overall Study||281||
48460461|NCT02739984|101463435|FG000|Received Study Drug|Overall Study||141||
48460462|NCT02739984|101463436|FG001|Received Study Drug|Overall Study||280||
48460463|NCT02739984|101463435|FG000|COMPLETED|Overall Study||138||
48460464|NCT02739984|101463436|FG001|COMPLETED|Overall Study||279||
48460465|NCT02739984|101463435|FG000|NOT COMPLETED|Overall Study||5||
48460466|NCT02739984|101463436|FG001|NOT COMPLETED|Overall Study||2||
48460467|NCT03220230|101463437|FG000|STARTED|Overall Study||4240||
48460468|NCT03220230|101463437|FG000|COMPLETED|Overall Study||4240||
48664329|NCT00088699|101961986|FG001|STARTED|Infusion 2||18||
48460469|NCT03220230|101463437|FG000|NOT COMPLETED|Overall Study||0||
48460470|NCT00671671|101463438|FG000|STARTED|Overall Study||10||
48460471|NCT00671671|101463439|FG001|STARTED|Overall Study||10||
48460472|NCT00671671|101463438|FG000|COMPLETED|Overall Study||10||
48460473|NCT00671671|101463439|FG001|COMPLETED|Overall Study||10||
48460474|NCT00671671|101463438|FG000|NOT COMPLETED|Overall Study||0||
48460475|NCT00671671|101463439|FG001|NOT COMPLETED|Overall Study||0||
48460476|NCT02585258|101463440|FG000|STARTED|Overall Study||226||
48460477|NCT02585258|101463441|FG001|STARTED|Overall Study||225||
48460478|NCT02585258|101463440|FG000|Started Study Meds: Safety Population|Overall Study||224||
48460479|NCT02585258|101463441|FG001|Started Study Meds: Safety Population|Overall Study||225||
48460480|NCT02585258|101463440|FG000|Returned for Follow up: Modified Intention-to-treat (ITT) Population|Overall Study||221||
48460481|NCT02585258|101463441|FG001|Returned for Follow up: Modified Intention-to-treat (ITT) Population|Overall Study||223||
48664330|NCT00088699|101961987|FG002|STARTED|Infusion 2||11||
48775109|NCT02505919|102240081|FG000|COMPLETED|3 Months Follow-Up||116||
48369789|NCT02371759|101232844|FG005|COMPLETED|Overall Study||25||
48369790|NCT02371759|101232845|FG006|COMPLETED|Overall Study||25||
48369791|NCT02371759|101232846|FG007|COMPLETED|Overall Study||24||
48369792|NCT02371759|101232839|FG000|NOT COMPLETED|Overall Study||3||
48369793|NCT02371759|101232840|FG001|NOT COMPLETED|Overall Study||1||
48369794|NCT02371759|101232841|FG002|NOT COMPLETED|Overall Study||1||
48369795|NCT02371759|101232842|FG003|NOT COMPLETED|Overall Study||0||
48369796|NCT02371759|101232843|FG004|NOT COMPLETED|Overall Study||3||
48369797|NCT02371759|101232844|FG005|NOT COMPLETED|Overall Study||1||
48369798|NCT02371759|101232845|FG006|NOT COMPLETED|Overall Study||0||
48369799|NCT02371759|101232846|FG007|NOT COMPLETED|Overall Study||4||
48369800|NCT01293396|101232847|FG000|STARTED|First Intervention||6||
48369801|NCT01293396|101232848|FG001|STARTED|First Intervention||7||
48369802|NCT01293396|101232849|FG002|STARTED|First Intervention||7||
48369803|NCT01293396|101232847|FG000|COMPLETED|First Intervention||6||
48369804|NCT01293396|101232848|FG001|COMPLETED|First Intervention||7||
48369805|NCT01293396|101232849|FG002|COMPLETED|First Intervention||7||
48369806|NCT01293396|101232847|FG000|NOT COMPLETED|First Intervention||0||
48369807|NCT01293396|101232848|FG001|NOT COMPLETED|First Intervention||0||
48369808|NCT01293396|101232849|FG002|NOT COMPLETED|First Intervention||0||
48369809|NCT01293396|101232847|FG000|STARTED|Wash Out Period 1 (3 Days)||6||
48369810|NCT01293396|101232848|FG001|STARTED|Wash Out Period 1 (3 Days)||7||
48369811|NCT01293396|101232849|FG002|STARTED|Wash Out Period 1 (3 Days)||7||
48369812|NCT01293396|101232847|FG000|COMPLETED|Wash Out Period 1 (3 Days)||6||
48369813|NCT01293396|101232848|FG001|COMPLETED|Wash Out Period 1 (3 Days)||7||
48369814|NCT01293396|101232849|FG002|COMPLETED|Wash Out Period 1 (3 Days)||7||
48369815|NCT01293396|101232847|FG000|NOT COMPLETED|Wash Out Period 1 (3 Days)||0||
48369816|NCT01293396|101232848|FG001|NOT COMPLETED|Wash Out Period 1 (3 Days)||0||
48369817|NCT01293396|101232849|FG002|NOT COMPLETED|Wash Out Period 1 (3 Days)||0||
48369818|NCT01293396|101232847|FG000|STARTED|Second Intervention||5|"20 participants finished washout-period 1 and were randomized to the 3 interventions (BiAsp30, BiAsp70 and IAsp).~In this cross over design the participants first received BiAsp30, then e.g. switched to BiAsp70 and then to IAsp. Therefore, the number of participants could not be the same to participants who completed previous period. However, the total number of partcipants who finished the washout period is equal to the number of particpants who started this intervention sequence."|
48369819|NCT01293396|101232848|FG001|STARTED|Second Intervention||5|"20 participants finished washout-period 1 and were randomized to the 3 interventions (BiAsp30, BiAsp70 and IAsp).~In this cross over design the participants first received BiAsp30, then e.g. switched to BiAsp70 and then to IAsp. Therefore, the number of participants could not be the same to participants who completed previous period. However, the total number of partcipants who finished the washout period is equal to the number of particpants who started this intervention sequence."|
48369820|NCT01293396|101232849|FG002|STARTED|Second Intervention||10|"20 participants finished washout-period 1 and were randomized to the 3 interventions (BiAsp30, BiAsp70 and IAsp).~In this cross over design the participants first received BiAsp30, then e.g. switched to BiAsp70 and then to IAsp. Therefore, the number of participants could not be the same to participants who completed previous period. However, the total number of partcipants who finished the washout period is equal to the number of particpants who started this intervention sequence."|
48369821|NCT01293396|101232847|FG000|COMPLETED|Second Intervention||5||
48369822|NCT01293396|101232848|FG001|COMPLETED|Second Intervention||5||
48369823|NCT01293396|101232849|FG002|COMPLETED|Second Intervention||10||
48369824|NCT01293396|101232847|FG000|NOT COMPLETED|Second Intervention||0||
48369825|NCT01293396|101232848|FG001|NOT COMPLETED|Second Intervention||0||
48369826|NCT01293396|101232849|FG002|NOT COMPLETED|Second Intervention||0||
48369827|NCT01293396|101232847|FG000|STARTED|Wash Out Period 2 (3 Days)||5||
48369828|NCT01293396|101232848|FG001|STARTED|Wash Out Period 2 (3 Days)||5||
48460482|NCT02585258|101463440|FG000|COMPLETED|Overall Study||141||
48460483|NCT02585258|101463441|FG001|COMPLETED|Overall Study||137||
48460484|NCT02585258|101463440|FG000|NOT COMPLETED|Overall Study||85||
48460485|NCT02585258|101463441|FG001|NOT COMPLETED|Overall Study||88||
48460486|NCT03818737|101463442|FG000|STARTED|Overall Study||118|Intent to treat population|
48460487|NCT03818737|101463443|FG001|STARTED|Overall Study||119|Intent to treat population|
48460488|NCT03818737|101463444|FG002|STARTED|Overall Study||118|Intent to treat population|
48460489|NCT03818737|101463445|FG003|STARTED|Overall Study||120|Intent to treat population|
48775110|NCT02505919|102240082|FG001|COMPLETED|3 Months Follow-Up||65||
48460490|NCT03818737|101463442|FG000|Received Study Intervention|Overall Study||107||
48460491|NCT03818737|101463443|FG001|Received Study Intervention|Overall Study||109||
48460492|NCT03818737|101463444|FG002|Received Study Intervention|Overall Study||116||
48460493|NCT03818737|101463445|FG003|Received Study Intervention|Overall Study||108||
48460494|NCT03818737|101463442|FG000|COMPLETED|Overall Study||97||
48460495|NCT03818737|101463443|FG001|COMPLETED|Overall Study||93||
48460496|NCT03818737|101463444|FG002|COMPLETED|Overall Study||103||
48460497|NCT03818737|101463445|FG003|COMPLETED|Overall Study||97||
48460498|NCT03818737|101463442|FG000|NOT COMPLETED|Overall Study||21||
48460499|NCT03818737|101463443|FG001|NOT COMPLETED|Overall Study||26||
48460500|NCT03818737|101463444|FG002|NOT COMPLETED|Overall Study||15||
48460501|NCT03818737|101463445|FG003|NOT COMPLETED|Overall Study||23||
48460502|NCT00673361|101463446|FG000|STARTED|Overall Study||9||
48460503|NCT00673361|101463446|FG000|COMPLETED|Overall Study||7||
48460504|NCT00673361|101463446|FG000|NOT COMPLETED|Overall Study||2||
48460505|NCT01626885|101463447|FG000|STARTED|Overall Study||42||
48460506|NCT01626885|101463447|FG000|COMPLETED|Overall Study||30||
48460507|NCT01626885|101463447|FG000|NOT COMPLETED|Overall Study||12||
48460508|NCT02041494|101463448|FG000|STARTED|Overall Study||82||
48460509|NCT02041494|101463449|FG001|STARTED|Overall Study||83||
48460510|NCT02041494|101463448|FG000|COMPLETED|Overall Study||63||
48460511|NCT02041494|101463449|FG001|COMPLETED|Overall Study||63||
48460512|NCT02041494|101463448|FG000|NOT COMPLETED|Overall Study||19||
48460513|NCT02041494|101463449|FG001|NOT COMPLETED|Overall Study||20||
48460514|NCT03355742|101463450|FG000|STARTED|Overall Study||963||
48460515|NCT03355742|101463450|FG000|COMPLETED|Overall Study||864||
48460516|NCT03355742|101463450|FG000|NOT COMPLETED|Overall Study||99||
48460517|NCT01313728|101463451|FG000|STARTED|Informed Consent to Baseline||26||
48460518|NCT01313728|101463451|FG000|COMPLETED|Informed Consent to Baseline||25||
48460519|NCT01313728|101463451|FG000|NOT COMPLETED|Informed Consent to Baseline||1||
48460520|NCT01313728|101463451|FG000|STARTED|Baseline to Completion||25||
48460521|NCT01313728|101463451|FG000|COMPLETED|Baseline to Completion||25||
48460522|NCT01313728|101463451|FG000|NOT COMPLETED|Baseline to Completion||0||
48460523|NCT01497938|101463452|FG000|STARTED|Overall Study||121||
48460524|NCT01497938|101463453|FG001|STARTED|Overall Study||126||
48460525|NCT01497938|101463452|FG000|COMPLETED|Overall Study||116||
48460526|NCT01497938|101463453|FG001|COMPLETED|Overall Study||124||
48460527|NCT01497938|101463452|FG000|NOT COMPLETED|Overall Study||5||
48460528|NCT01497938|101463453|FG001|NOT COMPLETED|Overall Study||2||
48460529|NCT00472446|101463454|FG000|STARTED|Overall Study||46||
48460530|NCT00472446|101463455|FG001|STARTED|Overall Study||47||
48460531|NCT00472446|101463456|FG002|STARTED|Overall Study||45||
48460532|NCT00472446|101463457|FG003|STARTED|Overall Study||45||
48460533|NCT00472446|101463454|FG000|COMPLETED|Overall Study||41||
48460534|NCT00472446|101463455|FG001|COMPLETED|Overall Study||41||
48460535|NCT00472446|101463456|FG002|COMPLETED|Overall Study||38||
48460536|NCT00472446|101463457|FG003|COMPLETED|Overall Study||39||
48460537|NCT00472446|101463454|FG000|NOT COMPLETED|Overall Study||5||
48460538|NCT00472446|101463455|FG001|NOT COMPLETED|Overall Study||6||
48460539|NCT00472446|101463456|FG002|NOT COMPLETED|Overall Study||7||
48460540|NCT00472446|101463457|FG003|NOT COMPLETED|Overall Study||6||
48460541|NCT00275028|101463458|FG000|STARTED|Overall Study||47||
48460542|NCT00275028|101463458|FG000|COMPLETED|Overall Study||0||
48460543|NCT00275028|101463458|FG000|NOT COMPLETED|Overall Study||47||
48460544|NCT00623623|101463459|FG000|STARTED|Overall Study||950||
48460545|NCT00623623|101463460|FG001|STARTED|Overall Study||949||
48460546|NCT00623623|101463459|FG000|COMPLETED|Overall Study||949||
48460547|NCT00623623|101463460|FG001|COMPLETED|Overall Study||948||
48460548|NCT00623623|101463459|FG000|NOT COMPLETED|Overall Study||1||
48460549|NCT00623623|101463460|FG001|NOT COMPLETED|Overall Study||1||
48460550|NCT01172353|101463461|FG000|STARTED|Overall Study||150||
48460551|NCT01172353|101463462|FG001|STARTED|Overall Study||151||
48460552|NCT01172353|101463461|FG000|COMPLETED|Overall Study||150||
48460553|NCT01172353|101463462|FG001|COMPLETED|Overall Study||151||
48460554|NCT01172353|101463461|FG000|NOT COMPLETED|Overall Study||0||
48460555|NCT01172353|101463462|FG001|NOT COMPLETED|Overall Study||0||
48460556|NCT02473991|101463463|FG000|STARTED|Overall Study||395||
48460557|NCT02473991|101463463|FG000|COMPLETED|Overall Study||395||
48460558|NCT02473991|101463463|FG000|NOT COMPLETED|Overall Study||0||
48460559|NCT00947427|101463464|FG000|STARTED|Overall Study||22||
48460560|NCT00947427|101463465|FG001|STARTED|Overall Study||49||
48460561|NCT00947427|101463464|FG000|COMPLETED|Overall Study||21||
48460562|NCT00947427|101463465|FG001|COMPLETED|Overall Study||45||
48460563|NCT00947427|101463464|FG000|NOT COMPLETED|Overall Study||1||
48460564|NCT00947427|101463465|FG001|NOT COMPLETED|Overall Study||4||
48460565|NCT02649231|101463466|FG000|STARTED|Overall Study||24||
48460566|NCT02649231|101463467|FG001|STARTED|Overall Study||24||
48460567|NCT02649231|101463468|FG002|STARTED|Overall Study||23||
48460568|NCT02649231|101463469|FG003|STARTED|Overall Study||25||
48460569|NCT02649231|101463466|FG000|COMPLETED|Overall Study||20||
48460570|NCT02649231|101463467|FG001|COMPLETED|Overall Study||21||
48460571|NCT02649231|101463468|FG002|COMPLETED|Overall Study||21||
48460572|NCT02649231|101463469|FG003|COMPLETED|Overall Study||23||
48460573|NCT02649231|101463466|FG000|NOT COMPLETED|Overall Study||4||
48460574|NCT02649231|101463467|FG001|NOT COMPLETED|Overall Study||3||
48460575|NCT02649231|101463468|FG002|NOT COMPLETED|Overall Study||2||
48460576|NCT02649231|101463469|FG003|NOT COMPLETED|Overall Study||2||
48460577|NCT00681863|101463470|FG000|STARTED|Overall Study||45||
48460578|NCT00681863|101463470|FG000|COMPLETED|Overall Study||22||
48460579|NCT00681863|101463470|FG000|NOT COMPLETED|Overall Study||23||
48460580|NCT00814320|101463471|FG000|STARTED|Epoch 1 (IV Treatment)||14||
48460581|NCT00814320|101463472|FG001|STARTED|Epoch 1 (IV Treatment)||73||
48460582|NCT00814320|101463471|FG000|COMPLETED|Epoch 1 (IV Treatment)||13||
48460583|NCT00814320|101463472|FG001|COMPLETED|Epoch 1 (IV Treatment)||71||
48460584|NCT00814320|101463471|FG000|NOT COMPLETED|Epoch 1 (IV Treatment)||1||
48460585|NCT00814320|101463472|FG001|NOT COMPLETED|Epoch 1 (IV Treatment)||2||
48460586|NCT00814320|101463471|FG000|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13||
48460587|NCT00814320|101463472|FG001|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||71||
48460588|NCT00814320|101463471|FG000|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13||
48460589|NCT00814320|101463472|FG001|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||70||
48460590|NCT00814320|101463471|FG000|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||0||
48460591|NCT00814320|101463472|FG001|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||1||
48460592|NCT00814320|101463471|FG000|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||13||
48460593|NCT00814320|101463472|FG001|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||70||
48460594|NCT00814320|101463471|FG000|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||11||
48460595|NCT00814320|101463472|FG001|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||70||
48460596|NCT00814320|101463471|FG000|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||2||
48460597|NCT00814320|101463472|FG001|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||0||
48460598|NCT00814320|101463471|FG000|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||11||
48460599|NCT00814320|101463472|FG001|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||70||
48460600|NCT00814320|101463471|FG000|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||8||
48460601|NCT00814320|101463472|FG001|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||60||
48460602|NCT00814320|101463471|FG000|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||3||
48460603|NCT00814320|101463472|FG001|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||10||
48460604|NCT04160078|101463473|FG000|STARTED|Overall Study||18||
48460605|NCT04160078|101463473|FG000|COMPLETED|Overall Study||18||
48460606|NCT04160078|101463473|FG000|NOT COMPLETED|Overall Study||0||
48460607|NCT01982383|101463474|FG000|STARTED|Overall Study||2||
48460608|NCT01982383|101463475|FG001|STARTED|Overall Study||0||
48460609|NCT01982383|101463474|FG000|COMPLETED|Overall Study||2||
48460610|NCT01982383|101463475|FG001|COMPLETED|Overall Study||0||
48460611|NCT01982383|101463474|FG000|NOT COMPLETED|Overall Study||0||
48460612|NCT01982383|101463475|FG001|NOT COMPLETED|Overall Study||0||
48460613|NCT03015142|101463476|FG000|STARTED|Overall Study||21||
48460614|NCT03015142|101463476|FG000|COMPLETED|Overall Study||20||
48460615|NCT03015142|101463476|FG000|NOT COMPLETED|Overall Study||1||
48460616|NCT01752920|101463477|FG000|STARTED|Overall Study||29||
48460617|NCT01752920|101463478|FG001|STARTED|Overall Study||13||
48460618|NCT01752920|101463479|FG002|STARTED|Overall Study||19||
48460619|NCT01752920|101463480|FG003|STARTED|Overall Study||58||
48460620|NCT01752920|101463477|FG000|COMPLETED|Overall Study||0||
48460621|NCT01752920|101463478|FG001|COMPLETED|Overall Study||0||
48460622|NCT01752920|101463479|FG002|COMPLETED|Overall Study||0||
48460623|NCT01752920|101463480|FG003|COMPLETED|Overall Study||0||
48460624|NCT01752920|101463477|FG000|NOT COMPLETED|Overall Study||29||
48460625|NCT01752920|101463478|FG001|NOT COMPLETED|Overall Study||13||
48460626|NCT01752920|101463479|FG002|NOT COMPLETED|Overall Study||19||
48460627|NCT01752920|101463480|FG003|NOT COMPLETED|Overall Study||58||
48460628|NCT02462421|101463481|FG000|STARTED|Overall Study||13||
48460629|NCT02462421|101463482|FG001|STARTED|Overall Study||4||
48460630|NCT02462421|101463483|FG002|STARTED|Overall Study||6||
48460631|NCT02462421|101463484|FG003|STARTED|Overall Study||7||
48460632|NCT02462421|101463481|FG000|COMPLETED|Overall Study||13||
48460633|NCT02462421|101463482|FG001|COMPLETED|Overall Study||4||
48460634|NCT02462421|101463483|FG002|COMPLETED|Overall Study||6||
48460635|NCT02462421|101463484|FG003|COMPLETED|Overall Study||7||
48460636|NCT02462421|101463481|FG000|NOT COMPLETED|Overall Study||0||
48460637|NCT02462421|101463482|FG001|NOT COMPLETED|Overall Study||0||
48460638|NCT02462421|101463483|FG002|NOT COMPLETED|Overall Study||0||
48460639|NCT02462421|101463484|FG003|NOT COMPLETED|Overall Study||0||
48460640|NCT01214330|101463485|FG000|STARTED|Overall Study||150||
48460641|NCT01214330|101463485|FG000|COMPLETED|Overall Study||146|(Analyzed)|
48460642|NCT01214330|101463485|FG000|NOT COMPLETED|Overall Study||4||
48460643|NCT01045499|101463486|FG000|STARTED|Overall Study||137||
48460644|NCT01045499|101463486|FG000|COMPLETED|Overall Study||127||
48460645|NCT01045499|101463486|FG000|NOT COMPLETED|Overall Study||10||
48460646|NCT01612000|101463487|FG000|STARTED|Overall Study||84||
48460647|NCT01612000|101463488|FG001|STARTED|Overall Study||86||
48775111|NCT02505919|102240081|FG000|NOT COMPLETED|3 Months Follow-Up||0||
48775112|NCT02505919|102240082|FG001|NOT COMPLETED|3 Months Follow-Up||0||
48775113|NCT02505919|102240081|FG000|STARTED|6 Months Follow-Up||116||
48460648|NCT01612000|101463489|FG002|STARTED|Overall Study||85||
48460649|NCT01612000|101463490|FG003|STARTED|Overall Study||86||
48460650|NCT01612000|101463487|FG000|COMPLETED|Overall Study||75||
48775114|NCT02505919|102240082|FG001|STARTED|6 Months Follow-Up||65||
48460651|NCT01612000|101463488|FG001|COMPLETED|Overall Study||81||
48460652|NCT01612000|101463489|FG002|COMPLETED|Overall Study||78||
48460653|NCT01612000|101463490|FG003|COMPLETED|Overall Study||76||
48460654|NCT01612000|101463487|FG000|NOT COMPLETED|Overall Study||9||
48460655|NCT01612000|101463488|FG001|NOT COMPLETED|Overall Study||5||
48460656|NCT01612000|101463489|FG002|NOT COMPLETED|Overall Study||7||
48460657|NCT01612000|101463490|FG003|NOT COMPLETED|Overall Study||10||
48460658|NCT01725815|101463491|FG000|STARTED|Overall Study||198||
48460659|NCT01725815|101463492|FG001|STARTED|Overall Study||202||
48460660|NCT01725815|101463491|FG000|COMPLETED|Overall Study||198||
48460661|NCT01725815|101463492|FG001|COMPLETED|Overall Study||202||
48460662|NCT01725815|101463491|FG000|NOT COMPLETED|Overall Study||0||
48460663|NCT01725815|101463492|FG001|NOT COMPLETED|Overall Study||0||
48460664|NCT02950753|101463493|FG000|STARTED|Overall Study||15||
48460665|NCT02950753|101463494|FG001|STARTED|Overall Study||15||
48460666|NCT02950753|101463493|FG000|COMPLETED|Overall Study||15||
48460667|NCT02950753|101463494|FG001|COMPLETED|Overall Study||15||
48460668|NCT02950753|101463493|FG000|NOT COMPLETED|Overall Study||0||
48460669|NCT02950753|101463494|FG001|NOT COMPLETED|Overall Study||0||
48460670|NCT02891200|101463495|FG000|STARTED|Overall Study||145||
48460671|NCT02891200|101463496|FG001|STARTED|Overall Study||147||
48460672|NCT02891200|101463495|FG000|COMPLETED|Overall Study||103||
48460673|NCT02891200|101463496|FG001|COMPLETED|Overall Study||98||
48460674|NCT02891200|101463495|FG000|NOT COMPLETED|Overall Study||42||
48460675|NCT02891200|101463496|FG001|NOT COMPLETED|Overall Study||49||
48460676|NCT00566709|101463497|FG000|STARTED|Overall Study||51||
48460677|NCT00566709|101463498|FG001|STARTED|Overall Study||51||
48460678|NCT00566709|101463497|FG000|COMPLETED|Overall Study||46||
48460679|NCT00566709|101463498|FG001|COMPLETED|Overall Study||51||
48460680|NCT00566709|101463497|FG000|NOT COMPLETED|Overall Study||5||
48460681|NCT00566709|101463498|FG001|NOT COMPLETED|Overall Study||0||
48460682|NCT01754259|101463499|FG000|STARTED|Overall Study||23||
48460683|NCT01754259|101463500|FG001|STARTED|Overall Study||24||
48460684|NCT01754259|101463499|FG000|COMPLETED|Overall Study||18||
48460685|NCT01754259|101463500|FG001|COMPLETED|Overall Study||18||
48460686|NCT01754259|101463499|FG000|NOT COMPLETED|Overall Study||5||
48460687|NCT01754259|101463500|FG001|NOT COMPLETED|Overall Study||6||
48460688|NCT01565083|101463501|FG000|STARTED|Overall Study||106||
48460689|NCT01565083|101463502|FG001|STARTED|Overall Study||107||
48775115|NCT02505919|102240081|FG000|COMPLETED|6 Months Follow-Up||116||
48460690|NCT01565083|101463501|FG000|COMPLETED|Overall Study||73||
48460691|NCT01565083|101463502|FG001|COMPLETED|Overall Study||68||
48460692|NCT01565083|101463501|FG000|NOT COMPLETED|Overall Study||33||
48460693|NCT01565083|101463502|FG001|NOT COMPLETED|Overall Study||39||
48460694|NCT01466686|101463503|FG000|STARTED|Overall Study||31||
48460695|NCT01466686|101463503|FG000|COMPLETED|Overall Study||30||
48460696|NCT01466686|101463503|FG000|NOT COMPLETED|Overall Study||1||
48460697|NCT01038557|101463504|FG000|STARTED|Overall Study||82||
48460698|NCT01038557|101463505|FG001|STARTED|Overall Study||86||
48460699|NCT01038557|101463506|FG002|STARTED|Overall Study||86||
48460700|NCT01038557|101463504|FG000|COMPLETED|Overall Study||82||
48460701|NCT01038557|101463505|FG001|COMPLETED|Overall Study||86||
48460702|NCT01038557|101463506|FG002|COMPLETED|Overall Study||86||
48460703|NCT01038557|101463504|FG000|NOT COMPLETED|Overall Study||0||
48460704|NCT01038557|101463505|FG001|NOT COMPLETED|Overall Study||0||
48460705|NCT01038557|101463506|FG002|NOT COMPLETED|Overall Study||0||
48460706|NCT02330081|101463507|FG000|STARTED|Overall Study||22||
48460707|NCT02330081|101463507|FG000|COMPLETED|Overall Study||14||
48460708|NCT02330081|101463507|FG000|NOT COMPLETED|Overall Study||8||
48460709|NCT02497391|101463508|FG000|STARTED|Period 1 (14 Days)||16||
48460710|NCT02497391|101463509|FG001|STARTED|Period 1 (14 Days)||15||
48460711|NCT02497391|101463510|FG002|STARTED|Period 1 (14 Days)||16||
48460712|NCT02497391|101463511|FG003|STARTED|Period 1 (14 Days)||16||
48460713|NCT02497391|101463512|FG004|STARTED|Period 1 (14 Days)||16||
48775116|NCT02505919|102240082|FG001|COMPLETED|6 Months Follow-Up||63||
48460714|NCT02497391|101463513|FG005|STARTED|Period 1 (14 Days)||16||
48460715|NCT02497391|101463508|FG000|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16||
48460716|NCT02497391|101463509|FG001|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||15||
48460717|NCT02497391|101463510|FG002|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16||
48460718|NCT02497391|101463511|FG003|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16||
48460719|NCT02497391|101463512|FG004|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16||
48460720|NCT02497391|101463513|FG005|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16||
48775117|NCT02505919|102240081|FG000|NOT COMPLETED|6 Months Follow-Up||0||
48460721|NCT02497391|101463508|FG000|COMPLETED|Period 1 (14 Days)||16||
48460722|NCT02497391|101463509|FG001|COMPLETED|Period 1 (14 Days)||15||
48460723|NCT02497391|101463510|FG002|COMPLETED|Period 1 (14 Days)||16||
48460724|NCT02497391|101463511|FG003|COMPLETED|Period 1 (14 Days)||16||
48460725|NCT02497391|101463512|FG004|COMPLETED|Period 1 (14 Days)||16||
48460726|NCT02497391|101463513|FG005|COMPLETED|Period 1 (14 Days)||16||
48460727|NCT02497391|101463508|FG000|NOT COMPLETED|Period 1 (14 Days)||0||
48460728|NCT02497391|101463509|FG001|NOT COMPLETED|Period 1 (14 Days)||0||
48460729|NCT02497391|101463510|FG002|NOT COMPLETED|Period 1 (14 Days)||0||
48460730|NCT02497391|101463511|FG003|NOT COMPLETED|Period 1 (14 Days)||0||
48460731|NCT02497391|101463512|FG004|NOT COMPLETED|Period 1 (14 Days)||0||
48460732|NCT02497391|101463513|FG005|NOT COMPLETED|Period 1 (14 Days)||0||
48460733|NCT02497391|101463508|FG000|STARTED|Period 2 (14 Days)||16||
48460734|NCT02497391|101463509|FG001|STARTED|Period 2 (14 Days)||15||
48460735|NCT02497391|101463510|FG002|STARTED|Period 2 (14 Days)||16||
48460736|NCT02497391|101463511|FG003|STARTED|Period 2 (14 Days)||16||
48460737|NCT02497391|101463512|FG004|STARTED|Period 2 (14 Days)||16||
48460738|NCT02497391|101463513|FG005|STARTED|Period 2 (14 Days)||16||
48460739|NCT02497391|101463508|FG000|COMPLETED|Period 2 (14 Days)||12||
48460740|NCT02497391|101463509|FG001|COMPLETED|Period 2 (14 Days)||14||
48460741|NCT02497391|101463510|FG002|COMPLETED|Period 2 (14 Days)||13||
48460742|NCT02497391|101463511|FG003|COMPLETED|Period 2 (14 Days)||13||
48460743|NCT02497391|101463512|FG004|COMPLETED|Period 2 (14 Days)||14||
48460744|NCT02497391|101463513|FG005|COMPLETED|Period 2 (14 Days)||13||
48460745|NCT02497391|101463508|FG000|NOT COMPLETED|Period 2 (14 Days)||4||
48460746|NCT02497391|101463509|FG001|NOT COMPLETED|Period 2 (14 Days)||1||
48460747|NCT02497391|101463510|FG002|NOT COMPLETED|Period 2 (14 Days)||3||
48460748|NCT02497391|101463511|FG003|NOT COMPLETED|Period 2 (14 Days)||3||
48460749|NCT02497391|101463512|FG004|NOT COMPLETED|Period 2 (14 Days)||2||
48460750|NCT02497391|101463513|FG005|NOT COMPLETED|Period 2 (14 Days)||3||
48460751|NCT02497391|101463508|FG000|STARTED|Period 3 (14 Days)||12||
48460752|NCT02497391|101463509|FG001|STARTED|Period 3 (14 Days)||14||
48460753|NCT02497391|101463510|FG002|STARTED|Period 3 (14 Days)||13||
48460754|NCT02497391|101463511|FG003|STARTED|Period 3 (14 Days)||13||
48460755|NCT02497391|101463512|FG004|STARTED|Period 3 (14 Days)||14||
48460756|NCT02497391|101463513|FG005|STARTED|Period 3 (14 Days)||13||
48460757|NCT02497391|101463508|FG000|COMPLETED|Period 3 (14 Days)||12||
48460758|NCT02497391|101463509|FG001|COMPLETED|Period 3 (14 Days)||13||
48460759|NCT02497391|101463510|FG002|COMPLETED|Period 3 (14 Days)||12||
48460760|NCT02497391|101463511|FG003|COMPLETED|Period 3 (14 Days)||13||
48460761|NCT02497391|101463512|FG004|COMPLETED|Period 3 (14 Days)||13||
48460762|NCT02497391|101463513|FG005|COMPLETED|Period 3 (14 Days)||13||
48460763|NCT02497391|101463508|FG000|NOT COMPLETED|Period 3 (14 Days)||0||
48460764|NCT02497391|101463509|FG001|NOT COMPLETED|Period 3 (14 Days)||1||
48460765|NCT02497391|101463510|FG002|NOT COMPLETED|Period 3 (14 Days)||1||
48460766|NCT02497391|101463511|FG003|NOT COMPLETED|Period 3 (14 Days)||0||
48460767|NCT02497391|101463512|FG004|NOT COMPLETED|Period 3 (14 Days)||1||
48460768|NCT02497391|101463513|FG005|NOT COMPLETED|Period 3 (14 Days)||0||
48460769|NCT05085613|101463514|FG000|STARTED|Overall Study||27||
48460770|NCT05085613|101463515|FG001|STARTED|Overall Study||27||
48460771|NCT05085613|101463516|FG002|STARTED|Overall Study||24||
48460772|NCT05085613|101463517|FG003|STARTED|Overall Study||22||
48460773|NCT05085613|101463514|FG000|COMPLETED|Overall Study||27||
48460774|NCT05085613|101463515|FG001|COMPLETED|Overall Study||27||
48460775|NCT05085613|101463516|FG002|COMPLETED|Overall Study||24||
48460776|NCT05085613|101463517|FG003|COMPLETED|Overall Study||22||
48460777|NCT05085613|101463514|FG000|NOT COMPLETED|Overall Study||0||
48460778|NCT05085613|101463515|FG001|NOT COMPLETED|Overall Study||0||
48460779|NCT05085613|101463516|FG002|NOT COMPLETED|Overall Study||0||
48460780|NCT05085613|101463517|FG003|NOT COMPLETED|Overall Study||0||
48775118|NCT02505919|102240082|FG001|NOT COMPLETED|6 Months Follow-Up||2||
48775119|NCT02505919|102240081|FG000|STARTED|12 Months Follow-Up||116||
48775120|NCT02505919|102240082|FG001|STARTED|12 Months Follow-Up||63||
48775121|NCT02505919|102240081|FG000|COMPLETED|12 Months Follow-Up||115||
48775122|NCT02505919|102240082|FG001|COMPLETED|12 Months Follow-Up||61||
48775123|NCT02505919|102240081|FG000|NOT COMPLETED|12 Months Follow-Up||1||
48775124|NCT02505919|102240082|FG001|NOT COMPLETED|12 Months Follow-Up||2||
48775125|NCT02505919|102240081|FG000|STARTED|24 Months Follow-Up||115||
48775126|NCT02505919|102240082|FG001|STARTED|24 Months Follow-Up||61||
48775127|NCT02505919|102240081|FG000|COMPLETED|24 Months Follow-Up||112||
48775128|NCT02505919|102240082|FG001|COMPLETED|24 Months Follow-Up||60||
48775129|NCT02505919|102240081|FG000|NOT COMPLETED|24 Months Follow-Up||3||
48460781|NCT01405820|101463518|FG000|STARTED|Randomized Treatment Period||54||
48775130|NCT02505919|102240082|FG001|NOT COMPLETED|24 Months Follow-Up||1||
48460782|NCT01405820|101463519|FG001|STARTED|Randomized Treatment Period||45||
48460783|NCT01405820|101463520|FG002|STARTED|Randomized Treatment Period||52||
48460784|NCT01405820|101463521|FG003|STARTED|Randomized Treatment Period||54||
48460785|NCT01405820|101463522|FG004|STARTED|Randomized Treatment Period||47||
48460786|NCT01405820|101463523|FG005|STARTED|Randomized Treatment Period||38||
48460787|NCT01405820|101463518|FG000|Safety Population|Randomized Treatment Period||54||
48460788|NCT01405820|101463519|FG001|Safety Population|Randomized Treatment Period||45||
48460789|NCT01405820|101463520|FG002|Safety Population|Randomized Treatment Period||52||
48460790|NCT01405820|101463521|FG003|Safety Population|Randomized Treatment Period||53||
48775131|NCT02505919|102240081|FG000|STARTED|36 Months Follow-Up||112||
48775132|NCT02505919|102240082|FG001|STARTED|36 Months Follow-Up||60||
48775133|NCT02505919|102240081|FG000|COMPLETED|36 Months Follow-Up||97||
48775134|NCT02505919|102240082|FG001|COMPLETED|36 Months Follow-Up||55||
48775135|NCT02505919|102240081|FG000|NOT COMPLETED|36 Months Follow-Up||15||
48460791|NCT01405820|101463522|FG004|Safety Population|Randomized Treatment Period||47||
48460792|NCT01405820|101463523|FG005|Safety Population|Randomized Treatment Period||38||
48460793|NCT01405820|101463518|FG000|COMPLETED|Randomized Treatment Period||43||
48460794|NCT01405820|101463519|FG001|COMPLETED|Randomized Treatment Period||35||
48460795|NCT01405820|101463520|FG002|COMPLETED|Randomized Treatment Period||9||
48460796|NCT01405820|101463521|FG003|COMPLETED|Randomized Treatment Period||3||
48460797|NCT01405820|101463522|FG004|COMPLETED|Randomized Treatment Period||2||
48460798|NCT01405820|101463523|FG005|COMPLETED|Randomized Treatment Period||1||
48460799|NCT01405820|101463518|FG000|NOT COMPLETED|Randomized Treatment Period||11||
48460800|NCT01405820|101463519|FG001|NOT COMPLETED|Randomized Treatment Period||10||
48664331|NCT00088699|101961988|FG003|STARTED|Infusion 2||11||
48664332|NCT00088699|101961985|FG000|COMPLETED|Infusion 2||19||
48664333|NCT00088699|101961986|FG001|COMPLETED|Infusion 2||18||
48664334|NCT00088699|101961987|FG002|COMPLETED|Infusion 2||11||
48664335|NCT00088699|101961988|FG003|COMPLETED|Infusion 2||10||
48664336|NCT00088699|101961985|FG000|NOT COMPLETED|Infusion 2||0||
48664337|NCT00088699|101961986|FG001|NOT COMPLETED|Infusion 2||0||
48664338|NCT00088699|101961987|FG002|NOT COMPLETED|Infusion 2||0||
48664339|NCT00088699|101961988|FG003|NOT COMPLETED|Infusion 2||1||
48664340|NCT04603560|101961989|FG000|STARTED|Overall Study||173|Providers Randomized|
48664341|NCT04603560|101961990|FG001|STARTED|Overall Study||143|Providers Randomized|
48664342|NCT04603560|101961991|FG002|STARTED|Overall Study||150|Providers Randomized|
48664343|NCT04603560|101961992|FG003|STARTED|Overall Study||16|Providers Randomized|
48460801|NCT01405820|101463520|FG002|NOT COMPLETED|Randomized Treatment Period||43||
48460802|NCT01405820|101463521|FG003|NOT COMPLETED|Randomized Treatment Period||51||
48460803|NCT01405820|101463522|FG004|NOT COMPLETED|Randomized Treatment Period||45||
48460804|NCT01405820|101463523|FG005|NOT COMPLETED|Randomized Treatment Period||37||
48460805|NCT01405820|101463518|FG000|STARTED|Open-Label Treatment Period||44||
48460806|NCT01405820|101463519|FG001|STARTED|Open-Label Treatment Period||35||
48460807|NCT01405820|101463520|FG002|STARTED|Open-Label Treatment Period||42||
48460808|NCT01405820|101463521|FG003|STARTED|Open-Label Treatment Period||42||
48460809|NCT01405820|101463522|FG004|STARTED|Open-Label Treatment Period||42||
48460810|NCT01405820|101463523|FG005|STARTED|Open-Label Treatment Period||32||
48460811|NCT01405820|101463518|FG000|COMPLETED|Open-Label Treatment Period||40||
48460812|NCT01405820|101463519|FG001|COMPLETED|Open-Label Treatment Period||33||
48460813|NCT01405820|101463520|FG002|COMPLETED|Open-Label Treatment Period||39||
48460814|NCT01405820|101463521|FG003|COMPLETED|Open-Label Treatment Period||37||
48460815|NCT01405820|101463522|FG004|COMPLETED|Open-Label Treatment Period||40||
48460816|NCT01405820|101463523|FG005|COMPLETED|Open-Label Treatment Period||30||
48460817|NCT01405820|101463518|FG000|NOT COMPLETED|Open-Label Treatment Period||4||
48460818|NCT01405820|101463519|FG001|NOT COMPLETED|Open-Label Treatment Period||2||
48460819|NCT01405820|101463520|FG002|NOT COMPLETED|Open-Label Treatment Period||3||
48460820|NCT01405820|101463521|FG003|NOT COMPLETED|Open-Label Treatment Period||5||
48460821|NCT01405820|101463522|FG004|NOT COMPLETED|Open-Label Treatment Period||2||
48460822|NCT01405820|101463523|FG005|NOT COMPLETED|Open-Label Treatment Period||2||
48460823|NCT00252187|101463524|FG000|STARTED|Overall Study||24||
48460824|NCT00252187|101463525|FG001|STARTED|Overall Study||21||
48460825|NCT00252187|101463524|FG000|COMPLETED|Overall Study||20||
48460826|NCT00252187|101463525|FG001|COMPLETED|Overall Study||20||
48460827|NCT00252187|101463524|FG000|NOT COMPLETED|Overall Study||4||
48460828|NCT00252187|101463525|FG001|NOT COMPLETED|Overall Study||1||
48460829|NCT02959775|101463526|FG000|STARTED|Overall Study||160||
48460830|NCT02959775|101463527|FG001|STARTED|Overall Study||160||
48460831|NCT02959775|101463528|FG002|STARTED|Overall Study||160||
48460832|NCT02959775|101463526|FG000|COMPLETED|Overall Study||133||
48460833|NCT02959775|101463527|FG001|COMPLETED|Overall Study||133||
48460834|NCT02959775|101463528|FG002|COMPLETED|Overall Study||124||
48460835|NCT02959775|101463526|FG000|NOT COMPLETED|Overall Study||27||
48460836|NCT02959775|101463527|FG001|NOT COMPLETED|Overall Study||27||
48460837|NCT02959775|101463528|FG002|NOT COMPLETED|Overall Study||36||
48460838|NCT00112489|101463529|FG000|STARTED|Overall Study||55||
48460839|NCT00112489|101463529|FG000|COMPLETED|Overall Study||15||
48460840|NCT00112489|101463529|FG000|NOT COMPLETED|Overall Study||40||
48460841|NCT02753400|101463530|FG000|STARTED|Overall Study||12||
48460842|NCT02753400|101463531|FG001|STARTED|Overall Study||12||
48460843|NCT02753400|101463530|FG000|COMPLETED|Overall Study||7||
48460844|NCT02753400|101463531|FG001|COMPLETED|Overall Study||11||
48460845|NCT02753400|101463530|FG000|NOT COMPLETED|Overall Study||5||
48460846|NCT02753400|101463531|FG001|NOT COMPLETED|Overall Study||1||
48460847|NCT02786498|101463532|FG000|STARTED|Overall Study||27||
48460848|NCT02786498|101463533|FG001|STARTED|Overall Study||24||
48460849|NCT02786498|101463534|FG002|STARTED|Overall Study||24||
48664344|NCT04603560|101961993|FG004|STARTED|Overall Study||15|Providers Randomized|
48664345|NCT04603560|101961994|FG005|STARTED|Overall Study||14|Providers Randomized|
48664346|NCT04603560|101961989|FG000|COMPLETED|Overall Study||173|Providers Completed Study|
48664347|NCT04603560|101961990|FG001|COMPLETED|Overall Study||143|Providers Completed Study|
48664348|NCT04603560|101961991|FG002|COMPLETED|Overall Study||150|Providers Completed Study|
48664349|NCT04603560|101961992|FG003|COMPLETED|Overall Study||16|Providers Completed Study|
48460850|NCT02786498|101463535|FG003|STARTED|Overall Study||27||
48460851|NCT02786498|101463532|FG000|COMPLETED|Overall Study||25||
48460852|NCT02786498|101463533|FG001|COMPLETED|Overall Study||24||
48460853|NCT02786498|101463534|FG002|COMPLETED|Overall Study||24||
48460854|NCT02786498|101463535|FG003|COMPLETED|Overall Study||26||
48460855|NCT02786498|101463532|FG000|NOT COMPLETED|Overall Study||2||
48460856|NCT02786498|101463533|FG001|NOT COMPLETED|Overall Study||0||
48460857|NCT02786498|101463534|FG002|NOT COMPLETED|Overall Study||0||
48460858|NCT02786498|101463535|FG003|NOT COMPLETED|Overall Study||1||
48460859|NCT01759381|101463536|FG000|STARTED|Overall Study||8||
48460860|NCT01759381|101463537|FG001|STARTED|Overall Study||11||
48460861|NCT01759381|101463536|FG000|COMPLETED|Overall Study||7||
48460862|NCT01759381|101463537|FG001|COMPLETED|Overall Study||11||
48460863|NCT01759381|101463536|FG000|NOT COMPLETED|Overall Study||1||
48460864|NCT01759381|101463537|FG001|NOT COMPLETED|Overall Study||0||
48460865|NCT00685919|101463538|FG000|STARTED|Overall Study||8||
48460866|NCT00685919|101463539|FG001|STARTED|Overall Study||9||
48460867|NCT00685919|101463540|FG002|STARTED|Overall Study||8||
48460868|NCT00685919|101463541|FG003|STARTED|Overall Study||3||
48460869|NCT00685919|101463538|FG000|Baseline A|Overall Study||8||
48460870|NCT00685919|101463539|FG001|Baseline A|Overall Study||9||
48460871|NCT00685919|101463540|FG002|Baseline A|Overall Study||8||
48460872|NCT00685919|101463541|FG003|Baseline A|Overall Study||3||
48460873|NCT00685919|101463538|FG000|Treatment A|Overall Study||7||
48460874|NCT00685919|101463539|FG001|Treatment A|Overall Study||9||
48460875|NCT00685919|101463540|FG002|Treatment A|Overall Study||8||
48460876|NCT00685919|101463541|FG003|Treatment A|Overall Study||3||
48460877|NCT00685919|101463538|FG000|24 hr Post-treatment A|Overall Study||7||
48664350|NCT04603560|101961993|FG004|COMPLETED|Overall Study||15|Providers Completed Study|
48664351|NCT04603560|101961994|FG005|COMPLETED|Overall Study||14|Providers Completed Study|
48664352|NCT04603560|101961989|FG000|NOT COMPLETED|Overall Study||0||
48664353|NCT04603560|101961990|FG001|NOT COMPLETED|Overall Study||0||
48664354|NCT04603560|101961991|FG002|NOT COMPLETED|Overall Study||0||
48664355|NCT04603560|101961992|FG003|NOT COMPLETED|Overall Study||0||
48664356|NCT04603560|101961993|FG004|NOT COMPLETED|Overall Study||0||
48664357|NCT04603560|101961994|FG005|NOT COMPLETED|Overall Study||0||
48664358|NCT03888287|101961995|FG000|STARTED|Overall Study||131||
48664359|NCT03888287|101961996|FG001|STARTED|Overall Study||0||
48664360|NCT03888287|101961997|FG002|STARTED|Overall Study||266||
48664361|NCT03888287|101961998|FG003|STARTED|Overall Study||80||
48664362|NCT03888287|101961995|FG000|COMPLETED|Overall Study||131||
48664363|NCT03888287|101961996|FG001|COMPLETED|Overall Study||0||
48664364|NCT03888287|101961997|FG002|COMPLETED|Overall Study||266||
48664365|NCT03888287|101961998|FG003|COMPLETED|Overall Study||80||
48664366|NCT03888287|101961995|FG000|NOT COMPLETED|Overall Study||0||
48664367|NCT03888287|101961996|FG001|NOT COMPLETED|Overall Study||0||
48664368|NCT03888287|101961997|FG002|NOT COMPLETED|Overall Study||0||
48664369|NCT03888287|101961998|FG003|NOT COMPLETED|Overall Study||0||
48664370|NCT00085735|101961999|FG000|STARTED|Overall Study||64||
48664371|NCT00085735|101962000|FG001|STARTED|Overall Study||64||
48664372|NCT00085735|101962001|FG002|STARTED|Overall Study||63||
48664373|NCT00085735|101962002|FG003|STARTED|Overall Study||65||
48664374|NCT00085735|101962003|FG004|STARTED|Overall Study||147||
48664375|NCT00085735|101962004|FG005|STARTED|Overall Study||146||
48664376|NCT00085735|101961999|FG000|COMPLETED|Overall Study||52||
48664377|NCT00085735|101962000|FG001|COMPLETED|Overall Study||54||
48664378|NCT00085735|101962001|FG002|COMPLETED|Overall Study||46||
48664379|NCT00085735|101962002|FG003|COMPLETED|Overall Study||46||
48664380|NCT00085735|101962003|FG004|COMPLETED|Overall Study||105||
48664381|NCT00085735|101962004|FG005|COMPLETED|Overall Study||115||
48664382|NCT00085735|101961999|FG000|NOT COMPLETED|Overall Study||12||
48664383|NCT00085735|101962000|FG001|NOT COMPLETED|Overall Study||10||
48664384|NCT00085735|101962001|FG002|NOT COMPLETED|Overall Study||17||
48664385|NCT00085735|101962002|FG003|NOT COMPLETED|Overall Study||19||
48664386|NCT00085735|101962003|FG004|NOT COMPLETED|Overall Study||42||
48664387|NCT00085735|101962004|FG005|NOT COMPLETED|Overall Study||31||
48664388|NCT05135754|101962005|FG000|STARTED|Overall Study||100||
48664389|NCT05135754|101962005|FG000|Baseline (Intention to Treat Population)|Overall Study||92||
48460878|NCT00685919|101463539|FG001|24 hr Post-treatment A|Overall Study||9||
48460879|NCT00685919|101463540|FG002|24 hr Post-treatment A|Overall Study||7||
48460880|NCT00685919|101463541|FG003|24 hr Post-treatment A|Overall Study||3||
48460881|NCT00685919|101463538|FG000|Baseline B|Overall Study||7||
48460882|NCT00685919|101463539|FG001|Baseline B|Overall Study||9||
48460883|NCT00685919|101463540|FG002|Baseline B|Overall Study||7||
48460884|NCT00685919|101463541|FG003|Baseline B|Overall Study||3||
48460885|NCT00685919|101463538|FG000|Treatment B|Overall Study||7||
48460886|NCT00685919|101463539|FG001|Treatment B|Overall Study||9||
48460887|NCT00685919|101463540|FG002|Treatment B|Overall Study||7||
48460888|NCT00685919|101463541|FG003|Treatment B|Overall Study||3||
48460889|NCT00685919|101463538|FG000|24 hr Post Treatment B|Overall Study||7||
48460890|NCT00685919|101463539|FG001|24 hr Post Treatment B|Overall Study||9||
48460891|NCT00685919|101463540|FG002|24 hr Post Treatment B|Overall Study||7||
48460892|NCT00685919|101463541|FG003|24 hr Post Treatment B|Overall Study||3||
48460893|NCT00685919|101463538|FG000|COMPLETED|Overall Study||7||
48775136|NCT02505919|102240082|FG001|NOT COMPLETED|36 Months Follow-Up||5||
48775137|NCT02505919|102240081|FG000|STARTED|60 Months Follow-Up||97||
48775138|NCT02505919|102240082|FG001|STARTED|60 Months Follow-Up||55||
48775139|NCT02505919|102240081|FG000|COMPLETED|60 Months Follow-Up||58||
48775140|NCT02505919|102240082|FG001|COMPLETED|60 Months Follow-Up||32||
48775141|NCT02505919|102240081|FG000|NOT COMPLETED|60 Months Follow-Up||39||
48775142|NCT02505919|102240082|FG001|NOT COMPLETED|60 Months Follow-Up||23||
48775143|NCT00948441|102240083|FG000|STARTED|Overall Study||8||
48775144|NCT00948441|102240084|FG001|STARTED|Overall Study||8||
48775145|NCT00948441|102240083|FG000|COMPLETED|Overall Study||7||
48775146|NCT00948441|102240084|FG001|COMPLETED|Overall Study||4||
48775147|NCT00948441|102240083|FG000|NOT COMPLETED|Overall Study||1||
48775148|NCT00948441|102240084|FG001|NOT COMPLETED|Overall Study||4||
48775149|NCT03519711|102240085|FG000|STARTED|Treatment Period 1 (7 Days)||4||
48775150|NCT03519711|102240086|FG001|STARTED|Treatment Period 1 (7 Days)||4||
48775151|NCT03519711|102240085|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 (7 Days)||4||
48775152|NCT03519711|102240086|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 (7 Days)||4||
48775153|NCT03519711|102240085|FG000|COMPLETED|Treatment Period 1 (7 Days)||4||
48664390|NCT05135754|101962005|FG000|COMPLETED|Overall Study||80||
48664391|NCT05135754|101962005|FG000|NOT COMPLETED|Overall Study||20||
48664392|NCT02790736|101962006|FG000|STARTED|Overall Study||5||
48664393|NCT02790736|101962007|FG001|STARTED|Overall Study||1||
48664394|NCT02790736|101962006|FG000|COMPLETED|Overall Study||5||
48664395|NCT02790736|101962007|FG001|COMPLETED|Overall Study||1||
48775154|NCT03519711|102240086|FG001|COMPLETED|Treatment Period 1 (7 Days)||4||
48775155|NCT03519711|102240085|FG000|NOT COMPLETED|Treatment Period 1 (7 Days)||0||
48775156|NCT03519711|102240086|FG001|NOT COMPLETED|Treatment Period 1 (7 Days)||0||
48460894|NCT00685919|101463539|FG001|COMPLETED|Overall Study||9||
48460895|NCT00685919|101463540|FG002|COMPLETED|Overall Study||7||
48460896|NCT00685919|101463541|FG003|COMPLETED|Overall Study||3||
48460897|NCT00685919|101463538|FG000|NOT COMPLETED|Overall Study||1||
48460898|NCT00685919|101463539|FG001|NOT COMPLETED|Overall Study||0||
48460899|NCT00685919|101463540|FG002|NOT COMPLETED|Overall Study||1||
48460900|NCT00685919|101463541|FG003|NOT COMPLETED|Overall Study||0||
48460901|NCT03507439|101463542|FG000|STARTED|Overall Study||14||
48460902|NCT03507439|101463543|FG001|STARTED|Overall Study||13||
48775157|NCT03519711|102240085|FG000|STARTED|Treatment Period 2 (7 Days)||4||
48775158|NCT03519711|102240086|FG001|STARTED|Treatment Period 2 (7 Days)||4||
48775159|NCT03519711|102240085|FG000|COMPLETED|Treatment Period 2 (7 Days)||4||
48775160|NCT03519711|102240086|FG001|COMPLETED|Treatment Period 2 (7 Days)||4||
48775161|NCT03519711|102240085|FG000|NOT COMPLETED|Treatment Period 2 (7 Days)||0||
48775162|NCT03519711|102240086|FG001|NOT COMPLETED|Treatment Period 2 (7 Days)||0||
48775163|NCT02792829|102240087|FG000|STARTED|Treatment Period 1||10||
48775164|NCT02792829|102240088|FG001|STARTED|Treatment Period 1||10||
48775165|NCT02792829|102240089|FG002|STARTED|Treatment Period 1||5||
48775166|NCT02792829|102240090|FG003|STARTED|Treatment Period 1||5||
48775167|NCT02792829|102240091|FG004|STARTED|Treatment Period 1||5||
48775168|NCT02792829|102240092|FG005|STARTED|Treatment Period 1||5||
48775169|NCT02792829|102240093|FG006|STARTED|Treatment Period 1||10||
48775170|NCT02792829|102240094|FG007|STARTED|Treatment Period 1||10||
48775171|NCT02792829|102240087|FG000|COMPLETED|Treatment Period 1||10||
48775172|NCT02792829|102240088|FG001|COMPLETED|Treatment Period 1||10||
48775173|NCT02792829|102240089|FG002|COMPLETED|Treatment Period 1||5||
48775174|NCT02792829|102240090|FG003|COMPLETED|Treatment Period 1||5||
48775175|NCT02792829|102240091|FG004|COMPLETED|Treatment Period 1||5||
48189689|NCT01027871|100786279|FG000|Received at Least One Dose of Study Drug|Overall Study||93||
48189690|NCT01027871|100786280|FG001|Received at Least One Dose of Study Drug|Overall Study||98||
48460903|NCT03507439|101463542|FG000|COMPLETED|Overall Study||10||
48460904|NCT03507439|101463543|FG001|COMPLETED|Overall Study||11||
48460905|NCT03507439|101463542|FG000|NOT COMPLETED|Overall Study||4||
48460906|NCT03507439|101463543|FG001|NOT COMPLETED|Overall Study||2||
48664396|NCT02790736|101962006|FG000|NOT COMPLETED|Overall Study||0||
48664397|NCT02790736|101962007|FG001|NOT COMPLETED|Overall Study||0||
48664398|NCT00830336|101962008|FG000|STARTED|First Intervention||40||
48664399|NCT00830336|101962009|FG001|STARTED|First Intervention||40||
48775176|NCT02792829|102240092|FG005|COMPLETED|Treatment Period 1||5||
48775177|NCT02792829|102240093|FG006|COMPLETED|Treatment Period 1||10||
48775178|NCT02792829|102240094|FG007|COMPLETED|Treatment Period 1||10||
48775179|NCT02792829|102240087|FG000|NOT COMPLETED|Treatment Period 1||0||
48775180|NCT02792829|102240088|FG001|NOT COMPLETED|Treatment Period 1||0||
48775181|NCT02792829|102240089|FG002|NOT COMPLETED|Treatment Period 1||0||
48775182|NCT02792829|102240090|FG003|NOT COMPLETED|Treatment Period 1||0||
48775183|NCT02792829|102240091|FG004|NOT COMPLETED|Treatment Period 1||0||
48775184|NCT02792829|102240092|FG005|NOT COMPLETED|Treatment Period 1||0||
48775185|NCT02792829|102240093|FG006|NOT COMPLETED|Treatment Period 1||0||
48775186|NCT02792829|102240094|FG007|NOT COMPLETED|Treatment Period 1||0||
48460907|NCT03867383|101463544|FG000|STARTED|Overall Study||20||
48460908|NCT03867383|101463545|FG001|STARTED|Overall Study||20||
48460909|NCT03867383|101463544|FG000|COMPLETED|Overall Study||20||
48460910|NCT03867383|101463545|FG001|COMPLETED|Overall Study||20||
48460911|NCT03867383|101463544|FG000|NOT COMPLETED|Overall Study||0||
48460912|NCT03867383|101463545|FG001|NOT COMPLETED|Overall Study||0||
48460913|NCT03141177|101463546|FG000|STARTED|Overall Study||323|Started=Randomized|
48460914|NCT03141177|101463547|FG001|STARTED|Overall Study||50|Started=Randomized|
48460915|NCT03141177|101463548|FG002|STARTED|Overall Study||328|Started=Randomized|
48460916|NCT03141177|101463546|FG000|Treated|Overall Study||320|Treated=Started treatment period|
48460917|NCT03141177|101463547|FG001|Treated|Overall Study||50|Treated=Started treatment period|
48460918|NCT03141177|101463548|FG002|Treated|Overall Study||320|Treated=Started treatment period|
48460919|NCT03141177|101463546|FG000|COMPLETED|Overall Study||242|Completed=Continuing in the Study|
48460920|NCT03141177|101463547|FG001|COMPLETED|Overall Study||34|Completed=Continuing in the Study|
48460921|NCT03141177|101463548|FG002|COMPLETED|Overall Study||210|Completed=Continuing in the Study|
48460922|NCT03141177|101463546|FG000|NOT COMPLETED|Overall Study||81||
48460923|NCT03141177|101463547|FG001|NOT COMPLETED|Overall Study||16||
48460924|NCT03141177|101463548|FG002|NOT COMPLETED|Overall Study||118||
48460925|NCT03731182|101463549|FG000|STARTED|Overall Study||70||
48460926|NCT03731182|101463550|FG001|STARTED|Overall Study||34||
48460927|NCT03731182|101463549|FG000|V114 or Prevnar 13™ Vaccination (Day 1)|Overall Study||69||
48460928|NCT03731182|101463550|FG001|V114 or Prevnar 13™ Vaccination (Day 1)|Overall Study||34||
48460929|NCT03731182|101463549|FG000|COMPLETED|Overall Study||65||
48460930|NCT03731182|101463550|FG001|COMPLETED|Overall Study||34||
48460931|NCT03731182|101463549|FG000|NOT COMPLETED|Overall Study||5||
48460932|NCT03731182|101463550|FG001|NOT COMPLETED|Overall Study||0||
48460933|NCT03922477|101463551|FG000|STARTED|Overall Study||13||
48460934|NCT03922477|101463551|FG000|COMPLETED|Overall Study||0||
48460935|NCT03922477|101463551|FG000|NOT COMPLETED|Overall Study||13||
48460936|NCT04690413|101463552|FG000|STARTED|Overall Study||129||
48460937|NCT04690413|101463552|FG000|COMPLETED|Overall Study||124||
48460938|NCT04690413|101463552|FG000|NOT COMPLETED|Overall Study||5||
48460939|NCT00321711|101463553|FG000|STARTED|Part A||13||
48460940|NCT00321711|101463554|FG001|STARTED|Part A||13||
48460941|NCT00321711|101463555|FG002|STARTED|Part A||14||
48460942|NCT00321711|101463556|FG003|STARTED|Part A||0||
48460943|NCT00321711|101463557|FG004|STARTED|Part A||0||
48460944|NCT00321711|101463553|FG000|COMPLETED|Part A||8||
48460945|NCT00321711|101463554|FG001|COMPLETED|Part A||3||
48460946|NCT00321711|101463555|FG002|COMPLETED|Part A||3||
48460947|NCT00321711|101463556|FG003|COMPLETED|Part A||0||
48460948|NCT00321711|101463557|FG004|COMPLETED|Part A||0||
48460949|NCT00321711|101463553|FG000|NOT COMPLETED|Part A||5||
48460950|NCT00321711|101463554|FG001|NOT COMPLETED|Part A||10||
48460951|NCT00321711|101463555|FG002|NOT COMPLETED|Part A||11||
48460952|NCT00321711|101463556|FG003|NOT COMPLETED|Part A||0||
48460953|NCT00321711|101463557|FG004|NOT COMPLETED|Part A||0||
48460954|NCT00321711|101463553|FG000|STARTED|Part B||0||
48460955|NCT00321711|101463554|FG001|STARTED|Part B||0||
48460956|NCT00321711|101463555|FG002|STARTED|Part B||0||
48460957|NCT00321711|101463556|FG003|STARTED|Part B||14||
48460958|NCT00321711|101463557|FG004|STARTED|Part B||15||
48460959|NCT00321711|101463553|FG000|COMPLETED|Part B||0||
48460960|NCT00321711|101463554|FG001|COMPLETED|Part B||0||
48460961|NCT00321711|101463555|FG002|COMPLETED|Part B||0||
48460962|NCT00321711|101463556|FG003|COMPLETED|Part B||8||
48460963|NCT00321711|101463557|FG004|COMPLETED|Part B||10||
48460964|NCT00321711|101463553|FG000|NOT COMPLETED|Part B||0||
48460965|NCT00321711|101463554|FG001|NOT COMPLETED|Part B||0||
48189691|NCT01027871|100786281|FG002|Received at Least One Dose of Study Drug|Overall Study||97||
48189692|NCT01027871|100786279|FG000|COMPLETED|Overall Study||91||
48460966|NCT00321711|101463555|FG002|NOT COMPLETED|Part B||0||
48460967|NCT00321711|101463556|FG003|NOT COMPLETED|Part B||6||
48460968|NCT00321711|101463557|FG004|NOT COMPLETED|Part B||5||
48460969|NCT01567306|101463558|FG000|STARTED|Overall Study||27||
48460970|NCT01567306|101463559|FG001|STARTED|Overall Study||25||
48460971|NCT01567306|101463560|FG002|STARTED|Overall Study||24||
48460972|NCT01567306|101463561|FG003|STARTED|Overall Study||24||
48460973|NCT01567306|101463562|FG004|STARTED|Overall Study||25||
48460974|NCT01567306|101463563|FG005|STARTED|Overall Study||26||
48460975|NCT01567306|101463558|FG000|COMPLETED|Overall Study||24||
48460976|NCT01567306|101463559|FG001|COMPLETED|Overall Study||23||
48460977|NCT01567306|101463560|FG002|COMPLETED|Overall Study||24||
48460978|NCT01567306|101463561|FG003|COMPLETED|Overall Study||19||
48460979|NCT01567306|101463562|FG004|COMPLETED|Overall Study||18||
48460980|NCT01567306|101463563|FG005|COMPLETED|Overall Study||23||
48460981|NCT01567306|101463558|FG000|NOT COMPLETED|Overall Study||3||
48189693|NCT01027871|100786280|FG001|COMPLETED|Overall Study||85||
48189694|NCT01027871|100786281|FG002|COMPLETED|Overall Study||91||
48460982|NCT01567306|101463559|FG001|NOT COMPLETED|Overall Study||2||
48460983|NCT01567306|101463560|FG002|NOT COMPLETED|Overall Study||0||
48460984|NCT01567306|101463561|FG003|NOT COMPLETED|Overall Study||5||
48460985|NCT01567306|101463562|FG004|NOT COMPLETED|Overall Study||7||
48460986|NCT01567306|101463563|FG005|NOT COMPLETED|Overall Study||3||
48460987|NCT02035137|101463564|FG000|STARTED|Overall Study||38||
48460988|NCT02035137|101463565|FG001|STARTED|Overall Study||37||
48460989|NCT02035137|101463566|FG002|STARTED|Overall Study||39||
48460990|NCT02035137|101463564|FG000|COMPLETED|Overall Study||36||
48460991|NCT02035137|101463565|FG001|COMPLETED|Overall Study||35||
48460992|NCT02035137|101463566|FG002|COMPLETED|Overall Study||34||
48460993|NCT02035137|101463564|FG000|NOT COMPLETED|Overall Study||2||
48460994|NCT02035137|101463565|FG001|NOT COMPLETED|Overall Study||2||
48460995|NCT02035137|101463566|FG002|NOT COMPLETED|Overall Study||5||
48460996|NCT03520283|101463567|FG000|STARTED|Overall Study||24||
48460997|NCT03520283|101463568|FG001|STARTED|Overall Study||42||
48460998|NCT03520283|101463567|FG000|COMPLETED|Overall Study||24||
48460999|NCT03520283|101463568|FG001|COMPLETED|Overall Study||42||
48461000|NCT03520283|101463567|FG000|NOT COMPLETED|Overall Study||0||
48461001|NCT03520283|101463568|FG001|NOT COMPLETED|Overall Study||0||
48461002|NCT00745251|101463569|FG000|STARTED|Overall Study||23||
48461003|NCT00745251|101463570|FG001|STARTED|Overall Study||22||
48461004|NCT00745251|101463569|FG000|COMPLETED|Overall Study||21||
48461005|NCT00745251|101463570|FG001|COMPLETED|Overall Study||19||
48461006|NCT00745251|101463569|FG000|NOT COMPLETED|Overall Study||2||
48461007|NCT00745251|101463570|FG001|NOT COMPLETED|Overall Study||3||
48461008|NCT02711956|101463571|FG000|STARTED|Overall Study||2||
48461009|NCT02711956|101463572|FG001|STARTED|Overall Study||2||
48461010|NCT02711956|101463573|FG002|STARTED|Overall Study||3||
48461011|NCT02711956|101463574|FG003|STARTED|Overall Study||5||
48461012|NCT02711956|101463575|FG004|STARTED|Overall Study||4||
48461013|NCT02711956|101463576|FG005|STARTED|Overall Study||3||
48461014|NCT02711956|101463577|FG006|STARTED|Overall Study||4||
48461015|NCT02711956|101463578|FG007|STARTED|Overall Study||4||
48461016|NCT02711956|101463579|FG008|STARTED|Overall Study||4||
48461017|NCT02711956|101463580|FG009|STARTED|Overall Study||3||
48775187|NCT02792829|102240087|FG000|STARTED|Wash Out Period||10||
48775188|NCT02792829|102240088|FG001|STARTED|Wash Out Period||10||
48775189|NCT02792829|102240089|FG002|STARTED|Wash Out Period||5||
48775190|NCT02792829|102240090|FG003|STARTED|Wash Out Period||5||
48461018|NCT02711956|101463581|FG010|STARTED|Overall Study||1||
48461019|NCT02711956|101463582|FG011|STARTED|Overall Study||9||
48461020|NCT02711956|101463583|FG012|STARTED|Overall Study||17||
48461021|NCT02711956|101463584|FG013|STARTED|Overall Study||6||
48461022|NCT02711956|101463585|FG014|STARTED|Overall Study||8||
48461023|NCT02711956|101463571|FG000|COMPLETED|Overall Study||0||
48461024|NCT02711956|101463572|FG001|COMPLETED|Overall Study||0||
48461025|NCT02711956|101463573|FG002|COMPLETED|Overall Study||1||
48461026|NCT02711956|101463574|FG003|COMPLETED|Overall Study||2||
48461027|NCT02711956|101463575|FG004|COMPLETED|Overall Study||0||
48461028|NCT02711956|101463576|FG005|COMPLETED|Overall Study||1||
48461029|NCT02711956|101463577|FG006|COMPLETED|Overall Study||0||
48461030|NCT02711956|101463578|FG007|COMPLETED|Overall Study||2||
48461031|NCT02711956|101463579|FG008|COMPLETED|Overall Study||0||
48461032|NCT02711956|101463580|FG009|COMPLETED|Overall Study||0||
48461033|NCT02711956|101463581|FG010|COMPLETED|Overall Study||0||
48461034|NCT02711956|101463582|FG011|COMPLETED|Overall Study||0||
48461035|NCT02711956|101463583|FG012|COMPLETED|Overall Study||1||
48461036|NCT02711956|101463584|FG013|COMPLETED|Overall Study||1||
48461037|NCT02711956|101463585|FG014|COMPLETED|Overall Study||0||
48461038|NCT02711956|101463571|FG000|NOT COMPLETED|Overall Study||2||
48461039|NCT02711956|101463572|FG001|NOT COMPLETED|Overall Study||2||
48461040|NCT02711956|101463573|FG002|NOT COMPLETED|Overall Study||2||
48461041|NCT02711956|101463574|FG003|NOT COMPLETED|Overall Study||3||
48461042|NCT02711956|101463575|FG004|NOT COMPLETED|Overall Study||4||
48461043|NCT02711956|101463576|FG005|NOT COMPLETED|Overall Study||2||
48461044|NCT02711956|101463577|FG006|NOT COMPLETED|Overall Study||4||
48461045|NCT02711956|101463578|FG007|NOT COMPLETED|Overall Study||2||
48461046|NCT02711956|101463579|FG008|NOT COMPLETED|Overall Study||4||
48461047|NCT02711956|101463580|FG009|NOT COMPLETED|Overall Study||3||
48461048|NCT02711956|101463581|FG010|NOT COMPLETED|Overall Study||1||
48461049|NCT02711956|101463582|FG011|NOT COMPLETED|Overall Study||9||
48461050|NCT02711956|101463583|FG012|NOT COMPLETED|Overall Study||16||
48775191|NCT02792829|102240091|FG004|STARTED|Wash Out Period||5||
48775192|NCT02792829|102240092|FG005|STARTED|Wash Out Period||5||
48461051|NCT02711956|101463584|FG013|NOT COMPLETED|Overall Study||5||
48461052|NCT02711956|101463585|FG014|NOT COMPLETED|Overall Study||8||
48461053|NCT01828255|101463586|FG000|STARTED|Overall Study||20||
48461054|NCT01828255|101463587|FG001|STARTED|Overall Study||20||
48461055|NCT01828255|101463586|FG000|COMPLETED|Overall Study||20||
48775193|NCT02792829|102240093|FG006|STARTED|Wash Out Period||10||
48775194|NCT02792829|102240094|FG007|STARTED|Wash Out Period||10||
48461056|NCT01828255|101463587|FG001|COMPLETED|Overall Study||20||
48461057|NCT01828255|101463586|FG000|NOT COMPLETED|Overall Study||0||
48461058|NCT01828255|101463587|FG001|NOT COMPLETED|Overall Study||0||
48461059|NCT03020472|101463588|FG000|STARTED|Overall Study||6||
48461060|NCT03020472|101463588|FG000|COMPLETED|Overall Study||6||
48461061|NCT03020472|101463588|FG000|NOT COMPLETED|Overall Study||0||
48461062|NCT01488578|101463589|FG000|STARTED|Overall Study||11157||
48461063|NCT01488578|101463589|FG000|COMPLETED|Overall Study||9321||
48461064|NCT01488578|101463589|FG000|NOT COMPLETED|Overall Study||1836||
48461065|NCT03979209|101463590|FG000|STARTED|Overall Study||2||
48461066|NCT03979209|101463591|FG001|STARTED|Overall Study||14||
48461067|NCT03979209|101463592|FG002|STARTED|Overall Study||0||
48461068|NCT03979209|101463590|FG000|COMPLETED|Overall Study||2||
48461069|NCT03979209|101463591|FG001|COMPLETED|Overall Study||14||
48461070|NCT03979209|101463592|FG002|COMPLETED|Overall Study||0||
48461071|NCT03979209|101463590|FG000|NOT COMPLETED|Overall Study||0||
48461072|NCT03979209|101463591|FG001|NOT COMPLETED|Overall Study||0||
48461073|NCT03979209|101463592|FG002|NOT COMPLETED|Overall Study||0||
48461074|NCT00395083|101463593|FG000|STARTED|Overall Study||217||
48461075|NCT00395083|101463594|FG001|STARTED|Overall Study||209||
48461076|NCT00395083|101463593|FG000|COMPLETED|Overall Study||207||
48461077|NCT00395083|101463594|FG001|COMPLETED|Overall Study||201||
48461078|NCT00395083|101463593|FG000|NOT COMPLETED|Overall Study||10||
48461079|NCT00395083|101463594|FG001|NOT COMPLETED|Overall Study||8||
48461080|NCT02087046|101463595|FG000|STARTED|Overall Study||127||
48461081|NCT02087046|101463595|FG000|Primary Endpoint|Overall Study||121||
48461082|NCT02087046|101463595|FG000|COMPLETED|Overall Study||116||
48461083|NCT02087046|101463595|FG000|NOT COMPLETED|Overall Study||11||
48461084|NCT02429869|101463596|FG000|STARTED|Overall Study||10||
48461085|NCT02429869|101463596|FG000|COMPLETED|Overall Study||10||
48461086|NCT02429869|101463596|FG000|NOT COMPLETED|Overall Study||0||
48461087|NCT03008460|101463597|FG000|STARTED|Overall Study||126|Randomised|
48461088|NCT03008460|101463598|FG001|STARTED|Overall Study||124|Randomised|
48461089|NCT03008460|101463597|FG000|COMPLETED|Overall Study||119||
48461090|NCT03008460|101463598|FG001|COMPLETED|Overall Study||110||
48461091|NCT03008460|101463597|FG000|NOT COMPLETED|Overall Study||7||
48664400|NCT00830336|101962008|FG000|COMPLETED|First Intervention||40||
48664401|NCT00830336|101962009|FG001|COMPLETED|First Intervention||40||
48664402|NCT00830336|101962008|FG000|NOT COMPLETED|First Intervention||0||
48664403|NCT00830336|101962009|FG001|NOT COMPLETED|First Intervention||0||
48664404|NCT00830336|101962008|FG000|STARTED|Washout: 21 Days||40||
48664405|NCT00830336|101962009|FG001|STARTED|Washout: 21 Days||40||
48664406|NCT00830336|101962008|FG000|COMPLETED|Washout: 21 Days||39||
48664407|NCT00830336|101962009|FG001|COMPLETED|Washout: 21 Days||40||
48664408|NCT00830336|101962008|FG000|NOT COMPLETED|Washout: 21 Days||1||
48664409|NCT00830336|101962009|FG001|NOT COMPLETED|Washout: 21 Days||0||
48664410|NCT00830336|101962008|FG000|STARTED|Second Intervention||39||
48664411|NCT00830336|101962009|FG001|STARTED|Second Intervention||40||
48664412|NCT00830336|101962008|FG000|COMPLETED|Second Intervention||39||
48664413|NCT00830336|101962009|FG001|COMPLETED|Second Intervention||40||
48664414|NCT00830336|101962008|FG000|NOT COMPLETED|Second Intervention||0||
48664415|NCT00830336|101962009|FG001|NOT COMPLETED|Second Intervention||0||
48664416|NCT01673919|101962010|FG000|STARTED|Overall Study||7||
48664417|NCT01673919|101962010|FG000|COMPLETED|Overall Study||7||
48664418|NCT01673919|101962010|FG000|NOT COMPLETED|Overall Study||0||
48664419|NCT02614248|101962011|FG000|STARTED|Overall Study||75||
48664420|NCT02614248|101962012|FG001|STARTED|Overall Study||74||
48664421|NCT02614248|101962011|FG000|COMPLETED|Overall Study||72||
48664422|NCT02614248|101962012|FG001|COMPLETED|Overall Study||70||
48664423|NCT02614248|101962011|FG000|NOT COMPLETED|Overall Study||3||
48775195|NCT02792829|102240087|FG000|COMPLETED|Wash Out Period||10||
48775196|NCT02792829|102240088|FG001|COMPLETED|Wash Out Period||10||
48775197|NCT02792829|102240089|FG002|COMPLETED|Wash Out Period||5||
48461092|NCT03008460|101463598|FG001|NOT COMPLETED|Overall Study||14||
48461093|NCT00820235|101463599|FG000|STARTED|Overall Study||48||48
48461094|NCT00820235|101463600|FG001|STARTED|Overall Study||49||49
48461095|NCT00820235|101463601|FG002|STARTED|Overall Study||44||44
48461096|NCT00820235|101463599|FG000|COMPLETED|Overall Study||33||33
48461097|NCT00820235|101463600|FG001|COMPLETED|Overall Study||28||28
48461098|NCT00820235|101463601|FG002|COMPLETED|Overall Study||27||27
48664424|NCT02614248|101962012|FG001|NOT COMPLETED|Overall Study||4||
48664425|NCT00511199|101962013|FG000|STARTED|Overall Study||1591||
48664426|NCT00511199|101962014|FG001|STARTED|Overall Study||535||
48664427|NCT00511199|101962013|FG000|COMPLETED|Overall Study||1142||
48664428|NCT00511199|101962014|FG001|COMPLETED|Overall Study||410||
48664429|NCT00511199|101962013|FG000|NOT COMPLETED|Overall Study||449||
48664430|NCT00511199|101962014|FG001|NOT COMPLETED|Overall Study||125||
48775198|NCT02792829|102240090|FG003|COMPLETED|Wash Out Period||5||
48775199|NCT02792829|102240091|FG004|COMPLETED|Wash Out Period||5||
48775200|NCT02792829|102240092|FG005|COMPLETED|Wash Out Period||5||
48461099|NCT00820235|101463599|FG000|NOT COMPLETED|Overall Study||15||15
48461100|NCT00820235|101463600|FG001|NOT COMPLETED|Overall Study||21||21
48461101|NCT00820235|101463601|FG002|NOT COMPLETED|Overall Study||17||17
48461102|NCT01636297|101463602|FG000|STARTED|Overall Study||40||
48461103|NCT01636297|101463603|FG001|STARTED|Overall Study||40||
48664431|NCT04770285|101962015|FG000|STARTED|Overall Study||194||
48664432|NCT04770285|101962016|FG001|STARTED|Overall Study||192||
48670064|NCT02626533|101974882|FG000|4 Weeks Post-op|Overall Study||162|Participants who were successfully contacted for 4 weeks post-operation follow up.|
48670222|NCT03711734|101974915|FG000|STARTED|Overall Study||20||
48775201|NCT02792829|102240093|FG006|COMPLETED|Wash Out Period||10||
48775202|NCT02792829|102240094|FG007|COMPLETED|Wash Out Period||10||
48461104|NCT01636297|101463604|FG002|STARTED|Overall Study||20||
48461105|NCT01636297|101463602|FG000|COMPLETED|Overall Study||36||
48461106|NCT01636297|101463603|FG001|COMPLETED|Overall Study||36||
48461107|NCT01636297|101463604|FG002|COMPLETED|Overall Study||19||
48461108|NCT01636297|101463602|FG000|NOT COMPLETED|Overall Study||4||
48461109|NCT01636297|101463603|FG001|NOT COMPLETED|Overall Study||4||
48461110|NCT01636297|101463604|FG002|NOT COMPLETED|Overall Study||1||
48461111|NCT01703741|101463605|FG000|STARTED|Overall Study||145||
48461112|NCT01703741|101463605|FG000|Per Protocol (PP) Population|Overall Study||106||
48461113|NCT01703741|101463605|FG000|COMPLETED|Overall Study||127||
48461114|NCT01703741|101463605|FG000|NOT COMPLETED|Overall Study||18||
48461115|NCT03654898|101463606|FG000|STARTED|Overall Study||395||
48461116|NCT03654898|101463607|FG001|STARTED|Overall Study||405||
48461117|NCT03654898|101463606|FG000|COMPLETED|Overall Study||304||
48461118|NCT03654898|101463607|FG001|COMPLETED|Overall Study||314||
48461119|NCT03654898|101463606|FG000|NOT COMPLETED|Overall Study||91||
48461120|NCT03654898|101463607|FG001|NOT COMPLETED|Overall Study||91||
48461121|NCT00310856|101463608|FG000|STARTED|Overall Study||64||
48461122|NCT00310856|101463609|FG001|STARTED|Overall Study||61||
48461123|NCT00310856|101463610|FG002|STARTED|Overall Study||50||
48461124|NCT00310856|101463608|FG000|COMPLETED|Overall Study||59||
48461125|NCT00310856|101463609|FG001|COMPLETED|Overall Study||56||
48461126|NCT00310856|101463610|FG002|COMPLETED|Overall Study||42||
48461127|NCT00310856|101463608|FG000|NOT COMPLETED|Overall Study||5||
48461128|NCT00310856|101463609|FG001|NOT COMPLETED|Overall Study||5||
48461129|NCT00310856|101463610|FG002|NOT COMPLETED|Overall Study||8||
48461130|NCT03273387|101463611|FG000|STARTED|Overall Study||13||
48461131|NCT03273387|101463612|FG001|STARTED|Overall Study||13||
48461132|NCT03273387|101463611|FG000|COMPLETED|Overall Study||10||
48461133|NCT03273387|101463612|FG001|COMPLETED|Overall Study||10||
48461134|NCT03273387|101463611|FG000|NOT COMPLETED|Overall Study||3||
48461135|NCT03273387|101463612|FG001|NOT COMPLETED|Overall Study||3||
48461136|NCT02737306|101463613|FG000|STARTED|Overall Study||6||
48461137|NCT02737306|101463614|FG001|STARTED|Overall Study||5||
48461138|NCT02737306|101463613|FG000|COMPLETED|Overall Study||2||
48461139|NCT02737306|101463614|FG001|COMPLETED|Overall Study||5||
48461140|NCT02737306|101463613|FG000|NOT COMPLETED|Overall Study||4||
48461141|NCT02737306|101463614|FG001|NOT COMPLETED|Overall Study||0||
48461142|NCT03267030|101463615|FG000|STARTED|Overall Study||55||
48461143|NCT03267030|101463615|FG000|COMPLETED|Overall Study||50||
48461144|NCT03267030|101463615|FG000|NOT COMPLETED|Overall Study||5||
48461145|NCT01841606|101463616|FG000|STARTED|Overall Study||25||
48461146|NCT01841606|101463617|FG001|STARTED|Overall Study||27||
48461147|NCT01841606|101463616|FG000|COMPLETED|Overall Study||25||
48461148|NCT01841606|101463617|FG001|COMPLETED|Overall Study||27||
48461149|NCT01841606|101463616|FG000|NOT COMPLETED|Overall Study||0||
48461150|NCT01841606|101463617|FG001|NOT COMPLETED|Overall Study||0||
48461151|NCT00712010|101463618|FG000|STARTED|1st Protein Testing (1 Day)||24||
48461152|NCT00712010|101463618|FG000|COMPLETED|1st Protein Testing (1 Day)||24||
48461153|NCT00712010|101463618|FG000|NOT COMPLETED|1st Protein Testing (1 Day)||0||
48461154|NCT00712010|101463618|FG000|STARTED|Washout (7 Days)||24||
48461155|NCT00712010|101463618|FG000|COMPLETED|Washout (7 Days)||24||
48461156|NCT00712010|101463618|FG000|NOT COMPLETED|Washout (7 Days)||0||
48461157|NCT00712010|101463618|FG000|STARTED|2nd Protein Testing (1 Day)||24||
48461158|NCT00712010|101463618|FG000|COMPLETED|2nd Protein Testing (1 Day)||24||
48461159|NCT00712010|101463618|FG000|NOT COMPLETED|2nd Protein Testing (1 Day)||0||
48461160|NCT00712010|101463618|FG000|STARTED|Washout (7 Days)||24||
48461161|NCT00712010|101463618|FG000|COMPLETED|Washout (7 Days)||24||
48461162|NCT00712010|101463618|FG000|NOT COMPLETED|Washout (7 Days)||0||
48461163|NCT00712010|101463618|FG000|STARTED|3rd Protein Testing (1 Day)||24||
48461164|NCT00712010|101463618|FG000|COMPLETED|3rd Protein Testing (1 Day)||24||
48461165|NCT00712010|101463618|FG000|NOT COMPLETED|3rd Protein Testing (1 Day)||0||
48461166|NCT00712010|101463618|FG000|STARTED|Washout (7 Days)||24||
48461167|NCT00712010|101463618|FG000|COMPLETED|Washout (7 Days)||24||
48461168|NCT00712010|101463618|FG000|NOT COMPLETED|Washout (7 Days)||0||
48461169|NCT00712010|101463618|FG000|STARTED|4th Protein Testing (1 Day)||24||
48369829|NCT01293396|101232849|FG002|STARTED|Wash Out Period 2 (3 Days)||10||
48461170|NCT00712010|101463618|FG000|COMPLETED|4th Protein Testing (1 Day)||24||
48461171|NCT00712010|101463618|FG000|NOT COMPLETED|4th Protein Testing (1 Day)||0||
48461172|NCT00712010|101463618|FG000|STARTED|Washout (7 Days)||24||
48461173|NCT00712010|101463618|FG000|COMPLETED|Washout (7 Days)||23||
48461174|NCT00712010|101463618|FG000|NOT COMPLETED|Washout (7 Days)||1||
48369830|NCT01293396|101232847|FG000|COMPLETED|Wash Out Period 2 (3 Days)||5||
48369831|NCT01293396|101232848|FG001|COMPLETED|Wash Out Period 2 (3 Days)||5||
48369832|NCT01293396|101232849|FG002|COMPLETED|Wash Out Period 2 (3 Days)||10||
48369833|NCT01293396|101232847|FG000|NOT COMPLETED|Wash Out Period 2 (3 Days)||0||
48369834|NCT01293396|101232848|FG001|NOT COMPLETED|Wash Out Period 2 (3 Days)||0||
48369835|NCT01293396|101232849|FG002|NOT COMPLETED|Wash Out Period 2 (3 Days)||0||
48369836|NCT01293396|101232847|FG000|STARTED|Third Intervention||9|20 participants finished washout-period 2 and were randomized to the 3 interventions (BiAsp30, BiAsp70 and IAsp).|
48369837|NCT01293396|101232848|FG001|STARTED|Third Intervention||8|20 participants finished washout-period 2 and were randomized to the 3 interventions (BiAsp30, BiAsp70 and IAsp).|
48369838|NCT01293396|101232849|FG002|STARTED|Third Intervention||3|20 participants finished washout-period 2 and were randomized to the 3 interventions (BiAsp30, BiAsp70 and IAsp).|
48369839|NCT01293396|101232847|FG000|COMPLETED|Third Intervention||9||
48775203|NCT02792829|102240087|FG000|NOT COMPLETED|Wash Out Period||0||
48775204|NCT02792829|102240088|FG001|NOT COMPLETED|Wash Out Period||0||
48775205|NCT02792829|102240089|FG002|NOT COMPLETED|Wash Out Period||0||
48775206|NCT02792829|102240090|FG003|NOT COMPLETED|Wash Out Period||0||
48775207|NCT02792829|102240091|FG004|NOT COMPLETED|Wash Out Period||0||
48775208|NCT02792829|102240092|FG005|NOT COMPLETED|Wash Out Period||0||
48775209|NCT02792829|102240093|FG006|NOT COMPLETED|Wash Out Period||0||
48775210|NCT02792829|102240094|FG007|NOT COMPLETED|Wash Out Period||0||
48775211|NCT02792829|102240087|FG000|STARTED|Treatment Period 2||10||
48775212|NCT02792829|102240088|FG001|STARTED|Treatment Period 2||10||
48775213|NCT02792829|102240089|FG002|STARTED|Treatment Period 2||5||
48775214|NCT02792829|102240090|FG003|STARTED|Treatment Period 2||5||
48775215|NCT02792829|102240091|FG004|STARTED|Treatment Period 2||5||
48775216|NCT02792829|102240092|FG005|STARTED|Treatment Period 2||5||
48775217|NCT02792829|102240093|FG006|STARTED|Treatment Period 2||10||
48775218|NCT02792829|102240094|FG007|STARTED|Treatment Period 2||10||
48775219|NCT02792829|102240087|FG000|COMPLETED|Treatment Period 2||10||
48775220|NCT02792829|102240088|FG001|COMPLETED|Treatment Period 2||9||
48775221|NCT02792829|102240089|FG002|COMPLETED|Treatment Period 2||5||
48775222|NCT02792829|102240090|FG003|COMPLETED|Treatment Period 2||5||
48775223|NCT02792829|102240091|FG004|COMPLETED|Treatment Period 2||4||
48775224|NCT02792829|102240092|FG005|COMPLETED|Treatment Period 2||5||
48775225|NCT02792829|102240093|FG006|COMPLETED|Treatment Period 2||9||
48775226|NCT02792829|102240094|FG007|COMPLETED|Treatment Period 2||8||
48775227|NCT02792829|102240087|FG000|NOT COMPLETED|Treatment Period 2||0||
48775228|NCT02792829|102240088|FG001|NOT COMPLETED|Treatment Period 2||1||
48775229|NCT02792829|102240089|FG002|NOT COMPLETED|Treatment Period 2||0||
48775230|NCT02792829|102240090|FG003|NOT COMPLETED|Treatment Period 2||0||
48775231|NCT02792829|102240091|FG004|NOT COMPLETED|Treatment Period 2||1||
48775232|NCT02792829|102240092|FG005|NOT COMPLETED|Treatment Period 2||0||
48775233|NCT02792829|102240093|FG006|NOT COMPLETED|Treatment Period 2||1||
48775234|NCT02792829|102240094|FG007|NOT COMPLETED|Treatment Period 2||2||
48775235|NCT00565084|102240095|FG000|STARTED|First Treatment Period||11||
48461175|NCT00712010|101463618|FG000|STARTED|5th Protein Testing (1 Day)||23||
48461176|NCT00712010|101463618|FG000|COMPLETED|5th Protein Testing (1 Day)||23||
48461177|NCT00712010|101463618|FG000|NOT COMPLETED|5th Protein Testing (1 Day)||0||
48461178|NCT00712010|101463618|FG000|STARTED|Washout (7 Days)||23||
48461179|NCT00712010|101463618|FG000|COMPLETED|Washout (7 Days)||23||
48461180|NCT00712010|101463618|FG000|NOT COMPLETED|Washout (7 Days)||0||
48461181|NCT00712010|101463618|FG000|STARTED|6th Protein Testing (1 Day)||23||
48461182|NCT00712010|101463618|FG000|COMPLETED|6th Protein Testing (1 Day)||23||
48461183|NCT00712010|101463618|FG000|NOT COMPLETED|6th Protein Testing (1 Day)||0||
48461184|NCT00712010|101463618|FG000|STARTED|Washout (7 Days)||23||
48461185|NCT00712010|101463618|FG000|COMPLETED|Washout (7 Days)||23||
48461186|NCT00712010|101463618|FG000|NOT COMPLETED|Washout (7 Days)||0||
48461187|NCT00712010|101463618|FG000|STARTED|7th and Last Protein Testing (1 Day)||23||
48461188|NCT00712010|101463618|FG000|COMPLETED|7th and Last Protein Testing (1 Day)||23||
48461189|NCT00712010|101463618|FG000|NOT COMPLETED|7th and Last Protein Testing (1 Day)||0||
48461190|NCT03687125|101463619|FG000|STARTED|Overall Study||3||
48461191|NCT03687125|101463620|FG001|STARTED|Overall Study||3||
48461192|NCT03687125|101463619|FG000|COMPLETED|Overall Study||0||
48461193|NCT03687125|101463620|FG001|COMPLETED|Overall Study||2||
48461194|NCT03687125|101463619|FG000|NOT COMPLETED|Overall Study||3||
48775236|NCT00565084|102240096|FG001|STARTED|First Treatment Period||11||
48775237|NCT00565084|102240097|FG002|STARTED|First Treatment Period||11||
48775238|NCT00565084|102240095|FG000|COMPLETED|First Treatment Period||11||
48775239|NCT00565084|102240096|FG001|COMPLETED|First Treatment Period||11||
48775240|NCT00565084|102240097|FG002|COMPLETED|First Treatment Period||11||
48775241|NCT00565084|102240095|FG000|NOT COMPLETED|First Treatment Period||0||
48775242|NCT00565084|102240096|FG001|NOT COMPLETED|First Treatment Period||0||
48775243|NCT00565084|102240097|FG002|NOT COMPLETED|First Treatment Period||0||
48775244|NCT00565084|102240095|FG000|STARTED|Second Treatment Period||11||
48775245|NCT00565084|102240096|FG001|STARTED|Second Treatment Period||11||
48775246|NCT00565084|102240097|FG002|STARTED|Second Treatment Period||11||
48775247|NCT00565084|102240095|FG000|COMPLETED|Second Treatment Period||11||
48775248|NCT00565084|102240096|FG001|COMPLETED|Second Treatment Period||11||
48775249|NCT00565084|102240097|FG002|COMPLETED|Second Treatment Period||11||
48775250|NCT00565084|102240095|FG000|NOT COMPLETED|Second Treatment Period||0||
48369840|NCT01293396|101232848|FG001|COMPLETED|Third Intervention||8||
48461195|NCT03687125|101463620|FG001|NOT COMPLETED|Overall Study||1||
48461196|NCT01693484|101463621|FG000|STARTED|Overall Study||13||
48461197|NCT01693484|101463621|FG000|COMPLETED|Overall Study||0||
48461198|NCT01693484|101463621|FG000|NOT COMPLETED|Overall Study||13||
48461199|NCT02140957|101463622|FG000|STARTED|Overall Study||129||
48461200|NCT02140957|101463623|FG001|STARTED|Overall Study||122||
48775251|NCT00565084|102240096|FG001|NOT COMPLETED|Second Treatment Period||0||
48775252|NCT00565084|102240097|FG002|NOT COMPLETED|Second Treatment Period||0||
48775253|NCT00565084|102240095|FG000|STARTED|Third Treatment Period||11||
48775254|NCT00565084|102240096|FG001|STARTED|Third Treatment Period||11||
48775255|NCT00565084|102240097|FG002|STARTED|Third Treatment Period||11||
48775256|NCT00565084|102240095|FG000|COMPLETED|Third Treatment Period||11||
48775257|NCT00565084|102240096|FG001|COMPLETED|Third Treatment Period||11||
48775258|NCT00565084|102240097|FG002|COMPLETED|Third Treatment Period||11||
48775259|NCT00565084|102240095|FG000|NOT COMPLETED|Third Treatment Period||0||
48775260|NCT00565084|102240096|FG001|NOT COMPLETED|Third Treatment Period||0||
48775261|NCT00565084|102240097|FG002|NOT COMPLETED|Third Treatment Period||0||
48775262|NCT01339052|102240098|FG000|STARTED|Overall Study||15||
48775263|NCT01339052|102240099|FG001|STARTED|Overall Study||50||
48775264|NCT01339052|102240098|FG000|Measurable Disease|Overall Study||11|Measurable disease post-surgery for Cohort 1 participants.|
48775265|NCT01339052|102240099|FG001|Measurable Disease|Overall Study||40|Measurable disease post-surgery for Cohort 1 participants.|
48775266|NCT01339052|102240098|FG000|Evaluable Tumor Sample at Surgery|Overall Study||14||
48775267|NCT01339052|102240099|FG001|Evaluable Tumor Sample at Surgery|Overall Study||0||
48775268|NCT01339052|102240098|FG000|Evaluable Plasma Sample at Surgery|Overall Study||13||
48775269|NCT01339052|102240099|FG001|Evaluable Plasma Sample at Surgery|Overall Study||0||
48775270|NCT01339052|102240098|FG000|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|
48775271|NCT01339052|102240099|FG001|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|
48775272|NCT01339052|102240098|FG000|NOT COMPLETED|Overall Study||15||
48775273|NCT01339052|102240099|FG001|NOT COMPLETED|Overall Study||50||
48775274|NCT03819114|102240100|FG000|STARTED|Overall Study||17||
48775275|NCT03819114|102240101|FG001|STARTED|Overall Study||36||
48775276|NCT03819114|102240102|FG002|STARTED|Overall Study||35||
48775277|NCT03819114|102240103|FG003|STARTED|Overall Study||34||
48775278|NCT03819114|102240100|FG000|Received LNG Treatment|Overall Study||17||
48775279|NCT03819114|102240101|FG001|Received LNG Treatment|Overall Study||36||
48775280|NCT03819114|102240102|FG002|Received LNG Treatment|Overall Study||35||
48775281|NCT03819114|102240103|FG003|Received LNG Treatment|Overall Study||34||
48775282|NCT03819114|102240100|FG000|COMPLETED|Overall Study||17||
48775283|NCT03819114|102240101|FG001|COMPLETED|Overall Study||35||
48775284|NCT03819114|102240102|FG002|COMPLETED|Overall Study||33||
48775285|NCT03819114|102240103|FG003|COMPLETED|Overall Study||34||
48775286|NCT03819114|102240100|FG000|NOT COMPLETED|Overall Study||0||
48775287|NCT03819114|102240101|FG001|NOT COMPLETED|Overall Study||1||
48775288|NCT03819114|102240102|FG002|NOT COMPLETED|Overall Study||2||
48775289|NCT03819114|102240103|FG003|NOT COMPLETED|Overall Study||0||
48775290|NCT04827680|102240104|FG000|STARTED|Overall Study||20||
48775291|NCT04827680|102240104|FG000|COMPLETED|Overall Study||14||
48775292|NCT04827680|102240104|FG000|NOT COMPLETED|Overall Study||6||
48775293|NCT00842296|102240105|FG000|STARTED|Overall Study||326||396
48775294|NCT00842296|102240105|FG000|COMPLETED|Overall Study||326||396
48775295|NCT00842296|102240105|FG000|NOT COMPLETED|Overall Study||0||0
48775296|NCT03656380|102240106|FG000|STARTED|Overall Study||32||
48775297|NCT03656380|102240107|FG001|STARTED|Overall Study||34||
48775298|NCT03656380|102240106|FG000|Received Intervention|Overall Study||32||
48775299|NCT03656380|102240107|FG001|Received Intervention|Overall Study||33||
48775300|NCT03656380|102240106|FG000|Completed Month 3|Overall Study||31||
48775301|NCT03656380|102240107|FG001|Completed Month 3|Overall Study||33||
48775302|NCT03656380|102240106|FG000|Subsequent 3 Months of Treatment (Part 2)|Overall Study||28||
48775303|NCT03656380|102240107|FG001|Subsequent 3 Months of Treatment (Part 2)|Overall Study||28||
48775304|NCT03656380|102240106|FG000|Completed Month 6|Overall Study||28||
48775305|NCT03656380|102240107|FG001|Completed Month 6|Overall Study||28||
48775306|NCT03656380|102240106|FG000|COMPLETED|Overall Study||27||
48775307|NCT03656380|102240107|FG001|COMPLETED|Overall Study||26||
48775308|NCT03656380|102240106|FG000|NOT COMPLETED|Overall Study||5||
48775309|NCT03656380|102240107|FG001|NOT COMPLETED|Overall Study||8||
48775310|NCT03436082|102240108|FG000|STARTED|Overall Study||30||
48775311|NCT03436082|102240109|FG001|STARTED|Overall Study||30||
48775312|NCT03436082|102240108|FG000|COMPLETED|Overall Study||29||
48775313|NCT03436082|102240109|FG001|COMPLETED|Overall Study||30||
48775314|NCT03436082|102240108|FG000|NOT COMPLETED|Overall Study||1||
48775315|NCT03436082|102240109|FG001|NOT COMPLETED|Overall Study||0||
48775316|NCT02696967|102240110|FG000|STARTED|Overall Study||4|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
48775317|NCT02696967|102240111|FG001|STARTED|Overall Study||6|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
48775318|NCT02696967|102240112|FG002|STARTED|Overall Study||6|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
48775319|NCT02696967|102240113|FG003|STARTED|Overall Study||10|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
48775320|NCT02696967|102240110|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||4|At least one dose of study drug and one evaluable PK concentration measurement|
48775321|NCT02696967|102240111|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||6|At least one dose of study drug and one evaluable PK concentration measurement|
48775322|NCT02696967|102240112|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||4|At least one dose of study drug and one evaluable PK concentration measurement|
48775323|NCT02696967|102240113|FG003|Pharmacokinetic (PK) Analysis Set|Overall Study||0|At least one dose of study drug and one evaluable PK concentration measurement|
48775324|NCT02696967|102240110|FG000|COMPLETED|Overall Study||4||
48775325|NCT02696967|102240111|FG001|COMPLETED|Overall Study||6||
48775326|NCT02696967|102240112|FG002|COMPLETED|Overall Study||6||
48775327|NCT02696967|102240113|FG003|COMPLETED|Overall Study||10||
48369841|NCT01293396|101232849|FG002|COMPLETED|Third Intervention||3||
48461201|NCT02140957|101463622|FG000|COMPLETED|Overall Study||102||
48461202|NCT02140957|101463623|FG001|COMPLETED|Overall Study||99||
48461203|NCT02140957|101463622|FG000|NOT COMPLETED|Overall Study||27||
48461204|NCT02140957|101463623|FG001|NOT COMPLETED|Overall Study||23||
48461205|NCT02295774|101463624|FG000|STARTED|Overall Study||13||
48461206|NCT02295774|101463624|FG000|COMPLETED|Overall Study||10||
48461207|NCT02295774|101463624|FG000|NOT COMPLETED|Overall Study||3||
48461208|NCT00631670|101467260|FG000|STARTED|Overall Study||21||
48664433|NCT04770285|101962015|FG000|Full Analysis Set (FAS)|Overall Study||177|FAS included all randomized participants who received at least 1 occurrence of either CT-152 or sham use and had baseline and at least 1 postbaseline assessment of Montgomery-Asberg Depression Rating Scale (MADRS) total score.|
48664434|NCT04770285|101962016|FG001|Full Analysis Set (FAS)|Overall Study||177|FAS included all randomized participants who received at least 1 occurrence of either CT-152 or sham use and had baseline and at least 1 postbaseline assessment of Montgomery-Asberg Depression Rating Scale (MADRS) total score.|
48664435|NCT04770285|101962015|FG000|COMPLETED|Overall Study||165||
48664436|NCT04770285|101962016|FG001|COMPLETED|Overall Study||164||
48664437|NCT04770285|101962015|FG000|NOT COMPLETED|Overall Study||29||
48664438|NCT04770285|101962016|FG001|NOT COMPLETED|Overall Study||28||
48664439|NCT03648892|101962017|FG000|STARTED|Overall Study||61||
48664440|NCT03648892|101962017|FG000|COMPLETED|Overall Study||61||
48664441|NCT03648892|101962017|FG000|NOT COMPLETED|Overall Study||0||
48664442|NCT06351371|101962018|FG000|STARTED|Overall Study||35||
48664443|NCT06351371|101962018|FG000|Eligible|Overall Study||34||
48664444|NCT06351371|101962018|FG000|Started Protocol Therapy|Overall Study||34||
48664445|NCT06351371|101962018|FG000|Eligible and Treated|Overall Study||33||
48664446|NCT06351371|101962018|FG000|Mutation Status Confirmed|Overall Study||26||
48664447|NCT06351371|101962018|FG000|Eligible, Treated and Mutation Status Confirmed|Overall Study||25|Primary efficacy analysis population|
48664448|NCT06351371|101962018|FG000|COMPLETED|Overall Study||0|Treatment continued until disease progression or intolerability|
48664449|NCT06351371|101962018|FG000|NOT COMPLETED|Overall Study||35||
48664450|NCT00432965|101962019|FG000|STARTED|Overall Study||169||
48664451|NCT00432965|101962020|FG001|STARTED|Overall Study||166||
48664452|NCT00432965|101962019|FG000|COMPLETED|Overall Study||75||
48664453|NCT00432965|101962020|FG001|COMPLETED|Overall Study||80||
48664454|NCT00432965|101962019|FG000|NOT COMPLETED|Overall Study||94||
48664455|NCT00432965|101962020|FG001|NOT COMPLETED|Overall Study||86||
48664456|NCT02251041|101962021|FG000|STARTED|Overall Study||53||
48775328|NCT02696967|102240110|FG000|NOT COMPLETED|Overall Study||0||
48775329|NCT02696967|102240111|FG001|NOT COMPLETED|Overall Study||0||
48775330|NCT02696967|102240112|FG002|NOT COMPLETED|Overall Study||0||
48775331|NCT02696967|102240113|FG003|NOT COMPLETED|Overall Study||0||
48775332|NCT02948634|102240114|FG000|STARTED|Overall Study||17||
48775333|NCT02948634|102240115|FG001|STARTED|Overall Study||11||
48775334|NCT02948634|102240114|FG000|COMPLETED|Overall Study||7||
48775335|NCT02948634|102240115|FG001|COMPLETED|Overall Study||9||
48775336|NCT02948634|102240114|FG000|NOT COMPLETED|Overall Study||10||
48775337|NCT02948634|102240115|FG001|NOT COMPLETED|Overall Study||2||
48775338|NCT01424215|102240116|FG000|STARTED|Overall Study||50||
48775339|NCT01424215|102240117|FG001|STARTED|Overall Study||50||
48775340|NCT01424215|102240116|FG000|COMPLETED|Overall Study||50||
48775341|NCT01424215|102240117|FG001|COMPLETED|Overall Study||50||
48775342|NCT01424215|102240116|FG000|NOT COMPLETED|Overall Study||0||
48775343|NCT01424215|102240117|FG001|NOT COMPLETED|Overall Study||0||
48775344|NCT02885025|102240118|FG000|STARTED|Overall Study||16||
48775345|NCT02885025|102240119|FG001|STARTED|Overall Study||14||
48775346|NCT02885025|102240120|FG002|STARTED|Overall Study||9||
48775347|NCT02885025|102240121|FG003|STARTED|Overall Study||8||
48775348|NCT02885025|102240118|FG000|COMPLETED|Overall Study||16||
48775349|NCT02885025|102240119|FG001|COMPLETED|Overall Study||12||
48775350|NCT02885025|102240120|FG002|COMPLETED|Overall Study||9||
48775351|NCT02885025|102240121|FG003|COMPLETED|Overall Study||8||
48775352|NCT02885025|102240118|FG000|NOT COMPLETED|Overall Study||0||
48775353|NCT02885025|102240119|FG001|NOT COMPLETED|Overall Study||2||
48775354|NCT02885025|102240120|FG002|NOT COMPLETED|Overall Study||0||
48775355|NCT02885025|102240121|FG003|NOT COMPLETED|Overall Study||0||
48775356|NCT01583296|102240122|FG000|STARTED|Overall Study||27||
48775357|NCT01583296|102240123|FG001|STARTED|Overall Study||26||
48775358|NCT01583296|102240122|FG000|COMPLETED|Overall Study||16||
48775359|NCT01583296|102240123|FG001|COMPLETED|Overall Study||16||
48775360|NCT01583296|102240122|FG000|NOT COMPLETED|Overall Study||11||
48369842|NCT01293396|101232847|FG000|NOT COMPLETED|Third Intervention||0||
48369843|NCT01293396|101232848|FG001|NOT COMPLETED|Third Intervention||0||
48369844|NCT01293396|101232849|FG002|NOT COMPLETED|Third Intervention||0||
48369845|NCT04752189|101232850|FG000|STARTED|Overall Study||369||5
48369846|NCT04752189|101232851|FG001|STARTED|Overall Study||456||4
48369847|NCT04752189|101232850|FG000|Teacher Participants- Completed Pre-implementation Interview|Overall Study||5||5
48369848|NCT04752189|101232851|FG001|Teacher Participants- Completed Pre-implementation Interview|Overall Study||5||4
48369849|NCT04752189|101232850|FG000|Student Participants- Completed Baseline Student Survey|Overall Study||364|Students enrolled in the study were a part of the randomized teachers' classrooms.|4
48461209|NCT00631670|101467261|FG001|STARTED|Overall Study||0||
48775361|NCT01583296|102240123|FG001|NOT COMPLETED|Overall Study||10||
48775362|NCT04591353|102240124|FG000|STARTED|Overall Study||61||
48775363|NCT04591353|102240125|FG001|STARTED|Overall Study||61||
48775364|NCT04591353|102240124|FG000|COMPLETED|Overall Study||56||
48775365|NCT04591353|102240125|FG001|COMPLETED|Overall Study||56||
48775366|NCT04591353|102240124|FG000|NOT COMPLETED|Overall Study||5||
48775367|NCT04591353|102240125|FG001|NOT COMPLETED|Overall Study||5||
48775368|NCT01469715|102240126|FG000|STARTED|Overall Study||16||
48775369|NCT01469715|102240126|FG000|COMPLETED|Overall Study||16||
48775370|NCT01469715|102240126|FG000|NOT COMPLETED|Overall Study||0||
48775371|NCT00241839|102240127|FG000|STARTED|Overall Study||71||
48775372|NCT00241839|102240128|FG001|STARTED|Overall Study||71||
48775373|NCT00241839|102240127|FG000|COMPLETED|Overall Study||52||
48775374|NCT00241839|102240128|FG001|COMPLETED|Overall Study||53||
48775375|NCT00241839|102240127|FG000|NOT COMPLETED|Overall Study||19||
48775376|NCT00241839|102240128|FG001|NOT COMPLETED|Overall Study||18||
48775377|NCT01033448|102240129|FG000|STARTED|Overall Study||59||
48775378|NCT01033448|102240129|FG000|COMPLETED|Overall Study||47||
48775379|NCT01033448|102240129|FG000|NOT COMPLETED|Overall Study||12||
48775380|NCT00221117|102240130|FG000|STARTED|Overall Study||12||
48775381|NCT00221117|102240131|FG001|STARTED|Overall Study||9||
48775382|NCT00221117|102240130|FG000|COMPLETED|Overall Study||12||
48775383|NCT00221117|102240131|FG001|COMPLETED|Overall Study||9||
48775384|NCT00221117|102240130|FG000|NOT COMPLETED|Overall Study||0||
48775385|NCT00221117|102240131|FG001|NOT COMPLETED|Overall Study||0||
48775386|NCT00834093|102240132|FG000|STARTED|Overall Study||18||
48775387|NCT00834093|102240132|FG000|Eligible and Treated|Overall Study||13||
48775388|NCT00834093|102240132|FG000|COMPLETED|Overall Study||10||
48775389|NCT00834093|102240132|FG000|NOT COMPLETED|Overall Study||8||
48775390|NCT01227993|102240133|FG000|STARTED|Overall Study||3||
48775391|NCT01227993|102240133|FG000|COMPLETED|Overall Study||3||
48775392|NCT01227993|102240133|FG000|NOT COMPLETED|Overall Study||0||
48775393|NCT01524796|102240134|FG000|STARTED|Overall Study||128||
48775394|NCT01524796|102240134|FG000|COMPLETED|Overall Study||100||
48775395|NCT01524796|102240134|FG000|NOT COMPLETED|Overall Study||28||
48775396|NCT00594815|102240135|FG000|STARTED|Overall Study||52||
48775397|NCT00594815|102240135|FG000|COMPLETED|Overall Study||43||
48775398|NCT00594815|102240135|FG000|NOT COMPLETED|Overall Study||9||
48775399|NCT03179319|102240136|FG000|STARTED|Overall Study||40||
48775400|NCT03179319|102240137|FG001|STARTED|Overall Study||20||
48775401|NCT03179319|102240136|FG000|3 Month Visit|Overall Study||37||
48775402|NCT03179319|102240137|FG001|3 Month Visit|Overall Study||20||
48775403|NCT03179319|102240136|FG000|COMPLETED|Overall Study||34|6-month follow up|
48775404|NCT03179319|102240137|FG001|COMPLETED|Overall Study||20|6-month follow up|
48775405|NCT03179319|102240136|FG000|NOT COMPLETED|Overall Study||6||
48775406|NCT03179319|102240137|FG001|NOT COMPLETED|Overall Study||0||
48775407|NCT04455815|102240138|FG000|STARTED|Randomisation Phase||16||
48775408|NCT04455815|102240139|FG001|STARTED|Randomisation Phase||18||
48775409|NCT04455815|102240138|FG000|COMPLETED|Randomisation Phase||15||
48775410|NCT04455815|102240139|FG001|COMPLETED|Randomisation Phase||18||
48775411|NCT04455815|102240138|FG000|NOT COMPLETED|Randomisation Phase||1||
48775412|NCT04455815|102240139|FG001|NOT COMPLETED|Randomisation Phase||0||
48775413|NCT04455815|102240138|FG000|STARTED|Treatment Phase||15||
48775414|NCT04455815|102240139|FG001|STARTED|Treatment Phase||18||
48775415|NCT04455815|102240138|FG000|COMPLETED|Treatment Phase||13||
48775416|NCT04455815|102240139|FG001|COMPLETED|Treatment Phase||16||
48775417|NCT04455815|102240138|FG000|NOT COMPLETED|Treatment Phase||2||
48775418|NCT04455815|102240139|FG001|NOT COMPLETED|Treatment Phase||2||
48775419|NCT03339219|102240140|FG000|STARTED|Overall Study||35||
48775420|NCT03339219|102240140|FG000|COMPLETED|Overall Study||0||
48775421|NCT03339219|102240140|FG000|NOT COMPLETED|Overall Study||35||
48775422|NCT03212144|102240141|FG000|STARTED|First Sequence (4 Weeks)||2||
48775423|NCT03212144|102240142|FG001|STARTED|First Sequence (4 Weeks)||1||
48775424|NCT03212144|102240141|FG000|COMPLETED|First Sequence (4 Weeks)||1||
48775425|NCT03212144|102240142|FG001|COMPLETED|First Sequence (4 Weeks)||1||
48775426|NCT03212144|102240141|FG000|NOT COMPLETED|First Sequence (4 Weeks)||1||
48775427|NCT03212144|102240142|FG001|NOT COMPLETED|First Sequence (4 Weeks)||0||
48775428|NCT03212144|102240141|FG000|STARTED|Washout (4 Weeks)||1||
48775429|NCT03212144|102240142|FG001|STARTED|Washout (4 Weeks)||1||
48775430|NCT03212144|102240141|FG000|COMPLETED|Washout (4 Weeks)||1||
48775431|NCT03212144|102240142|FG001|COMPLETED|Washout (4 Weeks)||1||
48775432|NCT03212144|102240141|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
48775433|NCT03212144|102240142|FG001|NOT COMPLETED|Washout (4 Weeks)||0||
48775434|NCT03212144|102240141|FG000|STARTED|Second Sequence (4 Weeks)||1||
48775435|NCT03212144|102240142|FG001|STARTED|Second Sequence (4 Weeks)||1||
48775436|NCT03212144|102240141|FG000|COMPLETED|Second Sequence (4 Weeks)||0||
48775437|NCT03212144|102240142|FG001|COMPLETED|Second Sequence (4 Weeks)||0||
48775438|NCT03212144|102240141|FG000|NOT COMPLETED|Second Sequence (4 Weeks)||1||
48775439|NCT03212144|102240142|FG001|NOT COMPLETED|Second Sequence (4 Weeks)||1||
48461210|NCT00631670|101467260|FG000|COMPLETED|Overall Study||21||
48461211|NCT00631670|101467261|FG001|COMPLETED|Overall Study||0||
48461212|NCT00631670|101467260|FG000|NOT COMPLETED|Overall Study||0||
48461213|NCT00631670|101467261|FG001|NOT COMPLETED|Overall Study||0||
48461214|NCT05216978|101467262|FG000|STARTED|Overall Study||23||
48461215|NCT05216978|101467262|FG000|COMPLETED|Overall Study||15||
48461216|NCT05216978|101467262|FG000|NOT COMPLETED|Overall Study||8||
48461217|NCT01620983|101467263|FG000|STARTED|Overall Study||130||
48461218|NCT01620983|101467264|FG001|STARTED|Overall Study||135||
48461219|NCT01620983|101467265|FG002|STARTED|Overall Study||137||
48461220|NCT01620983|101467263|FG000|COMPLETED|Overall Study||111||
48664457|NCT02251041|101962022|FG001|STARTED|Overall Study||40||
48664458|NCT02251041|101962021|FG000|COMPLETED|Overall Study||38||
48664459|NCT02251041|101962022|FG001|COMPLETED|Overall Study||36||
48664460|NCT02251041|101962021|FG000|NOT COMPLETED|Overall Study||15||
48664461|NCT02251041|101962022|FG001|NOT COMPLETED|Overall Study||4||
48664462|NCT03413995|101962023|FG000|STARTED|Overall Study||12||
48664463|NCT03413995|101962023|FG000|COMPLETED|Overall Study||12||
48664464|NCT03413995|101962023|FG000|NOT COMPLETED|Overall Study||0||
48664465|NCT04933708|101962024|FG000|STARTED|Overall Study||101||
48664466|NCT04933708|101962025|FG001|STARTED|Overall Study||100||
48664467|NCT04933708|101962024|FG000|COMPLETED|Overall Study||78||
48664468|NCT04933708|101962025|FG001|COMPLETED|Overall Study||75||
48664469|NCT04933708|101962024|FG000|NOT COMPLETED|Overall Study||23||
48664470|NCT04933708|101962025|FG001|NOT COMPLETED|Overall Study||25||
48664471|NCT01969058|101962026|FG000|STARTED|Overall Study||50||
48664472|NCT01969058|101962027|FG001|STARTED|Overall Study||26||
48664473|NCT01969058|101962026|FG000|COMPLETED|Overall Study||47||
48664474|NCT01969058|101962027|FG001|COMPLETED|Overall Study||26||
48664475|NCT01969058|101962026|FG000|NOT COMPLETED|Overall Study||3||
48664476|NCT01969058|101962027|FG001|NOT COMPLETED|Overall Study||0||
48664477|NCT03630679|101962028|FG000|STARTED|Overall Study||20||
48664478|NCT03630679|101962029|FG001|STARTED|Overall Study||25||
48664479|NCT03630679|101962028|FG000|COMPLETED|Overall Study||13||
48664480|NCT03630679|101962029|FG001|COMPLETED|Overall Study||13||
48664481|NCT03630679|101962028|FG000|NOT COMPLETED|Overall Study||7||
48664482|NCT03630679|101962029|FG001|NOT COMPLETED|Overall Study||12||
48664483|NCT04630769|101962030|FG000|STARTED|Overall Study||1||
48664484|NCT04630769|101962031|FG001|STARTED|Overall Study||1||
48664485|NCT04630769|101962032|FG002|STARTED|Overall Study||1||
48664486|NCT04630769|101962033|FG003|STARTED|Overall Study||0||
48664487|NCT04630769|101962034|FG004|STARTED|Overall Study||0||
48664488|NCT04630769|101962030|FG000|COMPLETED|Overall Study||1||
48664489|NCT04630769|101962031|FG001|COMPLETED|Overall Study||1||
48664490|NCT04630769|101962032|FG002|COMPLETED|Overall Study||1||
48664491|NCT04630769|101962033|FG003|COMPLETED|Overall Study||0||
48664492|NCT04630769|101962034|FG004|COMPLETED|Overall Study||0||
48664493|NCT04630769|101962030|FG000|NOT COMPLETED|Overall Study||0||
48664494|NCT04630769|101962031|FG001|NOT COMPLETED|Overall Study||0||
48664495|NCT04630769|101962032|FG002|NOT COMPLETED|Overall Study||0||
48664496|NCT04630769|101962033|FG003|NOT COMPLETED|Overall Study||0||
48664497|NCT04630769|101962034|FG004|NOT COMPLETED|Overall Study||0||
48664498|NCT03189719|101962035|FG000|STARTED|Overall Study||373||
48664499|NCT03189719|101962036|FG001|STARTED|Overall Study||376||
48664500|NCT03189719|101962035|FG000|Treated|Overall Study||370||
48664501|NCT03189719|101962036|FG001|Treated|Overall Study||370||
48664502|NCT03189719|101962035|FG000|COMPLETED|Overall Study||0||
48664503|NCT03189719|101962036|FG001|COMPLETED|Overall Study||0||
48664504|NCT03189719|101962035|FG000|NOT COMPLETED|Overall Study||373||
48664505|NCT03189719|101962036|FG001|NOT COMPLETED|Overall Study||376||
48664506|NCT03449576|101962037|FG000|STARTED|Overall Study||40||
48664507|NCT03449576|101962038|FG001|STARTED|Overall Study||29||
48664508|NCT03449576|101962037|FG000|COMPLETED|Overall Study||29||
48664509|NCT03449576|101962038|FG001|COMPLETED|Overall Study||24||
48664510|NCT03449576|101962037|FG000|NOT COMPLETED|Overall Study||11||
48775440|NCT02721966|102240143|FG000|STARTED|Overall Study||167|Randomized|
48775441|NCT02721966|102240144|FG001|STARTED|Overall Study||165|Randomized|
48461221|NCT01620983|101467264|FG001|COMPLETED|Overall Study||113||
48461222|NCT01620983|101467265|FG002|COMPLETED|Overall Study||122||
48664511|NCT03449576|101962038|FG001|NOT COMPLETED|Overall Study||5||
48664512|NCT04134936|101962039|FG000|STARTED|Overall Study||33||
48664513|NCT04134936|101962040|FG001|STARTED|Overall Study||33||
48664514|NCT04134936|101962039|FG000|COMPLETED|Overall Study||26||
48664515|NCT04134936|101962040|FG001|COMPLETED|Overall Study||27||
48664516|NCT04134936|101962039|FG000|NOT COMPLETED|Overall Study||7||
48664517|NCT04134936|101962040|FG001|NOT COMPLETED|Overall Study||6||
48775442|NCT02721966|102240145|FG002|STARTED|Overall Study||81|Randomized|
48461223|NCT01620983|101467263|FG000|NOT COMPLETED|Overall Study||19||
48664518|NCT00833703|101962041|FG000|STARTED|Overall Study||23||
48664519|NCT00833703|101962042|FG001|STARTED|Overall Study||26||
48461224|NCT01620983|101467264|FG001|NOT COMPLETED|Overall Study||22||
48461225|NCT01620983|101467265|FG002|NOT COMPLETED|Overall Study||15||
48461226|NCT02802514|101467266|FG000|STARTED|Session 1 (up to Day 8)||1||
48461227|NCT02802514|101467267|FG001|STARTED|Session 1 (up to Day 8)||1||
48461228|NCT02802514|101467268|FG002|STARTED|Session 1 (up to Day 8)||1||
48461229|NCT02802514|101467269|FG003|STARTED|Session 1 (up to Day 8)||1||
48461230|NCT02802514|101467266|FG000|COMPLETED|Session 1 (up to Day 8)||1||
48461231|NCT02802514|101467267|FG001|COMPLETED|Session 1 (up to Day 8)||1||
48461232|NCT02802514|101467268|FG002|COMPLETED|Session 1 (up to Day 8)||1||
48461233|NCT02802514|101467269|FG003|COMPLETED|Session 1 (up to Day 8)||1||
48461234|NCT02802514|101467266|FG000|NOT COMPLETED|Session 1 (up to Day 8)||0||
48461235|NCT02802514|101467267|FG001|NOT COMPLETED|Session 1 (up to Day 8)||0||
48461236|NCT02802514|101467268|FG002|NOT COMPLETED|Session 1 (up to Day 8)||0||
48461237|NCT02802514|101467269|FG003|NOT COMPLETED|Session 1 (up to Day 8)||0||
48461238|NCT02802514|101467266|FG000|STARTED|Wash Out Period (up to Week 9)||1||
48461239|NCT02802514|101467267|FG001|STARTED|Wash Out Period (up to Week 9)||1||
48461240|NCT02802514|101467268|FG002|STARTED|Wash Out Period (up to Week 9)||1||
48461241|NCT02802514|101467269|FG003|STARTED|Wash Out Period (up to Week 9)||1||
48461242|NCT02802514|101467266|FG000|COMPLETED|Wash Out Period (up to Week 9)||1||
48461243|NCT02802514|101467267|FG001|COMPLETED|Wash Out Period (up to Week 9)||1||
48461244|NCT02802514|101467268|FG002|COMPLETED|Wash Out Period (up to Week 9)||1||
48461245|NCT02802514|101467269|FG003|COMPLETED|Wash Out Period (up to Week 9)||1||
48461246|NCT02802514|101467266|FG000|NOT COMPLETED|Wash Out Period (up to Week 9)||0||
48461247|NCT02802514|101467267|FG001|NOT COMPLETED|Wash Out Period (up to Week 9)||0||
48461248|NCT02802514|101467268|FG002|NOT COMPLETED|Wash Out Period (up to Week 9)||0||
48461249|NCT02802514|101467269|FG003|NOT COMPLETED|Wash Out Period (up to Week 9)||0||
48461250|NCT02802514|101467266|FG000|STARTED|Session 2 (Up to Day 8)||1||
48461251|NCT02802514|101467267|FG001|STARTED|Session 2 (Up to Day 8)||1||
48461252|NCT02802514|101467268|FG002|STARTED|Session 2 (Up to Day 8)||1||
48461253|NCT02802514|101467269|FG003|STARTED|Session 2 (Up to Day 8)||1||
48461254|NCT02802514|101467266|FG000|COMPLETED|Session 2 (Up to Day 8)||1||
48461255|NCT02802514|101467267|FG001|COMPLETED|Session 2 (Up to Day 8)||1||
48461256|NCT02802514|101467268|FG002|COMPLETED|Session 2 (Up to Day 8)||1||
48461257|NCT02802514|101467269|FG003|COMPLETED|Session 2 (Up to Day 8)||1||
48461258|NCT02802514|101467266|FG000|NOT COMPLETED|Session 2 (Up to Day 8)||0||
48461259|NCT02802514|101467267|FG001|NOT COMPLETED|Session 2 (Up to Day 8)||0||
48461260|NCT02802514|101467268|FG002|NOT COMPLETED|Session 2 (Up to Day 8)||0||
48461261|NCT02802514|101467269|FG003|NOT COMPLETED|Session 2 (Up to Day 8)||0||
48461262|NCT04896385|101467270|FG000|STARTED|24-Week Double-Blind Period||41||
48775443|NCT02721966|102240146|FG003|STARTED|Overall Study||80|Randomized|
48775444|NCT02721966|102240147|FG004|STARTED|Overall Study||5|Randomized|
48775445|NCT02721966|102240143|FG000|Completed Period 1 & Went to Period 2|Overall Study||162||
48775446|NCT02721966|102240144|FG001|Completed Period 1 & Went to Period 2|Overall Study||153||
48775447|NCT02721966|102240145|FG002|Completed Period 1 & Went to Period 2|Overall Study||81||
48775448|NCT02721966|102240146|FG003|Completed Period 1 & Went to Period 2|Overall Study||80||
48775449|NCT02721966|102240147|FG004|Completed Period 1 & Went to Period 2|Overall Study||0||
48775450|NCT02721966|102240143|FG000|COMPLETED|Overall Study||138|Completed treatment period 2|
48775451|NCT02721966|102240144|FG001|COMPLETED|Overall Study||142|Completed treatment period 2|
48775452|NCT02721966|102240145|FG002|COMPLETED|Overall Study||72|Completed treatment period 2|
48775453|NCT02721966|102240146|FG003|COMPLETED|Overall Study||73|Completed treatment period 2|
48775454|NCT02721966|102240147|FG004|COMPLETED|Overall Study||0|Completed treatment period 2|
48775455|NCT02721966|102240143|FG000|NOT COMPLETED|Overall Study||29||
48775456|NCT02721966|102240144|FG001|NOT COMPLETED|Overall Study||23||
48775457|NCT02721966|102240145|FG002|NOT COMPLETED|Overall Study||9||
48775458|NCT02721966|102240146|FG003|NOT COMPLETED|Overall Study||7||
48775459|NCT02721966|102240147|FG004|NOT COMPLETED|Overall Study||5||
48775460|NCT00035932|102240148|FG000|STARTED|Overall Study||119||
48775461|NCT00035932|102240149|FG001|STARTED|Overall Study||110||
48775462|NCT00035932|102240150|FG002|STARTED|Overall Study||118||
48775463|NCT00035932|102240148|FG000|Discontinued Prior to Week 48 Visit|Overall Study||26||
48775464|NCT00035932|102240149|FG001|Discontinued Prior to Week 48 Visit|Overall Study||29||
48775465|NCT00035932|102240150|FG002|Discontinued Prior to Week 48 Visit|Overall Study||13||
48775466|NCT00035932|102240148|FG000|Discontinued Between Weeks 48 and 96|Overall Study||26||
48461263|NCT04896385|101467271|FG001|STARTED|24-Week Double-Blind Period||19||
48461264|NCT04896385|101467272|FG002|STARTED|24-Week Double-Blind Period||0||
48775467|NCT00035932|102240149|FG001|Discontinued Between Weeks 48 and 96|Overall Study||27||
48775468|NCT00035932|102240150|FG002|Discontinued Between Weeks 48 and 96|Overall Study||30||
48775469|NCT00035932|102240148|FG000|Discontinued on or After Week 96|Overall Study||4||
48775470|NCT00035932|102240149|FG001|Discontinued on or After Week 96|Overall Study||4||
48461265|NCT04896385|101467273|FG003|STARTED|24-Week Double-Blind Period||0||
48461266|NCT04896385|101467270|FG000|COMPLETED|24-Week Double-Blind Period||37||
48461267|NCT04896385|101467271|FG001|COMPLETED|24-Week Double-Blind Period||14||
48461268|NCT04896385|101467272|FG002|COMPLETED|24-Week Double-Blind Period||0||
48461269|NCT04896385|101467273|FG003|COMPLETED|24-Week Double-Blind Period||0||
48461270|NCT04896385|101467270|FG000|NOT COMPLETED|24-Week Double-Blind Period||4||
48775471|NCT00035932|102240150|FG002|Discontinued on or After Week 96|Overall Study||6||
48775472|NCT00035932|102240148|FG000|COMPLETED|Overall Study||63||
48775473|NCT00035932|102240149|FG001|COMPLETED|Overall Study||50||
48775474|NCT00035932|102240150|FG002|COMPLETED|Overall Study||69||
48775475|NCT00035932|102240148|FG000|NOT COMPLETED|Overall Study||56||
48775476|NCT00035932|102240149|FG001|NOT COMPLETED|Overall Study||60||
48775477|NCT00035932|102240150|FG002|NOT COMPLETED|Overall Study||49||
48775478|NCT03117140|102240151|FG000|STARTED|Overall Study||40||
48775479|NCT03117140|102240152|FG001|STARTED|Overall Study||40||
48775480|NCT03117140|102240153|FG002|STARTED|Overall Study||40||
48775481|NCT03117140|102240154|FG003|STARTED|Overall Study||40||
48775482|NCT03117140|102240151|FG000|COMPLETED|Overall Study||40||
48775483|NCT03117140|102240152|FG001|COMPLETED|Overall Study||40||
48775484|NCT03117140|102240153|FG002|COMPLETED|Overall Study||40||
48775485|NCT03117140|102240154|FG003|COMPLETED|Overall Study||40||
48775486|NCT03117140|102240151|FG000|NOT COMPLETED|Overall Study||0||
48775487|NCT03117140|102240152|FG001|NOT COMPLETED|Overall Study||0||
48775488|NCT03117140|102240153|FG002|NOT COMPLETED|Overall Study||0||
48775489|NCT03117140|102240154|FG003|NOT COMPLETED|Overall Study||0||
48775490|NCT04216264|102240155|FG000|STARTED|Overall Study||7||
48775491|NCT04216264|102240156|FG001|STARTED|Overall Study||7||
48775492|NCT04216264|102240157|FG002|STARTED|Overall Study||7||
48775493|NCT04216264|102240158|FG003|STARTED|Overall Study||7||
48775494|NCT04216264|102240155|FG000|COMPLETED|Overall Study||5||
48775495|NCT04216264|102240156|FG001|COMPLETED|Overall Study||5||
48775496|NCT04216264|102240157|FG002|COMPLETED|Overall Study||2||
48775497|NCT04216264|102240158|FG003|COMPLETED|Overall Study||2||
48775498|NCT04216264|102240155|FG000|NOT COMPLETED|Overall Study||2||
48775499|NCT04216264|102240156|FG001|NOT COMPLETED|Overall Study||2||
48775500|NCT04216264|102240157|FG002|NOT COMPLETED|Overall Study||5||
48775501|NCT04216264|102240158|FG003|NOT COMPLETED|Overall Study||5||
48775502|NCT02902146|102240159|FG000|STARTED|Overall Study||381||
48775503|NCT02902146|102240160|FG001|STARTED|Overall Study||376||
48775504|NCT02902146|102240159|FG000|COMPLETED|Overall Study||381||
48775505|NCT02902146|102240160|FG001|COMPLETED|Overall Study||376||
48775506|NCT02902146|102240159|FG000|NOT COMPLETED|Overall Study||0||
48775507|NCT02902146|102240160|FG001|NOT COMPLETED|Overall Study||0||
48775508|NCT02541604|102240161|FG000|STARTED|Overall Study||11||
48775509|NCT02541604|102240162|FG001|STARTED|Overall Study||9||
48775510|NCT02541604|102240163|FG002|STARTED|Overall Study||11||
48775511|NCT02541604|102240164|FG003|STARTED|Overall Study||3||
48775512|NCT02541604|102240165|FG004|STARTED|Overall Study||10||
48775513|NCT02541604|102240166|FG005|STARTED|Overall Study||10||
48775514|NCT02541604|102240167|FG006|STARTED|Overall Study||10||
48775515|NCT02541604|102240168|FG007|STARTED|Overall Study||10||
48775516|NCT02541604|102240169|FG008|STARTED|Overall Study||4||
48775517|NCT02541604|102240170|FG009|STARTED|Overall Study||4||
48775518|NCT02541604|102240171|FG010|STARTED|Overall Study||2||
48775519|NCT02541604|102240172|FG011|STARTED|Overall Study||3||
48775520|NCT02541604|102240161|FG000|COMPLETED|Overall Study||0||
48775521|NCT02541604|102240162|FG001|COMPLETED|Overall Study||0||
48775522|NCT02541604|102240163|FG002|COMPLETED|Overall Study||0||
48775523|NCT02541604|102240164|FG003|COMPLETED|Overall Study||0||
48775524|NCT02541604|102240165|FG004|COMPLETED|Overall Study||0||
48775525|NCT02541604|102240166|FG005|COMPLETED|Overall Study||0||
48775526|NCT02541604|102240167|FG006|COMPLETED|Overall Study||0||
48775527|NCT02541604|102240168|FG007|COMPLETED|Overall Study||0||
48775528|NCT02541604|102240169|FG008|COMPLETED|Overall Study||0||
48775529|NCT02541604|102240170|FG009|COMPLETED|Overall Study||0||
48775530|NCT02541604|102240171|FG010|COMPLETED|Overall Study||0||
48775531|NCT02541604|102240172|FG011|COMPLETED|Overall Study||0||
48775532|NCT02541604|102240161|FG000|NOT COMPLETED|Overall Study||11||
48775533|NCT02541604|102240162|FG001|NOT COMPLETED|Overall Study||9||
48775534|NCT02541604|102240163|FG002|NOT COMPLETED|Overall Study||11||
48775535|NCT02541604|102240164|FG003|NOT COMPLETED|Overall Study||3||
48775536|NCT02541604|102240165|FG004|NOT COMPLETED|Overall Study||10||
48775537|NCT02541604|102240166|FG005|NOT COMPLETED|Overall Study||10||
48775538|NCT02541604|102240167|FG006|NOT COMPLETED|Overall Study||10||
48775539|NCT02541604|102240168|FG007|NOT COMPLETED|Overall Study||10||
48775540|NCT02541604|102240169|FG008|NOT COMPLETED|Overall Study||4||
48775541|NCT02541604|102240170|FG009|NOT COMPLETED|Overall Study||4||
48775542|NCT02541604|102240171|FG010|NOT COMPLETED|Overall Study||2||
48775543|NCT02541604|102240172|FG011|NOT COMPLETED|Overall Study||3||
48775544|NCT02350478|102240173|FG000|STARTED|Overall Study||25||
48775545|NCT02350478|102240174|FG001|STARTED|Overall Study||24||
48775546|NCT02350478|102240173|FG000|COMPLETED|Overall Study||20||
48775547|NCT02350478|102240174|FG001|COMPLETED|Overall Study||23||
48775548|NCT02350478|102240173|FG000|NOT COMPLETED|Overall Study||5||
48775549|NCT02350478|102240174|FG001|NOT COMPLETED|Overall Study||1||
48775550|NCT01470118|102240175|FG000|STARTED|Overall Study||43||
48775551|NCT01470118|102240176|FG001|STARTED|Overall Study||43||
48775552|NCT01470118|102240177|FG002|STARTED|Overall Study||41||
48775553|NCT01470118|102240175|FG000|COMPLETED|Overall Study||38||
48775554|NCT01470118|102240176|FG001|COMPLETED|Overall Study||38||
48775555|NCT01470118|102240177|FG002|COMPLETED|Overall Study||39||
48775556|NCT01470118|102240175|FG000|NOT COMPLETED|Overall Study||5||
48775557|NCT01470118|102240176|FG001|NOT COMPLETED|Overall Study||5||
48775558|NCT01470118|102240177|FG002|NOT COMPLETED|Overall Study||2||
48775559|NCT01869764|102240178|FG000|STARTED|Overall Study||28||
48775560|NCT01869764|102240179|FG001|STARTED|Overall Study||29||
48775561|NCT01869764|102240178|FG000|COMPLETED|Overall Study||28||
48775562|NCT01869764|102240179|FG001|COMPLETED|Overall Study||27||
48775563|NCT01869764|102240178|FG000|NOT COMPLETED|Overall Study||0||
48775564|NCT01869764|102240179|FG001|NOT COMPLETED|Overall Study||2||
48775565|NCT00078897|102240180|FG000|STARTED|Overall Study||809||
48775566|NCT00078897|102240181|FG001|STARTED|Overall Study||812||
48775567|NCT00078897|102240180|FG000|COMPLETED|Overall Study||685||
48775568|NCT00078897|102240181|FG001|COMPLETED|Overall Study||689||
48775569|NCT00078897|102240180|FG000|NOT COMPLETED|Overall Study||124||
48775570|NCT00078897|102240181|FG001|NOT COMPLETED|Overall Study||123||
48775571|NCT01400880|102240182|FG000|STARTED|Overall Study||103||
48775572|NCT01400880|102240182|FG000|COMPLETED|Overall Study||101||
48775573|NCT01400880|102240182|FG000|NOT COMPLETED|Overall Study||2||
48775574|NCT01077050|102240183|FG000|STARTED|Overall Study||1951||
48775575|NCT01077050|102240183|FG000|COMPLETED|Overall Study||1942||
48775576|NCT01077050|102240183|FG000|NOT COMPLETED|Overall Study||9||
48775577|NCT01079299|102240184|FG000|STARTED|Overall Study||27||
48775578|NCT01079299|102240185|FG001|STARTED|Overall Study||25||
48775579|NCT01079299|102240184|FG000|COMPLETED|Overall Study||27||
48775580|NCT01079299|102240185|FG001|COMPLETED|Overall Study||25||
48775581|NCT01079299|102240184|FG000|NOT COMPLETED|Overall Study||0||
48775582|NCT01079299|102240185|FG001|NOT COMPLETED|Overall Study||0||
48775583|NCT00092443|102240186|FG000|STARTED|Overall Study||651||
48775584|NCT00092443|102240187|FG001|STARTED|Overall Study||661||
48775585|NCT00092443|102240186|FG000|Vaccinated at Visit 1|Overall Study||650||
48775586|NCT00092443|102240187|FG001|Vaccinated at Visit 1|Overall Study||660||
48775587|NCT00092443|102240186|FG000|Vaccinated at Visit 2|Overall Study||618||
48775588|NCT00092443|102240187|FG001|Vaccinated at Visit 2|Overall Study||627||
48775589|NCT00092443|102240186|FG000|Vaccinated at Visit 3|Overall Study||593||
48775590|NCT00092443|102240187|FG001|Vaccinated at Visit 3|Overall Study||608||
48775591|NCT00092443|102240186|FG000|COMPLETED|Overall Study||593||
48775592|NCT00092443|102240187|FG001|COMPLETED|Overall Study||607||
48775593|NCT00092443|102240186|FG000|NOT COMPLETED|Overall Study||58||
48775594|NCT00092443|102240187|FG001|NOT COMPLETED|Overall Study||54||
48775595|NCT02876601|102240188|FG000|STARTED|First Intervention (24 Hours)||8||
48775596|NCT02876601|102240189|FG001|STARTED|First Intervention (24 Hours)||8||
48775597|NCT02876601|102240190|FG002|STARTED|First Intervention (24 Hours)||2||
48775598|NCT02876601|102240191|FG003|STARTED|First Intervention (24 Hours)||2||
48775599|NCT02876601|102240188|FG000|COMPLETED|First Intervention (24 Hours)||8||
48775600|NCT02876601|102240189|FG001|COMPLETED|First Intervention (24 Hours)||8||
48775601|NCT02876601|102240190|FG002|COMPLETED|First Intervention (24 Hours)||2||
48775602|NCT02876601|102240191|FG003|COMPLETED|First Intervention (24 Hours)||2||
48775603|NCT02876601|102240188|FG000|NOT COMPLETED|First Intervention (24 Hours)||0||
48775604|NCT02876601|102240189|FG001|NOT COMPLETED|First Intervention (24 Hours)||0||
48775605|NCT02876601|102240190|FG002|NOT COMPLETED|First Intervention (24 Hours)||0||
48775606|NCT02876601|102240191|FG003|NOT COMPLETED|First Intervention (24 Hours)||0||
48775607|NCT02876601|102240188|FG000|STARTED|Washout (Minimum of 6 Weeks)||8||
48775608|NCT02876601|102240189|FG001|STARTED|Washout (Minimum of 6 Weeks)||8||
48775609|NCT02876601|102240190|FG002|STARTED|Washout (Minimum of 6 Weeks)||2||
48775610|NCT02876601|102240191|FG003|STARTED|Washout (Minimum of 6 Weeks)||2||
48775611|NCT02876601|102240188|FG000|COMPLETED|Washout (Minimum of 6 Weeks)||8||
48775612|NCT02876601|102240189|FG001|COMPLETED|Washout (Minimum of 6 Weeks)||8||
48775613|NCT02876601|102240190|FG002|COMPLETED|Washout (Minimum of 6 Weeks)||1||
48189695|NCT01027871|100786279|FG000|NOT COMPLETED|Overall Study||2||
48461271|NCT04896385|101467271|FG001|NOT COMPLETED|24-Week Double-Blind Period||5||
48461272|NCT04896385|101467272|FG002|NOT COMPLETED|24-Week Double-Blind Period||0||
48189696|NCT01027871|100786280|FG001|NOT COMPLETED|Overall Study||13||
48189697|NCT01027871|100786281|FG002|NOT COMPLETED|Overall Study||7||
48189698|NCT01348854|100786282|FG000|STARTED|Overall Study||34||
48189699|NCT01348854|100786283|FG001|STARTED|Overall Study||6||
48189700|NCT01348854|100786282|FG000|COMPLETED|Overall Study||31||
48189701|NCT01348854|100786283|FG001|COMPLETED|Overall Study||5||
48189702|NCT01348854|100786282|FG000|NOT COMPLETED|Overall Study||3||
48189703|NCT01348854|100786283|FG001|NOT COMPLETED|Overall Study||1||
48189704|NCT03748771|100786284|FG000|STARTED|Overall Study||20||
48189705|NCT03748771|100786284|FG000|COMPLETED|Overall Study||20||
48189706|NCT03748771|100786284|FG000|NOT COMPLETED|Overall Study||0||
48189707|NCT01824446|100786285|FG000|STARTED|Overall Study||6||
48189708|NCT01824446|100786285|FG000|COMPLETED|Overall Study||6||
48189709|NCT01824446|100786285|FG000|NOT COMPLETED|Overall Study||0||
48189710|NCT00372970|100786286|FG000|STARTED|Overall Study||16||
48664520|NCT00833703|101962041|FG000|Treated|Overall Study||23||
48664521|NCT00833703|101962042|FG001|Treated|Overall Study||26||
48664522|NCT00833703|101962041|FG000|Completed Treatment|Overall Study||22||
48664523|NCT00833703|101962042|FG001|Completed Treatment|Overall Study||24||
48664524|NCT00833703|101962041|FG000|COMPLETED|Overall Study||23||
48664525|NCT00833703|101962042|FG001|COMPLETED|Overall Study||25||
48664526|NCT00833703|101962041|FG000|NOT COMPLETED|Overall Study||0||
48664527|NCT00833703|101962042|FG001|NOT COMPLETED|Overall Study||1||
48664528|NCT04144517|101962043|FG000|STARTED|Overall Study||8||
48664529|NCT04144517|101962044|FG001|STARTED|Overall Study||6||
48664530|NCT04144517|101962043|FG000|COMPLETED|Overall Study||0||
48664531|NCT04144517|101962044|FG001|COMPLETED|Overall Study||0||
48664532|NCT04144517|101962043|FG000|NOT COMPLETED|Overall Study||8||
48664533|NCT04144517|101962044|FG001|NOT COMPLETED|Overall Study||6||
48664534|NCT02871440|101962045|FG000|STARTED|Overall Study||12||
48664535|NCT02871440|101962046|FG001|STARTED|Overall Study||13||
48664536|NCT02871440|101962047|FG002|STARTED|Overall Study||15||
48664537|NCT02871440|101962045|FG000|COMPLETED|Overall Study||12||
48664538|NCT02871440|101962046|FG001|COMPLETED|Overall Study||13||
48664539|NCT02871440|101962047|FG002|COMPLETED|Overall Study||15||
48664540|NCT02871440|101962045|FG000|NOT COMPLETED|Overall Study||0||
48664541|NCT02871440|101962046|FG001|NOT COMPLETED|Overall Study||0||
48664542|NCT02871440|101962047|FG002|NOT COMPLETED|Overall Study||0||
48664543|NCT02170519|101962048|FG000|STARTED|Overall Study||22||
48664544|NCT02170519|101962049|FG001|STARTED|Overall Study||5||
48664545|NCT02170519|101962048|FG000|COMPLETED|Overall Study||22||
48664546|NCT02170519|101962049|FG001|COMPLETED|Overall Study||5||
48664547|NCT02170519|101962048|FG000|NOT COMPLETED|Overall Study||0||
48664548|NCT02170519|101962049|FG001|NOT COMPLETED|Overall Study||0||
48664549|NCT04035486|101962050|FG000|STARTED|Overall Study||15||
48664550|NCT04035486|101962051|FG001|STARTED|Overall Study||15||
48664551|NCT04035486|101962052|FG002|STARTED|Overall Study||279||
48664552|NCT04035486|101962053|FG003|STARTED|Overall Study||278||
48664553|NCT04035486|101962050|FG000|Completed 4 Cycles of Carboplatin/Cisplatin Treatment|Overall Study||13|At Time of Data Cut Off (03APR2023)|
48664554|NCT04035486|101962051|FG001|Completed 4 Cycles of Carboplatin/Cisplatin Treatment|Overall Study||11|At Time of Data Cut Off (03APR2023)|
48664555|NCT04035486|101962052|FG002|Completed 4 Cycles of Carboplatin/Cisplatin Treatment|Overall Study||212|At Time of Data Cut Off (03APR2023)|
48664556|NCT04035486|101962053|FG003|Completed 4 Cycles of Carboplatin/Cisplatin Treatment|Overall Study||0|At Time of Data Cut Off (03APR2023)|
48664557|NCT04035486|101962050|FG000|Ongoing Any Study Treatment|Overall Study||6|At time of Data Cut Off (03APR2023)|
48664558|NCT04035486|101962051|FG001|Ongoing Any Study Treatment|Overall Study||8|At time of Data Cut Off (03APR2023)|
48664559|NCT04035486|101962052|FG002|Ongoing Any Study Treatment|Overall Study||154|At time of Data Cut Off (03APR2023)|
48664560|NCT04035486|101962053|FG003|Ongoing Any Study Treatment|Overall Study||123|At time of Data Cut Off (03APR2023)|
48664561|NCT04035486|101962050|FG000|Received at Least One Dose of Investigational Product|Overall Study||15|Includes Osimertinib, Cisplatin, Carboplatin, or Pemetrexed|
48775614|NCT02876601|102240191|FG003|COMPLETED|Washout (Minimum of 6 Weeks)||2||
48775615|NCT02876601|102240188|FG000|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0||
48775616|NCT02876601|102240189|FG001|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0||
48775617|NCT02876601|102240190|FG002|NOT COMPLETED|Washout (Minimum of 6 Weeks)||1||
48775618|NCT02876601|102240191|FG003|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0||
48775619|NCT02876601|102240188|FG000|STARTED|Second Intervention (24 Hours)||8||
48775620|NCT02876601|102240189|FG001|STARTED|Second Intervention (24 Hours)||8||
48775621|NCT02876601|102240190|FG002|STARTED|Second Intervention (24 Hours)||1||
48775622|NCT02876601|102240191|FG003|STARTED|Second Intervention (24 Hours)||2||
48775623|NCT02876601|102240188|FG000|COMPLETED|Second Intervention (24 Hours)||8||
48775624|NCT02876601|102240189|FG001|COMPLETED|Second Intervention (24 Hours)||8||
48775625|NCT02876601|102240190|FG002|COMPLETED|Second Intervention (24 Hours)||1||
48775626|NCT02876601|102240191|FG003|COMPLETED|Second Intervention (24 Hours)||2||
48775627|NCT02876601|102240188|FG000|NOT COMPLETED|Second Intervention (24 Hours)||0||
48775628|NCT02876601|102240189|FG001|NOT COMPLETED|Second Intervention (24 Hours)||0||
48775629|NCT02876601|102240190|FG002|NOT COMPLETED|Second Intervention (24 Hours)||0||
48775630|NCT02876601|102240191|FG003|NOT COMPLETED|Second Intervention (24 Hours)||0||
48775631|NCT04449263|102240192|FG000|STARTED|First Intervention||29||
48775632|NCT04449263|102240193|FG001|STARTED|First Intervention||30||
48775633|NCT04449263|102240192|FG000|COMPLETED|First Intervention||29||
48664562|NCT04035486|101962051|FG001|Received at Least One Dose of Investigational Product|Overall Study||15|Includes Osimertinib, Cisplatin, Carboplatin, or Pemetrexed|
48670223|NCT03711734|101974916|FG001|STARTED|Overall Study||20||
48775634|NCT04449263|102240193|FG001|COMPLETED|First Intervention||30||
48775635|NCT04449263|102240192|FG000|NOT COMPLETED|First Intervention||0||
48775636|NCT04449263|102240193|FG001|NOT COMPLETED|First Intervention||0||
48775637|NCT04449263|102240192|FG000|STARTED|Second Intervention||29||
48775638|NCT04449263|102240193|FG001|STARTED|Second Intervention||30||
48775639|NCT04449263|102240192|FG000|COMPLETED|Second Intervention||29||
48775640|NCT04449263|102240193|FG001|COMPLETED|Second Intervention||30||
48775641|NCT04449263|102240192|FG000|NOT COMPLETED|Second Intervention||0||
48775642|NCT04449263|102240193|FG001|NOT COMPLETED|Second Intervention||0||
48775643|NCT04449263|102240192|FG000|STARTED|Third Intervention||29||
48775644|NCT04449263|102240193|FG001|STARTED|Third Intervention||30||
48775645|NCT04449263|102240192|FG000|COMPLETED|Third Intervention||29||
48775646|NCT04449263|102240193|FG001|COMPLETED|Third Intervention||30||
48775647|NCT04449263|102240192|FG000|NOT COMPLETED|Third Intervention||0||
48775648|NCT04449263|102240193|FG001|NOT COMPLETED|Third Intervention||0||
48775649|NCT01696188|102240194|FG000|STARTED|Overall Study||41||
48775650|NCT01696188|102240195|FG001|STARTED|Overall Study||43||
48775651|NCT01696188|102240194|FG000|COMPLETED|Overall Study||40||
48775652|NCT01696188|102240195|FG001|COMPLETED|Overall Study||42||
48775653|NCT01696188|102240194|FG000|NOT COMPLETED|Overall Study||1||
48775654|NCT01696188|102240195|FG001|NOT COMPLETED|Overall Study||1||
48775655|NCT00566696|102240196|FG000|STARTED|Overall Study||73||
48775656|NCT00566696|102240196|FG000|COMPLETED|Overall Study||31||
48775657|NCT00566696|102240196|FG000|NOT COMPLETED|Overall Study||42||
48461273|NCT04896385|101467273|FG003|NOT COMPLETED|24-Week Double-Blind Period||0||
48461274|NCT04896385|101467270|FG000|STARTED|28-Week Treatment-Extension Period||0||
48461275|NCT04896385|101467271|FG001|STARTED|28-Week Treatment-Extension Period||0||
48461276|NCT04896385|101467272|FG002|STARTED|28-Week Treatment-Extension Period||37||
48461277|NCT04896385|101467273|FG003|STARTED|28-Week Treatment-Extension Period||14||
48461278|NCT04896385|101467270|FG000|COMPLETED|28-Week Treatment-Extension Period||0||
48461279|NCT04896385|101467271|FG001|COMPLETED|28-Week Treatment-Extension Period||0||
48461280|NCT04896385|101467272|FG002|COMPLETED|28-Week Treatment-Extension Period||27||
48461281|NCT04896385|101467273|FG003|COMPLETED|28-Week Treatment-Extension Period||9||
48461282|NCT04896385|101467270|FG000|NOT COMPLETED|28-Week Treatment-Extension Period||0||
48461283|NCT04896385|101467271|FG001|NOT COMPLETED|28-Week Treatment-Extension Period||0||
48461284|NCT04896385|101467272|FG002|NOT COMPLETED|28-Week Treatment-Extension Period||10||
48461285|NCT04896385|101467273|FG003|NOT COMPLETED|28-Week Treatment-Extension Period||5||
48461286|NCT01725113|101467274|FG000|STARTED|Overall Study||6||
48461287|NCT01725113|101467275|FG001|STARTED|Overall Study||6||
48461288|NCT01725113|101467274|FG000|COMPLETED|Overall Study||5||
48461289|NCT01725113|101467275|FG001|COMPLETED|Overall Study||4||
48461290|NCT01725113|101467274|FG000|NOT COMPLETED|Overall Study||1||
48461291|NCT01725113|101467275|FG001|NOT COMPLETED|Overall Study||2||
48461292|NCT03551730|101467276|FG000|STARTED|Overall Study||9||
48461293|NCT03551730|101467277|FG001|STARTED|Overall Study||6||
48461294|NCT03551730|101467278|FG002|STARTED|Overall Study||6||
48461295|NCT03551730|101467279|FG003|STARTED|Overall Study||6||
48461296|NCT03551730|101467276|FG000|COMPLETED|Overall Study||8||
48461297|NCT03551730|101467277|FG001|COMPLETED|Overall Study||6||
48461298|NCT03551730|101467278|FG002|COMPLETED|Overall Study||6||
48461299|NCT03551730|101467279|FG003|COMPLETED|Overall Study||6||
48461300|NCT03551730|101467276|FG000|NOT COMPLETED|Overall Study||1||
48461301|NCT03551730|101467277|FG001|NOT COMPLETED|Overall Study||0||
48461302|NCT03551730|101467278|FG002|NOT COMPLETED|Overall Study||0||
48461303|NCT03551730|101467279|FG003|NOT COMPLETED|Overall Study||0||
48461304|NCT00974493|101467280|FG000|STARTED|Overall Study||527||
48461305|NCT00974493|101467281|FG001|STARTED|Overall Study||527||
48461306|NCT00974493|101467280|FG000|COMPLETED|Overall Study||509||
48461307|NCT00974493|101467281|FG001|COMPLETED|Overall Study||506||
48461308|NCT00974493|101467280|FG000|NOT COMPLETED|Overall Study||18||
48461309|NCT00974493|101467281|FG001|NOT COMPLETED|Overall Study||21||
48461310|NCT00278512|101467282|FG000|STARTED|Overall Study||7||
48461311|NCT00278512|101467283|FG001|STARTED|Overall Study||0||
48461312|NCT00278512|101467282|FG000|COMPLETED|Overall Study||6||
48461313|NCT00278512|101467283|FG001|COMPLETED|Overall Study||0||
48461314|NCT00278512|101467282|FG000|NOT COMPLETED|Overall Study||1||
48461315|NCT00278512|101467283|FG001|NOT COMPLETED|Overall Study||0||
48461316|NCT01953783|101467284|FG000|STARTED|Overall Study||7||
48461317|NCT01953783|101467284|FG000|COMPLETED|Overall Study||5||
48461318|NCT01953783|101467284|FG000|NOT COMPLETED|Overall Study||2||
48461319|NCT02492958|101467285|FG000|STARTED|Overall Study||34||
48461320|NCT02492958|101467286|FG001|STARTED|Overall Study||34||
48461321|NCT02492958|101467287|FG002|STARTED|Overall Study||34||
48775658|NCT04154189|102240197|FG000|STARTED|Overall Study||40|Participant Flow (including deaths in reasons of discontinuation) was based on Full Analysis Set (Full Analysis Set included all randomized participants regardless of the treatment actually received).|
48461322|NCT02492958|101467288|FG003|STARTED|Overall Study||34||
48461323|NCT02492958|101467285|FG000|COMPLETED|Overall Study||33||
48461324|NCT02492958|101467286|FG001|COMPLETED|Overall Study||34||
48461325|NCT02492958|101467287|FG002|COMPLETED|Overall Study||32||
48461326|NCT02492958|101467288|FG003|COMPLETED|Overall Study||34||
48461327|NCT02492958|101467285|FG000|NOT COMPLETED|Overall Study||1||
48461328|NCT02492958|101467286|FG001|NOT COMPLETED|Overall Study||0||
48461329|NCT02492958|101467287|FG002|NOT COMPLETED|Overall Study||2||
48461330|NCT02492958|101467288|FG003|NOT COMPLETED|Overall Study||0||
48775659|NCT04154189|102240198|FG001|STARTED|Overall Study||41|Participant Flow (including deaths in reasons of discontinuation) was based on Full Analysis Set (Full Analysis Set included all randomized participants regardless of the treatment actually received).|
48189711|NCT00372970|100786287|FG001|STARTED|Overall Study||16||
48189712|NCT00372970|100786286|FG000|COMPLETED|Overall Study||16||
48189713|NCT00372970|100786287|FG001|COMPLETED|Overall Study||16||
48189714|NCT00372970|100786286|FG000|NOT COMPLETED|Overall Study||0||
48461331|NCT02363010|101467289|FG000|STARTED|Overall Study||110||
48461332|NCT02363010|101467290|FG001|STARTED|Overall Study||105||
48461333|NCT02363010|101467291|FG002|STARTED|Overall Study||105||
48461334|NCT02363010|101467289|FG000|COMPLETED|Overall Study||88||
48461335|NCT02363010|101467290|FG001|COMPLETED|Overall Study||94||
48461336|NCT02363010|101467291|FG002|COMPLETED|Overall Study||89||
48461337|NCT02363010|101467289|FG000|NOT COMPLETED|Overall Study||22||
48461338|NCT02363010|101467290|FG001|NOT COMPLETED|Overall Study||11||
48461339|NCT02363010|101467291|FG002|NOT COMPLETED|Overall Study||16||
48461340|NCT01717456|101467292|FG000|STARTED|End of Treatment||11||
48461341|NCT01717456|101467293|FG001|STARTED|End of Treatment||8||
48461342|NCT01717456|101467292|FG000|COMPLETED|End of Treatment||11||
48461343|NCT01717456|101467293|FG001|COMPLETED|End of Treatment||6||
48461344|NCT01717456|101467292|FG000|NOT COMPLETED|End of Treatment||0||
48461345|NCT01717456|101467293|FG001|NOT COMPLETED|End of Treatment||2||
48461346|NCT01717456|101467292|FG000|STARTED|Follow-Up 6 Months After End of Tx||11||
48461347|NCT01717456|101467293|FG001|STARTED|Follow-Up 6 Months After End of Tx||6||
48461348|NCT01717456|101467292|FG000|COMPLETED|Follow-Up 6 Months After End of Tx||7||
48461349|NCT01717456|101467293|FG001|COMPLETED|Follow-Up 6 Months After End of Tx||2||
48461350|NCT01717456|101467292|FG000|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4||
48664563|NCT04035486|101962052|FG002|Received at Least One Dose of Investigational Product|Overall Study||276|Includes Osimertinib, Cisplatin, Carboplatin, or Pemetrexed|
48664564|NCT04035486|101962053|FG003|Received at Least One Dose of Investigational Product|Overall Study||275|Includes Osimertinib, Cisplatin, Carboplatin, or Pemetrexed|
48664565|NCT04035486|101962050|FG000|COMPLETED|Overall Study||1|At time of Data Cut Off (03APR2023)|
48664566|NCT04035486|101962051|FG001|COMPLETED|Overall Study||1|At time of Data Cut Off (03APR2023)|
48664567|NCT04035486|101962052|FG002|COMPLETED|Overall Study||0|At time of Data Cut Off (03APR2023)|
48664568|NCT04035486|101962053|FG003|COMPLETED|Overall Study||0|At time of Data Cut Off (03APR2023)|
48664569|NCT04035486|101962050|FG000|NOT COMPLETED|Overall Study||14||
48664570|NCT04035486|101962051|FG001|NOT COMPLETED|Overall Study||14||
48664571|NCT04035486|101962052|FG002|NOT COMPLETED|Overall Study||279||
48664572|NCT04035486|101962053|FG003|NOT COMPLETED|Overall Study||278||
48664573|NCT01950520|101962054|FG000|STARTED|Overall Study||16||
48664574|NCT01950520|101962055|FG001|STARTED|Overall Study||18||
48664575|NCT01950520|101962056|FG002|STARTED|Overall Study||13||
48664576|NCT01950520|101962054|FG000|COMPLETED|Overall Study||16||
48664577|NCT01950520|101962055|FG001|COMPLETED|Overall Study||17||
48664578|NCT01950520|101962056|FG002|COMPLETED|Overall Study||12||
48664579|NCT01950520|101962054|FG000|NOT COMPLETED|Overall Study||0||
48664580|NCT01950520|101962055|FG001|NOT COMPLETED|Overall Study||1||
48664581|NCT01950520|101962056|FG002|NOT COMPLETED|Overall Study||1||
48664582|NCT00835042|101962057|FG000|STARTED|First Intervention||30||
48664583|NCT00835042|101962058|FG001|STARTED|First Intervention||28||
48664584|NCT00835042|101962057|FG000|COMPLETED|First Intervention||26||
48664585|NCT00835042|101962058|FG001|COMPLETED|First Intervention||26||
48664586|NCT00835042|101962057|FG000|NOT COMPLETED|First Intervention||4||
48664587|NCT00835042|101962058|FG001|NOT COMPLETED|First Intervention||2||
48664588|NCT00835042|101962057|FG000|STARTED|Washout of 21 Days||26||
48664589|NCT00835042|101962058|FG001|STARTED|Washout of 21 Days||26||
48664590|NCT00835042|101962057|FG000|COMPLETED|Washout of 21 Days||26||
48664591|NCT00835042|101962058|FG001|COMPLETED|Washout of 21 Days||24||
48664592|NCT00835042|101962057|FG000|NOT COMPLETED|Washout of 21 Days||0||
48664593|NCT00835042|101962058|FG001|NOT COMPLETED|Washout of 21 Days||2||
48664594|NCT00835042|101962057|FG000|STARTED|Second Intervention||26||
48664595|NCT00835042|101962058|FG001|STARTED|Second Intervention||24||
48664596|NCT00835042|101962057|FG000|COMPLETED|Second Intervention||26||
48664597|NCT00835042|101962058|FG001|COMPLETED|Second Intervention||24||
48664598|NCT00835042|101962057|FG000|NOT COMPLETED|Second Intervention||0||
48664599|NCT00835042|101962058|FG001|NOT COMPLETED|Second Intervention||0||
48461351|NCT01717456|101467293|FG001|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4||
48461352|NCT02114931|101467294|FG000|STARTED|Overall Study||230||
48461353|NCT02114931|101467295|FG001|STARTED|Overall Study||237||
48461354|NCT02114931|101467294|FG000|Received Treatment|Overall Study||229||
48461355|NCT02114931|101467295|FG001|Received Treatment|Overall Study||237||
48461356|NCT02114931|101467294|FG000|COMPLETED|Overall Study||205||
48461357|NCT02114931|101467295|FG001|COMPLETED|Overall Study||207||
48461358|NCT02114931|101467294|FG000|NOT COMPLETED|Overall Study||25||
48461359|NCT02114931|101467295|FG001|NOT COMPLETED|Overall Study||30||
48189715|NCT00372970|100786287|FG001|NOT COMPLETED|Overall Study||0||
48189716|NCT06044948|100786288|FG000|STARTED|Overall Study||96||192
48189717|NCT06044948|100786288|FG000|COMPLETED|Overall Study||96||192
48189718|NCT06044948|100786288|FG000|NOT COMPLETED|Overall Study||0||0
48189719|NCT01555762|100786289|FG000|STARTED|Overall Study||402||
48461360|NCT04104646|101467296|FG000|STARTED|Overall Study||5||
48461361|NCT04104646|101467297|FG001|STARTED|Overall Study||2||
48461362|NCT04104646|101467296|FG000|COMPLETED|Overall Study||1||
48461363|NCT04104646|101467297|FG001|COMPLETED|Overall Study||1||
48461364|NCT04104646|101467296|FG000|NOT COMPLETED|Overall Study||4||
48461365|NCT04104646|101467297|FG001|NOT COMPLETED|Overall Study||1||
48461366|NCT01873859|101467298|FG000|STARTED|Overall Study||83||
48461367|NCT01873859|101467299|FG001|STARTED|Overall Study||83||
48461368|NCT01873859|101467298|FG000|COMPLETED|Overall Study||83||
48461369|NCT01873859|101467299|FG001|COMPLETED|Overall Study||79||
48461370|NCT01873859|101467298|FG000|NOT COMPLETED|Overall Study||0||
48461371|NCT01873859|101467299|FG001|NOT COMPLETED|Overall Study||4||
48461372|NCT00671879|101467300|FG000|STARTED|Overall Study||281||
48461373|NCT00671879|101467301|FG001|STARTED|Overall Study||279||
48461374|NCT00671879|101467302|FG002|STARTED|Overall Study||280||
48461375|NCT00671879|101467300|FG000|COMPLETED|Overall Study||281||
48461376|NCT00671879|101467301|FG001|COMPLETED|Overall Study||275||
48461377|NCT00671879|101467302|FG002|COMPLETED|Overall Study||274||
48461378|NCT00671879|101467300|FG000|NOT COMPLETED|Overall Study||0||
48461379|NCT00671879|101467301|FG001|NOT COMPLETED|Overall Study||4||
48461380|NCT00671879|101467302|FG002|NOT COMPLETED|Overall Study||6||
48461381|NCT00384033|101467303|FG000|STARTED|Overall Study||164||
48461382|NCT00384033|101467304|FG001|STARTED|Overall Study||155||
48461383|NCT00384033|101467305|FG002|STARTED|Overall Study||160||
48775660|NCT04154189|102240197|FG000|Treated (Safety Analysis Set)|Overall Study||39||
48775661|NCT04154189|102240198|FG001|Treated (Safety Analysis Set)|Overall Study||39||
48775662|NCT04154189|102240197|FG000|Optional Lenvatinib Treatment (Arm B Only)|Overall Study||0|Participants from Treatment Arm B: Ifosfamide + Etoposide who had PD per RECIST v1.1 were eligible to receive an optional lenvatinib treatment plus any remaining cycles of chemotherapy (ifosfamide + etoposide) if 5 cycles were not completed prior to PD.|
48775663|NCT04154189|102240198|FG001|Optional Lenvatinib Treatment (Arm B Only)|Overall Study||16|Participants from Treatment Arm B: Ifosfamide + Etoposide who had PD per RECIST v1.1 were eligible to receive an optional lenvatinib treatment plus any remaining cycles of chemotherapy (ifosfamide + etoposide) if 5 cycles were not completed prior to PD.|
48775664|NCT04154189|102240197|FG000|COMPLETED|Overall Study||0||
48775665|NCT04154189|102240198|FG001|COMPLETED|Overall Study||0||
48461384|NCT00384033|101467306|FG003|STARTED|Overall Study||159||
48461385|NCT00384033|101467303|FG000|Treated|Overall Study||161||
48461386|NCT00384033|101467304|FG001|Treated|Overall Study||148||
48461387|NCT00384033|101467305|FG002|Treated|Overall Study||150||
48461388|NCT00384033|101467306|FG003|Treated|Overall Study||157||
48461389|NCT00384033|101467303|FG000|COMPLETED|Overall Study||123||
48461390|NCT00384033|101467304|FG001|COMPLETED|Overall Study||120||
48461391|NCT00384033|101467305|FG002|COMPLETED|Overall Study||117||
48461392|NCT00384033|101467306|FG003|COMPLETED|Overall Study||119||
48461393|NCT00384033|101467303|FG000|NOT COMPLETED|Overall Study||41||
48664600|NCT02304159|101962059|FG000|STARTED|Overall Study||21||
48664601|NCT02304159|101962060|FG001|STARTED|Overall Study||18||
48664602|NCT02304159|101962059|FG000|COMPLETED|Overall Study||19||
48664603|NCT02304159|101962060|FG001|COMPLETED|Overall Study||16||
48775666|NCT04154189|102240197|FG000|NOT COMPLETED|Overall Study||40||
48775667|NCT04154189|102240198|FG001|NOT COMPLETED|Overall Study||41||
48775668|NCT01938716|102240199|FG000|STARTED|Overall Study||12||
48461394|NCT00384033|101467304|FG001|NOT COMPLETED|Overall Study||35||
48461395|NCT00384033|101467305|FG002|NOT COMPLETED|Overall Study||43||
48461396|NCT00384033|101467306|FG003|NOT COMPLETED|Overall Study||40||
48461397|NCT02669264|101467307|FG000|STARTED|Overall Study||5||
48461398|NCT02669264|101467308|FG001|STARTED|Overall Study||7||
48461399|NCT02669264|101467309|FG002|STARTED|Overall Study||3||
48461400|NCT02669264|101467310|FG003|STARTED|Overall Study||4||
48664604|NCT02304159|101962059|FG000|NOT COMPLETED|Overall Study||2||
48664605|NCT02304159|101962060|FG001|NOT COMPLETED|Overall Study||2||
48664606|NCT02284893|101962061|FG000|STARTED|26 Week (Short Term)||232||
48664607|NCT02284893|101962062|FG001|STARTED|26 Week (Short Term)||229||
48664608|NCT02284893|101962061|FG000|COMPLETED|26 Week (Short Term)||213||
48664609|NCT02284893|101962062|FG001|COMPLETED|26 Week (Short Term)||198||
48664610|NCT02284893|101962061|FG000|NOT COMPLETED|26 Week (Short Term)||19||
48664611|NCT02284893|101962062|FG001|NOT COMPLETED|26 Week (Short Term)||31||
48461401|NCT02669264|101467311|FG004|STARTED|Overall Study||5||
48461402|NCT02669264|101467312|FG005|STARTED|Overall Study||6||
48664612|NCT02284893|101962061|FG000|STARTED|52 Week (Long Term)||209||
48664613|NCT02284893|101962062|FG001|STARTED|52 Week (Long Term)||193||
48461403|NCT02669264|101467313|FG006|STARTED|Overall Study||5||
48461404|NCT02669264|101467307|FG000|COMPLETED|Overall Study||0||
48461405|NCT02669264|101467308|FG001|COMPLETED|Overall Study||1||
48461406|NCT02669264|101467309|FG002|COMPLETED|Overall Study||0||
48461407|NCT02669264|101467310|FG003|COMPLETED|Overall Study||1||
48461408|NCT02669264|101467311|FG004|COMPLETED|Overall Study||0||
48461409|NCT02669264|101467312|FG005|COMPLETED|Overall Study||0||
48461410|NCT02669264|101467313|FG006|COMPLETED|Overall Study||0||
48461411|NCT02669264|101467307|FG000|NOT COMPLETED|Overall Study||5||
48461412|NCT02669264|101467308|FG001|NOT COMPLETED|Overall Study||6||
48461413|NCT02669264|101467309|FG002|NOT COMPLETED|Overall Study||3||
48461414|NCT02669264|101467310|FG003|NOT COMPLETED|Overall Study||3||
48775669|NCT01938716|102240199|FG000|COMPLETED|Overall Study||8||
48775670|NCT01938716|102240199|FG000|NOT COMPLETED|Overall Study||4||
48775671|NCT03001817|102240200|FG000|STARTED|12 Week Efficacy||368||
48775672|NCT03001817|102240201|FG001|STARTED|12 Week Efficacy||183||
48775673|NCT03001817|102240200|FG000|COMPLETED|12 Week Efficacy||356|Including 2 participants (one participant each group) who skipped Week 12 but did not discontinue study drug and entered the 40-week Extension Period.|
48775674|NCT03001817|102240201|FG001|COMPLETED|12 Week Efficacy||179|Including 2 participants (one participant each group) who skipped Week 12 but did not discontinue study drug and entered the 40-week Extension Period.|
48775675|NCT03001817|102240200|FG000|NOT COMPLETED|12 Week Efficacy||12||
48775676|NCT03001817|102240201|FG001|NOT COMPLETED|12 Week Efficacy||4||
48775677|NCT03001817|102240200|FG000|STARTED|40 Week Extension||350|Note that 8 participants (6 participants in the K-877 group and 2 participants in the placebo/fenofibrate 145 mg group) withdrew after completing the 12-week Efficacy Period and did not start the 40-week Extension Period.|
48775678|NCT03001817|102240201|FG001|STARTED|40 Week Extension||177|Note that 8 participants (6 participants in the K-877 group and 2 participants in the placebo/fenofibrate 145 mg group) withdrew after completing the 12-week Efficacy Period and did not start the 40-week Extension Period.|
48775679|NCT03001817|102240200|FG000|COMPLETED|40 Week Extension||335||
48775680|NCT03001817|102240201|FG001|COMPLETED|40 Week Extension||163||
48775681|NCT03001817|102240200|FG000|NOT COMPLETED|40 Week Extension||15||
48775682|NCT03001817|102240201|FG001|NOT COMPLETED|40 Week Extension||14||
48775683|NCT00068419|102240202|FG000|STARTED|Overall Study||70||
48775684|NCT00068419|102240202|FG000|COMPLETED|Overall Study||10||
48189720|NCT01555762|100786289|FG000|Safety Population|Overall Study||383||
48461415|NCT02669264|101467311|FG004|NOT COMPLETED|Overall Study||5||
48461416|NCT02669264|101467312|FG005|NOT COMPLETED|Overall Study||6||
48461417|NCT02669264|101467313|FG006|NOT COMPLETED|Overall Study||5||
48461418|NCT00368537|101467314|FG000|STARTED|Randomization||281||
48461419|NCT00368537|101467315|FG001|STARTED|Randomization||269||
48461420|NCT00368537|101467314|FG000|COMPLETED|Randomization||268||
48461421|NCT00368537|101467315|FG001|COMPLETED|Randomization||263||
48461422|NCT00368537|101467314|FG000|NOT COMPLETED|Randomization||13||
48461423|NCT00368537|101467315|FG001|NOT COMPLETED|Randomization||6||
48461424|NCT00368537|101467314|FG000|STARTED|Baseline Participants||268||
48461425|NCT00368537|101467315|FG001|STARTED|Baseline Participants||263||
48461426|NCT00368537|101467314|FG000|COMPLETED|Baseline Participants||244||
48461427|NCT00368537|101467315|FG001|COMPLETED|Baseline Participants||239||
48461428|NCT00368537|101467314|FG000|NOT COMPLETED|Baseline Participants||24||
48461429|NCT00368537|101467315|FG001|NOT COMPLETED|Baseline Participants||24||
48461430|NCT02668783|101467316|FG000|STARTED|Overall Study||13||
48461431|NCT02668783|101467317|FG001|STARTED|Overall Study||12||
48461432|NCT02668783|101467316|FG000|Treated|Overall Study||13||
48461433|NCT02668783|101467317|FG001|Treated|Overall Study||11||
48461434|NCT02668783|101467316|FG000|COMPLETED|Overall Study||0||
48461435|NCT02668783|101467317|FG001|COMPLETED|Overall Study||0||
48461436|NCT02668783|101467316|FG000|NOT COMPLETED|Overall Study||13||
48461437|NCT02668783|101467317|FG001|NOT COMPLETED|Overall Study||12||
48461438|NCT04248855|101467318|FG000|STARTED|Overall Study||4||
48461439|NCT04248855|101467319|FG001|STARTED|Overall Study||3||
48461440|NCT04248855|101467320|FG002|STARTED|Overall Study||3||
48461441|NCT04248855|101467321|FG003|STARTED|Overall Study||3||
48461442|NCT04248855|101467322|FG004|STARTED|Overall Study||1||
48664614|NCT02284893|101962061|FG000|COMPLETED|52 Week (Long Term)||198||
48664615|NCT02284893|101962062|FG001|COMPLETED|52 Week (Long Term)||180||
48664616|NCT02284893|101962061|FG000|NOT COMPLETED|52 Week (Long Term)||11||
48189721|NCT01555762|100786289|FG000|Efficacy Population|Overall Study||358||
48189722|NCT01555762|100786289|FG000|COMPLETED|Overall Study||128||
48461443|NCT04248855|101467323|FG005|STARTED|Overall Study||6||
48461444|NCT04248855|101467324|FG006|STARTED|Overall Study||7||
48461445|NCT04248855|101467325|FG007|STARTED|Overall Study||8||
48461446|NCT04248855|101467326|FG008|STARTED|Overall Study||6||
48461447|NCT04248855|101467318|FG000|COMPLETED|Overall Study||4||
48461448|NCT04248855|101467319|FG001|COMPLETED|Overall Study||3||
48461449|NCT04248855|101467320|FG002|COMPLETED|Overall Study||3||
48461450|NCT04248855|101467321|FG003|COMPLETED|Overall Study||3||
48461451|NCT04248855|101467322|FG004|COMPLETED|Overall Study||1||
48461452|NCT04248855|101467323|FG005|COMPLETED|Overall Study||6||
48461453|NCT04248855|101467324|FG006|COMPLETED|Overall Study||6||
48461454|NCT04248855|101467325|FG007|COMPLETED|Overall Study||7||
48461455|NCT04248855|101467326|FG008|COMPLETED|Overall Study||6||
48461456|NCT04248855|101467318|FG000|NOT COMPLETED|Overall Study||0||
48461457|NCT04248855|101467319|FG001|NOT COMPLETED|Overall Study||0||
48461458|NCT04248855|101467320|FG002|NOT COMPLETED|Overall Study||0||
48461459|NCT04248855|101467321|FG003|NOT COMPLETED|Overall Study||0||
48461460|NCT04248855|101467322|FG004|NOT COMPLETED|Overall Study||0||
48461461|NCT04248855|101467323|FG005|NOT COMPLETED|Overall Study||0||
48461462|NCT04248855|101467324|FG006|NOT COMPLETED|Overall Study||1||
48461463|NCT04248855|101467325|FG007|NOT COMPLETED|Overall Study||1||
48775685|NCT00068419|102240202|FG000|NOT COMPLETED|Overall Study||60||
48775686|NCT02670811|102240203|FG000|STARTED|Overall Study||18||
48775687|NCT02670811|102240204|FG001|STARTED|Overall Study||18||
48775688|NCT02670811|102240203|FG000|COMPLETED|Overall Study||17||
48775689|NCT02670811|102240204|FG001|COMPLETED|Overall Study||18||
48775690|NCT02670811|102240203|FG000|NOT COMPLETED|Overall Study||1||
48775691|NCT02670811|102240204|FG001|NOT COMPLETED|Overall Study||0||
48775692|NCT02283762|102240205|FG000|STARTED|Main Treatment Phase (MT)||60||
48775693|NCT02283762|102240206|FG001|STARTED|Main Treatment Phase (MT)||61||
48461464|NCT04248855|101467326|FG008|NOT COMPLETED|Overall Study||0||
48461465|NCT00192296|101467327|FG000|STARTED|Overall Study||6||
48461466|NCT00192296|101467328|FG001|STARTED|Overall Study||6||
48461467|NCT00192296|101467329|FG002|STARTED|Overall Study||6||
48461468|NCT00192296|101467330|FG003|STARTED|Overall Study||6||
48461469|NCT00192296|101467327|FG000|COMPLETED|Overall Study||6||
48461470|NCT00192296|101467328|FG001|COMPLETED|Overall Study||5||
48461471|NCT00192296|101467329|FG002|COMPLETED|Overall Study||6||
48775694|NCT02283762|102240205|FG000|COMPLETED|Main Treatment Phase (MT)||42||
48775695|NCT02283762|102240206|FG001|COMPLETED|Main Treatment Phase (MT)||46||
48775696|NCT02283762|102240205|FG000|NOT COMPLETED|Main Treatment Phase (MT)||18||
48775697|NCT02283762|102240206|FG001|NOT COMPLETED|Main Treatment Phase (MT)||15||
48775698|NCT02283762|102240205|FG000|STARTED|Long-term Extension Phase (LTE)||42||
48775699|NCT02283762|102240206|FG001|STARTED|Long-term Extension Phase (LTE)||45||
48775700|NCT02283762|102240205|FG000|COMPLETED|Long-term Extension Phase (LTE)||32||
48775701|NCT02283762|102240206|FG001|COMPLETED|Long-term Extension Phase (LTE)||31||
48775702|NCT02283762|102240205|FG000|NOT COMPLETED|Long-term Extension Phase (LTE)||10||
48775703|NCT02283762|102240206|FG001|NOT COMPLETED|Long-term Extension Phase (LTE)||14||
48775704|NCT02043808|102240207|FG000|STARTED|Overall Study||12793||
48775705|NCT02043808|102240208|FG001|STARTED|Overall Study||12793||
48775706|NCT02043808|102240207|FG000|COMPLETED|Overall Study||12793||
48775707|NCT02043808|102240208|FG001|COMPLETED|Overall Study||12793||
48775708|NCT02043808|102240207|FG000|NOT COMPLETED|Overall Study||0||
48775709|NCT02043808|102240208|FG001|NOT COMPLETED|Overall Study||0||
48775710|NCT04328077|102240209|FG000|STARTED|Overall Study||26||
48775711|NCT04328077|102240210|FG001|STARTED|Overall Study||25||
48775712|NCT04328077|102240211|FG002|STARTED|Overall Study||26||
48775713|NCT04328077|102240212|FG003|STARTED|Overall Study||24||
48775714|NCT04328077|102240209|FG000|COMPLETED|Overall Study||26||
48775715|NCT04328077|102240210|FG001|COMPLETED|Overall Study||23||
48775716|NCT04328077|102240211|FG002|COMPLETED|Overall Study||25||
48775717|NCT04328077|102240212|FG003|COMPLETED|Overall Study||21||
48775718|NCT04328077|102240209|FG000|NOT COMPLETED|Overall Study||0||
48775719|NCT04328077|102240210|FG001|NOT COMPLETED|Overall Study||2||
48775720|NCT04328077|102240211|FG002|NOT COMPLETED|Overall Study||1||
48775721|NCT04328077|102240212|FG003|NOT COMPLETED|Overall Study||3||
48775722|NCT00387790|102240213|FG000|STARTED|Overall Study||64||
48775723|NCT00387790|102240213|FG000|COMPLETED|Overall Study||50||
48461472|NCT00192296|101467330|FG003|COMPLETED|Overall Study||6||
48461473|NCT00192296|101467327|FG000|NOT COMPLETED|Overall Study||0||
48461474|NCT00192296|101467328|FG001|NOT COMPLETED|Overall Study||1||
48461475|NCT00192296|101467329|FG002|NOT COMPLETED|Overall Study||0||
48461476|NCT00192296|101467330|FG003|NOT COMPLETED|Overall Study||0||
48461477|NCT00557882|101467331|FG000|STARTED|Overall Study||32||
48461478|NCT00557882|101467332|FG001|STARTED|Overall Study||33||
48461479|NCT00557882|101467331|FG000|COMPLETED|Overall Study||27||
48461480|NCT00557882|101467332|FG001|COMPLETED|Overall Study||33||
48461481|NCT00557882|101467331|FG000|NOT COMPLETED|Overall Study||5||
48775724|NCT00387790|102240213|FG000|NOT COMPLETED|Overall Study||14||
48775725|NCT03070964|102240214|FG000|STARTED|Overall Study||14||
48775726|NCT03070964|102240214|FG000|COMPLETED|Overall Study||0||
48775727|NCT03070964|102240214|FG000|NOT COMPLETED|Overall Study||14||
48775728|NCT00392769|102240215|FG000|STARTED|Overall Study||33||
48775729|NCT00392769|102240215|FG000|COMPLETED|Overall Study||23||
48775730|NCT00392769|102240215|FG000|NOT COMPLETED|Overall Study||10||
48775731|NCT01160822|102240216|FG000|STARTED|Overall Study||6||
48775732|NCT01160822|102240217|FG001|STARTED|Overall Study||7||
48775733|NCT01160822|102240218|FG002|STARTED|Overall Study||6||
48775734|NCT01160822|102240219|FG003|STARTED|Overall Study||5||
48775735|NCT01160822|102240220|FG004|STARTED|Overall Study||45||
48775736|NCT01160822|102240221|FG005|STARTED|Overall Study||47||
48775737|NCT01160822|102240222|FG006|STARTED|Overall Study||53||
48775738|NCT01160822|102240216|FG000|COMPLETED|Overall Study||6||
48775739|NCT01160822|102240217|FG001|COMPLETED|Overall Study||7||
48775740|NCT01160822|102240218|FG002|COMPLETED|Overall Study||6||
48775741|NCT01160822|102240219|FG003|COMPLETED|Overall Study||5||
48775742|NCT01160822|102240220|FG004|COMPLETED|Overall Study||36||
48775743|NCT01160822|102240221|FG005|COMPLETED|Overall Study||40||
48775744|NCT01160822|102240222|FG006|COMPLETED|Overall Study||44||
48775745|NCT01160822|102240216|FG000|NOT COMPLETED|Overall Study||0||
48775746|NCT01160822|102240217|FG001|NOT COMPLETED|Overall Study||0||
48775747|NCT01160822|102240218|FG002|NOT COMPLETED|Overall Study||0||
48775748|NCT01160822|102240219|FG003|NOT COMPLETED|Overall Study||0||
48775749|NCT01160822|102240220|FG004|NOT COMPLETED|Overall Study||9||
48775750|NCT01160822|102240221|FG005|NOT COMPLETED|Overall Study||7||
48775751|NCT01160822|102240222|FG006|NOT COMPLETED|Overall Study||9||
48775752|NCT01607255|102240223|FG000|STARTED|Overall Study||161||
48775753|NCT01607255|102240224|FG001|STARTED|Overall Study||160||
48775754|NCT01607255|102240225|FG002|STARTED|Overall Study||159||
48775755|NCT01607255|102240223|FG000|COMPLETED|Overall Study||161||
48775756|NCT01607255|102240224|FG001|COMPLETED|Overall Study||160||
48775757|NCT01607255|102240225|FG002|COMPLETED|Overall Study||159||
48775758|NCT01607255|102240223|FG000|NOT COMPLETED|Overall Study||0||
48775759|NCT01607255|102240224|FG001|NOT COMPLETED|Overall Study||0||
48775760|NCT01607255|102240225|FG002|NOT COMPLETED|Overall Study||0||
48775761|NCT00123422|102240226|FG000|STARTED|Overall Study||35||
48775762|NCT00123422|102240227|FG001|STARTED|Overall Study||33||
48775763|NCT00123422|102240228|FG002|STARTED|Overall Study||35||
48775764|NCT00123422|102240226|FG000|8-week Testing|Overall Study||32||
48775765|NCT00123422|102240227|FG001|8-week Testing|Overall Study||30||
48461482|NCT00557882|101467332|FG001|NOT COMPLETED|Overall Study||0||
48461483|NCT01738581|101467333|FG000|STARTED|Overall Study||5||
48461484|NCT01738581|101467334|FG001|STARTED|Overall Study||4||
48461485|NCT01738581|101467333|FG000|COMPLETED|Overall Study||4||
48461486|NCT01738581|101467334|FG001|COMPLETED|Overall Study||4||
48775766|NCT00123422|102240228|FG002|8-week Testing|Overall Study||27||
48775767|NCT00123422|102240226|FG000|COMPLETED|Overall Study||31||
48461487|NCT01738581|101467333|FG000|NOT COMPLETED|Overall Study||1||
48461488|NCT01738581|101467334|FG001|NOT COMPLETED|Overall Study||0||
48461489|NCT00614055|101467335|FG000|STARTED|Overall Study||59||
48461490|NCT00614055|101467336|FG001|STARTED|Overall Study||59||
48461491|NCT00614055|101467337|FG002|STARTED|Overall Study||60||
48461492|NCT00614055|101467335|FG000|Exposed|Overall Study||59||
48461493|NCT00614055|101467336|FG001|Exposed|Overall Study||59||
48461494|NCT00614055|101467337|FG002|Exposed|Overall Study||60||
48461495|NCT00614055|101467335|FG000|COMPLETED|Overall Study||55||
48461496|NCT00614055|101467336|FG001|COMPLETED|Overall Study||53||
48461497|NCT00614055|101467337|FG002|COMPLETED|Overall Study||55||
48461498|NCT00614055|101467335|FG000|NOT COMPLETED|Overall Study||4||
48461499|NCT00614055|101467336|FG001|NOT COMPLETED|Overall Study||6||
48461500|NCT00614055|101467337|FG002|NOT COMPLETED|Overall Study||5||
48461501|NCT02853929|101467338|FG000|STARTED|Overall Study||270|Number of subjects enrolled|
48461502|NCT02853929|101467339|FG001|STARTED|Overall Study||281|Number of subjects enrolled|
48461503|NCT02853929|101467338|FG000|Vaccinated|Overall Study||263||
48461504|NCT02853929|101467339|FG001|Vaccinated|Overall Study||277||
48664617|NCT02284893|101962062|FG001|NOT COMPLETED|52 Week (Long Term)||13||
48664618|NCT00086515|101962063|FG000|STARTED|Phase A (Weeks 0-24)||464||
48664619|NCT00086515|101962064|FG001|STARTED|Phase A (Weeks 0-24)||237||
48664620|NCT00086515|101962063|FG000|COMPLETED|Phase A (Weeks 0-24)||415||
48664621|NCT00086515|101962064|FG001|COMPLETED|Phase A (Weeks 0-24)||192||
48664622|NCT00086515|101962063|FG000|NOT COMPLETED|Phase A (Weeks 0-24)||49||
48664623|NCT00086515|101962064|FG001|NOT COMPLETED|Phase A (Weeks 0-24)||45||
48664624|NCT00086515|101962063|FG000|STARTED|Phase A to Phase B Transition Period||415||
48664625|NCT00086515|101962064|FG001|STARTED|Phase A to Phase B Transition Period||192||
48664626|NCT00086515|101962063|FG000|COMPLETED|Phase A to Phase B Transition Period||391||
48664627|NCT00086515|101962064|FG001|COMPLETED|Phase A to Phase B Transition Period||164||
48664628|NCT00086515|101962063|FG000|NOT COMPLETED|Phase A to Phase B Transition Period||24||
48664629|NCT00086515|101962064|FG001|NOT COMPLETED|Phase A to Phase B Transition Period||28||
48664630|NCT00086515|101962063|FG000|STARTED|Phase B (Weeks 24-104)||391||
48664631|NCT00086515|101962064|FG001|STARTED|Phase B (Weeks 24-104)||164||
48664632|NCT00086515|101962063|FG000|COMPLETED|Phase B (Weeks 24-104)||201||
48664633|NCT00086515|101962064|FG001|COMPLETED|Phase B (Weeks 24-104)||109||
48664634|NCT00086515|101962063|FG000|NOT COMPLETED|Phase B (Weeks 24-104)||190||
48775768|NCT00123422|102240227|FG001|COMPLETED|Overall Study||27||
48775769|NCT00123422|102240228|FG002|COMPLETED|Overall Study||25||
48775770|NCT00123422|102240226|FG000|NOT COMPLETED|Overall Study||4||
48775771|NCT00123422|102240227|FG001|NOT COMPLETED|Overall Study||6||
48775772|NCT00123422|102240228|FG002|NOT COMPLETED|Overall Study||10||
48775773|NCT01047553|102240229|FG000|STARTED|Overall Study||125||
48775774|NCT01047553|102240230|FG001|STARTED|Overall Study||126||
48775775|NCT01047553|102240229|FG000|COMPLETED|Overall Study||108||
48775776|NCT01047553|102240230|FG001|COMPLETED|Overall Study||117||
48775777|NCT01047553|102240229|FG000|NOT COMPLETED|Overall Study||17||
48775778|NCT01047553|102240230|FG001|NOT COMPLETED|Overall Study||9||
48775779|NCT01623050|102240231|FG000|STARTED|Overall Study||36||
48461505|NCT02853929|101467338|FG000|COMPLETED|Overall Study||259||
48461506|NCT02853929|101467339|FG001|COMPLETED|Overall Study||277||
48461507|NCT02853929|101467338|FG000|NOT COMPLETED|Overall Study||11||
48461508|NCT02853929|101467339|FG001|NOT COMPLETED|Overall Study||4||
48461509|NCT01684566|101467340|FG000|STARTED|Overall Study||60||
48461510|NCT01684566|101467341|FG001|STARTED|Overall Study||56||
48461511|NCT01684566|101467340|FG000|Treated (ITT)|Overall Study||57||
48461512|NCT01684566|101467341|FG001|Treated (ITT)|Overall Study||52||
48461513|NCT01684566|101467340|FG000|COMPLETED|Overall Study||44||
48461514|NCT01684566|101467341|FG001|COMPLETED|Overall Study||49||
48461515|NCT01684566|101467340|FG000|NOT COMPLETED|Overall Study||16||
48461516|NCT01684566|101467341|FG001|NOT COMPLETED|Overall Study||7||
48461517|NCT01808209|101467342|FG000|STARTED|Overall Study||33||
48461518|NCT01808209|101467343|FG001|STARTED|Overall Study||27||
48461519|NCT01808209|101467342|FG000|COMPLETED|Overall Study||33||
48461520|NCT01808209|101467343|FG001|COMPLETED|Overall Study||26||
48461521|NCT01808209|101467342|FG000|NOT COMPLETED|Overall Study||0||
48461522|NCT01808209|101467343|FG001|NOT COMPLETED|Overall Study||1||
48461523|NCT02062606|101467344|FG000|STARTED|Overall Study||188||
48461524|NCT02062606|101467344|FG000|COMPLETED|Overall Study||99||
48461525|NCT02062606|101467344|FG000|NOT COMPLETED|Overall Study||89||
48461526|NCT02115256|101467345|FG000|STARTED|Overall Study||3||
48461527|NCT02115256|101467346|FG001|STARTED|Overall Study||3||
48461528|NCT02115256|101467345|FG000|COMPLETED|Overall Study||3||
48461529|NCT02115256|101467346|FG001|COMPLETED|Overall Study||2||
48461530|NCT02115256|101467345|FG000|NOT COMPLETED|Overall Study||0||
48461531|NCT02115256|101467346|FG001|NOT COMPLETED|Overall Study||1||
48461532|NCT01793610|101467347|FG000|STARTED|Overall Study||6||
48461533|NCT01793610|101467348|FG001|STARTED|Overall Study||9||
48461534|NCT01793610|101467349|FG002|STARTED|Overall Study||13||
48461535|NCT01793610|101467347|FG000|COMPLETED|Overall Study||5||
48461536|NCT01793610|101467348|FG001|COMPLETED|Overall Study||9||
48461537|NCT01793610|101467349|FG002|COMPLETED|Overall Study||12||
48461538|NCT01793610|101467347|FG000|NOT COMPLETED|Overall Study||1||
48461539|NCT01793610|101467348|FG001|NOT COMPLETED|Overall Study||0||
48461540|NCT01793610|101467349|FG002|NOT COMPLETED|Overall Study||1||
48461541|NCT02226796|101467350|FG000|STARTED|First Intervention Phase (Week 1)||2||
48461542|NCT02226796|101467351|FG001|STARTED|First Intervention Phase (Week 1)||1||
48461543|NCT02226796|101467350|FG000|Baseline Assessment|First Intervention Phase (Week 1)||2||
48461544|NCT02226796|101467351|FG001|Baseline Assessment|First Intervention Phase (Week 1)||1||
48461545|NCT02226796|101467350|FG000|Follow Up Assessment|First Intervention Phase (Week 1)||2||
48461546|NCT02226796|101467351|FG001|Follow Up Assessment|First Intervention Phase (Week 1)||1||
48461547|NCT02226796|101467350|FG000|COMPLETED|First Intervention Phase (Week 1)||2||
48461548|NCT02226796|101467351|FG001|COMPLETED|First Intervention Phase (Week 1)||1||
48461549|NCT02226796|101467350|FG000|NOT COMPLETED|First Intervention Phase (Week 1)||0||
48461550|NCT02226796|101467351|FG001|NOT COMPLETED|First Intervention Phase (Week 1)||0||
48461551|NCT02226796|101467350|FG000|STARTED|Washout (Weeks 2-5)||2||
48461552|NCT02226796|101467351|FG001|STARTED|Washout (Weeks 2-5)||1||
48461553|NCT02226796|101467350|FG000|COMPLETED|Washout (Weeks 2-5)||2||
48461554|NCT02226796|101467351|FG001|COMPLETED|Washout (Weeks 2-5)||1||
48461555|NCT02226796|101467350|FG000|NOT COMPLETED|Washout (Weeks 2-5)||0||
48461556|NCT02226796|101467351|FG001|NOT COMPLETED|Washout (Weeks 2-5)||0||
48461557|NCT02226796|101467350|FG000|STARTED|Second Intervention Phase (Week 6)||2||
48461558|NCT02226796|101467351|FG001|STARTED|Second Intervention Phase (Week 6)||1||
48461559|NCT02226796|101467350|FG000|Baseline Assessment|Second Intervention Phase (Week 6)||2||
48664635|NCT00086515|101962064|FG001|NOT COMPLETED|Phase B (Weeks 24-104)||55||
48664636|NCT03331354|101962065|FG000|STARTED|Overall Study||47||
48664637|NCT03331354|101962066|FG001|STARTED|Overall Study||50||
48664638|NCT03331354|101962065|FG000|COMPLETED|Overall Study||43||
48664639|NCT03331354|101962066|FG001|COMPLETED|Overall Study||40||
48664640|NCT03331354|101962065|FG000|NOT COMPLETED|Overall Study||4||
48664641|NCT03331354|101962066|FG001|NOT COMPLETED|Overall Study||10||
48664642|NCT01189760|101962067|FG000|STARTED|Overall Study||305||
48664643|NCT01189760|101962068|FG001|STARTED|Overall Study||306||
48664644|NCT01189760|101962069|FG002|STARTED|Overall Study||306||
48664645|NCT01189760|101962067|FG000|COMPLETED|Overall Study||291||
48664646|NCT01189760|101962068|FG001|COMPLETED|Overall Study||283||
48461560|NCT02226796|101467351|FG001|Baseline Assessment|Second Intervention Phase (Week 6)||1||
48461561|NCT02226796|101467350|FG000|Follow Up Assessment|Second Intervention Phase (Week 6)||2||
48461562|NCT02226796|101467351|FG001|Follow Up Assessment|Second Intervention Phase (Week 6)||1||
48461563|NCT02226796|101467350|FG000|COMPLETED|Second Intervention Phase (Week 6)||2||
48461564|NCT02226796|101467351|FG001|COMPLETED|Second Intervention Phase (Week 6)||1||
48461565|NCT02226796|101467350|FG000|NOT COMPLETED|Second Intervention Phase (Week 6)||0||
48461566|NCT02226796|101467351|FG001|NOT COMPLETED|Second Intervention Phase (Week 6)||0||
48461567|NCT01618266|101467352|FG000|STARTED|Overall Study||375||
48461568|NCT01618266|101467352|FG000|COMPLETED|Overall Study||279||
48461569|NCT01618266|101467352|FG000|NOT COMPLETED|Overall Study||96||
48461570|NCT02971956|101467353|FG000|STARTED|Overall Study||49||
48461571|NCT02971956|101467353|FG000|COMPLETED|Overall Study||49||
48461572|NCT02971956|101467353|FG000|NOT COMPLETED|Overall Study||0||
48461573|NCT01215123|101467354|FG000|STARTED|Overall Study||28||
48461574|NCT01215123|101467354|FG000|COMPLETED|Overall Study||28||
48461575|NCT01215123|101467354|FG000|NOT COMPLETED|Overall Study||0||
48461576|NCT01095757|101467355|FG000|STARTED|Overall Study||45||
48461577|NCT01095757|101467355|FG000|COMPLETED|Overall Study||45||
48461578|NCT01095757|101467355|FG000|NOT COMPLETED|Overall Study||0||
48664647|NCT01189760|101962069|FG002|COMPLETED|Overall Study||255||
48775780|NCT01623050|102240231|FG000|Treated|Overall Study||34||
48775781|NCT01623050|102240231|FG000|COMPLETED|Overall Study||27||
48775782|NCT01623050|102240231|FG000|NOT COMPLETED|Overall Study||9||
48775783|NCT02425943|102240232|FG000|STARTED|Overall Study||557||
48775784|NCT02425943|102240233|FG001|STARTED|Overall Study||310||
48775785|NCT02425943|102240232|FG000|COMPLETED|Overall Study||421||
48775786|NCT02425943|102240233|FG001|COMPLETED|Overall Study||240||
48775787|NCT02425943|102240232|FG000|NOT COMPLETED|Overall Study||136||
48775788|NCT02425943|102240233|FG001|NOT COMPLETED|Overall Study||70||
48775789|NCT02745080|102240234|FG000|STARTED|Overall Study||426|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF)|
48775790|NCT02745080|102240235|FG001|STARTED|Overall Study||427|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF)|
48775791|NCT02745080|102240234|FG000|COMPLETED|Overall Study||371||
48461579|NCT00988169|101467356|FG000|STARTED|Overall Study||6||
48461580|NCT00988169|101467356|FG000|COMPLETED|Overall Study||5||
48461581|NCT00988169|101467356|FG000|NOT COMPLETED|Overall Study||1||
48461582|NCT03827213|101467357|FG000|STARTED|Overall Study||11||
48461583|NCT03827213|101467358|FG001|STARTED|Overall Study||12||
48461584|NCT03827213|101467357|FG000|COMPLETED|Overall Study||7||
48775792|NCT02745080|102240235|FG001|COMPLETED|Overall Study||338||
48775793|NCT02745080|102240234|FG000|NOT COMPLETED|Overall Study||55||
48775794|NCT02745080|102240235|FG001|NOT COMPLETED|Overall Study||89||
48775795|NCT01976741|102240236|FG000|STARTED|Overall Study||4||
48775796|NCT01976741|102240237|FG001|STARTED|Overall Study||4||
48775797|NCT01976741|102240238|FG002|STARTED|Overall Study||4||
48775798|NCT01976741|102240239|FG003|STARTED|Overall Study||3||
48775799|NCT01976741|102240240|FG004|STARTED|Overall Study||4||
48775800|NCT01976741|102240241|FG005|STARTED|Overall Study||4||
48775801|NCT01976741|102240242|FG006|STARTED|Overall Study||23||
48775802|NCT01976741|102240243|FG007|STARTED|Overall Study||74||
48775803|NCT01976741|102240244|FG008|STARTED|Overall Study||8||
48775804|NCT01976741|102240245|FG009|STARTED|Overall Study||40||
48775805|NCT01976741|102240236|FG000|COMPLETED|Overall Study||3||
48775806|NCT01976741|102240237|FG001|COMPLETED|Overall Study||4||
48775807|NCT01976741|102240238|FG002|COMPLETED|Overall Study||1||
48775808|NCT01976741|102240239|FG003|COMPLETED|Overall Study||2||
48775809|NCT01976741|102240240|FG004|COMPLETED|Overall Study||4||
48775810|NCT01976741|102240241|FG005|COMPLETED|Overall Study||4||
48775811|NCT01976741|102240242|FG006|COMPLETED|Overall Study||19||
48775812|NCT01976741|102240243|FG007|COMPLETED|Overall Study||62||
48775813|NCT01976741|102240244|FG008|COMPLETED|Overall Study||7||
48461585|NCT03827213|101467358|FG001|COMPLETED|Overall Study||11||
48461586|NCT03827213|101467357|FG000|NOT COMPLETED|Overall Study||4||
48461587|NCT03827213|101467358|FG001|NOT COMPLETED|Overall Study||1||
48461588|NCT00753714|101467359|FG000|STARTED|Overall Study||61||
48461589|NCT00753714|101467360|FG001|STARTED|Overall Study||63||
48461590|NCT00753714|101467359|FG000|COMPLETED|Overall Study||1||
48461591|NCT00753714|101467360|FG001|COMPLETED|Overall Study||1||
48461592|NCT00753714|101467359|FG000|NOT COMPLETED|Overall Study||60||
48461593|NCT00753714|101467360|FG001|NOT COMPLETED|Overall Study||62||
48461594|NCT01405950|101467361|FG000|STARTED|Overall Study||8||
48461595|NCT01405950|101467362|FG001|STARTED|Overall Study||2||
48461596|NCT01405950|101467363|FG002|STARTED|Overall Study||0||
48461597|NCT01405950|101467364|FG003|STARTED|Overall Study||0||
48461598|NCT01405950|101467361|FG000|COMPLETED|Overall Study||7||
48461599|NCT01405950|101467362|FG001|COMPLETED|Overall Study||2||
48461600|NCT01405950|101467363|FG002|COMPLETED|Overall Study||0||
48461601|NCT01405950|101467364|FG003|COMPLETED|Overall Study||0||
48461602|NCT01405950|101467361|FG000|NOT COMPLETED|Overall Study||1||
48461603|NCT01405950|101467362|FG001|NOT COMPLETED|Overall Study||0||
48461604|NCT01405950|101467363|FG002|NOT COMPLETED|Overall Study||0||
48461605|NCT01405950|101467364|FG003|NOT COMPLETED|Overall Study||0||
48461606|NCT03331965|101467365|FG000|STARTED|Overall Study||55||
48461607|NCT03331965|101467366|FG001|STARTED|Overall Study||55||
48775814|NCT01976741|102240245|FG009|COMPLETED|Overall Study||36||
48775815|NCT01976741|102240236|FG000|NOT COMPLETED|Overall Study||1||
48775816|NCT01976741|102240237|FG001|NOT COMPLETED|Overall Study||0||
48775817|NCT01976741|102240238|FG002|NOT COMPLETED|Overall Study||3||
48775818|NCT01976741|102240239|FG003|NOT COMPLETED|Overall Study||1||
48775819|NCT01976741|102240240|FG004|NOT COMPLETED|Overall Study||0||
48775820|NCT01976741|102240241|FG005|NOT COMPLETED|Overall Study||0||
48775821|NCT01976741|102240242|FG006|NOT COMPLETED|Overall Study||4||
48775822|NCT01976741|102240243|FG007|NOT COMPLETED|Overall Study||12||
48775823|NCT01976741|102240244|FG008|NOT COMPLETED|Overall Study||1||
48775824|NCT01976741|102240245|FG009|NOT COMPLETED|Overall Study||4||
48775825|NCT03433040|102240246|FG000|STARTED|Overall Study||19||
48775826|NCT03433040|102240247|FG001|STARTED|Overall Study||16||
48775827|NCT03433040|102240248|FG002|STARTED|Overall Study||9||
48775828|NCT03433040|102240246|FG000|COMPLETED|Overall Study||17||
48461608|NCT03331965|101467365|FG000|COMPLETED|Overall Study||45||
48461609|NCT03331965|101467366|FG001|COMPLETED|Overall Study||51||
48461610|NCT03331965|101467365|FG000|NOT COMPLETED|Overall Study||10||
48461611|NCT03331965|101467366|FG001|NOT COMPLETED|Overall Study||4||
48461612|NCT00310427|101467367|FG000|STARTED|Overall Study||27||
48461613|NCT00310427|101467368|FG001|STARTED|Overall Study||26||
48775829|NCT03433040|102240247|FG001|COMPLETED|Overall Study||8||
48775830|NCT03433040|102240248|FG002|COMPLETED|Overall Study||5||
48775831|NCT03433040|102240246|FG000|NOT COMPLETED|Overall Study||2||
48775832|NCT03433040|102240247|FG001|NOT COMPLETED|Overall Study||8||
48775833|NCT03433040|102240248|FG002|NOT COMPLETED|Overall Study||4||
48775834|NCT02167139|102240249|FG000|STARTED|Randomised, Double-blind||271||
48775835|NCT02167139|102240250|FG001|STARTED|Randomised, Double-blind||273||
48775836|NCT02167139|102240251|FG002|STARTED|Randomised, Double-blind||0||
48775837|NCT02167139|102240252|FG003|STARTED|Randomised, Double-blind||0||
48775838|NCT02167139|102240249|FG000|COMPLETED|Randomised, Double-blind||254||
48775839|NCT02167139|102240250|FG001|COMPLETED|Randomised, Double-blind||254||
48775840|NCT02167139|102240251|FG002|COMPLETED|Randomised, Double-blind||0||
48775841|NCT02167139|102240252|FG003|COMPLETED|Randomised, Double-blind||0||
48775842|NCT02167139|102240249|FG000|NOT COMPLETED|Randomised, Double-blind||17||
48775843|NCT02167139|102240250|FG001|NOT COMPLETED|Randomised, Double-blind||19||
48775844|NCT02167139|102240251|FG002|NOT COMPLETED|Randomised, Double-blind||0||
48775845|NCT02167139|102240252|FG003|NOT COMPLETED|Randomised, Double-blind||0||
48775846|NCT02167139|102240249|FG000|STARTED|Transition-extension||254||
48775847|NCT02167139|102240250|FG001|STARTED|Transition-extension||0||
48775848|NCT02167139|102240251|FG002|STARTED|Transition-extension||125||
48775849|NCT02167139|102240252|FG003|STARTED|Transition-extension||129||
48775850|NCT02167139|102240249|FG000|COMPLETED|Transition-extension||248||
48775851|NCT02167139|102240250|FG001|COMPLETED|Transition-extension||0||
48775852|NCT02167139|102240251|FG002|COMPLETED|Transition-extension||117||
48775853|NCT02167139|102240252|FG003|COMPLETED|Transition-extension||124||
48775854|NCT02167139|102240249|FG000|NOT COMPLETED|Transition-extension||6||
48775855|NCT02167139|102240250|FG001|NOT COMPLETED|Transition-extension||0||
48775856|NCT02167139|102240251|FG002|NOT COMPLETED|Transition-extension||8||
48775857|NCT02167139|102240252|FG003|NOT COMPLETED|Transition-extension||5||
48775858|NCT03048578|102240253|FG000|STARTED|Overall Study||89||
48775859|NCT03048578|102240254|FG001|STARTED|Overall Study||43||
48775860|NCT03048578|102240253|FG000|COMPLETED|Overall Study||58||
48775861|NCT03048578|102240254|FG001|COMPLETED|Overall Study||23||
48775862|NCT03048578|102240253|FG000|NOT COMPLETED|Overall Study||31||
48775863|NCT03048578|102240254|FG001|NOT COMPLETED|Overall Study||20||
48775864|NCT04195893|102240255|FG000|STARTED|First Intervention||27||
48775865|NCT04195893|102240256|FG001|STARTED|First Intervention||29||
48775866|NCT04195893|102240255|FG000|COMPLETED|First Intervention||27||
48775867|NCT04195893|102240256|FG001|COMPLETED|First Intervention||29||
48775868|NCT04195893|102240255|FG000|NOT COMPLETED|First Intervention||0||
48775869|NCT04195893|102240256|FG001|NOT COMPLETED|First Intervention||0||
48775870|NCT04195893|102240255|FG000|STARTED|Second Intervention||27||
48775871|NCT04195893|102240256|FG001|STARTED|Second Intervention||29||
48775872|NCT04195893|102240255|FG000|COMPLETED|Second Intervention||26||
48775873|NCT04195893|102240256|FG001|COMPLETED|Second Intervention||29||
48775874|NCT04195893|102240255|FG000|NOT COMPLETED|Second Intervention||1||
48775875|NCT04195893|102240256|FG001|NOT COMPLETED|Second Intervention||0||
48775876|NCT01010867|102240257|FG000|STARTED|Overall Study||31||
48775877|NCT01010867|102240257|FG000|COMPLETED|Overall Study||30||
48775878|NCT01010867|102240257|FG000|NOT COMPLETED|Overall Study||1||
48775879|NCT04953728|102240258|FG000|STARTED|Overall Study||23|Started means randomized to treatment but not, necessarily, receiving any treatment.|
48775880|NCT04953728|102240258|FG000|ST36 100 HZ|Overall Study||20||
48775881|NCT04953728|102240258|FG000|ST36 25 HZ|Overall Study||20||
48775882|NCT04953728|102240258|FG000|PC6 100 HZ|Overall Study||20||
48775883|NCT04953728|102240258|FG000|PC6 25 HZ|Overall Study||19||
48461614|NCT00310427|101467367|FG000|COMPLETED|Overall Study||25||
48775884|NCT04953728|102240258|FG000|Sham 25 HZ|Overall Study||22||
48775885|NCT04953728|102240258|FG000|COMPLETED|Overall Study||19|Completed means all participants for whom all treatments were administered.|
48775886|NCT04953728|102240258|FG000|NOT COMPLETED|Overall Study||4||
48775887|NCT04080167|102240259|FG000|STARTED|Overall Study||136||2
48775888|NCT04080167|102240260|FG001|STARTED|Overall Study||99||2
48775889|NCT04080167|102240261|FG002|STARTED|Overall Study||147||3
48775890|NCT04080167|102240259|FG000|Patients-All Enrolled|Overall Study||94||2
48775891|NCT04080167|102240260|FG001|Patients-All Enrolled|Overall Study||88||2
48775892|NCT04080167|102240261|FG002|Patients-All Enrolled|Overall Study||111||3
48775893|NCT04080167|102240259|FG000|Providers-All Enrolled|Overall Study||42||2
48775894|NCT04080167|102240260|FG001|Providers-All Enrolled|Overall Study||11||2
48775895|NCT04080167|102240261|FG002|Providers-All Enrolled|Overall Study||36||3
48775896|NCT04080167|102240259|FG000|Patients-Completed|Overall Study||84||2
48461615|NCT00310427|101467368|FG001|COMPLETED|Overall Study||25||
48461616|NCT00310427|101467367|FG000|NOT COMPLETED|Overall Study||2||
48461617|NCT00310427|101467368|FG001|NOT COMPLETED|Overall Study||1||
48775897|NCT04080167|102240260|FG001|Patients-Completed|Overall Study||67||2
48775898|NCT04080167|102240261|FG002|Patients-Completed|Overall Study||110||3
48775899|NCT04080167|102240259|FG000|Providers-Completed|Overall Study||40||2
48775900|NCT04080167|102240260|FG001|Providers-Completed|Overall Study||9||2
48775901|NCT04080167|102240261|FG002|Providers-Completed|Overall Study||32||3
48775902|NCT04080167|102240259|FG000|COMPLETED|Overall Study||124||2
48775903|NCT04080167|102240260|FG001|COMPLETED|Overall Study||76||2
48775904|NCT04080167|102240261|FG002|COMPLETED|Overall Study||142||3
48775905|NCT04080167|102240259|FG000|NOT COMPLETED|Overall Study||12||0
48775906|NCT04080167|102240260|FG001|NOT COMPLETED|Overall Study||23||0
48775907|NCT04080167|102240261|FG002|NOT COMPLETED|Overall Study||5||0
48775908|NCT00568386|102240262|FG000|STARTED|Overall Study||20||
48775909|NCT00568386|102240263|FG001|STARTED|Overall Study||20||
48775910|NCT00568386|102240262|FG000|COMPLETED|Overall Study||20||
48775911|NCT00568386|102240263|FG001|COMPLETED|Overall Study||20||
48775912|NCT00568386|102240262|FG000|NOT COMPLETED|Overall Study||0||
48775913|NCT00568386|102240263|FG001|NOT COMPLETED|Overall Study||0||
48775914|NCT05343624|102240264|FG000|STARTED|Overall Study||9||
48775915|NCT05343624|102240264|FG000|COMPLETED|Overall Study||8||
48775916|NCT05343624|102240264|FG000|NOT COMPLETED|Overall Study||1||
48775917|NCT00124514|102240265|FG000|STARTED|Overall Study||6||
48775918|NCT00124514|102240266|FG001|STARTED|Overall Study||9||
48775919|NCT00124514|102240267|FG002|STARTED|Overall Study||8||
48775920|NCT00124514|102240268|FG003|STARTED|Overall Study||6||
48461618|NCT02087059|101467369|FG000|STARTED|Overall Study||51||
48461619|NCT02087059|101467369|FG000|COMPLETED|Overall Study||44||
48461620|NCT02087059|101467369|FG000|NOT COMPLETED|Overall Study||7||
48461621|NCT03103581|101467370|FG000|STARTED|Overall Study||17||
48461622|NCT03103581|101467370|FG000|COMPLETED|Overall Study||15||
48461623|NCT03103581|101467370|FG000|NOT COMPLETED|Overall Study||2||
48461624|NCT03349333|101467371|FG000|STARTED|Overall Study||71||
48461625|NCT03349333|101467371|FG000|COMPLETED|Overall Study||0||
48461626|NCT03349333|101467371|FG000|NOT COMPLETED|Overall Study||71||
48461627|NCT02419313|101467372|FG000|STARTED|First Intervention||18||
48461628|NCT02419313|101467373|FG001|STARTED|First Intervention||15||
48664648|NCT01189760|101962067|FG000|NOT COMPLETED|Overall Study||14||
48664649|NCT01189760|101962068|FG001|NOT COMPLETED|Overall Study||23||
48664650|NCT01189760|101962069|FG002|NOT COMPLETED|Overall Study||51||
48664651|NCT00500331|101962070|FG000|STARTED|Overall Study||48||
48664652|NCT00500331|101962071|FG001|STARTED|Overall Study||47||
48664653|NCT00500331|101962072|FG002|STARTED|Overall Study||48||
48664654|NCT00500331|101962073|FG003|STARTED|Overall Study||48||
48775921|NCT00124514|102240269|FG004|STARTED|Overall Study||2||
48775922|NCT00124514|102240265|FG000|COMPLETED|Overall Study||2||
48775923|NCT00124514|102240266|FG001|COMPLETED|Overall Study||7||
48775924|NCT00124514|102240267|FG002|COMPLETED|Overall Study||7||
48775925|NCT00124514|102240268|FG003|COMPLETED|Overall Study||5||
48775926|NCT00124514|102240269|FG004|COMPLETED|Overall Study||1||
48775927|NCT00124514|102240265|FG000|NOT COMPLETED|Overall Study||4||
48775928|NCT00124514|102240266|FG001|NOT COMPLETED|Overall Study||2||
48775929|NCT00124514|102240267|FG002|NOT COMPLETED|Overall Study||1||
48775930|NCT00124514|102240268|FG003|NOT COMPLETED|Overall Study||1||
48775931|NCT00124514|102240269|FG004|NOT COMPLETED|Overall Study||1||
48775932|NCT05225805|102240270|FG000|STARTED|Overall Study||6||
48775933|NCT05225805|102240271|FG001|STARTED|Overall Study||7||
48775934|NCT05225805|102240270|FG000|COMPLETED|Overall Study||6||
48775935|NCT05225805|102240271|FG001|COMPLETED|Overall Study||7||
48775936|NCT05225805|102240270|FG000|NOT COMPLETED|Overall Study||0||
48775937|NCT05225805|102240271|FG001|NOT COMPLETED|Overall Study||0||
48775938|NCT02597478|102240272|FG000|STARTED|Overall Study||16||
48775939|NCT02597478|102240273|FG001|STARTED|Overall Study||18||
48461629|NCT02419313|101467372|FG000|COMPLETED|First Intervention||16||
48461630|NCT02419313|101467373|FG001|COMPLETED|First Intervention||15||
48461631|NCT02419313|101467372|FG000|NOT COMPLETED|First Intervention||2||
48461632|NCT02419313|101467373|FG001|NOT COMPLETED|First Intervention||0||
48461633|NCT02419313|101467372|FG000|STARTED|Second Intervention||16||
48461634|NCT02419313|101467373|FG001|STARTED|Second Intervention||15||
48461635|NCT02419313|101467372|FG000|COMPLETED|Second Intervention||15||
48775940|NCT02597478|102240272|FG000|COMPLETED|Overall Study||13||
48775941|NCT02597478|102240273|FG001|COMPLETED|Overall Study||17||
48461636|NCT02419313|101467373|FG001|COMPLETED|Second Intervention||15||
48461637|NCT02419313|101467372|FG000|NOT COMPLETED|Second Intervention||1||
48775942|NCT02597478|102240272|FG000|NOT COMPLETED|Overall Study||3||
48775943|NCT02597478|102240273|FG001|NOT COMPLETED|Overall Study||1||
48664655|NCT00500331|101962074|FG004|STARTED|Overall Study||48||
48664656|NCT00500331|101962075|FG005|STARTED|Overall Study||47||
48664657|NCT00500331|101962076|FG006|STARTED|Overall Study||48||
48775944|NCT00839319|102240274|FG000|STARTED|Overall Study||8||
48775945|NCT00839319|102240275|FG001|STARTED|Overall Study||8||
48775946|NCT00839319|102240276|FG002|STARTED|Overall Study||8||
48775947|NCT00839319|102240277|FG003|STARTED|Overall Study||8||
48775948|NCT00839319|102240278|FG004|STARTED|Overall Study||8||
48775949|NCT00839319|102240274|FG000|COMPLETED|Overall Study||6||
48775950|NCT00839319|102240275|FG001|COMPLETED|Overall Study||7||
48775951|NCT00839319|102240276|FG002|COMPLETED|Overall Study||5||
48775952|NCT00839319|102240277|FG003|COMPLETED|Overall Study||5||
48775953|NCT00839319|102240278|FG004|COMPLETED|Overall Study||8||
48775954|NCT00839319|102240274|FG000|NOT COMPLETED|Overall Study||2||
48775955|NCT00839319|102240275|FG001|NOT COMPLETED|Overall Study||1||
48775956|NCT00839319|102240276|FG002|NOT COMPLETED|Overall Study||3||
48775957|NCT00839319|102240277|FG003|NOT COMPLETED|Overall Study||3||
48775958|NCT00839319|102240278|FG004|NOT COMPLETED|Overall Study||0||
48775959|NCT03959176|102240279|FG000|STARTED|First Eye Exam||7||7
48775960|NCT03959176|102240280|FG001|STARTED|First Eye Exam||6||6
48775961|NCT03959176|102240279|FG000|COMPLETED|First Eye Exam||7||7
48775962|NCT03959176|102240280|FG001|COMPLETED|First Eye Exam||6||6
48775963|NCT03959176|102240279|FG000|NOT COMPLETED|First Eye Exam||0||0
48775964|NCT03959176|102240280|FG001|NOT COMPLETED|First Eye Exam||0||0
48775965|NCT03959176|102240279|FG000|STARTED|Opposite Eye Exam||7||7
48775966|NCT03959176|102240280|FG001|STARTED|Opposite Eye Exam||6||6
48775967|NCT03959176|102240279|FG000|COMPLETED|Opposite Eye Exam||7||7
48775968|NCT03959176|102240280|FG001|COMPLETED|Opposite Eye Exam||6||6
48775969|NCT03959176|102240279|FG000|NOT COMPLETED|Opposite Eye Exam||0||0
48775970|NCT03959176|102240280|FG001|NOT COMPLETED|Opposite Eye Exam||0||0
48775971|NCT02693132|102240281|FG000|STARTED|Overall Study||17||
48775972|NCT02693132|102240282|FG001|STARTED|Overall Study||17||
48775973|NCT02693132|102240283|FG002|STARTED|Overall Study||18||
48775974|NCT02693132|102240281|FG000|COMPLETED|Overall Study||16||
48775975|NCT02693132|102240282|FG001|COMPLETED|Overall Study||16||
48775976|NCT02693132|102240283|FG002|COMPLETED|Overall Study||17||
48775977|NCT02693132|102240281|FG000|NOT COMPLETED|Overall Study||1||
48775978|NCT02693132|102240282|FG001|NOT COMPLETED|Overall Study||1||
48775979|NCT02693132|102240283|FG002|NOT COMPLETED|Overall Study||1||
48775980|NCT02118441|102240284|FG000|STARTED|Overall Study||65||
48775981|NCT02118441|102240285|FG001|STARTED|Overall Study||64||
48775982|NCT02118441|102240284|FG000|COMPLETED|Overall Study||62||
48775983|NCT02118441|102240285|FG001|COMPLETED|Overall Study||63||
48775984|NCT02118441|102240284|FG000|NOT COMPLETED|Overall Study||3||
48775985|NCT02118441|102240285|FG001|NOT COMPLETED|Overall Study||1||
48775986|NCT02118961|102240286|FG000|STARTED|Overall Study||224||
48775987|NCT02118961|102240287|FG001|STARTED|Overall Study||222||
48775988|NCT02118961|102240286|FG000|COMPLETED|Overall Study||223||
48775989|NCT02118961|102240287|FG001|COMPLETED|Overall Study||222||
48775990|NCT02118961|102240286|FG000|NOT COMPLETED|Overall Study||1||
48775991|NCT02118961|102240287|FG001|NOT COMPLETED|Overall Study||0||
48775992|NCT01781299|102240288|FG000|STARTED|Overall Study||4||
48775993|NCT01781299|102240289|FG001|STARTED|Overall Study||5||
48775994|NCT01781299|102240288|FG000|COMPLETED|Overall Study||4||
48775995|NCT01781299|102240289|FG001|COMPLETED|Overall Study||4||
48775996|NCT01781299|102240288|FG000|NOT COMPLETED|Overall Study||0||
48775997|NCT01781299|102240289|FG001|NOT COMPLETED|Overall Study||1||
48775998|NCT00557856|102240290|FG000|STARTED|Part 1: Dose Escalation Phase||7||
48775999|NCT00557856|102240291|FG001|STARTED|Part 1: Dose Escalation Phase||5||
48776000|NCT00557856|102240292|FG002|STARTED|Part 1: Dose Escalation Phase||6||
48776001|NCT00557856|102240293|FG003|STARTED|Part 1: Dose Escalation Phase||3||
48776002|NCT00557856|102240294|FG004|STARTED|Part 1: Dose Escalation Phase||4||
48776003|NCT00557856|102240295|FG005|STARTED|Part 1: Dose Escalation Phase||8||
48776004|NCT00557856|102240296|FG006|STARTED|Part 1: Dose Escalation Phase||7||
48776005|NCT00557856|102240297|FG007|STARTED|Part 1: Dose Escalation Phase||6||
48776006|NCT00557856|102240298|FG008|STARTED|Part 1: Dose Escalation Phase||0||
48776007|NCT00557856|102240290|FG000|Treated|Part 1: Dose Escalation Phase||5||
48776008|NCT00557856|102240291|FG001|Treated|Part 1: Dose Escalation Phase||5||
48776009|NCT00557856|102240292|FG002|Treated|Part 1: Dose Escalation Phase||6||
48776010|NCT00557856|102240293|FG003|Treated|Part 1: Dose Escalation Phase||3||
48776011|NCT00557856|102240294|FG004|Treated|Part 1: Dose Escalation Phase||4||
48776012|NCT00557856|102240295|FG005|Treated|Part 1: Dose Escalation Phase||8||
48776013|NCT00557856|102240296|FG006|Treated|Part 1: Dose Escalation Phase||7||
48776014|NCT00557856|102240297|FG007|Treated|Part 1: Dose Escalation Phase||6||
48776015|NCT00557856|102240298|FG008|Treated|Part 1: Dose Escalation Phase||0||
48776016|NCT00557856|102240290|FG000|COMPLETED|Part 1: Dose Escalation Phase||0||
48776017|NCT00557856|102240291|FG001|COMPLETED|Part 1: Dose Escalation Phase||0||
48776018|NCT00557856|102240292|FG002|COMPLETED|Part 1: Dose Escalation Phase||0||
48776019|NCT00557856|102240293|FG003|COMPLETED|Part 1: Dose Escalation Phase||0||
48776020|NCT00557856|102240294|FG004|COMPLETED|Part 1: Dose Escalation Phase||0||
48776021|NCT00557856|102240295|FG005|COMPLETED|Part 1: Dose Escalation Phase||0||
48776022|NCT00557856|102240296|FG006|COMPLETED|Part 1: Dose Escalation Phase||0||
48776023|NCT00557856|102240297|FG007|COMPLETED|Part 1: Dose Escalation Phase||0||
48776024|NCT00557856|102240298|FG008|COMPLETED|Part 1: Dose Escalation Phase||0||
48776025|NCT00557856|102240290|FG000|NOT COMPLETED|Part 1: Dose Escalation Phase||7||
48776026|NCT00557856|102240291|FG001|NOT COMPLETED|Part 1: Dose Escalation Phase||5||
48776027|NCT00557856|102240292|FG002|NOT COMPLETED|Part 1: Dose Escalation Phase||6||
48776028|NCT00557856|102240293|FG003|NOT COMPLETED|Part 1: Dose Escalation Phase||3||
48776029|NCT00557856|102240294|FG004|NOT COMPLETED|Part 1: Dose Escalation Phase||4||
48776030|NCT00557856|102240295|FG005|NOT COMPLETED|Part 1: Dose Escalation Phase||8||
48776031|NCT00557856|102240296|FG006|NOT COMPLETED|Part 1: Dose Escalation Phase||7||
48776032|NCT00557856|102240297|FG007|NOT COMPLETED|Part 1: Dose Escalation Phase||6||
48776033|NCT00557856|102240298|FG008|NOT COMPLETED|Part 1: Dose Escalation Phase||0||
48776034|NCT00557856|102240290|FG000|STARTED|Part 2: Exploratory Phase||0||
48776035|NCT00557856|102240291|FG001|STARTED|Part 2: Exploratory Phase||0||
48776036|NCT00557856|102240292|FG002|STARTED|Part 2: Exploratory Phase||0||
48776037|NCT00557856|102240293|FG003|STARTED|Part 2: Exploratory Phase||0||
48776038|NCT00557856|102240294|FG004|STARTED|Part 2: Exploratory Phase||0||
48776039|NCT00557856|102240295|FG005|STARTED|Part 2: Exploratory Phase||0||
48776040|NCT00557856|102240296|FG006|STARTED|Part 2: Exploratory Phase||0||
48776041|NCT00557856|102240297|FG007|STARTED|Part 2: Exploratory Phase||0||
48776042|NCT00557856|102240298|FG008|STARTED|Part 2: Exploratory Phase||24||
48776043|NCT00557856|102240290|FG000|COMPLETED|Part 2: Exploratory Phase||0||
48776044|NCT00557856|102240291|FG001|COMPLETED|Part 2: Exploratory Phase||0||
48776045|NCT00557856|102240292|FG002|COMPLETED|Part 2: Exploratory Phase||0||
48776046|NCT00557856|102240293|FG003|COMPLETED|Part 2: Exploratory Phase||0||
48776047|NCT00557856|102240294|FG004|COMPLETED|Part 2: Exploratory Phase||0||
48776048|NCT00557856|102240295|FG005|COMPLETED|Part 2: Exploratory Phase||0||
48776049|NCT00557856|102240296|FG006|COMPLETED|Part 2: Exploratory Phase||0||
48776050|NCT00557856|102240297|FG007|COMPLETED|Part 2: Exploratory Phase||0||
48776051|NCT00557856|102240298|FG008|COMPLETED|Part 2: Exploratory Phase||0||
48776052|NCT00557856|102240290|FG000|NOT COMPLETED|Part 2: Exploratory Phase||0||
48776053|NCT00557856|102240291|FG001|NOT COMPLETED|Part 2: Exploratory Phase||0||
48776054|NCT00557856|102240292|FG002|NOT COMPLETED|Part 2: Exploratory Phase||0||
48776055|NCT00557856|102240293|FG003|NOT COMPLETED|Part 2: Exploratory Phase||0||
48776056|NCT00557856|102240294|FG004|NOT COMPLETED|Part 2: Exploratory Phase||0||
48776057|NCT00557856|102240295|FG005|NOT COMPLETED|Part 2: Exploratory Phase||0||
48776058|NCT00557856|102240296|FG006|NOT COMPLETED|Part 2: Exploratory Phase||0||
48776059|NCT00557856|102240297|FG007|NOT COMPLETED|Part 2: Exploratory Phase||0||
48776060|NCT00557856|102240298|FG008|NOT COMPLETED|Part 2: Exploratory Phase||24||
48776061|NCT00556504|102240299|FG000|STARTED|Overall Study||42||
48776062|NCT00556504|102240300|FG001|STARTED|Overall Study||42||
48776063|NCT00556504|102240299|FG000|Intend-to Treat Population|Overall Study||42||
48776064|NCT00556504|102240300|FG001|Intend-to Treat Population|Overall Study||42||
48776065|NCT00556504|102240299|FG000|Safety Population|Overall Study||41||
48776066|NCT00556504|102240300|FG001|Safety Population|Overall Study||42||
48776067|NCT00556504|102240299|FG000|COMPLETED|Overall Study||34||
48776068|NCT00556504|102240300|FG001|COMPLETED|Overall Study||33||
48776069|NCT00556504|102240299|FG000|NOT COMPLETED|Overall Study||8||
48776070|NCT00556504|102240300|FG001|NOT COMPLETED|Overall Study||9||
48776071|NCT00419952|102240301|FG000|STARTED|Overall Study||377||
48776072|NCT00419952|102240302|FG001|STARTED|Overall Study||365||
48776073|NCT00419952|102240301|FG000|COMPLETED|Overall Study||228||
48776074|NCT00419952|102240302|FG001|COMPLETED|Overall Study||240||
48776075|NCT00419952|102240301|FG000|NOT COMPLETED|Overall Study||149||
48776076|NCT00419952|102240302|FG001|NOT COMPLETED|Overall Study||125||
48776077|NCT01255436|102240303|FG000|STARTED|Overall Study||333||
48776078|NCT01255436|102240304|FG001|STARTED|Overall Study||329||
48776079|NCT01255436|102240303|FG000|COMPLETED|Overall Study||151||
48776080|NCT01255436|102240304|FG001|COMPLETED|Overall Study||135||
48776081|NCT01255436|102240303|FG000|NOT COMPLETED|Overall Study||182||
48776082|NCT01255436|102240304|FG001|NOT COMPLETED|Overall Study||194||
48776083|NCT02930018|102240305|FG000|STARTED|Overall Study||556||
48776084|NCT02930018|102240306|FG001|STARTED|Overall Study||549||
48776085|NCT02930018|102240305|FG000|COMPLETED|Overall Study||550||
48776086|NCT02930018|102240306|FG001|COMPLETED|Overall Study||546||
48776087|NCT02930018|102240305|FG000|NOT COMPLETED|Overall Study||6||
48776088|NCT02930018|102240306|FG001|NOT COMPLETED|Overall Study||3||
48776089|NCT03702283|102240307|FG000|STARTED|Overall Study||205||
48776090|NCT03702283|102240307|FG000|COMPLETED|Overall Study||205||
48776091|NCT03702283|102240307|FG000|NOT COMPLETED|Overall Study||0||
48776092|NCT04413617|102240308|FG000|STARTED|Overall Study||102||
48776093|NCT04413617|102240309|FG001|STARTED|Overall Study||77||
48776094|NCT04413617|102240310|FG002|STARTED|Overall Study||77||
48776095|NCT04413617|102240311|FG003|STARTED|Overall Study||103||
48776096|NCT04413617|102240312|FG004|STARTED|Overall Study||101||
48776097|NCT04413617|102240308|FG000|COMPLETED|Overall Study||95||
48776098|NCT04413617|102240309|FG001|COMPLETED|Overall Study||71||
48776099|NCT04413617|102240310|FG002|COMPLETED|Overall Study||73||
48776100|NCT04413617|102240311|FG003|COMPLETED|Overall Study||95||
48776101|NCT04413617|102240312|FG004|COMPLETED|Overall Study||96||
48776102|NCT04413617|102240308|FG000|NOT COMPLETED|Overall Study||7||
48776103|NCT04413617|102240309|FG001|NOT COMPLETED|Overall Study||6||
48776104|NCT04413617|102240310|FG002|NOT COMPLETED|Overall Study||4||
48776105|NCT04413617|102240311|FG003|NOT COMPLETED|Overall Study||8||
48776106|NCT04413617|102240312|FG004|NOT COMPLETED|Overall Study||5||
48776107|NCT01847027|102240313|FG000|STARTED|Overall Study||11||
48776108|NCT01847027|102240314|FG001|STARTED|Overall Study||12||
48776109|NCT01847027|102240313|FG000|COMPLETED|Overall Study||10||
48776110|NCT01847027|102240314|FG001|COMPLETED|Overall Study||10||
48776111|NCT01847027|102240313|FG000|NOT COMPLETED|Overall Study||1||
48776112|NCT01847027|102240314|FG001|NOT COMPLETED|Overall Study||2||
48776113|NCT03898557|102240315|FG000|STARTED|Overall Study||747||
48776114|NCT03898557|102240316|FG001|STARTED|Overall Study||731||
48776115|NCT03898557|102240315|FG000|COMPLETED|Overall Study||747||
48776116|NCT03898557|102240316|FG001|COMPLETED|Overall Study||731||
48776117|NCT03898557|102240315|FG000|NOT COMPLETED|Overall Study||0||
48776118|NCT03898557|102240316|FG001|NOT COMPLETED|Overall Study||0||
48776119|NCT00372593|102240317|FG000|STARTED|Overall Study||531||
48776120|NCT00372593|102240318|FG001|STARTED|Overall Study||532||
48776121|NCT00372593|102240319|FG002|STARTED|Overall Study||7||
48776122|NCT00372593|102240317|FG000|COMPLETED|Overall Study||327||
48776123|NCT00372593|102240318|FG001|COMPLETED|Overall Study||334||
48776124|NCT00372593|102240319|FG002|COMPLETED|Overall Study||3||
48776125|NCT00372593|102240317|FG000|NOT COMPLETED|Overall Study||204||
48776126|NCT00372593|102240318|FG001|NOT COMPLETED|Overall Study||198||
48776127|NCT00372593|102240319|FG002|NOT COMPLETED|Overall Study||4||
48776128|NCT04587661|102240320|FG000|STARTED|Overall Study||11||
48776129|NCT04587661|102240321|FG001|STARTED|Overall Study||10||
48776130|NCT04587661|102240320|FG000|COMPLETED|Overall Study||11||
48776131|NCT04587661|102240321|FG001|COMPLETED|Overall Study||8||
48776132|NCT04587661|102240320|FG000|NOT COMPLETED|Overall Study||0||
48776133|NCT04587661|102240321|FG001|NOT COMPLETED|Overall Study||2||
48776134|NCT01576809|102240322|FG000|STARTED|Overall Study||51||
48461638|NCT02419313|101467373|FG001|NOT COMPLETED|Second Intervention||0||
48776135|NCT01576809|102240322|FG000|COMPLETED|Overall Study||51||
48776136|NCT01576809|102240322|FG000|NOT COMPLETED|Overall Study||0||
48776137|NCT01750229|102240323|FG000|STARTED|Randomized Crossover Phase||30||
48776138|NCT01750229|102240323|FG000|Subject Received Sham|Randomized Crossover Phase||24||
48776139|NCT01750229|102240323|FG000|Subjects Received 1200 Hz|Randomized Crossover Phase||24||
48776140|NCT01750229|102240323|FG000|Subjects Received 3030 Hz|Randomized Crossover Phase||24||
48776141|NCT01750229|102240323|FG000|Subjects Received 5882 Hz|Randomized Crossover Phase||24||
48776142|NCT01750229|102240323|FG000|Protocol Violation|Randomized Crossover Phase||4||
48776143|NCT01750229|102240323|FG000|COMPLETED|Randomized Crossover Phase||28||
48776144|NCT01750229|102240323|FG000|NOT COMPLETED|Randomized Crossover Phase||2||
48776145|NCT01750229|102240323|FG000|STARTED|Long-term Follow-up Phase||28||
48776146|NCT01750229|102240323|FG000|COMPLETED|Long-term Follow-up Phase||25||
48776147|NCT01750229|102240323|FG000|NOT COMPLETED|Long-term Follow-up Phase||3||
48776148|NCT01469377|102240324|FG000|STARTED|Overall Study||269||
48776149|NCT01469377|102240325|FG001|STARTED|Overall Study||274||
48776150|NCT01469377|102240326|FG002|STARTED|Overall Study||276||
48776151|NCT01469377|102240324|FG000|COMPLETED|Overall Study||234||
48776152|NCT01469377|102240325|FG001|COMPLETED|Overall Study||226||
48776153|NCT01469377|102240326|FG002|COMPLETED|Overall Study||210||
48776154|NCT01469377|102240324|FG000|NOT COMPLETED|Overall Study||35||
48461639|NCT01393990|101467374|FG000|STARTED|Overall Study||4||
48461640|NCT01393990|101467375|FG001|STARTED|Overall Study||3||
48461641|NCT01393990|101467376|FG002|STARTED|Overall Study||3||
48776155|NCT01469377|102240325|FG001|NOT COMPLETED|Overall Study||48||
48776156|NCT01469377|102240326|FG002|NOT COMPLETED|Overall Study||66||
48776157|NCT00702299|102240327|FG000|STARTED|Overall Study||15||
48776158|NCT00702299|102240327|FG000|COMPLETED|Overall Study||15||
48776159|NCT00702299|102240327|FG000|NOT COMPLETED|Overall Study||0||
48776160|NCT00101452|102240328|FG000|STARTED|Overall Study||65||
48461642|NCT01393990|101467377|FG003|STARTED|Overall Study||3||
48776161|NCT00101452|102240329|FG001|STARTED|Overall Study||69||
48776162|NCT00101452|102240330|FG002|STARTED|Overall Study||65||
48776163|NCT00101452|102240328|FG000|COMPLETED|Overall Study||21||
48776164|NCT00101452|102240329|FG001|COMPLETED|Overall Study||26||
48776165|NCT00101452|102240330|FG002|COMPLETED|Overall Study||22||
48776166|NCT00101452|102240328|FG000|NOT COMPLETED|Overall Study||44||
48776167|NCT00101452|102240329|FG001|NOT COMPLETED|Overall Study||43||
48776168|NCT00101452|102240330|FG002|NOT COMPLETED|Overall Study||43||
48776169|NCT00774566|102240331|FG000|STARTED|Overall Study||159||
48776170|NCT00774566|102240332|FG001|STARTED|Overall Study||156||
48776171|NCT00774566|102240331|FG000|6 Month Follow up|Overall Study||154||
48776172|NCT00774566|102240332|FG001|6 Month Follow up|Overall Study||150||
48776173|NCT00774566|102240331|FG000|12 Month Follow up|Overall Study||141||
48776174|NCT00774566|102240332|FG001|12 Month Follow up|Overall Study||141||
48776175|NCT00774566|102240331|FG000|COMPLETED|Overall Study||141||
48776176|NCT00774566|102240332|FG001|COMPLETED|Overall Study||141||
48776177|NCT00774566|102240331|FG000|NOT COMPLETED|Overall Study||18||
48776178|NCT00774566|102240332|FG001|NOT COMPLETED|Overall Study||15||
48776179|NCT02974543|102240333|FG000|STARTED|Overall Study||11||
48776180|NCT02974543|102240334|FG001|STARTED|Overall Study||10||
48776181|NCT02974543|102240333|FG000|Began Washout Period|Overall Study||10||
48776182|NCT02974543|102240334|FG001|Began Washout Period|Overall Study||10||
48776183|NCT02974543|102240333|FG000|Began Crossover Assignment|Overall Study||10||
48776184|NCT02974543|102240334|FG001|Began Crossover Assignment|Overall Study||10||
48776185|NCT02974543|102240333|FG000|COMPLETED|Overall Study||10||
48776186|NCT02974543|102240334|FG001|COMPLETED|Overall Study||10||
48776187|NCT02974543|102240333|FG000|NOT COMPLETED|Overall Study||1||
48776188|NCT02974543|102240334|FG001|NOT COMPLETED|Overall Study||0||
48776189|NCT03007225|102240335|FG000|STARTED|Overall Study||25|Study completed|
48776190|NCT03007225|102240336|FG001|STARTED|Overall Study||25|Study completed|
48776191|NCT03007225|102240335|FG000|COMPLETED|Overall Study||25|Study completed|
48776192|NCT03007225|102240336|FG001|COMPLETED|Overall Study||25|Study completed|
48776193|NCT03007225|102240335|FG000|NOT COMPLETED|Overall Study||0||
48776194|NCT03007225|102240336|FG001|NOT COMPLETED|Overall Study||0||
48776195|NCT00865280|102240337|FG000|STARTED|Overall Study||70||
48776196|NCT00865280|102240338|FG001|STARTED|Overall Study||73||
48776197|NCT00865280|102240337|FG000|COMPLETED|Overall Study||64||
48776198|NCT00865280|102240338|FG001|COMPLETED|Overall Study||70||
48776199|NCT00865280|102240337|FG000|NOT COMPLETED|Overall Study||6||
48776200|NCT00865280|102240338|FG001|NOT COMPLETED|Overall Study||3||
48776201|NCT00273793|102240339|FG000|STARTED|Overall Study||36||
48776202|NCT00273793|102240340|FG001|STARTED|Overall Study||38||
48776203|NCT00273793|102240341|FG002|STARTED|Overall Study||18||
48776204|NCT00273793|102240342|FG003|STARTED|Overall Study||60||
48776205|NCT00273793|102240343|FG004|STARTED|Overall Study||58||
48189723|NCT01555762|100786289|FG000|NOT COMPLETED|Overall Study||274||
48369850|NCT04752189|101232851|FG001|Student Participants- Completed Baseline Student Survey|Overall Study||451|Students enrolled in the study were a part of the randomized teachers' classrooms.|4
48461643|NCT01393990|101467378|FG004|STARTED|Overall Study||5||
48664658|NCT00500331|101962070|FG000|COMPLETED|Overall Study||33||
48664659|NCT00500331|101962071|FG001|COMPLETED|Overall Study||42||
48664660|NCT00500331|101962072|FG002|COMPLETED|Overall Study||43||
48664661|NCT00500331|101962073|FG003|COMPLETED|Overall Study||38||
48664662|NCT00500331|101962074|FG004|COMPLETED|Overall Study||44||
48664663|NCT00500331|101962075|FG005|COMPLETED|Overall Study||42||
48664664|NCT00500331|101962076|FG006|COMPLETED|Overall Study||46||
48664665|NCT00500331|101962070|FG000|NOT COMPLETED|Overall Study||15||
48776206|NCT00273793|102240344|FG005|STARTED|Overall Study||29||
48776207|NCT00273793|102240339|FG000|COMPLETED|Overall Study||36||
48776208|NCT00273793|102240340|FG001|COMPLETED|Overall Study||38||
48776209|NCT00273793|102240341|FG002|COMPLETED|Overall Study||18||
48776210|NCT00273793|102240342|FG003|COMPLETED|Overall Study||60||
48776211|NCT00273793|102240343|FG004|COMPLETED|Overall Study||58||
48776212|NCT00273793|102240344|FG005|COMPLETED|Overall Study||29||
48776213|NCT00273793|102240339|FG000|NOT COMPLETED|Overall Study||0||
48776214|NCT00273793|102240340|FG001|NOT COMPLETED|Overall Study||0||
48776215|NCT00273793|102240341|FG002|NOT COMPLETED|Overall Study||0||
48664666|NCT00500331|101962071|FG001|NOT COMPLETED|Overall Study||5||
48664667|NCT00500331|101962072|FG002|NOT COMPLETED|Overall Study||5||
48664668|NCT00500331|101962073|FG003|NOT COMPLETED|Overall Study||10||
48664669|NCT00500331|101962074|FG004|NOT COMPLETED|Overall Study||4||
48664670|NCT00500331|101962075|FG005|NOT COMPLETED|Overall Study||5||
48664671|NCT00500331|101962076|FG006|NOT COMPLETED|Overall Study||2||
48664672|NCT02376010|101962077|FG000|STARTED|Overall Study||55||
48664673|NCT02376010|101962078|FG001|STARTED|Overall Study||55||
48664674|NCT02376010|101962077|FG000|COMPLETED|Overall Study||46||
48664675|NCT02376010|101962078|FG001|COMPLETED|Overall Study||51||
48664676|NCT02376010|101962077|FG000|NOT COMPLETED|Overall Study||9||
48664677|NCT02376010|101962078|FG001|NOT COMPLETED|Overall Study||4||
48664678|NCT05309291|101962079|FG000|STARTED|Overall Study||138||
48664679|NCT05309291|101962080|FG001|STARTED|Overall Study||136||
48664680|NCT05309291|101962079|FG000|As Treated|Overall Study||139|"All enrolled patients who were treated; based on actual treatment received.~Note: 1 patient was treated with the incorrect device after randomization, (i.e., the patient was assigned to the FX800 group according to randomization result but was treated with Theranova 400)."|
48664681|NCT05309291|101962080|FG001|As Treated|Overall Study||135|"All enrolled patients who were treated; based on actual treatment received.~Note: 1 patient was treated with the incorrect device after randomization, (i.e., the patient was assigned to the FX800 group according to randomization result but was treated with Theranova 400)."|
48664682|NCT05309291|101962079|FG000|COMPLETED|Overall Study||138||
48664683|NCT05309291|101962080|FG001|COMPLETED|Overall Study||135||
48664684|NCT05309291|101962079|FG000|NOT COMPLETED|Overall Study||0||
48664685|NCT05309291|101962080|FG001|NOT COMPLETED|Overall Study||1||
48776216|NCT00273793|102240342|FG003|NOT COMPLETED|Overall Study||0||
48776217|NCT00273793|102240343|FG004|NOT COMPLETED|Overall Study||0||
48776218|NCT00273793|102240344|FG005|NOT COMPLETED|Overall Study||0||
48776219|NCT01574183|102240345|FG000|STARTED|Overall Study||41||
48776220|NCT01574183|102240346|FG001|STARTED|Overall Study||35||
48776221|NCT01574183|102240345|FG000|COMPLETED|Overall Study||14||
48776222|NCT01574183|102240346|FG001|COMPLETED|Overall Study||17||
48776223|NCT01574183|102240345|FG000|NOT COMPLETED|Overall Study||27||
48776224|NCT01574183|102240346|FG001|NOT COMPLETED|Overall Study||18||
48776225|NCT01411891|102240347|FG000|STARTED|Overall Study||50||
48776226|NCT01411891|102240348|FG001|STARTED|Overall Study||50||
48776227|NCT01411891|102240347|FG000|COMPLETED|Overall Study||47||
48776228|NCT01411891|102240348|FG001|COMPLETED|Overall Study||48||
48776229|NCT01411891|102240347|FG000|NOT COMPLETED|Overall Study||3||
48776230|NCT01411891|102240348|FG001|NOT COMPLETED|Overall Study||2||
48776231|NCT03313037|102240349|FG000|STARTED|Overall Study||222||
48776232|NCT03313037|102240350|FG001|STARTED|Overall Study||222||
48776233|NCT03313037|102240349|FG000|Safety Population|Overall Study||221||
48776234|NCT03313037|102240350|FG001|Safety Population|Overall Study||222||
48776235|NCT03313037|102240349|FG000|Evaluable Immunogenicity Population(EIP)|Overall Study||210||
48776236|NCT03313037|102240350|FG001|Evaluable Immunogenicity Population(EIP)|Overall Study||208||
48776237|NCT03313037|102240349|FG000|COMPLETED|Overall Study||202||
48776238|NCT03313037|102240350|FG001|COMPLETED|Overall Study||202||
48776239|NCT03313037|102240349|FG000|NOT COMPLETED|Overall Study||20||
48776240|NCT03313037|102240350|FG001|NOT COMPLETED|Overall Study||20||
48776241|NCT00975780|102240351|FG000|STARTED|Allocation||400||
48461644|NCT01393990|101467379|FG005|STARTED|Overall Study||3||
48461645|NCT01393990|101467380|FG006|STARTED|Overall Study||3||
48461646|NCT01393990|101467381|FG007|STARTED|Overall Study||7||
48461647|NCT01393990|101467382|FG008|STARTED|Overall Study||6||
48461648|NCT01393990|101467383|FG009|STARTED|Overall Study||3||
48461649|NCT01393990|101467384|FG010|STARTED|Overall Study||3||
48461650|NCT01393990|101467385|FG011|STARTED|Overall Study||3||
48461651|NCT01393990|101467386|FG012|STARTED|Overall Study||3||
48461652|NCT01393990|101467387|FG013|STARTED|Overall Study||5||
48461653|NCT01393990|101467388|FG014|STARTED|Overall Study||18||
48461654|NCT01393990|101467389|FG015|STARTED|Overall Study||8||
48461655|NCT01393990|101467390|FG016|STARTED|Overall Study||3||
48664686|NCT00835354|101964618|FG000|STARTED|First Intervention||13||
48664687|NCT00835354|101964619|FG001|STARTED|First Intervention||13||
48664688|NCT00835354|101964618|FG000|COMPLETED|First Intervention||13||
48664689|NCT00835354|101964619|FG001|COMPLETED|First Intervention||12||
48664690|NCT00835354|101964618|FG000|NOT COMPLETED|First Intervention||0||
48664691|NCT00835354|101964619|FG001|NOT COMPLETED|First Intervention||1||
48664692|NCT00835354|101964618|FG000|STARTED|Washout of 7 Days||13||
48664693|NCT00835354|101964619|FG001|STARTED|Washout of 7 Days||12||
48664694|NCT00835354|101964618|FG000|COMPLETED|Washout of 7 Days||13||
48664695|NCT00835354|101964619|FG001|COMPLETED|Washout of 7 Days||12||
48664696|NCT00835354|101964618|FG000|NOT COMPLETED|Washout of 7 Days||0||
48664697|NCT00835354|101964619|FG001|NOT COMPLETED|Washout of 7 Days||0||
48664698|NCT00835354|101964618|FG000|STARTED|Second Intervention||13||
48776242|NCT00975780|102240352|FG001|STARTED|Allocation||434||
48776243|NCT00975780|102240351|FG000|COMPLETED|Allocation||400||
48776244|NCT00975780|102240352|FG001|COMPLETED|Allocation||434||
48776245|NCT00975780|102240351|FG000|NOT COMPLETED|Allocation||0||
48776246|NCT00975780|102240352|FG001|NOT COMPLETED|Allocation||0||
48776247|NCT00975780|102240351|FG000|STARTED|Follow Up||400||
48776248|NCT00975780|102240352|FG001|STARTED|Follow Up||434||
48776249|NCT00975780|102240351|FG000|COMPLETED|Follow Up||298||
48776250|NCT00975780|102240352|FG001|COMPLETED|Follow Up||277||
48776251|NCT00975780|102240351|FG000|NOT COMPLETED|Follow Up||102||
48776252|NCT00975780|102240352|FG001|NOT COMPLETED|Follow Up||157||
48776253|NCT01500720|102240353|FG000|STARTED|Overall Study||90||
48776254|NCT01500720|102240354|FG001|STARTED|Overall Study||89||
48776255|NCT01500720|102240353|FG000|Treated|Overall Study||89||
48776256|NCT01500720|102240354|FG001|Treated|Overall Study||88||
48461656|NCT01393990|101467391|FG017|STARTED|Overall Study||6||
48461657|NCT01393990|101467374|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4||
48461658|NCT01393990|101467375|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3||
48461659|NCT01393990|101467376|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
48461660|NCT01393990|101467377|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3||
48664699|NCT00835354|101964619|FG001|STARTED|Second Intervention||12||
48664700|NCT00835354|101964618|FG000|COMPLETED|Second Intervention||13||
48664701|NCT00835354|101964619|FG001|COMPLETED|Second Intervention||12||
48664702|NCT00835354|101964618|FG000|NOT COMPLETED|Second Intervention||0||
48664703|NCT00835354|101964619|FG001|NOT COMPLETED|Second Intervention||0||
48664704|NCT03374956|101964620|FG000|STARTED|Overall Study||93||
48664705|NCT03374956|101964621|FG001|STARTED|Overall Study||100||
48461661|NCT01393990|101467378|FG004|Received at Least 1 Dose of Study Drug|Overall Study||5||
48461662|NCT01393990|101467379|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3||
48664706|NCT03374956|101964620|FG000|COMPLETED|Overall Study||93||
48776257|NCT01500720|102240353|FG000|COMPLETED|Overall Study||85||
48776258|NCT01500720|102240354|FG001|COMPLETED|Overall Study||80||
48776259|NCT01500720|102240353|FG000|NOT COMPLETED|Overall Study||5||
48776260|NCT01500720|102240354|FG001|NOT COMPLETED|Overall Study||9||
48776261|NCT02223377|102240355|FG000|STARTED|Overall Study||199||
48776262|NCT02223377|102240356|FG001|STARTED|Overall Study||203||
48776263|NCT02223377|102240355|FG000|COMPLETED|Overall Study||199||
48776264|NCT02223377|102240356|FG001|COMPLETED|Overall Study||203||
48776265|NCT02223377|102240355|FG000|NOT COMPLETED|Overall Study||0||
48776266|NCT02223377|102240356|FG001|NOT COMPLETED|Overall Study||0||
48776267|NCT03037580|102244013|FG000|STARTED|Overall Study||41||
48776268|NCT03037580|102244014|FG001|STARTED|Overall Study||43||
48776269|NCT03037580|102244013|FG000|COMPLETED|Overall Study||25||
48776270|NCT03037580|102244014|FG001|COMPLETED|Overall Study||27||
48776271|NCT03037580|102244013|FG000|NOT COMPLETED|Overall Study||16||
48776272|NCT03037580|102244014|FG001|NOT COMPLETED|Overall Study||16||
48776273|NCT03083873|102244015|FG000|STARTED|Overall Study||10|Enrolled / Tumor Harvested|
48776274|NCT03083873|102244016|FG001|STARTED|Overall Study||22|Enrolled / Tumor Harvested|
48776275|NCT03083873|102244017|FG002|STARTED|Overall Study||19|Enrolled / Tumor Harvested|
48776276|NCT03083873|102244018|FG003|STARTED|Overall Study||13|Enrolled / Tumor Harvested|
48776277|NCT03083873|102244019|FG004|STARTED|Overall Study||0|Enrolled / Tumor Harvested|
48776278|NCT03083873|102244015|FG000|Infused With TIL|Overall Study||8||
48776279|NCT03083873|102244016|FG001|Infused With TIL|Overall Study||17||
48776280|NCT03083873|102244017|FG002|Infused With TIL|Overall Study||16||
48776281|NCT03083873|102244018|FG003|Infused With TIL|Overall Study||12||
48776282|NCT03083873|102244019|FG004|Infused With TIL|Overall Study||0||
48776283|NCT03083873|102244015|FG000|Completed Assessment Period|Overall Study||8|From TIL infusion on Day 0 and ends upon disease progression, the start of a new anticancer therapy, withdrawal of consent, or after 2 years (Month 24), whichever occurred first.|
48776284|NCT03083873|102244016|FG001|Completed Assessment Period|Overall Study||15|From TIL infusion on Day 0 and ends upon disease progression, the start of a new anticancer therapy, withdrawal of consent, or after 2 years (Month 24), whichever occurred first.|
48776285|NCT03083873|102244017|FG002|Completed Assessment Period|Overall Study||11|From TIL infusion on Day 0 and ends upon disease progression, the start of a new anticancer therapy, withdrawal of consent, or after 2 years (Month 24), whichever occurred first.|
48776286|NCT03083873|102244018|FG003|Completed Assessment Period|Overall Study||9|From TIL infusion on Day 0 and ends upon disease progression, the start of a new anticancer therapy, withdrawal of consent, or after 2 years (Month 24), whichever occurred first.|
48776287|NCT03083873|102244019|FG004|Completed Assessment Period|Overall Study||0|From TIL infusion on Day 0 and ends upon disease progression, the start of a new anticancer therapy, withdrawal of consent, or after 2 years (Month 24), whichever occurred first.|
48776288|NCT03083873|102244015|FG000|COMPLETED|Overall Study||0|Completed 3 years after enrollment.|
48776289|NCT03083873|102244016|FG001|COMPLETED|Overall Study||0|Completed 3 years after enrollment.|
48776290|NCT03083873|102244017|FG002|COMPLETED|Overall Study||0|Completed 3 years after enrollment.|
48776291|NCT03083873|102244018|FG003|COMPLETED|Overall Study||0|Completed 3 years after enrollment.|
48776292|NCT03083873|102244019|FG004|COMPLETED|Overall Study||0|Completed 3 years after enrollment.|
48461663|NCT01393990|101467380|FG006|Received at Least 1 Dose of Study Drug|Overall Study||3||
48461664|NCT01393990|101467381|FG007|Received at Least 1 Dose of Study Drug|Overall Study||7||
48461665|NCT01393990|101467382|FG008|Received at Least 1 Dose of Study Drug|Overall Study||6||
48461666|NCT01393990|101467383|FG009|Received at Least 1 Dose of Study Drug|Overall Study||3||
48461667|NCT01393990|101467384|FG010|Received at Least 1 Dose of Study Drug|Overall Study||3||
48461668|NCT01393990|101467385|FG011|Received at Least 1 Dose of Study Drug|Overall Study||3||
48461669|NCT01393990|101467386|FG012|Received at Least 1 Dose of Study Drug|Overall Study||3||
48461670|NCT01393990|101467387|FG013|Received at Least 1 Dose of Study Drug|Overall Study||5||
48461671|NCT01393990|101467388|FG014|Received at Least 1 Dose of Study Drug|Overall Study||18||
48461672|NCT01393990|101467389|FG015|Received at Least 1 Dose of Study Drug|Overall Study||8||
48664707|NCT03374956|101964621|FG001|COMPLETED|Overall Study||100||
48664708|NCT03374956|101964620|FG000|NOT COMPLETED|Overall Study||0||
48664709|NCT03374956|101964621|FG001|NOT COMPLETED|Overall Study||0||
48664710|NCT03329131|101964622|FG000|STARTED|Overall Study||12||
48664711|NCT03329131|101964622|FG000|COMPLETED|Overall Study||8||
48664712|NCT03329131|101964622|FG000|NOT COMPLETED|Overall Study||4||
48664713|NCT04116489|101964623|FG000|STARTED|Overall Study||19||
48664714|NCT04116489|101964623|FG000|COMPLETED|Overall Study||14||
48664715|NCT04116489|101964623|FG000|NOT COMPLETED|Overall Study||5||
48664716|NCT00980798|101964624|FG000|STARTED|Overall Study||149||
48776293|NCT03083873|102244015|FG000|NOT COMPLETED|Overall Study||10||
48776294|NCT03083873|102244016|FG001|NOT COMPLETED|Overall Study||22||
48776295|NCT03083873|102244017|FG002|NOT COMPLETED|Overall Study||19||
48776296|NCT03083873|102244018|FG003|NOT COMPLETED|Overall Study||13||
48776297|NCT03083873|102244019|FG004|NOT COMPLETED|Overall Study||0||
48776298|NCT02280408|102244020|FG000|STARTED|Overall Study||10||
48776299|NCT02280408|102244021|FG001|STARTED|Overall Study||10||
48776300|NCT02280408|102244022|FG002|STARTED|Overall Study||10||
48776301|NCT02280408|102244023|FG003|STARTED|Overall Study||9||
48776302|NCT02280408|102244020|FG000|Vaccination 1|Overall Study||10||
48776303|NCT02280408|102244021|FG001|Vaccination 1|Overall Study||10||
48776304|NCT02280408|102244022|FG002|Vaccination 1|Overall Study||10||
48776305|NCT02280408|102244023|FG003|Vaccination 1|Overall Study||9||
48776306|NCT02280408|102244020|FG000|Vaccination 2|Overall Study||10||
48776307|NCT02280408|102244021|FG001|Vaccination 2|Overall Study||10||
48776308|NCT02280408|102244022|FG002|Vaccination 2|Overall Study||10||
48776309|NCT02280408|102244023|FG003|Vaccination 2|Overall Study||9||
48776310|NCT02280408|102244020|FG000|COMPLETED|Overall Study||10||
48776311|NCT02280408|102244021|FG001|COMPLETED|Overall Study||8||
48776312|NCT02280408|102244022|FG002|COMPLETED|Overall Study||10||
48776313|NCT02280408|102244023|FG003|COMPLETED|Overall Study||9||
48461673|NCT01393990|101467390|FG016|Received at Least 1 Dose of Study Drug|Overall Study||3||
48461674|NCT01393990|101467391|FG017|Received at Least 1 Dose of Study Drug|Overall Study||6||
48461675|NCT01393990|101467374|FG000|COMPLETED|Overall Study||3||
48461676|NCT01393990|101467375|FG001|COMPLETED|Overall Study||3||
48461677|NCT01393990|101467376|FG002|COMPLETED|Overall Study||3||
48461678|NCT01393990|101467377|FG003|COMPLETED|Overall Study||2||
48461679|NCT01393990|101467378|FG004|COMPLETED|Overall Study||3||
48461680|NCT01393990|101467379|FG005|COMPLETED|Overall Study||2||
48461681|NCT01393990|101467380|FG006|COMPLETED|Overall Study||2||
48461682|NCT01393990|101467381|FG007|COMPLETED|Overall Study||6||
48461683|NCT01393990|101467382|FG008|COMPLETED|Overall Study||3||
48461684|NCT01393990|101467383|FG009|COMPLETED|Overall Study||2||
48461685|NCT01393990|101467384|FG010|COMPLETED|Overall Study||3||
48461686|NCT01393990|101467385|FG011|COMPLETED|Overall Study||3||
48461687|NCT01393990|101467386|FG012|COMPLETED|Overall Study||3||
48461688|NCT01393990|101467387|FG013|COMPLETED|Overall Study||3||
48461689|NCT01393990|101467388|FG014|COMPLETED|Overall Study||9||
48461690|NCT01393990|101467389|FG015|COMPLETED|Overall Study||5||
48461691|NCT01393990|101467390|FG016|COMPLETED|Overall Study||3||
48461692|NCT01393990|101467391|FG017|COMPLETED|Overall Study||6||
48461693|NCT01393990|101467374|FG000|NOT COMPLETED|Overall Study||1||
48461694|NCT01393990|101467375|FG001|NOT COMPLETED|Overall Study||0||
48461695|NCT01393990|101467376|FG002|NOT COMPLETED|Overall Study||0||
48461696|NCT01393990|101467377|FG003|NOT COMPLETED|Overall Study||1||
48461697|NCT01393990|101467378|FG004|NOT COMPLETED|Overall Study||2||
48461698|NCT01393990|101467379|FG005|NOT COMPLETED|Overall Study||1||
48461699|NCT01393990|101467380|FG006|NOT COMPLETED|Overall Study||1||
48461700|NCT01393990|101467381|FG007|NOT COMPLETED|Overall Study||1||
48461701|NCT01393990|101467382|FG008|NOT COMPLETED|Overall Study||3||
48461702|NCT01393990|101467383|FG009|NOT COMPLETED|Overall Study||1||
48461703|NCT01393990|101467384|FG010|NOT COMPLETED|Overall Study||0||
48461704|NCT01393990|101467385|FG011|NOT COMPLETED|Overall Study||0||
48461705|NCT01393990|101467386|FG012|NOT COMPLETED|Overall Study||0||
48461706|NCT01393990|101467387|FG013|NOT COMPLETED|Overall Study||2||
48461707|NCT01393990|101467388|FG014|NOT COMPLETED|Overall Study||9||
48461708|NCT01393990|101467389|FG015|NOT COMPLETED|Overall Study||3||
48461709|NCT01393990|101467390|FG016|NOT COMPLETED|Overall Study||0||
48776314|NCT02280408|102244020|FG000|NOT COMPLETED|Overall Study||0||
48461710|NCT01393990|101467391|FG017|NOT COMPLETED|Overall Study||0||
48461711|NCT04978454|101467392|FG000|STARTED|Overall Study||12||
48461712|NCT04978454|101467393|FG001|STARTED|Overall Study||10||
48461713|NCT04978454|101467394|FG002|STARTED|Overall Study||36||
48461714|NCT04978454|101467395|FG003|STARTED|Overall Study||2||
48461715|NCT04978454|101467392|FG000|COMPLETED|Overall Study||12||
48461716|NCT04978454|101467393|FG001|COMPLETED|Overall Study||10||
48461717|NCT04978454|101467394|FG002|COMPLETED|Overall Study||36||
48461718|NCT04978454|101467395|FG003|COMPLETED|Overall Study||2||
48461719|NCT04978454|101467392|FG000|NOT COMPLETED|Overall Study||0||
48461720|NCT04978454|101467393|FG001|NOT COMPLETED|Overall Study||0||
48461721|NCT04978454|101467394|FG002|NOT COMPLETED|Overall Study||0||
48461722|NCT04978454|101467395|FG003|NOT COMPLETED|Overall Study||0||
48461723|NCT03072459|101467396|FG000|STARTED|Overall Study||128||
48461724|NCT03072459|101467396|FG000|COMPLETED|Overall Study||126||
48461725|NCT03072459|101467396|FG000|NOT COMPLETED|Overall Study||2||
48461726|NCT00906347|101467397|FG000|STARTED|Randomized||176||
48461727|NCT00906347|101467398|FG001|STARTED|Randomized||174||
48461728|NCT00906347|101467397|FG000|COMPLETED|Randomized||176||
48461729|NCT00906347|101467398|FG001|COMPLETED|Randomized||174||
48461730|NCT00906347|101467397|FG000|NOT COMPLETED|Randomized||0||
48461731|NCT00906347|101467398|FG001|NOT COMPLETED|Randomized||0||
48461732|NCT00906347|101467397|FG000|STARTED|Received Study Drug||176||
48461733|NCT00906347|101467398|FG001|STARTED|Received Study Drug||174||
48461734|NCT00906347|101467397|FG000|COMPLETED|Received Study Drug||136||
48461735|NCT00906347|101467398|FG001|COMPLETED|Received Study Drug||143||
48461736|NCT00906347|101467397|FG000|NOT COMPLETED|Received Study Drug||40||
48461737|NCT00906347|101467398|FG001|NOT COMPLETED|Received Study Drug||31||
48461738|NCT00674219|101467399|FG000|STARTED|Overall Study||10||
48461739|NCT00674219|101467400|FG001|STARTED|Overall Study||7||
48461740|NCT00674219|101467399|FG000|COMPLETED|Overall Study||10||
48461741|NCT00674219|101467400|FG001|COMPLETED|Overall Study||7||
48461742|NCT00674219|101467399|FG000|NOT COMPLETED|Overall Study||0||
48461743|NCT00674219|101467400|FG001|NOT COMPLETED|Overall Study||0||
48461744|NCT02655354|101467401|FG000|STARTED|Overall Study||265||
48461745|NCT02655354|101467402|FG001|STARTED|Overall Study||370||
48461746|NCT02655354|101467401|FG000|COMPLETED|Overall Study||188||
48461747|NCT02655354|101467402|FG001|COMPLETED|Overall Study||289||
48461748|NCT02655354|101467401|FG000|NOT COMPLETED|Overall Study||77||
48461749|NCT02655354|101467402|FG001|NOT COMPLETED|Overall Study||81||
48461750|NCT02322879|101467403|FG000|STARTED|First Intervention||11||
48461751|NCT02322879|101467404|FG001|STARTED|First Intervention||10||
48461752|NCT02322879|101467403|FG000|COMPLETED|First Intervention||10||
48461753|NCT02322879|101467404|FG001|COMPLETED|First Intervention||10||
48776315|NCT02280408|102244021|FG001|NOT COMPLETED|Overall Study||2||
48776316|NCT02280408|102244022|FG002|NOT COMPLETED|Overall Study||0||
48461754|NCT02322879|101467403|FG000|NOT COMPLETED|First Intervention||1||
48461755|NCT02322879|101467404|FG001|NOT COMPLETED|First Intervention||0||
48461756|NCT02322879|101467403|FG000|STARTED|Washout||10||
48461757|NCT02322879|101467404|FG001|STARTED|Washout||10||
48461758|NCT02322879|101467403|FG000|COMPLETED|Washout||10||
48461759|NCT02322879|101467404|FG001|COMPLETED|Washout||10||
48461760|NCT02322879|101467403|FG000|NOT COMPLETED|Washout||0||
48461761|NCT02322879|101467404|FG001|NOT COMPLETED|Washout||0||
48461762|NCT02322879|101467403|FG000|STARTED|Second Intervention||10||
48461763|NCT02322879|101467404|FG001|STARTED|Second Intervention||10||
48461764|NCT02322879|101467403|FG000|COMPLETED|Second Intervention||10||
48461765|NCT02322879|101467404|FG001|COMPLETED|Second Intervention||10||
48461766|NCT02322879|101467403|FG000|NOT COMPLETED|Second Intervention||0||
48461767|NCT02322879|101467404|FG001|NOT COMPLETED|Second Intervention||0||
48461768|NCT02135874|101467405|FG000|STARTED|Overall Study||16||
48461769|NCT02135874|101467405|FG000|COMPLETED|Overall Study||16||
48461770|NCT02135874|101467405|FG000|NOT COMPLETED|Overall Study||0||
48461771|NCT02473510|101467406|FG000|STARTED|Overall Study||60||
48461772|NCT02473510|101467407|FG001|STARTED|Overall Study||240||
48461773|NCT02473510|101467406|FG000|COMPLETED|Overall Study||59||
48461774|NCT02473510|101467407|FG001|COMPLETED|Overall Study||238||
48461775|NCT02473510|101467406|FG000|NOT COMPLETED|Overall Study||1||
48461776|NCT02473510|101467407|FG001|NOT COMPLETED|Overall Study||2||
48461777|NCT02286518|101467408|FG000|STARTED|All Parts (16 Days)||6||
48461778|NCT02286518|101467409|FG001|STARTED|All Parts (16 Days)||6||
48461779|NCT02286518|101467410|FG002|STARTED|All Parts (16 Days)||6||
48461780|NCT02286518|101467411|FG003|STARTED|All Parts (16 Days)||6||
48461781|NCT02286518|101467412|FG004|STARTED|All Parts (16 Days)||6||
48461782|NCT02286518|101467413|FG005|STARTED|All Parts (16 Days)||6||
48461783|NCT02286518|101467414|FG006|STARTED|All Parts (16 Days)||6||
48461784|NCT02286518|101467415|FG007|STARTED|All Parts (16 Days)||6||
48461785|NCT02286518|101467416|FG008|STARTED|All Parts (16 Days)||6||
48461786|NCT02286518|101467417|FG009|STARTED|All Parts (16 Days)||4||
48461787|NCT02286518|101467418|FG010|STARTED|All Parts (16 Days)||6||
48461788|NCT02286518|101467419|FG011|STARTED|All Parts (16 Days)||6||
48461789|NCT02286518|101467420|FG012|STARTED|All Parts (16 Days)||6||
48461790|NCT02286518|101467421|FG013|STARTED|All Parts (16 Days)||6||
48461791|NCT02286518|101467408|FG000|COMPLETED|All Parts (16 Days)||6||
48461792|NCT02286518|101467409|FG001|COMPLETED|All Parts (16 Days)||6||
48461793|NCT02286518|101467410|FG002|COMPLETED|All Parts (16 Days)||6||
48461794|NCT02286518|101467411|FG003|COMPLETED|All Parts (16 Days)||6||
48461795|NCT02286518|101467412|FG004|COMPLETED|All Parts (16 Days)||6||
48461796|NCT02286518|101467413|FG005|COMPLETED|All Parts (16 Days)||6||
48461797|NCT02286518|101467414|FG006|COMPLETED|All Parts (16 Days)||6||
48461798|NCT02286518|101467415|FG007|COMPLETED|All Parts (16 Days)||6||
48461799|NCT02286518|101467416|FG008|COMPLETED|All Parts (16 Days)||6||
48461800|NCT02286518|101467417|FG009|COMPLETED|All Parts (16 Days)||4||
48461801|NCT02286518|101467418|FG010|COMPLETED|All Parts (16 Days)||6||
48461802|NCT02286518|101467419|FG011|COMPLETED|All Parts (16 Days)||6||
48461803|NCT02286518|101467420|FG012|COMPLETED|All Parts (16 Days)||6||
48461804|NCT02286518|101467421|FG013|COMPLETED|All Parts (16 Days)||6||
48461805|NCT02286518|101467408|FG000|NOT COMPLETED|All Parts (16 Days)||0||
48461806|NCT02286518|101467409|FG001|NOT COMPLETED|All Parts (16 Days)||0||
48461807|NCT02286518|101467410|FG002|NOT COMPLETED|All Parts (16 Days)||0||
48461808|NCT02286518|101467411|FG003|NOT COMPLETED|All Parts (16 Days)||0||
48461809|NCT02286518|101467412|FG004|NOT COMPLETED|All Parts (16 Days)||0||
48461810|NCT02286518|101467413|FG005|NOT COMPLETED|All Parts (16 Days)||0||
48461811|NCT02286518|101467414|FG006|NOT COMPLETED|All Parts (16 Days)||0||
48461812|NCT02286518|101467415|FG007|NOT COMPLETED|All Parts (16 Days)||0||
48461813|NCT02286518|101467416|FG008|NOT COMPLETED|All Parts (16 Days)||0||
48461814|NCT02286518|101467417|FG009|NOT COMPLETED|All Parts (16 Days)||0||
48461815|NCT02286518|101467418|FG010|NOT COMPLETED|All Parts (16 Days)||0||
48461816|NCT02286518|101467419|FG011|NOT COMPLETED|All Parts (16 Days)||0||
48461817|NCT02286518|101467420|FG012|NOT COMPLETED|All Parts (16 Days)||0||
48461818|NCT02286518|101467421|FG013|NOT COMPLETED|All Parts (16 Days)||0||
48461819|NCT02286518|101467408|FG000|STARTED|Washout Crossover Period(Part 2:14 Days)||0||
48461820|NCT02286518|101467409|FG001|STARTED|Washout Crossover Period(Part 2:14 Days)||0||
48461821|NCT02286518|101467410|FG002|STARTED|Washout Crossover Period(Part 2:14 Days)||0||
48461822|NCT02286518|101467411|FG003|STARTED|Washout Crossover Period(Part 2:14 Days)||0||
48461823|NCT02286518|101467412|FG004|STARTED|Washout Crossover Period(Part 2:14 Days)||0||
48461824|NCT02286518|101467413|FG005|STARTED|Washout Crossover Period(Part 2:14 Days)||0||
48461825|NCT02286518|101467414|FG006|STARTED|Washout Crossover Period(Part 2:14 Days)||0||
48461826|NCT02286518|101467415|FG007|STARTED|Washout Crossover Period(Part 2:14 Days)||6||
48461827|NCT02286518|101467416|FG008|STARTED|Washout Crossover Period(Part 2:14 Days)||6||
48461828|NCT02286518|101467417|FG009|STARTED|Washout Crossover Period(Part 2:14 Days)||0||
48461829|NCT02286518|101467418|FG010|STARTED|Washout Crossover Period(Part 2:14 Days)||0||
48461830|NCT02286518|101467419|FG011|STARTED|Washout Crossover Period(Part 2:14 Days)||0||
48776317|NCT02280408|102244023|FG003|NOT COMPLETED|Overall Study||0||
48776318|NCT02533453|102244024|FG000|STARTED|Overall Study||110||
48776319|NCT02533453|102244024|FG000|COMPLETED|Overall Study||101||
48776320|NCT02533453|102244024|FG000|NOT COMPLETED|Overall Study||9||
48776321|NCT02369172|102244025|FG000|STARTED|Overall Study||24||
48776322|NCT02369172|102244025|FG000|COMPLETED|Overall Study||24||
48776323|NCT02369172|102244025|FG000|NOT COMPLETED|Overall Study||0||
48776324|NCT00074490|102244026|FG000|STARTED|Overall Study||1||
48776325|NCT00074490|102244027|FG001|STARTED|Overall Study||34||
48776326|NCT00074490|102244028|FG002|STARTED|Overall Study||40||
48776327|NCT00074490|102244029|FG003|STARTED|Overall Study||44||
48776328|NCT00074490|102244030|FG004|STARTED|Overall Study||45||
48776329|NCT00074490|102244031|FG005|STARTED|Overall Study||221||
48776330|NCT00074490|102244026|FG000|COMPLETED|Overall Study||1||
48776331|NCT00074490|102244027|FG001|COMPLETED|Overall Study||27||
48776332|NCT00074490|102244028|FG002|COMPLETED|Overall Study||40||
48776333|NCT00074490|102244029|FG003|COMPLETED|Overall Study||44||
48776334|NCT00074490|102244030|FG004|COMPLETED|Overall Study||42||
48776335|NCT00074490|102244031|FG005|COMPLETED|Overall Study||221||
48776336|NCT00074490|102244026|FG000|NOT COMPLETED|Overall Study||0||
48776337|NCT00074490|102244027|FG001|NOT COMPLETED|Overall Study||7||
48776338|NCT00074490|102244028|FG002|NOT COMPLETED|Overall Study||0||
48189724|NCT04530344|100786290|FG000|STARTED|Overall Study||58||
48664717|NCT00980798|101964625|FG001|STARTED|Overall Study||139||
48776339|NCT00074490|102244029|FG003|NOT COMPLETED|Overall Study||0||
48776340|NCT00074490|102244030|FG004|NOT COMPLETED|Overall Study||3||
48776341|NCT00074490|102244031|FG005|NOT COMPLETED|Overall Study||0||
48189725|NCT04530344|100786291|FG001|STARTED|Overall Study||58||
48189726|NCT04530344|100786292|FG002|STARTED|Overall Study||118||
48189727|NCT04530344|100786293|FG003|STARTED|Overall Study||224||
48189728|NCT04530344|100786290|FG000|COMPLETED|Overall Study||41||
48189729|NCT04530344|100786291|FG001|COMPLETED|Overall Study||50||
48664718|NCT00980798|101964624|FG000|COMPLETED|Overall Study||116||
48664719|NCT00980798|101964625|FG001|COMPLETED|Overall Study||84||
48664720|NCT00980798|101964624|FG000|NOT COMPLETED|Overall Study||33||
48664721|NCT00980798|101964625|FG001|NOT COMPLETED|Overall Study||55||
48664722|NCT00879398|101964626|FG000|STARTED|Overall Study||3109||
48664723|NCT00879398|101964626|FG000|COMPLETED|Overall Study||2434||
48664724|NCT00879398|101964626|FG000|NOT COMPLETED|Overall Study||675||
48664725|NCT01889251|101964627|FG000|STARTED|Overall Study||115||
48664726|NCT01889251|101964628|FG001|STARTED|Overall Study||57||
48664727|NCT01889251|101964627|FG000|COMPLETED|Overall Study||114||
48664728|NCT01889251|101964628|FG001|COMPLETED|Overall Study||57||
48664729|NCT01889251|101964627|FG000|NOT COMPLETED|Overall Study||1||
48664730|NCT01889251|101964628|FG001|NOT COMPLETED|Overall Study||0||
48664731|NCT03379870|101964629|FG000|STARTED|Overall Study||16||
48664732|NCT03379870|101964630|FG001|STARTED|Overall Study||12||
48664733|NCT03379870|101964629|FG000|COMPLETED|Overall Study||14||
48664734|NCT03379870|101964630|FG001|COMPLETED|Overall Study||11||
48664735|NCT03379870|101964629|FG000|NOT COMPLETED|Overall Study||2||
48776342|NCT00787267|102244032|FG000|STARTED|Overall Study||37||
48776343|NCT00787267|102244032|FG000|COMPLETED|Overall Study||25||
48776344|NCT00787267|102244032|FG000|NOT COMPLETED|Overall Study||12||
48776345|NCT02888119|102244033|FG000|STARTED|Overall Study||11||
48776346|NCT02888119|102244034|FG001|STARTED|Overall Study||7||
48776347|NCT02888119|102244035|FG002|STARTED|Overall Study||30||
48776348|NCT02888119|102244033|FG000|COMPLETED|Overall Study||6||
48776349|NCT02888119|102244034|FG001|COMPLETED|Overall Study||3||
48776350|NCT02888119|102244035|FG002|COMPLETED|Overall Study||30||
48776351|NCT02888119|102244033|FG000|NOT COMPLETED|Overall Study||5||
48776352|NCT02888119|102244034|FG001|NOT COMPLETED|Overall Study||4||
48776353|NCT02888119|102244035|FG002|NOT COMPLETED|Overall Study||0||
48776354|NCT04987788|102244036|FG000|STARTED|Overall Study||22||
48776355|NCT04987788|102244037|FG001|STARTED|Overall Study||20||
48776356|NCT04987788|102244036|FG000|COMPLETED|Overall Study||22||
48776357|NCT04987788|102244037|FG001|COMPLETED|Overall Study||20||
48776358|NCT04987788|102244036|FG000|NOT COMPLETED|Overall Study||0||
48776359|NCT04987788|102244037|FG001|NOT COMPLETED|Overall Study||0||
48776360|NCT04150861|102244038|FG000|STARTED|Overall Study||8||
48776361|NCT04150861|102244039|FG001|STARTED|Overall Study||8||
48776362|NCT04150861|102244040|FG002|STARTED|Overall Study||8||
48776363|NCT04150861|102244038|FG000|COMPLETED|Overall Study||8||
48776364|NCT04150861|102244039|FG001|COMPLETED|Overall Study||8||
48776365|NCT04150861|102244040|FG002|COMPLETED|Overall Study||8||
48776366|NCT04150861|102244038|FG000|NOT COMPLETED|Overall Study||0||
48776367|NCT04150861|102244039|FG001|NOT COMPLETED|Overall Study||0||
48776368|NCT04150861|102244040|FG002|NOT COMPLETED|Overall Study||0||
48776369|NCT01621802|102244041|FG000|STARTED|Overall Study||802||
48776370|NCT01621802|102244042|FG001|STARTED|Overall Study||298||
48776371|NCT01621802|102244043|FG002|STARTED|Overall Study||796||
48776372|NCT01621802|102244044|FG003|STARTED|Overall Study||303||
48776373|NCT01621802|102244045|FG004|STARTED|Overall Study||1319||
48776374|NCT01621802|102244046|FG005|STARTED|Overall Study||489||
48776375|NCT01621802|102244041|FG000|COMPLETED|Overall Study||755||
48776376|NCT01621802|102244042|FG001|COMPLETED|Overall Study||275||
48776377|NCT01621802|102244043|FG002|COMPLETED|Overall Study||763||
48776378|NCT01621802|102244044|FG003|COMPLETED|Overall Study||292||
48776379|NCT01621802|102244045|FG004|COMPLETED|Overall Study||1284||
48776380|NCT01621802|102244046|FG005|COMPLETED|Overall Study||477||
48776381|NCT01621802|102244041|FG000|NOT COMPLETED|Overall Study||47||
48776382|NCT01621802|102244042|FG001|NOT COMPLETED|Overall Study||23||
48776383|NCT01621802|102244043|FG002|NOT COMPLETED|Overall Study||33||
48776384|NCT01621802|102244044|FG003|NOT COMPLETED|Overall Study||11||
48776385|NCT01621802|102244045|FG004|NOT COMPLETED|Overall Study||35||
48776386|NCT01621802|102244046|FG005|NOT COMPLETED|Overall Study||12||
48776387|NCT03894813|102244047|FG000|STARTED|Overall Study||63||
48776388|NCT03894813|102244048|FG001|STARTED|Overall Study||63||
48776389|NCT03894813|102244047|FG000|COMPLETED|Overall Study||52||
48776390|NCT03894813|102244048|FG001|COMPLETED|Overall Study||47||
48776391|NCT03894813|102244047|FG000|NOT COMPLETED|Overall Study||11||
48776392|NCT03894813|102244048|FG001|NOT COMPLETED|Overall Study||16||
48776393|NCT02399163|102244049|FG000|STARTED|Overall Study||62||
48776394|NCT02399163|102244049|FG000|COMPLETED|Overall Study||53||
48776395|NCT02399163|102244049|FG000|NOT COMPLETED|Overall Study||9||
48776396|NCT02509026|102244050|FG000|STARTED|Induction Period (24 Weeks)||210||
48776397|NCT02509026|102244050|FG000|Treated|Induction Period (24 Weeks)||209||
48776398|NCT02509026|102244050|FG000|COMPLETED|Induction Period (24 Weeks)||188||
48776399|NCT02509026|102244050|FG000|NOT COMPLETED|Induction Period (24 Weeks)||22||
48776400|NCT02509026|102244050|FG000|STARTED|Withdrawal Period (40 Weeks)||119||
48776401|NCT02509026|102244050|FG000|COMPLETED|Withdrawal Period (40 Weeks)||112||
48776402|NCT02509026|102244050|FG000|NOT COMPLETED|Withdrawal Period (40 Weeks)||7||
48776403|NCT02509026|102244050|FG000|STARTED|Retreatment Period (12 Weeks)||88||
48776404|NCT02509026|102244050|FG000|Treated|Retreatment Period (12 Weeks)||87||
48776405|NCT02509026|102244050|FG000|COMPLETED|Retreatment Period (12 Weeks)||84||
48776406|NCT02509026|102244050|FG000|NOT COMPLETED|Retreatment Period (12 Weeks)||4||
48776407|NCT00176917|102244051|FG000|STARTED|Overall Study||41||
48776408|NCT00176917|102244051|FG000|COMPLETED|Overall Study||41||
48776409|NCT00176917|102244051|FG000|NOT COMPLETED|Overall Study||0||
48776410|NCT00845897|102244052|FG000|STARTED|Overall Study||5||
48776411|NCT00845897|102244053|FG001|STARTED|Overall Study||7||
48776412|NCT00845897|102244054|FG002|STARTED|Overall Study||5||
48776413|NCT00845897|102244052|FG000|COMPLETED|Overall Study||3||
48776414|NCT00845897|102244053|FG001|COMPLETED|Overall Study||2||
48776415|NCT00845897|102244054|FG002|COMPLETED|Overall Study||2||
48776416|NCT00845897|102244052|FG000|NOT COMPLETED|Overall Study||2||
48776417|NCT00845897|102244053|FG001|NOT COMPLETED|Overall Study||5||
48776418|NCT00845897|102244054|FG002|NOT COMPLETED|Overall Study||3||
48776419|NCT03429270|102244055|FG000|STARTED|Overall Study||28||
48776420|NCT03429270|102244055|FG000|COMPLETED|Overall Study||28||
48776421|NCT03429270|102244055|FG000|NOT COMPLETED|Overall Study||0||
48776422|NCT00934362|102244056|FG000|STARTED|Overall Study||8||
48776423|NCT00934362|102244057|FG001|STARTED|Overall Study||8||
48776424|NCT00934362|102244056|FG000|COMPLETED|Overall Study||7||
48776425|NCT00934362|102244057|FG001|COMPLETED|Overall Study||8||
48776426|NCT00934362|102244056|FG000|NOT COMPLETED|Overall Study||1||
48189730|NCT04530344|100786292|FG002|COMPLETED|Overall Study||92||
48776427|NCT00934362|102244057|FG001|NOT COMPLETED|Overall Study||0||
48776428|NCT03763877|102244058|FG000|STARTED|Overall Study||31|Randomized|
48776429|NCT03763877|102244059|FG001|STARTED|Overall Study||30|Randomized|
48776430|NCT03763877|102244060|FG002|STARTED|Overall Study||31|Randomized|
48776431|NCT03763877|102244061|FG003|STARTED|Overall Study||29|Randomized|
48776432|NCT03763877|102244058|FG000|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||31||
48776433|NCT03763877|102244059|FG001|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||30||
48776434|NCT03763877|102244060|FG002|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||30||
48776435|NCT03763877|102244061|FG003|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||29||
48776436|NCT03763877|102244058|FG000|Completed the Double-blind Period|Overall Study||27||
48776437|NCT03763877|102244059|FG001|Completed the Double-blind Period|Overall Study||26||
48776438|NCT03763877|102244060|FG002|Completed the Double-blind Period|Overall Study||25||
48776439|NCT03763877|102244061|FG003|Completed the Double-blind Period|Overall Study||24||
48776440|NCT03763877|102244058|FG000|COMPLETED|Overall Study||26|Completed the follow-up period|
48776441|NCT03763877|102244059|FG001|COMPLETED|Overall Study||26|Completed the follow-up period|
48776442|NCT03763877|102244060|FG002|COMPLETED|Overall Study||24|Completed the follow-up period|
48776443|NCT03763877|102244061|FG003|COMPLETED|Overall Study||24|Completed the follow-up period|
48776444|NCT03763877|102244058|FG000|NOT COMPLETED|Overall Study||5||
48776445|NCT03763877|102244059|FG001|NOT COMPLETED|Overall Study||4||
48776446|NCT03763877|102244060|FG002|NOT COMPLETED|Overall Study||7||
48776447|NCT03763877|102244061|FG003|NOT COMPLETED|Overall Study||5||
48776448|NCT02640508|102244062|FG000|STARTED|Overall Study||29||
48776449|NCT02640508|102244062|FG000|Escalation to Higher Dose|Overall Study||0||
48776450|NCT02640508|102244062|FG000|COMPLETED|Overall Study||0||
48776451|NCT02640508|102244062|FG000|NOT COMPLETED|Overall Study||29||
48776452|NCT03208985|102244063|FG000|STARTED|Overall Study||1270||
48776453|NCT03208985|102244063|FG000|COMPLETED|Overall Study||868||
48776454|NCT03208985|102244063|FG000|NOT COMPLETED|Overall Study||402||
48776455|NCT02921841|102244064|FG000|STARTED|Overall Study||68||
48776456|NCT02921841|102244065|FG001|STARTED|Overall Study||57||
48776457|NCT02921841|102244064|FG000|COMPLETED|Overall Study||52||
48461831|NCT02286518|101467420|FG012|STARTED|Washout Crossover Period(Part 2:14 Days)||0||
48461832|NCT02286518|101467421|FG013|STARTED|Washout Crossover Period(Part 2:14 Days)||0||
48461833|NCT02286518|101467408|FG000|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
48461834|NCT02286518|101467409|FG001|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
48461835|NCT02286518|101467410|FG002|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
48461836|NCT02286518|101467411|FG003|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
48461837|NCT02286518|101467412|FG004|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
48461838|NCT02286518|101467413|FG005|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
48461839|NCT02286518|101467414|FG006|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
48461840|NCT02286518|101467415|FG007|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6||
48461841|NCT02286518|101467416|FG008|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6||
48461842|NCT02286518|101467417|FG009|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
48461843|NCT02286518|101467418|FG010|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
48461844|NCT02286518|101467419|FG011|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
48461845|NCT02286518|101467420|FG012|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
48461846|NCT02286518|101467421|FG013|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
48461847|NCT02286518|101467408|FG000|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
48461848|NCT02286518|101467409|FG001|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
48461849|NCT02286518|101467410|FG002|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
48461850|NCT02286518|101467411|FG003|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
48461851|NCT02286518|101467412|FG004|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
48461852|NCT02286518|101467413|FG005|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
48461853|NCT02286518|101467414|FG006|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
48461854|NCT02286518|101467415|FG007|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
48461855|NCT02286518|101467416|FG008|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
48461856|NCT02286518|101467417|FG009|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
48461857|NCT02286518|101467418|FG010|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
48461858|NCT02286518|101467419|FG011|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
48461859|NCT02286518|101467420|FG012|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
48461860|NCT02286518|101467421|FG013|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
48461861|NCT02286518|101467408|FG000|STARTED|Crossover Treatment (Part 2: 3 Days)||0||
48461862|NCT02286518|101467409|FG001|STARTED|Crossover Treatment (Part 2: 3 Days)||0||
48461863|NCT02286518|101467410|FG002|STARTED|Crossover Treatment (Part 2: 3 Days)||0||
48461864|NCT02286518|101467411|FG003|STARTED|Crossover Treatment (Part 2: 3 Days)||0||
48461865|NCT02286518|101467412|FG004|STARTED|Crossover Treatment (Part 2: 3 Days)||0||
48461866|NCT02286518|101467413|FG005|STARTED|Crossover Treatment (Part 2: 3 Days)||0||
48461867|NCT02286518|101467414|FG006|STARTED|Crossover Treatment (Part 2: 3 Days)||0||
48461868|NCT02286518|101467415|FG007|STARTED|Crossover Treatment (Part 2: 3 Days)||6||
48461869|NCT02286518|101467416|FG008|STARTED|Crossover Treatment (Part 2: 3 Days)||6||
48461870|NCT02286518|101467417|FG009|STARTED|Crossover Treatment (Part 2: 3 Days)||0||
48461871|NCT02286518|101467418|FG010|STARTED|Crossover Treatment (Part 2: 3 Days)||0||
48461872|NCT02286518|101467419|FG011|STARTED|Crossover Treatment (Part 2: 3 Days)||0||
48461873|NCT02286518|101467420|FG012|STARTED|Crossover Treatment (Part 2: 3 Days)||0||
48461874|NCT02286518|101467421|FG013|STARTED|Crossover Treatment (Part 2: 3 Days)||0||
48461875|NCT02286518|101467408|FG000|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
48461876|NCT02286518|101467409|FG001|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
48461877|NCT02286518|101467410|FG002|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
48461878|NCT02286518|101467411|FG003|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
48461879|NCT02286518|101467412|FG004|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
48461880|NCT02286518|101467413|FG005|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
48461881|NCT02286518|101467414|FG006|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
48461882|NCT02286518|101467415|FG007|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6||
48461883|NCT02286518|101467416|FG008|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6||
48461884|NCT02286518|101467417|FG009|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
48461885|NCT02286518|101467418|FG010|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
48461886|NCT02286518|101467419|FG011|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
48461887|NCT02286518|101467420|FG012|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
48664736|NCT03379870|101964630|FG001|NOT COMPLETED|Overall Study||1||
48776458|NCT02921841|102244065|FG001|COMPLETED|Overall Study||44||
48776459|NCT02921841|102244064|FG000|NOT COMPLETED|Overall Study||16||
48776460|NCT02921841|102244065|FG001|NOT COMPLETED|Overall Study||13||
48776461|NCT01733680|102244066|FG000|STARTED|Overall Study||2||
48776462|NCT01733680|102244067|FG001|STARTED|Overall Study||1||
48776463|NCT01733680|102244066|FG000|COMPLETED|Overall Study||2||
48776464|NCT01733680|102244067|FG001|COMPLETED|Overall Study||0||
48461888|NCT02286518|101467421|FG013|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
48461889|NCT02286518|101467408|FG000|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
48461890|NCT02286518|101467409|FG001|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
48461891|NCT02286518|101467410|FG002|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
48461892|NCT02286518|101467411|FG003|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
48461893|NCT02286518|101467412|FG004|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
48461894|NCT02286518|101467413|FG005|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
48461895|NCT02286518|101467414|FG006|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
48461896|NCT02286518|101467415|FG007|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
48461897|NCT02286518|101467416|FG008|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
48461898|NCT02286518|101467417|FG009|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
48461899|NCT02286518|101467418|FG010|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
48461900|NCT02286518|101467419|FG011|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
48461901|NCT02286518|101467420|FG012|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
48461902|NCT02286518|101467421|FG013|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
48461903|NCT00606684|101467422|FG000|STARTED|2-week Single-Blind Run-in Period||851||
48461904|NCT00606684|101467423|FG001|STARTED|2-week Single-Blind Run-in Period||0||
48461905|NCT00606684|101467424|FG002|STARTED|2-week Single-Blind Run-in Period||0||
48461906|NCT00606684|101467425|FG003|STARTED|2-week Single-Blind Run-in Period||0||
48461907|NCT00606684|101467426|FG004|STARTED|2-week Single-Blind Run-in Period||0||
48461908|NCT00606684|101467427|FG005|STARTED|2-week Single-Blind Run-in Period||0||
48461909|NCT00606684|101467428|FG006|STARTED|2-week Single-Blind Run-in Period||0||
48461910|NCT00606684|101467422|FG000|COMPLETED|2-week Single-Blind Run-in Period||605||
48461911|NCT00606684|101467423|FG001|COMPLETED|2-week Single-Blind Run-in Period||0||
48461912|NCT00606684|101467424|FG002|COMPLETED|2-week Single-Blind Run-in Period||0||
48461913|NCT00606684|101467425|FG003|COMPLETED|2-week Single-Blind Run-in Period||0||
48461914|NCT00606684|101467426|FG004|COMPLETED|2-week Single-Blind Run-in Period||0||
48461915|NCT00606684|101467427|FG005|COMPLETED|2-week Single-Blind Run-in Period||0||
48461916|NCT00606684|101467428|FG006|COMPLETED|2-week Single-Blind Run-in Period||0||
48461917|NCT00606684|101467422|FG000|NOT COMPLETED|2-week Single-Blind Run-in Period||246||
48461918|NCT00606684|101467423|FG001|NOT COMPLETED|2-week Single-Blind Run-in Period||0||
48461919|NCT00606684|101467424|FG002|NOT COMPLETED|2-week Single-Blind Run-in Period||0||
48461920|NCT00606684|101467425|FG003|NOT COMPLETED|2-week Single-Blind Run-in Period||0||
48461921|NCT00606684|101467426|FG004|NOT COMPLETED|2-week Single-Blind Run-in Period||0||
48461922|NCT00606684|101467427|FG005|NOT COMPLETED|2-week Single-Blind Run-in Period||0||
48461923|NCT00606684|101467428|FG006|NOT COMPLETED|2-week Single-Blind Run-in Period||0||
48461924|NCT00606684|101467422|FG000|STARTED|Double-Blind Treatment Period||0||
48461925|NCT00606684|101467423|FG001|STARTED|Double-Blind Treatment Period||101||
48461926|NCT00606684|101467424|FG002|STARTED|Double-Blind Treatment Period||99||
48461927|NCT00606684|101467425|FG003|STARTED|Double-Blind Treatment Period||101||
48461928|NCT00606684|101467426|FG004|STARTED|Double-Blind Treatment Period||101||
48461929|NCT00606684|101467427|FG005|STARTED|Double-Blind Treatment Period||101||
48461930|NCT00606684|101467428|FG006|STARTED|Double-Blind Treatment Period||99||
48461931|NCT00606684|101467422|FG000|COMPLETED|Double-Blind Treatment Period||0||
48461932|NCT00606684|101467423|FG001|COMPLETED|Double-Blind Treatment Period||85||
48461933|NCT00606684|101467424|FG002|COMPLETED|Double-Blind Treatment Period||88||
48461934|NCT00606684|101467425|FG003|COMPLETED|Double-Blind Treatment Period||91||
48461935|NCT00606684|101467426|FG004|COMPLETED|Double-Blind Treatment Period||92||
48461936|NCT00606684|101467427|FG005|COMPLETED|Double-Blind Treatment Period||92||
48461937|NCT00606684|101467428|FG006|COMPLETED|Double-Blind Treatment Period||91||
48461938|NCT00606684|101467422|FG000|NOT COMPLETED|Double-Blind Treatment Period||0||
48461939|NCT00606684|101467423|FG001|NOT COMPLETED|Double-Blind Treatment Period||16||
48461940|NCT00606684|101467424|FG002|NOT COMPLETED|Double-Blind Treatment Period||11||
48461941|NCT00606684|101467425|FG003|NOT COMPLETED|Double-Blind Treatment Period||10||
48461942|NCT00606684|101467426|FG004|NOT COMPLETED|Double-Blind Treatment Period||9||
48461943|NCT00606684|101467427|FG005|NOT COMPLETED|Double-Blind Treatment Period||9||
48461944|NCT00606684|101467428|FG006|NOT COMPLETED|Double-Blind Treatment Period||8||
48461945|NCT03487796|101467429|FG000|STARTED|Overall Study||41|Started: individuals - 46 MySTYLE, 33 Control|
48461946|NCT03487796|101467430|FG001|STARTED|Overall Study||31|Started: individuals - 46 MySTYLE, 33 Control|
48461947|NCT03487796|101467429|FG000|2 Month Follow-up|Overall Study||24|2 Month Follow-up: individuals- 27 MySTYLE, 28 Control|
48461948|NCT03487796|101467430|FG001|2 Month Follow-up|Overall Study||26|2 Month Follow-up: individuals- 27 MySTYLE, 28 Control|
48461949|NCT03487796|101467429|FG000|COMPLETED|Overall Study||23|Completed: Individuals- 27 MySTYLE, 27 Control|
48461950|NCT03487796|101467430|FG001|COMPLETED|Overall Study||25|Completed: Individuals- 27 MySTYLE, 27 Control|
48461951|NCT03487796|101467429|FG000|NOT COMPLETED|Overall Study||18||
48776465|NCT01733680|102244066|FG000|NOT COMPLETED|Overall Study||0||
48776466|NCT01733680|102244067|FG001|NOT COMPLETED|Overall Study||1||
48776467|NCT02516969|102244068|FG000|STARTED|Overall Study||3||
48461952|NCT03487796|101467430|FG001|NOT COMPLETED|Overall Study||6||
48461953|NCT02008721|101467431|FG000|STARTED|Overall Study||47||
48461954|NCT02008721|101467432|FG001|STARTED|Overall Study||45||
48461955|NCT02008721|101467431|FG000|Completion of Study Assessment|Overall Study||31||
48461956|NCT02008721|101467432|FG001|Completion of Study Assessment|Overall Study||33||
48461957|NCT02008721|101467431|FG000|Completion Without Protocol Violation|Overall Study||30||
48461958|NCT02008721|101467432|FG001|Completion Without Protocol Violation|Overall Study||33||
48461959|NCT02008721|101467431|FG000|Participation in MRI Substudy|Overall Study||17||
48461960|NCT02008721|101467432|FG001|Participation in MRI Substudy|Overall Study||15||
48461961|NCT02008721|101467431|FG000|Completion of MRI Substudy|Overall Study||11||
48461962|NCT02008721|101467432|FG001|Completion of MRI Substudy|Overall Study||8||
48461963|NCT02008721|101467431|FG000|COMPLETED|Overall Study||32||
48461964|NCT02008721|101467432|FG001|COMPLETED|Overall Study||35||
48461965|NCT02008721|101467431|FG000|NOT COMPLETED|Overall Study||15||
48461966|NCT02008721|101467432|FG001|NOT COMPLETED|Overall Study||10||
48461967|NCT01297257|101467433|FG000|STARTED|Overall Study||7740||
48461968|NCT01297257|101467433|FG000|COMPLETED|Overall Study||7740||
48461969|NCT01297257|101467433|FG000|NOT COMPLETED|Overall Study||0||
48461970|NCT03118739|101467434|FG000|STARTED|Overall Study||32||
48461971|NCT03118739|101467435|FG001|STARTED|Overall Study||28||
48461972|NCT03118739|101467434|FG000|Completed 12 Weeks of Treatment|Overall Study||26||
48461973|NCT03118739|101467435|FG001|Completed 12 Weeks of Treatment|Overall Study||25||
48461974|NCT03118739|101467434|FG000|Completed 24 Weeks of Treatment|Overall Study||24||
48461975|NCT03118739|101467435|FG001|Completed 24 Weeks of Treatment|Overall Study||25||
48461976|NCT03118739|101467434|FG000|COMPLETED|Overall Study||25||
48461977|NCT03118739|101467435|FG001|COMPLETED|Overall Study||24||
48461978|NCT03118739|101467434|FG000|NOT COMPLETED|Overall Study||7||
48461979|NCT03118739|101467435|FG001|NOT COMPLETED|Overall Study||4||
48461980|NCT01415921|101467436|FG000|STARTED|Overall Study||16||
48461981|NCT01415921|101467437|FG001|STARTED|Overall Study||17||
48461982|NCT01415921|101467436|FG000|COMPLETED|Overall Study||13||
48461983|NCT01415921|101467437|FG001|COMPLETED|Overall Study||14||
48461984|NCT01415921|101467436|FG000|NOT COMPLETED|Overall Study||3||
48776468|NCT02516969|102244069|FG001|STARTED|Overall Study||4||
48776469|NCT02516969|102244068|FG000|COMPLETED|Overall Study||3||
48776470|NCT02516969|102244069|FG001|COMPLETED|Overall Study||4||
48776471|NCT02516969|102244068|FG000|NOT COMPLETED|Overall Study||0||
48776472|NCT02516969|102244069|FG001|NOT COMPLETED|Overall Study||0||
48776473|NCT02037230|102244070|FG000|STARTED|Overall Study||1||
48776474|NCT02037230|102244071|FG001|STARTED|Overall Study||13||
48776475|NCT02037230|102244072|FG002|STARTED|Overall Study||9||
48776476|NCT02037230|102244073|FG003|STARTED|Overall Study||11||
48776477|NCT02037230|102244070|FG000|Completed 4 Cycles of Treatment|Overall Study||1||
48776478|NCT02037230|102244071|FG001|Completed 4 Cycles of Treatment|Overall Study||9||
48776479|NCT02037230|102244072|FG002|Completed 4 Cycles of Treatment|Overall Study||7||
48776480|NCT02037230|102244073|FG003|Completed 4 Cycles of Treatment|Overall Study||9||
48776481|NCT02037230|102244070|FG000|COMPLETED|Overall Study||0|Completed is defined as finishing 8 cycles of treatment|
48776482|NCT02037230|102244071|FG001|COMPLETED|Overall Study||7|Completed is defined as finishing 8 cycles of treatment|
48776483|NCT02037230|102244072|FG002|COMPLETED|Overall Study||3|Completed is defined as finishing 8 cycles of treatment|
48776484|NCT02037230|102244073|FG003|COMPLETED|Overall Study||5|Completed is defined as finishing 8 cycles of treatment|
48776485|NCT02037230|102244070|FG000|NOT COMPLETED|Overall Study||1||
48776486|NCT02037230|102244071|FG001|NOT COMPLETED|Overall Study||6||
48776487|NCT02037230|102244072|FG002|NOT COMPLETED|Overall Study||6||
48776488|NCT02037230|102244073|FG003|NOT COMPLETED|Overall Study||6||
48776489|NCT04200352|102244074|FG000|STARTED|Overall Study||44||
48776490|NCT04200352|102244074|FG000|Received at Least 1 Dose of Study Drug|Overall Study||44||
48776491|NCT04200352|102244074|FG000|COMPLETED|Overall Study||24||
48776492|NCT04200352|102244074|FG000|NOT COMPLETED|Overall Study||20||
48776493|NCT02537015|102244075|FG000|STARTED|Overall Study||81||
48776494|NCT02537015|102244075|FG000|COMPLETED|Overall Study||75||
48776495|NCT02537015|102244075|FG000|NOT COMPLETED|Overall Study||6||
48776496|NCT03021343|102244076|FG000|STARTED|Overall Study||179||
48776497|NCT03021343|102244077|FG001|STARTED|Overall Study||181||
48776498|NCT03021343|102244076|FG000|COMPLETED|Overall Study||174||
48776499|NCT03021343|102244077|FG001|COMPLETED|Overall Study||174||
48776500|NCT03021343|102244076|FG000|NOT COMPLETED|Overall Study||5||
48776501|NCT03021343|102244077|FG001|NOT COMPLETED|Overall Study||7||
48776502|NCT01085006|102244078|FG000|STARTED|Overall Study||50||
48776503|NCT01085006|102244079|FG001|STARTED|Overall Study||50||
48189731|NCT04530344|100786293|FG003|COMPLETED|Overall Study||173||
48189732|NCT04530344|100786290|FG000|NOT COMPLETED|Overall Study||17||
48461985|NCT01415921|101467437|FG001|NOT COMPLETED|Overall Study||3||
48461986|NCT00322556|101467438|FG000|STARTED|Overall Study||55||
48461987|NCT00322556|101467438|FG000|COMPLETED|Overall Study||43||
48776504|NCT01085006|102244078|FG000|COMPLETED|Overall Study||50||
48776505|NCT01085006|102244079|FG001|COMPLETED|Overall Study||50||
48776506|NCT01085006|102244078|FG000|NOT COMPLETED|Overall Study||0||
48776507|NCT01085006|102244079|FG001|NOT COMPLETED|Overall Study||0||
48776508|NCT01742117|102244080|FG000|STARTED|Overall Study||2641||
48461988|NCT00322556|101467438|FG000|NOT COMPLETED|Overall Study||12||
48461989|NCT01886300|101467439|FG000|STARTED|Overall Study||16||
48461990|NCT01886300|101467439|FG000|COMPLETED|Overall Study||0||
48461991|NCT01886300|101467439|FG000|NOT COMPLETED|Overall Study||16||
48461992|NCT01830920|101467440|FG000|STARTED|Overall Study||126||
48189733|NCT04530344|100786291|FG001|NOT COMPLETED|Overall Study||8||
48461993|NCT01830920|101467441|FG001|STARTED|Overall Study||46||
48461994|NCT01830920|101467442|FG002|STARTED|Overall Study||48||
48461995|NCT01830920|101467443|FG003|STARTED|Overall Study||125||
48461996|NCT01830920|101467444|FG004|STARTED|Overall Study||107||
48461997|NCT01830920|101467440|FG000|Received Allocated Drug|Overall Study||115||
48461998|NCT01830920|101467441|FG001|Received Allocated Drug|Overall Study||45||
48461999|NCT01830920|101467442|FG002|Received Allocated Drug|Overall Study||47||
48462000|NCT01830920|101467443|FG003|Received Allocated Drug|Overall Study||119||
48462001|NCT01830920|101467444|FG004|Received Allocated Drug|Overall Study||105||
48462002|NCT01830920|101467440|FG000|COMPLETED|Overall Study||105||
48462003|NCT01830920|101467441|FG001|COMPLETED|Overall Study||40||
48462004|NCT01830920|101467442|FG002|COMPLETED|Overall Study||40||
48462005|NCT01830920|101467443|FG003|COMPLETED|Overall Study||109||
48462006|NCT01830920|101467444|FG004|COMPLETED|Overall Study||99||
48462007|NCT01830920|101467440|FG000|NOT COMPLETED|Overall Study||21||
48462008|NCT01830920|101467441|FG001|NOT COMPLETED|Overall Study||6||
48462009|NCT01830920|101467442|FG002|NOT COMPLETED|Overall Study||8||
48462010|NCT01830920|101467443|FG003|NOT COMPLETED|Overall Study||16||
48462011|NCT01830920|101467444|FG004|NOT COMPLETED|Overall Study||8||
48462012|NCT00290745|101467445|FG000|STARTED|Overall Study||79||
48462013|NCT00290745|101467445|FG000|COMPLETED|Overall Study||67||
48462014|NCT00290745|101467445|FG000|NOT COMPLETED|Overall Study||12||
48462015|NCT00798889|101467446|FG000|STARTED|Overall Study||314||
48462016|NCT00798889|101467446|FG000|Treated|Overall Study||311||
48462017|NCT00798889|101467446|FG000|COMPLETED|Overall Study||0||
48776509|NCT01742117|102244081|FG001|STARTED|Overall Study||2635||
48776510|NCT01742117|102244080|FG000|COMPLETED|Overall Study||2641||
48776511|NCT01742117|102244081|FG001|COMPLETED|Overall Study||2635||
48776512|NCT01742117|102244080|FG000|NOT COMPLETED|Overall Study||0||
48776513|NCT01742117|102244081|FG001|NOT COMPLETED|Overall Study||0||
48776514|NCT01262989|102244082|FG000|STARTED|Period 1||20||
48462018|NCT00798889|101467446|FG000|NOT COMPLETED|Overall Study||314||
48462019|NCT01492582|101467447|FG000|STARTED|Overall Study||453|Type of vaccine based on standard of care at time of enrollment|
48462020|NCT01492582|101467448|FG001|STARTED|Overall Study||1046|Type of vaccine based on standard of care at time of enrollment|
48462021|NCT01492582|101467447|FG000|Received First Quadrivalent Vaccine Dose|Overall Study||254||
48462022|NCT01492582|101467448|FG001|Received First Quadrivalent Vaccine Dose|Overall Study||0||
48462023|NCT01492582|101467447|FG000|Received First Nonavalent Vaccine Dose|Overall Study||182||
48462024|NCT01492582|101467448|FG001|Received First Nonavalent Vaccine Dose|Overall Study||0||
48462025|NCT01492582|101467447|FG000|COMPLETED|Overall Study||384||
48462026|NCT01492582|101467448|FG001|COMPLETED|Overall Study||982||
48462027|NCT01492582|101467447|FG000|NOT COMPLETED|Overall Study||69||
48462028|NCT01492582|101467448|FG001|NOT COMPLETED|Overall Study||64||
48462029|NCT02764489|101467449|FG000|STARTED|Part 1: Day 1 up to Day 16||17||
48462030|NCT02764489|101467450|FG001|STARTED|Part 1: Day 1 up to Day 16||16||
48776515|NCT01262989|102244083|FG001|STARTED|Period 1||20||
48776516|NCT01262989|102244082|FG000|COMPLETED|Period 1||19||
48776517|NCT01262989|102244083|FG001|COMPLETED|Period 1||17||
48776518|NCT01262989|102244082|FG000|NOT COMPLETED|Period 1||1||
48462031|NCT02764489|101467449|FG000|COMPLETED|Part 1: Day 1 up to Day 16||14||
48462032|NCT02764489|101467450|FG001|COMPLETED|Part 1: Day 1 up to Day 16||16||
48462033|NCT02764489|101467449|FG000|NOT COMPLETED|Part 1: Day 1 up to Day 16||3||
48462034|NCT02764489|101467450|FG001|NOT COMPLETED|Part 1: Day 1 up to Day 16||0||
48462035|NCT02764489|101467449|FG000|STARTED|Part 2: Day 19 up to Day 41||14|Participants who completed Part 1 of the study entered Part 2 of the study:|
48462036|NCT02764489|101467450|FG001|STARTED|Part 2: Day 19 up to Day 41||16|Participants who completed Part 1 of the study entered Part 2 of the study:|
48462037|NCT02764489|101467449|FG000|Part 2: FEIBA 85±15U/kg 50% Reduced Volume at 4U/kg/Min Rate|Part 2: Day 19 up to Day 41||14|Participants who completed Part 1 of the study received up to 3 infusions of FEIBA 85 ± 15 U/kg IV reconstituted in 50% reduced volume SWFI at an increased infusion rate of 4 U/kg/min, every 48 hours (infusions 7, 8, and 9).|
48664737|NCT03809000|101964631|FG000|STARTED|Overall Study||98||
48664738|NCT03809000|101964632|FG001|STARTED|Overall Study||90||
48664739|NCT03809000|101964631|FG000|Adverse Event Population|Overall Study||98|Randomized participants who started treatment and were assessed for adverse events.|
48664740|NCT03809000|101964632|FG001|Adverse Event Population|Overall Study||89|Randomized participants who started treatment and were assessed for adverse events.|
48664741|NCT03809000|101964631|FG000|COMPLETED|Overall Study||98|Participants contributing data to results are considered to have completed the study.|
48664742|NCT03809000|101964632|FG001|COMPLETED|Overall Study||90|Participants contributing data to results are considered to have completed the study.|
48664743|NCT03809000|101964631|FG000|NOT COMPLETED|Overall Study||0||
48664744|NCT03809000|101964632|FG001|NOT COMPLETED|Overall Study||0||
48664745|NCT05987813|101964633|FG000|STARTED|Overall Study||5||
48664746|NCT05987813|101964634|FG001|STARTED|Overall Study||3||
48664747|NCT05987813|101964633|FG000|COMPLETED|Overall Study||5||
48664748|NCT05987813|101964634|FG001|COMPLETED|Overall Study||3||
48664749|NCT05987813|101964633|FG000|NOT COMPLETED|Overall Study||0||
48776519|NCT01262989|102244083|FG001|NOT COMPLETED|Period 1||3||
48776520|NCT01262989|102244082|FG000|STARTED|7-Day Washout Period||19||
48776521|NCT01262989|102244083|FG001|STARTED|7-Day Washout Period||17||
48776522|NCT01262989|102244082|FG000|COMPLETED|7-Day Washout Period||19||
48462038|NCT02764489|101467450|FG001|Part 2: FEIBA 85±15U/kg 50% Reduced Volume at 4U/kg/Min Rate|Part 2: Day 19 up to Day 41||16|Participants who completed Part 1 of the study received up to 3 infusions of FEIBA 85 ± 15 U/kg IV reconstituted in 50% reduced volume SWFI at an increased infusion rate of 4 U/kg/min, every 48 hours (infusions 7, 8, and 9).|
48462039|NCT02764489|101467449|FG000|Part 2: FEIBA 85±15U/kg 50% Reduced Volume at 10U/kg/Min Rate|Part 2: Day 19 up to Day 41||12|Participants who completed Part 1 of the study and received up to 3 infusions (infusions 7, 8, and 9) at the rate of 4 U/kg/min in Part 2 received up to 3 infusions (10, 11, and 12) of FEIBA 85 ± 15 U/kg IV reconstituted in 50% reduced volume SWFI at an increased infusion rate of 10 U/kg/min, every 48 hours.|
48462040|NCT02764489|101467450|FG001|Part 2: FEIBA 85±15U/kg 50% Reduced Volume at 10U/kg/Min Rate|Part 2: Day 19 up to Day 41||16|Participants who completed Part 1 of the study and received up to 3 infusions (infusions 7, 8, and 9) at the rate of 4 U/kg/min in Part 2 received up to 3 infusions (10, 11, and 12) of FEIBA 85 ± 15 U/kg IV reconstituted in 50% reduced volume SWFI at an increased infusion rate of 10 U/kg/min, every 48 hours.|
48462041|NCT02764489|101467449|FG000|COMPLETED|Part 2: Day 19 up to Day 41||12||
48462042|NCT02764489|101467450|FG001|COMPLETED|Part 2: Day 19 up to Day 41||16||
48462043|NCT02764489|101467449|FG000|NOT COMPLETED|Part 2: Day 19 up to Day 41||2||
48462044|NCT02764489|101467450|FG001|NOT COMPLETED|Part 2: Day 19 up to Day 41||0||
48462045|NCT00892697|101467451|FG000|STARTED|Overall Study||15||
48462046|NCT00892697|101467451|FG000|COMPLETED|Overall Study||15||
48462047|NCT00892697|101467451|FG000|NOT COMPLETED|Overall Study||0||
48462048|NCT01082952|101467452|FG000|STARTED|Overall Study||6||
48462049|NCT01082952|101467453|FG001|STARTED|Overall Study||6||
48462050|NCT01082952|101467452|FG000|COMPLETED|Overall Study||6||
48462051|NCT01082952|101467453|FG001|COMPLETED|Overall Study||6||
48462052|NCT01082952|101467452|FG000|NOT COMPLETED|Overall Study||0||
48462053|NCT01082952|101467453|FG001|NOT COMPLETED|Overall Study||0||
48462054|NCT01195922|101467454|FG000|STARTED|Overall Study||16||
48462055|NCT01195922|101467454|FG000|COMPLETED|Overall Study||16||
48462056|NCT01195922|101467454|FG000|NOT COMPLETED|Overall Study||0||
48462057|NCT05784571|101467455|FG000|STARTED|Overall Study||40||
48462058|NCT05784571|101467455|FG000|COMPLETED|Overall Study||40||
48462059|NCT05784571|101467455|FG000|NOT COMPLETED|Overall Study||0||
48462060|NCT00936377|101467456|FG000|STARTED|Overall Study||8||
48462061|NCT00936377|101467457|FG001|STARTED|Overall Study||8||
48462062|NCT00936377|101467458|FG002|STARTED|Overall Study||8||
48462063|NCT00936377|101467456|FG000|COMPLETED|Overall Study||8||
48462064|NCT00936377|101467457|FG001|COMPLETED|Overall Study||8||
48664750|NCT05987813|101964634|FG001|NOT COMPLETED|Overall Study||0||
48664751|NCT00811850|101964635|FG000|STARTED|Treatment Period 1: Combigan® or Cosopt®||15||
48664752|NCT00811850|101964635|FG000|COMPLETED|Treatment Period 1: Combigan® or Cosopt®||15||
48664753|NCT00811850|101964635|FG000|NOT COMPLETED|Treatment Period 1: Combigan® or Cosopt®||0||
48664754|NCT00811850|101964635|FG000|STARTED|Treatment Period 2: Wash Out||15||
48664755|NCT00811850|101964635|FG000|COMPLETED|Treatment Period 2: Wash Out||15||
48189734|NCT04530344|100786292|FG002|NOT COMPLETED|Overall Study||26||
48189735|NCT04530344|100786293|FG003|NOT COMPLETED|Overall Study||51||
48189736|NCT00551213|100786294|FG000|STARTED|Overall Study||50||
48189737|NCT00551213|100786295|FG001|STARTED|Overall Study||17||
48189738|NCT00551213|100786294|FG000|Treated|Overall Study||49||
48189739|NCT00551213|100786295|FG001|Treated|Overall Study||15||
48189740|NCT00551213|100786294|FG000|COMPLETED|Overall Study||0||
48189741|NCT00551213|100786295|FG001|COMPLETED|Overall Study||0||
48189742|NCT00551213|100786294|FG000|NOT COMPLETED|Overall Study||50||
48189743|NCT00551213|100786295|FG001|NOT COMPLETED|Overall Study||17||
48189744|NCT02179918|100786296|FG000|STARTED|Overall Study||5||
48189745|NCT02179918|100786297|FG001|STARTED|Overall Study||3||
48189746|NCT02179918|100786298|FG002|STARTED|Overall Study||3||
48189747|NCT02179918|100786299|FG003|STARTED|Overall Study||3||
48189748|NCT02179918|100786300|FG004|STARTED|Overall Study||9||
48189749|NCT02179918|100786296|FG000|COMPLETED|Overall Study||1||
48189750|NCT02179918|100786297|FG001|COMPLETED|Overall Study||0||
48189751|NCT02179918|100786298|FG002|COMPLETED|Overall Study||1||
48664756|NCT00811850|101964635|FG000|NOT COMPLETED|Treatment Period 2: Wash Out||0||
48664757|NCT00811850|101964635|FG000|STARTED|Treatment Period 3: Combigan® or Cosopt®||15||
48664758|NCT00811850|101964635|FG000|COMPLETED|Treatment Period 3: Combigan® or Cosopt®||15||
48189752|NCT02179918|100786299|FG003|COMPLETED|Overall Study||0||
48189753|NCT02179918|100786300|FG004|COMPLETED|Overall Study||1||
48189754|NCT02179918|100786296|FG000|NOT COMPLETED|Overall Study||4||
48189755|NCT02179918|100786297|FG001|NOT COMPLETED|Overall Study||3||
48189756|NCT02179918|100786298|FG002|NOT COMPLETED|Overall Study||2||
48189757|NCT02179918|100786299|FG003|NOT COMPLETED|Overall Study||3||
48189758|NCT02179918|100786300|FG004|NOT COMPLETED|Overall Study||8||
48189759|NCT01330355|100786301|FG000|STARTED|Overall Study||16||
48189760|NCT01330355|100786302|FG001|STARTED|Overall Study||17||
48462065|NCT00936377|101467458|FG002|COMPLETED|Overall Study||8||
48462066|NCT00936377|101467456|FG000|NOT COMPLETED|Overall Study||0||
48462067|NCT00936377|101467457|FG001|NOT COMPLETED|Overall Study||0||
48462068|NCT00936377|101467458|FG002|NOT COMPLETED|Overall Study||0||
48462069|NCT02038634|101467459|FG000|STARTED|Overall Study||3||
48462070|NCT02038634|101467460|FG001|STARTED|Overall Study||13||
48462071|NCT02038634|101467459|FG000|COMPLETED|Overall Study||3||
48462072|NCT02038634|101467460|FG001|COMPLETED|Overall Study||12||
48189761|NCT01330355|100786301|FG000|COMPLETED|Overall Study||16||
48664759|NCT00811850|101964635|FG000|NOT COMPLETED|Treatment Period 3: Combigan® or Cosopt®||0||
48664760|NCT02721732|101964636|FG000|STARTED|Overall Study||20||
48664761|NCT02721732|101964637|FG001|STARTED|Overall Study||12||
48776523|NCT01262989|102244083|FG001|COMPLETED|7-Day Washout Period||17||
48776524|NCT01262989|102244082|FG000|NOT COMPLETED|7-Day Washout Period||0||
48776525|NCT01262989|102244083|FG001|NOT COMPLETED|7-Day Washout Period||0||
48776526|NCT01262989|102244082|FG000|STARTED|Period 2||19||
48776527|NCT01262989|102244083|FG001|STARTED|Period 2||17||
48776528|NCT01262989|102244082|FG000|COMPLETED|Period 2||19||
48776529|NCT01262989|102244083|FG001|COMPLETED|Period 2||16||
48776530|NCT01262989|102244082|FG000|NOT COMPLETED|Period 2||0||
48776531|NCT01262989|102244083|FG001|NOT COMPLETED|Period 2||1||
48776532|NCT01926496|102244084|FG000|STARTED|Overall Study||240||
48776533|NCT01926496|102244085|FG001|STARTED|Overall Study||245||
48776534|NCT01926496|102244084|FG000|COMPLETED|Overall Study||203||
48776535|NCT01926496|102244085|FG001|COMPLETED|Overall Study||197||
48776536|NCT01926496|102244084|FG000|NOT COMPLETED|Overall Study||37||
48776537|NCT01926496|102244085|FG001|NOT COMPLETED|Overall Study||48||
48776538|NCT01924949|102244086|FG000|STARTED|Overall Study||5||
48776539|NCT01924949|102244086|FG000|COMPLETED|Overall Study||5||
48776540|NCT01924949|102244086|FG000|NOT COMPLETED|Overall Study||0||
48776541|NCT02722304|102244087|FG000|STARTED|Overall Study||1||
48776542|NCT02722304|102244088|FG001|STARTED|Overall Study||0||
48776543|NCT02722304|102244089|FG002|STARTED|Overall Study||2||
48776544|NCT02722304|102244090|FG003|STARTED|Overall Study||2||
48776545|NCT02722304|102244091|FG004|STARTED|Overall Study||2||
48776546|NCT02722304|102244087|FG000|Treated|Overall Study||1||
48776547|NCT02722304|102244088|FG001|Treated|Overall Study||0||
48776548|NCT02722304|102244089|FG002|Treated|Overall Study||1||
48776549|NCT02722304|102244090|FG003|Treated|Overall Study||1||
48776550|NCT02722304|102244091|FG004|Treated|Overall Study||2||
48776551|NCT02722304|102244087|FG000|COMPLETED|Overall Study||0||
48776552|NCT02722304|102244088|FG001|COMPLETED|Overall Study||0||
48664762|NCT02721732|101964638|FG002|STARTED|Overall Study||24||
48664763|NCT02721732|101964639|FG003|STARTED|Overall Study||5||
48664764|NCT02721732|101964640|FG004|STARTED|Overall Study||29||
48189762|NCT01330355|100786302|FG001|COMPLETED|Overall Study||17||
48664765|NCT02721732|101964641|FG005|STARTED|Overall Study||3||
48664766|NCT02721732|101964642|FG006|STARTED|Overall Study||11||
48664767|NCT02721732|101964643|FG007|STARTED|Overall Study||12||
48189763|NCT01330355|100786301|FG000|NOT COMPLETED|Overall Study||0||
48664768|NCT02721732|101964644|FG008|STARTED|Overall Study||13||
48664769|NCT02721732|101964645|FG009|STARTED|Overall Study||28||
48664770|NCT02721732|101964636|FG000|COMPLETED|Overall Study||3||
48664771|NCT02721732|101964637|FG001|COMPLETED|Overall Study||0||
48664772|NCT02721732|101964638|FG002|COMPLETED|Overall Study||2||
48664773|NCT02721732|101964639|FG003|COMPLETED|Overall Study||0||
48664774|NCT02721732|101964640|FG004|COMPLETED|Overall Study||3||
48664775|NCT02721732|101964641|FG005|COMPLETED|Overall Study||0||
48776553|NCT02722304|102244089|FG002|COMPLETED|Overall Study||0||
48776554|NCT02722304|102244090|FG003|COMPLETED|Overall Study||0||
48776555|NCT02722304|102244091|FG004|COMPLETED|Overall Study||0||
48776556|NCT02722304|102244087|FG000|NOT COMPLETED|Overall Study||1||
48776557|NCT02722304|102244088|FG001|NOT COMPLETED|Overall Study||0||
48776558|NCT02722304|102244089|FG002|NOT COMPLETED|Overall Study||2||
48776559|NCT02722304|102244090|FG003|NOT COMPLETED|Overall Study||2||
48776560|NCT02722304|102244091|FG004|NOT COMPLETED|Overall Study||2||
48776561|NCT03962504|102244092|FG000|STARTED|Overall Study||88||
48462073|NCT02038634|101467459|FG000|NOT COMPLETED|Overall Study||0||
48462074|NCT02038634|101467460|FG001|NOT COMPLETED|Overall Study||1||
48462075|NCT03828461|101467461|FG000|STARTED|Overall Study||13||
48776562|NCT03962504|102244093|FG001|STARTED|Overall Study||90||
48776563|NCT03962504|102244092|FG000|COMPLETED|Overall Study||77||
48776564|NCT03962504|102244093|FG001|COMPLETED|Overall Study||58||
48776565|NCT03962504|102244092|FG000|NOT COMPLETED|Overall Study||11||
48776566|NCT03962504|102244093|FG001|NOT COMPLETED|Overall Study||32||
48776567|NCT02637037|102244094|FG000|STARTED|Overall Study||40||
48776568|NCT02637037|102244095|FG001|STARTED|Overall Study||40||
48776569|NCT02637037|102244094|FG000|COMPLETED|Overall Study||36||
48776570|NCT02637037|102244095|FG001|COMPLETED|Overall Study||39||
48776571|NCT02637037|102244094|FG000|NOT COMPLETED|Overall Study||4||
48776572|NCT02637037|102244095|FG001|NOT COMPLETED|Overall Study||1||
48189764|NCT01330355|100786302|FG001|NOT COMPLETED|Overall Study||0||
48462076|NCT03828461|101467461|FG000|COMPLETED|Overall Study||9||
48462077|NCT03828461|101467461|FG000|NOT COMPLETED|Overall Study||4||
48462078|NCT01431755|101467462|FG000|STARTED|Overall Study||54||
48462079|NCT01431755|101467462|FG000|COMPLETED|Overall Study||49||
48462080|NCT01431755|101467462|FG000|NOT COMPLETED|Overall Study||5||
48462081|NCT03644095|101467463|FG000|STARTED|Period 1||15||
48462082|NCT03644095|101467464|FG001|STARTED|Period 1||15||
48462083|NCT03644095|101467463|FG000|COMPLETED|Period 1||15||
48462084|NCT03644095|101467464|FG001|COMPLETED|Period 1||15||
48462085|NCT03644095|101467463|FG000|NOT COMPLETED|Period 1||0||
48462086|NCT03644095|101467464|FG001|NOT COMPLETED|Period 1||0||
48462087|NCT03644095|101467463|FG000|STARTED|Washout (7 Days)||15||
48776573|NCT02970942|102244096|FG000|STARTED|Overall Study||80||
48462088|NCT03644095|101467464|FG001|STARTED|Washout (7 Days)||15||
48462089|NCT03644095|101467463|FG000|COMPLETED|Washout (7 Days)||15||
48462090|NCT03644095|101467464|FG001|COMPLETED|Washout (7 Days)||15||
48776574|NCT02970942|102244097|FG001|STARTED|Overall Study||78||
48462091|NCT03644095|101467463|FG000|NOT COMPLETED|Washout (7 Days)||0||
48462092|NCT03644095|101467464|FG001|NOT COMPLETED|Washout (7 Days)||0||
48776575|NCT02970942|102244098|FG002|STARTED|Overall Study||82||
48776576|NCT02970942|102244099|FG003|STARTED|Overall Study||80||
48776577|NCT02970942|102244096|FG000|Full Analysis Set|Overall Study||80||
48776578|NCT02970942|102244097|FG001|Full Analysis Set|Overall Study||78||
48776579|NCT02970942|102244098|FG002|Full Analysis Set|Overall Study||82||
48776580|NCT02970942|102244099|FG003|Full Analysis Set|Overall Study||80||
48776581|NCT02970942|102244096|FG000|Safety Analysis Set|Overall Study||80||
48776582|NCT02970942|102244097|FG001|Safety Analysis Set|Overall Study||78||
48776583|NCT02970942|102244098|FG002|Safety Analysis Set|Overall Study||81||
48776584|NCT02970942|102244099|FG003|Safety Analysis Set|Overall Study||80||
48776585|NCT02970942|102244096|FG000|Exposed|Overall Study||80||
48776586|NCT02970942|102244097|FG001|Exposed|Overall Study||78||
48776587|NCT02970942|102244098|FG002|Exposed|Overall Study||81||
48776588|NCT02970942|102244099|FG003|Exposed|Overall Study||80||
48776589|NCT02970942|102244096|FG000|COMPLETED|Overall Study||76||
48776590|NCT02970942|102244097|FG001|COMPLETED|Overall Study||72||
48776591|NCT02970942|102244098|FG002|COMPLETED|Overall Study||77||
48776592|NCT02970942|102244099|FG003|COMPLETED|Overall Study||77||
48776593|NCT02970942|102244096|FG000|NOT COMPLETED|Overall Study||4||
48776594|NCT02970942|102244097|FG001|NOT COMPLETED|Overall Study||6||
48776595|NCT02970942|102244098|FG002|NOT COMPLETED|Overall Study||5||
48776596|NCT02970942|102244099|FG003|NOT COMPLETED|Overall Study||3||
48776597|NCT02803580|102244100|FG000|STARTED|Overall Study||209||
48776598|NCT02803580|102244100|FG000|COMPLETED|Overall Study||173||
48776599|NCT02803580|102244100|FG000|NOT COMPLETED|Overall Study||36||
48462093|NCT03644095|101467463|FG000|STARTED|Period 2||15||
48462094|NCT03644095|101467464|FG001|STARTED|Period 2||15||
48462095|NCT03644095|101467463|FG000|COMPLETED|Period 2||15||
48462096|NCT03644095|101467464|FG001|COMPLETED|Period 2||15||
48462097|NCT03644095|101467463|FG000|NOT COMPLETED|Period 2||0||
48462098|NCT03644095|101467464|FG001|NOT COMPLETED|Period 2||0||
48462099|NCT00859469|101467465|FG000|STARTED|Overall Study||29||
48462100|NCT00859469|101467465|FG000|6 Cycles|Overall Study||16||
48462101|NCT00859469|101467465|FG000|COMPLETED|Overall Study||1||
48462102|NCT00859469|101467465|FG000|NOT COMPLETED|Overall Study||28||
48462103|NCT01842958|101467466|FG000|STARTED|Overall Study||25||
48462104|NCT01842958|101467467|FG001|STARTED|Overall Study||25||
48462105|NCT01842958|101467466|FG000|Randomized|Overall Study||25||
48462106|NCT01842958|101467467|FG001|Randomized|Overall Study||25||
48462107|NCT01842958|101467466|FG000|COMPLETED|Overall Study||24||
48462108|NCT01842958|101467467|FG001|COMPLETED|Overall Study||24||
48462109|NCT01842958|101467466|FG000|NOT COMPLETED|Overall Study||1||
48664776|NCT02721732|101964642|FG006|COMPLETED|Overall Study||0||
48664777|NCT02721732|101964643|FG007|COMPLETED|Overall Study||0||
48664778|NCT02721732|101964644|FG008|COMPLETED|Overall Study||2||
48664779|NCT02721732|101964645|FG009|COMPLETED|Overall Study||3||
48664780|NCT02721732|101964636|FG000|NOT COMPLETED|Overall Study||17||
48776600|NCT00981058|102244101|FG000|STARTED|Overall Study||545||
48776601|NCT00981058|102244102|FG001|STARTED|Overall Study||548||
48776602|NCT00981058|102244101|FG000|Received at Least 1 Dose of Study Drug|Overall Study||538||
48776603|NCT00981058|102244102|FG001|Received at Least 1 Dose of Study Drug|Overall Study||541||
48776604|NCT00981058|102244101|FG000|Death Due to Any Cause|Overall Study||418||
48462110|NCT01842958|101467467|FG001|NOT COMPLETED|Overall Study||1||
48462111|NCT00324415|101467468|FG000|STARTED|Overall Study||45||
48462112|NCT00324415|101467468|FG000|COMPLETED|Overall Study||45||
48462113|NCT00324415|101467468|FG000|NOT COMPLETED|Overall Study||0||
48462114|NCT02742090|101467469|FG000|STARTED|Overall Study||51||
48462115|NCT02742090|101467469|FG000|COMPLETED|Overall Study||0||
48462116|NCT02742090|101467469|FG000|NOT COMPLETED|Overall Study||51||
48462117|NCT04633837|101467470|FG000|STARTED|Overall Study||5||
48664781|NCT02721732|101964637|FG001|NOT COMPLETED|Overall Study||12||
48776605|NCT00981058|102244102|FG001|Death Due to Any Cause|Overall Study||442||
48776606|NCT00981058|102244101|FG000|COMPLETED|Overall Study||425||
48776607|NCT00981058|102244102|FG001|COMPLETED|Overall Study||451||
48776608|NCT00981058|102244101|FG000|NOT COMPLETED|Overall Study||120||
48776609|NCT00981058|102244102|FG001|NOT COMPLETED|Overall Study||97||
48462118|NCT04633837|101467471|FG001|STARTED|Overall Study||0||
48462119|NCT04633837|101467470|FG000|COMPLETED|Overall Study||0||
48462120|NCT04633837|101467471|FG001|COMPLETED|Overall Study||0||
48462121|NCT04633837|101467470|FG000|NOT COMPLETED|Overall Study||5||
48462122|NCT04633837|101467471|FG001|NOT COMPLETED|Overall Study||0||
48664782|NCT02721732|101964638|FG002|NOT COMPLETED|Overall Study||22||
48664783|NCT02721732|101964639|FG003|NOT COMPLETED|Overall Study||5||
48664784|NCT02721732|101964640|FG004|NOT COMPLETED|Overall Study||26||
48664785|NCT02721732|101964641|FG005|NOT COMPLETED|Overall Study||3||
48664786|NCT02721732|101964642|FG006|NOT COMPLETED|Overall Study||11||
48664787|NCT02721732|101964643|FG007|NOT COMPLETED|Overall Study||12||
48462123|NCT01288859|101467472|FG000|STARTED|Free Then Encapsulated Curcumin (1 Day)||5||
48462124|NCT01288859|101467473|FG001|STARTED|Free Then Encapsulated Curcumin (1 Day)||0||
48462125|NCT01288859|101467474|FG002|STARTED|Free Then Encapsulated Curcumin (1 Day)||0||
48462126|NCT01288859|101467475|FG003|STARTED|Free Then Encapsulated Curcumin (1 Day)||0||
48462127|NCT01288859|101467476|FG004|STARTED|Free Then Encapsulated Curcumin (1 Day)||0||
48462128|NCT01288859|101467477|FG005|STARTED|Free Then Encapsulated Curcumin (1 Day)||5||
48462129|NCT01288859|101467472|FG000|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5||
48462130|NCT01288859|101467473|FG001|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0||
48462131|NCT01288859|101467474|FG002|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0||
48462132|NCT01288859|101467475|FG003|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0||
48462133|NCT01288859|101467476|FG004|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0||
48462134|NCT01288859|101467477|FG005|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5||
48462135|NCT01288859|101467472|FG000|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0||
48462136|NCT01288859|101467473|FG001|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0||
48462137|NCT01288859|101467474|FG002|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0||
48462138|NCT01288859|101467475|FG003|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0||
48462139|NCT01288859|101467476|FG004|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0||
48462140|NCT01288859|101467477|FG005|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0||
48462141|NCT01288859|101467472|FG000|STARTED|Washout Period of 1 Week||5||
48462142|NCT01288859|101467473|FG001|STARTED|Washout Period of 1 Week||0||
48462143|NCT01288859|101467474|FG002|STARTED|Washout Period of 1 Week||0||
48462144|NCT01288859|101467475|FG003|STARTED|Washout Period of 1 Week||0||
48462145|NCT01288859|101467476|FG004|STARTED|Washout Period of 1 Week||0||
48462146|NCT01288859|101467477|FG005|STARTED|Washout Period of 1 Week||5||
48462147|NCT01288859|101467472|FG000|COMPLETED|Washout Period of 1 Week||5||
48462148|NCT01288859|101467473|FG001|COMPLETED|Washout Period of 1 Week||0||
48462149|NCT01288859|101467474|FG002|COMPLETED|Washout Period of 1 Week||0||
48462150|NCT01288859|101467475|FG003|COMPLETED|Washout Period of 1 Week||0||
48462151|NCT01288859|101467476|FG004|COMPLETED|Washout Period of 1 Week||0||
48462152|NCT01288859|101467477|FG005|COMPLETED|Washout Period of 1 Week||5||
48462153|NCT01288859|101467472|FG000|NOT COMPLETED|Washout Period of 1 Week||0||
48462154|NCT01288859|101467473|FG001|NOT COMPLETED|Washout Period of 1 Week||0||
48462155|NCT01288859|101467474|FG002|NOT COMPLETED|Washout Period of 1 Week||0||
48462156|NCT01288859|101467475|FG003|NOT COMPLETED|Washout Period of 1 Week||0||
48462157|NCT01288859|101467476|FG004|NOT COMPLETED|Washout Period of 1 Week||0||
48462158|NCT01288859|101467477|FG005|NOT COMPLETED|Washout Period of 1 Week||0||
48462159|NCT01288859|101467472|FG000|STARTED|Encapsulated Then Free Curcumin (1 Day)||5||
48462160|NCT01288859|101467473|FG001|STARTED|Encapsulated Then Free Curcumin (1 Day)||0||
48462161|NCT01288859|101467474|FG002|STARTED|Encapsulated Then Free Curcumin (1 Day)||0||
48462162|NCT01288859|101467475|FG003|STARTED|Encapsulated Then Free Curcumin (1 Day)||0||
48462163|NCT01288859|101467476|FG004|STARTED|Encapsulated Then Free Curcumin (1 Day)||0||
48462164|NCT01288859|101467477|FG005|STARTED|Encapsulated Then Free Curcumin (1 Day)||5||
48462165|NCT01288859|101467472|FG000|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5||
48462166|NCT01288859|101467473|FG001|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0||
48462167|NCT01288859|101467474|FG002|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0||
48462168|NCT01288859|101467475|FG003|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0||
48462169|NCT01288859|101467476|FG004|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0||
48462170|NCT01288859|101467477|FG005|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5||
48462171|NCT01288859|101467472|FG000|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0||
48462172|NCT01288859|101467473|FG001|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0||
48462173|NCT01288859|101467474|FG002|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0||
48462174|NCT01288859|101467475|FG003|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0||
48462175|NCT01288859|101467476|FG004|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0||
48462176|NCT01288859|101467477|FG005|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0||
48462177|NCT01288859|101467472|FG000|STARTED|Washout Period of 1 Week||5||
48462178|NCT01288859|101467473|FG001|STARTED|Washout Period of 1 Week||0||
48462179|NCT01288859|101467474|FG002|STARTED|Washout Period of 1 Week||0||
48462180|NCT01288859|101467475|FG003|STARTED|Washout Period of 1 Week||0||
48664788|NCT02721732|101964644|FG008|NOT COMPLETED|Overall Study||11||
48664789|NCT02721732|101964645|FG009|NOT COMPLETED|Overall Study||25||
48664790|NCT02135133|101964646|FG000|STARTED|Overall Study||27||
48462181|NCT01288859|101467476|FG004|STARTED|Washout Period of 1 Week||0||
48664791|NCT02135133|101964646|FG000|COMPLETED|Overall Study||12||
48664792|NCT02135133|101964646|FG000|NOT COMPLETED|Overall Study||15||
48664793|NCT00137449|101964647|FG000|STARTED|Overall Study||30||
48664794|NCT00137449|101964648|FG001|STARTED|Overall Study||30||
48664795|NCT00137449|101964647|FG000|COMPLETED|Overall Study||14||
48462182|NCT01288859|101467477|FG005|STARTED|Washout Period of 1 Week||5||
48462183|NCT01288859|101467472|FG000|COMPLETED|Washout Period of 1 Week||5||
48462184|NCT01288859|101467473|FG001|COMPLETED|Washout Period of 1 Week||0||
48462185|NCT01288859|101467474|FG002|COMPLETED|Washout Period of 1 Week||0||
48664796|NCT00137449|101964648|FG001|COMPLETED|Overall Study||12||
48664797|NCT00137449|101964647|FG000|NOT COMPLETED|Overall Study||16||
48664798|NCT00137449|101964648|FG001|NOT COMPLETED|Overall Study||18||
48776610|NCT00518089|102244103|FG000|STARTED|Overall Study||430||
48776611|NCT00518089|102244104|FG001|STARTED|Overall Study||429||
48776612|NCT00518089|102244103|FG000|COMPLETED|Overall Study||402||
48776613|NCT00518089|102244104|FG001|COMPLETED|Overall Study||398||
48776614|NCT00518089|102244103|FG000|NOT COMPLETED|Overall Study||28||
48776615|NCT00518089|102244104|FG001|NOT COMPLETED|Overall Study||31||
48776616|NCT04947085|102244105|FG000|STARTED|Overall Study||75||
48776617|NCT04947085|102244106|FG001|STARTED|Overall Study||75||
48776618|NCT04947085|102244105|FG000|COMPLETED|Overall Study||72||
48776619|NCT04947085|102244106|FG001|COMPLETED|Overall Study||75||
48776620|NCT04947085|102244105|FG000|NOT COMPLETED|Overall Study||3||
48776621|NCT04947085|102244106|FG001|NOT COMPLETED|Overall Study||0||
48776622|NCT01146795|102244107|FG000|STARTED|Overall Study||32||
48776623|NCT01146795|102244107|FG000|COMPLETED|Overall Study||12||
48776624|NCT01146795|102244107|FG000|NOT COMPLETED|Overall Study||20||
48776625|NCT03534180|102244108|FG000|STARTED|Overall Study||9||
48776626|NCT03534180|102244108|FG000|COMPLETED|Overall Study||8||
48776627|NCT03534180|102244108|FG000|NOT COMPLETED|Overall Study||1||
48776628|NCT01594216|102244109|FG000|STARTED|Overall Study||15||
48776629|NCT01594216|102244110|FG001|STARTED|Overall Study||10||
48776630|NCT01594216|102244109|FG000|COMPLETED|Overall Study||15||
48776631|NCT01594216|102244110|FG001|COMPLETED|Overall Study||10||
48776632|NCT01594216|102244109|FG000|NOT COMPLETED|Overall Study||0||
48776633|NCT01594216|102244110|FG001|NOT COMPLETED|Overall Study||0||
48776634|NCT02053376|102244111|FG000|STARTED|Overall Study||43||
48776635|NCT02053376|102244111|FG000|COMPLETED|Overall Study||43||
48776636|NCT02053376|102244111|FG000|NOT COMPLETED|Overall Study||0||
48776637|NCT00842751|102244112|FG000|STARTED|Overall Study||11||
48776638|NCT00842751|102244112|FG000|COMPLETED|Overall Study||11||
48776639|NCT00842751|102244112|FG000|NOT COMPLETED|Overall Study||0||
48776640|NCT01544335|102244113|FG000|STARTED|Overall Study||191||
48776641|NCT01544335|102244113|FG000|COMPLETED|Overall Study||138||
48776642|NCT01544335|102244113|FG000|NOT COMPLETED|Overall Study||53||
48776643|NCT00611026|102244114|FG000|STARTED|Randomized to Double-blind Treatment||480||
48776644|NCT00611026|102244115|FG001|STARTED|Randomized to Double-blind Treatment||974||
48776645|NCT00611026|102244116|FG002|STARTED|Randomized to Double-blind Treatment||963||
48776646|NCT00611026|102244114|FG000|COMPLETED|Randomized to Double-blind Treatment||478||
48776647|NCT00611026|102244115|FG001|COMPLETED|Randomized to Double-blind Treatment||973||
48776648|NCT00611026|102244116|FG002|COMPLETED|Randomized to Double-blind Treatment||960||
48776649|NCT00611026|102244114|FG000|NOT COMPLETED|Randomized to Double-blind Treatment||2||
48776650|NCT00611026|102244115|FG001|NOT COMPLETED|Randomized to Double-blind Treatment||1||
48776651|NCT00611026|102244116|FG002|NOT COMPLETED|Randomized to Double-blind Treatment||3||
48776652|NCT00611026|102244114|FG000|STARTED|Double-blind Treatment Period||478||
48776653|NCT00611026|102244115|FG001|STARTED|Double-blind Treatment Period||973||
48776654|NCT00611026|102244116|FG002|STARTED|Double-blind Treatment Period||960||
48776655|NCT00611026|102244114|FG000|COMPLETED|Double-blind Treatment Period||431||
48776656|NCT00611026|102244115|FG001|COMPLETED|Double-blind Treatment Period||885||
48776657|NCT00611026|102244116|FG002|COMPLETED|Double-blind Treatment Period||862||
48776658|NCT00611026|102244114|FG000|NOT COMPLETED|Double-blind Treatment Period||47||
48776659|NCT00611026|102244115|FG001|NOT COMPLETED|Double-blind Treatment Period||88||
48776660|NCT00611026|102244116|FG002|NOT COMPLETED|Double-blind Treatment Period||98||
48776661|NCT02023697|102244117|FG000|STARTED|Treatment Period||130|Randomized, Intent-To-Treatment (ITT)|
48776662|NCT02023697|102244118|FG001|STARTED|Treatment Period||130|Randomized, Intent-To-Treatment (ITT)|
48776663|NCT02023697|102244119|FG002|STARTED|Treatment Period||131|Randomized, Intent-To-Treatment (ITT)|
48462186|NCT01288859|101467475|FG003|COMPLETED|Washout Period of 1 Week||0||
48462187|NCT01288859|101467476|FG004|COMPLETED|Washout Period of 1 Week||0||
48462188|NCT01288859|101467477|FG005|COMPLETED|Washout Period of 1 Week||5||
48462189|NCT01288859|101467472|FG000|NOT COMPLETED|Washout Period of 1 Week||0||
48462190|NCT01288859|101467473|FG001|NOT COMPLETED|Washout Period of 1 Week||0||
48462191|NCT01288859|101467474|FG002|NOT COMPLETED|Washout Period of 1 Week||0||
48462192|NCT01288859|101467475|FG003|NOT COMPLETED|Washout Period of 1 Week||0||
48462193|NCT01288859|101467476|FG004|NOT COMPLETED|Washout Period of 1 Week||0||
48462194|NCT01288859|101467477|FG005|NOT COMPLETED|Washout Period of 1 Week||0||
48462195|NCT01288859|101467472|FG000|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0||
48776664|NCT02023697|102244117|FG000|Received Treatment|Treatment Period||125||
48776665|NCT02023697|102244118|FG001|Received Treatment|Treatment Period||124||
48776666|NCT02023697|102244119|FG002|Received Treatment|Treatment Period||121||
48462196|NCT01288859|101467473|FG001|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5||
48462197|NCT01288859|101467474|FG002|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5||
48462198|NCT01288859|101467475|FG003|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0||
48462199|NCT01288859|101467476|FG004|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0||
48462200|NCT01288859|101467477|FG005|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0||
48776667|NCT02023697|102244117|FG000|COMPLETED|Treatment Period||84||
48776668|NCT02023697|102244118|FG001|COMPLETED|Treatment Period||67||
48776669|NCT02023697|102244119|FG002|COMPLETED|Treatment Period||29||
48776670|NCT02023697|102244117|FG000|NOT COMPLETED|Treatment Period||46||
48776671|NCT02023697|102244118|FG001|NOT COMPLETED|Treatment Period||63||
48462201|NCT01288859|101467472|FG000|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0||
48462202|NCT01288859|101467473|FG001|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5||
48462203|NCT01288859|101467474|FG002|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5||
48462204|NCT01288859|101467475|FG003|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0||
48462205|NCT01288859|101467476|FG004|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0||
48462206|NCT01288859|101467477|FG005|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0||
48462207|NCT01288859|101467472|FG000|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0||
48462208|NCT01288859|101467473|FG001|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0||
48462209|NCT01288859|101467474|FG002|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0||
48462210|NCT01288859|101467475|FG003|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0||
48462211|NCT01288859|101467476|FG004|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0||
48462212|NCT01288859|101467477|FG005|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0||
48462213|NCT01288859|101467472|FG000|STARTED|Washout Period of 1 Week||0||
48462214|NCT01288859|101467473|FG001|STARTED|Washout Period of 1 Week||5||
48462215|NCT01288859|101467474|FG002|STARTED|Washout Period of 1 Week||5||
48462216|NCT01288859|101467475|FG003|STARTED|Washout Period of 1 Week||0||
48462217|NCT01288859|101467476|FG004|STARTED|Washout Period of 1 Week||0||
48462218|NCT01288859|101467477|FG005|STARTED|Washout Period of 1 Week||0||
48462219|NCT01288859|101467472|FG000|COMPLETED|Washout Period of 1 Week||0||
48462220|NCT01288859|101467473|FG001|COMPLETED|Washout Period of 1 Week||5||
48462221|NCT01288859|101467474|FG002|COMPLETED|Washout Period of 1 Week||5||
48462222|NCT01288859|101467475|FG003|COMPLETED|Washout Period of 1 Week||0||
48462223|NCT01288859|101467476|FG004|COMPLETED|Washout Period of 1 Week||0||
48462224|NCT01288859|101467477|FG005|COMPLETED|Washout Period of 1 Week||0||
48462225|NCT01288859|101467472|FG000|NOT COMPLETED|Washout Period of 1 Week||0||
48462226|NCT01288859|101467473|FG001|NOT COMPLETED|Washout Period of 1 Week||0||
48776672|NCT02023697|102244119|FG002|NOT COMPLETED|Treatment Period||102||
48776673|NCT02023697|102244117|FG000|STARTED|Active Follow-up Period||120|Entered active follow-up|
48776674|NCT02023697|102244118|FG001|STARTED|Active Follow-up Period||120|Entered active follow-up|
48776675|NCT02023697|102244119|FG002|STARTED|Active Follow-up Period||116|Entered active follow-up|
48776676|NCT02023697|102244117|FG000|COMPLETED|Active Follow-up Period||28||
48776677|NCT02023697|102244118|FG001|COMPLETED|Active Follow-up Period||21||
48776678|NCT02023697|102244119|FG002|COMPLETED|Active Follow-up Period||17||
48776679|NCT02023697|102244117|FG000|NOT COMPLETED|Active Follow-up Period||92||
48776680|NCT02023697|102244118|FG001|NOT COMPLETED|Active Follow-up Period||99||
48776681|NCT02023697|102244119|FG002|NOT COMPLETED|Active Follow-up Period||99||
48776682|NCT02023697|102244117|FG000|STARTED|Long-term Follow-up Period||28||
48776683|NCT02023697|102244118|FG001|STARTED|Long-term Follow-up Period||21||
48776684|NCT02023697|102244119|FG002|STARTED|Long-term Follow-up Period||17||
48776685|NCT02023697|102244117|FG000|COMPLETED|Long-term Follow-up Period||0||
48776686|NCT02023697|102244118|FG001|COMPLETED|Long-term Follow-up Period||0||
48776687|NCT02023697|102244119|FG002|COMPLETED|Long-term Follow-up Period||0||
48776688|NCT02023697|102244117|FG000|NOT COMPLETED|Long-term Follow-up Period||28||
48776689|NCT02023697|102244118|FG001|NOT COMPLETED|Long-term Follow-up Period||21||
48776690|NCT02023697|102244119|FG002|NOT COMPLETED|Long-term Follow-up Period||17||
48776691|NCT02549365|102244120|FG000|STARTED|Overall Study||164||
48776692|NCT02549365|102244121|FG001|STARTED|Overall Study||112||
48776693|NCT02549365|102244120|FG000|COMPLETED|Overall Study||164||
48776694|NCT02549365|102244121|FG001|COMPLETED|Overall Study||112||
48776695|NCT02549365|102244120|FG000|NOT COMPLETED|Overall Study||0||
48776696|NCT02549365|102244121|FG001|NOT COMPLETED|Overall Study||0||
48776697|NCT01519869|102244122|FG000|STARTED|Overall Study||28||
48776698|NCT01519869|102244122|FG000|COMPLETED|Overall Study||27||
48776699|NCT01519869|102244122|FG000|NOT COMPLETED|Overall Study||1||
48776700|NCT00607373|102244123|FG000|STARTED|Treatment Period||17||
48776701|NCT00607373|102244124|FG001|STARTED|Treatment Period||34||
48776702|NCT00607373|102244123|FG000|COMPLETED|Treatment Period||17||
48776703|NCT00607373|102244124|FG001|COMPLETED|Treatment Period||28||
48776704|NCT00607373|102244123|FG000|NOT COMPLETED|Treatment Period||0||
48189765|NCT02362035|100786303|FG000|STARTED|Overall Study||161||
48462227|NCT01288859|101467474|FG002|NOT COMPLETED|Washout Period of 1 Week||0||
48462228|NCT01288859|101467475|FG003|NOT COMPLETED|Washout Period of 1 Week||0||
48462229|NCT01288859|101467476|FG004|NOT COMPLETED|Washout Period of 1 Week||0||
48462230|NCT01288859|101467477|FG005|NOT COMPLETED|Washout Period of 1 Week||0||
48462231|NCT01288859|101467472|FG000|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0||
48189766|NCT02362035|100786303|FG000|COMPLETED|Overall Study||0||
48462232|NCT01288859|101467473|FG001|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5||
48462233|NCT01288859|101467474|FG002|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5||
48776705|NCT00607373|102244124|FG001|NOT COMPLETED|Treatment Period||6||
48776706|NCT00607373|102244123|FG000|STARTED|Follow-up Period||1||
48776707|NCT00607373|102244124|FG001|STARTED|Follow-up Period||11||
48776708|NCT00607373|102244123|FG000|COMPLETED|Follow-up Period||0||
48776709|NCT00607373|102244124|FG001|COMPLETED|Follow-up Period||6||
48776710|NCT00607373|102244123|FG000|NOT COMPLETED|Follow-up Period||1||
48776711|NCT00607373|102244124|FG001|NOT COMPLETED|Follow-up Period||5||
48776712|NCT01151904|102244125|FG000|STARTED|Overall Study||17||
48776713|NCT01151904|102244125|FG000|COMPLETED|Overall Study||17||
48776714|NCT01151904|102244125|FG000|NOT COMPLETED|Overall Study||0||
48776715|NCT03810105|102244126|FG000|STARTED|Overall Study||5||
48776716|NCT03810105|102244126|FG000|COMPLETED|Overall Study||5||
48776717|NCT03810105|102244126|FG000|NOT COMPLETED|Overall Study||0||
48776718|NCT00334113|102244127|FG000|STARTED|Overall Study||32||
48776719|NCT00334113|102244128|FG001|STARTED|Overall Study||34||
48776720|NCT00334113|102244127|FG000|COMPLETED|Overall Study||30||
48776721|NCT00334113|102244128|FG001|COMPLETED|Overall Study||31||
48776722|NCT00334113|102244127|FG000|NOT COMPLETED|Overall Study||2||
48776723|NCT00334113|102244128|FG001|NOT COMPLETED|Overall Study||3||
48776724|NCT00867815|102244129|FG000|STARTED|Overall Study||10|Safety Analysis Set|
48776725|NCT00867815|102244129|FG000|COMPLETED|Overall Study||9||
48776726|NCT00867815|102244129|FG000|NOT COMPLETED|Overall Study||1||
48776727|NCT03048006|102244130|FG000|STARTED|Overall Study||44456||
48776728|NCT03048006|102244130|FG000|COMPLETED|Overall Study||44456||
48776729|NCT03048006|102244130|FG000|NOT COMPLETED|Overall Study||0||
48776730|NCT02872935|102244131|FG000|STARTED|Overall Study||11||
48776731|NCT02872935|102244132|FG001|STARTED|Overall Study||11||
48776732|NCT02872935|102244131|FG000|COMPLETED|Overall Study||11||
48776733|NCT02872935|102244132|FG001|COMPLETED|Overall Study||10||
48776734|NCT02872935|102244131|FG000|NOT COMPLETED|Overall Study||0||
48776735|NCT02872935|102244132|FG001|NOT COMPLETED|Overall Study||1||
48776736|NCT00006289|102244133|FG000|STARTED|First Intervention (5 Weeks)||11||
48776737|NCT00006289|102244134|FG001|STARTED|First Intervention (5 Weeks)||10||
48776738|NCT00006289|102244133|FG000|COMPLETED|First Intervention (5 Weeks)||10||
48776739|NCT00006289|102244134|FG001|COMPLETED|First Intervention (5 Weeks)||10||
48776740|NCT00006289|102244133|FG000|NOT COMPLETED|First Intervention (5 Weeks)||1||
48462234|NCT01288859|101467475|FG003|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0||
48462235|NCT01288859|101467476|FG004|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0||
48462236|NCT01288859|101467477|FG005|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0||
48462237|NCT01288859|101467472|FG000|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0||
48462238|NCT01288859|101467473|FG001|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5||
48462239|NCT01288859|101467474|FG002|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5||
48462240|NCT01288859|101467475|FG003|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0||
48462241|NCT01288859|101467476|FG004|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0||
48462242|NCT01288859|101467477|FG005|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0||
48462243|NCT01288859|101467472|FG000|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0||
48462244|NCT01288859|101467473|FG001|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0||
48462245|NCT01288859|101467474|FG002|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0||
48462246|NCT01288859|101467475|FG003|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0||
48462247|NCT01288859|101467476|FG004|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0||
48462248|NCT01288859|101467477|FG005|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0||
48462249|NCT01288859|101467472|FG000|STARTED|Washout Period of 1 Week||0||
48462250|NCT01288859|101467473|FG001|STARTED|Washout Period of 1 Week||0||
48462251|NCT01288859|101467474|FG002|STARTED|Washout Period of 1 Week||0||
48462252|NCT01288859|101467475|FG003|STARTED|Washout Period of 1 Week||5||
48462253|NCT01288859|101467476|FG004|STARTED|Washout Period of 1 Week||5||
48462254|NCT01288859|101467477|FG005|STARTED|Washout Period of 1 Week||0||
48462255|NCT01288859|101467472|FG000|COMPLETED|Washout Period of 1 Week||0||
48462256|NCT01288859|101467473|FG001|COMPLETED|Washout Period of 1 Week||0||
48462257|NCT01288859|101467474|FG002|COMPLETED|Washout Period of 1 Week||0||
48462258|NCT01288859|101467475|FG003|COMPLETED|Washout Period of 1 Week||5||
48462259|NCT01288859|101467476|FG004|COMPLETED|Washout Period of 1 Week||5||
48462260|NCT01288859|101467477|FG005|COMPLETED|Washout Period of 1 Week||0||
48462261|NCT01288859|101467472|FG000|NOT COMPLETED|Washout Period of 1 Week||0||
48462262|NCT01288859|101467473|FG001|NOT COMPLETED|Washout Period of 1 Week||0||
48462263|NCT01288859|101467474|FG002|NOT COMPLETED|Washout Period of 1 Week||0||
48776741|NCT00006289|102244134|FG001|NOT COMPLETED|First Intervention (5 Weeks)||0||
48776742|NCT00006289|102244133|FG000|STARTED|Washout (>= 1 Week)||10||
48776743|NCT00006289|102244134|FG001|STARTED|Washout (>= 1 Week)||10||
48776744|NCT00006289|102244133|FG000|COMPLETED|Washout (>= 1 Week)||10||
48776745|NCT00006289|102244134|FG001|COMPLETED|Washout (>= 1 Week)||10||
48776746|NCT00006289|102244133|FG000|NOT COMPLETED|Washout (>= 1 Week)||0||
48776747|NCT00006289|102244134|FG001|NOT COMPLETED|Washout (>= 1 Week)||0||
48776748|NCT00006289|102244133|FG000|STARTED|Second Intervention (5 Weeks)||10||
48776749|NCT00006289|102244134|FG001|STARTED|Second Intervention (5 Weeks)||10||
48462264|NCT01288859|101467475|FG003|NOT COMPLETED|Washout Period of 1 Week||0||
48462265|NCT01288859|101467476|FG004|NOT COMPLETED|Washout Period of 1 Week||0||
48462266|NCT01288859|101467477|FG005|NOT COMPLETED|Washout Period of 1 Week||0||
48776750|NCT00006289|102244133|FG000|COMPLETED|Second Intervention (5 Weeks)||9||
48776751|NCT00006289|102244134|FG001|COMPLETED|Second Intervention (5 Weeks)||9||
48776752|NCT00006289|102244133|FG000|NOT COMPLETED|Second Intervention (5 Weeks)||1||
48776753|NCT00006289|102244134|FG001|NOT COMPLETED|Second Intervention (5 Weeks)||1||
48776754|NCT02950467|102244135|FG000|STARTED|Open-label Treatment||18||
48462267|NCT01288859|101467472|FG000|STARTED|Enc Polyph. Then Control Cream (1 Day)||0||
48462268|NCT01288859|101467473|FG001|STARTED|Enc Polyph. Then Control Cream (1 Day)||0||
48462269|NCT01288859|101467474|FG002|STARTED|Enc Polyph. Then Control Cream (1 Day)||0||
48776755|NCT02950467|102244135|FG000|COMPLETED|Open-label Treatment||18||
48776756|NCT02950467|102244135|FG000|NOT COMPLETED|Open-label Treatment||0||
48776757|NCT02950467|102244135|FG000|STARTED|3-month Follow-up||18||
48776758|NCT02950467|102244135|FG000|COMPLETED|3-month Follow-up||18||
48776759|NCT02950467|102244135|FG000|NOT COMPLETED|3-month Follow-up||0||
48776760|NCT01229267|102244136|FG000|STARTED|Overall Study||189||
48776761|NCT01229267|102244137|FG001|STARTED|Overall Study||184||
48776762|NCT01229267|102244138|FG002|STARTED|Overall Study||187||
48776763|NCT01229267|102244139|FG003|STARTED|Overall Study||106||
48776764|NCT01229267|102244140|FG004|STARTED|Overall Study||564||
48776765|NCT01229267|102244136|FG000|Received Vaccination 1|Overall Study||188||
48776766|NCT01229267|102244137|FG001|Received Vaccination 1|Overall Study||180||
48776767|NCT01229267|102244138|FG002|Received Vaccination 1|Overall Study||186||
48776768|NCT01229267|102244139|FG003|Received Vaccination 1|Overall Study||104||
48776769|NCT01229267|102244140|FG004|Received Vaccination 1|Overall Study||556||
48776770|NCT01229267|102244136|FG000|Received Vaccination 2|Overall Study||171||
48776771|NCT01229267|102244137|FG001|Received Vaccination 2|Overall Study||163||
48776772|NCT01229267|102244138|FG002|Received Vaccination 2|Overall Study||168||
48776773|NCT01229267|102244139|FG003|Received Vaccination 2|Overall Study||94||
48776774|NCT01229267|102244140|FG004|Received Vaccination 2|Overall Study||511||
48776775|NCT01229267|102244136|FG000|Received Vaccination 3|Overall Study||163||
48776776|NCT01229267|102244137|FG001|Received Vaccination 3|Overall Study||155||
48776777|NCT01229267|102244138|FG002|Received Vaccination 3|Overall Study||160||
48776778|NCT01229267|102244139|FG003|Received Vaccination 3|Overall Study||89||
48776779|NCT01229267|102244140|FG004|Received Vaccination 3|Overall Study||491||
48776780|NCT01229267|102244136|FG000|Received Vaccination 4|Overall Study||155||
48776781|NCT01229267|102244137|FG001|Received Vaccination 4|Overall Study||149||
48776782|NCT01229267|102244138|FG002|Received Vaccination 4|Overall Study||149||
48776783|NCT01229267|102244139|FG003|Received Vaccination 4|Overall Study||87||
48776784|NCT01229267|102244140|FG004|Received Vaccination 4|Overall Study||477||
48776785|NCT01229267|102244136|FG000|COMPLETED|Overall Study||108||
48776786|NCT01229267|102244137|FG001|COMPLETED|Overall Study||102||
48776787|NCT01229267|102244138|FG002|COMPLETED|Overall Study||101||
48776788|NCT01229267|102244139|FG003|COMPLETED|Overall Study||71||
48776789|NCT01229267|102244140|FG004|COMPLETED|Overall Study||344||
48776790|NCT01229267|102244136|FG000|NOT COMPLETED|Overall Study||81||
48776791|NCT01229267|102244137|FG001|NOT COMPLETED|Overall Study||82||
48776792|NCT01229267|102244138|FG002|NOT COMPLETED|Overall Study||86||
48776793|NCT01229267|102244139|FG003|NOT COMPLETED|Overall Study||35||
48776794|NCT01229267|102244140|FG004|NOT COMPLETED|Overall Study||220||
48776795|NCT00899431|102244141|FG000|STARTED|Overall Study||22||
48776796|NCT00899431|102244142|FG001|STARTED|Overall Study||8||
48776797|NCT00899431|102244143|FG002|STARTED|Overall Study||9||
48776798|NCT00899431|102244141|FG000|COMPLETED|Overall Study||21||
48776799|NCT00899431|102244142|FG001|COMPLETED|Overall Study||8||
48776800|NCT00899431|102244143|FG002|COMPLETED|Overall Study||9||
48776801|NCT00899431|102244141|FG000|NOT COMPLETED|Overall Study||1||
48776802|NCT00899431|102244142|FG001|NOT COMPLETED|Overall Study||0||
48776803|NCT00899431|102244143|FG002|NOT COMPLETED|Overall Study||0||
48776804|NCT04743778|102244144|FG000|STARTED|Overall Study||12||
48462270|NCT01288859|101467475|FG003|STARTED|Enc Polyph. Then Control Cream (1 Day)||5||
48462271|NCT01288859|101467476|FG004|STARTED|Enc Polyph. Then Control Cream (1 Day)||5||
48462272|NCT01288859|101467477|FG005|STARTED|Enc Polyph. Then Control Cream (1 Day)||0||
48462273|NCT01288859|101467472|FG000|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0||
48462274|NCT01288859|101467473|FG001|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0||
48462275|NCT01288859|101467474|FG002|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0||
48462276|NCT01288859|101467475|FG003|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5||
48462277|NCT01288859|101467476|FG004|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5||
48462278|NCT01288859|101467477|FG005|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0||
48776805|NCT04743778|102244144|FG000|COMPLETED|Overall Study||8||
48776806|NCT04743778|102244144|FG000|NOT COMPLETED|Overall Study||4||
48776807|NCT00423917|102244145|FG000|STARTED|Overall Study||36||
48776808|NCT00423917|102244145|FG000|COMPLETED|Overall Study||33||
48776809|NCT00423917|102244145|FG000|NOT COMPLETED|Overall Study||3||
48776810|NCT03124342|102244146|FG000|STARTED|Overall Study||111||
48189767|NCT02362035|100786303|FG000|NOT COMPLETED|Overall Study||161||
48776811|NCT03124342|102244147|FG001|STARTED|Overall Study||121||
48776812|NCT03124342|102244146|FG000|COMPLETED|Overall Study||111||
48776813|NCT03124342|102244147|FG001|COMPLETED|Overall Study||121||
48776814|NCT03124342|102244146|FG000|NOT COMPLETED|Overall Study||0||
48776815|NCT03124342|102244147|FG001|NOT COMPLETED|Overall Study||0||
48776816|NCT00610480|102244148|FG000|STARTED|Overall Study||10||
48776817|NCT00610480|102244149|FG001|STARTED|Overall Study||10||
48776818|NCT00610480|102244148|FG000|COMPLETED|Overall Study||10||
48776819|NCT00610480|102244149|FG001|COMPLETED|Overall Study||10||
48776820|NCT00610480|102244148|FG000|NOT COMPLETED|Overall Study||0||
48776821|NCT00610480|102244149|FG001|NOT COMPLETED|Overall Study||0||
48776822|NCT01179113|102244150|FG000|STARTED|Overall Study||17||
48776823|NCT01179113|102244151|FG001|STARTED|Overall Study||16||
48776824|NCT01179113|102244150|FG000|COMPLETED|Overall Study||17||
48776825|NCT01179113|102244151|FG001|COMPLETED|Overall Study||16||
48776826|NCT01179113|102244150|FG000|NOT COMPLETED|Overall Study||0||
48776827|NCT01179113|102244151|FG001|NOT COMPLETED|Overall Study||0||
48776828|NCT02086500|102244152|FG000|STARTED|Overall Study||447||
48776829|NCT02086500|102244153|FG001|STARTED|Overall Study||456||
48776830|NCT02086500|102244152|FG000|COMPLETED|Overall Study||447||
48776831|NCT02086500|102244153|FG001|COMPLETED|Overall Study||456||
48776832|NCT02086500|102244152|FG000|NOT COMPLETED|Overall Study||0||
48776833|NCT02086500|102244153|FG001|NOT COMPLETED|Overall Study||0||
48776834|NCT01039376|102244154|FG000|STARTED|Overall Study||240||
48776835|NCT01039376|102244155|FG001|STARTED|Overall Study||240||
48776836|NCT01039376|102244154|FG000|COMPLETED|Overall Study||110||
48776837|NCT01039376|102244155|FG001|COMPLETED|Overall Study||114||
48776838|NCT01039376|102244154|FG000|NOT COMPLETED|Overall Study||130||
48776839|NCT01039376|102244155|FG001|NOT COMPLETED|Overall Study||126||
48776840|NCT04816669|102244156|FG000|STARTED|Part 1||279||
48462279|NCT01288859|101467472|FG000|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0||
48462280|NCT01288859|101467473|FG001|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0||
48462281|NCT01288859|101467474|FG002|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0||
48462282|NCT01288859|101467475|FG003|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0||
48462283|NCT01288859|101467476|FG004|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0||
48462284|NCT01288859|101467477|FG005|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0||
48462285|NCT01288859|101467472|FG000|STARTED|Washout Period of 1 Week||0||
48462286|NCT01288859|101467473|FG001|STARTED|Washout Period of 1 Week||0||
48462287|NCT01288859|101467474|FG002|STARTED|Washout Period of 1 Week||0||
48462288|NCT01288859|101467475|FG003|STARTED|Washout Period of 1 Week||5||
48462289|NCT01288859|101467476|FG004|STARTED|Washout Period of 1 Week||5||
48462290|NCT01288859|101467477|FG005|STARTED|Washout Period of 1 Week||0||
48462291|NCT01288859|101467472|FG000|COMPLETED|Washout Period of 1 Week||0||
48462292|NCT01288859|101467473|FG001|COMPLETED|Washout Period of 1 Week||0||
48462293|NCT01288859|101467474|FG002|COMPLETED|Washout Period of 1 Week||0||
48462294|NCT01288859|101467475|FG003|COMPLETED|Washout Period of 1 Week||5||
48462295|NCT01288859|101467476|FG004|COMPLETED|Washout Period of 1 Week||5||
48462296|NCT01288859|101467477|FG005|COMPLETED|Washout Period of 1 Week||0||
48462297|NCT01288859|101467472|FG000|NOT COMPLETED|Washout Period of 1 Week||0||
48462298|NCT01288859|101467473|FG001|NOT COMPLETED|Washout Period of 1 Week||0||
48462299|NCT01288859|101467474|FG002|NOT COMPLETED|Washout Period of 1 Week||0||
48462300|NCT01288859|101467475|FG003|NOT COMPLETED|Washout Period of 1 Week||0||
48462301|NCT01288859|101467476|FG004|NOT COMPLETED|Washout Period of 1 Week||0||
48462302|NCT01288859|101467477|FG005|NOT COMPLETED|Washout Period of 1 Week||0||
48462303|NCT01288859|101467472|FG000|STARTED|Control Cream Then Enc Polyph. (1 Day)||0||
48462304|NCT01288859|101467473|FG001|STARTED|Control Cream Then Enc Polyph. (1 Day)||0||
48462305|NCT01288859|101467474|FG002|STARTED|Control Cream Then Enc Polyph. (1 Day)||0||
48462306|NCT01288859|101467475|FG003|STARTED|Control Cream Then Enc Polyph. (1 Day)||5||
48462307|NCT01288859|101467476|FG004|STARTED|Control Cream Then Enc Polyph. (1 Day)||5||
48462308|NCT01288859|101467477|FG005|STARTED|Control Cream Then Enc Polyph. (1 Day)||0||
48462309|NCT01288859|101467472|FG000|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0||
48776841|NCT04816669|102244157|FG001|STARTED|Part 1||280||
48776842|NCT04816669|102244158|FG002|STARTED|Part 1||0||
48776843|NCT04816669|102244159|FG003|STARTED|Part 1||0||
48776844|NCT04816669|102244156|FG000|Vaccinated at Dose 1|Part 1||279||
48776845|NCT04816669|102244157|FG001|Vaccinated at Dose 1|Part 1||280||
48776846|NCT04816669|102244158|FG002|Vaccinated at Dose 1|Part 1||0||
48462310|NCT01288859|101467473|FG001|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0||
48462311|NCT01288859|101467474|FG002|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0||
48462312|NCT01288859|101467475|FG003|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5||
48462313|NCT01288859|101467476|FG004|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5||
48776847|NCT04816669|102244159|FG003|Vaccinated at Dose 1|Part 1||0||
48462314|NCT01288859|101467477|FG005|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0||
48462315|NCT01288859|101467472|FG000|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0||
48462316|NCT01288859|101467473|FG001|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0||
48462317|NCT01288859|101467474|FG002|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0||
48462318|NCT01288859|101467475|FG003|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0||
48776848|NCT04816669|102244156|FG000|Vaccinated at Dose 2|Part 1||276||
48664799|NCT00522379|101964649|FG000|STARTED|Overall Study||101||
48776849|NCT04816669|102244157|FG001|Vaccinated at Dose 2|Part 1||277||
48776850|NCT04816669|102244158|FG002|Vaccinated at Dose 2|Part 1||0||
48776851|NCT04816669|102244159|FG003|Vaccinated at Dose 2|Part 1||0||
48462319|NCT01288859|101467476|FG004|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0||
48462320|NCT01288859|101467477|FG005|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0||
48462321|NCT01855126|101467478|FG000|STARTED|First Intervention (8 Weeks)||24||
48462322|NCT01855126|101467479|FG001|STARTED|First Intervention (8 Weeks)||22||
48462323|NCT01855126|101467478|FG000|COMPLETED|First Intervention (8 Weeks)||20||
48462324|NCT01855126|101467479|FG001|COMPLETED|First Intervention (8 Weeks)||16||
48776852|NCT04816669|102244156|FG000|Vaccination at Dose 3|Part 1||114||
48776853|NCT04816669|102244157|FG001|Vaccination at Dose 3|Part 1||0||
48776854|NCT04816669|102244158|FG002|Vaccination at Dose 3|Part 1||0||
48776855|NCT04816669|102244159|FG003|Vaccination at Dose 3|Part 1||0||
48776856|NCT04816669|102244156|FG000|COMPLETED|Part 1||275||
48776857|NCT04816669|102244157|FG001|COMPLETED|Part 1||274||
48776858|NCT04816669|102244158|FG002|COMPLETED|Part 1||0||
48776859|NCT04816669|102244159|FG003|COMPLETED|Part 1||0||
48776860|NCT04816669|102244156|FG000|NOT COMPLETED|Part 1||4||
48776861|NCT04816669|102244157|FG001|NOT COMPLETED|Part 1||6||
48776862|NCT04816669|102244158|FG002|NOT COMPLETED|Part 1||0||
48776863|NCT04816669|102244159|FG003|NOT COMPLETED|Part 1||0||
48776864|NCT04816669|102244156|FG000|STARTED|Part 2||0||
48776865|NCT04816669|102244157|FG001|STARTED|Part 2||0||
48776866|NCT04816669|102244158|FG002|STARTED|Part 2||35||
48776867|NCT04816669|102244159|FG003|STARTED|Part 2||35||
48776868|NCT04816669|102244156|FG000|Vaccinated at Dose 1|Part 2||0||
48776869|NCT04816669|102244157|FG001|Vaccinated at Dose 1|Part 2||0||
48776870|NCT04816669|102244158|FG002|Vaccinated at Dose 1|Part 2||35||
48776871|NCT04816669|102244159|FG003|Vaccinated at Dose 1|Part 2||35||
48776872|NCT04816669|102244156|FG000|Vaccinated at Dose 2|Part 2||0||
48776873|NCT04816669|102244157|FG001|Vaccinated at Dose 2|Part 2||0||
48776874|NCT04816669|102244158|FG002|Vaccinated at Dose 2|Part 2||35||
48776875|NCT04816669|102244159|FG003|Vaccinated at Dose 2|Part 2||35||
48776876|NCT04816669|102244156|FG000|COMPLETED|Part 2||0||
48776877|NCT04816669|102244157|FG001|COMPLETED|Part 2||0||
48776878|NCT04816669|102244158|FG002|COMPLETED|Part 2||33||
48776879|NCT04816669|102244159|FG003|COMPLETED|Part 2||34||
48776880|NCT04816669|102244156|FG000|NOT COMPLETED|Part 2||0||
48776881|NCT04816669|102244157|FG001|NOT COMPLETED|Part 2||0||
48776882|NCT04816669|102244158|FG002|NOT COMPLETED|Part 2||2||
48776883|NCT04816669|102244159|FG003|NOT COMPLETED|Part 2||1||
48776884|NCT00459732|102244160|FG000|STARTED|Overall Study||23||
48776885|NCT00459732|102244161|FG001|STARTED|Overall Study||17||
48776886|NCT00459732|102244160|FG000|COMPLETED|Overall Study||19||
48776887|NCT00459732|102244161|FG001|COMPLETED|Overall Study||14||
48776888|NCT00459732|102244160|FG000|NOT COMPLETED|Overall Study||4||
48776889|NCT00459732|102244161|FG001|NOT COMPLETED|Overall Study||3||
48776890|NCT04173494|102244162|FG000|STARTED|Randomized DB TP (Up to Week 24)||130||
48776891|NCT04173494|102244163|FG001|STARTED|Randomized DB TP (Up to Week 24)||65||
48776892|NCT04173494|102244162|FG000|COMPLETED|Randomized DB TP (Up to Week 24)||94||
48776893|NCT04173494|102244163|FG001|COMPLETED|Randomized DB TP (Up to Week 24)||38||
48776894|NCT04173494|102244162|FG000|NOT COMPLETED|Randomized DB TP (Up to Week 24)||36||
48776895|NCT04173494|102244163|FG001|NOT COMPLETED|Randomized DB TP (Up to Week 24)||27||
48776896|NCT04173494|102244162|FG000|STARTED|Open-Label Extended TP(Weeks 24 to 151)||93||
48776897|NCT04173494|102244163|FG001|STARTED|Open-Label Extended TP(Weeks 24 to 151)||41||
48776898|NCT04173494|102244162|FG000|COMPLETED|Open-Label Extended TP(Weeks 24 to 151)||0||
48776899|NCT04173494|102244163|FG001|COMPLETED|Open-Label Extended TP(Weeks 24 to 151)||0||
48776900|NCT04173494|102244162|FG000|NOT COMPLETED|Open-Label Extended TP(Weeks 24 to 151)||93||
48776901|NCT04173494|102244163|FG001|NOT COMPLETED|Open-Label Extended TP(Weeks 24 to 151)||41||
48776902|NCT00990704|102244164|FG000|STARTED|Overall Study||14||
48776903|NCT00990704|102244165|FG001|STARTED|Overall Study||33||
48776904|NCT00990704|102244164|FG000|COMPLETED|Overall Study||13||
48776905|NCT00990704|102244165|FG001|COMPLETED|Overall Study||31||
48462325|NCT01855126|101467478|FG000|NOT COMPLETED|First Intervention (8 Weeks)||4||
48462326|NCT01855126|101467479|FG001|NOT COMPLETED|First Intervention (8 Weeks)||6||
48462327|NCT01855126|101467478|FG000|STARTED|Washout Period (2 Weeks)||20||
48462328|NCT01855126|101467479|FG001|STARTED|Washout Period (2 Weeks)||16||
48462329|NCT01855126|101467478|FG000|COMPLETED|Washout Period (2 Weeks)||20||
48462330|NCT01855126|101467479|FG001|COMPLETED|Washout Period (2 Weeks)||16||
48462331|NCT01855126|101467478|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0||
48462332|NCT01855126|101467479|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0||
48776906|NCT00990704|102244164|FG000|NOT COMPLETED|Overall Study||1||
48776907|NCT00990704|102244165|FG001|NOT COMPLETED|Overall Study||2||
48776908|NCT02301416|102244166|FG000|STARTED|Overall Study||25||
48462333|NCT01855126|101467478|FG000|STARTED|Second Intervention (8 Weeks)||20||
48462334|NCT01855126|101467479|FG001|STARTED|Second Intervention (8 Weeks)||16||
48664800|NCT00522379|101964650|FG001|STARTED|Overall Study||107||
48664801|NCT00522379|101964651|FG002|STARTED|Overall Study||104||
48664802|NCT00522379|101964652|FG003|STARTED|Overall Study||94||
48664803|NCT00522379|101964653|FG004|STARTED|Overall Study||108||
48664804|NCT00522379|101964649|FG000|COMPLETED|Overall Study||79||
48664805|NCT00522379|101964650|FG001|COMPLETED|Overall Study||84||
48664806|NCT00522379|101964651|FG002|COMPLETED|Overall Study||82||
48664807|NCT00522379|101964652|FG003|COMPLETED|Overall Study||80||
48776909|NCT02301416|102244167|FG001|STARTED|Overall Study||40||
48776910|NCT02301416|102244166|FG000|COMPLETED|Overall Study||15||
48776911|NCT02301416|102244167|FG001|COMPLETED|Overall Study||40||
48776912|NCT02301416|102244166|FG000|NOT COMPLETED|Overall Study||10||
48776913|NCT02301416|102244167|FG001|NOT COMPLETED|Overall Study||0||
48776914|NCT00673738|102244168|FG000|STARTED|Overall Study||27||
48776915|NCT00673738|102244168|FG000|COMPLETED|Overall Study||27||
48776916|NCT00673738|102244168|FG000|NOT COMPLETED|Overall Study||0||
48776917|NCT00808080|102244169|FG000|STARTED|Overall Study||6||
48776918|NCT00808080|102244169|FG000|COMPLETED|Overall Study||0||
48776919|NCT00808080|102244169|FG000|NOT COMPLETED|Overall Study||6||
48776920|NCT02139007|102244170|FG000|STARTED|Study Site Recruitment||4||
48776921|NCT02139007|102244171|FG001|STARTED|Study Site Recruitment||5||
48776922|NCT02139007|102244170|FG000|COMPLETED|Study Site Recruitment||1||
48776923|NCT02139007|102244171|FG001|COMPLETED|Study Site Recruitment||1||
48776924|NCT02139007|102244170|FG000|NOT COMPLETED|Study Site Recruitment||3||
48776925|NCT02139007|102244171|FG001|NOT COMPLETED|Study Site Recruitment||4||
48776926|NCT02139007|102244170|FG000|STARTED|Patient Participant Recruitment||13||
48776927|NCT02139007|102244171|FG001|STARTED|Patient Participant Recruitment||14||
48776928|NCT02139007|102244170|FG000|COMPLETED|Patient Participant Recruitment||11||
48776929|NCT02139007|102244171|FG001|COMPLETED|Patient Participant Recruitment||13||
48776930|NCT02139007|102244170|FG000|NOT COMPLETED|Patient Participant Recruitment||2||
48776931|NCT02139007|102244171|FG001|NOT COMPLETED|Patient Participant Recruitment||1||
48776932|NCT03210337|102244172|FG000|STARTED|Overall Study||78||
48776933|NCT03210337|102244173|FG001|STARTED|Overall Study||79||
48776934|NCT03210337|102244172|FG000|COMPLETED|Overall Study||70||
48776935|NCT03210337|102244173|FG001|COMPLETED|Overall Study||74||
48776936|NCT03210337|102244172|FG000|NOT COMPLETED|Overall Study||8||
48776937|NCT03210337|102244173|FG001|NOT COMPLETED|Overall Study||5||
48776938|NCT02660983|102244174|FG000|STARTED|Double-blind (DB) Phase (24 Weeks)||154||
48776939|NCT02660983|102244175|FG001|STARTED|Double-blind (DB) Phase (24 Weeks)||148||
48776940|NCT02660983|102244174|FG000|Treated/Safety Set|Double-blind (DB) Phase (24 Weeks)||153||
48776941|NCT02660983|102244175|FG001|Treated/Safety Set|Double-blind (DB) Phase (24 Weeks)||147||
48776942|NCT02660983|102244174|FG000|COMPLETED|Double-blind (DB) Phase (24 Weeks)||130||
48776943|NCT02660983|102244175|FG001|COMPLETED|Double-blind (DB) Phase (24 Weeks)||122||
48776944|NCT02660983|102244174|FG000|NOT COMPLETED|Double-blind (DB) Phase (24 Weeks)||24||
48776945|NCT02660983|102244175|FG001|NOT COMPLETED|Double-blind (DB) Phase (24 Weeks)||26||
48776946|NCT02660983|102244174|FG000|STARTED|Open Label Extension Phase (24 Weeks)||86||
48776947|NCT02660983|102244175|FG001|STARTED|Open Label Extension Phase (24 Weeks)||75||
48776948|NCT02660983|102244174|FG000|Safety Set|Open Label Extension Phase (24 Weeks)||86||
48776949|NCT02660983|102244175|FG001|Safety Set|Open Label Extension Phase (24 Weeks)||75||
48776950|NCT02660983|102244174|FG000|COMPLETED|Open Label Extension Phase (24 Weeks)||83||
48776951|NCT02660983|102244175|FG001|COMPLETED|Open Label Extension Phase (24 Weeks)||66||
48776952|NCT02660983|102244174|FG000|NOT COMPLETED|Open Label Extension Phase (24 Weeks)||3||
48776953|NCT02660983|102244175|FG001|NOT COMPLETED|Open Label Extension Phase (24 Weeks)||9||
48776954|NCT01075685|102244176|FG000|STARTED|Overall Study||743||
48776955|NCT01075685|102244177|FG001|STARTED|Overall Study||414||
48776956|NCT01075685|102244176|FG000|Met Inclusion Criteria|Overall Study||734||
48776957|NCT01075685|102244177|FG001|Met Inclusion Criteria|Overall Study||413||
48189768|NCT02788656|100786304|FG000|STARTED|Overall Study||2||
48776958|NCT01075685|102244176|FG000|Completed Baseline Measures|Overall Study||225||
48776959|NCT01075685|102244177|FG001|Completed Baseline Measures|Overall Study||263||
48776960|NCT01075685|102244176|FG000|COMPLETED|Overall Study||151||
48776961|NCT01075685|102244177|FG001|COMPLETED|Overall Study||188||
48776962|NCT01075685|102244176|FG000|NOT COMPLETED|Overall Study||592||
48776963|NCT01075685|102244177|FG001|NOT COMPLETED|Overall Study||226||
48776964|NCT02527421|102244178|FG000|STARTED|Overall Study||2||
48776965|NCT02527421|102244179|FG001|STARTED|Overall Study||1||
48189769|NCT02788656|100786305|FG001|STARTED|Overall Study||2||
48189770|NCT02788656|100786304|FG000|COMPLETED|Overall Study||1||
48776966|NCT02527421|102244178|FG000|COMPLETED|Overall Study||1||
48776967|NCT02527421|102244179|FG001|COMPLETED|Overall Study||1||
48776968|NCT02527421|102244178|FG000|NOT COMPLETED|Overall Study||1||
48776969|NCT02527421|102244179|FG001|NOT COMPLETED|Overall Study||0||
48776970|NCT00114517|102244180|FG000|STARTED|Overall Study||137||
48776971|NCT00114517|102244181|FG001|STARTED|Overall Study||134||
48776972|NCT00114517|102244182|FG002|STARTED|Overall Study||186||
48776973|NCT00114517|102244183|FG003|STARTED|Overall Study||186||
48776974|NCT00114517|102244180|FG000|COMPLETED|Overall Study||125||
48776975|NCT00114517|102244181|FG001|COMPLETED|Overall Study||123||
48776976|NCT00114517|102244182|FG002|COMPLETED|Overall Study||172||
48776977|NCT00114517|102244183|FG003|COMPLETED|Overall Study||176||
48776978|NCT00114517|102244180|FG000|NOT COMPLETED|Overall Study||12||
48462335|NCT01855126|101467478|FG000|COMPLETED|Second Intervention (8 Weeks)||18||
48776979|NCT00114517|102244181|FG001|NOT COMPLETED|Overall Study||11||
48776980|NCT00114517|102244182|FG002|NOT COMPLETED|Overall Study||14||
48776981|NCT00114517|102244183|FG003|NOT COMPLETED|Overall Study||10||
48776982|NCT03052426|102244184|FG000|STARTED|Overall Study||6||
48462336|NCT01855126|101467479|FG001|COMPLETED|Second Intervention (8 Weeks)||14||
48462337|NCT01855126|101467478|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||2||
48462338|NCT01855126|101467479|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||2||
48462339|NCT01033383|101467480|FG000|STARTED|Overall Study||20||
48462340|NCT01033383|101467481|FG001|STARTED|Overall Study||20||
48462341|NCT01033383|101467482|FG002|STARTED|Overall Study||20||
48462342|NCT01033383|101467483|FG003|STARTED|Overall Study||20||
48462343|NCT01033383|101467480|FG000|COMPLETED|Overall Study||20||
48462344|NCT01033383|101467481|FG001|COMPLETED|Overall Study||20||
48462345|NCT01033383|101467482|FG002|COMPLETED|Overall Study||20||
48462346|NCT01033383|101467483|FG003|COMPLETED|Overall Study||20||
48462347|NCT01033383|101467480|FG000|NOT COMPLETED|Overall Study||0||
48462348|NCT01033383|101467481|FG001|NOT COMPLETED|Overall Study||0||
48462349|NCT01033383|101467482|FG002|NOT COMPLETED|Overall Study||0||
48462350|NCT01033383|101467483|FG003|NOT COMPLETED|Overall Study||0||
48462351|NCT00891293|101467484|FG000|STARTED|Overall Study||93||
48462352|NCT00891293|101467484|FG000|COMPLETED|Overall Study||9||
48462353|NCT00891293|101467484|FG000|NOT COMPLETED|Overall Study||84||
48462354|NCT01214603|101467485|FG000|STARTED|Overall Study||7||
48462355|NCT01214603|101467486|FG001|STARTED|Overall Study||6||
48462356|NCT01214603|101467487|FG002|STARTED|Overall Study||7||
48462357|NCT01214603|101467485|FG000|Received at Least 1 Dose of LY2090314|Overall Study||7||
48462358|NCT01214603|101467486|FG001|Received at Least 1 Dose of LY2090314|Overall Study||6||
48462359|NCT01214603|101467487|FG002|Received at Least 1 Dose of LY2090314|Overall Study||7||
48462360|NCT01214603|101467485|FG000|COMPLETED|Overall Study||2||
48462361|NCT01214603|101467486|FG001|COMPLETED|Overall Study||5||
48462362|NCT01214603|101467487|FG002|COMPLETED|Overall Study||3||
48462363|NCT01214603|101467485|FG000|NOT COMPLETED|Overall Study||5||
48462364|NCT01214603|101467486|FG001|NOT COMPLETED|Overall Study||1||
48462365|NCT01214603|101467487|FG002|NOT COMPLETED|Overall Study||4||
48462366|NCT00447603|101467488|FG000|STARTED|Screening||40||
48462367|NCT00447603|101467489|FG001|STARTED|Screening||0||
48462368|NCT00447603|101467490|FG002|STARTED|Screening||0||
48462369|NCT00447603|101467488|FG000|COMPLETED|Screening||19||
48462370|NCT00447603|101467489|FG001|COMPLETED|Screening||0||
48462371|NCT00447603|101467490|FG002|COMPLETED|Screening||0||
48462372|NCT00447603|101467488|FG000|NOT COMPLETED|Screening||21||
48462373|NCT00447603|101467489|FG001|NOT COMPLETED|Screening||0||
48462374|NCT00447603|101467490|FG002|NOT COMPLETED|Screening||0||
48462375|NCT00447603|101467488|FG000|STARTED|Filter Period||0||
48462376|NCT00447603|101467489|FG001|STARTED|Filter Period||4||
48462377|NCT00447603|101467490|FG002|STARTED|Filter Period||15||
48462378|NCT00447603|101467488|FG000|COMPLETED|Filter Period||0||
48462379|NCT00447603|101467489|FG001|COMPLETED|Filter Period||0||
48462380|NCT00447603|101467490|FG002|COMPLETED|Filter Period||0||
48462381|NCT00447603|101467488|FG000|NOT COMPLETED|Filter Period||0||
48462382|NCT00447603|101467489|FG001|NOT COMPLETED|Filter Period||4||
48462383|NCT00447603|101467490|FG002|NOT COMPLETED|Filter Period||15||
48462384|NCT01141283|101467491|FG000|STARTED|Overall Study||290||
48462385|NCT01141283|101467491|FG000|COMPLETED|Overall Study||202||
48462386|NCT01141283|101467491|FG000|NOT COMPLETED|Overall Study||88||
48462387|NCT01464827|101467492|FG000|STARTED|Overall Study||80||
48462388|NCT01464827|101467493|FG001|STARTED|Overall Study||43||
48462389|NCT01464827|101467494|FG002|STARTED|Overall Study||39||
48462390|NCT01464827|101467495|FG003|STARTED|Overall Study||40||
48462391|NCT01464827|101467496|FG004|STARTED|Overall Study||80||
48462392|NCT01464827|101467497|FG005|STARTED|Overall Study||39||
48462393|NCT01464827|101467498|FG006|STARTED|Overall Study||41||
48462394|NCT01464827|101467499|FG007|STARTED|Overall Study||40||
48462395|NCT01464827|101467500|FG008|STARTED|Overall Study||40||
48462396|NCT01464827|101467501|FG009|STARTED|Overall Study||47||
48462397|NCT01464827|101467502|FG010|STARTED|Overall Study||23||
48462398|NCT01464827|101467503|FG011|STARTED|Overall Study||23||
48462399|NCT01464827|101467504|FG012|STARTED|Overall Study||23||
48462400|NCT01464827|101467505|FG013|STARTED|Overall Study||22||
48462401|NCT01464827|101467492|FG000|Treated|Overall Study||80||
48462402|NCT01464827|101467493|FG001|Treated|Overall Study||41||
48462403|NCT01464827|101467494|FG002|Treated|Overall Study||39||
48462404|NCT01464827|101467495|FG003|Treated|Overall Study||40||
48462405|NCT01464827|101467496|FG004|Treated|Overall Study||79||
48462406|NCT01464827|101467497|FG005|Treated|Overall Study||39||
48462407|NCT01464827|101467498|FG006|Treated|Overall Study||40||
48462408|NCT01464827|101467499|FG007|Treated|Overall Study||40||
48462409|NCT01464827|101467500|FG008|Treated|Overall Study||40||
48462410|NCT01464827|101467501|FG009|Treated|Overall Study||45||
48462411|NCT01464827|101467502|FG010|Treated|Overall Study||23||
48462412|NCT01464827|101467503|FG011|Treated|Overall Study||22||
48462413|NCT01464827|101467504|FG012|Treated|Overall Study||23||
48462414|NCT01464827|101467505|FG013|Treated|Overall Study||20||
48462415|NCT01464827|101467492|FG000|COMPLETED|Overall Study||77||
48462416|NCT01464827|101467493|FG001|COMPLETED|Overall Study||36||
48462417|NCT01464827|101467494|FG002|COMPLETED|Overall Study||39||
48462418|NCT01464827|101467495|FG003|COMPLETED|Overall Study||36||
48462419|NCT01464827|101467496|FG004|COMPLETED|Overall Study||72||
48462420|NCT01464827|101467497|FG005|COMPLETED|Overall Study||38||
48462421|NCT01464827|101467498|FG006|COMPLETED|Overall Study||37||
48462422|NCT01464827|101467499|FG007|COMPLETED|Overall Study||37||
48776983|NCT03052426|102244185|FG001|STARTED|Overall Study||6||
48776984|NCT03052426|102244186|FG002|STARTED|Overall Study||6||
48776985|NCT03052426|102244184|FG000|COMPLETED|Overall Study||4||
48776986|NCT03052426|102244185|FG001|COMPLETED|Overall Study||5||
48776987|NCT03052426|102244186|FG002|COMPLETED|Overall Study||5||
48776988|NCT03052426|102244184|FG000|NOT COMPLETED|Overall Study||2||
48776989|NCT03052426|102244185|FG001|NOT COMPLETED|Overall Study||1||
48776990|NCT03052426|102244186|FG002|NOT COMPLETED|Overall Study||1||
48776991|NCT00363480|102244187|FG000|STARTED|Overall Study||221||
48776992|NCT00363480|102244187|FG000|COMPLETED|Overall Study||204||
48776993|NCT00363480|102244187|FG000|NOT COMPLETED|Overall Study||17||
48776994|NCT03214666|102244188|FG000|STARTED|Cohort 1: Dose Level 1: 5 ug/kg/Day||2||
48776995|NCT03214666|102244189|FG001|STARTED|Cohort 1: Dose Level 1: 5 ug/kg/Day||0||
48776996|NCT03214666|102244190|FG002|STARTED|Cohort 1: Dose Level 1: 5 ug/kg/Day||0||
48776997|NCT03214666|102244191|FG003|STARTED|Cohort 1: Dose Level 1: 5 ug/kg/Day||0||
48776998|NCT03214666|102244192|FG004|STARTED|Cohort 1: Dose Level 1: 5 ug/kg/Day||0||
48776999|NCT03214666|102244193|FG005|STARTED|Cohort 1: Dose Level 1: 5 ug/kg/Day||0||
48777000|NCT03214666|102244188|FG000|COMPLETED|Cohort 1: Dose Level 1: 5 ug/kg/Day||2||
48777001|NCT03214666|102244189|FG001|COMPLETED|Cohort 1: Dose Level 1: 5 ug/kg/Day||0||
48777002|NCT03214666|102244190|FG002|COMPLETED|Cohort 1: Dose Level 1: 5 ug/kg/Day||0||
48777003|NCT03214666|102244191|FG003|COMPLETED|Cohort 1: Dose Level 1: 5 ug/kg/Day||0||
48777004|NCT03214666|102244192|FG004|COMPLETED|Cohort 1: Dose Level 1: 5 ug/kg/Day||0||
48777005|NCT03214666|102244193|FG005|COMPLETED|Cohort 1: Dose Level 1: 5 ug/kg/Day||0||
48777006|NCT03214666|102244188|FG000|NOT COMPLETED|Cohort 1: Dose Level 1: 5 ug/kg/Day||0||
48777007|NCT03214666|102244189|FG001|NOT COMPLETED|Cohort 1: Dose Level 1: 5 ug/kg/Day||0||
48777008|NCT03214666|102244190|FG002|NOT COMPLETED|Cohort 1: Dose Level 1: 5 ug/kg/Day||0||
48777009|NCT03214666|102244191|FG003|NOT COMPLETED|Cohort 1: Dose Level 1: 5 ug/kg/Day||0||
48777010|NCT03214666|102244192|FG004|NOT COMPLETED|Cohort 1: Dose Level 1: 5 ug/kg/Day||0||
48777011|NCT03214666|102244193|FG005|NOT COMPLETED|Cohort 1: Dose Level 1: 5 ug/kg/Day||0||
48777012|NCT03214666|102244188|FG000|STARTED|Cohort 2: Dose Level 2: 10ug/kg/Day||0||
48777013|NCT03214666|102244189|FG001|STARTED|Cohort 2: Dose Level 2: 10ug/kg/Day||2||
48777014|NCT03214666|102244190|FG002|STARTED|Cohort 2: Dose Level 2: 10ug/kg/Day||0||
48777015|NCT03214666|102244191|FG003|STARTED|Cohort 2: Dose Level 2: 10ug/kg/Day||0||
48777016|NCT03214666|102244192|FG004|STARTED|Cohort 2: Dose Level 2: 10ug/kg/Day||0||
48777017|NCT03214666|102244193|FG005|STARTED|Cohort 2: Dose Level 2: 10ug/kg/Day||0||
48777018|NCT03214666|102244188|FG000|COMPLETED|Cohort 2: Dose Level 2: 10ug/kg/Day||0||
48777019|NCT03214666|102244189|FG001|COMPLETED|Cohort 2: Dose Level 2: 10ug/kg/Day||2||
48777020|NCT03214666|102244190|FG002|COMPLETED|Cohort 2: Dose Level 2: 10ug/kg/Day||0||
48777021|NCT03214666|102244191|FG003|COMPLETED|Cohort 2: Dose Level 2: 10ug/kg/Day||0||
48777022|NCT03214666|102244192|FG004|COMPLETED|Cohort 2: Dose Level 2: 10ug/kg/Day||0||
48777023|NCT03214666|102244193|FG005|COMPLETED|Cohort 2: Dose Level 2: 10ug/kg/Day||0||
48777024|NCT03214666|102244188|FG000|NOT COMPLETED|Cohort 2: Dose Level 2: 10ug/kg/Day||0||
48777025|NCT03214666|102244189|FG001|NOT COMPLETED|Cohort 2: Dose Level 2: 10ug/kg/Day||0||
48777026|NCT03214666|102244190|FG002|NOT COMPLETED|Cohort 2: Dose Level 2: 10ug/kg/Day||0||
48777027|NCT03214666|102244191|FG003|NOT COMPLETED|Cohort 2: Dose Level 2: 10ug/kg/Day||0||
48777028|NCT03214666|102244192|FG004|NOT COMPLETED|Cohort 2: Dose Level 2: 10ug/kg/Day||0||
48777029|NCT03214666|102244193|FG005|NOT COMPLETED|Cohort 2: Dose Level 2: 10ug/kg/Day||0||
48777030|NCT03214666|102244188|FG000|STARTED|Cohort 3: Dose Level 3: 25 ug/kg/Day||0||
48777031|NCT03214666|102244189|FG001|STARTED|Cohort 3: Dose Level 3: 25 ug/kg/Day||0||
48777032|NCT03214666|102244190|FG002|STARTED|Cohort 3: Dose Level 3: 25 ug/kg/Day||2||
48777033|NCT03214666|102244191|FG003|STARTED|Cohort 3: Dose Level 3: 25 ug/kg/Day||0||
48777034|NCT03214666|102244192|FG004|STARTED|Cohort 3: Dose Level 3: 25 ug/kg/Day||0||
48777035|NCT03214666|102244193|FG005|STARTED|Cohort 3: Dose Level 3: 25 ug/kg/Day||0||
48777036|NCT03214666|102244188|FG000|COMPLETED|Cohort 3: Dose Level 3: 25 ug/kg/Day||0||
48777037|NCT03214666|102244189|FG001|COMPLETED|Cohort 3: Dose Level 3: 25 ug/kg/Day||0||
48777038|NCT03214666|102244190|FG002|COMPLETED|Cohort 3: Dose Level 3: 25 ug/kg/Day||2||
48777039|NCT03214666|102244191|FG003|COMPLETED|Cohort 3: Dose Level 3: 25 ug/kg/Day||0||
48777040|NCT03214666|102244192|FG004|COMPLETED|Cohort 3: Dose Level 3: 25 ug/kg/Day||0||
48777041|NCT03214666|102244193|FG005|COMPLETED|Cohort 3: Dose Level 3: 25 ug/kg/Day||0||
48777042|NCT03214666|102244188|FG000|NOT COMPLETED|Cohort 3: Dose Level 3: 25 ug/kg/Day||0||
48777043|NCT03214666|102244189|FG001|NOT COMPLETED|Cohort 3: Dose Level 3: 25 ug/kg/Day||0||
48777044|NCT03214666|102244190|FG002|NOT COMPLETED|Cohort 3: Dose Level 3: 25 ug/kg/Day||0||
48777045|NCT03214666|102244191|FG003|NOT COMPLETED|Cohort 3: Dose Level 3: 25 ug/kg/Day||0||
48777046|NCT03214666|102244192|FG004|NOT COMPLETED|Cohort 3: Dose Level 3: 25 ug/kg/Day||0||
48777047|NCT03214666|102244193|FG005|NOT COMPLETED|Cohort 3: Dose Level 3: 25 ug/kg/Day||0||
48777048|NCT03214666|102244188|FG000|STARTED|Cohort 4: Dose Level 4: 50 ug/kg/Day||0||
48189771|NCT02788656|100786305|FG001|COMPLETED|Overall Study||2||
48777049|NCT03214666|102244189|FG001|STARTED|Cohort 4: Dose Level 4: 50 ug/kg/Day||0||
48777050|NCT03214666|102244190|FG002|STARTED|Cohort 4: Dose Level 4: 50 ug/kg/Day||0||
48777051|NCT03214666|102244191|FG003|STARTED|Cohort 4: Dose Level 4: 50 ug/kg/Day||2||
48777052|NCT03214666|102244192|FG004|STARTED|Cohort 4: Dose Level 4: 50 ug/kg/Day||0||
48189772|NCT02788656|100786304|FG000|NOT COMPLETED|Overall Study||1||
48777053|NCT03214666|102244193|FG005|STARTED|Cohort 4: Dose Level 4: 50 ug/kg/Day||0||
48777054|NCT03214666|102244188|FG000|COMPLETED|Cohort 4: Dose Level 4: 50 ug/kg/Day||0||
48777055|NCT03214666|102244189|FG001|COMPLETED|Cohort 4: Dose Level 4: 50 ug/kg/Day||0||
48777056|NCT03214666|102244190|FG002|COMPLETED|Cohort 4: Dose Level 4: 50 ug/kg/Day||0||
48777057|NCT03214666|102244191|FG003|COMPLETED|Cohort 4: Dose Level 4: 50 ug/kg/Day||2||
48777058|NCT03214666|102244192|FG004|COMPLETED|Cohort 4: Dose Level 4: 50 ug/kg/Day||0||
48777059|NCT03214666|102244193|FG005|COMPLETED|Cohort 4: Dose Level 4: 50 ug/kg/Day||0||
48777060|NCT03214666|102244188|FG000|NOT COMPLETED|Cohort 4: Dose Level 4: 50 ug/kg/Day||0||
48777061|NCT03214666|102244189|FG001|NOT COMPLETED|Cohort 4: Dose Level 4: 50 ug/kg/Day||0||
48777062|NCT03214666|102244190|FG002|NOT COMPLETED|Cohort 4: Dose Level 4: 50 ug/kg/Day||0||
48777063|NCT03214666|102244191|FG003|NOT COMPLETED|Cohort 4: Dose Level 4: 50 ug/kg/Day||0||
48777064|NCT03214666|102244192|FG004|NOT COMPLETED|Cohort 4: Dose Level 4: 50 ug/kg/Day||0||
48777065|NCT03214666|102244193|FG005|NOT COMPLETED|Cohort 4: Dose Level 4: 50 ug/kg/Day||0||
48777066|NCT03214666|102244188|FG000|STARTED|Cohort 5: Dose Level 5: 100 ug/kg/Day||0||
48777067|NCT03214666|102244189|FG001|STARTED|Cohort 5: Dose Level 5: 100 ug/kg/Day||0||
48777068|NCT03214666|102244190|FG002|STARTED|Cohort 5: Dose Level 5: 100 ug/kg/Day||0||
48777069|NCT03214666|102244191|FG003|STARTED|Cohort 5: Dose Level 5: 100 ug/kg/Day||0||
48777070|NCT03214666|102244192|FG004|STARTED|Cohort 5: Dose Level 5: 100 ug/kg/Day||2||
48777071|NCT03214666|102244193|FG005|STARTED|Cohort 5: Dose Level 5: 100 ug/kg/Day||0||
48777072|NCT03214666|102244188|FG000|COMPLETED|Cohort 5: Dose Level 5: 100 ug/kg/Day||0||
48777073|NCT03214666|102244189|FG001|COMPLETED|Cohort 5: Dose Level 5: 100 ug/kg/Day||0||
48777074|NCT03214666|102244190|FG002|COMPLETED|Cohort 5: Dose Level 5: 100 ug/kg/Day||0||
48777075|NCT03214666|102244191|FG003|COMPLETED|Cohort 5: Dose Level 5: 100 ug/kg/Day||0||
48777076|NCT03214666|102244192|FG004|COMPLETED|Cohort 5: Dose Level 5: 100 ug/kg/Day||1||
48777077|NCT03214666|102244193|FG005|COMPLETED|Cohort 5: Dose Level 5: 100 ug/kg/Day||0||
48777078|NCT03214666|102244188|FG000|NOT COMPLETED|Cohort 5: Dose Level 5: 100 ug/kg/Day||0||
48777079|NCT03214666|102244189|FG001|NOT COMPLETED|Cohort 5: Dose Level 5: 100 ug/kg/Day||0||
48777080|NCT03214666|102244190|FG002|NOT COMPLETED|Cohort 5: Dose Level 5: 100 ug/kg/Day||0||
48777081|NCT03214666|102244191|FG003|NOT COMPLETED|Cohort 5: Dose Level 5: 100 ug/kg/Day||0||
48777082|NCT03214666|102244192|FG004|NOT COMPLETED|Cohort 5: Dose Level 5: 100 ug/kg/Day||1||
48777083|NCT03214666|102244193|FG005|NOT COMPLETED|Cohort 5: Dose Level 5: 100 ug/kg/Day||0||
48777084|NCT03214666|102244188|FG000|STARTED|Cohort 6: Dose Level 6: 150 ug/kg/Day||0||
48777085|NCT03214666|102244189|FG001|STARTED|Cohort 6: Dose Level 6: 150 ug/kg/Day||0||
48777086|NCT03214666|102244190|FG002|STARTED|Cohort 6: Dose Level 6: 150 ug/kg/Day||0||
48777087|NCT03214666|102244191|FG003|STARTED|Cohort 6: Dose Level 6: 150 ug/kg/Day||0||
48777088|NCT03214666|102244192|FG004|STARTED|Cohort 6: Dose Level 6: 150 ug/kg/Day||0||
48777089|NCT03214666|102244193|FG005|STARTED|Cohort 6: Dose Level 6: 150 ug/kg/Day||2||
48777090|NCT03214666|102244188|FG000|COMPLETED|Cohort 6: Dose Level 6: 150 ug/kg/Day||0||
48777091|NCT03214666|102244189|FG001|COMPLETED|Cohort 6: Dose Level 6: 150 ug/kg/Day||0||
48777092|NCT03214666|102244190|FG002|COMPLETED|Cohort 6: Dose Level 6: 150 ug/kg/Day||0||
48777093|NCT03214666|102244191|FG003|COMPLETED|Cohort 6: Dose Level 6: 150 ug/kg/Day||0||
48777094|NCT03214666|102244192|FG004|COMPLETED|Cohort 6: Dose Level 6: 150 ug/kg/Day||0||
48777095|NCT03214666|102244193|FG005|COMPLETED|Cohort 6: Dose Level 6: 150 ug/kg/Day||2||
48777096|NCT03214666|102244188|FG000|NOT COMPLETED|Cohort 6: Dose Level 6: 150 ug/kg/Day||0||
48777097|NCT03214666|102244189|FG001|NOT COMPLETED|Cohort 6: Dose Level 6: 150 ug/kg/Day||0||
48777098|NCT03214666|102244190|FG002|NOT COMPLETED|Cohort 6: Dose Level 6: 150 ug/kg/Day||0||
48777099|NCT03214666|102244191|FG003|NOT COMPLETED|Cohort 6: Dose Level 6: 150 ug/kg/Day||0||
48777100|NCT03214666|102244192|FG004|NOT COMPLETED|Cohort 6: Dose Level 6: 150 ug/kg/Day||0||
48777101|NCT03214666|102244193|FG005|NOT COMPLETED|Cohort 6: Dose Level 6: 150 ug/kg/Day||0||
48777102|NCT01136980|102244194|FG000|STARTED|Overall Study||42||
48777103|NCT01136980|102244195|FG001|STARTED|Overall Study||87||
48777104|NCT01136980|102244194|FG000|COMPLETED|Overall Study||28||
48777105|NCT01136980|102244195|FG001|COMPLETED|Overall Study||76||
48777106|NCT01136980|102244194|FG000|NOT COMPLETED|Overall Study||14||
48777107|NCT01136980|102244195|FG001|NOT COMPLETED|Overall Study||11||
48777108|NCT03134703|102244196|FG000|STARTED|Overall Study||6||
48777109|NCT03134703|102244197|FG001|STARTED|Overall Study||5||
48777110|NCT03134703|102244196|FG000|COMPLETED|Overall Study||0||
48777111|NCT03134703|102244197|FG001|COMPLETED|Overall Study||3||
48777112|NCT03134703|102244196|FG000|NOT COMPLETED|Overall Study||6||
48777113|NCT03134703|102244197|FG001|NOT COMPLETED|Overall Study||2||
48777114|NCT03500224|102244198|FG000|STARTED|Overall Study||6||
48777115|NCT03500224|102244198|FG000|COMPLETED|Overall Study||4||
48777116|NCT03500224|102244198|FG000|NOT COMPLETED|Overall Study||2||
48777117|NCT00268853|102244199|FG000|STARTED|Overall Study||61||
48777118|NCT00268853|102244200|FG001|STARTED|Overall Study||63||
48777119|NCT00268853|102244199|FG000|COMPLETED|Overall Study||45||
48777120|NCT00268853|102244200|FG001|COMPLETED|Overall Study||44||
48777121|NCT00268853|102244199|FG000|NOT COMPLETED|Overall Study||16||
48777122|NCT00268853|102244200|FG001|NOT COMPLETED|Overall Study||19||
48777123|NCT00746512|102244201|FG000|STARTED|Overall Study||8||
48777124|NCT00746512|102244202|FG001|STARTED|Overall Study||10||
48777125|NCT00746512|102244203|FG002|STARTED|Overall Study||18||
48777126|NCT00746512|102244204|FG003|STARTED|Overall Study||9||
48777127|NCT00746512|102244201|FG000|COMPLETED|Overall Study||8||
48777128|NCT00746512|102244202|FG001|COMPLETED|Overall Study||10||
48777129|NCT00746512|102244203|FG002|COMPLETED|Overall Study||18||
48777130|NCT00746512|102244204|FG003|COMPLETED|Overall Study||9||
48777131|NCT00746512|102244201|FG000|NOT COMPLETED|Overall Study||0||
48777132|NCT00746512|102244202|FG001|NOT COMPLETED|Overall Study||0||
48777133|NCT00746512|102244203|FG002|NOT COMPLETED|Overall Study||0||
48777134|NCT00746512|102244204|FG003|NOT COMPLETED|Overall Study||0||
48777135|NCT00706342|102244205|FG000|STARTED|Overall Study||18||
48777136|NCT00706342|102244205|FG000|COMPLETED|Overall Study||0||
48777137|NCT00706342|102244205|FG000|NOT COMPLETED|Overall Study||18||
48777138|NCT00643162|102244206|FG000|STARTED|Overall Study||7||
48777139|NCT00643162|102244207|FG001|STARTED|Overall Study||5||
48777140|NCT00643162|102244206|FG000|COMPLETED|Overall Study||6||
48462423|NCT01464827|101467500|FG008|COMPLETED|Overall Study||37||
48462424|NCT01464827|101467501|FG009|COMPLETED|Overall Study||44||
48462425|NCT01464827|101467502|FG010|COMPLETED|Overall Study||21||
48462426|NCT01464827|101467503|FG011|COMPLETED|Overall Study||21||
48462427|NCT01464827|101467504|FG012|COMPLETED|Overall Study||21||
48462428|NCT01464827|101467505|FG013|COMPLETED|Overall Study||19||
48664808|NCT00522379|101964653|FG004|COMPLETED|Overall Study||81||
48664809|NCT00522379|101964649|FG000|NOT COMPLETED|Overall Study||22||
48664810|NCT00522379|101964650|FG001|NOT COMPLETED|Overall Study||23||
48777141|NCT00643162|102244207|FG001|COMPLETED|Overall Study||4||
48777142|NCT00643162|102244206|FG000|NOT COMPLETED|Overall Study||1||
48777143|NCT00643162|102244207|FG001|NOT COMPLETED|Overall Study||1||
48777144|NCT00773604|102244208|FG000|STARTED|Overall Study||9||
48777145|NCT00773604|102244208|FG000|COMPLETED|Overall Study||9||
48777146|NCT00773604|102244208|FG000|NOT COMPLETED|Overall Study||0||
48462429|NCT01464827|101467492|FG000|NOT COMPLETED|Overall Study||3||
48462430|NCT01464827|101467493|FG001|NOT COMPLETED|Overall Study||7||
48462431|NCT01464827|101467494|FG002|NOT COMPLETED|Overall Study||0||
48462432|NCT01464827|101467495|FG003|NOT COMPLETED|Overall Study||4||
48462433|NCT01464827|101467496|FG004|NOT COMPLETED|Overall Study||8||
48462434|NCT01464827|101467497|FG005|NOT COMPLETED|Overall Study||1||
48462435|NCT01464827|101467498|FG006|NOT COMPLETED|Overall Study||4||
48462436|NCT01464827|101467499|FG007|NOT COMPLETED|Overall Study||3||
48462437|NCT01464827|101467500|FG008|NOT COMPLETED|Overall Study||3||
48462438|NCT01464827|101467501|FG009|NOT COMPLETED|Overall Study||3||
48462439|NCT01464827|101467502|FG010|NOT COMPLETED|Overall Study||2||
48462440|NCT01464827|101467503|FG011|NOT COMPLETED|Overall Study||2||
48462441|NCT01464827|101467504|FG012|NOT COMPLETED|Overall Study||2||
48462442|NCT01464827|101467505|FG013|NOT COMPLETED|Overall Study||3||
48462443|NCT04634409|101467506|FG000|STARTED|Overall Study||155||
48462444|NCT04634409|101467507|FG001|STARTED|Overall Study||83||
48462445|NCT04634409|101467508|FG002|STARTED|Overall Study||158||
48462446|NCT04634409|101467509|FG003|STARTED|Overall Study||103||
48664811|NCT00522379|101964651|FG002|NOT COMPLETED|Overall Study||22||
48664812|NCT00522379|101964652|FG003|NOT COMPLETED|Overall Study||14||
48664813|NCT00522379|101964653|FG004|NOT COMPLETED|Overall Study||27||
48664814|NCT05810597|101964654|FG000|STARTED|Period 1||34||
48664815|NCT05810597|101964655|FG001|STARTED|Period 1||31||
48664816|NCT05810597|101964654|FG000|Received At Least 1 Dose of Study Drug|Period 1||34||
48664817|NCT05810597|101964655|FG001|Received At Least 1 Dose of Study Drug|Period 1||31||
48664818|NCT05810597|101964654|FG000|COMPLETED|Period 1||31||
48664819|NCT05810597|101964655|FG001|COMPLETED|Period 1||31||
48664820|NCT05810597|101964654|FG000|NOT COMPLETED|Period 1||3||
48664821|NCT05810597|101964655|FG001|NOT COMPLETED|Period 1||0||
48664822|NCT05810597|101964654|FG000|STARTED|Period 2||31||
48664823|NCT05810597|101964655|FG001|STARTED|Period 2||31||
48664824|NCT05810597|101964654|FG000|Received At Least 1 Dose of Study Drug|Period 2||31||
48664825|NCT05810597|101964655|FG001|Received At Least 1 Dose of Study Drug|Period 2||31||
48664826|NCT05810597|101964654|FG000|COMPLETED|Period 2||31||
48664827|NCT05810597|101964655|FG001|COMPLETED|Period 2||31||
48664828|NCT05810597|101964654|FG000|NOT COMPLETED|Period 2||0||
48664829|NCT05810597|101964655|FG001|NOT COMPLETED|Period 2||0||
48664830|NCT05360784|101964656|FG000|STARTED|Overall Study||190||
48777147|NCT00947882|102244209|FG000|STARTED|Overall Study||100||
48777148|NCT00947882|102244210|FG001|STARTED|Overall Study||101||
48777149|NCT00947882|102244211|FG002|STARTED|Overall Study||101||
48777150|NCT00947882|102244212|FG003|STARTED|Overall Study||102||
48462447|NCT04634409|101467510|FG004|STARTED|Overall Study||105||
48777151|NCT00947882|102244209|FG000|Full Analysis Set (FAS)|Overall Study||100||
48462448|NCT04634409|101467511|FG005|STARTED|Overall Study||101||
48664831|NCT05360784|101964657|FG001|STARTED|Overall Study||190||
48664832|NCT05360784|101964656|FG000|COMPLETED|Overall Study||165||
48777152|NCT00947882|102244210|FG001|Full Analysis Set (FAS)|Overall Study||101||
48777153|NCT00947882|102244211|FG002|Full Analysis Set (FAS)|Overall Study||100||
48664833|NCT05360784|101964657|FG001|COMPLETED|Overall Study||179||
48664834|NCT05360784|101964656|FG000|NOT COMPLETED|Overall Study||25||
48664835|NCT05360784|101964657|FG001|NOT COMPLETED|Overall Study||11||
48664836|NCT03462745|101964658|FG000|STARTED|Overall Study||92||
48777154|NCT00947882|102244212|FG003|Full Analysis Set (FAS)|Overall Study||102||
48777155|NCT00947882|102244209|FG000|Actual Treatment|Overall Study||98||
48777156|NCT00947882|102244210|FG001|Actual Treatment|Overall Study||101||
48777157|NCT00947882|102244211|FG002|Actual Treatment|Overall Study||100||
48777158|NCT00947882|102244212|FG003|Actual Treatment|Overall Study||105||
48777159|NCT00947882|102244209|FG000|Safety Analysis Set|Overall Study||98||
48777160|NCT00947882|102244210|FG001|Safety Analysis Set|Overall Study||101||
48777161|NCT00947882|102244211|FG002|Safety Analysis Set|Overall Study||100||
48777162|NCT00947882|102244212|FG003|Safety Analysis Set|Overall Study||105||
48777163|NCT00947882|102244209|FG000|Visit 12, Month 6|Overall Study||93||
48777164|NCT00947882|102244210|FG001|Visit 12, Month 6|Overall Study||91||
48777165|NCT00947882|102244211|FG002|Visit 12, Month 6|Overall Study||90||
48777166|NCT00947882|102244212|FG003|Visit 12, Month 6|Overall Study||95||
48777167|NCT00947882|102244209|FG000|COMPLETED|Overall Study||26||
48777168|NCT00947882|102244210|FG001|COMPLETED|Overall Study||24||
48777169|NCT00947882|102244211|FG002|COMPLETED|Overall Study||22||
48777170|NCT00947882|102244212|FG003|COMPLETED|Overall Study||20||
48777171|NCT00947882|102244209|FG000|NOT COMPLETED|Overall Study||74||
48777172|NCT00947882|102244210|FG001|NOT COMPLETED|Overall Study||77||
48777173|NCT00947882|102244211|FG002|NOT COMPLETED|Overall Study||79||
48777174|NCT00947882|102244212|FG003|NOT COMPLETED|Overall Study||82||
48777175|NCT03436290|102244213|FG000|STARTED|Overall Study||118||
48777176|NCT03436290|102244214|FG001|STARTED|Overall Study||118||
48777177|NCT03436290|102244213|FG000|COMPLETED|Overall Study||77||
48777178|NCT03436290|102244214|FG001|COMPLETED|Overall Study||118||
48777179|NCT03436290|102244213|FG000|NOT COMPLETED|Overall Study||41||
48777180|NCT03436290|102244214|FG001|NOT COMPLETED|Overall Study||0||
48777181|NCT01317277|102244215|FG000|STARTED|Overall Study||50||
48777182|NCT01317277|102244216|FG001|STARTED|Overall Study||25||
48777183|NCT01317277|102244215|FG000|COMPLETED|Overall Study||43||
48777184|NCT01317277|102244216|FG001|COMPLETED|Overall Study||23||
48777185|NCT01317277|102244215|FG000|NOT COMPLETED|Overall Study||7||
48777186|NCT01317277|102244216|FG001|NOT COMPLETED|Overall Study||2||
48777187|NCT01319552|102244217|FG000|STARTED|Overall Study||14||
48777188|NCT01319552|102244217|FG000|COMPLETED|Overall Study||14||
48777189|NCT01319552|102244217|FG000|NOT COMPLETED|Overall Study||0||
48777190|NCT02624986|102244218|FG000|STARTED|Overall Study||2|Intent-to-Treat (ITT) Population|
48777191|NCT02624986|102244219|FG001|STARTED|Overall Study||3|Intent-to-Treat (ITT) Population|
48777192|NCT02624986|102244220|FG002|STARTED|Overall Study||2|Intent-to-Treat (ITT) Population|
48777193|NCT02624986|102244221|FG003|STARTED|Overall Study||3|Intent-to-Treat (ITT) Population|
48777194|NCT02624986|102244222|FG004|STARTED|Overall Study||4|Intent-to-Treat (ITT) Population|
48777195|NCT02624986|102244223|FG005|STARTED|Overall Study||2|Intent-to-Treat (ITT) Population|
48777196|NCT02624986|102244224|FG006|STARTED|Overall Study||4|Intent-to-Treat (ITT) Population|
48777197|NCT02624986|102244225|FG007|STARTED|Overall Study||5|Intent-to-Treat (ITT) Population|
48777198|NCT02624986|102244218|FG000|Received Any Study Treatment|Overall Study||1|Safety Population|
48777199|NCT02624986|102244219|FG001|Received Any Study Treatment|Overall Study||3|Safety Population|
48777200|NCT02624986|102244220|FG002|Received Any Study Treatment|Overall Study||2|Safety Population|
48777201|NCT02624986|102244221|FG003|Received Any Study Treatment|Overall Study||3|Safety Population|
48777202|NCT02624986|102244222|FG004|Received Any Study Treatment|Overall Study||4|Safety Population|
48777203|NCT02624986|102244223|FG005|Received Any Study Treatment|Overall Study||2|Safety Population|
48777204|NCT02624986|102244224|FG006|Received Any Study Treatment|Overall Study||4|Safety Population|
48777205|NCT02624986|102244225|FG007|Received Any Study Treatment|Overall Study||5|Safety Population|
48777206|NCT02624986|102244218|FG000|COMPLETED|Overall Study||0||
48777207|NCT02624986|102244219|FG001|COMPLETED|Overall Study||0||
48777208|NCT02624986|102244220|FG002|COMPLETED|Overall Study||0||
48777209|NCT02624986|102244221|FG003|COMPLETED|Overall Study||0||
48777210|NCT02624986|102244222|FG004|COMPLETED|Overall Study||0||
48189773|NCT02788656|100786305|FG001|NOT COMPLETED|Overall Study||0||
48189774|NCT02633891|100786306|FG000|STARTED|Overall Study||7||
48189775|NCT02633891|100786307|FG001|STARTED|Overall Study||5||
48189776|NCT02633891|100786306|FG000|COMPLETED|Overall Study||5||
48189777|NCT02633891|100786307|FG001|COMPLETED|Overall Study||4||
48777211|NCT02624986|102244223|FG005|COMPLETED|Overall Study||0||
48189778|NCT02633891|100786306|FG000|NOT COMPLETED|Overall Study||2||
48777212|NCT02624986|102244224|FG006|COMPLETED|Overall Study||0||
48777213|NCT02624986|102244225|FG007|COMPLETED|Overall Study||0||
48777214|NCT02624986|102244218|FG000|NOT COMPLETED|Overall Study||2||
48777215|NCT02624986|102244219|FG001|NOT COMPLETED|Overall Study||3||
48777216|NCT02624986|102244220|FG002|NOT COMPLETED|Overall Study||2||
48777217|NCT02624986|102244221|FG003|NOT COMPLETED|Overall Study||3||
48777218|NCT02624986|102244222|FG004|NOT COMPLETED|Overall Study||4||
48777219|NCT02624986|102244223|FG005|NOT COMPLETED|Overall Study||2||
48777220|NCT02624986|102244224|FG006|NOT COMPLETED|Overall Study||4||
48777221|NCT02624986|102244225|FG007|NOT COMPLETED|Overall Study||5||
48189779|NCT02633891|100786307|FG001|NOT COMPLETED|Overall Study||1||
48777222|NCT01742286|102244226|FG000|STARTED|Escalation Phase||5||
48189780|NCT00335556|100786308|FG000|STARTED|Overall Study||68||
48189781|NCT00335556|100786309|FG001|STARTED|Overall Study||98||
48189782|NCT00335556|100786310|FG002|STARTED|Overall Study||7||
48777223|NCT01742286|102244227|FG001|STARTED|Escalation Phase||12||
48777224|NCT01742286|102244228|FG002|STARTED|Escalation Phase||6||
48777225|NCT01742286|102244229|FG003|STARTED|Escalation Phase||2||
48777226|NCT01742286|102244230|FG004|STARTED|Escalation Phase||4||
48777227|NCT01742286|102244231|FG005|STARTED|Escalation Phase||5||
48462449|NCT04634409|101467512|FG006|STARTED|Overall Study||20||
48462450|NCT04634409|101467513|FG007|STARTED|Overall Study||101||
48462451|NCT04634409|101467514|FG008|STARTED|Overall Study||101||
48462452|NCT04634409|101467515|FG009|STARTED|Overall Study||125||
48462453|NCT04634409|101467516|FG010|STARTED|Overall Study||127||
48462454|NCT04634409|101467517|FG011|STARTED|Overall Study||128||
48462455|NCT04634409|101467518|FG012|STARTED|Overall Study||100||
48462456|NCT04634409|101467519|FG013|STARTED|Overall Study||50||
48462457|NCT04634409|101467520|FG014|STARTED|Overall Study||176||
48462458|NCT04634409|101467521|FG015|STARTED|Overall Study||30||
48462459|NCT04634409|101467522|FG016|STARTED|Overall Study||6||
48462460|NCT04634409|101467523|FG017|STARTED|Overall Study||30||
48462461|NCT04634409|101467524|FG018|STARTED|Overall Study||10||
48462462|NCT04634409|101467525|FG019|STARTED|Overall Study||6||
48462463|NCT04634409|101467526|FG020|STARTED|Overall Study||6||
48462464|NCT04634409|101467527|FG021|STARTED|Overall Study||6||
48462465|NCT04634409|101467528|FG022|STARTED|Overall Study||6||
48462466|NCT04634409|101467529|FG023|STARTED|Overall Study||6||
48462467|NCT04634409|101467530|FG024|STARTED|Overall Study||4||
48462468|NCT04634409|101467531|FG025|STARTED|Overall Study||6||
48462469|NCT04634409|101467532|FG026|STARTED|Overall Study||6||
48462470|NCT04634409|101467506|FG000|Received at Least One Dose of Study Drug|Overall Study||155||
48462471|NCT04634409|101467507|FG001|Received at Least One Dose of Study Drug|Overall Study||83||
48462472|NCT04634409|101467508|FG002|Received at Least One Dose of Study Drug|Overall Study||158||
48462473|NCT04634409|101467509|FG003|Received at Least One Dose of Study Drug|Overall Study||103||
48462474|NCT04634409|101467510|FG004|Received at Least One Dose of Study Drug|Overall Study||105||
48462475|NCT04634409|101467511|FG005|Received at Least One Dose of Study Drug|Overall Study||101||
48462476|NCT04634409|101467512|FG006|Received at Least One Dose of Study Drug|Overall Study||20||
48462477|NCT04634409|101467513|FG007|Received at Least One Dose of Study Drug|Overall Study||101||
48462478|NCT04634409|101467514|FG008|Received at Least One Dose of Study Drug|Overall Study||101||
48462479|NCT04634409|101467515|FG009|Received at Least One Dose of Study Drug|Overall Study||125||
48462480|NCT04634409|101467516|FG010|Received at Least One Dose of Study Drug|Overall Study||127||
48462481|NCT04634409|101467517|FG011|Received at Least One Dose of Study Drug|Overall Study||128||
48462482|NCT04634409|101467518|FG012|Received at Least One Dose of Study Drug|Overall Study||100||
48462483|NCT04634409|101467519|FG013|Received at Least One Dose of Study Drug|Overall Study||50||
48462484|NCT04634409|101467520|FG014|Received at Least One Dose of Study Drug|Overall Study||176||
48462485|NCT04634409|101467521|FG015|Received at Least One Dose of Study Drug|Overall Study||30||
48462486|NCT04634409|101467522|FG016|Received at Least One Dose of Study Drug|Overall Study||6||
48462487|NCT04634409|101467523|FG017|Received at Least One Dose of Study Drug|Overall Study||30||
48462488|NCT04634409|101467524|FG018|Received at Least One Dose of Study Drug|Overall Study||10||
48462489|NCT04634409|101467525|FG019|Received at Least One Dose of Study Drug|Overall Study||6||
48462490|NCT04634409|101467526|FG020|Received at Least One Dose of Study Drug|Overall Study||6||
48462491|NCT04634409|101467527|FG021|Received at Least One Dose of Study Drug|Overall Study||6||
48462492|NCT04634409|101467528|FG022|Received at Least One Dose of Study Drug|Overall Study||6||
48462493|NCT04634409|101467529|FG023|Received at Least One Dose of Study Drug|Overall Study||6||
48462494|NCT04634409|101467530|FG024|Received at Least One Dose of Study Drug|Overall Study||4||
48462495|NCT04634409|101467531|FG025|Received at Least One Dose of Study Drug|Overall Study||6||
48462496|NCT04634409|101467532|FG026|Received at Least One Dose of Study Drug|Overall Study||6||
48462497|NCT04634409|101467506|FG000|COMPLETED|Overall Study||148||
48462498|NCT04634409|101467507|FG001|COMPLETED|Overall Study||81||
48462499|NCT04634409|101467508|FG002|COMPLETED|Overall Study||150||
48462500|NCT04634409|101467509|FG003|COMPLETED|Overall Study||96||
48462501|NCT04634409|101467510|FG004|COMPLETED|Overall Study||102||
48462502|NCT04634409|101467511|FG005|COMPLETED|Overall Study||99||
48462503|NCT04634409|101467512|FG006|COMPLETED|Overall Study||19||
48462504|NCT04634409|101467513|FG007|COMPLETED|Overall Study||90||
48462505|NCT04634409|101467514|FG008|COMPLETED|Overall Study||91||
48462506|NCT04634409|101467515|FG009|COMPLETED|Overall Study||112||
48777228|NCT01742286|102244232|FG006|STARTED|Escalation Phase||6||
48777229|NCT01742286|102244226|FG000|Ended Treatment = Not Completed)|Escalation Phase||5||
48777230|NCT01742286|102244227|FG001|Ended Treatment = Not Completed)|Escalation Phase||12||
48462507|NCT04634409|101467516|FG010|COMPLETED|Overall Study||114||
48462508|NCT04634409|101467517|FG011|COMPLETED|Overall Study||109||
48462509|NCT04634409|101467518|FG012|COMPLETED|Overall Study||92||
48462510|NCT04634409|101467519|FG013|COMPLETED|Overall Study||46||
48462511|NCT04634409|101467520|FG014|COMPLETED|Overall Study||164||
48462512|NCT04634409|101467521|FG015|COMPLETED|Overall Study||30||
48462513|NCT04634409|101467522|FG016|COMPLETED|Overall Study||6||
48462514|NCT04634409|101467523|FG017|COMPLETED|Overall Study||29||
48462515|NCT04634409|101467524|FG018|COMPLETED|Overall Study||10||
48777231|NCT01742286|102244228|FG002|Ended Treatment = Not Completed)|Escalation Phase||6||
48777232|NCT01742286|102244229|FG003|Ended Treatment = Not Completed)|Escalation Phase||2||
48462516|NCT04634409|101467525|FG019|COMPLETED|Overall Study||6||
48777233|NCT01742286|102244230|FG004|Ended Treatment = Not Completed)|Escalation Phase||4||
48777234|NCT01742286|102244231|FG005|Ended Treatment = Not Completed)|Escalation Phase||5||
48777235|NCT01742286|102244232|FG006|Ended Treatment = Not Completed)|Escalation Phase||6||
48777236|NCT01742286|102244226|FG000|COMPLETED|Escalation Phase||0||
48777237|NCT01742286|102244227|FG001|COMPLETED|Escalation Phase||0||
48777238|NCT01742286|102244228|FG002|COMPLETED|Escalation Phase||0||
48777239|NCT01742286|102244229|FG003|COMPLETED|Escalation Phase||0||
48777240|NCT01742286|102244230|FG004|COMPLETED|Escalation Phase||0||
48777241|NCT01742286|102244231|FG005|COMPLETED|Escalation Phase||0||
48777242|NCT01742286|102244232|FG006|COMPLETED|Escalation Phase||0||
48777243|NCT01742286|102244226|FG000|NOT COMPLETED|Escalation Phase||5||
48777244|NCT01742286|102244227|FG001|NOT COMPLETED|Escalation Phase||12||
48777245|NCT01742286|102244228|FG002|NOT COMPLETED|Escalation Phase||6||
48777246|NCT01742286|102244229|FG003|NOT COMPLETED|Escalation Phase||2||
48777247|NCT01742286|102244230|FG004|NOT COMPLETED|Escalation Phase||4||
48777248|NCT01742286|102244231|FG005|NOT COMPLETED|Escalation Phase||5||
48777249|NCT01742286|102244232|FG006|NOT COMPLETED|Escalation Phase||6||
48777250|NCT01742286|102244226|FG000|STARTED|Expansion Phase||0||
48777251|NCT01742286|102244227|FG001|STARTED|Expansion Phase||0||
48777252|NCT01742286|102244228|FG002|STARTED|Expansion Phase||7||
48777253|NCT01742286|102244229|FG003|STARTED|Expansion Phase||0||
48777254|NCT01742286|102244230|FG004|STARTED|Expansion Phase||0||
48777255|NCT01742286|102244231|FG005|STARTED|Expansion Phase||0||
48777256|NCT01742286|102244232|FG006|STARTED|Expansion Phase||36||
48777257|NCT01742286|102244226|FG000|End of Treatment = Not Ccompleted|Expansion Phase||0||
48777258|NCT01742286|102244227|FG001|End of Treatment = Not Ccompleted|Expansion Phase||0||
48777259|NCT01742286|102244228|FG002|End of Treatment = Not Ccompleted|Expansion Phase||7||
48777260|NCT01742286|102244229|FG003|End of Treatment = Not Ccompleted|Expansion Phase||0||
48777261|NCT01742286|102244230|FG004|End of Treatment = Not Ccompleted|Expansion Phase||0||
48777262|NCT01742286|102244231|FG005|End of Treatment = Not Ccompleted|Expansion Phase||0||
48777263|NCT01742286|102244232|FG006|End of Treatment = Not Ccompleted|Expansion Phase||36||
48777264|NCT01742286|102244226|FG000|COMPLETED|Expansion Phase||0||
48777265|NCT01742286|102244227|FG001|COMPLETED|Expansion Phase||0||
48777266|NCT01742286|102244228|FG002|COMPLETED|Expansion Phase||0||
48777267|NCT01742286|102244229|FG003|COMPLETED|Expansion Phase||0||
48777268|NCT01742286|102244230|FG004|COMPLETED|Expansion Phase||0||
48777269|NCT01742286|102244231|FG005|COMPLETED|Expansion Phase||0||
48777270|NCT01742286|102244232|FG006|COMPLETED|Expansion Phase||0||
48777271|NCT01742286|102244226|FG000|NOT COMPLETED|Expansion Phase||0||
48777272|NCT01742286|102244227|FG001|NOT COMPLETED|Expansion Phase||0||
48777273|NCT01742286|102244228|FG002|NOT COMPLETED|Expansion Phase||7||
48777274|NCT01742286|102244229|FG003|NOT COMPLETED|Expansion Phase||0||
48777275|NCT01742286|102244230|FG004|NOT COMPLETED|Expansion Phase||0||
48777276|NCT01742286|102244231|FG005|NOT COMPLETED|Expansion Phase||0||
48777277|NCT01742286|102244232|FG006|NOT COMPLETED|Expansion Phase||36||
48777278|NCT00787618|102244233|FG000|STARTED|Overall Study||3||
48777279|NCT00787618|102244234|FG001|STARTED|Overall Study||0||
48777280|NCT00787618|102244235|FG002|STARTED|Overall Study||3||
48777281|NCT00787618|102244233|FG000|COMPLETED|Overall Study||3||
48777282|NCT00787618|102244234|FG001|COMPLETED|Overall Study||0||
48777283|NCT00787618|102244235|FG002|COMPLETED|Overall Study||3||
48777284|NCT00787618|102244233|FG000|NOT COMPLETED|Overall Study||0||
48777285|NCT00787618|102244234|FG001|NOT COMPLETED|Overall Study||0||
48777286|NCT00787618|102244235|FG002|NOT COMPLETED|Overall Study||0||
48777287|NCT01243580|102244236|FG000|STARTED|Overall Study||18||
48777288|NCT01243580|102244237|FG001|STARTED|Overall Study||18||
48777289|NCT01243580|102244236|FG000|COMPLETED|Overall Study||18||
48777290|NCT01243580|102244237|FG001|COMPLETED|Overall Study||16||
48777291|NCT01243580|102244236|FG000|NOT COMPLETED|Overall Study||0||
48777292|NCT01243580|102244237|FG001|NOT COMPLETED|Overall Study||2||
48777293|NCT00635999|102244238|FG000|STARTED|Overall Study||27||
48777294|NCT00635999|102244239|FG001|STARTED|Overall Study||25||
48777295|NCT00635999|102244240|FG002|STARTED|Overall Study||24||
48777296|NCT00635999|102244238|FG000|COMPLETED|Overall Study||23||
48777297|NCT00635999|102244239|FG001|COMPLETED|Overall Study||23||
48777298|NCT00635999|102244240|FG002|COMPLETED|Overall Study||23||
48777299|NCT00635999|102244238|FG000|NOT COMPLETED|Overall Study||4||
48777300|NCT00635999|102244239|FG001|NOT COMPLETED|Overall Study||2||
48777301|NCT00635999|102244240|FG002|NOT COMPLETED|Overall Study||1||
48777302|NCT04803396|102244241|FG000|STARTED|Overall Study||8||
48777303|NCT04803396|102244242|FG001|STARTED|Overall Study||6||
48777304|NCT04803396|102244243|FG002|STARTED|Overall Study||6||
48777305|NCT04803396|102244244|FG003|STARTED|Overall Study||6||
48777306|NCT04803396|102244245|FG004|STARTED|Overall Study||6||
48777307|NCT04803396|102244241|FG000|COMPLETED|Overall Study||8||
48777308|NCT04803396|102244242|FG001|COMPLETED|Overall Study||6||
48777309|NCT04803396|102244243|FG002|COMPLETED|Overall Study||6||
48777310|NCT04803396|102244244|FG003|COMPLETED|Overall Study||6||
48777311|NCT04803396|102244245|FG004|COMPLETED|Overall Study||6||
48777312|NCT04803396|102244241|FG000|NOT COMPLETED|Overall Study||0||
48777313|NCT04803396|102244242|FG001|NOT COMPLETED|Overall Study||0||
48777314|NCT04803396|102244243|FG002|NOT COMPLETED|Overall Study||0||
48777315|NCT04803396|102244244|FG003|NOT COMPLETED|Overall Study||0||
48777316|NCT04803396|102244245|FG004|NOT COMPLETED|Overall Study||0||
48777317|NCT05366738|102244246|FG000|STARTED|Overall Study||9||
48777318|NCT05366738|102244247|FG001|STARTED|Overall Study||9||
48777319|NCT05366738|102244248|FG002|STARTED|Overall Study||9||
48777320|NCT05366738|102244246|FG000|Completed Treatment A (Vonoprazan 20 mg Sprinkle Capsule on Pudding)|Overall Study||9||
48777321|NCT05366738|102244247|FG001|Completed Treatment A (Vonoprazan 20 mg Sprinkle Capsule on Pudding)|Overall Study||8||
48777322|NCT05366738|102244248|FG002|Completed Treatment A (Vonoprazan 20 mg Sprinkle Capsule on Pudding)|Overall Study||9||
48777323|NCT05366738|102244246|FG000|Completed Treatment B (Vonoprazan 20 mg Sprinkle Capsule on Applesauce)|Overall Study||9||
48777324|NCT05366738|102244247|FG001|Completed Treatment B (Vonoprazan 20 mg Sprinkle Capsule on Applesauce)|Overall Study||8||
48777325|NCT05366738|102244248|FG002|Completed Treatment B (Vonoprazan 20 mg Sprinkle Capsule on Applesauce)|Overall Study||9||
48777326|NCT05366738|102244246|FG000|Completed Treatment C (Vonoprazan 20 mg Tablet)|Overall Study||9||
48777327|NCT05366738|102244247|FG001|Completed Treatment C (Vonoprazan 20 mg Tablet)|Overall Study||9||
48777328|NCT05366738|102244248|FG002|Completed Treatment C (Vonoprazan 20 mg Tablet)|Overall Study||9||
48777329|NCT05366738|102244246|FG000|COMPLETED|Overall Study||9||
48777330|NCT05366738|102244247|FG001|COMPLETED|Overall Study||8||
48777331|NCT05366738|102244248|FG002|COMPLETED|Overall Study||9||
48777332|NCT05366738|102244246|FG000|NOT COMPLETED|Overall Study||0||
48777333|NCT05366738|102244247|FG001|NOT COMPLETED|Overall Study||1||
48777334|NCT05366738|102244248|FG002|NOT COMPLETED|Overall Study||0||
48777335|NCT02914301|102244249|FG000|STARTED|Overall Study||60||
48777336|NCT02914301|102244250|FG001|STARTED|Overall Study||58||
48777337|NCT02914301|102244249|FG000|COMPLETED|Overall Study||47||
48777338|NCT02914301|102244250|FG001|COMPLETED|Overall Study||41||
48777339|NCT02914301|102244249|FG000|NOT COMPLETED|Overall Study||13||
48777340|NCT02914301|102244250|FG001|NOT COMPLETED|Overall Study||17||
48777341|NCT01063283|102244251|FG000|STARTED|Cycle 1||20||
48777342|NCT01063283|102244252|FG001|STARTED|Cycle 1||0||
48777343|NCT01063283|102244253|FG002|STARTED|Cycle 1||0||
48777344|NCT01063283|102244251|FG000|COMPLETED|Cycle 1||17||
48777345|NCT01063283|102244252|FG001|COMPLETED|Cycle 1||0||
48777346|NCT01063283|102244253|FG002|COMPLETED|Cycle 1||0||
48777347|NCT01063283|102244251|FG000|NOT COMPLETED|Cycle 1||3||
48777348|NCT01063283|102244252|FG001|NOT COMPLETED|Cycle 1||0||
48777349|NCT01063283|102244253|FG002|NOT COMPLETED|Cycle 1||0||
48777350|NCT01063283|102244251|FG000|STARTED|Randomized Phase (Cycle 2 and Beyond)||0||
48777351|NCT01063283|102244252|FG001|STARTED|Randomized Phase (Cycle 2 and Beyond)||6||
48777352|NCT01063283|102244253|FG002|STARTED|Randomized Phase (Cycle 2 and Beyond)||11||
48777353|NCT01063283|102244251|FG000|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0||
48777354|NCT01063283|102244252|FG001|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||6||
48777355|NCT01063283|102244253|FG002|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||11||
48777356|NCT01063283|102244251|FG000|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0||
48777357|NCT01063283|102244252|FG001|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0||
48777358|NCT01063283|102244253|FG002|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0||
48777359|NCT00539864|102244254|FG000|STARTED|Overall Study||300||
48777360|NCT00539864|102244255|FG001|STARTED|Overall Study||302||
48777361|NCT00539864|102244254|FG000|COMPLETED|Overall Study||299||
48777362|NCT00539864|102244255|FG001|COMPLETED|Overall Study||300||
48777363|NCT00539864|102244254|FG000|NOT COMPLETED|Overall Study||1||
48777364|NCT00539864|102244255|FG001|NOT COMPLETED|Overall Study||2||
48777365|NCT02685267|102244256|FG000|STARTED|Overall Study||5||
48777366|NCT02685267|102244257|FG001|STARTED|Overall Study||4||
48777367|NCT02685267|102244256|FG000|COMPLETED|Overall Study||5||
48777368|NCT02685267|102244257|FG001|COMPLETED|Overall Study||4||
48777369|NCT02685267|102244256|FG000|NOT COMPLETED|Overall Study||0||
48777370|NCT02685267|102244257|FG001|NOT COMPLETED|Overall Study||0||
48777371|NCT01069900|102244258|FG000|STARTED|Overall Study||305||
48777372|NCT01069900|102244259|FG001|STARTED|Overall Study||153||
48777373|NCT01069900|102244258|FG000|Treated|Overall Study||301||
48777374|NCT01069900|102244259|FG001|Treated|Overall Study||150||
48777375|NCT01069900|102244258|FG000|COMPLETED|Overall Study||287||
48777376|NCT01069900|102244259|FG001|COMPLETED|Overall Study||149||
48777377|NCT01069900|102244258|FG000|NOT COMPLETED|Overall Study||18||
48777378|NCT01069900|102244259|FG001|NOT COMPLETED|Overall Study||4||
48777379|NCT03583385|102244260|FG000|STARTED|Treatment Period 1||24||
48777380|NCT03583385|102244261|FG001|STARTED|Treatment Period 1||24||
48777381|NCT03583385|102244260|FG000|COMPLETED|Treatment Period 1||23||
48777382|NCT03583385|102244261|FG001|COMPLETED|Treatment Period 1||23||
48777383|NCT03583385|102244260|FG000|NOT COMPLETED|Treatment Period 1||1||
48777384|NCT03583385|102244261|FG001|NOT COMPLETED|Treatment Period 1||1||
48777385|NCT03583385|102244260|FG000|STARTED|Treatment Period 2||22||
48777386|NCT03583385|102244261|FG001|STARTED|Treatment Period 2||23||
48777387|NCT03583385|102244260|FG000|COMPLETED|Treatment Period 2||21||
48189783|NCT00335556|100786311|FG003|STARTED|Overall Study||10||
48777388|NCT03583385|102244261|FG001|COMPLETED|Treatment Period 2||23||
48777389|NCT03583385|102244260|FG000|NOT COMPLETED|Treatment Period 2||1||
48777390|NCT03583385|102244261|FG001|NOT COMPLETED|Treatment Period 2||0||
48777391|NCT02446899|102244262|FG000|STARTED|Overall Study||181||
48777392|NCT02446899|102244263|FG001|STARTED|Overall Study||184||
48777393|NCT02446899|102244262|FG000|Received Study Drug|Overall Study||180||
48777394|NCT02446899|102244263|FG001|Received Study Drug|Overall Study||182||
48777395|NCT02446899|102244262|FG000|COMPLETED|Overall Study||156||
48777396|NCT02446899|102244263|FG001|COMPLETED|Overall Study||136||
48777397|NCT02446899|102244262|FG000|NOT COMPLETED|Overall Study||25||
48777398|NCT02446899|102244263|FG001|NOT COMPLETED|Overall Study||48||
48777399|NCT01026324|102244264|FG000|STARTED|Treatment Allocation||5||
48777400|NCT01026324|102244265|FG001|STARTED|Treatment Allocation||3||
48777401|NCT01026324|102244266|FG002|STARTED|Treatment Allocation||4||
48777402|NCT01026324|102244264|FG000|Discontinued Intervention (Toxicity)|Treatment Allocation||1||
48777403|NCT01026324|102244265|FG001|Discontinued Intervention (Toxicity)|Treatment Allocation||0||
48777404|NCT01026324|102244266|FG002|Discontinued Intervention (Toxicity)|Treatment Allocation||0||
48777405|NCT01026324|102244264|FG000|Discontinuted Intervention (Progression)|Treatment Allocation||3||
48777406|NCT01026324|102244265|FG001|Discontinuted Intervention (Progression)|Treatment Allocation||3||
48777407|NCT01026324|102244266|FG002|Discontinuted Intervention (Progression)|Treatment Allocation||4||
48777408|NCT01026324|102244264|FG000|Discontinued Intervention (Withdrew)|Treatment Allocation||1||
48777409|NCT01026324|102244265|FG001|Discontinued Intervention (Withdrew)|Treatment Allocation||0||
48777410|NCT01026324|102244266|FG002|Discontinued Intervention (Withdrew)|Treatment Allocation||0||
48777411|NCT01026324|102244264|FG000|COMPLETED|Treatment Allocation||5||
48777412|NCT01026324|102244265|FG001|COMPLETED|Treatment Allocation||3||
48777413|NCT01026324|102244266|FG002|COMPLETED|Treatment Allocation||4||
48777414|NCT01026324|102244264|FG000|NOT COMPLETED|Treatment Allocation||0||
48777415|NCT01026324|102244265|FG001|NOT COMPLETED|Treatment Allocation||0||
48777416|NCT01026324|102244266|FG002|NOT COMPLETED|Treatment Allocation||0||
48777417|NCT01026324|102244264|FG000|STARTED|Follow up/Survival||5||
48777418|NCT01026324|102244265|FG001|STARTED|Follow up/Survival||3||
48777419|NCT01026324|102244266|FG002|STARTED|Follow up/Survival||4||
48777420|NCT01026324|102244264|FG000|Follow up Discontinuation (Death)|Follow up/Survival||4||
48777421|NCT01026324|102244265|FG001|Follow up Discontinuation (Death)|Follow up/Survival||3||
48777422|NCT01026324|102244266|FG002|Follow up Discontinuation (Death)|Follow up/Survival||4||
48777423|NCT01026324|102244264|FG000|COMPLETED|Follow up/Survival||4||
48777424|NCT01026324|102244265|FG001|COMPLETED|Follow up/Survival||3||
48777425|NCT01026324|102244266|FG002|COMPLETED|Follow up/Survival||4||
48777426|NCT01026324|102244264|FG000|NOT COMPLETED|Follow up/Survival||1||
48777427|NCT01026324|102244265|FG001|NOT COMPLETED|Follow up/Survival||0||
48777428|NCT01026324|102244266|FG002|NOT COMPLETED|Follow up/Survival||0||
48777429|NCT01262820|102244267|FG000|STARTED|Overall Study||15||
48777430|NCT01262820|102244267|FG000|COMPLETED|Overall Study||0||
48777431|NCT01262820|102244267|FG000|NOT COMPLETED|Overall Study||15||
48777432|NCT03062540|102244268|FG000|STARTED|Overall Study||179||
48777433|NCT03062540|102244269|FG001|STARTED|Overall Study||179||
48777434|NCT03062540|102244268|FG000|COMPLETED|Overall Study||110||
48777435|NCT03062540|102244269|FG001|COMPLETED|Overall Study||120||
48777436|NCT03062540|102244268|FG000|NOT COMPLETED|Overall Study||69||
48777437|NCT03062540|102244269|FG001|NOT COMPLETED|Overall Study||59||
48777438|NCT00280748|102244270|FG000|STARTED|Overall Study||10||
48777439|NCT00280748|102244270|FG000|COMPLETED|Overall Study||6||
48777440|NCT00280748|102244270|FG000|NOT COMPLETED|Overall Study||4||
48777441|NCT00080899|102244271|FG000|STARTED|Overall Study||23||
48777442|NCT00080899|102244271|FG000|COMPLETED|Overall Study||22||
48777443|NCT00080899|102244271|FG000|NOT COMPLETED|Overall Study||1||
48777444|NCT03116152|102244272|FG000|STARTED|Overall Study||95||
48777445|NCT03116152|102244273|FG001|STARTED|Overall Study||95||
48777446|NCT03116152|102244272|FG000|Treated|Overall Study||94|The number of participants who were treated after randomization|
48777447|NCT03116152|102244273|FG001|Treated|Overall Study||87|The number of participants who were treated after randomization|
48777448|NCT03116152|102244272|FG000|COMPLETED|Overall Study||4||
48777449|NCT03116152|102244273|FG001|COMPLETED|Overall Study||0||
48777450|NCT03116152|102244272|FG000|NOT COMPLETED|Overall Study||91||
48777451|NCT03116152|102244273|FG001|NOT COMPLETED|Overall Study||95||
48777452|NCT02840799|102244274|FG000|STARTED|Phase 1||41||
48777453|NCT02840799|102244275|FG001|STARTED|Phase 1||43||
48777454|NCT02840799|102244274|FG000|COMPLETED|Phase 1||36||
48777455|NCT02840799|102244275|FG001|COMPLETED|Phase 1||40||
48777456|NCT02840799|102244274|FG000|NOT COMPLETED|Phase 1||5||
48777457|NCT02840799|102244275|FG001|NOT COMPLETED|Phase 1||3||
48777458|NCT02840799|102244274|FG000|STARTED|Phase 2 (Crossover)||41|Nine participants did not cross over due to dispensing error. The subjects received the same treatment that was originally dispensed during Period 1/Phase 1.|
48777459|NCT02840799|102244275|FG001|STARTED|Phase 2 (Crossover)||35|Nine participants did not cross over due to dispensing error. The subjects received the same treatment that was originally dispensed during Period 1/Phase 1.|
48777460|NCT02840799|102244274|FG000|COMPLETED|Phase 2 (Crossover)||41||
48777461|NCT02840799|102244275|FG001|COMPLETED|Phase 2 (Crossover)||33||
48777462|NCT02840799|102244274|FG000|NOT COMPLETED|Phase 2 (Crossover)||0||
48777463|NCT02840799|102244275|FG001|NOT COMPLETED|Phase 2 (Crossover)||2||
48777464|NCT01254760|102244276|FG000|STARTED|First Period, 5 Days of Wear||34||
48777465|NCT01254760|102244277|FG001|STARTED|First Period, 5 Days of Wear||38||
48777466|NCT01254760|102244276|FG000|COMPLETED|First Period, 5 Days of Wear||34||
48777467|NCT01254760|102244277|FG001|COMPLETED|First Period, 5 Days of Wear||38||
48777468|NCT01254760|102244276|FG000|NOT COMPLETED|First Period, 5 Days of Wear||0||
48777469|NCT01254760|102244277|FG001|NOT COMPLETED|First Period, 5 Days of Wear||0||
48777470|NCT01254760|102244276|FG000|STARTED|Second Period, 5 Days of Wear||34||
48777471|NCT01254760|102244277|FG001|STARTED|Second Period, 5 Days of Wear||38||
48777472|NCT01254760|102244276|FG000|COMPLETED|Second Period, 5 Days of Wear||34||
48777473|NCT01254760|102244277|FG001|COMPLETED|Second Period, 5 Days of Wear||38||
48777474|NCT01254760|102244276|FG000|NOT COMPLETED|Second Period, 5 Days of Wear||0||
48777475|NCT01254760|102244277|FG001|NOT COMPLETED|Second Period, 5 Days of Wear||0||
48777476|NCT01657019|102244278|FG000|STARTED|Overall Study||604||
48777477|NCT01657019|102244278|FG000|COMPLETED|Overall Study||369||
48777478|NCT01657019|102244278|FG000|NOT COMPLETED|Overall Study||235||
48777479|NCT00393861|102244279|FG000|STARTED|Overall Study||29||
48777480|NCT00393861|102244279|FG000|COMPLETED|Overall Study||3||
48777481|NCT00393861|102244279|FG000|NOT COMPLETED|Overall Study||26||
48777482|NCT01474018|102244280|FG000|STARTED|Overall Study||5||
48777483|NCT01474018|102244281|FG001|STARTED|Overall Study||10||
48777484|NCT01474018|102244280|FG000|COMPLETED|Overall Study||5||
48777485|NCT01474018|102244281|FG001|COMPLETED|Overall Study||7||
48777486|NCT01474018|102244280|FG000|NOT COMPLETED|Overall Study||0||
48777487|NCT01474018|102244281|FG001|NOT COMPLETED|Overall Study||3||
48777488|NCT05334212|102244282|FG000|STARTED|Overall Study||7||
48777489|NCT05334212|102244282|FG000|COMPLETED|Overall Study||0||
48777490|NCT05334212|102244282|FG000|NOT COMPLETED|Overall Study||7||
48777491|NCT00554216|102244283|FG000|STARTED|Overall Study||514||
48777492|NCT00554216|102244284|FG001|STARTED|Overall Study||241||
48777493|NCT00554216|102244285|FG002|STARTED|Overall Study||512||
48777494|NCT00554216|102244283|FG000|COMPLETED|Overall Study||272||
48777495|NCT00554216|102244284|FG001|COMPLETED|Overall Study||147||
48777496|NCT00554216|102244285|FG002|COMPLETED|Overall Study||340||
48777497|NCT00554216|102244283|FG000|NOT COMPLETED|Overall Study||242||
48777498|NCT00554216|102244284|FG001|NOT COMPLETED|Overall Study||94||
48777499|NCT00554216|102244285|FG002|NOT COMPLETED|Overall Study||172||
48777500|NCT00330967|102244286|FG000|STARTED|Overall Study||0||
48777501|NCT00330967|102244287|FG001|STARTED|Overall Study||25||
48777502|NCT00330967|102244286|FG000|COMPLETED|Overall Study||0||
48777503|NCT00330967|102244287|FG001|COMPLETED|Overall Study||11||
48777504|NCT00330967|102244286|FG000|NOT COMPLETED|Overall Study||0||
48777505|NCT00330967|102244287|FG001|NOT COMPLETED|Overall Study||14||
48777506|NCT01561313|102244288|FG000|STARTED|Overall Study||33||
48777507|NCT01561313|102244289|FG001|STARTED|Overall Study||31||
48777508|NCT01561313|102244288|FG000|COMPLETED|Overall Study||31||
48777509|NCT01561313|102244289|FG001|COMPLETED|Overall Study||31||
48777510|NCT01561313|102244288|FG000|NOT COMPLETED|Overall Study||2||
48777511|NCT01561313|102244289|FG001|NOT COMPLETED|Overall Study||0||
48777512|NCT01099449|102244290|FG000|STARTED|Overall Study||118|Nine patients were deemed ineligible or withdrew prior to randomization.|
48777513|NCT01099449|102244291|FG001|STARTED|Overall Study||119|Nine patients were deemed ineligible or withdrew prior to randomization.|
48777514|NCT01099449|102244292|FG002|STARTED|Overall Study||116|Nine patients were deemed ineligible or withdrew prior to randomization.|
48777515|NCT01099449|102244290|FG000|COMPLETED|Overall Study||118||
48777516|NCT01099449|102244291|FG001|COMPLETED|Overall Study||119||
48777517|NCT01099449|102244292|FG002|COMPLETED|Overall Study||116||
48777518|NCT01099449|102244290|FG000|NOT COMPLETED|Overall Study||0||
48777519|NCT01099449|102244291|FG001|NOT COMPLETED|Overall Study||0||
48777520|NCT01099449|102244292|FG002|NOT COMPLETED|Overall Study||0||
48777521|NCT00734539|102244293|FG000|STARTED|Main Study||189||
48777522|NCT00734539|102244294|FG001|STARTED|Main Study||173||
48777523|NCT00734539|102244293|FG000|COMPLETED|Main Study||152||
48777524|NCT00734539|102244294|FG001|COMPLETED|Main Study||138||
48777525|NCT00734539|102244293|FG000|NOT COMPLETED|Main Study||37||
48777526|NCT00734539|102244294|FG001|NOT COMPLETED|Main Study||35||
48777527|NCT00734539|102244293|FG000|STARTED|Long Term Follow up||152||
48777528|NCT00734539|102244294|FG001|STARTED|Long Term Follow up||138||
48777529|NCT00734539|102244293|FG000|COMPLETED|Long Term Follow up||118||
48777530|NCT00734539|102244294|FG001|COMPLETED|Long Term Follow up||107||
48777531|NCT00734539|102244293|FG000|NOT COMPLETED|Long Term Follow up||34||
48777532|NCT00734539|102244294|FG001|NOT COMPLETED|Long Term Follow up||31||
48777533|NCT03566485|102244295|FG000|STARTED|Overall Study||5||
48777534|NCT03566485|102244296|FG001|STARTED|Overall Study||7||
48777535|NCT03566485|102244295|FG000|COMPLETED|Overall Study||0||
48777536|NCT03566485|102244296|FG001|COMPLETED|Overall Study||0||
48777537|NCT03566485|102244295|FG000|NOT COMPLETED|Overall Study||5||
48462517|NCT04634409|101467526|FG020|COMPLETED|Overall Study||6||
48462518|NCT04634409|101467527|FG021|COMPLETED|Overall Study||6||
48462519|NCT04634409|101467528|FG022|COMPLETED|Overall Study||6||
48462520|NCT04634409|101467529|FG023|COMPLETED|Overall Study||5||
48462521|NCT04634409|101467530|FG024|COMPLETED|Overall Study||4||
48462522|NCT04634409|101467531|FG025|COMPLETED|Overall Study||6||
48462523|NCT04634409|101467532|FG026|COMPLETED|Overall Study||6||
48462524|NCT04634409|101467506|FG000|NOT COMPLETED|Overall Study||7||
48462525|NCT04634409|101467507|FG001|NOT COMPLETED|Overall Study||2||
48462526|NCT04634409|101467508|FG002|NOT COMPLETED|Overall Study||8||
48462527|NCT04634409|101467509|FG003|NOT COMPLETED|Overall Study||7||
48462528|NCT04634409|101467510|FG004|NOT COMPLETED|Overall Study||3||
48462529|NCT04634409|101467511|FG005|NOT COMPLETED|Overall Study||2||
48462530|NCT04634409|101467512|FG006|NOT COMPLETED|Overall Study||1||
48462531|NCT04634409|101467513|FG007|NOT COMPLETED|Overall Study||11||
48462532|NCT04634409|101467514|FG008|NOT COMPLETED|Overall Study||10||
48462533|NCT04634409|101467515|FG009|NOT COMPLETED|Overall Study||13||
48462534|NCT04634409|101467516|FG010|NOT COMPLETED|Overall Study||13||
48462535|NCT04634409|101467517|FG011|NOT COMPLETED|Overall Study||19||
48462536|NCT04634409|101467518|FG012|NOT COMPLETED|Overall Study||8||
48462537|NCT04634409|101467519|FG013|NOT COMPLETED|Overall Study||4||
48462538|NCT04634409|101467520|FG014|NOT COMPLETED|Overall Study||12||
48462539|NCT04634409|101467521|FG015|NOT COMPLETED|Overall Study||0||
48462540|NCT04634409|101467522|FG016|NOT COMPLETED|Overall Study||0||
48462541|NCT04634409|101467523|FG017|NOT COMPLETED|Overall Study||1||
48462542|NCT04634409|101467524|FG018|NOT COMPLETED|Overall Study||0||
48462543|NCT04634409|101467525|FG019|NOT COMPLETED|Overall Study||0||
48462544|NCT04634409|101467526|FG020|NOT COMPLETED|Overall Study||0||
48462545|NCT04634409|101467527|FG021|NOT COMPLETED|Overall Study||0||
48462546|NCT04634409|101467528|FG022|NOT COMPLETED|Overall Study||0||
48462547|NCT04634409|101467529|FG023|NOT COMPLETED|Overall Study||1||
48462548|NCT04634409|101467530|FG024|NOT COMPLETED|Overall Study||0||
48462549|NCT04634409|101467531|FG025|NOT COMPLETED|Overall Study||0||
48462550|NCT04634409|101467532|FG026|NOT COMPLETED|Overall Study||0||
48462551|NCT02231710|101467533|FG000|STARTED|Overall Study||1||
48462552|NCT02231710|101467533|FG000|COMPLETED|Overall Study||0||
48462553|NCT02231710|101467533|FG000|NOT COMPLETED|Overall Study||1||
48462554|NCT04049552|101467534|FG000|STARTED|Overall Study||4||8
48462555|NCT04049552|101467534|FG000|COMPLETED|Overall Study||3||6
48462556|NCT04049552|101467534|FG000|NOT COMPLETED|Overall Study||1||2
48462557|NCT02140164|101467535|FG000|STARTED|Overall Study||7||
48462558|NCT02140164|101467535|FG000|COMPLETED|Overall Study||5||
48462559|NCT02140164|101467535|FG000|NOT COMPLETED|Overall Study||2||
48462560|NCT01602614|101467536|FG000|STARTED|Overall Study||0||
48462561|NCT01602614|101467537|FG001|STARTED|Overall Study||10||
48664837|NCT03462745|101964659|FG001|STARTED|Overall Study||92||
48664838|NCT03462745|101964658|FG000|COMPLETED|Overall Study||92||
48664839|NCT03462745|101964659|FG001|COMPLETED|Overall Study||92||
48664840|NCT03462745|101964658|FG000|NOT COMPLETED|Overall Study||0||
48664841|NCT03462745|101964659|FG001|NOT COMPLETED|Overall Study||0||
48664842|NCT01587196|101964660|FG000|STARTED|Overall Study||72||
48664843|NCT01587196|101964660|FG000|COMPLETED|Overall Study||18||
48777538|NCT03566485|102244296|FG001|NOT COMPLETED|Overall Study||7||
48777539|NCT02093819|102244297|FG000|STARTED|Overall Study||15||
48777540|NCT02093819|102244298|FG001|STARTED|Overall Study||6||
48777541|NCT02093819|102244299|FG002|STARTED|Overall Study||10||
48777542|NCT02093819|102244300|FG003|STARTED|Overall Study||6||
48777543|NCT02093819|102244301|FG004|STARTED|Overall Study||6||
48462562|NCT01602614|101467538|FG002|STARTED|Overall Study||8||
48664844|NCT01587196|101964660|FG000|NOT COMPLETED|Overall Study||54||
48664845|NCT04316143|101964661|FG000|STARTED|50 mg Toleration Period - Dose A||29||
48664846|NCT04316143|101964662|FG001|STARTED|50 mg Toleration Period - Dose A||0||
48664847|NCT04316143|101964663|FG002|STARTED|50 mg Toleration Period - Dose A||0||
48664848|NCT04316143|101964664|FG003|STARTED|50 mg Toleration Period - Dose A||0||
48664849|NCT04316143|101964661|FG000|COMPLETED|50 mg Toleration Period - Dose A||27||
48777544|NCT02093819|102244302|FG005|STARTED|Overall Study||6||
48777545|NCT02093819|102244303|FG006|STARTED|Overall Study||5||
48777546|NCT02093819|102244304|FG007|STARTED|Overall Study||6||
48777547|NCT02093819|102244297|FG000|COMPLETED|Overall Study||15||
48462563|NCT01602614|101467539|FG003|STARTED|Overall Study||0||
48462564|NCT01602614|101467536|FG000|COMPLETED|Overall Study||0||
48462565|NCT01602614|101467537|FG001|COMPLETED|Overall Study||10||
48462566|NCT01602614|101467538|FG002|COMPLETED|Overall Study||8||
48462567|NCT01602614|101467539|FG003|COMPLETED|Overall Study||0||
48462568|NCT01602614|101467536|FG000|NOT COMPLETED|Overall Study||0||
48462569|NCT01602614|101467537|FG001|NOT COMPLETED|Overall Study||0||
48462570|NCT01602614|101467538|FG002|NOT COMPLETED|Overall Study||0||
48462571|NCT01602614|101467539|FG003|NOT COMPLETED|Overall Study||0||
48462572|NCT00996866|101467540|FG000|STARTED|Overall Study||13||
48664850|NCT04316143|101964662|FG001|COMPLETED|50 mg Toleration Period - Dose A||0||
48664851|NCT04316143|101964663|FG002|COMPLETED|50 mg Toleration Period - Dose A||0||
48664852|NCT04316143|101964664|FG003|COMPLETED|50 mg Toleration Period - Dose A||0||
48462573|NCT00996866|101467541|FG001|STARTED|Overall Study||14||
48462574|NCT00996866|101467540|FG000|COMPLETED|Overall Study||13||
48462575|NCT00996866|101467541|FG001|COMPLETED|Overall Study||14||
48462576|NCT00996866|101467540|FG000|NOT COMPLETED|Overall Study||0||
48462577|NCT00996866|101467541|FG001|NOT COMPLETED|Overall Study||0||
48462578|NCT02180061|101467542|FG000|STARTED|Overall Study||34||
48462579|NCT02180061|101467543|FG001|STARTED|Overall Study||8||
48462580|NCT02180061|101467542|FG000|COMPLETED|Overall Study||9||
48462581|NCT02180061|101467543|FG001|COMPLETED|Overall Study||0||
48462582|NCT02180061|101467542|FG000|NOT COMPLETED|Overall Study||25||
48462583|NCT02180061|101467543|FG001|NOT COMPLETED|Overall Study||8||
48462584|NCT01396044|101467544|FG000|STARTED|Overall Study||125||
48462585|NCT01396044|101467545|FG001|STARTED|Overall Study||171||
48462586|NCT01396044|101467544|FG000|COMPLETED|Overall Study||125||
48462587|NCT01396044|101467545|FG001|COMPLETED|Overall Study||171||
48462588|NCT01396044|101467544|FG000|NOT COMPLETED|Overall Study||0||
48462589|NCT01396044|101467545|FG001|NOT COMPLETED|Overall Study||0||
48462590|NCT00106028|101467546|FG000|STARTED|Overall Study||49||
48462591|NCT00106028|101467547|FG001|STARTED|Overall Study||94||
48462592|NCT00106028|101467546|FG000|Month 12 Completed/Started Open Label|Overall Study||49||
48462593|NCT00106028|101467547|FG001|Month 12 Completed/Started Open Label|Overall Study||87||
48462594|NCT00106028|101467546|FG000|COMPLETED|Overall Study||43||
48462595|NCT00106028|101467547|FG001|COMPLETED|Overall Study||82||
48462596|NCT00106028|101467546|FG000|NOT COMPLETED|Overall Study||6||
48462597|NCT00106028|101467547|FG001|NOT COMPLETED|Overall Study||12||
48462598|NCT00969332|101467548|FG000|STARTED|Overall Study||62||
48462599|NCT00969332|101467548|FG000|COMPLETED|Overall Study||51||
48462600|NCT00969332|101467548|FG000|NOT COMPLETED|Overall Study||11||
48462601|NCT03588390|101467549|FG000|STARTED|Overall Study||15||
48462602|NCT03588390|101467550|FG001|STARTED|Overall Study||6||
48462603|NCT03588390|101467551|FG002|STARTED|Overall Study||6||
48462604|NCT03588390|101467552|FG003|STARTED|Overall Study||6||
48462605|NCT03588390|101467553|FG004|STARTED|Overall Study||6||
48462606|NCT03588390|101467554|FG005|STARTED|Overall Study||6||
48462607|NCT03588390|101467555|FG006|STARTED|Overall Study||6||
48462608|NCT03588390|101467556|FG007|STARTED|Overall Study||6||
48462609|NCT03588390|101467557|FG008|STARTED|Overall Study||6||
48462610|NCT03588390|101467549|FG000|COMPLETED|Overall Study||15||
48462611|NCT03588390|101467550|FG001|COMPLETED|Overall Study||6||
48462612|NCT03588390|101467551|FG002|COMPLETED|Overall Study||6||
48462613|NCT03588390|101467552|FG003|COMPLETED|Overall Study||6||
48462614|NCT03588390|101467553|FG004|COMPLETED|Overall Study||6||
48462615|NCT03588390|101467554|FG005|COMPLETED|Overall Study||6||
48462616|NCT03588390|101467555|FG006|COMPLETED|Overall Study||6||
48462617|NCT03588390|101467556|FG007|COMPLETED|Overall Study||6||
48462618|NCT03588390|101467557|FG008|COMPLETED|Overall Study||6||
48664853|NCT04316143|101964661|FG000|NOT COMPLETED|50 mg Toleration Period - Dose A||2||
48664854|NCT04316143|101964662|FG001|NOT COMPLETED|50 mg Toleration Period - Dose A||0||
48664855|NCT04316143|101964663|FG002|NOT COMPLETED|50 mg Toleration Period - Dose A||0||
48462619|NCT03588390|101467549|FG000|NOT COMPLETED|Overall Study||0||
48462620|NCT03588390|101467550|FG001|NOT COMPLETED|Overall Study||0||
48462621|NCT03588390|101467551|FG002|NOT COMPLETED|Overall Study||0||
48462622|NCT03588390|101467552|FG003|NOT COMPLETED|Overall Study||0||
48462623|NCT03588390|101467553|FG004|NOT COMPLETED|Overall Study||0||
48462624|NCT03588390|101467554|FG005|NOT COMPLETED|Overall Study||0||
48462625|NCT03588390|101467555|FG006|NOT COMPLETED|Overall Study||0||
48462626|NCT03588390|101467556|FG007|NOT COMPLETED|Overall Study||0||
48462627|NCT03588390|101467557|FG008|NOT COMPLETED|Overall Study||0||
48462628|NCT02566135|101467558|FG000|STARTED|Overall Study||29||
48462629|NCT02566135|101467559|FG001|STARTED|Overall Study||29||
48462630|NCT02566135|101467558|FG000|COMPLETED|Overall Study||29||
48462631|NCT02566135|101467559|FG001|COMPLETED|Overall Study||29||
48462632|NCT02566135|101467558|FG000|NOT COMPLETED|Overall Study||0||
48462633|NCT02566135|101467559|FG001|NOT COMPLETED|Overall Study||0||
48462634|NCT01896297|101467560|FG000|STARTED|Overall Study||60||
48462635|NCT01896297|101467560|FG000|COMPLETED|Overall Study||59||
48462636|NCT01896297|101467560|FG000|NOT COMPLETED|Overall Study||1||
48462637|NCT03271528|101467561|FG000|STARTED|Medication Dispense/Exposure Period 1||13||
48462638|NCT03271528|101467562|FG001|STARTED|Medication Dispense/Exposure Period 1||14||
48462639|NCT03271528|101467561|FG000|COMPLETED|Medication Dispense/Exposure Period 1||11||
48462640|NCT03271528|101467562|FG001|COMPLETED|Medication Dispense/Exposure Period 1||12||
48462641|NCT03271528|101467561|FG000|NOT COMPLETED|Medication Dispense/Exposure Period 1||2||
48462642|NCT03271528|101467562|FG001|NOT COMPLETED|Medication Dispense/Exposure Period 1||2||
48462643|NCT03271528|101467561|FG000|STARTED|Alcohol Trial 1, Washout Period 1||11||
48462644|NCT03271528|101467562|FG001|STARTED|Alcohol Trial 1, Washout Period 1||12||
48462645|NCT03271528|101467561|FG000|COMPLETED|Alcohol Trial 1, Washout Period 1||9||
48462646|NCT03271528|101467562|FG001|COMPLETED|Alcohol Trial 1, Washout Period 1||11||
48462647|NCT03271528|101467561|FG000|NOT COMPLETED|Alcohol Trial 1, Washout Period 1||2||
48462648|NCT03271528|101467562|FG001|NOT COMPLETED|Alcohol Trial 1, Washout Period 1||1||
48462649|NCT03271528|101467561|FG000|STARTED|Medication Dispense/Exposure Period 2||9||
48462650|NCT03271528|101467562|FG001|STARTED|Medication Dispense/Exposure Period 2||11||
48777548|NCT02093819|102244298|FG001|COMPLETED|Overall Study||6||
48777549|NCT02093819|102244299|FG002|COMPLETED|Overall Study||10||
48777550|NCT02093819|102244300|FG003|COMPLETED|Overall Study||6||
48189784|NCT00335556|100786312|FG004|STARTED|Overall Study||78||
48462651|NCT03271528|101467561|FG000|COMPLETED|Medication Dispense/Exposure Period 2||8||
48462652|NCT03271528|101467562|FG001|COMPLETED|Medication Dispense/Exposure Period 2||11||
48462653|NCT03271528|101467561|FG000|NOT COMPLETED|Medication Dispense/Exposure Period 2||1||
48462654|NCT03271528|101467562|FG001|NOT COMPLETED|Medication Dispense/Exposure Period 2||0||
48462655|NCT03271528|101467561|FG000|STARTED|Alcohol Self-Administration Trial 2||8||
48462656|NCT03271528|101467562|FG001|STARTED|Alcohol Self-Administration Trial 2||11||
48462657|NCT03271528|101467561|FG000|COMPLETED|Alcohol Self-Administration Trial 2||8||
48462658|NCT03271528|101467562|FG001|COMPLETED|Alcohol Self-Administration Trial 2||11||
48462659|NCT03271528|101467561|FG000|NOT COMPLETED|Alcohol Self-Administration Trial 2||0||
48462660|NCT03271528|101467562|FG001|NOT COMPLETED|Alcohol Self-Administration Trial 2||0||
48462661|NCT04820842|101467563|FG000|STARTED|Active Drug Extension Period (8 Weeks)||8||
48462662|NCT04820842|101467564|FG001|STARTED|Active Drug Extension Period (8 Weeks)||9||
48462663|NCT04820842|101467565|FG002|STARTED|Active Drug Extension Period (8 Weeks)||9||
48462664|NCT04820842|101467566|FG003|STARTED|Active Drug Extension Period (8 Weeks)||0||
48462665|NCT04820842|101467567|FG004|STARTED|Active Drug Extension Period (8 Weeks)||0||
48462666|NCT04820842|101467568|FG005|STARTED|Active Drug Extension Period (8 Weeks)||0||
48462667|NCT04820842|101467569|FG006|STARTED|Active Drug Extension Period (8 Weeks)||0||
48462668|NCT04820842|101467563|FG000|COMPLETED|Active Drug Extension Period (8 Weeks)||5||
48462669|NCT04820842|101467564|FG001|COMPLETED|Active Drug Extension Period (8 Weeks)||1||
48462670|NCT04820842|101467565|FG002|COMPLETED|Active Drug Extension Period (8 Weeks)||2||
48462671|NCT04820842|101467566|FG003|COMPLETED|Active Drug Extension Period (8 Weeks)||0||
48462672|NCT04820842|101467567|FG004|COMPLETED|Active Drug Extension Period (8 Weeks)||0||
48462673|NCT04820842|101467568|FG005|COMPLETED|Active Drug Extension Period (8 Weeks)||0||
48462674|NCT04820842|101467569|FG006|COMPLETED|Active Drug Extension Period (8 Weeks)||0||
48462675|NCT04820842|101467563|FG000|NOT COMPLETED|Active Drug Extension Period (8 Weeks)||3||
48462676|NCT04820842|101467564|FG001|NOT COMPLETED|Active Drug Extension Period (8 Weeks)||8||
48462677|NCT04820842|101467565|FG002|NOT COMPLETED|Active Drug Extension Period (8 Weeks)||7||
48462678|NCT04820842|101467566|FG003|NOT COMPLETED|Active Drug Extension Period (8 Weeks)||0||
48462679|NCT04820842|101467567|FG004|NOT COMPLETED|Active Drug Extension Period (8 Weeks)||0||
48462680|NCT04820842|101467568|FG005|NOT COMPLETED|Active Drug Extension Period (8 Weeks)||0||
48462681|NCT04820842|101467569|FG006|NOT COMPLETED|Active Drug Extension Period (8 Weeks)||0||
48462682|NCT04820842|101467563|FG000|STARTED|Randomized Withdrawal Period (4 Weeks)||0||
48462683|NCT04820842|101467564|FG001|STARTED|Randomized Withdrawal Period (4 Weeks)||0||
48462684|NCT04820842|101467565|FG002|STARTED|Randomized Withdrawal Period (4 Weeks)||0||
48462685|NCT04820842|101467566|FG003|STARTED|Randomized Withdrawal Period (4 Weeks)||3||
48462686|NCT04820842|101467567|FG004|STARTED|Randomized Withdrawal Period (4 Weeks)||1||
48462687|NCT04820842|101467568|FG005|STARTED|Randomized Withdrawal Period (4 Weeks)||1||
48462688|NCT04820842|101467569|FG006|STARTED|Randomized Withdrawal Period (4 Weeks)||3||
48462689|NCT04820842|101467563|FG000|COMPLETED|Randomized Withdrawal Period (4 Weeks)||0||
48664856|NCT04316143|101964664|FG003|NOT COMPLETED|50 mg Toleration Period - Dose A||0||
48664857|NCT04316143|101964661|FG000|STARTED|100 mg Toleration Period - Dose B||0||
48664858|NCT04316143|101964662|FG001|STARTED|100 mg Toleration Period - Dose B||27||
48664859|NCT04316143|101964663|FG002|STARTED|100 mg Toleration Period - Dose B||0||
48664860|NCT04316143|101964664|FG003|STARTED|100 mg Toleration Period - Dose B||0||
48664861|NCT04316143|101964661|FG000|COMPLETED|100 mg Toleration Period - Dose B||0||
48664862|NCT04316143|101964662|FG001|COMPLETED|100 mg Toleration Period - Dose B||21||
48664863|NCT04316143|101964663|FG002|COMPLETED|100 mg Toleration Period - Dose B||0||
48664864|NCT04316143|101964664|FG003|COMPLETED|100 mg Toleration Period - Dose B||0||
48664865|NCT04316143|101964661|FG000|NOT COMPLETED|100 mg Toleration Period - Dose B||0||
48664866|NCT04316143|101964662|FG001|NOT COMPLETED|100 mg Toleration Period - Dose B||6||
48664867|NCT04316143|101964663|FG002|NOT COMPLETED|100 mg Toleration Period - Dose B||0||
48664868|NCT04316143|101964664|FG003|NOT COMPLETED|100 mg Toleration Period - Dose B||0||
48664869|NCT04316143|101964661|FG000|STARTED|150 mg Toleration Period - Dose C||0||
48664870|NCT04316143|101964662|FG001|STARTED|150 mg Toleration Period - Dose C||0||
48664871|NCT04316143|101964663|FG002|STARTED|150 mg Toleration Period - Dose C||21||
48664872|NCT04316143|101964664|FG003|STARTED|150 mg Toleration Period - Dose C||0||
48664873|NCT04316143|101964661|FG000|COMPLETED|150 mg Toleration Period - Dose C||0||
48664874|NCT04316143|101964662|FG001|COMPLETED|150 mg Toleration Period - Dose C||0||
48664875|NCT04316143|101964663|FG002|COMPLETED|150 mg Toleration Period - Dose C||19||
48664876|NCT04316143|101964664|FG003|COMPLETED|150 mg Toleration Period - Dose C||0||
48664877|NCT04316143|101964661|FG000|NOT COMPLETED|150 mg Toleration Period - Dose C||0||
48777551|NCT02093819|102244301|FG004|COMPLETED|Overall Study||6||
48777552|NCT02093819|102244302|FG005|COMPLETED|Overall Study||6||
48189785|NCT00335556|100786313|FG005|STARTED|Overall Study||30||
48189786|NCT00335556|100786308|FG000|COMPLETED|Overall Study||66||
48189787|NCT00335556|100786309|FG001|COMPLETED|Overall Study||64||
48664878|NCT04316143|101964662|FG001|NOT COMPLETED|150 mg Toleration Period - Dose C||0||
48664879|NCT04316143|101964663|FG002|NOT COMPLETED|150 mg Toleration Period - Dose C||2||
48462690|NCT04820842|101467564|FG001|COMPLETED|Randomized Withdrawal Period (4 Weeks)||0||
48462691|NCT04820842|101467565|FG002|COMPLETED|Randomized Withdrawal Period (4 Weeks)||0||
48462692|NCT04820842|101467566|FG003|COMPLETED|Randomized Withdrawal Period (4 Weeks)||1||
48462693|NCT04820842|101467567|FG004|COMPLETED|Randomized Withdrawal Period (4 Weeks)||1||
48462694|NCT04820842|101467568|FG005|COMPLETED|Randomized Withdrawal Period (4 Weeks)||1||
48462695|NCT04820842|101467569|FG006|COMPLETED|Randomized Withdrawal Period (4 Weeks)||2||
48462696|NCT04820842|101467563|FG000|NOT COMPLETED|Randomized Withdrawal Period (4 Weeks)||0||
48462697|NCT04820842|101467564|FG001|NOT COMPLETED|Randomized Withdrawal Period (4 Weeks)||0||
48462698|NCT04820842|101467565|FG002|NOT COMPLETED|Randomized Withdrawal Period (4 Weeks)||0||
48462699|NCT04820842|101467566|FG003|NOT COMPLETED|Randomized Withdrawal Period (4 Weeks)||2||
48664880|NCT04316143|101964664|FG003|NOT COMPLETED|150 mg Toleration Period - Dose C||0||
48664881|NCT04316143|101964661|FG000|STARTED|200 mg Toleration Period - Dose D||0||
48664882|NCT04316143|101964662|FG001|STARTED|200 mg Toleration Period - Dose D||0||
48664883|NCT04316143|101964663|FG002|STARTED|200 mg Toleration Period - Dose D||0||
48664884|NCT04316143|101964664|FG003|STARTED|200 mg Toleration Period - Dose D||19||
48664885|NCT04316143|101964661|FG000|COMPLETED|200 mg Toleration Period - Dose D||0||
48664886|NCT04316143|101964662|FG001|COMPLETED|200 mg Toleration Period - Dose D||0||
48664887|NCT04316143|101964663|FG002|COMPLETED|200 mg Toleration Period - Dose D||0||
48664888|NCT04316143|101964664|FG003|COMPLETED|200 mg Toleration Period - Dose D||19||
48664889|NCT04316143|101964661|FG000|NOT COMPLETED|200 mg Toleration Period - Dose D||0||
48664890|NCT04316143|101964662|FG001|NOT COMPLETED|200 mg Toleration Period - Dose D||0||
48664891|NCT04316143|101964663|FG002|NOT COMPLETED|200 mg Toleration Period - Dose D||0||
48664892|NCT04316143|101964664|FG003|NOT COMPLETED|200 mg Toleration Period - Dose D||0||
48664893|NCT04169009|101964665|FG000|STARTED|Overall Study||18||
48664894|NCT04169009|101964666|FG001|STARTED|Overall Study||32||
48664895|NCT04169009|101964667|FG002|STARTED|Overall Study||35||
48664896|NCT04169009|101964668|FG003|STARTED|Overall Study||20||
48664897|NCT04169009|101964665|FG000|COMPLETED|Overall Study||18||
48664898|NCT04169009|101964666|FG001|COMPLETED|Overall Study||31||
48664899|NCT04169009|101964667|FG002|COMPLETED|Overall Study||35||
48664900|NCT04169009|101964668|FG003|COMPLETED|Overall Study||19||
48664901|NCT04169009|101964665|FG000|NOT COMPLETED|Overall Study||0||
48664902|NCT04169009|101964666|FG001|NOT COMPLETED|Overall Study||1||
48664903|NCT04169009|101964667|FG002|NOT COMPLETED|Overall Study||0||
48664904|NCT04169009|101964668|FG003|NOT COMPLETED|Overall Study||1||
48664905|NCT04103814|101964669|FG000|STARTED|Overall Study||8||
48664906|NCT04103814|101964670|FG001|STARTED|Overall Study||3||
48664907|NCT04103814|101964669|FG000|COMPLETED|Overall Study||0||
48664908|NCT04103814|101964670|FG001|COMPLETED|Overall Study||0||
48664909|NCT04103814|101964669|FG000|NOT COMPLETED|Overall Study||8||
48664910|NCT04103814|101964670|FG001|NOT COMPLETED|Overall Study||3||
48664911|NCT03546439|101964671|FG000|STARTED|Overall Study||203||
48664912|NCT03546439|101964672|FG001|STARTED|Overall Study||156||
48664913|NCT03546439|101964673|FG002|STARTED|Overall Study||75||
48664914|NCT03546439|101964671|FG000|COMPLETED|Overall Study||203||
48664915|NCT03546439|101964672|FG001|COMPLETED|Overall Study||156||
48664916|NCT03546439|101964673|FG002|COMPLETED|Overall Study||75||
48664917|NCT03546439|101964671|FG000|NOT COMPLETED|Overall Study||0||
48664918|NCT03546439|101964672|FG001|NOT COMPLETED|Overall Study||0||
48664919|NCT03546439|101964673|FG002|NOT COMPLETED|Overall Study||0||
48664920|NCT04503616|101964674|FG000|STARTED|Overall Study||46||
48664921|NCT04503616|101964674|FG000|COMPLETED|Overall Study||46||
48664922|NCT04503616|101964674|FG000|NOT COMPLETED|Overall Study||0||
48664923|NCT01798225|101964675|FG000|STARTED|Overall Study||57||
48664924|NCT01798225|101964676|FG001|STARTED|Overall Study||56||
48664925|NCT01798225|101964675|FG000|COMPLETED|Overall Study||57||
48664926|NCT01798225|101964676|FG001|COMPLETED|Overall Study||53||
48664927|NCT01798225|101964675|FG000|NOT COMPLETED|Overall Study||0||
48664928|NCT01798225|101964676|FG001|NOT COMPLETED|Overall Study||3||
48777553|NCT02093819|102244303|FG006|COMPLETED|Overall Study||5||
48777554|NCT02093819|102244304|FG007|COMPLETED|Overall Study||6||
48777555|NCT02093819|102244297|FG000|NOT COMPLETED|Overall Study||0||
48462700|NCT04820842|101467567|FG004|NOT COMPLETED|Randomized Withdrawal Period (4 Weeks)||0||
48462701|NCT04820842|101467568|FG005|NOT COMPLETED|Randomized Withdrawal Period (4 Weeks)||0||
48462702|NCT04820842|101467569|FG006|NOT COMPLETED|Randomized Withdrawal Period (4 Weeks)||1||
48462703|NCT01890707|101467570|FG000|STARTED|Overall Study||11||
48462704|NCT01890707|101467571|FG001|STARTED|Overall Study||8||
48462705|NCT01890707|101467570|FG000|COMPLETED|Overall Study||10||
48664929|NCT03537508|101964677|FG000|STARTED|Overall Study||1746||
48664930|NCT03537508|101964678|FG001|STARTED|Overall Study||881||
48664931|NCT03537508|101964677|FG000|Safety Analysis Set (SafAS)|Overall Study||1727||
48664932|NCT03537508|101964678|FG001|Safety Analysis Set (SafAS)|Overall Study||867||
48664933|NCT03537508|101964677|FG000|Vaccinated at 2 Months|Overall Study||1727||
48664934|NCT03537508|101964678|FG001|Vaccinated at 2 Months|Overall Study||869||
48664935|NCT03537508|101964677|FG000|Vaccinated at 4 Months|Overall Study||1619||
48664936|NCT03537508|101964678|FG001|Vaccinated at 4 Months|Overall Study||828||
48664937|NCT03537508|101964677|FG000|Vaccinated at 6 Months|Overall Study||1543||
48664938|NCT03537508|101964678|FG001|Vaccinated at 6 Months|Overall Study||793||
48777556|NCT02093819|102244298|FG001|NOT COMPLETED|Overall Study||0||
48462706|NCT01890707|101467571|FG001|COMPLETED|Overall Study||7||
48462707|NCT01890707|101467570|FG000|NOT COMPLETED|Overall Study||1||
48462708|NCT01890707|101467571|FG001|NOT COMPLETED|Overall Study||1||
48462709|NCT01014390|101467572|FG000|STARTED|Overall Study||187||
48462710|NCT01014390|101467572|FG000|COMPLETED|Overall Study||177||
48462711|NCT01014390|101467572|FG000|NOT COMPLETED|Overall Study||10||
48462712|NCT01965561|101467573|FG000|STARTED|Overall Study||10||
48462713|NCT01965561|101467573|FG000|COMPLETED|Overall Study||10||
48462714|NCT01965561|101467573|FG000|NOT COMPLETED|Overall Study||0||
48462715|NCT01748890|101467574|FG000|STARTED|Overall Study||4||
48462716|NCT01748890|101467574|FG000|COMPLETED|Overall Study||0||
48462717|NCT01748890|101467574|FG000|NOT COMPLETED|Overall Study||4||
48462718|NCT00613574|101467575|FG000|STARTED|Overall Study||407||
48462719|NCT00613574|101467575|FG000|COMPLETED|Overall Study||401||
48462720|NCT00613574|101467575|FG000|NOT COMPLETED|Overall Study||6||
48462721|NCT02004847|101467576|FG000|STARTED|Overall Study||24||
48462722|NCT02004847|101467577|FG001|STARTED|Overall Study||23||
48462723|NCT02004847|101467576|FG000|COMPLETED|Overall Study||23||
48462724|NCT02004847|101467577|FG001|COMPLETED|Overall Study||22||
48462725|NCT02004847|101467576|FG000|NOT COMPLETED|Overall Study||1||
48462726|NCT02004847|101467577|FG001|NOT COMPLETED|Overall Study||1||
48462727|NCT00860314|101467578|FG000|STARTED|Overall Study||48||
48462728|NCT00860314|101467579|FG001|STARTED|Overall Study||48||
48462729|NCT00860314|101467578|FG000|COMPLETED|Overall Study||48||
48462730|NCT00860314|101467579|FG001|COMPLETED|Overall Study||48||
48462731|NCT00860314|101467578|FG000|NOT COMPLETED|Overall Study||0||
48462732|NCT00860314|101467579|FG001|NOT COMPLETED|Overall Study||0||
48462733|NCT04895618|101467580|FG000|STARTED|Overall Study||43||
48664939|NCT03537508|101964677|FG000|Vaccinated at 12 Months|Overall Study||1411||
48664940|NCT03537508|101964678|FG001|Vaccinated at 12 Months|Overall Study||708||
48664941|NCT03537508|101964677|FG000|Vaccinated at 15 Months|Overall Study||445||
48664942|NCT03537508|101964678|FG001|Vaccinated at 15 Months|Overall Study||644||
48462734|NCT04895618|101467580|FG000|COMPLETED|Overall Study||43||
48462735|NCT04895618|101467580|FG000|NOT COMPLETED|Overall Study||0||
48462736|NCT00545233|101467581|FG000|STARTED|Overall Study||79||
48462737|NCT00545233|101467582|FG001|STARTED|Overall Study||76||
48462738|NCT00545233|101467581|FG000|Safety Set|Overall Study||77||
48462739|NCT00545233|101467582|FG001|Safety Set|Overall Study||75||
48462740|NCT00545233|101467581|FG000|Intent-to-Treat (ITT)|Overall Study||77||
48462741|NCT00545233|101467582|FG001|Intent-to-Treat (ITT)|Overall Study||73||
48462742|NCT00545233|101467581|FG000|COMPLETED|Overall Study||33||
48462743|NCT00545233|101467582|FG001|COMPLETED|Overall Study||41||
48462744|NCT00545233|101467581|FG000|NOT COMPLETED|Overall Study||46||
48462745|NCT00545233|101467582|FG001|NOT COMPLETED|Overall Study||35||
48462746|NCT02588573|101467583|FG000|STARTED|Overall Study||45||90
48462747|NCT02588573|101467584|FG001|STARTED|Overall Study||45||90
48462748|NCT02588573|101467583|FG000|Randomized Eye Etafilcon A|Overall Study||45||45
48462749|NCT02588573|101467584|FG001|Randomized Eye Etafilcon A|Overall Study||45||45
48462750|NCT02588573|101467583|FG000|Randomized Eye Somofilcon A|Overall Study||45||45
48462751|NCT02588573|101467584|FG001|Randomized Eye Somofilcon A|Overall Study||45||45
48462752|NCT02588573|101467583|FG000|COMPLETED|Overall Study||45||90
48462753|NCT02588573|101467584|FG001|COMPLETED|Overall Study||45||90
48462754|NCT02588573|101467583|FG000|NOT COMPLETED|Overall Study||0||0
48462755|NCT02588573|101467584|FG001|NOT COMPLETED|Overall Study||0||0
48462756|NCT02539563|101467585|FG000|STARTED|Overall Study||45||
48462757|NCT02539563|101467586|FG001|STARTED|Overall Study||56||
48664943|NCT03537508|101964677|FG000|COMPLETED|Overall Study||1330||
48664944|NCT03537508|101964678|FG001|COMPLETED|Overall Study||623||
48777557|NCT02093819|102244299|FG002|NOT COMPLETED|Overall Study||0||
48462758|NCT02539563|101467585|FG000|COMPLETED|Overall Study||39||
48462759|NCT02539563|101467586|FG001|COMPLETED|Overall Study||42||
48462760|NCT02539563|101467585|FG000|NOT COMPLETED|Overall Study||6||
48462761|NCT02539563|101467586|FG001|NOT COMPLETED|Overall Study||14||
48462762|NCT01928446|101467587|FG000|STARTED|Overall Study||255||
48462763|NCT01928446|101467588|FG001|STARTED|Overall Study||264||
48462764|NCT01928446|101467587|FG000|COMPLETED|Overall Study||144||
48462765|NCT01928446|101467588|FG001|COMPLETED|Overall Study||125||
48462766|NCT01928446|101467587|FG000|NOT COMPLETED|Overall Study||111||
48462767|NCT01928446|101467588|FG001|NOT COMPLETED|Overall Study||139||
48462768|NCT03465891|101467589|FG000|STARTED|Overall Study||1||
48462769|NCT03465891|101467590|FG001|STARTED|Overall Study||1||
48462770|NCT03465891|101467589|FG000|COMPLETED|Overall Study||0||
48462771|NCT03465891|101467590|FG001|COMPLETED|Overall Study||0||
48462772|NCT03465891|101467589|FG000|NOT COMPLETED|Overall Study||1||
48777558|NCT02093819|102244300|FG003|NOT COMPLETED|Overall Study||0||
48462773|NCT03465891|101467590|FG001|NOT COMPLETED|Overall Study||1||
48462774|NCT03276975|101467591|FG000|STARTED|Overall Study||8||
48462775|NCT03276975|101467592|FG001|STARTED|Overall Study||7||
48462776|NCT03276975|101467591|FG000|Crossover At 2 Months|Overall Study||0||
48462777|NCT03276975|101467592|FG001|Crossover At 2 Months|Overall Study||7||
48462778|NCT03276975|101467591|FG000|COMPLETED|Overall Study||7||
48462779|NCT03276975|101467592|FG001|COMPLETED|Overall Study||7||
48664945|NCT03537508|101964677|FG000|NOT COMPLETED|Overall Study||416||
48777559|NCT02093819|102244301|FG004|NOT COMPLETED|Overall Study||0||
48777560|NCT02093819|102244302|FG005|NOT COMPLETED|Overall Study||0||
48462780|NCT03276975|101467591|FG000|NOT COMPLETED|Overall Study||1||
48462781|NCT03276975|101467592|FG001|NOT COMPLETED|Overall Study||0||
48462782|NCT02919475|101467593|FG000|STARTED|Overall Study||52||
48462783|NCT02919475|101467594|FG001|STARTED|Overall Study||52||
48462784|NCT02919475|101467595|FG002|STARTED|Overall Study||52||
48462785|NCT02919475|101467596|FG003|STARTED|Overall Study||51||
48777561|NCT02093819|102244303|FG006|NOT COMPLETED|Overall Study||0||
48777562|NCT02093819|102244304|FG007|NOT COMPLETED|Overall Study||0||
48777563|NCT01134705|102244305|FG000|STARTED|Overall Study||236||
48777564|NCT01134705|102244306|FG001|STARTED|Overall Study||238||
48777565|NCT01134705|102244305|FG000|Intent to Treat Population|Overall Study||232||
48777566|NCT01134705|102244306|FG001|Intent to Treat Population|Overall Study||234||
48777567|NCT01134705|102244305|FG000|COMPLETED|Overall Study||221||
48777568|NCT01134705|102244306|FG001|COMPLETED|Overall Study||216||
48777569|NCT01134705|102244305|FG000|NOT COMPLETED|Overall Study||15||
48462786|NCT02919475|101467597|FG004|STARTED|Overall Study||52||
48462787|NCT02919475|101467593|FG000|Started Dosing|Overall Study||51||
48462788|NCT02919475|101467594|FG001|Started Dosing|Overall Study||52||
48462789|NCT02919475|101467595|FG002|Started Dosing|Overall Study||52||
48462790|NCT02919475|101467596|FG003|Started Dosing|Overall Study||51||
48462791|NCT02919475|101467597|FG004|Started Dosing|Overall Study||52||
48462792|NCT02919475|101467593|FG000|COMPLETED|Overall Study||46||
48462793|NCT02919475|101467594|FG001|COMPLETED|Overall Study||44||
48462794|NCT02919475|101467595|FG002|COMPLETED|Overall Study||47||
48462795|NCT02919475|101467596|FG003|COMPLETED|Overall Study||38||
48462796|NCT02919475|101467597|FG004|COMPLETED|Overall Study||48||
48462797|NCT02919475|101467593|FG000|NOT COMPLETED|Overall Study||6||
48462798|NCT02919475|101467594|FG001|NOT COMPLETED|Overall Study||8||
48462799|NCT02919475|101467595|FG002|NOT COMPLETED|Overall Study||5||
48462800|NCT02919475|101467596|FG003|NOT COMPLETED|Overall Study||13||
48462801|NCT02919475|101467597|FG004|NOT COMPLETED|Overall Study||4||
48462802|NCT05431153|101467598|FG000|STARTED|Treatment Period 1 (Day 1)||5||
48462803|NCT05431153|101467599|FG001|STARTED|Treatment Period 1 (Day 1)||5||
48777570|NCT01134705|102244306|FG001|NOT COMPLETED|Overall Study||22||
48777571|NCT01620216|102244307|FG000|STARTED|Overall Study||4||
48777572|NCT01620216|102244308|FG001|STARTED|Overall Study||2||
48777573|NCT01620216|102244309|FG002|STARTED|Overall Study||6||
48777574|NCT01620216|102244310|FG003|STARTED|Overall Study||0||
48777575|NCT01620216|102244311|FG004|STARTED|Overall Study||0||
48777576|NCT01620216|102244312|FG005|STARTED|Overall Study||0||
48777577|NCT01620216|102244313|FG006|STARTED|Overall Study||0||
48777578|NCT01620216|102244307|FG000|COMPLETED|Overall Study||4||
48777579|NCT01620216|102244308|FG001|COMPLETED|Overall Study||2||
48777580|NCT01620216|102244309|FG002|COMPLETED|Overall Study||6||
48777581|NCT01620216|102244310|FG003|COMPLETED|Overall Study||0||
48777582|NCT01620216|102244311|FG004|COMPLETED|Overall Study||0||
48777583|NCT01620216|102244312|FG005|COMPLETED|Overall Study||0||
48462804|NCT05431153|101467600|FG002|STARTED|Treatment Period 1 (Day 1)||5||
48462805|NCT05431153|101467601|FG003|STARTED|Treatment Period 1 (Day 1)||5||
48462806|NCT05431153|101467602|FG004|STARTED|Treatment Period 1 (Day 1)||5||
48462807|NCT05431153|101467603|FG005|STARTED|Treatment Period 1 (Day 1)||5||
48462808|NCT05431153|101467598|FG000|COMPLETED|Treatment Period 1 (Day 1)||5||
48462809|NCT05431153|101467599|FG001|COMPLETED|Treatment Period 1 (Day 1)||5||
48462810|NCT05431153|101467600|FG002|COMPLETED|Treatment Period 1 (Day 1)||5||
48462811|NCT05431153|101467601|FG003|COMPLETED|Treatment Period 1 (Day 1)||5||
48777584|NCT01620216|102244313|FG006|COMPLETED|Overall Study||0||
48777585|NCT01620216|102244307|FG000|NOT COMPLETED|Overall Study||0||
48777586|NCT01620216|102244308|FG001|NOT COMPLETED|Overall Study||0||
48777587|NCT01620216|102244309|FG002|NOT COMPLETED|Overall Study||0||
48462812|NCT05431153|101467602|FG004|COMPLETED|Treatment Period 1 (Day 1)||4||
48462813|NCT05431153|101467603|FG005|COMPLETED|Treatment Period 1 (Day 1)||5||
48462814|NCT05431153|101467598|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48664946|NCT03537508|101964678|FG001|NOT COMPLETED|Overall Study||258||
48664947|NCT01394185|101964679|FG000|STARTED|Overall Study||8||
48664948|NCT01394185|101964680|FG001|STARTED|Overall Study||2||
48664949|NCT01394185|101964681|FG002|STARTED|Overall Study||2||
48664950|NCT01394185|101964682|FG003|STARTED|Overall Study||4||
48664951|NCT01394185|101964683|FG004|STARTED|Overall Study||6||
48664952|NCT01394185|101964684|FG005|STARTED|Overall Study||3||
48664953|NCT01394185|101964679|FG000|COMPLETED|Overall Study||2||
48664954|NCT01394185|101964680|FG001|COMPLETED|Overall Study||2||
48777588|NCT01620216|102244310|FG003|NOT COMPLETED|Overall Study||0||
48777589|NCT01620216|102244311|FG004|NOT COMPLETED|Overall Study||0||
48777590|NCT01620216|102244312|FG005|NOT COMPLETED|Overall Study||0||
48462815|NCT05431153|101467599|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48462816|NCT05431153|101467600|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48462817|NCT05431153|101467601|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48664955|NCT01394185|101964681|FG002|COMPLETED|Overall Study||2||
48664956|NCT01394185|101964682|FG003|COMPLETED|Overall Study||3||
48777591|NCT01620216|102244313|FG006|NOT COMPLETED|Overall Study||0||
48777592|NCT00955916|102244314|FG000|STARTED|Overall Study||38||
48777593|NCT00955916|102244314|FG000|COMPLETED|Overall Study||38||
48777594|NCT00955916|102244314|FG000|NOT COMPLETED|Overall Study||0||
48777595|NCT00578734|102244315|FG000|STARTED|Overall Study||84||
48777596|NCT00578734|102244316|FG001|STARTED|Overall Study||81||
48777597|NCT00578734|102244315|FG000|COMPLETED|Overall Study||84||
48777598|NCT00578734|102244316|FG001|COMPLETED|Overall Study||81||
48777599|NCT00578734|102244315|FG000|NOT COMPLETED|Overall Study||0||
48777600|NCT00578734|102244316|FG001|NOT COMPLETED|Overall Study||0||
48777601|NCT00126490|102244317|FG000|STARTED|Overall Study||19||
48777602|NCT00126490|102244317|FG000|COMPLETED|Overall Study||18||
48777603|NCT00126490|102244317|FG000|NOT COMPLETED|Overall Study||1||
48777604|NCT03275350|102244318|FG000|STARTED|Overall Study||55||
48777605|NCT03275350|102244319|FG001|STARTED|Overall Study||59||
48777606|NCT03275350|102244318|FG000|COMPLETED|Overall Study||47||
48777607|NCT03275350|102244319|FG001|COMPLETED|Overall Study||51||
48777608|NCT03275350|102244318|FG000|NOT COMPLETED|Overall Study||8||
48777609|NCT03275350|102244319|FG001|NOT COMPLETED|Overall Study||8||
48777610|NCT00233064|102244320|FG000|STARTED|Overall Study||211||
48777611|NCT00233064|102244321|FG001|STARTED|Overall Study||202||
48777612|NCT00233064|102244320|FG000|COMPLETED|Overall Study||197||
48777613|NCT00233064|102244321|FG001|COMPLETED|Overall Study||190||
48777614|NCT00233064|102244320|FG000|NOT COMPLETED|Overall Study||14||
48777615|NCT00233064|102244321|FG001|NOT COMPLETED|Overall Study||12||
48777616|NCT00806819|102244322|FG000|STARTED|Overall Study||353||
48777617|NCT00806819|102244323|FG001|STARTED|Overall Study||360||
48777618|NCT00806819|102244322|FG000|COMPLETED|Overall Study||7||
48462818|NCT05431153|101467602|FG004|NOT COMPLETED|Treatment Period 1 (Day 1)||1||
48462819|NCT05431153|101467603|FG005|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48777619|NCT00806819|102244323|FG001|COMPLETED|Overall Study||2||
48777620|NCT00806819|102244322|FG000|NOT COMPLETED|Overall Study||346||
48777621|NCT00806819|102244323|FG001|NOT COMPLETED|Overall Study||358||
48777622|NCT01379508|102244324|FG000|STARTED|Treatment to Week 104||99||
48777623|NCT01379508|102244325|FG001|STARTED|Treatment to Week 104||22||
48777624|NCT01379508|102244326|FG002|STARTED|Treatment to Week 104||109||
48777625|NCT01379508|102244327|FG003|STARTED|Treatment to Week 104||11||
48777626|NCT01379508|102244324|FG000|Completed Wk 24|Treatment to Week 104||93||
48777627|NCT01379508|102244325|FG001|Completed Wk 24|Treatment to Week 104||22||
48777628|NCT01379508|102244326|FG002|Completed Wk 24|Treatment to Week 104||107||
48777629|NCT01379508|102244327|FG003|Completed Wk 24|Treatment to Week 104||11||
48777630|NCT01379508|102244324|FG000|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||91||
48777631|NCT01379508|102244325|FG001|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||21||
48777632|NCT01379508|102244326|FG002|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||105||
48777633|NCT01379508|102244327|FG003|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||11||
48777634|NCT01379508|102244324|FG000|COMPLETED|Treatment to Week 104||80||
48777635|NCT01379508|102244325|FG001|COMPLETED|Treatment to Week 104||19||
48777636|NCT01379508|102244326|FG002|COMPLETED|Treatment to Week 104||96||
48777637|NCT01379508|102244327|FG003|COMPLETED|Treatment to Week 104||11||
48777638|NCT01379508|102244324|FG000|NOT COMPLETED|Treatment to Week 104||19||
48777639|NCT01379508|102244325|FG001|NOT COMPLETED|Treatment to Week 104||3||
48777640|NCT01379508|102244326|FG002|NOT COMPLETED|Treatment to Week 104||13||
48777641|NCT01379508|102244327|FG003|NOT COMPLETED|Treatment to Week 104||0||
48777642|NCT01379508|102244324|FG000|STARTED|Extension Period Weeks 109-156||64||
48777643|NCT01379508|102244325|FG001|STARTED|Extension Period Weeks 109-156||17||
48777644|NCT01379508|102244326|FG002|STARTED|Extension Period Weeks 109-156||79||
48777645|NCT01379508|102244327|FG003|STARTED|Extension Period Weeks 109-156||10||
48777646|NCT01379508|102244324|FG000|COMPLETED|Extension Period Weeks 109-156||45||
48777647|NCT01379508|102244325|FG001|COMPLETED|Extension Period Weeks 109-156||14||
48777648|NCT01379508|102244326|FG002|COMPLETED|Extension Period Weeks 109-156||65||
48369851|NCT04752189|101232850|FG000|Teacher Participants - Participated in Interim Interview|Overall Study||1|Teachers with more than one term of health class in their school participated in an interim interview between semesters. Teachers with only one class per school year were not eligible for an interim interview.|1
48369852|NCT04752189|101232851|FG001|Teacher Participants - Participated in Interim Interview|Overall Study||2|Teachers with more than one term of health class in their school participated in an interim interview between semesters. Teachers with only one class per school year were not eligible for an interim interview.|2
48462820|NCT05431153|101467598|FG000|STARTED|Washout Period 1 (5 Days)||5||
48462821|NCT05431153|101467599|FG001|STARTED|Washout Period 1 (5 Days)||5||
48777649|NCT01379508|102244327|FG003|COMPLETED|Extension Period Weeks 109-156||10||
48777650|NCT01379508|102244324|FG000|NOT COMPLETED|Extension Period Weeks 109-156||19||
48777651|NCT01379508|102244325|FG001|NOT COMPLETED|Extension Period Weeks 109-156||3||
48777652|NCT01379508|102244326|FG002|NOT COMPLETED|Extension Period Weeks 109-156||14||
48777653|NCT01379508|102244327|FG003|NOT COMPLETED|Extension Period Weeks 109-156||0||
48777654|NCT02920242|102244328|FG000|STARTED|Overall Study||13||
48777655|NCT02920242|102244329|FG001|STARTED|Overall Study||11||
48777656|NCT02920242|102244330|FG002|STARTED|Overall Study||4||
48777657|NCT02920242|102244328|FG000|Safety Set|Overall Study||12||
48777658|NCT02920242|102244329|FG001|Safety Set|Overall Study||11||
48777659|NCT02920242|102244330|FG002|Safety Set|Overall Study||4||
48462822|NCT05431153|101467600|FG002|STARTED|Washout Period 1 (5 Days)||5||
48462823|NCT05431153|101467601|FG003|STARTED|Washout Period 1 (5 Days)||5||
48462824|NCT05431153|101467602|FG004|STARTED|Washout Period 1 (5 Days)||4||
48462825|NCT05431153|101467603|FG005|STARTED|Washout Period 1 (5 Days)||5||
48462826|NCT05431153|101467598|FG000|COMPLETED|Washout Period 1 (5 Days)||5||
48462827|NCT05431153|101467599|FG001|COMPLETED|Washout Period 1 (5 Days)||5||
48462828|NCT05431153|101467600|FG002|COMPLETED|Washout Period 1 (5 Days)||5||
48462829|NCT05431153|101467601|FG003|COMPLETED|Washout Period 1 (5 Days)||5||
48462830|NCT05431153|101467602|FG004|COMPLETED|Washout Period 1 (5 Days)||4||
48462831|NCT05431153|101467603|FG005|COMPLETED|Washout Period 1 (5 Days)||5||
48462832|NCT05431153|101467598|FG000|NOT COMPLETED|Washout Period 1 (5 Days)||0||
48462833|NCT05431153|101467599|FG001|NOT COMPLETED|Washout Period 1 (5 Days)||0||
48777660|NCT02920242|102244328|FG000|COMPLETED|Overall Study||11||
48777661|NCT02920242|102244329|FG001|COMPLETED|Overall Study||11||
48777662|NCT02920242|102244330|FG002|COMPLETED|Overall Study||3||
48777663|NCT02920242|102244328|FG000|NOT COMPLETED|Overall Study||2||
48777664|NCT02920242|102244329|FG001|NOT COMPLETED|Overall Study||0||
48777665|NCT02920242|102244330|FG002|NOT COMPLETED|Overall Study||1||
48777666|NCT01974635|102244331|FG000|STARTED|Overall Study||2||
48777667|NCT01974635|102244331|FG000|COMPLETED|Overall Study||2||
48777668|NCT01974635|102244331|FG000|NOT COMPLETED|Overall Study||0||
48777669|NCT00621348|102248256|FG000|STARTED|Overall Study||58||
48777670|NCT00621348|102248257|FG001|STARTED|Overall Study||53||
48777671|NCT00621348|102248258|FG002|STARTED|Overall Study||56||
48777672|NCT00621348|102248256|FG000|COMPLETED|Overall Study||58||
48777673|NCT00621348|102248257|FG001|COMPLETED|Overall Study||53||
48777674|NCT00621348|102248258|FG002|COMPLETED|Overall Study||56||
48777675|NCT00621348|102248256|FG000|NOT COMPLETED|Overall Study||0||
48777676|NCT00621348|102248257|FG001|NOT COMPLETED|Overall Study||0||
48777677|NCT00621348|102248258|FG002|NOT COMPLETED|Overall Study||0||
48777678|NCT03753113|102248259|FG000|STARTED|Overall Study||12||
48777679|NCT03753113|102248260|FG001|STARTED|Overall Study||12||
48777680|NCT03753113|102248259|FG000|COMPLETED|Overall Study||12||
48777681|NCT03753113|102248260|FG001|COMPLETED|Overall Study||12||
48777682|NCT03753113|102248259|FG000|NOT COMPLETED|Overall Study||0||
48777683|NCT03753113|102248260|FG001|NOT COMPLETED|Overall Study||0||
48777684|NCT00939393|102248261|FG000|STARTED|Overall Study||37||
48777685|NCT00939393|102248262|FG001|STARTED|Overall Study||35||
48777686|NCT00939393|102248261|FG000|COMPLETED|Overall Study||33||
48777687|NCT00939393|102248262|FG001|COMPLETED|Overall Study||35||
48777688|NCT00939393|102248261|FG000|NOT COMPLETED|Overall Study||4||
48777689|NCT00939393|102248262|FG001|NOT COMPLETED|Overall Study||0||
48777690|NCT01519167|102248263|FG000|STARTED|Overall Study||1||
48777691|NCT01519167|102248264|FG001|STARTED|Overall Study||89||
48777692|NCT01519167|102248263|FG000|COMPLETED|Overall Study||1||
48777693|NCT01519167|102248264|FG001|COMPLETED|Overall Study||81||
48777694|NCT01519167|102248263|FG000|NOT COMPLETED|Overall Study||0||
48777695|NCT01519167|102248264|FG001|NOT COMPLETED|Overall Study||8||
48777696|NCT02228980|102248265|FG000|STARTED|Overall Study||150||
48777697|NCT02228980|102248266|FG001|STARTED|Overall Study||150||
48777698|NCT02228980|102248267|FG002|STARTED|Overall Study||151||
48777699|NCT02228980|102248268|FG003|STARTED|Overall Study||151||
48777700|NCT02228980|102248265|FG000|COMPLETED|Overall Study||126||
48777701|NCT02228980|102248266|FG001|COMPLETED|Overall Study||147||
48777702|NCT02228980|102248267|FG002|COMPLETED|Overall Study||149||
48777703|NCT02228980|102248268|FG003|COMPLETED|Overall Study||148||
48777704|NCT02228980|102248265|FG000|NOT COMPLETED|Overall Study||24||
48777705|NCT02228980|102248266|FG001|NOT COMPLETED|Overall Study||3||
48777706|NCT02228980|102248267|FG002|NOT COMPLETED|Overall Study||2||
48777707|NCT02228980|102248268|FG003|NOT COMPLETED|Overall Study||3||
48777708|NCT04772560|102248269|FG000|STARTED|Overall Study||11||
48462834|NCT05431153|101467600|FG002|NOT COMPLETED|Washout Period 1 (5 Days)||0||
48777709|NCT04772560|102248270|FG001|STARTED|Overall Study||12||
48777710|NCT04772560|102248269|FG000|COMPLETED|Overall Study||11||
48777711|NCT04772560|102248270|FG001|COMPLETED|Overall Study||12||
48777712|NCT04772560|102248269|FG000|NOT COMPLETED|Overall Study||0||
48777713|NCT04772560|102248270|FG001|NOT COMPLETED|Overall Study||0||
48777714|NCT02424578|102248271|FG000|STARTED|Overall Study||15||
48777715|NCT02424578|102248272|FG001|STARTED|Overall Study||15||
48462835|NCT05431153|101467601|FG003|NOT COMPLETED|Washout Period 1 (5 Days)||0||
48462836|NCT05431153|101467602|FG004|NOT COMPLETED|Washout Period 1 (5 Days)||0||
48462837|NCT05431153|101467603|FG005|NOT COMPLETED|Washout Period 1 (5 Days)||0||
48462838|NCT05431153|101467598|FG000|STARTED|Treatment Period 2 (Day 1)||5||
48777716|NCT02424578|102248271|FG000|COMPLETED|Overall Study||15||
48777717|NCT02424578|102248272|FG001|COMPLETED|Overall Study||14||
48777718|NCT02424578|102248271|FG000|NOT COMPLETED|Overall Study||0||
48777719|NCT02424578|102248272|FG001|NOT COMPLETED|Overall Study||1||
48462839|NCT05431153|101467599|FG001|STARTED|Treatment Period 2 (Day 1)||5||
48462840|NCT05431153|101467600|FG002|STARTED|Treatment Period 2 (Day 1)||5||
48462841|NCT05431153|101467601|FG003|STARTED|Treatment Period 2 (Day 1)||5||
48462842|NCT05431153|101467602|FG004|STARTED|Treatment Period 2 (Day 1)||4||
48462843|NCT05431153|101467603|FG005|STARTED|Treatment Period 2 (Day 1)||5||
48462844|NCT05431153|101467598|FG000|COMPLETED|Treatment Period 2 (Day 1)||5||
48462845|NCT05431153|101467599|FG001|COMPLETED|Treatment Period 2 (Day 1)||5||
48462846|NCT05431153|101467600|FG002|COMPLETED|Treatment Period 2 (Day 1)||5||
48462847|NCT05431153|101467601|FG003|COMPLETED|Treatment Period 2 (Day 1)||5||
48462848|NCT05431153|101467602|FG004|COMPLETED|Treatment Period 2 (Day 1)||4||
48462849|NCT05431153|101467603|FG005|COMPLETED|Treatment Period 2 (Day 1)||5||
48462850|NCT05431153|101467598|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
48462851|NCT05431153|101467599|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
48462852|NCT05431153|101467600|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
48462853|NCT05431153|101467601|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
48462854|NCT05431153|101467602|FG004|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
48462855|NCT05431153|101467603|FG005|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
48462856|NCT05431153|101467598|FG000|STARTED|Washout Period 2 (5 Days)||5||
48462857|NCT05431153|101467599|FG001|STARTED|Washout Period 2 (5 Days)||5||
48462858|NCT05431153|101467600|FG002|STARTED|Washout Period 2 (5 Days)||5||
48462859|NCT05431153|101467601|FG003|STARTED|Washout Period 2 (5 Days)||5||
48664957|NCT01394185|101964683|FG004|COMPLETED|Overall Study||2||
48664958|NCT01394185|101964684|FG005|COMPLETED|Overall Study||2||
48664959|NCT01394185|101964679|FG000|NOT COMPLETED|Overall Study||6||
48664960|NCT01394185|101964680|FG001|NOT COMPLETED|Overall Study||0||
48664961|NCT01394185|101964681|FG002|NOT COMPLETED|Overall Study||0||
48664962|NCT01394185|101964682|FG003|NOT COMPLETED|Overall Study||1||
48664963|NCT01394185|101964683|FG004|NOT COMPLETED|Overall Study||4||
48664964|NCT01394185|101964684|FG005|NOT COMPLETED|Overall Study||1||
48664965|NCT00952692|101964685|FG000|STARTED|Overall Study||12||
48664966|NCT00952692|101964685|FG000|COMPLETED|Overall Study||12||
48664967|NCT00952692|101964685|FG000|NOT COMPLETED|Overall Study||0||
48664968|NCT00963638|101964686|FG000|STARTED|Overall Study||20||
48664969|NCT00963638|101964687|FG001|STARTED|Overall Study||20||
48664970|NCT00963638|101964686|FG000|COMPLETED|Overall Study||20||
48664971|NCT00963638|101964687|FG001|COMPLETED|Overall Study||20||
48664972|NCT00963638|101964686|FG000|NOT COMPLETED|Overall Study||0||
48664973|NCT00963638|101964687|FG001|NOT COMPLETED|Overall Study||0||
48664974|NCT03213405|101964688|FG000|STARTED|Overall Study||6||
48664975|NCT03213405|101964689|FG001|STARTED|Overall Study||6||
48664976|NCT03213405|101964690|FG002|STARTED|Overall Study||6||
48664977|NCT03213405|101964691|FG003|STARTED|Overall Study||6||
48664978|NCT03213405|101964688|FG000|COMPLETED|Overall Study||6||
48664979|NCT03213405|101964689|FG001|COMPLETED|Overall Study||6||
48664980|NCT03213405|101964690|FG002|COMPLETED|Overall Study||6||
48664981|NCT03213405|101964691|FG003|COMPLETED|Overall Study||6||
48664982|NCT03213405|101964688|FG000|NOT COMPLETED|Overall Study||0||
48664983|NCT03213405|101964689|FG001|NOT COMPLETED|Overall Study||0||
48664984|NCT03213405|101964690|FG002|NOT COMPLETED|Overall Study||0||
48664985|NCT03213405|101964691|FG003|NOT COMPLETED|Overall Study||0||
48664986|NCT01355627|101964692|FG000|STARTED|Overall Study||362||
48664987|NCT01355627|101964693|FG001|STARTED|Overall Study||364||
48664988|NCT01355627|101964692|FG000|Safety Analysis Set|Overall Study||362||
48664989|NCT01355627|101964693|FG001|Safety Analysis Set|Overall Study||364||
48664990|NCT01355627|101964692|FG000|Full Analysis Set|Overall Study||361||
48664991|NCT01355627|101964693|FG001|Full Analysis Set|Overall Study||365||
48664992|NCT01355627|101964692|FG000|COMPLETED|Overall Study||329||
48664993|NCT01355627|101964693|FG001|COMPLETED|Overall Study||326||
48664994|NCT01355627|101964692|FG000|NOT COMPLETED|Overall Study||33||
48664995|NCT01355627|101964693|FG001|NOT COMPLETED|Overall Study||38||
48664996|NCT02527512|101964694|FG000|STARTED|Overall Study||85||
48664997|NCT02527512|101964695|FG001|STARTED|Overall Study||82||
48664998|NCT02527512|101964694|FG000|COMPLETED|Overall Study||77||
48664999|NCT02527512|101964695|FG001|COMPLETED|Overall Study||76||
48665000|NCT02527512|101964694|FG000|NOT COMPLETED|Overall Study||8||
48665001|NCT02527512|101964695|FG001|NOT COMPLETED|Overall Study||6||
48462860|NCT05431153|101467602|FG004|STARTED|Washout Period 2 (5 Days)||4||
48462861|NCT05431153|101467603|FG005|STARTED|Washout Period 2 (5 Days)||5||
48462862|NCT05431153|101467598|FG000|COMPLETED|Washout Period 2 (5 Days)||5||
48462863|NCT05431153|101467599|FG001|COMPLETED|Washout Period 2 (5 Days)||5||
48665002|NCT04756531|101964696|FG000|STARTED|Overall Study||2||
48665003|NCT04756531|101964697|FG001|STARTED|Overall Study||2||
48665004|NCT04756531|101964698|FG002|STARTED|Overall Study||2||
48665005|NCT04756531|101964699|FG003|STARTED|Overall Study||2||
48665006|NCT04756531|101964700|FG004|STARTED|Overall Study||3||
48462864|NCT05431153|101467600|FG002|COMPLETED|Washout Period 2 (5 Days)||5||
48462865|NCT05431153|101467601|FG003|COMPLETED|Washout Period 2 (5 Days)||5||
48665007|NCT04756531|101964701|FG005|STARTED|Overall Study||2||
48665008|NCT04756531|101964702|FG006|STARTED|Overall Study||8||
48665009|NCT04756531|101964703|FG007|STARTED|Overall Study||4||
48665010|NCT04756531|101964704|FG008|STARTED|Overall Study||4||
48665011|NCT04756531|101964705|FG009|STARTED|Overall Study||7||
48462866|NCT05431153|101467602|FG004|COMPLETED|Washout Period 2 (5 Days)||4||
48462867|NCT05431153|101467603|FG005|COMPLETED|Washout Period 2 (5 Days)||5||
48462868|NCT05431153|101467598|FG000|NOT COMPLETED|Washout Period 2 (5 Days)||0||
48462869|NCT05431153|101467599|FG001|NOT COMPLETED|Washout Period 2 (5 Days)||0||
48462870|NCT05431153|101467600|FG002|NOT COMPLETED|Washout Period 2 (5 Days)||0||
48665012|NCT04756531|101964706|FG010|STARTED|Overall Study||2||
48665013|NCT04756531|101964707|FG011|STARTED|Overall Study||4||
48665014|NCT04756531|101964708|FG012|STARTED|Overall Study||4||
48665015|NCT04756531|101964709|FG013|STARTED|Overall Study||4||
48665016|NCT04756531|101964710|FG014|STARTED|Overall Study||4||
48665017|NCT04756531|101964711|FG015|STARTED|Overall Study||6||
48665018|NCT04756531|101964712|FG016|STARTED|Overall Study||5||
48665019|NCT04756531|101964713|FG017|STARTED|Overall Study||5||
48665020|NCT04756531|101964696|FG000|COMPLETED|Overall Study||2||
48665021|NCT04756531|101964697|FG001|COMPLETED|Overall Study||2||
48665022|NCT04756531|101964698|FG002|COMPLETED|Overall Study||2||
48665023|NCT04756531|101964699|FG003|COMPLETED|Overall Study||2||
48665024|NCT04756531|101964700|FG004|COMPLETED|Overall Study||2||
48665025|NCT04756531|101964701|FG005|COMPLETED|Overall Study||2||
48665026|NCT04756531|101964702|FG006|COMPLETED|Overall Study||7||
48665027|NCT04756531|101964703|FG007|COMPLETED|Overall Study||4||
48665028|NCT04756531|101964704|FG008|COMPLETED|Overall Study||4||
48665029|NCT04756531|101964705|FG009|COMPLETED|Overall Study||7||
48665030|NCT04756531|101964706|FG010|COMPLETED|Overall Study||2||
48665031|NCT04756531|101964707|FG011|COMPLETED|Overall Study||4||
48665032|NCT04756531|101964708|FG012|COMPLETED|Overall Study||4||
48665033|NCT04756531|101964709|FG013|COMPLETED|Overall Study||4||
48665034|NCT04756531|101964710|FG014|COMPLETED|Overall Study||4||
48665035|NCT04756531|101964711|FG015|COMPLETED|Overall Study||6||
48665036|NCT04756531|101964712|FG016|COMPLETED|Overall Study||5||
48665037|NCT04756531|101964713|FG017|COMPLETED|Overall Study||5||
48665038|NCT04756531|101964696|FG000|NOT COMPLETED|Overall Study||0||
48665039|NCT04756531|101964697|FG001|NOT COMPLETED|Overall Study||0||
48665040|NCT04756531|101964698|FG002|NOT COMPLETED|Overall Study||0||
48665041|NCT04756531|101964699|FG003|NOT COMPLETED|Overall Study||0||
48665042|NCT04756531|101964700|FG004|NOT COMPLETED|Overall Study||1||
48665043|NCT04756531|101964701|FG005|NOT COMPLETED|Overall Study||0||
48665044|NCT04756531|101964702|FG006|NOT COMPLETED|Overall Study||1||
48665045|NCT04756531|101964703|FG007|NOT COMPLETED|Overall Study||0||
48665046|NCT04756531|101964704|FG008|NOT COMPLETED|Overall Study||0||
48665047|NCT04756531|101964705|FG009|NOT COMPLETED|Overall Study||0||
48665048|NCT04756531|101964706|FG010|NOT COMPLETED|Overall Study||0||
48665049|NCT04756531|101964707|FG011|NOT COMPLETED|Overall Study||0||
48665050|NCT04756531|101964708|FG012|NOT COMPLETED|Overall Study||0||
48665051|NCT04756531|101964709|FG013|NOT COMPLETED|Overall Study||0||
48665052|NCT04756531|101964710|FG014|NOT COMPLETED|Overall Study||0||
48665053|NCT04756531|101964711|FG015|NOT COMPLETED|Overall Study||0||
48665054|NCT04756531|101964712|FG016|NOT COMPLETED|Overall Study||0||
48665055|NCT04756531|101964713|FG017|NOT COMPLETED|Overall Study||0||
48665056|NCT00543127|101964714|FG000|STARTED|Overall Study||433||
48665057|NCT00543127|101964715|FG001|STARTED|Overall Study||437||
48665058|NCT00543127|101964714|FG000|COMPLETED|Overall Study||303||
48665059|NCT00543127|101964715|FG001|COMPLETED|Overall Study||350||
48665060|NCT00543127|101964714|FG000|NOT COMPLETED|Overall Study||130||
48665061|NCT00543127|101964715|FG001|NOT COMPLETED|Overall Study||87||
48665062|NCT04011241|101964716|FG000|STARTED|Treatment Period 1||14||
48665063|NCT04011241|101964716|FG000|COMPLETED|Treatment Period 1||14||
48665064|NCT04011241|101964716|FG000|NOT COMPLETED|Treatment Period 1||0||
48665065|NCT04011241|101964716|FG000|STARTED|Washout Period||14||
48665066|NCT04011241|101964716|FG000|COMPLETED|Washout Period||14||
48665067|NCT04011241|101964716|FG000|NOT COMPLETED|Washout Period||0||
48665068|NCT04011241|101964716|FG000|STARTED|Treatment Period 2||14||
48665069|NCT04011241|101964716|FG000|COMPLETED|Treatment Period 2||14||
48777720|NCT01518270|102248273|FG000|STARTED|Overall Study||179||
48777721|NCT01518270|102248273|FG000|COMPLETED|Overall Study||179||
48777722|NCT01518270|102248273|FG000|NOT COMPLETED|Overall Study||0||
48462871|NCT05431153|101467601|FG003|NOT COMPLETED|Washout Period 2 (5 Days)||0||
48462872|NCT05431153|101467602|FG004|NOT COMPLETED|Washout Period 2 (5 Days)||0||
48462873|NCT05431153|101467603|FG005|NOT COMPLETED|Washout Period 2 (5 Days)||0||
48665070|NCT04011241|101964716|FG000|NOT COMPLETED|Treatment Period 2||0||
48462874|NCT05431153|101467598|FG000|STARTED|Treatment Period 3 (Day 1)||5||
48665071|NCT02758626|101964717|FG000|STARTED|Double-Blind Phase (Week 0 - Week 28)||9||
48665072|NCT02758626|101964718|FG001|STARTED|Double-Blind Phase (Week 0 - Week 28)||6||
48665073|NCT02758626|101964717|FG000|COMPLETED|Double-Blind Phase (Week 0 - Week 28)||8||
48665074|NCT02758626|101964718|FG001|COMPLETED|Double-Blind Phase (Week 0 - Week 28)||6||
48665075|NCT02758626|101964717|FG000|NOT COMPLETED|Double-Blind Phase (Week 0 - Week 28)||1||
48665076|NCT02758626|101964718|FG001|NOT COMPLETED|Double-Blind Phase (Week 0 - Week 28)||0||
48665077|NCT02758626|101964717|FG000|STARTED|Open-Label Extension (Week 28-Week 124)||8||
48665078|NCT02758626|101964718|FG001|STARTED|Open-Label Extension (Week 28-Week 124)||6||
48665079|NCT02758626|101964717|FG000|COMPLETED|Open-Label Extension (Week 28-Week 124)||6||
48665080|NCT02758626|101964718|FG001|COMPLETED|Open-Label Extension (Week 28-Week 124)||3||
48777723|NCT04270370|102248274|FG000|STARTED|Overall Study||10||
48462875|NCT05431153|101467599|FG001|STARTED|Treatment Period 3 (Day 1)||5||
48462876|NCT05431153|101467600|FG002|STARTED|Treatment Period 3 (Day 1)||5||
48462877|NCT05431153|101467601|FG003|STARTED|Treatment Period 3 (Day 1)||5||
48462878|NCT05431153|101467602|FG004|STARTED|Treatment Period 3 (Day 1)||4||
48462879|NCT05431153|101467603|FG005|STARTED|Treatment Period 3 (Day 1)||5||
48462880|NCT05431153|101467598|FG000|COMPLETED|Treatment Period 3 (Day 1)||5||
48462881|NCT05431153|101467599|FG001|COMPLETED|Treatment Period 3 (Day 1)||5||
48462882|NCT05431153|101467600|FG002|COMPLETED|Treatment Period 3 (Day 1)||5||
48462883|NCT05431153|101467601|FG003|COMPLETED|Treatment Period 3 (Day 1)||5||
48462884|NCT05431153|101467602|FG004|COMPLETED|Treatment Period 3 (Day 1)||4||
48462885|NCT05431153|101467603|FG005|COMPLETED|Treatment Period 3 (Day 1)||5||
48462886|NCT05431153|101467598|FG000|NOT COMPLETED|Treatment Period 3 (Day 1)||0||
48462887|NCT05431153|101467599|FG001|NOT COMPLETED|Treatment Period 3 (Day 1)||0||
48462888|NCT05431153|101467600|FG002|NOT COMPLETED|Treatment Period 3 (Day 1)||0||
48462889|NCT05431153|101467601|FG003|NOT COMPLETED|Treatment Period 3 (Day 1)||0||
48462890|NCT05431153|101467602|FG004|NOT COMPLETED|Treatment Period 3 (Day 1)||0||
48462891|NCT05431153|101467603|FG005|NOT COMPLETED|Treatment Period 3 (Day 1)||0||
48462892|NCT05431153|101467598|FG000|STARTED|Washout Period 3 (5 Days)||5||
48462893|NCT05431153|101467599|FG001|STARTED|Washout Period 3 (5 Days)||5||
48462894|NCT05431153|101467600|FG002|STARTED|Washout Period 3 (5 Days)||5||
48462895|NCT05431153|101467601|FG003|STARTED|Washout Period 3 (5 Days)||5||
48462896|NCT05431153|101467602|FG004|STARTED|Washout Period 3 (5 Days)||4||
48462897|NCT05431153|101467603|FG005|STARTED|Washout Period 3 (5 Days)||5||
48462898|NCT05431153|101467598|FG000|COMPLETED|Washout Period 3 (5 Days)||5||
48462899|NCT05431153|101467599|FG001|COMPLETED|Washout Period 3 (5 Days)||5||
48462900|NCT05431153|101467600|FG002|COMPLETED|Washout Period 3 (5 Days)||5||
48462901|NCT05431153|101467601|FG003|COMPLETED|Washout Period 3 (5 Days)||5||
48462902|NCT05431153|101467602|FG004|COMPLETED|Washout Period 3 (5 Days)||4||
48462903|NCT05431153|101467603|FG005|COMPLETED|Washout Period 3 (5 Days)||5||
48462904|NCT05431153|101467598|FG000|NOT COMPLETED|Washout Period 3 (5 Days)||0||
48462905|NCT05431153|101467599|FG001|NOT COMPLETED|Washout Period 3 (5 Days)||0||
48462906|NCT05431153|101467600|FG002|NOT COMPLETED|Washout Period 3 (5 Days)||0||
48462907|NCT05431153|101467601|FG003|NOT COMPLETED|Washout Period 3 (5 Days)||0||
48462908|NCT05431153|101467602|FG004|NOT COMPLETED|Washout Period 3 (5 Days)||0||
48462909|NCT05431153|101467603|FG005|NOT COMPLETED|Washout Period 3 (5 Days)||0||
48462910|NCT05431153|101467598|FG000|STARTED|Treatment Period 4 (Day 1)||5||
48462911|NCT05431153|101467599|FG001|STARTED|Treatment Period 4 (Day 1)||5||
48462912|NCT05431153|101467600|FG002|STARTED|Treatment Period 4 (Day 1)||5||
48462913|NCT05431153|101467601|FG003|STARTED|Treatment Period 4 (Day 1)||5||
48462914|NCT05431153|101467602|FG004|STARTED|Treatment Period 4 (Day 1)||4||
48462915|NCT05431153|101467603|FG005|STARTED|Treatment Period 4 (Day 1)||5||
48462916|NCT05431153|101467598|FG000|COMPLETED|Treatment Period 4 (Day 1)||5||
48462917|NCT05431153|101467599|FG001|COMPLETED|Treatment Period 4 (Day 1)||5||
48462918|NCT05431153|101467600|FG002|COMPLETED|Treatment Period 4 (Day 1)||5||
48462919|NCT05431153|101467601|FG003|COMPLETED|Treatment Period 4 (Day 1)||5||
48462920|NCT05431153|101467602|FG004|COMPLETED|Treatment Period 4 (Day 1)||4||
48462921|NCT05431153|101467603|FG005|COMPLETED|Treatment Period 4 (Day 1)||5||
48462922|NCT05431153|101467598|FG000|NOT COMPLETED|Treatment Period 4 (Day 1)||0||
48462923|NCT05431153|101467599|FG001|NOT COMPLETED|Treatment Period 4 (Day 1)||0||
48462924|NCT05431153|101467600|FG002|NOT COMPLETED|Treatment Period 4 (Day 1)||0||
48462925|NCT05431153|101467601|FG003|NOT COMPLETED|Treatment Period 4 (Day 1)||0||
48462926|NCT05431153|101467602|FG004|NOT COMPLETED|Treatment Period 4 (Day 1)||0||
48462927|NCT05431153|101467603|FG005|NOT COMPLETED|Treatment Period 4 (Day 1)||0||
48462928|NCT01625377|101467604|FG000|STARTED|Overall Study||95||
48462929|NCT01625377|101467605|FG001|STARTED|Overall Study||93||
48462930|NCT01625377|101467604|FG000|Safety Set of Population|Overall Study||94||
48462931|NCT01625377|101467605|FG001|Safety Set of Population|Overall Study||90||
48462932|NCT01625377|101467604|FG000|Intent to Treat Population|Overall Study||93||
48462933|NCT01625377|101467605|FG001|Intent to Treat Population|Overall Study||90||
48462934|NCT01625377|101467604|FG000|COMPLETED|Overall Study||88||
48462935|NCT01625377|101467605|FG001|COMPLETED|Overall Study||71||
48462936|NCT01625377|101467604|FG000|NOT COMPLETED|Overall Study||7||
48462937|NCT01625377|101467605|FG001|NOT COMPLETED|Overall Study||22||
48462938|NCT03443869|101467606|FG000|STARTED|Overall Study||301||
48462939|NCT03443869|101467607|FG001|STARTED|Overall Study||300||
48462940|NCT03443869|101467606|FG000|Treated|Overall Study||292||
48462941|NCT03443869|101467607|FG001|Treated|Overall Study||297||
48462942|NCT03443869|101467606|FG000|COMPLETED|Overall Study||256||
48462943|NCT03443869|101467607|FG001|COMPLETED|Overall Study||266||
48777724|NCT04270370|102248275|FG001|STARTED|Overall Study||6||
48462944|NCT03443869|101467606|FG000|NOT COMPLETED|Overall Study||45||
48462945|NCT03443869|101467607|FG001|NOT COMPLETED|Overall Study||34||
48462946|NCT05432271|101467608|FG000|STARTED|Overall Study||1627||
48462947|NCT05432271|101467609|FG001|STARTED|Overall Study||1639||
48462948|NCT05432271|101467610|FG002|STARTED|Overall Study||1623||
48462949|NCT05432271|101467611|FG003|STARTED|Overall Study||1633||
48777725|NCT04270370|102248276|FG002|STARTED|Overall Study||6||
48462950|NCT05432271|101467612|FG004|STARTED|Overall Study||1623||
48462951|NCT05432271|101467608|FG000|COMPLETED|Overall Study||1627||
48462952|NCT05432271|101467609|FG001|COMPLETED|Overall Study||1639||
48462953|NCT05432271|101467610|FG002|COMPLETED|Overall Study||1623||
48462954|NCT05432271|101467611|FG003|COMPLETED|Overall Study||1633||
48462955|NCT05432271|101467612|FG004|COMPLETED|Overall Study||1623||
48462956|NCT05432271|101467608|FG000|NOT COMPLETED|Overall Study||0||
48462957|NCT05432271|101467609|FG001|NOT COMPLETED|Overall Study||0||
48462958|NCT05432271|101467610|FG002|NOT COMPLETED|Overall Study||0||
48462959|NCT05432271|101467611|FG003|NOT COMPLETED|Overall Study||0||
48462960|NCT05432271|101467612|FG004|NOT COMPLETED|Overall Study||0||
48462961|NCT02668302|101467613|FG000|STARTED|Overall Study||20||
48462962|NCT02668302|101467614|FG001|STARTED|Overall Study||20||
48462963|NCT02668302|101467613|FG000|COMPLETED|Overall Study||19||
48462964|NCT02668302|101467614|FG001|COMPLETED|Overall Study||20||
48462965|NCT02668302|101467613|FG000|NOT COMPLETED|Overall Study||1||
48462966|NCT02668302|101467614|FG001|NOT COMPLETED|Overall Study||0||
48462967|NCT00467584|101467615|FG000|STARTED|Overall Study||21||
48462968|NCT00467584|101467616|FG001|STARTED|Overall Study||20||
48462969|NCT00467584|101467617|FG002|STARTED|Overall Study||21||
48462970|NCT00467584|101467615|FG000|COMPLETED|Overall Study||17||
48462971|NCT00467584|101467616|FG001|COMPLETED|Overall Study||15||
48462972|NCT00467584|101467617|FG002|COMPLETED|Overall Study||20||
48462973|NCT00467584|101467615|FG000|NOT COMPLETED|Overall Study||4||
48462974|NCT00467584|101467616|FG001|NOT COMPLETED|Overall Study||5||
48462975|NCT00467584|101467617|FG002|NOT COMPLETED|Overall Study||1||
48462976|NCT01960816|101467618|FG000|STARTED|Overall Study||33||
48462977|NCT01960816|101467618|FG000|COMPLETED|Overall Study||32||
48462978|NCT01960816|101467618|FG000|NOT COMPLETED|Overall Study||1||
48462979|NCT03538756|101467619|FG000|STARTED|Baseline Cross-over||36||
48462980|NCT03538756|101467620|FG001|STARTED|Baseline Cross-over||33||
48462981|NCT03538756|101467621|FG002|STARTED|Baseline Cross-over||0||
48462982|NCT03538756|101467619|FG000|COMPLETED|Baseline Cross-over||36||
48462983|NCT03538756|101467620|FG001|COMPLETED|Baseline Cross-over||33||
48462984|NCT03538756|101467621|FG002|COMPLETED|Baseline Cross-over||0||
48462985|NCT03538756|101467619|FG000|NOT COMPLETED|Baseline Cross-over||0||
48462986|NCT03538756|101467620|FG001|NOT COMPLETED|Baseline Cross-over||0||
48462987|NCT03538756|101467621|FG002|NOT COMPLETED|Baseline Cross-over||0||
48462988|NCT03538756|101467619|FG000|STARTED|Long-Term Follow-up||0||
48462989|NCT03538756|101467620|FG001|STARTED|Long-Term Follow-up||0||
48462990|NCT03538756|101467621|FG002|STARTED|Long-Term Follow-up||69||
48462991|NCT03538756|101467619|FG000|COMPLETED|Long-Term Follow-up||0|Week 52 Follow-up Visit|
48462992|NCT03538756|101467620|FG001|COMPLETED|Long-Term Follow-up||0|Week 52 Follow-up Visit|
48462993|NCT03538756|101467621|FG002|COMPLETED|Long-Term Follow-up||36|Week 52 Follow-up Visit|
48462994|NCT03538756|101467619|FG000|NOT COMPLETED|Long-Term Follow-up||0||
48462995|NCT03538756|101467620|FG001|NOT COMPLETED|Long-Term Follow-up||0||
48462996|NCT03538756|101467621|FG002|NOT COMPLETED|Long-Term Follow-up||33||
48462997|NCT02265848|101467622|FG000|STARTED|Overall Study||11||
48462998|NCT02265848|101467623|FG001|STARTED|Overall Study||11||
48462999|NCT02265848|101467622|FG000|COMPLETED|Overall Study||11||
48463000|NCT02265848|101467623|FG001|COMPLETED|Overall Study||11||
48463001|NCT02265848|101467622|FG000|NOT COMPLETED|Overall Study||0||
48463002|NCT02265848|101467623|FG001|NOT COMPLETED|Overall Study||0||
48463003|NCT01309919|101467624|FG000|STARTED|Overall Study||75||
48463004|NCT01309919|101467625|FG001|STARTED|Overall Study||75||
48463005|NCT01309919|101467624|FG000|COMPLETED|Overall Study||58||
48463006|NCT01309919|101467625|FG001|COMPLETED|Overall Study||27||
48463007|NCT01309919|101467624|FG000|NOT COMPLETED|Overall Study||17||
48463008|NCT01309919|101467625|FG001|NOT COMPLETED|Overall Study||48||
48463009|NCT02153736|101467626|FG000|STARTED|Overall Study||7||
48463010|NCT02153736|101467627|FG001|STARTED|Overall Study||7||
48463011|NCT02153736|101467626|FG000|COMPLETED|Overall Study||5||
48463012|NCT02153736|101467627|FG001|COMPLETED|Overall Study||5||
48463013|NCT02153736|101467626|FG000|NOT COMPLETED|Overall Study||2||
48463014|NCT02153736|101467627|FG001|NOT COMPLETED|Overall Study||2||
48463015|NCT01280981|101467628|FG000|STARTED|Overall Study||288||
48463016|NCT01280981|101467628|FG000|Intent to Treat (ITT) Population|Overall Study||260||
48463017|NCT01280981|101467628|FG000|COMPLETED|Overall Study||196||
48463018|NCT01280981|101467628|FG000|NOT COMPLETED|Overall Study||92||
48463019|NCT02117193|101467629|FG000|STARTED|Overall Study||10||
48463020|NCT02117193|101467629|FG000|Alcohol Intake + Normal Sleep|Overall Study||10||
48463021|NCT02117193|101467629|FG000|Placebo Intake + Normal Sleep|Overall Study||10||
48463022|NCT02117193|101467629|FG000|Alcohol Intake + Sleep Deprivation|Overall Study||10||
48463023|NCT02117193|101467629|FG000|Placebo Intake + Sleep Deprivation|Overall Study||10||
48463024|NCT02117193|101467629|FG000|COMPLETED|Overall Study||10||
48463025|NCT02117193|101467629|FG000|NOT COMPLETED|Overall Study||0||
48463026|NCT01346410|101467630|FG000|STARTED|Overall Study||1||
48463027|NCT01346410|101467630|FG000|COMPLETED|Overall Study||0||
48463028|NCT01346410|101467630|FG000|NOT COMPLETED|Overall Study||1||
48463029|NCT02688608|101467631|FG000|STARTED|Overall Study||6||
48463030|NCT02688608|101467631|FG000|COMPLETED|Overall Study||5||
48463031|NCT02688608|101467631|FG000|NOT COMPLETED|Overall Study||1||
48463032|NCT02780700|101467632|FG000|STARTED|Overall Study||1||
48463033|NCT02780700|101467632|FG000|COMPLETED|Overall Study||0||
48463034|NCT02780700|101467632|FG000|NOT COMPLETED|Overall Study||1||
48463035|NCT01595009|101467633|FG000|STARTED|Core||126||
48463036|NCT01595009|101467634|FG001|STARTED|Core||120||
48463037|NCT01595009|101467635|FG002|STARTED|Core||0||
48463038|NCT01595009|101467636|FG003|STARTED|Core||0||
48463039|NCT01595009|101467633|FG000|COMPLETED|Core||0||
48463040|NCT01595009|101467634|FG001|COMPLETED|Core||0||
48463041|NCT01595009|101467635|FG002|COMPLETED|Core||0||
48463042|NCT01595009|101467636|FG003|COMPLETED|Core||0||
48463043|NCT01595009|101467633|FG000|NOT COMPLETED|Core||126||
48463044|NCT01595009|101467634|FG001|NOT COMPLETED|Core||120||
48463045|NCT01595009|101467635|FG002|NOT COMPLETED|Core||0||
48463046|NCT01595009|101467636|FG003|NOT COMPLETED|Core||0||
48463047|NCT01595009|101467633|FG000|STARTED|Extension||0||
48463048|NCT01595009|101467634|FG001|STARTED|Extension||0||
48463049|NCT01595009|101467635|FG002|STARTED|Extension||4||
48463050|NCT01595009|101467636|FG003|STARTED|Extension||11||
48463051|NCT01595009|101467633|FG000|COMPLETED|Extension||0||
48463052|NCT01595009|101467634|FG001|COMPLETED|Extension||0||
48463053|NCT01595009|101467635|FG002|COMPLETED|Extension||0||
48463054|NCT01595009|101467636|FG003|COMPLETED|Extension||0||
48463055|NCT01595009|101467633|FG000|NOT COMPLETED|Extension||0||
48463056|NCT01595009|101467634|FG001|NOT COMPLETED|Extension||0||
48463057|NCT01595009|101467635|FG002|NOT COMPLETED|Extension||4||
48463058|NCT01595009|101467636|FG003|NOT COMPLETED|Extension||11||
48463059|NCT04947579|101470883|FG000|STARTED|Week 0 - Week 12 (Placebo-Controlled)||49||
48463060|NCT04947579|101470884|FG001|STARTED|Week 0 - Week 12 (Placebo-Controlled)||49||
48463061|NCT04947579|101470885|FG002|STARTED|Week 0 - Week 12 (Placebo-Controlled)||49||
48463062|NCT04947579|101470886|FG003|STARTED|Week 0 - Week 12 (Placebo-Controlled)||5||
48463063|NCT04947579|101470887|FG004|STARTED|Week 0 - Week 12 (Placebo-Controlled)||7||
48463064|NCT04947579|101470888|FG005|STARTED|Week 0 - Week 12 (Placebo-Controlled)||8||
48463065|NCT04947579|101470883|FG000|COMPLETED|Week 0 - Week 12 (Placebo-Controlled)||42||
48463066|NCT04947579|101470884|FG001|COMPLETED|Week 0 - Week 12 (Placebo-Controlled)||42||
48463067|NCT04947579|101470885|FG002|COMPLETED|Week 0 - Week 12 (Placebo-Controlled)||39||
48463068|NCT04947579|101470886|FG003|COMPLETED|Week 0 - Week 12 (Placebo-Controlled)||3||
48463069|NCT04947579|101470887|FG004|COMPLETED|Week 0 - Week 12 (Placebo-Controlled)||5||
48463070|NCT04947579|101470888|FG005|COMPLETED|Week 0 - Week 12 (Placebo-Controlled)||7||
48463071|NCT04947579|101470883|FG000|NOT COMPLETED|Week 0 - Week 12 (Placebo-Controlled)||7||
48463072|NCT04947579|101470884|FG001|NOT COMPLETED|Week 0 - Week 12 (Placebo-Controlled)||7||
48463073|NCT04947579|101470885|FG002|NOT COMPLETED|Week 0 - Week 12 (Placebo-Controlled)||10||
48463074|NCT04947579|101470886|FG003|NOT COMPLETED|Week 0 - Week 12 (Placebo-Controlled)||2||
48463075|NCT04947579|101470887|FG004|NOT COMPLETED|Week 0 - Week 12 (Placebo-Controlled)||2||
48463076|NCT04947579|101470888|FG005|NOT COMPLETED|Week 0 - Week 12 (Placebo-Controlled)||1||
48463077|NCT04947579|101470883|FG000|STARTED|Week 12 - Week 64 (Long-Term Extension)||0||
48463078|NCT04947579|101470884|FG001|STARTED|Week 12 - Week 64 (Long-Term Extension)||63||
48463079|NCT04947579|101470885|FG002|STARTED|Week 12 - Week 64 (Long-Term Extension)||61||
48463080|NCT04947579|101470886|FG003|STARTED|Week 12 - Week 64 (Long-Term Extension)||0||
48463081|NCT04947579|101470887|FG004|STARTED|Week 12 - Week 64 (Long-Term Extension)||7||
48463082|NCT04947579|101470888|FG005|STARTED|Week 12 - Week 64 (Long-Term Extension)||8||
48463083|NCT04947579|101470883|FG000|Placebo Patients Re-randomized to CC-99677 60 mg|Week 12 - Week 64 (Long-Term Extension)||0||
48463084|NCT04947579|101470884|FG001|Placebo Patients Re-randomized to CC-99677 60 mg|Week 12 - Week 64 (Long-Term Extension)||21||
48463085|NCT04947579|101470885|FG002|Placebo Patients Re-randomized to CC-99677 60 mg|Week 12 - Week 64 (Long-Term Extension)||0||
48463086|NCT04947579|101470886|FG003|Placebo Patients Re-randomized to CC-99677 60 mg|Week 12 - Week 64 (Long-Term Extension)||0||
48463087|NCT04947579|101470887|FG004|Placebo Patients Re-randomized to CC-99677 60 mg|Week 12 - Week 64 (Long-Term Extension)||2||
48463088|NCT04947579|101470888|FG005|Placebo Patients Re-randomized to CC-99677 60 mg|Week 12 - Week 64 (Long-Term Extension)||0||
48463089|NCT04947579|101470883|FG000|Placebo Patients Re-randomized to CC-99677 150 mg|Week 12 - Week 64 (Long-Term Extension)||0||
48463090|NCT04947579|101470884|FG001|Placebo Patients Re-randomized to CC-99677 150 mg|Week 12 - Week 64 (Long-Term Extension)||0||
48463091|NCT04947579|101470885|FG002|Placebo Patients Re-randomized to CC-99677 150 mg|Week 12 - Week 64 (Long-Term Extension)||21||
48463092|NCT04947579|101470886|FG003|Placebo Patients Re-randomized to CC-99677 150 mg|Week 12 - Week 64 (Long-Term Extension)||0||
48463093|NCT04947579|101470887|FG004|Placebo Patients Re-randomized to CC-99677 150 mg|Week 12 - Week 64 (Long-Term Extension)||0||
48665081|NCT02758626|101964717|FG000|NOT COMPLETED|Open-Label Extension (Week 28-Week 124)||2||
48777726|NCT04270370|102248277|FG003|STARTED|Overall Study||6||
48777727|NCT04270370|102248278|FG004|STARTED|Overall Study||6||
48777728|NCT04270370|102248279|FG005|STARTED|Overall Study||6||
48463094|NCT04947579|101470888|FG005|Placebo Patients Re-randomized to CC-99677 150 mg|Week 12 - Week 64 (Long-Term Extension)||1||
48463095|NCT04947579|101470883|FG000|COMPLETED|Week 12 - Week 64 (Long-Term Extension)||0||
48463096|NCT04947579|101470884|FG001|COMPLETED|Week 12 - Week 64 (Long-Term Extension)||1||
48463097|NCT04947579|101470885|FG002|COMPLETED|Week 12 - Week 64 (Long-Term Extension)||1||
48463098|NCT04947579|101470886|FG003|COMPLETED|Week 12 - Week 64 (Long-Term Extension)||0||
48463099|NCT04947579|101470887|FG004|COMPLETED|Week 12 - Week 64 (Long-Term Extension)||0||
48463100|NCT04947579|101470888|FG005|COMPLETED|Week 12 - Week 64 (Long-Term Extension)||0||
48463101|NCT04947579|101470883|FG000|NOT COMPLETED|Week 12 - Week 64 (Long-Term Extension)||0||
48463102|NCT04947579|101470884|FG001|NOT COMPLETED|Week 12 - Week 64 (Long-Term Extension)||62||
48777729|NCT04270370|102248280|FG006|STARTED|Overall Study||4||
48777730|NCT04270370|102248281|FG007|STARTED|Overall Study||4||
48777731|NCT04270370|102248282|FG008|STARTED|Overall Study||6||
48777732|NCT04270370|102248283|FG009|STARTED|Overall Study||6||
48777733|NCT04270370|102248284|FG010|STARTED|Overall Study||6||
48777734|NCT04270370|102248285|FG011|STARTED|Overall Study||6||
48777735|NCT04270370|102248274|FG000|Received at Least One Dose of Study Drug|Overall Study||10||
48777736|NCT04270370|102248275|FG001|Received at Least One Dose of Study Drug|Overall Study||6||
48777737|NCT04270370|102248276|FG002|Received at Least One Dose of Study Drug|Overall Study||6||
48463103|NCT04947579|101470885|FG002|NOT COMPLETED|Week 12 - Week 64 (Long-Term Extension)||60||
48463104|NCT04947579|101470886|FG003|NOT COMPLETED|Week 12 - Week 64 (Long-Term Extension)||0||
48463105|NCT04947579|101470887|FG004|NOT COMPLETED|Week 12 - Week 64 (Long-Term Extension)||7||
48463106|NCT04947579|101470888|FG005|NOT COMPLETED|Week 12 - Week 64 (Long-Term Extension)||8||
48463107|NCT00467818|101470889|FG000|STARTED|Overall Study||9||
48463108|NCT00467818|101470890|FG001|STARTED|Overall Study||8||
48463109|NCT00467818|101470889|FG000|COMPLETED|Overall Study||6||
48463110|NCT00467818|101470890|FG001|COMPLETED|Overall Study||6||
48463111|NCT00467818|101470889|FG000|NOT COMPLETED|Overall Study||3||
48463112|NCT00467818|101470890|FG001|NOT COMPLETED|Overall Study||2||
48463113|NCT00330421|101470891|FG000|STARTED|Overall Study||15||
48463114|NCT00330421|101470892|FG001|STARTED|Overall Study||0||
48463115|NCT00330421|101470891|FG000|COMPLETED|Overall Study||15||
48463116|NCT00330421|101470892|FG001|COMPLETED|Overall Study||0||
48463117|NCT00330421|101470891|FG000|NOT COMPLETED|Overall Study||0||
48463118|NCT00330421|101470892|FG001|NOT COMPLETED|Overall Study||0||
48463119|NCT00928252|101470893|FG000|STARTED|Overall Study||45||
48463120|NCT00928252|101470893|FG000|COMPLETED|Overall Study||42||
48665082|NCT02758626|101964718|FG001|NOT COMPLETED|Open-Label Extension (Week 28-Week 124)||3||
48665083|NCT01254214|101964719|FG000|STARTED|Overall Study||27||
48665084|NCT01254214|101964720|FG001|STARTED|Overall Study||28||
48665085|NCT01254214|101964719|FG000|COMPLETED|Overall Study||24||
48665086|NCT01254214|101964720|FG001|COMPLETED|Overall Study||27||
48665087|NCT01254214|101964719|FG000|NOT COMPLETED|Overall Study||3||
48665088|NCT01254214|101964720|FG001|NOT COMPLETED|Overall Study||1||
48665089|NCT03802396|101964721|FG000|STARTED|Overall Study||140||
48665090|NCT03802396|101964722|FG001|STARTED|Overall Study||49||
48665091|NCT03802396|101964721|FG000|COMPLETED|Overall Study||137||
48665092|NCT03802396|101964722|FG001|COMPLETED|Overall Study||49||
48665093|NCT03802396|101964721|FG000|NOT COMPLETED|Overall Study||3||
48665094|NCT03802396|101964722|FG001|NOT COMPLETED|Overall Study||0||
48665095|NCT00492050|101964723|FG000|STARTED|Overall Study||37|(Additonal cycle 3); Bortezomib 1.6 mg/m2, Rituximab 375 mg/m2 (1 additional cycle)|
48665096|NCT00492050|101964723|FG000|Inadequate Response to First Two Cycles|Overall Study||25||
48665097|NCT00492050|101964723|FG000|Inadequate Response to First 3 Cycles|Overall Study||12|Rituximab 375 mg/m\^2, Cyclophosphamide 100 mg/m\^2, Doborubicine 9 mg/m\^2/day, dexamethasone 40 mg/day (2 cycles)|
48665098|NCT00492050|101964723|FG000|If Adequate Response to First Two Cycles-participants Proceed to Stem Cell Collection|Overall Study||30|+ 1 cycle of 2CdA 3.0 mg/m2, cyclophosphamide 60 mg/m2, rituximab 375 mg/m2|
48665099|NCT00492050|101964723|FG000|COMPLETED|Overall Study||28||
48665100|NCT00492050|101964723|FG000|NOT COMPLETED|Overall Study||9||
48665101|NCT04618276|101964724|FG000|STARTED|Overall Study||10|Each of the 10 participant was his own control. We performed PDT on the right leg and on the left leg no PDT (control)|20
48665102|NCT04618276|101964725|FG001|STARTED|Overall Study||10|Each of the 10 participant was his own control. We performed PDT on the right leg and on the left leg no PDT (control)|20
48665103|NCT04618276|101964724|FG000|COMPLETED|Overall Study||10|Each participant was his own control (no PDT on the contralateral leg)|20
48665104|NCT04618276|101964725|FG001|COMPLETED|Overall Study||10|Each participant was his own control (no PDT on the contralateral leg)|20
48665105|NCT04618276|101964724|FG000|NOT COMPLETED|Overall Study||0||0
48665106|NCT04618276|101964725|FG001|NOT COMPLETED|Overall Study||0||0
48665107|NCT01356147|101964726|FG000|STARTED|Overall Study||5||
48665108|NCT01356147|101964727|FG001|STARTED|Overall Study||6||
48463121|NCT00928252|101470893|FG000|NOT COMPLETED|Overall Study||3||
48463122|NCT02043366|101470894|FG000|STARTED|Overall Study||30||
48463123|NCT02043366|101470895|FG001|STARTED|Overall Study||30||
48463124|NCT02043366|101470896|FG002|STARTED|Overall Study||30||
48463125|NCT02043366|101470897|FG003|STARTED|Overall Study||30||
48777738|NCT04270370|102248277|FG003|Received at Least One Dose of Study Drug|Overall Study||6||
48777739|NCT04270370|102248278|FG004|Received at Least One Dose of Study Drug|Overall Study||6||
48189788|NCT00335556|100786310|FG002|COMPLETED|Overall Study||2||
48189789|NCT00335556|100786311|FG003|COMPLETED|Overall Study||5||
48777740|NCT04270370|102248279|FG005|Received at Least One Dose of Study Drug|Overall Study||6||
48777741|NCT04270370|102248280|FG006|Received at Least One Dose of Study Drug|Overall Study||4||
48777742|NCT04270370|102248281|FG007|Received at Least One Dose of Study Drug|Overall Study||4||
48777743|NCT04270370|102248282|FG008|Received at Least One Dose of Study Drug|Overall Study||6||
48777744|NCT04270370|102248283|FG009|Received at Least One Dose of Study Drug|Overall Study||6||
48777745|NCT04270370|102248284|FG010|Received at Least One Dose of Study Drug|Overall Study||6||
48777746|NCT04270370|102248285|FG011|Received at Least One Dose of Study Drug|Overall Study||6||
48777747|NCT04270370|102248274|FG000|COMPLETED|Overall Study||9||
48777748|NCT04270370|102248275|FG001|COMPLETED|Overall Study||6||
48777749|NCT04270370|102248276|FG002|COMPLETED|Overall Study||6||
48777750|NCT04270370|102248277|FG003|COMPLETED|Overall Study||6||
48777751|NCT04270370|102248278|FG004|COMPLETED|Overall Study||6||
48777752|NCT04270370|102248279|FG005|COMPLETED|Overall Study||6||
48777753|NCT04270370|102248280|FG006|COMPLETED|Overall Study||4||
48777754|NCT04270370|102248281|FG007|COMPLETED|Overall Study||4||
48777755|NCT04270370|102248282|FG008|COMPLETED|Overall Study||5||
48777756|NCT04270370|102248283|FG009|COMPLETED|Overall Study||6||
48777757|NCT04270370|102248284|FG010|COMPLETED|Overall Study||6||
48777758|NCT04270370|102248285|FG011|COMPLETED|Overall Study||6||
48777759|NCT04270370|102248274|FG000|NOT COMPLETED|Overall Study||1||
48777760|NCT04270370|102248275|FG001|NOT COMPLETED|Overall Study||0||
48777761|NCT04270370|102248276|FG002|NOT COMPLETED|Overall Study||0||
48777762|NCT04270370|102248277|FG003|NOT COMPLETED|Overall Study||0||
48777763|NCT04270370|102248278|FG004|NOT COMPLETED|Overall Study||0||
48777764|NCT04270370|102248279|FG005|NOT COMPLETED|Overall Study||0||
48777765|NCT04270370|102248280|FG006|NOT COMPLETED|Overall Study||0||
48777766|NCT04270370|102248281|FG007|NOT COMPLETED|Overall Study||0||
48777767|NCT04270370|102248282|FG008|NOT COMPLETED|Overall Study||1||
48777768|NCT04270370|102248283|FG009|NOT COMPLETED|Overall Study||0||
48777769|NCT04270370|102248284|FG010|NOT COMPLETED|Overall Study||0||
48777770|NCT04270370|102248285|FG011|NOT COMPLETED|Overall Study||0||
48777771|NCT01493167|102248286|FG000|STARTED|Overall Study||97||
48777772|NCT01493167|102248286|FG000|COMPLETED|Overall Study||97||
48777773|NCT01493167|102248286|FG000|NOT COMPLETED|Overall Study||0||
48777774|NCT01209325|102248287|FG000|STARTED|Overall Study||149|Enrolled|
48777775|NCT01209325|102248287|FG000|Eligible|Overall Study||145||
48777776|NCT01209325|102248287|FG000|Received First Vaccine Injection|Overall Study||144||
48777777|NCT01209325|102248287|FG000|Received Second Vaccine Injection|Overall Study||141||
48777778|NCT01209325|102248287|FG000|Received Third Vaccine Infjection|Overall Study||138||
48777779|NCT01209325|102248287|FG000|Returned After Week 28|Overall Study||124||
48777780|NCT01209325|102248287|FG000|COMPLETED|Overall Study||106||
48777781|NCT01209325|102248287|FG000|NOT COMPLETED|Overall Study||43||
48777782|NCT02404025|102248288|FG000|STARTED|Overall Study||10||
48777783|NCT02404025|102248288|FG000|COMPLETED|Overall Study||6||
48777784|NCT02404025|102248288|FG000|NOT COMPLETED|Overall Study||4||
48777785|NCT00329797|102248289|FG000|STARTED|Overall Study||57||
48777786|NCT00329797|102248290|FG001|STARTED|Overall Study||52||
48777787|NCT00329797|102248289|FG000|COMPLETED|Overall Study||50||
48777788|NCT00329797|102248290|FG001|COMPLETED|Overall Study||46||
48777789|NCT00329797|102248289|FG000|NOT COMPLETED|Overall Study||7||
48777790|NCT00329797|102248290|FG001|NOT COMPLETED|Overall Study||6||
48777791|NCT03926611|102248291|FG000|STARTED|Overall Study||44||
48777792|NCT03926611|102248292|FG001|STARTED|Overall Study||44||
48777793|NCT03926611|102248293|FG002|STARTED|Overall Study||47||
48777794|NCT03926611|102248294|FG003|STARTED|Overall Study||44||
48777795|NCT03926611|102248295|FG004|STARTED|Overall Study||44||
48777796|NCT03926611|102248296|FG005|STARTED|Overall Study||45||
48777797|NCT03926611|102248297|FG006|STARTED|Overall Study||43||
48777798|NCT03926611|102248291|FG000|Randomized Set (RAN)|Overall Study||44||
48777799|NCT03926611|102248292|FG001|Randomized Set (RAN)|Overall Study||44||
48777800|NCT03926611|102248293|FG002|Randomized Set (RAN)|Overall Study||47||
48777801|NCT03926611|102248294|FG003|Randomized Set (RAN)|Overall Study||44||
48777802|NCT03926611|102248295|FG004|Randomized Set (RAN)|Overall Study||44||
48777803|NCT03926611|102248296|FG005|Randomized Set (RAN)|Overall Study||45||
48777804|NCT03926611|102248297|FG006|Randomized Set (RAN)|Overall Study||43||
48777805|NCT03926611|102248291|FG000|Full Analysis Set (FAS)|Overall Study||44||
48777806|NCT03926611|102248292|FG001|Full Analysis Set (FAS)|Overall Study||44||
48777807|NCT03926611|102248293|FG002|Full Analysis Set (FAS)|Overall Study||47||
48777808|NCT03926611|102248294|FG003|Full Analysis Set (FAS)|Overall Study||44||
48777809|NCT03926611|102248295|FG004|Full Analysis Set (FAS)|Overall Study||43||
48777810|NCT03926611|102248296|FG005|Full Analysis Set (FAS)|Overall Study||45||
48777811|NCT03926611|102248297|FG006|Full Analysis Set (FAS)|Overall Study||42||
48777812|NCT03926611|102248291|FG000|Safety Set (SAF)|Overall Study||44||
48777813|NCT03926611|102248292|FG001|Safety Set (SAF)|Overall Study||44||
48777814|NCT03926611|102248293|FG002|Safety Set (SAF)|Overall Study||47||
48777815|NCT03926611|102248294|FG003|Safety Set (SAF)|Overall Study||44||
48777816|NCT03926611|102248295|FG004|Safety Set (SAF)|Overall Study||43||
48777817|NCT03926611|102248296|FG005|Safety Set (SAF)|Overall Study||45||
48777818|NCT03926611|102248297|FG006|Safety Set (SAF)|Overall Study||42||
48777819|NCT03926611|102248291|FG000|COMPLETED|Overall Study||41||
48777820|NCT03926611|102248292|FG001|COMPLETED|Overall Study||41||
48777821|NCT03926611|102248293|FG002|COMPLETED|Overall Study||45||
48777822|NCT03926611|102248294|FG003|COMPLETED|Overall Study||40||
48777823|NCT03926611|102248295|FG004|COMPLETED|Overall Study||40||
48777824|NCT03926611|102248296|FG005|COMPLETED|Overall Study||36||
48777825|NCT03926611|102248297|FG006|COMPLETED|Overall Study||38||
48777826|NCT03926611|102248291|FG000|NOT COMPLETED|Overall Study||3||
48777827|NCT03926611|102248292|FG001|NOT COMPLETED|Overall Study||3||
48777828|NCT03926611|102248293|FG002|NOT COMPLETED|Overall Study||2||
48777829|NCT03926611|102248294|FG003|NOT COMPLETED|Overall Study||4||
48777830|NCT03926611|102248295|FG004|NOT COMPLETED|Overall Study||4||
48777831|NCT03926611|102248296|FG005|NOT COMPLETED|Overall Study||9||
48777832|NCT03926611|102248297|FG006|NOT COMPLETED|Overall Study||5||
48777833|NCT02331277|102248298|FG000|STARTED|Overall Study||3||
48777834|NCT02331277|102248299|FG001|STARTED|Overall Study||9||
48777835|NCT02331277|102248298|FG000|COMPLETED|Overall Study||2||
48777836|NCT02331277|102248299|FG001|COMPLETED|Overall Study||9||
48777837|NCT02331277|102248298|FG000|NOT COMPLETED|Overall Study||1||
48777838|NCT02331277|102248299|FG001|NOT COMPLETED|Overall Study||0||
48777839|NCT01417377|102248300|FG000|STARTED|Overall Study||22||
48777840|NCT01417377|102248300|FG000|Treated|Overall Study||21||
48777841|NCT01417377|102248300|FG000|COMPLETED|Overall Study||9||
48777842|NCT01417377|102248300|FG000|NOT COMPLETED|Overall Study||13||
48777843|NCT01235741|102248301|FG000|STARTED|Non-Randomized Low Calorie Diet Lead-In||213||
48777844|NCT01235741|102248302|FG001|STARTED|Non-Randomized Low Calorie Diet Lead-In||0||
48777845|NCT01235741|102248303|FG002|STARTED|Non-Randomized Low Calorie Diet Lead-In||0||
48777846|NCT01235741|102248301|FG000|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||72||
48777847|NCT01235741|102248302|FG001|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0||
48777848|NCT01235741|102248303|FG002|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0||
48777849|NCT01235741|102248301|FG000|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||141||
48777850|NCT01235741|102248302|FG001|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0||
48777851|NCT01235741|102248303|FG002|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0||
48777852|NCT01235741|102248301|FG000|STARTED|Randomized to Treatment||0||
48777853|NCT01235741|102248302|FG001|STARTED|Randomized to Treatment||36||
48777854|NCT01235741|102248303|FG002|STARTED|Randomized to Treatment||36||
48777855|NCT01235741|102248301|FG000|COMPLETED|Randomized to Treatment||0||
48777856|NCT01235741|102248302|FG001|COMPLETED|Randomized to Treatment||0||
48777857|NCT01235741|102248303|FG002|COMPLETED|Randomized to Treatment||0||
48777858|NCT01235741|102248301|FG000|NOT COMPLETED|Randomized to Treatment||0||
48777859|NCT01235741|102248302|FG001|NOT COMPLETED|Randomized to Treatment||36||
48777860|NCT01235741|102248303|FG002|NOT COMPLETED|Randomized to Treatment||36||
48777861|NCT01235741|102248301|FG000|STARTED|Follow-Up Post Treatment up to Month 6||0||
48777862|NCT01235741|102248302|FG001|STARTED|Follow-Up Post Treatment up to Month 6||36||
48777863|NCT01235741|102248303|FG002|STARTED|Follow-Up Post Treatment up to Month 6||36||
48777864|NCT01235741|102248301|FG000|COMPLETED|Follow-Up Post Treatment up to Month 6||0||
48777865|NCT01235741|102248302|FG001|COMPLETED|Follow-Up Post Treatment up to Month 6||27||
48777866|NCT01235741|102248303|FG002|COMPLETED|Follow-Up Post Treatment up to Month 6||29||
48777867|NCT01235741|102248301|FG000|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||0||
48777868|NCT01235741|102248302|FG001|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||9||
48777869|NCT01235741|102248303|FG002|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||7||
48777870|NCT02169427|102248304|FG000|STARTED|Overall Study||6||
48777871|NCT02169427|102248304|FG000|COMPLETED|Overall Study||6||
48777872|NCT02169427|102248304|FG000|NOT COMPLETED|Overall Study||0||
48777873|NCT04828343|102248305|FG000|STARTED|Overall Study||6||
48777874|NCT04828343|102248306|FG001|STARTED|Overall Study||2||
48777875|NCT04828343|102248307|FG002|STARTED|Overall Study||6||
48777876|NCT04828343|102248308|FG003|STARTED|Overall Study||2||
48777877|NCT04828343|102248309|FG004|STARTED|Overall Study||6||
48777878|NCT04828343|102248310|FG005|STARTED|Overall Study||2||
48777879|NCT04828343|102248311|FG006|STARTED|Overall Study||6||
48777880|NCT04828343|102248312|FG007|STARTED|Overall Study||2||
48777881|NCT04828343|102248305|FG000|COMPLETED|Overall Study||6||
48777882|NCT04828343|102248306|FG001|COMPLETED|Overall Study||2||
48777883|NCT04828343|102248307|FG002|COMPLETED|Overall Study||6||
48777884|NCT04828343|102248308|FG003|COMPLETED|Overall Study||2||
48777885|NCT04828343|102248309|FG004|COMPLETED|Overall Study||6||
48777886|NCT04828343|102248310|FG005|COMPLETED|Overall Study||2||
48777887|NCT04828343|102248311|FG006|COMPLETED|Overall Study||6||
48777888|NCT04828343|102248312|FG007|COMPLETED|Overall Study||2||
48777889|NCT04828343|102248305|FG000|NOT COMPLETED|Overall Study||0||
48777890|NCT04828343|102248306|FG001|NOT COMPLETED|Overall Study||0||
48777891|NCT04828343|102248307|FG002|NOT COMPLETED|Overall Study||0||
48777892|NCT04828343|102248308|FG003|NOT COMPLETED|Overall Study||0||
48777893|NCT04828343|102248309|FG004|NOT COMPLETED|Overall Study||0||
48777894|NCT04828343|102248310|FG005|NOT COMPLETED|Overall Study||0||
48777895|NCT04828343|102248311|FG006|NOT COMPLETED|Overall Study||0||
48777896|NCT04828343|102248312|FG007|NOT COMPLETED|Overall Study||0||
48777897|NCT02175030|102248313|FG000|STARTED|Overall Study||356||
48777898|NCT02175030|102248314|FG001|STARTED|Overall Study||355||
48777899|NCT02175030|102248313|FG000|COMPLETED|Overall Study||321||
48777900|NCT02175030|102248314|FG001|COMPLETED|Overall Study||317||
48777901|NCT02175030|102248313|FG000|NOT COMPLETED|Overall Study||35||
48777902|NCT02175030|102248314|FG001|NOT COMPLETED|Overall Study||38||
48777903|NCT00220636|102248315|FG000|STARTED|Overall Study||15||
48777904|NCT00220636|102248315|FG000|COMPLETED|Overall Study||11||
48777905|NCT00220636|102248315|FG000|NOT COMPLETED|Overall Study||4||
48777906|NCT01148979|102248316|FG000|STARTED|Overall Study||13||
48777907|NCT01148979|102248317|FG001|STARTED|Overall Study||16||
48777908|NCT01148979|102248316|FG000|COMPLETED|Overall Study||13||
48189790|NCT00335556|100786312|FG004|COMPLETED|Overall Study||77||
48189791|NCT00335556|100786313|FG005|COMPLETED|Overall Study||29||
48463126|NCT02043366|101470898|FG004|STARTED|Overall Study||30||
48463127|NCT02043366|101470899|FG005|STARTED|Overall Study||30||
48463128|NCT02043366|101470894|FG000|COMPLETED|Overall Study||28||
48463129|NCT02043366|101470895|FG001|COMPLETED|Overall Study||28||
48463130|NCT02043366|101470896|FG002|COMPLETED|Overall Study||28||
48463131|NCT02043366|101470897|FG003|COMPLETED|Overall Study||28||
48463132|NCT02043366|101470898|FG004|COMPLETED|Overall Study||28||
48463133|NCT02043366|101470899|FG005|COMPLETED|Overall Study||28||
48463134|NCT02043366|101470894|FG000|NOT COMPLETED|Overall Study||2||
48463135|NCT02043366|101470895|FG001|NOT COMPLETED|Overall Study||2||
48463136|NCT02043366|101470896|FG002|NOT COMPLETED|Overall Study||2||
48463137|NCT02043366|101470897|FG003|NOT COMPLETED|Overall Study||2||
48463138|NCT02043366|101470898|FG004|NOT COMPLETED|Overall Study||2||
48463139|NCT02043366|101470899|FG005|NOT COMPLETED|Overall Study||2||
48463140|NCT02833415|101470900|FG000|STARTED|Overall Study||20||
48463141|NCT02833415|101470901|FG001|STARTED|Overall Study||20||
48463142|NCT02833415|101470900|FG000|COMPLETED|Overall Study||18||
48463143|NCT02833415|101470901|FG001|COMPLETED|Overall Study||17||
48463144|NCT02833415|101470900|FG000|NOT COMPLETED|Overall Study||2||
48463145|NCT02833415|101470901|FG001|NOT COMPLETED|Overall Study||3||
48463146|NCT00720122|101470902|FG000|STARTED|Overall Study||28||
48463147|NCT00720122|101470902|FG000|COMPLETED|Overall Study||19||
48463148|NCT00720122|101470902|FG000|NOT COMPLETED|Overall Study||9||
48463149|NCT01041781|101470903|FG000|STARTED|Overall Study||154||
48463150|NCT01041781|101470904|FG001|STARTED|Overall Study||158||
48463151|NCT01041781|101470903|FG000|COMPLETED|Overall Study||154||
48463152|NCT01041781|101470904|FG001|COMPLETED|Overall Study||158||
48463153|NCT01041781|101470903|FG000|NOT COMPLETED|Overall Study||0||
48463154|NCT01041781|101470904|FG001|NOT COMPLETED|Overall Study||0||
48463155|NCT01413399|101470905|FG000|STARTED|Overall Study||208||
48463156|NCT01413399|101470906|FG001|STARTED|Overall Study||334||
48463157|NCT01413399|101470905|FG000|COMPLETED|Overall Study||208||
48463158|NCT01413399|101470906|FG001|COMPLETED|Overall Study||334||
48463159|NCT01413399|101470905|FG000|NOT COMPLETED|Overall Study||0||
48463160|NCT01413399|101470906|FG001|NOT COMPLETED|Overall Study||0||
48463161|NCT01584609|101470907|FG000|STARTED|Overall Study||98||
48463162|NCT01584609|101470908|FG001|STARTED|Overall Study||100||
48463163|NCT01584609|101470907|FG000|COMPLETED|Overall Study||86||
48463164|NCT01584609|101470908|FG001|COMPLETED|Overall Study||96||
48463165|NCT01584609|101470907|FG000|NOT COMPLETED|Overall Study||12||
48665109|NCT01356147|101964726|FG000|COMPLETED|Overall Study||5||
48665110|NCT01356147|101964727|FG001|COMPLETED|Overall Study||6||
48665111|NCT01356147|101964726|FG000|NOT COMPLETED|Overall Study||0||
48665112|NCT01356147|101964727|FG001|NOT COMPLETED|Overall Study||0||
48665113|NCT04906512|101964728|FG000|STARTED|Overall Study||62||
48665114|NCT04906512|101964729|FG001|STARTED|Overall Study||61||
48665115|NCT04906512|101964728|FG000|COMPLETED|Overall Study||39||
48665116|NCT04906512|101964729|FG001|COMPLETED|Overall Study||42||
48665117|NCT04906512|101964728|FG000|NOT COMPLETED|Overall Study||23||
48665118|NCT04906512|101964729|FG001|NOT COMPLETED|Overall Study||19||
48665119|NCT02989857|101964730|FG000|STARTED|Randomization Phase||126||
48665120|NCT02989857|101964731|FG001|STARTED|Randomization Phase||61||
48665121|NCT02989857|101964732|FG002|STARTED|Randomization Phase||0||
48665122|NCT02989857|101964730|FG000|COMPLETED|Randomization Phase||123||
48665123|NCT02989857|101964731|FG001|COMPLETED|Randomization Phase||59||
48665124|NCT02989857|101964732|FG002|COMPLETED|Randomization Phase||0||
48665125|NCT02989857|101964730|FG000|NOT COMPLETED|Randomization Phase||3||
48665126|NCT02989857|101964731|FG001|NOT COMPLETED|Randomization Phase||2||
48665127|NCT02989857|101964732|FG002|NOT COMPLETED|Randomization Phase||0||
48463166|NCT01584609|101470908|FG001|NOT COMPLETED|Overall Study||4||
48463167|NCT04634110|101470909|FG000|STARTED|Overall Study||1||
48463168|NCT04634110|101470909|FG000|COMPLETED|Overall Study||0|Subject did not complete treatment|
48665128|NCT02989857|101964730|FG000|STARTED|Cross Over Phase||0||
48665129|NCT02989857|101964731|FG001|STARTED|Cross Over Phase||0||
48463169|NCT04634110|101470909|FG000|NOT COMPLETED|Overall Study||1||
48463170|NCT02637076|101470910|FG000|STARTED|Overall Study||2||
48463171|NCT02637076|101470911|FG001|STARTED|Overall Study||15||
48463172|NCT02637076|101470910|FG000|COMPLETED|Overall Study||1||
48665130|NCT02989857|101964732|FG002|STARTED|Cross Over Phase||43||
48665131|NCT02989857|101964730|FG000|COMPLETED|Cross Over Phase||0||
48777909|NCT01148979|102248317|FG001|COMPLETED|Overall Study||15||
48777910|NCT01148979|102248316|FG000|NOT COMPLETED|Overall Study||0||
48777911|NCT01148979|102248317|FG001|NOT COMPLETED|Overall Study||1||
48777912|NCT03196349|102248318|FG000|STARTED|Overall Study||17||
48777913|NCT03196349|102248319|FG001|STARTED|Overall Study||14||
48777914|NCT03196349|102248320|FG002|STARTED|Overall Study||13||
48777915|NCT03196349|102248318|FG000|COMPLETED|Overall Study||0||
48777916|NCT03196349|102248319|FG001|COMPLETED|Overall Study||0||
48777917|NCT03196349|102248320|FG002|COMPLETED|Overall Study||0||
48777918|NCT03196349|102248318|FG000|NOT COMPLETED|Overall Study||17||
48777919|NCT03196349|102248319|FG001|NOT COMPLETED|Overall Study||14||
48777920|NCT03196349|102248320|FG002|NOT COMPLETED|Overall Study||13||
48777921|NCT00509145|102248321|FG000|STARTED|Overall Study||550||
48777922|NCT00509145|102248322|FG001|STARTED|Overall Study||556||
48777923|NCT00509145|102248321|FG000|COMPLETED|Overall Study||437||
48777924|NCT00509145|102248322|FG001|COMPLETED|Overall Study||427||
48777925|NCT00509145|102248321|FG000|NOT COMPLETED|Overall Study||113||
48777926|NCT00509145|102248322|FG001|NOT COMPLETED|Overall Study||129||
48777927|NCT01677377|102248323|FG000|STARTED|Overall Study||15||
48777928|NCT01677377|102248324|FG001|STARTED|Overall Study||15||
48777929|NCT01677377|102248325|FG002|STARTED|Overall Study||15||
48777930|NCT01677377|102248323|FG000|COMPLETED|Overall Study||14||
48777931|NCT01677377|102248324|FG001|COMPLETED|Overall Study||14||
48463173|NCT02637076|101470911|FG001|COMPLETED|Overall Study||10||
48463174|NCT02637076|101470910|FG000|NOT COMPLETED|Overall Study||1||
48463175|NCT02637076|101470911|FG001|NOT COMPLETED|Overall Study||5||
48463176|NCT01236170|101470912|FG000|STARTED|Overall Study||497||
48463177|NCT01236170|101470912|FG000|COMPLETED|Overall Study||482||
48463178|NCT01236170|101470912|FG000|NOT COMPLETED|Overall Study||15||
48463179|NCT00993616|101470913|FG000|STARTED|Overall Study||29||
48463180|NCT00993616|101470913|FG000|COMPLETED|Overall Study||27||
48463181|NCT00993616|101470913|FG000|NOT COMPLETED|Overall Study||2||
48463182|NCT00672620|101470914|FG000|STARTED|Overall Study||153||
48463183|NCT00672620|101470915|FG001|STARTED|Overall Study||153||
48463184|NCT00672620|101470916|FG002|STARTED|Overall Study||153||
48463185|NCT00672620|101470917|FG003|STARTED|Overall Study||152||
48463186|NCT00672620|101470914|FG000|Treated|Overall Study||151||
48463187|NCT00672620|101470915|FG001|Treated|Overall Study||149||
48463188|NCT00672620|101470916|FG002|Treated|Overall Study||153||
48777932|NCT01677377|102248325|FG002|COMPLETED|Overall Study||9||
48777933|NCT01677377|102248323|FG000|NOT COMPLETED|Overall Study||1||
48777934|NCT01677377|102248324|FG001|NOT COMPLETED|Overall Study||1||
48777935|NCT01677377|102248325|FG002|NOT COMPLETED|Overall Study||6||
48777936|NCT00473382|102248326|FG000|STARTED|Core Study||130||
48777937|NCT00473382|102248327|FG001|STARTED|Core Study||125||
48777938|NCT00473382|102248328|FG002|STARTED|Core Study||127||
48777939|NCT00473382|102248326|FG000|COMPLETED|Core Study||102||
48777940|NCT00473382|102248327|FG001|COMPLETED|Core Study||98||
48777941|NCT00473382|102248328|FG002|COMPLETED|Core Study||98||
48777942|NCT00473382|102248326|FG000|NOT COMPLETED|Core Study||28||
48463189|NCT00672620|101470917|FG003|Treated|Overall Study||150||
48463190|NCT00672620|101470914|FG000|COMPLETED|Overall Study||120||
48463191|NCT00672620|101470915|FG001|COMPLETED|Overall Study||99||
48463192|NCT00672620|101470916|FG002|COMPLETED|Overall Study||122||
48463193|NCT00672620|101470917|FG003|COMPLETED|Overall Study||110||
48463194|NCT00672620|101470914|FG000|NOT COMPLETED|Overall Study||33||
48463195|NCT00672620|101470915|FG001|NOT COMPLETED|Overall Study||54||
48463196|NCT00672620|101470916|FG002|NOT COMPLETED|Overall Study||31||
48463197|NCT00672620|101470917|FG003|NOT COMPLETED|Overall Study||42||
48463198|NCT00385541|101470918|FG000|STARTED|Overall Study||25||
48463199|NCT00385541|101470919|FG001|STARTED|Overall Study||25||
48463200|NCT00385541|101470918|FG000|COMPLETED|Overall Study||25||
48463201|NCT00385541|101470919|FG001|COMPLETED|Overall Study||24||
48463202|NCT00385541|101470918|FG000|NOT COMPLETED|Overall Study||0||
48463203|NCT00385541|101470919|FG001|NOT COMPLETED|Overall Study||1||
48463204|NCT03522948|101470920|FG000|STARTED|Overall Study||8||
48463205|NCT03522948|101470920|FG000|COMPLETED|Overall Study||7||
48463206|NCT03522948|101470920|FG000|NOT COMPLETED|Overall Study||1||
48463207|NCT01557595|101470921|FG000|STARTED|Overall Study||22||
48777943|NCT00473382|102248327|FG001|NOT COMPLETED|Core Study||27||
48777944|NCT00473382|102248328|FG002|NOT COMPLETED|Core Study||29||
48777945|NCT00473382|102248326|FG000|STARTED|Open-label Extension Through Month 48||88||
48777946|NCT00473382|102248327|FG001|STARTED|Open-label Extension Through Month 48||83||
48777947|NCT00473382|102248328|FG002|STARTED|Open-label Extension Through Month 48||84||
48777948|NCT00473382|102248326|FG000|COMPLETED|Open-label Extension Through Month 48||38||
48777949|NCT00473382|102248327|FG001|COMPLETED|Open-label Extension Through Month 48||42||
48777950|NCT00473382|102248328|FG002|COMPLETED|Open-label Extension Through Month 48||37||
48777951|NCT00473382|102248326|FG000|NOT COMPLETED|Open-label Extension Through Month 48||50||
48463208|NCT01557595|101470921|FG000|COMPLETED|Overall Study||14||
48777952|NCT00473382|102248327|FG001|NOT COMPLETED|Open-label Extension Through Month 48||41||
48463209|NCT01557595|101470921|FG000|NOT COMPLETED|Overall Study||8||
48463210|NCT01958281|101470922|FG000|STARTED|Overall Study||10||
48463211|NCT01958281|101470923|FG001|STARTED|Overall Study||10||
48463212|NCT01958281|101470924|FG002|STARTED|Overall Study||18||
48463213|NCT01958281|101470922|FG000|COMPLETED|Overall Study||4||
48463214|NCT01958281|101470923|FG001|COMPLETED|Overall Study||6||
48463215|NCT01958281|101470924|FG002|COMPLETED|Overall Study||18||
48463216|NCT01958281|101470922|FG000|NOT COMPLETED|Overall Study||6||
48463217|NCT01958281|101470923|FG001|NOT COMPLETED|Overall Study||4||
48463218|NCT01958281|101470924|FG002|NOT COMPLETED|Overall Study||0||
48463219|NCT00580853|101470925|FG000|STARTED|Overall Study||20||
48463220|NCT00580853|101470926|FG001|STARTED|Overall Study||21||
48463221|NCT00580853|101470927|FG002|STARTED|Overall Study||21||
48463222|NCT00580853|101470925|FG000|COMPLETED|Overall Study||20||
48463223|NCT00580853|101470926|FG001|COMPLETED|Overall Study||21||
48463224|NCT00580853|101470927|FG002|COMPLETED|Overall Study||21||
48463225|NCT00580853|101470925|FG000|NOT COMPLETED|Overall Study||0||
48463226|NCT00580853|101470926|FG001|NOT COMPLETED|Overall Study||0||
48463227|NCT00580853|101470927|FG002|NOT COMPLETED|Overall Study||0||
48463228|NCT00981253|101470928|FG000|STARTED|Overall Study||76||
48463229|NCT00981253|101470929|FG001|STARTED|Overall Study||75||
48463230|NCT00981253|101470928|FG000|COMPLETED|Overall Study||73||
48463231|NCT00981253|101470929|FG001|COMPLETED|Overall Study||72||
48463232|NCT00981253|101470928|FG000|NOT COMPLETED|Overall Study||3||
48463233|NCT00981253|101470929|FG001|NOT COMPLETED|Overall Study||3||
48463234|NCT02661126|101470930|FG000|STARTED|Overall Study||8||
48463235|NCT02661126|101470931|FG001|STARTED|Overall Study||8||
48463236|NCT02661126|101470930|FG000|COMPLETED|Overall Study||8||
48463237|NCT02661126|101470931|FG001|COMPLETED|Overall Study||8||
48463238|NCT02661126|101470930|FG000|NOT COMPLETED|Overall Study||0||
48463239|NCT02661126|101470931|FG001|NOT COMPLETED|Overall Study||0||
48463240|NCT00264810|101470932|FG000|STARTED|Baseline||120||
48463241|NCT00264810|101470933|FG001|STARTED|Baseline||120||
48463242|NCT00264810|101470932|FG000|COMPLETED|Baseline||97||
48463243|NCT00264810|101470933|FG001|COMPLETED|Baseline||94||
48463244|NCT00264810|101470932|FG000|NOT COMPLETED|Baseline||23||
48463245|NCT00264810|101470933|FG001|NOT COMPLETED|Baseline||26||
48463246|NCT00264810|101470932|FG000|STARTED|Post-Operative Stabilization Period||97||
48463247|NCT00264810|101470933|FG001|STARTED|Post-Operative Stabilization Period||94||
48463248|NCT00264810|101470932|FG000|COMPLETED|Post-Operative Stabilization Period||97||
48463249|NCT00264810|101470933|FG001|COMPLETED|Post-Operative Stabilization Period||94||
48463250|NCT00264810|101470932|FG000|NOT COMPLETED|Post-Operative Stabilization Period||0||
48463251|NCT00264810|101470933|FG001|NOT COMPLETED|Post-Operative Stabilization Period||0||
48463252|NCT00264810|101470932|FG000|STARTED|Stimulation Optimization Period||97||
48463253|NCT00264810|101470933|FG001|STARTED|Stimulation Optimization Period||94||
48463254|NCT00264810|101470932|FG000|COMPLETED|Stimulation Optimization Period||96||
48463255|NCT00264810|101470933|FG001|COMPLETED|Stimulation Optimization Period||93||
48463256|NCT00264810|101470932|FG000|NOT COMPLETED|Stimulation Optimization Period||1||
48463257|NCT00264810|101470933|FG001|NOT COMPLETED|Stimulation Optimization Period||1||
48463258|NCT00264810|101470932|FG000|STARTED|Blinded Evaluation Period||96||
48463259|NCT00264810|101470933|FG001|STARTED|Blinded Evaluation Period||93||
48463260|NCT00264810|101470932|FG000|COMPLETED|Blinded Evaluation Period||95||
48463261|NCT00264810|101470933|FG001|COMPLETED|Blinded Evaluation Period||92||
48463262|NCT00264810|101470932|FG000|NOT COMPLETED|Blinded Evaluation Period||1||
48463263|NCT00264810|101470933|FG001|NOT COMPLETED|Blinded Evaluation Period||1||
48463264|NCT00264810|101470932|FG000|STARTED|Open Label Evaluation Period||95||
48463265|NCT00264810|101470933|FG001|STARTED|Open Label Evaluation Period||92||
48463266|NCT00264810|101470932|FG000|1-year Post-implant|Open Label Evaluation Period||92||
48463267|NCT00264810|101470933|FG001|1-year Post-implant|Open Label Evaluation Period||90||
48463268|NCT00264810|101470932|FG000|COMPLETED|Open Label Evaluation Period||89||
48463269|NCT00264810|101470933|FG001|COMPLETED|Open Label Evaluation Period||86||
48463270|NCT00264810|101470932|FG000|NOT COMPLETED|Open Label Evaluation Period||6||
48463271|NCT00264810|101470933|FG001|NOT COMPLETED|Open Label Evaluation Period||6||
48463272|NCT01165996|101470934|FG000|STARTED|Overall Study||25||
48463273|NCT01165996|101470934|FG000|Induction Phase|Overall Study||25||
48463274|NCT01165996|101470934|FG000|Maintenance Phase|Overall Study||23||
48463275|NCT01165996|101470934|FG000|COMPLETED|Overall Study||23||
48463276|NCT01165996|101470934|FG000|NOT COMPLETED|Overall Study||2||
48463277|NCT01809054|101470935|FG000|STARTED|Overall Study||27||
48463278|NCT01809054|101470936|FG001|STARTED|Overall Study||22||
48463279|NCT01809054|101470935|FG000|COMPLETED|Overall Study||27||
48463280|NCT01809054|101470936|FG001|COMPLETED|Overall Study||22||
48463281|NCT01809054|101470935|FG000|NOT COMPLETED|Overall Study||0||
48463282|NCT01809054|101470936|FG001|NOT COMPLETED|Overall Study||0||
48463283|NCT01460927|101470937|FG000|STARTED|Overall Study||25||
48463284|NCT01460927|101470937|FG000|COMPLETED|Overall Study||25||
48463285|NCT01460927|101470937|FG000|NOT COMPLETED|Overall Study||0||
48463286|NCT03650400|101470938|FG000|STARTED|Overall Study||6||
48463287|NCT03650400|101470939|FG001|STARTED|Overall Study||5||
48463288|NCT03650400|101470938|FG000|COMPLETED|Overall Study||6||
48463289|NCT03650400|101470939|FG001|COMPLETED|Overall Study||0||
48463290|NCT03650400|101470938|FG000|NOT COMPLETED|Overall Study||0||
48463291|NCT03650400|101470939|FG001|NOT COMPLETED|Overall Study||5||
48463292|NCT01894984|101470940|FG000|STARTED|Overall Study||396||
48463293|NCT01894984|101470941|FG001|STARTED|Overall Study||244||
48463294|NCT01894984|101470940|FG000|COMPLETED|Overall Study||82||
48463295|NCT01894984|101470941|FG001|COMPLETED|Overall Study||69||
48463296|NCT01894984|101470940|FG000|NOT COMPLETED|Overall Study||314||
48777953|NCT00473382|102248328|FG002|NOT COMPLETED|Open-label Extension Through Month 48||47||
48777954|NCT00473382|102248326|FG000|STARTED|Open-label Extension Through Month 60||88||
48777955|NCT00473382|102248327|FG001|STARTED|Open-label Extension Through Month 60||83||
48777956|NCT00473382|102248328|FG002|STARTED|Open-label Extension Through Month 60||84||
48463297|NCT01894984|101470941|FG001|NOT COMPLETED|Overall Study||175||
48463298|NCT04467697|101470942|FG000|STARTED|Overall Study||155||
48463299|NCT04467697|101470942|FG000|COMPLETED|Overall Study||135||
48463300|NCT04467697|101470942|FG000|NOT COMPLETED|Overall Study||20||
48463301|NCT04081337|101470943|FG000|STARTED|Overall Study||28||
48463302|NCT04081337|101470944|FG001|STARTED|Overall Study||27||
48463303|NCT04081337|101470943|FG000|Received at Least One Dose of Study Drug|Overall Study||28||
48463304|NCT04081337|101470944|FG001|Received at Least One Dose of Study Drug|Overall Study||27||
48463305|NCT04081337|101470943|FG000|COMPLETED|Overall Study||24||
48463306|NCT04081337|101470944|FG001|COMPLETED|Overall Study||24||
48463307|NCT04081337|101470943|FG000|NOT COMPLETED|Overall Study||4||
48463308|NCT04081337|101470944|FG001|NOT COMPLETED|Overall Study||3||
48463309|NCT03654209|101470945|FG000|STARTED|Overall Study||126||
48463310|NCT03654209|101470946|FG001|STARTED|Overall Study||126||
48463311|NCT03654209|101470947|FG002|STARTED|Overall Study||132||
48463312|NCT03654209|101470945|FG000|COMPLETED|Overall Study||103||
48463313|NCT03654209|101470946|FG001|COMPLETED|Overall Study||100||
48463314|NCT03654209|101470947|FG002|COMPLETED|Overall Study||105||
48463315|NCT03654209|101470945|FG000|NOT COMPLETED|Overall Study||23||
48463316|NCT03654209|101470946|FG001|NOT COMPLETED|Overall Study||26||
48463317|NCT03654209|101470947|FG002|NOT COMPLETED|Overall Study||27||
48463318|NCT04064229|101470948|FG000|STARTED|Overall Study||99||198
48463319|NCT04064229|101470948|FG000|COMPLETED|Overall Study||99||198
48463320|NCT04064229|101470948|FG000|NOT COMPLETED|Overall Study||0||0
48463321|NCT02203747|101470949|FG000|STARTED|Overall Study||45||
48463322|NCT02203747|101470950|FG001|STARTED|Overall Study||34||
48463323|NCT02203747|101470949|FG000|COMPLETED|Overall Study||45||
48463324|NCT02203747|101470950|FG001|COMPLETED|Overall Study||34||
48463325|NCT02203747|101470949|FG000|NOT COMPLETED|Overall Study||0||
48463326|NCT02203747|101470950|FG001|NOT COMPLETED|Overall Study||0||
48463327|NCT04527471|101470951|FG000|STARTED|Overall Study||30||
48463328|NCT04527471|101470952|FG001|STARTED|Overall Study||15||
48463329|NCT04527471|101470951|FG000|Hospitalized up to 7 Days|Overall Study||24||
48463330|NCT04527471|101470952|FG001|Hospitalized up to 7 Days|Overall Study||12||
48463331|NCT04527471|101470951|FG000|Hospitalized for > 7 Days|Overall Study||6||
48665132|NCT02989857|101964731|FG001|COMPLETED|Cross Over Phase||0||
48665133|NCT02989857|101964732|FG002|COMPLETED|Cross Over Phase||43||
48665134|NCT02989857|101964730|FG000|NOT COMPLETED|Cross Over Phase||0||
48665135|NCT02989857|101964731|FG001|NOT COMPLETED|Cross Over Phase||0||
48665136|NCT02989857|101964732|FG002|NOT COMPLETED|Cross Over Phase||0||
48665137|NCT02801578|101964733|FG000|STARTED|Overall Study||11||
48665138|NCT02801578|101964733|FG000|COMPLETED|Overall Study||9||
48665139|NCT02801578|101964733|FG000|NOT COMPLETED|Overall Study||2||
48665140|NCT04591080|101964734|FG000|STARTED|Overall Study||12||12
48665141|NCT04591080|101964735|FG001|STARTED|Overall Study||12||12
48665142|NCT04591080|101964734|FG000|COMPLETED|Overall Study||6||6
48665143|NCT04591080|101964735|FG001|COMPLETED|Overall Study||6||6
48665144|NCT04591080|101964734|FG000|NOT COMPLETED|Overall Study||6||6
48665145|NCT04591080|101964735|FG001|NOT COMPLETED|Overall Study||6||6
48665146|NCT02971839|101964736|FG000|STARTED|Overall Study||2||
48665147|NCT02971839|101964737|FG001|STARTED|Overall Study||2||
48665148|NCT02971839|101964738|FG002|STARTED|Overall Study||2||
48665149|NCT02971839|101964739|FG003|STARTED|Overall Study||2||
48665150|NCT02971839|101964740|FG004|STARTED|Overall Study||3||
48665151|NCT02971839|101964736|FG000|COMPLETED|Overall Study||2||
48665152|NCT02971839|101964737|FG001|COMPLETED|Overall Study||2||
48665153|NCT02971839|101964738|FG002|COMPLETED|Overall Study||2||
48777957|NCT00473382|102248326|FG000|COMPLETED|Open-label Extension Through Month 60||2||
48777958|NCT00473382|102248327|FG001|COMPLETED|Open-label Extension Through Month 60||1||
48463332|NCT04527471|101470952|FG001|Hospitalized for > 7 Days|Overall Study||3||
48463333|NCT04527471|101470951|FG000|COMPLETED|Overall Study||28|Through Day 60 Follow-up|
48463334|NCT04527471|101470952|FG001|COMPLETED|Overall Study||15|Through Day 60 Follow-up|
48463335|NCT04527471|101470951|FG000|NOT COMPLETED|Overall Study||2||
48463336|NCT04527471|101470952|FG001|NOT COMPLETED|Overall Study||0||
48463337|NCT00717756|101470953|FG000|STARTED|Overall Study||41||
48463338|NCT00717756|101470953|FG000|COMPLETED|Overall Study||40||
48463339|NCT00717756|101470953|FG000|NOT COMPLETED|Overall Study||1||
48463340|NCT03692676|101470954|FG000|STARTED|Overall Study||10365||
48463341|NCT03692676|101470955|FG001|STARTED|Overall Study||51142||
48463342|NCT03692676|101470956|FG002|STARTED|Overall Study||49479||
48463343|NCT03692676|101470957|FG003|STARTED|Overall Study||5147||
48463344|NCT03692676|101470954|FG000|COMPLETED|Overall Study||940||
48665154|NCT02971839|101964739|FG003|COMPLETED|Overall Study||2||
48665155|NCT02971839|101964740|FG004|COMPLETED|Overall Study||3||
48665156|NCT02971839|101964736|FG000|NOT COMPLETED|Overall Study||0||
48665157|NCT02971839|101964737|FG001|NOT COMPLETED|Overall Study||0||
48463345|NCT03692676|101470955|FG001|COMPLETED|Overall Study||3704||
48463346|NCT03692676|101470956|FG002|COMPLETED|Overall Study||11135||
48463347|NCT03692676|101470957|FG003|COMPLETED|Overall Study||1561||
48463348|NCT03692676|101470954|FG000|NOT COMPLETED|Overall Study||9425||
48463349|NCT03692676|101470955|FG001|NOT COMPLETED|Overall Study||47438||
48463350|NCT03692676|101470956|FG002|NOT COMPLETED|Overall Study||38344||
48463351|NCT03692676|101470957|FG003|NOT COMPLETED|Overall Study||3586||
48463352|NCT01259427|101470958|FG000|STARTED|Overall Study||124||
48463353|NCT01259427|101470959|FG001|STARTED|Overall Study||124||
48463354|NCT01259427|101470958|FG000|COMPLETED|Overall Study||106||
48463355|NCT01259427|101470959|FG001|COMPLETED|Overall Study||110||
48463356|NCT01259427|101470958|FG000|NOT COMPLETED|Overall Study||18||
48463357|NCT01259427|101470959|FG001|NOT COMPLETED|Overall Study||14||
48463358|NCT01314742|101470960|FG000|STARTED|Overall Study||20||
48463359|NCT01314742|101470961|FG001|STARTED|Overall Study||21||
48463360|NCT01314742|101470960|FG000|COMPLETED|Overall Study||20||
48463361|NCT01314742|101470961|FG001|COMPLETED|Overall Study||21||
48189792|NCT00335556|100786308|FG000|NOT COMPLETED|Overall Study||2||
48463362|NCT01314742|101470960|FG000|NOT COMPLETED|Overall Study||0||
48463363|NCT01314742|101470961|FG001|NOT COMPLETED|Overall Study||0||
48463364|NCT01411267|101470962|FG000|STARTED|Overall Study||0||
48463365|NCT01411267|101470963|FG001|STARTED|Overall Study||3||
48463366|NCT01411267|101470964|FG002|STARTED|Overall Study||2||
48463367|NCT01411267|101470965|FG003|STARTED|Overall Study||5||
48463368|NCT01411267|101470966|FG004|STARTED|Overall Study||2||
48463369|NCT01411267|101470967|FG005|STARTED|Overall Study||12||
48463370|NCT01411267|101470968|FG006|STARTED|Overall Study||0||
48463371|NCT01411267|101470969|FG007|STARTED|Overall Study||0||
48463372|NCT01411267|101470970|FG008|STARTED|Overall Study||0||
48463373|NCT01411267|101470971|FG009|STARTED|Overall Study||0||
48463374|NCT01411267|101470962|FG000|COMPLETED|Overall Study||0||
48463375|NCT01411267|101470963|FG001|COMPLETED|Overall Study||3||
48463376|NCT01411267|101470964|FG002|COMPLETED|Overall Study||2||
48463377|NCT01411267|101470965|FG003|COMPLETED|Overall Study||4||
48463378|NCT01411267|101470966|FG004|COMPLETED|Overall Study||0||
48463379|NCT01411267|101470967|FG005|COMPLETED|Overall Study||10||
48463380|NCT01411267|101470968|FG006|COMPLETED|Overall Study||0||
48463381|NCT01411267|101470969|FG007|COMPLETED|Overall Study||0||
48463382|NCT01411267|101470970|FG008|COMPLETED|Overall Study||0||
48463383|NCT01411267|101470971|FG009|COMPLETED|Overall Study||0||
48665158|NCT02971839|101964738|FG002|NOT COMPLETED|Overall Study||0||
48665159|NCT02971839|101964739|FG003|NOT COMPLETED|Overall Study||0||
48463384|NCT01411267|101470962|FG000|NOT COMPLETED|Overall Study||0||
48665160|NCT02971839|101964740|FG004|NOT COMPLETED|Overall Study||0||
48665161|NCT04258631|101964741|FG000|STARTED|Overall Study||59||
48665162|NCT04258631|101964742|FG001|STARTED|Overall Study||46||
48665163|NCT04258631|101964741|FG000|COMPLETED|Overall Study||59||
48665164|NCT04258631|101964742|FG001|COMPLETED|Overall Study||46||
48665165|NCT04258631|101964741|FG000|NOT COMPLETED|Overall Study||0||
48665166|NCT04258631|101964742|FG001|NOT COMPLETED|Overall Study||0||
48665167|NCT00381641|101964743|FG000|STARTED|Overall Study||38||
48665168|NCT00381641|101964744|FG001|STARTED|Overall Study||25||
48665169|NCT00381641|101964743|FG000|COMPLETED|Overall Study||38||
48665170|NCT00381641|101964744|FG001|COMPLETED|Overall Study||23||
48665171|NCT00381641|101964743|FG000|NOT COMPLETED|Overall Study||0||
48665172|NCT00381641|101964744|FG001|NOT COMPLETED|Overall Study||2||
48665173|NCT02678377|101964745|FG000|STARTED|Overall Study||45||
48665174|NCT02678377|101964746|FG001|STARTED|Overall Study||43||
48189793|NCT00335556|100786309|FG001|NOT COMPLETED|Overall Study||34||
48189794|NCT00335556|100786310|FG002|NOT COMPLETED|Overall Study||5||
48463385|NCT01411267|101470963|FG001|NOT COMPLETED|Overall Study||0||
48463386|NCT01411267|101470964|FG002|NOT COMPLETED|Overall Study||0||
48463387|NCT01411267|101470965|FG003|NOT COMPLETED|Overall Study||1||
48463388|NCT01411267|101470966|FG004|NOT COMPLETED|Overall Study||2||
48463389|NCT01411267|101470967|FG005|NOT COMPLETED|Overall Study||2||
48463390|NCT01411267|101470968|FG006|NOT COMPLETED|Overall Study||0||
48463391|NCT01411267|101470969|FG007|NOT COMPLETED|Overall Study||0||
48463392|NCT01411267|101470970|FG008|NOT COMPLETED|Overall Study||0||
48463393|NCT01411267|101470971|FG009|NOT COMPLETED|Overall Study||0||
48463394|NCT01797471|101470972|FG000|STARTED|Overall Study||1||
48463395|NCT01797471|101470972|FG000|COMPLETED|Overall Study||1||
48463396|NCT01797471|101470972|FG000|NOT COMPLETED|Overall Study||0||
48463397|NCT03082391|101470973|FG000|STARTED|Overall Study||173||
48463398|NCT03082391|101470974|FG001|STARTED|Overall Study||177||
48463399|NCT03082391|101470973|FG000|COMPLETED|Overall Study||173||
48463400|NCT03082391|101470974|FG001|COMPLETED|Overall Study||177||
48463401|NCT03082391|101470973|FG000|NOT COMPLETED|Overall Study||0||
48463402|NCT03082391|101470974|FG001|NOT COMPLETED|Overall Study||0||
48463403|NCT02784925|101470975|FG000|STARTED|Overall Study||30||
48463404|NCT02784925|101470975|FG000|COMPLETED|Overall Study||30||
48463405|NCT02784925|101470975|FG000|NOT COMPLETED|Overall Study||0||
48463406|NCT00331630|101470976|FG000|STARTED|Treatment on Study||30||
48463407|NCT00331630|101470976|FG000|Completed 1st Cycle|Treatment on Study||30||
48665175|NCT02678377|101964745|FG000|COMPLETED|Overall Study||41||
48665176|NCT02678377|101964746|FG001|COMPLETED|Overall Study||37||
48777959|NCT00473382|102248328|FG002|COMPLETED|Open-label Extension Through Month 60||2||
48777960|NCT00473382|102248326|FG000|NOT COMPLETED|Open-label Extension Through Month 60||86||
48777961|NCT00473382|102248327|FG001|NOT COMPLETED|Open-label Extension Through Month 60||82||
48777962|NCT00473382|102248328|FG002|NOT COMPLETED|Open-label Extension Through Month 60||82||
48463408|NCT00331630|101470976|FG000|Completed 4 Cycles|Treatment on Study||30||
48463409|NCT00331630|101470976|FG000|COMPLETED|Treatment on Study||30||
48463410|NCT00331630|101470976|FG000|NOT COMPLETED|Treatment on Study||0||
48463411|NCT00331630|101470976|FG000|STARTED|Evaluated for and Completed SOC Surgery||30||
48665177|NCT02678377|101964745|FG000|NOT COMPLETED|Overall Study||4||
48665178|NCT02678377|101964746|FG001|NOT COMPLETED|Overall Study||6||
48665179|NCT04197583|101964747|FG000|STARTED|Overall Study||215||
48665180|NCT04197583|101964748|FG001|STARTED|Overall Study||164||
48665181|NCT04197583|101964747|FG000|COMPLETED|Overall Study||162||
48665182|NCT04197583|101964748|FG001|COMPLETED|Overall Study||131||
48665183|NCT04197583|101964747|FG000|NOT COMPLETED|Overall Study||53||
48665184|NCT04197583|101964748|FG001|NOT COMPLETED|Overall Study||33||
48665185|NCT01550510|101964749|FG000|STARTED|Overall Study||4||
48777963|NCT03181529|102248329|FG000|STARTED|Overall Study||15||
48777964|NCT03181529|102248330|FG001|STARTED|Overall Study||12||
48463412|NCT00331630|101470976|FG000|COMPLETED|Evaluated for and Completed SOC Surgery||28||
48463413|NCT00331630|101470976|FG000|NOT COMPLETED|Evaluated for and Completed SOC Surgery||2||
48463414|NCT00331630|101470976|FG000|STARTED|Follow up for 5 Years||29|All patients that are treated on the study go into follow up period.|
48463415|NCT00331630|101470976|FG000|COMPLETED|Follow up for 5 Years||0||
48463416|NCT00331630|101470976|FG000|NOT COMPLETED|Follow up for 5 Years||29||
48463417|NCT00608205|101470977|FG000|STARTED|Overall Study||35||
48463418|NCT00608205|101470978|FG001|STARTED|Overall Study||34||
48463419|NCT00608205|101470977|FG000|COMPLETED|Overall Study||32||
48463420|NCT00608205|101470978|FG001|COMPLETED|Overall Study||31||
48463421|NCT00608205|101470977|FG000|NOT COMPLETED|Overall Study||3||
48463422|NCT00608205|101470978|FG001|NOT COMPLETED|Overall Study||3||
48463423|NCT02232074|101470979|FG000|STARTED|Overall Study||154||
48777965|NCT03181529|102248329|FG000|COMPLETED|Overall Study||13||
48777966|NCT03181529|102248330|FG001|COMPLETED|Overall Study||11||
48777967|NCT03181529|102248329|FG000|NOT COMPLETED|Overall Study||2||
48777968|NCT03181529|102248330|FG001|NOT COMPLETED|Overall Study||1||
48777969|NCT02100696|102248331|FG000|STARTED|Induction Phase||130||
48777970|NCT02100696|102248332|FG001|STARTED|Induction Phase||95||
48777971|NCT02100696|102248333|FG002|STARTED|Induction Phase||384||
48777972|NCT02100696|102248334|FG003|STARTED|Induction Phase||0||
48777973|NCT02100696|102248335|FG004|STARTED|Induction Phase||0||
48777974|NCT02100696|102248336|FG005|STARTED|Induction Phase||0||
48777975|NCT02100696|102248331|FG000|COMPLETED|Induction Phase||115||
48777976|NCT02100696|102248332|FG001|COMPLETED|Induction Phase||90||
48777977|NCT02100696|102248333|FG002|COMPLETED|Induction Phase||358||
48777978|NCT02100696|102248334|FG003|COMPLETED|Induction Phase||0||
48777979|NCT02100696|102248335|FG004|COMPLETED|Induction Phase||0||
48777980|NCT02100696|102248336|FG005|COMPLETED|Induction Phase||0||
48777981|NCT02100696|102248331|FG000|NOT COMPLETED|Induction Phase||15||
48777982|NCT02100696|102248332|FG001|NOT COMPLETED|Induction Phase||5||
48777983|NCT02100696|102248333|FG002|NOT COMPLETED|Induction Phase||26||
48777984|NCT02100696|102248334|FG003|NOT COMPLETED|Induction Phase||0||
48777985|NCT02100696|102248335|FG004|NOT COMPLETED|Induction Phase||0||
48777986|NCT02100696|102248336|FG005|NOT COMPLETED|Induction Phase||0||
48777987|NCT02100696|102248331|FG000|STARTED|Maintenance Phase||0||
48777988|NCT02100696|102248332|FG001|STARTED|Maintenance Phase||0||
48777989|NCT02100696|102248333|FG002|STARTED|Maintenance Phase||0||
48777990|NCT02100696|102248334|FG003|STARTED|Maintenance Phase||27||
48777991|NCT02100696|102248335|FG004|STARTED|Maintenance Phase||115||
48777992|NCT02100696|102248336|FG005|STARTED|Maintenance Phase||117||
48777993|NCT02100696|102248331|FG000|COMPLETED|Maintenance Phase||0||
48777994|NCT02100696|102248332|FG001|COMPLETED|Maintenance Phase||0||
48777995|NCT02100696|102248333|FG002|COMPLETED|Maintenance Phase||0||
48189795|NCT00335556|100786311|FG003|NOT COMPLETED|Overall Study||5||
48189796|NCT00335556|100786312|FG004|NOT COMPLETED|Overall Study||1||
48777996|NCT02100696|102248334|FG003|COMPLETED|Maintenance Phase||26||
48189797|NCT00335556|100786313|FG005|NOT COMPLETED|Overall Study||1||
48463424|NCT02232074|101470980|FG001|STARTED|Overall Study||152||
48463425|NCT02232074|101470979|FG000|COMPLETED|Overall Study||113||
48463426|NCT02232074|101470980|FG001|COMPLETED|Overall Study||107||
48463427|NCT02232074|101470979|FG000|NOT COMPLETED|Overall Study||41||
48463428|NCT02232074|101470980|FG001|NOT COMPLETED|Overall Study||45||
48463429|NCT02337933|101470981|FG000|STARTED|Overall Study||12||
48463430|NCT02337933|101470982|FG001|STARTED|Overall Study||12||
48463431|NCT02337933|101470981|FG000|COMPLETED|Overall Study||12||
48463432|NCT02337933|101470982|FG001|COMPLETED|Overall Study||12||
48463433|NCT02337933|101470981|FG000|NOT COMPLETED|Overall Study||0||
48463434|NCT02337933|101470982|FG001|NOT COMPLETED|Overall Study||0||
48665186|NCT01550510|101964750|FG001|STARTED|Overall Study||0||
48777997|NCT02100696|102248335|FG004|COMPLETED|Maintenance Phase||106||
48777998|NCT02100696|102248336|FG005|COMPLETED|Maintenance Phase||112||
48777999|NCT02100696|102248331|FG000|NOT COMPLETED|Maintenance Phase||0||
48778000|NCT02100696|102248332|FG001|NOT COMPLETED|Maintenance Phase||0||
48463435|NCT01674478|101470983|FG000|STARTED|Overall Study||9||
48463436|NCT01674478|101470984|FG001|STARTED|Overall Study||9||
48463437|NCT01674478|101470983|FG000|COMPLETED|Overall Study||9||
48463438|NCT01674478|101470984|FG001|COMPLETED|Overall Study||9||
48463439|NCT01674478|101470983|FG000|NOT COMPLETED|Overall Study||0||
48463440|NCT01674478|101470984|FG001|NOT COMPLETED|Overall Study||0||
48463441|NCT03291509|101470985|FG000|STARTED|Overall Study||60||
48463442|NCT03291509|101470986|FG001|STARTED|Overall Study||60||
48463443|NCT03291509|101470985|FG000|6 Months|Overall Study||53||
48463444|NCT03291509|101470986|FG001|6 Months|Overall Study||57||
48463445|NCT03291509|101470985|FG000|18 Months|Overall Study||39||
48463446|NCT03291509|101470986|FG001|18 Months|Overall Study||48||
48463447|NCT03291509|101470985|FG000|COMPLETED|Overall Study||33||
48463448|NCT03291509|101470986|FG001|COMPLETED|Overall Study||46||
48463449|NCT03291509|101470985|FG000|NOT COMPLETED|Overall Study||27||
48463450|NCT03291509|101470986|FG001|NOT COMPLETED|Overall Study||14||
48463451|NCT01766778|101470987|FG000|STARTED|Overall Study||56||
48463452|NCT01766778|101470988|FG001|STARTED|Overall Study||61||
48463453|NCT01766778|101470987|FG000|COMPLETED|Overall Study||51||
48463454|NCT01766778|101470988|FG001|COMPLETED|Overall Study||57||
48463455|NCT01766778|101470987|FG000|NOT COMPLETED|Overall Study||5||
48463456|NCT01766778|101470988|FG001|NOT COMPLETED|Overall Study||4||
48463457|NCT01136226|101470989|FG000|STARTED|Overall Study||42||
48778001|NCT02100696|102248333|FG002|NOT COMPLETED|Maintenance Phase||0||
48778002|NCT02100696|102248334|FG003|NOT COMPLETED|Maintenance Phase||1||
48189798|NCT03283553|100786314|FG000|STARTED|Patient Participant Flow||69||
48189799|NCT03283553|100786315|FG001|STARTED|Patient Participant Flow||63||
48463458|NCT01136226|101470989|FG000|COMPLETED|Overall Study||29||
48463459|NCT01136226|101470989|FG000|NOT COMPLETED|Overall Study||13||
48463460|NCT02866175|101470990|FG000|STARTED|Overall Study||751||
48463461|NCT02866175|101470991|FG001|STARTED|Overall Study||755||
48463462|NCT02866175|101470990|FG000|COMPLETED|Overall Study||616||
48463463|NCT02866175|101470991|FG001|COMPLETED|Overall Study||580||
48463464|NCT02866175|101470990|FG000|NOT COMPLETED|Overall Study||135||
48463465|NCT02866175|101470991|FG001|NOT COMPLETED|Overall Study||175||
48463466|NCT00325403|101470992|FG000|STARTED|Overall Study||116||
48463467|NCT00325403|101470993|FG001|STARTED|Overall Study||233||
48463468|NCT00325403|101470992|FG000|COMPLETED|Overall Study||98||
48463469|NCT00325403|101470993|FG001|COMPLETED|Overall Study||182||
48463470|NCT00325403|101470992|FG000|NOT COMPLETED|Overall Study||18||
48463471|NCT00325403|101470993|FG001|NOT COMPLETED|Overall Study||51||
48463472|NCT00440596|101470994|FG000|STARTED|Overall Study||28||
48463473|NCT00440596|101470995|FG001|STARTED|Overall Study||28||
48778003|NCT02100696|102248335|FG004|NOT COMPLETED|Maintenance Phase||9||
48778004|NCT02100696|102248336|FG005|NOT COMPLETED|Maintenance Phase||5||
48369853|NCT04752189|101232850|FG000|Student Participants- Completed Post-implementation Survey Matched to Baseline Survey|Overall Study||104|Students were unable to participate in the post-implementation survey if the participating teacher withdrew from the study for any reason.|4
48369854|NCT04752189|101232851|FG001|Student Participants- Completed Post-implementation Survey Matched to Baseline Survey|Overall Study||178|Students were unable to participate in the post-implementation survey if the participating teacher withdrew from the study for any reason.|2
48369855|NCT04752189|101232850|FG000|Teacher Participants- Completed Post-implementation Interview|Overall Study||4||4
48369856|NCT04752189|101232851|FG001|Teacher Participants- Completed Post-implementation Interview|Overall Study||2||2
48369857|NCT04752189|101232850|FG000|COMPLETED|Overall Study||108||4
48369858|NCT04752189|101232851|FG001|COMPLETED|Overall Study||180||2
48369859|NCT04752189|101232850|FG000|NOT COMPLETED|Overall Study||261||1
48369860|NCT04752189|101232851|FG001|NOT COMPLETED|Overall Study||276||2
48369861|NCT03238235|101232852|FG000|STARTED|Overall Study||34||
48369862|NCT03238235|101232853|FG001|STARTED|Overall Study||17||
48369863|NCT03238235|101232852|FG000|Per Protocol|Overall Study||25||
48369864|NCT03238235|101232853|FG001|Per Protocol|Overall Study||14||
48369865|NCT03238235|101232852|FG000|ITT|Overall Study||34||
48369866|NCT03238235|101232853|FG001|ITT|Overall Study||17||
48369867|NCT03238235|101232852|FG000|Safety|Overall Study||34||
48369868|NCT03238235|101232853|FG001|Safety|Overall Study||17||
48369869|NCT03238235|101232852|FG000|PK|Overall Study||34||
48369870|NCT03238235|101232853|FG001|PK|Overall Study||17||
48369871|NCT03238235|101232852|FG000|COMPLETED|Overall Study||30||
48369872|NCT03238235|101232853|FG001|COMPLETED|Overall Study||17||
48369873|NCT03238235|101232852|FG000|NOT COMPLETED|Overall Study||4||
48369874|NCT03238235|101232853|FG001|NOT COMPLETED|Overall Study||0||
48369875|NCT04174638|101232854|FG000|STARTED|Overall Study||32||
48369876|NCT04174638|101232855|FG001|STARTED|Overall Study||28||
48369877|NCT04174638|101232854|FG000|COMPLETED|Overall Study||32||
48369878|NCT04174638|101232855|FG001|COMPLETED|Overall Study||28||
48369879|NCT04174638|101232854|FG000|NOT COMPLETED|Overall Study||0||
48463474|NCT00440596|101470994|FG000|COMPLETED|Overall Study||21||
48463475|NCT00440596|101470995|FG001|COMPLETED|Overall Study||17||
48463476|NCT00440596|101470994|FG000|NOT COMPLETED|Overall Study||7||
48463477|NCT00440596|101470995|FG001|NOT COMPLETED|Overall Study||11||
48189800|NCT03283553|100786314|FG000|Patient Baseline Interview|Patient Participant Flow||69||
48463478|NCT01957657|101470996|FG000|STARTED|Overall Study||4||
48463479|NCT01957657|101470996|FG000|COMPLETED|Overall Study||4||
48463480|NCT01957657|101470996|FG000|NOT COMPLETED|Overall Study||0||
48778005|NCT02453672|102248337|FG000|STARTED|Overall Study||40||
48778006|NCT02453672|102248338|FG001|STARTED|Overall Study||40||
48778007|NCT02453672|102248339|FG002|STARTED|Overall Study||39||
48778008|NCT02453672|102248337|FG000|COMPLETED|Overall Study||37||
48778009|NCT02453672|102248338|FG001|COMPLETED|Overall Study||38||
48778010|NCT02453672|102248339|FG002|COMPLETED|Overall Study||38||
48778011|NCT02453672|102248337|FG000|NOT COMPLETED|Overall Study||3||
48778012|NCT02453672|102248338|FG001|NOT COMPLETED|Overall Study||2||
48778013|NCT02453672|102248339|FG002|NOT COMPLETED|Overall Study||1||
48778014|NCT01711216|102248340|FG000|STARTED|Overall Study||999||
48778015|NCT01711216|102248340|FG000|COMPLETED|Overall Study||782||
48778016|NCT01711216|102248340|FG000|NOT COMPLETED|Overall Study||217||
48463481|NCT00929357|101470997|FG000|STARTED|Overall Study||92||
48463482|NCT00929357|101470998|FG001|STARTED|Overall Study||64||
48463483|NCT00929357|101470997|FG000|COMPLETED|Overall Study||92||
48463484|NCT00929357|101470998|FG001|COMPLETED|Overall Study||64||
48463485|NCT00929357|101470997|FG000|NOT COMPLETED|Overall Study||0||
48778017|NCT02252939|102248341|FG000|STARTED|Overall Study||62||
48778018|NCT02252939|102248341|FG000|COMPLETED|Overall Study||59||
48778019|NCT02252939|102248341|FG000|NOT COMPLETED|Overall Study||3||
48778020|NCT02969655|102248342|FG000|STARTED|Overall Study||136||
48778021|NCT02969655|102248343|FG001|STARTED|Overall Study||135||
48778022|NCT02969655|102248342|FG000|COMPLETED|Overall Study||115||
48778023|NCT02969655|102248343|FG001|COMPLETED|Overall Study||120||
48778024|NCT02969655|102248342|FG000|NOT COMPLETED|Overall Study||21||
48778025|NCT02969655|102248343|FG001|NOT COMPLETED|Overall Study||15||
48778026|NCT03158285|102248344|FG000|STARTED|Placebo-controlled Period: Week 0 - 24||246||
48778027|NCT03158285|102248345|FG001|STARTED|Placebo-controlled Period: Week 0 - 24||248||
48778028|NCT03158285|102248346|FG002|STARTED|Placebo-controlled Period: Week 0 - 24||245||
48778029|NCT03158285|102248344|FG000|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24||255||
48778030|NCT03158285|102248345|FG001|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24||230||
48778031|NCT03158285|102248346|FG002|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24||243||
48778032|NCT03158285|102248344|FG000|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24||154||
48778033|NCT03158285|102248345|FG001|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24||160||
48778034|NCT03158285|102248346|FG002|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24||159||
48778035|NCT03158285|102248344|FG000|COMPLETED|Placebo-controlled Period: Week 0 - 24||240||
48778036|NCT03158285|102248345|FG001|COMPLETED|Placebo-controlled Period: Week 0 - 24||240||
48778037|NCT03158285|102248346|FG002|COMPLETED|Placebo-controlled Period: Week 0 - 24||236||
48778038|NCT03158285|102248344|FG000|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||6||
48463486|NCT00929357|101470998|FG001|NOT COMPLETED|Overall Study||0||
48778039|NCT03158285|102248345|FG001|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||8||
48778040|NCT03158285|102248346|FG002|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||9||
48778041|NCT03158285|102248344|FG000|STARTED|Active Treatment Period: Week 24 - 52||238||
48778042|NCT03158285|102248345|FG001|STARTED|Active Treatment Period: Week 24 - 52||240||
48778043|NCT03158285|102248346|FG002|STARTED|Active Treatment Period: Week 24 - 52||234||
48778044|NCT03158285|102248344|FG000|COMPLETED|Active Treatment Period: Week 24 - 52||228||
48778045|NCT03158285|102248345|FG001|COMPLETED|Active Treatment Period: Week 24 - 52||234||
48778046|NCT03158285|102248346|FG002|COMPLETED|Active Treatment Period: Week 24 - 52||227||
48778047|NCT03158285|102248344|FG000|NOT COMPLETED|Active Treatment Period: Week 24 - 52||10||
48778048|NCT03158285|102248345|FG001|NOT COMPLETED|Active Treatment Period: Week 24 - 52||6||
48778049|NCT03158285|102248346|FG002|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7||
48778050|NCT03158285|102248344|FG000|STARTED|Active Treatment Period: Week 52-100||228||
48778051|NCT03158285|102248345|FG001|STARTED|Active Treatment Period: Week 52-100||232||
48778052|NCT03158285|102248346|FG002|STARTED|Active Treatment Period: Week 52-100||227||
48778053|NCT03158285|102248344|FG000|COMPLETED|Active Treatment Period: Week 52-100||210||
48778054|NCT03158285|102248345|FG001|COMPLETED|Active Treatment Period: Week 52-100||223||
48778055|NCT03158285|102248346|FG002|COMPLETED|Active Treatment Period: Week 52-100||219||
48778056|NCT03158285|102248344|FG000|NOT COMPLETED|Active Treatment Period: Week 52-100||18||
48778057|NCT03158285|102248345|FG001|NOT COMPLETED|Active Treatment Period: Week 52-100||9||
48189801|NCT03283553|100786315|FG001|Patient Baseline Interview|Patient Participant Flow||62||
48778058|NCT03158285|102248346|FG002|NOT COMPLETED|Active Treatment Period: Week 52-100||8||
48778059|NCT01534897|102248347|FG000|STARTED|Overall Study||10||
48778060|NCT01534897|102248347|FG000|Day 25 Iodine-131 Scan|Overall Study||10||
48369880|NCT04174638|101232855|FG001|NOT COMPLETED|Overall Study||0||
48369881|NCT03909763|101232856|FG000|STARTED|Overall Study||55||
48369882|NCT03909763|101232856|FG000|COMPLETED|Overall Study||45||
48369883|NCT03909763|101232856|FG000|NOT COMPLETED|Overall Study||10||
48369884|NCT04614545|101232857|FG000|STARTED|Overall Study||35||
48369885|NCT04614545|101232858|FG001|STARTED|Overall Study||35||
48369886|NCT04614545|101232857|FG000|COMPLETED|Overall Study||32||
48369887|NCT04614545|101232858|FG001|COMPLETED|Overall Study||32||
48463487|NCT02576990|101470999|FG000|STARTED|Overall Study||56||
48463488|NCT02576990|101471000|FG001|STARTED|Overall Study||24||
48369888|NCT04614545|101232857|FG000|NOT COMPLETED|Overall Study||3||
48369889|NCT04614545|101232858|FG001|NOT COMPLETED|Overall Study||3||
48778061|NCT01534897|102248347|FG000|Day 37 Iodine-131 Treatment|Overall Study||6||
48778062|NCT01534897|102248347|FG000|COMPLETED|Overall Study||10||
48778063|NCT01534897|102248347|FG000|NOT COMPLETED|Overall Study||0||
48778064|NCT00312195|102248348|FG000|STARTED|Overall Study||138||
48778065|NCT00312195|102248349|FG001|STARTED|Overall Study||129||
48778066|NCT00312195|102248348|FG000|COMPLETED|Overall Study||132||
48778067|NCT00312195|102248349|FG001|COMPLETED|Overall Study||123||
48778068|NCT00312195|102248348|FG000|NOT COMPLETED|Overall Study||6||
48778069|NCT00312195|102248349|FG001|NOT COMPLETED|Overall Study||6||
48778070|NCT00916929|102248350|FG000|STARTED|Overall Study||80||
48778071|NCT00916929|102248351|FG001|STARTED|Overall Study||82||
48778072|NCT00916929|102248350|FG000|COMPLETED|Overall Study||70||
48463489|NCT02576990|101470999|FG000|Treated|Overall Study||53||
48463490|NCT02576990|101471000|FG001|Treated|Overall Study||23||
48463491|NCT02576990|101470999|FG000|COMPLETED|Overall Study||0||
48778073|NCT00916929|102248351|FG001|COMPLETED|Overall Study||53||
48778074|NCT00916929|102248350|FG000|NOT COMPLETED|Overall Study||10||
48778075|NCT00916929|102248351|FG001|NOT COMPLETED|Overall Study||29||
48778076|NCT04473469|102248352|FG000|STARTED|Overall Study||5||
48778077|NCT04473469|102248352|FG000|COMPLETED|Overall Study||5||
48778078|NCT04473469|102248352|FG000|NOT COMPLETED|Overall Study||0||
48778079|NCT01732718|102248353|FG000|STARTED|First Intervention||7||
48778080|NCT01732718|102248354|FG001|STARTED|First Intervention||6||
48778081|NCT01732718|102248353|FG000|COMPLETED|First Intervention||7||
48778082|NCT01732718|102248354|FG001|COMPLETED|First Intervention||6||
48778083|NCT01732718|102248353|FG000|NOT COMPLETED|First Intervention||0||
48778084|NCT01732718|102248354|FG001|NOT COMPLETED|First Intervention||0||
48778085|NCT01732718|102248353|FG000|STARTED|Washout (4 Weeks)||7||
48778086|NCT01732718|102248354|FG001|STARTED|Washout (4 Weeks)||6||
48463492|NCT02576990|101471000|FG001|COMPLETED|Overall Study||0||
48463493|NCT02576990|101470999|FG000|NOT COMPLETED|Overall Study||56||
48463494|NCT02576990|101471000|FG001|NOT COMPLETED|Overall Study||24||
48463495|NCT03907280|101471001|FG000|STARTED|Treatment Period 1 + Washout Period 1||4|= Randomized to treatment sequence|
48463496|NCT03907280|101471002|FG001|STARTED|Treatment Period 1 + Washout Period 1||4|= Randomized to treatment sequence|
48463497|NCT03907280|101471003|FG002|STARTED|Treatment Period 1 + Washout Period 1||4|= Randomized to treatment sequence|
48463498|NCT03907280|101471001|FG000|Treated With BI 1265162|Treatment Period 1 + Washout Period 1||4||
48463499|NCT03907280|101471002|FG001|Treated With BI 1265162|Treatment Period 1 + Washout Period 1||4||
48463500|NCT03907280|101471003|FG002|Treated With BI 1265162|Treatment Period 1 + Washout Period 1||4||
48463501|NCT03907280|101471001|FG000|COMPLETED|Treatment Period 1 + Washout Period 1||4||
48463502|NCT03907280|101471002|FG001|COMPLETED|Treatment Period 1 + Washout Period 1||4||
48463503|NCT03907280|101471003|FG002|COMPLETED|Treatment Period 1 + Washout Period 1||4||
48463504|NCT03907280|101471001|FG000|NOT COMPLETED|Treatment Period 1 + Washout Period 1||0||
48463505|NCT03907280|101471002|FG001|NOT COMPLETED|Treatment Period 1 + Washout Period 1||0||
48463506|NCT03907280|101471003|FG002|NOT COMPLETED|Treatment Period 1 + Washout Period 1||0||
48463507|NCT03907280|101471001|FG000|STARTED|Treatment Period 2 + Washout Period 2||4|= Randomized to treatment sequence|
48463508|NCT03907280|101471002|FG001|STARTED|Treatment Period 2 + Washout Period 2||4|= Randomized to treatment sequence|
48463509|NCT03907280|101471003|FG002|STARTED|Treatment Period 2 + Washout Period 2||4|= Randomized to treatment sequence|
48778087|NCT01732718|102248353|FG000|COMPLETED|Washout (4 Weeks)||7||
48778088|NCT01732718|102248354|FG001|COMPLETED|Washout (4 Weeks)||6||
48778089|NCT01732718|102248353|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
48778090|NCT01732718|102248354|FG001|NOT COMPLETED|Washout (4 Weeks)||0||
48778091|NCT01732718|102248353|FG000|STARTED|Second Intervention||7||
48778092|NCT01732718|102248354|FG001|STARTED|Second Intervention||6||
48778093|NCT01732718|102248353|FG000|COMPLETED|Second Intervention||7||
48778094|NCT01732718|102248354|FG001|COMPLETED|Second Intervention||6||
48778095|NCT01732718|102248353|FG000|NOT COMPLETED|Second Intervention||0||
48778096|NCT01732718|102248354|FG001|NOT COMPLETED|Second Intervention||0||
48778097|NCT02427464|102248355|FG000|STARTED|Overall Study||338||
48778098|NCT02427464|102248356|FG001|STARTED|Overall Study||169||
48778099|NCT02427464|102248355|FG000|Intent-to-Treat Population|Overall Study||336||
48778100|NCT02427464|102248356|FG001|Intent-to-Treat Population|Overall Study||164||
48778101|NCT02427464|102248355|FG000|COMPLETED|Overall Study||288||
48778102|NCT02427464|102248356|FG001|COMPLETED|Overall Study||145||
48778103|NCT02427464|102248355|FG000|NOT COMPLETED|Overall Study||50||
48778104|NCT02427464|102248356|FG001|NOT COMPLETED|Overall Study||24||
48778105|NCT03152929|102248357|FG000|STARTED|Overall Study||40||
48778106|NCT03152929|102248358|FG001|STARTED|Overall Study||49||
48778107|NCT03152929|102248357|FG000|COMPLETED|Overall Study||40||
48778108|NCT03152929|102248358|FG001|COMPLETED|Overall Study||49||
48778109|NCT03152929|102248357|FG000|NOT COMPLETED|Overall Study||0||
48778110|NCT03152929|102248358|FG001|NOT COMPLETED|Overall Study||0||
48778111|NCT02209532|102248359|FG000|STARTED|Overall Study||90||
48778112|NCT02209532|102248360|FG001|STARTED|Overall Study||90||
48778113|NCT02209532|102248359|FG000|COMPLETED|Overall Study||87||
48778114|NCT02209532|102248360|FG001|COMPLETED|Overall Study||89||
48778115|NCT02209532|102248359|FG000|NOT COMPLETED|Overall Study||3||
48778116|NCT02209532|102248360|FG001|NOT COMPLETED|Overall Study||1||
48463510|NCT03907280|101471001|FG000|Treated With BI 1265162|Treatment Period 2 + Washout Period 2||4||
48463511|NCT03907280|101471002|FG001|Treated With BI 1265162|Treatment Period 2 + Washout Period 2||4||
48463512|NCT03907280|101471003|FG002|Treated With BI 1265162|Treatment Period 2 + Washout Period 2||4||
48463513|NCT03907280|101471001|FG000|COMPLETED|Treatment Period 2 + Washout Period 2||4||
48463514|NCT03907280|101471002|FG001|COMPLETED|Treatment Period 2 + Washout Period 2||4||
48463515|NCT03907280|101471003|FG002|COMPLETED|Treatment Period 2 + Washout Period 2||4||
48463516|NCT03907280|101471001|FG000|NOT COMPLETED|Treatment Period 2 + Washout Period 2||0||
48463517|NCT03907280|101471002|FG001|NOT COMPLETED|Treatment Period 2 + Washout Period 2||0||
48463518|NCT03907280|101471003|FG002|NOT COMPLETED|Treatment Period 2 + Washout Period 2||0||
48463519|NCT03907280|101471001|FG000|STARTED|Treatment Period 3 + Washout Period 3||4|= Randomized to treatment sequence|
48463520|NCT03907280|101471002|FG001|STARTED|Treatment Period 3 + Washout Period 3||4|= Randomized to treatment sequence|
48463521|NCT03907280|101471003|FG002|STARTED|Treatment Period 3 + Washout Period 3||4|= Randomized to treatment sequence|
48463522|NCT03907280|101471001|FG000|Treated With BI 1265162|Treatment Period 3 + Washout Period 3||4||
48463523|NCT03907280|101471002|FG001|Treated With BI 1265162|Treatment Period 3 + Washout Period 3||3||
48463524|NCT03907280|101471003|FG002|Treated With BI 1265162|Treatment Period 3 + Washout Period 3||4||
48463525|NCT03907280|101471001|FG000|COMPLETED|Treatment Period 3 + Washout Period 3||4||
48463526|NCT03907280|101471002|FG001|COMPLETED|Treatment Period 3 + Washout Period 3||3||
48463527|NCT03907280|101471003|FG002|COMPLETED|Treatment Period 3 + Washout Period 3||4||
48463528|NCT03907280|101471001|FG000|NOT COMPLETED|Treatment Period 3 + Washout Period 3||0||
48463529|NCT03907280|101471002|FG001|NOT COMPLETED|Treatment Period 3 + Washout Period 3||1||
48463530|NCT03907280|101471003|FG002|NOT COMPLETED|Treatment Period 3 + Washout Period 3||0||
48463531|NCT03907280|101471001|FG000|STARTED|Treatment Period 4: Fixed Treatment T3||4|= Randomized to treatment sequence|
48463532|NCT03907280|101471002|FG001|STARTED|Treatment Period 4: Fixed Treatment T3||4|= Randomized to treatment sequence|
48463533|NCT03907280|101471003|FG002|STARTED|Treatment Period 4: Fixed Treatment T3||4|= Randomized to treatment sequence|
48778117|NCT02139592|102248361|FG000|STARTED|Overall Study||292||
48778118|NCT02139592|102248361|FG000|COMPLETED|Overall Study||284||
48778119|NCT02139592|102248361|FG000|NOT COMPLETED|Overall Study||8||
48778120|NCT02269267|102248362|FG000|STARTED|Overall Study||173||
48778121|NCT02269267|102248362|FG000|COMPLETED|Overall Study||168||
48778122|NCT02269267|102248362|FG000|NOT COMPLETED|Overall Study||5||
48778123|NCT02453347|102248363|FG000|STARTED|Overall Study||6||
48778124|NCT02453347|102248363|FG000|COMPLETED|Overall Study||6||
48778125|NCT02453347|102248363|FG000|NOT COMPLETED|Overall Study||0||
48778126|NCT00528450|102248364|FG000|STARTED|Overall Study||1||
48778127|NCT00528450|102248364|FG000|COMPLETED|Overall Study||1||
48778128|NCT00528450|102248364|FG000|NOT COMPLETED|Overall Study||0||
48778129|NCT00499083|102248365|FG000|STARTED|Overall Study||17||
48778130|NCT00499083|102248365|FG000|Participants at UNMC|Overall Study||3||
48778131|NCT00499083|102248365|FG000|Participants at Moffitt Cancer Center|Overall Study||14||
48778132|NCT00499083|102248365|FG000|COMPLETED|Overall Study||14||
48778133|NCT00499083|102248365|FG000|NOT COMPLETED|Overall Study||3||
48778134|NCT04211909|102248366|FG000|STARTED|Overall Study||54||
48778135|NCT04211909|102248367|FG001|STARTED|Overall Study||33||
48778136|NCT04211909|102248366|FG000|COMPLETED|Overall Study||54||
48778137|NCT04211909|102248367|FG001|COMPLETED|Overall Study||33||
48463534|NCT03907280|101471001|FG000|Treated With BI 1265162|Treatment Period 4: Fixed Treatment T3||4||
48463535|NCT03907280|101471002|FG001|Treated With BI 1265162|Treatment Period 4: Fixed Treatment T3||4||
48463536|NCT03907280|101471003|FG002|Treated With BI 1265162|Treatment Period 4: Fixed Treatment T3||4||
48463537|NCT03907280|101471001|FG000|COMPLETED|Treatment Period 4: Fixed Treatment T3||4||
48463538|NCT03907280|101471002|FG001|COMPLETED|Treatment Period 4: Fixed Treatment T3||4||
48463539|NCT03907280|101471003|FG002|COMPLETED|Treatment Period 4: Fixed Treatment T3||4||
48778138|NCT04211909|102248366|FG000|NOT COMPLETED|Overall Study||0||
48778139|NCT04211909|102248367|FG001|NOT COMPLETED|Overall Study||0||
48778140|NCT03588884|102248368|FG000|STARTED|Overall Study||18||
48778141|NCT03588884|102248369|FG001|STARTED|Overall Study||18||
48778142|NCT03588884|102248370|FG002|STARTED|Overall Study||18||
48778143|NCT03588884|102248371|FG003|STARTED|Overall Study||15||
48778144|NCT03588884|102248368|FG000|COMPLETED|Overall Study||18||
48778145|NCT03588884|102248369|FG001|COMPLETED|Overall Study||15||
48778146|NCT03588884|102248370|FG002|COMPLETED|Overall Study||15||
48778147|NCT03588884|102248371|FG003|COMPLETED|Overall Study||14||
48778148|NCT03588884|102248368|FG000|NOT COMPLETED|Overall Study||0||
48778149|NCT03588884|102248369|FG001|NOT COMPLETED|Overall Study||3||
48778150|NCT03588884|102248370|FG002|NOT COMPLETED|Overall Study||3||
48778151|NCT03588884|102248371|FG003|NOT COMPLETED|Overall Study||1||
48778152|NCT00436345|102248372|FG000|STARTED|Overall Study||21||
48369890|NCT02986958|101232859|FG000|STARTED|Overall Study||49||
48778153|NCT00436345|102248373|FG001|STARTED|Overall Study||18||
48778154|NCT00436345|102248372|FG000|COMPLETED|Overall Study||18||
48778155|NCT00436345|102248373|FG001|COMPLETED|Overall Study||18||
48778156|NCT00436345|102248372|FG000|NOT COMPLETED|Overall Study||3||
48778157|NCT00436345|102248373|FG001|NOT COMPLETED|Overall Study||0||
48778158|NCT04990804|102248374|FG000|STARTED|Overall Study||5||
48778159|NCT04990804|102248375|FG001|STARTED|Overall Study||3||
48778160|NCT04990804|102248374|FG000|COMPLETED|Overall Study||4||
48778161|NCT04990804|102248375|FG001|COMPLETED|Overall Study||2||
48778162|NCT04990804|102248374|FG000|NOT COMPLETED|Overall Study||1||
48778163|NCT04990804|102248375|FG001|NOT COMPLETED|Overall Study||1||
48778164|NCT00974480|102248376|FG000|STARTED|Overall Study||40||
48778165|NCT00974480|102248377|FG001|STARTED|Overall Study||40||
48778166|NCT00974480|102248378|FG002|STARTED|Overall Study||40||
48778167|NCT00974480|102248376|FG000|COMPLETED|Overall Study||29||
48778168|NCT00974480|102248377|FG001|COMPLETED|Overall Study||33||
48778169|NCT00974480|102248378|FG002|COMPLETED|Overall Study||30||
48778170|NCT00974480|102248376|FG000|NOT COMPLETED|Overall Study||11||
48778171|NCT00974480|102248377|FG001|NOT COMPLETED|Overall Study||7||
48463540|NCT03907280|101471001|FG000|NOT COMPLETED|Treatment Period 4: Fixed Treatment T3||0||
48463541|NCT03907280|101471002|FG001|NOT COMPLETED|Treatment Period 4: Fixed Treatment T3||0||
48463542|NCT03907280|101471003|FG002|NOT COMPLETED|Treatment Period 4: Fixed Treatment T3||0||
48463543|NCT02752256|101471004|FG000|STARTED|Overall Study||35||
48463544|NCT02752256|101471005|FG001|STARTED|Overall Study||41||
48463545|NCT02752256|101471004|FG000|COMPLETED|Overall Study||35||
48463546|NCT02752256|101471005|FG001|COMPLETED|Overall Study||41||
48778172|NCT00974480|102248378|FG002|NOT COMPLETED|Overall Study||10||
48778173|NCT02873702|102248379|FG000|STARTED|Healing Period (up to Week 8)||20||
48778174|NCT02873702|102248380|FG001|STARTED|Healing Period (up to Week 8)||17||
48778175|NCT02873702|102248381|FG002|STARTED|Healing Period (up to Week 8)||0||
48778176|NCT02873702|102248382|FG003|STARTED|Healing Period (up to Week 8)||0||
48778177|NCT02873702|102248379|FG000|COMPLETED|Healing Period (up to Week 8)||19||
48369891|NCT02986958|101232860|FG001|STARTED|Overall Study||44||
48369892|NCT02986958|101232859|FG000|COMPLETED|Overall Study||49||
48369893|NCT02986958|101232860|FG001|COMPLETED|Overall Study||44||
48369894|NCT02986958|101232859|FG000|NOT COMPLETED|Overall Study||0||
48369895|NCT02986958|101232860|FG001|NOT COMPLETED|Overall Study||0||
48369896|NCT01477892|101232861|FG000|STARTED|Overall Study||7||
48778178|NCT02873702|102248380|FG001|COMPLETED|Healing Period (up to Week 8)||16||
48778179|NCT02873702|102248381|FG002|COMPLETED|Healing Period (up to Week 8)||0||
48778180|NCT02873702|102248382|FG003|COMPLETED|Healing Period (up to Week 8)||0||
48778181|NCT02873702|102248379|FG000|NOT COMPLETED|Healing Period (up to Week 8)||1||
48778182|NCT02873702|102248380|FG001|NOT COMPLETED|Healing Period (up to Week 8)||1||
48778183|NCT02873702|102248381|FG002|NOT COMPLETED|Healing Period (up to Week 8)||0||
48778184|NCT02873702|102248382|FG003|NOT COMPLETED|Healing Period (up to Week 8)||0||
48778185|NCT02873702|102248379|FG000|STARTED|Maintenance Period (up to Month 6)||0||
48778186|NCT02873702|102248380|FG001|STARTED|Maintenance Period (up to Month 6)||0||
48778187|NCT02873702|102248381|FG002|STARTED|Maintenance Period (up to Month 6)||8||
48778188|NCT02873702|102248382|FG003|STARTED|Maintenance Period (up to Month 6)||8||
48778189|NCT02873702|102248379|FG000|COMPLETED|Maintenance Period (up to Month 6)||0||
48778190|NCT02873702|102248380|FG001|COMPLETED|Maintenance Period (up to Month 6)||0||
48778191|NCT02873702|102248381|FG002|COMPLETED|Maintenance Period (up to Month 6)||1||
48778192|NCT02873702|102248382|FG003|COMPLETED|Maintenance Period (up to Month 6)||6||
48778193|NCT02873702|102248379|FG000|NOT COMPLETED|Maintenance Period (up to Month 6)||0||
48778194|NCT02873702|102248380|FG001|NOT COMPLETED|Maintenance Period (up to Month 6)||0||
48778195|NCT02873702|102248381|FG002|NOT COMPLETED|Maintenance Period (up to Month 6)||7||
48778196|NCT02873702|102248382|FG003|NOT COMPLETED|Maintenance Period (up to Month 6)||2||
48778197|NCT01284335|102248383|FG000|STARTED|Overall Study||25||
48778198|NCT01284335|102248384|FG001|STARTED|Overall Study||33||
48778199|NCT01284335|102248385|FG002|STARTED|Overall Study||5||
48778200|NCT01284335|102248386|FG003|STARTED|Overall Study||5||
48778201|NCT01284335|102248387|FG004|STARTED|Overall Study||24||
48778202|NCT01284335|102248388|FG005|STARTED|Overall Study||26||
48369897|NCT01477892|101232862|FG001|STARTED|Overall Study||7||
48369898|NCT01477892|101232861|FG000|COMPLETED|Overall Study||7||
48463547|NCT02752256|101471004|FG000|NOT COMPLETED|Overall Study||0||
48463548|NCT02752256|101471005|FG001|NOT COMPLETED|Overall Study||0||
48463549|NCT01835145|101471006|FG000|STARTED|Overall Study||32||
48463550|NCT01835145|101471007|FG001|STARTED|Overall Study||15||
48463551|NCT01835145|101471006|FG000|COMPLETED|Overall Study||31||
48463552|NCT01835145|101471007|FG001|COMPLETED|Overall Study||15||
48463553|NCT01835145|101471006|FG000|NOT COMPLETED|Overall Study||1||
48463554|NCT01835145|101471007|FG001|NOT COMPLETED|Overall Study||0||
48463555|NCT03387033|101471008|FG000|STARTED|Overall Study||20||
48463556|NCT03387033|101471008|FG000|COMPLETED|Overall Study||20||
48463557|NCT03387033|101471008|FG000|NOT COMPLETED|Overall Study||0||
48463558|NCT03384745|101471009|FG000|STARTED|Placebo Controlled Induction (W0 - W12)||52||
48463559|NCT03384745|101471010|FG001|STARTED|Placebo Controlled Induction (W0 - W12)||52||
48463560|NCT03384745|101471011|FG002|STARTED|Placebo Controlled Induction (W0 - W12)||53||
48463561|NCT03384745|101471012|FG003|STARTED|Placebo Controlled Induction (W0 - W12)||51||
48463562|NCT03384745|101471013|FG004|STARTED|Placebo Controlled Induction (W0 - W12)||52||
48463563|NCT03384745|101471014|FG005|STARTED|Placebo Controlled Induction (W0 - W12)||53||
48463564|NCT03384745|101471009|FG000|COMPLETED|Placebo Controlled Induction (W0 - W12)||52||
48369899|NCT01477892|101232862|FG001|COMPLETED|Overall Study||5||
48369900|NCT01477892|101232861|FG000|NOT COMPLETED|Overall Study||0||
48463565|NCT03384745|101471010|FG001|COMPLETED|Placebo Controlled Induction (W0 - W12)||51||
48463566|NCT03384745|101471011|FG002|COMPLETED|Placebo Controlled Induction (W0 - W12)||50||
48463567|NCT03384745|101471012|FG003|COMPLETED|Placebo Controlled Induction (W0 - W12)||49||
48463568|NCT03384745|101471013|FG004|COMPLETED|Placebo Controlled Induction (W0 - W12)||49||
48463569|NCT03384745|101471014|FG005|COMPLETED|Placebo Controlled Induction (W0 - W12)||51||
48463570|NCT03384745|101471009|FG000|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||0||
48463571|NCT03384745|101471010|FG001|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||1||
48463572|NCT03384745|101471011|FG002|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||3||
48463573|NCT03384745|101471012|FG003|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||2||
48463574|NCT03384745|101471013|FG004|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||3||
48463575|NCT03384745|101471014|FG005|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||2||
48463576|NCT03384745|101471009|FG000|STARTED|Maintenance/Escalation (W12-W24)||52||
48463577|NCT03384745|101471010|FG001|STARTED|Maintenance/Escalation (W12-W24)||51||
48463578|NCT03384745|101471011|FG002|STARTED|Maintenance/Escalation (W12-W24)||50||
48463579|NCT03384745|101471012|FG003|STARTED|Maintenance/Escalation (W12-W24)||49||
48463580|NCT03384745|101471013|FG004|STARTED|Maintenance/Escalation (W12-W24)||49||
48463581|NCT03384745|101471014|FG005|STARTED|Maintenance/Escalation (W12-W24)||51||
48463582|NCT03384745|101471009|FG000|COMPLETED|Maintenance/Escalation (W12-W24)||52||
48463583|NCT03384745|101471010|FG001|COMPLETED|Maintenance/Escalation (W12-W24)||51||
48463584|NCT03384745|101471011|FG002|COMPLETED|Maintenance/Escalation (W12-W24)||49||
48463585|NCT03384745|101471012|FG003|COMPLETED|Maintenance/Escalation (W12-W24)||47||
48463586|NCT03384745|101471013|FG004|COMPLETED|Maintenance/Escalation (W12-W24)||47||
48463587|NCT03384745|101471014|FG005|COMPLETED|Maintenance/Escalation (W12-W24)||51||
48463588|NCT03384745|101471009|FG000|NOT COMPLETED|Maintenance/Escalation (W12-W24)||0||
48463589|NCT03384745|101471010|FG001|NOT COMPLETED|Maintenance/Escalation (W12-W24)||0||
48463590|NCT03384745|101471011|FG002|NOT COMPLETED|Maintenance/Escalation (W12-W24)||1||
48463591|NCT03384745|101471012|FG003|NOT COMPLETED|Maintenance/Escalation (W12-W24)||2||
48463592|NCT03384745|101471013|FG004|NOT COMPLETED|Maintenance/Escalation (W12-W24)||2||
48463593|NCT03384745|101471014|FG005|NOT COMPLETED|Maintenance/Escalation (W12-W24)||0||
48463594|NCT03384745|101471009|FG000|STARTED|Response Assess/Dose Hold (W24-W48)||52||
48463595|NCT03384745|101471010|FG001|STARTED|Response Assess/Dose Hold (W24-W48)||51||
48463596|NCT03384745|101471011|FG002|STARTED|Response Assess/Dose Hold (W24-W48)||49||
48463597|NCT03384745|101471012|FG003|STARTED|Response Assess/Dose Hold (W24-W48)||47||
48463598|NCT03384745|101471013|FG004|STARTED|Response Assess/Dose Hold (W24-W48)||47||
48463599|NCT03384745|101471014|FG005|STARTED|Response Assess/Dose Hold (W24-W48)||51||
48463600|NCT03384745|101471009|FG000|COMPLETED|Response Assess/Dose Hold (W24-W48)||51||
48463601|NCT03384745|101471010|FG001|COMPLETED|Response Assess/Dose Hold (W24-W48)||48||
48463602|NCT03384745|101471011|FG002|COMPLETED|Response Assess/Dose Hold (W24-W48)||45||
48463603|NCT03384745|101471012|FG003|COMPLETED|Response Assess/Dose Hold (W24-W48)||43||
48463604|NCT03384745|101471013|FG004|COMPLETED|Response Assess/Dose Hold (W24-W48)||46||
48463605|NCT03384745|101471014|FG005|COMPLETED|Response Assess/Dose Hold (W24-W48)||49||
48463606|NCT03384745|101471009|FG000|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||1||
48463607|NCT03384745|101471010|FG001|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||3||
48463608|NCT03384745|101471011|FG002|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||4||
48463609|NCT03384745|101471012|FG003|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||4||
48463610|NCT03384745|101471013|FG004|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||1||
48463611|NCT03384745|101471014|FG005|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||2||
48463612|NCT02732561|101471015|FG000|STARTED|Overall Study||5||
48463613|NCT02732561|101471016|FG001|STARTED|Overall Study||5||
48463614|NCT02732561|101471015|FG000|COMPLETED|Overall Study||3||
48463615|NCT02732561|101471016|FG001|COMPLETED|Overall Study||4||
48463616|NCT02732561|101471015|FG000|NOT COMPLETED|Overall Study||2||
48463617|NCT02732561|101471016|FG001|NOT COMPLETED|Overall Study||1||
48463618|NCT01829477|101471017|FG000|STARTED|Overall Study||17||
48463619|NCT01829477|101471018|FG001|STARTED|Overall Study||16||
48463620|NCT01829477|101471017|FG000|COMPLETED|Overall Study||1||
48463621|NCT01829477|101471018|FG001|COMPLETED|Overall Study||1||
48463622|NCT01829477|101471017|FG000|NOT COMPLETED|Overall Study||16||
48463623|NCT01829477|101471018|FG001|NOT COMPLETED|Overall Study||15||
48463624|NCT02688400|101471019|FG000|STARTED|Overall Study||187||
48463625|NCT02688400|101471020|FG001|STARTED|Overall Study||193||
48463626|NCT02688400|101471019|FG000|COMPLETED|Overall Study||141||
48463627|NCT02688400|101471020|FG001|COMPLETED|Overall Study||149||
48463628|NCT02688400|101471019|FG000|NOT COMPLETED|Overall Study||46||
48463629|NCT02688400|101471020|FG001|NOT COMPLETED|Overall Study||44||
48463630|NCT02795104|101471021|FG000|STARTED|Overall Study||389||
48463631|NCT02795104|101471022|FG001|STARTED|Overall Study||395||
48665187|NCT01550510|101964749|FG000|COMPLETED|Overall Study||4||
48463632|NCT02795104|101471023|FG002|STARTED|Overall Study||201||
48463633|NCT02795104|101471021|FG000|COMPLETED|Overall Study||382||
48463634|NCT02795104|101471022|FG001|COMPLETED|Overall Study||388||
48463635|NCT02795104|101471023|FG002|COMPLETED|Overall Study||193||
48463636|NCT02795104|101471021|FG000|NOT COMPLETED|Overall Study||7||
48463637|NCT02795104|101471022|FG001|NOT COMPLETED|Overall Study||7||
48463638|NCT02795104|101471023|FG002|NOT COMPLETED|Overall Study||8||
48778203|NCT01284335|102248389|FG006|STARTED|Overall Study||19||
48778204|NCT01284335|102248390|FG007|STARTED|Overall Study||6||
48778205|NCT01284335|102248391|FG008|STARTED|Overall Study||4||
48778206|NCT01284335|102248392|FG009|STARTED|Overall Study||14||
48778207|NCT01284335|102248393|FG010|STARTED|Overall Study||45||
48778208|NCT01284335|102248394|FG011|STARTED|Overall Study||16||
48778209|NCT01284335|102248395|FG012|STARTED|Overall Study||12||
48778210|NCT01284335|102248383|FG000|Received at Least One Dose of Study Drug|Overall Study||25||
48778211|NCT01284335|102248384|FG001|Received at Least One Dose of Study Drug|Overall Study||33||
48778212|NCT01284335|102248385|FG002|Received at Least One Dose of Study Drug|Overall Study||5||
48778213|NCT01284335|102248386|FG003|Received at Least One Dose of Study Drug|Overall Study||5||
48778214|NCT01284335|102248387|FG004|Received at Least One Dose of Study Drug|Overall Study||24||
48778215|NCT01284335|102248388|FG005|Received at Least One Dose of Study Drug|Overall Study||26||
48778216|NCT01284335|102248389|FG006|Received at Least One Dose of Study Drug|Overall Study||19||
48778217|NCT01284335|102248390|FG007|Received at Least One Dose of Study Drug|Overall Study||6||
48778218|NCT01284335|102248391|FG008|Received at Least One Dose of Study Drug|Overall Study||4||
48778219|NCT01284335|102248392|FG009|Received at Least One Dose of Study Drug|Overall Study||14||
48778220|NCT01284335|102248393|FG010|Received at Least One Dose of Study Drug|Overall Study||45||
48778221|NCT01284335|102248394|FG011|Received at Least One Dose of Study Drug|Overall Study||16||
48778222|NCT01284335|102248395|FG012|Received at Least One Dose of Study Drug|Overall Study||12||
48778223|NCT01284335|102248383|FG000|COMPLETED|Overall Study||25||
48778224|NCT01284335|102248384|FG001|COMPLETED|Overall Study||33||
48778225|NCT01284335|102248385|FG002|COMPLETED|Overall Study||5||
48778226|NCT01284335|102248386|FG003|COMPLETED|Overall Study||5||
48778227|NCT01284335|102248387|FG004|COMPLETED|Overall Study||24||
48778228|NCT01284335|102248388|FG005|COMPLETED|Overall Study||26||
48778229|NCT01284335|102248389|FG006|COMPLETED|Overall Study||19||
48778230|NCT01284335|102248390|FG007|COMPLETED|Overall Study||6||
48778231|NCT01284335|102248391|FG008|COMPLETED|Overall Study||4||
48778232|NCT01284335|102248392|FG009|COMPLETED|Overall Study||14||
48778233|NCT01284335|102248393|FG010|COMPLETED|Overall Study||45||
48778234|NCT01284335|102248394|FG011|COMPLETED|Overall Study||16||
48778235|NCT01284335|102248395|FG012|COMPLETED|Overall Study||12||
48778236|NCT01284335|102248383|FG000|NOT COMPLETED|Overall Study||0||
48778237|NCT01284335|102248384|FG001|NOT COMPLETED|Overall Study||0||
48778238|NCT01284335|102248385|FG002|NOT COMPLETED|Overall Study||0||
48778239|NCT01284335|102248386|FG003|NOT COMPLETED|Overall Study||0||
48778240|NCT01284335|102248387|FG004|NOT COMPLETED|Overall Study||0||
48778241|NCT01284335|102248388|FG005|NOT COMPLETED|Overall Study||0||
48778242|NCT01284335|102248389|FG006|NOT COMPLETED|Overall Study||0||
48778243|NCT01284335|102248390|FG007|NOT COMPLETED|Overall Study||0||
48778244|NCT01284335|102248391|FG008|NOT COMPLETED|Overall Study||0||
48778245|NCT01284335|102248392|FG009|NOT COMPLETED|Overall Study||0||
48778246|NCT01284335|102248393|FG010|NOT COMPLETED|Overall Study||0||
48778247|NCT01284335|102248394|FG011|NOT COMPLETED|Overall Study||0||
48778248|NCT01284335|102248395|FG012|NOT COMPLETED|Overall Study||0||
48778249|NCT00433004|102248396|FG000|STARTED|Overall Study||27||
48778250|NCT00433004|102248397|FG001|STARTED|Overall Study||23||
48778251|NCT00433004|102248396|FG000|COMPLETED|Overall Study||22||
48778252|NCT00433004|102248397|FG001|COMPLETED|Overall Study||16||
48778253|NCT00433004|102248396|FG000|NOT COMPLETED|Overall Study||5||
48778254|NCT00433004|102248397|FG001|NOT COMPLETED|Overall Study||7||
48778255|NCT05083585|102248398|FG000|STARTED|Overall Study||125||
48778256|NCT05083585|102248399|FG001|STARTED|Overall Study||125||
48778257|NCT05083585|102248398|FG000|Vaccinated (Full Analysis Set [FAS])|Overall Study||123||
48778258|NCT05083585|102248399|FG001|Vaccinated (Full Analysis Set [FAS])|Overall Study||125||
48778259|NCT05083585|102248398|FG000|COMPLETED|Overall Study||119||
48778260|NCT05083585|102248399|FG001|COMPLETED|Overall Study||123||
48778261|NCT05083585|102248398|FG000|NOT COMPLETED|Overall Study||6||
48778262|NCT05083585|102248399|FG001|NOT COMPLETED|Overall Study||2||
48778263|NCT00774267|102248400|FG000|STARTED|Overall Study||132||
48778264|NCT00774267|102248401|FG001|STARTED|Overall Study||111||
48778265|NCT00774267|102248402|FG002|STARTED|Overall Study||129||
48778266|NCT00774267|102248403|FG003|STARTED|Overall Study||135||
48778267|NCT00774267|102248400|FG000|COMPLETED|Overall Study||132||
48778268|NCT00774267|102248401|FG001|COMPLETED|Overall Study||111||
48778269|NCT00774267|102248402|FG002|COMPLETED|Overall Study||129||
48778270|NCT00774267|102248403|FG003|COMPLETED|Overall Study||135||
48778271|NCT00774267|102248400|FG000|NOT COMPLETED|Overall Study||0||
48369901|NCT01477892|101232862|FG001|NOT COMPLETED|Overall Study||2||
48778272|NCT00774267|102248401|FG001|NOT COMPLETED|Overall Study||0||
48778273|NCT00774267|102248402|FG002|NOT COMPLETED|Overall Study||0||
48778274|NCT00774267|102248403|FG003|NOT COMPLETED|Overall Study||0||
48778275|NCT02474069|102248404|FG000|STARTED|Selection Phase (SP)||772||
48778276|NCT02474069|102248405|FG001|STARTED|Selection Phase (SP)||0||
48778277|NCT02474069|102248406|FG002|STARTED|Selection Phase (SP)||0||
48778278|NCT02474069|102248404|FG000|COMPLETED|Selection Phase (SP)||749||
48778279|NCT02474069|102248405|FG001|COMPLETED|Selection Phase (SP)||0||
48778280|NCT02474069|102248406|FG002|COMPLETED|Selection Phase (SP)||0||
48778281|NCT02474069|102248404|FG000|NOT COMPLETED|Selection Phase (SP)||23||
48778282|NCT02474069|102248405|FG001|NOT COMPLETED|Selection Phase (SP)||0||
48778283|NCT02474069|102248406|FG002|NOT COMPLETED|Selection Phase (SP)||0||
48778284|NCT02474069|102248404|FG000|STARTED|Comparative Dosing Phase (CDP)||0||
48778285|NCT02474069|102248405|FG001|STARTED|Comparative Dosing Phase (CDP)||162||
48778286|NCT02474069|102248406|FG002|STARTED|Comparative Dosing Phase (CDP)||163||
48778287|NCT02474069|102248404|FG000|COMPLETED|Comparative Dosing Phase (CDP)||0||
48778288|NCT02474069|102248405|FG001|COMPLETED|Comparative Dosing Phase (CDP)||153||
48778289|NCT02474069|102248406|FG002|COMPLETED|Comparative Dosing Phase (CDP)||157||
48778290|NCT02474069|102248404|FG000|NOT COMPLETED|Comparative Dosing Phase (CDP)||0||
48778291|NCT02474069|102248405|FG001|NOT COMPLETED|Comparative Dosing Phase (CDP)||9||
48778292|NCT02474069|102248406|FG002|NOT COMPLETED|Comparative Dosing Phase (CDP)||6||
48778293|NCT01330108|102248407|FG000|STARTED|Overall Study||32||
48778294|NCT01330108|102248407|FG000|COMPLETED|Overall Study||28||
48778295|NCT01330108|102248407|FG000|NOT COMPLETED|Overall Study||4||
48778296|NCT01213199|102248408|FG000|STARTED|Overall Study||20||
48778297|NCT01213199|102248408|FG000|COMPLETED|Overall Study||16||
48778298|NCT01213199|102248408|FG000|NOT COMPLETED|Overall Study||4||
48778299|NCT01821560|102248409|FG000|STARTED|Overall Study||22||
48778300|NCT01821560|102248410|FG001|STARTED|Overall Study||22||
48778301|NCT01821560|102248409|FG000|COMPLETED|Overall Study||16||
48778302|NCT01821560|102248410|FG001|COMPLETED|Overall Study||15||
48778303|NCT01821560|102248409|FG000|NOT COMPLETED|Overall Study||6||
48778304|NCT01821560|102248410|FG001|NOT COMPLETED|Overall Study||7||
48778305|NCT02810509|102248411|FG000|STARTED|Overall Study||584||
48778306|NCT02810509|102248412|FG001|STARTED|Overall Study||1230||
48778307|NCT02810509|102248411|FG000|COMPLETED|Overall Study||584||
48778308|NCT02810509|102248412|FG001|COMPLETED|Overall Study||1230||
48778309|NCT02810509|102248411|FG000|NOT COMPLETED|Overall Study||0||
48778310|NCT02810509|102248412|FG001|NOT COMPLETED|Overall Study||0||
48778311|NCT04176848|102248413|FG000|STARTED|Overall Study||15||
48778312|NCT04176848|102248413|FG000|COMPLETED|Overall Study||15||
48778313|NCT04176848|102248413|FG000|NOT COMPLETED|Overall Study||0||
48778314|NCT01646125|102248414|FG000|STARTED|Overall Study||31||
48778315|NCT01646125|102248415|FG001|STARTED|Overall Study||28||
48778316|NCT01646125|102248414|FG000|COMPLETED|Overall Study||0||
48778317|NCT01646125|102248415|FG001|COMPLETED|Overall Study||0||
48778318|NCT01646125|102248414|FG000|NOT COMPLETED|Overall Study||31||
48778319|NCT01646125|102248415|FG001|NOT COMPLETED|Overall Study||28||
48778320|NCT00853567|102248416|FG000|STARTED|Overall Study||71||
48778321|NCT00853567|102248416|FG000|COMPLETED|Overall Study||0||
48778322|NCT00853567|102248416|FG000|NOT COMPLETED|Overall Study||71||
48778323|NCT01908803|102248417|FG000|STARTED|Overall Study||46||
48778324|NCT01908803|102248418|FG001|STARTED|Overall Study||24||
48778325|NCT01908803|102248417|FG000|Treated|Overall Study||44||
48778326|NCT01908803|102248418|FG001|Treated|Overall Study||24||
48778327|NCT01908803|102248417|FG000|COMPLETED|Overall Study||42||
48778328|NCT01908803|102248418|FG001|COMPLETED|Overall Study||23||
48778329|NCT01908803|102248417|FG000|NOT COMPLETED|Overall Study||4||
48778330|NCT01908803|102248418|FG001|NOT COMPLETED|Overall Study||1||
48778331|NCT03111628|102248419|FG000|STARTED|Overall Study||18||
48778332|NCT03111628|102248419|FG000|COMPLETED|Overall Study||18||
48778333|NCT03111628|102248419|FG000|NOT COMPLETED|Overall Study||0||
48778334|NCT01765972|102248420|FG000|STARTED|Overall Study||6||
48778335|NCT01765972|102248421|FG001|STARTED|Overall Study||6||
48778336|NCT01765972|102248422|FG002|STARTED|Overall Study||6||
48778337|NCT01765972|102248423|FG003|STARTED|Overall Study||6||
48778338|NCT01765972|102248420|FG000|COMPLETED|Overall Study||6||
48778339|NCT01765972|102248421|FG001|COMPLETED|Overall Study||6||
48778340|NCT01765972|102248422|FG002|COMPLETED|Overall Study||6||
48778341|NCT01765972|102248423|FG003|COMPLETED|Overall Study||6||
48778342|NCT01765972|102248420|FG000|NOT COMPLETED|Overall Study||0||
48778343|NCT01765972|102248421|FG001|NOT COMPLETED|Overall Study||0||
48778344|NCT01765972|102248422|FG002|NOT COMPLETED|Overall Study||0||
48778345|NCT01765972|102248423|FG003|NOT COMPLETED|Overall Study||0||
48778346|NCT03284307|102248424|FG000|STARTED|Overall Study||35||
48778347|NCT03284307|102248424|FG000|Completed Sedation and/or Sleep Visit|Overall Study||27||
48778348|NCT03284307|102248424|FG000|Completed Sedation Visit|Overall Study||21||
48778349|NCT03284307|102248424|FG000|Sleep|Overall Study||15|Participants were fitted with a saline gel EEG cap and a pre-sleep recording was collected. After the pre-sleep recording, participants laid down within 30 minutes of their usual bedtime and were left to sleep for 2-3 hours. Then, the participant was woken up every 15-30 minutes to answer standardized wake report form questions. After awaking a final time, the participant repeated 10 minutes of awake eyes open and eyes closed recordings and a predictive coding cognitive task on a computer.|
48778350|NCT03284307|102248424|FG000|Dexmedetomidine|Overall Study||20|Rapid infusion of 3.0 mg kg-1 h-1 was administered over a 10 min period followed by a 0.5 mg kg-1 h-1 maintenance infusion to achieve the first drug step. The second drug step was similarly achieved by a 10 min infusion of 3.0 mg kg-1 h-1 followed by a 1.5 mg kg-1 h-1 maintenance infusion. Duration of drug exposure was limited to 4 hours.|
48778351|NCT03284307|102248424|FG000|Ketamine|Overall Study||15|Ketamine was titrated using up to a 4.5mg/kg bolus over 10 minutes followed by 0.1-0.5mg/min intravenous infusion with 5 minutes between increments and titrated to desired observed alertness/sedation level. Short-lived emergence delirium (confusion on awakening) may occur on emergence from ketamine anesthesia and this will be managed through standard clinical practice including administration of midazolam (up to 4mg IV) if required. Duration of drug exposure was limited to 4 hours.|
48778352|NCT03284307|102248424|FG000|Propofol|Overall Study||6|A target-controlled infusion model used to predict plasma concentrations of propofol at 0.5 mcg/mL increments allowing 5-minutes to equilibrate between any step change. Dosing will be confined to FDA approved limits with up to a 2.5mg/kg bolus over 1 to 3 minute followed by an infusion of 50-200mcg/kg/min titrated to the desired observed alertness/sedation levels. Drug exposure was limited to 4 hours.|
48778353|NCT03284307|102248424|FG000|Midazolam|Overall Study||0|Initial boluses of up to 0.35mg/kg followed by doses up to 0.1mg/kg/h as a maintenance infusion. Duration of drug exposure was limited to 4 hours.|
48778354|NCT03284307|102248424|FG000|COMPLETED|Overall Study||27||
48778355|NCT03284307|102248424|FG000|NOT COMPLETED|Overall Study||8||
48778356|NCT02191865|102248425|FG000|STARTED|Overall Study||8||
48778357|NCT02191865|102248426|FG001|STARTED|Overall Study||8||
48778358|NCT02191865|102248427|FG002|STARTED|Overall Study||17||
48778359|NCT02191865|102248425|FG000|COMPLETED|Overall Study||8||
48778360|NCT02191865|102248426|FG001|COMPLETED|Overall Study||8||
48778361|NCT02191865|102248427|FG002|COMPLETED|Overall Study||17||
48778362|NCT02191865|102248425|FG000|NOT COMPLETED|Overall Study||0||
48778363|NCT02191865|102248426|FG001|NOT COMPLETED|Overall Study||0||
48778364|NCT02191865|102248427|FG002|NOT COMPLETED|Overall Study||0||
48778365|NCT00282308|102248428|FG000|STARTED|Treatment Period||69||
48778366|NCT00282308|102248429|FG001|STARTED|Treatment Period||34||
48778367|NCT00282308|102248430|FG002|STARTED|Treatment Period||0||
48778368|NCT00282308|102248428|FG000|COMPLETED|Treatment Period||65||
48778369|NCT00282308|102248429|FG001|COMPLETED|Treatment Period||28||
48778370|NCT00282308|102248430|FG002|COMPLETED|Treatment Period||0||
48778371|NCT00282308|102248428|FG000|NOT COMPLETED|Treatment Period||4||
48778372|NCT00282308|102248429|FG001|NOT COMPLETED|Treatment Period||6||
48778373|NCT00282308|102248430|FG002|NOT COMPLETED|Treatment Period||0||
48778374|NCT00282308|102248428|FG000|STARTED|Optional Extension Re-treatment Period||0||
48778375|NCT00282308|102248429|FG001|STARTED|Optional Extension Re-treatment Period||0||
48778376|NCT00282308|102248430|FG002|STARTED|Optional Extension Re-treatment Period||78||
48778377|NCT00282308|102248428|FG000|COMPLETED|Optional Extension Re-treatment Period||0||
48778378|NCT00282308|102248429|FG001|COMPLETED|Optional Extension Re-treatment Period||0||
48778379|NCT00282308|102248430|FG002|COMPLETED|Optional Extension Re-treatment Period||72||
48778380|NCT00282308|102248428|FG000|NOT COMPLETED|Optional Extension Re-treatment Period||0||
48778381|NCT00282308|102248429|FG001|NOT COMPLETED|Optional Extension Re-treatment Period||0||
48778382|NCT00282308|102248430|FG002|NOT COMPLETED|Optional Extension Re-treatment Period||6||
48778383|NCT00282308|102248428|FG000|STARTED|Safety Follow-up Period||0||
48778384|NCT00282308|102248429|FG001|STARTED|Safety Follow-up Period||0||
48778385|NCT00282308|102248430|FG002|STARTED|Safety Follow-up Period||100||
48778386|NCT00282308|102248428|FG000|COMPLETED|Safety Follow-up Period||0||
48778387|NCT00282308|102248429|FG001|COMPLETED|Safety Follow-up Period||0||
48778388|NCT00282308|102248430|FG002|COMPLETED|Safety Follow-up Period||81||
48778389|NCT00282308|102248428|FG000|NOT COMPLETED|Safety Follow-up Period||0||
48778390|NCT00282308|102248429|FG001|NOT COMPLETED|Safety Follow-up Period||0||
48778391|NCT00282308|102248430|FG002|NOT COMPLETED|Safety Follow-up Period||19||
48778392|NCT05801341|102248431|FG000|STARTED|Overall Study||17||
48778393|NCT05801341|102248431|FG000|COMPLETED|Overall Study||17||
48778394|NCT05801341|102248431|FG000|NOT COMPLETED|Overall Study||0||
48778395|NCT01350401|102248432|FG000|STARTED|Overall Study||4||
48778396|NCT01350401|102248432|FG000|COMPLETED|Overall Study||4||
48778397|NCT01350401|102248432|FG000|NOT COMPLETED|Overall Study||0||
48778398|NCT03565497|102248433|FG000|STARTED|Overall Study||8|Participants that were enrolled and randomized to study groups.|
48778399|NCT03565497|102248434|FG001|STARTED|Overall Study||8|Participants that were enrolled and randomized to study groups.|
48778400|NCT03565497|102248435|FG002|STARTED|Overall Study||8|Participants that were enrolled and randomized to study groups.|
48778401|NCT03565497|102248433|FG000|V1|Overall Study||8|Intervention visit 1 completed.|
48778402|NCT03565497|102248434|FG001|V1|Overall Study||7|Intervention visit 1 completed.|
48778403|NCT03565497|102248435|FG002|V1|Overall Study||7|Intervention visit 1 completed.|
48778404|NCT03565497|102248433|FG000|V2|Overall Study||8|Intervention visit 2 completed|
48778405|NCT03565497|102248434|FG001|V2|Overall Study||7|Intervention visit 2 completed|
48778406|NCT03565497|102248435|FG002|V2|Overall Study||5|Intervention visit 2 completed|
48778407|NCT03565497|102248433|FG000|V3|Overall Study||6|Intervention visit 3 completed|
48778408|NCT03565497|102248434|FG001|V3|Overall Study||6|Intervention visit 3 completed|
48778409|NCT03565497|102248435|FG002|V3|Overall Study||5|Intervention visit 3 completed|
48778410|NCT03565497|102248433|FG000|V4|Overall Study||6|Intervention visit 4 completed|
48778411|NCT03565497|102248434|FG001|V4|Overall Study||6|Intervention visit 4 completed|
48778412|NCT03565497|102248435|FG002|V4|Overall Study||5|Intervention visit 4 completed|
48778413|NCT03565497|102248433|FG000|V5|Overall Study||6|Intervention visit 5 completed|
48778414|NCT03565497|102248434|FG001|V5|Overall Study||6|Intervention visit 5 completed|
48778415|NCT03565497|102248435|FG002|V5|Overall Study||5|Intervention visit 5 completed|
48778416|NCT03565497|102248433|FG000|V6|Overall Study||6|Intervention visit 6 completed|
48778417|NCT03565497|102248434|FG001|V6|Overall Study||6|Intervention visit 6 completed|
48778418|NCT03565497|102248435|FG002|V6|Overall Study||5|Intervention visit 6 completed|
48778419|NCT03565497|102248433|FG000|SSA|Overall Study||6|1-week Post-Intervention Smoking Context- Standard smoking assessment (SSA) completed|
48778420|NCT03565497|102248434|FG001|SSA|Overall Study||6|1-week Post-Intervention Smoking Context- Standard smoking assessment (SSA) completed|
48778421|NCT03565497|102248435|FG002|SSA|Overall Study||5|1-week Post-Intervention Smoking Context- Standard smoking assessment (SSA) completed|
48778422|NCT03565497|102248433|FG000|DWA|Overall Study||6|1week+2days Post-Intervention Deprivation Context- Deprivation window assessment (DWA) completed|
48778423|NCT03565497|102248434|FG001|DWA|Overall Study||5|1week+2days Post-Intervention Deprivation Context- Deprivation window assessment (DWA) completed|
48778424|NCT03565497|102248435|FG002|DWA|Overall Study||4|1week+2days Post-Intervention Deprivation Context- Deprivation window assessment (DWA) completed|
48778425|NCT03565497|102248433|FG000|PFU|Overall Study||6|6 week Post-Intervention- Phone follow-up (PFU) completed|
48778426|NCT03565497|102248434|FG001|PFU|Overall Study||5|6 week Post-Intervention- Phone follow-up (PFU) completed|
48778427|NCT03565497|102248435|FG002|PFU|Overall Study||4|6 week Post-Intervention- Phone follow-up (PFU) completed|
48778428|NCT03565497|102248433|FG000|COMPLETED|Overall Study||6||
48778429|NCT03565497|102248434|FG001|COMPLETED|Overall Study||5||
48778430|NCT03565497|102248435|FG002|COMPLETED|Overall Study||4||
48778431|NCT03565497|102248433|FG000|NOT COMPLETED|Overall Study||2||
48778432|NCT03565497|102248434|FG001|NOT COMPLETED|Overall Study||3||
48778433|NCT03565497|102248435|FG002|NOT COMPLETED|Overall Study||4||
48778434|NCT01814241|102248436|FG000|STARTED|Overall Study||20||
48778435|NCT01814241|102248436|FG000|COMPLETED|Overall Study||16||
48778436|NCT01814241|102248436|FG000|NOT COMPLETED|Overall Study||4||
48778437|NCT02465099|102248437|FG000|STARTED|Overall Study||45||
48778438|NCT02465099|102248438|FG001|STARTED|Overall Study||19||
48778439|NCT02465099|102248437|FG000|COMPLETED|Overall Study||45||
48778440|NCT02465099|102248438|FG001|COMPLETED|Overall Study||19||
48778441|NCT02465099|102248437|FG000|NOT COMPLETED|Overall Study||0||
48778442|NCT02465099|102248438|FG001|NOT COMPLETED|Overall Study||0||
48778443|NCT00098813|102248439|FG000|STARTED|Overall Study||20||
48778444|NCT00098813|102248439|FG000|COMPLETED|Overall Study||1||
48778445|NCT00098813|102248439|FG000|NOT COMPLETED|Overall Study||19||
48778446|NCT03983317|102248440|FG000|STARTED|Overall Study||25||
48778447|NCT03983317|102248440|FG000|COMPLETED|Overall Study||20||
48778448|NCT03983317|102248440|FG000|NOT COMPLETED|Overall Study||5||
48778449|NCT01525225|102248441|FG000|STARTED|Enrollment||4||
48778450|NCT01525225|102248441|FG000|COMPLETED|Enrollment||2||
48778451|NCT01525225|102248441|FG000|NOT COMPLETED|Enrollment||2||
48778452|NCT01525225|102248441|FG000|STARTED|Treated||2||
48778453|NCT01525225|102248441|FG000|COMPLETED|Treated||2||
48778454|NCT01525225|102248441|FG000|NOT COMPLETED|Treated||0||
48778455|NCT01761240|102248442|FG000|STARTED|Overall Study||3||
48778456|NCT01761240|102248443|FG001|STARTED|Overall Study||4||
48778457|NCT01761240|102248444|FG002|STARTED|Overall Study||5||
48778458|NCT01761240|102248445|FG003|STARTED|Overall Study||7||
48778459|NCT01761240|102248446|FG004|STARTED|Overall Study||8||
48778460|NCT01761240|102248442|FG000|COMPLETED|Overall Study||0||
48778461|NCT01761240|102248443|FG001|COMPLETED|Overall Study||0||
48778462|NCT01761240|102248444|FG002|COMPLETED|Overall Study||0||
48778463|NCT01761240|102248445|FG003|COMPLETED|Overall Study||0||
48778464|NCT01761240|102248446|FG004|COMPLETED|Overall Study||0||
48778465|NCT01761240|102248442|FG000|NOT COMPLETED|Overall Study||3||
48665188|NCT01550510|101964750|FG001|COMPLETED|Overall Study||0||
48665189|NCT01550510|101964749|FG000|NOT COMPLETED|Overall Study||0||
48778466|NCT01761240|102248443|FG001|NOT COMPLETED|Overall Study||4||
48778467|NCT01761240|102248444|FG002|NOT COMPLETED|Overall Study||5||
48778468|NCT01761240|102248445|FG003|NOT COMPLETED|Overall Study||7||
48778469|NCT01761240|102248446|FG004|NOT COMPLETED|Overall Study||8||
48778470|NCT00567398|102248447|FG000|STARTED|Overall Study||127||
48778471|NCT00567398|102248448|FG001|STARTED|Overall Study||124||
48778472|NCT00567398|102248447|FG000|COMPLETED|Overall Study||120||
48778473|NCT00567398|102248448|FG001|COMPLETED|Overall Study||101||
48665190|NCT01550510|101964750|FG001|NOT COMPLETED|Overall Study||0||
48665191|NCT00023595|101964751|FG000|STARTED|5 Year Follow up||602||
48778474|NCT00567398|102248447|FG000|NOT COMPLETED|Overall Study||7||
48778475|NCT00567398|102248448|FG001|NOT COMPLETED|Overall Study||23||
48778476|NCT00884741|102248449|FG000|STARTED|Step 1 Registration: Tissue Screening||978||
48778477|NCT00884741|102248450|FG001|STARTED|Step 1 Registration: Tissue Screening||0||
48778478|NCT00884741|102248451|FG002|STARTED|Step 1 Registration: Tissue Screening||0||
48778479|NCT00884741|102248452|FG003|STARTED|Step 1 Registration: Tissue Screening||0||
48778480|NCT00884741|102248449|FG000|COMPLETED|Step 1 Registration: Tissue Screening||666||
48778481|NCT00884741|102248450|FG001|COMPLETED|Step 1 Registration: Tissue Screening||0||
48778482|NCT00884741|102248451|FG002|COMPLETED|Step 1 Registration: Tissue Screening||0||
48778483|NCT00884741|102248452|FG003|COMPLETED|Step 1 Registration: Tissue Screening||0||
48778484|NCT00884741|102248449|FG000|NOT COMPLETED|Step 1 Registration: Tissue Screening||312||
48778485|NCT00884741|102248450|FG001|NOT COMPLETED|Step 1 Registration: Tissue Screening||0||
48778486|NCT00884741|102248451|FG002|NOT COMPLETED|Step 1 Registration: Tissue Screening||0||
48778487|NCT00884741|102248452|FG003|NOT COMPLETED|Step 1 Registration: Tissue Screening||0||
48778488|NCT00884741|102248449|FG000|STARTED|Step 2 Registration: Tissue Analysis||0||
48778489|NCT00884741|102248450|FG001|STARTED|Step 2 Registration: Tissue Analysis||666||
48778490|NCT00884741|102248451|FG002|STARTED|Step 2 Registration: Tissue Analysis||0||
48778491|NCT00884741|102248452|FG003|STARTED|Step 2 Registration: Tissue Analysis||0||
48778492|NCT00884741|102248449|FG000|COMPLETED|Step 2 Registration: Tissue Analysis||0||
48778493|NCT00884741|102248450|FG001|COMPLETED|Step 2 Registration: Tissue Analysis||637||
48778494|NCT00884741|102248451|FG002|COMPLETED|Step 2 Registration: Tissue Analysis||0||
48778495|NCT00884741|102248452|FG003|COMPLETED|Step 2 Registration: Tissue Analysis||0||
48778496|NCT00884741|102248449|FG000|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0||
48778497|NCT00884741|102248450|FG001|NOT COMPLETED|Step 2 Registration: Tissue Analysis||29||
48778498|NCT00884741|102248451|FG002|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0||
48778499|NCT00884741|102248452|FG003|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0||
48778500|NCT00884741|102248449|FG000|STARTED|Randomization||0||
48778501|NCT00884741|102248450|FG001|STARTED|Randomization||0||
48778502|NCT00884741|102248451|FG002|STARTED|Randomization||317||
48778503|NCT00884741|102248452|FG003|STARTED|Randomization||320||
48778504|NCT00884741|102248449|FG000|COMPLETED|Randomization||0||
48778505|NCT00884741|102248450|FG001|COMPLETED|Randomization||0||
48778506|NCT00884741|102248451|FG002|COMPLETED|Randomization||309||
48778507|NCT00884741|102248452|FG003|COMPLETED|Randomization||312||
48778508|NCT00884741|102248449|FG000|NOT COMPLETED|Randomization||0||
48778509|NCT00884741|102248450|FG001|NOT COMPLETED|Randomization||0||
48778510|NCT00884741|102248451|FG002|NOT COMPLETED|Randomization||8||
48778511|NCT00884741|102248452|FG003|NOT COMPLETED|Randomization||8||
48778512|NCT01754727|102248453|FG000|STARTED|Overall Study||452||
48778513|NCT01754727|102248453|FG000|COMPLETED|Overall Study||450||
48778514|NCT01754727|102248453|FG000|NOT COMPLETED|Overall Study||2||
48778515|NCT02605122|102248454|FG000|STARTED|Overall Study||73||
48778516|NCT02605122|102248455|FG001|STARTED|Overall Study||24||
48778517|NCT02605122|102248454|FG000|Received Study Drug|Overall Study||70||
48778518|NCT02605122|102248455|FG001|Received Study Drug|Overall Study||24||
48778519|NCT02605122|102248454|FG000|COMPLETED|Overall Study||68||
48778520|NCT02605122|102248455|FG001|COMPLETED|Overall Study||22||
48778521|NCT02605122|102248454|FG000|NOT COMPLETED|Overall Study||5||
48778522|NCT02605122|102248455|FG001|NOT COMPLETED|Overall Study||2||
48778523|NCT01955629|102248456|FG000|STARTED|Overall Study||4||
48778524|NCT01955629|102248456|FG000|COMPLETED|Overall Study||4||
48778525|NCT01955629|102248456|FG000|NOT COMPLETED|Overall Study||0||
48778526|NCT00167219|102248457|FG000|STARTED|Overall Study||15||
48778527|NCT00167219|102248457|FG000|COMPLETED|Overall Study||15||
48778528|NCT00167219|102248457|FG000|NOT COMPLETED|Overall Study||0||
48778529|NCT02703337|102248458|FG000|STARTED|Period One (Part A)||5||
48778530|NCT02703337|102248459|FG001|STARTED|Period One (Part A)||5||
48778531|NCT02703337|102248460|FG002|STARTED|Period One (Part A)||5||
48778532|NCT02703337|102248461|FG003|STARTED|Period One (Part A)||5||
48778533|NCT02703337|102248462|FG004|STARTED|Period One (Part A)||5||
48778534|NCT02703337|102248463|FG005|STARTED|Period One (Part A)||5||
48778535|NCT02703337|102248464|FG006|STARTED|Period One (Part A)||0||
48778536|NCT02703337|102248465|FG007|STARTED|Period One (Part A)||0||
48778537|NCT02703337|102248458|FG000|Received Study Drug|Period One (Part A)||5||
48778538|NCT02703337|102248459|FG001|Received Study Drug|Period One (Part A)||5||
48778539|NCT02703337|102248460|FG002|Received Study Drug|Period One (Part A)||5||
48778540|NCT02703337|102248461|FG003|Received Study Drug|Period One (Part A)||5||
48778541|NCT02703337|102248462|FG004|Received Study Drug|Period One (Part A)||5||
48778542|NCT02703337|102248463|FG005|Received Study Drug|Period One (Part A)||5||
48778543|NCT02703337|102248464|FG006|Received Study Drug|Period One (Part A)||0||
48778544|NCT02703337|102248465|FG007|Received Study Drug|Period One (Part A)||0||
48778545|NCT02703337|102248458|FG000|COMPLETED|Period One (Part A)||5||
48778546|NCT02703337|102248459|FG001|COMPLETED|Period One (Part A)||5||
48778547|NCT02703337|102248460|FG002|COMPLETED|Period One (Part A)||5||
48778548|NCT02703337|102248461|FG003|COMPLETED|Period One (Part A)||5||
48778549|NCT02703337|102248462|FG004|COMPLETED|Period One (Part A)||4||
48778550|NCT02703337|102248463|FG005|COMPLETED|Period One (Part A)||5||
48778551|NCT02703337|102248464|FG006|COMPLETED|Period One (Part A)||0||
48778552|NCT02703337|102248465|FG007|COMPLETED|Period One (Part A)||0||
48778553|NCT02703337|102248458|FG000|NOT COMPLETED|Period One (Part A)||0||
48778554|NCT02703337|102248459|FG001|NOT COMPLETED|Period One (Part A)||0||
48778555|NCT02703337|102248460|FG002|NOT COMPLETED|Period One (Part A)||0||
48778556|NCT02703337|102248461|FG003|NOT COMPLETED|Period One (Part A)||0||
48778557|NCT02703337|102248462|FG004|NOT COMPLETED|Period One (Part A)||1||
48778558|NCT02703337|102248463|FG005|NOT COMPLETED|Period One (Part A)||0||
48778559|NCT02703337|102248464|FG006|NOT COMPLETED|Period One (Part A)||0||
48778560|NCT02703337|102248465|FG007|NOT COMPLETED|Period One (Part A)||0||
48778561|NCT02703337|102248458|FG000|STARTED|Period Two (Part A)||5||
48778562|NCT02703337|102248459|FG001|STARTED|Period Two (Part A)||5||
48778563|NCT02703337|102248460|FG002|STARTED|Period Two (Part A)||5||
48778564|NCT02703337|102248461|FG003|STARTED|Period Two (Part A)||5||
48778565|NCT02703337|102248462|FG004|STARTED|Period Two (Part A)||4||
48778566|NCT02703337|102248463|FG005|STARTED|Period Two (Part A)||5||
48778567|NCT02703337|102248464|FG006|STARTED|Period Two (Part A)||0||
48778568|NCT02703337|102248465|FG007|STARTED|Period Two (Part A)||0||
48778569|NCT02703337|102248458|FG000|Received Study Drug|Period Two (Part A)||5||
48778570|NCT02703337|102248459|FG001|Received Study Drug|Period Two (Part A)||5||
48778571|NCT02703337|102248460|FG002|Received Study Drug|Period Two (Part A)||5||
48778572|NCT02703337|102248461|FG003|Received Study Drug|Period Two (Part A)||5||
48778573|NCT02703337|102248462|FG004|Received Study Drug|Period Two (Part A)||4||
48778574|NCT02703337|102248463|FG005|Received Study Drug|Period Two (Part A)||5||
48778575|NCT02703337|102248464|FG006|Received Study Drug|Period Two (Part A)||0||
48778576|NCT02703337|102248465|FG007|Received Study Drug|Period Two (Part A)||0||
48778577|NCT02703337|102248458|FG000|COMPLETED|Period Two (Part A)||5||
48778578|NCT02703337|102248459|FG001|COMPLETED|Period Two (Part A)||5||
48778579|NCT02703337|102248460|FG002|COMPLETED|Period Two (Part A)||5||
48778580|NCT02703337|102248461|FG003|COMPLETED|Period Two (Part A)||5||
48778581|NCT02703337|102248462|FG004|COMPLETED|Period Two (Part A)||4||
48778582|NCT02703337|102248463|FG005|COMPLETED|Period Two (Part A)||5||
48778583|NCT02703337|102248464|FG006|COMPLETED|Period Two (Part A)||0||
48778584|NCT02703337|102248465|FG007|COMPLETED|Period Two (Part A)||0||
48778585|NCT02703337|102248458|FG000|NOT COMPLETED|Period Two (Part A)||0||
48778586|NCT02703337|102248459|FG001|NOT COMPLETED|Period Two (Part A)||0||
48778587|NCT02703337|102248460|FG002|NOT COMPLETED|Period Two (Part A)||0||
48778588|NCT02703337|102248461|FG003|NOT COMPLETED|Period Two (Part A)||0||
48778589|NCT02703337|102248462|FG004|NOT COMPLETED|Period Two (Part A)||0||
48778590|NCT02703337|102248463|FG005|NOT COMPLETED|Period Two (Part A)||0||
48778591|NCT02703337|102248464|FG006|NOT COMPLETED|Period Two (Part A)||0||
48778592|NCT02703337|102248465|FG007|NOT COMPLETED|Period Two (Part A)||0||
48778593|NCT02703337|102248458|FG000|STARTED|Period Three (Part A)||5||
48778594|NCT02703337|102248459|FG001|STARTED|Period Three (Part A)||5||
48778595|NCT02703337|102248460|FG002|STARTED|Period Three (Part A)||5||
48778596|NCT02703337|102248461|FG003|STARTED|Period Three (Part A)||5||
48778597|NCT02703337|102248462|FG004|STARTED|Period Three (Part A)||4||
48778598|NCT02703337|102248463|FG005|STARTED|Period Three (Part A)||5||
48778599|NCT02703337|102248464|FG006|STARTED|Period Three (Part A)||0||
48778600|NCT02703337|102248465|FG007|STARTED|Period Three (Part A)||0||
48778601|NCT02703337|102248458|FG000|Received Study Drug|Period Three (Part A)||5||
48778602|NCT02703337|102248459|FG001|Received Study Drug|Period Three (Part A)||5||
48778603|NCT02703337|102248460|FG002|Received Study Drug|Period Three (Part A)||5||
48778604|NCT02703337|102248461|FG003|Received Study Drug|Period Three (Part A)||5||
48665192|NCT00023595|101964752|FG001|STARTED|5 Year Follow up||534||
48665193|NCT00023595|101964753|FG002|STARTED|5 Year Follow up||76||
48778605|NCT02703337|102248462|FG004|Received Study Drug|Period Three (Part A)||4||
48778606|NCT02703337|102248463|FG005|Received Study Drug|Period Three (Part A)||5||
48778607|NCT02703337|102248464|FG006|Received Study Drug|Period Three (Part A)||0||
48778608|NCT02703337|102248465|FG007|Received Study Drug|Period Three (Part A)||0||
48778609|NCT02703337|102248458|FG000|COMPLETED|Period Three (Part A)||5||
48778610|NCT02703337|102248459|FG001|COMPLETED|Period Three (Part A)||5||
48778611|NCT02703337|102248460|FG002|COMPLETED|Period Three (Part A)||5||
48778612|NCT02703337|102248461|FG003|COMPLETED|Period Three (Part A)||5||
48778613|NCT02703337|102248462|FG004|COMPLETED|Period Three (Part A)||4||
48778614|NCT02703337|102248463|FG005|COMPLETED|Period Three (Part A)||5||
48778615|NCT02703337|102248464|FG006|COMPLETED|Period Three (Part A)||0||
48778616|NCT02703337|102248465|FG007|COMPLETED|Period Three (Part A)||0||
48778617|NCT02703337|102248458|FG000|NOT COMPLETED|Period Three (Part A)||0||
48778618|NCT02703337|102248459|FG001|NOT COMPLETED|Period Three (Part A)||0||
48778619|NCT02703337|102248460|FG002|NOT COMPLETED|Period Three (Part A)||0||
48778620|NCT02703337|102248461|FG003|NOT COMPLETED|Period Three (Part A)||0||
48665194|NCT00023595|101964754|FG003|STARTED|5 Year Follow up||423||
48778621|NCT02703337|102248462|FG004|NOT COMPLETED|Period Three (Part A)||0||
48778622|NCT02703337|102248463|FG005|NOT COMPLETED|Period Three (Part A)||0||
48778623|NCT02703337|102248464|FG006|NOT COMPLETED|Period Three (Part A)||0||
48778624|NCT02703337|102248465|FG007|NOT COMPLETED|Period Three (Part A)||0||
48778625|NCT02703337|102248458|FG000|STARTED|Period Four (Part A)||5||
48778626|NCT02703337|102248459|FG001|STARTED|Period Four (Part A)||5||
48778627|NCT02703337|102248460|FG002|STARTED|Period Four (Part A)||5||
48778628|NCT02703337|102248461|FG003|STARTED|Period Four (Part A)||5||
48778629|NCT02703337|102248462|FG004|STARTED|Period Four (Part A)||4||
48778630|NCT02703337|102248463|FG005|STARTED|Period Four (Part A)||5||
48778631|NCT02703337|102248464|FG006|STARTED|Period Four (Part A)||0||
48778632|NCT02703337|102248465|FG007|STARTED|Period Four (Part A)||0||
48778633|NCT02703337|102248458|FG000|Received Study Drug|Period Four (Part A)||5||
48778634|NCT02703337|102248459|FG001|Received Study Drug|Period Four (Part A)||5||
48778635|NCT02703337|102248460|FG002|Received Study Drug|Period Four (Part A)||5||
48778636|NCT02703337|102248461|FG003|Received Study Drug|Period Four (Part A)||5||
48463639|NCT01506323|101471024|FG000|STARTED|Overall Study||89||
48463640|NCT01506323|101471025|FG001|STARTED|Overall Study||84||
48463641|NCT01506323|101471024|FG000|Post-treatment Completers|Overall Study||69||
48463642|NCT01506323|101471025|FG001|Post-treatment Completers|Overall Study||72||
48463643|NCT01506323|101471024|FG000|Post-treatment Completed CAPS|Overall Study||68||
48463644|NCT01506323|101471025|FG001|Post-treatment Completed CAPS|Overall Study||72||
48463645|NCT01506323|101471024|FG000|COMPLETED|Overall Study||65||
48463646|NCT01506323|101471025|FG001|COMPLETED|Overall Study||71||
48463647|NCT01506323|101471024|FG000|NOT COMPLETED|Overall Study||24||
48463648|NCT01506323|101471025|FG001|NOT COMPLETED|Overall Study||13||
48463649|NCT01628120|101471026|FG000|STARTED|Overall Study||173||
48463650|NCT01628120|101471026|FG000|Treated|Overall Study||170||
48463651|NCT01628120|101471026|FG000|COMPLETED|Overall Study||129||
48463652|NCT01628120|101471026|FG000|NOT COMPLETED|Overall Study||44||
48463653|NCT00176904|101471027|FG000|STARTED|Overall Study||135||
48463654|NCT00176904|101471027|FG000|COMPLETED|Overall Study||135||
48463655|NCT00176904|101471027|FG000|NOT COMPLETED|Overall Study||0||
48463656|NCT00909727|101471028|FG000|STARTED|Overall Study||26||
48463657|NCT00909727|101471029|FG001|STARTED|Overall Study||26||
48463658|NCT00909727|101471028|FG000|Completed Treatment Period, Week 24|Overall Study||23||
48463659|NCT00909727|101471029|FG001|Completed Treatment Period, Week 24|Overall Study||26||
48463660|NCT00909727|101471028|FG000|COMPLETED|Overall Study||22||
48463661|NCT00909727|101471029|FG001|COMPLETED|Overall Study||26||
48463662|NCT00909727|101471028|FG000|NOT COMPLETED|Overall Study||4||
48463663|NCT00909727|101471029|FG001|NOT COMPLETED|Overall Study||0||
48463664|NCT00455663|101471030|FG000|STARTED|Overall Study||37||
48463665|NCT00455663|101471031|FG001|STARTED|Overall Study||36||
48463666|NCT00455663|101471032|FG002|STARTED|Overall Study||32||
48463667|NCT00455663|101471030|FG000|COMPLETED|Overall Study||34||
48463668|NCT00455663|101471031|FG001|COMPLETED|Overall Study||32||
48463669|NCT00455663|101471032|FG002|COMPLETED|Overall Study||29||
48463670|NCT00455663|101471030|FG000|NOT COMPLETED|Overall Study||3||
48463671|NCT00455663|101471031|FG001|NOT COMPLETED|Overall Study||4||
48665195|NCT00023595|101964755|FG004|STARTED|5 Year Follow up||501||
48665196|NCT00023595|101964751|FG000|COMPLETED|5 Year Follow up||600||
48665197|NCT00023595|101964752|FG001|COMPLETED|5 Year Follow up||532||
48665198|NCT00023595|101964753|FG002|COMPLETED|5 Year Follow up||75||
48665199|NCT00023595|101964754|FG003|COMPLETED|5 Year Follow up||416||
48665200|NCT00023595|101964755|FG004|COMPLETED|5 Year Follow up||498||
48665201|NCT00023595|101964751|FG000|NOT COMPLETED|5 Year Follow up||2||
48665202|NCT00023595|101964752|FG001|NOT COMPLETED|5 Year Follow up||2||
48665203|NCT00023595|101964753|FG002|NOT COMPLETED|5 Year Follow up||1||
48665204|NCT00023595|101964754|FG003|NOT COMPLETED|5 Year Follow up||7||
48665205|NCT00023595|101964755|FG004|NOT COMPLETED|5 Year Follow up||3||
48665206|NCT00023595|101964751|FG000|STARTED|10 Year Follow up||602||
48463672|NCT00455663|101471032|FG002|NOT COMPLETED|Overall Study||3||
48463673|NCT01090765|101471033|FG000|STARTED|Overall Study||3||
48463674|NCT01090765|101471034|FG001|STARTED|Overall Study||3||
48463675|NCT01090765|101471035|FG002|STARTED|Overall Study||3||
48463676|NCT01090765|101471036|FG003|STARTED|Overall Study||2||
48463677|NCT01090765|101471037|FG004|STARTED|Overall Study||6||
48463678|NCT01090765|101471038|FG005|STARTED|Overall Study||4||
48463679|NCT01090765|101471033|FG000|COMPLETED|Overall Study||3||
48463680|NCT01090765|101471034|FG001|COMPLETED|Overall Study||3||
48463681|NCT01090765|101471035|FG002|COMPLETED|Overall Study||3||
48463682|NCT01090765|101471036|FG003|COMPLETED|Overall Study||1||
48463683|NCT01090765|101471037|FG004|COMPLETED|Overall Study||4||
48463684|NCT01090765|101471038|FG005|COMPLETED|Overall Study||3||
48463685|NCT01090765|101471033|FG000|NOT COMPLETED|Overall Study||0||
48463686|NCT01090765|101471034|FG001|NOT COMPLETED|Overall Study||0||
48463687|NCT01090765|101471035|FG002|NOT COMPLETED|Overall Study||0||
48463688|NCT01090765|101471036|FG003|NOT COMPLETED|Overall Study||1||
48463689|NCT01090765|101471037|FG004|NOT COMPLETED|Overall Study||2||
48463690|NCT01090765|101471038|FG005|NOT COMPLETED|Overall Study||1||
48463691|NCT00006156|101471039|FG000|STARTED|Overall Study||42||
48463692|NCT00006156|101471040|FG001|STARTED|Overall Study||7||
48463693|NCT00006156|101471039|FG000|COMPLETED|Overall Study||42||
48463694|NCT00006156|101471040|FG001|COMPLETED|Overall Study||7||
48463695|NCT00006156|101471039|FG000|NOT COMPLETED|Overall Study||0||
48463696|NCT00006156|101471040|FG001|NOT COMPLETED|Overall Study||0||
48463697|NCT01077713|101471041|FG000|STARTED|Overall Study||44||
48463698|NCT01077713|101471042|FG001|STARTED|Overall Study||42||
48463699|NCT01077713|101471041|FG000|COMPLETED|Overall Study||8||
48463700|NCT01077713|101471042|FG001|COMPLETED|Overall Study||6||
48665207|NCT00023595|101964752|FG001|STARTED|10 Year Follow up||534||
48665208|NCT00023595|101964753|FG002|STARTED|10 Year Follow up||76||
48778637|NCT02703337|102248462|FG004|Received Study Drug|Period Four (Part A)||4||
48463701|NCT01077713|101471041|FG000|NOT COMPLETED|Overall Study||36||
48463702|NCT01077713|101471042|FG001|NOT COMPLETED|Overall Study||36||
48463703|NCT01001169|101471043|FG000|STARTED|Overall Study||30||
48463704|NCT01001169|101471044|FG001|STARTED|Overall Study||30||
48463705|NCT01001169|101471043|FG000|COMPLETED|Overall Study||28||
48463706|NCT01001169|101471044|FG001|COMPLETED|Overall Study||29||
48463707|NCT01001169|101471043|FG000|NOT COMPLETED|Overall Study||2||
48463708|NCT01001169|101471044|FG001|NOT COMPLETED|Overall Study||1||
48463709|NCT02015793|101471045|FG000|STARTED|Overall Study||15||
48463710|NCT02015793|101471046|FG001|STARTED|Overall Study||15||
48665209|NCT00023595|101964754|FG003|STARTED|10 Year Follow up||0||
48665210|NCT00023595|101964755|FG004|STARTED|10 Year Follow up||0||
48665211|NCT00023595|101964751|FG000|COMPLETED|10 Year Follow up||590||
48665212|NCT00023595|101964752|FG001|COMPLETED|10 Year Follow up||524||
48665213|NCT00023595|101964753|FG002|COMPLETED|10 Year Follow up||73||
48665214|NCT00023595|101964754|FG003|COMPLETED|10 Year Follow up||0||
48665215|NCT00023595|101964755|FG004|COMPLETED|10 Year Follow up||0||
48665216|NCT00023595|101964751|FG000|NOT COMPLETED|10 Year Follow up||12||
48665217|NCT00023595|101964752|FG001|NOT COMPLETED|10 Year Follow up||10||
48665218|NCT00023595|101964753|FG002|NOT COMPLETED|10 Year Follow up||3||
48665219|NCT00023595|101964754|FG003|NOT COMPLETED|10 Year Follow up||0||
48778638|NCT02703337|102248463|FG005|Received Study Drug|Period Four (Part A)||5||
48778639|NCT02703337|102248464|FG006|Received Study Drug|Period Four (Part A)||0||
48778640|NCT02703337|102248465|FG007|Received Study Drug|Period Four (Part A)||0||
48778641|NCT02703337|102248458|FG000|COMPLETED|Period Four (Part A)||5||
48778642|NCT02703337|102248459|FG001|COMPLETED|Period Four (Part A)||5||
48778643|NCT02703337|102248460|FG002|COMPLETED|Period Four (Part A)||5||
48463711|NCT02015793|101471045|FG000|Completed Double-Blind Period|Overall Study||14||
48463712|NCT02015793|101471046|FG001|Completed Double-Blind Period|Overall Study||14||
48665220|NCT00023595|101964755|FG004|NOT COMPLETED|10 Year Follow up||0||
48665221|NCT01969409|101964756|FG000|STARTED|Overall Study||28||
48665222|NCT01969409|101964757|FG001|STARTED|Overall Study||30||
48665223|NCT01969409|101964756|FG000|COMPLETED|Overall Study||25||
48665224|NCT01969409|101964757|FG001|COMPLETED|Overall Study||26||
48665225|NCT01969409|101964756|FG000|NOT COMPLETED|Overall Study||3||
48665226|NCT01969409|101964757|FG001|NOT COMPLETED|Overall Study||4||
48665227|NCT01405196|101964758|FG000|STARTED|Overall Study||45||
48665228|NCT01405196|101964759|FG001|STARTED|Overall Study||47||
48665229|NCT01405196|101964760|FG002|STARTED|Overall Study||46||
48665230|NCT01405196|101964761|FG003|STARTED|Overall Study||45||
48665231|NCT01405196|101964758|FG000|COMPLETED|Overall Study||34||
48665232|NCT01405196|101964759|FG001|COMPLETED|Overall Study||35||
48665233|NCT01405196|101964760|FG002|COMPLETED|Overall Study||23||
48665234|NCT01405196|101964761|FG003|COMPLETED|Overall Study||36||
48665235|NCT01405196|101964758|FG000|NOT COMPLETED|Overall Study||11||
48665236|NCT01405196|101964759|FG001|NOT COMPLETED|Overall Study||12||
48665237|NCT01405196|101964760|FG002|NOT COMPLETED|Overall Study||23||
48665238|NCT01405196|101964761|FG003|NOT COMPLETED|Overall Study||9||
48665239|NCT03440411|101964762|FG000|STARTED|Overall Study||3||
48665240|NCT03440411|101964763|FG001|STARTED|Overall Study||1||
48665241|NCT03440411|101964764|FG002|STARTED|Overall Study||2||
48665242|NCT03440411|101964765|FG003|STARTED|Overall Study||2||
48665243|NCT03440411|101964762|FG000|COMPLETED|Overall Study||0|"Treatment is continous until progression disease (PD), so treatment has not a specific duration and so completed is Not Applicable."|
48665244|NCT03440411|101964763|FG001|COMPLETED|Overall Study||0|"Treatment is continous until progression disease (PD), so treatment has not a specific duration and so completed is Not Applicable."|
48665245|NCT03440411|101964764|FG002|COMPLETED|Overall Study||0|"Treatment is continous until progression disease (PD), so treatment has not a specific duration and so completed is Not Applicable."|
48665246|NCT03440411|101964765|FG003|COMPLETED|Overall Study||0|"Treatment is continous until progression disease (PD), so treatment has not a specific duration and so completed is Not Applicable."|
48665247|NCT03440411|101964762|FG000|NOT COMPLETED|Overall Study||3||
48665248|NCT03440411|101964763|FG001|NOT COMPLETED|Overall Study||1||
48778644|NCT02703337|102248461|FG003|COMPLETED|Period Four (Part A)||5||
48778645|NCT02703337|102248462|FG004|COMPLETED|Period Four (Part A)||4||
48778646|NCT02703337|102248463|FG005|COMPLETED|Period Four (Part A)||5||
48778647|NCT02703337|102248464|FG006|COMPLETED|Period Four (Part A)||0||
48778648|NCT02703337|102248465|FG007|COMPLETED|Period Four (Part A)||0||
48778649|NCT02703337|102248458|FG000|NOT COMPLETED|Period Four (Part A)||0||
48778650|NCT02703337|102248459|FG001|NOT COMPLETED|Period Four (Part A)||0||
48778651|NCT02703337|102248460|FG002|NOT COMPLETED|Period Four (Part A)||0||
48778652|NCT02703337|102248461|FG003|NOT COMPLETED|Period Four (Part A)||0||
48778653|NCT02703337|102248462|FG004|NOT COMPLETED|Period Four (Part A)||0||
48463713|NCT02015793|101471045|FG000|Entered Open-label Extension Period|Overall Study||13||
48463714|NCT02015793|101471046|FG001|Entered Open-label Extension Period|Overall Study||14||
48463715|NCT02015793|101471045|FG000|COMPLETED|Overall Study||11||
48463716|NCT02015793|101471046|FG001|COMPLETED|Overall Study||11||
48463717|NCT02015793|101471045|FG000|NOT COMPLETED|Overall Study||4||
48463718|NCT02015793|101471046|FG001|NOT COMPLETED|Overall Study||4||
48463719|NCT00322309|101471047|FG000|STARTED|Overall Study||11||
48463720|NCT00322309|101471048|FG001|STARTED|Overall Study||13||
48463721|NCT00322309|101471047|FG000|COMPLETED|Overall Study||9||
48463722|NCT00322309|101471048|FG001|COMPLETED|Overall Study||9||
48463723|NCT00322309|101471047|FG000|NOT COMPLETED|Overall Study||2||
48463724|NCT00322309|101471048|FG001|NOT COMPLETED|Overall Study||4||
48463725|NCT03342898|101471049|FG000|STARTED|Overall Study||300||
48463726|NCT03342898|101471050|FG001|STARTED|Overall Study||300||
48463727|NCT03342898|101471051|FG002|STARTED|Overall Study||300||
48463728|NCT03342898|101471049|FG000|COMPLETED|Overall Study||246||
48463729|NCT03342898|101471050|FG001|COMPLETED|Overall Study||247||
48463730|NCT03342898|101471051|FG002|COMPLETED|Overall Study||246||
48463731|NCT03342898|101471049|FG000|NOT COMPLETED|Overall Study||54||
48463732|NCT03342898|101471050|FG001|NOT COMPLETED|Overall Study||53||
48463733|NCT03342898|101471051|FG002|NOT COMPLETED|Overall Study||54||
48463734|NCT02637557|101471052|FG000|STARTED|Overall Study||71||
48369902|NCT00912158|101232863|FG000|STARTED|Overall Study||44||
48369903|NCT00912158|101232864|FG001|STARTED|Overall Study||44||
48369904|NCT00912158|101232865|FG002|STARTED|Overall Study||41||
48369905|NCT00912158|101232863|FG000|COMPLETED|Overall Study||44||
48369906|NCT00912158|101232864|FG001|COMPLETED|Overall Study||44||
48369907|NCT00912158|101232865|FG002|COMPLETED|Overall Study||41||
48369908|NCT00912158|101232863|FG000|NOT COMPLETED|Overall Study||0||
48369909|NCT00912158|101232864|FG001|NOT COMPLETED|Overall Study||0||
48369910|NCT00912158|101232865|FG002|NOT COMPLETED|Overall Study||0||
48369911|NCT00878072|101232866|FG000|STARTED|Overall Study||53||
48369912|NCT00878072|101232866|FG000|COMPLETED|Overall Study||51||
48369913|NCT00878072|101232866|FG000|NOT COMPLETED|Overall Study||2||
48369914|NCT03393013|101232867|FG000|STARTED|Phase 1b||8||
48369915|NCT03393013|101232868|FG001|STARTED|Phase 1b||5||
48369916|NCT03393013|101232869|FG002|STARTED|Phase 1b||14||
48369917|NCT03393013|101232870|FG003|STARTED|Phase 1b||6||
48369918|NCT03393013|101232871|FG004|STARTED|Phase 1b||8||
48369919|NCT03393013|101232872|FG005|STARTED|Phase 1b||6||
48369920|NCT03393013|101232873|FG006|STARTED|Phase 1b||0||
48369921|NCT03393013|101232867|FG000|COMPLETED|Phase 1b||5||
48369922|NCT03393013|101232868|FG001|COMPLETED|Phase 1b||2||
48369923|NCT03393013|101232869|FG002|COMPLETED|Phase 1b||10||
48369924|NCT03393013|101232870|FG003|COMPLETED|Phase 1b||6||
48369925|NCT03393013|101232871|FG004|COMPLETED|Phase 1b||8||
48369926|NCT03393013|101232872|FG005|COMPLETED|Phase 1b||4||
48369927|NCT03393013|101232873|FG006|COMPLETED|Phase 1b||0||
48369928|NCT03393013|101232867|FG000|NOT COMPLETED|Phase 1b||3||
48369929|NCT03393013|101232868|FG001|NOT COMPLETED|Phase 1b||3||
48369930|NCT03393013|101232869|FG002|NOT COMPLETED|Phase 1b||4||
48369931|NCT03393013|101232870|FG003|NOT COMPLETED|Phase 1b||0||
48369932|NCT03393013|101232871|FG004|NOT COMPLETED|Phase 1b||0||
48369933|NCT03393013|101232872|FG005|NOT COMPLETED|Phase 1b||2||
48369934|NCT03393013|101232873|FG006|NOT COMPLETED|Phase 1b||0||
48369935|NCT03393013|101232867|FG000|STARTED|Phase 2||0|Patients who were in Cohorts 1, 2, 2a, 2b, 2c, and 3 were enrolled in Phase 1b only.|
48369936|NCT03393013|101232868|FG001|STARTED|Phase 2||0|Patients who were in Cohorts 1, 2, 2a, 2b, 2c, and 3 were enrolled in Phase 1b only.|
48369937|NCT03393013|101232869|FG002|STARTED|Phase 2||0|Patients who were in Cohorts 1, 2, 2a, 2b, 2c, and 3 were enrolled in Phase 1b only.|
48369938|NCT03393013|101232870|FG003|STARTED|Phase 2||0|Patients who were in Cohorts 1, 2, 2a, 2b, 2c, and 3 were enrolled in Phase 1b only.|
48369939|NCT03393013|101232871|FG004|STARTED|Phase 2||0|Patients who were in Cohorts 1, 2, 2a, 2b, 2c, and 3 were enrolled in Phase 1b only.|
48369940|NCT03393013|101232872|FG005|STARTED|Phase 2||0|Patients who were in Cohorts 1, 2, 2a, 2b, 2c, and 3 were enrolled in Phase 1b only.|
48369941|NCT03393013|101232873|FG006|STARTED|Phase 2||22|Patients who were in Cohorts 1, 2, 2a, 2b, 2c, and 3 were enrolled in Phase 1b only.|
48369942|NCT03393013|101232867|FG000|COMPLETED|Phase 2||0||
48369943|NCT03393013|101232868|FG001|COMPLETED|Phase 2||0||
48369944|NCT03393013|101232869|FG002|COMPLETED|Phase 2||0||
48463735|NCT02637557|101471053|FG001|STARTED|Overall Study||71||
48463736|NCT02637557|101471054|FG002|STARTED|Overall Study||71||
48369945|NCT03393013|101232870|FG003|COMPLETED|Phase 2||0||
48369946|NCT03393013|101232871|FG004|COMPLETED|Phase 2||0||
48369947|NCT03393013|101232872|FG005|COMPLETED|Phase 2||0||
48369948|NCT03393013|101232873|FG006|COMPLETED|Phase 2||18||
48369949|NCT03393013|101232867|FG000|NOT COMPLETED|Phase 2||0||
48369950|NCT03393013|101232868|FG001|NOT COMPLETED|Phase 2||0||
48369951|NCT03393013|101232869|FG002|NOT COMPLETED|Phase 2||0||
48369952|NCT03393013|101232870|FG003|NOT COMPLETED|Phase 2||0||
48369953|NCT03393013|101232871|FG004|NOT COMPLETED|Phase 2||0||
48463737|NCT02637557|101471055|FG003|STARTED|Overall Study||69||
48463738|NCT02637557|101471052|FG000|COMPLETED|Overall Study||63||
48463739|NCT02637557|101471053|FG001|COMPLETED|Overall Study||66||
48463740|NCT02637557|101471054|FG002|COMPLETED|Overall Study||62||
48463741|NCT02637557|101471055|FG003|COMPLETED|Overall Study||62||
48463742|NCT02637557|101471052|FG000|NOT COMPLETED|Overall Study||8||
48463743|NCT02637557|101471053|FG001|NOT COMPLETED|Overall Study||5||
48463744|NCT02637557|101471054|FG002|NOT COMPLETED|Overall Study||9||
48463745|NCT02637557|101471055|FG003|NOT COMPLETED|Overall Study||7||
48463746|NCT04169282|101471056|FG000|STARTED|Overall Study||10||
48463747|NCT04169282|101471056|FG000|COMPLETED|Overall Study||9||
48463748|NCT04169282|101471056|FG000|NOT COMPLETED|Overall Study||1||
48463749|NCT02752776|101471057|FG000|STARTED|Overall Study||663||
48463750|NCT02752776|101471058|FG001|STARTED|Overall Study||673||
48463751|NCT02752776|101471059|FG002|STARTED|Overall Study||324||
48463752|NCT02752776|101471057|FG000|COMPLETED|Overall Study||611||
48463753|NCT02752776|101471058|FG001|COMPLETED|Overall Study||597||
48463754|NCT02752776|101471059|FG002|COMPLETED|Overall Study||276||
48463755|NCT02752776|101471057|FG000|NOT COMPLETED|Overall Study||52||
48463756|NCT02752776|101471058|FG001|NOT COMPLETED|Overall Study||76||
48463757|NCT02752776|101471059|FG002|NOT COMPLETED|Overall Study||48||
48463758|NCT00329602|101471060|FG000|STARTED|26-Week Double-Blind Treatment Phase||207||
48463759|NCT00329602|101471061|FG001|STARTED|26-Week Double-Blind Treatment Phase||197||
48463760|NCT00329602|101471062|FG002|STARTED|26-Week Double-Blind Treatment Phase||0||
48463761|NCT00329602|101471060|FG000|COMPLETED|26-Week Double-Blind Treatment Phase||88||
48463762|NCT00329602|101471061|FG001|COMPLETED|26-Week Double-Blind Treatment Phase||98||
48463763|NCT00329602|101471062|FG002|COMPLETED|26-Week Double-Blind Treatment Phase||0||
48463764|NCT00329602|101471060|FG000|NOT COMPLETED|26-Week Double-Blind Treatment Phase||119||
48463765|NCT00329602|101471061|FG001|NOT COMPLETED|26-Week Double-Blind Treatment Phase||99||
48463766|NCT00329602|101471062|FG002|NOT COMPLETED|26-Week Double-Blind Treatment Phase||0||
48463767|NCT00329602|101471060|FG000|STARTED|40-Week Open-Label Treatment Phase||0||
48463768|NCT00329602|101471061|FG001|STARTED|40-Week Open-Label Treatment Phase||0||
48463769|NCT00329602|101471062|FG002|STARTED|40-Week Open-Label Treatment Phase||269||
48463770|NCT00329602|101471060|FG000|COMPLETED|40-Week Open-Label Treatment Phase||0||
48463771|NCT00329602|101471061|FG001|COMPLETED|40-Week Open-Label Treatment Phase||0||
48463772|NCT00329602|101471062|FG002|COMPLETED|40-Week Open-Label Treatment Phase||233||
48463773|NCT00329602|101471060|FG000|NOT COMPLETED|40-Week Open-Label Treatment Phase||0||
48463774|NCT00329602|101471061|FG001|NOT COMPLETED|40-Week Open-Label Treatment Phase||0||
48463775|NCT00329602|101471062|FG002|NOT COMPLETED|40-Week Open-Label Treatment Phase||36||
48463776|NCT01901055|101471063|FG000|STARTED|Randomization But Not Titrated||49|49 Subjects were randomized to each group. Milestone is that they completed overnight sleep study and were successfully titrated to CPAP or sham-CPAP/|
48463777|NCT01901055|101471064|FG001|STARTED|Randomization But Not Titrated||49|49 Subjects were randomized to each group. Milestone is that they completed overnight sleep study and were successfully titrated to CPAP or sham-CPAP/|
48463778|NCT01901055|101471063|FG000|COMPLETED|Randomization But Not Titrated||48||
48463779|NCT01901055|101471064|FG001|COMPLETED|Randomization But Not Titrated||47||
48463780|NCT01901055|101471063|FG000|NOT COMPLETED|Randomization But Not Titrated||1||
48463781|NCT01901055|101471064|FG001|NOT COMPLETED|Randomization But Not Titrated||2||
48463782|NCT01901055|101471063|FG000|STARTED|Started Protocol to Week 6||48||
48463783|NCT01901055|101471064|FG001|STARTED|Started Protocol to Week 6||47||
48463784|NCT01901055|101471063|FG000|COMPLETED|Started Protocol to Week 6||45||
48463785|NCT01901055|101471064|FG001|COMPLETED|Started Protocol to Week 6||43||
48463786|NCT01901055|101471063|FG000|NOT COMPLETED|Started Protocol to Week 6||3||
48463787|NCT01901055|101471064|FG001|NOT COMPLETED|Started Protocol to Week 6||4||
48463788|NCT01901055|101471063|FG000|STARTED|Week 12 Assessment||45||
48463789|NCT01901055|101471064|FG001|STARTED|Week 12 Assessment||43||
48463790|NCT01901055|101471063|FG000|COMPLETED|Week 12 Assessment||44||
48463791|NCT01901055|101471064|FG001|COMPLETED|Week 12 Assessment||39||
48463792|NCT01901055|101471063|FG000|NOT COMPLETED|Week 12 Assessment||1||
48463793|NCT01901055|101471064|FG001|NOT COMPLETED|Week 12 Assessment||4||
48463794|NCT01901055|101471063|FG000|STARTED|Week 24||44|This is the final assessment of persons on active CPAP treatment. After the 12 week assessment, all participant were told their group assignment. Those on sham-CPAP were allowed to titrate to active CPAP. This assessment (week 24 in protocol) is 12 weeks after the participants started active treatment.|
48463795|NCT01901055|101471064|FG001|STARTED|Week 24||39|This is the final assessment of persons on active CPAP treatment. After the 12 week assessment, all participant were told their group assignment. Those on sham-CPAP were allowed to titrate to active CPAP. This assessment (week 24 in protocol) is 12 weeks after the participants started active treatment.|
48463796|NCT01901055|101471063|FG000|COMPLETED|Week 24||30||
48463797|NCT01901055|101471064|FG001|COMPLETED|Week 24||20||
48463798|NCT01901055|101471063|FG000|NOT COMPLETED|Week 24||14||
48463799|NCT01901055|101471064|FG001|NOT COMPLETED|Week 24||19||
48463800|NCT01901055|101471063|FG000|STARTED|Week 36||30||
48463801|NCT01901055|101471064|FG001|STARTED|Week 36||20||
48463802|NCT01901055|101471063|FG000|COMPLETED|Week 36||30|Only participants originally in the sham-CPAP group were in this time period where they completed being on 24 weeks active CPAP.|
48463803|NCT01901055|101471064|FG001|COMPLETED|Week 36||15|Only participants originally in the sham-CPAP group were in this time period where they completed being on 24 weeks active CPAP.|
48463804|NCT01901055|101471063|FG000|NOT COMPLETED|Week 36||0||
48463805|NCT01901055|101471064|FG001|NOT COMPLETED|Week 36||5||
48463806|NCT01665053|101471065|FG000|STARTED|Overall Study||838||
48463807|NCT01665053|101471066|FG001|STARTED|Overall Study||846||
48463808|NCT01665053|101471065|FG000|Completed 12-Month Clinical F/U|Overall Study||797||
48463809|NCT01665053|101471066|FG001|Completed 12-Month Clinical F/U|Overall Study||822||
48463810|NCT01665053|101471065|FG000|No 12-Month F/U|Overall Study||32||
48463811|NCT01665053|101471066|FG001|No 12-Month F/U|Overall Study||15||
48463812|NCT01665053|101471065|FG000|Death With No 12-month Clinical FU|Overall Study||9||
48463813|NCT01665053|101471066|FG001|Death With No 12-month Clinical FU|Overall Study||9||
48463814|NCT01665053|101471065|FG000|COMPLETED|Overall Study||806||
48463815|NCT01665053|101471066|FG001|COMPLETED|Overall Study||831||
48463816|NCT01665053|101471065|FG000|NOT COMPLETED|Overall Study||32||
48463817|NCT01665053|101471066|FG001|NOT COMPLETED|Overall Study||15||
48463818|NCT03377556|101471067|FG000|STARTED|Overall Study||47||
48463819|NCT03377556|101471067|FG000|Primary Analysis Population (HRRD-positive Per MDVN Criteria)|Overall Study||24||
48463820|NCT03377556|101471067|FG000|COMPLETED|Overall Study||0||
48463821|NCT03377556|101471067|FG000|NOT COMPLETED|Overall Study||47||
48463822|NCT02938494|101471068|FG000|STARTED|Overall Study||69||
48463823|NCT02938494|101471069|FG001|STARTED|Overall Study||72||
48463824|NCT02938494|101471070|FG002|STARTED|Overall Study||34||
48463825|NCT02938494|101471071|FG003|STARTED|Overall Study||35||
48463826|NCT02938494|101471068|FG000|COMPLETED|Overall Study||65||
48463827|NCT02938494|101471069|FG001|COMPLETED|Overall Study||63||
48463828|NCT02938494|101471070|FG002|COMPLETED|Overall Study||30||
48463829|NCT02938494|101471071|FG003|COMPLETED|Overall Study||31||
48463830|NCT02938494|101471068|FG000|NOT COMPLETED|Overall Study||4||
48463831|NCT02938494|101471069|FG001|NOT COMPLETED|Overall Study||9||
48463832|NCT02938494|101471070|FG002|NOT COMPLETED|Overall Study||4||
48463833|NCT02938494|101471071|FG003|NOT COMPLETED|Overall Study||4||
48463834|NCT00492089|101471072|FG000|STARTED|First Intervention (6 Weeks)||5||
48463835|NCT00492089|101471073|FG001|STARTED|First Intervention (6 Weeks)||6||
48463836|NCT00492089|101471072|FG000|COMPLETED|First Intervention (6 Weeks)||5||
48463837|NCT00492089|101471073|FG001|COMPLETED|First Intervention (6 Weeks)||6||
48463838|NCT00492089|101471072|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0||
48463839|NCT00492089|101471073|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0||
48463840|NCT00492089|101471072|FG000|STARTED|Second Intervention (6 Weeks)||5||
48463841|NCT00492089|101471073|FG001|STARTED|Second Intervention (6 Weeks)||6||
48463842|NCT00492089|101471072|FG000|COMPLETED|Second Intervention (6 Weeks)||5||
48463843|NCT00492089|101471073|FG001|COMPLETED|Second Intervention (6 Weeks)||6||
48463844|NCT00492089|101471072|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0||
48463845|NCT00492089|101471073|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0||
48463846|NCT01569828|101471074|FG000|STARTED|Overall Study||6||
48463847|NCT01569828|101471075|FG001|STARTED|Overall Study||6||
48463848|NCT01569828|101471074|FG000|COMPLETED|Overall Study||6||
48463849|NCT01569828|101471075|FG001|COMPLETED|Overall Study||6||
48463850|NCT01569828|101471074|FG000|NOT COMPLETED|Overall Study||0||
48463851|NCT01569828|101471075|FG001|NOT COMPLETED|Overall Study||0||
48463852|NCT00918671|101471076|FG000|STARTED|Overall Study||60||
48463853|NCT00918671|101471076|FG000|COMPLETED|Overall Study||60||
48463854|NCT00918671|101471076|FG000|NOT COMPLETED|Overall Study||0||
48463855|NCT04535609|101471077|FG000|STARTED|Overall Study||108||
48463856|NCT04535609|101471078|FG001|STARTED|Overall Study||104||
48463857|NCT04535609|101471077|FG000|COMPLETED|Overall Study||100||
48463858|NCT04535609|101471078|FG001|COMPLETED|Overall Study||98||
48463859|NCT04535609|101471077|FG000|NOT COMPLETED|Overall Study||8||
48463860|NCT04535609|101471078|FG001|NOT COMPLETED|Overall Study||6||
48463861|NCT02292238|101471079|FG000|STARTED|Overall Study||34||
48463862|NCT02292238|101471080|FG001|STARTED|Overall Study||37||
48463863|NCT02292238|101471079|FG000|COMPLETED|Overall Study||30||
48463864|NCT02292238|101471080|FG001|COMPLETED|Overall Study||33||
48463865|NCT02292238|101471079|FG000|NOT COMPLETED|Overall Study||4||
48463866|NCT02292238|101471080|FG001|NOT COMPLETED|Overall Study||4||
48463867|NCT03572933|101471081|FG000|STARTED|Overall Study||51||
48463868|NCT03572933|101471082|FG001|STARTED|Overall Study||50||
48463869|NCT03572933|101471081|FG000|COMPLETED|Overall Study||47||
48463870|NCT03572933|101471082|FG001|COMPLETED|Overall Study||48||
48463871|NCT03572933|101471081|FG000|NOT COMPLETED|Overall Study||4||
48463872|NCT03572933|101471082|FG001|NOT COMPLETED|Overall Study||2||
48463873|NCT01717014|101471083|FG000|STARTED|Overall Study||8||
48463874|NCT01717014|101471083|FG000|COMPLETED|Overall Study||8||
48463875|NCT01717014|101471083|FG000|NOT COMPLETED|Overall Study||0||
48463876|NCT03850509|101471084|FG000|STARTED|Overall Study||2||
48463877|NCT03850509|101471085|FG001|STARTED|Overall Study||1||
48665249|NCT03440411|101964764|FG002|NOT COMPLETED|Overall Study||2||
48463878|NCT03850509|101471084|FG000|COMPLETED|Overall Study||0||
48463879|NCT03850509|101471085|FG001|COMPLETED|Overall Study||0||
48463880|NCT03850509|101471084|FG000|NOT COMPLETED|Overall Study||2||
48463881|NCT03850509|101471085|FG001|NOT COMPLETED|Overall Study||1||
48463882|NCT01992107|101471086|FG000|STARTED|Overall Study||1159||
48463883|NCT01992107|101471087|FG001|STARTED|Overall Study||593||
48463884|NCT01992107|101471088|FG002|STARTED|Overall Study||581||
48463885|NCT01992107|101471086|FG000|COMPLETED|Overall Study||1091||
48463886|NCT01992107|101471087|FG001|COMPLETED|Overall Study||560||
48463887|NCT01992107|101471088|FG002|COMPLETED|Overall Study||545||
48463888|NCT01992107|101471086|FG000|NOT COMPLETED|Overall Study||68||
48463889|NCT01992107|101471087|FG001|NOT COMPLETED|Overall Study||33||
48463890|NCT01992107|101471088|FG002|NOT COMPLETED|Overall Study||36||
48463891|NCT01165684|101471089|FG000|STARTED|Overall Study||201||
48463892|NCT01165684|101471090|FG001|STARTED|Overall Study||200||
48463893|NCT01165684|101471089|FG000|Exposed|Overall Study||198||
48463894|NCT01165684|101471090|FG001|Exposed|Overall Study||199||
48463895|NCT01165684|101471089|FG000|COMPLETED|Overall Study||173||
48463896|NCT01165684|101471090|FG001|COMPLETED|Overall Study||148||
48463897|NCT01165684|101471089|FG000|NOT COMPLETED|Overall Study||28||
48463898|NCT01165684|101471090|FG001|NOT COMPLETED|Overall Study||52||
48463899|NCT01132118|101471091|FG000|STARTED|First Intervention (8 Weeks)||15||
48463900|NCT01132118|101471092|FG001|STARTED|First Intervention (8 Weeks)||15||
48463901|NCT01132118|101471091|FG000|COMPLETED|First Intervention (8 Weeks)||12||
48463902|NCT01132118|101471092|FG001|COMPLETED|First Intervention (8 Weeks)||12||
48463903|NCT01132118|101471091|FG000|NOT COMPLETED|First Intervention (8 Weeks)||3||
48463904|NCT01132118|101471092|FG001|NOT COMPLETED|First Intervention (8 Weeks)||3||
48463905|NCT01132118|101471091|FG000|STARTED|Second Intervention (8 Weeks)||12||
48463906|NCT01132118|101471092|FG001|STARTED|Second Intervention (8 Weeks)||12||
48463907|NCT01132118|101471091|FG000|COMPLETED|Second Intervention (8 Weeks)||12||
48463908|NCT01132118|101471092|FG001|COMPLETED|Second Intervention (8 Weeks)||11||
48463909|NCT01132118|101471091|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0||
48463910|NCT01132118|101471092|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||1||
48463911|NCT01924871|101471093|FG000|STARTED|Overall Study||31||
48463912|NCT01924871|101471094|FG001|STARTED|Overall Study||31||
48463913|NCT01924871|101471093|FG000|COMPLETED|Overall Study||25||
48463914|NCT01924871|101471094|FG001|COMPLETED|Overall Study||29||
48463915|NCT01924871|101471093|FG000|NOT COMPLETED|Overall Study||6||
48463916|NCT01924871|101471094|FG001|NOT COMPLETED|Overall Study||2||
48463917|NCT00295854|101471095|FG000|STARTED|Overall Study||95||
48463918|NCT00295854|101471096|FG001|STARTED|Overall Study||108||
48463919|NCT00295854|101471097|FG002|STARTED|Overall Study||102||
48463920|NCT00295854|101471095|FG000|Safety Population (N=304)|Overall Study||95||
48463921|NCT00295854|101471096|FG001|Safety Population (N=304)|Overall Study||108||
48463922|NCT00295854|101471097|FG002|Safety Population (N=304)|Overall Study||101||
48463923|NCT00295854|101471095|FG000|ITT Population (N=296)|Overall Study||92||
48463924|NCT00295854|101471096|FG001|ITT Population (N=296)|Overall Study||105||
48463925|NCT00295854|101471097|FG002|ITT Population (N=296)|Overall Study||99||
48463926|NCT00295854|101471095|FG000|COMPLETED|Overall Study||77||
48463927|NCT00295854|101471096|FG001|COMPLETED|Overall Study||87||
48463928|NCT00295854|101471097|FG002|COMPLETED|Overall Study||87||
48463929|NCT00295854|101471095|FG000|NOT COMPLETED|Overall Study||18||
48463930|NCT00295854|101471096|FG001|NOT COMPLETED|Overall Study||21||
48463931|NCT00295854|101471097|FG002|NOT COMPLETED|Overall Study||15||
48463932|NCT02491788|101471098|FG000|STARTED|Overall Study||8||
48463933|NCT02491788|101471099|FG001|STARTED|Overall Study||11||
48463934|NCT02491788|101471098|FG000|COMPLETED|Overall Study||8||
48463935|NCT02491788|101471099|FG001|COMPLETED|Overall Study||11||
48463936|NCT02491788|101471098|FG000|NOT COMPLETED|Overall Study||0||
48463937|NCT02491788|101471099|FG001|NOT COMPLETED|Overall Study||0||
48665250|NCT03440411|101964765|FG003|NOT COMPLETED|Overall Study||2||
48665251|NCT01554904|101964766|FG000|STARTED|Overall Study||18||
48665252|NCT01554904|101964766|FG000|Home Sleep Study 1|Overall Study||18||
48665253|NCT01554904|101964766|FG000|Start 6 Weeks of Facial Training|Overall Study||17||
48665254|NCT01554904|101964766|FG000|Complete 6 Weeks of Facial Training|Overall Study||14||
48665255|NCT01554904|101964766|FG000|Home Sleep Study 2|Overall Study||14||
48665256|NCT01554904|101964766|FG000|COMPLETED|Overall Study||14||
48665257|NCT01554904|101964766|FG000|NOT COMPLETED|Overall Study||4||
48665258|NCT04805593|101964767|FG000|STARTED|Overall Study||30||60
48665259|NCT04805593|101964767|FG000|COMPLETED|Overall Study||30||60
48665260|NCT04805593|101964767|FG000|NOT COMPLETED|Overall Study||0||0
48778654|NCT02703337|102248463|FG005|NOT COMPLETED|Period Four (Part A)||0||
48665261|NCT03562156|101964768|FG000|STARTED|Overall Study||217||
48778655|NCT02703337|102248464|FG006|NOT COMPLETED|Period Four (Part A)||0||
48463938|NCT03982433|101471100|FG000|STARTED|Overall Study||8||
48463939|NCT03982433|101471100|FG000|COMPLETED|Overall Study||7||
48463940|NCT03982433|101471100|FG000|NOT COMPLETED|Overall Study||1||
48463941|NCT02346201|101471101|FG000|STARTED|Overall Study||99||
48463942|NCT02346201|101471102|FG001|STARTED|Overall Study||101||
48463943|NCT02346201|101471101|FG000|COMPLETED|Overall Study||89||
48463944|NCT02346201|101471102|FG001|COMPLETED|Overall Study||92||
48463945|NCT02346201|101471101|FG000|NOT COMPLETED|Overall Study||10||
48463946|NCT02346201|101471102|FG001|NOT COMPLETED|Overall Study||9||
48463947|NCT02097121|101471103|FG000|STARTED|Overall Study||19||
48463948|NCT02097121|101471104|FG001|STARTED|Overall Study||18||
48463949|NCT02097121|101471105|FG002|STARTED|Overall Study||19||
48463950|NCT02097121|101471103|FG000|Received Any Treatment|Overall Study||19||
48463951|NCT02097121|101471104|FG001|Received Any Treatment|Overall Study||17||
48463952|NCT02097121|101471105|FG002|Received Any Treatment|Overall Study||19||
48463953|NCT02097121|101471103|FG000|Actual Treatment Received in Cycle 1|Overall Study||18||
48463954|NCT02097121|101471104|FG001|Actual Treatment Received in Cycle 1|Overall Study||17||
48463955|NCT02097121|101471105|FG002|Actual Treatment Received in Cycle 1|Overall Study||20||
48463956|NCT02097121|101471103|FG000|Actual Treatment Received in Cycle 2|Overall Study||1||
48463957|NCT02097121|101471104|FG001|Actual Treatment Received in Cycle 2|Overall Study||17||
48463958|NCT02097121|101471105|FG002|Actual Treatment Received in Cycle 2|Overall Study||28||
48463959|NCT02097121|101471103|FG000|Actual Treatment Received in Cycle 3|Overall Study||2||
48463960|NCT02097121|101471104|FG001|Actual Treatment Received in Cycle 3|Overall Study||7||
48463961|NCT02097121|101471105|FG002|Actual Treatment Received in Cycle 3|Overall Study||13||
48463962|NCT02097121|101471103|FG000|Actual Treatment Received in Cycle 4|Overall Study||0||
48463963|NCT02097121|101471104|FG001|Actual Treatment Received in Cycle 4|Overall Study||1||
48463964|NCT02097121|101471105|FG002|Actual Treatment Received in Cycle 4|Overall Study||3||
48463965|NCT02097121|101471103|FG000|COMPLETED|Overall Study||12||
48463966|NCT02097121|101471104|FG001|COMPLETED|Overall Study||12||
48463967|NCT02097121|101471105|FG002|COMPLETED|Overall Study||9||
48463968|NCT02097121|101471103|FG000|NOT COMPLETED|Overall Study||7||
48463969|NCT02097121|101471104|FG001|NOT COMPLETED|Overall Study||6||
48463970|NCT02097121|101471105|FG002|NOT COMPLETED|Overall Study||10||
48463971|NCT02114307|101471106|FG000|STARTED|Overall Study||11||
48463972|NCT02114307|101471107|FG001|STARTED|Overall Study||11||
48463973|NCT02114307|101471106|FG000|COMPLETED|Overall Study||10||
48463974|NCT02114307|101471107|FG001|COMPLETED|Overall Study||11||
48463975|NCT02114307|101471106|FG000|NOT COMPLETED|Overall Study||1||
48463976|NCT02114307|101471107|FG001|NOT COMPLETED|Overall Study||0||
48463977|NCT03495869|101471108|FG000|STARTED|Overall Study||54||
48463978|NCT03495869|101471109|FG001|STARTED|Overall Study||124||
48463979|NCT03495869|101471110|FG002|STARTED|Overall Study||61||
48463980|NCT03495869|101471111|FG003|STARTED|Overall Study||129||
48665262|NCT03562156|101964769|FG001|STARTED|Overall Study||109||
48665263|NCT03562156|101964768|FG000|COMPLETED|Overall Study||182||
48665264|NCT03562156|101964769|FG001|COMPLETED|Overall Study||91||
48665265|NCT03562156|101964768|FG000|NOT COMPLETED|Overall Study||35||
48665266|NCT03562156|101964769|FG001|NOT COMPLETED|Overall Study||18||
48665267|NCT00835172|101964770|FG000|STARTED|First Intervention||16||
48778656|NCT02703337|102248465|FG007|NOT COMPLETED|Period Four (Part A)||0||
48778657|NCT02703337|102248458|FG000|STARTED|Period Five (Part A)||5||
48778658|NCT02703337|102248459|FG001|STARTED|Period Five (Part A)||5||
48778659|NCT02703337|102248460|FG002|STARTED|Period Five (Part A)||5||
48463981|NCT03495869|101471108|FG000|COMPLETED|Overall Study||50||
48463982|NCT03495869|101471109|FG001|COMPLETED|Overall Study||97||
48463983|NCT03495869|101471110|FG002|COMPLETED|Overall Study||51||
48463984|NCT03495869|101471111|FG003|COMPLETED|Overall Study||108||
48463985|NCT03495869|101471108|FG000|NOT COMPLETED|Overall Study||4||
48463986|NCT03495869|101471109|FG001|NOT COMPLETED|Overall Study||27||
48665268|NCT00835172|101964771|FG001|STARTED|First Intervention||16||
48665269|NCT00835172|101964770|FG000|COMPLETED|First Intervention||16||
48665270|NCT00835172|101964771|FG001|COMPLETED|First Intervention||16||
48665271|NCT00835172|101964770|FG000|NOT COMPLETED|First Intervention||0||
48665272|NCT00835172|101964771|FG001|NOT COMPLETED|First Intervention||0||
48665273|NCT00835172|101964770|FG000|STARTED|Washout||16||
48665274|NCT00835172|101964771|FG001|STARTED|Washout||16||
48778660|NCT02703337|102248461|FG003|STARTED|Period Five (Part A)||5||
48778661|NCT02703337|102248462|FG004|STARTED|Period Five (Part A)||4||
48665275|NCT00835172|101964770|FG000|COMPLETED|Washout||16||
48665276|NCT00835172|101964771|FG001|COMPLETED|Washout||15||
48665277|NCT00835172|101964770|FG000|NOT COMPLETED|Washout||0||
48665278|NCT00835172|101964771|FG001|NOT COMPLETED|Washout||1||
48665279|NCT00835172|101964770|FG000|STARTED|Second Intervention||16||
48665280|NCT00835172|101964771|FG001|STARTED|Second Intervention||15||
48665281|NCT00835172|101964770|FG000|COMPLETED|Second Intervention||16||
48665282|NCT00835172|101964771|FG001|COMPLETED|Second Intervention||15||
48665283|NCT00835172|101964770|FG000|NOT COMPLETED|Second Intervention||0||
48665284|NCT00835172|101964771|FG001|NOT COMPLETED|Second Intervention||0||
48665285|NCT05022719|101964772|FG000|STARTED|Overall Study||5||
48665286|NCT05022719|101964773|FG001|STARTED|Overall Study||3||
48665287|NCT05022719|101964772|FG000|COMPLETED|Overall Study||5||
48778662|NCT02703337|102248463|FG005|STARTED|Period Five (Part A)||5||
48463987|NCT03495869|101471110|FG002|NOT COMPLETED|Overall Study||10||
48463988|NCT03495869|101471111|FG003|NOT COMPLETED|Overall Study||21||
48463989|NCT00929708|101471112|FG000|STARTED|Overall Study||65||
48463990|NCT00929708|101471113|FG001|STARTED|Overall Study||69||
48463991|NCT00929708|101471114|FG002|STARTED|Overall Study||65||
48463992|NCT00929708|101471115|FG003|STARTED|Overall Study||67||
48665288|NCT05022719|101964773|FG001|COMPLETED|Overall Study||3||
48665289|NCT05022719|101964772|FG000|NOT COMPLETED|Overall Study||0||
48665290|NCT05022719|101964773|FG001|NOT COMPLETED|Overall Study||0||
48463993|NCT00929708|101471116|FG004|STARTED|Overall Study||63||
48463994|NCT00929708|101471112|FG000|COMPLETED|Overall Study||61||
48665291|NCT00723632|101964774|FG000|STARTED|Overall Study||901||
48665292|NCT00723632|101964774|FG000|COMPLETED|Overall Study||698||
48665293|NCT00723632|101964774|FG000|NOT COMPLETED|Overall Study||203||
48463995|NCT00929708|101471113|FG001|COMPLETED|Overall Study||66||
48463996|NCT00929708|101471114|FG002|COMPLETED|Overall Study||62||
48463997|NCT00929708|101471115|FG003|COMPLETED|Overall Study||61||
48463998|NCT00929708|101471116|FG004|COMPLETED|Overall Study||57||
48463999|NCT00929708|101471112|FG000|NOT COMPLETED|Overall Study||4||
48464000|NCT00929708|101471113|FG001|NOT COMPLETED|Overall Study||3||
48464001|NCT00929708|101471114|FG002|NOT COMPLETED|Overall Study||3||
48464002|NCT00929708|101471115|FG003|NOT COMPLETED|Overall Study||6||
48464003|NCT00929708|101471116|FG004|NOT COMPLETED|Overall Study||6||
48464004|NCT02030574|101471117|FG000|STARTED|Overall Study||2||
48464005|NCT02030574|101471117|FG000|COMPLETED|Overall Study||2||
48464006|NCT02030574|101471117|FG000|NOT COMPLETED|Overall Study||0||
48464007|NCT02498522|101471118|FG000|STARTED|Overall Study||85||
48464008|NCT02498522|101471119|FG001|STARTED|Overall Study||85||
48464009|NCT02498522|101471118|FG000|COMPLETED|Overall Study||83||
48464010|NCT02498522|101471119|FG001|COMPLETED|Overall Study||83||
48464011|NCT02498522|101471118|FG000|NOT COMPLETED|Overall Study||2||
48464012|NCT02498522|101471119|FG001|NOT COMPLETED|Overall Study||2||
48464013|NCT03463525|101471120|FG000|STARTED|Overall Study||4||
48464014|NCT03463525|101471120|FG000|COMPLETED|Overall Study||4||
48464015|NCT03463525|101471120|FG000|NOT COMPLETED|Overall Study||0||
48464016|NCT01937364|101471121|FG000|STARTED|Overall Study||9||
48464017|NCT01937364|101471122|FG001|STARTED|Overall Study||8||
48464018|NCT01937364|101471121|FG000|COMPLETED|Overall Study||7||
48464019|NCT01937364|101471122|FG001|COMPLETED|Overall Study||7||
48464020|NCT01937364|101471121|FG000|NOT COMPLETED|Overall Study||2||
48464021|NCT01937364|101471122|FG001|NOT COMPLETED|Overall Study||1||
48464022|NCT00524459|101471123|FG000|STARTED|Overall Study||6||
48464023|NCT00524459|101471123|FG000|COMPLETED|Overall Study||4||
48464024|NCT00524459|101471123|FG000|NOT COMPLETED|Overall Study||2||
48464025|NCT01505465|101471124|FG000|STARTED|Overall Study||25||
48464026|NCT01505465|101471125|FG001|STARTED|Overall Study||25||
48464027|NCT01505465|101471124|FG000|COMPLETED|Overall Study||19||
48464028|NCT01505465|101471125|FG001|COMPLETED|Overall Study||18||
48464029|NCT01505465|101471124|FG000|NOT COMPLETED|Overall Study||6||
48464030|NCT01505465|101471125|FG001|NOT COMPLETED|Overall Study||7||
48464031|NCT04326842|101471126|FG000|STARTED|Overall Study||40||
48464032|NCT04326842|101471127|FG001|STARTED|Overall Study||89||
48464033|NCT04326842|101471126|FG000|COMPLETED|Overall Study||31||
48464034|NCT04326842|101471127|FG001|COMPLETED|Overall Study||31||
48464035|NCT04326842|101471126|FG000|NOT COMPLETED|Overall Study||9||
48464036|NCT04326842|101471127|FG001|NOT COMPLETED|Overall Study||58||
48464037|NCT04738279|101471128|FG000|STARTED|Overall Study||5||
48464038|NCT04738279|101471129|FG001|STARTED|Overall Study||15||
48464039|NCT04738279|101471128|FG000|COMPLETED|Overall Study||4||
48464040|NCT04738279|101471129|FG001|COMPLETED|Overall Study||13||
48464041|NCT04738279|101471128|FG000|NOT COMPLETED|Overall Study||1||
48464042|NCT04738279|101471129|FG001|NOT COMPLETED|Overall Study||2||
48464043|NCT04120194|101471130|FG000|STARTED|Overall Study||1332||
48464044|NCT04120194|101471131|FG001|STARTED|Overall Study||1322||
48464045|NCT04120194|101471130|FG000|Safety Population|Overall Study||1333|The Safety Population was analyzed as actually treated (ie, based on the actual dose received).|
48464046|NCT04120194|101471131|FG001|Safety Population|Overall Study||1319|The Safety Population was analyzed as actually treated (ie, based on the actual dose received).|
48464047|NCT04120194|101471130|FG000|COMPLETED|Overall Study||1312||
48464048|NCT04120194|101471131|FG001|COMPLETED|Overall Study||1302||
48464049|NCT04120194|101471130|FG000|NOT COMPLETED|Overall Study||20||
48464050|NCT04120194|101471131|FG001|NOT COMPLETED|Overall Study||20||
48464051|NCT00294723|101471132|FG000|STARTED|Double-Blind Period 52 Weeks||247||
48464052|NCT00294723|101471133|FG001|STARTED|Double-Blind Period 52 Weeks||251||
48464053|NCT00294723|101471134|FG002|STARTED|Double-Blind Period 52 Weeks||248||
48464054|NCT00294723|101471132|FG000|Exposed to Study Drug|Double-Blind Period 52 Weeks||246||
48464055|NCT00294723|101471133|FG001|Exposed to Study Drug|Double-Blind Period 52 Weeks||251||
48464056|NCT00294723|101471134|FG002|Exposed to Study Drug|Double-Blind Period 52 Weeks||248||
48464057|NCT00294723|101471132|FG000|COMPLETED|Double-Blind Period 52 Weeks||173||
48464058|NCT00294723|101471133|FG001|COMPLETED|Double-Blind Period 52 Weeks||162||
48464059|NCT00294723|101471134|FG002|COMPLETED|Double-Blind Period 52 Weeks||152||
48464060|NCT00294723|101471132|FG000|NOT COMPLETED|Double-Blind Period 52 Weeks||74||
48464061|NCT00294723|101471133|FG001|NOT COMPLETED|Double-Blind Period 52 Weeks||89||
48464062|NCT00294723|101471134|FG002|NOT COMPLETED|Double-Blind Period 52 Weeks||96||
48464063|NCT00294723|101471132|FG000|STARTED|Open-Label Extension 52 Weeks||154||
48464064|NCT00294723|101471133|FG001|STARTED|Open-Label Extension 52 Weeks||149||
48464065|NCT00294723|101471134|FG002|STARTED|Open-Label Extension 52 Weeks||137||
48464066|NCT00294723|101471132|FG000|COMPLETED|Open-Label Extension 52 Weeks||114||
48464067|NCT00294723|101471133|FG001|COMPLETED|Open-Label Extension 52 Weeks||110||
48464068|NCT00294723|101471134|FG002|COMPLETED|Open-Label Extension 52 Weeks||97||
48464069|NCT00294723|101471132|FG000|NOT COMPLETED|Open-Label Extension 52 Weeks||40||
48464070|NCT00294723|101471133|FG001|NOT COMPLETED|Open-Label Extension 52 Weeks||39||
48464071|NCT00294723|101471134|FG002|NOT COMPLETED|Open-Label Extension 52 Weeks||40||
48464072|NCT00294723|101471132|FG000|STARTED|Additional Open-Label Extension 91 Weeks||62||
48464073|NCT00294723|101471133|FG001|STARTED|Additional Open-Label Extension 91 Weeks||53||
48464074|NCT00294723|101471134|FG002|STARTED|Additional Open-Label Extension 91 Weeks||28||
48464075|NCT00294723|101471132|FG000|COMPLETED|Additional Open-Label Extension 91 Weeks||34||
48464076|NCT00294723|101471133|FG001|COMPLETED|Additional Open-Label Extension 91 Weeks||32||
48464077|NCT00294723|101471134|FG002|COMPLETED|Additional Open-Label Extension 91 Weeks||8||
48464078|NCT00294723|101471132|FG000|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||28||
48464079|NCT00294723|101471133|FG001|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||21||
48464080|NCT00294723|101471134|FG002|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||20||
48464081|NCT01333033|101471135|FG000|STARTED|Overall Study||72||
48464082|NCT01333033|101471136|FG001|STARTED|Overall Study||39||
48464083|NCT01333033|101471137|FG002|STARTED|Overall Study||64||
48464084|NCT01333033|101471138|FG003|STARTED|Overall Study||50||
48464085|NCT01333033|101471139|FG004|STARTED|Overall Study||14||
48464086|NCT01333033|101471140|FG005|STARTED|Overall Study||18||
48464087|NCT01333033|101471135|FG000|COMPLETED|Overall Study||72||
48464088|NCT01333033|101471136|FG001|COMPLETED|Overall Study||39||
48464089|NCT01333033|101471137|FG002|COMPLETED|Overall Study||64||
48778663|NCT02703337|102248464|FG006|STARTED|Period Five (Part A)||0||
48778664|NCT02703337|102248465|FG007|STARTED|Period Five (Part A)||0||
48778665|NCT02703337|102248458|FG000|Received Study Drug|Period Five (Part A)||5||
48778666|NCT02703337|102248459|FG001|Received Study Drug|Period Five (Part A)||5||
48778667|NCT02703337|102248460|FG002|Received Study Drug|Period Five (Part A)||5||
48778668|NCT02703337|102248461|FG003|Received Study Drug|Period Five (Part A)||5||
48778669|NCT02703337|102248462|FG004|Received Study Drug|Period Five (Part A)||4||
48778670|NCT02703337|102248463|FG005|Received Study Drug|Period Five (Part A)||5||
48778671|NCT02703337|102248464|FG006|Received Study Drug|Period Five (Part A)||0||
48778672|NCT02703337|102248465|FG007|Received Study Drug|Period Five (Part A)||0||
48778673|NCT02703337|102248458|FG000|COMPLETED|Period Five (Part A)||5||
48778674|NCT02703337|102248459|FG001|COMPLETED|Period Five (Part A)||5||
48778675|NCT02703337|102248460|FG002|COMPLETED|Period Five (Part A)||5||
48778676|NCT02703337|102248461|FG003|COMPLETED|Period Five (Part A)||5||
48778677|NCT02703337|102248462|FG004|COMPLETED|Period Five (Part A)||4||
48778678|NCT02703337|102248463|FG005|COMPLETED|Period Five (Part A)||5||
48778679|NCT02703337|102248464|FG006|COMPLETED|Period Five (Part A)||0||
48778680|NCT02703337|102248465|FG007|COMPLETED|Period Five (Part A)||0||
48778681|NCT02703337|102248458|FG000|NOT COMPLETED|Period Five (Part A)||0||
48464090|NCT01333033|101471138|FG003|COMPLETED|Overall Study||50||
48464091|NCT01333033|101471139|FG004|COMPLETED|Overall Study||0||
48464092|NCT01333033|101471140|FG005|COMPLETED|Overall Study||0||
48464093|NCT01333033|101471135|FG000|NOT COMPLETED|Overall Study||0||
48464094|NCT01333033|101471136|FG001|NOT COMPLETED|Overall Study||0||
48464095|NCT01333033|101471137|FG002|NOT COMPLETED|Overall Study||0||
48464096|NCT01333033|101471138|FG003|NOT COMPLETED|Overall Study||0||
48464097|NCT01333033|101471139|FG004|NOT COMPLETED|Overall Study||14||
48464098|NCT01333033|101471140|FG005|NOT COMPLETED|Overall Study||18||
48464099|NCT02410252|101471141|FG000|STARTED|Overall Study||25||
48464100|NCT02410252|101471141|FG000|COMPLETED|Overall Study||19||
48464101|NCT02410252|101471141|FG000|NOT COMPLETED|Overall Study||6||
48464102|NCT00759148|101471142|FG000|STARTED|Overall Study||593||
48665294|NCT02496000|101964775|FG000|STARTED|Overall Study||64||
48665295|NCT02496000|101964776|FG001|STARTED|Overall Study||61||
48778682|NCT02703337|102248459|FG001|NOT COMPLETED|Period Five (Part A)||0||
48778683|NCT02703337|102248460|FG002|NOT COMPLETED|Period Five (Part A)||0||
48778684|NCT02703337|102248461|FG003|NOT COMPLETED|Period Five (Part A)||0||
48778685|NCT02703337|102248462|FG004|NOT COMPLETED|Period Five (Part A)||0||
48778686|NCT02703337|102248463|FG005|NOT COMPLETED|Period Five (Part A)||0||
48778687|NCT02703337|102248464|FG006|NOT COMPLETED|Period Five (Part A)||0||
48464103|NCT00759148|101471143|FG001|STARTED|Overall Study||586||
48464104|NCT00759148|101471142|FG000|COMPLETED|Overall Study||579||
48464105|NCT00759148|101471143|FG001|COMPLETED|Overall Study||554||
48464106|NCT00759148|101471142|FG000|NOT COMPLETED|Overall Study||14||
48464107|NCT00759148|101471143|FG001|NOT COMPLETED|Overall Study||32||
48464108|NCT03229252|101471144|FG000|STARTED|Overall Study||31||
48464109|NCT03229252|101471145|FG001|STARTED|Overall Study||15||
48464110|NCT03229252|101471146|FG002|STARTED|Overall Study||45||
48665296|NCT02496000|101964777|FG002|STARTED|Overall Study||63||
48665297|NCT02496000|101964775|FG000|COMPLETED|Overall Study||62||
48665298|NCT02496000|101964776|FG001|COMPLETED|Overall Study||56||
48665299|NCT02496000|101964777|FG002|COMPLETED|Overall Study||61||
48665300|NCT02496000|101964775|FG000|NOT COMPLETED|Overall Study||2||
48665301|NCT02496000|101964776|FG001|NOT COMPLETED|Overall Study||5||
48464111|NCT03229252|101471144|FG000|COMPLETED|Overall Study||29||
48464112|NCT03229252|101471145|FG001|COMPLETED|Overall Study||15||
48464113|NCT03229252|101471146|FG002|COMPLETED|Overall Study||39||
48464114|NCT03229252|101471144|FG000|NOT COMPLETED|Overall Study||2||
48464115|NCT03229252|101471145|FG001|NOT COMPLETED|Overall Study||0||
48464116|NCT03229252|101471146|FG002|NOT COMPLETED|Overall Study||6||
48464117|NCT02557945|101471147|FG000|STARTED|Overall Study||3||
48464118|NCT02557945|101471148|FG001|STARTED|Overall Study||3||
48665302|NCT02496000|101964777|FG002|NOT COMPLETED|Overall Study||2||
48464119|NCT02557945|101471147|FG000|COMPLETED|Overall Study||3||
48464120|NCT02557945|101471148|FG001|COMPLETED|Overall Study||3||
48464121|NCT02557945|101471147|FG000|NOT COMPLETED|Overall Study||0||
48464122|NCT02557945|101471148|FG001|NOT COMPLETED|Overall Study||0||
48464123|NCT00696709|101471149|FG000|STARTED|Overall Study||65||
48464124|NCT00696709|101471150|FG001|STARTED|Overall Study||63||
48464125|NCT00696709|101471151|FG002|STARTED|Overall Study||33||
48464126|NCT00696709|101471152|FG003|STARTED|Overall Study||64||
48464127|NCT00696709|101471153|FG004|STARTED|Overall Study||65||
48464128|NCT00696709|101471149|FG000|Vaccination 1 (Day 1)|Overall Study||65||
48464129|NCT00696709|101471150|FG001|Vaccination 1 (Day 1)|Overall Study||63||
48464130|NCT00696709|101471151|FG002|Vaccination 1 (Day 1)|Overall Study||32||
48464131|NCT00696709|101471152|FG003|Vaccination 1 (Day 1)|Overall Study||64||
48464132|NCT00696709|101471153|FG004|Vaccination 1 (Day 1)|Overall Study||65||
48464133|NCT00696709|101471149|FG000|Vaccination 2 (~Day 30)|Overall Study||64||
48464134|NCT00696709|101471150|FG001|Vaccination 2 (~Day 30)|Overall Study||60||
48464135|NCT00696709|101471151|FG002|Vaccination 2 (~Day 30)|Overall Study||32||
48464136|NCT00696709|101471152|FG003|Vaccination 2 (~Day 30)|Overall Study||61||
48464137|NCT00696709|101471153|FG004|Vaccination 2 (~Day 30)|Overall Study||64||
48464138|NCT00696709|101471149|FG000|Vaccination 3 (~Day 60)|Overall Study||64||
48464139|NCT00696709|101471150|FG001|Vaccination 3 (~Day 60)|Overall Study||60||
48464140|NCT00696709|101471151|FG002|Vaccination 3 (~Day 60)|Overall Study||32||
48464141|NCT00696709|101471152|FG003|Vaccination 3 (~Day 60)|Overall Study||59||
48464142|NCT00696709|101471153|FG004|Vaccination 3 (~Day 60)|Overall Study||63||
48464143|NCT00696709|101471149|FG000|Vaccination 4 (~Day 90)|Overall Study||62||
48464144|NCT00696709|101471150|FG001|Vaccination 4 (~Day 90)|Overall Study||60||
48464145|NCT00696709|101471151|FG002|Vaccination 4 (~Day 90)|Overall Study||32||
48464146|NCT00696709|101471152|FG003|Vaccination 4 (~Day 90)|Overall Study||59||
48464147|NCT00696709|101471153|FG004|Vaccination 4 (~Day 90)|Overall Study||63||
48464148|NCT00696709|101471149|FG000|COMPLETED|Overall Study||62||
48464149|NCT00696709|101471150|FG001|COMPLETED|Overall Study||60||
48464150|NCT00696709|101471151|FG002|COMPLETED|Overall Study||32||
48464151|NCT00696709|101471152|FG003|COMPLETED|Overall Study||59||
48464152|NCT00696709|101471153|FG004|COMPLETED|Overall Study||62||
48464153|NCT00696709|101471149|FG000|NOT COMPLETED|Overall Study||3||
48464154|NCT00696709|101471150|FG001|NOT COMPLETED|Overall Study||3||
48464155|NCT00696709|101471151|FG002|NOT COMPLETED|Overall Study||1||
48464156|NCT00696709|101471152|FG003|NOT COMPLETED|Overall Study||5||
48464157|NCT00696709|101471153|FG004|NOT COMPLETED|Overall Study||3||
48778688|NCT02703337|102248465|FG007|NOT COMPLETED|Period Five (Part A)||0||
48778689|NCT02703337|102248458|FG000|STARTED|Period Six (Part A)||5||
48464158|NCT01273610|101471154|FG000|STARTED|Overall Study||30||
48464159|NCT01273610|101471155|FG001|STARTED|Overall Study||10||
48464160|NCT01273610|101471154|FG000|COMPLETED|Overall Study||30||
48464161|NCT01273610|101471155|FG001|COMPLETED|Overall Study||10||
48464162|NCT01273610|101471154|FG000|NOT COMPLETED|Overall Study||0||
48464163|NCT01273610|101471155|FG001|NOT COMPLETED|Overall Study||0||
48464164|NCT00093964|101471156|FG000|STARTED|Overall Study||41||
48464165|NCT00093964|101471157|FG001|STARTED|Overall Study||40||
48464166|NCT00093964|101471156|FG000|COMPLETED|Overall Study||41||
48464167|NCT00093964|101471157|FG001|COMPLETED|Overall Study||40||
48464168|NCT00093964|101471156|FG000|NOT COMPLETED|Overall Study||0||
48464169|NCT00093964|101471157|FG001|NOT COMPLETED|Overall Study||0||
48464170|NCT00585351|101471158|FG000|STARTED|Notification Period (Informed Consent)||50||
48464171|NCT00585351|101471159|FG001|STARTED|Notification Period (Informed Consent)||50||
48464172|NCT00585351|101471160|FG002|STARTED|Notification Period (Informed Consent)||0||
48464173|NCT00585351|101471161|FG003|STARTED|Notification Period (Informed Consent)||0||
48464174|NCT00585351|101471162|FG004|STARTED|Notification Period (Informed Consent)||0||
48464175|NCT00585351|101471163|FG005|STARTED|Notification Period (Informed Consent)||0||
48464176|NCT00585351|101471164|FG006|STARTED|Notification Period (Informed Consent)||0||
48464177|NCT00585351|101471165|FG007|STARTED|Notification Period (Informed Consent)||0||
48464178|NCT00585351|101471158|FG000|COMPLETED|Notification Period (Informed Consent)||27||
48464179|NCT00585351|101471159|FG001|COMPLETED|Notification Period (Informed Consent)||25||
48464180|NCT00585351|101471160|FG002|COMPLETED|Notification Period (Informed Consent)||0||
48464181|NCT00585351|101471161|FG003|COMPLETED|Notification Period (Informed Consent)||0||
48464182|NCT00585351|101471162|FG004|COMPLETED|Notification Period (Informed Consent)||0||
48464183|NCT00585351|101471163|FG005|COMPLETED|Notification Period (Informed Consent)||0||
48464184|NCT00585351|101471164|FG006|COMPLETED|Notification Period (Informed Consent)||0||
48464185|NCT00585351|101471165|FG007|COMPLETED|Notification Period (Informed Consent)||0||
48464186|NCT00585351|101471158|FG000|NOT COMPLETED|Notification Period (Informed Consent)||23||
48464187|NCT00585351|101471159|FG001|NOT COMPLETED|Notification Period (Informed Consent)||25||
48464188|NCT00585351|101471160|FG002|NOT COMPLETED|Notification Period (Informed Consent)||0||
48464189|NCT00585351|101471161|FG003|NOT COMPLETED|Notification Period (Informed Consent)||0||
48464190|NCT00585351|101471162|FG004|NOT COMPLETED|Notification Period (Informed Consent)||0||
48464191|NCT00585351|101471163|FG005|NOT COMPLETED|Notification Period (Informed Consent)||0||
48464192|NCT00585351|101471164|FG006|NOT COMPLETED|Notification Period (Informed Consent)||0||
48464193|NCT00585351|101471165|FG007|NOT COMPLETED|Notification Period (Informed Consent)||0||
48778690|NCT02703337|102248459|FG001|STARTED|Period Six (Part A)||5||
48778691|NCT02703337|102248460|FG002|STARTED|Period Six (Part A)||5||
48778692|NCT02703337|102248461|FG003|STARTED|Period Six (Part A)||5||
48464194|NCT00585351|101471158|FG000|STARTED|Enrollment Period (Intervention)||0||
48464195|NCT00585351|101471159|FG001|STARTED|Enrollment Period (Intervention)||0||
48464196|NCT00585351|101471160|FG002|STARTED|Enrollment Period (Intervention)||15||
48464197|NCT00585351|101471161|FG003|STARTED|Enrollment Period (Intervention)||15||
48464198|NCT00585351|101471162|FG004|STARTED|Enrollment Period (Intervention)||5||
48464199|NCT00585351|101471163|FG005|STARTED|Enrollment Period (Intervention)||7||
48464200|NCT00585351|101471164|FG006|STARTED|Enrollment Period (Intervention)||7||
48464201|NCT00585351|101471165|FG007|STARTED|Enrollment Period (Intervention)||3||
48464202|NCT00585351|101471158|FG000|COMPLETED|Enrollment Period (Intervention)||0||
48464203|NCT00585351|101471159|FG001|COMPLETED|Enrollment Period (Intervention)||0||
48464204|NCT00585351|101471160|FG002|COMPLETED|Enrollment Period (Intervention)||15||
48464205|NCT00585351|101471161|FG003|COMPLETED|Enrollment Period (Intervention)||15||
48464206|NCT00585351|101471162|FG004|COMPLETED|Enrollment Period (Intervention)||3||
48464207|NCT00585351|101471163|FG005|COMPLETED|Enrollment Period (Intervention)||5||
48464208|NCT00585351|101471164|FG006|COMPLETED|Enrollment Period (Intervention)||5||
48464209|NCT00585351|101471165|FG007|COMPLETED|Enrollment Period (Intervention)||2||
48464210|NCT00585351|101471158|FG000|NOT COMPLETED|Enrollment Period (Intervention)||0||
48464211|NCT00585351|101471159|FG001|NOT COMPLETED|Enrollment Period (Intervention)||0||
48464212|NCT00585351|101471160|FG002|NOT COMPLETED|Enrollment Period (Intervention)||0||
48464213|NCT00585351|101471161|FG003|NOT COMPLETED|Enrollment Period (Intervention)||0||
48464214|NCT00585351|101471162|FG004|NOT COMPLETED|Enrollment Period (Intervention)||2||
48464215|NCT00585351|101471163|FG005|NOT COMPLETED|Enrollment Period (Intervention)||2||
48464216|NCT00585351|101471164|FG006|NOT COMPLETED|Enrollment Period (Intervention)||2||
48464217|NCT00585351|101471165|FG007|NOT COMPLETED|Enrollment Period (Intervention)||1||
48464218|NCT03267264|101471166|FG000|STARTED|Overall Study||66||
48464219|NCT03267264|101471167|FG001|STARTED|Overall Study||49||
48464220|NCT03267264|101471168|FG002|STARTED|Overall Study||68||
48464221|NCT03267264|101471169|FG003|STARTED|Overall Study||65||
48464222|NCT03267264|101471166|FG000|Sequence A(Nucleus)|Overall Study||34||
48464223|NCT03267264|101471167|FG001|Sequence A(Nucleus)|Overall Study||25||
48464224|NCT03267264|101471168|FG002|Sequence A(Nucleus)|Overall Study||33||
48464225|NCT03267264|101471169|FG003|Sequence A(Nucleus)|Overall Study||33||
48464226|NCT03267264|101471166|FG000|Sequence B(Comparator)|Overall Study||32||
48464227|NCT03267264|101471167|FG001|Sequence B(Comparator)|Overall Study||24||
48464228|NCT03267264|101471168|FG002|Sequence B(Comparator)|Overall Study||33||
48464229|NCT03267264|101471169|FG003|Sequence B(Comparator)|Overall Study||32||
48464230|NCT03267264|101471166|FG000|COMPLETED|Overall Study||65||
48464231|NCT03267264|101471167|FG001|COMPLETED|Overall Study||49||
48464232|NCT03267264|101471168|FG002|COMPLETED|Overall Study||66||
48464233|NCT03267264|101471169|FG003|COMPLETED|Overall Study||61||
48464234|NCT03267264|101471166|FG000|NOT COMPLETED|Overall Study||1||
48464235|NCT03267264|101471167|FG001|NOT COMPLETED|Overall Study||0||
48464236|NCT03267264|101471168|FG002|NOT COMPLETED|Overall Study||2||
48464237|NCT03267264|101471169|FG003|NOT COMPLETED|Overall Study||4||
48464238|NCT00278200|101471170|FG000|STARTED|Overall Study||2||
48464239|NCT00278200|101471171|FG001|STARTED|Overall Study||12||
48464240|NCT00278200|101471170|FG000|COMPLETED|Overall Study||1||
48464241|NCT00278200|101471171|FG001|COMPLETED|Overall Study||8||
48464242|NCT00278200|101471170|FG000|NOT COMPLETED|Overall Study||1||
48464243|NCT00278200|101471171|FG001|NOT COMPLETED|Overall Study||4||
48464244|NCT02281409|101471172|FG000|STARTED|Overall Study||3||
48464245|NCT02281409|101471173|FG001|STARTED|Overall Study||3||
48464246|NCT02281409|101471174|FG002|STARTED|Overall Study||5||
48464247|NCT02281409|101471175|FG003|STARTED|Overall Study||6||
48464248|NCT02281409|101471172|FG000|COMPLETED|Overall Study||3||
48464249|NCT02281409|101471173|FG001|COMPLETED|Overall Study||3||
48464250|NCT02281409|101471174|FG002|COMPLETED|Overall Study||5||
48464251|NCT02281409|101471175|FG003|COMPLETED|Overall Study||6||
48464252|NCT02281409|101471172|FG000|NOT COMPLETED|Overall Study||0||
48464253|NCT02281409|101471173|FG001|NOT COMPLETED|Overall Study||0||
48464254|NCT02281409|101471174|FG002|NOT COMPLETED|Overall Study||0||
48464255|NCT02281409|101471175|FG003|NOT COMPLETED|Overall Study||0||
48464256|NCT00679783|101471176|FG000|STARTED|Overall Study||4||
48464257|NCT00679783|101471177|FG001|STARTED|Overall Study||13||
48778693|NCT02703337|102248462|FG004|STARTED|Period Six (Part A)||4||
48778694|NCT02703337|102248463|FG005|STARTED|Period Six (Part A)||5||
48778695|NCT02703337|102248464|FG006|STARTED|Period Six (Part A)||0||
48778696|NCT02703337|102248465|FG007|STARTED|Period Six (Part A)||0||
48778697|NCT02703337|102248458|FG000|Received Study Drug|Period Six (Part A)||5||
48464258|NCT00679783|101471178|FG002|STARTED|Overall Study||3||
48464259|NCT00679783|101471179|FG003|STARTED|Overall Study||45||
48778698|NCT02703337|102248459|FG001|Received Study Drug|Period Six (Part A)||5||
48778699|NCT02703337|102248460|FG002|Received Study Drug|Period Six (Part A)||5||
48778700|NCT02703337|102248461|FG003|Received Study Drug|Period Six (Part A)||5||
48778701|NCT02703337|102248462|FG004|Received Study Drug|Period Six (Part A)||4||
48778702|NCT02703337|102248463|FG005|Received Study Drug|Period Six (Part A)||5||
48464260|NCT00679783|101471180|FG004|STARTED|Overall Study||5||
48778703|NCT02703337|102248464|FG006|Received Study Drug|Period Six (Part A)||0||
48778704|NCT02703337|102248465|FG007|Received Study Drug|Period Six (Part A)||0||
48778705|NCT02703337|102248458|FG000|COMPLETED|Period Six (Part A)||5||
48464261|NCT00679783|101471181|FG005|STARTED|Overall Study||5||
48464262|NCT00679783|101471182|FG006|STARTED|Overall Study||16||
48464263|NCT00679783|101471176|FG000|COMPLETED|Overall Study||2||
48464264|NCT00679783|101471177|FG001|COMPLETED|Overall Study||10||
48464265|NCT00679783|101471178|FG002|COMPLETED|Overall Study||2||
48464266|NCT00679783|101471179|FG003|COMPLETED|Overall Study||25||
48464267|NCT00679783|101471180|FG004|COMPLETED|Overall Study||4||
48464268|NCT00679783|101471181|FG005|COMPLETED|Overall Study||5||
48464269|NCT00679783|101471182|FG006|COMPLETED|Overall Study||15||
48665303|NCT05697380|101964778|FG000|STARTED|Overall Study||4||
48665304|NCT05697380|101964779|FG001|STARTED|Overall Study||4||
48665305|NCT05697380|101964778|FG000|COMPLETED|Overall Study||4||
48665306|NCT05697380|101964779|FG001|COMPLETED|Overall Study||4||
48665307|NCT05697380|101964778|FG000|NOT COMPLETED|Overall Study||0||
48665308|NCT05697380|101964779|FG001|NOT COMPLETED|Overall Study||0||
48665309|NCT03332056|101964780|FG000|STARTED|Overall Study||35||
48665310|NCT03332056|101964781|FG001|STARTED|Overall Study||36||
48665311|NCT03332056|101964780|FG000|COMPLETED|Overall Study||26||
48778706|NCT02703337|102248459|FG001|COMPLETED|Period Six (Part A)||5||
48778707|NCT02703337|102248460|FG002|COMPLETED|Period Six (Part A)||5||
48778708|NCT02703337|102248461|FG003|COMPLETED|Period Six (Part A)||5||
48778709|NCT02703337|102248462|FG004|COMPLETED|Period Six (Part A)||4||
48778710|NCT02703337|102248463|FG005|COMPLETED|Period Six (Part A)||5||
48665312|NCT03332056|101964781|FG001|COMPLETED|Overall Study||26||
48665313|NCT03332056|101964780|FG000|NOT COMPLETED|Overall Study||9||
48665314|NCT03332056|101964781|FG001|NOT COMPLETED|Overall Study||10||
48665315|NCT01344226|101964782|FG000|STARTED|Overall Study||49||
48665316|NCT01344226|101964782|FG000|COMPLETED|Overall Study||41||
48665317|NCT01344226|101964782|FG000|NOT COMPLETED|Overall Study||8||
48665318|NCT01506726|101964783|FG000|STARTED|Overall Study||6||
48665319|NCT01506726|101964784|FG001|STARTED|Overall Study||5||
48665320|NCT01506726|101964783|FG000|COMPLETED|Overall Study||5||
48665321|NCT01506726|101964784|FG001|COMPLETED|Overall Study||3||
48665322|NCT01506726|101964783|FG000|NOT COMPLETED|Overall Study||1||
48778711|NCT02703337|102248464|FG006|COMPLETED|Period Six (Part A)||0||
48778712|NCT02703337|102248465|FG007|COMPLETED|Period Six (Part A)||0||
48778713|NCT02703337|102248458|FG000|NOT COMPLETED|Period Six (Part A)||0||
48778714|NCT02703337|102248459|FG001|NOT COMPLETED|Period Six (Part A)||0||
48778715|NCT02703337|102248460|FG002|NOT COMPLETED|Period Six (Part A)||0||
48778716|NCT02703337|102248461|FG003|NOT COMPLETED|Period Six (Part A)||0||
48665323|NCT01506726|101964784|FG001|NOT COMPLETED|Overall Study||2||
48665324|NCT00642759|101964785|FG000|STARTED|Overall Study||36||
48665325|NCT00642759|101964785|FG000|COMPLETED|Overall Study||35||
48665326|NCT00642759|101964785|FG000|NOT COMPLETED|Overall Study||1||
48665327|NCT00539500|101964786|FG000|STARTED|Overall Study||3||
48665328|NCT00539500|101964786|FG000|COMPLETED|Overall Study||0||
48665329|NCT00539500|101964786|FG000|NOT COMPLETED|Overall Study||3||
48665330|NCT00443456|101964787|FG000|STARTED|Overall Study||134||
48665331|NCT00443456|101964787|FG000|COMPLETED|Overall Study||116||
48665332|NCT00443456|101964787|FG000|NOT COMPLETED|Overall Study||18||
48665333|NCT02971163|101964788|FG000|STARTED|Overall Study||24||
48665334|NCT02971163|101964789|FG001|STARTED|Overall Study||26||
48665335|NCT02971163|101964788|FG000|COMPLETED|Overall Study||20||
48665336|NCT02971163|101964789|FG001|COMPLETED|Overall Study||24||
48665337|NCT02971163|101964788|FG000|NOT COMPLETED|Overall Study||4||
48665338|NCT02971163|101964789|FG001|NOT COMPLETED|Overall Study||2||
48665339|NCT02706392|101964790|FG000|STARTED|Overall Study||2||
48778717|NCT02703337|102248462|FG004|NOT COMPLETED|Period Six (Part A)||0||
48369954|NCT03393013|101232872|FG005|NOT COMPLETED|Phase 2||0||
48369955|NCT03393013|101232873|FG006|NOT COMPLETED|Phase 2||4||
48369956|NCT04598165|101232874|FG000|STARTED|Completed 6-week Follow-up||2509||
48369957|NCT04598165|101232875|FG001|STARTED|Completed 6-week Follow-up||2511||
48369958|NCT04598165|101232874|FG000|COMPLETED|Completed 6-week Follow-up||2471||
48369959|NCT04598165|101232875|FG001|COMPLETED|Completed 6-week Follow-up||2470||
48369960|NCT04598165|101232874|FG000|NOT COMPLETED|Completed 6-week Follow-up||38||
48369961|NCT04598165|101232875|FG001|NOT COMPLETED|Completed 6-week Follow-up||41||
48369962|NCT04598165|101232874|FG000|STARTED|Included in Intention to Treat Analysis||2509||
48369963|NCT04598165|101232875|FG001|STARTED|Included in Intention to Treat Analysis||2511||
48369964|NCT04598165|101232874|FG000|COMPLETED|Included in Intention to Treat Analysis||2442||
48369965|NCT04598165|101232875|FG001|COMPLETED|Included in Intention to Treat Analysis||2442||
48369966|NCT04598165|101232874|FG000|NOT COMPLETED|Included in Intention to Treat Analysis||67||
48369967|NCT04598165|101232875|FG001|NOT COMPLETED|Included in Intention to Treat Analysis||69||
48369968|NCT02424955|101232876|FG000|STARTED|Overall Study||11||
48369969|NCT02424955|101232876|FG000|COMPLETED|Overall Study||11||
48464270|NCT00679783|101471176|FG000|NOT COMPLETED|Overall Study||2||
48464271|NCT00679783|101471177|FG001|NOT COMPLETED|Overall Study||3||
48464272|NCT00679783|101471178|FG002|NOT COMPLETED|Overall Study||1||
48464273|NCT00679783|101471179|FG003|NOT COMPLETED|Overall Study||20||
48464274|NCT00679783|101471180|FG004|NOT COMPLETED|Overall Study||1||
48778718|NCT02703337|102248463|FG005|NOT COMPLETED|Period Six (Part A)||0||
48778719|NCT02703337|102248464|FG006|NOT COMPLETED|Period Six (Part A)||0||
48778720|NCT02703337|102248465|FG007|NOT COMPLETED|Period Six (Part A)||0||
48778721|NCT02703337|102248458|FG000|STARTED|Part B||0|Participants who completed all six periods in Part A were eligible for Part B.|
48778722|NCT02703337|102248459|FG001|STARTED|Part B||0|Participants who completed all six periods in Part A were eligible for Part B.|
48778723|NCT02703337|102248460|FG002|STARTED|Part B||0|Participants who completed all six periods in Part A were eligible for Part B.|
48778724|NCT02703337|102248461|FG003|STARTED|Part B||0|Participants who completed all six periods in Part A were eligible for Part B.|
48778725|NCT02703337|102248462|FG004|STARTED|Part B||0|Participants who completed all six periods in Part A were eligible for Part B.|
48778726|NCT02703337|102248463|FG005|STARTED|Part B||0|Participants who completed all six periods in Part A were eligible for Part B.|
48778727|NCT02703337|102248464|FG006|STARTED|Part B||15|Participants who completed all six periods in Part A were eligible for Part B.|
48464275|NCT00679783|101471181|FG005|NOT COMPLETED|Overall Study||0||
48464276|NCT00679783|101471182|FG006|NOT COMPLETED|Overall Study||1||
48464277|NCT00836927|101471183|FG000|STARTED|Overall Study||3||
48464278|NCT00836927|101471184|FG001|STARTED|Overall Study||1||
48464279|NCT00836927|101471185|FG002|STARTED|Overall Study||1||
48464280|NCT00836927|101471186|FG003|STARTED|Overall Study||1||
48464281|NCT00836927|101471187|FG004|STARTED|Overall Study||1||
48464282|NCT00836927|101471183|FG000|Completed Dosing Through 03 Apr 2017|Overall Study||0||
48464283|NCT00836927|101471184|FG001|Completed Dosing Through 03 Apr 2017|Overall Study||1||
48464284|NCT00836927|101471185|FG002|Completed Dosing Through 03 Apr 2017|Overall Study||1||
48464285|NCT00836927|101471186|FG003|Completed Dosing Through 03 Apr 2017|Overall Study||0||
48464286|NCT00836927|101471187|FG004|Completed Dosing Through 03 Apr 2017|Overall Study||0||
48464287|NCT00836927|101471183|FG000|COMPLETED|Overall Study||0||
48464288|NCT00836927|101471184|FG001|COMPLETED|Overall Study||1||
48464289|NCT00836927|101471185|FG002|COMPLETED|Overall Study||1||
48464290|NCT00836927|101471186|FG003|COMPLETED|Overall Study||0||
48464291|NCT00836927|101471187|FG004|COMPLETED|Overall Study||0||
48464292|NCT00836927|101471183|FG000|NOT COMPLETED|Overall Study||3||
48464293|NCT00836927|101471184|FG001|NOT COMPLETED|Overall Study||0||
48464294|NCT00836927|101471185|FG002|NOT COMPLETED|Overall Study||0||
48464295|NCT00836927|101471186|FG003|NOT COMPLETED|Overall Study||1||
48464296|NCT00836927|101471187|FG004|NOT COMPLETED|Overall Study||1||
48464297|NCT00598559|101471188|FG000|STARTED|Overall Study||92||
48464298|NCT00598559|101471189|FG001|STARTED|Overall Study||91||
48464299|NCT00598559|101471190|FG002|STARTED|Overall Study||30||
48464300|NCT00598559|101471188|FG000|COMPLETED|Overall Study||65||
48665340|NCT02706392|101964791|FG001|STARTED|Overall Study||1||
48665341|NCT02706392|101964792|FG002|STARTED|Overall Study||2||
48464301|NCT00598559|101471189|FG001|COMPLETED|Overall Study||63||
48464302|NCT00598559|101471190|FG002|COMPLETED|Overall Study||27||
48464303|NCT00598559|101471188|FG000|NOT COMPLETED|Overall Study||27||
48464304|NCT00598559|101471189|FG001|NOT COMPLETED|Overall Study||28||
48464305|NCT00598559|101471190|FG002|NOT COMPLETED|Overall Study||3||
48464306|NCT02607800|101471191|FG000|STARTED|Overall Study||502||
48464307|NCT02607800|101471192|FG001|STARTED|Overall Study||441||
48464308|NCT02607800|101471191|FG000|COMPLETED|Overall Study||492||
48464309|NCT02607800|101471192|FG001|COMPLETED|Overall Study||430||
48464310|NCT02607800|101471191|FG000|NOT COMPLETED|Overall Study||10||
48665342|NCT02706392|101964793|FG003|STARTED|Overall Study||3||
48665343|NCT02706392|101964794|FG004|STARTED|Overall Study||11||
48665344|NCT02706392|101964795|FG005|STARTED|Overall Study||2||
48665345|NCT02706392|101964790|FG000|COMPLETED|Overall Study||1||
48778728|NCT02703337|102248465|FG007|STARTED|Part B||14|Participants who completed all six periods in Part A were eligible for Part B.|
48464311|NCT02607800|101471192|FG001|NOT COMPLETED|Overall Study||11||
48464312|NCT03843957|101471193|FG000|STARTED|Overall Study||49583||10
48665346|NCT02706392|101964791|FG001|COMPLETED|Overall Study||1||
48665347|NCT02706392|101964792|FG002|COMPLETED|Overall Study||0||
48665348|NCT02706392|101964793|FG003|COMPLETED|Overall Study||1||
48665349|NCT02706392|101964794|FG004|COMPLETED|Overall Study||6||
48665350|NCT02706392|101964795|FG005|COMPLETED|Overall Study||0||
48665351|NCT02706392|101964790|FG000|NOT COMPLETED|Overall Study||1||
48665352|NCT02706392|101964791|FG001|NOT COMPLETED|Overall Study||0||
48665353|NCT02706392|101964792|FG002|NOT COMPLETED|Overall Study||2||
48665354|NCT02706392|101964793|FG003|NOT COMPLETED|Overall Study||2||
48464313|NCT03843957|101471194|FG001|STARTED|Overall Study||27562||8
48464314|NCT03843957|101471193|FG000|All Adult Clinic Patients Post-Implementation: 18 or Older|Overall Study||43775||10
48464315|NCT03843957|101471194|FG001|All Adult Clinic Patients Post-Implementation: 18 or Older|Overall Study||23359||8
48778729|NCT02703337|102248458|FG000|Received Study Drug|Part B||0||
48778730|NCT02703337|102248459|FG001|Received Study Drug|Part B||0||
48778731|NCT02703337|102248460|FG002|Received Study Drug|Part B||0||
48778732|NCT02703337|102248461|FG003|Received Study Drug|Part B||0||
48778733|NCT02703337|102248462|FG004|Received Study Drug|Part B||0||
48778734|NCT02703337|102248463|FG005|Received Study Drug|Part B||0||
48778735|NCT02703337|102248464|FG006|Received Study Drug|Part B||15||
48778736|NCT02703337|102248465|FG007|Received Study Drug|Part B||14||
48778737|NCT02703337|102248458|FG000|COMPLETED|Part B||0||
48778738|NCT02703337|102248459|FG001|COMPLETED|Part B||0||
48778739|NCT02703337|102248460|FG002|COMPLETED|Part B||0||
48778740|NCT02703337|102248461|FG003|COMPLETED|Part B||0||
48778741|NCT02703337|102248462|FG004|COMPLETED|Part B||0||
48778742|NCT02703337|102248463|FG005|COMPLETED|Part B||0||
48778743|NCT02703337|102248464|FG006|COMPLETED|Part B||15||
48778744|NCT02703337|102248465|FG007|COMPLETED|Part B||14||
48778745|NCT02703337|102248458|FG000|NOT COMPLETED|Part B||0||
48778746|NCT02703337|102248459|FG001|NOT COMPLETED|Part B||0||
48778747|NCT02703337|102248460|FG002|NOT COMPLETED|Part B||0||
48778748|NCT02703337|102248461|FG003|NOT COMPLETED|Part B||0||
48778749|NCT02703337|102248462|FG004|NOT COMPLETED|Part B||0||
48778750|NCT02703337|102248463|FG005|NOT COMPLETED|Part B||0||
48778751|NCT02703337|102248464|FG006|NOT COMPLETED|Part B||0||
48778752|NCT02703337|102248465|FG007|NOT COMPLETED|Part B||0||
48778753|NCT02140593|102248466|FG000|STARTED|Overall Study||63||
48778754|NCT02140593|102248467|FG001|STARTED|Overall Study||65||
48778755|NCT02140593|102248466|FG000|COMPLETED|Overall Study||63||
48778756|NCT02140593|102248467|FG001|COMPLETED|Overall Study||65||
48778757|NCT02140593|102248466|FG000|NOT COMPLETED|Overall Study||0||
48778758|NCT02140593|102248467|FG001|NOT COMPLETED|Overall Study||0||
48778759|NCT00921518|102248468|FG000|STARTED|Overall Study||48||
48778760|NCT00921518|102248469|FG001|STARTED|Overall Study||44||
48778761|NCT00921518|102248468|FG000|COMPLETED|Overall Study||48||
48778762|NCT00921518|102248469|FG001|COMPLETED|Overall Study||44||
48778763|NCT00921518|102248468|FG000|NOT COMPLETED|Overall Study||0||
48778764|NCT00921518|102248469|FG001|NOT COMPLETED|Overall Study||0||
48778765|NCT01999517|102248470|FG000|STARTED|Overall Study||68||
48778766|NCT01999517|102248471|FG001|STARTED|Overall Study||54||
48778767|NCT01999517|102248470|FG000|COMPLETED|Overall Study||68||
48778768|NCT01999517|102248471|FG001|COMPLETED|Overall Study||54||
48778769|NCT01999517|102248470|FG000|NOT COMPLETED|Overall Study||0||
48778770|NCT01999517|102248471|FG001|NOT COMPLETED|Overall Study||0||
48778771|NCT02695420|102248472|FG000|STARTED|Overall Study||21||
48778772|NCT02695420|102248473|FG001|STARTED|Overall Study||21||
48778773|NCT02695420|102248474|FG002|STARTED|Overall Study||19||
48778774|NCT02695420|102248475|FG003|STARTED|Overall Study||20||
48778775|NCT02695420|102248472|FG000|COMPLETED|Overall Study||21||
48464316|NCT03843957|101471193|FG000|Adult Clinic Patients Eligible for CRC Screening Post-Implementation: Aged 50-74|Overall Study||7933||10
48464317|NCT03843957|101471194|FG001|Adult Clinic Patients Eligible for CRC Screening Post-Implementation: Aged 50-74|Overall Study||5159||8
48464318|NCT03843957|101471193|FG000|Clinic Personnel Post-Implementation|Overall Study||282||10
48464319|NCT03843957|101471194|FG001|Clinic Personnel Post-Implementation|Overall Study||232||8
48464320|NCT03843957|101471193|FG000|Adult Clinic Patients Eligible for CRC Screening Pre-Implementation: Aged 50-74|Overall Study||5526||10
48464321|NCT03843957|101471194|FG001|Adult Clinic Patients Eligible for CRC Screening Pre-Implementation: Aged 50-74|Overall Study||3971||8
48778776|NCT02695420|102248473|FG001|COMPLETED|Overall Study||20||
48778777|NCT02695420|102248474|FG002|COMPLETED|Overall Study||19||
48464322|NCT03843957|101471193|FG000|COMPLETED|Overall Study||49583||10
48464323|NCT03843957|101471194|FG001|COMPLETED|Overall Study||27562||8
48464324|NCT03843957|101471193|FG000|NOT COMPLETED|Overall Study||0||0
48464325|NCT03843957|101471194|FG001|NOT COMPLETED|Overall Study||0||0
48464326|NCT01006707|101471195|FG000|STARTED|Study Session 1||15||
48464327|NCT01006707|101471196|FG001|STARTED|Study Session 1||0||
48778778|NCT02695420|102248475|FG003|COMPLETED|Overall Study||20||
48464328|NCT01006707|101471197|FG002|STARTED|Study Session 1||0||
48464329|NCT01006707|101471195|FG000|COMPLETED|Study Session 1||10|After run-in, participants were randomized to Ondansetron then Placebo, or Placebo then Ondansetron|
48665355|NCT02706392|101964794|FG004|NOT COMPLETED|Overall Study||5||
48778779|NCT02695420|102248472|FG000|NOT COMPLETED|Overall Study||0||
48778780|NCT02695420|102248473|FG001|NOT COMPLETED|Overall Study||1||
48778781|NCT02695420|102248474|FG002|NOT COMPLETED|Overall Study||0||
48778782|NCT02695420|102248475|FG003|NOT COMPLETED|Overall Study||0||
48778783|NCT03110770|102248476|FG000|STARTED|Overall Study||30||
48778784|NCT03110770|102248477|FG001|STARTED|Overall Study||30||
48778785|NCT03110770|102248478|FG002|STARTED|Overall Study||30||
48778786|NCT03110770|102248479|FG003|STARTED|Overall Study||1170||
48778787|NCT03110770|102248480|FG004|STARTED|Overall Study||1168||
48778788|NCT03110770|102248476|FG000|Received First Product Administration|Overall Study||30||
48778789|NCT03110770|102248477|FG001|Received First Product Administration|Overall Study||30||
48778790|NCT03110770|102248478|FG002|Received First Product Administration|Overall Study||30||
48778791|NCT03110770|102248479|FG003|Received First Product Administration|Overall Study||1162||
48778792|NCT03110770|102248480|FG004|Received First Product Administration|Overall Study||1161||
48778793|NCT03110770|102248476|FG000|Received Second Product Administration|Overall Study||30||
48778794|NCT03110770|102248477|FG001|Received Second Product Administration|Overall Study||29||
48778795|NCT03110770|102248478|FG002|Received Second Product Administration|Overall Study||29||
48778796|NCT03110770|102248479|FG003|Received Second Product Administration|Overall Study||1126||
48778797|NCT03110770|102248480|FG004|Received Second Product Administration|Overall Study||1127||
48778798|NCT03110770|102248476|FG000|Received Third Product Administration|Overall Study||29||
48778799|NCT03110770|102248477|FG001|Received Third Product Administration|Overall Study||27||
48778800|NCT03110770|102248478|FG002|Received Third Product Administration|Overall Study||28||
48778801|NCT03110770|102248479|FG003|Received Third Product Administration|Overall Study||1107||
48778802|NCT03110770|102248480|FG004|Received Third Product Administration|Overall Study||1107||
48778803|NCT03110770|102248476|FG000|COMPLETED|Overall Study||24||
48778804|NCT03110770|102248477|FG001|COMPLETED|Overall Study||30||
48778805|NCT03110770|102248478|FG002|COMPLETED|Overall Study||28||
48778806|NCT03110770|102248479|FG003|COMPLETED|Overall Study||1037||
48778807|NCT03110770|102248480|FG004|COMPLETED|Overall Study||1045||
48778808|NCT03110770|102248476|FG000|NOT COMPLETED|Overall Study||6||
48778809|NCT03110770|102248477|FG001|NOT COMPLETED|Overall Study||0||
48778810|NCT03110770|102248478|FG002|NOT COMPLETED|Overall Study||2||
48778811|NCT03110770|102248479|FG003|NOT COMPLETED|Overall Study||133||
48778812|NCT03110770|102248480|FG004|NOT COMPLETED|Overall Study||123||
48778813|NCT02642315|102248481|FG000|STARTED|Overall Study||10||
48778814|NCT02642315|102248481|FG000|COMPLETED|Overall Study||8||
48778815|NCT02642315|102248481|FG000|NOT COMPLETED|Overall Study||2||
48778816|NCT01278212|102248482|FG000|STARTED|Overall Study||158||
48778817|NCT01278212|102248482|FG000|COMPLETED|Overall Study||158||
48778818|NCT01278212|102248482|FG000|NOT COMPLETED|Overall Study||0||
48778819|NCT01296672|102248483|FG000|STARTED|Overall Study||306||
48778820|NCT01296672|102248484|FG001|STARTED|Overall Study||77||
48778821|NCT01296672|102248483|FG000|COMPLETED|Overall Study||233||
48778822|NCT01296672|102248484|FG001|COMPLETED|Overall Study||59||
48778823|NCT01296672|102248483|FG000|NOT COMPLETED|Overall Study||73||
48778824|NCT01296672|102248484|FG001|NOT COMPLETED|Overall Study||18||
48778825|NCT00479687|102248485|FG000|STARTED|Ph 1: Blinded, Randomized, Controlled||150||
48778826|NCT00479687|102248486|FG001|STARTED|Ph 1: Blinded, Randomized, Controlled||150||
48778827|NCT00479687|102248487|FG002|STARTED|Ph 1: Blinded, Randomized, Controlled||0||
48778828|NCT00479687|102248485|FG000|COMPLETED|Ph 1: Blinded, Randomized, Controlled||125||
48778829|NCT00479687|102248486|FG001|COMPLETED|Ph 1: Blinded, Randomized, Controlled||131||
48778830|NCT00479687|102248487|FG002|COMPLETED|Ph 1: Blinded, Randomized, Controlled||0||
48464330|NCT01006707|101471196|FG001|COMPLETED|Study Session 1||0|After run-in, participants were randomized to Ondansetron then Placebo, or Placebo then Ondansetron|
48464331|NCT01006707|101471197|FG002|COMPLETED|Study Session 1||0|After run-in, participants were randomized to Ondansetron then Placebo, or Placebo then Ondansetron|
48464332|NCT01006707|101471195|FG000|NOT COMPLETED|Study Session 1||5||
48464333|NCT01006707|101471196|FG001|NOT COMPLETED|Study Session 1||0||
48464334|NCT01006707|101471197|FG002|NOT COMPLETED|Study Session 1||0||
48464335|NCT01006707|101471195|FG000|STARTED|Study Session 2||0||
48464336|NCT01006707|101471196|FG001|STARTED|Study Session 2||4||
48464337|NCT01006707|101471197|FG002|STARTED|Study Session 2||6||
48464338|NCT01006707|101471195|FG000|COMPLETED|Study Session 2||0||
48464339|NCT01006707|101471196|FG001|COMPLETED|Study Session 2||4||
48464340|NCT01006707|101471197|FG002|COMPLETED|Study Session 2||6||
48464341|NCT01006707|101471195|FG000|NOT COMPLETED|Study Session 2||0||
48464342|NCT01006707|101471196|FG001|NOT COMPLETED|Study Session 2||0||
48464343|NCT01006707|101471197|FG002|NOT COMPLETED|Study Session 2||0||
48464344|NCT01006707|101471195|FG000|STARTED|Study Session 3||0||
48464345|NCT01006707|101471196|FG001|STARTED|Study Session 3||4||
48778831|NCT00479687|102248485|FG000|NOT COMPLETED|Ph 1: Blinded, Randomized, Controlled||25||
48778832|NCT00479687|102248486|FG001|NOT COMPLETED|Ph 1: Blinded, Randomized, Controlled||19||
48778833|NCT00479687|102248487|FG002|NOT COMPLETED|Ph 1: Blinded, Randomized, Controlled||0||
48778834|NCT00479687|102248485|FG000|STARTED|Ph 2: Open Label, Single (Supartz) Arm||0||
48778835|NCT00479687|102248486|FG001|STARTED|Ph 2: Open Label, Single (Supartz) Arm||0||
48778836|NCT00479687|102248487|FG002|STARTED|Ph 2: Open Label, Single (Supartz) Arm||224||
48778837|NCT00479687|102248485|FG000|COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0||
48778838|NCT00479687|102248486|FG001|COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0||
48778839|NCT00479687|102248487|FG002|COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||215||
48778840|NCT00479687|102248485|FG000|NOT COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0||
48778841|NCT00479687|102248486|FG001|NOT COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0||
48464346|NCT01006707|101471197|FG002|STARTED|Study Session 3||6||
48464347|NCT01006707|101471195|FG000|COMPLETED|Study Session 3||0||
48464348|NCT01006707|101471196|FG001|COMPLETED|Study Session 3||4||
48464349|NCT01006707|101471197|FG002|COMPLETED|Study Session 3||6||
48778842|NCT00479687|102248487|FG002|NOT COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||9||
48778843|NCT02653417|102248488|FG000|STARTED|Overall Study||38||
48778844|NCT02653417|102248489|FG001|STARTED|Overall Study||34||
48778845|NCT02653417|102248490|FG002|STARTED|Overall Study||29||
48778846|NCT02653417|102248491|FG003|STARTED|Overall Study||38||
48778847|NCT02653417|102248488|FG000|COMPLETED|Overall Study||37||
48778848|NCT02653417|102248489|FG001|COMPLETED|Overall Study||32||
48778849|NCT02653417|102248490|FG002|COMPLETED|Overall Study||26||
48778850|NCT02653417|102248491|FG003|COMPLETED|Overall Study||33||
48778851|NCT02653417|102248488|FG000|NOT COMPLETED|Overall Study||1||
48778852|NCT02653417|102248489|FG001|NOT COMPLETED|Overall Study||2||
48778853|NCT02653417|102248490|FG002|NOT COMPLETED|Overall Study||3||
48778854|NCT02653417|102248491|FG003|NOT COMPLETED|Overall Study||5||
48778855|NCT02246413|102248492|FG000|STARTED|12-months (Primary Outcome)||204||
48778856|NCT02246413|102248493|FG001|STARTED|12-months (Primary Outcome)||205||
48778857|NCT02246413|102248492|FG000|COMPLETED|12-months (Primary Outcome)||169||
48778858|NCT02246413|102248493|FG001|COMPLETED|12-months (Primary Outcome)||175||
48778859|NCT02246413|102248492|FG000|NOT COMPLETED|12-months (Primary Outcome)||35||
48778860|NCT02246413|102248493|FG001|NOT COMPLETED|12-months (Primary Outcome)||30||
48464350|NCT01006707|101471195|FG000|NOT COMPLETED|Study Session 3||0||
48464351|NCT01006707|101471196|FG001|NOT COMPLETED|Study Session 3||0||
48464352|NCT01006707|101471197|FG002|NOT COMPLETED|Study Session 3||0||
48464353|NCT01767597|101471198|FG000|STARTED|Overall Study||500||
48464354|NCT01767597|101471199|FG001|STARTED|Overall Study||500||
48464355|NCT01767597|101471198|FG000|COMPLETED|Overall Study||496||
48464356|NCT01767597|101471199|FG001|COMPLETED|Overall Study||499||
48464357|NCT01767597|101471198|FG000|NOT COMPLETED|Overall Study||4||
48464358|NCT01767597|101471199|FG001|NOT COMPLETED|Overall Study||1||
48464359|NCT00582309|101471200|FG000|STARTED|Overall Study||56||
48464360|NCT00582309|101471201|FG001|STARTED|Overall Study||49||
48464361|NCT00582309|101471202|FG002|STARTED|Overall Study||46||
48464362|NCT00582309|101471200|FG000|COMPLETED|Overall Study||56||
48464363|NCT00582309|101471201|FG001|COMPLETED|Overall Study||49||
48464364|NCT00582309|101471202|FG002|COMPLETED|Overall Study||44||
48464365|NCT00582309|101471200|FG000|NOT COMPLETED|Overall Study||0||
48464366|NCT00582309|101471201|FG001|NOT COMPLETED|Overall Study||0||
48464367|NCT00582309|101471202|FG002|NOT COMPLETED|Overall Study||2||
48464368|NCT01118728|101471203|FG000|STARTED|Overall Study||223||
48464369|NCT01118728|101471203|FG000|COMPLETED|Overall Study||0||
48464370|NCT01118728|101471203|FG000|NOT COMPLETED|Overall Study||223||
48464371|NCT01533428|101471204|FG000|STARTED|Overall Study||186||
48464372|NCT01533428|101471205|FG001|STARTED|Overall Study||183||
48464373|NCT01533428|101471204|FG000|COMPLETED|Overall Study||177||
48464374|NCT01533428|101471205|FG001|COMPLETED|Overall Study||175||
48464375|NCT01533428|101471204|FG000|NOT COMPLETED|Overall Study||9||
48464376|NCT01533428|101471205|FG001|NOT COMPLETED|Overall Study||8||
48464377|NCT01048333|101471206|FG000|STARTED|Treatment Period 1||21||
48464378|NCT01048333|101471207|FG001|STARTED|Treatment Period 1||19||
48464379|NCT01048333|101471208|FG002|STARTED|Treatment Period 1||16||
48464380|NCT01048333|101471209|FG003|STARTED|Treatment Period 1||18||
48464381|NCT01048333|101471210|FG004|STARTED|Treatment Period 1||17||
48464382|NCT01048333|101471211|FG005|STARTED|Treatment Period 1||18||
48464383|NCT01048333|101471206|FG000|COMPLETED|Treatment Period 1||21||
48778861|NCT02246413|102248492|FG000|STARTED|24-months (Secondary Outcome)||204||
48778862|NCT02246413|102248493|FG001|STARTED|24-months (Secondary Outcome)||205||
48778863|NCT02246413|102248492|FG000|COMPLETED|24-months (Secondary Outcome)||153||
48778864|NCT02246413|102248493|FG001|COMPLETED|24-months (Secondary Outcome)||173||
48778865|NCT02246413|102248492|FG000|NOT COMPLETED|24-months (Secondary Outcome)||51||
48778866|NCT02246413|102248493|FG001|NOT COMPLETED|24-months (Secondary Outcome)||32||
48778867|NCT04082819|102248494|FG000|STARTED|Overall Study||37||
48778868|NCT04082819|102248495|FG001|STARTED|Overall Study||54||
48778869|NCT04082819|102248496|FG002|STARTED|Overall Study||3||
48778870|NCT04082819|102248494|FG000|COMPLETED|Overall Study||37||
48464384|NCT01048333|101471207|FG001|COMPLETED|Treatment Period 1||19||
48464385|NCT01048333|101471208|FG002|COMPLETED|Treatment Period 1||16||
48778871|NCT04082819|102248495|FG001|COMPLETED|Overall Study||54||
48778872|NCT04082819|102248496|FG002|COMPLETED|Overall Study||3||
48778873|NCT04082819|102248494|FG000|NOT COMPLETED|Overall Study||0||
48778874|NCT04082819|102248495|FG001|NOT COMPLETED|Overall Study||0||
48778875|NCT04082819|102248496|FG002|NOT COMPLETED|Overall Study||0||
48778876|NCT01396070|102248497|FG000|STARTED|Overall Study||36||
48778877|NCT01396070|102248497|FG000|COMPLETED|Overall Study||17||
48778878|NCT01396070|102248497|FG000|NOT COMPLETED|Overall Study||19||
48778879|NCT00499590|102248498|FG000|STARTED|Overall Study||113||
48778880|NCT00499590|102248499|FG001|STARTED|Overall Study||112||
48778881|NCT00499590|102248500|FG002|STARTED|Overall Study||113||
48464386|NCT01048333|101471209|FG003|COMPLETED|Treatment Period 1||18||
48464387|NCT01048333|101471210|FG004|COMPLETED|Treatment Period 1||17||
48464388|NCT01048333|101471211|FG005|COMPLETED|Treatment Period 1||18||
48464389|NCT01048333|101471206|FG000|NOT COMPLETED|Treatment Period 1||0||
48464390|NCT01048333|101471207|FG001|NOT COMPLETED|Treatment Period 1||0||
48778882|NCT00499590|102248498|FG000|COMPLETED|Overall Study||0||
48464391|NCT01048333|101471208|FG002|NOT COMPLETED|Treatment Period 1||0||
48778883|NCT00499590|102248499|FG001|COMPLETED|Overall Study||0||
48778884|NCT00499590|102248500|FG002|COMPLETED|Overall Study||0||
48464392|NCT01048333|101471209|FG003|NOT COMPLETED|Treatment Period 1||0||
48464393|NCT01048333|101471210|FG004|NOT COMPLETED|Treatment Period 1||0||
48464394|NCT01048333|101471211|FG005|NOT COMPLETED|Treatment Period 1||0||
48464395|NCT01048333|101471206|FG000|STARTED|Wash-Out Period 1 of 2 - 7 Days||21||
48464396|NCT01048333|101471207|FG001|STARTED|Wash-Out Period 1 of 2 - 7 Days||19||
48464397|NCT01048333|101471208|FG002|STARTED|Wash-Out Period 1 of 2 - 7 Days||16||
48464398|NCT01048333|101471209|FG003|STARTED|Wash-Out Period 1 of 2 - 7 Days||18||
48464399|NCT01048333|101471210|FG004|STARTED|Wash-Out Period 1 of 2 - 7 Days||17||
48464400|NCT01048333|101471211|FG005|STARTED|Wash-Out Period 1 of 2 - 7 Days||18||
48464401|NCT01048333|101471206|FG000|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||21||
48464402|NCT01048333|101471207|FG001|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||19||
48464403|NCT01048333|101471208|FG002|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||16||
48464404|NCT01048333|101471209|FG003|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18||
48464405|NCT01048333|101471210|FG004|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||17||
48665356|NCT02706392|101964795|FG005|NOT COMPLETED|Overall Study||2||
48665357|NCT01649869|101964796|FG000|STARTED|Overall Study||18||
48778885|NCT00499590|102248498|FG000|NOT COMPLETED|Overall Study||113||
48778886|NCT00499590|102248499|FG001|NOT COMPLETED|Overall Study||112||
48778887|NCT00499590|102248500|FG002|NOT COMPLETED|Overall Study||113||
48778888|NCT02656693|102248501|FG000|STARTED|Overall Study||326||
48778889|NCT02656693|102248502|FG001|STARTED|Overall Study||216||
48778890|NCT02656693|102248503|FG002|STARTED|Overall Study||298||
48778891|NCT02656693|102248501|FG000|COMPLETED|Overall Study||325||
48778892|NCT02656693|102248502|FG001|COMPLETED|Overall Study||214||
48778893|NCT02656693|102248503|FG002|COMPLETED|Overall Study||295||
48778894|NCT02656693|102248501|FG000|NOT COMPLETED|Overall Study||1||
48778895|NCT02656693|102248502|FG001|NOT COMPLETED|Overall Study||2||
48778896|NCT02656693|102248503|FG002|NOT COMPLETED|Overall Study||3||
48778897|NCT00452361|102248504|FG000|STARTED|Overall Study||21||
48778898|NCT00452361|102248505|FG001|STARTED|Overall Study||10||
48778899|NCT00452361|102248504|FG000|COMPLETED|Overall Study||0||
48778900|NCT00452361|102248505|FG001|COMPLETED|Overall Study||0||
48778901|NCT00452361|102248504|FG000|NOT COMPLETED|Overall Study||21||
48778902|NCT00452361|102248505|FG001|NOT COMPLETED|Overall Study||10||
48778903|NCT01798849|102248506|FG000|STARTED|Overall Study||8||
48778904|NCT01798849|102248507|FG001|STARTED|Overall Study||8||
48369970|NCT02424955|101232876|FG000|NOT COMPLETED|Overall Study||0||
48464406|NCT01048333|101471211|FG005|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18||
48464407|NCT01048333|101471206|FG000|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0||
48464408|NCT01048333|101471207|FG001|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0||
48778905|NCT01798849|102248508|FG002|STARTED|Overall Study||9||
48778906|NCT01798849|102248506|FG000|COMPLETED|Overall Study||8||
48778907|NCT01798849|102248507|FG001|COMPLETED|Overall Study||8||
48778908|NCT01798849|102248508|FG002|COMPLETED|Overall Study||8||
48778909|NCT01798849|102248506|FG000|NOT COMPLETED|Overall Study||0||
48778910|NCT01798849|102248507|FG001|NOT COMPLETED|Overall Study||0||
48778911|NCT01798849|102248508|FG002|NOT COMPLETED|Overall Study||1||
48369971|NCT03762850|101232877|FG000|STARTED|Overall Study||203||
48369972|NCT03762850|101232878|FG001|STARTED|Overall Study||203||
48369973|NCT03762850|101232877|FG000|Received at Least 1 Dose of Study Drug|Overall Study||202||
48369974|NCT03762850|101232878|FG001|Received at Least 1 Dose of Study Drug|Overall Study||202||
48369975|NCT03762850|101232877|FG000|COMPLETED|Overall Study||199|The participant flow presented is based on the double-blind period of the study.|
48369976|NCT03762850|101232878|FG001|COMPLETED|Overall Study||191|The participant flow presented is based on the double-blind period of the study.|
48464409|NCT01048333|101471208|FG002|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0||
48464410|NCT01048333|101471209|FG003|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0||
48464411|NCT01048333|101471210|FG004|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0||
48464412|NCT01048333|101471211|FG005|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0||
48665358|NCT01649869|101964797|FG001|STARTED|Overall Study||17||
48665359|NCT01649869|101964796|FG000|COMPLETED|Overall Study||16||
48665360|NCT01649869|101964797|FG001|COMPLETED|Overall Study||16||
48665361|NCT01649869|101964796|FG000|NOT COMPLETED|Overall Study||2||
48665362|NCT01649869|101964797|FG001|NOT COMPLETED|Overall Study||1||
48665363|NCT00163293|101964798|FG000|STARTED|Overall Study||79||
48665364|NCT00163293|101964799|FG001|STARTED|Overall Study||76||
48665365|NCT00163293|101964800|FG002|STARTED|Overall Study||85||
48665366|NCT00163293|101964798|FG000|COMPLETED|Overall Study||66||
48665367|NCT00163293|101964799|FG001|COMPLETED|Overall Study||69||
48665368|NCT00163293|101964800|FG002|COMPLETED|Overall Study||66||
48778912|NCT02657408|102248509|FG000|STARTED|Overall Study||28||
48778913|NCT02657408|102248510|FG001|STARTED|Overall Study||29||
48778914|NCT02657408|102248509|FG000|COMPLETED|Overall Study||25||
48778915|NCT02657408|102248510|FG001|COMPLETED|Overall Study||22||
48778916|NCT02657408|102248509|FG000|NOT COMPLETED|Overall Study||3||
48778917|NCT02657408|102248510|FG001|NOT COMPLETED|Overall Study||7||
48778918|NCT02152956|102248511|FG000|STARTED|Overall Study||1||
48778919|NCT02152956|102248512|FG001|STARTED|Overall Study||4||
48778920|NCT02152956|102248513|FG002|STARTED|Overall Study||5||
48778921|NCT02152956|102248514|FG003|STARTED|Overall Study||4||
48778922|NCT02152956|102248515|FG004|STARTED|Overall Study||3||
48778923|NCT02152956|102248516|FG005|STARTED|Overall Study||4||
48778924|NCT02152956|102248517|FG006|STARTED|Overall Study||6||
48778925|NCT02152956|102248518|FG007|STARTED|Overall Study||6||
48778926|NCT02152956|102248519|FG008|STARTED|Overall Study||6||
48778927|NCT02152956|102248520|FG009|STARTED|Overall Study||5||
48778928|NCT02152956|102248521|FG010|STARTED|Overall Study||3||
48778929|NCT02152956|102248522|FG011|STARTED|Overall Study||185||
48778930|NCT02152956|102248523|FG012|STARTED|Overall Study||12||
48778931|NCT02152956|102248511|FG000|COMPLETED|Overall Study||0||
48778932|NCT02152956|102248512|FG001|COMPLETED|Overall Study||0||
48778933|NCT02152956|102248513|FG002|COMPLETED|Overall Study||1||
48778934|NCT02152956|102248514|FG003|COMPLETED|Overall Study||0||
48778935|NCT02152956|102248515|FG004|COMPLETED|Overall Study||0||
48778936|NCT02152956|102248516|FG005|COMPLETED|Overall Study||0||
48778937|NCT02152956|102248517|FG006|COMPLETED|Overall Study||0||
48778938|NCT02152956|102248518|FG007|COMPLETED|Overall Study||0||
48778939|NCT02152956|102248519|FG008|COMPLETED|Overall Study||0||
48778940|NCT02152956|102248520|FG009|COMPLETED|Overall Study||0||
48778941|NCT02152956|102248521|FG010|COMPLETED|Overall Study||0||
48778942|NCT02152956|102248522|FG011|COMPLETED|Overall Study||0||
48778943|NCT02152956|102248523|FG012|COMPLETED|Overall Study||0||
48778944|NCT02152956|102248511|FG000|NOT COMPLETED|Overall Study||1||
48778945|NCT02152956|102248512|FG001|NOT COMPLETED|Overall Study||4||
48778946|NCT02152956|102248513|FG002|NOT COMPLETED|Overall Study||4||
48778947|NCT02152956|102248514|FG003|NOT COMPLETED|Overall Study||4||
48778948|NCT02152956|102248515|FG004|NOT COMPLETED|Overall Study||3||
48778949|NCT02152956|102248516|FG005|NOT COMPLETED|Overall Study||4||
48778950|NCT02152956|102248517|FG006|NOT COMPLETED|Overall Study||6||
48778951|NCT02152956|102248518|FG007|NOT COMPLETED|Overall Study||6||
48778952|NCT02152956|102248519|FG008|NOT COMPLETED|Overall Study||6||
48778953|NCT02152956|102248520|FG009|NOT COMPLETED|Overall Study||5||
48778954|NCT02152956|102248521|FG010|NOT COMPLETED|Overall Study||3||
48778955|NCT02152956|102248522|FG011|NOT COMPLETED|Overall Study||185||
48778956|NCT02152956|102248523|FG012|NOT COMPLETED|Overall Study||12||
48778957|NCT00862082|102248524|FG000|STARTED|Overall Study||8||
48778958|NCT00862082|102248525|FG001|STARTED|Overall Study||6||
48778959|NCT00862082|102248524|FG000|COMPLETED|Overall Study||3||
48778960|NCT00862082|102248525|FG001|COMPLETED|Overall Study||5||
48778961|NCT00862082|102248524|FG000|NOT COMPLETED|Overall Study||5||
48778962|NCT00862082|102248525|FG001|NOT COMPLETED|Overall Study||1||
48778963|NCT01942733|102248526|FG000|STARTED|Overall Study||44||
48778964|NCT01942733|102248526|FG000|COMPLETED|Overall Study||41||
48778965|NCT01942733|102248526|FG000|NOT COMPLETED|Overall Study||3||
48778966|NCT02116205|102248527|FG000|STARTED|Overall Study||31||
48778967|NCT02116205|102248528|FG001|STARTED|Overall Study||33||
48778968|NCT02116205|102248529|FG002|STARTED|Overall Study||33||
48778969|NCT02116205|102248530|FG003|STARTED|Overall Study||33||
48778970|NCT02116205|102248527|FG000|COMPLETED|Overall Study||29||
48778971|NCT02116205|102248528|FG001|COMPLETED|Overall Study||26||
48778972|NCT02116205|102248529|FG002|COMPLETED|Overall Study||29||
48778973|NCT02116205|102248530|FG003|COMPLETED|Overall Study||27||
48778974|NCT02116205|102248527|FG000|NOT COMPLETED|Overall Study||2||
48778975|NCT02116205|102248528|FG001|NOT COMPLETED|Overall Study||7||
48778976|NCT02116205|102248529|FG002|NOT COMPLETED|Overall Study||4||
48778977|NCT02116205|102248530|FG003|NOT COMPLETED|Overall Study||6||
48778978|NCT03198507|102248531|FG000|STARTED|Overall Study||228||
48778979|NCT03198507|102248532|FG001|STARTED|Overall Study||227||
48464413|NCT01048333|101471206|FG000|STARTED|Treatment Period 2||21||
48464414|NCT01048333|101471207|FG001|STARTED|Treatment Period 2||19||
48464415|NCT01048333|101471208|FG002|STARTED|Treatment Period 2||16||
48778980|NCT03198507|102248531|FG000|COMPLETED|Overall Study||227||
48464416|NCT01048333|101471209|FG003|STARTED|Treatment Period 2||18||
48464417|NCT01048333|101471210|FG004|STARTED|Treatment Period 2||17||
48464418|NCT01048333|101471211|FG005|STARTED|Treatment Period 2||18||
48464419|NCT01048333|101471206|FG000|COMPLETED|Treatment Period 2||21||
48464420|NCT01048333|101471207|FG001|COMPLETED|Treatment Period 2||19||
48464421|NCT01048333|101471208|FG002|COMPLETED|Treatment Period 2||16||
48778981|NCT03198507|102248532|FG001|COMPLETED|Overall Study||227||
48778982|NCT03198507|102248531|FG000|NOT COMPLETED|Overall Study||1||
48778983|NCT03198507|102248532|FG001|NOT COMPLETED|Overall Study||0||
48778984|NCT02413151|102248533|FG000|STARTED|Overall Study||32||
48778985|NCT02413151|102248534|FG001|STARTED|Overall Study||30||
48778986|NCT02413151|102248533|FG000|COMPLETED|Overall Study||22||
48778987|NCT02413151|102248534|FG001|COMPLETED|Overall Study||28||
48778988|NCT02413151|102248533|FG000|NOT COMPLETED|Overall Study||10||
48778989|NCT02413151|102248534|FG001|NOT COMPLETED|Overall Study||2||
48778990|NCT02250703|102248535|FG000|STARTED|Overall Study||38||
48464422|NCT01048333|101471209|FG003|COMPLETED|Treatment Period 2||18||
48464423|NCT01048333|101471210|FG004|COMPLETED|Treatment Period 2||17||
48778991|NCT02250703|102248536|FG001|STARTED|Overall Study||37||
48778992|NCT02250703|102248535|FG000|COMPLETED|Overall Study||37||
48778993|NCT02250703|102248536|FG001|COMPLETED|Overall Study||36||
48778994|NCT02250703|102248535|FG000|NOT COMPLETED|Overall Study||1||
48464424|NCT01048333|101471211|FG005|COMPLETED|Treatment Period 2||18||
48464425|NCT01048333|101471206|FG000|NOT COMPLETED|Treatment Period 2||0||
48464426|NCT01048333|101471207|FG001|NOT COMPLETED|Treatment Period 2||0||
48464427|NCT01048333|101471208|FG002|NOT COMPLETED|Treatment Period 2||0||
48464428|NCT01048333|101471209|FG003|NOT COMPLETED|Treatment Period 2||0||
48464429|NCT01048333|101471210|FG004|NOT COMPLETED|Treatment Period 2||0||
48464430|NCT01048333|101471211|FG005|NOT COMPLETED|Treatment Period 2||0||
48464431|NCT01048333|101471206|FG000|STARTED|Wash-Out Period 2 of 2 - 7 Days||21||
48464432|NCT01048333|101471207|FG001|STARTED|Wash-Out Period 2 of 2 - 7 Days||19||
48464433|NCT01048333|101471208|FG002|STARTED|Wash-Out Period 2 of 2 - 7 Days||16||
48464434|NCT01048333|101471209|FG003|STARTED|Wash-Out Period 2 of 2 - 7 Days||18||
48464435|NCT01048333|101471210|FG004|STARTED|Wash-Out Period 2 of 2 - 7 Days||17||
48464436|NCT01048333|101471211|FG005|STARTED|Wash-Out Period 2 of 2 - 7 Days||18||
48464437|NCT01048333|101471206|FG000|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||21||
48464438|NCT01048333|101471207|FG001|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18||
48464439|NCT01048333|101471208|FG002|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||16||
48464440|NCT01048333|101471209|FG003|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18||
48464441|NCT01048333|101471210|FG004|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||17||
48464442|NCT01048333|101471211|FG005|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18||
48464443|NCT01048333|101471206|FG000|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0||
48464444|NCT01048333|101471207|FG001|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||1||
48464445|NCT01048333|101471208|FG002|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0||
48464446|NCT01048333|101471209|FG003|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0||
48464447|NCT01048333|101471210|FG004|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0||
48778995|NCT02250703|102248536|FG001|NOT COMPLETED|Overall Study||1||
48778996|NCT04254913|102248537|FG000|STARTED|Overall Study||6||
48778997|NCT04254913|102248537|FG000|COMPLETED|Overall Study||5||
48464448|NCT01048333|101471211|FG005|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0||
48464449|NCT01048333|101471206|FG000|STARTED|Treatment Period 3||21||
48464450|NCT01048333|101471207|FG001|STARTED|Treatment Period 3||18||
48464451|NCT01048333|101471208|FG002|STARTED|Treatment Period 3||16||
48464452|NCT01048333|101471209|FG003|STARTED|Treatment Period 3||18||
48464453|NCT01048333|101471210|FG004|STARTED|Treatment Period 3||17||
48464454|NCT01048333|101471211|FG005|STARTED|Treatment Period 3||18||
48464455|NCT01048333|101471206|FG000|COMPLETED|Treatment Period 3||21||
48464456|NCT01048333|101471207|FG001|COMPLETED|Treatment Period 3||18||
48464457|NCT01048333|101471208|FG002|COMPLETED|Treatment Period 3||16||
48464458|NCT01048333|101471209|FG003|COMPLETED|Treatment Period 3||18||
48464459|NCT01048333|101471210|FG004|COMPLETED|Treatment Period 3||17||
48464460|NCT01048333|101471211|FG005|COMPLETED|Treatment Period 3||18||
48464461|NCT01048333|101471206|FG000|NOT COMPLETED|Treatment Period 3||0||
48464462|NCT01048333|101471207|FG001|NOT COMPLETED|Treatment Period 3||0||
48464463|NCT01048333|101471208|FG002|NOT COMPLETED|Treatment Period 3||0||
48464464|NCT01048333|101471209|FG003|NOT COMPLETED|Treatment Period 3||0||
48464465|NCT01048333|101471210|FG004|NOT COMPLETED|Treatment Period 3||0||
48464466|NCT01048333|101471211|FG005|NOT COMPLETED|Treatment Period 3||0||
48464467|NCT01787825|101471212|FG000|STARTED|Overall Study||60||
48464468|NCT01787825|101471213|FG001|STARTED|Overall Study||61||
48464469|NCT01787825|101471212|FG000|COMPLETED|Overall Study||54|This was a paired study with crossover with randomization.|
48464470|NCT01787825|101471213|FG001|COMPLETED|Overall Study||60|This was a paired study with crossover with randomization.|
48464471|NCT01787825|101471212|FG000|NOT COMPLETED|Overall Study||6||
48464472|NCT01787825|101471213|FG001|NOT COMPLETED|Overall Study||1||
48464473|NCT00952484|101471214|FG000|STARTED|Overall Study||6||
48464474|NCT00952484|101471215|FG001|STARTED|Overall Study||7||
48464475|NCT00952484|101471216|FG002|STARTED|Overall Study||16||
48464476|NCT00952484|101471214|FG000|COMPLETED|Overall Study||6||
48464477|NCT00952484|101471215|FG001|COMPLETED|Overall Study||6||
48464478|NCT00952484|101471216|FG002|COMPLETED|Overall Study||16||
48464479|NCT00952484|101471214|FG000|NOT COMPLETED|Overall Study||0||
48778998|NCT04254913|102248537|FG000|NOT COMPLETED|Overall Study||1||
48778999|NCT01421355|102248538|FG000|STARTED|Overall Study||21||
48779000|NCT01421355|102248538|FG000|COMPLETED|Overall Study||15||
48779001|NCT01421355|102248538|FG000|NOT COMPLETED|Overall Study||6||
48779002|NCT01012089|102248539|FG000|STARTED|Overall Study||6||
48779003|NCT01012089|102248539|FG000|COMPLETED|Overall Study||6||
48779004|NCT01012089|102248539|FG000|NOT COMPLETED|Overall Study||0||
48779005|NCT01227018|102248540|FG000|STARTED|Overall Study||15||
48779006|NCT01227018|102248540|FG000|COMPLETED|Overall Study||0||
48779007|NCT01227018|102248540|FG000|NOT COMPLETED|Overall Study||15||
48779008|NCT05043142|102248541|FG000|STARTED|Overall Study||3632||
48779009|NCT05043142|102248541|FG000|COMPLETED|Overall Study||3443||
48779010|NCT05043142|102248541|FG000|NOT COMPLETED|Overall Study||189||
48779011|NCT02773576|102248542|FG000|STARTED|Overall Study||0||
48779012|NCT02773576|102248543|FG001|STARTED|Overall Study||0||
48779013|NCT02773576|102248542|FG000|COMPLETED|Overall Study||0||
48779014|NCT02773576|102248543|FG001|COMPLETED|Overall Study||0||
48779015|NCT02773576|102248542|FG000|NOT COMPLETED|Overall Study||0||
48779016|NCT02773576|102248543|FG001|NOT COMPLETED|Overall Study||0||
48779017|NCT00740857|102248544|FG000|STARTED|Overall Study||33||
48779018|NCT00740857|102248545|FG001|STARTED|Overall Study||88||
48189802|NCT03283553|100786314|FG000|Patient 3-Month Interview|Patient Participant Flow||67||
48189803|NCT03283553|100786315|FG001|Patient 3-Month Interview|Patient Participant Flow||60||
48189804|NCT03283553|100786314|FG000|Patient 9-Month Interview|Patient Participant Flow||63||
48369977|NCT03762850|101232877|FG000|NOT COMPLETED|Overall Study||4||
48464480|NCT00952484|101471215|FG001|NOT COMPLETED|Overall Study||1||
48464481|NCT00952484|101471216|FG002|NOT COMPLETED|Overall Study||0||
48464482|NCT01614509|101471217|FG000|STARTED|Overall Study||24||
48464483|NCT01614509|101471218|FG001|STARTED|Overall Study||21||
48464484|NCT01614509|101471217|FG000|COMPLETED|Overall Study||23||
48464485|NCT01614509|101471218|FG001|COMPLETED|Overall Study||18||
48464486|NCT01614509|101471217|FG000|NOT COMPLETED|Overall Study||1||
48464487|NCT01614509|101471218|FG001|NOT COMPLETED|Overall Study||3||
48464488|NCT00927810|101471219|FG000|STARTED|Overall Study||75||
48464489|NCT00927810|101471220|FG001|STARTED|Overall Study||181||
48464490|NCT00927810|101471221|FG002|STARTED|Overall Study||25||
48464491|NCT00927810|101471222|FG003|STARTED|Overall Study||60||
48665369|NCT00163293|101964798|FG000|NOT COMPLETED|Overall Study||13||
48665370|NCT00163293|101964799|FG001|NOT COMPLETED|Overall Study||7||
48665371|NCT00163293|101964800|FG002|NOT COMPLETED|Overall Study||19||
48665372|NCT00553254|101964801|FG000|STARTED|Overall Study||6||
48665373|NCT00553254|101964802|FG001|STARTED|Overall Study||6||
48665374|NCT00553254|101964803|FG002|STARTED|Overall Study||43||
48665375|NCT00553254|101964801|FG000|COMPLETED|Overall Study||0||
48665376|NCT00553254|101964802|FG001|COMPLETED|Overall Study||0||
48665377|NCT00553254|101964803|FG002|COMPLETED|Overall Study||0||
48665378|NCT00553254|101964801|FG000|NOT COMPLETED|Overall Study||6||
48665379|NCT00553254|101964802|FG001|NOT COMPLETED|Overall Study||6||
48665380|NCT00553254|101964803|FG002|NOT COMPLETED|Overall Study||43||
48665381|NCT00761137|101964804|FG000|STARTED|Overall Study||19||
48665382|NCT00761137|101964804|FG000|Placebo|Overall Study||19||
48665383|NCT00761137|101964804|FG000|0.3 mg Tropicamide|Overall Study||19||
48665384|NCT00761137|101964804|FG000|1 mg Tropicamide|Overall Study||19||
48665385|NCT00761137|101964804|FG000|3 mg Tropicamide|Overall Study||19||
48665386|NCT00761137|101964804|FG000|COMPLETED|Overall Study||19||
48665387|NCT00761137|101964804|FG000|NOT COMPLETED|Overall Study||0||
48665388|NCT03826472|101964805|FG000|STARTED|First Intervention (1-week)||5||
48665389|NCT03826472|101964806|FG001|STARTED|First Intervention (1-week)||5||
48665390|NCT03826472|101964805|FG000|COMPLETED|First Intervention (1-week)||5||
48665391|NCT03826472|101964806|FG001|COMPLETED|First Intervention (1-week)||5||
48665392|NCT03826472|101964805|FG000|NOT COMPLETED|First Intervention (1-week)||0||
48665393|NCT03826472|101964806|FG001|NOT COMPLETED|First Intervention (1-week)||0||
48665394|NCT03826472|101964805|FG000|STARTED|Second Intervention (1-week)||5||
48665395|NCT03826472|101964806|FG001|STARTED|Second Intervention (1-week)||5||
48665396|NCT03826472|101964805|FG000|COMPLETED|Second Intervention (1-week)||5||
48369978|NCT03762850|101232878|FG001|NOT COMPLETED|Overall Study||12||
48369979|NCT00298610|101232879|FG000|STARTED|Overall Study||30||
48369980|NCT00298610|101232879|FG000|COMPLETED|Overall Study||30||
48369981|NCT00298610|101232879|FG000|NOT COMPLETED|Overall Study||0||
48369982|NCT03884101|101232880|FG000|STARTED|Overall Study||420||
48369983|NCT03884101|101232881|FG001|STARTED|Overall Study||422||
48369984|NCT03884101|101232880|FG000|Treated|Overall Study||420||
48369985|NCT03884101|101232881|FG001|Treated|Overall Study||411||
48369986|NCT03884101|101232880|FG000|Received a Second Course of Pembrolizumab|Overall Study||10||
48369987|NCT03884101|101232881|FG001|Received a Second Course of Pembrolizumab|Overall Study||0||
48369988|NCT03884101|101232880|FG000|COMPLETED|Overall Study||0||
48369989|NCT03884101|101232881|FG001|COMPLETED|Overall Study||0||
48369990|NCT03884101|101232880|FG000|NOT COMPLETED|Overall Study||420||
48464492|NCT00927810|101471219|FG000|COMPLETED|Overall Study||75||
48464493|NCT00927810|101471220|FG001|COMPLETED|Overall Study||173||
48464494|NCT00927810|101471221|FG002|COMPLETED|Overall Study||24||
48464495|NCT00927810|101471222|FG003|COMPLETED|Overall Study||58||
48464496|NCT00927810|101471219|FG000|NOT COMPLETED|Overall Study||0||
48464497|NCT00927810|101471220|FG001|NOT COMPLETED|Overall Study||8||
48464498|NCT00927810|101471221|FG002|NOT COMPLETED|Overall Study||1||
48464499|NCT00927810|101471222|FG003|NOT COMPLETED|Overall Study||2||
48464500|NCT00601484|101471223|FG000|STARTED|Overall Study||34||
48464501|NCT00601484|101471224|FG001|STARTED|Overall Study||31||
48464502|NCT00601484|101471223|FG000|Treated|Overall Study||34||
48464503|NCT00601484|101471224|FG001|Treated|Overall Study||30||
48464504|NCT00601484|101471223|FG000|COMPLETED|Overall Study||29||
48464505|NCT00601484|101471224|FG001|COMPLETED|Overall Study||23||
48464506|NCT00601484|101471223|FG000|NOT COMPLETED|Overall Study||5||
48464507|NCT00601484|101471224|FG001|NOT COMPLETED|Overall Study||8||
48464508|NCT05751629|101471225|FG000|STARTED|Overall Study||41||
48779019|NCT00740857|102248546|FG002|STARTED|Overall Study||90||
48779020|NCT00740857|102248544|FG000|COMPLETED|Overall Study||32||
48779021|NCT00740857|102248545|FG001|COMPLETED|Overall Study||88||
48779022|NCT00740857|102248546|FG002|COMPLETED|Overall Study||90||
48779023|NCT00740857|102248544|FG000|NOT COMPLETED|Overall Study||1||
48779024|NCT00740857|102248545|FG001|NOT COMPLETED|Overall Study||0||
48779025|NCT00740857|102248546|FG002|NOT COMPLETED|Overall Study||0||
48779026|NCT00959985|102248547|FG000|STARTED|Overall Study||8||
48779027|NCT00959985|102248548|FG001|STARTED|Overall Study||7||
48779028|NCT00959985|102248549|FG002|STARTED|Overall Study||4||
48779029|NCT00959985|102248550|FG003|STARTED|Overall Study||4||
48779030|NCT00959985|102248547|FG000|COMPLETED|Overall Study||8||
48779031|NCT00959985|102248548|FG001|COMPLETED|Overall Study||7||
48779032|NCT00959985|102248549|FG002|COMPLETED|Overall Study||4||
48779033|NCT00959985|102248550|FG003|COMPLETED|Overall Study||4||
48779034|NCT00959985|102248547|FG000|NOT COMPLETED|Overall Study||0||
48779035|NCT00959985|102248548|FG001|NOT COMPLETED|Overall Study||0||
48779036|NCT00959985|102248549|FG002|NOT COMPLETED|Overall Study||0||
48779037|NCT00959985|102248550|FG003|NOT COMPLETED|Overall Study||0||
48779038|NCT00476229|102248551|FG000|STARTED|Overall Study||20||
48779039|NCT00476229|102248551|FG000|COMPLETED|Overall Study||19||
48779040|NCT00476229|102248551|FG000|NOT COMPLETED|Overall Study||1||
48464509|NCT05751629|101471225|FG000|COMPLETED|Overall Study||0||
48464510|NCT05751629|101471225|FG000|NOT COMPLETED|Overall Study||41||
48464511|NCT01016652|101471226|FG000|STARTED|Period 1||25||
48464512|NCT01016652|101471227|FG001|STARTED|Period 1||24||
48464513|NCT01016652|101471226|FG000|COMPLETED|Period 1||25||
48464514|NCT01016652|101471227|FG001|COMPLETED|Period 1||24||
48464515|NCT01016652|101471226|FG000|NOT COMPLETED|Period 1||0||
48464516|NCT01016652|101471227|FG001|NOT COMPLETED|Period 1||0||
48464517|NCT01016652|101471226|FG000|STARTED|Period 2||25||
48464518|NCT01016652|101471227|FG001|STARTED|Period 2||24||
48779041|NCT00145158|102248552|FG000|STARTED|Overall Study||16||
48779042|NCT00145158|102248553|FG001|STARTED|Overall Study||7||
48779043|NCT00145158|102248552|FG000|COMPLETED|Overall Study||14||
48779044|NCT00145158|102248553|FG001|COMPLETED|Overall Study||4||
48779045|NCT00145158|102248552|FG000|NOT COMPLETED|Overall Study||2||
48779046|NCT00145158|102248553|FG001|NOT COMPLETED|Overall Study||3||
48779047|NCT05300763|102248554|FG000|STARTED|Overall Study||171||
48779048|NCT05300763|102248555|FG001|STARTED|Overall Study||171||
48779049|NCT05300763|102248554|FG000|COMPLETED|Overall Study||169||
48779050|NCT05300763|102248555|FG001|COMPLETED|Overall Study||170||
48779051|NCT05300763|102248554|FG000|NOT COMPLETED|Overall Study||2||
48779052|NCT05300763|102248555|FG001|NOT COMPLETED|Overall Study||1||
48779053|NCT01594528|102248556|FG000|STARTED|Overall Study||16||
48779054|NCT01594528|102248557|FG001|STARTED|Overall Study||17||
48779055|NCT01594528|102248558|FG002|STARTED|Overall Study||16||
48779056|NCT01594528|102248556|FG000|COMPLETED|Overall Study||16||
48779057|NCT01594528|102248557|FG001|COMPLETED|Overall Study||17||
48779058|NCT01594528|102248558|FG002|COMPLETED|Overall Study||16||
48779059|NCT01594528|102248556|FG000|NOT COMPLETED|Overall Study||0||
48779060|NCT01594528|102248557|FG001|NOT COMPLETED|Overall Study||0||
48779061|NCT01594528|102248558|FG002|NOT COMPLETED|Overall Study||0||
48779062|NCT02004041|102248559|FG000|STARTED|Overall Study||34||
48779063|NCT02004041|102248560|FG001|STARTED|Overall Study||35||
48779064|NCT02004041|102248559|FG000|COMPLETED|Overall Study||30||
48464519|NCT01016652|101471226|FG000|COMPLETED|Period 2||25||
48464520|NCT01016652|101471227|FG001|COMPLETED|Period 2||24||
48464521|NCT01016652|101471226|FG000|NOT COMPLETED|Period 2||0||
48464522|NCT01016652|101471227|FG001|NOT COMPLETED|Period 2||0||
48464523|NCT00210626|101471228|FG000|STARTED|Overall Study||97||
48779065|NCT02004041|102248560|FG001|COMPLETED|Overall Study||31||
48779066|NCT02004041|102248559|FG000|NOT COMPLETED|Overall Study||4||
48779067|NCT02004041|102248560|FG001|NOT COMPLETED|Overall Study||4||
48779068|NCT00332722|102248561|FG000|STARTED|Overall Study||60||
48779069|NCT00332722|102248562|FG001|STARTED|Overall Study||60||
48779070|NCT00332722|102248561|FG000|COMPLETED|Overall Study||60||
48779071|NCT00332722|102248562|FG001|COMPLETED|Overall Study||60||
48779072|NCT00332722|102248561|FG000|NOT COMPLETED|Overall Study||0||
48779073|NCT00332722|102248562|FG001|NOT COMPLETED|Overall Study||0||
48779074|NCT00946153|102248563|FG000|STARTED|Phase 1||6||
48779075|NCT00946153|102248564|FG001|STARTED|Phase 1||3||
48779076|NCT00946153|102248565|FG002|STARTED|Phase 1||6||
48464524|NCT00210626|101471229|FG001|STARTED|Overall Study||95||
48464525|NCT00210626|101471228|FG000|COMPLETED|Overall Study||49||
48464526|NCT00210626|101471229|FG001|COMPLETED|Overall Study||50||
48464527|NCT00210626|101471228|FG000|NOT COMPLETED|Overall Study||48||
48464528|NCT00210626|101471229|FG001|NOT COMPLETED|Overall Study||45||
48464529|NCT00886483|101471230|FG000|STARTED|Overall Study||26||
48464530|NCT00886483|101471231|FG001|STARTED|Overall Study||13||
48464531|NCT00886483|101471230|FG000|Completed 20 Treatments|Overall Study||25||
48464532|NCT00886483|101471231|FG001|Completed 20 Treatments|Overall Study||11||
48464533|NCT00886483|101471230|FG000|COMPLETED|Overall Study||24||
48464534|NCT00886483|101471231|FG001|COMPLETED|Overall Study||10||
48464535|NCT00886483|101471230|FG000|NOT COMPLETED|Overall Study||2||
48369991|NCT03884101|101232881|FG001|NOT COMPLETED|Overall Study||422||
48464536|NCT00886483|101471231|FG001|NOT COMPLETED|Overall Study||3||
48464537|NCT02577354|101471232|FG000|STARTED|Overall Study||102||
48369992|NCT00496873|101232882|FG000|STARTED|Overall Study||85||
48369993|NCT00496873|101232882|FG000|COMPLETED|Overall Study||78||
48369994|NCT00496873|101232882|FG000|NOT COMPLETED|Overall Study||7||
48369995|NCT02639182|101232883|FG000|STARTED|Overall Study||67||
48369996|NCT02639182|101232884|FG001|STARTED|Overall Study||66||
48369997|NCT02639182|101232883|FG000|Treated|Overall Study||66||
48369998|NCT02639182|101232884|FG001|Treated|Overall Study||65||
48369999|NCT02639182|101232883|FG000|COMPLETED|Overall Study||0||
48370000|NCT02639182|101232884|FG001|COMPLETED|Overall Study||0||
48370001|NCT02639182|101232883|FG000|NOT COMPLETED|Overall Study||67||
48370002|NCT02639182|101232884|FG001|NOT COMPLETED|Overall Study||66||
48370003|NCT01975935|101232885|FG000|STARTED|Overall Study||21||
48370004|NCT01975935|101232886|FG001|STARTED|Overall Study||21||
48370005|NCT01975935|101232885|FG000|COMPLETED|Overall Study||18||
48370006|NCT01975935|101232886|FG001|COMPLETED|Overall Study||20||
48370007|NCT01975935|101232885|FG000|NOT COMPLETED|Overall Study||3||
48370008|NCT01975935|101232886|FG001|NOT COMPLETED|Overall Study||1||
48370009|NCT02951988|101232887|FG000|STARTED|Open-Label Treatment Period||1304||
48370010|NCT02951988|101232888|FG001|STARTED|Open-Label Treatment Period||0||
48370011|NCT02951988|101232889|FG002|STARTED|Open-Label Treatment Period||0||
48370012|NCT02951988|101232890|FG003|STARTED|Open-Label Treatment Period||0||
48370013|NCT02951988|101232887|FG000|COMPLETED|Open-Label Treatment Period||1056||
48370014|NCT02951988|101232888|FG001|COMPLETED|Open-Label Treatment Period||0||
48370015|NCT02951988|101232889|FG002|COMPLETED|Open-Label Treatment Period||0||
48464538|NCT02577354|101471233|FG001|STARTED|Overall Study||102||
48670224|NCT03711734|101974915|FG000|COMPLETED|Overall Study||20||
48370016|NCT02951988|101232890|FG003|COMPLETED|Open-Label Treatment Period||0||
48670225|NCT03711734|101974916|FG001|COMPLETED|Overall Study||20||
48670226|NCT03711734|101974915|FG000|NOT COMPLETED|Overall Study||0||
48670227|NCT03711734|101974916|FG001|NOT COMPLETED|Overall Study||0||
48670228|NCT00324805|101974917|FG000|STARTED|Overall Study||749||
48670229|NCT00324805|101974918|FG001|STARTED|Overall Study||752||
48670230|NCT00324805|101974917|FG000|Started Assigned Therapy|Overall Study||737||
48670231|NCT00324805|101974918|FG001|Started Assigned Therapy|Overall Study||735||
48670232|NCT00324805|101974917|FG000|COMPLETED|Overall Study||599||
48670233|NCT00324805|101974918|FG001|COMPLETED|Overall Study||269||
48670234|NCT00324805|101974917|FG000|NOT COMPLETED|Overall Study||150||
48670235|NCT00324805|101974918|FG001|NOT COMPLETED|Overall Study||483||
48670236|NCT04084288|101974919|FG000|STARTED|Overall Study||41||
48670237|NCT04084288|101974919|FG000|COMPLETED|Overall Study||41||
48670238|NCT04084288|101974919|FG000|NOT COMPLETED|Overall Study||0||
48670239|NCT03584633|101974920|FG000|STARTED|Overall Study||9||
48670240|NCT03584633|101974920|FG000|COMPLETED|Overall Study||9||
48670241|NCT03584633|101974920|FG000|NOT COMPLETED|Overall Study||0||
48670242|NCT01928394|101974921|FG000|STARTED|Treatment Period||18|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
48670243|NCT01928394|101974922|FG001|STARTED|Treatment Period||3|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
48670244|NCT01928394|101974923|FG002|STARTED|Treatment Period||18|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
48670245|NCT01928394|101974924|FG003|STARTED|Treatment Period||59|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
48670246|NCT01928394|101974925|FG004|STARTED|Treatment Period||3|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
48670247|NCT01928394|101974926|FG005|STARTED|Treatment Period||49|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
48670248|NCT01928394|101974927|FG006|STARTED|Treatment Period||52|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
48670249|NCT01928394|101974928|FG007|STARTED|Treatment Period||18|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
48670250|NCT01928394|101974929|FG008|STARTED|Treatment Period||3|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
48464539|NCT02577354|101471232|FG000|120 Day Primary Endpoint|Overall Study||100|Three participants in total lost to follow-up|
48464540|NCT02577354|101471233|FG001|120 Day Primary Endpoint|Overall Study||101|Three participants in total lost to follow-up|
48464541|NCT02577354|101471232|FG000|COMPLETED|Overall Study||87|Completed 1 year follow-up for FDA PMA report (a minimum of 150 participants required)|
48464542|NCT02577354|101471233|FG001|COMPLETED|Overall Study||89|Completed 1 year follow-up for FDA PMA report (a minimum of 150 participants required)|
48464543|NCT02577354|101471232|FG000|NOT COMPLETED|Overall Study||15||
48464544|NCT02577354|101471233|FG001|NOT COMPLETED|Overall Study||13||
48464545|NCT03322462|101474197|FG000|STARTED|Overall Study||155||
48779077|NCT00946153|102248566|FG003|STARTED|Phase 1||5||
48779078|NCT00946153|102248567|FG004|STARTED|Phase 1||0||
48779079|NCT00946153|102248563|FG000|COMPLETED|Phase 1||6||
48779080|NCT00946153|102248564|FG001|COMPLETED|Phase 1||3||
48779081|NCT00946153|102248565|FG002|COMPLETED|Phase 1||6||
48779082|NCT00946153|102248566|FG003|COMPLETED|Phase 1||5||
48464546|NCT03322462|101474197|FG000|Flortaucipir PET Scan|Overall Study||155||
48464547|NCT03322462|101474197|FG000|COMPLETED|Overall Study||152||
48464548|NCT03322462|101474197|FG000|NOT COMPLETED|Overall Study||3||
48464549|NCT04571242|101474198|FG000|STARTED|3 Months||51||
48464550|NCT04571242|101474199|FG001|STARTED|3 Months||54||
48464551|NCT04571242|101474198|FG000|COMPLETED|3 Months||46||
48779083|NCT00946153|102248567|FG004|COMPLETED|Phase 1||0||
48779084|NCT00946153|102248563|FG000|NOT COMPLETED|Phase 1||0||
48779085|NCT00946153|102248564|FG001|NOT COMPLETED|Phase 1||0||
48779086|NCT00946153|102248565|FG002|NOT COMPLETED|Phase 1||0||
48779087|NCT00946153|102248566|FG003|NOT COMPLETED|Phase 1||0||
48779088|NCT00946153|102248567|FG004|NOT COMPLETED|Phase 1||0||
48464552|NCT04571242|101474199|FG001|COMPLETED|3 Months||44||
48464553|NCT04571242|101474198|FG000|NOT COMPLETED|3 Months||5||
48464554|NCT04571242|101474199|FG001|NOT COMPLETED|3 Months||10||
48464555|NCT04571242|101474198|FG000|STARTED|6 Months||46||
48464556|NCT04571242|101474199|FG001|STARTED|6 Months||44||
48464557|NCT04571242|101474198|FG000|COMPLETED|6 Months||42||
48464558|NCT04571242|101474199|FG001|COMPLETED|6 Months||43||
48464559|NCT04571242|101474198|FG000|NOT COMPLETED|6 Months||4||
48464560|NCT04571242|101474199|FG001|NOT COMPLETED|6 Months||1||
48464561|NCT04571242|101474198|FG000|STARTED|9 Months||56||
48464562|NCT04571242|101474199|FG001|STARTED|9 Months||29||
48464563|NCT04571242|101474198|FG000|COMPLETED|9 Months||56||
48464564|NCT04571242|101474199|FG001|COMPLETED|9 Months||28||
48464565|NCT04571242|101474198|FG000|NOT COMPLETED|9 Months||0||
48464566|NCT04571242|101474199|FG001|NOT COMPLETED|9 Months||1||
48464567|NCT04571242|101474198|FG000|STARTED|12 Months||56||
48464568|NCT04571242|101474199|FG001|STARTED|12 Months||28||
48464569|NCT04571242|101474198|FG000|COMPLETED|12 Months||55||
48464570|NCT04571242|101474199|FG001|COMPLETED|12 Months||28||
48464571|NCT04571242|101474198|FG000|NOT COMPLETED|12 Months||1||
48779089|NCT00946153|102248563|FG000|STARTED|Phase 2||0||
48779090|NCT00946153|102248564|FG001|STARTED|Phase 2||0||
48779091|NCT00946153|102248565|FG002|STARTED|Phase 2||0||
48464572|NCT04571242|101474199|FG001|NOT COMPLETED|12 Months||0||
48464573|NCT01107535|101474200|FG000|STARTED|Overall Study||82||
48464574|NCT01107535|101474200|FG000|Number of Participants Analyzed|Overall Study||82||
48464575|NCT01107535|101474200|FG000|COMPLETED|Overall Study||77||
48779092|NCT00946153|102248566|FG003|STARTED|Phase 2||0||
48779093|NCT00946153|102248567|FG004|STARTED|Phase 2||46||
48779094|NCT00946153|102248563|FG000|COMPLETED|Phase 2||0||
48779095|NCT00946153|102248564|FG001|COMPLETED|Phase 2||0||
48464576|NCT01107535|101474200|FG000|NOT COMPLETED|Overall Study||5||
48779096|NCT00946153|102248565|FG002|COMPLETED|Phase 2||0||
48779097|NCT00946153|102248566|FG003|COMPLETED|Phase 2||0||
48779098|NCT00946153|102248567|FG004|COMPLETED|Phase 2||33||
48779099|NCT00946153|102248563|FG000|NOT COMPLETED|Phase 2||0||
48779100|NCT00946153|102248564|FG001|NOT COMPLETED|Phase 2||0||
48779101|NCT00946153|102248565|FG002|NOT COMPLETED|Phase 2||0||
48779102|NCT00946153|102248566|FG003|NOT COMPLETED|Phase 2||0||
48779103|NCT00946153|102248567|FG004|NOT COMPLETED|Phase 2||13||
48464577|NCT02545998|101474201|FG000|STARTED|Overall Study||44||
48464578|NCT02545998|101474202|FG001|STARTED|Overall Study||44||
48464579|NCT02545998|101474201|FG000|Received the Intervention|Overall Study||33||
48464580|NCT02545998|101474202|FG001|Received the Intervention|Overall Study||42||
48464581|NCT02545998|101474201|FG000|COMPLETED|Overall Study||29||
48464582|NCT02545998|101474202|FG001|COMPLETED|Overall Study||39||
48464583|NCT02545998|101474201|FG000|NOT COMPLETED|Overall Study||15||
48464584|NCT02545998|101474202|FG001|NOT COMPLETED|Overall Study||5||
48464585|NCT01170364|101474203|FG000|STARTED|Overall Study||8||
48464586|NCT01170364|101474204|FG001|STARTED|Overall Study||6||
48464587|NCT01170364|101474203|FG000|COMPLETED|Overall Study||4||
48464588|NCT01170364|101474204|FG001|COMPLETED|Overall Study||5||
48464589|NCT01170364|101474203|FG000|NOT COMPLETED|Overall Study||4||
48464590|NCT01170364|101474204|FG001|NOT COMPLETED|Overall Study||1||
48464591|NCT00319956|101474205|FG000|STARTED|Overall Study||111||
48464592|NCT00319956|101474206|FG001|STARTED|Overall Study||109||
48779104|NCT01721837|102248568|FG000|STARTED|Overall Study||2120||
48779105|NCT01721837|102248568|FG000|COMPLETED|Overall Study||2120||
48779106|NCT01721837|102248568|FG000|NOT COMPLETED|Overall Study||0||
48779107|NCT03801044|102248569|FG000|STARTED|Overall Study||21||
48779108|NCT03801044|102248569|FG000|COMPLETED|Overall Study||21||
48779109|NCT03801044|102248569|FG000|NOT COMPLETED|Overall Study||0||
48189805|NCT03283553|100786315|FG001|Patient 9-Month Interview|Patient Participant Flow||57||
48189806|NCT03283553|100786314|FG000|Patient 12-Month Interview|Patient Participant Flow||59||
48464593|NCT00319956|101474205|FG000|COMPLETED|Overall Study||91||
48464594|NCT00319956|101474206|FG001|COMPLETED|Overall Study||85||
48464595|NCT00319956|101474205|FG000|NOT COMPLETED|Overall Study||20||
48464596|NCT00319956|101474206|FG001|NOT COMPLETED|Overall Study||24||
48464597|NCT01368276|101474207|FG000|STARTED|Overall Study||3||
48464598|NCT01368276|101474208|FG001|STARTED|Overall Study||28||
48464599|NCT01368276|101474207|FG000|COMPLETED|Overall Study||2||
48464600|NCT01368276|101474208|FG001|COMPLETED|Overall Study||18||
48464601|NCT01368276|101474207|FG000|NOT COMPLETED|Overall Study||1||
48464602|NCT01368276|101474208|FG001|NOT COMPLETED|Overall Study||10||
48464603|NCT00730522|101474209|FG000|STARTED|Overall Study||28||
48464604|NCT00730522|101474210|FG001|STARTED|Overall Study||27||
48464605|NCT00730522|101474209|FG000|COMPLETED|Overall Study||28||
48464606|NCT00730522|101474210|FG001|COMPLETED|Overall Study||27||
48464607|NCT00730522|101474209|FG000|NOT COMPLETED|Overall Study||0||
48464608|NCT00730522|101474210|FG001|NOT COMPLETED|Overall Study||0||
48464609|NCT02511236|101474211|FG000|STARTED|Overall Study||165||
48464610|NCT02511236|101474212|FG001|STARTED|Overall Study||191||
48464611|NCT02511236|101474211|FG000|COMPLETED|Overall Study||125||
48464612|NCT02511236|101474212|FG001|COMPLETED|Overall Study||146||
48779110|NCT02249832|102248570|FG000|STARTED|Overall Study||55||
48779111|NCT02249832|102248570|FG000|COMPLETED|Overall Study||42||
48779112|NCT02249832|102248570|FG000|NOT COMPLETED|Overall Study||13||
48779113|NCT00463567|102248571|FG000|STARTED|Overall Study||420||
48464613|NCT02511236|101474211|FG000|NOT COMPLETED|Overall Study||40||
48779114|NCT00463567|102248572|FG001|STARTED|Overall Study||418||
48779115|NCT00463567|102248573|FG002|STARTED|Overall Study||420||
48779116|NCT00463567|102248574|FG003|STARTED|Overall Study||425||
48779117|NCT00463567|102248575|FG004|STARTED|Overall Study||130||
48464614|NCT02511236|101474212|FG001|NOT COMPLETED|Overall Study||45||
48464615|NCT00752791|101474213|FG000|STARTED|Overall Study||59||
48464616|NCT00752791|101474213|FG000|COMPLETED|Overall Study||43||
48464617|NCT00752791|101474213|FG000|NOT COMPLETED|Overall Study||16||
48189807|NCT03283553|100786315|FG001|Patient 12-Month Interview|Patient Participant Flow||50||
48464618|NCT02352337|101474214|FG000|STARTED|Overall Study||91||
48464619|NCT02352337|101474215|FG001|STARTED|Overall Study||92||
48779118|NCT00463567|102248576|FG005|STARTED|Overall Study||123||
48779119|NCT00463567|102248577|FG006|STARTED|Overall Study||123||
48779120|NCT00463567|102248571|FG000|Safety Population: Received Study Drug|Overall Study||416||
48464620|NCT02352337|101474216|FG002|STARTED|Overall Study||90||
48464621|NCT02352337|101474214|FG000|COMPLETED|Overall Study||87||
48464622|NCT02352337|101474215|FG001|COMPLETED|Overall Study||91||
48464623|NCT02352337|101474216|FG002|COMPLETED|Overall Study||88||
48464624|NCT02352337|101474214|FG000|NOT COMPLETED|Overall Study||4||
48464625|NCT02352337|101474215|FG001|NOT COMPLETED|Overall Study||1||
48464626|NCT02352337|101474216|FG002|NOT COMPLETED|Overall Study||2||
48464627|NCT01650324|101474217|FG000|STARTED|Overall Study||8||
48464628|NCT01650324|101474218|FG001|STARTED|Overall Study||6||
48464629|NCT01650324|101474219|FG002|STARTED|Overall Study||6||
48464630|NCT01650324|101474220|FG003|STARTED|Overall Study||6||
48464631|NCT01650324|101474221|FG004|STARTED|Overall Study||6||
48464632|NCT01650324|101474217|FG000|COMPLETED|Overall Study||8||
48464633|NCT01650324|101474218|FG001|COMPLETED|Overall Study||6||
48464634|NCT01650324|101474219|FG002|COMPLETED|Overall Study||6||
48665397|NCT03826472|101964806|FG001|COMPLETED|Second Intervention (1-week)||5||
48665398|NCT03826472|101964805|FG000|NOT COMPLETED|Second Intervention (1-week)||0||
48665399|NCT03826472|101964806|FG001|NOT COMPLETED|Second Intervention (1-week)||0||
48665400|NCT03508674|101964807|FG000|STARTED|Overall Study||54||
48665401|NCT03508674|101964807|FG000|COMPLETED|Overall Study||50||
48665402|NCT03508674|101964807|FG000|NOT COMPLETED|Overall Study||4||
48665403|NCT04100018|101964808|FG000|STARTED|Pre-Treatment Period||514||
48665404|NCT04100018|101964809|FG001|STARTED|Pre-Treatment Period||516||
48665405|NCT04100018|101964808|FG000|COMPLETED|Pre-Treatment Period||510||
48665406|NCT04100018|101964809|FG001|COMPLETED|Pre-Treatment Period||510||
48665407|NCT04100018|101964808|FG000|NOT COMPLETED|Pre-Treatment Period||4||
48665408|NCT04100018|101964809|FG001|NOT COMPLETED|Pre-Treatment Period||6||
48665409|NCT04100018|101964808|FG000|STARTED|Treatment Period||510||
48665410|NCT04100018|101964809|FG001|STARTED|Treatment Period||510||
48665411|NCT04100018|101964808|FG000|COMPLETED|Treatment Period||8||
48665412|NCT04100018|101964809|FG001|COMPLETED|Treatment Period||7||
48665413|NCT04100018|101964808|FG000|NOT COMPLETED|Treatment Period||502||
48665414|NCT04100018|101964809|FG001|NOT COMPLETED|Treatment Period||503||
48665415|NCT02592863|101964810|FG000|STARTED|Overall Study||10||
48665416|NCT02592863|101964811|FG001|STARTED|Overall Study||16||
48665417|NCT02592863|101964810|FG000|COMPLETED|Overall Study||7||
48665418|NCT02592863|101964811|FG001|COMPLETED|Overall Study||13||
48665419|NCT02592863|101964810|FG000|NOT COMPLETED|Overall Study||3||
48665420|NCT02592863|101964811|FG001|NOT COMPLETED|Overall Study||3||
48665421|NCT00939185|101964812|FG000|STARTED|Overall Study||400||
48779121|NCT00463567|102248572|FG001|Safety Population: Received Study Drug|Overall Study||416||
48779122|NCT00463567|102248573|FG002|Safety Population: Received Study Drug|Overall Study||415||
48779123|NCT00463567|102248574|FG003|Safety Population: Received Study Drug|Overall Study||418||
48779124|NCT00463567|102248575|FG004|Safety Population: Received Study Drug|Overall Study||127||
48779125|NCT00463567|102248576|FG005|Safety Population: Received Study Drug|Overall Study||122||
48779126|NCT00463567|102248577|FG006|Safety Population: Received Study Drug|Overall Study||122||
48665422|NCT00939185|101964812|FG000|Received Treatment|Overall Study||390||
48665423|NCT00939185|101964812|FG000|COMPLETED|Overall Study||375||
48665424|NCT00939185|101964812|FG000|NOT COMPLETED|Overall Study||25||
48665425|NCT02923167|101964813|FG000|STARTED|Overall Study||6||
48665426|NCT02923167|101964813|FG000|COMPLETED|Overall Study||4||
48665427|NCT02923167|101964813|FG000|NOT COMPLETED|Overall Study||2||
48665428|NCT00835367|101964814|FG000|STARTED|First Intervention||34||
48665429|NCT00835367|101964815|FG001|STARTED|First Intervention||34||
48665430|NCT00835367|101964814|FG000|COMPLETED|First Intervention||34||
48665431|NCT00835367|101964815|FG001|COMPLETED|First Intervention||34||
48665432|NCT00835367|101964814|FG000|NOT COMPLETED|First Intervention||0||
48665433|NCT00835367|101964815|FG001|NOT COMPLETED|First Intervention||0||
48665434|NCT00835367|101964814|FG000|STARTED|Washout||34||
48665435|NCT00835367|101964815|FG001|STARTED|Washout||34||
48665436|NCT00835367|101964814|FG000|COMPLETED|Washout||31||
48665437|NCT00835367|101964815|FG001|COMPLETED|Washout||34||
48665438|NCT00835367|101964814|FG000|NOT COMPLETED|Washout||3||
48665439|NCT00835367|101964815|FG001|NOT COMPLETED|Washout||0||
48665440|NCT00835367|101964814|FG000|STARTED|Second Intervention||31||
48665441|NCT00835367|101964815|FG001|STARTED|Second Intervention||34||
48665442|NCT00835367|101964814|FG000|COMPLETED|Second Intervention||30||
48665443|NCT00835367|101964815|FG001|COMPLETED|Second Intervention||33||
48665444|NCT00835367|101964814|FG000|NOT COMPLETED|Second Intervention||1||
48665445|NCT00835367|101964815|FG001|NOT COMPLETED|Second Intervention||1||
48665446|NCT04951193|101964816|FG000|STARTED|Overall Study||56||
48665447|NCT04951193|101964817|FG001|STARTED|Overall Study||50||
48665448|NCT04951193|101964816|FG000|COMPLETED|Overall Study||49||
48665449|NCT04951193|101964817|FG001|COMPLETED|Overall Study||45||
48665450|NCT04951193|101964816|FG000|NOT COMPLETED|Overall Study||7||
48665451|NCT04951193|101964817|FG001|NOT COMPLETED|Overall Study||5||
48665452|NCT03131479|101964818|FG000|STARTED|Overall Study||10||
48464635|NCT01650324|101474220|FG003|COMPLETED|Overall Study||6||
48464636|NCT01650324|101474221|FG004|COMPLETED|Overall Study||6||
48665453|NCT03131479|101964819|FG001|STARTED|Overall Study||10||
48665454|NCT03131479|101964820|FG002|STARTED|Overall Study||11||
48665455|NCT03131479|101964821|FG003|STARTED|Overall Study||12||
48665456|NCT03131479|101964822|FG004|STARTED|Overall Study||10||
48779127|NCT00463567|102248571|FG000|COMPLETED|Overall Study||325||
48779128|NCT00463567|102248572|FG001|COMPLETED|Overall Study||341||
48779129|NCT00463567|102248573|FG002|COMPLETED|Overall Study||331||
48779130|NCT00463567|102248574|FG003|COMPLETED|Overall Study||294||
48779131|NCT00463567|102248575|FG004|COMPLETED|Overall Study||107||
48779132|NCT00463567|102248576|FG005|COMPLETED|Overall Study||102||
48779133|NCT00463567|102248577|FG006|COMPLETED|Overall Study||112||
48779134|NCT00463567|102248571|FG000|NOT COMPLETED|Overall Study||95||
48779135|NCT00463567|102248572|FG001|NOT COMPLETED|Overall Study||77||
48779136|NCT00463567|102248573|FG002|NOT COMPLETED|Overall Study||89||
48779137|NCT00463567|102248574|FG003|NOT COMPLETED|Overall Study||131||
48779138|NCT00463567|102248575|FG004|NOT COMPLETED|Overall Study||23||
48779139|NCT00463567|102248576|FG005|NOT COMPLETED|Overall Study||21||
48779140|NCT00463567|102248577|FG006|NOT COMPLETED|Overall Study||11||
48779141|NCT02469870|102248578|FG000|STARTED|Overall Study||77||
48779142|NCT02469870|102248579|FG001|STARTED|Overall Study||79||
48779143|NCT02469870|102248578|FG000|COMPLETED|Overall Study||73||
48779144|NCT02469870|102248579|FG001|COMPLETED|Overall Study||72||
48779145|NCT02469870|102248578|FG000|NOT COMPLETED|Overall Study||4||
48779146|NCT02469870|102248579|FG001|NOT COMPLETED|Overall Study||7||
48779147|NCT01155518|102252430|FG000|STARTED|Overall Study||1||
48779148|NCT01155518|102252431|FG001|STARTED|Overall Study||1||
48779149|NCT01155518|102252432|FG002|STARTED|Overall Study||0||
48779150|NCT01155518|102252433|FG003|STARTED|Overall Study||0||
48464637|NCT01650324|101474217|FG000|NOT COMPLETED|Overall Study||0||
48464638|NCT01650324|101474218|FG001|NOT COMPLETED|Overall Study||0||
48464639|NCT01650324|101474219|FG002|NOT COMPLETED|Overall Study||0||
48464640|NCT01650324|101474220|FG003|NOT COMPLETED|Overall Study||0||
48464641|NCT01650324|101474221|FG004|NOT COMPLETED|Overall Study||0||
48464642|NCT01709383|101474222|FG000|STARTED|Overall Study||24||
48464643|NCT01709383|101474223|FG001|STARTED|Overall Study||14||
48464644|NCT01709383|101474222|FG000|Completed Treatment|Overall Study||24||
48464645|NCT01709383|101474223|FG001|Completed Treatment|Overall Study||14||
48464646|NCT01709383|101474222|FG000|Completed Follow-ups|Overall Study||23||
48464647|NCT01709383|101474223|FG001|Completed Follow-ups|Overall Study||14||
48464648|NCT01709383|101474222|FG000|Included in Analysis|Overall Study||22||
48464649|NCT01709383|101474223|FG001|Included in Analysis|Overall Study||13||
48464650|NCT01709383|101474222|FG000|COMPLETED|Overall Study||23||
48464651|NCT01709383|101474223|FG001|COMPLETED|Overall Study||14||
48779151|NCT01155518|102252434|FG004|STARTED|Overall Study||1||
48779152|NCT01155518|102252435|FG005|STARTED|Overall Study||2||
48779153|NCT01155518|102252430|FG000|COMPLETED|Overall Study||1||
48464652|NCT01709383|101474222|FG000|NOT COMPLETED|Overall Study||1||
48464653|NCT01709383|101474223|FG001|NOT COMPLETED|Overall Study||0||
48464654|NCT02130466|101474224|FG000|STARTED|Overall Study||7||
48464655|NCT02130466|101474225|FG001|STARTED|Overall Study||3||
48464656|NCT02130466|101474226|FG002|STARTED|Overall Study||2||
48464657|NCT02130466|101474227|FG003|STARTED|Overall Study||8||
48464658|NCT02130466|101474228|FG004|STARTED|Overall Study||2||
48464659|NCT02130466|101474229|FG005|STARTED|Overall Study||60||
48464660|NCT02130466|101474230|FG006|STARTED|Overall Study||60||
48464661|NCT02130466|101474231|FG007|STARTED|Overall Study||3||
48464662|NCT02130466|101474232|FG008|STARTED|Overall Study||4||
48464663|NCT02130466|101474233|FG009|STARTED|Overall Study||5||
48464664|NCT02130466|101474234|FG010|STARTED|Overall Study||6||
48464665|NCT02130466|101474235|FG011|STARTED|Overall Study||3||
48464666|NCT02130466|101474236|FG012|STARTED|Overall Study||12||
48464667|NCT02130466|101474237|FG013|STARTED|Overall Study||9||
48464668|NCT02130466|101474224|FG000|Treated|Overall Study||7||
48464669|NCT02130466|101474225|FG001|Treated|Overall Study||3||
48464670|NCT02130466|101474226|FG002|Treated|Overall Study||2||
48464671|NCT02130466|101474227|FG003|Treated|Overall Study||8||
48464672|NCT02130466|101474228|FG004|Treated|Overall Study||2||
48464673|NCT02130466|101474229|FG005|Treated|Overall Study||60||
48464674|NCT02130466|101474230|FG006|Treated|Overall Study||60||
48464675|NCT02130466|101474231|FG007|Treated|Overall Study||3||
48464676|NCT02130466|101474232|FG008|Treated|Overall Study||4||
48464677|NCT02130466|101474233|FG009|Treated|Overall Study||5||
48464678|NCT02130466|101474234|FG010|Treated|Overall Study||6||
48464679|NCT02130466|101474235|FG011|Treated|Overall Study||3||
48464680|NCT02130466|101474236|FG012|Treated|Overall Study||12||
48464681|NCT02130466|101474237|FG013|Treated|Overall Study||9||
48464682|NCT02130466|101474224|FG000|COMPLETED|Overall Study||0||
48464683|NCT02130466|101474225|FG001|COMPLETED|Overall Study||0||
48464684|NCT02130466|101474226|FG002|COMPLETED|Overall Study||0||
48464685|NCT02130466|101474227|FG003|COMPLETED|Overall Study||0||
48464686|NCT02130466|101474228|FG004|COMPLETED|Overall Study||0||
48779154|NCT01155518|102252431|FG001|COMPLETED|Overall Study||0||
48779155|NCT01155518|102252432|FG002|COMPLETED|Overall Study||0||
48464687|NCT02130466|101474229|FG005|COMPLETED|Overall Study||0||
48464688|NCT02130466|101474230|FG006|COMPLETED|Overall Study||0||
48779156|NCT01155518|102252433|FG003|COMPLETED|Overall Study||0||
48779157|NCT01155518|102252434|FG004|COMPLETED|Overall Study||1||
48779158|NCT01155518|102252435|FG005|COMPLETED|Overall Study||2||
48779159|NCT01155518|102252430|FG000|NOT COMPLETED|Overall Study||0||
48779160|NCT01155518|102252431|FG001|NOT COMPLETED|Overall Study||1||
48779161|NCT01155518|102252432|FG002|NOT COMPLETED|Overall Study||0||
48779162|NCT01155518|102252433|FG003|NOT COMPLETED|Overall Study||0||
48665457|NCT03131479|101964818|FG000|Safety Analysis Set (SS)|Overall Study||10|All subjects that received study drug|
48665458|NCT03131479|101964819|FG001|Safety Analysis Set (SS)|Overall Study||10|All subjects that received study drug|
48665459|NCT03131479|101964820|FG002|Safety Analysis Set (SS)|Overall Study||11|All subjects that received study drug|
48665460|NCT03131479|101964821|FG003|Safety Analysis Set (SS)|Overall Study||12|All subjects that received study drug|
48665461|NCT03131479|101964822|FG004|Safety Analysis Set (SS)|Overall Study||10|All subjects that received study drug|
48665462|NCT03131479|101964818|FG000|Pharmacokinetic Analysis Set (PAS)|Overall Study||10|At least one dose of study drug and had at least 1 valid PK concentration measurement|
48665463|NCT03131479|101964819|FG001|Pharmacokinetic Analysis Set (PAS)|Overall Study||10|At least one dose of study drug and had at least 1 valid PK concentration measurement|
48665464|NCT03131479|101964820|FG002|Pharmacokinetic Analysis Set (PAS)|Overall Study||11|At least one dose of study drug and had at least 1 valid PK concentration measurement|
48665465|NCT03131479|101964821|FG003|Pharmacokinetic Analysis Set (PAS)|Overall Study||12|At least one dose of study drug and had at least 1 valid PK concentration measurement|
48665466|NCT03131479|101964822|FG004|Pharmacokinetic Analysis Set (PAS)|Overall Study||10|At least one dose of study drug and had at least 1 valid PK concentration measurement|
48665467|NCT03131479|101964818|FG000|Pharcodynamic Analysis Set (PD)|Overall Study||10|At least one dose of study drug and had at least 1 valid post baseline PD|
48464689|NCT02130466|101474231|FG007|COMPLETED|Overall Study||0||
48665468|NCT03131479|101964819|FG001|Pharcodynamic Analysis Set (PD)|Overall Study||10|At least one dose of study drug and had at least 1 valid post baseline PD|
48665469|NCT03131479|101964820|FG002|Pharcodynamic Analysis Set (PD)|Overall Study||11|At least one dose of study drug and had at least 1 valid post baseline PD|
48665470|NCT03131479|101964821|FG003|Pharcodynamic Analysis Set (PD)|Overall Study||12|At least one dose of study drug and had at least 1 valid post baseline PD|
48665471|NCT03131479|101964822|FG004|Pharcodynamic Analysis Set (PD)|Overall Study||10|At least one dose of study drug and had at least 1 valid post baseline PD|
48665472|NCT03131479|101964818|FG000|COMPLETED|Overall Study||10||
48665473|NCT03131479|101964819|FG001|COMPLETED|Overall Study||10||
48665474|NCT03131479|101964820|FG002|COMPLETED|Overall Study||10||
48665475|NCT03131479|101964821|FG003|COMPLETED|Overall Study||10||
48665476|NCT03131479|101964822|FG004|COMPLETED|Overall Study||10||
48665477|NCT03131479|101964818|FG000|NOT COMPLETED|Overall Study||0||
48665478|NCT03131479|101964819|FG001|NOT COMPLETED|Overall Study||0||
48665479|NCT03131479|101964820|FG002|NOT COMPLETED|Overall Study||1||
48665480|NCT03131479|101964821|FG003|NOT COMPLETED|Overall Study||2||
48665481|NCT03131479|101964822|FG004|NOT COMPLETED|Overall Study||0||
48665482|NCT02956473|101964823|FG000|STARTED|Overall Study||57||
48665483|NCT02956473|101964823|FG000|COMPLETED|Overall Study||57||
48665484|NCT02956473|101964823|FG000|NOT COMPLETED|Overall Study||0||
48665485|NCT03584490|101964824|FG000|STARTED|Overall Study||362||
48665486|NCT03584490|101964825|FG001|STARTED|Overall Study||367||
48665487|NCT03584490|101964824|FG000|COMPLETED|Overall Study||235||
48665488|NCT03584490|101964825|FG001|COMPLETED|Overall Study||230||
48665489|NCT03584490|101964824|FG000|NOT COMPLETED|Overall Study||127||
48665490|NCT03584490|101964825|FG001|NOT COMPLETED|Overall Study||137||
48665491|NCT02772302|101964826|FG000|STARTED|Overall Study||10||
48665492|NCT02772302|101964827|FG001|STARTED|Overall Study||10||
48665493|NCT02772302|101964826|FG000|COMPLETED|Overall Study||10||
48665494|NCT02772302|101964827|FG001|COMPLETED|Overall Study||10||
48665495|NCT02772302|101964826|FG000|NOT COMPLETED|Overall Study||0||
48665496|NCT02772302|101964827|FG001|NOT COMPLETED|Overall Study||0||
48665497|NCT03456076|101964828|FG000|STARTED|Overall Study||130||
48665498|NCT03456076|101964829|FG001|STARTED|Overall Study||127||
48665499|NCT03456076|101964828|FG000|COMPLETED|Overall Study||0||
48665500|NCT03456076|101964829|FG001|COMPLETED|Overall Study||0||
48665501|NCT03456076|101964828|FG000|NOT COMPLETED|Overall Study||130||
48665502|NCT03456076|101964829|FG001|NOT COMPLETED|Overall Study||127||
48665503|NCT02022202|101964830|FG000|STARTED|Overall Study||132||
48665504|NCT02022202|101964830|FG000|COMPLETED|Overall Study||124||
48665505|NCT02022202|101964830|FG000|NOT COMPLETED|Overall Study||8||
48665506|NCT01847014|101964831|FG000|STARTED|Baseline Extension Visit||4||
48665507|NCT01847014|101964831|FG000|COMPLETED|Baseline Extension Visit||4||
48665508|NCT01847014|101964831|FG000|NOT COMPLETED|Baseline Extension Visit||0||
48665509|NCT01847014|101964831|FG000|STARTED|Completion of Extension Study||4||
48665510|NCT01847014|101964831|FG000|COMPLETED|Completion of Extension Study||0||
48665511|NCT01847014|101964831|FG000|NOT COMPLETED|Completion of Extension Study||4||
48665512|NCT02310269|101964832|FG000|STARTED|Overall Study||152||
48665513|NCT02310269|101964832|FG000|COMPLETED|Overall Study||29||
48779163|NCT01155518|102252434|FG004|NOT COMPLETED|Overall Study||0||
48779164|NCT01155518|102252435|FG005|NOT COMPLETED|Overall Study||0||
48779165|NCT01818752|102252436|FG000|STARTED|Overall Study||477||
48779166|NCT01818752|102252437|FG001|STARTED|Overall Study||478||
48779167|NCT01818752|102252436|FG000|Received Treatment|Overall Study||470||
48779168|NCT01818752|102252437|FG001|Received Treatment|Overall Study||474||
48779169|NCT01818752|102252436|FG000|COMPLETED|Overall Study||290||
48779170|NCT01818752|102252437|FG001|COMPLETED|Overall Study||280||
48779171|NCT01818752|102252436|FG000|NOT COMPLETED|Overall Study||187||
48779172|NCT01818752|102252437|FG001|NOT COMPLETED|Overall Study||198||
48189808|NCT03283553|100786314|FG000|COMPLETED|Patient Participant Flow||59||
48189809|NCT03283553|100786315|FG001|COMPLETED|Patient Participant Flow||50||
48665514|NCT02310269|101964832|FG000|NOT COMPLETED|Overall Study||123||
48665515|NCT00685295|101964833|FG000|STARTED|Overall Study||30||
48665516|NCT00685295|101964834|FG001|STARTED|Overall Study||30||
48665517|NCT00685295|101964833|FG000|COMPLETED|Overall Study||30||
48665518|NCT00685295|101964834|FG001|COMPLETED|Overall Study||30||
48665519|NCT00685295|101964833|FG000|NOT COMPLETED|Overall Study||0||
48665520|NCT00685295|101964834|FG001|NOT COMPLETED|Overall Study||0||
48665521|NCT00937105|101964835|FG000|STARTED|Overall Study||109||
48665522|NCT00937105|101964836|FG001|STARTED|Overall Study||109||
48665523|NCT00937105|101964835|FG000|COMPLETED|Overall Study||69||
48779173|NCT00850421|102252438|FG000|STARTED|Overall Study||35||
48779174|NCT00850421|102252438|FG000|COMPLETED|Overall Study||18||
48779175|NCT00850421|102252438|FG000|NOT COMPLETED|Overall Study||17||
48779176|NCT03773796|102252439|FG000|STARTED|Overall Study||22||
48779177|NCT03773796|102252439|FG000|COMPLETED|Overall Study||19||
48779178|NCT03773796|102252439|FG000|NOT COMPLETED|Overall Study||3||
48779179|NCT02448641|102252440|FG000|STARTED|Overall Study||55||
48779180|NCT02448641|102252441|FG001|STARTED|Overall Study||56||
48779181|NCT02448641|102252442|FG002|STARTED|Overall Study||52||
48779182|NCT02448641|102252440|FG000|COMPLETED|Overall Study||54||
48779183|NCT02448641|102252441|FG001|COMPLETED|Overall Study||51||
48779184|NCT02448641|102252442|FG002|COMPLETED|Overall Study||48||
48779185|NCT02448641|102252440|FG000|NOT COMPLETED|Overall Study||1||
48779186|NCT02448641|102252441|FG001|NOT COMPLETED|Overall Study||5||
48779187|NCT02448641|102252442|FG002|NOT COMPLETED|Overall Study||4||
48779188|NCT01971086|102252443|FG000|STARTED|Overall Study||300||
48779189|NCT01971086|102252443|FG000|COMPLETED|Overall Study||300||
48779190|NCT01971086|102252443|FG000|NOT COMPLETED|Overall Study||0||
48779191|NCT01509053|102252444|FG000|STARTED|Oral Aripirazole (Phase A)||19||
48779192|NCT01509053|102252444|FG000|COMPLETED|Oral Aripirazole (Phase A)||8||
48779193|NCT01509053|102252444|FG000|NOT COMPLETED|Oral Aripirazole (Phase A)||11||
48779194|NCT01509053|102252444|FG000|STARTED|Aripiprazole IM Depot Treatment Phase(B)||19||
48779195|NCT01509053|102252444|FG000|COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||3||
48779196|NCT01509053|102252444|FG000|NOT COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||16||
48779197|NCT01509053|102252444|FG000|STARTED|Aripiprazole IM Depot Extension Phase(C)||3||
48779198|NCT01509053|102252444|FG000|COMPLETED|Aripiprazole IM Depot Extension Phase(C)||0||
48779199|NCT01509053|102252444|FG000|NOT COMPLETED|Aripiprazole IM Depot Extension Phase(C)||3||
48779200|NCT00441064|102252445|FG000|STARTED|Overall Study||69||
48779201|NCT00441064|102252446|FG001|STARTED|Overall Study||63||
48779202|NCT00441064|102252445|FG000|Safety Population (SP)|Overall Study||69||
48779203|NCT00441064|102252446|FG001|Safety Population (SP)|Overall Study||63||
48779204|NCT00441064|102252445|FG000|Intent-to-treat (ITT) Population|Overall Study||61||
48779205|NCT00441064|102252446|FG001|Intent-to-treat (ITT) Population|Overall Study||57||
48779206|NCT00441064|102252445|FG000|COMPLETED|Overall Study||59||
48779207|NCT00441064|102252446|FG001|COMPLETED|Overall Study||56||
48779208|NCT00441064|102252445|FG000|NOT COMPLETED|Overall Study||10||
48779209|NCT00441064|102252446|FG001|NOT COMPLETED|Overall Study||7||
48779210|NCT00333762|102252447|FG000|STARTED|Overall Study||4||
48779211|NCT00333762|102252447|FG000|COMPLETED|Overall Study||0||
48779212|NCT00333762|102252447|FG000|NOT COMPLETED|Overall Study||4||
48779213|NCT03710083|102252448|FG000|STARTED|Overall Study||66||
48779214|NCT03710083|102252448|FG000|COMPLETED|Overall Study||63||
48779215|NCT03710083|102252448|FG000|NOT COMPLETED|Overall Study||3||
48779216|NCT01209702|102252449|FG000|STARTED|Overall Study||51||
48779217|NCT01209702|102252450|FG001|STARTED|Overall Study||51||
48779218|NCT01209702|102252451|FG002|STARTED|Overall Study||51||
48779219|NCT01209702|102252452|FG003|STARTED|Overall Study||153||
48779220|NCT01209702|102252449|FG000|Treated|Overall Study||51||
48779221|NCT01209702|102252450|FG001|Treated|Overall Study||51||
48779222|NCT01209702|102252451|FG002|Treated|Overall Study||51||
48779223|NCT01209702|102252452|FG003|Treated|Overall Study||152||
48779224|NCT01209702|102252449|FG000|Escape or Switched to Tocilizumab|Overall Study||51||
48779225|NCT01209702|102252450|FG001|Escape or Switched to Tocilizumab|Overall Study||0||
48779226|NCT01209702|102252451|FG002|Escape or Switched to Tocilizumab|Overall Study||6||
48779227|NCT01209702|102252452|FG003|Escape or Switched to Tocilizumab|Overall Study||0||
48779228|NCT01209702|102252449|FG000|Completed 12 Weeks Treatment|Overall Study||50||
48779229|NCT01209702|102252450|FG001|Completed 12 Weeks Treatment|Overall Study||48||
48779230|NCT01209702|102252451|FG002|Completed 12 Weeks Treatment|Overall Study||12||
48779231|NCT01209702|102252452|FG003|Completed 12 Weeks Treatment|Overall Study||59||
48779232|NCT01209702|102252449|FG000|Completed 24 Weeks Treatment|Overall Study||19||
48779233|NCT01209702|102252450|FG001|Completed 24 Weeks Treatment|Overall Study||28||
48189810|NCT03283553|100786314|FG000|NOT COMPLETED|Patient Participant Flow||10||
48665524|NCT00937105|101964836|FG001|COMPLETED|Overall Study||70||
48779234|NCT01209702|102252451|FG002|Completed 24 Weeks Treatment|Overall Study||3||
48779235|NCT01209702|102252452|FG003|Completed 24 Weeks Treatment|Overall Study||10||
48779236|NCT01209702|102252449|FG000|COMPLETED|Overall Study||0||
48779237|NCT01209702|102252450|FG001|COMPLETED|Overall Study||0||
48464690|NCT02130466|101474232|FG008|COMPLETED|Overall Study||0||
48464691|NCT02130466|101474233|FG009|COMPLETED|Overall Study||0||
48464692|NCT02130466|101474234|FG010|COMPLETED|Overall Study||0||
48464693|NCT02130466|101474235|FG011|COMPLETED|Overall Study||0||
48464694|NCT02130466|101474236|FG012|COMPLETED|Overall Study||0||
48464695|NCT02130466|101474237|FG013|COMPLETED|Overall Study||0||
48464696|NCT02130466|101474224|FG000|NOT COMPLETED|Overall Study||7||
48464697|NCT02130466|101474225|FG001|NOT COMPLETED|Overall Study||3||
48464698|NCT02130466|101474226|FG002|NOT COMPLETED|Overall Study||2||
48464699|NCT02130466|101474227|FG003|NOT COMPLETED|Overall Study||8||
48464700|NCT02130466|101474228|FG004|NOT COMPLETED|Overall Study||2||
48464701|NCT02130466|101474229|FG005|NOT COMPLETED|Overall Study||60||
48464702|NCT02130466|101474230|FG006|NOT COMPLETED|Overall Study||60||
48464703|NCT02130466|101474231|FG007|NOT COMPLETED|Overall Study||3||
48464704|NCT02130466|101474232|FG008|NOT COMPLETED|Overall Study||4||
48464705|NCT02130466|101474233|FG009|NOT COMPLETED|Overall Study||5||
48464706|NCT02130466|101474234|FG010|NOT COMPLETED|Overall Study||6||
48464707|NCT02130466|101474235|FG011|NOT COMPLETED|Overall Study||3||
48464708|NCT02130466|101474236|FG012|NOT COMPLETED|Overall Study||12||
48464709|NCT02130466|101474237|FG013|NOT COMPLETED|Overall Study||9||
48464710|NCT00582036|101474238|FG000|STARTED|Overall Study||5||
48464711|NCT00582036|101474239|FG001|STARTED|Overall Study||6||
48464712|NCT00582036|101474238|FG000|COMPLETED|Overall Study||5||
48464713|NCT00582036|101474239|FG001|COMPLETED|Overall Study||5||
48464714|NCT00582036|101474238|FG000|NOT COMPLETED|Overall Study||0||
48464715|NCT00582036|101474239|FG001|NOT COMPLETED|Overall Study||1||
48464716|NCT03211156|101474240|FG000|STARTED|Overall Study||49||
48464717|NCT03211156|101474241|FG001|STARTED|Overall Study||48||
48464718|NCT03211156|101474240|FG000|Received Study Drug|Overall Study||47||
48464719|NCT03211156|101474241|FG001|Received Study Drug|Overall Study||45||
48464720|NCT03211156|101474240|FG000|COMPLETED|Overall Study||47||
48464721|NCT03211156|101474241|FG001|COMPLETED|Overall Study||45||
48464722|NCT03211156|101474240|FG000|NOT COMPLETED|Overall Study||2||
48464723|NCT03211156|101474241|FG001|NOT COMPLETED|Overall Study||3||
48464724|NCT02322528|101474242|FG000|STARTED|Overall Study||10||
48464725|NCT02322528|101474242|FG000|COMPLETED|Overall Study||10||
48464726|NCT02322528|101474242|FG000|NOT COMPLETED|Overall Study||0||
48464727|NCT01544166|101474243|FG000|STARTED|Overall Study||44||
48464728|NCT01544166|101474243|FG000|COMPLETED|Overall Study||44||
48464729|NCT01544166|101474243|FG000|NOT COMPLETED|Overall Study||0||
48464730|NCT04579926|101474244|FG000|STARTED|Overall Study||24||
48464731|NCT04579926|101474244|FG000|Parents|Overall Study||24||
48464732|NCT04579926|101474244|FG000|Adolescents|Overall Study||24||
48464733|NCT04579926|101474244|FG000|COMPLETED|Overall Study||24|For the stepped wedge design, n=18 were instructed to complete 0 week, 4 week, 8 week, and 12 week. n=6 were instructed to complete 0 week, 4 week, 8 week, and 12 week, and 16 week surveys.|
48464734|NCT04579926|101474244|FG000|NOT COMPLETED|Overall Study||0||
48464735|NCT03402893|101474245|FG000|STARTED|Overall Study||21||
48464736|NCT03402893|101474245|FG000|COMPLETED|Overall Study||20||
48464737|NCT03402893|101474245|FG000|NOT COMPLETED|Overall Study||1||
48779238|NCT01209702|102252451|FG002|COMPLETED|Overall Study||0||
48779239|NCT01209702|102252452|FG003|COMPLETED|Overall Study||0||
48779240|NCT01209702|102252449|FG000|NOT COMPLETED|Overall Study||51||
48779241|NCT01209702|102252450|FG001|NOT COMPLETED|Overall Study||51||
48779242|NCT01209702|102252451|FG002|NOT COMPLETED|Overall Study||51||
48779243|NCT01209702|102252452|FG003|NOT COMPLETED|Overall Study||153||
48779244|NCT02064582|102252453|FG000|STARTED|Overall Study||7||
48779245|NCT02064582|102252453|FG000|COMPLETED|Overall Study||7||
48779246|NCT02064582|102252453|FG000|NOT COMPLETED|Overall Study||0||
48779247|NCT00796419|102252454|FG000|STARTED|Overall Study||13||
48464738|NCT00630565|101474246|FG000|STARTED|Overall Study||12||
48464739|NCT00630565|101474247|FG001|STARTED|Overall Study||0||
48464740|NCT00630565|101474246|FG000|COMPLETED|Overall Study||12||
48464741|NCT00630565|101474247|FG001|COMPLETED|Overall Study||0||
48464742|NCT00630565|101474246|FG000|NOT COMPLETED|Overall Study||0||
48464743|NCT00630565|101474247|FG001|NOT COMPLETED|Overall Study||0||
48464744|NCT03467477|101474248|FG000|STARTED|Overall Study||161||
48464745|NCT03467477|101474248|FG000|COMPLETED|Overall Study||161||
48464746|NCT03467477|101474248|FG000|NOT COMPLETED|Overall Study||0||
48464747|NCT00686036|101474249|FG000|STARTED|Overall Study||9||
48464748|NCT00686036|101474250|FG001|STARTED|Overall Study||8||
48464749|NCT00686036|101474249|FG000|COMPLETED|Overall Study||0||
48464750|NCT00686036|101474250|FG001|COMPLETED|Overall Study||2||
48464751|NCT00686036|101474249|FG000|NOT COMPLETED|Overall Study||9||
48464752|NCT00686036|101474250|FG001|NOT COMPLETED|Overall Study||6||
48464753|NCT02710071|101474251|FG000|STARTED|Placebo (2 Weeks).||21||
48464754|NCT02710071|101474252|FG001|STARTED|Placebo (2 Weeks).||20||
48464755|NCT02710071|101474251|FG000|COMPLETED|Placebo (2 Weeks).||21||
48464756|NCT02710071|101474252|FG001|COMPLETED|Placebo (2 Weeks).||20||
48464757|NCT02710071|101474251|FG000|NOT COMPLETED|Placebo (2 Weeks).||0||
48779248|NCT00796419|102252455|FG001|STARTED|Overall Study||14||
48779249|NCT00796419|102252454|FG000|COMPLETED|Overall Study||13||
48779250|NCT00796419|102252455|FG001|COMPLETED|Overall Study||13||
48779251|NCT00796419|102252454|FG000|NOT COMPLETED|Overall Study||0||
48779252|NCT00796419|102252455|FG001|NOT COMPLETED|Overall Study||1||
48779253|NCT02504216|102252456|FG000|STARTED|Overall Study||3286||
48779254|NCT02504216|102252457|FG001|STARTED|Overall Study||3278||
48779255|NCT02504216|102252456|FG000|Received Treatment|Overall Study||3256||
48779256|NCT02504216|102252457|FG001|Received Treatment|Overall Study||3248||
48779257|NCT02504216|102252456|FG000|COMPLETED|Overall Study||3275|Vital status known at ECOD|
48779258|NCT02504216|102252457|FG001|COMPLETED|Overall Study||3263|Vital status known at ECOD|
48779259|NCT02504216|102252456|FG000|NOT COMPLETED|Overall Study||11||
48779260|NCT02504216|102252457|FG001|NOT COMPLETED|Overall Study||15||
48779261|NCT00661427|102252458|FG000|STARTED|Overall Study||35||
48779262|NCT00661427|102252459|FG001|STARTED|Overall Study||26||
48779263|NCT00661427|102252458|FG000|COMPLETED|Overall Study||30||
48779264|NCT00661427|102252459|FG001|COMPLETED|Overall Study||19||
48779265|NCT00661427|102252458|FG000|NOT COMPLETED|Overall Study||5||
48779266|NCT00661427|102252459|FG001|NOT COMPLETED|Overall Study||7||
48779267|NCT01712399|102252460|FG000|STARTED|Overall Study||397||
48779268|NCT01712399|102252460|FG000|COMPLETED|Overall Study||0||
48779269|NCT01712399|102252460|FG000|NOT COMPLETED|Overall Study||397||
48779270|NCT04458090|102252461|FG000|STARTED|Overall Study||72||
48779271|NCT04458090|102252462|FG001|STARTED|Overall Study||72||
48779272|NCT04458090|102252461|FG000|COMPLETED|Overall Study||72||
48779273|NCT04458090|102252462|FG001|COMPLETED|Overall Study||72||
48779274|NCT04458090|102252461|FG000|NOT COMPLETED|Overall Study||0||
48464758|NCT02710071|101474252|FG001|NOT COMPLETED|Placebo (2 Weeks).||0||
48464759|NCT02710071|101474251|FG000|STARTED|First Intervention (6 Weeks).||21||
48464760|NCT02710071|101474252|FG001|STARTED|First Intervention (6 Weeks).||20||
48464761|NCT02710071|101474251|FG000|COMPLETED|First Intervention (6 Weeks).||18||
48779275|NCT04458090|102252462|FG001|NOT COMPLETED|Overall Study||0||
48779276|NCT03091348|102252463|FG000|STARTED|Overall Study||2||
48779277|NCT03091348|102252464|FG001|STARTED|Overall Study||2||
48779278|NCT03091348|102252463|FG000|COMPLETED|Overall Study||0||
48779279|NCT03091348|102252464|FG001|COMPLETED|Overall Study||1||
48779280|NCT03091348|102252463|FG000|NOT COMPLETED|Overall Study||2||
48779281|NCT03091348|102252464|FG001|NOT COMPLETED|Overall Study||1||
48779282|NCT02197078|102252465|FG000|STARTED|Overall Study||14688||
48779283|NCT02197078|102252466|FG001|STARTED|Overall Study||14688||
48779284|NCT02197078|102252467|FG002|STARTED|Overall Study||10614||
48779285|NCT02197078|102252468|FG003|STARTED|Overall Study||10614||
48779286|NCT02197078|102252469|FG004|STARTED|Overall Study||9538||
48779287|NCT02197078|102252470|FG005|STARTED|Overall Study||9538||
48779288|NCT02197078|102252471|FG006|STARTED|Overall Study||25135||
48779289|NCT02197078|102252472|FG007|STARTED|Overall Study||25135||
48779290|NCT02197078|102252473|FG008|STARTED|Overall Study||18996||
48779291|NCT02197078|102252474|FG009|STARTED|Overall Study||18996||
48779292|NCT02197078|102252475|FG010|STARTED|Overall Study||15742||
48779293|NCT02197078|102252476|FG011|STARTED|Overall Study||15742||
48779294|NCT02197078|102252465|FG000|COMPLETED|Overall Study||14688||
48779295|NCT02197078|102252466|FG001|COMPLETED|Overall Study||14688||
48779296|NCT02197078|102252467|FG002|COMPLETED|Overall Study||10614||
48779297|NCT02197078|102252468|FG003|COMPLETED|Overall Study||10614||
48779298|NCT02197078|102252469|FG004|COMPLETED|Overall Study||9538||
48779299|NCT02197078|102252470|FG005|COMPLETED|Overall Study||9538||
48779300|NCT02197078|102252471|FG006|COMPLETED|Overall Study||25135||
48779301|NCT02197078|102252472|FG007|COMPLETED|Overall Study||25135||
48779302|NCT02197078|102252473|FG008|COMPLETED|Overall Study||18996||
48779303|NCT02197078|102252474|FG009|COMPLETED|Overall Study||18996||
48779304|NCT02197078|102252475|FG010|COMPLETED|Overall Study||15742||
48779305|NCT02197078|102252476|FG011|COMPLETED|Overall Study||15742||
48779306|NCT02197078|102252465|FG000|NOT COMPLETED|Overall Study||0||
48464762|NCT02710071|101474252|FG001|COMPLETED|First Intervention (6 Weeks).||16||
48464763|NCT02710071|101474251|FG000|NOT COMPLETED|First Intervention (6 Weeks).||3||
48779307|NCT02197078|102252466|FG001|NOT COMPLETED|Overall Study||0||
48779308|NCT02197078|102252467|FG002|NOT COMPLETED|Overall Study||0||
48779309|NCT02197078|102252468|FG003|NOT COMPLETED|Overall Study||0||
48779310|NCT02197078|102252469|FG004|NOT COMPLETED|Overall Study||0||
48779311|NCT02197078|102252470|FG005|NOT COMPLETED|Overall Study||0||
48779312|NCT02197078|102252471|FG006|NOT COMPLETED|Overall Study||0||
48779313|NCT02197078|102252472|FG007|NOT COMPLETED|Overall Study||0||
48779314|NCT02197078|102252473|FG008|NOT COMPLETED|Overall Study||0||
48779315|NCT02197078|102252474|FG009|NOT COMPLETED|Overall Study||0||
48779316|NCT02197078|102252475|FG010|NOT COMPLETED|Overall Study||0||
48779317|NCT02197078|102252476|FG011|NOT COMPLETED|Overall Study||0||
48779318|NCT00486291|102252477|FG000|STARTED|Overall Study||105||
48464764|NCT02710071|101474252|FG001|NOT COMPLETED|First Intervention (6 Weeks).||4||
48464765|NCT02710071|101474251|FG000|STARTED|Second Intervention (6 Weeks).||18||
48464766|NCT02710071|101474252|FG001|STARTED|Second Intervention (6 Weeks).||16||
48464767|NCT02710071|101474251|FG000|COMPLETED|Second Intervention (6 Weeks).||17||
48464768|NCT02710071|101474252|FG001|COMPLETED|Second Intervention (6 Weeks).||14||
48779319|NCT00486291|102252478|FG001|STARTED|Overall Study||105||
48779320|NCT00486291|102252477|FG000|COMPLETED|Overall Study||89||
48779321|NCT00486291|102252478|FG001|COMPLETED|Overall Study||76||
48779322|NCT00486291|102252477|FG000|NOT COMPLETED|Overall Study||16||
48779323|NCT00486291|102252478|FG001|NOT COMPLETED|Overall Study||29||
48779324|NCT01522937|102252479|FG000|STARTED|Overall Study||146||
48779325|NCT01522937|102252479|FG000|COMPLETED|Overall Study||146||
48779326|NCT01522937|102252479|FG000|NOT COMPLETED|Overall Study||0||
48779327|NCT04040933|102252480|FG000|STARTED|Overall Study||36||
48779328|NCT04040933|102252480|FG000|Treated|Overall Study||36||
48779329|NCT04040933|102252480|FG000|COMPLETED|Overall Study||33||
48779330|NCT04040933|102252480|FG000|NOT COMPLETED|Overall Study||3||
48779331|NCT00955201|102252481|FG000|STARTED|Overall Study||12||
48779332|NCT00955201|102252482|FG001|STARTED|Overall Study||11||
48779333|NCT00955201|102252483|FG002|STARTED|Overall Study||11||
48779334|NCT00955201|102252484|FG003|STARTED|Overall Study||11||
48779335|NCT00955201|102252481|FG000|COMPLETED|Overall Study||8||
48779336|NCT00955201|102252482|FG001|COMPLETED|Overall Study||11||
48779337|NCT00955201|102252483|FG002|COMPLETED|Overall Study||10||
48779338|NCT00955201|102252484|FG003|COMPLETED|Overall Study||7||
48779339|NCT00955201|102252481|FG000|NOT COMPLETED|Overall Study||4||
48779340|NCT00955201|102252482|FG001|NOT COMPLETED|Overall Study||0||
48779341|NCT00955201|102252483|FG002|NOT COMPLETED|Overall Study||1||
48779342|NCT00955201|102252484|FG003|NOT COMPLETED|Overall Study||4||
48779343|NCT01419197|102252485|FG000|STARTED|Overall Study||404||
48779344|NCT01419197|102252486|FG001|STARTED|Overall Study||198||
48779345|NCT01419197|102252485|FG000|Switched to Trastuzumab Emtansine|Overall Study||0||
48779346|NCT01419197|102252486|FG001|Switched to Trastuzumab Emtansine|Overall Study||94||
48779347|NCT01419197|102252485|FG000|COMPLETED|Overall Study||0||
48779348|NCT01419197|102252486|FG001|COMPLETED|Overall Study||0||
48779349|NCT01419197|102252485|FG000|NOT COMPLETED|Overall Study||404||
48779350|NCT01419197|102252486|FG001|NOT COMPLETED|Overall Study||198||
48779351|NCT03508908|102252487|FG000|STARTED|Month 0-3||249||2
48779352|NCT03508908|102252488|FG001|STARTED|Month 0-3||0||0
48779353|NCT03508908|102252489|FG002|STARTED|Month 0-3||0||0
48779354|NCT03508908|102252490|FG003|STARTED|Month 0-3||0||0
48779355|NCT03508908|102252487|FG000|COMPLETED|Month 0-3||249||2
48779356|NCT03508908|102252488|FG001|COMPLETED|Month 0-3||0||0
48779357|NCT03508908|102252489|FG002|COMPLETED|Month 0-3||0||0
48779358|NCT03508908|102252490|FG003|COMPLETED|Month 0-3||0||0
48779359|NCT03508908|102252487|FG000|NOT COMPLETED|Month 0-3||0||0
48779360|NCT03508908|102252488|FG001|NOT COMPLETED|Month 0-3||0||0
48779361|NCT03508908|102252489|FG002|NOT COMPLETED|Month 0-3||0||0
48779362|NCT03508908|102252490|FG003|NOT COMPLETED|Month 0-3||0||0
48779363|NCT03508908|102252487|FG000|STARTED|Month 4-6||250||2
48779364|NCT03508908|102252488|FG001|STARTED|Month 4-6||125||1
48779365|NCT03508908|102252489|FG002|STARTED|Month 4-6||1||1
48779366|NCT03508908|102252490|FG003|STARTED|Month 4-6||1||1
48779367|NCT03508908|102252487|FG000|COMPLETED|Month 4-6||250||2
48779368|NCT03508908|102252488|FG001|COMPLETED|Month 4-6||125||1
48779369|NCT03508908|102252489|FG002|COMPLETED|Month 4-6||1||1
48779370|NCT03508908|102252490|FG003|COMPLETED|Month 4-6||1||1
48779371|NCT03508908|102252487|FG000|NOT COMPLETED|Month 4-6||0||0
48779372|NCT03508908|102252488|FG001|NOT COMPLETED|Month 4-6||0||0
48779373|NCT03508908|102252489|FG002|NOT COMPLETED|Month 4-6||0||0
48779374|NCT03508908|102252490|FG003|NOT COMPLETED|Month 4-6||0||0
48779375|NCT03508908|102252487|FG000|STARTED|Month 7-9||250||2
48779376|NCT03508908|102252488|FG001|STARTED|Month 7-9||250||2
48779377|NCT03508908|102252489|FG002|STARTED|Month 7-9||1||1
48779378|NCT03508908|102252490|FG003|STARTED|Month 7-9||1||1
48779379|NCT03508908|102252487|FG000|COMPLETED|Month 7-9||250||2
48779380|NCT03508908|102252488|FG001|COMPLETED|Month 7-9||250||2
48779381|NCT03508908|102252489|FG002|COMPLETED|Month 7-9||1||1
48779382|NCT03508908|102252490|FG003|COMPLETED|Month 7-9||1||1
48779383|NCT03508908|102252487|FG000|NOT COMPLETED|Month 7-9||0||0
48779384|NCT03508908|102252488|FG001|NOT COMPLETED|Month 7-9||0||0
48779385|NCT03508908|102252489|FG002|NOT COMPLETED|Month 7-9||0||0
48779386|NCT03508908|102252490|FG003|NOT COMPLETED|Month 7-9||0||0
48779387|NCT03508908|102252487|FG000|STARTED|Month 10-12||250||2
48779388|NCT03508908|102252488|FG001|STARTED|Month 10-12||250||2
48779389|NCT03508908|102252489|FG002|STARTED|Month 10-12||0||0
48779390|NCT03508908|102252490|FG003|STARTED|Month 10-12||2||2
48779391|NCT03508908|102252487|FG000|COMPLETED|Month 10-12||250||2
48779392|NCT03508908|102252488|FG001|COMPLETED|Month 10-12||250||2
48779393|NCT03508908|102252489|FG002|COMPLETED|Month 10-12||0||0
48779394|NCT03508908|102252490|FG003|COMPLETED|Month 10-12||2||2
48779395|NCT03508908|102252487|FG000|NOT COMPLETED|Month 10-12||0||0
48779396|NCT03508908|102252488|FG001|NOT COMPLETED|Month 10-12||0||0
48779397|NCT03508908|102252489|FG002|NOT COMPLETED|Month 10-12||0||0
48779398|NCT03508908|102252490|FG003|NOT COMPLETED|Month 10-12||0||0
48779399|NCT03508908|102252487|FG000|STARTED|Month 13-15||250||2
48779400|NCT03508908|102252488|FG001|STARTED|Month 13-15||250||2
48779401|NCT03508908|102252489|FG002|STARTED|Month 13-15||0||0
48779402|NCT03508908|102252490|FG003|STARTED|Month 13-15||2||2
48779403|NCT03508908|102252487|FG000|COMPLETED|Month 13-15||250||2
48779404|NCT03508908|102252488|FG001|COMPLETED|Month 13-15||250||2
48779405|NCT03508908|102252489|FG002|COMPLETED|Month 13-15||0||0
48779406|NCT03508908|102252490|FG003|COMPLETED|Month 13-15||2||2
48779407|NCT03508908|102252487|FG000|NOT COMPLETED|Month 13-15||0||0
48779408|NCT03508908|102252488|FG001|NOT COMPLETED|Month 13-15||0||0
48779409|NCT03508908|102252489|FG002|NOT COMPLETED|Month 13-15||0||0
48779410|NCT03508908|102252490|FG003|NOT COMPLETED|Month 13-15||0||0
48779411|NCT03508908|102252487|FG000|STARTED|Month 16-18||125||1
48779412|NCT03508908|102252488|FG001|STARTED|Month 16-18||250||2
48779413|NCT03508908|102252489|FG002|STARTED|Month 16-18||1||1
48779414|NCT03508908|102252490|FG003|STARTED|Month 16-18||1||1
48779415|NCT03508908|102252487|FG000|COMPLETED|Month 16-18||125||1
48779416|NCT03508908|102252488|FG001|COMPLETED|Month 16-18||250||2
48779417|NCT03508908|102252489|FG002|COMPLETED|Month 16-18||1||1
48779418|NCT03508908|102252490|FG003|COMPLETED|Month 16-18||1||1
48779419|NCT03508908|102252487|FG000|NOT COMPLETED|Month 16-18||0||0
48779420|NCT03508908|102252488|FG001|NOT COMPLETED|Month 16-18||0||0
48779421|NCT03508908|102252489|FG002|NOT COMPLETED|Month 16-18||0||0
48779422|NCT03508908|102252490|FG003|NOT COMPLETED|Month 16-18||0||0
48779423|NCT03508908|102252487|FG000|STARTED|Month 19-21||0||0
48779424|NCT03508908|102252488|FG001|STARTED|Month 19-21||250||2
48779425|NCT03508908|102252489|FG002|STARTED|Month 19-21||0||0
48779426|NCT03508908|102252490|FG003|STARTED|Month 19-21||3||2
48779427|NCT03508908|102252487|FG000|COMPLETED|Month 19-21||0||0
48779428|NCT03508908|102252488|FG001|COMPLETED|Month 19-21||250||2
48779429|NCT03508908|102252489|FG002|COMPLETED|Month 19-21||0||0
48779430|NCT03508908|102252490|FG003|COMPLETED|Month 19-21||3||2
48779431|NCT03508908|102252487|FG000|NOT COMPLETED|Month 19-21||0||0
48779432|NCT03508908|102252488|FG001|NOT COMPLETED|Month 19-21||0||0
48779433|NCT03508908|102252489|FG002|NOT COMPLETED|Month 19-21||0||0
48779434|NCT03508908|102252490|FG003|NOT COMPLETED|Month 19-21||0||0
48779435|NCT03508908|102252487|FG000|STARTED|Month 22-24||0||0
48779436|NCT03508908|102252488|FG001|STARTED|Month 22-24||125||1
48779437|NCT03508908|102252489|FG002|STARTED|Month 22-24||0||0
48779438|NCT03508908|102252490|FG003|STARTED|Month 22-24||0||0
48779439|NCT03508908|102252487|FG000|COMPLETED|Month 22-24||0||0
48779440|NCT03508908|102252488|FG001|COMPLETED|Month 22-24||125||1
48779441|NCT03508908|102252489|FG002|COMPLETED|Month 22-24||0||0
48779442|NCT03508908|102252490|FG003|COMPLETED|Month 22-24||0||0
48779443|NCT03508908|102252487|FG000|NOT COMPLETED|Month 22-24||0||0
48779444|NCT03508908|102252488|FG001|NOT COMPLETED|Month 22-24||0||0
48189811|NCT03283553|100786315|FG001|NOT COMPLETED|Patient Participant Flow||13||
48779445|NCT03508908|102252489|FG002|NOT COMPLETED|Month 22-24||0||0
48779446|NCT03508908|102252490|FG003|NOT COMPLETED|Month 22-24||0||0
48779447|NCT01474239|102252491|FG000|STARTED|Overall Study||59||
48779448|NCT01474239|102252492|FG001|STARTED|Overall Study||32||
48779449|NCT01474239|102252491|FG000|COMPLETED|Overall Study||0||
48779450|NCT01474239|102252492|FG001|COMPLETED|Overall Study||0||
48779451|NCT01474239|102252491|FG000|NOT COMPLETED|Overall Study||59||
48779452|NCT01474239|102252492|FG001|NOT COMPLETED|Overall Study||32||
48779453|NCT02779556|102252493|FG000|STARTED|Baseline||394||
48779454|NCT02779556|102252494|FG001|STARTED|Baseline||362||
48779455|NCT02779556|102252493|FG000|COMPLETED|Baseline||393||
48779456|NCT02779556|102252494|FG001|COMPLETED|Baseline||362||
48779457|NCT02779556|102252493|FG000|NOT COMPLETED|Baseline||1||
48779458|NCT02779556|102252494|FG001|NOT COMPLETED|Baseline||0||
48779459|NCT02779556|102252493|FG000|STARTED|3 Months||393||
48779460|NCT02779556|102252494|FG001|STARTED|3 Months||362||
48779461|NCT02779556|102252493|FG000|COMPLETED|3 Months||326||
48779462|NCT02779556|102252494|FG001|COMPLETED|3 Months||314||
48779463|NCT02779556|102252493|FG000|NOT COMPLETED|3 Months||67||
48779464|NCT02779556|102252494|FG001|NOT COMPLETED|3 Months||48||
48779465|NCT02779556|102252493|FG000|STARTED|6 Month||353||
48779466|NCT02779556|102252494|FG001|STARTED|6 Month||333||
48779467|NCT02779556|102252493|FG000|COMPLETED|6 Month||320||
48779468|NCT02779556|102252494|FG001|COMPLETED|6 Month||294||
48779469|NCT02779556|102252493|FG000|NOT COMPLETED|6 Month||33||
48779470|NCT02779556|102252494|FG001|NOT COMPLETED|6 Month||39||
48370017|NCT02951988|101232887|FG000|NOT COMPLETED|Open-Label Treatment Period||248||
48779471|NCT02779556|102252493|FG000|STARTED|6 Month HbA1c||394||
48779472|NCT02779556|102252494|FG001|STARTED|6 Month HbA1c||362||
48779473|NCT02779556|102252493|FG000|COMPLETED|6 Month HbA1c||325||
48779474|NCT02779556|102252494|FG001|COMPLETED|6 Month HbA1c||312||
48779475|NCT02779556|102252493|FG000|NOT COMPLETED|6 Month HbA1c||69||
48779476|NCT02779556|102252494|FG001|NOT COMPLETED|6 Month HbA1c||50||
48370018|NCT02951988|101232888|FG001|NOT COMPLETED|Open-Label Treatment Period||0||
48779477|NCT02779556|102252493|FG000|STARTED|12 Month HbA1c||394||
48779478|NCT02779556|102252494|FG001|STARTED|12 Month HbA1c||362||
48779479|NCT02779556|102252493|FG000|COMPLETED|12 Month HbA1c||256||
48779480|NCT02779556|102252494|FG001|COMPLETED|12 Month HbA1c||260||
48779481|NCT02779556|102252493|FG000|NOT COMPLETED|12 Month HbA1c||138||
48779482|NCT02779556|102252494|FG001|NOT COMPLETED|12 Month HbA1c||102||
48779483|NCT03236662|102252495|FG000|STARTED|Overall Study||2||
48779484|NCT03236662|102252495|FG000|COMPLETED|Overall Study||2||
48779485|NCT03236662|102252495|FG000|NOT COMPLETED|Overall Study||0||
48779486|NCT01071798|102252496|FG000|STARTED|Participants Who Received One Cycle||1653||
48779487|NCT01071798|102252496|FG000|Baseline and Safety Analysis Set|Participants Who Received One Cycle||1653||
48464769|NCT02710071|101474251|FG000|NOT COMPLETED|Second Intervention (6 Weeks).||1||
48464770|NCT02710071|101474252|FG001|NOT COMPLETED|Second Intervention (6 Weeks).||2||
48464771|NCT00458302|101474253|FG000|STARTED|Overall Study||129||
48464772|NCT00458302|101474254|FG001|STARTED|Overall Study||127||
48464773|NCT00458302|101474253|FG000|COMPLETED|Overall Study||109||
48464774|NCT00458302|101474254|FG001|COMPLETED|Overall Study||103||
48464775|NCT00458302|101474253|FG000|NOT COMPLETED|Overall Study||20||
48464776|NCT00458302|101474254|FG001|NOT COMPLETED|Overall Study||24||
48464777|NCT03381248|101474255|FG000|STARTED|0-6 Months||89||
48464778|NCT03381248|101474256|FG001|STARTED|0-6 Months||88||
48464779|NCT03381248|101474255|FG000|COMPLETED|0-6 Months||76|Completion is with respect to the 6-month primary outcome.|
48464780|NCT03381248|101474256|FG001|COMPLETED|0-6 Months||82|Completion is with respect to the 6-month primary outcome.|
48464781|NCT03381248|101474255|FG000|NOT COMPLETED|0-6 Months||13||
48464782|NCT03381248|101474256|FG001|NOT COMPLETED|0-6 Months||6||
48464783|NCT03381248|101474255|FG000|STARTED|6-12 Months||76||
48464784|NCT03381248|101474256|FG001|STARTED|6-12 Months||82||
48464785|NCT03381248|101474255|FG000|Received Crossover Treatment|6-12 Months||0||
48464786|NCT03381248|101474256|FG001|Received Crossover Treatment|6-12 Months||68||
48464787|NCT03381248|101474255|FG000|COMPLETED|6-12 Months||66||
48464788|NCT03381248|101474256|FG001|COMPLETED|6-12 Months||73||
48464789|NCT03381248|101474255|FG000|NOT COMPLETED|6-12 Months||10||
48464790|NCT03381248|101474256|FG001|NOT COMPLETED|6-12 Months||9||
48464791|NCT03381248|101474255|FG000|STARTED|12 - 24 Months (Extension Study)||36||
48464792|NCT03381248|101474256|FG001|STARTED|12 - 24 Months (Extension Study)||0||
48464793|NCT03381248|101474255|FG000|COMPLETED|12 - 24 Months (Extension Study)||27||
48464794|NCT03381248|101474256|FG001|COMPLETED|12 - 24 Months (Extension Study)||0||
48464795|NCT03381248|101474255|FG000|NOT COMPLETED|12 - 24 Months (Extension Study)||9||
48464796|NCT03381248|101474256|FG001|NOT COMPLETED|12 - 24 Months (Extension Study)||0||
48464797|NCT00804609|101474257|FG000|STARTED|Overall Study||15||
48464798|NCT00804609|101474258|FG001|STARTED|Overall Study||15||
48464799|NCT00804609|101474257|FG000|COMPLETED|Overall Study||15||
48464800|NCT00804609|101474258|FG001|COMPLETED|Overall Study||14||
48464801|NCT00804609|101474257|FG000|NOT COMPLETED|Overall Study||0||
48464802|NCT00804609|101474258|FG001|NOT COMPLETED|Overall Study||1||
48464803|NCT01751412|101474259|FG000|STARTED|Overall Study||12||
48464804|NCT01751412|101474259|FG000|COMPLETED|Overall Study||11||
48464805|NCT01751412|101474259|FG000|NOT COMPLETED|Overall Study||1||
48464806|NCT03283709|101474260|FG000|STARTED|Overall Study||0||
48464807|NCT03283709|101474261|FG001|STARTED|Overall Study||1||
48464808|NCT03283709|101474260|FG000|COMPLETED|Overall Study||0||
48464809|NCT03283709|101474261|FG001|COMPLETED|Overall Study||0||
48464810|NCT03283709|101474260|FG000|NOT COMPLETED|Overall Study||0||
48464811|NCT03283709|101474261|FG001|NOT COMPLETED|Overall Study||1||
48464812|NCT00492206|101474262|FG000|STARTED|Overall Study||40||
48464813|NCT00492206|101474262|FG000|COMPLETED|Overall Study||40||
48464814|NCT00492206|101474262|FG000|NOT COMPLETED|Overall Study||0||
48464815|NCT03718455|101474263|FG000|STARTED|Overall Study||1||
48464816|NCT03718455|101474263|FG000|COMPLETED|Overall Study||1||
48464817|NCT03718455|101474263|FG000|NOT COMPLETED|Overall Study||0||
48464818|NCT01656889|101474264|FG000|STARTED|Treatment Period, 12 Weeks||222||
48464819|NCT01656889|101474265|FG001|STARTED|Treatment Period, 12 Weeks||225||
48779488|NCT01071798|102252496|FG000|COMPLETED|Participants Who Received One Cycle||1588||
48464820|NCT01656889|101474264|FG000|COMPLETED|Treatment Period, 12 Weeks||210||
48464821|NCT01656889|101474265|FG001|COMPLETED|Treatment Period, 12 Weeks||214||
48464822|NCT01656889|101474264|FG000|NOT COMPLETED|Treatment Period, 12 Weeks||12||
48779489|NCT01071798|102252496|FG000|NOT COMPLETED|Participants Who Received One Cycle||65||
48464823|NCT01656889|101474265|FG001|NOT COMPLETED|Treatment Period, 12 Weeks||11||
48464824|NCT01656889|101474264|FG000|STARTED|Post Treatment Follow-Up, 3 Months||210||
48464825|NCT01656889|101474265|FG001|STARTED|Post Treatment Follow-Up, 3 Months||213||
48464826|NCT01656889|101474264|FG000|COMPLETED|Post Treatment Follow-Up, 3 Months||206||
48464827|NCT01656889|101474265|FG001|COMPLETED|Post Treatment Follow-Up, 3 Months||204||
48464828|NCT01656889|101474264|FG000|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||4||
48464829|NCT01656889|101474265|FG001|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||9||
48464830|NCT00601354|101474266|FG000|STARTED|Overall Study||8||
48464831|NCT00601354|101474267|FG001|STARTED|Overall Study||9||
48779490|NCT01071798|102252496|FG000|STARTED|Subpopulation Who Received Two Cycles||820||
48464832|NCT00601354|101474266|FG000|COMPLETED|Overall Study||4||
48464833|NCT00601354|101474267|FG001|COMPLETED|Overall Study||4||
48464834|NCT00601354|101474266|FG000|NOT COMPLETED|Overall Study||4||
48464835|NCT00601354|101474267|FG001|NOT COMPLETED|Overall Study||5||
48464836|NCT04574583|101474268|FG000|STARTED|Overall Study||3||
48464837|NCT04574583|101474269|FG001|STARTED|Overall Study||6||
48464838|NCT04574583|101474270|FG002|STARTED|Overall Study||3||
48464839|NCT04574583|101474268|FG000|COMPLETED|Overall Study||3||
48464840|NCT04574583|101474269|FG001|COMPLETED|Overall Study||6||
48464841|NCT04574583|101474270|FG002|COMPLETED|Overall Study||3||
48464842|NCT04574583|101474268|FG000|NOT COMPLETED|Overall Study||0||
48464843|NCT04574583|101474269|FG001|NOT COMPLETED|Overall Study||0||
48464844|NCT04574583|101474270|FG002|NOT COMPLETED|Overall Study||0||
48464845|NCT01172600|101474271|FG000|STARTED|Overall Study||39||
48779491|NCT01071798|102252496|FG000|Baseline and Safety Analysis Set|Subpopulation Who Received Two Cycles||820||
48779492|NCT01071798|102252496|FG000|COMPLETED|Subpopulation Who Received Two Cycles||805||
48779493|NCT01071798|102252496|FG000|NOT COMPLETED|Subpopulation Who Received Two Cycles||15||
48779494|NCT02442804|102252497|FG000|STARTED|Overall Study||8||
48779495|NCT02442804|102252498|FG001|STARTED|Overall Study||8||
48779496|NCT02442804|102252497|FG000|COMPLETED|Overall Study||7||
48779497|NCT02442804|102252498|FG001|COMPLETED|Overall Study||7||
48779498|NCT02442804|102252497|FG000|NOT COMPLETED|Overall Study||1||
48779499|NCT02442804|102252498|FG001|NOT COMPLETED|Overall Study||1||
48779500|NCT01590888|102252499|FG000|STARTED|Overall Study||36||
48779501|NCT01590888|102252500|FG001|STARTED|Overall Study||38||
48779502|NCT01590888|102252501|FG002|STARTED|Overall Study||35||
48779503|NCT01590888|102252499|FG000|COMPLETED|Overall Study||32||
48779504|NCT01590888|102252500|FG001|COMPLETED|Overall Study||38||
48779505|NCT01590888|102252501|FG002|COMPLETED|Overall Study||34||
48779506|NCT01590888|102252499|FG000|NOT COMPLETED|Overall Study||4||
48779507|NCT01590888|102252500|FG001|NOT COMPLETED|Overall Study||0||
48779508|NCT01590888|102252501|FG002|NOT COMPLETED|Overall Study||1||
48779509|NCT04762719|102252502|FG000|STARTED|Overall Study||4||
48779510|NCT04762719|102252503|FG001|STARTED|Overall Study||4||
48779511|NCT04762719|102252504|FG002|STARTED|Overall Study||4||
48779512|NCT04762719|102252502|FG000|COMPLETED|Overall Study||4||
48779513|NCT04762719|102252503|FG001|COMPLETED|Overall Study||4||
48779514|NCT04762719|102252504|FG002|COMPLETED|Overall Study||4||
48779515|NCT04762719|102252502|FG000|NOT COMPLETED|Overall Study||0||
48779516|NCT04762719|102252503|FG001|NOT COMPLETED|Overall Study||0||
48779517|NCT04762719|102252504|FG002|NOT COMPLETED|Overall Study||0||
48779518|NCT02641561|102252505|FG000|STARTED|Overall Study||48||
48779519|NCT02641561|102252506|FG001|STARTED|Overall Study||48||
48779520|NCT02641561|102252507|FG002|STARTED|Overall Study||48||
48779521|NCT02641561|102252508|FG003|STARTED|Overall Study||48||
48779522|NCT02641561|102252505|FG000|COMPLETED|Overall Study||48||
48779523|NCT02641561|102252506|FG001|COMPLETED|Overall Study||48||
48779524|NCT02641561|102252507|FG002|COMPLETED|Overall Study||48||
48779525|NCT02641561|102252508|FG003|COMPLETED|Overall Study||48||
48779526|NCT02641561|102252505|FG000|NOT COMPLETED|Overall Study||0||
48779527|NCT02641561|102252506|FG001|NOT COMPLETED|Overall Study||0||
48779528|NCT02641561|102252507|FG002|NOT COMPLETED|Overall Study||0||
48779529|NCT02641561|102252508|FG003|NOT COMPLETED|Overall Study||0||
48779530|NCT02722499|102252509|FG000|STARTED|Overall Study||20||
48779531|NCT02722499|102252510|FG001|STARTED|Overall Study||20||
48779532|NCT02722499|102252511|FG002|STARTED|Overall Study||20||
48779533|NCT02722499|102252509|FG000|COMPLETED|Overall Study||18||
48779534|NCT02722499|102252510|FG001|COMPLETED|Overall Study||20||
48779535|NCT02722499|102252511|FG002|COMPLETED|Overall Study||19||
48779536|NCT02722499|102252509|FG000|NOT COMPLETED|Overall Study||2||
48779537|NCT02722499|102252510|FG001|NOT COMPLETED|Overall Study||0||
48779538|NCT02722499|102252511|FG002|NOT COMPLETED|Overall Study||1||
48779539|NCT01006291|102252512|FG000|STARTED|Overall Study||229||
48779540|NCT01006291|102252513|FG001|STARTED|Overall Study||228||
48779541|NCT01006291|102252514|FG002|STARTED|Overall Study||230||
48779542|NCT01006291|102252512|FG000|Exposed|Overall Study||230||
48779543|NCT01006291|102252513|FG001|Exposed|Overall Study||226||
48779544|NCT01006291|102252514|FG002|Exposed|Overall Study||229||
48779545|NCT01006291|102252512|FG000|COMPLETED|Overall Study||203||
48779546|NCT01006291|102252513|FG001|COMPLETED|Overall Study||204||
48779547|NCT01006291|102252514|FG002|COMPLETED|Overall Study||203||
48779548|NCT01006291|102252512|FG000|NOT COMPLETED|Overall Study||26||
48779549|NCT01006291|102252513|FG001|NOT COMPLETED|Overall Study||24||
48779550|NCT01006291|102252514|FG002|NOT COMPLETED|Overall Study||27||
48779551|NCT00441116|102252515|FG000|STARTED|Overall Study||76||
48779552|NCT00441116|102252516|FG001|STARTED|Overall Study||77||
48370019|NCT02951988|101232889|FG002|NOT COMPLETED|Open-Label Treatment Period||0||
48370020|NCT02951988|101232890|FG003|NOT COMPLETED|Open-Label Treatment Period||0||
48779553|NCT00441116|102252515|FG000|COMPLETED|Overall Study||73||
48779554|NCT00441116|102252516|FG001|COMPLETED|Overall Study||75||
48779555|NCT00441116|102252515|FG000|NOT COMPLETED|Overall Study||3||
48779556|NCT00441116|102252516|FG001|NOT COMPLETED|Overall Study||2||
48779557|NCT02105961|102252517|FG000|STARTED|Overall Study||226||
48779558|NCT02105961|102252518|FG001|STARTED|Overall Study||223||
48779559|NCT02105961|102252519|FG002|STARTED|Overall Study||225||
48779560|NCT02105961|102252517|FG000|Completed Investigational Product (IP)|Overall Study||170||
48779561|NCT02105961|102252518|FG001|Completed Investigational Product (IP)|Overall Study||196||
48779562|NCT02105961|102252519|FG002|Completed Investigational Product (IP)|Overall Study||183||
48779563|NCT02105961|102252517|FG000|Not Completed IP|Overall Study||56||
48779564|NCT02105961|102252518|FG001|Not Completed IP|Overall Study||27||
48779565|NCT02105961|102252519|FG002|Not Completed IP|Overall Study||42||
48779566|NCT02105961|102252517|FG000|Withdrew IP Due to: Adverse Event|Overall Study||27||
48779567|NCT02105961|102252518|FG001|Withdrew IP Due to: Adverse Event|Overall Study||9||
48779568|NCT02105961|102252519|FG002|Withdrew IP Due to: Adverse Event|Overall Study||25||
48779569|NCT02105961|102252517|FG000|Withdrew IP Due to: Stopping Criteria|Overall Study||1||
48779570|NCT02105961|102252518|FG001|Withdrew IP Due to: Stopping Criteria|Overall Study||1||
48189812|NCT03283553|100786314|FG000|STARTED|Care Partner Participant Flow||69|Patients and Care Partners were distinctly contacted for baseline and follow up, so the participation of one was not necessarily contingent on the participation of the other.|
48370021|NCT02951988|101232887|FG000|STARTED|Double-Blind Treatment Period||0||
48370022|NCT02951988|101232888|FG001|STARTED|Double-Blind Treatment Period||202||
48464846|NCT01172600|101474272|FG001|STARTED|Overall Study||39||
48464847|NCT01172600|101474271|FG000|COMPLETED|Overall Study||39||
48464848|NCT01172600|101474272|FG001|COMPLETED|Overall Study||39||
48464849|NCT01172600|101474271|FG000|NOT COMPLETED|Overall Study||0||
48464850|NCT01172600|101474272|FG001|NOT COMPLETED|Overall Study||0||
48464851|NCT01046253|101474273|FG000|STARTED|First Intervention||25||
48464852|NCT01046253|101474274|FG001|STARTED|First Intervention||25||
48464853|NCT01046253|101474273|FG000|COMPLETED|First Intervention||25||
48464854|NCT01046253|101474274|FG001|COMPLETED|First Intervention||25||
48464855|NCT01046253|101474273|FG000|NOT COMPLETED|First Intervention||0||
48464856|NCT01046253|101474274|FG001|NOT COMPLETED|First Intervention||0||
48464857|NCT01046253|101474273|FG000|STARTED|First Washout of 7 Days||25||
48464858|NCT01046253|101474274|FG001|STARTED|First Washout of 7 Days||25||
48464859|NCT01046253|101474273|FG000|COMPLETED|First Washout of 7 Days||25||
48665525|NCT00937105|101964835|FG000|NOT COMPLETED|Overall Study||40||
48665526|NCT00937105|101964836|FG001|NOT COMPLETED|Overall Study||39||
48665527|NCT05752487|101964837|FG000|STARTED|Overall Study||149||
48665528|NCT05752487|101964837|FG000|Treated|Overall Study||140||
48665529|NCT05752487|101964837|FG000|COMPLETED|Overall Study||0||
48665530|NCT05752487|101964837|FG000|NOT COMPLETED|Overall Study||149||
48665531|NCT03384966|101964838|FG000|STARTED|Randomized at End of Screening Period||115||
48665532|NCT03384966|101964839|FG001|STARTED|Randomized at End of Screening Period||115||
48665533|NCT03384966|101964840|FG002|STARTED|Randomized at End of Screening Period||116||
48665534|NCT03384966|101964838|FG000|COMPLETED|Randomized at End of Screening Period||114||
48665535|NCT03384966|101964839|FG001|COMPLETED|Randomized at End of Screening Period||115||
48665536|NCT03384966|101964840|FG002|COMPLETED|Randomized at End of Screening Period||116||
48370023|NCT02951988|101232889|FG002|STARTED|Double-Blind Treatment Period||202||
48370024|NCT02951988|101232890|FG003|STARTED|Double-Blind Treatment Period||200||
48370025|NCT02951988|101232887|FG000|COMPLETED|Double-Blind Treatment Period||0||
48370026|NCT02951988|101232888|FG001|COMPLETED|Double-Blind Treatment Period||101||
48370027|NCT02951988|101232889|FG002|COMPLETED|Double-Blind Treatment Period||101||
48370028|NCT02951988|101232890|FG003|COMPLETED|Double-Blind Treatment Period||85||
48370029|NCT02951988|101232887|FG000|NOT COMPLETED|Double-Blind Treatment Period||0||
48370030|NCT02951988|101232888|FG001|NOT COMPLETED|Double-Blind Treatment Period||101||
48370031|NCT02951988|101232889|FG002|NOT COMPLETED|Double-Blind Treatment Period||101||
48370032|NCT02951988|101232890|FG003|NOT COMPLETED|Double-Blind Treatment Period||115||
48370033|NCT02086565|101232891|FG000|STARTED|Overall Study||151||
48370034|NCT02086565|101232892|FG001|STARTED|Overall Study||150||
48370035|NCT02086565|101232891|FG000|COMPLETED|Overall Study||135||
48370036|NCT02086565|101232892|FG001|COMPLETED|Overall Study||138||
48370037|NCT02086565|101232891|FG000|NOT COMPLETED|Overall Study||16||
48370038|NCT02086565|101232892|FG001|NOT COMPLETED|Overall Study||12||
48370039|NCT02535949|101232893|FG000|STARTED|Overall Study||50||
48370040|NCT02535949|101232894|FG001|STARTED|Overall Study||50||
48370041|NCT02535949|101232895|FG002|STARTED|Overall Study||50||
48370042|NCT02535949|101232893|FG000|COMPLETED|Overall Study||49||
48370043|NCT02535949|101232894|FG001|COMPLETED|Overall Study||50||
48370044|NCT02535949|101232895|FG002|COMPLETED|Overall Study||50||
48370045|NCT02535949|101232893|FG000|NOT COMPLETED|Overall Study||1||
48370046|NCT02535949|101232894|FG001|NOT COMPLETED|Overall Study||0||
48370047|NCT02535949|101232895|FG002|NOT COMPLETED|Overall Study||0||
48370048|NCT01984346|101234804|FG000|STARTED|Overall Study||115|FDA full approval|
48370049|NCT01984346|101234805|FG001|STARTED|Overall Study||55|FDA full approval|
48370050|NCT01984346|101234804|FG000|Treated|Overall Study||102||
48370051|NCT01984346|101234805|FG001|Treated|Overall Study||51||
48370052|NCT01984346|101234804|FG000|COMPLETED|Overall Study||98|enrollment complete 153 treated|
48370053|NCT01984346|101234805|FG001|COMPLETED|Overall Study||50|enrollment complete 153 treated|
48370054|NCT01984346|101234804|FG000|NOT COMPLETED|Overall Study||17||
48370055|NCT01984346|101234805|FG001|NOT COMPLETED|Overall Study||5||
48370056|NCT00804193|101234806|FG000|STARTED|Overall Study||220||
48370057|NCT00804193|101234807|FG001|STARTED|Overall Study||224||
48370058|NCT00804193|101234808|FG002|STARTED|Overall Study||109||
48370059|NCT00804193|101234806|FG000|COMPLETED|Overall Study||181||
48370060|NCT00804193|101234807|FG001|COMPLETED|Overall Study||180||
48370061|NCT00804193|101234808|FG002|COMPLETED|Overall Study||77||
48370062|NCT00804193|101234806|FG000|NOT COMPLETED|Overall Study||39||
48370063|NCT00804193|101234807|FG001|NOT COMPLETED|Overall Study||44||
48370064|NCT00804193|101234808|FG002|NOT COMPLETED|Overall Study||32||
48370065|NCT00222729|101234809|FG000|STARTED|Overall Study||40||
48370066|NCT00222729|101234809|FG000|COMPLETED|Overall Study||37||
48370067|NCT00222729|101234809|FG000|NOT COMPLETED|Overall Study||3||
48370068|NCT03993691|101234810|FG000|STARTED|Overall Study||30||
48370069|NCT03993691|101234810|FG000|COMPLETED|Overall Study||30||
48370070|NCT03993691|101234810|FG000|NOT COMPLETED|Overall Study||0||
48779571|NCT02105961|102252519|FG002|Withdrew IP Due to: Stopping Criteria|Overall Study||0||
48779572|NCT02105961|102252517|FG000|Withdrew IP Due to: Lack of Efficacy|Overall Study||6||
48779573|NCT02105961|102252518|FG001|Withdrew IP Due to: Lack of Efficacy|Overall Study||2||
48779574|NCT02105961|102252519|FG002|Withdrew IP Due to: Lack of Efficacy|Overall Study||2||
48779575|NCT02105961|102252517|FG000|Withdrew IP Due to: Protocol Deviation|Overall Study||2||
48779576|NCT02105961|102252518|FG001|Withdrew IP Due to: Protocol Deviation|Overall Study||0||
48779577|NCT02105961|102252519|FG002|Withdrew IP Due to: Protocol Deviation|Overall Study||1||
48779578|NCT02105961|102252517|FG000|Withdrew IP Due to: Lost to Follow-up|Overall Study||1||
48779579|NCT02105961|102252518|FG001|Withdrew IP Due to: Lost to Follow-up|Overall Study||1||
48779580|NCT02105961|102252519|FG002|Withdrew IP Due to: Lost to Follow-up|Overall Study||1||
48779581|NCT02105961|102252517|FG000|Withdrew IP Due to: Physician Decision|Overall Study||2||
48779582|NCT02105961|102252518|FG001|Withdrew IP Due to: Physician Decision|Overall Study||3||
48779583|NCT02105961|102252519|FG002|Withdrew IP Due to: Physician Decision|Overall Study||1||
48779584|NCT02105961|102252517|FG000|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16||
48779585|NCT02105961|102252518|FG001|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11||
48779586|NCT02105961|102252519|FG002|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11||
48779587|NCT02105961|102252517|FG000|Withdrew IP Due to: Site Closed|Overall Study||1||
48779588|NCT02105961|102252518|FG001|Withdrew IP Due to: Site Closed|Overall Study||0||
48779589|NCT02105961|102252519|FG002|Withdrew IP Due to: Site Closed|Overall Study||1||
48779590|NCT02105961|102252517|FG000|COMPLETED|Overall Study||185||
48779591|NCT02105961|102252518|FG001|COMPLETED|Overall Study||206||
48779592|NCT02105961|102252519|FG002|COMPLETED|Overall Study||195||
48779593|NCT02105961|102252517|FG000|NOT COMPLETED|Overall Study||41||
48779594|NCT02105961|102252518|FG001|NOT COMPLETED|Overall Study||17||
48779595|NCT02105961|102252519|FG002|NOT COMPLETED|Overall Study||30||
48779596|NCT00485134|102252520|FG000|STARTED|Overall Study||12||
48779597|NCT00485134|102252521|FG001|STARTED|Overall Study||12||
48779598|NCT00485134|102252522|FG002|STARTED|Overall Study||12||
48464860|NCT01046253|101474274|FG001|COMPLETED|First Washout of 7 Days||25||
48464861|NCT01046253|101474273|FG000|NOT COMPLETED|First Washout of 7 Days||0||
48464862|NCT01046253|101474274|FG001|NOT COMPLETED|First Washout of 7 Days||0||
48464863|NCT01046253|101474273|FG000|STARTED|Second Intervention||25||
48464864|NCT01046253|101474274|FG001|STARTED|Second Intervention||25||
48464865|NCT01046253|101474273|FG000|COMPLETED|Second Intervention||25||
48464866|NCT01046253|101474274|FG001|COMPLETED|Second Intervention||23||
48464867|NCT01046253|101474273|FG000|NOT COMPLETED|Second Intervention||0||
48464868|NCT01046253|101474274|FG001|NOT COMPLETED|Second Intervention||2||
48464869|NCT01046253|101474273|FG000|STARTED|Second Washout of 7 Days||25||
48464870|NCT01046253|101474274|FG001|STARTED|Second Washout of 7 Days||23||
48464871|NCT01046253|101474273|FG000|COMPLETED|Second Washout of 7 Days||25||
48464872|NCT01046253|101474274|FG001|COMPLETED|Second Washout of 7 Days||23||
48464873|NCT01046253|101474273|FG000|NOT COMPLETED|Second Washout of 7 Days||0||
48464874|NCT01046253|101474274|FG001|NOT COMPLETED|Second Washout of 7 Days||0||
48464875|NCT01046253|101474273|FG000|STARTED|Third Intervention||25||
48464876|NCT01046253|101474274|FG001|STARTED|Third Intervention||23||
48464877|NCT01046253|101474273|FG000|COMPLETED|Third Intervention||25||
48464878|NCT01046253|101474274|FG001|COMPLETED|Third Intervention||23||
48464879|NCT01046253|101474273|FG000|NOT COMPLETED|Third Intervention||0||
48665537|NCT03384966|101964838|FG000|NOT COMPLETED|Randomized at End of Screening Period||1||
48665538|NCT03384966|101964839|FG001|NOT COMPLETED|Randomized at End of Screening Period||0||
48665539|NCT03384966|101964840|FG002|NOT COMPLETED|Randomized at End of Screening Period||0||
48665540|NCT03384966|101964838|FG000|STARTED|Treatment Period||114||
48779599|NCT00485134|102252523|FG003|STARTED|Overall Study||8||
48779600|NCT00485134|102252524|FG004|STARTED|Overall Study||10||
48779601|NCT00485134|102252525|FG005|STARTED|Overall Study||7||
48665541|NCT03384966|101964839|FG001|STARTED|Treatment Period||115||
48779602|NCT00485134|102252526|FG006|STARTED|Overall Study||31||
48779603|NCT00485134|102252527|FG007|STARTED|Overall Study||21||
48779604|NCT00485134|102252520|FG000|COMPLETED|Overall Study||11||
48779605|NCT00485134|102252521|FG001|COMPLETED|Overall Study||10||
48464880|NCT01046253|101474274|FG001|NOT COMPLETED|Third Intervention||0||
48464881|NCT01046253|101474273|FG000|STARTED|Third Washout of 7 Days||25||
48665542|NCT03384966|101964840|FG002|STARTED|Treatment Period||116||
48464882|NCT01046253|101474274|FG001|STARTED|Third Washout of 7 Days||23||
48464883|NCT01046253|101474273|FG000|COMPLETED|Third Washout of 7 Days||25||
48665543|NCT03384966|101964838|FG000|Thigh Administration|Treatment Period||57||
48665544|NCT03384966|101964839|FG001|Thigh Administration|Treatment Period||57||
48665545|NCT03384966|101964840|FG002|Thigh Administration|Treatment Period||58||
48665546|NCT03384966|101964838|FG000|Abdomen Administration|Treatment Period||57||
48665547|NCT03384966|101964839|FG001|Abdomen Administration|Treatment Period||58||
48779606|NCT00485134|102252522|FG002|COMPLETED|Overall Study||9||
48779607|NCT00485134|102252523|FG003|COMPLETED|Overall Study||7||
48779608|NCT00485134|102252524|FG004|COMPLETED|Overall Study||7||
48779609|NCT00485134|102252525|FG005|COMPLETED|Overall Study||3||
48779610|NCT00485134|102252526|FG006|COMPLETED|Overall Study||28||
48464884|NCT01046253|101474274|FG001|COMPLETED|Third Washout of 7 Days||23||
48464885|NCT01046253|101474273|FG000|NOT COMPLETED|Third Washout of 7 Days||0||
48464886|NCT01046253|101474274|FG001|NOT COMPLETED|Third Washout of 7 Days||0||
48464887|NCT01046253|101474273|FG000|STARTED|Fourth Intervention||25||
48464888|NCT01046253|101474274|FG001|STARTED|Fourth Intervention||23||
48464889|NCT01046253|101474273|FG000|COMPLETED|Fourth Intervention||25||
48464890|NCT01046253|101474274|FG001|COMPLETED|Fourth Intervention||23||
48464891|NCT01046253|101474273|FG000|NOT COMPLETED|Fourth Intervention||0||
48464892|NCT01046253|101474274|FG001|NOT COMPLETED|Fourth Intervention||0||
48464893|NCT02034799|101474275|FG000|STARTED|Overall Study||129||
48464894|NCT02034799|101474276|FG001|STARTED|Overall Study||127||
48464895|NCT02034799|101474275|FG000|COMPLETED|Overall Study||127||
48464896|NCT02034799|101474276|FG001|COMPLETED|Overall Study||123||
48464897|NCT02034799|101474275|FG000|NOT COMPLETED|Overall Study||2||
48464898|NCT02034799|101474276|FG001|NOT COMPLETED|Overall Study||4||
48464899|NCT04538040|101474277|FG000|STARTED|Overall Study||20||
48464900|NCT04538040|101474277|FG000|COMPLETED|Overall Study||20||
48464901|NCT04538040|101474277|FG000|NOT COMPLETED|Overall Study||0||
48464902|NCT02767388|101474278|FG000|STARTED|Overall Study||15||
48464903|NCT02767388|101474279|FG001|STARTED|Overall Study||15||
48464904|NCT02767388|101474280|FG002|STARTED|Overall Study||15||
48464905|NCT02767388|101474278|FG000|COMPLETED|Overall Study||8||
48464906|NCT02767388|101474279|FG001|COMPLETED|Overall Study||10||
48464907|NCT02767388|101474280|FG002|COMPLETED|Overall Study||12||
48464908|NCT02767388|101474278|FG000|NOT COMPLETED|Overall Study||7||
48464909|NCT02767388|101474279|FG001|NOT COMPLETED|Overall Study||5||
48464910|NCT02767388|101474280|FG002|NOT COMPLETED|Overall Study||3||
48464911|NCT00491504|101474281|FG000|STARTED|Overall Study||77||
48665548|NCT03384966|101964840|FG002|Abdomen Administration|Treatment Period||58||
48665549|NCT03384966|101964838|FG000|Per-protocol Analysis Set|Treatment Period||96|The per-protocol set includes all participants who complied with the protocol sufficiently to allow adequate estimation of the treatment effect (including availability of primary pharmacodynamic endpoint assessment and absence of protocol deviations that impact on the treatment effect).|
48665550|NCT03384966|101964839|FG001|Per-protocol Analysis Set|Treatment Period||90|The per-protocol set includes all participants who complied with the protocol sufficiently to allow adequate estimation of the treatment effect (including availability of primary pharmacodynamic endpoint assessment and absence of protocol deviations that impact on the treatment effect).|
48665551|NCT03384966|101964840|FG002|Per-protocol Analysis Set|Treatment Period||93|The per-protocol set includes all participants who complied with the protocol sufficiently to allow adequate estimation of the treatment effect (including availability of primary pharmacodynamic endpoint assessment and absence of protocol deviations that impact on the treatment effect).|
48665552|NCT03384966|101964838|FG000|Safety Analysis Set|Treatment Period||114|The safety analysis set (SAF) includes all participants who received at least one dose of study treatment. Participants were evaluated according to the actual treatment they received.|
48665553|NCT03384966|101964839|FG001|Safety Analysis Set|Treatment Period||115|The safety analysis set (SAF) includes all participants who received at least one dose of study treatment. Participants were evaluated according to the actual treatment they received.|
48779611|NCT00485134|102252527|FG007|COMPLETED|Overall Study||20||
48779612|NCT00485134|102252520|FG000|NOT COMPLETED|Overall Study||1||
48779613|NCT00485134|102252521|FG001|NOT COMPLETED|Overall Study||2||
48779614|NCT00485134|102252522|FG002|NOT COMPLETED|Overall Study||3||
48464912|NCT00491504|101474282|FG001|STARTED|Overall Study||78||
48464913|NCT00491504|101474283|FG002|STARTED|Overall Study||78||
48464914|NCT00491504|101474284|FG003|STARTED|Overall Study||77||
48665554|NCT03384966|101964840|FG002|Safety Analysis Set|Treatment Period||116|The safety analysis set (SAF) includes all participants who received at least one dose of study treatment. Participants were evaluated according to the actual treatment they received.|
48665555|NCT03384966|101964838|FG000|Pharmacokinetic Analysis Set|Treatment Period||111|The PK analysis set includes all participants from the SAF who have at least one plasma concentration measurement after administration of study treatment. Participants in the PK set were evaluated according to the actual treatment they received.|
48670434|NCT02460458|101974944|FG000|NOT COMPLETED|First Prospective Phase||84||
48779615|NCT00485134|102252523|FG003|NOT COMPLETED|Overall Study||1||
48779616|NCT00485134|102252524|FG004|NOT COMPLETED|Overall Study||3||
48779617|NCT00485134|102252525|FG005|NOT COMPLETED|Overall Study||4||
48779618|NCT00485134|102252526|FG006|NOT COMPLETED|Overall Study||3||
48779619|NCT00485134|102252527|FG007|NOT COMPLETED|Overall Study||1||
48464915|NCT00491504|101474281|FG000|COMPLETED|Overall Study||77||
48464916|NCT00491504|101474282|FG001|COMPLETED|Overall Study||77||
48464917|NCT00491504|101474283|FG002|COMPLETED|Overall Study||74||
48464918|NCT00491504|101474284|FG003|COMPLETED|Overall Study||73||
48464919|NCT00491504|101474281|FG000|NOT COMPLETED|Overall Study||0||
48464920|NCT00491504|101474282|FG001|NOT COMPLETED|Overall Study||1||
48464921|NCT00491504|101474283|FG002|NOT COMPLETED|Overall Study||4||
48464922|NCT00491504|101474284|FG003|NOT COMPLETED|Overall Study||4||
48464923|NCT01579474|101474285|FG000|STARTED|Overall Study||44||
48464924|NCT01579474|101474286|FG001|STARTED|Overall Study||43||
48464925|NCT01579474|101474287|FG002|STARTED|Overall Study||29||
48464926|NCT01579474|101474288|FG003|STARTED|Overall Study||3||
48464927|NCT01579474|101474289|FG004|STARTED|Overall Study||10||
48464928|NCT01579474|101474290|FG005|STARTED|Overall Study||2||
48464929|NCT01579474|101474285|FG000|COMPLETED|Overall Study||41||
48464930|NCT01579474|101474286|FG001|COMPLETED|Overall Study||30||
48464931|NCT01579474|101474287|FG002|COMPLETED|Overall Study||27||
48464932|NCT01579474|101474288|FG003|COMPLETED|Overall Study||3||
48464933|NCT01579474|101474289|FG004|COMPLETED|Overall Study||9||
48464934|NCT01579474|101474290|FG005|COMPLETED|Overall Study||1||
48464935|NCT01579474|101474285|FG000|NOT COMPLETED|Overall Study||3||
48464936|NCT01579474|101474286|FG001|NOT COMPLETED|Overall Study||13||
48464937|NCT01579474|101474287|FG002|NOT COMPLETED|Overall Study||2||
48464938|NCT01579474|101474288|FG003|NOT COMPLETED|Overall Study||0||
48464939|NCT01579474|101474289|FG004|NOT COMPLETED|Overall Study||1||
48464940|NCT01579474|101474290|FG005|NOT COMPLETED|Overall Study||1||
48464941|NCT00992264|101474291|FG000|STARTED|Overall Study||116||
48464942|NCT00992264|101474292|FG001|STARTED|Overall Study||116||
48464943|NCT00992264|101474293|FG002|STARTED|Overall Study||117||
48464944|NCT00992264|101474294|FG003|STARTED|Overall Study||117||
48464945|NCT00992264|101474295|FG004|STARTED|Overall Study||117||
48464946|NCT00992264|101474296|FG005|STARTED|Overall Study||117||
48464947|NCT00992264|101474297|FG006|STARTED|Overall Study||116||
48464948|NCT00992264|101474298|FG007|STARTED|Overall Study||117||
48779620|NCT00982423|102252528|FG000|STARTED|Overall Study||13||
48779621|NCT00982423|102252529|FG001|STARTED|Overall Study||19||
48779622|NCT00982423|102252528|FG000|COMPLETED|Overall Study||13||
48779623|NCT00982423|102252529|FG001|COMPLETED|Overall Study||19||
48779624|NCT00982423|102252528|FG000|NOT COMPLETED|Overall Study||0||
48779625|NCT00982423|102252529|FG001|NOT COMPLETED|Overall Study||0||
48779626|NCT00634101|102252530|FG000|STARTED|Overall Study||66||
48779627|NCT00634101|102252531|FG001|STARTED|Overall Study||59||
48464949|NCT00992264|101474299|FG008|STARTED|Overall Study||116||
48464950|NCT00992264|101474300|FG009|STARTED|Overall Study||116||
48464951|NCT00992264|101474301|FG010|STARTED|Overall Study||117||
48464952|NCT00992264|101474302|FG011|STARTED|Overall Study||117||
48464953|NCT00992264|101474303|FG012|STARTED|Overall Study||116||
48464954|NCT00992264|101474304|FG013|STARTED|Overall Study||117||
48464955|NCT00992264|101474305|FG014|STARTED|Overall Study||117||
48464956|NCT00992264|101474306|FG015|STARTED|Overall Study||116||
48464957|NCT00992264|101474291|FG000|COMPLETED|Overall Study||116||
48464958|NCT00992264|101474292|FG001|COMPLETED|Overall Study||116||
48464959|NCT00992264|101474293|FG002|COMPLETED|Overall Study||117||
48464960|NCT00992264|101474294|FG003|COMPLETED|Overall Study||117||
48464961|NCT00992264|101474295|FG004|COMPLETED|Overall Study||117||
48464962|NCT00992264|101474296|FG005|COMPLETED|Overall Study||117||
48464963|NCT00992264|101474297|FG006|COMPLETED|Overall Study||116||
48464964|NCT00992264|101474298|FG007|COMPLETED|Overall Study||117||
48464965|NCT00992264|101474299|FG008|COMPLETED|Overall Study||116||
48464966|NCT00992264|101474300|FG009|COMPLETED|Overall Study||116||
48464967|NCT00992264|101474301|FG010|COMPLETED|Overall Study||117||
48464968|NCT00992264|101474302|FG011|COMPLETED|Overall Study||117||
48464969|NCT00992264|101474303|FG012|COMPLETED|Overall Study||116||
48464970|NCT00992264|101474304|FG013|COMPLETED|Overall Study||117||
48464971|NCT00992264|101474305|FG014|COMPLETED|Overall Study||117||
48464972|NCT00992264|101474306|FG015|COMPLETED|Overall Study||116||
48464973|NCT00992264|101474291|FG000|NOT COMPLETED|Overall Study||0||
48464974|NCT00992264|101474292|FG001|NOT COMPLETED|Overall Study||0||
48464975|NCT00992264|101474293|FG002|NOT COMPLETED|Overall Study||0||
48464976|NCT00992264|101474294|FG003|NOT COMPLETED|Overall Study||0||
48464977|NCT00992264|101474295|FG004|NOT COMPLETED|Overall Study||0||
48464978|NCT00992264|101474296|FG005|NOT COMPLETED|Overall Study||0||
48464979|NCT00992264|101474297|FG006|NOT COMPLETED|Overall Study||0||
48464980|NCT00992264|101474298|FG007|NOT COMPLETED|Overall Study||0||
48464981|NCT00992264|101474299|FG008|NOT COMPLETED|Overall Study||0||
48779628|NCT00634101|102252530|FG000|COMPLETED|Overall Study||61||
48464982|NCT00992264|101474300|FG009|NOT COMPLETED|Overall Study||0||
48464983|NCT00992264|101474301|FG010|NOT COMPLETED|Overall Study||0||
48464984|NCT00992264|101474302|FG011|NOT COMPLETED|Overall Study||0||
48464985|NCT00992264|101474303|FG012|NOT COMPLETED|Overall Study||0||
48464986|NCT00992264|101474304|FG013|NOT COMPLETED|Overall Study||0||
48464987|NCT00992264|101474305|FG014|NOT COMPLETED|Overall Study||0||
48464988|NCT00992264|101474306|FG015|NOT COMPLETED|Overall Study||0||
48464989|NCT02809183|101474307|FG000|STARTED|Overall Study||25||
48464990|NCT02809183|101474308|FG001|STARTED|Overall Study||25||
48464991|NCT02809183|101474309|FG002|STARTED|Overall Study||25||
48464992|NCT02809183|101474310|FG003|STARTED|Overall Study||26||
48464993|NCT02809183|101474311|FG004|STARTED|Overall Study||6||
48464994|NCT02809183|101474312|FG005|STARTED|Overall Study||28||
48464995|NCT02809183|101474307|FG000|COMPLETED|Overall Study||25||
48779629|NCT00634101|102252531|FG001|COMPLETED|Overall Study||56||
48464996|NCT02809183|101474308|FG001|COMPLETED|Overall Study||25||
48464997|NCT02809183|101474309|FG002|COMPLETED|Overall Study||25||
48464998|NCT02809183|101474310|FG003|COMPLETED|Overall Study||26||
48464999|NCT02809183|101474311|FG004|COMPLETED|Overall Study||6||
48779630|NCT00634101|102252530|FG000|NOT COMPLETED|Overall Study||5||
48779631|NCT00634101|102252531|FG001|NOT COMPLETED|Overall Study||3||
48779632|NCT01034670|102252532|FG000|STARTED|Overall Study||3||
48779633|NCT01034670|102252532|FG000|COMPLETED|Overall Study||3||
48779634|NCT01034670|102252532|FG000|NOT COMPLETED|Overall Study||0||
48465000|NCT02809183|101474312|FG005|COMPLETED|Overall Study||28||
48465001|NCT02809183|101474307|FG000|NOT COMPLETED|Overall Study||0||
48465002|NCT02809183|101474308|FG001|NOT COMPLETED|Overall Study||0||
48465003|NCT02809183|101474309|FG002|NOT COMPLETED|Overall Study||0||
48665556|NCT03384966|101964839|FG001|Pharmacokinetic Analysis Set|Treatment Period||115|The PK analysis set includes all participants from the SAF who have at least one plasma concentration measurement after administration of study treatment. Participants in the PK set were evaluated according to the actual treatment they received.|
48665557|NCT03384966|101964840|FG002|Pharmacokinetic Analysis Set|Treatment Period||0|The PK analysis set includes all participants from the SAF who have at least one plasma concentration measurement after administration of study treatment. Participants in the PK set were evaluated according to the actual treatment they received.|
48665558|NCT03384966|101964838|FG000|COMPLETED|Treatment Period||114||
48665559|NCT03384966|101964839|FG001|COMPLETED|Treatment Period||115||
48665560|NCT03384966|101964840|FG002|COMPLETED|Treatment Period||116||
48665561|NCT03384966|101964838|FG000|NOT COMPLETED|Treatment Period||0||
48665562|NCT03384966|101964839|FG001|NOT COMPLETED|Treatment Period||0||
48665563|NCT03384966|101964840|FG002|NOT COMPLETED|Treatment Period||0||
48665564|NCT03384966|101964838|FG000|STARTED|Follow-up Period||114||
48665565|NCT03384966|101964839|FG001|STARTED|Follow-up Period||115||
48779635|NCT00775593|102252533|FG000|STARTED|Overall Study||60||
48779636|NCT00775593|102252533|FG000|COMPLETED|Overall Study||53||
48779637|NCT00775593|102252533|FG000|NOT COMPLETED|Overall Study||7||
48779638|NCT04603027|102252534|FG000|STARTED|Overall Study||56||
48779639|NCT04603027|102252535|FG001|STARTED|Overall Study||28||
48465004|NCT02809183|101474310|FG003|NOT COMPLETED|Overall Study||0||
48665566|NCT03384966|101964840|FG002|STARTED|Follow-up Period||116||
48665567|NCT03384966|101964838|FG000|COMPLETED|Follow-up Period||113||
48779640|NCT04603027|102252536|FG002|STARTED|Overall Study||55||
48779641|NCT04603027|102252537|FG003|STARTED|Overall Study||27||
48779642|NCT04603027|102252538|FG004|STARTED|Overall Study||55||
48665568|NCT03384966|101964839|FG001|COMPLETED|Follow-up Period||115||
48665569|NCT03384966|101964840|FG002|COMPLETED|Follow-up Period||116||
48665570|NCT03384966|101964838|FG000|NOT COMPLETED|Follow-up Period||1||
48665571|NCT03384966|101964839|FG001|NOT COMPLETED|Follow-up Period||0||
48665572|NCT03384966|101964840|FG002|NOT COMPLETED|Follow-up Period||0||
48665573|NCT00321932|101964841|FG000|STARTED|Overall Study||29||
48665574|NCT00321932|101964842|FG001|STARTED|Overall Study||32||
48665575|NCT00321932|101964841|FG000|COMPLETED|Overall Study||19||
48665576|NCT00321932|101964842|FG001|COMPLETED|Overall Study||11||
48665577|NCT00321932|101964841|FG000|NOT COMPLETED|Overall Study||10||
48665578|NCT00321932|101964842|FG001|NOT COMPLETED|Overall Study||21||
48665579|NCT02078726|101964843|FG000|STARTED|Overall Study||64||
48665580|NCT02078726|101964844|FG001|STARTED|Overall Study||36||
48665581|NCT02078726|101964843|FG000|COMPLETED|Overall Study||64||
48665582|NCT02078726|101964844|FG001|COMPLETED|Overall Study||36||
48665583|NCT02078726|101964843|FG000|NOT COMPLETED|Overall Study||0||
48665584|NCT02078726|101964844|FG001|NOT COMPLETED|Overall Study||0||
48665585|NCT02697448|101964845|FG000|STARTED|Overall Study||67||
48665586|NCT02697448|101964846|FG001|STARTED|Overall Study||68||
48665587|NCT02697448|101964845|FG000|COMPLETED|Overall Study||62||
48779643|NCT04603027|102252539|FG005|STARTED|Overall Study||28||
48779644|NCT04603027|102252534|FG000|COMPLETED|Overall Study||40||
48665588|NCT02697448|101964846|FG001|COMPLETED|Overall Study||63||
48665589|NCT02697448|101964845|FG000|NOT COMPLETED|Overall Study||5||
48665590|NCT02697448|101964846|FG001|NOT COMPLETED|Overall Study||5||
48665591|NCT01422382|101964847|FG000|STARTED|NK-104 4mg Once Daily (QD)||28||
48665592|NCT01422382|101964847|FG000|COMPLETED|NK-104 4mg Once Daily (QD)||28||
48665593|NCT01422382|101964847|FG000|NOT COMPLETED|NK-104 4mg Once Daily (QD)||0||
48665594|NCT01422382|101964847|FG000|STARTED|Diltiazem 240 mg QD||28||
48665595|NCT01422382|101964847|FG000|COMPLETED|Diltiazem 240 mg QD||28||
48665596|NCT01422382|101964847|FG000|NOT COMPLETED|Diltiazem 240 mg QD||0||
48665597|NCT01422382|101964847|FG000|STARTED|NK-104 4mg QD and Diltiazem 240 mg QD||28||
48665598|NCT01422382|101964847|FG000|COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||27||
48665599|NCT01422382|101964847|FG000|NOT COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||1||
48665600|NCT00071032|101964848|FG000|STARTED|Overall Study||1007||
48665601|NCT00071032|101964849|FG001|STARTED|Overall Study||1009||
48665602|NCT00071032|101964848|FG000|COMPLETED|Overall Study||998||
48665603|NCT00071032|101964849|FG001|COMPLETED|Overall Study||1001||
48665604|NCT00071032|101964848|FG000|NOT COMPLETED|Overall Study||9||
48665605|NCT00071032|101964849|FG001|NOT COMPLETED|Overall Study||8||
48665606|NCT02516813|101964850|FG000|STARTED|Overall Study||7||
48665607|NCT02516813|101964851|FG001|STARTED|Overall Study||3||
48665608|NCT02516813|101964852|FG002|STARTED|Overall Study||3||
48665609|NCT02516813|101964853|FG003|STARTED|Overall Study||6||
48779645|NCT04603027|102252535|FG001|COMPLETED|Overall Study||20||
48779646|NCT04603027|102252536|FG002|COMPLETED|Overall Study||48||
48465005|NCT02809183|101474311|FG004|NOT COMPLETED|Overall Study||0||
48465006|NCT02809183|101474312|FG005|NOT COMPLETED|Overall Study||0||
48465007|NCT02261428|101474313|FG000|STARTED|Overall Study||10||
48465008|NCT02261428|101474314|FG001|STARTED|Overall Study||10||
48465009|NCT02261428|101474313|FG000|COMPLETED|Overall Study||10||
48465010|NCT02261428|101474314|FG001|COMPLETED|Overall Study||10||
48465011|NCT02261428|101474313|FG000|NOT COMPLETED|Overall Study||0||
48465012|NCT02261428|101474314|FG001|NOT COMPLETED|Overall Study||0||
48465013|NCT03256799|101474315|FG000|STARTED|Overall Study||1||
48465014|NCT03256799|101474315|FG000|COMPLETED|Overall Study||1||
48465015|NCT03256799|101474315|FG000|NOT COMPLETED|Overall Study||0||
48465016|NCT00635154|101474316|FG000|STARTED|Overall Study||54||
48465017|NCT00635154|101474316|FG000|COMPLETED|Overall Study||21||
48465018|NCT00635154|101474316|FG000|NOT COMPLETED|Overall Study||33||
48465019|NCT03083483|101474317|FG000|STARTED|Overall Study||24||
48465020|NCT03083483|101474318|FG001|STARTED|Overall Study||22||
48465021|NCT03083483|101474319|FG002|STARTED|Overall Study||23||
48779647|NCT04603027|102252537|FG003|COMPLETED|Overall Study||26||
48779648|NCT04603027|102252538|FG004|COMPLETED|Overall Study||42||
48779649|NCT04603027|102252539|FG005|COMPLETED|Overall Study||22||
48779650|NCT04603027|102252534|FG000|NOT COMPLETED|Overall Study||16||
48779651|NCT04603027|102252535|FG001|NOT COMPLETED|Overall Study||8||
48779652|NCT04603027|102252536|FG002|NOT COMPLETED|Overall Study||7||
48779653|NCT04603027|102252537|FG003|NOT COMPLETED|Overall Study||1||
48779654|NCT04603027|102252538|FG004|NOT COMPLETED|Overall Study||13||
48779655|NCT04603027|102252539|FG005|NOT COMPLETED|Overall Study||6||
48779656|NCT02609113|102252540|FG000|STARTED|Overall Study||11||
48779657|NCT02609113|102252541|FG001|STARTED|Overall Study||11||
48779658|NCT02609113|102252540|FG000|COMPLETED|Overall Study||9||
48779659|NCT02609113|102252541|FG001|COMPLETED|Overall Study||9||
48779660|NCT02609113|102252540|FG000|NOT COMPLETED|Overall Study||2||
48779661|NCT02609113|102252541|FG001|NOT COMPLETED|Overall Study||2||
48779662|NCT00771953|102252542|FG000|STARTED|Overall Study||36||
48779663|NCT00771953|102252543|FG001|STARTED|Overall Study||36||
48779664|NCT00771953|102252542|FG000|COMPLETED|Overall Study||26||
48779665|NCT00771953|102252543|FG001|COMPLETED|Overall Study||26||
48779666|NCT00771953|102252542|FG000|NOT COMPLETED|Overall Study||10||
48779667|NCT00771953|102252543|FG001|NOT COMPLETED|Overall Study||10||
48779668|NCT02744040|102252544|FG000|STARTED|Overall Study||28||
48779669|NCT02744040|102252545|FG001|STARTED|Overall Study||51||
48779670|NCT02744040|102252546|FG002|STARTED|Overall Study||72||
48779671|NCT02744040|102252544|FG000|COMPLETED|Overall Study||22||
48779672|NCT02744040|102252545|FG001|COMPLETED|Overall Study||40||
48779673|NCT02744040|102252546|FG002|COMPLETED|Overall Study||50||
48779674|NCT02744040|102252544|FG000|NOT COMPLETED|Overall Study||6||
48779675|NCT02744040|102252545|FG001|NOT COMPLETED|Overall Study||11||
48779676|NCT02744040|102252546|FG002|NOT COMPLETED|Overall Study||22||
48779677|NCT02420015|102252547|FG000|STARTED|Overall Study||21||
48779678|NCT02420015|102252548|FG001|STARTED|Overall Study||13||
48779679|NCT02420015|102252547|FG000|COMPLETED|Overall Study||21||
48779680|NCT02420015|102252548|FG001|COMPLETED|Overall Study||13||
48779681|NCT02420015|102252547|FG000|NOT COMPLETED|Overall Study||0||
48779682|NCT02420015|102252548|FG001|NOT COMPLETED|Overall Study||0||
48779683|NCT02057081|102252549|FG000|STARTED|Overall Study||136|Includes both veteran and partner participants|
48779684|NCT02057081|102252550|FG001|STARTED|Overall Study||112|Includes both veteran and partner participants|
48779685|NCT02057081|102252549|FG000|Completed Baseline|Overall Study||88|Veterans and partners who were consented, randomized, completed baseline and deemed eligible|
48779686|NCT02057081|102252550|FG001|Completed Baseline|Overall Study||80|Veterans and partners who were consented, randomized, completed baseline and deemed eligible|
48779687|NCT02057081|102252549|FG000|Post-Treatment Assessment|Overall Study||58|Includes both veteran and partner participants|
48779688|NCT02057081|102252550|FG001|Post-Treatment Assessment|Overall Study||52|Includes both veteran and partner participants|
48779689|NCT02057081|102252549|FG000|COMPLETED|Overall Study||46|Includes both veteran and partner participants|
48779690|NCT02057081|102252550|FG001|COMPLETED|Overall Study||44|Includes both veteran and partner participants|
48779691|NCT02057081|102252549|FG000|NOT COMPLETED|Overall Study||90||
48779692|NCT02057081|102252550|FG001|NOT COMPLETED|Overall Study||68||
48779693|NCT01864603|102252551|FG000|STARTED|Stage 1||79818||16
48779694|NCT01864603|102252552|FG001|STARTED|Stage 1||70577||16
48779695|NCT01864603|102252551|FG000|COMPLETED|Stage 1||71028||16
48465022|NCT03083483|101474317|FG000|COMPLETED|Overall Study||20||
48465023|NCT03083483|101474318|FG001|COMPLETED|Overall Study||20||
48779696|NCT01864603|102252552|FG001|COMPLETED|Stage 1||62912||16
48779697|NCT01864603|102252551|FG000|NOT COMPLETED|Stage 1||8790||0
48779698|NCT01864603|102252552|FG001|NOT COMPLETED|Stage 1||7665||0
48779699|NCT01864603|102252551|FG000|STARTED|Stage 2||91533||16
48779700|NCT01864603|102252552|FG001|STARTED|Stage 2||92558||16
48779701|NCT01864603|102252551|FG000|COMPLETED|Stage 2||5477||16
48779702|NCT01864603|102252552|FG001|COMPLETED|Stage 2||0||0
48465024|NCT03083483|101474319|FG002|COMPLETED|Overall Study||20||
48465025|NCT03083483|101474317|FG000|NOT COMPLETED|Overall Study||4||
48465026|NCT03083483|101474318|FG001|NOT COMPLETED|Overall Study||2||
48465027|NCT03083483|101474319|FG002|NOT COMPLETED|Overall Study||3||
48465028|NCT01387282|101474320|FG000|STARTED|Overall Study||330||
48465029|NCT01387282|101474321|FG001|STARTED|Overall Study||165||
48779703|NCT01864603|102252551|FG000|NOT COMPLETED|Stage 2||86056||0
48779704|NCT01864603|102252552|FG001|NOT COMPLETED|Stage 2||92558||16
48779705|NCT02791763|102252553|FG000|STARTED|Overall Study||149||
48779706|NCT02791763|102252554|FG001|STARTED|Overall Study||150||
48779707|NCT02791763|102252555|FG002|STARTED|Overall Study||56||
48779708|NCT02791763|102252553|FG000|COMPLETED|Overall Study||111||
48779709|NCT02791763|102252554|FG001|COMPLETED|Overall Study||113||
48779710|NCT02791763|102252555|FG002|COMPLETED|Overall Study||43||
48779711|NCT02791763|102252553|FG000|NOT COMPLETED|Overall Study||38||
48779712|NCT02791763|102252554|FG001|NOT COMPLETED|Overall Study||37||
48779713|NCT02791763|102252555|FG002|NOT COMPLETED|Overall Study||13||
48779714|NCT00001213|102252556|FG000|STARTED|Overall Study||328||
48779715|NCT00001213|102252556|FG000|COMPLETED|Overall Study||310||
48779716|NCT00001213|102252556|FG000|NOT COMPLETED|Overall Study||18||
48779717|NCT00194532|102252557|FG000|STARTED|Overall Study||150||
48779718|NCT00194532|102252558|FG001|STARTED|Overall Study||150||
48779719|NCT00194532|102252557|FG000|COMPLETED|Overall Study||150||
48779720|NCT00194532|102252558|FG001|COMPLETED|Overall Study||150||
48779721|NCT00194532|102252557|FG000|NOT COMPLETED|Overall Study||0||
48779722|NCT00194532|102252558|FG001|NOT COMPLETED|Overall Study||0||
48779723|NCT02538354|102252559|FG000|STARTED|Overall Study||40||
48779724|NCT02538354|102252560|FG001|STARTED|Overall Study||30||
48779725|NCT02538354|102252559|FG000|COMPLETED|Overall Study||40||
48779726|NCT02538354|102252560|FG001|COMPLETED|Overall Study||30||
48779727|NCT02538354|102252559|FG000|NOT COMPLETED|Overall Study||0||
48779728|NCT02538354|102252560|FG001|NOT COMPLETED|Overall Study||0||
48779729|NCT03237286|102252561|FG000|STARTED|Overall Study||53||
48779730|NCT03237286|102252562|FG001|STARTED|Overall Study||50||
48779731|NCT03237286|102252563|FG002|STARTED|Overall Study||51||
48779732|NCT03237286|102252561|FG000|COMPLETED|Overall Study||52||
48779733|NCT03237286|102252562|FG001|COMPLETED|Overall Study||50||
48779734|NCT03237286|102252563|FG002|COMPLETED|Overall Study||48||
48779735|NCT03237286|102252561|FG000|NOT COMPLETED|Overall Study||1||
48779736|NCT03237286|102252562|FG001|NOT COMPLETED|Overall Study||0||
48779737|NCT03237286|102252563|FG002|NOT COMPLETED|Overall Study||3||
48779738|NCT02409277|102252564|FG000|STARTED|Overall Study||267||
48779739|NCT02409277|102252565|FG001|STARTED|Overall Study||60||
48779740|NCT02409277|102252566|FG002|STARTED|Overall Study||599||
48779741|NCT02409277|102252564|FG000|3 Months Follow-up|Overall Study||178||
48779742|NCT02409277|102252565|FG001|3 Months Follow-up|Overall Study||40||
48779743|NCT02409277|102252566|FG002|3 Months Follow-up|Overall Study||599||
48779744|NCT02409277|102252564|FG000|6 Months Follow-up|Overall Study||182||
48779745|NCT02409277|102252565|FG001|6 Months Follow-up|Overall Study||42||
48779746|NCT02409277|102252566|FG002|6 Months Follow-up|Overall Study||599||
48779747|NCT02409277|102252564|FG000|12 Months Follow-up|Overall Study||167||
48779748|NCT02409277|102252565|FG001|12 Months Follow-up|Overall Study||43||
48779749|NCT02409277|102252566|FG002|12 Months Follow-up|Overall Study||599||
48779750|NCT02409277|102252564|FG000|COMPLETED|Overall Study||167||
48779751|NCT02409277|102252565|FG001|COMPLETED|Overall Study||43||
48779752|NCT02409277|102252566|FG002|COMPLETED|Overall Study||599||
48779753|NCT02409277|102252564|FG000|NOT COMPLETED|Overall Study||100||
48779754|NCT02409277|102252565|FG001|NOT COMPLETED|Overall Study||17||
48779755|NCT02409277|102252566|FG002|NOT COMPLETED|Overall Study||0||
48779756|NCT00742235|102252567|FG000|STARTED|Overall Study||32||
48779757|NCT00742235|102252568|FG001|STARTED|Overall Study||67||
48779758|NCT00742235|102252567|FG000|COMPLETED|Overall Study||32||
48779759|NCT00742235|102252568|FG001|COMPLETED|Overall Study||36||
48779760|NCT00742235|102252567|FG000|NOT COMPLETED|Overall Study||0||
48779761|NCT00742235|102252568|FG001|NOT COMPLETED|Overall Study||31||
48779762|NCT01950013|102252569|FG000|STARTED|Overall Study||15||
48779763|NCT01950013|102252570|FG001|STARTED|Overall Study||15||
48779764|NCT01950013|102252571|FG002|STARTED|Overall Study||15||
48779765|NCT01950013|102252569|FG000|COMPLETED|Overall Study||15||
48779766|NCT01950013|102252570|FG001|COMPLETED|Overall Study||13||
48779767|NCT01950013|102252571|FG002|COMPLETED|Overall Study||15||
48779768|NCT01950013|102252569|FG000|NOT COMPLETED|Overall Study||0||
48779769|NCT01950013|102252570|FG001|NOT COMPLETED|Overall Study||2||
48779770|NCT01950013|102252571|FG002|NOT COMPLETED|Overall Study||0||
48779771|NCT04629066|102252572|FG000|STARTED|Overall Study||7||
48779772|NCT04629066|102252573|FG001|STARTED|Overall Study||6||
48779773|NCT04629066|102252572|FG000|COMPLETED|Overall Study||4||
48779774|NCT04629066|102252573|FG001|COMPLETED|Overall Study||4||
48779775|NCT04629066|102252572|FG000|NOT COMPLETED|Overall Study||3||
48779776|NCT04629066|102252573|FG001|NOT COMPLETED|Overall Study||2||
48779777|NCT01763996|102252574|FG000|STARTED|Treatment Period 1||15||
48779778|NCT01763996|102252575|FG001|STARTED|Treatment Period 1||15||
48779779|NCT01763996|102252574|FG000|COMPLETED|Treatment Period 1||15||
48779780|NCT01763996|102252575|FG001|COMPLETED|Treatment Period 1||15||
48779781|NCT01763996|102252574|FG000|NOT COMPLETED|Treatment Period 1||0||
48370071|NCT01963117|101234811|FG000|STARTED|Overall Study||11||
48779782|NCT01763996|102252575|FG001|NOT COMPLETED|Treatment Period 1||0||
48779783|NCT01763996|102252574|FG000|STARTED|Treatment Period 2||15||
48779784|NCT01763996|102252575|FG001|STARTED|Treatment Period 2||15||
48465030|NCT01387282|101474320|FG000|ITT Population|Overall Study||330||
48465031|NCT01387282|101474321|FG001|ITT Population|Overall Study||165||
48465032|NCT01387282|101474320|FG000|MITT Population|Overall Study||268||
48465033|NCT01387282|101474321|FG001|MITT Population|Overall Study||136||
48465034|NCT01387282|101474320|FG000|Safety Population|Overall Study||330||
48465035|NCT01387282|101474321|FG001|Safety Population|Overall Study||161||
48465036|NCT01387282|101474320|FG000|COMPLETED|Overall Study||233|A patient was considered to have completed the study if the patient completed Week 12/Day 85 Visit.|
48465037|NCT01387282|101474321|FG001|COMPLETED|Overall Study||118|A patient was considered to have completed the study if the patient completed Week 12/Day 85 Visit.|
48465038|NCT01387282|101474320|FG000|NOT COMPLETED|Overall Study||97||
48465039|NCT01387282|101474321|FG001|NOT COMPLETED|Overall Study||47||
48465040|NCT00004143|101474322|FG000|STARTED|Overall Study||2||
48465041|NCT00004143|101474322|FG000|COMPLETED|Overall Study||2||
48465042|NCT00004143|101474322|FG000|NOT COMPLETED|Overall Study||0||
48465043|NCT03027661|101474323|FG000|STARTED|Overall Study||20||
48465044|NCT03027661|101474324|FG001|STARTED|Overall Study||21||
48465045|NCT03027661|101474323|FG000|COMPLETED|Overall Study||20||
48465046|NCT03027661|101474324|FG001|COMPLETED|Overall Study||21||
48465047|NCT03027661|101474323|FG000|NOT COMPLETED|Overall Study||0||
48465048|NCT03027661|101474324|FG001|NOT COMPLETED|Overall Study||0||
48465049|NCT04828161|101474325|FG000|STARTED|Overall Study||100|Randomized|
48465050|NCT04828161|101474326|FG001|STARTED|Overall Study||102|Randomized|
48465051|NCT04828161|101474327|FG002|STARTED|Overall Study||103|Randomized|
48465052|NCT04828161|101474328|FG003|STARTED|Overall Study||102|Randomized|
48465053|NCT04828161|101474325|FG000|COMPLETED|Overall Study||97||
48465054|NCT04828161|101474326|FG001|COMPLETED|Overall Study||95||
48465055|NCT04828161|101474327|FG002|COMPLETED|Overall Study||96||
48465056|NCT04828161|101474328|FG003|COMPLETED|Overall Study||94||
48465057|NCT04828161|101474325|FG000|NOT COMPLETED|Overall Study||3||
48465058|NCT04828161|101474326|FG001|NOT COMPLETED|Overall Study||7||
48465059|NCT04828161|101474327|FG002|NOT COMPLETED|Overall Study||7||
48465060|NCT04828161|101474328|FG003|NOT COMPLETED|Overall Study||8||
48465061|NCT03565211|101474329|FG000|STARTED|Overall Study||254||
48465062|NCT03565211|101474329|FG000|Modified Intention-to-treat (mITT)|Overall Study||243||
48465063|NCT03565211|101474329|FG000|COMPLETED|Overall Study||206||
48465064|NCT03565211|101474329|FG000|NOT COMPLETED|Overall Study||48||
48465065|NCT00434161|101474330|FG000|STARTED|Overall Study||109||
48465066|NCT00434161|101474331|FG001|STARTED|Overall Study||57||
48465067|NCT00434161|101474332|FG002|STARTED|Overall Study||115||
48465068|NCT00434161|101474330|FG000|COMPLETED|Overall Study||99||
48465069|NCT00434161|101474331|FG001|COMPLETED|Overall Study||54||
48465070|NCT00434161|101474332|FG002|COMPLETED|Overall Study||104||
48465071|NCT00434161|101474330|FG000|NOT COMPLETED|Overall Study||10||
48465072|NCT00434161|101474331|FG001|NOT COMPLETED|Overall Study||3||
48465073|NCT00434161|101474332|FG002|NOT COMPLETED|Overall Study||11||
48465074|NCT03495648|101474333|FG000|STARTED|Overall Study||60||
48465075|NCT03495648|101474334|FG001|STARTED|Overall Study||61||
48465076|NCT03495648|101474333|FG000|COMPLETED|Overall Study||60||
48465077|NCT03495648|101474334|FG001|COMPLETED|Overall Study||61||
48465078|NCT03495648|101474333|FG000|NOT COMPLETED|Overall Study||0||
48465079|NCT03495648|101474334|FG001|NOT COMPLETED|Overall Study||0||
48465080|NCT02736227|101474335|FG000|STARTED|Overall Study||5||
48465081|NCT02736227|101474336|FG001|STARTED|Overall Study||15||
48465082|NCT02736227|101474337|FG002|STARTED|Overall Study||8||
48465083|NCT02736227|101474335|FG000|COMPLETED|Overall Study||5||
48465084|NCT02736227|101474336|FG001|COMPLETED|Overall Study||15||
48465085|NCT02736227|101474337|FG002|COMPLETED|Overall Study||0||
48465086|NCT02736227|101474335|FG000|NOT COMPLETED|Overall Study||0||
48465087|NCT02736227|101474336|FG001|NOT COMPLETED|Overall Study||0||
48465088|NCT02736227|101474337|FG002|NOT COMPLETED|Overall Study||8||
48465089|NCT00429923|101474338|FG000|STARTED|Overall Study||57||
48465090|NCT00429923|101474339|FG001|STARTED|Overall Study||55||
48465091|NCT00429923|101474340|FG002|STARTED|Overall Study||107||
48465092|NCT00429923|101474338|FG000|COMPLETED|Overall Study||52||
48465093|NCT00429923|101474339|FG001|COMPLETED|Overall Study||51||
48465094|NCT00429923|101474340|FG002|COMPLETED|Overall Study||68||
48465095|NCT00429923|101474338|FG000|NOT COMPLETED|Overall Study||5||
48465096|NCT00429923|101474339|FG001|NOT COMPLETED|Overall Study||4||
48465097|NCT00429923|101474340|FG002|NOT COMPLETED|Overall Study||39||
48465098|NCT02784106|101474341|FG000|STARTED|Double-Blind Treatment Period (12 Weeks)||32||
48465099|NCT02784106|101474342|FG001|STARTED|Double-Blind Treatment Period (12 Weeks)||33||
48465100|NCT02784106|101474343|FG002|STARTED|Double-Blind Treatment Period (12 Weeks)||0||
48465101|NCT02784106|101474344|FG003|STARTED|Double-Blind Treatment Period (12 Weeks)||0||
48465102|NCT02784106|101474341|FG000|COMPLETED|Double-Blind Treatment Period (12 Weeks)||24||
48465103|NCT02784106|101474342|FG001|COMPLETED|Double-Blind Treatment Period (12 Weeks)||27||
48465104|NCT02784106|101474343|FG002|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0||
48465105|NCT02784106|101474344|FG003|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0||
48465106|NCT02784106|101474341|FG000|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||8||
48465107|NCT02784106|101474342|FG001|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||6||
48465108|NCT02784106|101474343|FG002|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0||
48665610|NCT02516813|101964854|FG004|STARTED|Overall Study||6||
48779785|NCT01763996|102252574|FG000|COMPLETED|Treatment Period 2||15||
48779786|NCT01763996|102252575|FG001|COMPLETED|Treatment Period 2||14||
48779787|NCT01763996|102252574|FG000|NOT COMPLETED|Treatment Period 2||0||
48779788|NCT01763996|102252575|FG001|NOT COMPLETED|Treatment Period 2||1||
48779789|NCT01088048|102252576|FG000|STARTED|Overall Study||51||
48779790|NCT01088048|102252577|FG001|STARTED|Overall Study||51||
48465109|NCT02784106|101474344|FG003|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0||
48465110|NCT02784106|101474341|FG000|STARTED|Open-Label Extension Period (26 Weeks)||0||
48465111|NCT02784106|101474342|FG001|STARTED|Open-Label Extension Period (26 Weeks)||0||
48465112|NCT02784106|101474343|FG002|STARTED|Open-Label Extension Period (26 Weeks)||18||
48465113|NCT02784106|101474344|FG003|STARTED|Open-Label Extension Period (26 Weeks)||21||
48465114|NCT02784106|101474341|FG000|COMPLETED|Open-Label Extension Period (26 Weeks)||0||
48465115|NCT02784106|101474342|FG001|COMPLETED|Open-Label Extension Period (26 Weeks)||0||
48465116|NCT02784106|101474343|FG002|COMPLETED|Open-Label Extension Period (26 Weeks)||15||
48465117|NCT02784106|101474344|FG003|COMPLETED|Open-Label Extension Period (26 Weeks)||19||
48465118|NCT02784106|101474341|FG000|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0||
48465119|NCT02784106|101474342|FG001|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0||
48465120|NCT02784106|101474343|FG002|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||3||
48465121|NCT02784106|101474344|FG003|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||2||
48465122|NCT03167099|101474345|FG000|STARTED|Overall Study||26||
48465123|NCT03167099|101474346|FG001|STARTED|Overall Study||27||
48465124|NCT03167099|101474345|FG000|COMPLETED|Overall Study||19||
48665611|NCT02516813|101964855|FG005|STARTED|Overall Study||3||
48665612|NCT02516813|101964856|FG006|STARTED|Overall Study||6||
48665613|NCT02516813|101964857|FG007|STARTED|Overall Study||8||
48665614|NCT02516813|101964858|FG008|STARTED|Overall Study||3||
48665615|NCT02516813|101964859|FG009|STARTED|Overall Study||3||
48779791|NCT01088048|102252578|FG002|STARTED|Overall Study||18||
48779792|NCT01088048|102252579|FG003|STARTED|Overall Study||18||
48779793|NCT01088048|102252580|FG004|STARTED|Overall Study||33||
48779794|NCT01088048|102252581|FG005|STARTED|Overall Study||21||
48779795|NCT01088048|102252582|FG006|STARTED|Overall Study||12||
48779796|NCT01088048|102252583|FG007|STARTED|Overall Study||15||
48779797|NCT01088048|102252584|FG008|STARTED|Overall Study||15||
48779798|NCT01088048|102252585|FG009|STARTED|Overall Study||7||
48779799|NCT01088048|102252576|FG000|Participants With CLL|Overall Study||19||
48779800|NCT01088048|102252577|FG001|Participants With CLL|Overall Study||18||
48779801|NCT01088048|102252578|FG002|Participants With CLL|Overall Study||0||
48779802|NCT01088048|102252579|FG003|Participants With CLL|Overall Study||0||
48779803|NCT01088048|102252580|FG004|Participants With CLL|Overall Study||15||
48779804|NCT01088048|102252581|FG005|Participants With CLL|Overall Study||21||
48779805|NCT01088048|102252582|FG006|Participants With CLL|Overall Study||12||
48779806|NCT01088048|102252583|FG007|Participants With CLL|Overall Study||15||
48370072|NCT01963117|101234811|FG000|COMPLETED|Overall Study||10||
48779807|NCT01088048|102252584|FG008|Participants With CLL|Overall Study||14||
48779808|NCT01088048|102252585|FG009|Participants With CLL|Overall Study||1||
48370073|NCT01963117|101234811|FG000|NOT COMPLETED|Overall Study||1||
48665616|NCT02516813|101964860|FG010|STARTED|Overall Study||3||
48665617|NCT02516813|101964861|FG011|STARTED|Overall Study||1||
48665618|NCT02516813|101964850|FG000|COMPLETED|Overall Study||7||
48665619|NCT02516813|101964851|FG001|COMPLETED|Overall Study||3||
48665620|NCT02516813|101964852|FG002|COMPLETED|Overall Study||3||
48665621|NCT02516813|101964853|FG003|COMPLETED|Overall Study||6||
48665622|NCT02516813|101964854|FG004|COMPLETED|Overall Study||6||
48779809|NCT01088048|102252576|FG000|Participants With Indolent NHL|Overall Study||32||
48779810|NCT01088048|102252577|FG001|Participants With Indolent NHL|Overall Study||33||
48779811|NCT01088048|102252578|FG002|Participants With Indolent NHL|Overall Study||0||
48665623|NCT02516813|101964855|FG005|COMPLETED|Overall Study||3||
48665624|NCT02516813|101964856|FG006|COMPLETED|Overall Study||6||
48465125|NCT03167099|101474346|FG001|COMPLETED|Overall Study||19||
48465126|NCT03167099|101474345|FG000|NOT COMPLETED|Overall Study||7||
48465127|NCT03167099|101474346|FG001|NOT COMPLETED|Overall Study||8||
48465128|NCT01966042|101474347|FG000|STARTED|Overall Study||13||
48465129|NCT01966042|101474347|FG000|COMPLETED|Overall Study||11||
48465130|NCT01966042|101474347|FG000|NOT COMPLETED|Overall Study||2||
48465131|NCT00553540|101474348|FG000|STARTED|Overall Study||25||
48465132|NCT00553540|101474349|FG001|STARTED|Overall Study||25||
48465133|NCT00553540|101474348|FG000|COMPLETED|Overall Study||23||
48465134|NCT00553540|101474349|FG001|COMPLETED|Overall Study||20||
48465135|NCT00553540|101474348|FG000|NOT COMPLETED|Overall Study||2||
48465136|NCT00553540|101474349|FG001|NOT COMPLETED|Overall Study||5||
48465137|NCT05266456|101474350|FG000|STARTED|Phase 1, Adults 18-49 Years of Age||16||
48465138|NCT05266456|101474351|FG001|STARTED|Phase 1, Adults 18-49 Years of Age||16||
48465139|NCT05266456|101474352|FG002|STARTED|Phase 1, Adults 18-49 Years of Age||16||
48465140|NCT05266456|101474353|FG003|STARTED|Phase 1, Adults 18-49 Years of Age||16||
48465141|NCT05266456|101474350|FG000|COMPLETED|Phase 1, Adults 18-49 Years of Age||15||
48465142|NCT05266456|101474351|FG001|COMPLETED|Phase 1, Adults 18-49 Years of Age||15||
48465143|NCT05266456|101474352|FG002|COMPLETED|Phase 1, Adults 18-49 Years of Age||16||
48465144|NCT05266456|101474353|FG003|COMPLETED|Phase 1, Adults 18-49 Years of Age||15||
48465145|NCT05266456|101474350|FG000|NOT COMPLETED|Phase 1, Adults 18-49 Years of Age||1||
48465146|NCT05266456|101474351|FG001|NOT COMPLETED|Phase 1, Adults 18-49 Years of Age||1||
48465147|NCT05266456|101474352|FG002|NOT COMPLETED|Phase 1, Adults 18-49 Years of Age||0||
48465148|NCT05266456|101474353|FG003|NOT COMPLETED|Phase 1, Adults 18-49 Years of Age||1||
48465149|NCT05266456|101474350|FG000|STARTED|Phase 2, Adults 50-64 Years||193||
48465150|NCT05266456|101474351|FG001|STARTED|Phase 2, Adults 50-64 Years||192||
48465151|NCT05266456|101474352|FG002|STARTED|Phase 2, Adults 50-64 Years||192||
48465152|NCT05266456|101474353|FG003|STARTED|Phase 2, Adults 50-64 Years||194||
48465153|NCT05266456|101474350|FG000|COMPLETED|Phase 2, Adults 50-64 Years||186||
48465154|NCT05266456|101474351|FG001|COMPLETED|Phase 2, Adults 50-64 Years||186||
48465155|NCT05266456|101474352|FG002|COMPLETED|Phase 2, Adults 50-64 Years||187||
48465156|NCT05266456|101474353|FG003|COMPLETED|Phase 2, Adults 50-64 Years||192||
48465157|NCT05266456|101474350|FG000|NOT COMPLETED|Phase 2, Adults 50-64 Years||7||
48465158|NCT05266456|101474351|FG001|NOT COMPLETED|Phase 2, Adults 50-64 Years||6||
48465159|NCT05266456|101474352|FG002|NOT COMPLETED|Phase 2, Adults 50-64 Years||5||
48465160|NCT05266456|101474353|FG003|NOT COMPLETED|Phase 2, Adults 50-64 Years||2||
48465161|NCT01215942|101474354|FG000|STARTED|Treatment Period||414||
48465162|NCT01215942|101474355|FG001|STARTED|Treatment Period||672||
48465163|NCT01215942|101474354|FG000|COMPLETED|Treatment Period||0||
48465164|NCT01215942|101474355|FG001|COMPLETED|Treatment Period||0||
48465165|NCT01215942|101474354|FG000|NOT COMPLETED|Treatment Period||414||
48465166|NCT01215942|101474355|FG001|NOT COMPLETED|Treatment Period||672||
48465167|NCT01215942|101474354|FG000|STARTED|Post-Treatment Follow-Up Period||368||
48465168|NCT01215942|101474355|FG001|STARTED|Post-Treatment Follow-Up Period||591||
48465169|NCT01215942|101474354|FG000|COMPLETED|Post-Treatment Follow-Up Period||283||
48465170|NCT01215942|101474355|FG001|COMPLETED|Post-Treatment Follow-Up Period||445||
48465171|NCT01215942|101474354|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||85||
48465172|NCT01215942|101474355|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||146||
48465173|NCT03051256|101474356|FG000|STARTED|Overall Study||19||
48465174|NCT03051256|101474357|FG001|STARTED|Overall Study||21||
48465175|NCT03051256|101474358|FG002|STARTED|Overall Study||22||
48465176|NCT03051256|101474356|FG000|COMPLETED|Overall Study||19|Day 7|
48465177|NCT03051256|101474357|FG001|COMPLETED|Overall Study||21|Day 7|
48465178|NCT03051256|101474358|FG002|COMPLETED|Overall Study||21|Day 7|
48465179|NCT03051256|101474356|FG000|NOT COMPLETED|Overall Study||0||
48465180|NCT03051256|101474357|FG001|NOT COMPLETED|Overall Study||0||
48465181|NCT03051256|101474358|FG002|NOT COMPLETED|Overall Study||1||
48465182|NCT02334059|101474359|FG000|STARTED|Overall Study||37||
48465183|NCT02334059|101474360|FG001|STARTED|Overall Study||34||
48465184|NCT02334059|101474361|FG002|STARTED|Overall Study||37||
48465185|NCT02334059|101474359|FG000|COMPLETED|Overall Study||37||
48465186|NCT02334059|101474360|FG001|COMPLETED|Overall Study||34||
48665625|NCT02516813|101964857|FG007|COMPLETED|Overall Study||8||
48665626|NCT02516813|101964858|FG008|COMPLETED|Overall Study||3||
48665627|NCT02516813|101964859|FG009|COMPLETED|Overall Study||3||
48370074|NCT01515176|101234812|FG000|STARTED|Overall Study||4||
48665628|NCT02516813|101964860|FG010|COMPLETED|Overall Study||3||
48665629|NCT02516813|101964861|FG011|COMPLETED|Overall Study||1||
48665630|NCT02516813|101964850|FG000|NOT COMPLETED|Overall Study||0||
48665631|NCT02516813|101964851|FG001|NOT COMPLETED|Overall Study||0||
48665632|NCT02516813|101964852|FG002|NOT COMPLETED|Overall Study||0||
48665633|NCT02516813|101964853|FG003|NOT COMPLETED|Overall Study||0||
48665634|NCT02516813|101964854|FG004|NOT COMPLETED|Overall Study||0||
48665635|NCT02516813|101964855|FG005|NOT COMPLETED|Overall Study||0||
48665636|NCT02516813|101964856|FG006|NOT COMPLETED|Overall Study||0||
48465187|NCT02334059|101474361|FG002|COMPLETED|Overall Study||37||
48465188|NCT02334059|101474359|FG000|NOT COMPLETED|Overall Study||0||
48465189|NCT02334059|101474360|FG001|NOT COMPLETED|Overall Study||0||
48465190|NCT02334059|101474361|FG002|NOT COMPLETED|Overall Study||0||
48665637|NCT02516813|101964857|FG007|NOT COMPLETED|Overall Study||0||
48465191|NCT03175120|101474362|FG000|STARTED|Overall Study||302||
48465192|NCT03175120|101474363|FG001|STARTED|Overall Study||151||
48465193|NCT03175120|101474362|FG000|Treated|Overall Study||301||
48465194|NCT03175120|101474363|FG001|Treated|Overall Study||151||
48465195|NCT03175120|101474362|FG000|Full Analysis Set (FAS)|Overall Study||302|FAS included all randomised participants.|
48465196|NCT03175120|101474363|FG001|Full Analysis Set (FAS)|Overall Study||151|FAS included all randomised participants.|
48465197|NCT03175120|101474362|FG000|Safety Analysis Set (SAS)|Overall Study||301|SAS included all participants who received at least one dose of IDegLira or IDeg.|
48465198|NCT03175120|101474363|FG001|Safety Analysis Set (SAS)|Overall Study||151|SAS included all participants who received at least one dose of IDegLira or IDeg.|
48465199|NCT03175120|101474362|FG000|COMPLETED|Overall Study||290||
48465200|NCT03175120|101474363|FG001|COMPLETED|Overall Study||139||
48465201|NCT03175120|101474362|FG000|NOT COMPLETED|Overall Study||12||
48465202|NCT03175120|101474363|FG001|NOT COMPLETED|Overall Study||12||
48465203|NCT00444795|101474364|FG000|STARTED|Overall Study||620||
48465204|NCT00444795|101474364|FG000|COMPLETED|Overall Study||617||
48465205|NCT00444795|101474364|FG000|NOT COMPLETED|Overall Study||3||
48465206|NCT00760383|101474365|FG000|STARTED|Overall Study||21||
48465207|NCT00760383|101474366|FG001|STARTED|Overall Study||19||
48665638|NCT02516813|101964858|FG008|NOT COMPLETED|Overall Study||0||
48665639|NCT02516813|101964859|FG009|NOT COMPLETED|Overall Study||0||
48665640|NCT02516813|101964860|FG010|NOT COMPLETED|Overall Study||0||
48665641|NCT02516813|101964861|FG011|NOT COMPLETED|Overall Study||0||
48665642|NCT00143845|101967380|FG000|STARTED|Overall Study||54||
48665643|NCT00143845|101967380|FG000|COMPLETED|Overall Study||54||
48665644|NCT00143845|101967380|FG000|NOT COMPLETED|Overall Study||0||
48665645|NCT05878067|101967381|FG000|STARTED|Overall Study||40||
48665646|NCT05878067|101967381|FG000|COMPLETED|Overall Study||38||
48665647|NCT05878067|101967381|FG000|NOT COMPLETED|Overall Study||2||
48665648|NCT03636022|101967382|FG000|STARTED|Overall Study||25||
48665649|NCT03636022|101967383|FG001|STARTED|Overall Study||20||
48665650|NCT03636022|101967382|FG000|COMPLETED|Overall Study||24||
48665651|NCT03636022|101967383|FG001|COMPLETED|Overall Study||17||
48665652|NCT03636022|101967382|FG000|NOT COMPLETED|Overall Study||1||
48779812|NCT01088048|102252579|FG003|Participants With Indolent NHL|Overall Study||0||
48779813|NCT01088048|102252580|FG004|Participants With Indolent NHL|Overall Study||14||
48779814|NCT01088048|102252581|FG005|Participants With Indolent NHL|Overall Study||0||
48779815|NCT01088048|102252582|FG006|Participants With Indolent NHL|Overall Study||0||
48665653|NCT03636022|101967383|FG001|NOT COMPLETED|Overall Study||3||
48665654|NCT02329587|101967384|FG000|STARTED|Baseline Thru Post-treatment Assessment||5||
48665655|NCT02329587|101967385|FG001|STARTED|Baseline Thru Post-treatment Assessment||7||
48665656|NCT02329587|101967384|FG000|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||3||
48665657|NCT02329587|101967385|FG001|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||4||
48665658|NCT02329587|101967384|FG000|COMPLETED|Baseline Thru Post-treatment Assessment||4||
48665659|NCT02329587|101967385|FG001|COMPLETED|Baseline Thru Post-treatment Assessment||6||
48665660|NCT02329587|101967384|FG000|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1||
48665661|NCT02329587|101967385|FG001|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1||
48665662|NCT02329587|101967384|FG000|STARTED|1-month Follow-up||4||
48665663|NCT02329587|101967385|FG001|STARTED|1-month Follow-up||6||
48665664|NCT02329587|101967384|FG000|COMPLETED|1-month Follow-up||4||
48665665|NCT02329587|101967385|FG001|COMPLETED|1-month Follow-up||5||
48665666|NCT02329587|101967384|FG000|NOT COMPLETED|1-month Follow-up||0||
48665667|NCT02329587|101967385|FG001|NOT COMPLETED|1-month Follow-up||1||
48665668|NCT01661595|101967386|FG000|STARTED|Phase 1: Week 0-4||5||
48665669|NCT01661595|101967387|FG001|STARTED|Phase 1: Week 0-4||4||
48665670|NCT01661595|101967388|FG002|STARTED|Phase 1: Week 0-4||5||
48665671|NCT01661595|101967389|FG003|STARTED|Phase 1: Week 0-4||4||
48665672|NCT01661595|101967386|FG000|COMPLETED|Phase 1: Week 0-4||4||
48665673|NCT01661595|101967387|FG001|COMPLETED|Phase 1: Week 0-4||4||
48665674|NCT01661595|101967388|FG002|COMPLETED|Phase 1: Week 0-4||5||
48665675|NCT01661595|101967389|FG003|COMPLETED|Phase 1: Week 0-4||4||
48665676|NCT01661595|101967386|FG000|NOT COMPLETED|Phase 1: Week 0-4||1||
48665677|NCT01661595|101967387|FG001|NOT COMPLETED|Phase 1: Week 0-4||0||
48665678|NCT01661595|101967388|FG002|NOT COMPLETED|Phase 1: Week 0-4||0||
48665679|NCT01661595|101967389|FG003|NOT COMPLETED|Phase 1: Week 0-4||0||
48665680|NCT01661595|101967386|FG000|STARTED|Phase 2: Week 5-8.||4||
48665681|NCT01661595|101967387|FG001|STARTED|Phase 2: Week 5-8.||4||
48665682|NCT01661595|101967388|FG002|STARTED|Phase 2: Week 5-8.||5||
48665683|NCT01661595|101967389|FG003|STARTED|Phase 2: Week 5-8.||4||
48665684|NCT01661595|101967386|FG000|COMPLETED|Phase 2: Week 5-8.||4||
48665685|NCT01661595|101967387|FG001|COMPLETED|Phase 2: Week 5-8.||4||
48665686|NCT01661595|101967388|FG002|COMPLETED|Phase 2: Week 5-8.||4||
48665687|NCT01661595|101967389|FG003|COMPLETED|Phase 2: Week 5-8.||4||
48665688|NCT01661595|101967386|FG000|NOT COMPLETED|Phase 2: Week 5-8.||0||
48665689|NCT01661595|101967387|FG001|NOT COMPLETED|Phase 2: Week 5-8.||0||
48779816|NCT01088048|102252583|FG007|Participants With Indolent NHL|Overall Study||0||
48779817|NCT01088048|102252584|FG008|Participants With Indolent NHL|Overall Study||1||
48779818|NCT01088048|102252585|FG009|Participants With Indolent NHL|Overall Study||6||
48779819|NCT01088048|102252576|FG000|Participants With MCL|Overall Study||0||
48779820|NCT01088048|102252577|FG001|Participants With MCL|Overall Study||0||
48779821|NCT01088048|102252578|FG002|Participants With MCL|Overall Study||18||
48779822|NCT01088048|102252579|FG003|Participants With MCL|Overall Study||18||
48779823|NCT01088048|102252580|FG004|Participants With MCL|Overall Study||4||
48779824|NCT01088048|102252581|FG005|Participants With MCL|Overall Study||0||
48779825|NCT01088048|102252582|FG006|Participants With MCL|Overall Study||0||
48779826|NCT01088048|102252583|FG007|Participants With MCL|Overall Study||0||
48779827|NCT01088048|102252584|FG008|Participants With MCL|Overall Study||0||
48779828|NCT01088048|102252585|FG009|Participants With MCL|Overall Study||0||
48779829|NCT01088048|102252576|FG000|COMPLETED|Overall Study||29||
48779830|NCT01088048|102252577|FG001|COMPLETED|Overall Study||24||
48779831|NCT01088048|102252578|FG002|COMPLETED|Overall Study||4||
48779832|NCT01088048|102252579|FG003|COMPLETED|Overall Study||4||
48779833|NCT01088048|102252580|FG004|COMPLETED|Overall Study||16||
48779834|NCT01088048|102252581|FG005|COMPLETED|Overall Study||10||
48779835|NCT01088048|102252582|FG006|COMPLETED|Overall Study||6||
48779836|NCT01088048|102252583|FG007|COMPLETED|Overall Study||10||
48779837|NCT01088048|102252584|FG008|COMPLETED|Overall Study||8||
48779838|NCT01088048|102252585|FG009|COMPLETED|Overall Study||3||
48779839|NCT01088048|102252576|FG000|NOT COMPLETED|Overall Study||22||
48779840|NCT01088048|102252577|FG001|NOT COMPLETED|Overall Study||27||
48779841|NCT01088048|102252578|FG002|NOT COMPLETED|Overall Study||14||
48779842|NCT01088048|102252579|FG003|NOT COMPLETED|Overall Study||14||
48779843|NCT01088048|102252580|FG004|NOT COMPLETED|Overall Study||17||
48779844|NCT01088048|102252581|FG005|NOT COMPLETED|Overall Study||11||
48779845|NCT01088048|102252582|FG006|NOT COMPLETED|Overall Study||6||
48779846|NCT01088048|102252583|FG007|NOT COMPLETED|Overall Study||5||
48779847|NCT01088048|102252584|FG008|NOT COMPLETED|Overall Study||7||
48779848|NCT01088048|102252585|FG009|NOT COMPLETED|Overall Study||4||
48779849|NCT04463069|102252586|FG000|STARTED|Overall Study||41||
48779850|NCT04463069|102252587|FG001|STARTED|Overall Study||45||
48779851|NCT04463069|102252586|FG000|COMPLETED|Overall Study||39||
48779852|NCT04463069|102252587|FG001|COMPLETED|Overall Study||22||
48779853|NCT04463069|102252586|FG000|NOT COMPLETED|Overall Study||2||
48779854|NCT04463069|102252587|FG001|NOT COMPLETED|Overall Study||23||
48779855|NCT00122980|102252588|FG000|STARTED|Overall Study||67||
48779856|NCT00122980|102252589|FG001|STARTED|Overall Study||66||
48779857|NCT00122980|102252588|FG000|COMPLETED|Overall Study||24||
48779858|NCT00122980|102252589|FG001|COMPLETED|Overall Study||26||
48779859|NCT00122980|102252588|FG000|NOT COMPLETED|Overall Study||43||
48779860|NCT00122980|102252589|FG001|NOT COMPLETED|Overall Study||40||
48779861|NCT03554486|102252590|FG000|STARTED|Run-in Period (2 Weeks)||24||
48779862|NCT03554486|102252591|FG001|STARTED|Run-in Period (2 Weeks)||0||
48779863|NCT03554486|102252592|FG002|STARTED|Run-in Period (2 Weeks)||0||
48779864|NCT03554486|102252590|FG000|COMPLETED|Run-in Period (2 Weeks)||21||
48779865|NCT03554486|102252591|FG001|COMPLETED|Run-in Period (2 Weeks)||0||
48779866|NCT03554486|102252592|FG002|COMPLETED|Run-in Period (2 Weeks)||0||
48779867|NCT03554486|102252590|FG000|NOT COMPLETED|Run-in Period (2 Weeks)||3||
48779868|NCT03554486|102252591|FG001|NOT COMPLETED|Run-in Period (2 Weeks)||0||
48779869|NCT03554486|102252592|FG002|NOT COMPLETED|Run-in Period (2 Weeks)||0||
48779870|NCT03554486|102252590|FG000|STARTED|Treatment Period 1 (2 Weeks)||0||
48779871|NCT03554486|102252591|FG001|STARTED|Treatment Period 1 (2 Weeks)||11||
48779872|NCT03554486|102252592|FG002|STARTED|Treatment Period 1 (2 Weeks)||10||
48779873|NCT03554486|102252590|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||0||
48779874|NCT03554486|102252591|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||10||
48779875|NCT03554486|102252592|FG002|COMPLETED|Treatment Period 1 (2 Weeks)||9||
48779876|NCT03554486|102252590|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0||
48779877|NCT03554486|102252591|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1||
48779878|NCT03554486|102252592|FG002|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1||
48779879|NCT03554486|102252590|FG000|STARTED|Treatment Period 2 (2 Weeks)||0||
48779880|NCT03554486|102252591|FG001|STARTED|Treatment Period 2 (2 Weeks)||10||
48779881|NCT03554486|102252592|FG002|STARTED|Treatment Period 2 (2 Weeks)||9||
48779882|NCT03554486|102252590|FG000|COMPLETED|Treatment Period 2 (2 Weeks)||0||
48779883|NCT03554486|102252591|FG001|COMPLETED|Treatment Period 2 (2 Weeks)||10||
48779884|NCT03554486|102252592|FG002|COMPLETED|Treatment Period 2 (2 Weeks)||9||
48779885|NCT03554486|102252590|FG000|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0||
48779886|NCT03554486|102252591|FG001|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0||
48779887|NCT03554486|102252592|FG002|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0||
48779888|NCT03783078|102252593|FG000|STARTED|Overall Study||55||
48779889|NCT03783078|102252593|FG000|COMPLETED|Overall Study||0||
48779890|NCT03783078|102252593|FG000|NOT COMPLETED|Overall Study||55||
48779891|NCT01358721|102252594|FG000|STARTED|Overall Study||22||
48779892|NCT01358721|102252595|FG001|STARTED|Overall Study||22||
48779893|NCT01358721|102252596|FG002|STARTED|Overall Study||23||
48779894|NCT01358721|102252597|FG003|STARTED|Overall Study||24||
48779895|NCT01358721|102252594|FG000|COMPLETED|Overall Study||1|Completed = continuing in the treatment period|
48779896|NCT01358721|102252595|FG001|COMPLETED|Overall Study||0|Completed = continuing in the treatment period|
48779897|NCT01358721|102252596|FG002|COMPLETED|Overall Study||1|Completed = continuing in the treatment period|
48779898|NCT01358721|102252597|FG003|COMPLETED|Overall Study||0|Completed = continuing in the treatment period|
48779899|NCT01358721|102252594|FG000|NOT COMPLETED|Overall Study||21||
48779900|NCT01358721|102252595|FG001|NOT COMPLETED|Overall Study||22||
48779901|NCT01358721|102252596|FG002|NOT COMPLETED|Overall Study||22||
48779902|NCT01358721|102252597|FG003|NOT COMPLETED|Overall Study||24||
48779903|NCT01014351|102252598|FG000|STARTED|Overall Study||70||
48779904|NCT01014351|102252598|FG000|COMPLETED|Overall Study||33||
48779905|NCT01014351|102252598|FG000|NOT COMPLETED|Overall Study||37||
48779906|NCT01215097|102252599|FG000|STARTED|Overall Study||100||
48779907|NCT01215097|102252600|FG001|STARTED|Overall Study||205||
48779908|NCT01215097|102252599|FG000|COMPLETED|Overall Study||88||
48779909|NCT01215097|102252600|FG001|COMPLETED|Overall Study||191||
48779910|NCT01215097|102252599|FG000|NOT COMPLETED|Overall Study||12||
48779911|NCT01215097|102252600|FG001|NOT COMPLETED|Overall Study||14||
48779912|NCT02644109|102252601|FG000|STARTED|Overall Study||24||
48779913|NCT02644109|102252602|FG001|STARTED|Overall Study||28||
48779914|NCT02644109|102252601|FG000|COMPLETED|Overall Study||24||
48779915|NCT02644109|102252602|FG001|COMPLETED|Overall Study||24||
48779916|NCT02644109|102252601|FG000|NOT COMPLETED|Overall Study||0||
48189813|NCT03283553|100786315|FG001|STARTED|Care Partner Participant Flow||63|Patients and Care Partners were distinctly contacted for baseline and follow up, so the participation of one was not necessarily contingent on the participation of the other.|
48189814|NCT03283553|100786314|FG000|Care Partner Baseline Interview|Care Partner Participant Flow||69||
48370075|NCT01515176|101234813|FG001|STARTED|Overall Study||32||
48465208|NCT00760383|101474365|FG000|COMPLETED|Overall Study||16||
48465209|NCT00760383|101474366|FG001|COMPLETED|Overall Study||12||
48465210|NCT00760383|101474365|FG000|NOT COMPLETED|Overall Study||5||
48465211|NCT00760383|101474366|FG001|NOT COMPLETED|Overall Study||7||
48465212|NCT02059993|101474367|FG000|STARTED|Overall Study||42||
48465213|NCT02059993|101474368|FG001|STARTED|Overall Study||41||
48465214|NCT02059993|101474367|FG000|COMPLETED|Overall Study||40||
48465215|NCT02059993|101474368|FG001|COMPLETED|Overall Study||37||
48465216|NCT02059993|101474367|FG000|NOT COMPLETED|Overall Study||2||
48465217|NCT02059993|101474368|FG001|NOT COMPLETED|Overall Study||4||
48465218|NCT01059071|101474369|FG000|STARTED|Overall Study||4||
48465219|NCT01059071|101474370|FG001|STARTED|Overall Study||5||
48465220|NCT01059071|101474371|FG002|STARTED|Overall Study||3||
48465221|NCT01059071|101474372|FG003|STARTED|Overall Study||9||
48465222|NCT01059071|101474369|FG000|COMPLETED|Overall Study||2||
48665690|NCT01661595|101967388|FG002|NOT COMPLETED|Phase 2: Week 5-8.||1||
48665691|NCT01661595|101967389|FG003|NOT COMPLETED|Phase 2: Week 5-8.||0||
48665692|NCT01651208|101967390|FG000|STARTED|Overall Study||227||
48665693|NCT01651208|101967391|FG001|STARTED|Overall Study||225||
48665694|NCT01651208|101967390|FG000|COMPLETED|Overall Study||213||
48665695|NCT01651208|101967391|FG001|COMPLETED|Overall Study||209||
48665696|NCT01651208|101967390|FG000|NOT COMPLETED|Overall Study||14||
48665697|NCT01651208|101967391|FG001|NOT COMPLETED|Overall Study||16||
48665698|NCT00928772|101967392|FG000|STARTED|Overall Study||39||
48465223|NCT01059071|101474370|FG001|COMPLETED|Overall Study||1||
48465224|NCT01059071|101474371|FG002|COMPLETED|Overall Study||1||
48465225|NCT01059071|101474372|FG003|COMPLETED|Overall Study||3||
48465226|NCT01059071|101474369|FG000|NOT COMPLETED|Overall Study||2||
48465227|NCT01059071|101474370|FG001|NOT COMPLETED|Overall Study||4||
48465228|NCT01059071|101474371|FG002|NOT COMPLETED|Overall Study||2||
48465229|NCT01059071|101474372|FG003|NOT COMPLETED|Overall Study||6||
48465230|NCT02006706|101474373|FG000|STARTED|Overall Study||15||
48465231|NCT02006706|101474373|FG000|COMPLETED|Overall Study||14||
48465232|NCT02006706|101474373|FG000|NOT COMPLETED|Overall Study||1||
48465233|NCT02708277|101474374|FG000|STARTED|Overall Study||50||
48465234|NCT02708277|101474375|FG001|STARTED|Overall Study||43||
48465235|NCT02708277|101474374|FG000|COMPLETED|Overall Study||43||
48465236|NCT02708277|101474375|FG001|COMPLETED|Overall Study||39||
48465237|NCT02708277|101474374|FG000|NOT COMPLETED|Overall Study||7||
48465238|NCT02708277|101474375|FG001|NOT COMPLETED|Overall Study||4||
48465239|NCT00962000|101474376|FG000|STARTED|Period 1 - 1 Week||21||
48465240|NCT00962000|101474377|FG001|STARTED|Period 1 - 1 Week||21||
48465241|NCT00962000|101474376|FG000|COMPLETED|Period 1 - 1 Week||21||
48465242|NCT00962000|101474377|FG001|COMPLETED|Period 1 - 1 Week||21||
48465243|NCT00962000|101474376|FG000|NOT COMPLETED|Period 1 - 1 Week||0||
48465244|NCT00962000|101474377|FG001|NOT COMPLETED|Period 1 - 1 Week||0||
48465245|NCT00962000|101474376|FG000|STARTED|Period 2 - 1 Week||21||
48465246|NCT00962000|101474377|FG001|STARTED|Period 2 - 1 Week||21||
48465247|NCT00962000|101474376|FG000|COMPLETED|Period 2 - 1 Week||21||
48465248|NCT00962000|101474377|FG001|COMPLETED|Period 2 - 1 Week||21||
48465249|NCT00962000|101474376|FG000|NOT COMPLETED|Period 2 - 1 Week||0||
48465250|NCT00962000|101474377|FG001|NOT COMPLETED|Period 2 - 1 Week||0||
48465251|NCT00962000|101474376|FG000|STARTED|Period 3 - 1 Week||21||
48665699|NCT00928772|101967393|FG001|STARTED|Overall Study||38||
48665700|NCT00928772|101967394|FG002|STARTED|Overall Study||38||
48779917|NCT02644109|102252602|FG001|NOT COMPLETED|Overall Study||4||
48779918|NCT02369744|102252603|FG000|STARTED|Overall Study||0||
48779919|NCT02369744|102252604|FG001|STARTED|Overall Study||0||
48779920|NCT02369744|102252603|FG000|COMPLETED|Overall Study||0||
48779921|NCT02369744|102252604|FG001|COMPLETED|Overall Study||0||
48779922|NCT02369744|102252603|FG000|NOT COMPLETED|Overall Study||0||
48779923|NCT02369744|102252604|FG001|NOT COMPLETED|Overall Study||0||
48465252|NCT00962000|101474377|FG001|STARTED|Period 3 - 1 Week||21||
48465253|NCT00962000|101474376|FG000|COMPLETED|Period 3 - 1 Week||21||
48465254|NCT00962000|101474377|FG001|COMPLETED|Period 3 - 1 Week||21||
48465255|NCT00962000|101474376|FG000|NOT COMPLETED|Period 3 - 1 Week||0||
48465256|NCT00962000|101474377|FG001|NOT COMPLETED|Period 3 - 1 Week||0||
48779924|NCT00202878|102252605|FG000|STARTED|Overall Study||9067||
48779925|NCT00202878|102252606|FG001|STARTED|Overall Study||9077||
48779926|NCT00202878|102252605|FG000|COMPLETED|Overall Study||6868||
48779927|NCT00202878|102252606|FG001|COMPLETED|Overall Study||6860||
48779928|NCT00202878|102252605|FG000|NOT COMPLETED|Overall Study||2199||
48779929|NCT00202878|102252606|FG001|NOT COMPLETED|Overall Study||2217||
48779930|NCT00950859|102252607|FG000|STARTED|Overall Study||27||
48779931|NCT00950859|102252608|FG001|STARTED|Overall Study||24||
48779932|NCT00950859|102252607|FG000|COMPLETED|Overall Study||11||
48779933|NCT00950859|102252608|FG001|COMPLETED|Overall Study||14||
48779934|NCT00950859|102252607|FG000|NOT COMPLETED|Overall Study||16||
48779935|NCT00950859|102252608|FG001|NOT COMPLETED|Overall Study||10||
48779936|NCT01462253|102252609|FG000|STARTED|Overall Study||35||
48779937|NCT01462253|102252609|FG000|COMPLETED|Overall Study||27||
48779938|NCT01462253|102252609|FG000|NOT COMPLETED|Overall Study||8||
48779939|NCT04343235|102252610|FG000|STARTED|Overall Study||6||
48779940|NCT04343235|102252611|FG001|STARTED|Overall Study||7||
48779941|NCT04343235|102252610|FG000|COMPLETED|Overall Study||3||
48779942|NCT04343235|102252611|FG001|COMPLETED|Overall Study||5||
48779943|NCT04343235|102252610|FG000|NOT COMPLETED|Overall Study||3||
48779944|NCT04343235|102252611|FG001|NOT COMPLETED|Overall Study||2||
48779945|NCT00467753|102252612|FG000|STARTED|Overall Study||3||
48779946|NCT00467753|102252613|FG001|STARTED|Overall Study||2||
48779947|NCT00467753|102252612|FG000|COMPLETED|Overall Study||0||
48779948|NCT00467753|102252613|FG001|COMPLETED|Overall Study||0||
48779949|NCT00467753|102252612|FG000|NOT COMPLETED|Overall Study||3||
48779950|NCT00467753|102252613|FG001|NOT COMPLETED|Overall Study||2||
48779951|NCT00590772|102252614|FG000|STARTED|Overall Study||31||
48779952|NCT00590772|102252614|FG000|COMPLETED|Overall Study||31||
48779953|NCT00590772|102252614|FG000|NOT COMPLETED|Overall Study||0||
48779954|NCT00960570|102252615|FG000|STARTED|Efavirenz Alone||30||
48779955|NCT00960570|102252615|FG000|COMPLETED|Efavirenz Alone||30||
48779956|NCT00960570|102252615|FG000|NOT COMPLETED|Efavirenz Alone||0||
48779957|NCT00960570|102252615|FG000|STARTED|21 Day Washout Period||30||
48779958|NCT00960570|102252615|FG000|COMPLETED|21 Day Washout Period||28||
48779959|NCT00960570|102252615|FG000|NOT COMPLETED|21 Day Washout Period||2||
48779960|NCT00960570|102252615|FG000|STARTED|Fenofibric Acid Alone||28||
48779961|NCT00960570|102252615|FG000|COMPLETED|Fenofibric Acid Alone||28||
48779962|NCT00960570|102252615|FG000|NOT COMPLETED|Fenofibric Acid Alone||0||
48779963|NCT00960570|102252615|FG000|STARTED|1 Day Period Between Dosing||28||
48779964|NCT00960570|102252615|FG000|COMPLETED|1 Day Period Between Dosing||25||
48779965|NCT00960570|102252615|FG000|NOT COMPLETED|1 Day Period Between Dosing||3||
48779966|NCT00960570|102252615|FG000|STARTED|Efavirenz and Fenofibric Acid||25||
48465257|NCT00962000|101474376|FG000|STARTED|Period 4 - 1 Week||21||
48465258|NCT00962000|101474377|FG001|STARTED|Period 4 - 1 Week||21||
48465259|NCT00962000|101474376|FG000|COMPLETED|Period 4 - 1 Week||21||
48465260|NCT00962000|101474377|FG001|COMPLETED|Period 4 - 1 Week||21||
48465261|NCT00962000|101474376|FG000|NOT COMPLETED|Period 4 - 1 Week||0||
48465262|NCT00962000|101474377|FG001|NOT COMPLETED|Period 4 - 1 Week||0||
48779967|NCT00960570|102252615|FG000|COMPLETED|Efavirenz and Fenofibric Acid||25||
48779968|NCT00960570|102252615|FG000|NOT COMPLETED|Efavirenz and Fenofibric Acid||0||
48465263|NCT02985151|101474378|FG000|STARTED|Original Randomization||25||
48465264|NCT02985151|101474379|FG001|STARTED|Original Randomization||26||
48465265|NCT02985151|101474378|FG000|COMPLETED|Original Randomization||25||
48465266|NCT02985151|101474379|FG001|COMPLETED|Original Randomization||25||
48465267|NCT02985151|101474378|FG000|NOT COMPLETED|Original Randomization||0||
48465268|NCT02985151|101474379|FG001|NOT COMPLETED|Original Randomization||1||
48465269|NCT02985151|101474378|FG000|STARTED|Crossover From Low to High Energy||0||
48465270|NCT02985151|101474379|FG001|STARTED|Crossover From Low to High Energy||10||
48779969|NCT04726969|102252616|FG000|STARTED|Overall Study||85||
48779970|NCT04726969|102252617|FG001|STARTED|Overall Study||84||
48779971|NCT04726969|102252618|FG002|STARTED|Overall Study||86||
48779972|NCT04726969|102252616|FG000|COMPLETED|Overall Study||72||
48779973|NCT04726969|102252617|FG001|COMPLETED|Overall Study||67||
48779974|NCT04726969|102252618|FG002|COMPLETED|Overall Study||71||
48779975|NCT04726969|102252616|FG000|NOT COMPLETED|Overall Study||13||
48779976|NCT04726969|102252617|FG001|NOT COMPLETED|Overall Study||17||
48779977|NCT04726969|102252618|FG002|NOT COMPLETED|Overall Study||15||
48779978|NCT01032889|102252619|FG000|STARTED|Overall Study||41||
48779979|NCT01032889|102252620|FG001|STARTED|Overall Study||43||
48779980|NCT01032889|102252621|FG002|STARTED|Overall Study||45||
48779981|NCT01032889|102252619|FG000|Received Treatment|Overall Study||41||
48779982|NCT01032889|102252620|FG001|Received Treatment|Overall Study||43||
48465271|NCT02985151|101474378|FG000|COMPLETED|Crossover From Low to High Energy||0||
48465272|NCT02985151|101474379|FG001|COMPLETED|Crossover From Low to High Energy||10||
48465273|NCT02985151|101474378|FG000|NOT COMPLETED|Crossover From Low to High Energy||0||
48465274|NCT02985151|101474379|FG001|NOT COMPLETED|Crossover From Low to High Energy||0||
48465275|NCT01336894|101474380|FG000|STARTED|Protocol Interventions||4||
48465276|NCT01336894|101474381|FG001|STARTED|Protocol Interventions||7||
48465277|NCT01336894|101474380|FG000|COMPLETED|Protocol Interventions||4||
48665701|NCT00928772|101967392|FG000|COMPLETED|Overall Study||39||
48665702|NCT00928772|101967393|FG001|COMPLETED|Overall Study||38||
48665703|NCT00928772|101967394|FG002|COMPLETED|Overall Study||38||
48665704|NCT00928772|101967392|FG000|NOT COMPLETED|Overall Study||0||
48665705|NCT00928772|101967393|FG001|NOT COMPLETED|Overall Study||0||
48665706|NCT00928772|101967394|FG002|NOT COMPLETED|Overall Study||0||
48665707|NCT01437189|101967395|FG000|STARTED|Overall Study||35||
48665708|NCT01437189|101967395|FG000|COMPLETED|Overall Study||20||
48665709|NCT01437189|101967395|FG000|NOT COMPLETED|Overall Study||15||
48665710|NCT02489279|101967396|FG000|STARTED|Overall Study||44||
48665711|NCT02489279|101967397|FG001|STARTED|Overall Study||41||
48665712|NCT02489279|101967396|FG000|COMPLETED|Overall Study||32||
48665713|NCT02489279|101967397|FG001|COMPLETED|Overall Study||31||
48665714|NCT02489279|101967396|FG000|NOT COMPLETED|Overall Study||12||
48665715|NCT02489279|101967397|FG001|NOT COMPLETED|Overall Study||10||
48779983|NCT01032889|102252621|FG002|Received Treatment|Overall Study||45||
48779984|NCT01032889|102252619|FG000|COMPLETED|Overall Study||33||
48779985|NCT01032889|102252620|FG001|COMPLETED|Overall Study||28||
48779986|NCT01032889|102252621|FG002|COMPLETED|Overall Study||42||
48779987|NCT01032889|102252619|FG000|NOT COMPLETED|Overall Study||8||
48779988|NCT01032889|102252620|FG001|NOT COMPLETED|Overall Study||15||
48779989|NCT01032889|102252621|FG002|NOT COMPLETED|Overall Study||3||
48779990|NCT00684060|102252622|FG000|STARTED|Overall Study||58||
48779991|NCT00684060|102252623|FG001|STARTED|Overall Study||29||
48779992|NCT00684060|102252622|FG000|COMPLETED|Overall Study||55||
48779993|NCT00684060|102252623|FG001|COMPLETED|Overall Study||26||
48779994|NCT00684060|102252622|FG000|NOT COMPLETED|Overall Study||3||
48779995|NCT00684060|102252623|FG001|NOT COMPLETED|Overall Study||3||
48779996|NCT02405442|102252624|FG000|STARTED|Double-Blind Phase (up to Week 8)||53||
48779997|NCT02405442|102252625|FG001|STARTED|Double-Blind Phase (up to Week 8)||53||
48779998|NCT02405442|102252626|FG002|STARTED|Double-Blind Phase (up to Week 8)||53||
48779999|NCT02405442|102252627|FG003|STARTED|Double-Blind Phase (up to Week 8)||28||
48780000|NCT02405442|102252624|FG000|COMPLETED|Double-Blind Phase (up to Week 8)||52||
48780001|NCT02405442|102252625|FG001|COMPLETED|Double-Blind Phase (up to Week 8)||48||
48780002|NCT02405442|102252626|FG002|COMPLETED|Double-Blind Phase (up to Week 8)||47||
48780003|NCT02405442|102252627|FG003|COMPLETED|Double-Blind Phase (up to Week 8)||27||
48780004|NCT02405442|102252624|FG000|NOT COMPLETED|Double-Blind Phase (up to Week 8)||1||
48780005|NCT02405442|102252625|FG001|NOT COMPLETED|Double-Blind Phase (up to Week 8)||5||
48780006|NCT02405442|102252626|FG002|NOT COMPLETED|Double-Blind Phase (up to Week 8)||6||
48780007|NCT02405442|102252627|FG003|NOT COMPLETED|Double-Blind Phase (up to Week 8)||1||
48780008|NCT02405442|102252624|FG000|STARTED|Open-Label Phase (up to Week 52)||52||
48780009|NCT02405442|102252625|FG001|STARTED|Open-Label Phase (up to Week 52)||48||
48780010|NCT02405442|102252626|FG002|STARTED|Open-Label Phase (up to Week 52)||47||
48780011|NCT02405442|102252627|FG003|STARTED|Open-Label Phase (up to Week 52)||26||
48780012|NCT02405442|102252624|FG000|COMPLETED|Open-Label Phase (up to Week 52)||4||
48780013|NCT02405442|102252625|FG001|COMPLETED|Open-Label Phase (up to Week 52)||3||
48780014|NCT02405442|102252626|FG002|COMPLETED|Open-Label Phase (up to Week 52)||2||
48780015|NCT02405442|102252627|FG003|COMPLETED|Open-Label Phase (up to Week 52)||2||
48780016|NCT02405442|102252624|FG000|NOT COMPLETED|Open-Label Phase (up to Week 52)||48||
48780017|NCT02405442|102252625|FG001|NOT COMPLETED|Open-Label Phase (up to Week 52)||45||
48780018|NCT02405442|102252626|FG002|NOT COMPLETED|Open-Label Phase (up to Week 52)||45||
48780019|NCT02405442|102252627|FG003|NOT COMPLETED|Open-Label Phase (up to Week 52)||24||
48780020|NCT02405442|102252624|FG000|STARTED|Extended Treatment Phase(up to Week 208)||3||
48780021|NCT02405442|102252625|FG001|STARTED|Extended Treatment Phase(up to Week 208)||2||
48780022|NCT02405442|102252626|FG002|STARTED|Extended Treatment Phase(up to Week 208)||2||
48780023|NCT02405442|102252627|FG003|STARTED|Extended Treatment Phase(up to Week 208)||2||
48780024|NCT02405442|102252624|FG000|COMPLETED|Extended Treatment Phase(up to Week 208)||0||
48780025|NCT02405442|102252625|FG001|COMPLETED|Extended Treatment Phase(up to Week 208)||0||
48780026|NCT02405442|102252626|FG002|COMPLETED|Extended Treatment Phase(up to Week 208)||0||
48780027|NCT02405442|102252627|FG003|COMPLETED|Extended Treatment Phase(up to Week 208)||0||
48780028|NCT02405442|102252624|FG000|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||3||
48665716|NCT01702298|101967398|FG000|STARTED|Overall Study||42||
48665717|NCT01702298|101967398|FG000|COMPLETED|Overall Study||41||
48780029|NCT02405442|102252625|FG001|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2||
48465278|NCT01336894|101474381|FG001|COMPLETED|Protocol Interventions||7||
48465279|NCT01336894|101474380|FG000|NOT COMPLETED|Protocol Interventions||0||
48465280|NCT01336894|101474381|FG001|NOT COMPLETED|Protocol Interventions||0||
48465281|NCT01336894|101474380|FG000|STARTED|Follow-up||4||
48465282|NCT01336894|101474381|FG001|STARTED|Follow-up||7||
48465283|NCT01336894|101474380|FG000|COMPLETED|Follow-up||2||
48465284|NCT01336894|101474381|FG001|COMPLETED|Follow-up||0||
48465285|NCT01336894|101474380|FG000|NOT COMPLETED|Follow-up||2||
48465286|NCT01336894|101474381|FG001|NOT COMPLETED|Follow-up||7||
48465287|NCT01133821|101474382|FG000|STARTED|Overall Study||45||
48465288|NCT01133821|101474383|FG001|STARTED|Overall Study||47||
48465289|NCT01133821|101474382|FG000|COMPLETED|Overall Study||27||
48465290|NCT01133821|101474383|FG001|COMPLETED|Overall Study||28||
48465291|NCT01133821|101474382|FG000|NOT COMPLETED|Overall Study||18||
48465292|NCT01133821|101474383|FG001|NOT COMPLETED|Overall Study||19||
48465293|NCT00124020|101474384|FG000|STARTED|Overall Study||377||
48465294|NCT00124020|101474385|FG001|STARTED|Overall Study||380||
48465295|NCT00124020|101474384|FG000|COMPLETED|Overall Study||289||
48465296|NCT00124020|101474385|FG001|COMPLETED|Overall Study||289||
48465297|NCT00124020|101474384|FG000|NOT COMPLETED|Overall Study||88||
48465298|NCT00124020|101474385|FG001|NOT COMPLETED|Overall Study||91||
48465299|NCT02236130|101474386|FG000|STARTED|Overall Study||22||
48465300|NCT02236130|101474387|FG001|STARTED|Overall Study||27||
48465301|NCT02236130|101474386|FG000|COMPLETED|Overall Study||15||
48465302|NCT02236130|101474387|FG001|COMPLETED|Overall Study||15||
48465303|NCT02236130|101474386|FG000|NOT COMPLETED|Overall Study||7||
48465304|NCT02236130|101474387|FG001|NOT COMPLETED|Overall Study||12||
48465305|NCT02518685|101474388|FG000|STARTED|Overall Study||213|Subjects randomized|
48465306|NCT02518685|101474389|FG001|STARTED|Overall Study||89|Subjects randomized|
48465307|NCT02518685|101474388|FG000|Safety Cohort|Overall Study||203|Ten subjects did not receive TPS|
48465308|NCT02518685|101474389|FG001|Safety Cohort|Overall Study||89|Ten subjects did not receive TPS|
48465309|NCT02518685|101474388|FG000|Randomized Cohort|Overall Study||181||
48465310|NCT02518685|101474389|FG001|Randomized Cohort|Overall Study||89||
48465311|NCT02518685|101474388|FG000|Enrolled|Overall Study||213||
48465312|NCT02518685|101474389|FG001|Enrolled|Overall Study||89||
48465313|NCT02518685|101474388|FG000|Per Protocol Analysis|Overall Study||168||
48465314|NCT02518685|101474389|FG001|Per Protocol Analysis|Overall Study||89||
48465315|NCT02518685|101474388|FG000|COMPLETED|Overall Study||164|Completed 12-Month Visit|
48465316|NCT02518685|101474389|FG001|COMPLETED|Overall Study||79|Completed 12-Month Visit|
48465317|NCT02518685|101474388|FG000|NOT COMPLETED|Overall Study||49||
48465318|NCT02518685|101474389|FG001|NOT COMPLETED|Overall Study||10||
48465319|NCT01047345|101474390|FG000|STARTED|Base Study||618||
48465320|NCT01047345|101474391|FG001|STARTED|Base Study||306||
48465321|NCT01047345|101474392|FG002|STARTED|Base Study||0||
48465322|NCT01047345|101474390|FG000|Vaccination 1|Base Study||615||
48465323|NCT01047345|101474391|FG001|Vaccination 1|Base Study||306||
48465324|NCT01047345|101474392|FG002|Vaccination 1|Base Study||0||
48465325|NCT01047345|101474390|FG000|Vaccination 2|Base Study||604||
48465326|NCT01047345|101474391|FG001|Vaccination 2|Base Study||304||
48465327|NCT01047345|101474392|FG002|Vaccination 2|Base Study||0||
48465328|NCT01047345|101474390|FG000|Vaccination 3|Base Study||597||
48465329|NCT01047345|101474391|FG001|Vaccination 3|Base Study||300||
48465330|NCT01047345|101474392|FG002|Vaccination 3|Base Study||0||
48465331|NCT01047345|101474390|FG000|COMPLETED|Base Study||596||
48465332|NCT01047345|101474391|FG001|COMPLETED|Base Study||300||
48465333|NCT01047345|101474392|FG002|COMPLETED|Base Study||0||
48465334|NCT01047345|101474390|FG000|NOT COMPLETED|Base Study||22||
48465335|NCT01047345|101474391|FG001|NOT COMPLETED|Base Study||6||
48465336|NCT01047345|101474392|FG002|NOT COMPLETED|Base Study||0||
48465337|NCT01047345|101474390|FG000|STARTED|Extension||0||
48465338|NCT01047345|101474391|FG001|STARTED|Extension||0||
48465339|NCT01047345|101474392|FG002|STARTED|Extension||102||
48465340|NCT01047345|101474390|FG000|Vaccination 4|Extension||0||
48465341|NCT01047345|101474391|FG001|Vaccination 4|Extension||0||
48465342|NCT01047345|101474392|FG002|Vaccination 4|Extension||102||
48465343|NCT01047345|101474390|FG000|Vaccination 5|Extension||0||
48189815|NCT03283553|100786315|FG001|Care Partner Baseline Interview|Care Partner Participant Flow||63||
48189816|NCT03283553|100786314|FG000|Care Partner 3-Month Interview|Care Partner Participant Flow||69||
48189817|NCT03283553|100786315|FG001|Care Partner 3-Month Interview|Care Partner Participant Flow||60||
48465344|NCT01047345|101474391|FG001|Vaccination 5|Extension||0||
48465345|NCT01047345|101474392|FG002|Vaccination 5|Extension||99||
48465346|NCT01047345|101474390|FG000|Vaccination 6|Extension||0||
48465347|NCT01047345|101474391|FG001|Vaccination 6|Extension||0||
48465348|NCT01047345|101474392|FG002|Vaccination 6|Extension||95||
48465349|NCT01047345|101474390|FG000|COMPLETED|Extension||0||
48465350|NCT01047345|101474391|FG001|COMPLETED|Extension||0||
48465351|NCT01047345|101474392|FG002|COMPLETED|Extension||96||
48465352|NCT01047345|101474390|FG000|NOT COMPLETED|Extension||0||
48465353|NCT01047345|101474391|FG001|NOT COMPLETED|Extension||0||
48465354|NCT01047345|101474392|FG002|NOT COMPLETED|Extension||6||
48465355|NCT02720952|101474393|FG000|STARTED|Overall Study||24||
48665718|NCT01702298|101967398|FG000|NOT COMPLETED|Overall Study||1||
48665719|NCT02287779|101967399|FG000|STARTED|Overall Study||21||
48665720|NCT02287779|101967400|FG001|STARTED|Overall Study||9||
48665721|NCT02287779|101967401|FG002|STARTED|Overall Study||9||
48465356|NCT02720952|101474393|FG000|COMPLETED|Overall Study||24||
48465357|NCT02720952|101474393|FG000|NOT COMPLETED|Overall Study||0||
48465358|NCT02322047|101474394|FG000|STARTED|Overall Study||8||
48465359|NCT02322047|101474395|FG001|STARTED|Overall Study||7||
48465360|NCT02322047|101474396|FG002|STARTED|Overall Study||7||
48465361|NCT02322047|101474397|FG003|STARTED|Overall Study||9||
48465362|NCT02322047|101474394|FG000|COMPLETED|Overall Study||6||
48465363|NCT02322047|101474395|FG001|COMPLETED|Overall Study||6||
48465364|NCT02322047|101474396|FG002|COMPLETED|Overall Study||6||
48465365|NCT02322047|101474397|FG003|COMPLETED|Overall Study||7||
48465366|NCT02322047|101474394|FG000|NOT COMPLETED|Overall Study||2||
48665722|NCT02287779|101967402|FG003|STARTED|Overall Study||9||
48665723|NCT02287779|101967403|FG004|STARTED|Overall Study||9||
48665724|NCT02287779|101967404|FG005|STARTED|Overall Study||9||
48665725|NCT02287779|101967405|FG006|STARTED|Overall Study||9||
48665726|NCT02287779|101967406|FG007|STARTED|Overall Study||9||
48665727|NCT02287779|101967399|FG000|COMPLETED|Overall Study||21||
48665728|NCT02287779|101967400|FG001|COMPLETED|Overall Study||9||
48665729|NCT02287779|101967401|FG002|COMPLETED|Overall Study||9||
48665730|NCT02287779|101967402|FG003|COMPLETED|Overall Study||9||
48665731|NCT02287779|101967403|FG004|COMPLETED|Overall Study||9||
48665732|NCT02287779|101967404|FG005|COMPLETED|Overall Study||9||
48665733|NCT02287779|101967405|FG006|COMPLETED|Overall Study||9||
48665734|NCT02287779|101967406|FG007|COMPLETED|Overall Study||9||
48665735|NCT02287779|101967399|FG000|NOT COMPLETED|Overall Study||0||
48665736|NCT02287779|101967400|FG001|NOT COMPLETED|Overall Study||0||
48665737|NCT02287779|101967401|FG002|NOT COMPLETED|Overall Study||0||
48665738|NCT02287779|101967402|FG003|NOT COMPLETED|Overall Study||0||
48665739|NCT02287779|101967403|FG004|NOT COMPLETED|Overall Study||0||
48665740|NCT02287779|101967404|FG005|NOT COMPLETED|Overall Study||0||
48665741|NCT02287779|101967405|FG006|NOT COMPLETED|Overall Study||0||
48665742|NCT02287779|101967406|FG007|NOT COMPLETED|Overall Study||0||
48665743|NCT03770286|101967407|FG000|STARTED|Overall Study||17||60
48665744|NCT03770286|101967408|FG001|STARTED|Overall Study||17||74
48665745|NCT03770286|101967409|FG002|STARTED|Overall Study||17||81
48665746|NCT03770286|101967407|FG000|COMPLETED|Overall Study||10||24
48780030|NCT02405442|102252626|FG002|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2||
48780031|NCT02405442|102252627|FG003|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2||
48780032|NCT00620503|102252628|FG000|STARTED|Screening (up to 21 Days)||2||
48780033|NCT00620503|102252629|FG001|STARTED|Screening (up to 21 Days)||2||
48465367|NCT02322047|101474395|FG001|NOT COMPLETED|Overall Study||1||
48665747|NCT03770286|101967408|FG001|COMPLETED|Overall Study||13||33
48465368|NCT02322047|101474396|FG002|NOT COMPLETED|Overall Study||1||
48465369|NCT02322047|101474397|FG003|NOT COMPLETED|Overall Study||2||
48465370|NCT00783796|101474398|FG000|STARTED|Overall Study||150||
48465371|NCT00783796|101474398|FG000|COMPLETED|Overall Study||144||
48465372|NCT00783796|101474398|FG000|NOT COMPLETED|Overall Study||6||
48465373|NCT01498484|101474399|FG000|STARTED|Overall Study||25||
48465374|NCT01498484|101474400|FG001|STARTED|Overall Study||10||
48465375|NCT01498484|101474401|FG002|STARTED|Overall Study||3||
48465376|NCT01498484|101474402|FG003|STARTED|Overall Study||3||
48465377|NCT01498484|101474403|FG004|STARTED|Overall Study||2||
48465378|NCT01498484|101474404|FG005|STARTED|Overall Study||3||
48665748|NCT03770286|101967409|FG002|COMPLETED|Overall Study||12||30
48665749|NCT03770286|101967407|FG000|NOT COMPLETED|Overall Study||7||36
48665750|NCT03770286|101967408|FG001|NOT COMPLETED|Overall Study||4||41
48780034|NCT00620503|102252630|FG002|STARTED|Screening (up to 21 Days)||2||
48780035|NCT00620503|102252631|FG003|STARTED|Screening (up to 21 Days)||2||
48370076|NCT01515176|101234812|FG000|COMPLETED|Overall Study||4||
48465379|NCT01498484|101474405|FG006|STARTED|Overall Study||25||
48465380|NCT01498484|101474406|FG007|STARTED|Overall Study||14||
48665751|NCT03770286|101967409|FG002|NOT COMPLETED|Overall Study||5||51
48665752|NCT02921256|101967410|FG000|STARTED|Arm 1a v. Arm II||88||
48665753|NCT02921256|101967411|FG001|STARTED|Arm 1a v. Arm II||90||
48665754|NCT02921256|101967412|FG002|STARTED|Arm 1a v. Arm II||0||
48665755|NCT02921256|101967410|FG000|COMPLETED|Arm 1a v. Arm II||72||
48780036|NCT00620503|102252632|FG004|STARTED|Screening (up to 21 Days)||2||
48780037|NCT00620503|102252633|FG005|STARTED|Screening (up to 21 Days)||2||
48465381|NCT01498484|101474407|FG008|STARTED|Overall Study||2||
48465382|NCT01498484|101474399|FG000|COMPLETED|Overall Study||11||
48465383|NCT01498484|101474400|FG001|COMPLETED|Overall Study||3||
48465384|NCT01498484|101474401|FG002|COMPLETED|Overall Study||1||
48465385|NCT01498484|101474402|FG003|COMPLETED|Overall Study||0||
48465386|NCT01498484|101474403|FG004|COMPLETED|Overall Study||1||
48465387|NCT01498484|101474404|FG005|COMPLETED|Overall Study||2||
48465388|NCT01498484|101474405|FG006|COMPLETED|Overall Study||3||
48465389|NCT01498484|101474406|FG007|COMPLETED|Overall Study||0||
48465390|NCT01498484|101474407|FG008|COMPLETED|Overall Study||0||
48465391|NCT01498484|101474399|FG000|NOT COMPLETED|Overall Study||14||
48465392|NCT01498484|101474400|FG001|NOT COMPLETED|Overall Study||7||
48465393|NCT01498484|101474401|FG002|NOT COMPLETED|Overall Study||2||
48465394|NCT01498484|101474402|FG003|NOT COMPLETED|Overall Study||3||
48465395|NCT01498484|101474403|FG004|NOT COMPLETED|Overall Study||1||
48465396|NCT01498484|101474404|FG005|NOT COMPLETED|Overall Study||1||
48465397|NCT01498484|101474405|FG006|NOT COMPLETED|Overall Study||22||
48465398|NCT01498484|101474406|FG007|NOT COMPLETED|Overall Study||14||
48465399|NCT01498484|101474407|FG008|NOT COMPLETED|Overall Study||2||
48465400|NCT00640978|101474408|FG000|STARTED|Overall Study||15||
48465401|NCT00640978|101474408|FG000|COMPLETED|Overall Study||15||
48465402|NCT00640978|101474408|FG000|NOT COMPLETED|Overall Study||0||
48465403|NCT04552704|101474409|FG000|STARTED|Overall Study||3||
48465404|NCT04552704|101474409|FG000|COMPLETED|Overall Study||3||
48465405|NCT04552704|101474409|FG000|NOT COMPLETED|Overall Study||0||
48465406|NCT00745095|101474410|FG000|STARTED|Overall Study||15||
48465407|NCT00745095|101474411|FG001|STARTED|Overall Study||15||
48465408|NCT00745095|101474412|FG002|STARTED|Overall Study||15||
48465409|NCT00745095|101474413|FG003|STARTED|Overall Study||15||
48465410|NCT00745095|101474414|FG004|STARTED|Overall Study||150||
48465411|NCT00745095|101474415|FG005|STARTED|Overall Study||150||
48465412|NCT00745095|101474410|FG000|COMPLETED|Overall Study||14||
48465413|NCT00745095|101474411|FG001|COMPLETED|Overall Study||13||
48465414|NCT00745095|101474412|FG002|COMPLETED|Overall Study||12||
48465415|NCT00745095|101474413|FG003|COMPLETED|Overall Study||12||
48465416|NCT00745095|101474414|FG004|COMPLETED|Overall Study||28||
48465417|NCT00745095|101474415|FG005|COMPLETED|Overall Study||27||
48465418|NCT00745095|101474410|FG000|NOT COMPLETED|Overall Study||1||
48465419|NCT00745095|101474411|FG001|NOT COMPLETED|Overall Study||2||
48465420|NCT00745095|101474412|FG002|NOT COMPLETED|Overall Study||3||
48465421|NCT00745095|101474413|FG003|NOT COMPLETED|Overall Study||3||
48465422|NCT00745095|101474414|FG004|NOT COMPLETED|Overall Study||122||
48665756|NCT02921256|101967411|FG001|COMPLETED|Arm 1a v. Arm II||57||
48780038|NCT00620503|102252628|FG000|COMPLETED|Screening (up to 21 Days)||2||
48780039|NCT00620503|102252629|FG001|COMPLETED|Screening (up to 21 Days)||2||
48780040|NCT00620503|102252630|FG002|COMPLETED|Screening (up to 21 Days)||2||
48780041|NCT00620503|102252631|FG003|COMPLETED|Screening (up to 21 Days)||2||
48780042|NCT00620503|102252632|FG004|COMPLETED|Screening (up to 21 Days)||2||
48780043|NCT00620503|102252633|FG005|COMPLETED|Screening (up to 21 Days)||2||
48780044|NCT00620503|102252628|FG000|NOT COMPLETED|Screening (up to 21 Days)||0||
48780045|NCT00620503|102252629|FG001|NOT COMPLETED|Screening (up to 21 Days)||0||
48665757|NCT02921256|101967412|FG002|COMPLETED|Arm 1a v. Arm II||0||
48370077|NCT01515176|101234813|FG001|COMPLETED|Overall Study||32||
48370078|NCT01515176|101234812|FG000|NOT COMPLETED|Overall Study||0||
48370079|NCT01515176|101234813|FG001|NOT COMPLETED|Overall Study||0||
48370080|NCT00532948|101234814|FG000|STARTED|Overall Study||4||
48370081|NCT00532948|101234815|FG001|STARTED|Overall Study||14||
48370082|NCT00532948|101234816|FG002|STARTED|Overall Study||6||
48370083|NCT00532948|101234814|FG000|COMPLETED|Overall Study||0||
48370084|NCT00532948|101234815|FG001|COMPLETED|Overall Study||9||
48370085|NCT00532948|101234816|FG002|COMPLETED|Overall Study||2||
48370086|NCT00532948|101234814|FG000|NOT COMPLETED|Overall Study||4||
48465423|NCT00745095|101474415|FG005|NOT COMPLETED|Overall Study||123||
48465424|NCT01341639|101474416|FG000|STARTED|Infant Series||628|All Randomized Participants|
48465425|NCT01341639|101474417|FG001|STARTED|Infant Series||622|All Randomized Participants|
48465426|NCT01341639|101474416|FG000|Site 0048 Excluded|Infant Series||611|Participants from Site 0048 were excluded from all analyses due to major findings in study conduct.|
48465427|NCT01341639|101474417|FG001|Site 0048 Excluded|Infant Series||606|Participants from Site 0048 were excluded from all analyses due to major findings in study conduct.|
48465428|NCT01341639|101474416|FG000|Treated|Infant Series||610||
48465429|NCT01341639|101474417|FG001|Treated|Infant Series||605||
48465430|NCT01341639|101474416|FG000|COMPLETED|Infant Series||599||
48465431|NCT01341639|101474417|FG001|COMPLETED|Infant Series||590||
48465432|NCT01341639|101474416|FG000|NOT COMPLETED|Infant Series||29||
48465433|NCT01341639|101474417|FG001|NOT COMPLETED|Infant Series||32||
48465434|NCT01341639|101474416|FG000|STARTED|Interim Period||599||
48465435|NCT01341639|101474417|FG001|STARTED|Interim Period||590||
48465436|NCT01341639|101474416|FG000|COMPLETED|Interim Period||591||
48780046|NCT00620503|102252630|FG002|NOT COMPLETED|Screening (up to 21 Days)||0||
48780047|NCT00620503|102252631|FG003|NOT COMPLETED|Screening (up to 21 Days)||0||
48780048|NCT00620503|102252632|FG004|NOT COMPLETED|Screening (up to 21 Days)||0||
48780049|NCT00620503|102252633|FG005|NOT COMPLETED|Screening (up to 21 Days)||0||
48780050|NCT00620503|102252628|FG000|STARTED|Treatment Period 1 (TP1) (7days)||2||
48780051|NCT00620503|102252629|FG001|STARTED|Treatment Period 1 (TP1) (7days)||2||
48780052|NCT00620503|102252630|FG002|STARTED|Treatment Period 1 (TP1) (7days)||2||
48465437|NCT01341639|101474417|FG001|COMPLETED|Interim Period||581||
48465438|NCT01341639|101474416|FG000|NOT COMPLETED|Interim Period||8||
48465439|NCT01341639|101474417|FG001|NOT COMPLETED|Interim Period||9||
48465440|NCT01341639|101474416|FG000|STARTED|Toddler Dose||590||
48465441|NCT01341639|101474417|FG001|STARTED|Toddler Dose||582||
48465442|NCT01341639|101474416|FG000|COMPLETED|Toddler Dose||539||
48465443|NCT01341639|101474417|FG001|COMPLETED|Toddler Dose||548||
48465444|NCT01341639|101474416|FG000|NOT COMPLETED|Toddler Dose||51||
48465445|NCT01341639|101474417|FG001|NOT COMPLETED|Toddler Dose||34||
48465446|NCT01341639|101474416|FG000|STARTED|Post-Treatment||539||
48465447|NCT01341639|101474417|FG001|STARTED|Post-Treatment||548||
48465448|NCT01341639|101474416|FG000|COMPLETED|Post-Treatment||539||
48465449|NCT01341639|101474417|FG001|COMPLETED|Post-Treatment||545||
48465450|NCT01341639|101474416|FG000|NOT COMPLETED|Post-Treatment||0||
48465451|NCT01341639|101474417|FG001|NOT COMPLETED|Post-Treatment||3||
48465452|NCT05200858|101474418|FG000|STARTED|Blinded Phase (4 Weeks)||15||
48465453|NCT05200858|101474419|FG001|STARTED|Blinded Phase (4 Weeks)||15||
48465454|NCT05200858|101474420|FG002|STARTED|Blinded Phase (4 Weeks)||0||
48780053|NCT00620503|102252631|FG003|STARTED|Treatment Period 1 (TP1) (7days)||2||
48780054|NCT00620503|102252632|FG004|STARTED|Treatment Period 1 (TP1) (7days)||2||
48780055|NCT00620503|102252633|FG005|STARTED|Treatment Period 1 (TP1) (7days)||2||
48780056|NCT00620503|102252628|FG000|COMPLETED|Treatment Period 1 (TP1) (7days)||2||
48780057|NCT00620503|102252629|FG001|COMPLETED|Treatment Period 1 (TP1) (7days)||2||
48780058|NCT00620503|102252630|FG002|COMPLETED|Treatment Period 1 (TP1) (7days)||2||
48780059|NCT00620503|102252631|FG003|COMPLETED|Treatment Period 1 (TP1) (7days)||2||
48780060|NCT00620503|102252632|FG004|COMPLETED|Treatment Period 1 (TP1) (7days)||2||
48780061|NCT00620503|102252633|FG005|COMPLETED|Treatment Period 1 (TP1) (7days)||2||
48780062|NCT00620503|102252628|FG000|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0||
48780063|NCT00620503|102252629|FG001|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0||
48780064|NCT00620503|102252630|FG002|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0||
48780065|NCT00620503|102252631|FG003|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0||
48780066|NCT00620503|102252632|FG004|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0||
48780067|NCT00620503|102252633|FG005|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0||
48780068|NCT00620503|102252628|FG000|STARTED|Washout (at Least 1 Day)||2||
48780069|NCT00620503|102252629|FG001|STARTED|Washout (at Least 1 Day)||2||
48780070|NCT00620503|102252630|FG002|STARTED|Washout (at Least 1 Day)||2||
48780071|NCT00620503|102252631|FG003|STARTED|Washout (at Least 1 Day)||2||
48780072|NCT00620503|102252632|FG004|STARTED|Washout (at Least 1 Day)||2||
48780073|NCT00620503|102252633|FG005|STARTED|Washout (at Least 1 Day)||2||
48780074|NCT00620503|102252628|FG000|COMPLETED|Washout (at Least 1 Day)||2||
48780075|NCT00620503|102252629|FG001|COMPLETED|Washout (at Least 1 Day)||2||
48780076|NCT00620503|102252630|FG002|COMPLETED|Washout (at Least 1 Day)||2||
48780077|NCT00620503|102252631|FG003|COMPLETED|Washout (at Least 1 Day)||2||
48780078|NCT00620503|102252632|FG004|COMPLETED|Washout (at Least 1 Day)||2||
48465455|NCT05200858|101474421|FG003|STARTED|Blinded Phase (4 Weeks)||0||
48465456|NCT05200858|101474418|FG000|COMPLETED|Blinded Phase (4 Weeks)||12||
48465457|NCT05200858|101474419|FG001|COMPLETED|Blinded Phase (4 Weeks)||13||
48465458|NCT05200858|101474420|FG002|COMPLETED|Blinded Phase (4 Weeks)||0||
48465459|NCT05200858|101474421|FG003|COMPLETED|Blinded Phase (4 Weeks)||0||
48465460|NCT05200858|101474418|FG000|NOT COMPLETED|Blinded Phase (4 Weeks)||3||
48465461|NCT05200858|101474419|FG001|NOT COMPLETED|Blinded Phase (4 Weeks)||2||
48465462|NCT05200858|101474420|FG002|NOT COMPLETED|Blinded Phase (4 Weeks)||0||
48465463|NCT05200858|101474421|FG003|NOT COMPLETED|Blinded Phase (4 Weeks)||0||
48465464|NCT05200858|101474418|FG000|STARTED|Unblinded Phase (4 Weeks)||0||
48465465|NCT05200858|101474419|FG001|STARTED|Unblinded Phase (4 Weeks)||0||
48465466|NCT05200858|101474420|FG002|STARTED|Unblinded Phase (4 Weeks)||12||
48465467|NCT05200858|101474421|FG003|STARTED|Unblinded Phase (4 Weeks)||13||
48465468|NCT05200858|101474418|FG000|COMPLETED|Unblinded Phase (4 Weeks)||0||
48780079|NCT00620503|102252633|FG005|COMPLETED|Washout (at Least 1 Day)||2||
48780080|NCT00620503|102252628|FG000|NOT COMPLETED|Washout (at Least 1 Day)||0||
48780081|NCT00620503|102252629|FG001|NOT COMPLETED|Washout (at Least 1 Day)||0||
48780082|NCT00620503|102252630|FG002|NOT COMPLETED|Washout (at Least 1 Day)||0||
48780083|NCT00620503|102252631|FG003|NOT COMPLETED|Washout (at Least 1 Day)||0||
48780084|NCT00620503|102252632|FG004|NOT COMPLETED|Washout (at Least 1 Day)||0||
48780085|NCT00620503|102252633|FG005|NOT COMPLETED|Washout (at Least 1 Day)||0||
48780086|NCT00620503|102252628|FG000|STARTED|Treatment Period 2 (TP2) (7days)||2||
48780087|NCT00620503|102252629|FG001|STARTED|Treatment Period 2 (TP2) (7days)||2||
48780088|NCT00620503|102252630|FG002|STARTED|Treatment Period 2 (TP2) (7days)||2||
48780089|NCT00620503|102252631|FG003|STARTED|Treatment Period 2 (TP2) (7days)||2||
48780090|NCT00620503|102252632|FG004|STARTED|Treatment Period 2 (TP2) (7days)||2||
48780091|NCT00620503|102252633|FG005|STARTED|Treatment Period 2 (TP2) (7days)||2||
48780092|NCT00620503|102252628|FG000|COMPLETED|Treatment Period 2 (TP2) (7days)||2||
48780093|NCT00620503|102252629|FG001|COMPLETED|Treatment Period 2 (TP2) (7days)||2||
48780094|NCT00620503|102252630|FG002|COMPLETED|Treatment Period 2 (TP2) (7days)||2||
48780095|NCT00620503|102252631|FG003|COMPLETED|Treatment Period 2 (TP2) (7days)||2||
48780096|NCT00620503|102252632|FG004|COMPLETED|Treatment Period 2 (TP2) (7days)||2||
48780097|NCT00620503|102252633|FG005|COMPLETED|Treatment Period 2 (TP2) (7days)||2||
48780098|NCT00620503|102252628|FG000|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0||
48370087|NCT00532948|101234815|FG001|NOT COMPLETED|Overall Study||5||
48465469|NCT05200858|101474419|FG001|COMPLETED|Unblinded Phase (4 Weeks)||0||
48780099|NCT00620503|102252629|FG001|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0||
48780100|NCT00620503|102252630|FG002|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0||
48780101|NCT00620503|102252631|FG003|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0||
48780102|NCT00620503|102252632|FG004|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0||
48780103|NCT00620503|102252633|FG005|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0||
48780104|NCT00620503|102252628|FG000|STARTED|Washout (at Least 1 Day)||2||
48780105|NCT00620503|102252629|FG001|STARTED|Washout (at Least 1 Day)||2||
48465470|NCT05200858|101474420|FG002|COMPLETED|Unblinded Phase (4 Weeks)||10||
48465471|NCT05200858|101474421|FG003|COMPLETED|Unblinded Phase (4 Weeks)||10||
48465472|NCT05200858|101474418|FG000|NOT COMPLETED|Unblinded Phase (4 Weeks)||0||
48465473|NCT05200858|101474419|FG001|NOT COMPLETED|Unblinded Phase (4 Weeks)||0||
48465474|NCT05200858|101474420|FG002|NOT COMPLETED|Unblinded Phase (4 Weeks)||2||
48465475|NCT05200858|101474421|FG003|NOT COMPLETED|Unblinded Phase (4 Weeks)||3||
48465476|NCT03482713|101474422|FG000|STARTED|Overall Study||11||
48465477|NCT03482713|101474423|FG001|STARTED|Overall Study||12||
48465478|NCT03482713|101474422|FG000|COMPLETED|Overall Study||11||
48465479|NCT03482713|101474423|FG001|COMPLETED|Overall Study||12||
48465480|NCT03482713|101474422|FG000|NOT COMPLETED|Overall Study||0||
48465481|NCT03482713|101474423|FG001|NOT COMPLETED|Overall Study||0||
48465482|NCT00710203|101474424|FG000|STARTED|Overall Study||10||
48465483|NCT00710203|101474424|FG000|COMPLETED|Overall Study||10||
48465484|NCT00710203|101474424|FG000|NOT COMPLETED|Overall Study||0||
48465485|NCT02746263|101474425|FG000|STARTED|Overall Study||0||
48465486|NCT02746263|101474426|FG001|STARTED|Overall Study||1||
48465487|NCT02746263|101474425|FG000|Per Protocol Analysis Set|Overall Study||0||
48465488|NCT02746263|101474426|FG001|Per Protocol Analysis Set|Overall Study||0||
48465489|NCT02746263|101474425|FG000|COMPLETED|Overall Study||0||
48465490|NCT02746263|101474426|FG001|COMPLETED|Overall Study||1||
48465491|NCT02746263|101474425|FG000|NOT COMPLETED|Overall Study||0||
48465492|NCT02746263|101474426|FG001|NOT COMPLETED|Overall Study||0||
48465493|NCT00958581|101474427|FG000|STARTED|Overall Study||61||
48465494|NCT00958581|101474428|FG001|STARTED|Overall Study||61||
48465495|NCT00958581|101474429|FG002|STARTED|Overall Study||55||
48465496|NCT00958581|101474427|FG000|COMPLETED|Overall Study||61||
48465497|NCT00958581|101474428|FG001|COMPLETED|Overall Study||61||
48465498|NCT00958581|101474429|FG002|COMPLETED|Overall Study||55||
48465499|NCT00958581|101474427|FG000|NOT COMPLETED|Overall Study||0||
48465500|NCT00958581|101474428|FG001|NOT COMPLETED|Overall Study||0||
48465501|NCT00958581|101474429|FG002|NOT COMPLETED|Overall Study||0||
48465502|NCT01983020|101474430|FG000|STARTED|Overall Study||12||
48465503|NCT01983020|101474431|FG001|STARTED|Overall Study||11||
48465504|NCT01983020|101474432|FG002|STARTED|Overall Study||12||
48465505|NCT01983020|101474433|FG003|STARTED|Overall Study||11||
48465506|NCT01983020|101474430|FG000|COMPLETED|Overall Study||12||
48465507|NCT01983020|101474431|FG001|COMPLETED|Overall Study||11||
48465508|NCT01983020|101474432|FG002|COMPLETED|Overall Study||12||
48465509|NCT01983020|101474433|FG003|COMPLETED|Overall Study||11||
48465510|NCT01983020|101474430|FG000|NOT COMPLETED|Overall Study||0||
48465511|NCT01983020|101474431|FG001|NOT COMPLETED|Overall Study||0||
48465512|NCT01983020|101474432|FG002|NOT COMPLETED|Overall Study||0||
48465513|NCT01983020|101474433|FG003|NOT COMPLETED|Overall Study||0||
48465514|NCT00387712|101474434|FG000|STARTED|Overall Study||47||
48465515|NCT00387712|101474435|FG001|STARTED|Overall Study||52||
48465516|NCT00387712|101474434|FG000|COMPLETED|Overall Study||18||
48780106|NCT00620503|102252630|FG002|STARTED|Washout (at Least 1 Day)||2||
48780107|NCT00620503|102252631|FG003|STARTED|Washout (at Least 1 Day)||2||
48465517|NCT00387712|101474435|FG001|COMPLETED|Overall Study||16||
48780108|NCT00620503|102252632|FG004|STARTED|Washout (at Least 1 Day)||2||
48465518|NCT00387712|101474434|FG000|NOT COMPLETED|Overall Study||29||
48465519|NCT00387712|101474435|FG001|NOT COMPLETED|Overall Study||36||
48465520|NCT04272775|101474436|FG000|STARTED|Overall Study||7||
48465521|NCT04272775|101474437|FG001|STARTED|Overall Study||7||
48465522|NCT04272775|101474436|FG000|COMPLETED|Overall Study||0||
48465523|NCT04272775|101474437|FG001|COMPLETED|Overall Study||0||
48465524|NCT04272775|101474436|FG000|NOT COMPLETED|Overall Study||7||
48465525|NCT04272775|101474437|FG001|NOT COMPLETED|Overall Study||7||
48465526|NCT03363581|101474438|FG000|STARTED|Overall Study||14||
48465527|NCT03363581|101474439|FG001|STARTED|Overall Study||20||
48465528|NCT03363581|101474438|FG000|COMPLETED|Overall Study||14||
48465529|NCT03363581|101474439|FG001|COMPLETED|Overall Study||20||
48465530|NCT03363581|101474438|FG000|NOT COMPLETED|Overall Study||0||
48465531|NCT03363581|101474439|FG001|NOT COMPLETED|Overall Study||0||
48465532|NCT04967313|101474440|FG000|STARTED|Baseline||72||
48465533|NCT04967313|101474440|FG000|Ineligible After Baseline|Baseline||11||
48780109|NCT00620503|102252633|FG005|STARTED|Washout (at Least 1 Day)||2||
48780110|NCT00620503|102252628|FG000|COMPLETED|Washout (at Least 1 Day)||2||
48780111|NCT00620503|102252629|FG001|COMPLETED|Washout (at Least 1 Day)||2||
48780112|NCT00620503|102252630|FG002|COMPLETED|Washout (at Least 1 Day)||2||
48465534|NCT04967313|101474440|FG000|Did Not Sign Addendum|Baseline||1||
48465535|NCT04967313|101474440|FG000|COMPLETED|Baseline||60||
48465536|NCT04967313|101474440|FG000|NOT COMPLETED|Baseline||12||
48465537|NCT04967313|101474440|FG000|STARTED|Intervention||60||
48465538|NCT04967313|101474440|FG000|COMPLETED|Intervention||59||
48465539|NCT04967313|101474440|FG000|NOT COMPLETED|Intervention||1||
48465540|NCT02518230|101474441|FG000|STARTED|Overall Study||11||
48465541|NCT02518230|101474442|FG001|STARTED|Overall Study||11||
48465542|NCT02518230|101474441|FG000|COMPLETED|Overall Study||11||
48465543|NCT02518230|101474442|FG001|COMPLETED|Overall Study||11||
48465544|NCT02518230|101474441|FG000|NOT COMPLETED|Overall Study||0||
48465545|NCT02518230|101474442|FG001|NOT COMPLETED|Overall Study||0||
48465546|NCT01399723|101474443|FG000|STARTED|Overall Study||263||
48465547|NCT01399723|101474444|FG001|STARTED|Overall Study||264||
48465548|NCT01399723|101474443|FG000|COMPLETED|Overall Study||263||
48465549|NCT01399723|101474444|FG001|COMPLETED|Overall Study||263||
48465550|NCT01399723|101474443|FG000|NOT COMPLETED|Overall Study||0||
48465551|NCT01399723|101474444|FG001|NOT COMPLETED|Overall Study||1||
48465552|NCT01110681|101474445|FG000|STARTED|Overall Study||115||
48465553|NCT01110681|101474445|FG000|COMPLETED|Overall Study||83||
48465554|NCT01110681|101474445|FG000|NOT COMPLETED|Overall Study||32||
48465555|NCT00982410|101474446|FG000|STARTED|3-month Follow-up Assessment||65||
48465556|NCT00982410|101474447|FG001|STARTED|3-month Follow-up Assessment||66||
48465557|NCT00982410|101474446|FG000|COMPLETED|3-month Follow-up Assessment||56||
48465558|NCT00982410|101474447|FG001|COMPLETED|3-month Follow-up Assessment||53||
48465559|NCT00982410|101474446|FG000|NOT COMPLETED|3-month Follow-up Assessment||9||
48465560|NCT00982410|101474447|FG001|NOT COMPLETED|3-month Follow-up Assessment||13||
48465561|NCT00982410|101474446|FG000|STARTED|6-month Follow-up Assessment||65||
48465562|NCT00982410|101474447|FG001|STARTED|6-month Follow-up Assessment||64||
48465563|NCT00982410|101474446|FG000|COMPLETED|6-month Follow-up Assessment||59||
48465564|NCT00982410|101474447|FG001|COMPLETED|6-month Follow-up Assessment||53||
48465565|NCT00982410|101474446|FG000|NOT COMPLETED|6-month Follow-up Assessment||6||
48465566|NCT00982410|101474447|FG001|NOT COMPLETED|6-month Follow-up Assessment||11||
48465567|NCT00982410|101474446|FG000|STARTED|12-month Follow-up Assessment||65||
48465568|NCT00982410|101474447|FG001|STARTED|12-month Follow-up Assessment||64||
48780113|NCT00620503|102252631|FG003|COMPLETED|Washout (at Least 1 Day)||2||
48780114|NCT00620503|102252632|FG004|COMPLETED|Washout (at Least 1 Day)||2||
48780115|NCT00620503|102252633|FG005|COMPLETED|Washout (at Least 1 Day)||2||
48780116|NCT00620503|102252628|FG000|NOT COMPLETED|Washout (at Least 1 Day)||0||
48780117|NCT00620503|102252629|FG001|NOT COMPLETED|Washout (at Least 1 Day)||0||
48780118|NCT00620503|102252630|FG002|NOT COMPLETED|Washout (at Least 1 Day)||0||
48780119|NCT00620503|102252631|FG003|NOT COMPLETED|Washout (at Least 1 Day)||0||
48780120|NCT00620503|102252632|FG004|NOT COMPLETED|Washout (at Least 1 Day)||0||
48780121|NCT00620503|102252633|FG005|NOT COMPLETED|Washout (at Least 1 Day)||0||
48780122|NCT00620503|102252628|FG000|STARTED|Treatment Period 3 (TP3) (7 Days)||2||
48780123|NCT00620503|102252629|FG001|STARTED|Treatment Period 3 (TP3) (7 Days)||2||
48780124|NCT00620503|102252630|FG002|STARTED|Treatment Period 3 (TP3) (7 Days)||2||
48465569|NCT00982410|101474446|FG000|COMPLETED|12-month Follow-up Assessment||56||
48465570|NCT00982410|101474447|FG001|COMPLETED|12-month Follow-up Assessment||55||
48465571|NCT00982410|101474446|FG000|NOT COMPLETED|12-month Follow-up Assessment||9||
48465572|NCT00982410|101474447|FG001|NOT COMPLETED|12-month Follow-up Assessment||9||
48465573|NCT00555009|101474448|FG000|STARTED|Overall Study||4||
48465574|NCT00555009|101474449|FG001|STARTED|Overall Study||6||
48465575|NCT00555009|101474448|FG000|COMPLETED|Overall Study||2||
48465576|NCT00555009|101474449|FG001|COMPLETED|Overall Study||0||
48465577|NCT00555009|101474448|FG000|NOT COMPLETED|Overall Study||2||
48465578|NCT00555009|101474449|FG001|NOT COMPLETED|Overall Study||6||
48465579|NCT03341273|101474450|FG000|STARTED|Overall Study||249||
48465580|NCT03341273|101474451|FG001|STARTED|Overall Study||250||
48465581|NCT03341273|101474450|FG000|COMPLETED|Overall Study||229||
48465582|NCT03341273|101474451|FG001|COMPLETED|Overall Study||238||
48780125|NCT00620503|102252631|FG003|STARTED|Treatment Period 3 (TP3) (7 Days)||2||
48780126|NCT00620503|102252632|FG004|STARTED|Treatment Period 3 (TP3) (7 Days)||2||
48465583|NCT03341273|101474450|FG000|NOT COMPLETED|Overall Study||20||
48465584|NCT03341273|101474451|FG001|NOT COMPLETED|Overall Study||12||
48465585|NCT00208949|101474452|FG000|STARTED|Overall Study||25||
48465586|NCT00208949|101474453|FG001|STARTED|Overall Study||25||
48465587|NCT00208949|101474452|FG000|COMPLETED|Overall Study||25||
48465588|NCT00208949|101474453|FG001|COMPLETED|Overall Study||25||
48780127|NCT00620503|102252633|FG005|STARTED|Treatment Period 3 (TP3) (7 Days)||2||
48465589|NCT00208949|101474452|FG000|NOT COMPLETED|Overall Study||0||
48465590|NCT00208949|101474453|FG001|NOT COMPLETED|Overall Study||0||
48465591|NCT03996603|101474454|FG000|STARTED|Overall Study||20||
48465592|NCT03996603|101474455|FG001|STARTED|Overall Study||5||
48465593|NCT03996603|101474454|FG000|COMPLETED|Overall Study||16||
48465594|NCT03996603|101474455|FG001|COMPLETED|Overall Study||5||
48465595|NCT03996603|101474454|FG000|NOT COMPLETED|Overall Study||4||
48465596|NCT03996603|101474455|FG001|NOT COMPLETED|Overall Study||0||
48465597|NCT00182091|101474456|FG000|STARTED|Overall Study||15||
48780128|NCT00620503|102252628|FG000|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2||
48780129|NCT00620503|102252629|FG001|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2||
48780130|NCT00620503|102252630|FG002|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2||
48780131|NCT00620503|102252631|FG003|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2||
48780132|NCT00620503|102252632|FG004|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2||
48780133|NCT00620503|102252633|FG005|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2||
48780134|NCT00620503|102252628|FG000|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0||
48780135|NCT00620503|102252629|FG001|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0||
48780136|NCT00620503|102252630|FG002|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0||
48780137|NCT00620503|102252631|FG003|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0||
48780138|NCT00620503|102252632|FG004|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0||
48780139|NCT00620503|102252633|FG005|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0||
48780140|NCT00620503|102252628|FG000|STARTED|Follow-up (up to 14 Days)||2||
48780141|NCT00620503|102252629|FG001|STARTED|Follow-up (up to 14 Days)||2||
48780142|NCT00620503|102252630|FG002|STARTED|Follow-up (up to 14 Days)||2||
48780143|NCT00620503|102252631|FG003|STARTED|Follow-up (up to 14 Days)||2||
48780144|NCT00620503|102252632|FG004|STARTED|Follow-up (up to 14 Days)||2||
48780145|NCT00620503|102252633|FG005|STARTED|Follow-up (up to 14 Days)||2||
48780146|NCT00620503|102252628|FG000|COMPLETED|Follow-up (up to 14 Days)||2||
48780147|NCT00620503|102252629|FG001|COMPLETED|Follow-up (up to 14 Days)||2||
48780148|NCT00620503|102252630|FG002|COMPLETED|Follow-up (up to 14 Days)||2||
48780149|NCT00620503|102252631|FG003|COMPLETED|Follow-up (up to 14 Days)||2||
48780150|NCT00620503|102252632|FG004|COMPLETED|Follow-up (up to 14 Days)||2||
48780151|NCT00620503|102252633|FG005|COMPLETED|Follow-up (up to 14 Days)||2||
48780152|NCT00620503|102252628|FG000|NOT COMPLETED|Follow-up (up to 14 Days)||0||
48780153|NCT00620503|102252629|FG001|NOT COMPLETED|Follow-up (up to 14 Days)||0||
48780154|NCT00620503|102252630|FG002|NOT COMPLETED|Follow-up (up to 14 Days)||0||
48780155|NCT00620503|102252631|FG003|NOT COMPLETED|Follow-up (up to 14 Days)||0||
48780156|NCT00620503|102252632|FG004|NOT COMPLETED|Follow-up (up to 14 Days)||0||
48780157|NCT00620503|102252633|FG005|NOT COMPLETED|Follow-up (up to 14 Days)||0||
48780158|NCT03899467|102252634|FG000|STARTED|Overall Study||31||
48780159|NCT03899467|102252635|FG001|STARTED|Overall Study||30||
48780160|NCT03899467|102252634|FG000|COMPLETED|Overall Study||19||
48780161|NCT03899467|102252635|FG001|COMPLETED|Overall Study||22||
48780162|NCT03899467|102252634|FG000|NOT COMPLETED|Overall Study||12||
48780163|NCT03899467|102252635|FG001|NOT COMPLETED|Overall Study||8||
48780164|NCT01600170|102252636|FG000|STARTED|Period 1||6||
48780165|NCT01600170|102252637|FG001|STARTED|Period 1||5||
48780166|NCT01600170|102252636|FG000|COMPLETED|Period 1||6||
48780167|NCT01600170|102252637|FG001|COMPLETED|Period 1||5||
48780168|NCT01600170|102252636|FG000|NOT COMPLETED|Period 1||0||
48780169|NCT01600170|102252637|FG001|NOT COMPLETED|Period 1||0||
48780170|NCT01600170|102252636|FG000|STARTED|Period 2||6||
48780171|NCT01600170|102252637|FG001|STARTED|Period 2||5||
48780172|NCT01600170|102252636|FG000|COMPLETED|Period 2||5||
48780173|NCT01600170|102252637|FG001|COMPLETED|Period 2||5||
48780174|NCT01600170|102252636|FG000|NOT COMPLETED|Period 2||1||
48780175|NCT01600170|102252637|FG001|NOT COMPLETED|Period 2||0||
48780176|NCT03304249|102252638|FG000|STARTED|Overall Study||128|0 months|9
48780177|NCT03304249|102252639|FG001|STARTED|Overall Study||168|0 months|9
48780178|NCT03304249|102252638|FG000|8 Months|Overall Study||118||9
48780179|NCT03304249|102252639|FG001|8 Months|Overall Study||166||9
48780180|NCT03304249|102252638|FG000|COMPLETED|Overall Study||104|20 months|9
48780181|NCT03304249|102252639|FG001|COMPLETED|Overall Study||154|20 months|9
48780182|NCT03304249|102252638|FG000|NOT COMPLETED|Overall Study||24||0
48780183|NCT03304249|102252639|FG001|NOT COMPLETED|Overall Study||14||0
48780184|NCT03961009|102252640|FG000|STARTED|Overall Study||47||
48780185|NCT03961009|102252640|FG000|COMPLETED|Overall Study||47||
48780186|NCT03961009|102252640|FG000|NOT COMPLETED|Overall Study||0||
48780187|NCT04849559|102252641|FG000|STARTED|Overall Study||13||
48780188|NCT04849559|102252642|FG001|STARTED|Overall Study||14||
48780189|NCT04849559|102252641|FG000|COMPLETED|Overall Study||11||
48780190|NCT04849559|102252642|FG001|COMPLETED|Overall Study||13||
48780191|NCT04849559|102252641|FG000|NOT COMPLETED|Overall Study||2||
48780192|NCT04849559|102252642|FG001|NOT COMPLETED|Overall Study||1||
48465598|NCT00182091|101474457|FG001|STARTED|Overall Study||15||
48465599|NCT00182091|101474458|FG002|STARTED|Overall Study||25||
48465600|NCT00182091|101474459|FG003|STARTED|Overall Study||20||
48465601|NCT00182091|101474456|FG000|COMPLETED|Overall Study||14||
48465602|NCT00182091|101474457|FG001|COMPLETED|Overall Study||15||
48465603|NCT00182091|101474458|FG002|COMPLETED|Overall Study||25||
48465604|NCT00182091|101474459|FG003|COMPLETED|Overall Study||20||
48465605|NCT00182091|101474456|FG000|NOT COMPLETED|Overall Study||1||
48465606|NCT00182091|101474457|FG001|NOT COMPLETED|Overall Study||0||
48465607|NCT00182091|101474458|FG002|NOT COMPLETED|Overall Study||0||
48465608|NCT00182091|101474459|FG003|NOT COMPLETED|Overall Study||0||
48465609|NCT00999609|101474460|FG000|STARTED|Overall Study||21||
48465610|NCT00999609|101474461|FG001|STARTED|Overall Study||10||
48465611|NCT00999609|101474460|FG000|COMPLETED|Overall Study||20||
48465612|NCT00999609|101474461|FG001|COMPLETED|Overall Study||9||
48465613|NCT00999609|101474460|FG000|NOT COMPLETED|Overall Study||1||
48465614|NCT00999609|101474461|FG001|NOT COMPLETED|Overall Study||1||
48465615|NCT02675543|101474462|FG000|STARTED|Overall Study||15||
48465616|NCT02675543|101474463|FG001|STARTED|Overall Study||20||
48465617|NCT02675543|101474462|FG000|COMPLETED|Overall Study||15||
48465618|NCT02675543|101474463|FG001|COMPLETED|Overall Study||20||
48465619|NCT02675543|101474462|FG000|NOT COMPLETED|Overall Study||0||
48465620|NCT02675543|101474463|FG001|NOT COMPLETED|Overall Study||0||
48465621|NCT01621490|101474464|FG000|STARTED|Overall Study||41||
48465622|NCT01621490|101474465|FG001|STARTED|Overall Study||44||
48465623|NCT01621490|101474466|FG002|STARTED|Overall Study||11||
48465624|NCT01621490|101474467|FG003|STARTED|Overall Study||10||
48465625|NCT01621490|101474468|FG004|STARTED|Overall Study||6||
48465626|NCT01621490|101474469|FG005|STARTED|Overall Study||25||
48465627|NCT01621490|101474470|FG006|STARTED|Overall Study||11||
48465628|NCT01621490|101474471|FG007|STARTED|Overall Study||10||
48465629|NCT01621490|101474472|FG008|STARTED|Overall Study||10||
48465630|NCT01621490|101474473|FG009|STARTED|Overall Study||1||
48465631|NCT01621490|101474474|FG010|STARTED|Overall Study||1||
48465632|NCT01621490|101474464|FG000|COMPLETED|Overall Study||0||
48465633|NCT01621490|101474465|FG001|COMPLETED|Overall Study||0||
48465634|NCT01621490|101474466|FG002|COMPLETED|Overall Study||0||
48465635|NCT01621490|101474467|FG003|COMPLETED|Overall Study||0||
48465636|NCT01621490|101474468|FG004|COMPLETED|Overall Study||0||
48465637|NCT01621490|101474469|FG005|COMPLETED|Overall Study||1||
48465638|NCT01621490|101474470|FG006|COMPLETED|Overall Study||0||
48465639|NCT01621490|101474471|FG007|COMPLETED|Overall Study||0||
48465640|NCT01621490|101474472|FG008|COMPLETED|Overall Study||0||
48465641|NCT01621490|101474473|FG009|COMPLETED|Overall Study||0||
48465642|NCT01621490|101474474|FG010|COMPLETED|Overall Study||0||
48465643|NCT01621490|101474464|FG000|NOT COMPLETED|Overall Study||41||
48465644|NCT01621490|101474465|FG001|NOT COMPLETED|Overall Study||44||
48465645|NCT01621490|101474466|FG002|NOT COMPLETED|Overall Study||11||
48465646|NCT01621490|101474467|FG003|NOT COMPLETED|Overall Study||10||
48465647|NCT01621490|101474468|FG004|NOT COMPLETED|Overall Study||6||
48465648|NCT01621490|101474469|FG005|NOT COMPLETED|Overall Study||24||
48465649|NCT01621490|101474470|FG006|NOT COMPLETED|Overall Study||11||
48465650|NCT01621490|101474471|FG007|NOT COMPLETED|Overall Study||10||
48465651|NCT01621490|101474472|FG008|NOT COMPLETED|Overall Study||10||
48465652|NCT01621490|101474473|FG009|NOT COMPLETED|Overall Study||1||
48465653|NCT01621490|101474474|FG010|NOT COMPLETED|Overall Study||1||
48465654|NCT02750761|101474475|FG000|STARTED|Overall Study||5||
48465655|NCT02750761|101474476|FG001|STARTED|Overall Study||5||
48465656|NCT02750761|101474477|FG002|STARTED|Overall Study||5||
48465657|NCT02750761|101474478|FG003|STARTED|Overall Study||5||
48465658|NCT02750761|101474479|FG004|STARTED|Overall Study||6||
48465659|NCT02750761|101474480|FG005|STARTED|Overall Study||6||
48465660|NCT02750761|101474475|FG000|COMPLETED|Overall Study||5||
48465661|NCT02750761|101474476|FG001|COMPLETED|Overall Study||5||
48465662|NCT02750761|101474477|FG002|COMPLETED|Overall Study||4||
48465663|NCT02750761|101474478|FG003|COMPLETED|Overall Study||5||
48465664|NCT02750761|101474479|FG004|COMPLETED|Overall Study||6||
48465665|NCT02750761|101474480|FG005|COMPLETED|Overall Study||6||
48465666|NCT02750761|101474475|FG000|NOT COMPLETED|Overall Study||0||
48465667|NCT02750761|101474476|FG001|NOT COMPLETED|Overall Study||0||
48465668|NCT02750761|101474477|FG002|NOT COMPLETED|Overall Study||1||
48465669|NCT02750761|101474478|FG003|NOT COMPLETED|Overall Study||0||
48465670|NCT02750761|101474479|FG004|NOT COMPLETED|Overall Study||0||
48465671|NCT02750761|101474480|FG005|NOT COMPLETED|Overall Study||0||
48465672|NCT01909466|101474481|FG000|STARTED|Overall Study||68||
48465673|NCT01909466|101474482|FG001|STARTED|Overall Study||73||
48465674|NCT01909466|101474481|FG000|COMPLETED|Overall Study||46||
48465675|NCT01909466|101474482|FG001|COMPLETED|Overall Study||50||
48465676|NCT01909466|101474481|FG000|NOT COMPLETED|Overall Study||22||
48465677|NCT01909466|101474482|FG001|NOT COMPLETED|Overall Study||23||
48465678|NCT04107493|101474483|FG000|STARTED|First Intervention (1 Hour)||16||
48465679|NCT04107493|101474484|FG001|STARTED|First Intervention (1 Hour)||17||
48465680|NCT04107493|101474483|FG000|COMPLETED|First Intervention (1 Hour)||16||
48465681|NCT04107493|101474484|FG001|COMPLETED|First Intervention (1 Hour)||17||
48465682|NCT04107493|101474483|FG000|NOT COMPLETED|First Intervention (1 Hour)||0||
48465683|NCT04107493|101474484|FG001|NOT COMPLETED|First Intervention (1 Hour)||0||
48780193|NCT01536067|102252643|FG000|STARTED|Overall Study||3||
48780194|NCT01536067|102252643|FG000|COMPLETED|Overall Study||2||
48780195|NCT01536067|102252643|FG000|NOT COMPLETED|Overall Study||1||
48780196|NCT01994889|102252644|FG000|STARTED|Overall Study||88||
48780197|NCT01994889|102252645|FG001|STARTED|Overall Study||176||
48780198|NCT01994889|102252646|FG002|STARTED|Overall Study||177||
48780199|NCT01994889|102252644|FG000|COMPLETED|Overall Study||60||
48780200|NCT01994889|102252645|FG001|COMPLETED|Overall Study||113||
48780201|NCT01994889|102252646|FG002|COMPLETED|Overall Study||85||
48780202|NCT01994889|102252644|FG000|NOT COMPLETED|Overall Study||28||
48780203|NCT01994889|102252645|FG001|NOT COMPLETED|Overall Study||63||
48780204|NCT01994889|102252646|FG002|NOT COMPLETED|Overall Study||92||
48780205|NCT01805791|102252647|FG000|STARTED|Overall Study||66||
48780206|NCT01805791|102252648|FG001|STARTED|Overall Study||67||
48780207|NCT01805791|102252649|FG002|STARTED|Overall Study||68||
48780208|NCT01805791|102252647|FG000|COMPLETED|Overall Study||44||
48780209|NCT01805791|102252648|FG001|COMPLETED|Overall Study||50||
48780210|NCT01805791|102252649|FG002|COMPLETED|Overall Study||48||
48780211|NCT01805791|102252647|FG000|NOT COMPLETED|Overall Study||22||
48780212|NCT01805791|102252648|FG001|NOT COMPLETED|Overall Study||17||
48780213|NCT01805791|102252649|FG002|NOT COMPLETED|Overall Study||20||
48780214|NCT02059291|102252650|FG000|STARTED|Epoch 2||31||
48780215|NCT02059291|102252651|FG001|STARTED|Epoch 2||32||
48780216|NCT02059291|102252652|FG002|STARTED|Epoch 2||37||
48780217|NCT02059291|102252653|FG003|STARTED|Epoch 2||35||
48780218|NCT02059291|102252654|FG004|STARTED|Epoch 2||22||
48780219|NCT02059291|102252655|FG005|STARTED|Epoch 2||24||
48780220|NCT02059291|102252656|FG006|STARTED|Epoch 2||2||
48780221|NCT02059291|102252657|FG007|STARTED|Epoch 2||2||
48780222|NCT02059291|102252658|FG008|STARTED|Epoch 2||18||
48780223|NCT02059291|102252659|FG009|STARTED|Epoch 2||0||
48780224|NCT02059291|102252660|FG010|STARTED|Epoch 2||0||
48780225|NCT02059291|102252661|FG011|STARTED|Epoch 2||0||
48780226|NCT02059291|102252662|FG012|STARTED|Epoch 2||0||
48780227|NCT02059291|102252663|FG013|STARTED|Epoch 2||0||
48780228|NCT02059291|102252664|FG014|STARTED|Epoch 2||0||
48780229|NCT02059291|102252665|FG015|STARTED|Epoch 2||0||
48780230|NCT02059291|102252666|FG016|STARTED|Epoch 2||0||
48780231|NCT02059291|102252667|FG017|STARTED|Epoch 2||0||
48780232|NCT02059291|102252668|FG018|STARTED|Epoch 2||0||
48780233|NCT02059291|102252669|FG019|STARTED|Epoch 2||0||
48780234|NCT02059291|102252670|FG020|STARTED|Epoch 2||0||
48780235|NCT02059291|102252671|FG021|STARTED|Epoch 2||0||
48780236|NCT02059291|102252672|FG022|STARTED|Epoch 2||0||
48780237|NCT02059291|102252673|FG023|STARTED|Epoch 2||0||
48780238|NCT02059291|102252674|FG024|STARTED|Epoch 2||0||
48780239|NCT02059291|102252650|FG000|COMPLETED|Epoch 2||31||
48780240|NCT02059291|102252651|FG001|COMPLETED|Epoch 2||31||
48780241|NCT02059291|102252652|FG002|COMPLETED|Epoch 2||36||
48780242|NCT02059291|102252653|FG003|COMPLETED|Epoch 2||33||
48780243|NCT02059291|102252654|FG004|COMPLETED|Epoch 2||22||
48780244|NCT02059291|102252655|FG005|COMPLETED|Epoch 2||22||
48780245|NCT02059291|102252656|FG006|COMPLETED|Epoch 2||2||
48780246|NCT02059291|102252657|FG007|COMPLETED|Epoch 2||1||
48780247|NCT02059291|102252658|FG008|COMPLETED|Epoch 2||16||
48780248|NCT02059291|102252659|FG009|COMPLETED|Epoch 2||0||
48780249|NCT02059291|102252660|FG010|COMPLETED|Epoch 2||0||
48780250|NCT02059291|102252661|FG011|COMPLETED|Epoch 2||0||
48780251|NCT02059291|102252662|FG012|COMPLETED|Epoch 2||0||
48780252|NCT02059291|102252663|FG013|COMPLETED|Epoch 2||0||
48780253|NCT02059291|102252664|FG014|COMPLETED|Epoch 2||0||
48780254|NCT02059291|102252665|FG015|COMPLETED|Epoch 2||0||
48780255|NCT02059291|102252666|FG016|COMPLETED|Epoch 2||0||
48780256|NCT02059291|102252667|FG017|COMPLETED|Epoch 2||0||
48780257|NCT02059291|102252668|FG018|COMPLETED|Epoch 2||0||
48780258|NCT02059291|102252669|FG019|COMPLETED|Epoch 2||0||
48780259|NCT02059291|102252670|FG020|COMPLETED|Epoch 2||0||
48780260|NCT02059291|102252671|FG021|COMPLETED|Epoch 2||0||
48780261|NCT02059291|102252672|FG022|COMPLETED|Epoch 2||0||
48780262|NCT02059291|102252673|FG023|COMPLETED|Epoch 2||0||
48780263|NCT02059291|102252674|FG024|COMPLETED|Epoch 2||0||
48780264|NCT02059291|102252650|FG000|NOT COMPLETED|Epoch 2||0||
48780265|NCT02059291|102252651|FG001|NOT COMPLETED|Epoch 2||1||
48780266|NCT02059291|102252652|FG002|NOT COMPLETED|Epoch 2||1||
48780267|NCT02059291|102252653|FG003|NOT COMPLETED|Epoch 2||2||
48780268|NCT02059291|102252654|FG004|NOT COMPLETED|Epoch 2||0||
48780269|NCT02059291|102252655|FG005|NOT COMPLETED|Epoch 2||2||
48780270|NCT02059291|102252656|FG006|NOT COMPLETED|Epoch 2||0||
48780271|NCT02059291|102252657|FG007|NOT COMPLETED|Epoch 2||1||
48780272|NCT02059291|102252658|FG008|NOT COMPLETED|Epoch 2||2||
48780273|NCT02059291|102252659|FG009|NOT COMPLETED|Epoch 2||0||
48780274|NCT02059291|102252660|FG010|NOT COMPLETED|Epoch 2||0||
48780275|NCT02059291|102252661|FG011|NOT COMPLETED|Epoch 2||0||
48780276|NCT02059291|102252662|FG012|NOT COMPLETED|Epoch 2||0||
48780277|NCT02059291|102252663|FG013|NOT COMPLETED|Epoch 2||0||
48780278|NCT02059291|102252664|FG014|NOT COMPLETED|Epoch 2||0||
48780279|NCT02059291|102252665|FG015|NOT COMPLETED|Epoch 2||0||
48780280|NCT02059291|102252666|FG016|NOT COMPLETED|Epoch 2||0||
48780281|NCT02059291|102252667|FG017|NOT COMPLETED|Epoch 2||0||
48780282|NCT02059291|102252668|FG018|NOT COMPLETED|Epoch 2||0||
48780283|NCT02059291|102252669|FG019|NOT COMPLETED|Epoch 2||0||
48780284|NCT02059291|102252670|FG020|NOT COMPLETED|Epoch 2||0||
48780285|NCT02059291|102252671|FG021|NOT COMPLETED|Epoch 2||0||
48780286|NCT02059291|102252672|FG022|NOT COMPLETED|Epoch 2||0||
48780287|NCT02059291|102252673|FG023|NOT COMPLETED|Epoch 2||0||
48780288|NCT02059291|102252674|FG024|NOT COMPLETED|Epoch 2||0||
48780289|NCT02059291|102252650|FG000|STARTED|Epoch 3||0||
48780290|NCT02059291|102252651|FG001|STARTED|Epoch 3||0||
48780291|NCT02059291|102252652|FG002|STARTED|Epoch 3||0||
48780292|NCT02059291|102252653|FG003|STARTED|Epoch 3||0||
48780293|NCT02059291|102252654|FG004|STARTED|Epoch 3||0||
48780294|NCT02059291|102252655|FG005|STARTED|Epoch 3||0||
48780295|NCT02059291|102252656|FG006|STARTED|Epoch 3||2||
48189818|NCT03283553|100786314|FG000|Care Partner 9-Month Interview|Care Partner Participant Flow||64||
48189819|NCT03283553|100786315|FG001|Care Partner 9-Month Interview|Care Partner Participant Flow||55||
48780296|NCT02059291|102252657|FG007|STARTED|Epoch 3||1||
48780297|NCT02059291|102252658|FG008|STARTED|Epoch 3||0||
48780298|NCT02059291|102252659|FG009|STARTED|Epoch 3||9||
48780299|NCT02059291|102252660|FG010|STARTED|Epoch 3||10||
48780300|NCT02059291|102252661|FG011|STARTED|Epoch 3||6||
48780301|NCT02059291|102252662|FG012|STARTED|Epoch 3||7||
48780302|NCT02059291|102252663|FG013|STARTED|Epoch 3||4||
48780303|NCT02059291|102252664|FG014|STARTED|Epoch 3||5||
48780304|NCT02059291|102252665|FG015|STARTED|Epoch 3||126||
48780305|NCT02059291|102252666|FG016|STARTED|Epoch 3||0||
48780306|NCT02059291|102252667|FG017|STARTED|Epoch 3||0||
48780307|NCT02059291|102252668|FG018|STARTED|Epoch 3||0||
48780308|NCT02059291|102252669|FG019|STARTED|Epoch 3||0||
48780309|NCT02059291|102252670|FG020|STARTED|Epoch 3||0||
48780310|NCT02059291|102252671|FG021|STARTED|Epoch 3||0||
48780311|NCT02059291|102252672|FG022|STARTED|Epoch 3||0||
48780312|NCT02059291|102252673|FG023|STARTED|Epoch 3||0||
48780313|NCT02059291|102252674|FG024|STARTED|Epoch 3||0||
48780314|NCT02059291|102252650|FG000|COMPLETED|Epoch 3||0||
48780315|NCT02059291|102252651|FG001|COMPLETED|Epoch 3||0||
48780316|NCT02059291|102252652|FG002|COMPLETED|Epoch 3||0||
48780317|NCT02059291|102252653|FG003|COMPLETED|Epoch 3||0||
48780318|NCT02059291|102252654|FG004|COMPLETED|Epoch 3||0||
48780319|NCT02059291|102252655|FG005|COMPLETED|Epoch 3||0||
48780320|NCT02059291|102252656|FG006|COMPLETED|Epoch 3||2||
48780321|NCT02059291|102252657|FG007|COMPLETED|Epoch 3||1||
48780322|NCT02059291|102252658|FG008|COMPLETED|Epoch 3||0||
48780323|NCT02059291|102252659|FG009|COMPLETED|Epoch 3||9||
48780324|NCT02059291|102252660|FG010|COMPLETED|Epoch 3||10||
48780325|NCT02059291|102252661|FG011|COMPLETED|Epoch 3||6||
48780326|NCT02059291|102252662|FG012|COMPLETED|Epoch 3||7||
48780327|NCT02059291|102252663|FG013|COMPLETED|Epoch 3||3||
48780328|NCT02059291|102252664|FG014|COMPLETED|Epoch 3||5||
48780329|NCT02059291|102252665|FG015|COMPLETED|Epoch 3||120||
48780330|NCT02059291|102252666|FG016|COMPLETED|Epoch 3||0||
48780331|NCT02059291|102252667|FG017|COMPLETED|Epoch 3||0||
48780332|NCT02059291|102252668|FG018|COMPLETED|Epoch 3||0||
48780333|NCT02059291|102252669|FG019|COMPLETED|Epoch 3||0||
48780334|NCT02059291|102252670|FG020|COMPLETED|Epoch 3||0||
48780335|NCT02059291|102252671|FG021|COMPLETED|Epoch 3||0||
48780336|NCT02059291|102252672|FG022|COMPLETED|Epoch 3||0||
48780337|NCT02059291|102252673|FG023|COMPLETED|Epoch 3||0||
48780338|NCT02059291|102252674|FG024|COMPLETED|Epoch 3||0||
48780339|NCT02059291|102252650|FG000|NOT COMPLETED|Epoch 3||0||
48780340|NCT02059291|102252651|FG001|NOT COMPLETED|Epoch 3||0||
48780341|NCT02059291|102252652|FG002|NOT COMPLETED|Epoch 3||0||
48780342|NCT02059291|102252653|FG003|NOT COMPLETED|Epoch 3||0||
48370088|NCT00532948|101234816|FG002|NOT COMPLETED|Overall Study||4||
48189820|NCT03283553|100786314|FG000|Care Partner 12-Month Interview|Care Partner Participant Flow||59||
48780343|NCT02059291|102252654|FG004|NOT COMPLETED|Epoch 3||0||
48780344|NCT02059291|102252655|FG005|NOT COMPLETED|Epoch 3||0||
48780345|NCT02059291|102252656|FG006|NOT COMPLETED|Epoch 3||0||
48780346|NCT02059291|102252657|FG007|NOT COMPLETED|Epoch 3||0||
48780347|NCT02059291|102252658|FG008|NOT COMPLETED|Epoch 3||0||
48780348|NCT02059291|102252659|FG009|NOT COMPLETED|Epoch 3||0||
48780349|NCT02059291|102252660|FG010|NOT COMPLETED|Epoch 3||0||
48780350|NCT02059291|102252661|FG011|NOT COMPLETED|Epoch 3||0||
48780351|NCT02059291|102252662|FG012|NOT COMPLETED|Epoch 3||0||
48780352|NCT02059291|102252663|FG013|NOT COMPLETED|Epoch 3||1||
48780353|NCT02059291|102252664|FG014|NOT COMPLETED|Epoch 3||0||
48780354|NCT02059291|102252665|FG015|NOT COMPLETED|Epoch 3||6||
48780355|NCT02059291|102252666|FG016|NOT COMPLETED|Epoch 3||0||
48780356|NCT02059291|102252667|FG017|NOT COMPLETED|Epoch 3||0||
48780357|NCT02059291|102252668|FG018|NOT COMPLETED|Epoch 3||0||
48780358|NCT02059291|102252669|FG019|NOT COMPLETED|Epoch 3||0||
48780359|NCT02059291|102252670|FG020|NOT COMPLETED|Epoch 3||0||
48780360|NCT02059291|102252671|FG021|NOT COMPLETED|Epoch 3||0||
48780361|NCT02059291|102252672|FG022|NOT COMPLETED|Epoch 3||0||
48780362|NCT02059291|102252673|FG023|NOT COMPLETED|Epoch 3||0||
48780363|NCT02059291|102252674|FG024|NOT COMPLETED|Epoch 3||0||
48780364|NCT02059291|102252650|FG000|STARTED|Epoch 4||0||
48780365|NCT02059291|102252651|FG001|STARTED|Epoch 4||0||
48780366|NCT02059291|102252652|FG002|STARTED|Epoch 4||0||
48780367|NCT02059291|102252653|FG003|STARTED|Epoch 4||0||
48780368|NCT02059291|102252654|FG004|STARTED|Epoch 4||0||
48780369|NCT02059291|102252655|FG005|STARTED|Epoch 4||0||
48780370|NCT02059291|102252656|FG006|STARTED|Epoch 4||0||
48780371|NCT02059291|102252657|FG007|STARTED|Epoch 4||0||
48780372|NCT02059291|102252658|FG008|STARTED|Epoch 4||0||
48780373|NCT02059291|102252659|FG009|STARTED|Epoch 4||0||
48780374|NCT02059291|102252660|FG010|STARTED|Epoch 4||0||
48780375|NCT02059291|102252661|FG011|STARTED|Epoch 4||0||
48780376|NCT02059291|102252662|FG012|STARTED|Epoch 4||0||
48780377|NCT02059291|102252663|FG013|STARTED|Epoch 4||0||
48780378|NCT02059291|102252664|FG014|STARTED|Epoch 4||0||
48780379|NCT02059291|102252665|FG015|STARTED|Epoch 4||0||
48780380|NCT02059291|102252666|FG016|STARTED|Epoch 4||43||
48780381|NCT02059291|102252667|FG017|STARTED|Epoch 4||14||
48780382|NCT02059291|102252668|FG018|STARTED|Epoch 4||2||
48780383|NCT02059291|102252669|FG019|STARTED|Epoch 4||18||
48780384|NCT02059291|102252670|FG020|STARTED|Epoch 4||34||
48780385|NCT02059291|102252671|FG021|STARTED|Epoch 4||14||
48780386|NCT02059291|102252672|FG022|STARTED|Epoch 4||31||
48780387|NCT02059291|102252673|FG023|STARTED|Epoch 4||22||
48780388|NCT02059291|102252674|FG024|STARTED|Epoch 4||0||
48780389|NCT02059291|102252650|FG000|COMPLETED|Epoch 4||0||
48780390|NCT02059291|102252651|FG001|COMPLETED|Epoch 4||0||
48780391|NCT02059291|102252652|FG002|COMPLETED|Epoch 4||0||
48780392|NCT02059291|102252653|FG003|COMPLETED|Epoch 4||0||
48780393|NCT02059291|102252654|FG004|COMPLETED|Epoch 4||0||
48780394|NCT02059291|102252655|FG005|COMPLETED|Epoch 4||0||
48780395|NCT02059291|102252656|FG006|COMPLETED|Epoch 4||0||
48780396|NCT02059291|102252657|FG007|COMPLETED|Epoch 4||0||
48780397|NCT02059291|102252658|FG008|COMPLETED|Epoch 4||0||
48780398|NCT02059291|102252659|FG009|COMPLETED|Epoch 4||0||
48780399|NCT02059291|102252660|FG010|COMPLETED|Epoch 4||0||
48780400|NCT02059291|102252661|FG011|COMPLETED|Epoch 4||0||
48780401|NCT02059291|102252662|FG012|COMPLETED|Epoch 4||0||
48780402|NCT02059291|102252663|FG013|COMPLETED|Epoch 4||0||
48780403|NCT02059291|102252664|FG014|COMPLETED|Epoch 4||0||
48780404|NCT02059291|102252665|FG015|COMPLETED|Epoch 4||0||
48780405|NCT02059291|102252666|FG016|COMPLETED|Epoch 4||41||
48370089|NCT02518620|101234817|FG000|STARTED|Overall Study||257||
48780406|NCT02059291|102252667|FG017|COMPLETED|Epoch 4||14||
48780407|NCT02059291|102252668|FG018|COMPLETED|Epoch 4||2||
48780408|NCT02059291|102252669|FG019|COMPLETED|Epoch 4||18||
48780409|NCT02059291|102252670|FG020|COMPLETED|Epoch 4||33||
48780410|NCT02059291|102252671|FG021|COMPLETED|Epoch 4||14||
48780411|NCT02059291|102252672|FG022|COMPLETED|Epoch 4||30||
48780412|NCT02059291|102252673|FG023|COMPLETED|Epoch 4||21||
48780413|NCT02059291|102252674|FG024|COMPLETED|Epoch 4||0||
48780414|NCT02059291|102252650|FG000|NOT COMPLETED|Epoch 4||0||
48780415|NCT02059291|102252651|FG001|NOT COMPLETED|Epoch 4||0||
48780416|NCT02059291|102252652|FG002|NOT COMPLETED|Epoch 4||0||
48780417|NCT02059291|102252653|FG003|NOT COMPLETED|Epoch 4||0||
48780418|NCT02059291|102252654|FG004|NOT COMPLETED|Epoch 4||0||
48780419|NCT02059291|102252655|FG005|NOT COMPLETED|Epoch 4||0||
48780420|NCT02059291|102252656|FG006|NOT COMPLETED|Epoch 4||0||
48780421|NCT02059291|102252657|FG007|NOT COMPLETED|Epoch 4||0||
48780422|NCT02059291|102252658|FG008|NOT COMPLETED|Epoch 4||0||
48780423|NCT02059291|102252659|FG009|NOT COMPLETED|Epoch 4||0||
48780424|NCT02059291|102252660|FG010|NOT COMPLETED|Epoch 4||0||
48780425|NCT02059291|102252661|FG011|NOT COMPLETED|Epoch 4||0||
48780426|NCT02059291|102252662|FG012|NOT COMPLETED|Epoch 4||0||
48780427|NCT02059291|102252663|FG013|NOT COMPLETED|Epoch 4||0||
48780428|NCT02059291|102252664|FG014|NOT COMPLETED|Epoch 4||0||
48780429|NCT02059291|102252665|FG015|NOT COMPLETED|Epoch 4||0||
48780430|NCT02059291|102252666|FG016|NOT COMPLETED|Epoch 4||2||
48780431|NCT02059291|102252667|FG017|NOT COMPLETED|Epoch 4||0||
48780432|NCT02059291|102252668|FG018|NOT COMPLETED|Epoch 4||0||
48780433|NCT02059291|102252669|FG019|NOT COMPLETED|Epoch 4||0||
48780434|NCT02059291|102252670|FG020|NOT COMPLETED|Epoch 4||1||
48780435|NCT02059291|102252671|FG021|NOT COMPLETED|Epoch 4||0||
48780436|NCT02059291|102252672|FG022|NOT COMPLETED|Epoch 4||1||
48780437|NCT02059291|102252673|FG023|NOT COMPLETED|Epoch 4||1||
48780438|NCT02059291|102252674|FG024|NOT COMPLETED|Epoch 4||0||
48780439|NCT01324401|102252675|FG000|STARTED|Overall Study||4||
48780440|NCT01324401|102252676|FG001|STARTED|Overall Study||26||
48780441|NCT01324401|102252675|FG000|COMPLETED|Overall Study||3||
48780442|NCT01324401|102252676|FG001|COMPLETED|Overall Study||20||
48780443|NCT01324401|102252675|FG000|NOT COMPLETED|Overall Study||1||
48780444|NCT01324401|102252676|FG001|NOT COMPLETED|Overall Study||6||
48780445|NCT03937999|102252677|FG000|STARTED|Overall Study||0||
48780446|NCT03937999|102252678|FG001|STARTED|Overall Study||1||
48780447|NCT03937999|102252677|FG000|COMPLETED|Overall Study||0||
48780448|NCT03937999|102252678|FG001|COMPLETED|Overall Study||1||
48780449|NCT03937999|102252677|FG000|NOT COMPLETED|Overall Study||0||
48780450|NCT03937999|102252678|FG001|NOT COMPLETED|Overall Study||0||
48780451|NCT00578292|102252679|FG000|STARTED|Overall Study||10||
48780452|NCT00578292|102252679|FG000|COMPLETED|Overall Study||7||
48780453|NCT00578292|102252679|FG000|NOT COMPLETED|Overall Study||3||
48780454|NCT00711477|102252680|FG000|STARTED|Overall Study||23||
48780455|NCT00711477|102252681|FG001|STARTED|Overall Study||23||
48780456|NCT00711477|102252680|FG000|COMPLETED|Overall Study||20||
48780457|NCT00711477|102252681|FG001|COMPLETED|Overall Study||20||
48780458|NCT00711477|102252680|FG000|NOT COMPLETED|Overall Study||3||
48780459|NCT00711477|102252681|FG001|NOT COMPLETED|Overall Study||3||
48780460|NCT04296448|102252682|FG000|STARTED|Overall Study||98||
48780461|NCT04296448|102252683|FG001|STARTED|Overall Study||99||
48780462|NCT04296448|102252682|FG000|COMPLETED|Overall Study||98||
48780463|NCT04296448|102252683|FG001|COMPLETED|Overall Study||99||
48780464|NCT04296448|102252682|FG000|NOT COMPLETED|Overall Study||0||
48780465|NCT04296448|102252683|FG001|NOT COMPLETED|Overall Study||0||
48780466|NCT01497366|102252684|FG000|STARTED|Overall Study||263||
48780467|NCT01497366|102252685|FG001|STARTED|Overall Study||264||
48780468|NCT01497366|102252684|FG000|Randomized But Not Treated|Overall Study||7||
48780469|NCT01497366|102252685|FG001|Randomized But Not Treated|Overall Study||21||
48780470|NCT01497366|102252684|FG000|COMPLETED|Overall Study||224||
48780471|NCT01497366|102252685|FG001|COMPLETED|Overall Study||176||
48780472|NCT01497366|102252684|FG000|NOT COMPLETED|Overall Study||39||
48780473|NCT01497366|102252685|FG001|NOT COMPLETED|Overall Study||88||
48780474|NCT04625517|102252686|FG000|STARTED|Overall Study||6||
48780475|NCT04625517|102252686|FG000|COMPLETED|Overall Study||3||
48780476|NCT04625517|102252686|FG000|NOT COMPLETED|Overall Study||3||
48780477|NCT00715910|102252687|FG000|STARTED|Year 1||433||
48780478|NCT00715910|102252688|FG001|STARTED|Year 1||147||
48780479|NCT00715910|102252689|FG002|STARTED|Year 1||68||
48780480|NCT00715910|102252690|FG003|STARTED|Year 1||0||
48780481|NCT00715910|102252691|FG004|STARTED|Year 1||0||
48780482|NCT00715910|102252692|FG005|STARTED|Year 1||0||
48780483|NCT00715910|102252687|FG000|COMPLETED|Year 1||433||
48780484|NCT00715910|102252688|FG001|COMPLETED|Year 1||147||
48780485|NCT00715910|102252689|FG002|COMPLETED|Year 1||68||
48780486|NCT00715910|102252690|FG003|COMPLETED|Year 1||0||
48780487|NCT00715910|102252691|FG004|COMPLETED|Year 1||0||
48780488|NCT00715910|102252692|FG005|COMPLETED|Year 1||0||
48780489|NCT00715910|102252687|FG000|NOT COMPLETED|Year 1||0||
48780490|NCT00715910|102252688|FG001|NOT COMPLETED|Year 1||0||
48780491|NCT00715910|102252689|FG002|NOT COMPLETED|Year 1||0||
48780492|NCT00715910|102252690|FG003|NOT COMPLETED|Year 1||0||
48465684|NCT04107493|101474483|FG000|STARTED|Washout (One Hour)||16||
48780493|NCT00715910|102252691|FG004|NOT COMPLETED|Year 1||0||
48780494|NCT00715910|102252692|FG005|NOT COMPLETED|Year 1||0||
48780495|NCT00715910|102252687|FG000|STARTED|Year 3||345||
48780496|NCT00715910|102252688|FG001|STARTED|Year 3||86||
48780497|NCT00715910|102252689|FG002|STARTED|Year 3||56||
48780498|NCT00715910|102252690|FG003|STARTED|Year 3||0||
48780499|NCT00715910|102252691|FG004|STARTED|Year 3||0||
48780500|NCT00715910|102252692|FG005|STARTED|Year 3||0||
48780501|NCT00715910|102252687|FG000|COMPLETED|Year 3||345||
48780502|NCT00715910|102252688|FG001|COMPLETED|Year 3||86||
48780503|NCT00715910|102252689|FG002|COMPLETED|Year 3||56||
48780504|NCT00715910|102252690|FG003|COMPLETED|Year 3||0||
48780505|NCT00715910|102252691|FG004|COMPLETED|Year 3||0||
48780506|NCT00715910|102252692|FG005|COMPLETED|Year 3||0||
48780507|NCT00715910|102252687|FG000|NOT COMPLETED|Year 3||0||
48780508|NCT00715910|102252688|FG001|NOT COMPLETED|Year 3||0||
48780509|NCT00715910|102252689|FG002|NOT COMPLETED|Year 3||0||
48780510|NCT00715910|102252690|FG003|NOT COMPLETED|Year 3||0||
48780511|NCT00715910|102252691|FG004|NOT COMPLETED|Year 3||0||
48780512|NCT00715910|102252692|FG005|NOT COMPLETED|Year 3||0||
48780513|NCT00715910|102252687|FG000|STARTED|Year 5||218||
48780514|NCT00715910|102252688|FG001|STARTED|Year 5||56||
48780515|NCT00715910|102252689|FG002|STARTED|Year 5||38||
48780516|NCT00715910|102252690|FG003|STARTED|Year 5||0||
48780517|NCT00715910|102252691|FG004|STARTED|Year 5||0||
48780518|NCT00715910|102252692|FG005|STARTED|Year 5||0||
48780519|NCT00715910|102252687|FG000|COMPLETED|Year 5||218||
48780520|NCT00715910|102252688|FG001|COMPLETED|Year 5||56||
48780521|NCT00715910|102252689|FG002|COMPLETED|Year 5||38||
48780522|NCT00715910|102252690|FG003|COMPLETED|Year 5||0||
48780523|NCT00715910|102252691|FG004|COMPLETED|Year 5||0||
48780524|NCT00715910|102252692|FG005|COMPLETED|Year 5||0||
48780525|NCT00715910|102252687|FG000|NOT COMPLETED|Year 5||0||
48780526|NCT00715910|102252688|FG001|NOT COMPLETED|Year 5||0||
48780527|NCT00715910|102252689|FG002|NOT COMPLETED|Year 5||0||
48780528|NCT00715910|102252690|FG003|NOT COMPLETED|Year 5||0||
48780529|NCT00715910|102252691|FG004|NOT COMPLETED|Year 5||0||
48780530|NCT00715910|102252692|FG005|NOT COMPLETED|Year 5||0||
48780531|NCT00715910|102252687|FG000|STARTED|Booster and ESFU Phase||0||
48780532|NCT00715910|102252688|FG001|STARTED|Booster and ESFU Phase||0||
48780533|NCT00715910|102252689|FG002|STARTED|Booster and ESFU Phase||0||
48780534|NCT00715910|102252690|FG003|STARTED|Booster and ESFU Phase||183||
48780535|NCT00715910|102252691|FG004|STARTED|Booster and ESFU Phase||38||
48780536|NCT00715910|102252692|FG005|STARTED|Booster and ESFU Phase||101||
48780537|NCT00715910|102252687|FG000|COMPLETED|Booster and ESFU Phase||0||
48780538|NCT00715910|102252688|FG001|COMPLETED|Booster and ESFU Phase||0||
48780539|NCT00715910|102252689|FG002|COMPLETED|Booster and ESFU Phase||0||
48780540|NCT00715910|102252690|FG003|COMPLETED|Booster and ESFU Phase||172||
48780541|NCT00715910|102252691|FG004|COMPLETED|Booster and ESFU Phase||36||
48780542|NCT00715910|102252692|FG005|COMPLETED|Booster and ESFU Phase||88||
48780543|NCT00715910|102252687|FG000|NOT COMPLETED|Booster and ESFU Phase||0||
48780544|NCT00715910|102252688|FG001|NOT COMPLETED|Booster and ESFU Phase||0||
48780545|NCT00715910|102252689|FG002|NOT COMPLETED|Booster and ESFU Phase||0||
48780546|NCT00715910|102252690|FG003|NOT COMPLETED|Booster and ESFU Phase||11||
48780547|NCT00715910|102252691|FG004|NOT COMPLETED|Booster and ESFU Phase||2||
48780548|NCT00715910|102252692|FG005|NOT COMPLETED|Booster and ESFU Phase||13||
48780549|NCT01170247|102252693|FG000|STARTED|Overall Study||2||
48780550|NCT01170247|102252694|FG001|STARTED|Overall Study||1||
48780551|NCT01170247|102252693|FG000|COMPLETED|Overall Study||2||
48780552|NCT01170247|102252694|FG001|COMPLETED|Overall Study||1||
48780553|NCT01170247|102252693|FG000|NOT COMPLETED|Overall Study||0||
48780554|NCT01170247|102252694|FG001|NOT COMPLETED|Overall Study||0||
48780555|NCT02604160|102252695|FG000|STARTED|Overall Study||2||
48780556|NCT02604160|102252696|FG001|STARTED|Overall Study||5||
48780557|NCT02604160|102252695|FG000|Received at Least One Dose of Study Drug|Overall Study||2||
48780558|NCT02604160|102252696|FG001|Received at Least One Dose of Study Drug|Overall Study||5||
48780559|NCT02604160|102252695|FG000|COMPLETED|Overall Study||2||
48780560|NCT02604160|102252696|FG001|COMPLETED|Overall Study||3||
48780561|NCT02604160|102252695|FG000|NOT COMPLETED|Overall Study||0||
48780562|NCT02604160|102252696|FG001|NOT COMPLETED|Overall Study||2||
48780563|NCT04074161|102252697|FG000|STARTED|Overall Study||126||
48780564|NCT04074161|102252698|FG001|STARTED|Overall Study||127||
48780565|NCT04074161|102252699|FG002|STARTED|Overall Study||85||
48780566|NCT04074161|102252697|FG000|Full Analysis Set|Overall Study||126||
48780567|NCT04074161|102252698|FG001|Full Analysis Set|Overall Study||127||
48780568|NCT04074161|102252699|FG002|Full Analysis Set|Overall Study||85||
48780569|NCT04074161|102252697|FG000|Safety Analysis Set|Overall Study||126||
48780570|NCT04074161|102252698|FG001|Safety Analysis Set|Overall Study||127||
48780571|NCT04074161|102252699|FG002|Safety Analysis Set|Overall Study||85||
48780572|NCT04074161|102252697|FG000|COMPLETED|Overall Study||120||
48780573|NCT04074161|102252698|FG001|COMPLETED|Overall Study||118||
48780574|NCT04074161|102252699|FG002|COMPLETED|Overall Study||81||
48780575|NCT04074161|102252697|FG000|NOT COMPLETED|Overall Study||6||
48780576|NCT04074161|102252698|FG001|NOT COMPLETED|Overall Study||9||
48780577|NCT04074161|102252699|FG002|NOT COMPLETED|Overall Study||4||
48780578|NCT00555061|102252700|FG000|STARTED|Overall Study||87||
48780579|NCT00555061|102252700|FG000|COMPLETED|Overall Study||78||
48780580|NCT00555061|102252700|FG000|NOT COMPLETED|Overall Study||9||
48780581|NCT01191762|102252701|FG000|STARTED|Overall Study||15||
48780582|NCT01191762|102252702|FG001|STARTED|Overall Study||15||
48780583|NCT01191762|102252701|FG000|COMPLETED|Overall Study||14||
48780584|NCT01191762|102252702|FG001|COMPLETED|Overall Study||15||
48780585|NCT01191762|102252701|FG000|NOT COMPLETED|Overall Study||1||
48780586|NCT01191762|102252702|FG001|NOT COMPLETED|Overall Study||0||
48780587|NCT02039843|102252703|FG000|STARTED|Randomization and Observation Period||113|Number of participants randomized to each arm.|
48780588|NCT02039843|102252704|FG001|STARTED|Randomization and Observation Period||114|Number of participants randomized to each arm.|
48780589|NCT02039843|102252703|FG000|COMPLETED|Randomization and Observation Period||84|Randomized participants paired with a study dog.|
48780590|NCT02039843|102252704|FG001|COMPLETED|Randomization and Observation Period||97|Randomized participants paired with a study dog.|
48780591|NCT02039843|102252703|FG000|NOT COMPLETED|Randomization and Observation Period||29||
48780592|NCT02039843|102252704|FG001|NOT COMPLETED|Randomization and Observation Period||17||
48780593|NCT02039843|102252703|FG000|STARTED|Pairing With a Study Dog||84||
48780594|NCT02039843|102252704|FG001|STARTED|Pairing With a Study Dog||97||
48780595|NCT02039843|102252703|FG000|COMPLETED|Pairing With a Study Dog||65||
48780596|NCT02039843|102252704|FG001|COMPLETED|Pairing With a Study Dog||88||
48780597|NCT02039843|102252703|FG000|NOT COMPLETED|Pairing With a Study Dog||19||
48780598|NCT02039843|102252704|FG001|NOT COMPLETED|Pairing With a Study Dog||9||
48780599|NCT02563067|102252705|FG000|STARTED|Overall Study||296||
48780600|NCT02563067|102252706|FG001|STARTED|Overall Study||294||
48780601|NCT02563067|102252707|FG002|STARTED|Overall Study||287||
48780602|NCT02563067|102252705|FG000|FAS/SAF: High Eosinophils Subpopulation|Overall Study||198|Full analysis set/safety set. All patients who received study drug and had high eosinophils count|
48780603|NCT02563067|102252706|FG001|FAS/SAF: High Eosinophils Subpopulation|Overall Study||196|Full analysis set/safety set. All patients who received study drug and had high eosinophils count|
48780604|NCT02563067|102252707|FG002|FAS/SAF: High Eosinophils Subpopulation|Overall Study||193|Full analysis set/safety set. All patients who received study drug and had high eosinophils count|
48780605|NCT02563067|102252705|FG000|FAS/SAF: Overall Population|Overall Study||296|Full analysis set/safety set. All patients who received study drug|
48780606|NCT02563067|102252706|FG001|FAS/SAF: Overall Population|Overall Study||293|Full analysis set/safety set. All patients who received study drug|
48780607|NCT02563067|102252707|FG002|FAS/SAF: Overall Population|Overall Study||287|Full analysis set/safety set. All patients who received study drug|
48780608|NCT02563067|102252705|FG000|COMPLETED|Overall Study||277||
48780609|NCT02563067|102252706|FG001|COMPLETED|Overall Study||268||
48780610|NCT02563067|102252707|FG002|COMPLETED|Overall Study||267||
48780611|NCT02563067|102252705|FG000|NOT COMPLETED|Overall Study||19||
48780612|NCT02563067|102252706|FG001|NOT COMPLETED|Overall Study||26||
48780613|NCT02563067|102252707|FG002|NOT COMPLETED|Overall Study||20||
48780614|NCT01402102|102252708|FG000|STARTED|Overall Study||30||
48780615|NCT01402102|102252709|FG001|STARTED|Overall Study||30||
48780616|NCT01402102|102252708|FG000|COMPLETED|Overall Study||28||
48780617|NCT01402102|102252709|FG001|COMPLETED|Overall Study||27||
48780618|NCT01402102|102252708|FG000|NOT COMPLETED|Overall Study||2||
48780619|NCT01402102|102252709|FG001|NOT COMPLETED|Overall Study||3||
48780620|NCT00552188|102252710|FG000|STARTED|Overall Study||26||
48780621|NCT00552188|102252711|FG001|STARTED|Overall Study||26||
48780622|NCT00552188|102252710|FG000|COMPLETED|Overall Study||24||
48780623|NCT00552188|102252711|FG001|COMPLETED|Overall Study||21||
48780624|NCT00552188|102252710|FG000|NOT COMPLETED|Overall Study||2||
48780625|NCT00552188|102252711|FG001|NOT COMPLETED|Overall Study||5||
48780626|NCT01640314|102252712|FG000|STARTED|Overall Study||63||
48780627|NCT01640314|102252713|FG001|STARTED|Overall Study||63||
48780628|NCT01640314|102252712|FG000|COMPLETED|Overall Study||63||
48780629|NCT01640314|102252713|FG001|COMPLETED|Overall Study||62||
48780630|NCT01640314|102252712|FG000|NOT COMPLETED|Overall Study||0||
48780631|NCT01640314|102252713|FG001|NOT COMPLETED|Overall Study||1||
48780632|NCT00324259|102252714|FG000|STARTED|Overall Study||34||
48780633|NCT00324259|102252715|FG001|STARTED|Overall Study||32||
48780634|NCT00324259|102252714|FG000|COMPLETED|Overall Study||34||
48780635|NCT00324259|102252715|FG001|COMPLETED|Overall Study||32||
48780636|NCT00324259|102252714|FG000|NOT COMPLETED|Overall Study||0||
48780637|NCT00324259|102252715|FG001|NOT COMPLETED|Overall Study||0||
48780638|NCT02973438|102252716|FG000|STARTED|First Treatment Session (4 Days)||2||
48780639|NCT02973438|102252717|FG001|STARTED|First Treatment Session (4 Days)||1||
48780640|NCT02973438|102252718|FG002|STARTED|First Treatment Session (4 Days)||2||
48780641|NCT02973438|102252719|FG003|STARTED|First Treatment Session (4 Days)||1||
48780642|NCT02973438|102252716|FG000|COMPLETED|First Treatment Session (4 Days)||2||
48780643|NCT02973438|102252717|FG001|COMPLETED|First Treatment Session (4 Days)||1||
48780644|NCT02973438|102252718|FG002|COMPLETED|First Treatment Session (4 Days)||2||
48189821|NCT03283553|100786315|FG001|Care Partner 12-Month Interview|Care Partner Participant Flow||48||
48189822|NCT03283553|100786314|FG000|COMPLETED|Care Partner Participant Flow||59||
48465685|NCT04107493|101474484|FG001|STARTED|Washout (One Hour)||17||
48780645|NCT02973438|102252719|FG003|COMPLETED|First Treatment Session (4 Days)||1||
48465686|NCT04107493|101474483|FG000|COMPLETED|Washout (One Hour)||16||
48465687|NCT04107493|101474484|FG001|COMPLETED|Washout (One Hour)||17||
48780646|NCT02973438|102252716|FG000|NOT COMPLETED|First Treatment Session (4 Days)||0||
48780647|NCT02973438|102252717|FG001|NOT COMPLETED|First Treatment Session (4 Days)||0||
48780648|NCT02973438|102252718|FG002|NOT COMPLETED|First Treatment Session (4 Days)||0||
48465688|NCT04107493|101474483|FG000|NOT COMPLETED|Washout (One Hour)||0||
48780649|NCT02973438|102252719|FG003|NOT COMPLETED|First Treatment Session (4 Days)||0||
48780650|NCT02973438|102252716|FG000|STARTED|Washout (Three Weeks)||2||
48780651|NCT02973438|102252717|FG001|STARTED|Washout (Three Weeks)||1||
48780652|NCT02973438|102252718|FG002|STARTED|Washout (Three Weeks)||2||
48780653|NCT02973438|102252719|FG003|STARTED|Washout (Three Weeks)||1||
48780654|NCT02973438|102252716|FG000|COMPLETED|Washout (Three Weeks)||2||
48780655|NCT02973438|102252717|FG001|COMPLETED|Washout (Three Weeks)||1||
48780656|NCT02973438|102252718|FG002|COMPLETED|Washout (Three Weeks)||2||
48780657|NCT02973438|102252719|FG003|COMPLETED|Washout (Three Weeks)||1||
48780658|NCT02973438|102252716|FG000|NOT COMPLETED|Washout (Three Weeks)||0||
48780659|NCT02973438|102252717|FG001|NOT COMPLETED|Washout (Three Weeks)||0||
48780660|NCT02973438|102252718|FG002|NOT COMPLETED|Washout (Three Weeks)||0||
48780661|NCT02973438|102252719|FG003|NOT COMPLETED|Washout (Three Weeks)||0||
48780662|NCT02973438|102252716|FG000|STARTED|Second Treatment Session (4 Days)||2||
48780663|NCT02973438|102252717|FG001|STARTED|Second Treatment Session (4 Days)||1||
48780664|NCT02973438|102252718|FG002|STARTED|Second Treatment Session (4 Days)||2||
48780665|NCT02973438|102252719|FG003|STARTED|Second Treatment Session (4 Days)||1||
48780666|NCT02973438|102252716|FG000|COMPLETED|Second Treatment Session (4 Days)||2||
48780667|NCT02973438|102252717|FG001|COMPLETED|Second Treatment Session (4 Days)||1||
48780668|NCT02973438|102252718|FG002|COMPLETED|Second Treatment Session (4 Days)||2||
48780669|NCT02973438|102252719|FG003|COMPLETED|Second Treatment Session (4 Days)||1||
48780670|NCT02973438|102252716|FG000|NOT COMPLETED|Second Treatment Session (4 Days)||0||
48780671|NCT02973438|102252717|FG001|NOT COMPLETED|Second Treatment Session (4 Days)||0||
48780672|NCT02973438|102252718|FG002|NOT COMPLETED|Second Treatment Session (4 Days)||0||
48780673|NCT02973438|102252719|FG003|NOT COMPLETED|Second Treatment Session (4 Days)||0||
48780674|NCT00104520|102252720|FG000|STARTED|Overall Study||76||
48780675|NCT00104520|102252721|FG001|STARTED|Overall Study||135||
48780676|NCT00104520|102252720|FG000|COMPLETED|Overall Study||26||
48780677|NCT00104520|102252721|FG001|COMPLETED|Overall Study||64||
48780678|NCT00104520|102252720|FG000|NOT COMPLETED|Overall Study||50||
48780679|NCT00104520|102252721|FG001|NOT COMPLETED|Overall Study||71||
48780680|NCT01120717|102252722|FG000|STARTED|Overall Study||226||
48780681|NCT01120717|102252723|FG001|STARTED|Overall Study||113||
48780682|NCT01120717|102252722|FG000|Safety Population: Received Study Drug|Overall Study||225||
48780683|NCT01120717|102252723|FG001|Safety Population: Received Study Drug|Overall Study||113||
48780684|NCT01120717|102252722|FG000|COMPLETED|Overall Study||194||
48780685|NCT01120717|102252723|FG001|COMPLETED|Overall Study||89||
48780686|NCT01120717|102252722|FG000|NOT COMPLETED|Overall Study||32||
48780687|NCT01120717|102252723|FG001|NOT COMPLETED|Overall Study||24||
48780688|NCT00782834|102252724|FG000|STARTED|Screened Patients||15||
48780689|NCT00782834|102252724|FG000|COMPLETED|Screened Patients||14||
48780690|NCT00782834|102252724|FG000|NOT COMPLETED|Screened Patients||1||
48780691|NCT00782834|102252724|FG000|STARTED|Treatment Phase||14||
48780692|NCT00782834|102252724|FG000|COMPLETED|Treatment Phase||13||
48780693|NCT00782834|102252724|FG000|NOT COMPLETED|Treatment Phase||1||
48780694|NCT00862641|102252725|FG000|STARTED|Overall Study||177||
48780695|NCT00862641|102252726|FG001|STARTED|Overall Study||360||
48780696|NCT00862641|102252727|FG002|STARTED|Overall Study||152||
48780697|NCT00862641|102252728|FG003|STARTED|Overall Study||320||
48780698|NCT00862641|102252725|FG000|COMPLETED|Overall Study||176||
48780699|NCT00862641|102252726|FG001|COMPLETED|Overall Study||356||
48780700|NCT00862641|102252727|FG002|COMPLETED|Overall Study||151||
48780701|NCT00862641|102252728|FG003|COMPLETED|Overall Study||316||
48780702|NCT00862641|102252725|FG000|NOT COMPLETED|Overall Study||1||
48780703|NCT00862641|102252726|FG001|NOT COMPLETED|Overall Study||4||
48780704|NCT00862641|102252727|FG002|NOT COMPLETED|Overall Study||1||
48780705|NCT00862641|102252728|FG003|NOT COMPLETED|Overall Study||4||
48780706|NCT00796991|102252729|FG000|STARTED|Overall Study||20||
48780707|NCT00796991|102252730|FG001|STARTED|Overall Study||19||
48780708|NCT00796991|102252731|FG002|STARTED|Overall Study||20||
48780709|NCT00796991|102252729|FG000|COMPLETED|Overall Study||5||
48780710|NCT00796991|102252730|FG001|COMPLETED|Overall Study||7||
48780711|NCT00796991|102252731|FG002|COMPLETED|Overall Study||6||
48780712|NCT00796991|102252729|FG000|NOT COMPLETED|Overall Study||15||
48780713|NCT00796991|102252730|FG001|NOT COMPLETED|Overall Study||12||
48780714|NCT00796991|102252731|FG002|NOT COMPLETED|Overall Study||14||
48780715|NCT03328208|102252732|FG000|STARTED|Overall Study||37||
48780716|NCT03328208|102252733|FG001|STARTED|Overall Study||35||
48780717|NCT03328208|102252732|FG000|COMPLETED|Overall Study||37||
48780718|NCT03328208|102252733|FG001|COMPLETED|Overall Study||35||
48189823|NCT03283553|100786315|FG001|COMPLETED|Care Partner Participant Flow||48||
48465689|NCT04107493|101474484|FG001|NOT COMPLETED|Washout (One Hour)||0||
48465690|NCT04107493|101474483|FG000|STARTED|Second Intervention||16||
48465691|NCT04107493|101474484|FG001|STARTED|Second Intervention||17||
48465692|NCT04107493|101474483|FG000|COMPLETED|Second Intervention||16||
48465693|NCT04107493|101474484|FG001|COMPLETED|Second Intervention||17||
48465694|NCT04107493|101474483|FG000|NOT COMPLETED|Second Intervention||0||
48465695|NCT04107493|101474484|FG001|NOT COMPLETED|Second Intervention||0||
48465696|NCT03937466|101474485|FG000|STARTED|Overall Study||38||
48465697|NCT03937466|101474485|FG000|COMPLETED|Overall Study||15||
48465698|NCT03937466|101474485|FG000|NOT COMPLETED|Overall Study||23||
48465699|NCT04583579|101474486|FG000|STARTED|Overall Study||17||
48465700|NCT04583579|101474486|FG000|COMPLETED|Overall Study||13||
48465701|NCT04583579|101474486|FG000|NOT COMPLETED|Overall Study||4||
48465702|NCT03513497|101474487|FG000|STARTED|Overall Study||36||
48465703|NCT03513497|101474488|FG001|STARTED|Overall Study||33||
48465704|NCT03513497|101474487|FG000|COMPLETED|Overall Study||31||
48465705|NCT03513497|101474488|FG001|COMPLETED|Overall Study||23||
48465706|NCT03513497|101474487|FG000|NOT COMPLETED|Overall Study||5||
48465707|NCT03513497|101474488|FG001|NOT COMPLETED|Overall Study||10||
48465708|NCT02422290|101474489|FG000|STARTED|Overall Study||5||
48465709|NCT02422290|101474489|FG000|COMPLETED|Overall Study||5||
48465710|NCT02422290|101474489|FG000|NOT COMPLETED|Overall Study||0||
48465711|NCT05286528|101474490|FG000|STARTED|Overall Study||1484||
48465712|NCT05286528|101474490|FG000|COMPLETED|Overall Study||1484||
48465713|NCT05286528|101474490|FG000|NOT COMPLETED|Overall Study||0||
48465714|NCT02354378|101474491|FG000|STARTED|Overall Study||64||
48465715|NCT02354378|101474492|FG001|STARTED|Overall Study||20||
48465716|NCT02354378|101474491|FG000|COMPLETED|Overall Study||30||
48465717|NCT02354378|101474492|FG001|COMPLETED|Overall Study||16||
48465718|NCT02354378|101474491|FG000|NOT COMPLETED|Overall Study||34||
48465719|NCT02354378|101474492|FG001|NOT COMPLETED|Overall Study||4||
48465720|NCT02497781|101474493|FG000|STARTED|Overall Study||68||
48465721|NCT02497781|101474494|FG001|STARTED|Overall Study||29||
48465722|NCT02497781|101474493|FG000|Treated|Overall Study||67||
48465723|NCT02497781|101474494|FG001|Treated|Overall Study||28||
48465724|NCT02497781|101474493|FG000|COMPLETED|Overall Study||64||
48465725|NCT02497781|101474494|FG001|COMPLETED|Overall Study||26||
48465726|NCT02497781|101474493|FG000|NOT COMPLETED|Overall Study||4||
48465727|NCT02497781|101474494|FG001|NOT COMPLETED|Overall Study||3||
48465728|NCT00815490|101474495|FG000|STARTED|Overall Study||9||
48465729|NCT00815490|101474496|FG001|STARTED|Overall Study||9||
48465730|NCT00815490|101474495|FG000|COMPLETED|Overall Study||9||
48465731|NCT00815490|101474496|FG001|COMPLETED|Overall Study||9||
48465732|NCT00815490|101474495|FG000|NOT COMPLETED|Overall Study||0||
48465733|NCT00815490|101474496|FG001|NOT COMPLETED|Overall Study||0||
48465734|NCT05117099|101474497|FG000|STARTED|Baseline||166||
48465735|NCT05117099|101474498|FG001|STARTED|Baseline||142||
48465736|NCT05117099|101474497|FG000|COMPLETED|Baseline||166||
48465737|NCT05117099|101474498|FG001|COMPLETED|Baseline||142||
48465738|NCT05117099|101474497|FG000|NOT COMPLETED|Baseline||0||
48465739|NCT05117099|101474498|FG001|NOT COMPLETED|Baseline||0||
48465740|NCT05117099|101474497|FG000|STARTED|2-month Follow-up||73|Parent participants only.|
48465741|NCT05117099|101474498|FG001|STARTED|2-month Follow-up||70|Parent participants only.|
48465742|NCT05117099|101474497|FG000|COMPLETED|2-month Follow-up||73||
48780719|NCT03328208|102252732|FG000|NOT COMPLETED|Overall Study||0||
48189824|NCT03283553|100786314|FG000|NOT COMPLETED|Care Partner Participant Flow||10||
48465743|NCT05117099|101474498|FG001|COMPLETED|2-month Follow-up||70||
48465744|NCT05117099|101474497|FG000|NOT COMPLETED|2-month Follow-up||0||
48465745|NCT05117099|101474498|FG001|NOT COMPLETED|2-month Follow-up||0||
48465746|NCT05117099|101474497|FG000|STARTED|4-month Follow-up||71||
48465747|NCT05117099|101474498|FG001|STARTED|4-month Follow-up||63||
48780720|NCT03328208|102252733|FG001|NOT COMPLETED|Overall Study||0||
48780721|NCT02032238|102252734|FG000|STARTED|Overall Study||12||
48780722|NCT02032238|102252735|FG001|STARTED|Overall Study||0||
48780723|NCT02032238|102252734|FG000|COMPLETED|Overall Study||10||
48780724|NCT02032238|102252735|FG001|COMPLETED|Overall Study||0||
48780725|NCT02032238|102252734|FG000|NOT COMPLETED|Overall Study||2||
48780726|NCT02032238|102252735|FG001|NOT COMPLETED|Overall Study||0||
48465748|NCT05117099|101474497|FG000|COMPLETED|4-month Follow-up||71||
48465749|NCT05117099|101474498|FG001|COMPLETED|4-month Follow-up||63||
48465750|NCT05117099|101474497|FG000|NOT COMPLETED|4-month Follow-up||0||
48465751|NCT05117099|101474498|FG001|NOT COMPLETED|4-month Follow-up||0||
48465752|NCT05117099|101474497|FG000|STARTED|6-month Follow-up||135||
48465753|NCT05117099|101474498|FG001|STARTED|6-month Follow-up||124||
48465754|NCT05117099|101474497|FG000|COMPLETED|6-month Follow-up||135||
48465755|NCT05117099|101474498|FG001|COMPLETED|6-month Follow-up||124||
48465756|NCT05117099|101474497|FG000|NOT COMPLETED|6-month Follow-up||0||
48465757|NCT05117099|101474498|FG001|NOT COMPLETED|6-month Follow-up||0||
48465758|NCT04616417|101474499|FG000|STARTED|Overall Study||29||
48465759|NCT04616417|101474499|FG000|Cancer Patients Who Completed Follow up Interview and Fertility Qulaity of Life Questionnaire|Overall Study||1||
48465760|NCT04616417|101474499|FG000|Patients With Non-medical Reasons Who Completed Interview Fertility Quality of Life Questionnaire|Overall Study||9||
48780727|NCT01264705|102252736|FG000|STARTED|Overall Study||3||
48780728|NCT01264705|102252737|FG001|STARTED|Overall Study||3||
48780729|NCT01264705|102252738|FG002|STARTED|Overall Study||41||
48465761|NCT04616417|101474499|FG000|COMPLETED|Overall Study||20||
48465762|NCT04616417|101474499|FG000|NOT COMPLETED|Overall Study||9||
48465763|NCT03533946|101474500|FG000|STARTED|Overall Study||7||
48465764|NCT03533946|101474500|FG000|COMPLETED|Overall Study||7||
48465765|NCT03533946|101474500|FG000|NOT COMPLETED|Overall Study||0||
48465766|NCT02789033|101476688|FG000|STARTED|Overall Study||17||
48780730|NCT01264705|102252736|FG000|COMPLETED|Overall Study||3||
48780731|NCT01264705|102252737|FG001|COMPLETED|Overall Study||3||
48780732|NCT01264705|102252738|FG002|COMPLETED|Overall Study||41||
48780733|NCT01264705|102252736|FG000|NOT COMPLETED|Overall Study||0||
48780734|NCT01264705|102252737|FG001|NOT COMPLETED|Overall Study||0||
48780735|NCT01264705|102252738|FG002|NOT COMPLETED|Overall Study||0||
48780736|NCT02561338|102252739|FG000|STARTED|Overall Study||53||
48780737|NCT02561338|102252740|FG001|STARTED|Overall Study||50||
48465767|NCT02789033|101476689|FG001|STARTED|Overall Study||17||
48465768|NCT02789033|101476690|FG002|STARTED|Overall Study||17||
48465769|NCT02789033|101476691|FG003|STARTED|Overall Study||17||
48465770|NCT02789033|101476688|FG000|COMPLETED|Overall Study||15||
48465771|NCT02789033|101476689|FG001|COMPLETED|Overall Study||15||
48465772|NCT02789033|101476690|FG002|COMPLETED|Overall Study||16||
48465773|NCT02789033|101476691|FG003|COMPLETED|Overall Study||15||
48465774|NCT02789033|101476688|FG000|NOT COMPLETED|Overall Study||2||
48465775|NCT02789033|101476689|FG001|NOT COMPLETED|Overall Study||2||
48465776|NCT02789033|101476690|FG002|NOT COMPLETED|Overall Study||1||
48465777|NCT02789033|101476691|FG003|NOT COMPLETED|Overall Study||2||
48465778|NCT00615784|101476692|FG000|STARTED|Overall Study||24||
48780738|NCT02561338|102252741|FG002|STARTED|Overall Study||51||
48189825|NCT03283553|100786315|FG001|NOT COMPLETED|Care Partner Participant Flow||15||
48465779|NCT00615784|101476692|FG000|COMPLETED|Overall Study||24||
48465780|NCT00615784|101476692|FG000|NOT COMPLETED|Overall Study||0||
48465781|NCT01185288|101476693|FG000|STARTED|Overall Study||154||
48780739|NCT02561338|102252742|FG003|STARTED|Overall Study||51||
48780740|NCT02561338|102252743|FG004|STARTED|Overall Study||53||
48780741|NCT02561338|102252739|FG000|COMPLETED|Overall Study||45||
48780742|NCT02561338|102252740|FG001|COMPLETED|Overall Study||44||
48780743|NCT02561338|102252741|FG002|COMPLETED|Overall Study||42||
48780744|NCT02561338|102252742|FG003|COMPLETED|Overall Study||46||
48780745|NCT02561338|102252743|FG004|COMPLETED|Overall Study||51||
48780746|NCT02561338|102252739|FG000|NOT COMPLETED|Overall Study||8||
48780747|NCT02561338|102252740|FG001|NOT COMPLETED|Overall Study||6||
48780748|NCT02561338|102252741|FG002|NOT COMPLETED|Overall Study||9||
48780749|NCT02561338|102252742|FG003|NOT COMPLETED|Overall Study||5||
48780750|NCT02561338|102252743|FG004|NOT COMPLETED|Overall Study||2||
48780751|NCT03544333|102252744|FG000|STARTED|Overall Study||3||
48780752|NCT03544333|102252745|FG001|STARTED|Overall Study||2||
48780753|NCT03544333|102252744|FG000|COMPLETED|Overall Study||2||
48780754|NCT03544333|102252745|FG001|COMPLETED|Overall Study||2||
48780755|NCT03544333|102252744|FG000|NOT COMPLETED|Overall Study||1||
48780756|NCT03544333|102252745|FG001|NOT COMPLETED|Overall Study||0||
48780757|NCT00442364|102252746|FG000|STARTED|Overall Study||60||
48780758|NCT00442364|102252746|FG000|COMPLETED|Overall Study||60||
48780759|NCT00442364|102252746|FG000|NOT COMPLETED|Overall Study||0||
48780760|NCT03865381|102252747|FG000|STARTED|Overall Study||60||
48780761|NCT03865381|102252747|FG000|COMPLETED|Overall Study||55||
48780762|NCT03865381|102252747|FG000|NOT COMPLETED|Overall Study||5||
48780763|NCT00539942|102252748|FG000|STARTED|Overall Study||4||
48780764|NCT00539942|102252749|FG001|STARTED|Overall Study||3||
48189826|NCT00594932|100786316|FG000|STARTED|First 3 Months||13||
48465782|NCT01185288|101476694|FG001|STARTED|Overall Study||155||
48465783|NCT01185288|101476693|FG000|COMPLETED|Overall Study||135||
48465784|NCT01185288|101476694|FG001|COMPLETED|Overall Study||139||
48465785|NCT01185288|101476693|FG000|NOT COMPLETED|Overall Study||19||
48780765|NCT00539942|102252748|FG000|COMPLETED|Overall Study||4||
48780766|NCT00539942|102252749|FG001|COMPLETED|Overall Study||3||
48780767|NCT00539942|102252748|FG000|NOT COMPLETED|Overall Study||0||
48780768|NCT00539942|102252749|FG001|NOT COMPLETED|Overall Study||0||
48780769|NCT02067676|102252750|FG000|STARTED|Overall Study||8||
48780770|NCT02067676|102252751|FG001|STARTED|Overall Study||8||
48780771|NCT02067676|102252752|FG002|STARTED|Overall Study||8||
48780772|NCT02067676|102252753|FG003|STARTED|Overall Study||8||
48780773|NCT02067676|102252754|FG004|STARTED|Overall Study||8||
48780774|NCT02067676|102252755|FG005|STARTED|Overall Study||8||
48780775|NCT02067676|102252750|FG000|COMPLETED|Overall Study||7||
48189827|NCT00594932|100786317|FG001|STARTED|First 3 Months||14||
48465786|NCT01185288|101476694|FG001|NOT COMPLETED|Overall Study||16||
48465787|NCT01193608|101476695|FG000|STARTED|Overall Study||6||
48465788|NCT01193608|101476696|FG001|STARTED|Overall Study||6||
48465789|NCT01193608|101476697|FG002|STARTED|Overall Study||16||
48465790|NCT01193608|101476698|FG003|STARTED|Overall Study||17||
48780776|NCT02067676|102252751|FG001|COMPLETED|Overall Study||8||
48780777|NCT02067676|102252752|FG002|COMPLETED|Overall Study||8||
48780778|NCT02067676|102252753|FG003|COMPLETED|Overall Study||8||
48780779|NCT02067676|102252754|FG004|COMPLETED|Overall Study||8||
48465791|NCT01193608|101476699|FG004|STARTED|Overall Study||24||
48465792|NCT01193608|101476700|FG005|STARTED|Overall Study||19||
48465793|NCT01193608|101476695|FG000|COMPLETED|Overall Study||6||
48465794|NCT01193608|101476696|FG001|COMPLETED|Overall Study||4||
48465795|NCT01193608|101476697|FG002|COMPLETED|Overall Study||14||
48465796|NCT01193608|101476698|FG003|COMPLETED|Overall Study||14||
48465797|NCT01193608|101476699|FG004|COMPLETED|Overall Study||19||
48465798|NCT01193608|101476700|FG005|COMPLETED|Overall Study||17||
48465799|NCT01193608|101476695|FG000|NOT COMPLETED|Overall Study||0||
48465800|NCT01193608|101476696|FG001|NOT COMPLETED|Overall Study||2||
48465801|NCT01193608|101476697|FG002|NOT COMPLETED|Overall Study||2||
48465802|NCT01193608|101476698|FG003|NOT COMPLETED|Overall Study||3||
48465803|NCT01193608|101476699|FG004|NOT COMPLETED|Overall Study||5||
48465804|NCT01193608|101476700|FG005|NOT COMPLETED|Overall Study||2||
48465805|NCT01400113|101476701|FG000|STARTED|Overall Study||60||
48465806|NCT01400113|101476702|FG001|STARTED|Overall Study||60||
48465807|NCT01400113|101476701|FG000|COMPLETED|Overall Study||59||
48465808|NCT01400113|101476702|FG001|COMPLETED|Overall Study||59||
48465809|NCT01400113|101476701|FG000|NOT COMPLETED|Overall Study||1||
48465810|NCT01400113|101476702|FG001|NOT COMPLETED|Overall Study||1||
48465811|NCT01927757|101476703|FG000|STARTED|Overall Study||90||
48465812|NCT01927757|101476703|FG000|Received Etanercept|Overall Study||88||
48465813|NCT01927757|101476703|FG000|COMPLETED|Overall Study||67||
48465814|NCT01927757|101476703|FG000|NOT COMPLETED|Overall Study||23||
48465815|NCT01315145|101476704|FG000|STARTED|Overall Study||122||
48465816|NCT01315145|101476705|FG001|STARTED|Overall Study||16||
48465817|NCT01315145|101476704|FG000|COMPLETED|Overall Study||105||
48465818|NCT01315145|101476705|FG001|COMPLETED|Overall Study||11||
48465819|NCT01315145|101476704|FG000|NOT COMPLETED|Overall Study||17||
48465820|NCT01315145|101476705|FG001|NOT COMPLETED|Overall Study||5||
48465821|NCT01568008|101476706|FG000|STARTED|Overall Study||933||
48465822|NCT01568008|101476706|FG000|COMPLETED|Overall Study||699||
48465823|NCT01568008|101476706|FG000|NOT COMPLETED|Overall Study||234||
48465824|NCT03294538|101476707|FG000|STARTED|Overall Study||268||
48465825|NCT03294538|101476708|FG001|STARTED|Overall Study||262||
48465826|NCT03294538|101476709|FG002|STARTED|Overall Study||133||
48465827|NCT03294538|101476707|FG000|Safety Population|Overall Study||267|All participants who were randomized and administered at least 1 dose of study drug|
48465828|NCT03294538|101476708|FG001|Safety Population|Overall Study||262|All participants who were randomized and administered at least 1 dose of study drug|
48465829|NCT03294538|101476709|FG002|Safety Population|Overall Study||132|All participants who were randomized and administered at least 1 dose of study drug|
48465830|NCT03294538|101476707|FG000|mITT Population|Overall Study||267|mITT population, administered at least 1 dose of study drug, and had a post-randomization evaluation|
48465831|NCT03294538|101476708|FG001|mITT Population|Overall Study||262|mITT population, administered at least 1 dose of study drug, and had a post-randomization evaluation|
48465832|NCT03294538|101476709|FG002|mITT Population|Overall Study||132|mITT population, administered at least 1 dose of study drug, and had a post-randomization evaluation|
48465833|NCT03294538|101476707|FG000|PP Population|Overall Study||244|Met I/E criteria, didn't develop concurrent vaginal infection, completed Day 8 visit, took 6-8 doses|
48465834|NCT03294538|101476708|FG001|PP Population|Overall Study||227|Met I/E criteria, didn't develop concurrent vaginal infection, completed Day 8 visit, took 6-8 doses|
48465835|NCT03294538|101476709|FG002|PP Population|Overall Study||126|Met I/E criteria, didn't develop concurrent vaginal infection, completed Day 8 visit, took 6-8 doses|
48465836|NCT03294538|101476707|FG000|COMPLETED|Overall Study||263||
48780780|NCT02067676|102252755|FG005|COMPLETED|Overall Study||8||
48780781|NCT02067676|102252750|FG000|NOT COMPLETED|Overall Study||1||
48780782|NCT02067676|102252751|FG001|NOT COMPLETED|Overall Study||0||
48780783|NCT02067676|102252752|FG002|NOT COMPLETED|Overall Study||0||
48780784|NCT02067676|102252753|FG003|NOT COMPLETED|Overall Study||0||
48465837|NCT03294538|101476708|FG001|COMPLETED|Overall Study||257||
48465838|NCT03294538|101476709|FG002|COMPLETED|Overall Study||131||
48465839|NCT03294538|101476707|FG000|NOT COMPLETED|Overall Study||5||
48465840|NCT03294538|101476708|FG001|NOT COMPLETED|Overall Study||5||
48465841|NCT03294538|101476709|FG002|NOT COMPLETED|Overall Study||2||
48465842|NCT04126057|101476710|FG000|STARTED|Overall Study||50||50
48465843|NCT04126057|101476711|FG001|STARTED|Overall Study||50||50
48465844|NCT04126057|101476710|FG000|COMPLETED|Overall Study||47||47
48465845|NCT04126057|101476711|FG001|COMPLETED|Overall Study||46||46
48465846|NCT04126057|101476710|FG000|NOT COMPLETED|Overall Study||3||3
48465847|NCT04126057|101476711|FG001|NOT COMPLETED|Overall Study||4||4
48465848|NCT01933295|101476712|FG000|STARTED|Overall Study||50||
48465849|NCT01933295|101476713|FG001|STARTED|Overall Study||52||
48465850|NCT01933295|101476714|FG002|STARTED|Overall Study||52||
48465851|NCT01933295|101476712|FG000|COMPLETED|Overall Study||43||
48465852|NCT01933295|101476713|FG001|COMPLETED|Overall Study||41||
48465853|NCT01933295|101476714|FG002|COMPLETED|Overall Study||42||
48780785|NCT02067676|102252754|FG004|NOT COMPLETED|Overall Study||0||
48780786|NCT02067676|102252755|FG005|NOT COMPLETED|Overall Study||0||
48780787|NCT00314795|102252756|FG000|STARTED|Overall Study||22||
48465854|NCT01933295|101476712|FG000|NOT COMPLETED|Overall Study||7||
48465855|NCT01933295|101476713|FG001|NOT COMPLETED|Overall Study||11||
48465856|NCT01933295|101476714|FG002|NOT COMPLETED|Overall Study||10||
48465857|NCT02507375|101476715|FG000|STARTED|Overall Study||6||
48780788|NCT00314795|102252756|FG000|COMPLETED|Overall Study||2||
48780789|NCT00314795|102252756|FG000|NOT COMPLETED|Overall Study||20||
48780790|NCT03672097|102252757|FG000|STARTED|Period 1||204||
48780791|NCT03672097|102252757|FG000|COMPLETED|Period 1||200||
48780792|NCT03672097|102252757|FG000|NOT COMPLETED|Period 1||4||
48780793|NCT03672097|102252757|FG000|STARTED|Period 2||200||
48780794|NCT03672097|102252757|FG000|COMPLETED|Period 2||196||
48780795|NCT03672097|102252757|FG000|NOT COMPLETED|Period 2||4||
48780796|NCT02978781|102252758|FG000|STARTED|Part A||2||
48780797|NCT02978781|102252759|FG001|STARTED|Part A||14||
48780798|NCT02978781|102252760|FG002|STARTED|Part A||0||
48780799|NCT02978781|102252761|FG003|STARTED|Part A||0||
48780800|NCT02978781|102252762|FG004|STARTED|Part A||0||
48780801|NCT02978781|102252758|FG000|COMPLETED|Part A||1||
48780802|NCT02978781|102252759|FG001|COMPLETED|Part A||12||
48780803|NCT02978781|102252760|FG002|COMPLETED|Part A||0||
48780804|NCT02978781|102252761|FG003|COMPLETED|Part A||0||
48780805|NCT02978781|102252762|FG004|COMPLETED|Part A||0||
48780806|NCT02978781|102252758|FG000|NOT COMPLETED|Part A||1||
48780807|NCT02978781|102252759|FG001|NOT COMPLETED|Part A||2||
48780808|NCT02978781|102252760|FG002|NOT COMPLETED|Part A||0||
48780809|NCT02978781|102252761|FG003|NOT COMPLETED|Part A||0||
48780810|NCT02978781|102252762|FG004|NOT COMPLETED|Part A||0||
48780811|NCT02978781|102252758|FG000|STARTED|Part B||0||
48780812|NCT02978781|102252759|FG001|STARTED|Part B||0||
48780813|NCT02978781|102252760|FG002|STARTED|Part B||4||
48780814|NCT02978781|102252761|FG003|STARTED|Part B||4||
48780815|NCT02978781|102252762|FG004|STARTED|Part B||0||
48780816|NCT02978781|102252758|FG000|COMPLETED|Part B||0||
48780817|NCT02978781|102252759|FG001|COMPLETED|Part B||0||
48780818|NCT02978781|102252760|FG002|COMPLETED|Part B||4||
48780819|NCT02978781|102252761|FG003|COMPLETED|Part B||3||
48780820|NCT02978781|102252762|FG004|COMPLETED|Part B||0||
48780821|NCT02978781|102252758|FG000|NOT COMPLETED|Part B||0||
48780822|NCT02978781|102252759|FG001|NOT COMPLETED|Part B||0||
48780823|NCT02978781|102252760|FG002|NOT COMPLETED|Part B||0||
48780824|NCT02978781|102252761|FG003|NOT COMPLETED|Part B||1||
48780825|NCT02978781|102252762|FG004|NOT COMPLETED|Part B||0||
48780826|NCT02978781|102252758|FG000|STARTED|Part C||0||
48780827|NCT02978781|102252759|FG001|STARTED|Part C||0||
48780828|NCT02978781|102252760|FG002|STARTED|Part C||0||
48780829|NCT02978781|102252761|FG003|STARTED|Part C||0||
48780830|NCT02978781|102252762|FG004|STARTED|Part C||18||
48780831|NCT02978781|102252758|FG000|COMPLETED|Part C||0||
48780832|NCT02978781|102252759|FG001|COMPLETED|Part C||0||
48780833|NCT02978781|102252760|FG002|COMPLETED|Part C||0||
48780834|NCT02978781|102252761|FG003|COMPLETED|Part C||0||
48780835|NCT02978781|102252762|FG004|COMPLETED|Part C||14||
48780836|NCT02978781|102252758|FG000|NOT COMPLETED|Part C||0||
48780837|NCT02978781|102252759|FG001|NOT COMPLETED|Part C||0||
48780838|NCT02978781|102252760|FG002|NOT COMPLETED|Part C||0||
48780839|NCT02978781|102252761|FG003|NOT COMPLETED|Part C||0||
48780840|NCT02978781|102252762|FG004|NOT COMPLETED|Part C||4||
48780841|NCT03435783|102252763|FG000|STARTED|Overall Study||20||
48780842|NCT03435783|102252764|FG001|STARTED|Overall Study||20||
48780843|NCT03435783|102252763|FG000|COMPLETED|Overall Study||20||
48780844|NCT03435783|102252764|FG001|COMPLETED|Overall Study||19||
48780845|NCT03435783|102252763|FG000|NOT COMPLETED|Overall Study||0||
48780846|NCT03435783|102252764|FG001|NOT COMPLETED|Overall Study||1||
48780847|NCT02184624|102252765|FG000|STARTED|Overall Study||171||
48780848|NCT02184624|102252766|FG001|STARTED|Overall Study||80||
48780849|NCT02184624|102252767|FG002|STARTED|Overall Study||100||
48780850|NCT02184624|102252768|FG003|STARTED|Overall Study||118||
48780851|NCT02184624|102252769|FG004|STARTED|Overall Study||98||
48780852|NCT02184624|102252765|FG000|COMPLETED|Overall Study||171||
48780853|NCT02184624|102252766|FG001|COMPLETED|Overall Study||80||
48780854|NCT02184624|102252767|FG002|COMPLETED|Overall Study||100||
48780855|NCT02184624|102252768|FG003|COMPLETED|Overall Study||118||
48780856|NCT02184624|102252769|FG004|COMPLETED|Overall Study||98||
48780857|NCT02184624|102252765|FG000|NOT COMPLETED|Overall Study||0||
48780858|NCT02184624|102252766|FG001|NOT COMPLETED|Overall Study||0||
48780859|NCT02184624|102252767|FG002|NOT COMPLETED|Overall Study||0||
48780860|NCT02184624|102252768|FG003|NOT COMPLETED|Overall Study||0||
48780861|NCT02184624|102252769|FG004|NOT COMPLETED|Overall Study||0||
48780862|NCT02314637|102252770|FG000|STARTED|Overall Study||151||
48780863|NCT02314637|102252771|FG001|STARTED|Overall Study||89||
48780864|NCT02314637|102252770|FG000|COMPLETED|Overall Study||135||
48780865|NCT02314637|102252771|FG001|COMPLETED|Overall Study||75||
48780866|NCT02314637|102252770|FG000|NOT COMPLETED|Overall Study||16||
48780867|NCT02314637|102252771|FG001|NOT COMPLETED|Overall Study||14||
48780868|NCT00790088|102252772|FG000|STARTED|Overall Study||274||
48780869|NCT00790088|102252772|FG000|Eligible for Data Analysis|Overall Study||263||
48780870|NCT00790088|102252772|FG000|COMPLETED|Overall Study||235||
48780871|NCT00790088|102252772|FG000|NOT COMPLETED|Overall Study||39||
48780872|NCT03180840|102252773|FG000|STARTED|Overall Study||30||
48780873|NCT03180840|102252773|FG000|COMPLETED|Overall Study||29|Of the 30 patients who were enrolled in the study and treated,1 patient withdrew consent after receiving the first infusion of PRX-102 2.0 mg/kg and 29 patients completed the study. The PRX-102 dosing regimen was changed to 1.0 mg/kg E2W for 1 patient during the study. A further patient was treated for more than 52 weeks due to the COVID-19 pandemic restrictions.|
48780874|NCT03180840|102252773|FG000|NOT COMPLETED|Overall Study||1||
48780875|NCT01601652|102252774|FG000|STARTED|Overall Study||12|"12 started omegaven~1 Died of complications unrelated to omegaven 6 DC home on PN (3M still on PN; 2M \& 1F weaned from PN) 5 Weaned from PN prior to DC (2F, 3M)"|
48780876|NCT01601652|102252774|FG000|COMPLETED|Overall Study||11|Last patient admitted to study on 2/18/2017 and data collection ended a month later.|
48780877|NCT01601652|102252774|FG000|NOT COMPLETED|Overall Study||1||
48780878|NCT03563183|102252775|FG000|STARTED|Overall Study||26976||
48780879|NCT03563183|102252775|FG000|COMPLETED|Overall Study||26976||
48780880|NCT03563183|102252775|FG000|NOT COMPLETED|Overall Study||0||
48780881|NCT01837823|102252776|FG000|STARTED|Overall Study||91||
48780882|NCT01837823|102252776|FG000|COMPLETED|Overall Study||85||
48780883|NCT01837823|102252776|FG000|NOT COMPLETED|Overall Study||6||
48780884|NCT02173509|102252777|FG000|STARTED|Overall Study||1679||
48780885|NCT02173509|102252778|FG001|STARTED|Overall Study||621||
48780886|NCT02173509|102252777|FG000|COMPLETED|Overall Study||1679||
48780887|NCT02173509|102252778|FG001|COMPLETED|Overall Study||621||
48780888|NCT02173509|102252777|FG000|NOT COMPLETED|Overall Study||0||
48780889|NCT02173509|102252778|FG001|NOT COMPLETED|Overall Study||0||
48780890|NCT00794313|102252779|FG000|STARTED|Overall Study||1||
48780891|NCT00794313|102252780|FG001|STARTED|Overall Study||1||
48780892|NCT00794313|102252781|FG002|STARTED|Overall Study||1||
48780893|NCT00794313|102252779|FG000|COMPLETED|Overall Study||1||
48780894|NCT00794313|102252780|FG001|COMPLETED|Overall Study||1||
48780895|NCT00794313|102252781|FG002|COMPLETED|Overall Study||1||
48465858|NCT02507375|101476716|FG001|STARTED|Overall Study||9||
48465859|NCT02507375|101476715|FG000|Cycle 1|Overall Study||6||
48465860|NCT02507375|101476716|FG001|Cycle 1|Overall Study||9||
48465861|NCT02507375|101476715|FG000|Received Pertuzumab|Overall Study||6||
48465862|NCT02507375|101476716|FG001|Received Pertuzumab|Overall Study||6||
48465863|NCT02507375|101476715|FG000|Cycle 2|Overall Study||5||
48780896|NCT00794313|102252779|FG000|NOT COMPLETED|Overall Study||0||
48780897|NCT00794313|102252780|FG001|NOT COMPLETED|Overall Study||0||
48780898|NCT00794313|102252781|FG002|NOT COMPLETED|Overall Study||0||
48780899|NCT01802073|102252782|FG000|STARTED|Overall Study||14||
48780900|NCT01802073|102252783|FG001|STARTED|Overall Study||20||
48780901|NCT01802073|102252782|FG000|COMPLETED|Overall Study||9||
48780902|NCT01802073|102252783|FG001|COMPLETED|Overall Study||9||
48780903|NCT01802073|102252782|FG000|NOT COMPLETED|Overall Study||5||
48189828|NCT00594932|100786316|FG000|COMPLETED|First 3 Months||12||
48189829|NCT00594932|100786317|FG001|COMPLETED|First 3 Months||11||
48189830|NCT00594932|100786316|FG000|NOT COMPLETED|First 3 Months||1||
48189831|NCT00594932|100786317|FG001|NOT COMPLETED|First 3 Months||3||
48189832|NCT00594932|100786316|FG000|STARTED|Final 3 Months||12||
48189833|NCT00594932|100786317|FG001|STARTED|Final 3 Months||11||
48465864|NCT02507375|101476716|FG001|Cycle 2|Overall Study||5||
48465865|NCT02507375|101476715|FG000|Cycle 3|Overall Study||4||
48465866|NCT02507375|101476716|FG001|Cycle 3|Overall Study||5||
48465867|NCT02507375|101476715|FG000|Cycle 4|Overall Study||4||
48465868|NCT02507375|101476716|FG001|Cycle 4|Overall Study||2||
48465869|NCT02507375|101476715|FG000|Cycle 5|Overall Study||3||
48465870|NCT02507375|101476716|FG001|Cycle 5|Overall Study||1||
48465871|NCT02507375|101476715|FG000|Cycle 6|Overall Study||3||
48465872|NCT02507375|101476716|FG001|Cycle 6|Overall Study||1||
48465873|NCT02507375|101476715|FG000|Extension Period|Overall Study||2||
48465874|NCT02507375|101476716|FG001|Extension Period|Overall Study||1||
48465875|NCT02507375|101476715|FG000|COMPLETED|Overall Study||2||
48465876|NCT02507375|101476716|FG001|COMPLETED|Overall Study||1||
48465877|NCT02507375|101476715|FG000|NOT COMPLETED|Overall Study||4||
48465878|NCT02507375|101476716|FG001|NOT COMPLETED|Overall Study||8||
48465879|NCT01633827|101476717|FG000|STARTED|First Intervention||11||
48465880|NCT01633827|101476718|FG001|STARTED|First Intervention||11||
48465881|NCT01633827|101476717|FG000|COMPLETED|First Intervention||11||
48465882|NCT01633827|101476718|FG001|COMPLETED|First Intervention||11||
48465883|NCT01633827|101476717|FG000|NOT COMPLETED|First Intervention||0||
48465884|NCT01633827|101476718|FG001|NOT COMPLETED|First Intervention||0||
48465885|NCT01633827|101476717|FG000|STARTED|Washout Period||11||
48465886|NCT01633827|101476718|FG001|STARTED|Washout Period||11||
48465887|NCT01633827|101476717|FG000|COMPLETED|Washout Period||11||
48465888|NCT01633827|101476718|FG001|COMPLETED|Washout Period||11||
48780904|NCT01802073|102252783|FG001|NOT COMPLETED|Overall Study||11||
48780905|NCT00481091|102252784|FG000|STARTED|Overall Study||3||
48780906|NCT00481091|102252785|FG001|STARTED|Overall Study||6||
48780907|NCT00481091|102252786|FG002|STARTED|Overall Study||3||
48780908|NCT00481091|102252787|FG003|STARTED|Overall Study||3||
48780909|NCT00481091|102252788|FG004|STARTED|Overall Study||3||
48780910|NCT00481091|102252789|FG005|STARTED|Overall Study||4||
48780911|NCT00481091|102252790|FG006|STARTED|Overall Study||3||
48780912|NCT00481091|102252791|FG007|STARTED|Overall Study||4||
48780913|NCT00481091|102252792|FG008|STARTED|Overall Study||4||
48465889|NCT01633827|101476717|FG000|NOT COMPLETED|Washout Period||0||
48465890|NCT01633827|101476718|FG001|NOT COMPLETED|Washout Period||0||
48465891|NCT01633827|101476717|FG000|STARTED|Second Intervention||11||
48465892|NCT01633827|101476718|FG001|STARTED|Second Intervention||11||
48465893|NCT01633827|101476717|FG000|COMPLETED|Second Intervention||11||
48465894|NCT01633827|101476718|FG001|COMPLETED|Second Intervention||11||
48465895|NCT01633827|101476717|FG000|NOT COMPLETED|Second Intervention||0||
48465896|NCT01633827|101476718|FG001|NOT COMPLETED|Second Intervention||0||
48465897|NCT00901628|101476719|FG000|STARTED|Overall Study||49||
48465898|NCT00901628|101476720|FG001|STARTED|Overall Study||52||
48465899|NCT00901628|101476719|FG000|COMPLETED|Overall Study||45||
48465900|NCT00901628|101476720|FG001|COMPLETED|Overall Study||42||
48465901|NCT00901628|101476719|FG000|NOT COMPLETED|Overall Study||4||
48780914|NCT00481091|102252793|FG009|STARTED|Overall Study||27||
48780915|NCT00481091|102252784|FG000|COMPLETED|Overall Study||0||
48780916|NCT00481091|102252785|FG001|COMPLETED|Overall Study||0||
48780917|NCT00481091|102252786|FG002|COMPLETED|Overall Study||0||
48780918|NCT00481091|102252787|FG003|COMPLETED|Overall Study||0||
48780919|NCT00481091|102252788|FG004|COMPLETED|Overall Study||0||
48780920|NCT00481091|102252789|FG005|COMPLETED|Overall Study||0||
48780921|NCT00481091|102252790|FG006|COMPLETED|Overall Study||0||
48780922|NCT00481091|102252791|FG007|COMPLETED|Overall Study||0||
48780923|NCT00481091|102252792|FG008|COMPLETED|Overall Study||0||
48780924|NCT00481091|102252793|FG009|COMPLETED|Overall Study||0||
48780925|NCT00481091|102252784|FG000|NOT COMPLETED|Overall Study||3||
48780926|NCT00481091|102252785|FG001|NOT COMPLETED|Overall Study||6||
48780927|NCT00481091|102252786|FG002|NOT COMPLETED|Overall Study||3||
48780928|NCT00481091|102252787|FG003|NOT COMPLETED|Overall Study||3||
48780929|NCT00481091|102252788|FG004|NOT COMPLETED|Overall Study||3||
48780930|NCT00481091|102252789|FG005|NOT COMPLETED|Overall Study||4||
48780931|NCT00481091|102252790|FG006|NOT COMPLETED|Overall Study||3||
48780932|NCT00481091|102252791|FG007|NOT COMPLETED|Overall Study||4||
48780933|NCT00481091|102252792|FG008|NOT COMPLETED|Overall Study||4||
48780934|NCT00481091|102252793|FG009|NOT COMPLETED|Overall Study||27||
48780935|NCT00373113|102252794|FG000|STARTED|Overall Study||238||
48780936|NCT00373113|102252795|FG001|STARTED|Overall Study||244||
48465902|NCT00901628|101476720|FG001|NOT COMPLETED|Overall Study||10||
48465903|NCT01807871|101476721|FG000|STARTED|Overall Study||356||
48465904|NCT01807871|101476722|FG001|STARTED|Overall Study||345||
48465905|NCT01807871|101476721|FG000|COMPLETED|Overall Study||178||
48465906|NCT01807871|101476722|FG001|COMPLETED|Overall Study||127||
48465907|NCT01807871|101476721|FG000|NOT COMPLETED|Overall Study||178||
48465908|NCT01807871|101476722|FG001|NOT COMPLETED|Overall Study||218||
48465909|NCT00135707|101476723|FG000|STARTED|Overall Study||5088||
48465910|NCT00135707|101476724|FG001|STARTED|Overall Study||5066||
48780937|NCT00373113|102252794|FG000|Received Treatment|Overall Study||238||
48780938|NCT00373113|102252795|FG001|Received Treatment|Overall Study||240||
48780939|NCT00373113|102252794|FG000|COMPLETED|Overall Study||0||
48780940|NCT00373113|102252795|FG001|COMPLETED|Overall Study||0||
48780941|NCT00373113|102252794|FG000|NOT COMPLETED|Overall Study||238||
48780942|NCT00373113|102252795|FG001|NOT COMPLETED|Overall Study||244||
48780943|NCT02934503|102252796|FG000|STARTED|Overall Study||5||
48780944|NCT02934503|102252796|FG000|COMPLETED|Overall Study||1||
48780945|NCT02934503|102252796|FG000|NOT COMPLETED|Overall Study||4||
48780946|NCT01309282|102252797|FG000|STARTED|Overall Study||9||
48780947|NCT01309282|102252797|FG000|COMPLETED|Overall Study||8||
48780948|NCT01309282|102252797|FG000|NOT COMPLETED|Overall Study||1||
48780949|NCT01675167|102252798|FG000|STARTED|Open-label Titration Phase||815||
48780950|NCT01675167|102252799|FG001|STARTED|Open-label Titration Phase||0||
48780951|NCT01675167|102252800|FG002|STARTED|Open-label Titration Phase||0||
48189834|NCT00594932|100786316|FG000|COMPLETED|Final 3 Months||8||
48465911|NCT00135707|101476723|FG000|COMPLETED|Overall Study||4993||
48465912|NCT00135707|101476724|FG001|COMPLETED|Overall Study||4976||
48465913|NCT00135707|101476723|FG000|NOT COMPLETED|Overall Study||95||
48465914|NCT00135707|101476724|FG001|NOT COMPLETED|Overall Study||90||
48465915|NCT02524379|101476725|FG000|STARTED|Overall Study||3||
48780952|NCT01675167|102252798|FG000|COMPLETED|Open-label Titration Phase||511||
48780953|NCT01675167|102252799|FG001|COMPLETED|Open-label Titration Phase||0||
48780954|NCT01675167|102252800|FG002|COMPLETED|Open-label Titration Phase||0||
48780955|NCT01675167|102252798|FG000|NOT COMPLETED|Open-label Titration Phase||304||
48780956|NCT01675167|102252799|FG001|NOT COMPLETED|Open-label Titration Phase||0||
48780957|NCT01675167|102252800|FG002|NOT COMPLETED|Open-label Titration Phase||0||
48780958|NCT01675167|102252798|FG000|STARTED|Double-blind Treatment Phase||0||
48780959|NCT01675167|102252799|FG001|STARTED|Double-blind Treatment Phase||254||
48780960|NCT01675167|102252800|FG002|STARTED|Double-blind Treatment Phase||257||
48780961|NCT01675167|102252798|FG000|COMPLETED|Double-blind Treatment Phase||0||
48780962|NCT01675167|102252799|FG001|COMPLETED|Double-blind Treatment Phase||206||
48780963|NCT01675167|102252800|FG002|COMPLETED|Double-blind Treatment Phase||147||
48780964|NCT01675167|102252798|FG000|NOT COMPLETED|Double-blind Treatment Phase||0||
48780965|NCT01675167|102252799|FG001|NOT COMPLETED|Double-blind Treatment Phase||48||
48465916|NCT02524379|101476725|FG000|COMPLETED|Overall Study||2||
48780966|NCT01675167|102252800|FG002|NOT COMPLETED|Double-blind Treatment Phase||110||
48780967|NCT03337490|102252801|FG000|STARTED|Overall Study||128||
48780968|NCT03337490|102252802|FG001|STARTED|Overall Study||126||
48465917|NCT02524379|101476725|FG000|NOT COMPLETED|Overall Study||1||
48465918|NCT00265759|101476726|FG000|STARTED|Overall Study||124||
48465919|NCT00265759|101476727|FG001|STARTED|Overall Study||128||
48465920|NCT00265759|101476728|FG002|STARTED|Overall Study||125||
48465921|NCT00265759|101476729|FG003|STARTED|Overall Study||245||
48465922|NCT00265759|101476726|FG000|COMPLETED|Overall Study||124||
48465923|NCT00265759|101476727|FG001|COMPLETED|Overall Study||127||
48465924|NCT00265759|101476728|FG002|COMPLETED|Overall Study||123||
48465925|NCT00265759|101476729|FG003|COMPLETED|Overall Study||236||
48465926|NCT00265759|101476726|FG000|NOT COMPLETED|Overall Study||0||
48465927|NCT00265759|101476727|FG001|NOT COMPLETED|Overall Study||1||
48780969|NCT03337490|102252803|FG002|STARTED|Overall Study||42||
48780970|NCT03337490|102252801|FG000|COMPLETED|Overall Study||117||
48780971|NCT03337490|102252802|FG001|COMPLETED|Overall Study||112||
48780972|NCT03337490|102252803|FG002|COMPLETED|Overall Study||7||
48780973|NCT03337490|102252801|FG000|NOT COMPLETED|Overall Study||11||
48780974|NCT03337490|102252802|FG001|NOT COMPLETED|Overall Study||14||
48780975|NCT03337490|102252803|FG002|NOT COMPLETED|Overall Study||35||
48780976|NCT00459186|102252804|FG000|STARTED|Single Agent RAD001||19||
48780977|NCT00459186|102252804|FG000|COMPLETED|Single Agent RAD001||18||
48780978|NCT00459186|102252804|FG000|NOT COMPLETED|Single Agent RAD001||1||
48780979|NCT00459186|102252804|FG000|STARTED|PET Imaging and Assessment||18||
48780980|NCT00459186|102252804|FG000|COMPLETED|PET Imaging and Assessment||15||
48465928|NCT00265759|101476728|FG002|NOT COMPLETED|Overall Study||2||
48465929|NCT00265759|101476729|FG003|NOT COMPLETED|Overall Study||9||
48465930|NCT01630200|101476730|FG000|STARTED|Overall Study||40||
48465931|NCT01630200|101476731|FG001|STARTED|Overall Study||40||
48465932|NCT01630200|101476730|FG000|COMPLETED|Overall Study||33||
48465933|NCT01630200|101476731|FG001|COMPLETED|Overall Study||34||
48465934|NCT01630200|101476730|FG000|NOT COMPLETED|Overall Study||7||
48780981|NCT00459186|102252804|FG000|NOT COMPLETED|PET Imaging and Assessment||3||
48780982|NCT00459186|102252804|FG000|STARTED|Combination RAD001 + Docetaxel||15||
48780983|NCT00459186|102252804|FG000|COMPLETED|Combination RAD001 + Docetaxel||15||
48780984|NCT00459186|102252804|FG000|NOT COMPLETED|Combination RAD001 + Docetaxel||0||
48780985|NCT04145219|102252805|FG000|STARTED|Overall Study||727|Randomised and treated|
48780986|NCT04145219|102252806|FG001|STARTED|Overall Study||731|Randomised and treated|
48780987|NCT04145219|102252805|FG000|COMPLETED|Overall Study||688|Completed IMP|
48780988|NCT04145219|102252806|FG001|COMPLETED|Overall Study||705|Completed IMP|
48780989|NCT04145219|102252805|FG000|NOT COMPLETED|Overall Study||39||
48465935|NCT01630200|101476731|FG001|NOT COMPLETED|Overall Study||6||
48465936|NCT00796510|101476732|FG000|STARTED|Overall Study||3||
48465937|NCT00796510|101476733|FG001|STARTED|Overall Study||0||
48465938|NCT00796510|101476732|FG000|COMPLETED|Overall Study||0||
48465939|NCT00796510|101476733|FG001|COMPLETED|Overall Study||0||
48780990|NCT04145219|102252806|FG001|NOT COMPLETED|Overall Study||26||
48780991|NCT00947193|102252807|FG000|STARTED|Overall Study||3||
48780992|NCT00947193|102252808|FG001|STARTED|Overall Study||10||
48780993|NCT00947193|102252807|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
48780994|NCT00947193|102252808|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10||
48780995|NCT00947193|102252807|FG000|COMPLETED|Overall Study||0||
48189835|NCT00594932|100786317|FG001|COMPLETED|Final 3 Months||8||
48465940|NCT00796510|101476732|FG000|NOT COMPLETED|Overall Study||3||
48465941|NCT00796510|101476733|FG001|NOT COMPLETED|Overall Study||0||
48465942|NCT02901899|101476734|FG000|STARTED|Reached 1st Response Assessment||45||
48465943|NCT02901899|101476734|FG000|Registered|Reached 1st Response Assessment||45||
48780996|NCT00947193|102252808|FG001|COMPLETED|Overall Study||10||
48780997|NCT00947193|102252807|FG000|NOT COMPLETED|Overall Study||3||
48780998|NCT00947193|102252808|FG001|NOT COMPLETED|Overall Study||0||
48780999|NCT02238080|102252809|FG000|STARTED|Overall Study||197||
48465944|NCT02901899|101476734|FG000|Started Treatment|Reached 1st Response Assessment||43||
48781000|NCT02238080|102252809|FG000|COMPLETED|Overall Study||172||
48781001|NCT02238080|102252809|FG000|NOT COMPLETED|Overall Study||25||
48781002|NCT00823615|102252810|FG000|STARTED|Period 1||19||
48781003|NCT00823615|102252811|FG001|STARTED|Period 1||19||
48781004|NCT00823615|102252810|FG000|COMPLETED|Period 1||19||
48781005|NCT00823615|102252811|FG001|COMPLETED|Period 1||19||
48781006|NCT00823615|102252810|FG000|NOT COMPLETED|Period 1||0||
48781007|NCT00823615|102252811|FG001|NOT COMPLETED|Period 1||0||
48781008|NCT00823615|102252810|FG000|STARTED|Period 2||19||
48781009|NCT00823615|102252811|FG001|STARTED|Period 2||19||
48781010|NCT00823615|102252810|FG000|COMPLETED|Period 2||16||
48781011|NCT00823615|102252811|FG001|COMPLETED|Period 2||17||
48781012|NCT00823615|102252810|FG000|NOT COMPLETED|Period 2||3||
48781013|NCT00823615|102252811|FG001|NOT COMPLETED|Period 2||2||
48781014|NCT01587014|102252812|FG000|STARTED|Overall Study||26||
48781015|NCT01587014|102252812|FG000|COMPLETED|Overall Study||24||
48781016|NCT01587014|102252812|FG000|NOT COMPLETED|Overall Study||2||
48781017|NCT00244140|102256115|FG000|STARTED|Overall Study||412||
48781018|NCT00244140|102256116|FG001|STARTED|Overall Study||22||
48781019|NCT00244140|102256115|FG000|COMPLETED|Overall Study||412||
48781020|NCT00244140|102256116|FG001|COMPLETED|Overall Study||22||
48781021|NCT00244140|102256115|FG000|NOT COMPLETED|Overall Study||0||
48781022|NCT00244140|102256116|FG001|NOT COMPLETED|Overall Study||0||
48781023|NCT01354899|102256117|FG000|STARTED|Overall Study||24||
48781024|NCT01354899|102256117|FG000|COMPLETED|Overall Study||21||
48781025|NCT01354899|102256117|FG000|NOT COMPLETED|Overall Study||3||
48781026|NCT01297491|102256118|FG000|STARTED|Overall Study||30||
48781027|NCT01297491|102256119|FG001|STARTED|Overall Study||33||
48781028|NCT01297491|102256118|FG000|COMPLETED|Overall Study||0||
48781029|NCT01297491|102256119|FG001|COMPLETED|Overall Study||0||
48781030|NCT01297491|102256118|FG000|NOT COMPLETED|Overall Study||30||
48781031|NCT01297491|102256119|FG001|NOT COMPLETED|Overall Study||33||
48781032|NCT01055067|102256120|FG000|STARTED|Overall Study||27||
48781033|NCT01055067|102256120|FG000|COMPLETED|Overall Study||27|Defined as participants who had progressive disease|
48781034|NCT01055067|102256120|FG000|NOT COMPLETED|Overall Study||0||
48781035|NCT02834793|102256121|FG000|STARTED|Core Study (Up to 18 Weeks)||36||
48781036|NCT02834793|102256122|FG001|STARTED|Core Study (Up to 18 Weeks)||34||
48781037|NCT02834793|102256123|FG002|STARTED|Core Study (Up to 18 Weeks)||0||
48781038|NCT02834793|102256124|FG003|STARTED|Core Study (Up to 18 Weeks)||0||
48781039|NCT02834793|102256121|FG000|COMPLETED|Core Study (Up to 18 Weeks)||32||
48781040|NCT02834793|102256122|FG001|COMPLETED|Core Study (Up to 18 Weeks)||29||
48781041|NCT02834793|102256123|FG002|COMPLETED|Core Study (Up to 18 Weeks)||0||
48781042|NCT02834793|102256124|FG003|COMPLETED|Core Study (Up to 18 Weeks)||0||
48781043|NCT02834793|102256121|FG000|NOT COMPLETED|Core Study (Up to 18 Weeks)||4||
48781044|NCT02834793|102256122|FG001|NOT COMPLETED|Core Study (Up to 18 Weeks)||5||
48781045|NCT02834793|102256123|FG002|NOT COMPLETED|Core Study (Up to 18 Weeks)||0||
48781046|NCT02834793|102256124|FG003|NOT COMPLETED|Core Study (Up to 18 Weeks)||0||
48781047|NCT02834793|102256121|FG000|STARTED|Extension Phase A (up to 52 Weeks)||0||
48781048|NCT02834793|102256122|FG001|STARTED|Extension Phase A (up to 52 Weeks)||0||
48781049|NCT02834793|102256123|FG002|STARTED|Extension Phase A (up to 52 Weeks)||58||
48781050|NCT02834793|102256124|FG003|STARTED|Extension Phase A (up to 52 Weeks)||0||
48781051|NCT02834793|102256121|FG000|COMPLETED|Extension Phase A (up to 52 Weeks)||0||
48781052|NCT02834793|102256122|FG001|COMPLETED|Extension Phase A (up to 52 Weeks)||0||
48781053|NCT02834793|102256123|FG002|COMPLETED|Extension Phase A (up to 52 Weeks)||32||
48781054|NCT02834793|102256124|FG003|COMPLETED|Extension Phase A (up to 52 Weeks)||0||
48781055|NCT02834793|102256121|FG000|NOT COMPLETED|Extension Phase A (up to 52 Weeks)||0||
48781056|NCT02834793|102256122|FG001|NOT COMPLETED|Extension Phase A (up to 52 Weeks)||0||
48781057|NCT02834793|102256123|FG002|NOT COMPLETED|Extension Phase A (up to 52 Weeks)||26||
48781058|NCT02834793|102256124|FG003|NOT COMPLETED|Extension Phase A (up to 52 Weeks)||0||
48781059|NCT02834793|102256121|FG000|STARTED|Extension Phase B (up to 188 Weeks)||0||
48781060|NCT02834793|102256122|FG001|STARTED|Extension Phase B (up to 188 Weeks)||0||
48781061|NCT02834793|102256123|FG002|STARTED|Extension Phase B (up to 188 Weeks)||0||
48781062|NCT02834793|102256124|FG003|STARTED|Extension Phase B (up to 188 Weeks)||13||
48781063|NCT02834793|102256121|FG000|COMPLETED|Extension Phase B (up to 188 Weeks)||0||
48781064|NCT02834793|102256122|FG001|COMPLETED|Extension Phase B (up to 188 Weeks)||0||
48781065|NCT02834793|102256123|FG002|COMPLETED|Extension Phase B (up to 188 Weeks)||0||
48781066|NCT02834793|102256124|FG003|COMPLETED|Extension Phase B (up to 188 Weeks)||1||
48781067|NCT02834793|102256121|FG000|NOT COMPLETED|Extension Phase B (up to 188 Weeks)||0||
48189836|NCT00594932|100786316|FG000|NOT COMPLETED|Final 3 Months||4||
48781068|NCT02834793|102256122|FG001|NOT COMPLETED|Extension Phase B (up to 188 Weeks)||0||
48781069|NCT02834793|102256123|FG002|NOT COMPLETED|Extension Phase B (up to 188 Weeks)||0||
48781070|NCT02834793|102256124|FG003|NOT COMPLETED|Extension Phase B (up to 188 Weeks)||12||
48781071|NCT00348881|102256125|FG000|STARTED|Overall Study||1424||
48781072|NCT00348881|102256126|FG001|STARTED|Overall Study||709||
48781073|NCT00348881|102256125|FG000|COMPLETED|Overall Study||1407||
48781074|NCT00348881|102256126|FG001|COMPLETED|Overall Study||697||
48781075|NCT00348881|102256125|FG000|NOT COMPLETED|Overall Study||17||
48781076|NCT00348881|102256126|FG001|NOT COMPLETED|Overall Study||12||
48781077|NCT00838513|102256127|FG000|STARTED|Screening Period||23||
48781078|NCT00838513|102256127|FG000|COMPLETED|Screening Period||20||
48781079|NCT00838513|102256127|FG000|NOT COMPLETED|Screening Period||3||
48781080|NCT00838513|102256127|FG000|STARTED|Observation Period (8 Weeks)||20||
48781081|NCT00838513|102256127|FG000|COMPLETED|Observation Period (8 Weeks)||20||
48781082|NCT00838513|102256127|FG000|NOT COMPLETED|Observation Period (8 Weeks)||0||
48781083|NCT00838513|102256127|FG000|STARTED|Treatment Period (26 Weeks)||20||
48781084|NCT00838513|102256127|FG000|COMPLETED|Treatment Period (26 Weeks)||20||
48781085|NCT00838513|102256127|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||0||
48781086|NCT00838513|102256127|FG000|STARTED|Extension Treatment Period||19||
48781087|NCT00838513|102256127|FG000|COMPLETED|Extension Treatment Period||18||
48781088|NCT00838513|102256127|FG000|NOT COMPLETED|Extension Treatment Period||1||
48781089|NCT00838513|102256127|FG000|STARTED|Post Treatment Period (Patients Who Disc||5||
48781090|NCT00838513|102256127|FG000|COMPLETED|Post Treatment Period (Patients Who Disc||4||
48781091|NCT00838513|102256127|FG000|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1||
48781092|NCT03848182|102256128|FG000|STARTED|Overall Study||10||
48781093|NCT03848182|102256128|FG000|COMPLETED|Overall Study||9||
48781094|NCT03848182|102256128|FG000|NOT COMPLETED|Overall Study||1||
48781095|NCT00929643|102256129|FG000|STARTED|Overall Study||203||
48781096|NCT00929643|102256129|FG000|COMPLETED|Overall Study||201||
48781097|NCT00929643|102256129|FG000|NOT COMPLETED|Overall Study||2||
48781098|NCT00539188|102256130|FG000|STARTED|Overall Study||4||
48781099|NCT00539188|102256131|FG001|STARTED|Overall Study||2||
48781100|NCT00539188|102256130|FG000|Received Allocated Intervention|Overall Study||3||
48781101|NCT00539188|102256131|FG001|Received Allocated Intervention|Overall Study||2||
48781102|NCT00539188|102256130|FG000|COMPLETED|Overall Study||1||
48781103|NCT00539188|102256131|FG001|COMPLETED|Overall Study||1||
48781104|NCT00539188|102256130|FG000|NOT COMPLETED|Overall Study||3||
48781105|NCT00539188|102256131|FG001|NOT COMPLETED|Overall Study||1||
48781106|NCT03023813|102256132|FG000|STARTED|Overall Study||39||
48781107|NCT03023813|102256133|FG001|STARTED|Overall Study||34||
48781108|NCT03023813|102256134|FG002|STARTED|Overall Study||31||
48781109|NCT03023813|102256132|FG000|COMPLETED|Overall Study||38||
48781110|NCT03023813|102256133|FG001|COMPLETED|Overall Study||32||
48781111|NCT03023813|102256134|FG002|COMPLETED|Overall Study||31||
48781112|NCT03023813|102256132|FG000|NOT COMPLETED|Overall Study||1||
48781113|NCT03023813|102256133|FG001|NOT COMPLETED|Overall Study||2||
48781114|NCT03023813|102256134|FG002|NOT COMPLETED|Overall Study||0||
48781115|NCT01616693|102256135|FG000|STARTED|Evaluated for Safety||155||
48781116|NCT01616693|102256136|FG001|STARTED|Evaluated for Safety||155||
48781117|NCT01616693|102256137|FG002|STARTED|Evaluated for Safety||155||
48781118|NCT01616693|102256138|FG003|STARTED|Evaluated for Safety||155||
48781119|NCT01616693|102256135|FG000|COMPLETED|Evaluated for Safety||154||
48781120|NCT01616693|102256136|FG001|COMPLETED|Evaluated for Safety||155||
48781121|NCT01616693|102256137|FG002|COMPLETED|Evaluated for Safety||154||
48781122|NCT01616693|102256138|FG003|COMPLETED|Evaluated for Safety||155||
48781123|NCT01616693|102256135|FG000|NOT COMPLETED|Evaluated for Safety||1||
48781124|NCT01616693|102256136|FG001|NOT COMPLETED|Evaluated for Safety||0||
48781125|NCT01616693|102256137|FG002|NOT COMPLETED|Evaluated for Safety||1||
48781126|NCT01616693|102256138|FG003|NOT COMPLETED|Evaluated for Safety||0||
48781127|NCT01616693|102256135|FG000|STARTED|Received Both Vaccines||154||
48781128|NCT01616693|102256136|FG001|STARTED|Received Both Vaccines||155||
48781129|NCT01616693|102256137|FG002|STARTED|Received Both Vaccines||154||
48781130|NCT01616693|102256138|FG003|STARTED|Received Both Vaccines||155||
48781131|NCT01616693|102256135|FG000|COMPLETED|Received Both Vaccines||141||
48781132|NCT01616693|102256136|FG001|COMPLETED|Received Both Vaccines||145||
48781133|NCT01616693|102256137|FG002|COMPLETED|Received Both Vaccines||142||
48781134|NCT01616693|102256138|FG003|COMPLETED|Received Both Vaccines||136||
48781135|NCT01616693|102256135|FG000|NOT COMPLETED|Received Both Vaccines||13||
48781136|NCT01616693|102256136|FG001|NOT COMPLETED|Received Both Vaccines||10||
48781137|NCT01616693|102256137|FG002|NOT COMPLETED|Received Both Vaccines||12||
48781138|NCT01616693|102256138|FG003|NOT COMPLETED|Received Both Vaccines||19||
48781139|NCT01616693|102256135|FG000|STARTED|Blood Analyzed for Immunogenicity||141||
48781140|NCT01616693|102256136|FG001|STARTED|Blood Analyzed for Immunogenicity||145||
48781141|NCT01616693|102256137|FG002|STARTED|Blood Analyzed for Immunogenicity||142||
48781142|NCT01616693|102256138|FG003|STARTED|Blood Analyzed for Immunogenicity||136||
48781143|NCT01616693|102256135|FG000|COMPLETED|Blood Analyzed for Immunogenicity||137||
48781144|NCT01616693|102256136|FG001|COMPLETED|Blood Analyzed for Immunogenicity||143||
48781145|NCT01616693|102256137|FG002|COMPLETED|Blood Analyzed for Immunogenicity||136||
48781146|NCT01616693|102256138|FG003|COMPLETED|Blood Analyzed for Immunogenicity||135||
48665758|NCT02921256|101967410|FG000|NOT COMPLETED|Arm 1a v. Arm II||16||
48781147|NCT01616693|102256135|FG000|NOT COMPLETED|Blood Analyzed for Immunogenicity||4||
48781148|NCT01616693|102256136|FG001|NOT COMPLETED|Blood Analyzed for Immunogenicity||2||
48781149|NCT01616693|102256137|FG002|NOT COMPLETED|Blood Analyzed for Immunogenicity||6||
48781150|NCT01616693|102256138|FG003|NOT COMPLETED|Blood Analyzed for Immunogenicity||1||
48781151|NCT00145119|102256139|FG000|STARTED|Overall Study||312||
48781152|NCT00145119|102256139|FG000|COMPLETED|Overall Study||267||
48781153|NCT00145119|102256139|FG000|NOT COMPLETED|Overall Study||45||
48781154|NCT01510769|102256140|FG000|STARTED|Overall Study||106||
48781155|NCT01510769|102256141|FG001|STARTED|Overall Study||109||
48781156|NCT01510769|102256142|FG002|STARTED|Overall Study||109||
48781157|NCT01510769|102256140|FG000|COMPLETED|Overall Study||79||
48781158|NCT01510769|102256141|FG001|COMPLETED|Overall Study||84||
48781159|NCT01510769|102256142|FG002|COMPLETED|Overall Study||87||
48781160|NCT01510769|102256140|FG000|NOT COMPLETED|Overall Study||27||
48781161|NCT01510769|102256141|FG001|NOT COMPLETED|Overall Study||25||
48781162|NCT01510769|102256142|FG002|NOT COMPLETED|Overall Study||22||
48465945|NCT02901899|101476734|FG000|Attempted 2 Cycles of Treatment/Reached First Response|Reached 1st Response Assessment||37||
48465946|NCT02901899|101476734|FG000|COMPLETED|Reached 1st Response Assessment||37||
48465947|NCT02901899|101476734|FG000|NOT COMPLETED|Reached 1st Response Assessment||8||
48465948|NCT02901899|101476734|FG000|STARTED|Continued Treatment After 1st Response||37|Treatment may continue in the absence of disease progression, unacceptable toxicity, death and withdrawal from the study.|
48465949|NCT02901899|101476734|FG000|Went on to Start Cycle 3|Continued Treatment After 1st Response||21||
48465950|NCT02901899|101476734|FG000|COMPLETED|Continued Treatment After 1st Response||21||
48781163|NCT01856218|102256143|FG000|STARTED|First Phase||3||
48781164|NCT01856218|102256143|FG000|COMPLETED|First Phase||3||
48781165|NCT01856218|102256143|FG000|NOT COMPLETED|First Phase||0||
48781166|NCT01856218|102256143|FG000|STARTED|Long-Term Extension Phase||3||
48781167|NCT01856218|102256143|FG000|COMPLETED|Long-Term Extension Phase||3||
48781168|NCT01856218|102256143|FG000|NOT COMPLETED|Long-Term Extension Phase||0||
48781169|NCT03052400|102256144|FG000|STARTED|Overall Study||4||
48781170|NCT03052400|102256145|FG001|STARTED|Overall Study||4||
48781171|NCT03052400|102256144|FG000|COMPLETED|Overall Study||3||
48781172|NCT03052400|102256145|FG001|COMPLETED|Overall Study||3||
48781173|NCT03052400|102256144|FG000|NOT COMPLETED|Overall Study||1||
48781174|NCT03052400|102256145|FG001|NOT COMPLETED|Overall Study||1||
48781175|NCT00763698|102256146|FG000|STARTED|Overall Study||86||
48781176|NCT00763698|102256146|FG000|COMPLETED|Overall Study||76||
48781177|NCT00763698|102256146|FG000|NOT COMPLETED|Overall Study||10||
48781178|NCT01598129|102256147|FG000|STARTED|Overall Study||12||
48781179|NCT01598129|102256147|FG000|COMPLETED|Overall Study||3||
48781180|NCT01598129|102256147|FG000|NOT COMPLETED|Overall Study||9||
48781181|NCT02762370|102256148|FG000|STARTED|Overall Study||18||
48781182|NCT02762370|102256149|FG001|STARTED|Overall Study||15||
48781183|NCT02762370|102256148|FG000|COMPLETED|Overall Study||17||
48781184|NCT02762370|102256149|FG001|COMPLETED|Overall Study||15||
48781185|NCT02762370|102256148|FG000|NOT COMPLETED|Overall Study||1||
48781186|NCT02762370|102256149|FG001|NOT COMPLETED|Overall Study||0||
48781187|NCT02954172|102256150|FG000|STARTED|Overall Study||226||
48781188|NCT02954172|102256151|FG001|STARTED|Overall Study||224||
48781189|NCT02954172|102256150|FG000|COMPLETED|Overall Study||220||
48781190|NCT02954172|102256151|FG001|COMPLETED|Overall Study||221||
48781191|NCT02954172|102256150|FG000|NOT COMPLETED|Overall Study||6||
48781192|NCT02954172|102256151|FG001|NOT COMPLETED|Overall Study||3||
48781193|NCT01092117|102256152|FG000|STARTED|Index Procedure to 1 Month||161||
48781194|NCT01092117|102256152|FG000|COMPLETED|Index Procedure to 1 Month||160||
48781195|NCT01092117|102256152|FG000|NOT COMPLETED|Index Procedure to 1 Month||1||
48781196|NCT01092117|102256152|FG000|STARTED|1 Month||160||
48781197|NCT01092117|102256152|FG000|COMPLETED|1 Month||157||
48781198|NCT01092117|102256152|FG000|NOT COMPLETED|1 Month||3||
48781199|NCT01092117|102256152|FG000|STARTED|6 Months||157||
48781200|NCT01092117|102256152|FG000|COMPLETED|6 Months||152||
48781201|NCT01092117|102256152|FG000|NOT COMPLETED|6 Months||5||
48781202|NCT01092117|102256152|FG000|STARTED|12 Month||152||
48781203|NCT01092117|102256152|FG000|COMPLETED|12 Month||138||
48781204|NCT01092117|102256152|FG000|NOT COMPLETED|12 Month||14||
48781205|NCT01092117|102256152|FG000|STARTED|Year 2||138||
48781206|NCT01092117|102256152|FG000|COMPLETED|Year 2||128||
48781207|NCT01092117|102256152|FG000|NOT COMPLETED|Year 2||10||
48781208|NCT01092117|102256152|FG000|STARTED|Year 3||128||
48781209|NCT01092117|102256152|FG000|COMPLETED|Year 3||109||
48781210|NCT01092117|102256152|FG000|NOT COMPLETED|Year 3||19||
48781211|NCT01092117|102256152|FG000|STARTED|Year 4||109||
48781212|NCT01092117|102256152|FG000|COMPLETED|Year 4||93||
48781213|NCT01092117|102256152|FG000|NOT COMPLETED|Year 4||16||
48781214|NCT01320137|102256153|FG000|STARTED|Overall Study||40||
48781215|NCT01320137|102256154|FG001|STARTED|Overall Study||40||
48781216|NCT01320137|102256153|FG000|COMPLETED|Overall Study||40||
48781217|NCT01320137|102256154|FG001|COMPLETED|Overall Study||40||
48781218|NCT01320137|102256153|FG000|NOT COMPLETED|Overall Study||0||
48781219|NCT01320137|102256154|FG001|NOT COMPLETED|Overall Study||0||
48781220|NCT02704143|102256155|FG000|STARTED|Overall Study||63||
48781221|NCT02704143|102256155|FG000|COMPLETED|Overall Study||53||
48781222|NCT02704143|102256155|FG000|NOT COMPLETED|Overall Study||10||
48781223|NCT02433080|102256156|FG000|STARTED|Overall Study||26||
48781224|NCT02433080|102256157|FG001|STARTED|Overall Study||28||
48781225|NCT02433080|102256156|FG000|8 Weeks|Overall Study||25||
48781226|NCT02433080|102256157|FG001|8 Weeks|Overall Study||24||
48781227|NCT02433080|102256156|FG000|COMPLETED|Overall Study||25|24 weeks and analyzed|
48781228|NCT02433080|102256157|FG001|COMPLETED|Overall Study||24|24 weeks and analyzed|
48781229|NCT02433080|102256156|FG000|NOT COMPLETED|Overall Study||1||
48781230|NCT02433080|102256157|FG001|NOT COMPLETED|Overall Study||4||
48781231|NCT03194737|102256158|FG000|STARTED|Overall Study||52||
48781232|NCT03194737|102256159|FG001|STARTED|Overall Study||49||
48781233|NCT03194737|102256158|FG000|COMPLETED|Overall Study||47||
48465951|NCT02901899|101476734|FG000|NOT COMPLETED|Continued Treatment After 1st Response||16||
48781234|NCT03194737|102256159|FG001|COMPLETED|Overall Study||49||
48781235|NCT03194737|102256158|FG000|NOT COMPLETED|Overall Study||5||
48781236|NCT03194737|102256159|FG001|NOT COMPLETED|Overall Study||0||
48781237|NCT01765218|102256160|FG000|STARTED|Overall Study||17|Enrolled|
48781238|NCT01765218|102256161|FG001|STARTED|Overall Study||17|Enrolled|
48781239|NCT01765218|102256160|FG000|COMPLETED|Overall Study||16|Received 5 doses of Topiramate|
48781240|NCT01765218|102256161|FG001|COMPLETED|Overall Study||15|Received 5 doses of Topiramate|
48781241|NCT01765218|102256160|FG000|NOT COMPLETED|Overall Study||1||
48781242|NCT01765218|102256161|FG001|NOT COMPLETED|Overall Study||2||
48781243|NCT02267317|102256162|FG000|STARTED|Infusion1||8||
48781244|NCT02267317|102256163|FG001|STARTED|Infusion1||3||
48781245|NCT02267317|102256164|FG002|STARTED|Infusion1||1||
48781246|NCT02267317|102256165|FG003|STARTED|Infusion1||2||
48781247|NCT02267317|102256166|FG004|STARTED|Infusion1||0||
48781248|NCT02267317|102256167|FG005|STARTED|Infusion1||1||
48781249|NCT02267317|102256162|FG000|COMPLETED|Infusion1||8||
48781250|NCT02267317|102256163|FG001|COMPLETED|Infusion1||3||
48781251|NCT02267317|102256164|FG002|COMPLETED|Infusion1||1||
48781252|NCT02267317|102256165|FG003|COMPLETED|Infusion1||2||
48781253|NCT02267317|102256166|FG004|COMPLETED|Infusion1||0||
48781254|NCT02267317|102256167|FG005|COMPLETED|Infusion1||1||
48465952|NCT02901899|101476734|FG000|STARTED|Follow up||43|Follow up continues until death, withdrawal of consent or the end of the study, whichever comes first.|
48465953|NCT02901899|101476734|FG000|COMPLETED|Follow up||27||
48465954|NCT02901899|101476734|FG000|NOT COMPLETED|Follow up||16||
48465955|NCT00747552|101476735|FG000|STARTED|Overall Study||30||
48465956|NCT00747552|101476735|FG000|COMPLETED|Overall Study||30||
48465957|NCT00747552|101476735|FG000|NOT COMPLETED|Overall Study||0||
48465958|NCT01797120|101476736|FG000|STARTED|Overall Study||66||
48465959|NCT01797120|101476737|FG001|STARTED|Overall Study||65||
48781255|NCT02267317|102256162|FG000|NOT COMPLETED|Infusion1||0||
48781256|NCT02267317|102256163|FG001|NOT COMPLETED|Infusion1||0||
48781257|NCT02267317|102256164|FG002|NOT COMPLETED|Infusion1||0||
48465960|NCT01797120|101476736|FG000|COMPLETED|Overall Study||0||
48465961|NCT01797120|101476737|FG001|COMPLETED|Overall Study||0||
48465962|NCT01797120|101476736|FG000|NOT COMPLETED|Overall Study||66||
48781258|NCT02267317|102256165|FG003|NOT COMPLETED|Infusion1||0||
48781259|NCT02267317|102256166|FG004|NOT COMPLETED|Infusion1||0||
48781260|NCT02267317|102256167|FG005|NOT COMPLETED|Infusion1||0||
48781261|NCT02267317|102256162|FG000|STARTED|Washout (3-4weeks Between Infusions)||8||
48781262|NCT02267317|102256163|FG001|STARTED|Washout (3-4weeks Between Infusions)||3||
48781263|NCT02267317|102256164|FG002|STARTED|Washout (3-4weeks Between Infusions)||1||
48781264|NCT02267317|102256165|FG003|STARTED|Washout (3-4weeks Between Infusions)||2||
48781265|NCT02267317|102256166|FG004|STARTED|Washout (3-4weeks Between Infusions)||0||
48781266|NCT02267317|102256167|FG005|STARTED|Washout (3-4weeks Between Infusions)||1||
48781267|NCT02267317|102256162|FG000|COMPLETED|Washout (3-4weeks Between Infusions)||6||
48781268|NCT02267317|102256163|FG001|COMPLETED|Washout (3-4weeks Between Infusions)||3||
48781269|NCT02267317|102256164|FG002|COMPLETED|Washout (3-4weeks Between Infusions)||1||
48781270|NCT02267317|102256165|FG003|COMPLETED|Washout (3-4weeks Between Infusions)||2||
48781271|NCT02267317|102256166|FG004|COMPLETED|Washout (3-4weeks Between Infusions)||0||
48465963|NCT01797120|101476737|FG001|NOT COMPLETED|Overall Study||65||
48465964|NCT00522457|101476738|FG000|STARTED|Overall Study||19||
48465965|NCT00522457|101476738|FG000|COMPLETED|Overall Study||1||
48465966|NCT00522457|101476738|FG000|NOT COMPLETED|Overall Study||18||
48465967|NCT00829413|101476739|FG000|STARTED|Overall Study||353||
48781272|NCT02267317|102256167|FG005|COMPLETED|Washout (3-4weeks Between Infusions)||1||
48781273|NCT02267317|102256162|FG000|NOT COMPLETED|Washout (3-4weeks Between Infusions)||2||
48781274|NCT02267317|102256163|FG001|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0||
48781275|NCT02267317|102256164|FG002|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0||
48781276|NCT02267317|102256165|FG003|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0||
48781277|NCT02267317|102256166|FG004|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0||
48781278|NCT02267317|102256167|FG005|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0||
48781279|NCT02267317|102256162|FG000|STARTED|Infusion2||6||
48781280|NCT02267317|102256163|FG001|STARTED|Infusion2||3||
48781281|NCT02267317|102256164|FG002|STARTED|Infusion2||1||
48781282|NCT02267317|102256165|FG003|STARTED|Infusion2||2||
48781283|NCT02267317|102256166|FG004|STARTED|Infusion2||0||
48465968|NCT00829413|101476739|FG000|COMPLETED|Overall Study||259||
48465969|NCT00829413|101476739|FG000|NOT COMPLETED|Overall Study||94||
48781284|NCT02267317|102256167|FG005|STARTED|Infusion2||1||
48781285|NCT02267317|102256162|FG000|COMPLETED|Infusion2||6||
48465970|NCT01844583|101476740|FG000|STARTED|Overall Study||26||
48465971|NCT01844583|101476741|FG001|STARTED|Overall Study||29||
48465972|NCT01844583|101476740|FG000|COMPLETED|Overall Study||18||
48781286|NCT02267317|102256163|FG001|COMPLETED|Infusion2||3||
48781287|NCT02267317|102256164|FG002|COMPLETED|Infusion2||1||
48781288|NCT02267317|102256165|FG003|COMPLETED|Infusion2||2||
48781289|NCT02267317|102256166|FG004|COMPLETED|Infusion2||0||
48781290|NCT02267317|102256167|FG005|COMPLETED|Infusion2||1||
48781291|NCT02267317|102256162|FG000|NOT COMPLETED|Infusion2||0||
48781292|NCT02267317|102256163|FG001|NOT COMPLETED|Infusion2||0||
48465973|NCT01844583|101476741|FG001|COMPLETED|Overall Study||19||
48465974|NCT01844583|101476740|FG000|NOT COMPLETED|Overall Study||8||
48465975|NCT01844583|101476741|FG001|NOT COMPLETED|Overall Study||10||
48781293|NCT02267317|102256164|FG002|NOT COMPLETED|Infusion2||0||
48781294|NCT02267317|102256165|FG003|NOT COMPLETED|Infusion2||0||
48781295|NCT02267317|102256166|FG004|NOT COMPLETED|Infusion2||0||
48781296|NCT02267317|102256167|FG005|NOT COMPLETED|Infusion2||0||
48781297|NCT01387542|102256168|FG000|STARTED|Overall Study||40||
48781298|NCT01387542|102256168|FG000|Treated|Overall Study||38||
48781299|NCT01387542|102256168|FG000|COMPLETED|Overall Study||32||
48781300|NCT01387542|102256168|FG000|NOT COMPLETED|Overall Study||8||
48781301|NCT02036853|102256169|FG000|STARTED|Overall Study||6||
48781302|NCT02036853|102256170|FG001|STARTED|Overall Study||14||
48781303|NCT02036853|102256169|FG000|COMPLETED|Overall Study||6||
48781304|NCT02036853|102256170|FG001|COMPLETED|Overall Study||8||
48781305|NCT02036853|102256169|FG000|NOT COMPLETED|Overall Study||0||
48781306|NCT02036853|102256170|FG001|NOT COMPLETED|Overall Study||6||
48781307|NCT00084136|102256171|FG000|STARTED|PI Comparison||519||
48781308|NCT00084136|102256172|FG001|STARTED|PI Comparison||526||
48781309|NCT00084136|102256173|FG002|STARTED|PI Comparison||0||
48781310|NCT00084136|102256171|FG000|COMPLETED|PI Comparison||464||
48781311|NCT00084136|102256172|FG001|COMPLETED|PI Comparison||479||
48781312|NCT00084136|102256173|FG002|COMPLETED|PI Comparison||0||
48781313|NCT00084136|102256171|FG000|NOT COMPLETED|PI Comparison||55||
48781314|NCT00084136|102256172|FG001|NOT COMPLETED|PI Comparison||47||
48781315|NCT00084136|102256173|FG002|NOT COMPLETED|PI Comparison||0||
48781316|NCT00084136|102256171|FG000|STARTED|NRTI Comparison||519||
48781317|NCT00084136|102256172|FG001|STARTED|NRTI Comparison||0||
48781318|NCT00084136|102256173|FG002|STARTED|NRTI Comparison||526||
48781319|NCT00084136|102256171|FG000|COMPLETED|NRTI Comparison||418||
48781320|NCT00084136|102256172|FG001|COMPLETED|NRTI Comparison||0||
48781321|NCT00084136|102256173|FG002|COMPLETED|NRTI Comparison||444||
48781322|NCT00084136|102256171|FG000|NOT COMPLETED|NRTI Comparison||101||
48781323|NCT00084136|102256172|FG001|NOT COMPLETED|NRTI Comparison||0||
48781324|NCT00084136|102256173|FG002|NOT COMPLETED|NRTI Comparison||82||
48781325|NCT01396447|102256174|FG000|STARTED|Overall Study||148||
48781326|NCT01396447|102256175|FG001|STARTED|Overall Study||143||
48465976|NCT03347695|101476742|FG000|STARTED|Overall Study||20||
48465977|NCT03347695|101476743|FG001|STARTED|Overall Study||120||
48465978|NCT03347695|101476742|FG000|COMPLETED|Overall Study||20||
48465979|NCT03347695|101476743|FG001|COMPLETED|Overall Study||115||
48465980|NCT03347695|101476742|FG000|NOT COMPLETED|Overall Study||0||
48465981|NCT03347695|101476743|FG001|NOT COMPLETED|Overall Study||5||
48465982|NCT00810732|101476744|FG000|STARTED|First Intervention Period (6 Weeks)||5||
48465983|NCT00810732|101476745|FG001|STARTED|First Intervention Period (6 Weeks)||4||
48465984|NCT00810732|101476746|FG002|STARTED|First Intervention Period (6 Weeks)||4||
48465985|NCT00810732|101476747|FG003|STARTED|First Intervention Period (6 Weeks)||5||
48465986|NCT00810732|101476748|FG004|STARTED|First Intervention Period (6 Weeks)||5||
48465987|NCT00810732|101476749|FG005|STARTED|First Intervention Period (6 Weeks)||4||
48465988|NCT00810732|101476744|FG000|COMPLETED|First Intervention Period (6 Weeks)||5||
48465989|NCT00810732|101476745|FG001|COMPLETED|First Intervention Period (6 Weeks)||4||
48465990|NCT00810732|101476746|FG002|COMPLETED|First Intervention Period (6 Weeks)||4||
48465991|NCT00810732|101476747|FG003|COMPLETED|First Intervention Period (6 Weeks)||5||
48465992|NCT00810732|101476748|FG004|COMPLETED|First Intervention Period (6 Weeks)||5||
48465993|NCT00810732|101476749|FG005|COMPLETED|First Intervention Period (6 Weeks)||4||
48465994|NCT00810732|101476744|FG000|NOT COMPLETED|First Intervention Period (6 Weeks)||0||
48465995|NCT00810732|101476745|FG001|NOT COMPLETED|First Intervention Period (6 Weeks)||0||
48465996|NCT00810732|101476746|FG002|NOT COMPLETED|First Intervention Period (6 Weeks)||0||
48465997|NCT00810732|101476747|FG003|NOT COMPLETED|First Intervention Period (6 Weeks)||0||
48465998|NCT00810732|101476748|FG004|NOT COMPLETED|First Intervention Period (6 Weeks)||0||
48465999|NCT00810732|101476749|FG005|NOT COMPLETED|First Intervention Period (6 Weeks)||0||
48781327|NCT01396447|102256176|FG002|STARTED|Overall Study||147||
48781328|NCT01396447|102256177|FG003|STARTED|Overall Study||146||
48781329|NCT01396447|102256174|FG000|Received Treatment|Overall Study||145||
48781330|NCT01396447|102256175|FG001|Received Treatment|Overall Study||141||
48781331|NCT01396447|102256176|FG002|Received Treatment|Overall Study||146||
48466000|NCT00810732|101476744|FG000|STARTED|First Washout Period (at Least 2 Weeks)||5||
48466001|NCT00810732|101476745|FG001|STARTED|First Washout Period (at Least 2 Weeks)||4||
48466002|NCT00810732|101476746|FG002|STARTED|First Washout Period (at Least 2 Weeks)||4||
48466003|NCT00810732|101476747|FG003|STARTED|First Washout Period (at Least 2 Weeks)||5||
48781332|NCT01396447|102256177|FG003|Received Treatment|Overall Study||146||
48781333|NCT01396447|102256174|FG000|COMPLETED|Overall Study||105||
48466004|NCT00810732|101476748|FG004|STARTED|First Washout Period (at Least 2 Weeks)||5||
48781334|NCT01396447|102256175|FG001|COMPLETED|Overall Study||103||
48781335|NCT01396447|102256176|FG002|COMPLETED|Overall Study||117||
48781336|NCT01396447|102256177|FG003|COMPLETED|Overall Study||94||
48781337|NCT01396447|102256174|FG000|NOT COMPLETED|Overall Study||43||
48781338|NCT01396447|102256175|FG001|NOT COMPLETED|Overall Study||40||
48781339|NCT01396447|102256176|FG002|NOT COMPLETED|Overall Study||30||
48781340|NCT01396447|102256177|FG003|NOT COMPLETED|Overall Study||52||
48781341|NCT01590758|102256178|FG000|STARTED|Overall Study||85||
48781342|NCT01590758|102256179|FG001|STARTED|Overall Study||104||
48781343|NCT01590758|102256178|FG000|COMPLETED|Overall Study||80||
48781344|NCT01590758|102256179|FG001|COMPLETED|Overall Study||97||
48781345|NCT01590758|102256178|FG000|NOT COMPLETED|Overall Study||5||
48781346|NCT01590758|102256179|FG001|NOT COMPLETED|Overall Study||7||
48781347|NCT01705509|102256180|FG000|STARTED|Inclusion CPET||14||
48781348|NCT01705509|102256180|FG000|COMPLETED|Inclusion CPET||7||
48781349|NCT01705509|102256180|FG000|NOT COMPLETED|Inclusion CPET||7||
48781350|NCT01705509|102256180|FG000|STARTED|CPET w/ Ranexa||7||
48781351|NCT01705509|102256180|FG000|COMPLETED|CPET w/ Ranexa||5||
48781352|NCT01705509|102256180|FG000|NOT COMPLETED|CPET w/ Ranexa||2||
48781353|NCT02164461|102256181|FG000|STARTED|Overall Study||1||
48781354|NCT02164461|102256182|FG001|STARTED|Overall Study||6||
48781355|NCT02164461|102256183|FG002|STARTED|Overall Study||5||
48781356|NCT02164461|102256181|FG000|Enrolled Participants|Overall Study||0||
48781357|NCT02164461|102256182|FG001|Enrolled Participants|Overall Study||6||
48781358|NCT02164461|102256183|FG002|Enrolled Participants|Overall Study||6||
48781359|NCT02164461|102256181|FG000|Treated Participants|Overall Study||1||
48781360|NCT02164461|102256182|FG001|Treated Participants|Overall Study||6||
48781361|NCT02164461|102256183|FG002|Treated Participants|Overall Study||5||
48781362|NCT02164461|102256181|FG000|COMPLETED|Overall Study||0||
48781363|NCT02164461|102256182|FG001|COMPLETED|Overall Study||0||
48781364|NCT02164461|102256183|FG002|COMPLETED|Overall Study||0||
48781365|NCT02164461|102256181|FG000|NOT COMPLETED|Overall Study||1||
48781366|NCT02164461|102256182|FG001|NOT COMPLETED|Overall Study||6||
48781367|NCT02164461|102256183|FG002|NOT COMPLETED|Overall Study||5||
48781368|NCT04335136|102256184|FG000|STARTED|Overall Study||91|Patients randomized.|
48781369|NCT04335136|102256185|FG001|STARTED|Overall Study||90|Patients randomized.|
48781370|NCT04335136|102256184|FG000|Treated|Overall Study||88||
48781371|NCT04335136|102256185|FG001|Treated|Overall Study||90||
48781372|NCT04335136|102256184|FG000|COMPLETED|Overall Study||77||
48781373|NCT04335136|102256185|FG001|COMPLETED|Overall Study||83||
48781374|NCT04335136|102256184|FG000|NOT COMPLETED|Overall Study||14||
48781375|NCT04335136|102256185|FG001|NOT COMPLETED|Overall Study||7||
48781376|NCT01454258|102256186|FG000|STARTED|Overall Study||10100||
48781377|NCT01454258|102256186|FG000|COMPLETED|Overall Study||9103||
48781378|NCT01454258|102256186|FG000|NOT COMPLETED|Overall Study||997||
48781379|NCT01137604|102256187|FG000|STARTED|Overall Study||38||
48781380|NCT01137604|102256188|FG001|STARTED|Overall Study||42||
48781381|NCT01137604|102256189|FG002|STARTED|Overall Study||39||
48781382|NCT01137604|102256190|FG003|STARTED|Overall Study||32||
48781383|NCT01137604|102256187|FG000|Treatment Discontinued Due to Disease Progression|Overall Study||34||
48781384|NCT01137604|102256188|FG001|Treatment Discontinued Due to Disease Progression|Overall Study||32||
48781385|NCT01137604|102256189|FG002|Treatment Discontinued Due to Disease Progression|Overall Study||26||
48781386|NCT01137604|102256190|FG003|Treatment Discontinued Due to Disease Progression|Overall Study||21||
48781387|NCT01137604|102256187|FG000|COMPLETED|Overall Study||34||
48781388|NCT01137604|102256188|FG001|COMPLETED|Overall Study||32||
48781389|NCT01137604|102256189|FG002|COMPLETED|Overall Study||26||
48781390|NCT01137604|102256190|FG003|COMPLETED|Overall Study||21||
48781391|NCT01137604|102256187|FG000|NOT COMPLETED|Overall Study||4||
48781392|NCT01137604|102256188|FG001|NOT COMPLETED|Overall Study||10||
48781393|NCT01137604|102256189|FG002|NOT COMPLETED|Overall Study||13||
48781394|NCT01137604|102256190|FG003|NOT COMPLETED|Overall Study||11||
48781395|NCT01745822|102256191|FG000|STARTED|Overall Study||331||
48781396|NCT01745822|102256192|FG001|STARTED|Overall Study||323||
48781397|NCT01745822|102256191|FG000|COMPLETED|Overall Study||331||
48781398|NCT01745822|102256192|FG001|COMPLETED|Overall Study||323||
48781399|NCT01745822|102256191|FG000|NOT COMPLETED|Overall Study||0||
48781400|NCT01745822|102256192|FG001|NOT COMPLETED|Overall Study||0||
48781401|NCT04075734|102256193|FG000|STARTED|Overall Study||25||
48781402|NCT04075734|102256194|FG001|STARTED|Overall Study||25||
48781403|NCT04075734|102256195|FG002|STARTED|Overall Study||10||
48781404|NCT04075734|102256193|FG000|COMPLETED|Overall Study||21||
48781405|NCT04075734|102256194|FG001|COMPLETED|Overall Study||24||
48781406|NCT04075734|102256195|FG002|COMPLETED|Overall Study||10||
48781407|NCT04075734|102256193|FG000|NOT COMPLETED|Overall Study||4||
48781408|NCT04075734|102256194|FG001|NOT COMPLETED|Overall Study||1||
48781409|NCT04075734|102256195|FG002|NOT COMPLETED|Overall Study||0||
48781410|NCT01627288|102256196|FG000|STARTED|Overall Study||3||
48781411|NCT01627288|102256197|FG001|STARTED|Overall Study||3||
48781412|NCT01627288|102256198|FG002|STARTED|Overall Study||6||
48781413|NCT01627288|102256199|FG003|STARTED|Overall Study||0||
48781414|NCT01627288|102256196|FG000|COMPLETED|Overall Study||3||
48781415|NCT01627288|102256197|FG001|COMPLETED|Overall Study||3||
48781416|NCT01627288|102256198|FG002|COMPLETED|Overall Study||6||
48781417|NCT01627288|102256199|FG003|COMPLETED|Overall Study||0||
48781418|NCT01627288|102256196|FG000|NOT COMPLETED|Overall Study||0||
48781419|NCT01627288|102256197|FG001|NOT COMPLETED|Overall Study||0||
48781420|NCT01627288|102256198|FG002|NOT COMPLETED|Overall Study||0||
48781421|NCT01627288|102256199|FG003|NOT COMPLETED|Overall Study||0||
48781422|NCT00800254|102256200|FG000|STARTED|Overall Study||35||
48781423|NCT00800254|102256201|FG001|STARTED|Overall Study||31||
48781424|NCT00800254|102256200|FG000|3.5 Weeks Post-operatively|Overall Study||31||
48781425|NCT00800254|102256201|FG001|3.5 Weeks Post-operatively|Overall Study||31||
48781426|NCT00800254|102256200|FG000|COMPLETED|Overall Study||30||
48781427|NCT00800254|102256201|FG001|COMPLETED|Overall Study||25||
48781428|NCT00800254|102256200|FG000|NOT COMPLETED|Overall Study||5||
48781429|NCT00800254|102256201|FG001|NOT COMPLETED|Overall Study||6||
48781430|NCT02042872|102256202|FG000|STARTED|Overall Study||8||
48781431|NCT02042872|102256203|FG001|STARTED|Overall Study||13||
48781432|NCT02042872|102256202|FG000|COMPLETED|Overall Study||8||
48466005|NCT00810732|101476749|FG005|STARTED|First Washout Period (at Least 2 Weeks)||4||
48466006|NCT00810732|101476744|FG000|COMPLETED|First Washout Period (at Least 2 Weeks)||5||
48466007|NCT00810732|101476745|FG001|COMPLETED|First Washout Period (at Least 2 Weeks)||4||
48466008|NCT00810732|101476746|FG002|COMPLETED|First Washout Period (at Least 2 Weeks)||4||
48466009|NCT00810732|101476747|FG003|COMPLETED|First Washout Period (at Least 2 Weeks)||5||
48466010|NCT00810732|101476748|FG004|COMPLETED|First Washout Period (at Least 2 Weeks)||5||
48466011|NCT00810732|101476749|FG005|COMPLETED|First Washout Period (at Least 2 Weeks)||4||
48466012|NCT00810732|101476744|FG000|NOT COMPLETED|First Washout Period (at Least 2 Weeks)||0||
48466013|NCT00810732|101476745|FG001|NOT COMPLETED|First Washout Period (at Least 2 Weeks)||0||
48466014|NCT00810732|101476746|FG002|NOT COMPLETED|First Washout Period (at Least 2 Weeks)||0||
48466015|NCT00810732|101476747|FG003|NOT COMPLETED|First Washout Period (at Least 2 Weeks)||0||
48466016|NCT00810732|101476748|FG004|NOT COMPLETED|First Washout Period (at Least 2 Weeks)||0||
48466017|NCT00810732|101476749|FG005|NOT COMPLETED|First Washout Period (at Least 2 Weeks)||0||
48466018|NCT00810732|101476744|FG000|STARTED|Second Intervention Period (6 Weeks)||5||
48466019|NCT00810732|101476745|FG001|STARTED|Second Intervention Period (6 Weeks)||4||
48466020|NCT00810732|101476746|FG002|STARTED|Second Intervention Period (6 Weeks)||4||
48466021|NCT00810732|101476747|FG003|STARTED|Second Intervention Period (6 Weeks)||5||
48466022|NCT00810732|101476748|FG004|STARTED|Second Intervention Period (6 Weeks)||5||
48466023|NCT00810732|101476749|FG005|STARTED|Second Intervention Period (6 Weeks)||4||
48466024|NCT00810732|101476744|FG000|COMPLETED|Second Intervention Period (6 Weeks)||5||
48466025|NCT00810732|101476745|FG001|COMPLETED|Second Intervention Period (6 Weeks)||4||
48466026|NCT00810732|101476746|FG002|COMPLETED|Second Intervention Period (6 Weeks)||4||
48466027|NCT00810732|101476747|FG003|COMPLETED|Second Intervention Period (6 Weeks)||5||
48466028|NCT00810732|101476748|FG004|COMPLETED|Second Intervention Period (6 Weeks)||5||
48466029|NCT00810732|101476749|FG005|COMPLETED|Second Intervention Period (6 Weeks)||4||
48466030|NCT00810732|101476744|FG000|NOT COMPLETED|Second Intervention Period (6 Weeks)||0||
48466031|NCT00810732|101476745|FG001|NOT COMPLETED|Second Intervention Period (6 Weeks)||0||
48466032|NCT00810732|101476746|FG002|NOT COMPLETED|Second Intervention Period (6 Weeks)||0||
48781433|NCT02042872|102256203|FG001|COMPLETED|Overall Study||8||
48781434|NCT02042872|102256202|FG000|NOT COMPLETED|Overall Study||0||
48781435|NCT02042872|102256203|FG001|NOT COMPLETED|Overall Study||5||
48781436|NCT01727024|102256204|FG000|STARTED|Period 1||71||
48781437|NCT01727024|102256205|FG001|STARTED|Period 1||68||
48781438|NCT01727024|102256204|FG000|COMPLETED|Period 1||68||
48781439|NCT01727024|102256205|FG001|COMPLETED|Period 1||64||
48781440|NCT01727024|102256204|FG000|NOT COMPLETED|Period 1||3||
48781441|NCT01727024|102256205|FG001|NOT COMPLETED|Period 1||4||
48781442|NCT01727024|102256204|FG000|STARTED|Period 2||68||
48781443|NCT01727024|102256205|FG001|STARTED|Period 2||64||
48781444|NCT01727024|102256204|FG000|COMPLETED|Period 2||68||
48466033|NCT00810732|101476747|FG003|NOT COMPLETED|Second Intervention Period (6 Weeks)||0||
48466034|NCT00810732|101476748|FG004|NOT COMPLETED|Second Intervention Period (6 Weeks)||0||
48466035|NCT00810732|101476749|FG005|NOT COMPLETED|Second Intervention Period (6 Weeks)||0||
48466036|NCT00810732|101476744|FG000|STARTED|Second Washout Period (at Least 2 Weeks)||5||
48466037|NCT00810732|101476745|FG001|STARTED|Second Washout Period (at Least 2 Weeks)||4||
48781445|NCT01727024|102256205|FG001|COMPLETED|Period 2||64||
48781446|NCT01727024|102256204|FG000|NOT COMPLETED|Period 2||0||
48781447|NCT01727024|102256205|FG001|NOT COMPLETED|Period 2||0||
48781448|NCT00843284|102256206|FG000|STARTED|Overall Study||691||
48781449|NCT00843284|102256206|FG000|COMPLETED|Overall Study||619||
48781450|NCT00843284|102256206|FG000|NOT COMPLETED|Overall Study||72||
48781451|NCT01396057|102256207|FG000|STARTED|Overall Study||126||
48781452|NCT01396057|102256208|FG001|STARTED|Overall Study||118||
48781453|NCT01396057|102256207|FG000|COMPLETED|Overall Study||115||
48781454|NCT01396057|102256208|FG001|COMPLETED|Overall Study||100||
48781455|NCT01396057|102256207|FG000|NOT COMPLETED|Overall Study||11||
48781456|NCT01396057|102256208|FG001|NOT COMPLETED|Overall Study||18||
48781457|NCT00750152|102256209|FG000|STARTED|Overall Study||166||
48781458|NCT00750152|102256210|FG001|STARTED|Overall Study||168||
48781459|NCT00750152|102256209|FG000|COMPLETED|Overall Study||144||
48781460|NCT00750152|102256210|FG001|COMPLETED|Overall Study||141||
48781461|NCT00750152|102256209|FG000|NOT COMPLETED|Overall Study||22||
48781462|NCT00750152|102256210|FG001|NOT COMPLETED|Overall Study||27||
48781463|NCT02917642|102256211|FG000|STARTED|Overall Study||25||
48781464|NCT02917642|102256212|FG001|STARTED|Overall Study||25||
48781465|NCT02917642|102256211|FG000|COMPLETED|Overall Study||25||
48781466|NCT02917642|102256212|FG001|COMPLETED|Overall Study||25||
48781467|NCT02917642|102256211|FG000|NOT COMPLETED|Overall Study||0||
48781468|NCT02917642|102256212|FG001|NOT COMPLETED|Overall Study||0||
48781469|NCT01962961|102256213|FG000|STARTED|Overall Study||9||
48781470|NCT01962961|102256214|FG001|STARTED|Overall Study||8||
48781471|NCT01962961|102256215|FG002|STARTED|Overall Study||7||
48781472|NCT01962961|102256213|FG000|COMPLETED|Overall Study||9||
48781473|NCT01962961|102256214|FG001|COMPLETED|Overall Study||7||
48781474|NCT01962961|102256215|FG002|COMPLETED|Overall Study||6||
48781475|NCT01962961|102256213|FG000|NOT COMPLETED|Overall Study||0||
48781476|NCT01962961|102256214|FG001|NOT COMPLETED|Overall Study||1||
48781477|NCT01962961|102256215|FG002|NOT COMPLETED|Overall Study||1||
48781478|NCT03263702|102256216|FG000|STARTED|Overall Study||38||
48781479|NCT03263702|102256217|FG001|STARTED|Overall Study||26||
48781480|NCT03263702|102256216|FG000|COMPLETED|Overall Study||35||
48781481|NCT03263702|102256217|FG001|COMPLETED|Overall Study||22||
48781482|NCT03263702|102256216|FG000|NOT COMPLETED|Overall Study||3||
48781483|NCT03263702|102256217|FG001|NOT COMPLETED|Overall Study||4||
48781484|NCT00635219|102256218|FG000|STARTED|Overall Study||148||
48781485|NCT00635219|102256219|FG001|STARTED|Overall Study||155||
48781486|NCT00635219|102256220|FG002|STARTED|Overall Study||157||
48781487|NCT00635219|102256221|FG003|STARTED|Overall Study||151||
48781488|NCT00635219|102256222|FG004|STARTED|Overall Study||155||
48466038|NCT00810732|101476746|FG002|STARTED|Second Washout Period (at Least 2 Weeks)||4||
48466039|NCT00810732|101476747|FG003|STARTED|Second Washout Period (at Least 2 Weeks)||5||
48466040|NCT00810732|101476748|FG004|STARTED|Second Washout Period (at Least 2 Weeks)||5||
48466041|NCT00810732|101476749|FG005|STARTED|Second Washout Period (at Least 2 Weeks)||4||
48466042|NCT00810732|101476744|FG000|COMPLETED|Second Washout Period (at Least 2 Weeks)||5||
48466043|NCT00810732|101476745|FG001|COMPLETED|Second Washout Period (at Least 2 Weeks)||4||
48466044|NCT00810732|101476746|FG002|COMPLETED|Second Washout Period (at Least 2 Weeks)||4||
48781489|NCT00635219|102256218|FG000|COMPLETED|Overall Study||123||
48781490|NCT00635219|102256219|FG001|COMPLETED|Overall Study||130||
48781491|NCT00635219|102256220|FG002|COMPLETED|Overall Study||122||
48781492|NCT00635219|102256221|FG003|COMPLETED|Overall Study||117||
48781493|NCT00635219|102256222|FG004|COMPLETED|Overall Study||113||
48781494|NCT00635219|102256218|FG000|NOT COMPLETED|Overall Study||25||
48781495|NCT00635219|102256219|FG001|NOT COMPLETED|Overall Study||25||
48781496|NCT00635219|102256220|FG002|NOT COMPLETED|Overall Study||35||
48781497|NCT00635219|102256221|FG003|NOT COMPLETED|Overall Study||34||
48781498|NCT00635219|102256222|FG004|NOT COMPLETED|Overall Study||42||
48781499|NCT00402740|102256223|FG000|STARTED|Overall Study||322||
48781500|NCT00402740|102256223|FG000|COMPLETED|Overall Study||242||
48781501|NCT00402740|102256223|FG000|NOT COMPLETED|Overall Study||80||
48781502|NCT03849118|102256224|FG000|STARTED|Overall Study||300||
48781503|NCT03849118|102256224|FG000|COMPLETED|Overall Study||275||
48781504|NCT03849118|102256224|FG000|NOT COMPLETED|Overall Study||25||
48781505|NCT01388985|102256225|FG000|STARTED|Overall Study||249||
48781506|NCT01388985|102256226|FG001|STARTED|Overall Study||249||
48781507|NCT01388985|102256225|FG000|Primary Vaccination Period|Overall Study||231||
48781508|NCT01388985|102256226|FG001|Primary Vaccination Period|Overall Study||238||
48781509|NCT01388985|102256225|FG000|COMPLETED|Overall Study||200||
48781510|NCT01388985|102256226|FG001|COMPLETED|Overall Study||211||
48781511|NCT01388985|102256225|FG000|NOT COMPLETED|Overall Study||49||
48781512|NCT01388985|102256226|FG001|NOT COMPLETED|Overall Study||38||
48781513|NCT03085797|102256227|FG000|STARTED|Treatment Period (TP) (52 Weeks)||201|Data presented for ITT Population|
48781514|NCT03085797|102256228|FG001|STARTED|Treatment Period (TP) (52 Weeks)||206|Data presented for ITT Population|
48781515|NCT03085797|102256227|FG000|Completed Investigational Product (IP)|Treatment Period (TP) (52 Weeks)||167||
48781516|NCT03085797|102256228|FG001|Completed Investigational Product (IP)|Treatment Period (TP) (52 Weeks)||183||
48781517|NCT03085797|102256227|FG000|Not Completed IP|Treatment Period (TP) (52 Weeks)||34||
48781518|NCT03085797|102256228|FG001|Not Completed IP|Treatment Period (TP) (52 Weeks)||23||
48781519|NCT03085797|102256227|FG000|Withdrew IP Due to: Adverse Event|Treatment Period (TP) (52 Weeks)||4||
48781520|NCT03085797|102256228|FG001|Withdrew IP Due to: Adverse Event|Treatment Period (TP) (52 Weeks)||4||
48781521|NCT03085797|102256227|FG000|Withdrew IP Due to: Lack of Efficacy|Treatment Period (TP) (52 Weeks)||11||
48781522|NCT03085797|102256228|FG001|Withdrew IP Due to: Lack of Efficacy|Treatment Period (TP) (52 Weeks)||5||
48781523|NCT03085797|102256227|FG000|Withdrew IP Due to: Protocol Deviation|Treatment Period (TP) (52 Weeks)||1||
48781524|NCT03085797|102256228|FG001|Withdrew IP Due to: Protocol Deviation|Treatment Period (TP) (52 Weeks)||0||
48781525|NCT03085797|102256227|FG000|Withdrew IP Due to: Stopping Criteria|Treatment Period (TP) (52 Weeks)||1||
48781526|NCT03085797|102256228|FG001|Withdrew IP Due to: Stopping Criteria|Treatment Period (TP) (52 Weeks)||1||
48781527|NCT03085797|102256227|FG000|Withdrew IP Due to: Physician Decision|Treatment Period (TP) (52 Weeks)||2||
48781528|NCT03085797|102256228|FG001|Withdrew IP Due to: Physician Decision|Treatment Period (TP) (52 Weeks)||1||
48781529|NCT03085797|102256227|FG000|Withdrew IP Due to: Withdrawal by Par.|Treatment Period (TP) (52 Weeks)||15||
48781530|NCT03085797|102256228|FG001|Withdrew IP Due to: Withdrawal by Par.|Treatment Period (TP) (52 Weeks)||12||
48781531|NCT03085797|102256227|FG000|COMPLETED|Treatment Period (TP) (52 Weeks)||184||
48781532|NCT03085797|102256228|FG001|COMPLETED|Treatment Period (TP) (52 Weeks)||189||
48781533|NCT03085797|102256227|FG000|NOT COMPLETED|Treatment Period (TP) (52 Weeks)||17||
48781534|NCT03085797|102256228|FG001|NOT COMPLETED|Treatment Period (TP) (52 Weeks)||17||
48781535|NCT03085797|102256227|FG000|STARTED|No-treatment Follow-up Period (6 Months)||65||
48781536|NCT03085797|102256228|FG001|STARTED|No-treatment Follow-up Period (6 Months)||69||
48781537|NCT03085797|102256227|FG000|COMPLETED|No-treatment Follow-up Period (6 Months)||65||
48781538|NCT03085797|102256228|FG001|COMPLETED|No-treatment Follow-up Period (6 Months)||68||
48781539|NCT03085797|102256227|FG000|NOT COMPLETED|No-treatment Follow-up Period (6 Months)||0||
48781540|NCT03085797|102256228|FG001|NOT COMPLETED|No-treatment Follow-up Period (6 Months)||1||
48781541|NCT03036215|102256229|FG000|STARTED|Overall Study||41||
48781542|NCT03036215|102256230|FG001|STARTED|Overall Study||39||
48781543|NCT03036215|102256229|FG000|COMPLETED|Overall Study||39||
48781544|NCT03036215|102256230|FG001|COMPLETED|Overall Study||36||
48781545|NCT03036215|102256229|FG000|NOT COMPLETED|Overall Study||2||
48781546|NCT03036215|102256230|FG001|NOT COMPLETED|Overall Study||3||
48781547|NCT02054104|102256231|FG000|STARTED|Overall Study||10||
48781548|NCT02054104|102256232|FG001|STARTED|Overall Study||11||
48781549|NCT02054104|102256231|FG000|COMPLETED|Overall Study||2||
48781550|NCT02054104|102256232|FG001|COMPLETED|Overall Study||2||
48781551|NCT02054104|102256231|FG000|NOT COMPLETED|Overall Study||8||
48781552|NCT02054104|102256232|FG001|NOT COMPLETED|Overall Study||9||
48781553|NCT02709538|102256233|FG000|STARTED|Overall Study||400||
48781554|NCT02709538|102256234|FG001|STARTED|Overall Study||100||
48781555|NCT02709538|102256235|FG002|STARTED|Overall Study||101||
48781556|NCT02709538|102256233|FG000|COMPLETED|Overall Study||287||
48781557|NCT02709538|102256234|FG001|COMPLETED|Overall Study||72||
48781558|NCT02709538|102256235|FG002|COMPLETED|Overall Study||81||
48781559|NCT02709538|102256233|FG000|NOT COMPLETED|Overall Study||113||
48781560|NCT02709538|102256234|FG001|NOT COMPLETED|Overall Study||28||
48781561|NCT02709538|102256235|FG002|NOT COMPLETED|Overall Study||20||
48781562|NCT02975557|102256236|FG000|STARTED|Overall Study||4||
48781563|NCT02975557|102256237|FG001|STARTED|Overall Study||5||
48781564|NCT02975557|102256238|FG002|STARTED|Overall Study||6||
48781565|NCT02975557|102256236|FG000|COMPLETED|Overall Study||3||
48781566|NCT02975557|102256237|FG001|COMPLETED|Overall Study||2||
48781567|NCT02975557|102256238|FG002|COMPLETED|Overall Study||5||
48781568|NCT02975557|102256236|FG000|NOT COMPLETED|Overall Study||1||
48781569|NCT02975557|102256237|FG001|NOT COMPLETED|Overall Study||3||
48781570|NCT02975557|102256238|FG002|NOT COMPLETED|Overall Study||1||
48781571|NCT00419445|102256239|FG000|STARTED|Overall Study||8||
48781572|NCT00419445|102256240|FG001|STARTED|Overall Study||16||
48781573|NCT00419445|102256241|FG002|STARTED|Overall Study||8||
48781574|NCT00419445|102256239|FG000|COMPLETED|Overall Study||7||
48781575|NCT00419445|102256240|FG001|COMPLETED|Overall Study||14||
48781576|NCT00419445|102256241|FG002|COMPLETED|Overall Study||7||
48781577|NCT00419445|102256239|FG000|NOT COMPLETED|Overall Study||1||
48781578|NCT00419445|102256240|FG001|NOT COMPLETED|Overall Study||2||
48466045|NCT00810732|101476747|FG003|COMPLETED|Second Washout Period (at Least 2 Weeks)||5||
48781579|NCT00419445|102256241|FG002|NOT COMPLETED|Overall Study||1||
48781580|NCT00942994|102256242|FG000|STARTED|Overall Study||203||
48781581|NCT00942994|102256243|FG001|STARTED|Overall Study||209||
48781582|NCT00942994|102256242|FG000|COMPLETED|Overall Study||187||
48781583|NCT00942994|102256243|FG001|COMPLETED|Overall Study||190||
48781584|NCT00942994|102256242|FG000|NOT COMPLETED|Overall Study||16||
48781585|NCT00942994|102256243|FG001|NOT COMPLETED|Overall Study||19||
48781586|NCT00324961|102256244|FG000|STARTED|Overall Study||533||
48781587|NCT00324961|102256244|FG000|COMPLETED|Overall Study||490||
48781588|NCT00324961|102256244|FG000|NOT COMPLETED|Overall Study||43||
48781589|NCT00947167|102256245|FG000|STARTED|Pertuzumab Alone||4||
48781590|NCT00947167|102256245|FG000|COMPLETED|Pertuzumab Alone||4||
48781591|NCT00947167|102256245|FG000|NOT COMPLETED|Pertuzumab Alone||0||
48781592|NCT00947167|102256245|FG000|STARTED|Erlotinib Added to Pertuzumab||3||
48781593|NCT00947167|102256245|FG000|COMPLETED|Erlotinib Added to Pertuzumab||3||
48781594|NCT00947167|102256245|FG000|NOT COMPLETED|Erlotinib Added to Pertuzumab||0||
48781595|NCT01874340|102256246|FG000|STARTED|Overall Study||6||
48781596|NCT01874340|102256247|FG001|STARTED|Overall Study||8||
48781597|NCT01874340|102256248|FG002|STARTED|Overall Study||8||
48781598|NCT01874340|102256249|FG003|STARTED|Overall Study||6||
48781599|NCT01874340|102256246|FG000|COMPLETED|Overall Study||0||
48781600|NCT01874340|102256247|FG001|COMPLETED|Overall Study||0||
48781601|NCT01874340|102256248|FG002|COMPLETED|Overall Study||0||
48781602|NCT01874340|102256249|FG003|COMPLETED|Overall Study||1||
48781603|NCT01874340|102256246|FG000|NOT COMPLETED|Overall Study||6||
48781604|NCT01874340|102256247|FG001|NOT COMPLETED|Overall Study||8||
48781605|NCT01874340|102256248|FG002|NOT COMPLETED|Overall Study||8||
48781606|NCT01874340|102256249|FG003|NOT COMPLETED|Overall Study||5||
48781607|NCT00260962|102256250|FG000|STARTED|Overall Study||18||
48781608|NCT00260962|102256251|FG001|STARTED|Overall Study||16||
48781609|NCT00260962|102256250|FG000|COMPLETED|Overall Study||14||
48781610|NCT00260962|102256251|FG001|COMPLETED|Overall Study||14||
48781611|NCT00260962|102256250|FG000|NOT COMPLETED|Overall Study||4||
48781612|NCT00260962|102256251|FG001|NOT COMPLETED|Overall Study||2||
48781613|NCT01543633|102256252|FG000|STARTED|Overall Study||36||
48466046|NCT00810732|101476748|FG004|COMPLETED|Second Washout Period (at Least 2 Weeks)||5||
48466047|NCT00810732|101476749|FG005|COMPLETED|Second Washout Period (at Least 2 Weeks)||4||
48781614|NCT01543633|102256252|FG000|COMPLETED|Overall Study||17||
48781615|NCT01543633|102256252|FG000|NOT COMPLETED|Overall Study||19||
48781616|NCT00831493|102256253|FG000|STARTED|Overall Study||3||
48781617|NCT00831493|102256253|FG000|COMPLETED|Overall Study||2||
48781618|NCT00831493|102256253|FG000|NOT COMPLETED|Overall Study||1||
48781619|NCT01057589|102256254|FG000|STARTED|Overall Study||66||
48781620|NCT01057589|102256254|FG000|COMPLETED|Overall Study||0||
48781621|NCT01057589|102256254|FG000|NOT COMPLETED|Overall Study||66||
48781622|NCT00295880|102256255|FG000|STARTED|Overall Study||12||
48781623|NCT00295880|102256255|FG000|COMPLETED|Overall Study||10||
48781624|NCT00295880|102256255|FG000|NOT COMPLETED|Overall Study||2||
48781625|NCT04359901|102256256|FG000|STARTED|Overall Study||20||
48781626|NCT04359901|102256257|FG001|STARTED|Overall Study||30||
48781627|NCT04359901|102256256|FG000|Follow up to 14 Days|Overall Study||15||
48781628|NCT04359901|102256257|FG001|Follow up to 14 Days|Overall Study||28||
48781629|NCT04359901|102256256|FG000|Follow up to 30 Days|Overall Study||14||
48781630|NCT04359901|102256257|FG001|Follow up to 30 Days|Overall Study||27||
48781631|NCT04359901|102256256|FG000|COMPLETED|Overall Study||14||
48781632|NCT04359901|102256257|FG001|COMPLETED|Overall Study||27||
48781633|NCT04359901|102256256|FG000|NOT COMPLETED|Overall Study||6||
48781634|NCT04359901|102256257|FG001|NOT COMPLETED|Overall Study||3||
48781635|NCT00243269|102256258|FG000|STARTED|Overall Study||31||
48781636|NCT00243269|102256259|FG001|STARTED|Overall Study||11||
48781637|NCT00243269|102256260|FG002|STARTED|Overall Study||12||
48781638|NCT00243269|102256261|FG003|STARTED|Overall Study||29||
48781639|NCT00243269|102256258|FG000|COMPLETED|Overall Study||28||
48466048|NCT00810732|101476744|FG000|NOT COMPLETED|Second Washout Period (at Least 2 Weeks)||0||
48466049|NCT00810732|101476745|FG001|NOT COMPLETED|Second Washout Period (at Least 2 Weeks)||0||
48466050|NCT00810732|101476746|FG002|NOT COMPLETED|Second Washout Period (at Least 2 Weeks)||0||
48466051|NCT00810732|101476747|FG003|NOT COMPLETED|Second Washout Period (at Least 2 Weeks)||0||
48781640|NCT00243269|102256259|FG001|COMPLETED|Overall Study||10||
48781641|NCT00243269|102256260|FG002|COMPLETED|Overall Study||11||
48781642|NCT00243269|102256261|FG003|COMPLETED|Overall Study||25||
48781643|NCT00243269|102256258|FG000|NOT COMPLETED|Overall Study||3||
48781644|NCT00243269|102256259|FG001|NOT COMPLETED|Overall Study||1||
48781645|NCT00243269|102256260|FG002|NOT COMPLETED|Overall Study||1||
48781646|NCT00243269|102256261|FG003|NOT COMPLETED|Overall Study||4||
48781647|NCT01988584|102256262|FG000|STARTED|Blinded Phase||3||
48781648|NCT01988584|102256263|FG001|STARTED|Blinded Phase||10||
48781649|NCT01988584|102256264|FG002|STARTED|Blinded Phase||2||
48781650|NCT01988584|102256265|FG003|STARTED|Blinded Phase||5||
48781651|NCT01988584|102256262|FG000|12 Month Follow-up|Blinded Phase||3||
48781652|NCT01988584|102256263|FG001|12 Month Follow-up|Blinded Phase||9||
48781653|NCT01988584|102256264|FG002|12 Month Follow-up|Blinded Phase||2||
48781654|NCT01988584|102256265|FG003|12 Month Follow-up|Blinded Phase||5||
48781655|NCT01988584|102256262|FG000|COMPLETED|Blinded Phase||3||
48781656|NCT01988584|102256263|FG001|COMPLETED|Blinded Phase||9||
48781657|NCT01988584|102256264|FG002|COMPLETED|Blinded Phase||2||
48781658|NCT01988584|102256265|FG003|COMPLETED|Blinded Phase||4||
48781659|NCT01988584|102256262|FG000|NOT COMPLETED|Blinded Phase||0||
48781660|NCT01988584|102256263|FG001|NOT COMPLETED|Blinded Phase||1||
48466052|NCT00810732|101476748|FG004|NOT COMPLETED|Second Washout Period (at Least 2 Weeks)||0||
48466053|NCT00810732|101476749|FG005|NOT COMPLETED|Second Washout Period (at Least 2 Weeks)||0||
48466054|NCT00810732|101476744|FG000|STARTED|Third Intervention Period (6 Weeks)||5||
48466055|NCT00810732|101476745|FG001|STARTED|Third Intervention Period (6 Weeks)||4||
48781661|NCT01988584|102256264|FG002|NOT COMPLETED|Blinded Phase||0||
48781662|NCT01988584|102256265|FG003|NOT COMPLETED|Blinded Phase||1||
48781663|NCT01988584|102256262|FG000|STARTED|Unblinded Phase - Placebo Arm Crossover||0|Placebo arms cross over to stem cell intervention 12 months after start of study.|
48781664|NCT01988584|102256263|FG001|STARTED|Unblinded Phase - Placebo Arm Crossover||0|Placebo arms cross over to stem cell intervention 12 months after start of study.|
48781665|NCT01988584|102256264|FG002|STARTED|Unblinded Phase - Placebo Arm Crossover||2|Placebo arms cross over to stem cell intervention 12 months after start of study.|
48781666|NCT01988584|102256265|FG003|STARTED|Unblinded Phase - Placebo Arm Crossover||5|Placebo arms cross over to stem cell intervention 12 months after start of study.|
48781667|NCT01988584|102256262|FG000|COMPLETED|Unblinded Phase - Placebo Arm Crossover||0|Crossover arms complete follow-up 12 months after start of stem cell intervention (which is 24 months after start of study).|
48781668|NCT01988584|102256263|FG001|COMPLETED|Unblinded Phase - Placebo Arm Crossover||0|Crossover arms complete follow-up 12 months after start of stem cell intervention (which is 24 months after start of study).|
48781669|NCT01988584|102256264|FG002|COMPLETED|Unblinded Phase - Placebo Arm Crossover||2|Crossover arms complete follow-up 12 months after start of stem cell intervention (which is 24 months after start of study).|
48781670|NCT01988584|102256265|FG003|COMPLETED|Unblinded Phase - Placebo Arm Crossover||4|Crossover arms complete follow-up 12 months after start of stem cell intervention (which is 24 months after start of study).|
48781671|NCT01988584|102256262|FG000|NOT COMPLETED|Unblinded Phase - Placebo Arm Crossover||0||
48781672|NCT01988584|102256263|FG001|NOT COMPLETED|Unblinded Phase - Placebo Arm Crossover||0||
48781673|NCT01988584|102256264|FG002|NOT COMPLETED|Unblinded Phase - Placebo Arm Crossover||0||
48781674|NCT01988584|102256265|FG003|NOT COMPLETED|Unblinded Phase - Placebo Arm Crossover||1||
48781675|NCT00029146|102256266|FG000|STARTED|Overall Study||97||
48781676|NCT00029146|102256267|FG001|STARTED|Overall Study||98||
48781677|NCT00029146|102256266|FG000|COMPLETED|Overall Study||95||
48781678|NCT00029146|102256267|FG001|COMPLETED|Overall Study||97||
48781679|NCT00029146|102256266|FG000|NOT COMPLETED|Overall Study||2||
48781680|NCT00029146|102256267|FG001|NOT COMPLETED|Overall Study||1||
48781681|NCT02636361|102256268|FG000|STARTED|Period 1||5||
48781682|NCT02636361|102256269|FG001|STARTED|Period 1||6||
48466056|NCT00810732|101476746|FG002|STARTED|Third Intervention Period (6 Weeks)||4||
48781683|NCT02636361|102256270|FG002|STARTED|Period 1||5||
48781684|NCT02636361|102256271|FG003|STARTED|Period 1||5||
48781685|NCT02636361|102256272|FG004|STARTED|Period 1||5||
48781686|NCT02636361|102256268|FG000|Received at Least One Dose of Study Drug|Period 1||5||
48781687|NCT02636361|102256269|FG001|Received at Least One Dose of Study Drug|Period 1||5||
48781688|NCT02636361|102256270|FG002|Received at Least One Dose of Study Drug|Period 1||5||
48781689|NCT02636361|102256271|FG003|Received at Least One Dose of Study Drug|Period 1||5||
48781690|NCT02636361|102256272|FG004|Received at Least One Dose of Study Drug|Period 1||4||
48781691|NCT02636361|102256268|FG000|COMPLETED|Period 1||5||
48781692|NCT02636361|102256269|FG001|COMPLETED|Period 1||5||
48781693|NCT02636361|102256270|FG002|COMPLETED|Period 1||5||
48781694|NCT02636361|102256271|FG003|COMPLETED|Period 1||5||
48781695|NCT02636361|102256272|FG004|COMPLETED|Period 1||4||
48781696|NCT02636361|102256268|FG000|NOT COMPLETED|Period 1||0||
48781697|NCT02636361|102256269|FG001|NOT COMPLETED|Period 1||1||
48781698|NCT02636361|102256270|FG002|NOT COMPLETED|Period 1||0||
48781699|NCT02636361|102256271|FG003|NOT COMPLETED|Period 1||0||
48781700|NCT02636361|102256272|FG004|NOT COMPLETED|Period 1||1||
48781701|NCT02636361|102256268|FG000|STARTED|Period 2||5||
48781702|NCT02636361|102256269|FG001|STARTED|Period 2||5||
48781703|NCT02636361|102256270|FG002|STARTED|Period 2||5||
48781704|NCT02636361|102256271|FG003|STARTED|Period 2||5||
48781705|NCT02636361|102256272|FG004|STARTED|Period 2||4||
48781706|NCT02636361|102256268|FG000|COMPLETED|Period 2||5||
48781707|NCT02636361|102256269|FG001|COMPLETED|Period 2||5||
48781708|NCT02636361|102256270|FG002|COMPLETED|Period 2||5||
48781709|NCT02636361|102256271|FG003|COMPLETED|Period 2||5||
48781710|NCT02636361|102256272|FG004|COMPLETED|Period 2||4||
48781711|NCT02636361|102256268|FG000|NOT COMPLETED|Period 2||0||
48781712|NCT02636361|102256269|FG001|NOT COMPLETED|Period 2||0||
48781713|NCT02636361|102256270|FG002|NOT COMPLETED|Period 2||0||
48781714|NCT02636361|102256271|FG003|NOT COMPLETED|Period 2||0||
48781715|NCT02636361|102256272|FG004|NOT COMPLETED|Period 2||0||
48781716|NCT02636361|102256268|FG000|STARTED|Period 3||5||
48781717|NCT02636361|102256269|FG001|STARTED|Period 3||5||
48781718|NCT02636361|102256270|FG002|STARTED|Period 3||5||
48781719|NCT02636361|102256271|FG003|STARTED|Period 3||5||
48781720|NCT02636361|102256272|FG004|STARTED|Period 3||4||
48781721|NCT02636361|102256268|FG000|COMPLETED|Period 3||5||
48781722|NCT02636361|102256269|FG001|COMPLETED|Period 3||5||
48781723|NCT02636361|102256270|FG002|COMPLETED|Period 3||5||
48781724|NCT02636361|102256271|FG003|COMPLETED|Period 3||5||
48781725|NCT02636361|102256272|FG004|COMPLETED|Period 3||4||
48781726|NCT02636361|102256268|FG000|NOT COMPLETED|Period 3||0||
48781727|NCT02636361|102256269|FG001|NOT COMPLETED|Period 3||0||
48781728|NCT02636361|102256270|FG002|NOT COMPLETED|Period 3||0||
48781729|NCT02636361|102256271|FG003|NOT COMPLETED|Period 3||0||
48781730|NCT02636361|102256272|FG004|NOT COMPLETED|Period 3||0||
48781731|NCT02636361|102256268|FG000|STARTED|Period 4||5||
48781732|NCT02636361|102256269|FG001|STARTED|Period 4||5||
48781733|NCT02636361|102256270|FG002|STARTED|Period 4||5||
48781734|NCT02636361|102256271|FG003|STARTED|Period 4||5||
48781735|NCT02636361|102256272|FG004|STARTED|Period 4||4||
48781736|NCT02636361|102256268|FG000|COMPLETED|Period 4||5||
48781737|NCT02636361|102256269|FG001|COMPLETED|Period 4||5||
48781738|NCT02636361|102256270|FG002|COMPLETED|Period 4||5||
48781739|NCT02636361|102256271|FG003|COMPLETED|Period 4||4||
48781740|NCT02636361|102256272|FG004|COMPLETED|Period 4||4||
48781741|NCT02636361|102256268|FG000|NOT COMPLETED|Period 4||0||
48781742|NCT02636361|102256269|FG001|NOT COMPLETED|Period 4||0||
48781743|NCT02636361|102256270|FG002|NOT COMPLETED|Period 4||0||
48781744|NCT02636361|102256271|FG003|NOT COMPLETED|Period 4||1||
48781745|NCT02636361|102256272|FG004|NOT COMPLETED|Period 4||0||
48781746|NCT02636361|102256268|FG000|STARTED|Period 5||5||
48781747|NCT02636361|102256269|FG001|STARTED|Period 5||5||
48781748|NCT02636361|102256270|FG002|STARTED|Period 5||5||
48781749|NCT02636361|102256271|FG003|STARTED|Period 5||4||
48781750|NCT02636361|102256272|FG004|STARTED|Period 5||4||
48781751|NCT02636361|102256268|FG000|COMPLETED|Period 5||5||
48781752|NCT02636361|102256269|FG001|COMPLETED|Period 5||5||
48781753|NCT02636361|102256270|FG002|COMPLETED|Period 5||5||
48781754|NCT02636361|102256271|FG003|COMPLETED|Period 5||4||
48189837|NCT00594932|100786317|FG001|NOT COMPLETED|Final 3 Months||3||
48189838|NCT03251144|100786318|FG000|STARTED|Overall Study||15||
48189839|NCT03251144|100786319|FG001|STARTED|Overall Study||11||
48781755|NCT02636361|102256272|FG004|COMPLETED|Period 5||4||
48781756|NCT02636361|102256268|FG000|NOT COMPLETED|Period 5||0||
48189840|NCT03251144|100786318|FG000|COMPLETED|Overall Study||15||
48189841|NCT03251144|100786319|FG001|COMPLETED|Overall Study||11||
48781757|NCT02636361|102256269|FG001|NOT COMPLETED|Period 5||0||
48781758|NCT02636361|102256270|FG002|NOT COMPLETED|Period 5||0||
48781759|NCT02636361|102256271|FG003|NOT COMPLETED|Period 5||0||
48781760|NCT02636361|102256272|FG004|NOT COMPLETED|Period 5||0||
48781761|NCT01776307|102256273|FG000|STARTED|Overall Study||49||
48781762|NCT01776307|102256274|FG001|STARTED|Overall Study||75||
48781763|NCT01776307|102256275|FG002|STARTED|Overall Study||76||
48781764|NCT01776307|102256273|FG000|COMPLETED|Overall Study||49||
48781765|NCT01776307|102256274|FG001|COMPLETED|Overall Study||75||
48781766|NCT01776307|102256275|FG002|COMPLETED|Overall Study||75||
48781767|NCT01776307|102256273|FG000|NOT COMPLETED|Overall Study||0||
48781768|NCT01776307|102256274|FG001|NOT COMPLETED|Overall Study||0||
48781769|NCT01776307|102256275|FG002|NOT COMPLETED|Overall Study||1||
48781770|NCT01491984|102256276|FG000|STARTED|Overall Study||49||
48781771|NCT01491984|102256277|FG001|STARTED|Overall Study||45||
48781772|NCT01491984|102256276|FG000|COMPLETED|Overall Study||47||
48466057|NCT00810732|101476747|FG003|STARTED|Third Intervention Period (6 Weeks)||5||
48466058|NCT00810732|101476748|FG004|STARTED|Third Intervention Period (6 Weeks)||5||
48466059|NCT00810732|101476749|FG005|STARTED|Third Intervention Period (6 Weeks)||4||
48466060|NCT00810732|101476744|FG000|COMPLETED|Third Intervention Period (6 Weeks)||5||
48466061|NCT00810732|101476745|FG001|COMPLETED|Third Intervention Period (6 Weeks)||4||
48466062|NCT00810732|101476746|FG002|COMPLETED|Third Intervention Period (6 Weeks)||4||
48466063|NCT00810732|101476747|FG003|COMPLETED|Third Intervention Period (6 Weeks)||5||
48466064|NCT00810732|101476748|FG004|COMPLETED|Third Intervention Period (6 Weeks)||5||
48466065|NCT00810732|101476749|FG005|COMPLETED|Third Intervention Period (6 Weeks)||4||
48466066|NCT00810732|101476744|FG000|NOT COMPLETED|Third Intervention Period (6 Weeks)||0||
48466067|NCT00810732|101476745|FG001|NOT COMPLETED|Third Intervention Period (6 Weeks)||0||
48466068|NCT00810732|101476746|FG002|NOT COMPLETED|Third Intervention Period (6 Weeks)||0||
48466069|NCT00810732|101476747|FG003|NOT COMPLETED|Third Intervention Period (6 Weeks)||0||
48466070|NCT00810732|101476748|FG004|NOT COMPLETED|Third Intervention Period (6 Weeks)||0||
48466071|NCT00810732|101476749|FG005|NOT COMPLETED|Third Intervention Period (6 Weeks)||0||
48466072|NCT02486796|101476750|FG000|STARTED|Overall Study||3||
48466073|NCT02486796|101476751|FG001|STARTED|Overall Study||2||
48466074|NCT02486796|101476750|FG000|COMPLETED|Overall Study||1||
48466075|NCT02486796|101476751|FG001|COMPLETED|Overall Study||1||
48466076|NCT02486796|101476750|FG000|NOT COMPLETED|Overall Study||2||
48466077|NCT02486796|101476751|FG001|NOT COMPLETED|Overall Study||1||
48781773|NCT01491984|102256277|FG001|COMPLETED|Overall Study||44||
48781774|NCT01491984|102256276|FG000|NOT COMPLETED|Overall Study||2||
48781775|NCT01491984|102256277|FG001|NOT COMPLETED|Overall Study||1||
48781776|NCT03601117|102256278|FG000|STARTED|Overall Study||20||
48781777|NCT03601117|102256279|FG001|STARTED|Overall Study||2||
48781778|NCT03601117|102256278|FG000|COMPLETED|Overall Study||17||
48781779|NCT03601117|102256279|FG001|COMPLETED|Overall Study||1||
48781780|NCT03601117|102256278|FG000|NOT COMPLETED|Overall Study||3||
48781781|NCT03601117|102256279|FG001|NOT COMPLETED|Overall Study||1||
48781782|NCT01221311|102256280|FG000|STARTED|Overall Study||57||
48781783|NCT01221311|102256281|FG001|STARTED|Overall Study||55||
48781784|NCT01221311|102256280|FG000|COMPLETED|Overall Study||57||
48781785|NCT01221311|102256281|FG001|COMPLETED|Overall Study||55||
48781786|NCT01221311|102256280|FG000|NOT COMPLETED|Overall Study||0||
48781787|NCT01221311|102256281|FG001|NOT COMPLETED|Overall Study||0||
48781788|NCT02565784|102256282|FG000|STARTED|First Treatment||100||
48781789|NCT02565784|102256282|FG000|6 Months Follow-up|First Treatment||99||
48781790|NCT02565784|102256282|FG000|12 Months Follow-up|First Treatment||98||
48781791|NCT02565784|102256282|FG000|COMPLETED|First Treatment||98||
48781792|NCT02565784|102256282|FG000|NOT COMPLETED|First Treatment||2||
48781793|NCT02565784|102256282|FG000|STARTED|Second Treatment||98||
48781794|NCT02565784|102256282|FG000|6 Months Follow-up|Second Treatment||97||
48781795|NCT02565784|102256282|FG000|12 Months Follow-up|Second Treatment||96||
48781796|NCT02565784|102256282|FG000|COMPLETED|Second Treatment||96||
48781797|NCT02565784|102256282|FG000|NOT COMPLETED|Second Treatment||2||
48466078|NCT02958956|101476752|FG000|STARTED|Overall Study||38190||
48466079|NCT02958956|101476753|FG001|STARTED|Overall Study||198317||
48466080|NCT02958956|101476752|FG000|COMPLETED|Overall Study||38190||
48466081|NCT02958956|101476753|FG001|COMPLETED|Overall Study||198317||
48466082|NCT02958956|101476752|FG000|NOT COMPLETED|Overall Study||0||
48466083|NCT02958956|101476753|FG001|NOT COMPLETED|Overall Study||0||
48781798|NCT00488683|102256283|FG000|STARTED|Overall Study||108||
48781799|NCT00488683|102256284|FG001|STARTED|Overall Study||54||
48781800|NCT00488683|102256285|FG002|STARTED|Overall Study||54||
48466084|NCT01626859|101476754|FG000|STARTED|Overall Study||11||
48466085|NCT01626859|101476755|FG001|STARTED|Overall Study||16||
48466086|NCT01626859|101476756|FG002|STARTED|Overall Study||11||
48466087|NCT01626859|101476754|FG000|COMPLETED|Overall Study||9||
48466088|NCT01626859|101476755|FG001|COMPLETED|Overall Study||8||
48466089|NCT01626859|101476756|FG002|COMPLETED|Overall Study||7||
48466090|NCT01626859|101476754|FG000|NOT COMPLETED|Overall Study||2||
48466091|NCT01626859|101476755|FG001|NOT COMPLETED|Overall Study||8||
48466092|NCT01626859|101476756|FG002|NOT COMPLETED|Overall Study||4||
48466093|NCT03305055|101476757|FG000|STARTED|Overall Study||2||
48781801|NCT00488683|102256283|FG000|COMPLETED|Overall Study||96||
48466094|NCT03305055|101476758|FG001|STARTED|Overall Study||2||
48781802|NCT00488683|102256284|FG001|COMPLETED|Overall Study||48||
48781803|NCT00488683|102256285|FG002|COMPLETED|Overall Study||52||
48781804|NCT00488683|102256283|FG000|NOT COMPLETED|Overall Study||12||
48781805|NCT00488683|102256284|FG001|NOT COMPLETED|Overall Study||6||
48781806|NCT00488683|102256285|FG002|NOT COMPLETED|Overall Study||2||
48781807|NCT00580671|102256286|FG000|STARTED|Overall Study||51||
48781808|NCT00580671|102256287|FG001|STARTED|Overall Study||51||
48781809|NCT00580671|102256288|FG002|STARTED|Overall Study||51||
48781810|NCT00580671|102256286|FG000|COMPLETED|Overall Study||35||
48781811|NCT00580671|102256287|FG001|COMPLETED|Overall Study||35||
48781812|NCT00580671|102256288|FG002|COMPLETED|Overall Study||34||
48781813|NCT00580671|102256286|FG000|NOT COMPLETED|Overall Study||16||
48781814|NCT00580671|102256287|FG001|NOT COMPLETED|Overall Study||16||
48781815|NCT00580671|102256288|FG002|NOT COMPLETED|Overall Study||17||
48781816|NCT01738646|102256289|FG000|STARTED|Overall Study||40||
48781817|NCT01738646|102256289|FG000|COMPLETED|Overall Study||38||
48781818|NCT01738646|102256289|FG000|NOT COMPLETED|Overall Study||2||
48781819|NCT00637780|102256290|FG000|STARTED|Overall Study||2||
48781820|NCT00637780|102256290|FG000|COMPLETED|Overall Study||2||
48781821|NCT00637780|102256290|FG000|NOT COMPLETED|Overall Study||0||
48781822|NCT01652469|102256291|FG000|STARTED|Overall Study||38||
48781823|NCT01652469|102256292|FG001|STARTED|Overall Study||42||
48781824|NCT01652469|102256291|FG000|COMPLETED|Overall Study||37||
48781825|NCT01652469|102256292|FG001|COMPLETED|Overall Study||36||
48781826|NCT01652469|102256291|FG000|NOT COMPLETED|Overall Study||1||
48781827|NCT01652469|102256292|FG001|NOT COMPLETED|Overall Study||6||
48781828|NCT01237899|102256293|FG000|STARTED|First Dosing Period||1||
48781829|NCT01237899|102256294|FG001|STARTED|First Dosing Period||3||
48781830|NCT01237899|102256295|FG002|STARTED|First Dosing Period||4||
48781831|NCT01237899|102256296|FG003|STARTED|First Dosing Period||3||
48781832|NCT01237899|102256297|FG004|STARTED|First Dosing Period||2||
48781833|NCT01237899|102256298|FG005|STARTED|First Dosing Period||4||
48781834|NCT01237899|102256299|FG006|STARTED|First Dosing Period||1||
48781835|NCT01237899|102256300|FG007|STARTED|First Dosing Period||3||
48781836|NCT01237899|102256301|FG008|STARTED|First Dosing Period||4||
48781837|NCT01237899|102256302|FG009|STARTED|First Dosing Period||3||
48781838|NCT01237899|102256303|FG010|STARTED|First Dosing Period||4||
48781839|NCT01237899|102256293|FG000|COMPLETED|First Dosing Period||1||
48781840|NCT01237899|102256294|FG001|COMPLETED|First Dosing Period||3||
48781841|NCT01237899|102256295|FG002|COMPLETED|First Dosing Period||4||
48781842|NCT01237899|102256296|FG003|COMPLETED|First Dosing Period||3||
48781843|NCT01237899|102256297|FG004|COMPLETED|First Dosing Period||2||
48781844|NCT01237899|102256298|FG005|COMPLETED|First Dosing Period||4||
48781845|NCT01237899|102256299|FG006|COMPLETED|First Dosing Period||1||
48781846|NCT01237899|102256300|FG007|COMPLETED|First Dosing Period||3||
48781847|NCT01237899|102256301|FG008|COMPLETED|First Dosing Period||4||
48781848|NCT01237899|102256302|FG009|COMPLETED|First Dosing Period||3||
48781849|NCT01237899|102256303|FG010|COMPLETED|First Dosing Period||4||
48781850|NCT01237899|102256293|FG000|NOT COMPLETED|First Dosing Period||0||
48781851|NCT01237899|102256294|FG001|NOT COMPLETED|First Dosing Period||0||
48781852|NCT01237899|102256295|FG002|NOT COMPLETED|First Dosing Period||0||
48781853|NCT01237899|102256296|FG003|NOT COMPLETED|First Dosing Period||0||
48781854|NCT01237899|102256297|FG004|NOT COMPLETED|First Dosing Period||0||
48781855|NCT01237899|102256298|FG005|NOT COMPLETED|First Dosing Period||0||
48781856|NCT01237899|102256299|FG006|NOT COMPLETED|First Dosing Period||0||
48781857|NCT01237899|102256300|FG007|NOT COMPLETED|First Dosing Period||0||
48781858|NCT01237899|102256301|FG008|NOT COMPLETED|First Dosing Period||0||
48781859|NCT01237899|102256302|FG009|NOT COMPLETED|First Dosing Period||0||
48781860|NCT01237899|102256303|FG010|NOT COMPLETED|First Dosing Period||0||
48781861|NCT01237899|102256293|FG000|STARTED|Washout Period of at Least 7 Days||1||
48781862|NCT01237899|102256294|FG001|STARTED|Washout Period of at Least 7 Days||3||
48781863|NCT01237899|102256295|FG002|STARTED|Washout Period of at Least 7 Days||4||
48781864|NCT01237899|102256296|FG003|STARTED|Washout Period of at Least 7 Days||3||
48466095|NCT03305055|101476757|FG000|COMPLETED|Overall Study||1||
48466096|NCT03305055|101476758|FG001|COMPLETED|Overall Study||0||
48781865|NCT01237899|102256297|FG004|STARTED|Washout Period of at Least 7 Days||2||
48781866|NCT01237899|102256298|FG005|STARTED|Washout Period of at Least 7 Days||4||
48781867|NCT01237899|102256299|FG006|STARTED|Washout Period of at Least 7 Days||1||
48781868|NCT01237899|102256300|FG007|STARTED|Washout Period of at Least 7 Days||3||
48781869|NCT01237899|102256301|FG008|STARTED|Washout Period of at Least 7 Days||4||
48781870|NCT01237899|102256302|FG009|STARTED|Washout Period of at Least 7 Days||3||
48466097|NCT03305055|101476757|FG000|NOT COMPLETED|Overall Study||1||
48466098|NCT03305055|101476758|FG001|NOT COMPLETED|Overall Study||2||
48466099|NCT02729896|101476759|FG000|STARTED|Overall Study||3||
48466100|NCT02729896|101476760|FG001|STARTED|Overall Study||10||
48466101|NCT02729896|101476761|FG002|STARTED|Overall Study||23||
48466102|NCT02729896|101476759|FG000|COMPLETED|Overall Study||1||
48466103|NCT02729896|101476760|FG001|COMPLETED|Overall Study||1||
48466104|NCT02729896|101476761|FG002|COMPLETED|Overall Study||1||
48466105|NCT02729896|101476759|FG000|NOT COMPLETED|Overall Study||2||
48466106|NCT02729896|101476760|FG001|NOT COMPLETED|Overall Study||9||
48466107|NCT02729896|101476761|FG002|NOT COMPLETED|Overall Study||22||
48466108|NCT01924390|101476762|FG000|STARTED|Overall Study||22||
48466109|NCT01924390|101476763|FG001|STARTED|Overall Study||22||
48466110|NCT01924390|101476762|FG000|COMPLETED|Overall Study||21||
48466111|NCT01924390|101476763|FG001|COMPLETED|Overall Study||21||
48466112|NCT01924390|101476762|FG000|NOT COMPLETED|Overall Study||1||
48466113|NCT01924390|101476763|FG001|NOT COMPLETED|Overall Study||1||
48466114|NCT03081767|101476764|FG000|STARTED|Overall Study||199||
48466115|NCT03081767|101476764|FG000|COMPLETED|Overall Study||199||
48781871|NCT01237899|102256303|FG010|STARTED|Washout Period of at Least 7 Days||4||
48781872|NCT01237899|102256293|FG000|COMPLETED|Washout Period of at Least 7 Days||1||
48189842|NCT03251144|100786318|FG000|NOT COMPLETED|Overall Study||0||
48466116|NCT03081767|101476764|FG000|NOT COMPLETED|Overall Study||0||
48466117|NCT00449072|101476765|FG000|STARTED|Overall Study||148||
48466118|NCT00449072|101476766|FG001|STARTED|Overall Study||151||
48466119|NCT00449072|101476765|FG000|COMPLETED|Overall Study||107||
48466120|NCT00449072|101476766|FG001|COMPLETED|Overall Study||109||
48466121|NCT00449072|101476765|FG000|NOT COMPLETED|Overall Study||41||
48466122|NCT00449072|101476766|FG001|NOT COMPLETED|Overall Study||42||
48781873|NCT01237899|102256294|FG001|COMPLETED|Washout Period of at Least 7 Days||3||
48781874|NCT01237899|102256295|FG002|COMPLETED|Washout Period of at Least 7 Days||3||
48781875|NCT01237899|102256296|FG003|COMPLETED|Washout Period of at Least 7 Days||3||
48781876|NCT01237899|102256297|FG004|COMPLETED|Washout Period of at Least 7 Days||2||
48781877|NCT01237899|102256298|FG005|COMPLETED|Washout Period of at Least 7 Days||4||
48781878|NCT01237899|102256299|FG006|COMPLETED|Washout Period of at Least 7 Days||1||
48781879|NCT01237899|102256300|FG007|COMPLETED|Washout Period of at Least 7 Days||3||
48781880|NCT01237899|102256301|FG008|COMPLETED|Washout Period of at Least 7 Days||4||
48781881|NCT01237899|102256302|FG009|COMPLETED|Washout Period of at Least 7 Days||3||
48781882|NCT01237899|102256303|FG010|COMPLETED|Washout Period of at Least 7 Days||4||
48781883|NCT01237899|102256293|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||0||
48781884|NCT01237899|102256294|FG001|NOT COMPLETED|Washout Period of at Least 7 Days||0||
48781885|NCT01237899|102256295|FG002|NOT COMPLETED|Washout Period of at Least 7 Days||1||
48781886|NCT01237899|102256296|FG003|NOT COMPLETED|Washout Period of at Least 7 Days||0||
48781887|NCT01237899|102256297|FG004|NOT COMPLETED|Washout Period of at Least 7 Days||0||
48781888|NCT01237899|102256298|FG005|NOT COMPLETED|Washout Period of at Least 7 Days||0||
48781889|NCT01237899|102256299|FG006|NOT COMPLETED|Washout Period of at Least 7 Days||0||
48781890|NCT01237899|102256300|FG007|NOT COMPLETED|Washout Period of at Least 7 Days||0||
48781891|NCT01237899|102256301|FG008|NOT COMPLETED|Washout Period of at Least 7 Days||0||
48781892|NCT01237899|102256302|FG009|NOT COMPLETED|Washout Period of at Least 7 Days||0||
48781893|NCT01237899|102256303|FG010|NOT COMPLETED|Washout Period of at Least 7 Days||0||
48781894|NCT01237899|102256293|FG000|STARTED|Second Dosing Period||1||
48781895|NCT01237899|102256294|FG001|STARTED|Second Dosing Period||3||
48781896|NCT01237899|102256295|FG002|STARTED|Second Dosing Period||3||
48781897|NCT01237899|102256296|FG003|STARTED|Second Dosing Period||3||
48781898|NCT01237899|102256297|FG004|STARTED|Second Dosing Period||2||
48781899|NCT01237899|102256298|FG005|STARTED|Second Dosing Period||4||
48781900|NCT01237899|102256299|FG006|STARTED|Second Dosing Period||1||
48781901|NCT01237899|102256300|FG007|STARTED|Second Dosing Period||3||
48781902|NCT01237899|102256301|FG008|STARTED|Second Dosing Period||4||
48781903|NCT01237899|102256302|FG009|STARTED|Second Dosing Period||3||
48781904|NCT01237899|102256303|FG010|STARTED|Second Dosing Period||4||
48781905|NCT01237899|102256293|FG000|COMPLETED|Second Dosing Period||1||
48781906|NCT01237899|102256294|FG001|COMPLETED|Second Dosing Period||3||
48466123|NCT01411995|101476767|FG000|STARTED|Overall Study||100||
48466124|NCT01411995|101476768|FG001|STARTED|Overall Study||100||
48466125|NCT01411995|101476767|FG000|COMPLETED|Overall Study||100||
48466126|NCT01411995|101476768|FG001|COMPLETED|Overall Study||99||
48466127|NCT01411995|101476767|FG000|NOT COMPLETED|Overall Study||0||
48466128|NCT01411995|101476768|FG001|NOT COMPLETED|Overall Study||1||
48466129|NCT05780437|101476769|FG000|STARTED|Overall Study||710||
48466130|NCT05780437|101476770|FG001|STARTED|Overall Study||707||
48466131|NCT05780437|101476769|FG000|COMPLETED|Overall Study||710||
48466132|NCT05780437|101476770|FG001|COMPLETED|Overall Study||707||
48781907|NCT01237899|102256295|FG002|COMPLETED|Second Dosing Period||3||
48466133|NCT05780437|101476769|FG000|NOT COMPLETED|Overall Study||0||
48781908|NCT01237899|102256296|FG003|COMPLETED|Second Dosing Period||3||
48781909|NCT01237899|102256297|FG004|COMPLETED|Second Dosing Period||2||
48781910|NCT01237899|102256298|FG005|COMPLETED|Second Dosing Period||4||
48466134|NCT05780437|101476770|FG001|NOT COMPLETED|Overall Study||0||
48781911|NCT01237899|102256299|FG006|COMPLETED|Second Dosing Period||1||
48781912|NCT01237899|102256300|FG007|COMPLETED|Second Dosing Period||3||
48781913|NCT01237899|102256301|FG008|COMPLETED|Second Dosing Period||4||
48781914|NCT01237899|102256302|FG009|COMPLETED|Second Dosing Period||3||
48781915|NCT01237899|102256303|FG010|COMPLETED|Second Dosing Period||4||
48781916|NCT01237899|102256293|FG000|NOT COMPLETED|Second Dosing Period||0||
48781917|NCT01237899|102256294|FG001|NOT COMPLETED|Second Dosing Period||0||
48781918|NCT01237899|102256295|FG002|NOT COMPLETED|Second Dosing Period||0||
48781919|NCT01237899|102256296|FG003|NOT COMPLETED|Second Dosing Period||0||
48781920|NCT01237899|102256297|FG004|NOT COMPLETED|Second Dosing Period||0||
48189843|NCT03251144|100786319|FG001|NOT COMPLETED|Overall Study||0||
48189844|NCT00412516|100786320|FG000|STARTED|Overall Study||93||
48189845|NCT00412516|100786321|FG001|STARTED|Overall Study||212||
48189846|NCT00412516|100786322|FG002|STARTED|Overall Study||214||
48466135|NCT00622908|101476771|FG000|STARTED|Overall Study||137||
48466136|NCT00622908|101476772|FG001|STARTED|Overall Study||132||
48466137|NCT00622908|101476771|FG000|COMPLETED|Overall Study||134||
48466138|NCT00622908|101476772|FG001|COMPLETED|Overall Study||122||
48466139|NCT00622908|101476771|FG000|NOT COMPLETED|Overall Study||3||
48466140|NCT00622908|101476772|FG001|NOT COMPLETED|Overall Study||10||
48466141|NCT03158298|101476773|FG000|STARTED|Overall Study||82||
48466142|NCT03158298|101476773|FG000|COMPLETED|Overall Study||82||
48466143|NCT03158298|101476773|FG000|NOT COMPLETED|Overall Study||0||
48466144|NCT05188521|101476774|FG000|STARTED|Baricitinib 2mg Initial Study||12||
48466145|NCT05188521|101476775|FG001|STARTED|Baricitinib 2mg Initial Study||0||
48466146|NCT05188521|101476774|FG000|COMPLETED|Baricitinib 2mg Initial Study||11||
48466147|NCT05188521|101476775|FG001|COMPLETED|Baricitinib 2mg Initial Study||0||
48466148|NCT05188521|101476774|FG000|NOT COMPLETED|Baricitinib 2mg Initial Study||1||
48466149|NCT05188521|101476775|FG001|NOT COMPLETED|Baricitinib 2mg Initial Study||0||
48466150|NCT05188521|101476774|FG000|STARTED|Baricitinib 4mg Extension Study||0||
48781921|NCT01237899|102256298|FG005|NOT COMPLETED|Second Dosing Period||0||
48781922|NCT01237899|102256299|FG006|NOT COMPLETED|Second Dosing Period||0||
48781923|NCT01237899|102256300|FG007|NOT COMPLETED|Second Dosing Period||0||
48781924|NCT01237899|102256301|FG008|NOT COMPLETED|Second Dosing Period||0||
48781925|NCT01237899|102256302|FG009|NOT COMPLETED|Second Dosing Period||0||
48781926|NCT01237899|102256303|FG010|NOT COMPLETED|Second Dosing Period||0||
48781927|NCT01901250|102256304|FG000|STARTED|Overall Study||260||
48781928|NCT01901250|102256305|FG001|STARTED|Overall Study||265||
48781929|NCT01901250|102256304|FG000|End of Kidergarten|Overall Study||215||
48781930|NCT01901250|102256305|FG001|End of Kidergarten|Overall Study||212||
48781931|NCT01901250|102256304|FG000|Start of 1st Grade|Overall Study||173||
48781932|NCT01901250|102256305|FG001|Start of 1st Grade|Overall Study||176||
48781933|NCT01901250|102256304|FG000|End of 1st Grade|Overall Study||143||
48781934|NCT01901250|102256305|FG001|End of 1st Grade|Overall Study||151||
48781935|NCT01901250|102256304|FG000|COMPLETED|Overall Study||122||
48781936|NCT01901250|102256305|FG001|COMPLETED|Overall Study||139||
48781937|NCT01901250|102256304|FG000|NOT COMPLETED|Overall Study||138||
48781938|NCT01901250|102256305|FG001|NOT COMPLETED|Overall Study||126||
48781939|NCT01322841|102256306|FG000|STARTED|Overall Study||1116||
48781940|NCT01322841|102256307|FG001|STARTED|Overall Study||1123||
48781941|NCT01322841|102256306|FG000|COMPLETED|Overall Study||1116||
48781942|NCT01322841|102256307|FG001|COMPLETED|Overall Study||1123||
48781943|NCT01322841|102256306|FG000|NOT COMPLETED|Overall Study||0||
48781944|NCT01322841|102256307|FG001|NOT COMPLETED|Overall Study||0||
48781945|NCT00329524|102256308|FG000|STARTED|Overall Study||5||
48781946|NCT00329524|102256308|FG000|COMPLETED|Overall Study||5||
48781947|NCT00329524|102256308|FG000|NOT COMPLETED|Overall Study||0||
48781948|NCT01182844|102256309|FG000|STARTED|Overall Study||15||
48781949|NCT01182844|102256310|FG001|STARTED|Overall Study||15||
48781950|NCT01182844|102256309|FG000|COMPLETED|Overall Study||15||
48781951|NCT01182844|102256310|FG001|COMPLETED|Overall Study||13||
48781952|NCT01182844|102256309|FG000|NOT COMPLETED|Overall Study||0||
48781953|NCT01182844|102256310|FG001|NOT COMPLETED|Overall Study||2||
48781954|NCT00904033|102256311|FG000|STARTED|Overall Study||10||
48466151|NCT05188521|101476775|FG001|STARTED|Baricitinib 4mg Extension Study||5||
48466152|NCT05188521|101476774|FG000|COMPLETED|Baricitinib 4mg Extension Study||0||
48466153|NCT05188521|101476775|FG001|COMPLETED|Baricitinib 4mg Extension Study||5||
48781955|NCT00904033|102256312|FG001|STARTED|Overall Study||10||
48781956|NCT00904033|102256313|FG002|STARTED|Overall Study||10||
48781957|NCT00904033|102256314|FG003|STARTED|Overall Study||11||
48781958|NCT00904033|102256311|FG000|COMPLETED|Overall Study||9||
48781959|NCT00904033|102256312|FG001|COMPLETED|Overall Study||9||
48189847|NCT00412516|100786320|FG000|COMPLETED|Overall Study||93||
48466154|NCT05188521|101476774|FG000|NOT COMPLETED|Baricitinib 4mg Extension Study||0||
48466155|NCT05188521|101476775|FG001|NOT COMPLETED|Baricitinib 4mg Extension Study||0||
48781960|NCT00904033|102256313|FG002|COMPLETED|Overall Study||9||
48781961|NCT00904033|102256314|FG003|COMPLETED|Overall Study||9||
48781962|NCT00904033|102256311|FG000|NOT COMPLETED|Overall Study||1||
48781963|NCT00904033|102256312|FG001|NOT COMPLETED|Overall Study||1||
48781964|NCT00904033|102256313|FG002|NOT COMPLETED|Overall Study||1||
48781965|NCT00904033|102256314|FG003|NOT COMPLETED|Overall Study||2||
48781966|NCT02175199|102256315|FG000|STARTED|Overall Study||74||
48466156|NCT01339910|101476776|FG000|STARTED|Overall Study||135||
48466157|NCT01339910|101476777|FG001|STARTED|Overall Study||137||
48466158|NCT01339910|101476776|FG000|COMPLETED|Overall Study||132||
48466159|NCT01339910|101476777|FG001|COMPLETED|Overall Study||133||
48466160|NCT01339910|101476776|FG000|NOT COMPLETED|Overall Study||3||
48466161|NCT01339910|101476777|FG001|NOT COMPLETED|Overall Study||4||
48466162|NCT02158936|101476778|FG000|STARTED|Overall Study||179||
48466163|NCT02158936|101476779|FG001|STARTED|Overall Study||177||
48466164|NCT02158936|101476778|FG000|Treated|Overall Study||177||
48466165|NCT02158936|101476779|FG001|Treated|Overall Study||177||
48466166|NCT02158936|101476778|FG000|Untreated|Overall Study||2||
48466167|NCT02158936|101476779|FG001|Untreated|Overall Study||0||
48466168|NCT02158936|101476778|FG000|COMPLETED|Overall Study||0||
48466169|NCT02158936|101476779|FG001|COMPLETED|Overall Study||0||
48466170|NCT02158936|101476778|FG000|NOT COMPLETED|Overall Study||179||
48466171|NCT02158936|101476779|FG001|NOT COMPLETED|Overall Study||177||
48466172|NCT00132002|101476780|FG000|STARTED|Overall Study||14||
48466173|NCT00132002|101476780|FG000|COMPLETED|Overall Study||14||
48466174|NCT00132002|101476780|FG000|NOT COMPLETED|Overall Study||0||
48466175|NCT01974895|101476781|FG000|STARTED|Overall Study||158||
48466176|NCT01974895|101476782|FG001|STARTED|Overall Study||156||
48466177|NCT01974895|101476781|FG000|COMPLETED|Overall Study||143||
48466178|NCT01974895|101476782|FG001|COMPLETED|Overall Study||141||
48466179|NCT01974895|101476781|FG000|NOT COMPLETED|Overall Study||15||
48466180|NCT01974895|101476782|FG001|NOT COMPLETED|Overall Study||15||
48466181|NCT02255513|101476783|FG000|STARTED|Open-label, Treatment Optimization||43||
48466182|NCT02255513|101476784|FG001|STARTED|Open-label, Treatment Optimization||0||
48466183|NCT02255513|101476783|FG000|COMPLETED|Open-label, Treatment Optimization||43||
48466184|NCT02255513|101476784|FG001|COMPLETED|Open-label, Treatment Optimization||0||
48466185|NCT02255513|101476783|FG000|NOT COMPLETED|Open-label, Treatment Optimization||0||
48466186|NCT02255513|101476784|FG001|NOT COMPLETED|Open-label, Treatment Optimization||0||
48466187|NCT02255513|101476783|FG000|STARTED|Double Blind, Placebo-controlled||22||
48466188|NCT02255513|101476784|FG001|STARTED|Double Blind, Placebo-controlled||21||
48466189|NCT02255513|101476783|FG000|COMPLETED|Double Blind, Placebo-controlled||22||
48466190|NCT02255513|101476784|FG001|COMPLETED|Double Blind, Placebo-controlled||21||
48466191|NCT02255513|101476783|FG000|NOT COMPLETED|Double Blind, Placebo-controlled||0||
48466192|NCT02255513|101476784|FG001|NOT COMPLETED|Double Blind, Placebo-controlled||0||
48466193|NCT00661505|101476785|FG000|STARTED|Overall Study||132||
48466194|NCT00661505|101476785|FG000|COMPLETED|Overall Study||102||
48466195|NCT00661505|101476785|FG000|NOT COMPLETED|Overall Study||30||
48466196|NCT00365261|101476786|FG000|STARTED|Overall Study||23||
48466197|NCT00365261|101476787|FG001|STARTED|Overall Study||22||
48466198|NCT00365261|101476786|FG000|COMPLETED|Overall Study||20||
48466199|NCT00365261|101476787|FG001|COMPLETED|Overall Study||19||
48466200|NCT00365261|101476786|FG000|NOT COMPLETED|Overall Study||3||
48466201|NCT00365261|101476787|FG001|NOT COMPLETED|Overall Study||3||
48466202|NCT03529955|101476788|FG000|STARTED|Overall Study||8||
48466203|NCT03529955|101476788|FG000|COMPLETED|Overall Study||6||
48466204|NCT03529955|101476788|FG000|NOT COMPLETED|Overall Study||2||
48466205|NCT00475020|101476789|FG000|STARTED|Overall Study||63||
48466206|NCT00475020|101476789|FG000|COMPLETED|Overall Study||58||
48466207|NCT00475020|101476789|FG000|NOT COMPLETED|Overall Study||5||
48466208|NCT02442856|101476790|FG000|STARTED|Overall Study||21||
48466209|NCT02442856|101476790|FG000|COMPLETED|Overall Study||21||
48466210|NCT02442856|101476790|FG000|NOT COMPLETED|Overall Study||0||
48466211|NCT02563522|101476791|FG000|STARTED|Overall Study||27||
48466212|NCT02563522|101476792|FG001|STARTED|Overall Study||17||
48466213|NCT02563522|101476791|FG000|COMPLETED|Overall Study||23||
48466214|NCT02563522|101476792|FG001|COMPLETED|Overall Study||12||
48466215|NCT02563522|101476791|FG000|NOT COMPLETED|Overall Study||4||
48466216|NCT02563522|101476792|FG001|NOT COMPLETED|Overall Study||5||
48466217|NCT01127581|101476793|FG000|STARTED|Overall Study||678||
48466218|NCT01127581|101476794|FG001|STARTED|Overall Study||680||
48466219|NCT01127581|101476793|FG000|COMPLETED|Overall Study||678||
48466220|NCT01127581|101476794|FG001|COMPLETED|Overall Study||680||
48466221|NCT01127581|101476793|FG000|NOT COMPLETED|Overall Study||0||
48466222|NCT01127581|101476794|FG001|NOT COMPLETED|Overall Study||0||
48466223|NCT05343156|101476795|FG000|STARTED|Overall Study||99||
48466224|NCT05343156|101476796|FG001|STARTED|Overall Study||45||
48466225|NCT05343156|101476795|FG000|COMPLETED|Overall Study||91||
48466226|NCT05343156|101476796|FG001|COMPLETED|Overall Study||42||
48466227|NCT05343156|101476795|FG000|NOT COMPLETED|Overall Study||8||
48466228|NCT05343156|101476796|FG001|NOT COMPLETED|Overall Study||3||
48466229|NCT01176448|101476797|FG000|STARTED|Overall Study||6||
48466230|NCT01176448|101476797|FG000|COMPLETED|Overall Study||6||
48466231|NCT01176448|101476797|FG000|NOT COMPLETED|Overall Study||0||
48466232|NCT01105650|101476798|FG000|STARTED|Overall Study||3||
48466233|NCT01105650|101476799|FG001|STARTED|Overall Study||3||
48466234|NCT01105650|101476800|FG002|STARTED|Overall Study||7||
48466235|NCT01105650|101476801|FG003|STARTED|Overall Study||0||
48466236|NCT01105650|101476798|FG000|COMPLETED|Overall Study||3||
48466237|NCT01105650|101476799|FG001|COMPLETED|Overall Study||3||
48466238|NCT01105650|101476800|FG002|COMPLETED|Overall Study||7||
48466239|NCT01105650|101476801|FG003|COMPLETED|Overall Study||0||
48781967|NCT02175199|102256316|FG001|STARTED|Overall Study||76||
48781968|NCT02175199|102256315|FG000|Dispensed|Overall Study||72||
48781969|NCT02175199|102256316|FG001|Dispensed|Overall Study||74||
48466240|NCT01105650|101476798|FG000|NOT COMPLETED|Overall Study||0||
48466241|NCT01105650|101476799|FG001|NOT COMPLETED|Overall Study||0||
48466242|NCT01105650|101476800|FG002|NOT COMPLETED|Overall Study||0||
48781970|NCT02175199|102256315|FG000|COMPLETED|Overall Study||71||
48781971|NCT02175199|102256316|FG001|COMPLETED|Overall Study||71||
48781972|NCT02175199|102256315|FG000|NOT COMPLETED|Overall Study||3||
48781973|NCT02175199|102256316|FG001|NOT COMPLETED|Overall Study||5||
48781974|NCT00612807|102256317|FG000|STARTED|Overall Study||14||
48781975|NCT00612807|102256318|FG001|STARTED|Overall Study||28||
48781976|NCT00612807|102256317|FG000|COMPLETED|Overall Study||12||
48781977|NCT00612807|102256318|FG001|COMPLETED|Overall Study||28||
48781978|NCT00612807|102256317|FG000|NOT COMPLETED|Overall Study||2||
48781979|NCT00612807|102256318|FG001|NOT COMPLETED|Overall Study||0||
48781980|NCT01086358|102256319|FG000|STARTED|First Intervention||30||
48781981|NCT01086358|102256320|FG001|STARTED|First Intervention||29||
48781982|NCT01086358|102256319|FG000|COMPLETED|First Intervention||21||
48466243|NCT01105650|101476801|FG003|NOT COMPLETED|Overall Study||0||
48466244|NCT02456909|101476802|FG000|STARTED|Overall Study||88||
48466245|NCT02456909|101476803|FG001|STARTED|Overall Study||88||
48466246|NCT02456909|101476802|FG000|COMPLETED|Overall Study||64||
48466247|NCT02456909|101476803|FG001|COMPLETED|Overall Study||61||
48466248|NCT02456909|101476802|FG000|NOT COMPLETED|Overall Study||24||
48466249|NCT02456909|101476803|FG001|NOT COMPLETED|Overall Study||27||
48466250|NCT01326026|101476804|FG000|STARTED|Overall Study||111||
48466251|NCT01326026|101476805|FG001|STARTED|Overall Study||111||
48466252|NCT01326026|101476804|FG000|Exposed|Overall Study||110||
48466253|NCT01326026|101476805|FG001|Exposed|Overall Study||111||
48466254|NCT01326026|101476804|FG000|COMPLETED|Overall Study||99||
48466255|NCT01326026|101476805|FG001|COMPLETED|Overall Study||98||
48466256|NCT01326026|101476804|FG000|NOT COMPLETED|Overall Study||12||
48466257|NCT01326026|101476805|FG001|NOT COMPLETED|Overall Study||13||
48466258|NCT02354586|101476806|FG000|STARTED|Overall Study||463||
48466259|NCT02354586|101476806|FG000|COMPLETED|Overall Study||0||
48466260|NCT02354586|101476806|FG000|NOT COMPLETED|Overall Study||463||
48466261|NCT01673009|101476807|FG000|STARTED|Overall Study||36||
48781983|NCT01086358|102256320|FG001|COMPLETED|First Intervention||24||
48781984|NCT01086358|102256319|FG000|NOT COMPLETED|First Intervention||9||
48781985|NCT01086358|102256320|FG001|NOT COMPLETED|First Intervention||5||
48781986|NCT01086358|102256319|FG000|STARTED|Second Intervention||21||
48781987|NCT01086358|102256320|FG001|STARTED|Second Intervention||24||
48781988|NCT01086358|102256319|FG000|COMPLETED|Second Intervention||17||
48781989|NCT01086358|102256320|FG001|COMPLETED|Second Intervention||20||
48781990|NCT01086358|102256319|FG000|NOT COMPLETED|Second Intervention||4||
48781991|NCT01086358|102256320|FG001|NOT COMPLETED|Second Intervention||4||
48781992|NCT03073733|102256321|FG000|STARTED|Overall Study||29||
48781993|NCT03073733|102256322|FG001|STARTED|Overall Study||27||
48781994|NCT03073733|102256323|FG002|STARTED|Overall Study||27||
48781995|NCT03073733|102256321|FG000|COMPLETED|Overall Study||28||
48781996|NCT03073733|102256322|FG001|COMPLETED|Overall Study||26||
48781997|NCT03073733|102256323|FG002|COMPLETED|Overall Study||26||
48781998|NCT03073733|102256321|FG000|NOT COMPLETED|Overall Study||1||
48781999|NCT03073733|102256322|FG001|NOT COMPLETED|Overall Study||1||
48782000|NCT03073733|102256323|FG002|NOT COMPLETED|Overall Study||1||
48782001|NCT00702715|102256324|FG000|STARTED|Overall Study||35||
48782002|NCT00702715|102256325|FG001|STARTED|Overall Study||33||
48782003|NCT00702715|102256324|FG000|COMPLETED|Overall Study||34||
48782004|NCT00702715|102256325|FG001|COMPLETED|Overall Study||33||
48782005|NCT00702715|102256324|FG000|NOT COMPLETED|Overall Study||1||
48782006|NCT00702715|102256325|FG001|NOT COMPLETED|Overall Study||0||
48466262|NCT01673009|101476807|FG000|COMPLETED|Overall Study||23||
48466263|NCT01673009|101476807|FG000|NOT COMPLETED|Overall Study||13||
48466264|NCT01095003|101476808|FG000|STARTED|Overall Study||384||
48466265|NCT01095003|101476809|FG001|STARTED|Overall Study||386||
48466266|NCT01095003|101476808|FG000|COMPLETED|Overall Study||0||
48466267|NCT01095003|101476809|FG001|COMPLETED|Overall Study||0||
48466268|NCT01095003|101476808|FG000|NOT COMPLETED|Overall Study||384||
48782007|NCT01097005|102256326|FG000|STARTED|Overall Study||466||
48466269|NCT01095003|101476809|FG001|NOT COMPLETED|Overall Study||386||
48782008|NCT01097005|102256326|FG000|Analysis of Safety|Overall Study||441||
48782009|NCT01097005|102256326|FG000|Analysis of NTM Lung Disease|Overall Study||340||
48782010|NCT01097005|102256326|FG000|Analysis of Bacilli Negative Conversion|Overall Study||285||
48466270|NCT03504852|101476810|FG000|STARTED|Overall Study||165||
48466271|NCT03504852|101476811|FG001|STARTED|Overall Study||135||
48782011|NCT01097005|102256326|FG000|Analysis of CGI|Overall Study||249||
48466272|NCT03504852|101476812|FG002|STARTED|Overall Study||31||
48782012|NCT01097005|102256326|FG000|COMPLETED|Overall Study||101||
48782013|NCT01097005|102256326|FG000|NOT COMPLETED|Overall Study||365||
48466273|NCT03504852|101476810|FG000|COMPLETED|Overall Study||148||
48466274|NCT03504852|101476811|FG001|COMPLETED|Overall Study||117||
48466275|NCT03504852|101476812|FG002|COMPLETED|Overall Study||28||
48466276|NCT03504852|101476810|FG000|NOT COMPLETED|Overall Study||17||
48466277|NCT03504852|101476811|FG001|NOT COMPLETED|Overall Study||18||
48466278|NCT03504852|101476812|FG002|NOT COMPLETED|Overall Study||3||
48466279|NCT03519256|101476813|FG000|STARTED|Overall Study||16||
48466280|NCT03519256|101476814|FG001|STARTED|Overall Study||26||
48466281|NCT03519256|101476815|FG002|STARTED|Overall Study||17||
48466282|NCT03519256|101476816|FG003|STARTED|Overall Study||10||
48466283|NCT03519256|101476813|FG000|Safety-Lead In Phase|Overall Study||0||
48466284|NCT03519256|101476814|FG001|Safety-Lead In Phase|Overall Study||10||
48466285|NCT03519256|101476815|FG002|Safety-Lead In Phase|Overall Study||0||
48466286|NCT03519256|101476816|FG003|Safety-Lead In Phase|Overall Study||10||
48466287|NCT03519256|101476813|FG000|COMPLETED|Overall Study||6||
48466288|NCT03519256|101476814|FG001|COMPLETED|Overall Study||15||
48466289|NCT03519256|101476815|FG002|COMPLETED|Overall Study||2||
48466290|NCT03519256|101476816|FG003|COMPLETED|Overall Study||3||
48466291|NCT03519256|101476813|FG000|NOT COMPLETED|Overall Study||10||
48466292|NCT03519256|101476814|FG001|NOT COMPLETED|Overall Study||11||
48466293|NCT03519256|101476815|FG002|NOT COMPLETED|Overall Study||15||
48466294|NCT03519256|101476816|FG003|NOT COMPLETED|Overall Study||7||
48466295|NCT01821625|101476817|FG000|STARTED|Overall Study||7||
48466296|NCT01821625|101476817|FG000|COMPLETED|Overall Study||1||
48466297|NCT01821625|101476817|FG000|NOT COMPLETED|Overall Study||6||
48782014|NCT05387434|102256327|FG000|STARTED|Overall Study||16||
48782015|NCT05387434|102256328|FG001|STARTED|Overall Study||15||
48782016|NCT05387434|102256327|FG000|COMPLETED|Overall Study||14||
48782017|NCT05387434|102256328|FG001|COMPLETED|Overall Study||13||
48782018|NCT05387434|102256327|FG000|NOT COMPLETED|Overall Study||2||
48782019|NCT05387434|102256328|FG001|NOT COMPLETED|Overall Study||2||
48782020|NCT03192358|102256329|FG000|STARTED|Overall Study||20||
48782021|NCT03192358|102256330|FG001|STARTED|Overall Study||20||
48782022|NCT03192358|102256329|FG000|COMPLETED|Overall Study||20||
48782023|NCT03192358|102256330|FG001|COMPLETED|Overall Study||20||
48466298|NCT04543136|101476818|FG000|STARTED|Overall Study||3||
48466299|NCT04543136|101476819|FG001|STARTED|Overall Study||3||
48466300|NCT04543136|101476820|FG002|STARTED|Overall Study||2||
48466301|NCT04543136|101476821|FG003|STARTED|Overall Study||3||
48466302|NCT04543136|101476822|FG004|STARTED|Overall Study||2||
48466303|NCT04543136|101476823|FG005|STARTED|Overall Study||3||
48782024|NCT03192358|102256329|FG000|NOT COMPLETED|Overall Study||0||
48782025|NCT03192358|102256330|FG001|NOT COMPLETED|Overall Study||0||
48782026|NCT00934440|102256331|FG000|STARTED|Overall Study||11||
48782027|NCT00934440|102256331|FG000|COMPLETED|Overall Study||10||
48782028|NCT00934440|102256331|FG000|NOT COMPLETED|Overall Study||1||
48782029|NCT01947855|102256332|FG000|STARTED|Overall Study||21||
48782030|NCT01947855|102256333|FG001|STARTED|Overall Study||20||
48782031|NCT01947855|102256334|FG002|STARTED|Overall Study||19||
48782032|NCT01947855|102256332|FG000|COMPLETED|Overall Study||20||
48782033|NCT01947855|102256333|FG001|COMPLETED|Overall Study||20||
48466304|NCT04543136|101476818|FG000|COMPLETED|Overall Study||3||
48466305|NCT04543136|101476819|FG001|COMPLETED|Overall Study||2||
48466306|NCT04543136|101476820|FG002|COMPLETED|Overall Study||2||
48466307|NCT04543136|101476821|FG003|COMPLETED|Overall Study||2||
48466308|NCT04543136|101476822|FG004|COMPLETED|Overall Study||2||
48466309|NCT04543136|101476823|FG005|COMPLETED|Overall Study||3||
48466310|NCT04543136|101476818|FG000|NOT COMPLETED|Overall Study||0||
48466311|NCT04543136|101476819|FG001|NOT COMPLETED|Overall Study||1||
48466312|NCT04543136|101476820|FG002|NOT COMPLETED|Overall Study||0||
48782034|NCT01947855|102256334|FG002|COMPLETED|Overall Study||19||
48782035|NCT01947855|102256332|FG000|NOT COMPLETED|Overall Study||1||
48782036|NCT01947855|102256333|FG001|NOT COMPLETED|Overall Study||0||
48782037|NCT01947855|102256334|FG002|NOT COMPLETED|Overall Study||0||
48782038|NCT03376295|102256335|FG000|STARTED|Overall Study||1977||
48782039|NCT03376295|102256336|FG001|STARTED|Overall Study||1977||
48782040|NCT03376295|102256335|FG000|COMPLETED|Overall Study||1977||
48782041|NCT03376295|102256336|FG001|COMPLETED|Overall Study||1977||
48782042|NCT03376295|102256335|FG000|NOT COMPLETED|Overall Study||0||
48782043|NCT03376295|102256336|FG001|NOT COMPLETED|Overall Study||0||
48782044|NCT00275340|102256337|FG000|STARTED|Overall Study||52||
48782045|NCT00275340|102256338|FG001|STARTED|Overall Study||49||
48782046|NCT00275340|102256337|FG000|COMPLETED|Overall Study||50||
48782047|NCT00275340|102256338|FG001|COMPLETED|Overall Study||45||
48782048|NCT00275340|102256337|FG000|NOT COMPLETED|Overall Study||2||
48782049|NCT00275340|102256338|FG001|NOT COMPLETED|Overall Study||4||
48466313|NCT04543136|101476821|FG003|NOT COMPLETED|Overall Study||1||
48466314|NCT04543136|101476822|FG004|NOT COMPLETED|Overall Study||0||
48466315|NCT04543136|101476823|FG005|NOT COMPLETED|Overall Study||0||
48466316|NCT00017563|101476824|FG000|STARTED|Overall Study||57||
48466317|NCT00017563|101476824|FG000|COMPLETED|Overall Study||56||
48466318|NCT00017563|101476824|FG000|NOT COMPLETED|Overall Study||1||
48466319|NCT03580343|101476825|FG000|STARTED|Overall Study||5||
48466320|NCT03580343|101476825|FG000|COMPLETED|Overall Study||4||
48466321|NCT03580343|101476825|FG000|NOT COMPLETED|Overall Study||1||
48782050|NCT03163017|102256339|FG000|STARTED|Overall Study||30||
48782051|NCT03163017|102256339|FG000|COMPLETED|Overall Study||30||
48782052|NCT03163017|102256339|FG000|NOT COMPLETED|Overall Study||0||
48782053|NCT01864005|102256340|FG000|STARTED|Overall Study||29||
48782054|NCT01864005|102256341|FG001|STARTED|Overall Study||31||
48782055|NCT01864005|102256340|FG000|COMPLETED|Overall Study||26||
48782056|NCT01864005|102256341|FG001|COMPLETED|Overall Study||25||
48782057|NCT01864005|102256340|FG000|NOT COMPLETED|Overall Study||3||
48782058|NCT01864005|102256341|FG001|NOT COMPLETED|Overall Study||6||
48782059|NCT02147561|102256342|FG000|STARTED|Overall Study||280||
48466322|NCT00698685|101476826|FG000|STARTED|Overall Study||14||
48466323|NCT00698685|101476826|FG000|COMPLETED|Overall Study||12||
48466324|NCT00698685|101476826|FG000|NOT COMPLETED|Overall Study||2||
48466325|NCT00922779|101476827|FG000|STARTED|Overall Study||6661||
48466326|NCT00922779|101476827|FG000|COMPLETED|Overall Study||4334||
48466327|NCT00922779|101476827|FG000|NOT COMPLETED|Overall Study||2327||
48782060|NCT02147561|102256342|FG000|COMPLETED|Overall Study||276||
48782061|NCT02147561|102256342|FG000|NOT COMPLETED|Overall Study||4||
48782062|NCT01305577|102256343|FG000|STARTED|Overall Study||120||
48466328|NCT02192905|101476828|FG000|STARTED|Overall Study||43||
48466329|NCT02192905|101476828|FG000|COMPLETED|Overall Study||42||
48466330|NCT02192905|101476828|FG000|NOT COMPLETED|Overall Study||1||
48466331|NCT02739542|101476829|FG000|STARTED|Overall Study||44||
48466332|NCT02739542|101476830|FG001|STARTED|Overall Study||43||
48466333|NCT02739542|101476829|FG000|COMPLETED|Overall Study||30||
48466334|NCT02739542|101476830|FG001|COMPLETED|Overall Study||29||
48466335|NCT02739542|101476829|FG000|NOT COMPLETED|Overall Study||14||
48466336|NCT02739542|101476830|FG001|NOT COMPLETED|Overall Study||14||
48466337|NCT01693783|101476831|FG000|STARTED|Overall Study||42||
48466338|NCT01693783|101476831|FG000|COMPLETED|Overall Study||42||
48466339|NCT01693783|101476831|FG000|NOT COMPLETED|Overall Study||0||
48466340|NCT02224456|101476832|FG000|STARTED|Overall Study||197||
48466341|NCT02224456|101476832|FG000|COMPLETED|Overall Study||161||
48466342|NCT02224456|101476832|FG000|NOT COMPLETED|Overall Study||36||
48466343|NCT01691859|101476833|FG000|STARTED|Overall Study||347||
48466344|NCT01691859|101476833|FG000|COMPLETED|Overall Study||0||
48466345|NCT01691859|101476833|FG000|NOT COMPLETED|Overall Study||347||
48466346|NCT01364870|101476834|FG000|STARTED|Overall Study||122||
48466347|NCT01364870|101476835|FG001|STARTED|Overall Study||123||
48466348|NCT01364870|101476836|FG002|STARTED|Overall Study||72||
48466349|NCT01364870|101476834|FG000|COMPLETED|Overall Study||100||
48466350|NCT01364870|101476835|FG001|COMPLETED|Overall Study||93||
48466351|NCT01364870|101476836|FG002|COMPLETED|Overall Study||58||
48466352|NCT01364870|101476834|FG000|NOT COMPLETED|Overall Study||22||
48466353|NCT01364870|101476835|FG001|NOT COMPLETED|Overall Study||30||
48466354|NCT01364870|101476836|FG002|NOT COMPLETED|Overall Study||14||
48466355|NCT01508936|101476837|FG000|STARTED|Overall Study||102||
48466356|NCT01508936|101476838|FG001|STARTED|Overall Study||409||
48466357|NCT01508936|101476837|FG000|Randomized, Not Analyzed|Overall Study||4||
48782063|NCT01305577|102256344|FG001|STARTED|Overall Study||121||
48782064|NCT01305577|102256345|FG002|STARTED|Overall Study||122||
48782065|NCT01305577|102256343|FG000|Received Treatment|Overall Study||119||
48782066|NCT01305577|102256344|FG001|Received Treatment|Overall Study||121||
48782067|NCT01305577|102256345|FG002|Received Treatment|Overall Study||122||
48189848|NCT00412516|100786321|FG001|COMPLETED|Overall Study||212||
48466358|NCT01508936|101476838|FG001|Randomized, Not Analyzed|Overall Study||11||
48466359|NCT01508936|101476837|FG000|Randomized|Overall Study||98||
48466360|NCT01508936|101476838|FG001|Randomized|Overall Study||398||
48466361|NCT01508936|101476837|FG000|Randomized, Not Treated|Overall Study||1||
48466362|NCT01508936|101476838|FG001|Randomized, Not Treated|Overall Study||3||
48466363|NCT01508936|101476837|FG000|Safety Analysis Set|Overall Study||97||
48466364|NCT01508936|101476838|FG001|Safety Analysis Set|Overall Study||395||
48466365|NCT01508936|101476837|FG000|Full Analysis Set|Overall Study||97||
48466366|NCT01508936|101476838|FG001|Full Analysis Set|Overall Study||395||
48466367|NCT01508936|101476837|FG000|FEV1 Subpopulation Analysis Set|Overall Study||91||
48466368|NCT01508936|101476838|FG001|FEV1 Subpopulation Analysis Set|Overall Study||346||
48466369|NCT01508936|101476837|FG000|COMPLETED|Overall Study||79||
48466370|NCT01508936|101476838|FG001|COMPLETED|Overall Study||330||
48466371|NCT01508936|101476837|FG000|NOT COMPLETED|Overall Study||23||
48466372|NCT01508936|101476838|FG001|NOT COMPLETED|Overall Study||79||
48466373|NCT03295643|101476839|FG000|STARTED|Overall Study||319||
48466374|NCT03295643|101476839|FG000|Completed Explore Stage|Overall Study||283||
48466375|NCT03295643|101476839|FG000|Completed Build Stage|Overall Study||183||
48782068|NCT01305577|102256343|FG000|COMPLETED|Overall Study||107||
48782069|NCT01305577|102256344|FG001|COMPLETED|Overall Study||110||
48782070|NCT01305577|102256345|FG002|COMPLETED|Overall Study||112||
48782071|NCT01305577|102256343|FG000|NOT COMPLETED|Overall Study||13||
48782072|NCT01305577|102256344|FG001|NOT COMPLETED|Overall Study||11||
48782073|NCT01305577|102256345|FG002|NOT COMPLETED|Overall Study||10||
48466376|NCT03295643|101476839|FG000|Completed Mobilize Stage|Overall Study||139||
48466377|NCT03295643|101476839|FG000|Completed Quit Stage|Overall Study||131||
48466378|NCT03295643|101476839|FG000|Completed Secure Stage|Overall Study||126||
48665759|NCT02921256|101967411|FG001|NOT COMPLETED|Arm 1a v. Arm II||33||
48782074|NCT00575146|102256346|FG000|STARTED|Overall Study||20||
48782075|NCT00575146|102256346|FG000|COMPLETED|Overall Study||17||
48782076|NCT00575146|102256346|FG000|NOT COMPLETED|Overall Study||3||
48782077|NCT02529553|102256347|FG000|STARTED|Overall Study||1||
48782078|NCT02529553|102256348|FG001|STARTED|Overall Study||1||
48782079|NCT02529553|102256349|FG002|STARTED|Overall Study||1||
48782080|NCT02529553|102256350|FG003|STARTED|Overall Study||3||
48782081|NCT02529553|102256351|FG004|STARTED|Overall Study||3||
48782082|NCT02529553|102256352|FG005|STARTED|Overall Study||4||
48782083|NCT02529553|102256353|FG006|STARTED|Overall Study||3||
48782084|NCT02529553|102256354|FG007|STARTED|Overall Study||6||
48782085|NCT02529553|102256355|FG008|STARTED|Overall Study||3||
48782086|NCT02529553|102256347|FG000|COMPLETED|Overall Study||0||
48782087|NCT02529553|102256348|FG001|COMPLETED|Overall Study||0||
48466379|NCT03295643|101476839|FG000|COMPLETED|Overall Study||272|Completed the end-of-Pivot questionnaire and thus completed the study|
48466380|NCT03295643|101476839|FG000|NOT COMPLETED|Overall Study||47||
48466381|NCT00506753|101476840|FG000|STARTED|Overall Study||100||
48466382|NCT00506753|101476841|FG001|STARTED|Overall Study||99||
48466383|NCT00506753|101476840|FG000|COMPLETED|Overall Study||79||
48466384|NCT00506753|101476841|FG001|COMPLETED|Overall Study||84||
48466385|NCT00506753|101476840|FG000|NOT COMPLETED|Overall Study||21||
48466386|NCT00506753|101476841|FG001|NOT COMPLETED|Overall Study||15||
48466387|NCT03581474|101476842|FG000|STARTED|Overall Study||12||
48466388|NCT03581474|101476842|FG000|COMPLETED|Overall Study||12|Early completion due to recruitment issues. Originally the study aimed to include 90 subjects.|
48466389|NCT03581474|101476842|FG000|NOT COMPLETED|Overall Study||0||
48466390|NCT03583333|101476843|FG000|STARTED|Overall Study||138||
48466391|NCT03583333|101476844|FG001|STARTED|Overall Study||136||
48466392|NCT03583333|101476843|FG000|Treated|Overall Study||134||
48466393|NCT03583333|101476844|FG001|Treated|Overall Study||136||
48466394|NCT03583333|101476843|FG000|COMPLETED|Overall Study||90||
48466395|NCT03583333|101476844|FG001|COMPLETED|Overall Study||106||
48466396|NCT03583333|101476843|FG000|NOT COMPLETED|Overall Study||48||
48466397|NCT03583333|101476844|FG001|NOT COMPLETED|Overall Study||30||
48466398|NCT02568384|101476845|FG000|STARTED|Overall Study||45||
48466399|NCT02568384|101476845|FG000|COMPLETED|Overall Study||43||
48466400|NCT02568384|101476845|FG000|NOT COMPLETED|Overall Study||2||
48466401|NCT02385526|101476846|FG000|STARTED|Overall Study||22||
48466402|NCT02385526|101476847|FG001|STARTED|Overall Study||20||
48466403|NCT02385526|101476848|FG002|STARTED|Overall Study||20||
48466404|NCT02385526|101476846|FG000|COMPLETED|Overall Study||20||
48466405|NCT02385526|101476847|FG001|COMPLETED|Overall Study||17||
48466406|NCT02385526|101476848|FG002|COMPLETED|Overall Study||20||
48466407|NCT02385526|101476846|FG000|NOT COMPLETED|Overall Study||2||
48466408|NCT02385526|101476847|FG001|NOT COMPLETED|Overall Study||3||
48466409|NCT02385526|101476848|FG002|NOT COMPLETED|Overall Study||0||
48466410|NCT00231868|101476849|FG000|STARTED|Overall Study||81||
48466411|NCT00231868|101476849|FG000|COMPLETED|Overall Study||65||
48466412|NCT00231868|101476849|FG000|NOT COMPLETED|Overall Study||16||
48466413|NCT02022007|101476850|FG000|STARTED|Overall Study||13||
48466414|NCT02022007|101476851|FG001|STARTED|Overall Study||12||
48466415|NCT02022007|101476852|FG002|STARTED|Overall Study||13||
48466416|NCT02022007|101476850|FG000|COMPLETED|Overall Study||12||
48466417|NCT02022007|101476851|FG001|COMPLETED|Overall Study||11||
48466418|NCT02022007|101476852|FG002|COMPLETED|Overall Study||11||
48466419|NCT02022007|101476850|FG000|NOT COMPLETED|Overall Study||1||
48466420|NCT02022007|101476851|FG001|NOT COMPLETED|Overall Study||1||
48466421|NCT02022007|101476852|FG002|NOT COMPLETED|Overall Study||2||
48466422|NCT01684410|101476853|FG000|STARTED|Overall Study||10||
48466423|NCT01684410|101476854|FG001|STARTED|Overall Study||10||
48782088|NCT02529553|102256349|FG002|COMPLETED|Overall Study||0||
48782089|NCT02529553|102256350|FG003|COMPLETED|Overall Study||0||
48782090|NCT02529553|102256351|FG004|COMPLETED|Overall Study||0||
48782091|NCT02529553|102256352|FG005|COMPLETED|Overall Study||0||
48466424|NCT01684410|101476855|FG002|STARTED|Overall Study||10||
48782092|NCT02529553|102256353|FG006|COMPLETED|Overall Study||0||
48782093|NCT02529553|102256354|FG007|COMPLETED|Overall Study||0||
48782094|NCT02529553|102256355|FG008|COMPLETED|Overall Study||0||
48782095|NCT02529553|102256347|FG000|NOT COMPLETED|Overall Study||1||
48782096|NCT02529553|102256348|FG001|NOT COMPLETED|Overall Study||1||
48782097|NCT02529553|102256349|FG002|NOT COMPLETED|Overall Study||1||
48782098|NCT02529553|102256350|FG003|NOT COMPLETED|Overall Study||3||
48782099|NCT02529553|102256351|FG004|NOT COMPLETED|Overall Study||3||
48782100|NCT02529553|102256352|FG005|NOT COMPLETED|Overall Study||4||
48782101|NCT02529553|102256353|FG006|NOT COMPLETED|Overall Study||3||
48782102|NCT02529553|102256354|FG007|NOT COMPLETED|Overall Study||6||
48782103|NCT02529553|102256355|FG008|NOT COMPLETED|Overall Study||3||
48782104|NCT04530136|102256356|FG000|STARTED|Overall Study||27||
48782105|NCT04530136|102256357|FG001|STARTED|Overall Study||11||
48782106|NCT04530136|102256356|FG000|COMPLETED|Overall Study||24||
48782107|NCT04530136|102256357|FG001|COMPLETED|Overall Study||7||
48782108|NCT04530136|102256356|FG000|NOT COMPLETED|Overall Study||3||
48782109|NCT04530136|102256357|FG001|NOT COMPLETED|Overall Study||4||
48782110|NCT01516034|102256358|FG000|STARTED|Overall Study||8||
48782111|NCT01516034|102256358|FG000|COMPLETED|Overall Study||0||
48782112|NCT01516034|102256358|FG000|NOT COMPLETED|Overall Study||8||
48782113|NCT03535727|102256359|FG000|STARTED|Overall Study||3||
48782114|NCT03535727|102256360|FG001|STARTED|Overall Study||6||
48782115|NCT03535727|102256361|FG002|STARTED|Overall Study||6||
48782116|NCT03535727|102256362|FG003|STARTED|Overall Study||6||
48782117|NCT03535727|102256363|FG004|STARTED|Overall Study||6||
48782118|NCT03535727|102256364|FG005|STARTED|Overall Study||3||
48782119|NCT03535727|102256365|FG006|STARTED|Overall Study||3||
48782120|NCT03535727|102256366|FG007|STARTED|Overall Study||7||
48782121|NCT03535727|102256367|FG008|STARTED|Overall Study||8||
48782122|NCT03535727|102256359|FG000|COMPLETED|Overall Study||3||
48782123|NCT03535727|102256360|FG001|COMPLETED|Overall Study||6||
48782124|NCT03535727|102256361|FG002|COMPLETED|Overall Study||6||
48782125|NCT03535727|102256362|FG003|COMPLETED|Overall Study||6||
48782126|NCT03535727|102256363|FG004|COMPLETED|Overall Study||6||
48782127|NCT03535727|102256364|FG005|COMPLETED|Overall Study||3||
48782128|NCT03535727|102256365|FG006|COMPLETED|Overall Study||3||
48782129|NCT03535727|102256366|FG007|COMPLETED|Overall Study||7||
48782130|NCT03535727|102256367|FG008|COMPLETED|Overall Study||8||
48782131|NCT03535727|102256359|FG000|NOT COMPLETED|Overall Study||0||
48782132|NCT03535727|102256360|FG001|NOT COMPLETED|Overall Study||0||
48782133|NCT03535727|102256361|FG002|NOT COMPLETED|Overall Study||0||
48782134|NCT03535727|102256362|FG003|NOT COMPLETED|Overall Study||0||
48782135|NCT03535727|102256363|FG004|NOT COMPLETED|Overall Study||0||
48782136|NCT03535727|102256364|FG005|NOT COMPLETED|Overall Study||0||
48782137|NCT03535727|102256365|FG006|NOT COMPLETED|Overall Study||0||
48782138|NCT03535727|102256366|FG007|NOT COMPLETED|Overall Study||0||
48782139|NCT03535727|102256367|FG008|NOT COMPLETED|Overall Study||0||
48782140|NCT02560025|102256368|FG000|STARTED|Overall Study||42||
48782141|NCT02560025|102256368|FG000|COMPLETED|Overall Study||39||
48782142|NCT02560025|102256368|FG000|NOT COMPLETED|Overall Study||3||
48782143|NCT00856518|102256369|FG000|STARTED|Overall Study||24||
48782144|NCT00856518|102256370|FG001|STARTED|Overall Study||18||
48782145|NCT00856518|102256369|FG000|COMPLETED|Overall Study||20||
48782146|NCT00856518|102256370|FG001|COMPLETED|Overall Study||16||
48782147|NCT00856518|102256369|FG000|NOT COMPLETED|Overall Study||4||
48782148|NCT00856518|102256370|FG001|NOT COMPLETED|Overall Study||2||
48782149|NCT03698591|102256371|FG000|STARTED|Overall Study||20||
48782150|NCT03698591|102256372|FG001|STARTED|Overall Study||20||
48782151|NCT03698591|102256371|FG000|COMPLETED|Overall Study||15||
48782152|NCT03698591|102256372|FG001|COMPLETED|Overall Study||15||
48782153|NCT03698591|102256371|FG000|NOT COMPLETED|Overall Study||5||
48782154|NCT03698591|102256372|FG001|NOT COMPLETED|Overall Study||5||
48782155|NCT01338298|102256373|FG000|STARTED|Overall Study||24||
48782156|NCT01338298|102256374|FG001|STARTED|Overall Study||18||
48782157|NCT01338298|102256373|FG000|COMPLETED|Overall Study||20||
48782158|NCT01338298|102256374|FG001|COMPLETED|Overall Study||15||
48782159|NCT01338298|102256373|FG000|NOT COMPLETED|Overall Study||4||
48782160|NCT01338298|102256374|FG001|NOT COMPLETED|Overall Study||3||
48782161|NCT04248491|102256375|FG000|STARTED|Overall Study||6||
48782162|NCT04248491|102256376|FG001|STARTED|Overall Study||5||
48782163|NCT04248491|102256375|FG000|COMPLETED|Overall Study||5||
48782164|NCT04248491|102256376|FG001|COMPLETED|Overall Study||5||
48782165|NCT04248491|102256375|FG000|NOT COMPLETED|Overall Study||1||
48782166|NCT04248491|102256376|FG001|NOT COMPLETED|Overall Study||0||
48782167|NCT00899392|102256377|FG000|STARTED|Overall Study||68||
48782168|NCT00899392|102256378|FG001|STARTED|Overall Study||74||
48782169|NCT00899392|102256377|FG000|COMPLETED|Overall Study||47||
48782170|NCT00899392|102256378|FG001|COMPLETED|Overall Study||50||
48782171|NCT00899392|102256377|FG000|NOT COMPLETED|Overall Study||21||
48782172|NCT00899392|102256378|FG001|NOT COMPLETED|Overall Study||24||
48782173|NCT00796978|102256379|FG000|STARTED|Overall Study||56||
48782174|NCT00796978|102256379|FG000|COMPLETED|Overall Study||44||
48782175|NCT00796978|102256379|FG000|NOT COMPLETED|Overall Study||12||
48782176|NCT00530816|102256380|FG000|STARTED|Overall Study||35||
48782177|NCT00530816|102256381|FG001|STARTED|Overall Study||59||
48782178|NCT00530816|102256382|FG002|STARTED|Overall Study||70||
48782179|NCT00530816|102256380|FG000|COMPLETED|Overall Study||9||
48782180|NCT00530816|102256381|FG001|COMPLETED|Overall Study||17||
48782181|NCT00530816|102256382|FG002|COMPLETED|Overall Study||29||
48782182|NCT00530816|102256380|FG000|NOT COMPLETED|Overall Study||26||
48782183|NCT00530816|102256381|FG001|NOT COMPLETED|Overall Study||42||
48782184|NCT00530816|102256382|FG002|NOT COMPLETED|Overall Study||41||
48782185|NCT01124006|102256383|FG000|STARTED|Overall Study||10||
48782186|NCT01124006|102256384|FG001|STARTED|Overall Study||10||
48466425|NCT01684410|101476853|FG000|COMPLETED|Overall Study||10||
48782187|NCT01124006|102256385|FG002|STARTED|Overall Study||4||
48782188|NCT01124006|102256383|FG000|COMPLETED|Overall Study||7||
48782189|NCT01124006|102256384|FG001|COMPLETED|Overall Study||8||
48782190|NCT01124006|102256385|FG002|COMPLETED|Overall Study||2||
48782191|NCT01124006|102256383|FG000|NOT COMPLETED|Overall Study||3||
48782192|NCT01124006|102256384|FG001|NOT COMPLETED|Overall Study||2||
48782193|NCT01124006|102256385|FG002|NOT COMPLETED|Overall Study||2||
48782194|NCT01958489|102256386|FG000|STARTED|Period 1||24||
48782195|NCT01958489|102256387|FG001|STARTED|Period 1||0||
48782196|NCT01958489|102256386|FG000|Received at Least 1 Dose of Study Drug|Period 1||24||
48782197|NCT01958489|102256387|FG001|Received at Least 1 Dose of Study Drug|Period 1||0||
48782198|NCT01958489|102256386|FG000|COMPLETED|Period 1||24||
48782199|NCT01958489|102256387|FG001|COMPLETED|Period 1||0||
48782200|NCT01958489|102256386|FG000|NOT COMPLETED|Period 1||0||
48782201|NCT01958489|102256387|FG001|NOT COMPLETED|Period 1||0||
48782202|NCT01958489|102256386|FG000|STARTED|Period 2||0||
48782203|NCT01958489|102256387|FG001|STARTED|Period 2||24||
48782204|NCT01958489|102256386|FG000|Received at Least 1 Dose of Study Drug|Period 2||0||
48782205|NCT01958489|102256387|FG001|Received at Least 1 Dose of Study Drug|Period 2||24||
48782206|NCT01958489|102256386|FG000|COMPLETED|Period 2||0||
48782207|NCT01958489|102256387|FG001|COMPLETED|Period 2||23||
48782208|NCT01958489|102256386|FG000|NOT COMPLETED|Period 2||0||
48782209|NCT01958489|102256387|FG001|NOT COMPLETED|Period 2||1||
48782210|NCT00573144|102256388|FG000|STARTED|Overall Study||30||
48782211|NCT00573144|102256389|FG001|STARTED|Overall Study||28||
48782212|NCT00573144|102256388|FG000|COMPLETED|Overall Study||28||
48782213|NCT00573144|102256389|FG001|COMPLETED|Overall Study||25||
48782214|NCT00573144|102256388|FG000|NOT COMPLETED|Overall Study||2||
48782215|NCT00573144|102256389|FG001|NOT COMPLETED|Overall Study||3||
48782216|NCT00530504|102256390|FG000|STARTED|Overall Study||1500||
48782217|NCT00530504|102256390|FG000|COMPLETED|Overall Study||1348||
48782218|NCT00530504|102256390|FG000|NOT COMPLETED|Overall Study||152||
48782219|NCT00139477|102256391|FG000|STARTED|First Intervention -Baseline to 6Months||31||
48782220|NCT00139477|102256392|FG001|STARTED|First Intervention -Baseline to 6Months||35||
48782221|NCT00139477|102256391|FG000|COMPLETED|First Intervention -Baseline to 6Months||19||
48782222|NCT00139477|102256392|FG001|COMPLETED|First Intervention -Baseline to 6Months||23||
48782223|NCT00139477|102256391|FG000|NOT COMPLETED|First Intervention -Baseline to 6Months||12||
48782224|NCT00139477|102256392|FG001|NOT COMPLETED|First Intervention -Baseline to 6Months||12||
48782225|NCT00139477|102256391|FG000|STARTED|Second Intervention -6Months to 12Months||19||
48782226|NCT00139477|102256392|FG001|STARTED|Second Intervention -6Months to 12Months||23||
48782227|NCT00139477|102256391|FG000|COMPLETED|Second Intervention -6Months to 12Months||14||
48782228|NCT00139477|102256392|FG001|COMPLETED|Second Intervention -6Months to 12Months||18||
48782229|NCT00139477|102256391|FG000|NOT COMPLETED|Second Intervention -6Months to 12Months||5||
48782230|NCT00139477|102256392|FG001|NOT COMPLETED|Second Intervention -6Months to 12Months||5||
48466426|NCT01684410|101476854|FG001|COMPLETED|Overall Study||10||
48466427|NCT01684410|101476855|FG002|COMPLETED|Overall Study||10||
48466428|NCT01684410|101476853|FG000|NOT COMPLETED|Overall Study||0||
48466429|NCT01684410|101476854|FG001|NOT COMPLETED|Overall Study||0||
48466430|NCT01684410|101476855|FG002|NOT COMPLETED|Overall Study||0||
48466431|NCT03093454|101476856|FG000|STARTED|Overall Study||28||
48466432|NCT03093454|101476857|FG001|STARTED|Overall Study||30||
48466433|NCT03093454|101476856|FG000|COMPLETED|Overall Study||22||
48466434|NCT03093454|101476857|FG001|COMPLETED|Overall Study||27||
48466435|NCT03093454|101476856|FG000|NOT COMPLETED|Overall Study||6||
48466436|NCT03093454|101476857|FG001|NOT COMPLETED|Overall Study||3||
48782231|NCT01838980|102256393|FG000|STARTED|Overall Study||15||
48782232|NCT01838980|102256393|FG000|COMPLETED|Overall Study||15||
48782233|NCT01838980|102256393|FG000|NOT COMPLETED|Overall Study||0||
48782234|NCT01311024|102256394|FG000|STARTED|Overall Study||1530||
48466437|NCT03734237|101476858|FG000|STARTED|Overall Study||5145||
48466438|NCT03734237|101476859|FG001|STARTED|Overall Study||5150||
48466439|NCT03734237|101476860|FG002|STARTED|Overall Study||5137||
48466440|NCT03734237|101476858|FG000|COMPLETED|Overall Study||5137||
48466441|NCT03734237|101476859|FG001|COMPLETED|Overall Study||5138||
48466442|NCT03734237|101476860|FG002|COMPLETED|Overall Study||5127||
48466443|NCT03734237|101476858|FG000|NOT COMPLETED|Overall Study||8||
48466444|NCT03734237|101476859|FG001|NOT COMPLETED|Overall Study||12||
48466445|NCT03734237|101476860|FG002|NOT COMPLETED|Overall Study||10||
48466446|NCT01948505|101476861|FG000|STARTED|Overall Study||105||
48466447|NCT01948505|101476862|FG001|STARTED|Overall Study||105||
48466448|NCT01948505|101476861|FG000|COMPLETED|Overall Study||105||
48466449|NCT01948505|101476862|FG001|COMPLETED|Overall Study||105||
48466450|NCT01948505|101476861|FG000|NOT COMPLETED|Overall Study||0||
48782235|NCT01311024|102256395|FG001|STARTED|Overall Study||811||
48782236|NCT01311024|102256394|FG000|COMPLETED|Overall Study||1495||
48782237|NCT01311024|102256395|FG001|COMPLETED|Overall Study||789||
48782238|NCT01311024|102256394|FG000|NOT COMPLETED|Overall Study||35||
48782239|NCT01311024|102256395|FG001|NOT COMPLETED|Overall Study||22||
48782240|NCT01689532|102256396|FG000|STARTED|Overall Study||61||
48782241|NCT01689532|102256397|FG001|STARTED|Overall Study||61||
48782242|NCT01689532|102256396|FG000|COMPLETED|Overall Study||47||
48782243|NCT01689532|102256397|FG001|COMPLETED|Overall Study||52||
48782244|NCT01689532|102256396|FG000|NOT COMPLETED|Overall Study||14||
48782245|NCT01689532|102256397|FG001|NOT COMPLETED|Overall Study||9||
48782246|NCT00243841|102256398|FG000|STARTED|Overall Study||3||
48782247|NCT00243841|102256399|FG001|STARTED|Overall Study||6||
48782248|NCT00243841|102256400|FG002|STARTED|Overall Study||5||
48782249|NCT00243841|102256401|FG003|STARTED|Overall Study||3||
48782250|NCT00243841|102256402|FG004|STARTED|Overall Study||39||
48782251|NCT00243841|102256403|FG005|STARTED|Overall Study||21||
48782252|NCT00243841|102256398|FG000|COMPLETED|Overall Study||3||
48782253|NCT00243841|102256399|FG001|COMPLETED|Overall Study||6||
48782254|NCT00243841|102256400|FG002|COMPLETED|Overall Study||4||
48782255|NCT00243841|102256401|FG003|COMPLETED|Overall Study||3||
48782256|NCT00243841|102256402|FG004|COMPLETED|Overall Study||39||
48782257|NCT00243841|102256403|FG005|COMPLETED|Overall Study||19||
48782258|NCT00243841|102256398|FG000|NOT COMPLETED|Overall Study||0||
48782259|NCT00243841|102256399|FG001|NOT COMPLETED|Overall Study||0||
48782260|NCT00243841|102256400|FG002|NOT COMPLETED|Overall Study||1||
48782261|NCT00243841|102256401|FG003|NOT COMPLETED|Overall Study||0||
48782262|NCT00243841|102256402|FG004|NOT COMPLETED|Overall Study||0||
48782263|NCT00243841|102256403|FG005|NOT COMPLETED|Overall Study||2||
48782264|NCT00975689|102256404|FG000|STARTED|Overall Study||17||
48782265|NCT00975689|102256405|FG001|STARTED|Overall Study||18||
48782266|NCT00975689|102256404|FG000|COMPLETED|Overall Study||15||
48782267|NCT00975689|102256405|FG001|COMPLETED|Overall Study||15||
48782268|NCT00975689|102256404|FG000|NOT COMPLETED|Overall Study||2||
48782269|NCT00975689|102256405|FG001|NOT COMPLETED|Overall Study||3||
48782270|NCT00641641|102256406|FG000|STARTED|Overall Study||16||
48782271|NCT00641641|102256406|FG000|COMPLETED|Overall Study||16||
48782272|NCT00641641|102256406|FG000|NOT COMPLETED|Overall Study||0||
48782273|NCT02509117|102256407|FG000|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2||
48782274|NCT02509117|102256408|FG001|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2||
48782275|NCT02509117|102256409|FG002|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2||
48782276|NCT02509117|102256410|FG003|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2||
48782277|NCT02509117|102256411|FG004|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8||
48782278|NCT02509117|102256412|FG005|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8||
48782279|NCT02509117|102256413|FG006|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8||
48782280|NCT02509117|102256414|FG007|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8||
48782281|NCT02509117|102256415|FG008|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||4||
48782282|NCT02509117|102256416|FG009|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||10||
48782283|NCT02509117|102256407|FG000|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2||
48782284|NCT02509117|102256408|FG001|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||1||
48782285|NCT02509117|102256409|FG002|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2||
48782286|NCT02509117|102256410|FG003|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2||
48782287|NCT02509117|102256411|FG004|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8||
48782288|NCT02509117|102256412|FG005|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8||
48782289|NCT02509117|102256413|FG006|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8||
48782290|NCT02509117|102256414|FG007|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8||
48782291|NCT02509117|102256415|FG008|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||4||
48782292|NCT02509117|102256416|FG009|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||10||
48782293|NCT02509117|102256407|FG000|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2||
48782294|NCT02509117|102256408|FG001|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||1||
48782295|NCT02509117|102256409|FG002|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2||
48782296|NCT02509117|102256410|FG003|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2||
48782297|NCT02509117|102256411|FG004|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8||
48782298|NCT02509117|102256412|FG005|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8||
48782299|NCT02509117|102256413|FG006|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8||
48782300|NCT02509117|102256414|FG007|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8||
48782301|NCT02509117|102256415|FG008|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||4||
48782302|NCT02509117|102256416|FG009|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8||
48782303|NCT02509117|102256407|FG000|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0||
48782304|NCT02509117|102256408|FG001|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||1||
48782305|NCT02509117|102256409|FG002|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0||
48782306|NCT02509117|102256410|FG003|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0||
48782307|NCT02509117|102256411|FG004|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0||
48782308|NCT02509117|102256412|FG005|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0||
48782309|NCT02509117|102256413|FG006|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0||
48782310|NCT02509117|102256414|FG007|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0||
48782311|NCT02509117|102256415|FG008|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0||
48782312|NCT02509117|102256416|FG009|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2||
48782313|NCT02509117|102256407|FG000|STARTED|Washout Period 1 (Part A: 7 Days)||2||
48782314|NCT02509117|102256408|FG001|STARTED|Washout Period 1 (Part A: 7 Days)||1||
48782315|NCT02509117|102256409|FG002|STARTED|Washout Period 1 (Part A: 7 Days)||2||
48782316|NCT02509117|102256410|FG003|STARTED|Washout Period 1 (Part A: 7 Days)||2||
48782317|NCT02509117|102256411|FG004|STARTED|Washout Period 1 (Part A: 7 Days)||0||
48782318|NCT02509117|102256412|FG005|STARTED|Washout Period 1 (Part A: 7 Days)||0||
48782319|NCT02509117|102256413|FG006|STARTED|Washout Period 1 (Part A: 7 Days)||0||
48782320|NCT02509117|102256414|FG007|STARTED|Washout Period 1 (Part A: 7 Days)||0||
48782321|NCT02509117|102256415|FG008|STARTED|Washout Period 1 (Part A: 7 Days)||0||
48782322|NCT02509117|102256416|FG009|STARTED|Washout Period 1 (Part A: 7 Days)||0||
48782323|NCT02509117|102256407|FG000|COMPLETED|Washout Period 1 (Part A: 7 Days)||2||
48782324|NCT02509117|102256408|FG001|COMPLETED|Washout Period 1 (Part A: 7 Days)||1||
48782325|NCT02509117|102256409|FG002|COMPLETED|Washout Period 1 (Part A: 7 Days)||2||
48466451|NCT01948505|101476862|FG001|NOT COMPLETED|Overall Study||0||
48782326|NCT02509117|102256410|FG003|COMPLETED|Washout Period 1 (Part A: 7 Days)||2||
48782327|NCT02509117|102256411|FG004|COMPLETED|Washout Period 1 (Part A: 7 Days)||0||
48782328|NCT02509117|102256412|FG005|COMPLETED|Washout Period 1 (Part A: 7 Days)||0||
48782329|NCT02509117|102256413|FG006|COMPLETED|Washout Period 1 (Part A: 7 Days)||0||
48782330|NCT02509117|102256414|FG007|COMPLETED|Washout Period 1 (Part A: 7 Days)||0||
48782331|NCT02509117|102256415|FG008|COMPLETED|Washout Period 1 (Part A: 7 Days)||0||
48782332|NCT02509117|102256416|FG009|COMPLETED|Washout Period 1 (Part A: 7 Days)||0||
48466452|NCT00729859|101476863|FG000|STARTED|Overall Study||8||
48466453|NCT00729859|101476864|FG001|STARTED|Overall Study||8||
48466454|NCT00729859|101476865|FG002|STARTED|Overall Study||8||
48782333|NCT02509117|102256407|FG000|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0||
48782334|NCT02509117|102256408|FG001|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0||
48782335|NCT02509117|102256409|FG002|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0||
48782336|NCT02509117|102256410|FG003|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0||
48782337|NCT02509117|102256411|FG004|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0||
48782338|NCT02509117|102256412|FG005|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0||
48782339|NCT02509117|102256413|FG006|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0||
48782340|NCT02509117|102256414|FG007|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0||
48782341|NCT02509117|102256415|FG008|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0||
48782342|NCT02509117|102256416|FG009|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0||
48782343|NCT02509117|102256407|FG000|STARTED|Period 2 -Part A: 4 Days||2||
48782344|NCT02509117|102256408|FG001|STARTED|Period 2 -Part A: 4 Days||2||
48782345|NCT02509117|102256409|FG002|STARTED|Period 2 -Part A: 4 Days||2||
48782346|NCT02509117|102256410|FG003|STARTED|Period 2 -Part A: 4 Days||2||
48782347|NCT02509117|102256411|FG004|STARTED|Period 2 -Part A: 4 Days||0||
48782348|NCT02509117|102256412|FG005|STARTED|Period 2 -Part A: 4 Days||0||
48782349|NCT02509117|102256413|FG006|STARTED|Period 2 -Part A: 4 Days||0||
48782350|NCT02509117|102256414|FG007|STARTED|Period 2 -Part A: 4 Days||0||
48782351|NCT02509117|102256415|FG008|STARTED|Period 2 -Part A: 4 Days||0||
48782352|NCT02509117|102256416|FG009|STARTED|Period 2 -Part A: 4 Days||0||
48782353|NCT02509117|102256407|FG000|Treated|Period 2 -Part A: 4 Days||2||
48782354|NCT02509117|102256408|FG001|Treated|Period 2 -Part A: 4 Days||2||
48782355|NCT02509117|102256409|FG002|Treated|Period 2 -Part A: 4 Days||2||
48782356|NCT02509117|102256410|FG003|Treated|Period 2 -Part A: 4 Days||2||
48782357|NCT02509117|102256411|FG004|Treated|Period 2 -Part A: 4 Days||0||
48782358|NCT02509117|102256412|FG005|Treated|Period 2 -Part A: 4 Days||0||
48466455|NCT00729859|101476863|FG000|COMPLETED|Overall Study||8||
48466456|NCT00729859|101476864|FG001|COMPLETED|Overall Study||6||
48466457|NCT00729859|101476865|FG002|COMPLETED|Overall Study||8||
48466458|NCT00729859|101476863|FG000|NOT COMPLETED|Overall Study||0||
48466459|NCT00729859|101476864|FG001|NOT COMPLETED|Overall Study||2||
48466460|NCT00729859|101476865|FG002|NOT COMPLETED|Overall Study||0||
48782359|NCT02509117|102256413|FG006|Treated|Period 2 -Part A: 4 Days||0||
48782360|NCT02509117|102256414|FG007|Treated|Period 2 -Part A: 4 Days||0||
48782361|NCT02509117|102256415|FG008|Treated|Period 2 -Part A: 4 Days||0||
48782362|NCT02509117|102256416|FG009|Treated|Period 2 -Part A: 4 Days||0||
48782363|NCT02509117|102256407|FG000|COMPLETED|Period 2 -Part A: 4 Days||2||
48782364|NCT02509117|102256408|FG001|COMPLETED|Period 2 -Part A: 4 Days||2||
48782365|NCT02509117|102256409|FG002|COMPLETED|Period 2 -Part A: 4 Days||2||
48466461|NCT02275923|101476866|FG000|STARTED|Overall Study||9||
48466462|NCT02275923|101476866|FG000|COMPLETED|Overall Study||7||
48466463|NCT02275923|101476866|FG000|NOT COMPLETED|Overall Study||2||
48466464|NCT01054599|101476867|FG000|STARTED|Overall Study||13||
48466465|NCT01054599|101476868|FG001|STARTED|Overall Study||16||
48466466|NCT01054599|101476867|FG000|COMPLETED|Overall Study||9||
48466467|NCT01054599|101476868|FG001|COMPLETED|Overall Study||9||
48466468|NCT01054599|101476867|FG000|NOT COMPLETED|Overall Study||4||
48189849|NCT00412516|100786322|FG002|COMPLETED|Overall Study||214||
48189850|NCT00412516|100786320|FG000|NOT COMPLETED|Overall Study||0||
48466469|NCT01054599|101476868|FG001|NOT COMPLETED|Overall Study||7||
48189851|NCT00412516|100786321|FG001|NOT COMPLETED|Overall Study||0||
48466470|NCT00521456|101476869|FG000|STARTED|Overall Study||176||
48466471|NCT00521456|101476870|FG001|STARTED|Overall Study||87||
48466472|NCT00521456|101476869|FG000|COMPLETED|Overall Study||163||
48189852|NCT00412516|100786322|FG002|NOT COMPLETED|Overall Study||0||
48189853|NCT01008748|100786323|FG000|STARTED|Overall Study||200||
48782366|NCT02509117|102256410|FG003|COMPLETED|Period 2 -Part A: 4 Days||2||
48782367|NCT02509117|102256411|FG004|COMPLETED|Period 2 -Part A: 4 Days||0||
48782368|NCT02509117|102256412|FG005|COMPLETED|Period 2 -Part A: 4 Days||0||
48782369|NCT02509117|102256413|FG006|COMPLETED|Period 2 -Part A: 4 Days||0||
48782370|NCT02509117|102256414|FG007|COMPLETED|Period 2 -Part A: 4 Days||0||
48782371|NCT02509117|102256415|FG008|COMPLETED|Period 2 -Part A: 4 Days||0||
48782372|NCT02509117|102256416|FG009|COMPLETED|Period 2 -Part A: 4 Days||0||
48782373|NCT02509117|102256407|FG000|NOT COMPLETED|Period 2 -Part A: 4 Days||0||
48782374|NCT02509117|102256408|FG001|NOT COMPLETED|Period 2 -Part A: 4 Days||0||
48782375|NCT02509117|102256409|FG002|NOT COMPLETED|Period 2 -Part A: 4 Days||0||
48189854|NCT01008748|100786323|FG000|Baseline|Overall Study||188||
48782376|NCT02509117|102256410|FG003|NOT COMPLETED|Period 2 -Part A: 4 Days||0||
48189855|NCT01008748|100786323|FG000|Week 0|Overall Study||182||
48782377|NCT02509117|102256411|FG004|NOT COMPLETED|Period 2 -Part A: 4 Days||0||
48189856|NCT01008748|100786323|FG000|Week 3|Overall Study||168||
48189857|NCT01008748|100786323|FG000|Week 26|Overall Study||119||
48466473|NCT00521456|101476870|FG001|COMPLETED|Overall Study||59||
48466474|NCT00521456|101476869|FG000|NOT COMPLETED|Overall Study||13||
48466475|NCT00521456|101476870|FG001|NOT COMPLETED|Overall Study||28||
48466476|NCT00049036|101476871|FG000|STARTED|Overall Study||51||
48466477|NCT00049036|101476872|FG001|STARTED|Overall Study||55||
48466478|NCT00049036|101476871|FG000|COMPLETED|Overall Study||51||
48782378|NCT02509117|102256412|FG005|NOT COMPLETED|Period 2 -Part A: 4 Days||0||
48782379|NCT02509117|102256413|FG006|NOT COMPLETED|Period 2 -Part A: 4 Days||0||
48782380|NCT02509117|102256414|FG007|NOT COMPLETED|Period 2 -Part A: 4 Days||0||
48782381|NCT02509117|102256415|FG008|NOT COMPLETED|Period 2 -Part A: 4 Days||0||
48782382|NCT02509117|102256416|FG009|NOT COMPLETED|Period 2 -Part A: 4 Days||0||
48782383|NCT02509117|102256407|FG000|STARTED|Washout Period 2 (Part A: 7 Days)||2||
48782384|NCT02509117|102256408|FG001|STARTED|Washout Period 2 (Part A: 7 Days)||2||
48782385|NCT02509117|102256409|FG002|STARTED|Washout Period 2 (Part A: 7 Days)||2||
48466479|NCT00049036|101476872|FG001|COMPLETED|Overall Study||55||
48466480|NCT00049036|101476871|FG000|NOT COMPLETED|Overall Study||0||
48466481|NCT00049036|101476872|FG001|NOT COMPLETED|Overall Study||0||
48466482|NCT00897897|101476873|FG000|STARTED|Overall Study||33||
48782386|NCT02509117|102256410|FG003|STARTED|Washout Period 2 (Part A: 7 Days)||2||
48782387|NCT02509117|102256411|FG004|STARTED|Washout Period 2 (Part A: 7 Days)||0||
48782388|NCT02509117|102256412|FG005|STARTED|Washout Period 2 (Part A: 7 Days)||0||
48782389|NCT02509117|102256413|FG006|STARTED|Washout Period 2 (Part A: 7 Days)||0||
48782390|NCT02509117|102256414|FG007|STARTED|Washout Period 2 (Part A: 7 Days)||0||
48782391|NCT02509117|102256415|FG008|STARTED|Washout Period 2 (Part A: 7 Days)||0||
48782392|NCT02509117|102256416|FG009|STARTED|Washout Period 2 (Part A: 7 Days)||0||
48782393|NCT02509117|102256407|FG000|COMPLETED|Washout Period 2 (Part A: 7 Days)||2||
48782394|NCT02509117|102256408|FG001|COMPLETED|Washout Period 2 (Part A: 7 Days)||2||
48782395|NCT02509117|102256409|FG002|COMPLETED|Washout Period 2 (Part A: 7 Days)||2||
48782396|NCT02509117|102256410|FG003|COMPLETED|Washout Period 2 (Part A: 7 Days)||2||
48782397|NCT02509117|102256411|FG004|COMPLETED|Washout Period 2 (Part A: 7 Days)||0||
48782398|NCT02509117|102256412|FG005|COMPLETED|Washout Period 2 (Part A: 7 Days)||0||
48782399|NCT02509117|102256413|FG006|COMPLETED|Washout Period 2 (Part A: 7 Days)||0||
48782400|NCT02509117|102256414|FG007|COMPLETED|Washout Period 2 (Part A: 7 Days)||0||
48782401|NCT02509117|102256415|FG008|COMPLETED|Washout Period 2 (Part A: 7 Days)||0||
48782402|NCT02509117|102256416|FG009|COMPLETED|Washout Period 2 (Part A: 7 Days)||0||
48782403|NCT02509117|102256407|FG000|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0||
48782404|NCT02509117|102256408|FG001|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0||
48466483|NCT00897897|101476873|FG000|COMPLETED|Overall Study||33||
48466484|NCT00897897|101476873|FG000|NOT COMPLETED|Overall Study||0||
48466485|NCT01566409|101476874|FG000|STARTED|Overall Study||49||
48466486|NCT01566409|101476875|FG001|STARTED|Overall Study||53||
48782405|NCT02509117|102256409|FG002|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0||
48782406|NCT02509117|102256410|FG003|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0||
48782407|NCT02509117|102256411|FG004|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0||
48782408|NCT02509117|102256412|FG005|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0||
48782409|NCT02509117|102256413|FG006|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0||
48782410|NCT02509117|102256414|FG007|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0||
48782411|NCT02509117|102256415|FG008|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0||
48782412|NCT02509117|102256416|FG009|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0||
48782413|NCT02509117|102256407|FG000|STARTED|Period 3 -Part A: 4 Days||2||
48782414|NCT02509117|102256408|FG001|STARTED|Period 3 -Part A: 4 Days||2||
48782415|NCT02509117|102256409|FG002|STARTED|Period 3 -Part A: 4 Days||2||
48782416|NCT02509117|102256410|FG003|STARTED|Period 3 -Part A: 4 Days||2||
48782417|NCT02509117|102256411|FG004|STARTED|Period 3 -Part A: 4 Days||0||
48782418|NCT02509117|102256412|FG005|STARTED|Period 3 -Part A: 4 Days||0||
48782419|NCT02509117|102256413|FG006|STARTED|Period 3 -Part A: 4 Days||0||
48782420|NCT02509117|102256414|FG007|STARTED|Period 3 -Part A: 4 Days||0||
48782421|NCT02509117|102256415|FG008|STARTED|Period 3 -Part A: 4 Days||0||
48782422|NCT02509117|102256416|FG009|STARTED|Period 3 -Part A: 4 Days||0||
48782423|NCT02509117|102256407|FG000|COMPLETED|Period 3 -Part A: 4 Days||2||
48782424|NCT02509117|102256408|FG001|COMPLETED|Period 3 -Part A: 4 Days||2||
48782425|NCT02509117|102256409|FG002|COMPLETED|Period 3 -Part A: 4 Days||2||
48782426|NCT02509117|102256410|FG003|COMPLETED|Period 3 -Part A: 4 Days||2||
48782427|NCT02509117|102256411|FG004|COMPLETED|Period 3 -Part A: 4 Days||0||
48782428|NCT02509117|102256412|FG005|COMPLETED|Period 3 -Part A: 4 Days||0||
48782429|NCT02509117|102256413|FG006|COMPLETED|Period 3 -Part A: 4 Days||0||
48782430|NCT02509117|102256414|FG007|COMPLETED|Period 3 -Part A: 4 Days||0||
48782431|NCT02509117|102256415|FG008|COMPLETED|Period 3 -Part A: 4 Days||0||
48782432|NCT02509117|102256416|FG009|COMPLETED|Period 3 -Part A: 4 Days||0||
48782433|NCT02509117|102256407|FG000|NOT COMPLETED|Period 3 -Part A: 4 Days||0||
48782434|NCT02509117|102256408|FG001|NOT COMPLETED|Period 3 -Part A: 4 Days||0||
48782435|NCT02509117|102256409|FG002|NOT COMPLETED|Period 3 -Part A: 4 Days||0||
48782436|NCT02509117|102256410|FG003|NOT COMPLETED|Period 3 -Part A: 4 Days||0||
48782437|NCT02509117|102256411|FG004|NOT COMPLETED|Period 3 -Part A: 4 Days||0||
48782438|NCT02509117|102256412|FG005|NOT COMPLETED|Period 3 -Part A: 4 Days||0||
48782439|NCT02509117|102256413|FG006|NOT COMPLETED|Period 3 -Part A: 4 Days||0||
48782440|NCT02509117|102256414|FG007|NOT COMPLETED|Period 3 -Part A: 4 Days||0||
48782441|NCT02509117|102256415|FG008|NOT COMPLETED|Period 3 -Part A: 4 Days||0||
48782442|NCT02509117|102256416|FG009|NOT COMPLETED|Period 3 -Part A: 4 Days||0||
48782443|NCT02509117|102256407|FG000|STARTED|Washout Period 3 (Part A: 7 Days)||2||
48782444|NCT02509117|102256408|FG001|STARTED|Washout Period 3 (Part A: 7 Days)||2||
48782445|NCT02509117|102256409|FG002|STARTED|Washout Period 3 (Part A: 7 Days)||2||
48782446|NCT02509117|102256410|FG003|STARTED|Washout Period 3 (Part A: 7 Days)||2||
48782447|NCT02509117|102256411|FG004|STARTED|Washout Period 3 (Part A: 7 Days)||0||
48782448|NCT02509117|102256412|FG005|STARTED|Washout Period 3 (Part A: 7 Days)||0||
48782449|NCT02509117|102256413|FG006|STARTED|Washout Period 3 (Part A: 7 Days)||0||
48782450|NCT02509117|102256414|FG007|STARTED|Washout Period 3 (Part A: 7 Days)||0||
48782451|NCT02509117|102256415|FG008|STARTED|Washout Period 3 (Part A: 7 Days)||0||
48782452|NCT02509117|102256416|FG009|STARTED|Washout Period 3 (Part A: 7 Days)||0||
48782453|NCT02509117|102256407|FG000|COMPLETED|Washout Period 3 (Part A: 7 Days)||2||
48782454|NCT02509117|102256408|FG001|COMPLETED|Washout Period 3 (Part A: 7 Days)||2||
48782455|NCT02509117|102256409|FG002|COMPLETED|Washout Period 3 (Part A: 7 Days)||2||
48782456|NCT02509117|102256410|FG003|COMPLETED|Washout Period 3 (Part A: 7 Days)||2||
48782457|NCT02509117|102256411|FG004|COMPLETED|Washout Period 3 (Part A: 7 Days)||0||
48782458|NCT02509117|102256412|FG005|COMPLETED|Washout Period 3 (Part A: 7 Days)||0||
48782459|NCT02509117|102256413|FG006|COMPLETED|Washout Period 3 (Part A: 7 Days)||0||
48782460|NCT02509117|102256414|FG007|COMPLETED|Washout Period 3 (Part A: 7 Days)||0||
48782461|NCT02509117|102256415|FG008|COMPLETED|Washout Period 3 (Part A: 7 Days)||0||
48782462|NCT02509117|102256416|FG009|COMPLETED|Washout Period 3 (Part A: 7 Days)||0||
48782463|NCT02509117|102256407|FG000|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0||
48782464|NCT02509117|102256408|FG001|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0||
48782465|NCT02509117|102256409|FG002|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0||
48782466|NCT02509117|102256410|FG003|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0||
48782467|NCT02509117|102256411|FG004|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0||
48782468|NCT02509117|102256412|FG005|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0||
48782469|NCT02509117|102256413|FG006|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0||
48782470|NCT02509117|102256414|FG007|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0||
48782471|NCT02509117|102256415|FG008|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0||
48782472|NCT02509117|102256416|FG009|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0||
48782473|NCT02509117|102256407|FG000|STARTED|Period 4 -Part A: 4 Days||2||
48782474|NCT02509117|102256408|FG001|STARTED|Period 4 -Part A: 4 Days||2||
48782475|NCT02509117|102256409|FG002|STARTED|Period 4 -Part A: 4 Days||2||
48782476|NCT02509117|102256410|FG003|STARTED|Period 4 -Part A: 4 Days||2||
48782477|NCT02509117|102256411|FG004|STARTED|Period 4 -Part A: 4 Days||0||
48782478|NCT02509117|102256412|FG005|STARTED|Period 4 -Part A: 4 Days||0||
48782479|NCT02509117|102256413|FG006|STARTED|Period 4 -Part A: 4 Days||0||
48782480|NCT02509117|102256414|FG007|STARTED|Period 4 -Part A: 4 Days||0||
48782481|NCT02509117|102256415|FG008|STARTED|Period 4 -Part A: 4 Days||0||
48782482|NCT02509117|102256416|FG009|STARTED|Period 4 -Part A: 4 Days||0||
48782483|NCT02509117|102256407|FG000|COMPLETED|Period 4 -Part A: 4 Days||2||
48782484|NCT02509117|102256408|FG001|COMPLETED|Period 4 -Part A: 4 Days||2||
48782485|NCT02509117|102256409|FG002|COMPLETED|Period 4 -Part A: 4 Days||2||
48782486|NCT02509117|102256410|FG003|COMPLETED|Period 4 -Part A: 4 Days||2||
48782487|NCT02509117|102256411|FG004|COMPLETED|Period 4 -Part A: 4 Days||0||
48782488|NCT02509117|102256412|FG005|COMPLETED|Period 4 -Part A: 4 Days||0||
48782489|NCT02509117|102256413|FG006|COMPLETED|Period 4 -Part A: 4 Days||0||
48782490|NCT02509117|102256414|FG007|COMPLETED|Period 4 -Part A: 4 Days||0||
48782491|NCT02509117|102256415|FG008|COMPLETED|Period 4 -Part A: 4 Days||0||
48782492|NCT02509117|102256416|FG009|COMPLETED|Period 4 -Part A: 4 Days||0||
48782493|NCT02509117|102256407|FG000|NOT COMPLETED|Period 4 -Part A: 4 Days||0||
48782494|NCT02509117|102256408|FG001|NOT COMPLETED|Period 4 -Part A: 4 Days||0||
48782495|NCT02509117|102256409|FG002|NOT COMPLETED|Period 4 -Part A: 4 Days||0||
48782496|NCT02509117|102256410|FG003|NOT COMPLETED|Period 4 -Part A: 4 Days||0||
48782497|NCT02509117|102256411|FG004|NOT COMPLETED|Period 4 -Part A: 4 Days||0||
48782498|NCT02509117|102256412|FG005|NOT COMPLETED|Period 4 -Part A: 4 Days||0||
48782499|NCT02509117|102256413|FG006|NOT COMPLETED|Period 4 -Part A: 4 Days||0||
48782500|NCT02509117|102256414|FG007|NOT COMPLETED|Period 4 -Part A: 4 Days||0||
48782501|NCT02509117|102256415|FG008|NOT COMPLETED|Period 4 -Part A: 4 Days||0||
48782502|NCT02509117|102256416|FG009|NOT COMPLETED|Period 4 -Part A: 4 Days||0||
48782503|NCT03976648|102256417|FG000|STARTED|Overall Study||21||
48782504|NCT03976648|102256418|FG001|STARTED|Overall Study||10||
48782505|NCT03976648|102256417|FG000|COMPLETED|Overall Study||0||
48782506|NCT03976648|102256418|FG001|COMPLETED|Overall Study||0||
48782507|NCT03976648|102256417|FG000|NOT COMPLETED|Overall Study||21||
48782508|NCT03976648|102256418|FG001|NOT COMPLETED|Overall Study||10||
48782509|NCT01812668|102256419|FG000|STARTED|Overall Study||20||
48782510|NCT01812668|102256419|FG000|COMPLETED|Overall Study||20||
48782511|NCT01812668|102256419|FG000|NOT COMPLETED|Overall Study||0||
48782512|NCT04535453|102256420|FG000|STARTED|Overall Study||86||
48782513|NCT04535453|102256421|FG001|STARTED|Overall Study||81||
48782514|NCT04535453|102256422|FG002|STARTED|Overall Study||75||
48782515|NCT04535453|102256423|FG003|STARTED|Overall Study||74||
48782516|NCT04535453|102256424|FG004|STARTED|Overall Study||81||
48782517|NCT04535453|102256425|FG005|STARTED|Overall Study||26||
48782518|NCT04535453|102256426|FG006|STARTED|Overall Study||56||
48782519|NCT04535453|102256427|FG007|STARTED|Overall Study||27||
48782520|NCT04535453|102256428|FG008|STARTED|Overall Study||53||
48782521|NCT04535453|102256429|FG009|STARTED|Overall Study||25||
48782522|NCT04535453|102256430|FG010|STARTED|Overall Study||30||
48782523|NCT04535453|102256431|FG011|STARTED|Overall Study||3||
48782524|NCT04535453|102256420|FG000|COMPLETED|Overall Study||82||
48782525|NCT04535453|102256421|FG001|COMPLETED|Overall Study||73||
48782526|NCT04535453|102256422|FG002|COMPLETED|Overall Study||70||
48782527|NCT04535453|102256423|FG003|COMPLETED|Overall Study||70||
48782528|NCT04535453|102256424|FG004|COMPLETED|Overall Study||75||
48782529|NCT04535453|102256425|FG005|COMPLETED|Overall Study||24||
48782530|NCT04535453|102256426|FG006|COMPLETED|Overall Study||54||
48782531|NCT04535453|102256427|FG007|COMPLETED|Overall Study||25||
48782532|NCT04535453|102256428|FG008|COMPLETED|Overall Study||50||
48782533|NCT04535453|102256429|FG009|COMPLETED|Overall Study||23||
48782534|NCT04535453|102256430|FG010|COMPLETED|Overall Study||30||
48782535|NCT04535453|102256431|FG011|COMPLETED|Overall Study||2||
48782536|NCT04535453|102256420|FG000|NOT COMPLETED|Overall Study||4||
48782537|NCT04535453|102256421|FG001|NOT COMPLETED|Overall Study||8||
48782538|NCT04535453|102256422|FG002|NOT COMPLETED|Overall Study||5||
48782539|NCT04535453|102256423|FG003|NOT COMPLETED|Overall Study||4||
48782540|NCT04535453|102256424|FG004|NOT COMPLETED|Overall Study||6||
48782541|NCT04535453|102256425|FG005|NOT COMPLETED|Overall Study||2||
48782542|NCT04535453|102256426|FG006|NOT COMPLETED|Overall Study||2||
48782543|NCT04535453|102256427|FG007|NOT COMPLETED|Overall Study||2||
48782544|NCT04535453|102256428|FG008|NOT COMPLETED|Overall Study||3||
48782545|NCT04535453|102256429|FG009|NOT COMPLETED|Overall Study||2||
48782546|NCT04535453|102256430|FG010|NOT COMPLETED|Overall Study||0||
48782547|NCT04535453|102256431|FG011|NOT COMPLETED|Overall Study||1||
48782548|NCT02082119|102256432|FG000|STARTED|Overall Study||82||
48782549|NCT02082119|102256432|FG000|COMPLETED|Overall Study||82||
48782550|NCT02082119|102256432|FG000|NOT COMPLETED|Overall Study||0||
48782551|NCT03539549|102256433|FG000|STARTED|Overall Study||123||
48782552|NCT03539549|102256433|FG000|COMPLETED|Overall Study||106||
48782553|NCT03539549|102256433|FG000|NOT COMPLETED|Overall Study||17||
48782554|NCT01587898|102256434|FG000|STARTED|Overall Study||18||
48782555|NCT01587898|102256435|FG001|STARTED|Overall Study||17||
48782556|NCT01587898|102256436|FG002|STARTED|Overall Study||18||
48782557|NCT01587898|102256437|FG003|STARTED|Overall Study||19||
48782558|NCT01587898|102256434|FG000|COMPLETED|Overall Study||14||
48782559|NCT01587898|102256435|FG001|COMPLETED|Overall Study||12||
48782560|NCT01587898|102256436|FG002|COMPLETED|Overall Study||16||
48782561|NCT01587898|102256437|FG003|COMPLETED|Overall Study||17||
48782562|NCT01587898|102256434|FG000|NOT COMPLETED|Overall Study||4||
48782563|NCT01587898|102256435|FG001|NOT COMPLETED|Overall Study||5||
48782564|NCT01587898|102256436|FG002|NOT COMPLETED|Overall Study||2||
48782565|NCT01587898|102256437|FG003|NOT COMPLETED|Overall Study||2||
48782566|NCT01932437|102256438|FG000|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||1||
48782567|NCT01932437|102256439|FG001|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||3||
48782568|NCT01932437|102256440|FG002|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0||
48782569|NCT01932437|102256441|FG003|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0||
48782570|NCT01932437|102256442|FG004|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0||
48782571|NCT01932437|102256443|FG005|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0||
48782572|NCT01932437|102256438|FG000|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||1||
48782573|NCT01932437|102256439|FG001|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||3||
48782574|NCT01932437|102256440|FG002|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0||
48782575|NCT01932437|102256441|FG003|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0||
48782576|NCT01932437|102256442|FG004|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0||
48782577|NCT01932437|102256443|FG005|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0||
48782578|NCT01932437|102256438|FG000|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0||
48782579|NCT01932437|102256439|FG001|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0||
48782580|NCT01932437|102256440|FG002|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0||
48782581|NCT01932437|102256441|FG003|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0||
48782582|NCT01932437|102256442|FG004|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0||
48782583|NCT01932437|102256443|FG005|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0||
48782584|NCT01932437|102256438|FG000|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||2||
48782585|NCT01932437|102256439|FG001|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0||
48782586|NCT01932437|102256440|FG002|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||6||
48782587|NCT01932437|102256441|FG003|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0||
48782588|NCT01932437|102256442|FG004|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0||
48782589|NCT01932437|102256443|FG005|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0||
48782590|NCT01932437|102256438|FG000|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||2||
48782591|NCT01932437|102256439|FG001|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0||
48782592|NCT01932437|102256440|FG002|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||6||
48782593|NCT01932437|102256441|FG003|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0||
48782594|NCT01932437|102256442|FG004|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0||
48782595|NCT01932437|102256443|FG005|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0||
48782596|NCT01932437|102256438|FG000|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0||
48782597|NCT01932437|102256439|FG001|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0||
48782598|NCT01932437|102256440|FG002|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0||
48782599|NCT01932437|102256441|FG003|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0||
48782600|NCT01932437|102256442|FG004|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0||
48782601|NCT01932437|102256443|FG005|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0||
48782602|NCT01932437|102256438|FG000|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||2||
48782603|NCT01932437|102256439|FG001|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0||
48782604|NCT01932437|102256440|FG002|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0||
48782605|NCT01932437|102256441|FG003|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||6||
48782606|NCT01932437|102256442|FG004|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0||
48782607|NCT01932437|102256443|FG005|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0||
48782608|NCT01932437|102256438|FG000|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||2||
48782609|NCT01932437|102256439|FG001|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0||
48782610|NCT01932437|102256440|FG002|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0||
48782611|NCT01932437|102256441|FG003|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||6||
48782612|NCT01932437|102256442|FG004|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0||
48782613|NCT01932437|102256443|FG005|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0||
48782614|NCT01932437|102256438|FG000|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0||
48782615|NCT01932437|102256439|FG001|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0||
48782616|NCT01932437|102256440|FG002|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0||
48782617|NCT01932437|102256441|FG003|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0||
48782618|NCT01932437|102256442|FG004|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0||
48782619|NCT01932437|102256443|FG005|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0||
48782620|NCT01932437|102256438|FG000|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||2||
48782621|NCT01932437|102256439|FG001|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0||
48782622|NCT01932437|102256440|FG002|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0||
48782623|NCT01932437|102256441|FG003|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0||
48782624|NCT01932437|102256442|FG004|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||6||
48782625|NCT01932437|102256443|FG005|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0||
48782626|NCT01932437|102256438|FG000|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||2||
48782627|NCT01932437|102256439|FG001|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0||
48782628|NCT01932437|102256440|FG002|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0||
48782629|NCT01932437|102256441|FG003|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0||
48782630|NCT01932437|102256442|FG004|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||6||
48782631|NCT01932437|102256443|FG005|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0||
48782632|NCT01932437|102256438|FG000|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0||
48782633|NCT01932437|102256439|FG001|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0||
48782634|NCT01932437|102256440|FG002|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0||
48782635|NCT01932437|102256441|FG003|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0||
48782636|NCT01932437|102256442|FG004|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0||
48782637|NCT01932437|102256443|FG005|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0||
48782638|NCT01932437|102256438|FG000|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||2||
48782639|NCT01932437|102256439|FG001|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0||
48782640|NCT01932437|102256440|FG002|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0||
48782641|NCT01932437|102256441|FG003|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0||
48782642|NCT01932437|102256442|FG004|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0||
48782643|NCT01932437|102256443|FG005|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||6||
48782644|NCT01932437|102256438|FG000|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||2||
48782645|NCT01932437|102256439|FG001|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0||
48782646|NCT01932437|102256440|FG002|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0||
48782647|NCT01932437|102256441|FG003|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0||
48782648|NCT01932437|102256442|FG004|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0||
48782649|NCT01932437|102256443|FG005|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||5||
48782650|NCT01932437|102256438|FG000|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0||
48782651|NCT01932437|102256439|FG001|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0||
48782652|NCT01932437|102256440|FG002|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0||
48782653|NCT01932437|102256441|FG003|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0||
48782654|NCT01932437|102256442|FG004|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0||
48782655|NCT01932437|102256443|FG005|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||1||
48782656|NCT02105662|102256444|FG000|STARTED|Overall Study||218||
48782657|NCT02105662|102256444|FG000|COMPLETED|Overall Study||212||
48782658|NCT02105662|102256444|FG000|NOT COMPLETED|Overall Study||6||
48782659|NCT02350764|102256445|FG000|STARTED|Overall Study||29||
48782660|NCT02350764|102256445|FG000|COMPLETED|Overall Study||18||
48189858|NCT01008748|100786323|FG000|COMPLETED|Overall Study||119||
48466487|NCT01566409|101476874|FG000|COMPLETED|Overall Study||47||
48782661|NCT02350764|102256445|FG000|NOT COMPLETED|Overall Study||11||
48782662|NCT00534599|102256446|FG000|STARTED|Overall Study||209||
48782663|NCT00534599|102256447|FG001|STARTED|Overall Study||200||
48782664|NCT00534599|102256446|FG000|COMPLETED|Overall Study||152||
48782665|NCT00534599|102256447|FG001|COMPLETED|Overall Study||168||
48782666|NCT00534599|102256446|FG000|NOT COMPLETED|Overall Study||57||
48782667|NCT00534599|102256447|FG001|NOT COMPLETED|Overall Study||32||
48782668|NCT01707238|102259581|FG000|STARTED|Overall Study||48||
48782669|NCT01707238|102259582|FG001|STARTED|Overall Study||52||
48782670|NCT01707238|102259581|FG000|COMPLETED|Overall Study||48||
48782671|NCT01707238|102259582|FG001|COMPLETED|Overall Study||52||
48782672|NCT01707238|102259581|FG000|NOT COMPLETED|Overall Study||0||
48782673|NCT01707238|102259582|FG001|NOT COMPLETED|Overall Study||0||
48782674|NCT03816709|102259583|FG000|STARTED|Overall Study||25||
48782675|NCT03816709|102259583|FG000|COMPLETED|Overall Study||25||
48782676|NCT03816709|102259583|FG000|NOT COMPLETED|Overall Study||0||
48782677|NCT02872285|102259584|FG000|STARTED|Overall Study||22||
48782678|NCT02872285|102259585|FG001|STARTED|Overall Study||11||
48782679|NCT02872285|102259584|FG000|COMPLETED|Overall Study||17||
48782680|NCT02872285|102259585|FG001|COMPLETED|Overall Study||9||
48782681|NCT02872285|102259584|FG000|NOT COMPLETED|Overall Study||5||
48782682|NCT02872285|102259585|FG001|NOT COMPLETED|Overall Study||2||
48782683|NCT05396599|102259586|FG000|STARTED|Overall Study||11||
48782684|NCT05396599|102259587|FG001|STARTED|Overall Study||13||
48782685|NCT05396599|102259588|FG002|STARTED|Overall Study||11||
48782686|NCT05396599|102259586|FG000|COMPLETED|Overall Study||11||
48782687|NCT05396599|102259587|FG001|COMPLETED|Overall Study||13||
48782688|NCT05396599|102259588|FG002|COMPLETED|Overall Study||11||
48782689|NCT05396599|102259586|FG000|NOT COMPLETED|Overall Study||0||
48782690|NCT05396599|102259587|FG001|NOT COMPLETED|Overall Study||0||
48782691|NCT05396599|102259588|FG002|NOT COMPLETED|Overall Study||0||
48782692|NCT01290796|102259589|FG000|STARTED|Overall Study||153||
48782693|NCT01290796|102259589|FG000|COMPLETED|Overall Study||123||
48782694|NCT01290796|102259589|FG000|NOT COMPLETED|Overall Study||30||
48782695|NCT01760785|102259590|FG000|STARTED|Overall Study||23||
48782696|NCT01760785|102259591|FG001|STARTED|Overall Study||27||
48782697|NCT01760785|102259590|FG000|COMPLETED|Overall Study||23||
48782698|NCT01760785|102259591|FG001|COMPLETED|Overall Study||27||
48782699|NCT01760785|102259590|FG000|NOT COMPLETED|Overall Study||0||
48782700|NCT01760785|102259591|FG001|NOT COMPLETED|Overall Study||0||
48782701|NCT02230670|102259592|FG000|STARTED|Overall Study||44||
48782702|NCT02230670|102259593|FG001|STARTED|Overall Study||42||
48782703|NCT02230670|102259592|FG000|COMPLETED|Overall Study||40||
48782704|NCT02230670|102259593|FG001|COMPLETED|Overall Study||34||
48782705|NCT02230670|102259592|FG000|NOT COMPLETED|Overall Study||4||
48782706|NCT02230670|102259593|FG001|NOT COMPLETED|Overall Study||8||
48782707|NCT02123472|102259594|FG000|STARTED|Period 1 (7 Days)||14||
48782708|NCT02123472|102259595|FG001|STARTED|Period 1 (7 Days)||14||
48782709|NCT02123472|102259594|FG000|COMPLETED|Period 1 (7 Days)||14||
48782710|NCT02123472|102259595|FG001|COMPLETED|Period 1 (7 Days)||14||
48782711|NCT02123472|102259594|FG000|NOT COMPLETED|Period 1 (7 Days)||0||
48782712|NCT02123472|102259595|FG001|NOT COMPLETED|Period 1 (7 Days)||0||
48782713|NCT02123472|102259594|FG000|STARTED|Washout Period (1 Day)||14||
48782714|NCT02123472|102259595|FG001|STARTED|Washout Period (1 Day)||14||
48782715|NCT02123472|102259594|FG000|COMPLETED|Washout Period (1 Day)||14||
48782716|NCT02123472|102259595|FG001|COMPLETED|Washout Period (1 Day)||14||
48782717|NCT02123472|102259594|FG000|NOT COMPLETED|Washout Period (1 Day)||0||
48782718|NCT02123472|102259595|FG001|NOT COMPLETED|Washout Period (1 Day)||0||
48782719|NCT02123472|102259594|FG000|STARTED|Period 2 (7 Days)||14||
48782720|NCT02123472|102259595|FG001|STARTED|Period 2 (7 Days)||14||
48782721|NCT02123472|102259594|FG000|COMPLETED|Period 2 (7 Days)||14||
48782722|NCT02123472|102259595|FG001|COMPLETED|Period 2 (7 Days)||13||
48782723|NCT02123472|102259594|FG000|NOT COMPLETED|Period 2 (7 Days)||0||
48782724|NCT02123472|102259595|FG001|NOT COMPLETED|Period 2 (7 Days)||1||
48782725|NCT01909011|102259596|FG000|STARTED|Overall Study||7||
48782726|NCT01909011|102259597|FG001|STARTED|Overall Study||9||
48782727|NCT01909011|102259596|FG000|COMPLETED|Overall Study||7||
48782728|NCT01909011|102259597|FG001|COMPLETED|Overall Study||9||
48782729|NCT01909011|102259596|FG000|NOT COMPLETED|Overall Study||0||
48782730|NCT01909011|102259597|FG001|NOT COMPLETED|Overall Study||0||
48782731|NCT00918736|102259598|FG000|STARTED|Overall Study||50||
48782732|NCT00918736|102259598|FG000|COMPLETED|Overall Study||46||
48782733|NCT00918736|102259598|FG000|NOT COMPLETED|Overall Study||4||
48782734|NCT00859456|102259599|FG000|STARTED|Overall Study||9||
48782735|NCT00859456|102259599|FG000|COMPLETED|Overall Study||1||
48782736|NCT00859456|102259599|FG000|NOT COMPLETED|Overall Study||8||
48782737|NCT02766582|102259600|FG000|STARTED|Overall Study||29||
48782738|NCT02766582|102259600|FG000|COMPLETED|Overall Study||29||
48782739|NCT02766582|102259600|FG000|NOT COMPLETED|Overall Study||0||
48782740|NCT01731938|102259601|FG000|STARTED|Preliminary Part I||51||
48782741|NCT01731938|102259602|FG001|STARTED|Preliminary Part I||52||
48782742|NCT01731938|102259601|FG000|COMPLETED|Preliminary Part I||48||
48782743|NCT01731938|102259602|FG001|COMPLETED|Preliminary Part I||44||
48782744|NCT01731938|102259601|FG000|NOT COMPLETED|Preliminary Part I||3||
48782745|NCT01731938|102259602|FG001|NOT COMPLETED|Preliminary Part I||8||
48782746|NCT01731938|102259601|FG000|STARTED|Primary Part II||116||
48782747|NCT01731938|102259602|FG001|STARTED|Primary Part II||108||
48782748|NCT01731938|102259601|FG000|COMPLETED|Primary Part II||103||
48782749|NCT01731938|102259602|FG001|COMPLETED|Primary Part II||95||
48782750|NCT01731938|102259601|FG000|NOT COMPLETED|Primary Part II||13||
48782751|NCT01731938|102259602|FG001|NOT COMPLETED|Primary Part II||13||
48782752|NCT00147069|102259603|FG000|STARTED|Overall Study||15||
48782753|NCT00147069|102259604|FG001|STARTED|Overall Study||15||
48782754|NCT00147069|102259605|FG002|STARTED|Overall Study||15||
48782755|NCT00147069|102259606|FG003|STARTED|Overall Study||15||
48782756|NCT00147069|102259603|FG000|COMPLETED|Overall Study||15||
48782757|NCT00147069|102259604|FG001|COMPLETED|Overall Study||15||
48782758|NCT00147069|102259605|FG002|COMPLETED|Overall Study||15||
48782759|NCT00147069|102259606|FG003|COMPLETED|Overall Study||15||
48782760|NCT00147069|102259603|FG000|NOT COMPLETED|Overall Study||0||
48782761|NCT00147069|102259604|FG001|NOT COMPLETED|Overall Study||0||
48782762|NCT00147069|102259605|FG002|NOT COMPLETED|Overall Study||0||
48782763|NCT00147069|102259606|FG003|NOT COMPLETED|Overall Study||0||
48782764|NCT00615901|102259607|FG000|STARTED|Overall Study||38||
48782765|NCT00615901|102259607|FG000|COMPLETED|Overall Study||29||
48782766|NCT00615901|102259607|FG000|NOT COMPLETED|Overall Study||9||
48782767|NCT02078960|102259608|FG000|STARTED|Treatment Period||2||
48782768|NCT02078960|102259609|FG001|STARTED|Treatment Period||4||
48782769|NCT02078960|102259610|FG002|STARTED|Treatment Period||4||
48782770|NCT02078960|102259608|FG000|COMPLETED|Treatment Period||0|Treatment completed|
48782771|NCT02078960|102259609|FG001|COMPLETED|Treatment Period||1|Treatment completed|
48782772|NCT02078960|102259610|FG002|COMPLETED|Treatment Period||1|Treatment completed|
48782773|NCT02078960|102259608|FG000|NOT COMPLETED|Treatment Period||2||
48782774|NCT02078960|102259609|FG001|NOT COMPLETED|Treatment Period||3||
48782775|NCT02078960|102259610|FG002|NOT COMPLETED|Treatment Period||3||
48782776|NCT02078960|102259608|FG000|STARTED|Follow-up Period||2||
48782777|NCT02078960|102259609|FG001|STARTED|Follow-up Period||2||
48782778|NCT02078960|102259610|FG002|STARTED|Follow-up Period||1||
48782779|NCT02078960|102259608|FG000|COMPLETED|Follow-up Period||0|Monitored for progression and survival for at least 1 year following treatment.|
48782780|NCT02078960|102259609|FG001|COMPLETED|Follow-up Period||1|Monitored for progression and survival for at least 1 year following treatment.|
48782781|NCT02078960|102259610|FG002|COMPLETED|Follow-up Period||1|Monitored for progression and survival for at least 1 year following treatment.|
48782782|NCT02078960|102259608|FG000|NOT COMPLETED|Follow-up Period||2||
48782783|NCT02078960|102259609|FG001|NOT COMPLETED|Follow-up Period||1||
48782784|NCT02078960|102259610|FG002|NOT COMPLETED|Follow-up Period||0||
48782785|NCT00653939|102259611|FG000|STARTED|Overall Study||31||
48782786|NCT00653939|102259612|FG001|STARTED|Overall Study||32||
48782787|NCT00653939|102259611|FG000|COMPLETED|Overall Study||19||
48782788|NCT00653939|102259612|FG001|COMPLETED|Overall Study||17||
48782789|NCT00653939|102259611|FG000|NOT COMPLETED|Overall Study||12||
48782790|NCT00653939|102259612|FG001|NOT COMPLETED|Overall Study||15||
48782791|NCT02034409|102259613|FG000|STARTED|Sham Run-in Period||140||
48782792|NCT02034409|102259614|FG001|STARTED|Sham Run-in Period||0||
48782793|NCT02034409|102259613|FG000|COMPLETED|Sham Run-in Period||136||
48782794|NCT02034409|102259614|FG001|COMPLETED|Sham Run-in Period||0||
48782795|NCT02034409|102259613|FG000|NOT COMPLETED|Sham Run-in Period||4||
48782796|NCT02034409|102259614|FG001|NOT COMPLETED|Sham Run-in Period||0||
48782797|NCT02034409|102259613|FG000|STARTED|Sham-Controlled Treatment Period||67||
48782798|NCT02034409|102259614|FG001|STARTED|Sham-Controlled Treatment Period||69||
48782799|NCT02034409|102259613|FG000|COMPLETED|Sham-Controlled Treatment Period||55||
48782800|NCT02034409|102259614|FG001|COMPLETED|Sham-Controlled Treatment Period||54||
48782801|NCT02034409|102259613|FG000|NOT COMPLETED|Sham-Controlled Treatment Period||12||
48782802|NCT02034409|102259614|FG001|NOT COMPLETED|Sham-Controlled Treatment Period||15||
48782803|NCT02902484|102259615|FG000|STARTED|Nintedanib Monotherapy 150 mg||3||
48782804|NCT02902484|102259616|FG001|STARTED|Nintedanib Monotherapy 150 mg||0||
48782805|NCT02902484|102259615|FG000|COMPLETED|Nintedanib Monotherapy 150 mg||3||
48782806|NCT02902484|102259616|FG001|COMPLETED|Nintedanib Monotherapy 150 mg||0||
48782807|NCT02902484|102259615|FG000|NOT COMPLETED|Nintedanib Monotherapy 150 mg||0||
48782808|NCT02902484|102259616|FG001|NOT COMPLETED|Nintedanib Monotherapy 150 mg||0||
48782809|NCT02902484|102259615|FG000|STARTED|Nintedanib Monotherapy 200 mg||0||
48782810|NCT02902484|102259616|FG001|STARTED|Nintedanib Monotherapy 200 mg||10||
48782811|NCT02902484|102259615|FG000|COMPLETED|Nintedanib Monotherapy 200 mg||0||
48782812|NCT02902484|102259616|FG001|COMPLETED|Nintedanib Monotherapy 200 mg||10||
48782813|NCT02902484|102259615|FG000|NOT COMPLETED|Nintedanib Monotherapy 200 mg||0||
48782814|NCT02902484|102259616|FG001|NOT COMPLETED|Nintedanib Monotherapy 200 mg||0||
48782815|NCT02902484|102259615|FG000|STARTED|Nintedanib 150 mg + Chemotherapy||3||
48782816|NCT02902484|102259616|FG001|STARTED|Nintedanib 150 mg + Chemotherapy||0||
48782817|NCT02902484|102259615|FG000|COMPLETED|Nintedanib 150 mg + Chemotherapy||3||
48782818|NCT02902484|102259616|FG001|COMPLETED|Nintedanib 150 mg + Chemotherapy||0||
48782819|NCT02902484|102259615|FG000|NOT COMPLETED|Nintedanib 150 mg + Chemotherapy||0||
48782820|NCT02902484|102259616|FG001|NOT COMPLETED|Nintedanib 150 mg + Chemotherapy||0||
48782821|NCT02902484|102259615|FG000|STARTED|Nintedanib 200 mg + Chemotherapy||0||
48782822|NCT02902484|102259616|FG001|STARTED|Nintedanib 200 mg + Chemotherapy||10||
48782823|NCT02902484|102259615|FG000|COMPLETED|Nintedanib 200 mg + Chemotherapy||0||
48782824|NCT02902484|102259616|FG001|COMPLETED|Nintedanib 200 mg + Chemotherapy||10||
48782825|NCT02902484|102259615|FG000|NOT COMPLETED|Nintedanib 200 mg + Chemotherapy||0||
48782826|NCT02902484|102259616|FG001|NOT COMPLETED|Nintedanib 200 mg + Chemotherapy||0||
48782827|NCT00228553|102259617|FG000|STARTED|Overall Study||743||
48782828|NCT00228553|102259617|FG000|COMPLETED|Overall Study||313||
48782829|NCT00228553|102259617|FG000|NOT COMPLETED|Overall Study||430||
48782830|NCT00759564|102259618|FG000|STARTED|First Intervention Period (4 Days)||8||
48782831|NCT00759564|102259619|FG001|STARTED|First Intervention Period (4 Days)||8||
48782832|NCT00759564|102259620|FG002|STARTED|First Intervention Period (4 Days)||8||
48466488|NCT01566409|101476875|FG001|COMPLETED|Overall Study||48||
48466489|NCT01566409|101476874|FG000|NOT COMPLETED|Overall Study||2||
48466490|NCT01566409|101476875|FG001|NOT COMPLETED|Overall Study||5||
48466491|NCT03845933|101476876|FG000|STARTED|Overall Study||131||
48466492|NCT03845933|101476877|FG001|STARTED|Overall Study||131||
48466493|NCT03845933|101476876|FG000|COMPLETED|Overall Study||131||
48466494|NCT03845933|101476877|FG001|COMPLETED|Overall Study||131||
48466495|NCT03845933|101476876|FG000|NOT COMPLETED|Overall Study||0||
48466496|NCT03845933|101476877|FG001|NOT COMPLETED|Overall Study||0||
48466497|NCT01058421|101476878|FG000|STARTED|1 Month Outcomes||59||
48466498|NCT01058421|101476879|FG001|STARTED|1 Month Outcomes||61||
48466499|NCT01058421|101476878|FG000|COMPLETED|1 Month Outcomes||20||
48466500|NCT01058421|101476879|FG001|COMPLETED|1 Month Outcomes||19||
48466501|NCT01058421|101476878|FG000|NOT COMPLETED|1 Month Outcomes||39||
48466502|NCT01058421|101476879|FG001|NOT COMPLETED|1 Month Outcomes||42||
48466503|NCT01058421|101476878|FG000|STARTED|3 Month Outcomes||49|Deceased subjects were not included in subsequent Period beginning subject started totals.|
48466504|NCT01058421|101476879|FG001|STARTED|3 Month Outcomes||55|Deceased subjects were not included in subsequent Period beginning subject started totals.|
48466505|NCT01058421|101476878|FG000|COMPLETED|3 Month Outcomes||29||
48466506|NCT01058421|101476879|FG001|COMPLETED|3 Month Outcomes||29||
48466507|NCT01058421|101476878|FG000|NOT COMPLETED|3 Month Outcomes||20||
48466508|NCT01058421|101476879|FG001|NOT COMPLETED|3 Month Outcomes||26||
48466509|NCT01058421|101476878|FG000|STARTED|6 Month Outcomes||46|Deceased subjects were not included in subsequent Period beginning subject started totals.|
48466510|NCT01058421|101476879|FG001|STARTED|6 Month Outcomes||50|Deceased subjects were not included in subsequent Period beginning subject started totals.|
48466511|NCT01058421|101476878|FG000|COMPLETED|6 Month Outcomes||27||
48466512|NCT01058421|101476879|FG001|COMPLETED|6 Month Outcomes||24||
48466513|NCT01058421|101476878|FG000|NOT COMPLETED|6 Month Outcomes||19||
48466514|NCT01058421|101476879|FG001|NOT COMPLETED|6 Month Outcomes||26||
48466515|NCT03154658|101476880|FG000|STARTED|Overall Study||33||
48466516|NCT03154658|101476881|FG001|STARTED|Overall Study||33||
48466517|NCT03154658|101476880|FG000|COMPLETED|Overall Study||32||
48466518|NCT03154658|101476881|FG001|COMPLETED|Overall Study||32||
48466519|NCT03154658|101476880|FG000|NOT COMPLETED|Overall Study||1||
48466520|NCT03154658|101476881|FG001|NOT COMPLETED|Overall Study||1||
48466521|NCT00424489|101476882|FG000|STARTED|Overall Study||9||
48466522|NCT00424489|101476882|FG000|COMPLETED|Overall Study||6||
48466523|NCT00424489|101476882|FG000|NOT COMPLETED|Overall Study||3||
48466524|NCT02584140|101476883|FG000|STARTED|Overall Study||136||
48466525|NCT02584140|101476883|FG000|COMPLETED|Overall Study||83||
48466526|NCT02584140|101476883|FG000|NOT COMPLETED|Overall Study||53||
48466527|NCT03775681|101476884|FG000|STARTED|Overall Study||33||
48466528|NCT03775681|101476884|FG000|COMPLETED|Overall Study||30||
48466529|NCT03775681|101476884|FG000|NOT COMPLETED|Overall Study||3||
48466530|NCT00767507|101476885|FG000|STARTED|Overall Study||5||
48466531|NCT00767507|101476886|FG001|STARTED|Overall Study||6||
48466532|NCT00767507|101476887|FG002|STARTED|Overall Study||106||
48466533|NCT00767507|101476888|FG003|STARTED|Overall Study||104||
48466534|NCT00767507|101476885|FG000|COMPLETED|Overall Study||5||
48466535|NCT00767507|101476886|FG001|COMPLETED|Overall Study||6||
48466536|NCT00767507|101476887|FG002|COMPLETED|Overall Study||106||
48466537|NCT00767507|101476888|FG003|COMPLETED|Overall Study||101||
48466538|NCT00767507|101476885|FG000|NOT COMPLETED|Overall Study||0||
48466539|NCT00767507|101476886|FG001|NOT COMPLETED|Overall Study||0||
48466540|NCT00767507|101476887|FG002|NOT COMPLETED|Overall Study||0||
48466541|NCT00767507|101476888|FG003|NOT COMPLETED|Overall Study||3||
48466542|NCT01523899|101476889|FG000|STARTED|Overall Study||126||
48466543|NCT01523899|101476890|FG001|STARTED|Overall Study||126||
48466544|NCT01523899|101476889|FG000|COMPLETED|Overall Study||126||
48466545|NCT01523899|101476890|FG001|COMPLETED|Overall Study||126||
48466546|NCT01523899|101476889|FG000|NOT COMPLETED|Overall Study||0||
48466547|NCT01523899|101476890|FG001|NOT COMPLETED|Overall Study||0||
48466548|NCT03104322|101476891|FG000|STARTED|Overall Study||7||
48466549|NCT03104322|101476891|FG000|COMPLETED|Overall Study||6||
48466550|NCT03104322|101476891|FG000|NOT COMPLETED|Overall Study||1||
48466551|NCT00708422|101476892|FG000|STARTED|Overall Study||116||
48466552|NCT00708422|101476893|FG001|STARTED|Overall Study||115||
48466553|NCT00708422|101476892|FG000|COMPLETED|Overall Study||112||
48466554|NCT00708422|101476893|FG001|COMPLETED|Overall Study||114||
48466555|NCT00708422|101476892|FG000|NOT COMPLETED|Overall Study||4||
48466556|NCT00708422|101476893|FG001|NOT COMPLETED|Overall Study||1||
48466557|NCT01691248|101476894|FG000|STARTED|Overall Study||305||
48466558|NCT01691248|101476895|FG001|STARTED|Overall Study||306||
48466559|NCT01691248|101476894|FG000|Treated|Overall Study||301||
48466560|NCT01691248|101476895|FG001|Treated|Overall Study||299||
48466561|NCT01691248|101476894|FG000|Safety Analysis Set|Overall Study||300||
48466562|NCT01691248|101476895|FG001|Safety Analysis Set|Overall Study||300||
48466563|NCT01691248|101476894|FG000|COMPLETED|Overall Study||194||
48466564|NCT01691248|101476895|FG001|COMPLETED|Overall Study||192||
48466565|NCT01691248|101476894|FG000|NOT COMPLETED|Overall Study||111||
48466566|NCT01691248|101476895|FG001|NOT COMPLETED|Overall Study||114||
48466567|NCT01937390|101476896|FG000|STARTED|Overall Study||585||
48466568|NCT01937390|101476896|FG000|COMPLETED|Overall Study||550||
48466569|NCT01937390|101476896|FG000|NOT COMPLETED|Overall Study||35||
48466570|NCT01606306|101476897|FG000|STARTED|Overall Study||50||
48466571|NCT01606306|101476898|FG001|STARTED|Overall Study||49||
48466572|NCT01606306|101476899|FG002|STARTED|Overall Study||51||
48466573|NCT01606306|101476900|FG003|STARTED|Overall Study||51||
48466574|NCT01606306|101476901|FG004|STARTED|Overall Study||52||
48466575|NCT01606306|101476902|FG005|STARTED|Overall Study||47||
48466576|NCT01606306|101476897|FG000|Completed First Treatment Period|Overall Study||43||
48466577|NCT01606306|101476898|FG001|Completed First Treatment Period|Overall Study||47||
48466578|NCT01606306|101476899|FG002|Completed First Treatment Period|Overall Study||47||
48466579|NCT01606306|101476900|FG003|Completed First Treatment Period|Overall Study||45||
48466580|NCT01606306|101476901|FG004|Completed First Treatment Period|Overall Study||47||
48466581|NCT01606306|101476902|FG005|Completed First Treatment Period|Overall Study||44||
48466582|NCT01606306|101476897|FG000|Completed Second Treatment Period|Overall Study||41||
48466583|NCT01606306|101476898|FG001|Completed Second Treatment Period|Overall Study||38||
48466584|NCT01606306|101476899|FG002|Completed Second Treatment Period|Overall Study||43||
48466585|NCT01606306|101476900|FG003|Completed Second Treatment Period|Overall Study||44||
48466586|NCT01606306|101476901|FG004|Completed Second Treatment Period|Overall Study||46||
48466587|NCT01606306|101476902|FG005|Completed Second Treatment Period|Overall Study||41||
48466588|NCT01606306|101476897|FG000|Completed Third Treatment Period|Overall Study||35||
48466589|NCT01606306|101476898|FG001|Completed Third Treatment Period|Overall Study||39||
48466590|NCT01606306|101476899|FG002|Completed Third Treatment Period|Overall Study||37||
48466591|NCT01606306|101476900|FG003|Completed Third Treatment Period|Overall Study||38||
48782833|NCT00759564|102259621|FG003|STARTED|First Intervention Period (4 Days)||1||
48782834|NCT00759564|102259622|FG004|STARTED|First Intervention Period (4 Days)||4||
48782835|NCT00759564|102259618|FG000|COMPLETED|First Intervention Period (4 Days)||8||
48782836|NCT00759564|102259619|FG001|COMPLETED|First Intervention Period (4 Days)||8||
48782837|NCT00759564|102259620|FG002|COMPLETED|First Intervention Period (4 Days)||8||
48782838|NCT00759564|102259621|FG003|COMPLETED|First Intervention Period (4 Days)||1||
48466592|NCT01606306|101476901|FG004|Completed Third Treatment Period|Overall Study||41||
48466593|NCT01606306|101476902|FG005|Completed Third Treatment Period|Overall Study||36||
48466594|NCT01606306|101476897|FG000|COMPLETED|Overall Study||35||
48466595|NCT01606306|101476898|FG001|COMPLETED|Overall Study||39||
48466596|NCT01606306|101476899|FG002|COMPLETED|Overall Study||37||
48466597|NCT01606306|101476900|FG003|COMPLETED|Overall Study||38||
48466598|NCT01606306|101476901|FG004|COMPLETED|Overall Study||41||
48466599|NCT01606306|101476902|FG005|COMPLETED|Overall Study||36||
48782839|NCT00759564|102259622|FG004|COMPLETED|First Intervention Period (4 Days)||4||
48782840|NCT00759564|102259618|FG000|NOT COMPLETED|First Intervention Period (4 Days)||0||
48782841|NCT00759564|102259619|FG001|NOT COMPLETED|First Intervention Period (4 Days)||0||
48782842|NCT00759564|102259620|FG002|NOT COMPLETED|First Intervention Period (4 Days)||0||
48466600|NCT01606306|101476897|FG000|NOT COMPLETED|Overall Study||15||
48466601|NCT01606306|101476898|FG001|NOT COMPLETED|Overall Study||10||
48782843|NCT00759564|102259621|FG003|NOT COMPLETED|First Intervention Period (4 Days)||0||
48782844|NCT00759564|102259622|FG004|NOT COMPLETED|First Intervention Period (4 Days)||0||
48782845|NCT00759564|102259618|FG000|STARTED|Washout Period (at Least 14 Days)||8||
48782846|NCT00759564|102259619|FG001|STARTED|Washout Period (at Least 14 Days)||8||
48782847|NCT00759564|102259620|FG002|STARTED|Washout Period (at Least 14 Days)||8||
48782848|NCT00759564|102259621|FG003|STARTED|Washout Period (at Least 14 Days)||1||
48782849|NCT00759564|102259622|FG004|STARTED|Washout Period (at Least 14 Days)||4||
48782850|NCT00759564|102259618|FG000|COMPLETED|Washout Period (at Least 14 Days)||8||
48782851|NCT00759564|102259619|FG001|COMPLETED|Washout Period (at Least 14 Days)||8||
48782852|NCT00759564|102259620|FG002|COMPLETED|Washout Period (at Least 14 Days)||8||
48782853|NCT00759564|102259621|FG003|COMPLETED|Washout Period (at Least 14 Days)||1||
48782854|NCT00759564|102259622|FG004|COMPLETED|Washout Period (at Least 14 Days)||3||
48782855|NCT00759564|102259618|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48782856|NCT00759564|102259619|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48782857|NCT00759564|102259620|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48782858|NCT00759564|102259621|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
48782859|NCT00759564|102259622|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||1||
48782860|NCT00759564|102259618|FG000|STARTED|Second Intervention Period (4 Days)||8||
48782861|NCT00759564|102259619|FG001|STARTED|Second Intervention Period (4 Days)||8||
48782862|NCT00759564|102259620|FG002|STARTED|Second Intervention Period (4 Days)||8||
48782863|NCT00759564|102259621|FG003|STARTED|Second Intervention Period (4 Days)||1||
48782864|NCT00759564|102259622|FG004|STARTED|Second Intervention Period (4 Days)||3||
48782865|NCT00759564|102259618|FG000|COMPLETED|Second Intervention Period (4 Days)||8||
48466602|NCT01606306|101476899|FG002|NOT COMPLETED|Overall Study||14||
48466603|NCT01606306|101476900|FG003|NOT COMPLETED|Overall Study||13||
48466604|NCT01606306|101476901|FG004|NOT COMPLETED|Overall Study||11||
48466605|NCT01606306|101476902|FG005|NOT COMPLETED|Overall Study||11||
48466606|NCT03341507|101476903|FG000|STARTED|Overall Study||64||
48466607|NCT03341507|101476903|FG000|COMPLETED|Overall Study||30||
48466608|NCT03341507|101476903|FG000|NOT COMPLETED|Overall Study||34||
48466609|NCT02942966|101476904|FG000|STARTED|Overall Study||233||
48466610|NCT02942966|101476904|FG000|COMPLETED|Overall Study||205||
48466611|NCT02942966|101476904|FG000|NOT COMPLETED|Overall Study||28||
48466612|NCT00981305|101476905|FG000|STARTED|Overall Study||69||
48466613|NCT00981305|101476906|FG001|STARTED|Overall Study||67||
48466614|NCT00981305|101476905|FG000|COMPLETED|Overall Study||50||
48466615|NCT00981305|101476906|FG001|COMPLETED|Overall Study||57||
48466616|NCT00981305|101476905|FG000|NOT COMPLETED|Overall Study||19||
48466617|NCT00981305|101476906|FG001|NOT COMPLETED|Overall Study||10||
48466618|NCT01576588|101476907|FG000|STARTED|Overall Study||25||
48466619|NCT01576588|101476907|FG000|COMPLETED|Overall Study||23||
48466620|NCT01576588|101476907|FG000|NOT COMPLETED|Overall Study||2||
48466621|NCT01075763|101476908|FG000|STARTED|Overall Study||23||
48466622|NCT01075763|101476909|FG001|STARTED|Overall Study||19||
48466623|NCT01075763|101476908|FG000|COMPLETED|Overall Study||19||
48466624|NCT01075763|101476909|FG001|COMPLETED|Overall Study||15||
48466625|NCT01075763|101476908|FG000|NOT COMPLETED|Overall Study||4||
48466626|NCT01075763|101476909|FG001|NOT COMPLETED|Overall Study||4||
48466627|NCT00462982|101476910|FG000|STARTED|Overall Study||8||
48466628|NCT00462982|101476910|FG000|COMPLETED|Overall Study||5||
48466629|NCT00462982|101476910|FG000|NOT COMPLETED|Overall Study||3||
48466630|NCT01485536|101476911|FG000|STARTED|Overall Study||21||
48466631|NCT01485536|101476911|FG000|COMPLETED|Overall Study||17||
48466632|NCT01485536|101476911|FG000|NOT COMPLETED|Overall Study||4||
48466633|NCT00743197|101476912|FG000|STARTED|Overall Study||1||
48466634|NCT00743197|101476913|FG001|STARTED|Overall Study||2||
48466635|NCT00743197|101476912|FG000|COMPLETED|Overall Study||0||
48466636|NCT00743197|101476913|FG001|COMPLETED|Overall Study||0||
48466637|NCT00743197|101476912|FG000|NOT COMPLETED|Overall Study||1||
48466638|NCT00743197|101476913|FG001|NOT COMPLETED|Overall Study||2||
48466639|NCT00860028|101476914|FG000|STARTED|Placebo Controlled Pretreatment Period||15||
48466640|NCT00860028|101476915|FG001|STARTED|Placebo Controlled Pretreatment Period||15||
48466641|NCT00860028|101476914|FG000|COMPLETED|Placebo Controlled Pretreatment Period||13||
48782866|NCT00759564|102259619|FG001|COMPLETED|Second Intervention Period (4 Days)||8||
48782867|NCT00759564|102259620|FG002|COMPLETED|Second Intervention Period (4 Days)||8||
48782868|NCT00759564|102259621|FG003|COMPLETED|Second Intervention Period (4 Days)||1||
48782869|NCT00759564|102259622|FG004|COMPLETED|Second Intervention Period (4 Days)||3||
48782870|NCT00759564|102259618|FG000|NOT COMPLETED|Second Intervention Period (4 Days)||0||
48466642|NCT00860028|101476915|FG001|COMPLETED|Placebo Controlled Pretreatment Period||14||
48466643|NCT00860028|101476914|FG000|NOT COMPLETED|Placebo Controlled Pretreatment Period||2||
48466644|NCT00860028|101476915|FG001|NOT COMPLETED|Placebo Controlled Pretreatment Period||1||
48466645|NCT00860028|101476914|FG000|STARTED|Smoking Cessation Phase||13||
48466646|NCT00860028|101476915|FG001|STARTED|Smoking Cessation Phase||14||
48466647|NCT00860028|101476914|FG000|COMPLETED|Smoking Cessation Phase||13||
48466648|NCT00860028|101476915|FG001|COMPLETED|Smoking Cessation Phase||12||
48466649|NCT00860028|101476914|FG000|NOT COMPLETED|Smoking Cessation Phase||0||
48466650|NCT00860028|101476915|FG001|NOT COMPLETED|Smoking Cessation Phase||2||
48466651|NCT01104662|101476916|FG000|STARTED|Overall Study||20||
48466652|NCT01104662|101476917|FG001|STARTED|Overall Study||21||
48466653|NCT01104662|101476918|FG002|STARTED|Overall Study||5||
48782871|NCT00759564|102259619|FG001|NOT COMPLETED|Second Intervention Period (4 Days)||0||
48782872|NCT00759564|102259620|FG002|NOT COMPLETED|Second Intervention Period (4 Days)||0||
48782873|NCT00759564|102259621|FG003|NOT COMPLETED|Second Intervention Period (4 Days)||0||
48782874|NCT00759564|102259622|FG004|NOT COMPLETED|Second Intervention Period (4 Days)||0||
48782875|NCT00591318|102259623|FG000|STARTED|Overall Study||5||
48782876|NCT00591318|102259624|FG001|STARTED|Overall Study||5||
48782877|NCT00591318|102259623|FG000|COMPLETED|Overall Study||1||
48782878|NCT00591318|102259624|FG001|COMPLETED|Overall Study||5||
48782879|NCT00591318|102259623|FG000|NOT COMPLETED|Overall Study||4||
48466654|NCT01104662|101476919|FG003|STARTED|Overall Study||4||
48466655|NCT01104662|101476920|FG004|STARTED|Overall Study||15||
48466656|NCT01104662|101476921|FG005|STARTED|Overall Study||16||
48466657|NCT01104662|101476922|FG006|STARTED|Overall Study||5||
48466658|NCT01104662|101476923|FG007|STARTED|Overall Study||6||
48466659|NCT01104662|101476916|FG000|Received at Least 1 Dose of Study Drug|Overall Study||17||
48466660|NCT01104662|101476917|FG001|Received at Least 1 Dose of Study Drug|Overall Study||17||
48466661|NCT01104662|101476918|FG002|Received at Least 1 Dose of Study Drug|Overall Study||4||
48782880|NCT00591318|102259624|FG001|NOT COMPLETED|Overall Study||0||
48782881|NCT05480111|102259625|FG000|STARTED|Overall Study||38||
48782882|NCT05480111|102259626|FG001|STARTED|Overall Study||38||
48782883|NCT05480111|102259625|FG000|Follow up at 24 Hours|Overall Study||32||
48782884|NCT05480111|102259626|FG001|Follow up at 24 Hours|Overall Study||37||
48782885|NCT05480111|102259625|FG000|Follow up at 6 Weeks|Overall Study||29||
48782886|NCT05480111|102259626|FG001|Follow up at 6 Weeks|Overall Study||34||
48782887|NCT05480111|102259625|FG000|COMPLETED|Overall Study||29||
48782888|NCT05480111|102259626|FG001|COMPLETED|Overall Study||34||
48782889|NCT05480111|102259625|FG000|NOT COMPLETED|Overall Study||9||
48782890|NCT05480111|102259626|FG001|NOT COMPLETED|Overall Study||4||
48782891|NCT00781885|102259627|FG000|STARTED|Overall Study||19||
48782892|NCT00781885|102259627|FG000|Received at Least 1 Dose of Study Drug|Overall Study||19||
48782893|NCT00781885|102259627|FG000|COMPLETED|Overall Study||18||
48370090|NCT02518620|101234818|FG001|STARTED|Overall Study||149||
48370091|NCT02518620|101234817|FG000|COMPLETED|Overall Study||205||
48370092|NCT02518620|101234818|FG001|COMPLETED|Overall Study||123||
48370093|NCT02518620|101234817|FG000|NOT COMPLETED|Overall Study||52||
48370094|NCT02518620|101234818|FG001|NOT COMPLETED|Overall Study||26||
48370095|NCT01234402|101234819|FG000|STARTED|Overall Study||52||
48370096|NCT01234402|101234820|FG001|STARTED|Overall Study||51||
48466662|NCT01104662|101476919|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4||
48782894|NCT00781885|102259627|FG000|NOT COMPLETED|Overall Study||1||
48782895|NCT04556383|102259628|FG000|STARTED|PCP||78||
48782896|NCT04556383|102259629|FG001|STARTED|PCP||78||
48782897|NCT04556383|102259630|FG002|STARTED|PCP||80||
48782898|NCT04556383|102259631|FG003|STARTED|PCP||0||
48782899|NCT04556383|102259628|FG000|COMPLETED|PCP||23||
48782900|NCT04556383|102259629|FG001|COMPLETED|PCP||25||
48466663|NCT01104662|101476920|FG004|Received at Least 1 Dose of Study Drug|Overall Study||15||
48466664|NCT01104662|101476921|FG005|Received at Least 1 Dose of Study Drug|Overall Study||15||
48782901|NCT04556383|102259630|FG002|COMPLETED|PCP||26||
48782902|NCT04556383|102259631|FG003|COMPLETED|PCP||0||
48189859|NCT01008748|100786323|FG000|NOT COMPLETED|Overall Study||81||
48189860|NCT00350532|100786324|FG000|STARTED|Overall Study||24||
48189861|NCT00350532|100786325|FG001|STARTED|Overall Study||19||
48782903|NCT04556383|102259628|FG000|NOT COMPLETED|PCP||55||
48189862|NCT00350532|100786324|FG000|COMPLETED|Overall Study||24||
48370097|NCT01234402|101234821|FG002|STARTED|Overall Study||50||
48370098|NCT01234402|101234819|FG000|Received at Least One Dose of Study Drug|Overall Study||52||
48782904|NCT04556383|102259629|FG001|NOT COMPLETED|PCP||53||
48782905|NCT04556383|102259630|FG002|NOT COMPLETED|PCP||54||
48782906|NCT04556383|102259631|FG003|NOT COMPLETED|PCP||0||
48782907|NCT04556383|102259628|FG000|STARTED|OLE||0||
48782908|NCT04556383|102259629|FG001|STARTED|OLE||0||
48782909|NCT04556383|102259630|FG002|STARTED|OLE||0||
48782910|NCT04556383|102259631|FG003|STARTED|OLE||130||
48782911|NCT04556383|102259628|FG000|COMPLETED|OLE||0||
48782912|NCT04556383|102259629|FG001|COMPLETED|OLE||0||
48782913|NCT04556383|102259630|FG002|COMPLETED|OLE||0||
48782914|NCT04556383|102259631|FG003|COMPLETED|OLE||39||
48782915|NCT04556383|102259628|FG000|NOT COMPLETED|OLE||0||
48782916|NCT04556383|102259629|FG001|NOT COMPLETED|OLE||0||
48782917|NCT04556383|102259630|FG002|NOT COMPLETED|OLE||0||
48782918|NCT04556383|102259631|FG003|NOT COMPLETED|OLE||91||
48782919|NCT03396952|102259632|FG000|STARTED|Overall Study||27||
48782920|NCT03396952|102259632|FG000|COMPLETED|Overall Study||27||
48782921|NCT03396952|102259632|FG000|NOT COMPLETED|Overall Study||0||
48782922|NCT01009619|102259633|FG000|STARTED|Overall Study||40||
48782923|NCT01009619|102259634|FG001|STARTED|Overall Study||43||
48782924|NCT01009619|102259633|FG000|COMPLETED|Overall Study||40||
48782925|NCT01009619|102259634|FG001|COMPLETED|Overall Study||43||
48782926|NCT01009619|102259633|FG000|NOT COMPLETED|Overall Study||0||
48782927|NCT01009619|102259634|FG001|NOT COMPLETED|Overall Study||0||
48782928|NCT03774719|102259635|FG000|STARTED|Overall Study||6||
48782929|NCT03774719|102259635|FG000|COMPLETED|Overall Study||6||
48782930|NCT03774719|102259635|FG000|NOT COMPLETED|Overall Study||0||
48782931|NCT00992589|102259636|FG000|STARTED|Open-Label Phase||344||
48782932|NCT00992589|102259637|FG001|STARTED|Open-Label Phase||0||
48782933|NCT00992589|102259638|FG002|STARTED|Open-Label Phase||0||
48782934|NCT00992589|102259639|FG003|STARTED|Open-Label Phase||0||
48782935|NCT00992589|102259636|FG000|COMPLETED|Open-Label Phase||267||
48782936|NCT00992589|102259637|FG001|COMPLETED|Open-Label Phase||0||
48782937|NCT00992589|102259638|FG002|COMPLETED|Open-Label Phase||0||
48782938|NCT00992589|102259639|FG003|COMPLETED|Open-Label Phase||0||
48782939|NCT00992589|102259636|FG000|NOT COMPLETED|Open-Label Phase||77||
48782940|NCT00992589|102259637|FG001|NOT COMPLETED|Open-Label Phase||0||
48782941|NCT00992589|102259638|FG002|NOT COMPLETED|Open-Label Phase||0||
48782942|NCT00992589|102259639|FG003|NOT COMPLETED|Open-Label Phase||0||
48782943|NCT00992589|102259636|FG000|STARTED|Double-Blind Phase||0||
48782944|NCT00992589|102259637|FG001|STARTED|Double-Blind Phase||89||
48782945|NCT00992589|102259638|FG002|STARTED|Double-Blind Phase||90||
48782946|NCT00992589|102259639|FG003|STARTED|Double-Blind Phase||88||
48782947|NCT00992589|102259636|FG000|COMPLETED|Double-Blind Phase||0||
48782948|NCT00992589|102259637|FG001|COMPLETED|Double-Blind Phase||76||
48782949|NCT00992589|102259638|FG002|COMPLETED|Double-Blind Phase||77||
48782950|NCT00992589|102259639|FG003|COMPLETED|Double-Blind Phase||78||
48782951|NCT00992589|102259636|FG000|NOT COMPLETED|Double-Blind Phase||0||
48782952|NCT00992589|102259637|FG001|NOT COMPLETED|Double-Blind Phase||13||
48782953|NCT00992589|102259638|FG002|NOT COMPLETED|Double-Blind Phase||13||
48782954|NCT00992589|102259639|FG003|NOT COMPLETED|Double-Blind Phase||10||
48782955|NCT02238067|102259640|FG000|STARTED|Overall Study||196||
48782956|NCT02238067|102259640|FG000|COMPLETED|Overall Study||151||
48782957|NCT02238067|102259640|FG000|NOT COMPLETED|Overall Study||45||
48782958|NCT01966718|102259641|FG000|STARTED|Overall Study||8||
48782959|NCT01966718|102259641|FG000|COMPLETED|Overall Study||8||
48782960|NCT01966718|102259641|FG000|NOT COMPLETED|Overall Study||0||
48782961|NCT03645434|102259642|FG000|STARTED|Period 1||12||
48782962|NCT03645434|102259643|FG001|STARTED|Period 1||13||
48782963|NCT03645434|102259644|FG002|STARTED|Period 1||13||
48782964|NCT03645434|102259645|FG003|STARTED|Period 1||11||
48782965|NCT03645434|102259646|FG004|STARTED|Period 1||12||
48782966|NCT03645434|102259647|FG005|STARTED|Period 1||12||
48782967|NCT03645434|102259642|FG000|COMPLETED|Period 1||12||
48782968|NCT03645434|102259643|FG001|COMPLETED|Period 1||13||
48782969|NCT03645434|102259644|FG002|COMPLETED|Period 1||13||
48782970|NCT03645434|102259645|FG003|COMPLETED|Period 1||10||
48782971|NCT03645434|102259646|FG004|COMPLETED|Period 1||11||
48782972|NCT03645434|102259647|FG005|COMPLETED|Period 1||12||
48782973|NCT03645434|102259642|FG000|NOT COMPLETED|Period 1||0||
48782974|NCT03645434|102259643|FG001|NOT COMPLETED|Period 1||0||
48782975|NCT03645434|102259644|FG002|NOT COMPLETED|Period 1||0||
48782976|NCT03645434|102259645|FG003|NOT COMPLETED|Period 1||1||
48782977|NCT03645434|102259646|FG004|NOT COMPLETED|Period 1||1||
48782978|NCT03645434|102259647|FG005|NOT COMPLETED|Period 1||0||
48782979|NCT03645434|102259642|FG000|STARTED|Period 2||10||
48782980|NCT03645434|102259643|FG001|STARTED|Period 2||13||
48782981|NCT03645434|102259644|FG002|STARTED|Period 2||13||
48782982|NCT03645434|102259645|FG003|STARTED|Period 2||10||
48782983|NCT03645434|102259646|FG004|STARTED|Period 2||11||
48782984|NCT03645434|102259647|FG005|STARTED|Period 2||11||
48782985|NCT03645434|102259642|FG000|COMPLETED|Period 2||10||
48782986|NCT03645434|102259643|FG001|COMPLETED|Period 2||13||
48782987|NCT03645434|102259644|FG002|COMPLETED|Period 2||13||
48782988|NCT03645434|102259645|FG003|COMPLETED|Period 2||10||
48782989|NCT03645434|102259646|FG004|COMPLETED|Period 2||11||
48782990|NCT03645434|102259647|FG005|COMPLETED|Period 2||11||
48782991|NCT03645434|102259642|FG000|NOT COMPLETED|Period 2||0||
48782992|NCT03645434|102259643|FG001|NOT COMPLETED|Period 2||0||
48782993|NCT03645434|102259644|FG002|NOT COMPLETED|Period 2||0||
48782994|NCT03645434|102259645|FG003|NOT COMPLETED|Period 2||0||
48782995|NCT03645434|102259646|FG004|NOT COMPLETED|Period 2||0||
48782996|NCT03645434|102259647|FG005|NOT COMPLETED|Period 2||0||
48782997|NCT03645434|102259642|FG000|STARTED|Period 3||10||
48782998|NCT03645434|102259643|FG001|STARTED|Period 3||13||
48782999|NCT03645434|102259644|FG002|STARTED|Period 3||11||
48783000|NCT03645434|102259645|FG003|STARTED|Period 3||10||
48783001|NCT03645434|102259646|FG004|STARTED|Period 3||11||
48783002|NCT03645434|102259647|FG005|STARTED|Period 3||11||
48783003|NCT03645434|102259642|FG000|COMPLETED|Period 3||10||
48783004|NCT03645434|102259643|FG001|COMPLETED|Period 3||13||
48783005|NCT03645434|102259644|FG002|COMPLETED|Period 3||11||
48783006|NCT03645434|102259645|FG003|COMPLETED|Period 3||10||
48783007|NCT03645434|102259646|FG004|COMPLETED|Period 3||11||
48783008|NCT03645434|102259647|FG005|COMPLETED|Period 3||11||
48783009|NCT03645434|102259642|FG000|NOT COMPLETED|Period 3||0||
48783010|NCT03645434|102259643|FG001|NOT COMPLETED|Period 3||0||
48783011|NCT03645434|102259644|FG002|NOT COMPLETED|Period 3||0||
48783012|NCT03645434|102259645|FG003|NOT COMPLETED|Period 3||0||
48783013|NCT03645434|102259646|FG004|NOT COMPLETED|Period 3||0||
48783014|NCT03645434|102259647|FG005|NOT COMPLETED|Period 3||0||
48783015|NCT00160667|102259648|FG000|STARTED|Overall Study||50||
48783016|NCT00160667|102259649|FG001|STARTED|Overall Study||51||
48783017|NCT00160667|102259650|FG002|STARTED|Overall Study||51||
48783018|NCT00160667|102259648|FG000|COMPLETED|Overall Study||45||
48783019|NCT00160667|102259649|FG001|COMPLETED|Overall Study||48||
48783020|NCT00160667|102259650|FG002|COMPLETED|Overall Study||45||
48783021|NCT00160667|102259648|FG000|NOT COMPLETED|Overall Study||5||
48783022|NCT00160667|102259649|FG001|NOT COMPLETED|Overall Study||3||
48783023|NCT00160667|102259650|FG002|NOT COMPLETED|Overall Study||6||
48783024|NCT02223702|102259651|FG000|STARTED|Overall Study||20||
48783025|NCT02223702|102259652|FG001|STARTED|Overall Study||19||
48783026|NCT02223702|102259651|FG000|COMPLETED|Overall Study||19||
48783027|NCT02223702|102259652|FG001|COMPLETED|Overall Study||15||
48783028|NCT02223702|102259651|FG000|NOT COMPLETED|Overall Study||1||
48783029|NCT02223702|102259652|FG001|NOT COMPLETED|Overall Study||4||
48783030|NCT03805659|102259653|FG000|STARTED|Overall Study||2||
48783031|NCT03805659|102259654|FG001|STARTED|Overall Study||3||
48783032|NCT03805659|102259653|FG000|First Intervention (2 Weeks)|Overall Study||2||
48783033|NCT03805659|102259654|FG001|First Intervention (2 Weeks)|Overall Study||2||
48783034|NCT03805659|102259653|FG000|Assessment 1 Cognitive Testing (8 Weeks After First Intervention)|Overall Study||2||
48783035|NCT03805659|102259654|FG001|Assessment 1 Cognitive Testing (8 Weeks After First Intervention)|Overall Study||2||
48783036|NCT03805659|102259653|FG000|Washout (16 Weeks)|Overall Study||2||
48783037|NCT03805659|102259654|FG001|Washout (16 Weeks)|Overall Study||2||
48783038|NCT03805659|102259653|FG000|Second Intervention (2 Weeks)|Overall Study||2||
48783039|NCT03805659|102259654|FG001|Second Intervention (2 Weeks)|Overall Study||2||
48783040|NCT03805659|102259653|FG000|Assessment 2 Cognitive Testing (8 Weeks After Intervention)|Overall Study||2||
48783041|NCT03805659|102259654|FG001|Assessment 2 Cognitive Testing (8 Weeks After Intervention)|Overall Study||2||
48783042|NCT03805659|102259653|FG000|COMPLETED|Overall Study||2||
48783043|NCT03805659|102259654|FG001|COMPLETED|Overall Study||2||
48783044|NCT03805659|102259653|FG000|NOT COMPLETED|Overall Study||0||
48783045|NCT03805659|102259654|FG001|NOT COMPLETED|Overall Study||1||
48783046|NCT01159431|102259655|FG000|STARTED|Overall Study||25||
48783047|NCT01159431|102259656|FG001|STARTED|Overall Study||25||
48783048|NCT01159431|102259655|FG000|COMPLETED|Overall Study||23||
48783049|NCT01159431|102259656|FG001|COMPLETED|Overall Study||19||
48783050|NCT01159431|102259655|FG000|NOT COMPLETED|Overall Study||2||
48783051|NCT01159431|102259656|FG001|NOT COMPLETED|Overall Study||6||
48783052|NCT00943072|102259657|FG000|STARTED|Overall Study||115||
48783053|NCT00943072|102259658|FG001|STARTED|Overall Study||74||
48783054|NCT00943072|102259657|FG000|Participants Received Treatment|Overall Study||114||
48783055|NCT00943072|102259658|FG001|Participants Received Treatment|Overall Study||74||
48783056|NCT00943072|102259657|FG000|Full Analysis Set (FAS) Population|Overall Study||114||
48783057|NCT00943072|102259658|FG001|Full Analysis Set (FAS) Population|Overall Study||73||
48783058|NCT00943072|102259657|FG000|COMPLETED|Overall Study||110||
48783059|NCT00943072|102259658|FG001|COMPLETED|Overall Study||60||
48783060|NCT00943072|102259657|FG000|NOT COMPLETED|Overall Study||5||
48783061|NCT00943072|102259658|FG001|NOT COMPLETED|Overall Study||14||
48783062|NCT00854113|102259659|FG000|STARTED|Overall Study||6||
48783063|NCT00854113|102259660|FG001|STARTED|Overall Study||6||
48783064|NCT00854113|102259661|FG002|STARTED|Overall Study||6||
48783065|NCT00854113|102259662|FG003|STARTED|Overall Study||6||
48783066|NCT00854113|102259663|FG004|STARTED|Overall Study||6||
48783067|NCT00854113|102259664|FG005|STARTED|Overall Study||6||
48783068|NCT00854113|102259665|FG006|STARTED|Overall Study||12||
48783069|NCT00854113|102259666|FG007|STARTED|Overall Study||8||
48783070|NCT00854113|102259667|FG008|STARTED|Overall Study||8||
48783071|NCT00854113|102259668|FG009|STARTED|Overall Study||8||
48783072|NCT00854113|102259669|FG010|STARTED|Overall Study||6||
48783073|NCT00854113|102259659|FG000|COMPLETED|Overall Study||6||
48783074|NCT00854113|102259660|FG001|COMPLETED|Overall Study||6||
48783075|NCT00854113|102259661|FG002|COMPLETED|Overall Study||6||
48783076|NCT00854113|102259662|FG003|COMPLETED|Overall Study||6||
48783077|NCT00854113|102259663|FG004|COMPLETED|Overall Study||6||
48783078|NCT00854113|102259664|FG005|COMPLETED|Overall Study||6||
48783079|NCT00854113|102259665|FG006|COMPLETED|Overall Study||12||
48783080|NCT00854113|102259666|FG007|COMPLETED|Overall Study||5||
48783081|NCT00854113|102259667|FG008|COMPLETED|Overall Study||7||
48783082|NCT00854113|102259668|FG009|COMPLETED|Overall Study||8||
48783083|NCT00854113|102259669|FG010|COMPLETED|Overall Study||6||
48783084|NCT00854113|102259659|FG000|NOT COMPLETED|Overall Study||0||
48783085|NCT00854113|102259660|FG001|NOT COMPLETED|Overall Study||0||
48783086|NCT00854113|102259661|FG002|NOT COMPLETED|Overall Study||0||
48783087|NCT00854113|102259662|FG003|NOT COMPLETED|Overall Study||0||
48783088|NCT00854113|102259663|FG004|NOT COMPLETED|Overall Study||0||
48783089|NCT00854113|102259664|FG005|NOT COMPLETED|Overall Study||0||
48783090|NCT00854113|102259665|FG006|NOT COMPLETED|Overall Study||0||
48783091|NCT00854113|102259666|FG007|NOT COMPLETED|Overall Study||3||
48783092|NCT00854113|102259667|FG008|NOT COMPLETED|Overall Study||1||
48783093|NCT00854113|102259668|FG009|NOT COMPLETED|Overall Study||0||
48783094|NCT00854113|102259669|FG010|NOT COMPLETED|Overall Study||0||
48783095|NCT00826462|102259670|FG000|STARTED|Overall Study||59||
48783096|NCT00826462|102259671|FG001|STARTED|Overall Study||58||
48783097|NCT00826462|102259672|FG002|STARTED|Overall Study||60||
48783098|NCT00826462|102259670|FG000|COMPLETED|Overall Study||52||
48783099|NCT00826462|102259671|FG001|COMPLETED|Overall Study||53||
48783100|NCT00826462|102259672|FG002|COMPLETED|Overall Study||52||
48783101|NCT00826462|102259670|FG000|NOT COMPLETED|Overall Study||7||
48783102|NCT00826462|102259671|FG001|NOT COMPLETED|Overall Study||5||
48783103|NCT00826462|102259672|FG002|NOT COMPLETED|Overall Study||8||
48189863|NCT00350532|100786325|FG001|COMPLETED|Overall Study||19||
48189864|NCT00350532|100786324|FG000|NOT COMPLETED|Overall Study||0||
48783104|NCT01404936|102259673|FG000|STARTED|Overall Study||30||
48783105|NCT01404936|102259673|FG000|COMPLETED|Overall Study||30||
48783106|NCT01404936|102259673|FG000|NOT COMPLETED|Overall Study||0||
48783107|NCT01738477|102259674|FG000|STARTED|Overall Study||37||
48783108|NCT01738477|102259675|FG001|STARTED|Overall Study||128||
48783109|NCT01738477|102259674|FG000|COMPLETED|Overall Study||36||
48783110|NCT01738477|102259675|FG001|COMPLETED|Overall Study||124||
48783111|NCT01738477|102259674|FG000|NOT COMPLETED|Overall Study||1||
48783112|NCT01738477|102259675|FG001|NOT COMPLETED|Overall Study||4||
48783113|NCT00700141|102259676|FG000|STARTED|Overall Study||482||
48783114|NCT00700141|102259676|FG000|COMPLETED|Overall Study||482||
48783115|NCT00700141|102259676|FG000|NOT COMPLETED|Overall Study||0||
48783116|NCT03764293|102259677|FG000|STARTED|Overall Study||272||
48783117|NCT03764293|102259678|FG001|STARTED|Overall Study||271||
48783118|NCT03764293|102259677|FG000|Treated|Overall Study||272||
48783119|NCT03764293|102259678|FG001|Treated|Overall Study||269||
48783120|NCT03764293|102259677|FG000|COMPLETED|Overall Study||230||
48783121|NCT03764293|102259678|FG001|COMPLETED|Overall Study||249||
48783122|NCT03764293|102259677|FG000|NOT COMPLETED|Overall Study||42||
48783123|NCT03764293|102259678|FG001|NOT COMPLETED|Overall Study||22||
48783124|NCT01324141|102259679|FG000|STARTED|Overall Study||6||
48783125|NCT01324141|102259679|FG000|COMPLETED|Overall Study||4||
48783126|NCT01324141|102259679|FG000|NOT COMPLETED|Overall Study||2||
48783127|NCT02692391|102259680|FG000|STARTED|Overall Study||24||
48783128|NCT02692391|102259681|FG001|STARTED|Overall Study||18||
48783129|NCT02692391|102259680|FG000|COMPLETED|Overall Study||24||
48783130|NCT02692391|102259681|FG001|COMPLETED|Overall Study||18||
48783131|NCT02692391|102259680|FG000|NOT COMPLETED|Overall Study||0||
48783132|NCT02692391|102259681|FG001|NOT COMPLETED|Overall Study||0||
48783133|NCT02741518|102259682|FG000|STARTED|Overall Study||11||
48783134|NCT02741518|102259683|FG001|STARTED|Overall Study||11||
48783135|NCT02741518|102259682|FG000|COMPLETED|Overall Study||10||
48783136|NCT02741518|102259683|FG001|COMPLETED|Overall Study||10||
48783137|NCT02741518|102259682|FG000|NOT COMPLETED|Overall Study||1||
48783138|NCT02741518|102259683|FG001|NOT COMPLETED|Overall Study||1||
48783139|NCT01290913|102259684|FG000|STARTED|Overall Study||13||
48783140|NCT01290913|102259684|FG000|COMPLETED|Overall Study||12||
48783141|NCT01290913|102259684|FG000|NOT COMPLETED|Overall Study||1||
48783142|NCT00743106|102259685|FG000|STARTED|Overall Study||42||
48783143|NCT00743106|102259686|FG001|STARTED|Overall Study||48||
48783144|NCT00743106|102259685|FG000|COMPLETED|Overall Study||34||
48783145|NCT00743106|102259686|FG001|COMPLETED|Overall Study||43||
48783146|NCT00743106|102259685|FG000|NOT COMPLETED|Overall Study||8||
48783147|NCT00743106|102259686|FG001|NOT COMPLETED|Overall Study||5||
48783148|NCT04450381|102259687|FG000|STARTED|Overall Study||131||
48783149|NCT04450381|102259687|FG000|COMPLETED|Overall Study||125||
48783150|NCT04450381|102259687|FG000|NOT COMPLETED|Overall Study||6||
48783151|NCT02445794|102259688|FG000|STARTED|Overall Study||6||
48783152|NCT02445794|102259689|FG001|STARTED|Overall Study||3||
48783153|NCT02445794|102259690|FG002|STARTED|Overall Study||7||
48783154|NCT02445794|102259691|FG003|STARTED|Overall Study||3||
48783155|NCT02445794|102259688|FG000|COMPLETED|Overall Study||6||
48783156|NCT02445794|102259689|FG001|COMPLETED|Overall Study||3||
48783157|NCT02445794|102259690|FG002|COMPLETED|Overall Study||5||
48783158|NCT02445794|102259691|FG003|COMPLETED|Overall Study||3||
48783159|NCT02445794|102259688|FG000|NOT COMPLETED|Overall Study||0||
48783160|NCT02445794|102259689|FG001|NOT COMPLETED|Overall Study||0||
48783161|NCT02445794|102259690|FG002|NOT COMPLETED|Overall Study||2||
48783162|NCT02445794|102259691|FG003|NOT COMPLETED|Overall Study||0||
48783163|NCT00724867|102259692|FG000|STARTED|Overall Study||268||
48783164|NCT00724867|102259692|FG000|COMPLETED|Overall Study||140||
48783165|NCT00724867|102259692|FG000|NOT COMPLETED|Overall Study||128||
48783166|NCT01839604|102259693|FG000|STARTED|Overall Study||6||
48783167|NCT01839604|102259694|FG001|STARTED|Overall Study||6||
48783168|NCT01839604|102259695|FG002|STARTED|Overall Study||7||
48783169|NCT01839604|102259696|FG003|STARTED|Overall Study||5||
48783170|NCT01839604|102259697|FG004|STARTED|Overall Study||15||
48783171|NCT01839604|102259693|FG000|COMPLETED|Overall Study||6||
48783172|NCT01839604|102259694|FG001|COMPLETED|Overall Study||6||
48783173|NCT01839604|102259695|FG002|COMPLETED|Overall Study||7||
48783174|NCT01839604|102259696|FG003|COMPLETED|Overall Study||5||
48783175|NCT01839604|102259697|FG004|COMPLETED|Overall Study||15||
48783176|NCT01839604|102259693|FG000|NOT COMPLETED|Overall Study||0||
48783177|NCT01839604|102259694|FG001|NOT COMPLETED|Overall Study||0||
48783178|NCT01839604|102259695|FG002|NOT COMPLETED|Overall Study||0||
48783179|NCT01839604|102259696|FG003|NOT COMPLETED|Overall Study||0||
48783180|NCT01839604|102259697|FG004|NOT COMPLETED|Overall Study||0||
48783181|NCT00335764|102259698|FG000|STARTED|Overall Study||17||
48783182|NCT00335764|102259699|FG001|STARTED|Overall Study||13||
48783183|NCT00335764|102259700|FG002|STARTED|Overall Study||24||
48783184|NCT00335764|102259701|FG003|STARTED|Overall Study||19||
48783185|NCT00335764|102259702|FG004|STARTED|Overall Study||19||
48783186|NCT00335764|102259698|FG000|COMPLETED|Overall Study||16||
48783187|NCT00335764|102259699|FG001|COMPLETED|Overall Study||13||
48783188|NCT00335764|102259700|FG002|COMPLETED|Overall Study||24||
48783189|NCT00335764|102259701|FG003|COMPLETED|Overall Study||19||
48783190|NCT00335764|102259702|FG004|COMPLETED|Overall Study||18||
48783191|NCT00335764|102259698|FG000|NOT COMPLETED|Overall Study||1||
48783192|NCT00335764|102259699|FG001|NOT COMPLETED|Overall Study||0||
48783193|NCT00335764|102259700|FG002|NOT COMPLETED|Overall Study||0||
48783194|NCT00335764|102259701|FG003|NOT COMPLETED|Overall Study||0||
48783195|NCT00335764|102259702|FG004|NOT COMPLETED|Overall Study||1||
48783196|NCT00475982|102259703|FG000|STARTED|Overall Study||23||
48783197|NCT00475982|102259704|FG001|STARTED|Overall Study||21||
48783198|NCT00475982|102259703|FG000|COMPLETED|Overall Study||16||
48783199|NCT00475982|102259704|FG001|COMPLETED|Overall Study||18||
48783200|NCT00475982|102259703|FG000|NOT COMPLETED|Overall Study||7||
48783201|NCT00475982|102259704|FG001|NOT COMPLETED|Overall Study||3||
48783202|NCT02299791|102259705|FG000|STARTED|Overall Study||2053||6
48783203|NCT02299791|102259706|FG001|STARTED|Overall Study||2803||5
48783204|NCT02299791|102259705|FG000|COMPLETED|Overall Study||2053||6
48783205|NCT02299791|102259706|FG001|COMPLETED|Overall Study||2803||5
48783206|NCT02299791|102259705|FG000|NOT COMPLETED|Overall Study||0||0
48783207|NCT02299791|102259706|FG001|NOT COMPLETED|Overall Study||0||0
48783208|NCT03098615|102259707|FG000|STARTED|Overall Study||19||
48783209|NCT03098615|102259707|FG000|COMPLETED|Overall Study||17||
48783210|NCT03098615|102259707|FG000|NOT COMPLETED|Overall Study||2||
48783211|NCT04780919|102259708|FG000|STARTED|Overall Study||9||
48783212|NCT04780919|102259709|FG001|STARTED|Overall Study||9||
48783213|NCT04780919|102259708|FG000|COMPLETED|Overall Study||9||
48783214|NCT04780919|102259709|FG001|COMPLETED|Overall Study||9||
48783215|NCT04780919|102259708|FG000|NOT COMPLETED|Overall Study||0||
48783216|NCT04780919|102259709|FG001|NOT COMPLETED|Overall Study||0||
48783217|NCT02260180|102259710|FG000|STARTED|Overall Study||39||
48783218|NCT02260180|102259711|FG001|STARTED|Overall Study||39||
48783219|NCT02260180|102259712|FG002|STARTED|Overall Study||41||
48783220|NCT02260180|102259710|FG000|COMPLETED|Overall Study||37||
48783221|NCT02260180|102259711|FG001|COMPLETED|Overall Study||39||
48783222|NCT02260180|102259712|FG002|COMPLETED|Overall Study||40||
48783223|NCT02260180|102259710|FG000|NOT COMPLETED|Overall Study||2||
48783224|NCT02260180|102259711|FG001|NOT COMPLETED|Overall Study||0||
48783225|NCT02260180|102259712|FG002|NOT COMPLETED|Overall Study||1||
48783226|NCT03565328|102259713|FG000|STARTED|Overall Study||1||
48783227|NCT03565328|102259713|FG000|COMPLETED|Overall Study||1||
48783228|NCT03565328|102259713|FG000|NOT COMPLETED|Overall Study||0||
48783229|NCT01214395|102259714|FG000|STARTED|Overall Study||5||
48783230|NCT01214395|102259714|FG000|COMPLETED|Overall Study||0||
48783231|NCT01214395|102259714|FG000|NOT COMPLETED|Overall Study||5||
48783232|NCT01409811|102259715|FG000|STARTED|Overall Study||9||
48783233|NCT01409811|102259715|FG000|COMPLETED|Overall Study||8||
48783234|NCT01409811|102259715|FG000|NOT COMPLETED|Overall Study||1||
48783235|NCT02948088|102259716|FG000|STARTED|Overall Study||183|Baseline Analysis Set and All Documented Patient Set|
48783236|NCT02948088|102259716|FG000|Full Analysis Set|Overall Study||176||
48783237|NCT02948088|102259716|FG000|COMPLETED|Overall Study||168||
48783238|NCT02948088|102259716|FG000|NOT COMPLETED|Overall Study||15||
48783239|NCT02936648|102259717|FG000|STARTED|Overall Study||2209||
48783240|NCT02936648|102259717|FG000|COMPLETED|Overall Study||2209||
48783241|NCT02936648|102259717|FG000|NOT COMPLETED|Overall Study||0||
48783242|NCT02490670|102259718|FG000|STARTED|Period 1 (19 Days)||14||
48783243|NCT02490670|102259719|FG001|STARTED|Period 1 (19 Days)||14||
48783244|NCT02490670|102259718|FG000|COMPLETED|Period 1 (19 Days)||14||
48783245|NCT02490670|102259719|FG001|COMPLETED|Period 1 (19 Days)||14||
48783246|NCT02490670|102259718|FG000|NOT COMPLETED|Period 1 (19 Days)||0||
48783247|NCT02490670|102259719|FG001|NOT COMPLETED|Period 1 (19 Days)||0||
48783248|NCT02490670|102259718|FG000|STARTED|Washout Period (7 Days)||14||
48783249|NCT02490670|102259719|FG001|STARTED|Washout Period (7 Days)||14||
48783250|NCT02490670|102259718|FG000|COMPLETED|Washout Period (7 Days)||14||
48783251|NCT02490670|102259719|FG001|COMPLETED|Washout Period (7 Days)||14||
48783252|NCT02490670|102259718|FG000|NOT COMPLETED|Washout Period (7 Days)||0||
48783253|NCT02490670|102259719|FG001|NOT COMPLETED|Washout Period (7 Days)||0||
48783254|NCT02490670|102259718|FG000|STARTED|Period 2 (19 Days)||14||
48783255|NCT02490670|102259719|FG001|STARTED|Period 2 (19 Days)||14||
48783256|NCT02490670|102259718|FG000|COMPLETED|Period 2 (19 Days)||14||
48466665|NCT01104662|101476922|FG006|Received at Least 1 Dose of Study Drug|Overall Study||5||
48466666|NCT01104662|101476923|FG007|Received at Least 1 Dose of Study Drug|Overall Study||6||
48466667|NCT01104662|101476916|FG000|COMPLETED|Overall Study||10||
48466668|NCT01104662|101476917|FG001|COMPLETED|Overall Study||11||
48466669|NCT01104662|101476918|FG002|COMPLETED|Overall Study||4||
48466670|NCT01104662|101476919|FG003|COMPLETED|Overall Study||3||
48466671|NCT01104662|101476920|FG004|COMPLETED|Overall Study||14||
48466672|NCT01104662|101476921|FG005|COMPLETED|Overall Study||12||
48466673|NCT01104662|101476922|FG006|COMPLETED|Overall Study||5||
48466674|NCT01104662|101476923|FG007|COMPLETED|Overall Study||6||
48466675|NCT01104662|101476916|FG000|NOT COMPLETED|Overall Study||10||
48466676|NCT01104662|101476917|FG001|NOT COMPLETED|Overall Study||10||
48466677|NCT01104662|101476918|FG002|NOT COMPLETED|Overall Study||1||
48466678|NCT01104662|101476919|FG003|NOT COMPLETED|Overall Study||1||
48466679|NCT01104662|101476920|FG004|NOT COMPLETED|Overall Study||1||
48466680|NCT01104662|101476921|FG005|NOT COMPLETED|Overall Study||4||
48466681|NCT01104662|101476922|FG006|NOT COMPLETED|Overall Study||0||
48466682|NCT01104662|101476923|FG007|NOT COMPLETED|Overall Study||0||
48466683|NCT00704418|101476924|FG000|STARTED|Overall Study||78||
48466684|NCT00704418|101476925|FG001|STARTED|Overall Study||78||
48466685|NCT00704418|101476924|FG000|COMPLETED|Overall Study||73||
48466686|NCT00704418|101476925|FG001|COMPLETED|Overall Study||72||
48466687|NCT00704418|101476924|FG000|NOT COMPLETED|Overall Study||5||
48783257|NCT02490670|102259719|FG001|COMPLETED|Period 2 (19 Days)||14||
48783258|NCT02490670|102259718|FG000|NOT COMPLETED|Period 2 (19 Days)||0||
48783259|NCT02490670|102259719|FG001|NOT COMPLETED|Period 2 (19 Days)||0||
48783260|NCT01548833|102259720|FG000|STARTED|Overall Study||39||
48783261|NCT01548833|102259720|FG000|COMPLETED|Overall Study||39||
48783262|NCT01548833|102259720|FG000|NOT COMPLETED|Overall Study||0||
48783263|NCT04166240|102259721|FG000|STARTED|Pre Intervention for All Sites||0||4
48783264|NCT04166240|102259722|FG001|STARTED|Pre Intervention for All Sites||0||4
48783265|NCT04166240|102259723|FG002|STARTED|Pre Intervention for All Sites||0||4
48783266|NCT04166240|102259721|FG000|COMPLETED|Pre Intervention for All Sites||0||4
48783267|NCT04166240|102259722|FG001|COMPLETED|Pre Intervention for All Sites||0||4
48783268|NCT04166240|102259723|FG002|COMPLETED|Pre Intervention for All Sites||0||3
48783269|NCT04166240|102259721|FG000|NOT COMPLETED|Pre Intervention for All Sites||0||0
48783270|NCT04166240|102259722|FG001|NOT COMPLETED|Pre Intervention for All Sites||0||0
48783271|NCT04166240|102259723|FG002|NOT COMPLETED|Pre Intervention for All Sites||0||1
48783272|NCT04166240|102259721|FG000|STARTED|Action Phase for Sequence 1||0||4
48783273|NCT04166240|102259722|FG001|STARTED|Action Phase for Sequence 1||0||4
48466688|NCT00704418|101476925|FG001|NOT COMPLETED|Overall Study||6||
48466689|NCT00996736|101476926|FG000|STARTED|Overall Study||162||
48466690|NCT00996736|101476927|FG001|STARTED|Overall Study||161||
48466691|NCT00996736|101476926|FG000|3-week Visit|Overall Study||155||
48466692|NCT00996736|101476927|FG001|3-week Visit|Overall Study||151||
48466693|NCT00996736|101476926|FG000|3-month Visit|Overall Study||146||
48466694|NCT00996736|101476927|FG001|3-month Visit|Overall Study||146||
48783274|NCT04166240|102259723|FG002|STARTED|Action Phase for Sequence 1||0||3
48783275|NCT04166240|102259721|FG000|COMPLETED|Action Phase for Sequence 1||0||4
48783276|NCT04166240|102259722|FG001|COMPLETED|Action Phase for Sequence 1||0||4
48783277|NCT04166240|102259723|FG002|COMPLETED|Action Phase for Sequence 1||0||3
48783278|NCT04166240|102259721|FG000|NOT COMPLETED|Action Phase for Sequence 1||0||0
48783279|NCT04166240|102259722|FG001|NOT COMPLETED|Action Phase for Sequence 1||0||0
48783280|NCT04166240|102259723|FG002|NOT COMPLETED|Action Phase for Sequence 1||0||0
48783281|NCT04166240|102259721|FG000|STARTED|Action Phase for Sequence 2||0||4
48783282|NCT04166240|102259722|FG001|STARTED|Action Phase for Sequence 2||0||4
48783283|NCT04166240|102259723|FG002|STARTED|Action Phase for Sequence 2||0||3
48783284|NCT04166240|102259721|FG000|COMPLETED|Action Phase for Sequence 2||0||4
48783285|NCT04166240|102259722|FG001|COMPLETED|Action Phase for Sequence 2||0||4
48783286|NCT04166240|102259723|FG002|COMPLETED|Action Phase for Sequence 2||0||3
48783287|NCT04166240|102259721|FG000|NOT COMPLETED|Action Phase for Sequence 2||0||0
48783288|NCT04166240|102259722|FG001|NOT COMPLETED|Action Phase for Sequence 2||0||0
48783289|NCT04166240|102259723|FG002|NOT COMPLETED|Action Phase for Sequence 2||0||0
48783290|NCT04166240|102259721|FG000|STARTED|Action Phase for Sequence 3||0||4
48783291|NCT04166240|102259722|FG001|STARTED|Action Phase for Sequence 3||0||4
48783292|NCT04166240|102259723|FG002|STARTED|Action Phase for Sequence 3||0||3
48783293|NCT04166240|102259721|FG000|COMPLETED|Action Phase for Sequence 3||0||4
48783294|NCT04166240|102259722|FG001|COMPLETED|Action Phase for Sequence 3||0||4
48783295|NCT04166240|102259723|FG002|COMPLETED|Action Phase for Sequence 3||0||3
48783296|NCT04166240|102259721|FG000|NOT COMPLETED|Action Phase for Sequence 3||0||0
48783297|NCT04166240|102259722|FG001|NOT COMPLETED|Action Phase for Sequence 3||0||0
48783298|NCT04166240|102259723|FG002|NOT COMPLETED|Action Phase for Sequence 3||0||0
48783299|NCT00223080|102259724|FG000|STARTED|Overall Study||8197||
48783300|NCT00223080|102259725|FG001|STARTED|Overall Study||8198||
48783301|NCT00223080|102259724|FG000|COMPLETED|Overall Study||7401||
48783302|NCT00223080|102259725|FG001|COMPLETED|Overall Study||7401||
48783303|NCT00223080|102259724|FG000|NOT COMPLETED|Overall Study||796||
48783304|NCT00223080|102259725|FG001|NOT COMPLETED|Overall Study||797||
48783305|NCT01105767|102259726|FG000|STARTED|Overall Study||9315||
48783306|NCT01105767|102259727|FG001|STARTED|Overall Study||10864||
48783307|NCT01105767|102259728|FG002|STARTED|Overall Study||10030||
48783308|NCT01105767|102259726|FG000|COMPLETED|Overall Study||8155||
48783309|NCT01105767|102259727|FG001|COMPLETED|Overall Study||9250||
48783310|NCT01105767|102259728|FG002|COMPLETED|Overall Study||8846||
48783311|NCT01105767|102259726|FG000|NOT COMPLETED|Overall Study||1160||
48783312|NCT01105767|102259727|FG001|NOT COMPLETED|Overall Study||1614||
48783313|NCT01105767|102259728|FG002|NOT COMPLETED|Overall Study||1184||
48783314|NCT04180540|102259729|FG000|STARTED|Overall Study||55||
48783315|NCT04180540|102259730|FG001|STARTED|Overall Study||54||
48783316|NCT04180540|102259729|FG000|COMPLETED|Overall Study||53||
48783317|NCT04180540|102259730|FG001|COMPLETED|Overall Study||54||
48783318|NCT04180540|102259729|FG000|NOT COMPLETED|Overall Study||2||
48783319|NCT04180540|102259730|FG001|NOT COMPLETED|Overall Study||0||
48783320|NCT03010488|102259731|FG000|STARTED|Overall Study||22||
48783321|NCT03010488|102259732|FG001|STARTED|Overall Study||22||
48783322|NCT03010488|102259731|FG000|COMPLETED|Overall Study||17||
48783323|NCT03010488|102259732|FG001|COMPLETED|Overall Study||15||
48783324|NCT03010488|102259731|FG000|NOT COMPLETED|Overall Study||5||
48783325|NCT03010488|102259732|FG001|NOT COMPLETED|Overall Study||7||
48783326|NCT00946985|102259733|FG000|STARTED|Stabilization Phase (25 Weeks)||162||
48783327|NCT00946985|102259733|FG000|COMPLETED|Stabilization Phase (25 Weeks)||2||
48783328|NCT00946985|102259733|FG000|NOT COMPLETED|Stabilization Phase (25 Weeks)||160||
48783329|NCT00946985|102259733|FG000|STARTED|Relapse Prevention Phase (24 Months)||2||
48783330|NCT00946985|102259733|FG000|COMPLETED|Relapse Prevention Phase (24 Months)||0||
48783331|NCT00946985|102259733|FG000|NOT COMPLETED|Relapse Prevention Phase (24 Months)||2||
48783332|NCT02270944|102259734|FG000|STARTED|Overall Study||529||
48783333|NCT02270944|102259735|FG001|STARTED|Overall Study||521||
48783334|NCT02270944|102259734|FG000|COMPLETED|Overall Study||518||
48783335|NCT02270944|102259735|FG001|COMPLETED|Overall Study||516||
48783336|NCT02270944|102259734|FG000|NOT COMPLETED|Overall Study||11||
48783337|NCT02270944|102259735|FG001|NOT COMPLETED|Overall Study||5||
48783338|NCT00093379|102259736|FG000|STARTED|Overall Study||20||
48783339|NCT00093379|102259736|FG000|COMPLETED|Overall Study||20||
48783340|NCT00093379|102259736|FG000|NOT COMPLETED|Overall Study||0||
48783341|NCT01456897|102259737|FG000|STARTED|Overall Study||184||
48783342|NCT01456897|102259738|FG001|STARTED|Overall Study||98||
48466695|NCT00996736|101476926|FG000|COMPLETED|Overall Study||141||
48783343|NCT01456897|102259737|FG000|COMPLETED|Overall Study||109||
48783344|NCT01456897|102259738|FG001|COMPLETED|Overall Study||41||
48783345|NCT01456897|102259737|FG000|NOT COMPLETED|Overall Study||75||
48783346|NCT01456897|102259738|FG001|NOT COMPLETED|Overall Study||57||
48783347|NCT02751385|102259739|FG000|STARTED|Period 1||2||
48783348|NCT02751385|102259740|FG001|STARTED|Period 1||0||
48783349|NCT02751385|102259739|FG000|COMPLETED|Period 1||2||
48783350|NCT02751385|102259740|FG001|COMPLETED|Period 1||0||
48783351|NCT02751385|102259739|FG000|NOT COMPLETED|Period 1||0||
48783352|NCT02751385|102259740|FG001|NOT COMPLETED|Period 1||0||
48783353|NCT02751385|102259739|FG000|STARTED|Period 2||0||
48783354|NCT02751385|102259740|FG001|STARTED|Period 2||2||
48783355|NCT02751385|102259739|FG000|COMPLETED|Period 2||0||
48783356|NCT02751385|102259740|FG001|COMPLETED|Period 2||2||
48783357|NCT02751385|102259739|FG000|NOT COMPLETED|Period 2||0||
48783358|NCT02751385|102259740|FG001|NOT COMPLETED|Period 2||0||
48783359|NCT03207035|102259741|FG000|STARTED|Overall Study||10||
48783360|NCT03207035|102259742|FG001|STARTED|Overall Study||10||
48783361|NCT03207035|102259741|FG000|COMPLETED|Overall Study||10||
48783362|NCT03207035|102259742|FG001|COMPLETED|Overall Study||10||
48783363|NCT03207035|102259741|FG000|NOT COMPLETED|Overall Study||0||
48783364|NCT03207035|102259742|FG001|NOT COMPLETED|Overall Study||0||
48783365|NCT00945295|102259743|FG000|STARTED|Overall Study||15||
48783366|NCT00945295|102259744|FG001|STARTED|Overall Study||16||
48783367|NCT00945295|102259743|FG000|COMPLETED|Overall Study||15||
48783368|NCT00945295|102259744|FG001|COMPLETED|Overall Study||14||
48783369|NCT00945295|102259743|FG000|NOT COMPLETED|Overall Study||0||
48783370|NCT00945295|102259744|FG001|NOT COMPLETED|Overall Study||2||
48783371|NCT04784442|102259745|FG000|STARTED|Overall Study||47||
48783372|NCT04784442|102259746|FG001|STARTED|Overall Study||46||
48783373|NCT04784442|102259747|FG002|STARTED|Overall Study||48||
48783374|NCT04784442|102259748|FG003|STARTED|Overall Study||47||
48783375|NCT04784442|102259745|FG000|COMPLETED|Overall Study||44||
48783376|NCT04784442|102259746|FG001|COMPLETED|Overall Study||46||
48783377|NCT04784442|102259747|FG002|COMPLETED|Overall Study||46||
48783378|NCT04784442|102259748|FG003|COMPLETED|Overall Study||46||
48783379|NCT04784442|102259745|FG000|NOT COMPLETED|Overall Study||3||
48783380|NCT04784442|102259746|FG001|NOT COMPLETED|Overall Study||0||
48783381|NCT04784442|102259747|FG002|NOT COMPLETED|Overall Study||2||
48783382|NCT04784442|102259748|FG003|NOT COMPLETED|Overall Study||1||
48783383|NCT05780424|102259749|FG000|STARTED|Overall Study||176||
48783384|NCT05780424|102259750|FG001|STARTED|Overall Study||177||
48783385|NCT05780424|102259749|FG000|COMPLETED|Overall Study||176||
48783386|NCT05780424|102259750|FG001|COMPLETED|Overall Study||177||
48783387|NCT05780424|102259749|FG000|NOT COMPLETED|Overall Study||0||
48783388|NCT05780424|102259750|FG001|NOT COMPLETED|Overall Study||0||
48783389|NCT01499277|102259751|FG000|STARTED|Overall Study||506||
48783390|NCT01499277|102259752|FG001|STARTED|Overall Study||255||
48783391|NCT01499277|102259751|FG000|COMPLETED|Overall Study||459||
48783392|NCT01499277|102259752|FG001|COMPLETED|Overall Study||223||
48783393|NCT01499277|102259751|FG000|NOT COMPLETED|Overall Study||47||
48783394|NCT01499277|102259752|FG001|NOT COMPLETED|Overall Study||32||
48783395|NCT00171834|102259753|FG000|STARTED|Overall Study||6||
48783396|NCT00171834|102259754|FG001|STARTED|Overall Study||12||
48783397|NCT00171834|102259755|FG002|STARTED|Overall Study||12||
48783398|NCT00171834|102259756|FG003|STARTED|Overall Study||12||
48783399|NCT00171834|102259757|FG004|STARTED|Overall Study||8||
48783400|NCT00171834|102259758|FG005|STARTED|Overall Study||35||
48783401|NCT00171834|102259759|FG006|STARTED|Overall Study||4||
48783402|NCT00171834|102259753|FG000|Completed 6 Cycles of Treatment|Overall Study||0||
48783403|NCT00171834|102259754|FG001|Completed 6 Cycles of Treatment|Overall Study||0||
48783404|NCT00171834|102259755|FG002|Completed 6 Cycles of Treatment|Overall Study||1||
48783405|NCT00171834|102259756|FG003|Completed 6 Cycles of Treatment|Overall Study||0||
48783406|NCT00171834|102259757|FG004|Completed 6 Cycles of Treatment|Overall Study||2||
48783407|NCT00171834|102259758|FG005|Completed 6 Cycles of Treatment|Overall Study||1||
48783408|NCT00171834|102259759|FG006|Completed 6 Cycles of Treatment|Overall Study||0||
48783409|NCT00171834|102259753|FG000|COMPLETED|Overall Study||0||
48783410|NCT00171834|102259754|FG001|COMPLETED|Overall Study||0||
48783411|NCT00171834|102259755|FG002|COMPLETED|Overall Study||0||
48783412|NCT00171834|102259756|FG003|COMPLETED|Overall Study||0||
48783413|NCT00171834|102259757|FG004|COMPLETED|Overall Study||0||
48783414|NCT00171834|102259758|FG005|COMPLETED|Overall Study||0||
48783415|NCT00171834|102259759|FG006|COMPLETED|Overall Study||0||
48783416|NCT00171834|102259753|FG000|NOT COMPLETED|Overall Study||6||
48783417|NCT00171834|102259754|FG001|NOT COMPLETED|Overall Study||12||
48783418|NCT00171834|102259755|FG002|NOT COMPLETED|Overall Study||12||
48466696|NCT00996736|101476927|FG001|COMPLETED|Overall Study||143||
48466697|NCT00996736|101476926|FG000|NOT COMPLETED|Overall Study||21||
48466698|NCT00996736|101476927|FG001|NOT COMPLETED|Overall Study||18||
48783419|NCT00171834|102259756|FG003|NOT COMPLETED|Overall Study||12||
48783420|NCT00171834|102259757|FG004|NOT COMPLETED|Overall Study||8||
48783421|NCT00171834|102259758|FG005|NOT COMPLETED|Overall Study||35||
48783422|NCT00171834|102259759|FG006|NOT COMPLETED|Overall Study||4||
48783423|NCT00125528|102259760|FG000|STARTED|Overall Study||20||
48466699|NCT00319111|101476928|FG000|STARTED|Overall Study||151||
48783424|NCT00125528|102259761|FG001|STARTED|Overall Study||21||
48783425|NCT00125528|102259760|FG000|COMPLETED|Overall Study||18||
48783426|NCT00125528|102259761|FG001|COMPLETED|Overall Study||20||
48783427|NCT00125528|102259760|FG000|NOT COMPLETED|Overall Study||2||
48783428|NCT00125528|102259761|FG001|NOT COMPLETED|Overall Study||1||
48783429|NCT02813577|102259762|FG000|STARTED|Overall Study||4||
48783430|NCT02813577|102259762|FG000|COMPLETED|Overall Study||0||
48783431|NCT02813577|102259762|FG000|NOT COMPLETED|Overall Study||4||
48783432|NCT03412565|102259763|FG000|STARTED|Overall Study||67||
48783433|NCT03412565|102259764|FG001|STARTED|Overall Study||67||
48466700|NCT00319111|101476928|FG000|COMPLETED|Overall Study||104||
48466701|NCT00319111|101476928|FG000|NOT COMPLETED|Overall Study||47||
48466702|NCT00672854|101476929|FG000|STARTED|Overall Study||49||
48466703|NCT00672854|101476930|FG001|STARTED|Overall Study||51||
48466704|NCT00672854|101476929|FG000|COMPLETED|Overall Study||49||
48466705|NCT00672854|101476930|FG001|COMPLETED|Overall Study||51||
48466706|NCT00672854|101476929|FG000|NOT COMPLETED|Overall Study||0||
48466707|NCT00672854|101476930|FG001|NOT COMPLETED|Overall Study||0||
48783434|NCT03412565|102259765|FG002|STARTED|Overall Study||65||
48783435|NCT03412565|102259766|FG003|STARTED|Overall Study||66||
48783436|NCT03412565|102259763|FG000|COMPLETED|Overall Study||66||
48783437|NCT03412565|102259764|FG001|COMPLETED|Overall Study||19||
48783438|NCT03412565|102259765|FG002|COMPLETED|Overall Study||14||
48783439|NCT03412565|102259766|FG003|COMPLETED|Overall Study||15||
48783440|NCT03412565|102259763|FG000|NOT COMPLETED|Overall Study||1||
48783441|NCT03412565|102259764|FG001|NOT COMPLETED|Overall Study||48||
48783442|NCT03412565|102259765|FG002|NOT COMPLETED|Overall Study||51||
48783443|NCT03412565|102259766|FG003|NOT COMPLETED|Overall Study||51||
48783444|NCT00970684|102259767|FG000|STARTED|Overall Study||13||
48783445|NCT00970684|102259767|FG000|COMPLETED|Overall Study||3||
48783446|NCT00970684|102259767|FG000|NOT COMPLETED|Overall Study||10||
48783447|NCT03844945|102259768|FG000|STARTED|Overall Study||55||
48783448|NCT03844945|102259769|FG001|STARTED|Overall Study||54||
48783449|NCT03844945|102259770|FG002|STARTED|Overall Study||51||
48783450|NCT03844945|102259771|FG003|STARTED|Overall Study||55||
48783451|NCT03844945|102259768|FG000|COMPLETED|Overall Study||54||
48783452|NCT03844945|102259769|FG001|COMPLETED|Overall Study||53||
48783453|NCT03844945|102259770|FG002|COMPLETED|Overall Study||46||
48783454|NCT03844945|102259771|FG003|COMPLETED|Overall Study||54||
48783455|NCT03844945|102259768|FG000|NOT COMPLETED|Overall Study||1||
48783456|NCT03844945|102259769|FG001|NOT COMPLETED|Overall Study||1||
48783457|NCT03844945|102259770|FG002|NOT COMPLETED|Overall Study||5||
48783458|NCT03844945|102259771|FG003|NOT COMPLETED|Overall Study||1||
48783459|NCT02080819|102259772|FG000|STARTED|Overall Study||63||
48783460|NCT02080819|102259773|FG001|STARTED|Overall Study||35||
48783461|NCT02080819|102259774|FG002|STARTED|Overall Study||33||
48783462|NCT02080819|102259772|FG000|COMPLETED|Overall Study||38||
48783463|NCT02080819|102259773|FG001|COMPLETED|Overall Study||9||
48783464|NCT02080819|102259774|FG002|COMPLETED|Overall Study||11||
48783465|NCT02080819|102259772|FG000|NOT COMPLETED|Overall Study||25||
48783466|NCT02080819|102259773|FG001|NOT COMPLETED|Overall Study||26||
48783467|NCT02080819|102259774|FG002|NOT COMPLETED|Overall Study||22||
48783468|NCT00807560|102259775|FG000|STARTED|Overall Study||38||
48783469|NCT00807560|102259776|FG001|STARTED|Overall Study||39||
48783470|NCT00807560|102259775|FG000|COMPLETED|Overall Study||38||
48783471|NCT00807560|102259776|FG001|COMPLETED|Overall Study||39||
48783472|NCT00807560|102259775|FG000|NOT COMPLETED|Overall Study||0||
48783473|NCT00807560|102259776|FG001|NOT COMPLETED|Overall Study||0||
48783474|NCT02929407|102259777|FG000|STARTED|Overall Study||4||
48783475|NCT02929407|102259777|FG000|COMPLETED|Overall Study||3||
48783476|NCT02929407|102259777|FG000|NOT COMPLETED|Overall Study||1||
48783477|NCT00337675|102259778|FG000|STARTED|Overall Study||589||
48783478|NCT00337675|102259779|FG001|STARTED|Overall Study||591||
48783479|NCT00337675|102259780|FG002|STARTED|Overall Study||591||
48783480|NCT00337675|102259778|FG000|COMPLETED|Overall Study||492||
48783481|NCT00337675|102259779|FG001|COMPLETED|Overall Study||488||
48783482|NCT00337675|102259780|FG002|COMPLETED|Overall Study||492||
48783483|NCT00337675|102259778|FG000|NOT COMPLETED|Overall Study||97||
48783484|NCT00337675|102259779|FG001|NOT COMPLETED|Overall Study||103||
48783485|NCT00337675|102259780|FG002|NOT COMPLETED|Overall Study||99||
48783486|NCT04202419|102259781|FG000|STARTED|Overall Study||30||
48783487|NCT04202419|102259781|FG000|COMPLETED|Overall Study||20||
48783488|NCT04202419|102259781|FG000|NOT COMPLETED|Overall Study||10||
48783489|NCT00280384|102259782|FG000|STARTED|Overall Study||6||
48783490|NCT00280384|102259783|FG001|STARTED|Overall Study||6||
48783491|NCT00280384|102259784|FG002|STARTED|Overall Study||6||
48783492|NCT00280384|102259785|FG003|STARTED|Overall Study||6||
48783493|NCT00280384|102259786|FG004|STARTED|Overall Study||6||
48783494|NCT00280384|102259787|FG005|STARTED|Overall Study||6||
48783495|NCT00280384|102259788|FG006|STARTED|Overall Study||6||
48783496|NCT00280384|102259789|FG007|STARTED|Overall Study||6||
48783497|NCT00280384|102259782|FG000|COMPLETED|Overall Study||6||
48783498|NCT00280384|102259783|FG001|COMPLETED|Overall Study||6||
48783499|NCT00280384|102259784|FG002|COMPLETED|Overall Study||6||
48783500|NCT00280384|102259785|FG003|COMPLETED|Overall Study||6||
48783501|NCT00280384|102259786|FG004|COMPLETED|Overall Study||6||
48466708|NCT01475474|101476931|FG000|STARTED|Baseline Period - 4 Weeks||97||
48466709|NCT01475474|101476931|FG000|COMPLETED|Baseline Period - 4 Weeks||91||
48466710|NCT01475474|101476931|FG000|NOT COMPLETED|Baseline Period - 4 Weeks||6||
48783502|NCT00280384|102259787|FG005|COMPLETED|Overall Study||6||
48783503|NCT00280384|102259788|FG006|COMPLETED|Overall Study||6||
48783504|NCT00280384|102259789|FG007|COMPLETED|Overall Study||6||
48783505|NCT00280384|102259782|FG000|NOT COMPLETED|Overall Study||0||
48783506|NCT00280384|102259783|FG001|NOT COMPLETED|Overall Study||0||
48783507|NCT00280384|102259784|FG002|NOT COMPLETED|Overall Study||0||
48783508|NCT00280384|102259785|FG003|NOT COMPLETED|Overall Study||0||
48783509|NCT00280384|102259786|FG004|NOT COMPLETED|Overall Study||0||
48783510|NCT00280384|102259787|FG005|NOT COMPLETED|Overall Study||0||
48783511|NCT00280384|102259788|FG006|NOT COMPLETED|Overall Study||0||
48783512|NCT00280384|102259789|FG007|NOT COMPLETED|Overall Study||0||
48783513|NCT01363349|102259790|FG000|STARTED|Overall Study||133||
48783514|NCT01363349|102259791|FG001|STARTED|Overall Study||136||
48783515|NCT01363349|102259790|FG000|Randomized|Overall Study||133||
48783516|NCT01363349|102259791|FG001|Randomized|Overall Study||136||
48783517|NCT01363349|102259790|FG000|COMPLETED|Overall Study||66||
48466711|NCT01475474|101476931|FG000|STARTED|Treatment Period - 12 Weeks||91||
48466712|NCT01475474|101476931|FG000|COMPLETED|Treatment Period - 12 Weeks||73||
48466713|NCT01475474|101476931|FG000|NOT COMPLETED|Treatment Period - 12 Weeks||18||
48783518|NCT01363349|102259791|FG001|COMPLETED|Overall Study||66||
48783519|NCT01363349|102259790|FG000|NOT COMPLETED|Overall Study||67||
48783520|NCT01363349|102259791|FG001|NOT COMPLETED|Overall Study||70||
48783521|NCT00246740|102259792|FG000|STARTED|Initial Enrollment||28||
48783522|NCT00246740|102259793|FG001|STARTED|Initial Enrollment||28||
48783523|NCT00246740|102259792|FG000|COMPLETED|Initial Enrollment||22||
48783524|NCT00246740|102259793|FG001|COMPLETED|Initial Enrollment||20||
48783525|NCT00246740|102259792|FG000|NOT COMPLETED|Initial Enrollment||6||
48783526|NCT00246740|102259793|FG001|NOT COMPLETED|Initial Enrollment||8||
48783527|NCT00246740|102259792|FG000|STARTED|Experimental Phase||22||
48783528|NCT00246740|102259793|FG001|STARTED|Experimental Phase||20||
48783529|NCT00246740|102259792|FG000|COMPLETED|Experimental Phase||22||
48783530|NCT00246740|102259793|FG001|COMPLETED|Experimental Phase||20||
48783531|NCT00246740|102259792|FG000|NOT COMPLETED|Experimental Phase||0||
48466714|NCT01475474|101476931|FG000|STARTED|Return to Baseline Period - 4 Weeks||73||
48466715|NCT01475474|101476931|FG000|COMPLETED|Return to Baseline Period - 4 Weeks||71||
48466716|NCT01475474|101476931|FG000|NOT COMPLETED|Return to Baseline Period - 4 Weeks||2||
48466717|NCT01829464|101476932|FG000|STARTED|Overall Study||30||
48466718|NCT01829464|101476933|FG001|STARTED|Overall Study||31||
48466719|NCT01829464|101476934|FG002|STARTED|Overall Study||29||
48466720|NCT01829464|101476932|FG000|COMPLETED|Overall Study||2||
48466721|NCT01829464|101476933|FG001|COMPLETED|Overall Study||2||
48466722|NCT01829464|101476934|FG002|COMPLETED|Overall Study||3||
48466723|NCT01829464|101476932|FG000|NOT COMPLETED|Overall Study||28||
48466724|NCT01829464|101476933|FG001|NOT COMPLETED|Overall Study||29||
48466725|NCT01829464|101476934|FG002|NOT COMPLETED|Overall Study||26||
48466726|NCT01003886|101476935|FG000|STARTED|Overall Study||989||
48466727|NCT01003886|101476935|FG000|COMPLETED|Overall Study||759||
48466728|NCT01003886|101476935|FG000|NOT COMPLETED|Overall Study||230||
48466729|NCT03036579|101476936|FG000|STARTED|Baseline||41||50
48466730|NCT03036579|101476937|FG001|STARTED|Baseline||32||50
48466731|NCT03036579|101476936|FG000|COMPLETED|Baseline||41||50
48466732|NCT03036579|101476937|FG001|COMPLETED|Baseline||32||50
48466733|NCT03036579|101476936|FG000|NOT COMPLETED|Baseline||0||0
48466734|NCT03036579|101476937|FG001|NOT COMPLETED|Baseline||0||0
48466735|NCT03036579|101476936|FG000|STARTED|6 Months||41||50
48466736|NCT03036579|101476937|FG001|STARTED|6 Months||32||50
48466737|NCT03036579|101476936|FG000|COMPLETED|6 Months||41||50
48466738|NCT03036579|101476937|FG001|COMPLETED|6 Months||32||50
48466739|NCT03036579|101476936|FG000|NOT COMPLETED|6 Months||0||0
48466740|NCT03036579|101476937|FG001|NOT COMPLETED|6 Months||0||0
48466741|NCT03036579|101476936|FG000|STARTED|1 Year||41||50
48466742|NCT03036579|101476937|FG001|STARTED|1 Year||32||50
48466743|NCT03036579|101476936|FG000|COMPLETED|1 Year||41||50
48466744|NCT03036579|101476937|FG001|COMPLETED|1 Year||32||50
48466745|NCT03036579|101476936|FG000|NOT COMPLETED|1 Year||0||0
48783532|NCT00246740|102259793|FG001|NOT COMPLETED|Experimental Phase||0||
48783533|NCT02273596|102259794|FG000|STARTED|24-Week Treatment Period||29||
48783534|NCT02273596|102259794|FG000|Received at Least 1 Dose of Study Drug|24-Week Treatment Period||28|One participant was enrolled but not treated|
48783535|NCT02273596|102259794|FG000|COMPLETED|24-Week Treatment Period||22||
48783536|NCT02273596|102259794|FG000|NOT COMPLETED|24-Week Treatment Period||7||
48783537|NCT02273596|102259794|FG000|STARTED|Extension Period||22||
48783538|NCT02273596|102259794|FG000|Received at Least 1 Dose of Study Drug|Extension Period||22||
48783539|NCT02273596|102259794|FG000|COMPLETED|Extension Period||0|19 participants who completed the 24-week treatment period were considered to have discontinued Study WTX101-201 to enter Study WTX101-301 (NCT03403205)|
48783540|NCT02273596|102259794|FG000|NOT COMPLETED|Extension Period||22||
48783541|NCT03595228|102259795|FG000|STARTED|Overall Study||29||
48783542|NCT03595228|102259795|FG000|COMPLETED|Overall Study||10||
48783543|NCT03595228|102259795|FG000|NOT COMPLETED|Overall Study||19||
48783544|NCT04497038|102259796|FG000|STARTED|Overall Study||3||
48783545|NCT04497038|102259796|FG000|COMPLETED|Overall Study||3||
48466746|NCT03036579|101476937|FG001|NOT COMPLETED|1 Year||0||0
48466747|NCT03036579|101476936|FG000|STARTED|2 Years||41||50
48466748|NCT03036579|101476937|FG001|STARTED|2 Years||32||50
48466749|NCT03036579|101476936|FG000|COMPLETED|2 Years||40||49
48466750|NCT03036579|101476937|FG001|COMPLETED|2 Years||32||50
48466751|NCT03036579|101476936|FG000|NOT COMPLETED|2 Years||1||1
48466752|NCT03036579|101476937|FG001|NOT COMPLETED|2 Years||0||0
48783546|NCT04497038|102259796|FG000|NOT COMPLETED|Overall Study||0||
48783547|NCT00791817|102259797|FG000|STARTED|1: Single Dose Followed by Week Washout||5||
48783548|NCT00791817|102259798|FG001|STARTED|1: Single Dose Followed by Week Washout||5||
48783549|NCT00791817|102259797|FG000|COMPLETED|1: Single Dose Followed by Week Washout||5||
48783550|NCT00791817|102259798|FG001|COMPLETED|1: Single Dose Followed by Week Washout||5||
48783551|NCT00791817|102259797|FG000|NOT COMPLETED|1: Single Dose Followed by Week Washout||0||
48783552|NCT00791817|102259798|FG001|NOT COMPLETED|1: Single Dose Followed by Week Washout||0||
48783553|NCT00791817|102259797|FG000|STARTED|2: Single Dose||5||
48783554|NCT00791817|102259798|FG001|STARTED|2: Single Dose||5||
48783555|NCT00791817|102259797|FG000|COMPLETED|2: Single Dose||5||
48783556|NCT00791817|102259798|FG001|COMPLETED|2: Single Dose||5||
48783557|NCT00791817|102259797|FG000|NOT COMPLETED|2: Single Dose||0||
48783558|NCT00791817|102259798|FG001|NOT COMPLETED|2: Single Dose||0||
48783559|NCT02036970|102259799|FG000|STARTED|Part 1: Day 1 Through Week 16||6||
48783560|NCT02036970|102259800|FG001|STARTED|Part 1: Day 1 Through Week 16||12||
48783561|NCT02036970|102259801|FG002|STARTED|Part 1: Day 1 Through Week 16||11||
48783562|NCT02036970|102259802|FG003|STARTED|Part 1: Day 1 Through Week 16||12||
48783563|NCT02036970|102259803|FG004|STARTED|Part 1: Day 1 Through Week 16||2||
48783564|NCT02036970|102259804|FG005|STARTED|Part 1: Day 1 Through Week 16||4||
48783565|NCT02036970|102259805|FG006|STARTED|Part 1: Day 1 Through Week 16||3||
48783566|NCT02036970|102259806|FG007|STARTED|Part 1: Day 1 Through Week 16||4||
48783567|NCT02036970|102259807|FG008|STARTED|Part 1: Day 1 Through Week 16||74||
48783568|NCT02036970|102259808|FG009|STARTED|Part 1: Day 1 Through Week 16||38||
48783569|NCT02036970|102259799|FG000|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||6||
48783570|NCT02036970|102259800|FG001|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||6||
48783571|NCT02036970|102259801|FG002|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||11||
48783572|NCT02036970|102259802|FG003|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||6||
48466753|NCT03036579|101476936|FG000|STARTED|3 Years||41||50
48783573|NCT02036970|102259803|FG004|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||2||
48783574|NCT02036970|102259804|FG005|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||2||
48783575|NCT02036970|102259805|FG006|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||3||
48783576|NCT02036970|102259806|FG007|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||2||
48783577|NCT02036970|102259807|FG008|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||0||
48783578|NCT02036970|102259808|FG009|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||0||
48783579|NCT02036970|102259799|FG000|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0||
48783580|NCT02036970|102259800|FG001|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||6||
48783581|NCT02036970|102259801|FG002|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0||
48783582|NCT02036970|102259802|FG003|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||6||
48783583|NCT02036970|102259803|FG004|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0||
48783584|NCT02036970|102259804|FG005|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||2||
48783585|NCT02036970|102259805|FG006|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0||
48783586|NCT02036970|102259806|FG007|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||2||
48783587|NCT02036970|102259807|FG008|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0||
48783588|NCT02036970|102259808|FG009|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0||
48783589|NCT02036970|102259799|FG000|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0||
48783590|NCT02036970|102259800|FG001|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0||
48783591|NCT02036970|102259801|FG002|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0||
48783592|NCT02036970|102259802|FG003|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0||
48783593|NCT02036970|102259803|FG004|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0||
48783594|NCT02036970|102259804|FG005|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0||
48783595|NCT02036970|102259805|FG006|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0||
48783596|NCT02036970|102259806|FG007|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0||
48783597|NCT02036970|102259807|FG008|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||14||
48783598|NCT02036970|102259808|FG009|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||8||
48783599|NCT02036970|102259799|FG000|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0||
48783600|NCT02036970|102259800|FG001|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0||
48783601|NCT02036970|102259801|FG002|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0||
48783602|NCT02036970|102259802|FG003|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0||
48466754|NCT03036579|101476937|FG001|STARTED|3 Years||32||50
48466755|NCT03036579|101476936|FG000|COMPLETED|3 Years||41||50
48783603|NCT02036970|102259803|FG004|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0||
48783604|NCT02036970|102259804|FG005|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0||
48783605|NCT02036970|102259805|FG006|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0||
48783606|NCT02036970|102259806|FG007|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0||
48783607|NCT02036970|102259807|FG008|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||16||
48783608|NCT02036970|102259808|FG009|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||9||
48783609|NCT02036970|102259799|FG000|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0||
48783610|NCT02036970|102259800|FG001|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0||
48783611|NCT02036970|102259801|FG002|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0||
48783612|NCT02036970|102259802|FG003|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0||
48783613|NCT02036970|102259803|FG004|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0||
48783614|NCT02036970|102259804|FG005|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0||
48783615|NCT02036970|102259805|FG006|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0||
48783616|NCT02036970|102259806|FG007|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0||
48466756|NCT03036579|101476937|FG001|COMPLETED|3 Years||31||49
48466757|NCT03036579|101476936|FG000|NOT COMPLETED|3 Years||0||0
48466758|NCT03036579|101476937|FG001|NOT COMPLETED|3 Years||1||1
48466759|NCT00268346|101476938|FG000|STARTED|Overall Study||18||
48466760|NCT00268346|101476939|FG001|STARTED|Overall Study||40||
48466761|NCT00268346|101476938|FG000|Started Treatment|Overall Study||18||
48466762|NCT00268346|101476939|FG001|Started Treatment|Overall Study||40||
48466763|NCT00268346|101476938|FG000|COMPLETED|Overall Study||18||
48466764|NCT00268346|101476939|FG001|COMPLETED|Overall Study||37||
48466765|NCT00268346|101476938|FG000|NOT COMPLETED|Overall Study||0||
48466766|NCT00268346|101476939|FG001|NOT COMPLETED|Overall Study||3||
48466767|NCT00546390|101476940|FG000|STARTED|Overall Study||27||
48466768|NCT00546390|101476941|FG001|STARTED|Overall Study||28||
48466769|NCT00546390|101476940|FG000|COMPLETED|Overall Study||27||
48783617|NCT02036970|102259807|FG008|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||17||
48783618|NCT02036970|102259808|FG009|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||8||
48783619|NCT02036970|102259799|FG000|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0||
48783620|NCT02036970|102259800|FG001|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0||
48783621|NCT02036970|102259801|FG002|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0||
48783622|NCT02036970|102259802|FG003|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0||
48783623|NCT02036970|102259803|FG004|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0||
48783624|NCT02036970|102259804|FG005|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0||
48783625|NCT02036970|102259805|FG006|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0||
48783626|NCT02036970|102259806|FG007|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0||
48783627|NCT02036970|102259807|FG008|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||6||
48783628|NCT02036970|102259808|FG009|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||2||
48783629|NCT02036970|102259799|FG000|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0||
48783630|NCT02036970|102259800|FG001|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0||
48783631|NCT02036970|102259801|FG002|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0||
48783632|NCT02036970|102259802|FG003|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0||
48783633|NCT02036970|102259803|FG004|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0||
48783634|NCT02036970|102259804|FG005|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0||
48783635|NCT02036970|102259805|FG006|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0||
48783636|NCT02036970|102259806|FG007|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0||
48783637|NCT02036970|102259807|FG008|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||4||
48783638|NCT02036970|102259808|FG009|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||1||
48783639|NCT02036970|102259799|FG000|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0||
48783640|NCT02036970|102259800|FG001|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0||
48783641|NCT02036970|102259801|FG002|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0||
48783642|NCT02036970|102259802|FG003|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0||
48466770|NCT00546390|101476941|FG001|COMPLETED|Overall Study||28||
48466771|NCT00546390|101476940|FG000|NOT COMPLETED|Overall Study||0||
48466772|NCT00546390|101476941|FG001|NOT COMPLETED|Overall Study||0||
48466773|NCT00658320|101476942|FG000|STARTED|Core Study: 12 Months||61||
48466774|NCT00658320|101476943|FG001|STARTED|Core Study: 12 Months||61||
48466775|NCT00658320|101476942|FG000|COMPLETED|Core Study: 12 Months||56||
48466776|NCT00658320|101476943|FG001|COMPLETED|Core Study: 12 Months||58||
48466777|NCT00658320|101476942|FG000|NOT COMPLETED|Core Study: 12 Months||5||
48466778|NCT00658320|101476943|FG001|NOT COMPLETED|Core Study: 12 Months||3||
48466779|NCT00658320|101476942|FG000|STARTED|Extension Study: Month 12 to Month 24||53||
48466780|NCT00658320|101476943|FG001|STARTED|Extension Study: Month 12 to Month 24||57||
48466781|NCT00658320|101476942|FG000|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50||
48466782|NCT00658320|101476943|FG001|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50||
48466783|NCT00658320|101476942|FG000|COMPLETED|Extension Study: Month 12 to Month 24||47||
48466784|NCT00658320|101476943|FG001|COMPLETED|Extension Study: Month 12 to Month 24||50||
48466785|NCT00658320|101476942|FG000|NOT COMPLETED|Extension Study: Month 12 to Month 24||6||
48466786|NCT00658320|101476943|FG001|NOT COMPLETED|Extension Study: Month 12 to Month 24||7||
48466787|NCT00658320|101476942|FG000|STARTED|Extension Study: After Month 24||44||
48783643|NCT02036970|102259803|FG004|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0||
48783644|NCT02036970|102259804|FG005|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0||
48783645|NCT02036970|102259805|FG006|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0||
48783646|NCT02036970|102259806|FG007|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0||
48466788|NCT00658320|101476943|FG001|STARTED|Extension Study: After Month 24||0||
48783647|NCT02036970|102259807|FG008|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||17||
48783648|NCT02036970|102259808|FG009|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||1||
48783649|NCT02036970|102259799|FG000|COMPLETED|Part 1: Day 1 Through Week 16||5||
48783650|NCT02036970|102259800|FG001|COMPLETED|Part 1: Day 1 Through Week 16||12||
48783651|NCT02036970|102259801|FG002|COMPLETED|Part 1: Day 1 Through Week 16||7||
48783652|NCT02036970|102259802|FG003|COMPLETED|Part 1: Day 1 Through Week 16||9||
48783653|NCT02036970|102259803|FG004|COMPLETED|Part 1: Day 1 Through Week 16||1||
48783654|NCT02036970|102259804|FG005|COMPLETED|Part 1: Day 1 Through Week 16||3||
48783655|NCT02036970|102259805|FG006|COMPLETED|Part 1: Day 1 Through Week 16||3||
48783656|NCT02036970|102259806|FG007|COMPLETED|Part 1: Day 1 Through Week 16||3||
48783657|NCT02036970|102259807|FG008|COMPLETED|Part 1: Day 1 Through Week 16||66||
48783658|NCT02036970|102259808|FG009|COMPLETED|Part 1: Day 1 Through Week 16||33||
48783659|NCT02036970|102259799|FG000|NOT COMPLETED|Part 1: Day 1 Through Week 16||1||
48783660|NCT02036970|102259800|FG001|NOT COMPLETED|Part 1: Day 1 Through Week 16||0||
48783661|NCT02036970|102259801|FG002|NOT COMPLETED|Part 1: Day 1 Through Week 16||4||
48783662|NCT02036970|102259802|FG003|NOT COMPLETED|Part 1: Day 1 Through Week 16||3||
48783663|NCT02036970|102259803|FG004|NOT COMPLETED|Part 1: Day 1 Through Week 16||1||
48783664|NCT02036970|102259804|FG005|NOT COMPLETED|Part 1: Day 1 Through Week 16||1||
48783665|NCT02036970|102259805|FG006|NOT COMPLETED|Part 1: Day 1 Through Week 16||0||
48783666|NCT02036970|102259806|FG007|NOT COMPLETED|Part 1: Day 1 Through Week 16||1||
48783667|NCT02036970|102259807|FG008|NOT COMPLETED|Part 1: Day 1 Through Week 16||8||
48783668|NCT02036970|102259808|FG009|NOT COMPLETED|Part 1: Day 1 Through Week 16||5||
48783669|NCT02036970|102259799|FG000|STARTED|Part 2: Week 16 Onwards||5||
48783670|NCT02036970|102259800|FG001|STARTED|Part 2: Week 16 Onwards||11||
48783671|NCT02036970|102259801|FG002|STARTED|Part 2: Week 16 Onwards||6||
48783672|NCT02036970|102259802|FG003|STARTED|Part 2: Week 16 Onwards||9||
48783673|NCT02036970|102259803|FG004|STARTED|Part 2: Week 16 Onwards||1||
48783674|NCT02036970|102259804|FG005|STARTED|Part 2: Week 16 Onwards||3||
48783675|NCT02036970|102259805|FG006|STARTED|Part 2: Week 16 Onwards||3||
48783676|NCT02036970|102259806|FG007|STARTED|Part 2: Week 16 Onwards||3||
48783677|NCT02036970|102259807|FG008|STARTED|Part 2: Week 16 Onwards||63||
48783678|NCT02036970|102259808|FG009|STARTED|Part 2: Week 16 Onwards||33||
48665760|NCT02921256|101967412|FG002|NOT COMPLETED|Arm 1a v. Arm II||0||
48665761|NCT02921256|101967410|FG000|STARTED|Arm Ib v Arm III||95||
48665762|NCT02921256|101967411|FG001|STARTED|Arm Ib v Arm III||0||
48665763|NCT02921256|101967412|FG002|STARTED|Arm Ib v Arm III||90||
48665764|NCT02921256|101967410|FG000|COMPLETED|Arm Ib v Arm III||71||
48665765|NCT02921256|101967411|FG001|COMPLETED|Arm Ib v Arm III||0||
48665766|NCT02921256|101967412|FG002|COMPLETED|Arm Ib v Arm III||75||
48665767|NCT02921256|101967410|FG000|NOT COMPLETED|Arm Ib v Arm III||24||
48665768|NCT02921256|101967411|FG001|NOT COMPLETED|Arm Ib v Arm III||0||
48665769|NCT02921256|101967412|FG002|NOT COMPLETED|Arm Ib v Arm III||15||
48665770|NCT03078868|101967413|FG000|STARTED|Overall Study||3||
48665771|NCT03078868|101967413|FG000|COMPLETED|Overall Study||0||
48665772|NCT03078868|101967413|FG000|NOT COMPLETED|Overall Study||3||
48665773|NCT00835549|101967414|FG000|STARTED|First Intervention||16||
48665774|NCT00835549|101967415|FG001|STARTED|First Intervention||16||
48665775|NCT00835549|101967414|FG000|COMPLETED|First Intervention||16||
48665776|NCT00835549|101967415|FG001|COMPLETED|First Intervention||16||
48665777|NCT00835549|101967414|FG000|NOT COMPLETED|First Intervention||0||
48665778|NCT00835549|101967415|FG001|NOT COMPLETED|First Intervention||0||
48665779|NCT00835549|101967414|FG000|STARTED|Washout of 7 Days||16||
48665780|NCT00835549|101967415|FG001|STARTED|Washout of 7 Days||16||
48665781|NCT00835549|101967414|FG000|COMPLETED|Washout of 7 Days||14||
48665782|NCT00835549|101967415|FG001|COMPLETED|Washout of 7 Days||16||
48665783|NCT00835549|101967414|FG000|NOT COMPLETED|Washout of 7 Days||2||
48665784|NCT00835549|101967415|FG001|NOT COMPLETED|Washout of 7 Days||0||
48665785|NCT00835549|101967414|FG000|STARTED|Second Intervention||14||
48665786|NCT00835549|101967415|FG001|STARTED|Second Intervention||16||
48665787|NCT00835549|101967414|FG000|COMPLETED|Second Intervention||14||
48665788|NCT00835549|101967415|FG001|COMPLETED|Second Intervention||16||
48665789|NCT00835549|101967414|FG000|NOT COMPLETED|Second Intervention||0||
48665790|NCT00835549|101967415|FG001|NOT COMPLETED|Second Intervention||0||
48466789|NCT00658320|101476942|FG000|COMPLETED|Extension Study: After Month 24||42||
48466790|NCT00658320|101476943|FG001|COMPLETED|Extension Study: After Month 24||0||
48466791|NCT00658320|101476942|FG000|NOT COMPLETED|Extension Study: After Month 24||2||
48466792|NCT00658320|101476943|FG001|NOT COMPLETED|Extension Study: After Month 24||0||
48466793|NCT01325207|101480818|FG000|STARTED|Completed 4 Weeks/1 Cycle of Treatment||3||
48466794|NCT01325207|101480819|FG001|STARTED|Completed 4 Weeks/1 Cycle of Treatment||3||
48466795|NCT01325207|101480820|FG002|STARTED|Completed 4 Weeks/1 Cycle of Treatment||1||
48466796|NCT01325207|101480821|FG003|STARTED|Completed 4 Weeks/1 Cycle of Treatment||1||
48466797|NCT01325207|101480822|FG004|STARTED|Completed 4 Weeks/1 Cycle of Treatment||7||
48466798|NCT01325207|101480823|FG005|STARTED|Completed 4 Weeks/1 Cycle of Treatment||19||
48466799|NCT01325207|101480818|FG000|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||3||
48466800|NCT01325207|101480819|FG001|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||3||
48783679|NCT02036970|102259799|FG000|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||5||
48783680|NCT02036970|102259800|FG001|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||5||
48783681|NCT02036970|102259801|FG002|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||6||
48783682|NCT02036970|102259802|FG003|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||5||
48783683|NCT02036970|102259803|FG004|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||1||
48783684|NCT02036970|102259804|FG005|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||1||
48783685|NCT02036970|102259805|FG006|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||3||
48783686|NCT02036970|102259806|FG007|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||2||
48783687|NCT02036970|102259807|FG008|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||0||
48783688|NCT02036970|102259808|FG009|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||0||
48783689|NCT02036970|102259799|FG000|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0||
48783690|NCT02036970|102259800|FG001|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||6||
48783691|NCT02036970|102259801|FG002|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0||
48783692|NCT02036970|102259802|FG003|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||4||
48783693|NCT02036970|102259803|FG004|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0||
48783694|NCT02036970|102259804|FG005|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||2||
48783695|NCT02036970|102259805|FG006|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0||
48783696|NCT02036970|102259806|FG007|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||1||
48783697|NCT02036970|102259807|FG008|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0||
48783698|NCT02036970|102259808|FG009|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0||
48783699|NCT02036970|102259799|FG000|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0||
48783700|NCT02036970|102259800|FG001|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0||
48783701|NCT02036970|102259801|FG002|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0||
48783702|NCT02036970|102259802|FG003|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0||
48783703|NCT02036970|102259803|FG004|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0||
48783704|NCT02036970|102259804|FG005|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0||
48783705|NCT02036970|102259805|FG006|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0||
48783706|NCT02036970|102259806|FG007|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0||
48783707|NCT02036970|102259807|FG008|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||12||
48783708|NCT02036970|102259808|FG009|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||8||
48783709|NCT02036970|102259799|FG000|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0||
48783710|NCT02036970|102259800|FG001|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0||
48783711|NCT02036970|102259801|FG002|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0||
48783712|NCT02036970|102259802|FG003|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0||
48466801|NCT01325207|101480820|FG002|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||1||
48466802|NCT01325207|101480821|FG003|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||1||
48783713|NCT02036970|102259803|FG004|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0||
48783714|NCT02036970|102259804|FG005|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0||
48783715|NCT02036970|102259805|FG006|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0||
48783716|NCT02036970|102259806|FG007|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0||
48783717|NCT02036970|102259807|FG008|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||12||
48783718|NCT02036970|102259808|FG009|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||7||
48783719|NCT02036970|102259799|FG000|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0||
48783720|NCT02036970|102259800|FG001|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0||
48783721|NCT02036970|102259801|FG002|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0||
48783722|NCT02036970|102259802|FG003|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0||
48466803|NCT01325207|101480822|FG004|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||5||
48466804|NCT01325207|101480823|FG005|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||19||
48466805|NCT01325207|101480818|FG000|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0||
48466806|NCT01325207|101480819|FG001|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0||
48466807|NCT01325207|101480820|FG002|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0||
48466808|NCT01325207|101480821|FG003|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0||
48466809|NCT01325207|101480822|FG004|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||2||
48466810|NCT01325207|101480823|FG005|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0||
48466811|NCT01325207|101480818|FG000|STARTED|Completed 8 Weeks/2 Cycles of Treatment||3||
48466812|NCT01325207|101480819|FG001|STARTED|Completed 8 Weeks/2 Cycles of Treatment||3||
48466813|NCT01325207|101480820|FG002|STARTED|Completed 8 Weeks/2 Cycles of Treatment||1||
48466814|NCT01325207|101480821|FG003|STARTED|Completed 8 Weeks/2 Cycles of Treatment||1||
48466815|NCT01325207|101480822|FG004|STARTED|Completed 8 Weeks/2 Cycles of Treatment||5||
48466816|NCT01325207|101480823|FG005|STARTED|Completed 8 Weeks/2 Cycles of Treatment||19||
48466817|NCT01325207|101480818|FG000|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2||
48466818|NCT01325207|101480819|FG001|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2||
48466819|NCT01325207|101480820|FG002|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1||
48466820|NCT01325207|101480821|FG003|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1||
48466821|NCT01325207|101480822|FG004|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||3||
48466822|NCT01325207|101480823|FG005|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||14||
48466823|NCT01325207|101480818|FG000|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1||
48466824|NCT01325207|101480819|FG001|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1||
48466825|NCT01325207|101480820|FG002|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||0||
48783723|NCT02036970|102259803|FG004|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0||
48783724|NCT02036970|102259804|FG005|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0||
48783725|NCT02036970|102259805|FG006|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0||
48783726|NCT02036970|102259806|FG007|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0||
48783727|NCT02036970|102259807|FG008|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||16||
48783728|NCT02036970|102259808|FG009|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||7||
48783729|NCT02036970|102259799|FG000|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0||
48783730|NCT02036970|102259800|FG001|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0||
48783731|NCT02036970|102259801|FG002|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0||
48783732|NCT02036970|102259802|FG003|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0||
48783733|NCT02036970|102259803|FG004|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0||
48783734|NCT02036970|102259804|FG005|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0||
48783735|NCT02036970|102259805|FG006|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0||
48783736|NCT02036970|102259806|FG007|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0||
48783737|NCT02036970|102259807|FG008|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||5||
48783738|NCT02036970|102259808|FG009|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||2||
48783739|NCT02036970|102259799|FG000|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0||
48783740|NCT02036970|102259800|FG001|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0||
48783741|NCT02036970|102259801|FG002|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0||
48783742|NCT02036970|102259802|FG003|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0||
48783743|NCT02036970|102259803|FG004|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0||
48783744|NCT02036970|102259804|FG005|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0||
48783745|NCT02036970|102259805|FG006|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0||
48783746|NCT02036970|102259806|FG007|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0||
48783747|NCT02036970|102259807|FG008|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||3||
48783748|NCT02036970|102259808|FG009|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||1||
48466826|NCT01325207|101480821|FG003|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||0||
48466827|NCT01325207|101480822|FG004|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2||
48466828|NCT01325207|101480823|FG005|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||5||
48466829|NCT01325207|101480818|FG000|STARTED|Started 9th Week/Cycle 3 of Treatment||2||
48466830|NCT01325207|101480819|FG001|STARTED|Started 9th Week/Cycle 3 of Treatment||2||
48466831|NCT01325207|101480820|FG002|STARTED|Started 9th Week/Cycle 3 of Treatment||1||
48466832|NCT01325207|101480821|FG003|STARTED|Started 9th Week/Cycle 3 of Treatment||1||
48466833|NCT01325207|101480822|FG004|STARTED|Started 9th Week/Cycle 3 of Treatment||3||
48466834|NCT01325207|101480823|FG005|STARTED|Started 9th Week/Cycle 3 of Treatment||14||
48466835|NCT01325207|101480818|FG000|COMPLETED|Started 9th Week/Cycle 3 of Treatment||1||
48466836|NCT01325207|101480819|FG001|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0||
48466837|NCT01325207|101480820|FG002|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0||
48466838|NCT01325207|101480821|FG003|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0||
48783749|NCT02036970|102259799|FG000|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0||
48783750|NCT02036970|102259800|FG001|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0||
48783751|NCT02036970|102259801|FG002|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0||
48783752|NCT02036970|102259802|FG003|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0||
48783753|NCT02036970|102259803|FG004|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0||
48783754|NCT02036970|102259804|FG005|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0||
48783755|NCT02036970|102259805|FG006|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0||
48783756|NCT02036970|102259806|FG007|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0||
48783757|NCT02036970|102259807|FG008|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||15||
48783758|NCT02036970|102259808|FG009|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||8||
48783759|NCT02036970|102259799|FG000|COMPLETED|Part 2: Week 16 Onwards||5||
48783760|NCT02036970|102259800|FG001|COMPLETED|Part 2: Week 16 Onwards||6||
48783761|NCT02036970|102259801|FG002|COMPLETED|Part 2: Week 16 Onwards||3||
48783762|NCT02036970|102259802|FG003|COMPLETED|Part 2: Week 16 Onwards||7||
48783763|NCT02036970|102259803|FG004|COMPLETED|Part 2: Week 16 Onwards||0||
48783764|NCT02036970|102259804|FG005|COMPLETED|Part 2: Week 16 Onwards||3||
48783765|NCT02036970|102259805|FG006|COMPLETED|Part 2: Week 16 Onwards||2||
48783766|NCT02036970|102259806|FG007|COMPLETED|Part 2: Week 16 Onwards||2||
48783767|NCT02036970|102259807|FG008|COMPLETED|Part 2: Week 16 Onwards||54||
48783768|NCT02036970|102259808|FG009|COMPLETED|Part 2: Week 16 Onwards||28||
48783769|NCT02036970|102259799|FG000|NOT COMPLETED|Part 2: Week 16 Onwards||0||
48783770|NCT02036970|102259800|FG001|NOT COMPLETED|Part 2: Week 16 Onwards||5||
48783771|NCT02036970|102259801|FG002|NOT COMPLETED|Part 2: Week 16 Onwards||3||
48783772|NCT02036970|102259802|FG003|NOT COMPLETED|Part 2: Week 16 Onwards||2||
48783773|NCT02036970|102259803|FG004|NOT COMPLETED|Part 2: Week 16 Onwards||1||
48783774|NCT02036970|102259804|FG005|NOT COMPLETED|Part 2: Week 16 Onwards||0||
48783775|NCT02036970|102259805|FG006|NOT COMPLETED|Part 2: Week 16 Onwards||1||
48783776|NCT02036970|102259806|FG007|NOT COMPLETED|Part 2: Week 16 Onwards||1||
48783777|NCT02036970|102259807|FG008|NOT COMPLETED|Part 2: Week 16 Onwards||9||
48783778|NCT02036970|102259808|FG009|NOT COMPLETED|Part 2: Week 16 Onwards||5||
48783779|NCT02160899|102259809|FG000|STARTED|Overall Study||26||
48783780|NCT02160899|102259810|FG001|STARTED|Overall Study||4||
48783781|NCT02160899|102259811|FG002|STARTED|Overall Study||21||
48783782|NCT02160899|102259812|FG003|STARTED|Overall Study||3||
48783783|NCT02160899|102259813|FG004|STARTED|Overall Study||2||
48783784|NCT02160899|102259814|FG005|STARTED|Overall Study||8||
48783785|NCT02160899|102259809|FG000|COMPLETED|Overall Study||26||
48783786|NCT02160899|102259810|FG001|COMPLETED|Overall Study||3||
48783787|NCT02160899|102259811|FG002|COMPLETED|Overall Study||21||
48783788|NCT02160899|102259812|FG003|COMPLETED|Overall Study||2||
48783789|NCT02160899|102259813|FG004|COMPLETED|Overall Study||0||
48783790|NCT02160899|102259814|FG005|COMPLETED|Overall Study||8||
48783791|NCT02160899|102259809|FG000|NOT COMPLETED|Overall Study||0||
48783792|NCT02160899|102259810|FG001|NOT COMPLETED|Overall Study||1||
48783793|NCT02160899|102259811|FG002|NOT COMPLETED|Overall Study||0||
48783794|NCT02160899|102259812|FG003|NOT COMPLETED|Overall Study||1||
48783795|NCT02160899|102259813|FG004|NOT COMPLETED|Overall Study||2||
48783796|NCT02160899|102259814|FG005|NOT COMPLETED|Overall Study||0||
48783797|NCT01667419|102259815|FG000|STARTED|Overall Study||157||
48783798|NCT01667419|102259816|FG001|STARTED|Overall Study||157||
48783799|NCT01667419|102259817|FG002|STARTED|Overall Study||93||
48783800|NCT01667419|102259818|FG003|STARTED|Overall Study||91||
48783801|NCT01667419|102259815|FG000|COMPLETED|Overall Study||114||
48783802|NCT01667419|102259816|FG001|COMPLETED|Overall Study||110||
48783803|NCT01667419|102259817|FG002|COMPLETED|Overall Study||57||
48783804|NCT01667419|102259818|FG003|COMPLETED|Overall Study||52||
48783805|NCT01667419|102259815|FG000|NOT COMPLETED|Overall Study||43||
48783806|NCT01667419|102259816|FG001|NOT COMPLETED|Overall Study||47||
48783807|NCT01667419|102259817|FG002|NOT COMPLETED|Overall Study||36||
48189865|NCT00350532|100786325|FG001|NOT COMPLETED|Overall Study||0||
48466839|NCT01325207|101480822|FG004|COMPLETED|Started 9th Week/Cycle 3 of Treatment||3||
48466840|NCT01325207|101480823|FG005|COMPLETED|Started 9th Week/Cycle 3 of Treatment||9||
48466841|NCT01325207|101480818|FG000|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1||
48466842|NCT01325207|101480819|FG001|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||2||
48466843|NCT01325207|101480820|FG002|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1||
48466844|NCT01325207|101480821|FG003|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1||
48783808|NCT01667419|102259818|FG003|NOT COMPLETED|Overall Study||39||
48783809|NCT02252744|102259819|FG000|STARTED|Overall Study||286||
48783810|NCT02252744|102259819|FG000|COMPLETED|Overall Study||286||
48783811|NCT02252744|102259819|FG000|NOT COMPLETED|Overall Study||0||
48783812|NCT04380519|102259820|FG000|STARTED|Overall Study||124||
48783813|NCT04380519|102259821|FG001|STARTED|Overall Study||124||
48189866|NCT02320253|100788952|FG000|STARTED|Overall Study||69||
48783814|NCT04380519|102259822|FG002|STARTED|Overall Study||124||
48783815|NCT04380519|102259820|FG000|Intent-to-Treat (ITT)|Overall Study||124||
48783816|NCT04380519|102259821|FG001|Intent-to-Treat (ITT)|Overall Study||124||
48783817|NCT04380519|102259822|FG002|Intent-to-Treat (ITT)|Overall Study||124||
48783818|NCT04380519|102259820|FG000|Modified Intent-to-Treat (mITT)|Overall Study||115||
48783819|NCT04380519|102259821|FG001|Modified Intent-to-Treat (mITT)|Overall Study||119||
48783820|NCT04380519|102259822|FG002|Modified Intent-to-Treat (mITT)|Overall Study||118||
48783821|NCT04380519|102259820|FG000|Safety Population|Overall Study||123||
48783822|NCT04380519|102259821|FG001|Safety Population|Overall Study||124||
48783823|NCT04380519|102259822|FG002|Safety Population|Overall Study||124||
48783824|NCT04380519|102259820|FG000|COMPLETED|Overall Study||106||
48783825|NCT04380519|102259821|FG001|COMPLETED|Overall Study||113||
48783826|NCT04380519|102259822|FG002|COMPLETED|Overall Study||117||
48783827|NCT04380519|102259820|FG000|NOT COMPLETED|Overall Study||18||
48783828|NCT04380519|102259821|FG001|NOT COMPLETED|Overall Study||11||
48783829|NCT04380519|102259822|FG002|NOT COMPLETED|Overall Study||7||
48783830|NCT01808092|102259823|FG000|STARTED|Overall Study||409||
48783831|NCT01808092|102259824|FG001|STARTED|Overall Study||408||
48783832|NCT01808092|102259823|FG000|COMPLETED|Overall Study||355||
48783833|NCT01808092|102259824|FG001|COMPLETED|Overall Study||363||
48783834|NCT01808092|102259823|FG000|NOT COMPLETED|Overall Study||54||
48783835|NCT01808092|102259824|FG001|NOT COMPLETED|Overall Study||45||
48783836|NCT00597597|102259825|FG000|STARTED|Overall Study||11||
48783837|NCT00597597|102259825|FG000|COMPLETED|Overall Study||11||
48783838|NCT00597597|102259825|FG000|NOT COMPLETED|Overall Study||0||
48783839|NCT01485172|102259826|FG000|STARTED|Overall Study||40||
48783840|NCT01485172|102259827|FG001|STARTED|Overall Study||13||
48783841|NCT01485172|102259828|FG002|STARTED|Overall Study||41||
48783842|NCT01485172|102259829|FG003|STARTED|Overall Study||40||
48783843|NCT01485172|102259830|FG004|STARTED|Overall Study||39||
48783844|NCT01485172|102259831|FG005|STARTED|Overall Study||13||
48783845|NCT01485172|102259826|FG000|COMPLETED|Overall Study||33||
48783846|NCT01485172|102259827|FG001|COMPLETED|Overall Study||12||
48783847|NCT01485172|102259828|FG002|COMPLETED|Overall Study||34||
48783848|NCT01485172|102259829|FG003|COMPLETED|Overall Study||32||
48783849|NCT01485172|102259830|FG004|COMPLETED|Overall Study||34||
48783850|NCT01485172|102259831|FG005|COMPLETED|Overall Study||9||
48783851|NCT01485172|102259826|FG000|NOT COMPLETED|Overall Study||7||
48783852|NCT01485172|102259827|FG001|NOT COMPLETED|Overall Study||1||
48783853|NCT01485172|102259828|FG002|NOT COMPLETED|Overall Study||7||
48783854|NCT01485172|102259829|FG003|NOT COMPLETED|Overall Study||8||
48783855|NCT01485172|102259830|FG004|NOT COMPLETED|Overall Study||5||
48783856|NCT01485172|102259831|FG005|NOT COMPLETED|Overall Study||4||
48783857|NCT03288142|102259832|FG000|STARTED|Overall Study||166||
48783858|NCT03288142|102259833|FG001|STARTED|Overall Study||167||
48783859|NCT03288142|102259832|FG000|COMPLETED|Overall Study||144||
48783860|NCT03288142|102259833|FG001|COMPLETED|Overall Study||152||
48783861|NCT03288142|102259832|FG000|NOT COMPLETED|Overall Study||22||
48783862|NCT03288142|102259833|FG001|NOT COMPLETED|Overall Study||15||
48783863|NCT00476008|102259834|FG000|STARTED|Overall Study||22||
48783864|NCT00476008|102259835|FG001|STARTED|Overall Study||21||
48783865|NCT00476008|102259834|FG000|6 Month Testing|Overall Study||15||
48783866|NCT00476008|102259835|FG001|6 Month Testing|Overall Study||14||
48783867|NCT00476008|102259834|FG000|COMPLETED|Overall Study||13||
48466845|NCT01325207|101480822|FG004|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||0||
48783868|NCT00476008|102259835|FG001|COMPLETED|Overall Study||13||
48783869|NCT00476008|102259834|FG000|NOT COMPLETED|Overall Study||9||
48783870|NCT00476008|102259835|FG001|NOT COMPLETED|Overall Study||8||
48783871|NCT01634191|102259836|FG000|STARTED|Overall Study||18||
48783872|NCT01634191|102259837|FG001|STARTED|Overall Study||18||
48783873|NCT01634191|102259836|FG000|COMPLETED|Overall Study||18||
48783874|NCT01634191|102259837|FG001|COMPLETED|Overall Study||18||
48783875|NCT01634191|102259836|FG000|NOT COMPLETED|Overall Study||0||
48783876|NCT01634191|102259837|FG001|NOT COMPLETED|Overall Study||0||
48783877|NCT00502203|102259838|FG000|STARTED|Overall Study||23||
48783878|NCT00502203|102259838|FG000|COMPLETED|Overall Study||22||
48189867|NCT02320253|100788953|FG001|STARTED|Overall Study||70||
48783879|NCT00502203|102259838|FG000|NOT COMPLETED|Overall Study||1||
48783880|NCT03043105|102259839|FG000|STARTED|Overall Study||25||
48783881|NCT03043105|102259839|FG000|COMPLETED|Overall Study||25||
48783882|NCT03043105|102259839|FG000|NOT COMPLETED|Overall Study||0||
48783883|NCT01421472|102259840|FG000|STARTED|Overall Study||67||
48783884|NCT01421472|102259841|FG001|STARTED|Overall Study||33||
48783885|NCT01421472|102259842|FG002|STARTED|Overall Study||64||
48783886|NCT01421472|102259843|FG003|STARTED|Overall Study||32||
48783887|NCT01421472|102259840|FG000|COMPLETED|Overall Study||67||
48783888|NCT01421472|102259841|FG001|COMPLETED|Overall Study||33||
48783889|NCT01421472|102259842|FG002|COMPLETED|Overall Study||64||
48783890|NCT01421472|102259843|FG003|COMPLETED|Overall Study||32||
48783891|NCT01421472|102259840|FG000|NOT COMPLETED|Overall Study||0||
48783892|NCT01421472|102259841|FG001|NOT COMPLETED|Overall Study||0||
48783893|NCT01421472|102259842|FG002|NOT COMPLETED|Overall Study||0||
48783894|NCT01421472|102259843|FG003|NOT COMPLETED|Overall Study||0||
48783895|NCT02873429|102259844|FG000|STARTED|Baseline||109||
48783896|NCT02873429|102259845|FG001|STARTED|Baseline||100||
48783897|NCT02873429|102259844|FG000|COMPLETED|Baseline||109||
48783898|NCT02873429|102259845|FG001|COMPLETED|Baseline||100||
48783899|NCT02873429|102259844|FG000|NOT COMPLETED|Baseline||0||
48783900|NCT02873429|102259845|FG001|NOT COMPLETED|Baseline||0||
48783901|NCT02873429|102259844|FG000|STARTED|6-8 Weeks||105||
48783902|NCT02873429|102259845|FG001|STARTED|6-8 Weeks||98||
48783903|NCT02873429|102259844|FG000|COMPLETED|6-8 Weeks||95||
48783904|NCT02873429|102259845|FG001|COMPLETED|6-8 Weeks||97||
48783905|NCT02873429|102259844|FG000|NOT COMPLETED|6-8 Weeks||10||
48783906|NCT02873429|102259845|FG001|NOT COMPLETED|6-8 Weeks||1||
48783907|NCT02873429|102259844|FG000|STARTED|16 Weeks||105||
48783908|NCT02873429|102259845|FG001|STARTED|16 Weeks||98||
48783909|NCT02873429|102259844|FG000|COMPLETED|16 Weeks||100||
48783910|NCT02873429|102259845|FG001|COMPLETED|16 Weeks||96||
48783911|NCT02873429|102259844|FG000|NOT COMPLETED|16 Weeks||5||
48783912|NCT02873429|102259845|FG001|NOT COMPLETED|16 Weeks||2||
48783913|NCT00647270|102259846|FG000|STARTED|Period 1, Placebo-control (12 Weeks)||56||
48783914|NCT00647270|102259847|FG001|STARTED|Period 1, Placebo-control (12 Weeks)||159||
48783915|NCT00647270|102259848|FG002|STARTED|Period 1, Placebo-control (12 Weeks)||205||
48783916|NCT00647270|102259846|FG000|COMPLETED|Period 1, Placebo-control (12 Weeks)||48||
48783917|NCT00647270|102259847|FG001|COMPLETED|Period 1, Placebo-control (12 Weeks)||146||
48783918|NCT00647270|102259848|FG002|COMPLETED|Period 1, Placebo-control (12 Weeks)||182||
48783919|NCT00647270|102259846|FG000|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||8||
48783920|NCT00647270|102259847|FG001|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||13||
48783921|NCT00647270|102259848|FG002|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||23||
48783922|NCT00647270|102259846|FG000|STARTED|Period 2, Placebo Switched to Adalimumab||48||
48783923|NCT00647270|102259847|FG001|STARTED|Period 2, Placebo Switched to Adalimumab||146||
48783924|NCT00647270|102259848|FG002|STARTED|Period 2, Placebo Switched to Adalimumab||182||
48783925|NCT00647270|102259846|FG000|COMPLETED|Period 2, Placebo Switched to Adalimumab||45||
48783926|NCT00647270|102259847|FG001|COMPLETED|Period 2, Placebo Switched to Adalimumab||137||
48783927|NCT00647270|102259848|FG002|COMPLETED|Period 2, Placebo Switched to Adalimumab||175||
48783928|NCT00647270|102259846|FG000|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||3||
48783929|NCT00647270|102259847|FG001|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||9||
48783930|NCT00647270|102259848|FG002|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||7||
48783931|NCT01433289|102259849|FG000|STARTED|Overall Study||6||
48783932|NCT01433289|102259850|FG001|STARTED|Overall Study||6||
48783933|NCT01433289|102259851|FG002|STARTED|Overall Study||5||
48783934|NCT01433289|102259852|FG003|STARTED|Overall Study||6||
48783935|NCT01433289|102259849|FG000|COMPLETED|Overall Study||6||
48783936|NCT01433289|102259850|FG001|COMPLETED|Overall Study||5||
48783937|NCT01433289|102259851|FG002|COMPLETED|Overall Study||5||
48783938|NCT01433289|102259852|FG003|COMPLETED|Overall Study||6||
48783939|NCT01433289|102259849|FG000|NOT COMPLETED|Overall Study||0||
48783940|NCT01433289|102259850|FG001|NOT COMPLETED|Overall Study||1||
48783941|NCT01433289|102259851|FG002|NOT COMPLETED|Overall Study||0||
48783942|NCT01433289|102259852|FG003|NOT COMPLETED|Overall Study||0||
48783943|NCT01008423|102259853|FG000|STARTED|Overall Study||134||
48783944|NCT01008423|102259854|FG001|STARTED|Overall Study||147||
48783945|NCT01008423|102259853|FG000|Received at Least 1 Dose of Study Drug|Overall Study||134||
48783946|NCT01008423|102259854|FG001|Received at Least 1 Dose of Study Drug|Overall Study||147||
48783947|NCT01008423|102259853|FG000|COMPLETED|Overall Study||115||
48783948|NCT01008423|102259854|FG001|COMPLETED|Overall Study||125||
48783949|NCT01008423|102259853|FG000|NOT COMPLETED|Overall Study||19||
48783950|NCT01008423|102259854|FG001|NOT COMPLETED|Overall Study||22||
48783951|NCT00640224|102259855|FG000|STARTED|Overall Study||23||
48783952|NCT00640224|102259856|FG001|STARTED|Overall Study||23||
48783953|NCT00640224|102259857|FG002|STARTED|Overall Study||0||
48783954|NCT00640224|102259858|FG003|STARTED|Overall Study||0||
48783955|NCT00640224|102259855|FG000|COMPLETED|Overall Study||17||
48783956|NCT00640224|102259856|FG001|COMPLETED|Overall Study||20||
48783957|NCT00640224|102259857|FG002|COMPLETED|Overall Study||0||
48783958|NCT00640224|102259858|FG003|COMPLETED|Overall Study||0||
48783959|NCT00640224|102259855|FG000|NOT COMPLETED|Overall Study||6||
48783960|NCT00640224|102259856|FG001|NOT COMPLETED|Overall Study||3||
48783961|NCT00640224|102259857|FG002|NOT COMPLETED|Overall Study||0||
48783962|NCT00640224|102259858|FG003|NOT COMPLETED|Overall Study||0||
48783963|NCT00636363|102259859|FG000|STARTED|Overall Study||178||
48783964|NCT00636363|102259860|FG001|STARTED|Overall Study||176||
48783965|NCT00636363|102259861|FG002|STARTED|Overall Study||181||
48783966|NCT00636363|102259859|FG000|COMPLETED|Overall Study||165||
48783967|NCT00636363|102259860|FG001|COMPLETED|Overall Study||156||
48783968|NCT00636363|102259861|FG002|COMPLETED|Overall Study||163||
48783969|NCT00636363|102259859|FG000|NOT COMPLETED|Overall Study||13||
48783970|NCT00636363|102259860|FG001|NOT COMPLETED|Overall Study||20||
48783971|NCT00636363|102259861|FG002|NOT COMPLETED|Overall Study||18||
48783972|NCT01657461|102259862|FG000|STARTED|Overall Study||98||
48783973|NCT01657461|102259863|FG001|STARTED|Overall Study||98||
48783974|NCT01657461|102259862|FG000|COMPLETED|Overall Study||88||
48783975|NCT01657461|102259863|FG001|COMPLETED|Overall Study||78||
48783976|NCT01657461|102259862|FG000|NOT COMPLETED|Overall Study||10||
48783977|NCT01657461|102259863|FG001|NOT COMPLETED|Overall Study||20||
48783978|NCT02343549|102259864|FG000|STARTED|Overall Study||13||
48783979|NCT02343549|102259864|FG000|COMPLETED|Overall Study||0||
48783980|NCT02343549|102259864|FG000|NOT COMPLETED|Overall Study||13||
48783981|NCT01015638|102259865|FG000|STARTED|Overall Study||17||
48783982|NCT01015638|102259866|FG001|STARTED|Overall Study||19||
48783983|NCT01015638|102259865|FG000|COMPLETED|Overall Study||16||
48783984|NCT01015638|102259866|FG001|COMPLETED|Overall Study||19||
48783985|NCT01015638|102259865|FG000|NOT COMPLETED|Overall Study||1||
48783986|NCT01015638|102259866|FG001|NOT COMPLETED|Overall Study||0||
48783987|NCT01343693|102259867|FG000|STARTED|Overall Study||119||
48783988|NCT01343693|102259867|FG000|COMPLETED|Overall Study||110||
48783989|NCT01343693|102259867|FG000|NOT COMPLETED|Overall Study||9||
48783990|NCT01640834|102259868|FG000|STARTED|Overall Study||8||
48783991|NCT01640834|102259869|FG001|STARTED|Overall Study||8||
48783992|NCT01640834|102259870|FG002|STARTED|Overall Study||4||
48783993|NCT01640834|102259868|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8||
48783994|NCT01640834|102259869|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8||
48783995|NCT01640834|102259870|FG002|Received at Least 1 Dose of Study Drug|Overall Study||4||
48783996|NCT01640834|102259868|FG000|COMPLETED|Overall Study||8||
48783997|NCT01640834|102259869|FG001|COMPLETED|Overall Study||8||
48783998|NCT01640834|102259870|FG002|COMPLETED|Overall Study||4||
48783999|NCT01640834|102259868|FG000|NOT COMPLETED|Overall Study||0||
48784000|NCT01640834|102259869|FG001|NOT COMPLETED|Overall Study||0||
48784001|NCT01640834|102259870|FG002|NOT COMPLETED|Overall Study||0||
48784002|NCT01090323|102259871|FG000|STARTED|Overall Study||132||
48784003|NCT01090323|102259872|FG001|STARTED|Overall Study||53||
48784004|NCT01090323|102259871|FG000|COMPLETED|Overall Study||43||
48466846|NCT01325207|101480823|FG005|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||5||
48466847|NCT01325207|101480818|FG000|STARTED|Follow-up Every 3 Months Until Death||3|All patients treated on study went into the follow up period.|
48466848|NCT01325207|101480819|FG001|STARTED|Follow-up Every 3 Months Until Death||3|All patients treated on study went into the follow up period.|
48466849|NCT01325207|101480820|FG002|STARTED|Follow-up Every 3 Months Until Death||1|All patients treated on study went into the follow up period.|
48466850|NCT01325207|101480821|FG003|STARTED|Follow-up Every 3 Months Until Death||1|All patients treated on study went into the follow up period.|
48466851|NCT01325207|101480822|FG004|STARTED|Follow-up Every 3 Months Until Death||7|All patients treated on study went into the follow up period.|
48466852|NCT01325207|101480823|FG005|STARTED|Follow-up Every 3 Months Until Death||19|All patients treated on study went into the follow up period.|
48466853|NCT01325207|101480818|FG000|COMPLETED|Follow-up Every 3 Months Until Death||3||
48466854|NCT01325207|101480819|FG001|COMPLETED|Follow-up Every 3 Months Until Death||3||
48466855|NCT01325207|101480820|FG002|COMPLETED|Follow-up Every 3 Months Until Death||1||
48466856|NCT01325207|101480821|FG003|COMPLETED|Follow-up Every 3 Months Until Death||1||
48466857|NCT01325207|101480822|FG004|COMPLETED|Follow-up Every 3 Months Until Death||6||
48466858|NCT01325207|101480823|FG005|COMPLETED|Follow-up Every 3 Months Until Death||18||
48466859|NCT01325207|101480818|FG000|NOT COMPLETED|Follow-up Every 3 Months Until Death||0||
48466860|NCT01325207|101480819|FG001|NOT COMPLETED|Follow-up Every 3 Months Until Death||0||
48466861|NCT01325207|101480820|FG002|NOT COMPLETED|Follow-up Every 3 Months Until Death||0||
48466862|NCT01325207|101480821|FG003|NOT COMPLETED|Follow-up Every 3 Months Until Death||0||
48466863|NCT01325207|101480822|FG004|NOT COMPLETED|Follow-up Every 3 Months Until Death||1||
48665791|NCT04716725|101967416|FG000|STARTED|Overall Study||15||
48784005|NCT01090323|102259872|FG001|COMPLETED|Overall Study||19||
48784006|NCT01090323|102259871|FG000|NOT COMPLETED|Overall Study||89||
48784007|NCT01090323|102259872|FG001|NOT COMPLETED|Overall Study||34||
48784008|NCT03364270|102259873|FG000|STARTED|Overall Study||6||
48784009|NCT03364270|102259873|FG000|COMPLETED|Overall Study||6||
48784010|NCT03364270|102259873|FG000|NOT COMPLETED|Overall Study||0||
48784011|NCT01094522|102259874|FG000|STARTED|Overall Study||20||
48784012|NCT01094522|102259875|FG001|STARTED|Overall Study||20||
48784013|NCT01094522|102259874|FG000|COMPLETED|Overall Study||20||
48466864|NCT01325207|101480823|FG005|NOT COMPLETED|Follow-up Every 3 Months Until Death||1||
48466865|NCT02918162|101480824|FG000|STARTED|Overall Study||36||
48466866|NCT02918162|101480824|FG000|COMPLETED|Overall Study||34||
48466867|NCT02918162|101480824|FG000|NOT COMPLETED|Overall Study||2||
48466868|NCT02914795|101480825|FG000|STARTED|Overall Study||77||
48466869|NCT02914795|101480826|FG001|STARTED|Overall Study||22||
48466870|NCT02914795|101480825|FG000|COMPLETED|Overall Study||77||
48466871|NCT02914795|101480826|FG001|COMPLETED|Overall Study||22||
48784014|NCT01094522|102259875|FG001|COMPLETED|Overall Study||20||
48784015|NCT01094522|102259874|FG000|NOT COMPLETED|Overall Study||0||
48784016|NCT01094522|102259875|FG001|NOT COMPLETED|Overall Study||0||
48784017|NCT03615040|102259876|FG000|STARTED|Overall Study||42||
48784018|NCT03615040|102259877|FG001|STARTED|Overall Study||39||
48784019|NCT03615040|102259876|FG000|COMPLETED|Overall Study||36||
48784020|NCT03615040|102259877|FG001|COMPLETED|Overall Study||34||
48784021|NCT03615040|102259876|FG000|NOT COMPLETED|Overall Study||6||
48784022|NCT03615040|102259877|FG001|NOT COMPLETED|Overall Study||5||
48466872|NCT02914795|101480825|FG000|NOT COMPLETED|Overall Study||0||
48784023|NCT01175083|102259878|FG000|STARTED|Primary Epoch||50||
48784024|NCT01175083|102259879|FG001|STARTED|Primary Epoch||50||
48784025|NCT01175083|102259880|FG002|STARTED|Primary Epoch||50||
48784026|NCT01175083|102259881|FG003|STARTED|Primary Epoch||50||
48784027|NCT01175083|102259882|FG004|STARTED|Primary Epoch||50||
48784028|NCT01175083|102259883|FG005|STARTED|Primary Epoch||50||
48784029|NCT01175083|102259878|FG000|COMPLETED|Primary Epoch||50||
48784030|NCT01175083|102259879|FG001|COMPLETED|Primary Epoch||50||
48466873|NCT02914795|101480826|FG001|NOT COMPLETED|Overall Study||0||
48466874|NCT02339909|101480827|FG000|STARTED|Overall Study||524||
48466875|NCT02339909|101480828|FG001|STARTED|Overall Study||375||
48466876|NCT02339909|101480829|FG002|STARTED|Overall Study||375||
48466877|NCT02339909|101480827|FG000|COMPLETED|Overall Study||435||
48466878|NCT02339909|101480828|FG001|COMPLETED|Overall Study||312||
48466879|NCT02339909|101480829|FG002|COMPLETED|Overall Study||304||
48466880|NCT02339909|101480827|FG000|NOT COMPLETED|Overall Study||89||
48466881|NCT02339909|101480828|FG001|NOT COMPLETED|Overall Study||63||
48466882|NCT02339909|101480829|FG002|NOT COMPLETED|Overall Study||71||
48466883|NCT02324465|101480830|FG000|STARTED|Overall Study||18||
48466884|NCT02324465|101480831|FG001|STARTED|Overall Study||22||
48466885|NCT02324465|101480830|FG000|COMPLETED|Overall Study||18||
48466886|NCT02324465|101480831|FG001|COMPLETED|Overall Study||21||
48466887|NCT02324465|101480830|FG000|NOT COMPLETED|Overall Study||0||
48466888|NCT02324465|101480831|FG001|NOT COMPLETED|Overall Study||1||
48466889|NCT02785913|101480832|FG000|STARTED|Overall Study||26||
48466890|NCT02785913|101480832|FG000|COMPLETED|Overall Study||0||
48466891|NCT02785913|101480832|FG000|NOT COMPLETED|Overall Study||26||
48466892|NCT01430741|101480833|FG000|STARTED|Overall Study||22||
48466893|NCT01430741|101480834|FG001|STARTED|Overall Study||87||
48466894|NCT01430741|101480835|FG002|STARTED|Overall Study||47||
48466895|NCT01430741|101480836|FG003|STARTED|Overall Study||81||
48466896|NCT01430741|101480833|FG000|COMPLETED|Overall Study||22||
48466897|NCT01430741|101480834|FG001|COMPLETED|Overall Study||87||
48466898|NCT01430741|101480835|FG002|COMPLETED|Overall Study||37||
48466899|NCT01430741|101480836|FG003|COMPLETED|Overall Study||81||
48466900|NCT01430741|101480833|FG000|NOT COMPLETED|Overall Study||0||
48466901|NCT01430741|101480834|FG001|NOT COMPLETED|Overall Study||0||
48466902|NCT01430741|101480835|FG002|NOT COMPLETED|Overall Study||10||
48466903|NCT01430741|101480836|FG003|NOT COMPLETED|Overall Study||0||
48466904|NCT02806232|101480837|FG000|STARTED|Overall Study||60||
48466905|NCT02806232|101480838|FG001|STARTED|Overall Study||60||
48466906|NCT02806232|101480839|FG002|STARTED|Overall Study||60||
48466907|NCT02806232|101480840|FG003|STARTED|Overall Study||60||
48466908|NCT02806232|101480841|FG004|STARTED|Overall Study||60||
48466909|NCT02806232|101480842|FG005|STARTED|Overall Study||60||
48466910|NCT02806232|101480843|FG006|STARTED|Overall Study||60||
48784031|NCT01175083|102259880|FG002|COMPLETED|Primary Epoch||50||
48784032|NCT01175083|102259881|FG003|COMPLETED|Primary Epoch||50||
48784033|NCT01175083|102259882|FG004|COMPLETED|Primary Epoch||50||
48784034|NCT01175083|102259883|FG005|COMPLETED|Primary Epoch||47||
48466911|NCT02806232|101480844|FG007|STARTED|Overall Study||20||
48466912|NCT02806232|101480845|FG008|STARTED|Overall Study||4||
48466913|NCT02806232|101480837|FG000|COMPLETED|Overall Study||59||
48466914|NCT02806232|101480838|FG001|COMPLETED|Overall Study||56||
48466915|NCT02806232|101480839|FG002|COMPLETED|Overall Study||59||
48466916|NCT02806232|101480840|FG003|COMPLETED|Overall Study||60||
48466917|NCT02806232|101480841|FG004|COMPLETED|Overall Study||58||
48466918|NCT02806232|101480842|FG005|COMPLETED|Overall Study||58||
48466919|NCT02806232|101480843|FG006|COMPLETED|Overall Study||60||
48784035|NCT01175083|102259878|FG000|NOT COMPLETED|Primary Epoch||0||
48784036|NCT01175083|102259879|FG001|NOT COMPLETED|Primary Epoch||0||
48784037|NCT01175083|102259880|FG002|NOT COMPLETED|Primary Epoch||0||
48466920|NCT02806232|101480844|FG007|COMPLETED|Overall Study||20||
48784038|NCT01175083|102259881|FG003|NOT COMPLETED|Primary Epoch||0||
48784039|NCT01175083|102259882|FG004|NOT COMPLETED|Primary Epoch||0||
48784040|NCT01175083|102259883|FG005|NOT COMPLETED|Primary Epoch||3||
48784041|NCT01175083|102259878|FG000|STARTED|Booster Epoch||49||
48784042|NCT01175083|102259879|FG001|STARTED|Booster Epoch||49||
48784043|NCT01175083|102259880|FG002|STARTED|Booster Epoch||50||
48784044|NCT01175083|102259881|FG003|STARTED|Booster Epoch||50||
48784045|NCT01175083|102259882|FG004|STARTED|Booster Epoch||0||
48784046|NCT01175083|102259883|FG005|STARTED|Booster Epoch||0||
48784047|NCT01175083|102259878|FG000|COMPLETED|Booster Epoch||49||
48784048|NCT01175083|102259879|FG001|COMPLETED|Booster Epoch||49||
48784049|NCT01175083|102259880|FG002|COMPLETED|Booster Epoch||49||
48784050|NCT01175083|102259881|FG003|COMPLETED|Booster Epoch||49||
48784051|NCT01175083|102259882|FG004|COMPLETED|Booster Epoch||0||
48784052|NCT01175083|102259883|FG005|COMPLETED|Booster Epoch||0||
48466921|NCT02806232|101480845|FG008|COMPLETED|Overall Study||4||
48466922|NCT02806232|101480837|FG000|NOT COMPLETED|Overall Study||1||
48466923|NCT02806232|101480838|FG001|NOT COMPLETED|Overall Study||4||
48466924|NCT02806232|101480839|FG002|NOT COMPLETED|Overall Study||1||
48466925|NCT02806232|101480840|FG003|NOT COMPLETED|Overall Study||0||
48466926|NCT02806232|101480841|FG004|NOT COMPLETED|Overall Study||2||
48466927|NCT02806232|101480842|FG005|NOT COMPLETED|Overall Study||2||
48784053|NCT01175083|102259878|FG000|NOT COMPLETED|Booster Epoch||0||
48784054|NCT01175083|102259879|FG001|NOT COMPLETED|Booster Epoch||0||
48784055|NCT01175083|102259880|FG002|NOT COMPLETED|Booster Epoch||1||
48784056|NCT01175083|102259881|FG003|NOT COMPLETED|Booster Epoch||1||
48784057|NCT01175083|102259882|FG004|NOT COMPLETED|Booster Epoch||0||
48466928|NCT02806232|101480843|FG006|NOT COMPLETED|Overall Study||0||
48466929|NCT02806232|101480844|FG007|NOT COMPLETED|Overall Study||0||
48466930|NCT02806232|101480845|FG008|NOT COMPLETED|Overall Study||0||
48466931|NCT01884025|101480846|FG000|STARTED|Overall Study||13||
48784058|NCT01175083|102259883|FG005|NOT COMPLETED|Booster Epoch||0||
48784059|NCT00200343|102259884|FG000|STARTED|Overall Study||199||
48784060|NCT00200343|102259885|FG001|STARTED|Overall Study||200||
48784061|NCT00200343|102259886|FG002|STARTED|Overall Study||197||
48784062|NCT00200343|102259884|FG000|COMPLETED|Overall Study||183||
48784063|NCT00200343|102259885|FG001|COMPLETED|Overall Study||192||
48784064|NCT00200343|102259886|FG002|COMPLETED|Overall Study||184||
48784065|NCT00200343|102259884|FG000|NOT COMPLETED|Overall Study||16||
48784066|NCT00200343|102259885|FG001|NOT COMPLETED|Overall Study||8||
48784067|NCT00200343|102259886|FG002|NOT COMPLETED|Overall Study||13||
48784068|NCT04027608|102259887|FG000|STARTED|Overall Study||165||
48784069|NCT04027608|102259888|FG001|STARTED|Overall Study||36||
48189868|NCT02320253|100788954|FG002|STARTED|Overall Study||72||
48466932|NCT01884025|101480847|FG001|STARTED|Overall Study||14||
48466933|NCT01884025|101480846|FG000|COMPLETED|Overall Study||10||
48466934|NCT01884025|101480847|FG001|COMPLETED|Overall Study||10||
48466935|NCT01884025|101480846|FG000|NOT COMPLETED|Overall Study||3||
48466936|NCT01884025|101480847|FG001|NOT COMPLETED|Overall Study||4||
48466937|NCT00249821|101480848|FG000|STARTED|Overall Study||10||
48784070|NCT04027608|102259887|FG000|COMPLETED|Overall Study||129||
48784071|NCT04027608|102259888|FG001|COMPLETED|Overall Study||29||
48784072|NCT04027608|102259887|FG000|NOT COMPLETED|Overall Study||36||
48784073|NCT04027608|102259888|FG001|NOT COMPLETED|Overall Study||7||
48784074|NCT01675544|102259889|FG000|STARTED|Overall Study||46||
48784075|NCT01675544|102259889|FG000|COMPLETED|Overall Study||44||
48784076|NCT01675544|102259889|FG000|NOT COMPLETED|Overall Study||2||
48784077|NCT01068600|102259890|FG000|STARTED|Overall Study||159||
48784078|NCT01068600|102259891|FG001|STARTED|Overall Study||159||
48370099|NCT01234402|101234820|FG001|Received at Least One Dose of Study Drug|Overall Study||49||
48466938|NCT00249821|101480849|FG001|STARTED|Overall Study||12||
48466939|NCT00249821|101480848|FG000|COMPLETED|Overall Study||10||
48466940|NCT00249821|101480849|FG001|COMPLETED|Overall Study||11||
48466941|NCT00249821|101480848|FG000|NOT COMPLETED|Overall Study||0||
48466942|NCT00249821|101480849|FG001|NOT COMPLETED|Overall Study||1||
48466943|NCT02396381|101480850|FG000|STARTED|Overall Study||488|Randomized|
48466944|NCT02396381|101480851|FG001|STARTED|Overall Study||496|Randomized|
48466945|NCT02396381|101480850|FG000|Full Analysis Set - As Exposed (FAS-EX)|Overall Study||414|Subjects with at least one record of reported use post-randomization.|
48370100|NCT01234402|101234821|FG002|Received at Least One Dose of Study Drug|Overall Study||49||
48370101|NCT01234402|101234819|FG000|Capecitabine Crossover to Ramucirumab|Overall Study||0||
48370102|NCT01234402|101234820|FG001|Capecitabine Crossover to Ramucirumab|Overall Study||0||
48370103|NCT01234402|101234821|FG002|Capecitabine Crossover to Ramucirumab|Overall Study||29||
48370104|NCT01234402|101234819|FG000|Capecitabine Crossover to Icrucumab|Overall Study||0||
48370105|NCT01234402|101234820|FG001|Capecitabine Crossover to Icrucumab|Overall Study||0||
48370106|NCT01234402|101234821|FG002|Capecitabine Crossover to Icrucumab|Overall Study||1||
48370107|NCT01234402|101234819|FG000|COMPLETED|Overall Study||51||
48466946|NCT02396381|101480851|FG001|Full Analysis Set - As Exposed (FAS-EX)|Overall Study||443|Subjects with at least one record of reported use post-randomization.|
48466947|NCT02396381|101480850|FG000|COMPLETED|Overall Study||381||
48466948|NCT02396381|101480851|FG001|COMPLETED|Overall Study||422||
48189869|NCT02320253|100788952|FG000|COMPLETED|Overall Study||63||
48189870|NCT02320253|100788953|FG001|COMPLETED|Overall Study||68||
48189871|NCT02320253|100788954|FG002|COMPLETED|Overall Study||70||
48189872|NCT02320253|100788952|FG000|NOT COMPLETED|Overall Study||6||
48189873|NCT02320253|100788953|FG001|NOT COMPLETED|Overall Study||2||
48189874|NCT02320253|100788954|FG002|NOT COMPLETED|Overall Study||2||
48189875|NCT00315627|100788955|FG000|STARTED|Overall Study||3||
48189876|NCT00315627|100788955|FG000|COMPLETED|Overall Study||3||
48189877|NCT00315627|100788955|FG000|NOT COMPLETED|Overall Study||0||
48189878|NCT01653743|100788956|FG000|STARTED|Overall Study||54||
48189879|NCT01653743|100788957|FG001|STARTED|Overall Study||27||
48189880|NCT01653743|100788956|FG000|COMPLETED|Overall Study||50||
48189881|NCT01653743|100788957|FG001|COMPLETED|Overall Study||27||
48189882|NCT01653743|100788956|FG000|NOT COMPLETED|Overall Study||4||
48189883|NCT01653743|100788957|FG001|NOT COMPLETED|Overall Study||0||
48189884|NCT00688688|100788958|FG000|STARTED|Overall Study||815||
48189885|NCT00688688|100788959|FG001|STARTED|Overall Study||824||
48189886|NCT00688688|100788960|FG002|STARTED|Overall Study||813||
48189887|NCT00688688|100788958|FG000|Safety Analysis Set (SAF)|Overall Study||812||
48189888|NCT00688688|100788959|FG001|Safety Analysis Set (SAF)|Overall Study||820||
48189889|NCT00688688|100788960|FG002|Safety Analysis Set (SAF)|Overall Study||812||
48189890|NCT00688688|100788958|FG000|Full Analysis Set (FAS)|Overall Study||789||
48189891|NCT00688688|100788959|FG001|Full Analysis Set (FAS)|Overall Study||802||
48189892|NCT00688688|100788960|FG002|Full Analysis Set (FAS)|Overall Study||791||
48189893|NCT00688688|100788958|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study||479||
48466949|NCT02396381|101480850|FG000|NOT COMPLETED|Overall Study||107||
48466950|NCT02396381|101480851|FG001|NOT COMPLETED|Overall Study||74||
48466951|NCT01412541|101480852|FG000|STARTED|Overall Study||372||
48466952|NCT01412541|101480853|FG001|STARTED|Overall Study||160||
48466953|NCT01412541|101480852|FG000|COMPLETED|Overall Study||246||
48466954|NCT01412541|101480853|FG001|COMPLETED|Overall Study||117||
48189894|NCT00688688|100788959|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study||483||
48189895|NCT00688688|100788960|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study||488||
48189896|NCT00688688|100788958|FG000|COMPLETED|Overall Study||629||
48189897|NCT00688688|100788959|FG001|COMPLETED|Overall Study||645||
48189898|NCT00688688|100788960|FG002|COMPLETED|Overall Study||621||
48189899|NCT00688688|100788958|FG000|NOT COMPLETED|Overall Study||186||
48189900|NCT00688688|100788959|FG001|NOT COMPLETED|Overall Study||179||
48189901|NCT00688688|100788960|FG002|NOT COMPLETED|Overall Study||192||
48189902|NCT02655653|100788961|FG000|STARTED|Overall Study||56||
48466955|NCT01412541|101480852|FG000|NOT COMPLETED|Overall Study||126||
48466956|NCT01412541|101480853|FG001|NOT COMPLETED|Overall Study||43||
48466957|NCT00586521|101480854|FG000|STARTED|On Demand Treatment (Months 1-6)||20||
48466958|NCT00586521|101480854|FG000|COMPLETED|On Demand Treatment (Months 1-6)||19||
48189903|NCT02655653|100788962|FG001|STARTED|Overall Study||58||
48189904|NCT02655653|100788961|FG000|COMPLETED|Overall Study||56||
48189905|NCT02655653|100788962|FG001|COMPLETED|Overall Study||58||
48189906|NCT02655653|100788961|FG000|NOT COMPLETED|Overall Study||0||
48189907|NCT02655653|100788962|FG001|NOT COMPLETED|Overall Study||0||
48189908|NCT00121199|100788963|FG000|STARTED|Overall Study||73||
48189909|NCT00121199|100788963|FG000|Eligible|Overall Study||64||
48189910|NCT00121199|100788963|FG000|Eligible and Began Protocol Therapy|Overall Study||64||
48189911|NCT00121199|100788963|FG000|COMPLETED|Overall Study||45||
48189912|NCT00121199|100788963|FG000|NOT COMPLETED|Overall Study||28||
48466959|NCT00586521|101480854|FG000|NOT COMPLETED|On Demand Treatment (Months 1-6)||1||
48466960|NCT00586521|101480854|FG000|STARTED|Prophylactic Treatment (Months 8-13)||19||
48466961|NCT00586521|101480854|FG000|COMPLETED|Prophylactic Treatment (Months 8-13)||19||
48466962|NCT00586521|101480854|FG000|NOT COMPLETED|Prophylactic Treatment (Months 8-13)||0||
48466963|NCT00721409|101480855|FG000|STARTED|Overall Study||12||
48466964|NCT00721409|101480856|FG001|STARTED|Overall Study||84||
48466965|NCT00721409|101480857|FG002|STARTED|Overall Study||81||
48466966|NCT00721409|101480855|FG000|Treated|Overall Study||12||
48466967|NCT00721409|101480856|FG001|Treated|Overall Study||83||
48466968|NCT00721409|101480857|FG002|Treated|Overall Study||77||
48466969|NCT00721409|101480855|FG000|COMPLETED|Overall Study||0||
48466970|NCT00721409|101480856|FG001|COMPLETED|Overall Study||2||
48466971|NCT00721409|101480857|FG002|COMPLETED|Overall Study||2||
48466972|NCT00721409|101480855|FG000|NOT COMPLETED|Overall Study||12||
48466973|NCT00721409|101480856|FG001|NOT COMPLETED|Overall Study||82||
48466974|NCT00721409|101480857|FG002|NOT COMPLETED|Overall Study||79||
48466975|NCT00125359|101480858|FG000|STARTED|Overall Study||42||
48466976|NCT00125359|101480858|FG000|COMPLETED|Overall Study||19||
48466977|NCT00125359|101480858|FG000|NOT COMPLETED|Overall Study||23||
48466978|NCT03177603|101480859|FG000|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||4||
48466979|NCT03177603|101480860|FG001|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0||
48466980|NCT03177603|101480861|FG002|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0||
48466981|NCT03177603|101480862|FG003|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0||
48466982|NCT03177603|101480859|FG000|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||4||
48466983|NCT03177603|101480860|FG001|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0||
48466984|NCT03177603|101480861|FG002|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0||
48466985|NCT03177603|101480862|FG003|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0||
48466986|NCT03177603|101480859|FG000|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0||
48466987|NCT03177603|101480860|FG001|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0||
48466988|NCT03177603|101480861|FG002|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0||
48466989|NCT03177603|101480862|FG003|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0||
48466990|NCT03177603|101480859|FG000|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0||
48466991|NCT03177603|101480860|FG001|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||5||
48466992|NCT03177603|101480861|FG002|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0||
48466993|NCT03177603|101480862|FG003|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0||
48466994|NCT03177603|101480859|FG000|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0||
48466995|NCT03177603|101480860|FG001|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||5||
48466996|NCT03177603|101480861|FG002|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0||
48466997|NCT03177603|101480862|FG003|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0||
48466998|NCT03177603|101480859|FG000|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0||
48466999|NCT03177603|101480860|FG001|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0||
48467000|NCT03177603|101480861|FG002|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0||
48467001|NCT03177603|101480862|FG003|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0||
48784079|NCT01068600|102259890|FG000|COMPLETED|Overall Study||148||
48467002|NCT03177603|101480859|FG000|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0||
48467003|NCT03177603|101480860|FG001|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0||
48467004|NCT03177603|101480861|FG002|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||6||
48467005|NCT03177603|101480862|FG003|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0||
48467006|NCT03177603|101480859|FG000|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0||
48784080|NCT01068600|102259891|FG001|COMPLETED|Overall Study||142||
48784081|NCT01068600|102259890|FG000|NOT COMPLETED|Overall Study||11||
48784082|NCT01068600|102259891|FG001|NOT COMPLETED|Overall Study||17||
48784083|NCT03291964|102259892|FG000|STARTED|Overall Study||73||
48784084|NCT03291964|102259892|FG000|COMPLETED|Overall Study||73||
48784085|NCT03291964|102259892|FG000|NOT COMPLETED|Overall Study||0||
48784086|NCT00776919|102259893|FG000|STARTED|Overall Study||327||
48784087|NCT00776919|102259894|FG001|STARTED|Overall Study||328||
48784088|NCT00776919|102259895|FG002|STARTED|Overall Study||328||
48784089|NCT00776919|102259896|FG003|STARTED|Overall Study||332||
48784090|NCT00776919|102259893|FG000|COMPLETED|Overall Study||300||
48784091|NCT00776919|102259894|FG001|COMPLETED|Overall Study||295||
48784092|NCT00776919|102259895|FG002|COMPLETED|Overall Study||296||
48784093|NCT00776919|102259896|FG003|COMPLETED|Overall Study||293||
48784094|NCT00776919|102259893|FG000|NOT COMPLETED|Overall Study||27||
48784095|NCT00776919|102259894|FG001|NOT COMPLETED|Overall Study||33||
48189913|NCT02331940|100788964|FG000|STARTED|Overall Study||100||
48189914|NCT02331940|100788965|FG001|STARTED|Overall Study||100||
48467007|NCT03177603|101480860|FG001|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0||
48467008|NCT03177603|101480861|FG002|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||6||
48467009|NCT03177603|101480862|FG003|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0||
48467010|NCT03177603|101480859|FG000|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0||
48467011|NCT03177603|101480860|FG001|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0||
48467012|NCT03177603|101480861|FG002|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0||
48467013|NCT03177603|101480862|FG003|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0||
48467014|NCT03177603|101480859|FG000|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0||
48467015|NCT03177603|101480860|FG001|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0||
48467016|NCT03177603|101480861|FG002|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0||
48467017|NCT03177603|101480862|FG003|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||8||
48784096|NCT00776919|102259895|FG002|NOT COMPLETED|Overall Study||32||
48467018|NCT03177603|101480859|FG000|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0||
48467019|NCT03177603|101480860|FG001|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0||
48467020|NCT03177603|101480861|FG002|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0||
48467021|NCT03177603|101480862|FG003|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||8||
48467022|NCT03177603|101480859|FG000|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0||
48467023|NCT03177603|101480860|FG001|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0||
48467024|NCT03177603|101480861|FG002|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0||
48467025|NCT03177603|101480862|FG003|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0||
48467026|NCT03758365|101480863|FG000|STARTED|Overall Study||36||
48467027|NCT03758365|101480863|FG000|MC2-01 Cream|Overall Study||36||
48467028|NCT03758365|101480863|FG000|Clobetasol Propionate 0.05% Lotion|Overall Study||36||
48467029|NCT03758365|101480863|FG000|Betamethasone Dipropionate 0.05% Cream|Overall Study||36||
48467030|NCT03758365|101480863|FG000|Triamcinolone Acetonide 0,1% Cream|Overall Study||36||
48467031|NCT03758365|101480863|FG000|Hydrocortisone Butyrate 0.1% Cream|Overall Study||36||
48467032|NCT03758365|101480863|FG000|Desonide 0.05% Cream|Overall Study||36||
48467033|NCT03758365|101480863|FG000|Vehicle Cream|Overall Study||36||
48467034|NCT03758365|101480863|FG000|COMPLETED|Overall Study||36||
48467035|NCT03758365|101480863|FG000|NOT COMPLETED|Overall Study||0||
48467036|NCT01523964|101480864|FG000|STARTED|Overall Study||31||
48467037|NCT01523964|101480865|FG001|STARTED|Overall Study||30||
48467038|NCT01523964|101480866|FG002|STARTED|Overall Study||16||
48467039|NCT01523964|101480867|FG003|STARTED|Overall Study||15||
48467040|NCT01523964|101480864|FG000|COMPLETED|Overall Study||31||
48467041|NCT01523964|101480865|FG001|COMPLETED|Overall Study||30||
48467042|NCT01523964|101480866|FG002|COMPLETED|Overall Study||16||
48467043|NCT01523964|101480867|FG003|COMPLETED|Overall Study||15||
48467044|NCT01523964|101480864|FG000|NOT COMPLETED|Overall Study||0||
48467045|NCT01523964|101480865|FG001|NOT COMPLETED|Overall Study||0||
48467046|NCT01523964|101480866|FG002|NOT COMPLETED|Overall Study||0||
48467047|NCT01523964|101480867|FG003|NOT COMPLETED|Overall Study||0||
48467048|NCT03361423|101480868|FG000|STARTED|Overall Study||126||
48467049|NCT03361423|101480869|FG001|STARTED|Overall Study||126||
48370108|NCT01234402|101234820|FG001|COMPLETED|Overall Study||45||
48467050|NCT03361423|101480868|FG000|COMPLETED|Overall Study||99||
48467051|NCT03361423|101480869|FG001|COMPLETED|Overall Study||103||
48467052|NCT03361423|101480868|FG000|NOT COMPLETED|Overall Study||27||
48467053|NCT03361423|101480869|FG001|NOT COMPLETED|Overall Study||23||
48467054|NCT00198029|101480870|FG000|STARTED|Overall Study||32||
48467055|NCT00198029|101480870|FG000|COMPLETED|Overall Study||28||
48467056|NCT00198029|101480870|FG000|NOT COMPLETED|Overall Study||4||
48467057|NCT02315898|101480871|FG000|STARTED|Overall Study||10||
48467058|NCT02315898|101480872|FG001|STARTED|Overall Study||8||
48467059|NCT02315898|101480873|FG002|STARTED|Overall Study||9||
48370109|NCT01234402|101234821|FG002|COMPLETED|Overall Study||42||
48370110|NCT01234402|101234819|FG000|NOT COMPLETED|Overall Study||1||
48370111|NCT01234402|101234820|FG001|NOT COMPLETED|Overall Study||6||
48370112|NCT01234402|101234821|FG002|NOT COMPLETED|Overall Study||8||
48370113|NCT02858193|101234822|FG000|STARTED|First Treatment Period||15||
48370114|NCT02858193|101234823|FG001|STARTED|First Treatment Period||15||
48370115|NCT02858193|101234822|FG000|COMPLETED|First Treatment Period||15||
48370116|NCT02858193|101234823|FG001|COMPLETED|First Treatment Period||15||
48370117|NCT02858193|101234822|FG000|NOT COMPLETED|First Treatment Period||0||
48370118|NCT02858193|101234823|FG001|NOT COMPLETED|First Treatment Period||0||
48370119|NCT02858193|101234822|FG000|STARTED|Washout Period (at Least 4 Days)||15||
48370120|NCT02858193|101234823|FG001|STARTED|Washout Period (at Least 4 Days)||15||
48370121|NCT02858193|101234822|FG000|COMPLETED|Washout Period (at Least 4 Days)||15||
48370122|NCT02858193|101234823|FG001|COMPLETED|Washout Period (at Least 4 Days)||15||
48370123|NCT02858193|101234822|FG000|NOT COMPLETED|Washout Period (at Least 4 Days)||0||
48370124|NCT02858193|101234823|FG001|NOT COMPLETED|Washout Period (at Least 4 Days)||0||
48370125|NCT02858193|101234822|FG000|STARTED|Second Treatment Period||15||
48370126|NCT02858193|101234823|FG001|STARTED|Second Treatment Period||15||
48370127|NCT02858193|101234822|FG000|COMPLETED|Second Treatment Period||15||
48370128|NCT02858193|101234823|FG001|COMPLETED|Second Treatment Period||15||
48370129|NCT02858193|101234822|FG000|NOT COMPLETED|Second Treatment Period||0||
48370130|NCT02858193|101234823|FG001|NOT COMPLETED|Second Treatment Period||0||
48370131|NCT01752842|101234824|FG000|STARTED|Overall Study||34||
48370132|NCT01752842|101234825|FG001|STARTED|Overall Study||36||
48370133|NCT01752842|101234824|FG000|COMPLETED|Overall Study||31||
48370134|NCT01752842|101234825|FG001|COMPLETED|Overall Study||34||
48370135|NCT01752842|101234824|FG000|NOT COMPLETED|Overall Study||3||
48370136|NCT01752842|101234825|FG001|NOT COMPLETED|Overall Study||2||
48370137|NCT00450372|101234826|FG000|STARTED|Overall Study||38||
48370138|NCT00450372|101234826|FG000|COMPLETED|Overall Study||37||
48370139|NCT00450372|101234826|FG000|NOT COMPLETED|Overall Study||1||
48370140|NCT03422133|101234827|FG000|STARTED|Overall Study||104||
48370141|NCT03422133|101234828|FG001|STARTED|Overall Study||97||
48370142|NCT03422133|101234827|FG000|COMPLETED|Overall Study||90||
48467060|NCT02315898|101480874|FG003|STARTED|Overall Study||13||
48467061|NCT02315898|101480871|FG000|COMPLETED|Overall Study||8||
48467062|NCT02315898|101480872|FG001|COMPLETED|Overall Study||8||
48467063|NCT02315898|101480873|FG002|COMPLETED|Overall Study||9||
48467064|NCT02315898|101480874|FG003|COMPLETED|Overall Study||12||
48467065|NCT02315898|101480871|FG000|NOT COMPLETED|Overall Study||2||
48467066|NCT02315898|101480872|FG001|NOT COMPLETED|Overall Study||0||
48467067|NCT02315898|101480873|FG002|NOT COMPLETED|Overall Study||0||
48467068|NCT02315898|101480874|FG003|NOT COMPLETED|Overall Study||1||
48467069|NCT04480463|101480875|FG000|STARTED|Overall Study||288||
48467070|NCT04480463|101480876|FG001|STARTED|Overall Study||288||
48467071|NCT04480463|101480875|FG000|COMPLETED|Overall Study||259||
48467072|NCT04480463|101480876|FG001|COMPLETED|Overall Study||256||
48467073|NCT04480463|101480875|FG000|NOT COMPLETED|Overall Study||29||
48467074|NCT04480463|101480876|FG001|NOT COMPLETED|Overall Study||32||
48467075|NCT02579096|101480877|FG000|STARTED|Phase 1, Weeks 0 - 24||468||
48467076|NCT02579096|101480878|FG001|STARTED|Phase 1, Weeks 0 - 24||472||
48784097|NCT00776919|102259896|FG003|NOT COMPLETED|Overall Study||39||
48784098|NCT00856232|102259897|FG000|STARTED|Overall Study||26||
48784099|NCT00856232|102259898|FG001|STARTED|Overall Study||29||
48784100|NCT00856232|102259899|FG002|STARTED|Overall Study||36||
48784101|NCT00856232|102259897|FG000|COMPLETED|Overall Study||26||
48784102|NCT00856232|102259898|FG001|COMPLETED|Overall Study||29||
48784103|NCT00856232|102259899|FG002|COMPLETED|Overall Study||36||
48784104|NCT00856232|102259897|FG000|NOT COMPLETED|Overall Study||0||
48784105|NCT00856232|102259898|FG001|NOT COMPLETED|Overall Study||0||
48784106|NCT00856232|102259899|FG002|NOT COMPLETED|Overall Study||0||
48784107|NCT04345367|102259900|FG000|STARTED|Overall Study||362||
48784108|NCT04345367|102259901|FG001|STARTED|Overall Study||365||
48784109|NCT04345367|102259900|FG000|COMPLETED|Overall Study||327||
48784110|NCT04345367|102259901|FG001|COMPLETED|Overall Study||334||
48784111|NCT04345367|102259900|FG000|NOT COMPLETED|Overall Study||35||
48784112|NCT04345367|102259901|FG001|NOT COMPLETED|Overall Study||31||
48784113|NCT01578850|102259902|FG000|STARTED|Period 1||489||
48784114|NCT01578850|102259903|FG001|STARTED|Period 1||0||
48784115|NCT01578850|102259904|FG002|STARTED|Period 1||0||
48784116|NCT01578850|102259902|FG000|COMPLETED|Period 1||452||
48784117|NCT01578850|102259903|FG001|COMPLETED|Period 1||0||
48784118|NCT01578850|102259904|FG002|COMPLETED|Period 1||0||
48784119|NCT01578850|102259902|FG000|NOT COMPLETED|Period 1||37||
48784120|NCT01578850|102259903|FG001|NOT COMPLETED|Period 1||0||
48784121|NCT01578850|102259904|FG002|NOT COMPLETED|Period 1||0||
48784122|NCT01578850|102259902|FG000|STARTED|Period 2||0||
48784123|NCT01578850|102259903|FG001|STARTED|Period 2||167||
48784124|NCT01578850|102259904|FG002|STARTED|Period 2||176||
48784125|NCT01578850|102259902|FG000|COMPLETED|Period 2||0||
48784126|NCT01578850|102259903|FG001|COMPLETED|Period 2||154||
48784127|NCT01578850|102259904|FG002|COMPLETED|Period 2||162||
48784128|NCT01578850|102259902|FG000|NOT COMPLETED|Period 2||0||
48784129|NCT01578850|102259903|FG001|NOT COMPLETED|Period 2||13||
48784130|NCT01578850|102259904|FG002|NOT COMPLETED|Period 2||14||
48784131|NCT04364984|102259905|FG000|STARTED|Overall Study||37||
48784132|NCT04364984|102259906|FG001|STARTED|Overall Study||44||
48784133|NCT04364984|102259907|FG002|STARTED|Overall Study||31||
48784134|NCT04364984|102259905|FG000|COMPLETED|Overall Study||35||
48784135|NCT04364984|102259906|FG001|COMPLETED|Overall Study||42||
48784136|NCT04364984|102259907|FG002|COMPLETED|Overall Study||31||
48784137|NCT04364984|102259905|FG000|NOT COMPLETED|Overall Study||2||
48784138|NCT04364984|102259906|FG001|NOT COMPLETED|Overall Study||2||
48784139|NCT04364984|102259907|FG002|NOT COMPLETED|Overall Study||0||
48784140|NCT03179605|102262708|FG000|STARTED|Overall Study||22||
48784141|NCT03179605|102262708|FG000|COMPLETED|Overall Study||21||
48784142|NCT03179605|102262708|FG000|NOT COMPLETED|Overall Study||1||
48784143|NCT03425253|102262709|FG000|STARTED|Overall Study||58||
48784144|NCT03425253|102262709|FG000|Safety Analysis Set|Overall Study||53|Safety Analysis Set included participants who are defined as Full Analysis Set (FAS) participants and those participants who underwent biopsy procedure but did not receive the BELKYRA® treatment.|
48784145|NCT03425253|102262709|FG000|FAS|Overall Study||53|FAS population included all participants who received BELKYRA®.|
48467077|NCT02579096|101480877|FG000|COMPLETED|Phase 1, Weeks 0 - 24||411||
48467078|NCT02579096|101480878|FG001|COMPLETED|Phase 1, Weeks 0 - 24||422||
48467079|NCT02579096|101480877|FG000|NOT COMPLETED|Phase 1, Weeks 0 - 24||57||
48784146|NCT03425253|102262709|FG000|Evaluable Set (ES)|Overall Study||42|ES population included all participants who received BELKYRA® plus VOLUMA™.|
48784147|NCT03425253|102262709|FG000|COMPLETED|Overall Study||42||
48784148|NCT03425253|102262709|FG000|NOT COMPLETED|Overall Study||16||
48784149|NCT02737891|102262710|FG000|STARTED|Overall Study||30||
48784150|NCT02737891|102262711|FG001|STARTED|Overall Study||30||
48784151|NCT02737891|102262710|FG000|COMPLETED|Overall Study||30||
48784152|NCT02737891|102262711|FG001|COMPLETED|Overall Study||28||
48784153|NCT02737891|102262710|FG000|NOT COMPLETED|Overall Study||0||
48784154|NCT02737891|102262711|FG001|NOT COMPLETED|Overall Study||2||
48467080|NCT02579096|101480878|FG001|NOT COMPLETED|Phase 1, Weeks 0 - 24||50||
48467081|NCT02579096|101480877|FG000|STARTED|Phase 2, Weeks 25 - 48||411||
48467082|NCT02579096|101480878|FG001|STARTED|Phase 2, Weeks 25 - 48||422||
48467083|NCT02579096|101480877|FG000|COMPLETED|Phase 2, Weeks 25 - 48||389||
48784155|NCT01546623|102262712|FG000|STARTED|Overall Study||82||
48784156|NCT01546623|102262713|FG001|STARTED|Overall Study||80||
48784157|NCT01546623|102262712|FG000|Received Study Drug|Overall Study||81||
48784158|NCT01546623|102262713|FG001|Received Study Drug|Overall Study||79||
48784159|NCT01546623|102262712|FG000|COMPLETED|Overall Study||76||
48784160|NCT01546623|102262713|FG001|COMPLETED|Overall Study||74||
48784161|NCT01546623|102262712|FG000|NOT COMPLETED|Overall Study||6||
48784162|NCT01546623|102262713|FG001|NOT COMPLETED|Overall Study||6||
48784163|NCT03083990|102262714|FG000|STARTED|Overall Study||50||
48784164|NCT03083990|102262715|FG001|STARTED|Overall Study||50||
48784165|NCT03083990|102262714|FG000|COMPLETED|Overall Study||49||
48784166|NCT03083990|102262715|FG001|COMPLETED|Overall Study||50||
48784167|NCT03083990|102262714|FG000|NOT COMPLETED|Overall Study||1||
48784168|NCT03083990|102262715|FG001|NOT COMPLETED|Overall Study||0||
48784169|NCT01710137|102262716|FG000|STARTED|Overall Study||89||
48784170|NCT01710137|102262717|FG001|STARTED|Overall Study||90||
48784171|NCT01710137|102262716|FG000|COMPLETED|Overall Study||65||
48784172|NCT01710137|102262717|FG001|COMPLETED|Overall Study||76||
48784173|NCT01710137|102262716|FG000|NOT COMPLETED|Overall Study||24||
48784174|NCT01710137|102262717|FG001|NOT COMPLETED|Overall Study||14||
48784175|NCT01331213|102262718|FG000|STARTED|Overall Study||8||
48784176|NCT01331213|102262719|FG001|STARTED|Overall Study||10||
48784177|NCT01331213|102262718|FG000|COMPLETED|Overall Study||8||
48784178|NCT01331213|102262719|FG001|COMPLETED|Overall Study||10||
48784179|NCT01331213|102262718|FG000|NOT COMPLETED|Overall Study||0||
48784180|NCT01331213|102262719|FG001|NOT COMPLETED|Overall Study||0||
48784181|NCT04093024|102262720|FG000|STARTED|Double-blind Period||13||
48784182|NCT04093024|102262721|FG001|STARTED|Double-blind Period||26||
48784183|NCT04093024|102262720|FG000|COMPLETED|Double-blind Period||11||
48784184|NCT04093024|102262721|FG001|COMPLETED|Double-blind Period||21||
48784185|NCT04093024|102262720|FG000|NOT COMPLETED|Double-blind Period||2||
48784186|NCT04093024|102262721|FG001|NOT COMPLETED|Double-blind Period||5||
48784187|NCT04093024|102262720|FG000|STARTED|Open-label Nintedanib Period (OLNP)||11||
48784188|NCT04093024|102262721|FG001|STARTED|Open-label Nintedanib Period (OLNP)||21||
48784189|NCT04093024|102262720|FG000|COMPLETED|Open-label Nintedanib Period (OLNP)||11||
48784190|NCT04093024|102262721|FG001|COMPLETED|Open-label Nintedanib Period (OLNP)||20||
48784191|NCT04093024|102262720|FG000|NOT COMPLETED|Open-label Nintedanib Period (OLNP)||0||
48784192|NCT04093024|102262721|FG001|NOT COMPLETED|Open-label Nintedanib Period (OLNP)||1||
48784193|NCT01639729|102262722|FG000|STARTED|Overall Study||4||
48784194|NCT01639729|102262723|FG001|STARTED|Overall Study||4||
48784195|NCT01639729|102262724|FG002|STARTED|Overall Study||4||
48784196|NCT01639729|102262725|FG003|STARTED|Overall Study||5||
48784197|NCT01639729|102262726|FG004|STARTED|Overall Study||4||
48784198|NCT01639729|102262727|FG005|STARTED|Overall Study||4||
48784199|NCT01639729|102262722|FG000|COMPLETED|Overall Study||3||
48784200|NCT01639729|102262723|FG001|COMPLETED|Overall Study||4||
48784201|NCT01639729|102262724|FG002|COMPLETED|Overall Study||3||
48784202|NCT01639729|102262725|FG003|COMPLETED|Overall Study||4||
48784203|NCT01639729|102262726|FG004|COMPLETED|Overall Study||4||
48784204|NCT01639729|102262727|FG005|COMPLETED|Overall Study||4||
48784205|NCT01639729|102262722|FG000|NOT COMPLETED|Overall Study||1||
48784206|NCT01639729|102262723|FG001|NOT COMPLETED|Overall Study||0||
48784207|NCT01639729|102262724|FG002|NOT COMPLETED|Overall Study||1||
48784208|NCT01639729|102262725|FG003|NOT COMPLETED|Overall Study||1||
48784209|NCT01639729|102262726|FG004|NOT COMPLETED|Overall Study||0||
48784210|NCT01639729|102262727|FG005|NOT COMPLETED|Overall Study||0||
48784211|NCT00835211|102262728|FG000|STARTED|First Intervention||24||
48784212|NCT00835211|102262729|FG001|STARTED|First Intervention||24||
48784213|NCT00835211|102262728|FG000|COMPLETED|First Intervention||24||
48784214|NCT00835211|102262729|FG001|COMPLETED|First Intervention||23||
48784215|NCT00835211|102262728|FG000|NOT COMPLETED|First Intervention||0||
48784216|NCT00835211|102262729|FG001|NOT COMPLETED|First Intervention||1||
48784217|NCT00835211|102262728|FG000|STARTED|Washout: 7 Days||24||
48784218|NCT00835211|102262729|FG001|STARTED|Washout: 7 Days||23||
48784219|NCT00835211|102262728|FG000|COMPLETED|Washout: 7 Days||21||
48784220|NCT00835211|102262729|FG001|COMPLETED|Washout: 7 Days||22||
48784221|NCT00835211|102262728|FG000|NOT COMPLETED|Washout: 7 Days||3||
48784222|NCT00835211|102262729|FG001|NOT COMPLETED|Washout: 7 Days||1||
48784223|NCT00835211|102262728|FG000|STARTED|Second Intervention||21||
48784224|NCT00835211|102262729|FG001|STARTED|Second Intervention||22||
48784225|NCT00835211|102262728|FG000|COMPLETED|Second Intervention||21||
48784226|NCT00835211|102262729|FG001|COMPLETED|Second Intervention||22||
48784227|NCT00835211|102262728|FG000|NOT COMPLETED|Second Intervention||0||
48784228|NCT00835211|102262729|FG001|NOT COMPLETED|Second Intervention||0||
48784229|NCT02687191|102262730|FG000|STARTED|Overall Study||3||
48784230|NCT02687191|102262731|FG001|STARTED|Overall Study||3||
48467084|NCT02579096|101480878|FG001|COMPLETED|Phase 2, Weeks 25 - 48||391||
48467085|NCT02579096|101480877|FG000|NOT COMPLETED|Phase 2, Weeks 25 - 48||22||
48467086|NCT02579096|101480878|FG001|NOT COMPLETED|Phase 2, Weeks 25 - 48||31||
48467087|NCT02579096|101480877|FG000|STARTED|Phase 3, Weeks 49 - 72||389||
48467088|NCT02579096|101480878|FG001|STARTED|Phase 3, Weeks 49 - 72||391||
48467089|NCT02579096|101480877|FG000|COMPLETED|Phase 3, Weeks 49 - 72||367||
48467090|NCT02579096|101480878|FG001|COMPLETED|Phase 3, Weeks 49 - 72||373||
48467091|NCT02579096|101480877|FG000|NOT COMPLETED|Phase 3, Weeks 49 - 72||22||
48467092|NCT02579096|101480878|FG001|NOT COMPLETED|Phase 3, Weeks 49 - 72||18||
48467093|NCT01491620|101480879|FG000|STARTED|Overall Study||24||
48467094|NCT01491620|101480879|FG000|COMPLETED|Overall Study||24||
48467095|NCT01491620|101480879|FG000|NOT COMPLETED|Overall Study||0||
48665792|NCT04716725|101967416|FG000|COMPLETED|Overall Study||15||
48665793|NCT04716725|101967416|FG000|NOT COMPLETED|Overall Study||0||
48784231|NCT02687191|102262732|FG002|STARTED|Overall Study||3||
48784232|NCT02687191|102262733|FG003|STARTED|Overall Study||6||
48784233|NCT02687191|102262734|FG004|STARTED|Overall Study||3||
48784234|NCT02687191|102262735|FG005|STARTED|Overall Study||3||
48784235|NCT02687191|102262730|FG000|COMPLETED|Overall Study||3||
48784236|NCT02687191|102262731|FG001|COMPLETED|Overall Study||2||
48784237|NCT02687191|102262732|FG002|COMPLETED|Overall Study||2||
48784238|NCT02687191|102262733|FG003|COMPLETED|Overall Study||5||
48784239|NCT02687191|102262734|FG004|COMPLETED|Overall Study||2||
48784240|NCT02687191|102262735|FG005|COMPLETED|Overall Study||2||
48784241|NCT02687191|102262730|FG000|NOT COMPLETED|Overall Study||0||
48784242|NCT02687191|102262731|FG001|NOT COMPLETED|Overall Study||1||
48784243|NCT02687191|102262732|FG002|NOT COMPLETED|Overall Study||1||
48784244|NCT02687191|102262733|FG003|NOT COMPLETED|Overall Study||1||
48784245|NCT02687191|102262734|FG004|NOT COMPLETED|Overall Study||1||
48784246|NCT02687191|102262735|FG005|NOT COMPLETED|Overall Study||1||
48784247|NCT01028300|102262736|FG000|STARTED|Overall Study||4||
48784248|NCT01028300|102262736|FG000|COMPLETED|Overall Study||0||
48784249|NCT01028300|102262736|FG000|NOT COMPLETED|Overall Study||4||
48784250|NCT00834080|102262737|FG000|STARTED|Overall Study||38||
48784251|NCT00834080|102262737|FG000|COMPLETED|Overall Study||15||
48784252|NCT00834080|102262737|FG000|NOT COMPLETED|Overall Study||23||
48784253|NCT00490529|102262738|FG000|STARTED|Completed Pre-CpG-MCL Vaccine Procedures||59||
48467096|NCT01946165|101480880|FG000|STARTED|Overall Study||45||
48467097|NCT01946165|101480881|FG001|STARTED|Overall Study||23||
48467098|NCT01946165|101480880|FG000|COMPLETED|Overall Study||43||
48467099|NCT01946165|101480881|FG001|COMPLETED|Overall Study||21||
48467100|NCT01946165|101480880|FG000|NOT COMPLETED|Overall Study||2||
48467101|NCT01946165|101480881|FG001|NOT COMPLETED|Overall Study||2||
48665794|NCT01230411|101967417|FG000|STARTED|Overall Study||21||
48665795|NCT01230411|101967418|FG001|STARTED|Overall Study||23||
48665796|NCT01230411|101967417|FG000|COMPLETED|Overall Study||21||
48665797|NCT01230411|101967418|FG001|COMPLETED|Overall Study||23||
48665798|NCT01230411|101967417|FG000|NOT COMPLETED|Overall Study||0||
48665799|NCT01230411|101967418|FG001|NOT COMPLETED|Overall Study||0||
48665800|NCT01117779|101967419|FG000|STARTED|Overall Study||246||
48665801|NCT01117779|101967419|FG000|COMPLETED|Overall Study||246||
48665802|NCT01117779|101967419|FG000|NOT COMPLETED|Overall Study||0||
48665803|NCT03559530|101967420|FG000|STARTED|Overall Study||197||
48665804|NCT03559530|101967421|FG001|STARTED|Overall Study||65||
48665805|NCT03559530|101967420|FG000|COMPLETED|Overall Study||106||
48665806|NCT03559530|101967421|FG001|COMPLETED|Overall Study||65||
48665807|NCT03559530|101967420|FG000|NOT COMPLETED|Overall Study||91||
48665808|NCT03559530|101967421|FG001|NOT COMPLETED|Overall Study||0||
48665809|NCT03664544|101967422|FG000|STARTED|Overall Study||6||
48665810|NCT03664544|101967423|FG001|STARTED|Overall Study||6||
48665811|NCT03664544|101967422|FG000|COMPLETED|Overall Study||6||
48665812|NCT03664544|101967423|FG001|COMPLETED|Overall Study||6||
48665813|NCT03664544|101967422|FG000|NOT COMPLETED|Overall Study||0||
48665814|NCT03664544|101967423|FG001|NOT COMPLETED|Overall Study||0||
48665815|NCT03880019|101967424|FG000|STARTED|Overall Study||23||
48665816|NCT03880019|101967424|FG000|COMPLETED|Overall Study||22||
48665817|NCT03880019|101967424|FG000|NOT COMPLETED|Overall Study||1||
48467102|NCT01922349|101480882|FG000|STARTED|Single Rising Dose (SRD) Period||25||
48467103|NCT01922349|101480883|FG001|STARTED|Single Rising Dose (SRD) Period||27||
48467104|NCT01922349|101480884|FG002|STARTED|Single Rising Dose (SRD) Period||18||
48467105|NCT01922349|101480885|FG003|STARTED|Single Rising Dose (SRD) Period||27||
48467106|NCT01922349|101480882|FG000|COMPLETED|Single Rising Dose (SRD) Period||25||
48467107|NCT01922349|101480883|FG001|COMPLETED|Single Rising Dose (SRD) Period||27||
48467108|NCT01922349|101480884|FG002|COMPLETED|Single Rising Dose (SRD) Period||18||
48467109|NCT01922349|101480885|FG003|COMPLETED|Single Rising Dose (SRD) Period||27||
48467110|NCT01922349|101480882|FG000|NOT COMPLETED|Single Rising Dose (SRD) Period||0||
48467111|NCT01922349|101480883|FG001|NOT COMPLETED|Single Rising Dose (SRD) Period||0||
48467112|NCT01922349|101480884|FG002|NOT COMPLETED|Single Rising Dose (SRD) Period||0||
48467113|NCT01922349|101480885|FG003|NOT COMPLETED|Single Rising Dose (SRD) Period||0||
48467114|NCT01922349|101480882|FG000|STARTED|Multiple Rising Dose (MRD) Period||24||
48467115|NCT01922349|101480883|FG001|STARTED|Multiple Rising Dose (MRD) Period||27||
48467116|NCT01922349|101480884|FG002|STARTED|Multiple Rising Dose (MRD) Period||18||
48467117|NCT01922349|101480885|FG003|STARTED|Multiple Rising Dose (MRD) Period||27||
48467118|NCT01922349|101480882|FG000|COMPLETED|Multiple Rising Dose (MRD) Period||24||
48467119|NCT01922349|101480883|FG001|COMPLETED|Multiple Rising Dose (MRD) Period||27||
48467120|NCT01922349|101480884|FG002|COMPLETED|Multiple Rising Dose (MRD) Period||18||
48467121|NCT01922349|101480885|FG003|COMPLETED|Multiple Rising Dose (MRD) Period||26||
48467122|NCT01922349|101480882|FG000|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0||
48467123|NCT01922349|101480883|FG001|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0||
48467124|NCT01922349|101480884|FG002|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0||
48467125|NCT01922349|101480885|FG003|NOT COMPLETED|Multiple Rising Dose (MRD) Period||1||
48467126|NCT00368966|101480886|FG000|STARTED|Infant Series||315||
48467127|NCT00368966|101480887|FG001|STARTED|Infant Series||304||
48467128|NCT00368966|101480886|FG000|Vaccinated Dose 1|Infant Series||314||
48467129|NCT00368966|101480887|FG001|Vaccinated Dose 1|Infant Series||302||
48467130|NCT00368966|101480886|FG000|Vaccinated Dose 2|Infant Series||307||
48467131|NCT00368966|101480887|FG001|Vaccinated Dose 2|Infant Series||298||
48467132|NCT00368966|101480886|FG000|Vaccinated Dose 3|Infant Series||301||
48467133|NCT00368966|101480887|FG001|Vaccinated Dose 3|Infant Series||296||
48467134|NCT00368966|101480886|FG000|COMPLETED|Infant Series||299||
48467135|NCT00368966|101480887|FG001|COMPLETED|Infant Series||294||
48467136|NCT00368966|101480886|FG000|NOT COMPLETED|Infant Series||16||
48467137|NCT00368966|101480887|FG001|NOT COMPLETED|Infant Series||10||
48467138|NCT00368966|101480886|FG000|STARTED|After Infant||299||
48467139|NCT00368966|101480887|FG001|STARTED|After Infant||294||
48467140|NCT00368966|101480886|FG000|COMPLETED|After Infant||293||
48467141|NCT00368966|101480887|FG001|COMPLETED|After Infant||289||
48467142|NCT00368966|101480886|FG000|NOT COMPLETED|After Infant||6||
48467143|NCT00368966|101480887|FG001|NOT COMPLETED|After Infant||5||
48467144|NCT00368966|101480886|FG000|STARTED|Toddler Dose||293||
48467145|NCT00368966|101480887|FG001|STARTED|Toddler Dose||289||
48467146|NCT00368966|101480886|FG000|COMPLETED|Toddler Dose||292||
48467147|NCT00368966|101480887|FG001|COMPLETED|Toddler Dose||286||
48467148|NCT00368966|101480886|FG000|NOT COMPLETED|Toddler Dose||1||
48467149|NCT00368966|101480887|FG001|NOT COMPLETED|Toddler Dose||3||
48467150|NCT02623829|101480888|FG000|STARTED|Overall Study||21||
48467151|NCT02623829|101480889|FG001|STARTED|Overall Study||21||
48467152|NCT02623829|101480888|FG000|COMPLETED|Overall Study||20||
48467153|NCT02623829|101480889|FG001|COMPLETED|Overall Study||20||
48467154|NCT02623829|101480888|FG000|NOT COMPLETED|Overall Study||1||
48467155|NCT02623829|101480889|FG001|NOT COMPLETED|Overall Study||1||
48467156|NCT03392974|101480890|FG000|STARTED|Overall Study||1||
48467157|NCT03392974|101480890|FG000|COMPLETED|Overall Study||1||
48467158|NCT03392974|101480890|FG000|NOT COMPLETED|Overall Study||0||
48467159|NCT02228174|101480891|FG000|STARTED|Overall Study||147||
48467160|NCT02228174|101480891|FG000|Full Analysis Population|Overall Study||143||
48467161|NCT02228174|101480891|FG000|COMPLETED|Overall Study||142||
48467162|NCT02228174|101480891|FG000|NOT COMPLETED|Overall Study||5||
48467163|NCT01654380|101480892|FG000|STARTED|Part A, Period 1||4||
48467164|NCT01654380|101480893|FG001|STARTED|Part A, Period 1||4||
48467165|NCT01654380|101480894|FG002|STARTED|Part A, Period 1||0||
48467166|NCT01654380|101480895|FG003|STARTED|Part A, Period 1||0||
48467167|NCT01654380|101480892|FG000|Received at Least 1 Dose of Study Drug|Part A, Period 1||4||
48467168|NCT01654380|101480893|FG001|Received at Least 1 Dose of Study Drug|Part A, Period 1||4||
48467169|NCT01654380|101480894|FG002|Received at Least 1 Dose of Study Drug|Part A, Period 1||0||
48467170|NCT01654380|101480895|FG003|Received at Least 1 Dose of Study Drug|Part A, Period 1||0||
48467171|NCT01654380|101480892|FG000|COMPLETED|Part A, Period 1||4||
48467172|NCT01654380|101480893|FG001|COMPLETED|Part A, Period 1||4||
48784254|NCT00490529|102262738|FG000|COMPLETED|Completed Pre-CpG-MCL Vaccine Procedures||48||
48784255|NCT00490529|102262738|FG000|NOT COMPLETED|Completed Pre-CpG-MCL Vaccine Procedures||11||
48784256|NCT00490529|102262738|FG000|STARTED|Treatment With CpG-MCL Vaccine||48||
48784257|NCT00490529|102262738|FG000|COMPLETED|Treatment With CpG-MCL Vaccine||47||
48784258|NCT00490529|102262738|FG000|NOT COMPLETED|Treatment With CpG-MCL Vaccine||1||
48784259|NCT02933450|102262739|FG000|STARTED|Overall Study||20||
48784260|NCT02933450|102262740|FG001|STARTED|Overall Study||23||
48784261|NCT02933450|102262739|FG000|COMPLETED|Overall Study||15||
48784262|NCT02933450|102262740|FG001|COMPLETED|Overall Study||15||
48784263|NCT02933450|102262739|FG000|NOT COMPLETED|Overall Study||5||
48784264|NCT02933450|102262740|FG001|NOT COMPLETED|Overall Study||8||
48784265|NCT02736890|102262741|FG000|STARTED|First 12 Weeks||5||
48784266|NCT02736890|102262742|FG001|STARTED|First 12 Weeks||3||
48784267|NCT02736890|102262741|FG000|COMPLETED|First 12 Weeks||5||
48784268|NCT02736890|102262742|FG001|COMPLETED|First 12 Weeks||3||
48784269|NCT02736890|102262741|FG000|NOT COMPLETED|First 12 Weeks||0||
48784270|NCT02736890|102262742|FG001|NOT COMPLETED|First 12 Weeks||0||
48784271|NCT02736890|102262741|FG000|STARTED|Crossover Next 12 Weeks||5||
48784272|NCT02736890|102262742|FG001|STARTED|Crossover Next 12 Weeks||3||
48784273|NCT02736890|102262741|FG000|COMPLETED|Crossover Next 12 Weeks||3||
48784274|NCT02736890|102262742|FG001|COMPLETED|Crossover Next 12 Weeks||1||
48784275|NCT02736890|102262741|FG000|NOT COMPLETED|Crossover Next 12 Weeks||2||
48784276|NCT02736890|102262742|FG001|NOT COMPLETED|Crossover Next 12 Weeks||2||
48784277|NCT03137069|102262743|FG000|STARTED|Overall Study||13||
48784278|NCT03137069|102262744|FG001|STARTED|Overall Study||28||
48784279|NCT03137069|102262745|FG002|STARTED|Overall Study||23||
48784280|NCT03137069|102262746|FG003|STARTED|Overall Study||23||
48784281|NCT03137069|102262747|FG004|STARTED|Overall Study||24||
48784282|NCT03137069|102262748|FG005|STARTED|Overall Study||23||
48784283|NCT03137069|102262743|FG000|COMPLETED|Overall Study||12||
48784284|NCT03137069|102262744|FG001|COMPLETED|Overall Study||22||
48784285|NCT03137069|102262745|FG002|COMPLETED|Overall Study||20||
48784286|NCT03137069|102262746|FG003|COMPLETED|Overall Study||17||
48784287|NCT03137069|102262747|FG004|COMPLETED|Overall Study||22||
48784288|NCT03137069|102262748|FG005|COMPLETED|Overall Study||21||
48784289|NCT03137069|102262743|FG000|NOT COMPLETED|Overall Study||1||
48784290|NCT03137069|102262744|FG001|NOT COMPLETED|Overall Study||6||
48784291|NCT03137069|102262745|FG002|NOT COMPLETED|Overall Study||3||
48784292|NCT03137069|102262746|FG003|NOT COMPLETED|Overall Study||6||
48784293|NCT03137069|102262747|FG004|NOT COMPLETED|Overall Study||2||
48784294|NCT03137069|102262748|FG005|NOT COMPLETED|Overall Study||2||
48784295|NCT03753789|102262749|FG000|STARTED|Overall Study||38|38|47
48784296|NCT03753789|102262749|FG000|COMPLETED|Overall Study||36|36|44
48784297|NCT03753789|102262749|FG000|NOT COMPLETED|Overall Study||2||3
48784298|NCT02055638|102262750|FG000|STARTED|Overall Study||49||
48784299|NCT02055638|102262751|FG001|STARTED|Overall Study||48||
48784300|NCT02055638|102262750|FG000|COMPLETED|Overall Study||39||
48784301|NCT02055638|102262751|FG001|COMPLETED|Overall Study||40||
48784302|NCT02055638|102262750|FG000|NOT COMPLETED|Overall Study||10||
48784303|NCT02055638|102262751|FG001|NOT COMPLETED|Overall Study||8||
48784304|NCT00146848|102262752|FG000|STARTED|Pre-randomization||1742||
48784305|NCT00146848|102262753|FG001|STARTED|Pre-randomization||0||
48784306|NCT00146848|102262754|FG002|STARTED|Pre-randomization||0||
48784307|NCT00146848|102262752|FG000|COMPLETED|Pre-randomization||1433||
48784308|NCT00146848|102262753|FG001|COMPLETED|Pre-randomization||0||
48784309|NCT00146848|102262754|FG002|COMPLETED|Pre-randomization||0||
48784310|NCT00146848|102262752|FG000|NOT COMPLETED|Pre-randomization||309||
48784311|NCT00146848|102262753|FG001|NOT COMPLETED|Pre-randomization||0||
48784312|NCT00146848|102262754|FG002|NOT COMPLETED|Pre-randomization||0||
48784313|NCT00146848|102262752|FG000|STARTED|Post-randomization||475||
48784314|NCT00146848|102262753|FG001|STARTED|Post-randomization||488||
48784315|NCT00146848|102262754|FG002|STARTED|Post-randomization||470||
48784316|NCT00146848|102262752|FG000|COMPLETED|Post-randomization||437||
48784317|NCT00146848|102262753|FG001|COMPLETED|Post-randomization||441||
48784318|NCT00146848|102262754|FG002|COMPLETED|Post-randomization||431||
48784319|NCT00146848|102262752|FG000|NOT COMPLETED|Post-randomization||38||
48784320|NCT00146848|102262753|FG001|NOT COMPLETED|Post-randomization||47||
48784321|NCT00146848|102262754|FG002|NOT COMPLETED|Post-randomization||39||
48784322|NCT01252732|102262755|FG000|STARTED|Overall Study||509||
48784323|NCT01252732|102262756|FG001|STARTED|Overall Study||510||
48784324|NCT01252732|102262755|FG000|Modified Intent to Treat Population|Overall Study||503||
48784325|NCT01252732|102262756|FG001|Modified Intent to Treat Population|Overall Study||502||
48784326|NCT01252732|102262755|FG000|COMPLETED|Overall Study||455||
48784327|NCT01252732|102262756|FG001|COMPLETED|Overall Study||446||
48784328|NCT01252732|102262755|FG000|NOT COMPLETED|Overall Study||54||
48784329|NCT01252732|102262756|FG001|NOT COMPLETED|Overall Study||64||
48784330|NCT01964755|102262757|FG000|STARTED|Overall Study||6||
48784331|NCT01964755|102262757|FG000|Cycle 2|Overall Study||5||
48784332|NCT01964755|102262757|FG000|Cycle 3|Overall Study||4||
48784333|NCT01964755|102262757|FG000|Cycle 4|Overall Study||4||
48784334|NCT01964755|102262757|FG000|Cycle 5|Overall Study||4||
48784335|NCT01964755|102262757|FG000|COMPLETED|Overall Study||4||
48784336|NCT01964755|102262757|FG000|NOT COMPLETED|Overall Study||2||
48784337|NCT03120351|102262758|FG000|STARTED|Overall Study||40||
48784338|NCT03120351|102262759|FG001|STARTED|Overall Study||40||
48784339|NCT03120351|102262758|FG000|COMPLETED|Overall Study||39||
48189915|NCT02331940|100788964|FG000|COMPLETED|Overall Study||93||
48189916|NCT02331940|100788965|FG001|COMPLETED|Overall Study||95||
48189917|NCT02331940|100788964|FG000|NOT COMPLETED|Overall Study||7||
48467173|NCT01654380|101480894|FG002|COMPLETED|Part A, Period 1||0||
48467174|NCT01654380|101480895|FG003|COMPLETED|Part A, Period 1||0||
48467175|NCT01654380|101480892|FG000|NOT COMPLETED|Part A, Period 1||0||
48467176|NCT01654380|101480893|FG001|NOT COMPLETED|Part A, Period 1||0||
48784340|NCT03120351|102262759|FG001|COMPLETED|Overall Study||39||
48784341|NCT03120351|102262758|FG000|NOT COMPLETED|Overall Study||1||
48784342|NCT03120351|102262759|FG001|NOT COMPLETED|Overall Study||1||
48784343|NCT01870076|102262760|FG000|STARTED|Overall Study||10||
48784344|NCT01870076|102262761|FG001|STARTED|Overall Study||12||
48784345|NCT01870076|102262762|FG002|STARTED|Overall Study||8||
48784346|NCT01870076|102262763|FG003|STARTED|Overall Study||11||
48784347|NCT01870076|102262760|FG000|COMPLETED|Overall Study||9||
48784348|NCT01870076|102262761|FG001|COMPLETED|Overall Study||12||
48784349|NCT01870076|102262762|FG002|COMPLETED|Overall Study||7||
48784350|NCT01870076|102262763|FG003|COMPLETED|Overall Study||11||
48784351|NCT01870076|102262760|FG000|NOT COMPLETED|Overall Study||1||
48784352|NCT01870076|102262761|FG001|NOT COMPLETED|Overall Study||0||
48784353|NCT01870076|102262762|FG002|NOT COMPLETED|Overall Study||1||
48784354|NCT01870076|102262763|FG003|NOT COMPLETED|Overall Study||0||
48784355|NCT04491604|102262764|FG000|STARTED|Overall Study||31||62
48784356|NCT04491604|102262764|FG000|B-VEC|Overall Study||31||31
48784357|NCT04491604|102262764|FG000|Placebo|Overall Study||31||31
48784358|NCT04491604|102262764|FG000|COMPLETED|Overall Study||28||56
48784359|NCT04491604|102262764|FG000|NOT COMPLETED|Overall Study||3||6
48784360|NCT02428478|102262765|FG000|STARTED|First Study Night||9||
48784361|NCT02428478|102262766|FG001|STARTED|First Study Night||8||
48784362|NCT02428478|102262765|FG000|COMPLETED|First Study Night||9||
48784363|NCT02428478|102262766|FG001|COMPLETED|First Study Night||8||
48784364|NCT02428478|102262765|FG000|NOT COMPLETED|First Study Night||0||
48784365|NCT02428478|102262766|FG001|NOT COMPLETED|First Study Night||0||
48784366|NCT02428478|102262765|FG000|STARTED|Second Study Night||8||
48784367|NCT02428478|102262766|FG001|STARTED|Second Study Night||6||
48784368|NCT02428478|102262765|FG000|COMPLETED|Second Study Night||8||
48784369|NCT02428478|102262766|FG001|COMPLETED|Second Study Night||6||
48784370|NCT02428478|102262765|FG000|NOT COMPLETED|Second Study Night||0||
48784371|NCT02428478|102262766|FG001|NOT COMPLETED|Second Study Night||0||
48784372|NCT03890666|102262767|FG000|STARTED|Overall Study||166|Intent-to-treat (ITT) analysis set: included all randomized participants|
48784373|NCT03890666|102262768|FG001|STARTED|Overall Study||167|Intent-to-treat (ITT) analysis set: included all randomized participants|
48784374|NCT03890666|102262767|FG000|Safety Analysis Set|Overall Study||166|All participants in the DS group who receive at least 1 dose of IMP and all participants in the CC group.|
48784375|NCT03890666|102262768|FG001|Safety Analysis Set|Overall Study||150|All participants in the DS group who receive at least 1 dose of IMP and all participants in the CC group.|
48784376|NCT03890666|102262767|FG000|Modified Intent-to-treat (mITT) Analysis Set|Overall Study||163|Al participants who received at least 1 dose of IMP and at least 1 postbaseline assessment on any of the study endpoints.|
48784377|NCT03890666|102262768|FG001|Modified Intent-to-treat (mITT) Analysis Set|Overall Study||150|Al participants who received at least 1 dose of IMP and at least 1 postbaseline assessment on any of the study endpoints.|
48784378|NCT03890666|102262767|FG000|COMPLETED|Overall Study||162||
48784379|NCT03890666|102262768|FG001|COMPLETED|Overall Study||149||
48784380|NCT03890666|102262767|FG000|NOT COMPLETED|Overall Study||4||
48467177|NCT01654380|101480894|FG002|NOT COMPLETED|Part A, Period 1||0||
48467178|NCT01654380|101480895|FG003|NOT COMPLETED|Part A, Period 1||0||
48784381|NCT03890666|102262768|FG001|NOT COMPLETED|Overall Study||18||
48784382|NCT01282463|102262769|FG000|STARTED|Overall Study||49||
48784383|NCT01282463|102262770|FG001|STARTED|Overall Study||49||
48784384|NCT01282463|102262771|FG002|STARTED|Overall Study||50||
48784385|NCT01282463|102262769|FG000|Received at Least 1 Dose of Study Drug|Overall Study||45||
48784386|NCT01282463|102262770|FG001|Received at Least 1 Dose of Study Drug|Overall Study||46||
48784387|NCT01282463|102262771|FG002|Received at Least 1 Dose of Study Drug|Overall Study||49||
48189918|NCT02331940|100788965|FG001|NOT COMPLETED|Overall Study||5||
48784388|NCT01282463|102262769|FG000|COMPLETED|Overall Study||41||
48784389|NCT01282463|102262770|FG001|COMPLETED|Overall Study||45||
48784390|NCT01282463|102262771|FG002|COMPLETED|Overall Study||46||
48784391|NCT01282463|102262769|FG000|NOT COMPLETED|Overall Study||8||
48784392|NCT01282463|102262770|FG001|NOT COMPLETED|Overall Study||4||
48784393|NCT01282463|102262771|FG002|NOT COMPLETED|Overall Study||4||
48784394|NCT00119678|102262772|FG000|STARTED|Double-blind Treatment Period||122||
48784395|NCT00119678|102262773|FG001|STARTED|Double-blind Treatment Period||61||
48189919|NCT04830514|100788966|FG000|STARTED|Overall Study||18||
48189920|NCT04830514|100788967|FG001|STARTED|Overall Study||14||
48467179|NCT01654380|101480892|FG000|STARTED|Part A, Washout of at Least 6 Days||4||
48784396|NCT00119678|102262772|FG000|RANDOMIZED AND TREATED|Double-blind Treatment Period||121||
48467180|NCT01654380|101480893|FG001|STARTED|Part A, Washout of at Least 6 Days||4||
48665818|NCT00323622|101967425|FG000|STARTED|Overall Study||176||
48467181|NCT01654380|101480894|FG002|STARTED|Part A, Washout of at Least 6 Days||0||
48467182|NCT01654380|101480895|FG003|STARTED|Part A, Washout of at Least 6 Days||0||
48665819|NCT00323622|101967426|FG001|STARTED|Overall Study||515||
48665820|NCT00323622|101967427|FG002|STARTED|Overall Study||42||
48665821|NCT00323622|101967428|FG003|STARTED|Overall Study||134||
48665822|NCT00323622|101967429|FG004|STARTED|Overall Study||159||
48665823|NCT00323622|101967430|FG005|STARTED|Overall Study||528||
48665824|NCT00323622|101967431|FG006|STARTED|Overall Study||43||
48665825|NCT00323622|101967432|FG007|STARTED|Overall Study||140||
48665826|NCT00323622|101967425|FG000|COMPLETED|Overall Study||145||
48665827|NCT00323622|101967426|FG001|COMPLETED|Overall Study||423||
48665828|NCT00323622|101967427|FG002|COMPLETED|Overall Study||38||
48665829|NCT00323622|101967428|FG003|COMPLETED|Overall Study||122||
48665830|NCT00323622|101967429|FG004|COMPLETED|Overall Study||120||
48665831|NCT00323622|101967430|FG005|COMPLETED|Overall Study||454||
48665832|NCT00323622|101967431|FG006|COMPLETED|Overall Study||38||
48665833|NCT00323622|101967432|FG007|COMPLETED|Overall Study||125||
48665834|NCT00323622|101967425|FG000|NOT COMPLETED|Overall Study||31||
48665835|NCT00323622|101967426|FG001|NOT COMPLETED|Overall Study||92||
48665836|NCT00323622|101967427|FG002|NOT COMPLETED|Overall Study||4||
48665837|NCT00323622|101967428|FG003|NOT COMPLETED|Overall Study||12||
48665838|NCT00323622|101967429|FG004|NOT COMPLETED|Overall Study||39||
48665839|NCT00323622|101967430|FG005|NOT COMPLETED|Overall Study||74||
48665840|NCT00323622|101967431|FG006|NOT COMPLETED|Overall Study||5||
48665841|NCT00323622|101967432|FG007|NOT COMPLETED|Overall Study||15||
48665842|NCT04255381|101967433|FG000|STARTED|Overall Study||20||
48665843|NCT04255381|101967433|FG000|COMPLETED|Overall Study||20||
48665844|NCT04255381|101967433|FG000|NOT COMPLETED|Overall Study||0||
48665845|NCT02657343|101967434|FG000|STARTED|Overall Study||3||
48665846|NCT02657343|101967435|FG001|STARTED|Overall Study||3||
48665847|NCT02657343|101967436|FG002|STARTED|Overall Study||3||
48665848|NCT02657343|101967437|FG003|STARTED|Overall Study||3||
48665849|NCT02657343|101967438|FG004|STARTED|Overall Study||13||
48665850|NCT02657343|101967439|FG005|STARTED|Overall Study||0||
48665851|NCT02657343|101967434|FG000|COMPLETED|Overall Study||2||
48665852|NCT02657343|101967435|FG001|COMPLETED|Overall Study||1||
48665853|NCT02657343|101967436|FG002|COMPLETED|Overall Study||3||
48665854|NCT02657343|101967437|FG003|COMPLETED|Overall Study||3||
48665855|NCT02657343|101967438|FG004|COMPLETED|Overall Study||12||
48665856|NCT02657343|101967439|FG005|COMPLETED|Overall Study||0||
48665857|NCT02657343|101967434|FG000|NOT COMPLETED|Overall Study||1||
48665858|NCT02657343|101967435|FG001|NOT COMPLETED|Overall Study||2||
48665859|NCT02657343|101967436|FG002|NOT COMPLETED|Overall Study||0||
48665860|NCT02657343|101967437|FG003|NOT COMPLETED|Overall Study||0||
48665861|NCT02657343|101967438|FG004|NOT COMPLETED|Overall Study||1||
48665862|NCT02657343|101967439|FG005|NOT COMPLETED|Overall Study||0||
48665863|NCT03729609|101967440|FG000|STARTED|Overall Study||113||
48665864|NCT03729609|101967440|FG000|COMPLETED|Overall Study||112||
48665865|NCT03729609|101967440|FG000|NOT COMPLETED|Overall Study||1||
48665866|NCT04724837|101967441|FG000|STARTED|Overall Study||91||
48665867|NCT04724837|101967442|FG001|STARTED|Overall Study||179||
48665868|NCT04724837|101967443|FG002|STARTED|Overall Study||177||
48665869|NCT04724837|101967441|FG000|Full Analysis Set|Overall Study||91||
48665870|NCT04724837|101967442|FG001|Full Analysis Set|Overall Study||179||
48665871|NCT04724837|101967443|FG002|Full Analysis Set|Overall Study||177||
48665872|NCT04724837|101967441|FG000|Safety Analysis Set|Overall Study||91||
48665873|NCT04724837|101967442|FG001|Safety Analysis Set|Overall Study||179||
48665874|NCT04724837|101967443|FG002|Safety Analysis Set|Overall Study||177||
48665875|NCT04724837|101967441|FG000|COMPLETED|Overall Study||82||
48665876|NCT04724837|101967442|FG001|COMPLETED|Overall Study||142||
48665877|NCT04724837|101967443|FG002|COMPLETED|Overall Study||157||
48665878|NCT04724837|101967441|FG000|NOT COMPLETED|Overall Study||9||
48665879|NCT04724837|101967442|FG001|NOT COMPLETED|Overall Study||37||
48665880|NCT04724837|101967443|FG002|NOT COMPLETED|Overall Study||20||
48665881|NCT00668642|101967444|FG000|STARTED|First Off-cycle||7||
48665882|NCT00668642|101967445|FG001|STARTED|First Off-cycle||6||
48665883|NCT00668642|101967444|FG000|Research Biopsy|First Off-cycle||4|A research biopsy of the prostate was planned at end of off-cycle 1 to determine expression of U19 tumor suppressor gene|
48665884|NCT00668642|101967445|FG001|Research Biopsy|First Off-cycle||3|A research biopsy of the prostate was planned at end of off-cycle 1 to determine expression of U19 tumor suppressor gene|
48665885|NCT00668642|101967444|FG000|COMPLETED|First Off-cycle||6||
48665886|NCT00668642|101967445|FG001|COMPLETED|First Off-cycle||6||
48665887|NCT00668642|101967444|FG000|NOT COMPLETED|First Off-cycle||1||
48665888|NCT00668642|101967445|FG001|NOT COMPLETED|First Off-cycle||0||
48665889|NCT00668642|101967444|FG000|STARTED|Second AAT Treatment (On-cycle 2)||6||
48665890|NCT00668642|101967445|FG001|STARTED|Second AAT Treatment (On-cycle 2)||6||
48665891|NCT00668642|101967444|FG000|COMPLETED|Second AAT Treatment (On-cycle 2)||4||
48784397|NCT00119678|102262773|FG001|RANDOMIZED AND TREATED|Double-blind Treatment Period||59||
48784398|NCT00119678|102262772|FG000|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||118||
48784399|NCT00119678|102262773|FG001|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||57||
48784400|NCT00119678|102262772|FG000|COMPLETED|Double-blind Treatment Period||81||
48784401|NCT00119678|102262773|FG001|COMPLETED|Double-blind Treatment Period||35||
48784402|NCT00119678|102262772|FG000|NOT COMPLETED|Double-blind Treatment Period||41||
48784403|NCT00119678|102262773|FG001|NOT COMPLETED|Double-blind Treatment Period||26||
48784404|NCT00119678|102262772|FG000|STARTED|Open-label Treatment Period||110||
48784405|NCT00119678|102262773|FG001|STARTED|Open-label Treatment Period||0||
48784406|NCT00119678|102262772|FG000|COMPLETED|Open-label Treatment Period||0||
48784407|NCT00119678|102262773|FG001|COMPLETED|Open-label Treatment Period||0||
48784408|NCT00119678|102262772|FG000|NOT COMPLETED|Open-label Treatment Period||110||
48784409|NCT00119678|102262773|FG001|NOT COMPLETED|Open-label Treatment Period||0||
48784410|NCT01743859|102262774|FG000|STARTED|Overall Study||37||
48784411|NCT01743859|102262774|FG000|COMPLETED|Overall Study||28||
48784412|NCT01743859|102262774|FG000|NOT COMPLETED|Overall Study||9||
48784413|NCT00375609|102262775|FG000|STARTED|Overall Study||88||
48784414|NCT00375609|102262776|FG001|STARTED|Overall Study||84||
48784415|NCT00375609|102262777|FG002|STARTED|Overall Study||43||
48784416|NCT00375609|102262775|FG000|COMPLETED|Overall Study||84||
48784417|NCT00375609|102262776|FG001|COMPLETED|Overall Study||77||
48784418|NCT00375609|102262777|FG002|COMPLETED|Overall Study||42||
48784419|NCT00375609|102262775|FG000|NOT COMPLETED|Overall Study||4||
48784420|NCT00375609|102262776|FG001|NOT COMPLETED|Overall Study||7||
48784421|NCT00375609|102262777|FG002|NOT COMPLETED|Overall Study||1||
48784422|NCT04114617|102262778|FG000|STARTED|Overall Study||80||
48784423|NCT04114617|102262778|FG000|COMPLETED|Overall Study||80||
48784424|NCT04114617|102262778|FG000|NOT COMPLETED|Overall Study||0||
48784425|NCT03093662|102262779|FG000|STARTED|First Intervention (3 Minutes)||18||
48784426|NCT03093662|102262780|FG001|STARTED|First Intervention (3 Minutes)||19||
48784427|NCT03093662|102262779|FG000|COMPLETED|First Intervention (3 Minutes)||18||
48784428|NCT03093662|102262780|FG001|COMPLETED|First Intervention (3 Minutes)||19||
48784429|NCT03093662|102262779|FG000|NOT COMPLETED|First Intervention (3 Minutes)||0||
48784430|NCT03093662|102262780|FG001|NOT COMPLETED|First Intervention (3 Minutes)||0||
48784431|NCT03093662|102262779|FG000|STARTED|Washout Period (5 Minutes)||18||
48784432|NCT03093662|102262780|FG001|STARTED|Washout Period (5 Minutes)||19||
48784433|NCT03093662|102262779|FG000|COMPLETED|Washout Period (5 Minutes)||18||
48784434|NCT03093662|102262780|FG001|COMPLETED|Washout Period (5 Minutes)||19||
48784435|NCT03093662|102262779|FG000|NOT COMPLETED|Washout Period (5 Minutes)||0||
48784436|NCT03093662|102262780|FG001|NOT COMPLETED|Washout Period (5 Minutes)||0||
48784437|NCT03093662|102262779|FG000|STARTED|Second Intervention (3 Minutes)||18||
48784438|NCT03093662|102262780|FG001|STARTED|Second Intervention (3 Minutes)||19||
48784439|NCT03093662|102262779|FG000|COMPLETED|Second Intervention (3 Minutes)||18||
48784440|NCT03093662|102262780|FG001|COMPLETED|Second Intervention (3 Minutes)||19||
48784441|NCT03093662|102262779|FG000|NOT COMPLETED|Second Intervention (3 Minutes)||0||
48784442|NCT03093662|102262780|FG001|NOT COMPLETED|Second Intervention (3 Minutes)||0||
48784443|NCT00470834|102262781|FG000|STARTED|Treatment Period (18 Months)||65||
48784444|NCT00470834|102262782|FG001|STARTED|Treatment Period (18 Months)||62||
48784445|NCT00470834|102262781|FG000|COMPLETED|Treatment Period (18 Months)||27||
48784446|NCT00470834|102262782|FG001|COMPLETED|Treatment Period (18 Months)||31||
48784447|NCT00470834|102262781|FG000|NOT COMPLETED|Treatment Period (18 Months)||38||
48784448|NCT00470834|102262782|FG001|NOT COMPLETED|Treatment Period (18 Months)||31||
48784449|NCT00470834|102262781|FG000|STARTED|Extension Period (24 Months)||26||
48784450|NCT00470834|102262782|FG001|STARTED|Extension Period (24 Months)||30||
48784451|NCT00470834|102262781|FG000|COMPLETED|Extension Period (24 Months)||11||
48784452|NCT00470834|102262782|FG001|COMPLETED|Extension Period (24 Months)||7||
48784453|NCT00470834|102262781|FG000|NOT COMPLETED|Extension Period (24 Months)||15||
48784454|NCT00470834|102262782|FG001|NOT COMPLETED|Extension Period (24 Months)||23||
48784455|NCT00833664|102262783|FG000|STARTED|First Intervention||11||
48784456|NCT00833664|102262784|FG001|STARTED|First Intervention||11||
48784457|NCT00833664|102262783|FG000|COMPLETED|First Intervention||11||
48784458|NCT00833664|102262784|FG001|COMPLETED|First Intervention||11||
48784459|NCT00833664|102262783|FG000|NOT COMPLETED|First Intervention||0||
48784460|NCT00833664|102262784|FG001|NOT COMPLETED|First Intervention||0||
48784461|NCT00833664|102262783|FG000|STARTED|Washout: 14 Days||11||
48784462|NCT00833664|102262784|FG001|STARTED|Washout: 14 Days||11||
48784463|NCT00833664|102262783|FG000|COMPLETED|Washout: 14 Days||10||
48784464|NCT00833664|102262784|FG001|COMPLETED|Washout: 14 Days||11||
48784465|NCT00833664|102262783|FG000|NOT COMPLETED|Washout: 14 Days||1||
48784466|NCT00833664|102262784|FG001|NOT COMPLETED|Washout: 14 Days||0||
48784467|NCT00833664|102262783|FG000|STARTED|Second Intervention||10||
48784468|NCT00833664|102262784|FG001|STARTED|Second Intervention||11||
48784469|NCT00833664|102262783|FG000|COMPLETED|Second Intervention||10||
48784470|NCT00833664|102262784|FG001|COMPLETED|Second Intervention||11||
48784471|NCT00833664|102262783|FG000|NOT COMPLETED|Second Intervention||0||
48784472|NCT00833664|102262784|FG001|NOT COMPLETED|Second Intervention||0||
48784473|NCT04050202|102262785|FG000|STARTED|Overall Study||42||
48784474|NCT04050202|102262785|FG000|COMPLETED|Overall Study||40||
48784475|NCT04050202|102262785|FG000|NOT COMPLETED|Overall Study||2||
48784476|NCT00388583|102262786|FG000|STARTED|Overall Study||407||
48784477|NCT00388583|102262787|FG001|STARTED|Overall Study||410||
48784478|NCT00388583|102262786|FG000|COMPLETED|Overall Study||401||
48784479|NCT00388583|102262787|FG001|COMPLETED|Overall Study||406||
48784480|NCT00388583|102262786|FG000|NOT COMPLETED|Overall Study||6||
48784481|NCT00388583|102262787|FG001|NOT COMPLETED|Overall Study||4||
48784482|NCT02654717|102262788|FG000|STARTED|Overall Study||56||
48784483|NCT02654717|102262789|FG001|STARTED|Overall Study||55||
48784484|NCT02654717|102262788|FG000|COMPLETED|Overall Study||50||
48784485|NCT02654717|102262789|FG001|COMPLETED|Overall Study||50||
48784486|NCT02654717|102262788|FG000|NOT COMPLETED|Overall Study||6||
48784487|NCT02654717|102262789|FG001|NOT COMPLETED|Overall Study||5||
48784488|NCT02874144|102262790|FG000|STARTED|Overall Study||22||
48784489|NCT02874144|102262791|FG001|STARTED|Overall Study||21||
48784490|NCT02874144|102262790|FG000|COMPLETED|Overall Study||19||
48784491|NCT02874144|102262791|FG001|COMPLETED|Overall Study||16||
48784492|NCT02874144|102262790|FG000|NOT COMPLETED|Overall Study||3||
48784493|NCT02874144|102262791|FG001|NOT COMPLETED|Overall Study||5||
48784494|NCT00611403|102262792|FG000|STARTED|Treatment Phase||68||
48784495|NCT00611403|102262793|FG001|STARTED|Treatment Phase||69||
48784496|NCT00611403|102262792|FG000|COMPLETED|Treatment Phase||62||
48784497|NCT00611403|102262793|FG001|COMPLETED|Treatment Phase||58||
48784498|NCT00611403|102262792|FG000|NOT COMPLETED|Treatment Phase||6||
48784499|NCT00611403|102262793|FG001|NOT COMPLETED|Treatment Phase||11||
48784500|NCT00611403|102262792|FG000|STARTED|Post Treatment Extension Phase||26||
48784501|NCT00611403|102262793|FG001|STARTED|Post Treatment Extension Phase||25||
48784502|NCT00611403|102262792|FG000|COMPLETED|Post Treatment Extension Phase||22||
48784503|NCT00611403|102262793|FG001|COMPLETED|Post Treatment Extension Phase||24||
48784504|NCT00611403|102262792|FG000|NOT COMPLETED|Post Treatment Extension Phase||4||
48784505|NCT00611403|102262793|FG001|NOT COMPLETED|Post Treatment Extension Phase||1||
48784506|NCT01250145|102262794|FG000|STARTED|Overall Study||41||
48784507|NCT01250145|102262795|FG001|STARTED|Overall Study||210||
48784508|NCT01250145|102262794|FG000|COMPLETED|Overall Study||39||
48784509|NCT01250145|102262795|FG001|COMPLETED|Overall Study||205||
48784510|NCT01250145|102262794|FG000|NOT COMPLETED|Overall Study||2||
48784511|NCT01250145|102262795|FG001|NOT COMPLETED|Overall Study||5||
48784512|NCT03567343|102262796|FG000|STARTED|Overall Study||53||
48784513|NCT03567343|102262797|FG001|STARTED|Overall Study||52||
48784514|NCT03567343|102262796|FG000|COMPLETED|Overall Study||47||
48784515|NCT03567343|102262797|FG001|COMPLETED|Overall Study||49||
48784516|NCT03567343|102262796|FG000|NOT COMPLETED|Overall Study||6||
48784517|NCT03567343|102262797|FG001|NOT COMPLETED|Overall Study||3||
48784518|NCT01981551|102262798|FG000|STARTED|Overall Study||17||
48784519|NCT01981551|102262798|FG000|COMPLETED|Overall Study||8||
48784520|NCT01981551|102262798|FG000|NOT COMPLETED|Overall Study||9||
48784521|NCT02547363|102262799|FG000|STARTED|3-day Treatment and 8-week Follow-up||211||
48784522|NCT02547363|102262800|FG001|STARTED|3-day Treatment and 8-week Follow-up||105||
48784523|NCT02547363|102262799|FG000|Treated|3-day Treatment and 8-week Follow-up||209||
48784524|NCT02547363|102262800|FG001|Treated|3-day Treatment and 8-week Follow-up||104||
48784525|NCT02547363|102262799|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||207||
48784526|NCT02547363|102262800|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||94||
48784527|NCT02547363|102262799|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||4||
48784528|NCT02547363|102262800|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||11||
48784529|NCT02547363|102262799|FG000|STARTED|12-month Follow-up||204||
48784530|NCT02547363|102262800|FG001|STARTED|12-month Follow-up||86||
48784531|NCT02547363|102262799|FG000|COMPLETED|12-month Follow-up||194||
48784532|NCT02547363|102262800|FG001|COMPLETED|12-month Follow-up||81||
48784533|NCT02547363|102262799|FG000|NOT COMPLETED|12-month Follow-up||10||
48784534|NCT02547363|102262800|FG001|NOT COMPLETED|12-month Follow-up||5||
48784535|NCT01112306|102262801|FG000|STARTED|Overall Study||709||
48784536|NCT01112306|102262801|FG000|COMPLETED|Overall Study||424||
48784537|NCT01112306|102262801|FG000|NOT COMPLETED|Overall Study||285||
48784538|NCT01451437|102262802|FG000|STARTED|Overall Study||1||
48784539|NCT01451437|102262803|FG001|STARTED|Overall Study||1||
48784540|NCT01451437|102262804|FG002|STARTED|Overall Study||3||
48784541|NCT01451437|102262805|FG003|STARTED|Overall Study||1||
48784542|NCT01451437|102262806|FG004|STARTED|Overall Study||4||
48784543|NCT01451437|102262807|FG005|STARTED|Overall Study||3||
48784544|NCT01451437|102262808|FG006|STARTED|Overall Study||6||
48784545|NCT01451437|102262809|FG007|STARTED|Overall Study||3||
48784546|NCT01451437|102262810|FG008|STARTED|Overall Study||4||
48784547|NCT01451437|102262802|FG000|COMPLETED|Overall Study||0||
48784548|NCT01451437|102262803|FG001|COMPLETED|Overall Study||0||
48784549|NCT01451437|102262804|FG002|COMPLETED|Overall Study||0||
48784550|NCT01451437|102262805|FG003|COMPLETED|Overall Study||0||
48784551|NCT01451437|102262806|FG004|COMPLETED|Overall Study||0||
48784552|NCT01451437|102262807|FG005|COMPLETED|Overall Study||0||
48784553|NCT01451437|102262808|FG006|COMPLETED|Overall Study||0||
48784554|NCT01451437|102262809|FG007|COMPLETED|Overall Study||0||
48784555|NCT01451437|102262810|FG008|COMPLETED|Overall Study||0||
48784556|NCT01451437|102262802|FG000|NOT COMPLETED|Overall Study||1||
48784557|NCT01451437|102262803|FG001|NOT COMPLETED|Overall Study||1||
48784558|NCT01451437|102262804|FG002|NOT COMPLETED|Overall Study||3||
48784559|NCT01451437|102262805|FG003|NOT COMPLETED|Overall Study||1||
48784560|NCT01451437|102262806|FG004|NOT COMPLETED|Overall Study||4||
48784561|NCT01451437|102262807|FG005|NOT COMPLETED|Overall Study||3||
48784562|NCT01451437|102262808|FG006|NOT COMPLETED|Overall Study||6||
48784563|NCT01451437|102262809|FG007|NOT COMPLETED|Overall Study||3||
48784564|NCT01451437|102262810|FG008|NOT COMPLETED|Overall Study||4||
48784565|NCT03642132|102262811|FG000|STARTED|Chemotherapy Period||32||
48784566|NCT03642132|102262812|FG001|STARTED|Chemotherapy Period||13||
48784567|NCT03642132|102262813|FG002|STARTED|Chemotherapy Period||34||
48784568|NCT03642132|102262811|FG000|COMPLETED|Chemotherapy Period||19||
48784569|NCT03642132|102262812|FG001|COMPLETED|Chemotherapy Period||8||
48784570|NCT03642132|102262813|FG002|COMPLETED|Chemotherapy Period||27||
48784571|NCT03642132|102262811|FG000|NOT COMPLETED|Chemotherapy Period||13||
48467183|NCT01654380|101480892|FG000|COMPLETED|Part A, Washout of at Least 6 Days||4||
48467184|NCT01654380|101480893|FG001|COMPLETED|Part A, Washout of at Least 6 Days||4||
48467185|NCT01654380|101480894|FG002|COMPLETED|Part A, Washout of at Least 6 Days||0||
48189921|NCT04830514|100788968|FG002|STARTED|Overall Study||12||
48665892|NCT00668642|101967445|FG001|COMPLETED|Second AAT Treatment (On-cycle 2)||5||
48784572|NCT03642132|102262812|FG001|NOT COMPLETED|Chemotherapy Period||5||
48784573|NCT03642132|102262813|FG002|NOT COMPLETED|Chemotherapy Period||7||
48784574|NCT03642132|102262811|FG000|STARTED|Maintenance Period||18||
48784575|NCT03642132|102262812|FG001|STARTED|Maintenance Period||9||
48784576|NCT03642132|102262813|FG002|STARTED|Maintenance Period||23||
48784577|NCT03642132|102262811|FG000|COMPLETED|Maintenance Period||5||
48784578|NCT03642132|102262812|FG001|COMPLETED|Maintenance Period||1||
48784579|NCT03642132|102262813|FG002|COMPLETED|Maintenance Period||9||
48467186|NCT01654380|101480895|FG003|COMPLETED|Part A, Washout of at Least 6 Days||0||
48467187|NCT01654380|101480892|FG000|NOT COMPLETED|Part A, Washout of at Least 6 Days||0||
48467188|NCT01654380|101480893|FG001|NOT COMPLETED|Part A, Washout of at Least 6 Days||0||
48784580|NCT03642132|102262811|FG000|NOT COMPLETED|Maintenance Period||13||
48784581|NCT03642132|102262812|FG001|NOT COMPLETED|Maintenance Period||8||
48784582|NCT03642132|102262813|FG002|NOT COMPLETED|Maintenance Period||14||
48784583|NCT03642132|102262811|FG000|STARTED|Follow-up Period||19||
48784584|NCT03642132|102262812|FG001|STARTED|Follow-up Period||9||
48784585|NCT03642132|102262813|FG002|STARTED|Follow-up Period||28||
48784586|NCT03642132|102262811|FG000|COMPLETED|Follow-up Period||14||
48784587|NCT03642132|102262812|FG001|COMPLETED|Follow-up Period||7||
48784588|NCT03642132|102262813|FG002|COMPLETED|Follow-up Period||24||
48784589|NCT03642132|102262811|FG000|NOT COMPLETED|Follow-up Period||5||
48784590|NCT03642132|102262812|FG001|NOT COMPLETED|Follow-up Period||2||
48784591|NCT03642132|102262813|FG002|NOT COMPLETED|Follow-up Period||4||
48784592|NCT00918931|102262814|FG000|STARTED|Overall Study||3||
48784593|NCT00918931|102262814|FG000|COMPLETED|Overall Study||3||
48784594|NCT00918931|102262814|FG000|NOT COMPLETED|Overall Study||0||
48784595|NCT00832624|102262815|FG000|STARTED|Overall Study||10||
48784596|NCT00832624|102262815|FG000|COMPLETED|Overall Study||0||
48784597|NCT00832624|102262815|FG000|NOT COMPLETED|Overall Study||10||
48784598|NCT02194985|102262816|FG000|STARTED|Overall Study||84||
48784599|NCT02194985|102262816|FG000|Received at Least 1 Dose of Study Drug|Overall Study||84||
48784600|NCT02194985|102262816|FG000|COMPLETED|Overall Study||73||
48784601|NCT02194985|102262816|FG000|NOT COMPLETED|Overall Study||11||
48784602|NCT02471326|102262817|FG000|STARTED|Overall Study||10||
48784603|NCT02471326|102262817|FG000|COMPLETED|Overall Study||9||
48784604|NCT02471326|102262817|FG000|NOT COMPLETED|Overall Study||1||
48784605|NCT01700387|102262818|FG000|STARTED|Overall Study||10||
48784606|NCT01700387|102262819|FG001|STARTED|Overall Study||10||
48784607|NCT01700387|102262818|FG000|COMPLETED|Overall Study||6||
48784608|NCT01700387|102262819|FG001|COMPLETED|Overall Study||6||
48784609|NCT01700387|102262818|FG000|NOT COMPLETED|Overall Study||4||
48784610|NCT01700387|102262819|FG001|NOT COMPLETED|Overall Study||4||
48784611|NCT03241030|102262820|FG000|STARTED|Overall Study||50||
48784612|NCT03241030|102262821|FG001|STARTED|Overall Study||52||
48784613|NCT03241030|102262820|FG000|COMPLETED|Overall Study||49||
48784614|NCT03241030|102262821|FG001|COMPLETED|Overall Study||51||
48784615|NCT03241030|102262820|FG000|NOT COMPLETED|Overall Study||1||
48784616|NCT03241030|102262821|FG001|NOT COMPLETED|Overall Study||1||
48784617|NCT03801031|102262822|FG000|STARTED|Overall Study||3||
48784618|NCT03801031|102262823|FG001|STARTED|Overall Study||1||
48784619|NCT03801031|102262822|FG000|COMPLETED|Overall Study||1||
48784620|NCT03801031|102262823|FG001|COMPLETED|Overall Study||0||
48784621|NCT03801031|102262822|FG000|NOT COMPLETED|Overall Study||2||
48784622|NCT03801031|102262823|FG001|NOT COMPLETED|Overall Study||1||
48784623|NCT01788215|102262824|FG000|STARTED|Overall Study||5||
48784624|NCT01788215|102262825|FG001|STARTED|Overall Study||5||
48784625|NCT01788215|102262824|FG000|12 Weeks of Doxycycline or Placebo|Overall Study||5||
48784626|NCT01788215|102262825|FG001|12 Weeks of Doxycycline or Placebo|Overall Study||5||
48784627|NCT01788215|102262824|FG000|COMPLETED|Overall Study||3||
48784628|NCT01788215|102262825|FG001|COMPLETED|Overall Study||4||
48784629|NCT01788215|102262824|FG000|NOT COMPLETED|Overall Study||2||
48784630|NCT01788215|102262825|FG001|NOT COMPLETED|Overall Study||1||
48784631|NCT02925338|102262826|FG000|STARTED|Overall Study||547||
48784632|NCT02925338|102262827|FG001|STARTED|Overall Study||230||
48784633|NCT02925338|102262828|FG002|STARTED|Overall Study||142||
48784634|NCT02925338|102262829|FG003|STARTED|Overall Study||411||
48784635|NCT02925338|102262830|FG004|STARTED|Overall Study||96||
48784636|NCT02925338|102262826|FG000|Adult Population|Overall Study||530||
48784637|NCT02925338|102262827|FG001|Adult Population|Overall Study||221||
48784638|NCT02925338|102262828|FG002|Adult Population|Overall Study||142||
48784639|NCT02925338|102262829|FG003|Adult Population|Overall Study||411||
48784640|NCT02925338|102262830|FG004|Adult Population|Overall Study||96||
48784641|NCT02925338|102262826|FG000|Pediatric Population|Overall Study||17||
48784642|NCT02925338|102262827|FG001|Pediatric Population|Overall Study||9||
48784643|NCT02925338|102262828|FG002|Pediatric Population|Overall Study||0||
48784644|NCT02925338|102262829|FG003|Pediatric Population|Overall Study||0||
48784645|NCT02925338|102262830|FG004|Pediatric Population|Overall Study||0||
48784646|NCT02925338|102262826|FG000|COMPLETED|Overall Study||321||
48784647|NCT02925338|102262827|FG001|COMPLETED|Overall Study||119||
48784648|NCT02925338|102262828|FG002|COMPLETED|Overall Study||78||
48784649|NCT02925338|102262829|FG003|COMPLETED|Overall Study||251||
48784650|NCT02925338|102262830|FG004|COMPLETED|Overall Study||66||
48784651|NCT02925338|102262826|FG000|NOT COMPLETED|Overall Study||226||
48784652|NCT02925338|102262827|FG001|NOT COMPLETED|Overall Study||111||
48784653|NCT02925338|102262828|FG002|NOT COMPLETED|Overall Study||64||
48784654|NCT02925338|102262829|FG003|NOT COMPLETED|Overall Study||160||
48784655|NCT02925338|102262830|FG004|NOT COMPLETED|Overall Study||30||
48784656|NCT01588470|102262831|FG000|STARTED|Overall Study||130||
48784657|NCT01588470|102262831|FG000|COMPLETED|Overall Study||50||
48784658|NCT01588470|102262831|FG000|NOT COMPLETED|Overall Study||80||
48784659|NCT03236155|102262832|FG000|STARTED|Overall Study||143||
48784660|NCT03236155|102262833|FG001|STARTED|Overall Study||161||
48784661|NCT03236155|102262832|FG000|COMPLETED|Overall Study||143||
48784662|NCT03236155|102262833|FG001|COMPLETED|Overall Study||161||
48784663|NCT03236155|102262832|FG000|NOT COMPLETED|Overall Study||0||
48784664|NCT03236155|102262833|FG001|NOT COMPLETED|Overall Study||0||
48784665|NCT00744042|102262834|FG000|STARTED|Overall Study||11||
48784666|NCT00744042|102262834|FG000|COMPLETED|Overall Study||10||
48784667|NCT00744042|102262834|FG000|NOT COMPLETED|Overall Study||1||
48784668|NCT03159260|102262835|FG000|STARTED|Overall Study||28||
48784669|NCT03159260|102262836|FG001|STARTED|Overall Study||29||
48784670|NCT03159260|102262835|FG000|COMPLETED|Overall Study||25||
48784671|NCT03159260|102262836|FG001|COMPLETED|Overall Study||25||
48784672|NCT03159260|102262835|FG000|NOT COMPLETED|Overall Study||3||
48784673|NCT03159260|102262836|FG001|NOT COMPLETED|Overall Study||4||
48784674|NCT02891070|102262837|FG000|STARTED|Overall Study||110||
48784675|NCT02891070|102262838|FG001|STARTED|Overall Study||114||
48784676|NCT02891070|102262837|FG000|COMPLETED|Overall Study||100||
48784677|NCT02891070|102262838|FG001|COMPLETED|Overall Study||106||
48784678|NCT02891070|102262837|FG000|NOT COMPLETED|Overall Study||10||
48784679|NCT02891070|102262838|FG001|NOT COMPLETED|Overall Study||8||
48784680|NCT02778113|102262839|FG000|STARTED|Study Period One||4||
48784681|NCT02778113|102262840|FG001|STARTED|Study Period One||4||
48784682|NCT02778113|102262841|FG002|STARTED|Study Period One||4||
48784683|NCT02778113|102262842|FG003|STARTED|Study Period One||4||
48784684|NCT02778113|102262839|FG000|Received Study Drug|Study Period One||4||
48784685|NCT02778113|102262840|FG001|Received Study Drug|Study Period One||4||
48784686|NCT02778113|102262841|FG002|Received Study Drug|Study Period One||4||
48784687|NCT02778113|102262842|FG003|Received Study Drug|Study Period One||4||
48784688|NCT02778113|102262839|FG000|COMPLETED|Study Period One||4||
48784689|NCT02778113|102262840|FG001|COMPLETED|Study Period One||4||
48784690|NCT02778113|102262841|FG002|COMPLETED|Study Period One||4||
48784691|NCT02778113|102262842|FG003|COMPLETED|Study Period One||4||
48784692|NCT02778113|102262839|FG000|NOT COMPLETED|Study Period One||0||
48784693|NCT02778113|102262840|FG001|NOT COMPLETED|Study Period One||0||
48784694|NCT02778113|102262841|FG002|NOT COMPLETED|Study Period One||0||
48784695|NCT02778113|102262842|FG003|NOT COMPLETED|Study Period One||0||
48784696|NCT02778113|102262839|FG000|STARTED|Study Period Two||4||
48784697|NCT02778113|102262840|FG001|STARTED|Study Period Two||4||
48784698|NCT02778113|102262841|FG002|STARTED|Study Period Two||4||
48467189|NCT01654380|101480894|FG002|NOT COMPLETED|Part A, Washout of at Least 6 Days||0||
48467190|NCT01654380|101480895|FG003|NOT COMPLETED|Part A, Washout of at Least 6 Days||0||
48784699|NCT02778113|102262842|FG003|STARTED|Study Period Two||4||
48784700|NCT02778113|102262839|FG000|Received Study Drug|Study Period Two||4||
48784701|NCT02778113|102262840|FG001|Received Study Drug|Study Period Two||4||
48784702|NCT02778113|102262841|FG002|Received Study Drug|Study Period Two||4||
48784703|NCT02778113|102262842|FG003|Received Study Drug|Study Period Two||4||
48784704|NCT02778113|102262839|FG000|COMPLETED|Study Period Two||4||
48784705|NCT02778113|102262840|FG001|COMPLETED|Study Period Two||4||
48784706|NCT02778113|102262841|FG002|COMPLETED|Study Period Two||4||
48784707|NCT02778113|102262842|FG003|COMPLETED|Study Period Two||4||
48784708|NCT02778113|102262839|FG000|NOT COMPLETED|Study Period Two||0||
48784709|NCT02778113|102262840|FG001|NOT COMPLETED|Study Period Two||0||
48784710|NCT02778113|102262841|FG002|NOT COMPLETED|Study Period Two||0||
48784711|NCT02778113|102262842|FG003|NOT COMPLETED|Study Period Two||0||
48784712|NCT02778113|102262839|FG000|STARTED|Study Period Three||4||
48784713|NCT02778113|102262840|FG001|STARTED|Study Period Three||4||
48784714|NCT02778113|102262841|FG002|STARTED|Study Period Three||3||
48784715|NCT02778113|102262842|FG003|STARTED|Study Period Three||4||
48784716|NCT02778113|102262839|FG000|Received Study Drug|Study Period Three||4||
48784717|NCT02778113|102262840|FG001|Received Study Drug|Study Period Three||4||
48784718|NCT02778113|102262841|FG002|Received Study Drug|Study Period Three||3||
48784719|NCT02778113|102262842|FG003|Received Study Drug|Study Period Three||4||
48784720|NCT02778113|102262839|FG000|COMPLETED|Study Period Three||4||
48784721|NCT02778113|102262840|FG001|COMPLETED|Study Period Three||4||
48784722|NCT02778113|102262841|FG002|COMPLETED|Study Period Three||3||
48784723|NCT02778113|102262842|FG003|COMPLETED|Study Period Three||4||
48784724|NCT02778113|102262839|FG000|NOT COMPLETED|Study Period Three||0||
48784725|NCT02778113|102262840|FG001|NOT COMPLETED|Study Period Three||0||
48784726|NCT02778113|102262841|FG002|NOT COMPLETED|Study Period Three||0||
48784727|NCT02778113|102262842|FG003|NOT COMPLETED|Study Period Three||0||
48784728|NCT02778113|102262839|FG000|STARTED|Study Period Four||3||
48784729|NCT02778113|102262840|FG001|STARTED|Study Period Four||4||
48784730|NCT02778113|102262841|FG002|STARTED|Study Period Four||2||
48784731|NCT02778113|102262842|FG003|STARTED|Study Period Four||4||
48784732|NCT02778113|102262839|FG000|Received Study Drug|Study Period Four||3||
48784733|NCT02778113|102262840|FG001|Received Study Drug|Study Period Four||4||
48784734|NCT02778113|102262841|FG002|Received Study Drug|Study Period Four||2||
48784735|NCT02778113|102262842|FG003|Received Study Drug|Study Period Four||4||
48784736|NCT02778113|102262839|FG000|COMPLETED|Study Period Four||3||
48784737|NCT02778113|102262840|FG001|COMPLETED|Study Period Four||4||
48784738|NCT02778113|102262841|FG002|COMPLETED|Study Period Four||2||
48784739|NCT02778113|102262842|FG003|COMPLETED|Study Period Four||4||
48467191|NCT01654380|101480892|FG000|STARTED|Part A, Period 2||4||
48467192|NCT01654380|101480893|FG001|STARTED|Part A, Period 2||4||
48467193|NCT01654380|101480894|FG002|STARTED|Part A, Period 2||0||
48467194|NCT01654380|101480895|FG003|STARTED|Part A, Period 2||0||
48467195|NCT01654380|101480892|FG000|COMPLETED|Part A, Period 2||4||
48467196|NCT01654380|101480893|FG001|COMPLETED|Part A, Period 2||4||
48467197|NCT01654380|101480894|FG002|COMPLETED|Part A, Period 2||0||
48467198|NCT01654380|101480895|FG003|COMPLETED|Part A, Period 2||0||
48467199|NCT01654380|101480892|FG000|NOT COMPLETED|Part A, Period 2||0||
48467200|NCT01654380|101480893|FG001|NOT COMPLETED|Part A, Period 2||0||
48467201|NCT01654380|101480894|FG002|NOT COMPLETED|Part A, Period 2||0||
48467202|NCT01654380|101480895|FG003|NOT COMPLETED|Part A, Period 2||0||
48467203|NCT01654380|101480892|FG000|STARTED|Part A, Washout of at Least 6 Days||4||
48467204|NCT01654380|101480893|FG001|STARTED|Part A, Washout of at Least 6 Days||4||
48467205|NCT01654380|101480894|FG002|STARTED|Part A, Washout of at Least 6 Days||0||
48467206|NCT01654380|101480895|FG003|STARTED|Part A, Washout of at Least 6 Days||0||
48467207|NCT01654380|101480892|FG000|COMPLETED|Part A, Washout of at Least 6 Days||4||
48467208|NCT01654380|101480893|FG001|COMPLETED|Part A, Washout of at Least 6 Days||4||
48467209|NCT01654380|101480894|FG002|COMPLETED|Part A, Washout of at Least 6 Days||0||
48467210|NCT01654380|101480895|FG003|COMPLETED|Part A, Washout of at Least 6 Days||0||
48467211|NCT01654380|101480892|FG000|NOT COMPLETED|Part A, Washout of at Least 6 Days||0||
48467212|NCT01654380|101480893|FG001|NOT COMPLETED|Part A, Washout of at Least 6 Days||0||
48467213|NCT01654380|101480894|FG002|NOT COMPLETED|Part A, Washout of at Least 6 Days||0||
48467214|NCT01654380|101480895|FG003|NOT COMPLETED|Part A, Washout of at Least 6 Days||0||
48467215|NCT01654380|101480892|FG000|STARTED|Part A, Period 3||4||
48467216|NCT01654380|101480893|FG001|STARTED|Part A, Period 3||4||
48467217|NCT01654380|101480894|FG002|STARTED|Part A, Period 3||0||
48467218|NCT01654380|101480895|FG003|STARTED|Part A, Period 3||0||
48467219|NCT01654380|101480892|FG000|COMPLETED|Part A, Period 3||4||
48467220|NCT01654380|101480893|FG001|COMPLETED|Part A, Period 3||4||
48467221|NCT01654380|101480894|FG002|COMPLETED|Part A, Period 3||0||
48467222|NCT01654380|101480895|FG003|COMPLETED|Part A, Period 3||0||
48467223|NCT01654380|101480892|FG000|NOT COMPLETED|Part A, Period 3||0||
48467224|NCT01654380|101480893|FG001|NOT COMPLETED|Part A, Period 3||0||
48467225|NCT01654380|101480894|FG002|NOT COMPLETED|Part A, Period 3||0||
48467226|NCT01654380|101480895|FG003|NOT COMPLETED|Part A, Period 3||0||
48467227|NCT01654380|101480892|FG000|STARTED|Part A, Washout of at Least 6 Days||4||
48467228|NCT01654380|101480893|FG001|STARTED|Part A, Washout of at Least 6 Days||4||
48467229|NCT01654380|101480894|FG002|STARTED|Part A, Washout of at Least 6 Days||0||
48467230|NCT01654380|101480895|FG003|STARTED|Part A, Washout of at Least 6 Days||0||
48467231|NCT01654380|101480892|FG000|COMPLETED|Part A, Washout of at Least 6 Days||4||
48467232|NCT01654380|101480893|FG001|COMPLETED|Part A, Washout of at Least 6 Days||4||
48467233|NCT01654380|101480894|FG002|COMPLETED|Part A, Washout of at Least 6 Days||0||
48467234|NCT01654380|101480895|FG003|COMPLETED|Part A, Washout of at Least 6 Days||0||
48467235|NCT01654380|101480892|FG000|NOT COMPLETED|Part A, Washout of at Least 6 Days||0||
48467236|NCT01654380|101480893|FG001|NOT COMPLETED|Part A, Washout of at Least 6 Days||0||
48467237|NCT01654380|101480894|FG002|NOT COMPLETED|Part A, Washout of at Least 6 Days||0||
48467238|NCT01654380|101480895|FG003|NOT COMPLETED|Part A, Washout of at Least 6 Days||0||
48467239|NCT01654380|101480892|FG000|STARTED|Part A, Period 4||4||
48467240|NCT01654380|101480893|FG001|STARTED|Part A, Period 4||4||
48467241|NCT01654380|101480894|FG002|STARTED|Part A, Period 4||0||
48467242|NCT01654380|101480895|FG003|STARTED|Part A, Period 4||0||
48467243|NCT01654380|101480892|FG000|COMPLETED|Part A, Period 4||4||
48467244|NCT01654380|101480893|FG001|COMPLETED|Part A, Period 4||4||
48467245|NCT01654380|101480894|FG002|COMPLETED|Part A, Period 4||0||
48467246|NCT01654380|101480895|FG003|COMPLETED|Part A, Period 4||0||
48467247|NCT01654380|101480892|FG000|NOT COMPLETED|Part A, Period 4||0||
48467248|NCT01654380|101480893|FG001|NOT COMPLETED|Part A, Period 4||0||
48467249|NCT01654380|101480894|FG002|NOT COMPLETED|Part A, Period 4||0||
48784740|NCT02778113|102262839|FG000|NOT COMPLETED|Study Period Four||0||
48784741|NCT02778113|102262840|FG001|NOT COMPLETED|Study Period Four||0||
48784742|NCT02778113|102262841|FG002|NOT COMPLETED|Study Period Four||0||
48784743|NCT02778113|102262842|FG003|NOT COMPLETED|Study Period Four||0||
48784744|NCT01764919|102262843|FG000|STARTED|Overall Study||4||
48467250|NCT01654380|101480895|FG003|NOT COMPLETED|Part A, Period 4||0||
48467251|NCT01654380|101480892|FG000|STARTED|Part B, Period 1||0||
48467252|NCT01654380|101480893|FG001|STARTED|Part B, Period 1||0||
48467253|NCT01654380|101480894|FG002|STARTED|Part B, Period 1||7||
48467254|NCT01654380|101480895|FG003|STARTED|Part B, Period 1||7||
48467255|NCT01654380|101480892|FG000|Received at Least 1 Dose of Study Drug|Part B, Period 1||0||
48467256|NCT01654380|101480893|FG001|Received at Least 1 Dose of Study Drug|Part B, Period 1||0||
48467257|NCT01654380|101480894|FG002|Received at Least 1 Dose of Study Drug|Part B, Period 1||7||
48467258|NCT01654380|101480895|FG003|Received at Least 1 Dose of Study Drug|Part B, Period 1||7||
48467259|NCT01654380|101480892|FG000|COMPLETED|Part B, Period 1||0||
48467260|NCT01654380|101480893|FG001|COMPLETED|Part B, Period 1||0||
48467261|NCT01654380|101480894|FG002|COMPLETED|Part B, Period 1||6||
48467262|NCT01654380|101480895|FG003|COMPLETED|Part B, Period 1||7||
48784745|NCT01764919|102262843|FG000|COMPLETED|Overall Study||4||
48784746|NCT01764919|102262843|FG000|NOT COMPLETED|Overall Study||0||
48784747|NCT01155011|102262844|FG000|STARTED|Baseline to 6 Months||151||
48784748|NCT01155011|102262845|FG001|STARTED|Baseline to 6 Months||156||
48784749|NCT01155011|102262844|FG000|COMPLETED|Baseline to 6 Months||129||
48784750|NCT01155011|102262845|FG001|COMPLETED|Baseline to 6 Months||131||
48784751|NCT01155011|102262844|FG000|NOT COMPLETED|Baseline to 6 Months||22||
48784752|NCT01155011|102262845|FG001|NOT COMPLETED|Baseline to 6 Months||25||
48784753|NCT01155011|102262844|FG000|STARTED|6 to 12 Months||129||
48784754|NCT01155011|102262845|FG001|STARTED|6 to 12 Months||131||
48784755|NCT01155011|102262844|FG000|COMPLETED|6 to 12 Months||120||
48784756|NCT01155011|102262845|FG001|COMPLETED|6 to 12 Months||121||
48784757|NCT01155011|102262844|FG000|NOT COMPLETED|6 to 12 Months||9||
48784758|NCT01155011|102262845|FG001|NOT COMPLETED|6 to 12 Months||10||
48784759|NCT05194579|102262846|FG000|STARTED|Overall Study||70||
48784760|NCT05194579|102262847|FG001|STARTED|Overall Study||71||
48784761|NCT05194579|102262846|FG000|Assigned to Treatment|Overall Study||70||
48784762|NCT05194579|102262847|FG001|Assigned to Treatment|Overall Study||71||
48784763|NCT05194579|102262846|FG000|COMPLETED|Overall Study||64||
48784764|NCT05194579|102262847|FG001|COMPLETED|Overall Study||63||
48784765|NCT05194579|102262846|FG000|NOT COMPLETED|Overall Study||6||
48784766|NCT05194579|102262847|FG001|NOT COMPLETED|Overall Study||8||
48784767|NCT03079102|102262848|FG000|STARTED|Overall Study||30||
48784768|NCT03079102|102262849|FG001|STARTED|Overall Study||27||
48784769|NCT03079102|102262848|FG000|COMPLETED|Overall Study||30||
48784770|NCT03079102|102262849|FG001|COMPLETED|Overall Study||26||
48784771|NCT03079102|102262848|FG000|NOT COMPLETED|Overall Study||0||
48784772|NCT03079102|102262849|FG001|NOT COMPLETED|Overall Study||1||
48784773|NCT00856414|102262850|FG000|STARTED|Overall Study||45||
48784774|NCT00856414|102262850|FG000|COMPLETED|Overall Study||45||
48784775|NCT00856414|102262850|FG000|NOT COMPLETED|Overall Study||0||
48784776|NCT03145818|102262851|FG000|STARTED|Overall Study||99||
48784777|NCT03145818|102262852|FG001|STARTED|Overall Study||8||
48784778|NCT03145818|102262853|FG002|STARTED|Overall Study||10||
48784779|NCT03145818|102262854|FG003|STARTED|Overall Study||9||
48784780|NCT03145818|102262851|FG000|COMPLETED|Overall Study||8||
48784781|NCT03145818|102262852|FG001|COMPLETED|Overall Study||0||
48784782|NCT03145818|102262853|FG002|COMPLETED|Overall Study||10||
48784783|NCT03145818|102262854|FG003|COMPLETED|Overall Study||9||
48784784|NCT03145818|102262851|FG000|NOT COMPLETED|Overall Study||91||
48784785|NCT03145818|102262852|FG001|NOT COMPLETED|Overall Study||8||
48784786|NCT03145818|102262853|FG002|NOT COMPLETED|Overall Study||0||
48784787|NCT03145818|102262854|FG003|NOT COMPLETED|Overall Study||0||
48784788|NCT04657666|102262855|FG000|STARTED|Period 1||33||
48784789|NCT04657666|102262856|FG001|STARTED|Period 1||35||
48784790|NCT04657666|102262855|FG000|COMPLETED|Period 1||30||
48784791|NCT04657666|102262856|FG001|COMPLETED|Period 1||33||
48784792|NCT04657666|102262855|FG000|NOT COMPLETED|Period 1||3||
48784793|NCT04657666|102262856|FG001|NOT COMPLETED|Period 1||2||
48784794|NCT04657666|102262855|FG000|STARTED|Period 2||30||
48784795|NCT04657666|102262856|FG001|STARTED|Period 2||33||
48784796|NCT04657666|102262855|FG000|COMPLETED|Period 2||28||
48784797|NCT04657666|102262856|FG001|COMPLETED|Period 2||30||
48784798|NCT04657666|102262855|FG000|NOT COMPLETED|Period 2||2||
48784799|NCT04657666|102262856|FG001|NOT COMPLETED|Period 2||3||
48784800|NCT04126278|102262857|FG000|STARTED|Overall Study||0||
48784801|NCT04126278|102262858|FG001|STARTED|Overall Study||4||
48784802|NCT04126278|102262857|FG000|COMPLETED|Overall Study||0||
48784803|NCT04126278|102262858|FG001|COMPLETED|Overall Study||4||
48784804|NCT04126278|102262857|FG000|NOT COMPLETED|Overall Study||0||
48784805|NCT04126278|102262858|FG001|NOT COMPLETED|Overall Study||0||
48784806|NCT01788358|102262859|FG000|STARTED|Overall Study||508||
48784807|NCT01788358|102262859|FG000|Treated|Overall Study||508||
48784808|NCT01788358|102262859|FG000|Completed Week 28|Overall Study||417||
48784809|NCT01788358|102262859|FG000|Entered Extension to Week 52|Overall Study||200||
48784810|NCT01788358|102262859|FG000|Completed Week 52|Overall Study||193||
48784811|NCT01788358|102262859|FG000|COMPLETED|Overall Study||410||
48784812|NCT01788358|102262859|FG000|NOT COMPLETED|Overall Study||98||
48784813|NCT02878798|102262860|FG000|STARTED|Overall Study||66||
48784814|NCT02878798|102262861|FG001|STARTED|Overall Study||66||
48784815|NCT02878798|102262860|FG000|COMPLETED|Overall Study||59||
48784816|NCT02878798|102262861|FG001|COMPLETED|Overall Study||59||
48784817|NCT02878798|102262860|FG000|NOT COMPLETED|Overall Study||7||
48784818|NCT02878798|102262861|FG001|NOT COMPLETED|Overall Study||7||
48784819|NCT02371941|102262862|FG000|STARTED|Overall Study||9||
48784820|NCT02371941|102262863|FG001|STARTED|Overall Study||7||
48784821|NCT02371941|102262862|FG000|COMPLETED|Overall Study||9||
48784822|NCT02371941|102262863|FG001|COMPLETED|Overall Study||6||
48784823|NCT02371941|102262862|FG000|NOT COMPLETED|Overall Study||0||
48784824|NCT02371941|102262863|FG001|NOT COMPLETED|Overall Study||1||
48784825|NCT02471612|102262864|FG000|STARTED|Overall Study||159||
48784826|NCT02471612|102262864|FG000|COMPLETED|Overall Study||157||
48784827|NCT02471612|102262864|FG000|NOT COMPLETED|Overall Study||2||
48784828|NCT01868542|102262865|FG000|STARTED|Overall Study||23||
48784829|NCT01868542|102262866|FG001|STARTED|Overall Study||23||
48784830|NCT01868542|102262865|FG000|COMPLETED|Overall Study||23||
48784831|NCT01868542|102262866|FG001|COMPLETED|Overall Study||21||
48784832|NCT01868542|102262865|FG000|NOT COMPLETED|Overall Study||0||
48784833|NCT01868542|102262866|FG001|NOT COMPLETED|Overall Study||2||
48784834|NCT00932828|102262867|FG000|STARTED|Overall Study||37||
48784835|NCT00932828|102262867|FG000|COMPLETED|Overall Study||32||
48784836|NCT00932828|102262867|FG000|NOT COMPLETED|Overall Study||5||
48784837|NCT02102204|102262868|FG000|STARTED|Overall Study||902||
48784838|NCT02102204|102262868|FG000|Received Etelcalcetide|Overall Study||884||
48784839|NCT02102204|102262868|FG000|COMPLETED|Overall Study||598||
48784840|NCT02102204|102262868|FG000|NOT COMPLETED|Overall Study||304||
48784841|NCT01781468|102262869|FG000|STARTED|Overall Study||109||
48784842|NCT01781468|102262870|FG001|STARTED|Overall Study||110||
48784843|NCT01781468|102262871|FG002|STARTED|Overall Study||109||
48784844|NCT01781468|102262869|FG000|COMPLETED|Overall Study||103|Evaluable for the Primary Endpoint|
48784845|NCT01781468|102262870|FG001|COMPLETED|Overall Study||97|Evaluable for the Primary Endpoint|
48784846|NCT01781468|102262871|FG002|COMPLETED|Overall Study||97|Evaluable for the Primary Endpoint|
48784847|NCT01781468|102262869|FG000|NOT COMPLETED|Overall Study||6||
48784848|NCT01781468|102262870|FG001|NOT COMPLETED|Overall Study||13||
48784849|NCT01781468|102262871|FG002|NOT COMPLETED|Overall Study||12||
48784850|NCT01915303|102262872|FG000|STARTED|Core Phase||68||
48784851|NCT01915303|102262872|FG000|COMPLETED|Core Phase||52||
48784852|NCT01915303|102262872|FG000|NOT COMPLETED|Core Phase||16||
48784853|NCT01915303|102262872|FG000|STARTED|Extension Phase||29||
48784854|NCT01915303|102262872|FG000|COMPLETED|Extension Phase||12||
48784855|NCT01915303|102262872|FG000|NOT COMPLETED|Extension Phase||17||
48784856|NCT00773838|102262873|FG000|STARTED|Overall Study||143||
48784857|NCT00773838|102262873|FG000|COMPLETED|Overall Study||0||
48784858|NCT00773838|102262873|FG000|NOT COMPLETED|Overall Study||143||
48784859|NCT04881942|102262874|FG000|STARTED|Overall Study||8||
48784860|NCT04881942|102262875|FG001|STARTED|Overall Study||8||
48784861|NCT04881942|102262876|FG002|STARTED|Overall Study||8||
48784862|NCT04881942|102262877|FG003|STARTED|Overall Study||8||
48784863|NCT04881942|102262878|FG004|STARTED|Overall Study||3||
48784864|NCT04881942|102262874|FG000|Completed Day 1 Product Use|Overall Study||8||
48784865|NCT04881942|102262875|FG001|Completed Day 1 Product Use|Overall Study||8||
48784866|NCT04881942|102262876|FG002|Completed Day 1 Product Use|Overall Study||8||
48784867|NCT04881942|102262877|FG003|Completed Day 1 Product Use|Overall Study||8||
48784868|NCT04881942|102262878|FG004|Completed Day 1 Product Use|Overall Study||0||
48784869|NCT04881942|102262874|FG000|Completed Day 2 Product Use|Overall Study||8||
48784870|NCT04881942|102262875|FG001|Completed Day 2 Product Use|Overall Study||8||
48784871|NCT04881942|102262876|FG002|Completed Day 2 Product Use|Overall Study||8||
48784872|NCT04881942|102262877|FG003|Completed Day 2 Product Use|Overall Study||8||
48784873|NCT04881942|102262878|FG004|Completed Day 2 Product Use|Overall Study||0||
48784874|NCT04881942|102262874|FG000|Completed Day 3 Product Use|Overall Study||8||
48784875|NCT04881942|102262875|FG001|Completed Day 3 Product Use|Overall Study||8||
48784876|NCT04881942|102262876|FG002|Completed Day 3 Product Use|Overall Study||8||
48784877|NCT04881942|102262877|FG003|Completed Day 3 Product Use|Overall Study||8||
48784878|NCT04881942|102262878|FG004|Completed Day 3 Product Use|Overall Study||0||
48784879|NCT04881942|102262874|FG000|Completed Day 4 Product Use|Overall Study||8||
48784880|NCT04881942|102262875|FG001|Completed Day 4 Product Use|Overall Study||8||
48784881|NCT04881942|102262876|FG002|Completed Day 4 Product Use|Overall Study||8||
48784882|NCT04881942|102262877|FG003|Completed Day 4 Product Use|Overall Study||8||
48784883|NCT04881942|102262878|FG004|Completed Day 4 Product Use|Overall Study||0||
48784884|NCT04881942|102262874|FG000|COMPLETED|Overall Study||8||
48784885|NCT04881942|102262875|FG001|COMPLETED|Overall Study||8||
48784886|NCT04881942|102262876|FG002|COMPLETED|Overall Study||8||
48784887|NCT04881942|102262877|FG003|COMPLETED|Overall Study||8||
48784888|NCT04881942|102262878|FG004|COMPLETED|Overall Study||0||
48784889|NCT04881942|102262874|FG000|NOT COMPLETED|Overall Study||0||
48784890|NCT04881942|102262875|FG001|NOT COMPLETED|Overall Study||0||
48784891|NCT04881942|102262876|FG002|NOT COMPLETED|Overall Study||0||
48784892|NCT04881942|102262877|FG003|NOT COMPLETED|Overall Study||0||
48784893|NCT04881942|102262878|FG004|NOT COMPLETED|Overall Study||3||
48784894|NCT03887702|102262879|FG000|STARTED|Overall Study||0|This represents the number of participants registered to the arms.|
48784895|NCT03887702|102262880|FG001|STARTED|Overall Study||0|This represents the number of participants registered to the arms.|
48784896|NCT03887702|102262881|FG002|STARTED|Overall Study||2|This represents the number of participants registered to the arms.|
48784897|NCT03887702|102262882|FG003|STARTED|Overall Study||2|This represents the number of participants registered to the arms.|
48784898|NCT03887702|102262879|FG000|Received Anti-HBV Treatment Per Assignment|Overall Study||0|This represents the number of participants who actually received any anti-viral HBV therapy on their assigned study arm (Arms 2 and 3 are upon indication; Arm 4 is physician discretion with any anti-HBV therapy allowed)|
48467263|NCT01654380|101480892|FG000|NOT COMPLETED|Part B, Period 1||0||
48467264|NCT01654380|101480893|FG001|NOT COMPLETED|Part B, Period 1||0||
48467265|NCT01654380|101480894|FG002|NOT COMPLETED|Part B, Period 1||1||
48370143|NCT03422133|101234828|FG001|COMPLETED|Overall Study||93||
48370144|NCT03422133|101234827|FG000|NOT COMPLETED|Overall Study||14||
48370145|NCT03422133|101234828|FG001|NOT COMPLETED|Overall Study||4||
48370146|NCT00872170|101234829|FG000|STARTED|Overall Study||14||
48370147|NCT00872170|101234830|FG001|STARTED|Overall Study||13||
48370148|NCT00872170|101234829|FG000|COMPLETED|Overall Study||13||
48370149|NCT00872170|101234830|FG001|COMPLETED|Overall Study||13||
48370150|NCT00872170|101234829|FG000|NOT COMPLETED|Overall Study||1||
48370151|NCT00872170|101234830|FG001|NOT COMPLETED|Overall Study||0||
48370152|NCT01929044|101234831|FG000|STARTED|Overall Study||153||
48370153|NCT01929044|101234832|FG001|STARTED|Overall Study||146||
48370154|NCT01929044|101234831|FG000|COMPLETED|Overall Study||142||
48370155|NCT01929044|101234832|FG001|COMPLETED|Overall Study||129||
48370156|NCT01929044|101234831|FG000|NOT COMPLETED|Overall Study||11||
48370157|NCT01929044|101234832|FG001|NOT COMPLETED|Overall Study||17||
48370158|NCT01617681|101234833|FG000|STARTED|Period 1 Double Blind||32||
48370159|NCT01617681|101234834|FG001|STARTED|Period 1 Double Blind||31||
48370160|NCT01617681|101234835|FG002|STARTED|Period 1 Double Blind||33||
48370161|NCT01617681|101234836|FG003|STARTED|Period 1 Double Blind||31||
48370162|NCT01617681|101234837|FG004|STARTED|Period 1 Double Blind||0||
48370163|NCT01617681|101234833|FG000|Full Analysis Set (FAS)|Period 1 Double Blind||31||
48370164|NCT01617681|101234834|FG001|Full Analysis Set (FAS)|Period 1 Double Blind||31||
48370165|NCT01617681|101234835|FG002|Full Analysis Set (FAS)|Period 1 Double Blind||33||
48370166|NCT01617681|101234836|FG003|Full Analysis Set (FAS)|Period 1 Double Blind||31||
48370167|NCT01617681|101234837|FG004|Full Analysis Set (FAS)|Period 1 Double Blind||0||
48370168|NCT01617681|101234833|FG000|COMPLETED|Period 1 Double Blind||29||
48370169|NCT01617681|101234834|FG001|COMPLETED|Period 1 Double Blind||30||
48370170|NCT01617681|101234835|FG002|COMPLETED|Period 1 Double Blind||32||
48370171|NCT01617681|101234836|FG003|COMPLETED|Period 1 Double Blind||29||
48370172|NCT01617681|101234837|FG004|COMPLETED|Period 1 Double Blind||0||
48370173|NCT01617681|101234833|FG000|NOT COMPLETED|Period 1 Double Blind||3||
48370174|NCT01617681|101234834|FG001|NOT COMPLETED|Period 1 Double Blind||1||
48370175|NCT01617681|101234835|FG002|NOT COMPLETED|Period 1 Double Blind||1||
48370176|NCT01617681|101234836|FG003|NOT COMPLETED|Period 1 Double Blind||2||
48370177|NCT01617681|101234837|FG004|NOT COMPLETED|Period 1 Double Blind||0||
48370178|NCT01617681|101234833|FG000|STARTED|Period 2 Open Label||0||
48370179|NCT01617681|101234834|FG001|STARTED|Period 2 Open Label||0||
48370180|NCT01617681|101234835|FG002|STARTED|Period 2 Open Label||0||
48370181|NCT01617681|101234836|FG003|STARTED|Period 2 Open Label||0||
48370182|NCT01617681|101234837|FG004|STARTED|Period 2 Open Label||120||
48370183|NCT01617681|101234833|FG000|COMPLETED|Period 2 Open Label||0||
48370184|NCT01617681|101234834|FG001|COMPLETED|Period 2 Open Label||0||
48370185|NCT01617681|101234835|FG002|COMPLETED|Period 2 Open Label||0||
48370186|NCT01617681|101234836|FG003|COMPLETED|Period 2 Open Label||0||
48370187|NCT01617681|101234837|FG004|COMPLETED|Period 2 Open Label||114||
48370188|NCT01617681|101234833|FG000|NOT COMPLETED|Period 2 Open Label||0||
48370189|NCT01617681|101234834|FG001|NOT COMPLETED|Period 2 Open Label||0||
48370190|NCT01617681|101234835|FG002|NOT COMPLETED|Period 2 Open Label||0||
48370191|NCT01617681|101234836|FG003|NOT COMPLETED|Period 2 Open Label||0||
48370192|NCT01617681|101234837|FG004|NOT COMPLETED|Period 2 Open Label||6||
48370193|NCT01921270|101234838|FG000|STARTED|Overall Study||18||
48370194|NCT01921270|101234838|FG000|COMPLETED|Overall Study||17||
48370195|NCT01921270|101234838|FG000|NOT COMPLETED|Overall Study||1||
48370196|NCT05085392|101234839|FG000|STARTED|Overall Study||20||
48370197|NCT05085392|101234839|FG000|COMPLETED|Overall Study||20||
48370198|NCT05085392|101234839|FG000|NOT COMPLETED|Overall Study||0||
48370199|NCT00960440|101234840|FG000|STARTED|Overall Study||133||
48370200|NCT00960440|101234841|FG001|STARTED|Overall Study||134||
48370201|NCT00960440|101234842|FG002|STARTED|Overall Study||66||
48370202|NCT00960440|101234843|FG003|STARTED|Overall Study||66||
48370203|NCT00960440|101234840|FG000|COMPLETED|Overall Study||107||
48370204|NCT00960440|101234841|FG001|COMPLETED|Overall Study||103||
48370205|NCT00960440|101234842|FG002|COMPLETED|Overall Study||53||
48370206|NCT00960440|101234843|FG003|COMPLETED|Overall Study||48||
48370207|NCT00960440|101234840|FG000|NOT COMPLETED|Overall Study||26||
48370208|NCT00960440|101234841|FG001|NOT COMPLETED|Overall Study||31||
48370209|NCT00960440|101234842|FG002|NOT COMPLETED|Overall Study||13||
48370210|NCT00960440|101234843|FG003|NOT COMPLETED|Overall Study||18||
48370211|NCT02796924|101234844|FG000|STARTED|Overall Study||10||
48370212|NCT02796924|101234844|FG000|COMPLETED|Overall Study||10||
48467266|NCT01654380|101480895|FG003|NOT COMPLETED|Part B, Period 1||0||
48467267|NCT01654380|101480892|FG000|STARTED|Part B, Washout of at Least 6 Days||0||
48467268|NCT01654380|101480893|FG001|STARTED|Part B, Washout of at Least 6 Days||0||
48467269|NCT01654380|101480894|FG002|STARTED|Part B, Washout of at Least 6 Days||6||
48467270|NCT01654380|101480895|FG003|STARTED|Part B, Washout of at Least 6 Days||7||
48467271|NCT01654380|101480892|FG000|COMPLETED|Part B, Washout of at Least 6 Days||0||
48467272|NCT01654380|101480893|FG001|COMPLETED|Part B, Washout of at Least 6 Days||0||
48784899|NCT03887702|102262880|FG001|Received Anti-HBV Treatment Per Assignment|Overall Study||0|This represents the number of participants who actually received any anti-viral HBV therapy on their assigned study arm (Arms 2 and 3 are upon indication; Arm 4 is physician discretion with any anti-HBV therapy allowed)|
48467273|NCT01654380|101480894|FG002|COMPLETED|Part B, Washout of at Least 6 Days||6||
48467274|NCT01654380|101480895|FG003|COMPLETED|Part B, Washout of at Least 6 Days||7||
48467275|NCT01654380|101480892|FG000|NOT COMPLETED|Part B, Washout of at Least 6 Days||0||
48467276|NCT01654380|101480893|FG001|NOT COMPLETED|Part B, Washout of at Least 6 Days||0||
48467277|NCT01654380|101480894|FG002|NOT COMPLETED|Part B, Washout of at Least 6 Days||0||
48467278|NCT01654380|101480895|FG003|NOT COMPLETED|Part B, Washout of at Least 6 Days||0||
48467279|NCT01654380|101480892|FG000|STARTED|Part B, Period 2||0||
48467280|NCT01654380|101480893|FG001|STARTED|Part B, Period 2||0||
48467281|NCT01654380|101480894|FG002|STARTED|Part B, Period 2||6||
48467282|NCT01654380|101480895|FG003|STARTED|Part B, Period 2||7||
48467283|NCT01654380|101480892|FG000|COMPLETED|Part B, Period 2||0||
48467284|NCT01654380|101480893|FG001|COMPLETED|Part B, Period 2||0||
48467285|NCT01654380|101480894|FG002|COMPLETED|Part B, Period 2||6||
48467286|NCT01654380|101480895|FG003|COMPLETED|Part B, Period 2||7||
48467287|NCT01654380|101480892|FG000|NOT COMPLETED|Part B, Period 2||0||
48467288|NCT01654380|101480893|FG001|NOT COMPLETED|Part B, Period 2||0||
48467289|NCT01654380|101480894|FG002|NOT COMPLETED|Part B, Period 2||0||
48467290|NCT01654380|101480895|FG003|NOT COMPLETED|Part B, Period 2||0||
48467291|NCT01654380|101480892|FG000|STARTED|Part B, Washout of at Least 6 Days||0||
48467292|NCT01654380|101480893|FG001|STARTED|Part B, Washout of at Least 6 Days||0||
48467293|NCT01654380|101480894|FG002|STARTED|Part B, Washout of at Least 6 Days||6||
48467294|NCT01654380|101480895|FG003|STARTED|Part B, Washout of at Least 6 Days||7||
48467295|NCT01654380|101480892|FG000|COMPLETED|Part B, Washout of at Least 6 Days||0||
48467296|NCT01654380|101480893|FG001|COMPLETED|Part B, Washout of at Least 6 Days||0||
48467297|NCT01654380|101480894|FG002|COMPLETED|Part B, Washout of at Least 6 Days||6||
48784900|NCT03887702|102262881|FG002|Received Anti-HBV Treatment Per Assignment|Overall Study||0|This represents the number of participants who actually received any anti-viral HBV therapy on their assigned study arm (Arms 2 and 3 are upon indication; Arm 4 is physician discretion with any anti-HBV therapy allowed)|
48784901|NCT03887702|102262882|FG003|Received Anti-HBV Treatment Per Assignment|Overall Study||1|This represents the number of participants who actually received any anti-viral HBV therapy on their assigned study arm (Arms 2 and 3 are upon indication; Arm 4 is physician discretion with any anti-HBV therapy allowed)|
48784902|NCT03887702|102262879|FG000|COMPLETED|Overall Study||0||
48784903|NCT03887702|102262880|FG001|COMPLETED|Overall Study||0||
48784904|NCT03887702|102262881|FG002|COMPLETED|Overall Study||0||
48784905|NCT03887702|102262882|FG003|COMPLETED|Overall Study||0||
48784906|NCT03887702|102262879|FG000|NOT COMPLETED|Overall Study||0||
48784907|NCT03887702|102262880|FG001|NOT COMPLETED|Overall Study||0||
48784908|NCT03887702|102262881|FG002|NOT COMPLETED|Overall Study||2||
48784909|NCT03887702|102262882|FG003|NOT COMPLETED|Overall Study||2||
48784910|NCT00606905|102262883|FG000|STARTED|Overall Study||38||
48784911|NCT00606905|102262884|FG001|STARTED|Overall Study||39||
48784912|NCT00606905|102262883|FG000|Pregnancy|Overall Study||29||
48784913|NCT00606905|102262884|FG001|Pregnancy|Overall Study||33||
48784914|NCT00606905|102262883|FG000|COMPLETED|Overall Study||23||
48784915|NCT00606905|102262884|FG001|COMPLETED|Overall Study||24||
48784916|NCT00606905|102262883|FG000|NOT COMPLETED|Overall Study||15||
48784917|NCT00606905|102262884|FG001|NOT COMPLETED|Overall Study||15||
48784918|NCT00233454|102262885|FG000|STARTED|Overall Study||26||
48784919|NCT00233454|102262885|FG000|2 Months (for Response Rate)|Overall Study||26||
48784920|NCT00233454|102262885|FG000|COMPLETED|Overall Study||20||
48784921|NCT00233454|102262885|FG000|NOT COMPLETED|Overall Study||6||
48784922|NCT03353233|102262886|FG000|STARTED|Overall Study||25||
48784923|NCT03353233|102262887|FG001|STARTED|Overall Study||25||
48784924|NCT03353233|102262886|FG000|COMPLETED|Overall Study||25||
48784925|NCT03353233|102262887|FG001|COMPLETED|Overall Study||25||
48784926|NCT03353233|102262886|FG000|NOT COMPLETED|Overall Study||0||
48784927|NCT03353233|102262887|FG001|NOT COMPLETED|Overall Study||0||
48784928|NCT04157673|102262888|FG000|STARTED|Overall Study||4||
48784929|NCT04157673|102262888|FG000|COMPLETED|Overall Study||4||
48784930|NCT04157673|102262888|FG000|NOT COMPLETED|Overall Study||0||
48784931|NCT00701662|102262889|FG000|STARTED|Overall Study||8||
48784932|NCT00701662|102262889|FG000|COMPLETED|Overall Study||7||
48784933|NCT00701662|102262889|FG000|NOT COMPLETED|Overall Study||1||
48784934|NCT03830892|102262890|FG000|STARTED|Overall Study||25||
48784935|NCT03830892|102262891|FG001|STARTED|Overall Study||23||
48784936|NCT03830892|102262890|FG000|15 Watts, 10 mg Nicotine|Overall Study||19||
48784937|NCT03830892|102262891|FG001|15 Watts, 10 mg Nicotine|Overall Study||17||
48467298|NCT01654380|101480895|FG003|COMPLETED|Part B, Washout of at Least 6 Days||7||
48784938|NCT03830892|102262890|FG000|15 Watts, 30 mg Nicotine|Overall Study||19||
48784939|NCT03830892|102262891|FG001|15 Watts, 30 mg Nicotine|Overall Study||17||
48784940|NCT03830892|102262890|FG000|30 Watts, 10 mg Nicotine|Overall Study||19||
48784941|NCT03830892|102262891|FG001|30 Watts, 10 mg Nicotine|Overall Study||17||
48784942|NCT03830892|102262890|FG000|30 Watts, 30 mg Nicotine|Overall Study||19||
48784943|NCT03830892|102262891|FG001|30 Watts, 30 mg Nicotine|Overall Study||17||
48784944|NCT03830892|102262890|FG000|Own Brand|Overall Study||19|Exclusive e-cigarette users only used e-cigarettes during own brand session, dual users used either their cigarettes and e-cigarettes. Completion of either one considered a milestone depending on study arm|
48784945|NCT03830892|102262891|FG001|Own Brand|Overall Study||17|Exclusive e-cigarette users only used e-cigarettes during own brand session, dual users used either their cigarettes and e-cigarettes. Completion of either one considered a milestone depending on study arm|
48784946|NCT03830892|102262890|FG000|COMPLETED|Overall Study||19||
48784947|NCT03830892|102262891|FG001|COMPLETED|Overall Study||17||
48784948|NCT03830892|102262890|FG000|NOT COMPLETED|Overall Study||6||
48784949|NCT03830892|102262891|FG001|NOT COMPLETED|Overall Study||6||
48784950|NCT02466659|102262892|FG000|STARTED|Overall Study||5||
48784951|NCT02466659|102262893|FG001|STARTED|Overall Study||3||
48784952|NCT02466659|102262892|FG000|COMPLETED|Overall Study||0||
48784953|NCT02466659|102262893|FG001|COMPLETED|Overall Study||1||
48784954|NCT02466659|102262892|FG000|NOT COMPLETED|Overall Study||5||
48784955|NCT02466659|102262893|FG001|NOT COMPLETED|Overall Study||2||
48784956|NCT01478048|102262894|FG000|STARTED|Overall Study||77||
48784957|NCT01478048|102262895|FG001|STARTED|Overall Study||75||
48784958|NCT01478048|102262894|FG000|Received Treatment|Overall Study||76||
48784959|NCT01478048|102262895|FG001|Received Treatment|Overall Study||74||
48784960|NCT01478048|102262894|FG000|COMPLETED|Overall Study||0|Completed = Still on treatment|
48784961|NCT01478048|102262895|FG001|COMPLETED|Overall Study||0|Completed = Still on treatment|
48784962|NCT01478048|102262894|FG000|NOT COMPLETED|Overall Study||77||
48784963|NCT01478048|102262895|FG001|NOT COMPLETED|Overall Study||75||
48784964|NCT02317744|102262896|FG000|STARTED|Overall Study||12||
48784965|NCT02317744|102262897|FG001|STARTED|Overall Study||10||
48784966|NCT02317744|102262896|FG000|Completed Treatment|Overall Study||10||
48784967|NCT02317744|102262897|FG001|Completed Treatment|Overall Study||7||
48784968|NCT02317744|102262896|FG000|COMPLETED|Overall Study||11||
48784969|NCT02317744|102262897|FG001|COMPLETED|Overall Study||8||
48784970|NCT02317744|102262896|FG000|NOT COMPLETED|Overall Study||1||
48784971|NCT02317744|102262897|FG001|NOT COMPLETED|Overall Study||2||
48784972|NCT01589653|102262898|FG000|STARTED|Overall Study||76||
48784973|NCT01589653|102262899|FG001|STARTED|Overall Study||79||
48784974|NCT01589653|102262898|FG000|Exposed|Overall Study||76||
48784975|NCT01589653|102262899|FG001|Exposed|Overall Study||78||
48784976|NCT01589653|102262898|FG000|COMPLETED|Overall Study||69||
48784977|NCT01589653|102262899|FG001|COMPLETED|Overall Study||68||
48784978|NCT01589653|102262898|FG000|NOT COMPLETED|Overall Study||7||
48784979|NCT01589653|102262899|FG001|NOT COMPLETED|Overall Study||11||
48784980|NCT02500056|102262900|FG000|STARTED|Overall Study||70||
48784981|NCT02500056|102262901|FG001|STARTED|Overall Study||73||
48784982|NCT02500056|102262900|FG000|COMPLETED|Overall Study||63||
48784983|NCT02500056|102262901|FG001|COMPLETED|Overall Study||65||
48784984|NCT02500056|102262900|FG000|NOT COMPLETED|Overall Study||7||
48784985|NCT02500056|102262901|FG001|NOT COMPLETED|Overall Study||8||
48784986|NCT01754402|102262902|FG000|STARTED|Overall Study||6||
48784987|NCT01754402|102262903|FG001|STARTED|Overall Study||2||
48784988|NCT01754402|102262904|FG002|STARTED|Overall Study||30||
48784989|NCT01754402|102262902|FG000|COMPLETED|Overall Study||4||
48784990|NCT01754402|102262903|FG001|COMPLETED|Overall Study||0||
48784991|NCT01754402|102262904|FG002|COMPLETED|Overall Study||26||
48784992|NCT01754402|102262902|FG000|NOT COMPLETED|Overall Study||2||
48784993|NCT01754402|102262903|FG001|NOT COMPLETED|Overall Study||2||
48784994|NCT01754402|102262904|FG002|NOT COMPLETED|Overall Study||4||
48189922|NCT04830514|100788966|FG000|COMPLETED|Overall Study||10||
48784995|NCT02712047|102262905|FG000|STARTED|Treatment Period 1 (35 Days)||14||
48784996|NCT02712047|102262906|FG001|STARTED|Treatment Period 1 (35 Days)||13||
48784997|NCT02712047|102262905|FG000|COMPLETED|Treatment Period 1 (35 Days)||14||
48784998|NCT02712047|102262906|FG001|COMPLETED|Treatment Period 1 (35 Days)||13||
48784999|NCT02712047|102262905|FG000|NOT COMPLETED|Treatment Period 1 (35 Days)||0||
48785000|NCT02712047|102262906|FG001|NOT COMPLETED|Treatment Period 1 (35 Days)||0||
48785001|NCT02712047|102262905|FG000|STARTED|Washout Period (21 Days)||14||
48785002|NCT02712047|102262906|FG001|STARTED|Washout Period (21 Days)||13||
48189923|NCT04830514|100788967|FG001|COMPLETED|Overall Study||11||
48189924|NCT04830514|100788968|FG002|COMPLETED|Overall Study||9||
48785003|NCT02712047|102262905|FG000|COMPLETED|Washout Period (21 Days)||14||
48785004|NCT02712047|102262906|FG001|COMPLETED|Washout Period (21 Days)||13||
48785005|NCT02712047|102262905|FG000|NOT COMPLETED|Washout Period (21 Days)||0||
48785006|NCT02712047|102262906|FG001|NOT COMPLETED|Washout Period (21 Days)||0||
48785007|NCT02712047|102262905|FG000|STARTED|Treatment Period 2 (35 Days)||14||
48785008|NCT02712047|102262906|FG001|STARTED|Treatment Period 2 (35 Days)||13||
48785009|NCT02712047|102262905|FG000|COMPLETED|Treatment Period 2 (35 Days)||14||
48785010|NCT02712047|102262906|FG001|COMPLETED|Treatment Period 2 (35 Days)||13||
48785011|NCT02712047|102262905|FG000|NOT COMPLETED|Treatment Period 2 (35 Days)||0||
48785012|NCT02712047|102262906|FG001|NOT COMPLETED|Treatment Period 2 (35 Days)||0||
48785013|NCT01505764|102262907|FG000|STARTED|Overall Study||6||
48785014|NCT01505764|102262908|FG001|STARTED|Overall Study||3||
48785015|NCT01505764|102262907|FG000|COMPLETED|Overall Study||3|not completed due to poor recruitment|
48785016|NCT01505764|102262908|FG001|COMPLETED|Overall Study||2|not completed due to poor recruitment|
48785017|NCT01505764|102262907|FG000|NOT COMPLETED|Overall Study||3||
48785018|NCT01505764|102262908|FG001|NOT COMPLETED|Overall Study||1||
48785019|NCT01243242|102262909|FG000|STARTED|Overall Study||60||
48785020|NCT01243242|102262910|FG001|STARTED|Overall Study||60||
48785021|NCT01243242|102262909|FG000|COMPLETED|Overall Study||57||
48785022|NCT01243242|102262910|FG001|COMPLETED|Overall Study||56||
48785023|NCT01243242|102262909|FG000|NOT COMPLETED|Overall Study||3||
48785024|NCT01243242|102262910|FG001|NOT COMPLETED|Overall Study||4||
48467299|NCT01654380|101480892|FG000|NOT COMPLETED|Part B, Washout of at Least 6 Days||0||
48665893|NCT00668642|101967444|FG000|NOT COMPLETED|Second AAT Treatment (On-cycle 2)||2||
48665894|NCT00668642|101967445|FG001|NOT COMPLETED|Second AAT Treatment (On-cycle 2)||1||
48785025|NCT04681352|102262911|FG000|STARTED|Overall Study||99||
48785026|NCT04681352|102262911|FG000|COMPLETED|Overall Study||75||
48785027|NCT04681352|102262911|FG000|NOT COMPLETED|Overall Study||24||
48785028|NCT01105065|102262912|FG000|STARTED|Overall Study||23||
48785029|NCT01105065|102262912|FG000|COMPLETED|Overall Study||17||
48785030|NCT01105065|102262912|FG000|NOT COMPLETED|Overall Study||6||
48785031|NCT01043939|102262913|FG000|STARTED|First Intervention||12||
48785032|NCT01043939|102262914|FG001|STARTED|First Intervention||12||
48785033|NCT01043939|102262913|FG000|COMPLETED|First Intervention||12||
48785034|NCT01043939|102262914|FG001|COMPLETED|First Intervention||12||
48785035|NCT01043939|102262913|FG000|NOT COMPLETED|First Intervention||0||
48785036|NCT01043939|102262914|FG001|NOT COMPLETED|First Intervention||0||
48785037|NCT01043939|102262913|FG000|STARTED|Washout Period||12||
48785038|NCT01043939|102262914|FG001|STARTED|Washout Period||12||
48785039|NCT01043939|102262913|FG000|COMPLETED|Washout Period||12||
48785040|NCT01043939|102262914|FG001|COMPLETED|Washout Period||12||
48785041|NCT01043939|102262913|FG000|NOT COMPLETED|Washout Period||0||
48665895|NCT00668642|101967444|FG000|STARTED|Second Off Treatment (Off-cycle 2)||4||
48665896|NCT00668642|101967445|FG001|STARTED|Second Off Treatment (Off-cycle 2)||5||
48665897|NCT00668642|101967444|FG000|Research Biopsy|Second Off Treatment (Off-cycle 2)||2|A research biopsy of the prostate was planned at end of off-cycle 2 to determine expression of U19 tumor suppressor gene|
48665898|NCT00668642|101967445|FG001|Research Biopsy|Second Off Treatment (Off-cycle 2)||2|A research biopsy of the prostate was planned at end of off-cycle 2 to determine expression of U19 tumor suppressor gene|
48665899|NCT00668642|101967444|FG000|COMPLETED|Second Off Treatment (Off-cycle 2)||4||
48665900|NCT00668642|101967445|FG001|COMPLETED|Second Off Treatment (Off-cycle 2)||5||
48665901|NCT00668642|101967444|FG000|NOT COMPLETED|Second Off Treatment (Off-cycle 2)||0||
48665902|NCT00668642|101967445|FG001|NOT COMPLETED|Second Off Treatment (Off-cycle 2)||0||
48665903|NCT03896581|101967446|FG000|STARTED|Overall Study||133||
48665904|NCT03896581|101967447|FG001|STARTED|Overall Study||267||
48665905|NCT03896581|101967446|FG000|COMPLETED|Overall Study||125||
48665906|NCT03896581|101967447|FG001|COMPLETED|Overall Study||263||
48665907|NCT03896581|101967446|FG000|NOT COMPLETED|Overall Study||8||
48665908|NCT03896581|101967447|FG001|NOT COMPLETED|Overall Study||4||
48665909|NCT01542788|101967448|FG000|STARTED|Overall Study||209||
48665910|NCT01542788|101967449|FG001|STARTED|Overall Study||71||
48665911|NCT01542788|101967448|FG000|Randomized and Treated|Overall Study||207||
48665912|NCT01542788|101967449|FG001|Randomized and Treated|Overall Study||71||
48665913|NCT01542788|101967448|FG000|COMPLETED|Overall Study||154||
48665914|NCT01542788|101967449|FG001|COMPLETED|Overall Study||0||
48665915|NCT01542788|101967448|FG000|NOT COMPLETED|Overall Study||55||
48665916|NCT01542788|101967449|FG001|NOT COMPLETED|Overall Study||71||
48665917|NCT03524157|101967450|FG000|STARTED|Overall Study||10||
48665918|NCT03524157|101967451|FG001|STARTED|Overall Study||10||
48665919|NCT03524157|101967452|FG002|STARTED|Overall Study||10||
48665920|NCT03524157|101967450|FG000|COMPLETED|Overall Study||10||
48665921|NCT03524157|101967451|FG001|COMPLETED|Overall Study||10||
48665922|NCT03524157|101967452|FG002|COMPLETED|Overall Study||9||
48665923|NCT03524157|101967450|FG000|NOT COMPLETED|Overall Study||0||
48665924|NCT03524157|101967451|FG001|NOT COMPLETED|Overall Study||0||
48665925|NCT03524157|101967452|FG002|NOT COMPLETED|Overall Study||1||
48665926|NCT00329420|101967453|FG000|STARTED|Re-induction Phase||18||
48665927|NCT00329420|101967454|FG001|STARTED|Re-induction Phase||13||
48665928|NCT00329420|101967455|FG002|STARTED|Re-induction Phase||15||
48665929|NCT00329420|101967453|FG000|COMPLETED|Re-induction Phase||12||
48665930|NCT00329420|101967454|FG001|COMPLETED|Re-induction Phase||7||
48665931|NCT00329420|101967455|FG002|COMPLETED|Re-induction Phase||7||
48665932|NCT00329420|101967453|FG000|NOT COMPLETED|Re-induction Phase||6||
48665933|NCT00329420|101967454|FG001|NOT COMPLETED|Re-induction Phase||6||
48665934|NCT00329420|101967455|FG002|NOT COMPLETED|Re-induction Phase||8||
48665935|NCT00329420|101967453|FG000|STARTED|4-weekly Dosing Phase (Responders Only)||12||
48665936|NCT00329420|101967454|FG001|STARTED|4-weekly Dosing Phase (Responders Only)||7||
48665937|NCT00329420|101967455|FG002|STARTED|4-weekly Dosing Phase (Responders Only)||7||
48665938|NCT00329420|101967453|FG000|COMPLETED|4-weekly Dosing Phase (Responders Only)||8||
48665939|NCT00329420|101967454|FG001|COMPLETED|4-weekly Dosing Phase (Responders Only)||5||
48665940|NCT00329420|101967455|FG002|COMPLETED|4-weekly Dosing Phase (Responders Only)||6||
48665941|NCT00329420|101967453|FG000|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||4||
48785042|NCT01043939|102262914|FG001|NOT COMPLETED|Washout Period||0||
48785043|NCT01043939|102262913|FG000|STARTED|Second Intervention||12||
48785044|NCT01043939|102262914|FG001|STARTED|Second Intervention||12||
48785045|NCT01043939|102262913|FG000|COMPLETED|Second Intervention||12||
48785046|NCT01043939|102262914|FG001|COMPLETED|Second Intervention||12||
48785047|NCT01043939|102262913|FG000|NOT COMPLETED|Second Intervention||0||
48785048|NCT01043939|102262914|FG001|NOT COMPLETED|Second Intervention||0||
48785049|NCT01149148|102262915|FG000|STARTED|Overall Study||12||
48785050|NCT01149148|102262916|FG001|STARTED|Overall Study||13||
48785051|NCT01149148|102262915|FG000|COMPLETED|Overall Study||10||
48785052|NCT01149148|102262916|FG001|COMPLETED|Overall Study||11||
48785053|NCT01149148|102262915|FG000|NOT COMPLETED|Overall Study||2||
48785054|NCT01149148|102262916|FG001|NOT COMPLETED|Overall Study||2||
48785055|NCT01087736|102262917|FG000|STARTED|Overall Study||14||
48785056|NCT01087736|102262918|FG001|STARTED|Overall Study||16||
48785057|NCT01087736|102262917|FG000|COMPLETED|Overall Study||13||
48785058|NCT01087736|102262918|FG001|COMPLETED|Overall Study||14||
48785059|NCT01087736|102262917|FG000|NOT COMPLETED|Overall Study||1||
48785060|NCT01087736|102262918|FG001|NOT COMPLETED|Overall Study||2||
48785061|NCT00881868|102262919|FG000|STARTED|Overall Study||41||
48785062|NCT00881868|102262920|FG001|STARTED|Overall Study||40||
48785063|NCT00881868|102262919|FG000|COMPLETED|Overall Study||33||
48785064|NCT00881868|102262920|FG001|COMPLETED|Overall Study||38||
48785065|NCT00881868|102262919|FG000|NOT COMPLETED|Overall Study||8||
48785066|NCT00881868|102262920|FG001|NOT COMPLETED|Overall Study||2||
48785067|NCT01715857|102262921|FG000|STARTED|Overall Study||4100||
48785068|NCT01715857|102262921|FG000|COMPLETED|Overall Study||4004||
48785069|NCT01715857|102262921|FG000|NOT COMPLETED|Overall Study||96||
48785070|NCT01138917|102262922|FG000|STARTED|Overall Study||101||
48785071|NCT01138917|102262922|FG000|COMPLETED|Overall Study||77||
48785072|NCT01138917|102262922|FG000|NOT COMPLETED|Overall Study||24||
48785073|NCT03390842|102262923|FG000|STARTED|Overall Study||114||
48785074|NCT03390842|102262924|FG001|STARTED|Overall Study||82||
48785075|NCT03390842|102262923|FG000|COMPLETED|Overall Study||111||
48785076|NCT03390842|102262924|FG001|COMPLETED|Overall Study||74||
48785077|NCT03390842|102262923|FG000|NOT COMPLETED|Overall Study||3||
48785078|NCT03390842|102262924|FG001|NOT COMPLETED|Overall Study||8||
48785079|NCT00095940|102262925|FG000|STARTED|Molecular Biology Phase||2||
48785080|NCT00095940|102262926|FG001|STARTED|Molecular Biology Phase||2||
48785081|NCT00095940|102262927|FG002|STARTED|Molecular Biology Phase||0||
48785082|NCT00095940|102262928|FG003|STARTED|Molecular Biology Phase||0||
48785083|NCT00095940|102262929|FG004|STARTED|Molecular Biology Phase||0||
48785084|NCT00095940|102262930|FG005|STARTED|Molecular Biology Phase||0||
48785085|NCT00095940|102262931|FG006|STARTED|Molecular Biology Phase||2||
48785086|NCT00095940|102262932|FG007|STARTED|Molecular Biology Phase||2||
48785087|NCT00095940|102262933|FG008|STARTED|Molecular Biology Phase||0||
48785088|NCT00095940|102262925|FG000|COMPLETED|Molecular Biology Phase||2||
48785089|NCT00095940|102262926|FG001|COMPLETED|Molecular Biology Phase||2||
48785090|NCT00095940|102262927|FG002|COMPLETED|Molecular Biology Phase||0||
48785091|NCT00095940|102262928|FG003|COMPLETED|Molecular Biology Phase||0||
48785092|NCT00095940|102262929|FG004|COMPLETED|Molecular Biology Phase||0||
48785093|NCT00095940|102262930|FG005|COMPLETED|Molecular Biology Phase||0||
48785094|NCT00095940|102262931|FG006|COMPLETED|Molecular Biology Phase||2||
48785095|NCT00095940|102262932|FG007|COMPLETED|Molecular Biology Phase||2||
48785096|NCT00095940|102262933|FG008|COMPLETED|Molecular Biology Phase||0||
48785097|NCT00095940|102262925|FG000|NOT COMPLETED|Molecular Biology Phase||0||
48785098|NCT00095940|102262926|FG001|NOT COMPLETED|Molecular Biology Phase||0||
48785099|NCT00095940|102262927|FG002|NOT COMPLETED|Molecular Biology Phase||0||
48785100|NCT00095940|102262928|FG003|NOT COMPLETED|Molecular Biology Phase||0||
48785101|NCT00095940|102262929|FG004|NOT COMPLETED|Molecular Biology Phase||0||
48785102|NCT00095940|102262930|FG005|NOT COMPLETED|Molecular Biology Phase||0||
48785103|NCT00095940|102262931|FG006|NOT COMPLETED|Molecular Biology Phase||0||
48785104|NCT00095940|102262932|FG007|NOT COMPLETED|Molecular Biology Phase||0||
48785105|NCT00095940|102262933|FG008|NOT COMPLETED|Molecular Biology Phase||0||
48189925|NCT04830514|100788966|FG000|NOT COMPLETED|Overall Study||8||
48785106|NCT00095940|102262925|FG000|STARTED|Lapatinib Continuation/Phase II||2||
48785107|NCT00095940|102262926|FG001|STARTED|Lapatinib Continuation/Phase II||2||
48785108|NCT00095940|102262927|FG002|STARTED|Lapatinib Continuation/Phase II||17||
48785109|NCT00095940|102262928|FG003|STARTED|Lapatinib Continuation/Phase II||0||
48785110|NCT00095940|102262929|FG004|STARTED|Lapatinib Continuation/Phase II||0||
48785111|NCT00095940|102262930|FG005|STARTED|Lapatinib Continuation/Phase II||13||
48785112|NCT00095940|102262931|FG006|STARTED|Lapatinib Continuation/Phase II||2||
48785113|NCT00095940|102262932|FG007|STARTED|Lapatinib Continuation/Phase II||2||
48785114|NCT00095940|102262933|FG008|STARTED|Lapatinib Continuation/Phase II||14||
48785115|NCT00095940|102262925|FG000|COMPLETED|Lapatinib Continuation/Phase II||0||
48785116|NCT00095940|102262926|FG001|COMPLETED|Lapatinib Continuation/Phase II||0||
48785117|NCT00095940|102262927|FG002|COMPLETED|Lapatinib Continuation/Phase II||1||
48785118|NCT00095940|102262928|FG003|COMPLETED|Lapatinib Continuation/Phase II||0||
48785119|NCT00095940|102262929|FG004|COMPLETED|Lapatinib Continuation/Phase II||0||
48785120|NCT00095940|102262930|FG005|COMPLETED|Lapatinib Continuation/Phase II||0||
48785121|NCT00095940|102262931|FG006|COMPLETED|Lapatinib Continuation/Phase II||0||
48785122|NCT00095940|102262932|FG007|COMPLETED|Lapatinib Continuation/Phase II||0||
48785123|NCT00095940|102262933|FG008|COMPLETED|Lapatinib Continuation/Phase II||1||
48785124|NCT00095940|102262925|FG000|NOT COMPLETED|Lapatinib Continuation/Phase II||2||
48785125|NCT00095940|102262926|FG001|NOT COMPLETED|Lapatinib Continuation/Phase II||2||
48785126|NCT00095940|102262927|FG002|NOT COMPLETED|Lapatinib Continuation/Phase II||16||
48785127|NCT00095940|102262928|FG003|NOT COMPLETED|Lapatinib Continuation/Phase II||0||
48785128|NCT00095940|102262929|FG004|NOT COMPLETED|Lapatinib Continuation/Phase II||0||
48785129|NCT00095940|102262930|FG005|NOT COMPLETED|Lapatinib Continuation/Phase II||13||
48785130|NCT00095940|102262931|FG006|NOT COMPLETED|Lapatinib Continuation/Phase II||2||
48785131|NCT00095940|102262932|FG007|NOT COMPLETED|Lapatinib Continuation/Phase II||2||
48785132|NCT00095940|102262933|FG008|NOT COMPLETED|Lapatinib Continuation/Phase II||13||
48785133|NCT00336856|102262934|FG000|STARTED|Overall Study||35||
48785134|NCT00336856|102262934|FG000|COMPLETED|Overall Study||31||
48785135|NCT00336856|102262934|FG000|NOT COMPLETED|Overall Study||4||
48785136|NCT00006409|102262935|FG000|STARTED|Baseline||865||
48785137|NCT00006409|102262936|FG001|STARTED|Baseline||856||
48785138|NCT00006409|102262937|FG002|STARTED|Baseline||0||
48785139|NCT00006409|102262938|FG003|STARTED|Baseline||0||
48785140|NCT00006409|102262939|FG004|STARTED|Baseline||0||
48785141|NCT00006409|102262940|FG005|STARTED|Baseline||0||
48785142|NCT00006409|102262935|FG000|COMPLETED|Baseline||817||
48785143|NCT00006409|102262936|FG001|COMPLETED|Baseline||786||
48785144|NCT00006409|102262937|FG002|COMPLETED|Baseline||0||
48785145|NCT00006409|102262938|FG003|COMPLETED|Baseline||0||
48785146|NCT00006409|102262939|FG004|COMPLETED|Baseline||0||
48785147|NCT00006409|102262940|FG005|COMPLETED|Baseline||0||
48785148|NCT00006409|102262935|FG000|NOT COMPLETED|Baseline||48||
48785149|NCT00006409|102262936|FG001|NOT COMPLETED|Baseline||70||
48785150|NCT00006409|102262937|FG002|NOT COMPLETED|Baseline||0||
48785151|NCT00006409|102262938|FG003|NOT COMPLETED|Baseline||0||
48785152|NCT00006409|102262939|FG004|NOT COMPLETED|Baseline||0||
48785153|NCT00006409|102262940|FG005|NOT COMPLETED|Baseline||0||
48785154|NCT00006409|102262935|FG000|STARTED|Post-2 Year Intervention||0||
48785155|NCT00006409|102262936|FG001|STARTED|Post-2 Year Intervention||0||
48785156|NCT00006409|102262937|FG002|STARTED|Post-2 Year Intervention||1791||
48785157|NCT00006409|102262938|FG003|STARTED|Post-2 Year Intervention||1713||
48785158|NCT00006409|102262939|FG004|STARTED|Post-2 Year Intervention||0||
48785159|NCT00006409|102262940|FG005|STARTED|Post-2 Year Intervention||0||
48785160|NCT00006409|102262935|FG000|COMPLETED|Post-2 Year Intervention||0||
48785161|NCT00006409|102262936|FG001|COMPLETED|Post-2 Year Intervention||0||
48785162|NCT00006409|102262937|FG002|COMPLETED|Post-2 Year Intervention||1540||
48785163|NCT00006409|102262938|FG003|COMPLETED|Post-2 Year Intervention||1545||
48785164|NCT00006409|102262939|FG004|COMPLETED|Post-2 Year Intervention||0||
48785165|NCT00006409|102262940|FG005|COMPLETED|Post-2 Year Intervention||0||
48785166|NCT00006409|102262935|FG000|NOT COMPLETED|Post-2 Year Intervention||0||
48785167|NCT00006409|102262936|FG001|NOT COMPLETED|Post-2 Year Intervention||0||
48785168|NCT00006409|102262937|FG002|NOT COMPLETED|Post-2 Year Intervention||251||
48785169|NCT00006409|102262938|FG003|NOT COMPLETED|Post-2 Year Intervention||168||
48785170|NCT00006409|102262939|FG004|NOT COMPLETED|Post-2 Year Intervention||0||
48785171|NCT00006409|102262940|FG005|NOT COMPLETED|Post-2 Year Intervention||0||
48785172|NCT00006409|102262935|FG000|STARTED|Post-3 Year Intervention||0||
48785173|NCT00006409|102262936|FG001|STARTED|Post-3 Year Intervention||0||
48785174|NCT00006409|102262937|FG002|STARTED|Post-3 Year Intervention||0||
48785175|NCT00006409|102262938|FG003|STARTED|Post-3 Year Intervention||0||
48785176|NCT00006409|102262939|FG004|STARTED|Post-3 Year Intervention||1726||
48785177|NCT00006409|102262940|FG005|STARTED|Post-3 Year Intervention||1776||
48785178|NCT00006409|102262935|FG000|COMPLETED|Post-3 Year Intervention||0||
48785179|NCT00006409|102262936|FG001|COMPLETED|Post-3 Year Intervention||0||
48785180|NCT00006409|102262937|FG002|COMPLETED|Post-3 Year Intervention||0||
48785181|NCT00006409|102262938|FG003|COMPLETED|Post-3 Year Intervention||0||
48785182|NCT00006409|102262939|FG004|COMPLETED|Post-3 Year Intervention||1664||
48785183|NCT00006409|102262940|FG005|COMPLETED|Post-3 Year Intervention||1714||
48785184|NCT00006409|102262935|FG000|NOT COMPLETED|Post-3 Year Intervention||0||
48785185|NCT00006409|102262936|FG001|NOT COMPLETED|Post-3 Year Intervention||0||
48785186|NCT00006409|102262937|FG002|NOT COMPLETED|Post-3 Year Intervention||0||
48785187|NCT00006409|102262938|FG003|NOT COMPLETED|Post-3 Year Intervention||0||
48785188|NCT00006409|102262939|FG004|NOT COMPLETED|Post-3 Year Intervention||62||
48785189|NCT00006409|102262940|FG005|NOT COMPLETED|Post-3 Year Intervention||62||
48785190|NCT01643772|102262941|FG000|STARTED|Overall Study||15||
48785191|NCT01643772|102262942|FG001|STARTED|Overall Study||15||
48785192|NCT01643772|102262943|FG002|STARTED|Overall Study||15||
48785193|NCT01643772|102262944|FG003|STARTED|Overall Study||16||
48785194|NCT01643772|102262941|FG000|COMPLETED|Overall Study||15||
48785195|NCT01643772|102262942|FG001|COMPLETED|Overall Study||15||
48785196|NCT01643772|102262943|FG002|COMPLETED|Overall Study||15||
48785197|NCT01643772|102262944|FG003|COMPLETED|Overall Study||14||
48785198|NCT01643772|102262941|FG000|NOT COMPLETED|Overall Study||0||
48785199|NCT01643772|102262942|FG001|NOT COMPLETED|Overall Study||0||
48785200|NCT01643772|102262943|FG002|NOT COMPLETED|Overall Study||0||
48785201|NCT01643772|102262944|FG003|NOT COMPLETED|Overall Study||2||
48785202|NCT00638183|102262945|FG000|STARTED|Overall Study||385||
48785203|NCT00638183|102262945|FG000|COMPLETED|Overall Study||266||
48785204|NCT00638183|102262945|FG000|NOT COMPLETED|Overall Study||119||
48785205|NCT03930264|102262946|FG000|STARTED|Overall Study||15||
48785206|NCT03930264|102262947|FG001|STARTED|Overall Study||15||
48785207|NCT03930264|102262946|FG000|COMPLETED|Overall Study||15||
48785208|NCT03930264|102262947|FG001|COMPLETED|Overall Study||14||
48785209|NCT03930264|102262946|FG000|NOT COMPLETED|Overall Study||0||
48785210|NCT03930264|102262947|FG001|NOT COMPLETED|Overall Study||1||
48785211|NCT02028208|102262948|FG000|STARTED|Overall Study||21||
48785212|NCT02028208|102262949|FG001|STARTED|Overall Study||13||
48785213|NCT02028208|102262950|FG002|STARTED|Overall Study||22||
48785214|NCT02028208|102262948|FG000|COMPLETED|Overall Study||21||
48785215|NCT02028208|102262949|FG001|COMPLETED|Overall Study||13||
48785216|NCT02028208|102262950|FG002|COMPLETED|Overall Study||21||
48785217|NCT02028208|102262948|FG000|NOT COMPLETED|Overall Study||0||
48785218|NCT02028208|102262949|FG001|NOT COMPLETED|Overall Study||0||
48785219|NCT02028208|102262950|FG002|NOT COMPLETED|Overall Study||1||
48785220|NCT00344487|102262951|FG000|STARTED|Overall Study||3||
48785221|NCT00344487|102262951|FG000|COMPLETED|Overall Study||2||
48785222|NCT00344487|102262951|FG000|NOT COMPLETED|Overall Study||1||
48785223|NCT00531427|102262952|FG000|STARTED|Overall Study||282||
48785224|NCT00531427|102262953|FG001|STARTED|Overall Study||285||
48785225|NCT00531427|102262952|FG000|COMPLETED|Overall Study||209||
48785226|NCT00531427|102262953|FG001|COMPLETED|Overall Study||191||
48785227|NCT00531427|102262952|FG000|NOT COMPLETED|Overall Study||73||
48785228|NCT00531427|102262953|FG001|NOT COMPLETED|Overall Study||94||
48785229|NCT03113136|102262954|FG000|STARTED|Overall Study||105||
48785230|NCT03113136|102262955|FG001|STARTED|Overall Study||133||
48785231|NCT03113136|102262956|FG002|STARTED|Overall Study||134||
48785232|NCT03113136|102262954|FG000|Week 1|Overall Study||101||
48785233|NCT03113136|102262955|FG001|Week 1|Overall Study||115||
48785234|NCT03113136|102262956|FG002|Week 1|Overall Study||122||
48785235|NCT03113136|102262954|FG000|Week 4|Overall Study||99||
48785236|NCT03113136|102262955|FG001|Week 4|Overall Study||97||
48785237|NCT03113136|102262956|FG002|Week 4|Overall Study||113||
48785238|NCT03113136|102262954|FG000|Week 8|Overall Study||98||
48785239|NCT03113136|102262955|FG001|Week 8|Overall Study||86||
48785240|NCT03113136|102262956|FG002|Week 8|Overall Study||94||
48785241|NCT03113136|102262954|FG000|Week 12|Overall Study||95||
48785242|NCT03113136|102262955|FG001|Week 12|Overall Study||84||
48785243|NCT03113136|102262956|FG002|Week 12|Overall Study||92||
48785244|NCT03113136|102262954|FG000|Week 26|Overall Study||77||
48785245|NCT03113136|102262955|FG001|Week 26|Overall Study||69||
48785246|NCT03113136|102262956|FG002|Week 26|Overall Study||73||
48785247|NCT03113136|102262954|FG000|Week 52|Overall Study||78||
48785248|NCT03113136|102262955|FG001|Week 52|Overall Study||67||
48785249|NCT03113136|102262956|FG002|Week 52|Overall Study||65||
48785250|NCT03113136|102262954|FG000|COMPLETED|Overall Study||78||
48785251|NCT03113136|102262955|FG001|COMPLETED|Overall Study||67||
48785252|NCT03113136|102262956|FG002|COMPLETED|Overall Study||65||
48785253|NCT03113136|102262954|FG000|NOT COMPLETED|Overall Study||27||
48785254|NCT03113136|102262955|FG001|NOT COMPLETED|Overall Study||66||
48785255|NCT03113136|102262956|FG002|NOT COMPLETED|Overall Study||69||
48785256|NCT00499616|102262957|FG000|STARTED|Overall Study||176||
48785257|NCT00499616|102262958|FG001|STARTED|Overall Study||142||
48785258|NCT00499616|102262959|FG002|STARTED|Overall Study||89||
48785259|NCT00499616|102262960|FG003|STARTED|Overall Study||57||
48785260|NCT00499616|102262957|FG000|COMPLETED|Overall Study||161||
48785261|NCT00499616|102262958|FG001|COMPLETED|Overall Study||114||
48785262|NCT00499616|102262959|FG002|COMPLETED|Overall Study||53||
48785263|NCT00499616|102262960|FG003|COMPLETED|Overall Study||0||
48785264|NCT00499616|102262957|FG000|NOT COMPLETED|Overall Study||15||
48785265|NCT00499616|102262958|FG001|NOT COMPLETED|Overall Study||28||
48785266|NCT00499616|102262959|FG002|NOT COMPLETED|Overall Study||36||
48785267|NCT00499616|102262960|FG003|NOT COMPLETED|Overall Study||57||
48785268|NCT01077921|102262961|FG000|STARTED|First Intervention||14||
48785269|NCT01077921|102262962|FG001|STARTED|First Intervention||13||
48785270|NCT01077921|102262961|FG000|COMPLETED|First Intervention||13||
48785271|NCT01077921|102262962|FG001|COMPLETED|First Intervention||12||
48785272|NCT01077921|102262961|FG000|NOT COMPLETED|First Intervention||1||
48785273|NCT01077921|102262962|FG001|NOT COMPLETED|First Intervention||1||
48785274|NCT01077921|102262961|FG000|STARTED|Washout||13||
48785275|NCT01077921|102262962|FG001|STARTED|Washout||12||
48785276|NCT01077921|102262961|FG000|COMPLETED|Washout||13||
48785277|NCT01077921|102262962|FG001|COMPLETED|Washout||10||
48785278|NCT01077921|102262961|FG000|NOT COMPLETED|Washout||0||
48785279|NCT01077921|102262962|FG001|NOT COMPLETED|Washout||2||
48785280|NCT01077921|102262961|FG000|STARTED|Second Intervention||13||
48785281|NCT01077921|102262962|FG001|STARTED|Second Intervention||10||
48785282|NCT01077921|102262961|FG000|COMPLETED|Second Intervention||13||
48785283|NCT01077921|102262962|FG001|COMPLETED|Second Intervention||9||
48785284|NCT01077921|102262961|FG000|NOT COMPLETED|Second Intervention||0||
48785285|NCT01077921|102262962|FG001|NOT COMPLETED|Second Intervention||1||
48785286|NCT00874939|102262963|FG000|STARTED|Overall Study||4||
48785287|NCT00874939|102262963|FG000|Treated|Overall Study||0||
48785288|NCT00874939|102262963|FG000|COMPLETED|Overall Study||0||
48785289|NCT00874939|102262963|FG000|NOT COMPLETED|Overall Study||4||
48785290|NCT00003590|102262964|FG000|STARTED|Overall Study||29||
48785291|NCT00003590|102262964|FG000|Eligible|Overall Study||28||
48785292|NCT00003590|102262964|FG000|Eligible and Began Protocol Therapy|Overall Study||28||
48785293|NCT00003590|102262964|FG000|COMPLETED|Overall Study||7||
48785294|NCT00003590|102262964|FG000|NOT COMPLETED|Overall Study||22||
48785295|NCT00271505|102262965|FG000|STARTED|Overall Study||43||
48785296|NCT00271505|102262965|FG000|COMPLETED|Overall Study||38||
48785297|NCT00271505|102262965|FG000|NOT COMPLETED|Overall Study||5||
48785298|NCT01349049|102262966|FG000|STARTED|Overall Study||3||
48785299|NCT01349049|102262967|FG001|STARTED|Overall Study||7||
48785300|NCT01349049|102262968|FG002|STARTED|Overall Study||3||
48785301|NCT01349049|102262969|FG003|STARTED|Overall Study||3||
48785302|NCT01349049|102262970|FG004|STARTED|Overall Study||3||
48785303|NCT01349049|102262971|FG005|STARTED|Overall Study||6||
48785304|NCT01349049|102262972|FG006|STARTED|Overall Study||5||
48785305|NCT01349049|102262973|FG007|STARTED|Overall Study||4||
48785306|NCT01349049|102262974|FG008|STARTED|Overall Study||56||
48785307|NCT01349049|102262966|FG000|COMPLETED|Overall Study||0||
48785308|NCT01349049|102262967|FG001|COMPLETED|Overall Study||0||
48785309|NCT01349049|102262968|FG002|COMPLETED|Overall Study||0||
48785310|NCT01349049|102262969|FG003|COMPLETED|Overall Study||0||
48785311|NCT01349049|102262970|FG004|COMPLETED|Overall Study||0||
48785312|NCT01349049|102262971|FG005|COMPLETED|Overall Study||0||
48785313|NCT01349049|102262972|FG006|COMPLETED|Overall Study||0||
48785314|NCT01349049|102262973|FG007|COMPLETED|Overall Study||0||
48785315|NCT01349049|102262974|FG008|COMPLETED|Overall Study||1||
48785316|NCT01349049|102262966|FG000|NOT COMPLETED|Overall Study||3||
48785317|NCT01349049|102262967|FG001|NOT COMPLETED|Overall Study||7||
48785318|NCT01349049|102262968|FG002|NOT COMPLETED|Overall Study||3||
48785319|NCT01349049|102262969|FG003|NOT COMPLETED|Overall Study||3||
48785320|NCT01349049|102262970|FG004|NOT COMPLETED|Overall Study||3||
48785321|NCT01349049|102262971|FG005|NOT COMPLETED|Overall Study||6||
48785322|NCT01349049|102262972|FG006|NOT COMPLETED|Overall Study||5||
48785323|NCT01349049|102262973|FG007|NOT COMPLETED|Overall Study||4||
48785324|NCT01349049|102262974|FG008|NOT COMPLETED|Overall Study||55||
48785325|NCT00582075|102262975|FG000|STARTED|Overall Study||25||
48785326|NCT00582075|102262975|FG000|COMPLETED|Overall Study||25||
48785327|NCT00582075|102262975|FG000|NOT COMPLETED|Overall Study||0||
48785328|NCT02720042|102262976|FG000|STARTED|Overall Study||84||
48785329|NCT02720042|102262976|FG000|COMPLETED|Overall Study||69||
48785330|NCT02720042|102262976|FG000|NOT COMPLETED|Overall Study||15||
48785331|NCT01748240|102262977|FG000|STARTED|Overall Study||21||
48785332|NCT01748240|102262977|FG000|COMPLETED|Overall Study||21||
48785333|NCT01748240|102262977|FG000|NOT COMPLETED|Overall Study||0||
48785334|NCT04661579|102262978|FG000|STARTED|Overall Study||164||
48785335|NCT04661579|102262979|FG001|STARTED|Overall Study||128||
48785336|NCT04661579|102262980|FG002|STARTED|Overall Study||36||
48785337|NCT04661579|102262981|FG003|STARTED|Overall Study||164||
48785338|NCT04661579|102262982|FG004|STARTED|Overall Study||128||
48785339|NCT04661579|102262978|FG000|Received Study Vaccination|Overall Study||160||
48785340|NCT04661579|102262979|FG001|Received Study Vaccination|Overall Study||124||
48785341|NCT04661579|102262980|FG002|Received Study Vaccination|Overall Study||35||
48785342|NCT04661579|102262981|FG003|Received Study Vaccination|Overall Study||159||
48785343|NCT04661579|102262982|FG004|Received Study Vaccination|Overall Study||127||
48785344|NCT04661579|102262978|FG000|COMPLETED|Overall Study||136||
48785345|NCT04661579|102262979|FG001|COMPLETED|Overall Study||108||
48785346|NCT04661579|102262980|FG002|COMPLETED|Overall Study||32||
48785347|NCT04661579|102262981|FG003|COMPLETED|Overall Study||148||
48785348|NCT04661579|102262982|FG004|COMPLETED|Overall Study||115||
48785349|NCT04661579|102262978|FG000|NOT COMPLETED|Overall Study||28||
48785350|NCT04661579|102262979|FG001|NOT COMPLETED|Overall Study||20||
48785351|NCT04661579|102262980|FG002|NOT COMPLETED|Overall Study||4||
48785352|NCT04661579|102262981|FG003|NOT COMPLETED|Overall Study||16||
48785353|NCT04661579|102262982|FG004|NOT COMPLETED|Overall Study||13||
48785354|NCT04876690|102262983|FG000|STARTED|Overall Study||15||
48785355|NCT04876690|102262983|FG000|COMPLETED|Overall Study||15||
48785356|NCT04876690|102262983|FG000|NOT COMPLETED|Overall Study||0||
48785357|NCT03562988|102262984|FG000|STARTED|Overall Study||17||
48785358|NCT03562988|102262985|FG001|STARTED|Overall Study||18||
48785359|NCT03562988|102262984|FG000|COMPLETED|Overall Study||15||
48785360|NCT03562988|102262985|FG001|COMPLETED|Overall Study||15||
48785361|NCT03562988|102262984|FG000|NOT COMPLETED|Overall Study||2||
48785362|NCT03562988|102262985|FG001|NOT COMPLETED|Overall Study||3||
48785363|NCT02992197|102262986|FG000|STARTED|Overall Study||110||
48785364|NCT02992197|102262987|FG001|STARTED|Overall Study||110||
48785365|NCT02992197|102262986|FG000|COMPLETED|Overall Study||99||
48785366|NCT02992197|102262987|FG001|COMPLETED|Overall Study||103||
48785367|NCT02992197|102262986|FG000|NOT COMPLETED|Overall Study||11||
48785368|NCT02992197|102262987|FG001|NOT COMPLETED|Overall Study||7||
48785369|NCT02083861|102262988|FG000|STARTED|Overall Study||57||
48785370|NCT02083861|102262989|FG001|STARTED|Overall Study||36||
48785371|NCT02083861|102262988|FG000|Treated|Overall Study||55||
48785372|NCT02083861|102262989|FG001|Treated|Overall Study||35||
48785373|NCT02083861|102262988|FG000|COMPLETED|Overall Study||51||
48785374|NCT02083861|102262989|FG001|COMPLETED|Overall Study||33||
48785375|NCT02083861|102262988|FG000|NOT COMPLETED|Overall Study||6||
48785376|NCT02083861|102262989|FG001|NOT COMPLETED|Overall Study||3||
48785377|NCT00899353|102265542|FG000|STARTED|Overall Study||16||
48785378|NCT00899353|102265542|FG000|COMPLETED|Overall Study||11||
48785379|NCT00899353|102265542|FG000|NOT COMPLETED|Overall Study||5||
48785380|NCT01284491|102265543|FG000|STARTED|Overall Study||13||
48785381|NCT01284491|102265543|FG000|COMPLETED|Overall Study||0||
48785382|NCT01284491|102265543|FG000|NOT COMPLETED|Overall Study||13||
48785383|NCT02646371|102265544|FG000|STARTED|Overall Study||34||
48785384|NCT02646371|102265545|FG001|STARTED|Overall Study||33||
48785385|NCT02646371|102265544|FG000|COMPLETED|Overall Study||34||
48785386|NCT02646371|102265545|FG001|COMPLETED|Overall Study||33||
48785387|NCT02646371|102265544|FG000|NOT COMPLETED|Overall Study||0||
48785388|NCT02646371|102265545|FG001|NOT COMPLETED|Overall Study||0||
48785389|NCT01761162|102265546|FG000|STARTED|Overall Study||229||
48785390|NCT01761162|102265546|FG000|COMPLETED|Overall Study||226||
48785391|NCT01761162|102265546|FG000|NOT COMPLETED|Overall Study||3||
48785392|NCT01536392|102265547|FG000|STARTED|Overall Study||41||
48785393|NCT01536392|102265548|FG001|STARTED|Overall Study||34||
48785394|NCT01536392|102265547|FG000|COMPLETED|Overall Study||28||
48785395|NCT01536392|102265548|FG001|COMPLETED|Overall Study||19||
48785396|NCT01536392|102265547|FG000|NOT COMPLETED|Overall Study||13||
48785397|NCT01536392|102265548|FG001|NOT COMPLETED|Overall Study||15||
48785398|NCT02438475|102265549|FG000|STARTED|Overall Study||104||
48785399|NCT02438475|102265550|FG001|STARTED|Overall Study||104||
48785400|NCT02438475|102265549|FG000|COMPLETED|Overall Study||102||
48785401|NCT02438475|102265550|FG001|COMPLETED|Overall Study||104||
48785402|NCT02438475|102265549|FG000|NOT COMPLETED|Overall Study||2||
48785403|NCT02438475|102265550|FG001|NOT COMPLETED|Overall Study||0||
48785404|NCT02576145|102265551|FG000|STARTED|Overall Study||6||
48785405|NCT02576145|102265552|FG001|STARTED|Overall Study||5||
48785406|NCT02576145|102265551|FG000|COMPLETED|Overall Study||3||
48785407|NCT02576145|102265552|FG001|COMPLETED|Overall Study||4||
48785408|NCT02576145|102265551|FG000|NOT COMPLETED|Overall Study||3||
48785409|NCT02576145|102265552|FG001|NOT COMPLETED|Overall Study||1||
48785410|NCT03704636|102265553|FG000|STARTED|Overall Study||23||
48785411|NCT03704636|102265553|FG000|COMPLETED|Overall Study||20||
48785412|NCT03704636|102265553|FG000|NOT COMPLETED|Overall Study||3||
48785413|NCT01876329|102265554|FG000|STARTED|Overall Study||45||
48785414|NCT01876329|102265555|FG001|STARTED|Overall Study||36||
48785415|NCT01876329|102265556|FG002|STARTED|Overall Study||44||
48785416|NCT01876329|102265554|FG000|COMPLETED|Overall Study||45||
48785417|NCT01876329|102265555|FG001|COMPLETED|Overall Study||36||
48785418|NCT01876329|102265556|FG002|COMPLETED|Overall Study||44||
48785419|NCT01876329|102265554|FG000|NOT COMPLETED|Overall Study||0||
48785420|NCT01876329|102265555|FG001|NOT COMPLETED|Overall Study||0||
48785421|NCT01876329|102265556|FG002|NOT COMPLETED|Overall Study||0||
48785422|NCT01523275|102265557|FG000|STARTED|Overall Study||6||
48785423|NCT01523275|102265558|FG001|STARTED|Overall Study||9||
48785424|NCT01523275|102265557|FG000|COMPLETED|Overall Study||4||
48785425|NCT01523275|102265558|FG001|COMPLETED|Overall Study||7||
48785426|NCT01523275|102265557|FG000|NOT COMPLETED|Overall Study||2||
48785427|NCT01523275|102265558|FG001|NOT COMPLETED|Overall Study||2||
48785428|NCT00145977|102265559|FG000|STARTED|Overall Study||19||
48785429|NCT00145977|102265560|FG001|STARTED|Overall Study||17||
48785430|NCT00145977|102265559|FG000|COMPLETED|Overall Study||17||
48785431|NCT00145977|102265560|FG001|COMPLETED|Overall Study||13||
48785432|NCT00145977|102265559|FG000|NOT COMPLETED|Overall Study||2||
48785433|NCT00145977|102265560|FG001|NOT COMPLETED|Overall Study||4||
48785434|NCT00536913|102265561|FG000|STARTED|Overall Study||55||
48785435|NCT00536913|102265562|FG001|STARTED|Overall Study||52||
48785436|NCT00536913|102265561|FG000|COMPLETED|Overall Study||55||
48785437|NCT00536913|102265562|FG001|COMPLETED|Overall Study||52||
48785438|NCT00536913|102265561|FG000|NOT COMPLETED|Overall Study||0||
48785439|NCT00536913|102265562|FG001|NOT COMPLETED|Overall Study||0||
48785440|NCT03032380|102265563|FG000|STARTED|Overall Study||148||
48785441|NCT03032380|102265564|FG001|STARTED|Overall Study||152||
48785442|NCT03032380|102265563|FG000|Received Treatment|Overall Study||148||
48785443|NCT03032380|102265564|FG001|Received Treatment|Overall Study||150||
48785444|NCT03032380|102265563|FG000|COMPLETED|Overall Study||106||
48785445|NCT03032380|102265564|FG001|COMPLETED|Overall Study||112||
48785446|NCT03032380|102265563|FG000|NOT COMPLETED|Overall Study||42||
48785447|NCT03032380|102265564|FG001|NOT COMPLETED|Overall Study||40||
48785448|NCT00548652|102265565|FG000|STARTED|Overall Study||18||
48785449|NCT00548652|102265566|FG001|STARTED|Overall Study||38||
48785450|NCT00548652|102265567|FG002|STARTED|Overall Study||45||
48785451|NCT00548652|102265565|FG000|COMPLETED|Overall Study||16||
48785452|NCT00548652|102265566|FG001|COMPLETED|Overall Study||29||
48785453|NCT00548652|102265567|FG002|COMPLETED|Overall Study||34||
48785454|NCT00548652|102265565|FG000|NOT COMPLETED|Overall Study||2||
48785455|NCT00548652|102265566|FG001|NOT COMPLETED|Overall Study||9||
48467300|NCT01654380|101480893|FG001|NOT COMPLETED|Part B, Washout of at Least 6 Days||0||
48467301|NCT01654380|101480894|FG002|NOT COMPLETED|Part B, Washout of at Least 6 Days||0||
48467302|NCT01654380|101480895|FG003|NOT COMPLETED|Part B, Washout of at Least 6 Days||0||
48467303|NCT01654380|101480892|FG000|STARTED|Part B, Period 3||0||
48467304|NCT01654380|101480893|FG001|STARTED|Part B, Period 3||0||
48467305|NCT01654380|101480894|FG002|STARTED|Part B, Period 3||6||
48467306|NCT01654380|101480895|FG003|STARTED|Part B, Period 3||7||
48467307|NCT01654380|101480892|FG000|COMPLETED|Part B, Period 3||0||
48467308|NCT01654380|101480893|FG001|COMPLETED|Part B, Period 3||0||
48467309|NCT01654380|101480894|FG002|COMPLETED|Part B, Period 3||6||
48467310|NCT01654380|101480895|FG003|COMPLETED|Part B, Period 3||7||
48467311|NCT01654380|101480892|FG000|NOT COMPLETED|Part B, Period 3||0||
48467312|NCT01654380|101480893|FG001|NOT COMPLETED|Part B, Period 3||0||
48467313|NCT01654380|101480894|FG002|NOT COMPLETED|Part B, Period 3||0||
48467314|NCT01654380|101480895|FG003|NOT COMPLETED|Part B, Period 3||0||
48467315|NCT01654380|101480892|FG000|STARTED|Part B, Washout of at Least 6 Days||0||
48467316|NCT01654380|101480893|FG001|STARTED|Part B, Washout of at Least 6 Days||0||
48467317|NCT01654380|101480894|FG002|STARTED|Part B, Washout of at Least 6 Days||6||
48467318|NCT01654380|101480895|FG003|STARTED|Part B, Washout of at Least 6 Days||7||
48467319|NCT01654380|101480892|FG000|COMPLETED|Part B, Washout of at Least 6 Days||0||
48467320|NCT01654380|101480893|FG001|COMPLETED|Part B, Washout of at Least 6 Days||0||
48467321|NCT01654380|101480894|FG002|COMPLETED|Part B, Washout of at Least 6 Days||6||
48467322|NCT01654380|101480895|FG003|COMPLETED|Part B, Washout of at Least 6 Days||7||
48467323|NCT01654380|101480892|FG000|NOT COMPLETED|Part B, Washout of at Least 6 Days||0||
48467324|NCT01654380|101480893|FG001|NOT COMPLETED|Part B, Washout of at Least 6 Days||0||
48467325|NCT01654380|101480894|FG002|NOT COMPLETED|Part B, Washout of at Least 6 Days||0||
48467326|NCT01654380|101480895|FG003|NOT COMPLETED|Part B, Washout of at Least 6 Days||0||
48467327|NCT01654380|101480892|FG000|STARTED|Part B, Period 4||0||
48467328|NCT01654380|101480893|FG001|STARTED|Part B, Period 4||0||
48467329|NCT01654380|101480894|FG002|STARTED|Part B, Period 4||6||
48467330|NCT01654380|101480895|FG003|STARTED|Part B, Period 4||7||
48467331|NCT01654380|101480892|FG000|COMPLETED|Part B, Period 4||0||
48467332|NCT01654380|101480893|FG001|COMPLETED|Part B, Period 4||0||
48467333|NCT01654380|101480894|FG002|COMPLETED|Part B, Period 4||6||
48467334|NCT01654380|101480895|FG003|COMPLETED|Part B, Period 4||7||
48467335|NCT01654380|101480892|FG000|NOT COMPLETED|Part B, Period 4||0||
48467336|NCT01654380|101480893|FG001|NOT COMPLETED|Part B, Period 4||0||
48467337|NCT01654380|101480894|FG002|NOT COMPLETED|Part B, Period 4||0||
48467338|NCT01654380|101480895|FG003|NOT COMPLETED|Part B, Period 4||0||
48467339|NCT01941095|101480896|FG000|STARTED|Overall Study||97||
48467340|NCT01941095|101480896|FG000|COMPLETED|Overall Study||41||
48467341|NCT01941095|101480896|FG000|NOT COMPLETED|Overall Study||56||
48467342|NCT00203307|101480897|FG000|STARTED|First Intervention||3||
48467343|NCT00203307|101480898|FG001|STARTED|First Intervention||0||
48467344|NCT00203307|101480897|FG000|COMPLETED|First Intervention||1||
48467345|NCT00203307|101480898|FG001|COMPLETED|First Intervention||0||
48467346|NCT00203307|101480897|FG000|NOT COMPLETED|First Intervention||2||
48467347|NCT00203307|101480898|FG001|NOT COMPLETED|First Intervention||0||
48467348|NCT00203307|101480897|FG000|STARTED|Second Intervention||1||
48467349|NCT00203307|101480898|FG001|STARTED|Second Intervention||0||
48467350|NCT00203307|101480897|FG000|COMPLETED|Second Intervention||1||
48785456|NCT00548652|102265567|FG002|NOT COMPLETED|Overall Study||11||
48785457|NCT01368562|102265568|FG000|STARTED|Overall Study||26||
48785458|NCT01368562|102265568|FG000|Received at Least 1 Dose of Study Drug|Overall Study||25||
48785459|NCT01368562|102265568|FG000|COMPLETED|Overall Study||7||
48785460|NCT01368562|102265568|FG000|NOT COMPLETED|Overall Study||19||
48785461|NCT03860818|102265569|FG000|STARTED|Overall Study||896||
48785462|NCT03860818|102265570|FG001|STARTED|Overall Study||1300||
48785463|NCT03860818|102265569|FG000|COMPLETED|Overall Study||720||
48785464|NCT03860818|102265570|FG001|COMPLETED|Overall Study||1060||
48785465|NCT03860818|102265569|FG000|NOT COMPLETED|Overall Study||176||
48785466|NCT03860818|102265570|FG001|NOT COMPLETED|Overall Study||240||
48785467|NCT01651806|102265571|FG000|STARTED|Overall Study||13||
48785468|NCT01651806|102265572|FG001|STARTED|Overall Study||12||
48785469|NCT01651806|102265573|FG002|STARTED|Overall Study||25||
48785470|NCT01651806|102265574|FG003|STARTED|Overall Study||7||
48785471|NCT01651806|102265575|FG004|STARTED|Overall Study||8||
48785472|NCT01651806|102265571|FG000|COMPLETED|Overall Study||13||
48785473|NCT01651806|102265572|FG001|COMPLETED|Overall Study||12||
48785474|NCT01651806|102265573|FG002|COMPLETED|Overall Study||25||
48785475|NCT01651806|102265574|FG003|COMPLETED|Overall Study||7||
48785476|NCT01651806|102265575|FG004|COMPLETED|Overall Study||8||
48467351|NCT00203307|101480898|FG001|COMPLETED|Second Intervention||0||
48467352|NCT00203307|101480897|FG000|NOT COMPLETED|Second Intervention||0||
48467353|NCT00203307|101480898|FG001|NOT COMPLETED|Second Intervention||0||
48467354|NCT04534283|101480899|FG000|STARTED|Overall Study||16||
48467355|NCT04534283|101480899|FG000|COMPLETED|Overall Study||0||
48467356|NCT04534283|101480899|FG000|NOT COMPLETED|Overall Study||16||
48785477|NCT01651806|102265571|FG000|NOT COMPLETED|Overall Study||0||
48785478|NCT01651806|102265572|FG001|NOT COMPLETED|Overall Study||0||
48785479|NCT01651806|102265573|FG002|NOT COMPLETED|Overall Study||0||
48785480|NCT01651806|102265574|FG003|NOT COMPLETED|Overall Study||0||
48785481|NCT01651806|102265575|FG004|NOT COMPLETED|Overall Study||0||
48785482|NCT01442844|102265576|FG000|STARTED|Overall Study||1||
48785483|NCT01442844|102265577|FG001|STARTED|Overall Study||2||
48785484|NCT01442844|102265576|FG000|COMPLETED|Overall Study||1||
48785485|NCT01442844|102265577|FG001|COMPLETED|Overall Study||2||
48785486|NCT01442844|102265576|FG000|NOT COMPLETED|Overall Study||0||
48785487|NCT01442844|102265577|FG001|NOT COMPLETED|Overall Study||0||
48785488|NCT00422513|102265578|FG000|STARTED|Overall Study||130||
48785489|NCT00422513|102265579|FG001|STARTED|Overall Study||130||
48467357|NCT00619385|101480900|FG000|STARTED|Overall Study||7||
48467358|NCT00619385|101480901|FG001|STARTED|Overall Study||8||
48467359|NCT00619385|101480902|FG002|STARTED|Overall Study||10||
48467360|NCT00619385|101480900|FG000|COMPLETED|Overall Study||6||
48467361|NCT00619385|101480901|FG001|COMPLETED|Overall Study||6||
48467362|NCT00619385|101480902|FG002|COMPLETED|Overall Study||6||
48785490|NCT00422513|102265578|FG000|COMPLETED|Overall Study||23||
48785491|NCT00422513|102265579|FG001|COMPLETED|Overall Study||24||
48785492|NCT00422513|102265578|FG000|NOT COMPLETED|Overall Study||107||
48785493|NCT00422513|102265579|FG001|NOT COMPLETED|Overall Study||106||
48785494|NCT00574236|102265580|FG000|STARTED|Overall Study||4||
48785495|NCT00574236|102265580|FG000|COMPLETED|Overall Study||4||
48785496|NCT00574236|102265580|FG000|NOT COMPLETED|Overall Study||0||
48785497|NCT01410344|102265581|FG000|STARTED|Overall Study||20||
48785498|NCT01410344|102265581|FG000|COMPLETED|Overall Study||17||
48785499|NCT01410344|102265581|FG000|NOT COMPLETED|Overall Study||3||
48785500|NCT03041129|102265582|FG000|STARTED|Overall Study||19||
48785501|NCT03041129|102265583|FG001|STARTED|Overall Study||0||
48785502|NCT03041129|102265584|FG002|STARTED|Overall Study||0||
48785503|NCT03041129|102265585|FG003|STARTED|Overall Study||0||
48785504|NCT03041129|102265582|FG000|COMPLETED|Overall Study||17||
48785505|NCT03041129|102265583|FG001|COMPLETED|Overall Study||0||
48785506|NCT03041129|102265584|FG002|COMPLETED|Overall Study||0||
48785507|NCT03041129|102265585|FG003|COMPLETED|Overall Study||0||
48785508|NCT03041129|102265582|FG000|NOT COMPLETED|Overall Study||2||
48785509|NCT03041129|102265583|FG001|NOT COMPLETED|Overall Study||0||
48785510|NCT03041129|102265584|FG002|NOT COMPLETED|Overall Study||0||
48785511|NCT03041129|102265585|FG003|NOT COMPLETED|Overall Study||0||
48785512|NCT02199717|102265586|FG000|STARTED|Overall Study||66||
48785513|NCT02199717|102265586|FG000|COMPLETED|Overall Study||66||
48785514|NCT02199717|102265586|FG000|NOT COMPLETED|Overall Study||0||
48785515|NCT02864862|102265587|FG000|STARTED|Overall Study||15||
48785516|NCT02864862|102265588|FG001|STARTED|Overall Study||15||
48785517|NCT02864862|102265589|FG002|STARTED|Overall Study||16||
48785518|NCT02864862|102265587|FG000|Received Intervention|Overall Study||15||
48785519|NCT02864862|102265588|FG001|Received Intervention|Overall Study||15||
48785520|NCT02864862|102265589|FG002|Received Intervention|Overall Study||16||
48785521|NCT02864862|102265587|FG000|3-month Follow up|Overall Study||15||
48785522|NCT02864862|102265588|FG001|3-month Follow up|Overall Study||15||
48785523|NCT02864862|102265589|FG002|3-month Follow up|Overall Study||16||
48785524|NCT02864862|102265587|FG000|6-month Follow up|Overall Study||15||
48785525|NCT02864862|102265588|FG001|6-month Follow up|Overall Study||15||
48785526|NCT02864862|102265589|FG002|6-month Follow up|Overall Study||15||
48785527|NCT02864862|102265587|FG000|12-month Follow up|Overall Study||14||
48785528|NCT02864862|102265588|FG001|12-month Follow up|Overall Study||15||
48785529|NCT02864862|102265589|FG002|12-month Follow up|Overall Study||14||
48785530|NCT02864862|102265587|FG000|COMPLETED|Overall Study||14||
48785531|NCT02864862|102265588|FG001|COMPLETED|Overall Study||15||
48785532|NCT02864862|102265589|FG002|COMPLETED|Overall Study||14||
48785533|NCT02864862|102265587|FG000|NOT COMPLETED|Overall Study||1||
48785534|NCT02864862|102265588|FG001|NOT COMPLETED|Overall Study||0||
48467363|NCT00619385|101480900|FG000|NOT COMPLETED|Overall Study||1||
48467364|NCT00619385|101480901|FG001|NOT COMPLETED|Overall Study||2||
48467365|NCT00619385|101480902|FG002|NOT COMPLETED|Overall Study||4||
48467366|NCT03352427|101480903|FG000|STARTED|Overall Study||3||
48467367|NCT03352427|101480903|FG000|COMPLETED|Overall Study||3||
48467368|NCT03352427|101480903|FG000|NOT COMPLETED|Overall Study||0||
48467369|NCT02106065|101480904|FG000|STARTED|Overall Study||6||
48467370|NCT02106065|101480905|FG001|STARTED|Overall Study||11||
48467371|NCT02106065|101480906|FG002|STARTED|Overall Study||15||
48467372|NCT02106065|101480904|FG000|6 Month Completion|Overall Study||3||
48785535|NCT02864862|102265589|FG002|NOT COMPLETED|Overall Study||2||
48785536|NCT00505076|102265590|FG000|STARTED|Overall Study||22||
48785537|NCT00505076|102265591|FG001|STARTED|Overall Study||19||
48785538|NCT00505076|102265592|FG002|STARTED|Overall Study||22||
48785539|NCT00505076|102265590|FG000|COMPLETED|Overall Study||19||
48785540|NCT00505076|102265591|FG001|COMPLETED|Overall Study||17||
48785541|NCT00505076|102265592|FG002|COMPLETED|Overall Study||17||
48785542|NCT00505076|102265590|FG000|NOT COMPLETED|Overall Study||3||
48467373|NCT02106065|101480905|FG001|6 Month Completion|Overall Study||8||
48467374|NCT02106065|101480906|FG002|6 Month Completion|Overall Study||5||
48467375|NCT02106065|101480904|FG000|COMPLETED|Overall Study||3||
48467376|NCT02106065|101480905|FG001|COMPLETED|Overall Study||8||
48785543|NCT00505076|102265591|FG001|NOT COMPLETED|Overall Study||2||
48785544|NCT00505076|102265592|FG002|NOT COMPLETED|Overall Study||5||
48785545|NCT02437110|102265593|FG000|STARTED|Screening||118||
48785546|NCT02437110|102265593|FG000|COMPLETED|Screening||114||
48785547|NCT02437110|102265593|FG000|NOT COMPLETED|Screening||4||
48785548|NCT02437110|102265593|FG000|STARTED|ART||34||
48785549|NCT02437110|102265593|FG000|COMPLETED|ART||20||
48785550|NCT02437110|102265593|FG000|NOT COMPLETED|ART||14||
48785551|NCT02437110|102265593|FG000|STARTED|Post-ART||19||
48785552|NCT02437110|102265593|FG000|COMPLETED|Post-ART||9||
48785553|NCT02437110|102265593|FG000|NOT COMPLETED|Post-ART||10||
48785554|NCT02870933|102265594|FG000|STARTED|Overall Study||15||
48785555|NCT02870933|102265595|FG001|STARTED|Overall Study||15||
48785556|NCT02870933|102265594|FG000|COMPLETED|Overall Study||13||
48785557|NCT02870933|102265595|FG001|COMPLETED|Overall Study||13||
48785558|NCT02870933|102265594|FG000|NOT COMPLETED|Overall Study||2||
48785559|NCT02870933|102265595|FG001|NOT COMPLETED|Overall Study||2||
48785560|NCT01233232|102265596|FG000|STARTED|Overall Study||29||
48785561|NCT01233232|102265597|FG001|STARTED|Overall Study||30||
48785562|NCT01233232|102265598|FG002|STARTED|Overall Study||28||
48785563|NCT01233232|102265596|FG000|COMPLETED|Overall Study||28||
48785564|NCT01233232|102265597|FG001|COMPLETED|Overall Study||30||
48785565|NCT01233232|102265598|FG002|COMPLETED|Overall Study||28||
48785566|NCT01233232|102265596|FG000|NOT COMPLETED|Overall Study||1||
48785567|NCT01233232|102265597|FG001|NOT COMPLETED|Overall Study||0||
48785568|NCT01233232|102265598|FG002|NOT COMPLETED|Overall Study||0||
48785569|NCT03135119|102265599|FG000|STARTED|Overall Study||16||
48785570|NCT03135119|102265600|FG001|STARTED|Overall Study||17||
48785571|NCT03135119|102265599|FG000|COMPLETED|Overall Study||11||
48785572|NCT03135119|102265600|FG001|COMPLETED|Overall Study||14||
48785573|NCT03135119|102265599|FG000|NOT COMPLETED|Overall Study||5||
48785574|NCT03135119|102265600|FG001|NOT COMPLETED|Overall Study||3||
48785575|NCT01056302|102265601|FG000|STARTED|Overall Study||3||
48785576|NCT01056302|102265601|FG000|COMPLETED|Overall Study||3||
48785577|NCT01056302|102265601|FG000|NOT COMPLETED|Overall Study||0||
48785578|NCT00724711|102265602|FG000|STARTED|Overall Study||155||
48785579|NCT00724711|102265603|FG001|STARTED|Overall Study||156||
48785580|NCT00724711|102265602|FG000|COMPLETED|Overall Study||138||
48785581|NCT00724711|102265603|FG001|COMPLETED|Overall Study||139||
48785582|NCT00724711|102265602|FG000|NOT COMPLETED|Overall Study||17||
48785583|NCT00724711|102265603|FG001|NOT COMPLETED|Overall Study||17||
48785584|NCT00363545|102265604|FG000|STARTED|Overall Study||636||
48785585|NCT00363545|102265605|FG001|STARTED|Overall Study||638||
48785586|NCT00363545|102265604|FG000|COMPLETED|Overall Study||592||
48785587|NCT00363545|102265605|FG001|COMPLETED|Overall Study||581||
48785588|NCT00363545|102265604|FG000|NOT COMPLETED|Overall Study||44||
48785589|NCT00363545|102265605|FG001|NOT COMPLETED|Overall Study||57||
48785590|NCT03087617|102265606|FG000|STARTED|Overall Study||79||
48785591|NCT03087617|102265607|FG001|STARTED|Overall Study||80||
48785592|NCT03087617|102265608|FG002|STARTED|Overall Study||82||
48785593|NCT03087617|102265609|FG003|STARTED|Overall Study||80||
48785594|NCT03087617|102265606|FG000|COMPLETED|Overall Study||47||
48785595|NCT03087617|102265607|FG001|COMPLETED|Overall Study||50||
48785596|NCT03087617|102265608|FG002|COMPLETED|Overall Study||52||
48785597|NCT03087617|102265609|FG003|COMPLETED|Overall Study||41||
48785598|NCT03087617|102265606|FG000|NOT COMPLETED|Overall Study||32||
48785599|NCT03087617|102265607|FG001|NOT COMPLETED|Overall Study||30||
48785600|NCT03087617|102265608|FG002|NOT COMPLETED|Overall Study||30||
48785601|NCT03087617|102265609|FG003|NOT COMPLETED|Overall Study||39||
48785602|NCT00993226|102265610|FG000|STARTED|Overall Study||61||
48785603|NCT00993226|102265611|FG001|STARTED|Overall Study||27||
48785604|NCT00993226|102265612|FG002|STARTED|Overall Study||27||
48785605|NCT00993226|102265610|FG000|COMPLETED|Overall Study||60||
48785606|NCT00993226|102265611|FG001|COMPLETED|Overall Study||26||
48785607|NCT00993226|102265612|FG002|COMPLETED|Overall Study||27||
48785608|NCT00993226|102265610|FG000|NOT COMPLETED|Overall Study||1||
48189926|NCT04830514|100788967|FG001|NOT COMPLETED|Overall Study||3||
48785609|NCT00993226|102265611|FG001|NOT COMPLETED|Overall Study||1||
48785610|NCT00993226|102265612|FG002|NOT COMPLETED|Overall Study||0||
48785611|NCT03060551|102265613|FG000|STARTED|Overall Study||20||
48785612|NCT03060551|102265613|FG000|COMPLETED|Overall Study||18||
48785613|NCT03060551|102265613|FG000|NOT COMPLETED|Overall Study||2||
48785614|NCT00296296|102265614|FG000|STARTED|Overall Study||11||
48785615|NCT00296296|102265615|FG001|STARTED|Overall Study||18||
48785616|NCT00296296|102265614|FG000|COMPLETED|Overall Study||9||
48785617|NCT00296296|102265615|FG001|COMPLETED|Overall Study||5||
48785618|NCT00296296|102265614|FG000|NOT COMPLETED|Overall Study||2||
48785619|NCT00296296|102265615|FG001|NOT COMPLETED|Overall Study||13||
48785620|NCT00200356|102265616|FG000|STARTED|Overall Study||199||
48785621|NCT00200356|102265617|FG001|STARTED|Overall Study||202||
48785622|NCT00200356|102265616|FG000|Safety Analysis Set|Overall Study||194||
48785623|NCT00200356|102265617|FG001|Safety Analysis Set|Overall Study||198||
48785624|NCT00200356|102265616|FG000|COMPLETED|Overall Study||191||
48785625|NCT00200356|102265617|FG001|COMPLETED|Overall Study||195||
48785626|NCT00200356|102265616|FG000|NOT COMPLETED|Overall Study||8||
48785627|NCT00200356|102265617|FG001|NOT COMPLETED|Overall Study||7||
48785628|NCT01848041|102265618|FG000|STARTED|Overall Study||15||
48785629|NCT01848041|102265619|FG001|STARTED|Overall Study||16||
48785630|NCT01848041|102265620|FG002|STARTED|Overall Study||15||
48785631|NCT01848041|102265618|FG000|COMPLETED|Overall Study||15||
48785632|NCT01848041|102265619|FG001|COMPLETED|Overall Study||16||
48785633|NCT01848041|102265620|FG002|COMPLETED|Overall Study||15||
48785634|NCT01848041|102265618|FG000|NOT COMPLETED|Overall Study||0||
48785635|NCT01848041|102265619|FG001|NOT COMPLETED|Overall Study||0||
48785636|NCT01848041|102265620|FG002|NOT COMPLETED|Overall Study||0||
48785637|NCT03319745|102265621|FG000|STARTED|Overall Study||18||
48785638|NCT03319745|102265621|FG000|COMPLETED|Overall Study||16||
48785639|NCT03319745|102265621|FG000|NOT COMPLETED|Overall Study||2||
48785640|NCT04525885|102265622|FG000|STARTED|Overall Study||68||
48785641|NCT04525885|102265623|FG001|STARTED|Overall Study||27||
48785642|NCT04525885|102265624|FG002|STARTED|Overall Study||66||
48785643|NCT04525885|102265622|FG000|Number Treated|Overall Study||67||
48785644|NCT04525885|102265623|FG001|Number Treated|Overall Study||27||
48785645|NCT04525885|102265624|FG002|Number Treated|Overall Study||66||
48785646|NCT04525885|102265622|FG000|COMPLETED|Overall Study||52||
48785647|NCT04525885|102265623|FG001|COMPLETED|Overall Study||21||
48785648|NCT04525885|102265624|FG002|COMPLETED|Overall Study||45||
48785649|NCT04525885|102265622|FG000|NOT COMPLETED|Overall Study||16||
48785650|NCT04525885|102265623|FG001|NOT COMPLETED|Overall Study||6||
48785651|NCT04525885|102265624|FG002|NOT COMPLETED|Overall Study||21||
48785652|NCT00792571|102265625|FG000|STARTED|Overall Study||18||
48785653|NCT00792571|102265625|FG000|COMPLETED|Overall Study||8||
48785654|NCT00792571|102265625|FG000|NOT COMPLETED|Overall Study||10||
48785655|NCT03800420|102265626|FG000|STARTED|Overall Study||12||
48785656|NCT03800420|102265627|FG001|STARTED|Overall Study||4||
48785657|NCT03800420|102265626|FG000|COMPLETED|Overall Study||10||
48785658|NCT03800420|102265627|FG001|COMPLETED|Overall Study||3||
48785659|NCT03800420|102265626|FG000|NOT COMPLETED|Overall Study||2||
48785660|NCT03800420|102265627|FG001|NOT COMPLETED|Overall Study||1||
48785661|NCT04469998|102265628|FG000|STARTED|Full Analysis Set (ITT Population)||43||
48785662|NCT04469998|102265629|FG001|STARTED|Full Analysis Set (ITT Population)||44||
48785663|NCT04469998|102265630|FG002|STARTED|Full Analysis Set (ITT Population)||42||
48785664|NCT04469998|102265628|FG000|COMPLETED|Full Analysis Set (ITT Population)||42||
48785665|NCT04469998|102265629|FG001|COMPLETED|Full Analysis Set (ITT Population)||43||
48785666|NCT04469998|102265630|FG002|COMPLETED|Full Analysis Set (ITT Population)||42||
48785667|NCT04469998|102265628|FG000|NOT COMPLETED|Full Analysis Set (ITT Population)||1||
48785668|NCT04469998|102265629|FG001|NOT COMPLETED|Full Analysis Set (ITT Population)||1||
48785669|NCT04469998|102265630|FG002|NOT COMPLETED|Full Analysis Set (ITT Population)||0||
48785670|NCT04469998|102265628|FG000|STARTED|Safety Set (as Treated)||42||
48785671|NCT04469998|102265629|FG001|STARTED|Safety Set (as Treated)||43||
48785672|NCT04469998|102265630|FG002|STARTED|Safety Set (as Treated)||43||
48785673|NCT04469998|102265628|FG000|COMPLETED|Safety Set (as Treated)||41||
48785674|NCT04469998|102265629|FG001|COMPLETED|Safety Set (as Treated)||42||
48785675|NCT04469998|102265630|FG002|COMPLETED|Safety Set (as Treated)||43||
48785676|NCT04469998|102265628|FG000|NOT COMPLETED|Safety Set (as Treated)||1||
48785677|NCT04469998|102265629|FG001|NOT COMPLETED|Safety Set (as Treated)||1||
48785678|NCT04469998|102265630|FG002|NOT COMPLETED|Safety Set (as Treated)||0||
48785679|NCT03720652|102265631|FG000|STARTED|Overall Study||12|# of Participants to Complete Screening Questionnaire|
48785680|NCT03720652|102265632|FG001|STARTED|Overall Study||27|# of Participants to Complete Screening Questionnaire|
48785681|NCT03720652|102265631|FG000|Baseline Interview|Overall Study||12|# Participants to Complete Baseline Interview|
48785682|NCT03720652|102265632|FG001|Baseline Interview|Overall Study||22|# Participants to Complete Baseline Interview|
48785683|NCT03720652|102265631|FG000|Start Intervention|Overall Study||11|# of Participants to Start Intervention (i.e. attend at least one intervention session)|
48785684|NCT03720652|102265632|FG001|Start Intervention|Overall Study||21|# of Participants to Start Intervention (i.e. attend at least one intervention session)|
48785685|NCT03720652|102265631|FG000|Complete Intervention|Overall Study||10|# of Participants to Finish Intervention (i.e. attend throughout intervention)|
48785686|NCT03720652|102265632|FG001|Complete Intervention|Overall Study||20|# of Participants to Finish Intervention (i.e. attend throughout intervention)|
48785687|NCT03720652|102265631|FG000|3-Month Follow Up Interview|Overall Study||10|# Participants to Complete 3-Month Follow Up Interview|
48785688|NCT03720652|102265632|FG001|3-Month Follow Up Interview|Overall Study||19|# Participants to Complete 3-Month Follow Up Interview|
48785689|NCT03720652|102265631|FG000|6-Month Follow Up Interview|Overall Study||10|# Participants to Complete 6-Month Follow Up Interview|
48785690|NCT03720652|102265632|FG001|6-Month Follow Up Interview|Overall Study||16|# Participants to Complete 6-Month Follow Up Interview|
48785691|NCT03720652|102265631|FG000|COMPLETED|Overall Study||10||
48785692|NCT03720652|102265632|FG001|COMPLETED|Overall Study||16||
48785693|NCT03720652|102265631|FG000|NOT COMPLETED|Overall Study||2||
48785694|NCT03720652|102265632|FG001|NOT COMPLETED|Overall Study||11||
48785695|NCT01014910|102265633|FG000|STARTED|Overall Study||80||
48785696|NCT01014910|102265634|FG001|STARTED|Overall Study||81||
48785697|NCT01014910|102265633|FG000|COMPLETED|Overall Study||80||
48785698|NCT01014910|102265634|FG001|COMPLETED|Overall Study||79||
48785699|NCT01014910|102265633|FG000|NOT COMPLETED|Overall Study||0||
48785700|NCT01014910|102265634|FG001|NOT COMPLETED|Overall Study||2||
48785701|NCT03630770|102265635|FG000|STARTED|Overall Study||4||
48785702|NCT03630770|102265636|FG001|STARTED|Overall Study||8||
48785703|NCT03630770|102265635|FG000|COMPLETED|Overall Study||4||
48785704|NCT03630770|102265636|FG001|COMPLETED|Overall Study||8||
48785705|NCT03630770|102265635|FG000|NOT COMPLETED|Overall Study||0||
48785706|NCT03630770|102265636|FG001|NOT COMPLETED|Overall Study||0||
48785707|NCT01181986|102265637|FG000|STARTED|Phase 1||19||
48785708|NCT01181986|102265638|FG001|STARTED|Phase 1||23||
48785709|NCT01181986|102265639|FG002|STARTED|Phase 1||34||
48785710|NCT01181986|102265637|FG000|Saline+Exenatide|Phase 1||0||
48785711|NCT01181986|102265638|FG001|Saline+Exenatide|Phase 1||0||
48785712|NCT01181986|102265639|FG002|Saline+Exenatide|Phase 1||32||
48785713|NCT01181986|102265637|FG000|Saline+Placebo|Phase 1||0||
48785714|NCT01181986|102265638|FG001|Saline+Placebo|Phase 1||0||
48785715|NCT01181986|102265639|FG002|Saline+Placebo|Phase 1||33||
48785716|NCT01181986|102265637|FG000|Exendin-9+Exenatide|Phase 1||0||
48785717|NCT01181986|102265638|FG001|Exendin-9+Exenatide|Phase 1||0||
48785718|NCT01181986|102265639|FG002|Exendin-9+Exenatide|Phase 1||33||
48785719|NCT01181986|102265637|FG000|COMPLETED|Phase 1||18||
48785720|NCT01181986|102265638|FG001|COMPLETED|Phase 1||22||
48785721|NCT01181986|102265639|FG002|COMPLETED|Phase 1||32||
48785722|NCT01181986|102265637|FG000|NOT COMPLETED|Phase 1||1||
48785723|NCT01181986|102265638|FG001|NOT COMPLETED|Phase 1||1||
48785724|NCT01181986|102265639|FG002|NOT COMPLETED|Phase 1||2||
48785725|NCT01181986|102265637|FG000|STARTED|Phase 2||18||
48785726|NCT01181986|102265638|FG001|STARTED|Phase 2||22||
48785727|NCT01181986|102265639|FG002|STARTED|Phase 2||0||
48785728|NCT01181986|102265637|FG000|COMPLETED|Phase 2||18||
48785729|NCT01181986|102265638|FG001|COMPLETED|Phase 2||18||
48785730|NCT01181986|102265639|FG002|COMPLETED|Phase 2||0||
48785731|NCT01181986|102265637|FG000|NOT COMPLETED|Phase 2||0||
48785732|NCT01181986|102265638|FG001|NOT COMPLETED|Phase 2||4||
48785733|NCT01181986|102265639|FG002|NOT COMPLETED|Phase 2||0||
48785734|NCT00847509|102265640|FG000|STARTED|Overall Study||49||
48785735|NCT00847509|102265640|FG000|COMPLETED|Overall Study||38||
48785736|NCT00847509|102265640|FG000|NOT COMPLETED|Overall Study||11||
48785737|NCT02103153|102265641|FG000|STARTED|Overall Study||44||
48785738|NCT02103153|102265641|FG000|COMPLETED|Overall Study||27||
48785739|NCT02103153|102265641|FG000|NOT COMPLETED|Overall Study||17||
48785740|NCT02160041|102265642|FG000|STARTED|Overall Study||84||
48467377|NCT02106065|101480906|FG002|COMPLETED|Overall Study||5||
48467378|NCT02106065|101480904|FG000|NOT COMPLETED|Overall Study||3||
48467379|NCT02106065|101480905|FG001|NOT COMPLETED|Overall Study||3||
48467380|NCT02106065|101480906|FG002|NOT COMPLETED|Overall Study||10||
48467381|NCT00993187|101480907|FG000|STARTED|Overall Study||147||
48467382|NCT00993187|101480908|FG001|STARTED|Overall Study||145||
48467383|NCT00993187|101480907|FG000|Received at Least 1 Dose of Study Drug|Overall Study||146||
48467384|NCT00993187|101480908|FG001|Received at Least 1 Dose of Study Drug|Overall Study||144||
48467385|NCT00993187|101480907|FG000|COMPLETED|Overall Study||121||
48467386|NCT00993187|101480908|FG001|COMPLETED|Overall Study||108||
48467387|NCT00993187|101480907|FG000|NOT COMPLETED|Overall Study||26||
48467388|NCT00993187|101480908|FG001|NOT COMPLETED|Overall Study||37||
48467389|NCT03339349|101480909|FG000|STARTED|Overall Study||80||
48467390|NCT03339349|101480909|FG000|COMPLETED|Overall Study||80||
48467391|NCT03339349|101480909|FG000|NOT COMPLETED|Overall Study||0||
48467392|NCT02199509|101480910|FG000|STARTED|Overall Study||3||
48467393|NCT02199509|101480911|FG001|STARTED|Overall Study||4||
48467394|NCT02199509|101480910|FG000|COMPLETED|Overall Study||2||
48467395|NCT02199509|101480911|FG001|COMPLETED|Overall Study||3||
48467396|NCT02199509|101480910|FG000|NOT COMPLETED|Overall Study||1||
48467397|NCT02199509|101480911|FG001|NOT COMPLETED|Overall Study||1||
48467398|NCT02093689|101480912|FG000|STARTED|Overall Study||18||
48467399|NCT02093689|101480913|FG001|STARTED|Overall Study||0||
48467400|NCT02093689|101480914|FG002|STARTED|Overall Study||0||
48467401|NCT02093689|101480912|FG000|COMPLETED|Overall Study||14||
48467402|NCT02093689|101480913|FG001|COMPLETED|Overall Study||0||
48467403|NCT02093689|101480914|FG002|COMPLETED|Overall Study||0||
48467404|NCT02093689|101480912|FG000|NOT COMPLETED|Overall Study||4||
48467405|NCT02093689|101480913|FG001|NOT COMPLETED|Overall Study||0||
48467406|NCT02093689|101480914|FG002|NOT COMPLETED|Overall Study||0||
48467407|NCT01874951|101480915|FG000|STARTED|Overall Study||6||
48467408|NCT01874951|101480916|FG001|STARTED|Overall Study||6||
48467409|NCT01874951|101480915|FG000|COMPLETED|Overall Study||6||
48467410|NCT01874951|101480916|FG001|COMPLETED|Overall Study||6||
48467411|NCT01874951|101480915|FG000|NOT COMPLETED|Overall Study||0||
48467412|NCT01874951|101480916|FG001|NOT COMPLETED|Overall Study||0||
48467413|NCT01725984|101480917|FG000|STARTED|Overall Study||39||
48467414|NCT01725984|101480918|FG001|STARTED|Overall Study||41||
48467415|NCT01725984|101480917|FG000|COMPLETED|Overall Study||39||
48467416|NCT01725984|101480918|FG001|COMPLETED|Overall Study||41||
48467417|NCT01725984|101480917|FG000|NOT COMPLETED|Overall Study||0||
48467418|NCT01725984|101480918|FG001|NOT COMPLETED|Overall Study||0||
48467419|NCT04588259|101480919|FG000|STARTED|Run-in Period||0||
48467420|NCT04588259|101480920|FG001|STARTED|Run-in Period||331||
48467421|NCT04588259|101480919|FG000|COMPLETED|Run-in Period||0||
48467422|NCT04588259|101480920|FG001|COMPLETED|Run-in Period||300||
48467423|NCT04588259|101480919|FG000|NOT COMPLETED|Run-in Period||0||
48467424|NCT04588259|101480920|FG001|NOT COMPLETED|Run-in Period||31||
48467425|NCT04588259|101480919|FG000|STARTED|Treatment Period||150||
48467426|NCT04588259|101480920|FG001|STARTED|Treatment Period||150||
48467427|NCT04588259|101480919|FG000|Full Analysis Set|Treatment Period||150||
48467428|NCT04588259|101480920|FG001|Full Analysis Set|Treatment Period||150||
48467429|NCT04588259|101480919|FG000|Safety Analysis Set|Treatment Period||150||
48467430|NCT04588259|101480920|FG001|Safety Analysis Set|Treatment Period||150||
48467431|NCT04588259|101480919|FG000|COMPLETED|Treatment Period||144||
48467432|NCT04588259|101480920|FG001|COMPLETED|Treatment Period||144||
48467433|NCT04588259|101480919|FG000|NOT COMPLETED|Treatment Period||6||
48467434|NCT04588259|101480920|FG001|NOT COMPLETED|Treatment Period||6||
48467435|NCT02220907|101480921|FG000|STARTED|Overall Study||153||
48467436|NCT02220907|101480921|FG000|COMPLETED|Overall Study||142||
48467437|NCT02220907|101480921|FG000|NOT COMPLETED|Overall Study||11||
48467438|NCT00108732|101480922|FG000|STARTED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||50||
48467439|NCT00108732|101480922|FG000|Eligible and Treated|Step 1 (Vaccinia/Fowlpox/GM-CSF)||40||
48467440|NCT00108732|101480922|FG000|COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||36||
48467441|NCT00108732|101480922|FG000|NOT COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||14||
48467442|NCT00108732|101480922|FG000|STARTED|Step 2 (Androgen Ablation and Vaccine)||31||
48467443|NCT00108732|101480922|FG000|COMPLETED|Step 2 (Androgen Ablation and Vaccine)||26||
48467444|NCT00108732|101480922|FG000|NOT COMPLETED|Step 2 (Androgen Ablation and Vaccine)||5||
48467445|NCT00865709|101480923|FG000|STARTED|Treatment||97||
48467446|NCT00865709|101480924|FG001|STARTED|Treatment||101||
48467447|NCT00865709|101480923|FG000|Received Treatment|Treatment||97||
48467448|NCT00865709|101480924|FG001|Received Treatment|Treatment||101||
48467449|NCT00865709|101480923|FG000|COMPLETED|Treatment||67||
48467450|NCT00865709|101480924|FG001|COMPLETED|Treatment||83||
48467451|NCT00865709|101480923|FG000|NOT COMPLETED|Treatment||30||
48467452|NCT00865709|101480924|FG001|NOT COMPLETED|Treatment||18||
48467453|NCT00865709|101480923|FG000|STARTED|Active Follow-up||25||
48467454|NCT00865709|101480924|FG001|STARTED|Active Follow-up||16||
48467455|NCT00865709|101480923|FG000|COMPLETED|Active Follow-up||17||
48467456|NCT00865709|101480924|FG001|COMPLETED|Active Follow-up||15||
48467457|NCT00865709|101480923|FG000|NOT COMPLETED|Active Follow-up||8||
48467458|NCT00865709|101480924|FG001|NOT COMPLETED|Active Follow-up||1||
48467459|NCT00865709|101480923|FG000|STARTED|Long Term Follow-up||70||
48467460|NCT00865709|101480924|FG001|STARTED|Long Term Follow-up||82||
48467461|NCT00865709|101480923|FG000|COMPLETED|Long Term Follow-up||24||
48467462|NCT00865709|101480924|FG001|COMPLETED|Long Term Follow-up||33||
48467463|NCT00865709|101480923|FG000|NOT COMPLETED|Long Term Follow-up||46||
48785741|NCT02160041|102265642|FG000|COMPLETED|Overall Study||0||
48189927|NCT04830514|100788968|FG002|NOT COMPLETED|Overall Study||3||
48467464|NCT00865709|101480924|FG001|NOT COMPLETED|Long Term Follow-up||49||
48467465|NCT05569148|101480925|FG000|STARTED|Overall Study||35||
48467466|NCT05569148|101480925|FG000|COMPLETED|Overall Study||35||
48467467|NCT05569148|101480925|FG000|NOT COMPLETED|Overall Study||0||
48785742|NCT02160041|102265642|FG000|NOT COMPLETED|Overall Study||84||
48785743|NCT01386970|102265643|FG000|STARTED|Overall Study||20||
48785744|NCT01386970|102265644|FG001|STARTED|Overall Study||23||
48785745|NCT01386970|102265643|FG000|COMPLETED|Overall Study||16||
48785746|NCT01386970|102265644|FG001|COMPLETED|Overall Study||21||
48785747|NCT01386970|102265643|FG000|NOT COMPLETED|Overall Study||4||
48785748|NCT01386970|102265644|FG001|NOT COMPLETED|Overall Study||2||
48785749|NCT00645450|102265645|FG000|STARTED|Overall Study||5||
48785750|NCT00645450|102265646|FG001|STARTED|Overall Study||4||
48785751|NCT00645450|102265645|FG000|COMPLETED|Overall Study||5||
48785752|NCT00645450|102265646|FG001|COMPLETED|Overall Study||4||
48785753|NCT00645450|102265645|FG000|NOT COMPLETED|Overall Study||0||
48785754|NCT00645450|102265646|FG001|NOT COMPLETED|Overall Study||0||
48785755|NCT00597896|102265647|FG000|STARTED|Overall Study||24||
48785756|NCT00597896|102265648|FG001|STARTED|Overall Study||26||
48785757|NCT00597896|102265647|FG000|COMPLETED|Overall Study||21||
48785758|NCT00597896|102265648|FG001|COMPLETED|Overall Study||24||
48785759|NCT00597896|102265647|FG000|NOT COMPLETED|Overall Study||3||
48785760|NCT00597896|102265648|FG001|NOT COMPLETED|Overall Study||2||
48785761|NCT00548184|102265649|FG000|STARTED|Overall Study||65||
48785762|NCT00548184|102265649|FG000|COMPLETED|Overall Study||60||
48785763|NCT00548184|102265649|FG000|NOT COMPLETED|Overall Study||5||
48785764|NCT02291016|102265650|FG000|STARTED|Visit 1||2||
48785765|NCT02291016|102265651|FG001|STARTED|Visit 1||5||
48785766|NCT02291016|102265650|FG000|COMPLETED|Visit 1||2||
48785767|NCT02291016|102265651|FG001|COMPLETED|Visit 1||5||
48785768|NCT02291016|102265650|FG000|NOT COMPLETED|Visit 1||0||
48785769|NCT02291016|102265651|FG001|NOT COMPLETED|Visit 1||0||
48785770|NCT02291016|102265650|FG000|STARTED|Visit 2||2||
48785771|NCT02291016|102265651|FG001|STARTED|Visit 2||5||
48785772|NCT02291016|102265650|FG000|COMPLETED|Visit 2||1||
48785773|NCT02291016|102265651|FG001|COMPLETED|Visit 2||5||
48785774|NCT02291016|102265650|FG000|NOT COMPLETED|Visit 2||1||
48785775|NCT02291016|102265651|FG001|NOT COMPLETED|Visit 2||0||
48785776|NCT01018810|102265652|FG000|STARTED|Overall Study||4||
48785777|NCT01018810|102265653|FG001|STARTED|Overall Study||1||
48785778|NCT01018810|102265654|FG002|STARTED|Overall Study||1||
48785779|NCT01018810|102265655|FG003|STARTED|Overall Study||1||
48785780|NCT01018810|102265656|FG004|STARTED|Overall Study||1||
48785781|NCT01018810|102265652|FG000|COMPLETED|Overall Study||2||
48785782|NCT01018810|102265653|FG001|COMPLETED|Overall Study||0||
48785783|NCT01018810|102265654|FG002|COMPLETED|Overall Study||0||
48785784|NCT01018810|102265655|FG003|COMPLETED|Overall Study||0||
48785785|NCT01018810|102265656|FG004|COMPLETED|Overall Study||0||
48785786|NCT01018810|102265652|FG000|NOT COMPLETED|Overall Study||2||
48785787|NCT01018810|102265653|FG001|NOT COMPLETED|Overall Study||1||
48785788|NCT01018810|102265654|FG002|NOT COMPLETED|Overall Study||1||
48785789|NCT01018810|102265655|FG003|NOT COMPLETED|Overall Study||1||
48785790|NCT01018810|102265656|FG004|NOT COMPLETED|Overall Study||1||
48785791|NCT01012219|102265657|FG000|STARTED|Period 1||36||
48785792|NCT01012219|102265657|FG000|COMPLETED|Period 1||35||
48785793|NCT01012219|102265657|FG000|NOT COMPLETED|Period 1||1||
48785794|NCT01012219|102265657|FG000|STARTED|Period 2||35||
48785795|NCT01012219|102265657|FG000|COMPLETED|Period 2||34||
48785796|NCT01012219|102265657|FG000|NOT COMPLETED|Period 2||1||
48785797|NCT01012219|102265657|FG000|STARTED|Period 3||20||
48785798|NCT01012219|102265657|FG000|COMPLETED|Period 3||20||
48785799|NCT01012219|102265657|FG000|NOT COMPLETED|Period 3||0||
48785800|NCT00475306|102265658|FG000|STARTED|Overall Study||73||
48785801|NCT00475306|102265659|FG001|STARTED|Overall Study||72||
48785802|NCT00475306|102265660|FG002|STARTED|Overall Study||72||
48785803|NCT00475306|102265661|FG003|STARTED|Overall Study||72||
48785804|NCT00475306|102265658|FG000|COMPLETED|Overall Study||72||
48785805|NCT00475306|102265659|FG001|COMPLETED|Overall Study||71||
48785806|NCT00475306|102265660|FG002|COMPLETED|Overall Study||72||
48785807|NCT00475306|102265661|FG003|COMPLETED|Overall Study||71||
48785808|NCT00475306|102265658|FG000|NOT COMPLETED|Overall Study||1||
48785809|NCT00475306|102265659|FG001|NOT COMPLETED|Overall Study||1||
48785810|NCT00475306|102265660|FG002|NOT COMPLETED|Overall Study||0||
48785811|NCT00475306|102265661|FG003|NOT COMPLETED|Overall Study||1||
48785812|NCT00439738|102265662|FG000|STARTED|Overall Study||206||
48785813|NCT00439738|102265663|FG001|STARTED|Overall Study||206||
48785814|NCT00439738|102265662|FG000|COMPLETED|Overall Study||170||
48785815|NCT00439738|102265663|FG001|COMPLETED|Overall Study||178||
48785816|NCT00439738|102265662|FG000|NOT COMPLETED|Overall Study||36||
48785817|NCT00439738|102265663|FG001|NOT COMPLETED|Overall Study||28||
48785818|NCT00689117|102265664|FG000|STARTED|Overall Study||476||
48785819|NCT00689117|102265665|FG001|STARTED|Overall Study||467||
48785820|NCT00689117|102265666|FG002|STARTED|Overall Study||464||
48785821|NCT00689117|102265667|FG003|STARTED|Overall Study||242||
48785822|NCT00689117|102265664|FG000|COMPLETED|Overall Study||414||
48785823|NCT00689117|102265665|FG001|COMPLETED|Overall Study||416||
48785824|NCT00689117|102265666|FG002|COMPLETED|Overall Study||405||
48785825|NCT00689117|102265667|FG003|COMPLETED|Overall Study||211||
48785826|NCT00689117|102265664|FG000|NOT COMPLETED|Overall Study||62||
48785827|NCT00689117|102265665|FG001|NOT COMPLETED|Overall Study||51||
48785828|NCT00689117|102265666|FG002|NOT COMPLETED|Overall Study||59||
48785829|NCT00689117|102265667|FG003|NOT COMPLETED|Overall Study||31||
48785830|NCT01454778|102265668|FG000|STARTED|Overall Study||50||
48785831|NCT01454778|102265668|FG000|COMPLETED|Overall Study||47||
48785832|NCT01454778|102265668|FG000|NOT COMPLETED|Overall Study||3||
48785833|NCT01068964|102265669|FG000|STARTED|Overall Study||121||
48785834|NCT01068964|102265670|FG001|STARTED|Overall Study||114||
48785835|NCT01068964|102265669|FG000|COMPLETED|Overall Study||113||
48785836|NCT01068964|102265670|FG001|COMPLETED|Overall Study||104||
48785837|NCT01068964|102265669|FG000|NOT COMPLETED|Overall Study||8||
48785838|NCT01068964|102265670|FG001|NOT COMPLETED|Overall Study||10||
48785839|NCT02356900|102265671|FG000|STARTED|Overall Study||11||
48785840|NCT02356900|102265672|FG001|STARTED|Overall Study||10||
48785841|NCT02356900|102265671|FG000|COMPLETED|Overall Study||11||
48785842|NCT02356900|102265672|FG001|COMPLETED|Overall Study||10||
48785843|NCT02356900|102265671|FG000|NOT COMPLETED|Overall Study||0||
48785844|NCT02356900|102265672|FG001|NOT COMPLETED|Overall Study||0||
48785845|NCT00915499|102265673|FG000|STARTED|Overall Study||33||
48785846|NCT00915499|102265674|FG001|STARTED|Overall Study||33||
48785847|NCT00915499|102265673|FG000|COMPLETED|Overall Study||29||
48785848|NCT00915499|102265674|FG001|COMPLETED|Overall Study||31||
48785849|NCT00915499|102265673|FG000|NOT COMPLETED|Overall Study||4||
48785850|NCT00915499|102265674|FG001|NOT COMPLETED|Overall Study||2||
48785851|NCT03029988|102265675|FG000|STARTED|Overall Study||3||
48785852|NCT03029988|102265675|FG000|COMPLETED|Overall Study||3||
48785853|NCT03029988|102265675|FG000|NOT COMPLETED|Overall Study||0||
48785854|NCT03232333|102265676|FG000|STARTED|Overall Study||53||
48785855|NCT03232333|102265676|FG000|COMPLETED|Overall Study||38||
48785856|NCT03232333|102265676|FG000|NOT COMPLETED|Overall Study||15||
48785857|NCT02894502|102265677|FG000|STARTED|Baseline||155||
48785858|NCT02894502|102265678|FG001|STARTED|Baseline||177||
48785859|NCT02894502|102265679|FG002|STARTED|Baseline||178||
48785860|NCT02894502|102265677|FG000|COMPLETED|Baseline||128||
48785861|NCT02894502|102265678|FG001|COMPLETED|Baseline||145||
48785862|NCT02894502|102265679|FG002|COMPLETED|Baseline||133||
48785863|NCT02894502|102265677|FG000|NOT COMPLETED|Baseline||27||
48785864|NCT02894502|102265678|FG001|NOT COMPLETED|Baseline||32||
48785865|NCT02894502|102265679|FG002|NOT COMPLETED|Baseline||45||
48785866|NCT02894502|102265677|FG000|STARTED|First Follow up||128||
48785867|NCT02894502|102265678|FG001|STARTED|First Follow up||145||
48785868|NCT02894502|102265679|FG002|STARTED|First Follow up||133||
48785869|NCT02894502|102265677|FG000|COMPLETED|First Follow up||94||
48785870|NCT02894502|102265678|FG001|COMPLETED|First Follow up||114||
48785871|NCT02894502|102265679|FG002|COMPLETED|First Follow up||93||
48785872|NCT02894502|102265677|FG000|NOT COMPLETED|First Follow up||34||
48189928|NCT04006795|100788969|FG000|STARTED|Induction Phase||37||
48189929|NCT04006795|100788969|FG000|COMPLETED|Induction Phase||37||
48467468|NCT01769209|101480926|FG000|STARTED|Overall Study||18||
48467469|NCT01769209|101480926|FG000|COMPLETED|Overall Study||18||
48467470|NCT01769209|101480926|FG000|NOT COMPLETED|Overall Study||0||
48467471|NCT02134522|101480927|FG000|STARTED|Overall Study||1||
48467472|NCT02134522|101480927|FG000|COMPLETED|Overall Study||1||
48467473|NCT02134522|101480927|FG000|NOT COMPLETED|Overall Study||0||
48467474|NCT04582266|101480928|FG000|STARTED|Overall Study||26||
48467475|NCT04582266|101480929|FG001|STARTED|Overall Study||28||
48467476|NCT04582266|101480928|FG000|Received RDV|Overall Study||25||
48467477|NCT04582266|101480929|FG001|Received RDV|Overall Study||28||
48467478|NCT04582266|101480928|FG000|COMPLETED|Overall Study||17||
48467479|NCT04582266|101480929|FG001|COMPLETED|Overall Study||23||
48467480|NCT04582266|101480928|FG000|NOT COMPLETED|Overall Study||9||
48467481|NCT04582266|101480929|FG001|NOT COMPLETED|Overall Study||5||
48467482|NCT01432171|101480930|FG000|STARTED|Overall Study||18||
48467483|NCT01432171|101480931|FG001|STARTED|Overall Study||19||
48785873|NCT02894502|102265678|FG001|NOT COMPLETED|First Follow up||31||
48785874|NCT02894502|102265679|FG002|NOT COMPLETED|First Follow up||40||
48785875|NCT02894502|102265677|FG000|STARTED|Second Follow up||94||
48785876|NCT02894502|102265678|FG001|STARTED|Second Follow up||114||
48785877|NCT02894502|102265679|FG002|STARTED|Second Follow up||93||
48785878|NCT02894502|102265677|FG000|COMPLETED|Second Follow up||79||
48785879|NCT02894502|102265678|FG001|COMPLETED|Second Follow up||96||
48785880|NCT02894502|102265679|FG002|COMPLETED|Second Follow up||79||
48785881|NCT02894502|102265677|FG000|NOT COMPLETED|Second Follow up||15||
48785882|NCT02894502|102265678|FG001|NOT COMPLETED|Second Follow up||18||
48785883|NCT02894502|102265679|FG002|NOT COMPLETED|Second Follow up||14||
48785884|NCT02894502|102265677|FG000|STARTED|Third Follow up||79||
48785885|NCT02894502|102265678|FG001|STARTED|Third Follow up||96||
48785886|NCT02894502|102265679|FG002|STARTED|Third Follow up||79||
48785887|NCT02894502|102265677|FG000|COMPLETED|Third Follow up||73||
48785888|NCT02894502|102265678|FG001|COMPLETED|Third Follow up||89||
48785889|NCT02894502|102265679|FG002|COMPLETED|Third Follow up||76||
48785890|NCT02894502|102265677|FG000|NOT COMPLETED|Third Follow up||6||
48785891|NCT02894502|102265678|FG001|NOT COMPLETED|Third Follow up||7||
48785892|NCT02894502|102265679|FG002|NOT COMPLETED|Third Follow up||3||
48785893|NCT02365480|102265680|FG000|STARTED|Overall Study||14||
48785894|NCT02365480|102265681|FG001|STARTED|Overall Study||4||
48785895|NCT02365480|102265680|FG000|COMPLETED|Overall Study||12||
48785896|NCT02365480|102265681|FG001|COMPLETED|Overall Study||4||
48785897|NCT02365480|102265680|FG000|NOT COMPLETED|Overall Study||2||
48785898|NCT02365480|102265681|FG001|NOT COMPLETED|Overall Study||0||
48785899|NCT00817596|102265682|FG000|STARTED|Overall Study||110||
48785900|NCT00817596|102265682|FG000|COMPLETED|Overall Study||62||
48785901|NCT00817596|102265682|FG000|NOT COMPLETED|Overall Study||48||
48785902|NCT01136785|102265683|FG000|STARTED|Overall Study||15||
48785903|NCT01136785|102265684|FG001|STARTED|Overall Study||7||
48785904|NCT01136785|102265683|FG000|COMPLETED|Overall Study||13||
48785905|NCT01136785|102265684|FG001|COMPLETED|Overall Study||6||
48785906|NCT01136785|102265683|FG000|NOT COMPLETED|Overall Study||2||
48785907|NCT01136785|102265684|FG001|NOT COMPLETED|Overall Study||1||
48785908|NCT02082340|102265685|FG000|STARTED|Overall Study||194||
48785909|NCT02082340|102265686|FG001|STARTED|Overall Study||198||
48785910|NCT02082340|102265685|FG000|COMPLETED|Overall Study||193||
48785911|NCT02082340|102265686|FG001|COMPLETED|Overall Study||197||
48467484|NCT01432171|101480930|FG000|COMPLETED|Overall Study||4||
48467485|NCT01432171|101480931|FG001|COMPLETED|Overall Study||8||
48467486|NCT01432171|101480930|FG000|NOT COMPLETED|Overall Study||14||
48467487|NCT01432171|101480931|FG001|NOT COMPLETED|Overall Study||11||
48785912|NCT02082340|102265685|FG000|NOT COMPLETED|Overall Study||1||
48785913|NCT02082340|102265686|FG001|NOT COMPLETED|Overall Study||1||
48785914|NCT01325337|102265687|FG000|STARTED|Overall Study||61||
48785915|NCT01325337|102265688|FG001|STARTED|Overall Study||61||
48785916|NCT01325337|102265689|FG002|STARTED|Overall Study||62||
48785917|NCT01325337|102265690|FG003|STARTED|Overall Study||62||
48785918|NCT01325337|102265691|FG004|STARTED|Overall Study||61||
48785919|NCT01325337|102265687|FG000|COMPLETED|Overall Study||56||
48785920|NCT01325337|102265688|FG001|COMPLETED|Overall Study||52||
48785921|NCT01325337|102265689|FG002|COMPLETED|Overall Study||53||
48189930|NCT04006795|100788969|FG000|NOT COMPLETED|Induction Phase||0||
48785922|NCT01325337|102265690|FG003|COMPLETED|Overall Study||52||
48785923|NCT01325337|102265691|FG004|COMPLETED|Overall Study||53||
48785924|NCT01325337|102265687|FG000|NOT COMPLETED|Overall Study||5||
48785925|NCT01325337|102265688|FG001|NOT COMPLETED|Overall Study||9||
48785926|NCT01325337|102265689|FG002|NOT COMPLETED|Overall Study||9||
48785927|NCT01325337|102265690|FG003|NOT COMPLETED|Overall Study||10||
48785928|NCT01325337|102265691|FG004|NOT COMPLETED|Overall Study||8||
48785929|NCT01089517|102265692|FG000|STARTED|Overall Study||148||
48785930|NCT01089517|102265693|FG001|STARTED|Overall Study||149||
48785931|NCT01089517|102265694|FG002|STARTED|Overall Study||152||
48785932|NCT01089517|102265692|FG000|COMPLETED|Overall Study||144||
48785933|NCT01089517|102265693|FG001|COMPLETED|Overall Study||144||
48785934|NCT01089517|102265694|FG002|COMPLETED|Overall Study||147||
48785935|NCT01089517|102265692|FG000|NOT COMPLETED|Overall Study||4||
48785936|NCT01089517|102265693|FG001|NOT COMPLETED|Overall Study||5||
48785937|NCT01089517|102265694|FG002|NOT COMPLETED|Overall Study||5||
48785938|NCT03495856|102265695|FG000|STARTED|Overall Study||23||
48785939|NCT03495856|102265695|FG000|COMPLETED|Overall Study||22||
48785940|NCT03495856|102265695|FG000|NOT COMPLETED|Overall Study||1||
48785941|NCT01896206|102265696|FG000|STARTED|Overall Study||21||
48785942|NCT01896206|102265696|FG000|COMPLETED|Overall Study||21||
48785943|NCT01896206|102265696|FG000|NOT COMPLETED|Overall Study||0||
48785944|NCT01699867|102265697|FG000|STARTED|Overall Study||50||
48785945|NCT01699867|102265697|FG000|COMPLETED|Overall Study||47||
48785946|NCT01699867|102265697|FG000|NOT COMPLETED|Overall Study||3||
48785947|NCT00483756|102265698|FG000|STARTED|Overall Study||110||
48785948|NCT00483756|102265699|FG001|STARTED|Overall Study||110||
48785949|NCT00483756|102265700|FG002|STARTED|Overall Study||111||
48785950|NCT00483756|102265698|FG000|Treated|Overall Study||109||
48785951|NCT00483756|102265699|FG001|Treated|Overall Study||106||
48785952|NCT00483756|102265700|FG002|Treated|Overall Study||107||
48785953|NCT00483756|102265698|FG000|COMPLETED|Overall Study||77||
48785954|NCT00483756|102265699|FG001|COMPLETED|Overall Study||60||
48785955|NCT00483756|102265700|FG002|COMPLETED|Overall Study||59||
48785956|NCT00483756|102265698|FG000|NOT COMPLETED|Overall Study||33||
48785957|NCT00483756|102265699|FG001|NOT COMPLETED|Overall Study||50||
48785958|NCT00483756|102265700|FG002|NOT COMPLETED|Overall Study||52||
48785959|NCT00796523|102265701|FG000|STARTED|Overall Study||27||
48785960|NCT00796523|102265702|FG001|STARTED|Overall Study||24||
48785961|NCT00796523|102265701|FG000|COMPLETED|Overall Study||18||
48785962|NCT00796523|102265702|FG001|COMPLETED|Overall Study||17||
48785963|NCT00796523|102265701|FG000|NOT COMPLETED|Overall Study||9||
48785964|NCT00796523|102265702|FG001|NOT COMPLETED|Overall Study||7||
48785965|NCT03207763|102265703|FG000|STARTED|Overall Study||8||
48785966|NCT03207763|102265704|FG001|STARTED|Overall Study||25||
48785967|NCT03207763|102265703|FG000|Eligible and Opted for Patches 2 and 3|Overall Study||5||
48785968|NCT03207763|102265704|FG001|Eligible and Opted for Patches 2 and 3|Overall Study||23||
48785969|NCT03207763|102265703|FG000|Completed Patches 2 and 3 Study|Overall Study||5||
48785970|NCT03207763|102265704|FG001|Completed Patches 2 and 3 Study|Overall Study||23||
48785971|NCT03207763|102265703|FG000|COMPLETED|Overall Study||7|Completed follow up for the main study of application of Patch 1|
48785972|NCT03207763|102265704|FG001|COMPLETED|Overall Study||25|Completed follow up for the main study of application of Patch 1|
48785973|NCT03207763|102265703|FG000|NOT COMPLETED|Overall Study||1||
48785974|NCT03207763|102265704|FG001|NOT COMPLETED|Overall Study||0||
48785975|NCT04493892|102265705|FG000|STARTED|Overall Study||46||
48785976|NCT04493892|102265705|FG000|COMPLETED|Overall Study||31||
48785977|NCT04493892|102265705|FG000|NOT COMPLETED|Overall Study||15||
48785978|NCT00662298|102265706|FG000|STARTED|Overall Study||5||
48785979|NCT00662298|102265706|FG000|COMPLETED|Overall Study||5||
48785980|NCT00662298|102265706|FG000|NOT COMPLETED|Overall Study||0||
48785981|NCT03124927|102265707|FG000|STARTED|Overall Study||25||
48785982|NCT03124927|102265707|FG000|COMPLETED|Overall Study||25||
48785983|NCT03124927|102265707|FG000|NOT COMPLETED|Overall Study||0||
48785984|NCT01332799|102265708|FG000|STARTED|Overall Study||10||
48785985|NCT01332799|102265709|FG001|STARTED|Overall Study||10||
48785986|NCT01332799|102265708|FG000|COMPLETED|Overall Study||0||
48785987|NCT01332799|102265709|FG001|COMPLETED|Overall Study||0||
48785988|NCT01332799|102265708|FG000|NOT COMPLETED|Overall Study||10||
48785989|NCT01332799|102265709|FG001|NOT COMPLETED|Overall Study||10||
48785990|NCT01767142|102265710|FG000|STARTED|Overall Study||40||40
48785991|NCT01767142|102265710|FG000|COMPLETED|Overall Study||37||37
48785992|NCT01767142|102265710|FG000|NOT COMPLETED|Overall Study||3||3
48785993|NCT01168219|102265711|FG000|STARTED|Overall Study||68||
48785994|NCT01168219|102265711|FG000|COMPLETED|Overall Study||63||
48785995|NCT01168219|102265711|FG000|NOT COMPLETED|Overall Study||5||
48785996|NCT01642615|102265712|FG000|STARTED|Open Label Maintenance Phase||63||
48785997|NCT01642615|102265713|FG001|STARTED|Open Label Maintenance Phase||0||
48785998|NCT01642615|102265714|FG002|STARTED|Open Label Maintenance Phase||0||
48785999|NCT01642615|102265712|FG000|Safety Analysis Set|Open Label Maintenance Phase||62||
48786000|NCT01642615|102265713|FG001|Safety Analysis Set|Open Label Maintenance Phase||0||
48786001|NCT01642615|102265714|FG002|Safety Analysis Set|Open Label Maintenance Phase||0||
48786002|NCT01642615|102265712|FG000|COMPLETED|Open Label Maintenance Phase||58||
48786003|NCT01642615|102265713|FG001|COMPLETED|Open Label Maintenance Phase||0||
48189931|NCT04006795|100788969|FG000|STARTED|Rest Phase||37||
48467488|NCT03992196|101480932|FG000|STARTED|Enrollment||1||
48467489|NCT03992196|101480933|FG001|STARTED|Enrollment||2||
48467490|NCT03992196|101480934|FG002|STARTED|Enrollment||7||
48467491|NCT03992196|101480932|FG000|COMPLETED|Enrollment||0||
48467492|NCT03992196|101480933|FG001|COMPLETED|Enrollment||2||
48467493|NCT03992196|101480934|FG002|COMPLETED|Enrollment||7||
48786004|NCT01642615|102265714|FG002|COMPLETED|Open Label Maintenance Phase||0||
48786005|NCT01642615|102265712|FG000|NOT COMPLETED|Open Label Maintenance Phase||5||
48786006|NCT01642615|102265713|FG001|NOT COMPLETED|Open Label Maintenance Phase||0||
48786007|NCT01642615|102265714|FG002|NOT COMPLETED|Open Label Maintenance Phase||0||
48786008|NCT01642615|102265712|FG000|STARTED|Double Blind Maintenance Phase||0||
48786009|NCT01642615|102265713|FG001|STARTED|Double Blind Maintenance Phase||25||
48786010|NCT01642615|102265714|FG002|STARTED|Double Blind Maintenance Phase||26||
48786011|NCT01642615|102265712|FG000|COMPLETED|Double Blind Maintenance Phase||0||
48786012|NCT01642615|102265713|FG001|COMPLETED|Double Blind Maintenance Phase||18||
48786013|NCT01642615|102265714|FG002|COMPLETED|Double Blind Maintenance Phase||20||
48786014|NCT01642615|102265712|FG000|NOT COMPLETED|Double Blind Maintenance Phase||0||
48786015|NCT01642615|102265713|FG001|NOT COMPLETED|Double Blind Maintenance Phase||7||
48786016|NCT01642615|102265714|FG002|NOT COMPLETED|Double Blind Maintenance Phase||6||
48786017|NCT03035487|102265715|FG000|STARTED|Overall Study||9||
48786018|NCT03035487|102265715|FG000|COMPLETED|Overall Study||9||
48786019|NCT03035487|102265715|FG000|NOT COMPLETED|Overall Study||0||
48786020|NCT03068091|102265716|FG000|STARTED|Overall Study||25||
48786021|NCT03068091|102265716|FG000|COMPLETED|Overall Study||24||
48786022|NCT03068091|102265716|FG000|NOT COMPLETED|Overall Study||1||
48786023|NCT02416622|102265717|FG000|STARTED|Overall Study||6||
48786024|NCT02416622|102265718|FG001|STARTED|Overall Study||8||
48786025|NCT02416622|102265719|FG002|STARTED|Overall Study||13||
48786026|NCT02416622|102265717|FG000|Completed Month 12|Overall Study||6||
48786027|NCT02416622|102265718|FG001|Completed Month 12|Overall Study||8||
48189932|NCT04006795|100788969|FG000|COMPLETED|Rest Phase||37||
48189933|NCT04006795|100788969|FG000|NOT COMPLETED|Rest Phase||0||
48467494|NCT03992196|101480932|FG000|NOT COMPLETED|Enrollment||1||
48467495|NCT03992196|101480933|FG001|NOT COMPLETED|Enrollment||0||
48467496|NCT03992196|101480934|FG002|NOT COMPLETED|Enrollment||0||
48467497|NCT03992196|101480932|FG000|STARTED|Treatment||0||
48467498|NCT03992196|101480933|FG001|STARTED|Treatment||2||
48467499|NCT03992196|101480934|FG002|STARTED|Treatment||7||
48467500|NCT03992196|101480932|FG000|COMPLETED|Treatment||0||
48467501|NCT03992196|101480933|FG001|COMPLETED|Treatment||2||
48467502|NCT03992196|101480934|FG002|COMPLETED|Treatment||1||
48467503|NCT03992196|101480932|FG000|NOT COMPLETED|Treatment||0||
48467504|NCT03992196|101480933|FG001|NOT COMPLETED|Treatment||0||
48467505|NCT03992196|101480934|FG002|NOT COMPLETED|Treatment||6||
48467506|NCT01977092|101480935|FG000|STARTED|Overall Study||149||
48467507|NCT01977092|101480936|FG001|STARTED|Overall Study||181||
48467508|NCT01977092|101480935|FG000|COMPLETED|Overall Study||118||
48467509|NCT01977092|101480936|FG001|COMPLETED|Overall Study||151||
48467510|NCT01977092|101480935|FG000|NOT COMPLETED|Overall Study||31||
48467511|NCT01977092|101480936|FG001|NOT COMPLETED|Overall Study||30||
48467512|NCT02203565|101480937|FG000|STARTED|Overall Study||20||
48467513|NCT02203565|101480937|FG000|COMPLETED|Overall Study||19||
48467514|NCT02203565|101480937|FG000|NOT COMPLETED|Overall Study||1||
48467515|NCT00422656|101480938|FG000|STARTED|Overall Study||37||
48467516|NCT00422656|101480938|FG000|COMPLETED|Overall Study||37||
48467517|NCT00422656|101480938|FG000|NOT COMPLETED|Overall Study||0||
48467518|NCT01631864|101480939|FG000|STARTED|Overall Study||50||
48467519|NCT01631864|101480940|FG001|STARTED|Overall Study||48||
48467520|NCT01631864|101480939|FG000|COMPLETED|Overall Study||48||
48467521|NCT01631864|101480940|FG001|COMPLETED|Overall Study||44||
48786028|NCT02416622|102265719|FG002|Completed Month 12|Overall Study||13||
48786029|NCT02416622|102265717|FG000|Started Long-Term Follow-Up|Overall Study||6||
48467522|NCT01631864|101480939|FG000|NOT COMPLETED|Overall Study||2||
48786030|NCT02416622|102265718|FG001|Started Long-Term Follow-Up|Overall Study||8||
48467523|NCT01631864|101480940|FG001|NOT COMPLETED|Overall Study||4||
48467524|NCT00635778|101480941|FG000|STARTED|Overall Study||1||
48467525|NCT00635778|101480942|FG001|STARTED|Overall Study||3||
48467526|NCT00635778|101480943|FG002|STARTED|Overall Study||3||
48467527|NCT00635778|101480944|FG003|STARTED|Overall Study||8||
48467528|NCT00635778|101480945|FG004|STARTED|Overall Study||8||
48467529|NCT00635778|101480946|FG005|STARTED|Overall Study||21||
48467530|NCT00635778|101480947|FG006|STARTED|Overall Study||6||
48467531|NCT00635778|101480941|FG000|COMPLETED|Overall Study||0||
48467532|NCT00635778|101480942|FG001|COMPLETED|Overall Study||0||
48467533|NCT00635778|101480943|FG002|COMPLETED|Overall Study||0||
48467534|NCT00635778|101480944|FG003|COMPLETED|Overall Study||0||
48467535|NCT00635778|101480945|FG004|COMPLETED|Overall Study||0||
48467536|NCT00635778|101480946|FG005|COMPLETED|Overall Study||0||
48467537|NCT00635778|101480947|FG006|COMPLETED|Overall Study||0||
48467538|NCT00635778|101480941|FG000|NOT COMPLETED|Overall Study||1||
48467539|NCT00635778|101480942|FG001|NOT COMPLETED|Overall Study||3||
48467540|NCT00635778|101480943|FG002|NOT COMPLETED|Overall Study||3||
48467541|NCT00635778|101480944|FG003|NOT COMPLETED|Overall Study||8||
48467542|NCT00635778|101480945|FG004|NOT COMPLETED|Overall Study||8||
48467543|NCT00635778|101480946|FG005|NOT COMPLETED|Overall Study||21||
48467544|NCT00635778|101480947|FG006|NOT COMPLETED|Overall Study||6||
48467545|NCT00282256|101480948|FG000|STARTED|Pharmacokinetic Treatment Period||19||
48467546|NCT00282256|101480948|FG000|Received Tacrolimus|Pharmacokinetic Treatment Period||19||
48467547|NCT00282256|101480948|FG000|Received Tacrolimus MR|Pharmacokinetic Treatment Period||18||
48467548|NCT00282256|101480948|FG000|COMPLETED|Pharmacokinetic Treatment Period||18||
48467549|NCT00282256|101480948|FG000|NOT COMPLETED|Pharmacokinetic Treatment Period||1||
48467550|NCT00282256|101480948|FG000|STARTED|Extension Treatment Period||18||
48467551|NCT00282256|101480948|FG000|COMPLETED|Extension Treatment Period||16||
48467552|NCT00282256|101480948|FG000|NOT COMPLETED|Extension Treatment Period||2||
48467553|NCT04094870|101480949|FG000|STARTED|Overall Study||40||
48467554|NCT04094870|101480950|FG001|STARTED|Overall Study||40||
48467555|NCT04094870|101480949|FG000|COMPLETED|Overall Study||39||
48467556|NCT04094870|101480950|FG001|COMPLETED|Overall Study||39||
48467557|NCT04094870|101480949|FG000|NOT COMPLETED|Overall Study||1||
48467558|NCT04094870|101480950|FG001|NOT COMPLETED|Overall Study||1||
48467559|NCT01929109|101480951|FG000|STARTED|Period 1 (All Groups)||14||
48467560|NCT01929109|101480952|FG001|STARTED|Period 1 (All Groups)||8||
48467561|NCT01929109|101480953|FG002|STARTED|Period 1 (All Groups)||9||
48467562|NCT01929109|101480954|FG003|STARTED|Period 1 (All Groups)||8||
48467563|NCT01929109|101480955|FG004|STARTED|Period 1 (All Groups)||8||
48467564|NCT01929109|101480951|FG000|COMPLETED|Period 1 (All Groups)||14||
48467565|NCT01929109|101480952|FG001|COMPLETED|Period 1 (All Groups)||8||
48467566|NCT01929109|101480953|FG002|COMPLETED|Period 1 (All Groups)||8||
48467567|NCT01929109|101480954|FG003|COMPLETED|Period 1 (All Groups)||8||
48467568|NCT01929109|101480955|FG004|COMPLETED|Period 1 (All Groups)||8||
48467569|NCT01929109|101480951|FG000|NOT COMPLETED|Period 1 (All Groups)||0||
48467570|NCT01929109|101480952|FG001|NOT COMPLETED|Period 1 (All Groups)||0||
48467571|NCT01929109|101480953|FG002|NOT COMPLETED|Period 1 (All Groups)||1||
48467572|NCT01929109|101480954|FG003|NOT COMPLETED|Period 1 (All Groups)||0||
48467573|NCT01929109|101480955|FG004|NOT COMPLETED|Period 1 (All Groups)||0||
48467574|NCT01929109|101480951|FG000|STARTED|Period 2 (End Stage Renal Disease Only)||0||
48467575|NCT01929109|101480952|FG001|STARTED|Period 2 (End Stage Renal Disease Only)||0||
48467576|NCT01929109|101480953|FG002|STARTED|Period 2 (End Stage Renal Disease Only)||0||
48467577|NCT01929109|101480954|FG003|STARTED|Period 2 (End Stage Renal Disease Only)||0||
48467578|NCT01929109|101480955|FG004|STARTED|Period 2 (End Stage Renal Disease Only)||8||
48467579|NCT01929109|101480951|FG000|COMPLETED|Period 2 (End Stage Renal Disease Only)||0||
48467580|NCT01929109|101480952|FG001|COMPLETED|Period 2 (End Stage Renal Disease Only)||0||
48467581|NCT01929109|101480953|FG002|COMPLETED|Period 2 (End Stage Renal Disease Only)||0||
48467582|NCT01929109|101480954|FG003|COMPLETED|Period 2 (End Stage Renal Disease Only)||0||
48467583|NCT01929109|101480955|FG004|COMPLETED|Period 2 (End Stage Renal Disease Only)||8||
48467584|NCT01929109|101480951|FG000|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0||
48467585|NCT01929109|101480952|FG001|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0||
48467586|NCT01929109|101480953|FG002|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0||
48467587|NCT01929109|101480954|FG003|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0||
48467588|NCT01929109|101480955|FG004|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0||
48467589|NCT02933866|101480956|FG000|STARTED|Overall Study||186||
48467590|NCT02933866|101480957|FG001|STARTED|Overall Study||185||
48467591|NCT02933866|101480956|FG000|COMPLETED|Overall Study||174||
48467592|NCT02933866|101480957|FG001|COMPLETED|Overall Study||176||
48467593|NCT02933866|101480956|FG000|NOT COMPLETED|Overall Study||12||
48467594|NCT02933866|101480957|FG001|NOT COMPLETED|Overall Study||9||
48467595|NCT03387098|101480958|FG000|STARTED|Overall Study||4||
48467596|NCT03387098|101480958|FG000|COMPLETED|Overall Study||0||
48467597|NCT03387098|101480958|FG000|NOT COMPLETED|Overall Study||4||
48467598|NCT00113490|101480959|FG000|STARTED|Overall Study||66||
48467599|NCT00113490|101480960|FG001|STARTED|Overall Study||70||
48467600|NCT00113490|101480959|FG000|COMPLETED|Overall Study||64||
48467601|NCT00113490|101480960|FG001|COMPLETED|Overall Study||67||
48467602|NCT00113490|101480959|FG000|NOT COMPLETED|Overall Study||2||
48467603|NCT00113490|101480960|FG001|NOT COMPLETED|Overall Study||3||
48467604|NCT01626820|101480961|FG000|STARTED|Overall Study||56||
48467605|NCT01626820|101480962|FG001|STARTED|Overall Study||57||
48467606|NCT01626820|101480961|FG000|COMPLETED|Overall Study||56||
48467607|NCT01626820|101480962|FG001|COMPLETED|Overall Study||57||
48467608|NCT01626820|101480961|FG000|NOT COMPLETED|Overall Study||0||
48467609|NCT01626820|101480962|FG001|NOT COMPLETED|Overall Study||0||
48467610|NCT01799590|101480963|FG000|STARTED|Overall Study||111||
48467611|NCT01799590|101480964|FG001|STARTED|Overall Study||94||
48467612|NCT01799590|101480965|FG002|STARTED|Overall Study||91||
48467613|NCT01799590|101480963|FG000|COMPLETED|Overall Study||85||
48467614|NCT01799590|101480964|FG001|COMPLETED|Overall Study||78||
48467615|NCT01799590|101480965|FG002|COMPLETED|Overall Study||77||
48467616|NCT01799590|101480963|FG000|NOT COMPLETED|Overall Study||26||
48467617|NCT01799590|101480964|FG001|NOT COMPLETED|Overall Study||16||
48786031|NCT02416622|102265719|FG002|Started Long-Term Follow-Up|Overall Study||13||
48786032|NCT02416622|102265717|FG000|COMPLETED|Overall Study||0||
48786033|NCT02416622|102265718|FG001|COMPLETED|Overall Study||0||
48467618|NCT01799590|101480965|FG002|NOT COMPLETED|Overall Study||14||
48467619|NCT00433381|101480966|FG000|STARTED|Overall Study||63||
48467620|NCT00433381|101480967|FG001|STARTED|Overall Study||60||
48467621|NCT00433381|101480966|FG000|COMPLETED|Overall Study||60||
48467622|NCT00433381|101480967|FG001|COMPLETED|Overall Study||57||
48467623|NCT00433381|101480966|FG000|NOT COMPLETED|Overall Study||3||
48467624|NCT00433381|101480967|FG001|NOT COMPLETED|Overall Study||3||
48467625|NCT05487456|101480968|FG000|STARTED|Overall Study||16||
48467626|NCT05487456|101480969|FG001|STARTED|Overall Study||17||
48467627|NCT05487456|101480970|FG002|STARTED|Overall Study||18||
48467628|NCT05487456|101480971|FG003|STARTED|Overall Study||17||
48467629|NCT05487456|101480968|FG000|COMPLETED|Overall Study||16||
48467630|NCT05487456|101480969|FG001|COMPLETED|Overall Study||17||
48467631|NCT05487456|101480970|FG002|COMPLETED|Overall Study||17||
48467632|NCT05487456|101480971|FG003|COMPLETED|Overall Study||17||
48786034|NCT02416622|102265719|FG002|COMPLETED|Overall Study||0||
48786035|NCT02416622|102265717|FG000|NOT COMPLETED|Overall Study||6||
48786036|NCT02416622|102265718|FG001|NOT COMPLETED|Overall Study||8||
48786037|NCT02416622|102265719|FG002|NOT COMPLETED|Overall Study||13||
48786038|NCT01328405|102265720|FG000|STARTED|Overall Study||52||
48786039|NCT01328405|102265721|FG001|STARTED|Overall Study||48||
48786040|NCT01328405|102265720|FG000|COMPLETED|Overall Study||52||
48786041|NCT01328405|102265721|FG001|COMPLETED|Overall Study||48||
48786042|NCT01328405|102265720|FG000|NOT COMPLETED|Overall Study||0||
48467633|NCT05487456|101480968|FG000|NOT COMPLETED|Overall Study||0||
48467634|NCT05487456|101480969|FG001|NOT COMPLETED|Overall Study||0||
48467635|NCT05487456|101480970|FG002|NOT COMPLETED|Overall Study||1||
48467636|NCT05487456|101480971|FG003|NOT COMPLETED|Overall Study||0||
48467637|NCT00368277|101480972|FG000|STARTED|Overall Study||457||
48467638|NCT00368277|101480973|FG001|STARTED|Overall Study||444||
48467639|NCT00368277|101480972|FG000|COMPLETED|Overall Study||344||
48467640|NCT00368277|101480973|FG001|COMPLETED|Overall Study||336||
48467641|NCT00368277|101480972|FG000|NOT COMPLETED|Overall Study||113||
48467642|NCT00368277|101480973|FG001|NOT COMPLETED|Overall Study||108||
48467643|NCT00275002|101480974|FG000|STARTED|Overall Study||25||
48467644|NCT00275002|101480975|FG001|STARTED|Overall Study||16||
48467645|NCT00275002|101480974|FG000|COMPLETED|Overall Study||3||
48467646|NCT00275002|101480975|FG001|COMPLETED|Overall Study||0||
48467647|NCT00275002|101480974|FG000|NOT COMPLETED|Overall Study||22||
48786043|NCT01328405|102265721|FG001|NOT COMPLETED|Overall Study||0||
48786044|NCT01430169|102265722|FG000|STARTED|Overall Study||20||
48786045|NCT01430169|102265722|FG000|COMPLETED|Overall Study||20||
48786046|NCT01430169|102265722|FG000|NOT COMPLETED|Overall Study||0||
48189934|NCT04006795|100788969|FG000|STARTED|Challenge Phase||37||
48467648|NCT00275002|101480975|FG001|NOT COMPLETED|Overall Study||16||
48467649|NCT00662129|101480976|FG000|STARTED|Overall Study||50||
48467650|NCT00662129|101480976|FG000|COMPLETED|Overall Study||47||
48467651|NCT00662129|101480976|FG000|NOT COMPLETED|Overall Study||3||
48467652|NCT04471935|101480977|FG000|STARTED|Overall Study||10||
48467653|NCT04471935|101480977|FG000|COMPLETED|Overall Study||8||
48467654|NCT04471935|101480977|FG000|NOT COMPLETED|Overall Study||2||
48467655|NCT00299156|101480978|FG000|STARTED|Period 1 (Non-Randomized)||32||
48467656|NCT00299156|101480979|FG001|STARTED|Period 1 (Non-Randomized)||0||
48467657|NCT00299156|101480980|FG002|STARTED|Period 1 (Non-Randomized)||0||
48467658|NCT00299156|101480978|FG000|COMPLETED|Period 1 (Non-Randomized)||32||
48467659|NCT00299156|101480979|FG001|COMPLETED|Period 1 (Non-Randomized)||0||
48467660|NCT00299156|101480980|FG002|COMPLETED|Period 1 (Non-Randomized)||0||
48467661|NCT00299156|101480978|FG000|NOT COMPLETED|Period 1 (Non-Randomized)||0||
48467662|NCT00299156|101480979|FG001|NOT COMPLETED|Period 1 (Non-Randomized)||0||
48467663|NCT00299156|101480980|FG002|NOT COMPLETED|Period 1 (Non-Randomized)||0||
48467664|NCT00299156|101480978|FG000|STARTED|Period 2 (Randomized)||0||
48467665|NCT00299156|101480979|FG001|STARTED|Period 2 (Randomized)||17||
48467666|NCT00299156|101480980|FG002|STARTED|Period 2 (Randomized)||16||
48786047|NCT01809639|102265723|FG000|STARTED|Overall Study||18||
48467667|NCT00299156|101480978|FG000|COMPLETED|Period 2 (Randomized)||0||
48467668|NCT00299156|101480979|FG001|COMPLETED|Period 2 (Randomized)||16||
48786048|NCT01809639|102265724|FG001|STARTED|Overall Study||7||
48467669|NCT00299156|101480980|FG002|COMPLETED|Period 2 (Randomized)||16||
48467670|NCT00299156|101480978|FG000|NOT COMPLETED|Period 2 (Randomized)||0||
48786049|NCT01809639|102265723|FG000|COMPLETED|Overall Study||18||
48467671|NCT00299156|101480979|FG001|NOT COMPLETED|Period 2 (Randomized)||1||
48467672|NCT00299156|101480980|FG002|NOT COMPLETED|Period 2 (Randomized)||0||
48467673|NCT02750306|101480981|FG000|STARTED|Overall Study||142||
48467674|NCT02750306|101480982|FG001|STARTED|Overall Study||143||
48467675|NCT02750306|101480981|FG000|COMPLETED|Overall Study||136||
48467676|NCT02750306|101480982|FG001|COMPLETED|Overall Study||141||
48467677|NCT02750306|101480981|FG000|NOT COMPLETED|Overall Study||6||
48467678|NCT02750306|101480982|FG001|NOT COMPLETED|Overall Study||2||
48467679|NCT01717898|101480983|FG000|STARTED|Overall Study||6||
48467680|NCT01717898|101480984|FG001|STARTED|Overall Study||0||
48467681|NCT01717898|101480985|FG002|STARTED|Overall Study||0||
48467682|NCT01717898|101480986|FG003|STARTED|Overall Study||0||
48467683|NCT01717898|101480983|FG000|COMPLETED|Overall Study||0||
48467684|NCT01717898|101480984|FG001|COMPLETED|Overall Study||0||
48467685|NCT01717898|101480985|FG002|COMPLETED|Overall Study||0||
48467686|NCT01717898|101480986|FG003|COMPLETED|Overall Study||0||
48467687|NCT01717898|101480983|FG000|NOT COMPLETED|Overall Study||6||
48467688|NCT01717898|101480984|FG001|NOT COMPLETED|Overall Study||0||
48467689|NCT01717898|101480985|FG002|NOT COMPLETED|Overall Study||0||
48467690|NCT01717898|101480986|FG003|NOT COMPLETED|Overall Study||0||
48467691|NCT04161144|101480987|FG000|STARTED|Overall Study||12||
48467692|NCT04161144|101480988|FG001|STARTED|Overall Study||10||
48467693|NCT04161144|101480987|FG000|COMPLETED|Overall Study||11||
48467694|NCT04161144|101480988|FG001|COMPLETED|Overall Study||9||
48467695|NCT04161144|101480987|FG000|NOT COMPLETED|Overall Study||1||
48467696|NCT04161144|101480988|FG001|NOT COMPLETED|Overall Study||1||
48467697|NCT02224391|101480989|FG000|STARTED|Overall Study||124||
48467698|NCT02224391|101480990|FG001|STARTED|Overall Study||122||
48467699|NCT02224391|101480989|FG000|COMPLETED|Overall Study||92||
48467700|NCT02224391|101480990|FG001|COMPLETED|Overall Study||98||
48467701|NCT02224391|101480989|FG000|NOT COMPLETED|Overall Study||32||
48467702|NCT02224391|101480990|FG001|NOT COMPLETED|Overall Study||24||
48467703|NCT02848599|101480991|FG000|STARTED|Overall Study||42||
48467704|NCT02848599|101480992|FG001|STARTED|Overall Study||44||
48467705|NCT02848599|101480991|FG000|COMPLETED|Overall Study||35||
48467706|NCT02848599|101480992|FG001|COMPLETED|Overall Study||35||
48467707|NCT02848599|101480991|FG000|NOT COMPLETED|Overall Study||7||
48467708|NCT02848599|101480992|FG001|NOT COMPLETED|Overall Study||9||
48467709|NCT00780026|101480993|FG000|STARTED|Overall Study||50||
48467710|NCT00780026|101480994|FG001|STARTED|Overall Study||50||
48467711|NCT00780026|101480993|FG000|COMPLETED|Overall Study||50||
48467712|NCT00780026|101480994|FG001|COMPLETED|Overall Study||50||
48467713|NCT00780026|101480993|FG000|NOT COMPLETED|Overall Study||0||
48467714|NCT00780026|101480994|FG001|NOT COMPLETED|Overall Study||0||
48467715|NCT01703507|101480995|FG000|STARTED|Overall Study||6||
48467716|NCT01703507|101480996|FG001|STARTED|Overall Study||11||
48467717|NCT01703507|101480995|FG000|COMPLETED|Overall Study||5||
48467718|NCT01703507|101480996|FG001|COMPLETED|Overall Study||11||
48467719|NCT01703507|101480995|FG000|NOT COMPLETED|Overall Study||1||
48467720|NCT01703507|101480996|FG001|NOT COMPLETED|Overall Study||0||
48467721|NCT02162758|101480997|FG000|STARTED|Overall Study||3||
48467722|NCT02162758|101480998|FG001|STARTED|Overall Study||3||
48467723|NCT02162758|101480997|FG000|COMPLETED|Overall Study||3||
48467724|NCT02162758|101480998|FG001|COMPLETED|Overall Study||2||
48467725|NCT02162758|101480997|FG000|NOT COMPLETED|Overall Study||0||
48467726|NCT02162758|101480998|FG001|NOT COMPLETED|Overall Study||1||
48467727|NCT00720798|101480999|FG000|STARTED|Overall Study||2067||
48467728|NCT00720798|101480999|FG000|COMPLETED|Overall Study||1311||
48467729|NCT00720798|101480999|FG000|NOT COMPLETED|Overall Study||756||
48467730|NCT01434342|101481000|FG000|STARTED|Overall Study||98||
48786050|NCT01809639|102265724|FG001|COMPLETED|Overall Study||7||
48786051|NCT01809639|102265723|FG000|NOT COMPLETED|Overall Study||0||
48786052|NCT01809639|102265724|FG001|NOT COMPLETED|Overall Study||0||
48467731|NCT01434342|101481001|FG001|STARTED|Overall Study||48||
48467732|NCT01434342|101481000|FG000|COMPLETED|Overall Study||50||
48467733|NCT01434342|101481001|FG001|COMPLETED|Overall Study||31||
48786053|NCT01170533|102265725|FG000|STARTED|Omeprazole Cross-over||20||
48467734|NCT01434342|101481000|FG000|NOT COMPLETED|Overall Study||48||
48467735|NCT01434342|101481001|FG001|NOT COMPLETED|Overall Study||17||
48467736|NCT00625807|101481002|FG000|STARTED|Overall Study||22||
48467737|NCT00625807|101481003|FG001|STARTED|Overall Study||28||
48467738|NCT00625807|101481002|FG000|COMPLETED|Overall Study||20||
48467739|NCT00625807|101481003|FG001|COMPLETED|Overall Study||20||
48467740|NCT00625807|101481002|FG000|NOT COMPLETED|Overall Study||2||
48467741|NCT00625807|101481003|FG001|NOT COMPLETED|Overall Study||8||
48467742|NCT04000009|101481004|FG000|STARTED|Overall Study||235||
48467743|NCT04000009|101481004|FG000|COMPLETED|Overall Study||70||
48467744|NCT04000009|101481004|FG000|NOT COMPLETED|Overall Study||165||
48467745|NCT00358826|101481005|FG000|STARTED|Core Study||49||
48467746|NCT00358826|101481006|FG001|STARTED|Core Study||46||
48467747|NCT00358826|101481007|FG002|STARTED|Core Study||44||
48467748|NCT00358826|101481008|FG003|STARTED|Core Study||52||
48467749|NCT00358826|101481009|FG004|STARTED|Core Study||0||
48467750|NCT00358826|101481010|FG005|STARTED|Core Study||0||
48467751|NCT00358826|101481011|FG006|STARTED|Core Study||0||
48786054|NCT01170533|102265726|FG001|STARTED|Omeprazole Cross-over||0||
48467752|NCT00358826|101481012|FG007|STARTED|Core Study||0||
48467753|NCT00358826|101481005|FG000|COMPLETED|Core Study||46||
48467754|NCT00358826|101481006|FG001|COMPLETED|Core Study||41||
48467755|NCT00358826|101481007|FG002|COMPLETED|Core Study||42||
48467756|NCT00358826|101481008|FG003|COMPLETED|Core Study||50||
48467757|NCT00358826|101481009|FG004|COMPLETED|Core Study||0||
48467758|NCT00358826|101481010|FG005|COMPLETED|Core Study||0||
48467759|NCT00358826|101481011|FG006|COMPLETED|Core Study||0||
48467760|NCT00358826|101481012|FG007|COMPLETED|Core Study||0||
48467761|NCT00358826|101481005|FG000|NOT COMPLETED|Core Study||3||
48467762|NCT00358826|101481006|FG001|NOT COMPLETED|Core Study||5||
48786055|NCT01170533|102265725|FG000|COMPLETED|Omeprazole Cross-over||20||
48786056|NCT01170533|102265726|FG001|COMPLETED|Omeprazole Cross-over||0||
48786057|NCT01170533|102265725|FG000|NOT COMPLETED|Omeprazole Cross-over||0||
48786058|NCT01170533|102265726|FG001|NOT COMPLETED|Omeprazole Cross-over||0||
48786059|NCT01170533|102265725|FG000|STARTED|Pantoprazole Cross-over||0||
48786060|NCT01170533|102265726|FG001|STARTED|Pantoprazole Cross-over||20||
48467763|NCT00358826|101481007|FG002|NOT COMPLETED|Core Study||2||
48467764|NCT00358826|101481008|FG003|NOT COMPLETED|Core Study||2||
48467765|NCT00358826|101481009|FG004|NOT COMPLETED|Core Study||0||
48467766|NCT00358826|101481010|FG005|NOT COMPLETED|Core Study||0||
48467767|NCT00358826|101481011|FG006|NOT COMPLETED|Core Study||0||
48467768|NCT00358826|101481012|FG007|NOT COMPLETED|Core Study||0||
48467769|NCT00358826|101481005|FG000|STARTED|MDCT Substudy||0||
48467770|NCT00358826|101481006|FG001|STARTED|MDCT Substudy||0||
48467771|NCT00358826|101481007|FG002|STARTED|MDCT Substudy||0||
48467772|NCT00358826|101481008|FG003|STARTED|MDCT Substudy||0||
48467773|NCT00358826|101481009|FG004|STARTED|MDCT Substudy||25||
48786061|NCT01170533|102265725|FG000|COMPLETED|Pantoprazole Cross-over||0||
48467774|NCT00358826|101481010|FG005|STARTED|MDCT Substudy||22||
48467775|NCT00358826|101481011|FG006|STARTED|MDCT Substudy||19||
48467776|NCT00358826|101481012|FG007|STARTED|MDCT Substudy||27||
48467777|NCT00358826|101481005|FG000|COMPLETED|MDCT Substudy||0||
48467778|NCT00358826|101481006|FG001|COMPLETED|MDCT Substudy||0||
48467779|NCT00358826|101481007|FG002|COMPLETED|MDCT Substudy||0||
48467780|NCT00358826|101481008|FG003|COMPLETED|MDCT Substudy||0||
48467781|NCT00358826|101481009|FG004|COMPLETED|MDCT Substudy||24||
48467782|NCT00358826|101481010|FG005|COMPLETED|MDCT Substudy||20||
48467783|NCT00358826|101481011|FG006|COMPLETED|MDCT Substudy||19||
48467784|NCT00358826|101481012|FG007|COMPLETED|MDCT Substudy||27||
48467785|NCT00358826|101481005|FG000|NOT COMPLETED|MDCT Substudy||0||
48467786|NCT00358826|101481006|FG001|NOT COMPLETED|MDCT Substudy||0||
48467787|NCT00358826|101481007|FG002|NOT COMPLETED|MDCT Substudy||0||
48467788|NCT00358826|101481008|FG003|NOT COMPLETED|MDCT Substudy||0||
48467789|NCT00358826|101481009|FG004|NOT COMPLETED|MDCT Substudy||1||
48467790|NCT00358826|101481010|FG005|NOT COMPLETED|MDCT Substudy||2||
48467791|NCT00358826|101481011|FG006|NOT COMPLETED|MDCT Substudy||0||
48467792|NCT00358826|101481012|FG007|NOT COMPLETED|MDCT Substudy||0||
48467793|NCT02768298|101481013|FG000|STARTED|Overall Study||103||
48467794|NCT02768298|101481014|FG001|STARTED|Overall Study||98||
48467795|NCT02768298|101481013|FG000|COMPLETED|Overall Study||99||
48467796|NCT02768298|101481014|FG001|COMPLETED|Overall Study||91||
48467797|NCT02768298|101481013|FG000|NOT COMPLETED|Overall Study||4||
48467798|NCT02768298|101481014|FG001|NOT COMPLETED|Overall Study||7||
48467799|NCT01296932|101481015|FG000|STARTED|Overall Study||3||
48467800|NCT01296932|101481016|FG001|STARTED|Overall Study||3||
48467801|NCT01296932|101481017|FG002|STARTED|Overall Study||6||
48467802|NCT01296932|101481018|FG003|STARTED|Overall Study||6||
48467803|NCT01296932|101481019|FG004|STARTED|Overall Study||3||
48467804|NCT01296932|101481020|FG005|STARTED|Overall Study||3||
48467805|NCT01296932|101481021|FG006|STARTED|Overall Study||6||
48467806|NCT01296932|101481022|FG007|STARTED|Overall Study||3||
48665942|NCT00329420|101967454|FG001|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||2||
48467807|NCT01296932|101481023|FG008|STARTED|Overall Study||4||
48467808|NCT01296932|101481015|FG000|COMPLETED|Overall Study||0||
48467809|NCT01296932|101481016|FG001|COMPLETED|Overall Study||0||
48467810|NCT01296932|101481017|FG002|COMPLETED|Overall Study||0||
48467811|NCT01296932|101481018|FG003|COMPLETED|Overall Study||0||
48467812|NCT01296932|101481019|FG004|COMPLETED|Overall Study||0||
48467813|NCT01296932|101481020|FG005|COMPLETED|Overall Study||0||
48467814|NCT01296932|101481021|FG006|COMPLETED|Overall Study||0||
48467815|NCT01296932|101481022|FG007|COMPLETED|Overall Study||1||
48467816|NCT01296932|101481023|FG008|COMPLETED|Overall Study||0||
48467817|NCT01296932|101481015|FG000|NOT COMPLETED|Overall Study||3||
48467818|NCT01296932|101481016|FG001|NOT COMPLETED|Overall Study||3||
48467819|NCT01296932|101481017|FG002|NOT COMPLETED|Overall Study||6||
48467820|NCT01296932|101481018|FG003|NOT COMPLETED|Overall Study||6||
48467821|NCT01296932|101481019|FG004|NOT COMPLETED|Overall Study||3||
48467822|NCT01296932|101481020|FG005|NOT COMPLETED|Overall Study||3||
48467823|NCT01296932|101481021|FG006|NOT COMPLETED|Overall Study||6||
48467824|NCT01296932|101481022|FG007|NOT COMPLETED|Overall Study||2||
48467825|NCT01296932|101481023|FG008|NOT COMPLETED|Overall Study||4||
48786062|NCT01170533|102265726|FG001|COMPLETED|Pantoprazole Cross-over||20||
48786063|NCT01170533|102265725|FG000|NOT COMPLETED|Pantoprazole Cross-over||0||
48786064|NCT01170533|102265726|FG001|NOT COMPLETED|Pantoprazole Cross-over||0||
48467826|NCT03218592|101481024|FG000|STARTED|Phase 1: 1 Dose||12||
48467827|NCT03218592|101481025|FG001|STARTED|Phase 1: 1 Dose||12||
48467828|NCT03218592|101481026|FG002|STARTED|Phase 1: 1 Dose||12||
48467829|NCT03218592|101481024|FG000|COMPLETED|Phase 1: 1 Dose||12||
48467830|NCT03218592|101481025|FG001|COMPLETED|Phase 1: 1 Dose||12||
48467831|NCT03218592|101481026|FG002|COMPLETED|Phase 1: 1 Dose||12||
48467832|NCT03218592|101481024|FG000|NOT COMPLETED|Phase 1: 1 Dose||0||
48467833|NCT03218592|101481025|FG001|NOT COMPLETED|Phase 1: 1 Dose||0||
48467834|NCT03218592|101481026|FG002|NOT COMPLETED|Phase 1: 1 Dose||0||
48467835|NCT03218592|101481024|FG000|STARTED|Phase 2: Daily Doses x 28 Days||12||
48467836|NCT03218592|101481025|FG001|STARTED|Phase 2: Daily Doses x 28 Days||12||
48467837|NCT03218592|101481026|FG002|STARTED|Phase 2: Daily Doses x 28 Days||12||
48467838|NCT03218592|101481024|FG000|COMPLETED|Phase 2: Daily Doses x 28 Days||12||
48467839|NCT03218592|101481025|FG001|COMPLETED|Phase 2: Daily Doses x 28 Days||12||
48467840|NCT03218592|101481026|FG002|COMPLETED|Phase 2: Daily Doses x 28 Days||12||
48467841|NCT03218592|101481024|FG000|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0||
48467842|NCT03218592|101481025|FG001|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0||
48467843|NCT03218592|101481026|FG002|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0||
48467844|NCT03218592|101481024|FG000|STARTED|Phase 3: 0 Doses Per Week||4||
48467845|NCT03218592|101481025|FG001|STARTED|Phase 3: 0 Doses Per Week||4||
48467846|NCT03218592|101481026|FG002|STARTED|Phase 3: 0 Doses Per Week||4||
48467847|NCT03218592|101481024|FG000|4 Patients Per Group|Phase 3: 0 Doses Per Week||4||
48467848|NCT03218592|101481025|FG001|4 Patients Per Group|Phase 3: 0 Doses Per Week||4||
48467849|NCT03218592|101481026|FG002|4 Patients Per Group|Phase 3: 0 Doses Per Week||4||
48467850|NCT03218592|101481024|FG000|COMPLETED|Phase 3: 0 Doses Per Week||4||
48467851|NCT03218592|101481025|FG001|COMPLETED|Phase 3: 0 Doses Per Week||4||
48467852|NCT03218592|101481026|FG002|COMPLETED|Phase 3: 0 Doses Per Week||4||
48467853|NCT03218592|101481024|FG000|NOT COMPLETED|Phase 3: 0 Doses Per Week||0||
48467854|NCT03218592|101481025|FG001|NOT COMPLETED|Phase 3: 0 Doses Per Week||0||
48467855|NCT03218592|101481026|FG002|NOT COMPLETED|Phase 3: 0 Doses Per Week||0||
48467856|NCT03218592|101481024|FG000|STARTED|Phase 3: 1 Dose Per Period||4||
48467857|NCT03218592|101481025|FG001|STARTED|Phase 3: 1 Dose Per Period||4||
48467858|NCT03218592|101481026|FG002|STARTED|Phase 3: 1 Dose Per Period||4||
48467859|NCT03218592|101481024|FG000|4 Patients Per Group|Phase 3: 1 Dose Per Period||4||
48467860|NCT03218592|101481025|FG001|4 Patients Per Group|Phase 3: 1 Dose Per Period||4||
48467861|NCT03218592|101481026|FG002|4 Patients Per Group|Phase 3: 1 Dose Per Period||4||
48467862|NCT03218592|101481024|FG000|COMPLETED|Phase 3: 1 Dose Per Period||4||
48467863|NCT03218592|101481025|FG001|COMPLETED|Phase 3: 1 Dose Per Period||4||
48467864|NCT03218592|101481026|FG002|COMPLETED|Phase 3: 1 Dose Per Period||4||
48467865|NCT03218592|101481024|FG000|NOT COMPLETED|Phase 3: 1 Dose Per Period||0||
48467866|NCT03218592|101481025|FG001|NOT COMPLETED|Phase 3: 1 Dose Per Period||0||
48467867|NCT03218592|101481026|FG002|NOT COMPLETED|Phase 3: 1 Dose Per Period||0||
48467868|NCT03218592|101481024|FG000|STARTED|Phase 3: 3 Doses Per Week||4||
48467869|NCT03218592|101481025|FG001|STARTED|Phase 3: 3 Doses Per Week||4||
48467870|NCT03218592|101481026|FG002|STARTED|Phase 3: 3 Doses Per Week||4||
48467871|NCT03218592|101481024|FG000|4 Patients Per Group|Phase 3: 3 Doses Per Week||4||
48467872|NCT03218592|101481025|FG001|4 Patients Per Group|Phase 3: 3 Doses Per Week||4||
48467873|NCT03218592|101481026|FG002|4 Patients Per Group|Phase 3: 3 Doses Per Week||4||
48467874|NCT03218592|101481024|FG000|COMPLETED|Phase 3: 3 Doses Per Week||4||
48467875|NCT03218592|101481025|FG001|COMPLETED|Phase 3: 3 Doses Per Week||4||
48467876|NCT03218592|101481026|FG002|COMPLETED|Phase 3: 3 Doses Per Week||4||
48467877|NCT03218592|101481024|FG000|NOT COMPLETED|Phase 3: 3 Doses Per Week||0||
48467878|NCT03218592|101481025|FG001|NOT COMPLETED|Phase 3: 3 Doses Per Week||0||
48467879|NCT03218592|101481026|FG002|NOT COMPLETED|Phase 3: 3 Doses Per Week||0||
48467880|NCT01478620|101481027|FG000|STARTED|Overall Study||125||
48467881|NCT01478620|101481027|FG000|COMPLETED|Overall Study||119||
48467882|NCT01478620|101481027|FG000|NOT COMPLETED|Overall Study||6||
48467883|NCT02201251|101481028|FG000|STARTED|Overall Study||28||
48467884|NCT02201251|101481029|FG001|STARTED|Overall Study||35||
48467885|NCT02201251|101481028|FG000|COMPLETED|Overall Study||24||
48467886|NCT02201251|101481029|FG001|COMPLETED|Overall Study||32||
48467887|NCT02201251|101481028|FG000|NOT COMPLETED|Overall Study||4||
48467888|NCT02201251|101481029|FG001|NOT COMPLETED|Overall Study||3||
48467889|NCT01645306|101481030|FG000|STARTED|Overall Study||51||
48467890|NCT01645306|101481031|FG001|STARTED|Overall Study||54||
48467891|NCT01645306|101481032|FG002|STARTED|Overall Study||53||
48467892|NCT01645306|101481030|FG000|COMPLETED|Overall Study||49||
48467893|NCT01645306|101481031|FG001|COMPLETED|Overall Study||50||
48467894|NCT01645306|101481032|FG002|COMPLETED|Overall Study||48||
48467895|NCT01645306|101481030|FG000|NOT COMPLETED|Overall Study||2||
48467896|NCT01645306|101481031|FG001|NOT COMPLETED|Overall Study||4||
48467897|NCT01645306|101481032|FG002|NOT COMPLETED|Overall Study||5||
48467898|NCT00696449|101481033|FG000|STARTED|Overall Study||15||
48467899|NCT00696449|101481034|FG001|STARTED|Overall Study||15||
48467900|NCT00696449|101481035|FG002|STARTED|Overall Study||15||
48467901|NCT00696449|101481036|FG003|STARTED|Overall Study||16||
48467902|NCT00696449|101481033|FG000|COMPLETED|Overall Study||12||
48467903|NCT00696449|101481034|FG001|COMPLETED|Overall Study||9||
48467904|NCT00696449|101481035|FG002|COMPLETED|Overall Study||14||
48467905|NCT00696449|101481036|FG003|COMPLETED|Overall Study||13||
48786065|NCT02156271|102265727|FG000|STARTED|Overall Study||26||
48786066|NCT02156271|102265728|FG001|STARTED|Overall Study||13||
48786067|NCT02156271|102265727|FG000|COMPLETED|Overall Study||22||
48786068|NCT02156271|102265728|FG001|COMPLETED|Overall Study||10||
48786069|NCT02156271|102265727|FG000|NOT COMPLETED|Overall Study||4||
48786070|NCT02156271|102265728|FG001|NOT COMPLETED|Overall Study||3||
48786071|NCT01978938|102265729|FG000|STARTED|Overall Study||455||
48786072|NCT01978938|102265730|FG001|STARTED|Overall Study||453||
48786073|NCT01978938|102265729|FG000|Received at Least 1 Dose of Study Drug|Overall Study||454|1 participant in the eravacycline group and 2 in the levofloxacin group did not receive study drug.|
48786074|NCT01978938|102265730|FG001|Received at Least 1 Dose of Study Drug|Overall Study||451|1 participant in the eravacycline group and 2 in the levofloxacin group did not receive study drug.|
48786075|NCT01978938|102265729|FG000|COMPLETED|Overall Study||432||
48786076|NCT01978938|102265730|FG001|COMPLETED|Overall Study||439||
48786077|NCT01978938|102265729|FG000|NOT COMPLETED|Overall Study||23||
48786078|NCT01978938|102265730|FG001|NOT COMPLETED|Overall Study||14||
48786079|NCT01049009|102265731|FG000|STARTED|Treatment Period 1 (12 Weeks)||23||
48786080|NCT01049009|102265732|FG001|STARTED|Treatment Period 1 (12 Weeks)||21||
48786081|NCT01049009|102265731|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||21||
48786082|NCT01049009|102265732|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||18||
48786083|NCT01049009|102265731|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2||
48786084|NCT01049009|102265732|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3||
48786085|NCT01049009|102265731|FG000|STARTED|Treatment Period 2 (12 Weeks)||21||
48786086|NCT01049009|102265732|FG001|STARTED|Treatment Period 2 (12 Weeks)||18||
48786087|NCT01049009|102265731|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||11||
48786088|NCT01049009|102265732|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||8||
48786089|NCT01049009|102265731|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10||
48786090|NCT01049009|102265732|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10||
48786091|NCT02756806|102265733|FG000|STARTED|Overall Study||7||
48786092|NCT02756806|102265733|FG000|COMPLETED|Overall Study||2||
48786093|NCT02756806|102265733|FG000|NOT COMPLETED|Overall Study||5||
48786094|NCT01124864|102265734|FG000|STARTED|Overall Study||28||
48786095|NCT01124864|102265735|FG001|STARTED|Overall Study||35||
48786096|NCT01124864|102265736|FG002|STARTED|Overall Study||34||
48786097|NCT01124864|102265737|FG003|STARTED|Overall Study||22||
48786098|NCT01124864|102265738|FG004|STARTED|Overall Study||31||
48786099|NCT01124864|102265739|FG005|STARTED|Overall Study||3||
48786100|NCT01124864|102265734|FG000|COMPLETED|Overall Study||0||
48786101|NCT01124864|102265735|FG001|COMPLETED|Overall Study||0||
48786102|NCT01124864|102265736|FG002|COMPLETED|Overall Study||0||
48786103|NCT01124864|102265737|FG003|COMPLETED|Overall Study||1||
48786104|NCT01124864|102265738|FG004|COMPLETED|Overall Study||1||
48786105|NCT01124864|102265739|FG005|COMPLETED|Overall Study||0||
48786106|NCT01124864|102265734|FG000|NOT COMPLETED|Overall Study||28||
48786107|NCT01124864|102265735|FG001|NOT COMPLETED|Overall Study||35||
48786108|NCT01124864|102265736|FG002|NOT COMPLETED|Overall Study||34||
48786109|NCT01124864|102265737|FG003|NOT COMPLETED|Overall Study||21||
48786110|NCT01124864|102265738|FG004|NOT COMPLETED|Overall Study||30||
48786111|NCT01124864|102265739|FG005|NOT COMPLETED|Overall Study||3||
48786112|NCT01632267|102265740|FG000|STARTED|Overall Study||104||
48786113|NCT01632267|102265740|FG000|COMPLETED|Overall Study||97||
48786114|NCT01632267|102265740|FG000|NOT COMPLETED|Overall Study||7||
48786115|NCT00777153|102265741|FG000|STARTED|Overall Study||131||
48786116|NCT00777153|102265742|FG001|STARTED|Overall Study||129||
48786117|NCT00777153|102265743|FG002|STARTED|Overall Study||65||
48786118|NCT00777153|102265741|FG000|COMPLETED|Overall Study||41||
48786119|NCT00777153|102265742|FG001|COMPLETED|Overall Study||46||
48786120|NCT00777153|102265743|FG002|COMPLETED|Overall Study||28||
48786121|NCT00777153|102265741|FG000|NOT COMPLETED|Overall Study||90||
48786122|NCT00777153|102265742|FG001|NOT COMPLETED|Overall Study||83||
48786123|NCT00777153|102265743|FG002|NOT COMPLETED|Overall Study||37||
48786124|NCT03085914|102265744|FG000|STARTED|Overall Study||9||
48786125|NCT03085914|102265745|FG001|STARTED|Overall Study||9||
48786126|NCT03085914|102265746|FG002|STARTED|Overall Study||11||
48786127|NCT03085914|102265747|FG003|STARTED|Overall Study||9||
48786128|NCT03085914|102265748|FG004|STARTED|Overall Study||13||
48786129|NCT03085914|102265749|FG005|STARTED|Overall Study||8||
48786130|NCT03085914|102265750|FG006|STARTED|Overall Study||11||
48786131|NCT03085914|102265744|FG000|COMPLETED|Overall Study||0||
48786132|NCT03085914|102265745|FG001|COMPLETED|Overall Study||0||
48786133|NCT03085914|102265746|FG002|COMPLETED|Overall Study||0||
48786134|NCT03085914|102265747|FG003|COMPLETED|Overall Study||0||
48786135|NCT03085914|102265748|FG004|COMPLETED|Overall Study||0||
48786136|NCT03085914|102265749|FG005|COMPLETED|Overall Study||0||
48189935|NCT04006795|100788969|FG000|COMPLETED|Challenge Phase||37||
48467906|NCT00696449|101481033|FG000|NOT COMPLETED|Overall Study||3||
48786137|NCT03085914|102265750|FG006|COMPLETED|Overall Study||0||
48786138|NCT03085914|102265744|FG000|NOT COMPLETED|Overall Study||9||
48786139|NCT03085914|102265745|FG001|NOT COMPLETED|Overall Study||9||
48786140|NCT03085914|102265746|FG002|NOT COMPLETED|Overall Study||11||
48467907|NCT00696449|101481034|FG001|NOT COMPLETED|Overall Study||6||
48467908|NCT00696449|101481035|FG002|NOT COMPLETED|Overall Study||1||
48467909|NCT00696449|101481036|FG003|NOT COMPLETED|Overall Study||3||
48786141|NCT03085914|102265747|FG003|NOT COMPLETED|Overall Study||9||
48786142|NCT03085914|102265748|FG004|NOT COMPLETED|Overall Study||13||
48786143|NCT03085914|102265749|FG005|NOT COMPLETED|Overall Study||8||
48786144|NCT03085914|102265750|FG006|NOT COMPLETED|Overall Study||11||
48786145|NCT03255083|102265751|FG000|STARTED|Overall Study||6||
48786146|NCT03255083|102265752|FG001|STARTED|Overall Study||3||
48786147|NCT03255083|102265753|FG002|STARTED|Overall Study||3||
48786148|NCT03255083|102265754|FG003|STARTED|Overall Study||1||
48786149|NCT03255083|102265751|FG000|COMPLETED|Overall Study||0||
48786150|NCT03255083|102265752|FG001|COMPLETED|Overall Study||0||
48786151|NCT03255083|102265753|FG002|COMPLETED|Overall Study||0||
48786152|NCT03255083|102265754|FG003|COMPLETED|Overall Study||0||
48467910|NCT00738673|101481037|FG000|STARTED|Overall Study||25||
48467911|NCT00738673|101481038|FG001|STARTED|Overall Study||12||
48467912|NCT00738673|101481037|FG000|Intent to Treat Population|Overall Study||24||
48467913|NCT00738673|101481038|FG001|Intent to Treat Population|Overall Study||12||
48467914|NCT00738673|101481037|FG000|COMPLETED|Overall Study||1||
48467915|NCT00738673|101481038|FG001|COMPLETED|Overall Study||1||
48467916|NCT00738673|101481037|FG000|NOT COMPLETED|Overall Study||24||
48467917|NCT00738673|101481038|FG001|NOT COMPLETED|Overall Study||11||
48467918|NCT01338636|101481039|FG000|STARTED|Overall Study||30||
48467919|NCT01338636|101481039|FG000|COMPLETED|Overall Study||22||
48786153|NCT03255083|102265751|FG000|NOT COMPLETED|Overall Study||6||
48786154|NCT03255083|102265752|FG001|NOT COMPLETED|Overall Study||3||
48786155|NCT03255083|102265753|FG002|NOT COMPLETED|Overall Study||3||
48786156|NCT03255083|102265754|FG003|NOT COMPLETED|Overall Study||1||
48786157|NCT03471624|102265755|FG000|STARTED|Overall Study||270||
48786158|NCT03471624|102265755|FG000|COMPLETED|Overall Study||258||
48786159|NCT03471624|102265755|FG000|NOT COMPLETED|Overall Study||12||
48786160|NCT00003472|102265756|FG000|STARTED|Overall Study||13||
48786161|NCT00003472|102265756|FG000|COMPLETED|Overall Study||10||
48786162|NCT00003472|102265756|FG000|NOT COMPLETED|Overall Study||3||
48786163|NCT01457352|102265757|FG000|STARTED|Period 1||392|16 subjects were discontinued during Part 1 of the study.|
48786164|NCT01457352|102265758|FG001|STARTED|Period 1||0|16 subjects were discontinued during Part 1 of the study.|
48786165|NCT01457352|102265757|FG000|COMPLETED|Period 1||376|6 subjects were discontinued during Part 3 of the study.|
48786166|NCT01457352|102265758|FG001|COMPLETED|Period 1||0|6 subjects were discontinued during Part 3 of the study.|
48786167|NCT01457352|102265757|FG000|NOT COMPLETED|Period 1||16||
48786168|NCT01457352|102265758|FG001|NOT COMPLETED|Period 1||0||
48786169|NCT01457352|102265757|FG000|STARTED|Period 2||376|80 subjects were discontinued in Part 2 of the study.|
48786170|NCT01457352|102265758|FG001|STARTED|Period 2||0|80 subjects were discontinued in Part 2 of the study.|
48786171|NCT01457352|102265757|FG000|COMPLETED|Period 2||296||
48786172|NCT01457352|102265758|FG001|COMPLETED|Period 2||0||
48786173|NCT01457352|102265757|FG000|NOT COMPLETED|Period 2||80||
48786174|NCT01457352|102265758|FG001|NOT COMPLETED|Period 2||0||
48786175|NCT01457352|102265757|FG000|STARTED|Period 3||147||
48786176|NCT01457352|102265758|FG001|STARTED|Period 3||149||
48786177|NCT01457352|102265757|FG000|Randomization|Period 3||147||
48786178|NCT01457352|102265758|FG001|Randomization|Period 3||149||
48786179|NCT01457352|102265757|FG000|COMPLETED|Period 3||146||
48786180|NCT01457352|102265758|FG001|COMPLETED|Period 3||144||
48786181|NCT01457352|102265757|FG000|NOT COMPLETED|Period 3||1||
48786182|NCT01457352|102265758|FG001|NOT COMPLETED|Period 3||5||
48786183|NCT03512457|102265759|FG000|STARTED|Overall Study||195||
48786184|NCT03512457|102265760|FG001|STARTED|Overall Study||225||
48786185|NCT03512457|102265759|FG000|COMPLETED|Overall Study||161||
48786186|NCT03512457|102265760|FG001|COMPLETED|Overall Study||185||
48786187|NCT03512457|102265759|FG000|NOT COMPLETED|Overall Study||34||
48786188|NCT03512457|102265760|FG001|NOT COMPLETED|Overall Study||40||
48786189|NCT03278067|102265761|FG000|STARTED|Overall Study||16433||
48467920|NCT01338636|101481039|FG000|NOT COMPLETED|Overall Study||8||
48467921|NCT02040766|101481040|FG000|STARTED|Overall Study||127||
48467922|NCT02040766|101481041|FG001|STARTED|Overall Study||126||
48467923|NCT02040766|101481042|FG002|STARTED|Overall Study||125||
48467924|NCT02040766|101481043|FG003|STARTED|Overall Study||125||
48786190|NCT03278067|102265762|FG001|STARTED|Overall Study||3310||
48467925|NCT02040766|101481044|FG004|STARTED|Overall Study||125||
48665943|NCT00329420|101967455|FG002|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||1||
48786191|NCT03278067|102265763|FG002|STARTED|Overall Study||4196||
48786192|NCT03278067|102265761|FG000|COMPLETED|Overall Study||16433||
48786193|NCT03278067|102265762|FG001|COMPLETED|Overall Study||3310||
48786194|NCT03278067|102265763|FG002|COMPLETED|Overall Study||4196||
48786195|NCT03278067|102265761|FG000|NOT COMPLETED|Overall Study||0||
48467926|NCT02040766|101481040|FG000|COMPLETED|Overall Study||109||
48786196|NCT03278067|102265762|FG001|NOT COMPLETED|Overall Study||0||
48786197|NCT03278067|102265763|FG002|NOT COMPLETED|Overall Study||0||
48786198|NCT01755026|102265764|FG000|STARTED|Overall Study||11||
48786199|NCT01755026|102265765|FG001|STARTED|Overall Study||12||
48467927|NCT02040766|101481041|FG001|COMPLETED|Overall Study||116||
48467928|NCT02040766|101481042|FG002|COMPLETED|Overall Study||113||
48467929|NCT02040766|101481043|FG003|COMPLETED|Overall Study||112||
48467930|NCT02040766|101481044|FG004|COMPLETED|Overall Study||112||
48467931|NCT02040766|101481040|FG000|NOT COMPLETED|Overall Study||18||
48467932|NCT02040766|101481041|FG001|NOT COMPLETED|Overall Study||10||
48467933|NCT02040766|101481042|FG002|NOT COMPLETED|Overall Study||12||
48467934|NCT02040766|101481043|FG003|NOT COMPLETED|Overall Study||13||
48467935|NCT02040766|101481044|FG004|NOT COMPLETED|Overall Study||13||
48467936|NCT01665170|101481045|FG000|STARTED|Overall Study||30||
48467937|NCT01665170|101481046|FG001|STARTED|Overall Study||30||
48467938|NCT01665170|101481045|FG000|Bevore TSST|Overall Study||30||
48467939|NCT01665170|101481046|FG001|Bevore TSST|Overall Study||30||
48467940|NCT01665170|101481045|FG000|During TSST|Overall Study||30||
48467941|NCT01665170|101481046|FG001|During TSST|Overall Study||30||
48467942|NCT01665170|101481045|FG000|After TSST|Overall Study||30||
48467943|NCT01665170|101481046|FG001|After TSST|Overall Study||30||
48467944|NCT01665170|101481045|FG000|COMPLETED|Overall Study||30||
48467945|NCT01665170|101481046|FG001|COMPLETED|Overall Study||30||
48467946|NCT01665170|101481045|FG000|NOT COMPLETED|Overall Study||0||
48467947|NCT01665170|101481046|FG001|NOT COMPLETED|Overall Study||0||
48467948|NCT00878995|101481047|FG000|STARTED|Baseline Study - Midpoint Study||12||
48467949|NCT00878995|101481048|FG001|STARTED|Baseline Study - Midpoint Study||12||
48467950|NCT00878995|101481047|FG000|Baseline Study|Baseline Study - Midpoint Study||12||
48467951|NCT00878995|101481048|FG001|Baseline Study|Baseline Study - Midpoint Study||12||
48467952|NCT00878995|101481047|FG000|COMPLETED|Baseline Study - Midpoint Study||12||
48467953|NCT00878995|101481048|FG001|COMPLETED|Baseline Study - Midpoint Study||10||
48467954|NCT00878995|101481047|FG000|NOT COMPLETED|Baseline Study - Midpoint Study||0||
48467955|NCT00878995|101481048|FG001|NOT COMPLETED|Baseline Study - Midpoint Study||2||
48467956|NCT00878995|101481047|FG000|STARTED|Midpoint Study - Post Study||12||
48786200|NCT01755026|102265764|FG000|COMPLETED|Overall Study||9||
48786201|NCT01755026|102265765|FG001|COMPLETED|Overall Study||11||
48786202|NCT01755026|102265764|FG000|NOT COMPLETED|Overall Study||2||
48786203|NCT01755026|102265765|FG001|NOT COMPLETED|Overall Study||1||
48786204|NCT01256294|102265766|FG000|STARTED|Overall Study||36||
48786205|NCT01256294|102265767|FG001|STARTED|Overall Study||35||
48786206|NCT01256294|102265766|FG000|COMPLETED|Overall Study||32||
48786207|NCT01256294|102265767|FG001|COMPLETED|Overall Study||33||
48786208|NCT01256294|102265766|FG000|NOT COMPLETED|Overall Study||4||
48786209|NCT01256294|102265767|FG001|NOT COMPLETED|Overall Study||2||
48786210|NCT03180619|102265768|FG000|STARTED|Overall Study||78||
48786211|NCT03180619|102265769|FG001|STARTED|Overall Study||15||
48786212|NCT03180619|102265770|FG002|STARTED|Overall Study||31||
48786213|NCT03180619|102265768|FG000|COMPLETED|Overall Study||67||
48786214|NCT03180619|102265769|FG001|COMPLETED|Overall Study||14||
48786215|NCT03180619|102265770|FG002|COMPLETED|Overall Study||25||
48786216|NCT03180619|102265768|FG000|NOT COMPLETED|Overall Study||11||
48786217|NCT03180619|102265769|FG001|NOT COMPLETED|Overall Study||1||
48786218|NCT03180619|102265770|FG002|NOT COMPLETED|Overall Study||6||
48786219|NCT01143701|102265771|FG000|STARTED|Overall Study||258||
48786220|NCT01143701|102265772|FG001|STARTED|Overall Study||319||
48786221|NCT01143701|102265771|FG000|COMPLETED|Overall Study||235||
48786222|NCT01143701|102265772|FG001|COMPLETED|Overall Study||287||
48786223|NCT01143701|102265771|FG000|NOT COMPLETED|Overall Study||23||
48786224|NCT01143701|102265772|FG001|NOT COMPLETED|Overall Study||32||
48786225|NCT02037555|102265773|FG000|STARTED|Overall Study||213||
48786226|NCT02037555|102265774|FG001|STARTED|Overall Study||212||
48786227|NCT02037555|102265773|FG000|Dosed|Overall Study||201|Reported for Safety Results|
48786228|NCT02037555|102265774|FG001|Dosed|Overall Study||198|Reported for Safety Results|
48467957|NCT00878995|101481048|FG001|STARTED|Midpoint Study - Post Study||10||
48467958|NCT00878995|101481047|FG000|COMPLETED|Midpoint Study - Post Study||12||
48786229|NCT02037555|102265773|FG000|Dosed and Operated On|Overall Study||200|Reported for Efficacy Results|
48786230|NCT02037555|102265774|FG001|Dosed and Operated On|Overall Study||196|Reported for Efficacy Results|
48786231|NCT02037555|102265773|FG000|COMPLETED|Overall Study||190||
48786232|NCT02037555|102265774|FG001|COMPLETED|Overall Study||191||
48786233|NCT02037555|102265773|FG000|NOT COMPLETED|Overall Study||23||
48786234|NCT02037555|102265774|FG001|NOT COMPLETED|Overall Study||21||
48786235|NCT02076425|102265775|FG000|STARTED|Overall Study||114||
48467959|NCT00878995|101481048|FG001|COMPLETED|Midpoint Study - Post Study||10||
48467960|NCT00878995|101481047|FG000|NOT COMPLETED|Midpoint Study - Post Study||0||
48786236|NCT02076425|102265776|FG001|STARTED|Overall Study||115||
48786237|NCT02076425|102265775|FG000|COMPLETED|Overall Study||100||
48786238|NCT02076425|102265776|FG001|COMPLETED|Overall Study||91||
48786239|NCT02076425|102265775|FG000|NOT COMPLETED|Overall Study||14||
48786240|NCT02076425|102265776|FG001|NOT COMPLETED|Overall Study||24||
48786241|NCT00783198|102265777|FG000|STARTED|Overall Study||190||
48467961|NCT00878995|101481048|FG001|NOT COMPLETED|Midpoint Study - Post Study||0||
48467962|NCT00266409|101481049|FG000|STARTED|Overall Study||137||
48467963|NCT00266409|101481050|FG001|STARTED|Overall Study||138||
48467964|NCT00266409|101481051|FG002|STARTED|Overall Study||72||
48786242|NCT00783198|102265778|FG001|STARTED|Overall Study||187||
48786243|NCT00783198|102265779|FG002|STARTED|Overall Study||188||
48786244|NCT00783198|102265777|FG000|COMPLETED|Overall Study||133||
48786245|NCT00783198|102265778|FG001|COMPLETED|Overall Study||144||
48786246|NCT00783198|102265779|FG002|COMPLETED|Overall Study||146||
48786247|NCT00783198|102265777|FG000|NOT COMPLETED|Overall Study||57||
48786248|NCT00783198|102265778|FG001|NOT COMPLETED|Overall Study||43||
48786249|NCT00783198|102265779|FG002|NOT COMPLETED|Overall Study||42||
48786250|NCT02495038|102265780|FG000|STARTED|Overall Study||27||
48786251|NCT02495038|102265781|FG001|STARTED|Overall Study||27||
48786252|NCT02495038|102265782|FG002|STARTED|Overall Study||27||
48786253|NCT02495038|102265780|FG000|COMPLETED|Overall Study||27||
48786254|NCT02495038|102265781|FG001|COMPLETED|Overall Study||27||
48786255|NCT02495038|102265782|FG002|COMPLETED|Overall Study||27||
48786256|NCT02495038|102265780|FG000|NOT COMPLETED|Overall Study||0||
48786257|NCT02495038|102265781|FG001|NOT COMPLETED|Overall Study||0||
48786258|NCT02495038|102265782|FG002|NOT COMPLETED|Overall Study||0||
48786259|NCT02184572|102265783|FG000|STARTED|Overall Study||1164||
48786260|NCT02184572|102265784|FG001|STARTED|Overall Study||572||
48786261|NCT02184572|102265783|FG000|COMPLETED|Overall Study||1117||
48786262|NCT02184572|102265784|FG001|COMPLETED|Overall Study||542||
48786263|NCT02184572|102265783|FG000|NOT COMPLETED|Overall Study||47||
48786264|NCT02184572|102265784|FG001|NOT COMPLETED|Overall Study||30||
48786265|NCT03574181|102265785|FG000|STARTED|Overall Study||9||
48786266|NCT03574181|102265785|FG000|COMPLETED|Overall Study||0||
48786267|NCT03574181|102265785|FG000|NOT COMPLETED|Overall Study||9||
48786268|NCT00905645|102265786|FG000|STARTED|Overall Study||1116||
48786269|NCT00905645|102265787|FG001|STARTED|Overall Study||363||
48786270|NCT00905645|102265788|FG002|STARTED|Overall Study||225||
48786271|NCT00905645|102265789|FG003|STARTED|Overall Study||84||
48786272|NCT00905645|102265786|FG000|COMPLETED|Overall Study||688||
48786273|NCT00905645|102265787|FG001|COMPLETED|Overall Study||192||
48786274|NCT00905645|102265788|FG002|COMPLETED|Overall Study||118||
48786275|NCT00905645|102265789|FG003|COMPLETED|Overall Study||32||
48786276|NCT00905645|102265786|FG000|NOT COMPLETED|Overall Study||428||
48786277|NCT00905645|102265787|FG001|NOT COMPLETED|Overall Study||171||
48786278|NCT00905645|102265788|FG002|NOT COMPLETED|Overall Study||107||
48786279|NCT00905645|102265789|FG003|NOT COMPLETED|Overall Study||52||
48786280|NCT02600819|102265790|FG000|STARTED|GEN Phase||55||
48786281|NCT02600819|102265791|FG001|STARTED|GEN Phase||0||
48786282|NCT02600819|102265790|FG000|COMPLETED|GEN Phase||39||
48786283|NCT02600819|102265791|FG001|COMPLETED|GEN Phase||0||
48786284|NCT02600819|102265790|FG000|NOT COMPLETED|GEN Phase||16||
48467965|NCT00266409|101481052|FG003|STARTED|Overall Study||71||
48786285|NCT02600819|102265791|FG001|NOT COMPLETED|GEN Phase||0||
48786286|NCT02600819|102265790|FG000|STARTED|BVY OL Extension Phase||0||
48786287|NCT02600819|102265791|FG001|STARTED|BVY OL Extension Phase||10||
48786288|NCT02600819|102265790|FG000|COMPLETED|BVY OL Extension Phase||0||
48786289|NCT02600819|102265791|FG001|COMPLETED|BVY OL Extension Phase||10||
48786290|NCT02600819|102265790|FG000|NOT COMPLETED|BVY OL Extension Phase||0||
48786291|NCT02600819|102265791|FG001|NOT COMPLETED|BVY OL Extension Phase||0||
48786292|NCT02366091|102265792|FG000|STARTED|Overall Study||24||
48786293|NCT02366091|102265793|FG001|STARTED|Overall Study||23||
48786294|NCT02366091|102265794|FG002|STARTED|Overall Study||24||
48786295|NCT02366091|102265795|FG003|STARTED|Overall Study||23||
48786296|NCT02366091|102265792|FG000|COMPLETED|Overall Study||21||
48786297|NCT02366091|102265793|FG001|COMPLETED|Overall Study||16||
48786298|NCT02366091|102265794|FG002|COMPLETED|Overall Study||21||
48786299|NCT02366091|102265795|FG003|COMPLETED|Overall Study||22||
48786300|NCT02366091|102265792|FG000|NOT COMPLETED|Overall Study||3||
48786301|NCT02366091|102265793|FG001|NOT COMPLETED|Overall Study||7||
48786302|NCT02366091|102265794|FG002|NOT COMPLETED|Overall Study||3||
48786303|NCT02366091|102265795|FG003|NOT COMPLETED|Overall Study||1||
48786304|NCT02717832|102265796|FG000|STARTED|Overall Study||20||
48786305|NCT02717832|102265796|FG000|COMPLETED|Overall Study||17||
48786306|NCT02717832|102265796|FG000|NOT COMPLETED|Overall Study||3||
48786307|NCT01250496|102265797|FG000|STARTED|Overall Study||124||
48786308|NCT01250496|102265798|FG001|STARTED|Overall Study||124||
48786309|NCT01250496|102265797|FG000|COMPLETED|Overall Study||0||
48786310|NCT01250496|102265798|FG001|COMPLETED|Overall Study||0||
48467966|NCT00266409|101481049|FG000|COMPLETED|Overall Study||92||
48786311|NCT01250496|102265797|FG000|NOT COMPLETED|Overall Study||124||
48786312|NCT01250496|102265798|FG001|NOT COMPLETED|Overall Study||124||
48786313|NCT00926029|102265799|FG000|STARTED|Overall Study||34||
48786314|NCT00926029|102265800|FG001|STARTED|Overall Study||34||
48786315|NCT00926029|102265801|FG002|STARTED|Overall Study||34||
48467967|NCT00266409|101481050|FG001|COMPLETED|Overall Study||92||
48786316|NCT00926029|102265799|FG000|COMPLETED|Overall Study||32||
48786317|NCT00926029|102265800|FG001|COMPLETED|Overall Study||33||
48786318|NCT00926029|102265801|FG002|COMPLETED|Overall Study||33||
48467968|NCT00266409|101481051|FG002|COMPLETED|Overall Study||55||
48786319|NCT00926029|102265799|FG000|NOT COMPLETED|Overall Study||2||
48467969|NCT00266409|101481052|FG003|COMPLETED|Overall Study||49||
48786320|NCT00926029|102265800|FG001|NOT COMPLETED|Overall Study||1||
48786321|NCT00926029|102265801|FG002|NOT COMPLETED|Overall Study||1||
48786322|NCT02282293|102265802|FG000|STARTED|Overall Study||100||
48786323|NCT02282293|102265803|FG001|STARTED|Overall Study||100||
48786324|NCT02282293|102265802|FG000|COMPLETED|Overall Study||97||
48786325|NCT02282293|102265803|FG001|COMPLETED|Overall Study||97||
48786326|NCT02282293|102265802|FG000|NOT COMPLETED|Overall Study||3||
48786327|NCT02282293|102265803|FG001|NOT COMPLETED|Overall Study||3||
48786328|NCT01051518|102265804|FG000|STARTED|Overall Study||126||
48786329|NCT01051518|102265804|FG000|COMPLETED|Overall Study||53||
48786330|NCT01051518|102265804|FG000|NOT COMPLETED|Overall Study||73||
48786331|NCT02010151|102265805|FG000|STARTED|Overall Study||1498||
48786332|NCT02010151|102265806|FG001|STARTED|Overall Study||1696||
48786333|NCT02010151|102265805|FG000|COMPLETED|Overall Study||1498||
48786334|NCT02010151|102265806|FG001|COMPLETED|Overall Study||1696||
48786335|NCT02010151|102265805|FG000|NOT COMPLETED|Overall Study||0||
48786336|NCT02010151|102265806|FG001|NOT COMPLETED|Overall Study||0||
48786337|NCT01264601|102265807|FG000|STARTED|Overall Study||17||
48786338|NCT01264601|102265808|FG001|STARTED|Overall Study||14||
48786339|NCT01264601|102265807|FG000|COMPLETED|Overall Study||17||
48786340|NCT01264601|102265808|FG001|COMPLETED|Overall Study||14||
48786341|NCT01264601|102265807|FG000|NOT COMPLETED|Overall Study||0||
48786342|NCT01264601|102265808|FG001|NOT COMPLETED|Overall Study||0||
48786343|NCT01588418|102265809|FG000|STARTED|Overall Study||11||
48786344|NCT01588418|102265810|FG001|STARTED|Overall Study||4||
48786345|NCT01588418|102265809|FG000|COMPLETED|Overall Study||11||
48786346|NCT01588418|102265810|FG001|COMPLETED|Overall Study||4||
48786347|NCT01588418|102265809|FG000|NOT COMPLETED|Overall Study||0||
48786348|NCT01588418|102265810|FG001|NOT COMPLETED|Overall Study||0||
48786349|NCT00662675|102265811|FG000|STARTED|Overall Study||20||
48786350|NCT00662675|102265812|FG001|STARTED|Overall Study||20||
48786351|NCT00662675|102265811|FG000|COMPLETED|Overall Study||20||
48786352|NCT00662675|102265812|FG001|COMPLETED|Overall Study||20||
48786353|NCT00662675|102265811|FG000|NOT COMPLETED|Overall Study||0||
48786354|NCT00662675|102265812|FG001|NOT COMPLETED|Overall Study||0||
48467970|NCT00266409|101481049|FG000|NOT COMPLETED|Overall Study||45||
48467971|NCT00266409|101481050|FG001|NOT COMPLETED|Overall Study||46||
48467972|NCT00266409|101481051|FG002|NOT COMPLETED|Overall Study||17||
48467973|NCT00266409|101481052|FG003|NOT COMPLETED|Overall Study||22||
48467974|NCT02098993|101481053|FG000|STARTED|Overall Study||4||
48467975|NCT02098993|101481054|FG001|STARTED|Overall Study||3||
48467976|NCT02098993|101481053|FG000|COMPLETED|Overall Study||4||
48467977|NCT02098993|101481054|FG001|COMPLETED|Overall Study||3||
48467978|NCT02098993|101481053|FG000|NOT COMPLETED|Overall Study||0||
48467979|NCT02098993|101481054|FG001|NOT COMPLETED|Overall Study||0||
48467980|NCT01893138|101481055|FG000|STARTED|Double-Blind Period||199||
48467981|NCT01893138|101481056|FG001|STARTED|Double-Blind Period||98||
48467982|NCT01893138|101481055|FG000|Injection|Double-Blind Period||199||
48467983|NCT01893138|101481056|FG001|Injection|Double-Blind Period||98||
48467984|NCT01893138|101481055|FG000|1 Month Follow-Up|Double-Blind Period||199||
48189936|NCT04006795|100788969|FG000|NOT COMPLETED|Challenge Phase||0||
48189937|NCT00367237|100788970|FG000|STARTED|Overall Study||57||
48467985|NCT01893138|101481056|FG001|1 Month Follow-Up|Double-Blind Period||97||
48467986|NCT01893138|101481055|FG000|3 Month Follow-Up|Double-Blind Period||199||
48467987|NCT01893138|101481056|FG001|3 Month Follow-Up|Double-Blind Period||97||
48467988|NCT01893138|101481055|FG000|6 Month Follow-Up|Double-Blind Period||198||
48467989|NCT01893138|101481056|FG001|6 Month Follow-Up|Double-Blind Period||97||
48467990|NCT01893138|101481055|FG000|12 Month Follow-Up|Double-Blind Period||198||
48467991|NCT01893138|101481056|FG001|12 Month Follow-Up|Double-Blind Period||97||
48467992|NCT01893138|101481055|FG000|COMPLETED|Double-Blind Period||198||
48467993|NCT01893138|101481056|FG001|COMPLETED|Double-Blind Period||97||
48467994|NCT01893138|101481055|FG000|NOT COMPLETED|Double-Blind Period||1||
48467995|NCT01893138|101481056|FG001|NOT COMPLETED|Double-Blind Period||1||
48467996|NCT01893138|101481055|FG000|STARTED|Open Label - Unblinded Period||198||
48467997|NCT01893138|101481056|FG001|STARTED|Open Label - Unblinded Period||97||
48467998|NCT01893138|101481055|FG000|Open Label Period|Open Label - Unblinded Period||166||
48467999|NCT01893138|101481056|FG001|Open Label Period|Open Label - Unblinded Period||97||
48468000|NCT01893138|101481055|FG000|Iltamiocel Injection|Open Label - Unblinded Period||0|"No additional treatment for iltamiocel arm.~Subjects originally randomized to placebo received single, open-label iltamiocel injection."|
48468001|NCT01893138|101481056|FG001|Iltamiocel Injection|Open Label - Unblinded Period||92|"No additional treatment for iltamiocel arm.~Subjects originally randomized to placebo received single, open-label iltamiocel injection."|
48468002|NCT01893138|101481055|FG000|2 Year Follow-Up|Open Label - Unblinded Period||166||
48468003|NCT01893138|101481056|FG001|2 Year Follow-Up|Open Label - Unblinded Period||87||
48468004|NCT01893138|101481055|FG000|COMPLETED|Open Label - Unblinded Period||166||
48468005|NCT01893138|101481056|FG001|COMPLETED|Open Label - Unblinded Period||87||
48468006|NCT01893138|101481055|FG000|NOT COMPLETED|Open Label - Unblinded Period||32||
48468007|NCT01893138|101481056|FG001|NOT COMPLETED|Open Label - Unblinded Period||10||
48468008|NCT02660242|101481057|FG000|STARTED|Control||16||
48468009|NCT02660242|101481057|FG000|COMPLETED|Control||16||
48468010|NCT02660242|101481057|FG000|NOT COMPLETED|Control||0||
48468011|NCT02660242|101481057|FG000|STARTED|Basal Insulin Reduction||16||
48468012|NCT02660242|101481057|FG000|COMPLETED|Basal Insulin Reduction||16||
48468013|NCT02660242|101481057|FG000|NOT COMPLETED|Basal Insulin Reduction||0||
48468014|NCT02660242|101481057|FG000|STARTED|Glucose Tabs||16||
48468015|NCT02660242|101481057|FG000|COMPLETED|Glucose Tabs||15||
48468016|NCT02660242|101481057|FG000|NOT COMPLETED|Glucose Tabs||1||
48468017|NCT02660242|101481057|FG000|STARTED|Glucagon Injection||16||
48468018|NCT02660242|101481057|FG000|COMPLETED|Glucagon Injection||15||
48468019|NCT02660242|101481057|FG000|NOT COMPLETED|Glucagon Injection||1||
48468020|NCT03086356|101481058|FG000|STARTED|Overall Study||12||
48468021|NCT03086356|101481058|FG000|COMPLETED|Overall Study||12||
48468022|NCT03086356|101481058|FG000|NOT COMPLETED|Overall Study||0||
48468023|NCT00782509|101481059|FG000|STARTED|Overall Study||216||
48468024|NCT00782509|101481060|FG001|STARTED|Overall Study||209||
48468025|NCT00782509|101481061|FG002|STARTED|Overall Study||217||
48665944|NCT02085980|101967456|FG000|STARTED|Overall Study||30||
48468026|NCT00782509|101481059|FG000|COMPLETED|Overall Study||175||
48468027|NCT00782509|101481060|FG001|COMPLETED|Overall Study||185||
48665945|NCT02085980|101967456|FG000|COMPLETED|Overall Study||27||
48665946|NCT02085980|101967456|FG000|NOT COMPLETED|Overall Study||3||
48665947|NCT03685149|101967457|FG000|STARTED|First Intervention (4 Weeks)||11||
48665948|NCT03685149|101967458|FG001|STARTED|First Intervention (4 Weeks)||11||
48665949|NCT03685149|101967457|FG000|COMPLETED|First Intervention (4 Weeks)||10||
48665950|NCT03685149|101967458|FG001|COMPLETED|First Intervention (4 Weeks)||9||
48665951|NCT03685149|101967457|FG000|NOT COMPLETED|First Intervention (4 Weeks)||1||
48665952|NCT03685149|101967458|FG001|NOT COMPLETED|First Intervention (4 Weeks)||2||
48665953|NCT03685149|101967457|FG000|STARTED|Washout (1 Week)||10||
48665954|NCT03685149|101967458|FG001|STARTED|Washout (1 Week)||9||
48665955|NCT03685149|101967457|FG000|COMPLETED|Washout (1 Week)||10||
48665956|NCT03685149|101967458|FG001|COMPLETED|Washout (1 Week)||9||
48665957|NCT03685149|101967457|FG000|NOT COMPLETED|Washout (1 Week)||0||
48665958|NCT03685149|101967458|FG001|NOT COMPLETED|Washout (1 Week)||0||
48665959|NCT03685149|101967457|FG000|STARTED|Second Intervention (4 Weeks)||10||
48665960|NCT03685149|101967458|FG001|STARTED|Second Intervention (4 Weeks)||9||
48665961|NCT03685149|101967457|FG000|COMPLETED|Second Intervention (4 Weeks)||9||
48665962|NCT03685149|101967458|FG001|COMPLETED|Second Intervention (4 Weeks)||9||
48665963|NCT03685149|101967457|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1||
48665964|NCT03685149|101967458|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0||
48665965|NCT01313676|101967459|FG000|STARTED|Overall Study||4131||
48665966|NCT01313676|101967460|FG001|STARTED|Overall Study||4157||
48665967|NCT01313676|101967461|FG002|STARTED|Overall Study||4140||
48665968|NCT01313676|101967462|FG003|STARTED|Overall Study||4140||
48665969|NCT01313676|101967459|FG000|COMPLETED|Overall Study||2881||
48665970|NCT01313676|101967460|FG001|COMPLETED|Overall Study||3044||
48665971|NCT01313676|101967461|FG002|COMPLETED|Overall Study||3052||
48665972|NCT01313676|101967462|FG003|COMPLETED|Overall Study||3146||
48665973|NCT01313676|101967459|FG000|NOT COMPLETED|Overall Study||1250||
48468028|NCT00782509|101481061|FG002|COMPLETED|Overall Study||181||
48189938|NCT00367237|100788971|FG001|STARTED|Overall Study||58||
48468029|NCT00782509|101481059|FG000|NOT COMPLETED|Overall Study||41||
48468030|NCT00782509|101481060|FG001|NOT COMPLETED|Overall Study||24||
48468031|NCT00782509|101481061|FG002|NOT COMPLETED|Overall Study||36||
48468032|NCT02178709|101481062|FG000|STARTED|Overall Study||48||
48468033|NCT02178709|101481062|FG000|COMPLETED|Overall Study||32||
48468034|NCT02178709|101481062|FG000|NOT COMPLETED|Overall Study||16||
48468035|NCT01620177|101481063|FG000|STARTED|Overall Study||98||
48468036|NCT01620177|101481063|FG000|COMPLETED|Overall Study||19||
48468037|NCT01620177|101481063|FG000|NOT COMPLETED|Overall Study||79||
48468038|NCT01521559|101481064|FG000|STARTED|Overall Study||92||
48468039|NCT01521559|101481065|FG001|STARTED|Overall Study||91||
48468040|NCT01521559|101481064|FG000|Completed Week 24|Overall Study||83||
48468041|NCT01521559|101481065|FG001|Completed Week 24|Overall Study||85||
48468042|NCT01521559|101481064|FG000|Completed Week 52|Overall Study||77||
48468043|NCT01521559|101481065|FG001|Completed Week 52|Overall Study||73||
48468044|NCT01521559|101481064|FG000|COMPLETED|Overall Study||77||
48468045|NCT01521559|101481065|FG001|COMPLETED|Overall Study||73||
48468046|NCT01521559|101481064|FG000|NOT COMPLETED|Overall Study||15||
48468047|NCT01521559|101481065|FG001|NOT COMPLETED|Overall Study||18||
48468048|NCT01254409|101481066|FG000|STARTED|Overall Study||6||
48468049|NCT01254409|101481067|FG001|STARTED|Overall Study||6||
48468050|NCT01254409|101481068|FG002|STARTED|Overall Study||5||
48468051|NCT01254409|101481069|FG003|STARTED|Overall Study||4||
48468052|NCT01254409|101481066|FG000|COMPLETED|Overall Study||6||
48468053|NCT01254409|101481067|FG001|COMPLETED|Overall Study||5||
48468054|NCT01254409|101481068|FG002|COMPLETED|Overall Study||5||
48468055|NCT01254409|101481069|FG003|COMPLETED|Overall Study||4||
48468056|NCT01254409|101481066|FG000|NOT COMPLETED|Overall Study||0||
48468057|NCT01254409|101481067|FG001|NOT COMPLETED|Overall Study||1||
48468058|NCT01254409|101481068|FG002|NOT COMPLETED|Overall Study||0||
48468059|NCT01254409|101481069|FG003|NOT COMPLETED|Overall Study||0||
48468060|NCT03534986|101481070|FG000|STARTED|Overall Study||10||
48468061|NCT03534986|101481071|FG001|STARTED|Overall Study||10||
48468062|NCT03534986|101481072|FG002|STARTED|Overall Study||12||
48468063|NCT03534986|101481070|FG000|COMPLETED|Overall Study||10||
48468064|NCT03534986|101481071|FG001|COMPLETED|Overall Study||10||
48468065|NCT03534986|101481072|FG002|COMPLETED|Overall Study||10||
48468066|NCT03534986|101481070|FG000|NOT COMPLETED|Overall Study||0||
48468067|NCT03534986|101481071|FG001|NOT COMPLETED|Overall Study||0||
48468068|NCT03534986|101481072|FG002|NOT COMPLETED|Overall Study||2||
48468069|NCT02204371|101481073|FG000|STARTED|Overall Study||7||
48468070|NCT02204371|101481073|FG000|COMPLETED|Overall Study||6||
48468071|NCT02204371|101481073|FG000|NOT COMPLETED|Overall Study||1||
48468072|NCT01747850|101481074|FG000|STARTED|Overall Study||5||
48468073|NCT01747850|101481075|FG001|STARTED|Overall Study||20||
48468074|NCT01747850|101481076|FG002|STARTED|Overall Study||20||
48189939|NCT00367237|100788970|FG000|COMPLETED|Overall Study||47||
48468075|NCT01747850|101481074|FG000|COMPLETED|Overall Study||4||
48468076|NCT01747850|101481075|FG001|COMPLETED|Overall Study||13||
48468077|NCT01747850|101481076|FG002|COMPLETED|Overall Study||14||
48468078|NCT01747850|101481074|FG000|NOT COMPLETED|Overall Study||1||
48468079|NCT01747850|101481075|FG001|NOT COMPLETED|Overall Study||7||
48468080|NCT01747850|101481076|FG002|NOT COMPLETED|Overall Study||6||
48468081|NCT02275364|101481077|FG000|STARTED|Period 1||14||
48468082|NCT02275364|101481078|FG001|STARTED|Period 1||14||
48468083|NCT02275364|101481077|FG000|COMPLETED|Period 1||12||
48468084|NCT02275364|101481078|FG001|COMPLETED|Period 1||14||
48468085|NCT02275364|101481077|FG000|NOT COMPLETED|Period 1||2||
48468086|NCT02275364|101481078|FG001|NOT COMPLETED|Period 1||0||
48468087|NCT02275364|101481077|FG000|STARTED|Washout Period 1||12||
48468088|NCT02275364|101481078|FG001|STARTED|Washout Period 1||14||
48468089|NCT02275364|101481077|FG000|COMPLETED|Washout Period 1||12||
48468090|NCT02275364|101481078|FG001|COMPLETED|Washout Period 1||14||
48468091|NCT02275364|101481077|FG000|NOT COMPLETED|Washout Period 1||0||
48468092|NCT02275364|101481078|FG001|NOT COMPLETED|Washout Period 1||0||
48468093|NCT02275364|101481077|FG000|STARTED|Period 2||12||
48665974|NCT01313676|101967460|FG001|NOT COMPLETED|Overall Study||1113||
48468094|NCT02275364|101481078|FG001|STARTED|Period 2||14||
48468095|NCT02275364|101481077|FG000|COMPLETED|Period 2||12||
48468096|NCT02275364|101481078|FG001|COMPLETED|Period 2||14||
48468097|NCT02275364|101481077|FG000|NOT COMPLETED|Period 2||0||
48468098|NCT02275364|101481078|FG001|NOT COMPLETED|Period 2||0||
48468099|NCT02275364|101481077|FG000|STARTED|Washout Period 2||12||
48468100|NCT02275364|101481078|FG001|STARTED|Washout Period 2||14||
48468101|NCT02275364|101481077|FG000|COMPLETED|Washout Period 2||12||
48468102|NCT02275364|101481078|FG001|COMPLETED|Washout Period 2||14||
48468103|NCT02275364|101481077|FG000|NOT COMPLETED|Washout Period 2||0||
48468104|NCT02275364|101481078|FG001|NOT COMPLETED|Washout Period 2||0||
48468105|NCT02275364|101481077|FG000|STARTED|Period 3||12||
48468106|NCT02275364|101481078|FG001|STARTED|Period 3||14||
48468107|NCT02275364|101481077|FG000|COMPLETED|Period 3||12||
48468108|NCT02275364|101481078|FG001|COMPLETED|Period 3||14||
48468109|NCT02275364|101481077|FG000|NOT COMPLETED|Period 3||0||
48468110|NCT02275364|101481078|FG001|NOT COMPLETED|Period 3||0||
48468111|NCT02275364|101481077|FG000|STARTED|Period 4||12||
48468112|NCT02275364|101481078|FG001|STARTED|Period 4||14||
48468113|NCT02275364|101481077|FG000|COMPLETED|Period 4||12||
48468114|NCT02275364|101481078|FG001|COMPLETED|Period 4||14||
48468115|NCT02275364|101481077|FG000|NOT COMPLETED|Period 4||0||
48468116|NCT02275364|101481078|FG001|NOT COMPLETED|Period 4||0||
48468117|NCT02359890|101481079|FG000|STARTED|Overall Study||165||
48468118|NCT02359890|101481079|FG000|Safety Population|Overall Study||159||
48468119|NCT02359890|101481079|FG000|mITT Population|Overall Study||155||
48468120|NCT02359890|101481079|FG000|Per-Protocol (PP) Population|Overall Study||155||
48468121|NCT02359890|101481079|FG000|COMPLETED|Overall Study||155||
48468122|NCT02359890|101481079|FG000|NOT COMPLETED|Overall Study||10||
48468123|NCT03222141|101481080|FG000|STARTED|Overall Study||583||
48468124|NCT03222141|101481080|FG000|COMPLETED|Overall Study||565|30-day Follow-up|
48468125|NCT03222141|101481080|FG000|NOT COMPLETED|Overall Study||18||
48468126|NCT02578732|101481081|FG000|STARTED|Overall Study||28||
48468127|NCT02578732|101481081|FG000|COMPLETED|Overall Study||28||
48468128|NCT02578732|101481081|FG000|NOT COMPLETED|Overall Study||0||
48468129|NCT01711021|101481082|FG000|STARTED|Open-Label Dose Optimization Period||110||
48468130|NCT01711021|101481083|FG001|STARTED|Open-Label Dose Optimization Period||0||
48468131|NCT01711021|101481082|FG000|COMPLETED|Open-Label Dose Optimization Period||106||
48468132|NCT01711021|101481083|FG001|COMPLETED|Open-Label Dose Optimization Period||0||
48468133|NCT01711021|101481082|FG000|NOT COMPLETED|Open-Label Dose Optimization Period||4||
48468134|NCT01711021|101481083|FG001|NOT COMPLETED|Open-Label Dose Optimization Period||0||
48468135|NCT01711021|101481082|FG000|STARTED|Double-blind Cross-Over Treatment Period||53||
48468136|NCT01711021|101481083|FG001|STARTED|Double-blind Cross-Over Treatment Period||53||
48468137|NCT01711021|101481082|FG000|COMPLETED|Double-blind Cross-Over Treatment Period||46||
48468138|NCT01711021|101481083|FG001|COMPLETED|Double-blind Cross-Over Treatment Period||46||
48468139|NCT01711021|101481082|FG000|NOT COMPLETED|Double-blind Cross-Over Treatment Period||7||
48468140|NCT01711021|101481083|FG001|NOT COMPLETED|Double-blind Cross-Over Treatment Period||7||
48468141|NCT02207309|101481084|FG000|STARTED|Overall Study||1||
48468142|NCT02207309|101481085|FG001|STARTED|Overall Study||0||
48468143|NCT02207309|101481084|FG000|COMPLETED|Overall Study||1||
48468144|NCT02207309|101481085|FG001|COMPLETED|Overall Study||0||
48468145|NCT02207309|101481084|FG000|NOT COMPLETED|Overall Study||0||
48468146|NCT02207309|101481085|FG001|NOT COMPLETED|Overall Study||0||
48468147|NCT01290263|101481086|FG000|STARTED|Overall Study||11||
48468148|NCT01290263|101481087|FG001|STARTED|Overall Study||3||
48468149|NCT01290263|101481088|FG002|STARTED|Overall Study||7||
48468150|NCT01290263|101481089|FG003|STARTED|Overall Study||27||
48468151|NCT01290263|101481090|FG004|STARTED|Overall Study||37||
48468152|NCT01290263|101481086|FG000|COMPLETED|Overall Study||0||
48468153|NCT01290263|101481087|FG001|COMPLETED|Overall Study||0||
48468154|NCT01290263|101481088|FG002|COMPLETED|Overall Study||0||
48468155|NCT01290263|101481089|FG003|COMPLETED|Overall Study||0||
48468156|NCT01290263|101481090|FG004|COMPLETED|Overall Study||0||
48468157|NCT01290263|101481086|FG000|NOT COMPLETED|Overall Study||11||
48468158|NCT01290263|101481087|FG001|NOT COMPLETED|Overall Study||3||
48468159|NCT01290263|101481088|FG002|NOT COMPLETED|Overall Study||7||
48468160|NCT01290263|101481089|FG003|NOT COMPLETED|Overall Study||27||
48468161|NCT01290263|101481090|FG004|NOT COMPLETED|Overall Study||37||
48468162|NCT01595503|101481091|FG000|STARTED|Overall Study||5||
48468163|NCT01595503|101481091|FG000|COMPLETED|Overall Study||5|Study was discontinued because of poor recruitment and insufficient data for analysis|
48468164|NCT01595503|101481091|FG000|NOT COMPLETED|Overall Study||0||
48468165|NCT00992407|101481092|FG000|STARTED|Overall Study||37||
48468166|NCT00992407|101481093|FG001|STARTED|Overall Study||38||
48468167|NCT00992407|101481092|FG000|Treated|Overall Study||20||
48468168|NCT00992407|101481093|FG001|Treated|Overall Study||25||
48468169|NCT00992407|101481092|FG000|COMPLETED|Overall Study||6||
48468170|NCT00992407|101481093|FG001|COMPLETED|Overall Study||14||
48468171|NCT00992407|101481092|FG000|NOT COMPLETED|Overall Study||31||
48468172|NCT00992407|101481093|FG001|NOT COMPLETED|Overall Study||24||
48468173|NCT01066052|101481094|FG000|STARTED|Overall Study||64||
48468174|NCT01066052|101481095|FG001|STARTED|Overall Study||51||
48468175|NCT01066052|101481094|FG000|Treated|Overall Study||61||
48468176|NCT01066052|101481095|FG001|Treated|Overall Study||0||
48468177|NCT01066052|101481094|FG000|COMPLETED|Overall Study||61||
48468178|NCT01066052|101481095|FG001|COMPLETED|Overall Study||51||
48665975|NCT01313676|101967461|FG002|NOT COMPLETED|Overall Study||1088||
48468179|NCT01066052|101481094|FG000|NOT COMPLETED|Overall Study||3||
48468180|NCT01066052|101481095|FG001|NOT COMPLETED|Overall Study||0||
48468181|NCT02370407|101481096|FG000|STARTED|Overall Study||20||
48468182|NCT02370407|101481097|FG001|STARTED|Overall Study||20||
48189940|NCT00367237|100788971|FG001|COMPLETED|Overall Study||47||
48468183|NCT02370407|101481096|FG000|COMPLETED|Overall Study||20||
48468184|NCT02370407|101481097|FG001|COMPLETED|Overall Study||20||
48468185|NCT02370407|101481096|FG000|NOT COMPLETED|Overall Study||0||
48468186|NCT02370407|101481097|FG001|NOT COMPLETED|Overall Study||0||
48468187|NCT00482547|101481098|FG000|STARTED|Overall Study||599||
48468188|NCT00482547|101481099|FG001|STARTED|Overall Study||589||
48468189|NCT00482547|101481098|FG000|Successful Catheterization|Overall Study||565||
48468190|NCT00482547|101481099|FG001|Successful Catheterization|Overall Study||568||
48468191|NCT00482547|101481098|FG000|48 Hour Evaluation|Overall Study||426||
48468192|NCT00482547|101481099|FG001|48 Hour Evaluation|Overall Study||428||
48468193|NCT00482547|101481098|FG000|COMPLETED|Overall Study||426||
48468194|NCT00482547|101481099|FG001|COMPLETED|Overall Study||428||
48468195|NCT00482547|101481098|FG000|NOT COMPLETED|Overall Study||173||
48468196|NCT00482547|101481099|FG001|NOT COMPLETED|Overall Study||161||
48468197|NCT01569152|101481100|FG000|STARTED|Phase IIa, Period 1||41||
48468198|NCT01569152|101481101|FG001|STARTED|Phase IIa, Period 1||41||
48468199|NCT01569152|101481102|FG002|STARTED|Phase IIa, Period 1||0||
48468200|NCT01569152|101481100|FG000|COMPLETED|Phase IIa, Period 1||20||
48468201|NCT01569152|101481101|FG001|COMPLETED|Phase IIa, Period 1||9||
48468202|NCT01569152|101481102|FG002|COMPLETED|Phase IIa, Period 1||0||
48468203|NCT01569152|101481100|FG000|NOT COMPLETED|Phase IIa, Period 1||21||
48468204|NCT01569152|101481101|FG001|NOT COMPLETED|Phase IIa, Period 1||32||
48468205|NCT01569152|101481102|FG002|NOT COMPLETED|Phase IIa, Period 1||0||
48468206|NCT01569152|101481100|FG000|STARTED|Safety Extension, Period 3||0||
48468207|NCT01569152|101481101|FG001|STARTED|Safety Extension, Period 3||0||
48468208|NCT01569152|101481102|FG002|STARTED|Safety Extension, Period 3||55||
48468209|NCT01569152|101481100|FG000|COMPLETED|Safety Extension, Period 3||0||
48468210|NCT01569152|101481101|FG001|COMPLETED|Safety Extension, Period 3||0||
48468211|NCT01569152|101481102|FG002|COMPLETED|Safety Extension, Period 3||0||
48468212|NCT01569152|101481100|FG000|NOT COMPLETED|Safety Extension, Period 3||0||
48468213|NCT01569152|101481101|FG001|NOT COMPLETED|Safety Extension, Period 3||0||
48665976|NCT01313676|101967462|FG003|NOT COMPLETED|Overall Study||994||
48189941|NCT00367237|100788970|FG000|NOT COMPLETED|Overall Study||10||
48468214|NCT01569152|101481102|FG002|NOT COMPLETED|Safety Extension, Period 3||55||
48468215|NCT02277769|101481103|FG000|STARTED|Overall Study||236||
48468216|NCT02277769|101481104|FG001|STARTED|Overall Study||233||
48468217|NCT02277769|101481105|FG002|STARTED|Overall Study||239||
48468218|NCT02277769|101481103|FG000|Treated|Overall Study||235||
48468219|NCT02277769|101481104|FG001|Treated|Overall Study||233||
48468220|NCT02277769|101481105|FG002|Treated|Overall Study||239||
48468221|NCT02277769|101481103|FG000|Safety Population|Overall Study||234||
48468222|NCT02277769|101481104|FG001|Safety Population|Overall Study||236||
48468223|NCT02277769|101481105|FG002|Safety Population|Overall Study||237||
48468224|NCT02277769|101481103|FG000|COMPLETED|Overall Study||190||
48468225|NCT02277769|101481104|FG001|COMPLETED|Overall Study||220||
48468226|NCT02277769|101481105|FG002|COMPLETED|Overall Study||221||
48468227|NCT02277769|101481103|FG000|NOT COMPLETED|Overall Study||46||
48468228|NCT02277769|101481104|FG001|NOT COMPLETED|Overall Study||13||
48468229|NCT02277769|101481105|FG002|NOT COMPLETED|Overall Study||18||
48468230|NCT00506909|101481106|FG000|STARTED|Overall Study||0||
48468231|NCT00506909|101481106|FG000|COMPLETED|Overall Study||0||
48468232|NCT00506909|101481106|FG000|NOT COMPLETED|Overall Study||0||
48468233|NCT01059500|101481107|FG000|STARTED|Overall Study||264||
48468234|NCT01059500|101481108|FG001|STARTED|Overall Study||277||
48468235|NCT01059500|101481107|FG000|COMPLETED|Overall Study||264||
48468236|NCT01059500|101481108|FG001|COMPLETED|Overall Study||277||
48468237|NCT01059500|101481107|FG000|NOT COMPLETED|Overall Study||0||
48468238|NCT01059500|101481108|FG001|NOT COMPLETED|Overall Study||0||
48468239|NCT01908127|101481109|FG000|STARTED|Overall Study||23||
48468240|NCT01908127|101481110|FG001|STARTED|Overall Study||23||
48468241|NCT01908127|101481109|FG000|COMPLETED|Overall Study||22||
48468242|NCT01908127|101481110|FG001|COMPLETED|Overall Study||23||
48468243|NCT01908127|101481109|FG000|NOT COMPLETED|Overall Study||1||
48468244|NCT01908127|101481110|FG001|NOT COMPLETED|Overall Study||0||
48468245|NCT01096290|101481111|FG000|STARTED|Overall Study||9||
48468246|NCT01096290|101481112|FG001|STARTED|Overall Study||14||
48468247|NCT01096290|101481111|FG000|COMPLETED|Overall Study||9||
48468248|NCT01096290|101481112|FG001|COMPLETED|Overall Study||14||
48468249|NCT01096290|101481111|FG000|NOT COMPLETED|Overall Study||0||
48189942|NCT00367237|100788971|FG001|NOT COMPLETED|Overall Study||11||
48468250|NCT01096290|101481112|FG001|NOT COMPLETED|Overall Study||0||
48468251|NCT02343120|101481113|FG000|STARTED|Part 1: Dose Escalation||3||
48468252|NCT02343120|101481114|FG001|STARTED|Part 1: Dose Escalation||4||
48468253|NCT02343120|101481115|FG002|STARTED|Part 1: Dose Escalation||5||
48468254|NCT02343120|101481116|FG003|STARTED|Part 1: Dose Escalation||4||
48468255|NCT02343120|101481117|FG004|STARTED|Part 1: Dose Escalation||1||
48468256|NCT02343120|101481113|FG000|COMPLETED|Part 1: Dose Escalation||0||
48468257|NCT02343120|101481114|FG001|COMPLETED|Part 1: Dose Escalation||0||
48468258|NCT02343120|101481115|FG002|COMPLETED|Part 1: Dose Escalation||0||
48468259|NCT02343120|101481116|FG003|COMPLETED|Part 1: Dose Escalation||0||
48468260|NCT02343120|101481117|FG004|COMPLETED|Part 1: Dose Escalation||0||
48665977|NCT00480532|101967463|FG000|STARTED|Overall Study||33||
48468261|NCT02343120|101481113|FG000|NOT COMPLETED|Part 1: Dose Escalation||3||
48468262|NCT02343120|101481114|FG001|NOT COMPLETED|Part 1: Dose Escalation||4||
48468263|NCT02343120|101481115|FG002|NOT COMPLETED|Part 1: Dose Escalation||5||
48468264|NCT02343120|101481116|FG003|NOT COMPLETED|Part 1: Dose Escalation||4||
48468265|NCT02343120|101481117|FG004|NOT COMPLETED|Part 1: Dose Escalation||1||
48468266|NCT02343120|101481113|FG000|STARTED|Part 2: Expansion||0||
48468267|NCT02343120|101481114|FG001|STARTED|Part 2: Expansion||0||
48468268|NCT02343120|101481115|FG002|STARTED|Part 2: Expansion||0||
48468269|NCT02343120|101481116|FG003|STARTED|Part 2: Expansion||274||
48468270|NCT02343120|101481117|FG004|STARTED|Part 2: Expansion||94||
48468271|NCT02343120|101481113|FG000|COMPLETED|Part 2: Expansion||0||
48468272|NCT02343120|101481114|FG001|COMPLETED|Part 2: Expansion||0||
48468273|NCT02343120|101481115|FG002|COMPLETED|Part 2: Expansion||0||
48468274|NCT02343120|101481116|FG003|COMPLETED|Part 2: Expansion||0||
48665978|NCT00480532|101967464|FG001|STARTED|Overall Study||33||
48468275|NCT02343120|101481117|FG004|COMPLETED|Part 2: Expansion||0||
48468276|NCT02343120|101481113|FG000|NOT COMPLETED|Part 2: Expansion||0||
48468277|NCT02343120|101481114|FG001|NOT COMPLETED|Part 2: Expansion||0||
48468278|NCT02343120|101481115|FG002|NOT COMPLETED|Part 2: Expansion||0||
48468279|NCT02343120|101481116|FG003|NOT COMPLETED|Part 2: Expansion||274||
48468280|NCT02343120|101481117|FG004|NOT COMPLETED|Part 2: Expansion||94||
48468281|NCT01531205|101481118|FG000|STARTED|Overall Study||2||
48468282|NCT01531205|101481118|FG000|COMPLETED|Overall Study||1||
48468283|NCT01531205|101481118|FG000|NOT COMPLETED|Overall Study||1||
48468284|NCT02928848|101481119|FG000|STARTED|Arm 1||9||
48468285|NCT02928848|101481120|FG001|STARTED|Arm 1||7||
48468286|NCT02928848|101481119|FG000|COMPLETED|Arm 1||9||
48468287|NCT02928848|101481120|FG001|COMPLETED|Arm 1||6||
48468288|NCT02928848|101481119|FG000|NOT COMPLETED|Arm 1||0||
48468289|NCT02928848|101481120|FG001|NOT COMPLETED|Arm 1||1||
48468290|NCT02928848|101481119|FG000|STARTED|Arm 2||9||
48468291|NCT02928848|101481120|FG001|STARTED|Arm 2||6||
48468292|NCT02928848|101481119|FG000|COMPLETED|Arm 2||8||
48468293|NCT02928848|101481120|FG001|COMPLETED|Arm 2||6||
48468294|NCT02928848|101481119|FG000|NOT COMPLETED|Arm 2||1||
48468295|NCT02928848|101481120|FG001|NOT COMPLETED|Arm 2||0||
48468296|NCT00764309|101481121|FG000|STARTED|Overall Study||31||
48468297|NCT00764309|101481121|FG000|COMPLETED|Overall Study||31||
48468298|NCT00764309|101481121|FG000|NOT COMPLETED|Overall Study||0||
48468299|NCT02623959|101481122|FG000|STARTED|Overall Study||0||
48468300|NCT02623959|101481123|FG001|STARTED|Overall Study||1||
48468301|NCT02623959|101481122|FG000|COMPLETED|Overall Study||0||
48468302|NCT02623959|101481123|FG001|COMPLETED|Overall Study||0||
48468303|NCT02623959|101481122|FG000|NOT COMPLETED|Overall Study||0||
48468304|NCT02623959|101481123|FG001|NOT COMPLETED|Overall Study||1||
48468305|NCT01298570|101481124|FG000|STARTED|Overall Study||120||
48468306|NCT01298570|101481125|FG001|STARTED|Overall Study||61||
48468307|NCT01298570|101481124|FG000|COMPLETED|Overall Study||0|Patients treated until progression|
48468308|NCT01298570|101481125|FG001|COMPLETED|Overall Study||0|Patients treated until progression|
48468309|NCT01298570|101481124|FG000|NOT COMPLETED|Overall Study||120||
48468310|NCT01298570|101481125|FG001|NOT COMPLETED|Overall Study||61||
48468311|NCT03587207|101481126|FG000|STARTED|Overall Study||100||
48468312|NCT03587207|101481127|FG001|STARTED|Overall Study||104||
48468313|NCT03587207|101481128|FG002|STARTED|Overall Study||100||
48468314|NCT03587207|101481129|FG003|STARTED|Overall Study||94||
48468315|NCT03587207|101481130|FG004|STARTED|Overall Study||102||
48468316|NCT03587207|101481126|FG000|COMPLETED|Overall Study||100||
48468317|NCT03587207|101481127|FG001|COMPLETED|Overall Study||104||
48468318|NCT03587207|101481128|FG002|COMPLETED|Overall Study||100||
48468319|NCT03587207|101481129|FG003|COMPLETED|Overall Study||94||
48468320|NCT03587207|101481130|FG004|COMPLETED|Overall Study||102||
48468321|NCT03587207|101481126|FG000|NOT COMPLETED|Overall Study||0||
48468322|NCT03587207|101481127|FG001|NOT COMPLETED|Overall Study||0||
48468323|NCT03587207|101481128|FG002|NOT COMPLETED|Overall Study||0||
48468324|NCT03587207|101481129|FG003|NOT COMPLETED|Overall Study||0||
48468325|NCT03587207|101481130|FG004|NOT COMPLETED|Overall Study||0||
48468326|NCT02801877|101481131|FG000|STARTED|Overall Study||74||
48468327|NCT02801877|101481132|FG001|STARTED|Overall Study||75||
48468328|NCT02801877|101481133|FG002|STARTED|Overall Study||76||
48468329|NCT02801877|101481134|FG003|STARTED|Overall Study||76||
48468330|NCT02801877|101481131|FG000|COMPLETED|Overall Study||71||
48468331|NCT02801877|101481132|FG001|COMPLETED|Overall Study||74||
48468332|NCT02801877|101481133|FG002|COMPLETED|Overall Study||70||
48468333|NCT02801877|101481134|FG003|COMPLETED|Overall Study||76||
48468334|NCT02801877|101481131|FG000|NOT COMPLETED|Overall Study||3||
48468335|NCT02801877|101481132|FG001|NOT COMPLETED|Overall Study||1||
48468336|NCT02801877|101481133|FG002|NOT COMPLETED|Overall Study||6||
48189943|NCT04758403|100788972|FG000|STARTED|Overall Study||10||
48468337|NCT02801877|101481134|FG003|NOT COMPLETED|Overall Study||0||
48468338|NCT04582396|101481135|FG000|STARTED|Overall Study||0||
48468339|NCT04582396|101481136|FG001|STARTED|Overall Study||1||
48468340|NCT04582396|101481135|FG000|COMPLETED|Overall Study||0||
48468341|NCT04582396|101481136|FG001|COMPLETED|Overall Study||1||
48468342|NCT04582396|101481135|FG000|NOT COMPLETED|Overall Study||0||
48468343|NCT04582396|101481136|FG001|NOT COMPLETED|Overall Study||0||
48468344|NCT00100165|101481137|FG000|STARTED|Baseline||10||
48468345|NCT00100165|101481138|FG001|STARTED|Baseline||10||
48468346|NCT00100165|101481139|FG002|STARTED|Baseline||9||
48468347|NCT00100165|101481137|FG000|COMPLETED|Baseline||10||
48468348|NCT00100165|101481138|FG001|COMPLETED|Baseline||10||
48468349|NCT00100165|101481139|FG002|COMPLETED|Baseline||9||
48468350|NCT00100165|101481137|FG000|NOT COMPLETED|Baseline||0||
48468351|NCT00100165|101481138|FG001|NOT COMPLETED|Baseline||0||
48468352|NCT00100165|101481139|FG002|NOT COMPLETED|Baseline||0||
48468353|NCT00100165|101481137|FG000|STARTED|First Intervention (4 Weeks)||10||
48468354|NCT00100165|101481138|FG001|STARTED|First Intervention (4 Weeks)||10||
48468355|NCT00100165|101481139|FG002|STARTED|First Intervention (4 Weeks)||9||
48468356|NCT00100165|101481137|FG000|COMPLETED|First Intervention (4 Weeks)||10||
48468357|NCT00100165|101481138|FG001|COMPLETED|First Intervention (4 Weeks)||10||
48468358|NCT00100165|101481139|FG002|COMPLETED|First Intervention (4 Weeks)||9||
48468359|NCT00100165|101481137|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0||
48468360|NCT00100165|101481138|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0||
48468361|NCT00100165|101481139|FG002|NOT COMPLETED|First Intervention (4 Weeks)||0||
48468362|NCT00100165|101481137|FG000|STARTED|Washout (1 Week)||10||
48468363|NCT00100165|101481138|FG001|STARTED|Washout (1 Week)||10||
48468364|NCT00100165|101481139|FG002|STARTED|Washout (1 Week)||9||
48468365|NCT00100165|101481137|FG000|COMPLETED|Washout (1 Week)||10||
48468366|NCT00100165|101481138|FG001|COMPLETED|Washout (1 Week)||10||
48468367|NCT00100165|101481139|FG002|COMPLETED|Washout (1 Week)||9||
48468368|NCT00100165|101481137|FG000|NOT COMPLETED|Washout (1 Week)||0||
48468369|NCT00100165|101481138|FG001|NOT COMPLETED|Washout (1 Week)||0||
48468370|NCT00100165|101481139|FG002|NOT COMPLETED|Washout (1 Week)||0||
48468371|NCT00100165|101481137|FG000|STARTED|Second Intervention (4 Weeks)||10||
48468372|NCT00100165|101481138|FG001|STARTED|Second Intervention (4 Weeks)||10||
48468373|NCT00100165|101481139|FG002|STARTED|Second Intervention (4 Weeks)||9||
48665979|NCT00480532|101967465|FG002|STARTED|Overall Study||33||
48468374|NCT00100165|101481137|FG000|COMPLETED|Second Intervention (4 Weeks)||10||
48468375|NCT00100165|101481138|FG001|COMPLETED|Second Intervention (4 Weeks)||10||
48468376|NCT00100165|101481139|FG002|COMPLETED|Second Intervention (4 Weeks)||9||
48468377|NCT00100165|101481137|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0||
48468378|NCT00100165|101481138|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0||
48468379|NCT00100165|101481139|FG002|NOT COMPLETED|Second Intervention (4 Weeks)||0||
48468380|NCT00100165|101481137|FG000|STARTED|Washout (1 Week)||10||
48468381|NCT00100165|101481138|FG001|STARTED|Washout (1 Week)||10||
48468382|NCT00100165|101481139|FG002|STARTED|Washout (1 Week)||9||
48468383|NCT00100165|101481137|FG000|COMPLETED|Washout (1 Week)||10||
48468384|NCT00100165|101481138|FG001|COMPLETED|Washout (1 Week)||10||
48468385|NCT00100165|101481139|FG002|COMPLETED|Washout (1 Week)||9||
48468386|NCT00100165|101481137|FG000|NOT COMPLETED|Washout (1 Week)||0||
48468387|NCT00100165|101481138|FG001|NOT COMPLETED|Washout (1 Week)||0||
48468388|NCT00100165|101481139|FG002|NOT COMPLETED|Washout (1 Week)||0||
48468389|NCT00100165|101481137|FG000|STARTED|Third Intervention (4 Weeks)||10||
48468390|NCT00100165|101481138|FG001|STARTED|Third Intervention (4 Weeks)||10||
48468391|NCT00100165|101481139|FG002|STARTED|Third Intervention (4 Weeks)||9||
48468392|NCT00100165|101481137|FG000|COMPLETED|Third Intervention (4 Weeks)||10||
48468393|NCT00100165|101481138|FG001|COMPLETED|Third Intervention (4 Weeks)||10||
48468394|NCT00100165|101481139|FG002|COMPLETED|Third Intervention (4 Weeks)||9||
48468395|NCT00100165|101481137|FG000|NOT COMPLETED|Third Intervention (4 Weeks)||0||
48468396|NCT00100165|101481138|FG001|NOT COMPLETED|Third Intervention (4 Weeks)||0||
48468397|NCT00100165|101481139|FG002|NOT COMPLETED|Third Intervention (4 Weeks)||0||
48468398|NCT03335371|101481140|FG000|STARTED|Overall Study||5||
48468399|NCT03335371|101481141|FG001|STARTED|Overall Study||9||
48468400|NCT03335371|101481142|FG002|STARTED|Overall Study||11||
48468401|NCT03335371|101481143|FG003|STARTED|Overall Study||40||
48468402|NCT03335371|101481144|FG004|STARTED|Overall Study||45||
48468403|NCT03335371|101481140|FG000|COMPLETED|Overall Study||5||
48468404|NCT03335371|101481141|FG001|COMPLETED|Overall Study||9||
48468405|NCT03335371|101481142|FG002|COMPLETED|Overall Study||10||
48189944|NCT04758403|100788973|FG001|STARTED|Overall Study||10||
48468406|NCT03335371|101481143|FG003|COMPLETED|Overall Study||40||
48468407|NCT03335371|101481144|FG004|COMPLETED|Overall Study||43||
48468408|NCT03335371|101481140|FG000|NOT COMPLETED|Overall Study||0||
48468409|NCT03335371|101481141|FG001|NOT COMPLETED|Overall Study||0||
48468410|NCT03335371|101481142|FG002|NOT COMPLETED|Overall Study||1||
48468411|NCT03335371|101481143|FG003|NOT COMPLETED|Overall Study||0||
48468412|NCT03335371|101481144|FG004|NOT COMPLETED|Overall Study||2||
48468413|NCT00602030|101481145|FG000|STARTED|Lead-in Phase||3||
48468414|NCT00602030|101481146|FG001|STARTED|Lead-in Phase||6||
48468415|NCT00602030|101481147|FG002|STARTED|Lead-in Phase||0||
48468416|NCT00602030|101481148|FG003|STARTED|Lead-in Phase||0||
48468417|NCT00602030|101481149|FG004|STARTED|Lead-in Phase||0||
48468418|NCT00602030|101481145|FG000|COMPLETED|Lead-in Phase||1||
48468419|NCT00602030|101481146|FG001|COMPLETED|Lead-in Phase||1||
48468420|NCT00602030|101481147|FG002|COMPLETED|Lead-in Phase||0||
48468421|NCT00602030|101481148|FG003|COMPLETED|Lead-in Phase||0||
48468422|NCT00602030|101481149|FG004|COMPLETED|Lead-in Phase||0||
48468423|NCT00602030|101481145|FG000|NOT COMPLETED|Lead-in Phase||2||
48189945|NCT04758403|100788972|FG000|COMPLETED|Overall Study||10||
48468424|NCT00602030|101481146|FG001|NOT COMPLETED|Lead-in Phase||5||
48468425|NCT00602030|101481147|FG002|NOT COMPLETED|Lead-in Phase||0||
48468426|NCT00602030|101481148|FG003|NOT COMPLETED|Lead-in Phase||0||
48468427|NCT00602030|101481149|FG004|NOT COMPLETED|Lead-in Phase||0||
48468428|NCT00602030|101481145|FG000|STARTED|Double-blind Phase||0||
48468429|NCT00602030|101481146|FG001|STARTED|Double-blind Phase||0||
48468430|NCT00602030|101481147|FG002|STARTED|Double-blind Phase||65||
48468431|NCT00602030|101481148|FG003|STARTED|Double-blind Phase||67||
48468432|NCT00602030|101481149|FG004|STARTED|Double-blind Phase||0||
48468433|NCT00602030|101481145|FG000|Received Treatment|Double-blind Phase||0||
48468434|NCT00602030|101481146|FG001|Received Treatment|Double-blind Phase||0||
48468435|NCT00602030|101481147|FG002|Received Treatment|Double-blind Phase||63||
48468436|NCT00602030|101481148|FG003|Received Treatment|Double-blind Phase||65||
48468437|NCT00602030|101481149|FG004|Received Treatment|Double-blind Phase||0||
48468438|NCT00602030|101481145|FG000|COMPLETED|Double-blind Phase||0||
48468439|NCT00602030|101481146|FG001|COMPLETED|Double-blind Phase||0||
48468440|NCT00602030|101481147|FG002|COMPLETED|Double-blind Phase||11||
48468441|NCT00602030|101481148|FG003|COMPLETED|Double-blind Phase||8||
48468442|NCT00602030|101481149|FG004|COMPLETED|Double-blind Phase||0||
48468443|NCT00602030|101481145|FG000|NOT COMPLETED|Double-blind Phase||0||
48665980|NCT00480532|101967466|FG003|STARTED|Overall Study||32||
48665981|NCT00480532|101967463|FG000|COMPLETED|Overall Study||31||
48665982|NCT00480532|101967464|FG001|COMPLETED|Overall Study||29||
48665983|NCT00480532|101967465|FG002|COMPLETED|Overall Study||29||
48665984|NCT00480532|101967466|FG003|COMPLETED|Overall Study||31||
48665985|NCT00480532|101967463|FG000|NOT COMPLETED|Overall Study||2||
48665986|NCT00480532|101967464|FG001|NOT COMPLETED|Overall Study||4||
48665987|NCT00480532|101967465|FG002|NOT COMPLETED|Overall Study||4||
48665988|NCT00480532|101967466|FG003|NOT COMPLETED|Overall Study||1||
48665989|NCT02314923|101967467|FG000|STARTED|Overall Study||64||
48665990|NCT02314923|101967468|FG001|STARTED|Overall Study||64||
48665991|NCT02314923|101967469|FG002|STARTED|Overall Study||64||
48665992|NCT02314923|101967470|FG003|STARTED|Overall Study||64||
48665993|NCT02314923|101967471|FG004|STARTED|Overall Study||74||
48665994|NCT02314923|101967472|FG005|STARTED|Overall Study||20||
48665995|NCT02314923|101967473|FG006|STARTED|Overall Study||48||
48665996|NCT02314923|101967474|FG007|STARTED|Overall Study||47||
48468444|NCT00602030|101481146|FG001|NOT COMPLETED|Double-blind Phase||0||
48468445|NCT00602030|101481147|FG002|NOT COMPLETED|Double-blind Phase||54||
48468446|NCT00602030|101481148|FG003|NOT COMPLETED|Double-blind Phase||59||
48468447|NCT00602030|101481149|FG004|NOT COMPLETED|Double-blind Phase||0||
48468448|NCT00602030|101481145|FG000|STARTED|Crossover Phase||0||
48468449|NCT00602030|101481146|FG001|STARTED|Crossover Phase||0||
48468450|NCT00602030|101481147|FG002|STARTED|Crossover Phase||0||
48468451|NCT00602030|101481148|FG003|STARTED|Crossover Phase||0||
48468452|NCT00602030|101481149|FG004|STARTED|Crossover Phase||16||
48468453|NCT00602030|101481145|FG000|COMPLETED|Crossover Phase||0||
48468454|NCT00602030|101481146|FG001|COMPLETED|Crossover Phase||0||
48468455|NCT00602030|101481147|FG002|COMPLETED|Crossover Phase||0||
48468456|NCT00602030|101481148|FG003|COMPLETED|Crossover Phase||0||
48468457|NCT00602030|101481149|FG004|COMPLETED|Crossover Phase||0||
48468458|NCT00602030|101481145|FG000|NOT COMPLETED|Crossover Phase||0||
48468459|NCT00602030|101481146|FG001|NOT COMPLETED|Crossover Phase||0||
48468460|NCT00602030|101481147|FG002|NOT COMPLETED|Crossover Phase||0||
48468461|NCT00602030|101481148|FG003|NOT COMPLETED|Crossover Phase||0||
48468462|NCT00602030|101481149|FG004|NOT COMPLETED|Crossover Phase||16||
48468463|NCT00531206|101481150|FG000|STARTED|Overall Study||65||
48468464|NCT00531206|101481150|FG000|COMPLETED|Overall Study||45||
48468465|NCT00531206|101481150|FG000|NOT COMPLETED|Overall Study||20||
48468466|NCT01346852|101481151|FG000|STARTED|Overall Study||41753||
48468467|NCT01346852|101481152|FG001|STARTED|Overall Study||59684||
48468468|NCT01346852|101481151|FG000|COMPLETED|Overall Study||41753||
48468469|NCT01346852|101481152|FG001|COMPLETED|Overall Study||59684||
48468470|NCT01346852|101481151|FG000|NOT COMPLETED|Overall Study||0||
48468471|NCT01346852|101481152|FG001|NOT COMPLETED|Overall Study||0||
48468472|NCT01816477|101481153|FG000|STARTED|Overall Study||43||
48468473|NCT01816477|101481154|FG001|STARTED|Overall Study||42||
48468474|NCT01816477|101481153|FG000|COMPLETED|Overall Study||27||
48468475|NCT01816477|101481154|FG001|COMPLETED|Overall Study||41||
48468476|NCT01816477|101481153|FG000|NOT COMPLETED|Overall Study||16||
48468477|NCT01816477|101481154|FG001|NOT COMPLETED|Overall Study||1||
48468478|NCT00655642|101481155|FG000|STARTED|Overall Study||42||
48468479|NCT00655642|101481156|FG001|STARTED|Overall Study||43||
48468480|NCT00655642|101481157|FG002|STARTED|Overall Study||45||
48468481|NCT00655642|101481158|FG003|STARTED|Overall Study||41||
48468482|NCT00655642|101481155|FG000|COMPLETED|Overall Study||41||
48468483|NCT00655642|101481156|FG001|COMPLETED|Overall Study||40||
48468484|NCT00655642|101481157|FG002|COMPLETED|Overall Study||43||
48468485|NCT00655642|101481158|FG003|COMPLETED|Overall Study||39||
48468486|NCT00655642|101481155|FG000|NOT COMPLETED|Overall Study||1||
48468487|NCT00655642|101481156|FG001|NOT COMPLETED|Overall Study||3||
48468488|NCT00655642|101481157|FG002|NOT COMPLETED|Overall Study||2||
48468489|NCT00655642|101481158|FG003|NOT COMPLETED|Overall Study||2||
48468490|NCT02799602|101481159|FG000|STARTED|Overall Study||651|Randomized: 1306 patients were randomized. One patient was excluded from analysis due to a GCP violation|
48468491|NCT02799602|101481160|FG001|STARTED|Overall Study||654|Randomized: 1306 patients were randomized. One patient was excluded from analysis due to a GCP violation|
48468492|NCT02799602|101481159|FG000|Started Treatment|Overall Study||651||
48468493|NCT02799602|101481160|FG001|Started Treatment|Overall Study||651||
48468494|NCT02799602|101481159|FG000|COMPLETED|Overall Study||0|Ongoing with treatment|
48468495|NCT02799602|101481160|FG001|COMPLETED|Overall Study||0|Ongoing with treatment|
48468496|NCT02799602|101481159|FG000|NOT COMPLETED|Overall Study||651||
48468497|NCT02799602|101481160|FG001|NOT COMPLETED|Overall Study||654||
48468498|NCT00670956|101481161|FG000|STARTED|Overall Study||1||
48468499|NCT00670956|101481161|FG000|COMPLETED|Overall Study||1||
48468500|NCT00670956|101481161|FG000|NOT COMPLETED|Overall Study||0||
48468501|NCT00536575|101481162|FG000|STARTED|Overall Study||13||
48468502|NCT00536575|101481162|FG000|COMPLETED|Overall Study||11||
48468503|NCT00536575|101481162|FG000|NOT COMPLETED|Overall Study||2||
48468504|NCT04488575|101481163|FG000|STARTED|Overall Study||7||
48189946|NCT04758403|100788973|FG001|COMPLETED|Overall Study||10||
48468505|NCT04488575|101481164|FG001|STARTED|Overall Study||9||
48468506|NCT04488575|101481163|FG000|COMPLETED|Overall Study||7||
48468507|NCT04488575|101481164|FG001|COMPLETED|Overall Study||4||
48468508|NCT04488575|101481163|FG000|NOT COMPLETED|Overall Study||0||
48468509|NCT04488575|101481164|FG001|NOT COMPLETED|Overall Study||5||
48468510|NCT00198081|101481165|FG000|STARTED|Overall Study||5||
48468511|NCT00198081|101481166|FG001|STARTED|Overall Study||0||
48468512|NCT00198081|101481165|FG000|COMPLETED|Overall Study||4||
48468513|NCT00198081|101481166|FG001|COMPLETED|Overall Study||0||
48468514|NCT00198081|101481165|FG000|NOT COMPLETED|Overall Study||1||
48468515|NCT00198081|101481166|FG001|NOT COMPLETED|Overall Study||0||
48468516|NCT03870997|101481167|FG000|STARTED|Overall Study||15702||
48468517|NCT03870997|101481168|FG001|STARTED|Overall Study||15702||
48468518|NCT03870997|101481169|FG002|STARTED|Overall Study||15756||
48468519|NCT03870997|101481170|FG003|STARTED|Overall Study||15757||
48468520|NCT03870997|101481171|FG004|STARTED|Overall Study||15702||
48468521|NCT03870997|101481172|FG005|STARTED|Overall Study||15702||
48468522|NCT03870997|101481167|FG000|COMPLETED|Overall Study||5158||
48468523|NCT03870997|101481168|FG001|COMPLETED|Overall Study||5271||
48468524|NCT03870997|101481169|FG002|COMPLETED|Overall Study||4778||
48468525|NCT03870997|101481170|FG003|COMPLETED|Overall Study||4810||
48468526|NCT03870997|101481171|FG004|COMPLETED|Overall Study||5114||
48468527|NCT03870997|101481172|FG005|COMPLETED|Overall Study||5171||
48468528|NCT03870997|101481167|FG000|NOT COMPLETED|Overall Study||10544||
48468529|NCT03870997|101481168|FG001|NOT COMPLETED|Overall Study||10431||
48468530|NCT03870997|101481169|FG002|NOT COMPLETED|Overall Study||10978||
48468531|NCT03870997|101481170|FG003|NOT COMPLETED|Overall Study||10947||
48468532|NCT03870997|101481171|FG004|NOT COMPLETED|Overall Study||10588||
48468533|NCT03870997|101481172|FG005|NOT COMPLETED|Overall Study||10531||
48468534|NCT01141725|101481173|FG000|STARTED|Overall Study||3||
48468535|NCT01141725|101481174|FG001|STARTED|Overall Study||33||
48468536|NCT01141725|101481175|FG002|STARTED|Overall Study||3||
48468537|NCT01141725|101481173|FG000|COMPLETED|Overall Study||3||
48468538|NCT01141725|101481174|FG001|COMPLETED|Overall Study||33||
48468539|NCT01141725|101481175|FG002|COMPLETED|Overall Study||3||
48468540|NCT01141725|101481173|FG000|NOT COMPLETED|Overall Study||0||
48468541|NCT01141725|101481174|FG001|NOT COMPLETED|Overall Study||0||
48665997|NCT02314923|101967475|FG008|STARTED|Overall Study||48||
48665998|NCT02314923|101967476|FG009|STARTED|Overall Study||20||
48468542|NCT01141725|101481175|FG002|NOT COMPLETED|Overall Study||0||
48468543|NCT02672553|101481176|FG000|STARTED|Overall Study||51||
48468544|NCT02672553|101481177|FG001|STARTED|Overall Study||49||
48468545|NCT02672553|101481176|FG000|Intent To Treated (ITT) Randomized Arm|Overall Study||49|Intent to treat (ITT) is defined as the initial treatment assignment.|
48468546|NCT02672553|101481177|FG001|Intent To Treated (ITT) Randomized Arm|Overall Study||48|Intent to treat (ITT) is defined as the initial treatment assignment.|
48468547|NCT02672553|101481176|FG000|As Treated (AT) Randomized Arm/Group|Overall Study||46||
48468548|NCT02672553|101481177|FG001|As Treated (AT) Randomized Arm/Group|Overall Study||51||
48468549|NCT02672553|101481176|FG000|As Intended (AI) Randomized Arm/Group|Overall Study||46|As intended (AI) excluded the three INTUITY subjects converted to control group from analysis.|
48468550|NCT02672553|101481177|FG001|As Intended (AI) Randomized Arm/Group|Overall Study||48|As intended (AI) excluded the three INTUITY subjects converted to control group from analysis.|
48468551|NCT02672553|101481176|FG000|COMPLETED|Overall Study||39||
48468552|NCT02672553|101481177|FG001|COMPLETED|Overall Study||41||
48468553|NCT02672553|101481176|FG000|NOT COMPLETED|Overall Study||12||
48468554|NCT02672553|101481177|FG001|NOT COMPLETED|Overall Study||8||
48468555|NCT02337465|101481178|FG000|STARTED|Overall Study||30||
48468556|NCT02337465|101481178|FG000|COMPLETED|Overall Study||30||
48468557|NCT02337465|101481178|FG000|NOT COMPLETED|Overall Study||0||
48468558|NCT04068142|101481179|FG000|STARTED|Overall Study||17||
48468559|NCT04068142|101481180|FG001|STARTED|Overall Study||20||
48468560|NCT04068142|101481179|FG000|COMPLETED|Overall Study||15||
48468561|NCT04068142|101481180|FG001|COMPLETED|Overall Study||16||
48468562|NCT04068142|101481179|FG000|NOT COMPLETED|Overall Study||2||
48468563|NCT04068142|101481180|FG001|NOT COMPLETED|Overall Study||4||
48468564|NCT03532009|101481181|FG000|STARTED|Overall Study||92||
48468565|NCT03532009|101481182|FG001|STARTED|Overall Study||90||
48468566|NCT03532009|101481181|FG000|Received Treatment|Overall Study||91||
48468567|NCT03532009|101481182|FG001|Received Treatment|Overall Study||90||
48468568|NCT03532009|101481181|FG000|COMPLETED|Overall Study||90||
48468569|NCT03532009|101481182|FG001|COMPLETED|Overall Study||86||
48468570|NCT03532009|101481181|FG000|NOT COMPLETED|Overall Study||2||
48468571|NCT03532009|101481182|FG001|NOT COMPLETED|Overall Study||4||
48468572|NCT02405195|101481183|FG000|STARTED|Overall Study||18||
48468573|NCT02405195|101481183|FG000|COMPLETED|Overall Study||18||
48468574|NCT02405195|101481183|FG000|NOT COMPLETED|Overall Study||0||
48468575|NCT00376220|101484427|FG000|STARTED|Overall Study||47||
48468576|NCT00376220|101484428|FG001|STARTED|Overall Study||47||
48468577|NCT00376220|101484427|FG000|COMPLETED|Overall Study||37||
48468578|NCT00376220|101484428|FG001|COMPLETED|Overall Study||35||
48468579|NCT00376220|101484427|FG000|NOT COMPLETED|Overall Study||10||
48468580|NCT00376220|101484428|FG001|NOT COMPLETED|Overall Study||12||
48468581|NCT03457909|101484429|FG000|STARTED|Overall Study||25||
48468582|NCT03457909|101484429|FG000|COMPLETED|Overall Study||25||
48468583|NCT03457909|101484429|FG000|NOT COMPLETED|Overall Study||0||
48468584|NCT00963157|101484430|FG000|STARTED|Overall Study||156||
48468585|NCT00963157|101484431|FG001|STARTED|Overall Study||163||
48468586|NCT00963157|101484432|FG002|STARTED|Overall Study||160||
48468587|NCT00963157|101484433|FG003|STARTED|Overall Study||157||
48468588|NCT00963157|101484434|FG004|STARTED|Overall Study||153||
48468589|NCT00963157|101484430|FG000|COMPLETED|Overall Study||151||
48468590|NCT00963157|101484431|FG001|COMPLETED|Overall Study||159||
48468591|NCT00963157|101484432|FG002|COMPLETED|Overall Study||155||
48468592|NCT00963157|101484433|FG003|COMPLETED|Overall Study||150||
48468593|NCT00963157|101484434|FG004|COMPLETED|Overall Study||151||
48468594|NCT00963157|101484430|FG000|NOT COMPLETED|Overall Study||5||
48468595|NCT00963157|101484431|FG001|NOT COMPLETED|Overall Study||4||
48468596|NCT00963157|101484432|FG002|NOT COMPLETED|Overall Study||5||
48468597|NCT00963157|101484433|FG003|NOT COMPLETED|Overall Study||7||
48468598|NCT00963157|101484434|FG004|NOT COMPLETED|Overall Study||2||
48468599|NCT00989261|101484435|FG000|STARTED|Overall Study||157||
48468600|NCT00989261|101484436|FG001|STARTED|Overall Study||176||
48468601|NCT00989261|101484435|FG000|COMPLETED|Overall Study||142||
48468602|NCT00989261|101484436|FG001|COMPLETED|Overall Study||154||
48468603|NCT00989261|101484435|FG000|NOT COMPLETED|Overall Study||15||
48468604|NCT00989261|101484436|FG001|NOT COMPLETED|Overall Study||22||
48468605|NCT03464136|101484437|FG000|STARTED|Overall Study||195||
48468606|NCT03464136|101484438|FG001|STARTED|Overall Study||191||
48468607|NCT03464136|101484437|FG000|COMPLETED|Overall Study||165||
48468608|NCT03464136|101484438|FG001|COMPLETED|Overall Study||166||
48468609|NCT03464136|101484437|FG000|NOT COMPLETED|Overall Study||30||
48468610|NCT03464136|101484438|FG001|NOT COMPLETED|Overall Study||25||
48468611|NCT02247479|101484439|FG000|STARTED|Overall Study||305||
48468612|NCT02247479|101484440|FG001|STARTED|Overall Study||298||
48468613|NCT02247479|101484441|FG002|STARTED|Overall Study||303||
48468614|NCT02247479|101484439|FG000|COMPLETED|Overall Study||163||
48468615|NCT02247479|101484440|FG001|COMPLETED|Overall Study||160||
48468616|NCT02247479|101484441|FG002|COMPLETED|Overall Study||165||
48468617|NCT02247479|101484439|FG000|NOT COMPLETED|Overall Study||142||
48468618|NCT02247479|101484440|FG001|NOT COMPLETED|Overall Study||138||
48468619|NCT02247479|101484441|FG002|NOT COMPLETED|Overall Study||138||
48468620|NCT01699607|101484442|FG000|STARTED|Overall Study||6||
48468621|NCT01699607|101484443|FG001|STARTED|Overall Study||4||
48468622|NCT01699607|101484442|FG000|COMPLETED|Overall Study||6||
48468623|NCT01699607|101484443|FG001|COMPLETED|Overall Study||4||
48468624|NCT01699607|101484442|FG000|NOT COMPLETED|Overall Study||0||
48468625|NCT01699607|101484443|FG001|NOT COMPLETED|Overall Study||0||
48468626|NCT02773836|101484444|FG000|STARTED|Wave 1- Pre-TPD Implementation||1000||
48468627|NCT02773836|101484445|FG001|STARTED|Wave 1- Pre-TPD Implementation||1003||
48468628|NCT02773836|101484446|FG002|STARTED|Wave 1- Pre-TPD Implementation||1001||
48468629|NCT02773836|101484447|FG003|STARTED|Wave 1- Pre-TPD Implementation||1001||
48468630|NCT02773836|101484448|FG004|STARTED|Wave 1- Pre-TPD Implementation||1000||
48468631|NCT02773836|101484449|FG005|STARTED|Wave 1- Pre-TPD Implementation||1006||
48468632|NCT02773836|101484444|FG000|COMPLETED|Wave 1- Pre-TPD Implementation||1000||
48468633|NCT02773836|101484445|FG001|COMPLETED|Wave 1- Pre-TPD Implementation||1003||
48468634|NCT02773836|101484446|FG002|COMPLETED|Wave 1- Pre-TPD Implementation||1001||
48468635|NCT02773836|101484447|FG003|COMPLETED|Wave 1- Pre-TPD Implementation||1001||
48468636|NCT02773836|101484448|FG004|COMPLETED|Wave 1- Pre-TPD Implementation||1000||
48468637|NCT02773836|101484449|FG005|COMPLETED|Wave 1- Pre-TPD Implementation||1006||
48468638|NCT02773836|101484444|FG000|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0||
48468639|NCT02773836|101484445|FG001|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0||
48468640|NCT02773836|101484446|FG002|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0||
48468641|NCT02773836|101484447|FG003|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0||
48468642|NCT02773836|101484448|FG004|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0||
48468643|NCT02773836|101484449|FG005|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0||
48468644|NCT02773836|101484444|FG000|STARTED|Wave 2- Post-TPD Implementation||1010|The reason there are more participants in Period 2 is because a replenishment sample was also used|
48468645|NCT02773836|101484445|FG001|STARTED|Wave 2- Post-TPD Implementation||1013|The reason there are more participants in Period 2 is because a replenishment sample was also used|
48468646|NCT02773836|101484446|FG002|STARTED|Wave 2- Post-TPD Implementation||1003|The reason there are more participants in Period 2 is because a replenishment sample was also used|
48468647|NCT02773836|101484447|FG003|STARTED|Wave 2- Post-TPD Implementation||1010|The reason there are more participants in Period 2 is because a replenishment sample was also used|
48468648|NCT02773836|101484448|FG004|STARTED|Wave 2- Post-TPD Implementation||1002|The reason there are more participants in Period 2 is because a replenishment sample was also used|
48468649|NCT02773836|101484449|FG005|STARTED|Wave 2- Post-TPD Implementation||998|The reason there are more participants in Period 2 is because a replenishment sample was also used|
48468650|NCT02773836|101484444|FG000|COMPLETED|Wave 2- Post-TPD Implementation||1010||
48468651|NCT02773836|101484445|FG001|COMPLETED|Wave 2- Post-TPD Implementation||1013||
48468652|NCT02773836|101484446|FG002|COMPLETED|Wave 2- Post-TPD Implementation||1003||
48468653|NCT02773836|101484447|FG003|COMPLETED|Wave 2- Post-TPD Implementation||1010||
48468654|NCT02773836|101484448|FG004|COMPLETED|Wave 2- Post-TPD Implementation||1002||
48468655|NCT02773836|101484449|FG005|COMPLETED|Wave 2- Post-TPD Implementation||998||
48468656|NCT02773836|101484444|FG000|NOT COMPLETED|Wave 2- Post-TPD Implementation||0||
48468657|NCT02773836|101484445|FG001|NOT COMPLETED|Wave 2- Post-TPD Implementation||0||
48468658|NCT02773836|101484446|FG002|NOT COMPLETED|Wave 2- Post-TPD Implementation||0||
48468659|NCT02773836|101484447|FG003|NOT COMPLETED|Wave 2- Post-TPD Implementation||0||
48468660|NCT02773836|101484448|FG004|NOT COMPLETED|Wave 2- Post-TPD Implementation||0||
48468661|NCT02773836|101484449|FG005|NOT COMPLETED|Wave 2- Post-TPD Implementation||0||
48468662|NCT01361126|101484450|FG000|STARTED|Overall Study||13||
48468663|NCT01361126|101484451|FG001|STARTED|Overall Study||4||
48468664|NCT01361126|101484450|FG000|COMPLETED|Overall Study||13||
48468665|NCT01361126|101484451|FG001|COMPLETED|Overall Study||2||
48468666|NCT01361126|101484450|FG000|NOT COMPLETED|Overall Study||0||
48468667|NCT01361126|101484451|FG001|NOT COMPLETED|Overall Study||2||
48468668|NCT02536378|101484452|FG000|STARTED|Overall Study||632||
48468669|NCT02536378|101484453|FG001|STARTED|Overall Study||60||
48468670|NCT02536378|101484452|FG000|COMPLETED|Overall Study||625||
48468671|NCT02536378|101484453|FG001|COMPLETED|Overall Study||53||
48468672|NCT02536378|101484452|FG000|NOT COMPLETED|Overall Study||7||
48468673|NCT02536378|101484453|FG001|NOT COMPLETED|Overall Study||7||
48468674|NCT00514137|101484454|FG000|STARTED|Overall Study||13||
48468675|NCT00514137|101484454|FG000|COMPLETED|Overall Study||13||
48468676|NCT00514137|101484454|FG000|NOT COMPLETED|Overall Study||0||
48468677|NCT00812253|101484455|FG000|STARTED|Overall Study||32||
48468678|NCT00812253|101484456|FG001|STARTED|Overall Study||42||
48468679|NCT00812253|101484455|FG000|COMPLETED|Overall Study||26||
48468680|NCT00812253|101484456|FG001|COMPLETED|Overall Study||39||
48468681|NCT00812253|101484455|FG000|NOT COMPLETED|Overall Study||6||
48468682|NCT00812253|101484456|FG001|NOT COMPLETED|Overall Study||3||
48468683|NCT03012477|101484457|FG000|STARTED|Overall Study||34||
48468684|NCT03012477|101484457|FG000|COMPLETED|Overall Study||34||
48468685|NCT03012477|101484457|FG000|NOT COMPLETED|Overall Study||0||
48468686|NCT03997448|101484458|FG000|STARTED|Study Treatment||3||
48468687|NCT03997448|101484458|FG000|COMPLETED|Study Treatment||1||
48468688|NCT03997448|101484458|FG000|NOT COMPLETED|Study Treatment||2||
48468689|NCT03997448|101484458|FG000|STARTED|Follow up||3||
48468690|NCT03997448|101484458|FG000|COMPLETED|Follow up||0||
48468691|NCT03997448|101484458|FG000|NOT COMPLETED|Follow up||3||
48468692|NCT01617577|101484459|FG000|STARTED|Overall Study||5||
48468693|NCT01617577|101484460|FG001|STARTED|Overall Study||3||
48468694|NCT01617577|101484459|FG000|COMPLETED|Overall Study||5||
48468695|NCT01617577|101484460|FG001|COMPLETED|Overall Study||3||
48468696|NCT01617577|101484459|FG000|NOT COMPLETED|Overall Study||0||
48468697|NCT01617577|101484460|FG001|NOT COMPLETED|Overall Study||0||
48468698|NCT00617461|101484461|FG000|STARTED|First Treatment Intervention Period||52||
48468699|NCT00617461|101484462|FG001|STARTED|First Treatment Intervention Period||44||
48468700|NCT00617461|101484461|FG000|COMPLETED|First Treatment Intervention Period||42||
48468701|NCT00617461|101484462|FG001|COMPLETED|First Treatment Intervention Period||41||
48468702|NCT00617461|101484461|FG000|NOT COMPLETED|First Treatment Intervention Period||10||
48468703|NCT00617461|101484462|FG001|NOT COMPLETED|First Treatment Intervention Period||3||
48468704|NCT00617461|101484461|FG000|STARTED|4-Day Crossover Period||42||
48468705|NCT00617461|101484462|FG001|STARTED|4-Day Crossover Period||40||
48468706|NCT00617461|101484461|FG000|COMPLETED|4-Day Crossover Period||41||
48468707|NCT00617461|101484462|FG001|COMPLETED|4-Day Crossover Period||40||
48468708|NCT00617461|101484461|FG000|NOT COMPLETED|4-Day Crossover Period||1||
48468709|NCT00617461|101484462|FG001|NOT COMPLETED|4-Day Crossover Period||0||
48468710|NCT00617461|101484461|FG000|STARTED|Second Treatment Intervention Period||41||
48468711|NCT00617461|101484462|FG001|STARTED|Second Treatment Intervention Period||41||
48468712|NCT00617461|101484461|FG000|COMPLETED|Second Treatment Intervention Period||41||
48468713|NCT00617461|101484462|FG001|COMPLETED|Second Treatment Intervention Period||37||
48468714|NCT00617461|101484461|FG000|NOT COMPLETED|Second Treatment Intervention Period||0||
48468715|NCT00617461|101484462|FG001|NOT COMPLETED|Second Treatment Intervention Period||4||
48468716|NCT00617461|101484461|FG000|STARTED|6-Day Down-Titration Period||41||
48468717|NCT00617461|101484462|FG001|STARTED|6-Day Down-Titration Period||37||
48468718|NCT00617461|101484461|FG000|COMPLETED|6-Day Down-Titration Period||39||
48468719|NCT00617461|101484462|FG001|COMPLETED|6-Day Down-Titration Period||35||
48468720|NCT00617461|101484461|FG000|NOT COMPLETED|6-Day Down-Titration Period||2||
48468721|NCT00617461|101484462|FG001|NOT COMPLETED|6-Day Down-Titration Period||2||
48468722|NCT03629925|101484463|FG000|STARTED|Overall Study||179||
48189947|NCT04758403|100788972|FG000|NOT COMPLETED|Overall Study||0||
48189948|NCT04758403|100788973|FG001|NOT COMPLETED|Overall Study||0||
48189949|NCT04411082|100788974|FG000|STARTED|Overall Study||29||
48189950|NCT04411082|100788975|FG001|STARTED|Overall Study||25||
48189951|NCT04411082|100788976|FG002|STARTED|Overall Study||20||
48189952|NCT04411082|100788977|FG003|STARTED|Overall Study||24||
48189953|NCT04411082|100788978|FG004|STARTED|Overall Study||12||
48189954|NCT04411082|100788979|FG005|STARTED|Overall Study||12||
48189955|NCT04411082|100788974|FG000|COMPLETED|Overall Study||18||
48189956|NCT04411082|100788975|FG001|COMPLETED|Overall Study||16||
48189957|NCT04411082|100788976|FG002|COMPLETED|Overall Study||16||
48189958|NCT04411082|100788977|FG003|COMPLETED|Overall Study||10||
48189959|NCT04411082|100788978|FG004|COMPLETED|Overall Study||8||
48189960|NCT04411082|100788979|FG005|COMPLETED|Overall Study||6||
48189961|NCT04411082|100788974|FG000|NOT COMPLETED|Overall Study||11||
48189962|NCT04411082|100788975|FG001|NOT COMPLETED|Overall Study||9||
48189963|NCT04411082|100788976|FG002|NOT COMPLETED|Overall Study||4||
48189964|NCT04411082|100788977|FG003|NOT COMPLETED|Overall Study||14||
48189965|NCT04411082|100788978|FG004|NOT COMPLETED|Overall Study||4||
48189966|NCT04411082|100788979|FG005|NOT COMPLETED|Overall Study||6||
48370213|NCT02796924|101234844|FG000|NOT COMPLETED|Overall Study||0||
48370214|NCT01096771|101234845|FG000|STARTED|Overall Study||7||
48370215|NCT01096771|101234846|FG001|STARTED|Overall Study||7||
48370216|NCT01096771|101234845|FG000|COMPLETED|Overall Study||7||
48370217|NCT01096771|101234846|FG001|COMPLETED|Overall Study||7||
48370218|NCT01096771|101234845|FG000|NOT COMPLETED|Overall Study||0||
48370219|NCT01096771|101234846|FG001|NOT COMPLETED|Overall Study||0||
48189967|NCT02466126|100788980|FG000|STARTED|Baseline||109||
48189968|NCT02466126|100788981|FG001|STARTED|Baseline||80||
48189969|NCT02466126|100788980|FG000|COMPLETED|Baseline||109||
48189970|NCT02466126|100788981|FG001|COMPLETED|Baseline||80||
48189971|NCT02466126|100788980|FG000|NOT COMPLETED|Baseline||0||
48370220|NCT01465178|101234847|FG000|STARTED|Overall Study||31||
48665999|NCT02314923|101967467|FG000|Treated|Overall Study||64||
48468723|NCT03629925|101484464|FG001|STARTED|Overall Study||178||
48468724|NCT03629925|101484463|FG000|COMPLETED|Overall Study||0||
48468725|NCT03629925|101484464|FG001|COMPLETED|Overall Study||0||
48468726|NCT03629925|101484463|FG000|NOT COMPLETED|Overall Study||179||
48468727|NCT03629925|101484464|FG001|NOT COMPLETED|Overall Study||178||
48468728|NCT00810368|101484465|FG000|STARTED|Overall Study||18||
48468729|NCT00810368|101484466|FG001|STARTED|Overall Study||15||
48468730|NCT00810368|101484465|FG000|COMPLETED|Overall Study||12||
48468731|NCT00810368|101484466|FG001|COMPLETED|Overall Study||13||
48468732|NCT00810368|101484465|FG000|NOT COMPLETED|Overall Study||6||
48468733|NCT00810368|101484466|FG001|NOT COMPLETED|Overall Study||2||
48468734|NCT04604184|101484467|FG000|STARTED|Overall Study||67||
48468735|NCT04604184|101484468|FG001|STARTED|Overall Study||66||
48468736|NCT04604184|101484467|FG000|Treated|Overall Study||65||
48468737|NCT04604184|101484468|FG001|Treated|Overall Study||64||
48468738|NCT04604184|101484467|FG000|COMPLETED|Overall Study||47||
48468739|NCT04604184|101484468|FG001|COMPLETED|Overall Study||47||
48468740|NCT04604184|101484467|FG000|NOT COMPLETED|Overall Study||20||
48468741|NCT04604184|101484468|FG001|NOT COMPLETED|Overall Study||19||
48468742|NCT01030965|101484469|FG000|STARTED|Overall Study||71||
48468743|NCT01030965|101484470|FG001|STARTED|Overall Study||71||
48468744|NCT01030965|101484471|FG002|STARTED|Overall Study||72||
48468745|NCT01030965|101484472|FG003|STARTED|Overall Study||71||
48468746|NCT01030965|101484469|FG000|COMPLETED|Overall Study||67||
48468747|NCT01030965|101484470|FG001|COMPLETED|Overall Study||65||
48468748|NCT01030965|101484471|FG002|COMPLETED|Overall Study||68||
48468749|NCT01030965|101484472|FG003|COMPLETED|Overall Study||64||
48468750|NCT01030965|101484469|FG000|NOT COMPLETED|Overall Study||4||
48468751|NCT01030965|101484470|FG001|NOT COMPLETED|Overall Study||6||
48468752|NCT01030965|101484471|FG002|NOT COMPLETED|Overall Study||4||
48468753|NCT01030965|101484472|FG003|NOT COMPLETED|Overall Study||7||
48468754|NCT00806156|101484473|FG000|STARTED|Overall Study||39||
48468755|NCT00806156|101484474|FG001|STARTED|Overall Study||139||
48468756|NCT00806156|101484473|FG000|COMPLETED|Overall Study||0||
48468757|NCT00806156|101484474|FG001|COMPLETED|Overall Study||0||
48468758|NCT00806156|101484473|FG000|NOT COMPLETED|Overall Study||39||
48468759|NCT00806156|101484474|FG001|NOT COMPLETED|Overall Study||139||
48468760|NCT02419690|101484475|FG000|STARTED|Overall Study||122||
48468761|NCT02419690|101484476|FG001|STARTED|Overall Study||122||
48468762|NCT02419690|101484475|FG000|COMPLETED|Overall Study||122||
48468763|NCT02419690|101484476|FG001|COMPLETED|Overall Study||122||
48468764|NCT02419690|101484475|FG000|NOT COMPLETED|Overall Study||0||
48468765|NCT02419690|101484476|FG001|NOT COMPLETED|Overall Study||0||
48468766|NCT04041609|101484477|FG000|STARTED|Overall Study||24||
48468767|NCT04041609|101484478|FG001|STARTED|Overall Study||23||
48468768|NCT04041609|101484479|FG002|STARTED|Overall Study||24||
48468769|NCT04041609|101484477|FG000|COMPLETED|Overall Study||17||
48468770|NCT04041609|101484478|FG001|COMPLETED|Overall Study||15||
48468771|NCT04041609|101484479|FG002|COMPLETED|Overall Study||17||
48468772|NCT04041609|101484477|FG000|NOT COMPLETED|Overall Study||7||
48468773|NCT04041609|101484478|FG001|NOT COMPLETED|Overall Study||8||
48468774|NCT04041609|101484479|FG002|NOT COMPLETED|Overall Study||7||
48468775|NCT01060592|101484480|FG000|STARTED|4-6w||35||
48468776|NCT01060592|101484481|FG001|STARTED|4-6w||49||
48468777|NCT01060592|101484480|FG000|COMPLETED|4-6w||23||
48468778|NCT01060592|101484481|FG001|COMPLETED|4-6w||39||
48468779|NCT01060592|101484480|FG000|NOT COMPLETED|4-6w||12||
48468780|NCT01060592|101484481|FG001|NOT COMPLETED|4-6w||10||
48468781|NCT01060592|101484480|FG000|STARTED|12m||35||
48468782|NCT01060592|101484481|FG001|STARTED|12m||49||
48468783|NCT01060592|101484480|FG000|COMPLETED|12m||35||
48468784|NCT01060592|101484481|FG001|COMPLETED|12m||31||
48468785|NCT01060592|101484480|FG000|NOT COMPLETED|12m||0||
48468786|NCT01060592|101484481|FG001|NOT COMPLETED|12m||18||
48468787|NCT03144687|101484482|FG000|STARTED|Overall Study||13||
48468788|NCT03144687|101484483|FG001|STARTED|Overall Study||10||
48468789|NCT03144687|101484482|FG000|COMPLETED|Overall Study||10||
48468790|NCT03144687|101484483|FG001|COMPLETED|Overall Study||3||
48468791|NCT03144687|101484482|FG000|NOT COMPLETED|Overall Study||3||
48468792|NCT03144687|101484483|FG001|NOT COMPLETED|Overall Study||7||
48468793|NCT03123822|101484484|FG000|STARTED|Overall Study||1||
48468794|NCT03123822|101484485|FG001|STARTED|Overall Study||1||
48468795|NCT03123822|101484486|FG002|STARTED|Overall Study||3||
48468796|NCT03123822|101484484|FG000|COMPLETED|Overall Study||1||
48468797|NCT03123822|101484485|FG001|COMPLETED|Overall Study||1||
48468798|NCT03123822|101484486|FG002|COMPLETED|Overall Study||3||
48468799|NCT03123822|101484484|FG000|NOT COMPLETED|Overall Study||0||
48468800|NCT03123822|101484485|FG001|NOT COMPLETED|Overall Study||0||
48468801|NCT03123822|101484486|FG002|NOT COMPLETED|Overall Study||0||
48468802|NCT01347788|101484487|FG000|STARTED|Overall Study||11||
48468803|NCT01347788|101484488|FG001|STARTED|Overall Study||10||
48468804|NCT01347788|101484489|FG002|STARTED|Overall Study||13||
48468805|NCT01347788|101484487|FG000|COMPLETED|Overall Study||11||
48468806|NCT01347788|101484488|FG001|COMPLETED|Overall Study||10||
48468807|NCT01347788|101484489|FG002|COMPLETED|Overall Study||13||
48468808|NCT01347788|101484487|FG000|NOT COMPLETED|Overall Study||0||
48468809|NCT01347788|101484488|FG001|NOT COMPLETED|Overall Study||0||
48468810|NCT01347788|101484489|FG002|NOT COMPLETED|Overall Study||0||
48468811|NCT01769378|101484490|FG000|STARTED|Overall Study||240||
48468812|NCT01769378|101484491|FG001|STARTED|Overall Study||60||
48468813|NCT01769378|101484490|FG000|Received at Least 1 Dose of Study Drug|Overall Study||239||
48468814|NCT01769378|101484491|FG001|Received at Least 1 Dose of Study Drug|Overall Study||60||
48468815|NCT01769378|101484490|FG000|COMPLETED|Overall Study||215||
48468816|NCT01769378|101484491|FG001|COMPLETED|Overall Study||56||
48468817|NCT01769378|101484490|FG000|NOT COMPLETED|Overall Study||25||
48468818|NCT01769378|101484491|FG001|NOT COMPLETED|Overall Study||4||
48468819|NCT02994056|101484492|FG000|STARTED|Overall Study||32||
48468820|NCT02994056|101484492|FG000|COMPLETED|Overall Study||23||
48468821|NCT02994056|101484492|FG000|NOT COMPLETED|Overall Study||9||
48468822|NCT00819247|101484493|FG000|STARTED|Overall Study||43||
48468823|NCT00819247|101484494|FG001|STARTED|Overall Study||46||
48468824|NCT00819247|101484495|FG002|STARTED|Overall Study||40||
48468825|NCT00819247|101484493|FG000|Randomized|Overall Study||43||
48468826|NCT00819247|101484494|FG001|Randomized|Overall Study||46||
48468827|NCT00819247|101484495|FG002|Randomized|Overall Study||40||
48468828|NCT00819247|101484493|FG000|Intent-to-treat Population|Overall Study||42||
48468829|NCT00819247|101484494|FG001|Intent-to-treat Population|Overall Study||46||
48468830|NCT00819247|101484495|FG002|Intent-to-treat Population|Overall Study||39||
48468831|NCT00819247|101484493|FG000|Per Protocol Population|Overall Study||38||
48468832|NCT00819247|101484494|FG001|Per Protocol Population|Overall Study||44||
48468833|NCT00819247|101484495|FG002|Per Protocol Population|Overall Study||38||
48468834|NCT00819247|101484493|FG000|COMPLETED|Overall Study||32||
48468835|NCT00819247|101484494|FG001|COMPLETED|Overall Study||30||
48468836|NCT00819247|101484495|FG002|COMPLETED|Overall Study||26||
48468837|NCT00819247|101484493|FG000|NOT COMPLETED|Overall Study||11||
48468838|NCT00819247|101484494|FG001|NOT COMPLETED|Overall Study||16||
48468839|NCT00819247|101484495|FG002|NOT COMPLETED|Overall Study||14||
48468840|NCT02427607|101484496|FG000|STARTED|Overall Study||7||
48468841|NCT02427607|101484496|FG000|COMPLETED|Overall Study||6||
48468842|NCT02427607|101484496|FG000|NOT COMPLETED|Overall Study||1||
48468843|NCT03977584|101484497|FG000|STARTED|Overall Study||44|114|
48468844|NCT03977584|101484498|FG001|STARTED|Overall Study||39|114|
48468845|NCT03977584|101484499|FG002|STARTED|Overall Study||31|114|
48468846|NCT03977584|101484497|FG000|COMPLETED|Overall Study||42||
48468847|NCT03977584|101484498|FG001|COMPLETED|Overall Study||39||
48468848|NCT03977584|101484499|FG002|COMPLETED|Overall Study||27||
48468849|NCT03977584|101484497|FG000|NOT COMPLETED|Overall Study||2||
48468850|NCT03977584|101484498|FG001|NOT COMPLETED|Overall Study||0||
48468851|NCT03977584|101484499|FG002|NOT COMPLETED|Overall Study||4||
48468852|NCT00803959|101484500|FG000|STARTED|Overall Study||315||
48468853|NCT00803959|101484501|FG001|STARTED|Overall Study||315||
48468854|NCT00803959|101484500|FG000|ITT Analysis With Primary Outcome Data|Overall Study||266||
48468855|NCT00803959|101484501|FG001|ITT Analysis With Primary Outcome Data|Overall Study||272||
48468856|NCT00803959|101484500|FG000|COMPLETED|Overall Study||259||
48468857|NCT00803959|101484501|FG001|COMPLETED|Overall Study||264||
48468858|NCT00803959|101484500|FG000|NOT COMPLETED|Overall Study||56||
48468859|NCT00803959|101484501|FG001|NOT COMPLETED|Overall Study||51||
48468860|NCT00970281|101484502|FG000|STARTED|Overall Study||46||
48468861|NCT00970281|101484503|FG001|STARTED|Overall Study||45||
48468862|NCT00970281|101484502|FG000|Full Analysis Set|Overall Study||45||
48468863|NCT00970281|101484503|FG001|Full Analysis Set|Overall Study||45||
48468864|NCT00970281|101484502|FG000|COMPLETED|Overall Study||44||
48468865|NCT00970281|101484503|FG001|COMPLETED|Overall Study||29||
48468866|NCT00970281|101484502|FG000|NOT COMPLETED|Overall Study||2||
48468867|NCT00970281|101484503|FG001|NOT COMPLETED|Overall Study||16||
48468868|NCT04471207|101484504|FG000|STARTED|Overall Study||29||
48468869|NCT04471207|101484505|FG001|STARTED|Overall Study||11||
48468870|NCT04471207|101484504|FG000|COMPLETED|Overall Study||18||
48468871|NCT04471207|101484505|FG001|COMPLETED|Overall Study||5||
48468872|NCT04471207|101484504|FG000|NOT COMPLETED|Overall Study||11||
48468873|NCT04471207|101484505|FG001|NOT COMPLETED|Overall Study||6||
48468874|NCT02380183|101484506|FG000|STARTED|Overall Study||36||
48468875|NCT02380183|101484507|FG001|STARTED|Overall Study||34||
48468876|NCT02380183|101484506|FG000|COMPLETED|Overall Study||36||
48468877|NCT02380183|101484507|FG001|COMPLETED|Overall Study||34||
48468878|NCT02380183|101484506|FG000|NOT COMPLETED|Overall Study||0||
48468879|NCT02380183|101484507|FG001|NOT COMPLETED|Overall Study||0||
48468880|NCT01759290|101484508|FG000|STARTED|Overall Study||1800||
48468881|NCT01759290|101484508|FG000|COMPLETED|Overall Study||1719||
48468882|NCT01759290|101484508|FG000|NOT COMPLETED|Overall Study||81||
48468883|NCT04849845|101484509|FG000|STARTED|Afrezza Dose 1||20||
48468884|NCT04849845|101484509|FG000|COMPLETED|Afrezza Dose 1||20||
48468885|NCT04849845|101484509|FG000|NOT COMPLETED|Afrezza Dose 1||0||
48468886|NCT04849845|101484509|FG000|STARTED|Afrezza Dose 2||20||
48468887|NCT04849845|101484509|FG000|COMPLETED|Afrezza Dose 2||20||
48468888|NCT04849845|101484509|FG000|NOT COMPLETED|Afrezza Dose 2||0||
48468889|NCT00454636|101484510|FG000|STARTED|Overall Study||41||
48468890|NCT00454636|101484511|FG001|STARTED|Overall Study||32||
48468891|NCT00454636|101484512|FG002|STARTED|Overall Study||27||
48468892|NCT00454636|101484513|FG003|STARTED|Overall Study||58||
48468893|NCT00454636|101484510|FG000|COMPLETED|Overall Study||10||
48468894|NCT00454636|101484511|FG001|COMPLETED|Overall Study||9||
48468895|NCT00454636|101484512|FG002|COMPLETED|Overall Study||7||
48468896|NCT00454636|101484513|FG003|COMPLETED|Overall Study||26||
48468897|NCT00454636|101484510|FG000|NOT COMPLETED|Overall Study||31||
48468898|NCT00454636|101484511|FG001|NOT COMPLETED|Overall Study||23||
48468899|NCT00454636|101484512|FG002|NOT COMPLETED|Overall Study||20||
48468900|NCT00454636|101484513|FG003|NOT COMPLETED|Overall Study||32||
48468901|NCT00922974|101484514|FG000|STARTED|Phase II Component||46||
48468902|NCT00922974|101484515|FG001|STARTED|Phase II Component||0||
48468903|NCT00922974|101484514|FG000|Eligible|Phase II Component||44||
48370221|NCT01465178|101234848|FG001|STARTED|Overall Study||31||
48370222|NCT01465178|101234847|FG000|COMPLETED|Overall Study||30||
48370223|NCT01465178|101234848|FG001|COMPLETED|Overall Study||31||
48370224|NCT01465178|101234847|FG000|NOT COMPLETED|Overall Study||1||
48370225|NCT01465178|101234848|FG001|NOT COMPLETED|Overall Study||0||
48370226|NCT02236546|101234849|FG000|STARTED|Overall Study||3||
48370227|NCT02236546|101234849|FG000|COMPLETED|Overall Study||3||
48468904|NCT00922974|101484515|FG001|Eligible|Phase II Component||0||
48468905|NCT00922974|101484514|FG000|Eligible and Started Treatment|Phase II Component||39||
48370228|NCT02236546|101234849|FG000|NOT COMPLETED|Overall Study||0||
48370229|NCT02699515|101234850|FG000|STARTED|Overall Study||4||
48370230|NCT02699515|101234851|FG001|STARTED|Overall Study||3||
48468906|NCT00922974|101484515|FG001|Eligible and Started Treatment|Phase II Component||0||
48468907|NCT00922974|101484514|FG000|Eligible, Treated, Adverse Event Data|Phase II Component||34|Eligible, started protocol treatment, and has adverse event data|
48468908|NCT00922974|101484515|FG001|Eligible, Treated, Adverse Event Data|Phase II Component||0|Eligible, started protocol treatment, and has adverse event data|
48468909|NCT00922974|101484514|FG000|COMPLETED|Phase II Component||39|Subjects contributing any data to analysis are considered to have completed the study|
48468910|NCT00922974|101484515|FG001|COMPLETED|Phase II Component||0|Subjects contributing any data to analysis are considered to have completed the study|
48468911|NCT00922974|101484514|FG000|NOT COMPLETED|Phase II Component||7||
48468912|NCT00922974|101484515|FG001|NOT COMPLETED|Phase II Component||0||
48468913|NCT00922974|101484514|FG000|STARTED|Phase III Component||217||
48468914|NCT00922974|101484515|FG001|STARTED|Phase III Component||136||
48468915|NCT00922974|101484514|FG000|Eligible|Phase III Component||209||
48468916|NCT00922974|101484515|FG001|Eligible|Phase III Component||130||
48468917|NCT00922974|101484514|FG000|Eligible With 3 mo. NRPS Data|Phase III Component||139|All eligible randomized patients with both baseline and 3 month NRPS scores|
48468918|NCT00922974|101484515|FG001|Eligible With 3 mo. NRPS Data|Phase III Component||76|All eligible randomized patients with both baseline and 3 month NRPS scores|
48468919|NCT00922974|101484514|FG000|Eligible With 3 mo. FACT-G Data|Phase III Component||87|Eligible and QOL consented patients with both baseline and follow up 3 month FACT-G total Score|
48468920|NCT00922974|101484515|FG001|Eligible With 3 mo. FACT-G Data|Phase III Component||58|Eligible and QOL consented patients with both baseline and follow up 3 month FACT-G total Score|
48468921|NCT00922974|101484514|FG000|Eligible With Adverse Event Data|Phase III Component||202||
48468922|NCT00922974|101484515|FG001|Eligible With Adverse Event Data|Phase III Component||117||
48468923|NCT00922974|101484514|FG000|Eligible, Treated, Adverse Event Data|Phase III Component||148|Eligible, started protocol treatment, and has adverse event data|
48468924|NCT00922974|101484515|FG001|Eligible, Treated, Adverse Event Data|Phase III Component||83|Eligible, started protocol treatment, and has adverse event data|
48468925|NCT00922974|101484514|FG000|Eligible and Consented to Quality of Life Participate in Quality of Life (QOL) Study Component|Phase III Component||152||
48468926|NCT00922974|101484515|FG001|Eligible and Consented to Quality of Life Participate in Quality of Life (QOL) Study Component|Phase III Component||100||
48468927|NCT00922974|101484514|FG000|COMPLETED|Phase III Component||209|Subjects contributing any data to analysis are considered to have completed the study|
48468928|NCT00922974|101484515|FG001|COMPLETED|Phase III Component||130|Subjects contributing any data to analysis are considered to have completed the study|
48468929|NCT00922974|101484514|FG000|NOT COMPLETED|Phase III Component||8||
48468930|NCT00922974|101484515|FG001|NOT COMPLETED|Phase III Component||6||
48468931|NCT00365352|101484516|FG000|STARTED|Overall Study||97||
48468932|NCT00365352|101484517|FG001|STARTED|Overall Study||115||
48468933|NCT00365352|101484518|FG002|STARTED|Overall Study||113||
48468934|NCT00365352|101484516|FG000|Safety Population|Overall Study||96||
48370231|NCT02699515|101234852|FG002|STARTED|Overall Study||7||
48370232|NCT02699515|101234853|FG003|STARTED|Overall Study||30||
48370233|NCT02699515|101234854|FG004|STARTED|Overall Study||31||
48370234|NCT02699515|101234855|FG005|STARTED|Overall Study||30||
48370235|NCT02699515|101234856|FG006|STARTED|Overall Study||3||
48370236|NCT02699515|101234857|FG007|STARTED|Overall Study||6||
48370237|NCT02699515|101234850|FG000|COMPLETED|Overall Study||0||
48370238|NCT02699515|101234851|FG001|COMPLETED|Overall Study||0||
48370239|NCT02699515|101234852|FG002|COMPLETED|Overall Study||0||
48370240|NCT02699515|101234853|FG003|COMPLETED|Overall Study||0||
48370241|NCT02699515|101234854|FG004|COMPLETED|Overall Study||0||
48370242|NCT02699515|101234855|FG005|COMPLETED|Overall Study||1||
48370243|NCT02699515|101234856|FG006|COMPLETED|Overall Study||0||
48370244|NCT02699515|101234857|FG007|COMPLETED|Overall Study||0||
48370245|NCT02699515|101234850|FG000|NOT COMPLETED|Overall Study||4||
48370246|NCT02699515|101234851|FG001|NOT COMPLETED|Overall Study||3||
48370247|NCT02699515|101234852|FG002|NOT COMPLETED|Overall Study||7||
48370248|NCT02699515|101234853|FG003|NOT COMPLETED|Overall Study||30||
48468935|NCT00365352|101484517|FG001|Safety Population|Overall Study||115||
48468936|NCT00365352|101484518|FG002|Safety Population|Overall Study||111||
48468937|NCT00365352|101484516|FG000|Modified Intent-to-Treat Population|Overall Study||96||
48468938|NCT00365352|101484517|FG001|Modified Intent-to-Treat Population|Overall Study||114||
48468939|NCT00365352|101484518|FG002|Modified Intent-to-Treat Population|Overall Study||111||
48468940|NCT00365352|101484516|FG000|COMPLETED|Overall Study||77||
48468941|NCT00365352|101484517|FG001|COMPLETED|Overall Study||104||
48468942|NCT00365352|101484518|FG002|COMPLETED|Overall Study||98||
48468943|NCT00365352|101484516|FG000|NOT COMPLETED|Overall Study||20||
48468944|NCT00365352|101484517|FG001|NOT COMPLETED|Overall Study||11||
48468945|NCT00365352|101484518|FG002|NOT COMPLETED|Overall Study||15||
48468946|NCT02070744|101484519|FG000|STARTED|PC Phase (12 Weeks)||6||
48370249|NCT02699515|101234854|FG004|NOT COMPLETED|Overall Study||31||
48370250|NCT02699515|101234855|FG005|NOT COMPLETED|Overall Study||29||
48370251|NCT02699515|101234856|FG006|NOT COMPLETED|Overall Study||3||
48468947|NCT02070744|101484520|FG001|STARTED|PC Phase (12 Weeks)||5||
48370252|NCT02699515|101234857|FG007|NOT COMPLETED|Overall Study||6||
48370253|NCT02786355|101234858|FG000|STARTED|Overall Study||35||
48370254|NCT02786355|101234858|FG000|COMPLETED|Overall Study||35||
48370255|NCT02786355|101234858|FG000|NOT COMPLETED|Overall Study||0||
48370256|NCT03568539|101234859|FG000|STARTED|Overall Study||3||
48370257|NCT03568539|101234860|FG001|STARTED|Overall Study||36||
48370258|NCT03568539|101234859|FG000|COMPLETED|Overall Study||3||
48370259|NCT03568539|101234860|FG001|COMPLETED|Overall Study||36||
48370260|NCT03568539|101234859|FG000|NOT COMPLETED|Overall Study||0||
48370261|NCT03568539|101234860|FG001|NOT COMPLETED|Overall Study||0||
48370262|NCT03140254|101234861|FG000|STARTED|Overall Study||145||
48370263|NCT03140254|101234861|FG000|Treatment IP - Groin|Overall Study||51||
48370264|NCT03140254|101234861|FG000|Treatment IP - Abdomen|Overall Study||48||
48370265|NCT03140254|101234861|FG000|Treatment AC - Groin|Overall Study||51||
48468948|NCT02070744|101484521|FG002|STARTED|PC Phase (12 Weeks)||15||
48468949|NCT02070744|101484522|FG003|STARTED|PC Phase (12 Weeks)||14||
48468950|NCT02070744|101484523|FG004|STARTED|PC Phase (12 Weeks)||0||
48468951|NCT02070744|101484519|FG000|Treated|PC Phase (12 Weeks)||6||
48468952|NCT02070744|101484520|FG001|Treated|PC Phase (12 Weeks)||5||
48468953|NCT02070744|101484521|FG002|Treated|PC Phase (12 Weeks)||15||
48468954|NCT02070744|101484522|FG003|Treated|PC Phase (12 Weeks)||13||
48468955|NCT02070744|101484523|FG004|Treated|PC Phase (12 Weeks)||0||
48468956|NCT02070744|101484519|FG000|COMPLETED|PC Phase (12 Weeks)||6||
48468957|NCT02070744|101484520|FG001|COMPLETED|PC Phase (12 Weeks)||5||
48468958|NCT02070744|101484521|FG002|COMPLETED|PC Phase (12 Weeks)||15||
48468959|NCT02070744|101484522|FG003|COMPLETED|PC Phase (12 Weeks)||13||
48468960|NCT02070744|101484523|FG004|COMPLETED|PC Phase (12 Weeks)||0||
48468961|NCT02070744|101484519|FG000|NOT COMPLETED|PC Phase (12 Weeks)||0||
48468962|NCT02070744|101484520|FG001|NOT COMPLETED|PC Phase (12 Weeks)||0||
48468963|NCT02070744|101484521|FG002|NOT COMPLETED|PC Phase (12 Weeks)||0||
48468964|NCT02070744|101484522|FG003|NOT COMPLETED|PC Phase (12 Weeks)||1||
48468965|NCT02070744|101484523|FG004|NOT COMPLETED|PC Phase (12 Weeks)||0||
48468966|NCT02070744|101484519|FG000|STARTED|OLE Phase (48 Weeks)||0||
48666000|NCT02314923|101967468|FG001|Treated|Overall Study||64||
48468967|NCT02070744|101484520|FG001|STARTED|OLE Phase (48 Weeks)||0||
48468968|NCT02070744|101484521|FG002|STARTED|OLE Phase (48 Weeks)||0||
48468969|NCT02070744|101484522|FG003|STARTED|OLE Phase (48 Weeks)||0||
48666001|NCT02314923|101967469|FG002|Treated|Overall Study||64||
48666002|NCT02314923|101967470|FG003|Treated|Overall Study||64||
48666003|NCT02314923|101967471|FG004|Treated|Overall Study||74||
48666004|NCT02314923|101967472|FG005|Treated|Overall Study||20||
48666005|NCT02314923|101967473|FG006|Treated|Overall Study||47||
48666006|NCT02314923|101967474|FG007|Treated|Overall Study||47||
48666007|NCT02314923|101967475|FG008|Treated|Overall Study||48||
48666008|NCT02314923|101967476|FG009|Treated|Overall Study||20||
48666009|NCT02314923|101967467|FG000|COMPLETED|Overall Study||61||
48666010|NCT02314923|101967468|FG001|COMPLETED|Overall Study||60||
48666011|NCT02314923|101967469|FG002|COMPLETED|Overall Study||62||
48666012|NCT02314923|101967470|FG003|COMPLETED|Overall Study||63||
48666013|NCT02314923|101967471|FG004|COMPLETED|Overall Study||73||
48666014|NCT02314923|101967472|FG005|COMPLETED|Overall Study||19||
48666015|NCT02314923|101967473|FG006|COMPLETED|Overall Study||43||
48666016|NCT02314923|101967474|FG007|COMPLETED|Overall Study||42||
48666017|NCT02314923|101967475|FG008|COMPLETED|Overall Study||46||
48666018|NCT02314923|101967476|FG009|COMPLETED|Overall Study||20||
48666019|NCT02314923|101967467|FG000|NOT COMPLETED|Overall Study||3||
48666020|NCT02314923|101967468|FG001|NOT COMPLETED|Overall Study||4||
48666021|NCT02314923|101967469|FG002|NOT COMPLETED|Overall Study||2||
48666022|NCT02314923|101967470|FG003|NOT COMPLETED|Overall Study||1||
48666023|NCT02314923|101967471|FG004|NOT COMPLETED|Overall Study||1||
48666024|NCT02314923|101967472|FG005|NOT COMPLETED|Overall Study||1||
48666025|NCT02314923|101967473|FG006|NOT COMPLETED|Overall Study||5||
48666026|NCT02314923|101967474|FG007|NOT COMPLETED|Overall Study||5||
48666027|NCT02314923|101967475|FG008|NOT COMPLETED|Overall Study||2||
48666028|NCT02314923|101967476|FG009|NOT COMPLETED|Overall Study||0||
48666029|NCT00356187|101967477|FG000|STARTED|Overall Study||0||
48666030|NCT00356187|101967478|FG001|STARTED|Overall Study||0||
48666031|NCT00356187|101967477|FG000|COMPLETED|Overall Study||0||
48666032|NCT00356187|101967478|FG001|COMPLETED|Overall Study||0||
48666033|NCT00356187|101967477|FG000|NOT COMPLETED|Overall Study||0||
48666034|NCT00356187|101967478|FG001|NOT COMPLETED|Overall Study||0||
48666035|NCT00526799|101967479|FG000|STARTED|Overall Study||16||
48666036|NCT00526799|101967480|FG001|STARTED|Overall Study||14||
48666037|NCT00526799|101967479|FG000|COMPLETED|Overall Study||15||
48666038|NCT00526799|101967480|FG001|COMPLETED|Overall Study||13||
48468970|NCT02070744|101484523|FG004|STARTED|OLE Phase (48 Weeks)||27||
48468971|NCT02070744|101484519|FG000|COMPLETED|OLE Phase (48 Weeks)||0||
48468972|NCT02070744|101484520|FG001|COMPLETED|OLE Phase (48 Weeks)||0||
48468973|NCT02070744|101484521|FG002|COMPLETED|OLE Phase (48 Weeks)||0||
48468974|NCT02070744|101484522|FG003|COMPLETED|OLE Phase (48 Weeks)||0||
48468975|NCT02070744|101484523|FG004|COMPLETED|OLE Phase (48 Weeks)||24||
48468976|NCT02070744|101484519|FG000|NOT COMPLETED|OLE Phase (48 Weeks)||0||
48468977|NCT02070744|101484520|FG001|NOT COMPLETED|OLE Phase (48 Weeks)||0||
48468978|NCT02070744|101484521|FG002|NOT COMPLETED|OLE Phase (48 Weeks)||0||
48468979|NCT02070744|101484522|FG003|NOT COMPLETED|OLE Phase (48 Weeks)||0||
48468980|NCT02070744|101484523|FG004|NOT COMPLETED|OLE Phase (48 Weeks)||3||
48468981|NCT02978326|101484524|FG000|STARTED|Part A (Up to 75 Days)||1||
48468982|NCT02978326|101484525|FG001|STARTED|Part A (Up to 75 Days)||0||
48468983|NCT02978326|101484526|FG002|STARTED|Part A (Up to 75 Days)||0||
48468984|NCT02978326|101484524|FG000|COMPLETED|Part A (Up to 75 Days)||1|Completed = Number of participants who completed Part A of the study.|
48468985|NCT02978326|101484525|FG001|COMPLETED|Part A (Up to 75 Days)||0|Completed = Number of participants who completed Part A of the study.|
48468986|NCT02978326|101484526|FG002|COMPLETED|Part A (Up to 75 Days)||0|Completed = Number of participants who completed Part A of the study.|
48468987|NCT02978326|101484524|FG000|NOT COMPLETED|Part A (Up to 75 Days)||0||
48468988|NCT02978326|101484525|FG001|NOT COMPLETED|Part A (Up to 75 Days)||0||
48468989|NCT02978326|101484526|FG002|NOT COMPLETED|Part A (Up to 75 Days)||0||
48468990|NCT02978326|101484524|FG000|STARTED|Part B (Up to 45 Days)||0|Started = Number of participants who were randomized to receive study drug in Part B of the study.|
48468991|NCT02978326|101484525|FG001|STARTED|Part B (Up to 45 Days)||76|Started = Number of participants who were randomized to receive study drug in Part B of the study.|
48468992|NCT02978326|101484526|FG002|STARTED|Part B (Up to 45 Days)||77|Started = Number of participants who were randomized to receive study drug in Part B of the study.|
48468993|NCT02978326|101484524|FG000|Received Study Drug|Part B (Up to 45 Days)||0|Two participants were randomized but did not receive study drug (1 in each treatment group).|
48468994|NCT02978326|101484525|FG001|Received Study Drug|Part B (Up to 45 Days)||73|Two participants were randomized but did not receive study drug (1 in each treatment group).|
48468995|NCT02978326|101484526|FG002|Received Study Drug|Part B (Up to 45 Days)||78|Two participants were randomized but did not receive study drug (1 in each treatment group).|
48468996|NCT02978326|101484524|FG000|Safety Set (Part B)|Part B (Up to 45 Days)||0|Safety Set (Part B) included all participants who were administered study drug in Part B and summarized by actual treatment received.|
48468997|NCT02978326|101484525|FG001|Safety Set (Part B)|Part B (Up to 45 Days)||73|Safety Set (Part B) included all participants who were administered study drug in Part B and summarized by actual treatment received.|
48468998|NCT02978326|101484526|FG002|Safety Set (Part B)|Part B (Up to 45 Days)||78|Safety Set (Part B) included all participants who were administered study drug in Part B and summarized by actual treatment received.|
48468999|NCT02978326|101484524|FG000|Efficacy Set (Part B)|Part B (Up to 45 Days)||0|Efficacy Set (Part B) included all participants who were administered study drug, had a valid Baseline and at least 1 post-baseline efficacy assessment.|
48469000|NCT02978326|101484525|FG001|Efficacy Set (Part B)|Part B (Up to 45 Days)||74|Efficacy Set (Part B) included all participants who were administered study drug, had a valid Baseline and at least 1 post-baseline efficacy assessment.|
48469001|NCT02978326|101484526|FG002|Efficacy Set (Part B)|Part B (Up to 45 Days)||76|Efficacy Set (Part B) included all participants who were administered study drug, had a valid Baseline and at least 1 post-baseline efficacy assessment.|
48469002|NCT02978326|101484524|FG000|COMPLETED|Part B (Up to 45 Days)||0||
48469003|NCT02978326|101484525|FG001|COMPLETED|Part B (Up to 45 Days)||69||
48469004|NCT02978326|101484526|FG002|COMPLETED|Part B (Up to 45 Days)||73||
48469005|NCT02978326|101484524|FG000|NOT COMPLETED|Part B (Up to 45 Days)||0||
48469006|NCT02978326|101484525|FG001|NOT COMPLETED|Part B (Up to 45 Days)||7||
48469007|NCT02978326|101484526|FG002|NOT COMPLETED|Part B (Up to 45 Days)||4||
48469008|NCT03481309|101484527|FG000|STARTED|First Intervention (1 Day)||4||
48469009|NCT03481309|101484528|FG001|STARTED|First Intervention (1 Day)||3||
48469010|NCT03481309|101484529|FG002|STARTED|First Intervention (1 Day)||3||
48469011|NCT03481309|101484530|FG003|STARTED|First Intervention (1 Day)||3||
48469012|NCT03481309|101484531|FG004|STARTED|First Intervention (1 Day)||3||
48469013|NCT03481309|101484532|FG005|STARTED|First Intervention (1 Day)||3||
48469014|NCT03481309|101484527|FG000|COMPLETED|First Intervention (1 Day)||4||
48469015|NCT03481309|101484528|FG001|COMPLETED|First Intervention (1 Day)||3||
48469016|NCT03481309|101484529|FG002|COMPLETED|First Intervention (1 Day)||3||
48469017|NCT03481309|101484530|FG003|COMPLETED|First Intervention (1 Day)||3||
48469018|NCT03481309|101484531|FG004|COMPLETED|First Intervention (1 Day)||3||
48469019|NCT03481309|101484532|FG005|COMPLETED|First Intervention (1 Day)||3||
48469020|NCT03481309|101484527|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48469021|NCT03481309|101484528|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48469022|NCT03481309|101484529|FG002|NOT COMPLETED|First Intervention (1 Day)||0||
48469023|NCT03481309|101484530|FG003|NOT COMPLETED|First Intervention (1 Day)||0||
48469024|NCT03481309|101484531|FG004|NOT COMPLETED|First Intervention (1 Day)||0||
48469025|NCT03481309|101484532|FG005|NOT COMPLETED|First Intervention (1 Day)||0||
48469026|NCT03481309|101484527|FG000|STARTED|Washout (at Least 3 Days)||4||
48370266|NCT03140254|101234861|FG000|Treatment AC - Abdomen|Overall Study||48||
48370267|NCT03140254|101234861|FG000|Treatment VC - Groin|Overall Study||18||
48469027|NCT03481309|101484528|FG001|STARTED|Washout (at Least 3 Days)||3||
48469028|NCT03481309|101484529|FG002|STARTED|Washout (at Least 3 Days)||3||
48469029|NCT03481309|101484530|FG003|STARTED|Washout (at Least 3 Days)||3||
48469030|NCT03481309|101484531|FG004|STARTED|Washout (at Least 3 Days)||3||
48469031|NCT03481309|101484532|FG005|STARTED|Washout (at Least 3 Days)||3||
48469032|NCT03481309|101484527|FG000|COMPLETED|Washout (at Least 3 Days)||3||
48469033|NCT03481309|101484528|FG001|COMPLETED|Washout (at Least 3 Days)||3||
48469034|NCT03481309|101484529|FG002|COMPLETED|Washout (at Least 3 Days)||3||
48469035|NCT03481309|101484530|FG003|COMPLETED|Washout (at Least 3 Days)||3||
48469036|NCT03481309|101484531|FG004|COMPLETED|Washout (at Least 3 Days)||3||
48469037|NCT03481309|101484532|FG005|COMPLETED|Washout (at Least 3 Days)||3||
48469038|NCT03481309|101484527|FG000|NOT COMPLETED|Washout (at Least 3 Days)||1||
48469039|NCT03481309|101484528|FG001|NOT COMPLETED|Washout (at Least 3 Days)||0||
48469040|NCT03481309|101484529|FG002|NOT COMPLETED|Washout (at Least 3 Days)||0||
48469041|NCT03481309|101484530|FG003|NOT COMPLETED|Washout (at Least 3 Days)||0||
48469042|NCT03481309|101484531|FG004|NOT COMPLETED|Washout (at Least 3 Days)||0||
48469043|NCT03481309|101484532|FG005|NOT COMPLETED|Washout (at Least 3 Days)||0||
48469044|NCT03481309|101484527|FG000|STARTED|Second Intervention (1 Day)||3||
48469045|NCT03481309|101484528|FG001|STARTED|Second Intervention (1 Day)||3||
48469046|NCT03481309|101484529|FG002|STARTED|Second Intervention (1 Day)||3||
48469047|NCT03481309|101484530|FG003|STARTED|Second Intervention (1 Day)||3||
48469048|NCT03481309|101484531|FG004|STARTED|Second Intervention (1 Day)||3||
48469049|NCT03481309|101484532|FG005|STARTED|Second Intervention (1 Day)||3||
48469050|NCT03481309|101484527|FG000|COMPLETED|Second Intervention (1 Day)||3||
48469051|NCT03481309|101484528|FG001|COMPLETED|Second Intervention (1 Day)||3||
48469052|NCT03481309|101484529|FG002|COMPLETED|Second Intervention (1 Day)||3||
48469053|NCT03481309|101484530|FG003|COMPLETED|Second Intervention (1 Day)||3||
48469054|NCT03481309|101484531|FG004|COMPLETED|Second Intervention (1 Day)||3||
48469055|NCT03481309|101484532|FG005|COMPLETED|Second Intervention (1 Day)||3||
48469056|NCT03481309|101484527|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48469057|NCT03481309|101484528|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48469058|NCT03481309|101484529|FG002|NOT COMPLETED|Second Intervention (1 Day)||0||
48469059|NCT03481309|101484530|FG003|NOT COMPLETED|Second Intervention (1 Day)||0||
48469060|NCT03481309|101484531|FG004|NOT COMPLETED|Second Intervention (1 Day)||0||
48469061|NCT03481309|101484532|FG005|NOT COMPLETED|Second Intervention (1 Day)||0||
48469062|NCT03481309|101484527|FG000|STARTED|Washout (at Least 3 Days)||3||
48469063|NCT03481309|101484528|FG001|STARTED|Washout (at Least 3 Days)||3||
48469064|NCT03481309|101484529|FG002|STARTED|Washout (at Least 3 Days)||3||
48469065|NCT03481309|101484530|FG003|STARTED|Washout (at Least 3 Days)||3||
48469066|NCT03481309|101484531|FG004|STARTED|Washout (at Least 3 Days)||3||
48469067|NCT03481309|101484532|FG005|STARTED|Washout (at Least 3 Days)||3||
48469068|NCT03481309|101484527|FG000|COMPLETED|Washout (at Least 3 Days)||3||
48469069|NCT03481309|101484528|FG001|COMPLETED|Washout (at Least 3 Days)||3||
48469070|NCT03481309|101484529|FG002|COMPLETED|Washout (at Least 3 Days)||3||
48469071|NCT03481309|101484530|FG003|COMPLETED|Washout (at Least 3 Days)||3||
48469072|NCT03481309|101484531|FG004|COMPLETED|Washout (at Least 3 Days)||3||
48469073|NCT03481309|101484532|FG005|COMPLETED|Washout (at Least 3 Days)||3||
48469074|NCT03481309|101484527|FG000|NOT COMPLETED|Washout (at Least 3 Days)||0||
48469075|NCT03481309|101484528|FG001|NOT COMPLETED|Washout (at Least 3 Days)||0||
48469076|NCT03481309|101484529|FG002|NOT COMPLETED|Washout (at Least 3 Days)||0||
48469077|NCT03481309|101484530|FG003|NOT COMPLETED|Washout (at Least 3 Days)||0||
48469078|NCT03481309|101484531|FG004|NOT COMPLETED|Washout (at Least 3 Days)||0||
48469079|NCT03481309|101484532|FG005|NOT COMPLETED|Washout (at Least 3 Days)||0||
48469080|NCT03481309|101484527|FG000|STARTED|Third Intervention (1 Day)||3||
48469081|NCT03481309|101484528|FG001|STARTED|Third Intervention (1 Day)||3||
48666039|NCT00526799|101967479|FG000|NOT COMPLETED|Overall Study||1||
48469082|NCT03481309|101484529|FG002|STARTED|Third Intervention (1 Day)||3||
48469083|NCT03481309|101484530|FG003|STARTED|Third Intervention (1 Day)||3||
48469084|NCT03481309|101484531|FG004|STARTED|Third Intervention (1 Day)||3||
48469085|NCT03481309|101484532|FG005|STARTED|Third Intervention (1 Day)||3||
48469086|NCT03481309|101484527|FG000|COMPLETED|Third Intervention (1 Day)||3||
48469087|NCT03481309|101484528|FG001|COMPLETED|Third Intervention (1 Day)||3||
48469088|NCT03481309|101484529|FG002|COMPLETED|Third Intervention (1 Day)||3||
48469089|NCT03481309|101484530|FG003|COMPLETED|Third Intervention (1 Day)||3||
48469090|NCT03481309|101484531|FG004|COMPLETED|Third Intervention (1 Day)||3||
48469091|NCT03481309|101484532|FG005|COMPLETED|Third Intervention (1 Day)||3||
48469092|NCT03481309|101484527|FG000|NOT COMPLETED|Third Intervention (1 Day)||0||
48469093|NCT03481309|101484528|FG001|NOT COMPLETED|Third Intervention (1 Day)||0||
48469094|NCT03481309|101484529|FG002|NOT COMPLETED|Third Intervention (1 Day)||0||
48469095|NCT03481309|101484530|FG003|NOT COMPLETED|Third Intervention (1 Day)||0||
48469096|NCT03481309|101484531|FG004|NOT COMPLETED|Third Intervention (1 Day)||0||
48469097|NCT03481309|101484532|FG005|NOT COMPLETED|Third Intervention (1 Day)||0||
48469098|NCT02494713|101484533|FG000|STARTED|Overall Study||4||
48469099|NCT02494713|101484533|FG000|COMPLETED|Overall Study||4||
48469100|NCT02494713|101484533|FG000|NOT COMPLETED|Overall Study||0||
48469101|NCT00502775|101484534|FG000|STARTED|Overall Study||229||
48469102|NCT00502775|101484535|FG001|STARTED|Overall Study||224||
48469103|NCT00502775|101484536|FG002|STARTED|Overall Study||227||
48469104|NCT00502775|101484534|FG000|COMPLETED|Overall Study||219||
48469105|NCT00502775|101484535|FG001|COMPLETED|Overall Study||209||
48469106|NCT00502775|101484536|FG002|COMPLETED|Overall Study||214||
48469107|NCT00502775|101484534|FG000|NOT COMPLETED|Overall Study||10||
48469108|NCT00502775|101484535|FG001|NOT COMPLETED|Overall Study||15||
48469109|NCT00502775|101484536|FG002|NOT COMPLETED|Overall Study||13||
48469110|NCT01934296|101484537|FG000|STARTED|Overall Study||9||
48469111|NCT01934296|101484537|FG000|COMPLETED|Overall Study||9||
48189972|NCT02466126|100788981|FG001|NOT COMPLETED|Baseline||0||
48370268|NCT03140254|101234861|FG000|Treatment VC - Abdomen|Overall Study||19||
48370269|NCT03140254|101234861|FG000|COMPLETED|Overall Study||144||
48370270|NCT03140254|101234861|FG000|NOT COMPLETED|Overall Study||1||
48370271|NCT03046472|101234862|FG000|STARTED|Overall Study||33||
48370272|NCT03046472|101234863|FG001|STARTED|Overall Study||17||
48469112|NCT01934296|101484537|FG000|NOT COMPLETED|Overall Study||0||
48469113|NCT00669864|101484538|FG000|STARTED|Overall Study||293||
48469114|NCT00669864|101484538|FG000|COMPLETED|Overall Study||284||
48469115|NCT00669864|101484538|FG000|NOT COMPLETED|Overall Study||9||
48469116|NCT01766921|101484539|FG000|STARTED|Overall Study||700||
48469117|NCT01766921|101484540|FG001|STARTED|Overall Study||693||
48469118|NCT01766921|101484539|FG000|COMPLETED|Overall Study||676||
48469119|NCT01766921|101484540|FG001|COMPLETED|Overall Study||676||
48469120|NCT01766921|101484539|FG000|NOT COMPLETED|Overall Study||24||
48469121|NCT01766921|101484540|FG001|NOT COMPLETED|Overall Study||17||
48469122|NCT01659567|101484541|FG000|STARTED|Overall Study||516||
48469123|NCT01659567|101484541|FG000|COMPLETED|Overall Study||393||
48469124|NCT01659567|101484541|FG000|NOT COMPLETED|Overall Study||123||
48469125|NCT00408902|101484542|FG000|STARTED|Overall Study||10||
48189973|NCT02466126|100788980|FG000|STARTED|4 Month Assessment||109||
48189974|NCT02466126|100788981|FG001|STARTED|4 Month Assessment||80||
48370273|NCT03046472|101234862|FG000|COMPLETED|Overall Study||33||
48370274|NCT03046472|101234863|FG001|COMPLETED|Overall Study||17||
48370275|NCT03046472|101234862|FG000|NOT COMPLETED|Overall Study||0||
48469126|NCT00408902|101484542|FG000|COMPLETED|Overall Study||0||
48469127|NCT00408902|101484542|FG000|NOT COMPLETED|Overall Study||10||
48370276|NCT03046472|101234863|FG001|NOT COMPLETED|Overall Study||0||
48370277|NCT00589472|101234864|FG000|STARTED|Overall Study||19||
48370278|NCT00589472|101234864|FG000|COMPLETED|Overall Study||18||
48370279|NCT00589472|101234864|FG000|NOT COMPLETED|Overall Study||1||
48370280|NCT03207022|101234865|FG000|STARTED|Overall Study||12||
48370281|NCT03207022|101234866|FG001|STARTED|Overall Study||12||
48370282|NCT03207022|101234865|FG000|COMPLETED|Overall Study||12||
48370283|NCT03207022|101234866|FG001|COMPLETED|Overall Study||12||
48370284|NCT03207022|101234865|FG000|NOT COMPLETED|Overall Study||0||
48370285|NCT03207022|101234866|FG001|NOT COMPLETED|Overall Study||0||
48370286|NCT03596177|101234867|FG000|STARTED|Single Blind Period||9||
48370287|NCT03596177|101234868|FG001|STARTED|Single Blind Period||19||
48370288|NCT03596177|101234867|FG000|COMPLETED|Single Blind Period||7||
48370289|NCT03596177|101234868|FG001|COMPLETED|Single Blind Period||18||
48370290|NCT03596177|101234867|FG000|NOT COMPLETED|Single Blind Period||2||
48370291|NCT03596177|101234868|FG001|NOT COMPLETED|Single Blind Period||1||
48370292|NCT03596177|101234867|FG000|STARTED|Double Blind Period||7||
48370293|NCT03596177|101234868|FG001|STARTED|Double Blind Period||18||
48370294|NCT03596177|101234867|FG000|COMPLETED|Double Blind Period||7||
48370295|NCT03596177|101234868|FG001|COMPLETED|Double Blind Period||12||
48370296|NCT03596177|101234867|FG000|NOT COMPLETED|Double Blind Period||0||
48469128|NCT01153984|101484543|FG000|STARTED|Overall Study||23||
48469129|NCT01153984|101484543|FG000|COMPLETED|Overall Study||21||
48469130|NCT01153984|101484543|FG000|NOT COMPLETED|Overall Study||2||
48469131|NCT03054103|101484544|FG000|STARTED|Overall Study||41||
48469132|NCT03054103|101484545|FG001|STARTED|Overall Study||29||
48469133|NCT03054103|101484546|FG002|STARTED|Overall Study||35||
48469134|NCT03054103|101484544|FG000|COMPLETED|Overall Study||41||
48469135|NCT03054103|101484545|FG001|COMPLETED|Overall Study||29||
48469136|NCT03054103|101484546|FG002|COMPLETED|Overall Study||35||
48469137|NCT03054103|101484544|FG000|NOT COMPLETED|Overall Study||0||
48469138|NCT03054103|101484545|FG001|NOT COMPLETED|Overall Study||0||
48469139|NCT03054103|101484546|FG002|NOT COMPLETED|Overall Study||0||
48469140|NCT01024738|101484547|FG000|STARTED|First Intervention:||7||
48469141|NCT01024738|101484548|FG001|STARTED|First Intervention:||7||
48469142|NCT01024738|101484549|FG002|STARTED|First Intervention:||8||
48469143|NCT01024738|101484547|FG000|COMPLETED|First Intervention:||7||
48469144|NCT01024738|101484548|FG001|COMPLETED|First Intervention:||7||
48469145|NCT01024738|101484549|FG002|COMPLETED|First Intervention:||8||
48469146|NCT01024738|101484547|FG000|NOT COMPLETED|First Intervention:||0||
48469147|NCT01024738|101484548|FG001|NOT COMPLETED|First Intervention:||0||
48469148|NCT01024738|101484549|FG002|NOT COMPLETED|First Intervention:||0||
48469149|NCT01024738|101484547|FG000|STARTED|Washout After 1st Intervention||7||
48469150|NCT01024738|101484548|FG001|STARTED|Washout After 1st Intervention||7||
48469151|NCT01024738|101484549|FG002|STARTED|Washout After 1st Intervention||8||
48469152|NCT01024738|101484547|FG000|COMPLETED|Washout After 1st Intervention||7||
48469153|NCT01024738|101484548|FG001|COMPLETED|Washout After 1st Intervention||7||
48469154|NCT01024738|101484549|FG002|COMPLETED|Washout After 1st Intervention||8||
48469155|NCT01024738|101484547|FG000|NOT COMPLETED|Washout After 1st Intervention||0||
48469156|NCT01024738|101484548|FG001|NOT COMPLETED|Washout After 1st Intervention||0||
48469157|NCT01024738|101484549|FG002|NOT COMPLETED|Washout After 1st Intervention||0||
48469158|NCT01024738|101484547|FG000|STARTED|Second Intervention:||7||
48469159|NCT01024738|101484548|FG001|STARTED|Second Intervention:||7||
48469160|NCT01024738|101484549|FG002|STARTED|Second Intervention:||8||
48469161|NCT01024738|101484547|FG000|COMPLETED|Second Intervention:||7||
48469162|NCT01024738|101484548|FG001|COMPLETED|Second Intervention:||7||
48469163|NCT01024738|101484549|FG002|COMPLETED|Second Intervention:||8||
48469164|NCT01024738|101484547|FG000|NOT COMPLETED|Second Intervention:||0||
48469165|NCT01024738|101484548|FG001|NOT COMPLETED|Second Intervention:||0||
48469166|NCT01024738|101484549|FG002|NOT COMPLETED|Second Intervention:||0||
48469167|NCT01024738|101484547|FG000|STARTED|Washout After 2nd Intervention||7||
48469168|NCT01024738|101484548|FG001|STARTED|Washout After 2nd Intervention||7||
48469169|NCT01024738|101484549|FG002|STARTED|Washout After 2nd Intervention||8||
48469170|NCT01024738|101484547|FG000|COMPLETED|Washout After 2nd Intervention||7||
48469171|NCT01024738|101484548|FG001|COMPLETED|Washout After 2nd Intervention||7||
48469172|NCT01024738|101484549|FG002|COMPLETED|Washout After 2nd Intervention||8||
48469173|NCT01024738|101484547|FG000|NOT COMPLETED|Washout After 2nd Intervention||0||
48469174|NCT01024738|101484548|FG001|NOT COMPLETED|Washout After 2nd Intervention||0||
48469175|NCT01024738|101484549|FG002|NOT COMPLETED|Washout After 2nd Intervention||0||
48469176|NCT01024738|101484547|FG000|STARTED|Third Intervention:||7||
48469177|NCT01024738|101484548|FG001|STARTED|Third Intervention:||7||
48469178|NCT01024738|101484549|FG002|STARTED|Third Intervention:||8||
48469179|NCT01024738|101484547|FG000|COMPLETED|Third Intervention:||7||
48469180|NCT01024738|101484548|FG001|COMPLETED|Third Intervention:||7||
48469181|NCT01024738|101484549|FG002|COMPLETED|Third Intervention:||8||
48469182|NCT01024738|101484547|FG000|NOT COMPLETED|Third Intervention:||0||
48469183|NCT01024738|101484548|FG001|NOT COMPLETED|Third Intervention:||0||
48469184|NCT01024738|101484549|FG002|NOT COMPLETED|Third Intervention:||0||
48469185|NCT04956666|101484550|FG000|STARTED|Overall Study||75||
48469186|NCT04956666|101484550|FG000|COMPLETED|Overall Study||52||
48469187|NCT04956666|101484550|FG000|NOT COMPLETED|Overall Study||23||
48469188|NCT01055223|101484551|FG000|STARTED|Overall Study||98483||
48469189|NCT01055223|101484551|FG000|COMPLETED|Overall Study||98483||
48469190|NCT01055223|101484551|FG000|NOT COMPLETED|Overall Study||0||
48469191|NCT00634907|101484552|FG000|STARTED|Overall Study||131||
48469192|NCT00634907|101484553|FG001|STARTED|Overall Study||132||
48469193|NCT00634907|101484552|FG000|COMPLETED|Overall Study||114||
48469194|NCT00634907|101484553|FG001|COMPLETED|Overall Study||115||
48469195|NCT00634907|101484552|FG000|NOT COMPLETED|Overall Study||17||
48469196|NCT00634907|101484553|FG001|NOT COMPLETED|Overall Study||17||
48469197|NCT02149303|101484554|FG000|STARTED|Overall Study||191||
48469198|NCT02149303|101484554|FG000|COMPLETED|Overall Study||191||
48469199|NCT02149303|101484554|FG000|NOT COMPLETED|Overall Study||0||
48469200|NCT02433665|101484555|FG000|STARTED|Overall Study||77||
48469201|NCT02433665|101484556|FG001|STARTED|Overall Study||79||
48469202|NCT02433665|101484555|FG000|COMPLETED|Overall Study||77||
48469203|NCT02433665|101484556|FG001|COMPLETED|Overall Study||79||
48469204|NCT02433665|101484555|FG000|NOT COMPLETED|Overall Study||0||
48469205|NCT02433665|101484556|FG001|NOT COMPLETED|Overall Study||0||
48469206|NCT02841774|101484557|FG000|STARTED|Overall Study||6||
48469207|NCT02841774|101484558|FG001|STARTED|Overall Study||4||
48469208|NCT02841774|101484557|FG000|COMPLETED|Overall Study||6||
48469209|NCT02841774|101484558|FG001|COMPLETED|Overall Study||4||
48469210|NCT02841774|101484557|FG000|NOT COMPLETED|Overall Study||0||
48469211|NCT02841774|101484558|FG001|NOT COMPLETED|Overall Study||0||
48469212|NCT01984242|101484559|FG000|STARTED|Overall Study||101||
48469213|NCT01984242|101484560|FG001|STARTED|Overall Study||103||
48469214|NCT01984242|101484561|FG002|STARTED|Overall Study||101||
48469215|NCT01984242|101484559|FG000|Treated|Overall Study||101||
48469216|NCT01984242|101484560|FG001|Treated|Overall Study||103||
48469217|NCT01984242|101484561|FG002|Treated|Overall Study||100||
48469218|NCT01984242|101484559|FG000|COMPLETED|Overall Study||0||
48189975|NCT02466126|100788980|FG000|COMPLETED|4 Month Assessment||93||
48370297|NCT03596177|101234868|FG001|NOT COMPLETED|Double Blind Period||6||
48370298|NCT04078152|101234869|FG000|STARTED|Overall Study||100||
48370299|NCT04078152|101234870|FG001|STARTED|Overall Study||25||
48370300|NCT04078152|101234871|FG002|STARTED|Overall Study||38||
48370301|NCT04078152|101234869|FG000|Received Treatment in This Study/Within 90 Days Prior Enrolment in This Study(Safety Analysis Set)|Overall Study||100||
48370302|NCT04078152|101234870|FG001|Received Treatment in This Study/Within 90 Days Prior Enrolment in This Study(Safety Analysis Set)|Overall Study||7||
48370303|NCT04078152|101234871|FG002|Received Treatment in This Study/Within 90 Days Prior Enrolment in This Study(Safety Analysis Set)|Overall Study||2||
48370304|NCT04078152|101234869|FG000|COMPLETED|Overall Study||0||
48370305|NCT04078152|101234870|FG001|COMPLETED|Overall Study||0||
48370306|NCT04078152|101234871|FG002|COMPLETED|Overall Study||0||
48469219|NCT01984242|101484560|FG001|COMPLETED|Overall Study||0||
48469220|NCT01984242|101484561|FG002|COMPLETED|Overall Study||0||
48469221|NCT01984242|101484559|FG000|NOT COMPLETED|Overall Study||101||
48469222|NCT01984242|101484560|FG001|NOT COMPLETED|Overall Study||103||
48469223|NCT01984242|101484561|FG002|NOT COMPLETED|Overall Study||101||
48469224|NCT00202449|101484562|FG000|STARTED|Overall Study||18||
48370307|NCT04078152|101234869|FG000|NOT COMPLETED|Overall Study||100||
48469225|NCT00202449|101484563|FG001|STARTED|Overall Study||20||
48469226|NCT00202449|101484564|FG002|STARTED|Overall Study||21||
48469227|NCT00202449|101484562|FG000|COMPLETED|Overall Study||7||
48469228|NCT00202449|101484563|FG001|COMPLETED|Overall Study||9||
48469229|NCT00202449|101484564|FG002|COMPLETED|Overall Study||9||
48469230|NCT00202449|101484562|FG000|NOT COMPLETED|Overall Study||11||
48370308|NCT04078152|101234870|FG001|NOT COMPLETED|Overall Study||25||
48370309|NCT04078152|101234871|FG002|NOT COMPLETED|Overall Study||38||
48370310|NCT05485779|101234872|FG000|STARTED|Treatment Period 1 (Fasted)||8||
48370311|NCT05485779|101234873|FG001|STARTED|Treatment Period 1 (Fasted)||6||
48370312|NCT05485779|101234874|FG002|STARTED|Treatment Period 1 (Fasted)||6||
48370313|NCT05485779|101234875|FG003|STARTED|Treatment Period 1 (Fasted)||2||
48370314|NCT05485779|101234876|FG004|STARTED|Treatment Period 1 (Fasted)||6||
48370315|NCT05485779|101234877|FG005|STARTED|Treatment Period 1 (Fasted)||6||
48370316|NCT05485779|101234878|FG006|STARTED|Treatment Period 1 (Fasted)||6||
48370317|NCT05485779|101234879|FG007|STARTED|Treatment Period 1 (Fasted)||7||
48370318|NCT05485779|101234880|FG008|STARTED|Treatment Period 1 (Fasted)||7||
48370319|NCT05485779|101234881|FG009|STARTED|Treatment Period 1 (Fasted)||6||
48370320|NCT05485779|101234882|FG010|STARTED|Treatment Period 1 (Fasted)||6||
48469231|NCT00202449|101484563|FG001|NOT COMPLETED|Overall Study||11||
48469232|NCT00202449|101484564|FG002|NOT COMPLETED|Overall Study||12||
48469233|NCT01095510|101484565|FG000|STARTED|Overall Study||3||
48469234|NCT01095510|101484566|FG001|STARTED|Overall Study||0||
48469235|NCT01095510|101484567|FG002|STARTED|Overall Study||3||
48469236|NCT01095510|101484568|FG003|STARTED|Overall Study||3||
48469237|NCT01095510|101484565|FG000|COMPLETED|Overall Study||3||
48469238|NCT01095510|101484566|FG001|COMPLETED|Overall Study||0||
48469239|NCT01095510|101484567|FG002|COMPLETED|Overall Study||3||
48469240|NCT01095510|101484568|FG003|COMPLETED|Overall Study||3||
48469241|NCT01095510|101484565|FG000|NOT COMPLETED|Overall Study||0||
48469242|NCT01095510|101484566|FG001|NOT COMPLETED|Overall Study||0||
48469243|NCT01095510|101484567|FG002|NOT COMPLETED|Overall Study||0||
48469244|NCT01095510|101484568|FG003|NOT COMPLETED|Overall Study||0||
48469245|NCT02401542|101484569|FG000|STARTED|Overall Study||41||
48469246|NCT02401542|101484570|FG001|STARTED|Overall Study||30||
48469247|NCT02401542|101484571|FG002|STARTED|Overall Study||0||
48469248|NCT02401542|101484569|FG000|COMPLETED|Overall Study||40||
48469249|NCT02401542|101484570|FG001|COMPLETED|Overall Study||30||
48469250|NCT02401542|101484571|FG002|COMPLETED|Overall Study||0||
48469251|NCT02401542|101484569|FG000|NOT COMPLETED|Overall Study||1||
48469252|NCT02401542|101484570|FG001|NOT COMPLETED|Overall Study||0||
48469253|NCT02401542|101484571|FG002|NOT COMPLETED|Overall Study||0||
48469254|NCT01085344|101484572|FG000|STARTED|Overall Study||56||
48469255|NCT01085344|101484572|FG000|COMPLETED|Overall Study||50||
48469256|NCT01085344|101484572|FG000|NOT COMPLETED|Overall Study||6||
48469257|NCT01191320|101484573|FG000|STARTED|Overall Study||43||
48469258|NCT01191320|101484574|FG001|STARTED|Overall Study||38||
48469259|NCT01191320|101484575|FG002|STARTED|Overall Study||38||
48469260|NCT01191320|101484573|FG000|COMPLETED|Overall Study||36||
48469261|NCT01191320|101484574|FG001|COMPLETED|Overall Study||32||
48469262|NCT01191320|101484575|FG002|COMPLETED|Overall Study||31||
48469263|NCT01191320|101484573|FG000|NOT COMPLETED|Overall Study||7||
48469264|NCT01191320|101484574|FG001|NOT COMPLETED|Overall Study||6||
48469265|NCT01191320|101484575|FG002|NOT COMPLETED|Overall Study||7||
48469266|NCT02774798|101484576|FG000|STARTED|Overall Study||7||
48469267|NCT02774798|101484577|FG001|STARTED|Overall Study||17||
48469268|NCT02774798|101484578|FG002|STARTED|Overall Study||7||
48469269|NCT02774798|101484576|FG000|COMPLETED|Overall Study||7||
48469270|NCT02774798|101484577|FG001|COMPLETED|Overall Study||17||
48469271|NCT02774798|101484578|FG002|COMPLETED|Overall Study||7||
48469272|NCT02774798|101484576|FG000|NOT COMPLETED|Overall Study||0||
48469273|NCT02774798|101484577|FG001|NOT COMPLETED|Overall Study||0||
48469274|NCT02774798|101484578|FG002|NOT COMPLETED|Overall Study||0||
48469275|NCT03594123|101484579|FG000|STARTED|Overall Study||163||
48469276|NCT03594123|101484580|FG001|STARTED|Overall Study||96||
48469277|NCT03594123|101484579|FG000|Efficacy Sample:|Overall Study||159|Efficacy sample comprised of all participants in the safety sample who have a baseline assessment and at least one postbaseline assessment for cohen-mansfield agitation inventory (CMAI) total score.|
48469278|NCT03594123|101484580|FG001|Efficacy Sample:|Overall Study||95|Efficacy sample comprised of all participants in the safety sample who have a baseline assessment and at least one postbaseline assessment for cohen-mansfield agitation inventory (CMAI) total score.|
48469279|NCT03594123|101484579|FG000|COMPLETED|Overall Study||142||
48469280|NCT03594123|101484580|FG001|COMPLETED|Overall Study||87||
48469281|NCT03594123|101484579|FG000|NOT COMPLETED|Overall Study||21||
48469282|NCT03594123|101484580|FG001|NOT COMPLETED|Overall Study||9||
48469283|NCT05034731|101484581|FG000|STARTED|Overall Study||13||
48469284|NCT05034731|101484582|FG001|STARTED|Overall Study||6||
48469285|NCT05034731|101484581|FG000|COMPLETED|Overall Study||12||
48469286|NCT05034731|101484582|FG001|COMPLETED|Overall Study||5||
48469287|NCT05034731|101484581|FG000|NOT COMPLETED|Overall Study||1||
48469288|NCT05034731|101484582|FG001|NOT COMPLETED|Overall Study||1||
48469289|NCT01029353|101484583|FG000|STARTED|Overall Study||148|Five infants in the preference cohort never received a Lap or Drain. These five infants are excluded from the summarization and analysis of preference cohort data.|
48469290|NCT01029353|101484584|FG001|STARTED|Overall Study||162|Five infants in the preference cohort never received a Lap or Drain. These five infants are excluded from the summarization and analysis of preference cohort data.|
48469291|NCT01029353|101484585|FG002|STARTED|Overall Study||100|Five infants in the preference cohort never received a Lap or Drain. These five infants are excluded from the summarization and analysis of preference cohort data.|
48469292|NCT01029353|101484586|FG003|STARTED|Overall Study||119|Five infants in the preference cohort never received a Lap or Drain. These five infants are excluded from the summarization and analysis of preference cohort data.|
48469293|NCT01029353|101484583|FG000|Included in ITT Analysis|Overall Study||146||
48469294|NCT01029353|101484584|FG001|Included in ITT Analysis|Overall Study||162||
48469295|NCT01029353|101484585|FG002|Included in ITT Analysis|Overall Study||100||
48469296|NCT01029353|101484586|FG003|Included in ITT Analysis|Overall Study||119||
48469297|NCT01029353|101484583|FG000|Reached Network Status|Overall Study||146||
48469298|NCT01029353|101484584|FG001|Reached Network Status|Overall Study||162||
48469299|NCT01029353|101484585|FG002|Reached Network Status|Overall Study||100||
48469300|NCT01029353|101484586|FG003|Reached Network Status|Overall Study||119||
48469301|NCT01029353|101484583|FG000|COMPLETED|Overall Study||141|Primary Outcome Observed|
48469302|NCT01029353|101484584|FG001|COMPLETED|Overall Study||154|Primary Outcome Observed|
48469303|NCT01029353|101484585|FG002|COMPLETED|Overall Study||93|Primary Outcome Observed|
48469304|NCT01029353|101484586|FG003|COMPLETED|Overall Study||115|Primary Outcome Observed|
48469305|NCT01029353|101484583|FG000|NOT COMPLETED|Overall Study||7||
48469306|NCT01029353|101484584|FG001|NOT COMPLETED|Overall Study||8||
48469307|NCT01029353|101484585|FG002|NOT COMPLETED|Overall Study||7||
48469308|NCT01029353|101484586|FG003|NOT COMPLETED|Overall Study||4||
48469309|NCT00678392|101484587|FG000|STARTED|Overall Study||361||
48469310|NCT00678392|101484588|FG001|STARTED|Overall Study||362||
48469311|NCT00678392|101484587|FG000|Treated|Overall Study||359||
48469312|NCT00678392|101484588|FG001|Treated|Overall Study||355||
48469313|NCT00678392|101484587|FG000|COMPLETED|Overall Study||0||
48469314|NCT00678392|101484588|FG001|COMPLETED|Overall Study||0||
48469315|NCT00678392|101484587|FG000|NOT COMPLETED|Overall Study||361||
48469316|NCT00678392|101484588|FG001|NOT COMPLETED|Overall Study||362||
48469317|NCT02336737|101484589|FG000|STARTED|Overall Study||160||
48469318|NCT02336737|101484589|FG000|COMPLETED|Overall Study||147||
48469319|NCT02336737|101484589|FG000|NOT COMPLETED|Overall Study||13||
48469320|NCT03445195|101484590|FG000|STARTED|Overall Study||53||
48469321|NCT03445195|101484591|FG001|STARTED|Overall Study||27||
48469322|NCT03445195|101484590|FG000|COMPLETED|Overall Study||51||
48469323|NCT03445195|101484591|FG001|COMPLETED|Overall Study||27||
48469324|NCT03445195|101484590|FG000|NOT COMPLETED|Overall Study||2||
48469325|NCT03445195|101484591|FG001|NOT COMPLETED|Overall Study||0||
48469326|NCT02974114|101484592|FG000|STARTED|Overall Study||6||
48469327|NCT02974114|101484593|FG001|STARTED|Overall Study||7||
48469328|NCT02974114|101484594|FG002|STARTED|Overall Study||8||
48469329|NCT02974114|101484592|FG000|COMPLETED|Overall Study||6||
48469330|NCT02974114|101484593|FG001|COMPLETED|Overall Study||6||
48469331|NCT02974114|101484594|FG002|COMPLETED|Overall Study||6||
48469332|NCT02974114|101484592|FG000|NOT COMPLETED|Overall Study||0||
48469333|NCT02974114|101484593|FG001|NOT COMPLETED|Overall Study||1||
48469334|NCT02974114|101484594|FG002|NOT COMPLETED|Overall Study||2||
48469335|NCT02518113|101484595|FG000|STARTED|Overall Study||6||
48469336|NCT02518113|101484596|FG001|STARTED|Overall Study||12||
48469337|NCT02518113|101484597|FG002|STARTED|Overall Study||15||
48469338|NCT02518113|101484598|FG003|STARTED|Overall Study||3||
48469339|NCT02518113|101484595|FG000|COMPLETED|Overall Study||3||
48469340|NCT02518113|101484596|FG001|COMPLETED|Overall Study||7||
48469341|NCT02518113|101484597|FG002|COMPLETED|Overall Study||11||
48469342|NCT02518113|101484598|FG003|COMPLETED|Overall Study||3||
48469343|NCT02518113|101484595|FG000|NOT COMPLETED|Overall Study||3||
48469344|NCT02518113|101484596|FG001|NOT COMPLETED|Overall Study||5||
48469345|NCT02518113|101484597|FG002|NOT COMPLETED|Overall Study||4||
48469346|NCT02518113|101484598|FG003|NOT COMPLETED|Overall Study||0||
48469347|NCT00944697|101484599|FG000|STARTED|Overall Study||50||
48469348|NCT00944697|101484600|FG001|STARTED|Overall Study||48||
48469349|NCT00944697|101484599|FG000|COMPLETED|Overall Study||48||
48469350|NCT00944697|101484600|FG001|COMPLETED|Overall Study||43||
48469351|NCT00944697|101484599|FG000|NOT COMPLETED|Overall Study||2||
48469352|NCT00944697|101484600|FG001|NOT COMPLETED|Overall Study||5||
48469353|NCT02324972|101484601|FG000|STARTED|Overall Study||26||
48469354|NCT02324972|101484602|FG001|STARTED|Overall Study||28||
48469355|NCT02324972|101484601|FG000|COMPLETED|Overall Study||19||
48469356|NCT02324972|101484602|FG001|COMPLETED|Overall Study||23||
48469357|NCT02324972|101484601|FG000|NOT COMPLETED|Overall Study||7||
48469358|NCT02324972|101484602|FG001|NOT COMPLETED|Overall Study||5||
48469359|NCT02448771|101484603|FG000|STARTED|Overall Study||36||
48469360|NCT02448771|101484603|FG000|COMPLETED|Overall Study||0||
48469361|NCT02448771|101484603|FG000|NOT COMPLETED|Overall Study||36||
48469362|NCT01890915|101484604|FG000|STARTED|Overall Study||11||
48469363|NCT01890915|101484605|FG001|STARTED|Overall Study||10||
48469364|NCT01890915|101484604|FG000|COMPLETED|Overall Study||8||
48469365|NCT01890915|101484605|FG001|COMPLETED|Overall Study||9||
48469366|NCT01890915|101484604|FG000|NOT COMPLETED|Overall Study||3||
48469367|NCT01890915|101484605|FG001|NOT COMPLETED|Overall Study||1||
48469368|NCT02540356|101484606|FG000|STARTED|Overall Study||1||
48469369|NCT02540356|101484607|FG001|STARTED|Overall Study||0||
48469370|NCT02540356|101484606|FG000|COMPLETED|Overall Study||0||
48469371|NCT02540356|101484607|FG001|COMPLETED|Overall Study||0||
48469372|NCT02540356|101484606|FG000|NOT COMPLETED|Overall Study||1||
48469373|NCT02540356|101484607|FG001|NOT COMPLETED|Overall Study||0||
48469374|NCT02619799|101484608|FG000|STARTED|Overall Study||25||
48469375|NCT02619799|101484609|FG001|STARTED|Overall Study||25||
48469376|NCT02619799|101484608|FG000|COMPLETED|Overall Study||25||
48469377|NCT02619799|101484609|FG001|COMPLETED|Overall Study||25||
48469378|NCT02619799|101484608|FG000|NOT COMPLETED|Overall Study||0||
48469379|NCT02619799|101484609|FG001|NOT COMPLETED|Overall Study||0||
48469380|NCT00966953|101484610|FG000|STARTED|1st Intervention||6||
48469381|NCT00966953|101484611|FG001|STARTED|1st Intervention||6||
48469382|NCT00966953|101484612|FG002|STARTED|1st Intervention||6||
48469383|NCT00966953|101484613|FG003|STARTED|1st Intervention||7||
48469384|NCT00966953|101484610|FG000|COMPLETED|1st Intervention||6||
48469385|NCT00966953|101484611|FG001|COMPLETED|1st Intervention||6||
48469386|NCT00966953|101484612|FG002|COMPLETED|1st Intervention||6||
48469387|NCT00966953|101484613|FG003|COMPLETED|1st Intervention||7||
48469388|NCT00966953|101484610|FG000|NOT COMPLETED|1st Intervention||0||
48469389|NCT00966953|101484611|FG001|NOT COMPLETED|1st Intervention||0||
48469390|NCT00966953|101484612|FG002|NOT COMPLETED|1st Intervention||0||
48469391|NCT00966953|101484613|FG003|NOT COMPLETED|1st Intervention||0||
48469392|NCT00966953|101484610|FG000|STARTED|1 Week Washout After 1st Intervention||6||
48469393|NCT00966953|101484611|FG001|STARTED|1 Week Washout After 1st Intervention||6||
48469394|NCT00966953|101484612|FG002|STARTED|1 Week Washout After 1st Intervention||6||
48469395|NCT00966953|101484613|FG003|STARTED|1 Week Washout After 1st Intervention||7||
48469396|NCT00966953|101484610|FG000|COMPLETED|1 Week Washout After 1st Intervention||6||
48469397|NCT00966953|101484611|FG001|COMPLETED|1 Week Washout After 1st Intervention||6||
48469398|NCT00966953|101484612|FG002|COMPLETED|1 Week Washout After 1st Intervention||6||
48469399|NCT00966953|101484613|FG003|COMPLETED|1 Week Washout After 1st Intervention||7||
48469400|NCT00966953|101484610|FG000|NOT COMPLETED|1 Week Washout After 1st Intervention||0||
48469401|NCT00966953|101484611|FG001|NOT COMPLETED|1 Week Washout After 1st Intervention||0||
48469402|NCT00966953|101484612|FG002|NOT COMPLETED|1 Week Washout After 1st Intervention||0||
48469403|NCT00966953|101484613|FG003|NOT COMPLETED|1 Week Washout After 1st Intervention||0||
48469404|NCT00966953|101484610|FG000|STARTED|2nd Intervention||6||
48469405|NCT00966953|101484611|FG001|STARTED|2nd Intervention||6||
48469406|NCT00966953|101484612|FG002|STARTED|2nd Intervention||6||
48469407|NCT00966953|101484613|FG003|STARTED|2nd Intervention||7||
48469408|NCT00966953|101484610|FG000|COMPLETED|2nd Intervention||6||
48469409|NCT00966953|101484611|FG001|COMPLETED|2nd Intervention||6||
48469410|NCT00966953|101484612|FG002|COMPLETED|2nd Intervention||6||
48469411|NCT00966953|101484613|FG003|COMPLETED|2nd Intervention||7||
48469412|NCT00966953|101484610|FG000|NOT COMPLETED|2nd Intervention||0||
48469413|NCT00966953|101484611|FG001|NOT COMPLETED|2nd Intervention||0||
48469414|NCT00966953|101484612|FG002|NOT COMPLETED|2nd Intervention||0||
48469415|NCT00966953|101484613|FG003|NOT COMPLETED|2nd Intervention||0||
48469416|NCT00966953|101484610|FG000|STARTED|1 Week Washout After 2nd Intervention||6||
48469417|NCT00966953|101484611|FG001|STARTED|1 Week Washout After 2nd Intervention||6||
48469418|NCT00966953|101484612|FG002|STARTED|1 Week Washout After 2nd Intervention||6||
48469419|NCT00966953|101484613|FG003|STARTED|1 Week Washout After 2nd Intervention||7||
48469420|NCT00966953|101484610|FG000|COMPLETED|1 Week Washout After 2nd Intervention||6||
48469421|NCT00966953|101484611|FG001|COMPLETED|1 Week Washout After 2nd Intervention||6||
48469422|NCT00966953|101484612|FG002|COMPLETED|1 Week Washout After 2nd Intervention||6||
48469423|NCT00966953|101484613|FG003|COMPLETED|1 Week Washout After 2nd Intervention||7||
48469424|NCT00966953|101484610|FG000|NOT COMPLETED|1 Week Washout After 2nd Intervention||0||
48469425|NCT00966953|101484611|FG001|NOT COMPLETED|1 Week Washout After 2nd Intervention||0||
48469426|NCT00966953|101484612|FG002|NOT COMPLETED|1 Week Washout After 2nd Intervention||0||
48469427|NCT00966953|101484613|FG003|NOT COMPLETED|1 Week Washout After 2nd Intervention||0||
48469428|NCT00966953|101484610|FG000|STARTED|3rd Intervention Order||6||
48469429|NCT00966953|101484611|FG001|STARTED|3rd Intervention Order||6||
48469430|NCT00966953|101484612|FG002|STARTED|3rd Intervention Order||6||
48370321|NCT05485779|101234872|FG000|COMPLETED|Treatment Period 1 (Fasted)||8||
48469431|NCT00966953|101484613|FG003|STARTED|3rd Intervention Order||7||
48370322|NCT05485779|101234873|FG001|COMPLETED|Treatment Period 1 (Fasted)||6||
48370323|NCT05485779|101234874|FG002|COMPLETED|Treatment Period 1 (Fasted)||6||
48370324|NCT05485779|101234875|FG003|COMPLETED|Treatment Period 1 (Fasted)||2||
48370325|NCT05485779|101234876|FG004|COMPLETED|Treatment Period 1 (Fasted)||6||
48370326|NCT05485779|101234877|FG005|COMPLETED|Treatment Period 1 (Fasted)||6||
48370327|NCT05485779|101234878|FG006|COMPLETED|Treatment Period 1 (Fasted)||6||
48370328|NCT05485779|101234879|FG007|COMPLETED|Treatment Period 1 (Fasted)||6||
48370329|NCT05485779|101234880|FG008|COMPLETED|Treatment Period 1 (Fasted)||6||
48370330|NCT05485779|101234881|FG009|COMPLETED|Treatment Period 1 (Fasted)||6||
48370331|NCT05485779|101234882|FG010|COMPLETED|Treatment Period 1 (Fasted)||5||
48370332|NCT05485779|101234872|FG000|NOT COMPLETED|Treatment Period 1 (Fasted)||0||
48370333|NCT05485779|101234873|FG001|NOT COMPLETED|Treatment Period 1 (Fasted)||0||
48370334|NCT05485779|101234874|FG002|NOT COMPLETED|Treatment Period 1 (Fasted)||0||
48370335|NCT05485779|101234875|FG003|NOT COMPLETED|Treatment Period 1 (Fasted)||0||
48370336|NCT05485779|101234876|FG004|NOT COMPLETED|Treatment Period 1 (Fasted)||0||
48370337|NCT05485779|101234877|FG005|NOT COMPLETED|Treatment Period 1 (Fasted)||0||
48370338|NCT05485779|101234878|FG006|NOT COMPLETED|Treatment Period 1 (Fasted)||0||
48370339|NCT05485779|101234879|FG007|NOT COMPLETED|Treatment Period 1 (Fasted)||1||
48370340|NCT05485779|101234880|FG008|NOT COMPLETED|Treatment Period 1 (Fasted)||1||
48370341|NCT05485779|101234881|FG009|NOT COMPLETED|Treatment Period 1 (Fasted)||0||
48370342|NCT05485779|101234882|FG010|NOT COMPLETED|Treatment Period 1 (Fasted)||1||
48370343|NCT05485779|101234872|FG000|STARTED|Treatment Period 2 (Fed Groups Only)||0|Fed Groups only in Treatment Period 2|
48370344|NCT05485779|101234873|FG001|STARTED|Treatment Period 2 (Fed Groups Only)||0|Fed Groups only in Treatment Period 2|
48370345|NCT05485779|101234874|FG002|STARTED|Treatment Period 2 (Fed Groups Only)||0|Fed Groups only in Treatment Period 2|
48370346|NCT05485779|101234875|FG003|STARTED|Treatment Period 2 (Fed Groups Only)||2|Fed Groups only in Treatment Period 2|
48370347|NCT05485779|101234876|FG004|STARTED|Treatment Period 2 (Fed Groups Only)||6|Fed Groups only in Treatment Period 2|
48370348|NCT05485779|101234877|FG005|STARTED|Treatment Period 2 (Fed Groups Only)||0|Fed Groups only in Treatment Period 2|
48469432|NCT00966953|101484610|FG000|COMPLETED|3rd Intervention Order||6||
48469433|NCT00966953|101484611|FG001|COMPLETED|3rd Intervention Order||6||
48469434|NCT00966953|101484612|FG002|COMPLETED|3rd Intervention Order||6||
48469435|NCT00966953|101484613|FG003|COMPLETED|3rd Intervention Order||7||
48469436|NCT00966953|101484610|FG000|NOT COMPLETED|3rd Intervention Order||0||
48469437|NCT00966953|101484611|FG001|NOT COMPLETED|3rd Intervention Order||0||
48469438|NCT00966953|101484612|FG002|NOT COMPLETED|3rd Intervention Order||0||
48469439|NCT00966953|101484613|FG003|NOT COMPLETED|3rd Intervention Order||0||
48469440|NCT00966953|101484610|FG000|STARTED|1 Week Washout After 3rd Intervention||6||
48469441|NCT00966953|101484611|FG001|STARTED|1 Week Washout After 3rd Intervention||6||
48469442|NCT00966953|101484612|FG002|STARTED|1 Week Washout After 3rd Intervention||6||
48469443|NCT00966953|101484613|FG003|STARTED|1 Week Washout After 3rd Intervention||7||
48469444|NCT00966953|101484610|FG000|COMPLETED|1 Week Washout After 3rd Intervention||6||
48469445|NCT00966953|101484611|FG001|COMPLETED|1 Week Washout After 3rd Intervention||6||
48469446|NCT00966953|101484612|FG002|COMPLETED|1 Week Washout After 3rd Intervention||6||
48469447|NCT00966953|101484613|FG003|COMPLETED|1 Week Washout After 3rd Intervention||7||
48469448|NCT00966953|101484610|FG000|NOT COMPLETED|1 Week Washout After 3rd Intervention||0||
48469449|NCT00966953|101484611|FG001|NOT COMPLETED|1 Week Washout After 3rd Intervention||0||
48469450|NCT00966953|101484612|FG002|NOT COMPLETED|1 Week Washout After 3rd Intervention||0||
48469451|NCT00966953|101484613|FG003|NOT COMPLETED|1 Week Washout After 3rd Intervention||0||
48469452|NCT00966953|101484610|FG000|STARTED|4th Intervention Order||6||
48469453|NCT00966953|101484611|FG001|STARTED|4th Intervention Order||6||
48469454|NCT00966953|101484612|FG002|STARTED|4th Intervention Order||6||
48469455|NCT00966953|101484613|FG003|STARTED|4th Intervention Order||7||
48469456|NCT00966953|101484610|FG000|COMPLETED|4th Intervention Order||6||
48469457|NCT00966953|101484611|FG001|COMPLETED|4th Intervention Order||6||
48189976|NCT02466126|100788981|FG001|COMPLETED|4 Month Assessment||71||
48189977|NCT02466126|100788980|FG000|NOT COMPLETED|4 Month Assessment||16||
48189978|NCT02466126|100788981|FG001|NOT COMPLETED|4 Month Assessment||9||
48469458|NCT00966953|101484612|FG002|COMPLETED|4th Intervention Order||6||
48469459|NCT00966953|101484613|FG003|COMPLETED|4th Intervention Order||7||
48469460|NCT00966953|101484610|FG000|NOT COMPLETED|4th Intervention Order||0||
48469461|NCT00966953|101484611|FG001|NOT COMPLETED|4th Intervention Order||0||
48469462|NCT00966953|101484612|FG002|NOT COMPLETED|4th Intervention Order||0||
48469463|NCT00966953|101484613|FG003|NOT COMPLETED|4th Intervention Order||0||
48469464|NCT02114697|101484614|FG000|STARTED|Overall Study||5||
48469465|NCT02114697|101484615|FG001|STARTED|Overall Study||4||
48469466|NCT02114697|101484614|FG000|Completed Month 18 Visit|Overall Study||0||
48469467|NCT02114697|101484615|FG001|Completed Month 18 Visit|Overall Study||1||
48469468|NCT02114697|101484614|FG000|COMPLETED|Overall Study||0||
48469469|NCT02114697|101484615|FG001|COMPLETED|Overall Study||0||
48469470|NCT02114697|101484614|FG000|NOT COMPLETED|Overall Study||5||
48469471|NCT02114697|101484615|FG001|NOT COMPLETED|Overall Study||4||
48469472|NCT01945138|101484616|FG000|STARTED|Overall Study||7||
48469473|NCT01945138|101484617|FG001|STARTED|Overall Study||7||
48469474|NCT01945138|101484616|FG000|COMPLETED|Overall Study||7||
48469475|NCT01945138|101484617|FG001|COMPLETED|Overall Study||7||
48469476|NCT01945138|101484616|FG000|NOT COMPLETED|Overall Study||0||
48469477|NCT01945138|101484617|FG001|NOT COMPLETED|Overall Study||0||
48469478|NCT01144663|101484618|FG000|STARTED|Primary Vaccination Phase||528||
48469479|NCT01144663|101484619|FG001|STARTED|Primary Vaccination Phase||524||
48469480|NCT01144663|101484620|FG002|STARTED|Primary Vaccination Phase||516||
48469481|NCT01144663|101484621|FG003|STARTED|Primary Vaccination Phase||527||
48469482|NCT01144663|101484618|FG000|COMPLETED|Primary Vaccination Phase||508||
48469483|NCT01144663|101484619|FG001|COMPLETED|Primary Vaccination Phase||517||
48469484|NCT01144663|101484620|FG002|COMPLETED|Primary Vaccination Phase||508||
48469485|NCT01144663|101484621|FG003|COMPLETED|Primary Vaccination Phase||509||
48469486|NCT01144663|101484618|FG000|NOT COMPLETED|Primary Vaccination Phase||20||
48469487|NCT01144663|101484619|FG001|NOT COMPLETED|Primary Vaccination Phase||7||
48469488|NCT01144663|101484620|FG002|NOT COMPLETED|Primary Vaccination Phase||8||
48469489|NCT01144663|101484621|FG003|NOT COMPLETED|Primary Vaccination Phase||18||
48469490|NCT01144663|101484618|FG000|STARTED|Booster Vaccination Phase||497||
48469491|NCT01144663|101484619|FG001|STARTED|Booster Vaccination Phase||511||
48469492|NCT01144663|101484620|FG002|STARTED|Booster Vaccination Phase||503||
48469493|NCT01144663|101484621|FG003|STARTED|Booster Vaccination Phase||506||
48189979|NCT02466126|100788980|FG000|STARTED|8 Month Assessment||93||
48189980|NCT02466126|100788981|FG001|STARTED|8 Month Assessment||71||
48189981|NCT02466126|100788980|FG000|COMPLETED|8 Month Assessment||86||
48189982|NCT02466126|100788981|FG001|COMPLETED|8 Month Assessment||68||
48189983|NCT02466126|100788980|FG000|NOT COMPLETED|8 Month Assessment||7||
48469494|NCT01144663|101484618|FG000|COMPLETED|Booster Vaccination Phase||494||
48469495|NCT01144663|101484619|FG001|COMPLETED|Booster Vaccination Phase||509||
48469496|NCT01144663|101484620|FG002|COMPLETED|Booster Vaccination Phase||498||
48469497|NCT01144663|101484621|FG003|COMPLETED|Booster Vaccination Phase||505||
48189984|NCT02466126|100788981|FG001|NOT COMPLETED|8 Month Assessment||3||
48469498|NCT01144663|101484618|FG000|NOT COMPLETED|Booster Vaccination Phase||3||
48469499|NCT01144663|101484619|FG001|NOT COMPLETED|Booster Vaccination Phase||2||
48469500|NCT01144663|101484620|FG002|NOT COMPLETED|Booster Vaccination Phase||5||
48469501|NCT01144663|101484621|FG003|NOT COMPLETED|Booster Vaccination Phase||1||
48469502|NCT01144663|101484618|FG000|STARTED|Extended Safety Follow-Up (ESFU)||497||
48469503|NCT01144663|101484619|FG001|STARTED|Extended Safety Follow-Up (ESFU)||511||
48469504|NCT01144663|101484620|FG002|STARTED|Extended Safety Follow-Up (ESFU)||503||
48469505|NCT01144663|101484621|FG003|STARTED|Extended Safety Follow-Up (ESFU)||506||
48469506|NCT01144663|101484618|FG000|COMPLETED|Extended Safety Follow-Up (ESFU)||492||
48469507|NCT01144663|101484619|FG001|COMPLETED|Extended Safety Follow-Up (ESFU)||502||
48469508|NCT01144663|101484620|FG002|COMPLETED|Extended Safety Follow-Up (ESFU)||496||
48469509|NCT01144663|101484621|FG003|COMPLETED|Extended Safety Follow-Up (ESFU)||505||
48469510|NCT01144663|101484618|FG000|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||5||
48469511|NCT01144663|101484619|FG001|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||9||
48469512|NCT01144663|101484620|FG002|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||7||
48469513|NCT01144663|101484621|FG003|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||1||
48189985|NCT02466126|100788980|FG000|STARTED|12 Month Assessment||86||
48189986|NCT02466126|100788981|FG001|STARTED|12 Month Assessment||68||
48189987|NCT02466126|100788980|FG000|COMPLETED|12 Month Assessment||85||
48189988|NCT02466126|100788981|FG001|COMPLETED|12 Month Assessment||66||
48370349|NCT05485779|101234878|FG006|STARTED|Treatment Period 2 (Fed Groups Only)||0|Fed Groups only in Treatment Period 2|
48370350|NCT05485779|101234879|FG007|STARTED|Treatment Period 2 (Fed Groups Only)||0|Fed Groups only in Treatment Period 2|
48370351|NCT05485779|101234880|FG008|STARTED|Treatment Period 2 (Fed Groups Only)||0|Fed Groups only in Treatment Period 2|
48370352|NCT05485779|101234881|FG009|STARTED|Treatment Period 2 (Fed Groups Only)||0|Fed Groups only in Treatment Period 2|
48370353|NCT05485779|101234882|FG010|STARTED|Treatment Period 2 (Fed Groups Only)||0|Fed Groups only in Treatment Period 2|
48370354|NCT05485779|101234872|FG000|COMPLETED|Treatment Period 2 (Fed Groups Only)||0||
48370355|NCT05485779|101234873|FG001|COMPLETED|Treatment Period 2 (Fed Groups Only)||0||
48370356|NCT05485779|101234874|FG002|COMPLETED|Treatment Period 2 (Fed Groups Only)||0||
48370357|NCT05485779|101234875|FG003|COMPLETED|Treatment Period 2 (Fed Groups Only)||1||
48370358|NCT05485779|101234876|FG004|COMPLETED|Treatment Period 2 (Fed Groups Only)||6||
48370359|NCT05485779|101234877|FG005|COMPLETED|Treatment Period 2 (Fed Groups Only)||0||
48370360|NCT05485779|101234878|FG006|COMPLETED|Treatment Period 2 (Fed Groups Only)||0||
48370361|NCT05485779|101234879|FG007|COMPLETED|Treatment Period 2 (Fed Groups Only)||0||
48370362|NCT05485779|101234880|FG008|COMPLETED|Treatment Period 2 (Fed Groups Only)||0||
48370363|NCT05485779|101234881|FG009|COMPLETED|Treatment Period 2 (Fed Groups Only)||0||
48370364|NCT05485779|101234882|FG010|COMPLETED|Treatment Period 2 (Fed Groups Only)||0||
48370365|NCT05485779|101234872|FG000|NOT COMPLETED|Treatment Period 2 (Fed Groups Only)||0||
48370366|NCT05485779|101234873|FG001|NOT COMPLETED|Treatment Period 2 (Fed Groups Only)||0||
48370367|NCT05485779|101234874|FG002|NOT COMPLETED|Treatment Period 2 (Fed Groups Only)||0||
48370368|NCT05485779|101234875|FG003|NOT COMPLETED|Treatment Period 2 (Fed Groups Only)||1||
48370369|NCT05485779|101234876|FG004|NOT COMPLETED|Treatment Period 2 (Fed Groups Only)||0||
48370370|NCT05485779|101234877|FG005|NOT COMPLETED|Treatment Period 2 (Fed Groups Only)||0||
48370371|NCT05485779|101234878|FG006|NOT COMPLETED|Treatment Period 2 (Fed Groups Only)||0||
48370372|NCT05485779|101234879|FG007|NOT COMPLETED|Treatment Period 2 (Fed Groups Only)||0||
48370373|NCT05485779|101234880|FG008|NOT COMPLETED|Treatment Period 2 (Fed Groups Only)||0||
48370374|NCT05485779|101234881|FG009|NOT COMPLETED|Treatment Period 2 (Fed Groups Only)||0||
48370375|NCT05485779|101234882|FG010|NOT COMPLETED|Treatment Period 2 (Fed Groups Only)||0||
48370376|NCT03569176|101234883|FG000|STARTED|Baseline (week0) to Post-Test 1 (week6)||40||
48370377|NCT03569176|101234884|FG001|STARTED|Baseline (week0) to Post-Test 1 (week6)||31||
48370378|NCT03569176|101234883|FG000|COMPLETED|Baseline (week0) to Post-Test 1 (week6)||27||
48370379|NCT03569176|101234884|FG001|COMPLETED|Baseline (week0) to Post-Test 1 (week6)||25||
48370380|NCT03569176|101234883|FG000|NOT COMPLETED|Baseline (week0) to Post-Test 1 (week6)||13||
48370381|NCT03569176|101234884|FG001|NOT COMPLETED|Baseline (week0) to Post-Test 1 (week6)||6||
48370382|NCT03569176|101234883|FG000|STARTED|Post-Test1(week6) to Post-Test2(week12)||27||
48370383|NCT03569176|101234884|FG001|STARTED|Post-Test1(week6) to Post-Test2(week12)||25||
48370384|NCT03569176|101234883|FG000|COMPLETED|Post-Test1(week6) to Post-Test2(week12)||24||
48370385|NCT03569176|101234884|FG001|COMPLETED|Post-Test1(week6) to Post-Test2(week12)||12||
48370386|NCT03569176|101234883|FG000|NOT COMPLETED|Post-Test1(week6) to Post-Test2(week12)||3||
48469514|NCT01004172|101484622|FG000|STARTED|Overall Study||38||
48469515|NCT01004172|101484622|FG000|COMPLETED|Overall Study||0||
48469516|NCT01004172|101484622|FG000|NOT COMPLETED|Overall Study||38||
48469517|NCT01996033|101484623|FG000|STARTED|Overall Study||25||
48469518|NCT01996033|101484623|FG000|COMPLETED|Overall Study||16||
48469519|NCT01996033|101484623|FG000|NOT COMPLETED|Overall Study||9||
48469520|NCT01789320|101484624|FG000|STARTED|Overall Study||11||
48469521|NCT01789320|101484624|FG000|COMPLETED|Overall Study||9||
48469522|NCT01789320|101484624|FG000|NOT COMPLETED|Overall Study||2||
48469523|NCT03617692|101484625|FG000|STARTED|Overall Study||27||
48469524|NCT03617692|101484625|FG000|COMPLETED|Overall Study||24||
48469525|NCT03617692|101484625|FG000|NOT COMPLETED|Overall Study||3||
48469526|NCT00757601|101484626|FG000|STARTED|Period 1||2||
48469527|NCT00757601|101484627|FG001|STARTED|Period 1||2||
48469528|NCT00757601|101484628|FG002|STARTED|Period 1||2||
48469529|NCT00757601|101484629|FG003|STARTED|Period 1||2||
48469530|NCT00757601|101484630|FG004|STARTED|Period 1||2||
48469531|NCT00757601|101484631|FG005|STARTED|Period 1||2||
48469532|NCT00757601|101484632|FG006|STARTED|Period 1||2||
48469533|NCT00757601|101484633|FG007|STARTED|Period 1||2||
48469534|NCT00757601|101484634|FG008|STARTED|Period 1||2||
48469535|NCT00757601|101484635|FG009|STARTED|Period 1||2||
48469536|NCT00757601|101484636|FG010|STARTED|Period 1||2||
48469537|NCT00757601|101484637|FG011|STARTED|Period 1||3||
48469538|NCT00757601|101484626|FG000|COMPLETED|Period 1||2||
48469539|NCT00757601|101484627|FG001|COMPLETED|Period 1||2||
48469540|NCT00757601|101484628|FG002|COMPLETED|Period 1||2||
48469541|NCT00757601|101484629|FG003|COMPLETED|Period 1||2||
48469542|NCT00757601|101484630|FG004|COMPLETED|Period 1||2||
48469543|NCT00757601|101484631|FG005|COMPLETED|Period 1||2||
48469544|NCT00757601|101484632|FG006|COMPLETED|Period 1||2||
48469545|NCT00757601|101484633|FG007|COMPLETED|Period 1||2||
48469546|NCT00757601|101484634|FG008|COMPLETED|Period 1||2||
48469547|NCT00757601|101484635|FG009|COMPLETED|Period 1||2||
48469548|NCT00757601|101484636|FG010|COMPLETED|Period 1||2||
48469549|NCT00757601|101484637|FG011|COMPLETED|Period 1||3||
48469550|NCT00757601|101484626|FG000|NOT COMPLETED|Period 1||0||
48469551|NCT00757601|101484627|FG001|NOT COMPLETED|Period 1||0||
48469552|NCT00757601|101484628|FG002|NOT COMPLETED|Period 1||0||
48469553|NCT00757601|101484629|FG003|NOT COMPLETED|Period 1||0||
48469554|NCT00757601|101484630|FG004|NOT COMPLETED|Period 1||0||
48666040|NCT00526799|101967480|FG001|NOT COMPLETED|Overall Study||1||
48666041|NCT00815633|101967481|FG000|STARTED|Overall Study||1||
48666042|NCT00815633|101967481|FG000|COMPLETED|Overall Study||0||
48666043|NCT00815633|101967481|FG000|NOT COMPLETED|Overall Study||1||
48666044|NCT00476645|101967482|FG000|STARTED|Overall Study||10||
48666045|NCT00476645|101967482|FG000|COMPLETED|Overall Study||10||
48666046|NCT00476645|101967482|FG000|NOT COMPLETED|Overall Study||0||
48666047|NCT05837481|101967483|FG000|STARTED|Overall Study||15||
48666048|NCT05837481|101967484|FG001|STARTED|Overall Study||15||
48666049|NCT05837481|101967483|FG000|COMPLETED|Overall Study||15||
48666050|NCT05837481|101967484|FG001|COMPLETED|Overall Study||14||
48666051|NCT05837481|101967483|FG000|NOT COMPLETED|Overall Study||0||
48666052|NCT05837481|101967484|FG001|NOT COMPLETED|Overall Study||1||
48666053|NCT01531335|101967485|FG000|STARTED|Overall Study||40||
48666054|NCT01531335|101967486|FG001|STARTED|Overall Study||40||
48666055|NCT01531335|101967485|FG000|COMPLETED|Overall Study||40||
48666056|NCT01531335|101967486|FG001|COMPLETED|Overall Study||40||
48666057|NCT01531335|101967485|FG000|NOT COMPLETED|Overall Study||0||
48666058|NCT01531335|101967486|FG001|NOT COMPLETED|Overall Study||0||
48666059|NCT03374306|101967487|FG000|STARTED|Overall Study||36||
48666060|NCT03374306|101967488|FG001|STARTED|Overall Study||35||
48666061|NCT03374306|101967487|FG000|COMPLETED|Overall Study||34||
48666062|NCT03374306|101967488|FG001|COMPLETED|Overall Study||27||
48666063|NCT03374306|101967487|FG000|NOT COMPLETED|Overall Study||2||
48666064|NCT03374306|101967488|FG001|NOT COMPLETED|Overall Study||8||
48666065|NCT03738228|101967489|FG000|STARTED|Overall Study||21||
48666066|NCT03738228|101967490|FG001|STARTED|Overall Study||19||
48666067|NCT03738228|101967489|FG000|COMPLETED|Overall Study||19||
48666068|NCT03738228|101967490|FG001|COMPLETED|Overall Study||17||
48666069|NCT03738228|101967489|FG000|NOT COMPLETED|Overall Study||2||
48666070|NCT03738228|101967490|FG001|NOT COMPLETED|Overall Study||2||
48666071|NCT00391716|101967491|FG000|STARTED|Overall Study||54||
48666072|NCT00391716|101967492|FG001|STARTED|Overall Study||47||
48666073|NCT00391716|101967493|FG002|STARTED|Overall Study||49||
48666074|NCT00391716|101967491|FG000|COMPLETED|Overall Study||27||
48666075|NCT00391716|101967492|FG001|COMPLETED|Overall Study||28||
48666076|NCT00391716|101967493|FG002|COMPLETED|Overall Study||30||
48666077|NCT00391716|101967491|FG000|NOT COMPLETED|Overall Study||27||
48666078|NCT00391716|101967492|FG001|NOT COMPLETED|Overall Study||19||
48666079|NCT00391716|101967493|FG002|NOT COMPLETED|Overall Study||19||
48666080|NCT05437419|101967494|FG000|STARTED|Overall Study||6||
48666081|NCT05437419|101967495|FG001|STARTED|Overall Study||6||
48666082|NCT05437419|101967496|FG002|STARTED|Overall Study||6||
48666083|NCT05437419|101967497|FG003|STARTED|Overall Study||6||
48666084|NCT05437419|101967498|FG004|STARTED|Overall Study||8||
48666085|NCT05437419|101967494|FG000|COMPLETED|Overall Study||6||
48666086|NCT05437419|101967495|FG001|COMPLETED|Overall Study||6||
48666087|NCT05437419|101967496|FG002|COMPLETED|Overall Study||6||
48666088|NCT05437419|101967497|FG003|COMPLETED|Overall Study||6||
48666089|NCT05437419|101967498|FG004|COMPLETED|Overall Study||8||
48666090|NCT05437419|101967494|FG000|NOT COMPLETED|Overall Study||0||
48666091|NCT05437419|101967495|FG001|NOT COMPLETED|Overall Study||0||
48666092|NCT05437419|101967496|FG002|NOT COMPLETED|Overall Study||0||
48666093|NCT05437419|101967497|FG003|NOT COMPLETED|Overall Study||0||
48666094|NCT05437419|101967498|FG004|NOT COMPLETED|Overall Study||0||
48666095|NCT00375713|101967499|FG000|STARTED|Overall Study||232||
48666096|NCT00375713|101967500|FG001|STARTED|Overall Study||234||
48666097|NCT00375713|101967499|FG000|COMPLETED|Overall Study||212||
48666098|NCT00375713|101967500|FG001|COMPLETED|Overall Study||211||
48666099|NCT00375713|101967499|FG000|NOT COMPLETED|Overall Study||20||
48666100|NCT00375713|101967500|FG001|NOT COMPLETED|Overall Study||23||
48666101|NCT04581395|101967501|FG000|STARTED|Overall Study||100||
48666102|NCT04581395|101967502|FG001|STARTED|Overall Study||100||
48666103|NCT04581395|101967503|FG002|STARTED|Overall Study||100||
48666104|NCT04581395|101967501|FG000|COMPLETED|Overall Study||96||
48666105|NCT04581395|101967502|FG001|COMPLETED|Overall Study||96||
48469555|NCT00757601|101484631|FG005|NOT COMPLETED|Period 1||0||
48469556|NCT00757601|101484632|FG006|NOT COMPLETED|Period 1||0||
48469557|NCT00757601|101484633|FG007|NOT COMPLETED|Period 1||0||
48469558|NCT00757601|101484634|FG008|NOT COMPLETED|Period 1||0||
48469559|NCT00757601|101484635|FG009|NOT COMPLETED|Period 1||0||
48666106|NCT04581395|101967503|FG002|COMPLETED|Overall Study||98||
48666107|NCT04581395|101967501|FG000|NOT COMPLETED|Overall Study||4||
48666108|NCT04581395|101967502|FG001|NOT COMPLETED|Overall Study||4||
48666109|NCT04581395|101967503|FG002|NOT COMPLETED|Overall Study||2||
48666110|NCT02160808|101967504|FG000|STARTED|Overall Study||87||
48189989|NCT02466126|100788980|FG000|NOT COMPLETED|12 Month Assessment||1||
48469560|NCT00757601|101484636|FG010|NOT COMPLETED|Period 1||0||
48469561|NCT00757601|101484637|FG011|NOT COMPLETED|Period 1||0||
48469562|NCT00757601|101484626|FG000|STARTED|Period 2||2||
48469563|NCT00757601|101484627|FG001|STARTED|Period 2||2||
48469564|NCT00757601|101484628|FG002|STARTED|Period 2||2||
48469565|NCT00757601|101484629|FG003|STARTED|Period 2||2||
48469566|NCT00757601|101484630|FG004|STARTED|Period 2||2||
48469567|NCT00757601|101484631|FG005|STARTED|Period 2||2||
48469568|NCT00757601|101484632|FG006|STARTED|Period 2||2||
48469569|NCT00757601|101484633|FG007|STARTED|Period 2||2||
48370387|NCT03569176|101234884|FG001|NOT COMPLETED|Post-Test1(week6) to Post-Test2(week12)||13||
48469570|NCT00757601|101484634|FG008|STARTED|Period 2||2||
48189990|NCT02466126|100788981|FG001|NOT COMPLETED|12 Month Assessment||2||
48370388|NCT03569176|101234883|FG000|STARTED|Post-Test1(week12) to Post-Test2(week18)||0||
48469571|NCT00757601|101484635|FG009|STARTED|Period 2||2||
48469572|NCT00757601|101484636|FG010|STARTED|Period 2||2||
48469573|NCT00757601|101484637|FG011|STARTED|Period 2||3||
48469574|NCT00757601|101484626|FG000|COMPLETED|Period 2||2||
48469575|NCT00757601|101484627|FG001|COMPLETED|Period 2||2||
48469576|NCT00757601|101484628|FG002|COMPLETED|Period 2||2||
48469577|NCT00757601|101484629|FG003|COMPLETED|Period 2||2||
48469578|NCT00757601|101484630|FG004|COMPLETED|Period 2||2||
48469579|NCT00757601|101484631|FG005|COMPLETED|Period 2||2||
48469580|NCT00757601|101484632|FG006|COMPLETED|Period 2||2||
48469581|NCT00757601|101484633|FG007|COMPLETED|Period 2||2||
48469582|NCT00757601|101484634|FG008|COMPLETED|Period 2||2||
48469583|NCT00757601|101484635|FG009|COMPLETED|Period 2||2||
48469584|NCT00757601|101484636|FG010|COMPLETED|Period 2||2||
48469585|NCT00757601|101484637|FG011|COMPLETED|Period 2||2||
48469586|NCT00757601|101484626|FG000|NOT COMPLETED|Period 2||0||
48469587|NCT00757601|101484627|FG001|NOT COMPLETED|Period 2||0||
48469588|NCT00757601|101484628|FG002|NOT COMPLETED|Period 2||0||
48469589|NCT00757601|101484629|FG003|NOT COMPLETED|Period 2||0||
48469590|NCT00757601|101484630|FG004|NOT COMPLETED|Period 2||0||
48469591|NCT00757601|101484631|FG005|NOT COMPLETED|Period 2||0||
48469592|NCT00757601|101484632|FG006|NOT COMPLETED|Period 2||0||
48469593|NCT00757601|101484633|FG007|NOT COMPLETED|Period 2||0||
48469594|NCT00757601|101484634|FG008|NOT COMPLETED|Period 2||0||
48469595|NCT00757601|101484635|FG009|NOT COMPLETED|Period 2||0||
48469596|NCT00757601|101484636|FG010|NOT COMPLETED|Period 2||0||
48469597|NCT00757601|101484637|FG011|NOT COMPLETED|Period 2||1||
48469598|NCT00757601|101484626|FG000|STARTED|Period 3||2||
48469599|NCT00757601|101484627|FG001|STARTED|Period 3||2||
48469600|NCT00757601|101484628|FG002|STARTED|Period 3||2||
48469601|NCT00757601|101484629|FG003|STARTED|Period 3||2||
48469602|NCT00757601|101484630|FG004|STARTED|Period 3||2||
48469603|NCT00757601|101484631|FG005|STARTED|Period 3||2||
48469604|NCT00757601|101484632|FG006|STARTED|Period 3||2||
48469605|NCT00757601|101484633|FG007|STARTED|Period 3||2||
48469606|NCT00757601|101484634|FG008|STARTED|Period 3||2||
48469607|NCT00757601|101484635|FG009|STARTED|Period 3||2||
48469608|NCT00757601|101484636|FG010|STARTED|Period 3||2||
48469609|NCT00757601|101484637|FG011|STARTED|Period 3||2||
48469610|NCT00757601|101484626|FG000|COMPLETED|Period 3||2||
48469611|NCT00757601|101484627|FG001|COMPLETED|Period 3||2||
48469612|NCT00757601|101484628|FG002|COMPLETED|Period 3||2||
48469613|NCT00757601|101484629|FG003|COMPLETED|Period 3||2||
48469614|NCT00757601|101484630|FG004|COMPLETED|Period 3||2||
48469615|NCT00757601|101484631|FG005|COMPLETED|Period 3||2||
48469616|NCT00757601|101484632|FG006|COMPLETED|Period 3||2||
48469617|NCT00757601|101484633|FG007|COMPLETED|Period 3||2||
48469618|NCT00757601|101484634|FG008|COMPLETED|Period 3||2||
48469619|NCT00757601|101484635|FG009|COMPLETED|Period 3||2||
48469620|NCT00757601|101484636|FG010|COMPLETED|Period 3||2||
48469621|NCT00757601|101484637|FG011|COMPLETED|Period 3||2||
48469622|NCT00757601|101484626|FG000|NOT COMPLETED|Period 3||0||
48469623|NCT00757601|101484627|FG001|NOT COMPLETED|Period 3||0||
48469624|NCT00757601|101484628|FG002|NOT COMPLETED|Period 3||0||
48469625|NCT00757601|101484629|FG003|NOT COMPLETED|Period 3||0||
48469626|NCT00757601|101484630|FG004|NOT COMPLETED|Period 3||0||
48469627|NCT00757601|101484631|FG005|NOT COMPLETED|Period 3||0||
48469628|NCT00757601|101484632|FG006|NOT COMPLETED|Period 3||0||
48469629|NCT00757601|101484633|FG007|NOT COMPLETED|Period 3||0||
48469630|NCT00757601|101484634|FG008|NOT COMPLETED|Period 3||0||
48469631|NCT00757601|101484635|FG009|NOT COMPLETED|Period 3||0||
48469632|NCT00757601|101484636|FG010|NOT COMPLETED|Period 3||0||
48469633|NCT00757601|101484637|FG011|NOT COMPLETED|Period 3||0||
48469634|NCT00757601|101484626|FG000|STARTED|Period 4||2||
48469635|NCT00757601|101484627|FG001|STARTED|Period 4||2||
48469636|NCT00757601|101484628|FG002|STARTED|Period 4||2||
48469637|NCT00757601|101484629|FG003|STARTED|Period 4||2||
48469638|NCT00757601|101484630|FG004|STARTED|Period 4||2||
48469639|NCT00757601|101484631|FG005|STARTED|Period 4||2||
48469640|NCT00757601|101484632|FG006|STARTED|Period 4||2||
48469641|NCT00757601|101484633|FG007|STARTED|Period 4||2||
48469642|NCT00757601|101484634|FG008|STARTED|Period 4||2||
48469643|NCT00757601|101484635|FG009|STARTED|Period 4||2||
48469644|NCT00757601|101484636|FG010|STARTED|Period 4||2||
48469645|NCT00757601|101484637|FG011|STARTED|Period 4||2||
48469646|NCT00757601|101484626|FG000|COMPLETED|Period 4||2||
48469647|NCT00757601|101484627|FG001|COMPLETED|Period 4||2||
48469648|NCT00757601|101484628|FG002|COMPLETED|Period 4||2||
48469649|NCT00757601|101484629|FG003|COMPLETED|Period 4||2||
48469650|NCT00757601|101484630|FG004|COMPLETED|Period 4||2||
48469651|NCT00757601|101484631|FG005|COMPLETED|Period 4||2||
48469652|NCT00757601|101484632|FG006|COMPLETED|Period 4||2||
48469653|NCT00757601|101484633|FG007|COMPLETED|Period 4||2||
48189991|NCT00811187|100788982|FG000|STARTED|Overall Study||40||
48189992|NCT00811187|100788983|FG001|STARTED|Overall Study||40||
48469654|NCT00757601|101484634|FG008|COMPLETED|Period 4||2||
48469655|NCT00757601|101484635|FG009|COMPLETED|Period 4||1||
48469656|NCT00757601|101484636|FG010|COMPLETED|Period 4||2||
48469657|NCT00757601|101484637|FG011|COMPLETED|Period 4||1||
48469658|NCT00757601|101484626|FG000|NOT COMPLETED|Period 4||0||
48469659|NCT00757601|101484627|FG001|NOT COMPLETED|Period 4||0||
48469660|NCT00757601|101484628|FG002|NOT COMPLETED|Period 4||0||
48469661|NCT00757601|101484629|FG003|NOT COMPLETED|Period 4||0||
48469662|NCT00757601|101484630|FG004|NOT COMPLETED|Period 4||0||
48469663|NCT00757601|101484631|FG005|NOT COMPLETED|Period 4||0||
48469664|NCT00757601|101484632|FG006|NOT COMPLETED|Period 4||0||
48469665|NCT00757601|101484633|FG007|NOT COMPLETED|Period 4||0||
48469666|NCT00757601|101484634|FG008|NOT COMPLETED|Period 4||0||
48469667|NCT00757601|101484635|FG009|NOT COMPLETED|Period 4||1||
48469668|NCT00757601|101484636|FG010|NOT COMPLETED|Period 4||0||
48469669|NCT00757601|101484637|FG011|NOT COMPLETED|Period 4||1||
48469670|NCT00757601|101484626|FG000|STARTED|Period 5||2||
48469671|NCT00757601|101484627|FG001|STARTED|Period 5||2||
48469672|NCT00757601|101484628|FG002|STARTED|Period 5||2||
48469673|NCT00757601|101484629|FG003|STARTED|Period 5||2||
48469674|NCT00757601|101484630|FG004|STARTED|Period 5||2||
48469675|NCT00757601|101484631|FG005|STARTED|Period 5||2||
48469676|NCT00757601|101484632|FG006|STARTED|Period 5||2||
48469677|NCT00757601|101484633|FG007|STARTED|Period 5||2||
48469678|NCT00757601|101484634|FG008|STARTED|Period 5||2||
48469679|NCT00757601|101484635|FG009|STARTED|Period 5||1||
48469680|NCT00757601|101484636|FG010|STARTED|Period 5||2||
48469681|NCT00757601|101484637|FG011|STARTED|Period 5||1||
48189993|NCT00811187|100788982|FG000|COMPLETED|Overall Study||37||
48189994|NCT00811187|100788983|FG001|COMPLETED|Overall Study||37||
48189995|NCT00811187|100788982|FG000|NOT COMPLETED|Overall Study||3||
48469682|NCT00757601|101484626|FG000|COMPLETED|Period 5||2||
48469683|NCT00757601|101484627|FG001|COMPLETED|Period 5||2||
48469684|NCT00757601|101484628|FG002|COMPLETED|Period 5||2||
48469685|NCT00757601|101484629|FG003|COMPLETED|Period 5||2||
48469686|NCT00757601|101484630|FG004|COMPLETED|Period 5||2||
48469687|NCT00757601|101484631|FG005|COMPLETED|Period 5||2||
48469688|NCT00757601|101484632|FG006|COMPLETED|Period 5||2||
48469689|NCT00757601|101484633|FG007|COMPLETED|Period 5||2||
48469690|NCT00757601|101484634|FG008|COMPLETED|Period 5||2||
48469691|NCT00757601|101484635|FG009|COMPLETED|Period 5||1||
48469692|NCT00757601|101484636|FG010|COMPLETED|Period 5||2||
48469693|NCT00757601|101484637|FG011|COMPLETED|Period 5||1||
48469694|NCT00757601|101484626|FG000|NOT COMPLETED|Period 5||0||
48469695|NCT00757601|101484627|FG001|NOT COMPLETED|Period 5||0||
48469696|NCT00757601|101484628|FG002|NOT COMPLETED|Period 5||0||
48469697|NCT00757601|101484629|FG003|NOT COMPLETED|Period 5||0||
48469698|NCT00757601|101484630|FG004|NOT COMPLETED|Period 5||0||
48469699|NCT00757601|101484631|FG005|NOT COMPLETED|Period 5||0||
48469700|NCT00757601|101484632|FG006|NOT COMPLETED|Period 5||0||
48469701|NCT00757601|101484633|FG007|NOT COMPLETED|Period 5||0||
48469702|NCT00757601|101484634|FG008|NOT COMPLETED|Period 5||0||
48469703|NCT00757601|101484635|FG009|NOT COMPLETED|Period 5||0||
48469704|NCT00757601|101484636|FG010|NOT COMPLETED|Period 5||0||
48469705|NCT00757601|101484637|FG011|NOT COMPLETED|Period 5||0||
48469706|NCT00510510|101484638|FG000|STARTED|Overall Study||92||
48469707|NCT00510510|101484639|FG001|STARTED|Overall Study||98||
48469708|NCT00510510|101484640|FG002|STARTED|Overall Study||91||
48469709|NCT00510510|101484638|FG000|COMPLETED|Overall Study||87||
48469710|NCT00510510|101484639|FG001|COMPLETED|Overall Study||89||
48469711|NCT00510510|101484640|FG002|COMPLETED|Overall Study||74||
48469712|NCT00510510|101484638|FG000|NOT COMPLETED|Overall Study||5||
48469713|NCT00510510|101484639|FG001|NOT COMPLETED|Overall Study||9||
48469714|NCT00510510|101484640|FG002|NOT COMPLETED|Overall Study||17||
48469715|NCT00561730|101484641|FG000|STARTED|Overall Study||1995||
48469716|NCT00561730|101484641|FG000|COMPLETED|Overall Study||1986||
48469717|NCT00561730|101484641|FG000|NOT COMPLETED|Overall Study||9||
48469718|NCT02841709|101484642|FG000|STARTED|1st Intervention||12||
48469719|NCT02841709|101484643|FG001|STARTED|1st Intervention||11||
48469720|NCT02841709|101484644|FG002|STARTED|1st Intervention||12||
48469721|NCT02841709|101484645|FG003|STARTED|1st Intervention||12||
48469722|NCT02841709|101484646|FG004|STARTED|1st Intervention||11||
48469723|NCT02841709|101484642|FG000|COMPLETED|1st Intervention||12||
48469724|NCT02841709|101484643|FG001|COMPLETED|1st Intervention||11||
48469725|NCT02841709|101484644|FG002|COMPLETED|1st Intervention||12||
48469726|NCT02841709|101484645|FG003|COMPLETED|1st Intervention||12||
48469727|NCT02841709|101484646|FG004|COMPLETED|1st Intervention||11||
48469728|NCT02841709|101484642|FG000|NOT COMPLETED|1st Intervention||0||
48469729|NCT02841709|101484643|FG001|NOT COMPLETED|1st Intervention||0||
48469730|NCT02841709|101484644|FG002|NOT COMPLETED|1st Intervention||0||
48469731|NCT02841709|101484645|FG003|NOT COMPLETED|1st Intervention||0||
48469732|NCT02841709|101484646|FG004|NOT COMPLETED|1st Intervention||0||
48469733|NCT02841709|101484642|FG000|STARTED|Washout Period 1||12||
48469734|NCT02841709|101484643|FG001|STARTED|Washout Period 1||11||
48469735|NCT02841709|101484644|FG002|STARTED|Washout Period 1||12||
48469736|NCT02841709|101484645|FG003|STARTED|Washout Period 1||12||
48469737|NCT02841709|101484646|FG004|STARTED|Washout Period 1||11||
48469738|NCT02841709|101484642|FG000|COMPLETED|Washout Period 1||12||
48469739|NCT02841709|101484643|FG001|COMPLETED|Washout Period 1||11||
48469740|NCT02841709|101484644|FG002|COMPLETED|Washout Period 1||12||
48469741|NCT02841709|101484645|FG003|COMPLETED|Washout Period 1||12||
48469742|NCT02841709|101484646|FG004|COMPLETED|Washout Period 1||11||
48469743|NCT02841709|101484642|FG000|NOT COMPLETED|Washout Period 1||0||
48469744|NCT02841709|101484643|FG001|NOT COMPLETED|Washout Period 1||0||
48469745|NCT02841709|101484644|FG002|NOT COMPLETED|Washout Period 1||0||
48469746|NCT02841709|101484645|FG003|NOT COMPLETED|Washout Period 1||0||
48469747|NCT02841709|101484646|FG004|NOT COMPLETED|Washout Period 1||0||
48469748|NCT02841709|101484642|FG000|STARTED|2nd Intervention||12||
48469749|NCT02841709|101484643|FG001|STARTED|2nd Intervention||11||
48469750|NCT02841709|101484644|FG002|STARTED|2nd Intervention||12||
48469751|NCT02841709|101484645|FG003|STARTED|2nd Intervention||12||
48469752|NCT02841709|101484646|FG004|STARTED|2nd Intervention||11||
48469753|NCT02841709|101484642|FG000|COMPLETED|2nd Intervention||12||
48469754|NCT02841709|101484643|FG001|COMPLETED|2nd Intervention||11||
48469755|NCT02841709|101484644|FG002|COMPLETED|2nd Intervention||12||
48469756|NCT02841709|101484645|FG003|COMPLETED|2nd Intervention||12||
48469757|NCT02841709|101484646|FG004|COMPLETED|2nd Intervention||11||
48469758|NCT02841709|101484642|FG000|NOT COMPLETED|2nd Intervention||0||
48469759|NCT02841709|101484643|FG001|NOT COMPLETED|2nd Intervention||0||
48469760|NCT02841709|101484644|FG002|NOT COMPLETED|2nd Intervention||0||
48469761|NCT02841709|101484645|FG003|NOT COMPLETED|2nd Intervention||0||
48469762|NCT02841709|101484646|FG004|NOT COMPLETED|2nd Intervention||0||
48469763|NCT02841709|101484642|FG000|STARTED|Washout Period 2||12||
48469764|NCT02841709|101484643|FG001|STARTED|Washout Period 2||11||
48469765|NCT02841709|101484644|FG002|STARTED|Washout Period 2||12||
48469766|NCT02841709|101484645|FG003|STARTED|Washout Period 2||12||
48469767|NCT02841709|101484646|FG004|STARTED|Washout Period 2||11||
48469768|NCT02841709|101484642|FG000|COMPLETED|Washout Period 2||12||
48469769|NCT02841709|101484643|FG001|COMPLETED|Washout Period 2||11||
48469770|NCT02841709|101484644|FG002|COMPLETED|Washout Period 2||12||
48469771|NCT02841709|101484645|FG003|COMPLETED|Washout Period 2||12||
48469772|NCT02841709|101484646|FG004|COMPLETED|Washout Period 2||11||
48469773|NCT02841709|101484642|FG000|NOT COMPLETED|Washout Period 2||0||
48469774|NCT02841709|101484643|FG001|NOT COMPLETED|Washout Period 2||0||
48469775|NCT02841709|101484644|FG002|NOT COMPLETED|Washout Period 2||0||
48469776|NCT02841709|101484645|FG003|NOT COMPLETED|Washout Period 2||0||
48469777|NCT02841709|101484646|FG004|NOT COMPLETED|Washout Period 2||0||
48469778|NCT02841709|101484642|FG000|STARTED|3rd Intervention||12||
48469779|NCT02841709|101484643|FG001|STARTED|3rd Intervention||11||
48469780|NCT02841709|101484644|FG002|STARTED|3rd Intervention||12||
48469781|NCT02841709|101484645|FG003|STARTED|3rd Intervention||12||
48469782|NCT02841709|101484646|FG004|STARTED|3rd Intervention||11||
48469783|NCT02841709|101484642|FG000|COMPLETED|3rd Intervention||12||
48469784|NCT02841709|101484643|FG001|COMPLETED|3rd Intervention||11||
48469785|NCT02841709|101484644|FG002|COMPLETED|3rd Intervention||12||
48469786|NCT02841709|101484645|FG003|COMPLETED|3rd Intervention||12||
48469787|NCT02841709|101484646|FG004|COMPLETED|3rd Intervention||11||
48469788|NCT02841709|101484642|FG000|NOT COMPLETED|3rd Intervention||0||
48469789|NCT02841709|101484643|FG001|NOT COMPLETED|3rd Intervention||0||
48469790|NCT02841709|101484644|FG002|NOT COMPLETED|3rd Intervention||0||
48469791|NCT02841709|101484645|FG003|NOT COMPLETED|3rd Intervention||0||
48469792|NCT02841709|101484646|FG004|NOT COMPLETED|3rd Intervention||0||
48469793|NCT02841709|101484642|FG000|STARTED|Washout Period 3||12||
48469794|NCT02841709|101484643|FG001|STARTED|Washout Period 3||11||
48469795|NCT02841709|101484644|FG002|STARTED|Washout Period 3||12||
48469796|NCT02841709|101484645|FG003|STARTED|Washout Period 3||12||
48469797|NCT02841709|101484646|FG004|STARTED|Washout Period 3||11||
48469798|NCT02841709|101484642|FG000|COMPLETED|Washout Period 3||12||
48469799|NCT02841709|101484643|FG001|COMPLETED|Washout Period 3||11||
48469800|NCT02841709|101484644|FG002|COMPLETED|Washout Period 3||12||
48469801|NCT02841709|101484645|FG003|COMPLETED|Washout Period 3||12||
48469802|NCT02841709|101484646|FG004|COMPLETED|Washout Period 3||11||
48469803|NCT02841709|101484642|FG000|NOT COMPLETED|Washout Period 3||0||
48469804|NCT02841709|101484643|FG001|NOT COMPLETED|Washout Period 3||0||
48469805|NCT02841709|101484644|FG002|NOT COMPLETED|Washout Period 3||0||
48469806|NCT02841709|101484645|FG003|NOT COMPLETED|Washout Period 3||0||
48469807|NCT02841709|101484646|FG004|NOT COMPLETED|Washout Period 3||0||
48469808|NCT02841709|101484642|FG000|STARTED|4th Intervention||12||
48469809|NCT02841709|101484643|FG001|STARTED|4th Intervention||11||
48469810|NCT02841709|101484644|FG002|STARTED|4th Intervention||12||
48469811|NCT02841709|101484645|FG003|STARTED|4th Intervention||12||
48469812|NCT02841709|101484646|FG004|STARTED|4th Intervention||11||
48469813|NCT02841709|101484642|FG000|COMPLETED|4th Intervention||12||
48469814|NCT02841709|101484643|FG001|COMPLETED|4th Intervention||11||
48469815|NCT02841709|101484644|FG002|COMPLETED|4th Intervention||12||
48469816|NCT02841709|101484645|FG003|COMPLETED|4th Intervention||12||
48469817|NCT02841709|101484646|FG004|COMPLETED|4th Intervention||11||
48469818|NCT02841709|101484642|FG000|NOT COMPLETED|4th Intervention||0||
48469819|NCT02841709|101484643|FG001|NOT COMPLETED|4th Intervention||0||
48469820|NCT02841709|101484644|FG002|NOT COMPLETED|4th Intervention||0||
48469821|NCT02841709|101484645|FG003|NOT COMPLETED|4th Intervention||0||
48469822|NCT02841709|101484646|FG004|NOT COMPLETED|4th Intervention||0||
48469823|NCT02841709|101484642|FG000|STARTED|Washout Period 4||12||
48469824|NCT02841709|101484643|FG001|STARTED|Washout Period 4||11||
48469825|NCT02841709|101484644|FG002|STARTED|Washout Period 4||12||
48469826|NCT02841709|101484645|FG003|STARTED|Washout Period 4||12||
48469827|NCT02841709|101484646|FG004|STARTED|Washout Period 4||11||
48469828|NCT02841709|101484642|FG000|COMPLETED|Washout Period 4||12||
48469829|NCT02841709|101484643|FG001|COMPLETED|Washout Period 4||11||
48469830|NCT02841709|101484644|FG002|COMPLETED|Washout Period 4||12||
48469831|NCT02841709|101484645|FG003|COMPLETED|Washout Period 4||12||
48469832|NCT02841709|101484646|FG004|COMPLETED|Washout Period 4||11||
48469833|NCT02841709|101484642|FG000|NOT COMPLETED|Washout Period 4||0||
48469834|NCT02841709|101484643|FG001|NOT COMPLETED|Washout Period 4||0||
48469835|NCT02841709|101484644|FG002|NOT COMPLETED|Washout Period 4||0||
48469836|NCT02841709|101484645|FG003|NOT COMPLETED|Washout Period 4||0||
48469837|NCT02841709|101484646|FG004|NOT COMPLETED|Washout Period 4||0||
48469838|NCT02841709|101484642|FG000|STARTED|5th Intervention||12||
48469839|NCT02841709|101484643|FG001|STARTED|5th Intervention||11||
48469840|NCT02841709|101484644|FG002|STARTED|5th Intervention||12||
48469841|NCT02841709|101484645|FG003|STARTED|5th Intervention||12||
48469842|NCT02841709|101484646|FG004|STARTED|5th Intervention||11||
48469843|NCT02841709|101484642|FG000|COMPLETED|5th Intervention||10||
48469844|NCT02841709|101484643|FG001|COMPLETED|5th Intervention||11||
48469845|NCT02841709|101484644|FG002|COMPLETED|5th Intervention||12||
48469846|NCT02841709|101484645|FG003|COMPLETED|5th Intervention||12||
48189996|NCT00811187|100788983|FG001|NOT COMPLETED|Overall Study||3||
48189997|NCT02359058|100788984|FG000|STARTED|Overall Study||6||
48469847|NCT02841709|101484646|FG004|COMPLETED|5th Intervention||9||
48469848|NCT02841709|101484642|FG000|NOT COMPLETED|5th Intervention||2||
48469849|NCT02841709|101484643|FG001|NOT COMPLETED|5th Intervention||0||
48189998|NCT02359058|100788985|FG001|STARTED|Overall Study||6||
48189999|NCT02359058|100788986|FG002|STARTED|Overall Study||6||
48190000|NCT02359058|100788984|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
48190001|NCT02359058|100788985|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
48190002|NCT02359058|100788986|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
48190003|NCT02359058|100788984|FG000|COMPLETED|Overall Study||6||
48190004|NCT02359058|100788985|FG001|COMPLETED|Overall Study||6||
48469850|NCT02841709|101484644|FG002|NOT COMPLETED|5th Intervention||0||
48469851|NCT02841709|101484645|FG003|NOT COMPLETED|5th Intervention||0||
48469852|NCT02841709|101484646|FG004|NOT COMPLETED|5th Intervention||2||
48469853|NCT02001558|101484647|FG000|STARTED|Overall Study||32||
48469854|NCT02001558|101484648|FG001|STARTED|Overall Study||33||
48469855|NCT02001558|101484647|FG000|COMPLETED|Overall Study||24||
48469856|NCT02001558|101484648|FG001|COMPLETED|Overall Study||19||
48469857|NCT02001558|101484647|FG000|NOT COMPLETED|Overall Study||8||
48469858|NCT02001558|101484648|FG001|NOT COMPLETED|Overall Study||14||
48469859|NCT02153398|101484649|FG000|STARTED|Overall Study||10||
48469860|NCT02153398|101484650|FG001|STARTED|Overall Study||10||
48469861|NCT02153398|101484651|FG002|STARTED|Overall Study||10||
48469862|NCT02153398|101484652|FG003|STARTED|Overall Study||10||
48469863|NCT02153398|101484653|FG004|STARTED|Overall Study||10||
48469864|NCT02153398|101484649|FG000|COMPLETED|Overall Study||9||
48469865|NCT02153398|101484650|FG001|COMPLETED|Overall Study||10||
48469866|NCT02153398|101484651|FG002|COMPLETED|Overall Study||9||
48469867|NCT02153398|101484652|FG003|COMPLETED|Overall Study||9||
48469868|NCT02153398|101484653|FG004|COMPLETED|Overall Study||10||
48469869|NCT02153398|101484649|FG000|NOT COMPLETED|Overall Study||1||
48469870|NCT02153398|101484650|FG001|NOT COMPLETED|Overall Study||0||
48190005|NCT02359058|100788986|FG002|COMPLETED|Overall Study||6||
48190006|NCT02359058|100788984|FG000|NOT COMPLETED|Overall Study||0||
48190007|NCT02359058|100788985|FG001|NOT COMPLETED|Overall Study||0||
48469871|NCT02153398|101484651|FG002|NOT COMPLETED|Overall Study||1||
48469872|NCT02153398|101484652|FG003|NOT COMPLETED|Overall Study||1||
48469873|NCT02153398|101484653|FG004|NOT COMPLETED|Overall Study||0||
48469874|NCT02192099|101484654|FG000|STARTED|Overall Study||61||
48469875|NCT02192099|101484654|FG000|COMPLETED|Overall Study||0||
48469876|NCT02192099|101484654|FG000|NOT COMPLETED|Overall Study||61||
48469877|NCT02374918|101484655|FG000|STARTED|Overall Study||17||
48469878|NCT02374918|101484656|FG001|STARTED|Overall Study||18||
48469879|NCT02374918|101484657|FG002|STARTED|Overall Study||22||
48469880|NCT02374918|101484658|FG003|STARTED|Overall Study||20||
48469881|NCT02374918|101484655|FG000|COMPLETED|Overall Study||14||
48469882|NCT02374918|101484656|FG001|COMPLETED|Overall Study||17||
48469883|NCT02374918|101484657|FG002|COMPLETED|Overall Study||18||
48469884|NCT02374918|101484658|FG003|COMPLETED|Overall Study||18||
48469885|NCT02374918|101484655|FG000|NOT COMPLETED|Overall Study||3||
48469886|NCT02374918|101484656|FG001|NOT COMPLETED|Overall Study||1||
48469887|NCT02374918|101484657|FG002|NOT COMPLETED|Overall Study||4||
48469888|NCT02374918|101484658|FG003|NOT COMPLETED|Overall Study||2||
48469889|NCT00084084|101484659|FG000|STARTED|Phase 1 (Treatment With Replagal RB)||17||
48469890|NCT00084084|101484659|FG000|COMPLETED|Phase 1 (Treatment With Replagal RB)||16||
48469891|NCT00084084|101484659|FG000|NOT COMPLETED|Phase 1 (Treatment With Replagal RB)||1||
48469892|NCT00084084|101484659|FG000|STARTED|Phase 2 (Transition to Replagal AF)||11||
48469893|NCT00084084|101484659|FG000|COMPLETED|Phase 2 (Transition to Replagal AF)||10||
48469894|NCT00084084|101484659|FG000|NOT COMPLETED|Phase 2 (Transition to Replagal AF)||1||
48469895|NCT02743702|101484660|FG000|STARTED|Overall Study||11||
48469896|NCT02743702|101484661|FG001|STARTED|Overall Study||10||
48469897|NCT02743702|101484660|FG000|COMPLETED|Overall Study||11||
48469898|NCT02743702|101484661|FG001|COMPLETED|Overall Study||10||
48469899|NCT02743702|101484660|FG000|NOT COMPLETED|Overall Study||0||
48469900|NCT02743702|101484661|FG001|NOT COMPLETED|Overall Study||0||
48469901|NCT01644890|101484662|FG000|STARTED|Overall Study||218||
48469902|NCT01644890|101484663|FG001|STARTED|Overall Study||218||
48469903|NCT01644890|101484662|FG000|COMPLETED|Overall Study||2||
48469904|NCT01644890|101484663|FG001|COMPLETED|Overall Study||3||
48469905|NCT01644890|101484662|FG000|NOT COMPLETED|Overall Study||216||
48469906|NCT01644890|101484663|FG001|NOT COMPLETED|Overall Study||215||
48469907|NCT02831569|101484664|FG000|STARTED|Overall Study||80||
48469908|NCT02831569|101484664|FG000|COMPLETED|Overall Study||80||
48469909|NCT02831569|101484664|FG000|NOT COMPLETED|Overall Study||0||
48469910|NCT01915732|101484665|FG000|STARTED|Overall Study||500||
48469911|NCT01915732|101484666|FG001|STARTED|Overall Study||516||
48469912|NCT01915732|101484665|FG000|COMPLETED|Overall Study||430||
48469913|NCT01915732|101484666|FG001|COMPLETED|Overall Study||445||
48469914|NCT01915732|101484665|FG000|NOT COMPLETED|Overall Study||70||
48469915|NCT01915732|101484666|FG001|NOT COMPLETED|Overall Study||71||
48469916|NCT01608295|101484667|FG000|STARTED|Overall Study||26||
48469917|NCT01608295|101484668|FG001|STARTED|Overall Study||30||
48469918|NCT01608295|101484667|FG000|COMPLETED|Overall Study||20||
48190008|NCT02359058|100788986|FG002|NOT COMPLETED|Overall Study||0||
48469919|NCT01608295|101484668|FG001|COMPLETED|Overall Study||25||
48469920|NCT01608295|101484667|FG000|NOT COMPLETED|Overall Study||6||
48469921|NCT01608295|101484668|FG001|NOT COMPLETED|Overall Study||5||
48469922|NCT00287118|101484669|FG000|STARTED|Overall Study||189||
48469923|NCT00287118|101484669|FG000|COMPLETED|Overall Study||137||
48469924|NCT00287118|101484669|FG000|NOT COMPLETED|Overall Study||52||
48469925|NCT02236338|101484670|FG000|STARTED|Overall Study||100||
48469926|NCT02236338|101484671|FG001|STARTED|Overall Study||100||
48469927|NCT02236338|101484670|FG000|COMPLETED|Overall Study||100||
48469928|NCT02236338|101484671|FG001|COMPLETED|Overall Study||100||
48469929|NCT02236338|101484670|FG000|NOT COMPLETED|Overall Study||0||
48469930|NCT02236338|101484671|FG001|NOT COMPLETED|Overall Study||0||
48469931|NCT02514174|101484672|FG000|STARTED|Overall Study||25|(Participants who were dispensed afatinib and were documented to have taken at least one dose.)|
48469932|NCT02514174|101484672|FG000|COMPLETED|Overall Study||0||
48469933|NCT02514174|101484672|FG000|NOT COMPLETED|Overall Study||25||
48469934|NCT00948675|101484673|FG000|STARTED|Overall Study||182||
48469935|NCT00948675|101484674|FG001|STARTED|Overall Study||179||
48469936|NCT00948675|101484673|FG000|Received Any Amount of Study Drug|Overall Study||171||
48469937|NCT00948675|101484674|FG001|Received Any Amount of Study Drug|Overall Study||166||
48469938|NCT00948675|101484673|FG000|COMPLETED|Overall Study||181||
48469939|NCT00948675|101484674|FG001|COMPLETED|Overall Study||179||
48469940|NCT00948675|101484673|FG000|NOT COMPLETED|Overall Study||1||
48370389|NCT03569176|101234884|FG001|STARTED|Post-Test1(week12) to Post-Test2(week18)||12||
48469941|NCT00948675|101484674|FG001|NOT COMPLETED|Overall Study||0||
48469942|NCT01241461|101484675|FG000|STARTED|Overall Study||3||
48469943|NCT01241461|101484676|FG001|STARTED|Overall Study||6||
48469944|NCT01241461|101484675|FG000|COMPLETED|Overall Study||0||
48469945|NCT01241461|101484676|FG001|COMPLETED|Overall Study||0||
48469946|NCT01241461|101484675|FG000|NOT COMPLETED|Overall Study||3||
48469947|NCT01241461|101484676|FG001|NOT COMPLETED|Overall Study||6||
48469948|NCT02983448|101484677|FG000|STARTED|Overall Study||12||
48370390|NCT03569176|101234883|FG000|COMPLETED|Post-Test1(week12) to Post-Test2(week18)||0||
48469949|NCT02983448|101484678|FG001|STARTED|Overall Study||12||
48469950|NCT02983448|101484677|FG000|COMPLETED|Overall Study||12||
48469951|NCT02983448|101484678|FG001|COMPLETED|Overall Study||12||
48469952|NCT02983448|101484677|FG000|NOT COMPLETED|Overall Study||0||
48469953|NCT02983448|101484678|FG001|NOT COMPLETED|Overall Study||0||
48469954|NCT03287050|101484679|FG000|STARTED|Overall Study||6||
48469955|NCT03287050|101484679|FG000|COMPLETED|Overall Study||6||
48469956|NCT03287050|101484679|FG000|NOT COMPLETED|Overall Study||0||
48469957|NCT02207231|101484680|FG000|STARTED|Placebo Controlled Period: Week 0 - 16||174||
48469958|NCT02207231|101484681|FG001|STARTED|Placebo Controlled Period: Week 0 - 16||329||
48469959|NCT02207231|101484682|FG002|STARTED|Placebo Controlled Period: Week 0 - 16||334||
48469960|NCT02207231|101484683|FG003|STARTED|Placebo Controlled Period: Week 0 - 16||0||
48469961|NCT02207231|101484680|FG000|Treated|Placebo Controlled Period: Week 0 - 16||174||
48469962|NCT02207231|101484681|FG001|Treated|Placebo Controlled Period: Week 0 - 16||329||
48469963|NCT02207231|101484682|FG002|Treated|Placebo Controlled Period: Week 0 - 16||333||
48469964|NCT02207231|101484683|FG003|Treated|Placebo Controlled Period: Week 0 - 16||0||
48469965|NCT02207231|101484680|FG000|COMPLETED|Placebo Controlled Period: Week 0 - 16||167||
48469966|NCT02207231|101484681|FG001|COMPLETED|Placebo Controlled Period: Week 0 - 16||322||
48469967|NCT02207231|101484682|FG002|COMPLETED|Placebo Controlled Period: Week 0 - 16||324||
48469968|NCT02207231|101484683|FG003|COMPLETED|Placebo Controlled Period: Week 0 - 16||0||
48469969|NCT02207231|101484680|FG000|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7||
48469970|NCT02207231|101484681|FG001|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7||
48469971|NCT02207231|101484682|FG002|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||10||
48469972|NCT02207231|101484683|FG003|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0||
48469973|NCT02207231|101484680|FG000|STARTED|Active Controlled Period: Week 16 - 48||165||
48469974|NCT02207231|101484681|FG001|STARTED|Active Controlled Period: Week 16 - 48||322||
48469975|NCT02207231|101484682|FG002|STARTED|Active Controlled Period: Week 16 - 48||324||
48666111|NCT02160808|101967505|FG001|STARTED|Overall Study||83||
48666112|NCT02160808|101967504|FG000|COMPLETED|Overall Study||87||
48666113|NCT02160808|101967505|FG001|COMPLETED|Overall Study||83||
48469976|NCT02207231|101484683|FG003|STARTED|Active Controlled Period: Week 16 - 48||0||
48469977|NCT02207231|101484680|FG000|COMPLETED|Active Controlled Period: Week 16 - 48||162||
48469978|NCT02207231|101484681|FG001|COMPLETED|Active Controlled Period: Week 16 - 48||301||
48469979|NCT02207231|101484682|FG002|COMPLETED|Active Controlled Period: Week 16 - 48||281||
48469980|NCT02207231|101484683|FG003|COMPLETED|Active Controlled Period: Week 16 - 48||0||
48469981|NCT02207231|101484680|FG000|NOT COMPLETED|Active Controlled Period: Week 16 - 48||3||
48469982|NCT02207231|101484681|FG001|NOT COMPLETED|Active Controlled Period: Week 16 - 48||21||
48469983|NCT02207231|101484682|FG002|NOT COMPLETED|Active Controlled Period: Week 16 - 48||43||
48469984|NCT02207231|101484683|FG003|NOT COMPLETED|Active Controlled Period: Week 16 - 48||0||
48469985|NCT02207231|101484680|FG000|STARTED|Open-label Guselkumab: Week 48 - 264||0||
48469986|NCT02207231|101484681|FG001|STARTED|Open-label Guselkumab: Week 48 - 264||0||
48469987|NCT02207231|101484682|FG002|STARTED|Open-label Guselkumab: Week 48 - 264||280||
48469988|NCT02207231|101484683|FG003|STARTED|Open-label Guselkumab: Week 48 - 264||463||
48469989|NCT02207231|101484680|FG000|COMPLETED|Open-label Guselkumab: Week 48 - 264||0||
48469990|NCT02207231|101484681|FG001|COMPLETED|Open-label Guselkumab: Week 48 - 264||0||
48469991|NCT02207231|101484682|FG002|COMPLETED|Open-label Guselkumab: Week 48 - 264||242||
48469992|NCT02207231|101484683|FG003|COMPLETED|Open-label Guselkumab: Week 48 - 264||380||
48469993|NCT02207231|101484680|FG000|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||0||
48469994|NCT02207231|101484681|FG001|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||0||
48666114|NCT02160808|101967504|FG000|NOT COMPLETED|Overall Study||0||
48469995|NCT02207231|101484682|FG002|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||38||
48469996|NCT02207231|101484683|FG003|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||83||
48469997|NCT02154529|101484684|FG000|STARTED|Overall Study||4||
48469998|NCT02154529|101484685|FG001|STARTED|Overall Study||3||
48469999|NCT02154529|101484686|FG002|STARTED|Overall Study||8||
48470000|NCT02154529|101484687|FG003|STARTED|Overall Study||2||
48470001|NCT02154529|101484684|FG000|COMPLETED|Overall Study||0||
48470002|NCT02154529|101484685|FG001|COMPLETED|Overall Study||0||
48190009|NCT00561574|100788987|FG000|STARTED|Overall Study||128||
48190010|NCT00561574|100788988|FG001|STARTED|Overall Study||131||
48190011|NCT00561574|100788987|FG000|COMPLETED|Overall Study||80||
48190012|NCT00561574|100788988|FG001|COMPLETED|Overall Study||73||
48190013|NCT00561574|100788987|FG000|NOT COMPLETED|Overall Study||48||
48190014|NCT00561574|100788988|FG001|NOT COMPLETED|Overall Study||58||
48190015|NCT01055782|100788989|FG000|STARTED|Overall Study||555||
48190016|NCT01055782|100788990|FG001|STARTED|Overall Study||449||
48190017|NCT01055782|100788989|FG000|COMPLETED|Overall Study||555||
48190018|NCT01055782|100788990|FG001|COMPLETED|Overall Study||449||
48190019|NCT01055782|100788989|FG000|NOT COMPLETED|Overall Study||0||
48190020|NCT01055782|100788990|FG001|NOT COMPLETED|Overall Study||0||
48190021|NCT02929069|100788991|FG000|STARTED|Overall Study||100||
48190022|NCT02929069|100788992|FG001|STARTED|Overall Study||102||
48190023|NCT02929069|100788993|FG002|STARTED|Overall Study||52||
48190024|NCT02929069|100788991|FG000|Completed 4 Month Follow Up|Overall Study||83||
48190025|NCT02929069|100788992|FG001|Completed 4 Month Follow Up|Overall Study||76||
48190026|NCT02929069|100788993|FG002|Completed 4 Month Follow Up|Overall Study||43||
48190027|NCT02929069|100788991|FG000|Completed 8 Month Follow Up|Overall Study||82||
48190028|NCT02929069|100788992|FG001|Completed 8 Month Follow Up|Overall Study||77||
48190029|NCT02929069|100788993|FG002|Completed 8 Month Follow Up|Overall Study||36||
48190030|NCT02929069|100788991|FG000|Assessed STI 12 Month|Overall Study||74||
48190031|NCT02929069|100788992|FG001|Assessed STI 12 Month|Overall Study||75||
48190032|NCT02929069|100788993|FG002|Assessed STI 12 Month|Overall Study||38||
48190033|NCT02929069|100788991|FG000|Assessed HIV 12 Month|Overall Study||76||
48190034|NCT02929069|100788992|FG001|Assessed HIV 12 Month|Overall Study||76||
48190035|NCT02929069|100788993|FG002|Assessed HIV 12 Month|Overall Study||39||
48190036|NCT02929069|100788991|FG000|Complete 12 Month Follow Up|Overall Study||81||
48190037|NCT02929069|100788992|FG001|Complete 12 Month Follow Up|Overall Study||81||
48190038|NCT02929069|100788993|FG002|Complete 12 Month Follow Up|Overall Study||42||
48190039|NCT02929069|100788991|FG000|COMPLETED|Overall Study||81||
48190040|NCT02929069|100788992|FG001|COMPLETED|Overall Study||81||
48190041|NCT02929069|100788993|FG002|COMPLETED|Overall Study||42||
48190042|NCT02929069|100788991|FG000|NOT COMPLETED|Overall Study||19||
48190043|NCT02929069|100788992|FG001|NOT COMPLETED|Overall Study||21||
48190044|NCT02929069|100788993|FG002|NOT COMPLETED|Overall Study||10||
48470003|NCT02154529|101484686|FG002|COMPLETED|Overall Study||0||
48470004|NCT02154529|101484687|FG003|COMPLETED|Overall Study||0||
48470005|NCT02154529|101484684|FG000|NOT COMPLETED|Overall Study||4||
48470006|NCT02154529|101484685|FG001|NOT COMPLETED|Overall Study||3||
48666115|NCT02160808|101967505|FG001|NOT COMPLETED|Overall Study||0||
48190045|NCT02065245|100788994|FG000|STARTED|Infusion 1||5||
48190046|NCT02065245|100788995|FG001|STARTED|Infusion 1||5||
48190047|NCT02065245|100788996|FG002|STARTED|Infusion 1||5||
48190048|NCT02065245|100788997|FG003|STARTED|Infusion 1||10||
48190049|NCT02065245|100788998|FG004|STARTED|Infusion 1||10||
48190050|NCT02065245|100788999|FG005|STARTED|Infusion 1||10||
48190051|NCT02065245|100789000|FG006|STARTED|Infusion 1||20||
48190052|NCT02065245|100788994|FG000|COMPLETED|Infusion 1||5||
48190053|NCT02065245|100788995|FG001|COMPLETED|Infusion 1||5||
48470007|NCT02154529|101484686|FG002|NOT COMPLETED|Overall Study||8||
48470008|NCT02154529|101484687|FG003|NOT COMPLETED|Overall Study||2||
48470009|NCT00680121|101484688|FG000|STARTED|Overall Study||60||
48470010|NCT00680121|101484689|FG001|STARTED|Overall Study||60||
48470011|NCT00680121|101484688|FG000|COMPLETED|Overall Study||33||
48470012|NCT00680121|101484689|FG001|COMPLETED|Overall Study||37||
48470013|NCT00680121|101484688|FG000|NOT COMPLETED|Overall Study||27||
48470014|NCT00680121|101484689|FG001|NOT COMPLETED|Overall Study||23||
48470015|NCT02456532|101484690|FG000|STARTED|Overall Study||14||
48470016|NCT02456532|101484691|FG001|STARTED|Overall Study||11||
48470017|NCT02456532|101484692|FG002|STARTED|Overall Study||16||
48470018|NCT02456532|101484690|FG000|COMPLETED|Overall Study||14||
48470019|NCT02456532|101484691|FG001|COMPLETED|Overall Study||11||
48470020|NCT02456532|101484692|FG002|COMPLETED|Overall Study||16||
48470021|NCT02456532|101484690|FG000|NOT COMPLETED|Overall Study||0||
48470022|NCT02456532|101484691|FG001|NOT COMPLETED|Overall Study||0||
48470023|NCT02456532|101484692|FG002|NOT COMPLETED|Overall Study||0||
48470024|NCT01600495|101484693|FG000|STARTED|Overall Study||23||
48470025|NCT01600495|101484694|FG001|STARTED|Overall Study||23||
48470026|NCT01600495|101484693|FG000|COMPLETED|Overall Study||23||
48470027|NCT01600495|101484694|FG001|COMPLETED|Overall Study||23||
48470028|NCT01600495|101484693|FG000|NOT COMPLETED|Overall Study||0||
48470029|NCT01600495|101484694|FG001|NOT COMPLETED|Overall Study||0||
48470030|NCT03730103|101484695|FG000|STARTED|Overall Study||61||
48190054|NCT02065245|100788996|FG002|COMPLETED|Infusion 1||4||
48190055|NCT02065245|100788997|FG003|COMPLETED|Infusion 1||10||
48190056|NCT02065245|100788998|FG004|COMPLETED|Infusion 1||9||
48190057|NCT02065245|100788999|FG005|COMPLETED|Infusion 1||10||
48190058|NCT02065245|100789000|FG006|COMPLETED|Infusion 1||19||
48190059|NCT02065245|100788994|FG000|NOT COMPLETED|Infusion 1||0||
48190060|NCT02065245|100788995|FG001|NOT COMPLETED|Infusion 1||0||
48190061|NCT02065245|100788996|FG002|NOT COMPLETED|Infusion 1||1||
48190062|NCT02065245|100788997|FG003|NOT COMPLETED|Infusion 1||0||
48190063|NCT02065245|100788998|FG004|NOT COMPLETED|Infusion 1||1||
48190064|NCT02065245|100788999|FG005|NOT COMPLETED|Infusion 1||0||
48190065|NCT02065245|100789000|FG006|NOT COMPLETED|Infusion 1||1||
48470031|NCT03730103|101484696|FG001|STARTED|Overall Study||52||
48470032|NCT03730103|101484695|FG000|COMPLETED|Overall Study||61||
48470033|NCT03730103|101484696|FG001|COMPLETED|Overall Study||47||
48470034|NCT03730103|101484695|FG000|NOT COMPLETED|Overall Study||0||
48470035|NCT03730103|101484696|FG001|NOT COMPLETED|Overall Study||5||
48470036|NCT02004704|101484697|FG000|STARTED|Overall Study||5||
48470037|NCT02004704|101484698|FG001|STARTED|Overall Study||20||
48190066|NCT02065245|100788994|FG000|STARTED|Infusion 2||5||
48470038|NCT02004704|101484697|FG000|COMPLETED|Overall Study||5||
48470039|NCT02004704|101484698|FG001|COMPLETED|Overall Study||20||
48470040|NCT02004704|101484697|FG000|NOT COMPLETED|Overall Study||0||
48470041|NCT02004704|101484698|FG001|NOT COMPLETED|Overall Study||0||
48470042|NCT03197064|101488115|FG000|STARTED|Overall Study||11||
48470043|NCT03197064|101488115|FG000|COMPLETED|Overall Study||11||
48470044|NCT03197064|101488115|FG000|NOT COMPLETED|Overall Study||0||
48470045|NCT01265784|101488116|FG000|STARTED|Overall Study||56||
48470046|NCT01265784|101488117|FG001|STARTED|Overall Study||57||
48470047|NCT01265784|101488118|FG002|STARTED|Overall Study||30||
48470048|NCT01265784|101488116|FG000|Received at Least 1 Dose of Study Drug|Overall Study||54||
48470049|NCT01265784|101488117|FG001|Received at Least 1 Dose of Study Drug|Overall Study||56||
48470050|NCT01265784|101488118|FG002|Received at Least 1 Dose of Study Drug|Overall Study||29||
48470051|NCT01265784|101488116|FG000|COMPLETED|Overall Study||44||
48470052|NCT01265784|101488117|FG001|COMPLETED|Overall Study||49||
48190067|NCT02065245|100788995|FG001|STARTED|Infusion 2||5||
48190068|NCT02065245|100788996|FG002|STARTED|Infusion 2||2||
48190069|NCT02065245|100788997|FG003|STARTED|Infusion 2||0||
48190070|NCT02065245|100788998|FG004|STARTED|Infusion 2||0||
48470053|NCT01265784|101488118|FG002|COMPLETED|Overall Study||26||
48470054|NCT01265784|101488116|FG000|NOT COMPLETED|Overall Study||12||
48470055|NCT01265784|101488117|FG001|NOT COMPLETED|Overall Study||8||
48470056|NCT01265784|101488118|FG002|NOT COMPLETED|Overall Study||4||
48470057|NCT04799158|101488119|FG000|STARTED|Run-In Period||458||
48470058|NCT04799158|101488120|FG001|STARTED|Run-In Period||0||
48470059|NCT04799158|101488121|FG002|STARTED|Run-In Period||0||
48470060|NCT04799158|101488122|FG003|STARTED|Run-In Period||0||
48470061|NCT04799158|101488123|FG004|STARTED|Run-In Period||0||
48470062|NCT04799158|101488119|FG000|COMPLETED|Run-In Period||207||
48470063|NCT04799158|101488120|FG001|COMPLETED|Run-In Period||0||
48470064|NCT04799158|101488121|FG002|COMPLETED|Run-In Period||0||
48470065|NCT04799158|101488122|FG003|COMPLETED|Run-In Period||0||
48470066|NCT04799158|101488123|FG004|COMPLETED|Run-In Period||0||
48470067|NCT04799158|101488119|FG000|NOT COMPLETED|Run-In Period||251||
48470068|NCT04799158|101488120|FG001|NOT COMPLETED|Run-In Period||0||
48470069|NCT04799158|101488121|FG002|NOT COMPLETED|Run-In Period||0||
48470070|NCT04799158|101488122|FG003|NOT COMPLETED|Run-In Period||0||
48470071|NCT04799158|101488123|FG004|NOT COMPLETED|Run-In Period||0||
48190071|NCT02065245|100788999|FG005|STARTED|Infusion 2||6||
48190072|NCT02065245|100789000|FG006|STARTED|Infusion 2||12||
48190073|NCT02065245|100788994|FG000|COMPLETED|Infusion 2||5||
48190074|NCT02065245|100788995|FG001|COMPLETED|Infusion 2||5||
48470072|NCT04799158|101488119|FG000|STARTED|On-Demand Treatment Period||0||
48470073|NCT04799158|101488120|FG001|STARTED|On-Demand Treatment Period||52||
48470074|NCT04799158|101488121|FG002|STARTED|On-Demand Treatment Period||52||
48470075|NCT04799158|101488122|FG003|STARTED|On-Demand Treatment Period||51||
48470076|NCT04799158|101488123|FG004|STARTED|On-Demand Treatment Period||52||
48470077|NCT04799158|101488119|FG000|COMPLETED|On-Demand Treatment Period||0||
48470078|NCT04799158|101488120|FG001|COMPLETED|On-Demand Treatment Period||51||
48470079|NCT04799158|101488121|FG002|COMPLETED|On-Demand Treatment Period||52||
48470080|NCT04799158|101488122|FG003|COMPLETED|On-Demand Treatment Period||49||
48470081|NCT04799158|101488123|FG004|COMPLETED|On-Demand Treatment Period||48||
48470082|NCT04799158|101488119|FG000|NOT COMPLETED|On-Demand Treatment Period||0||
48470083|NCT04799158|101488120|FG001|NOT COMPLETED|On-Demand Treatment Period||1||
48470084|NCT04799158|101488121|FG002|NOT COMPLETED|On-Demand Treatment Period||0||
48470085|NCT04799158|101488122|FG003|NOT COMPLETED|On-Demand Treatment Period||2||
48470086|NCT04799158|101488123|FG004|NOT COMPLETED|On-Demand Treatment Period||4||
48470087|NCT01644500|101488124|FG000|STARTED|Overall Study||244||
48470088|NCT01644500|101488125|FG001|STARTED|Overall Study||248||
48470089|NCT01644500|101488126|FG002|STARTED|Overall Study||245||
48470090|NCT01644500|101488124|FG000|Received at Least One Dose of Study Drug|Overall Study||244||
48470091|NCT01644500|101488125|FG001|Received at Least One Dose of Study Drug|Overall Study||248||
48470092|NCT01644500|101488126|FG002|Received at Least One Dose of Study Drug|Overall Study||243||
48470093|NCT01644500|101488124|FG000|Modified Intent-to-treat Population|Overall Study||239||
48470094|NCT01644500|101488125|FG001|Modified Intent-to-treat Population|Overall Study||239||
48470095|NCT01644500|101488126|FG002|Modified Intent-to-treat Population|Overall Study||242||
48470096|NCT01644500|101488124|FG000|COMPLETED|Overall Study||222||
48470097|NCT01644500|101488125|FG001|COMPLETED|Overall Study||224||
48470098|NCT01644500|101488126|FG002|COMPLETED|Overall Study||230||
48470099|NCT01644500|101488124|FG000|NOT COMPLETED|Overall Study||22||
48470100|NCT01644500|101488125|FG001|NOT COMPLETED|Overall Study||24||
48470101|NCT01644500|101488126|FG002|NOT COMPLETED|Overall Study||15||
48470102|NCT03104738|101488127|FG000|STARTED|Overall Study||20||
48470103|NCT03104738|101488128|FG001|STARTED|Overall Study||20||
48470104|NCT03104738|101488127|FG000|COMPLETED|Overall Study||20||
48470105|NCT03104738|101488128|FG001|COMPLETED|Overall Study||20||
48470106|NCT03104738|101488127|FG000|NOT COMPLETED|Overall Study||0||
48470107|NCT03104738|101488128|FG001|NOT COMPLETED|Overall Study||0||
48470108|NCT02576509|101488129|FG000|STARTED|Pre-Treatment Period||371|Started = Assigned to treatment (randomized/enrolled)|
48470109|NCT02576509|101488130|FG001|STARTED|Pre-Treatment Period||372|Started = Assigned to treatment (randomized/enrolled)|
48470110|NCT02576509|101488129|FG000|COMPLETED|Pre-Treatment Period||367|Completed = Entering treatment period|
48470111|NCT02576509|101488130|FG001|COMPLETED|Pre-Treatment Period||363|Completed = Entering treatment period|
48470112|NCT02576509|101488129|FG000|NOT COMPLETED|Pre-Treatment Period||4||
48470113|NCT02576509|101488130|FG001|NOT COMPLETED|Pre-Treatment Period||9||
48470114|NCT02576509|101488129|FG000|STARTED|Treatment Period||367|Started = Received treatment|
48470115|NCT02576509|101488130|FG001|STARTED|Treatment Period||363|Started = Received treatment|
48470116|NCT02576509|101488129|FG000|COMPLETED|Treatment Period||38|Completed = Continuing in the treatment period|
48470117|NCT02576509|101488130|FG001|COMPLETED|Treatment Period||8|Completed = Continuing in the treatment period|
48470118|NCT02576509|101488129|FG000|NOT COMPLETED|Treatment Period||329||
48470119|NCT02576509|101488130|FG001|NOT COMPLETED|Treatment Period||355||
48470120|NCT02576509|101488129|FG000|STARTED|Follow-up Period||367|Started = Received treatment|
48470121|NCT02576509|101488130|FG001|STARTED|Follow-up Period||363|Started = Received treatment|
48470122|NCT02576509|101488129|FG000|COMPLETED|Follow-up Period||318|Completed = Continuing in the study|
48470123|NCT02576509|101488130|FG001|COMPLETED|Follow-up Period||311|Completed = Continuing in the study|
48470124|NCT02576509|101488129|FG000|NOT COMPLETED|Follow-up Period||49||
48470125|NCT02576509|101488130|FG001|NOT COMPLETED|Follow-up Period||52||
48470126|NCT00777829|101488131|FG000|STARTED|Overall Study||15||
48470127|NCT00777829|101488132|FG001|STARTED|Overall Study||15||
48470128|NCT00777829|101488131|FG000|Study Orientation|Overall Study||15||
48470129|NCT00777829|101488132|FG001|Study Orientation|Overall Study||13||
48470130|NCT00777829|101488131|FG000|COMPLETED|Overall Study||15||
48470131|NCT00777829|101488132|FG001|COMPLETED|Overall Study||13||
48470132|NCT00777829|101488131|FG000|NOT COMPLETED|Overall Study||0||
48470133|NCT00777829|101488132|FG001|NOT COMPLETED|Overall Study||2||
48470134|NCT00472290|101488133|FG000|STARTED|Overall Study||72||
48470135|NCT00472290|101488133|FG000|COMPLETED|Overall Study||0||
48470136|NCT00472290|101488133|FG000|NOT COMPLETED|Overall Study||72||
48470137|NCT00337571|101488134|FG000|STARTED|Overall Study||52||
48470138|NCT00337571|101488135|FG001|STARTED|Overall Study||53||
48470139|NCT00337571|101488136|FG002|STARTED|Overall Study||59||
48470140|NCT00337571|101488137|FG003|STARTED|Overall Study||54||
48470141|NCT00337571|101488134|FG000|COMPLETED|Overall Study||38||
48470142|NCT00337571|101488135|FG001|COMPLETED|Overall Study||44||
48470143|NCT00337571|101488136|FG002|COMPLETED|Overall Study||49||
48470144|NCT00337571|101488137|FG003|COMPLETED|Overall Study||47||
48470145|NCT00337571|101488134|FG000|NOT COMPLETED|Overall Study||14||
48470146|NCT00337571|101488135|FG001|NOT COMPLETED|Overall Study||9||
48190075|NCT02065245|100788996|FG002|COMPLETED|Infusion 2||2||
48470147|NCT00337571|101488136|FG002|NOT COMPLETED|Overall Study||10||
48470148|NCT00337571|101488137|FG003|NOT COMPLETED|Overall Study||7||
48470149|NCT00958243|101488138|FG000|STARTED|Overall Study||26||
48470150|NCT00958243|101488139|FG001|STARTED|Overall Study||105||
48470151|NCT00958243|101488140|FG002|STARTED|Overall Study||96||
48470152|NCT00958243|101488141|FG003|STARTED|Overall Study||28||
48470153|NCT00958243|101488142|FG004|STARTED|Overall Study||109||
48470154|NCT00958243|101488143|FG005|STARTED|Overall Study||109||
48470155|NCT00958243|101488138|FG000|COMPLETED|Overall Study||24||
48470156|NCT00958243|101488139|FG001|COMPLETED|Overall Study||99||
48470157|NCT00958243|101488140|FG002|COMPLETED|Overall Study||82||
48470158|NCT00958243|101488141|FG003|COMPLETED|Overall Study||25||
48470159|NCT00958243|101488142|FG004|COMPLETED|Overall Study||100||
48470160|NCT00958243|101488143|FG005|COMPLETED|Overall Study||99||
48470161|NCT00958243|101488138|FG000|NOT COMPLETED|Overall Study||2||
48470162|NCT00958243|101488139|FG001|NOT COMPLETED|Overall Study||6||
48470163|NCT00958243|101488140|FG002|NOT COMPLETED|Overall Study||14||
48470164|NCT00958243|101488141|FG003|NOT COMPLETED|Overall Study||3||
48470165|NCT00958243|101488142|FG004|NOT COMPLETED|Overall Study||9||
48470166|NCT00958243|101488143|FG005|NOT COMPLETED|Overall Study||10||
48470167|NCT01238848|101488144|FG000|STARTED|Overall Study||50||
48470168|NCT01238848|101488145|FG001|STARTED|Overall Study||50||
48470169|NCT01238848|101488144|FG000|COMPLETED|Overall Study||37||
48470170|NCT01238848|101488145|FG001|COMPLETED|Overall Study||45||
48470171|NCT01238848|101488144|FG000|NOT COMPLETED|Overall Study||13||
48470172|NCT01238848|101488145|FG001|NOT COMPLETED|Overall Study||5||
48470173|NCT00193609|101488146|FG000|STARTED|Overall Study||48||
48470174|NCT00193609|101488146|FG000|COMPLETED|Overall Study||44||
48470175|NCT00193609|101488146|FG000|NOT COMPLETED|Overall Study||4||
48470176|NCT03295721|101488147|FG000|STARTED|Overall Study||157||
48470177|NCT03295721|101488148|FG001|STARTED|Overall Study||100||
48470178|NCT03295721|101488149|FG002|STARTED|Overall Study||155||
48470179|NCT03295721|101488147|FG000|COMPLETED|Overall Study||154||
48470180|NCT03295721|101488148|FG001|COMPLETED|Overall Study||99||
48470181|NCT03295721|101488149|FG002|COMPLETED|Overall Study||152||
48470182|NCT03295721|101488147|FG000|NOT COMPLETED|Overall Study||3||
48190076|NCT02065245|100788997|FG003|COMPLETED|Infusion 2||0||
48190077|NCT02065245|100788998|FG004|COMPLETED|Infusion 2||0||
48190078|NCT02065245|100788999|FG005|COMPLETED|Infusion 2||6||
48470183|NCT03295721|101488148|FG001|NOT COMPLETED|Overall Study||1||
48470184|NCT03295721|101488149|FG002|NOT COMPLETED|Overall Study||3||
48470185|NCT04026126|101488150|FG000|STARTED|Overall Study||15||
48470186|NCT04026126|101488150|FG000|COMPLETED|Overall Study||15||
48470187|NCT04026126|101488150|FG000|NOT COMPLETED|Overall Study||0||
48470188|NCT02304432|101488151|FG000|STARTED|Open Label DCS||2||
48470189|NCT02304432|101488152|FG001|STARTED|Open Label DCS||0||
48470190|NCT02304432|101488153|FG002|STARTED|Open Label DCS||0||
48470191|NCT02304432|101488154|FG003|STARTED|Open Label DCS||0||
48470192|NCT02304432|101488151|FG000|COMPLETED|Open Label DCS||2||
48190079|NCT02065245|100789000|FG006|COMPLETED|Infusion 2||11||
48190080|NCT02065245|100788994|FG000|NOT COMPLETED|Infusion 2||0||
48370391|NCT03569176|101234884|FG001|COMPLETED|Post-Test1(week12) to Post-Test2(week18)||12||
48470193|NCT02304432|101488152|FG001|COMPLETED|Open Label DCS||0||
48470194|NCT02304432|101488153|FG002|COMPLETED|Open Label DCS||0||
48470195|NCT02304432|101488154|FG003|COMPLETED|Open Label DCS||0||
48470196|NCT02304432|101488151|FG000|NOT COMPLETED|Open Label DCS||0||
48470197|NCT02304432|101488152|FG001|NOT COMPLETED|Open Label DCS||0||
48470198|NCT02304432|101488153|FG002|NOT COMPLETED|Open Label DCS||0||
48470199|NCT02304432|101488154|FG003|NOT COMPLETED|Open Label DCS||0||
48470200|NCT02304432|101488151|FG000|STARTED|Double-Blind DCS Placebo Crossover||0||
48470201|NCT02304432|101488152|FG001|STARTED|Double-Blind DCS Placebo Crossover||1||
48470202|NCT02304432|101488153|FG002|STARTED|Double-Blind DCS Placebo Crossover||1||
48470203|NCT02304432|101488154|FG003|STARTED|Double-Blind DCS Placebo Crossover||0||
48470204|NCT02304432|101488151|FG000|COMPLETED|Double-Blind DCS Placebo Crossover||0||
48470205|NCT02304432|101488152|FG001|COMPLETED|Double-Blind DCS Placebo Crossover||1||
48470206|NCT02304432|101488153|FG002|COMPLETED|Double-Blind DCS Placebo Crossover||1||
48470207|NCT02304432|101488154|FG003|COMPLETED|Double-Blind DCS Placebo Crossover||0||
48470208|NCT02304432|101488151|FG000|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0||
48470209|NCT02304432|101488152|FG001|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0||
48470210|NCT02304432|101488153|FG002|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0||
48470211|NCT02304432|101488154|FG003|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0||
48470212|NCT02304432|101488151|FG000|STARTED|Second Open Label DCS||0||
48470213|NCT02304432|101488152|FG001|STARTED|Second Open Label DCS||0||
48470214|NCT02304432|101488153|FG002|STARTED|Second Open Label DCS||0||
48470215|NCT02304432|101488154|FG003|STARTED|Second Open Label DCS||2||
48470216|NCT02304432|101488151|FG000|COMPLETED|Second Open Label DCS||0||
48370392|NCT03569176|101234883|FG000|NOT COMPLETED|Post-Test1(week12) to Post-Test2(week18)||0||
48370393|NCT03569176|101234884|FG001|NOT COMPLETED|Post-Test1(week12) to Post-Test2(week18)||0||
48370394|NCT04112316|101234885|FG000|STARTED|First Period (8 Weeks)||14||
48370395|NCT04112316|101234886|FG001|STARTED|First Period (8 Weeks)||14||
48370396|NCT04112316|101234885|FG000|COMPLETED|First Period (8 Weeks)||12||
48370397|NCT04112316|101234886|FG001|COMPLETED|First Period (8 Weeks)||14||
48370398|NCT04112316|101234885|FG000|NOT COMPLETED|First Period (8 Weeks)||2||
48370399|NCT04112316|101234886|FG001|NOT COMPLETED|First Period (8 Weeks)||0||
48370400|NCT04112316|101234885|FG000|STARTED|Washout (2 Weeks)||12||
48370401|NCT04112316|101234886|FG001|STARTED|Washout (2 Weeks)||14||
48370402|NCT04112316|101234885|FG000|COMPLETED|Washout (2 Weeks)||12||
48370403|NCT04112316|101234886|FG001|COMPLETED|Washout (2 Weeks)||14||
48370404|NCT04112316|101234885|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
48370405|NCT04112316|101234886|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
48370406|NCT04112316|101234885|FG000|STARTED|Second Intervention (8 Weeks)||12||
48370407|NCT04112316|101234886|FG001|STARTED|Second Intervention (8 Weeks)||14||
48370408|NCT04112316|101234885|FG000|COMPLETED|Second Intervention (8 Weeks)||12||
48370409|NCT04112316|101234886|FG001|COMPLETED|Second Intervention (8 Weeks)||14||
48370410|NCT04112316|101234885|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0||
48370411|NCT04112316|101234886|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0||
48370412|NCT04437511|101234887|FG000|STARTED|Overall Study||860||
48370413|NCT04437511|101234888|FG001|STARTED|Overall Study||876||
48370414|NCT04437511|101234887|FG000|Received at Least One Dose of Drug (Safety Population)|Overall Study||853||
48370415|NCT04437511|101234888|FG001|Received at Least One Dose of Drug (Safety Population)|Overall Study||874||
48370416|NCT04437511|101234887|FG000|COMPLETED|Overall Study||622||
48370417|NCT04437511|101234888|FG001|COMPLETED|Overall Study||698||
48370418|NCT04437511|101234887|FG000|NOT COMPLETED|Overall Study||238||
48370419|NCT04437511|101234888|FG001|NOT COMPLETED|Overall Study||178||
48370420|NCT04567238|101234889|FG000|STARTED|Overall Study||40||
48370421|NCT04567238|101234890|FG001|STARTED|Overall Study||20||
48370422|NCT04567238|101234889|FG000|COMPLETED|Overall Study||40||
48370423|NCT04567238|101234890|FG001|COMPLETED|Overall Study||20||
48370424|NCT04567238|101234889|FG000|NOT COMPLETED|Overall Study||0||
48370425|NCT04567238|101234890|FG001|NOT COMPLETED|Overall Study||0||
48370426|NCT03623321|101234891|FG000|STARTED|Overall Study||595||
48470217|NCT02304432|101488152|FG001|COMPLETED|Second Open Label DCS||0||
48666116|NCT01979185|101967506|FG000|STARTED|Period 1||15||
48370427|NCT03623321|101234891|FG000|COMPLETED|Overall Study||452||
48370428|NCT03623321|101234891|FG000|NOT COMPLETED|Overall Study||143||
48370429|NCT04849416|101234892|FG000|STARTED|Overall Study||39||
48190081|NCT02065245|100788995|FG001|NOT COMPLETED|Infusion 2||0||
48370430|NCT04849416|101234893|FG001|STARTED|Overall Study||17||
48370431|NCT04849416|101234894|FG002|STARTED|Overall Study||31||
48470218|NCT02304432|101488153|FG002|COMPLETED|Second Open Label DCS||0||
48470219|NCT02304432|101488154|FG003|COMPLETED|Second Open Label DCS||2||
48470220|NCT02304432|101488151|FG000|NOT COMPLETED|Second Open Label DCS||0||
48470221|NCT02304432|101488152|FG001|NOT COMPLETED|Second Open Label DCS||0||
48470222|NCT02304432|101488153|FG002|NOT COMPLETED|Second Open Label DCS||0||
48470223|NCT02304432|101488154|FG003|NOT COMPLETED|Second Open Label DCS||0||
48470224|NCT02927847|101488155|FG000|STARTED|Overall Study||16||
48470225|NCT02927847|101488156|FG001|STARTED|Overall Study||19||
48370432|NCT04849416|101234892|FG000|Received At Least One Dose of Study Drug|Overall Study||39||
48470226|NCT02927847|101488155|FG000|COMPLETED|Overall Study||10||
48470227|NCT02927847|101488156|FG001|COMPLETED|Overall Study||16||
48470228|NCT02927847|101488155|FG000|NOT COMPLETED|Overall Study||6||
48470229|NCT02927847|101488156|FG001|NOT COMPLETED|Overall Study||3||
48470230|NCT01578707|101488157|FG000|STARTED|Overall Study||196||
48470231|NCT01578707|101488158|FG001|STARTED|Overall Study||195||
48470232|NCT01578707|101488157|FG000|COMPLETED|Overall Study||196||
48470233|NCT01578707|101488158|FG001|COMPLETED|Overall Study||195||
48470234|NCT01578707|101488157|FG000|NOT COMPLETED|Overall Study||0||
48470235|NCT01578707|101488158|FG001|NOT COMPLETED|Overall Study||0||
48470236|NCT00958256|101488159|FG000|STARTED|Overall Study||21||
48470237|NCT00958256|101488159|FG000|COMPLETED|Overall Study||18||
48370433|NCT04849416|101234893|FG001|Received At Least One Dose of Study Drug|Overall Study||17||
48370434|NCT04849416|101234894|FG002|Received At Least One Dose of Study Drug|Overall Study||31||
48370435|NCT04849416|101234892|FG000|COMPLETED|Overall Study||18|Completers included participants who died from any cause and who did not attend the Follow-up.|
48370436|NCT04849416|101234893|FG001|COMPLETED|Overall Study||3|Completers included participants who died from any cause and who did not attend the Follow-up.|
48370437|NCT04849416|101234894|FG002|COMPLETED|Overall Study||17|Completers included participants who died from any cause and who did not attend the Follow-up.|
48370438|NCT04849416|101234892|FG000|NOT COMPLETED|Overall Study||21||
48370439|NCT04849416|101234893|FG001|NOT COMPLETED|Overall Study||14||
48370440|NCT04849416|101234894|FG002|NOT COMPLETED|Overall Study||14||
48370441|NCT05434078|101234895|FG000|STARTED|Overall Study||25||
48370442|NCT05434078|101234896|FG001|STARTED|Overall Study||25||
48370443|NCT05434078|101234895|FG000|COMPLETED|Overall Study||22||
48370444|NCT05434078|101234896|FG001|COMPLETED|Overall Study||24||
48370445|NCT05434078|101234895|FG000|NOT COMPLETED|Overall Study||3||
48370446|NCT05434078|101234896|FG001|NOT COMPLETED|Overall Study||1||
48370447|NCT03570892|101234897|FG000|STARTED|Overall Study||162||
48370448|NCT03570892|101234898|FG001|STARTED|Overall Study||160||
48370449|NCT03570892|101234897|FG000|COMPLETED|Overall Study||105|Completed = Study on-going at the time of data cut-off date of 6-May-2021|
48370450|NCT03570892|101234898|FG001|COMPLETED|Overall Study||106|Completed = Study on-going at the time of data cut-off date of 6-May-2021|
48370451|NCT03570892|101234897|FG000|NOT COMPLETED|Overall Study||57||
48370452|NCT03570892|101234898|FG001|NOT COMPLETED|Overall Study||54||
48370453|NCT04492722|101234899|FG000|STARTED|Overall Study||154||
48370454|NCT04492722|101234900|FG001|STARTED|Overall Study||153||
48370455|NCT04492722|101234901|FG002|STARTED|Overall Study||153||
48370456|NCT04492722|101234902|FG003|STARTED|Overall Study||153||
48370457|NCT04492722|101234899|FG000|COMPLETED|Overall Study||72||
48370458|NCT04492722|101234900|FG001|COMPLETED|Overall Study||82||
48370459|NCT04492722|101234901|FG002|COMPLETED|Overall Study||82||
48370460|NCT04492722|101234902|FG003|COMPLETED|Overall Study||82||
48370461|NCT04492722|101234899|FG000|NOT COMPLETED|Overall Study||82||
48370462|NCT04492722|101234900|FG001|NOT COMPLETED|Overall Study||71||
48370463|NCT04492722|101234901|FG002|NOT COMPLETED|Overall Study||71||
48370464|NCT04492722|101234902|FG003|NOT COMPLETED|Overall Study||71||
48370465|NCT02166463|101234903|FG000|STARTED|Overall Study||300||
48370466|NCT02166463|101234904|FG001|STARTED|Overall Study||300||
48370467|NCT02166463|101234903|FG000|COMPLETED|Overall Study||262||
48370468|NCT02166463|101234904|FG001|COMPLETED|Overall Study||273||
48370469|NCT02166463|101234903|FG000|NOT COMPLETED|Overall Study||38||
48370470|NCT02166463|101234904|FG001|NOT COMPLETED|Overall Study||27||
48370471|NCT01903811|101234905|FG000|STARTED|Overall Study||72||
48370472|NCT01903811|101234906|FG001|STARTED|Overall Study||71||
48370473|NCT01903811|101234905|FG000|Crossover to Arm II|Overall Study||16||
48370474|NCT01903811|101234906|FG001|Crossover to Arm II|Overall Study||0||
48370475|NCT01903811|101234905|FG000|COMPLETED|Overall Study||64|Completed implies patients were eligible for study treatment and analyzable for study endpoints.|
48370476|NCT01903811|101234906|FG001|COMPLETED|Overall Study||57|Completed implies patients were eligible for study treatment and analyzable for study endpoints.|
48370477|NCT01903811|101234905|FG000|NOT COMPLETED|Overall Study||8||
48370478|NCT01903811|101234906|FG001|NOT COMPLETED|Overall Study||14||
48370479|NCT04145440|101234907|FG000|STARTED|Overall Study||18||
48470238|NCT00958256|101488159|FG000|NOT COMPLETED|Overall Study||3||
48470239|NCT03309449|101488160|FG000|STARTED|Overall Study||46||
48470240|NCT03309449|101488161|FG001|STARTED|Overall Study||46||
48370480|NCT04145440|101234908|FG001|STARTED|Overall Study||13||
48370481|NCT04145440|101234907|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18||
48370482|NCT04145440|101234908|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13||
48370483|NCT04145440|101234907|FG000|COMPLETED|Overall Study||13||
48370484|NCT04145440|101234908|FG001|COMPLETED|Overall Study||10||
48370485|NCT04145440|101234907|FG000|NOT COMPLETED|Overall Study||5||
48370486|NCT04145440|101234908|FG001|NOT COMPLETED|Overall Study||3||
48370487|NCT03710603|101234909|FG000|STARTED|Overall Study||354||
48370488|NCT03710603|101234910|FG001|STARTED|Overall Study||355||
48370489|NCT03710603|101234909|FG000|COMPLETED|Overall Study||295|"Participants that are still on study are listed as completed"|
48370490|NCT03710603|101234910|FG001|COMPLETED|Overall Study||306|"Participants that are still on study are listed as completed"|
48370491|NCT03710603|101234909|FG000|NOT COMPLETED|Overall Study||59||
48370492|NCT03710603|101234910|FG001|NOT COMPLETED|Overall Study||49||
48370493|NCT03056755|101234911|FG000|STARTED|Treatment- Core Phase||127||
48370494|NCT03056755|101234912|FG001|STARTED|Treatment- Core Phase||126||
48370495|NCT03056755|101234913|FG002|STARTED|Treatment- Core Phase||126||
48370496|NCT03056755|101234911|FG000|COMPLETED|Treatment- Core Phase||1||
48370497|NCT03056755|101234912|FG001|COMPLETED|Treatment- Core Phase||0||
48370498|NCT03056755|101234913|FG002|COMPLETED|Treatment- Core Phase||10||
48370499|NCT03056755|101234911|FG000|NOT COMPLETED|Treatment- Core Phase||126||
48370500|NCT03056755|101234912|FG001|NOT COMPLETED|Treatment- Core Phase||126||
48370501|NCT03056755|101234913|FG002|NOT COMPLETED|Treatment- Core Phase||116||
48370502|NCT03056755|101234911|FG000|STARTED|Post-treatment Efficacy - Core Phase||14||
48370503|NCT03056755|101234912|FG001|STARTED|Post-treatment Efficacy - Core Phase||14||
48370504|NCT03056755|101234913|FG002|STARTED|Post-treatment Efficacy - Core Phase||7||
48370505|NCT03056755|101234911|FG000|COMPLETED|Post-treatment Efficacy - Core Phase||0||
48370506|NCT03056755|101234912|FG001|COMPLETED|Post-treatment Efficacy - Core Phase||0||
48370507|NCT03056755|101234913|FG002|COMPLETED|Post-treatment Efficacy - Core Phase||0||
48370508|NCT03056755|101234911|FG000|NOT COMPLETED|Post-treatment Efficacy - Core Phase||14||
48370509|NCT03056755|101234912|FG001|NOT COMPLETED|Post-treatment Efficacy - Core Phase||14||
48370510|NCT03056755|101234913|FG002|NOT COMPLETED|Post-treatment Efficacy - Core Phase||7||
48370511|NCT04252573|101234914|FG000|STARTED|Overall Study||13||
48370512|NCT04252573|101234914|FG000|COMPLETED|Overall Study||0||
48370513|NCT04252573|101234914|FG000|NOT COMPLETED|Overall Study||13||
48370514|NCT03485729|101234915|FG000|STARTED|Overall Study||10||
48370515|NCT03485729|101234916|FG001|STARTED|Overall Study||14||
48370516|NCT03485729|101234917|FG002|STARTED|Overall Study||3||
48370517|NCT03485729|101234915|FG000|COMPLETED|Overall Study||0||
48370518|NCT03485729|101234916|FG001|COMPLETED|Overall Study||0||
48370519|NCT03485729|101234917|FG002|COMPLETED|Overall Study||1||
48370520|NCT03485729|101234915|FG000|NOT COMPLETED|Overall Study||10||
48370521|NCT03485729|101234916|FG001|NOT COMPLETED|Overall Study||14||
48370522|NCT03485729|101234917|FG002|NOT COMPLETED|Overall Study||2||
48370523|NCT03603600|101234918|FG000|STARTED|Overall Study||332||
48370524|NCT03603600|101234919|FG001|STARTED|Overall Study||169||
48370525|NCT03603600|101234918|FG000|COMPLETED|Overall Study||319||
48370526|NCT03603600|101234919|FG001|COMPLETED|Overall Study||157||
48370527|NCT03603600|101234918|FG000|NOT COMPLETED|Overall Study||13||
48370528|NCT03603600|101234919|FG001|NOT COMPLETED|Overall Study||12||
48370529|NCT05603143|101234920|FG000|STARTED|Overall Study||233||
48370530|NCT05603143|101234921|FG001|STARTED|Overall Study||235||
48370531|NCT05603143|101234920|FG000|COMPLETED|Overall Study||224||
48370532|NCT05603143|101234921|FG001|COMPLETED|Overall Study||227||
48370533|NCT05603143|101234920|FG000|NOT COMPLETED|Overall Study||9||
48370534|NCT05603143|101234921|FG001|NOT COMPLETED|Overall Study||8||
48370535|NCT04928287|101234922|FG000|STARTED|Overall Study||15||
48370536|NCT04928287|101234923|FG001|STARTED|Overall Study||9||
48370537|NCT04928287|101234922|FG000|COMPLETED|Overall Study||15||
48370538|NCT04928287|101234923|FG001|COMPLETED|Overall Study||9||
48370539|NCT04928287|101234922|FG000|NOT COMPLETED|Overall Study||0||
48370540|NCT04928287|101234923|FG001|NOT COMPLETED|Overall Study||0||
48370541|NCT03995979|101234924|FG000|STARTED|Overall Study||12||
48370542|NCT03995979|101234924|FG000|COMPLETED|Overall Study||10||
48370543|NCT03995979|101234924|FG000|NOT COMPLETED|Overall Study||2||
48370544|NCT04410042|101234925|FG000|STARTED|Overall Study||7||
48470241|NCT03309449|101488162|FG002|STARTED|Overall Study||46||
48470242|NCT03309449|101488160|FG000|COMPLETED|Overall Study||46||
48470243|NCT03309449|101488161|FG001|COMPLETED|Overall Study||46||
48470244|NCT03309449|101488162|FG002|COMPLETED|Overall Study||46||
48470245|NCT03309449|101488160|FG000|NOT COMPLETED|Overall Study||0||
48470246|NCT03309449|101488161|FG001|NOT COMPLETED|Overall Study||0||
48470247|NCT03309449|101488162|FG002|NOT COMPLETED|Overall Study||0||
48470248|NCT01867242|101488163|FG000|STARTED|Overall Study||64||
48470249|NCT01867242|101488164|FG001|STARTED|Overall Study||60||
48470250|NCT01867242|101488165|FG002|STARTED|Overall Study||26||
48470251|NCT01867242|101488163|FG000|COMPLETED|Overall Study||40||
48470252|NCT01867242|101488164|FG001|COMPLETED|Overall Study||44||
48470253|NCT01867242|101488165|FG002|COMPLETED|Overall Study||18||
48470254|NCT01867242|101488163|FG000|NOT COMPLETED|Overall Study||24||
48470255|NCT01867242|101488164|FG001|NOT COMPLETED|Overall Study||16||
48470256|NCT01867242|101488165|FG002|NOT COMPLETED|Overall Study||8||
48470257|NCT03038113|101488166|FG000|STARTED|Overall Study||8||
48470258|NCT03038113|101488167|FG001|STARTED|Overall Study||8||
48470259|NCT03038113|101488168|FG002|STARTED|Overall Study||8||
48470260|NCT03038113|101488169|FG003|STARTED|Overall Study||8||
48470261|NCT03038113|101488170|FG004|STARTED|Overall Study||8||
48470262|NCT03038113|101488171|FG005|STARTED|Overall Study||8||
48470263|NCT03038113|101488172|FG006|STARTED|Overall Study||12||
48470264|NCT03038113|101488173|FG007|STARTED|Overall Study||6||
48470265|NCT03038113|101488174|FG008|STARTED|Overall Study||7||
48470266|NCT03038113|101488175|FG009|STARTED|Overall Study||6||
48470267|NCT03038113|101488176|FG010|STARTED|Overall Study||14||
48470268|NCT03038113|101488177|FG011|STARTED|Overall Study||7||
48470269|NCT03038113|101488178|FG012|STARTED|Overall Study||4||
48470270|NCT03038113|101488179|FG013|STARTED|Overall Study||15||
48470271|NCT03038113|101488166|FG000|COMPLETED|Overall Study||8||
48470272|NCT03038113|101488167|FG001|COMPLETED|Overall Study||8||
48470273|NCT03038113|101488168|FG002|COMPLETED|Overall Study||7||
48470274|NCT03038113|101488169|FG003|COMPLETED|Overall Study||8||
48470275|NCT03038113|101488170|FG004|COMPLETED|Overall Study||8||
48470276|NCT03038113|101488171|FG005|COMPLETED|Overall Study||8||
48370545|NCT04410042|101234926|FG001|STARTED|Overall Study||7||
48470277|NCT03038113|101488172|FG006|COMPLETED|Overall Study||11||
48470278|NCT03038113|101488173|FG007|COMPLETED|Overall Study||6||
48470279|NCT03038113|101488174|FG008|COMPLETED|Overall Study||7||
48470280|NCT03038113|101488175|FG009|COMPLETED|Overall Study||6||
48470281|NCT03038113|101488176|FG010|COMPLETED|Overall Study||14||
48470282|NCT03038113|101488177|FG011|COMPLETED|Overall Study||7||
48470283|NCT03038113|101488178|FG012|COMPLETED|Overall Study||4||
48470284|NCT03038113|101488179|FG013|COMPLETED|Overall Study||14||
48470285|NCT03038113|101488166|FG000|NOT COMPLETED|Overall Study||0||
48470286|NCT03038113|101488167|FG001|NOT COMPLETED|Overall Study||0||
48470287|NCT03038113|101488168|FG002|NOT COMPLETED|Overall Study||1||
48470288|NCT03038113|101488169|FG003|NOT COMPLETED|Overall Study||0||
48470289|NCT03038113|101488170|FG004|NOT COMPLETED|Overall Study||0||
48470290|NCT03038113|101488171|FG005|NOT COMPLETED|Overall Study||0||
48470291|NCT03038113|101488172|FG006|NOT COMPLETED|Overall Study||1||
48370546|NCT04410042|101234925|FG000|COMPLETED|Overall Study||6||
48370547|NCT04410042|101234926|FG001|COMPLETED|Overall Study||6||
48370548|NCT04410042|101234925|FG000|NOT COMPLETED|Overall Study||1||
48370549|NCT04410042|101234926|FG001|NOT COMPLETED|Overall Study||1||
48370550|NCT03885518|101234927|FG000|STARTED|Overall Study||32||
48370551|NCT03885518|101234928|FG001|STARTED|Overall Study||19||
48370552|NCT03885518|101234927|FG000|COMPLETED|Overall Study||22||
48370553|NCT03885518|101234928|FG001|COMPLETED|Overall Study||17||
48370554|NCT03885518|101234927|FG000|NOT COMPLETED|Overall Study||10||
48470292|NCT03038113|101488173|FG007|NOT COMPLETED|Overall Study||0||
48470293|NCT03038113|101488174|FG008|NOT COMPLETED|Overall Study||0||
48370555|NCT03885518|101234928|FG001|NOT COMPLETED|Overall Study||2||
48370556|NCT03582033|101234929|FG000|STARTED|Part A||2||
48470294|NCT03038113|101488175|FG009|NOT COMPLETED|Overall Study||0||
48470295|NCT03038113|101488176|FG010|NOT COMPLETED|Overall Study||0||
48470296|NCT03038113|101488177|FG011|NOT COMPLETED|Overall Study||0||
48470297|NCT03038113|101488178|FG012|NOT COMPLETED|Overall Study||0||
48190082|NCT02065245|100788996|FG002|NOT COMPLETED|Infusion 2||0||
48190083|NCT02065245|100788997|FG003|NOT COMPLETED|Infusion 2||0||
48470298|NCT03038113|101488179|FG013|NOT COMPLETED|Overall Study||1||
48470299|NCT00718159|101488180|FG000|STARTED|Overall Study||3||
48470300|NCT00718159|101488181|FG001|STARTED|Overall Study||3||
48470301|NCT00718159|101488182|FG002|STARTED|Overall Study||3||
48470302|NCT00718159|101488183|FG003|STARTED|Overall Study||4||
48470303|NCT00718159|101488184|FG004|STARTED|Overall Study||8||
48470304|NCT00718159|101488185|FG005|STARTED|Overall Study||1||
48470305|NCT00718159|101488186|FG006|STARTED|Overall Study||1||
48470306|NCT00718159|101488180|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
48190084|NCT02065245|100788998|FG004|NOT COMPLETED|Infusion 2||0||
48190085|NCT02065245|100788999|FG005|NOT COMPLETED|Infusion 2||0||
48190086|NCT02065245|100789000|FG006|NOT COMPLETED|Infusion 2||1||
48190087|NCT02065245|100788994|FG000|STARTED|Infusion 3||3||
48190088|NCT02065245|100788995|FG001|STARTED|Infusion 3||5||
48190089|NCT02065245|100788996|FG002|STARTED|Infusion 3||1||
48190090|NCT02065245|100788997|FG003|STARTED|Infusion 3||0||
48190091|NCT02065245|100788998|FG004|STARTED|Infusion 3||0||
48190092|NCT02065245|100788999|FG005|STARTED|Infusion 3||0||
48190093|NCT02065245|100789000|FG006|STARTED|Infusion 3||0||
48190094|NCT02065245|100788994|FG000|COMPLETED|Infusion 3||2||
48190095|NCT02065245|100788995|FG001|COMPLETED|Infusion 3||4||
48190096|NCT02065245|100788996|FG002|COMPLETED|Infusion 3||1||
48190097|NCT02065245|100788997|FG003|COMPLETED|Infusion 3||0||
48190098|NCT02065245|100788998|FG004|COMPLETED|Infusion 3||0||
48470307|NCT00718159|101488181|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3||
48190099|NCT02065245|100788999|FG005|COMPLETED|Infusion 3||0||
48190100|NCT02065245|100789000|FG006|COMPLETED|Infusion 3||0||
48190101|NCT02065245|100788994|FG000|NOT COMPLETED|Infusion 3||1||
48190102|NCT02065245|100788995|FG001|NOT COMPLETED|Infusion 3||1||
48190103|NCT02065245|100788996|FG002|NOT COMPLETED|Infusion 3||0||
48190104|NCT02065245|100788997|FG003|NOT COMPLETED|Infusion 3||0||
48190105|NCT02065245|100788998|FG004|NOT COMPLETED|Infusion 3||0||
48190106|NCT02065245|100788999|FG005|NOT COMPLETED|Infusion 3||0||
48190107|NCT02065245|100789000|FG006|NOT COMPLETED|Infusion 3||0||
48190108|NCT02065245|100788994|FG000|STARTED|Infusion 4||1||
48190109|NCT02065245|100788995|FG001|STARTED|Infusion 4||2||
48190110|NCT02065245|100788996|FG002|STARTED|Infusion 4||1||
48190111|NCT02065245|100788997|FG003|STARTED|Infusion 4||0||
48190112|NCT02065245|100788998|FG004|STARTED|Infusion 4||0||
48190113|NCT02065245|100788999|FG005|STARTED|Infusion 4||0||
48190114|NCT02065245|100789000|FG006|STARTED|Infusion 4||0||
48190115|NCT02065245|100788994|FG000|COMPLETED|Infusion 4||1||
48190116|NCT02065245|100788995|FG001|COMPLETED|Infusion 4||2||
48190117|NCT02065245|100788996|FG002|COMPLETED|Infusion 4||1||
48190118|NCT02065245|100788997|FG003|COMPLETED|Infusion 4||0||
48470308|NCT00718159|101488182|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
48470309|NCT00718159|101488183|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4||
48470310|NCT00718159|101488184|FG004|Received at Least 1 Dose of Study Drug|Overall Study||8||
48190119|NCT02065245|100788998|FG004|COMPLETED|Infusion 4||0||
48190120|NCT02065245|100788999|FG005|COMPLETED|Infusion 4||0||
48190121|NCT02065245|100789000|FG006|COMPLETED|Infusion 4||0||
48190122|NCT02065245|100788994|FG000|NOT COMPLETED|Infusion 4||0||
48190123|NCT02065245|100788995|FG001|NOT COMPLETED|Infusion 4||0||
48190124|NCT02065245|100788996|FG002|NOT COMPLETED|Infusion 4||0||
48190125|NCT02065245|100788997|FG003|NOT COMPLETED|Infusion 4||0||
48470311|NCT00718159|101488185|FG005|Received at Least 1 Dose of Study Drug|Overall Study||1||
48470312|NCT00718159|101488186|FG006|Received at Least 1 Dose of Study Drug|Overall Study||1||
48470313|NCT00718159|101488180|FG000|COMPLETED|Overall Study||0||
48470314|NCT00718159|101488181|FG001|COMPLETED|Overall Study||0||
48470315|NCT00718159|101488182|FG002|COMPLETED|Overall Study||0||
48470316|NCT00718159|101488183|FG003|COMPLETED|Overall Study||0||
48470317|NCT00718159|101488184|FG004|COMPLETED|Overall Study||0||
48470318|NCT00718159|101488185|FG005|COMPLETED|Overall Study||0||
48190126|NCT02065245|100788998|FG004|NOT COMPLETED|Infusion 4||0||
48190127|NCT02065245|100788999|FG005|NOT COMPLETED|Infusion 4||0||
48190128|NCT02065245|100789000|FG006|NOT COMPLETED|Infusion 4||0||
48190129|NCT01876043|100789001|FG000|STARTED|Overall Study||24||
48190130|NCT01876043|100789001|FG000|Interim Analysis Population|Overall Study||17|Following Simon's 2-stage design (see arm description), 17 patients included in the first stage.|
48370557|NCT03582033|101234930|FG001|STARTED|Part A||2||
48370558|NCT03582033|101234931|FG002|STARTED|Part A||2||
48370559|NCT03582033|101234932|FG003|STARTED|Part A||7||
48370560|NCT03582033|101234933|FG004|STARTED|Part A||22||
48370561|NCT03582033|101234934|FG005|STARTED|Part A||0||
48190131|NCT01876043|100789001|FG000|COMPLETED|Overall Study||22|Received one complete cycle or two incomplete cycles of treatment (17 patients included in the first stage of Simon's design + 5 additionnal patients included)|
48190132|NCT01876043|100789001|FG000|NOT COMPLETED|Overall Study||2||
48190133|NCT00438971|100789002|FG000|STARTED|Overall Study||17||
48190134|NCT00438971|100789002|FG000|COMPLETED|Overall Study||15||
48190135|NCT00438971|100789002|FG000|NOT COMPLETED|Overall Study||2||
48190136|NCT03569813|100789003|FG000|STARTED|Overall Study||211||
48190137|NCT03569813|100789004|FG001|STARTED|Overall Study||107||
48190138|NCT03569813|100789003|FG000|COMPLETED|Overall Study||126||
48190139|NCT03569813|100789004|FG001|COMPLETED|Overall Study||62||
48190140|NCT03569813|100789003|FG000|NOT COMPLETED|Overall Study||85||
48190141|NCT03569813|100789004|FG001|NOT COMPLETED|Overall Study||45||
48470319|NCT00718159|101488186|FG006|COMPLETED|Overall Study||0||
48470320|NCT00718159|101488180|FG000|NOT COMPLETED|Overall Study||3||
48470321|NCT00718159|101488181|FG001|NOT COMPLETED|Overall Study||3||
48470322|NCT00718159|101488182|FG002|NOT COMPLETED|Overall Study||3||
48470323|NCT00718159|101488183|FG003|NOT COMPLETED|Overall Study||4||
48470324|NCT00718159|101488184|FG004|NOT COMPLETED|Overall Study||8||
48470325|NCT00718159|101488185|FG005|NOT COMPLETED|Overall Study||1||
48470326|NCT00718159|101488186|FG006|NOT COMPLETED|Overall Study||1||
48470327|NCT04591626|101488187|FG000|STARTED|Overall Study||144||
48470328|NCT04591626|101488188|FG001|STARTED|Overall Study||147||
48470329|NCT04591626|101488187|FG000|Received At Least One Dose of Study Drug|Overall Study||144||
48470330|NCT04591626|101488188|FG001|Received At Least One Dose of Study Drug|Overall Study||147||
48470331|NCT04591626|101488187|FG000|COMPLETED|Overall Study||134||
48470332|NCT04591626|101488188|FG001|COMPLETED|Overall Study||142||
48470333|NCT04591626|101488187|FG000|NOT COMPLETED|Overall Study||10||
48470334|NCT04591626|101488188|FG001|NOT COMPLETED|Overall Study||5||
48470335|NCT00417274|101488189|FG000|STARTED|Overall Study||31||
48470336|NCT00417274|101488189|FG000|COMPLETED|Overall Study||31||
48470337|NCT00417274|101488189|FG000|NOT COMPLETED|Overall Study||0||
48470338|NCT04700449|101488190|FG000|STARTED|Stage 1: Double-Blind Period||39||
48470339|NCT04700449|101488191|FG001|STARTED|Stage 1: Double-Blind Period||53||
48470340|NCT04700449|101488192|FG002|STARTED|Stage 1: Double-Blind Period||52||
48470341|NCT04700449|101488193|FG003|STARTED|Stage 1: Double-Blind Period||0||
48470342|NCT04700449|101488190|FG000|COMPLETED|Stage 1: Double-Blind Period||28||
48470343|NCT04700449|101488191|FG001|COMPLETED|Stage 1: Double-Blind Period||50||
48470344|NCT04700449|101488192|FG002|COMPLETED|Stage 1: Double-Blind Period||47||
48470345|NCT04700449|101488193|FG003|COMPLETED|Stage 1: Double-Blind Period||0||
48470346|NCT04700449|101488190|FG000|NOT COMPLETED|Stage 1: Double-Blind Period||11||
48470347|NCT04700449|101488191|FG001|NOT COMPLETED|Stage 1: Double-Blind Period||3||
48470348|NCT04700449|101488192|FG002|NOT COMPLETED|Stage 1: Double-Blind Period||5||
48470349|NCT04700449|101488193|FG003|NOT COMPLETED|Stage 1: Double-Blind Period||0||
48470350|NCT04700449|101488190|FG000|STARTED|Stage 2 Sub-study 1||12||
48470351|NCT04700449|101488191|FG001|STARTED|Stage 2 Sub-study 1||21||
48470352|NCT04700449|101488192|FG002|STARTED|Stage 2 Sub-study 1||13||
48470353|NCT04700449|101488193|FG003|STARTED|Stage 2 Sub-study 1||0||
48470354|NCT04700449|101488190|FG000|COMPLETED|Stage 2 Sub-study 1||10||
48470355|NCT04700449|101488191|FG001|COMPLETED|Stage 2 Sub-study 1||17||
48470356|NCT04700449|101488192|FG002|COMPLETED|Stage 2 Sub-study 1||9||
48470357|NCT04700449|101488193|FG003|COMPLETED|Stage 2 Sub-study 1||0||
48470358|NCT04700449|101488190|FG000|NOT COMPLETED|Stage 2 Sub-study 1||2||
48470359|NCT04700449|101488191|FG001|NOT COMPLETED|Stage 2 Sub-study 1||4||
48470360|NCT04700449|101488192|FG002|NOT COMPLETED|Stage 2 Sub-study 1||4||
48470361|NCT04700449|101488193|FG003|NOT COMPLETED|Stage 2 Sub-study 1||0||
48470362|NCT04700449|101488190|FG000|STARTED|Stage 2 Sub-study 2||0||
48470363|NCT04700449|101488191|FG001|STARTED|Stage 2 Sub-study 2||0||
48470364|NCT04700449|101488192|FG002|STARTED|Stage 2 Sub-study 2||0||
48470365|NCT04700449|101488193|FG003|STARTED|Stage 2 Sub-study 2||40||
48190142|NCT01929993|100789005|FG000|STARTED|Overall Study||82||
48470366|NCT04700449|101488190|FG000|COMPLETED|Stage 2 Sub-study 2||0||
48470367|NCT04700449|101488191|FG001|COMPLETED|Stage 2 Sub-study 2||0||
48470368|NCT04700449|101488192|FG002|COMPLETED|Stage 2 Sub-study 2||0||
48470369|NCT04700449|101488193|FG003|COMPLETED|Stage 2 Sub-study 2||17||
48470370|NCT04700449|101488190|FG000|NOT COMPLETED|Stage 2 Sub-study 2||0||
48470371|NCT04700449|101488191|FG001|NOT COMPLETED|Stage 2 Sub-study 2||0||
48470372|NCT04700449|101488192|FG002|NOT COMPLETED|Stage 2 Sub-study 2||0||
48470373|NCT04700449|101488193|FG003|NOT COMPLETED|Stage 2 Sub-study 2||23||
48470374|NCT01151813|101488194|FG000|STARTED|Period 1||8||
48470375|NCT01151813|101488195|FG001|STARTED|Period 1||7||
48470376|NCT01151813|101488194|FG000|COMPLETED|Period 1||8||
48470377|NCT01151813|101488195|FG001|COMPLETED|Period 1||7||
48470378|NCT01151813|101488194|FG000|NOT COMPLETED|Period 1||0||
48470379|NCT01151813|101488195|FG001|NOT COMPLETED|Period 1||0||
48470380|NCT01151813|101488194|FG000|STARTED|Period 2||8||
48470381|NCT01151813|101488195|FG001|STARTED|Period 2||7||
48470382|NCT01151813|101488194|FG000|COMPLETED|Period 2||8||
48470383|NCT01151813|101488195|FG001|COMPLETED|Period 2||7||
48470384|NCT01151813|101488194|FG000|NOT COMPLETED|Period 2||0||
48470385|NCT01151813|101488195|FG001|NOT COMPLETED|Period 2||0||
48470386|NCT01031537|101488196|FG000|STARTED|Overall Study||66||
48470387|NCT01031537|101488196|FG000|COMPLETED|Overall Study||34||
48470388|NCT01031537|101488196|FG000|NOT COMPLETED|Overall Study||32||
48470389|NCT01968382|101488197|FG000|STARTED|Overall Study||18||
48470390|NCT01968382|101488198|FG001|STARTED|Overall Study||19||
48470391|NCT01968382|101488199|FG002|STARTED|Overall Study||20||
48470392|NCT01968382|101488197|FG000|COMPLETED|Overall Study||18||
48470393|NCT01968382|101488198|FG001|COMPLETED|Overall Study||19||
48470394|NCT01968382|101488199|FG002|COMPLETED|Overall Study||20||
48470395|NCT01968382|101488197|FG000|NOT COMPLETED|Overall Study||0||
48470396|NCT01968382|101488198|FG001|NOT COMPLETED|Overall Study||0||
48470397|NCT01968382|101488199|FG002|NOT COMPLETED|Overall Study||0||
48470398|NCT02258256|101488200|FG000|STARTED|Overall Study||11||
48470399|NCT02258256|101488200|FG000|COMPLETED|Overall Study||11||
48470400|NCT02258256|101488200|FG000|NOT COMPLETED|Overall Study||0||
48470401|NCT02309099|101488201|FG000|STARTED|Overall Study||7||
48470402|NCT02309099|101488202|FG001|STARTED|Overall Study||3||
48470403|NCT02309099|101488201|FG000|Cochlear Implantation|Overall Study||7|Cochlear implantation following initial surgical procedure (schannoma resection or labyrinthectomy)|
48470404|NCT02309099|101488202|FG001|Cochlear Implantation|Overall Study||3|Cochlear implantation following initial surgical procedure (schannoma resection or labyrinthectomy)|
48470405|NCT02309099|101488201|FG000|Initial Activation|Overall Study||7|Initial activation of cochlear implant (2-4 weeks following surgical procedure/implantation)|
48470406|NCT02309099|101488202|FG001|Initial Activation|Overall Study||3|Initial activation of cochlear implant (2-4 weeks following surgical procedure/implantation)|
48470407|NCT02309099|101488201|FG000|Cochlear Implant Use/Follow-Up|Overall Study||5|Device use over the initial 12 months following initial activation (1-month to 12-months)|
48470408|NCT02309099|101488202|FG001|Cochlear Implant Use/Follow-Up|Overall Study||3|Device use over the initial 12 months following initial activation (1-month to 12-months)|
48470409|NCT02309099|101488201|FG000|COMPLETED|Overall Study||5||
48470410|NCT02309099|101488202|FG001|COMPLETED|Overall Study||3||
48470411|NCT02309099|101488201|FG000|NOT COMPLETED|Overall Study||2||
48470412|NCT02309099|101488202|FG001|NOT COMPLETED|Overall Study||0||
48470413|NCT04622709|101488203|FG000|STARTED|Period 1 (First 6 Weeks)||39||
48470414|NCT04622709|101488203|FG000|COMPLETED|Period 1 (First 6 Weeks)||36||
48470415|NCT04622709|101488203|FG000|NOT COMPLETED|Period 1 (First 6 Weeks)||3||
48470416|NCT04622709|101488203|FG000|STARTED|Period 2 (Subsequent 12 Weeks)||36||
48470417|NCT04622709|101488203|FG000|COMPLETED|Period 2 (Subsequent 12 Weeks)||32||
48470418|NCT04622709|101488203|FG000|NOT COMPLETED|Period 2 (Subsequent 12 Weeks)||4||
48470419|NCT02132247|101488204|FG000|STARTED|Overall Study||52||
48470420|NCT02132247|101488205|FG001|STARTED|Overall Study||52||
48470421|NCT02132247|101488204|FG000|COMPLETED|Overall Study||51||
48470422|NCT02132247|101488205|FG001|COMPLETED|Overall Study||52||
48470423|NCT02132247|101488204|FG000|NOT COMPLETED|Overall Study||1||
48470424|NCT02132247|101488205|FG001|NOT COMPLETED|Overall Study||0||
48470425|NCT01267266|101488206|FG000|STARTED|Enrollment Phase||33||
48470426|NCT01267266|101488207|FG001|STARTED|Enrollment Phase||0||
48470427|NCT01267266|101488206|FG000|COMPLETED|Enrollment Phase||31||
48470428|NCT01267266|101488207|FG001|COMPLETED|Enrollment Phase||0||
48470429|NCT01267266|101488206|FG000|NOT COMPLETED|Enrollment Phase||2||
48470430|NCT01267266|101488207|FG001|NOT COMPLETED|Enrollment Phase||0||
48470431|NCT01267266|101488206|FG000|STARTED|Lead-in Phase||31||
48470432|NCT01267266|101488207|FG001|STARTED|Lead-in Phase||0||
48470433|NCT01267266|101488206|FG000|COMPLETED|Lead-in Phase||8||
48470434|NCT01267266|101488207|FG001|COMPLETED|Lead-in Phase||0||
48470435|NCT01267266|101488206|FG000|NOT COMPLETED|Lead-in Phase||23||
48470436|NCT01267266|101488207|FG001|NOT COMPLETED|Lead-in Phase||0||
48470437|NCT01267266|101488206|FG000|STARTED|Randomized Phase||3||
48470438|NCT01267266|101488207|FG001|STARTED|Randomized Phase||5||
48470439|NCT01267266|101488206|FG000|COMPLETED|Randomized Phase||3||
48470440|NCT01267266|101488207|FG001|COMPLETED|Randomized Phase||5||
48470441|NCT01267266|101488206|FG000|NOT COMPLETED|Randomized Phase||0||
48470442|NCT01267266|101488207|FG001|NOT COMPLETED|Randomized Phase||0||
48470443|NCT01365650|101488208|FG000|STARTED|Treatment A||24||
48470444|NCT01365650|101488208|FG000|COMPLETED|Treatment A||24||
48470445|NCT01365650|101488208|FG000|NOT COMPLETED|Treatment A||0||
48470446|NCT01365650|101488208|FG000|STARTED|Treatment B||24||
48470447|NCT01365650|101488208|FG000|COMPLETED|Treatment B||24||
48470448|NCT01365650|101488208|FG000|NOT COMPLETED|Treatment B||0||
48470449|NCT01365650|101488208|FG000|STARTED|Treatment C||24||
48470450|NCT01365650|101488208|FG000|COMPLETED|Treatment C||24||
48470451|NCT01365650|101488208|FG000|NOT COMPLETED|Treatment C||0||
48470452|NCT01346085|101488209|FG000|STARTED|Overall Study||10||
48470453|NCT01346085|101488209|FG000|COMPLETED|Overall Study||10||
48470454|NCT01346085|101488209|FG000|NOT COMPLETED|Overall Study||0||
48470455|NCT01575054|101488210|FG000|STARTED|Overall Study||233||
48470456|NCT01575054|101488211|FG001|STARTED|Overall Study||235||
48470457|NCT01575054|101488210|FG000|COMPLETED|Overall Study||204||
48470458|NCT01575054|101488211|FG001|COMPLETED|Overall Study||209||
48470459|NCT01575054|101488210|FG000|NOT COMPLETED|Overall Study||29||
48470460|NCT01575054|101488211|FG001|NOT COMPLETED|Overall Study||26||
48470461|NCT02585700|101488212|FG000|STARTED|Overall Study||30||
48470462|NCT02585700|101488213|FG001|STARTED|Overall Study||30||
48470463|NCT02585700|101488212|FG000|COMPLETED|Overall Study||30||
48470464|NCT02585700|101488213|FG001|COMPLETED|Overall Study||30||
48470465|NCT02585700|101488212|FG000|NOT COMPLETED|Overall Study||0||
48470466|NCT02585700|101488213|FG001|NOT COMPLETED|Overall Study||0||
48470467|NCT01681030|101488214|FG000|STARTED|Overall Study||13||
48470468|NCT01681030|101488215|FG001|STARTED|Overall Study||18||
48470469|NCT01681030|101488216|FG002|STARTED|Overall Study||11||
48470470|NCT01681030|101488214|FG000|COMPLETED|Overall Study||13||
48470471|NCT01681030|101488215|FG001|COMPLETED|Overall Study||18||
48470472|NCT01681030|101488216|FG002|COMPLETED|Overall Study||11||
48470473|NCT01681030|101488214|FG000|NOT COMPLETED|Overall Study||0||
48470474|NCT01681030|101488215|FG001|NOT COMPLETED|Overall Study||0||
48470475|NCT01681030|101488216|FG002|NOT COMPLETED|Overall Study||0||
48470476|NCT00683020|101488217|FG000|STARTED|Overall Study||182||
48470477|NCT00683020|101488218|FG001|STARTED|Overall Study||180||
48470478|NCT00683020|101488217|FG000|COMPLETED|Overall Study||127||
48470479|NCT00683020|101488218|FG001|COMPLETED|Overall Study||125||
48470480|NCT00683020|101488217|FG000|NOT COMPLETED|Overall Study||55||
48470481|NCT00683020|101488218|FG001|NOT COMPLETED|Overall Study||55||
48470482|NCT01802879|101488219|FG000|STARTED|Overall Study||8||
48470483|NCT01802879|101488219|FG000|COMPLETED|Overall Study||0||
48470484|NCT01802879|101488219|FG000|NOT COMPLETED|Overall Study||8||
48470485|NCT04394754|101488220|FG000|STARTED|Overall Study||44||
48470486|NCT04394754|101488221|FG001|STARTED|Overall Study||46||
48470487|NCT04394754|101488222|FG002|STARTED|Overall Study||46||
48470488|NCT04394754|101488223|FG003|STARTED|Overall Study||46||
48470489|NCT04394754|101488220|FG000|COMPLETED|Overall Study||36||
48470490|NCT04394754|101488221|FG001|COMPLETED|Overall Study||39||
48470491|NCT04394754|101488222|FG002|COMPLETED|Overall Study||38||
48470492|NCT04394754|101488223|FG003|COMPLETED|Overall Study||38||
48470493|NCT04394754|101488220|FG000|NOT COMPLETED|Overall Study||8||
48470494|NCT04394754|101488221|FG001|NOT COMPLETED|Overall Study||7||
48470495|NCT04394754|101488222|FG002|NOT COMPLETED|Overall Study||8||
48470496|NCT04394754|101488223|FG003|NOT COMPLETED|Overall Study||8||
48190143|NCT01929993|100789006|FG001|STARTED|Overall Study||82||
48190144|NCT01929993|100789005|FG000|COMPLETED|Overall Study||52||
48190145|NCT01929993|100789006|FG001|COMPLETED|Overall Study||54||
48190146|NCT01929993|100789005|FG000|NOT COMPLETED|Overall Study||30||
48190147|NCT01929993|100789006|FG001|NOT COMPLETED|Overall Study||28||
48190148|NCT00836810|100789007|FG000|STARTED|Overall Study||5||
48190149|NCT00836810|100789008|FG001|STARTED|Overall Study||6||
48190150|NCT00836810|100789007|FG000|COMPLETED|Overall Study||4||
48190151|NCT00836810|100789008|FG001|COMPLETED|Overall Study||6||
48190152|NCT00836810|100789007|FG000|NOT COMPLETED|Overall Study||1||
48190153|NCT00836810|100789008|FG001|NOT COMPLETED|Overall Study||0||
48190154|NCT02491411|100789009|FG000|STARTED|Overall Study||4||
48190155|NCT02491411|100789009|FG000|COMPLETED|Overall Study||0||
48190156|NCT02491411|100789009|FG000|NOT COMPLETED|Overall Study||4||
48190157|NCT04992442|100789010|FG000|STARTED|Treatment Period 1||6||
48190158|NCT04992442|100789010|FG000|COMPLETED|Treatment Period 1||6||
48470497|NCT00638365|101488224|FG000|STARTED|Overall Study||9||
48470498|NCT00638365|101488225|FG001|STARTED|Overall Study||10||
48470499|NCT00638365|101488226|FG002|STARTED|Overall Study||8||
48470500|NCT00638365|101488224|FG000|COMPLETED|Overall Study||9||
48470501|NCT00638365|101488225|FG001|COMPLETED|Overall Study||10||
48470502|NCT00638365|101488226|FG002|COMPLETED|Overall Study||8||
48190159|NCT04992442|100789010|FG000|NOT COMPLETED|Treatment Period 1||0||
48190160|NCT04992442|100789010|FG000|STARTED|Washout Period||6||
48190161|NCT04992442|100789010|FG000|COMPLETED|Washout Period||6||
48190162|NCT04992442|100789010|FG000|NOT COMPLETED|Washout Period||0||
48190163|NCT04992442|100789010|FG000|STARTED|Treatment Period 2||6||
48190164|NCT04992442|100789010|FG000|COMPLETED|Treatment Period 2||6||
48190165|NCT04992442|100789010|FG000|NOT COMPLETED|Treatment Period 2||0||
48190166|NCT02775617|100789011|FG000|STARTED|Overall Study||653||
48190167|NCT02775617|100789012|FG001|STARTED|Overall Study||638||
48190168|NCT02775617|100789011|FG000|COMPLETED|Overall Study||605||
48190169|NCT02775617|100789012|FG001|COMPLETED|Overall Study||478||
48190170|NCT02775617|100789011|FG000|NOT COMPLETED|Overall Study||48||
48190171|NCT02775617|100789012|FG001|NOT COMPLETED|Overall Study||160||
48190172|NCT02982928|100789013|FG000|STARTED|Overall Study||11||
48190173|NCT02982928|100789013|FG000|COMPLETED|Overall Study||11||
48190174|NCT02982928|100789013|FG000|NOT COMPLETED|Overall Study||0||
48190175|NCT01104103|100789014|FG000|STARTED|Overall Study||243||
48190176|NCT01104103|100789015|FG001|STARTED|Overall Study||224||
48190177|NCT01104103|100789014|FG000|COMPLETED|Overall Study||243||
48190178|NCT01104103|100789015|FG001|COMPLETED|Overall Study||224||
48190179|NCT01104103|100789014|FG000|NOT COMPLETED|Overall Study||0||
48190180|NCT01104103|100789015|FG001|NOT COMPLETED|Overall Study||0||
48190181|NCT00180687|100789016|FG000|STARTED|Overall Study||20||
48190182|NCT00180687|100789017|FG001|STARTED|Overall Study||20||
48190183|NCT00180687|100789018|FG002|STARTED|Overall Study||20||
48190184|NCT00180687|100789019|FG003|STARTED|Overall Study||20||
48190185|NCT00180687|100789016|FG000|COMPLETED|Overall Study||20||
48190186|NCT00180687|100789017|FG001|COMPLETED|Overall Study||20||
48190187|NCT00180687|100789018|FG002|COMPLETED|Overall Study||20||
48190188|NCT00180687|100789019|FG003|COMPLETED|Overall Study||20||
48190189|NCT00180687|100789016|FG000|NOT COMPLETED|Overall Study||0||
48190190|NCT00180687|100789017|FG001|NOT COMPLETED|Overall Study||0||
48190191|NCT00180687|100789018|FG002|NOT COMPLETED|Overall Study||0||
48470503|NCT00638365|101488224|FG000|NOT COMPLETED|Overall Study||0||
48470504|NCT00638365|101488225|FG001|NOT COMPLETED|Overall Study||0||
48470505|NCT00638365|101488226|FG002|NOT COMPLETED|Overall Study||0||
48470506|NCT01226797|101488227|FG000|STARTED|Overall Study||12||
48470507|NCT01226797|101488228|FG001|STARTED|Overall Study||12||
48470508|NCT01226797|101488227|FG000|COMPLETED|Overall Study||10||
48190192|NCT00180687|100789019|FG003|NOT COMPLETED|Overall Study||0||
48190193|NCT00079937|100789020|FG000|STARTED|Overall Study||421||
48190194|NCT00079937|100789021|FG001|STARTED|Overall Study||207||
48190195|NCT00079937|100789020|FG000|COMPLETED|Overall Study||352||
48190196|NCT00079937|100789021|FG001|COMPLETED|Overall Study||175||
48190197|NCT00079937|100789020|FG000|NOT COMPLETED|Overall Study||69||
48190198|NCT00079937|100789021|FG001|NOT COMPLETED|Overall Study||32||
48190199|NCT04036799|100789022|FG000|STARTED|Overall Study||572||
48190200|NCT04036799|100789022|FG000|COMPLETED|Overall Study||572||
48470509|NCT01226797|101488228|FG001|COMPLETED|Overall Study||11||
48470510|NCT01226797|101488227|FG000|NOT COMPLETED|Overall Study||2||
48470511|NCT01226797|101488228|FG001|NOT COMPLETED|Overall Study||1||
48190201|NCT04036799|100789022|FG000|NOT COMPLETED|Overall Study||0||
48190202|NCT02987829|100789023|FG000|STARTED|Overall Study||1||
48190203|NCT02987829|100789024|FG001|STARTED|Overall Study||1||
48190204|NCT02987829|100789025|FG002|STARTED|Overall Study||2||
48190205|NCT02987829|100789026|FG003|STARTED|Overall Study||7||
48190206|NCT02987829|100789027|FG004|STARTED|Overall Study||51||
48190207|NCT02987829|100789028|FG005|STARTED|Overall Study||10||
48190208|NCT02987829|100789023|FG000|COMPLETED|Overall Study||1||
48190209|NCT02987829|100789024|FG001|COMPLETED|Overall Study||1||
48190210|NCT02987829|100789025|FG002|COMPLETED|Overall Study||2||
48190211|NCT02987829|100789026|FG003|COMPLETED|Overall Study||7||
48190212|NCT02987829|100789027|FG004|COMPLETED|Overall Study||51||
48190213|NCT02987829|100789028|FG005|COMPLETED|Overall Study||10||
48190214|NCT02987829|100789023|FG000|NOT COMPLETED|Overall Study||0||
48190215|NCT02987829|100789024|FG001|NOT COMPLETED|Overall Study||0||
48190216|NCT02987829|100789025|FG002|NOT COMPLETED|Overall Study||0||
48190217|NCT02987829|100789026|FG003|NOT COMPLETED|Overall Study||0||
48190218|NCT02987829|100789027|FG004|NOT COMPLETED|Overall Study||0||
48190219|NCT02987829|100789028|FG005|NOT COMPLETED|Overall Study||0||
48190220|NCT01518257|100789029|FG000|STARTED|Overall Study||61||
48190221|NCT01518257|100789030|FG001|STARTED|Overall Study||60||
48190222|NCT01518257|100789029|FG000|COMPLETED|Overall Study||59||
48190223|NCT01518257|100789030|FG001|COMPLETED|Overall Study||60||
48190224|NCT01518257|100789029|FG000|NOT COMPLETED|Overall Study||2||
48190225|NCT01518257|100789030|FG001|NOT COMPLETED|Overall Study||0||
48190226|NCT00764868|100789031|FG000|STARTED|Overall Study||269||
48190227|NCT00764868|100789031|FG000|COMPLETED|Overall Study||156||
48190228|NCT00764868|100789031|FG000|NOT COMPLETED|Overall Study||113||
48190229|NCT01734811|100789032|FG000|STARTED|Overall Study||58||
48190230|NCT01734811|100789033|FG001|STARTED|Overall Study||62||
48190231|NCT01734811|100789032|FG000|COMPLETED|Overall Study||54||
48190232|NCT01734811|100789033|FG001|COMPLETED|Overall Study||59||
48190233|NCT01734811|100789032|FG000|NOT COMPLETED|Overall Study||4||
48190234|NCT01734811|100789033|FG001|NOT COMPLETED|Overall Study||3||
48190235|NCT04436029|100789034|FG000|STARTED|Overall Study||4||
48190236|NCT04436029|100789034|FG000|COMPLETED|Overall Study||4||
48190237|NCT04436029|100789034|FG000|NOT COMPLETED|Overall Study||0||
48190238|NCT02373813|100789035|FG000|STARTED|Run-In Period||371||
48190239|NCT02373813|100789036|FG001|STARTED|Run-In Period||0||
48190240|NCT02373813|100789037|FG002|STARTED|Run-In Period||0||
48190241|NCT02373813|100789038|FG003|STARTED|Run-In Period||0||
48190242|NCT02373813|100789035|FG000|Treated|Run-In Period||368||
48190243|NCT02373813|100789036|FG001|Treated|Run-In Period||0||
48190244|NCT02373813|100789037|FG002|Treated|Run-In Period||0||
48190245|NCT02373813|100789038|FG003|Treated|Run-In Period||0||
48190246|NCT02373813|100789035|FG000|COMPLETED|Run-In Period||255||
48190247|NCT02373813|100789036|FG001|COMPLETED|Run-In Period||0||
48190248|NCT02373813|100789037|FG002|COMPLETED|Run-In Period||0||
48190249|NCT02373813|100789038|FG003|COMPLETED|Run-In Period||0||
48190250|NCT02373813|100789035|FG000|NOT COMPLETED|Run-In Period||116||
48190251|NCT02373813|100789036|FG001|NOT COMPLETED|Run-In Period||0||
48190252|NCT02373813|100789037|FG002|NOT COMPLETED|Run-In Period||0||
48190253|NCT02373813|100789038|FG003|NOT COMPLETED|Run-In Period||0||
48190254|NCT02373813|100789035|FG000|STARTED|Double-Blind Treatment Period||0|One participant who completed the run-in period was not randomized.|
48190255|NCT02373813|100789036|FG001|STARTED|Double-Blind Treatment Period||101|One participant who completed the run-in period was not randomized.|
48190256|NCT02373813|100789037|FG002|STARTED|Double-Blind Treatment Period||101|One participant who completed the run-in period was not randomized.|
48190257|NCT02373813|100789038|FG003|STARTED|Double-Blind Treatment Period||51|One participant who completed the run-in period was not randomized.|
48190258|NCT02373813|100789035|FG000|Received Investigational Product (IP)|Double-Blind Treatment Period||0||
48190259|NCT02373813|100789036|FG001|Received Investigational Product (IP)|Double-Blind Treatment Period||101||
48470512|NCT01424722|101488229|FG000|STARTED|Overall Study||2258||
48470513|NCT01424722|101488229|FG000|COMPLETED|Overall Study||0||
48470514|NCT01424722|101488229|FG000|NOT COMPLETED|Overall Study||2258||
48190260|NCT02373813|100789037|FG002|Received Investigational Product (IP)|Double-Blind Treatment Period||100||
48190261|NCT02373813|100789038|FG003|Received Investigational Product (IP)|Double-Blind Treatment Period||51||
48470515|NCT02467621|101488230|FG000|STARTED|Overall Study||1645|"52 patients were randomised in error BEFORE receiving the first dose of IMP/placebo.~3350-52=3298"|
48470516|NCT02467621|101488231|FG001|STARTED|Overall Study||1653|"52 patients were randomised in error BEFORE receiving the first dose of IMP/placebo.~3350-52=3298"|
48470517|NCT02467621|101488230|FG000|COMPLETED|Overall Study||1644|1644/1647 in the secondary outcome analyses 1642/1640 in the primary outcome analysis|
48666117|NCT01979185|101967507|FG001|STARTED|Period 1||15||
48190262|NCT02373813|100789035|FG000|Received Rescue Treatment|Double-Blind Treatment Period||0||
48190263|NCT02373813|100789036|FG001|Received Rescue Treatment|Double-Blind Treatment Period||52||
48190264|NCT02373813|100789037|FG002|Received Rescue Treatment|Double-Blind Treatment Period||36||
48190265|NCT02373813|100789038|FG003|Received Rescue Treatment|Double-Blind Treatment Period||15||
48190266|NCT02373813|100789035|FG000|COMPLETED|Double-Blind Treatment Period||0||
48190267|NCT02373813|100789036|FG001|COMPLETED|Double-Blind Treatment Period||88||
48190268|NCT02373813|100789037|FG002|COMPLETED|Double-Blind Treatment Period||92||
48190269|NCT02373813|100789038|FG003|COMPLETED|Double-Blind Treatment Period||47||
48190270|NCT02373813|100789035|FG000|NOT COMPLETED|Double-Blind Treatment Period||0||
48190271|NCT02373813|100789036|FG001|NOT COMPLETED|Double-Blind Treatment Period||13||
48190272|NCT02373813|100789037|FG002|NOT COMPLETED|Double-Blind Treatment Period||9||
48190273|NCT02373813|100789038|FG003|NOT COMPLETED|Double-Blind Treatment Period||4||
48190274|NCT01369355|100789039|FG000|STARTED|Week 0 - Week 44 (Maintenance)||133||
48190275|NCT01369355|100789040|FG001|STARTED|Week 0 - Week 44 (Maintenance)||132||
48190276|NCT01369355|100789041|FG002|STARTED|Week 0 - Week 44 (Maintenance)||132||
48190277|NCT01369355|100789042|FG003|STARTED|Week 0 - Week 44 (Maintenance)||123||
48190278|NCT01369355|100789043|FG004|STARTED|Week 0 - Week 44 (Maintenance)||285||
48190279|NCT01369355|100789044|FG005|STARTED|Week 0 - Week 44 (Maintenance)||476||
48190280|NCT01369355|100789045|FG006|STARTED|Week 0 - Week 44 (Maintenance)||0||
48190281|NCT01369355|100789046|FG007|STARTED|Week 0 - Week 44 (Maintenance)||0||
48190282|NCT01369355|100789047|FG008|STARTED|Week 0 - Week 44 (Maintenance)||0||
48190283|NCT01369355|100789039|FG000|COMPLETED|Week 0 - Week 44 (Maintenance)||102||
48190284|NCT01369355|100789040|FG001|COMPLETED|Week 0 - Week 44 (Maintenance)||103||
48190285|NCT01369355|100789041|FG002|COMPLETED|Week 0 - Week 44 (Maintenance)||101||
48190286|NCT01369355|100789042|FG003|COMPLETED|Week 0 - Week 44 (Maintenance)||93||
48470518|NCT02467621|101488231|FG001|COMPLETED|Overall Study||1647|1644/1647 in the secondary outcome analyses 1642/1640 in the primary outcome analysis|
48470519|NCT02467621|101488230|FG000|NOT COMPLETED|Overall Study||1||
48470520|NCT02467621|101488231|FG001|NOT COMPLETED|Overall Study||6||
48470521|NCT00868309|101488232|FG000|STARTED|Overall Study||6||
48470522|NCT00868309|101488233|FG001|STARTED|Overall Study||6||
48190287|NCT01369355|100789043|FG004|COMPLETED|Week 0 - Week 44 (Maintenance)||131||
48190288|NCT01369355|100789044|FG005|COMPLETED|Week 0 - Week 44 (Maintenance)||204||
48190289|NCT01369355|100789045|FG006|COMPLETED|Week 0 - Week 44 (Maintenance)||0||
48470523|NCT00868309|101488232|FG000|COMPLETED|Overall Study||6||
48470524|NCT00868309|101488233|FG001|COMPLETED|Overall Study||6||
48470525|NCT00868309|101488232|FG000|NOT COMPLETED|Overall Study||0||
48470526|NCT00868309|101488233|FG001|NOT COMPLETED|Overall Study||0||
48470527|NCT01957488|101488234|FG000|STARTED|Test Period 1 (2 Weeks)||30||
48470528|NCT01957488|101488235|FG001|STARTED|Test Period 1 (2 Weeks)||31||
48470529|NCT01957488|101488236|FG002|STARTED|Test Period 1 (2 Weeks)||30||
48470530|NCT01957488|101488237|FG003|STARTED|Test Period 1 (2 Weeks)||32||
48370562|NCT03582033|101234935|FG006|STARTED|Part A||0||
48370563|NCT03582033|101234936|FG007|STARTED|Part A||0||
48370564|NCT03582033|101234937|FG008|STARTED|Part A||0||
48370565|NCT03582033|101234938|FG009|STARTED|Part A||0||
48370566|NCT03582033|101234929|FG000|COMPLETED|Part A||0||
48370567|NCT03582033|101234930|FG001|COMPLETED|Part A||0||
48370568|NCT03582033|101234931|FG002|COMPLETED|Part A||0||
48370569|NCT03582033|101234932|FG003|COMPLETED|Part A||0||
48370570|NCT03582033|101234933|FG004|COMPLETED|Part A||0||
48370571|NCT03582033|101234934|FG005|COMPLETED|Part A||0||
48370572|NCT03582033|101234935|FG006|COMPLETED|Part A||0||
48370573|NCT03582033|101234936|FG007|COMPLETED|Part A||0||
48370574|NCT03582033|101234937|FG008|COMPLETED|Part A||0||
48370575|NCT03582033|101234938|FG009|COMPLETED|Part A||0||
48370576|NCT03582033|101234929|FG000|NOT COMPLETED|Part A||2||
48370577|NCT03582033|101234930|FG001|NOT COMPLETED|Part A||2||
48370578|NCT03582033|101234931|FG002|NOT COMPLETED|Part A||2||
48370579|NCT03582033|101234932|FG003|NOT COMPLETED|Part A||7||
48370580|NCT03582033|101234933|FG004|NOT COMPLETED|Part A||22||
48370581|NCT03582033|101234934|FG005|NOT COMPLETED|Part A||0||
48370582|NCT03582033|101234935|FG006|NOT COMPLETED|Part A||0||
48370583|NCT03582033|101234936|FG007|NOT COMPLETED|Part A||0||
48370584|NCT03582033|101234937|FG008|NOT COMPLETED|Part A||0||
48370585|NCT03582033|101234938|FG009|NOT COMPLETED|Part A||0||
48370586|NCT03582033|101234929|FG000|STARTED|Part B||0||
48370587|NCT03582033|101234930|FG001|STARTED|Part B||0||
48370588|NCT03582033|101234931|FG002|STARTED|Part B||0||
48370589|NCT03582033|101234932|FG003|STARTED|Part B||0||
48370590|NCT03582033|101234933|FG004|STARTED|Part B||0||
48370591|NCT03582033|101234934|FG005|STARTED|Part B||20||
48370592|NCT03582033|101234935|FG006|STARTED|Part B||0||
48370593|NCT03582033|101234936|FG007|STARTED|Part B||0||
48370594|NCT03582033|101234937|FG008|STARTED|Part B||0||
48370595|NCT03582033|101234938|FG009|STARTED|Part B||0||
48370596|NCT03582033|101234929|FG000|COMPLETED|Part B||0||
48370597|NCT03582033|101234930|FG001|COMPLETED|Part B||0||
48370598|NCT03582033|101234931|FG002|COMPLETED|Part B||0||
48370599|NCT03582033|101234932|FG003|COMPLETED|Part B||0||
48370600|NCT03582033|101234933|FG004|COMPLETED|Part B||0||
48370601|NCT03582033|101234934|FG005|COMPLETED|Part B||0||
48370602|NCT03582033|101234935|FG006|COMPLETED|Part B||0||
48370603|NCT03582033|101234936|FG007|COMPLETED|Part B||0||
48370604|NCT03582033|101234937|FG008|COMPLETED|Part B||0||
48370605|NCT03582033|101234938|FG009|COMPLETED|Part B||0||
48370606|NCT03582033|101234929|FG000|NOT COMPLETED|Part B||0||
48370607|NCT03582033|101234930|FG001|NOT COMPLETED|Part B||0||
48370608|NCT03582033|101234931|FG002|NOT COMPLETED|Part B||0||
48370609|NCT03582033|101234932|FG003|NOT COMPLETED|Part B||0||
48370610|NCT03582033|101234933|FG004|NOT COMPLETED|Part B||0||
48370611|NCT03582033|101234934|FG005|NOT COMPLETED|Part B||20||
48370612|NCT03582033|101234935|FG006|NOT COMPLETED|Part B||0||
48370613|NCT03582033|101234936|FG007|NOT COMPLETED|Part B||0||
48370614|NCT03582033|101234937|FG008|NOT COMPLETED|Part B||0||
48370615|NCT03582033|101234938|FG009|NOT COMPLETED|Part B||0||
48370616|NCT03582033|101234929|FG000|STARTED|Part C||0||
48370617|NCT03582033|101234930|FG001|STARTED|Part C||0||
48370618|NCT03582033|101234931|FG002|STARTED|Part C||0||
48370619|NCT03582033|101234932|FG003|STARTED|Part C||0||
48370620|NCT03582033|101234933|FG004|STARTED|Part C||0||
48370621|NCT03582033|101234934|FG005|STARTED|Part C||0||
48370622|NCT03582033|101234935|FG006|STARTED|Part C||12||
48370623|NCT03582033|101234936|FG007|STARTED|Part C||6||
48370624|NCT03582033|101234937|FG008|STARTED|Part C||5||
48370625|NCT03582033|101234938|FG009|STARTED|Part C||0||
48370626|NCT03582033|101234929|FG000|COMPLETED|Part C||0||
48370627|NCT03582033|101234930|FG001|COMPLETED|Part C||0||
48370628|NCT03582033|101234931|FG002|COMPLETED|Part C||0||
48370629|NCT03582033|101234932|FG003|COMPLETED|Part C||0||
48370630|NCT03582033|101234933|FG004|COMPLETED|Part C||0||
48370631|NCT03582033|101234934|FG005|COMPLETED|Part C||0||
48370632|NCT03582033|101234935|FG006|COMPLETED|Part C||0||
48370633|NCT03582033|101234936|FG007|COMPLETED|Part C||0||
48190290|NCT01369355|100789046|FG007|COMPLETED|Week 0 - Week 44 (Maintenance)||0||
48370634|NCT03582033|101234937|FG008|COMPLETED|Part C||0||
48470531|NCT01957488|101488238|FG004|STARTED|Test Period 1 (2 Weeks)||30||
48470532|NCT01957488|101488239|FG005|STARTED|Test Period 1 (2 Weeks)||30||
48470533|NCT01957488|101488234|FG000|COMPLETED|Test Period 1 (2 Weeks)||27||
48470534|NCT01957488|101488235|FG001|COMPLETED|Test Period 1 (2 Weeks)||28||
48470535|NCT01957488|101488236|FG002|COMPLETED|Test Period 1 (2 Weeks)||26||
48470536|NCT01957488|101488237|FG003|COMPLETED|Test Period 1 (2 Weeks)||29||
48470537|NCT01957488|101488238|FG004|COMPLETED|Test Period 1 (2 Weeks)||27||
48470538|NCT01957488|101488239|FG005|COMPLETED|Test Period 1 (2 Weeks)||24||
48470539|NCT01957488|101488234|FG000|NOT COMPLETED|Test Period 1 (2 Weeks)||3||
48470540|NCT01957488|101488235|FG001|NOT COMPLETED|Test Period 1 (2 Weeks)||3||
48470541|NCT01957488|101488236|FG002|NOT COMPLETED|Test Period 1 (2 Weeks)||4||
48470542|NCT01957488|101488237|FG003|NOT COMPLETED|Test Period 1 (2 Weeks)||3||
48470543|NCT01957488|101488238|FG004|NOT COMPLETED|Test Period 1 (2 Weeks)||3||
48470544|NCT01957488|101488239|FG005|NOT COMPLETED|Test Period 1 (2 Weeks)||6||
48470545|NCT01957488|101488234|FG000|STARTED|Test Period 2 (2 Weeks)||27||
48470546|NCT01957488|101488235|FG001|STARTED|Test Period 2 (2 Weeks)||28||
48470547|NCT01957488|101488236|FG002|STARTED|Test Period 2 (2 Weeks)||26||
48470548|NCT01957488|101488237|FG003|STARTED|Test Period 2 (2 Weeks)||29||
48470549|NCT01957488|101488238|FG004|STARTED|Test Period 2 (2 Weeks)||27||
48470550|NCT01957488|101488239|FG005|STARTED|Test Period 2 (2 Weeks)||24||
48470551|NCT01957488|101488234|FG000|COMPLETED|Test Period 2 (2 Weeks)||24||
48470552|NCT01957488|101488235|FG001|COMPLETED|Test Period 2 (2 Weeks)||27||
48470553|NCT01957488|101488236|FG002|COMPLETED|Test Period 2 (2 Weeks)||25||
48470554|NCT01957488|101488237|FG003|COMPLETED|Test Period 2 (2 Weeks)||28||
48470555|NCT01957488|101488238|FG004|COMPLETED|Test Period 2 (2 Weeks)||25||
48470556|NCT01957488|101488239|FG005|COMPLETED|Test Period 2 (2 Weeks)||23||
48470557|NCT01957488|101488234|FG000|NOT COMPLETED|Test Period 2 (2 Weeks)||3||
48470558|NCT01957488|101488235|FG001|NOT COMPLETED|Test Period 2 (2 Weeks)||1||
48470559|NCT01957488|101488236|FG002|NOT COMPLETED|Test Period 2 (2 Weeks)||1||
48470560|NCT01957488|101488237|FG003|NOT COMPLETED|Test Period 2 (2 Weeks)||1||
48470561|NCT01957488|101488238|FG004|NOT COMPLETED|Test Period 2 (2 Weeks)||2||
48470562|NCT01957488|101488239|FG005|NOT COMPLETED|Test Period 2 (2 Weeks)||1||
48470563|NCT01957488|101488234|FG000|STARTED|Test Period 3 (2 Weeks)||24||
48470564|NCT01957488|101488235|FG001|STARTED|Test Period 3 (2 Weeks)||27||
48470565|NCT01957488|101488236|FG002|STARTED|Test Period 3 (2 Weeks)||25||
48470566|NCT01957488|101488237|FG003|STARTED|Test Period 3 (2 Weeks)||28||
48470567|NCT01957488|101488238|FG004|STARTED|Test Period 3 (2 Weeks)||25||
48470568|NCT01957488|101488239|FG005|STARTED|Test Period 3 (2 Weeks)||23||
48470569|NCT01957488|101488234|FG000|COMPLETED|Test Period 3 (2 Weeks)||23||
48470570|NCT01957488|101488235|FG001|COMPLETED|Test Period 3 (2 Weeks)||26||
48470571|NCT01957488|101488236|FG002|COMPLETED|Test Period 3 (2 Weeks)||25||
48470572|NCT01957488|101488237|FG003|COMPLETED|Test Period 3 (2 Weeks)||28||
48470573|NCT01957488|101488238|FG004|COMPLETED|Test Period 3 (2 Weeks)||25||
48470574|NCT01957488|101488239|FG005|COMPLETED|Test Period 3 (2 Weeks)||23||
48470575|NCT01957488|101488234|FG000|NOT COMPLETED|Test Period 3 (2 Weeks)||1||
48470576|NCT01957488|101488235|FG001|NOT COMPLETED|Test Period 3 (2 Weeks)||1||
48470577|NCT01957488|101488236|FG002|NOT COMPLETED|Test Period 3 (2 Weeks)||0||
48470578|NCT01957488|101488237|FG003|NOT COMPLETED|Test Period 3 (2 Weeks)||0||
48470579|NCT01957488|101488238|FG004|NOT COMPLETED|Test Period 3 (2 Weeks)||0||
48470580|NCT01957488|101488239|FG005|NOT COMPLETED|Test Period 3 (2 Weeks)||0||
48470581|NCT01264952|101488240|FG000|STARTED|Overall Study||6||
48470582|NCT01264952|101488241|FG001|STARTED|Overall Study||2||
48470583|NCT01264952|101488242|FG002|STARTED|Overall Study||8||
48470584|NCT01264952|101488240|FG000|COMPLETED|Overall Study||6||
48470585|NCT01264952|101488241|FG001|COMPLETED|Overall Study||2||
48470586|NCT01264952|101488242|FG002|COMPLETED|Overall Study||8||
48470587|NCT01264952|101488240|FG000|NOT COMPLETED|Overall Study||0||
48470588|NCT01264952|101488241|FG001|NOT COMPLETED|Overall Study||0||
48470589|NCT01264952|101488242|FG002|NOT COMPLETED|Overall Study||0||
48470590|NCT01379781|101488243|FG000|STARTED|Overall Study||27||
48470591|NCT01379781|101488244|FG001|STARTED|Overall Study||27||
48470592|NCT01379781|101488243|FG000|COMPLETED|Overall Study||16||
48470593|NCT01379781|101488244|FG001|COMPLETED|Overall Study||19||
48470594|NCT01379781|101488243|FG000|NOT COMPLETED|Overall Study||11||
48470595|NCT01379781|101488244|FG001|NOT COMPLETED|Overall Study||8||
48470596|NCT00661999|101488245|FG000|STARTED|Overall Study||164||
48470597|NCT00661999|101488246|FG001|STARTED|Overall Study||163||
48470598|NCT00661999|101488247|FG002|STARTED|Overall Study||163||
48470599|NCT00661999|101488245|FG000|COMPLETED|Overall Study||105||
48470600|NCT00661999|101488246|FG001|COMPLETED|Overall Study||113||
48470601|NCT00661999|101488247|FG002|COMPLETED|Overall Study||106||
48470602|NCT00661999|101488245|FG000|NOT COMPLETED|Overall Study||59||
48470603|NCT00661999|101488246|FG001|NOT COMPLETED|Overall Study||50||
48470604|NCT00661999|101488247|FG002|NOT COMPLETED|Overall Study||57||
48470605|NCT00235456|101488248|FG000|STARTED|Overall Study||150||
48470606|NCT00235456|101488249|FG001|STARTED|Overall Study||150||
48470607|NCT00235456|101488248|FG000|COMPLETED|Overall Study||148||
48470608|NCT00235456|101488249|FG001|COMPLETED|Overall Study||143||
48470609|NCT00235456|101488248|FG000|NOT COMPLETED|Overall Study||2||
48470610|NCT00235456|101488249|FG001|NOT COMPLETED|Overall Study||7||
48470611|NCT02582970|101488250|FG000|STARTED|Overall Study||40||
48470612|NCT02582970|101488250|FG000|COMPLETED|Overall Study||40||
48470613|NCT02582970|101488250|FG000|NOT COMPLETED|Overall Study||0||
48470614|NCT02658084|101488251|FG000|STARTED|Overall Study||2||
48470615|NCT02658084|101488252|FG001|STARTED|Overall Study||0||
48470616|NCT02658084|101488251|FG000|COMPLETED|Overall Study||0||
48470617|NCT02658084|101488252|FG001|COMPLETED|Overall Study||0||
48470618|NCT02658084|101488251|FG000|NOT COMPLETED|Overall Study||2||
48470619|NCT02658084|101488252|FG001|NOT COMPLETED|Overall Study||0||
48470620|NCT02974153|101488253|FG000|STARTED|Overall Study||374||
48470621|NCT02974153|101488254|FG001|STARTED|Overall Study||372||
48470622|NCT02974153|101488255|FG002|STARTED|Overall Study||375||
48470623|NCT02974153|101488253|FG000|Participants Treated|Overall Study||350||
48470624|NCT02974153|101488254|FG001|Participants Treated|Overall Study||356||
48470625|NCT02974153|101488255|FG002|Participants Treated|Overall Study||366||
48470626|NCT02974153|101488253|FG000|COMPLETED|Overall Study||322||
48470627|NCT02974153|101488254|FG001|COMPLETED|Overall Study||324||
48470628|NCT02974153|101488255|FG002|COMPLETED|Overall Study||325||
48470629|NCT02974153|101488253|FG000|NOT COMPLETED|Overall Study||52||
48470630|NCT02974153|101488254|FG001|NOT COMPLETED|Overall Study||48||
48470631|NCT02974153|101488255|FG002|NOT COMPLETED|Overall Study||50||
48470632|NCT03066999|101488256|FG000|STARTED|Overall Study||2||
48470633|NCT03066999|101488257|FG001|STARTED|Overall Study||3||
48470634|NCT03066999|101488256|FG000|COMPLETED|Overall Study||2||
48470635|NCT03066999|101488257|FG001|COMPLETED|Overall Study||1||
48470636|NCT03066999|101488256|FG000|NOT COMPLETED|Overall Study||0||
48470637|NCT03066999|101488257|FG001|NOT COMPLETED|Overall Study||2||
48470638|NCT03882047|101488258|FG000|STARTED|Overall Study||104||
48190291|NCT01369355|100789047|FG008|COMPLETED|Week 0 - Week 44 (Maintenance)||0||
48190292|NCT01369355|100789039|FG000|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||31||
48190293|NCT01369355|100789040|FG001|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||29||
48190294|NCT01369355|100789041|FG002|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||31||
48190295|NCT01369355|100789042|FG003|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||30||
48190296|NCT01369355|100789043|FG004|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||154||
48370635|NCT03582033|101234938|FG009|COMPLETED|Part C||0||
48190297|NCT01369355|100789044|FG005|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||272||
48190298|NCT01369355|100789045|FG006|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0||
48190299|NCT01369355|100789046|FG007|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0||
48190300|NCT01369355|100789047|FG008|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0||
48190301|NCT01369355|100789039|FG000|STARTED|Long-term Extension (Week 44-272)||0||
48470639|NCT03882047|101488259|FG001|STARTED|Overall Study||105||
48470640|NCT03882047|101488260|FG002|STARTED|Overall Study||104||
48470641|NCT03882047|101488258|FG000|Treated|Overall Study||104||
48470642|NCT03882047|101488259|FG001|Treated|Overall Study||104||
48470643|NCT03882047|101488260|FG002|Treated|Overall Study||103||
48470644|NCT03882047|101488258|FG000|COMPLETED|Overall Study||98||
48470645|NCT03882047|101488259|FG001|COMPLETED|Overall Study||95||
48470646|NCT03882047|101488260|FG002|COMPLETED|Overall Study||88||
48470647|NCT03882047|101488258|FG000|NOT COMPLETED|Overall Study||6||
48470648|NCT03882047|101488259|FG001|NOT COMPLETED|Overall Study||10||
48470649|NCT03882047|101488260|FG002|NOT COMPLETED|Overall Study||16||
48470650|NCT01000337|101488261|FG000|STARTED|Overall Study||34||
48470651|NCT01000337|101488262|FG001|STARTED|Overall Study||33||
48470652|NCT01000337|101488261|FG000|COMPLETED|Overall Study||30||
48470653|NCT01000337|101488262|FG001|COMPLETED|Overall Study||30||
48470654|NCT01000337|101488261|FG000|NOT COMPLETED|Overall Study||4||
48470655|NCT01000337|101488262|FG001|NOT COMPLETED|Overall Study||3||
48470656|NCT01513148|101488263|FG000|STARTED|Overall Study||16||
48470657|NCT01513148|101488264|FG001|STARTED|Overall Study||16||
48470658|NCT01513148|101488263|FG000|COMPLETED|Overall Study||14||
48470659|NCT01513148|101488264|FG001|COMPLETED|Overall Study||14||
48470660|NCT01513148|101488263|FG000|NOT COMPLETED|Overall Study||2||
48470661|NCT01513148|101488264|FG001|NOT COMPLETED|Overall Study||2||
48470662|NCT00322491|101488265|FG000|STARTED|Overall Study||23||
48470663|NCT00322491|101488266|FG001|STARTED|Overall Study||26||
48470664|NCT00322491|101488265|FG000|COMPLETED|Overall Study||21||
48470665|NCT00322491|101488266|FG001|COMPLETED|Overall Study||24||
48470666|NCT00322491|101488265|FG000|NOT COMPLETED|Overall Study||2||
48470667|NCT00322491|101488266|FG001|NOT COMPLETED|Overall Study||2||
48470668|NCT01661270|101488267|FG000|STARTED|Overall Study||109||
48470669|NCT01661270|101488268|FG001|STARTED|Overall Study||223||
48470670|NCT01661270|101488267|FG000|Adverse Event|Overall Study||26||
48470671|NCT01661270|101488268|FG001|Adverse Event|Overall Study||47||
48470672|NCT01661270|101488267|FG000|Disease Progression|Overall Study||67||
48470673|NCT01661270|101488268|FG001|Disease Progression|Overall Study||118||
48190302|NCT01369355|100789040|FG001|STARTED|Long-term Extension (Week 44-272)||0||
48190303|NCT01369355|100789041|FG002|STARTED|Long-term Extension (Week 44-272)||0||
48190304|NCT01369355|100789042|FG003|STARTED|Long-term Extension (Week 44-272)||0||
48190305|NCT01369355|100789043|FG004|STARTED|Long-term Extension (Week 44-272)||0||
48190306|NCT01369355|100789044|FG005|STARTED|Long-term Extension (Week 44-272)||0||
48190307|NCT01369355|100789045|FG006|STARTED|Long-term Extension (Week 44-272)||151||
48190308|NCT01369355|100789046|FG007|STARTED|Long-term Extension (Week 44-272)||213||
48190309|NCT01369355|100789047|FG008|STARTED|Long-term Extension (Week 44-272)||354||
48190310|NCT01369355|100789039|FG000|COMPLETED|Long-term Extension (Week 44-272)||0||
48190311|NCT01369355|100789040|FG001|COMPLETED|Long-term Extension (Week 44-272)||0||
48190312|NCT01369355|100789041|FG002|COMPLETED|Long-term Extension (Week 44-272)||0||
48470674|NCT01661270|101488267|FG000|Physician Decision|Overall Study||1||
48190313|NCT01369355|100789042|FG003|COMPLETED|Long-term Extension (Week 44-272)||0||
48190314|NCT01369355|100789043|FG004|COMPLETED|Long-term Extension (Week 44-272)||0||
48190315|NCT01369355|100789044|FG005|COMPLETED|Long-term Extension (Week 44-272)||0||
48190316|NCT01369355|100789045|FG006|COMPLETED|Long-term Extension (Week 44-272)||0||
48190317|NCT01369355|100789046|FG007|COMPLETED|Long-term Extension (Week 44-272)||107||
48190318|NCT01369355|100789047|FG008|COMPLETED|Long-term Extension (Week 44-272)||183||
48470675|NCT01661270|101488268|FG001|Physician Decision|Overall Study||8||
48470676|NCT01661270|101488267|FG000|Participant's Request|Overall Study||15||
48470677|NCT01661270|101488268|FG001|Participant's Request|Overall Study||48||
48470678|NCT01661270|101488267|FG000|Other Reasons|Overall Study||0||
48470679|NCT01661270|101488268|FG001|Other Reasons|Overall Study||2||
48470680|NCT01661270|101488267|FG000|COMPLETED|Overall Study||109||
48470681|NCT01661270|101488268|FG001|COMPLETED|Overall Study||223||
48470682|NCT01661270|101488267|FG000|NOT COMPLETED|Overall Study||0||
48470683|NCT01661270|101488268|FG001|NOT COMPLETED|Overall Study||0||
48470684|NCT02532764|101488269|FG000|STARTED|Single Ascending Dose (SAD) Cohorts||6||
48470685|NCT02532764|101488270|FG001|STARTED|Single Ascending Dose (SAD) Cohorts||6||
48470686|NCT02532764|101488271|FG002|STARTED|Single Ascending Dose (SAD) Cohorts||9||
48470687|NCT02532764|101488272|FG003|STARTED|Single Ascending Dose (SAD) Cohorts||6||
48470688|NCT02532764|101488273|FG004|STARTED|Single Ascending Dose (SAD) Cohorts||9||
48470689|NCT02532764|101488274|FG005|STARTED|Single Ascending Dose (SAD) Cohorts||0||
48470690|NCT02532764|101488275|FG006|STARTED|Single Ascending Dose (SAD) Cohorts||0||
48190319|NCT01369355|100789039|FG000|NOT COMPLETED|Long-term Extension (Week 44-272)||0||
48470691|NCT02532764|101488276|FG007|STARTED|Single Ascending Dose (SAD) Cohorts||0||
48470692|NCT02532764|101488277|FG008|STARTED|Single Ascending Dose (SAD) Cohorts||0||
48470693|NCT02532764|101488278|FG009|STARTED|Single Ascending Dose (SAD) Cohorts||0||
48470694|NCT02532764|101488269|FG000|COMPLETED|Single Ascending Dose (SAD) Cohorts||6||
48470695|NCT02532764|101488270|FG001|COMPLETED|Single Ascending Dose (SAD) Cohorts||6||
48470696|NCT02532764|101488271|FG002|COMPLETED|Single Ascending Dose (SAD) Cohorts||9||
48470697|NCT02532764|101488272|FG003|COMPLETED|Single Ascending Dose (SAD) Cohorts||6||
48470698|NCT02532764|101488273|FG004|COMPLETED|Single Ascending Dose (SAD) Cohorts||9||
48470699|NCT02532764|101488274|FG005|COMPLETED|Single Ascending Dose (SAD) Cohorts||0||
48470700|NCT02532764|101488275|FG006|COMPLETED|Single Ascending Dose (SAD) Cohorts||0||
48470701|NCT02532764|101488276|FG007|COMPLETED|Single Ascending Dose (SAD) Cohorts||0||
48470702|NCT02532764|101488277|FG008|COMPLETED|Single Ascending Dose (SAD) Cohorts||0||
48470703|NCT02532764|101488278|FG009|COMPLETED|Single Ascending Dose (SAD) Cohorts||0||
48470704|NCT02532764|101488269|FG000|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0||
48470705|NCT02532764|101488270|FG001|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0||
48470706|NCT02532764|101488271|FG002|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0||
48470707|NCT02532764|101488272|FG003|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0||
48470708|NCT02532764|101488273|FG004|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0||
48470709|NCT02532764|101488274|FG005|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0||
48470710|NCT02532764|101488275|FG006|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0||
48470711|NCT02532764|101488276|FG007|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0||
48470712|NCT02532764|101488277|FG008|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0||
48470713|NCT02532764|101488278|FG009|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0||
48470714|NCT02532764|101488269|FG000|STARTED|Multiple Ascending Dose (MAD) Cohorst||0||
48470715|NCT02532764|101488270|FG001|STARTED|Multiple Ascending Dose (MAD) Cohorst||0||
48470716|NCT02532764|101488271|FG002|STARTED|Multiple Ascending Dose (MAD) Cohorst||0||
48470717|NCT02532764|101488272|FG003|STARTED|Multiple Ascending Dose (MAD) Cohorst||0||
48470718|NCT02532764|101488273|FG004|STARTED|Multiple Ascending Dose (MAD) Cohorst||0||
48470719|NCT02532764|101488274|FG005|STARTED|Multiple Ascending Dose (MAD) Cohorst||6||
48470720|NCT02532764|101488275|FG006|STARTED|Multiple Ascending Dose (MAD) Cohorst||6||
48470721|NCT02532764|101488276|FG007|STARTED|Multiple Ascending Dose (MAD) Cohorst||7||
48470722|NCT02532764|101488277|FG008|STARTED|Multiple Ascending Dose (MAD) Cohorst||6||
48470723|NCT02532764|101488278|FG009|STARTED|Multiple Ascending Dose (MAD) Cohorst||9||
48470724|NCT02532764|101488269|FG000|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0||
48470725|NCT02532764|101488270|FG001|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0||
48470726|NCT02532764|101488271|FG002|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0||
48470727|NCT02532764|101488272|FG003|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0||
48470728|NCT02532764|101488273|FG004|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0||
48470729|NCT02532764|101488274|FG005|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6||
48470730|NCT02532764|101488275|FG006|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6||
48470731|NCT02532764|101488276|FG007|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6||
48470732|NCT02532764|101488277|FG008|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||5||
48470733|NCT02532764|101488278|FG009|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||8||
48470734|NCT02532764|101488269|FG000|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0||
48470735|NCT02532764|101488270|FG001|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0||
48470736|NCT02532764|101488271|FG002|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0||
48470737|NCT02532764|101488272|FG003|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0||
48470738|NCT02532764|101488273|FG004|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0||
48470739|NCT02532764|101488274|FG005|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0||
48470740|NCT02532764|101488275|FG006|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0||
48470741|NCT02532764|101488276|FG007|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1||
48190320|NCT01369355|100789040|FG001|NOT COMPLETED|Long-term Extension (Week 44-272)||0||
48190321|NCT01369355|100789041|FG002|NOT COMPLETED|Long-term Extension (Week 44-272)||0||
48190322|NCT01369355|100789042|FG003|NOT COMPLETED|Long-term Extension (Week 44-272)||0||
48190323|NCT01369355|100789043|FG004|NOT COMPLETED|Long-term Extension (Week 44-272)||0||
48190324|NCT01369355|100789044|FG005|NOT COMPLETED|Long-term Extension (Week 44-272)||0||
48190325|NCT01369355|100789045|FG006|NOT COMPLETED|Long-term Extension (Week 44-272)||151||
48190326|NCT01369355|100789046|FG007|NOT COMPLETED|Long-term Extension (Week 44-272)||106||
48190327|NCT01369355|100789047|FG008|NOT COMPLETED|Long-term Extension (Week 44-272)||171||
48190328|NCT01101165|100789048|FG000|STARTED|Period 1||47||
48190329|NCT01101165|100789049|FG001|STARTED|Period 1||45||
48190330|NCT01101165|100789048|FG000|COMPLETED|Period 1||45||
48190331|NCT01101165|100789049|FG001|COMPLETED|Period 1||40||
48190332|NCT01101165|100789048|FG000|NOT COMPLETED|Period 1||2||
48190333|NCT01101165|100789049|FG001|NOT COMPLETED|Period 1||5||
48190334|NCT01101165|100789048|FG000|STARTED|Period 2||45||
48190335|NCT01101165|100789049|FG001|STARTED|Period 2||40||
48190336|NCT01101165|100789048|FG000|COMPLETED|Period 2||41||
48190337|NCT01101165|100789049|FG001|COMPLETED|Period 2||39||
48190338|NCT01101165|100789048|FG000|NOT COMPLETED|Period 2||4||
48190339|NCT01101165|100789049|FG001|NOT COMPLETED|Period 2||1||
48190340|NCT05064761|100789050|FG000|STARTED|Overall Study||29||
48190341|NCT05064761|100789050|FG000|COMPLETED|Overall Study||29||
48190342|NCT05064761|100789050|FG000|NOT COMPLETED|Overall Study||0||
48190343|NCT00248287|100789051|FG000|STARTED|Overall Study||75||
48190344|NCT00248287|100789052|FG001|STARTED|Overall Study||79||
48190345|NCT00248287|100789051|FG000|COMPLETED|Overall Study||51||
48190346|NCT00248287|100789052|FG001|COMPLETED|Overall Study||60||
48190347|NCT00248287|100789051|FG000|NOT COMPLETED|Overall Study||24||
48190348|NCT00248287|100789052|FG001|NOT COMPLETED|Overall Study||19||
48190349|NCT01878890|100789053|FG000|STARTED|Overall Study||5||
48190350|NCT01878890|100789054|FG001|STARTED|Overall Study||11||
48190351|NCT01878890|100789055|FG002|STARTED|Overall Study||4||
48190352|NCT01878890|100789056|FG003|STARTED|Overall Study||5||
48190353|NCT01878890|100789053|FG000|COMPLETED|Overall Study||5||
48190354|NCT01878890|100789054|FG001|COMPLETED|Overall Study||10||
48190355|NCT01878890|100789055|FG002|COMPLETED|Overall Study||4||
48190356|NCT01878890|100789056|FG003|COMPLETED|Overall Study||5||
48190357|NCT01878890|100789053|FG000|NOT COMPLETED|Overall Study||0||
48190358|NCT01878890|100789054|FG001|NOT COMPLETED|Overall Study||1||
48190359|NCT01878890|100789055|FG002|NOT COMPLETED|Overall Study||0||
48190360|NCT01878890|100789056|FG003|NOT COMPLETED|Overall Study||0||
48190361|NCT05336123|100789057|FG000|STARTED|Overall Study||20||
48190362|NCT05336123|100789058|FG001|STARTED|Overall Study||20||
48190363|NCT05336123|100789057|FG000|COMPLETED|Overall Study||18||
48190364|NCT05336123|100789058|FG001|COMPLETED|Overall Study||19||
48190365|NCT05336123|100789057|FG000|NOT COMPLETED|Overall Study||2||
48190366|NCT05336123|100789058|FG001|NOT COMPLETED|Overall Study||1||
48190367|NCT00748969|100789059|FG000|STARTED|Overall Study||1||
48190368|NCT00748969|100789060|FG001|STARTED|Overall Study||1||
48190369|NCT00748969|100789059|FG000|COMPLETED|Overall Study||0||
48190370|NCT00748969|100789060|FG001|COMPLETED|Overall Study||0||
48190371|NCT00748969|100789059|FG000|NOT COMPLETED|Overall Study||1||
48190372|NCT00748969|100789060|FG001|NOT COMPLETED|Overall Study||1||
48190373|NCT01101542|100789061|FG000|STARTED|Year 3 Surveillance Period||105||
48190374|NCT01101542|100789061|FG000|COMPLETED|Year 3 Surveillance Period||94||
48190375|NCT01101542|100789061|FG000|NOT COMPLETED|Year 3 Surveillance Period||11||
48190376|NCT01101542|100789061|FG000|STARTED|Year 4 Surveillance Period||569||
48190377|NCT01101542|100789061|FG000|COMPLETED|Year 4 Surveillance Period||282||
48190378|NCT01101542|100789061|FG000|NOT COMPLETED|Year 4 Surveillance Period||287||
48190379|NCT01101542|100789061|FG000|STARTED|Year 5 Surveillance Period||809||
48190380|NCT01101542|100789061|FG000|COMPLETED|Year 5 Surveillance Period||668||
48190381|NCT01101542|100789061|FG000|NOT COMPLETED|Year 5 Surveillance Period||141||
48190382|NCT01101542|100789061|FG000|STARTED|Year 6 Surveillance Period||3091||
48190383|NCT01101542|100789061|FG000|COMPLETED|Year 6 Surveillance Period||2100||
48190384|NCT01101542|100789061|FG000|NOT COMPLETED|Year 6 Surveillance Period||991||
48190385|NCT02692235|100789062|FG000|STARTED|Overall Study||14||
48190386|NCT02692235|100789063|FG001|STARTED|Overall Study||14||
48190387|NCT02692235|100789062|FG000|COMPLETED|Overall Study||11||
48190388|NCT02692235|100789063|FG001|COMPLETED|Overall Study||11||
48190389|NCT02692235|100789062|FG000|NOT COMPLETED|Overall Study||3||
48190390|NCT02692235|100789063|FG001|NOT COMPLETED|Overall Study||3||
48190391|NCT00797225|100789064|FG000|STARTED|Weeks 1 to 12||43||
48190392|NCT00797225|100789065|FG001|STARTED|Weeks 1 to 12||43||
48190393|NCT00797225|100789066|FG002|STARTED|Weeks 1 to 12||44||
48470742|NCT02532764|101488277|FG008|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1||
48470743|NCT02532764|101488278|FG009|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1||
48470744|NCT02564263|101488279|FG000|STARTED|Overall Study||314||
48470745|NCT02564263|101488280|FG001|STARTED|Overall Study||314||
48470746|NCT02564263|101488279|FG000|Treated|Overall Study||314||
48470747|NCT02564263|101488280|FG001|Treated|Overall Study||296||
48470748|NCT02564263|101488279|FG000|Received Second Course of Pembrolizumab|Overall Study||5||
48470749|NCT02564263|101488280|FG001|Received Second Course of Pembrolizumab|Overall Study||0||
48470750|NCT02564263|101488279|FG000|COMPLETED|Overall Study||0||
48470751|NCT02564263|101488280|FG001|COMPLETED|Overall Study||0||
48470752|NCT02564263|101488279|FG000|NOT COMPLETED|Overall Study||314||
48190394|NCT00797225|100789067|FG003|STARTED|Weeks 1 to 12||44||
48190395|NCT00797225|100789068|FG004|STARTED|Weeks 1 to 12||0||
48190396|NCT00797225|100789069|FG005|STARTED|Weeks 1 to 12||0||
48190397|NCT00797225|100789070|FG006|STARTED|Weeks 1 to 12||0||
48190398|NCT00797225|100789071|FG007|STARTED|Weeks 1 to 12||0||
48190399|NCT00797225|100789064|FG000|Received Study Drug|Weeks 1 to 12||43||
48190400|NCT00797225|100789065|FG001|Received Study Drug|Weeks 1 to 12||43||
48190401|NCT00797225|100789066|FG002|Received Study Drug|Weeks 1 to 12||44||
48190402|NCT00797225|100789067|FG003|Received Study Drug|Weeks 1 to 12||44||
48190403|NCT00797225|100789068|FG004|Received Study Drug|Weeks 1 to 12||0||
48190404|NCT00797225|100789069|FG005|Received Study Drug|Weeks 1 to 12||0||
48190405|NCT00797225|100789070|FG006|Received Study Drug|Weeks 1 to 12||0||
48190406|NCT00797225|100789071|FG007|Received Study Drug|Weeks 1 to 12||0||
48190407|NCT00797225|100789064|FG000|COMPLETED|Weeks 1 to 12||41||
48190408|NCT00797225|100789065|FG001|COMPLETED|Weeks 1 to 12||42||
48190409|NCT00797225|100789066|FG002|COMPLETED|Weeks 1 to 12||43||
48190410|NCT00797225|100789067|FG003|COMPLETED|Weeks 1 to 12||44||
48190411|NCT00797225|100789068|FG004|COMPLETED|Weeks 1 to 12||0||
48190412|NCT00797225|100789069|FG005|COMPLETED|Weeks 1 to 12||0||
48190413|NCT00797225|100789070|FG006|COMPLETED|Weeks 1 to 12||0||
48190414|NCT00797225|100789071|FG007|COMPLETED|Weeks 1 to 12||0||
48190415|NCT00797225|100789064|FG000|NOT COMPLETED|Weeks 1 to 12||2||
48190416|NCT00797225|100789065|FG001|NOT COMPLETED|Weeks 1 to 12||1||
48190417|NCT00797225|100789066|FG002|NOT COMPLETED|Weeks 1 to 12||1||
48190418|NCT00797225|100789067|FG003|NOT COMPLETED|Weeks 1 to 12||0||
48190419|NCT00797225|100789068|FG004|NOT COMPLETED|Weeks 1 to 12||0||
48190420|NCT00797225|100789069|FG005|NOT COMPLETED|Weeks 1 to 12||0||
48190421|NCT00797225|100789070|FG006|NOT COMPLETED|Weeks 1 to 12||0||
48190422|NCT00797225|100789071|FG007|NOT COMPLETED|Weeks 1 to 12||0||
48190423|NCT00797225|100789064|FG000|STARTED|Weeks 13 to 24||0||
48190424|NCT00797225|100789065|FG001|STARTED|Weeks 13 to 24||42||
48470753|NCT02564263|101488280|FG001|NOT COMPLETED|Overall Study||314||
48470754|NCT02016300|101488281|FG000|STARTED|Overall Study||12||
48470755|NCT02016300|101488282|FG001|STARTED|Overall Study||12||
48470756|NCT02016300|101488281|FG000|COMPLETED|Overall Study||12||
48470757|NCT02016300|101488282|FG001|COMPLETED|Overall Study||9||
48470758|NCT02016300|101488281|FG000|NOT COMPLETED|Overall Study||0||
48470759|NCT02016300|101488282|FG001|NOT COMPLETED|Overall Study||3||
48470760|NCT01367275|101488283|FG000|STARTED|Overall Study||8||
48190425|NCT00797225|100789066|FG002|STARTED|Weeks 13 to 24||43||
48190426|NCT00797225|100789067|FG003|STARTED|Weeks 13 to 24||0||
48190427|NCT00797225|100789068|FG004|STARTED|Weeks 13 to 24||20||
48190428|NCT00797225|100789069|FG005|STARTED|Weeks 13 to 24||21||
48190429|NCT00797225|100789070|FG006|STARTED|Weeks 13 to 24||22||
48470761|NCT01367275|101488283|FG000|COMPLETED|Overall Study||5||
48470762|NCT01367275|101488283|FG000|NOT COMPLETED|Overall Study||3||
48190430|NCT00797225|100789071|FG007|STARTED|Weeks 13 to 24||22||
48190431|NCT00797225|100789064|FG000|COMPLETED|Weeks 13 to 24||0||
48190432|NCT00797225|100789065|FG001|COMPLETED|Weeks 13 to 24||38||
48190433|NCT00797225|100789066|FG002|COMPLETED|Weeks 13 to 24||41||
48190434|NCT00797225|100789067|FG003|COMPLETED|Weeks 13 to 24||0||
48190435|NCT00797225|100789068|FG004|COMPLETED|Weeks 13 to 24||19||
48190436|NCT00797225|100789069|FG005|COMPLETED|Weeks 13 to 24||21||
48190437|NCT00797225|100789070|FG006|COMPLETED|Weeks 13 to 24||20||
48190438|NCT00797225|100789071|FG007|COMPLETED|Weeks 13 to 24||22||
48190439|NCT00797225|100789064|FG000|NOT COMPLETED|Weeks 13 to 24||0||
48190440|NCT00797225|100789065|FG001|NOT COMPLETED|Weeks 13 to 24||4||
48190441|NCT00797225|100789066|FG002|NOT COMPLETED|Weeks 13 to 24||2||
48190442|NCT00797225|100789067|FG003|NOT COMPLETED|Weeks 13 to 24||0||
48190443|NCT00797225|100789068|FG004|NOT COMPLETED|Weeks 13 to 24||1||
48470763|NCT04849988|101488284|FG000|STARTED|Overall Study||15|Two participants were randomized in error, but they were not dosed due to failure to meet eligibility criteria.|
48470764|NCT04849988|101488285|FG001|STARTED|Overall Study||15|Two participants were randomized in error, but they were not dosed due to failure to meet eligibility criteria.|
48470765|NCT04849988|101488286|FG002|STARTED|Overall Study||16|Two participants were randomized in error, but they were not dosed due to failure to meet eligibility criteria.|
48470766|NCT04849988|101488287|FG003|STARTED|Overall Study||15|Two participants were randomized in error, but they were not dosed due to failure to meet eligibility criteria.|
48470767|NCT04849988|101488284|FG000|Randomized But Not Dosed|Overall Study||1||
48470768|NCT04849988|101488285|FG001|Randomized But Not Dosed|Overall Study||1||
48470769|NCT04849988|101488286|FG002|Randomized But Not Dosed|Overall Study||0||
48470770|NCT04849988|101488287|FG003|Randomized But Not Dosed|Overall Study||0||
48470771|NCT04849988|101488284|FG000|Treated|Overall Study||14||
48470772|NCT04849988|101488285|FG001|Treated|Overall Study||14||
48190444|NCT00797225|100789069|FG005|NOT COMPLETED|Weeks 13 to 24||0||
48190445|NCT00797225|100789070|FG006|NOT COMPLETED|Weeks 13 to 24||2||
48190446|NCT00797225|100789071|FG007|NOT COMPLETED|Weeks 13 to 24||0||
48190447|NCT02424344|100789072|FG000|STARTED|Overall Study||134||
48470773|NCT04849988|101488286|FG002|Treated|Overall Study||16||
48470774|NCT04849988|101488287|FG003|Treated|Overall Study||15||
48470775|NCT04849988|101488284|FG000|Safety Analysis Set|Overall Study||14|For this row and below, the number of participants in the Safety Analysis Set is used as the denominator for percentages.|
48470776|NCT04849988|101488285|FG001|Safety Analysis Set|Overall Study||14|For this row and below, the number of participants in the Safety Analysis Set is used as the denominator for percentages.|
48470777|NCT04849988|101488286|FG002|Safety Analysis Set|Overall Study||16|For this row and below, the number of participants in the Safety Analysis Set is used as the denominator for percentages.|
48470778|NCT04849988|101488287|FG003|Safety Analysis Set|Overall Study||15|For this row and below, the number of participants in the Safety Analysis Set is used as the denominator for percentages.|
48470779|NCT04849988|101488284|FG000|Full Analysis Set|Overall Study||14||
48470780|NCT04849988|101488285|FG001|Full Analysis Set|Overall Study||14||
48470781|NCT04849988|101488286|FG002|Full Analysis Set|Overall Study||16||
48470782|NCT04849988|101488287|FG003|Full Analysis Set|Overall Study||15||
48470783|NCT04849988|101488284|FG000|Modified Full Analysis Set|Overall Study||14|Two participants were excluded from the modified Full Analysis Set due to a change in their background medication.|
48470784|NCT04849988|101488285|FG001|Modified Full Analysis Set|Overall Study||14|Two participants were excluded from the modified Full Analysis Set due to a change in their background medication.|
48470785|NCT04849988|101488286|FG002|Modified Full Analysis Set|Overall Study||14|Two participants were excluded from the modified Full Analysis Set due to a change in their background medication.|
48470786|NCT04849988|101488287|FG003|Modified Full Analysis Set|Overall Study||15|Two participants were excluded from the modified Full Analysis Set due to a change in their background medication.|
48470787|NCT04849988|101488284|FG000|COMPLETED|Overall Study||11||
48470788|NCT04849988|101488285|FG001|COMPLETED|Overall Study||9||
48470789|NCT04849988|101488286|FG002|COMPLETED|Overall Study||13||
48470790|NCT04849988|101488287|FG003|COMPLETED|Overall Study||10||
48470791|NCT04849988|101488284|FG000|NOT COMPLETED|Overall Study||4||
48190448|NCT02424344|100789073|FG001|STARTED|Overall Study||133||
48470792|NCT04849988|101488285|FG001|NOT COMPLETED|Overall Study||6||
48470793|NCT04849988|101488286|FG002|NOT COMPLETED|Overall Study||3||
48470794|NCT04849988|101488287|FG003|NOT COMPLETED|Overall Study||5||
48470795|NCT01180244|101488288|FG000|STARTED|Overall Study||45||
48470796|NCT01180244|101488289|FG001|STARTED|Overall Study||46||
48470797|NCT01180244|101488288|FG000|Received Treatment|Overall Study||40||
48470798|NCT01180244|101488289|FG001|Received Treatment|Overall Study||45||
48470799|NCT01180244|101488288|FG000|COMPLETED|Overall Study||39||
48470800|NCT01180244|101488289|FG001|COMPLETED|Overall Study||38||
48470801|NCT01180244|101488288|FG000|NOT COMPLETED|Overall Study||6||
48470802|NCT01180244|101488289|FG001|NOT COMPLETED|Overall Study||8||
48470803|NCT00143819|101488290|FG000|STARTED|Overall Study||5||
48470804|NCT00143819|101488291|FG001|STARTED|Overall Study||8||
48470805|NCT00143819|101488290|FG000|COMPLETED|Overall Study||3||
48470806|NCT00143819|101488291|FG001|COMPLETED|Overall Study||5||
48470807|NCT00143819|101488290|FG000|NOT COMPLETED|Overall Study||2||
48470808|NCT00143819|101488291|FG001|NOT COMPLETED|Overall Study||3||
48470809|NCT04567342|101488292|FG000|STARTED|Overall Study||329||
48470810|NCT04567342|101488293|FG001|STARTED|Overall Study||328||
48470811|NCT04567342|101488294|FG002|STARTED|Overall Study||328||
48470812|NCT04567342|101488295|FG003|STARTED|Overall Study||327||
48470813|NCT04567342|101488292|FG000|COMPLETED|Overall Study||329||
48470814|NCT04567342|101488293|FG001|COMPLETED|Overall Study||328||
48470815|NCT04567342|101488294|FG002|COMPLETED|Overall Study||328||
48470816|NCT04567342|101488295|FG003|COMPLETED|Overall Study||327||
48470817|NCT04567342|101488292|FG000|NOT COMPLETED|Overall Study||0||
48470818|NCT04567342|101488293|FG001|NOT COMPLETED|Overall Study||0||
48470819|NCT04567342|101488294|FG002|NOT COMPLETED|Overall Study||0||
48470820|NCT04567342|101488295|FG003|NOT COMPLETED|Overall Study||0||
48470821|NCT03444038|101488296|FG000|STARTED|Overall Study||85||
48470822|NCT03444038|101488296|FG000|COMPLETED|Overall Study||56||
48470823|NCT03444038|101488296|FG000|NOT COMPLETED|Overall Study||29||
48470824|NCT00623103|101488297|FG000|STARTED|Overall Study||295||
48470825|NCT00623103|101488298|FG001|STARTED|Overall Study||288||
48470826|NCT00623103|101488297|FG000|Safety Set: Received Study Drug|Overall Study||294||
48470827|NCT00623103|101488298|FG001|Safety Set: Received Study Drug|Overall Study||288||
48470828|NCT00623103|101488297|FG000|COMPLETED|Overall Study||184||
48470829|NCT00623103|101488298|FG001|COMPLETED|Overall Study||175||
48470830|NCT00623103|101488297|FG000|NOT COMPLETED|Overall Study||111||
48470831|NCT00623103|101488298|FG001|NOT COMPLETED|Overall Study||113||
48470832|NCT02252562|101488299|FG000|STARTED|Overall Study||1620|Operating rooms|1620
48470833|NCT02252562|101488300|FG001|STARTED|Overall Study||1636|Operating rooms|1636
48470834|NCT02252562|101488299|FG000|COMPLETED|Overall Study||1620|Operating rooms|1620
48470835|NCT02252562|101488300|FG001|COMPLETED|Overall Study||1636|Operating rooms|1636
48470836|NCT02252562|101488299|FG000|NOT COMPLETED|Overall Study||0||0
48470837|NCT02252562|101488300|FG001|NOT COMPLETED|Overall Study||0||0
48470838|NCT00797108|101488301|FG000|STARTED|Overall Study||12||
48470839|NCT00797108|101488302|FG001|STARTED|Overall Study||11||
48470840|NCT00797108|101488303|FG002|STARTED|Overall Study||12||
48470841|NCT00797108|101488301|FG000|Treated|Overall Study||10||
48470842|NCT00797108|101488302|FG001|Treated|Overall Study||11||
48470843|NCT00797108|101488303|FG002|Treated|Overall Study||12||
48470844|NCT00797108|101488301|FG000|COMPLETED|Overall Study||8||
48470845|NCT00797108|101488302|FG001|COMPLETED|Overall Study||9||
48470846|NCT00797108|101488303|FG002|COMPLETED|Overall Study||6||
48470847|NCT00797108|101488301|FG000|NOT COMPLETED|Overall Study||4||
48470848|NCT00797108|101488302|FG001|NOT COMPLETED|Overall Study||2||
48470849|NCT00797108|101488303|FG002|NOT COMPLETED|Overall Study||6||
48470850|NCT02398188|101488304|FG000|STARTED|Overall Study||398||
48470851|NCT02398188|101488305|FG001|STARTED|Overall Study||395||
48470852|NCT02398188|101488304|FG000|COMPLETED|Overall Study||371||
48470853|NCT02398188|101488305|FG001|COMPLETED|Overall Study||361||
48470854|NCT02398188|101488304|FG000|NOT COMPLETED|Overall Study||27||
48470855|NCT02398188|101488305|FG001|NOT COMPLETED|Overall Study||34||
48470856|NCT02624843|101488306|FG000|STARTED|Overall Study||107||
48470857|NCT02624843|101488307|FG001|STARTED|Overall Study||108||
48470858|NCT02624843|101488308|FG002|STARTED|Overall Study||24||
48470859|NCT02624843|101488306|FG000|COMPLETED|Overall Study||70||
48470860|NCT02624843|101488307|FG001|COMPLETED|Overall Study||72||
48470861|NCT02624843|101488308|FG002|COMPLETED|Overall Study||16||
48470862|NCT02624843|101488306|FG000|NOT COMPLETED|Overall Study||37||
48470863|NCT02624843|101488307|FG001|NOT COMPLETED|Overall Study||36||
48470864|NCT02624843|101488308|FG002|NOT COMPLETED|Overall Study||8||
48470865|NCT01202747|101488309|FG000|STARTED|Overall Study||50||
48470866|NCT01202747|101488309|FG000|COMPLETED|Overall Study||49||
48470867|NCT01202747|101488309|FG000|NOT COMPLETED|Overall Study||1||
48470868|NCT00585780|101488310|FG000|STARTED|Overall Study||21||
48470869|NCT00585780|101488311|FG001|STARTED|Overall Study||23||
48470870|NCT00585780|101488312|FG002|STARTED|Overall Study||34||
48470871|NCT00585780|101488313|FG003|STARTED|Overall Study||22||
48470872|NCT00585780|101488310|FG000|COMPLETED|Overall Study||13||
48470873|NCT00585780|101488311|FG001|COMPLETED|Overall Study||14||
48470874|NCT00585780|101488312|FG002|COMPLETED|Overall Study||21||
48470875|NCT00585780|101488313|FG003|COMPLETED|Overall Study||14||
48470876|NCT00585780|101488310|FG000|NOT COMPLETED|Overall Study||8||
48470877|NCT00585780|101488311|FG001|NOT COMPLETED|Overall Study||9||
48470878|NCT00585780|101488312|FG002|NOT COMPLETED|Overall Study||13||
48470879|NCT00585780|101488313|FG003|NOT COMPLETED|Overall Study||8||
48470880|NCT04128007|101488314|FG000|STARTED|Overall Study||200||
48470881|NCT04128007|101488315|FG001|STARTED|Overall Study||104||
48190449|NCT02424344|100789072|FG000|COMPLETED|Overall Study||127||
48470882|NCT04128007|101488314|FG000|COMPLETED|Overall Study||177||
48470883|NCT04128007|101488315|FG001|COMPLETED|Overall Study||87||
48470884|NCT04128007|101488314|FG000|NOT COMPLETED|Overall Study||23||
48470885|NCT04128007|101488315|FG001|NOT COMPLETED|Overall Study||17||
48470886|NCT00560235|101488316|FG000|STARTED|Phase 1||10||
48470887|NCT00560235|101488317|FG001|STARTED|Phase 1||0||
48470888|NCT00560235|101488318|FG002|STARTED|Phase 1||0||
48470889|NCT00560235|101488316|FG000|COMPLETED|Phase 1||2||
48470890|NCT00560235|101488317|FG001|COMPLETED|Phase 1||0||
48470891|NCT00560235|101488318|FG002|COMPLETED|Phase 1||0||
48470892|NCT00560235|101488316|FG000|NOT COMPLETED|Phase 1||8||
48470893|NCT00560235|101488317|FG001|NOT COMPLETED|Phase 1||0||
48470894|NCT00560235|101488318|FG002|NOT COMPLETED|Phase 1||0||
48470895|NCT00560235|101488316|FG000|STARTED|Phase 1B||0||
48470896|NCT00560235|101488317|FG001|STARTED|Phase 1B||21||
48470897|NCT00560235|101488318|FG002|STARTED|Phase 1B||0||
48470898|NCT00560235|101488316|FG000|COMPLETED|Phase 1B||0||
48470899|NCT00560235|101488317|FG001|COMPLETED|Phase 1B||2||
48470900|NCT00560235|101488318|FG002|COMPLETED|Phase 1B||0||
48470901|NCT00560235|101488316|FG000|NOT COMPLETED|Phase 1B||0||
48470902|NCT00560235|101488317|FG001|NOT COMPLETED|Phase 1B||19||
48470903|NCT00560235|101488318|FG002|NOT COMPLETED|Phase 1B||0||
48470904|NCT00560235|101488316|FG000|STARTED|Phase 2||0||
48470905|NCT00560235|101488317|FG001|STARTED|Phase 2||0||
48470906|NCT00560235|101488318|FG002|STARTED|Phase 2||107||
48470907|NCT00560235|101488316|FG000|COMPLETED|Phase 2||0||
48470908|NCT00560235|101488317|FG001|COMPLETED|Phase 2||0||
48470909|NCT00560235|101488318|FG002|COMPLETED|Phase 2||10||
48470910|NCT00560235|101488316|FG000|NOT COMPLETED|Phase 2||0||
48470911|NCT00560235|101488317|FG001|NOT COMPLETED|Phase 2||0||
48470912|NCT00560235|101488318|FG002|NOT COMPLETED|Phase 2||97||
48190450|NCT02424344|100789073|FG001|COMPLETED|Overall Study||123||
48190451|NCT02424344|100789072|FG000|NOT COMPLETED|Overall Study||7||
48470913|NCT01694485|101488319|FG000|STARTED|Overall Study||117||
48470914|NCT01694485|101488320|FG001|STARTED|Overall Study||22||
48470915|NCT01694485|101488321|FG002|STARTED|Overall Study||40||
48470916|NCT01694485|101488322|FG003|STARTED|Overall Study||100||
48470917|NCT01694485|101488323|FG004|STARTED|Overall Study||80||
48470918|NCT01694485|101488319|FG000|Received Treatment|Overall Study||116||
48190452|NCT02424344|100789073|FG001|NOT COMPLETED|Overall Study||10||
48470919|NCT01694485|101488320|FG001|Received Treatment|Overall Study||21||
48470920|NCT01694485|101488321|FG002|Received Treatment|Overall Study||40||
48470921|NCT01694485|101488322|FG003|Received Treatment|Overall Study||98||
48470922|NCT01694485|101488323|FG004|Received Treatment|Overall Study||79||
48470923|NCT01694485|101488319|FG000|Completed Week 8 Assessment|Overall Study||106||
48470924|NCT01694485|101488320|FG001|Completed Week 8 Assessment|Overall Study||18||
48470925|NCT01694485|101488321|FG002|Completed Week 8 Assessment|Overall Study||38||
48470926|NCT01694485|101488322|FG003|Completed Week 8 Assessment|Overall Study||94||
48470927|NCT01694485|101488323|FG004|Completed Week 8 Assessment|Overall Study||76||
48470928|NCT01694485|101488319|FG000|Entered Open-label Period|Overall Study||100||
48470929|NCT01694485|101488320|FG001|Entered Open-label Period|Overall Study||19||
48470930|NCT01694485|101488321|FG002|Entered Open-label Period|Overall Study||36||
48470931|NCT01694485|101488322|FG003|Entered Open-label Period|Overall Study||88||
48190453|NCT04034238|100789074|FG000|STARTED|Dose Escalation Phase||7||
48190454|NCT04034238|100789075|FG001|STARTED|Dose Escalation Phase||3||
48190455|NCT04034238|100789076|FG002|STARTED|Dose Escalation Phase||0||
48470932|NCT01694485|101488323|FG004|Entered Open-label Period|Overall Study||68||
48470933|NCT01694485|101488319|FG000|COMPLETED|Overall Study||84|Defined as participants who completed the safety follow-up period|
48470934|NCT01694485|101488320|FG001|COMPLETED|Overall Study||15|Defined as participants who completed the safety follow-up period|
48470935|NCT01694485|101488321|FG002|COMPLETED|Overall Study||27|Defined as participants who completed the safety follow-up period|
48470936|NCT01694485|101488322|FG003|COMPLETED|Overall Study||62|Defined as participants who completed the safety follow-up period|
48470937|NCT01694485|101488323|FG004|COMPLETED|Overall Study||55|Defined as participants who completed the safety follow-up period|
48470938|NCT01694485|101488319|FG000|NOT COMPLETED|Overall Study||33||
48470939|NCT01694485|101488320|FG001|NOT COMPLETED|Overall Study||7||
48470940|NCT01694485|101488321|FG002|NOT COMPLETED|Overall Study||13||
48470941|NCT01694485|101488322|FG003|NOT COMPLETED|Overall Study||38||
48470942|NCT01694485|101488323|FG004|NOT COMPLETED|Overall Study||25||
48470943|NCT02041702|101488324|FG000|STARTED|Overall Study||140|Enrollment \& Baseline|
48470944|NCT02041702|101488325|FG001|STARTED|Overall Study||143|Enrollment \& Baseline|
48190456|NCT04034238|100789077|FG003|STARTED|Dose Escalation Phase||2||
48190457|NCT04034238|100789074|FG000|COMPLETED|Dose Escalation Phase||6||
48190458|NCT04034238|100789075|FG001|COMPLETED|Dose Escalation Phase||3||
48190459|NCT04034238|100789076|FG002|COMPLETED|Dose Escalation Phase||0||
48190460|NCT04034238|100789077|FG003|COMPLETED|Dose Escalation Phase||0||
48190461|NCT04034238|100789074|FG000|NOT COMPLETED|Dose Escalation Phase||1||
48190462|NCT04034238|100789075|FG001|NOT COMPLETED|Dose Escalation Phase||0||
48190463|NCT04034238|100789076|FG002|NOT COMPLETED|Dose Escalation Phase||0||
48190464|NCT04034238|100789077|FG003|NOT COMPLETED|Dose Escalation Phase||2||
48190465|NCT04034238|100789074|FG000|STARTED|Dose Expansion Phase||0||
48470945|NCT02041702|101488324|FG000|Pre MRI Scan/ Pre Waitng|Overall Study||129|Control Group: No non diagnostic cardiac MRI scan, subjects waited for 45 minutes +/- 15 minutes|
48190466|NCT04034238|100789075|FG001|STARTED|Dose Expansion Phase||0||
48190467|NCT04034238|100789076|FG002|STARTED|Dose Expansion Phase||6||
48190468|NCT04034238|100789077|FG003|STARTED|Dose Expansion Phase||1||
48190469|NCT04034238|100789074|FG000|COMPLETED|Dose Expansion Phase||0||
48190470|NCT04034238|100789075|FG001|COMPLETED|Dose Expansion Phase||0||
48190471|NCT04034238|100789076|FG002|COMPLETED|Dose Expansion Phase||5||
48190472|NCT04034238|100789077|FG003|COMPLETED|Dose Expansion Phase||0||
48190473|NCT04034238|100789074|FG000|NOT COMPLETED|Dose Expansion Phase||0||
48190474|NCT04034238|100789075|FG001|NOT COMPLETED|Dose Expansion Phase||0||
48190475|NCT04034238|100789076|FG002|NOT COMPLETED|Dose Expansion Phase||1||
48190476|NCT04034238|100789077|FG003|NOT COMPLETED|Dose Expansion Phase||1||
48190477|NCT04990687|100789078|FG000|STARTED|Overall Study||5||
48470946|NCT02041702|101488325|FG001|Pre MRI Scan/ Pre Waitng|Overall Study||140|Control Group: No non diagnostic cardiac MRI scan, subjects waited for 45 minutes +/- 15 minutes|
48470947|NCT02041702|101488324|FG000|Post MRI Scan/ Post Waiting|Overall Study||129|Control Group: No non diagnostic cardiac MRI scan, subjects waited for 45 minutes +/- 15 minutes|
48470948|NCT02041702|101488325|FG001|Post MRI Scan/ Post Waiting|Overall Study||140|Control Group: No non diagnostic cardiac MRI scan, subjects waited for 45 minutes +/- 15 minutes|
48470949|NCT02041702|101488324|FG000|COMPLETED|Overall Study||129|One month post MRI Scan|
48470950|NCT02041702|101488325|FG001|COMPLETED|Overall Study||134|One month post MRI Scan|
48470951|NCT02041702|101488324|FG000|NOT COMPLETED|Overall Study||11||
48470952|NCT02041702|101488325|FG001|NOT COMPLETED|Overall Study||9||
48470953|NCT01469546|101488326|FG000|STARTED|Received 5 mg Dose||42||
48190478|NCT04990687|100789078|FG000|COMPLETED|Overall Study||5||
48470954|NCT01469546|101488326|FG000|Completed First Cycle|Received 5 mg Dose||30||
48470955|NCT01469546|101488326|FG000|COMPLETED|Received 5 mg Dose||19||
48470956|NCT01469546|101488326|FG000|NOT COMPLETED|Received 5 mg Dose||23||
48470957|NCT01469546|101488326|FG000|STARTED|Dose Escalation to 10 mg||19||
48470958|NCT01469546|101488326|FG000|COMPLETED|Dose Escalation to 10 mg||19||
48470959|NCT01469546|101488326|FG000|NOT COMPLETED|Dose Escalation to 10 mg||0||
48470960|NCT02148302|101488327|FG000|STARTED|Overall Study||57||
48470961|NCT02148302|101488328|FG001|STARTED|Overall Study||66||
48470962|NCT02148302|101488327|FG000|COMPLETED|Overall Study||57||
48470963|NCT02148302|101488328|FG001|COMPLETED|Overall Study||66||
48470964|NCT02148302|101488327|FG000|NOT COMPLETED|Overall Study||0||
48470965|NCT02148302|101488328|FG001|NOT COMPLETED|Overall Study||0||
48470966|NCT01513551|101488329|FG000|STARTED|Overall Study||230||
48470967|NCT01513551|101488330|FG001|STARTED|Overall Study||231||
48470968|NCT01513551|101488331|FG002|STARTED|Overall Study||231||
48470969|NCT01513551|101488329|FG000|Vaccinated|Overall Study||230||
48470970|NCT01513551|101488330|FG001|Vaccinated|Overall Study||231||
48190479|NCT04990687|100789078|FG000|NOT COMPLETED|Overall Study||0||
48190480|NCT04610684|100789079|FG000|STARTED|Study Treatment||3||
48190481|NCT04610684|100789079|FG000|COMPLETED|Study Treatment||0||
48190482|NCT04610684|100789079|FG000|NOT COMPLETED|Study Treatment||3||
48190483|NCT04610684|100789079|FG000|STARTED|Follow up||3|Treatment and Follow up both are at different time period. Therefore, the number of subjects to start follow up is not equal to the number of subjects who have completed treatment.|
48190484|NCT04610684|100789079|FG000|COMPLETED|Follow up||0||
48190485|NCT04610684|100789079|FG000|NOT COMPLETED|Follow up||3||
48190486|NCT02941146|100789080|FG000|STARTED|Overall Study||15||
48190487|NCT02941146|100789080|FG000|COMPLETED|Overall Study||15||
48470971|NCT01513551|101488331|FG002|Vaccinated|Overall Study||230||
48470972|NCT01513551|101488329|FG000|COMPLETED|Overall Study||226||
48470973|NCT01513551|101488330|FG001|COMPLETED|Overall Study||225||
48470974|NCT01513551|101488331|FG002|COMPLETED|Overall Study||226||
48470975|NCT01513551|101488329|FG000|NOT COMPLETED|Overall Study||4||
48470976|NCT01513551|101488330|FG001|NOT COMPLETED|Overall Study||6||
48470977|NCT01513551|101488331|FG002|NOT COMPLETED|Overall Study||5||
48470978|NCT02744352|101488332|FG000|STARTED|Overall Study||4||
48470979|NCT02744352|101488333|FG001|STARTED|Overall Study||4||
48470980|NCT02744352|101488332|FG000|COMPLETED|Overall Study||4||
48470981|NCT02744352|101488333|FG001|COMPLETED|Overall Study||4||
48470982|NCT02744352|101488332|FG000|NOT COMPLETED|Overall Study||0||
48470983|NCT02744352|101488333|FG001|NOT COMPLETED|Overall Study||0||
48470984|NCT02688556|101488334|FG000|STARTED|Overall Study||372||
48470985|NCT02688556|101488335|FG001|STARTED|Overall Study||373||
48470986|NCT02688556|101488334|FG000|COMPLETED|Overall Study||347||
48470987|NCT02688556|101488335|FG001|COMPLETED|Overall Study||361||
48470988|NCT02688556|101488334|FG000|NOT COMPLETED|Overall Study||25||
48470989|NCT02688556|101488335|FG001|NOT COMPLETED|Overall Study||12||
48470990|NCT03702621|101488336|FG000|STARTED|Overall Study||44||
48470991|NCT03702621|101488337|FG001|STARTED|Overall Study||46||
48470992|NCT03702621|101488336|FG000|COMPLETED|Overall Study||38||
48470993|NCT03702621|101488337|FG001|COMPLETED|Overall Study||40||
48470994|NCT03702621|101488336|FG000|NOT COMPLETED|Overall Study||6||
48470995|NCT03702621|101488337|FG001|NOT COMPLETED|Overall Study||6||
48470996|NCT01179919|101488338|FG000|STARTED|Overall Study||21||
48470997|NCT01179919|101488338|FG000|COMPLETED|Overall Study||19||
48470998|NCT01179919|101488338|FG000|NOT COMPLETED|Overall Study||2||
48470999|NCT05346055|101488339|FG000|STARTED|Overall Study||8||
48471000|NCT05346055|101488339|FG000|COMPLETED|Overall Study||5||
48190488|NCT02941146|100789080|FG000|NOT COMPLETED|Overall Study||0||
48190489|NCT01941316|100789081|FG000|STARTED|Overall Study||4||
48190490|NCT01941316|100789082|FG001|STARTED|Overall Study||9||
48190491|NCT01941316|100789083|FG002|STARTED|Overall Study||3||
48190492|NCT01941316|100789084|FG003|STARTED|Overall Study||62||
48190493|NCT01941316|100789081|FG000|COMPLETED|Overall Study||1||
48190494|NCT01941316|100789082|FG001|COMPLETED|Overall Study||0||
48190495|NCT01941316|100789083|FG002|COMPLETED|Overall Study||0||
48190496|NCT01941316|100789084|FG003|COMPLETED|Overall Study||7||
48190497|NCT01941316|100789081|FG000|NOT COMPLETED|Overall Study||3||
48190498|NCT01941316|100789082|FG001|NOT COMPLETED|Overall Study||9||
48190499|NCT01941316|100789083|FG002|NOT COMPLETED|Overall Study||3||
48190500|NCT01941316|100789084|FG003|NOT COMPLETED|Overall Study||55||
48190501|NCT04730947|100789085|FG000|STARTED|Overall Study||21||
48190502|NCT04730947|100789086|FG001|STARTED|Overall Study||17||
48190503|NCT04730947|100789085|FG000|COMPLETED|Overall Study||21||
48190504|NCT04730947|100789086|FG001|COMPLETED|Overall Study||16||
48190505|NCT04730947|100789085|FG000|NOT COMPLETED|Overall Study||0||
48190506|NCT04730947|100789086|FG001|NOT COMPLETED|Overall Study||1||
48190507|NCT02263885|100789087|FG000|STARTED|Overall Study||20||
48190508|NCT02263885|100789087|FG000|COMPLETED|Overall Study||10||
48190509|NCT02263885|100789087|FG000|NOT COMPLETED|Overall Study||10||
48190510|NCT01113515|100789088|FG000|STARTED|Overall Study||10||
48471001|NCT05346055|101488339|FG000|NOT COMPLETED|Overall Study||3||
48471002|NCT02850068|101488340|FG000|STARTED|Overall Study||20||
48471003|NCT02850068|101488340|FG000|COMPLETED|Overall Study||0||
48471004|NCT02850068|101488340|FG000|NOT COMPLETED|Overall Study||20||
48471005|NCT00818623|101488341|FG000|STARTED|Overall Study||26||
48471006|NCT00818623|101488342|FG001|STARTED|Overall Study||12||
48471007|NCT00818623|101488343|FG002|STARTED|Overall Study||13||
48471008|NCT00818623|101488344|FG003|STARTED|Overall Study||24||
48471009|NCT00818623|101488345|FG004|STARTED|Overall Study||27||
48190511|NCT01113515|100789089|FG001|STARTED|Overall Study||9||
48190512|NCT01113515|100789090|FG002|STARTED|Overall Study||14||
48190513|NCT01113515|100789091|FG003|STARTED|Overall Study||11||
48190514|NCT01113515|100789088|FG000|COMPLETED|Overall Study||10||
48190515|NCT01113515|100789089|FG001|COMPLETED|Overall Study||9||
48471010|NCT00818623|101488346|FG005|STARTED|Overall Study||24||
48471011|NCT00818623|101488347|FG006|STARTED|Overall Study||27||
48471012|NCT00818623|101488348|FG007|STARTED|Overall Study||27||
48190516|NCT01113515|100789090|FG002|COMPLETED|Overall Study||10||
48190517|NCT01113515|100789091|FG003|COMPLETED|Overall Study||10||
48190518|NCT01113515|100789088|FG000|NOT COMPLETED|Overall Study||0||
48190519|NCT01113515|100789089|FG001|NOT COMPLETED|Overall Study||0||
48190520|NCT01113515|100789090|FG002|NOT COMPLETED|Overall Study||4||
48190521|NCT01113515|100789091|FG003|NOT COMPLETED|Overall Study||1||
48190522|NCT03163511|100789092|FG000|STARTED|Overall Study||2||
48190523|NCT03163511|100789093|FG001|STARTED|Overall Study||47||
48190524|NCT03163511|100789092|FG000|COMPLETED|Overall Study||1||
48190525|NCT03163511|100789093|FG001|COMPLETED|Overall Study||14||
48190526|NCT03163511|100789092|FG000|NOT COMPLETED|Overall Study||1||
48190527|NCT03163511|100789093|FG001|NOT COMPLETED|Overall Study||33||
48190528|NCT00578227|100789094|FG000|STARTED|Overall Study||272||
48190529|NCT00578227|100789095|FG001|STARTED|Overall Study||270||
48190530|NCT00578227|100789096|FG002|STARTED|Overall Study||271||
48190531|NCT00578227|100789094|FG000|COMPLETED|Overall Study||267||
48190532|NCT00578227|100789095|FG001|COMPLETED|Overall Study||268||
48190533|NCT00578227|100789096|FG002|COMPLETED|Overall Study||267||
48190534|NCT00578227|100789094|FG000|NOT COMPLETED|Overall Study||5||
48190535|NCT00578227|100789095|FG001|NOT COMPLETED|Overall Study||2||
48190536|NCT00578227|100789096|FG002|NOT COMPLETED|Overall Study||4||
48190537|NCT05489224|100789097|FG000|STARTED|Treatment Period I||234||
48190538|NCT05489224|100789098|FG001|STARTED|Treatment Period I||237||
48471013|NCT00818623|101488341|FG000|Intent-to-treat (ITT) Population|Overall Study||25||
48471014|NCT00818623|101488342|FG001|Intent-to-treat (ITT) Population|Overall Study||12||
48471015|NCT00818623|101488343|FG002|Intent-to-treat (ITT) Population|Overall Study||12||
48471016|NCT00818623|101488344|FG003|Intent-to-treat (ITT) Population|Overall Study||24||
48471017|NCT00818623|101488345|FG004|Intent-to-treat (ITT) Population|Overall Study||24||
48471018|NCT00818623|101488346|FG005|Intent-to-treat (ITT) Population|Overall Study||24||
48471019|NCT00818623|101488347|FG006|Intent-to-treat (ITT) Population|Overall Study||24||
48471020|NCT00818623|101488348|FG007|Intent-to-treat (ITT) Population|Overall Study||27||
48471021|NCT00818623|101488341|FG000|COMPLETED|Overall Study||24||
48471022|NCT00818623|101488342|FG001|COMPLETED|Overall Study||8||
48471023|NCT00818623|101488343|FG002|COMPLETED|Overall Study||9||
48471024|NCT00818623|101488344|FG003|COMPLETED|Overall Study||19||
48471025|NCT00818623|101488345|FG004|COMPLETED|Overall Study||23||
48471026|NCT00818623|101488346|FG005|COMPLETED|Overall Study||21||
48471027|NCT00818623|101488347|FG006|COMPLETED|Overall Study||23||
48471028|NCT00818623|101488348|FG007|COMPLETED|Overall Study||26||
48471029|NCT00818623|101488341|FG000|NOT COMPLETED|Overall Study||2||
48471030|NCT00818623|101488342|FG001|NOT COMPLETED|Overall Study||4||
48471031|NCT00818623|101488343|FG002|NOT COMPLETED|Overall Study||4||
48471032|NCT00818623|101488344|FG003|NOT COMPLETED|Overall Study||5||
48471033|NCT00818623|101488345|FG004|NOT COMPLETED|Overall Study||4||
48471034|NCT00818623|101488346|FG005|NOT COMPLETED|Overall Study||3||
48471035|NCT00818623|101488347|FG006|NOT COMPLETED|Overall Study||4||
48471036|NCT00818623|101488348|FG007|NOT COMPLETED|Overall Study||1||
48471037|NCT00761592|101488349|FG000|STARTED|Overall Study||32||
48471038|NCT00761592|101488350|FG001|STARTED|Overall Study||33||
48471039|NCT00761592|101488349|FG000|COMPLETED|Overall Study||31||
48471040|NCT00761592|101488350|FG001|COMPLETED|Overall Study||32||
48471041|NCT00761592|101488349|FG000|NOT COMPLETED|Overall Study||1||
48471042|NCT00761592|101488350|FG001|NOT COMPLETED|Overall Study||1||
48471043|NCT01734772|101488351|FG000|STARTED|Overall Study||24||
48471044|NCT01734772|101488352|FG001|STARTED|Overall Study||24||
48471045|NCT01734772|101488351|FG000|COMPLETED|Overall Study||23||
48471046|NCT01734772|101488352|FG001|COMPLETED|Overall Study||21||
48471047|NCT01734772|101488351|FG000|NOT COMPLETED|Overall Study||1||
48190539|NCT05489224|100789099|FG002|STARTED|Treatment Period I||0||
48190540|NCT05489224|100789097|FG000|COMPLETED|Treatment Period I||225|Patients who completed study drug administration in Treatment Period I|
48190541|NCT05489224|100789098|FG001|COMPLETED|Treatment Period I||219|Patients who completed study drug administration in Treatment Period I|
48190542|NCT05489224|100789099|FG002|COMPLETED|Treatment Period I||0|Patients who completed study drug administration in Treatment Period I|
48471048|NCT01734772|101488352|FG001|NOT COMPLETED|Overall Study||3||
48471049|NCT04117607|101488353|FG000|STARTED|Overall Study||3||
48471050|NCT04117607|101488354|FG001|STARTED|Overall Study||7||
48471051|NCT04117607|101488355|FG002|STARTED|Overall Study||0||
48471052|NCT04117607|101488356|FG003|STARTED|Overall Study||0||
48471053|NCT04117607|101488357|FG004|STARTED|Overall Study||0||
48471054|NCT04117607|101488358|FG005|STARTED|Overall Study||0||
48190543|NCT05489224|100789097|FG000|NOT COMPLETED|Treatment Period I||9||
48190544|NCT05489224|100789098|FG001|NOT COMPLETED|Treatment Period I||18||
48190545|NCT05489224|100789099|FG002|NOT COMPLETED|Treatment Period I||0||
48190546|NCT05489224|100789097|FG000|STARTED|Treatment Period II up to Week 32||225|Patients who had administrated RoActemra during Treatment Period I has been re-randomized in a 1:1 ratio into 2 groups - RoActemra Maintenance and switched to CT-P47.|
48190547|NCT05489224|100789098|FG001|STARTED|Treatment Period II up to Week 32||109|Patients who had administrated RoActemra during Treatment Period I has been re-randomized in a 1:1 ratio into 2 groups - RoActemra Maintenance and switched to CT-P47.|
48190548|NCT05489224|100789099|FG002|STARTED|Treatment Period II up to Week 32||110|Patients who had administrated RoActemra during Treatment Period I has been re-randomized in a 1:1 ratio into 2 groups - RoActemra Maintenance and switched to CT-P47.|
48190549|NCT05489224|100789097|FG000|COMPLETED|Treatment Period II up to Week 32||0|This data summary is based on the Week 32 results, so all patients were considered as Not Completed (whole study period; Week 52). All patients were considered as ongoing at the time of Week 32 data cut-off.|
48190550|NCT05489224|100789098|FG001|COMPLETED|Treatment Period II up to Week 32||0|This data summary is based on the Week 32 results, so all patients were considered as Not Completed (whole study period; Week 52). All patients were considered as ongoing at the time of Week 32 data cut-off.|
48190551|NCT05489224|100789099|FG002|COMPLETED|Treatment Period II up to Week 32||0|This data summary is based on the Week 32 results, so all patients were considered as Not Completed (whole study period; Week 52). All patients were considered as ongoing at the time of Week 32 data cut-off.|
48190552|NCT05489224|100789097|FG000|NOT COMPLETED|Treatment Period II up to Week 32||225||
48190553|NCT05489224|100789098|FG001|NOT COMPLETED|Treatment Period II up to Week 32||109||
48190554|NCT05489224|100789099|FG002|NOT COMPLETED|Treatment Period II up to Week 32||110||
48190555|NCT00087490|100789100|FG000|STARTED|Overall Study||544||
48190556|NCT00087490|100789101|FG001|STARTED|Overall Study||533||
48190557|NCT00087490|100789100|FG000|Treated|Overall Study||537||
48190558|NCT00087490|100789101|FG001|Treated|Overall Study||515||
48190559|NCT00087490|100789100|FG000|COMPLETED|Overall Study||286||
48190560|NCT00087490|100789101|FG001|COMPLETED|Overall Study||264||
48190561|NCT00087490|100789100|FG000|NOT COMPLETED|Overall Study||258||
48190562|NCT00087490|100789101|FG001|NOT COMPLETED|Overall Study||269||
48190563|NCT00755755|100789102|FG000|STARTED|Overall Study||95||
48190564|NCT00755755|100789103|FG001|STARTED|Overall Study||98||
48190565|NCT00755755|100789104|FG002|STARTED|Overall Study||48||
48190566|NCT00755755|100789102|FG000|COMPLETED|Overall Study||89||
48190567|NCT00755755|100789103|FG001|COMPLETED|Overall Study||90||
48190568|NCT00755755|100789104|FG002|COMPLETED|Overall Study||45||
48190569|NCT00755755|100789102|FG000|NOT COMPLETED|Overall Study||6||
48190570|NCT00755755|100789103|FG001|NOT COMPLETED|Overall Study||8||
48190571|NCT00755755|100789104|FG002|NOT COMPLETED|Overall Study||3||
48190572|NCT04939428|100789105|FG000|STARTED|Overall Study||768||
48190573|NCT04939428|100789106|FG001|STARTED|Overall Study||771||
48190574|NCT04939428|100789107|FG002|STARTED|Overall Study||902||
48190575|NCT04939428|100789105|FG000|Treated|Overall Study||763||
48190576|NCT04939428|100789106|FG001|Treated|Overall Study||765||
48190577|NCT04939428|100789107|FG002|Treated|Overall Study||0||
48190578|NCT04939428|100789105|FG000|COMPLETED|Overall Study||750||
48190579|NCT04939428|100789106|FG001|COMPLETED|Overall Study||751||
48190580|NCT04939428|100789107|FG002|COMPLETED|Overall Study||0||
48190581|NCT04939428|100789105|FG000|NOT COMPLETED|Overall Study||18||
48190582|NCT04939428|100789106|FG001|NOT COMPLETED|Overall Study||20||
48190583|NCT04939428|100789107|FG002|NOT COMPLETED|Overall Study||902||
48190584|NCT04654351|100789108|FG000|STARTED|Overall Study||2||
48190585|NCT04654351|100789108|FG000|COMPLETED|Overall Study||2||
48190586|NCT04654351|100789108|FG000|NOT COMPLETED|Overall Study||0||
48190587|NCT03415022|100789109|FG000|STARTED|Overall Study||21||
48190588|NCT03415022|100789110|FG001|STARTED|Overall Study||20||
48190589|NCT03415022|100789109|FG000|COMPLETED|Overall Study||16||
48190590|NCT03415022|100789110|FG001|COMPLETED|Overall Study||15||
48190591|NCT03415022|100789109|FG000|NOT COMPLETED|Overall Study||5||
48190592|NCT03415022|100789110|FG001|NOT COMPLETED|Overall Study||5||
48471055|NCT04117607|101488359|FG006|STARTED|Overall Study||4||
48471056|NCT04117607|101488360|FG007|STARTED|Overall Study||0||
48471057|NCT04117607|101488361|FG008|STARTED|Overall Study||0||
48471058|NCT04117607|101488362|FG009|STARTED|Overall Study||0||
48471059|NCT04117607|101488363|FG010|STARTED|Overall Study||0||
48471060|NCT04117607|101488364|FG011|STARTED|Overall Study||0||
48471061|NCT04117607|101488365|FG012|STARTED|Overall Study||0||
48190593|NCT01600703|100789111|FG000|STARTED|First Intervention||7||
48190594|NCT01600703|100789112|FG001|STARTED|First Intervention||8||
48190595|NCT01600703|100789111|FG000|COMPLETED|First Intervention||7||
48190596|NCT01600703|100789112|FG001|COMPLETED|First Intervention||8||
48190597|NCT01600703|100789111|FG000|NOT COMPLETED|First Intervention||0||
48190598|NCT01600703|100789112|FG001|NOT COMPLETED|First Intervention||0||
48370636|NCT03582033|101234929|FG000|NOT COMPLETED|Part C||0||
48471062|NCT04117607|101488366|FG013|STARTED|Overall Study||0||
48471063|NCT04117607|101488353|FG000|Received Study Product|Overall Study||3||
48471064|NCT04117607|101488354|FG001|Received Study Product|Overall Study||6||
48471065|NCT04117607|101488355|FG002|Received Study Product|Overall Study||0||
48190599|NCT01600703|100789111|FG000|STARTED|Second Intervention||7||
48190600|NCT01600703|100789112|FG001|STARTED|Second Intervention||8||
48471066|NCT04117607|101488356|FG003|Received Study Product|Overall Study||0||
48471067|NCT04117607|101488357|FG004|Received Study Product|Overall Study||0||
48471068|NCT04117607|101488358|FG005|Received Study Product|Overall Study||0||
48471069|NCT04117607|101488359|FG006|Received Study Product|Overall Study||3||
48471070|NCT04117607|101488360|FG007|Received Study Product|Overall Study||0||
48471071|NCT04117607|101488361|FG008|Received Study Product|Overall Study||0||
48471072|NCT04117607|101488362|FG009|Received Study Product|Overall Study||0||
48471073|NCT04117607|101488363|FG010|Received Study Product|Overall Study||0||
48471074|NCT04117607|101488364|FG011|Received Study Product|Overall Study||0||
48471075|NCT04117607|101488365|FG012|Received Study Product|Overall Study||0||
48471076|NCT04117607|101488366|FG013|Received Study Product|Overall Study||0||
48471077|NCT04117607|101488353|FG000|Completed All PK Blood Draws|Overall Study||0||
48471078|NCT04117607|101488354|FG001|Completed All PK Blood Draws|Overall Study||6||
48190601|NCT01600703|100789111|FG000|COMPLETED|Second Intervention||7||
48666118|NCT01979185|101967506|FG000|COMPLETED|Period 1||15||
48666119|NCT01979185|101967507|FG001|COMPLETED|Period 1||15||
48666120|NCT01979185|101967506|FG000|NOT COMPLETED|Period 1||0||
48666121|NCT01979185|101967507|FG001|NOT COMPLETED|Period 1||0||
48666122|NCT01979185|101967506|FG000|STARTED|Period 2||15||
48666123|NCT01979185|101967507|FG001|STARTED|Period 2||15||
48666124|NCT01979185|101967506|FG000|COMPLETED|Period 2||15||
48666125|NCT01979185|101967507|FG001|COMPLETED|Period 2||14||
48666126|NCT01979185|101967506|FG000|NOT COMPLETED|Period 2||0||
48666127|NCT01979185|101967507|FG001|NOT COMPLETED|Period 2||1||
48666128|NCT00095576|101967508|FG000|STARTED|Overall Study||1484||
48666129|NCT00095576|101967509|FG001|STARTED|Overall Study||1495||
48666130|NCT00095576|101967508|FG000|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1484||
48666131|NCT00095576|101967509|FG001|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1495||
48666132|NCT00095576|101967508|FG000|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1426||
48666133|NCT00095576|101967509|FG001|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1443||
48666134|NCT00095576|101967508|FG000|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1328||
48666135|NCT00095576|101967509|FG001|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1361||
48666136|NCT00095576|101967508|FG000|COMPLETED|Overall Study||9||
48666137|NCT00095576|101967509|FG001|COMPLETED|Overall Study||14||
48666138|NCT00095576|101967508|FG000|NOT COMPLETED|Overall Study||1475||
48666139|NCT00095576|101967509|FG001|NOT COMPLETED|Overall Study||1481||
48666140|NCT03232567|101967510|FG000|STARTED|Overall Study||15||
48666141|NCT03232567|101967511|FG001|STARTED|Overall Study||15||
48666142|NCT03232567|101967512|FG002|STARTED|Overall Study||15||
48666143|NCT03232567|101967513|FG003|STARTED|Overall Study||15||
48666144|NCT03232567|101967510|FG000|COMPLETED|Overall Study||15||
48666145|NCT03232567|101967511|FG001|COMPLETED|Overall Study||14||
48666146|NCT03232567|101967512|FG002|COMPLETED|Overall Study||15||
48666147|NCT03232567|101967513|FG003|COMPLETED|Overall Study||15||
48666148|NCT03232567|101967510|FG000|NOT COMPLETED|Overall Study||0||
48666149|NCT03232567|101967511|FG001|NOT COMPLETED|Overall Study||1||
48471079|NCT04117607|101488355|FG002|Completed All PK Blood Draws|Overall Study||0||
48471080|NCT04117607|101488356|FG003|Completed All PK Blood Draws|Overall Study||0||
48471081|NCT04117607|101488357|FG004|Completed All PK Blood Draws|Overall Study||0||
48471082|NCT04117607|101488358|FG005|Completed All PK Blood Draws|Overall Study||0||
48471083|NCT04117607|101488359|FG006|Completed All PK Blood Draws|Overall Study||1||
48471084|NCT04117607|101488360|FG007|Completed All PK Blood Draws|Overall Study||0||
48471085|NCT04117607|101488361|FG008|Completed All PK Blood Draws|Overall Study||0||
48471086|NCT04117607|101488362|FG009|Completed All PK Blood Draws|Overall Study||0||
48471087|NCT04117607|101488363|FG010|Completed All PK Blood Draws|Overall Study||0||
48471088|NCT04117607|101488364|FG011|Completed All PK Blood Draws|Overall Study||0||
48471089|NCT04117607|101488365|FG012|Completed All PK Blood Draws|Overall Study||0||
48471090|NCT04117607|101488366|FG013|Completed All PK Blood Draws|Overall Study||0||
48471091|NCT04117607|101488353|FG000|COMPLETED|Overall Study||3||
48471092|NCT04117607|101488354|FG001|COMPLETED|Overall Study||6||
48471093|NCT04117607|101488355|FG002|COMPLETED|Overall Study||0||
48471094|NCT04117607|101488356|FG003|COMPLETED|Overall Study||0||
48471095|NCT04117607|101488357|FG004|COMPLETED|Overall Study||0||
48471096|NCT04117607|101488358|FG005|COMPLETED|Overall Study||0||
48471097|NCT04117607|101488359|FG006|COMPLETED|Overall Study||3||
48471098|NCT04117607|101488360|FG007|COMPLETED|Overall Study||0||
48471099|NCT04117607|101488361|FG008|COMPLETED|Overall Study||0||
48471100|NCT04117607|101488362|FG009|COMPLETED|Overall Study||0||
48471101|NCT04117607|101488363|FG010|COMPLETED|Overall Study||0||
48471102|NCT04117607|101488364|FG011|COMPLETED|Overall Study||0||
48471103|NCT04117607|101488365|FG012|COMPLETED|Overall Study||0||
48471104|NCT04117607|101488366|FG013|COMPLETED|Overall Study||0||
48471105|NCT04117607|101488353|FG000|NOT COMPLETED|Overall Study||0||
48471106|NCT04117607|101488354|FG001|NOT COMPLETED|Overall Study||1||
48471107|NCT04117607|101488355|FG002|NOT COMPLETED|Overall Study||0||
48471108|NCT04117607|101488356|FG003|NOT COMPLETED|Overall Study||0||
48471109|NCT04117607|101488357|FG004|NOT COMPLETED|Overall Study||0||
48471110|NCT04117607|101488358|FG005|NOT COMPLETED|Overall Study||0||
48471111|NCT04117607|101488359|FG006|NOT COMPLETED|Overall Study||1||
48471112|NCT04117607|101488360|FG007|NOT COMPLETED|Overall Study||0||
48471113|NCT04117607|101488361|FG008|NOT COMPLETED|Overall Study||0||
48471114|NCT04117607|101488362|FG009|NOT COMPLETED|Overall Study||0||
48471115|NCT04117607|101488363|FG010|NOT COMPLETED|Overall Study||0||
48471116|NCT04117607|101488364|FG011|NOT COMPLETED|Overall Study||0||
48471117|NCT04117607|101488365|FG012|NOT COMPLETED|Overall Study||0||
48471118|NCT04117607|101488366|FG013|NOT COMPLETED|Overall Study||0||
48471119|NCT04025879|101488367|FG000|STARTED|Randomization||229||
48471120|NCT04025879|101488368|FG001|STARTED|Randomization||232||
48471121|NCT04025879|101488367|FG000|COMPLETED|Randomization||228|Continued to treatment period|
48471122|NCT04025879|101488368|FG001|COMPLETED|Randomization||230|Continued to treatment period|
48471123|NCT04025879|101488367|FG000|NOT COMPLETED|Randomization||1||
48471124|NCT04025879|101488368|FG001|NOT COMPLETED|Randomization||2||
48471125|NCT04025879|101488367|FG000|STARTED|Treatment||228||
48471126|NCT04025879|101488368|FG001|STARTED|Treatment||230||
48666150|NCT03232567|101967512|FG002|NOT COMPLETED|Overall Study||0||
48190602|NCT01600703|100789112|FG001|COMPLETED|Second Intervention||8||
48190603|NCT01600703|100789111|FG000|NOT COMPLETED|Second Intervention||0||
48471127|NCT04025879|101488367|FG000|Neoadjuvant Treatment|Treatment||228||
48471128|NCT04025879|101488368|FG001|Neoadjuvant Treatment|Treatment||230||
48471129|NCT04025879|101488367|FG000|Adjuvant Treatment|Treatment||142||
48471130|NCT04025879|101488368|FG001|Adjuvant Treatment|Treatment||152||
48471131|NCT04025879|101488367|FG000|COMPLETED|Treatment||85||
48471132|NCT04025879|101488368|FG001|COMPLETED|Treatment||92||
48471133|NCT04025879|101488367|FG000|NOT COMPLETED|Treatment||143||
48471134|NCT04025879|101488368|FG001|NOT COMPLETED|Treatment||138||
48471135|NCT01556009|101488369|FG000|STARTED|Overall Study||0||
48471136|NCT01556009|101488370|FG001|STARTED|Overall Study||0||
48471137|NCT01556009|101488369|FG000|COMPLETED|Overall Study||0||
48471138|NCT01556009|101488370|FG001|COMPLETED|Overall Study||0||
48471139|NCT01556009|101488369|FG000|NOT COMPLETED|Overall Study||0||
48471140|NCT01556009|101488370|FG001|NOT COMPLETED|Overall Study||0||
48471141|NCT05380635|101488371|FG000|STARTED|Overall Study||9||
48471142|NCT05380635|101488371|FG000|COMPLETED|Overall Study||9||
48471143|NCT05380635|101488371|FG000|NOT COMPLETED|Overall Study||0||
48471144|NCT00436007|101488372|FG000|STARTED|Overall Study||170||
48471145|NCT00436007|101488373|FG001|STARTED|Overall Study||170||
48471146|NCT00436007|101488374|FG002|STARTED|Overall Study||171||
48471147|NCT00436007|101488372|FG000|COMPLETED|Overall Study||151||
48471148|NCT00436007|101488373|FG001|COMPLETED|Overall Study||156||
48471149|NCT00436007|101488374|FG002|COMPLETED|Overall Study||148||
48471150|NCT00436007|101488372|FG000|NOT COMPLETED|Overall Study||19||
48471151|NCT00436007|101488373|FG001|NOT COMPLETED|Overall Study||14||
48471152|NCT00436007|101488374|FG002|NOT COMPLETED|Overall Study||23||
48471153|NCT02674334|101488375|FG000|STARTED|Overall Study||47||
48190604|NCT01600703|100789112|FG001|NOT COMPLETED|Second Intervention||0||
48190605|NCT01970943|100789113|FG000|STARTED|Overall Study||11||
48190606|NCT01970943|100789114|FG001|STARTED|Overall Study||12||
48190607|NCT01970943|100789113|FG000|COMPLETED|Overall Study||8||
48370637|NCT03582033|101234930|FG001|NOT COMPLETED|Part C||0||
48370638|NCT03582033|101234931|FG002|NOT COMPLETED|Part C||0||
48370639|NCT03582033|101234932|FG003|NOT COMPLETED|Part C||0||
48370640|NCT03582033|101234933|FG004|NOT COMPLETED|Part C||0||
48370641|NCT03582033|101234934|FG005|NOT COMPLETED|Part C||0||
48370642|NCT03582033|101234935|FG006|NOT COMPLETED|Part C||12||
48370643|NCT03582033|101234936|FG007|NOT COMPLETED|Part C||6||
48471154|NCT02674334|101488376|FG001|STARTED|Overall Study||43||
48471155|NCT02674334|101488375|FG000|COMPLETED|Overall Study||40||
48471156|NCT02674334|101488376|FG001|COMPLETED|Overall Study||40||
48471157|NCT02674334|101488375|FG000|NOT COMPLETED|Overall Study||7||
48471158|NCT02674334|101488376|FG001|NOT COMPLETED|Overall Study||3||
48471159|NCT02483975|101488377|FG000|STARTED|Overall Study||56||
48370644|NCT03582033|101234937|FG008|NOT COMPLETED|Part C||5||
48370645|NCT03582033|101234938|FG009|NOT COMPLETED|Part C||0||
48370646|NCT03582033|101234929|FG000|STARTED|Part D||0||
48370647|NCT03582033|101234930|FG001|STARTED|Part D||0||
48370648|NCT03582033|101234931|FG002|STARTED|Part D||0||
48370649|NCT03582033|101234932|FG003|STARTED|Part D||0||
48370650|NCT03582033|101234933|FG004|STARTED|Part D||0||
48370651|NCT03582033|101234934|FG005|STARTED|Part D||0||
48370652|NCT03582033|101234935|FG006|STARTED|Part D||0||
48370653|NCT03582033|101234936|FG007|STARTED|Part D||0||
48370654|NCT03582033|101234937|FG008|STARTED|Part D||0||
48370655|NCT03582033|101234938|FG009|STARTED|Part D||5||
48370656|NCT03582033|101234929|FG000|COMPLETED|Part D||0||
48370657|NCT03582033|101234930|FG001|COMPLETED|Part D||0||
48370658|NCT03582033|101234931|FG002|COMPLETED|Part D||0||
48370659|NCT03582033|101234932|FG003|COMPLETED|Part D||0||
48370660|NCT03582033|101234933|FG004|COMPLETED|Part D||0||
48370661|NCT03582033|101234934|FG005|COMPLETED|Part D||0||
48370662|NCT03582033|101234935|FG006|COMPLETED|Part D||0||
48370663|NCT03582033|101234936|FG007|COMPLETED|Part D||0||
48370664|NCT03582033|101234937|FG008|COMPLETED|Part D||0||
48471160|NCT02483975|101488378|FG001|STARTED|Overall Study||55||
48471161|NCT02483975|101488377|FG000|COMPLETED|Overall Study||54||
48471162|NCT02483975|101488378|FG001|COMPLETED|Overall Study||53||
48471163|NCT02483975|101488377|FG000|NOT COMPLETED|Overall Study||2||
48471164|NCT02483975|101488378|FG001|NOT COMPLETED|Overall Study||2||
48471165|NCT00684671|101488379|FG000|STARTED|Overall Study||172||
48471166|NCT00684671|101488380|FG001|STARTED|Overall Study||170||
48471167|NCT00684671|101488381|FG002|STARTED|Overall Study||164||
48471168|NCT00684671|101488379|FG000|COMPLETED|Overall Study||169||
48471169|NCT00684671|101488380|FG001|COMPLETED|Overall Study||170||
48471170|NCT00684671|101488381|FG002|COMPLETED|Overall Study||164||
48471171|NCT00684671|101488379|FG000|NOT COMPLETED|Overall Study||3||
48471172|NCT00684671|101488380|FG001|NOT COMPLETED|Overall Study||0||
48471173|NCT00684671|101488381|FG002|NOT COMPLETED|Overall Study||0||
48471174|NCT00356200|101488382|FG000|STARTED|Cohort 1: 10 ug/ml||5||
48471175|NCT00356200|101488383|FG001|STARTED|Cohort 1: 10 ug/ml||0||
48471176|NCT00356200|101488382|FG000|COMPLETED|Cohort 1: 10 ug/ml||4||
48471177|NCT00356200|101488383|FG001|COMPLETED|Cohort 1: 10 ug/ml||0||
48471178|NCT00356200|101488382|FG000|NOT COMPLETED|Cohort 1: 10 ug/ml||1||
48471179|NCT00356200|101488383|FG001|NOT COMPLETED|Cohort 1: 10 ug/ml||0||
48471180|NCT00356200|101488382|FG000|STARTED|Cohort 2: 100 ug/ml (New Patients)||0||
48471181|NCT00356200|101488383|FG001|STARTED|Cohort 2: 100 ug/ml (New Patients)||5||
48471182|NCT00356200|101488382|FG000|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0||
48471183|NCT00356200|101488383|FG001|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||3||
48471184|NCT00356200|101488382|FG000|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0||
48471185|NCT00356200|101488383|FG001|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||2||
48471186|NCT01166568|101488384|FG000|STARTED|Deferred Implantation- Randomized||0||0
48471187|NCT01166568|101488385|FG001|STARTED|Deferred Implantation- Randomized||0||0
48471188|NCT01166568|101488386|FG002|STARTED|Deferred Implantation- Randomized||16||32
48190608|NCT01970943|100789114|FG001|COMPLETED|Overall Study||11||
48190609|NCT01970943|100789113|FG000|NOT COMPLETED|Overall Study||3||
48190610|NCT01970943|100789114|FG001|NOT COMPLETED|Overall Study||1||
48471189|NCT01166568|101488384|FG000|COMPLETED|Deferred Implantation- Randomized||0||0
48471190|NCT01166568|101488385|FG001|COMPLETED|Deferred Implantation- Randomized||0||0
48471191|NCT01166568|101488386|FG002|COMPLETED|Deferred Implantation- Randomized||15||30
48471192|NCT01166568|101488384|FG000|NOT COMPLETED|Deferred Implantation- Randomized||0||0
48190611|NCT02651103|100789115|FG000|STARTED|Overall Study||30||
48190612|NCT02651103|100789115|FG000|COMPLETED|Overall Study||30||
48190613|NCT02651103|100789115|FG000|NOT COMPLETED|Overall Study||0||
48471193|NCT01166568|101488385|FG001|NOT COMPLETED|Deferred Implantation- Randomized||0||0
48471194|NCT01166568|101488386|FG002|NOT COMPLETED|Deferred Implantation- Randomized||1||2
48471195|NCT01166568|101488384|FG000|STARTED|Implantation- Nonrandomized & Randomized||288||562
48471196|NCT01166568|101488385|FG001|STARTED|Implantation- Nonrandomized & Randomized||33||66
48471197|NCT01166568|101488386|FG002|STARTED|Implantation- Nonrandomized & Randomized||9||17
48471198|NCT01166568|101488384|FG000|COMPLETED|Implantation- Nonrandomized & Randomized||274||537
48471199|NCT01166568|101488385|FG001|COMPLETED|Implantation- Nonrandomized & Randomized||32||64
48190614|NCT02825043|100789116|FG000|STARTED|Overall Study||6||
48190615|NCT02825043|100789116|FG000|COMPLETED|Overall Study||2||
48190616|NCT02825043|100789116|FG000|NOT COMPLETED|Overall Study||4||
48190617|NCT03541603|100789117|FG000|STARTED|Overall Study||18||
48190618|NCT03541603|100789118|FG001|STARTED|Overall Study||19||
48190619|NCT03541603|100789117|FG000|COMPLETED|Overall Study||18||
48190620|NCT03541603|100789118|FG001|COMPLETED|Overall Study||17||
48190621|NCT03541603|100789117|FG000|NOT COMPLETED|Overall Study||0||
48190622|NCT03541603|100789118|FG001|NOT COMPLETED|Overall Study||2||
48190623|NCT02806895|100789119|FG000|STARTED|Overall Study||17||
48190624|NCT02806895|100789120|FG001|STARTED|Overall Study||17||
48190625|NCT02806895|100789119|FG000|COMPLETED|Overall Study||16||
48190626|NCT02806895|100789120|FG001|COMPLETED|Overall Study||17||
48190627|NCT02806895|100789119|FG000|NOT COMPLETED|Overall Study||1||
48190628|NCT02806895|100789120|FG001|NOT COMPLETED|Overall Study||0||
48471200|NCT01166568|101488386|FG002|COMPLETED|Implantation- Nonrandomized & Randomized||8||16
48471201|NCT01166568|101488384|FG000|NOT COMPLETED|Implantation- Nonrandomized & Randomized||14||25
48471202|NCT01166568|101488385|FG001|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1||2
48471203|NCT01166568|101488386|FG002|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1||1
48471204|NCT01767064|101488387|FG000|STARTED|Overall Study||7||
48190629|NCT00558753|100789121|FG000|STARTED|Overall Study||120||
48190630|NCT00558753|100789122|FG001|STARTED|Overall Study||120||
48471205|NCT01767064|101488388|FG001|STARTED|Overall Study||7||
48471206|NCT01767064|101488387|FG000|COMPLETED|Overall Study||7||
48471207|NCT01767064|101488388|FG001|COMPLETED|Overall Study||7||
48471208|NCT01767064|101488387|FG000|NOT COMPLETED|Overall Study||0||
48471209|NCT01767064|101488388|FG001|NOT COMPLETED|Overall Study||0||
48471210|NCT03738332|101488389|FG000|STARTED|Overall Study||12||
48471211|NCT03738332|101488389|FG000|COMPLETED|Overall Study||11||
48471212|NCT03738332|101488389|FG000|NOT COMPLETED|Overall Study||1||
48471213|NCT00159965|101488390|FG000|STARTED|Overall Study||19||
48471214|NCT00159965|101488391|FG001|STARTED|Overall Study||19||
48471215|NCT00159965|101488390|FG000|COMPLETED|Overall Study||12||
48471216|NCT00159965|101488391|FG001|COMPLETED|Overall Study||14||
48471217|NCT00159965|101488390|FG000|NOT COMPLETED|Overall Study||7||
48471218|NCT00159965|101488391|FG001|NOT COMPLETED|Overall Study||5||
48190631|NCT00558753|100789121|FG000|COMPLETED|Overall Study||115||
48190632|NCT00558753|100789122|FG001|COMPLETED|Overall Study||113||
48190633|NCT00558753|100789121|FG000|NOT COMPLETED|Overall Study||5||
48471219|NCT01611090|101488392|FG000|STARTED|Randomized Period||289||
48471220|NCT01611090|101488393|FG001|STARTED|Randomized Period||289||
48471221|NCT01611090|101488394|FG002|STARTED|Randomized Period||0||
48471222|NCT01611090|101488392|FG000|Treated|Randomized Period||287||
48471223|NCT01611090|101488393|FG001|Treated|Randomized Period||287||
48471224|NCT01611090|101488394|FG002|Treated|Randomized Period||0||
48471225|NCT01611090|101488392|FG000|COMPLETED|Randomized Period||259||
48471226|NCT01611090|101488393|FG001|COMPLETED|Randomized Period||260||
48471227|NCT01611090|101488394|FG002|COMPLETED|Randomized Period||0||
48471228|NCT01611090|101488392|FG000|NOT COMPLETED|Randomized Period||30||
48471229|NCT01611090|101488393|FG001|NOT COMPLETED|Randomized Period||29||
48471230|NCT01611090|101488394|FG002|NOT COMPLETED|Randomized Period||0||
48471231|NCT01611090|101488392|FG000|STARTED|Cross Over (Placebo to Ibrutinib)||0||
48471232|NCT01611090|101488393|FG001|STARTED|Cross Over (Placebo to Ibrutinib)||0||
48471233|NCT01611090|101488394|FG002|STARTED|Cross Over (Placebo to Ibrutinib)||183||
48471234|NCT01611090|101488392|FG000|Treated|Cross Over (Placebo to Ibrutinib)||0||
48471235|NCT01611090|101488393|FG001|Treated|Cross Over (Placebo to Ibrutinib)||0||
48471236|NCT01611090|101488394|FG002|Treated|Cross Over (Placebo to Ibrutinib)||183||
48471237|NCT01611090|101488392|FG000|COMPLETED|Cross Over (Placebo to Ibrutinib)||0||
48471238|NCT01611090|101488393|FG001|COMPLETED|Cross Over (Placebo to Ibrutinib)||0||
48471239|NCT01611090|101488394|FG002|COMPLETED|Cross Over (Placebo to Ibrutinib)||178||
48471240|NCT01611090|101488392|FG000|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||0||
48471241|NCT01611090|101488393|FG001|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||0||
48471242|NCT01611090|101488394|FG002|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||5||
48471243|NCT03978403|101488395|FG000|STARTED|Overall Study||6||
48471244|NCT03978403|101488396|FG001|STARTED|Overall Study||6||
48471245|NCT03978403|101488397|FG002|STARTED|Overall Study||6||
48471246|NCT03978403|101488398|FG003|STARTED|Overall Study||6||
48471247|NCT03978403|101488395|FG000|COMPLETED|Overall Study||6||
48471248|NCT03978403|101488396|FG001|COMPLETED|Overall Study||6||
48471249|NCT03978403|101488397|FG002|COMPLETED|Overall Study||6||
48471250|NCT03978403|101488398|FG003|COMPLETED|Overall Study||6||
48471251|NCT03978403|101488395|FG000|NOT COMPLETED|Overall Study||0||
48370665|NCT03582033|101234938|FG009|COMPLETED|Part D||0||
48471252|NCT03978403|101488396|FG001|NOT COMPLETED|Overall Study||0||
48471253|NCT03978403|101488397|FG002|NOT COMPLETED|Overall Study||0||
48471254|NCT03978403|101488398|FG003|NOT COMPLETED|Overall Study||0||
48471255|NCT00663871|101488399|FG000|STARTED|Overall Study||134||
48471256|NCT00663871|101488400|FG001|STARTED|Overall Study||138||
48471257|NCT00663871|101488399|FG000|COMPLETED|Overall Study||124||
48471258|NCT00663871|101488400|FG001|COMPLETED|Overall Study||131||
48471259|NCT00663871|101488399|FG000|NOT COMPLETED|Overall Study||10||
48471260|NCT00663871|101488400|FG001|NOT COMPLETED|Overall Study||7||
48471261|NCT03717064|101488401|FG000|STARTED|Period 1||18||
48471262|NCT03717064|101488401|FG000|COMPLETED|Period 1||18||
48471263|NCT03717064|101488401|FG000|NOT COMPLETED|Period 1||0||
48471264|NCT03717064|101488401|FG000|STARTED|Period 2||18||
48471265|NCT03717064|101488401|FG000|COMPLETED|Period 2||17||
48471266|NCT03717064|101488401|FG000|NOT COMPLETED|Period 2||1||
48471267|NCT03213210|101488402|FG000|STARTED|Overall Study||5||
48471268|NCT03213210|101488402|FG000|6-month Follow-up|Overall Study||3||
48471269|NCT03213210|101488402|FG000|COMPLETED|Overall Study||0||
48471270|NCT03213210|101488402|FG000|NOT COMPLETED|Overall Study||5||
48471271|NCT02187042|101488403|FG000|STARTED|Overall Study||42||
48471272|NCT02187042|101488404|FG001|STARTED|Overall Study||27||
48190634|NCT00558753|100789122|FG001|NOT COMPLETED|Overall Study||7||
48190635|NCT02498613|100789123|FG000|STARTED|Overall Study||31|Participants are enrolled.|
48190636|NCT02498613|100789124|FG001|STARTED|Overall Study||39|Participants are enrolled.|
48190637|NCT02498613|100789125|FG002|STARTED|Overall Study||24|Participants are enrolled.|
48190638|NCT02498613|100789126|FG003|STARTED|Overall Study||28|Participants are enrolled.|
48190639|NCT02498613|100789123|FG000|Began Treatment|Overall Study||29||
48190640|NCT02498613|100789124|FG001|Began Treatment|Overall Study||38||
48190641|NCT02498613|100789125|FG002|Began Treatment|Overall Study||19||
48190642|NCT02498613|100789126|FG003|Began Treatment|Overall Study||27||
48190643|NCT02498613|100789123|FG000|COMPLETED|Overall Study||26||
48190644|NCT02498613|100789124|FG001|COMPLETED|Overall Study||37||
48190645|NCT02498613|100789125|FG002|COMPLETED|Overall Study||19||
48190646|NCT02498613|100789126|FG003|COMPLETED|Overall Study||27||
48190647|NCT02498613|100789123|FG000|NOT COMPLETED|Overall Study||5||
48190648|NCT02498613|100789124|FG001|NOT COMPLETED|Overall Study||2||
48190649|NCT02498613|100789125|FG002|NOT COMPLETED|Overall Study||5||
48190650|NCT02498613|100789126|FG003|NOT COMPLETED|Overall Study||1||
48190651|NCT01192295|100789127|FG000|STARTED|Overall Study||27||
48190652|NCT01192295|100789128|FG001|STARTED|Overall Study||128||
48190653|NCT01192295|100789127|FG000|COMPLETED|Overall Study||17||
48190654|NCT01192295|100789128|FG001|COMPLETED|Overall Study||105||
48471273|NCT02187042|101488403|FG000|COMPLETED|Overall Study||29||
48471274|NCT02187042|101488404|FG001|COMPLETED|Overall Study||13||
48471275|NCT02187042|101488403|FG000|NOT COMPLETED|Overall Study||13||
48471276|NCT02187042|101488404|FG001|NOT COMPLETED|Overall Study||14||
48471277|NCT03493126|101488405|FG000|STARTED|Overall Study||31||
48471278|NCT03493126|101488406|FG001|STARTED|Overall Study||28||
48471279|NCT03493126|101488405|FG000|COMPLETED|Overall Study||28||
48471280|NCT03493126|101488406|FG001|COMPLETED|Overall Study||28||
48471281|NCT03493126|101488405|FG000|NOT COMPLETED|Overall Study||3||
48471282|NCT03493126|101488406|FG001|NOT COMPLETED|Overall Study||0||
48471283|NCT02363907|101488407|FG000|STARTED|Overall Study||30||
48471284|NCT02363907|101488407|FG000|COMPLETED|Overall Study||30||
48471285|NCT02363907|101488407|FG000|NOT COMPLETED|Overall Study||0||
48471286|NCT04015232|101488408|FG000|STARTED|Overall Study||100||
48471287|NCT04015232|101488409|FG001|STARTED|Overall Study||100||
48471288|NCT04015232|101488408|FG000|COMPLETED|Overall Study||89||
48471289|NCT04015232|101488409|FG001|COMPLETED|Overall Study||93||
48471290|NCT04015232|101488408|FG000|NOT COMPLETED|Overall Study||11||
48471291|NCT04015232|101488409|FG001|NOT COMPLETED|Overall Study||7||
48471292|NCT03883607|101488410|FG000|STARTED|Overall Study||5|Randomized and treated participants.|
48471293|NCT03883607|101488411|FG001|STARTED|Overall Study||5|Randomized and treated participants.|
48471294|NCT03883607|101488410|FG000|COMPLETED|Overall Study||5||
48471295|NCT03883607|101488411|FG001|COMPLETED|Overall Study||5||
48471296|NCT03883607|101488410|FG000|NOT COMPLETED|Overall Study||0||
48471297|NCT03883607|101488411|FG001|NOT COMPLETED|Overall Study||0||
48471298|NCT03209570|101488412|FG000|STARTED|Overall Study||24||
48471299|NCT03209570|101488413|FG001|STARTED|Overall Study||25||
48471300|NCT03209570|101488412|FG000|COMPLETED|Overall Study||14||
48471301|NCT03209570|101488413|FG001|COMPLETED|Overall Study||12||
48471302|NCT03209570|101488412|FG000|NOT COMPLETED|Overall Study||10||
48471303|NCT03209570|101488413|FG001|NOT COMPLETED|Overall Study||13||
48471304|NCT00824265|101488414|FG000|STARTED|Treatment Phase||183||
48471305|NCT00824265|101488415|FG001|STARTED|Treatment Phase||182||
48471306|NCT00824265|101488414|FG000|COMPLETED|Treatment Phase||119||
48471307|NCT00824265|101488415|FG001|COMPLETED|Treatment Phase||102||
48190655|NCT01192295|100789127|FG000|NOT COMPLETED|Overall Study||10||
48190656|NCT01192295|100789128|FG001|NOT COMPLETED|Overall Study||23||
48370666|NCT03582033|101234929|FG000|NOT COMPLETED|Part D||0||
48471308|NCT00824265|101488414|FG000|NOT COMPLETED|Treatment Phase||64||
48471309|NCT00824265|101488415|FG001|NOT COMPLETED|Treatment Phase||80||
48471310|NCT00824265|101488414|FG000|STARTED|Follow-up Phase||172||
48190657|NCT04956692|100789129|FG000|STARTED|Overall Study||358||
48190658|NCT04956692|100789130|FG001|STARTED|Overall Study||173||
48190659|NCT04956692|100789129|FG000|Treated|Overall Study||356||
48190660|NCT04956692|100789130|FG001|Treated|Overall Study||172||
48471311|NCT00824265|101488415|FG001|STARTED|Follow-up Phase||160||
48190661|NCT04956692|100789129|FG000|COMPLETED|Overall Study||0||
48471312|NCT00824265|101488414|FG000|COMPLETED|Follow-up Phase||154||
48471313|NCT00824265|101488415|FG001|COMPLETED|Follow-up Phase||129||
48471314|NCT00824265|101488414|FG000|NOT COMPLETED|Follow-up Phase||18||
48471315|NCT00824265|101488415|FG001|NOT COMPLETED|Follow-up Phase||31||
48471316|NCT00824265|101488414|FG000|STARTED|Survival Follow-up Phase||96||
48471317|NCT00824265|101488415|FG001|STARTED|Survival Follow-up Phase||89||
48471318|NCT00824265|101488414|FG000|COMPLETED|Survival Follow-up Phase||87||
48471319|NCT00824265|101488415|FG001|COMPLETED|Survival Follow-up Phase||73||
48471320|NCT00824265|101488414|FG000|NOT COMPLETED|Survival Follow-up Phase||9||
48471321|NCT00824265|101488415|FG001|NOT COMPLETED|Survival Follow-up Phase||16||
48471322|NCT03676803|101488416|FG000|STARTED|Overall Study||15||
48471323|NCT03676803|101488417|FG001|STARTED|Overall Study||16||
48471324|NCT03676803|101488416|FG000|COMPLETED|Overall Study||15||
48471325|NCT03676803|101488417|FG001|COMPLETED|Overall Study||16||
48471326|NCT03676803|101488416|FG000|NOT COMPLETED|Overall Study||0||
48471327|NCT03676803|101488417|FG001|NOT COMPLETED|Overall Study||0||
48471328|NCT00444145|101488418|FG000|STARTED|Overall Study||38||
48471329|NCT00444145|101488418|FG000|COMPLETED|Overall Study||19||
48471330|NCT00444145|101488418|FG000|NOT COMPLETED|Overall Study||19||
48471331|NCT00337077|101492394|FG000|STARTED|Overall Study||43||
48471332|NCT00337077|101492395|FG001|STARTED|Overall Study||53||
48471333|NCT00337077|101492396|FG002|STARTED|Overall Study||25||
48471334|NCT00337077|101492394|FG000|Treated|Overall Study||42||
48471335|NCT00337077|101492395|FG001|Treated|Overall Study||52||
48471336|NCT00337077|101492396|FG002|Treated|Overall Study||25||
48471337|NCT00337077|101492394|FG000|Toxicity Assessed|Overall Study||42||
48471338|NCT00337077|101492395|FG001|Toxicity Assessed|Overall Study||51||
48471339|NCT00337077|101492396|FG002|Toxicity Assessed|Overall Study||25||
48471340|NCT00337077|101492394|FG000|Eligible and Treated|Overall Study||41||
48471341|NCT00337077|101492395|FG001|Eligible and Treated|Overall Study||51||
48471342|NCT00337077|101492396|FG002|Eligible and Treated|Overall Study||24||
48471343|NCT00337077|101492394|FG000|Patients With Measurable Disease|Overall Study||26||
48471344|NCT00337077|101492395|FG001|Patients With Measurable Disease|Overall Study||38||
48471345|NCT00337077|101492396|FG002|Patients With Measurable Disease|Overall Study||13||
48471346|NCT00337077|101492394|FG000|COMPLETED|Overall Study||0||
48471347|NCT00337077|101492395|FG001|COMPLETED|Overall Study||0||
48471348|NCT00337077|101492396|FG002|COMPLETED|Overall Study||0||
48471349|NCT00337077|101492394|FG000|NOT COMPLETED|Overall Study||43||
48471350|NCT00337077|101492395|FG001|NOT COMPLETED|Overall Study||53||
48666151|NCT03232567|101967513|FG003|NOT COMPLETED|Overall Study||0||
48370667|NCT03582033|101234930|FG001|NOT COMPLETED|Part D||0||
48370668|NCT03582033|101234931|FG002|NOT COMPLETED|Part D||0||
48190662|NCT04956692|100789130|FG001|COMPLETED|Overall Study||0||
48190663|NCT04956692|100789129|FG000|NOT COMPLETED|Overall Study||358||
48190664|NCT04956692|100789130|FG001|NOT COMPLETED|Overall Study||173||
48190665|NCT01124617|100789131|FG000|STARTED|Overall Study||60||
48471351|NCT00337077|101492396|FG002|NOT COMPLETED|Overall Study||25||
48471352|NCT02698800|101492397|FG000|STARTED|Overall Study||7||
48471353|NCT02698800|101492398|FG001|STARTED|Overall Study||8||
48471354|NCT02698800|101492397|FG000|COMPLETED|Overall Study||6||
48471355|NCT02698800|101492398|FG001|COMPLETED|Overall Study||8||
48471356|NCT02698800|101492397|FG000|NOT COMPLETED|Overall Study||1||
48471357|NCT02698800|101492398|FG001|NOT COMPLETED|Overall Study||0||
48471358|NCT02218164|101492399|FG000|STARTED|Overall Study||8||
48471359|NCT02218164|101492399|FG000|COMPLETED|Overall Study||8||
48471360|NCT02218164|101492399|FG000|NOT COMPLETED|Overall Study||0||
48190666|NCT01124617|100789132|FG001|STARTED|Overall Study||31||
48190667|NCT01124617|100789131|FG000|COMPLETED|Overall Study||41||
48471361|NCT02627742|101492400|FG000|STARTED|Overall Study||210||
48471362|NCT02627742|101492401|FG001|STARTED|Overall Study||209||
48471363|NCT02627742|101492400|FG000|COMPLETED|Overall Study||201||
48471364|NCT02627742|101492401|FG001|COMPLETED|Overall Study||202||
48471365|NCT02627742|101492400|FG000|NOT COMPLETED|Overall Study||9||
48471366|NCT02627742|101492401|FG001|NOT COMPLETED|Overall Study||7||
48471367|NCT01880073|101492402|FG000|STARTED|Overall Study||24||
48471368|NCT01880073|101492402|FG000|COMPLETED|Overall Study||24||
48471369|NCT01880073|101492402|FG000|NOT COMPLETED|Overall Study||0||
48471370|NCT03256968|101492403|FG000|STARTED|Overall Study||1||
48471371|NCT03256968|101492403|FG000|COMPLETED|Overall Study||1||
48471372|NCT03256968|101492403|FG000|NOT COMPLETED|Overall Study||0||
48471373|NCT03660839|101492404|FG000|STARTED|Overall Study||35||
48471374|NCT03660839|101492405|FG001|STARTED|Overall Study||36||
48471375|NCT03660839|101492406|FG002|STARTED|Overall Study||36||
48471376|NCT03660839|101492407|FG003|STARTED|Overall Study||33||
48471377|NCT03660839|101492404|FG000|COMPLETED|Overall Study||35|Completed study treatment.|
48471378|NCT03660839|101492405|FG001|COMPLETED|Overall Study||36|Completed study treatment.|
48471379|NCT03660839|101492406|FG002|COMPLETED|Overall Study||36|Completed study treatment.|
48471380|NCT03660839|101492407|FG003|COMPLETED|Overall Study||33|Completed study treatment.|
48471381|NCT03660839|101492404|FG000|NOT COMPLETED|Overall Study||0||
48471382|NCT03660839|101492405|FG001|NOT COMPLETED|Overall Study||0||
48471383|NCT03660839|101492406|FG002|NOT COMPLETED|Overall Study||0||
48471384|NCT03660839|101492407|FG003|NOT COMPLETED|Overall Study||0||
48190668|NCT01124617|100789132|FG001|COMPLETED|Overall Study||25||
48471385|NCT00650936|101492408|FG000|STARTED|Overall Study||1000||
48471386|NCT00650936|101492408|FG000|COMPLETED|Overall Study||930||
48471387|NCT00650936|101492408|FG000|NOT COMPLETED|Overall Study||70||
48471388|NCT00576901|101492409|FG000|STARTED|Overall Study||23||
48471389|NCT00576901|101492409|FG000|COMPLETED|Overall Study||20||
48190669|NCT01124617|100789131|FG000|NOT COMPLETED|Overall Study||19||
48471390|NCT00576901|101492409|FG000|NOT COMPLETED|Overall Study||3||
48471391|NCT00950872|101492410|FG000|STARTED|Overall Study||29||
48471392|NCT00950872|101492410|FG000|COMPLETED|Overall Study||26||
48471393|NCT00950872|101492410|FG000|NOT COMPLETED|Overall Study||3||
48471394|NCT04818242|101492411|FG000|STARTED|Overall Study||50||
48471395|NCT04818242|101492412|FG001|STARTED|Overall Study||50||
48471396|NCT04818242|101492411|FG000|COMPLETED|Overall Study||50||
48471397|NCT04818242|101492412|FG001|COMPLETED|Overall Study||47||
48471398|NCT04818242|101492411|FG000|NOT COMPLETED|Overall Study||0||
48471399|NCT04818242|101492412|FG001|NOT COMPLETED|Overall Study||3||
48471400|NCT03309956|101492413|FG000|STARTED|Overall Study||247||
48471401|NCT03309956|101492413|FG000|COMPLETED|Overall Study||200||
48471402|NCT03309956|101492413|FG000|NOT COMPLETED|Overall Study||47||
48471403|NCT03823300|101492414|FG000|STARTED|Overall Study||331|Intent-to-Treat (ITT) Population|
48471404|NCT03823300|101492415|FG001|STARTED|Overall Study||327|Intent-to-Treat (ITT) Population|
48471405|NCT03823300|101492414|FG000|Received at Least One Dose of Study Drug|Overall Study||331|Safety Population|
48471406|NCT03823300|101492415|FG001|Received at Least One Dose of Study Drug|Overall Study||326|Safety Population|
48471407|NCT03823300|101492414|FG000|Completed up to Week 48|Overall Study||321|Primary Completion Date Cutoff|
48471408|NCT03823300|101492415|FG001|Completed up to Week 48|Overall Study||309|Primary Completion Date Cutoff|
48471409|NCT03823300|101492414|FG000|COMPLETED|Overall Study||297||
48471410|NCT03823300|101492415|FG001|COMPLETED|Overall Study||273||
48471411|NCT03823300|101492414|FG000|NOT COMPLETED|Overall Study||34||
48471412|NCT03823300|101492415|FG001|NOT COMPLETED|Overall Study||54||
48471413|NCT00977106|101492416|FG000|STARTED|Overall Study||47||
48471414|NCT00977106|101492417|FG001|STARTED|Overall Study||56||
48471415|NCT00977106|101492416|FG000|COMPLETED|Overall Study||37||
48471416|NCT00977106|101492417|FG001|COMPLETED|Overall Study||45||
48471417|NCT00977106|101492416|FG000|NOT COMPLETED|Overall Study||10||
48471418|NCT00977106|101492417|FG001|NOT COMPLETED|Overall Study||11||
48471419|NCT02761980|101492418|FG000|STARTED|Overall Study||29||
48471420|NCT02761980|101492419|FG001|STARTED|Overall Study||87||
48471421|NCT02761980|101492420|FG002|STARTED|Overall Study||87||
48471422|NCT02761980|101492421|FG003|STARTED|Overall Study||87||
48471423|NCT02761980|101492418|FG000|COMPLETED|Overall Study||25||
48471424|NCT02761980|101492419|FG001|COMPLETED|Overall Study||80||
48471425|NCT02761980|101492420|FG002|COMPLETED|Overall Study||81||
48471426|NCT02761980|101492421|FG003|COMPLETED|Overall Study||81||
48471427|NCT02761980|101492418|FG000|NOT COMPLETED|Overall Study||4||
48471428|NCT02761980|101492419|FG001|NOT COMPLETED|Overall Study||7||
48471429|NCT02761980|101492420|FG002|NOT COMPLETED|Overall Study||6||
48471430|NCT02761980|101492421|FG003|NOT COMPLETED|Overall Study||6||
48471431|NCT02922868|101492422|FG000|STARTED|Overall Study||30||
48190670|NCT01124617|100789132|FG001|NOT COMPLETED|Overall Study||6||
48190671|NCT01528124|100789133|FG000|STARTED|Overall Study||6||
48190672|NCT01528124|100789134|FG001|STARTED|Overall Study||6||
48190673|NCT01528124|100789135|FG002|STARTED|Overall Study||6||
48471432|NCT02922868|101492423|FG001|STARTED|Overall Study||30||
48471433|NCT02922868|101492422|FG000|COMPLETED|Overall Study||30||
48471434|NCT02922868|101492423|FG001|COMPLETED|Overall Study||30||
48471435|NCT02922868|101492422|FG000|NOT COMPLETED|Overall Study||0||
48471436|NCT02922868|101492423|FG001|NOT COMPLETED|Overall Study||0||
48471437|NCT03441581|101492424|FG000|STARTED|Overall Study||12||
48471438|NCT03441581|101492425|FG001|STARTED|Overall Study||12||
48471439|NCT03441581|101492424|FG000|COMPLETED|Overall Study||12||
48471440|NCT03441581|101492425|FG001|COMPLETED|Overall Study||12||
48471441|NCT03441581|101492424|FG000|NOT COMPLETED|Overall Study||0||
48471442|NCT03441581|101492425|FG001|NOT COMPLETED|Overall Study||0||
48471443|NCT00497796|101492426|FG000|STARTED|Overall Study||147||
48471444|NCT00497796|101492427|FG001|STARTED|Overall Study||160||
48471445|NCT00497796|101492426|FG000|COMPLETED|Overall Study||62||
48471446|NCT00497796|101492427|FG001|COMPLETED|Overall Study||101||
48471447|NCT00497796|101492426|FG000|NOT COMPLETED|Overall Study||85||
48471448|NCT00497796|101492427|FG001|NOT COMPLETED|Overall Study||59||
48471449|NCT01725451|101492428|FG000|STARTED|Period 1||8||
48471450|NCT01725451|101492429|FG001|STARTED|Period 1||7||
48471451|NCT01725451|101492430|FG002|STARTED|Period 1||8||
48471452|NCT01725451|101492431|FG003|STARTED|Period 1||7||
48471453|NCT01725451|101492428|FG000|COMPLETED|Period 1||7||
48471454|NCT01725451|101492429|FG001|COMPLETED|Period 1||7||
48471455|NCT01725451|101492430|FG002|COMPLETED|Period 1||8||
48471456|NCT01725451|101492431|FG003|COMPLETED|Period 1||7||
48471457|NCT01725451|101492428|FG000|NOT COMPLETED|Period 1||1||
48190674|NCT01528124|100789136|FG003|STARTED|Overall Study||6||
48471458|NCT01725451|101492429|FG001|NOT COMPLETED|Period 1||0||
48471459|NCT01725451|101492430|FG002|NOT COMPLETED|Period 1||0||
48471460|NCT01725451|101492431|FG003|NOT COMPLETED|Period 1||0||
48471461|NCT01725451|101492428|FG000|STARTED|Washout From Period 1||7||
48471462|NCT01725451|101492429|FG001|STARTED|Washout From Period 1||7||
48471463|NCT01725451|101492430|FG002|STARTED|Washout From Period 1||8||
48471464|NCT01725451|101492431|FG003|STARTED|Washout From Period 1||7||
48471465|NCT01725451|101492428|FG000|COMPLETED|Washout From Period 1||7||
48471466|NCT01725451|101492429|FG001|COMPLETED|Washout From Period 1||7||
48471467|NCT01725451|101492430|FG002|COMPLETED|Washout From Period 1||8||
48471468|NCT01725451|101492431|FG003|COMPLETED|Washout From Period 1||7||
48471469|NCT01725451|101492428|FG000|NOT COMPLETED|Washout From Period 1||0||
48471470|NCT01725451|101492429|FG001|NOT COMPLETED|Washout From Period 1||0||
48471471|NCT01725451|101492430|FG002|NOT COMPLETED|Washout From Period 1||0||
48471472|NCT01725451|101492431|FG003|NOT COMPLETED|Washout From Period 1||0||
48471473|NCT01725451|101492428|FG000|STARTED|Period 2||7||
48471474|NCT01725451|101492429|FG001|STARTED|Period 2||7||
48471475|NCT01725451|101492430|FG002|STARTED|Period 2||8||
48471476|NCT01725451|101492431|FG003|STARTED|Period 2||7||
48471477|NCT01725451|101492428|FG000|COMPLETED|Period 2||7||
48471478|NCT01725451|101492429|FG001|COMPLETED|Period 2||7||
48471479|NCT01725451|101492430|FG002|COMPLETED|Period 2||8||
48471480|NCT01725451|101492431|FG003|COMPLETED|Period 2||7||
48471481|NCT01725451|101492428|FG000|NOT COMPLETED|Period 2||0||
48471482|NCT01725451|101492429|FG001|NOT COMPLETED|Period 2||0||
48471483|NCT01725451|101492430|FG002|NOT COMPLETED|Period 2||0||
48471484|NCT01725451|101492431|FG003|NOT COMPLETED|Period 2||0||
48471485|NCT01725451|101492428|FG000|STARTED|Washout From Period 2||7||
48471486|NCT01725451|101492429|FG001|STARTED|Washout From Period 2||7||
48471487|NCT01725451|101492430|FG002|STARTED|Washout From Period 2||8||
48471488|NCT01725451|101492431|FG003|STARTED|Washout From Period 2||7||
48471489|NCT01725451|101492428|FG000|COMPLETED|Washout From Period 2||7||
48471490|NCT01725451|101492429|FG001|COMPLETED|Washout From Period 2||7||
48471491|NCT01725451|101492430|FG002|COMPLETED|Washout From Period 2||8||
48471492|NCT01725451|101492431|FG003|COMPLETED|Washout From Period 2||7||
48471493|NCT01725451|101492428|FG000|NOT COMPLETED|Washout From Period 2||0||
48471494|NCT01725451|101492429|FG001|NOT COMPLETED|Washout From Period 2||0||
48471495|NCT01725451|101492430|FG002|NOT COMPLETED|Washout From Period 2||0||
48471496|NCT01725451|101492431|FG003|NOT COMPLETED|Washout From Period 2||0||
48471497|NCT01725451|101492428|FG000|STARTED|Period 3||7||
48471498|NCT01725451|101492429|FG001|STARTED|Period 3||7||
48471499|NCT01725451|101492430|FG002|STARTED|Period 3||8||
48471500|NCT01725451|101492431|FG003|STARTED|Period 3||7||
48471501|NCT01725451|101492428|FG000|COMPLETED|Period 3||7||
48471502|NCT01725451|101492429|FG001|COMPLETED|Period 3||7||
48471503|NCT01725451|101492430|FG002|COMPLETED|Period 3||8||
48471504|NCT01725451|101492431|FG003|COMPLETED|Period 3||7||
48471505|NCT01725451|101492428|FG000|NOT COMPLETED|Period 3||0||
48471506|NCT01725451|101492429|FG001|NOT COMPLETED|Period 3||0||
48471507|NCT01725451|101492430|FG002|NOT COMPLETED|Period 3||0||
48471508|NCT01725451|101492431|FG003|NOT COMPLETED|Period 3||0||
48471509|NCT01725451|101492428|FG000|STARTED|Washout From Period 3||7||
48471510|NCT01725451|101492429|FG001|STARTED|Washout From Period 3||7||
48471511|NCT01725451|101492430|FG002|STARTED|Washout From Period 3||8||
48471512|NCT01725451|101492431|FG003|STARTED|Washout From Period 3||7||
48471513|NCT01725451|101492428|FG000|COMPLETED|Washout From Period 3||7||
48471514|NCT01725451|101492429|FG001|COMPLETED|Washout From Period 3||6||
48471515|NCT01725451|101492430|FG002|COMPLETED|Washout From Period 3||7||
48471516|NCT01725451|101492431|FG003|COMPLETED|Washout From Period 3||7||
48471517|NCT01725451|101492428|FG000|NOT COMPLETED|Washout From Period 3||0||
48471518|NCT01725451|101492429|FG001|NOT COMPLETED|Washout From Period 3||1||
48471519|NCT01725451|101492430|FG002|NOT COMPLETED|Washout From Period 3||1||
48471520|NCT01725451|101492431|FG003|NOT COMPLETED|Washout From Period 3||0||
48471521|NCT01725451|101492428|FG000|STARTED|Period 4||7||
48471522|NCT01725451|101492429|FG001|STARTED|Period 4||6||
48471523|NCT01725451|101492430|FG002|STARTED|Period 4||7||
48471524|NCT01725451|101492431|FG003|STARTED|Period 4||7||
48471525|NCT01725451|101492428|FG000|COMPLETED|Period 4||7||
48471526|NCT01725451|101492429|FG001|COMPLETED|Period 4||6||
48471527|NCT01725451|101492430|FG002|COMPLETED|Period 4||6||
48471528|NCT01725451|101492431|FG003|COMPLETED|Period 4||7||
48471529|NCT01725451|101492428|FG000|NOT COMPLETED|Period 4||0||
48471530|NCT01725451|101492429|FG001|NOT COMPLETED|Period 4||0||
48471531|NCT01725451|101492430|FG002|NOT COMPLETED|Period 4||1||
48471532|NCT01725451|101492431|FG003|NOT COMPLETED|Period 4||0||
48471533|NCT01725451|101492428|FG000|STARTED|Washout From Period 4||7||
48471534|NCT01725451|101492429|FG001|STARTED|Washout From Period 4||6||
48471535|NCT01725451|101492430|FG002|STARTED|Washout From Period 4||6||
48471536|NCT01725451|101492431|FG003|STARTED|Washout From Period 4||7||
48471537|NCT01725451|101492428|FG000|COMPLETED|Washout From Period 4||7||
48471538|NCT01725451|101492429|FG001|COMPLETED|Washout From Period 4||6||
48471539|NCT01725451|101492430|FG002|COMPLETED|Washout From Period 4||6||
48471540|NCT01725451|101492431|FG003|COMPLETED|Washout From Period 4||7||
48471541|NCT01725451|101492428|FG000|NOT COMPLETED|Washout From Period 4||0||
48471542|NCT01725451|101492429|FG001|NOT COMPLETED|Washout From Period 4||0||
48471543|NCT01725451|101492430|FG002|NOT COMPLETED|Washout From Period 4||0||
48471544|NCT01725451|101492431|FG003|NOT COMPLETED|Washout From Period 4||0||
48471545|NCT01725451|101492428|FG000|STARTED|Period 5||7||
48471546|NCT01725451|101492429|FG001|STARTED|Period 5||6||
48471547|NCT01725451|101492430|FG002|STARTED|Period 5||6||
48471548|NCT01725451|101492431|FG003|STARTED|Period 5||7||
48471549|NCT01725451|101492428|FG000|COMPLETED|Period 5||7||
48471550|NCT01725451|101492429|FG001|COMPLETED|Period 5||6||
48471551|NCT01725451|101492430|FG002|COMPLETED|Period 5||6||
48471552|NCT01725451|101492431|FG003|COMPLETED|Period 5||7||
48471553|NCT01725451|101492428|FG000|NOT COMPLETED|Period 5||0||
48471554|NCT01725451|101492429|FG001|NOT COMPLETED|Period 5||0||
48471555|NCT01725451|101492430|FG002|NOT COMPLETED|Period 5||0||
48471556|NCT01725451|101492431|FG003|NOT COMPLETED|Period 5||0||
48471557|NCT01725451|101492428|FG000|STARTED|Washout From Period 5||7||
48471558|NCT01725451|101492429|FG001|STARTED|Washout From Period 5||6||
48471559|NCT01725451|101492430|FG002|STARTED|Washout From Period 5||6||
48471560|NCT01725451|101492431|FG003|STARTED|Washout From Period 5||7||
48471561|NCT01725451|101492428|FG000|COMPLETED|Washout From Period 5||7||
48471562|NCT01725451|101492429|FG001|COMPLETED|Washout From Period 5||6||
48471563|NCT01725451|101492430|FG002|COMPLETED|Washout From Period 5||6||
48471564|NCT01725451|101492431|FG003|COMPLETED|Washout From Period 5||7||
48471565|NCT01725451|101492428|FG000|NOT COMPLETED|Washout From Period 5||0||
48471566|NCT01725451|101492429|FG001|NOT COMPLETED|Washout From Period 5||0||
48471567|NCT01725451|101492430|FG002|NOT COMPLETED|Washout From Period 5||0||
48471568|NCT01725451|101492431|FG003|NOT COMPLETED|Washout From Period 5||0||
48471569|NCT01725451|101492428|FG000|STARTED|Period 6||7||
48471570|NCT01725451|101492429|FG001|STARTED|Period 6||6||
48471571|NCT01725451|101492430|FG002|STARTED|Period 6||6||
48471572|NCT01725451|101492431|FG003|STARTED|Period 6||7||
48471573|NCT01725451|101492428|FG000|COMPLETED|Period 6||7||
48471574|NCT01725451|101492429|FG001|COMPLETED|Period 6||6||
48471575|NCT01725451|101492430|FG002|COMPLETED|Period 6||6||
48471576|NCT01725451|101492431|FG003|COMPLETED|Period 6||7||
48471577|NCT01725451|101492428|FG000|NOT COMPLETED|Period 6||0||
48471578|NCT01725451|101492429|FG001|NOT COMPLETED|Period 6||0||
48471579|NCT01725451|101492430|FG002|NOT COMPLETED|Period 6||0||
48471580|NCT01725451|101492431|FG003|NOT COMPLETED|Period 6||0||
48471581|NCT01569451|101492432|FG000|STARTED|Overall Study||26||
48471582|NCT01569451|101492433|FG001|STARTED|Overall Study||27||
48471583|NCT01569451|101492432|FG000|COMPLETED|Overall Study||12|Represents patients who completed the entire protocol. The analysis of key outcomes included 53|
48471584|NCT01569451|101492433|FG001|COMPLETED|Overall Study||14|Represents patients who completed the entire protocol. The analysis of key outcomes included 53|
48471585|NCT01569451|101492432|FG000|NOT COMPLETED|Overall Study||14||
48471586|NCT01569451|101492433|FG001|NOT COMPLETED|Overall Study||13||
48471587|NCT00855842|101492434|FG000|STARTED|Overall Study||4||
48471588|NCT00855842|101492434|FG000|COMPLETED|Overall Study||4||
48471589|NCT00855842|101492434|FG000|NOT COMPLETED|Overall Study||0||
48471590|NCT01385033|101492435|FG000|STARTED|Part I||6||
48471591|NCT01385033|101492436|FG001|STARTED|Part I||14||
48471592|NCT01385033|101492437|FG002|STARTED|Part I||0||
48471593|NCT01385033|101492438|FG003|STARTED|Part I||0||
48471594|NCT01385033|101492439|FG004|STARTED|Part I||0||
48471595|NCT01385033|101492440|FG005|STARTED|Part I||0||
48471596|NCT01385033|101492435|FG000|COMPLETED|Part I||6||
48471597|NCT01385033|101492436|FG001|COMPLETED|Part I||14||
48471598|NCT01385033|101492437|FG002|COMPLETED|Part I||0||
48471599|NCT01385033|101492438|FG003|COMPLETED|Part I||0||
48471600|NCT01385033|101492439|FG004|COMPLETED|Part I||0||
48471601|NCT01385033|101492440|FG005|COMPLETED|Part I||0||
48471602|NCT01385033|101492435|FG000|NOT COMPLETED|Part I||0||
48471603|NCT01385033|101492436|FG001|NOT COMPLETED|Part I||0||
48471604|NCT01385033|101492437|FG002|NOT COMPLETED|Part I||0||
48471605|NCT01385033|101492438|FG003|NOT COMPLETED|Part I||0||
48471606|NCT01385033|101492439|FG004|NOT COMPLETED|Part I||0||
48471607|NCT01385033|101492440|FG005|NOT COMPLETED|Part I||0||
48471608|NCT01385033|101492435|FG000|STARTED|Part II||0||
48471609|NCT01385033|101492436|FG001|STARTED|Part II||0||
48471610|NCT01385033|101492437|FG002|STARTED|Part II||0||
48471611|NCT01385033|101492438|FG003|STARTED|Part II||0||
48471612|NCT01385033|101492439|FG004|STARTED|Part II||0||
48471613|NCT01385033|101492440|FG005|STARTED|Part II||0||
48471614|NCT01385033|101492435|FG000|COMPLETED|Part II||0||
48471615|NCT01385033|101492436|FG001|COMPLETED|Part II||0||
48471616|NCT01385033|101492437|FG002|COMPLETED|Part II||0||
48471617|NCT01385033|101492438|FG003|COMPLETED|Part II||0||
48471618|NCT01385033|101492439|FG004|COMPLETED|Part II||0||
48471619|NCT01385033|101492440|FG005|COMPLETED|Part II||0||
48471620|NCT01385033|101492435|FG000|NOT COMPLETED|Part II||0||
48471621|NCT01385033|101492436|FG001|NOT COMPLETED|Part II||0||
48471622|NCT01385033|101492437|FG002|NOT COMPLETED|Part II||0||
48471623|NCT01385033|101492438|FG003|NOT COMPLETED|Part II||0||
48190675|NCT01528124|100789137|FG004|STARTED|Overall Study||5||
48190676|NCT01528124|100789138|FG005|STARTED|Overall Study||6||
48190677|NCT01528124|100789139|FG006|STARTED|Overall Study||6||
48190678|NCT01528124|100789133|FG000|Received Study Drug|Overall Study||6||
48370669|NCT03582033|101234932|FG003|NOT COMPLETED|Part D||0||
48370670|NCT03582033|101234933|FG004|NOT COMPLETED|Part D||0||
48370671|NCT03582033|101234934|FG005|NOT COMPLETED|Part D||0||
48370672|NCT03582033|101234935|FG006|NOT COMPLETED|Part D||0||
48370673|NCT03582033|101234936|FG007|NOT COMPLETED|Part D||0||
48370674|NCT03582033|101234937|FG008|NOT COMPLETED|Part D||0||
48370675|NCT03582033|101234938|FG009|NOT COMPLETED|Part D||5||
48370676|NCT03318159|101234939|FG000|STARTED|Overall Study||20||
48370677|NCT03318159|101234939|FG000|COMPLETED|Overall Study||14||
48370678|NCT03318159|101234939|FG000|NOT COMPLETED|Overall Study||6||
48370679|NCT03952559|101234940|FG000|STARTED|High Dose Open Label - PK Lead-in||33||
48370680|NCT03952559|101234941|FG001|STARTED|High Dose Open Label - PK Lead-in||0||
48370681|NCT03952559|101234942|FG002|STARTED|High Dose Open Label - PK Lead-in||0||
48370682|NCT03952559|101234943|FG003|STARTED|High Dose Open Label - PK Lead-in||0||
48370683|NCT03952559|101234944|FG004|STARTED|High Dose Open Label - PK Lead-in||0||
48370684|NCT03952559|101234940|FG000|Received at Least One Dose of Study Drug|High Dose Open Label - PK Lead-in||33||
48370685|NCT03952559|101234941|FG001|Received at Least One Dose of Study Drug|High Dose Open Label - PK Lead-in||0||
48370686|NCT03952559|101234942|FG002|Received at Least One Dose of Study Drug|High Dose Open Label - PK Lead-in||0||
48370687|NCT03952559|101234943|FG003|Received at Least One Dose of Study Drug|High Dose Open Label - PK Lead-in||0||
48370688|NCT03952559|101234944|FG004|Received at Least One Dose of Study Drug|High Dose Open Label - PK Lead-in||0||
48370689|NCT03952559|101234940|FG000|COMPLETED|High Dose Open Label - PK Lead-in||33||
48370690|NCT03952559|101234941|FG001|COMPLETED|High Dose Open Label - PK Lead-in||0||
48370691|NCT03952559|101234942|FG002|COMPLETED|High Dose Open Label - PK Lead-in||0||
48370692|NCT03952559|101234943|FG003|COMPLETED|High Dose Open Label - PK Lead-in||0||
48370693|NCT03952559|101234944|FG004|COMPLETED|High Dose Open Label - PK Lead-in||0||
48370694|NCT03952559|101234940|FG000|NOT COMPLETED|High Dose Open Label - PK Lead-in||0||
48471624|NCT01385033|101492439|FG004|NOT COMPLETED|Part II||0||
48471625|NCT01385033|101492440|FG005|NOT COMPLETED|Part II||0||
48471626|NCT01385033|101492435|FG000|STARTED|Part III||0||
48471627|NCT01385033|101492436|FG001|STARTED|Part III||0||
48471628|NCT01385033|101492437|FG002|STARTED|Part III||0||
48471629|NCT01385033|101492438|FG003|STARTED|Part III||0||
48471630|NCT01385033|101492439|FG004|STARTED|Part III||0||
48666152|NCT03552029|101967514|FG000|STARTED|Overall Study||4||
48190679|NCT01528124|100789134|FG001|Received Study Drug|Overall Study||6||
48471631|NCT01385033|101492440|FG005|STARTED|Part III||0||
48190680|NCT01528124|100789135|FG002|Received Study Drug|Overall Study||6||
48190681|NCT01528124|100789136|FG003|Received Study Drug|Overall Study||6||
48190682|NCT01528124|100789137|FG004|Received Study Drug|Overall Study||5||
48190683|NCT01528124|100789138|FG005|Received Study Drug|Overall Study||6||
48471632|NCT01385033|101492435|FG000|COMPLETED|Part III||0||
48471633|NCT01385033|101492436|FG001|COMPLETED|Part III||0||
48190684|NCT01528124|100789139|FG006|Received Study Drug|Overall Study||6||
48190685|NCT01528124|100789133|FG000|COMPLETED|Overall Study||6||
48190686|NCT01528124|100789134|FG001|COMPLETED|Overall Study||6||
48471634|NCT01385033|101492437|FG002|COMPLETED|Part III||0||
48471635|NCT01385033|101492438|FG003|COMPLETED|Part III||0||
48471636|NCT01385033|101492439|FG004|COMPLETED|Part III||0||
48471637|NCT01385033|101492440|FG005|COMPLETED|Part III||0||
48471638|NCT01385033|101492435|FG000|NOT COMPLETED|Part III||0||
48471639|NCT01385033|101492436|FG001|NOT COMPLETED|Part III||0||
48471640|NCT01385033|101492437|FG002|NOT COMPLETED|Part III||0||
48471641|NCT01385033|101492438|FG003|NOT COMPLETED|Part III||0||
48471642|NCT01385033|101492439|FG004|NOT COMPLETED|Part III||0||
48471643|NCT01385033|101492440|FG005|NOT COMPLETED|Part III||0||
48471644|NCT00418184|101492441|FG000|STARTED|Double-blind Phase||137||
48471645|NCT00418184|101492442|FG001|STARTED|Double-blind Phase||63||
48471646|NCT00418184|101492441|FG000|COMPLETED|Double-blind Phase||110||
48471647|NCT00418184|101492442|FG001|COMPLETED|Double-blind Phase||52||
48471648|NCT00418184|101492441|FG000|NOT COMPLETED|Double-blind Phase||27||
48471649|NCT00418184|101492442|FG001|NOT COMPLETED|Double-blind Phase||11||
48471650|NCT00418184|101492441|FG000|STARTED|Open-label Phase||102||
48190687|NCT01528124|100789135|FG002|COMPLETED|Overall Study||6||
48471651|NCT00418184|101492442|FG001|STARTED|Open-label Phase||48||
48471652|NCT00418184|101492441|FG000|COMPLETED|Open-label Phase||97||
48471653|NCT00418184|101492442|FG001|COMPLETED|Open-label Phase||43||
48471654|NCT00418184|101492441|FG000|NOT COMPLETED|Open-label Phase||5||
48471655|NCT00418184|101492442|FG001|NOT COMPLETED|Open-label Phase||5||
48471656|NCT02907203|101492443|FG000|STARTED|Overall Study||52||
48190688|NCT01528124|100789136|FG003|COMPLETED|Overall Study||6||
48190689|NCT01528124|100789137|FG004|COMPLETED|Overall Study||5||
48370695|NCT03952559|101234941|FG001|NOT COMPLETED|High Dose Open Label - PK Lead-in||0||
48370696|NCT03952559|101234942|FG002|NOT COMPLETED|High Dose Open Label - PK Lead-in||0||
48370697|NCT03952559|101234943|FG003|NOT COMPLETED|High Dose Open Label - PK Lead-in||0||
48370698|NCT03952559|101234944|FG004|NOT COMPLETED|High Dose Open Label - PK Lead-in||0||
48370699|NCT03952559|101234940|FG000|STARTED|Double Blind Treatment Period||0||
48370700|NCT03952559|101234941|FG001|STARTED|Double Blind Treatment Period||122||
48370701|NCT03952559|101234942|FG002|STARTED|Double Blind Treatment Period||121||
48370702|NCT03952559|101234943|FG003|STARTED|Double Blind Treatment Period||120||
48370703|NCT03952559|101234944|FG004|STARTED|Double Blind Treatment Period||120||
48370704|NCT03952559|101234940|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Period||0||
48370705|NCT03952559|101234941|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Period||122||
48370706|NCT03952559|101234942|FG002|Received at Least One Dose of Study Drug|Double Blind Treatment Period||120||
48370707|NCT03952559|101234943|FG003|Received at Least One Dose of Study Drug|Double Blind Treatment Period||120||
48471657|NCT02907203|101492443|FG000|COMPLETED|Overall Study||44||
48190690|NCT01528124|100789138|FG005|COMPLETED|Overall Study||6||
48190691|NCT01528124|100789139|FG006|COMPLETED|Overall Study||6||
48190692|NCT01528124|100789133|FG000|NOT COMPLETED|Overall Study||0||
48471658|NCT02907203|101492443|FG000|NOT COMPLETED|Overall Study||8||
48471659|NCT02534493|101492444|FG000|STARTED|Overall Study||13||19
48471660|NCT02534493|101492444|FG000|COMPLETED|Overall Study||11||15
48471661|NCT02534493|101492444|FG000|NOT COMPLETED|Overall Study||2||4
48471662|NCT02428699|101492445|FG000|STARTED|Period 1||25||
48471663|NCT02428699|101492446|FG001|STARTED|Period 1||25||
48471664|NCT02428699|101492445|FG000|COMPLETED|Period 1||25||
48471665|NCT02428699|101492446|FG001|COMPLETED|Period 1||25||
48190693|NCT01528124|100789134|FG001|NOT COMPLETED|Overall Study||0||
48471666|NCT02428699|101492445|FG000|NOT COMPLETED|Period 1||0||
48471667|NCT02428699|101492446|FG001|NOT COMPLETED|Period 1||0||
48471668|NCT02428699|101492445|FG000|STARTED|Washout Period 1||25||
48471669|NCT02428699|101492446|FG001|STARTED|Washout Period 1||25||
48471670|NCT02428699|101492445|FG000|COMPLETED|Washout Period 1||24||
48471671|NCT02428699|101492446|FG001|COMPLETED|Washout Period 1||23||
48471672|NCT02428699|101492445|FG000|NOT COMPLETED|Washout Period 1||1||
48471673|NCT02428699|101492446|FG001|NOT COMPLETED|Washout Period 1||2||
48471674|NCT02428699|101492445|FG000|STARTED|Period 2||24||
48471675|NCT02428699|101492446|FG001|STARTED|Period 2||23||
48471676|NCT02428699|101492445|FG000|COMPLETED|Period 2||24||
48471677|NCT02428699|101492446|FG001|COMPLETED|Period 2||23||
48471678|NCT02428699|101492445|FG000|NOT COMPLETED|Period 2||0||
48471679|NCT02428699|101492446|FG001|NOT COMPLETED|Period 2||0||
48471680|NCT01025037|101492447|FG000|STARTED|Overall Study||61||
48471681|NCT01025037|101492447|FG000|COMPLETED|Overall Study||50||
48370708|NCT03952559|101234944|FG004|Received at Least One Dose of Study Drug|Double Blind Treatment Period||120||
48370709|NCT03952559|101234940|FG000|COMPLETED|Double Blind Treatment Period||0||
48190694|NCT01528124|100789135|FG002|NOT COMPLETED|Overall Study||0||
48190695|NCT01528124|100789136|FG003|NOT COMPLETED|Overall Study||0||
48190696|NCT01528124|100789137|FG004|NOT COMPLETED|Overall Study||0||
48190697|NCT01528124|100789138|FG005|NOT COMPLETED|Overall Study||0||
48190698|NCT01528124|100789139|FG006|NOT COMPLETED|Overall Study||0||
48190699|NCT02307123|100789140|FG000|STARTED|Overall Study||483||
48190700|NCT02307123|100789140|FG000|COMPLETED|Overall Study||483||
48190701|NCT02307123|100789140|FG000|NOT COMPLETED|Overall Study||0||
48190702|NCT01955382|100789141|FG000|STARTED|Overall Study||35||
48190703|NCT01955382|100789142|FG001|STARTED|Overall Study||35||
48190704|NCT01955382|100789141|FG000|COMPLETED|Overall Study||35||
48190705|NCT01955382|100789142|FG001|COMPLETED|Overall Study||35||
48190706|NCT01955382|100789141|FG000|NOT COMPLETED|Overall Study||0||
48190707|NCT01955382|100789142|FG001|NOT COMPLETED|Overall Study||0||
48190708|NCT04672460|100789143|FG000|STARTED|Bioequivalence Phase: Period 1 (28 Days)||35||
48190709|NCT04672460|100789144|FG001|STARTED|Bioequivalence Phase: Period 1 (28 Days)||38||
48190710|NCT04672460|100789143|FG000|COMPLETED|Bioequivalence Phase: Period 1 (28 Days)||28||
48190711|NCT04672460|100789144|FG001|COMPLETED|Bioequivalence Phase: Period 1 (28 Days)||28||
48190712|NCT04672460|100789143|FG000|NOT COMPLETED|Bioequivalence Phase: Period 1 (28 Days)||7||
48190713|NCT04672460|100789144|FG001|NOT COMPLETED|Bioequivalence Phase: Period 1 (28 Days)||10||
48190714|NCT04672460|100789143|FG000|STARTED|Bioequivalence Phase: Period 2 (21 Days)||27||
48190715|NCT04672460|100789144|FG001|STARTED|Bioequivalence Phase: Period 2 (21 Days)||25||
48190716|NCT04672460|100789143|FG000|COMPLETED|Bioequivalence Phase: Period 2 (21 Days)||25||
48190717|NCT04672460|100789144|FG001|COMPLETED|Bioequivalence Phase: Period 2 (21 Days)||20||
48190718|NCT04672460|100789143|FG000|NOT COMPLETED|Bioequivalence Phase: Period 2 (21 Days)||2||
48190719|NCT04672460|100789144|FG001|NOT COMPLETED|Bioequivalence Phase: Period 2 (21 Days)||5||
48190720|NCT04672460|100789143|FG000|STARTED|Food Effect Phase: Period 3 (21 Days)||16||
48190721|NCT04672460|100789144|FG001|STARTED|Food Effect Phase: Period 3 (21 Days)||14||
48190722|NCT04672460|100789143|FG000|COMPLETED|Food Effect Phase: Period 3 (21 Days)||11||
48190723|NCT04672460|100789144|FG001|COMPLETED|Food Effect Phase: Period 3 (21 Days)||11||
48190724|NCT04672460|100789143|FG000|NOT COMPLETED|Food Effect Phase: Period 3 (21 Days)||5||
48190725|NCT04672460|100789144|FG001|NOT COMPLETED|Food Effect Phase: Period 3 (21 Days)||3||
48190726|NCT04672460|100789143|FG000|STARTED|Maintenance Phase: Period 4 (28 Days)||21||
48190727|NCT04672460|100789144|FG001|STARTED|Maintenance Phase: Period 4 (28 Days)||20||
48190728|NCT04672460|100789143|FG000|COMPLETED|Maintenance Phase: Period 4 (28 Days)||0||
48190729|NCT04672460|100789144|FG001|COMPLETED|Maintenance Phase: Period 4 (28 Days)||0||
48190730|NCT04672460|100789143|FG000|NOT COMPLETED|Maintenance Phase: Period 4 (28 Days)||21||
48190731|NCT04672460|100789144|FG001|NOT COMPLETED|Maintenance Phase: Period 4 (28 Days)||20||
48190732|NCT00519779|100789145|FG000|STARTED|Overall Study||34||
48190733|NCT00519779|100789146|FG001|STARTED|Overall Study||34||
48190734|NCT00519779|100789145|FG000|COMPLETED|Overall Study||34||
48190735|NCT00519779|100789146|FG001|COMPLETED|Overall Study||33||
48190736|NCT00519779|100789145|FG000|NOT COMPLETED|Overall Study||0||
48190737|NCT00519779|100789146|FG001|NOT COMPLETED|Overall Study||1||
48190738|NCT02022462|100789147|FG000|STARTED|Overall Study||76||
48190739|NCT02022462|100789148|FG001|STARTED|Overall Study||75||
48190740|NCT02022462|100789147|FG000|COMPLETED|Overall Study||53||
48190741|NCT02022462|100789148|FG001|COMPLETED|Overall Study||50||
48190742|NCT02022462|100789147|FG000|NOT COMPLETED|Overall Study||23||
48190743|NCT02022462|100789148|FG001|NOT COMPLETED|Overall Study||25||
48190744|NCT01244984|100789149|FG000|STARTED|Overall Study||60||
48190745|NCT01244984|100789150|FG001|STARTED|Overall Study||93||
48190746|NCT01244984|100789151|FG002|STARTED|Overall Study||90||
48190747|NCT01244984|100789149|FG000|COMPLETED|Overall Study||55||
48190748|NCT01244984|100789150|FG001|COMPLETED|Overall Study||79||
48190749|NCT01244984|100789151|FG002|COMPLETED|Overall Study||86||
48190750|NCT01244984|100789149|FG000|NOT COMPLETED|Overall Study||5||
48190751|NCT01244984|100789150|FG001|NOT COMPLETED|Overall Study||14||
48190752|NCT01244984|100789151|FG002|NOT COMPLETED|Overall Study||4||
48190753|NCT03850444|100789152|FG000|STARTED|Overall Study||128||
48190754|NCT03850444|100789153|FG001|STARTED|Overall Study||134||
48190755|NCT03850444|100789152|FG000|Treated|Overall Study||128||
48471682|NCT01025037|101492447|FG000|NOT COMPLETED|Overall Study||11||
48471683|NCT01134081|101492448|FG000|STARTED|Overall Study||44||
48471684|NCT01134081|101492448|FG000|COMPLETED|Overall Study||44||
48471685|NCT01134081|101492448|FG000|NOT COMPLETED|Overall Study||0||
48471686|NCT03106870|101492449|FG000|STARTED|Overall Study||31||
48471687|NCT03106870|101492450|FG001|STARTED|Overall Study||31||
48666153|NCT03552029|101967515|FG001|STARTED|Overall Study||6||
48666154|NCT03552029|101967514|FG000|COMPLETED|Overall Study||0||
48666155|NCT03552029|101967515|FG001|COMPLETED|Overall Study||0||
48666156|NCT03552029|101967514|FG000|NOT COMPLETED|Overall Study||4||
48666157|NCT03552029|101967515|FG001|NOT COMPLETED|Overall Study||6||
48666158|NCT01052779|101967516|FG000|STARTED|Overall Study||80||
48666159|NCT01052779|101967517|FG001|STARTED|Overall Study||82||
48666160|NCT01052779|101967516|FG000|Received at Least 1 Dose of Study Drug|Overall Study||80||
48666161|NCT01052779|101967517|FG001|Received at Least 1 Dose of Study Drug|Overall Study||81||
48666162|NCT01052779|101967516|FG000|COMPLETED|Overall Study||75||
48666163|NCT01052779|101967517|FG001|COMPLETED|Overall Study||73||
48666164|NCT01052779|101967516|FG000|NOT COMPLETED|Overall Study||5||
48666165|NCT01052779|101967517|FG001|NOT COMPLETED|Overall Study||9||
48666166|NCT02267447|101967518|FG000|STARTED|Overall Study||77251||
48666167|NCT02267447|101967519|FG001|STARTED|Overall Study||26968||
48666168|NCT02267447|101967518|FG000|COMPLETED|Overall Study||77251||
48666169|NCT02267447|101967519|FG001|COMPLETED|Overall Study||26968||
48666170|NCT02267447|101967518|FG000|NOT COMPLETED|Overall Study||0||
48666171|NCT02267447|101967519|FG001|NOT COMPLETED|Overall Study||0||
48666172|NCT00618787|101967520|FG000|STARTED|Overall Study||22||
48666173|NCT00618787|101967521|FG001|STARTED|Overall Study||23||
48666174|NCT00618787|101967520|FG000|COMPLETED|Overall Study||19||
48666175|NCT00618787|101967521|FG001|COMPLETED|Overall Study||21||
48666176|NCT00618787|101967520|FG000|NOT COMPLETED|Overall Study||3||
48666177|NCT00618787|101967521|FG001|NOT COMPLETED|Overall Study||2||
48666178|NCT00505687|101967522|FG000|STARTED|Overall Study||186||
48666179|NCT00505687|101967522|FG000|COMPLETED|Overall Study||91||
48666180|NCT00505687|101967522|FG000|NOT COMPLETED|Overall Study||95||
48666181|NCT01107496|101967523|FG000|STARTED|Overall Study||26|Subjects who were randomly assigned to one of two treatment groups (Randomized Population).|
48666182|NCT01107496|101967524|FG001|STARTED|Overall Study||26|Subjects who were randomly assigned to one of two treatment groups (Randomized Population).|
48666183|NCT01107496|101967523|FG000|Dosed|Overall Study||26|Subjects who were randomly assigned to one of two treatment groups and took at least one dose of study medication (Safety Population)|
48670065|NCT02626533|101974882|FG000|6 Weeks Post-op|Overall Study||162|Participants who were successfully contacted for 6 weeks post-operation follow up.|
48471688|NCT03106870|101492449|FG000|COMPLETED|Overall Study||31||
48471689|NCT03106870|101492450|FG001|COMPLETED|Overall Study||31||
48471690|NCT03106870|101492449|FG000|NOT COMPLETED|Overall Study||0||
48471691|NCT03106870|101492450|FG001|NOT COMPLETED|Overall Study||0||
48471692|NCT01586741|101492451|FG000|STARTED|Overall Study||28||
48471693|NCT01586741|101492452|FG001|STARTED|Overall Study||29||
48471694|NCT01586741|101492453|FG002|STARTED|Overall Study||32||
48471695|NCT01586741|101492451|FG000|COMPLETED|Overall Study||27||
48471696|NCT01586741|101492452|FG001|COMPLETED|Overall Study||29||
48471697|NCT01586741|101492453|FG002|COMPLETED|Overall Study||30||
48471698|NCT01586741|101492451|FG000|NOT COMPLETED|Overall Study||1||
48471699|NCT01586741|101492452|FG001|NOT COMPLETED|Overall Study||0||
48471700|NCT01586741|101492453|FG002|NOT COMPLETED|Overall Study||2||
48471701|NCT01104207|101492454|FG000|STARTED|Overall Study||35||
48471702|NCT01104207|101492455|FG001|STARTED|Overall Study||35||
48471703|NCT01104207|101492454|FG000|COMPLETED|Overall Study||32||
48471704|NCT01104207|101492455|FG001|COMPLETED|Overall Study||32||
48471705|NCT01104207|101492454|FG000|NOT COMPLETED|Overall Study||3||
48471706|NCT01104207|101492455|FG001|NOT COMPLETED|Overall Study||3||
48471707|NCT02888171|101492456|FG000|STARTED|Overall Study||30||
48471708|NCT02888171|101492457|FG001|STARTED|Overall Study||30||
48471709|NCT02888171|101492456|FG000|COMPLETED|Overall Study||25||
48471710|NCT02888171|101492457|FG001|COMPLETED|Overall Study||26||
48471711|NCT02888171|101492456|FG000|NOT COMPLETED|Overall Study||5||
48471712|NCT02888171|101492457|FG001|NOT COMPLETED|Overall Study||4||
48471713|NCT00449150|101492458|FG000|STARTED|Overall Study||219||
48471714|NCT00449150|101492459|FG001|STARTED|Overall Study||230||
48471715|NCT00449150|101492460|FG002|STARTED|Overall Study||218||
48471716|NCT00449150|101492458|FG000|COMPLETED|Overall Study||173||
48471717|NCT00449150|101492459|FG001|COMPLETED|Overall Study||177||
48471718|NCT00449150|101492460|FG002|COMPLETED|Overall Study||171||
48471719|NCT00449150|101492458|FG000|NOT COMPLETED|Overall Study||46||
48471720|NCT00449150|101492459|FG001|NOT COMPLETED|Overall Study||53||
48471721|NCT00449150|101492460|FG002|NOT COMPLETED|Overall Study||47||
48471722|NCT02327195|101492461|FG000|STARTED|Overall Study||27||
48471723|NCT02327195|101492462|FG001|STARTED|Overall Study||27||
48471724|NCT02327195|101492461|FG000|COMPLETED|Overall Study||27||
48471725|NCT02327195|101492462|FG001|COMPLETED|Overall Study||27||
48471726|NCT02327195|101492461|FG000|NOT COMPLETED|Overall Study||0||
48471727|NCT02327195|101492462|FG001|NOT COMPLETED|Overall Study||0||
48471728|NCT03125200|101492463|FG000|STARTED|Overall Study||2||
48471729|NCT03125200|101492464|FG001|STARTED|Overall Study||2||
48471730|NCT03125200|101492465|FG002|STARTED|Overall Study||2||
48471731|NCT03125200|101492466|FG003|STARTED|Overall Study||5||
48471732|NCT03125200|101492467|FG004|STARTED|Overall Study||4||
48471733|NCT03125200|101492468|FG005|STARTED|Overall Study||3||
48471734|NCT03125200|101492469|FG006|STARTED|Overall Study||3||
48471735|NCT03125200|101492463|FG000|COMPLETED|Overall Study||0||
48471736|NCT03125200|101492464|FG001|COMPLETED|Overall Study||0||
48471737|NCT03125200|101492465|FG002|COMPLETED|Overall Study||0||
48471738|NCT03125200|101492466|FG003|COMPLETED|Overall Study||0||
48471739|NCT03125200|101492467|FG004|COMPLETED|Overall Study||0||
48471740|NCT03125200|101492468|FG005|COMPLETED|Overall Study||0||
48471741|NCT03125200|101492469|FG006|COMPLETED|Overall Study||0||
48471742|NCT03125200|101492463|FG000|NOT COMPLETED|Overall Study||2||
48471743|NCT03125200|101492464|FG001|NOT COMPLETED|Overall Study||2||
48471744|NCT03125200|101492465|FG002|NOT COMPLETED|Overall Study||2||
48471745|NCT03125200|101492466|FG003|NOT COMPLETED|Overall Study||5||
48471746|NCT03125200|101492467|FG004|NOT COMPLETED|Overall Study||4||
48471747|NCT03125200|101492468|FG005|NOT COMPLETED|Overall Study||3||
48471748|NCT03125200|101492469|FG006|NOT COMPLETED|Overall Study||3||
48471749|NCT02567968|101492470|FG000|STARTED|First Intervention||4||
48471750|NCT02567968|101492471|FG001|STARTED|First Intervention||4||
48471751|NCT02567968|101492470|FG000|COMPLETED|First Intervention||4||
48471752|NCT02567968|101492471|FG001|COMPLETED|First Intervention||4||
48471753|NCT02567968|101492470|FG000|NOT COMPLETED|First Intervention||0||
48471754|NCT02567968|101492471|FG001|NOT COMPLETED|First Intervention||0||
48471755|NCT02567968|101492470|FG000|STARTED|Washout (2 Weeks)||4||
48471756|NCT02567968|101492471|FG001|STARTED|Washout (2 Weeks)||4||
48471757|NCT02567968|101492470|FG000|COMPLETED|Washout (2 Weeks)||4||
48471758|NCT02567968|101492471|FG001|COMPLETED|Washout (2 Weeks)||4||
48471759|NCT02567968|101492470|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
48471760|NCT02567968|101492471|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
48471761|NCT02567968|101492470|FG000|STARTED|Second Intervention||4||
48471762|NCT02567968|101492471|FG001|STARTED|Second Intervention||4||
48471763|NCT02567968|101492470|FG000|COMPLETED|Second Intervention||4||
48471764|NCT02567968|101492471|FG001|COMPLETED|Second Intervention||4||
48471765|NCT02567968|101492470|FG000|NOT COMPLETED|Second Intervention||0||
48471766|NCT02567968|101492471|FG001|NOT COMPLETED|Second Intervention||0||
48471767|NCT02946385|101492472|FG000|STARTED|Overall Study||126||
48471768|NCT02946385|101492473|FG001|STARTED|Overall Study||127||
48471769|NCT02946385|101492474|FG002|STARTED|Overall Study||99||
48471770|NCT02946385|101492475|FG003|STARTED|Overall Study||74||
48471771|NCT02946385|101492476|FG004|STARTED|Overall Study||101||
48471772|NCT02946385|101492477|FG005|STARTED|Overall Study||77||
48471773|NCT02946385|101492472|FG000|COMPLETED|Overall Study||126||
48471774|NCT02946385|101492473|FG001|COMPLETED|Overall Study||127||
48471775|NCT02946385|101492474|FG002|COMPLETED|Overall Study||96||
48471776|NCT02946385|101492475|FG003|COMPLETED|Overall Study||74||
48471777|NCT02946385|101492476|FG004|COMPLETED|Overall Study||99||
48471778|NCT02946385|101492477|FG005|COMPLETED|Overall Study||76||
48471779|NCT02946385|101492472|FG000|NOT COMPLETED|Overall Study||0||
48471780|NCT02946385|101492473|FG001|NOT COMPLETED|Overall Study||0||
48471781|NCT02946385|101492474|FG002|NOT COMPLETED|Overall Study||3||
48471782|NCT02946385|101492475|FG003|NOT COMPLETED|Overall Study||0||
48471783|NCT02946385|101492476|FG004|NOT COMPLETED|Overall Study||2||
48471784|NCT02946385|101492477|FG005|NOT COMPLETED|Overall Study||1||
48471785|NCT00582400|101492478|FG000|STARTED|Overall Study||9||
48471786|NCT00582400|101492478|FG000|COMPLETED|Overall Study||6||
48471787|NCT00582400|101492478|FG000|NOT COMPLETED|Overall Study||3||
48471788|NCT03679741|101492479|FG000|STARTED|Period 1||59||
48471789|NCT03679741|101492480|FG001|STARTED|Period 1||61||
48471790|NCT03679741|101492479|FG000|COMPLETED|Period 1||57||
48471791|NCT03679741|101492480|FG001|COMPLETED|Period 1||58||
48471792|NCT03679741|101492479|FG000|NOT COMPLETED|Period 1||2||
48471793|NCT03679741|101492480|FG001|NOT COMPLETED|Period 1||3||
48471794|NCT03679741|101492479|FG000|STARTED|Period 2||57||
48471795|NCT03679741|101492480|FG001|STARTED|Period 2||58||
48471796|NCT03679741|101492479|FG000|COMPLETED|Period 2||54||
48471797|NCT03679741|101492480|FG001|COMPLETED|Period 2||56||
48471798|NCT03679741|101492479|FG000|NOT COMPLETED|Period 2||3||
48471799|NCT03679741|101492480|FG001|NOT COMPLETED|Period 2||2||
48471800|NCT03679741|101492479|FG000|STARTED|Period 3||54||
48471801|NCT03679741|101492480|FG001|STARTED|Period 3||56||
48471802|NCT03679741|101492479|FG000|COMPLETED|Period 3||54||
48471803|NCT03679741|101492480|FG001|COMPLETED|Period 3||56||
48471804|NCT03679741|101492479|FG000|NOT COMPLETED|Period 3||0||
48471805|NCT03679741|101492480|FG001|NOT COMPLETED|Period 3||0||
48471806|NCT02134756|101492481|FG000|STARTED|Overall Study||15||
48471807|NCT02134756|101492482|FG001|STARTED|Overall Study||15||
48471808|NCT02134756|101492481|FG000|COMPLETED|Overall Study||14||
48471809|NCT02134756|101492482|FG001|COMPLETED|Overall Study||13||
48471810|NCT02134756|101492481|FG000|NOT COMPLETED|Overall Study||1||
48471811|NCT02134756|101492482|FG001|NOT COMPLETED|Overall Study||2||
48471812|NCT00543309|101492483|FG000|STARTED|Overall Study||35||
48471813|NCT00543309|101492484|FG001|STARTED|Overall Study||36||
48471814|NCT00543309|101492485|FG002|STARTED|Overall Study||35||
48471815|NCT00543309|101492483|FG000|COMPLETED|Overall Study||35||
48471816|NCT00543309|101492484|FG001|COMPLETED|Overall Study||35||
48471817|NCT00543309|101492485|FG002|COMPLETED|Overall Study||35||
48471818|NCT00543309|101492483|FG000|NOT COMPLETED|Overall Study||0||
48471819|NCT00543309|101492484|FG001|NOT COMPLETED|Overall Study||1||
48471820|NCT00543309|101492485|FG002|NOT COMPLETED|Overall Study||0||
48471821|NCT04637997|101492486|FG000|STARTED|Overall Study||9||
48471822|NCT04637997|101492487|FG001|STARTED|Overall Study||9||
48471823|NCT04637997|101492486|FG000|COMPLETED|Overall Study||9||
48471824|NCT04637997|101492487|FG001|COMPLETED|Overall Study||9||
48471825|NCT04637997|101492486|FG000|NOT COMPLETED|Overall Study||0||
48471826|NCT04637997|101492487|FG001|NOT COMPLETED|Overall Study||0||
48471827|NCT03561883|101492488|FG000|STARTED|Overall Study||305||
48471828|NCT03561883|101492489|FG001|STARTED|Overall Study||304||
48471829|NCT03561883|101492488|FG000|COMPLETED|Overall Study||259||
48471830|NCT03561883|101492489|FG001|COMPLETED|Overall Study||261||
48471831|NCT03561883|101492488|FG000|NOT COMPLETED|Overall Study||46||
48471832|NCT03561883|101492489|FG001|NOT COMPLETED|Overall Study||43||
48471833|NCT00401778|101492490|FG000|STARTED|Overall Study||10||
48471834|NCT00401778|101492491|FG001|STARTED|Overall Study||12||
48471835|NCT00401778|101492492|FG002|STARTED|Overall Study||11||
48471836|NCT00401778|101492490|FG000|COMPLETED|Overall Study||9||
48471837|NCT00401778|101492491|FG001|COMPLETED|Overall Study||11||
48471838|NCT00401778|101492492|FG002|COMPLETED|Overall Study||10||
48471839|NCT00401778|101492490|FG000|NOT COMPLETED|Overall Study||1||
48471840|NCT00401778|101492491|FG001|NOT COMPLETED|Overall Study||1||
48471841|NCT00401778|101492492|FG002|NOT COMPLETED|Overall Study||1||
48471842|NCT02026453|101492493|FG000|STARTED|Overall Study||101||
48471843|NCT02026453|101492494|FG001|STARTED|Overall Study||103||
48471844|NCT02026453|101492495|FG002|STARTED|Overall Study||102||
48471845|NCT02026453|101492493|FG000|COMPLETED|Overall Study||95||
48471846|NCT02026453|101492494|FG001|COMPLETED|Overall Study||94||
48471847|NCT02026453|101492495|FG002|COMPLETED|Overall Study||89||
48471848|NCT02026453|101492493|FG000|NOT COMPLETED|Overall Study||6||
48471849|NCT02026453|101492494|FG001|NOT COMPLETED|Overall Study||9||
48471850|NCT02026453|101492495|FG002|NOT COMPLETED|Overall Study||13||
48471851|NCT01526538|101492496|FG000|STARTED|Overall Study||30||
48471852|NCT01526538|101492497|FG001|STARTED|Overall Study||22||
48471853|NCT01526538|101492496|FG000|COMPLETED|Overall Study||21||
48471854|NCT01526538|101492497|FG001|COMPLETED|Overall Study||18||
48471855|NCT01526538|101492496|FG000|NOT COMPLETED|Overall Study||9||
48471856|NCT01526538|101492497|FG001|NOT COMPLETED|Overall Study||4||
48471857|NCT02070237|101492498|FG000|STARTED|Overall Study||45||
48471858|NCT02070237|101492499|FG001|STARTED|Overall Study||45||
48471859|NCT02070237|101492498|FG000|COMPLETED|Overall Study||42||
48471860|NCT02070237|101492499|FG001|COMPLETED|Overall Study||42||
48471861|NCT02070237|101492498|FG000|NOT COMPLETED|Overall Study||3||
48471862|NCT02070237|101492499|FG001|NOT COMPLETED|Overall Study||3||
48471863|NCT02270736|101492500|FG000|STARTED|Main Period (MP) (up to 16 Weeks)||72||
48471864|NCT02270736|101492501|FG001|STARTED|Main Period (MP) (up to 16 Weeks)||148||
48471865|NCT02270736|101492502|FG002|STARTED|Main Period (MP) (up to 16 Weeks)||36||
48471866|NCT02270736|101492503|FG003|STARTED|Main Period (MP) (up to 16 Weeks)||0||
48471867|NCT02270736|101492504|FG004|STARTED|Main Period (MP) (up to 16 Weeks)||0||
48471868|NCT02270736|101492500|FG000|Treated|Main Period (MP) (up to 16 Weeks)||72||
48471869|NCT02270736|101492501|FG001|Treated|Main Period (MP) (up to 16 Weeks)||148||
48471870|NCT02270736|101492502|FG002|Treated|Main Period (MP) (up to 16 Weeks)||35||
48471871|NCT02270736|101492503|FG003|Treated|Main Period (MP) (up to 16 Weeks)||0||
48471872|NCT02270736|101492504|FG004|Treated|Main Period (MP) (up to 16 Weeks)||0||
48471873|NCT02270736|101492500|FG000|COMPLETED|Main Period (MP) (up to 16 Weeks)||70||
48471874|NCT02270736|101492501|FG001|COMPLETED|Main Period (MP) (up to 16 Weeks)||146||
48471875|NCT02270736|101492502|FG002|COMPLETED|Main Period (MP) (up to 16 Weeks)||34||
48471876|NCT02270736|101492503|FG003|COMPLETED|Main Period (MP) (up to 16 Weeks)||0||
48471877|NCT02270736|101492504|FG004|COMPLETED|Main Period (MP) (up to 16 Weeks)||0||
48471878|NCT02270736|101492500|FG000|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||2||
48471879|NCT02270736|101492501|FG001|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||2||
48471880|NCT02270736|101492502|FG002|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||2||
48471881|NCT02270736|101492503|FG003|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||0||
48471882|NCT02270736|101492504|FG004|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||0||
48471883|NCT02270736|101492500|FG000|STARTED|OLEX Period (up to 48 Weeks)||0||
48471884|NCT02270736|101492501|FG001|STARTED|OLEX Period (up to 48 Weeks)||0||
48471885|NCT02270736|101492502|FG002|STARTED|OLEX Period (up to 48 Weeks)||0||
48471886|NCT02270736|101492503|FG003|STARTED|OLEX Period (up to 48 Weeks)||214||
48471887|NCT02270736|101492504|FG004|STARTED|OLEX Period (up to 48 Weeks)||33||
48471888|NCT02270736|101492500|FG000|COMPLETED|OLEX Period (up to 48 Weeks)||0||
48471889|NCT02270736|101492501|FG001|COMPLETED|OLEX Period (up to 48 Weeks)||0||
48471890|NCT02270736|101492502|FG002|COMPLETED|OLEX Period (up to 48 Weeks)||0||
48471891|NCT02270736|101492503|FG003|COMPLETED|OLEX Period (up to 48 Weeks)||189||
48190756|NCT03850444|100789153|FG001|Treated|Overall Study||125||
48190757|NCT03850444|100789152|FG000|Received Second Course of Pembrolizumab|Overall Study||5||
48190758|NCT03850444|100789153|FG001|Received Second Course of Pembrolizumab|Overall Study||0||
48471892|NCT02270736|101492504|FG004|COMPLETED|OLEX Period (up to 48 Weeks)||33||
48471893|NCT02270736|101492500|FG000|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0||
48471894|NCT02270736|101492501|FG001|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0||
48471895|NCT02270736|101492502|FG002|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0||
48471896|NCT02270736|101492503|FG003|NOT COMPLETED|OLEX Period (up to 48 Weeks)||25||
48471897|NCT02270736|101492504|FG004|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0||
48471898|NCT00577460|101492505|FG000|STARTED|Overall Study||129||
48471899|NCT00577460|101492506|FG001|STARTED|Overall Study||123||
48471900|NCT00577460|101492507|FG002|STARTED|Overall Study||139||
48471901|NCT00577460|101492505|FG000|COMPLETED|Overall Study||113||
48471902|NCT00577460|101492506|FG001|COMPLETED|Overall Study||104||
48471903|NCT00577460|101492507|FG002|COMPLETED|Overall Study||112||
48471904|NCT00577460|101492505|FG000|NOT COMPLETED|Overall Study||16||
48471905|NCT00577460|101492506|FG001|NOT COMPLETED|Overall Study||19||
48471906|NCT00577460|101492507|FG002|NOT COMPLETED|Overall Study||27||
48471907|NCT01755858|101492508|FG000|STARTED|Overall Study||7||
48471908|NCT01755858|101492509|FG001|STARTED|Overall Study||9||
48471909|NCT01755858|101492508|FG000|COMPLETED|Overall Study||6||
48471910|NCT01755858|101492509|FG001|COMPLETED|Overall Study||8||
48471911|NCT01755858|101492508|FG000|NOT COMPLETED|Overall Study||1||
48471912|NCT01755858|101492509|FG001|NOT COMPLETED|Overall Study||1||
48471913|NCT01574248|101492510|FG000|STARTED|Overall Study||15||
48471914|NCT01574248|101492511|FG001|STARTED|Overall Study||18||
48471915|NCT01574248|101492510|FG000|COMPLETED|Overall Study||12||
48471916|NCT01574248|101492511|FG001|COMPLETED|Overall Study||18||
48471917|NCT01574248|101492510|FG000|NOT COMPLETED|Overall Study||3||
48471918|NCT01574248|101492511|FG001|NOT COMPLETED|Overall Study||0||
48471919|NCT02655237|101492512|FG000|STARTED|Overall Study||139||
48471920|NCT02655237|101492513|FG001|STARTED|Overall Study||142||
48471921|NCT02655237|101492512|FG000|COMPLETED|Overall Study||122||
48471922|NCT02655237|101492513|FG001|COMPLETED|Overall Study||131||
48471923|NCT02655237|101492512|FG000|NOT COMPLETED|Overall Study||17||
48471924|NCT02655237|101492513|FG001|NOT COMPLETED|Overall Study||11||
48471925|NCT02863575|101492514|FG000|STARTED|Overall Study||161||
48471926|NCT02863575|101492515|FG001|STARTED|Overall Study||161||
48471927|NCT02863575|101492516|FG002|STARTED|Overall Study||52||
48471928|NCT02863575|101492514|FG000|COMPLETED|Overall Study||160||
48471929|NCT02863575|101492515|FG001|COMPLETED|Overall Study||159||
48471930|NCT02863575|101492516|FG002|COMPLETED|Overall Study||51||
48471931|NCT02863575|101492514|FG000|NOT COMPLETED|Overall Study||1||
48471932|NCT02863575|101492515|FG001|NOT COMPLETED|Overall Study||2||
48471933|NCT02863575|101492516|FG002|NOT COMPLETED|Overall Study||1||
48471934|NCT00950807|101492517|FG000|STARTED|Treatment Period 1||59||
48471935|NCT00950807|101492518|FG001|STARTED|Treatment Period 1||13||
48471936|NCT00950807|101492519|FG002|STARTED|Treatment Period 1||14||
48471937|NCT00950807|101492520|FG003|STARTED|Treatment Period 1||12||
48471938|NCT00950807|101492521|FG004|STARTED|Treatment Period 1||13||
48471939|NCT00950807|101492522|FG005|STARTED|Treatment Period 1||13||
48471940|NCT00950807|101492523|FG006|STARTED|Treatment Period 1||12||
48471941|NCT00950807|101492524|FG007|STARTED|Treatment Period 1||14||
48471942|NCT00950807|101492525|FG008|STARTED|Treatment Period 1||13||
48471943|NCT00950807|101492526|FG009|STARTED|Treatment Period 1||13||
48471944|NCT00950807|101492517|FG000|COMPLETED|Treatment Period 1||56||
48471945|NCT00950807|101492518|FG001|COMPLETED|Treatment Period 1||13||
48471946|NCT00950807|101492519|FG002|COMPLETED|Treatment Period 1||13||
48471947|NCT00950807|101492520|FG003|COMPLETED|Treatment Period 1||12||
48471948|NCT00950807|101492521|FG004|COMPLETED|Treatment Period 1||12||
48471949|NCT00950807|101492522|FG005|COMPLETED|Treatment Period 1||11||
48471950|NCT00950807|101492523|FG006|COMPLETED|Treatment Period 1||12||
48471951|NCT00950807|101492524|FG007|COMPLETED|Treatment Period 1||14||
48471952|NCT00950807|101492525|FG008|COMPLETED|Treatment Period 1||12||
48471953|NCT00950807|101492526|FG009|COMPLETED|Treatment Period 1||13||
48471954|NCT00950807|101492517|FG000|NOT COMPLETED|Treatment Period 1||3||
48471955|NCT00950807|101492518|FG001|NOT COMPLETED|Treatment Period 1||0||
48471956|NCT00950807|101492519|FG002|NOT COMPLETED|Treatment Period 1||1||
48471957|NCT00950807|101492520|FG003|NOT COMPLETED|Treatment Period 1||0||
48471958|NCT00950807|101492521|FG004|NOT COMPLETED|Treatment Period 1||1||
48471959|NCT00950807|101492522|FG005|NOT COMPLETED|Treatment Period 1||2||
48471960|NCT00950807|101492523|FG006|NOT COMPLETED|Treatment Period 1||0||
48471961|NCT00950807|101492524|FG007|NOT COMPLETED|Treatment Period 1||0||
48471962|NCT00950807|101492525|FG008|NOT COMPLETED|Treatment Period 1||1||
48471963|NCT00950807|101492526|FG009|NOT COMPLETED|Treatment Period 1||0||
48471964|NCT00950807|101492517|FG000|STARTED|Washout Period 1||56||
48471965|NCT00950807|101492518|FG001|STARTED|Washout Period 1||13||
48471966|NCT00950807|101492519|FG002|STARTED|Washout Period 1||13||
48471967|NCT00950807|101492520|FG003|STARTED|Washout Period 1||12||
48471968|NCT00950807|101492521|FG004|STARTED|Washout Period 1||12||
48471969|NCT00950807|101492522|FG005|STARTED|Washout Period 1||11||
48190759|NCT03850444|100789152|FG000|COMPLETED|Overall Study||0||
48190760|NCT03850444|100789153|FG001|COMPLETED|Overall Study||0||
48190761|NCT03850444|100789152|FG000|NOT COMPLETED|Overall Study||128||
48190762|NCT03850444|100789153|FG001|NOT COMPLETED|Overall Study||134||
48190763|NCT05027971|100789154|FG000|STARTED|Overall Study||105||
48190764|NCT05027971|100789155|FG001|STARTED|Overall Study||104||
48190765|NCT05027971|100789154|FG000|COMPLETED|Overall Study||97||
48190766|NCT05027971|100789155|FG001|COMPLETED|Overall Study||95||
48190767|NCT05027971|100789154|FG000|NOT COMPLETED|Overall Study||8||
48190768|NCT05027971|100789155|FG001|NOT COMPLETED|Overall Study||9||
48190769|NCT02321540|100789156|FG000|STARTED|Overall Study||3||
48190770|NCT02321540|100789157|FG001|STARTED|Overall Study||10||
48190771|NCT02321540|100789156|FG000|COMPLETED|Overall Study||0||
48190772|NCT02321540|100789157|FG001|COMPLETED|Overall Study||0||
48190773|NCT02321540|100789156|FG000|NOT COMPLETED|Overall Study||3||
48190774|NCT02321540|100789157|FG001|NOT COMPLETED|Overall Study||10||
48190775|NCT04550039|100789158|FG000|STARTED|Overall Study||7||
48190776|NCT04550039|100789159|FG001|STARTED|Overall Study||7||
48190777|NCT04550039|100789158|FG000|COMPLETED|Overall Study||5||
48190778|NCT04550039|100789159|FG001|COMPLETED|Overall Study||5||
48190779|NCT04550039|100789158|FG000|NOT COMPLETED|Overall Study||2||
48190780|NCT04550039|100789159|FG001|NOT COMPLETED|Overall Study||2||
48190781|NCT04341298|100789160|FG000|STARTED|Overall Study||38||
48190782|NCT04341298|100789161|FG001|STARTED|Overall Study||40||
48190783|NCT04341298|100789160|FG000|COMPLETED|Overall Study||38||
48190784|NCT04341298|100789161|FG001|COMPLETED|Overall Study||40||
48190785|NCT04341298|100789160|FG000|NOT COMPLETED|Overall Study||0||
48190786|NCT04341298|100789161|FG001|NOT COMPLETED|Overall Study||0||
48190787|NCT03246672|100789162|FG000|STARTED|Overall Study||30||
48190788|NCT03246672|100789162|FG000|Completed First Phone Call|Overall Study||29||
48190789|NCT03246672|100789162|FG000|COMPLETED|Overall Study||28||
48190790|NCT03246672|100789162|FG000|NOT COMPLETED|Overall Study||2||
48190791|NCT02939183|100789163|FG000|STARTED|Overall Study||5||
48190792|NCT02939183|100789164|FG001|STARTED|Overall Study||8||
48190793|NCT02939183|100789165|FG002|STARTED|Overall Study||3||
48471970|NCT00950807|101492523|FG006|STARTED|Washout Period 1||12||
48471971|NCT00950807|101492524|FG007|STARTED|Washout Period 1||14||
48471972|NCT00950807|101492525|FG008|STARTED|Washout Period 1||12||
48471973|NCT00950807|101492526|FG009|STARTED|Washout Period 1||13||
48471974|NCT00950807|101492517|FG000|COMPLETED|Washout Period 1||51||
48471975|NCT00950807|101492518|FG001|COMPLETED|Washout Period 1||13||
48471976|NCT00950807|101492519|FG002|COMPLETED|Washout Period 1||13||
48471977|NCT00950807|101492520|FG003|COMPLETED|Washout Period 1||11||
48471978|NCT00950807|101492521|FG004|COMPLETED|Washout Period 1||11||
48471979|NCT00950807|101492522|FG005|COMPLETED|Washout Period 1||11||
48471980|NCT00950807|101492523|FG006|COMPLETED|Washout Period 1||10||
48471981|NCT00950807|101492524|FG007|COMPLETED|Washout Period 1||13||
48471982|NCT00950807|101492525|FG008|COMPLETED|Washout Period 1||11||
48471983|NCT00950807|101492526|FG009|COMPLETED|Washout Period 1||13||
48471984|NCT00950807|101492517|FG000|NOT COMPLETED|Washout Period 1||5||
48471985|NCT00950807|101492518|FG001|NOT COMPLETED|Washout Period 1||0||
48471986|NCT00950807|101492519|FG002|NOT COMPLETED|Washout Period 1||0||
48471987|NCT00950807|101492520|FG003|NOT COMPLETED|Washout Period 1||1||
48471988|NCT00950807|101492521|FG004|NOT COMPLETED|Washout Period 1||1||
48471989|NCT00950807|101492522|FG005|NOT COMPLETED|Washout Period 1||0||
48471990|NCT00950807|101492523|FG006|NOT COMPLETED|Washout Period 1||2||
48471991|NCT00950807|101492524|FG007|NOT COMPLETED|Washout Period 1||1||
48471992|NCT00950807|101492525|FG008|NOT COMPLETED|Washout Period 1||1||
48471993|NCT00950807|101492526|FG009|NOT COMPLETED|Washout Period 1||0||
48471994|NCT00950807|101492517|FG000|STARTED|Treatment Period 2||53||
48471995|NCT00950807|101492518|FG001|STARTED|Treatment Period 2||13||
48471996|NCT00950807|101492519|FG002|STARTED|Treatment Period 2||10||
48471997|NCT00950807|101492520|FG003|STARTED|Treatment Period 2||13||
48471998|NCT00950807|101492521|FG004|STARTED|Treatment Period 2||13||
48471999|NCT00950807|101492522|FG005|STARTED|Treatment Period 2||10||
48472000|NCT00950807|101492523|FG006|STARTED|Treatment Period 2||10||
48472001|NCT00950807|101492524|FG007|STARTED|Treatment Period 2||13||
48472002|NCT00950807|101492525|FG008|STARTED|Treatment Period 2||11||
48472003|NCT00950807|101492526|FG009|STARTED|Treatment Period 2||11||
48472004|NCT00950807|101492517|FG000|COMPLETED|Treatment Period 2||51||
48472005|NCT00950807|101492518|FG001|COMPLETED|Treatment Period 2||12||
48472006|NCT00950807|101492519|FG002|COMPLETED|Treatment Period 2||10||
48472007|NCT00950807|101492520|FG003|COMPLETED|Treatment Period 2||12||
48472008|NCT00950807|101492521|FG004|COMPLETED|Treatment Period 2||13||
48472009|NCT00950807|101492522|FG005|COMPLETED|Treatment Period 2||9||
48472010|NCT00950807|101492523|FG006|COMPLETED|Treatment Period 2||9||
48472011|NCT00950807|101492524|FG007|COMPLETED|Treatment Period 2||10||
48472012|NCT00950807|101492525|FG008|COMPLETED|Treatment Period 2||11||
48472013|NCT00950807|101492526|FG009|COMPLETED|Treatment Period 2||11||
48472014|NCT00950807|101492517|FG000|NOT COMPLETED|Treatment Period 2||2||
48472015|NCT00950807|101492518|FG001|NOT COMPLETED|Treatment Period 2||1||
48472016|NCT00950807|101492519|FG002|NOT COMPLETED|Treatment Period 2||0||
48472017|NCT00950807|101492520|FG003|NOT COMPLETED|Treatment Period 2||1||
48472018|NCT00950807|101492521|FG004|NOT COMPLETED|Treatment Period 2||0||
48472019|NCT00950807|101492522|FG005|NOT COMPLETED|Treatment Period 2||1||
48472020|NCT00950807|101492523|FG006|NOT COMPLETED|Treatment Period 2||1||
48472021|NCT00950807|101492524|FG007|NOT COMPLETED|Treatment Period 2||3||
48472022|NCT00950807|101492525|FG008|NOT COMPLETED|Treatment Period 2||0||
48472023|NCT00950807|101492526|FG009|NOT COMPLETED|Treatment Period 2||0||
48472024|NCT00950807|101492517|FG000|STARTED|Washout Period 2||51||
48472025|NCT00950807|101492518|FG001|STARTED|Washout Period 2||12||
48472026|NCT00950807|101492519|FG002|STARTED|Washout Period 2||10||
48472027|NCT00950807|101492520|FG003|STARTED|Washout Period 2||12||
48472028|NCT00950807|101492521|FG004|STARTED|Washout Period 2||13||
48472029|NCT00950807|101492522|FG005|STARTED|Washout Period 2||9||
48472030|NCT00950807|101492523|FG006|STARTED|Washout Period 2||9||
48472031|NCT00950807|101492524|FG007|STARTED|Washout Period 2||10||
48472032|NCT00950807|101492525|FG008|STARTED|Washout Period 2||11||
48472033|NCT00950807|101492526|FG009|STARTED|Washout Period 2||11||
48472034|NCT00950807|101492517|FG000|COMPLETED|Washout Period 2||47||
48472035|NCT00950807|101492518|FG001|COMPLETED|Washout Period 2||11||
48472036|NCT00950807|101492519|FG002|COMPLETED|Washout Period 2||10||
48472037|NCT00950807|101492520|FG003|COMPLETED|Washout Period 2||11||
48472038|NCT00950807|101492521|FG004|COMPLETED|Washout Period 2||12||
48472039|NCT00950807|101492522|FG005|COMPLETED|Washout Period 2||9||
48472040|NCT00950807|101492523|FG006|COMPLETED|Washout Period 2||8||
48472041|NCT00950807|101492524|FG007|COMPLETED|Washout Period 2||9||
48472042|NCT00950807|101492525|FG008|COMPLETED|Washout Period 2||11||
48190794|NCT02939183|100789166|FG003|STARTED|Overall Study||5||
48190795|NCT02939183|100789167|FG004|STARTED|Overall Study||9||
48190796|NCT02939183|100789168|FG005|STARTED|Overall Study||5||
48472043|NCT00950807|101492526|FG009|COMPLETED|Washout Period 2||11||
48472044|NCT00950807|101492517|FG000|NOT COMPLETED|Washout Period 2||4||
48472045|NCT00950807|101492518|FG001|NOT COMPLETED|Washout Period 2||1||
48472046|NCT00950807|101492519|FG002|NOT COMPLETED|Washout Period 2||0||
48472047|NCT00950807|101492520|FG003|NOT COMPLETED|Washout Period 2||1||
48472048|NCT00950807|101492521|FG004|NOT COMPLETED|Washout Period 2||1||
48472049|NCT00950807|101492522|FG005|NOT COMPLETED|Washout Period 2||0||
48472050|NCT00950807|101492523|FG006|NOT COMPLETED|Washout Period 2||1||
48472051|NCT00950807|101492524|FG007|NOT COMPLETED|Washout Period 2||1||
48472052|NCT00950807|101492525|FG008|NOT COMPLETED|Washout Period 2||0||
48472053|NCT00950807|101492526|FG009|NOT COMPLETED|Washout Period 2||0||
48472054|NCT00950807|101492517|FG000|STARTED|Treatment Period 3||46||
48472055|NCT00950807|101492518|FG001|STARTED|Treatment Period 3||9||
48472056|NCT00950807|101492519|FG002|STARTED|Treatment Period 3||10||
48472057|NCT00950807|101492520|FG003|STARTED|Treatment Period 3||11||
48472058|NCT00950807|101492521|FG004|STARTED|Treatment Period 3||12||
48472059|NCT00950807|101492522|FG005|STARTED|Treatment Period 3||9||
48472060|NCT00950807|101492523|FG006|STARTED|Treatment Period 3||12||
48472061|NCT00950807|101492524|FG007|STARTED|Treatment Period 3||10||
48472062|NCT00950807|101492525|FG008|STARTED|Treatment Period 3||9||
48472063|NCT00950807|101492526|FG009|STARTED|Treatment Period 3||11||
48472064|NCT00950807|101492517|FG000|COMPLETED|Treatment Period 3||45||
48472065|NCT00950807|101492518|FG001|COMPLETED|Treatment Period 3||9||
48472066|NCT00950807|101492519|FG002|COMPLETED|Treatment Period 3||10||
48472067|NCT00950807|101492520|FG003|COMPLETED|Treatment Period 3||11||
48472068|NCT00950807|101492521|FG004|COMPLETED|Treatment Period 3||12||
48472069|NCT00950807|101492522|FG005|COMPLETED|Treatment Period 3||9||
48472070|NCT00950807|101492523|FG006|COMPLETED|Treatment Period 3||11||
48472071|NCT00950807|101492524|FG007|COMPLETED|Treatment Period 3||9||
48472072|NCT00950807|101492525|FG008|COMPLETED|Treatment Period 3||9||
48472073|NCT00950807|101492526|FG009|COMPLETED|Treatment Period 3||10||
48472074|NCT00950807|101492517|FG000|NOT COMPLETED|Treatment Period 3||1||
48472075|NCT00950807|101492518|FG001|NOT COMPLETED|Treatment Period 3||0||
48472076|NCT00950807|101492519|FG002|NOT COMPLETED|Treatment Period 3||0||
48472077|NCT00950807|101492520|FG003|NOT COMPLETED|Treatment Period 3||0||
48472078|NCT00950807|101492521|FG004|NOT COMPLETED|Treatment Period 3||0||
48472079|NCT00950807|101492522|FG005|NOT COMPLETED|Treatment Period 3||0||
48472080|NCT00950807|101492523|FG006|NOT COMPLETED|Treatment Period 3||1||
48472081|NCT00950807|101492524|FG007|NOT COMPLETED|Treatment Period 3||1||
48472082|NCT00950807|101492525|FG008|NOT COMPLETED|Treatment Period 3||0||
48472083|NCT00950807|101492526|FG009|NOT COMPLETED|Treatment Period 3||1||
48472084|NCT01111110|101492527|FG000|STARTED|Overall Study||3||
48472085|NCT01111110|101492528|FG001|STARTED|Overall Study||4||
48472086|NCT01111110|101492527|FG000|COMPLETED|Overall Study||3||
48472087|NCT01111110|101492528|FG001|COMPLETED|Overall Study||4||
48472088|NCT01111110|101492527|FG000|NOT COMPLETED|Overall Study||0||
48472089|NCT01111110|101492528|FG001|NOT COMPLETED|Overall Study||0||
48472090|NCT01042366|101492529|FG000|STARTED|Overall Study||5||
48472091|NCT01042366|101492530|FG001|STARTED|Overall Study||6||
48472092|NCT01042366|101492531|FG002|STARTED|Overall Study||4||
48472093|NCT01042366|101492529|FG000|COMPLETED|Overall Study||5||
48472094|NCT01042366|101492530|FG001|COMPLETED|Overall Study||6||
48472095|NCT01042366|101492531|FG002|COMPLETED|Overall Study||4||
48472096|NCT01042366|101492529|FG000|NOT COMPLETED|Overall Study||0||
48472097|NCT01042366|101492530|FG001|NOT COMPLETED|Overall Study||0||
48472098|NCT01042366|101492531|FG002|NOT COMPLETED|Overall Study||0||
48472099|NCT00724568|101492532|FG000|STARTED|Overall Study||42||
48472100|NCT00724568|101492533|FG001|STARTED|Overall Study||32||
48472101|NCT00724568|101492532|FG000|COMPLETED|Overall Study||42||
48472102|NCT00724568|101492533|FG001|COMPLETED|Overall Study||32||
48472103|NCT00724568|101492532|FG000|NOT COMPLETED|Overall Study||0||
48472104|NCT00724568|101492533|FG001|NOT COMPLETED|Overall Study||0||
48472105|NCT00067236|101492534|FG000|STARTED|Overall Study||128||
48472106|NCT00067236|101492535|FG001|STARTED|Overall Study||125||
48472107|NCT00067236|101492534|FG000|COMPLETED|Overall Study||108||
48472108|NCT00067236|101492535|FG001|COMPLETED|Overall Study||99||
48472109|NCT00067236|101492534|FG000|NOT COMPLETED|Overall Study||20||
48472110|NCT00067236|101492535|FG001|NOT COMPLETED|Overall Study||26||
48472111|NCT04189848|101492536|FG000|STARTED|Treatment Period 1 (Day 1)||26||
48472112|NCT04189848|101492537|FG001|STARTED|Treatment Period 1 (Day 1)||26||
48472113|NCT04189848|101492538|FG002|STARTED|Treatment Period 1 (Day 1)||25||
48472114|NCT04189848|101492539|FG003|STARTED|Treatment Period 1 (Day 1)||27||
48472115|NCT04189848|101492536|FG000|COMPLETED|Treatment Period 1 (Day 1)||26||
48472116|NCT04189848|101492537|FG001|COMPLETED|Treatment Period 1 (Day 1)||26||
48472117|NCT04189848|101492538|FG002|COMPLETED|Treatment Period 1 (Day 1)||25||
48472118|NCT04189848|101492539|FG003|COMPLETED|Treatment Period 1 (Day 1)||27||
48472119|NCT04189848|101492536|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48190797|NCT02939183|100789169|FG006|STARTED|Overall Study||11||
48190798|NCT02939183|100789170|FG007|STARTED|Overall Study||8||
48190799|NCT02939183|100789171|FG008|STARTED|Overall Study||7||
48190800|NCT02939183|100789163|FG000|Received Oprozomib|Overall Study||5||
48190801|NCT02939183|100789164|FG001|Received Oprozomib|Overall Study||8||
48370710|NCT03952559|101234941|FG001|COMPLETED|Double Blind Treatment Period||115||
48472120|NCT04189848|101492537|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48472121|NCT04189848|101492538|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48370711|NCT03952559|101234942|FG002|COMPLETED|Double Blind Treatment Period||116||
48370712|NCT03952559|101234943|FG003|COMPLETED|Double Blind Treatment Period||117||
48370713|NCT03952559|101234944|FG004|COMPLETED|Double Blind Treatment Period||119||
48370714|NCT03952559|101234940|FG000|NOT COMPLETED|Double Blind Treatment Period||0||
48370715|NCT03952559|101234941|FG001|NOT COMPLETED|Double Blind Treatment Period||7||
48370716|NCT03952559|101234942|FG002|NOT COMPLETED|Double Blind Treatment Period||5||
48370717|NCT03952559|101234943|FG003|NOT COMPLETED|Double Blind Treatment Period||3||
48370718|NCT03952559|101234944|FG004|NOT COMPLETED|Double Blind Treatment Period||1||
48370719|NCT03052608|101234945|FG000|STARTED|Treatment Phase||149||
48370720|NCT03052608|101234946|FG001|STARTED|Treatment Phase||147||
48370721|NCT03052608|101234945|FG000|COMPLETED|Treatment Phase||26|"Completed refers to participants with confirmed RECIST version 1.1 defined disease progression assessed by the blinded independent central review or investigator."|
48472122|NCT04189848|101492539|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
48190802|NCT02939183|100789165|FG002|Received Oprozomib|Overall Study||3||
48472123|NCT04189848|101492536|FG000|STARTED|Treatment Period 2 (Day 1)||26||
48472124|NCT04189848|101492537|FG001|STARTED|Treatment Period 2 (Day 1)||26||
48472125|NCT04189848|101492538|FG002|STARTED|Treatment Period 2 (Day 1)||25||
48472126|NCT04189848|101492539|FG003|STARTED|Treatment Period 2 (Day 1)||27||
48472127|NCT04189848|101492536|FG000|COMPLETED|Treatment Period 2 (Day 1)||26||
48472128|NCT04189848|101492537|FG001|COMPLETED|Treatment Period 2 (Day 1)||26||
48472129|NCT04189848|101492538|FG002|COMPLETED|Treatment Period 2 (Day 1)||25||
48472130|NCT04189848|101492539|FG003|COMPLETED|Treatment Period 2 (Day 1)||27||
48190803|NCT02939183|100789166|FG003|Received Oprozomib|Overall Study||4||
48190804|NCT02939183|100789167|FG004|Received Oprozomib|Overall Study||9||
48472131|NCT04189848|101492536|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
48472132|NCT04189848|101492537|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
48472133|NCT04189848|101492538|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
48190805|NCT02939183|100789168|FG005|Received Oprozomib|Overall Study||5||
48472134|NCT04189848|101492539|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
48190806|NCT02939183|100789169|FG006|Received Oprozomib|Overall Study||10||
48190807|NCT02939183|100789170|FG007|Received Oprozomib|Overall Study||8||
48472135|NCT04558554|101492540|FG000|STARTED|Overall Study||287||
48472136|NCT04558554|101492541|FG001|STARTED|Overall Study||106||
48190808|NCT02939183|100789171|FG008|Received Oprozomib|Overall Study||7||
48472137|NCT04558554|101492542|FG002|STARTED|Overall Study||823||
48472138|NCT04558554|101492540|FG000|COMPLETED|Overall Study||287||
48472139|NCT04558554|101492541|FG001|COMPLETED|Overall Study||106||
48472140|NCT04558554|101492542|FG002|COMPLETED|Overall Study||823||
48472141|NCT04558554|101492540|FG000|NOT COMPLETED|Overall Study||0||
48472142|NCT04558554|101492541|FG001|NOT COMPLETED|Overall Study||0||
48472143|NCT04558554|101492542|FG002|NOT COMPLETED|Overall Study||0||
48472144|NCT03552757|101492543|FG000|STARTED|Overall Study||403||
48472145|NCT03552757|101492544|FG001|STARTED|Overall Study||404||
48472146|NCT03552757|101492545|FG002|STARTED|Overall Study||403||
48472147|NCT03552757|101492543|FG000|Exposed|Overall Study||402||
48472148|NCT03552757|101492544|FG001|Exposed|Overall Study||403||
48472149|NCT03552757|101492545|FG002|Exposed|Overall Study||402||
48472150|NCT03552757|101492543|FG000|Full Analysis Set (FAS)|Overall Study||403||
48472151|NCT03552757|101492544|FG001|Full Analysis Set (FAS)|Overall Study||404||
48472152|NCT03552757|101492545|FG002|Full Analysis Set (FAS)|Overall Study||403||
48472153|NCT03552757|101492543|FG000|Safety Analysis Set (SAS)|Overall Study||402||
48472154|NCT03552757|101492544|FG001|Safety Analysis Set (SAS)|Overall Study||403||
48472155|NCT03552757|101492545|FG002|Safety Analysis Set (SAS)|Overall Study||402||
48472156|NCT03552757|101492543|FG000|COMPLETED|Overall Study||390||
48472157|NCT03552757|101492544|FG001|COMPLETED|Overall Study||391||
48472158|NCT03552757|101492545|FG002|COMPLETED|Overall Study||383||
48472159|NCT03552757|101492543|FG000|NOT COMPLETED|Overall Study||13||
48472160|NCT03552757|101492544|FG001|NOT COMPLETED|Overall Study||13||
48472161|NCT03552757|101492545|FG002|NOT COMPLETED|Overall Study||20||
48472162|NCT03500484|101492546|FG000|STARTED|Overall Study||8||
48472163|NCT03500484|101492547|FG001|STARTED|Overall Study||5||
48472164|NCT03500484|101492546|FG000|COMPLETED|Overall Study||4||
48472165|NCT03500484|101492547|FG001|COMPLETED|Overall Study||5||
48472166|NCT03500484|101492546|FG000|NOT COMPLETED|Overall Study||4||
48472167|NCT03500484|101492547|FG001|NOT COMPLETED|Overall Study||0||
48472168|NCT00421174|101492548|FG000|STARTED|Overall Study||18||
48190809|NCT02939183|100789163|FG000|COMPLETED|Overall Study||5||
48472169|NCT00421174|101492549|FG001|STARTED|Overall Study||19||
48472170|NCT00421174|101492548|FG000|COMPLETED|Overall Study||16||
48472171|NCT00421174|101492549|FG001|COMPLETED|Overall Study||18||
48472172|NCT00421174|101492548|FG000|NOT COMPLETED|Overall Study||2||
48472173|NCT00421174|101492549|FG001|NOT COMPLETED|Overall Study||1||
48472174|NCT00175019|101492550|FG000|STARTED|Overall Study||606||
48472175|NCT00175019|101492551|FG001|STARTED|Overall Study||388||
48472176|NCT00175019|101492552|FG002|STARTED|Overall Study||92||
48472177|NCT00175019|101492550|FG000|COMPLETED|Overall Study||412||
48190810|NCT02939183|100789164|FG001|COMPLETED|Overall Study||5||
48472178|NCT00175019|101492551|FG001|COMPLETED|Overall Study||217||
48472179|NCT00175019|101492552|FG002|COMPLETED|Overall Study||35||
48472180|NCT00175019|101492550|FG000|NOT COMPLETED|Overall Study||194||
48472181|NCT00175019|101492551|FG001|NOT COMPLETED|Overall Study||171||
48472182|NCT00175019|101492552|FG002|NOT COMPLETED|Overall Study||57||
48472183|NCT03655106|101492553|FG000|STARTED|Overall Study||135||
48472184|NCT03655106|101492554|FG001|STARTED|Overall Study||135||
48472185|NCT03655106|101492553|FG000|COMPLETED|Overall Study||126||
48472186|NCT03655106|101492554|FG001|COMPLETED|Overall Study||131||
48472187|NCT03655106|101492553|FG000|NOT COMPLETED|Overall Study||9||
48472188|NCT03655106|101492554|FG001|NOT COMPLETED|Overall Study||4||
48472189|NCT00576381|101492555|FG000|STARTED|Overall Study||30||
48472190|NCT00576381|101492555|FG000|COMPLETED|Overall Study||23||
48472191|NCT00576381|101492555|FG000|NOT COMPLETED|Overall Study||7||
48472192|NCT01315249|101492556|FG000|STARTED|Overall Study||259||
48472193|NCT01315249|101492557|FG001|STARTED|Overall Study||264||
48472194|NCT01315249|101492556|FG000|COMPLETED|Overall Study||215||
48472195|NCT01315249|101492557|FG001|COMPLETED|Overall Study||217||
48472196|NCT01315249|101492556|FG000|NOT COMPLETED|Overall Study||44||
48472197|NCT01315249|101492557|FG001|NOT COMPLETED|Overall Study||47||
48472198|NCT01089647|101492558|FG000|STARTED|Overall Study||17||
48472199|NCT01089647|101492559|FG001|STARTED|Overall Study||17||
48472200|NCT01089647|101492558|FG000|COMPLETED|Overall Study||13||
48472201|NCT01089647|101492559|FG001|COMPLETED|Overall Study||13||
48472202|NCT01089647|101492558|FG000|NOT COMPLETED|Overall Study||4||
48472203|NCT01089647|101492559|FG001|NOT COMPLETED|Overall Study||4||
48472204|NCT00600925|101492560|FG000|STARTED|Overall Study||300||
48472205|NCT00600925|101492561|FG001|STARTED|Overall Study||302||
48472206|NCT00600925|101492560|FG000|COMPLETED|Overall Study||300||
48472207|NCT00600925|101492561|FG001|COMPLETED|Overall Study||302||
48472208|NCT00600925|101492560|FG000|NOT COMPLETED|Overall Study||0||
48472209|NCT00600925|101492561|FG001|NOT COMPLETED|Overall Study||0||
48472210|NCT01163760|101492562|FG000|STARTED|Period 1 (Fit)||12||
48472211|NCT01163760|101492563|FG001|STARTED|Period 1 (Fit)||13||
48472212|NCT01163760|101492564|FG002|STARTED|Period 1 (Fit)||13||
48472213|NCT01163760|101492565|FG003|STARTED|Period 1 (Fit)||12||
48472214|NCT01163760|101492562|FG000|COMPLETED|Period 1 (Fit)||12||
48472215|NCT01163760|101492563|FG001|COMPLETED|Period 1 (Fit)||13||
48472216|NCT01163760|101492564|FG002|COMPLETED|Period 1 (Fit)||13||
48472217|NCT01163760|101492565|FG003|COMPLETED|Period 1 (Fit)||12||
48472218|NCT01163760|101492562|FG000|NOT COMPLETED|Period 1 (Fit)||0||
48472219|NCT01163760|101492563|FG001|NOT COMPLETED|Period 1 (Fit)||0||
48472220|NCT01163760|101492564|FG002|NOT COMPLETED|Period 1 (Fit)||0||
48472221|NCT01163760|101492565|FG003|NOT COMPLETED|Period 1 (Fit)||0||
48472222|NCT01163760|101492562|FG000|STARTED|Period 2 (Follow-up)||12||
48472223|NCT01163760|101492563|FG001|STARTED|Period 2 (Follow-up)||13||
48472224|NCT01163760|101492564|FG002|STARTED|Period 2 (Follow-up)||13||
48472225|NCT01163760|101492565|FG003|STARTED|Period 2 (Follow-up)||12||
48472226|NCT01163760|101492562|FG000|COMPLETED|Period 2 (Follow-up)||12||
48472227|NCT01163760|101492563|FG001|COMPLETED|Period 2 (Follow-up)||13||
48472228|NCT01163760|101492564|FG002|COMPLETED|Period 2 (Follow-up)||13||
48472229|NCT01163760|101492565|FG003|COMPLETED|Period 2 (Follow-up)||12||
48472230|NCT01163760|101492562|FG000|NOT COMPLETED|Period 2 (Follow-up)||0||
48472231|NCT01163760|101492563|FG001|NOT COMPLETED|Period 2 (Follow-up)||0||
48472232|NCT01163760|101492564|FG002|NOT COMPLETED|Period 2 (Follow-up)||0||
48472233|NCT01163760|101492565|FG003|NOT COMPLETED|Period 2 (Follow-up)||0||
48472234|NCT01163760|101492562|FG000|STARTED|Period 3 (Fit)||12||
48472235|NCT01163760|101492563|FG001|STARTED|Period 3 (Fit)||13||
48472236|NCT01163760|101492564|FG002|STARTED|Period 3 (Fit)||13||
48472237|NCT01163760|101492565|FG003|STARTED|Period 3 (Fit)||12||
48472238|NCT01163760|101492562|FG000|COMPLETED|Period 3 (Fit)||12||
48472239|NCT01163760|101492563|FG001|COMPLETED|Period 3 (Fit)||13||
48472240|NCT01163760|101492564|FG002|COMPLETED|Period 3 (Fit)||13||
48472241|NCT01163760|101492565|FG003|COMPLETED|Period 3 (Fit)||12||
48472242|NCT01163760|101492562|FG000|NOT COMPLETED|Period 3 (Fit)||0||
48472243|NCT01163760|101492563|FG001|NOT COMPLETED|Period 3 (Fit)||0||
48472244|NCT01163760|101492564|FG002|NOT COMPLETED|Period 3 (Fit)||0||
48472245|NCT01163760|101492565|FG003|NOT COMPLETED|Period 3 (Fit)||0||
48472246|NCT01163760|101492562|FG000|STARTED|Period 4 (Follow-up)||12||
48472247|NCT01163760|101492563|FG001|STARTED|Period 4 (Follow-up)||13||
48472248|NCT01163760|101492564|FG002|STARTED|Period 4 (Follow-up)||13||
48472249|NCT01163760|101492565|FG003|STARTED|Period 4 (Follow-up)||12||
48472250|NCT01163760|101492562|FG000|COMPLETED|Period 4 (Follow-up)||12||
48472251|NCT01163760|101492563|FG001|COMPLETED|Period 4 (Follow-up)||13||
48472252|NCT01163760|101492564|FG002|COMPLETED|Period 4 (Follow-up)||13||
48472253|NCT01163760|101492565|FG003|COMPLETED|Period 4 (Follow-up)||12||
48472254|NCT01163760|101492562|FG000|NOT COMPLETED|Period 4 (Follow-up)||0||
48472255|NCT01163760|101492563|FG001|NOT COMPLETED|Period 4 (Follow-up)||0||
48472256|NCT01163760|101492564|FG002|NOT COMPLETED|Period 4 (Follow-up)||0||
48472257|NCT01163760|101492565|FG003|NOT COMPLETED|Period 4 (Follow-up)||0||
48472258|NCT03118466|101492566|FG000|STARTED|Overall Study||40||
48472259|NCT03118466|101492566|FG000|COMPLETED|Overall Study||40||
48472260|NCT03118466|101492566|FG000|NOT COMPLETED|Overall Study||0||
48472261|NCT02606500|101492567|FG000|STARTED|Overall Study||35||
48472262|NCT02606500|101492568|FG001|STARTED|Overall Study||35||
48472263|NCT02606500|101492567|FG000|COMPLETED|Overall Study||35||
48472264|NCT02606500|101492568|FG001|COMPLETED|Overall Study||35||
48472265|NCT02606500|101492567|FG000|NOT COMPLETED|Overall Study||0||
48472266|NCT02606500|101492568|FG001|NOT COMPLETED|Overall Study||0||
48472267|NCT02603952|101492569|FG000|STARTED|Overall Study||32||
48472268|NCT02603952|101492570|FG001|STARTED|Overall Study||31||
48472269|NCT02603952|101492571|FG002|STARTED|Overall Study||31||
48472270|NCT02603952|101492572|FG003|STARTED|Overall Study||32||
48472271|NCT02603952|101492569|FG000|Treated|Overall Study||32||
48472272|NCT02603952|101492570|FG001|Treated|Overall Study||31||
48472273|NCT02603952|101492571|FG002|Treated|Overall Study||31||
48472274|NCT02603952|101492572|FG003|Treated|Overall Study||31||
48472275|NCT02603952|101492569|FG000|COMPLETED|Overall Study||31||
48190811|NCT02939183|100789165|FG002|COMPLETED|Overall Study||2||
48190812|NCT02939183|100789166|FG003|COMPLETED|Overall Study||2||
48190813|NCT02939183|100789167|FG004|COMPLETED|Overall Study||7||
48190814|NCT02939183|100789168|FG005|COMPLETED|Overall Study||3||
48190815|NCT02939183|100789169|FG006|COMPLETED|Overall Study||4||
48190816|NCT02939183|100789170|FG007|COMPLETED|Overall Study||5||
48190817|NCT02939183|100789171|FG008|COMPLETED|Overall Study||1||
48472276|NCT02603952|101492570|FG001|COMPLETED|Overall Study||31||
48472277|NCT02603952|101492571|FG002|COMPLETED|Overall Study||31||
48472278|NCT02603952|101492572|FG003|COMPLETED|Overall Study||31||
48190818|NCT02939183|100789163|FG000|NOT COMPLETED|Overall Study||0||
48190819|NCT02939183|100789164|FG001|NOT COMPLETED|Overall Study||3||
48190820|NCT02939183|100789165|FG002|NOT COMPLETED|Overall Study||1||
48190821|NCT02939183|100789166|FG003|NOT COMPLETED|Overall Study||3||
48190822|NCT02939183|100789167|FG004|NOT COMPLETED|Overall Study||2||
48190823|NCT02939183|100789168|FG005|NOT COMPLETED|Overall Study||2||
48190824|NCT02939183|100789169|FG006|NOT COMPLETED|Overall Study||7||
48190825|NCT02939183|100789170|FG007|NOT COMPLETED|Overall Study||3||
48190826|NCT02939183|100789171|FG008|NOT COMPLETED|Overall Study||6||
48472279|NCT02603952|101492569|FG000|NOT COMPLETED|Overall Study||1||
48472280|NCT02603952|101492570|FG001|NOT COMPLETED|Overall Study||0||
48472281|NCT02603952|101492571|FG002|NOT COMPLETED|Overall Study||0||
48472282|NCT02603952|101492572|FG003|NOT COMPLETED|Overall Study||1||
48472283|NCT01506947|101492573|FG000|STARTED|Overall Study||65||
48472284|NCT01506947|101492573|FG000|COMPLETED|Overall Study||49||
48472285|NCT01506947|101492573|FG000|NOT COMPLETED|Overall Study||16||
48472286|NCT03331042|101492574|FG000|STARTED|Overall Study||22||
48472287|NCT03331042|101492575|FG001|STARTED|Overall Study||21||
48472288|NCT03331042|101492576|FG002|STARTED|Overall Study||21||
48190827|NCT02926937|100789172|FG000|STARTED|Overall Study||150||
48190828|NCT02926937|100789173|FG001|STARTED|Overall Study||142||
48190829|NCT02926937|100789174|FG002|STARTED|Overall Study||107||
48190830|NCT02926937|100789172|FG000|COMPLETED|Overall Study||131||
48472289|NCT03331042|101492577|FG003|STARTED|Overall Study||21||
48190831|NCT02926937|100789173|FG001|COMPLETED|Overall Study||127||
48190832|NCT02926937|100789174|FG002|COMPLETED|Overall Study||96||
48190833|NCT02926937|100789172|FG000|NOT COMPLETED|Overall Study||19||
48190834|NCT02926937|100789173|FG001|NOT COMPLETED|Overall Study||15||
48472290|NCT03331042|101492574|FG000|COMPLETED|Overall Study||21||
48472291|NCT03331042|101492575|FG001|COMPLETED|Overall Study||21||
48472292|NCT03331042|101492576|FG002|COMPLETED|Overall Study||20||
48472293|NCT03331042|101492577|FG003|COMPLETED|Overall Study||20||
48472294|NCT03331042|101492574|FG000|NOT COMPLETED|Overall Study||1||
48472295|NCT03331042|101492575|FG001|NOT COMPLETED|Overall Study||0||
48472296|NCT03331042|101492576|FG002|NOT COMPLETED|Overall Study||1||
48472297|NCT03331042|101492577|FG003|NOT COMPLETED|Overall Study||1||
48472298|NCT01400425|101492578|FG000|STARTED|Overall Study||239||
48472299|NCT01400425|101492578|FG000|COMPLETED|Overall Study||229||
48472300|NCT01400425|101492578|FG000|NOT COMPLETED|Overall Study||10||
48472301|NCT02305758|101492579|FG000|STARTED|Overall Study||65||
48472302|NCT02305758|101492580|FG001|STARTED|Overall Study||65||
48472303|NCT02305758|101492579|FG000|COMPLETED|Overall Study||0||
48472304|NCT02305758|101492580|FG001|COMPLETED|Overall Study||0||
48472305|NCT02305758|101492579|FG000|NOT COMPLETED|Overall Study||65||
48472306|NCT02305758|101492580|FG001|NOT COMPLETED|Overall Study||65||
48190835|NCT02926937|100789174|FG002|NOT COMPLETED|Overall Study||11||
48190836|NCT04305912|100789175|FG000|STARTED|First Intervention||26||
48190837|NCT04305912|100789176|FG001|STARTED|First Intervention||25||
48190838|NCT04305912|100789175|FG000|COMPLETED|First Intervention||24||
48190839|NCT04305912|100789176|FG001|COMPLETED|First Intervention||24||
48190840|NCT04305912|100789175|FG000|NOT COMPLETED|First Intervention||2||
48190841|NCT04305912|100789176|FG001|NOT COMPLETED|First Intervention||1||
48190842|NCT04305912|100789175|FG000|STARTED|Second Intervention||24||
48190843|NCT04305912|100789176|FG001|STARTED|Second Intervention||24||
48190844|NCT04305912|100789175|FG000|COMPLETED|Second Intervention||24||
48190845|NCT04305912|100789176|FG001|COMPLETED|Second Intervention||23||
48190846|NCT04305912|100789175|FG000|NOT COMPLETED|Second Intervention||0||
48190847|NCT04305912|100789176|FG001|NOT COMPLETED|Second Intervention||1||
48190848|NCT00601965|100789177|FG000|STARTED|Overall Study||18||
48190849|NCT00601965|100789178|FG001|STARTED|Overall Study||18||
48190850|NCT00601965|100789179|FG002|STARTED|Overall Study||19||
48190851|NCT00601965|100789180|FG003|STARTED|Overall Study||18||
48190852|NCT00601965|100789177|FG000|COMPLETED|Overall Study||18||
48190853|NCT00601965|100789178|FG001|COMPLETED|Overall Study||16||
48190854|NCT00601965|100789179|FG002|COMPLETED|Overall Study||19||
48190855|NCT00601965|100789180|FG003|COMPLETED|Overall Study||17||
48190856|NCT00601965|100789177|FG000|NOT COMPLETED|Overall Study||0||
48190857|NCT00601965|100789178|FG001|NOT COMPLETED|Overall Study||2||
48190858|NCT00601965|100789179|FG002|NOT COMPLETED|Overall Study||0||
48190859|NCT00601965|100789180|FG003|NOT COMPLETED|Overall Study||1||
48190860|NCT01354938|100789181|FG000|STARTED|Overall Study||220||
48190861|NCT01354938|100789181|FG000|COMPLETED|Overall Study||219||
48190862|NCT01354938|100789181|FG000|NOT COMPLETED|Overall Study||1||
48190863|NCT03788291|100789182|FG000|STARTED|Overall Study||38||
48190864|NCT03788291|100789182|FG000|COMPLETED|Overall Study||38||
48190865|NCT03788291|100789182|FG000|NOT COMPLETED|Overall Study||0||
48190866|NCT02516579|100789183|FG000|STARTED|Overall Study||1906||
48190867|NCT02516579|100789183|FG000|COMPLETED|Overall Study||1906||
48190868|NCT02516579|100789183|FG000|NOT COMPLETED|Overall Study||0||
48190869|NCT00790062|100789184|FG000|STARTED|Overall Study||659||
48190870|NCT00790062|100789185|FG001|STARTED|Overall Study||481||
48190871|NCT00790062|100789186|FG002|STARTED|Overall Study||658||
48190872|NCT00790062|100789184|FG000|COMPLETED|Overall Study||659||
48190873|NCT00790062|100789185|FG001|COMPLETED|Overall Study||481||
48190874|NCT00790062|100789186|FG002|COMPLETED|Overall Study||658||
48190875|NCT00790062|100789184|FG000|NOT COMPLETED|Overall Study||0||
48190876|NCT00790062|100789185|FG001|NOT COMPLETED|Overall Study||0||
48190877|NCT00790062|100789186|FG002|NOT COMPLETED|Overall Study||0||
48190878|NCT04438785|100789187|FG000|STARTED|Overall Study||20||
48190879|NCT04438785|100789188|FG001|STARTED|Overall Study||20||
48190880|NCT04438785|100789187|FG000|COMPLETED|Overall Study||18||
48190881|NCT04438785|100789188|FG001|COMPLETED|Overall Study||10||
48190882|NCT04438785|100789187|FG000|NOT COMPLETED|Overall Study||2||
48190883|NCT04438785|100789188|FG001|NOT COMPLETED|Overall Study||10||
48190884|NCT02206685|100789189|FG000|STARTED|Overall Study||37||
48472307|NCT01479439|101492581|FG000|STARTED|Overall Study||15||
48472308|NCT01479439|101492582|FG001|STARTED|Overall Study||13||
48472309|NCT01479439|101492583|FG002|STARTED|Overall Study||8||
48472310|NCT01479439|101492581|FG000|COMPLETED|Overall Study||14||
48472311|NCT01479439|101492582|FG001|COMPLETED|Overall Study||12||
48472312|NCT01479439|101492583|FG002|COMPLETED|Overall Study||6||
48472313|NCT01479439|101492581|FG000|NOT COMPLETED|Overall Study||1||
48472314|NCT01479439|101492582|FG001|NOT COMPLETED|Overall Study||1||
48472315|NCT01479439|101492583|FG002|NOT COMPLETED|Overall Study||2||
48472316|NCT03311646|101492584|FG000|STARTED|Overall Study||31||
48472317|NCT03311646|101492584|FG000|COMPLETED|Overall Study||16||
48472318|NCT03311646|101492584|FG000|NOT COMPLETED|Overall Study||15||
48472319|NCT00580138|101492585|FG000|STARTED|Overall Study||30||
48472320|NCT00580138|101492585|FG000|COMPLETED|Overall Study||30||
48190885|NCT02206685|100789190|FG001|STARTED|Overall Study||37||
48190886|NCT02206685|100789189|FG000|COMPLETED|Overall Study||32||
48190887|NCT02206685|100789190|FG001|COMPLETED|Overall Study||30||
48472321|NCT00580138|101492585|FG000|NOT COMPLETED|Overall Study||0||
48472322|NCT01179048|101492586|FG000|STARTED|Overall Study||4668||
48472323|NCT01179048|101492587|FG001|STARTED|Overall Study||4672||
48190888|NCT02206685|100789189|FG000|NOT COMPLETED|Overall Study||5||
48190889|NCT02206685|100789190|FG001|NOT COMPLETED|Overall Study||7||
48190890|NCT00783692|100789191|FG000|STARTED|Induction Phase||148||
48190891|NCT00783692|100789192|FG001|STARTED|Induction Phase||220||
48190892|NCT00783692|100789193|FG002|STARTED|Induction Phase||748||
48190893|NCT00783692|100789194|FG003|STARTED|Induction Phase||0||
48190894|NCT00783692|100789195|FG004|STARTED|Induction Phase||0||
48190895|NCT00783692|100789196|FG005|STARTED|Induction Phase||0||
48190896|NCT00783692|100789197|FG006|STARTED|Induction Phase||0||
48190897|NCT00783692|100789191|FG000|Treated|Induction Phase||148||
48190898|NCT00783692|100789192|FG001|Treated|Induction Phase||220||
48190899|NCT00783692|100789193|FG002|Treated|Induction Phase||747||
48472324|NCT01179048|101492586|FG000|COMPLETED|Overall Study||4529||
48472325|NCT01179048|101492587|FG001|COMPLETED|Overall Study||4513||
48472326|NCT01179048|101492586|FG000|NOT COMPLETED|Overall Study||139||
48472327|NCT01179048|101492587|FG001|NOT COMPLETED|Overall Study||159||
48472328|NCT01658943|101492588|FG000|STARTED|Overall Study||70||
48472329|NCT01658943|101492589|FG001|STARTED|Overall Study||67||
48472330|NCT01658943|101492588|FG000|Eligible|Overall Study||63||
48472331|NCT01658943|101492589|FG001|Eligible|Overall Study||58||
48472332|NCT01658943|101492588|FG000|Eligible and Began Protocol Therapy|Overall Study||62||
48472333|NCT01658943|101492589|FG001|Eligible and Began Protocol Therapy|Overall Study||58||
48472334|NCT01658943|101492588|FG000|COMPLETED|Overall Study||0||
48472335|NCT01658943|101492589|FG001|COMPLETED|Overall Study||0||
48472336|NCT01658943|101492588|FG000|NOT COMPLETED|Overall Study||70||
48472337|NCT01658943|101492589|FG001|NOT COMPLETED|Overall Study||67||
48472338|NCT00723554|101492590|FG000|STARTED|Overall Study||63||
48472339|NCT00723554|101492590|FG000|COMPLETED|Overall Study||34||
48190900|NCT00783692|100789194|FG003|Treated|Induction Phase||0||
48190901|NCT00783692|100789195|FG004|Treated|Induction Phase||0||
48190902|NCT00783692|100789196|FG005|Treated|Induction Phase||0||
48190903|NCT00783692|100789197|FG006|Treated|Induction Phase||0||
48190904|NCT00783692|100789191|FG000|COMPLETED|Induction Phase||137||
48190905|NCT00783692|100789192|FG001|COMPLETED|Induction Phase||199||
48190906|NCT00783692|100789193|FG002|COMPLETED|Induction Phase||674||
48190907|NCT00783692|100789194|FG003|COMPLETED|Induction Phase||0||
48190908|NCT00783692|100789195|FG004|COMPLETED|Induction Phase||0||
48190909|NCT00783692|100789196|FG005|COMPLETED|Induction Phase||0||
48190910|NCT00783692|100789197|FG006|COMPLETED|Induction Phase||0||
48190911|NCT00783692|100789191|FG000|NOT COMPLETED|Induction Phase||11||
48190912|NCT00783692|100789192|FG001|NOT COMPLETED|Induction Phase||21||
48190913|NCT00783692|100789193|FG002|NOT COMPLETED|Induction Phase||74||
48190914|NCT00783692|100789194|FG003|NOT COMPLETED|Induction Phase||0||
48190915|NCT00783692|100789195|FG004|NOT COMPLETED|Induction Phase||0||
48190916|NCT00783692|100789196|FG005|NOT COMPLETED|Induction Phase||0||
48190917|NCT00783692|100789197|FG006|NOT COMPLETED|Induction Phase||0||
48190918|NCT00783692|100789191|FG000|STARTED|Maintenance Phase||137||
48190919|NCT00783692|100789192|FG001|STARTED|Maintenance Phase||0||
48190920|NCT00783692|100789193|FG002|STARTED|Maintenance Phase||0||
48190921|NCT00783692|100789194|FG003|STARTED|Maintenance Phase||153||
48190922|NCT00783692|100789195|FG004|STARTED|Maintenance Phase||154||
48190923|NCT00783692|100789196|FG005|STARTED|Maintenance Phase||154||
48190924|NCT00783692|100789197|FG006|STARTED|Maintenance Phase||412||
48190925|NCT00783692|100789191|FG000|COMPLETED|Maintenance Phase||42||
48190926|NCT00783692|100789192|FG001|COMPLETED|Maintenance Phase||0||
48190927|NCT00783692|100789193|FG002|COMPLETED|Maintenance Phase||0||
48190928|NCT00783692|100789194|FG003|COMPLETED|Maintenance Phase||64||
48190929|NCT00783692|100789195|FG004|COMPLETED|Maintenance Phase||73||
48190930|NCT00783692|100789196|FG005|COMPLETED|Maintenance Phase||82||
48190931|NCT00783692|100789197|FG006|COMPLETED|Maintenance Phase||163||
48190932|NCT00783692|100789191|FG000|NOT COMPLETED|Maintenance Phase||95||
48190933|NCT00783692|100789192|FG001|NOT COMPLETED|Maintenance Phase||0||
48190934|NCT00783692|100789193|FG002|NOT COMPLETED|Maintenance Phase||0||
48190935|NCT00783692|100789194|FG003|NOT COMPLETED|Maintenance Phase||89||
48190936|NCT00783692|100789195|FG004|NOT COMPLETED|Maintenance Phase||81||
48190937|NCT00783692|100789196|FG005|NOT COMPLETED|Maintenance Phase||72||
48190938|NCT00783692|100789197|FG006|NOT COMPLETED|Maintenance Phase||249||
48190939|NCT01141660|100789198|FG000|STARTED|Overall Study||71||
48190940|NCT01141660|100789199|FG001|STARTED|Overall Study||60||
48190941|NCT01141660|100789198|FG000|COMPLETED|Overall Study||71||
48190942|NCT01141660|100789199|FG001|COMPLETED|Overall Study||48||
48472340|NCT00723554|101492590|FG000|NOT COMPLETED|Overall Study||29||
48472341|NCT00802100|101492591|FG000|STARTED|Overall Study||6||
48472342|NCT00802100|101492592|FG001|STARTED|Overall Study||9||
48472343|NCT00802100|101492593|FG002|STARTED|Overall Study||6||
48472344|NCT00802100|101492591|FG000|COMPLETED|Overall Study||0||
48472345|NCT00802100|101492592|FG001|COMPLETED|Overall Study||2||
48190943|NCT01141660|100789198|FG000|NOT COMPLETED|Overall Study||0||
48190944|NCT01141660|100789199|FG001|NOT COMPLETED|Overall Study||12||
48190945|NCT02099539|100789200|FG000|STARTED|Overall Study||3||
48190946|NCT02099539|100789201|FG001|STARTED|Overall Study||3||
48190947|NCT02099539|100789202|FG002|STARTED|Overall Study||3||
48190948|NCT02099539|100789203|FG003|STARTED|Overall Study||3||
48190949|NCT02099539|100789204|FG004|STARTED|Overall Study||4||
48190950|NCT02099539|100789205|FG005|STARTED|Overall Study||3||
48190951|NCT02099539|100789206|FG006|STARTED|Overall Study||0||
48190952|NCT02099539|100789200|FG000|COMPLETED|Overall Study||0||
48190953|NCT02099539|100789201|FG001|COMPLETED|Overall Study||1||
48190954|NCT02099539|100789202|FG002|COMPLETED|Overall Study||0||
48190955|NCT02099539|100789203|FG003|COMPLETED|Overall Study||1||
48190956|NCT02099539|100789204|FG004|COMPLETED|Overall Study||0||
48190957|NCT02099539|100789205|FG005|COMPLETED|Overall Study||0||
48190958|NCT02099539|100789206|FG006|COMPLETED|Overall Study||0||
48190959|NCT02099539|100789200|FG000|NOT COMPLETED|Overall Study||3||
48190960|NCT02099539|100789201|FG001|NOT COMPLETED|Overall Study||2||
48190961|NCT02099539|100789202|FG002|NOT COMPLETED|Overall Study||3||
48190962|NCT02099539|100789203|FG003|NOT COMPLETED|Overall Study||2||
48190963|NCT02099539|100789204|FG004|NOT COMPLETED|Overall Study||4||
48190964|NCT02099539|100789205|FG005|NOT COMPLETED|Overall Study||3||
48190965|NCT02099539|100789206|FG006|NOT COMPLETED|Overall Study||0||
48190966|NCT00916006|100789207|FG000|STARTED|Overall Study||135||
48190967|NCT00916006|100789208|FG001|STARTED|Overall Study||134||
48472346|NCT00802100|101492593|FG002|COMPLETED|Overall Study||2||
48472347|NCT00802100|101492591|FG000|NOT COMPLETED|Overall Study||6||
48472348|NCT00802100|101492592|FG001|NOT COMPLETED|Overall Study||7||
48190968|NCT00916006|100789207|FG000|COMPLETED|Overall Study||132||
48472349|NCT00802100|101492593|FG002|NOT COMPLETED|Overall Study||4||
48472350|NCT03172780|101492594|FG000|STARTED|Overall Study||406||
48472351|NCT03172780|101492595|FG001|STARTED|Overall Study||409||
48472352|NCT03172780|101492596|FG002|STARTED|Overall Study||405||
48472353|NCT03172780|101492594|FG000|COMPLETED|Overall Study||388||
48472354|NCT03172780|101492595|FG001|COMPLETED|Overall Study||389||
48472355|NCT03172780|101492596|FG002|COMPLETED|Overall Study||389||
48472356|NCT03172780|101492594|FG000|NOT COMPLETED|Overall Study||18||
48472357|NCT03172780|101492595|FG001|NOT COMPLETED|Overall Study||20||
48472358|NCT03172780|101492596|FG002|NOT COMPLETED|Overall Study||16||
48472359|NCT00520741|101492597|FG000|STARTED|Overall Study||106||
48472360|NCT00520741|101492598|FG001|STARTED|Overall Study||319||
48472361|NCT00520741|101492597|FG000|COMPLETED|Overall Study||69||
48472362|NCT00520741|101492598|FG001|COMPLETED|Overall Study||194||
48472363|NCT00520741|101492597|FG000|NOT COMPLETED|Overall Study||37||
48472364|NCT00520741|101492598|FG001|NOT COMPLETED|Overall Study||125||
48472365|NCT06076681|101492599|FG000|STARTED|Overall Study||10||
48472366|NCT06076681|101492600|FG001|STARTED|Overall Study||10||
48472367|NCT06076681|101492601|FG002|STARTED|Overall Study||10||
48472368|NCT06076681|101492602|FG003|STARTED|Overall Study||10||
48472369|NCT06076681|101492599|FG000|COMPLETED|Overall Study||10||
48472370|NCT06076681|101492600|FG001|COMPLETED|Overall Study||10||
48472371|NCT06076681|101492601|FG002|COMPLETED|Overall Study||10||
48472372|NCT06076681|101492602|FG003|COMPLETED|Overall Study||10||
48472373|NCT06076681|101492599|FG000|NOT COMPLETED|Overall Study||0||
48472374|NCT06076681|101492600|FG001|NOT COMPLETED|Overall Study||0||
48472375|NCT06076681|101492601|FG002|NOT COMPLETED|Overall Study||0||
48472376|NCT06076681|101492602|FG003|NOT COMPLETED|Overall Study||0||
48472377|NCT03312257|101492603|FG000|STARTED|Overall Study||49||
48472378|NCT03312257|101492603|FG000|COMPLETED|Overall Study||46||
48472379|NCT03312257|101492603|FG000|NOT COMPLETED|Overall Study||3||
48472380|NCT04099888|101492604|FG000|STARTED|Overall Study||21||
48472381|NCT04099888|101492605|FG001|STARTED|Overall Study||20||
48472382|NCT04099888|101492604|FG000|COMPLETED|Overall Study||0||
48472383|NCT04099888|101492605|FG001|COMPLETED|Overall Study||0||
48472384|NCT04099888|101492604|FG000|NOT COMPLETED|Overall Study||21||
48472385|NCT04099888|101492605|FG001|NOT COMPLETED|Overall Study||20||
48472386|NCT00920140|101492606|FG000|STARTED|Phase 1 (Dose Escalation)||5||
48472387|NCT00920140|101492607|FG001|STARTED|Phase 1 (Dose Escalation)||9||
48472388|NCT00920140|101492608|FG002|STARTED|Phase 1 (Dose Escalation)||0||
48472389|NCT00920140|101492609|FG003|STARTED|Phase 1 (Dose Escalation)||0||
48472390|NCT00920140|101492610|FG004|STARTED|Phase 1 (Dose Escalation)||0||
48472391|NCT00920140|101492606|FG000|COMPLETED|Phase 1 (Dose Escalation)||0||
48472392|NCT00920140|101492607|FG001|COMPLETED|Phase 1 (Dose Escalation)||0||
48472393|NCT00920140|101492608|FG002|COMPLETED|Phase 1 (Dose Escalation)||0||
48472394|NCT00920140|101492609|FG003|COMPLETED|Phase 1 (Dose Escalation)||0||
48472395|NCT00920140|101492610|FG004|COMPLETED|Phase 1 (Dose Escalation)||0||
48472396|NCT00920140|101492606|FG000|NOT COMPLETED|Phase 1 (Dose Escalation)||5||
48472397|NCT00920140|101492607|FG001|NOT COMPLETED|Phase 1 (Dose Escalation)||9||
48472398|NCT00920140|101492608|FG002|NOT COMPLETED|Phase 1 (Dose Escalation)||0||
48472399|NCT00920140|101492609|FG003|NOT COMPLETED|Phase 1 (Dose Escalation)||0||
48472400|NCT00920140|101492610|FG004|NOT COMPLETED|Phase 1 (Dose Escalation)||0||
48472401|NCT00920140|101492606|FG000|STARTED|Phase 2||0||
48472402|NCT00920140|101492607|FG001|STARTED|Phase 2||0||
48472403|NCT00920140|101492608|FG002|STARTED|Phase 2||50||
48472404|NCT00920140|101492609|FG003|STARTED|Phase 2||22||
48472405|NCT00920140|101492610|FG004|STARTED|Phase 2||11||
48472406|NCT00920140|101492606|FG000|COMPLETED|Phase 2||0||
48472407|NCT00920140|101492607|FG001|COMPLETED|Phase 2||0||
48472408|NCT00920140|101492608|FG002|COMPLETED|Phase 2||0||
48472409|NCT00920140|101492609|FG003|COMPLETED|Phase 2||0||
48472410|NCT00920140|101492610|FG004|COMPLETED|Phase 2||0||
48472411|NCT00920140|101492606|FG000|NOT COMPLETED|Phase 2||0||
48472412|NCT00920140|101492607|FG001|NOT COMPLETED|Phase 2||0||
48472413|NCT00920140|101492608|FG002|NOT COMPLETED|Phase 2||50||
48472414|NCT00920140|101492609|FG003|NOT COMPLETED|Phase 2||22||
48472415|NCT00920140|101492610|FG004|NOT COMPLETED|Phase 2||11||
48472416|NCT00117949|101492611|FG000|STARTED|Overall Study||10||
48472417|NCT00117949|101492612|FG001|STARTED|Overall Study||24||
48472418|NCT00117949|101492613|FG002|STARTED|Overall Study||24||
48472419|NCT00117949|101492614|FG003|STARTED|Overall Study||24||
48670435|NCT02460458|101974944|FG000|STARTED|Confirmation of Clinical Phase Data||126||
48472420|NCT00117949|101492611|FG000|COMPLETED|Overall Study||0||
48472421|NCT00117949|101492612|FG001|COMPLETED|Overall Study||0||
48472422|NCT00117949|101492613|FG002|COMPLETED|Overall Study||0||
48472423|NCT00117949|101492614|FG003|COMPLETED|Overall Study||0||
48472424|NCT00117949|101492611|FG000|NOT COMPLETED|Overall Study||10||
48472425|NCT00117949|101492612|FG001|NOT COMPLETED|Overall Study||24||
48472426|NCT00117949|101492613|FG002|NOT COMPLETED|Overall Study||24||
48472427|NCT00117949|101492614|FG003|NOT COMPLETED|Overall Study||24||
48472428|NCT03929367|101492615|FG000|STARTED|Overall Study||11||
48472429|NCT03929367|101492615|FG000|COMPLETED|Overall Study||11||
48472430|NCT03929367|101492615|FG000|NOT COMPLETED|Overall Study||0||
48472431|NCT01462565|101492616|FG000|STARTED|Overall Study||16||
48472432|NCT01462565|101492616|FG000|COMPLETED|Overall Study||16||
48472433|NCT01462565|101492616|FG000|NOT COMPLETED|Overall Study||0||
48472434|NCT00243932|101492617|FG000|STARTED|Stage 1: Dose Selection||35||
48472435|NCT00243932|101492618|FG001|STARTED|Stage 1: Dose Selection||35||
48472436|NCT00243932|101492619|FG002|STARTED|Stage 1: Dose Selection||35||
48472437|NCT00243932|101492617|FG000|COMPLETED|Stage 1: Dose Selection||33||
48472438|NCT00243932|101492618|FG001|COMPLETED|Stage 1: Dose Selection||35||
48666184|NCT01107496|101967524|FG001|Dosed|Overall Study||25|Subjects who were randomly assigned to one of two treatment groups and took at least one dose of study medication (Safety Population)|
48666185|NCT01107496|101967523|FG000|COMPLETED|Overall Study||24||
48666186|NCT01107496|101967524|FG001|COMPLETED|Overall Study||24||
48472439|NCT00243932|101492619|FG002|COMPLETED|Stage 1: Dose Selection||35||
48472440|NCT00243932|101492617|FG000|NOT COMPLETED|Stage 1: Dose Selection||2||
48472441|NCT00243932|101492618|FG001|NOT COMPLETED|Stage 1: Dose Selection||0||
48472442|NCT00243932|101492619|FG002|NOT COMPLETED|Stage 1: Dose Selection||0||
48472443|NCT00243932|101492617|FG000|STARTED|Stage 2: Efficacy||40||
48472444|NCT00243932|101492618|FG001|STARTED|Stage 2: Efficacy||40||
48472445|NCT00243932|101492619|FG002|STARTED|Stage 2: Efficacy||0||
48472446|NCT00243932|101492617|FG000|COMPLETED|Stage 2: Efficacy||40||
48472447|NCT00243932|101492618|FG001|COMPLETED|Stage 2: Efficacy||40||
48472448|NCT00243932|101492619|FG002|COMPLETED|Stage 2: Efficacy||0||
48472449|NCT00243932|101492617|FG000|NOT COMPLETED|Stage 2: Efficacy||0||
48472450|NCT00243932|101492618|FG001|NOT COMPLETED|Stage 2: Efficacy||0||
48472451|NCT00243932|101492619|FG002|NOT COMPLETED|Stage 2: Efficacy||0||
48472452|NCT01249664|101492620|FG000|STARTED|Overall Study||91||
48472453|NCT01249664|101492621|FG001|STARTED|Overall Study||31||
48472454|NCT01249664|101492620|FG000|Participants Received Treatment|Overall Study||91||
48472455|NCT01249664|101492621|FG001|Participants Received Treatment|Overall Study||31||
48472456|NCT01249664|101492620|FG000|Fulfilled Requirements of FAS Population|Overall Study||90||
48472457|NCT01249664|101492621|FG001|Fulfilled Requirements of FAS Population|Overall Study||31||
48472458|NCT01249664|101492620|FG000|Completed 24 Weeks Treatment|Overall Study||83||
48472459|NCT01249664|101492621|FG001|Completed 24 Weeks Treatment|Overall Study||25||
48472460|NCT01249664|101492620|FG000|Completed 48 Weeks Treatment|Overall Study||78||
48472461|NCT01249664|101492621|FG001|Completed 48 Weeks Treatment|Overall Study||24||
48472462|NCT01249664|101492620|FG000|COMPLETED|Overall Study||85||
48472463|NCT01249664|101492621|FG001|COMPLETED|Overall Study||31||
48472464|NCT01249664|101492620|FG000|NOT COMPLETED|Overall Study||6||
48472465|NCT01249664|101492621|FG001|NOT COMPLETED|Overall Study||0||
48472466|NCT02402166|101492622|FG000|STARTED|Overall Study||24||
48472467|NCT02402166|101492622|FG000|COMPLETED|Overall Study||19||
48472468|NCT02402166|101492622|FG000|NOT COMPLETED|Overall Study||5||
48472469|NCT01179490|101492623|FG000|STARTED|Overall Study||5||
48472470|NCT01179490|101492623|FG000|COMPLETED|Overall Study||5||
48472471|NCT01179490|101492623|FG000|NOT COMPLETED|Overall Study||0||
48472472|NCT01335477|101492624|FG000|STARTED|Overall Study||220||
48472473|NCT01335477|101492625|FG001|STARTED|Overall Study||331||
48472474|NCT01335477|101492624|FG000|COMPLETED|Overall Study||179||
48190969|NCT00916006|100789208|FG001|COMPLETED|Overall Study||127||
48190970|NCT00916006|100789207|FG000|NOT COMPLETED|Overall Study||3||
48190971|NCT00916006|100789208|FG001|NOT COMPLETED|Overall Study||7||
48190972|NCT02347917|100789209|FG000|STARTED|Overall Study||4||
48190973|NCT02347917|100789210|FG001|STARTED|Overall Study||24||
48190974|NCT02347917|100789209|FG000|Discontinued beforeBBI608 Administration|Overall Study||0||
48190975|NCT02347917|100789210|FG001|Discontinued beforeBBI608 Administration|Overall Study||0||
48190976|NCT02347917|100789209|FG000|Start BBI608 Administration|Overall Study||4||
48190977|NCT02347917|100789210|FG001|Start BBI608 Administration|Overall Study||24||
48190978|NCT02347917|100789209|FG000|Discontinued in DLT Evaluation Period|Overall Study||1|DLT was assessed in Phase 1 part only.|
48472475|NCT01335477|101492625|FG001|COMPLETED|Overall Study||272||
48472476|NCT01335477|101492624|FG000|NOT COMPLETED|Overall Study||41||
48472477|NCT01335477|101492625|FG001|NOT COMPLETED|Overall Study||59||
48472478|NCT02896361|101492626|FG000|STARTED|First Intervention (2 Weeks)||9||
48472479|NCT02896361|101492627|FG001|STARTED|First Intervention (2 Weeks)||10||
48472480|NCT02896361|101492628|FG002|STARTED|First Intervention (2 Weeks)||8||
48472481|NCT02896361|101492626|FG000|COMPLETED|First Intervention (2 Weeks)||9||
48472482|NCT02896361|101492627|FG001|COMPLETED|First Intervention (2 Weeks)||10||
48472483|NCT02896361|101492628|FG002|COMPLETED|First Intervention (2 Weeks)||8||
48472484|NCT02896361|101492626|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0||
48472485|NCT02896361|101492627|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0||
48472486|NCT02896361|101492628|FG002|NOT COMPLETED|First Intervention (2 Weeks)||0||
48472487|NCT02896361|101492626|FG000|STARTED|Second Intervention (2 Weeks)||9||
48472488|NCT02896361|101492627|FG001|STARTED|Second Intervention (2 Weeks)||10||
48472489|NCT02896361|101492628|FG002|STARTED|Second Intervention (2 Weeks)||8||
48472490|NCT02896361|101492626|FG000|COMPLETED|Second Intervention (2 Weeks)||9||
48472491|NCT02896361|101492627|FG001|COMPLETED|Second Intervention (2 Weeks)||10||
48472492|NCT02896361|101492628|FG002|COMPLETED|Second Intervention (2 Weeks)||8||
48190979|NCT02347917|100789210|FG001|Discontinued in DLT Evaluation Period|Overall Study||0|DLT was assessed in Phase 1 part only.|
48472493|NCT02896361|101492626|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48472494|NCT02896361|101492627|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48472495|NCT02896361|101492628|FG002|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48472496|NCT02896361|101492626|FG000|STARTED|Third Intervention (2 Weeks)||9||
48472497|NCT02896361|101492627|FG001|STARTED|Third Intervention (2 Weeks)||10||
48472498|NCT02896361|101492628|FG002|STARTED|Third Intervention (2 Weeks)||8||
48472499|NCT02896361|101492626|FG000|COMPLETED|Third Intervention (2 Weeks)||8||
48472500|NCT02896361|101492627|FG001|COMPLETED|Third Intervention (2 Weeks)||9||
48472501|NCT02896361|101492628|FG002|COMPLETED|Third Intervention (2 Weeks)||8||
48472502|NCT02896361|101492626|FG000|NOT COMPLETED|Third Intervention (2 Weeks)||1||
48472503|NCT02896361|101492627|FG001|NOT COMPLETED|Third Intervention (2 Weeks)||1||
48472504|NCT02896361|101492628|FG002|NOT COMPLETED|Third Intervention (2 Weeks)||0||
48472505|NCT01765530|101492629|FG000|STARTED|Overall Study||37||
48472506|NCT01765530|101492630|FG001|STARTED|Overall Study||37||
48472507|NCT01765530|101492629|FG000|COMPLETED|Overall Study||36||
48472508|NCT01765530|101492630|FG001|COMPLETED|Overall Study||36||
48472509|NCT01765530|101492629|FG000|NOT COMPLETED|Overall Study||1||
48472510|NCT01765530|101492630|FG001|NOT COMPLETED|Overall Study||1||
48472511|NCT03544138|101492631|FG000|STARTED|Overall Study||258||492
48472512|NCT03544138|101492631|FG000|COMPLETED|Overall Study||229||440
48472513|NCT03544138|101492631|FG000|NOT COMPLETED|Overall Study||29||52
48472514|NCT01060670|101492632|FG000|STARTED|Run In||0||
48472515|NCT01060670|101492633|FG001|STARTED|Run In||545||
48472516|NCT01060670|101492632|FG000|COMPLETED|Run In||0||
48472517|NCT01060670|101492633|FG001|COMPLETED|Run In||307||
48472518|NCT01060670|101492632|FG000|NOT COMPLETED|Run In||0||
48472519|NCT01060670|101492633|FG001|NOT COMPLETED|Run In||238||
48190980|NCT02347917|100789209|FG000|Complete DLT Evaluation Period|Overall Study||3|DLT was assessed in Phase 1 part only.|
48472520|NCT01060670|101492632|FG000|STARTED|Treatment Phase||154||
48472521|NCT01060670|101492633|FG001|STARTED|Treatment Phase||153||
48472522|NCT01060670|101492632|FG000|Healed at End of Treatment Phase|Treatment Phase||79||
48472523|NCT01060670|101492633|FG001|Healed at End of Treatment Phase|Treatment Phase||49||
48472524|NCT01060670|101492632|FG000|Did Not Heal by Treatment Visit 17|Treatment Phase||49||
48472525|NCT01060670|101492633|FG001|Did Not Heal by Treatment Visit 17|Treatment Phase||68||
48472526|NCT01060670|101492632|FG000|Withdrew From Treatment|Treatment Phase||26||
48472527|NCT01060670|101492633|FG001|Withdrew From Treatment|Treatment Phase||36||
48472528|NCT01060670|101492632|FG000|COMPLETED|Treatment Phase||128||
48472529|NCT01060670|101492633|FG001|COMPLETED|Treatment Phase||117||
48472530|NCT01060670|101492632|FG000|NOT COMPLETED|Treatment Phase||26||
48472531|NCT01060670|101492633|FG001|NOT COMPLETED|Treatment Phase||36||
48472532|NCT01060670|101492632|FG000|STARTED|Follow up Phase||128||
48472533|NCT01060670|101492633|FG001|STARTED|Follow up Phase||117||
48190981|NCT02347917|100789210|FG001|Complete DLT Evaluation Period|Overall Study||0|DLT was assessed in Phase 1 part only.|
48472534|NCT01060670|101492632|FG000|Recurrence|Follow up Phase||14||
48472535|NCT01060670|101492633|FG001|Recurrence|Follow up Phase||9||
48472536|NCT01060670|101492632|FG000|Withdrew From Follow up Phase|Follow up Phase||22||
48472537|NCT01060670|101492633|FG001|Withdrew From Follow up Phase|Follow up Phase||35||
48472538|NCT01060670|101492632|FG000|COMPLETED|Follow up Phase||106||
48472539|NCT01060670|101492633|FG001|COMPLETED|Follow up Phase||82||
48472540|NCT01060670|101492632|FG000|NOT COMPLETED|Follow up Phase||22||
48472541|NCT01060670|101492633|FG001|NOT COMPLETED|Follow up Phase||35||
48190982|NCT02347917|100789209|FG000|Discontinued After BBI608 Administration|Overall Study||4||
48190983|NCT02347917|100789210|FG001|Discontinued After BBI608 Administration|Overall Study||24||
48472542|NCT01345019|101492634|FG000|STARTED|Blinded Treatment Phase||859||
48472543|NCT01345019|101492635|FG001|STARTED|Blinded Treatment Phase||859||
48472544|NCT01345019|101492634|FG000|Received Treatment|Blinded Treatment Phase||852||
48472545|NCT01345019|101492635|FG001|Received Treatment|Blinded Treatment Phase||850||
48472546|NCT01345019|101492634|FG000|COMPLETED|Blinded Treatment Phase||541|Still on-study as of blinded treatment analysis cutoff date of 05 January 2017|
48472547|NCT01345019|101492635|FG001|COMPLETED|Blinded Treatment Phase||555|Still on-study as of blinded treatment analysis cutoff date of 05 January 2017|
48472548|NCT01345019|101492634|FG000|NOT COMPLETED|Blinded Treatment Phase||318||
48472549|NCT01345019|101492635|FG001|NOT COMPLETED|Blinded Treatment Phase||304||
48472550|NCT01345019|101492634|FG000|STARTED|Open Label Treatment Phase||418||
48472551|NCT01345019|101492635|FG001|STARTED|Open Label Treatment Phase||426||
48472552|NCT01345019|101492634|FG000|COMPLETED|Open Label Treatment Phase||227||
48472553|NCT01345019|101492635|FG001|COMPLETED|Open Label Treatment Phase||233||
48472554|NCT01345019|101492634|FG000|NOT COMPLETED|Open Label Treatment Phase||191||
48472555|NCT01345019|101492635|FG001|NOT COMPLETED|Open Label Treatment Phase||193||
48472556|NCT01535326|101492636|FG000|STARTED|Overall Study||90||
48472557|NCT01535326|101492637|FG001|STARTED|Overall Study||90||
48472558|NCT01535326|101492638|FG002|STARTED|Overall Study||90||
48472559|NCT01535326|101492636|FG000|COMPLETED|Overall Study||90||
48472560|NCT01535326|101492637|FG001|COMPLETED|Overall Study||90||
48472561|NCT01535326|101492638|FG002|COMPLETED|Overall Study||90||
48472562|NCT01535326|101492636|FG000|NOT COMPLETED|Overall Study||0||
48472563|NCT01535326|101492637|FG001|NOT COMPLETED|Overall Study||0||
48472564|NCT01535326|101492638|FG002|NOT COMPLETED|Overall Study||0||
48472565|NCT01411332|101492639|FG000|STARTED|Enrollment||9||
48472566|NCT01411332|101492640|FG001|STARTED|Enrollment||9||
48472567|NCT01411332|101492639|FG000|COMPLETED|Enrollment||9||
48472568|NCT01411332|101492640|FG001|COMPLETED|Enrollment||7||
48472569|NCT01411332|101492639|FG000|NOT COMPLETED|Enrollment||0||
48472570|NCT01411332|101492640|FG001|NOT COMPLETED|Enrollment||2||
48190984|NCT02347917|100789209|FG000|Discontinued Before Survival Observation|Overall Study||0||
48190985|NCT02347917|100789210|FG001|Discontinued Before Survival Observation|Overall Study||1||
48190986|NCT02347917|100789209|FG000|COMPLETED|Overall Study||4|Complete survival observation|
48190987|NCT02347917|100789210|FG001|COMPLETED|Overall Study||23|Complete survival observation|
48190988|NCT02347917|100789209|FG000|NOT COMPLETED|Overall Study||0||
48190989|NCT02347917|100789210|FG001|NOT COMPLETED|Overall Study||1||
48190990|NCT04170764|100789211|FG000|STARTED|Overall Study||664||
48190991|NCT04170764|100789211|FG000|COMPLETED|Overall Study||571||
48190992|NCT04170764|100789211|FG000|NOT COMPLETED|Overall Study||93||
48190993|NCT05576662|100789212|FG000|STARTED|Overall Study||102||
48190994|NCT05576662|100789213|FG001|STARTED|Overall Study||53||
48190995|NCT05576662|100789212|FG000|COMPLETED|Overall Study||98||
48190996|NCT05576662|100789213|FG001|COMPLETED|Overall Study||49||
48190997|NCT05576662|100789212|FG000|NOT COMPLETED|Overall Study||4||
48190998|NCT05576662|100789213|FG001|NOT COMPLETED|Overall Study||4||
48190999|NCT02530151|100789214|FG000|STARTED|Overall Study||37||
48191000|NCT02530151|100789215|FG001|STARTED|Overall Study||33||
48191001|NCT02530151|100789214|FG000|COMPLETED|Overall Study||16||
48191002|NCT02530151|100789215|FG001|COMPLETED|Overall Study||17||
48191003|NCT02530151|100789214|FG000|NOT COMPLETED|Overall Study||21||
48191004|NCT02530151|100789215|FG001|NOT COMPLETED|Overall Study||16||
48191005|NCT02060279|100789216|FG000|STARTED|Overall Study||10||
48191006|NCT02060279|100789217|FG001|STARTED|Overall Study||10||
48191007|NCT02060279|100789216|FG000|COMPLETED|Overall Study||8||
48191008|NCT02060279|100789217|FG001|COMPLETED|Overall Study||9||
48191009|NCT02060279|100789216|FG000|NOT COMPLETED|Overall Study||2||
48191010|NCT02060279|100789217|FG001|NOT COMPLETED|Overall Study||1||
48472571|NCT01411332|101492639|FG000|STARTED|Treatment||9||
48472572|NCT01411332|101492640|FG001|STARTED|Treatment||7||
48191011|NCT04548622|100789218|FG000|STARTED|Overall Study||15||
48191012|NCT04548622|100789218|FG000|COMPLETED|Overall Study||15||
48191013|NCT04548622|100789218|FG000|NOT COMPLETED|Overall Study||0||
48191014|NCT05780047|100789219|FG000|STARTED|Overall Study||434||
48191015|NCT05780047|100789219|FG000|COMPLETED|Overall Study||50||
48191016|NCT05780047|100789219|FG000|NOT COMPLETED|Overall Study||384||
48191017|NCT00448864|100789220|FG000|STARTED|Overall Study||27||
48191018|NCT00448864|100789221|FG001|STARTED|Overall Study||29||
48191019|NCT00448864|100789222|FG002|STARTED|Overall Study||19||
48191020|NCT00448864|100789220|FG000|Received at Least 1 Dose of Study Drug|Overall Study||26||
48191021|NCT00448864|100789221|FG001|Received at Least 1 Dose of Study Drug|Overall Study||25||
48191022|NCT00448864|100789222|FG002|Received at Least 1 Dose of Study Drug|Overall Study||18||
48191023|NCT00448864|100789220|FG000|Started Post-operative Period|Overall Study||26||
48191024|NCT00448864|100789221|FG001|Started Post-operative Period|Overall Study||25||
48191025|NCT00448864|100789222|FG002|Started Post-operative Period|Overall Study||18||
48191026|NCT00448864|100789220|FG000|Completed Post-operative Period|Overall Study||26||
48191027|NCT00448864|100789221|FG001|Completed Post-operative Period|Overall Study||25||
48191028|NCT00448864|100789222|FG002|Completed Post-operative Period|Overall Study||18||
48191029|NCT00448864|100789220|FG000|COMPLETED|Overall Study||22||
48191030|NCT00448864|100789221|FG001|COMPLETED|Overall Study||24||
48191031|NCT00448864|100789222|FG002|COMPLETED|Overall Study||18||
48191032|NCT00448864|100789220|FG000|NOT COMPLETED|Overall Study||5||
48191033|NCT00448864|100789221|FG001|NOT COMPLETED|Overall Study||5||
48191034|NCT00448864|100789222|FG002|NOT COMPLETED|Overall Study||1||
48191035|NCT03453385|100789223|FG000|STARTED|Overall Study||211||
48191036|NCT03453385|100789224|FG001|STARTED|Overall Study||427||
48191037|NCT03453385|100789223|FG000|COMPLETED|Overall Study||211||
48191038|NCT03453385|100789224|FG001|COMPLETED|Overall Study||427||
48191039|NCT03453385|100789223|FG000|NOT COMPLETED|Overall Study||0||
48191040|NCT03453385|100789224|FG001|NOT COMPLETED|Overall Study||0||
48191041|NCT01616563|100789225|FG000|STARTED|Overall Study||293||
48191042|NCT01616563|100789225|FG000|COMPLETED|Overall Study||253||
48191043|NCT01616563|100789225|FG000|NOT COMPLETED|Overall Study||40||
48472573|NCT01411332|101492639|FG000|COMPLETED|Treatment||8||
48472574|NCT01411332|101492640|FG001|COMPLETED|Treatment||7||
48472575|NCT01411332|101492639|FG000|NOT COMPLETED|Treatment||1||
48191044|NCT02408965|100789226|FG000|STARTED|Overall Study||140||
48191045|NCT02408965|100789227|FG001|STARTED|Overall Study||144||
48191046|NCT02408965|100789226|FG000|COMPLETED|Overall Study||140||
48191047|NCT02408965|100789227|FG001|COMPLETED|Overall Study||144||
48191048|NCT02408965|100789226|FG000|NOT COMPLETED|Overall Study||0||
48191049|NCT02408965|100789227|FG001|NOT COMPLETED|Overall Study||0||
48191050|NCT03815916|100789228|FG000|STARTED|Overall Study||13||
48191051|NCT03815916|100789228|FG000|COMPLETED|Overall Study||13||
48191052|NCT03815916|100789228|FG000|NOT COMPLETED|Overall Study||0||
48191053|NCT01414036|100789229|FG000|STARTED|Received Allocated Intervention||23||
48191054|NCT01414036|100789230|FG001|STARTED|Received Allocated Intervention||24||
48191055|NCT01414036|100789229|FG000|COMPLETED|Received Allocated Intervention||23||
48191056|NCT01414036|100789230|FG001|COMPLETED|Received Allocated Intervention||11||
48191057|NCT01414036|100789229|FG000|NOT COMPLETED|Received Allocated Intervention||0||
48472576|NCT01411332|101492640|FG001|NOT COMPLETED|Treatment||0||
48472577|NCT01706926|101492641|FG000|STARTED|Overall Study||81||
48191058|NCT01414036|100789230|FG001|NOT COMPLETED|Received Allocated Intervention||13||
48191059|NCT01414036|100789229|FG000|STARTED|Completed 3 Month Survey||23||
48191060|NCT01414036|100789230|FG001|STARTED|Completed 3 Month Survey||24||
48191061|NCT01414036|100789229|FG000|COMPLETED|Completed 3 Month Survey||14||
48191062|NCT01414036|100789230|FG001|COMPLETED|Completed 3 Month Survey||19||
48191063|NCT01414036|100789229|FG000|NOT COMPLETED|Completed 3 Month Survey||9||
48191064|NCT01414036|100789230|FG001|NOT COMPLETED|Completed 3 Month Survey||5||
48191065|NCT02347943|100789231|FG000|STARTED|Overall Study||140||
48191066|NCT02347943|100789232|FG001|STARTED|Overall Study||67||
48191067|NCT02347943|100789233|FG002|STARTED|Overall Study||45||
48191068|NCT02347943|100789231|FG000|COMPLETED|Overall Study||0||
48191069|NCT02347943|100789232|FG001|COMPLETED|Overall Study||0||
48191070|NCT02347943|100789233|FG002|COMPLETED|Overall Study||0||
48191071|NCT02347943|100789231|FG000|NOT COMPLETED|Overall Study||140||
48472578|NCT01706926|101492642|FG001|STARTED|Overall Study||81||
48472579|NCT01706926|101492643|FG002|STARTED|Overall Study||85||
48472580|NCT01706926|101492644|FG003|STARTED|Overall Study||79||
48472581|NCT01706926|101492641|FG000|COMPLETED|Overall Study||75||
48472582|NCT01706926|101492642|FG001|COMPLETED|Overall Study||77||
48472583|NCT01706926|101492643|FG002|COMPLETED|Overall Study||79||
48191072|NCT02347943|100789232|FG001|NOT COMPLETED|Overall Study||67||
48191073|NCT02347943|100789233|FG002|NOT COMPLETED|Overall Study||45||
48191074|NCT05191797|100789234|FG000|STARTED|Overall Study||3||
48191075|NCT05191797|100789234|FG000|COMPLETED|Overall Study||3||
48191076|NCT05191797|100789234|FG000|NOT COMPLETED|Overall Study||0||
48191077|NCT00478556|100789235|FG000|STARTED|Overall Study||151||
48191078|NCT00478556|100789236|FG001|STARTED|Overall Study||149||
48191079|NCT00478556|100789235|FG000|COMPLETED|Overall Study||151||
48472584|NCT01706926|101492644|FG003|COMPLETED|Overall Study||74||
48191080|NCT00478556|100789236|FG001|COMPLETED|Overall Study||149||
48191081|NCT00478556|100789235|FG000|NOT COMPLETED|Overall Study||0||
48472585|NCT01706926|101492641|FG000|NOT COMPLETED|Overall Study||6||
48191082|NCT00478556|100789236|FG001|NOT COMPLETED|Overall Study||0||
48191083|NCT01112735|100789237|FG000|STARTED|Overall Study||20||
48191084|NCT01112735|100789238|FG001|STARTED|Overall Study||20||
48191085|NCT01112735|100789237|FG000|COMPLETED|Overall Study||20||
48191086|NCT01112735|100789238|FG001|COMPLETED|Overall Study||20||
48191087|NCT01112735|100789237|FG000|NOT COMPLETED|Overall Study||0||
48191088|NCT01112735|100789238|FG001|NOT COMPLETED|Overall Study||0||
48191089|NCT03836664|100789239|FG000|STARTED|Overall Study||14||
48191090|NCT03836664|100789240|FG001|STARTED|Overall Study||11||
48191091|NCT03836664|100789239|FG000|COMPLETED|Overall Study||11||
48191092|NCT03836664|100789240|FG001|COMPLETED|Overall Study||8||
48191093|NCT03836664|100789239|FG000|NOT COMPLETED|Overall Study||3||
48191094|NCT03836664|100789240|FG001|NOT COMPLETED|Overall Study||3||
48191095|NCT01639443|100789241|FG000|STARTED|Overall Study||180||
48191096|NCT01639443|100789242|FG001|STARTED|Overall Study||4855||
48191097|NCT01639443|100789241|FG000|COMPLETED|Overall Study||180||
48191098|NCT01639443|100789242|FG001|COMPLETED|Overall Study||4855||
48191099|NCT01639443|100789241|FG000|NOT COMPLETED|Overall Study||0||
48191100|NCT01639443|100789242|FG001|NOT COMPLETED|Overall Study||0||
48191101|NCT02531438|100789243|FG000|STARTED|Overall Study||386||
48191102|NCT02531438|100789244|FG001|STARTED|Overall Study||388||
48191103|NCT02531438|100789243|FG000|COMPLETED|Overall Study||356||
48191104|NCT02531438|100789244|FG001|COMPLETED|Overall Study||362||
48191105|NCT02531438|100789243|FG000|NOT COMPLETED|Overall Study||30||
48191106|NCT02531438|100789244|FG001|NOT COMPLETED|Overall Study||26||
48191107|NCT01268566|100789245|FG000|STARTED|Overall Study||56||
48191108|NCT01268566|100789245|FG000|COMPLETED|Overall Study||13||
48191109|NCT01268566|100789245|FG000|NOT COMPLETED|Overall Study||43||
48191110|NCT00495469|100791416|FG000|STARTED|Overall Study||36||
48191111|NCT00495469|100791417|FG001|STARTED|Overall Study||37||
48191112|NCT00495469|100791418|FG002|STARTED|Overall Study||34||
48191113|NCT00495469|100791419|FG003|STARTED|Overall Study||36||
48472586|NCT01706926|101492642|FG001|NOT COMPLETED|Overall Study||4||
48191114|NCT00495469|100791420|FG004|STARTED|Overall Study||36||
48191115|NCT00495469|100791421|FG005|STARTED|Overall Study||36||
48191116|NCT00495469|100791422|FG006|STARTED|Overall Study||35||
48191117|NCT00495469|100791416|FG000|COMPLETED|Overall Study||30||
48191118|NCT00495469|100791417|FG001|COMPLETED|Overall Study||30||
48191119|NCT00495469|100791418|FG002|COMPLETED|Overall Study||27||
48191120|NCT00495469|100791419|FG003|COMPLETED|Overall Study||32||
48191121|NCT00495469|100791420|FG004|COMPLETED|Overall Study||31||
48191122|NCT00495469|100791421|FG005|COMPLETED|Overall Study||31||
48472587|NCT01706926|101492643|FG002|NOT COMPLETED|Overall Study||6||
48472588|NCT01706926|101492644|FG003|NOT COMPLETED|Overall Study||5||
48472589|NCT03458871|101492645|FG000|STARTED|Overall Study||16||
48472590|NCT03458871|101492645|FG000|COMPLETED|Overall Study||16||
48472591|NCT03458871|101492645|FG000|NOT COMPLETED|Overall Study||0||
48472592|NCT00442936|101492646|FG000|STARTED|Overall Study||333||
48472593|NCT00442936|101492647|FG001|STARTED|Overall Study||354||
48472594|NCT00442936|101492648|FG002|STARTED|Overall Study||345||
48472595|NCT00442936|101492649|FG003|STARTED|Overall Study||348||
48472596|NCT00442936|101492646|FG000|COMPLETED|Overall Study||332||
48472597|NCT00442936|101492647|FG001|COMPLETED|Overall Study||354||
48472598|NCT00442936|101492648|FG002|COMPLETED|Overall Study||344||
48472599|NCT00442936|101492649|FG003|COMPLETED|Overall Study||347||
48472600|NCT00442936|101492646|FG000|NOT COMPLETED|Overall Study||1||
48472601|NCT00442936|101492647|FG001|NOT COMPLETED|Overall Study||0||
48472602|NCT00442936|101492648|FG002|NOT COMPLETED|Overall Study||1||
48472603|NCT00442936|101492649|FG003|NOT COMPLETED|Overall Study||1||
48472604|NCT01189123|101492650|FG000|STARTED|Overall Study||52||
48472605|NCT01189123|101492651|FG001|STARTED|Overall Study||53||
48472606|NCT01189123|101492650|FG000|COMPLETED|Overall Study||50||
48472607|NCT01189123|101492651|FG001|COMPLETED|Overall Study||47||
48472608|NCT01189123|101492650|FG000|NOT COMPLETED|Overall Study||2||
48472609|NCT01189123|101492651|FG001|NOT COMPLETED|Overall Study||6||
48472610|NCT00048568|101492652|FG000|STARTED|Double-Blind Period Days 1 to 169||433||
48472611|NCT00048568|101492653|FG001|STARTED|Double-Blind Period Days 1 to 169||219||
48472612|NCT00048568|101492654|FG002|STARTED|Double-Blind Period Days 1 to 169||0||
48472613|NCT00048568|101492652|FG000|COMPLETED|Double-Blind Period Days 1 to 169||401||
48472614|NCT00048568|101492653|FG001|COMPLETED|Double-Blind Period Days 1 to 169||174||
48472615|NCT00048568|101492654|FG002|COMPLETED|Double-Blind Period Days 1 to 169||0||
48472616|NCT00048568|101492652|FG000|NOT COMPLETED|Double-Blind Period Days 1 to 169||32||
48472617|NCT00048568|101492653|FG001|NOT COMPLETED|Double-Blind Period Days 1 to 169||45||
48472618|NCT00048568|101492654|FG002|NOT COMPLETED|Double-Blind Period Days 1 to 169||0||
48472619|NCT00048568|101492652|FG000|STARTED|Double-Blind Period Days 170 to 365||401||
48472620|NCT00048568|101492653|FG001|STARTED|Double-Blind Period Days 170 to 365||174||
48472621|NCT00048568|101492654|FG002|STARTED|Double-Blind Period Days 170 to 365||0||
48472622|NCT00048568|101492652|FG000|COMPLETED|Double-Blind Period Days 170 to 365||385||
48472623|NCT00048568|101492653|FG001|COMPLETED|Double-Blind Period Days 170 to 365||162||
48472624|NCT00048568|101492654|FG002|COMPLETED|Double-Blind Period Days 170 to 365||0||
48472625|NCT00048568|101492652|FG000|NOT COMPLETED|Double-Blind Period Days 170 to 365||16||
48472626|NCT00048568|101492653|FG001|NOT COMPLETED|Double-Blind Period Days 170 to 365||12||
48472627|NCT00048568|101492654|FG002|NOT COMPLETED|Double-Blind Period Days 170 to 365||0||
48472628|NCT00048568|101492652|FG000|STARTED|Open-Label Period||0||
48472629|NCT00048568|101492653|FG001|STARTED|Open-Label Period||0||
48472630|NCT00048568|101492654|FG002|STARTED|Open-Label Period||539||
48472631|NCT00048568|101492652|FG000|COMPLETED|Open-Label Period||0||
48472632|NCT00048568|101492653|FG001|COMPLETED|Open-Label Period||0||
48472633|NCT00048568|101492654|FG002|COMPLETED|Open-Label Period||379||
48472634|NCT00048568|101492652|FG000|NOT COMPLETED|Open-Label Period||0||
48472635|NCT00048568|101492653|FG001|NOT COMPLETED|Open-Label Period||0||
48472636|NCT00048568|101492654|FG002|NOT COMPLETED|Open-Label Period||160||
48472637|NCT04087395|101492655|FG000|STARTED|Overall Study||30||
48472638|NCT04087395|101492655|FG000|COMPLETED|Overall Study||30||
48472639|NCT04087395|101492655|FG000|NOT COMPLETED|Overall Study||0||
48472640|NCT00534703|101492656|FG000|STARTED|Overall Study||4||
48472641|NCT00534703|101492657|FG001|STARTED|Overall Study||1||
48472642|NCT00534703|101492656|FG000|COMPLETED|Overall Study||4||
48472643|NCT00534703|101492657|FG001|COMPLETED|Overall Study||1||
48472644|NCT00534703|101492656|FG000|NOT COMPLETED|Overall Study||0||
48472645|NCT00534703|101492657|FG001|NOT COMPLETED|Overall Study||0||
48472646|NCT02143102|101492658|FG000|STARTED|Overall Study||97||
48472647|NCT02143102|101492659|FG001|STARTED|Overall Study||28||
48472648|NCT02143102|101492658|FG000|COMPLETED|Overall Study||86||
48472649|NCT02143102|101492659|FG001|COMPLETED|Overall Study||28||
48472650|NCT02143102|101492658|FG000|NOT COMPLETED|Overall Study||11||
48472651|NCT02143102|101492659|FG001|NOT COMPLETED|Overall Study||0||
48472652|NCT05150964|101492660|FG000|STARTED|Overall Study||16||
48472653|NCT05150964|101492660|FG000|COMPLETED|Overall Study||14||
48472654|NCT05150964|101492660|FG000|NOT COMPLETED|Overall Study||2||
48472655|NCT00788125|101492661|FG000|STARTED|Overall Study||7||
48472656|NCT00788125|101492661|FG000|COMPLETED|Overall Study||1||
48472657|NCT00788125|101492661|FG000|NOT COMPLETED|Overall Study||6||
48472658|NCT04529109|101492662|FG000|STARTED|Period 1||27||
48472659|NCT04529109|101492663|FG001|STARTED|Period 1||29||
48472660|NCT04529109|101492662|FG000|COMPLETED|Period 1||27||
48472661|NCT04529109|101492663|FG001|COMPLETED|Period 1||28||
48472662|NCT04529109|101492662|FG000|NOT COMPLETED|Period 1||0||
48472663|NCT04529109|101492663|FG001|NOT COMPLETED|Period 1||1||
48472664|NCT04529109|101492662|FG000|STARTED|Period 2||27||
48472665|NCT04529109|101492663|FG001|STARTED|Period 2||28||
48472666|NCT04529109|101492662|FG000|COMPLETED|Period 2||27||
48472667|NCT04529109|101492663|FG001|COMPLETED|Period 2||28||
48472668|NCT04529109|101492662|FG000|NOT COMPLETED|Period 2||0||
48472669|NCT04529109|101492663|FG001|NOT COMPLETED|Period 2||0||
48472670|NCT00094302|101492664|FG000|STARTED|Overall Study||1723||
48472671|NCT00094302|101492665|FG001|STARTED|Overall Study||1722||
48472672|NCT00094302|101492664|FG000|COMPLETED|Overall Study||1306||
48472673|NCT00094302|101492665|FG001|COMPLETED|Overall Study||1316||
48472674|NCT00094302|101492664|FG000|NOT COMPLETED|Overall Study||417||
48472675|NCT00094302|101492665|FG001|NOT COMPLETED|Overall Study||406||
48472676|NCT03247556|101492666|FG000|STARTED|Overall Study||97|"The total number of subjects started (N=296) is based on the Safety Population (defined as subjects who were randomized and took at least one dose of study medication). The total number of subjects enrolled (N=297) is based on the Randomized Population (defined as subjects who were randomized)."|
48472677|NCT03247556|101492667|FG001|STARTED|Overall Study||100|"The total number of subjects started (N=296) is based on the Safety Population (defined as subjects who were randomized and took at least one dose of study medication). The total number of subjects enrolled (N=297) is based on the Randomized Population (defined as subjects who were randomized)."|
48472678|NCT03247556|101492668|FG002|STARTED|Overall Study||99|"The total number of subjects started (N=296) is based on the Safety Population (defined as subjects who were randomized and took at least one dose of study medication). The total number of subjects enrolled (N=297) is based on the Randomized Population (defined as subjects who were randomized)."|
48472679|NCT03247556|101492666|FG000|COMPLETED|Overall Study||85||
48472680|NCT03247556|101492667|FG001|COMPLETED|Overall Study||88||
48472681|NCT03247556|101492668|FG002|COMPLETED|Overall Study||81||
48472682|NCT03247556|101492666|FG000|NOT COMPLETED|Overall Study||12||
48472683|NCT03247556|101492667|FG001|NOT COMPLETED|Overall Study||12||
48472684|NCT03247556|101492668|FG002|NOT COMPLETED|Overall Study||18||
48472685|NCT00796822|101492669|FG000|STARTED|Overall Study||13||
48472686|NCT00796822|101492670|FG001|STARTED|Overall Study||13||
48472687|NCT00796822|101492669|FG000|COMPLETED|Overall Study||10||
48472688|NCT00796822|101492670|FG001|COMPLETED|Overall Study||13||
48472689|NCT00796822|101492669|FG000|NOT COMPLETED|Overall Study||3||
48472690|NCT00796822|101492670|FG001|NOT COMPLETED|Overall Study||0||
48472691|NCT02385097|101492671|FG000|STARTED|Overall Study||106||
48472692|NCT02385097|101492672|FG001|STARTED|Overall Study||105||
48472693|NCT02385097|101492671|FG000|COMPLETED|Overall Study||106||
48472694|NCT02385097|101492672|FG001|COMPLETED|Overall Study||105||
48472695|NCT02385097|101492671|FG000|NOT COMPLETED|Overall Study||0||
48472696|NCT02385097|101492672|FG001|NOT COMPLETED|Overall Study||0||
48472697|NCT01225146|101492673|FG000|STARTED|Overall Study||6||
48472698|NCT01225146|101492674|FG001|STARTED|Overall Study||2||
48472699|NCT01225146|101492673|FG000|COMPLETED|Overall Study||6||
48472700|NCT01225146|101492674|FG001|COMPLETED|Overall Study||0||
48472701|NCT01225146|101492673|FG000|NOT COMPLETED|Overall Study||0||
48472702|NCT01225146|101492674|FG001|NOT COMPLETED|Overall Study||2||
48472703|NCT00870870|101492675|FG000|STARTED|Overall Study||4||
48472704|NCT00870870|101492676|FG001|STARTED|Overall Study||6||
48472705|NCT00870870|101492677|FG002|STARTED|Overall Study||29||
48472706|NCT00870870|101492678|FG003|STARTED|Overall Study||25||
48472707|NCT00870870|101492675|FG000|COMPLETED|Overall Study||4||
48472708|NCT00870870|101492676|FG001|COMPLETED|Overall Study||5||
48472709|NCT00870870|101492677|FG002|COMPLETED|Overall Study||26||
48472710|NCT00870870|101492678|FG003|COMPLETED|Overall Study||20||
48472711|NCT00870870|101492675|FG000|NOT COMPLETED|Overall Study||0||
48472712|NCT00870870|101492676|FG001|NOT COMPLETED|Overall Study||1||
48472713|NCT00870870|101492677|FG002|NOT COMPLETED|Overall Study||3||
48472714|NCT00870870|101492678|FG003|NOT COMPLETED|Overall Study||5||
48472715|NCT00483496|101492679|FG000|STARTED|Overall Study||16||
48472716|NCT00483496|101492679|FG000|COMPLETED|Overall Study||15||
48472717|NCT00483496|101492679|FG000|NOT COMPLETED|Overall Study||1||
48472718|NCT00784849|101492680|FG000|STARTED|Overall Study||62||
48472719|NCT00784849|101492680|FG000|COMPLETED|Overall Study||62||
48472720|NCT00784849|101492680|FG000|NOT COMPLETED|Overall Study||0||
48472721|NCT00727571|101492681|FG000|STARTED|Overall Study||232||
48472722|NCT00727571|101492682|FG001|STARTED|Overall Study||228||
48472723|NCT00727571|101492683|FG002|STARTED|Overall Study||165||
48472724|NCT00727571|101492684|FG003|STARTED|Overall Study||169||
48472725|NCT00727571|101492681|FG000|COMPLETED|Overall Study||231||
48472726|NCT00727571|101492682|FG001|COMPLETED|Overall Study||173||
48472727|NCT00727571|101492683|FG002|COMPLETED|Overall Study||135||
48472728|NCT00727571|101492684|FG003|COMPLETED|Overall Study||163||
48472729|NCT00727571|101492681|FG000|NOT COMPLETED|Overall Study||1||
48472730|NCT00727571|101492682|FG001|NOT COMPLETED|Overall Study||55||
48472731|NCT00727571|101492683|FG002|NOT COMPLETED|Overall Study||30||
48472732|NCT00727571|101492684|FG003|NOT COMPLETED|Overall Study||6||
48472733|NCT00688064|101492685|FG000|STARTED|Overall Study||232||
48472734|NCT00688064|101492686|FG001|STARTED|Overall Study||227||
48472735|NCT00688064|101492685|FG000|COMPLETED|Overall Study||211||
48472736|NCT00688064|101492686|FG001|COMPLETED|Overall Study||201||
48472737|NCT00688064|101492685|FG000|NOT COMPLETED|Overall Study||21||
48472738|NCT00688064|101492686|FG001|NOT COMPLETED|Overall Study||26||
48472739|NCT01632709|101492687|FG000|STARTED|Overall Study||4||
48472740|NCT01632709|101492688|FG001|STARTED|Overall Study||3||
48472741|NCT01632709|101492689|FG002|STARTED|Overall Study||5||
48472742|NCT01632709|101492690|FG003|STARTED|Overall Study||4||
48472743|NCT01632709|101492687|FG000|Completed Visit 2 (Received Injection)|Overall Study||4||
48472744|NCT01632709|101492688|FG001|Completed Visit 2 (Received Injection)|Overall Study||2||
48472745|NCT01632709|101492689|FG002|Completed Visit 2 (Received Injection)|Overall Study||5||
48472746|NCT01632709|101492690|FG003|Completed Visit 2 (Received Injection)|Overall Study||3||
48472747|NCT01632709|101492687|FG000|COMPLETED|Overall Study||2||
48472748|NCT01632709|101492688|FG001|COMPLETED|Overall Study||2||
48472749|NCT01632709|101492689|FG002|COMPLETED|Overall Study||5||
48472750|NCT01632709|101492690|FG003|COMPLETED|Overall Study||3||
48472751|NCT01632709|101492687|FG000|NOT COMPLETED|Overall Study||2||
48472752|NCT01632709|101492688|FG001|NOT COMPLETED|Overall Study||1||
48472753|NCT01632709|101492689|FG002|NOT COMPLETED|Overall Study||0||
48472754|NCT01632709|101492690|FG003|NOT COMPLETED|Overall Study||1||
48472755|NCT00048048|101492691|FG000|STARTED|Core Treatment||6||
48472756|NCT00048048|101492692|FG001|STARTED|Core Treatment||6||
48472757|NCT00048048|101492693|FG002|STARTED|Core Treatment||10||
48472758|NCT00048048|101492694|FG003|STARTED|Core Treatment||6||
48472759|NCT00048048|101492695|FG004|STARTED|Core Treatment||6||
48472760|NCT00048048|101492696|FG005|STARTED|Core Treatment||9||
48472761|NCT00048048|101492697|FG006|STARTED|Core Treatment||6||
48472762|NCT00048048|101492698|FG007|STARTED|Core Treatment||6||
48472763|NCT00048048|101492699|FG008|STARTED|Core Treatment||10||
48472764|NCT00048048|101492700|FG009|STARTED|Core Treatment||0||
48472765|NCT00048048|101492701|FG010|STARTED|Core Treatment||0||
48472766|NCT00048048|101492702|FG011|STARTED|Core Treatment||0||
48472767|NCT00048048|101492691|FG000|COMPLETED|Core Treatment||6||
48472768|NCT00048048|101492692|FG001|COMPLETED|Core Treatment||6||
48472769|NCT00048048|101492693|FG002|COMPLETED|Core Treatment||9||
48472770|NCT00048048|101492694|FG003|COMPLETED|Core Treatment||6||
48472771|NCT00048048|101492695|FG004|COMPLETED|Core Treatment||6||
48191123|NCT00495469|100791422|FG006|COMPLETED|Overall Study||30||
48191124|NCT00495469|100791416|FG000|NOT COMPLETED|Overall Study||6||
48191125|NCT00495469|100791417|FG001|NOT COMPLETED|Overall Study||7||
48191126|NCT00495469|100791418|FG002|NOT COMPLETED|Overall Study||7||
48191127|NCT00495469|100791419|FG003|NOT COMPLETED|Overall Study||4||
48472772|NCT00048048|101492696|FG005|COMPLETED|Core Treatment||9||
48472773|NCT00048048|101492697|FG006|COMPLETED|Core Treatment||6||
48472774|NCT00048048|101492698|FG007|COMPLETED|Core Treatment||5||
48472775|NCT00048048|101492699|FG008|COMPLETED|Core Treatment||10||
48472776|NCT00048048|101492700|FG009|COMPLETED|Core Treatment||0||
48472777|NCT00048048|101492701|FG010|COMPLETED|Core Treatment||0||
48472778|NCT00048048|101492702|FG011|COMPLETED|Core Treatment||0||
48191128|NCT00495469|100791420|FG004|NOT COMPLETED|Overall Study||5||
48191129|NCT00495469|100791421|FG005|NOT COMPLETED|Overall Study||5||
48472779|NCT00048048|101492691|FG000|NOT COMPLETED|Core Treatment||0||
48472780|NCT00048048|101492692|FG001|NOT COMPLETED|Core Treatment||0||
48472781|NCT00048048|101492693|FG002|NOT COMPLETED|Core Treatment||1||
48472782|NCT00048048|101492694|FG003|NOT COMPLETED|Core Treatment||0||
48472783|NCT00048048|101492695|FG004|NOT COMPLETED|Core Treatment||0||
48472784|NCT00048048|101492696|FG005|NOT COMPLETED|Core Treatment||0||
48472785|NCT00048048|101492697|FG006|NOT COMPLETED|Core Treatment||0||
48472786|NCT00048048|101492698|FG007|NOT COMPLETED|Core Treatment||1||
48472787|NCT00048048|101492699|FG008|NOT COMPLETED|Core Treatment||0||
48472788|NCT00048048|101492700|FG009|NOT COMPLETED|Core Treatment||0||
48472789|NCT00048048|101492701|FG010|NOT COMPLETED|Core Treatment||0||
48472790|NCT00048048|101492702|FG011|NOT COMPLETED|Core Treatment||0||
48472791|NCT00048048|101492691|FG000|STARTED|Extension Year 1||0||
48472792|NCT00048048|101492692|FG001|STARTED|Extension Year 1||0||
48472793|NCT00048048|101492693|FG002|STARTED|Extension Year 1||0||
48472794|NCT00048048|101492694|FG003|STARTED|Extension Year 1||0||
48472795|NCT00048048|101492695|FG004|STARTED|Extension Year 1||0||
48472796|NCT00048048|101492696|FG005|STARTED|Extension Year 1||0||
48472797|NCT00048048|101492697|FG006|STARTED|Extension Year 1||0||
48472798|NCT00048048|101492698|FG007|STARTED|Extension Year 1||0||
48472799|NCT00048048|101492699|FG008|STARTED|Extension Year 1||0||
48472800|NCT00048048|101492700|FG009|STARTED|Extension Year 1||16||
48472801|NCT00048048|101492701|FG010|STARTED|Extension Year 1||16||
48472802|NCT00048048|101492702|FG011|STARTED|Extension Year 1||19||
48472803|NCT00048048|101492691|FG000|COMPLETED|Extension Year 1||0||
48472804|NCT00048048|101492692|FG001|COMPLETED|Extension Year 1||0||
48472805|NCT00048048|101492693|FG002|COMPLETED|Extension Year 1||0||
48472806|NCT00048048|101492694|FG003|COMPLETED|Extension Year 1||0||
48472807|NCT00048048|101492695|FG004|COMPLETED|Extension Year 1||0||
48472808|NCT00048048|101492696|FG005|COMPLETED|Extension Year 1||0||
48472809|NCT00048048|101492697|FG006|COMPLETED|Extension Year 1||0||
48472810|NCT00048048|101492698|FG007|COMPLETED|Extension Year 1||0||
48472811|NCT00048048|101492699|FG008|COMPLETED|Extension Year 1||0||
48472812|NCT00048048|101492700|FG009|COMPLETED|Extension Year 1||14||
48472813|NCT00048048|101492701|FG010|COMPLETED|Extension Year 1||14||
48472814|NCT00048048|101492702|FG011|COMPLETED|Extension Year 1||15||
48472815|NCT00048048|101492691|FG000|NOT COMPLETED|Extension Year 1||0||
48472816|NCT00048048|101492692|FG001|NOT COMPLETED|Extension Year 1||0||
48472817|NCT00048048|101492693|FG002|NOT COMPLETED|Extension Year 1||0||
48472818|NCT00048048|101492694|FG003|NOT COMPLETED|Extension Year 1||0||
48472819|NCT00048048|101492695|FG004|NOT COMPLETED|Extension Year 1||0||
48472820|NCT00048048|101492696|FG005|NOT COMPLETED|Extension Year 1||0||
48472821|NCT00048048|101492697|FG006|NOT COMPLETED|Extension Year 1||0||
48472822|NCT00048048|101492698|FG007|NOT COMPLETED|Extension Year 1||0||
48472823|NCT00048048|101492699|FG008|NOT COMPLETED|Extension Year 1||0||
48472824|NCT00048048|101492700|FG009|NOT COMPLETED|Extension Year 1||2||
48472825|NCT00048048|101492701|FG010|NOT COMPLETED|Extension Year 1||2||
48472826|NCT00048048|101492702|FG011|NOT COMPLETED|Extension Year 1||4||
48472827|NCT00048048|101492691|FG000|STARTED|Extension Year 2||0||
48472828|NCT00048048|101492692|FG001|STARTED|Extension Year 2||0||
48472829|NCT00048048|101492693|FG002|STARTED|Extension Year 2||0||
48472830|NCT00048048|101492694|FG003|STARTED|Extension Year 2||0||
48472831|NCT00048048|101492695|FG004|STARTED|Extension Year 2||0||
48472832|NCT00048048|101492696|FG005|STARTED|Extension Year 2||0||
48472833|NCT00048048|101492697|FG006|STARTED|Extension Year 2||0||
48472834|NCT00048048|101492698|FG007|STARTED|Extension Year 2||0||
48472835|NCT00048048|101492699|FG008|STARTED|Extension Year 2||0||
48472836|NCT00048048|101492700|FG009|STARTED|Extension Year 2||2||
48472837|NCT00048048|101492701|FG010|STARTED|Extension Year 2||23||
48472838|NCT00048048|101492702|FG011|STARTED|Extension Year 2||15||
48472839|NCT00048048|101492691|FG000|COMPLETED|Extension Year 2||0||
48472840|NCT00048048|101492692|FG001|COMPLETED|Extension Year 2||0||
48472841|NCT00048048|101492693|FG002|COMPLETED|Extension Year 2||0||
48472842|NCT00048048|101492694|FG003|COMPLETED|Extension Year 2||0||
48472843|NCT00048048|101492695|FG004|COMPLETED|Extension Year 2||0||
48472844|NCT00048048|101492696|FG005|COMPLETED|Extension Year 2||0||
48472845|NCT00048048|101492697|FG006|COMPLETED|Extension Year 2||0||
48472846|NCT00048048|101492698|FG007|COMPLETED|Extension Year 2||0||
48472847|NCT00048048|101492699|FG008|COMPLETED|Extension Year 2||0||
48472848|NCT00048048|101492700|FG009|COMPLETED|Extension Year 2||2||
48472849|NCT00048048|101492701|FG010|COMPLETED|Extension Year 2||19||
48472850|NCT00048048|101492702|FG011|COMPLETED|Extension Year 2||13||
48472851|NCT00048048|101492691|FG000|NOT COMPLETED|Extension Year 2||0||
48472852|NCT00048048|101492692|FG001|NOT COMPLETED|Extension Year 2||0||
48472853|NCT00048048|101492693|FG002|NOT COMPLETED|Extension Year 2||0||
48472854|NCT00048048|101492694|FG003|NOT COMPLETED|Extension Year 2||0||
48472855|NCT00048048|101492695|FG004|NOT COMPLETED|Extension Year 2||0||
48472856|NCT00048048|101492696|FG005|NOT COMPLETED|Extension Year 2||0||
48472857|NCT00048048|101492697|FG006|NOT COMPLETED|Extension Year 2||0||
48472858|NCT00048048|101492698|FG007|NOT COMPLETED|Extension Year 2||0||
48472859|NCT00048048|101492699|FG008|NOT COMPLETED|Extension Year 2||0||
48472860|NCT00048048|101492700|FG009|NOT COMPLETED|Extension Year 2||0||
48472861|NCT00048048|101492701|FG010|NOT COMPLETED|Extension Year 2||4||
48472862|NCT00048048|101492702|FG011|NOT COMPLETED|Extension Year 2||2||
48472863|NCT00795665|101492703|FG000|STARTED|Overall Study||7||
48472864|NCT00795665|101492703|FG000|COMPLETED|Overall Study||7||
48472865|NCT00795665|101492703|FG000|NOT COMPLETED|Overall Study||0||
48472866|NCT00928083|101492704|FG000|STARTED|Overall Study||10||
48472867|NCT00928083|101492705|FG001|STARTED|Overall Study||8||
48472868|NCT00928083|101492706|FG002|STARTED|Overall Study||8||
48472869|NCT00928083|101492707|FG003|STARTED|Overall Study||6||
48472870|NCT00928083|101492708|FG004|STARTED|Overall Study||7||
48472871|NCT00928083|101492709|FG005|STARTED|Overall Study||6||
48472872|NCT00928083|101492710|FG006|STARTED|Overall Study||6||
48472873|NCT00928083|101492711|FG007|STARTED|Overall Study||6||
48472874|NCT00928083|101492712|FG008|STARTED|Overall Study||6||
48472875|NCT00928083|101492704|FG000|COMPLETED|Overall Study||6||
48472876|NCT00928083|101492705|FG001|COMPLETED|Overall Study||8||
48472877|NCT00928083|101492706|FG002|COMPLETED|Overall Study||8||
48472878|NCT00928083|101492707|FG003|COMPLETED|Overall Study||5||
48472879|NCT00928083|101492708|FG004|COMPLETED|Overall Study||6||
48472880|NCT00928083|101492709|FG005|COMPLETED|Overall Study||6||
48472881|NCT00928083|101492710|FG006|COMPLETED|Overall Study||6||
48472882|NCT00928083|101492711|FG007|COMPLETED|Overall Study||6||
48472883|NCT00928083|101492712|FG008|COMPLETED|Overall Study||6||
48472884|NCT00928083|101492704|FG000|NOT COMPLETED|Overall Study||4||
48472885|NCT00928083|101492705|FG001|NOT COMPLETED|Overall Study||0||
48472886|NCT00928083|101492706|FG002|NOT COMPLETED|Overall Study||0||
48472887|NCT00928083|101492707|FG003|NOT COMPLETED|Overall Study||1||
48472888|NCT00928083|101492708|FG004|NOT COMPLETED|Overall Study||1||
48472889|NCT00928083|101492709|FG005|NOT COMPLETED|Overall Study||0||
48472890|NCT00928083|101492710|FG006|NOT COMPLETED|Overall Study||0||
48472891|NCT00928083|101492711|FG007|NOT COMPLETED|Overall Study||0||
48472892|NCT00928083|101492712|FG008|NOT COMPLETED|Overall Study||0||
48472893|NCT03482882|101492713|FG000|STARTED|Overall Study||47||
48472894|NCT03482882|101492713|FG000|COMPLETED|Overall Study||40||
48472895|NCT03482882|101492713|FG000|NOT COMPLETED|Overall Study||7||
48472896|NCT04183231|101492714|FG000|STARTED|Overall Study||16||
48472897|NCT04183231|101492714|FG000|COMPLETED|Overall Study||16||
48472898|NCT04183231|101492714|FG000|NOT COMPLETED|Overall Study||0||
48472899|NCT01860976|101492715|FG000|STARTED|Blinded Treatment||213||
48472900|NCT01860976|101492716|FG001|STARTED|Blinded Treatment||211||
48472901|NCT01860976|101492715|FG000|COMPLETED|Blinded Treatment||125|completed = participants who completed treatment period|
48472902|NCT01860976|101492716|FG001|COMPLETED|Blinded Treatment||98|completed = participants who completed treatment period|
48472903|NCT01860976|101492715|FG000|NOT COMPLETED|Blinded Treatment||88||
48472904|NCT01860976|101492716|FG001|NOT COMPLETED|Blinded Treatment||113||
48472905|NCT01860976|101492715|FG000|STARTED|Open-Label||197||
48472906|NCT01860976|101492716|FG001|STARTED|Open-Label||185||
48472907|NCT01860976|101492715|FG000|COMPLETED|Open-Label||169|completed = participants who completed the open label period|
48472908|NCT01860976|101492716|FG001|COMPLETED|Open-Label||166|completed = participants who completed the open label period|
48472909|NCT01860976|101492715|FG000|NOT COMPLETED|Open-Label||28||
48472910|NCT01860976|101492716|FG001|NOT COMPLETED|Open-Label||19||
48472911|NCT01860976|101492715|FG000|STARTED|Long Term Extension||106||
48472912|NCT01860976|101492716|FG001|STARTED|Long Term Extension||0||
48472913|NCT01860976|101492715|FG000|COMPLETED|Long Term Extension||81|completed = completed long term extension period at the time of analysis|
48472914|NCT01860976|101492716|FG001|COMPLETED|Long Term Extension||0|completed = completed long term extension period at the time of analysis|
48472915|NCT01860976|101492715|FG000|NOT COMPLETED|Long Term Extension||25||
48472916|NCT01860976|101492716|FG001|NOT COMPLETED|Long Term Extension||0||
48472917|NCT01941030|101492717|FG000|STARTED|Overall Study||25||
48472918|NCT01941030|101492718|FG001|STARTED|Overall Study||26||
48472919|NCT01941030|101492717|FG000|COMPLETED|Overall Study||12||
48472920|NCT01941030|101492718|FG001|COMPLETED|Overall Study||13||
48472921|NCT01941030|101492717|FG000|NOT COMPLETED|Overall Study||13||
48472922|NCT01941030|101492718|FG001|NOT COMPLETED|Overall Study||13||
48472923|NCT00525590|101492719|FG000|STARTED|Overall Study||59||
48472924|NCT00525590|101492719|FG000|COMPLETED|Overall Study||14||
48472925|NCT00525590|101492719|FG000|NOT COMPLETED|Overall Study||45||
48472926|NCT00623779|101492720|FG000|STARTED|Overall Study||41||
48472927|NCT00623779|101492721|FG001|STARTED|Overall Study||42||
48472928|NCT00623779|101492722|FG002|STARTED|Overall Study||45||
48472929|NCT00623779|101492720|FG000|COMPLETED|Overall Study||38||
48472930|NCT00623779|101492721|FG001|COMPLETED|Overall Study||39||
48472931|NCT00623779|101492722|FG002|COMPLETED|Overall Study||44||
48472932|NCT00623779|101492720|FG000|NOT COMPLETED|Overall Study||3||
48472933|NCT00623779|101492721|FG001|NOT COMPLETED|Overall Study||3||
48472934|NCT00623779|101492722|FG002|NOT COMPLETED|Overall Study||1||
48472935|NCT02906709|101492723|FG000|STARTED|Phase A (Week 0 to Week 16)||123||
48472936|NCT02906709|101492724|FG001|STARTED|Phase A (Week 0 to Week 16)||61||
48472937|NCT02906709|101492723|FG000|COMPLETED|Phase A (Week 0 to Week 16)||122||
48472938|NCT02906709|101492724|FG001|COMPLETED|Phase A (Week 0 to Week 16)||58||
48472939|NCT02906709|101492723|FG000|NOT COMPLETED|Phase A (Week 0 to Week 16)||1||
48472940|NCT02906709|101492724|FG001|NOT COMPLETED|Phase A (Week 0 to Week 16)||3||
48472941|NCT02906709|101492723|FG000|STARTED|Phase B (Extension, Week 17 to Week 52)||122||
48472942|NCT02906709|101492724|FG001|STARTED|Phase B (Extension, Week 17 to Week 52)||58||
48472943|NCT02906709|101492723|FG000|COMPLETED|Phase B (Extension, Week 17 to Week 52)||117||
48472944|NCT02906709|101492724|FG001|COMPLETED|Phase B (Extension, Week 17 to Week 52)||58||
48472945|NCT02906709|101492723|FG000|NOT COMPLETED|Phase B (Extension, Week 17 to Week 52)||5||
48472946|NCT02906709|101492724|FG001|NOT COMPLETED|Phase B (Extension, Week 17 to Week 52)||0||
48472947|NCT04041570|101492725|FG000|STARTED|Overall Study||20||
48472948|NCT04041570|101492726|FG001|STARTED|Overall Study||20||
48472949|NCT04041570|101492725|FG000|COMPLETED|Overall Study||20||
48472950|NCT04041570|101492726|FG001|COMPLETED|Overall Study||18||
48472951|NCT04041570|101492725|FG000|NOT COMPLETED|Overall Study||0||
48472952|NCT04041570|101492726|FG001|NOT COMPLETED|Overall Study||2||
48472953|NCT00248638|101492727|FG000|STARTED|Overall Study||75||
48472954|NCT00248638|101492728|FG001|STARTED|Overall Study||75||
48472955|NCT00248638|101492727|FG000|COMPLETED|Overall Study||75||
48472956|NCT00248638|101492728|FG001|COMPLETED|Overall Study||75||
48472957|NCT00248638|101492727|FG000|NOT COMPLETED|Overall Study||0||
48472958|NCT00248638|101492728|FG001|NOT COMPLETED|Overall Study||0||
48472959|NCT03019965|101492729|FG000|STARTED|Overall Study||211||
48472960|NCT03019965|101492730|FG001|STARTED|Overall Study||215||
48472961|NCT03019965|101492729|FG000|COMPLETED|Overall Study||201||
48472962|NCT03019965|101492730|FG001|COMPLETED|Overall Study||202||
48472963|NCT03019965|101492729|FG000|NOT COMPLETED|Overall Study||10||
48472964|NCT03019965|101492730|FG001|NOT COMPLETED|Overall Study||13||
48472965|NCT02116803|101492731|FG000|STARTED|Overall Study||10||
48472966|NCT02116803|101492732|FG001|STARTED|Overall Study||2||
48472967|NCT02116803|101492731|FG000|COMPLETED|Overall Study||0||
48472968|NCT02116803|101492732|FG001|COMPLETED|Overall Study||0||
48472969|NCT02116803|101492731|FG000|NOT COMPLETED|Overall Study||10||
48472970|NCT02116803|101492732|FG001|NOT COMPLETED|Overall Study||2||
48472971|NCT00098371|101492733|FG000|STARTED|Overall Study||64||
48472972|NCT00098371|101492733|FG000|COMPLETED|Overall Study||64||
48472973|NCT00098371|101492733|FG000|NOT COMPLETED|Overall Study||0||
48472974|NCT01353495|101492734|FG000|STARTED|Overall Study||19||
48472975|NCT01353495|101492735|FG001|STARTED|Overall Study||20||
48472976|NCT01353495|101492734|FG000|COMPLETED|Overall Study||19||
48472977|NCT01353495|101492735|FG001|COMPLETED|Overall Study||20||
48472978|NCT01353495|101492734|FG000|NOT COMPLETED|Overall Study||0||
48472979|NCT01353495|101492735|FG001|NOT COMPLETED|Overall Study||0||
48472980|NCT00818337|101492736|FG000|STARTED|Overall Study||36||
48472981|NCT00818337|101492736|FG000|COMPLETED|Overall Study||36||
48472982|NCT00818337|101492736|FG000|NOT COMPLETED|Overall Study||0||
48472983|NCT02268500|101492737|FG000|STARTED|Overall Study||24||
48472984|NCT02268500|101492738|FG001|STARTED|Overall Study||24||
48472985|NCT02268500|101492737|FG000|COMPLETED|Overall Study||24||
48472986|NCT02268500|101492738|FG001|COMPLETED|Overall Study||24||
48472987|NCT02268500|101492737|FG000|NOT COMPLETED|Overall Study||0||
48472988|NCT02268500|101492738|FG001|NOT COMPLETED|Overall Study||0||
48472989|NCT01939197|101492739|FG000|STARTED|Overall Study||31||
48472990|NCT01939197|101492740|FG001|STARTED|Overall Study||32||
48472991|NCT01939197|101492741|FG002|STARTED|Overall Study||10||
48472992|NCT01939197|101492742|FG003|STARTED|Overall Study||12||
48472993|NCT01939197|101492743|FG004|STARTED|Overall Study||200||
48472994|NCT01939197|101492744|FG005|STARTED|Overall Study||5||
48472995|NCT01939197|101492745|FG006|STARTED|Overall Study||28||
48472996|NCT01939197|101492739|FG000|COMPLETED|Overall Study||30||
48472997|NCT01939197|101492740|FG001|COMPLETED|Overall Study||31||
48472998|NCT01939197|101492741|FG002|COMPLETED|Overall Study||10||
48472999|NCT01939197|101492742|FG003|COMPLETED|Overall Study||11||
48473000|NCT01939197|101492743|FG004|COMPLETED|Overall Study||196||
48473001|NCT01939197|101492744|FG005|COMPLETED|Overall Study||4||
48473002|NCT01939197|101492745|FG006|COMPLETED|Overall Study||26||
48473003|NCT01939197|101492739|FG000|NOT COMPLETED|Overall Study||1||
48473004|NCT01939197|101492740|FG001|NOT COMPLETED|Overall Study||1||
48473005|NCT01939197|101492741|FG002|NOT COMPLETED|Overall Study||0||
48473006|NCT01939197|101492742|FG003|NOT COMPLETED|Overall Study||1||
48473007|NCT01939197|101492743|FG004|NOT COMPLETED|Overall Study||4||
48473008|NCT01939197|101492744|FG005|NOT COMPLETED|Overall Study||1||
48473009|NCT01939197|101492745|FG006|NOT COMPLETED|Overall Study||2||
48473010|NCT00395226|101492746|FG000|STARTED|Overall Study||26||
48473011|NCT00395226|101492747|FG001|STARTED|Overall Study||27||
48473012|NCT00395226|101492746|FG000|COMPLETED|Overall Study||22||
48473013|NCT00395226|101492747|FG001|COMPLETED|Overall Study||22||
48191130|NCT00495469|100791422|FG006|NOT COMPLETED|Overall Study||5||
48473014|NCT00395226|101492746|FG000|NOT COMPLETED|Overall Study||4||
48473015|NCT00395226|101492747|FG001|NOT COMPLETED|Overall Study||5||
48473016|NCT00928954|101492748|FG000|STARTED|Overall Study||4||
48473017|NCT00928954|101492749|FG001|STARTED|Overall Study||6||
48473018|NCT00928954|101492748|FG000|COMPLETED|Overall Study||4||
48473019|NCT00928954|101492749|FG001|COMPLETED|Overall Study||6||
48473020|NCT00928954|101492748|FG000|NOT COMPLETED|Overall Study||0||
48473021|NCT00928954|101492749|FG001|NOT COMPLETED|Overall Study||0||
48473022|NCT02969499|101492750|FG000|STARTED|Overall Study||33||
48473023|NCT02969499|101492750|FG000|COMPLETED|Overall Study||33||
48473024|NCT02969499|101492750|FG000|NOT COMPLETED|Overall Study||0||
48473025|NCT01505530|101492751|FG000|STARTED|Overall Study||41||
48191131|NCT05805059|100791423|FG000|STARTED|Period 1 (1 Week)||34||
48191132|NCT05805059|100791424|FG001|STARTED|Period 1 (1 Week)||34||
48191133|NCT05805059|100791423|FG000|COMPLETED|Period 1 (1 Week)||34||
48191134|NCT05805059|100791424|FG001|COMPLETED|Period 1 (1 Week)||34||
48191135|NCT05805059|100791423|FG000|NOT COMPLETED|Period 1 (1 Week)||0||
48191136|NCT05805059|100791424|FG001|NOT COMPLETED|Period 1 (1 Week)||0||
48191137|NCT05805059|100791423|FG000|STARTED|Period 2 (1 Week)||34||
48191138|NCT05805059|100791424|FG001|STARTED|Period 2 (1 Week)||34||
48191139|NCT05805059|100791423|FG000|COMPLETED|Period 2 (1 Week)||34||
48191140|NCT05805059|100791424|FG001|COMPLETED|Period 2 (1 Week)||34||
48191141|NCT05805059|100791423|FG000|NOT COMPLETED|Period 2 (1 Week)||0||
48191142|NCT05805059|100791424|FG001|NOT COMPLETED|Period 2 (1 Week)||0||
48191143|NCT02760862|100791425|FG000|STARTED|Overall Study||25||
48191144|NCT02760862|100791426|FG001|STARTED|Overall Study||25||
48191145|NCT02760862|100791425|FG000|COMPLETED|Overall Study||25||
48191146|NCT02760862|100791426|FG001|COMPLETED|Overall Study||25||
48191147|NCT02760862|100791425|FG000|NOT COMPLETED|Overall Study||0||
48191148|NCT02760862|100791426|FG001|NOT COMPLETED|Overall Study||0||
48191149|NCT01702896|100791427|FG000|STARTED|Overall Study||8||
48191150|NCT01702896|100791427|FG000|COMPLETED|Overall Study||0||
48191151|NCT01702896|100791427|FG000|NOT COMPLETED|Overall Study||8||
48191152|NCT00530777|100791428|FG000|STARTED|Overall Study||74||
48191153|NCT00530777|100791429|FG001|STARTED|Overall Study||74||
48473026|NCT01505530|101492752|FG001|STARTED|Overall Study||43||
48473027|NCT01505530|101492753|FG002|STARTED|Overall Study||41||
48473028|NCT01505530|101492751|FG000|Received At Least One Dose of Study Drug|Overall Study||41||
48473029|NCT01505530|101492752|FG001|Received At Least One Dose of Study Drug|Overall Study||42||
48473030|NCT01505530|101492753|FG002|Received At Least One Dose of Study Drug|Overall Study||41||
48473031|NCT01505530|101492751|FG000|Completed One Cycle of Study Drug|Overall Study||29||
48473032|NCT01505530|101492752|FG001|Completed One Cycle of Study Drug|Overall Study||27||
48473033|NCT01505530|101492753|FG002|Completed One Cycle of Study Drug|Overall Study||31||
48191154|NCT00530777|100791428|FG000|COMPLETED|Overall Study||67||
48473034|NCT01505530|101492751|FG000|COMPLETED|Overall Study||0||
48473035|NCT01505530|101492752|FG001|COMPLETED|Overall Study||0||
48191155|NCT00530777|100791429|FG001|COMPLETED|Overall Study||69||
48473036|NCT01505530|101492753|FG002|COMPLETED|Overall Study||0||
48473037|NCT01505530|101492751|FG000|NOT COMPLETED|Overall Study||41||
48473038|NCT01505530|101492752|FG001|NOT COMPLETED|Overall Study||43||
48191156|NCT00530777|100791428|FG000|NOT COMPLETED|Overall Study||7||
48191157|NCT00530777|100791429|FG001|NOT COMPLETED|Overall Study||5||
48191158|NCT00051311|100791430|FG000|STARTED|Overall Study||31||
48191159|NCT00051311|100791431|FG001|STARTED|Overall Study||31||
48191160|NCT00051311|100791430|FG000|COMPLETED|Overall Study||19||
48191161|NCT00051311|100791431|FG001|COMPLETED|Overall Study||17||
48191162|NCT00051311|100791430|FG000|NOT COMPLETED|Overall Study||12||
48191163|NCT00051311|100791431|FG001|NOT COMPLETED|Overall Study||14||
48191164|NCT04391309|100791432|FG000|STARTED|Overall Study||21||
48191165|NCT04391309|100791433|FG001|STARTED|Overall Study||20||
48191166|NCT04391309|100791432|FG000|Included in the Modified Intent to Treat Population (miTT)|Overall Study||20||
48191167|NCT04391309|100791433|FG001|Included in the Modified Intent to Treat Population (miTT)|Overall Study||20||
48191168|NCT04391309|100791432|FG000|COMPLETED|Overall Study||15||
48191169|NCT04391309|100791433|FG001|COMPLETED|Overall Study||15||
48191170|NCT04391309|100791432|FG000|NOT COMPLETED|Overall Study||6||
48191171|NCT04391309|100791433|FG001|NOT COMPLETED|Overall Study||5||
48191172|NCT04880070|100791434|FG000|STARTED|Overall Study||5||
48191173|NCT04880070|100791434|FG000|COMPLETED|Overall Study||5||
48191174|NCT04880070|100791434|FG000|NOT COMPLETED|Overall Study||0||
48191175|NCT02005666|100791435|FG000|STARTED|Overall Study||338||
48191176|NCT02005666|100791436|FG001|STARTED|Overall Study||343||
48191177|NCT02005666|100791437|FG002|STARTED|Overall Study||169||
48191178|NCT02005666|100791435|FG000|COMPLETED|Overall Study||311||
48191179|NCT02005666|100791436|FG001|COMPLETED|Overall Study||299||
48191180|NCT02005666|100791437|FG002|COMPLETED|Overall Study||160||
48191181|NCT02005666|100791435|FG000|NOT COMPLETED|Overall Study||27||
48191182|NCT02005666|100791436|FG001|NOT COMPLETED|Overall Study||44||
48191183|NCT02005666|100791437|FG002|NOT COMPLETED|Overall Study||9||
48191184|NCT00126113|100791438|FG000|STARTED|Overall Study||37||
48191185|NCT00126113|100791439|FG001|STARTED|Overall Study||37||
48191186|NCT00126113|100791438|FG000|COMPLETED|Overall Study||34||
48191187|NCT00126113|100791439|FG001|COMPLETED|Overall Study||35||
48191188|NCT00126113|100791438|FG000|NOT COMPLETED|Overall Study||3||
48191189|NCT00126113|100791439|FG001|NOT COMPLETED|Overall Study||2||
48191190|NCT03032159|100791440|FG000|STARTED|Overall Study||110|Eligible parents randomized.|
48191191|NCT03032159|100791441|FG001|STARTED|Overall Study||111|Eligible parents randomized.|
48191192|NCT03032159|100791440|FG000|COMPLETED|Overall Study||91|Completed 12-month Follow-Up Survey|
48191193|NCT03032159|100791441|FG001|COMPLETED|Overall Study||77|Completed 12-month Follow-Up Survey|
48191194|NCT03032159|100791440|FG000|NOT COMPLETED|Overall Study||19||
48191195|NCT03032159|100791441|FG001|NOT COMPLETED|Overall Study||34||
48191196|NCT00601640|100791442|FG000|STARTED|Overall Study||52||
48191197|NCT00601640|100791443|FG001|STARTED|Overall Study||52||
48191198|NCT00601640|100791444|FG002|STARTED|Overall Study||52||
48191199|NCT00601640|100791442|FG000|COMPLETED|Overall Study||47||
48191200|NCT00601640|100791443|FG001|COMPLETED|Overall Study||47||
48191201|NCT00601640|100791444|FG002|COMPLETED|Overall Study||42||
48191202|NCT00601640|100791442|FG000|NOT COMPLETED|Overall Study||5||
48191203|NCT00601640|100791443|FG001|NOT COMPLETED|Overall Study||5||
48191204|NCT00601640|100791444|FG002|NOT COMPLETED|Overall Study||10||
48191205|NCT02600429|100791445|FG000|STARTED|Overall Study||10||
48191206|NCT02600429|100791446|FG001|STARTED|Overall Study||8||
48191207|NCT02600429|100791445|FG000|COMPLETED|Overall Study||10||
48191208|NCT02600429|100791446|FG001|COMPLETED|Overall Study||8||
48191209|NCT02600429|100791445|FG000|NOT COMPLETED|Overall Study||0||
48191210|NCT02600429|100791446|FG001|NOT COMPLETED|Overall Study||0||
48191211|NCT01649427|100791447|FG000|STARTED|Overall Study||35||
48191212|NCT01649427|100791448|FG001|STARTED|Overall Study||38||
48191213|NCT01649427|100791447|FG000|COMPLETED|Overall Study||24||
48191214|NCT01649427|100791448|FG001|COMPLETED|Overall Study||26||
48191215|NCT01649427|100791447|FG000|NOT COMPLETED|Overall Study||11||
48191216|NCT01649427|100791448|FG001|NOT COMPLETED|Overall Study||12||
48191217|NCT03647475|100791449|FG000|STARTED|Overall Study||752||
48191218|NCT03647475|100791449|FG000|NCT03647475 - Included in One Month Clear Analysis Population|Overall Study||601||
48191219|NCT03647475|100791449|FG000|NCT03344653- Included in One Month Clear Analysis Population|Overall Study||905||
48191220|NCT03647475|100791449|FG000|COMPLETED|Overall Study||75||
48191221|NCT03647475|100791449|FG000|NOT COMPLETED|Overall Study||677||
48191222|NCT02096003|100791450|FG000|STARTED|Overall Study||40||
48191223|NCT02096003|100791451|FG001|STARTED|Overall Study||40||
48191224|NCT02096003|100791450|FG000|COMPLETED|Overall Study||38||
48191225|NCT02096003|100791451|FG001|COMPLETED|Overall Study||37||
48191226|NCT02096003|100791450|FG000|NOT COMPLETED|Overall Study||2||
48191227|NCT02096003|100791451|FG001|NOT COMPLETED|Overall Study||3||
48191228|NCT05365386|100791452|FG000|STARTED|Overall Study||20||
48473039|NCT01505530|101492753|FG002|NOT COMPLETED|Overall Study||41||
48473040|NCT00626548|101495964|FG000|STARTED|Overall Study||705||
48473041|NCT00626548|101495965|FG001|STARTED|Overall Study||716||
48191229|NCT05365386|100791452|FG000|COMPLETED|Overall Study||20||
48191230|NCT05365386|100791452|FG000|NOT COMPLETED|Overall Study||0||
48191231|NCT01796665|100791453|FG000|STARTED|Overall Study||474||
48191232|NCT01796665|100791454|FG001|STARTED|Overall Study||469||
48191233|NCT01796665|100791455|FG002|STARTED|Overall Study||237||
48473042|NCT00626548|101495964|FG000|Patients Received Treatment|Overall Study||703||
48191234|NCT01796665|100791453|FG000|COMPLETED|Overall Study||416||
48473043|NCT00626548|101495965|FG001|Patients Received Treatment|Overall Study||712||
48473044|NCT00626548|101495964|FG000|COMPLETED|Overall Study||0||
48473045|NCT00626548|101495965|FG001|COMPLETED|Overall Study||0||
48473046|NCT00626548|101495964|FG000|NOT COMPLETED|Overall Study||705||
48473047|NCT00626548|101495965|FG001|NOT COMPLETED|Overall Study||716||
48473048|NCT00637299|101495966|FG000|STARTED|Overall Study||10||
48473049|NCT00637299|101495967|FG001|STARTED|Overall Study||10||
48473050|NCT00637299|101495966|FG000|COMPLETED|Overall Study||10||
48473051|NCT00637299|101495967|FG001|COMPLETED|Overall Study||10||
48473052|NCT00637299|101495966|FG000|NOT COMPLETED|Overall Study||0||
48473053|NCT00637299|101495967|FG001|NOT COMPLETED|Overall Study||0||
48473054|NCT02753842|101495968|FG000|STARTED|First Follow-Up (Set of Condoms)||85||
48473055|NCT02753842|101495969|FG001|STARTED|First Follow-Up (Set of Condoms)||84||
48473056|NCT02753842|101495970|FG002|STARTED|First Follow-Up (Set of Condoms)||85||
48473057|NCT02753842|101495971|FG003|STARTED|First Follow-Up (Set of Condoms)||83||
48473058|NCT02753842|101495972|FG004|STARTED|First Follow-Up (Set of Condoms)||83||
48473059|NCT02753842|101495973|FG005|STARTED|First Follow-Up (Set of Condoms)||84||
48473060|NCT02753842|101495968|FG000|COMPLETED|First Follow-Up (Set of Condoms)||75||
48473061|NCT02753842|101495969|FG001|COMPLETED|First Follow-Up (Set of Condoms)||76||
48473062|NCT02753842|101495970|FG002|COMPLETED|First Follow-Up (Set of Condoms)||76||
48473063|NCT02753842|101495971|FG003|COMPLETED|First Follow-Up (Set of Condoms)||81||
48191235|NCT01796665|100791454|FG001|COMPLETED|Overall Study||396||
48191236|NCT01796665|100791455|FG002|COMPLETED|Overall Study||195||
48191237|NCT01796665|100791453|FG000|NOT COMPLETED|Overall Study||58||
48191238|NCT01796665|100791454|FG001|NOT COMPLETED|Overall Study||73||
48191239|NCT01796665|100791455|FG002|NOT COMPLETED|Overall Study||42||
48191240|NCT00577629|100791456|FG000|STARTED|Treatment Period||39||
48191241|NCT00577629|100791456|FG000|COMPLETED|Treatment Period||38||
48191242|NCT00577629|100791456|FG000|NOT COMPLETED|Treatment Period||1||
48191243|NCT00577629|100791456|FG000|STARTED|Long Term Follow-Up||38||
48191244|NCT00577629|100791456|FG000|COMPLETED|Long Term Follow-Up||13||
48191245|NCT00577629|100791456|FG000|NOT COMPLETED|Long Term Follow-Up||25||
48191246|NCT02091063|100791457|FG000|STARTED|Cohort 1: 160 mg Once Daily (Phase 1)||3||
48191247|NCT02091063|100791458|FG001|STARTED|Cohort 1: 160 mg Once Daily (Phase 1)||0||
48191248|NCT02091063|100791459|FG002|STARTED|Cohort 1: 160 mg Once Daily (Phase 1)||0||
48191249|NCT02091063|100791460|FG003|STARTED|Cohort 1: 160 mg Once Daily (Phase 1)||0||
48191250|NCT02091063|100791457|FG000|COMPLETED|Cohort 1: 160 mg Once Daily (Phase 1)||3||
48191251|NCT02091063|100791458|FG001|COMPLETED|Cohort 1: 160 mg Once Daily (Phase 1)||0||
48191252|NCT02091063|100791459|FG002|COMPLETED|Cohort 1: 160 mg Once Daily (Phase 1)||0||
48191253|NCT02091063|100791460|FG003|COMPLETED|Cohort 1: 160 mg Once Daily (Phase 1)||0||
48191254|NCT02091063|100791457|FG000|NOT COMPLETED|Cohort 1: 160 mg Once Daily (Phase 1)||0||
48191255|NCT02091063|100791458|FG001|NOT COMPLETED|Cohort 1: 160 mg Once Daily (Phase 1)||0||
48191256|NCT02091063|100791459|FG002|NOT COMPLETED|Cohort 1: 160 mg Once Daily (Phase 1)||0||
48191257|NCT02091063|100791460|FG003|NOT COMPLETED|Cohort 1: 160 mg Once Daily (Phase 1)||0||
48191258|NCT02091063|100791457|FG000|STARTED|Cohort 2: 160 mg Twice Daily (Phase 1)||0||
48191259|NCT02091063|100791458|FG001|STARTED|Cohort 2: 160 mg Twice Daily (Phase 1)||6||
48191260|NCT02091063|100791459|FG002|STARTED|Cohort 2: 160 mg Twice Daily (Phase 1)||0||
48191261|NCT02091063|100791460|FG003|STARTED|Cohort 2: 160 mg Twice Daily (Phase 1)||0||
48191262|NCT02091063|100791457|FG000|COMPLETED|Cohort 2: 160 mg Twice Daily (Phase 1)||0||
48191263|NCT02091063|100791458|FG001|COMPLETED|Cohort 2: 160 mg Twice Daily (Phase 1)||6||
48191264|NCT02091063|100791459|FG002|COMPLETED|Cohort 2: 160 mg Twice Daily (Phase 1)||0||
48191265|NCT02091063|100791460|FG003|COMPLETED|Cohort 2: 160 mg Twice Daily (Phase 1)||0||
48191266|NCT02091063|100791457|FG000|NOT COMPLETED|Cohort 2: 160 mg Twice Daily (Phase 1)||0||
48191267|NCT02091063|100791458|FG001|NOT COMPLETED|Cohort 2: 160 mg Twice Daily (Phase 1)||0||
48191268|NCT02091063|100791459|FG002|NOT COMPLETED|Cohort 2: 160 mg Twice Daily (Phase 1)||0||
48191269|NCT02091063|100791460|FG003|NOT COMPLETED|Cohort 2: 160 mg Twice Daily (Phase 1)||0||
48191270|NCT02091063|100791457|FG000|STARTED|Expansion: 160 mg Twice Daily (Phase 1)||0||
48191271|NCT02091063|100791458|FG001|STARTED|Expansion: 160 mg Twice Daily (Phase 1)||0||
48473064|NCT02753842|101495972|FG004|COMPLETED|First Follow-Up (Set of Condoms)||76||
48473065|NCT02753842|101495973|FG005|COMPLETED|First Follow-Up (Set of Condoms)||79||
48473066|NCT02753842|101495968|FG000|NOT COMPLETED|First Follow-Up (Set of Condoms)||10||
48473067|NCT02753842|101495969|FG001|NOT COMPLETED|First Follow-Up (Set of Condoms)||8||
48473068|NCT02753842|101495970|FG002|NOT COMPLETED|First Follow-Up (Set of Condoms)||9||
48473069|NCT02753842|101495971|FG003|NOT COMPLETED|First Follow-Up (Set of Condoms)||2||
48473070|NCT02753842|101495972|FG004|NOT COMPLETED|First Follow-Up (Set of Condoms)||7||
48473071|NCT02753842|101495973|FG005|NOT COMPLETED|First Follow-Up (Set of Condoms)||5||
48473072|NCT02753842|101495968|FG000|STARTED|Second Follow-Up (Set of Condoms)||75||
48473073|NCT02753842|101495969|FG001|STARTED|Second Follow-Up (Set of Condoms)||76||
48473074|NCT02753842|101495970|FG002|STARTED|Second Follow-Up (Set of Condoms)||76||
48473075|NCT02753842|101495971|FG003|STARTED|Second Follow-Up (Set of Condoms)||81||
48473076|NCT02753842|101495972|FG004|STARTED|Second Follow-Up (Set of Condoms)||76||
48473077|NCT02753842|101495973|FG005|STARTED|Second Follow-Up (Set of Condoms)||79||
48473078|NCT02753842|101495968|FG000|COMPLETED|Second Follow-Up (Set of Condoms)||71||
48473079|NCT02753842|101495969|FG001|COMPLETED|Second Follow-Up (Set of Condoms)||71||
48473080|NCT02753842|101495970|FG002|COMPLETED|Second Follow-Up (Set of Condoms)||71||
48473081|NCT02753842|101495971|FG003|COMPLETED|Second Follow-Up (Set of Condoms)||76||
48473082|NCT02753842|101495972|FG004|COMPLETED|Second Follow-Up (Set of Condoms)||75||
48473083|NCT02753842|101495973|FG005|COMPLETED|Second Follow-Up (Set of Condoms)||72||
48473084|NCT02753842|101495968|FG000|NOT COMPLETED|Second Follow-Up (Set of Condoms)||4||
48473085|NCT02753842|101495969|FG001|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5||
48473086|NCT02753842|101495970|FG002|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5||
48473087|NCT02753842|101495971|FG003|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5||
48473088|NCT02753842|101495972|FG004|NOT COMPLETED|Second Follow-Up (Set of Condoms)||1||
48473089|NCT02753842|101495973|FG005|NOT COMPLETED|Second Follow-Up (Set of Condoms)||7||
48473090|NCT02753842|101495968|FG000|STARTED|Third Follow-Up (Set of Condoms)||71||
48473091|NCT02753842|101495969|FG001|STARTED|Third Follow-Up (Set of Condoms)||71||
48473092|NCT02753842|101495970|FG002|STARTED|Third Follow-Up (Set of Condoms)||71||
48473093|NCT02753842|101495971|FG003|STARTED|Third Follow-Up (Set of Condoms)||76||
48473094|NCT02753842|101495972|FG004|STARTED|Third Follow-Up (Set of Condoms)||75||
48473095|NCT02753842|101495973|FG005|STARTED|Third Follow-Up (Set of Condoms)||72||
48473096|NCT02753842|101495968|FG000|COMPLETED|Third Follow-Up (Set of Condoms)||65||
48473097|NCT02753842|101495969|FG001|COMPLETED|Third Follow-Up (Set of Condoms)||66||
48473098|NCT02753842|101495970|FG002|COMPLETED|Third Follow-Up (Set of Condoms)||68||
48473099|NCT02753842|101495971|FG003|COMPLETED|Third Follow-Up (Set of Condoms)||70||
48473100|NCT02753842|101495972|FG004|COMPLETED|Third Follow-Up (Set of Condoms)||71||
48473101|NCT02753842|101495973|FG005|COMPLETED|Third Follow-Up (Set of Condoms)||69||
48473102|NCT02753842|101495968|FG000|NOT COMPLETED|Third Follow-Up (Set of Condoms)||6||
48473103|NCT02753842|101495969|FG001|NOT COMPLETED|Third Follow-Up (Set of Condoms)||5||
48473104|NCT02753842|101495970|FG002|NOT COMPLETED|Third Follow-Up (Set of Condoms)||3||
48473105|NCT02753842|101495971|FG003|NOT COMPLETED|Third Follow-Up (Set of Condoms)||6||
48473106|NCT02753842|101495972|FG004|NOT COMPLETED|Third Follow-Up (Set of Condoms)||4||
48473107|NCT02753842|101495973|FG005|NOT COMPLETED|Third Follow-Up (Set of Condoms)||3||
48473108|NCT01453075|101495974|FG000|STARTED|Overall Study||16||
48473109|NCT01453075|101495975|FG001|STARTED|Overall Study||15||
48473110|NCT01453075|101495974|FG000|COMPLETED|Overall Study||11||
48473111|NCT01453075|101495975|FG001|COMPLETED|Overall Study||14||
48473112|NCT01453075|101495974|FG000|NOT COMPLETED|Overall Study||5||
48473113|NCT01453075|101495975|FG001|NOT COMPLETED|Overall Study||1||
48473114|NCT02242201|101495976|FG000|STARTED|Overall Study||55||
48473115|NCT02242201|101495977|FG001|STARTED|Overall Study||55||
48473116|NCT02242201|101495978|FG002|STARTED|Overall Study||55||
48473117|NCT02242201|101495976|FG000|COMPLETED|Overall Study||51||
48473118|NCT02242201|101495977|FG001|COMPLETED|Overall Study||54||
48473119|NCT02242201|101495978|FG002|COMPLETED|Overall Study||54||
48473120|NCT02242201|101495976|FG000|NOT COMPLETED|Overall Study||4||
48473121|NCT02242201|101495977|FG001|NOT COMPLETED|Overall Study||1||
48473122|NCT02242201|101495978|FG002|NOT COMPLETED|Overall Study||1||
48473123|NCT00556049|101495979|FG000|STARTED|Overall Study||72||
48473124|NCT00556049|101495979|FG000|COMPLETED|Overall Study||72||
48473125|NCT00556049|101495979|FG000|NOT COMPLETED|Overall Study||0||
48473126|NCT03238677|101495980|FG000|STARTED|Overall Study||9||
48473127|NCT03238677|101495981|FG001|STARTED|Overall Study||9||
48473128|NCT03238677|101495982|FG002|STARTED|Overall Study||10||
48473129|NCT03238677|101495983|FG003|STARTED|Overall Study||9||
48191272|NCT02091063|100791459|FG002|STARTED|Expansion: 160 mg Twice Daily (Phase 1)||4||
48191273|NCT02091063|100791460|FG003|STARTED|Expansion: 160 mg Twice Daily (Phase 1)||0||
48191274|NCT02091063|100791457|FG000|COMPLETED|Expansion: 160 mg Twice Daily (Phase 1)||0||
48191275|NCT02091063|100791458|FG001|COMPLETED|Expansion: 160 mg Twice Daily (Phase 1)||0||
48191276|NCT02091063|100791459|FG002|COMPLETED|Expansion: 160 mg Twice Daily (Phase 1)||4||
48191277|NCT02091063|100791460|FG003|COMPLETED|Expansion: 160 mg Twice Daily (Phase 1)||0||
48191278|NCT02091063|100791457|FG000|NOT COMPLETED|Expansion: 160 mg Twice Daily (Phase 1)||0||
48191279|NCT02091063|100791458|FG001|NOT COMPLETED|Expansion: 160 mg Twice Daily (Phase 1)||0||
48191280|NCT02091063|100791459|FG002|NOT COMPLETED|Expansion: 160 mg Twice Daily (Phase 1)||0||
48191281|NCT02091063|100791460|FG003|NOT COMPLETED|Expansion: 160 mg Twice Daily (Phase 1)||0||
48191282|NCT02091063|100791457|FG000|STARTED|160 mg Twice Daily (Phase 2)||0||
48473130|NCT03238677|101495984|FG004|STARTED|Overall Study||10||
48473131|NCT03238677|101495985|FG005|STARTED|Overall Study||9||
48473132|NCT03238677|101495980|FG000|COMPLETED|Overall Study||7||
48473133|NCT03238677|101495981|FG001|COMPLETED|Overall Study||7||
48473134|NCT03238677|101495982|FG002|COMPLETED|Overall Study||8||
48473135|NCT03238677|101495983|FG003|COMPLETED|Overall Study||8||
48473136|NCT03238677|101495984|FG004|COMPLETED|Overall Study||9||
48473137|NCT03238677|101495985|FG005|COMPLETED|Overall Study||9||
48473138|NCT03238677|101495980|FG000|NOT COMPLETED|Overall Study||2||
48473139|NCT03238677|101495981|FG001|NOT COMPLETED|Overall Study||2||
48473140|NCT03238677|101495982|FG002|NOT COMPLETED|Overall Study||2||
48473141|NCT03238677|101495983|FG003|NOT COMPLETED|Overall Study||1||
48473142|NCT03238677|101495984|FG004|NOT COMPLETED|Overall Study||1||
48473143|NCT03238677|101495985|FG005|NOT COMPLETED|Overall Study||0||
48473144|NCT00925769|101495986|FG000|STARTED|Overall Study||6||
48473145|NCT00925769|101495987|FG001|STARTED|Overall Study||6||
48473146|NCT00925769|101495988|FG002|STARTED|Overall Study||6||
48473147|NCT00925769|101495989|FG003|STARTED|Overall Study||6||
48473148|NCT00925769|101495990|FG004|STARTED|Overall Study||3||
48473149|NCT00925769|101495991|FG005|STARTED|Overall Study||3||
48473150|NCT00925769|101495986|FG000|COMPLETED|Overall Study||0||
48191283|NCT02091063|100791458|FG001|STARTED|160 mg Twice Daily (Phase 2)||0||
48191284|NCT02091063|100791459|FG002|STARTED|160 mg Twice Daily (Phase 2)||0||
48191285|NCT02091063|100791460|FG003|STARTED|160 mg Twice Daily (Phase 2)||8||
48473151|NCT00925769|101495987|FG001|COMPLETED|Overall Study||0||
48473152|NCT00925769|101495988|FG002|COMPLETED|Overall Study||0||
48473153|NCT00925769|101495989|FG003|COMPLETED|Overall Study||0||
48473154|NCT00925769|101495990|FG004|COMPLETED|Overall Study||0||
48473155|NCT00925769|101495991|FG005|COMPLETED|Overall Study||0||
48473156|NCT00925769|101495986|FG000|NOT COMPLETED|Overall Study||6||
48473157|NCT00925769|101495987|FG001|NOT COMPLETED|Overall Study||6||
48473158|NCT00925769|101495988|FG002|NOT COMPLETED|Overall Study||6||
48473159|NCT00925769|101495989|FG003|NOT COMPLETED|Overall Study||6||
48473160|NCT00925769|101495990|FG004|NOT COMPLETED|Overall Study||3||
48473161|NCT00925769|101495991|FG005|NOT COMPLETED|Overall Study||3||
48473162|NCT00957047|101495992|FG000|STARTED|PART I||100||
48473163|NCT00957047|101495993|FG001|STARTED|PART I||96||
48473164|NCT00957047|101495994|FG002|STARTED|PART I||101||
48473165|NCT00957047|101495995|FG003|STARTED|PART I||98||
48191286|NCT02091063|100791457|FG000|COMPLETED|160 mg Twice Daily (Phase 2)||0||
48191287|NCT02091063|100791458|FG001|COMPLETED|160 mg Twice Daily (Phase 2)||0||
48191288|NCT02091063|100791459|FG002|COMPLETED|160 mg Twice Daily (Phase 2)||0||
48191289|NCT02091063|100791460|FG003|COMPLETED|160 mg Twice Daily (Phase 2)||8||
48191290|NCT02091063|100791457|FG000|NOT COMPLETED|160 mg Twice Daily (Phase 2)||0||
48191291|NCT02091063|100791458|FG001|NOT COMPLETED|160 mg Twice Daily (Phase 2)||0||
48191292|NCT02091063|100791459|FG002|NOT COMPLETED|160 mg Twice Daily (Phase 2)||0||
48191293|NCT02091063|100791460|FG003|NOT COMPLETED|160 mg Twice Daily (Phase 2)||0||
48191294|NCT03971357|100791461|FG000|STARTED|Overall Study||10||
48191295|NCT03971357|100791462|FG001|STARTED|Overall Study||9||
48473166|NCT00957047|101495996|FG004|STARTED|PART I||0||
48473167|NCT00957047|101495992|FG000|Randomized/Safety Population|PART I||100||
48473168|NCT00957047|101495993|FG001|Randomized/Safety Population|PART I||96||
48473169|NCT00957047|101495994|FG002|Randomized/Safety Population|PART I||101||
48473170|NCT00957047|101495995|FG003|Randomized/Safety Population|PART I||98||
48473171|NCT00957047|101495996|FG004|Randomized/Safety Population|PART I||0||
48473172|NCT00957047|101495992|FG000|Intention-to-treat (ITT) Population|PART I||100||
48473173|NCT00957047|101495993|FG001|Intention-to-treat (ITT) Population|PART I||96||
48473174|NCT00957047|101495994|FG002|Intention-to-treat (ITT) Population|PART I||100||
48191296|NCT03971357|100791461|FG000|COMPLETED|Overall Study||10||
48191297|NCT03971357|100791462|FG001|COMPLETED|Overall Study||8||
48191298|NCT03971357|100791461|FG000|NOT COMPLETED|Overall Study||0||
48191299|NCT03971357|100791462|FG001|NOT COMPLETED|Overall Study||1||
48191300|NCT04978363|100791463|FG000|STARTED|Overall Study||2||
48191301|NCT04978363|100791464|FG001|STARTED|Overall Study||2||
48191302|NCT04978363|100791465|FG002|STARTED|Overall Study||2||
48191303|NCT04978363|100791466|FG003|STARTED|Overall Study||1||
48191304|NCT04978363|100791467|FG004|STARTED|Overall Study||3||
48473175|NCT00957047|101495995|FG003|Intention-to-treat (ITT) Population|PART I||97||
48473176|NCT00957047|101495996|FG004|Intention-to-treat (ITT) Population|PART I||0||
48473177|NCT00957047|101495992|FG000|Per-Protocol Population|PART I||81||
48473178|NCT00957047|101495993|FG001|Per-Protocol Population|PART I||70||
48473179|NCT00957047|101495994|FG002|Per-Protocol Population|PART I||75||
48473180|NCT00957047|101495995|FG003|Per-Protocol Population|PART I||54||
48473181|NCT00957047|101495996|FG004|Per-Protocol Population|PART I||0||
48473182|NCT00957047|101495992|FG000|COMPLETED|PART I||94||
48473183|NCT00957047|101495993|FG001|COMPLETED|PART I||83||
48473184|NCT00957047|101495994|FG002|COMPLETED|PART I||80||
48473185|NCT00957047|101495995|FG003|COMPLETED|PART I||68||
48473186|NCT00957047|101495996|FG004|COMPLETED|PART I||0||
48473187|NCT00957047|101495992|FG000|NOT COMPLETED|PART I||6||
48473188|NCT00957047|101495993|FG001|NOT COMPLETED|PART I||13||
48473189|NCT00957047|101495994|FG002|NOT COMPLETED|PART I||21||
48473190|NCT00957047|101495995|FG003|NOT COMPLETED|PART I||30||
48473191|NCT00957047|101495996|FG004|NOT COMPLETED|PART I||0||
48473192|NCT00957047|101495992|FG000|STARTED|PART II||0||
48473193|NCT00957047|101495993|FG001|STARTED|PART II||0||
48473194|NCT00957047|101495994|FG002|STARTED|PART II||0||
48473195|NCT00957047|101495995|FG003|STARTED|PART II||0||
48473196|NCT00957047|101495996|FG004|STARTED|PART II||325||
48473197|NCT00957047|101495992|FG000|Terminated Prematurely|PART II||0||
48473198|NCT00957047|101495993|FG001|Terminated Prematurely|PART II||0||
48473199|NCT00957047|101495994|FG002|Terminated Prematurely|PART II||0||
48473200|NCT00957047|101495995|FG003|Terminated Prematurely|PART II||0||
48473201|NCT00957047|101495996|FG004|Terminated Prematurely|PART II||102||
48473202|NCT00957047|101495992|FG000|COMPLETED|PART II||0||
48191305|NCT04978363|100791468|FG005|STARTED|Overall Study||1||
48191306|NCT04978363|100791469|FG006|STARTED|Overall Study||2||
48191307|NCT04978363|100791470|FG007|STARTED|Overall Study||2||
48191308|NCT04978363|100791471|FG008|STARTED|Overall Study||2||
48473203|NCT00957047|101495993|FG001|COMPLETED|PART II||0||
48473204|NCT00957047|101495994|FG002|COMPLETED|PART II||0||
48473205|NCT00957047|101495995|FG003|COMPLETED|PART II||0||
48473206|NCT00957047|101495996|FG004|COMPLETED|PART II||223||
48473207|NCT00957047|101495992|FG000|NOT COMPLETED|PART II||0||
48473208|NCT00957047|101495993|FG001|NOT COMPLETED|PART II||0||
48473209|NCT00957047|101495994|FG002|NOT COMPLETED|PART II||0||
48473210|NCT00957047|101495995|FG003|NOT COMPLETED|PART II||0||
48473211|NCT00957047|101495996|FG004|NOT COMPLETED|PART II||102||
48473212|NCT02003183|101495997|FG000|STARTED|Overall Study||7||
48473213|NCT02003183|101495998|FG001|STARTED|Overall Study||17||
48473214|NCT02003183|101495997|FG000|COMPLETED|Overall Study||7||
48473215|NCT02003183|101495998|FG001|COMPLETED|Overall Study||15||
48473216|NCT02003183|101495997|FG000|NOT COMPLETED|Overall Study||0||
48473217|NCT02003183|101495998|FG001|NOT COMPLETED|Overall Study||2||
48473218|NCT00881621|101495999|FG000|STARTED|Overall Study||51||
48473219|NCT00881621|101495999|FG000|COMPLETED|Overall Study||17||
48473220|NCT00881621|101495999|FG000|NOT COMPLETED|Overall Study||34||
48473221|NCT00302952|101496000|FG000|STARTED|Overall Study||34||
48473222|NCT00302952|101496001|FG001|STARTED|Overall Study||30||
48473223|NCT00302952|101496000|FG000|Started Intent-to-Treat (ITT)|Overall Study||34||
48473224|NCT00302952|101496001|FG001|Started Intent-to-Treat (ITT)|Overall Study||30||
48473225|NCT00302952|101496000|FG000|Completed Intent-to-Treat (ITT)|Overall Study||34||
48473226|NCT00302952|101496001|FG001|Completed Intent-to-Treat (ITT)|Overall Study||29||
48473227|NCT00302952|101496000|FG000|COMPLETED|Overall Study||31||
48473228|NCT00302952|101496001|FG001|COMPLETED|Overall Study||25||
48473229|NCT00302952|101496000|FG000|NOT COMPLETED|Overall Study||3||
48473230|NCT00302952|101496001|FG001|NOT COMPLETED|Overall Study||5||
48473231|NCT01936948|101496002|FG000|STARTED|Overall Study||227||
48473232|NCT01936948|101496003|FG001|STARTED|Overall Study||231||
48473233|NCT01936948|101496004|FG002|STARTED|Overall Study||237||
48473234|NCT01936948|101496005|FG003|STARTED|Overall Study||233||
48473235|NCT01936948|101496002|FG000|Crossover|Overall Study||31|The number of patients who did not receive their designated intervention (clip/no clip).|
48473236|NCT01936948|101496003|FG001|Crossover|Overall Study||27|The number of patients who did not receive their designated intervention (clip/no clip).|
48473237|NCT01936948|101496004|FG002|Crossover|Overall Study||22|The number of patients who did not receive their designated intervention (clip/no clip).|
48473238|NCT01936948|101496005|FG003|Crossover|Overall Study||25|The number of patients who did not receive their designated intervention (clip/no clip).|
48473239|NCT01936948|101496002|FG000|COMPLETED|Overall Study||227||
48473240|NCT01936948|101496003|FG001|COMPLETED|Overall Study||228||
48473241|NCT01936948|101496004|FG002|COMPLETED|Overall Study||234||
48473242|NCT01936948|101496005|FG003|COMPLETED|Overall Study||230||
48473243|NCT01936948|101496002|FG000|NOT COMPLETED|Overall Study||0||
48473244|NCT01936948|101496003|FG001|NOT COMPLETED|Overall Study||3||
48473245|NCT01936948|101496004|FG002|NOT COMPLETED|Overall Study||3||
48473246|NCT01936948|101496005|FG003|NOT COMPLETED|Overall Study||3||
48473247|NCT04149964|101496006|FG000|STARTED|Overall Study||34||
48473248|NCT04149964|101496007|FG001|STARTED|Overall Study||31||
48473249|NCT04149964|101496006|FG000|COMPLETED|Overall Study||15||
48473250|NCT04149964|101496007|FG001|COMPLETED|Overall Study||13||
48473251|NCT04149964|101496006|FG000|NOT COMPLETED|Overall Study||19||
48473252|NCT04149964|101496007|FG001|NOT COMPLETED|Overall Study||18||
48473253|NCT03641742|101496008|FG000|STARTED|Overall Study||27||
48473254|NCT03641742|101496009|FG001|STARTED|Overall Study||98||
48473255|NCT03641742|101496008|FG000|COMPLETED|Overall Study||27||
48473256|NCT03641742|101496009|FG001|COMPLETED|Overall Study||98||
48473257|NCT03641742|101496008|FG000|NOT COMPLETED|Overall Study||0||
48473258|NCT03641742|101496009|FG001|NOT COMPLETED|Overall Study||0||
48473259|NCT00662025|101496010|FG000|STARTED|Overall Study||63||
48473260|NCT00662025|101496010|FG000|COMPLETED|Overall Study||0||
48473261|NCT00662025|101496010|FG000|NOT COMPLETED|Overall Study||63||
48473262|NCT01333527|101496011|FG000|STARTED|Overall Study||105||
48473263|NCT01333527|101496012|FG001|STARTED|Overall Study||106||
48473264|NCT01333527|101496011|FG000|COMPLETED|Overall Study||87||
48473265|NCT01333527|101496012|FG001|COMPLETED|Overall Study||89||
48473266|NCT01333527|101496011|FG000|NOT COMPLETED|Overall Study||18||
48473267|NCT01333527|101496012|FG001|NOT COMPLETED|Overall Study||17||
48473268|NCT00440557|101496013|FG000|STARTED|Overall Study||123||
48473269|NCT00440557|101496014|FG001|STARTED|Overall Study||125||
48473270|NCT00440557|101496015|FG002|STARTED|Overall Study||125||
48473271|NCT00440557|101496013|FG000|COMPLETED|Overall Study||98||
48473272|NCT00440557|101496014|FG001|COMPLETED|Overall Study||96||
48473273|NCT00440557|101496015|FG002|COMPLETED|Overall Study||90||
48473274|NCT00440557|101496013|FG000|NOT COMPLETED|Overall Study||25||
48473275|NCT00440557|101496014|FG001|NOT COMPLETED|Overall Study||29||
48473276|NCT00440557|101496015|FG002|NOT COMPLETED|Overall Study||35||
48473277|NCT00883090|101496016|FG000|STARTED|Overall Study||15||
48473278|NCT00883090|101496016|FG000|COMPLETED|Overall Study||13||
48473279|NCT00883090|101496016|FG000|NOT COMPLETED|Overall Study||2||
48473280|NCT04646109|101496017|FG000|STARTED|Overall Study||30||
48473281|NCT04646109|101496018|FG001|STARTED|Overall Study||36||
48473282|NCT04646109|101496017|FG000|COMPLETED|Overall Study||30||
48473283|NCT04646109|101496018|FG001|COMPLETED|Overall Study||30||
48473284|NCT04646109|101496017|FG000|NOT COMPLETED|Overall Study||0||
48473285|NCT04646109|101496018|FG001|NOT COMPLETED|Overall Study||6||
48473286|NCT05780541|101496019|FG000|STARTED|Overall Study||32||
48473287|NCT05780541|101496020|FG001|STARTED|Overall Study||26||
48473288|NCT05780541|101496019|FG000|COMPLETED|Overall Study||32||
48473289|NCT05780541|101496020|FG001|COMPLETED|Overall Study||26||
48473290|NCT05780541|101496019|FG000|NOT COMPLETED|Overall Study||0||
48473291|NCT05780541|101496020|FG001|NOT COMPLETED|Overall Study||0||
48473292|NCT01739790|101496021|FG000|STARTED|Overall Study||24||
48473293|NCT01739790|101496022|FG001|STARTED|Overall Study||27||
48473294|NCT01739790|101496021|FG000|COMPLETED|Overall Study||22||
48473295|NCT01739790|101496022|FG001|COMPLETED|Overall Study||23||
48473296|NCT01739790|101496021|FG000|NOT COMPLETED|Overall Study||2||
48473297|NCT01739790|101496022|FG001|NOT COMPLETED|Overall Study||4||
48473298|NCT02920996|101496023|FG000|STARTED|Overall Study||12||
48473299|NCT02920996|101496024|FG001|STARTED|Overall Study||0||
48473300|NCT02920996|101496023|FG000|COMPLETED|Overall Study||0||
48473301|NCT02920996|101496024|FG001|COMPLETED|Overall Study||0||
48473302|NCT02920996|101496023|FG000|NOT COMPLETED|Overall Study||12||
48473303|NCT02920996|101496024|FG001|NOT COMPLETED|Overall Study||0||
48473304|NCT03272139|101496025|FG000|STARTED|Overall Study||63||
48473305|NCT03272139|101496026|FG001|STARTED|Overall Study||63||
48473306|NCT03272139|101496025|FG000|COMPLETED|Overall Study||63||
48473307|NCT03272139|101496026|FG001|COMPLETED|Overall Study||63||
48473308|NCT03272139|101496025|FG000|NOT COMPLETED|Overall Study||0||
48473309|NCT03272139|101496026|FG001|NOT COMPLETED|Overall Study||0||
48473310|NCT03682900|101496027|FG000|STARTED|Overall Study||1346||22
48473311|NCT03682900|101496028|FG001|STARTED|Overall Study||1327||21
48473312|NCT03682900|101496027|FG000|COMPLETED|Overall Study||1346||22
48473313|NCT03682900|101496028|FG001|COMPLETED|Overall Study||1327||21
48473314|NCT03682900|101496027|FG000|NOT COMPLETED|Overall Study||0||0
48473315|NCT03682900|101496028|FG001|NOT COMPLETED|Overall Study||0||0
48473316|NCT00720096|101496029|FG000|STARTED|Overall Study||2||
48473317|NCT00720096|101496030|FG001|STARTED|Overall Study||2||
48473318|NCT00720096|101496029|FG000|COMPLETED|Overall Study||2||
48473319|NCT00720096|101496030|FG001|COMPLETED|Overall Study||0||
48473320|NCT00720096|101496029|FG000|NOT COMPLETED|Overall Study||0||
48473321|NCT00720096|101496030|FG001|NOT COMPLETED|Overall Study||2||
48473322|NCT02227121|101496031|FG000|STARTED|Overall Study||16|Subject underwent attempted VF induction during surgery procedure|
48473323|NCT02227121|101496031|FG000|COMPLETED|Overall Study||16||
48473324|NCT02227121|101496031|FG000|NOT COMPLETED|Overall Study||0||
48473325|NCT03622658|101496032|FG000|STARTED|Overall Study||6||
48473326|NCT03622658|101496033|FG001|STARTED|Overall Study||36||
48473327|NCT03622658|101496032|FG000|COMPLETED|Overall Study||3||
48473328|NCT03622658|101496033|FG001|COMPLETED|Overall Study||32||
48473329|NCT03622658|101496032|FG000|NOT COMPLETED|Overall Study||3||
48473330|NCT03622658|101496033|FG001|NOT COMPLETED|Overall Study||4||
48473331|NCT03417544|101496034|FG000|STARTED|Overall Study||19||
48473332|NCT03417544|101496034|FG000|COMPLETED|Overall Study||19||
48473333|NCT03417544|101496034|FG000|NOT COMPLETED|Overall Study||0||
48473334|NCT02126306|101496035|FG000|STARTED|Overall Study||10||
48473335|NCT02126306|101496036|FG001|STARTED|Overall Study||13||
48473336|NCT02126306|101496035|FG000|COMPLETED|Overall Study||10||
48473337|NCT02126306|101496036|FG001|COMPLETED|Overall Study||13||
48473338|NCT02126306|101496035|FG000|NOT COMPLETED|Overall Study||0||
48473339|NCT02126306|101496036|FG001|NOT COMPLETED|Overall Study||0||
48473340|NCT00385684|101496037|FG000|STARTED|FIRST INTERVENTION OF PHASE A||6||
48473341|NCT00385684|101496038|FG001|STARTED|FIRST INTERVENTION OF PHASE A||5||
48473342|NCT00385684|101496037|FG000|COMPLETED|FIRST INTERVENTION OF PHASE A||5||
48473343|NCT00385684|101496038|FG001|COMPLETED|FIRST INTERVENTION OF PHASE A||5||
48473344|NCT00385684|101496037|FG000|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||1||
48473345|NCT00385684|101496038|FG001|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||0||
48473346|NCT00385684|101496037|FG000|STARTED|SECOND INTERVENTION OF PHASE A||5||
48473347|NCT00385684|101496038|FG001|STARTED|SECOND INTERVENTION OF PHASE A||5||
48473348|NCT00385684|101496037|FG000|COMPLETED|SECOND INTERVENTION OF PHASE A||5||
48473349|NCT00385684|101496038|FG001|COMPLETED|SECOND INTERVENTION OF PHASE A||3||
48473350|NCT00385684|101496037|FG000|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||0||
48473351|NCT00385684|101496038|FG001|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||2||
48473352|NCT00385684|101496037|FG000|STARTED|PHASE B||5||
48191309|NCT04978363|100791472|FG009|STARTED|Overall Study||2||
48191310|NCT04978363|100791473|FG010|STARTED|Overall Study||1||
48191311|NCT04978363|100791463|FG000|Discontinued Intervention|Overall Study||0||
48191312|NCT04978363|100791464|FG001|Discontinued Intervention|Overall Study||1||
48191313|NCT04978363|100791465|FG002|Discontinued Intervention|Overall Study||1||
48191314|NCT04978363|100791466|FG003|Discontinued Intervention|Overall Study||0||
48191315|NCT04978363|100791467|FG004|Discontinued Intervention|Overall Study||1||
48191316|NCT04978363|100791468|FG005|Discontinued Intervention|Overall Study||0||
48191317|NCT04978363|100791469|FG006|Discontinued Intervention|Overall Study||0||
48191318|NCT04978363|100791470|FG007|Discontinued Intervention|Overall Study||0||
48191319|NCT04978363|100791471|FG008|Discontinued Intervention|Overall Study||0||
48191320|NCT04978363|100791472|FG009|Discontinued Intervention|Overall Study||0||
48191321|NCT04978363|100791473|FG010|Discontinued Intervention|Overall Study||0||
48191322|NCT04978363|100791463|FG000|COMPLETED|Overall Study||2||
48191323|NCT04978363|100791464|FG001|COMPLETED|Overall Study||1||
48473353|NCT00385684|101496038|FG001|STARTED|PHASE B||3||
48473354|NCT00385684|101496037|FG000|COMPLETED|PHASE B||5||
48473355|NCT00385684|101496038|FG001|COMPLETED|PHASE B||3||
48191324|NCT04978363|100791465|FG002|COMPLETED|Overall Study||1||
48191325|NCT04978363|100791466|FG003|COMPLETED|Overall Study||1||
48191326|NCT04978363|100791467|FG004|COMPLETED|Overall Study||2||
48191327|NCT04978363|100791468|FG005|COMPLETED|Overall Study||1||
48191328|NCT04978363|100791469|FG006|COMPLETED|Overall Study||2||
48191329|NCT04978363|100791470|FG007|COMPLETED|Overall Study||2||
48191330|NCT04978363|100791471|FG008|COMPLETED|Overall Study||2||
48473356|NCT00385684|101496037|FG000|NOT COMPLETED|PHASE B||0||
48191331|NCT04978363|100791472|FG009|COMPLETED|Overall Study||2||
48191332|NCT04978363|100791473|FG010|COMPLETED|Overall Study||1||
48191333|NCT04978363|100791463|FG000|NOT COMPLETED|Overall Study||0||
48191334|NCT04978363|100791464|FG001|NOT COMPLETED|Overall Study||1||
48191335|NCT04978363|100791465|FG002|NOT COMPLETED|Overall Study||1||
48191336|NCT04978363|100791466|FG003|NOT COMPLETED|Overall Study||0||
48191337|NCT04978363|100791467|FG004|NOT COMPLETED|Overall Study||1||
48191338|NCT04978363|100791468|FG005|NOT COMPLETED|Overall Study||0||
48473357|NCT00385684|101496038|FG001|NOT COMPLETED|PHASE B||0||
48191339|NCT04978363|100791469|FG006|NOT COMPLETED|Overall Study||0||
48473358|NCT00369590|101496039|FG000|STARTED|Overall Study||16||
48473359|NCT00369590|101496040|FG001|STARTED|Overall Study||42||
48473360|NCT00369590|101496039|FG000|COMPLETED|Overall Study||16||
48473361|NCT00369590|101496040|FG001|COMPLETED|Overall Study||42||
48473362|NCT00369590|101496039|FG000|NOT COMPLETED|Overall Study||0||
48473363|NCT00369590|101496040|FG001|NOT COMPLETED|Overall Study||0||
48473364|NCT01256684|101496041|FG000|STARTED|Overall Study||81||
48473365|NCT01256684|101496042|FG001|STARTED|Overall Study||87||
48473366|NCT01256684|101496043|FG002|STARTED|Overall Study||87||
48473367|NCT01256684|101496041|FG000|Safety Population|Overall Study||80||
48473368|NCT01256684|101496042|FG001|Safety Population|Overall Study||86||
48473369|NCT01256684|101496043|FG002|Safety Population|Overall Study||87||
48473370|NCT01256684|101496041|FG000|ITT Population|Overall Study||77||
48473371|NCT01256684|101496042|FG001|ITT Population|Overall Study||79||
48473372|NCT01256684|101496043|FG002|ITT Population|Overall Study||81||
48473373|NCT01256684|101496041|FG000|COMPLETED|Overall Study||72||
48473374|NCT01256684|101496042|FG001|COMPLETED|Overall Study||74||
48473375|NCT01256684|101496043|FG002|COMPLETED|Overall Study||76||
48191340|NCT04978363|100791470|FG007|NOT COMPLETED|Overall Study||0||
48473376|NCT01256684|101496041|FG000|NOT COMPLETED|Overall Study||9||
48473377|NCT01256684|101496042|FG001|NOT COMPLETED|Overall Study||13||
48473378|NCT01256684|101496043|FG002|NOT COMPLETED|Overall Study||11||
48473379|NCT01234103|101496044|FG000|STARTED|Overall Study||542||
48473380|NCT01234103|101496045|FG001|STARTED|Overall Study||391||
48473381|NCT01234103|101496044|FG000|COMPLETED|Overall Study||542|Each was enrolled at baseline, completed all intervention sessions, but no follow-up sessions.|
48473382|NCT01234103|101496045|FG001|COMPLETED|Overall Study||391|Each was enrolled at baseline, completed all intervention sessions, but no follow-up sessions.|
48473383|NCT01234103|101496044|FG000|NOT COMPLETED|Overall Study||0||
48473384|NCT01234103|101496045|FG001|NOT COMPLETED|Overall Study||0||
48473385|NCT01617668|101496046|FG000|STARTED|Overall Study||51||
48473386|NCT01617668|101496047|FG001|STARTED|Overall Study||50||
48473387|NCT01617668|101496048|FG002|STARTED|Overall Study||55||
48473388|NCT01617668|101496049|FG003|STARTED|Overall Study||53||
48473389|NCT01617668|101496046|FG000|Randomized Patients|Overall Study||51||
48473390|NCT01617668|101496047|FG001|Randomized Patients|Overall Study||54||
48473391|NCT01617668|101496048|FG002|Randomized Patients|Overall Study||55||
48473392|NCT01617668|101496049|FG003|Randomized Patients|Overall Study||55||
48473393|NCT01617668|101496046|FG000|COMPLETED|Overall Study||38||
48473394|NCT01617668|101496047|FG001|COMPLETED|Overall Study||41||
48473395|NCT01617668|101496048|FG002|COMPLETED|Overall Study||32||
48473396|NCT01617668|101496049|FG003|COMPLETED|Overall Study||38||
48473397|NCT01617668|101496046|FG000|NOT COMPLETED|Overall Study||13||
48473398|NCT01617668|101496047|FG001|NOT COMPLETED|Overall Study||9||
48473399|NCT01617668|101496048|FG002|NOT COMPLETED|Overall Study||23||
48473400|NCT01617668|101496049|FG003|NOT COMPLETED|Overall Study||15||
48473401|NCT00118053|101496050|FG000|STARTED|Overall Study||5||
48473402|NCT00118053|101496050|FG000|COMPLETED|Overall Study||5||
48473403|NCT00118053|101496050|FG000|NOT COMPLETED|Overall Study||0||
48473404|NCT04347291|101496051|FG000|STARTED|Overall Study||314|Patient participants were randomized with their support person (if enrolled), but support person participation was not required. There were 294 patient/support person dyads (329 patient participants, 294 support persons; 35 patients participated without a support person).|
48473405|NCT04347291|101496052|FG001|STARTED|Overall Study||309|Patient participants were randomized with their support person (if enrolled), but support person participation was not required. There were 294 patient/support person dyads (329 patient participants, 294 support persons; 35 patients participated without a support person).|
48473406|NCT04347291|101496051|FG000|Patient Participants|Overall Study||164||
48473407|NCT04347291|101496052|FG001|Patient Participants|Overall Study||165||
48191341|NCT04978363|100791471|FG008|NOT COMPLETED|Overall Study||0||
48191342|NCT04978363|100791472|FG009|NOT COMPLETED|Overall Study||0||
48191343|NCT04978363|100791473|FG010|NOT COMPLETED|Overall Study||0||
48191344|NCT02485964|100791474|FG000|STARTED|Overall Study||10||
48191345|NCT02485964|100791474|FG000|COMPLETED|Overall Study||10||
48191346|NCT02485964|100791474|FG000|NOT COMPLETED|Overall Study||0||
48191347|NCT00920374|100791475|FG000|STARTED|Overall Study||61||
48191348|NCT00920374|100791476|FG001|STARTED|Overall Study||57||
48191349|NCT00920374|100791475|FG000|COMPLETED|Overall Study||61||
48191350|NCT00920374|100791476|FG001|COMPLETED|Overall Study||57||
48191351|NCT00920374|100791475|FG000|NOT COMPLETED|Overall Study||0||
48191352|NCT00920374|100791476|FG001|NOT COMPLETED|Overall Study||0||
48191353|NCT02138916|100791477|FG000|STARTED|Overall Study||554||
48191354|NCT02138916|100791478|FG001|STARTED|Overall Study||552||
48191355|NCT02138916|100791479|FG002|STARTED|Overall Study||550||
48191356|NCT02138916|100791477|FG000|COMPLETED|Overall Study||497||
48191357|NCT02138916|100791478|FG001|COMPLETED|Overall Study||492||
48191358|NCT02138916|100791479|FG002|COMPLETED|Overall Study||491||
48191359|NCT02138916|100791477|FG000|NOT COMPLETED|Overall Study||57||
48473408|NCT04347291|101496051|FG000|Support Persons|Overall Study||150||
48473409|NCT04347291|101496052|FG001|Support Persons|Overall Study||144||
48473410|NCT04347291|101496051|FG000|COMPLETED|Overall Study||304||
48473411|NCT04347291|101496052|FG001|COMPLETED|Overall Study||297||
48473412|NCT04347291|101496051|FG000|NOT COMPLETED|Overall Study||10||
48473413|NCT04347291|101496052|FG001|NOT COMPLETED|Overall Study||12||
48473414|NCT03209882|101496053|FG000|STARTED|Overall Study||6||
48473415|NCT03209882|101496054|FG001|STARTED|Overall Study||3||
48473416|NCT03209882|101496053|FG000|COMPLETED|Overall Study||6||
48473417|NCT03209882|101496054|FG001|COMPLETED|Overall Study||3||
48473418|NCT03209882|101496053|FG000|NOT COMPLETED|Overall Study||0||
48473419|NCT03209882|101496054|FG001|NOT COMPLETED|Overall Study||0||
48473420|NCT03500692|101496055|FG000|STARTED|Overall Study||500||
48473421|NCT03500692|101496055|FG000|COMPLETED|Overall Study||259|3 - year visit complete|
48473422|NCT03500692|101496055|FG000|NOT COMPLETED|Overall Study||241||
48473423|NCT01991470|101496056|FG000|STARTED|Enlite 1 Period||161||
48473424|NCT01991470|101496056|FG000|COMPLETED|Enlite 1 Period||141||
48473425|NCT01991470|101496056|FG000|NOT COMPLETED|Enlite 1 Period||20||
48473426|NCT01991470|101496056|FG000|STARTED|Enlite 3 Period||158||
48473427|NCT01991470|101496056|FG000|COMPLETED|Enlite 3 Period||146||
48473428|NCT01991470|101496056|FG000|NOT COMPLETED|Enlite 3 Period||12||
48473429|NCT03221374|101496057|FG000|STARTED|Overall Study||72||
48473430|NCT03221374|101496058|FG001|STARTED|Overall Study||72||
48473431|NCT03221374|101496059|FG002|STARTED|Overall Study||32||
48473432|NCT03221374|101496060|FG003|STARTED|Overall Study||34||
48473433|NCT03221374|101496061|FG004|STARTED|Overall Study||8||
48473434|NCT03221374|101496062|FG005|STARTED|Overall Study||8||
48473435|NCT03221374|101496063|FG006|STARTED|Overall Study||3||
48473436|NCT03221374|101496064|FG007|STARTED|Overall Study||2||
48473437|NCT03221374|101496057|FG000|COMPLETED|Overall Study||42||
48473438|NCT03221374|101496058|FG001|COMPLETED|Overall Study||34||
48473439|NCT03221374|101496059|FG002|COMPLETED|Overall Study||22||
48473440|NCT03221374|101496060|FG003|COMPLETED|Overall Study||26||
48473441|NCT03221374|101496061|FG004|COMPLETED|Overall Study||7||
48473442|NCT03221374|101496062|FG005|COMPLETED|Overall Study||5||
48473443|NCT03221374|101496063|FG006|COMPLETED|Overall Study||2||
48473444|NCT03221374|101496064|FG007|COMPLETED|Overall Study||1||
48473445|NCT03221374|101496057|FG000|NOT COMPLETED|Overall Study||30||
48473446|NCT03221374|101496058|FG001|NOT COMPLETED|Overall Study||38||
48473447|NCT03221374|101496059|FG002|NOT COMPLETED|Overall Study||10||
48473448|NCT03221374|101496060|FG003|NOT COMPLETED|Overall Study||8||
48473449|NCT03221374|101496061|FG004|NOT COMPLETED|Overall Study||1||
48473450|NCT03221374|101496062|FG005|NOT COMPLETED|Overall Study||3||
48473451|NCT03221374|101496063|FG006|NOT COMPLETED|Overall Study||1||
48473452|NCT03221374|101496064|FG007|NOT COMPLETED|Overall Study||1||
48473453|NCT01440283|101496065|FG000|STARTED|Overall Study||14||
48473454|NCT01440283|101496065|FG000|COMPLETED|Overall Study||4||
48473455|NCT01440283|101496065|FG000|NOT COMPLETED|Overall Study||10||
48473456|NCT00262600|101496066|FG000|STARTED|Overall Study||6015||
48473457|NCT00262600|101496067|FG001|STARTED|Overall Study||6076||
48473458|NCT00262600|101496068|FG002|STARTED|Overall Study||6022||
48473459|NCT00262600|101496066|FG000|COMPLETED|Overall Study||5780||
48473460|NCT00262600|101496067|FG001|COMPLETED|Overall Study||5824||
48473461|NCT00262600|101496068|FG002|COMPLETED|Overall Study||5756||
48473462|NCT00262600|101496066|FG000|NOT COMPLETED|Overall Study||235||
48473463|NCT00262600|101496067|FG001|NOT COMPLETED|Overall Study||252||
48473464|NCT00262600|101496068|FG002|NOT COMPLETED|Overall Study||266||
48473465|NCT01654107|101496069|FG000|STARTED|Overall Study||28||
48473466|NCT01654107|101496070|FG001|STARTED|Overall Study||30||
48473467|NCT01654107|101496069|FG000|COMPLETED|Overall Study||25||
48473468|NCT01654107|101496070|FG001|COMPLETED|Overall Study||22||
48473469|NCT01654107|101496069|FG000|NOT COMPLETED|Overall Study||3||
48473470|NCT01654107|101496070|FG001|NOT COMPLETED|Overall Study||8||
48473471|NCT04875065|101496071|FG000|STARTED|Overall Study||10||
48473472|NCT04875065|101496071|FG000|COMPLETED|Overall Study||8||
48473473|NCT04875065|101496071|FG000|NOT COMPLETED|Overall Study||2||
48473474|NCT02166697|101496072|FG000|STARTED|Overall Study||14151||
48191360|NCT02138916|100791478|FG001|NOT COMPLETED|Overall Study||60||
48191361|NCT02138916|100791479|FG002|NOT COMPLETED|Overall Study||59||
48191362|NCT02153788|100791480|FG000|STARTED|Overall Study||25||
48473475|NCT02166697|101496072|FG000|COMPLETED|Overall Study||13804||
48473476|NCT02166697|101496072|FG000|NOT COMPLETED|Overall Study||347||
48473477|NCT04908748|101496073|FG000|STARTED|Overall Study||98||
48473478|NCT04908748|101496074|FG001|STARTED|Overall Study||102||
48473479|NCT04908748|101496073|FG000|COMPLETED|Overall Study||98||
48473480|NCT04908748|101496074|FG001|COMPLETED|Overall Study||102||
48473481|NCT04908748|101496073|FG000|NOT COMPLETED|Overall Study||0||
48473482|NCT04908748|101496074|FG001|NOT COMPLETED|Overall Study||0||
48191363|NCT02153788|100791481|FG001|STARTED|Overall Study||19||
48473483|NCT03194464|101496075|FG000|STARTED|Overall Study||15||
48473484|NCT03194464|101496075|FG000|COMPLETED|Overall Study||13||
48473485|NCT03194464|101496075|FG000|NOT COMPLETED|Overall Study||2||
48473486|NCT02576249|101496076|FG000|STARTED|Overall Study||15||
48473487|NCT02576249|101496077|FG001|STARTED|Overall Study||14||
48473488|NCT02576249|101496076|FG000|COMPLETED|Overall Study||15||
48473489|NCT02576249|101496077|FG001|COMPLETED|Overall Study||14||
48473490|NCT02576249|101496076|FG000|NOT COMPLETED|Overall Study||0||
48473491|NCT02576249|101496077|FG001|NOT COMPLETED|Overall Study||0||
48473492|NCT01103505|101496078|FG000|STARTED|Overall Study||763||
48473493|NCT01103505|101496079|FG001|STARTED|Overall Study||757||
48473494|NCT01103505|101496078|FG000|COMPLETED|Overall Study||739||
48191364|NCT02153788|100791480|FG000|COMPLETED|Overall Study||23||
48473495|NCT01103505|101496079|FG001|COMPLETED|Overall Study||737||
48191365|NCT02153788|100791481|FG001|COMPLETED|Overall Study||18||
48191366|NCT02153788|100791480|FG000|NOT COMPLETED|Overall Study||2||
48191367|NCT02153788|100791481|FG001|NOT COMPLETED|Overall Study||1||
48191368|NCT00797862|100791482|FG000|STARTED|Overall Study||620||
48191369|NCT00797862|100791483|FG001|STARTED|Overall Study||318||
48191370|NCT00797862|100791484|FG002|STARTED|Overall Study||316||
48191371|NCT00797862|100791482|FG000|Entered Double-Blind Treatment (FAS)|Overall Study||617||
48191372|NCT00797862|100791483|FG001|Entered Double-Blind Treatment (FAS)|Overall Study||315||
48191373|NCT00797862|100791484|FG002|Entered Double-Blind Treatment (FAS)|Overall Study||315||
48191374|NCT00797862|100791482|FG000|COMPLETED|Overall Study||496||
48191375|NCT00797862|100791483|FG001|COMPLETED|Overall Study||250||
48191376|NCT00797862|100791484|FG002|COMPLETED|Overall Study||230||
48191377|NCT00797862|100791482|FG000|NOT COMPLETED|Overall Study||124||
48191378|NCT00797862|100791483|FG001|NOT COMPLETED|Overall Study||68||
48191379|NCT00797862|100791484|FG002|NOT COMPLETED|Overall Study||86||
48191380|NCT00462943|100791485|FG000|STARTED|Overall Study||46||
48191381|NCT00462943|100791486|FG001|STARTED|Overall Study||31||
48191382|NCT00462943|100791487|FG002|STARTED|Overall Study||23||
48473496|NCT01103505|101496078|FG000|NOT COMPLETED|Overall Study||24||
48473497|NCT01103505|101496079|FG001|NOT COMPLETED|Overall Study||20||
48473498|NCT01074554|101496080|FG000|STARTED|Overall Study||14||
48473499|NCT01074554|101496081|FG001|STARTED|Overall Study||15||
48473500|NCT01074554|101496080|FG000|COMPLETED|Overall Study||11||
48473501|NCT01074554|101496081|FG001|COMPLETED|Overall Study||11||
48191383|NCT00462943|100791485|FG000|COMPLETED|Overall Study||1||
48191384|NCT00462943|100791486|FG001|COMPLETED|Overall Study||1||
48191385|NCT00462943|100791487|FG002|COMPLETED|Overall Study||0||
48191386|NCT00462943|100791485|FG000|NOT COMPLETED|Overall Study||45||
48191387|NCT00462943|100791486|FG001|NOT COMPLETED|Overall Study||30||
48191388|NCT00462943|100791487|FG002|NOT COMPLETED|Overall Study||23||
48191389|NCT04783415|100791488|FG000|STARTED|Overall Study||12||
48191390|NCT04783415|100791488|FG000|COMPLETED|Overall Study||12||
48191391|NCT04783415|100791488|FG000|NOT COMPLETED|Overall Study||0||
48191392|NCT04018664|100791489|FG000|STARTED|Overall Study||14||
48191393|NCT04018664|100791490|FG001|STARTED|Overall Study||6||
48191394|NCT04018664|100791491|FG002|STARTED|Overall Study||6||
48191395|NCT04018664|100791492|FG003|STARTED|Overall Study||6||
48191396|NCT04018664|100791493|FG004|STARTED|Overall Study||6||
48191397|NCT04018664|100791494|FG005|STARTED|Overall Study||6||
48191398|NCT04018664|100791495|FG006|STARTED|Overall Study||6||
48191399|NCT04018664|100791496|FG007|STARTED|Overall Study||6||
48191400|NCT04018664|100791489|FG000|COMPLETED|Overall Study||14||
48191401|NCT04018664|100791490|FG001|COMPLETED|Overall Study||6||
48191402|NCT04018664|100791491|FG002|COMPLETED|Overall Study||6||
48191403|NCT04018664|100791492|FG003|COMPLETED|Overall Study||6||
48191404|NCT04018664|100791493|FG004|COMPLETED|Overall Study||6||
48191405|NCT04018664|100791494|FG005|COMPLETED|Overall Study||6||
48191406|NCT04018664|100791495|FG006|COMPLETED|Overall Study||6||
48191407|NCT04018664|100791496|FG007|COMPLETED|Overall Study||6||
48191408|NCT04018664|100791489|FG000|NOT COMPLETED|Overall Study||0||
48191409|NCT04018664|100791490|FG001|NOT COMPLETED|Overall Study||0||
48191410|NCT04018664|100791491|FG002|NOT COMPLETED|Overall Study||0||
48191411|NCT04018664|100791492|FG003|NOT COMPLETED|Overall Study||0||
48191412|NCT04018664|100791493|FG004|NOT COMPLETED|Overall Study||0||
48191413|NCT04018664|100791494|FG005|NOT COMPLETED|Overall Study||0||
48191414|NCT04018664|100791495|FG006|NOT COMPLETED|Overall Study||0||
48191415|NCT04018664|100791496|FG007|NOT COMPLETED|Overall Study||0||
48191416|NCT02443792|100791497|FG000|STARTED|Overall Study||50||
48191417|NCT02443792|100791498|FG001|STARTED|Overall Study||25||
48191418|NCT02443792|100791497|FG000|COMPLETED|Overall Study||43||
48191419|NCT02443792|100791498|FG001|COMPLETED|Overall Study||23||
48191420|NCT02443792|100791497|FG000|NOT COMPLETED|Overall Study||7||
48191421|NCT02443792|100791498|FG001|NOT COMPLETED|Overall Study||2||
48191422|NCT00630864|100791499|FG000|STARTED|Part 1 (up to Week 6)||21||
48191423|NCT00630864|100791499|FG000|COMPLETED|Part 1 (up to Week 6)||20||
48191424|NCT00630864|100791499|FG000|NOT COMPLETED|Part 1 (up to Week 6)||1||
48191425|NCT00630864|100791499|FG000|STARTED|Part 2 (After Week 6 up to Month 12)||20||
48191426|NCT00630864|100791499|FG000|COMPLETED|Part 2 (After Week 6 up to Month 12)||18||
48191427|NCT00630864|100791499|FG000|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||2||
48191428|NCT01872611|100791500|FG000|STARTED|Overall Study||301||
48191429|NCT01872611|100791501|FG001|STARTED|Overall Study||304||
48191430|NCT01872611|100791500|FG000|Randomized|Overall Study||301||
48191431|NCT01872611|100791501|FG001|Randomized|Overall Study||304||
48191432|NCT01872611|100791500|FG000|Treated (Safety Analysis Set)|Overall Study||293||
48191433|NCT01872611|100791501|FG001|Treated (Safety Analysis Set)|Overall Study||295||
48191434|NCT01872611|100791500|FG000|Full Analysis Set|Overall Study||289||
48191435|NCT01872611|100791501|FG001|Full Analysis Set|Overall Study||293||
48191436|NCT01872611|100791500|FG000|COMPLETED|Overall Study||277||
48191437|NCT01872611|100791501|FG001|COMPLETED|Overall Study||292||
48191438|NCT01872611|100791500|FG000|NOT COMPLETED|Overall Study||24||
48191439|NCT01872611|100791501|FG001|NOT COMPLETED|Overall Study||12||
48191440|NCT00112723|100791502|FG000|STARTED|Overall Study||13||
48191441|NCT00112723|100791503|FG001|STARTED|Overall Study||19||
48191442|NCT00112723|100791504|FG002|STARTED|Overall Study||14||
48191443|NCT00112723|100791502|FG000|Patients Evaluable for Toxicity|Overall Study||11||
48191444|NCT00112723|100791503|FG001|Patients Evaluable for Toxicity|Overall Study||12||
48191445|NCT00112723|100791504|FG002|Patients Evaluable for Toxicity|Overall Study||12||
48191446|NCT00112723|100791502|FG000|COMPLETED|Overall Study||11||
48191447|NCT00112723|100791503|FG001|COMPLETED|Overall Study||12||
48191448|NCT00112723|100791504|FG002|COMPLETED|Overall Study||12||
48191449|NCT00112723|100791502|FG000|NOT COMPLETED|Overall Study||2||
48191450|NCT00112723|100791503|FG001|NOT COMPLETED|Overall Study||7||
48191451|NCT00112723|100791504|FG002|NOT COMPLETED|Overall Study||2||
48191452|NCT00852475|100791505|FG000|STARTED|Overall Study||26||
48191453|NCT00852475|100791506|FG001|STARTED|Overall Study||20||
48191454|NCT00852475|100791505|FG000|COMPLETED|Overall Study||23||
48191455|NCT00852475|100791506|FG001|COMPLETED|Overall Study||16||
48191456|NCT00852475|100791505|FG000|NOT COMPLETED|Overall Study||3||
48191457|NCT00852475|100791506|FG001|NOT COMPLETED|Overall Study||4||
48191458|NCT00810303|100791507|FG000|STARTED|Efavirenz Alone - Day 1-5||12||
48191459|NCT00810303|100791507|FG000|COMPLETED|Efavirenz Alone - Day 1-5||12||
48191460|NCT00810303|100791507|FG000|NOT COMPLETED|Efavirenz Alone - Day 1-5||0||
48191461|NCT00810303|100791507|FG000|STARTED|Ezetimibe Alone - Day 6-15||12||
48191462|NCT00810303|100791507|FG000|COMPLETED|Ezetimibe Alone - Day 6-15||12||
48191463|NCT00810303|100791507|FG000|NOT COMPLETED|Ezetimibe Alone - Day 6-15||0||
48191464|NCT00810303|100791507|FG000|STARTED|Ezetimibe and Efavirenz - Day 16-20||12||
48191465|NCT00810303|100791507|FG000|COMPLETED|Ezetimibe and Efavirenz - Day 16-20||12||
48191466|NCT00810303|100791507|FG000|NOT COMPLETED|Ezetimibe and Efavirenz - Day 16-20||0||
48191467|NCT00810303|100791507|FG000|STARTED|Ezetimibe and Efavirenz - Day 21-30||12||
48191468|NCT00810303|100791507|FG000|COMPLETED|Ezetimibe and Efavirenz - Day 21-30||12||
48191469|NCT00810303|100791507|FG000|NOT COMPLETED|Ezetimibe and Efavirenz - Day 21-30||0||
48191470|NCT00828945|100791508|FG000|STARTED|Overall Study||257||
48191471|NCT00828945|100791508|FG000|COMPLETED|Overall Study||216||
48191472|NCT00828945|100791508|FG000|NOT COMPLETED|Overall Study||41||
48191473|NCT00658411|100791509|FG000|STARTED|Overall Study||5||
48191474|NCT00658411|100791509|FG000|COMPLETED|Overall Study||5||
48191475|NCT00658411|100791509|FG000|NOT COMPLETED|Overall Study||0||
48191476|NCT00248612|100791510|FG000|STARTED|Overall Study||24||
48191477|NCT00248612|100791511|FG001|STARTED|Overall Study||21||
48191478|NCT00248612|100791512|FG002|STARTED|Overall Study||14||
48191479|NCT00248612|100791513|FG003|STARTED|Overall Study||22||
48191480|NCT00248612|100791510|FG000|COMPLETED|Overall Study||24||
48191481|NCT00248612|100791511|FG001|COMPLETED|Overall Study||21||
48191482|NCT00248612|100791512|FG002|COMPLETED|Overall Study||14||
48191483|NCT00248612|100791513|FG003|COMPLETED|Overall Study||22||
48191484|NCT00248612|100791510|FG000|NOT COMPLETED|Overall Study||0||
48191485|NCT00248612|100791511|FG001|NOT COMPLETED|Overall Study||0||
48191486|NCT00248612|100791512|FG002|NOT COMPLETED|Overall Study||0||
48191487|NCT00248612|100791513|FG003|NOT COMPLETED|Overall Study||0||
48191488|NCT00875641|100791514|FG000|STARTED|Overall Study||57931||
48191489|NCT00875641|100791515|FG001|STARTED|Overall Study||173384||
48191490|NCT00875641|100791516|FG002|STARTED|Overall Study||159344||
48191491|NCT00875641|100791514|FG000|COMPLETED|Overall Study||57931||
48191492|NCT00875641|100791515|FG001|COMPLETED|Overall Study||173384||
48191493|NCT00875641|100791516|FG002|COMPLETED|Overall Study||159344||
48191494|NCT00875641|100791514|FG000|NOT COMPLETED|Overall Study||0||
48191495|NCT00875641|100791515|FG001|NOT COMPLETED|Overall Study||0||
48191496|NCT00875641|100791516|FG002|NOT COMPLETED|Overall Study||0||
48191497|NCT05822440|100791517|FG000|STARTED|Treatment Period 1 (5 Days)||12||
48191498|NCT05822440|100791518|FG001|STARTED|Treatment Period 1 (5 Days)||0||
48191499|NCT05822440|100791517|FG000|COMPLETED|Treatment Period 1 (5 Days)||12||
48191500|NCT05822440|100791518|FG001|COMPLETED|Treatment Period 1 (5 Days)||0||
48191501|NCT05822440|100791517|FG000|NOT COMPLETED|Treatment Period 1 (5 Days)||0||
48191502|NCT05822440|100791518|FG001|NOT COMPLETED|Treatment Period 1 (5 Days)||0||
48191503|NCT05822440|100791517|FG000|STARTED|Treatment Period 2 (8 Days)||0||
48191504|NCT05822440|100791518|FG001|STARTED|Treatment Period 2 (8 Days)||12||
48191505|NCT05822440|100791517|FG000|COMPLETED|Treatment Period 2 (8 Days)||0||
48191506|NCT05822440|100791518|FG001|COMPLETED|Treatment Period 2 (8 Days)||12||
48191507|NCT05822440|100791517|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
48191508|NCT05822440|100791518|FG001|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
48191509|NCT01304147|100791519|FG000|STARTED|First Intervention (7days)||10||
48191510|NCT01304147|100791520|FG001|STARTED|First Intervention (7days)||10||
48191511|NCT01304147|100791519|FG000|COMPLETED|First Intervention (7days)||10||
48191512|NCT01304147|100791520|FG001|COMPLETED|First Intervention (7days)||10||
48191513|NCT01304147|100791519|FG000|NOT COMPLETED|First Intervention (7days)||0||
48191514|NCT01304147|100791520|FG001|NOT COMPLETED|First Intervention (7days)||0||
48191515|NCT01304147|100791519|FG000|STARTED|Washout (1 Day)||10||
48191516|NCT01304147|100791520|FG001|STARTED|Washout (1 Day)||10||
48191517|NCT01304147|100791519|FG000|COMPLETED|Washout (1 Day)||10||
48191518|NCT01304147|100791520|FG001|COMPLETED|Washout (1 Day)||10||
48473502|NCT01074554|101496080|FG000|NOT COMPLETED|Overall Study||3||
48473503|NCT01074554|101496081|FG001|NOT COMPLETED|Overall Study||4||
48473504|NCT02003053|101496082|FG000|STARTED|Overall Study||4||
48473505|NCT02003053|101496083|FG001|STARTED|Overall Study||3||
48473506|NCT02003053|101496082|FG000|COMPLETED|Overall Study||4||
48473507|NCT02003053|101496083|FG001|COMPLETED|Overall Study||3||
48191519|NCT01304147|100791519|FG000|NOT COMPLETED|Washout (1 Day)||0||
48191520|NCT01304147|100791520|FG001|NOT COMPLETED|Washout (1 Day)||0||
48191521|NCT01304147|100791519|FG000|STARTED|Second Intervention (7days)||10||
48191522|NCT01304147|100791520|FG001|STARTED|Second Intervention (7days)||10||
48191523|NCT01304147|100791519|FG000|COMPLETED|Second Intervention (7days)||9||
48191524|NCT01304147|100791520|FG001|COMPLETED|Second Intervention (7days)||9||
48473508|NCT02003053|101496082|FG000|NOT COMPLETED|Overall Study||0||
48191525|NCT01304147|100791519|FG000|NOT COMPLETED|Second Intervention (7days)||1||
48191526|NCT01304147|100791520|FG001|NOT COMPLETED|Second Intervention (7days)||1||
48191527|NCT03921528|100791521|FG000|STARTED|Overall Study||11||
48191528|NCT03921528|100791522|FG001|STARTED|Overall Study||12||
48191529|NCT03921528|100791523|FG002|STARTED|Overall Study||15||
48191530|NCT03921528|100791524|FG003|STARTED|Overall Study||10||
48191531|NCT03921528|100791525|FG004|STARTED|Overall Study||10||
48191532|NCT03921528|100791521|FG000|COMPLETED|Overall Study||6||
48191533|NCT03921528|100791522|FG001|COMPLETED|Overall Study||10||
48473509|NCT02003053|101496083|FG001|NOT COMPLETED|Overall Study||0||
48473510|NCT00220337|101496084|FG000|STARTED|Overall Study||371||
48473511|NCT00220337|101496084|FG000|COMPLETED|Overall Study||192||
48473512|NCT00220337|101496084|FG000|NOT COMPLETED|Overall Study||179||
48473513|NCT01492361|101496085|FG000|STARTED|Overall Study||4089||
48473514|NCT01492361|101496086|FG001|STARTED|Overall Study||4090||
48473515|NCT01492361|101496085|FG000|Completed Final Visit|Overall Study||3419||
48473516|NCT01492361|101496086|FG001|Completed Final Visit|Overall Study||3335||
48473517|NCT01492361|101496085|FG000|Death Before Final Visit|Overall Study||265|Participants who died on trial were considered completed|
48473518|NCT01492361|101496086|FG001|Death Before Final Visit|Overall Study||295|Participants who died on trial were considered completed|
48473519|NCT01492361|101496085|FG000|COMPLETED|Overall Study||3684||
48473520|NCT01492361|101496086|FG001|COMPLETED|Overall Study||3630||
48473521|NCT01492361|101496085|FG000|NOT COMPLETED|Overall Study||405||
48473522|NCT01492361|101496086|FG001|NOT COMPLETED|Overall Study||460||
48473523|NCT00918567|101496087|FG000|STARTED|Overall Study||29||
48473524|NCT00918567|101496088|FG001|STARTED|Overall Study||27||
48473525|NCT00918567|101496087|FG000|COMPLETED|Overall Study||24||
48473526|NCT00918567|101496088|FG001|COMPLETED|Overall Study||25||
48473527|NCT00918567|101496087|FG000|NOT COMPLETED|Overall Study||5||
48473528|NCT00918567|101496088|FG001|NOT COMPLETED|Overall Study||2||
48191534|NCT03921528|100791523|FG002|COMPLETED|Overall Study||13||
48191535|NCT03921528|100791524|FG003|COMPLETED|Overall Study||10||
48191536|NCT03921528|100791525|FG004|COMPLETED|Overall Study||10||
48191537|NCT03921528|100791521|FG000|NOT COMPLETED|Overall Study||5||
48191538|NCT03921528|100791522|FG001|NOT COMPLETED|Overall Study||2||
48191539|NCT03921528|100791523|FG002|NOT COMPLETED|Overall Study||2||
48191540|NCT03921528|100791524|FG003|NOT COMPLETED|Overall Study||0||
48191541|NCT03921528|100791525|FG004|NOT COMPLETED|Overall Study||0||
48191542|NCT01324882|100791526|FG000|STARTED|Overall Study||27||
48191543|NCT01324882|100791527|FG001|STARTED|Overall Study||30||
48191544|NCT01324882|100791526|FG000|COMPLETED|Overall Study||27||
48191545|NCT01324882|100791527|FG001|COMPLETED|Overall Study||30||
48191546|NCT01324882|100791526|FG000|NOT COMPLETED|Overall Study||0||
48191547|NCT01324882|100791527|FG001|NOT COMPLETED|Overall Study||0||
48191548|NCT05205941|100791528|FG000|STARTED|Overall Study||3||
48191549|NCT05205941|100791529|FG001|STARTED|Overall Study||2||
48191550|NCT05205941|100791530|FG002|STARTED|Overall Study||2||
48191551|NCT05205941|100791531|FG003|STARTED|Overall Study||2||
48191552|NCT05205941|100791528|FG000|COMPLETED|Overall Study||3||
48191553|NCT05205941|100791529|FG001|COMPLETED|Overall Study||2||
48191554|NCT05205941|100791530|FG002|COMPLETED|Overall Study||2||
48191555|NCT05205941|100791531|FG003|COMPLETED|Overall Study||2||
48473529|NCT01475838|101496089|FG000|STARTED|Randomized Phase||293||
48473530|NCT01475838|101496090|FG001|STARTED|Randomized Phase||145||
48473531|NCT01475838|101496089|FG000|COMPLETED|Randomized Phase||263||
48473532|NCT01475838|101496090|FG001|COMPLETED|Randomized Phase||109||
48191556|NCT05205941|100791528|FG000|NOT COMPLETED|Overall Study||0||
48191557|NCT05205941|100791529|FG001|NOT COMPLETED|Overall Study||0||
48473533|NCT01475838|101496089|FG000|NOT COMPLETED|Randomized Phase||30||
48473534|NCT01475838|101496090|FG001|NOT COMPLETED|Randomized Phase||36||
48473535|NCT01475838|101496089|FG000|STARTED|Extension Phase||42||
48473536|NCT01475838|101496090|FG001|STARTED|Extension Phase||20||
48473537|NCT01475838|101496089|FG000|COMPLETED|Extension Phase||41||
48473538|NCT01475838|101496090|FG001|COMPLETED|Extension Phase||20||
48473539|NCT01475838|101496089|FG000|NOT COMPLETED|Extension Phase||1||
48473540|NCT01475838|101496090|FG001|NOT COMPLETED|Extension Phase||0||
48473541|NCT02079532|101496091|FG000|STARTED|Overall Study||302||
48473542|NCT02079532|101496091|FG000|COMPLETED|Overall Study||273||
48473543|NCT02079532|101496091|FG000|NOT COMPLETED|Overall Study||29||
48191558|NCT05205941|100791530|FG002|NOT COMPLETED|Overall Study||0||
48191559|NCT05205941|100791531|FG003|NOT COMPLETED|Overall Study||0||
48191560|NCT03487666|100791532|FG000|STARTED|Overall Study||15||
48191561|NCT03487666|100791533|FG001|STARTED|Overall Study||15||
48191562|NCT03487666|100791534|FG002|STARTED|Overall Study||15||
48191563|NCT03487666|100791532|FG000|COMPLETED|Overall Study||11||
48191564|NCT03487666|100791533|FG001|COMPLETED|Overall Study||13||
48191565|NCT03487666|100791534|FG002|COMPLETED|Overall Study||14||
48191566|NCT03487666|100791532|FG000|NOT COMPLETED|Overall Study||4||
48191567|NCT03487666|100791533|FG001|NOT COMPLETED|Overall Study||2||
48191568|NCT03487666|100791534|FG002|NOT COMPLETED|Overall Study||1||
48191569|NCT02967692|100791535|FG000|STARTED|Overall Study||9||
48191570|NCT02967692|100791536|FG001|STARTED|Overall Study||27||
48191571|NCT02967692|100791537|FG002|STARTED|Overall Study||267||
48191572|NCT02967692|100791538|FG003|STARTED|Overall Study||265||
48191573|NCT02967692|100791535|FG000|Treated|Overall Study||9|1 subject in the placebo arm (Part 3) was not treated as the subject died due to disease progression before receiving any treatment|
48191574|NCT02967692|100791536|FG001|Treated|Overall Study||27|1 subject in the placebo arm (Part 3) was not treated as the subject died due to disease progression before receiving any treatment|
48191575|NCT02967692|100791537|FG002|Treated|Overall Study||267|1 subject in the placebo arm (Part 3) was not treated as the subject died due to disease progression before receiving any treatment|
48191576|NCT02967692|100791538|FG003|Treated|Overall Study||264|1 subject in the placebo arm (Part 3) was not treated as the subject died due to disease progression before receiving any treatment|
48191577|NCT02967692|100791535|FG000|COMPLETED|Overall Study||0||
48191578|NCT02967692|100791536|FG001|COMPLETED|Overall Study||0||
48191579|NCT02967692|100791537|FG002|COMPLETED|Overall Study||0||
48191580|NCT02967692|100791538|FG003|COMPLETED|Overall Study||0||
48191581|NCT02967692|100791535|FG000|NOT COMPLETED|Overall Study||9||
48473544|NCT02829268|101496092|FG000|STARTED|Overall Study||8||
48473545|NCT02829268|101496093|FG001|STARTED|Overall Study||13||
48473546|NCT02829268|101496092|FG000|COMPLETED|Overall Study||8||
48473547|NCT02829268|101496093|FG001|COMPLETED|Overall Study||11||
48473548|NCT02829268|101496092|FG000|NOT COMPLETED|Overall Study||0||
48473549|NCT02829268|101496093|FG001|NOT COMPLETED|Overall Study||2||
48473550|NCT03239522|101496094|FG000|STARTED|Treatment Period 1 (Up to 7 Days)||6||
48473551|NCT03239522|101496094|FG000|COMPLETED|Treatment Period 1 (Up to 7 Days)||6||
48473552|NCT03239522|101496094|FG000|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0||
48473553|NCT03239522|101496094|FG000|STARTED|Washout Period (Up to 7 Days)||6||
48473554|NCT03239522|101496094|FG000|COMPLETED|Washout Period (Up to 7 Days)||6||
48473555|NCT03239522|101496094|FG000|NOT COMPLETED|Washout Period (Up to 7 Days)||0||
48473556|NCT03239522|101496094|FG000|STARTED|Treatment Period 2 (Up to 15 Days)||6||
48473557|NCT03239522|101496094|FG000|COMPLETED|Treatment Period 2 (Up to 15 Days)||6||
48473558|NCT03239522|101496094|FG000|NOT COMPLETED|Treatment Period 2 (Up to 15 Days)||0||
48473559|NCT02016170|101496095|FG000|STARTED|Overall Study||27||
48473560|NCT02016170|101496096|FG001|STARTED|Overall Study||28||
48473561|NCT02016170|101496097|FG002|STARTED|Overall Study||27||
48473562|NCT02016170|101496095|FG000|COMPLETED|Overall Study||25||
48473563|NCT02016170|101496096|FG001|COMPLETED|Overall Study||27||
48473564|NCT02016170|101496097|FG002|COMPLETED|Overall Study||27||
48473565|NCT02016170|101496095|FG000|NOT COMPLETED|Overall Study||2||
48473566|NCT02016170|101496096|FG001|NOT COMPLETED|Overall Study||1||
48191582|NCT02967692|100791536|FG001|NOT COMPLETED|Overall Study||27||
48191583|NCT02967692|100791537|FG002|NOT COMPLETED|Overall Study||267||
48191584|NCT02967692|100791538|FG003|NOT COMPLETED|Overall Study||265||
48191585|NCT04940390|100791539|FG000|STARTED|Overall Study||796||
48191586|NCT04940390|100791540|FG001|STARTED|Overall Study||795||
48191587|NCT04940390|100791539|FG000|Modified Intent-to Treat Population|Overall Study||716||
48191588|NCT04940390|100791540|FG001|Modified Intent-to Treat Population|Overall Study||708||
48191589|NCT04940390|100791539|FG000|Safety Population|Overall Study||731||
48191590|NCT04940390|100791540|FG001|Safety Population|Overall Study||729||
48191591|NCT04940390|100791539|FG000|COMPLETED|Overall Study||771||
48191592|NCT04940390|100791540|FG001|COMPLETED|Overall Study||770||
48191593|NCT04940390|100791539|FG000|NOT COMPLETED|Overall Study||25||
48191594|NCT04940390|100791540|FG001|NOT COMPLETED|Overall Study||25||
48191595|NCT00832780|100791541|FG000|STARTED|Overall Study||44||
48191596|NCT00832780|100791541|FG000|COMPLETED|Overall Study||19||
48191597|NCT00832780|100791541|FG000|NOT COMPLETED|Overall Study||25||
48191598|NCT00884611|100791542|FG000|STARTED|Overall Study||20||
48191599|NCT00884611|100791542|FG000|Enrolled, Not Treated|Overall Study||1||
48191600|NCT00884611|100791542|FG000|COMPLETED|Overall Study||19||
48191601|NCT00884611|100791542|FG000|NOT COMPLETED|Overall Study||1||
48191602|NCT03750656|100791543|FG000|STARTED|Overall Study||4||
48473567|NCT02016170|101496097|FG002|NOT COMPLETED|Overall Study||0||
48473568|NCT03980483|101496098|FG000|STARTED|Overall Study||513||
48473569|NCT03980483|101496099|FG001|STARTED|Overall Study||510||
48473570|NCT03980483|101496100|FG002|STARTED|Overall Study||258||
48473571|NCT03980483|101496101|FG003|STARTED|Overall Study||85||
48473572|NCT03980483|101496102|FG004|STARTED|Overall Study||86||
48473573|NCT03980483|101496103|FG005|STARTED|Overall Study||85||
48473574|NCT03980483|101496098|FG000|Safety Set|Overall Study||513|All randomized participants who received at least one dose of study treatment.|
48473575|NCT03980483|101496099|FG001|Safety Set|Overall Study||510|All randomized participants who received at least one dose of study treatment.|
48473576|NCT03980483|101496100|FG002|Safety Set|Overall Study||273|All randomized participants who received at least one dose of study treatment.|
48473577|NCT03980483|101496101|FG003|Safety Set|Overall Study||0|All randomized participants who received at least one dose of study treatment.|
48666187|NCT01107496|101967523|FG000|NOT COMPLETED|Overall Study||2||
48191603|NCT03750656|100791544|FG001|STARTED|Overall Study||1||
48191604|NCT03750656|100791543|FG000|COMPLETED|Overall Study||2||
48191605|NCT03750656|100791544|FG001|COMPLETED|Overall Study||0||
48191606|NCT03750656|100791543|FG000|NOT COMPLETED|Overall Study||2||
48191607|NCT03750656|100791544|FG001|NOT COMPLETED|Overall Study||1||
48191608|NCT05015478|100791545|FG000|STARTED|Initial Experimental Condition||11||
48191609|NCT05015478|100791546|FG001|STARTED|Initial Experimental Condition||15||
48191610|NCT05015478|100791547|FG002|STARTED|Initial Experimental Condition||12||
48191611|NCT05015478|100791548|FG003|STARTED|Initial Experimental Condition||14||
48191612|NCT05015478|100791545|FG000|COMPLETED|Initial Experimental Condition||11||
48191613|NCT05015478|100791546|FG001|COMPLETED|Initial Experimental Condition||15||
48191614|NCT05015478|100791547|FG002|COMPLETED|Initial Experimental Condition||12||
48191615|NCT05015478|100791548|FG003|COMPLETED|Initial Experimental Condition||14||
48191616|NCT05015478|100791545|FG000|NOT COMPLETED|Initial Experimental Condition||0||
48191617|NCT05015478|100791546|FG001|NOT COMPLETED|Initial Experimental Condition||0||
48191618|NCT05015478|100791547|FG002|NOT COMPLETED|Initial Experimental Condition||0||
48191619|NCT05015478|100791548|FG003|NOT COMPLETED|Initial Experimental Condition||0||
48191620|NCT05015478|100791545|FG000|STARTED|Second Experimental Condition||11||
48191621|NCT05015478|100791546|FG001|STARTED|Second Experimental Condition||15||
48191622|NCT05015478|100791547|FG002|STARTED|Second Experimental Condition||12||
48191623|NCT05015478|100791548|FG003|STARTED|Second Experimental Condition||14||
48191624|NCT05015478|100791545|FG000|COMPLETED|Second Experimental Condition||11||
48191625|NCT05015478|100791546|FG001|COMPLETED|Second Experimental Condition||15||
48191626|NCT05015478|100791547|FG002|COMPLETED|Second Experimental Condition||12||
48191627|NCT05015478|100791548|FG003|COMPLETED|Second Experimental Condition||13||
48191628|NCT05015478|100791545|FG000|NOT COMPLETED|Second Experimental Condition||0||
48191629|NCT05015478|100791546|FG001|NOT COMPLETED|Second Experimental Condition||0||
48191630|NCT05015478|100791547|FG002|NOT COMPLETED|Second Experimental Condition||0||
48191631|NCT05015478|100791548|FG003|NOT COMPLETED|Second Experimental Condition||1||
48473578|NCT03980483|101496102|FG004|Safety Set|Overall Study||0|All randomized participants who received at least one dose of study treatment.|
48473579|NCT03980483|101496103|FG005|Safety Set|Overall Study||0|All randomized participants who received at least one dose of study treatment.|
48191632|NCT03115346|100791549|FG000|STARTED|Overall Study||126||11
48191633|NCT03115346|100791550|FG001|STARTED|Overall Study||109||11
48191634|NCT03115346|100791549|FG000|COMPLETED|Overall Study||95||11
48191635|NCT03115346|100791550|FG001|COMPLETED|Overall Study||87||11
48191636|NCT03115346|100791549|FG000|NOT COMPLETED|Overall Study||31||0
48191637|NCT03115346|100791550|FG001|NOT COMPLETED|Overall Study||22||0
48191638|NCT02256969|100791551|FG000|STARTED|Overall Study||15||
48191639|NCT02256969|100791552|FG001|STARTED|Overall Study||15||
48191640|NCT02256969|100791553|FG002|STARTED|Overall Study||15||
48191641|NCT02256969|100791551|FG000|COMPLETED|Overall Study||13||
48191642|NCT02256969|100791552|FG001|COMPLETED|Overall Study||14||
48191643|NCT02256969|100791553|FG002|COMPLETED|Overall Study||14||
48191644|NCT02256969|100791551|FG000|NOT COMPLETED|Overall Study||2||
48191645|NCT02256969|100791552|FG001|NOT COMPLETED|Overall Study||1||
48191646|NCT02256969|100791553|FG002|NOT COMPLETED|Overall Study||1||
48666188|NCT01107496|101967524|FG001|NOT COMPLETED|Overall Study||2||
48191647|NCT00073957|100791554|FG000|STARTED|Overall Study||25||
48191648|NCT00073957|100791554|FG000|COMPLETED|Overall Study||25||
48191649|NCT00073957|100791554|FG000|NOT COMPLETED|Overall Study||0||
48191650|NCT04863898|100791555|FG000|STARTED|Overall Study||151||
48191651|NCT04863898|100791555|FG000|Baseline Survey|Overall Study||151||
48473580|NCT03980483|101496098|FG000|Safety Set-Placebo Switch|Overall Study||0|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment.|
48473581|NCT03980483|101496099|FG001|Safety Set-Placebo Switch|Overall Study||0|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment.|
48191652|NCT04863898|100791555|FG000|Stigma Reduction Intervention|Overall Study||141||
48191653|NCT04863898|100791555|FG000|Endline Survey|Overall Study||148||
48473582|NCT03980483|101496100|FG002|Safety Set-Placebo Switch|Overall Study||0|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment.|
48473583|NCT03980483|101496101|FG003|Safety Set-Placebo Switch|Overall Study||80|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment.|
48473584|NCT03980483|101496102|FG004|Safety Set-Placebo Switch|Overall Study||82|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment.|
48473585|NCT03980483|101496103|FG005|Safety Set-Placebo Switch|Overall Study||68|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment.|
48473586|NCT03980483|101496098|FG000|COMPLETED|Overall Study||431||
48473587|NCT03980483|101496099|FG001|COMPLETED|Overall Study||436||
48473588|NCT03980483|101496100|FG002|COMPLETED|Overall Study||221||
48473589|NCT03980483|101496101|FG003|COMPLETED|Overall Study||69||
48473590|NCT03980483|101496102|FG004|COMPLETED|Overall Study||73||
48473591|NCT03980483|101496103|FG005|COMPLETED|Overall Study||75||
48473592|NCT03980483|101496098|FG000|NOT COMPLETED|Overall Study||82||
48473593|NCT03980483|101496099|FG001|NOT COMPLETED|Overall Study||74||
48473594|NCT03980483|101496100|FG002|NOT COMPLETED|Overall Study||37||
48473595|NCT03980483|101496101|FG003|NOT COMPLETED|Overall Study||16||
48473596|NCT03980483|101496102|FG004|NOT COMPLETED|Overall Study||13||
48473597|NCT03980483|101496103|FG005|NOT COMPLETED|Overall Study||10||
48473598|NCT01023074|101496104|FG000|STARTED|Overall Study||26||
48473599|NCT01023074|101496105|FG001|STARTED|Overall Study||13||
48473600|NCT01023074|101496106|FG002|STARTED|Overall Study||13||
48473601|NCT01023074|101496104|FG000|COMPLETED|Overall Study||26||
48473602|NCT01023074|101496105|FG001|COMPLETED|Overall Study||13||
48473603|NCT01023074|101496106|FG002|COMPLETED|Overall Study||13||
48473604|NCT01023074|101496104|FG000|NOT COMPLETED|Overall Study||0||
48473605|NCT01023074|101496105|FG001|NOT COMPLETED|Overall Study||0||
48473606|NCT01023074|101496106|FG002|NOT COMPLETED|Overall Study||0||
48473607|NCT01643707|101496107|FG000|STARTED|Overall Study||858||
48473608|NCT01643707|101496108|FG001|STARTED|Overall Study||484||
48473609|NCT01643707|101496107|FG000|COMPLETED|Overall Study||823||
48473610|NCT01643707|101496108|FG001|COMPLETED|Overall Study||470||
48473611|NCT01643707|101496107|FG000|NOT COMPLETED|Overall Study||35||
48473612|NCT01643707|101496108|FG001|NOT COMPLETED|Overall Study||14||
48473613|NCT01545076|101496109|FG000|STARTED|IgPro10 Restabilization Period||208||
48473614|NCT01545076|101496110|FG001|STARTED|IgPro10 Restabilization Period||0||
48473615|NCT01545076|101496111|FG002|STARTED|IgPro10 Restabilization Period||0||
48473616|NCT01545076|101496112|FG003|STARTED|IgPro10 Restabilization Period||0||
48473617|NCT01545076|101496113|FG004|STARTED|IgPro10 Restabilization Period||0||
48473618|NCT01545076|101496109|FG000|COMPLETED|IgPro10 Restabilization Period||172||
48473619|NCT01545076|101496110|FG001|COMPLETED|IgPro10 Restabilization Period||0||
48473620|NCT01545076|101496111|FG002|COMPLETED|IgPro10 Restabilization Period||0||
48473621|NCT01545076|101496112|FG003|COMPLETED|IgPro10 Restabilization Period||0||
48473622|NCT01545076|101496113|FG004|COMPLETED|IgPro10 Restabilization Period||0||
48473623|NCT01545076|101496109|FG000|NOT COMPLETED|IgPro10 Restabilization Period||36||
48473624|NCT01545076|101496110|FG001|NOT COMPLETED|IgPro10 Restabilization Period||0||
48473625|NCT01545076|101496111|FG002|NOT COMPLETED|IgPro10 Restabilization Period||0||
48191654|NCT04863898|100791555|FG000|COMPLETED|Overall Study||141||
48191655|NCT04863898|100791555|FG000|NOT COMPLETED|Overall Study||10||
48191656|NCT04500821|100791556|FG000|STARTED|Overall Study||44||88
48473626|NCT01545076|101496112|FG003|NOT COMPLETED|IgPro10 Restabilization Period||0||
48473627|NCT01545076|101496113|FG004|NOT COMPLETED|IgPro10 Restabilization Period||0||
48473628|NCT01545076|101496109|FG000|STARTED|IgPro20 Subcutaneous Treatment Period||0||
48473629|NCT01545076|101496110|FG001|STARTED|IgPro20 Subcutaneous Treatment Period||58||
48473630|NCT01545076|101496111|FG002|STARTED|IgPro20 Subcutaneous Treatment Period||57||
48473631|NCT01545076|101496112|FG003|STARTED|IgPro20 Subcutaneous Treatment Period||57||
48473632|NCT01545076|101496113|FG004|STARTED|IgPro20 Subcutaneous Treatment Period||0||
48473633|NCT01545076|101496109|FG000|COMPLETED|IgPro20 Subcutaneous Treatment Period||0||
48473634|NCT01545076|101496110|FG001|COMPLETED|IgPro20 Subcutaneous Treatment Period||39||
48473635|NCT01545076|101496111|FG002|COMPLETED|IgPro20 Subcutaneous Treatment Period||36||
48473636|NCT01545076|101496112|FG003|COMPLETED|IgPro20 Subcutaneous Treatment Period||21||
48473637|NCT01545076|101496113|FG004|COMPLETED|IgPro20 Subcutaneous Treatment Period||0||
48473638|NCT01545076|101496109|FG000|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||0||
48473639|NCT01545076|101496110|FG001|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||19||
48473640|NCT01545076|101496111|FG002|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||21||
48473641|NCT01545076|101496112|FG003|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||36||
48473642|NCT01545076|101496113|FG004|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||0||
48473643|NCT01545076|101496109|FG000|STARTED|IgPro10 Rescue Period||0||
48473644|NCT01545076|101496110|FG001|STARTED|IgPro10 Rescue Period||0||
48473645|NCT01545076|101496111|FG002|STARTED|IgPro10 Rescue Period||0||
48473646|NCT01545076|101496112|FG003|STARTED|IgPro10 Rescue Period||0||
48473647|NCT01545076|101496113|FG004|STARTED|IgPro10 Rescue Period||60||
48473648|NCT01545076|101496109|FG000|COMPLETED|IgPro10 Rescue Period||0||
48473649|NCT01545076|101496110|FG001|COMPLETED|IgPro10 Rescue Period||0||
48473650|NCT01545076|101496111|FG002|COMPLETED|IgPro10 Rescue Period||0||
48473651|NCT01545076|101496112|FG003|COMPLETED|IgPro10 Rescue Period||0||
48191657|NCT04500821|100791556|FG000|COMPLETED|Overall Study||44||88
48191658|NCT04500821|100791556|FG000|NOT COMPLETED|Overall Study||0||0
48191659|NCT01093534|100791557|FG000|STARTED|Overall Study||186||
48191660|NCT01093534|100791558|FG001|STARTED|Overall Study||183||
48191661|NCT01093534|100791559|FG002|STARTED|Overall Study||178||
48191662|NCT01093534|100791557|FG000|Received Study Treatment|Overall Study||186||
48191663|NCT01093534|100791558|FG001|Received Study Treatment|Overall Study||182||
48191664|NCT01093534|100791559|FG002|Received Study Treatment|Overall Study||175||
48191665|NCT01093534|100791557|FG000|COMPLETED|Overall Study||176||
48191666|NCT01093534|100791558|FG001|COMPLETED|Overall Study||167||
48191667|NCT01093534|100791559|FG002|COMPLETED|Overall Study||169||
48191668|NCT01093534|100791557|FG000|NOT COMPLETED|Overall Study||10||
48191669|NCT01093534|100791558|FG001|NOT COMPLETED|Overall Study||16||
48191670|NCT01093534|100791559|FG002|NOT COMPLETED|Overall Study||9||
48191671|NCT01789203|100791560|FG000|STARTED|Overall Study||133||
48191672|NCT01789203|100791561|FG001|STARTED|Overall Study||67||
48191673|NCT01789203|100791560|FG000|COMPLETED|Overall Study||124||
48191674|NCT01789203|100791561|FG001|COMPLETED|Overall Study||63||
48191675|NCT01789203|100791560|FG000|NOT COMPLETED|Overall Study||9||
48191676|NCT01789203|100791561|FG001|NOT COMPLETED|Overall Study||4||
48191677|NCT04523181|100791562|FG000|STARTED|Overall Study||62||
48191678|NCT04523181|100791563|FG001|STARTED|Overall Study||62||
48191679|NCT04523181|100791562|FG000|Treated|Overall Study||60|In the Antroquinonol with SOC group, 2 patients were randomized but not treated.|
48473652|NCT01545076|101496113|FG004|COMPLETED|IgPro10 Rescue Period||60||
48473653|NCT01545076|101496109|FG000|NOT COMPLETED|IgPro10 Rescue Period||0||
48473654|NCT01545076|101496110|FG001|NOT COMPLETED|IgPro10 Rescue Period||0||
48473655|NCT01545076|101496111|FG002|NOT COMPLETED|IgPro10 Rescue Period||0||
48473656|NCT01545076|101496112|FG003|NOT COMPLETED|IgPro10 Rescue Period||0||
48473657|NCT01545076|101496113|FG004|NOT COMPLETED|IgPro10 Rescue Period||0||
48473658|NCT00097695|101496114|FG000|STARTED|The Controlled Phase||27||
48473659|NCT00097695|101496115|FG001|STARTED|The Controlled Phase||29||
48473660|NCT00097695|101496116|FG002|STARTED|The Controlled Phase||8||
48473661|NCT00097695|101496117|FG003|STARTED|The Controlled Phase||20||
48473662|NCT00097695|101496114|FG000|COMPLETED|The Controlled Phase||23||
48473663|NCT00097695|101496115|FG001|COMPLETED|The Controlled Phase||26||
48473664|NCT00097695|101496116|FG002|COMPLETED|The Controlled Phase||3||
48473665|NCT00097695|101496117|FG003|COMPLETED|The Controlled Phase||0||
48473666|NCT00097695|101496114|FG000|NOT COMPLETED|The Controlled Phase||4||
48473667|NCT00097695|101496115|FG001|NOT COMPLETED|The Controlled Phase||3||
48191680|NCT04523181|100791563|FG001|Treated|Overall Study||62|In the Antroquinonol with SOC group, 2 patients were randomized but not treated.|
48473668|NCT00097695|101496116|FG002|NOT COMPLETED|The Controlled Phase||5||
48666189|NCT03506360|101967525|FG000|STARTED|Overall Study||13||
48191681|NCT04523181|100791562|FG000|COMPLETED|Overall Study||54||
48473669|NCT00097695|101496117|FG003|NOT COMPLETED|The Controlled Phase||20||
48473670|NCT00097695|101496114|FG000|STARTED|The Open Label Extension (OLE) Phase||23||
48473671|NCT00097695|101496115|FG001|STARTED|The Open Label Extension (OLE) Phase||26||
48473672|NCT00097695|101496116|FG002|STARTED|The Open Label Extension (OLE) Phase||3||
48473673|NCT00097695|101496117|FG003|STARTED|The Open Label Extension (OLE) Phase||20||
48473674|NCT00097695|101496114|FG000|COMPLETED|The Open Label Extension (OLE) Phase||10||
48473675|NCT00097695|101496115|FG001|COMPLETED|The Open Label Extension (OLE) Phase||11||
48473676|NCT00097695|101496116|FG002|COMPLETED|The Open Label Extension (OLE) Phase||1||
48473677|NCT00097695|101496117|FG003|COMPLETED|The Open Label Extension (OLE) Phase||15||
48473678|NCT00097695|101496114|FG000|NOT COMPLETED|The Open Label Extension (OLE) Phase||13||
48473679|NCT00097695|101496115|FG001|NOT COMPLETED|The Open Label Extension (OLE) Phase||15||
48473680|NCT00097695|101496116|FG002|NOT COMPLETED|The Open Label Extension (OLE) Phase||2||
48473681|NCT00097695|101496117|FG003|NOT COMPLETED|The Open Label Extension (OLE) Phase||5||
48191682|NCT04523181|100791563|FG001|COMPLETED|Overall Study||53||
48473682|NCT01439165|101496118|FG000|STARTED|Overall Study||1002||
48473683|NCT01439165|101496119|FG001|STARTED|Overall Study||328||
48473684|NCT01439165|101496118|FG000|COMPLETED|Overall Study||981||
48473685|NCT01439165|101496119|FG001|COMPLETED|Overall Study||326||
48473686|NCT01439165|101496118|FG000|NOT COMPLETED|Overall Study||21||
48473687|NCT01439165|101496119|FG001|NOT COMPLETED|Overall Study||2||
48473688|NCT02146430|101496120|FG000|STARTED|Overall Study||323||
48473689|NCT02146430|101496121|FG001|STARTED|Overall Study||323||
48473690|NCT02146430|101496122|FG002|STARTED|Overall Study||324||
48473691|NCT02146430|101496123|FG003|STARTED|Overall Study||323||
48473692|NCT02146430|101496120|FG000|Safety Analysis Set|Overall Study||318||
48473693|NCT02146430|101496121|FG001|Safety Analysis Set|Overall Study||318||
48473694|NCT02146430|101496122|FG002|Safety Analysis Set|Overall Study||320||
48473695|NCT02146430|101496123|FG003|Safety Analysis Set|Overall Study||320||
48473696|NCT02146430|101496120|FG000|Modified Intent to Treat Set (mITT)|Overall Study||318||
48473697|NCT02146430|101496121|FG001|Modified Intent to Treat Set (mITT)|Overall Study||317||
48473698|NCT02146430|101496122|FG002|Modified Intent to Treat Set (mITT)|Overall Study||319||
48473699|NCT02146430|101496123|FG003|Modified Intent to Treat Set (mITT)|Overall Study||319||
48473700|NCT02146430|101496120|FG000|COMPLETED|Overall Study||256||
48473701|NCT02146430|101496121|FG001|COMPLETED|Overall Study||236||
48473702|NCT02146430|101496122|FG002|COMPLETED|Overall Study||242||
48473703|NCT02146430|101496123|FG003|COMPLETED|Overall Study||224||
48473704|NCT02146430|101496120|FG000|NOT COMPLETED|Overall Study||67||
48473705|NCT02146430|101496121|FG001|NOT COMPLETED|Overall Study||87||
48473706|NCT02146430|101496122|FG002|NOT COMPLETED|Overall Study||82||
48473707|NCT02146430|101496123|FG003|NOT COMPLETED|Overall Study||99||
48473708|NCT03724149|101496124|FG000|STARTED|Overall Study||10||
48473709|NCT03724149|101496124|FG000|COMPLETED|Overall Study||10||
48473710|NCT03724149|101496124|FG000|NOT COMPLETED|Overall Study||0||
48473711|NCT00515203|101496125|FG000|STARTED|Overall Study||17||
48473712|NCT00515203|101496126|FG001|STARTED|Overall Study||5||
48473713|NCT00515203|101496125|FG000|COMPLETED|Overall Study||17||
48473714|NCT00515203|101496126|FG001|COMPLETED|Overall Study||5||
48473715|NCT00515203|101496125|FG000|NOT COMPLETED|Overall Study||0||
48473716|NCT00515203|101496126|FG001|NOT COMPLETED|Overall Study||0||
48473717|NCT02365207|101496127|FG000|STARTED|Overall Study||6||
48473718|NCT02365207|101496127|FG000|COMPLETED|Overall Study||4||
48473719|NCT02365207|101496127|FG000|NOT COMPLETED|Overall Study||2||
48473720|NCT04652453|101496128|FG000|STARTED|Overall Study||50||
48473721|NCT04652453|101496129|FG001|STARTED|Overall Study||22||
48473722|NCT04652453|101496130|FG002|STARTED|Overall Study||11||
48473723|NCT04652453|101496128|FG000|COMPLETED|Overall Study||35||
48473724|NCT04652453|101496129|FG001|COMPLETED|Overall Study||15||
48473725|NCT04652453|101496130|FG002|COMPLETED|Overall Study||11||
48473726|NCT04652453|101496128|FG000|NOT COMPLETED|Overall Study||15||
48473727|NCT04652453|101496129|FG001|NOT COMPLETED|Overall Study||7||
48473728|NCT04652453|101496130|FG002|NOT COMPLETED|Overall Study||0||
48473729|NCT00313703|101496131|FG000|STARTED|Overall Study||186||
48473730|NCT00313703|101496132|FG001|STARTED|Overall Study||34||
48473731|NCT00313703|101496133|FG002|STARTED|Overall Study||77||
48473732|NCT00313703|101496134|FG003|STARTED|Overall Study||12||
48473733|NCT00313703|101496131|FG000|COMPLETED|Overall Study||175||
48473734|NCT00313703|101496132|FG001|COMPLETED|Overall Study||32||
48473735|NCT00313703|101496133|FG002|COMPLETED|Overall Study||72||
48473736|NCT00313703|101496134|FG003|COMPLETED|Overall Study||0||
48473737|NCT00313703|101496131|FG000|NOT COMPLETED|Overall Study||11||
48473738|NCT00313703|101496132|FG001|NOT COMPLETED|Overall Study||2||
48473739|NCT00313703|101496133|FG002|NOT COMPLETED|Overall Study||5||
48473740|NCT00313703|101496134|FG003|NOT COMPLETED|Overall Study||12||
48473741|NCT03805438|101496135|FG000|STARTED|Overall Study||47||
48473742|NCT03805438|101496135|FG000|COMPLETED|Overall Study||45||
48473743|NCT03805438|101496135|FG000|NOT COMPLETED|Overall Study||2||
48473744|NCT02980978|101496136|FG000|STARTED|Overall Study||60||
48473745|NCT02980978|101496137|FG001|STARTED|Overall Study||58||
48191683|NCT04523181|100791562|FG000|NOT COMPLETED|Overall Study||8||
48191684|NCT04523181|100791563|FG001|NOT COMPLETED|Overall Study||9||
48191685|NCT00331162|100791564|FG000|STARTED|Overall Study||113||
48473746|NCT02980978|101496136|FG000|COMPLETED|Overall Study||54||
48191686|NCT00331162|100791565|FG001|STARTED|Overall Study||109||
48370722|NCT03052608|101234946|FG001|COMPLETED|Treatment Phase||83|"Completed refers to participants with confirmed RECIST version 1.1 defined disease progression assessed by the blinded independent central review or investigator."|
48370723|NCT03052608|101234945|FG000|NOT COMPLETED|Treatment Phase||123||
48370724|NCT03052608|101234946|FG001|NOT COMPLETED|Treatment Phase||64||
48370725|NCT03052608|101234945|FG000|STARTED|Long-Term Follow-up Phase||149|The long-term follow-up phase included the post-treatment follow-up and the survival follow-up. Participants who started the long-term follow-up phase consisted of participants in both the post-treatment follow-up and the survival follow-up.|
48370726|NCT03052608|101234946|FG001|STARTED|Long-Term Follow-up Phase||147|The long-term follow-up phase included the post-treatment follow-up and the survival follow-up. Participants who started the long-term follow-up phase consisted of participants in both the post-treatment follow-up and the survival follow-up.|
48370727|NCT03052608|101234945|FG000|COMPLETED|Long-Term Follow-up Phase||0||
48370728|NCT03052608|101234946|FG001|COMPLETED|Long-Term Follow-up Phase||0||
48370729|NCT03052608|101234945|FG000|NOT COMPLETED|Long-Term Follow-up Phase||149||
48370730|NCT03052608|101234946|FG001|NOT COMPLETED|Long-Term Follow-up Phase||147||
48370731|NCT02784509|101234947|FG000|STARTED|Overall Study||342||
48370732|NCT02784509|101234947|FG000|COMPLETED|Overall Study||256||
48370733|NCT02784509|101234947|FG000|NOT COMPLETED|Overall Study||86||
48370734|NCT03391466|101234948|FG000|STARTED|Overall Study||180||
48370735|NCT03391466|101234949|FG001|STARTED|Overall Study||179||
48370736|NCT03391466|101234948|FG000|COMPLETED|Overall Study||0||
48370737|NCT03391466|101234949|FG001|COMPLETED|Overall Study||0||
48370738|NCT03391466|101234948|FG000|NOT COMPLETED|Overall Study||180||
48370739|NCT03391466|101234949|FG001|NOT COMPLETED|Overall Study||179||
48370740|NCT03474107|101234950|FG000|STARTED|Overall Study||301||
48370741|NCT03474107|101234951|FG001|STARTED|Overall Study||307||
48370742|NCT03474107|101234950|FG000|Treated|Overall Study||296||
48370743|NCT03474107|101234951|FG001|Treated|Overall Study||291||
48370744|NCT03474107|101234950|FG000|COMPLETED|Overall Study||56||
48370745|NCT03474107|101234951|FG001|COMPLETED|Overall Study||22||
48370746|NCT03474107|101234950|FG000|NOT COMPLETED|Overall Study||245||
48370747|NCT03474107|101234951|FG001|NOT COMPLETED|Overall Study||285||
48370748|NCT03092453|101234952|FG000|STARTED|Overall Study||5||
48370749|NCT03092453|101234952|FG000|COMPLETED|Overall Study||3||
48370750|NCT03092453|101234952|FG000|NOT COMPLETED|Overall Study||2||
48370751|NCT02677896|101234953|FG000|STARTED|Double Blind Period (up to 35 Months)||574||
48370752|NCT02677896|101234954|FG001|STARTED|Double Blind Period (up to 35 Months)||576||
48370753|NCT02677896|101234953|FG000|Treated|Double Blind Period (up to 35 Months)||572||
48473747|NCT02980978|101496137|FG001|COMPLETED|Overall Study||50||
48473748|NCT02980978|101496136|FG000|NOT COMPLETED|Overall Study||6||
48473749|NCT02980978|101496137|FG001|NOT COMPLETED|Overall Study||8||
48473750|NCT02519322|101496138|FG000|STARTED|Overall Study||0||
48473751|NCT02519322|101496139|FG001|STARTED|Overall Study||0||
48473752|NCT02519322|101496140|FG002|STARTED|Overall Study||34||
48473753|NCT02519322|101496138|FG000|COMPLETED|Overall Study||0||
48473754|NCT02519322|101496139|FG001|COMPLETED|Overall Study||0||
48473755|NCT02519322|101496140|FG002|COMPLETED|Overall Study||34||
48473756|NCT02519322|101496138|FG000|NOT COMPLETED|Overall Study||0||
48473757|NCT02519322|101496139|FG001|NOT COMPLETED|Overall Study||0||
48473758|NCT02519322|101496140|FG002|NOT COMPLETED|Overall Study||0||
48473759|NCT03527745|101496141|FG000|STARTED|Overall Study||27||
48473760|NCT03527745|101496142|FG001|STARTED|Overall Study||27||
48473761|NCT03527745|101496143|FG002|STARTED|Overall Study||30||
48473762|NCT03527745|101496144|FG003|STARTED|Overall Study||27||
48473763|NCT03527745|101496145|FG004|STARTED|Overall Study||46||
48473764|NCT03527745|101496146|FG005|STARTED|Overall Study||45||
48473765|NCT03527745|101496147|FG006|STARTED|Overall Study||46||
48473766|NCT03527745|101496148|FG007|STARTED|Overall Study||43||
48473767|NCT03527745|101496149|FG008|STARTED|Overall Study||10||
48473768|NCT03527745|101496150|FG009|STARTED|Overall Study||11||
48473769|NCT03527745|101496151|FG010|STARTED|Overall Study||9||
48473770|NCT03527745|101496152|FG011|STARTED|Overall Study||12||
48473771|NCT03527745|101496153|FG012|STARTED|Overall Study||0||
48473772|NCT03527745|101496154|FG013|STARTED|Overall Study||13||
48473773|NCT03527745|101496155|FG014|STARTED|Overall Study||13||
48473774|NCT03527745|101496156|FG015|STARTED|Overall Study||12||
48473775|NCT03527745|101496157|FG016|STARTED|Overall Study||24||
48473776|NCT03527745|101496158|FG017|STARTED|Overall Study||27||
48473777|NCT03527745|101496159|FG018|STARTED|Overall Study||27||
48473778|NCT03527745|101496160|FG019|STARTED|Overall Study||29||
48473779|NCT03527745|101496161|FG020|STARTED|Overall Study||26||
48473780|NCT03527745|101496162|FG021|STARTED|Overall Study||40||
48473781|NCT03527745|101496163|FG022|STARTED|Overall Study||41||
48473782|NCT03527745|101496164|FG023|STARTED|Overall Study||38||
48473783|NCT03527745|101496165|FG024|STARTED|Overall Study||40||
48473784|NCT03527745|101496166|FG025|STARTED|Overall Study||37||
48473785|NCT03527745|101496141|FG000|COMPLETED|Overall Study||24||
48473786|NCT03527745|101496142|FG001|COMPLETED|Overall Study||21||
48473787|NCT03527745|101496143|FG002|COMPLETED|Overall Study||23||
48473788|NCT03527745|101496144|FG003|COMPLETED|Overall Study||18||
48473789|NCT03527745|101496145|FG004|COMPLETED|Overall Study||46||
48473790|NCT03527745|101496146|FG005|COMPLETED|Overall Study||43||
48473791|NCT03527745|101496147|FG006|COMPLETED|Overall Study||43||
48473792|NCT03527745|101496148|FG007|COMPLETED|Overall Study||41||
48473793|NCT03527745|101496149|FG008|COMPLETED|Overall Study||7||
48473794|NCT03527745|101496150|FG009|COMPLETED|Overall Study||9||
48473795|NCT03527745|101496151|FG010|COMPLETED|Overall Study||8||
48191687|NCT00331162|100791564|FG000|COMPLETED|Overall Study||113||
48191688|NCT00331162|100791565|FG001|COMPLETED|Overall Study||109||
48191689|NCT00331162|100791564|FG000|NOT COMPLETED|Overall Study||0||
48191690|NCT00331162|100791565|FG001|NOT COMPLETED|Overall Study||0||
48191691|NCT00052962|100791566|FG000|STARTED|Overall Study||13||
48191692|NCT00052962|100791567|FG001|STARTED|Overall Study||17||
48191693|NCT00052962|100791566|FG000|COMPLETED|Overall Study||12||
48473796|NCT03527745|101496152|FG011|COMPLETED|Overall Study||11||
48191694|NCT00052962|100791567|FG001|COMPLETED|Overall Study||15||
48191695|NCT00052962|100791566|FG000|NOT COMPLETED|Overall Study||1||
48191696|NCT00052962|100791567|FG001|NOT COMPLETED|Overall Study||2||
48191697|NCT03825393|100791568|FG000|STARTED|Overall Study||100||
48191698|NCT03825393|100791569|FG001|STARTED|Overall Study||100||
48191699|NCT03825393|100791568|FG000|COMPLETED|Overall Study||100||
48191700|NCT03825393|100791569|FG001|COMPLETED|Overall Study||100||
48191701|NCT03825393|100791568|FG000|NOT COMPLETED|Overall Study||0||
48191702|NCT03825393|100791569|FG001|NOT COMPLETED|Overall Study||0||
48191703|NCT00555581|100791570|FG000|STARTED|Overall Study||30||
48191704|NCT00555581|100791570|FG000|COMPLETED|Overall Study||24||
48191705|NCT00555581|100791570|FG000|NOT COMPLETED|Overall Study||6||
48191706|NCT01675830|100791571|FG000|STARTED|Overall Study||10||
48191707|NCT01675830|100791571|FG000|COMPLETED|Overall Study||10||
48191708|NCT01675830|100791571|FG000|NOT COMPLETED|Overall Study||0||
48191709|NCT00490555|100791572|FG000|STARTED|Overall Study||8||
48191710|NCT00490555|100791573|FG001|STARTED|Overall Study||8||
48473797|NCT03527745|101496153|FG012|COMPLETED|Overall Study||0||
48473798|NCT03527745|101496154|FG013|COMPLETED|Overall Study||13||
48473799|NCT03527745|101496155|FG014|COMPLETED|Overall Study||13||
48473800|NCT03527745|101496156|FG015|COMPLETED|Overall Study||12||
48473801|NCT03527745|101496157|FG016|COMPLETED|Overall Study||23||
48473802|NCT03527745|101496158|FG017|COMPLETED|Overall Study||27||
48473803|NCT03527745|101496159|FG018|COMPLETED|Overall Study||27||
48473804|NCT03527745|101496160|FG019|COMPLETED|Overall Study||28||
48473805|NCT03527745|101496161|FG020|COMPLETED|Overall Study||25||
48473806|NCT03527745|101496162|FG021|COMPLETED|Overall Study||35||
48473807|NCT03527745|101496163|FG022|COMPLETED|Overall Study||35||
48473808|NCT03527745|101496164|FG023|COMPLETED|Overall Study||30||
48473809|NCT03527745|101496165|FG024|COMPLETED|Overall Study||39||
48473810|NCT03527745|101496166|FG025|COMPLETED|Overall Study||34||
48473811|NCT03527745|101496141|FG000|NOT COMPLETED|Overall Study||3||
48473812|NCT03527745|101496142|FG001|NOT COMPLETED|Overall Study||6||
48473813|NCT03527745|101496143|FG002|NOT COMPLETED|Overall Study||7||
48473814|NCT03527745|101496144|FG003|NOT COMPLETED|Overall Study||9||
48473815|NCT03527745|101496145|FG004|NOT COMPLETED|Overall Study||0||
48473816|NCT03527745|101496146|FG005|NOT COMPLETED|Overall Study||2||
48473817|NCT03527745|101496147|FG006|NOT COMPLETED|Overall Study||3||
48473818|NCT03527745|101496148|FG007|NOT COMPLETED|Overall Study||2||
48473819|NCT03527745|101496149|FG008|NOT COMPLETED|Overall Study||3||
48191711|NCT00490555|100791574|FG002|STARTED|Overall Study||9||
48191712|NCT00490555|100791575|FG003|STARTED|Overall Study||7||
48191713|NCT00490555|100791572|FG000|COMPLETED|Overall Study||8||
48191714|NCT00490555|100791573|FG001|COMPLETED|Overall Study||8||
48473820|NCT03527745|101496150|FG009|NOT COMPLETED|Overall Study||2||
48473821|NCT03527745|101496151|FG010|NOT COMPLETED|Overall Study||1||
48473822|NCT03527745|101496152|FG011|NOT COMPLETED|Overall Study||1||
48473823|NCT03527745|101496153|FG012|NOT COMPLETED|Overall Study||0||
48473824|NCT03527745|101496154|FG013|NOT COMPLETED|Overall Study||0||
48473825|NCT03527745|101496155|FG014|NOT COMPLETED|Overall Study||0||
48473826|NCT03527745|101496156|FG015|NOT COMPLETED|Overall Study||0||
48473827|NCT03527745|101496157|FG016|NOT COMPLETED|Overall Study||1||
48473828|NCT03527745|101496158|FG017|NOT COMPLETED|Overall Study||0||
48473829|NCT03527745|101496159|FG018|NOT COMPLETED|Overall Study||0||
48473830|NCT03527745|101496160|FG019|NOT COMPLETED|Overall Study||1||
48473831|NCT03527745|101496161|FG020|NOT COMPLETED|Overall Study||1||
48473832|NCT03527745|101496162|FG021|NOT COMPLETED|Overall Study||5||
48473833|NCT03527745|101496163|FG022|NOT COMPLETED|Overall Study||6||
48473834|NCT03527745|101496164|FG023|NOT COMPLETED|Overall Study||8||
48473835|NCT03527745|101496165|FG024|NOT COMPLETED|Overall Study||1||
48473836|NCT03527745|101496166|FG025|NOT COMPLETED|Overall Study||3||
48473837|NCT02849652|101496167|FG000|STARTED|Overall Study||344||
48473838|NCT02849652|101496168|FG001|STARTED|Overall Study||131||
48473839|NCT02849652|101496169|FG002|STARTED|Overall Study||266||
48473840|NCT02849652|101496170|FG003|STARTED|Overall Study||91||
48473841|NCT02849652|101496167|FG000|Week 12|Overall Study||294||
48473842|NCT02849652|101496168|FG001|Week 12|Overall Study||120||
48473843|NCT02849652|101496169|FG002|Week 12|Overall Study||222||
48473844|NCT02849652|101496170|FG003|Week 12|Overall Study||78||
48473845|NCT02849652|101496167|FG000|Week 24|Overall Study||279||
48473846|NCT02849652|101496168|FG001|Week 24|Overall Study||112||
48473847|NCT02849652|101496169|FG002|Week 24|Overall Study||188||
48473848|NCT02849652|101496170|FG003|Week 24|Overall Study||74||
48473849|NCT02849652|101496167|FG000|Week 36|Overall Study||250||
48473850|NCT02849652|101496168|FG001|Week 36|Overall Study||104||
48473851|NCT02849652|101496169|FG002|Week 36|Overall Study||166||
48473852|NCT02849652|101496170|FG003|Week 36|Overall Study||66||
48473853|NCT02849652|101496167|FG000|Week 52|Overall Study||230||
48473854|NCT02849652|101496168|FG001|Week 52|Overall Study||94||
48473855|NCT02849652|101496169|FG002|Week 52|Overall Study||142||
48473856|NCT02849652|101496170|FG003|Week 52|Overall Study||65||
48473857|NCT02849652|101496167|FG000|COMPLETED|Overall Study||230||
48473858|NCT02849652|101496168|FG001|COMPLETED|Overall Study||94||
48473859|NCT02849652|101496169|FG002|COMPLETED|Overall Study||142||
48473860|NCT02849652|101496170|FG003|COMPLETED|Overall Study||65||
48473861|NCT02849652|101496167|FG000|NOT COMPLETED|Overall Study||114||
48473862|NCT02849652|101496168|FG001|NOT COMPLETED|Overall Study||37||
48473863|NCT02849652|101496169|FG002|NOT COMPLETED|Overall Study||124||
48473864|NCT02849652|101496170|FG003|NOT COMPLETED|Overall Study||26||
48473865|NCT03765502|101496171|FG000|STARTED|Simulation 1||20||
48473866|NCT03765502|101496172|FG001|STARTED|Simulation 1||13||
48473867|NCT03765502|101496173|FG002|STARTED|Simulation 1||33||
48473868|NCT03765502|101496174|FG003|STARTED|Simulation 1||16||
48191715|NCT00490555|100791574|FG002|COMPLETED|Overall Study||7||
48473869|NCT03765502|101496175|FG004|STARTED|Simulation 1||17||
48473870|NCT03765502|101496171|FG000|COMPLETED|Simulation 1||20||
48473871|NCT03765502|101496172|FG001|COMPLETED|Simulation 1||13||
48473872|NCT03765502|101496173|FG002|COMPLETED|Simulation 1||33||
48473873|NCT03765502|101496174|FG003|COMPLETED|Simulation 1||16||
48473874|NCT03765502|101496175|FG004|COMPLETED|Simulation 1||17||
48473875|NCT03765502|101496171|FG000|NOT COMPLETED|Simulation 1||0||
48473876|NCT03765502|101496172|FG001|NOT COMPLETED|Simulation 1||0||
48473877|NCT03765502|101496173|FG002|NOT COMPLETED|Simulation 1||0||
48473878|NCT03765502|101496174|FG003|NOT COMPLETED|Simulation 1||0||
48473879|NCT03765502|101496175|FG004|NOT COMPLETED|Simulation 1||0||
48473880|NCT03765502|101496171|FG000|STARTED|Simulation 2||20||
48473881|NCT03765502|101496172|FG001|STARTED|Simulation 2||12||
48473882|NCT03765502|101496173|FG002|STARTED|Simulation 2||32||
48473883|NCT03765502|101496174|FG003|STARTED|Simulation 2||16||
48473884|NCT03765502|101496175|FG004|STARTED|Simulation 2||17||
48473885|NCT03765502|101496171|FG000|COMPLETED|Simulation 2||20||
48473886|NCT03765502|101496172|FG001|COMPLETED|Simulation 2||12||
48473887|NCT03765502|101496173|FG002|COMPLETED|Simulation 2||32||
48473888|NCT03765502|101496174|FG003|COMPLETED|Simulation 2||16||
48473889|NCT03765502|101496175|FG004|COMPLETED|Simulation 2||17||
48473890|NCT03765502|101496171|FG000|NOT COMPLETED|Simulation 2||0||
48473891|NCT03765502|101496172|FG001|NOT COMPLETED|Simulation 2||0||
48473892|NCT03765502|101496173|FG002|NOT COMPLETED|Simulation 2||0||
48473893|NCT03765502|101496174|FG003|NOT COMPLETED|Simulation 2||0||
48473894|NCT03765502|101496175|FG004|NOT COMPLETED|Simulation 2||0||
48473895|NCT04084483|101496176|FG000|STARTED|Overall Study||59||
48473896|NCT04084483|101496177|FG001|STARTED|Overall Study||59||
48473897|NCT04084483|101496178|FG002|STARTED|Overall Study||61||
48473898|NCT04084483|101496179|FG003|STARTED|Overall Study||59||
48473899|NCT04084483|101496176|FG000|COMPLETED|Overall Study||56||
48473900|NCT04084483|101496177|FG001|COMPLETED|Overall Study||57||
48473901|NCT04084483|101496178|FG002|COMPLETED|Overall Study||59||
48473902|NCT04084483|101496179|FG003|COMPLETED|Overall Study||57||
48473903|NCT04084483|101496176|FG000|NOT COMPLETED|Overall Study||3||
48473904|NCT04084483|101496177|FG001|NOT COMPLETED|Overall Study||2||
48473905|NCT04084483|101496178|FG002|NOT COMPLETED|Overall Study||2||
48473906|NCT04084483|101496179|FG003|NOT COMPLETED|Overall Study||2||
48473907|NCT01362998|101496180|FG000|STARTED|Overall Study||0||
48473908|NCT01362998|101496181|FG001|STARTED|Overall Study||2||
48473909|NCT01362998|101496180|FG000|COMPLETED|Overall Study||0||
48473910|NCT01362998|101496181|FG001|COMPLETED|Overall Study||1||
48473911|NCT01362998|101496180|FG000|NOT COMPLETED|Overall Study||0||
48473912|NCT01362998|101496181|FG001|NOT COMPLETED|Overall Study||1||
48473913|NCT01076972|101496182|FG000|STARTED|Overall Study||1184||
48473914|NCT01076972|101496182|FG000|COMPLETED|Overall Study||1184||
48473915|NCT01076972|101496182|FG000|NOT COMPLETED|Overall Study||0||
48473916|NCT03204526|101496183|FG000|STARTED|Overall Study||15||
48473917|NCT03204526|101496183|FG000|COMPLETED|Overall Study||15||
48473918|NCT03204526|101496183|FG000|NOT COMPLETED|Overall Study||0||
48473919|NCT03184441|101496184|FG000|STARTED|Overall Study||11||
48473920|NCT03184441|101496184|FG000|COMPLETED|Overall Study||10||
48473921|NCT03184441|101496184|FG000|NOT COMPLETED|Overall Study||1||
48473922|NCT02720510|101496185|FG000|STARTED|Overall Study||3||
48473923|NCT02720510|101496186|FG001|STARTED|Overall Study||3||
48473924|NCT02720510|101496185|FG000|COMPLETED|Overall Study||0||
48473925|NCT02720510|101496186|FG001|COMPLETED|Overall Study||0||
48473926|NCT02720510|101496185|FG000|NOT COMPLETED|Overall Study||3||
48473927|NCT02720510|101496186|FG001|NOT COMPLETED|Overall Study||3||
48473928|NCT00755326|101496187|FG000|STARTED|Overall Study||47||
48473929|NCT00755326|101496188|FG001|STARTED|Overall Study||45||
48473930|NCT00755326|101496187|FG000|COMPLETED|Overall Study||45||
48473931|NCT00755326|101496188|FG001|COMPLETED|Overall Study||42||
48473932|NCT00755326|101496187|FG000|NOT COMPLETED|Overall Study||2||
48473933|NCT00755326|101496188|FG001|NOT COMPLETED|Overall Study||3||
48473934|NCT02626949|101496189|FG000|STARTED|Randomization, Pre-Enrollment||56||
48473935|NCT02626949|101496190|FG001|STARTED|Randomization, Pre-Enrollment||58||
48473936|NCT02626949|101496189|FG000|COMPLETED|Randomization, Pre-Enrollment||40||
48473937|NCT02626949|101496190|FG001|COMPLETED|Randomization, Pre-Enrollment||44||
48473938|NCT02626949|101496189|FG000|NOT COMPLETED|Randomization, Pre-Enrollment||16||
48473939|NCT02626949|101496190|FG001|NOT COMPLETED|Randomization, Pre-Enrollment||14||
48473940|NCT02626949|101496189|FG000|STARTED|Enrolled||40||
48473941|NCT02626949|101496190|FG001|STARTED|Enrolled||44||
48473942|NCT02626949|101496189|FG000|COMPLETED|Enrolled||30||
48473943|NCT02626949|101496190|FG001|COMPLETED|Enrolled||36||
48473944|NCT02626949|101496189|FG000|NOT COMPLETED|Enrolled||10||
48473945|NCT02626949|101496190|FG001|NOT COMPLETED|Enrolled||8||
48473946|NCT02979353|101496191|FG000|STARTED|Overall Study||186||
48473947|NCT02979353|101496192|FG001|STARTED|Overall Study||186||
48473948|NCT02979353|101496191|FG000|Hospital Phase|Overall Study||174||
48473949|NCT02979353|101496192|FG001|Hospital Phase|Overall Study||181||
48473950|NCT02979353|101496191|FG000|Post-Acute Care Phase|Overall Study||142||
48473951|NCT02979353|101496192|FG001|Post-Acute Care Phase|Overall Study||142||
48473952|NCT02979353|101496191|FG000|7-Day Follow-Up|Overall Study||137||
48473953|NCT02979353|101496192|FG001|7-Day Follow-Up|Overall Study||133||
48473954|NCT02979353|101496191|FG000|60-Day Follow-Up|Overall Study||128||
48473955|NCT02979353|101496192|FG001|60-Day Follow-Up|Overall Study||125||
48473956|NCT02979353|101496191|FG000|COMPLETED|Overall Study||116||
48473957|NCT02979353|101496192|FG001|COMPLETED|Overall Study||115||
48473958|NCT02979353|101496191|FG000|NOT COMPLETED|Overall Study||70||
48473959|NCT02979353|101496192|FG001|NOT COMPLETED|Overall Study||71||
48473960|NCT00101582|101496193|FG000|STARTED|Overall Study||94||
48473961|NCT00101582|101496194|FG001|STARTED|Overall Study||94||
48473962|NCT00101582|101496193|FG000|Received Study Drug|Overall Study||91||
48473963|NCT00101582|101496194|FG001|Received Study Drug|Overall Study||94||
48473964|NCT00101582|101496193|FG000|COMPLETED|Overall Study||83||
48473965|NCT00101582|101496194|FG001|COMPLETED|Overall Study||79||
48191716|NCT00490555|100791575|FG003|COMPLETED|Overall Study||7||
48191717|NCT00490555|100791572|FG000|NOT COMPLETED|Overall Study||0||
48191718|NCT00490555|100791573|FG001|NOT COMPLETED|Overall Study||0||
48191719|NCT00490555|100791574|FG002|NOT COMPLETED|Overall Study||2||
48191720|NCT00490555|100791575|FG003|NOT COMPLETED|Overall Study||0||
48473966|NCT00101582|101496193|FG000|NOT COMPLETED|Overall Study||11||
48473967|NCT00101582|101496194|FG001|NOT COMPLETED|Overall Study||15||
48473968|NCT00571428|101496195|FG000|STARTED|Overall Study||15||
48473969|NCT00571428|101496196|FG001|STARTED|Overall Study||18||
48473970|NCT00571428|101496195|FG000|COMPLETED|Overall Study||15||
48473971|NCT00571428|101496196|FG001|COMPLETED|Overall Study||18||
48473972|NCT00571428|101496195|FG000|NOT COMPLETED|Overall Study||0||
48473973|NCT00571428|101496196|FG001|NOT COMPLETED|Overall Study||0||
48473974|NCT02296775|101496197|FG000|STARTED|Treatment and Evaluation||91||
48473975|NCT02296775|101496198|FG001|STARTED|Treatment and Evaluation||92||
48473976|NCT02296775|101496199|FG002|STARTED|Treatment and Evaluation||93||
48473977|NCT02296775|101496197|FG000|COMPLETED|Treatment and Evaluation||87||
48191721|NCT04210024|100791576|FG000|STARTED|Overall Study||91||
48473978|NCT02296775|101496198|FG001|COMPLETED|Treatment and Evaluation||84||
48473979|NCT02296775|101496199|FG002|COMPLETED|Treatment and Evaluation||83||
48473980|NCT02296775|101496197|FG000|NOT COMPLETED|Treatment and Evaluation||4||
48473981|NCT02296775|101496198|FG001|NOT COMPLETED|Treatment and Evaluation||8||
48473982|NCT02296775|101496199|FG002|NOT COMPLETED|Treatment and Evaluation||10||
48473983|NCT02296775|101496197|FG000|STARTED|Recovery and Follow-up||87||
48473984|NCT02296775|101496198|FG001|STARTED|Recovery and Follow-up||84||
48473985|NCT02296775|101496199|FG002|STARTED|Recovery and Follow-up||83||
48473986|NCT02296775|101496197|FG000|COMPLETED|Recovery and Follow-up||82||
48473987|NCT02296775|101496198|FG001|COMPLETED|Recovery and Follow-up||79||
48473988|NCT02296775|101496199|FG002|COMPLETED|Recovery and Follow-up||79||
48473989|NCT02296775|101496197|FG000|NOT COMPLETED|Recovery and Follow-up||5||
48473990|NCT02296775|101496198|FG001|NOT COMPLETED|Recovery and Follow-up||5||
48473991|NCT02296775|101496199|FG002|NOT COMPLETED|Recovery and Follow-up||4||
48473992|NCT03103100|101496200|FG000|STARTED|Overall Study||25||
48473993|NCT03103100|101496201|FG001|STARTED|Overall Study||25||
48473994|NCT03103100|101496202|FG002|STARTED|Overall Study||25||
48473995|NCT03103100|101496200|FG000|COMPLETED|Overall Study||23||
48473996|NCT03103100|101496201|FG001|COMPLETED|Overall Study||25||
48473997|NCT03103100|101496202|FG002|COMPLETED|Overall Study||23||
48473998|NCT03103100|101496200|FG000|NOT COMPLETED|Overall Study||2||
48473999|NCT03103100|101496201|FG001|NOT COMPLETED|Overall Study||0||
48474000|NCT03103100|101496202|FG002|NOT COMPLETED|Overall Study||2||
48474001|NCT03127137|101496203|FG000|STARTED|Overall Study||62||
48474002|NCT03127137|101496204|FG001|STARTED|Overall Study||61||
48474003|NCT03127137|101496203|FG000|COMPLETED|Overall Study||60||
48474004|NCT03127137|101496204|FG001|COMPLETED|Overall Study||60||
48474005|NCT03127137|101496203|FG000|NOT COMPLETED|Overall Study||2||
48474006|NCT03127137|101496204|FG001|NOT COMPLETED|Overall Study||1||
48191722|NCT04210024|100791576|FG000|COMPLETED|Overall Study||91||
48474007|NCT01196052|101496205|FG000|STARTED|Overall Study||153||
48474008|NCT01196052|101496205|FG000|Received Trastuzumab Emtansine|Overall Study||148||
48474009|NCT01196052|101496205|FG000|COMPLETED|Overall Study||130||
48474010|NCT01196052|101496205|FG000|NOT COMPLETED|Overall Study||23||
48474011|NCT01641445|101496206|FG000|STARTED|Overall Study||41||
48474012|NCT01641445|101496207|FG001|STARTED|Overall Study||41||
48474013|NCT01641445|101496206|FG000|COMPLETED|Overall Study||31||
48474014|NCT01641445|101496207|FG001|COMPLETED|Overall Study||36||
48474015|NCT01641445|101496206|FG000|NOT COMPLETED|Overall Study||10||
48474016|NCT01641445|101496207|FG001|NOT COMPLETED|Overall Study||5||
48474017|NCT00001849|101496208|FG000|STARTED|Overall Study||68||68
48474018|NCT00001849|101496208|FG000|COMPLETED|Overall Study||54||54
48474019|NCT00001849|101496208|FG000|NOT COMPLETED|Overall Study||14||14
48474020|NCT03312530|101496209|FG000|STARTED|Overall Study||6||
48191723|NCT04210024|100791576|FG000|NOT COMPLETED|Overall Study||0||
48191724|NCT02616263|100791577|FG000|STARTED|Baseline to 6 Month (Intervention Phase)||29||
48191725|NCT02616263|100791578|FG001|STARTED|Baseline to 6 Month (Intervention Phase)||31||
48191726|NCT02616263|100791577|FG000|COMPLETED|Baseline to 6 Month (Intervention Phase)||28||
48191727|NCT02616263|100791578|FG001|COMPLETED|Baseline to 6 Month (Intervention Phase)||28||
48191728|NCT02616263|100791577|FG000|NOT COMPLETED|Baseline to 6 Month (Intervention Phase)||1||
48191729|NCT02616263|100791578|FG001|NOT COMPLETED|Baseline to 6 Month (Intervention Phase)||3||
48191730|NCT02616263|100791577|FG000|STARTED|6 Month to 1.5 Year||28||
48191731|NCT02616263|100791578|FG001|STARTED|6 Month to 1.5 Year||28||
48191732|NCT02616263|100791577|FG000|COMPLETED|6 Month to 1.5 Year||26||
48191733|NCT02616263|100791578|FG001|COMPLETED|6 Month to 1.5 Year||25||
48191734|NCT02616263|100791577|FG000|NOT COMPLETED|6 Month to 1.5 Year||2||
48191735|NCT02616263|100791578|FG001|NOT COMPLETED|6 Month to 1.5 Year||3||
48191736|NCT02616263|100791577|FG000|STARTED|1.5 Year to 3+ Year Follow up||26||
48191737|NCT02616263|100791578|FG001|STARTED|1.5 Year to 3+ Year Follow up||25||
48191738|NCT02616263|100791577|FG000|COMPLETED|1.5 Year to 3+ Year Follow up||22||
48191739|NCT02616263|100791578|FG001|COMPLETED|1.5 Year to 3+ Year Follow up||23||
48191740|NCT02616263|100791577|FG000|NOT COMPLETED|1.5 Year to 3+ Year Follow up||4||
48474021|NCT03312530|101496210|FG001|STARTED|Overall Study||6||
48474022|NCT03312530|101496211|FG002|STARTED|Overall Study||6||
48474023|NCT03312530|101496212|FG003|STARTED|Overall Study||16||
48474024|NCT03312530|101496213|FG004|STARTED|Overall Study||15||
48474025|NCT03312530|101496209|FG000|COMPLETED|Overall Study||0||
48474026|NCT03312530|101496210|FG001|COMPLETED|Overall Study||0||
48474027|NCT03312530|101496211|FG002|COMPLETED|Overall Study||0||
48474028|NCT03312530|101496212|FG003|COMPLETED|Overall Study||0||
48474029|NCT03312530|101496213|FG004|COMPLETED|Overall Study||0||
48474030|NCT03312530|101496209|FG000|NOT COMPLETED|Overall Study||6||
48191741|NCT02616263|100791578|FG001|NOT COMPLETED|1.5 Year to 3+ Year Follow up||2||
48191742|NCT01636362|100791579|FG000|STARTED|Overall Study||45||
48191743|NCT01636362|100791579|FG000|COMPLETED|Overall Study||37||
48191744|NCT01636362|100791579|FG000|NOT COMPLETED|Overall Study||8||
48191745|NCT04213846|100791580|FG000|STARTED|Overall Study||203||
48191746|NCT04213846|100791581|FG001|STARTED|Overall Study||205||
48191747|NCT04213846|100791580|FG000|COMPLETED|Overall Study||181||
48191748|NCT04213846|100791581|FG001|COMPLETED|Overall Study||178||
48191749|NCT04213846|100791580|FG000|NOT COMPLETED|Overall Study||22||
48191750|NCT04213846|100791581|FG001|NOT COMPLETED|Overall Study||27||
48474031|NCT03312530|101496210|FG001|NOT COMPLETED|Overall Study||6||
48474032|NCT03312530|101496211|FG002|NOT COMPLETED|Overall Study||6||
48474033|NCT03312530|101496212|FG003|NOT COMPLETED|Overall Study||16||
48474034|NCT03312530|101496213|FG004|NOT COMPLETED|Overall Study||15||
48474035|NCT00841100|101496214|FG000|STARTED|Acute Component (24 Hours)||21||
48474036|NCT00841100|101496214|FG000|COMPLETED|Acute Component (24 Hours)||21||
48474037|NCT00841100|101496214|FG000|NOT COMPLETED|Acute Component (24 Hours)||0||
48474038|NCT00841100|101496214|FG000|STARTED|Phase 1 (28 Days)||18||
48474039|NCT00841100|101496214|FG000|COMPLETED|Phase 1 (28 Days)||15||
48474040|NCT00841100|101496214|FG000|NOT COMPLETED|Phase 1 (28 Days)||3||
48474041|NCT00841100|101496214|FG000|STARTED|Phase 2 (2 Weeks)||5||
48474042|NCT00841100|101496214|FG000|COMPLETED|Phase 2 (2 Weeks)||5||
48474043|NCT00841100|101496214|FG000|NOT COMPLETED|Phase 2 (2 Weeks)||0||
48474044|NCT00841100|101496214|FG000|STARTED|Phase 3 (28 Days)||4||
48191751|NCT03371108|100791582|FG000|STARTED|Safety Analysis Set||284||
48191752|NCT03371108|100791583|FG001|STARTED|Safety Analysis Set||283||
48191753|NCT03371108|100791582|FG000|COMPLETED|Safety Analysis Set||281||
48474045|NCT00841100|101496214|FG000|COMPLETED|Phase 3 (28 Days)||4||
48474046|NCT00841100|101496214|FG000|NOT COMPLETED|Phase 3 (28 Days)||0||
48474047|NCT01717976|101496215|FG000|STARTED|Overall Study||257||
48474048|NCT01717976|101496216|FG001|STARTED|Overall Study||257||
48474049|NCT01717976|101496215|FG000|COMPLETED|Overall Study||257||
48191754|NCT03371108|100791583|FG001|COMPLETED|Safety Analysis Set||282||
48191755|NCT03371108|100791582|FG000|NOT COMPLETED|Safety Analysis Set||3||
48191756|NCT03371108|100791583|FG001|NOT COMPLETED|Safety Analysis Set||1||
48191757|NCT03371108|100791582|FG000|STARTED|Completers||281||
48191758|NCT03371108|100791583|FG001|STARTED|Completers||282||
48191759|NCT03371108|100791582|FG000|COMPLETED|Completers||259||
48191760|NCT03371108|100791583|FG001|COMPLETED|Completers||256||
48191761|NCT03371108|100791582|FG000|NOT COMPLETED|Completers||22||
48191762|NCT03371108|100791583|FG001|NOT COMPLETED|Completers||26||
48191763|NCT03905135|100791584|FG000|STARTED|Dose Escalation||6||
48191764|NCT03905135|100791585|FG001|STARTED|Dose Escalation||2||
48191765|NCT03905135|100791584|FG000|COMPLETED|Dose Escalation||1||
48474050|NCT01717976|101496216|FG001|COMPLETED|Overall Study||256||
48474051|NCT01717976|101496215|FG000|NOT COMPLETED|Overall Study||0||
48191766|NCT03905135|100791585|FG001|COMPLETED|Dose Escalation||0||
48191767|NCT03905135|100791584|FG000|NOT COMPLETED|Dose Escalation||5||
48474052|NCT01717976|101496216|FG001|NOT COMPLETED|Overall Study||1||
48474053|NCT00825227|101496217|FG000|STARTED|Overall Study||6||
48474054|NCT00825227|101496218|FG001|STARTED|Overall Study||4||
48474055|NCT00825227|101496217|FG000|COMPLETED|Overall Study||6||
48474056|NCT00825227|101496218|FG001|COMPLETED|Overall Study||4||
48474057|NCT00825227|101496217|FG000|NOT COMPLETED|Overall Study||0||
48474058|NCT00825227|101496218|FG001|NOT COMPLETED|Overall Study||0||
48474059|NCT04642950|101496219|FG000|STARTED|Overall Study||47||
48474060|NCT04642950|101496220|FG001|STARTED|Overall Study||23||
48474061|NCT04642950|101496219|FG000|COMPLETED|Overall Study||44||
48474062|NCT04642950|101496220|FG001|COMPLETED|Overall Study||23||
48474063|NCT04642950|101496219|FG000|NOT COMPLETED|Overall Study||3||
48474064|NCT04642950|101496220|FG001|NOT COMPLETED|Overall Study||0||
48474065|NCT00352690|101496221|FG000|STARTED|Overall Study||10||
48474066|NCT00352690|101496222|FG001|STARTED|Overall Study||0||
48474067|NCT00352690|101496221|FG000|COMPLETED|Overall Study||8||
48474068|NCT00352690|101496222|FG001|COMPLETED|Overall Study||0||
48474069|NCT00352690|101496221|FG000|NOT COMPLETED|Overall Study||2||
48474070|NCT00352690|101496222|FG001|NOT COMPLETED|Overall Study||0||
48474071|NCT02228382|101496223|FG000|STARTED|Overall Study||46||
48474072|NCT02228382|101496224|FG001|STARTED|Overall Study||61||
48474073|NCT02228382|101496225|FG002|STARTED|Overall Study||49||
48474074|NCT02228382|101496226|FG003|STARTED|Overall Study||4||
48474075|NCT02228382|101496227|FG004|STARTED|Overall Study||3||
48474076|NCT02228382|101496223|FG000|COMPLETED|Overall Study||36||
48474077|NCT02228382|101496224|FG001|COMPLETED|Overall Study||43||
48474078|NCT02228382|101496225|FG002|COMPLETED|Overall Study||28||
48474079|NCT02228382|101496226|FG003|COMPLETED|Overall Study||2||
48474080|NCT02228382|101496227|FG004|COMPLETED|Overall Study||1||
48474081|NCT02228382|101496223|FG000|NOT COMPLETED|Overall Study||10||
48474082|NCT02228382|101496224|FG001|NOT COMPLETED|Overall Study||18||
48474083|NCT02228382|101496225|FG002|NOT COMPLETED|Overall Study||21||
48474084|NCT02228382|101496226|FG003|NOT COMPLETED|Overall Study||2||
48474085|NCT02228382|101496227|FG004|NOT COMPLETED|Overall Study||2||
48474086|NCT03977051|101496228|FG000|STARTED|Overall Study||26||
48474087|NCT03977051|101496228|FG000|COMPLETED|Overall Study||26||
48474088|NCT03977051|101496228|FG000|NOT COMPLETED|Overall Study||0||
48474089|NCT03361228|101496229|FG000|STARTED|Overall Study||4||
48474090|NCT03361228|101496230|FG001|STARTED|Overall Study||1||
48474091|NCT03361228|101496229|FG000|COMPLETED|Overall Study||0||
48474092|NCT03361228|101496230|FG001|COMPLETED|Overall Study||0||
48474093|NCT03361228|101496229|FG000|NOT COMPLETED|Overall Study||4||
48474094|NCT03361228|101496230|FG001|NOT COMPLETED|Overall Study||1||
48474095|NCT03093324|101496231|FG000|STARTED|Overall Study||254|All enrolled participants.|
48474096|NCT03093324|101496232|FG001|STARTED|Overall Study||252|All enrolled participants.|
48474097|NCT03093324|101496231|FG000|Safety Population|Overall Study||253|All enrolled participants who received at least one dose of study drug.|
48474098|NCT03093324|101496232|FG001|Safety Population|Overall Study||251|All enrolled participants who received at least one dose of study drug.|
48474099|NCT03093324|101496231|FG000|COMPLETED|Overall Study||245||
48474100|NCT03093324|101496232|FG001|COMPLETED|Overall Study||233||
48474101|NCT03093324|101496231|FG000|NOT COMPLETED|Overall Study||9||
48474102|NCT03093324|101496232|FG001|NOT COMPLETED|Overall Study||19||
48474103|NCT01402908|101496233|FG000|STARTED|Overall Study||258||
48474104|NCT01402908|101496234|FG001|STARTED|Overall Study||261||
48474105|NCT01402908|101496233|FG000|COMPLETED|Overall Study||224||
48474106|NCT01402908|101496234|FG001|COMPLETED|Overall Study||243||
48474107|NCT01402908|101496233|FG000|NOT COMPLETED|Overall Study||34||
48474108|NCT01402908|101496234|FG001|NOT COMPLETED|Overall Study||18||
48474109|NCT00771537|101496235|FG000|STARTED|Overall Study||135||
48474110|NCT00771537|101496236|FG001|STARTED|Overall Study||124||
48474111|NCT00771537|101496237|FG002|STARTED|Overall Study||151||
48474112|NCT00771537|101496238|FG003|STARTED|Overall Study||114||
48474113|NCT00771537|101496239|FG004|STARTED|Overall Study||127||
48474114|NCT00771537|101496240|FG005|STARTED|Overall Study||118||
48474115|NCT00771537|101496241|FG006|STARTED|Overall Study||128||
48474116|NCT00771537|101496242|FG007|STARTED|Overall Study||132||
48474117|NCT00771537|101496243|FG008|STARTED|Overall Study||115||
48474118|NCT00771537|101496244|FG009|STARTED|Overall Study||119||
48474119|NCT00771537|101496245|FG010|STARTED|Overall Study||133||
48474120|NCT00771537|101496246|FG011|STARTED|Overall Study||137||
48474121|NCT00771537|101496247|FG012|STARTED|Overall Study||128||
48474122|NCT00771537|101496248|FG013|STARTED|Overall Study||124||
48474123|NCT00771537|101496249|FG014|STARTED|Overall Study||124||
48474124|NCT00771537|101496250|FG015|STARTED|Overall Study||122||
48474125|NCT00771537|101496235|FG000|COMPLETED|Overall Study||135||
48474126|NCT00771537|101496236|FG001|COMPLETED|Overall Study||124||
48474127|NCT00771537|101496237|FG002|COMPLETED|Overall Study||151||
48474128|NCT00771537|101496238|FG003|COMPLETED|Overall Study||114||
48474129|NCT00771537|101496239|FG004|COMPLETED|Overall Study||127||
48474130|NCT00771537|101496240|FG005|COMPLETED|Overall Study||118||
48474131|NCT00771537|101496241|FG006|COMPLETED|Overall Study||128||
48474132|NCT00771537|101496242|FG007|COMPLETED|Overall Study||132||
48474133|NCT00771537|101496243|FG008|COMPLETED|Overall Study||115||
48474134|NCT00771537|101496244|FG009|COMPLETED|Overall Study||119||
48474135|NCT00771537|101496245|FG010|COMPLETED|Overall Study||133||
48474136|NCT00771537|101496246|FG011|COMPLETED|Overall Study||137||
48474137|NCT00771537|101496247|FG012|COMPLETED|Overall Study||128||
48474138|NCT00771537|101496248|FG013|COMPLETED|Overall Study||124||
48474139|NCT00771537|101496249|FG014|COMPLETED|Overall Study||124||
48474140|NCT00771537|101496250|FG015|COMPLETED|Overall Study||122||
48474141|NCT00771537|101496235|FG000|NOT COMPLETED|Overall Study||0||
48474142|NCT00771537|101496236|FG001|NOT COMPLETED|Overall Study||0||
48474143|NCT00771537|101496237|FG002|NOT COMPLETED|Overall Study||0||
48474144|NCT00771537|101496238|FG003|NOT COMPLETED|Overall Study||0||
48474145|NCT00771537|101496239|FG004|NOT COMPLETED|Overall Study||0||
48191768|NCT03905135|100791585|FG001|NOT COMPLETED|Dose Escalation||2||
48191769|NCT03905135|100791584|FG000|STARTED|Dose Expansion||0||
48191770|NCT03905135|100791585|FG001|STARTED|Dose Expansion||0||
48191771|NCT03905135|100791584|FG000|COMPLETED|Dose Expansion||0||
48191772|NCT03905135|100791585|FG001|COMPLETED|Dose Expansion||0||
48191773|NCT03905135|100791584|FG000|NOT COMPLETED|Dose Expansion||0||
48191774|NCT03905135|100791585|FG001|NOT COMPLETED|Dose Expansion||0||
48191775|NCT03566680|100791586|FG000|STARTED|Overall Study||46||
48191776|NCT03566680|100791586|FG000|COMPLETED|Overall Study||29||
48191777|NCT03566680|100791586|FG000|NOT COMPLETED|Overall Study||17||
48191778|NCT02775435|100791587|FG000|STARTED|Overall Study||278||
48191779|NCT02775435|100791588|FG001|STARTED|Overall Study||281||
48191780|NCT02775435|100791587|FG000|Treated|Overall Study||278||
48191781|NCT02775435|100791588|FG001|Treated|Overall Study||280||
48191782|NCT02775435|100791587|FG000|Received Second Course of Pembrolizumab|Overall Study||12||
48191783|NCT02775435|100791588|FG001|Received Second Course of Pembrolizumab|Overall Study||0||
48191784|NCT02775435|100791587|FG000|Received Switch-over Plus Second Course of Pembrolizuamb|Overall Study||0||
48191785|NCT02775435|100791588|FG001|Received Switch-over Plus Second Course of Pembrolizuamb|Overall Study||1||
48191786|NCT02775435|100791587|FG000|Switched to Pembrolizumab + Chemotherapy|Overall Study||0||
48191787|NCT02775435|100791588|FG001|Switched to Pembrolizumab + Chemotherapy|Overall Study||118||
48191788|NCT02775435|100791587|FG000|COMPLETED|Overall Study||0||
48191789|NCT02775435|100791588|FG001|COMPLETED|Overall Study||0||
48191790|NCT02775435|100791587|FG000|NOT COMPLETED|Overall Study||278||
48191791|NCT02775435|100791588|FG001|NOT COMPLETED|Overall Study||281||
48191792|NCT01796977|100791589|FG000|STARTED|Overall Study||27||
48191793|NCT01796977|100791589|FG000|COMPLETED|Overall Study||27||
48191794|NCT01796977|100791589|FG000|NOT COMPLETED|Overall Study||0||
48191795|NCT00945477|100791590|FG000|STARTED|Overall Study||11||
48191796|NCT00945477|100791590|FG000|COMPLETED|Overall Study||5||
48191797|NCT00945477|100791590|FG000|NOT COMPLETED|Overall Study||6||
48191798|NCT05567159|100791591|FG000|STARTED|Overall Study||42||
48191799|NCT05567159|100791591|FG000|Received at Least One IV Infusion of Donanemab|Overall Study||42||
48191800|NCT05567159|100791591|FG000|COMPLETED|Overall Study||34||
48191801|NCT05567159|100791591|FG000|NOT COMPLETED|Overall Study||8||
48191802|NCT01174550|100791592|FG000|STARTED|Overall Study||5007||
48191803|NCT01174550|100791593|FG001|STARTED|Overall Study||4996||
48191804|NCT01174550|100791592|FG000|COMPLETED|Overall Study||3737||
48191805|NCT01174550|100791593|FG001|COMPLETED|Overall Study||4123||
48191806|NCT01174550|100791592|FG000|NOT COMPLETED|Overall Study||1270||
48191807|NCT01174550|100791593|FG001|NOT COMPLETED|Overall Study||873||
48191808|NCT02892409|100791594|FG000|STARTED|Overall Study||15||
48191809|NCT02892409|100791595|FG001|STARTED|Overall Study||15||
48191810|NCT02892409|100791594|FG000|COMPLETED|Overall Study||12||
48191811|NCT02892409|100791595|FG001|COMPLETED|Overall Study||14||
48191812|NCT02892409|100791594|FG000|NOT COMPLETED|Overall Study||3||
48191813|NCT02892409|100791595|FG001|NOT COMPLETED|Overall Study||1||
48191814|NCT01648283|100791596|FG000|STARTED|Overall Study||78||
48191815|NCT01648283|100791596|FG000|COMPLETED|Overall Study||64||
48191816|NCT01648283|100791596|FG000|NOT COMPLETED|Overall Study||14||
48191817|NCT01565538|100791597|FG000|STARTED|Overall Study||61||
48191818|NCT01565538|100791598|FG001|STARTED|Overall Study||62||
48191819|NCT01565538|100791597|FG000|COMPLETED|Overall Study||61||
48191820|NCT01565538|100791598|FG001|COMPLETED|Overall Study||62||
48191821|NCT01565538|100791597|FG000|NOT COMPLETED|Overall Study||0||
48191822|NCT01565538|100791598|FG001|NOT COMPLETED|Overall Study||0||
48191823|NCT03079375|100791599|FG000|STARTED|Overall Study||503||
48191824|NCT03079375|100791600|FG001|STARTED|Overall Study||499||
48191825|NCT03079375|100791601|FG002|STARTED|Overall Study||497||
48191826|NCT03079375|100791599|FG000|COMPLETED|Overall Study||498||
48191827|NCT03079375|100791600|FG001|COMPLETED|Overall Study||493||
48191828|NCT03079375|100791601|FG002|COMPLETED|Overall Study||476||
48191829|NCT03079375|100791599|FG000|NOT COMPLETED|Overall Study||5||
48191830|NCT03079375|100791600|FG001|NOT COMPLETED|Overall Study||6||
48191831|NCT03079375|100791601|FG002|NOT COMPLETED|Overall Study||21||
48191832|NCT01143077|100791602|FG000|STARTED|Overall Study||74||
48191833|NCT01143077|100791603|FG001|STARTED|Overall Study||88||
48191834|NCT01143077|100791604|FG002|STARTED|Overall Study||82||
48191835|NCT01143077|100791602|FG000|COMPLETED|Overall Study||58||
48191836|NCT01143077|100791603|FG001|COMPLETED|Overall Study||73||
48191837|NCT01143077|100791604|FG002|COMPLETED|Overall Study||67||
48191838|NCT01143077|100791602|FG000|NOT COMPLETED|Overall Study||16||
48191839|NCT01143077|100791603|FG001|NOT COMPLETED|Overall Study||15||
48191840|NCT01143077|100791604|FG002|NOT COMPLETED|Overall Study||15||
48191841|NCT04739423|100791605|FG000|STARTED|Overall Study||12||
48191842|NCT04739423|100791606|FG001|STARTED|Overall Study||13||
48191843|NCT04739423|100791607|FG002|STARTED|Overall Study||6||
48191844|NCT04739423|100791608|FG003|STARTED|Overall Study||7||
48474146|NCT00771537|101496240|FG005|NOT COMPLETED|Overall Study||0||
48474147|NCT00771537|101496241|FG006|NOT COMPLETED|Overall Study||0||
48474148|NCT00771537|101496242|FG007|NOT COMPLETED|Overall Study||0||
48474149|NCT00771537|101496243|FG008|NOT COMPLETED|Overall Study||0||
48474150|NCT00771537|101496244|FG009|NOT COMPLETED|Overall Study||0||
48474151|NCT00771537|101496245|FG010|NOT COMPLETED|Overall Study||0||
48474152|NCT00771537|101496246|FG011|NOT COMPLETED|Overall Study||0||
48474153|NCT00771537|101496247|FG012|NOT COMPLETED|Overall Study||0||
48474154|NCT00771537|101496248|FG013|NOT COMPLETED|Overall Study||0||
48474155|NCT00771537|101496249|FG014|NOT COMPLETED|Overall Study||0||
48474156|NCT00771537|101496250|FG015|NOT COMPLETED|Overall Study||0||
48474157|NCT02356471|101496251|FG000|STARTED|Overall Study||34||
48474158|NCT02356471|101496251|FG000|COMPLETED|Overall Study||28||
48474159|NCT02356471|101496251|FG000|NOT COMPLETED|Overall Study||6||
48474160|NCT01259869|101496252|FG000|STARTED|Overall Study||34||
48474161|NCT01259869|101496252|FG000|COMPLETED|Overall Study||33||
48474162|NCT01259869|101496252|FG000|NOT COMPLETED|Overall Study||1||
48474163|NCT01469364|101496253|FG000|STARTED|Overall Study||30||
48474164|NCT01469364|101496253|FG000|COMPLETED|Overall Study||28||
48474165|NCT01469364|101496253|FG000|NOT COMPLETED|Overall Study||2||
48474166|NCT01575522|101496254|FG000|STARTED|Overall Study||22||
48474167|NCT01575522|101496254|FG000|COMPLETED|Overall Study||22||
48474168|NCT01575522|101496254|FG000|NOT COMPLETED|Overall Study||0||
48474169|NCT01106326|101496255|FG000|STARTED|Overall Study||30||
48474170|NCT01106326|101496255|FG000|COMPLETED|Overall Study||28||
48474171|NCT01106326|101496255|FG000|NOT COMPLETED|Overall Study||2||
48474172|NCT01124149|101496256|FG000|STARTED|Acute Phase||722||
48474173|NCT01124149|101496256|FG000|COMPLETED|Acute Phase||639||
48474174|NCT01124149|101496256|FG000|NOT COMPLETED|Acute Phase||83||
48474175|NCT01124149|101496256|FG000|STARTED|Maintenance Phase||469||
48474176|NCT01124149|101496256|FG000|COMPLETED|Maintenance Phase||373||
48474177|NCT01124149|101496256|FG000|NOT COMPLETED|Maintenance Phase||96||
48474178|NCT02909140|101496257|FG000|STARTED|Overall Study||0||
48474179|NCT02909140|101496258|FG001|STARTED|Overall Study||2||
48474180|NCT02909140|101496259|FG002|STARTED|Overall Study||0||
48474181|NCT02909140|101496257|FG000|COMPLETED|Overall Study||0||
48474182|NCT02909140|101496258|FG001|COMPLETED|Overall Study||2||
48474183|NCT02909140|101496259|FG002|COMPLETED|Overall Study||0||
48474184|NCT02909140|101496257|FG000|NOT COMPLETED|Overall Study||0||
48474185|NCT02909140|101496258|FG001|NOT COMPLETED|Overall Study||0||
48474186|NCT02909140|101496259|FG002|NOT COMPLETED|Overall Study||0||
48474187|NCT02388763|101496260|FG000|STARTED|Habitual, 10 Days of Wear||32||
48474188|NCT02388763|101496261|FG001|STARTED|Habitual, 10 Days of Wear||32||
48474189|NCT02388763|101496260|FG000|COMPLETED|Habitual, 10 Days of Wear||31||
48474190|NCT02388763|101496261|FG001|COMPLETED|Habitual, 10 Days of Wear||31||
48474191|NCT02388763|101496260|FG000|NOT COMPLETED|Habitual, 10 Days of Wear||1||
48474192|NCT02388763|101496261|FG001|NOT COMPLETED|Habitual, 10 Days of Wear||1||
48474193|NCT02388763|101496260|FG000|STARTED|Period 1, 10 Days of Wear||31||
48474194|NCT02388763|101496261|FG001|STARTED|Period 1, 10 Days of Wear||31||
48474195|NCT02388763|101496260|FG000|COMPLETED|Period 1, 10 Days of Wear||30||
48474196|NCT02388763|101496261|FG001|COMPLETED|Period 1, 10 Days of Wear||30||
48474197|NCT02388763|101496260|FG000|NOT COMPLETED|Period 1, 10 Days of Wear||1||
48474198|NCT02388763|101496261|FG001|NOT COMPLETED|Period 1, 10 Days of Wear||1||
48474199|NCT02388763|101496260|FG000|STARTED|Period 2, 10 Days of Wear||30||
48474200|NCT02388763|101496261|FG001|STARTED|Period 2, 10 Days of Wear||30||
48474201|NCT02388763|101496260|FG000|COMPLETED|Period 2, 10 Days of Wear||30||
48474202|NCT02388763|101496261|FG001|COMPLETED|Period 2, 10 Days of Wear||30||
48474203|NCT02388763|101496260|FG000|NOT COMPLETED|Period 2, 10 Days of Wear||0||
48474204|NCT02388763|101496261|FG001|NOT COMPLETED|Period 2, 10 Days of Wear||0||
48474205|NCT00220701|101496262|FG000|STARTED|Overall Study||17||
48474206|NCT00220701|101496263|FG001|STARTED|Overall Study||17||
48474207|NCT00220701|101496262|FG000|COMPLETED|Overall Study||12||
48474208|NCT00220701|101496263|FG001|COMPLETED|Overall Study||13||
48474209|NCT00220701|101496262|FG000|NOT COMPLETED|Overall Study||5||
48474210|NCT00220701|101496263|FG001|NOT COMPLETED|Overall Study||4||
48474211|NCT00290147|101496264|FG000|STARTED|Overall Study||10||
48474212|NCT00290147|101496265|FG001|STARTED|Overall Study||12||
48474213|NCT00290147|101496264|FG000|COMPLETED|Overall Study||10||
48474214|NCT00290147|101496265|FG001|COMPLETED|Overall Study||12||
48474215|NCT00290147|101496264|FG000|NOT COMPLETED|Overall Study||0||
48474216|NCT00290147|101496265|FG001|NOT COMPLETED|Overall Study||0||
48474217|NCT02129348|101496266|FG000|STARTED|Overall Study||38||
48474218|NCT02129348|101496267|FG001|STARTED|Overall Study||39||
48474219|NCT02129348|101496266|FG000|COMPLETED|Overall Study||29||
48474220|NCT02129348|101496267|FG001|COMPLETED|Overall Study||29||
48474221|NCT02129348|101496266|FG000|NOT COMPLETED|Overall Study||9||
48474222|NCT02129348|101496267|FG001|NOT COMPLETED|Overall Study||10||
48474223|NCT00494975|101496268|FG000|STARTED|Overall Study||10||
48474224|NCT00494975|101496269|FG001|STARTED|Overall Study||11||
48474225|NCT00494975|101496268|FG000|COMPLETED|Overall Study||8||
48474226|NCT00494975|101496269|FG001|COMPLETED|Overall Study||10||
48474227|NCT00494975|101496268|FG000|NOT COMPLETED|Overall Study||2||
48474228|NCT00494975|101496269|FG001|NOT COMPLETED|Overall Study||1||
48474229|NCT02999178|101496270|FG000|STARTED|Overall Study||332||
48474230|NCT02999178|101496271|FG001|STARTED|Overall Study||331||
48474231|NCT02999178|101496270|FG000|COMPLETED|Overall Study||218||
48474232|NCT02999178|101496271|FG001|COMPLETED|Overall Study||231||
48474233|NCT02999178|101496270|FG000|NOT COMPLETED|Overall Study||114||
48474234|NCT02999178|101496271|FG001|NOT COMPLETED|Overall Study||100||
48474235|NCT00973700|101496272|FG000|STARTED|Overall Study||56||
48474236|NCT00973700|101496273|FG001|STARTED|Overall Study||56||
48474237|NCT00973700|101496274|FG002|STARTED|Overall Study||168||
48474238|NCT00973700|101496275|FG003|STARTED|Overall Study||336||
48474239|NCT00973700|101496276|FG004|STARTED|Overall Study||168||
48474240|NCT00973700|101496272|FG000|COMPLETED|Overall Study||49||
48474241|NCT00973700|101496273|FG001|COMPLETED|Overall Study||54||
48474242|NCT00973700|101496274|FG002|COMPLETED|Overall Study||158||
48474243|NCT00973700|101496275|FG003|COMPLETED|Overall Study||318||
48474244|NCT00973700|101496276|FG004|COMPLETED|Overall Study||158||
48474245|NCT00973700|101496272|FG000|NOT COMPLETED|Overall Study||7||
48474246|NCT00973700|101496273|FG001|NOT COMPLETED|Overall Study||2||
48474247|NCT00973700|101496274|FG002|NOT COMPLETED|Overall Study||10||
48474248|NCT00973700|101496275|FG003|NOT COMPLETED|Overall Study||18||
48474249|NCT00973700|101496276|FG004|NOT COMPLETED|Overall Study||10||
48474250|NCT02848326|101496277|FG000|STARTED|Treatment Period||186||
48474251|NCT02848326|101496278|FG001|STARTED|Treatment Period||94||
48474252|NCT02848326|101496279|FG002|STARTED|Treatment Period||185||
48474253|NCT02848326|101496280|FG003|STARTED|Treatment Period||187||
48474254|NCT02848326|101496281|FG004|STARTED|Treatment Period||89||
48474255|NCT02848326|101496282|FG005|STARTED|Treatment Period||93||
48474256|NCT02848326|101496277|FG000|Safety Population: Received Study Drug|Treatment Period||186||
48474257|NCT02848326|101496278|FG001|Safety Population: Received Study Drug|Treatment Period||93||
48474258|NCT02848326|101496279|FG002|Safety Population: Received Study Drug|Treatment Period||183||
48474259|NCT02848326|101496280|FG003|Safety Population: Received Study Drug|Treatment Period||186||
48474260|NCT02848326|101496281|FG004|Safety Population: Received Study Drug|Treatment Period||86||
48474261|NCT02848326|101496282|FG005|Safety Population: Received Study Drug|Treatment Period||91||
48474262|NCT02848326|101496277|FG000|COMPLETED|Treatment Period||148||
48474263|NCT02848326|101496278|FG001|COMPLETED|Treatment Period||80||
48474264|NCT02848326|101496279|FG002|COMPLETED|Treatment Period||149||
48474265|NCT02848326|101496280|FG003|COMPLETED|Treatment Period||164||
48474266|NCT02848326|101496281|FG004|COMPLETED|Treatment Period||70||
48474267|NCT02848326|101496282|FG005|COMPLETED|Treatment Period||73||
48474268|NCT02848326|101496277|FG000|NOT COMPLETED|Treatment Period||38||
48474269|NCT02848326|101496278|FG001|NOT COMPLETED|Treatment Period||14||
48474270|NCT02848326|101496279|FG002|NOT COMPLETED|Treatment Period||36||
48474271|NCT02848326|101496280|FG003|NOT COMPLETED|Treatment Period||23||
48474272|NCT02848326|101496281|FG004|NOT COMPLETED|Treatment Period||19||
48474273|NCT02848326|101496282|FG005|NOT COMPLETED|Treatment Period||20||
48474274|NCT02848326|101496277|FG000|STARTED|Safety Follow-up Period||161||
48474275|NCT02848326|101496278|FG001|STARTED|Safety Follow-up Period||84||
48474276|NCT02848326|101496279|FG002|STARTED|Safety Follow-up Period||156||
48474277|NCT02848326|101496280|FG003|STARTED|Safety Follow-up Period||169||
48474278|NCT02848326|101496281|FG004|STARTED|Safety Follow-up Period||77||
48474279|NCT02848326|101496282|FG005|STARTED|Safety Follow-up Period||82||
48474280|NCT02848326|101496277|FG000|COMPLETED|Safety Follow-up Period||157||
48474281|NCT02848326|101496278|FG001|COMPLETED|Safety Follow-up Period||83||
48474282|NCT02848326|101496279|FG002|COMPLETED|Safety Follow-up Period||153||
48474283|NCT02848326|101496280|FG003|COMPLETED|Safety Follow-up Period||169||
48474284|NCT02848326|101496281|FG004|COMPLETED|Safety Follow-up Period||76||
48474285|NCT02848326|101496282|FG005|COMPLETED|Safety Follow-up Period||77||
48474286|NCT02848326|101496277|FG000|NOT COMPLETED|Safety Follow-up Period||4||
48474287|NCT02848326|101496278|FG001|NOT COMPLETED|Safety Follow-up Period||1||
48474288|NCT02848326|101496279|FG002|NOT COMPLETED|Safety Follow-up Period||3||
48474289|NCT02848326|101496280|FG003|NOT COMPLETED|Safety Follow-up Period||0||
48474290|NCT02848326|101496281|FG004|NOT COMPLETED|Safety Follow-up Period||1||
48474291|NCT02848326|101496282|FG005|NOT COMPLETED|Safety Follow-up Period||5||
48474292|NCT01626664|101496283|FG000|STARTED|Randomization Period||47||
48474293|NCT01626664|101496284|FG001|STARTED|Randomization Period||24||
48474294|NCT01626664|101496285|FG002|STARTED|Randomization Period||0||
48474295|NCT01626664|101496283|FG000|COMPLETED|Randomization Period||47||
48474296|NCT01626664|101496284|FG001|COMPLETED|Randomization Period||24||
48474297|NCT01626664|101496285|FG002|COMPLETED|Randomization Period||0||
48474298|NCT01626664|101496283|FG000|NOT COMPLETED|Randomization Period||0||
48474299|NCT01626664|101496284|FG001|NOT COMPLETED|Randomization Period||0||
48474300|NCT01626664|101496285|FG002|NOT COMPLETED|Randomization Period||0||
48474301|NCT01626664|101496283|FG000|STARTED|Crossover Period||0||
48191845|NCT04739423|100791609|FG004|STARTED|Overall Study||1||
48474302|NCT01626664|101496284|FG001|STARTED|Crossover Period||0||
48474303|NCT01626664|101496285|FG002|STARTED|Crossover Period||18||
48474304|NCT01626664|101496283|FG000|COMPLETED|Crossover Period||0||
48474305|NCT01626664|101496284|FG001|COMPLETED|Crossover Period||0||
48474306|NCT01626664|101496285|FG002|COMPLETED|Crossover Period||18||
48474307|NCT01626664|101496283|FG000|NOT COMPLETED|Crossover Period||0||
48474308|NCT01626664|101496284|FG001|NOT COMPLETED|Crossover Period||0||
48474309|NCT01626664|101496285|FG002|NOT COMPLETED|Crossover Period||0||
48474310|NCT03708211|101496286|FG000|STARTED|Overall Study||12||
48474311|NCT03708211|101496287|FG001|STARTED|Overall Study||8||
48474312|NCT03708211|101496286|FG000|COMPLETED|Overall Study||0||
48474313|NCT03708211|101496287|FG001|COMPLETED|Overall Study||0||
48474314|NCT03708211|101496286|FG000|NOT COMPLETED|Overall Study||12||
48474315|NCT03708211|101496287|FG001|NOT COMPLETED|Overall Study||8||
48474316|NCT02899338|101496288|FG000|STARTED|Overall Study||81||
48474317|NCT02899338|101496289|FG001|STARTED|Overall Study||81||
48474318|NCT02899338|101496288|FG000|COMPLETED|Overall Study||78||
48474319|NCT02899338|101496289|FG001|COMPLETED|Overall Study||79||
48474320|NCT02899338|101496288|FG000|NOT COMPLETED|Overall Study||3||
48474321|NCT02899338|101496289|FG001|NOT COMPLETED|Overall Study||2||
48474322|NCT02227862|101496290|FG000|STARTED|Overall Study||280||
48474323|NCT02227862|101496291|FG001|STARTED|Overall Study||278||
48474324|NCT02227862|101496290|FG000|Week 24|Overall Study||269||
48474325|NCT02227862|101496291|FG001|Week 24|Overall Study||263||
48474326|NCT02227862|101496290|FG000|COMPLETED|Overall Study||261||
48474327|NCT02227862|101496291|FG001|COMPLETED|Overall Study||256||
48191846|NCT04739423|100791610|FG005|STARTED|Overall Study||2||
48474328|NCT02227862|101496290|FG000|NOT COMPLETED|Overall Study||19||
48474329|NCT02227862|101496291|FG001|NOT COMPLETED|Overall Study||22||
48474330|NCT01434693|101496292|FG000|STARTED|Overall Study||9||
48191847|NCT04739423|100791605|FG000|COMPLETED|Overall Study||12||
48474331|NCT01434693|101496293|FG001|STARTED|Overall Study||9||
48474332|NCT01434693|101496294|FG002|STARTED|Overall Study||9||
48474333|NCT01434693|101496295|FG003|STARTED|Overall Study||9||
48474334|NCT01434693|101496292|FG000|COMPLETED|Overall Study||6||
48474335|NCT01434693|101496293|FG001|COMPLETED|Overall Study||9||
48474336|NCT01434693|101496294|FG002|COMPLETED|Overall Study||8||
48474337|NCT01434693|101496295|FG003|COMPLETED|Overall Study||8||
48474338|NCT01434693|101496292|FG000|NOT COMPLETED|Overall Study||3||
48474339|NCT01434693|101496293|FG001|NOT COMPLETED|Overall Study||0||
48474340|NCT01434693|101496294|FG002|NOT COMPLETED|Overall Study||1||
48474341|NCT01434693|101496295|FG003|NOT COMPLETED|Overall Study||1||
48474342|NCT02921737|101496296|FG000|STARTED|Overall Study||7||
48474343|NCT02921737|101496296|FG000|COMPLETED|Overall Study||7||
48474344|NCT02921737|101496296|FG000|NOT COMPLETED|Overall Study||0||
48474345|NCT01993875|101496297|FG000|STARTED|Overall Study||82||
48474346|NCT01993875|101496298|FG001|STARTED|Overall Study||82||
48474347|NCT01993875|101496297|FG000|COMPLETED|Overall Study||75||
48474348|NCT01993875|101496298|FG001|COMPLETED|Overall Study||76||
48474349|NCT01993875|101496297|FG000|NOT COMPLETED|Overall Study||7||
48474350|NCT01993875|101496298|FG001|NOT COMPLETED|Overall Study||6||
48474351|NCT02636907|101496299|FG000|STARTED|Autoinjector Assessment Period||77||
48191848|NCT04739423|100791606|FG001|COMPLETED|Overall Study||12||
48191849|NCT04739423|100791607|FG002|COMPLETED|Overall Study||5||
48474352|NCT02636907|101496299|FG000|COMPLETED|Autoinjector Assessment Period||73||
48474353|NCT02636907|101496299|FG000|NOT COMPLETED|Autoinjector Assessment Period||4||
48474354|NCT02636907|101496299|FG000|STARTED|Extension Phase||72||
48474355|NCT02636907|101496299|FG000|COMPLETED|Extension Phase||62||
48474356|NCT02636907|101496299|FG000|NOT COMPLETED|Extension Phase||10||
48474357|NCT01703832|101496300|FG000|STARTED|Overall Study||33||
48474358|NCT01703832|101496301|FG001|STARTED|Overall Study||32||
48474359|NCT01703832|101496300|FG000|COMPLETED|Overall Study||32||
48191850|NCT04739423|100791608|FG003|COMPLETED|Overall Study||7||
48474360|NCT01703832|101496301|FG001|COMPLETED|Overall Study||32||
48474361|NCT01703832|101496300|FG000|NOT COMPLETED|Overall Study||1||
48474362|NCT01703832|101496301|FG001|NOT COMPLETED|Overall Study||0||
48474363|NCT00458848|101496302|FG000|STARTED|Overall Study||51||
48474364|NCT00458848|101496302|FG000|COMPLETED|Overall Study||51||
48474365|NCT00458848|101496302|FG000|NOT COMPLETED|Overall Study||0||
48474366|NCT02246920|101496303|FG000|STARTED|Overall Study||484||
48474367|NCT02246920|101496304|FG001|STARTED|Overall Study||460||
48474368|NCT02246920|101496305|FG002|STARTED|Overall Study||234||
48474369|NCT02246920|101496303|FG000|COMPLETED|Overall Study||477||
48474370|NCT02246920|101496304|FG001|COMPLETED|Overall Study||453||
48474371|NCT02246920|101496305|FG002|COMPLETED|Overall Study||231||
48474372|NCT02246920|101496303|FG000|NOT COMPLETED|Overall Study||7||
48474373|NCT02246920|101496304|FG001|NOT COMPLETED|Overall Study||7||
48474374|NCT02246920|101496305|FG002|NOT COMPLETED|Overall Study||3||
48191851|NCT04739423|100791609|FG004|COMPLETED|Overall Study||0||
48474375|NCT02073643|101496306|FG000|STARTED|Overall Study||204||
48474376|NCT02073643|101496306|FG000|COMPLETED|Overall Study||180||
48474377|NCT02073643|101496306|FG000|NOT COMPLETED|Overall Study||24||
48474378|NCT03249584|101496307|FG000|STARTED|Overall Study||184|Subjects who received RF Ablation|
48191852|NCT04739423|100791610|FG005|COMPLETED|Overall Study||1||
48191853|NCT04739423|100791605|FG000|NOT COMPLETED|Overall Study||0||
48191854|NCT04739423|100791606|FG001|NOT COMPLETED|Overall Study||1||
48191855|NCT04739423|100791607|FG002|NOT COMPLETED|Overall Study||1||
48191856|NCT04739423|100791608|FG003|NOT COMPLETED|Overall Study||0||
48191857|NCT04739423|100791609|FG004|NOT COMPLETED|Overall Study||1||
48191858|NCT04739423|100791610|FG005|NOT COMPLETED|Overall Study||1||
48191859|NCT04580407|100791611|FG000|STARTED|Overall Study||5||
48191860|NCT04580407|100791611|FG000|COMPLETED|Overall Study||4||
48191861|NCT04580407|100791611|FG000|NOT COMPLETED|Overall Study||1||
48191862|NCT02790606|100791612|FG000|STARTED|Overall Study||110||
48191863|NCT02790606|100791612|FG000|COMPLETED|Overall Study||75|The Milestone is all participants who completed the study (24-month Follow-Up).|
48191864|NCT02790606|100791612|FG000|NOT COMPLETED|Overall Study||35||
48191865|NCT05355805|100791613|FG000|STARTED|Overall Study||30||
48191866|NCT05355805|100791614|FG001|STARTED|Overall Study||59||
48474379|NCT03249584|101496308|FG001|STARTED|Overall Study||22|Subjects who received RF Ablation|
48474380|NCT03249584|101496307|FG000|Month 3|Overall Study||132||
48191867|NCT05355805|100791615|FG002|STARTED|Overall Study||57||
48191868|NCT05355805|100791616|FG003|STARTED|Overall Study||59||
48191869|NCT05355805|100791613|FG000|COMPLETED|Overall Study||17||
48191870|NCT05355805|100791614|FG001|COMPLETED|Overall Study||3||
48191871|NCT05355805|100791615|FG002|COMPLETED|Overall Study||3||
48191872|NCT05355805|100791616|FG003|COMPLETED|Overall Study||6||
48191873|NCT05355805|100791613|FG000|NOT COMPLETED|Overall Study||13||
48191874|NCT05355805|100791614|FG001|NOT COMPLETED|Overall Study||56||
48191875|NCT05355805|100791615|FG002|NOT COMPLETED|Overall Study||54||
48191876|NCT05355805|100791616|FG003|NOT COMPLETED|Overall Study||53||
48191877|NCT03239210|100791617|FG000|STARTED|Overall Study||33||
48191878|NCT03239210|100791618|FG001|STARTED|Overall Study||29||
48191879|NCT03239210|100791617|FG000|COMPLETED|Overall Study||27||
48191880|NCT03239210|100791618|FG001|COMPLETED|Overall Study||24||
48191881|NCT03239210|100791617|FG000|NOT COMPLETED|Overall Study||6||
48191882|NCT03239210|100791618|FG001|NOT COMPLETED|Overall Study||5||
48191883|NCT03437668|100791619|FG000|STARTED|Overall Study||24||
48191884|NCT03437668|100791620|FG001|STARTED|Overall Study||23||
48474381|NCT03249584|101496308|FG001|Month 3|Overall Study||15||
48474382|NCT03249584|101496307|FG000|Month 3 Primary/Secondary Objectives|Overall Study||42||
48474383|NCT03249584|101496308|FG001|Month 3 Primary/Secondary Objectives|Overall Study||15||
48474384|NCT03249584|101496307|FG000|Month 6|Overall Study||101||
48474385|NCT03249584|101496308|FG001|Month 6|Overall Study||13||
48474386|NCT03249584|101496307|FG000|COMPLETED|Overall Study||51|The objectives are based on Month 3 outcomes (study 'Completed' is Month 12). The study ended when all subjects completed the 6 month visit.|
48474387|NCT03249584|101496308|FG001|COMPLETED|Overall Study||8|The objectives are based on Month 3 outcomes (study 'Completed' is Month 12). The study ended when all subjects completed the 6 month visit.|
48474388|NCT03249584|101496307|FG000|NOT COMPLETED|Overall Study||133||
48474389|NCT03249584|101496308|FG001|NOT COMPLETED|Overall Study||14||
48474390|NCT02173704|101499780|FG000|STARTED|Overall Study||150||
48474391|NCT02173704|101499781|FG001|STARTED|Overall Study||75||
48474392|NCT02173704|101499780|FG000|COMPLETED|Overall Study||137||
48474393|NCT02173704|101499781|FG001|COMPLETED|Overall Study||71||
48474394|NCT02173704|101499780|FG000|NOT COMPLETED|Overall Study||13||
48474395|NCT02173704|101499781|FG001|NOT COMPLETED|Overall Study||4||
48474396|NCT00659607|101499782|FG000|STARTED|Overall Study||3932||
48474397|NCT00659607|101499782|FG000|COMPLETED|Overall Study||3616||
48474398|NCT00659607|101499782|FG000|NOT COMPLETED|Overall Study||316||
48474399|NCT00154102|101499783|FG000|STARTED|Overall Study||599||
48474400|NCT00154102|101499784|FG001|STARTED|Overall Study||599||
48474401|NCT00154102|101499783|FG000|COMPLETED|Overall Study||592||
48474402|NCT00154102|101499784|FG001|COMPLETED|Overall Study||597||
48474403|NCT00154102|101499783|FG000|NOT COMPLETED|Overall Study||7||
48474404|NCT00154102|101499784|FG001|NOT COMPLETED|Overall Study||2||
48474405|NCT03879239|101499785|FG000|STARTED|Overall Study||163||
48474406|NCT03879239|101499786|FG001|STARTED|Overall Study||37||
48474407|NCT03879239|101499787|FG002|STARTED|Overall Study||149||
48474408|NCT03879239|101499785|FG000|COMPLETED|Overall Study||141||
48474409|NCT03879239|101499786|FG001|COMPLETED|Overall Study||30||
48474410|NCT03879239|101499787|FG002|COMPLETED|Overall Study||133||
48474411|NCT03879239|101499785|FG000|NOT COMPLETED|Overall Study||22||
48474412|NCT03879239|101499786|FG001|NOT COMPLETED|Overall Study||7||
48474413|NCT03879239|101499787|FG002|NOT COMPLETED|Overall Study||16||
48474414|NCT00105196|101499788|FG000|STARTED|Overall Study||177||
48474415|NCT00105196|101499789|FG001|STARTED|Overall Study||172||
48474416|NCT00105196|101499788|FG000|COMPLETED|Overall Study||147||
48474417|NCT00105196|101499789|FG001|COMPLETED|Overall Study||149||
48474418|NCT00105196|101499788|FG000|NOT COMPLETED|Overall Study||30||
48474419|NCT00105196|101499789|FG001|NOT COMPLETED|Overall Study||23||
48474420|NCT02597543|101499790|FG000|STARTED|Overall Study||6||
48474421|NCT02597543|101499791|FG001|STARTED|Overall Study||8||
48474422|NCT02597543|101499790|FG000|COMPLETED|Overall Study||6||
48191885|NCT03437668|100791619|FG000|COMPLETED|Overall Study||20||
48191886|NCT03437668|100791620|FG001|COMPLETED|Overall Study||19||
48191887|NCT03437668|100791619|FG000|NOT COMPLETED|Overall Study||4||
48191888|NCT03437668|100791620|FG001|NOT COMPLETED|Overall Study||4||
48474423|NCT02597543|101499791|FG001|COMPLETED|Overall Study||8||
48474424|NCT02597543|101499790|FG000|NOT COMPLETED|Overall Study||0||
48474425|NCT02597543|101499791|FG001|NOT COMPLETED|Overall Study||0||
48474426|NCT01471522|101499792|FG000|STARTED|Overall Study||2588||
48474427|NCT01471522|101499793|FG001|STARTED|Overall Study||2591||
48474428|NCT01471522|101499792|FG000|COMPLETED|Overall Study||2524||
48474429|NCT01471522|101499793|FG001|COMPLETED|Overall Study||2543||
48474430|NCT01471522|101499792|FG000|NOT COMPLETED|Overall Study||64||
48474431|NCT01471522|101499793|FG001|NOT COMPLETED|Overall Study||48||
48474432|NCT03252964|101499794|FG000|STARTED|Overall Study||52||
48474433|NCT03252964|101499794|FG000|COMPLETED|Overall Study||20||
48474434|NCT03252964|101499794|FG000|NOT COMPLETED|Overall Study||32||
48474435|NCT01648166|101499795|FG000|STARTED|Overall Study||153||
48474436|NCT01648166|101499796|FG001|STARTED|Overall Study||367||
48474437|NCT01648166|101499795|FG000|COMPLETED|Overall Study||100||
48474438|NCT01648166|101499796|FG001|COMPLETED|Overall Study||267||
48474439|NCT01648166|101499795|FG000|NOT COMPLETED|Overall Study||53||
48474440|NCT01648166|101499796|FG001|NOT COMPLETED|Overall Study||100||
48474441|NCT02031978|101499797|FG000|STARTED|Overall Study||4367||
48474442|NCT02031978|101499797|FG000|COMPLETED|Overall Study||4367||
48474443|NCT02031978|101499797|FG000|NOT COMPLETED|Overall Study||0||
48474444|NCT00323193|101499798|FG000|STARTED|Overall Study||53||
48474445|NCT00323193|101499799|FG001|STARTED|Overall Study||56||
48474446|NCT00323193|101499798|FG000|COMPLETED|Overall Study||30||
48474447|NCT00323193|101499799|FG001|COMPLETED|Overall Study||41||
48474448|NCT00323193|101499798|FG000|NOT COMPLETED|Overall Study||23||
48474449|NCT00323193|101499799|FG001|NOT COMPLETED|Overall Study||15||
48474450|NCT01139164|101499800|FG000|STARTED|Overall Study||4||
48474451|NCT01139164|101499801|FG001|STARTED|Overall Study||67||
48474452|NCT01139164|101499802|FG002|STARTED|Overall Study||7||
48474453|NCT01139164|101499800|FG000|COMPLETED|Overall Study||4||
48474454|NCT01139164|101499801|FG001|COMPLETED|Overall Study||65||
48474455|NCT01139164|101499802|FG002|COMPLETED|Overall Study||7||
48474456|NCT01139164|101499800|FG000|NOT COMPLETED|Overall Study||0||
48474457|NCT01139164|101499801|FG001|NOT COMPLETED|Overall Study||2||
48474458|NCT01139164|101499802|FG002|NOT COMPLETED|Overall Study||0||
48474459|NCT01790568|101499803|FG000|STARTED|Overall Study||12||
48474460|NCT01790568|101499804|FG001|STARTED|Overall Study||26||
48474461|NCT01790568|101499803|FG000|COMPLETED|Overall Study||12||
48474462|NCT01790568|101499804|FG001|COMPLETED|Overall Study||25||
48474463|NCT01790568|101499803|FG000|NOT COMPLETED|Overall Study||0||
48474464|NCT01790568|101499804|FG001|NOT COMPLETED|Overall Study||1||
48474465|NCT02005536|101499805|FG000|STARTED|Overall Study||60||
48474466|NCT02005536|101499805|FG000|COMPLETED|Overall Study||60||
48474467|NCT02005536|101499805|FG000|NOT COMPLETED|Overall Study||0||
48474468|NCT03325114|101499806|FG000|STARTED|Overall Study||1||
48474469|NCT03325114|101499806|FG000|COMPLETED|Overall Study||0||
48474470|NCT03325114|101499806|FG000|NOT COMPLETED|Overall Study||1||
48474471|NCT03227445|101499807|FG000|STARTED|Period 1 (28 Days)||60||
48191889|NCT04831775|100791621|FG000|STARTED|Overall Study||47||
48474472|NCT03227445|101499808|FG001|STARTED|Period 1 (28 Days)||59||
48474473|NCT03227445|101499809|FG002|STARTED|Period 1 (28 Days)||60||
48474474|NCT03227445|101499810|FG003|STARTED|Period 1 (28 Days)||60||
48474475|NCT03227445|101499807|FG000|COMPLETED|Period 1 (28 Days)||58||
48191890|NCT04831775|100791622|FG001|STARTED|Overall Study||48||
48191891|NCT04831775|100791621|FG000|Received Intervention (Week 0)|Overall Study||40||
48191892|NCT04831775|100791622|FG001|Received Intervention (Week 0)|Overall Study||48||
48191893|NCT04831775|100791621|FG000|Time 2 Follow-up (Week 2)|Overall Study||38||
48191894|NCT04831775|100791622|FG001|Time 2 Follow-up (Week 2)|Overall Study||40||
48191895|NCT04831775|100791621|FG000|COMPLETED|Overall Study||36||
48191896|NCT04831775|100791622|FG001|COMPLETED|Overall Study||35||
48191897|NCT04831775|100791621|FG000|NOT COMPLETED|Overall Study||11||
48191898|NCT04831775|100791622|FG001|NOT COMPLETED|Overall Study||13||
48191899|NCT03686384|100791623|FG000|STARTED|Overall Study||82||
48191900|NCT03686384|100791624|FG001|STARTED|Overall Study||36||
48191901|NCT03686384|100791623|FG000|COMPLETED|Overall Study||75||
48191902|NCT03686384|100791624|FG001|COMPLETED|Overall Study||21||
48474476|NCT03227445|101499808|FG001|COMPLETED|Period 1 (28 Days)||57||
48474477|NCT03227445|101499809|FG002|COMPLETED|Period 1 (28 Days)||59||
48474478|NCT03227445|101499810|FG003|COMPLETED|Period 1 (28 Days)||58||
48474479|NCT03227445|101499807|FG000|NOT COMPLETED|Period 1 (28 Days)||2||
48474480|NCT03227445|101499808|FG001|NOT COMPLETED|Period 1 (28 Days)||2||
48474481|NCT03227445|101499809|FG002|NOT COMPLETED|Period 1 (28 Days)||1||
48474482|NCT03227445|101499810|FG003|NOT COMPLETED|Period 1 (28 Days)||2||
48474483|NCT03227445|101499807|FG000|STARTED|Period 2 (28 Days)||58||
48474484|NCT03227445|101499808|FG001|STARTED|Period 2 (28 Days)||57||
48474485|NCT03227445|101499809|FG002|STARTED|Period 2 (28 Days)||59||
48474486|NCT03227445|101499810|FG003|STARTED|Period 2 (28 Days)||58||
48474487|NCT03227445|101499807|FG000|COMPLETED|Period 2 (28 Days)||57||
48474488|NCT03227445|101499808|FG001|COMPLETED|Period 2 (28 Days)||56||
48474489|NCT03227445|101499809|FG002|COMPLETED|Period 2 (28 Days)||57||
48191903|NCT03686384|100791623|FG000|NOT COMPLETED|Overall Study||7||
48191904|NCT03686384|100791624|FG001|NOT COMPLETED|Overall Study||15||
48191905|NCT01363479|100791625|FG000|STARTED|Overall Study||371||
48191906|NCT01363479|100791626|FG001|STARTED|Overall Study||372||
48191907|NCT01363479|100791625|FG000|COMPLETED|Overall Study||359||
48191908|NCT01363479|100791626|FG001|COMPLETED|Overall Study||351||
48191909|NCT01363479|100791625|FG000|NOT COMPLETED|Overall Study||12||
48191910|NCT01363479|100791626|FG001|NOT COMPLETED|Overall Study||21||
48191911|NCT04159506|100791627|FG000|STARTED|Overall Study||16||
48191912|NCT04159506|100791628|FG001|STARTED|Overall Study||15||
48474490|NCT03227445|101499810|FG003|COMPLETED|Period 2 (28 Days)||55||
48474491|NCT03227445|101499807|FG000|NOT COMPLETED|Period 2 (28 Days)||1||
48474492|NCT03227445|101499808|FG001|NOT COMPLETED|Period 2 (28 Days)||1||
48474493|NCT03227445|101499809|FG002|NOT COMPLETED|Period 2 (28 Days)||2||
48474494|NCT03227445|101499810|FG003|NOT COMPLETED|Period 2 (28 Days)||3||
48191913|NCT04159506|100791627|FG000|COMPLETED|Overall Study||14||
48191914|NCT04159506|100791628|FG001|COMPLETED|Overall Study||10||
48191915|NCT04159506|100791627|FG000|NOT COMPLETED|Overall Study||2||
48474495|NCT00760266|101499811|FG000|STARTED|Overall Study||228||
48474496|NCT00760266|101499812|FG001|STARTED|Overall Study||223||
48474497|NCT00760266|101499811|FG000|COMPLETED|Overall Study||204||
48191916|NCT04159506|100791628|FG001|NOT COMPLETED|Overall Study||5||
48191917|NCT02949271|100791629|FG000|STARTED|Overall Study||90||
48191918|NCT02949271|100791630|FG001|STARTED|Overall Study||89||
48474498|NCT00760266|101499812|FG001|COMPLETED|Overall Study||205||
48474499|NCT00760266|101499811|FG000|NOT COMPLETED|Overall Study||24||
48474500|NCT00760266|101499812|FG001|NOT COMPLETED|Overall Study||18||
48474501|NCT00153803|101499813|FG000|STARTED|Concurrent Chemoradiation||123|Patients randomized|
48474502|NCT00153803|101499814|FG001|STARTED|Concurrent Chemoradiation||122|Patients randomized|
48474503|NCT00153803|101499813|FG000|Received Chemoradiation|Concurrent Chemoradiation||118||
48191919|NCT02949271|100791629|FG000|COMPLETED|Overall Study||61||
48191920|NCT02949271|100791630|FG001|COMPLETED|Overall Study||59||
48191921|NCT02949271|100791629|FG000|NOT COMPLETED|Overall Study||29||
48191922|NCT02949271|100791630|FG001|NOT COMPLETED|Overall Study||30||
48191923|NCT00597883|100791631|FG000|STARTED|Overall Study||662||
48191924|NCT00597883|100791632|FG001|STARTED|Overall Study||155||
48191925|NCT00597883|100791631|FG000|COMPLETED|Overall Study||662||
48191926|NCT00597883|100791632|FG001|COMPLETED|Overall Study||155||
48191927|NCT00597883|100791631|FG000|NOT COMPLETED|Overall Study||0||
48191928|NCT00597883|100791632|FG001|NOT COMPLETED|Overall Study||0||
48191929|NCT01688973|100791633|FG000|STARTED|Overall Study||27||
48191930|NCT01688973|100791634|FG001|STARTED|Overall Study||28||
48191931|NCT01688973|100791633|FG000|Eligible/Evaluable Patients|Overall Study||25||
48191932|NCT01688973|100791634|FG001|Eligible/Evaluable Patients|Overall Study||25||
48191933|NCT01688973|100791633|FG000|COMPLETED|Overall Study||25||
48191934|NCT01688973|100791634|FG001|COMPLETED|Overall Study||25||
48191935|NCT01688973|100791633|FG000|NOT COMPLETED|Overall Study||2||
48191936|NCT01688973|100791634|FG001|NOT COMPLETED|Overall Study||3||
48191937|NCT03028948|100791635|FG000|STARTED|8 Week Follow-up||224||
48191938|NCT03028948|100791636|FG001|STARTED|8 Week Follow-up||217||
48191939|NCT03028948|100791635|FG000|COMPLETED|8 Week Follow-up||198||
48191940|NCT03028948|100791636|FG001|COMPLETED|8 Week Follow-up||215||
48191941|NCT03028948|100791635|FG000|NOT COMPLETED|8 Week Follow-up||26||
48191942|NCT03028948|100791636|FG001|NOT COMPLETED|8 Week Follow-up||2||
48191943|NCT03028948|100791635|FG000|STARTED|24 Week Follow-up||224||
48191944|NCT03028948|100791636|FG001|STARTED|24 Week Follow-up||217||
48191945|NCT03028948|100791635|FG000|COMPLETED|24 Week Follow-up||189||
48191946|NCT03028948|100791636|FG001|COMPLETED|24 Week Follow-up||207||
48191947|NCT03028948|100791635|FG000|NOT COMPLETED|24 Week Follow-up||35||
48191948|NCT03028948|100791636|FG001|NOT COMPLETED|24 Week Follow-up||10||
48191949|NCT03028948|100791635|FG000|STARTED|48 Week Follow-up||224||
48191950|NCT03028948|100791636|FG001|STARTED|48 Week Follow-up||217||
48191951|NCT03028948|100791635|FG000|COMPLETED|48 Week Follow-up||180||
48191952|NCT03028948|100791636|FG001|COMPLETED|48 Week Follow-up||202||
48474504|NCT00153803|101499814|FG001|Received Chemoradiation|Concurrent Chemoradiation||117||
48474505|NCT00153803|101499813|FG000|COMPLETED|Concurrent Chemoradiation||118||
48474506|NCT00153803|101499814|FG001|COMPLETED|Concurrent Chemoradiation||117||
48474507|NCT00153803|101499813|FG000|NOT COMPLETED|Concurrent Chemoradiation||5||
48474508|NCT00153803|101499814|FG001|NOT COMPLETED|Concurrent Chemoradiation||5||
48474509|NCT00153803|101499813|FG000|STARTED|Investigational Drug||118|Patients who participated in Period 1|
48474510|NCT00153803|101499814|FG001|STARTED|Investigational Drug||117|Patients who participated in Period 1|
48474511|NCT00153803|101499813|FG000|Investigational Drug Dispensed|Investigational Drug||77||
48474512|NCT00153803|101499814|FG001|Investigational Drug Dispensed|Investigational Drug||75||
48474513|NCT00153803|101499813|FG000|COMPLETED|Investigational Drug||77|Received at least one dose|
48474514|NCT00153803|101499814|FG001|COMPLETED|Investigational Drug||75|Received at least one dose|
48191953|NCT03028948|100791635|FG000|NOT COMPLETED|48 Week Follow-up||44||
48191954|NCT03028948|100791636|FG001|NOT COMPLETED|48 Week Follow-up||15||
48191955|NCT01454362|100791637|FG000|STARTED|Overall Study||28||
48474515|NCT00153803|101499813|FG000|NOT COMPLETED|Investigational Drug||41||
48474516|NCT00153803|101499814|FG001|NOT COMPLETED|Investigational Drug||42||
48474517|NCT01894178|101499815|FG000|STARTED|Overall Study||30||
48474518|NCT01894178|101499816|FG001|STARTED|Overall Study||30||
48474519|NCT01894178|101499815|FG000|COMPLETED|Overall Study||30||
48474520|NCT01894178|101499816|FG001|COMPLETED|Overall Study||30||
48474521|NCT01894178|101499815|FG000|NOT COMPLETED|Overall Study||0||
48474522|NCT01894178|101499816|FG001|NOT COMPLETED|Overall Study||0||
48474523|NCT00906425|101499817|FG000|STARTED|Overall Study||73||
48474524|NCT00906425|101499818|FG001|STARTED|Overall Study||72||
48474525|NCT00906425|101499817|FG000|6 Months|Overall Study||69||
48474526|NCT00906425|101499818|FG001|6 Months|Overall Study||64||
48474527|NCT00906425|101499817|FG000|1 Year|Overall Study||67||
48474528|NCT00906425|101499818|FG001|1 Year|Overall Study||60||
48474529|NCT00906425|101499817|FG000|2 Year|Overall Study||62||
48474530|NCT00906425|101499818|FG001|2 Year|Overall Study||58||
48474531|NCT00906425|101499817|FG000|COMPLETED|Overall Study||0||
48474532|NCT00906425|101499818|FG001|COMPLETED|Overall Study||0||
48474533|NCT00906425|101499817|FG000|NOT COMPLETED|Overall Study||73||
48474534|NCT00906425|101499818|FG001|NOT COMPLETED|Overall Study||72||
48191956|NCT01454362|100791638|FG001|STARTED|Overall Study||23||
48191957|NCT01454362|100791637|FG000|COMPLETED|Overall Study||28||
48191958|NCT01454362|100791638|FG001|COMPLETED|Overall Study||23||
48191959|NCT01454362|100791637|FG000|NOT COMPLETED|Overall Study||0||
48191960|NCT01454362|100791638|FG001|NOT COMPLETED|Overall Study||0||
48191961|NCT05273801|100791639|FG000|STARTED|Overall Study||18||
48191962|NCT05273801|100791639|FG000|Number of Participants Who Recieved HR Monitoring Without Visual Feedback|Overall Study||15||
48191963|NCT05273801|100791639|FG000|Number of Participants Who Received HR Monitoring With Visual Feedback|Overall Study||15||
48191964|NCT05273801|100791639|FG000|COMPLETED|Overall Study||17||
48191965|NCT05273801|100791639|FG000|NOT COMPLETED|Overall Study||1||
48191966|NCT03861273|100791640|FG000|STARTED|Screening Phase (3 Weeks)||51||
48191967|NCT03861273|100791640|FG000|COMPLETED|Screening Phase (3 Weeks)||45||
48191968|NCT03861273|100791640|FG000|NOT COMPLETED|Screening Phase (3 Weeks)||6||
48191969|NCT03861273|100791640|FG000|STARTED|Treatment Phase (Day 1)||45||
48191970|NCT03861273|100791640|FG000|COMPLETED|Treatment Phase (Day 1)||45||
48191971|NCT03861273|100791640|FG000|NOT COMPLETED|Treatment Phase (Day 1)||0||
48191972|NCT03861273|100791640|FG000|STARTED|Follow-up Phase (Year 1)||45||
48191973|NCT03861273|100791640|FG000|COMPLETED|Follow-up Phase (Year 1)||43||
48191974|NCT03861273|100791640|FG000|NOT COMPLETED|Follow-up Phase (Year 1)||2||
48191975|NCT03861273|100791640|FG000|STARTED|Long-Term Follow-Up (Year 2 to Year 6)||43||
48191976|NCT03861273|100791640|FG000|COMPLETED|Long-Term Follow-Up (Year 2 to Year 6)||0||
48191977|NCT03861273|100791640|FG000|NOT COMPLETED|Long-Term Follow-Up (Year 2 to Year 6)||43||
48191978|NCT03669042|100791641|FG000|STARTED|Overall Study||94||
48191979|NCT03669042|100791641|FG000|COMPLETED|Overall Study||94||
48191980|NCT03669042|100791641|FG000|NOT COMPLETED|Overall Study||0||
48191981|NCT01417000|100791642|FG000|STARTED|Overall Study||61|Participant flow values reflect original arm assignments and do not account for rollover subjects|
48191982|NCT01417000|100791643|FG001|STARTED|Overall Study||29|Participant flow values reflect original arm assignments and do not account for rollover subjects|
48191983|NCT01417000|100791642|FG000|COMPLETED|Overall Study||0|No predetermined study completion date or study completion event specified in protocol.|
48474535|NCT01893905|101499819|FG000|STARTED|Overall Study||80||
48474536|NCT01893905|101499820|FG001|STARTED|Overall Study||78||
48474537|NCT01893905|101499819|FG000|COMPLETED|Overall Study||55||
48474538|NCT01893905|101499820|FG001|COMPLETED|Overall Study||64||
48474539|NCT01893905|101499819|FG000|NOT COMPLETED|Overall Study||25||
48474540|NCT01893905|101499820|FG001|NOT COMPLETED|Overall Study||14||
48474541|NCT03344510|101499821|FG000|STARTED|First Injection (5 Minutes)||21||
48474542|NCT03344510|101499822|FG001|STARTED|First Injection (5 Minutes)||26||
48474543|NCT03344510|101499821|FG000|Received Injection|First Injection (5 Minutes)||21||
48474544|NCT03344510|101499822|FG001|Received Injection|First Injection (5 Minutes)||26||
48474545|NCT03344510|101499821|FG000|COMPLETED|First Injection (5 Minutes)||21||
48474546|NCT03344510|101499822|FG001|COMPLETED|First Injection (5 Minutes)||26||
48474547|NCT03344510|101499821|FG000|NOT COMPLETED|First Injection (5 Minutes)||0||
48474548|NCT03344510|101499822|FG001|NOT COMPLETED|First Injection (5 Minutes)||0||
48474549|NCT03344510|101499821|FG000|STARTED|Wash Out (10 Minutes||21||
48474550|NCT03344510|101499822|FG001|STARTED|Wash Out (10 Minutes||26||
48474551|NCT03344510|101499821|FG000|COMPLETED|Wash Out (10 Minutes||21||
48474552|NCT03344510|101499822|FG001|COMPLETED|Wash Out (10 Minutes||26||
48474553|NCT03344510|101499821|FG000|NOT COMPLETED|Wash Out (10 Minutes||0||
48474554|NCT03344510|101499822|FG001|NOT COMPLETED|Wash Out (10 Minutes||0||
48474555|NCT03344510|101499821|FG000|STARTED|Second Injection (5 Minutes)||21||
48474556|NCT03344510|101499822|FG001|STARTED|Second Injection (5 Minutes)||26||
48474557|NCT03344510|101499821|FG000|Received Injection|Second Injection (5 Minutes)||21||
48474558|NCT03344510|101499822|FG001|Received Injection|Second Injection (5 Minutes)||26||
48474559|NCT03344510|101499821|FG000|COMPLETED|Second Injection (5 Minutes)||21||
48474560|NCT03344510|101499822|FG001|COMPLETED|Second Injection (5 Minutes)||26||
48191984|NCT01417000|100791643|FG001|COMPLETED|Overall Study||0|No predetermined study completion date or study completion event specified in protocol.|
48474561|NCT03344510|101499821|FG000|NOT COMPLETED|Second Injection (5 Minutes)||0||
48191985|NCT01417000|100791642|FG000|NOT COMPLETED|Overall Study||61||
48191986|NCT01417000|100791643|FG001|NOT COMPLETED|Overall Study||29||
48191987|NCT02049437|100791644|FG000|STARTED|Period 1||17||
48474562|NCT03344510|101499822|FG001|NOT COMPLETED|Second Injection (5 Minutes)||0||
48474563|NCT01988922|101499823|FG000|STARTED|Overall Study||10||
48191988|NCT02049437|100791645|FG001|STARTED|Period 1||17||
48474564|NCT01988922|101499824|FG001|STARTED|Overall Study||10||
48474565|NCT01988922|101499825|FG002|STARTED|Overall Study||10||
48474566|NCT01988922|101499823|FG000|COMPLETED|Overall Study||10||
48191989|NCT02049437|100791644|FG000|COMPLETED|Period 1||15||
48474567|NCT01988922|101499824|FG001|COMPLETED|Overall Study||10||
48474568|NCT01988922|101499825|FG002|COMPLETED|Overall Study||10||
48191990|NCT02049437|100791645|FG001|COMPLETED|Period 1||16||
48474569|NCT01988922|101499823|FG000|NOT COMPLETED|Overall Study||0||
48474570|NCT01988922|101499824|FG001|NOT COMPLETED|Overall Study||0||
48474571|NCT01988922|101499825|FG002|NOT COMPLETED|Overall Study||0||
48474572|NCT00147030|101499826|FG000|STARTED|Overall Study||163||
48474573|NCT00147030|101499827|FG001|STARTED|Overall Study||162||
48474574|NCT00147030|101499826|FG000|COMPLETED|Overall Study||163||
48474575|NCT00147030|101499827|FG001|COMPLETED|Overall Study||162||
48474576|NCT00147030|101499826|FG000|NOT COMPLETED|Overall Study||0||
48474577|NCT00147030|101499827|FG001|NOT COMPLETED|Overall Study||0||
48474578|NCT03340727|101499828|FG000|STARTED|Overall Study||416||
48474579|NCT03340727|101499829|FG001|STARTED|Overall Study||411||
48474580|NCT03340727|101499828|FG000|Completed In-hospital Stay|Overall Study||390||
48474581|NCT03340727|101499829|FG001|Completed In-hospital Stay|Overall Study||397||
48474582|NCT03340727|101499828|FG000|COMPLETED|Overall Study||345|Completed At-home Portion|
48474583|NCT03340727|101499829|FG001|COMPLETED|Overall Study||351|Completed At-home Portion|
48474584|NCT03340727|101499828|FG000|NOT COMPLETED|Overall Study||71||
48474585|NCT03340727|101499829|FG001|NOT COMPLETED|Overall Study||60||
48474586|NCT02930005|101499830|FG000|STARTED|Overall Study||2||
48474587|NCT02930005|101499831|FG001|STARTED|Overall Study||6||
48474588|NCT02930005|101499830|FG000|Completed 2 Weeks|Overall Study||2||
48474589|NCT02930005|101499831|FG001|Completed 2 Weeks|Overall Study||2||
48474590|NCT02930005|101499830|FG000|COMPLETED|Overall Study||1|Completed the 8 week study|
48474591|NCT02930005|101499831|FG001|COMPLETED|Overall Study||1|Completed the 8 week study|
48474592|NCT02930005|101499830|FG000|NOT COMPLETED|Overall Study||1||
48474593|NCT02930005|101499831|FG001|NOT COMPLETED|Overall Study||5||
48474594|NCT01572948|101499832|FG000|STARTED|Overall Study||11||
48474595|NCT01572948|101499833|FG001|STARTED|Overall Study||16||
48474596|NCT01572948|101499832|FG000|COMPLETED|Overall Study||10||
48474597|NCT01572948|101499833|FG001|COMPLETED|Overall Study||15||
48474598|NCT01572948|101499832|FG000|NOT COMPLETED|Overall Study||1||
48474599|NCT01572948|101499833|FG001|NOT COMPLETED|Overall Study||1||
48474600|NCT00912288|101499834|FG000|STARTED|Overall Study||44||
48474601|NCT00912288|101499835|FG001|STARTED|Overall Study||42||
48474602|NCT00912288|101499834|FG000|COMPLETED|Overall Study||3||
48474603|NCT00912288|101499835|FG001|COMPLETED|Overall Study||2||
48474604|NCT00912288|101499834|FG000|NOT COMPLETED|Overall Study||41||
48474605|NCT00912288|101499835|FG001|NOT COMPLETED|Overall Study||40||
48474606|NCT02445456|101499836|FG000|STARTED|Overall Study||13||
48474607|NCT02445456|101499837|FG001|STARTED|Overall Study||2||
48474608|NCT02445456|101499836|FG000|COMPLETED|Overall Study||13||
48474609|NCT02445456|101499837|FG001|COMPLETED|Overall Study||2||
48474610|NCT02445456|101499836|FG000|NOT COMPLETED|Overall Study||0||
48474611|NCT02445456|101499837|FG001|NOT COMPLETED|Overall Study||0||
48474612|NCT00876200|101499838|FG000|STARTED|Overall Study||9||
48474613|NCT00876200|101499839|FG001|STARTED|Overall Study||12||
48474614|NCT00876200|101499838|FG000|COMPLETED|Overall Study||8||
48474615|NCT00876200|101499839|FG001|COMPLETED|Overall Study||9||
48474616|NCT00876200|101499838|FG000|NOT COMPLETED|Overall Study||1||
48474617|NCT00876200|101499839|FG001|NOT COMPLETED|Overall Study||3||
48474618|NCT00590395|101499840|FG000|STARTED|Overall Study||19||
48474619|NCT00590395|101499840|FG000|COMPLETED|Overall Study||19||
48474620|NCT00590395|101499840|FG000|NOT COMPLETED|Overall Study||0||
48474621|NCT03883906|101499841|FG000|STARTED|Overall Study||30||
48474622|NCT03883906|101499841|FG000|COMPLETED|Overall Study||23||
48474623|NCT03883906|101499841|FG000|NOT COMPLETED|Overall Study||7||
48474624|NCT02420210|101499842|FG000|STARTED|Overall Study||2||
48474625|NCT02420210|101499842|FG000|COMPLETED|Overall Study||2||
48474626|NCT02420210|101499842|FG000|NOT COMPLETED|Overall Study||0||
48474627|NCT01781637|101499843|FG000|STARTED|Overall Study||28||
48474628|NCT01781637|101499844|FG001|STARTED|Overall Study||8||
48474629|NCT01781637|101499843|FG000|COMPLETED|Overall Study||24||
48474630|NCT01781637|101499844|FG001|COMPLETED|Overall Study||2||
48474631|NCT01781637|101499843|FG000|NOT COMPLETED|Overall Study||4||
48474632|NCT01781637|101499844|FG001|NOT COMPLETED|Overall Study||6||
48474633|NCT05894577|101499845|FG000|STARTED|Overall Study||741||
48474634|NCT05894577|101499846|FG001|STARTED|Overall Study||712||
48474635|NCT05894577|101499845|FG000|COMPLETED|Overall Study||628||
48474636|NCT05894577|101499846|FG001|COMPLETED|Overall Study||622||
48474637|NCT05894577|101499845|FG000|NOT COMPLETED|Overall Study||113||
48474638|NCT05894577|101499846|FG001|NOT COMPLETED|Overall Study||90||
48474639|NCT02929979|101499847|FG000|STARTED|Overall Study||52||
48474640|NCT02929979|101499848|FG001|STARTED|Overall Study||38||
48474641|NCT02929979|101499847|FG000|COMPLETED|Overall Study||25||
48474642|NCT02929979|101499848|FG001|COMPLETED|Overall Study||28||
48474643|NCT02929979|101499847|FG000|NOT COMPLETED|Overall Study||27||
48474644|NCT02929979|101499848|FG001|NOT COMPLETED|Overall Study||10||
48191991|NCT02049437|100791644|FG000|NOT COMPLETED|Period 1||2||
48474645|NCT00818883|101499849|FG000|STARTED|Overall Study||303||
48474646|NCT00818883|101499850|FG001|STARTED|Overall Study||306||
48474647|NCT00818883|101499849|FG000|COMPLETED|Overall Study||252||
48474648|NCT00818883|101499850|FG001|COMPLETED|Overall Study||260||
48474649|NCT00818883|101499849|FG000|NOT COMPLETED|Overall Study||51||
48474650|NCT00818883|101499850|FG001|NOT COMPLETED|Overall Study||46||
48474651|NCT03486990|101499851|FG000|STARTED|Overall Study||2||
48474652|NCT03486990|101499852|FG001|STARTED|Overall Study||2||
48474653|NCT03486990|101499853|FG002|STARTED|Overall Study||3||
48191992|NCT02049437|100791645|FG001|NOT COMPLETED|Period 1||1||
48191993|NCT02049437|100791644|FG000|STARTED|Washout 1||15||
48191994|NCT02049437|100791645|FG001|STARTED|Washout 1||16||
48191995|NCT02049437|100791644|FG000|COMPLETED|Washout 1||15||
48191996|NCT02049437|100791645|FG001|COMPLETED|Washout 1||16||
48191997|NCT02049437|100791644|FG000|NOT COMPLETED|Washout 1||0||
48191998|NCT02049437|100791645|FG001|NOT COMPLETED|Washout 1||0||
48191999|NCT02049437|100791644|FG000|STARTED|Period 2||15||
48192000|NCT02049437|100791645|FG001|STARTED|Period 2||16||
48192001|NCT02049437|100791644|FG000|COMPLETED|Period 2||15||
48474654|NCT03486990|101499854|FG003|STARTED|Overall Study||3||
48474655|NCT03486990|101499855|FG004|STARTED|Overall Study||3||
48474656|NCT03486990|101499856|FG005|STARTED|Overall Study||4||
48192002|NCT02049437|100791645|FG001|COMPLETED|Period 2||16||
48192003|NCT02049437|100791644|FG000|NOT COMPLETED|Period 2||0||
48192004|NCT02049437|100791645|FG001|NOT COMPLETED|Period 2||0||
48192005|NCT02049437|100791644|FG000|STARTED|Washout 2||15||
48192006|NCT02049437|100791645|FG001|STARTED|Washout 2||16||
48192007|NCT02049437|100791644|FG000|COMPLETED|Washout 2||15||
48474657|NCT03486990|101499857|FG006|STARTED|Overall Study||2||
48474658|NCT03486990|101499858|FG007|STARTED|Overall Study||2||
48474659|NCT03486990|101499859|FG008|STARTED|Overall Study||2||
48474660|NCT03486990|101499851|FG000|COMPLETED|Overall Study||2||
48474661|NCT03486990|101499852|FG001|COMPLETED|Overall Study||2||
48474662|NCT03486990|101499853|FG002|COMPLETED|Overall Study||3||
48474663|NCT03486990|101499854|FG003|COMPLETED|Overall Study||3||
48474664|NCT03486990|101499855|FG004|COMPLETED|Overall Study||3||
48474665|NCT03486990|101499856|FG005|COMPLETED|Overall Study||4||
48474666|NCT03486990|101499857|FG006|COMPLETED|Overall Study||2||
48474667|NCT03486990|101499858|FG007|COMPLETED|Overall Study||2||
48474668|NCT03486990|101499859|FG008|COMPLETED|Overall Study||2||
48192008|NCT02049437|100791645|FG001|COMPLETED|Washout 2||16||
48474669|NCT03486990|101499851|FG000|NOT COMPLETED|Overall Study||0||
48474670|NCT03486990|101499852|FG001|NOT COMPLETED|Overall Study||0||
48474671|NCT03486990|101499853|FG002|NOT COMPLETED|Overall Study||0||
48474672|NCT03486990|101499854|FG003|NOT COMPLETED|Overall Study||0||
48474673|NCT03486990|101499855|FG004|NOT COMPLETED|Overall Study||0||
48474674|NCT03486990|101499856|FG005|NOT COMPLETED|Overall Study||0||
48474675|NCT03486990|101499857|FG006|NOT COMPLETED|Overall Study||0||
48474676|NCT03486990|101499858|FG007|NOT COMPLETED|Overall Study||0||
48192009|NCT02049437|100791644|FG000|NOT COMPLETED|Washout 2||0||
48474677|NCT03486990|101499859|FG008|NOT COMPLETED|Overall Study||0||
48474678|NCT00379340|101499860|FG000|STARTED|Overall Study||120||
48474679|NCT00379340|101499861|FG001|STARTED|Overall Study||135||
48474680|NCT00379340|101499862|FG002|STARTED|Overall Study||52||
48474681|NCT00379340|101499863|FG003|STARTED|Overall Study||50||
48474682|NCT00379340|101499864|FG004|STARTED|Overall Study||23||
48474683|NCT00379340|101499860|FG000|COMPLETED|Overall Study||107||
48474684|NCT00379340|101499861|FG001|COMPLETED|Overall Study||132||
48474685|NCT00379340|101499862|FG002|COMPLETED|Overall Study||50||
48474686|NCT00379340|101499863|FG003|COMPLETED|Overall Study||37||
48474687|NCT00379340|101499864|FG004|COMPLETED|Overall Study||9||
48474688|NCT00379340|101499860|FG000|NOT COMPLETED|Overall Study||13||
48474689|NCT00379340|101499861|FG001|NOT COMPLETED|Overall Study||3||
48474690|NCT00379340|101499862|FG002|NOT COMPLETED|Overall Study||2||
48474691|NCT00379340|101499863|FG003|NOT COMPLETED|Overall Study||13||
48474692|NCT00379340|101499864|FG004|NOT COMPLETED|Overall Study||14||
48192010|NCT02049437|100791645|FG001|NOT COMPLETED|Washout 2||0||
48192011|NCT04476043|100791646|FG000|STARTED|Overall Study||52||
48192012|NCT04476043|100791647|FG001|STARTED|Overall Study||52||
48474693|NCT02581345|101499865|FG000|STARTED|Part 1: up to Week 16||286||
48192013|NCT04476043|100791648|FG002|STARTED|Overall Study||52||
48192014|NCT04476043|100791649|FG003|STARTED|Overall Study||53||
48474694|NCT02581345|101499866|FG001|STARTED|Part 1: up to Week 16||286||
48474695|NCT02581345|101499867|FG002|STARTED|Part 1: up to Week 16||0||
48474696|NCT02581345|101499868|FG003|STARTED|Part 1: up to Week 16||0||
48192015|NCT04476043|100791646|FG000|COMPLETED|Overall Study||48||
48192016|NCT04476043|100791647|FG001|COMPLETED|Overall Study||47||
48192017|NCT04476043|100791648|FG002|COMPLETED|Overall Study||45||
48192018|NCT04476043|100791649|FG003|COMPLETED|Overall Study||51||
48192019|NCT04476043|100791646|FG000|NOT COMPLETED|Overall Study||4||
48192020|NCT04476043|100791647|FG001|NOT COMPLETED|Overall Study||5||
48192021|NCT04476043|100791648|FG002|NOT COMPLETED|Overall Study||7||
48474697|NCT02581345|101499865|FG000|COMPLETED|Part 1: up to Week 16||271||
48474698|NCT02581345|101499866|FG001|COMPLETED|Part 1: up to Week 16||263||
48474699|NCT02581345|101499867|FG002|COMPLETED|Part 1: up to Week 16||0||
48474700|NCT02581345|101499868|FG003|COMPLETED|Part 1: up to Week 16||0||
48474701|NCT02581345|101499865|FG000|NOT COMPLETED|Part 1: up to Week 16||15||
48474702|NCT02581345|101499866|FG001|NOT COMPLETED|Part 1: up to Week 16||23||
48474703|NCT02581345|101499867|FG002|NOT COMPLETED|Part 1: up to Week 16||0||
48474704|NCT02581345|101499868|FG003|NOT COMPLETED|Part 1: up to Week 16||0||
48474705|NCT02581345|101499865|FG000|STARTED|Part 2: Week 17 to Week 47||271||
48474706|NCT02581345|101499866|FG001|STARTED|Part 2: Week 17 to Week 47||0||
48474707|NCT02581345|101499867|FG002|STARTED|Part 2: Week 17 to Week 47||132||
48474708|NCT02581345|101499868|FG003|STARTED|Part 2: Week 17 to Week 47||131||
48474709|NCT02581345|101499865|FG000|COMPLETED|Part 2: Week 17 to Week 47||242||
48474710|NCT02581345|101499866|FG001|COMPLETED|Part 2: Week 17 to Week 47||0||
48474711|NCT02581345|101499867|FG002|COMPLETED|Part 2: Week 17 to Week 47||117||
48474712|NCT02581345|101499868|FG003|COMPLETED|Part 2: Week 17 to Week 47||119||
48474713|NCT02581345|101499865|FG000|NOT COMPLETED|Part 2: Week 17 to Week 47||29||
48474714|NCT02581345|101499866|FG001|NOT COMPLETED|Part 2: Week 17 to Week 47||0||
48192022|NCT04476043|100791649|FG003|NOT COMPLETED|Overall Study||2||
48192023|NCT01016353|100791650|FG000|STARTED|Overall Study||180||
48474715|NCT02581345|101499867|FG002|NOT COMPLETED|Part 2: Week 17 to Week 47||15||
48474716|NCT02581345|101499868|FG003|NOT COMPLETED|Part 2: Week 17 to Week 47||12||
48474717|NCT00076102|101499869|FG000|STARTED|Overall Study||36||
48474718|NCT00076102|101499869|FG000|COMPLETED|Overall Study||31||
48474719|NCT00076102|101499869|FG000|NOT COMPLETED|Overall Study||5||
48474720|NCT01735630|101499870|FG000|STARTED|Overall Study||175||
48474721|NCT01735630|101499871|FG001|STARTED|Overall Study||175||
48474722|NCT01735630|101499870|FG000|COMPLETED|Overall Study||157||
48474723|NCT01735630|101499871|FG001|COMPLETED|Overall Study||157||
48474724|NCT01735630|101499870|FG000|NOT COMPLETED|Overall Study||18||
48474725|NCT01735630|101499871|FG001|NOT COMPLETED|Overall Study||18||
48474726|NCT00927992|101499872|FG000|STARTED|Overall Study||11||
48474727|NCT00927992|101499872|FG000|COMPLETED|Overall Study||11||
48474728|NCT00927992|101499872|FG000|NOT COMPLETED|Overall Study||0||
48474729|NCT02684344|101499873|FG000|STARTED|Overall Study||1||
48474730|NCT02684344|101499874|FG001|STARTED|Overall Study||4||
48474731|NCT02684344|101499873|FG000|COMPLETED|Overall Study||1||
48474732|NCT02684344|101499874|FG001|COMPLETED|Overall Study||3||
48474733|NCT02684344|101499873|FG000|NOT COMPLETED|Overall Study||0||
48474734|NCT02684344|101499874|FG001|NOT COMPLETED|Overall Study||1||
48474735|NCT01062256|101499875|FG000|STARTED|Overall Study||55||
48474736|NCT01062256|101499876|FG001|STARTED|Overall Study||103||
48474737|NCT01062256|101499877|FG002|STARTED|Overall Study||107||
48474738|NCT01062256|101499875|FG000|COMPLETED|Overall Study||52||
48474739|NCT01062256|101499876|FG001|COMPLETED|Overall Study||96||
48474740|NCT01062256|101499877|FG002|COMPLETED|Overall Study||103||
48474741|NCT01062256|101499875|FG000|NOT COMPLETED|Overall Study||3||
48474742|NCT01062256|101499876|FG001|NOT COMPLETED|Overall Study||7||
48192024|NCT01016353|100791651|FG001|STARTED|Overall Study||103||
48474743|NCT01062256|101499877|FG002|NOT COMPLETED|Overall Study||4||
48192025|NCT01016353|100791650|FG000|COMPLETED|Overall Study||178||
48474744|NCT01210001|101499878|FG000|STARTED|Overall Study||166||
48474745|NCT01210001|101499879|FG001|STARTED|Overall Study||165||
48474746|NCT01210001|101499880|FG002|STARTED|Overall Study||168||
48474747|NCT01210001|101499878|FG000|COMPLETED|Overall Study||147||
48474748|NCT01210001|101499879|FG001|COMPLETED|Overall Study||154||
48474749|NCT01210001|101499880|FG002|COMPLETED|Overall Study||156||
48192026|NCT01016353|100791651|FG001|COMPLETED|Overall Study||102||
48474750|NCT01210001|101499878|FG000|NOT COMPLETED|Overall Study||19||
48474751|NCT01210001|101499879|FG001|NOT COMPLETED|Overall Study||11||
48474752|NCT01210001|101499880|FG002|NOT COMPLETED|Overall Study||12||
48474753|NCT01402947|101499881|FG000|STARTED|First Intervention||15||
48474754|NCT01402947|101499882|FG001|STARTED|First Intervention||15||
48474755|NCT01402947|101499881|FG000|COMPLETED|First Intervention||15||
48474756|NCT01402947|101499882|FG001|COMPLETED|First Intervention||14||
48192027|NCT01016353|100791650|FG000|NOT COMPLETED|Overall Study||2||
48192028|NCT01016353|100791651|FG001|NOT COMPLETED|Overall Study||1||
48192029|NCT01838551|100791652|FG000|STARTED|Overall Study||94||
48192030|NCT01838551|100791652|FG000|COMPLETED|Overall Study||46||
48192031|NCT01838551|100791652|FG000|NOT COMPLETED|Overall Study||48||
48192032|NCT02459964|100791653|FG000|STARTED|Overall Study||42||
48192033|NCT02459964|100791654|FG001|STARTED|Overall Study||40||
48474757|NCT01402947|101499881|FG000|NOT COMPLETED|First Intervention||0||
48474758|NCT01402947|101499882|FG001|NOT COMPLETED|First Intervention||1||
48474759|NCT01402947|101499881|FG000|STARTED|Second Intervention||15||
48474760|NCT01402947|101499882|FG001|STARTED|Second Intervention||14||
48474761|NCT01402947|101499881|FG000|COMPLETED|Second Intervention||15||
48474762|NCT01402947|101499882|FG001|COMPLETED|Second Intervention||14||
48474763|NCT01402947|101499881|FG000|NOT COMPLETED|Second Intervention||0||
48474764|NCT01402947|101499882|FG001|NOT COMPLETED|Second Intervention||0||
48474765|NCT00090857|101499883|FG000|STARTED|Overall Study||33||
48474766|NCT00090857|101499884|FG001|STARTED|Overall Study||16||
48474767|NCT00090857|101499883|FG000|COMPLETED|Overall Study||29||
48474768|NCT00090857|101499884|FG001|COMPLETED|Overall Study||13||
48474769|NCT00090857|101499883|FG000|NOT COMPLETED|Overall Study||4||
48474770|NCT00090857|101499884|FG001|NOT COMPLETED|Overall Study||3||
48474771|NCT03661528|101499885|FG000|STARTED|Overall Study||263||
48474772|NCT03661528|101499886|FG001|STARTED|Overall Study||267||
48474773|NCT03661528|101499885|FG000|Received at Least 1 Dose of Study Drug|Overall Study||262||
48474774|NCT03661528|101499886|FG001|Received at Least 1 Dose of Study Drug|Overall Study||265||
48474775|NCT03661528|101499885|FG000|COMPLETED|Overall Study||180||
48474776|NCT03661528|101499886|FG001|COMPLETED|Overall Study||193||
48474777|NCT03661528|101499885|FG000|NOT COMPLETED|Overall Study||83||
48474778|NCT03661528|101499886|FG001|NOT COMPLETED|Overall Study||74||
48192034|NCT02459964|100791655|FG002|STARTED|Overall Study||2||
48192035|NCT02459964|100791653|FG000|COMPLETED|Overall Study||42||
48474779|NCT01424644|101499887|FG000|STARTED|Overall Study||402||
48474780|NCT01424644|101499888|FG001|STARTED|Overall Study||399||
48474781|NCT01424644|101499887|FG000|COMPLETED|Overall Study||369||
48474782|NCT01424644|101499888|FG001|COMPLETED|Overall Study||372||
48474783|NCT01424644|101499887|FG000|NOT COMPLETED|Overall Study||33||
48474784|NCT01424644|101499888|FG001|NOT COMPLETED|Overall Study||27||
48474785|NCT00677365|101499889|FG000|STARTED|Overall Study||37||
48474786|NCT00677365|101499890|FG001|STARTED|Overall Study||38||
48474787|NCT00677365|101499891|FG002|STARTED|Overall Study||37||
48474788|NCT00677365|101499892|FG003|STARTED|Overall Study||39||
48474789|NCT00677365|101499889|FG000|COMPLETED|Overall Study||35||
48474790|NCT00677365|101499890|FG001|COMPLETED|Overall Study||37||
48474791|NCT00677365|101499891|FG002|COMPLETED|Overall Study||35||
48474792|NCT00677365|101499892|FG003|COMPLETED|Overall Study||36||
48474793|NCT00677365|101499889|FG000|NOT COMPLETED|Overall Study||2||
48474794|NCT00677365|101499890|FG001|NOT COMPLETED|Overall Study||1||
48474795|NCT00677365|101499891|FG002|NOT COMPLETED|Overall Study||2||
48474796|NCT00677365|101499892|FG003|NOT COMPLETED|Overall Study||3||
48474797|NCT00301756|101499893|FG000|STARTED|Overall Study||32||
48474798|NCT00301756|101499893|FG000|COMPLETED|Overall Study||32||
48474799|NCT00301756|101499893|FG000|NOT COMPLETED|Overall Study||0||
48474800|NCT00954915|101499894|FG000|STARTED|Overall Study||1||
48474801|NCT00954915|101499894|FG000|COMPLETED|Overall Study||1||
48474802|NCT00954915|101499894|FG000|NOT COMPLETED|Overall Study||0||
48474803|NCT03179345|101499895|FG000|STARTED|Overall Study||8||
48474804|NCT03179345|101499896|FG001|STARTED|Overall Study||8||
48474805|NCT03179345|101499897|FG002|STARTED|Overall Study||8||
48474806|NCT03179345|101499898|FG003|STARTED|Overall Study||8||
48474807|NCT03179345|101499895|FG000|Received Gralise®|Overall Study||8||
48474808|NCT03179345|101499896|FG001|Received Gralise®|Overall Study||7||
48474809|NCT03179345|101499897|FG002|Received Gralise®|Overall Study||7||
48474810|NCT03179345|101499898|FG003|Received Gralise®|Overall Study||6||
48474811|NCT03179345|101499895|FG000|Received Neurontin®|Overall Study||8||
48474812|NCT03179345|101499896|FG001|Received Neurontin®|Overall Study||8||
48474813|NCT03179345|101499897|FG002|Received Neurontin®|Overall Study||7||
48474814|NCT03179345|101499898|FG003|Received Neurontin®|Overall Study||8||
48474815|NCT03179345|101499895|FG000|Received Lyrica®|Overall Study||8||
48474816|NCT03179345|101499896|FG001|Received Lyrica®|Overall Study||7||
48474817|NCT03179345|101499897|FG002|Received Lyrica®|Overall Study||8||
48474818|NCT03179345|101499898|FG003|Received Lyrica®|Overall Study||8||
48474819|NCT03179345|101499895|FG000|Received Placebo|Overall Study||8||
48474820|NCT03179345|101499896|FG001|Received Placebo|Overall Study||7||
48474821|NCT03179345|101499897|FG002|Received Placebo|Overall Study||7||
48474822|NCT03179345|101499898|FG003|Received Placebo|Overall Study||8||
48474823|NCT03179345|101499895|FG000|COMPLETED|Overall Study||8||
48474824|NCT03179345|101499896|FG001|COMPLETED|Overall Study||7||
48474825|NCT03179345|101499897|FG002|COMPLETED|Overall Study||7||
48474826|NCT03179345|101499898|FG003|COMPLETED|Overall Study||6||
48474827|NCT03179345|101499895|FG000|NOT COMPLETED|Overall Study||0||
48474828|NCT03179345|101499896|FG001|NOT COMPLETED|Overall Study||1||
48474829|NCT03179345|101499897|FG002|NOT COMPLETED|Overall Study||1||
48474830|NCT03179345|101499898|FG003|NOT COMPLETED|Overall Study||2||
48474831|NCT01044732|101499899|FG000|STARTED|Overall Study||222||
48474832|NCT01044732|101499900|FG001|STARTED|Overall Study||226||
48474833|NCT01044732|101499899|FG000|COMPLETED|Overall Study||173||
48474834|NCT01044732|101499900|FG001|COMPLETED|Overall Study||176||
48474835|NCT01044732|101499899|FG000|NOT COMPLETED|Overall Study||49||
48474836|NCT01044732|101499900|FG001|NOT COMPLETED|Overall Study||50||
48474837|NCT01126736|101499901|FG000|STARTED|Overall Study||4||
48474838|NCT01126736|101499902|FG001|STARTED|Overall Study||6||
48474839|NCT01126736|101499903|FG002|STARTED|Overall Study||5||
48474840|NCT01126736|101499904|FG003|STARTED|Overall Study||42||
48474841|NCT01126736|101499905|FG004|STARTED|Overall Study||41||
48474842|NCT01126736|101499901|FG000|Safety Population|Overall Study||4||
48474843|NCT01126736|101499902|FG001|Safety Population|Overall Study||6||
48474844|NCT01126736|101499903|FG002|Safety Population|Overall Study||5||
48474845|NCT01126736|101499904|FG003|Safety Population|Overall Study||41||
48474846|NCT01126736|101499905|FG004|Safety Population|Overall Study||39||
48474847|NCT01126736|101499901|FG000|Modified Intent-to-treat (MITT)|Overall Study||4||
48474848|NCT01126736|101499902|FG001|Modified Intent-to-treat (MITT)|Overall Study||6||
48474849|NCT01126736|101499903|FG002|Modified Intent-to-treat (MITT)|Overall Study||5||
48474850|NCT01126736|101499904|FG003|Modified Intent-to-treat (MITT)|Overall Study||39||
48474851|NCT01126736|101499905|FG004|Modified Intent-to-treat (MITT)|Overall Study||39||
48474852|NCT01126736|101499901|FG000|COMPLETED|Overall Study||0||
48474853|NCT01126736|101499902|FG001|COMPLETED|Overall Study||0||
48474854|NCT01126736|101499903|FG002|COMPLETED|Overall Study||0||
48474855|NCT01126736|101499904|FG003|COMPLETED|Overall Study||0||
48474856|NCT01126736|101499905|FG004|COMPLETED|Overall Study||0||
48474857|NCT01126736|101499901|FG000|NOT COMPLETED|Overall Study||4||
48474858|NCT01126736|101499902|FG001|NOT COMPLETED|Overall Study||6||
48474859|NCT01126736|101499903|FG002|NOT COMPLETED|Overall Study||5||
48474860|NCT01126736|101499904|FG003|NOT COMPLETED|Overall Study||42||
48474861|NCT01126736|101499905|FG004|NOT COMPLETED|Overall Study||41||
48474862|NCT03048500|101499906|FG000|STARTED|2 Cycles of Treatment||17||
48474863|NCT03048500|101499906|FG000|Attempted 1st Cycle|2 Cycles of Treatment||17||
48474864|NCT03048500|101499906|FG000|Attempted 2nd Cycle|2 Cycles of Treatment||16||
48474865|NCT03048500|101499906|FG000|COMPLETED|2 Cycles of Treatment||16||
48474866|NCT03048500|101499906|FG000|NOT COMPLETED|2 Cycles of Treatment||1||
48474867|NCT03048500|101499906|FG000|STARTED|Reached 1st Response/Continued Treatment||16||
48474868|NCT03048500|101499906|FG000|Assessed for First Response|Reached 1st Response/Continued Treatment||16||
48474869|NCT03048500|101499906|FG000|Went on to Cycle 3 and Beyond|Reached 1st Response/Continued Treatment||9||
48474870|NCT03048500|101499906|FG000|COMPLETED|Reached 1st Response/Continued Treatment||9||
48474871|NCT03048500|101499906|FG000|NOT COMPLETED|Reached 1st Response/Continued Treatment||7||
48474872|NCT03048500|101499906|FG000|STARTED|Follow up for 3 Years||16|All patients that are treated on study go into the follow-up period.|
48474873|NCT03048500|101499906|FG000|COMPLETED|Follow up for 3 Years||0||
48474874|NCT03048500|101499906|FG000|NOT COMPLETED|Follow up for 3 Years||16||
48474875|NCT00728949|101499907|FG000|STARTED|Overall Study||62||
48474876|NCT00728949|101499908|FG001|STARTED|Overall Study||31||
48474877|NCT00728949|101499907|FG000|COMPLETED|Overall Study||51||
48474878|NCT00728949|101499908|FG001|COMPLETED|Overall Study||27||
48474879|NCT00728949|101499907|FG000|NOT COMPLETED|Overall Study||11||
48474880|NCT00728949|101499908|FG001|NOT COMPLETED|Overall Study||4||
48474881|NCT03401112|101499909|FG000|STARTED|Overall Study||15||
48474882|NCT03401112|101499910|FG001|STARTED|Overall Study||26||
48474883|NCT03401112|101499911|FG002|STARTED|Overall Study||22||
48474884|NCT03401112|101499912|FG003|STARTED|Overall Study||27||
48474885|NCT03401112|101499913|FG004|STARTED|Overall Study||10||
48474886|NCT03401112|101499909|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12||
48474887|NCT03401112|101499910|FG001|Received at Least 1 Dose of Study Drug|Overall Study||26||
48474888|NCT03401112|101499911|FG002|Received at Least 1 Dose of Study Drug|Overall Study||20||
48474889|NCT03401112|101499912|FG003|Received at Least 1 Dose of Study Drug|Overall Study||25||
48474890|NCT03401112|101499913|FG004|Received at Least 1 Dose of Study Drug|Overall Study||10||
48474891|NCT03401112|101499909|FG000|COMPLETED|Overall Study||10||
48474892|NCT03401112|101499910|FG001|COMPLETED|Overall Study||19||
48474893|NCT03401112|101499911|FG002|COMPLETED|Overall Study||11||
48474894|NCT03401112|101499912|FG003|COMPLETED|Overall Study||21||
48474895|NCT03401112|101499913|FG004|COMPLETED|Overall Study||10||
48474896|NCT03401112|101499909|FG000|NOT COMPLETED|Overall Study||5||
48474897|NCT03401112|101499910|FG001|NOT COMPLETED|Overall Study||7||
48474898|NCT03401112|101499911|FG002|NOT COMPLETED|Overall Study||11||
48474899|NCT03401112|101499912|FG003|NOT COMPLETED|Overall Study||6||
48474900|NCT03401112|101499913|FG004|NOT COMPLETED|Overall Study||0||
48474901|NCT02097290|101499914|FG000|STARTED|Overall Study||210||
48474902|NCT02097290|101499914|FG000|COMPLETED|Overall Study||193||
48474903|NCT02097290|101499914|FG000|NOT COMPLETED|Overall Study||17||
48474904|NCT00463606|101499915|FG000|STARTED|Overall Study||253||
48474905|NCT00463606|101499916|FG001|STARTED|Overall Study||254||
48474906|NCT00463606|101499917|FG002|STARTED|Overall Study||251||
48474907|NCT00463606|101499915|FG000|COMPLETED|Overall Study||212||
48474908|NCT00463606|101499916|FG001|COMPLETED|Overall Study||220||
48474909|NCT00463606|101499917|FG002|COMPLETED|Overall Study||231||
48474910|NCT00463606|101499915|FG000|NOT COMPLETED|Overall Study||41||
48474911|NCT00463606|101499916|FG001|NOT COMPLETED|Overall Study||34||
48474912|NCT00463606|101499917|FG002|NOT COMPLETED|Overall Study||20||
48474913|NCT03865654|101499918|FG000|STARTED|Overall Study||45||
48474914|NCT03865654|101499918|FG000|COMPLETED|Overall Study||40||
48474915|NCT03865654|101499918|FG000|NOT COMPLETED|Overall Study||5||
48474916|NCT02122796|101499919|FG000|STARTED|Visit 1||15||
48474917|NCT02122796|101499920|FG001|STARTED|Visit 1||15||
48474918|NCT02122796|101499919|FG000|COMPLETED|Visit 1||15||
48474919|NCT02122796|101499920|FG001|COMPLETED|Visit 1||15||
48474920|NCT02122796|101499919|FG000|NOT COMPLETED|Visit 1||0||
48474921|NCT02122796|101499920|FG001|NOT COMPLETED|Visit 1||0||
48474922|NCT02122796|101499919|FG000|STARTED|Visit 2||15||
48474923|NCT02122796|101499920|FG001|STARTED|Visit 2||15||
48474924|NCT02122796|101499919|FG000|COMPLETED|Visit 2||12||
48474925|NCT02122796|101499920|FG001|COMPLETED|Visit 2||14||
48474926|NCT02122796|101499919|FG000|NOT COMPLETED|Visit 2||3||
48474927|NCT02122796|101499920|FG001|NOT COMPLETED|Visit 2||1||
48474928|NCT00113425|101499921|FG000|STARTED|Overall Study||44||
48474929|NCT00113425|101499921|FG000|COMPLETED|Overall Study||29||
48474930|NCT00113425|101499921|FG000|NOT COMPLETED|Overall Study||15||
48474931|NCT02480764|101499922|FG000|STARTED|Overall Study||199||
48474932|NCT02480764|101499923|FG001|STARTED|Overall Study||209||
48474933|NCT02480764|101499924|FG002|STARTED|Overall Study||204||
48474934|NCT02480764|101499922|FG000|COMPLETED|Overall Study||189||
48474935|NCT02480764|101499923|FG001|COMPLETED|Overall Study||189||
48474936|NCT02480764|101499924|FG002|COMPLETED|Overall Study||183||
48474937|NCT02480764|101499922|FG000|NOT COMPLETED|Overall Study||10||
48474938|NCT02480764|101499923|FG001|NOT COMPLETED|Overall Study||20||
48474939|NCT02480764|101499924|FG002|NOT COMPLETED|Overall Study||21||
48474940|NCT01199861|101499925|FG000|STARTED|Overall Study||95||
48474941|NCT01199861|101499926|FG001|STARTED|Overall Study||43||
48192036|NCT02459964|100791654|FG001|COMPLETED|Overall Study||40||
48192037|NCT02459964|100791655|FG002|COMPLETED|Overall Study||0||
48192038|NCT02459964|100791653|FG000|NOT COMPLETED|Overall Study||0||
48192039|NCT02459964|100791654|FG001|NOT COMPLETED|Overall Study||0||
48192040|NCT02459964|100791655|FG002|NOT COMPLETED|Overall Study||2||
48192041|NCT04639947|100791656|FG000|STARTED|Overall Study||22||22
48192042|NCT04639947|100791656|FG000|COMPLETED|Overall Study||21||21
48192043|NCT04639947|100791656|FG000|NOT COMPLETED|Overall Study||1||1
48192044|NCT01492309|100791657|FG000|STARTED|Overall Study||11||
48192045|NCT01492309|100791658|FG001|STARTED|Overall Study||11||
48192046|NCT01492309|100791657|FG000|COMPLETED|Overall Study||11||
48192047|NCT01492309|100791658|FG001|COMPLETED|Overall Study||11||
48192048|NCT01492309|100791657|FG000|NOT COMPLETED|Overall Study||0||
48192049|NCT01492309|100791658|FG001|NOT COMPLETED|Overall Study||0||
48192050|NCT04816526|100793958|FG000|STARTED|Overall Study||13||
48192051|NCT04816526|100793958|FG000|COMPLETED|Overall Study||13||
48192052|NCT04816526|100793958|FG000|NOT COMPLETED|Overall Study||0||
48192053|NCT02008292|100793959|FG000|STARTED|Overall Study||43||
48192054|NCT02008292|100793960|FG001|STARTED|Overall Study||37||
48192055|NCT02008292|100793959|FG000|COMPLETED|Overall Study||43||
48192056|NCT02008292|100793960|FG001|COMPLETED|Overall Study||37||
48192057|NCT02008292|100793959|FG000|NOT COMPLETED|Overall Study||0||
48192058|NCT02008292|100793960|FG001|NOT COMPLETED|Overall Study||0||
48192059|NCT03686683|100793961|FG000|STARTED|Overall Study||356||
48192060|NCT03686683|100793962|FG001|STARTED|Overall Study||176||
48192061|NCT03686683|100793961|FG000|COMPLETED|Overall Study||262||
48192062|NCT03686683|100793962|FG001|COMPLETED|Overall Study||118||
48192063|NCT03686683|100793961|FG000|NOT COMPLETED|Overall Study||94||
48192064|NCT03686683|100793962|FG001|NOT COMPLETED|Overall Study||58||
48192065|NCT00765661|100793963|FG000|STARTED|Overall Study||32||
48192066|NCT00765661|100793964|FG001|STARTED|Overall Study||31||
48192067|NCT00765661|100793963|FG000|COMPLETED|Overall Study||32||
48192068|NCT00765661|100793964|FG001|COMPLETED|Overall Study||31||
48192069|NCT00765661|100793963|FG000|NOT COMPLETED|Overall Study||0||
48192070|NCT00765661|100793964|FG001|NOT COMPLETED|Overall Study||0||
48192071|NCT00819234|100793965|FG000|STARTED|Overall Study||31||
48192072|NCT00819234|100793966|FG001|STARTED|Overall Study||35||
48192073|NCT00819234|100793967|FG002|STARTED|Overall Study||36||
48192074|NCT00819234|100793968|FG003|STARTED|Overall Study||28||
48192075|NCT00819234|100793969|FG004|STARTED|Overall Study||13||
48192076|NCT00819234|100793970|FG005|STARTED|Overall Study||14||
48192077|NCT00819234|100793971|FG006|STARTED|Overall Study||13||
48474942|NCT01199861|101499925|FG000|COMPLETED|Overall Study||93||
48474943|NCT01199861|101499926|FG001|COMPLETED|Overall Study||43||
48474944|NCT01199861|101499925|FG000|NOT COMPLETED|Overall Study||2||
48474945|NCT01199861|101499926|FG001|NOT COMPLETED|Overall Study||0||
48474946|NCT00193037|101499927|FG000|STARTED|Randomized Treatment||50||
48192078|NCT00819234|100793972|FG007|STARTED|Overall Study||29||
48192079|NCT00819234|100793973|FG008|STARTED|Overall Study||37||
48192080|NCT00819234|100793974|FG009|STARTED|Overall Study||37||
48192081|NCT00819234|100793965|FG000|COMPLETED|Overall Study||21||
48192082|NCT00819234|100793966|FG001|COMPLETED|Overall Study||20||
48192083|NCT00819234|100793967|FG002|COMPLETED|Overall Study||28||
48192084|NCT00819234|100793968|FG003|COMPLETED|Overall Study||22||
48192085|NCT00819234|100793969|FG004|COMPLETED|Overall Study||12||
48192086|NCT00819234|100793970|FG005|COMPLETED|Overall Study||7||
48192087|NCT00819234|100793971|FG006|COMPLETED|Overall Study||8||
48192088|NCT00819234|100793972|FG007|COMPLETED|Overall Study||20||
48192089|NCT00819234|100793973|FG008|COMPLETED|Overall Study||31||
48192090|NCT00819234|100793974|FG009|COMPLETED|Overall Study||30||
48192091|NCT00819234|100793965|FG000|NOT COMPLETED|Overall Study||10||
48192092|NCT00819234|100793966|FG001|NOT COMPLETED|Overall Study||15||
48192093|NCT00819234|100793967|FG002|NOT COMPLETED|Overall Study||8||
48192094|NCT00819234|100793968|FG003|NOT COMPLETED|Overall Study||6||
48192095|NCT00819234|100793969|FG004|NOT COMPLETED|Overall Study||1||
48192096|NCT00819234|100793970|FG005|NOT COMPLETED|Overall Study||7||
48192097|NCT00819234|100793971|FG006|NOT COMPLETED|Overall Study||5||
48192098|NCT00819234|100793972|FG007|NOT COMPLETED|Overall Study||9||
48192099|NCT00819234|100793973|FG008|NOT COMPLETED|Overall Study||6||
48192100|NCT00819234|100793974|FG009|NOT COMPLETED|Overall Study||7||
48474947|NCT00193037|101499928|FG001|STARTED|Randomized Treatment||52||
48474948|NCT00193037|101499927|FG000|COMPLETED|Randomized Treatment||32||
48474949|NCT00193037|101499928|FG001|COMPLETED|Randomized Treatment||24||
48474950|NCT00193037|101499927|FG000|NOT COMPLETED|Randomized Treatment||18||
48474951|NCT00193037|101499928|FG001|NOT COMPLETED|Randomized Treatment||28||
48474952|NCT00193037|101499927|FG000|STARTED|Crossover Treatment||32||
48474953|NCT00193037|101499928|FG001|STARTED|Crossover Treatment||24||
48474954|NCT00193037|101499927|FG000|COMPLETED|Crossover Treatment||32||
48474955|NCT00193037|101499928|FG001|COMPLETED|Crossover Treatment||24||
48474956|NCT00193037|101499927|FG000|NOT COMPLETED|Crossover Treatment||0||
48474957|NCT00193037|101499928|FG001|NOT COMPLETED|Crossover Treatment||0||
48474958|NCT01919190|101499929|FG000|STARTED|Overall Study||33||
48474959|NCT01919190|101499930|FG001|STARTED|Overall Study||34||
48474960|NCT01919190|101499929|FG000|COMPLETED|Overall Study||30||
48474961|NCT01919190|101499930|FG001|COMPLETED|Overall Study||34||
48474962|NCT01919190|101499929|FG000|NOT COMPLETED|Overall Study||3||
48474963|NCT01919190|101499930|FG001|NOT COMPLETED|Overall Study||0||
48474964|NCT04638153|101499931|FG000|STARTED|Overall Study||20|Assigned to treatment and treated|
48474965|NCT04638153|101499932|FG001|STARTED|Overall Study||19|Assigned to treatment and treated|
48474966|NCT04638153|101499933|FG002|STARTED|Overall Study||18|Assigned to treatment and treated|
48474967|NCT04638153|101499931|FG000|COMPLETED|Overall Study||16||
48474968|NCT04638153|101499932|FG001|COMPLETED|Overall Study||17||
48474969|NCT04638153|101499933|FG002|COMPLETED|Overall Study||3||
48474970|NCT04638153|101499931|FG000|NOT COMPLETED|Overall Study||4||
48474971|NCT04638153|101499932|FG001|NOT COMPLETED|Overall Study||2||
48474972|NCT04638153|101499933|FG002|NOT COMPLETED|Overall Study||15||
48474973|NCT01806688|101499934|FG000|STARTED|First Intervention Seed Study||38|Day 1|
48474974|NCT01806688|101499935|FG001|STARTED|First Intervention Seed Study||0|Day 1|
48474975|NCT01806688|101499934|FG000|Experimental Snack #1|First Intervention Seed Study||13||
48474976|NCT01806688|101499935|FG001|Experimental Snack #1|First Intervention Seed Study||0||
48474977|NCT01806688|101499934|FG000|Placebo Comparator Reference Product #1|First Intervention Seed Study||13||
48474978|NCT01806688|101499935|FG001|Placebo Comparator Reference Product #1|First Intervention Seed Study||0||
48474979|NCT01806688|101499934|FG000|Placebo Comparator Non-caloric Control #1|First Intervention Seed Study||12||
48474980|NCT01806688|101499935|FG001|Placebo Comparator Non-caloric Control #1|First Intervention Seed Study||0||
48474981|NCT01806688|101499934|FG000|COMPLETED|First Intervention Seed Study||38||
48474982|NCT01806688|101499935|FG001|COMPLETED|First Intervention Seed Study||0||
48474983|NCT01806688|101499934|FG000|NOT COMPLETED|First Intervention Seed Study||0||
48474984|NCT01806688|101499935|FG001|NOT COMPLETED|First Intervention Seed Study||0||
48474985|NCT01806688|101499934|FG000|STARTED|Second Intervention Seed Study||38|Day 8|
48474986|NCT01806688|101499935|FG001|STARTED|Second Intervention Seed Study||0|Day 8|
48474987|NCT01806688|101499934|FG000|Experimental Snack #1|Second Intervention Seed Study||13||
48474988|NCT01806688|101499935|FG001|Experimental Snack #1|Second Intervention Seed Study||0||
48474989|NCT01806688|101499934|FG000|Placebo Comparator Reference Product #1|Second Intervention Seed Study||13||
48474990|NCT01806688|101499935|FG001|Placebo Comparator Reference Product #1|Second Intervention Seed Study||0||
48192101|NCT04348370|100793975|FG000|STARTED|Overall Study||334||
48192102|NCT04348370|100793976|FG001|STARTED|Overall Study||325||
48192103|NCT04348370|100793975|FG000|COMPLETED|Overall Study||263||
48192104|NCT04348370|100793976|FG001|COMPLETED|Overall Study||266||
48192105|NCT04348370|100793975|FG000|NOT COMPLETED|Overall Study||71||
48474991|NCT01806688|101499934|FG000|Placebo Comparator Non-caloric Control #1|Second Intervention Seed Study||12||
48474992|NCT01806688|101499935|FG001|Placebo Comparator Non-caloric Control #1|Second Intervention Seed Study||0||
48474993|NCT01806688|101499934|FG000|COMPLETED|Second Intervention Seed Study||38||
48192106|NCT04348370|100793976|FG001|NOT COMPLETED|Overall Study||59||
48192107|NCT01051778|100793977|FG000|STARTED|Overall Study||30||
48192108|NCT01051778|100793978|FG001|STARTED|Overall Study||30||
48192109|NCT01051778|100793977|FG000|COMPLETED|Overall Study||30||
48192110|NCT01051778|100793978|FG001|COMPLETED|Overall Study||30||
48370754|NCT02677896|101234954|FG001|Treated|Double Blind Period (up to 35 Months)||574||
48370755|NCT02677896|101234953|FG000|COMPLETED|Double Blind Period (up to 35 Months)||0||
48370756|NCT02677896|101234954|FG001|COMPLETED|Double Blind Period (up to 35 Months)||0||
48370757|NCT02677896|101234953|FG000|NOT COMPLETED|Double Blind Period (up to 35 Months)||574||
48370758|NCT02677896|101234954|FG001|NOT COMPLETED|Double Blind Period (up to 35 Months)||576||
48370759|NCT02677896|101234953|FG000|STARTED|Open-Label Extension (up to 25 Months)||365||
48474994|NCT01806688|101499935|FG001|COMPLETED|Second Intervention Seed Study||0||
48474995|NCT01806688|101499934|FG000|NOT COMPLETED|Second Intervention Seed Study||0||
48474996|NCT01806688|101499935|FG001|NOT COMPLETED|Second Intervention Seed Study||0||
48474997|NCT01806688|101499934|FG000|STARTED|Third Intervention Seed Study||38|Day 15|
48474998|NCT01806688|101499935|FG001|STARTED|Third Intervention Seed Study||0|Day 15|
48474999|NCT01806688|101499934|FG000|Experimental Snack #1|Third Intervention Seed Study||12||
48475000|NCT01806688|101499935|FG001|Experimental Snack #1|Third Intervention Seed Study||0||
48475001|NCT01806688|101499934|FG000|Placebo Comparator Reference Product #1|Third Intervention Seed Study||12||
48475002|NCT01806688|101499935|FG001|Placebo Comparator Reference Product #1|Third Intervention Seed Study||0||
48475003|NCT01806688|101499934|FG000|Placebo Comparator Non-caloric Control #1|Third Intervention Seed Study||14||
48475004|NCT01806688|101499935|FG001|Placebo Comparator Non-caloric Control #1|Third Intervention Seed Study||0||
48475005|NCT01806688|101499934|FG000|COMPLETED|Third Intervention Seed Study||38||
48475006|NCT01806688|101499935|FG001|COMPLETED|Third Intervention Seed Study||0||
48192111|NCT01051778|100793977|FG000|NOT COMPLETED|Overall Study||0||
48666190|NCT03506360|101967525|FG000|COMPLETED|Overall Study||13||
48475007|NCT01806688|101499934|FG000|NOT COMPLETED|Third Intervention Seed Study||0||
48475008|NCT01806688|101499935|FG001|NOT COMPLETED|Third Intervention Seed Study||0||
48475009|NCT01806688|101499934|FG000|STARTED|First Intervention Pita Study||0|Day 1|
48475010|NCT01806688|101499935|FG001|STARTED|First Intervention Pita Study||38|Day 1|
48666191|NCT03506360|101967525|FG000|NOT COMPLETED|Overall Study||0||
48666192|NCT02951481|101967526|FG000|STARTED|Overall Study||231||
48666193|NCT02951481|101967527|FG001|STARTED|Overall Study||172||
48666194|NCT02951481|101967526|FG000|COMPLETED|Overall Study||231||
48666195|NCT02951481|101967527|FG001|COMPLETED|Overall Study||172||
48666196|NCT02951481|101967526|FG000|NOT COMPLETED|Overall Study||0||
48666197|NCT02951481|101967527|FG001|NOT COMPLETED|Overall Study||0||
48666198|NCT01683812|101967528|FG000|STARTED|Overall Study||23||
48666199|NCT01683812|101967528|FG000|COMPLETED|Overall Study||23||
48666200|NCT01683812|101967528|FG000|NOT COMPLETED|Overall Study||0||
48666201|NCT03815344|101967529|FG000|STARTED|Overall Study||42||
48666202|NCT03815344|101967530|FG001|STARTED|Overall Study||32||
48666203|NCT03815344|101967529|FG000|COMPLETED|Overall Study||42||
48666204|NCT03815344|101967530|FG001|COMPLETED|Overall Study||32||
48666205|NCT03815344|101967529|FG000|NOT COMPLETED|Overall Study||0||
48666206|NCT03815344|101967530|FG001|NOT COMPLETED|Overall Study||0||
48666207|NCT04617860|101967531|FG000|STARTED|Overall Study||8||
48666208|NCT04617860|101967532|FG001|STARTED|Overall Study||10||
48666209|NCT04617860|101967533|FG002|STARTED|Overall Study||18||
48666210|NCT04617860|101967531|FG000|Dose Modified to 8 mg|Overall Study||8||
48666211|NCT04617860|101967532|FG001|Dose Modified to 8 mg|Overall Study||1||
48666212|NCT04617860|101967533|FG002|Dose Modified to 8 mg|Overall Study||0||
48666213|NCT04617860|101967531|FG000|Dose Modified to 16 mg|Overall Study||8||
48666214|NCT04617860|101967532|FG001|Dose Modified to 16 mg|Overall Study||9||
48666215|NCT04617860|101967533|FG002|Dose Modified to 16 mg|Overall Study||8||
48666216|NCT04617860|101967531|FG000|Dose Modified to 32 mg|Overall Study||2||
48666217|NCT04617860|101967532|FG001|Dose Modified to 32 mg|Overall Study||4||
48666218|NCT04617860|101967533|FG002|Dose Modified to 32 mg|Overall Study||11||
48666219|NCT04617860|101967531|FG000|COMPLETED|Overall Study||0||
48666220|NCT04617860|101967532|FG001|COMPLETED|Overall Study||0||
48666221|NCT04617860|101967533|FG002|COMPLETED|Overall Study||0||
48666222|NCT04617860|101967531|FG000|NOT COMPLETED|Overall Study||8||
48666223|NCT04617860|101967532|FG001|NOT COMPLETED|Overall Study||10||
48666224|NCT04617860|101967533|FG002|NOT COMPLETED|Overall Study||18||
48666225|NCT04319809|101967534|FG000|STARTED|Overall Study||4||
48666226|NCT04319809|101967535|FG001|STARTED|Overall Study||5||
48666227|NCT04319809|101967534|FG000|COMPLETED|Overall Study||4||
48666228|NCT04319809|101967535|FG001|COMPLETED|Overall Study||5||
48666229|NCT04319809|101967534|FG000|NOT COMPLETED|Overall Study||0||
48666230|NCT04319809|101967535|FG001|NOT COMPLETED|Overall Study||0||
48475011|NCT01806688|101499934|FG000|Experimental Snack #2|First Intervention Pita Study||0||
48475012|NCT01806688|101499935|FG001|Experimental Snack #2|First Intervention Pita Study||14||
48192112|NCT01051778|100793978|FG001|NOT COMPLETED|Overall Study||0||
48192113|NCT02485353|100793979|FG000|STARTED|Overall Study||2||
48192114|NCT02485353|100793979|FG000|COMPLETED|Overall Study||0||
48192115|NCT02485353|100793979|FG000|NOT COMPLETED|Overall Study||2||
48192116|NCT02846415|100793980|FG000|STARTED|Overall Study||18||
48192117|NCT02846415|100793981|FG001|STARTED|Overall Study||12||
48475013|NCT01806688|101499934|FG000|Placebo Comparator Reference Product #2|First Intervention Pita Study||0||
48475014|NCT01806688|101499935|FG001|Placebo Comparator Reference Product #2|First Intervention Pita Study||12||
48475015|NCT01806688|101499934|FG000|Placebo Comparator Non-caloric Control #2|First Intervention Pita Study||0||
48475016|NCT01806688|101499935|FG001|Placebo Comparator Non-caloric Control #2|First Intervention Pita Study||12||
48475017|NCT01806688|101499934|FG000|COMPLETED|First Intervention Pita Study||0||
48475018|NCT01806688|101499935|FG001|COMPLETED|First Intervention Pita Study||38||
48475019|NCT01806688|101499934|FG000|NOT COMPLETED|First Intervention Pita Study||0||
48192118|NCT02846415|100793980|FG000|COMPLETED|Overall Study||15||
48192119|NCT02846415|100793981|FG001|COMPLETED|Overall Study||11||
48192120|NCT02846415|100793980|FG000|NOT COMPLETED|Overall Study||3||
48192121|NCT02846415|100793981|FG001|NOT COMPLETED|Overall Study||1||
48192122|NCT01110174|100793982|FG000|STARTED|Overall Study||8||
48192123|NCT01110174|100793982|FG000|COMPLETED|Overall Study||8||
48192124|NCT01110174|100793982|FG000|NOT COMPLETED|Overall Study||0||
48192125|NCT01729871|100793983|FG000|STARTED|Overall Study||124||
48192126|NCT01729871|100793984|FG001|STARTED|Overall Study||124||
48192127|NCT01729871|100793983|FG000|COMPLETED|Overall Study||112||
48192128|NCT01729871|100793984|FG001|COMPLETED|Overall Study||101||
48192129|NCT01729871|100793983|FG000|NOT COMPLETED|Overall Study||12||
48192130|NCT01729871|100793984|FG001|NOT COMPLETED|Overall Study||23||
48192131|NCT03820986|100793985|FG000|STARTED|Overall Study||334||
48192132|NCT03820986|100793986|FG001|STARTED|Overall Study||340||
48192133|NCT03820986|100793985|FG000|COMPLETED|Overall Study||0||
48192134|NCT03820986|100793986|FG001|COMPLETED|Overall Study||0||
48192135|NCT03820986|100793985|FG000|NOT COMPLETED|Overall Study||334||
48192136|NCT03820986|100793986|FG001|NOT COMPLETED|Overall Study||340||
48192137|NCT00871429|100793987|FG000|STARTED|Overall Study||99||
48192138|NCT00871429|100793987|FG000|COMPLETED|Overall Study||75||
48192139|NCT00871429|100793987|FG000|NOT COMPLETED|Overall Study||24||
48192140|NCT03057132|100793988|FG000|STARTED|Overall Study||1||
48192141|NCT03057132|100793988|FG000|COMPLETED|Overall Study||1||
48192142|NCT03057132|100793988|FG000|NOT COMPLETED|Overall Study||0||
48192143|NCT00354029|100793989|FG000|STARTED|Overall Study||43||
48192144|NCT00354029|100793990|FG001|STARTED|Overall Study||40||
48192145|NCT00354029|100793989|FG000|COMPLETED|Overall Study||39||
48192146|NCT00354029|100793990|FG001|COMPLETED|Overall Study||38||
48192147|NCT00354029|100793989|FG000|NOT COMPLETED|Overall Study||4||
48192148|NCT00354029|100793990|FG001|NOT COMPLETED|Overall Study||2||
48192149|NCT03523702|100793991|FG000|STARTED|Overall Study||25||
48192150|NCT03523702|100793991|FG000|COMPLETED|Overall Study||25||
48192151|NCT03523702|100793991|FG000|NOT COMPLETED|Overall Study||0||
48192152|NCT00731042|100793992|FG000|STARTED|First Intervention||16||
48192153|NCT00731042|100793993|FG001|STARTED|First Intervention||17||
48475020|NCT01806688|101499935|FG001|NOT COMPLETED|First Intervention Pita Study||0||
48475021|NCT01806688|101499934|FG000|STARTED|Second Intervention Pita Study||0|Day 8|
48475022|NCT01806688|101499935|FG001|STARTED|Second Intervention Pita Study||38|Day 8|
48192154|NCT00731042|100793992|FG000|COMPLETED|First Intervention||16||
48192155|NCT00731042|100793993|FG001|COMPLETED|First Intervention||17||
48192156|NCT00731042|100793992|FG000|NOT COMPLETED|First Intervention||0||
48192157|NCT00731042|100793993|FG001|NOT COMPLETED|First Intervention||0||
48475023|NCT01806688|101499934|FG000|Experimental Snack #2|Second Intervention Pita Study||0||
48475024|NCT01806688|101499935|FG001|Experimental Snack #2|Second Intervention Pita Study||12||
48475025|NCT01806688|101499934|FG000|Placebo Comparator Reference Product #2|Second Intervention Pita Study||0||
48475026|NCT01806688|101499935|FG001|Placebo Comparator Reference Product #2|Second Intervention Pita Study||13||
48475027|NCT01806688|101499934|FG000|Placebo Comparator Non-caloric Control #2|Second Intervention Pita Study||0||
48475028|NCT01806688|101499935|FG001|Placebo Comparator Non-caloric Control #2|Second Intervention Pita Study||13||
48192158|NCT00731042|100793992|FG000|STARTED|Wash-out||16||
48192159|NCT00731042|100793993|FG001|STARTED|Wash-out||17||
48192160|NCT00731042|100793992|FG000|COMPLETED|Wash-out||16||
48192161|NCT00731042|100793993|FG001|COMPLETED|Wash-out||17||
48192162|NCT00731042|100793992|FG000|NOT COMPLETED|Wash-out||0||
48192163|NCT00731042|100793993|FG001|NOT COMPLETED|Wash-out||0||
48192164|NCT00731042|100793992|FG000|STARTED|Second Intervention||16||
48192165|NCT00731042|100793993|FG001|STARTED|Second Intervention||17||
48192166|NCT00731042|100793992|FG000|COMPLETED|Second Intervention||16||
48192167|NCT00731042|100793993|FG001|COMPLETED|Second Intervention||15||
48192168|NCT00731042|100793992|FG000|NOT COMPLETED|Second Intervention||0||
48192169|NCT00731042|100793993|FG001|NOT COMPLETED|Second Intervention||2||
48475029|NCT01806688|101499934|FG000|COMPLETED|Second Intervention Pita Study||0||
48475030|NCT01806688|101499935|FG001|COMPLETED|Second Intervention Pita Study||38||
48475031|NCT01806688|101499934|FG000|NOT COMPLETED|Second Intervention Pita Study||0||
48475032|NCT01806688|101499935|FG001|NOT COMPLETED|Second Intervention Pita Study||0||
48192170|NCT02068729|100793994|FG000|STARTED|Overall Study||131||
48192171|NCT02068729|100793994|FG000|COMPLETED|Overall Study||56||
48192172|NCT02068729|100793994|FG000|NOT COMPLETED|Overall Study||75||
48192173|NCT01097655|100793995|FG000|STARTED|Overall Study||3049||
48192174|NCT01097655|100793995|FG000|COMPLETED|Overall Study||3039||
48475033|NCT01806688|101499934|FG000|STARTED|Third Intervention Pita Study||0|Day 15|
48192175|NCT01097655|100793995|FG000|NOT COMPLETED|Overall Study||10||
48475034|NCT01806688|101499935|FG001|STARTED|Third Intervention Pita Study||38|Day 15|
48475035|NCT01806688|101499934|FG000|Experimental Snack #2|Third Intervention Pita Study||0||
48475036|NCT01806688|101499935|FG001|Experimental Snack #2|Third Intervention Pita Study||12||
48475037|NCT01806688|101499934|FG000|Placebo Comparator Reference Product #2|Third Intervention Pita Study||0||
48192176|NCT05343455|100793996|FG000|STARTED|Overall Study||123||
48475038|NCT01806688|101499935|FG001|Placebo Comparator Reference Product #2|Third Intervention Pita Study||13||
48475039|NCT01806688|101499934|FG000|Placebo Comparator Non-caloric Control #2|Third Intervention Pita Study||0||
48475040|NCT01806688|101499935|FG001|Placebo Comparator Non-caloric Control #2|Third Intervention Pita Study||13||
48475041|NCT01806688|101499934|FG000|COMPLETED|Third Intervention Pita Study||0||
48475042|NCT01806688|101499935|FG001|COMPLETED|Third Intervention Pita Study||38||
48475043|NCT01806688|101499934|FG000|NOT COMPLETED|Third Intervention Pita Study||0||
48475044|NCT01806688|101499935|FG001|NOT COMPLETED|Third Intervention Pita Study||0||
48475045|NCT01720264|101499936|FG000|STARTED|Transplant With Sitagliptin for 15 Days||15||
48475046|NCT01720264|101499936|FG000|COMPLETED|Transplant With Sitagliptin for 15 Days||14||
48475047|NCT01720264|101499936|FG000|NOT COMPLETED|Transplant With Sitagliptin for 15 Days||1||
48192177|NCT05343455|100793997|FG001|STARTED|Overall Study||125||
48192178|NCT05343455|100793998|FG002|STARTED|Overall Study||82||
48192179|NCT05343455|100793996|FG000|COMPLETED|Overall Study||115||
48192180|NCT05343455|100793997|FG001|COMPLETED|Overall Study||113||
48192181|NCT05343455|100793998|FG002|COMPLETED|Overall Study||68||
48192182|NCT05343455|100793996|FG000|NOT COMPLETED|Overall Study||8||
48192183|NCT05343455|100793997|FG001|NOT COMPLETED|Overall Study||12||
48192184|NCT05343455|100793998|FG002|NOT COMPLETED|Overall Study||14||
48192185|NCT03981549|100793999|FG000|STARTED|Overall Study||7||
48192186|NCT03981549|100794000|FG001|STARTED|Overall Study||9||
48192187|NCT03981549|100793999|FG000|COMPLETED|Overall Study||7||
48192188|NCT03981549|100794000|FG001|COMPLETED|Overall Study||9||
48192189|NCT03981549|100793999|FG000|NOT COMPLETED|Overall Study||0||
48192190|NCT03981549|100794000|FG001|NOT COMPLETED|Overall Study||0||
48192191|NCT02042443|100794001|FG000|STARTED|Overall Study||27||
48192192|NCT02042443|100794002|FG001|STARTED|Overall Study||26||
48192193|NCT02042443|100794001|FG000|Eligible and Analyzable|Overall Study||24||
48192194|NCT02042443|100794002|FG001|Eligible and Analyzable|Overall Study||20||
48192195|NCT02042443|100794001|FG000|COMPLETED|Overall Study||0||
48475048|NCT01720264|101499936|FG000|STARTED|Post-transplant (Day 16) to 1 Year||14||
48475049|NCT01720264|101499936|FG000|COMPLETED|Post-transplant (Day 16) to 1 Year||2||
48192196|NCT02042443|100794002|FG001|COMPLETED|Overall Study||0||
48192197|NCT02042443|100794001|FG000|NOT COMPLETED|Overall Study||27||
48192198|NCT02042443|100794002|FG001|NOT COMPLETED|Overall Study||26||
48475050|NCT01720264|101499936|FG000|NOT COMPLETED|Post-transplant (Day 16) to 1 Year||12||
48475051|NCT03185065|101499937|FG000|STARTED|Period 1 (6 Weeks)||35||
48192199|NCT00716079|100794003|FG000|STARTED|Overall Study||1403||
48192200|NCT00716079|100794004|FG001|STARTED|Overall Study||1436||
48475052|NCT03185065|101499938|FG001|STARTED|Period 1 (6 Weeks)||34||
48475053|NCT03185065|101499939|FG002|STARTED|Period 1 (6 Weeks)||35||
48475054|NCT03185065|101499940|FG003|STARTED|Period 1 (6 Weeks)||37||
48192201|NCT00716079|100794003|FG000|COMPLETED|Overall Study||1394||
48192202|NCT00716079|100794004|FG001|COMPLETED|Overall Study||1421||
48192203|NCT00716079|100794003|FG000|NOT COMPLETED|Overall Study||9||
48192204|NCT00716079|100794004|FG001|NOT COMPLETED|Overall Study||15||
48192205|NCT04887285|100794005|FG000|STARTED|Overall Study||48||
48192206|NCT04887285|100794006|FG001|STARTED|Overall Study||50||
48475055|NCT03185065|101499937|FG000|COMPLETED|Period 1 (6 Weeks)||32||
48475056|NCT03185065|101499938|FG001|COMPLETED|Period 1 (6 Weeks)||33||
48475057|NCT03185065|101499939|FG002|COMPLETED|Period 1 (6 Weeks)||32||
48475058|NCT03185065|101499940|FG003|COMPLETED|Period 1 (6 Weeks)||36||
48475059|NCT03185065|101499937|FG000|NOT COMPLETED|Period 1 (6 Weeks)||3||
48475060|NCT03185065|101499938|FG001|NOT COMPLETED|Period 1 (6 Weeks)||1||
48192207|NCT04887285|100794007|FG002|STARTED|Overall Study||48||
48192208|NCT04887285|100794005|FG000|COMPLETED|Overall Study||48||
48192209|NCT04887285|100794006|FG001|COMPLETED|Overall Study||48||
48192210|NCT04887285|100794007|FG002|COMPLETED|Overall Study||45||
48475061|NCT03185065|101499939|FG002|NOT COMPLETED|Period 1 (6 Weeks)||3||
48475062|NCT03185065|101499940|FG003|NOT COMPLETED|Period 1 (6 Weeks)||1||
48475063|NCT03185065|101499937|FG000|STARTED|Washout (2 Weeks)||32||
48475064|NCT03185065|101499938|FG001|STARTED|Washout (2 Weeks)||33||
48475065|NCT03185065|101499939|FG002|STARTED|Washout (2 Weeks)||32||
48475066|NCT03185065|101499940|FG003|STARTED|Washout (2 Weeks)||36||
48475067|NCT03185065|101499937|FG000|COMPLETED|Washout (2 Weeks)||32||
48192211|NCT04887285|100794005|FG000|NOT COMPLETED|Overall Study||0||
48192212|NCT04887285|100794006|FG001|NOT COMPLETED|Overall Study||2||
48192213|NCT04887285|100794007|FG002|NOT COMPLETED|Overall Study||3||
48192214|NCT01919619|100794008|FG000|STARTED|Overall Study||28||
48192215|NCT01919619|100794009|FG001|STARTED|Overall Study||13||
48192216|NCT01919619|100794008|FG000|COMPLETED|Overall Study||27||
48192217|NCT01919619|100794009|FG001|COMPLETED|Overall Study||12||
48192218|NCT01919619|100794008|FG000|NOT COMPLETED|Overall Study||1||
48192219|NCT01919619|100794009|FG001|NOT COMPLETED|Overall Study||1||
48192220|NCT05484726|100794010|FG000|STARTED|Overall Study||65||
48192221|NCT05484726|100794011|FG001|STARTED|Overall Study||65||
48192222|NCT05484726|100794010|FG000|Execution of Sensory Motor Stimulation|Overall Study||54|neonates were stable to start with oromotor stimulation followed by feeding.|
48192223|NCT05484726|100794011|FG001|Execution of Sensory Motor Stimulation|Overall Study||53|neonates were stable to start with oromotor stimulation followed by feeding.|
48192224|NCT05484726|100794010|FG000|COMPLETED|Overall Study||49||
48192225|NCT05484726|100794011|FG001|COMPLETED|Overall Study||48||
48192226|NCT05484726|100794010|FG000|NOT COMPLETED|Overall Study||16||
48192227|NCT05484726|100794011|FG001|NOT COMPLETED|Overall Study||17||
48192228|NCT04515797|100794012|FG000|STARTED|Overall Study||2||
48192229|NCT04515797|100794012|FG000|COMPLETED|Overall Study||2||
48192230|NCT04515797|100794012|FG000|NOT COMPLETED|Overall Study||0||
48192231|NCT04248829|100794013|FG000|STARTED|Overall Study||196||
48192232|NCT04248829|100794014|FG001|STARTED|Overall Study||197||
48192233|NCT04248829|100794013|FG000|COMPLETED|Overall Study||108|Participants ongoing study treatment at data cut-off|
48192234|NCT04248829|100794014|FG001|COMPLETED|Overall Study||47|Participants ongoing study treatment at data cut-off|
48192235|NCT04248829|100794013|FG000|NOT COMPLETED|Overall Study||88||
48192236|NCT04248829|100794014|FG001|NOT COMPLETED|Overall Study||150||
48192237|NCT03575962|100794015|FG000|STARTED|Treatment Period 1 (4 Days)||7||
48192238|NCT03575962|100794016|FG001|STARTED|Treatment Period 1 (4 Days)||7||
48192239|NCT03575962|100794015|FG000|COMPLETED|Treatment Period 1 (4 Days)||7||
48192240|NCT03575962|100794016|FG001|COMPLETED|Treatment Period 1 (4 Days)||7||
48192241|NCT03575962|100794015|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
48192242|NCT03575962|100794016|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
48192243|NCT03575962|100794015|FG000|STARTED|Washout Period (7 Days)||7||
48192244|NCT03575962|100794016|FG001|STARTED|Washout Period (7 Days)||7||
48192245|NCT03575962|100794015|FG000|COMPLETED|Washout Period (7 Days)||7||
48192246|NCT03575962|100794016|FG001|COMPLETED|Washout Period (7 Days)||7||
48192247|NCT03575962|100794015|FG000|NOT COMPLETED|Washout Period (7 Days)||0||
48192248|NCT03575962|100794016|FG001|NOT COMPLETED|Washout Period (7 Days)||0||
48192249|NCT03575962|100794015|FG000|STARTED|Treatment Period 2 (4 Days)||7||
48192250|NCT03575962|100794016|FG001|STARTED|Treatment Period 2 (4 Days)||7||
48192251|NCT03575962|100794015|FG000|COMPLETED|Treatment Period 2 (4 Days)||7||
48192252|NCT03575962|100794016|FG001|COMPLETED|Treatment Period 2 (4 Days)||7||
48192253|NCT03575962|100794015|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
48192254|NCT03575962|100794016|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
48192255|NCT05927480|100794017|FG000|STARTED|Overall Study||28||
48192256|NCT05927480|100794018|FG001|STARTED|Overall Study||26||
48192257|NCT05927480|100794017|FG000|COMPLETED|Overall Study||28||
48192258|NCT05927480|100794018|FG001|COMPLETED|Overall Study||26||
48192259|NCT05927480|100794017|FG000|NOT COMPLETED|Overall Study||0||
48192260|NCT05927480|100794018|FG001|NOT COMPLETED|Overall Study||0||
48192261|NCT01079598|100794019|FG000|STARTED|Overall Study||8||
48192262|NCT01079598|100794019|FG000|COMPLETED|Overall Study||8||
48192263|NCT01079598|100794019|FG000|NOT COMPLETED|Overall Study||0||
48192264|NCT03070392|100794020|FG000|STARTED|Overall Study||252||
48192265|NCT03070392|100794021|FG001|STARTED|Overall Study||7||
48192266|NCT03070392|100794022|FG002|STARTED|Overall Study||16||
48192267|NCT03070392|100794023|FG003|STARTED|Overall Study||103||
48192268|NCT03070392|100794020|FG000|COMPLETED|Overall Study||0||
48192269|NCT03070392|100794021|FG001|COMPLETED|Overall Study||0||
48192270|NCT03070392|100794022|FG002|COMPLETED|Overall Study||10||
48192271|NCT03070392|100794023|FG003|COMPLETED|Overall Study||0||
48192272|NCT03070392|100794020|FG000|NOT COMPLETED|Overall Study||252||
48192273|NCT03070392|100794021|FG001|NOT COMPLETED|Overall Study||7||
48192274|NCT03070392|100794022|FG002|NOT COMPLETED|Overall Study||6||
48192275|NCT03070392|100794023|FG003|NOT COMPLETED|Overall Study||103||
48192276|NCT03507309|100794024|FG000|STARTED|Overall Study||257948||
48192277|NCT03507309|100794024|FG000|COMPLETED|Overall Study||257948||
48192278|NCT03507309|100794024|FG000|NOT COMPLETED|Overall Study||0||
48192279|NCT02820051|100794025|FG000|STARTED|Overall Study||49||
48192280|NCT02820051|100794026|FG001|STARTED|Overall Study||53||
48192281|NCT02820051|100794025|FG000|COMPLETED|Overall Study||42||
48192282|NCT02820051|100794026|FG001|COMPLETED|Overall Study||49||
48192283|NCT02820051|100794025|FG000|NOT COMPLETED|Overall Study||7||
48192284|NCT02820051|100794026|FG001|NOT COMPLETED|Overall Study||4||
48192285|NCT04889118|100794027|FG000|STARTED|Overall Study||64||
48192286|NCT04889118|100794028|FG001|STARTED|Overall Study||67||
48192287|NCT04889118|100794027|FG000|COMPLETED|Overall Study||0||
48192288|NCT04889118|100794028|FG001|COMPLETED|Overall Study||0||
48192289|NCT04889118|100794027|FG000|NOT COMPLETED|Overall Study||64||
48192290|NCT04889118|100794028|FG001|NOT COMPLETED|Overall Study||67||
48192291|NCT00483262|100794029|FG000|STARTED|Overall Study||20||
48192292|NCT00483262|100794030|FG001|STARTED|Overall Study||43||
48192293|NCT00483262|100794029|FG000|COMPLETED|Overall Study||20||
48192294|NCT00483262|100794030|FG001|COMPLETED|Overall Study||43||
48192295|NCT00483262|100794029|FG000|NOT COMPLETED|Overall Study||0||
48192296|NCT00483262|100794030|FG001|NOT COMPLETED|Overall Study||0||
48192297|NCT01304706|100794031|FG000|STARTED|Overall Study||121||
48192298|NCT01304706|100794031|FG000|COMPLETED|Overall Study||104||
48192299|NCT01304706|100794031|FG000|NOT COMPLETED|Overall Study||17||
48192300|NCT04974489|100794032|FG000|STARTED|Overall Study||285|Participants included in the sample sent from the panel provider to the study team.|
48192301|NCT04974489|100794033|FG001|STARTED|Overall Study||274|Participants included in the sample sent from the panel provider to the study team.|
48192302|NCT04974489|100794034|FG002|STARTED|Overall Study||288|Participants included in the sample sent from the panel provider to the study team.|
48192303|NCT04974489|100794035|FG003|STARTED|Overall Study||285|Participants included in the sample sent from the panel provider to the study team.|
48192304|NCT04974489|100794032|FG000|COMPLETED|Overall Study||262||
48192305|NCT04974489|100794033|FG001|COMPLETED|Overall Study||261||
48192306|NCT04974489|100794034|FG002|COMPLETED|Overall Study||263||
48192307|NCT04974489|100794035|FG003|COMPLETED|Overall Study||267||
48192308|NCT04974489|100794032|FG000|NOT COMPLETED|Overall Study||23||
48192309|NCT04974489|100794033|FG001|NOT COMPLETED|Overall Study||13||
48192310|NCT04974489|100794034|FG002|NOT COMPLETED|Overall Study||25||
48192311|NCT04974489|100794035|FG003|NOT COMPLETED|Overall Study||18||
48192312|NCT05310084|100794036|FG000|STARTED|Overall Study||568||
48192313|NCT05310084|100794037|FG001|STARTED|Overall Study||566||
48192314|NCT05310084|100794036|FG000|Vaccinated|Overall Study||564||
48192315|NCT05310084|100794037|FG001|Vaccinated|Overall Study||564||
48192316|NCT05310084|100794036|FG000|COMPLETED|Overall Study||560||
48192317|NCT05310084|100794037|FG001|COMPLETED|Overall Study||555||
48192318|NCT05310084|100794036|FG000|NOT COMPLETED|Overall Study||8||
48192319|NCT05310084|100794037|FG001|NOT COMPLETED|Overall Study||11||
48475068|NCT03185065|101499938|FG001|COMPLETED|Washout (2 Weeks)||31||
48192320|NCT03111095|100794038|FG000|STARTED|Aim 1: Feasibility and Satisfaction||55||
48192321|NCT03111095|100794039|FG001|STARTED|Aim 1: Feasibility and Satisfaction||0||
48192322|NCT03111095|100794038|FG000|Eligible Participants|Aim 1: Feasibility and Satisfaction||263||
48192323|NCT03111095|100794039|FG001|Eligible Participants|Aim 1: Feasibility and Satisfaction||0||
48192324|NCT03111095|100794038|FG000|Participants Agreed to be Approached for Study|Aim 1: Feasibility and Satisfaction||124||
48192325|NCT03111095|100794039|FG001|Participants Agreed to be Approached for Study|Aim 1: Feasibility and Satisfaction||0||
48192326|NCT03111095|100794038|FG000|Consented to Study|Aim 1: Feasibility and Satisfaction||55||
48192327|NCT03111095|100794039|FG001|Consented to Study|Aim 1: Feasibility and Satisfaction||0||
48192328|NCT03111095|100794038|FG000|COMPLETED|Aim 1: Feasibility and Satisfaction||52||
48192329|NCT03111095|100794039|FG001|COMPLETED|Aim 1: Feasibility and Satisfaction||0||
48192330|NCT03111095|100794038|FG000|NOT COMPLETED|Aim 1: Feasibility and Satisfaction||3||
48192331|NCT03111095|100794039|FG001|NOT COMPLETED|Aim 1: Feasibility and Satisfaction||0||
48192332|NCT03111095|100794038|FG000|STARTED|Aims 2-5: Intervention||214|Aim 1 participants are included in the 214 participants enrolled and analyzed in Aims 2-5.|
48192333|NCT03111095|100794039|FG001|STARTED|Aims 2-5: Intervention||214|Aim 1 participants are included in the 214 participants enrolled and analyzed in Aims 2-5.|
48370760|NCT02677896|101234954|FG001|STARTED|Open-Label Extension (up to 25 Months)||180||
48475069|NCT03185065|101499939|FG002|COMPLETED|Washout (2 Weeks)||32||
48370761|NCT02677896|101234953|FG000|COMPLETED|Open-Label Extension (up to 25 Months)||0||
48370762|NCT02677896|101234954|FG001|COMPLETED|Open-Label Extension (up to 25 Months)||0||
48370763|NCT02677896|101234953|FG000|NOT COMPLETED|Open-Label Extension (up to 25 Months)||365||
48370764|NCT02677896|101234954|FG001|NOT COMPLETED|Open-Label Extension (up to 25 Months)||180||
48475070|NCT03185065|101499940|FG003|COMPLETED|Washout (2 Weeks)||35||
48475071|NCT03185065|101499937|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
48475072|NCT03185065|101499938|FG001|NOT COMPLETED|Washout (2 Weeks)||2||
48475073|NCT03185065|101499939|FG002|NOT COMPLETED|Washout (2 Weeks)||0||
48475074|NCT03185065|101499940|FG003|NOT COMPLETED|Washout (2 Weeks)||1||
48475075|NCT03185065|101499937|FG000|STARTED|Period 2 (6 Weeks)||32||
48475076|NCT03185065|101499938|FG001|STARTED|Period 2 (6 Weeks)||31||
48475077|NCT03185065|101499939|FG002|STARTED|Period 2 (6 Weeks)||32||
48475078|NCT03185065|101499940|FG003|STARTED|Period 2 (6 Weeks)||35||
48475079|NCT03185065|101499937|FG000|COMPLETED|Period 2 (6 Weeks)||32||
48475080|NCT03185065|101499938|FG001|COMPLETED|Period 2 (6 Weeks)||31||
48475081|NCT03185065|101499939|FG002|COMPLETED|Period 2 (6 Weeks)||32||
48475082|NCT03185065|101499940|FG003|COMPLETED|Period 2 (6 Weeks)||34||
48475083|NCT03185065|101499937|FG000|NOT COMPLETED|Period 2 (6 Weeks)||0||
48475084|NCT03185065|101499938|FG001|NOT COMPLETED|Period 2 (6 Weeks)||0||
48475085|NCT03185065|101499939|FG002|NOT COMPLETED|Period 2 (6 Weeks)||0||
48475086|NCT03185065|101499940|FG003|NOT COMPLETED|Period 2 (6 Weeks)||1||
48475087|NCT03185065|101499937|FG000|STARTED|Washout (2 Weeks)||32||
48475088|NCT03185065|101499938|FG001|STARTED|Washout (2 Weeks)||31||
48475089|NCT03185065|101499939|FG002|STARTED|Washout (2 Weeks)||32||
48475090|NCT03185065|101499940|FG003|STARTED|Washout (2 Weeks)||34||
48475091|NCT03185065|101499937|FG000|COMPLETED|Washout (2 Weeks)||31||
48475092|NCT03185065|101499938|FG001|COMPLETED|Washout (2 Weeks)||29||
48475093|NCT03185065|101499939|FG002|COMPLETED|Washout (2 Weeks)||31||
48475094|NCT03185065|101499940|FG003|COMPLETED|Washout (2 Weeks)||32||
48475095|NCT03185065|101499937|FG000|NOT COMPLETED|Washout (2 Weeks)||1||
48475096|NCT03185065|101499938|FG001|NOT COMPLETED|Washout (2 Weeks)||2||
48475097|NCT03185065|101499939|FG002|NOT COMPLETED|Washout (2 Weeks)||1||
48475098|NCT03185065|101499940|FG003|NOT COMPLETED|Washout (2 Weeks)||2||
48475099|NCT03185065|101499937|FG000|STARTED|Period 3 (6 Weeks)||31||
48475100|NCT03185065|101499938|FG001|STARTED|Period 3 (6 Weeks)||29||
48475101|NCT03185065|101499939|FG002|STARTED|Period 3 (6 Weeks)||31||
48475102|NCT03185065|101499940|FG003|STARTED|Period 3 (6 Weeks)||32||
48475103|NCT03185065|101499937|FG000|COMPLETED|Period 3 (6 Weeks)||31||
48475104|NCT03185065|101499938|FG001|COMPLETED|Period 3 (6 Weeks)||29||
48475105|NCT03185065|101499939|FG002|COMPLETED|Period 3 (6 Weeks)||29||
48475106|NCT03185065|101499940|FG003|COMPLETED|Period 3 (6 Weeks)||32||
48475107|NCT03185065|101499937|FG000|NOT COMPLETED|Period 3 (6 Weeks)||0||
48475108|NCT03185065|101499938|FG001|NOT COMPLETED|Period 3 (6 Weeks)||0||
48475109|NCT03185065|101499939|FG002|NOT COMPLETED|Period 3 (6 Weeks)||2||
48475110|NCT03185065|101499940|FG003|NOT COMPLETED|Period 3 (6 Weeks)||0||
48475111|NCT03185065|101499937|FG000|STARTED|Washout (2 Weeks)||31||
48475112|NCT03185065|101499938|FG001|STARTED|Washout (2 Weeks)||29||
48475113|NCT03185065|101499939|FG002|STARTED|Washout (2 Weeks)||29||
48475114|NCT03185065|101499940|FG003|STARTED|Washout (2 Weeks)||32||
48475115|NCT03185065|101499937|FG000|COMPLETED|Washout (2 Weeks)||31||
48475116|NCT03185065|101499938|FG001|COMPLETED|Washout (2 Weeks)||28||
48475117|NCT03185065|101499939|FG002|COMPLETED|Washout (2 Weeks)||27||
48475118|NCT03185065|101499940|FG003|COMPLETED|Washout (2 Weeks)||32||
48475119|NCT03185065|101499937|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
48475120|NCT03185065|101499938|FG001|NOT COMPLETED|Washout (2 Weeks)||1||
48475121|NCT03185065|101499939|FG002|NOT COMPLETED|Washout (2 Weeks)||2||
48475122|NCT03185065|101499940|FG003|NOT COMPLETED|Washout (2 Weeks)||0||
48475123|NCT03185065|101499937|FG000|STARTED|Period 4 (6 Weeks)||31||
48475124|NCT03185065|101499938|FG001|STARTED|Period 4 (6 Weeks)||28||
48475125|NCT03185065|101499939|FG002|STARTED|Period 4 (6 Weeks)||27||
48475126|NCT03185065|101499940|FG003|STARTED|Period 4 (6 Weeks)||32||
48475127|NCT03185065|101499937|FG000|COMPLETED|Period 4 (6 Weeks)||31||
48475128|NCT03185065|101499938|FG001|COMPLETED|Period 4 (6 Weeks)||27||
48475129|NCT03185065|101499939|FG002|COMPLETED|Period 4 (6 Weeks)||26||
48475130|NCT03185065|101499940|FG003|COMPLETED|Period 4 (6 Weeks)||31||
48475131|NCT03185065|101499937|FG000|NOT COMPLETED|Period 4 (6 Weeks)||0||
48475132|NCT03185065|101499938|FG001|NOT COMPLETED|Period 4 (6 Weeks)||1||
48475133|NCT03185065|101499939|FG002|NOT COMPLETED|Period 4 (6 Weeks)||1||
48475134|NCT03185065|101499940|FG003|NOT COMPLETED|Period 4 (6 Weeks)||1||
48475135|NCT01626079|101499941|FG000|STARTED|Overall Study||302||
48475136|NCT01626079|101499942|FG001|STARTED|Overall Study||312||
48475137|NCT01626079|101499943|FG002|STARTED|Overall Study||162||
48475138|NCT01626079|101499941|FG000|COMPLETED|Overall Study||104||
48475139|NCT01626079|101499942|FG001|COMPLETED|Overall Study||75||
48475140|NCT01626079|101499943|FG002|COMPLETED|Overall Study||110||
48475141|NCT01626079|101499941|FG000|NOT COMPLETED|Overall Study||198||
48475142|NCT01626079|101499942|FG001|NOT COMPLETED|Overall Study||237||
48475143|NCT01626079|101499943|FG002|NOT COMPLETED|Overall Study||52||
48475144|NCT01494506|101499944|FG000|STARTED|Overall Study||151||
48475145|NCT01494506|101499945|FG001|STARTED|Overall Study||149||
48475146|NCT01494506|101499946|FG002|STARTED|Overall Study||117||
48475147|NCT01494506|101499944|FG000|Treated Population|Overall Study||147||
48475148|NCT01494506|101499945|FG001|Treated Population|Overall Study||134||
48475149|NCT01494506|101499946|FG002|Treated Population|Overall Study||117||
48475150|NCT01494506|101499944|FG000|COMPLETED|Overall Study||3||
48475151|NCT01494506|101499945|FG001|COMPLETED|Overall Study||6||
48475152|NCT01494506|101499946|FG002|COMPLETED|Overall Study||14||
48475153|NCT01494506|101499944|FG000|NOT COMPLETED|Overall Study||148||
48475154|NCT01494506|101499945|FG001|NOT COMPLETED|Overall Study||143||
48475155|NCT01494506|101499946|FG002|NOT COMPLETED|Overall Study||103||
48475156|NCT00553280|101499947|FG000|STARTED|Overall Study||123||
48475157|NCT00553280|101499947|FG000|COMPLETED|Overall Study||97||
48475158|NCT00553280|101499947|FG000|NOT COMPLETED|Overall Study||26||
48475159|NCT00264797|101499948|FG000|STARTED|Overall Study||151||
48475160|NCT00264797|101499949|FG001|STARTED|Overall Study||152||
48475161|NCT00264797|101499948|FG000|COMPLETED|Overall Study||118||
48475162|NCT00264797|101499949|FG001|COMPLETED|Overall Study||109||
48475163|NCT00264797|101499948|FG000|NOT COMPLETED|Overall Study||33||
48475164|NCT00264797|101499949|FG001|NOT COMPLETED|Overall Study||43||
48475165|NCT00583700|101499950|FG000|STARTED|Overall Study||27||
48475166|NCT00583700|101499951|FG001|STARTED|Overall Study||27||
48475167|NCT00583700|101499950|FG000|COMPLETED|Overall Study||24||
48475168|NCT00583700|101499951|FG001|COMPLETED|Overall Study||23||
48475169|NCT00583700|101499950|FG000|NOT COMPLETED|Overall Study||3||
48475170|NCT00583700|101499951|FG001|NOT COMPLETED|Overall Study||4||
48192334|NCT03111095|100794038|FG000|Number Analyzed|Aims 2-5: Intervention||214||
48192335|NCT03111095|100794039|FG001|Number Analyzed|Aims 2-5: Intervention||214||
48475171|NCT02433678|101499952|FG000|STARTED|Overall Study||26||
48475172|NCT02433678|101499953|FG001|STARTED|Overall Study||26||
48475173|NCT02433678|101499952|FG000|COMPLETED|Overall Study||25||
48475174|NCT02433678|101499953|FG001|COMPLETED|Overall Study||24||
48475175|NCT02433678|101499952|FG000|NOT COMPLETED|Overall Study||1||
48475176|NCT02433678|101499953|FG001|NOT COMPLETED|Overall Study||2||
48475177|NCT02170688|101499954|FG000|STARTED|Overall Study||29||
48475178|NCT02170688|101499955|FG001|STARTED|Overall Study||29||
48475179|NCT02170688|101499956|FG002|STARTED|Overall Study||29||
48475180|NCT02170688|101499957|FG003|STARTED|Overall Study||27||
48475181|NCT02170688|101499958|FG004|STARTED|Overall Study||25||
48475182|NCT02170688|101499954|FG000|COMPLETED|Overall Study||25||
48192336|NCT03111095|100794038|FG000|COMPLETED|Aims 2-5: Intervention||195||
48192337|NCT03111095|100794039|FG001|COMPLETED|Aims 2-5: Intervention||214||
48192338|NCT03111095|100794038|FG000|NOT COMPLETED|Aims 2-5: Intervention||19||
48192339|NCT03111095|100794039|FG001|NOT COMPLETED|Aims 2-5: Intervention||0||
48192340|NCT01106287|100794040|FG000|STARTED|Overall Study||4||
48192341|NCT01106287|100794041|FG001|STARTED|Overall Study||3||
48192342|NCT01106287|100794042|FG002|STARTED|Overall Study||3||
48192343|NCT01106287|100794043|FG003|STARTED|Overall Study||3||
48192344|NCT01106287|100794040|FG000|COMPLETED|Overall Study||3||
48192345|NCT01106287|100794041|FG001|COMPLETED|Overall Study||3||
48192346|NCT01106287|100794042|FG002|COMPLETED|Overall Study||3||
48192347|NCT01106287|100794043|FG003|COMPLETED|Overall Study||3||
48192348|NCT01106287|100794040|FG000|NOT COMPLETED|Overall Study||1||
48192349|NCT01106287|100794041|FG001|NOT COMPLETED|Overall Study||0||
48192350|NCT01106287|100794042|FG002|NOT COMPLETED|Overall Study||0||
48475183|NCT02170688|101499955|FG001|COMPLETED|Overall Study||26||
48475184|NCT02170688|101499956|FG002|COMPLETED|Overall Study||25||
48475185|NCT02170688|101499957|FG003|COMPLETED|Overall Study||25||
48475186|NCT02170688|101499958|FG004|COMPLETED|Overall Study||25||
48475187|NCT02170688|101499954|FG000|NOT COMPLETED|Overall Study||4||
48475188|NCT02170688|101499955|FG001|NOT COMPLETED|Overall Study||3||
48475189|NCT02170688|101499956|FG002|NOT COMPLETED|Overall Study||4||
48475190|NCT02170688|101499957|FG003|NOT COMPLETED|Overall Study||2||
48475191|NCT02170688|101499958|FG004|NOT COMPLETED|Overall Study||0||
48475192|NCT03831048|101499959|FG000|STARTED|Overall Study||90||
48475193|NCT03831048|101499960|FG001|STARTED|Overall Study||90||
48475194|NCT03831048|101499959|FG000|Per Protocol Population|Overall Study||80||
48475195|NCT03831048|101499960|FG001|Per Protocol Population|Overall Study||86||
48475196|NCT03831048|101499959|FG000|COMPLETED|Overall Study||76||
48475197|NCT03831048|101499960|FG001|COMPLETED|Overall Study||75||
48475198|NCT03831048|101499959|FG000|NOT COMPLETED|Overall Study||14||
48475199|NCT03831048|101499960|FG001|NOT COMPLETED|Overall Study||15||
48475200|NCT02115646|101499961|FG000|STARTED|Overall Study||29||
48475201|NCT02115646|101499961|FG000|COMPLETED|Overall Study||22||
48475202|NCT02115646|101499961|FG000|NOT COMPLETED|Overall Study||7||
48475203|NCT01666730|101499962|FG000|STARTED|Overall Study||50||
48475204|NCT01666730|101499962|FG000|COMPLETED|Overall Study||0||
48475205|NCT01666730|101499962|FG000|NOT COMPLETED|Overall Study||50||
48475206|NCT01171690|101499963|FG000|STARTED|Overall Study||5||
48475207|NCT01171690|101499964|FG001|STARTED|Overall Study||5||
48475208|NCT01171690|101499963|FG000|COMPLETED|Overall Study||5||
48475209|NCT01171690|101499964|FG001|COMPLETED|Overall Study||5||
48475210|NCT01171690|101499963|FG000|NOT COMPLETED|Overall Study||0||
48475211|NCT01171690|101499964|FG001|NOT COMPLETED|Overall Study||0||
48475212|NCT04276883|101499965|FG000|STARTED|Overall Study||127||
48475213|NCT04276883|101499966|FG001|STARTED|Overall Study||127||
48475214|NCT04276883|101499967|FG002|STARTED|Overall Study||126||
48475215|NCT04276883|101499965|FG000|COMPLETED|Overall Study||123||
48475216|NCT04276883|101499966|FG001|COMPLETED|Overall Study||119||
48475217|NCT04276883|101499967|FG002|COMPLETED|Overall Study||120||
48475218|NCT04276883|101499965|FG000|NOT COMPLETED|Overall Study||4||
48475219|NCT04276883|101499966|FG001|NOT COMPLETED|Overall Study||8||
48475220|NCT04276883|101499967|FG002|NOT COMPLETED|Overall Study||6||
48475221|NCT00872079|101499968|FG000|STARTED|Overall Study||175||
48475222|NCT00872079|101499968|FG000|COMPLETED|Overall Study||175||
48475223|NCT00872079|101499968|FG000|NOT COMPLETED|Overall Study||0||
48475224|NCT01045096|101499969|FG000|STARTED|Overall Study||12||
48475225|NCT01045096|101499970|FG001|STARTED|Overall Study||12||
48475226|NCT01045096|101499971|FG002|STARTED|Overall Study||12||
48475227|NCT01045096|101499969|FG000|Pharmacokinetic Set|Overall Study||9||
48192351|NCT01106287|100794043|FG003|NOT COMPLETED|Overall Study||0||
48192352|NCT04318444|100794044|FG000|STARTED|Overall Study||4||
48192353|NCT04318444|100794045|FG001|STARTED|Overall Study||4||
48192354|NCT04318444|100794044|FG000|COMPLETED|Overall Study||4||
48192355|NCT04318444|100794045|FG001|COMPLETED|Overall Study||4||
48192356|NCT04318444|100794044|FG000|NOT COMPLETED|Overall Study||0||
48192357|NCT04318444|100794045|FG001|NOT COMPLETED|Overall Study||0||
48192358|NCT01779375|100794046|FG000|STARTED|Overall Study||47||
48192359|NCT01779375|100794047|FG001|STARTED|Overall Study||44||
48192360|NCT01779375|100794046|FG000|COMPLETED|Overall Study||45||
48192361|NCT01779375|100794047|FG001|COMPLETED|Overall Study||41||
48192362|NCT01779375|100794046|FG000|NOT COMPLETED|Overall Study||2||
48192363|NCT01779375|100794047|FG001|NOT COMPLETED|Overall Study||3||
48192364|NCT04531540|100794048|FG000|STARTED|Overall Study||225||
48192365|NCT04531540|100794048|FG000|Treated|Overall Study||222||
48192366|NCT04531540|100794048|FG000|COMPLETED|Overall Study||216||
48192367|NCT04531540|100794048|FG000|NOT COMPLETED|Overall Study||9||
48192368|NCT04866407|100794049|FG000|STARTED|Overall Study||4||
48192369|NCT04866407|100794050|FG001|STARTED|Overall Study||4||
48192370|NCT04866407|100794049|FG000|COMPLETED|Overall Study||4||
48192371|NCT04866407|100794050|FG001|COMPLETED|Overall Study||4||
48192372|NCT04866407|100794049|FG000|NOT COMPLETED|Overall Study||0||
48192373|NCT04866407|100794050|FG001|NOT COMPLETED|Overall Study||0||
48192374|NCT05176353|100794051|FG000|STARTED|Overall Study||4205||
48192375|NCT05176353|100794052|FG001|STARTED|Overall Study||687||
48192376|NCT05176353|100794051|FG000|COMPLETED|Overall Study||4205||
48192377|NCT05176353|100794052|FG001|COMPLETED|Overall Study||687||
48192378|NCT05176353|100794051|FG000|NOT COMPLETED|Overall Study||0||
48192379|NCT05176353|100794052|FG001|NOT COMPLETED|Overall Study||0||
48192380|NCT06268301|100794053|FG000|STARTED|Period 1||10||
48192381|NCT06268301|100794054|FG001|STARTED|Period 1||10||
48475228|NCT01045096|101499970|FG001|Pharmacokinetic Set|Overall Study||11||
48475229|NCT01045096|101499971|FG002|Pharmacokinetic Set|Overall Study||11||
48475230|NCT01045096|101499969|FG000|COMPLETED|Overall Study||9||
48475231|NCT01045096|101499970|FG001|COMPLETED|Overall Study||12||
48475232|NCT01045096|101499971|FG002|COMPLETED|Overall Study||12||
48475233|NCT01045096|101499969|FG000|NOT COMPLETED|Overall Study||3||
48475234|NCT01045096|101499970|FG001|NOT COMPLETED|Overall Study||0||
48192382|NCT06268301|100794053|FG000|COMPLETED|Period 1||10||
48192383|NCT06268301|100794054|FG001|COMPLETED|Period 1||10||
48192384|NCT06268301|100794053|FG000|NOT COMPLETED|Period 1||0||
48192385|NCT06268301|100794054|FG001|NOT COMPLETED|Period 1||0||
48192386|NCT06268301|100794053|FG000|STARTED|Period 2||10||
48192387|NCT06268301|100794054|FG001|STARTED|Period 2||10||
48475235|NCT01045096|101499971|FG002|NOT COMPLETED|Overall Study||0||
48475236|NCT00448175|101499972|FG000|STARTED|12 Weeks PTNS vs. Drug||50||
48475237|NCT00448175|101499973|FG001|STARTED|12 Weeks PTNS vs. Drug||50||
48475238|NCT00448175|101499972|FG000|COMPLETED|12 Weeks PTNS vs. Drug||41||
48475239|NCT00448175|101499973|FG001|COMPLETED|12 Weeks PTNS vs. Drug||43||
48475240|NCT00448175|101499972|FG000|NOT COMPLETED|12 Weeks PTNS vs. Drug||9||
48475241|NCT00448175|101499973|FG001|NOT COMPLETED|12 Weeks PTNS vs. Drug||7||
48475242|NCT00448175|101499972|FG000|STARTED|Continued PTNS Through 12 Months||35||
48475243|NCT00448175|101499973|FG001|STARTED|Continued PTNS Through 12 Months||0||
48475244|NCT00448175|101499972|FG000|COMPLETED|Continued PTNS Through 12 Months||25||
48475245|NCT00448175|101499973|FG001|COMPLETED|Continued PTNS Through 12 Months||0||
48475246|NCT00448175|101499972|FG000|NOT COMPLETED|Continued PTNS Through 12 Months||10||
48475247|NCT00448175|101499973|FG001|NOT COMPLETED|Continued PTNS Through 12 Months||0||
48475248|NCT03538587|101499974|FG000|STARTED|Overall Study||4||
48475249|NCT03538587|101499975|FG001|STARTED|Overall Study||6||
48192388|NCT06268301|100794053|FG000|COMPLETED|Period 2||10||
48192389|NCT06268301|100794054|FG001|COMPLETED|Period 2||10||
48475250|NCT03538587|101499974|FG000|Child Participants|Overall Study||2||
48475251|NCT03538587|101499975|FG001|Child Participants|Overall Study||3||
48475252|NCT03538587|101499974|FG000|Parent Participants|Overall Study||2||
48475253|NCT03538587|101499975|FG001|Parent Participants|Overall Study||3||
48475254|NCT03538587|101499974|FG000|COMPLETED|Overall Study||2||
48475255|NCT03538587|101499975|FG001|COMPLETED|Overall Study||2||
48475256|NCT03538587|101499974|FG000|NOT COMPLETED|Overall Study||2||
48475257|NCT03538587|101499975|FG001|NOT COMPLETED|Overall Study||4||
48475258|NCT01669538|101499976|FG000|STARTED|Overall Study||40||
48475259|NCT01669538|101499977|FG001|STARTED|Overall Study||42||
48475260|NCT01669538|101499976|FG000|COMPLETED|Overall Study||28||
48475261|NCT01669538|101499977|FG001|COMPLETED|Overall Study||33||
48475262|NCT01669538|101499976|FG000|NOT COMPLETED|Overall Study||12||
48475263|NCT01669538|101499977|FG001|NOT COMPLETED|Overall Study||9||
48475264|NCT02051309|101499978|FG000|STARTED|Overall Study||58||
48475265|NCT02051309|101499979|FG001|STARTED|Overall Study||63||
48475266|NCT02051309|101499978|FG000|COMPLETED|Overall Study||26||
48475267|NCT02051309|101499979|FG001|COMPLETED|Overall Study||35||
48475268|NCT02051309|101499978|FG000|NOT COMPLETED|Overall Study||32||
48475269|NCT02051309|101499979|FG001|NOT COMPLETED|Overall Study||28||
48475270|NCT00998023|101499980|FG000|STARTED|Overall Study||32||
48475271|NCT00998023|101499981|FG001|STARTED|Overall Study||32||
48475272|NCT00998023|101499980|FG000|COMPLETED|Overall Study||32||
48475273|NCT00998023|101499981|FG001|COMPLETED|Overall Study||32||
48475274|NCT00998023|101499980|FG000|NOT COMPLETED|Overall Study||0||
48475275|NCT00998023|101499981|FG001|NOT COMPLETED|Overall Study||0||
48475276|NCT03187678|101499982|FG000|STARTED|Period 1 (Oral Selexipag)||20||
48475277|NCT03187678|101499982|FG000|COMPLETED|Period 1 (Oral Selexipag)||20||
48475278|NCT03187678|101499982|FG000|NOT COMPLETED|Period 1 (Oral Selexipag)||0||
48475279|NCT03187678|101499982|FG000|STARTED|Period 2 (Intravenous Selexipag)||20||
48475280|NCT03187678|101499982|FG000|COMPLETED|Period 2 (Intravenous Selexipag)||20||
48475281|NCT03187678|101499982|FG000|NOT COMPLETED|Period 2 (Intravenous Selexipag)||0||
48475282|NCT03187678|101499982|FG000|STARTED|Period 3 (Oral Selexipag)||20||
48475283|NCT03187678|101499982|FG000|COMPLETED|Period 3 (Oral Selexipag)||20||
48475284|NCT03187678|101499982|FG000|NOT COMPLETED|Period 3 (Oral Selexipag)||0||
48475285|NCT02696070|101499983|FG000|STARTED|Overall Study||8||
48475286|NCT02696070|101499984|FG001|STARTED|Overall Study||14||
48475287|NCT02696070|101499983|FG000|COMPLETED|Overall Study||7||
48475288|NCT02696070|101499984|FG001|COMPLETED|Overall Study||12||
48475289|NCT02696070|101499983|FG000|NOT COMPLETED|Overall Study||1||
48475290|NCT02696070|101499984|FG001|NOT COMPLETED|Overall Study||2||
48475291|NCT00683293|101499985|FG000|STARTED|Overall Study||50||
48475292|NCT00683293|101499986|FG001|STARTED|Overall Study||50||
48475293|NCT00683293|101499985|FG000|COMPLETED|Overall Study||48||
48475294|NCT00683293|101499986|FG001|COMPLETED|Overall Study||47||
48475295|NCT00683293|101499985|FG000|NOT COMPLETED|Overall Study||2||
48475296|NCT00683293|101499986|FG001|NOT COMPLETED|Overall Study||3||
48475297|NCT05097326|101499987|FG000|STARTED|Overall Study||15||
48475298|NCT05097326|101499988|FG001|STARTED|Overall Study||15||
48475299|NCT05097326|101499987|FG000|Received Medication|Overall Study||14||
48475300|NCT05097326|101499988|FG001|Received Medication|Overall Study||15||
48475301|NCT05097326|101499987|FG000|COMPLETED|Overall Study||14||
48475302|NCT05097326|101499988|FG001|COMPLETED|Overall Study||15||
48475303|NCT05097326|101499987|FG000|NOT COMPLETED|Overall Study||1||
48192390|NCT06268301|100794053|FG000|NOT COMPLETED|Period 2||0||
48192391|NCT06268301|100794054|FG001|NOT COMPLETED|Period 2||0||
48192392|NCT03199469|100794055|FG000|STARTED|Overall Study||7||
48192393|NCT03199469|100794056|FG001|STARTED|Overall Study||20||
48192394|NCT03199469|100794055|FG000|Delayed Treatment Control (DTC) Group|Overall Study||1||
48475304|NCT05097326|101499988|FG001|NOT COMPLETED|Overall Study||0||
48192395|NCT03199469|100794056|FG001|Delayed Treatment Control (DTC) Group|Overall Study||6||
48192396|NCT03199469|100794055|FG000|Immediate Treatment Group|Overall Study||6||
48192397|NCT03199469|100794056|FG001|Immediate Treatment Group|Overall Study||14||
48192398|NCT03199469|100794055|FG000|COMPLETED|Overall Study||0||
48192399|NCT03199469|100794056|FG001|COMPLETED|Overall Study||0||
48192400|NCT03199469|100794055|FG000|NOT COMPLETED|Overall Study||7||
48192401|NCT03199469|100794056|FG001|NOT COMPLETED|Overall Study||20||
48192402|NCT04736056|100794057|FG000|STARTED|Overall Study||14||
48475305|NCT03889756|101499989|FG000|STARTED|Overall Study||1||
48475306|NCT03889756|101499990|FG001|STARTED|Overall Study||2||
48475307|NCT03889756|101499989|FG000|COMPLETED|Overall Study||1||
48475308|NCT03889756|101499990|FG001|COMPLETED|Overall Study||2||
48475309|NCT03889756|101499989|FG000|NOT COMPLETED|Overall Study||0||
48475310|NCT03889756|101499990|FG001|NOT COMPLETED|Overall Study||0||
48475311|NCT01391793|101499991|FG000|STARTED|Overall Study||271|Randomized to the treatment group|
48475312|NCT01391793|101499992|FG001|STARTED|Overall Study||275|Randomized to the treatment group|
48475313|NCT01391793|101499991|FG000|Had a Positive Urine Culture|Overall Study||197||
48475314|NCT01391793|101499992|FG001|Had a Positive Urine Culture|Overall Study||188||
48475315|NCT01391793|101499991|FG000|COMPLETED|Overall Study||124|Had an outcome Dimercaptosuccinic Acid (DMSA) renal scan 5-24 months from enrollment|
48475316|NCT01391793|101499992|FG001|COMPLETED|Overall Study||131|Had an outcome Dimercaptosuccinic Acid (DMSA) renal scan 5-24 months from enrollment|
48475317|NCT01391793|101499991|FG000|NOT COMPLETED|Overall Study||147||
48475318|NCT01391793|101499992|FG001|NOT COMPLETED|Overall Study||144||
48192403|NCT04736056|100794058|FG001|STARTED|Overall Study||6||
48192404|NCT04736056|100794059|FG002|STARTED|Overall Study||5||
48192405|NCT04736056|100794060|FG003|STARTED|Overall Study||32||
48192406|NCT04736056|100794057|FG000|COMPLETED|Overall Study||10||
48192407|NCT04736056|100794058|FG001|COMPLETED|Overall Study||6||
48192408|NCT04736056|100794059|FG002|COMPLETED|Overall Study||3||
48475319|NCT00708019|101499993|FG000|STARTED|Overall Study||92||
48475320|NCT00708019|101499994|FG001|STARTED|Overall Study||93||
48475321|NCT00708019|101499993|FG000|COMPLETED|Overall Study||77||
48192409|NCT04736056|100794060|FG003|COMPLETED|Overall Study||30||
48192410|NCT04736056|100794057|FG000|NOT COMPLETED|Overall Study||4||
48192411|NCT04736056|100794058|FG001|NOT COMPLETED|Overall Study||0||
48192412|NCT04736056|100794059|FG002|NOT COMPLETED|Overall Study||2||
48192413|NCT04736056|100794060|FG003|NOT COMPLETED|Overall Study||2||
48192414|NCT02929108|100794061|FG000|STARTED|Overall Study||122||
48192415|NCT02929108|100794062|FG001|STARTED|Overall Study||75||
48192416|NCT02929108|100794063|FG002|STARTED|Overall Study||39||
48192417|NCT02929108|100794064|FG003|STARTED|Overall Study||60||
48192418|NCT02929108|100794065|FG004|STARTED|Overall Study||73||
48192419|NCT02929108|100794066|FG005|STARTED|Overall Study||32||
48192420|NCT02929108|100794067|FG006|STARTED|Overall Study||88||
48192421|NCT02929108|100794061|FG000|Facebook|Overall Study||94||
48192422|NCT02929108|100794062|FG001|Facebook|Overall Study||0||
48192423|NCT02929108|100794063|FG002|Facebook|Overall Study||0||
48192424|NCT02929108|100794064|FG003|Facebook|Overall Study||11||
48192425|NCT02929108|100794065|FG004|Facebook|Overall Study||57||
48192426|NCT02929108|100794066|FG005|Facebook|Overall Study||10||
48192427|NCT02929108|100794067|FG006|Facebook|Overall Study||42||
48192428|NCT02929108|100794061|FG000|Access|Overall Study||28|Although the hospice site was assigned Facebook and Enhanced Usual Care, there were 5 caregivers that did receive the intervention of Access.|
48192429|NCT02929108|100794062|FG001|Access|Overall Study||47|Although the hospice site was assigned Facebook and Enhanced Usual Care, there were 5 caregivers that did receive the intervention of Access.|
48192430|NCT02929108|100794063|FG002|Access|Overall Study||23|Although the hospice site was assigned Facebook and Enhanced Usual Care, there were 5 caregivers that did receive the intervention of Access.|
48192431|NCT02929108|100794064|FG003|Access|Overall Study||0|Although the hospice site was assigned Facebook and Enhanced Usual Care, there were 5 caregivers that did receive the intervention of Access.|
48192432|NCT02929108|100794065|FG004|Access|Overall Study||5|Although the hospice site was assigned Facebook and Enhanced Usual Care, there were 5 caregivers that did receive the intervention of Access.|
48192433|NCT02929108|100794066|FG005|Access|Overall Study||0|Although the hospice site was assigned Facebook and Enhanced Usual Care, there were 5 caregivers that did receive the intervention of Access.|
48475322|NCT00708019|101499994|FG001|COMPLETED|Overall Study||78||
48475323|NCT00708019|101499993|FG000|NOT COMPLETED|Overall Study||15||
48475324|NCT00708019|101499994|FG001|NOT COMPLETED|Overall Study||15||
48475325|NCT02472522|101499995|FG000|STARTED|Overall Study||50||
48475326|NCT02472522|101499996|FG001|STARTED|Overall Study||50||
48475327|NCT02472522|101499995|FG000|COMPLETED|Overall Study||50||
48475328|NCT02472522|101499996|FG001|COMPLETED|Overall Study||50||
48475329|NCT02472522|101499995|FG000|NOT COMPLETED|Overall Study||0||
48475330|NCT02472522|101499996|FG001|NOT COMPLETED|Overall Study||0||
48475331|NCT02684578|101499997|FG000|STARTED|Overall Study||32||53
48475332|NCT02684578|101499998|FG001|STARTED|Overall Study||34||57
48475333|NCT02684578|101499997|FG000|COMPLETED|Overall Study||21||34
48475334|NCT02684578|101499998|FG001|COMPLETED|Overall Study||23||37
48475335|NCT02684578|101499997|FG000|NOT COMPLETED|Overall Study||11||19
48475336|NCT02684578|101499998|FG001|NOT COMPLETED|Overall Study||11||20
48475337|NCT02796664|101499999|FG000|STARTED|Overall Study||29||
48475338|NCT02796664|101500000|FG001|STARTED|Overall Study||29||
48475339|NCT02796664|101499999|FG000|COMPLETED|Overall Study||28||
48475340|NCT02796664|101500000|FG001|COMPLETED|Overall Study||24||
48475341|NCT02796664|101499999|FG000|NOT COMPLETED|Overall Study||1||
48475342|NCT02796664|101500000|FG001|NOT COMPLETED|Overall Study||5||
48475343|NCT00770510|101500001|FG000|STARTED|Overall Study||72||
48475344|NCT00770510|101500001|FG000|COMPLETED|Overall Study||67||
48475345|NCT00770510|101500001|FG000|NOT COMPLETED|Overall Study||5||
48475346|NCT00762307|101500002|FG000|STARTED|Overall Study||28||
48475347|NCT00762307|101500003|FG001|STARTED|Overall Study||11||
48475348|NCT00762307|101500004|FG002|STARTED|Overall Study||11||
48475349|NCT00762307|101500005|FG003|STARTED|Overall Study||10||
48475350|NCT00762307|101500002|FG000|COMPLETED|Overall Study||26||
48475351|NCT00762307|101500003|FG001|COMPLETED|Overall Study||11||
48475352|NCT00762307|101500004|FG002|COMPLETED|Overall Study||11||
48475353|NCT00762307|101500005|FG003|COMPLETED|Overall Study||9||
48475354|NCT00762307|101500002|FG000|NOT COMPLETED|Overall Study||2||
48475355|NCT00762307|101500003|FG001|NOT COMPLETED|Overall Study||0||
48475356|NCT00762307|101500004|FG002|NOT COMPLETED|Overall Study||0||
48475357|NCT00762307|101500005|FG003|NOT COMPLETED|Overall Study||1||
48475358|NCT01287013|101500006|FG000|STARTED|Overall Study||32||
48475359|NCT01287013|101500007|FG001|STARTED|Overall Study||34||
48475360|NCT01287013|101500008|FG002|STARTED|Overall Study||21||
48475361|NCT01287013|101500006|FG000|COMPLETED|Overall Study||29||
48475362|NCT01287013|101500007|FG001|COMPLETED|Overall Study||29||
48475363|NCT01287013|101500008|FG002|COMPLETED|Overall Study||0||
48475364|NCT01287013|101500006|FG000|NOT COMPLETED|Overall Study||3||
48475365|NCT01287013|101500007|FG001|NOT COMPLETED|Overall Study||5||
48475366|NCT01287013|101500008|FG002|NOT COMPLETED|Overall Study||21||
48475367|NCT00620763|101500009|FG000|STARTED|Period: First Intervention||10||
48475368|NCT00620763|101500010|FG001|STARTED|Period: First Intervention||12||
48475369|NCT00620763|101500009|FG000|COMPLETED|Period: First Intervention||10||
48475370|NCT00620763|101500010|FG001|COMPLETED|Period: First Intervention||7||
48475371|NCT00620763|101500009|FG000|NOT COMPLETED|Period: First Intervention||0||
48475372|NCT00620763|101500010|FG001|NOT COMPLETED|Period: First Intervention||5||
48475373|NCT00620763|101500009|FG000|STARTED|Period: Washout Period of 1 Week||10||
48475374|NCT00620763|101500010|FG001|STARTED|Period: Washout Period of 1 Week||7||
48475375|NCT00620763|101500009|FG000|COMPLETED|Period: Washout Period of 1 Week||10||
48475376|NCT00620763|101500010|FG001|COMPLETED|Period: Washout Period of 1 Week||7||
48475377|NCT00620763|101500009|FG000|NOT COMPLETED|Period: Washout Period of 1 Week||0||
48475378|NCT00620763|101500010|FG001|NOT COMPLETED|Period: Washout Period of 1 Week||0||
48475379|NCT00620763|101500009|FG000|STARTED|Period: Second Intervention||10||
48475380|NCT00620763|101500010|FG001|STARTED|Period: Second Intervention||7||
48475381|NCT00620763|101500009|FG000|COMPLETED|Period: Second Intervention||9||
48475382|NCT00620763|101500010|FG001|COMPLETED|Period: Second Intervention||7||
48475383|NCT00620763|101500009|FG000|NOT COMPLETED|Period: Second Intervention||1||
48475384|NCT00620763|101500010|FG001|NOT COMPLETED|Period: Second Intervention||0||
48475385|NCT00365300|101500011|FG000|STARTED|Open-label Phase||129||
48475386|NCT00365300|101500012|FG001|STARTED|Open-label Phase||0||
48475387|NCT00365300|101500011|FG000|COMPLETED|Open-label Phase||107||
48475388|NCT00365300|101500012|FG001|COMPLETED|Open-label Phase||0||
48192434|NCT02929108|100794067|FG006|Access|Overall Study||46|Although the hospice site was assigned Facebook and Enhanced Usual Care, there were 5 caregivers that did receive the intervention of Access.|
48192435|NCT02929108|100794061|FG000|Enhanced Usual Care|Overall Study||0||
48192436|NCT02929108|100794062|FG001|Enhanced Usual Care|Overall Study||28||
48192437|NCT02929108|100794063|FG002|Enhanced Usual Care|Overall Study||16||
48192438|NCT02929108|100794064|FG003|Enhanced Usual Care|Overall Study||49||
48192439|NCT02929108|100794065|FG004|Enhanced Usual Care|Overall Study||11||
48192440|NCT02929108|100794066|FG005|Enhanced Usual Care|Overall Study||22||
48192441|NCT02929108|100794067|FG006|Enhanced Usual Care|Overall Study||0||
48192442|NCT02929108|100794061|FG000|COMPLETED|Overall Study||22||
48192443|NCT02929108|100794062|FG001|COMPLETED|Overall Study||11||
48192444|NCT02929108|100794063|FG002|COMPLETED|Overall Study||11||
48475389|NCT00365300|101500011|FG000|NOT COMPLETED|Open-label Phase||22||
48475390|NCT00365300|101500012|FG001|NOT COMPLETED|Open-label Phase||0||
48475391|NCT00365300|101500011|FG000|STARTED|Double-blind Phase||54||
48475392|NCT00365300|101500012|FG001|STARTED|Double-blind Phase||54||
48475393|NCT00365300|101500011|FG000|COMPLETED|Double-blind Phase||43||
48475394|NCT00365300|101500012|FG001|COMPLETED|Double-blind Phase||45||
48192445|NCT02929108|100794064|FG003|COMPLETED|Overall Study||14||
48192446|NCT02929108|100794065|FG004|COMPLETED|Overall Study||18||
48192447|NCT02929108|100794066|FG005|COMPLETED|Overall Study||4||
48192448|NCT02929108|100794067|FG006|COMPLETED|Overall Study||10||
48192449|NCT02929108|100794061|FG000|NOT COMPLETED|Overall Study||100||
48192450|NCT02929108|100794062|FG001|NOT COMPLETED|Overall Study||64||
48192451|NCT02929108|100794063|FG002|NOT COMPLETED|Overall Study||28||
48192452|NCT02929108|100794064|FG003|NOT COMPLETED|Overall Study||46||
48192453|NCT02929108|100794065|FG004|NOT COMPLETED|Overall Study||55||
48192454|NCT02929108|100794066|FG005|NOT COMPLETED|Overall Study||28||
48192455|NCT02929108|100794067|FG006|NOT COMPLETED|Overall Study||78||
48192456|NCT02812966|100794068|FG000|STARTED|Overall Study||18||
48475395|NCT00365300|101500011|FG000|NOT COMPLETED|Double-blind Phase||11||
48475396|NCT00365300|101500012|FG001|NOT COMPLETED|Double-blind Phase||9||
48475397|NCT01581970|101500013|FG000|STARTED|Overall Study||7||
48475398|NCT01581970|101500013|FG000|COMPLETED|Overall Study||7||
48475399|NCT01581970|101500013|FG000|NOT COMPLETED|Overall Study||0||
48475400|NCT03897088|101500014|FG000|STARTED|Overall Study||114||
48475401|NCT03897088|101500015|FG001|STARTED|Overall Study||117||
48475402|NCT03897088|101500014|FG000|COMPLETED|Overall Study||88||
48192457|NCT02812966|100794069|FG001|STARTED|Overall Study||17||
48475403|NCT03897088|101500015|FG001|COMPLETED|Overall Study||86||
48475404|NCT03897088|101500014|FG000|NOT COMPLETED|Overall Study||26||
48475405|NCT03897088|101500015|FG001|NOT COMPLETED|Overall Study||31||
48475406|NCT00733330|101500016|FG000|STARTED|Overall Study||32||
48475407|NCT00733330|101500017|FG001|STARTED|Overall Study||52||
48475408|NCT00733330|101500016|FG000|COMPLETED|Overall Study||30||
48475409|NCT00733330|101500017|FG001|COMPLETED|Overall Study||48||
48475410|NCT00733330|101500016|FG000|NOT COMPLETED|Overall Study||2||
48192458|NCT02812966|100794068|FG000|COMPLETED|Overall Study||17||
48192459|NCT02812966|100794069|FG001|COMPLETED|Overall Study||17||
48192460|NCT02812966|100794068|FG000|NOT COMPLETED|Overall Study||1||
48192461|NCT02812966|100794069|FG001|NOT COMPLETED|Overall Study||0||
48192462|NCT04771273|100794070|FG000|STARTED|Dose Escalation Period||73|Randomised|
48192463|NCT04771273|100794071|FG001|STARTED|Dose Escalation Period||73|Randomised|
48475411|NCT00733330|101500017|FG001|NOT COMPLETED|Overall Study||4||
48475412|NCT02430870|101500018|FG000|STARTED|Part 1||6||
48475413|NCT02430870|101500019|FG001|STARTED|Part 1||6||
48475414|NCT02430870|101500020|FG002|STARTED|Part 1||4||
48475415|NCT02430870|101500021|FG003|STARTED|Part 1||0||
48475416|NCT02430870|101500022|FG004|STARTED|Part 1||0||
48475417|NCT02430870|101500023|FG005|STARTED|Part 1||0||
48475418|NCT02430870|101500024|FG006|STARTED|Part 1||0||
48475419|NCT02430870|101500025|FG007|STARTED|Part 1||0||
48192464|NCT04771273|100794072|FG002|STARTED|Dose Escalation Period||75|Randomised|
48192465|NCT04771273|100794073|FG003|STARTED|Dose Escalation Period||74|Randomised|
48192466|NCT04771273|100794070|FG000|Treated With Trial Medication|Dose Escalation Period||73||
48192467|NCT04771273|100794071|FG001|Treated With Trial Medication|Dose Escalation Period||72||
48475420|NCT02430870|101500018|FG000|COMPLETED|Part 1||6||
48475421|NCT02430870|101500019|FG001|COMPLETED|Part 1||6||
48475422|NCT02430870|101500020|FG002|COMPLETED|Part 1||4||
48475423|NCT02430870|101500021|FG003|COMPLETED|Part 1||0||
48475424|NCT02430870|101500022|FG004|COMPLETED|Part 1||0||
48475425|NCT02430870|101500023|FG005|COMPLETED|Part 1||0||
48475426|NCT02430870|101500024|FG006|COMPLETED|Part 1||0||
48192468|NCT04771273|100794072|FG002|Treated With Trial Medication|Dose Escalation Period||74||
48192469|NCT04771273|100794073|FG003|Treated With Trial Medication|Dose Escalation Period||74||
48192470|NCT04771273|100794070|FG000|COMPLETED|Dose Escalation Period||62|Completed treatment with trial medication|
48192471|NCT04771273|100794071|FG001|COMPLETED|Dose Escalation Period||63|Completed treatment with trial medication|
48475427|NCT02430870|101500025|FG007|COMPLETED|Part 1||0||
48475428|NCT02430870|101500018|FG000|NOT COMPLETED|Part 1||0||
48475429|NCT02430870|101500019|FG001|NOT COMPLETED|Part 1||0||
48475430|NCT02430870|101500020|FG002|NOT COMPLETED|Part 1||0||
48475431|NCT02430870|101500021|FG003|NOT COMPLETED|Part 1||0||
48475432|NCT02430870|101500022|FG004|NOT COMPLETED|Part 1||0||
48475433|NCT02430870|101500023|FG005|NOT COMPLETED|Part 1||0||
48475434|NCT02430870|101500024|FG006|NOT COMPLETED|Part 1||0||
48475435|NCT02430870|101500025|FG007|NOT COMPLETED|Part 1||0||
48475436|NCT02430870|101500018|FG000|STARTED|Part 2||0||
48475437|NCT02430870|101500019|FG001|STARTED|Part 2||0||
48475438|NCT02430870|101500020|FG002|STARTED|Part 2||0||
48475439|NCT02430870|101500021|FG003|STARTED|Part 2||6||
48475440|NCT02430870|101500022|FG004|STARTED|Part 2||6||
48475441|NCT02430870|101500023|FG005|STARTED|Part 2||6||
48475442|NCT02430870|101500024|FG006|STARTED|Part 2||6||
48475443|NCT02430870|101500025|FG007|STARTED|Part 2||8||
48475444|NCT02430870|101500018|FG000|COMPLETED|Part 2||0||
48475445|NCT02430870|101500019|FG001|COMPLETED|Part 2||0||
48475446|NCT02430870|101500020|FG002|COMPLETED|Part 2||0||
48475447|NCT02430870|101500021|FG003|COMPLETED|Part 2||6||
48475448|NCT02430870|101500022|FG004|COMPLETED|Part 2||6||
48475449|NCT02430870|101500023|FG005|COMPLETED|Part 2||6||
48475450|NCT02430870|101500024|FG006|COMPLETED|Part 2||5||
48475451|NCT02430870|101500025|FG007|COMPLETED|Part 2||7||
48475452|NCT02430870|101500018|FG000|NOT COMPLETED|Part 2||0||
48475453|NCT02430870|101500019|FG001|NOT COMPLETED|Part 2||0||
48475454|NCT02430870|101500020|FG002|NOT COMPLETED|Part 2||0||
48475455|NCT02430870|101500021|FG003|NOT COMPLETED|Part 2||0||
48475456|NCT02430870|101500022|FG004|NOT COMPLETED|Part 2||0||
48475457|NCT02430870|101500023|FG005|NOT COMPLETED|Part 2||0||
48475458|NCT02430870|101500024|FG006|NOT COMPLETED|Part 2||1||
48475459|NCT02430870|101500025|FG007|NOT COMPLETED|Part 2||1||
48475460|NCT03338972|101500026|FG000|STARTED|Overall Study||7||
48475461|NCT03338972|101500027|FG001|STARTED|Overall Study||8||
48475462|NCT03338972|101500028|FG002|STARTED|Overall Study||7||
48475463|NCT03338972|101500029|FG003|STARTED|Overall Study||3||
48475464|NCT03338972|101500026|FG000|COMPLETED|Overall Study||5||
48475465|NCT03338972|101500027|FG001|COMPLETED|Overall Study||7||
48475466|NCT03338972|101500028|FG002|COMPLETED|Overall Study||7||
48475467|NCT03338972|101500029|FG003|COMPLETED|Overall Study||3||
48475468|NCT03338972|101500026|FG000|NOT COMPLETED|Overall Study||2||
48475469|NCT03338972|101500027|FG001|NOT COMPLETED|Overall Study||1||
48475470|NCT03338972|101500028|FG002|NOT COMPLETED|Overall Study||0||
48475471|NCT03338972|101500029|FG003|NOT COMPLETED|Overall Study||0||
48475472|NCT00643578|101500030|FG000|STARTED|Overall Study||6||
48475473|NCT00643578|101500031|FG001|STARTED|Overall Study||6||
48475474|NCT00643578|101500030|FG000|COMPLETED|Overall Study||4||
48475475|NCT00643578|101500031|FG001|COMPLETED|Overall Study||6||
48475476|NCT00643578|101500030|FG000|NOT COMPLETED|Overall Study||2||
48475477|NCT00643578|101500031|FG001|NOT COMPLETED|Overall Study||0||
48475478|NCT01014728|101500032|FG000|STARTED|Overall Study||18||
48475479|NCT01014728|101500033|FG001|STARTED|Overall Study||15||
48475480|NCT01014728|101500032|FG000|COMPLETED|Overall Study||18||
48475481|NCT01014728|101500033|FG001|COMPLETED|Overall Study||15||
48475482|NCT01014728|101500032|FG000|NOT COMPLETED|Overall Study||0||
48475483|NCT01014728|101500033|FG001|NOT COMPLETED|Overall Study||0||
48475484|NCT00406848|101500034|FG000|STARTED|Overall Study||249||
48475485|NCT00406848|101500035|FG001|STARTED|Overall Study||121||
48475486|NCT00406848|101500034|FG000|COMPLETED|Overall Study||156||
48475487|NCT00406848|101500035|FG001|COMPLETED|Overall Study||67||
48475488|NCT00406848|101500034|FG000|NOT COMPLETED|Overall Study||93||
48475489|NCT00406848|101500035|FG001|NOT COMPLETED|Overall Study||54||
48475490|NCT02298322|101500036|FG000|STARTED|Overall Study||60||
48475491|NCT02298322|101500036|FG000|COMPLETED|Overall Study||60||
48475492|NCT02298322|101500036|FG000|NOT COMPLETED|Overall Study||0||
48475493|NCT04448678|101500037|FG000|STARTED|Overall Study||45||
48475494|NCT04448678|101500038|FG001|STARTED|Overall Study||41||
48475495|NCT04448678|101500037|FG000|COMPLETED|Overall Study||25||
48475496|NCT04448678|101500038|FG001|COMPLETED|Overall Study||39||
48475497|NCT04448678|101500037|FG000|NOT COMPLETED|Overall Study||20||
48475498|NCT04448678|101500038|FG001|NOT COMPLETED|Overall Study||2||
48475499|NCT01551095|101500039|FG000|STARTED|Overall Study||7||
48475500|NCT01551095|101500039|FG000|COMPLETED|Overall Study||7||
48475501|NCT01551095|101500039|FG000|NOT COMPLETED|Overall Study||0||
48475502|NCT01451762|101500040|FG000|STARTED|Overall Study||30||
48475503|NCT01451762|101500041|FG001|STARTED|Overall Study||30||
48475504|NCT01451762|101500042|FG002|STARTED|Overall Study||30||
48475505|NCT01451762|101500040|FG000|COMPLETED|Overall Study||27||
48475506|NCT01451762|101500041|FG001|COMPLETED|Overall Study||24||
48475507|NCT01451762|101500042|FG002|COMPLETED|Overall Study||24||
48475508|NCT01451762|101500040|FG000|NOT COMPLETED|Overall Study||3||
48475509|NCT01451762|101500041|FG001|NOT COMPLETED|Overall Study||6||
48475510|NCT01451762|101500042|FG002|NOT COMPLETED|Overall Study||6||
48475511|NCT02352298|101500043|FG000|STARTED|Overall Study||52||
48475512|NCT02352298|101500043|FG000|COMPLETED|Overall Study||52||
48475513|NCT02352298|101500043|FG000|NOT COMPLETED|Overall Study||0||
48475514|NCT03830164|101500044|FG000|STARTED|Overall Study||5||
48475515|NCT03830164|101500045|FG001|STARTED|Overall Study||8||
48475516|NCT03830164|101500046|FG002|STARTED|Overall Study||1||
48475517|NCT03830164|101500044|FG000|COMPLETED|Overall Study||3||
48475518|NCT03830164|101500045|FG001|COMPLETED|Overall Study||0||
48475519|NCT03830164|101500046|FG002|COMPLETED|Overall Study||1||
48475520|NCT03830164|101500044|FG000|NOT COMPLETED|Overall Study||2||
48475521|NCT03830164|101500045|FG001|NOT COMPLETED|Overall Study||8||
48475522|NCT03830164|101500046|FG002|NOT COMPLETED|Overall Study||0||
48475523|NCT00929500|101500047|FG000|STARTED|Overall Study||8||
48475524|NCT00929500|101500048|FG001|STARTED|Overall Study||4||
48475525|NCT00929500|101500047|FG000|COMPLETED|Overall Study||4||
48475526|NCT00929500|101500048|FG001|COMPLETED|Overall Study||4||
48475527|NCT00929500|101500047|FG000|NOT COMPLETED|Overall Study||4||
48475528|NCT00929500|101500048|FG001|NOT COMPLETED|Overall Study||0||
48475529|NCT01327963|101500049|FG000|STARTED|Overall Study||110||
48475530|NCT01327963|101500049|FG000|COMPLETED|Overall Study||110||
48475531|NCT01327963|101500049|FG000|NOT COMPLETED|Overall Study||0||
48475532|NCT05593965|101500050|FG000|STARTED|1st Intervention (1 Day)||17||
48475533|NCT05593965|101500051|FG001|STARTED|1st Intervention (1 Day)||7||
48475534|NCT05593965|101500050|FG000|COMPLETED|1st Intervention (1 Day)||16||
48475535|NCT05593965|101500051|FG001|COMPLETED|1st Intervention (1 Day)||7||
48475536|NCT05593965|101500050|FG000|NOT COMPLETED|1st Intervention (1 Day)||1||
48475537|NCT05593965|101500051|FG001|NOT COMPLETED|1st Intervention (1 Day)||0||
48475538|NCT05593965|101500050|FG000|STARTED|2nd Intervention (1 Day)||16||
48475539|NCT05593965|101500051|FG001|STARTED|2nd Intervention (1 Day)||7||
48475540|NCT05593965|101500050|FG000|COMPLETED|2nd Intervention (1 Day)||16||
48475541|NCT05593965|101500051|FG001|COMPLETED|2nd Intervention (1 Day)||7||
48475542|NCT05593965|101500050|FG000|NOT COMPLETED|2nd Intervention (1 Day)||0||
48475543|NCT05593965|101500051|FG001|NOT COMPLETED|2nd Intervention (1 Day)||0||
48475544|NCT02216071|101500052|FG000|STARTED|Overall Study||254||
48475545|NCT02216071|101500053|FG001|STARTED|Overall Study||245||
48475546|NCT02216071|101500052|FG000|COMPLETED|Overall Study||239||
48475547|NCT02216071|101500053|FG001|COMPLETED|Overall Study||233||
48475548|NCT02216071|101500052|FG000|NOT COMPLETED|Overall Study||15||
48475549|NCT02216071|101500053|FG001|NOT COMPLETED|Overall Study||12||
48475550|NCT02017964|101500054|FG000|STARTED|Overall Study||26||
48475551|NCT02017964|101500054|FG000|COMPLETED|Overall Study||25||
48475552|NCT02017964|101500054|FG000|NOT COMPLETED|Overall Study||1||
48475553|NCT01492400|101500055|FG000|STARTED|Overall Study||181||
48475554|NCT01492400|101500056|FG001|STARTED|Overall Study||182||
48475555|NCT01492400|101500055|FG000|COMPLETED|Overall Study||165||
48475556|NCT01492400|101500056|FG001|COMPLETED|Overall Study||166||
48475557|NCT01492400|101500055|FG000|NOT COMPLETED|Overall Study||16||
48475558|NCT01492400|101500056|FG001|NOT COMPLETED|Overall Study||16||
48475559|NCT02395822|101500057|FG000|STARTED|Overall Study||17||
48475560|NCT02395822|101500057|FG000|COMPLETED|Overall Study||15||
48475561|NCT02395822|101500057|FG000|NOT COMPLETED|Overall Study||2||
48475562|NCT04506866|101500058|FG000|STARTED|Overall Study||68||
48475563|NCT04506866|101500059|FG001|STARTED|Overall Study||53||
48475564|NCT04506866|101500060|FG002|STARTED|Overall Study||27||
48475565|NCT04506866|101500058|FG000|COMPLETED|Overall Study||67||
48475566|NCT04506866|101500059|FG001|COMPLETED|Overall Study||52||
48475567|NCT04506866|101500060|FG002|COMPLETED|Overall Study||25||
48475568|NCT04506866|101500058|FG000|NOT COMPLETED|Overall Study||1||
48475569|NCT04506866|101500059|FG001|NOT COMPLETED|Overall Study||1||
48475570|NCT04506866|101500060|FG002|NOT COMPLETED|Overall Study||2||
48475571|NCT02178722|101500061|FG000|STARTED|Overall Study||4||
48475572|NCT02178722|101500062|FG001|STARTED|Overall Study||20||
48475573|NCT02178722|101500063|FG002|STARTED|Overall Study||18||
48475574|NCT02178722|101500064|FG003|STARTED|Overall Study||20||
48475575|NCT02178722|101500065|FG004|STARTED|Overall Study||382||
48475576|NCT02178722|101500061|FG000|COMPLETED|Overall Study||0||
48475577|NCT02178722|101500062|FG001|COMPLETED|Overall Study||0||
48475578|NCT02178722|101500063|FG002|COMPLETED|Overall Study||0||
48475579|NCT02178722|101500064|FG003|COMPLETED|Overall Study||0||
48475580|NCT02178722|101500065|FG004|COMPLETED|Overall Study||0||
48475581|NCT02178722|101500061|FG000|NOT COMPLETED|Overall Study||4||
48475582|NCT02178722|101500062|FG001|NOT COMPLETED|Overall Study||20||
48475583|NCT02178722|101500063|FG002|NOT COMPLETED|Overall Study||18||
48475584|NCT02178722|101500064|FG003|NOT COMPLETED|Overall Study||20||
48475585|NCT02178722|101500065|FG004|NOT COMPLETED|Overall Study||382||
48475586|NCT00569374|101500066|FG000|STARTED|Overall Study||8||
48475587|NCT00569374|101500066|FG000|COMPLETED|Overall Study||4||
48475588|NCT00569374|101500066|FG000|NOT COMPLETED|Overall Study||4||
48475589|NCT00813293|101500067|FG000|STARTED|Overall Study||10||
48475590|NCT00813293|101500068|FG001|STARTED|Overall Study||10||
48475591|NCT00813293|101500067|FG000|Started Treatment|Overall Study||9||
48475592|NCT00813293|101500068|FG001|Started Treatment|Overall Study||10||
48475593|NCT00813293|101500067|FG000|Evaluable RFA|Overall Study||7||
48475594|NCT00813293|101500068|FG001|Evaluable RFA|Overall Study||8||
48475595|NCT00813293|101500067|FG000|COMPLETED|Overall Study||9||
48475596|NCT00813293|101500068|FG001|COMPLETED|Overall Study||9||
48475597|NCT00813293|101500067|FG000|NOT COMPLETED|Overall Study||1||
48475598|NCT00813293|101500068|FG001|NOT COMPLETED|Overall Study||1||
48475599|NCT00982553|101500069|FG000|STARTED|Phase1||14||
48475600|NCT00982553|101500069|FG000|COMPLETED|Phase1||14||
48475601|NCT00982553|101500069|FG000|NOT COMPLETED|Phase1||0||
48475602|NCT00982553|101500069|FG000|STARTED|Phase2||14||
48475603|NCT00982553|101500069|FG000|COMPLETED|Phase2||14||
48475604|NCT00982553|101500069|FG000|NOT COMPLETED|Phase2||0||
48475605|NCT00982553|101500069|FG000|STARTED|Phase3||14||
48475606|NCT00982553|101500069|FG000|COMPLETED|Phase3||14||
48475607|NCT00982553|101500069|FG000|NOT COMPLETED|Phase3||0||
48475608|NCT01273181|101500070|FG000|STARTED|Phase I, Dose 1||3||
48475609|NCT01273181|101500071|FG001|STARTED|Phase I, Dose 1||0||
48475610|NCT01273181|101500072|FG002|STARTED|Phase I, Dose 1||0||
48475611|NCT01273181|101500073|FG003|STARTED|Phase I, Dose 1||0||
48475612|NCT01273181|101500070|FG000|COMPLETED|Phase I, Dose 1||2||
48475613|NCT01273181|101500071|FG001|COMPLETED|Phase I, Dose 1||0||
48475614|NCT01273181|101500072|FG002|COMPLETED|Phase I, Dose 1||0||
48475615|NCT01273181|101500073|FG003|COMPLETED|Phase I, Dose 1||0||
48475616|NCT01273181|101500070|FG000|NOT COMPLETED|Phase I, Dose 1||1||
48475617|NCT01273181|101500071|FG001|NOT COMPLETED|Phase I, Dose 1||0||
48475618|NCT01273181|101500072|FG002|NOT COMPLETED|Phase I, Dose 1||0||
48475619|NCT01273181|101500073|FG003|NOT COMPLETED|Phase I, Dose 1||0||
48475620|NCT01273181|101500070|FG000|STARTED|Phase I, Dose 2||0||
48192472|NCT04771273|100794072|FG002|COMPLETED|Dose Escalation Period||57|Completed treatment with trial medication|
48475621|NCT01273181|101500071|FG001|STARTED|Phase I, Dose 2||3||
48475622|NCT01273181|101500072|FG002|STARTED|Phase I, Dose 2||0||
48475623|NCT01273181|101500073|FG003|STARTED|Phase I, Dose 2||0||
48475624|NCT01273181|101500070|FG000|COMPLETED|Phase I, Dose 2||0||
48475625|NCT01273181|101500071|FG001|COMPLETED|Phase I, Dose 2||2||
48475626|NCT01273181|101500072|FG002|COMPLETED|Phase I, Dose 2||0||
48475627|NCT01273181|101500073|FG003|COMPLETED|Phase I, Dose 2||0||
48475628|NCT01273181|101500070|FG000|NOT COMPLETED|Phase I, Dose 2||0||
48475629|NCT01273181|101500071|FG001|NOT COMPLETED|Phase I, Dose 2||1||
48475630|NCT01273181|101500072|FG002|NOT COMPLETED|Phase I, Dose 2||0||
48475631|NCT01273181|101500073|FG003|NOT COMPLETED|Phase I, Dose 2||0||
48475632|NCT01273181|101500070|FG000|STARTED|Phase 2, Dose 1||0||
48475633|NCT01273181|101500071|FG001|STARTED|Phase 2, Dose 1||0||
48475634|NCT01273181|101500072|FG002|STARTED|Phase 2, Dose 1||2||
48475635|NCT01273181|101500073|FG003|STARTED|Phase 2, Dose 1||0||
48475636|NCT01273181|101500070|FG000|COMPLETED|Phase 2, Dose 1||0||
48475637|NCT01273181|101500071|FG001|COMPLETED|Phase 2, Dose 1||0||
48475638|NCT01273181|101500072|FG002|COMPLETED|Phase 2, Dose 1||1||
48475639|NCT01273181|101500073|FG003|COMPLETED|Phase 2, Dose 1||0||
48475640|NCT01273181|101500070|FG000|NOT COMPLETED|Phase 2, Dose 1||0||
48475641|NCT01273181|101500071|FG001|NOT COMPLETED|Phase 2, Dose 1||0||
48475642|NCT01273181|101500072|FG002|NOT COMPLETED|Phase 2, Dose 1||1||
48475643|NCT01273181|101500073|FG003|NOT COMPLETED|Phase 2, Dose 1||0||
48475644|NCT01273181|101500070|FG000|STARTED|Phase 2, Dose 2||0||
48475645|NCT01273181|101500071|FG001|STARTED|Phase 2, Dose 2||0||
48475646|NCT01273181|101500072|FG002|STARTED|Phase 2, Dose 2||0||
48475647|NCT01273181|101500073|FG003|STARTED|Phase 2, Dose 2||1||
48475648|NCT01273181|101500070|FG000|COMPLETED|Phase 2, Dose 2||0||
48475649|NCT01273181|101500071|FG001|COMPLETED|Phase 2, Dose 2||0||
48475650|NCT01273181|101500072|FG002|COMPLETED|Phase 2, Dose 2||0||
48475651|NCT01273181|101500073|FG003|COMPLETED|Phase 2, Dose 2||0||
48475652|NCT01273181|101500070|FG000|NOT COMPLETED|Phase 2, Dose 2||0||
48475653|NCT01273181|101500071|FG001|NOT COMPLETED|Phase 2, Dose 2||0||
48475654|NCT01273181|101500072|FG002|NOT COMPLETED|Phase 2, Dose 2||0||
48475655|NCT01273181|101500073|FG003|NOT COMPLETED|Phase 2, Dose 2||1||
48192473|NCT04771273|100794073|FG003|COMPLETED|Dose Escalation Period||68|Completed treatment with trial medication|
48192474|NCT04771273|100794070|FG000|NOT COMPLETED|Dose Escalation Period||11||
48192475|NCT04771273|100794071|FG001|NOT COMPLETED|Dose Escalation Period||10||
48475656|NCT00762086|101500074|FG000|STARTED|Overall Study||39||
48475657|NCT00762086|101500075|FG001|STARTED|Overall Study||28||
48475658|NCT00762086|101500074|FG000|COMPLETED|Overall Study||33||
48475659|NCT00762086|101500075|FG001|COMPLETED|Overall Study||24||
48475660|NCT00762086|101500074|FG000|NOT COMPLETED|Overall Study||6||
48475661|NCT00762086|101500075|FG001|NOT COMPLETED|Overall Study||4||
48475662|NCT01417078|101500076|FG000|STARTED|Overall Study||31||
48475663|NCT01417078|101500076|FG000|COMPLETED|Overall Study||30||
48475664|NCT01417078|101500076|FG000|NOT COMPLETED|Overall Study||1||
48475665|NCT03831451|101500077|FG000|STARTED|Overall Study||74||
48475666|NCT03831451|101500078|FG001|STARTED|Overall Study||55||
48475667|NCT03831451|101500077|FG000|COMPLETED|Overall Study||74||
48475668|NCT03831451|101500078|FG001|COMPLETED|Overall Study||55||
48475669|NCT03831451|101500077|FG000|NOT COMPLETED|Overall Study||0||
48475670|NCT03831451|101500078|FG001|NOT COMPLETED|Overall Study||0||
48475671|NCT02016612|101500079|FG000|STARTED|Overall Study||25||
48475672|NCT02016612|101500080|FG001|STARTED|Overall Study||25||
48475673|NCT02016612|101500081|FG002|STARTED|Overall Study||26||
48475674|NCT02016612|101500082|FG003|STARTED|Overall Study||61||
48475675|NCT02016612|101500079|FG000|COMPLETED|Overall Study||25||
48475676|NCT02016612|101500080|FG001|COMPLETED|Overall Study||25||
48475677|NCT02016612|101500081|FG002|COMPLETED|Overall Study||26||
48475678|NCT02016612|101500082|FG003|COMPLETED|Overall Study||61||
48475679|NCT02016612|101500079|FG000|NOT COMPLETED|Overall Study||0||
48475680|NCT02016612|101500080|FG001|NOT COMPLETED|Overall Study||0||
48475681|NCT02016612|101500081|FG002|NOT COMPLETED|Overall Study||0||
48475682|NCT02016612|101500082|FG003|NOT COMPLETED|Overall Study||0||
48475683|NCT01483352|101500083|FG000|STARTED|Overall Study||12||
48475684|NCT01483352|101500083|FG000|COMPLETED|Overall Study||12||
48475685|NCT01483352|101500083|FG000|NOT COMPLETED|Overall Study||0||
48475686|NCT04453202|101500084|FG000|STARTED|Overall Study||51||
48475687|NCT04453202|101500085|FG001|STARTED|Overall Study||51||
48475688|NCT04453202|101500086|FG002|STARTED|Overall Study||51||
48475689|NCT04453202|101500087|FG003|STARTED|Overall Study||48||
48475690|NCT04453202|101500088|FG004|STARTED|Overall Study||25||
48475691|NCT04453202|101500089|FG005|STARTED|Overall Study||49||
48475692|NCT04453202|101500090|FG006|STARTED|Overall Study||49||
48475693|NCT04453202|101500091|FG007|STARTED|Overall Study||26||
48475694|NCT04453202|101500092|FG008|STARTED|Overall Study||27||
48475695|NCT04453202|101500093|FG009|STARTED|Overall Study||51||
48475696|NCT04453202|101500094|FG010|STARTED|Overall Study||26||
48475697|NCT04453202|101500084|FG000|Full Analysis Set (FAS)|Overall Study||51||
48475698|NCT04453202|101500085|FG001|Full Analysis Set (FAS)|Overall Study||51||
48475699|NCT04453202|101500086|FG002|Full Analysis Set (FAS)|Overall Study||51||
48475700|NCT04453202|101500087|FG003|Full Analysis Set (FAS)|Overall Study||48||
48475701|NCT04453202|101500088|FG004|Full Analysis Set (FAS)|Overall Study||25||
48192476|NCT04771273|100794072|FG002|NOT COMPLETED|Dose Escalation Period||18||
48192477|NCT04771273|100794073|FG003|NOT COMPLETED|Dose Escalation Period||6||
48475702|NCT04453202|101500089|FG005|Full Analysis Set (FAS)|Overall Study||49||
48475703|NCT04453202|101500090|FG006|Full Analysis Set (FAS)|Overall Study||49||
48475704|NCT04453202|101500091|FG007|Full Analysis Set (FAS)|Overall Study||26||
48475705|NCT04453202|101500092|FG008|Full Analysis Set (FAS)|Overall Study||27||
48475706|NCT04453202|101500093|FG009|Full Analysis Set (FAS)|Overall Study||51||
48475707|NCT04453202|101500094|FG010|Full Analysis Set (FAS)|Overall Study||26||
48475708|NCT04453202|101500084|FG000|Per-protocol Immunogenicity (PPI) Set|Overall Study||51||
48475709|NCT04453202|101500085|FG001|Per-protocol Immunogenicity (PPI) Set|Overall Study||50||
48475710|NCT04453202|101500086|FG002|Per-protocol Immunogenicity (PPI) Set|Overall Study||51||
48475711|NCT04453202|101500087|FG003|Per-protocol Immunogenicity (PPI) Set|Overall Study||48||
48475712|NCT04453202|101500088|FG004|Per-protocol Immunogenicity (PPI) Set|Overall Study||25||
48475713|NCT04453202|101500089|FG005|Per-protocol Immunogenicity (PPI) Set|Overall Study||47||
48475714|NCT04453202|101500090|FG006|Per-protocol Immunogenicity (PPI) Set|Overall Study||49||
48475715|NCT04453202|101500091|FG007|Per-protocol Immunogenicity (PPI) Set|Overall Study||26||
48475716|NCT04453202|101500092|FG008|Per-protocol Immunogenicity (PPI) Set|Overall Study||27||
48475717|NCT04453202|101500093|FG009|Per-protocol Immunogenicity (PPI) Set|Overall Study||50||
48475718|NCT04453202|101500094|FG010|Per-protocol Immunogenicity (PPI) Set|Overall Study||26||
48475719|NCT04453202|101500084|FG000|COMPLETED|Overall Study||50||
48475720|NCT04453202|101500085|FG001|COMPLETED|Overall Study||48||
48475721|NCT04453202|101500086|FG002|COMPLETED|Overall Study||50||
48475722|NCT04453202|101500087|FG003|COMPLETED|Overall Study||45||
48475723|NCT04453202|101500088|FG004|COMPLETED|Overall Study||24||
48475724|NCT04453202|101500089|FG005|COMPLETED|Overall Study||47||
48475725|NCT04453202|101500090|FG006|COMPLETED|Overall Study||48||
48475726|NCT04453202|101500091|FG007|COMPLETED|Overall Study||26||
48475727|NCT04453202|101500092|FG008|COMPLETED|Overall Study||27||
48475728|NCT04453202|101500093|FG009|COMPLETED|Overall Study||48||
48475729|NCT04453202|101500094|FG010|COMPLETED|Overall Study||25||
48475730|NCT04453202|101500084|FG000|NOT COMPLETED|Overall Study||1||
48475731|NCT04453202|101500085|FG001|NOT COMPLETED|Overall Study||3||
48475732|NCT04453202|101500086|FG002|NOT COMPLETED|Overall Study||1||
48475733|NCT04453202|101500087|FG003|NOT COMPLETED|Overall Study||3||
48475734|NCT04453202|101500088|FG004|NOT COMPLETED|Overall Study||1||
48475735|NCT04453202|101500089|FG005|NOT COMPLETED|Overall Study||2||
48475736|NCT04453202|101500090|FG006|NOT COMPLETED|Overall Study||1||
48475737|NCT04453202|101500091|FG007|NOT COMPLETED|Overall Study||0||
48475738|NCT04453202|101500092|FG008|NOT COMPLETED|Overall Study||0||
48475739|NCT04453202|101500093|FG009|NOT COMPLETED|Overall Study||3||
48475740|NCT04453202|101500094|FG010|NOT COMPLETED|Overall Study||1||
48475741|NCT00156247|101500095|FG000|STARTED|Overall Study||9||
48475742|NCT00156247|101500095|FG000|COMPLETED|Overall Study||5||
48475743|NCT00156247|101500095|FG000|NOT COMPLETED|Overall Study||4||
48475744|NCT02348385|101500096|FG000|STARTED|Overall Study||24||
48475745|NCT02348385|101500097|FG001|STARTED|Overall Study||25||
48475746|NCT02348385|101500096|FG000|COMPLETED|Overall Study||24||
48475747|NCT02348385|101500097|FG001|COMPLETED|Overall Study||25||
48475748|NCT02348385|101500096|FG000|NOT COMPLETED|Overall Study||0||
48475749|NCT02348385|101500097|FG001|NOT COMPLETED|Overall Study||0||
48475750|NCT02446626|101500098|FG000|STARTED|Overall Study||40||
48475751|NCT02446626|101500099|FG001|STARTED|Overall Study||20||
48475752|NCT02446626|101500100|FG002|STARTED|Overall Study||1||
48475753|NCT02446626|101500101|FG003|STARTED|Overall Study||1||
48475754|NCT02446626|101500102|FG004|STARTED|Overall Study||9||
48475755|NCT02446626|101500098|FG000|COMPLETED|Overall Study||40||
48475756|NCT02446626|101500099|FG001|COMPLETED|Overall Study||20||
48475757|NCT02446626|101500100|FG002|COMPLETED|Overall Study||1||
48475758|NCT02446626|101500101|FG003|COMPLETED|Overall Study||1||
48475759|NCT02446626|101500102|FG004|COMPLETED|Overall Study||9||
48475760|NCT02446626|101500098|FG000|NOT COMPLETED|Overall Study||0||
48475761|NCT02446626|101500099|FG001|NOT COMPLETED|Overall Study||0||
48475762|NCT02446626|101500100|FG002|NOT COMPLETED|Overall Study||0||
48475763|NCT02446626|101500101|FG003|NOT COMPLETED|Overall Study||0||
48475764|NCT02446626|101500102|FG004|NOT COMPLETED|Overall Study||0||
48475765|NCT00162123|101500103|FG000|STARTED|Overall Study||53||
48475766|NCT00162123|101500104|FG001|STARTED|Overall Study||34||
48475767|NCT00162123|101500105|FG002|STARTED|Overall Study||24||
48475768|NCT00162123|101500106|FG003|STARTED|Overall Study||11||
48475769|NCT00162123|101500107|FG004|STARTED|Overall Study||45||
48475770|NCT00162123|101500108|FG005|STARTED|Overall Study||13||
48475771|NCT00162123|101500109|FG006|STARTED|Overall Study||4||
48475772|NCT00162123|101500110|FG007|STARTED|Overall Study||58||
48475773|NCT00162123|101500103|FG000|Received Treatment|Overall Study||53||
48475774|NCT00162123|101500104|FG001|Received Treatment|Overall Study||34||
48475775|NCT00162123|101500105|FG002|Received Treatment|Overall Study||24||
48475776|NCT00162123|101500106|FG003|Received Treatment|Overall Study||11||
48475777|NCT00162123|101500107|FG004|Received Treatment|Overall Study||33||
48475778|NCT00162123|101500108|FG005|Received Treatment|Overall Study||12||
48475779|NCT00162123|101500109|FG006|Received Treatment|Overall Study||4||
48475780|NCT00162123|101500110|FG007|Received Treatment|Overall Study||0||
48475781|NCT00162123|101500103|FG000|COMPLETED|Overall Study||9||
48475782|NCT00162123|101500104|FG001|COMPLETED|Overall Study||5||
48475783|NCT00162123|101500105|FG002|COMPLETED|Overall Study||3||
48475784|NCT00162123|101500106|FG003|COMPLETED|Overall Study||3||
48475785|NCT00162123|101500107|FG004|COMPLETED|Overall Study||14||
48475786|NCT00162123|101500108|FG005|COMPLETED|Overall Study||4||
48475787|NCT00162123|101500109|FG006|COMPLETED|Overall Study||0||
48475788|NCT00162123|101500110|FG007|COMPLETED|Overall Study||0||
48475789|NCT00162123|101500103|FG000|NOT COMPLETED|Overall Study||44||
48475790|NCT00162123|101500104|FG001|NOT COMPLETED|Overall Study||29||
48475791|NCT00162123|101500105|FG002|NOT COMPLETED|Overall Study||21||
48475792|NCT00162123|101500106|FG003|NOT COMPLETED|Overall Study||8||
48475793|NCT00162123|101500107|FG004|NOT COMPLETED|Overall Study||31||
48475794|NCT00162123|101500108|FG005|NOT COMPLETED|Overall Study||9||
48475795|NCT00162123|101500109|FG006|NOT COMPLETED|Overall Study||4||
48475796|NCT00162123|101500110|FG007|NOT COMPLETED|Overall Study||58||
48475797|NCT01223365|101500111|FG000|STARTED|Open-label Titration Period||330||
48475798|NCT01223365|101500111|FG000|Safety Analysis Set|Open-label Titration Period||329||
48475799|NCT01223365|101500111|FG000|Achieved Stable Pain Relief|Open-label Titration Period||294||
48475800|NCT01223365|101500111|FG000|COMPLETED|Open-label Titration Period||291||
48475801|NCT01223365|101500111|FG000|NOT COMPLETED|Open-label Titration Period||39||
48475802|NCT01223365|101500111|FG000|STARTED|Open-label Treatment Period||291||
48475803|NCT01223365|101500111|FG000|COMPLETED|Open-label Treatment Period||189||
48475804|NCT01223365|101500111|FG000|NOT COMPLETED|Open-label Treatment Period||102||
48475805|NCT02319148|101502739|FG000|STARTED|First Intervention Period||22||
48475806|NCT02319148|101502740|FG001|STARTED|First Intervention Period||0||
48475807|NCT02319148|101502741|FG002|STARTED|First Intervention Period||0||
48475808|NCT02319148|101502742|FG003|STARTED|First Intervention Period||0||
48475809|NCT02319148|101502739|FG000|COMPLETED|First Intervention Period||22||
48475810|NCT02319148|101502740|FG001|COMPLETED|First Intervention Period||0||
48475811|NCT02319148|101502741|FG002|COMPLETED|First Intervention Period||0||
48475812|NCT02319148|101502742|FG003|COMPLETED|First Intervention Period||0||
48475813|NCT02319148|101502739|FG000|NOT COMPLETED|First Intervention Period||0||
48475814|NCT02319148|101502740|FG001|NOT COMPLETED|First Intervention Period||0||
48475815|NCT02319148|101502741|FG002|NOT COMPLETED|First Intervention Period||0||
48475816|NCT02319148|101502742|FG003|NOT COMPLETED|First Intervention Period||0||
48475817|NCT02319148|101502739|FG000|STARTED|Washout Period 4 Days||22||
48475818|NCT02319148|101502740|FG001|STARTED|Washout Period 4 Days||0||
48475819|NCT02319148|101502741|FG002|STARTED|Washout Period 4 Days||0||
48475820|NCT02319148|101502742|FG003|STARTED|Washout Period 4 Days||0||
48475821|NCT02319148|101502739|FG000|COMPLETED|Washout Period 4 Days||22||
48475822|NCT02319148|101502740|FG001|COMPLETED|Washout Period 4 Days||0||
48475823|NCT02319148|101502741|FG002|COMPLETED|Washout Period 4 Days||0||
48475824|NCT02319148|101502742|FG003|COMPLETED|Washout Period 4 Days||0||
48475825|NCT02319148|101502739|FG000|NOT COMPLETED|Washout Period 4 Days||0||
48475826|NCT02319148|101502740|FG001|NOT COMPLETED|Washout Period 4 Days||0||
48475827|NCT02319148|101502741|FG002|NOT COMPLETED|Washout Period 4 Days||0||
48475828|NCT02319148|101502742|FG003|NOT COMPLETED|Washout Period 4 Days||0||
48475829|NCT02319148|101502739|FG000|STARTED|Second Intervention Period||0||
48475830|NCT02319148|101502740|FG001|STARTED|Second Intervention Period||7||
48475831|NCT02319148|101502741|FG002|STARTED|Second Intervention Period||7||
48475832|NCT02319148|101502742|FG003|STARTED|Second Intervention Period||8||
48475833|NCT02319148|101502739|FG000|COMPLETED|Second Intervention Period||0||
48475834|NCT02319148|101502740|FG001|COMPLETED|Second Intervention Period||6||
48666231|NCT05014919|101967536|FG000|STARTED|Open-Label (12 Weeks)||33||
48475835|NCT02319148|101502741|FG002|COMPLETED|Second Intervention Period||6||
48475836|NCT02319148|101502742|FG003|COMPLETED|Second Intervention Period||6||
48475837|NCT02319148|101502739|FG000|NOT COMPLETED|Second Intervention Period||0||
48475838|NCT02319148|101502740|FG001|NOT COMPLETED|Second Intervention Period||1||
48475839|NCT02319148|101502741|FG002|NOT COMPLETED|Second Intervention Period||1||
48475840|NCT02319148|101502742|FG003|NOT COMPLETED|Second Intervention Period||2||
48475841|NCT03110003|101502743|FG000|STARTED|Overall Study||21||
48475842|NCT03110003|101502744|FG001|STARTED|Overall Study||24||
48192478|NCT04771273|100794070|FG000|STARTED|Maintenance Period||62||
48192479|NCT04771273|100794071|FG001|STARTED|Maintenance Period||63||
48192480|NCT04771273|100794072|FG002|STARTED|Maintenance Period||57||
48475843|NCT03110003|101502743|FG000|COMPLETED|Overall Study||21||
48475844|NCT03110003|101502744|FG001|COMPLETED|Overall Study||24||
48475845|NCT03110003|101502743|FG000|NOT COMPLETED|Overall Study||0||
48475846|NCT03110003|101502744|FG001|NOT COMPLETED|Overall Study||0||
48475847|NCT02066922|101502745|FG000|STARTED|Overall Study||15||
48475848|NCT02066922|101502745|FG000|COMPLETED|Overall Study||14||
48475849|NCT02066922|101502745|FG000|NOT COMPLETED|Overall Study||1||
48475850|NCT02665143|101502746|FG000|STARTED|Phase 1||6||
48475851|NCT02665143|101502746|FG000|COMPLETED|Phase 1||6||
48475852|NCT02665143|101502746|FG000|NOT COMPLETED|Phase 1||0||
48475853|NCT02665143|101502746|FG000|STARTED|Phase 2||19||
48475854|NCT02665143|101502746|FG000|Completed 0 Cycles|Phase 2||1||
48475855|NCT02665143|101502746|FG000|Completed 1 Cycle|Phase 2||12||
48475856|NCT02665143|101502746|FG000|Completed 2 Cycles|Phase 2||3||
48475857|NCT02665143|101502746|FG000|Completed 3 Cycles|Phase 2||3||
48475858|NCT02665143|101502746|FG000|COMPLETED|Phase 2||19||
48475859|NCT02665143|101502746|FG000|NOT COMPLETED|Phase 2||0||
48475860|NCT03187002|101502747|FG000|STARTED|Overall Study||55||
48475861|NCT03187002|101502748|FG001|STARTED|Overall Study||54||
48475862|NCT03187002|101502747|FG000|COMPLETED|Overall Study||55||
48475863|NCT03187002|101502748|FG001|COMPLETED|Overall Study||54||
48475864|NCT03187002|101502747|FG000|NOT COMPLETED|Overall Study||0||
48475865|NCT03187002|101502748|FG001|NOT COMPLETED|Overall Study||0||
48192481|NCT04771273|100794073|FG003|STARTED|Maintenance Period||68||
48475866|NCT01382719|101502749|FG000|STARTED|Overall Study||98||
48475867|NCT01382719|101502750|FG001|STARTED|Overall Study||100||
48475868|NCT01382719|101502751|FG002|STARTED|Overall Study||100||
48475869|NCT01382719|101502752|FG003|STARTED|Overall Study||99||
48475870|NCT01382719|101502749|FG000|Subjects Not Dosed|Overall Study||1||
48666232|NCT05014919|101967537|FG001|STARTED|Open-Label (12 Weeks)||0||
48192482|NCT04771273|100794070|FG000|COMPLETED|Maintenance Period||53|Completed treatment with trial medication|
48475871|NCT01382719|101502750|FG001|Subjects Not Dosed|Overall Study||0||
48475872|NCT01382719|101502751|FG002|Subjects Not Dosed|Overall Study||1||
48666233|NCT05014919|101967538|FG002|STARTED|Open-Label (12 Weeks)||0||
48666234|NCT05014919|101967536|FG000|Received at Least 1 Dose of Study Drug|Open-Label (12 Weeks)||33||
48666235|NCT05014919|101967537|FG001|Received at Least 1 Dose of Study Drug|Open-Label (12 Weeks)||0||
48666236|NCT05014919|101967538|FG002|Received at Least 1 Dose of Study Drug|Open-Label (12 Weeks)||0||
48666237|NCT05014919|101967536|FG000|COMPLETED|Open-Label (12 Weeks)||5||
48666238|NCT05014919|101967537|FG001|COMPLETED|Open-Label (12 Weeks)||0||
48666239|NCT05014919|101967538|FG002|COMPLETED|Open-Label (12 Weeks)||0||
48666240|NCT05014919|101967536|FG000|NOT COMPLETED|Open-Label (12 Weeks)||28||
48666241|NCT05014919|101967537|FG001|NOT COMPLETED|Open-Label (12 Weeks)||0||
48666242|NCT05014919|101967538|FG002|NOT COMPLETED|Open-Label (12 Weeks)||0||
48666243|NCT05014919|101967536|FG000|STARTED|Double-Blind (26 Weeks)||0||
48666244|NCT05014919|101967537|FG001|STARTED|Double-Blind (26 Weeks)||2||
48666245|NCT05014919|101967538|FG002|STARTED|Double-Blind (26 Weeks)||2||
48666246|NCT05014919|101967536|FG000|Received at Least 1 Dose of Study Drug|Double-Blind (26 Weeks)||0||
48666247|NCT05014919|101967537|FG001|Received at Least 1 Dose of Study Drug|Double-Blind (26 Weeks)||2||
48666248|NCT05014919|101967538|FG002|Received at Least 1 Dose of Study Drug|Double-Blind (26 Weeks)||2||
48666249|NCT05014919|101967536|FG000|COMPLETED|Double-Blind (26 Weeks)||0||
48666250|NCT05014919|101967537|FG001|COMPLETED|Double-Blind (26 Weeks)||1||
48666251|NCT05014919|101967538|FG002|COMPLETED|Double-Blind (26 Weeks)||0||
48666252|NCT05014919|101967536|FG000|NOT COMPLETED|Double-Blind (26 Weeks)||0||
48666253|NCT05014919|101967537|FG001|NOT COMPLETED|Double-Blind (26 Weeks)||1||
48666254|NCT05014919|101967538|FG002|NOT COMPLETED|Double-Blind (26 Weeks)||2||
48666255|NCT00113373|101967539|FG000|STARTED|Overall Study||28||
48666256|NCT00113373|101967539|FG000|COMPLETED|Overall Study||25||
48666257|NCT00113373|101967539|FG000|NOT COMPLETED|Overall Study||3||
48666258|NCT00363298|101967540|FG000|STARTED|First Study Week||12||
48666259|NCT00363298|101967541|FG001|STARTED|First Study Week||12||
48666260|NCT00363298|101967540|FG000|COMPLETED|First Study Week||6||
48666261|NCT00363298|101967541|FG001|COMPLETED|First Study Week||7||
48666262|NCT00363298|101967540|FG000|NOT COMPLETED|First Study Week||6||
48666263|NCT00363298|101967541|FG001|NOT COMPLETED|First Study Week||5||
48666264|NCT00363298|101967540|FG000|STARTED|4-week Study Continuation Phase||6||
48666265|NCT00363298|101967541|FG001|STARTED|4-week Study Continuation Phase||7||
48475873|NCT01382719|101502752|FG003|Subjects Not Dosed|Overall Study||1||
48475874|NCT01382719|101502749|FG000|COMPLETED|Overall Study||80||
48475875|NCT01382719|101502750|FG001|COMPLETED|Overall Study||81||
48475876|NCT01382719|101502751|FG002|COMPLETED|Overall Study||66||
48475877|NCT01382719|101502752|FG003|COMPLETED|Overall Study||66||
48666266|NCT00363298|101967540|FG000|COMPLETED|4-week Study Continuation Phase||5||
48475878|NCT01382719|101502749|FG000|NOT COMPLETED|Overall Study||18||
48475879|NCT01382719|101502750|FG001|NOT COMPLETED|Overall Study||19||
48475880|NCT01382719|101502751|FG002|NOT COMPLETED|Overall Study||34||
48475881|NCT01382719|101502752|FG003|NOT COMPLETED|Overall Study||33||
48475882|NCT02372630|101502753|FG000|STARTED|Overall Study||20||
48475883|NCT02372630|101502754|FG001|STARTED|Overall Study||20||
48475884|NCT02372630|101502753|FG000|COMPLETED|Overall Study||17||
48475885|NCT02372630|101502754|FG001|COMPLETED|Overall Study||17||
48475886|NCT02372630|101502753|FG000|NOT COMPLETED|Overall Study||3||
48475887|NCT02372630|101502754|FG001|NOT COMPLETED|Overall Study||3||
48475888|NCT01900730|101502755|FG000|STARTED|Overall Study||3||
48475889|NCT01900730|101502756|FG001|STARTED|Overall Study||0||
48475890|NCT01900730|101502755|FG000|COMPLETED|Overall Study||1||
48475891|NCT01900730|101502756|FG001|COMPLETED|Overall Study||0||
48475892|NCT01900730|101502755|FG000|NOT COMPLETED|Overall Study||2||
48475893|NCT01900730|101502756|FG001|NOT COMPLETED|Overall Study||0||
48475894|NCT00376623|101502757|FG000|STARTED|Overall Study||49|Entered|
48475895|NCT00376623|101502758|FG001|STARTED|Overall Study||26|Entered|
48475896|NCT00376623|101502759|FG002|STARTED|Overall Study||21|Entered|
48475897|NCT00376623|101502757|FG000|Treated With BI 2536|Overall Study||48||
48475898|NCT00376623|101502758|FG001|Treated With BI 2536|Overall Study||26||
48475899|NCT00376623|101502759|FG002|Treated With BI 2536|Overall Study||21||
48475900|NCT00376623|101502757|FG000|COMPLETED|Overall Study||0||
48475901|NCT00376623|101502758|FG001|COMPLETED|Overall Study||0||
48475902|NCT00376623|101502759|FG002|COMPLETED|Overall Study||0||
48475903|NCT00376623|101502757|FG000|NOT COMPLETED|Overall Study||49||
48475904|NCT00376623|101502758|FG001|NOT COMPLETED|Overall Study||26||
48475905|NCT00376623|101502759|FG002|NOT COMPLETED|Overall Study||21||
48475906|NCT00924326|101502760|FG000|STARTED|Dose Administration||8||
48475907|NCT00924326|101502761|FG001|STARTED|Dose Administration||2||
48475908|NCT00924326|101502762|FG002|STARTED|Dose Administration||5||
48475909|NCT00924326|101502763|FG003|STARTED|Dose Administration||6||
48475910|NCT00924326|101502764|FG004|STARTED|Dose Administration||7||
48475911|NCT00924326|101502765|FG005|STARTED|Dose Administration||10||
48475912|NCT00924326|101502766|FG006|STARTED|Dose Administration||1||
48475913|NCT00924326|101502767|FG007|STARTED|Dose Administration||2||
48475914|NCT00924326|101502768|FG008|STARTED|Dose Administration||2||
48475915|NCT00924326|101502760|FG000|COMPLETED|Dose Administration||8||
48475916|NCT00924326|101502761|FG001|COMPLETED|Dose Administration||2||
48475917|NCT00924326|101502762|FG002|COMPLETED|Dose Administration||5||
48475918|NCT00924326|101502763|FG003|COMPLETED|Dose Administration||6||
48475919|NCT00924326|101502764|FG004|COMPLETED|Dose Administration||7||
48475920|NCT00924326|101502765|FG005|COMPLETED|Dose Administration||10||
48475921|NCT00924326|101502766|FG006|COMPLETED|Dose Administration||1||
48475922|NCT00924326|101502767|FG007|COMPLETED|Dose Administration||2||
48475923|NCT00924326|101502768|FG008|COMPLETED|Dose Administration||2||
48475924|NCT00924326|101502760|FG000|NOT COMPLETED|Dose Administration||0||
48475925|NCT00924326|101502761|FG001|NOT COMPLETED|Dose Administration||0||
48475926|NCT00924326|101502762|FG002|NOT COMPLETED|Dose Administration||0||
48475927|NCT00924326|101502763|FG003|NOT COMPLETED|Dose Administration||0||
48475928|NCT00924326|101502764|FG004|NOT COMPLETED|Dose Administration||0||
48475929|NCT00924326|101502765|FG005|NOT COMPLETED|Dose Administration||0||
48475930|NCT00924326|101502766|FG006|NOT COMPLETED|Dose Administration||0||
48475931|NCT00924326|101502767|FG007|NOT COMPLETED|Dose Administration||0||
48475932|NCT00924326|101502768|FG008|NOT COMPLETED|Dose Administration||0||
48475933|NCT00924326|101502760|FG000|STARTED|1x10^9-1x10^10 + High Dose Retreat||3||
48475934|NCT00924326|101502761|FG001|STARTED|1x10^9-1x10^10 + High Dose Retreat||0||
48666267|NCT00363298|101967541|FG001|COMPLETED|4-week Study Continuation Phase||7||
48666268|NCT00363298|101967540|FG000|NOT COMPLETED|4-week Study Continuation Phase||1||
48666269|NCT00363298|101967541|FG001|NOT COMPLETED|4-week Study Continuation Phase||0||
48666270|NCT01073293|101967542|FG000|STARTED|Overall Study||526||
48666271|NCT01073293|101967543|FG001|STARTED|Overall Study||528||
48475935|NCT00924326|101502762|FG002|STARTED|1x10^9-1x10^10 + High Dose Retreat||0||
48666272|NCT01073293|101967542|FG000|COMPLETED|Overall Study||521||
48666273|NCT01073293|101967543|FG001|COMPLETED|Overall Study||517||
48666274|NCT01073293|101967542|FG000|NOT COMPLETED|Overall Study||5||
48666275|NCT01073293|101967543|FG001|NOT COMPLETED|Overall Study||11||
48666276|NCT03242434|101967544|FG000|STARTED|Overall Study||15||
48666277|NCT03242434|101967545|FG001|STARTED|Overall Study||3||
48666278|NCT03242434|101967544|FG000|COMPLETED|Overall Study||15||
48666279|NCT03242434|101967545|FG001|COMPLETED|Overall Study||1||
48666280|NCT03242434|101967544|FG000|NOT COMPLETED|Overall Study||0||
48666281|NCT03242434|101967545|FG001|NOT COMPLETED|Overall Study||2||
48666282|NCT01833078|101967546|FG000|STARTED|Overall Study||5||
48666283|NCT01833078|101967546|FG000|COMPLETED|Overall Study||5||
48666284|NCT01833078|101967546|FG000|NOT COMPLETED|Overall Study||0||
48475936|NCT00924326|101502763|FG003|STARTED|1x10^9-1x10^10 + High Dose Retreat||0||
48475937|NCT00924326|101502764|FG004|STARTED|1x10^9-1x10^10 + High Dose Retreat||0||
48475938|NCT00924326|101502765|FG005|STARTED|1x10^9-1x10^10 + High Dose Retreat||0||
48475939|NCT00924326|101502766|FG006|STARTED|1x10^9-1x10^10 + High Dose Retreat||0||
48475940|NCT00924326|101502767|FG007|STARTED|1x10^9-1x10^10 + High Dose Retreat||0||
48475941|NCT00924326|101502768|FG008|STARTED|1x10^9-1x10^10 + High Dose Retreat||0||
48475942|NCT00924326|101502760|FG000|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||3||
48475943|NCT00924326|101502761|FG001|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0||
48475944|NCT00924326|101502762|FG002|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0||
48475945|NCT00924326|101502763|FG003|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0||
48475946|NCT00924326|101502764|FG004|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0||
48475947|NCT00924326|101502765|FG005|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0||
48475948|NCT00924326|101502766|FG006|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0||
48475949|NCT00924326|101502767|FG007|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0||
48475950|NCT00924326|101502768|FG008|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0||
48475951|NCT00924326|101502760|FG000|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0||
48475952|NCT00924326|101502761|FG001|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0||
48475953|NCT00924326|101502762|FG002|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0||
48475954|NCT00924326|101502763|FG003|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0||
48475955|NCT00924326|101502764|FG004|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0||
48475956|NCT00924326|101502765|FG005|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0||
48192483|NCT04771273|100794071|FG001|COMPLETED|Maintenance Period||55|Completed treatment with trial medication|
48192484|NCT04771273|100794072|FG002|COMPLETED|Maintenance Period||49|Completed treatment with trial medication|
48192485|NCT04771273|100794073|FG003|COMPLETED|Maintenance Period||64|Completed treatment with trial medication|
48192486|NCT04771273|100794070|FG000|NOT COMPLETED|Maintenance Period||9||
48192487|NCT04771273|100794071|FG001|NOT COMPLETED|Maintenance Period||8||
48192488|NCT04771273|100794072|FG002|NOT COMPLETED|Maintenance Period||8||
48192489|NCT04771273|100794073|FG003|NOT COMPLETED|Maintenance Period||4||
48192490|NCT01456780|100794074|FG000|STARTED|Overall Study||20||
48475957|NCT00924326|101502766|FG006|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0||
48475958|NCT00924326|101502767|FG007|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0||
48475959|NCT00924326|101502768|FG008|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0||
48192491|NCT01456780|100794075|FG001|STARTED|Overall Study||20||
48475960|NCT02193880|101502769|FG000|STARTED|Overall Study||7||
48475961|NCT02193880|101502769|FG000|COMPLETED|Overall Study||4||
48475962|NCT02193880|101502769|FG000|NOT COMPLETED|Overall Study||3||
48192492|NCT01456780|100794076|FG002|STARTED|Overall Study||20||
48192493|NCT01456780|100794074|FG000|COMPLETED|Overall Study||17||
48475963|NCT01320696|101502770|FG000|STARTED|Overall Study||56||
48475964|NCT01320696|101502771|FG001|STARTED|Overall Study||55||
48475965|NCT01320696|101502772|FG002|STARTED|Overall Study||54||
48475966|NCT01320696|101502773|FG003|STARTED|Overall Study||55||
48475967|NCT01320696|101502774|FG004|STARTED|Overall Study||55||
48475968|NCT01320696|101502770|FG000|Vaccinated Vacc. 1|Overall Study||56||
48475969|NCT01320696|101502771|FG001|Vaccinated Vacc. 1|Overall Study||55||
48475970|NCT01320696|101502772|FG002|Vaccinated Vacc. 1|Overall Study||54||
48475971|NCT01320696|101502773|FG003|Vaccinated Vacc. 1|Overall Study||55||
48475972|NCT01320696|101502774|FG004|Vaccinated Vacc. 1|Overall Study||55||
48475973|NCT01320696|101502770|FG000|Vaccinated Vacc. 2|Overall Study||53||
48475974|NCT01320696|101502771|FG001|Vaccinated Vacc. 2|Overall Study||53||
48475975|NCT01320696|101502772|FG002|Vaccinated Vacc. 2|Overall Study||54||
48475976|NCT01320696|101502773|FG003|Vaccinated Vacc. 2|Overall Study||55||
48475977|NCT01320696|101502774|FG004|Vaccinated Vacc. 2|Overall Study||54||
48475978|NCT01320696|101502770|FG000|COMPLETED|Overall Study||51||
48475979|NCT01320696|101502771|FG001|COMPLETED|Overall Study||51||
48475980|NCT01320696|101502772|FG002|COMPLETED|Overall Study||51||
48475981|NCT01320696|101502773|FG003|COMPLETED|Overall Study||50||
48475982|NCT01320696|101502774|FG004|COMPLETED|Overall Study||52||
48475983|NCT01320696|101502770|FG000|NOT COMPLETED|Overall Study||5||
48475984|NCT01320696|101502771|FG001|NOT COMPLETED|Overall Study||4||
48475985|NCT01320696|101502772|FG002|NOT COMPLETED|Overall Study||3||
48475986|NCT01320696|101502773|FG003|NOT COMPLETED|Overall Study||5||
48475987|NCT01320696|101502774|FG004|NOT COMPLETED|Overall Study||3||
48475988|NCT00832377|101502775|FG000|STARTED|Overall Study||37||
48475989|NCT00832377|101502775|FG000|COMPLETED|Overall Study||36||
48475990|NCT00832377|101502775|FG000|NOT COMPLETED|Overall Study||1||
48475991|NCT00854100|101502776|FG000|STARTED|Overall Study||81||
48475992|NCT00854100|101502777|FG001|STARTED|Overall Study||76||
48475993|NCT00854100|101502778|FG002|STARTED|Overall Study||74||
48475994|NCT00854100|101502776|FG000|COMPLETED|Overall Study||72||
48475995|NCT00854100|101502777|FG001|COMPLETED|Overall Study||70||
48475996|NCT00854100|101502778|FG002|COMPLETED|Overall Study||63||
48475997|NCT00854100|101502776|FG000|NOT COMPLETED|Overall Study||9||
48475998|NCT00854100|101502777|FG001|NOT COMPLETED|Overall Study||6||
48475999|NCT00854100|101502778|FG002|NOT COMPLETED|Overall Study||11||
48476000|NCT01876706|101502779|FG000|STARTED|Overall Study||51||
48476001|NCT01876706|101502779|FG000|1 Month|Overall Study||51||
48476002|NCT01876706|101502779|FG000|3 Months|Overall Study||51||
48476003|NCT01876706|101502779|FG000|6 Months|Overall Study||46||
48476004|NCT01876706|101502779|FG000|12 Months|Overall Study||42||
48476005|NCT01876706|101502779|FG000|24 Months|Overall Study||35||
48476006|NCT01876706|101502779|FG000|36 Months|Overall Study||32||
48476007|NCT01876706|101502779|FG000|48 Months|Overall Study||31||
48476008|NCT01876706|101502779|FG000|60 Months|Overall Study||26||
48476009|NCT01876706|101502779|FG000|COMPLETED|Overall Study||26||
48192494|NCT01456780|100794075|FG001|COMPLETED|Overall Study||17||
48192495|NCT01456780|100794076|FG002|COMPLETED|Overall Study||20||
48192496|NCT01456780|100794074|FG000|NOT COMPLETED|Overall Study||3||
48192497|NCT01456780|100794075|FG001|NOT COMPLETED|Overall Study||3||
48192498|NCT01456780|100794076|FG002|NOT COMPLETED|Overall Study||0||
48192499|NCT01723774|100794077|FG000|STARTED|Neoadjuvant||34||
48192500|NCT01723774|100794078|FG001|STARTED|Neoadjuvant||16||
48192501|NCT01723774|100794079|FG002|STARTED|Neoadjuvant||34||
48192502|NCT01723774|100794080|FG003|STARTED|Neoadjuvant||0||
48192503|NCT01723774|100794077|FG000|COMPLETED|Neoadjuvant||27||
48192504|NCT01723774|100794078|FG001|COMPLETED|Neoadjuvant||12||
48192505|NCT01723774|100794079|FG002|COMPLETED|Neoadjuvant||21||
48192506|NCT01723774|100794080|FG003|COMPLETED|Neoadjuvant||0||
48192507|NCT01723774|100794077|FG000|NOT COMPLETED|Neoadjuvant||7||
48192508|NCT01723774|100794078|FG001|NOT COMPLETED|Neoadjuvant||4||
48192509|NCT01723774|100794079|FG002|NOT COMPLETED|Neoadjuvant||13||
48192510|NCT01723774|100794080|FG003|NOT COMPLETED|Neoadjuvant||0||
48192511|NCT01723774|100794077|FG000|STARTED|Adjuvant||0||
48192512|NCT01723774|100794078|FG001|STARTED|Adjuvant||0||
48192513|NCT01723774|100794079|FG002|STARTED|Adjuvant||0||
48192514|NCT01723774|100794080|FG003|STARTED|Adjuvant||7||
48192515|NCT01723774|100794077|FG000|COMPLETED|Adjuvant||0||
48192516|NCT01723774|100794078|FG001|COMPLETED|Adjuvant||0||
48192517|NCT01723774|100794079|FG002|COMPLETED|Adjuvant||0||
48192518|NCT01723774|100794080|FG003|COMPLETED|Adjuvant||7||
48192519|NCT01723774|100794077|FG000|NOT COMPLETED|Adjuvant||0||
48192520|NCT01723774|100794078|FG001|NOT COMPLETED|Adjuvant||0||
48192521|NCT01723774|100794079|FG002|NOT COMPLETED|Adjuvant||0||
48192522|NCT01723774|100794080|FG003|NOT COMPLETED|Adjuvant||0||
48192523|NCT01123161|100794081|FG000|STARTED|Overall Study||57||
48192524|NCT01123161|100794082|FG001|STARTED|Overall Study||63||
48192525|NCT01123161|100794081|FG000|COMPLETED|Overall Study||55||
48192526|NCT01123161|100794082|FG001|COMPLETED|Overall Study||63||
48192527|NCT01123161|100794081|FG000|NOT COMPLETED|Overall Study||2||
48192528|NCT01123161|100794082|FG001|NOT COMPLETED|Overall Study||0||
48192529|NCT02124460|100794083|FG000|STARTED|Overall Study||361||
48192530|NCT02124460|100794084|FG001|STARTED|Overall Study||360||
48192531|NCT02124460|100794083|FG000|COMPLETED|Overall Study||328||
48192532|NCT02124460|100794084|FG001|COMPLETED|Overall Study||336||
48192533|NCT02124460|100794083|FG000|NOT COMPLETED|Overall Study||33||
48192534|NCT02124460|100794084|FG001|NOT COMPLETED|Overall Study||24||
48192535|NCT03681639|100794085|FG000|STARTED|Overall Study||45||
48192536|NCT03681639|100794085|FG000|COMPLETED|Overall Study||36||
48192537|NCT03681639|100794085|FG000|NOT COMPLETED|Overall Study||9||
48192538|NCT01390857|100794086|FG000|STARTED|Overall Study||379||
48192539|NCT01390857|100794086|FG000|COMPLETED|Overall Study||369||
48192540|NCT01390857|100794086|FG000|NOT COMPLETED|Overall Study||10||
48192541|NCT02652130|100794087|FG000|STARTED|Overall Study||32||
48192542|NCT02652130|100794087|FG000|COMPLETED|Overall Study||31||
48192543|NCT02652130|100794087|FG000|NOT COMPLETED|Overall Study||1||
48192544|NCT00991276|100794088|FG000|STARTED|First Intervention Period||15||
48192545|NCT00991276|100794089|FG001|STARTED|First Intervention Period||13||
48192546|NCT00991276|100794090|FG002|STARTED|First Intervention Period||14||
48192547|NCT00991276|100794091|FG003|STARTED|First Intervention Period||15||
48192548|NCT00991276|100794092|FG004|STARTED|First Intervention Period||15||
48192549|NCT00991276|100794093|FG005|STARTED|First Intervention Period||13||
48192550|NCT00991276|100794088|FG000|COMPLETED|First Intervention Period||15||
48192551|NCT00991276|100794089|FG001|COMPLETED|First Intervention Period||10||
48192552|NCT00991276|100794090|FG002|COMPLETED|First Intervention Period||14||
48192553|NCT00991276|100794091|FG003|COMPLETED|First Intervention Period||11||
48192554|NCT00991276|100794092|FG004|COMPLETED|First Intervention Period||11||
48192555|NCT00991276|100794093|FG005|COMPLETED|First Intervention Period||12||
48192556|NCT00991276|100794088|FG000|NOT COMPLETED|First Intervention Period||0||
48192557|NCT00991276|100794089|FG001|NOT COMPLETED|First Intervention Period||3||
48192558|NCT00991276|100794090|FG002|NOT COMPLETED|First Intervention Period||0||
48192559|NCT00991276|100794091|FG003|NOT COMPLETED|First Intervention Period||4||
48192560|NCT00991276|100794092|FG004|NOT COMPLETED|First Intervention Period||4||
48192561|NCT00991276|100794093|FG005|NOT COMPLETED|First Intervention Period||1||
48192562|NCT00991276|100794088|FG000|STARTED|Placebo Wash-out Period (7 Days)||15||
48192563|NCT00991276|100794089|FG001|STARTED|Placebo Wash-out Period (7 Days)||10||
48192564|NCT00991276|100794090|FG002|STARTED|Placebo Wash-out Period (7 Days)||14||
48192565|NCT00991276|100794091|FG003|STARTED|Placebo Wash-out Period (7 Days)||11||
48192566|NCT00991276|100794092|FG004|STARTED|Placebo Wash-out Period (7 Days)||11||
48192567|NCT00991276|100794093|FG005|STARTED|Placebo Wash-out Period (7 Days)||12||
48192568|NCT00991276|100794088|FG000|COMPLETED|Placebo Wash-out Period (7 Days)||15||
48192569|NCT00991276|100794089|FG001|COMPLETED|Placebo Wash-out Period (7 Days)||10||
48192570|NCT00991276|100794090|FG002|COMPLETED|Placebo Wash-out Period (7 Days)||14||
48192571|NCT00991276|100794091|FG003|COMPLETED|Placebo Wash-out Period (7 Days)||11||
48192572|NCT00991276|100794092|FG004|COMPLETED|Placebo Wash-out Period (7 Days)||11||
48476010|NCT01876706|101502779|FG000|NOT COMPLETED|Overall Study||25||
48192573|NCT00991276|100794093|FG005|COMPLETED|Placebo Wash-out Period (7 Days)||12||
48192574|NCT00991276|100794088|FG000|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0||
48192575|NCT00991276|100794089|FG001|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0||
48192576|NCT00991276|100794090|FG002|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0||
48192577|NCT00991276|100794091|FG003|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0||
48192578|NCT00991276|100794092|FG004|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0||
48192579|NCT00991276|100794093|FG005|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0||
48192580|NCT00991276|100794088|FG000|STARTED|Second Intervention Period||15||
48192581|NCT00991276|100794089|FG001|STARTED|Second Intervention Period||10||
48192582|NCT00991276|100794090|FG002|STARTED|Second Intervention Period||14||
48192583|NCT00991276|100794091|FG003|STARTED|Second Intervention Period||11||
48192584|NCT00991276|100794092|FG004|STARTED|Second Intervention Period||11||
48192585|NCT00991276|100794093|FG005|STARTED|Second Intervention Period||12||
48192586|NCT00991276|100794088|FG000|COMPLETED|Second Intervention Period||14||
48192587|NCT00991276|100794089|FG001|COMPLETED|Second Intervention Period||8||
48192588|NCT00991276|100794090|FG002|COMPLETED|Second Intervention Period||14||
48192589|NCT00991276|100794091|FG003|COMPLETED|Second Intervention Period||9||
48192590|NCT00991276|100794092|FG004|COMPLETED|Second Intervention Period||10||
48192591|NCT00991276|100794093|FG005|COMPLETED|Second Intervention Period||11||
48476011|NCT00755196|101502780|FG000|STARTED|Overall Study||30||
48476012|NCT00755196|101502780|FG000|COMPLETED|Overall Study||28||
48476013|NCT00755196|101502780|FG000|NOT COMPLETED|Overall Study||2||
48476014|NCT01790581|101502781|FG000|STARTED|Overall Study||12||
48476015|NCT01790581|101502782|FG001|STARTED|Overall Study||12||
48476016|NCT01790581|101502781|FG000|COMPLETED|Overall Study||12||
48476017|NCT01790581|101502782|FG001|COMPLETED|Overall Study||12||
48476018|NCT01790581|101502781|FG000|NOT COMPLETED|Overall Study||0||
48476019|NCT01790581|101502782|FG001|NOT COMPLETED|Overall Study||0||
48476020|NCT02779543|101502783|FG000|STARTED|Overall Study||100||
48476021|NCT02779543|101502784|FG001|STARTED|Overall Study||100||
48476022|NCT02779543|101502783|FG000|COMPLETED|Overall Study||100||
48476023|NCT02779543|101502784|FG001|COMPLETED|Overall Study||100||
48476024|NCT02779543|101502783|FG000|NOT COMPLETED|Overall Study||0||
48476025|NCT02779543|101502784|FG001|NOT COMPLETED|Overall Study||0||
48476026|NCT02597998|101502785|FG000|STARTED|Overall Study||6||
48476027|NCT02597998|101502785|FG000|COMPLETED|Overall Study||6||
48476028|NCT02597998|101502785|FG000|NOT COMPLETED|Overall Study||0||
48192592|NCT00991276|100794088|FG000|NOT COMPLETED|Second Intervention Period||1||
48192593|NCT00991276|100794089|FG001|NOT COMPLETED|Second Intervention Period||2||
48476029|NCT00425672|101502786|FG000|STARTED|Overall Study||15||
48476030|NCT00425672|101502786|FG000|COMPLETED|Overall Study||14||
48476031|NCT00425672|101502786|FG000|NOT COMPLETED|Overall Study||1||
48476032|NCT00694551|101502787|FG000|STARTED|Overall Study||10||
48476033|NCT00694551|101502788|FG001|STARTED|Overall Study||10||
48476034|NCT00694551|101502789|FG002|STARTED|Overall Study||9||
48476035|NCT00694551|101502787|FG000|COMPLETED|Overall Study||9||
48192594|NCT00991276|100794090|FG002|NOT COMPLETED|Second Intervention Period||0||
48192595|NCT00991276|100794091|FG003|NOT COMPLETED|Second Intervention Period||2||
48192596|NCT00991276|100794092|FG004|NOT COMPLETED|Second Intervention Period||1||
48476036|NCT00694551|101502788|FG001|COMPLETED|Overall Study||10||
48476037|NCT00694551|101502789|FG002|COMPLETED|Overall Study||8||
48476038|NCT00694551|101502787|FG000|NOT COMPLETED|Overall Study||1||
48192597|NCT00991276|100794093|FG005|NOT COMPLETED|Second Intervention Period||1||
48192598|NCT00991276|100794088|FG000|STARTED|Placebo Wash-out Period (7 Days)||14||
48192599|NCT00991276|100794089|FG001|STARTED|Placebo Wash-out Period (7 Days)||8||
48192600|NCT00991276|100794090|FG002|STARTED|Placebo Wash-out Period (7 Days)||14||
48192601|NCT00991276|100794091|FG003|STARTED|Placebo Wash-out Period (7 Days)||9||
48192602|NCT00991276|100794092|FG004|STARTED|Placebo Wash-out Period (7 Days)||10||
48192603|NCT00991276|100794093|FG005|STARTED|Placebo Wash-out Period (7 Days)||11||
48192604|NCT00991276|100794088|FG000|COMPLETED|Placebo Wash-out Period (7 Days)||14||
48192605|NCT00991276|100794089|FG001|COMPLETED|Placebo Wash-out Period (7 Days)||8||
48192606|NCT00991276|100794090|FG002|COMPLETED|Placebo Wash-out Period (7 Days)||14||
48192607|NCT00991276|100794091|FG003|COMPLETED|Placebo Wash-out Period (7 Days)||9||
48192608|NCT00991276|100794092|FG004|COMPLETED|Placebo Wash-out Period (7 Days)||10||
48192609|NCT00991276|100794093|FG005|COMPLETED|Placebo Wash-out Period (7 Days)||11||
48192610|NCT00991276|100794088|FG000|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0||
48192611|NCT00991276|100794089|FG001|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0||
48192612|NCT00991276|100794090|FG002|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0||
48192613|NCT00991276|100794091|FG003|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0||
48192614|NCT00991276|100794092|FG004|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0||
48192615|NCT00991276|100794093|FG005|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0||
48192616|NCT00991276|100794088|FG000|STARTED|Third Intervention Period||14||
48192617|NCT00991276|100794089|FG001|STARTED|Third Intervention Period||8||
48192618|NCT00991276|100794090|FG002|STARTED|Third Intervention Period||14||
48192619|NCT00991276|100794091|FG003|STARTED|Third Intervention Period||9||
48192620|NCT00991276|100794092|FG004|STARTED|Third Intervention Period||10||
48192621|NCT00991276|100794093|FG005|STARTED|Third Intervention Period||11||
48192622|NCT00991276|100794088|FG000|COMPLETED|Third Intervention Period||13||
48192623|NCT00991276|100794089|FG001|COMPLETED|Third Intervention Period||8||
48192624|NCT00991276|100794090|FG002|COMPLETED|Third Intervention Period||13||
48192625|NCT00991276|100794091|FG003|COMPLETED|Third Intervention Period||8||
48192626|NCT00991276|100794092|FG004|COMPLETED|Third Intervention Period||10||
48192627|NCT00991276|100794093|FG005|COMPLETED|Third Intervention Period||10||
48192628|NCT00991276|100794088|FG000|NOT COMPLETED|Third Intervention Period||1||
48192629|NCT00991276|100794089|FG001|NOT COMPLETED|Third Intervention Period||0||
48192630|NCT00991276|100794090|FG002|NOT COMPLETED|Third Intervention Period||1||
48192631|NCT00991276|100794091|FG003|NOT COMPLETED|Third Intervention Period||1||
48192632|NCT00991276|100794092|FG004|NOT COMPLETED|Third Intervention Period||0||
48192633|NCT00991276|100794093|FG005|NOT COMPLETED|Third Intervention Period||1||
48192634|NCT00946192|100794094|FG000|STARTED|Overall Study||43||
48192635|NCT00946192|100794095|FG001|STARTED|Overall Study||40||
48192636|NCT00946192|100794096|FG002|STARTED|Overall Study||38||
48192637|NCT00946192|100794094|FG000|COMPLETED|Overall Study||25||
48192638|NCT00946192|100794095|FG001|COMPLETED|Overall Study||22||
48192639|NCT00946192|100794096|FG002|COMPLETED|Overall Study||26||
48192640|NCT00946192|100794094|FG000|NOT COMPLETED|Overall Study||18||
48192641|NCT00946192|100794095|FG001|NOT COMPLETED|Overall Study||18||
48192642|NCT00946192|100794096|FG002|NOT COMPLETED|Overall Study||12||
48192643|NCT00819910|100794097|FG000|STARTED|Overall Study||10||
48192644|NCT00819910|100794098|FG001|STARTED|Overall Study||10||
48192645|NCT00819910|100794099|FG002|STARTED|Overall Study||10||
48192646|NCT00819910|100794100|FG003|STARTED|Overall Study||11||
48192647|NCT00819910|100794097|FG000|COMPLETED|Overall Study||8||
48192648|NCT00819910|100794098|FG001|COMPLETED|Overall Study||9||
48476039|NCT00694551|101502788|FG001|NOT COMPLETED|Overall Study||0||
48476040|NCT00694551|101502789|FG002|NOT COMPLETED|Overall Study||1||
48192649|NCT00819910|100794099|FG002|COMPLETED|Overall Study||7||
48192650|NCT00819910|100794100|FG003|COMPLETED|Overall Study||10||
48192651|NCT00819910|100794097|FG000|NOT COMPLETED|Overall Study||2||
48192652|NCT00819910|100794098|FG001|NOT COMPLETED|Overall Study||1||
48192653|NCT00819910|100794099|FG002|NOT COMPLETED|Overall Study||3||
48192654|NCT00819910|100794100|FG003|NOT COMPLETED|Overall Study||1||
48192655|NCT04423393|100794101|FG000|STARTED|Overall Study||6||
48192656|NCT04423393|100794102|FG001|STARTED|Overall Study||6||
48192657|NCT04423393|100794103|FG002|STARTED|Overall Study||6||
48192658|NCT04423393|100794104|FG003|STARTED|Overall Study||6||
48192659|NCT04423393|100794105|FG004|STARTED|Overall Study||6||
48192660|NCT04423393|100794106|FG005|STARTED|Overall Study||11||
48192661|NCT04423393|100794107|FG006|STARTED|Overall Study||6||
48192662|NCT04423393|100794108|FG007|STARTED|Overall Study||6||
48192663|NCT04423393|100794109|FG008|STARTED|Overall Study||6||
48192664|NCT04423393|100794110|FG009|STARTED|Overall Study||6||
48192665|NCT04423393|100794111|FG010|STARTED|Overall Study||8||
48192666|NCT04423393|100794112|FG011|STARTED|Overall Study||6||
48192667|NCT04423393|100794113|FG012|STARTED|Overall Study||6||
48192668|NCT04423393|100794114|FG013|STARTED|Overall Study||6||
48192669|NCT04423393|100794115|FG014|STARTED|Overall Study||6||
48192670|NCT04423393|100794116|FG015|STARTED|Overall Study||6||
48192671|NCT04423393|100794117|FG016|STARTED|Overall Study||6||
48192672|NCT04423393|100794118|FG017|STARTED|Overall Study||4||
48192673|NCT04423393|100794101|FG000|Entered Extended Follow Up|Overall Study||0||
48192674|NCT04423393|100794102|FG001|Entered Extended Follow Up|Overall Study||0||
48192675|NCT04423393|100794103|FG002|Entered Extended Follow Up|Overall Study||0||
48192676|NCT04423393|100794104|FG003|Entered Extended Follow Up|Overall Study||0||
48192677|NCT04423393|100794105|FG004|Entered Extended Follow Up|Overall Study||0||
48192678|NCT04423393|100794106|FG005|Entered Extended Follow Up|Overall Study||0||
48192679|NCT04423393|100794107|FG006|Entered Extended Follow Up|Overall Study||1||
48192680|NCT04423393|100794108|FG007|Entered Extended Follow Up|Overall Study||1||
48192681|NCT04423393|100794109|FG008|Entered Extended Follow Up|Overall Study||5||
48192682|NCT04423393|100794110|FG009|Entered Extended Follow Up|Overall Study||5||
48192683|NCT04423393|100794111|FG010|Entered Extended Follow Up|Overall Study||0||
48192684|NCT04423393|100794112|FG011|Entered Extended Follow Up|Overall Study||1||
48192685|NCT04423393|100794113|FG012|Entered Extended Follow Up|Overall Study||0||
48476041|NCT00995553|101502790|FG000|STARTED|Overall Study||40||
48476042|NCT00995553|101502791|FG001|STARTED|Overall Study||41||
48476043|NCT00995553|101502790|FG000|COMPLETED|Overall Study||38||
48476044|NCT00995553|101502791|FG001|COMPLETED|Overall Study||35||
48476045|NCT00995553|101502790|FG000|NOT COMPLETED|Overall Study||2||
48476046|NCT00995553|101502791|FG001|NOT COMPLETED|Overall Study||6||
48476047|NCT00604500|101502792|FG000|STARTED|Overall Study||272||
48476048|NCT00604500|101502792|FG000|COMPLETED|Overall Study||261||
48476049|NCT00604500|101502792|FG000|NOT COMPLETED|Overall Study||11||
48476050|NCT03021538|101502793|FG000|STARTED|Overall Study||6||
48476051|NCT03021538|101502794|FG001|STARTED|Overall Study||7||
48476052|NCT03021538|101502793|FG000|COMPLETED|Overall Study||6||
48476053|NCT03021538|101502794|FG001|COMPLETED|Overall Study||7||
48476054|NCT03021538|101502793|FG000|NOT COMPLETED|Overall Study||0||
48476055|NCT03021538|101502794|FG001|NOT COMPLETED|Overall Study||0||
48476056|NCT04732195|101502795|FG000|STARTED|Overall Study||50||50
48476057|NCT04732195|101502796|FG001|STARTED|Overall Study||50||50
48476058|NCT04732195|101502795|FG000|COMPLETED|Overall Study||50||50
48476059|NCT04732195|101502796|FG001|COMPLETED|Overall Study||50||50
48476060|NCT04732195|101502795|FG000|NOT COMPLETED|Overall Study||0||0
48476061|NCT04732195|101502796|FG001|NOT COMPLETED|Overall Study||0||0
48476062|NCT03787680|101502797|FG000|STARTED|Overall Study||37||
48476063|NCT03787680|101502798|FG001|STARTED|Overall Study||12||
48476064|NCT03787680|101502797|FG000|COMPLETED|Overall Study||26||
48476065|NCT03787680|101502798|FG001|COMPLETED|Overall Study||5||
48476066|NCT03787680|101502797|FG000|NOT COMPLETED|Overall Study||11||
48192686|NCT04423393|100794114|FG013|Entered Extended Follow Up|Overall Study||3||
48192687|NCT04423393|100794115|FG014|Entered Extended Follow Up|Overall Study||0||
48192688|NCT04423393|100794116|FG015|Entered Extended Follow Up|Overall Study||0||
48192689|NCT04423393|100794117|FG016|Entered Extended Follow Up|Overall Study||0||
48192690|NCT04423393|100794118|FG017|Entered Extended Follow Up|Overall Study||0||
48476067|NCT03787680|101502798|FG001|NOT COMPLETED|Overall Study||7||
48476068|NCT03725605|101502799|FG000|STARTED|Overall Study||6||
48476069|NCT03725605|101502799|FG000|COMPLETED|Overall Study||4||
48476070|NCT03725605|101502799|FG000|NOT COMPLETED|Overall Study||2||
48476071|NCT03356821|101502800|FG000|STARTED|Overall Study||10||
48192691|NCT04423393|100794101|FG000|COMPLETED|Overall Study||6||
48192692|NCT04423393|100794102|FG001|COMPLETED|Overall Study||6||
48192693|NCT04423393|100794103|FG002|COMPLETED|Overall Study||6||
48192694|NCT04423393|100794104|FG003|COMPLETED|Overall Study||6||
48476072|NCT03356821|101502800|FG000|COMPLETED|Overall Study||10||
48476073|NCT03356821|101502800|FG000|NOT COMPLETED|Overall Study||0||
48476074|NCT01437501|101502801|FG000|STARTED|Overall Study||148||
48476075|NCT01437501|101502802|FG001|STARTED|Overall Study||143||
48476076|NCT01437501|101502801|FG000|COMPLETED|Overall Study||135||
48192695|NCT04423393|100794105|FG004|COMPLETED|Overall Study||6||
48476077|NCT01437501|101502802|FG001|COMPLETED|Overall Study||132||
48476078|NCT01437501|101502801|FG000|NOT COMPLETED|Overall Study||13||
48476079|NCT01437501|101502802|FG001|NOT COMPLETED|Overall Study||11||
48476080|NCT02107300|101502803|FG000|STARTED|Overall Study||16||
48476081|NCT02107300|101502804|FG001|STARTED|Overall Study||15||
48476082|NCT02107300|101502803|FG000|COMPLETED|Overall Study||16||
48476083|NCT02107300|101502804|FG001|COMPLETED|Overall Study||15||
48476084|NCT02107300|101502803|FG000|NOT COMPLETED|Overall Study||0||
48476085|NCT02107300|101502804|FG001|NOT COMPLETED|Overall Study||0||
48476086|NCT00076050|101502805|FG000|STARTED|Overall Study||122||
48476087|NCT00076050|101502806|FG001|STARTED|Overall Study||126||
48476088|NCT00076050|101502805|FG000|COMPLETED|Overall Study||99||
48476089|NCT00076050|101502806|FG001|COMPLETED|Overall Study||83||
48476090|NCT00076050|101502805|FG000|NOT COMPLETED|Overall Study||23||
48476091|NCT00076050|101502806|FG001|NOT COMPLETED|Overall Study||43||
48476092|NCT00051025|101502807|FG000|STARTED|Overall Study||5||
48476093|NCT00051025|101502808|FG001|STARTED|Overall Study||4||
48476094|NCT00051025|101502807|FG000|COMPLETED|Overall Study||3||
48476095|NCT00051025|101502808|FG001|COMPLETED|Overall Study||0||
48476096|NCT00051025|101502807|FG000|NOT COMPLETED|Overall Study||2||
48476097|NCT00051025|101502808|FG001|NOT COMPLETED|Overall Study||4||
48476098|NCT00630305|101502809|FG000|STARTED|Overall Study||37||
48476099|NCT00630305|101502809|FG000|COMPLETED|Overall Study||35||
48476100|NCT00630305|101502809|FG000|NOT COMPLETED|Overall Study||2||
48476101|NCT04494867|101502810|FG000|STARTED|Overall Study||10||
48476102|NCT04494867|101502811|FG001|STARTED|Overall Study||10||
48476103|NCT04494867|101502810|FG000|COMPLETED|Overall Study||7||
48476104|NCT04494867|101502811|FG001|COMPLETED|Overall Study||6||
48476105|NCT04494867|101502810|FG000|NOT COMPLETED|Overall Study||3||
48476106|NCT04494867|101502811|FG001|NOT COMPLETED|Overall Study||4||
48476107|NCT02091882|101502812|FG000|STARTED|Overall Study||30||
48476108|NCT02091882|101502812|FG000|COMPLETED|Overall Study||30||
48476109|NCT02091882|101502812|FG000|NOT COMPLETED|Overall Study||0||
48476110|NCT01203878|101502813|FG000|STARTED|Overall Study||9||
48476111|NCT01203878|101502814|FG001|STARTED|Overall Study||9||
48476112|NCT01203878|101502815|FG002|STARTED|Overall Study||3||
48476113|NCT01203878|101502813|FG000|COMPLETED|Overall Study||9||
48476114|NCT01203878|101502814|FG001|COMPLETED|Overall Study||9||
48476115|NCT01203878|101502815|FG002|COMPLETED|Overall Study||0||
48476116|NCT01203878|101502813|FG000|NOT COMPLETED|Overall Study||0||
48476117|NCT01203878|101502814|FG001|NOT COMPLETED|Overall Study||0||
48476118|NCT01203878|101502815|FG002|NOT COMPLETED|Overall Study||3||
48476119|NCT00679367|101502816|FG000|STARTED|Overall Study||16||
48476120|NCT00679367|101502816|FG000|COMPLETED|Overall Study||4||
48476121|NCT00679367|101502816|FG000|NOT COMPLETED|Overall Study||12||
48476122|NCT03450070|101502817|FG000|STARTED|Overall Study||118||
48476123|NCT03450070|101502817|FG000|COMPLETED|Overall Study||110||
48476124|NCT03450070|101502817|FG000|NOT COMPLETED|Overall Study||8||
48476125|NCT02735174|101502818|FG000|STARTED|Overall Study||21||
48476126|NCT02735174|101502818|FG000|COMPLETED|Overall Study||21||
48476127|NCT02735174|101502818|FG000|NOT COMPLETED|Overall Study||0||
48476128|NCT00386009|101502819|FG000|STARTED|Overall Study||101||
48476129|NCT00386009|101502820|FG001|STARTED|Overall Study||99||
48476130|NCT00386009|101502819|FG000|COMPLETED|Overall Study||92||
48476131|NCT00386009|101502820|FG001|COMPLETED|Overall Study||89||
48476132|NCT00386009|101502819|FG000|NOT COMPLETED|Overall Study||9||
48476133|NCT00386009|101502820|FG001|NOT COMPLETED|Overall Study||10||
48476134|NCT01027780|101502821|FG000|STARTED|Overall Study||105||
48476135|NCT01027780|101502822|FG001|STARTED|Overall Study||103||
48476136|NCT01027780|101502821|FG000|COMPLETED|Overall Study||105||
48476137|NCT01027780|101502822|FG001|COMPLETED|Overall Study||102||
48476138|NCT01027780|101502821|FG000|NOT COMPLETED|Overall Study||0||
48476139|NCT01027780|101502822|FG001|NOT COMPLETED|Overall Study||1||
48476140|NCT02869646|101502823|FG000|STARTED|Overall Study||47||
48476141|NCT02869646|101502824|FG001|STARTED|Overall Study||45||
48476142|NCT02869646|101502823|FG000|COMPLETED|Overall Study||39||
48476143|NCT02869646|101502824|FG001|COMPLETED|Overall Study||32||
48476144|NCT02869646|101502823|FG000|NOT COMPLETED|Overall Study||8||
48476145|NCT02869646|101502824|FG001|NOT COMPLETED|Overall Study||13||
48476146|NCT03553823|101502825|FG000|STARTED|Overall Study||20||
48476147|NCT03553823|101502826|FG001|STARTED|Overall Study||20||
48476148|NCT03553823|101502825|FG000|COMPLETED|Overall Study||20||
48476149|NCT03553823|101502826|FG001|COMPLETED|Overall Study||19||
48476150|NCT03553823|101502825|FG000|NOT COMPLETED|Overall Study||0||
48476151|NCT03553823|101502826|FG001|NOT COMPLETED|Overall Study||1||
48476152|NCT02589171|101502827|FG000|STARTED|Overall Study||35||
48476153|NCT02589171|101502828|FG001|STARTED|Overall Study||35||
48476154|NCT02589171|101502827|FG000|Day 1 Follow up|Overall Study||35||
48476155|NCT02589171|101502828|FG001|Day 1 Follow up|Overall Study||35||
48476156|NCT02589171|101502827|FG000|Week 1 Follow up|Overall Study||35||
48476157|NCT02589171|101502828|FG001|Week 1 Follow up|Overall Study||34||
48476158|NCT02589171|101502827|FG000|Week 6 Follow up|Overall Study||28||
48476159|NCT02589171|101502828|FG001|Week 6 Follow up|Overall Study||30||
48476160|NCT02589171|101502827|FG000|COMPLETED|Overall Study||28||
48476161|NCT02589171|101502828|FG001|COMPLETED|Overall Study||30||
48476162|NCT02589171|101502827|FG000|NOT COMPLETED|Overall Study||7||
48476163|NCT02589171|101502828|FG001|NOT COMPLETED|Overall Study||5||
48476164|NCT03472365|101502829|FG000|STARTED|Overall Study||48||
48476165|NCT03472365|101502830|FG001|STARTED|Overall Study||19||
48476166|NCT03472365|101502829|FG000|COMPLETED|Overall Study||48||
48476167|NCT03472365|101502830|FG001|COMPLETED|Overall Study||19||
48476168|NCT03472365|101502829|FG000|NOT COMPLETED|Overall Study||0||
48476169|NCT03472365|101502830|FG001|NOT COMPLETED|Overall Study||0||
48476170|NCT04538170|101502831|FG000|STARTED|Overall Study||158||
48476171|NCT04538170|101502832|FG001|STARTED|Overall Study||265||
48476172|NCT04538170|101502831|FG000|COMPLETED|Overall Study||54||
48476173|NCT04538170|101502832|FG001|COMPLETED|Overall Study||55||
48476174|NCT04538170|101502831|FG000|NOT COMPLETED|Overall Study||104||
48476175|NCT04538170|101502832|FG001|NOT COMPLETED|Overall Study||210||
48476176|NCT00527423|101502833|FG000|STARTED|Overall Study||157||
48476177|NCT00527423|101502833|FG000|COMPLETED|Overall Study||120||
48476178|NCT00527423|101502833|FG000|NOT COMPLETED|Overall Study||37||
48476179|NCT00995410|101502834|FG000|STARTED|Overall Study||380||
48476180|NCT00995410|101502834|FG000|Treated|Overall Study||379||
48476181|NCT00995410|101502834|FG000|COMPLETED|Overall Study||292||
48476182|NCT00995410|101502834|FG000|NOT COMPLETED|Overall Study||88||
48476183|NCT01313416|101502835|FG000|STARTED|Overall Study||2||
48666285|NCT00889330|101967547|FG000|STARTED|Overall Study||30||
48666286|NCT00889330|101967548|FG001|STARTED|Overall Study||30||
48666287|NCT00889330|101967547|FG000|COMPLETED|Overall Study||30||
48476184|NCT01313416|101502835|FG000|COMPLETED|Overall Study||2||
48476185|NCT01313416|101502835|FG000|NOT COMPLETED|Overall Study||0||
48476186|NCT01471093|101502836|FG000|STARTED|Overall Study||25||
48476187|NCT01471093|101502837|FG001|STARTED|Overall Study||25||
48476188|NCT01471093|101502838|FG002|STARTED|Overall Study||25||
48666288|NCT00889330|101967548|FG001|COMPLETED|Overall Study||30||
48666289|NCT00889330|101967547|FG000|NOT COMPLETED|Overall Study||0||
48476189|NCT01471093|101502839|FG003|STARTED|Overall Study||25||
48476190|NCT01471093|101502836|FG000|COMPLETED|Overall Study||24||
48476191|NCT01471093|101502837|FG001|COMPLETED|Overall Study||25||
48476192|NCT01471093|101502838|FG002|COMPLETED|Overall Study||25||
48476193|NCT01471093|101502839|FG003|COMPLETED|Overall Study||25||
48476194|NCT01471093|101502836|FG000|NOT COMPLETED|Overall Study||1||
48476195|NCT01471093|101502837|FG001|NOT COMPLETED|Overall Study||0||
48476196|NCT01471093|101502838|FG002|NOT COMPLETED|Overall Study||0||
48476197|NCT01471093|101502839|FG003|NOT COMPLETED|Overall Study||0||
48476198|NCT02303548|101502840|FG000|STARTED|Overall Study||25||
48476199|NCT02303548|101502841|FG001|STARTED|Overall Study||25||
48476200|NCT02303548|101502840|FG000|COMPLETED|Overall Study||25||
48476201|NCT02303548|101502841|FG001|COMPLETED|Overall Study||25||
48476202|NCT02303548|101502840|FG000|NOT COMPLETED|Overall Study||0||
48476203|NCT02303548|101502841|FG001|NOT COMPLETED|Overall Study||0||
48476204|NCT00419770|101502842|FG000|STARTED|Overall Study||11||
48476205|NCT00419770|101502843|FG001|STARTED|Overall Study||9||
48476206|NCT00419770|101502842|FG000|COMPLETED|Overall Study||6||
48476207|NCT00419770|101502843|FG001|COMPLETED|Overall Study||8||
48476208|NCT00419770|101502842|FG000|NOT COMPLETED|Overall Study||5||
48192696|NCT04423393|100794106|FG005|COMPLETED|Overall Study||10||
48192697|NCT04423393|100794107|FG006|COMPLETED|Overall Study||6||
48192698|NCT04423393|100794108|FG007|COMPLETED|Overall Study||6||
48192699|NCT04423393|100794109|FG008|COMPLETED|Overall Study||6||
48192700|NCT04423393|100794110|FG009|COMPLETED|Overall Study||6||
48192701|NCT04423393|100794111|FG010|COMPLETED|Overall Study||8||
48192702|NCT04423393|100794112|FG011|COMPLETED|Overall Study||6||
48192703|NCT04423393|100794113|FG012|COMPLETED|Overall Study||6||
48192704|NCT04423393|100794114|FG013|COMPLETED|Overall Study||4||
48192705|NCT04423393|100794115|FG014|COMPLETED|Overall Study||6||
48192706|NCT04423393|100794116|FG015|COMPLETED|Overall Study||6||
48192707|NCT04423393|100794117|FG016|COMPLETED|Overall Study||6||
48192708|NCT04423393|100794118|FG017|COMPLETED|Overall Study||4||
48192709|NCT04423393|100794101|FG000|NOT COMPLETED|Overall Study||0||
48192710|NCT04423393|100794102|FG001|NOT COMPLETED|Overall Study||0||
48192711|NCT04423393|100794103|FG002|NOT COMPLETED|Overall Study||0||
48192712|NCT04423393|100794104|FG003|NOT COMPLETED|Overall Study||0||
48192713|NCT04423393|100794105|FG004|NOT COMPLETED|Overall Study||0||
48192714|NCT04423393|100794106|FG005|NOT COMPLETED|Overall Study||1||
48192715|NCT04423393|100794107|FG006|NOT COMPLETED|Overall Study||0||
48192716|NCT04423393|100794108|FG007|NOT COMPLETED|Overall Study||0||
48192717|NCT04423393|100794109|FG008|NOT COMPLETED|Overall Study||0||
48192718|NCT04423393|100794110|FG009|NOT COMPLETED|Overall Study||0||
48192719|NCT04423393|100794111|FG010|NOT COMPLETED|Overall Study||0||
48192720|NCT04423393|100794112|FG011|NOT COMPLETED|Overall Study||0||
48192721|NCT04423393|100794113|FG012|NOT COMPLETED|Overall Study||0||
48192722|NCT04423393|100794114|FG013|NOT COMPLETED|Overall Study||2||
48192723|NCT04423393|100794115|FG014|NOT COMPLETED|Overall Study||0||
48192724|NCT04423393|100794116|FG015|NOT COMPLETED|Overall Study||0||
48192725|NCT04423393|100794117|FG016|NOT COMPLETED|Overall Study||0||
48192726|NCT04423393|100794118|FG017|NOT COMPLETED|Overall Study||0||
48192727|NCT05305040|100794119|FG000|STARTED|Overall Study||225|Participants Randomized|
48192728|NCT05305040|100794120|FG001|STARTED|Overall Study||226|Participants Randomized|
48192729|NCT05305040|100794119|FG000|Participants Dosed (Safety Population)|Overall Study||188||
48192730|NCT05305040|100794120|FG001|Participants Dosed (Safety Population)|Overall Study||189||
48192731|NCT05305040|100794119|FG000|COMPLETED|Overall Study||100||
48192732|NCT05305040|100794120|FG001|COMPLETED|Overall Study||101||
48192733|NCT05305040|100794119|FG000|NOT COMPLETED|Overall Study||125||
48192734|NCT05305040|100794120|FG001|NOT COMPLETED|Overall Study||125||
48192735|NCT02708862|100794121|FG000|STARTED|Overall Study||26||
48192736|NCT02708862|100794121|FG000|COMPLETED|Overall Study||26||
48192737|NCT02708862|100794121|FG000|NOT COMPLETED|Overall Study||0||
48192738|NCT01144949|100794122|FG000|STARTED|Overall Study||119||
48192739|NCT01144949|100794123|FG001|STARTED|Overall Study||120||
48192740|NCT01144949|100794122|FG000|COMPLETED|Overall Study||108||
48192741|NCT01144949|100794123|FG001|COMPLETED|Overall Study||106||
48476209|NCT00419770|101502843|FG001|NOT COMPLETED|Overall Study||1||
48476210|NCT00822926|101502844|FG000|STARTED|First Injection Visit||2||
48476211|NCT00822926|101502845|FG001|STARTED|First Injection Visit||3||
48476212|NCT00822926|101502844|FG000|COMPLETED|First Injection Visit||2||
48476213|NCT00822926|101502845|FG001|COMPLETED|First Injection Visit||3||
48476214|NCT00822926|101502844|FG000|NOT COMPLETED|First Injection Visit||0||
48192742|NCT01144949|100794122|FG000|NOT COMPLETED|Overall Study||11||
48192743|NCT01144949|100794123|FG001|NOT COMPLETED|Overall Study||14||
48192744|NCT04577183|100794124|FG000|STARTED|Overall Study||13||
48192745|NCT04577183|100794124|FG000|COMPLETED|Overall Study||7||
48192746|NCT04577183|100794124|FG000|NOT COMPLETED|Overall Study||6||
48192747|NCT03374072|100794125|FG000|STARTED|4 Months||10||
48192748|NCT03374072|100794126|FG001|STARTED|4 Months||9||
48192749|NCT03374072|100794125|FG000|COMPLETED|4 Months||8||
48192750|NCT03374072|100794126|FG001|COMPLETED|4 Months||9||
48192751|NCT03374072|100794125|FG000|NOT COMPLETED|4 Months||2||
48192752|NCT03374072|100794126|FG001|NOT COMPLETED|4 Months||0||
48192753|NCT03374072|100794125|FG000|STARTED|7 Months||8||
48192754|NCT03374072|100794126|FG001|STARTED|7 Months||9||
48192755|NCT03374072|100794125|FG000|COMPLETED|7 Months||8||
48192756|NCT03374072|100794126|FG001|COMPLETED|7 Months||9||
48192757|NCT03374072|100794125|FG000|NOT COMPLETED|7 Months||0||
48192758|NCT03374072|100794126|FG001|NOT COMPLETED|7 Months||0||
48192759|NCT01928940|100794127|FG000|STARTED|Overall Study||6||
48476215|NCT00822926|101502845|FG001|NOT COMPLETED|First Injection Visit||0||
48476216|NCT00822926|101502844|FG000|STARTED|Washout (Varies Based on Scheduling)||2||
48476217|NCT00822926|101502845|FG001|STARTED|Washout (Varies Based on Scheduling)||3||
48476218|NCT00822926|101502844|FG000|COMPLETED|Washout (Varies Based on Scheduling)||2||
48476219|NCT00822926|101502845|FG001|COMPLETED|Washout (Varies Based on Scheduling)||3||
48476220|NCT00822926|101502844|FG000|NOT COMPLETED|Washout (Varies Based on Scheduling)||0||
48476221|NCT00822926|101502845|FG001|NOT COMPLETED|Washout (Varies Based on Scheduling)||0||
48476222|NCT00822926|101502844|FG000|STARTED|Second Injection Visit||2||
48476223|NCT00822926|101502845|FG001|STARTED|Second Injection Visit||3||
48476224|NCT00822926|101502844|FG000|COMPLETED|Second Injection Visit||1||
48476225|NCT00822926|101502845|FG001|COMPLETED|Second Injection Visit||2||
48476226|NCT00822926|101502844|FG000|NOT COMPLETED|Second Injection Visit||1||
48476227|NCT00822926|101502845|FG001|NOT COMPLETED|Second Injection Visit||1||
48476228|NCT00414466|101502846|FG000|STARTED|Overall Study||44||
48476229|NCT00414466|101502847|FG001|STARTED|Overall Study||42||
48476230|NCT00414466|101502848|FG002|STARTED|Overall Study||41||
48476231|NCT00414466|101502849|FG003|STARTED|Overall Study||43||
48476232|NCT00414466|101502846|FG000|COMPLETED|Overall Study||42||
48476233|NCT00414466|101502847|FG001|COMPLETED|Overall Study||42||
48476234|NCT00414466|101502848|FG002|COMPLETED|Overall Study||40||
48476235|NCT00414466|101502849|FG003|COMPLETED|Overall Study||42||
48476236|NCT00414466|101502846|FG000|NOT COMPLETED|Overall Study||2||
48476237|NCT00414466|101502847|FG001|NOT COMPLETED|Overall Study||0||
48476238|NCT00414466|101502848|FG002|NOT COMPLETED|Overall Study||1||
48476239|NCT00414466|101502849|FG003|NOT COMPLETED|Overall Study||1||
48476240|NCT04091971|101502850|FG000|STARTED|Overall Study||9||
48476241|NCT04091971|101502850|FG000|COMPLETED|Overall Study||5||
48476242|NCT04091971|101502850|FG000|NOT COMPLETED|Overall Study||4||
48476243|NCT02353169|101502851|FG000|STARTED|Overall Study||15||
48476244|NCT02353169|101502852|FG001|STARTED|Overall Study||18||
48476245|NCT02353169|101502853|FG002|STARTED|Overall Study||16||
48476246|NCT02353169|101502854|FG003|STARTED|Overall Study||15||
48476247|NCT02353169|101502851|FG000|COMPLETED|Overall Study||12||
48476248|NCT02353169|101502852|FG001|COMPLETED|Overall Study||12||
48476249|NCT02353169|101502853|FG002|COMPLETED|Overall Study||12||
48476250|NCT02353169|101502854|FG003|COMPLETED|Overall Study||12||
48476251|NCT02353169|101502851|FG000|NOT COMPLETED|Overall Study||3||
48476252|NCT02353169|101502852|FG001|NOT COMPLETED|Overall Study||6||
48476253|NCT02353169|101502853|FG002|NOT COMPLETED|Overall Study||4||
48476254|NCT02353169|101502854|FG003|NOT COMPLETED|Overall Study||3||
48476255|NCT01087970|101502855|FG000|STARTED|Overall Study||69||
48476256|NCT01087970|101502855|FG000|Received ≥1 Dose of Any Study Drug|Overall Study||69||
48476257|NCT01087970|101502855|FG000|Completed 6 Cycles|Overall Study||69||
48476258|NCT01087970|101502855|FG000|Efficacy Population|Overall Study||58||
48476259|NCT01087970|101502855|FG000|Received Carboplatin|Overall Study||63||
48476260|NCT01087970|101502855|FG000|COMPLETED|Overall Study||67||
48476261|NCT01087970|101502855|FG000|NOT COMPLETED|Overall Study||2||
48476262|NCT04826809|101502856|FG000|STARTED|Overall Study||41||
48476263|NCT04826809|101502856|FG000|COMPLETED|Overall Study||41||
48476264|NCT04826809|101502856|FG000|NOT COMPLETED|Overall Study||0||
48476265|NCT00486837|101502857|FG000|STARTED|Overall Study||37||
48476266|NCT00486837|101502858|FG001|STARTED|Overall Study||35||
48476267|NCT00486837|101502857|FG000|COMPLETED|Overall Study||28||
48476268|NCT00486837|101502858|FG001|COMPLETED|Overall Study||28||
48476269|NCT00486837|101502857|FG000|NOT COMPLETED|Overall Study||9||
48476270|NCT00486837|101502858|FG001|NOT COMPLETED|Overall Study||7||
48476271|NCT00625443|101502859|FG000|STARTED|Overall Study||12||
48476272|NCT00625443|101502860|FG001|STARTED|Overall Study||26||
48476273|NCT00625443|101502861|FG002|STARTED|Overall Study||15||
48476274|NCT00625443|101502859|FG000|COMPLETED|Overall Study||10||
48476275|NCT00625443|101502860|FG001|COMPLETED|Overall Study||15||
48476276|NCT00625443|101502861|FG002|COMPLETED|Overall Study||10||
48476277|NCT00625443|101502859|FG000|NOT COMPLETED|Overall Study||2||
48476278|NCT00625443|101502860|FG001|NOT COMPLETED|Overall Study||11||
48476279|NCT00625443|101502861|FG002|NOT COMPLETED|Overall Study||5||
48476280|NCT01449630|101502862|FG000|STARTED|Period 1||2||
48476281|NCT01449630|101502863|FG001|STARTED|Period 1||6||
48476282|NCT01449630|101502864|FG002|STARTED|Period 1||2||
48476283|NCT01449630|101502865|FG003|STARTED|Period 1||2||
48476284|NCT01449630|101502866|FG004|STARTED|Period 1||5||
48476285|NCT01449630|101502867|FG005|STARTED|Period 1||2||
48476286|NCT01449630|101502868|FG006|STARTED|Period 1||2||
48192760|NCT01928940|100794128|FG001|STARTED|Overall Study||6||
48192761|NCT01928940|100794127|FG000|COMPLETED|Overall Study||6||
48192762|NCT01928940|100794128|FG001|COMPLETED|Overall Study||5||
48476287|NCT01449630|101502869|FG007|STARTED|Period 1||6||
48476288|NCT01449630|101502870|FG008|STARTED|Period 1||2||
48476289|NCT01449630|101502862|FG000|Received at Least 1 Dose|Period 1||2||
48476290|NCT01449630|101502863|FG001|Received at Least 1 Dose|Period 1||6||
48476291|NCT01449630|101502864|FG002|Received at Least 1 Dose|Period 1||2||
48192763|NCT01928940|100794127|FG000|NOT COMPLETED|Overall Study||0||
48476292|NCT01449630|101502865|FG003|Received at Least 1 Dose|Period 1||2||
48476293|NCT01449630|101502866|FG004|Received at Least 1 Dose|Period 1||5||
48476294|NCT01449630|101502867|FG005|Received at Least 1 Dose|Period 1||1||
48476295|NCT01449630|101502868|FG006|Received at Least 1 Dose|Period 1||2||
48476296|NCT01449630|101502869|FG007|Received at Least 1 Dose|Period 1||6||
48476297|NCT01449630|101502870|FG008|Received at Least 1 Dose|Period 1||2||
48666290|NCT00889330|101967548|FG001|NOT COMPLETED|Overall Study||0||
48476298|NCT01449630|101502862|FG000|COMPLETED|Period 1||1||
48476299|NCT01449630|101502863|FG001|COMPLETED|Period 1||6||
48476300|NCT01449630|101502864|FG002|COMPLETED|Period 1||2||
48476301|NCT01449630|101502865|FG003|COMPLETED|Period 1||1||
48476302|NCT01449630|101502866|FG004|COMPLETED|Period 1||5||
48476303|NCT01449630|101502867|FG005|COMPLETED|Period 1||1||
48476304|NCT01449630|101502868|FG006|COMPLETED|Period 1||2||
48192764|NCT01928940|100794128|FG001|NOT COMPLETED|Overall Study||1||
48476305|NCT01449630|101502869|FG007|COMPLETED|Period 1||6||
48476306|NCT01449630|101502870|FG008|COMPLETED|Period 1||2||
48476307|NCT01449630|101502862|FG000|NOT COMPLETED|Period 1||1||
48476308|NCT01449630|101502863|FG001|NOT COMPLETED|Period 1||0||
48476309|NCT01449630|101502864|FG002|NOT COMPLETED|Period 1||0||
48476310|NCT01449630|101502865|FG003|NOT COMPLETED|Period 1||1||
48476311|NCT01449630|101502866|FG004|NOT COMPLETED|Period 1||0||
48476312|NCT01449630|101502867|FG005|NOT COMPLETED|Period 1||1||
48476313|NCT01449630|101502868|FG006|NOT COMPLETED|Period 1||0||
48476314|NCT01449630|101502869|FG007|NOT COMPLETED|Period 1||0||
48476315|NCT01449630|101502870|FG008|NOT COMPLETED|Period 1||0||
48476316|NCT01449630|101502862|FG000|STARTED|Period 2||1||
48476317|NCT01449630|101502863|FG001|STARTED|Period 2||6||
48476318|NCT01449630|101502864|FG002|STARTED|Period 2||2||
48476319|NCT01449630|101502865|FG003|STARTED|Period 2||1||
48476320|NCT01449630|101502866|FG004|STARTED|Period 2||5||
48476321|NCT01449630|101502867|FG005|STARTED|Period 2||1||
48476322|NCT01449630|101502868|FG006|STARTED|Period 2||2||
48476323|NCT01449630|101502869|FG007|STARTED|Period 2||6||
48476324|NCT01449630|101502870|FG008|STARTED|Period 2||2||
48476325|NCT01449630|101502862|FG000|COMPLETED|Period 2||1||
48476326|NCT01449630|101502863|FG001|COMPLETED|Period 2||6||
48476327|NCT01449630|101502864|FG002|COMPLETED|Period 2||2||
48476328|NCT01449630|101502865|FG003|COMPLETED|Period 2||1||
48476329|NCT01449630|101502866|FG004|COMPLETED|Period 2||5||
48476330|NCT01449630|101502867|FG005|COMPLETED|Period 2||1||
48476331|NCT01449630|101502868|FG006|COMPLETED|Period 2||1||
48476332|NCT01449630|101502869|FG007|COMPLETED|Period 2||6||
48476333|NCT01449630|101502870|FG008|COMPLETED|Period 2||2||
48476334|NCT01449630|101502862|FG000|NOT COMPLETED|Period 2||0||
48476335|NCT01449630|101502863|FG001|NOT COMPLETED|Period 2||0||
48476336|NCT01449630|101502864|FG002|NOT COMPLETED|Period 2||0||
48476337|NCT01449630|101502865|FG003|NOT COMPLETED|Period 2||0||
48476338|NCT01449630|101502866|FG004|NOT COMPLETED|Period 2||0||
48476339|NCT01449630|101502867|FG005|NOT COMPLETED|Period 2||0||
48476340|NCT01449630|101502868|FG006|NOT COMPLETED|Period 2||1||
48476341|NCT01449630|101502869|FG007|NOT COMPLETED|Period 2||0||
48476342|NCT01449630|101502870|FG008|NOT COMPLETED|Period 2||0||
48476343|NCT01449630|101502862|FG000|STARTED|Period 3||1||
48476344|NCT01449630|101502863|FG001|STARTED|Period 3||6||
48476345|NCT01449630|101502864|FG002|STARTED|Period 3||2||
48476346|NCT01449630|101502865|FG003|STARTED|Period 3||1||
48476347|NCT01449630|101502866|FG004|STARTED|Period 3||5||
48476348|NCT01449630|101502867|FG005|STARTED|Period 3||1||
48476349|NCT01449630|101502868|FG006|STARTED|Period 3||1||
48476350|NCT01449630|101502869|FG007|STARTED|Period 3||6||
48476351|NCT01449630|101502870|FG008|STARTED|Period 3||2||
48476352|NCT01449630|101502862|FG000|COMPLETED|Period 3||1||
48476353|NCT01449630|101502863|FG001|COMPLETED|Period 3||6||
48476354|NCT01449630|101502864|FG002|COMPLETED|Period 3||2||
48476355|NCT01449630|101502865|FG003|COMPLETED|Period 3||1||
48476356|NCT01449630|101502866|FG004|COMPLETED|Period 3||5||
48476357|NCT01449630|101502867|FG005|COMPLETED|Period 3||1||
48476358|NCT01449630|101502868|FG006|COMPLETED|Period 3||1||
48476359|NCT01449630|101502869|FG007|COMPLETED|Period 3||6||
48476360|NCT01449630|101502870|FG008|COMPLETED|Period 3||2||
48476361|NCT01449630|101502862|FG000|NOT COMPLETED|Period 3||0||
48476362|NCT01449630|101502863|FG001|NOT COMPLETED|Period 3||0||
48476363|NCT01449630|101502864|FG002|NOT COMPLETED|Period 3||0||
48476364|NCT01449630|101502865|FG003|NOT COMPLETED|Period 3||0||
48192765|NCT01257503|100794129|FG000|STARTED|Overall Study||133||
48476365|NCT01449630|101502866|FG004|NOT COMPLETED|Period 3||0||
48666291|NCT00437073|101967549|FG000|STARTED|Overall Study||13||
48476366|NCT01449630|101502867|FG005|NOT COMPLETED|Period 3||0||
48476367|NCT01449630|101502868|FG006|NOT COMPLETED|Period 3||0||
48476368|NCT01449630|101502869|FG007|NOT COMPLETED|Period 3||0||
48476369|NCT01449630|101502870|FG008|NOT COMPLETED|Period 3||0||
48476370|NCT00552669|101502871|FG000|STARTED|Overall Study||100||
48476371|NCT00552669|101502872|FG001|STARTED|Overall Study||100||
48476372|NCT00552669|101502871|FG000|COMPLETED|Overall Study||97||
48476373|NCT00552669|101502872|FG001|COMPLETED|Overall Study||93||
48476374|NCT00552669|101502871|FG000|NOT COMPLETED|Overall Study||3||
48476375|NCT00552669|101502872|FG001|NOT COMPLETED|Overall Study||7||
48476376|NCT04109222|101502873|FG000|STARTED|Overall Study||30|Vaccinated participants.|
48666292|NCT00437073|101967550|FG001|STARTED|Overall Study||9||
48476377|NCT04109222|101502874|FG001|STARTED|Overall Study||30|Vaccinated participants.|
48476378|NCT04109222|101502875|FG002|STARTED|Overall Study||30|Vaccinated participants.|
48476379|NCT04109222|101502873|FG000|COMPLETED|Overall Study||29||
48476380|NCT04109222|101502874|FG001|COMPLETED|Overall Study||30||
48476381|NCT04109222|101502875|FG002|COMPLETED|Overall Study||30||
48476382|NCT04109222|101502873|FG000|NOT COMPLETED|Overall Study||1||
48476383|NCT04109222|101502874|FG001|NOT COMPLETED|Overall Study||0||
48476384|NCT04109222|101502875|FG002|NOT COMPLETED|Overall Study||0||
48476385|NCT00064753|101502876|FG000|STARTED|Overall Study||2056||
48476386|NCT00064753|101502877|FG001|STARTED|Overall Study||2054||
48476387|NCT00064753|101502876|FG000|COMPLETED|Overall Study||1382||
48476388|NCT00064753|101502877|FG001|COMPLETED|Overall Study||1406||
48476389|NCT00064753|101502876|FG000|NOT COMPLETED|Overall Study||674||
48476390|NCT00064753|101502877|FG001|NOT COMPLETED|Overall Study||648||
48476391|NCT02892500|101502878|FG000|STARTED|Overall Study||0||
48476392|NCT02892500|101502879|FG001|STARTED|Overall Study||0||
48476393|NCT02892500|101502878|FG000|COMPLETED|Overall Study||0||
48476394|NCT02892500|101502879|FG001|COMPLETED|Overall Study||0||
48476395|NCT02892500|101502878|FG000|NOT COMPLETED|Overall Study||0||
48476396|NCT02892500|101502879|FG001|NOT COMPLETED|Overall Study||0||
48476397|NCT00429364|101502880|FG000|STARTED|Overall Study||303||
48476398|NCT00429364|101502881|FG001|STARTED|Overall Study||305||
48476399|NCT00429364|101502880|FG000|COMPLETED|Overall Study||271||
48476400|NCT00429364|101502881|FG001|COMPLETED|Overall Study||272||
48476401|NCT00429364|101502880|FG000|NOT COMPLETED|Overall Study||32||
48476402|NCT00429364|101502881|FG001|NOT COMPLETED|Overall Study||33||
48476403|NCT00979732|101502882|FG000|STARTED|Overall Study||15||
48476404|NCT00979732|101502883|FG001|STARTED|Overall Study||18||
48476405|NCT00979732|101502882|FG000|COMPLETED|Overall Study||12||
48192766|NCT01257503|100794130|FG001|STARTED|Overall Study||130||
48192767|NCT01257503|100794129|FG000|Returned Symptom Diaries|Overall Study||80||
48192768|NCT01257503|100794130|FG001|Returned Symptom Diaries|Overall Study||83||
48192769|NCT01257503|100794129|FG000|Returned Dosage Logbooks|Overall Study||75||
48192770|NCT01257503|100794130|FG001|Returned Dosage Logbooks|Overall Study||80||
48192771|NCT01257503|100794129|FG000|COMPLETED|Overall Study||125||
48192772|NCT01257503|100794130|FG001|COMPLETED|Overall Study||119||
48192773|NCT01257503|100794129|FG000|NOT COMPLETED|Overall Study||8||
48476406|NCT00979732|101502883|FG001|COMPLETED|Overall Study||17||
48476407|NCT00979732|101502882|FG000|NOT COMPLETED|Overall Study||3||
48476408|NCT00979732|101502883|FG001|NOT COMPLETED|Overall Study||1||
48476409|NCT00454909|101502884|FG000|STARTED|Overall Study||587||
48476410|NCT00454909|101502885|FG001|STARTED|Overall Study||197||
48476411|NCT00454909|101502886|FG002|STARTED|Overall Study||88||
48476412|NCT00454909|101502884|FG000|COMPLETED|Overall Study||580||
48476413|NCT00454909|101502885|FG001|COMPLETED|Overall Study||194||
48476414|NCT00454909|101502886|FG002|COMPLETED|Overall Study||86||
48476415|NCT00454909|101502884|FG000|NOT COMPLETED|Overall Study||7||
48476416|NCT00454909|101502885|FG001|NOT COMPLETED|Overall Study||3||
48476417|NCT00454909|101502886|FG002|NOT COMPLETED|Overall Study||2||
48476418|NCT02024087|101502887|FG000|STARTED|Overall Study||5||
48476419|NCT02024087|101502888|FG001|STARTED|Overall Study||16||
48476420|NCT02024087|101502887|FG000|COMPLETED|Overall Study||5||
48476421|NCT02024087|101502888|FG001|COMPLETED|Overall Study||16||
48476422|NCT02024087|101502887|FG000|NOT COMPLETED|Overall Study||0||
48476423|NCT02024087|101502888|FG001|NOT COMPLETED|Overall Study||0||
48476424|NCT00984295|101502889|FG000|STARTED|Overall Study||949||
48476425|NCT00984295|101502890|FG001|STARTED|Overall Study||485||
48476426|NCT00984295|101502891|FG002|STARTED|Overall Study||479||
48476427|NCT00984295|101502889|FG000|Visit 1|Overall Study||949||
48476428|NCT00984295|101502890|FG001|Visit 1|Overall Study||485||
48476429|NCT00984295|101502891|FG002|Visit 1|Overall Study||479||
48476430|NCT00984295|101502889|FG000|Visit 2|Overall Study||909||
48476431|NCT00984295|101502890|FG001|Visit 2|Overall Study||468||
48476432|NCT00984295|101502891|FG002|Visit 2|Overall Study||453||
48476433|NCT00984295|101502889|FG000|COMPLETED|Overall Study||884||
48476434|NCT00984295|101502890|FG001|COMPLETED|Overall Study||453||
48476435|NCT00984295|101502891|FG002|COMPLETED|Overall Study||442||
48476436|NCT00984295|101502889|FG000|NOT COMPLETED|Overall Study||65||
48476437|NCT00984295|101502890|FG001|NOT COMPLETED|Overall Study||32||
48476438|NCT00984295|101502891|FG002|NOT COMPLETED|Overall Study||37||
48476439|NCT00939653|101502892|FG000|STARTED|Treatment Course 1||6||
48476440|NCT00939653|101502892|FG000|COMPLETED|Treatment Course 1||6||
48476441|NCT00939653|101502892|FG000|NOT COMPLETED|Treatment Course 1||0||
48666293|NCT00437073|101967549|FG000|COMPLETED|Overall Study||12||
48476442|NCT00939653|101502892|FG000|STARTED|Treatment Course 2||2|Required for all patients who achieve Complete Remission (CR) or CRp, unless proceeding to HSCT|
48476443|NCT00939653|101502892|FG000|COMPLETED|Treatment Course 2||2||
48476444|NCT00939653|101502892|FG000|NOT COMPLETED|Treatment Course 2||0||
48666294|NCT00437073|101967550|FG001|COMPLETED|Overall Study||8||
48476445|NCT00939653|101502892|FG000|STARTED|Treatment Course 3||0|Patients with CR or CRp and meeting other protocol-defined criteria may proceed to Courses 3 and 4.|
48476446|NCT00939653|101502892|FG000|COMPLETED|Treatment Course 3||0||
48476447|NCT00939653|101502892|FG000|NOT COMPLETED|Treatment Course 3||0||
48476448|NCT00939653|101502892|FG000|STARTED|Treatment Course 4||0||
48476449|NCT00939653|101502892|FG000|COMPLETED|Treatment Course 4||0||
48476450|NCT00939653|101502892|FG000|NOT COMPLETED|Treatment Course 4||0||
48476451|NCT03571048|101502893|FG000|STARTED|Overall Study||40||
48476452|NCT03571048|101502894|FG001|STARTED|Overall Study||41||
48476453|NCT03571048|101502893|FG000|COMPLETED|Overall Study||31||
48476454|NCT03571048|101502894|FG001|COMPLETED|Overall Study||32||
48476455|NCT03571048|101502893|FG000|NOT COMPLETED|Overall Study||9||
48476456|NCT03571048|101502894|FG001|NOT COMPLETED|Overall Study||9||
48476457|NCT03420300|101502895|FG000|STARTED|Overall Study||40||
48476458|NCT03420300|101502895|FG000|COMPLETED|Overall Study||38||
48476459|NCT03420300|101502895|FG000|NOT COMPLETED|Overall Study||2||
48476460|NCT04088760|101502896|FG000|STARTED|Overall Study||15||
48476461|NCT04088760|101502896|FG000|COMPLETED|Overall Study||14||
48476462|NCT04088760|101502896|FG000|NOT COMPLETED|Overall Study||1||
48476463|NCT02458638|101502897|FG000|STARTED|Overall Study||474||
48476464|NCT02458638|101502897|FG000|COMPLETED|Overall Study||15||
48476465|NCT02458638|101502897|FG000|NOT COMPLETED|Overall Study||459||
48476466|NCT01050647|101502898|FG000|STARTED|Overall Study||10||
48476467|NCT01050647|101502899|FG001|STARTED|Overall Study||11||
48476468|NCT01050647|101502898|FG000|COMPLETED|Overall Study||10||
48192774|NCT01257503|100794130|FG001|NOT COMPLETED|Overall Study||11||
48192775|NCT01251614|100794131|FG000|STARTED|Overall Study||37||
48192776|NCT01251614|100794132|FG001|STARTED|Overall Study||39||
48192777|NCT01251614|100794133|FG002|STARTED|Overall Study||38||
48192778|NCT01251614|100794131|FG000|Entered Period B|Overall Study||13||
48192779|NCT01251614|100794132|FG001|Entered Period B|Overall Study||18||
48192780|NCT01251614|100794133|FG002|Entered Period B|Overall Study||23||
48192781|NCT01251614|100794131|FG000|Entered Period C|Overall Study||8||
48192782|NCT01251614|100794132|FG001|Entered Period C|Overall Study||11||
48192783|NCT01251614|100794133|FG002|Entered Period C|Overall Study||19||
48192784|NCT01251614|100794131|FG000|Entered Period D|Overall Study||36||
48192785|NCT01251614|100794132|FG001|Entered Period D|Overall Study||36||
48192786|NCT01251614|100794133|FG002|Entered Period D|Overall Study||36||
48192787|NCT01251614|100794131|FG000|COMPLETED|Overall Study||34||
48192788|NCT01251614|100794132|FG001|COMPLETED|Overall Study||26||
48192789|NCT01251614|100794133|FG002|COMPLETED|Overall Study||30||
48192790|NCT01251614|100794131|FG000|NOT COMPLETED|Overall Study||3||
48192791|NCT01251614|100794132|FG001|NOT COMPLETED|Overall Study||13||
48192792|NCT01251614|100794133|FG002|NOT COMPLETED|Overall Study||8||
48192793|NCT03656133|100794134|FG000|STARTED|Overall Study||55||
48192794|NCT03656133|100794134|FG000|COMPLETED|Overall Study||55||
48192795|NCT03656133|100794134|FG000|NOT COMPLETED|Overall Study||0||
48192796|NCT01021332|100794135|FG000|STARTED|Overall Study||1066||
48192797|NCT01021332|100794135|FG000|Safety Analysis Set (SAF)|Overall Study||1066||
48192798|NCT01021332|100794135|FG000|Full Analysis Set (FAS)|Overall Study||1009||
48476469|NCT01050647|101502899|FG001|COMPLETED|Overall Study||11||
48476470|NCT01050647|101502898|FG000|NOT COMPLETED|Overall Study||0||
48476471|NCT01050647|101502899|FG001|NOT COMPLETED|Overall Study||0||
48476472|NCT01212874|101502900|FG000|STARTED|Overall Study||35||
48476473|NCT01212874|101502901|FG001|STARTED|Overall Study||35||
48476474|NCT01212874|101502900|FG000|Received Allocated Intervention|Overall Study||13||
48476475|NCT01212874|101502901|FG001|Received Allocated Intervention|Overall Study||12||
48476476|NCT01212874|101502900|FG000|COMPLETED|Overall Study||13||
48476477|NCT01212874|101502901|FG001|COMPLETED|Overall Study||12||
48476478|NCT01212874|101502900|FG000|NOT COMPLETED|Overall Study||22||
48476479|NCT01212874|101502901|FG001|NOT COMPLETED|Overall Study||23||
48476480|NCT01052116|101502902|FG000|STARTED|Overall Study||193||
48476481|NCT01052116|101502903|FG001|STARTED|Overall Study||193||
48476482|NCT01052116|101502902|FG000|COMPLETED|Overall Study||179||
48476483|NCT01052116|101502903|FG001|COMPLETED|Overall Study||166||
48192799|NCT01021332|100794135|FG000|COMPLETED|Overall Study||960||
48192800|NCT01021332|100794135|FG000|NOT COMPLETED|Overall Study||106||
48192801|NCT00088465|100794136|FG000|STARTED|Overall Study||931||
48192802|NCT00088465|100794136|FG000|COMPLETED|Overall Study||370||
48192803|NCT00088465|100794136|FG000|NOT COMPLETED|Overall Study||561||
48192804|NCT02734004|100794137|FG000|STARTED|Overall Study||40||
48192805|NCT02734004|100794138|FG001|STARTED|Overall Study||34||
48192806|NCT02734004|100794139|FG002|STARTED|Overall Study||34||
48192807|NCT02734004|100794140|FG003|STARTED|Overall Study||40||
48192808|NCT02734004|100794141|FG004|STARTED|Overall Study||51||
48192809|NCT02734004|100794142|FG005|STARTED|Overall Study||31||
48192810|NCT02734004|100794143|FG006|STARTED|Overall Study||32||
48192811|NCT02734004|100794137|FG000|COMPLETED|Overall Study||0||
48192812|NCT02734004|100794138|FG001|COMPLETED|Overall Study||0||
48476484|NCT01052116|101502902|FG000|NOT COMPLETED|Overall Study||14||
48476485|NCT01052116|101502903|FG001|NOT COMPLETED|Overall Study||27||
48476486|NCT02194998|101502904|FG000|STARTED|On-HCV Treatment||21||
48476487|NCT02194998|101502905|FG001|STARTED|On-HCV Treatment||6||
48476488|NCT02194998|101502906|FG002|STARTED|On-HCV Treatment||15||
48192813|NCT02734004|100794139|FG002|COMPLETED|Overall Study||0||
48192814|NCT02734004|100794140|FG003|COMPLETED|Overall Study||0||
48192815|NCT02734004|100794141|FG004|COMPLETED|Overall Study||0||
48192816|NCT02734004|100794142|FG005|COMPLETED|Overall Study||0||
48192817|NCT02734004|100794143|FG006|COMPLETED|Overall Study||0||
48192818|NCT02734004|100794137|FG000|NOT COMPLETED|Overall Study||40||
48192819|NCT02734004|100794138|FG001|NOT COMPLETED|Overall Study||34||
48192820|NCT02734004|100794139|FG002|NOT COMPLETED|Overall Study||34||
48192821|NCT02734004|100794140|FG003|NOT COMPLETED|Overall Study||40||
48192822|NCT02734004|100794141|FG004|NOT COMPLETED|Overall Study||51||
48192823|NCT02734004|100794142|FG005|NOT COMPLETED|Overall Study||31||
48192824|NCT02734004|100794143|FG006|NOT COMPLETED|Overall Study||32||
48192825|NCT02655692|100794144|FG000|STARTED|Overall Study||55||
48192826|NCT02655692|100794145|FG001|STARTED|Overall Study||55||
48192827|NCT02655692|100794146|FG002|STARTED|Overall Study||53||
48192828|NCT02655692|100794144|FG000|COMPLETED|Overall Study||36||
48192829|NCT02655692|100794145|FG001|COMPLETED|Overall Study||41||
48192830|NCT02655692|100794146|FG002|COMPLETED|Overall Study||40||
48192831|NCT02655692|100794144|FG000|NOT COMPLETED|Overall Study||19||
48192832|NCT02655692|100794145|FG001|NOT COMPLETED|Overall Study||14||
48476489|NCT02194998|101502907|FG003|STARTED|On-HCV Treatment||4||
48476490|NCT02194998|101502904|FG000|COMPLETED|On-HCV Treatment||21||
48476491|NCT02194998|101502905|FG001|COMPLETED|On-HCV Treatment||5||
48476492|NCT02194998|101502906|FG002|COMPLETED|On-HCV Treatment||15||
48476493|NCT02194998|101502907|FG003|COMPLETED|On-HCV Treatment||4||
48476494|NCT02194998|101502904|FG000|NOT COMPLETED|On-HCV Treatment||0||
48476495|NCT02194998|101502905|FG001|NOT COMPLETED|On-HCV Treatment||1||
48476496|NCT02194998|101502906|FG002|NOT COMPLETED|On-HCV Treatment||0||
48476497|NCT02194998|101502907|FG003|NOT COMPLETED|On-HCV Treatment||0||
48476498|NCT02194998|101502904|FG000|STARTED|Post-HCV Treatment Follow-Up||21||
48476499|NCT02194998|101502905|FG001|STARTED|Post-HCV Treatment Follow-Up||5||
48476500|NCT02194998|101502906|FG002|STARTED|Post-HCV Treatment Follow-Up||15||
48476501|NCT02194998|101502907|FG003|STARTED|Post-HCV Treatment Follow-Up||4||
48476502|NCT02194998|101502904|FG000|COMPLETED|Post-HCV Treatment Follow-Up||20||
48476503|NCT02194998|101502905|FG001|COMPLETED|Post-HCV Treatment Follow-Up||5||
48476504|NCT02194998|101502906|FG002|COMPLETED|Post-HCV Treatment Follow-Up||14||
48476505|NCT02194998|101502907|FG003|COMPLETED|Post-HCV Treatment Follow-Up||4||
48476506|NCT02194998|101502904|FG000|NOT COMPLETED|Post-HCV Treatment Follow-Up||1||
48476507|NCT02194998|101502905|FG001|NOT COMPLETED|Post-HCV Treatment Follow-Up||0||
48476508|NCT02194998|101502906|FG002|NOT COMPLETED|Post-HCV Treatment Follow-Up||1||
48476509|NCT02194998|101502907|FG003|NOT COMPLETED|Post-HCV Treatment Follow-Up||0||
48476510|NCT01406795|101502908|FG000|STARTED|Overall Study||1||
48476511|NCT01406795|101502908|FG000|COMPLETED|Overall Study||0||
48476512|NCT01406795|101502908|FG000|NOT COMPLETED|Overall Study||1||
48476513|NCT01931033|101502909|FG000|STARTED|Overall Study||8||
48476514|NCT01931033|101502909|FG000|COMPLETED|Overall Study||5||
48476515|NCT01931033|101502909|FG000|NOT COMPLETED|Overall Study||3||
48476516|NCT00565448|101502910|FG000|STARTED|Overall Study||50||
48476517|NCT00565448|101502911|FG001|STARTED|Overall Study||25||
48476518|NCT00565448|101502910|FG000|COMPLETED|Overall Study||47||
48476519|NCT00565448|101502911|FG001|COMPLETED|Overall Study||23||
48476520|NCT00565448|101502910|FG000|NOT COMPLETED|Overall Study||3||
48476521|NCT00565448|101502911|FG001|NOT COMPLETED|Overall Study||2||
48476522|NCT01001208|101502912|FG000|STARTED|Overall Study||239||
48476523|NCT01001208|101502913|FG001|STARTED|Overall Study||239||
48476524|NCT01001208|101502912|FG000|COMPLETED|Overall Study||211||
48476525|NCT01001208|101502913|FG001|COMPLETED|Overall Study||206||
48476526|NCT01001208|101502912|FG000|NOT COMPLETED|Overall Study||28||
48476527|NCT01001208|101502913|FG001|NOT COMPLETED|Overall Study||33||
48476528|NCT00591630|101502914|FG000|STARTED|Overall Study||6||
48476529|NCT00591630|101502915|FG001|STARTED|Overall Study||8||
48476530|NCT00591630|101502916|FG002|STARTED|Overall Study||10||
48476531|NCT00591630|101502917|FG003|STARTED|Overall Study||6||
48476532|NCT00591630|101502914|FG000|COMPLETED|Overall Study||6||
48476533|NCT00591630|101502915|FG001|COMPLETED|Overall Study||8||
48476534|NCT00591630|101502916|FG002|COMPLETED|Overall Study||9||
48476535|NCT00591630|101502917|FG003|COMPLETED|Overall Study||6||
48476536|NCT00591630|101502914|FG000|NOT COMPLETED|Overall Study||0||
48476537|NCT00591630|101502915|FG001|NOT COMPLETED|Overall Study||0||
48476538|NCT00591630|101502916|FG002|NOT COMPLETED|Overall Study||1||
48476539|NCT00591630|101502917|FG003|NOT COMPLETED|Overall Study||0||
48476540|NCT01652001|101502918|FG000|STARTED|Overall Study||100||
48476541|NCT01652001|101502919|FG001|STARTED|Overall Study||85||
48476542|NCT01652001|101502918|FG000|COMPLETED|Overall Study||91||
48476543|NCT01652001|101502919|FG001|COMPLETED|Overall Study||79||
48476544|NCT01652001|101502918|FG000|NOT COMPLETED|Overall Study||9||
48476545|NCT01652001|101502919|FG001|NOT COMPLETED|Overall Study||6||
48192833|NCT02655692|100794146|FG002|NOT COMPLETED|Overall Study||13||
48192834|NCT02197234|100794147|FG000|STARTED|Part A: Day 1-2 (Simvastatin Alone)||52||
48192835|NCT02197234|100794147|FG000|COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||52||
48192836|NCT02197234|100794147|FG000|NOT COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||0||
48192837|NCT02197234|100794147|FG000|STARTED|Part A: Day 3-30 (AZD9291 Alone)||52||
48192838|NCT02197234|100794147|FG000|COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||50||
48192839|NCT02197234|100794147|FG000|NOT COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||2||
48192840|NCT02197234|100794147|FG000|STARTED|Part A: Day 31-32 (Simvastatin+AZD9291)||49||
48192841|NCT02197234|100794147|FG000|COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||49||
48192842|NCT02197234|100794147|FG000|NOT COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||0||
48192843|NCT02197234|100794147|FG000|STARTED|Part B: Day 33 to End Part B (AZD9291)||50||
48192844|NCT02197234|100794147|FG000|COMPLETED|Part B: Day 33 to End Part B (AZD9291)||20||
48192845|NCT02197234|100794147|FG000|NOT COMPLETED|Part B: Day 33 to End Part B (AZD9291)||30||
48192846|NCT00531479|100794148|FG000|STARTED|Overall Study||230||
48192847|NCT00531479|100794149|FG001|STARTED|Overall Study||229||
48192848|NCT00531479|100794148|FG000|Treated|Overall Study||228||
48192849|NCT00531479|100794149|FG001|Treated|Overall Study||226||
48192850|NCT00531479|100794148|FG000|COMPLETED|Overall Study||154||
48192851|NCT00531479|100794149|FG001|COMPLETED|Overall Study||146||
48192852|NCT00531479|100794148|FG000|NOT COMPLETED|Overall Study||76||
48192853|NCT00531479|100794149|FG001|NOT COMPLETED|Overall Study||83||
48192854|NCT05373901|100794150|FG000|STARTED|Overall Study||8||
48192855|NCT05373901|100794150|FG000|COMPLETED|Overall Study||8||
48192856|NCT05373901|100794150|FG000|NOT COMPLETED|Overall Study||0||
48192857|NCT01078233|100794151|FG000|STARTED|Overall Study||656||
48192858|NCT01078233|100794152|FG001|STARTED|Overall Study||296||
48192859|NCT01078233|100794153|FG002|STARTED|Overall Study||1681||
48192860|NCT01078233|100794154|FG003|STARTED|Overall Study||631||
48192861|NCT01078233|100794155|FG004|STARTED|Overall Study||3199||
48192862|NCT01078233|100794156|FG005|STARTED|Overall Study||154||
48192863|NCT01078233|100794151|FG000|COMPLETED|Overall Study||656||
48192864|NCT01078233|100794152|FG001|COMPLETED|Overall Study||296||
48192865|NCT01078233|100794153|FG002|COMPLETED|Overall Study||1681||
48192866|NCT01078233|100794154|FG003|COMPLETED|Overall Study||631||
48192867|NCT01078233|100794155|FG004|COMPLETED|Overall Study||3199||
48192868|NCT01078233|100794156|FG005|COMPLETED|Overall Study||154||
48192869|NCT01078233|100794151|FG000|NOT COMPLETED|Overall Study||0||
48192870|NCT01078233|100794152|FG001|NOT COMPLETED|Overall Study||0||
48192871|NCT01078233|100794153|FG002|NOT COMPLETED|Overall Study||0||
48192872|NCT01078233|100794154|FG003|NOT COMPLETED|Overall Study||0||
48192873|NCT01078233|100794155|FG004|NOT COMPLETED|Overall Study||0||
48192874|NCT01078233|100794156|FG005|NOT COMPLETED|Overall Study||0||
48192875|NCT04549051|100794157|FG000|STARTED|First Intervention (4 Weeks)||16||
48192876|NCT04549051|100794158|FG001|STARTED|First Intervention (4 Weeks)||30||
48192877|NCT04549051|100794157|FG000|COMPLETED|First Intervention (4 Weeks)||16||
48192878|NCT04549051|100794158|FG001|COMPLETED|First Intervention (4 Weeks)||30||
48192879|NCT04549051|100794157|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0||
48192880|NCT04549051|100794158|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0||
48192881|NCT04549051|100794157|FG000|STARTED|Optional Second Intervention (11 Months)||9||
48192882|NCT04549051|100794158|FG001|STARTED|Optional Second Intervention (11 Months)||30||
48192883|NCT04549051|100794157|FG000|COMPLETED|Optional Second Intervention (11 Months)||9||
48192884|NCT04549051|100794158|FG001|COMPLETED|Optional Second Intervention (11 Months)||30||
48192885|NCT04549051|100794157|FG000|NOT COMPLETED|Optional Second Intervention (11 Months)||0||
48192886|NCT04549051|100794158|FG001|NOT COMPLETED|Optional Second Intervention (11 Months)||0||
48192887|NCT04824131|100794159|FG000|STARTED|CAB LA Oral Phase||55|5-week oral CAB 30mg QD|
48476546|NCT01051570|101502920|FG000|STARTED|Overall Study||26||
48476547|NCT01051570|101502920|FG000|COMPLETED|Overall Study||26||
48476548|NCT01051570|101502920|FG000|NOT COMPLETED|Overall Study||0||
48476549|NCT05227820|101502921|FG000|STARTED|Overall Study||23||
48476550|NCT05227820|101502921|FG000|COMPLETED|Overall Study||23||
48476551|NCT05227820|101502921|FG000|NOT COMPLETED|Overall Study||0||
48476552|NCT05386589|101502922|FG000|STARTED|Overall Study||7||
48476553|NCT05386589|101502923|FG001|STARTED|Overall Study||7||
48476554|NCT05386589|101502922|FG000|COMPLETED|Overall Study||7||
48476555|NCT05386589|101502923|FG001|COMPLETED|Overall Study||7||
48476556|NCT05386589|101502922|FG000|NOT COMPLETED|Overall Study||0||
48476557|NCT05386589|101502923|FG001|NOT COMPLETED|Overall Study||0||
48476558|NCT02465567|101502924|FG000|STARTED|Overall Study||2157||
48476559|NCT02465567|101502925|FG001|STARTED|Overall Study||2137||
48476560|NCT02465567|101502926|FG002|STARTED|Overall Study||2143||
48192888|NCT04824131|100794159|FG000|COMPLETED|CAB LA Oral Phase||53||
48476561|NCT02465567|101502927|FG003|STARTED|Overall Study||2151||
48476562|NCT02465567|101502924|FG000|COMPLETED|Overall Study||1708||
48476563|NCT02465567|101502925|FG001|COMPLETED|Overall Study||1713||
48476564|NCT02465567|101502926|FG002|COMPLETED|Overall Study||1580||
48476565|NCT02465567|101502927|FG003|COMPLETED|Overall Study||1643||
48476566|NCT02465567|101502924|FG000|NOT COMPLETED|Overall Study||449||
48476567|NCT02465567|101502925|FG001|NOT COMPLETED|Overall Study||424||
48476568|NCT02465567|101502926|FG002|NOT COMPLETED|Overall Study||563||
48476569|NCT02465567|101502927|FG003|NOT COMPLETED|Overall Study||508||
48476570|NCT03595657|101502928|FG000|STARTED|Overall Study||80||
48476571|NCT03595657|101502928|FG000|COMPLETED|Overall Study||13||
48476572|NCT03595657|101502928|FG000|NOT COMPLETED|Overall Study||67||
48476573|NCT04625114|101502929|FG000|STARTED|Overall Study||66||
48476574|NCT04625114|101502930|FG001|STARTED|Overall Study||30||
48476575|NCT04625114|101502929|FG000|Initial Treatment Period (D1-D5)|Overall Study||52||
48476576|NCT04625114|101502930|FG001|Initial Treatment Period (D1-D5)|Overall Study||25||
48476577|NCT04625114|101502929|FG000|Extension Needed (D6-D10)|Overall Study||9||
48476578|NCT04625114|101502930|FG001|Extension Needed (D6-D10)|Overall Study||4||
48476579|NCT04625114|101502929|FG000|COMPLETED|Overall Study||61||
48476580|NCT04625114|101502930|FG001|COMPLETED|Overall Study||29||
48476581|NCT04625114|101502929|FG000|NOT COMPLETED|Overall Study||5||
48476582|NCT04625114|101502930|FG001|NOT COMPLETED|Overall Study||1||
48476583|NCT05216081|101502931|FG000|STARTED|Overall Study||102||
48192889|NCT04824131|100794159|FG000|NOT COMPLETED|CAB LA Oral Phase||2||
48476584|NCT05216081|101502931|FG000|COMPLETED|Overall Study||101||
48476585|NCT05216081|101502931|FG000|NOT COMPLETED|Overall Study||1||
48476586|NCT02262377|101502932|FG000|STARTED|Overall Study||80||
48476587|NCT02262377|101502933|FG001|STARTED|Overall Study||79||
48476588|NCT02262377|101502932|FG000|COMPLETED|Overall Study||68||
48476589|NCT02262377|101502933|FG001|COMPLETED|Overall Study||73||
48476590|NCT02262377|101502932|FG000|NOT COMPLETED|Overall Study||12||
48476591|NCT02262377|101502933|FG001|NOT COMPLETED|Overall Study||6||
48476592|NCT02473640|101502934|FG000|STARTED|Treatment Period 1||15||
48476593|NCT02473640|101502934|FG000|COMPLETED|Treatment Period 1||14||
48476594|NCT02473640|101502934|FG000|NOT COMPLETED|Treatment Period 1||1||
48476595|NCT02473640|101502934|FG000|STARTED|Run-in Phase||14||
48476596|NCT02473640|101502934|FG000|COMPLETED|Run-in Phase||14||
48476597|NCT02473640|101502934|FG000|NOT COMPLETED|Run-in Phase||0||
48476598|NCT02473640|101502934|FG000|STARTED|Treatment Period 2||14||
48476599|NCT02473640|101502934|FG000|COMPLETED|Treatment Period 2||14||
48476600|NCT02473640|101502934|FG000|NOT COMPLETED|Treatment Period 2||0||
48476601|NCT03165058|101502935|FG000|STARTED|Overall Study||21||
48476602|NCT03165058|101502936|FG001|STARTED|Overall Study||11||
48476603|NCT03165058|101502935|FG000|COMPLETED|Overall Study||21||
48476604|NCT03165058|101502936|FG001|COMPLETED|Overall Study||11||
48476605|NCT03165058|101502935|FG000|NOT COMPLETED|Overall Study||0||
48476606|NCT03165058|101502936|FG001|NOT COMPLETED|Overall Study||0||
48476607|NCT01396278|101502937|FG000|STARTED|Overall Study||2||
48476608|NCT01396278|101502938|FG001|STARTED|Overall Study||2||
48476609|NCT01396278|101502939|FG002|STARTED|Overall Study||1||
48476610|NCT01396278|101502940|FG003|STARTED|Overall Study||2||
48476611|NCT01396278|101502941|FG004|STARTED|Overall Study||2||
48476612|NCT01396278|101502937|FG000|COMPLETED|Overall Study||0||
48476613|NCT01396278|101502938|FG001|COMPLETED|Overall Study||1||
48476614|NCT01396278|101502939|FG002|COMPLETED|Overall Study||0||
48476615|NCT01396278|101502940|FG003|COMPLETED|Overall Study||0||
48476616|NCT01396278|101502941|FG004|COMPLETED|Overall Study||0||
48476617|NCT01396278|101502937|FG000|NOT COMPLETED|Overall Study||2||
48476618|NCT01396278|101502938|FG001|NOT COMPLETED|Overall Study||1||
48476619|NCT01396278|101502939|FG002|NOT COMPLETED|Overall Study||1||
48476620|NCT01396278|101502940|FG003|NOT COMPLETED|Overall Study||2||
48476621|NCT01396278|101502941|FG004|NOT COMPLETED|Overall Study||2||
48476622|NCT01918800|101502942|FG000|STARTED|Overall Study||109||
48476623|NCT01918800|101502943|FG001|STARTED|Overall Study||109||
48476624|NCT01918800|101502942|FG000|COMPLETED|Overall Study||100||
48476625|NCT01918800|101502943|FG001|COMPLETED|Overall Study||104||
48476626|NCT01918800|101502942|FG000|NOT COMPLETED|Overall Study||9||
48476627|NCT01918800|101502943|FG001|NOT COMPLETED|Overall Study||5||
48476628|NCT02587962|101502944|FG000|STARTED|Overall Study||3||
48476629|NCT02587962|101502945|FG001|STARTED|Overall Study||3||
48476630|NCT02587962|101502946|FG002|STARTED|Overall Study||6||
48476631|NCT02587962|101502947|FG003|STARTED|Overall Study||7||
48476632|NCT02587962|101502948|FG004|STARTED|Overall Study||15||
48476633|NCT02587962|101502944|FG000|COMPLETED|Overall Study||1|Completed study treatment phase|
48476634|NCT02587962|101502945|FG001|COMPLETED|Overall Study||0|Completed study treatment phase|
48476635|NCT02587962|101502946|FG002|COMPLETED|Overall Study||0|Completed study treatment phase|
48476636|NCT02587962|101502947|FG003|COMPLETED|Overall Study||1|Completed study treatment phase|
48192890|NCT04824131|100794159|FG000|STARTED|CAB LA Injection Phase||53|5 intramuscular (IM) injections of 3 mL (600 mg) cabotegravir administered at 8-week intervals after a 4-week loading dose (injections at weeks 5, 9, 17, 25 \& 33)|
48192891|NCT04824131|100794159|FG000|COMPLETED|CAB LA Injection Phase||53||
48192892|NCT04824131|100794159|FG000|NOT COMPLETED|CAB LA Injection Phase||0||
48192893|NCT04824131|100794159|FG000|STARTED|Step 3||53|A blood draw visit, the +8 Week Visit, will follow the last injection to monitor CAB drug levels, with additional blood collection at the +24, +36, and +48 Week Visits. Waning levels of cabotegravir (the PK tail) will be covered with locally sourced oral Tenofovir/emtricitabine (Trade name: TDF/FTC, Truvada®) for daily use for 48 weeks|
48192894|NCT04824131|100794159|FG000|CAB Open-Label Extension|Step 3||49|"At Step 3 participants could either receive oral Tenofovir/emtricitabine OR enter an open-label extension study for Cabotegravir."|
48192895|NCT04824131|100794159|FG000|"Tenofovir/Emtricitabine"|Step 3||0|"At Step 3 participants could either receive oral Tenofovir/emtricitabine OR enter an open-label extension study for Cabotegravir."|
48192896|NCT04824131|100794159|FG000|COMPLETED|Step 3||51||
48192897|NCT04824131|100794159|FG000|NOT COMPLETED|Step 3||2||
48192898|NCT05458102|100794160|FG000|STARTED|Overall Study||16||
48192899|NCT05458102|100794161|FG001|STARTED|Overall Study||2||
48192900|NCT05458102|100794160|FG000|COMPLETED|Overall Study||11||
48476637|NCT02587962|101502948|FG004|COMPLETED|Overall Study||0|Completed study treatment phase|
48476638|NCT02587962|101502944|FG000|NOT COMPLETED|Overall Study||2||
48476639|NCT02587962|101502945|FG001|NOT COMPLETED|Overall Study||3||
48476640|NCT02587962|101502946|FG002|NOT COMPLETED|Overall Study||6||
48476641|NCT02587962|101502947|FG003|NOT COMPLETED|Overall Study||6||
48476642|NCT02587962|101502948|FG004|NOT COMPLETED|Overall Study||15||
48476643|NCT02379247|101502949|FG000|STARTED|Overall Study||3||
48476644|NCT02379247|101502950|FG001|STARTED|Overall Study||3||
48476645|NCT02379247|101502951|FG002|STARTED|Overall Study||7||
48476646|NCT02379247|101502952|FG003|STARTED|Overall Study||30||
48476647|NCT02379247|101502949|FG000|COMPLETED|Overall Study||3||
48476648|NCT02379247|101502950|FG001|COMPLETED|Overall Study||3||
48476649|NCT02379247|101502951|FG002|COMPLETED|Overall Study||7||
48476650|NCT02379247|101502952|FG003|COMPLETED|Overall Study||30||
48476651|NCT02379247|101502949|FG000|NOT COMPLETED|Overall Study||0||
48476652|NCT02379247|101502950|FG001|NOT COMPLETED|Overall Study||0||
48476653|NCT02379247|101502951|FG002|NOT COMPLETED|Overall Study||0||
48476654|NCT02379247|101502952|FG003|NOT COMPLETED|Overall Study||0||
48476655|NCT01619800|101502953|FG000|STARTED|Overall Study||2||
48476656|NCT01619800|101502954|FG001|STARTED|Overall Study||0||
48476657|NCT01619800|101502953|FG000|COMPLETED|Overall Study||0||
48476658|NCT01619800|101502954|FG001|COMPLETED|Overall Study||0||
48666295|NCT00437073|101967549|FG000|NOT COMPLETED|Overall Study||1||
48476659|NCT01619800|101502953|FG000|NOT COMPLETED|Overall Study||2||
48476660|NCT01619800|101502954|FG001|NOT COMPLETED|Overall Study||0||
48476661|NCT01387737|101502955|FG000|STARTED|Overall Study||584||
48476662|NCT01387737|101502956|FG001|STARTED|Overall Study||715||
48476663|NCT01387737|101502955|FG000|COMPLETED|Overall Study||532||
48476664|NCT01387737|101502956|FG001|COMPLETED|Overall Study||641||
48476665|NCT01387737|101502955|FG000|NOT COMPLETED|Overall Study||52||
48476666|NCT01387737|101502956|FG001|NOT COMPLETED|Overall Study||74||
48476667|NCT00095212|101502957|FG000|STARTED|Overall Study||13||
48476668|NCT00095212|101502958|FG001|STARTED|Overall Study||12||
48476669|NCT00095212|101502957|FG000|COMPLETED|Overall Study||12||
48476670|NCT00095212|101502958|FG001|COMPLETED|Overall Study||9||
48476671|NCT00095212|101502957|FG000|NOT COMPLETED|Overall Study||1||
48476672|NCT00095212|101502958|FG001|NOT COMPLETED|Overall Study||3||
48476673|NCT00048581|101502959|FG000|STARTED|Double-Blind Period||258||
48476674|NCT00048581|101502960|FG001|STARTED|Double-Blind Period||133||
48476675|NCT00048581|101502961|FG002|STARTED|Double-Blind Period||0||
48476676|NCT00048581|101502959|FG000|COMPLETED|Double-Blind Period||223||
48476677|NCT00048581|101502960|FG001|COMPLETED|Double-Blind Period||99||
48476678|NCT00048581|101502961|FG002|COMPLETED|Double-Blind Period||0||
48476679|NCT00048581|101502959|FG000|NOT COMPLETED|Double-Blind Period||35||
48476680|NCT00048581|101502960|FG001|NOT COMPLETED|Double-Blind Period||34||
48476681|NCT00048581|101502961|FG002|NOT COMPLETED|Double-Blind Period||0||
48476682|NCT00048581|101502959|FG000|STARTED|Open-Label Period||0||
48476683|NCT00048581|101502960|FG001|STARTED|Open-Label Period||0||
48476684|NCT00048581|101502961|FG002|STARTED|Open-Label Period||317||
48476685|NCT00048581|101502959|FG000|COMPLETED|Open-Label Period||0||
48476686|NCT00048581|101502960|FG001|COMPLETED|Open-Label Period||0||
48476687|NCT00048581|101502961|FG002|COMPLETED|Open-Label Period||150||
48476688|NCT00048581|101502959|FG000|NOT COMPLETED|Open-Label Period||0||
48476689|NCT00048581|101502960|FG001|NOT COMPLETED|Open-Label Period||0||
48476690|NCT00048581|101502961|FG002|NOT COMPLETED|Open-Label Period||167||
48476691|NCT01399736|101502962|FG000|STARTED|Overall Study||295||
48476692|NCT01399736|101502963|FG001|STARTED|Overall Study||590||
48476693|NCT01399736|101502962|FG000|COMPLETED|Overall Study||291||
48476694|NCT01399736|101502963|FG001|COMPLETED|Overall Study||586||
48476695|NCT01399736|101502962|FG000|NOT COMPLETED|Overall Study||4||
48476696|NCT01399736|101502963|FG001|NOT COMPLETED|Overall Study||4||
48476697|NCT00376948|101502964|FG000|STARTED|Overall Study||20||
48476698|NCT00376948|101502964|FG000|COMPLETED|Overall Study||20||
48476699|NCT00376948|101502964|FG000|NOT COMPLETED|Overall Study||0||
48476700|NCT01706536|101502965|FG000|STARTED|Overall Study||57||
48476701|NCT01706536|101502966|FG001|STARTED|Overall Study||55||
48476702|NCT01706536|101502967|FG002|STARTED|Overall Study||54||
48476703|NCT01706536|101502968|FG003|STARTED|Overall Study||57||
48476704|NCT01706536|101502969|FG004|STARTED|Overall Study||59||
48476705|NCT01706536|101502965|FG000|COMPLETED|Overall Study||53||
48476706|NCT01706536|101502966|FG001|COMPLETED|Overall Study||51||
48476707|NCT01706536|101502967|FG002|COMPLETED|Overall Study||49||
48476708|NCT01706536|101502968|FG003|COMPLETED|Overall Study||53||
48476709|NCT01706536|101502969|FG004|COMPLETED|Overall Study||57||
48476710|NCT01706536|101502965|FG000|NOT COMPLETED|Overall Study||4||
48476711|NCT01706536|101502966|FG001|NOT COMPLETED|Overall Study||4||
48476712|NCT01706536|101502967|FG002|NOT COMPLETED|Overall Study||5||
48476713|NCT01706536|101502968|FG003|NOT COMPLETED|Overall Study||4||
48476714|NCT01706536|101502969|FG004|NOT COMPLETED|Overall Study||2||
48476715|NCT00023309|101502970|FG000|STARTED|Overall Study||22||
48476716|NCT00023309|101502971|FG001|STARTED|Overall Study||19||
48476717|NCT00023309|101502970|FG000|COMPLETED|Overall Study||22||
48476718|NCT00023309|101502971|FG001|COMPLETED|Overall Study||19||
48476719|NCT00023309|101502970|FG000|NOT COMPLETED|Overall Study||0||
48476720|NCT00023309|101502971|FG001|NOT COMPLETED|Overall Study||0||
48476721|NCT03432897|101502972|FG000|STARTED|Overall Study||1||
48476722|NCT03432897|101502972|FG000|COMPLETED|Overall Study||1||
48476723|NCT03432897|101502972|FG000|NOT COMPLETED|Overall Study||0||
48476724|NCT01079988|101502973|FG000|STARTED|Overall Study||10||
48476725|NCT01079988|101502974|FG001|STARTED|Overall Study||1||
48476726|NCT01079988|101502975|FG002|STARTED|Overall Study||8||
48476727|NCT01079988|101502976|FG003|STARTED|Overall Study||20||
48476728|NCT01079988|101502977|FG004|STARTED|Overall Study||2||
48476729|NCT01079988|101502973|FG000|COMPLETED|Overall Study||9||
48476730|NCT01079988|101502974|FG001|COMPLETED|Overall Study||1||
48476731|NCT01079988|101502975|FG002|COMPLETED|Overall Study||8||
48476732|NCT01079988|101502976|FG003|COMPLETED|Overall Study||17||
48476733|NCT01079988|101502977|FG004|COMPLETED|Overall Study||1||
48476734|NCT01079988|101502973|FG000|NOT COMPLETED|Overall Study||1||
48476735|NCT01079988|101502974|FG001|NOT COMPLETED|Overall Study||0||
48476736|NCT01079988|101502975|FG002|NOT COMPLETED|Overall Study||0||
48476737|NCT01079988|101502976|FG003|NOT COMPLETED|Overall Study||3||
48476738|NCT01079988|101502977|FG004|NOT COMPLETED|Overall Study||1||
48476739|NCT03365375|101502978|FG000|STARTED|Overall Study||14||
48476740|NCT03365375|101502979|FG001|STARTED|Overall Study||14||
48476741|NCT03365375|101502978|FG000|COMPLETED|Overall Study||14||
48476742|NCT03365375|101502979|FG001|COMPLETED|Overall Study||9||
48476743|NCT03365375|101502978|FG000|NOT COMPLETED|Overall Study||0||
48476744|NCT03365375|101502979|FG001|NOT COMPLETED|Overall Study||5||
48476745|NCT00017953|101502980|FG000|STARTED|Overall Study||2570||
48476746|NCT00017953|101502981|FG001|STARTED|Overall Study||2575||
48476747|NCT00017953|101502980|FG000|COMPLETED|Overall Study||2481||
48476748|NCT00017953|101502981|FG001|COMPLETED|Overall Study||2476||
48476749|NCT00017953|101502980|FG000|NOT COMPLETED|Overall Study||89||
48476750|NCT00017953|101502981|FG001|NOT COMPLETED|Overall Study||99||
48192901|NCT05458102|100794161|FG001|COMPLETED|Overall Study||2||
48192902|NCT05458102|100794160|FG000|NOT COMPLETED|Overall Study||5||
48476751|NCT03469297|101502982|FG000|STARTED|Overall Study||8||
48476752|NCT03469297|101502982|FG000|COMPLETED|Overall Study||7||
48476753|NCT03469297|101502982|FG000|NOT COMPLETED|Overall Study||1||
48476754|NCT03117569|101502983|FG000|STARTED|Overall Study||127||
48476755|NCT03117569|101502984|FG001|STARTED|Overall Study||253||
48476756|NCT03117569|101502983|FG000|COMPLETED|Overall Study||123||
48476757|NCT03117569|101502984|FG001|COMPLETED|Overall Study||241||
48192903|NCT05458102|100794161|FG001|NOT COMPLETED|Overall Study||0||
48476758|NCT03117569|101502983|FG000|NOT COMPLETED|Overall Study||4||
48476759|NCT03117569|101502984|FG001|NOT COMPLETED|Overall Study||12||
48192904|NCT01021878|100794162|FG000|STARTED|Overall Study||33||
48192905|NCT01021878|100794163|FG001|STARTED|Overall Study||27||
48192906|NCT01021878|100794162|FG000|Completed Follow-up|Overall Study||17||
48192907|NCT01021878|100794163|FG001|Completed Follow-up|Overall Study||17||
48192908|NCT01021878|100794162|FG000|COMPLETED|Overall Study||17||
48476760|NCT02015390|101502985|FG000|STARTED|Overall Study||9||
48476761|NCT02015390|101502986|FG001|STARTED|Overall Study||7||
48476762|NCT02015390|101502985|FG000|COMPLETED|Overall Study||8||
48476763|NCT02015390|101502986|FG001|COMPLETED|Overall Study||3||
48476764|NCT02015390|101502985|FG000|NOT COMPLETED|Overall Study||1||
48476765|NCT02015390|101502986|FG001|NOT COMPLETED|Overall Study||4||
48476766|NCT01781286|101502987|FG000|STARTED|Overall Study||7||
48476767|NCT01781286|101502988|FG001|STARTED|Overall Study||4||
48476768|NCT01781286|101502989|FG002|STARTED|Overall Study||9||
48476769|NCT01781286|101502990|FG003|STARTED|Overall Study||8||
48192909|NCT01021878|100794163|FG001|COMPLETED|Overall Study||17||
48476770|NCT01781286|101502991|FG004|STARTED|Overall Study||6||
48192910|NCT01021878|100794162|FG000|NOT COMPLETED|Overall Study||16||
48476771|NCT01781286|101502992|FG005|STARTED|Overall Study||3||
48476772|NCT01781286|101502987|FG000|Started 1st Intervention|Overall Study||6||
48476773|NCT01781286|101502988|FG001|Started 1st Intervention|Overall Study||4||
48476774|NCT01781286|101502989|FG002|Started 1st Intervention|Overall Study||9||
48476775|NCT01781286|101502990|FG003|Started 1st Intervention|Overall Study||8||
48476776|NCT01781286|101502991|FG004|Started 1st Intervention|Overall Study||6||
48476777|NCT01781286|101502992|FG005|Started 1st Intervention|Overall Study||2||
48476778|NCT01781286|101502987|FG000|Started 2nd Intervention|Overall Study||5||
48476779|NCT01781286|101502988|FG001|Started 2nd Intervention|Overall Study||4||
48476780|NCT01781286|101502989|FG002|Started 2nd Intervention|Overall Study||9||
48476781|NCT01781286|101502990|FG003|Started 2nd Intervention|Overall Study||8||
48476782|NCT01781286|101502991|FG004|Started 2nd Intervention|Overall Study||6||
48476783|NCT01781286|101502992|FG005|Started 2nd Intervention|Overall Study||2||
48476784|NCT01781286|101502987|FG000|Started 3rd Intervention|Overall Study||5||
48476785|NCT01781286|101502988|FG001|Started 3rd Intervention|Overall Study||4||
48476786|NCT01781286|101502989|FG002|Started 3rd Intervention|Overall Study||7||
48476787|NCT01781286|101502990|FG003|Started 3rd Intervention|Overall Study||7||
48476788|NCT01781286|101502991|FG004|Started 3rd Intervention|Overall Study||6||
48476789|NCT01781286|101502992|FG005|Started 3rd Intervention|Overall Study||2||
48476790|NCT01781286|101502987|FG000|COMPLETED|Overall Study||5||
48476791|NCT01781286|101502988|FG001|COMPLETED|Overall Study||4||
48476792|NCT01781286|101502989|FG002|COMPLETED|Overall Study||7||
48476793|NCT01781286|101502990|FG003|COMPLETED|Overall Study||7||
48476794|NCT01781286|101502991|FG004|COMPLETED|Overall Study||6||
48476795|NCT01781286|101502992|FG005|COMPLETED|Overall Study||2||
48476796|NCT01781286|101502987|FG000|NOT COMPLETED|Overall Study||2||
48476797|NCT01781286|101502988|FG001|NOT COMPLETED|Overall Study||0||
48476798|NCT01781286|101502989|FG002|NOT COMPLETED|Overall Study||2||
48476799|NCT01781286|101502990|FG003|NOT COMPLETED|Overall Study||1||
48476800|NCT01781286|101502991|FG004|NOT COMPLETED|Overall Study||0||
48476801|NCT01781286|101502992|FG005|NOT COMPLETED|Overall Study||1||
48476802|NCT00205049|101502993|FG000|STARTED|Overall Study||0||
48476803|NCT00205049|101502994|FG001|STARTED|Overall Study||0||
48476804|NCT00205049|101502993|FG000|COMPLETED|Overall Study||0||
48476805|NCT00205049|101502994|FG001|COMPLETED|Overall Study||0||
48476806|NCT00205049|101502993|FG000|NOT COMPLETED|Overall Study||0||
48476807|NCT00205049|101502994|FG001|NOT COMPLETED|Overall Study||0||
48476808|NCT02246478|101502995|FG000|STARTED|Single-dose Phase||6||
48476809|NCT02246478|101502996|FG001|STARTED|Single-dose Phase||5||
48192911|NCT01021878|100794163|FG001|NOT COMPLETED|Overall Study||10||
48476810|NCT02246478|101502997|FG002|STARTED|Single-dose Phase||5||
48476811|NCT02246478|101502998|FG003|STARTED|Single-dose Phase||5||
48476812|NCT02246478|101502995|FG000|COMPLETED|Single-dose Phase||6||
48476813|NCT02246478|101502996|FG001|COMPLETED|Single-dose Phase||5||
48476814|NCT02246478|101502997|FG002|COMPLETED|Single-dose Phase||5||
48476815|NCT02246478|101502998|FG003|COMPLETED|Single-dose Phase||5||
48476816|NCT02246478|101502995|FG000|NOT COMPLETED|Single-dose Phase||0||
48476817|NCT02246478|101502996|FG001|NOT COMPLETED|Single-dose Phase||0||
48476818|NCT02246478|101502997|FG002|NOT COMPLETED|Single-dose Phase||0||
48476819|NCT02246478|101502998|FG003|NOT COMPLETED|Single-dose Phase||0||
48476820|NCT02246478|101502995|FG000|STARTED|Multiple-dose Phase||6||
48476821|NCT02246478|101502996|FG001|STARTED|Multiple-dose Phase||5||
48476822|NCT02246478|101502997|FG002|STARTED|Multiple-dose Phase||5||
48476823|NCT02246478|101502998|FG003|STARTED|Multiple-dose Phase||5||
48476824|NCT02246478|101502995|FG000|COMPLETED|Multiple-dose Phase||5||
48476825|NCT02246478|101502996|FG001|COMPLETED|Multiple-dose Phase||5||
48476826|NCT02246478|101502997|FG002|COMPLETED|Multiple-dose Phase||5||
48476827|NCT02246478|101502998|FG003|COMPLETED|Multiple-dose Phase||4||
48666296|NCT00437073|101967550|FG001|NOT COMPLETED|Overall Study||1||
48666297|NCT02526290|101967551|FG000|STARTED|Overall Study||97||
48666298|NCT02526290|101967551|FG000|COMPLETED|Overall Study||89||
48666299|NCT02526290|101967551|FG000|NOT COMPLETED|Overall Study||8||
48666300|NCT01148771|101967552|FG000|STARTED|First Intervention||6||
48666301|NCT01148771|101967553|FG001|STARTED|First Intervention||6||
48666302|NCT01148771|101967552|FG000|COMPLETED|First Intervention||6||
48666303|NCT01148771|101967553|FG001|COMPLETED|First Intervention||6||
48666304|NCT01148771|101967552|FG000|NOT COMPLETED|First Intervention||0||
48666305|NCT01148771|101967553|FG001|NOT COMPLETED|First Intervention||0||
48666306|NCT01148771|101967552|FG000|STARTED|Washout Period||6||
48666307|NCT01148771|101967553|FG001|STARTED|Washout Period||6||
48666308|NCT01148771|101967552|FG000|COMPLETED|Washout Period||6||
48666309|NCT01148771|101967553|FG001|COMPLETED|Washout Period||5||
48666310|NCT01148771|101967552|FG000|NOT COMPLETED|Washout Period||0||
48192912|NCT01598025|100794164|FG000|STARTED|Overall Study||0||
48192913|NCT01598025|100794165|FG001|STARTED|Overall Study||3||
48192914|NCT01598025|100794164|FG000|COMPLETED|Overall Study||0||
48192915|NCT01598025|100794165|FG001|COMPLETED|Overall Study||0||
48192916|NCT01598025|100794164|FG000|NOT COMPLETED|Overall Study||0||
48192917|NCT01598025|100794165|FG001|NOT COMPLETED|Overall Study||3||
48192918|NCT03614130|100794166|FG000|STARTED|Overall Study||10||20
48192919|NCT03614130|100794167|FG001|STARTED|Overall Study||12||24
48192920|NCT03614130|100794166|FG000|COMPLETED|Overall Study||10||20
48192921|NCT03614130|100794167|FG001|COMPLETED|Overall Study||12||24
48192922|NCT03614130|100794166|FG000|NOT COMPLETED|Overall Study||0||0
48192923|NCT03614130|100794167|FG001|NOT COMPLETED|Overall Study||0||0
48192924|NCT00477412|100796887|FG000|STARTED|Overall Study||4||
48192925|NCT00477412|100796888|FG001|STARTED|Overall Study||3||
48192926|NCT00477412|100796889|FG002|STARTED|Overall Study||5||
48192927|NCT00477412|100796890|FG003|STARTED|Overall Study||95||
48192928|NCT00477412|100796887|FG000|COMPLETED|Overall Study||3||
48192929|NCT00477412|100796888|FG001|COMPLETED|Overall Study||3||
48192930|NCT00477412|100796889|FG002|COMPLETED|Overall Study||4||
48192931|NCT00477412|100796890|FG003|COMPLETED|Overall Study||87||
48192932|NCT00477412|100796887|FG000|NOT COMPLETED|Overall Study||1||
48192933|NCT00477412|100796888|FG001|NOT COMPLETED|Overall Study||0||
48192934|NCT00477412|100796889|FG002|NOT COMPLETED|Overall Study||1||
48192935|NCT00477412|100796890|FG003|NOT COMPLETED|Overall Study||8||
48192936|NCT01873287|100796891|FG000|STARTED|Overall Study||2006||
48192937|NCT01873287|100796892|FG001|STARTED|Overall Study||1057||
48192938|NCT01873287|100796891|FG000|COMPLETED|Overall Study||1701||
48192939|NCT01873287|100796892|FG001|COMPLETED|Overall Study||883||
48192940|NCT01873287|100796891|FG000|NOT COMPLETED|Overall Study||305||
48192941|NCT01873287|100796892|FG001|NOT COMPLETED|Overall Study||174||
48192942|NCT01328587|100796893|FG000|STARTED|Overall Study||34||
48192943|NCT01328587|100796893|FG000|COMPLETED|Overall Study||34||
48192944|NCT01328587|100796893|FG000|NOT COMPLETED|Overall Study||0||
48192945|NCT02960776|100796894|FG000|STARTED|Overall Study||22||
48192946|NCT02960776|100796895|FG001|STARTED|Overall Study||23||
48192947|NCT02960776|100796894|FG000|COMPLETED|Overall Study||16||
48192948|NCT02960776|100796895|FG001|COMPLETED|Overall Study||20||
48192949|NCT02960776|100796894|FG000|NOT COMPLETED|Overall Study||6||
48192950|NCT02960776|100796895|FG001|NOT COMPLETED|Overall Study||3||
48192951|NCT01096056|100796896|FG000|STARTED|Overall Study||20||
48192952|NCT01096056|100796897|FG001|STARTED|Overall Study||20||
48192953|NCT01096056|100796896|FG000|Completed at Day 42|Overall Study||20||
48192954|NCT01096056|100796897|FG001|Completed at Day 42|Overall Study||20||
48192955|NCT01096056|100796896|FG000|COMPLETED|Overall Study||20||
48192956|NCT01096056|100796897|FG001|COMPLETED|Overall Study||19||
48192957|NCT01096056|100796896|FG000|NOT COMPLETED|Overall Study||0||
48192958|NCT01096056|100796897|FG001|NOT COMPLETED|Overall Study||1||
48192959|NCT02921230|100796898|FG000|STARTED|Overall Study||508||
48192960|NCT02921230|100796899|FG001|STARTED|Overall Study||267||
48192961|NCT02921230|100796898|FG000|COMPLETED|Overall Study||453||
48192962|NCT02921230|100796899|FG001|COMPLETED|Overall Study||249||
48192963|NCT02921230|100796898|FG000|NOT COMPLETED|Overall Study||55||
48192964|NCT02921230|100796899|FG001|NOT COMPLETED|Overall Study||18||
48192965|NCT01268891|100796900|FG000|STARTED|Overall Study||66||
48192966|NCT01268891|100796901|FG001|STARTED|Overall Study||66||
48192967|NCT01268891|100796900|FG000|COMPLETED|Overall Study||58||
48192968|NCT01268891|100796901|FG001|COMPLETED|Overall Study||58||
48192969|NCT01268891|100796900|FG000|NOT COMPLETED|Overall Study||8||
48192970|NCT01268891|100796901|FG001|NOT COMPLETED|Overall Study||8||
48192971|NCT05642000|100796902|FG000|STARTED|Wave 1: Late September||67||11
48192972|NCT05642000|100796903|FG001|STARTED|Wave 1: Late September||38||7
48192973|NCT05642000|100796904|FG002|STARTED|Wave 1: Late September||39||8
48192974|NCT05642000|100796902|FG000|COMPLETED|Wave 1: Late September||67||11
48192975|NCT05642000|100796903|FG001|COMPLETED|Wave 1: Late September||38||7
48192976|NCT05642000|100796904|FG002|COMPLETED|Wave 1: Late September||39||8
48192977|NCT05642000|100796902|FG000|NOT COMPLETED|Wave 1: Late September||0||0
48192978|NCT05642000|100796903|FG001|NOT COMPLETED|Wave 1: Late September||0||0
48192979|NCT05642000|100796904|FG002|NOT COMPLETED|Wave 1: Late September||0||0
48192980|NCT05642000|100796902|FG000|STARTED|Wave 2: Early October||52||11
48192981|NCT05642000|100796903|FG001|STARTED|Wave 2: Early October||50||7
48192982|NCT05642000|100796904|FG002|STARTED|Wave 2: Early October||42||8
48192983|NCT05642000|100796902|FG000|COMPLETED|Wave 2: Early October||52||11
48192984|NCT05642000|100796903|FG001|COMPLETED|Wave 2: Early October||50||7
48192985|NCT05642000|100796904|FG002|COMPLETED|Wave 2: Early October||42||8
48192986|NCT05642000|100796902|FG000|NOT COMPLETED|Wave 2: Early October||0||0
48192987|NCT05642000|100796903|FG001|NOT COMPLETED|Wave 2: Early October||0||0
48192988|NCT05642000|100796904|FG002|NOT COMPLETED|Wave 2: Early October||0||0
48192989|NCT05642000|100796902|FG000|STARTED|Wave 3: Late October||85||11
48192990|NCT05642000|100796903|FG001|STARTED|Wave 3: Late October||54||7
48192991|NCT05642000|100796904|FG002|STARTED|Wave 3: Late October||55||8
48192992|NCT05642000|100796902|FG000|COMPLETED|Wave 3: Late October||85||11
48192993|NCT05642000|100796903|FG001|COMPLETED|Wave 3: Late October||54||7
48192994|NCT05642000|100796904|FG002|COMPLETED|Wave 3: Late October||55||8
48192995|NCT05642000|100796902|FG000|NOT COMPLETED|Wave 3: Late October||0||0
48192996|NCT05642000|100796903|FG001|NOT COMPLETED|Wave 3: Late October||0||0
48192997|NCT05642000|100796904|FG002|NOT COMPLETED|Wave 3: Late October||0||0
48192998|NCT05642000|100796902|FG000|STARTED|Wave 4: Early November||51||11
48192999|NCT05642000|100796903|FG001|STARTED|Wave 4: Early November||24||7
48193000|NCT05642000|100796904|FG002|STARTED|Wave 4: Early November||54||8
48193001|NCT05642000|100796902|FG000|COMPLETED|Wave 4: Early November||51||11
48193002|NCT05642000|100796903|FG001|COMPLETED|Wave 4: Early November||24||7
48193003|NCT05642000|100796904|FG002|COMPLETED|Wave 4: Early November||54||8
48193004|NCT05642000|100796902|FG000|NOT COMPLETED|Wave 4: Early November||0||0
48193005|NCT05642000|100796903|FG001|NOT COMPLETED|Wave 4: Early November||0||0
48193006|NCT05642000|100796904|FG002|NOT COMPLETED|Wave 4: Early November||0||0
48193007|NCT05642000|100796902|FG000|STARTED|Wave 5: Mid November||71||11
48193008|NCT05642000|100796903|FG001|STARTED|Wave 5: Mid November||24||7
48193009|NCT05642000|100796904|FG002|STARTED|Wave 5: Mid November||54||8
48193010|NCT05642000|100796902|FG000|COMPLETED|Wave 5: Mid November||71||11
48193011|NCT05642000|100796903|FG001|COMPLETED|Wave 5: Mid November||24||7
48193012|NCT05642000|100796904|FG002|COMPLETED|Wave 5: Mid November||54||8
48193013|NCT05642000|100796902|FG000|NOT COMPLETED|Wave 5: Mid November||0||0
48193014|NCT05642000|100796903|FG001|NOT COMPLETED|Wave 5: Mid November||0||0
48193015|NCT05642000|100796904|FG002|NOT COMPLETED|Wave 5: Mid November||0||0
48193016|NCT05642000|100796902|FG000|STARTED|Wave 6: Early December||70||11
48193017|NCT05642000|100796903|FG001|STARTED|Wave 6: Early December||93||7
48193018|NCT05642000|100796904|FG002|STARTED|Wave 6: Early December||33||8
48193019|NCT05642000|100796902|FG000|COMPLETED|Wave 6: Early December||70||11
48193020|NCT05642000|100796903|FG001|COMPLETED|Wave 6: Early December||93||7
48193021|NCT05642000|100796904|FG002|COMPLETED|Wave 6: Early December||33||8
48193022|NCT05642000|100796902|FG000|NOT COMPLETED|Wave 6: Early December||0||0
48193023|NCT05642000|100796903|FG001|NOT COMPLETED|Wave 6: Early December||0||0
48193024|NCT05642000|100796904|FG002|NOT COMPLETED|Wave 6: Early December||0||0
48193025|NCT05642000|100796902|FG000|STARTED|Wave 7: Late December||17||11
48193026|NCT05642000|100796903|FG001|STARTED|Wave 7: Late December||35||7
48193027|NCT05642000|100796904|FG002|STARTED|Wave 7: Late December||21||8
48193028|NCT05642000|100796902|FG000|COMPLETED|Wave 7: Late December||17||11
48193029|NCT05642000|100796903|FG001|COMPLETED|Wave 7: Late December||35||7
48193030|NCT05642000|100796904|FG002|COMPLETED|Wave 7: Late December||21||8
48193031|NCT05642000|100796902|FG000|NOT COMPLETED|Wave 7: Late December||0||0
48193032|NCT05642000|100796903|FG001|NOT COMPLETED|Wave 7: Late December||0||0
48193033|NCT05642000|100796904|FG002|NOT COMPLETED|Wave 7: Late December||0||0
48193034|NCT05096117|100796905|FG000|STARTED|Overall Study||30||
48193035|NCT05096117|100796906|FG001|STARTED|Overall Study||30||
48193036|NCT05096117|100796905|FG000|COMPLETED|Overall Study||28||
48193037|NCT05096117|100796906|FG001|COMPLETED|Overall Study||26||
48193038|NCT05096117|100796905|FG000|NOT COMPLETED|Overall Study||2||
48193039|NCT05096117|100796906|FG001|NOT COMPLETED|Overall Study||4||
48193040|NCT02931396|100796907|FG000|STARTED|Overall Study||10||
48193041|NCT02931396|100796908|FG001|STARTED|Overall Study||10||
48193042|NCT02931396|100796907|FG000|COMPLETED|Overall Study||5||
48193043|NCT02931396|100796908|FG001|COMPLETED|Overall Study||10||
48193044|NCT02931396|100796907|FG000|NOT COMPLETED|Overall Study||5||
48193045|NCT02931396|100796908|FG001|NOT COMPLETED|Overall Study||0||
48193046|NCT01224678|100796909|FG000|STARTED|Overall Study||150||
48193047|NCT01224678|100796910|FG001|STARTED|Overall Study||150||
48193048|NCT01224678|100796909|FG000|COMPLETED|Overall Study||150||
48193049|NCT01224678|100796910|FG001|COMPLETED|Overall Study||150||
48193050|NCT01224678|100796909|FG000|NOT COMPLETED|Overall Study||0||
48193051|NCT01224678|100796910|FG001|NOT COMPLETED|Overall Study||0||
48193052|NCT00049517|100796911|FG000|STARTED|Induction||79||
48193053|NCT00049517|100796912|FG001|STARTED|Induction||90||
48193054|NCT00049517|100796913|FG002|STARTED|Induction||63||
48193055|NCT00049517|100796914|FG003|STARTED|Induction||75||
48193056|NCT00049517|100796915|FG004|STARTED|Induction||188||
48193057|NCT00049517|100796916|FG005|STARTED|Induction||162||
48193058|NCT00049517|100796911|FG000|Treated|Induction||79||
48193059|NCT00049517|100796912|FG001|Treated|Induction||90||
48193060|NCT00049517|100796913|FG002|Treated|Induction||63||
48193061|NCT00049517|100796914|FG003|Treated|Induction||75||
48193062|NCT00049517|100796915|FG004|Treated|Induction||186||
48193063|NCT00049517|100796916|FG005|Treated|Induction||160||
48193064|NCT00049517|100796911|FG000|COMPLETED|Induction||79||
48193065|NCT00049517|100796912|FG001|COMPLETED|Induction||90||
48193066|NCT00049517|100796913|FG002|COMPLETED|Induction||63||
48193067|NCT00049517|100796914|FG003|COMPLETED|Induction||75||
48193068|NCT00049517|100796915|FG004|COMPLETED|Induction||128||
48193069|NCT00049517|100796916|FG005|COMPLETED|Induction||108||
48193070|NCT00049517|100796911|FG000|NOT COMPLETED|Induction||0||
48193071|NCT00049517|100796912|FG001|NOT COMPLETED|Induction||0||
48193072|NCT00049517|100796913|FG002|NOT COMPLETED|Induction||0||
48193073|NCT00049517|100796914|FG003|NOT COMPLETED|Induction||0||
48193074|NCT00049517|100796915|FG004|NOT COMPLETED|Induction||60||
48193075|NCT00049517|100796916|FG005|NOT COMPLETED|Induction||54||
48193076|NCT00049517|100796911|FG000|STARTED|Conditioning/Transplant||79||
48193077|NCT00049517|100796912|FG001|STARTED|Conditioning/Transplant||90||
48193078|NCT00049517|100796913|FG002|STARTED|Conditioning/Transplant||63||
48193079|NCT00049517|100796914|FG003|STARTED|Conditioning/Transplant||75||
48193080|NCT00049517|100796915|FG004|STARTED|Conditioning/Transplant||21||
48193081|NCT00049517|100796916|FG005|STARTED|Conditioning/Transplant||24||
48193082|NCT00049517|100796911|FG000|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||59||
48193083|NCT00049517|100796912|FG001|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||73||
48193084|NCT00049517|100796913|FG002|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||63||
48193085|NCT00049517|100796914|FG003|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||75||
48193086|NCT00049517|100796915|FG004|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||0||
48193087|NCT00049517|100796916|FG005|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||0||
48193088|NCT00049517|100796911|FG000|COMPLETED|Conditioning/Transplant||27||
48476828|NCT02246478|101502995|FG000|NOT COMPLETED|Multiple-dose Phase||1||
48476829|NCT02246478|101502996|FG001|NOT COMPLETED|Multiple-dose Phase||0||
48193089|NCT00049517|100796912|FG001|COMPLETED|Conditioning/Transplant||40||
48476830|NCT02246478|101502997|FG002|NOT COMPLETED|Multiple-dose Phase||0||
48476831|NCT02246478|101502998|FG003|NOT COMPLETED|Multiple-dose Phase||1||
48193090|NCT00049517|100796913|FG002|COMPLETED|Conditioning/Transplant||25||
48193091|NCT00049517|100796914|FG003|COMPLETED|Conditioning/Transplant||32||
48193092|NCT00049517|100796915|FG004|COMPLETED|Conditioning/Transplant||15||
48193093|NCT00049517|100796916|FG005|COMPLETED|Conditioning/Transplant||18||
48193094|NCT00049517|100796911|FG000|NOT COMPLETED|Conditioning/Transplant||52||
48193095|NCT00049517|100796912|FG001|NOT COMPLETED|Conditioning/Transplant||50||
48476832|NCT02724800|101502999|FG000|STARTED|Overall Study||32||
48476833|NCT02724800|101503000|FG001|STARTED|Overall Study||31||
48476834|NCT02724800|101502999|FG000|COMPLETED|Overall Study||15||
48193096|NCT00049517|100796913|FG002|NOT COMPLETED|Conditioning/Transplant||38||
48193097|NCT00049517|100796914|FG003|NOT COMPLETED|Conditioning/Transplant||43||
48193098|NCT00049517|100796915|FG004|NOT COMPLETED|Conditioning/Transplant||6||
48476835|NCT02724800|101503000|FG001|COMPLETED|Overall Study||22||
48476836|NCT02724800|101502999|FG000|NOT COMPLETED|Overall Study||17||
48193099|NCT00049517|100796916|FG005|NOT COMPLETED|Conditioning/Transplant||6||
48193100|NCT00881335|100796917|FG000|STARTED|Overall Study||30||
48193101|NCT00881335|100796918|FG001|STARTED|Overall Study||30||
48193102|NCT00881335|100796917|FG000|COMPLETED|Overall Study||27||
48193103|NCT00881335|100796918|FG001|COMPLETED|Overall Study||28||
48193104|NCT00881335|100796917|FG000|NOT COMPLETED|Overall Study||3||
48193105|NCT00881335|100796918|FG001|NOT COMPLETED|Overall Study||2||
48193106|NCT01264718|100796919|FG000|STARTED|Overall Study||172||
48193107|NCT01264718|100796920|FG001|STARTED|Overall Study||157||
48193108|NCT01264718|100796919|FG000|COMPLETED|Overall Study||123||
48193109|NCT01264718|100796920|FG001|COMPLETED|Overall Study||114||
48193110|NCT01264718|100796919|FG000|NOT COMPLETED|Overall Study||49||
48193111|NCT01264718|100796920|FG001|NOT COMPLETED|Overall Study||43||
48193112|NCT01032850|100796921|FG000|STARTED|Overall Study||15||
48193113|NCT01032850|100796921|FG000|COMPLETED|Overall Study||13||
48193114|NCT01032850|100796921|FG000|NOT COMPLETED|Overall Study||2||
48193115|NCT05296629|100796922|FG000|STARTED|Overall Study||122||
48193116|NCT05296629|100796923|FG001|STARTED|Overall Study||121||
48193117|NCT05296629|100796924|FG002|STARTED|Overall Study||80||
48193118|NCT05296629|100796922|FG000|COMPLETED|Overall Study||117||
48193119|NCT05296629|100796923|FG001|COMPLETED|Overall Study||98||
48193120|NCT05296629|100796924|FG002|COMPLETED|Overall Study||73||
48193121|NCT05296629|100796922|FG000|NOT COMPLETED|Overall Study||5||
48193122|NCT05296629|100796923|FG001|NOT COMPLETED|Overall Study||23||
48193123|NCT05296629|100796924|FG002|NOT COMPLETED|Overall Study||7||
48193124|NCT03531905|100796925|FG000|STARTED|Overall Study||81||
48193125|NCT03531905|100796926|FG001|STARTED|Overall Study||81||
48193126|NCT03531905|100796927|FG002|STARTED|Overall Study||80||
48193127|NCT03531905|100796925|FG000|COMPLETED|Overall Study||74||
48193128|NCT03531905|100796926|FG001|COMPLETED|Overall Study||76||
48193129|NCT03531905|100796927|FG002|COMPLETED|Overall Study||77||
48193130|NCT03531905|100796925|FG000|NOT COMPLETED|Overall Study||7||
48193131|NCT03531905|100796926|FG001|NOT COMPLETED|Overall Study||5||
48193132|NCT03531905|100796927|FG002|NOT COMPLETED|Overall Study||3||
48193133|NCT00723294|100796928|FG000|STARTED|Overall Study||99||
48193134|NCT00723294|100796928|FG000|COMPLETED|Overall Study||86||
48193135|NCT00723294|100796928|FG000|NOT COMPLETED|Overall Study||13||
48193136|NCT03961256|100796929|FG000|STARTED|Overall Study||6||
48193137|NCT03961256|100796930|FG001|STARTED|Overall Study||3||
48193138|NCT03961256|100796929|FG000|COMPLETED|Overall Study||6||
48193139|NCT03961256|100796930|FG001|COMPLETED|Overall Study||3||
48193140|NCT03961256|100796929|FG000|NOT COMPLETED|Overall Study||0||
48193141|NCT03961256|100796930|FG001|NOT COMPLETED|Overall Study||0||
48193142|NCT01065454|100796931|FG000|STARTED|Treatment||67||
48193143|NCT01065454|100796932|FG001|STARTED|Treatment||33||
48193144|NCT01065454|100796933|FG002|STARTED|Treatment||32||
48193145|NCT01065454|100796934|FG003|STARTED|Treatment||69||
48193146|NCT01065454|100796931|FG000|COMPLETED|Treatment||54||
48193147|NCT01065454|100796932|FG001|COMPLETED|Treatment||28||
48193148|NCT01065454|100796933|FG002|COMPLETED|Treatment||23||
48193149|NCT01065454|100796934|FG003|COMPLETED|Treatment||57||
48193150|NCT01065454|100796931|FG000|NOT COMPLETED|Treatment||13||
48193151|NCT01065454|100796932|FG001|NOT COMPLETED|Treatment||5||
48193152|NCT01065454|100796933|FG002|NOT COMPLETED|Treatment||9||
48193153|NCT01065454|100796934|FG003|NOT COMPLETED|Treatment||12||
48193154|NCT01065454|100796931|FG000|STARTED|Follow up||54||
48193155|NCT01065454|100796932|FG001|STARTED|Follow up||28||
48193156|NCT01065454|100796933|FG002|STARTED|Follow up||23||
48193157|NCT01065454|100796934|FG003|STARTED|Follow up||57||
48193158|NCT01065454|100796931|FG000|Entering Follow-up|Follow up||49||
48193159|NCT01065454|100796932|FG001|Entering Follow-up|Follow up||27||
48193160|NCT01065454|100796933|FG002|Entering Follow-up|Follow up||23||
48193161|NCT01065454|100796934|FG003|Entering Follow-up|Follow up||51||
48193162|NCT01065454|100796931|FG000|COMPLETED|Follow up||15||
48193163|NCT01065454|100796932|FG001|COMPLETED|Follow up||4||
48193164|NCT01065454|100796933|FG002|COMPLETED|Follow up||6||
48193165|NCT01065454|100796934|FG003|COMPLETED|Follow up||13||
48193166|NCT01065454|100796931|FG000|NOT COMPLETED|Follow up||39||
48193167|NCT01065454|100796932|FG001|NOT COMPLETED|Follow up||24||
48193168|NCT01065454|100796933|FG002|NOT COMPLETED|Follow up||17||
48193169|NCT01065454|100796934|FG003|NOT COMPLETED|Follow up||44||
48193170|NCT00303303|100796935|FG000|STARTED|Overall Study||5||
48193171|NCT00303303|100796936|FG001|STARTED|Overall Study||4||
48193172|NCT00303303|100796937|FG002|STARTED|Overall Study||4||
48193173|NCT00303303|100796935|FG000|COMPLETED|Overall Study||5||
48193174|NCT00303303|100796936|FG001|COMPLETED|Overall Study||4||
48193175|NCT00303303|100796937|FG002|COMPLETED|Overall Study||3||
48193176|NCT00303303|100796935|FG000|NOT COMPLETED|Overall Study||0||
48193177|NCT00303303|100796936|FG001|NOT COMPLETED|Overall Study||0||
48193178|NCT00303303|100796937|FG002|NOT COMPLETED|Overall Study||1||
48193179|NCT04432974|100796938|FG000|STARTED|Overall Study||139||
48193180|NCT04432974|100796938|FG000|Operating Room Admission|Overall Study||139||
48193181|NCT04432974|100796938|FG000|Operating Room Discharge|Overall Study||139||
48193182|NCT04432974|100796938|FG000|Recovery Room Admission|Overall Study||139||
48193183|NCT04432974|100796938|FG000|Recovery Room Discharge|Overall Study||139||
48193184|NCT04432974|100796938|FG000|Ward 6 Hours Post-surgery|Overall Study||139||
48193185|NCT04432974|100796938|FG000|Ward 24 Hours Post-surgery|Overall Study||139||
48193186|NCT04432974|100796938|FG000|COMPLETED|Overall Study||139||
48193187|NCT04432974|100796938|FG000|NOT COMPLETED|Overall Study||0||
48193188|NCT05153174|100796939|FG000|STARTED|Overall Study||9||
48193189|NCT05153174|100796940|FG001|STARTED|Overall Study||9||
48193190|NCT05153174|100796939|FG000|COMPLETED|Overall Study||9||
48193191|NCT05153174|100796940|FG001|COMPLETED|Overall Study||9||
48193192|NCT05153174|100796939|FG000|NOT COMPLETED|Overall Study||0||
48193193|NCT05153174|100796940|FG001|NOT COMPLETED|Overall Study||0||
48476837|NCT02724800|101503000|FG001|NOT COMPLETED|Overall Study||9||
48193194|NCT00961805|100796941|FG000|STARTED|Overall Study||40||
48193195|NCT00961805|100796942|FG001|STARTED|Overall Study||40||
48193196|NCT00961805|100796941|FG000|COMPLETED|Overall Study||40||
48193197|NCT00961805|100796942|FG001|COMPLETED|Overall Study||40||
48193198|NCT00961805|100796941|FG000|NOT COMPLETED|Overall Study||0||
48193199|NCT00961805|100796942|FG001|NOT COMPLETED|Overall Study||0||
48193200|NCT00883350|100796943|FG000|STARTED|Overall Study||20||
48193201|NCT00883350|100796944|FG001|STARTED|Overall Study||20||
48193202|NCT00883350|100796943|FG000|COMPLETED|Overall Study||19||
48193203|NCT00883350|100796944|FG001|COMPLETED|Overall Study||19||
48193204|NCT00883350|100796943|FG000|NOT COMPLETED|Overall Study||1||
48193205|NCT00883350|100796944|FG001|NOT COMPLETED|Overall Study||1||
48193206|NCT05493787|100796945|FG000|STARTED|Overall Study||12531||
48193207|NCT05493787|100796946|FG001|STARTED|Overall Study||12531||
48193208|NCT05493787|100796947|FG002|STARTED|Overall Study||12531||
48193209|NCT05493787|100796948|FG003|STARTED|Overall Study||12531||
48193210|NCT05493787|100796949|FG004|STARTED|Overall Study||12530||
48193211|NCT05493787|100796950|FG005|STARTED|Overall Study||12531||
48193212|NCT05493787|100796951|FG006|STARTED|Overall Study||10705||
48193213|NCT05493787|100796952|FG007|STARTED|Overall Study||10743||
48193214|NCT05493787|100796953|FG008|STARTED|Overall Study||10657||
48193215|NCT05493787|100796954|FG009|STARTED|Overall Study||10783||
48193216|NCT05493787|100796955|FG010|STARTED|Overall Study||10702||
48193217|NCT05493787|100796956|FG011|STARTED|Overall Study||10728||
48193218|NCT05493787|100796945|FG000|COMPLETED|Overall Study||12531||
48193219|NCT05493787|100796946|FG001|COMPLETED|Overall Study||12531||
48193220|NCT05493787|100796947|FG002|COMPLETED|Overall Study||12531||
48193221|NCT05493787|100796948|FG003|COMPLETED|Overall Study||12531||
48193222|NCT05493787|100796949|FG004|COMPLETED|Overall Study||12530||
48193223|NCT05493787|100796950|FG005|COMPLETED|Overall Study||12531||
48193224|NCT05493787|100796951|FG006|COMPLETED|Overall Study||10705||
48193225|NCT05493787|100796952|FG007|COMPLETED|Overall Study||10743||
48193226|NCT05493787|100796953|FG008|COMPLETED|Overall Study||10657||
48193227|NCT05493787|100796954|FG009|COMPLETED|Overall Study||10783||
48193228|NCT05493787|100796955|FG010|COMPLETED|Overall Study||10702||
48193229|NCT05493787|100796956|FG011|COMPLETED|Overall Study||10728||
48193230|NCT05493787|100796945|FG000|NOT COMPLETED|Overall Study||0||
48193231|NCT05493787|100796946|FG001|NOT COMPLETED|Overall Study||0||
48193232|NCT05493787|100796947|FG002|NOT COMPLETED|Overall Study||0||
48476838|NCT01379664|101503001|FG000|STARTED|Overall Study||714||
48476839|NCT01379664|101503002|FG001|STARTED|Overall Study||870||
48666311|NCT01148771|101967553|FG001|NOT COMPLETED|Washout Period||1||
48193233|NCT05493787|100796948|FG003|NOT COMPLETED|Overall Study||0||
48193234|NCT05493787|100796949|FG004|NOT COMPLETED|Overall Study||0||
48476840|NCT01379664|101503001|FG000|COMPLETED|Overall Study||714||
48193235|NCT05493787|100796950|FG005|NOT COMPLETED|Overall Study||0||
48476841|NCT01379664|101503002|FG001|COMPLETED|Overall Study||870||
48193236|NCT05493787|100796951|FG006|NOT COMPLETED|Overall Study||0||
48193237|NCT05493787|100796952|FG007|NOT COMPLETED|Overall Study||0||
48193238|NCT05493787|100796953|FG008|NOT COMPLETED|Overall Study||0||
48193239|NCT05493787|100796954|FG009|NOT COMPLETED|Overall Study||0||
48193240|NCT05493787|100796955|FG010|NOT COMPLETED|Overall Study||0||
48193241|NCT05493787|100796956|FG011|NOT COMPLETED|Overall Study||0||
48193242|NCT04582877|100796957|FG000|STARTED|Overall Study||300||
48193243|NCT04582877|100796957|FG000|COMPLETED|Overall Study||292||
48193244|NCT04582877|100796957|FG000|NOT COMPLETED|Overall Study||8||
48193245|NCT01772719|100796958|FG000|STARTED|Overall Study||7||
48193246|NCT01772719|100796958|FG000|COMPLETED|Overall Study||0||
48193247|NCT01772719|100796958|FG000|NOT COMPLETED|Overall Study||7||
48193248|NCT00826280|100796959|FG000|STARTED|Overall Study||114||
48193249|NCT00826280|100796960|FG001|STARTED|Overall Study||116||
48193250|NCT00826280|100796961|FG002|STARTED|Overall Study||117||
48193251|NCT00826280|100796959|FG000|Safety Analysis Set|Overall Study||113||
48193252|NCT00826280|100796960|FG001|Safety Analysis Set|Overall Study||116||
48193253|NCT00826280|100796961|FG002|Safety Analysis Set|Overall Study||116||
48193254|NCT00826280|100796959|FG000|Completed Treatment|Overall Study||66||
48193255|NCT00826280|100796960|FG001|Completed Treatment|Overall Study||71||
48193256|NCT00826280|100796961|FG002|Completed Treatment|Overall Study||72||
48193257|NCT00826280|100796959|FG000|COMPLETED|Overall Study||66||
48193258|NCT00826280|100796960|FG001|COMPLETED|Overall Study||70||
48193259|NCT00826280|100796961|FG002|COMPLETED|Overall Study||71||
48193260|NCT00826280|100796959|FG000|NOT COMPLETED|Overall Study||48||
48193261|NCT00826280|100796960|FG001|NOT COMPLETED|Overall Study||46||
48193262|NCT00826280|100796961|FG002|NOT COMPLETED|Overall Study||46||
48193263|NCT01743729|100796962|FG000|STARTED|Overall Study||358||
48193264|NCT01743729|100796963|FG001|STARTED|Overall Study||360||
48193265|NCT01743729|100796962|FG000|COMPLETED|Overall Study||321||
48193266|NCT01743729|100796963|FG001|COMPLETED|Overall Study||348||
48193267|NCT01743729|100796962|FG000|NOT COMPLETED|Overall Study||37||
48193268|NCT01743729|100796963|FG001|NOT COMPLETED|Overall Study||12||
48193269|NCT03201809|100796964|FG000|STARTED|Overall Study||6||
48193270|NCT03201809|100796965|FG001|STARTED|Overall Study||6||
48193271|NCT03201809|100796964|FG000|COMPLETED|Overall Study||4||
48476842|NCT01379664|101503001|FG000|NOT COMPLETED|Overall Study||0||
48476843|NCT01379664|101503002|FG001|NOT COMPLETED|Overall Study||0||
48476844|NCT01856309|101503003|FG000|STARTED|Overall Study||305||
48476845|NCT01856309|101503004|FG001|STARTED|Overall Study||291||
48476846|NCT01856309|101503005|FG002|STARTED|Overall Study||606||
48476847|NCT01856309|101503006|FG003|STARTED|Overall Study||618||
48476848|NCT01856309|101503003|FG000|Participants From Study CNTO136ARA3002|Overall Study||197||
48476849|NCT01856309|101503004|FG001|Participants From Study CNTO136ARA3002|Overall Study||187||
48476850|NCT01856309|101503005|FG002|Participants From Study CNTO136ARA3002|Overall Study||405||
48666312|NCT01148771|101967552|FG000|STARTED|Second Intervention||6||
48193272|NCT03201809|100796965|FG001|COMPLETED|Overall Study||6||
48193273|NCT03201809|100796964|FG000|NOT COMPLETED|Overall Study||2||
48193274|NCT03201809|100796965|FG001|NOT COMPLETED|Overall Study||0||
48193275|NCT00506519|100796966|FG000|STARTED|Overall Study||10||
48193276|NCT00506519|100796967|FG001|STARTED|Overall Study||10||
48193277|NCT00506519|100796968|FG002|STARTED|Overall Study||5||
48193278|NCT00506519|100796966|FG000|Completed Treatment (Day 5)|Overall Study||8||
48193279|NCT00506519|100796967|FG001|Completed Treatment (Day 5)|Overall Study||7||
48193280|NCT00506519|100796968|FG002|Completed Treatment (Day 5)|Overall Study||5||
48193281|NCT00506519|100796966|FG000|Day 28 Follow up|Overall Study||8||
48193282|NCT00506519|100796967|FG001|Day 28 Follow up|Overall Study||6||
48193283|NCT00506519|100796968|FG002|Day 28 Follow up|Overall Study||5||
48193284|NCT00506519|100796966|FG000|COMPLETED|Overall Study||5|Day 90 follow up (trial completed)|
48193285|NCT00506519|100796967|FG001|COMPLETED|Overall Study||4|Day 90 follow up (trial completed)|
48193286|NCT00506519|100796968|FG002|COMPLETED|Overall Study||5|Day 90 follow up (trial completed)|
48193287|NCT00506519|100796966|FG000|NOT COMPLETED|Overall Study||5||
48193288|NCT00506519|100796967|FG001|NOT COMPLETED|Overall Study||6||
48193289|NCT00506519|100796968|FG002|NOT COMPLETED|Overall Study||0||
48193290|NCT02223793|100796969|FG000|STARTED|Overall Study||185||
48193291|NCT02223793|100796970|FG001|STARTED|Overall Study||199||
48193292|NCT02223793|100796971|FG002|STARTED|Overall Study||198||
48193293|NCT02223793|100796969|FG000|COMPLETED|Overall Study||168||
48193294|NCT02223793|100796970|FG001|COMPLETED|Overall Study||190||
48193295|NCT02223793|100796971|FG002|COMPLETED|Overall Study||185||
48193296|NCT02223793|100796969|FG000|NOT COMPLETED|Overall Study||17||
48193297|NCT02223793|100796970|FG001|NOT COMPLETED|Overall Study||9||
48193298|NCT02223793|100796971|FG002|NOT COMPLETED|Overall Study||13||
48193299|NCT00928200|100796972|FG000|STARTED|Overall Study||1||
48193300|NCT00928200|100796972|FG000|COMPLETED|Overall Study||1||
48193301|NCT00928200|100796972|FG000|NOT COMPLETED|Overall Study||0||
48193302|NCT05705167|100796973|FG000|STARTED|Overall Study||2||
48193303|NCT05705167|100796974|FG001|STARTED|Overall Study||3||
48193304|NCT05705167|100796975|FG002|STARTED|Overall Study||11||
48193305|NCT05705167|100796976|FG003|STARTED|Overall Study||11||
48193306|NCT05705167|100796977|FG004|STARTED|Overall Study||1||
48193307|NCT05705167|100796978|FG005|STARTED|Overall Study||1||
48193308|NCT05705167|100796979|FG006|STARTED|Overall Study||8||
48193309|NCT05705167|100796973|FG000|COMPLETED|Overall Study||2||
48193310|NCT05705167|100796974|FG001|COMPLETED|Overall Study||1||
48193311|NCT05705167|100796975|FG002|COMPLETED|Overall Study||7||
48193312|NCT05705167|100796976|FG003|COMPLETED|Overall Study||3||
48193313|NCT05705167|100796977|FG004|COMPLETED|Overall Study||0||
48193314|NCT05705167|100796978|FG005|COMPLETED|Overall Study||0||
48193315|NCT05705167|100796979|FG006|COMPLETED|Overall Study||6||
48193316|NCT05705167|100796973|FG000|NOT COMPLETED|Overall Study||0||
48193317|NCT05705167|100796974|FG001|NOT COMPLETED|Overall Study||2||
48193318|NCT05705167|100796975|FG002|NOT COMPLETED|Overall Study||4||
48193319|NCT05705167|100796976|FG003|NOT COMPLETED|Overall Study||8||
48193320|NCT05705167|100796977|FG004|NOT COMPLETED|Overall Study||1||
48193321|NCT05705167|100796978|FG005|NOT COMPLETED|Overall Study||1||
48193322|NCT05705167|100796979|FG006|NOT COMPLETED|Overall Study||2||
48193323|NCT03404609|100796980|FG000|STARTED|Overall Study||7||
48193324|NCT03404609|100796980|FG000|COMPLETED|Overall Study||7||
48193325|NCT03404609|100796980|FG000|NOT COMPLETED|Overall Study||0||
48193326|NCT00389519|100796981|FG000|STARTED|Placebo Run-In||422||
48193327|NCT00389519|100796982|FG001|STARTED|Placebo Run-In||0||
48193328|NCT00389519|100796983|FG002|STARTED|Placebo Run-In||0||
48193329|NCT00389519|100796984|FG003|STARTED|Placebo Run-In||0||
48193330|NCT00389519|100796981|FG000|COMPLETED|Placebo Run-In||244||
48193331|NCT00389519|100796982|FG001|COMPLETED|Placebo Run-In||0||
48193332|NCT00389519|100796983|FG002|COMPLETED|Placebo Run-In||0||
48193333|NCT00389519|100796984|FG003|COMPLETED|Placebo Run-In||0||
48193334|NCT00389519|100796981|FG000|NOT COMPLETED|Placebo Run-In||178||
48193335|NCT00389519|100796982|FG001|NOT COMPLETED|Placebo Run-In||0||
48193336|NCT00389519|100796983|FG002|NOT COMPLETED|Placebo Run-In||0||
48193337|NCT00389519|100796984|FG003|NOT COMPLETED|Placebo Run-In||0||
48193338|NCT00389519|100796981|FG000|STARTED|Randomized||83||
48193339|NCT00389519|100796982|FG001|STARTED|Randomized||41||
48193340|NCT00389519|100796983|FG002|STARTED|Randomized||40||
48193341|NCT00389519|100796984|FG003|STARTED|Randomized||80||
48193342|NCT00389519|100796981|FG000|COMPLETED|Randomized||81||
48193343|NCT00389519|100796982|FG001|COMPLETED|Randomized||41||
48193344|NCT00389519|100796983|FG002|COMPLETED|Randomized||40||
48193345|NCT00389519|100796984|FG003|COMPLETED|Randomized||80||
48193346|NCT00389519|100796981|FG000|NOT COMPLETED|Randomized||2||
48193347|NCT00389519|100796982|FG001|NOT COMPLETED|Randomized||0||
48193348|NCT00389519|100796983|FG002|NOT COMPLETED|Randomized||0||
48193349|NCT00389519|100796984|FG003|NOT COMPLETED|Randomized||0||
48193350|NCT00389519|100796981|FG000|STARTED|Treated||81||
48193351|NCT00389519|100796982|FG001|STARTED|Treated||41||
48193352|NCT00389519|100796983|FG002|STARTED|Treated||40||
48193353|NCT00389519|100796984|FG003|STARTED|Treated||80||
48193354|NCT00389519|100796981|FG000|COMPLETED|Treated||79||
48193355|NCT00389519|100796982|FG001|COMPLETED|Treated||40||
48193356|NCT00389519|100796983|FG002|COMPLETED|Treated||40||
48193357|NCT00389519|100796984|FG003|COMPLETED|Treated||76||
48193358|NCT00389519|100796981|FG000|NOT COMPLETED|Treated||2||
48193359|NCT00389519|100796982|FG001|NOT COMPLETED|Treated||1||
48193360|NCT00389519|100796983|FG002|NOT COMPLETED|Treated||0||
48193361|NCT00389519|100796984|FG003|NOT COMPLETED|Treated||4||
48193362|NCT00241644|100796985|FG000|STARTED|First Efficacy Period (Year 1)||1647||
48193363|NCT00241644|100796986|FG001|STARTED|First Efficacy Period (Year 1)||1651||
48193364|NCT00241644|100796987|FG002|STARTED|First Efficacy Period (Year 1)||1641||
48193365|NCT00241644|100796988|FG003|STARTED|First Efficacy Period (Year 1)||3298||
48193366|NCT00241644|100796985|FG000|COMPLETED|First Efficacy Period (Year 1)||1420||
48193367|NCT00241644|100796986|FG001|COMPLETED|First Efficacy Period (Year 1)||1383||
48193368|NCT00241644|100796987|FG002|COMPLETED|First Efficacy Period (Year 1)||1392||
48193369|NCT00241644|100796988|FG003|COMPLETED|First Efficacy Period (Year 1)||2803||
48193370|NCT00241644|100796985|FG000|NOT COMPLETED|First Efficacy Period (Year 1)||227||
48193371|NCT00241644|100796986|FG001|NOT COMPLETED|First Efficacy Period (Year 1)||268||
48193372|NCT00241644|100796987|FG002|NOT COMPLETED|First Efficacy Period (Year 1)||249||
48193373|NCT00241644|100796988|FG003|NOT COMPLETED|First Efficacy Period (Year 1)||495||
48193374|NCT00241644|100796985|FG000|STARTED|Second Efficacy Period (Year 2)||771||
48193375|NCT00241644|100796986|FG001|STARTED|Second Efficacy Period (Year 2)||754||
48193376|NCT00241644|100796987|FG002|STARTED|Second Efficacy Period (Year 2)||746||
48193377|NCT00241644|100796988|FG003|STARTED|Second Efficacy Period (Year 2)||1525||
48193378|NCT00241644|100796985|FG000|COMPLETED|Second Efficacy Period (Year 2)||710||
48193379|NCT00241644|100796986|FG001|COMPLETED|Second Efficacy Period (Year 2)||697||
48193380|NCT00241644|100796987|FG002|COMPLETED|Second Efficacy Period (Year 2)||682||
48193381|NCT00241644|100796988|FG003|COMPLETED|Second Efficacy Period (Year 2)||1407||
48193382|NCT00241644|100796985|FG000|NOT COMPLETED|Second Efficacy Period (Year 2)||61||
48193383|NCT00241644|100796986|FG001|NOT COMPLETED|Second Efficacy Period (Year 2)||57||
48193384|NCT00241644|100796987|FG002|NOT COMPLETED|Second Efficacy Period (Year 2)||64||
48193385|NCT00241644|100796988|FG003|NOT COMPLETED|Second Efficacy Period (Year 2)||118||
48193386|NCT00108524|100796989|FG000|STARTED|Overall Study||81||
48193387|NCT00108524|100796990|FG001|STARTED|Overall Study||79||
48193388|NCT00108524|100796989|FG000|COMPLETED|Overall Study||52||
48193389|NCT00108524|100796990|FG001|COMPLETED|Overall Study||61||
48193390|NCT00108524|100796989|FG000|NOT COMPLETED|Overall Study||29||
48193391|NCT00108524|100796990|FG001|NOT COMPLETED|Overall Study||18||
48193392|NCT05052983|100796991|FG000|STARTED|Overall Study||18||
48193393|NCT05052983|100796992|FG001|STARTED|Overall Study||16||
48193394|NCT05052983|100796991|FG000|COMPLETED|Overall Study||14||
48193395|NCT05052983|100796992|FG001|COMPLETED|Overall Study||4||
48193396|NCT05052983|100796991|FG000|NOT COMPLETED|Overall Study||4||
48193397|NCT05052983|100796992|FG001|NOT COMPLETED|Overall Study||12||
48193398|NCT03999944|100796993|FG000|STARTED|First Sleep Night||26||
48193399|NCT03999944|100796994|FG001|STARTED|First Sleep Night||26||
48193400|NCT03999944|100796993|FG000|COMPLETED|First Sleep Night||22||
48193401|NCT03999944|100796994|FG001|COMPLETED|First Sleep Night||24||
48193402|NCT03999944|100796993|FG000|NOT COMPLETED|First Sleep Night||4||
48193403|NCT03999944|100796994|FG001|NOT COMPLETED|First Sleep Night||2||
48193404|NCT03999944|100796993|FG000|STARTED|Second Sleep Night||22||
48193405|NCT03999944|100796994|FG001|STARTED|Second Sleep Night||24||
48193406|NCT03999944|100796993|FG000|COMPLETED|Second Sleep Night||22||
48476851|NCT01856309|101503006|FG003|Participants From Study CNTO136ARA3002|Overall Study||412||
48193407|NCT03999944|100796994|FG001|COMPLETED|Second Sleep Night||20||
48193408|NCT03999944|100796993|FG000|NOT COMPLETED|Second Sleep Night||0||
48193409|NCT03999944|100796994|FG001|NOT COMPLETED|Second Sleep Night||4||
48193410|NCT03106025|100796995|FG000|STARTED|Overall Study||5||
48476852|NCT01856309|101503003|FG000|Participants From Study CNTO136ARA3003|Overall Study||108||
48476853|NCT01856309|101503004|FG001|Participants From Study CNTO136ARA3003|Overall Study||104||
48476854|NCT01856309|101503005|FG002|Participants From Study CNTO136ARA3003|Overall Study||201||
48666313|NCT01148771|101967553|FG001|STARTED|Second Intervention||5||
48193411|NCT03106025|100796995|FG000|COMPLETED|Overall Study||5||
48193412|NCT03106025|100796995|FG000|NOT COMPLETED|Overall Study||0||
48193413|NCT02661997|100796996|FG000|STARTED|Baseline Assessment||58||
48193414|NCT02661997|100796997|FG001|STARTED|Baseline Assessment||56||
48193415|NCT02661997|100796996|FG000|COMPLETED|Baseline Assessment||58||
48193416|NCT02661997|100796997|FG001|COMPLETED|Baseline Assessment||56||
48193417|NCT02661997|100796996|FG000|NOT COMPLETED|Baseline Assessment||0||
48193418|NCT02661997|100796997|FG001|NOT COMPLETED|Baseline Assessment||0||
48193419|NCT02661997|100796996|FG000|STARTED|Post-Treatment Assessment||58||
48193420|NCT02661997|100796997|FG001|STARTED|Post-Treatment Assessment||56||
48193421|NCT02661997|100796996|FG000|COMPLETED|Post-Treatment Assessment||48||
48193422|NCT02661997|100796997|FG001|COMPLETED|Post-Treatment Assessment||50||
48193423|NCT02661997|100796996|FG000|NOT COMPLETED|Post-Treatment Assessment||10||
48193424|NCT02661997|100796997|FG001|NOT COMPLETED|Post-Treatment Assessment||6||
48193425|NCT02661997|100796996|FG000|STARTED|3-month Follow-up Assessment||58||
48193426|NCT02661997|100796997|FG001|STARTED|3-month Follow-up Assessment||56||
48193427|NCT02661997|100796996|FG000|COMPLETED|3-month Follow-up Assessment||52||
48193428|NCT02661997|100796997|FG001|COMPLETED|3-month Follow-up Assessment||50||
48193429|NCT02661997|100796996|FG000|NOT COMPLETED|3-month Follow-up Assessment||6||
48193430|NCT02661997|100796997|FG001|NOT COMPLETED|3-month Follow-up Assessment||6||
48193431|NCT02661997|100796996|FG000|STARTED|9-month Follow-up Assessment||58||
48193432|NCT02661997|100796997|FG001|STARTED|9-month Follow-up Assessment||56||
48193433|NCT02661997|100796996|FG000|COMPLETED|9-month Follow-up Assessment||45||
48193434|NCT02661997|100796997|FG001|COMPLETED|9-month Follow-up Assessment||46||
48193435|NCT02661997|100796996|FG000|NOT COMPLETED|9-month Follow-up Assessment||13||
48193436|NCT02661997|100796997|FG001|NOT COMPLETED|9-month Follow-up Assessment||10||
48193437|NCT03178201|100796998|FG000|STARTED|Overall Study||5||
48193438|NCT03178201|100796998|FG000|COMPLETED|Overall Study||0||
48193439|NCT03178201|100796998|FG000|NOT COMPLETED|Overall Study||5||
48193440|NCT04969822|100796999|FG000|STARTED|Overall Study||533||
48193441|NCT04969822|100797000|FG001|STARTED|Overall Study||533||
48193442|NCT04969822|100796999|FG000|COMPLETED|Overall Study||533||
48193443|NCT04969822|100797000|FG001|COMPLETED|Overall Study||533||
48193444|NCT04969822|100796999|FG000|NOT COMPLETED|Overall Study||0||
48193445|NCT04969822|100797000|FG001|NOT COMPLETED|Overall Study||0||
48193446|NCT03829332|100797001|FG000|STARTED|Overall Study||309||
48193447|NCT03829332|100797002|FG001|STARTED|Overall Study||314||
48193448|NCT03829332|100797001|FG000|Treated|Overall Study||309||
48193449|NCT03829332|100797002|FG001|Treated|Overall Study||312||
48193450|NCT03829332|100797001|FG000|COMPLETED|Overall Study||0||
48193451|NCT03829332|100797002|FG001|COMPLETED|Overall Study||0||
48193452|NCT03829332|100797001|FG000|NOT COMPLETED|Overall Study||309||
48193453|NCT03829332|100797002|FG001|NOT COMPLETED|Overall Study||314||
48193454|NCT05538754|100797003|FG000|STARTED|Overall Study||205||205
48193455|NCT05538754|100797004|FG001|STARTED|Overall Study||205||203
48193456|NCT05538754|100797003|FG000|COMPLETED|Overall Study||205||205
48193457|NCT05538754|100797004|FG001|COMPLETED|Overall Study||205||203
48193458|NCT05538754|100797003|FG000|NOT COMPLETED|Overall Study||0||0
48193459|NCT05538754|100797004|FG001|NOT COMPLETED|Overall Study||0||0
48193460|NCT01763047|100797005|FG000|STARTED|Period 1||139||
48193461|NCT01763047|100797006|FG001|STARTED|Period 1||137||
48193462|NCT01763047|100797005|FG000|Myopes|Period 1||77||
48193463|NCT01763047|100797006|FG001|Myopes|Period 1||76||
48193464|NCT01763047|100797005|FG000|Hyperopes|Period 1||62||
48193465|NCT01763047|100797006|FG001|Hyperopes|Period 1||61||
48193466|NCT01763047|100797005|FG000|COMPLETED|Period 1||130||
48193467|NCT01763047|100797006|FG001|COMPLETED|Period 1||126||
48193468|NCT01763047|100797005|FG000|NOT COMPLETED|Period 1||9||
48193469|NCT01763047|100797006|FG001|NOT COMPLETED|Period 1||11||
48193470|NCT01763047|100797005|FG000|STARTED|Period 2||130||
48193471|NCT01763047|100797006|FG001|STARTED|Period 2||126||
48193472|NCT01763047|100797005|FG000|Myopes|Period 2||74||
48193473|NCT01763047|100797006|FG001|Myopes|Period 2||72||
48193474|NCT01763047|100797005|FG000|Hyperopes|Period 2||56||
48193475|NCT01763047|100797006|FG001|Hyperopes|Period 2||54||
48193476|NCT01763047|100797005|FG000|COMPLETED|Period 2||126||
48193477|NCT01763047|100797006|FG001|COMPLETED|Period 2||121||
48193478|NCT01763047|100797005|FG000|NOT COMPLETED|Period 2||4||
48193479|NCT01763047|100797006|FG001|NOT COMPLETED|Period 2||5||
48193480|NCT04436120|100797007|FG000|STARTED|Overall Study||1||
48193481|NCT04436120|100797008|FG001|STARTED|Overall Study||4||
48193482|NCT04436120|100797009|FG002|STARTED|Overall Study||5||
48193483|NCT04436120|100797010|FG003|STARTED|Overall Study||11||
48193484|NCT04436120|100797011|FG004|STARTED|Overall Study||5||
48193485|NCT04436120|100797012|FG005|STARTED|Overall Study||11||
48193486|NCT04436120|100797013|FG006|STARTED|Overall Study||1||
48193487|NCT04436120|100797007|FG000|COMPLETED|Overall Study||1||
48193488|NCT04436120|100797008|FG001|COMPLETED|Overall Study||4||
48193489|NCT04436120|100797009|FG002|COMPLETED|Overall Study||5||
48193490|NCT04436120|100797010|FG003|COMPLETED|Overall Study||10||
48193491|NCT04436120|100797011|FG004|COMPLETED|Overall Study||5||
48193492|NCT04436120|100797012|FG005|COMPLETED|Overall Study||10||
48193493|NCT04436120|100797013|FG006|COMPLETED|Overall Study||1||
48193494|NCT04436120|100797007|FG000|NOT COMPLETED|Overall Study||0||
48193495|NCT04436120|100797008|FG001|NOT COMPLETED|Overall Study||0||
48193496|NCT04436120|100797009|FG002|NOT COMPLETED|Overall Study||0||
48193497|NCT04436120|100797010|FG003|NOT COMPLETED|Overall Study||1||
48193498|NCT04436120|100797011|FG004|NOT COMPLETED|Overall Study||0||
48193499|NCT04436120|100797012|FG005|NOT COMPLETED|Overall Study||1||
48193500|NCT04436120|100797013|FG006|NOT COMPLETED|Overall Study||0||
48193501|NCT05328973|100797014|FG000|STARTED|Overall Study||35||
48193502|NCT05328973|100797015|FG001|STARTED|Overall Study||35||
48193503|NCT05328973|100797014|FG000|COMPLETED|Overall Study||35||
48193504|NCT05328973|100797015|FG001|COMPLETED|Overall Study||34||
48193505|NCT05328973|100797014|FG000|NOT COMPLETED|Overall Study||0||
48193506|NCT05328973|100797015|FG001|NOT COMPLETED|Overall Study||1||
48193507|NCT02219490|100797016|FG000|STARTED|Overall Study||1596||
48193508|NCT02219490|100797016|FG000|COMPLETED|Overall Study||1258||
48193509|NCT02219490|100797016|FG000|NOT COMPLETED|Overall Study||338||
48193510|NCT00967369|100797017|FG000|STARTED|Overall Study||10||
48193511|NCT00967369|100797018|FG001|STARTED|Overall Study||10||
48193512|NCT00967369|100797017|FG000|Relapsed|Overall Study||4||
48193513|NCT00967369|100797018|FG001|Relapsed|Overall Study||7||
48193514|NCT00967369|100797017|FG000|Refractory|Overall Study||6||
48193515|NCT00967369|100797018|FG001|Refractory|Overall Study||3||
48193516|NCT00967369|100797017|FG000|COMPLETED|Overall Study||10||
48193517|NCT00967369|100797018|FG001|COMPLETED|Overall Study||10||
48193518|NCT00967369|100797017|FG000|NOT COMPLETED|Overall Study||0||
48193519|NCT00967369|100797018|FG001|NOT COMPLETED|Overall Study||0||
48193520|NCT01313182|100797019|FG000|STARTED|Overall Study||842||
48193521|NCT01313182|100797020|FG001|STARTED|Overall Study||855||
48193522|NCT01313182|100797019|FG000|COMPLETED|Overall Study||776||
48193523|NCT01313182|100797020|FG001|COMPLETED|Overall Study||763||
48193524|NCT01313182|100797019|FG000|NOT COMPLETED|Overall Study||66||
48193525|NCT01313182|100797020|FG001|NOT COMPLETED|Overall Study||92||
48193526|NCT03404960|100797021|FG000|STARTED|Overall Study||46||
48193527|NCT03404960|100797022|FG001|STARTED|Overall Study||45||
48193528|NCT03404960|100797021|FG000|COMPLETED|Overall Study||44||
48193529|NCT03404960|100797022|FG001|COMPLETED|Overall Study||40||
48193530|NCT03404960|100797021|FG000|NOT COMPLETED|Overall Study||2||
48193531|NCT03404960|100797022|FG001|NOT COMPLETED|Overall Study||5||
48193532|NCT01460381|100797023|FG000|STARTED|Period 1 (Days 1-7)||7||
48193533|NCT01460381|100797024|FG001|STARTED|Period 1 (Days 1-7)||11||
48193534|NCT01460381|100797023|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Days 1-7)||7||
48193535|NCT01460381|100797024|FG001|Received at Least 1 Dose of Study Drug|Period 1 (Days 1-7)||11||
48193536|NCT01460381|100797023|FG000|COMPLETED|Period 1 (Days 1-7)||7||
48193537|NCT01460381|100797024|FG001|COMPLETED|Period 1 (Days 1-7)||11||
48193538|NCT01460381|100797023|FG000|NOT COMPLETED|Period 1 (Days 1-7)||0||
48193539|NCT01460381|100797024|FG001|NOT COMPLETED|Period 1 (Days 1-7)||0||
48193540|NCT01460381|100797023|FG000|STARTED|Period 2 (Days 8-15)||7||
48193541|NCT01460381|100797024|FG001|STARTED|Period 2 (Days 8-15)||0||
48193542|NCT01460381|100797023|FG000|COMPLETED|Period 2 (Days 8-15)||6||
48193543|NCT01460381|100797024|FG001|COMPLETED|Period 2 (Days 8-15)||0||
48193544|NCT01460381|100797023|FG000|NOT COMPLETED|Period 2 (Days 8-15)||1||
48193545|NCT01460381|100797024|FG001|NOT COMPLETED|Period 2 (Days 8-15)||0||
48193546|NCT05826431|100797025|FG000|STARTED|Overall Study||21||
48193547|NCT05826431|100797025|FG000|COMPLETED|Overall Study||20||
48193548|NCT05826431|100797025|FG000|NOT COMPLETED|Overall Study||1||
48193549|NCT01120275|100797026|FG000|STARTED|Overall Study||36||
48193550|NCT01120275|100797026|FG000|Eligible and Treated|Overall Study||32||
48193551|NCT01120275|100797026|FG000|COMPLETED|Overall Study||0||
48193552|NCT01120275|100797026|FG000|NOT COMPLETED|Overall Study||36||
48193553|NCT04054661|100797027|FG000|STARTED|Overall Study||229||
48193554|NCT04054661|100797027|FG000|Enrolled in Repeatability Sub-study|Overall Study||15||
48193555|NCT04054661|100797027|FG000|Enrolled in Sample Stability Sub-study|Overall Study||3||
48193556|NCT04054661|100797027|FG000|COMPLETED|Overall Study||229||
48193557|NCT04054661|100797027|FG000|NOT COMPLETED|Overall Study||0||
48193558|NCT01711918|100797028|FG000|STARTED|Overall Study||9||
48193559|NCT01711918|100797028|FG000|COMPLETED|Overall Study||7||
48193560|NCT01711918|100797028|FG000|NOT COMPLETED|Overall Study||2||
48193561|NCT02365298|100797029|FG000|STARTED|Period 1||14||
48193562|NCT02365298|100797030|FG001|STARTED|Period 1||14||
48193563|NCT02365298|100797029|FG000|COMPLETED|Period 1||14||
48193564|NCT02365298|100797030|FG001|COMPLETED|Period 1||14||
48193565|NCT02365298|100797029|FG000|NOT COMPLETED|Period 1||0||
48193566|NCT02365298|100797030|FG001|NOT COMPLETED|Period 1||0||
48193567|NCT02365298|100797029|FG000|STARTED|Period 2||14||
48193568|NCT02365298|100797030|FG001|STARTED|Period 2||14||
48193569|NCT02365298|100797029|FG000|COMPLETED|Period 2||12||
48193570|NCT02365298|100797030|FG001|COMPLETED|Period 2||12||
48193571|NCT02365298|100797029|FG000|NOT COMPLETED|Period 2||2||
48193572|NCT02365298|100797030|FG001|NOT COMPLETED|Period 2||2||
48193573|NCT05030311|100797031|FG000|STARTED|Overall Study||313|All randomized patients, regardless of whether or not they received a dose of study drug.|
48193574|NCT05030311|100797032|FG001|STARTED|Overall Study||157|All randomized patients, regardless of whether or not they received a dose of study drug.|
48193575|NCT05030311|100797031|FG000|Safety Set|Overall Study||309|All patients who received at least one dose of study treatment, whether or not randomized.|
48193576|NCT05030311|100797032|FG001|Safety Set|Overall Study||153|All patients who received at least one dose of study treatment, whether or not randomized.|
48193577|NCT05030311|100797031|FG000|Full Analysis Set (FAS)|Overall Study||309|All patients to whom study treatment was assigned by randomization. Mis-randomized patients were excluded from FAS.|
48193578|NCT05030311|100797032|FG001|Full Analysis Set (FAS)|Overall Study||153|All patients to whom study treatment was assigned by randomization. Mis-randomized patients were excluded from FAS.|
48193579|NCT05030311|100797031|FG000|COMPLETED|Overall Study||251||
48193580|NCT05030311|100797032|FG001|COMPLETED|Overall Study||124||
48193581|NCT05030311|100797031|FG000|NOT COMPLETED|Overall Study||62||
48193582|NCT05030311|100797032|FG001|NOT COMPLETED|Overall Study||33||
48193583|NCT02023944|100797033|FG000|STARTED|Overall Study||25||
48193584|NCT02023944|100797034|FG001|STARTED|Overall Study||25||
48193585|NCT02023944|100797033|FG000|COMPLETED|Overall Study||25||
48193586|NCT02023944|100797034|FG001|COMPLETED|Overall Study||24||
48193587|NCT02023944|100797033|FG000|NOT COMPLETED|Overall Study||0||
48193588|NCT02023944|100797034|FG001|NOT COMPLETED|Overall Study||1||
48193589|NCT01720043|100797035|FG000|STARTED|Overall Study||8||
48193590|NCT01720043|100797035|FG000|COMPLETED|Overall Study||7||
48193591|NCT01720043|100797035|FG000|NOT COMPLETED|Overall Study||1||
48193592|NCT00310362|100797036|FG000|STARTED|Overall Study||1199||
48193593|NCT00310362|100797037|FG001|STARTED|Overall Study||1205||
48193594|NCT00310362|100797038|FG002|STARTED|Overall Study||1206||
48193595|NCT00310362|100797036|FG000|COMPLETED|Overall Study||1199||
48193596|NCT00310362|100797037|FG001|COMPLETED|Overall Study||1205||
48193597|NCT00310362|100797038|FG002|COMPLETED|Overall Study||1206||
48193598|NCT00310362|100797036|FG000|NOT COMPLETED|Overall Study||0||
48193599|NCT00310362|100797037|FG001|NOT COMPLETED|Overall Study||0||
48193600|NCT00310362|100797038|FG002|NOT COMPLETED|Overall Study||0||
48193601|NCT02014558|100797039|FG000|STARTED|Overall Study||5|Re-enrolled participants (assigned to the 120 mg \[1\] \& 200 mg \[4\] expansion groups) were excluded.|
48193602|NCT02014558|100797040|FG001|STARTED|Overall Study||3|Re-enrolled participants (assigned to the 120 mg \[1\] \& 200 mg \[4\] expansion groups) were excluded.|
48193603|NCT02014558|100797041|FG002|STARTED|Overall Study||3|Re-enrolled participants (assigned to the 120 mg \[1\] \& 200 mg \[4\] expansion groups) were excluded.|
48193604|NCT02014558|100797042|FG003|STARTED|Overall Study||3|Re-enrolled participants (assigned to the 120 mg \[1\] \& 200 mg \[4\] expansion groups) were excluded.|
48193605|NCT02014558|100797043|FG004|STARTED|Overall Study||4|Re-enrolled participants (assigned to the 120 mg \[1\] \& 200 mg \[4\] expansion groups) were excluded.|
48193606|NCT02014558|100797044|FG005|STARTED|Overall Study||3|Re-enrolled participants (assigned to the 120 mg \[1\] \& 200 mg \[4\] expansion groups) were excluded.|
48193607|NCT02014558|100797045|FG006|STARTED|Overall Study||4|Re-enrolled participants (assigned to the 120 mg \[1\] \& 200 mg \[4\] expansion groups) were excluded.|
48193608|NCT02014558|100797046|FG007|STARTED|Overall Study||11|Re-enrolled participants (assigned to the 120 mg \[1\] \& 200 mg \[4\] expansion groups) were excluded.|
48193609|NCT02014558|100797047|FG008|STARTED|Overall Study||15|Re-enrolled participants (assigned to the 120 mg \[1\] \& 200 mg \[4\] expansion groups) were excluded.|
48193610|NCT02014558|100797048|FG009|STARTED|Overall Study||21|Re-enrolled participants (assigned to the 120 mg \[1\] \& 200 mg \[4\] expansion groups) were excluded.|
48666314|NCT01148771|101967552|FG000|COMPLETED|Second Intervention||6||
48193611|NCT02014558|100797049|FG010|STARTED|Overall Study||69|Re-enrolled participants (assigned to the 120 mg \[1\] \& 200 mg \[4\] expansion groups) were excluded.|
48193612|NCT02014558|100797050|FG011|STARTED|Overall Study||102|Re-enrolled participants (assigned to the 120 mg \[1\] \& 200 mg \[4\] expansion groups) were excluded.|
48193613|NCT02014558|100797051|FG012|STARTED|Overall Study||17|Re-enrolled participants (assigned to the 120 mg \[1\] \& 200 mg \[4\] expansion groups) were excluded.|
48193614|NCT02014558|100797039|FG000|Treated|Overall Study||5||
48193615|NCT02014558|100797040|FG001|Treated|Overall Study||3||
48193616|NCT02014558|100797041|FG002|Treated|Overall Study||3||
48193617|NCT02014558|100797042|FG003|Treated|Overall Study||3||
48193618|NCT02014558|100797043|FG004|Treated|Overall Study||3||
48193619|NCT02014558|100797044|FG005|Treated|Overall Study||3||
48193620|NCT02014558|100797045|FG006|Treated|Overall Study||3||
48193621|NCT02014558|100797046|FG007|Treated|Overall Study||12||
48193622|NCT02014558|100797047|FG008|Treated|Overall Study||13||
48193623|NCT02014558|100797048|FG009|Treated|Overall Study||21||
48193624|NCT02014558|100797049|FG010|Treated|Overall Study||66||
48193625|NCT02014558|100797050|FG011|Treated|Overall Study||100||
48193626|NCT02014558|100797051|FG012|Treated|Overall Study||17||
48193627|NCT02014558|100797039|FG000|COMPLETED|Overall Study||0||
48193628|NCT02014558|100797040|FG001|COMPLETED|Overall Study||0||
48193629|NCT02014558|100797041|FG002|COMPLETED|Overall Study||0||
48193630|NCT02014558|100797042|FG003|COMPLETED|Overall Study||0||
48193631|NCT02014558|100797043|FG004|COMPLETED|Overall Study||0||
48193632|NCT02014558|100797044|FG005|COMPLETED|Overall Study||0||
48193633|NCT02014558|100797045|FG006|COMPLETED|Overall Study||0||
48193634|NCT02014558|100797046|FG007|COMPLETED|Overall Study||0||
48193635|NCT02014558|100797047|FG008|COMPLETED|Overall Study||0||
48193636|NCT02014558|100797048|FG009|COMPLETED|Overall Study||0||
48193637|NCT02014558|100797049|FG010|COMPLETED|Overall Study||0||
48193638|NCT02014558|100797050|FG011|COMPLETED|Overall Study||0||
48193639|NCT02014558|100797051|FG012|COMPLETED|Overall Study||0||
48193640|NCT02014558|100797039|FG000|NOT COMPLETED|Overall Study||5||
48193641|NCT02014558|100797040|FG001|NOT COMPLETED|Overall Study||3||
48193642|NCT02014558|100797041|FG002|NOT COMPLETED|Overall Study||3||
48193643|NCT02014558|100797042|FG003|NOT COMPLETED|Overall Study||3||
48193644|NCT02014558|100797043|FG004|NOT COMPLETED|Overall Study||4||
48193645|NCT02014558|100797044|FG005|NOT COMPLETED|Overall Study||3||
48193646|NCT02014558|100797045|FG006|NOT COMPLETED|Overall Study||4||
48193647|NCT02014558|100797046|FG007|NOT COMPLETED|Overall Study||11||
48476855|NCT01856309|101503006|FG003|Participants From Study CNTO136ARA3003|Overall Study||206||
48193648|NCT02014558|100797047|FG008|NOT COMPLETED|Overall Study||15||
48476856|NCT01856309|101503003|FG000|Treated Partcipants|Overall Study||305||
48476857|NCT01856309|101503004|FG001|Treated Partcipants|Overall Study||290||
48476858|NCT01856309|101503005|FG002|Treated Partcipants|Overall Study||605||
48193649|NCT02014558|100797048|FG009|NOT COMPLETED|Overall Study||21||
48193650|NCT02014558|100797049|FG010|NOT COMPLETED|Overall Study||69||
48193651|NCT02014558|100797050|FG011|NOT COMPLETED|Overall Study||102||
48476859|NCT01856309|101503006|FG003|Treated Partcipants|Overall Study||618||
48476860|NCT01856309|101503003|FG000|COMPLETED|Overall Study||6||
48476861|NCT01856309|101503004|FG001|COMPLETED|Overall Study||3||
48193652|NCT02014558|100797051|FG012|NOT COMPLETED|Overall Study||17||
48193653|NCT00256308|100797052|FG000|STARTED|Overall Study||6||
48193654|NCT00256308|100797052|FG000|COMPLETED|Overall Study||4||
48193655|NCT00256308|100797052|FG000|NOT COMPLETED|Overall Study||2||
48193656|NCT03441984|100797053|FG000|STARTED|Part 1: Period 1 (Up to Day 4)||3||
48193657|NCT03441984|100797054|FG001|STARTED|Part 1: Period 1 (Up to Day 4)||3||
48193658|NCT03441984|100797055|FG002|STARTED|Part 1: Period 1 (Up to Day 4)||3||
48193659|NCT03441984|100797056|FG003|STARTED|Part 1: Period 1 (Up to Day 4)||3||
48193660|NCT03441984|100797057|FG004|STARTED|Part 1: Period 1 (Up to Day 4)||3||
48193661|NCT03441984|100797058|FG005|STARTED|Part 1: Period 1 (Up to Day 4)||3||
48193662|NCT03441984|100797059|FG006|STARTED|Part 1: Period 1 (Up to Day 4)||0||
48193663|NCT03441984|100797060|FG007|STARTED|Part 1: Period 1 (Up to Day 4)||0||
48193664|NCT03441984|100797061|FG008|STARTED|Part 1: Period 1 (Up to Day 4)||0||
48193665|NCT03441984|100797062|FG009|STARTED|Part 1: Period 1 (Up to Day 4)||0||
48193666|NCT03441984|100797063|FG010|STARTED|Part 1: Period 1 (Up to Day 4)||0||
48193667|NCT03441984|100797064|FG011|STARTED|Part 1: Period 1 (Up to Day 4)||0||
48193668|NCT03441984|100797053|FG000|COMPLETED|Part 1: Period 1 (Up to Day 4)||3||
48193669|NCT03441984|100797054|FG001|COMPLETED|Part 1: Period 1 (Up to Day 4)||3||
48193670|NCT03441984|100797055|FG002|COMPLETED|Part 1: Period 1 (Up to Day 4)||3||
48193671|NCT03441984|100797056|FG003|COMPLETED|Part 1: Period 1 (Up to Day 4)||3||
48193672|NCT03441984|100797057|FG004|COMPLETED|Part 1: Period 1 (Up to Day 4)||3||
48193673|NCT03441984|100797058|FG005|COMPLETED|Part 1: Period 1 (Up to Day 4)||3||
48193674|NCT03441984|100797059|FG006|COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
48193675|NCT03441984|100797060|FG007|COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
48193676|NCT03441984|100797061|FG008|COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
48193677|NCT03441984|100797062|FG009|COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
48193678|NCT03441984|100797063|FG010|COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
48193679|NCT03441984|100797064|FG011|COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
48193680|NCT03441984|100797053|FG000|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
48193681|NCT03441984|100797054|FG001|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
48193682|NCT03441984|100797055|FG002|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
48193683|NCT03441984|100797056|FG003|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
48193684|NCT03441984|100797057|FG004|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
48193685|NCT03441984|100797058|FG005|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
48193686|NCT03441984|100797059|FG006|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
48193687|NCT03441984|100797060|FG007|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
48193688|NCT03441984|100797061|FG008|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
48193689|NCT03441984|100797062|FG009|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
48193690|NCT03441984|100797063|FG010|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
48193691|NCT03441984|100797064|FG011|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
48193692|NCT03441984|100797053|FG000|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3||
48193693|NCT03441984|100797054|FG001|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3||
48193694|NCT03441984|100797055|FG002|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3||
48193695|NCT03441984|100797056|FG003|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3||
48193696|NCT03441984|100797057|FG004|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3||
48193697|NCT03441984|100797058|FG005|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3||
48193698|NCT03441984|100797059|FG006|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0||
48193699|NCT03441984|100797060|FG007|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0||
48193700|NCT03441984|100797061|FG008|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0||
48193701|NCT03441984|100797062|FG009|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0||
48193702|NCT03441984|100797063|FG010|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0||
48193703|NCT03441984|100797064|FG011|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0||
48193704|NCT03441984|100797053|FG000|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3||
48193705|NCT03441984|100797054|FG001|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3||
48193706|NCT03441984|100797055|FG002|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3||
48193707|NCT03441984|100797056|FG003|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3||
48193708|NCT03441984|100797057|FG004|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3||
48193709|NCT03441984|100797058|FG005|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3||
48193710|NCT03441984|100797059|FG006|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
48193711|NCT03441984|100797060|FG007|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
48193712|NCT03441984|100797061|FG008|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
48193713|NCT03441984|100797062|FG009|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
48193714|NCT03441984|100797063|FG010|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
48193715|NCT03441984|100797064|FG011|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
48193716|NCT03441984|100797053|FG000|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
48193717|NCT03441984|100797054|FG001|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
48193718|NCT03441984|100797055|FG002|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
48193719|NCT03441984|100797056|FG003|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
48193720|NCT03441984|100797057|FG004|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
48193721|NCT03441984|100797058|FG005|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
48193722|NCT03441984|100797059|FG006|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
48193723|NCT03441984|100797060|FG007|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
48193724|NCT03441984|100797061|FG008|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
48193725|NCT03441984|100797062|FG009|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
48193726|NCT03441984|100797063|FG010|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
48193727|NCT03441984|100797064|FG011|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
48193728|NCT03441984|100797053|FG000|STARTED|Part 1: Period 2 (Up to Day 4 )||3||
48193729|NCT03441984|100797054|FG001|STARTED|Part 1: Period 2 (Up to Day 4 )||3||
48193730|NCT03441984|100797055|FG002|STARTED|Part 1: Period 2 (Up to Day 4 )||3||
48193731|NCT03441984|100797056|FG003|STARTED|Part 1: Period 2 (Up to Day 4 )||3||
48193732|NCT03441984|100797057|FG004|STARTED|Part 1: Period 2 (Up to Day 4 )||3||
48193733|NCT03441984|100797058|FG005|STARTED|Part 1: Period 2 (Up to Day 4 )||3||
48193734|NCT03441984|100797059|FG006|STARTED|Part 1: Period 2 (Up to Day 4 )||0||
48193735|NCT03441984|100797060|FG007|STARTED|Part 1: Period 2 (Up to Day 4 )||0||
48193736|NCT03441984|100797061|FG008|STARTED|Part 1: Period 2 (Up to Day 4 )||0||
48193737|NCT03441984|100797062|FG009|STARTED|Part 1: Period 2 (Up to Day 4 )||0||
48193738|NCT03441984|100797063|FG010|STARTED|Part 1: Period 2 (Up to Day 4 )||0||
48193739|NCT03441984|100797064|FG011|STARTED|Part 1: Period 2 (Up to Day 4 )||0||
48193740|NCT03441984|100797053|FG000|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3||
48193741|NCT03441984|100797054|FG001|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3||
48193742|NCT03441984|100797055|FG002|COMPLETED|Part 1: Period 2 (Up to Day 4 )||2||
48193743|NCT03441984|100797056|FG003|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3||
48193744|NCT03441984|100797057|FG004|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3||
48193745|NCT03441984|100797058|FG005|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3||
48193746|NCT03441984|100797059|FG006|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0||
48193747|NCT03441984|100797060|FG007|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0||
48193748|NCT03441984|100797061|FG008|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0||
48193749|NCT03441984|100797062|FG009|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0||
48193750|NCT03441984|100797063|FG010|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0||
48193751|NCT03441984|100797064|FG011|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0||
48193752|NCT03441984|100797053|FG000|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0||
48193753|NCT03441984|100797054|FG001|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0||
48193754|NCT03441984|100797055|FG002|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||1||
48193755|NCT03441984|100797056|FG003|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0||
48193756|NCT03441984|100797057|FG004|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0||
48193757|NCT03441984|100797058|FG005|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0||
48193758|NCT03441984|100797059|FG006|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0||
48193759|NCT03441984|100797060|FG007|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0||
48476862|NCT01856309|101503005|FG002|COMPLETED|Overall Study||11||
48476863|NCT01856309|101503006|FG003|COMPLETED|Overall Study||9||
48476864|NCT01856309|101503003|FG000|NOT COMPLETED|Overall Study||299||
48476865|NCT01856309|101503004|FG001|NOT COMPLETED|Overall Study||288||
48476866|NCT01856309|101503005|FG002|NOT COMPLETED|Overall Study||595||
48476867|NCT01856309|101503006|FG003|NOT COMPLETED|Overall Study||609||
48476868|NCT01604850|101503007|FG000|STARTED|Overall Study||103||
48476869|NCT01604850|101503008|FG001|STARTED|Overall Study||99||
48476870|NCT01604850|101503007|FG000|Enrolled and Treated|Overall Study||103||
48476871|NCT01604850|101503008|FG001|Enrolled and Treated|Overall Study||98||
48476872|NCT01604850|101503007|FG000|COMPLETED|Overall Study||51||
48476873|NCT01604850|101503008|FG001|COMPLETED|Overall Study||69||
48476874|NCT01604850|101503007|FG000|NOT COMPLETED|Overall Study||52||
48193760|NCT03441984|100797061|FG008|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0||
48193761|NCT03441984|100797062|FG009|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0||
48193762|NCT03441984|100797063|FG010|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0||
48193763|NCT03441984|100797064|FG011|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0||
48193764|NCT03441984|100797053|FG000|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3||
48193765|NCT03441984|100797054|FG001|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3||
48193766|NCT03441984|100797055|FG002|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||2||
48193767|NCT03441984|100797056|FG003|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3||
48193768|NCT03441984|100797057|FG004|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3||
48193769|NCT03441984|100797058|FG005|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3||
48193770|NCT03441984|100797059|FG006|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0||
48476875|NCT01604850|101503008|FG001|NOT COMPLETED|Overall Study||30||
48476876|NCT01458405|101503009|FG000|STARTED|Phase 1 (up to 12 Months)||4||
48193771|NCT03441984|100797060|FG007|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0||
48193772|NCT03441984|100797061|FG008|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0||
48193773|NCT03441984|100797062|FG009|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0||
48193774|NCT03441984|100797063|FG010|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0||
48476877|NCT01458405|101503010|FG001|STARTED|Phase 1 (up to 12 Months)||10||
48476878|NCT01458405|101503011|FG002|STARTED|Phase 1 (up to 12 Months)||0||
48476879|NCT01458405|101503012|FG003|STARTED|Phase 1 (up to 12 Months)||0||
48476880|NCT01458405|101503009|FG000|COMPLETED|Phase 1 (up to 12 Months)||4||
48476881|NCT01458405|101503010|FG001|COMPLETED|Phase 1 (up to 12 Months)||9||
48476882|NCT01458405|101503011|FG002|COMPLETED|Phase 1 (up to 12 Months)||0||
48476883|NCT01458405|101503012|FG003|COMPLETED|Phase 1 (up to 12 Months)||0||
48476884|NCT01458405|101503009|FG000|NOT COMPLETED|Phase 1 (up to 12 Months)||0||
48476885|NCT01458405|101503010|FG001|NOT COMPLETED|Phase 1 (up to 12 Months)||1||
48476886|NCT01458405|101503011|FG002|NOT COMPLETED|Phase 1 (up to 12 Months)||0||
48476887|NCT01458405|101503012|FG003|NOT COMPLETED|Phase 1 (up to 12 Months)||0||
48476888|NCT01458405|101503009|FG000|STARTED|Phase 2 (up to 12 Months)||0||
48476889|NCT01458405|101503010|FG001|STARTED|Phase 2 (up to 12 Months)||0||
48476890|NCT01458405|101503011|FG002|STARTED|Phase 2 (up to 12 Months)||44||
48476891|NCT01458405|101503012|FG003|STARTED|Phase 2 (up to 12 Months)||77||
48476892|NCT01458405|101503009|FG000|COMPLETED|Phase 2 (up to 12 Months)||0||
48476893|NCT01458405|101503010|FG001|COMPLETED|Phase 2 (up to 12 Months)||0||
48476894|NCT01458405|101503011|FG002|COMPLETED|Phase 2 (up to 12 Months)||33||
48476895|NCT01458405|101503012|FG003|COMPLETED|Phase 2 (up to 12 Months)||54||
48476896|NCT01458405|101503009|FG000|NOT COMPLETED|Phase 2 (up to 12 Months)||0||
48476897|NCT01458405|101503010|FG001|NOT COMPLETED|Phase 2 (up to 12 Months)||0||
48193775|NCT03441984|100797064|FG011|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0||
48193776|NCT03441984|100797053|FG000|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3||
48193777|NCT03441984|100797054|FG001|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3||
48193778|NCT03441984|100797055|FG002|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||2||
48193779|NCT03441984|100797056|FG003|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3||
48193780|NCT03441984|100797057|FG004|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3||
48193781|NCT03441984|100797058|FG005|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3||
48193782|NCT03441984|100797059|FG006|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
48476898|NCT01458405|101503011|FG002|NOT COMPLETED|Phase 2 (up to 12 Months)||11||
48476899|NCT01458405|101503012|FG003|NOT COMPLETED|Phase 2 (up to 12 Months)||23||
48476900|NCT02339233|101503013|FG000|STARTED|Overall Study||8||
48476901|NCT02339233|101503013|FG000|COMPLETED|Overall Study||8||
48476902|NCT02339233|101503013|FG000|NOT COMPLETED|Overall Study||0||
48476903|NCT01422538|101503014|FG000|STARTED|Overall Study||10||
48476904|NCT01422538|101503015|FG001|STARTED|Overall Study||10||
48476905|NCT01422538|101503016|FG002|STARTED|Overall Study||10||
48476906|NCT01422538|101503014|FG000|COMPLETED|Overall Study||10||
48476907|NCT01422538|101503015|FG001|COMPLETED|Overall Study||8||
48476908|NCT01422538|101503016|FG002|COMPLETED|Overall Study||8||
48476909|NCT01422538|101503014|FG000|NOT COMPLETED|Overall Study||0||
48476910|NCT01422538|101503015|FG001|NOT COMPLETED|Overall Study||2||
48476911|NCT01422538|101503016|FG002|NOT COMPLETED|Overall Study||2||
48476912|NCT00905125|101503017|FG000|STARTED|Overall Study||46||
48476913|NCT00905125|101503018|FG001|STARTED|Overall Study||56||
48476914|NCT00905125|101503017|FG000|COMPLETED|Overall Study||42||
48476915|NCT00905125|101503018|FG001|COMPLETED|Overall Study||53||
48476916|NCT00905125|101503017|FG000|NOT COMPLETED|Overall Study||4||
48476917|NCT00905125|101503018|FG001|NOT COMPLETED|Overall Study||3||
48476918|NCT01709032|101505718|FG000|STARTED|Overall Study||9||
48476919|NCT01709032|101505718|FG000|COMPLETED|Overall Study||6||
48476920|NCT01709032|101505718|FG000|NOT COMPLETED|Overall Study||3||
48476921|NCT04992052|101505719|FG000|STARTED|Overall Study||29||
48476922|NCT04992052|101505720|FG001|STARTED|Overall Study||23||
48476923|NCT04992052|101505719|FG000|COMPLETED|Overall Study||29||
48476924|NCT04992052|101505720|FG001|COMPLETED|Overall Study||23||
48476925|NCT04992052|101505719|FG000|NOT COMPLETED|Overall Study||0||
48476926|NCT04992052|101505720|FG001|NOT COMPLETED|Overall Study||0||
48476927|NCT00999037|101505721|FG000|STARTED|Overall Study||9||
48476928|NCT00999037|101505722|FG001|STARTED|Overall Study||9||
48476929|NCT00999037|101505721|FG000|COMPLETED|Overall Study||9||
48476930|NCT00999037|101505722|FG001|COMPLETED|Overall Study||9||
48476931|NCT00999037|101505721|FG000|NOT COMPLETED|Overall Study||0||
48476932|NCT00999037|101505722|FG001|NOT COMPLETED|Overall Study||0||
48476933|NCT02460159|101505723|FG000|STARTED|Overall Study||117||
48476934|NCT02460159|101505724|FG001|STARTED|Overall Study||18||
48476935|NCT02460159|101505723|FG000|COMPLETED|Overall Study||111||
48476936|NCT02460159|101505724|FG001|COMPLETED|Overall Study||17||
48476937|NCT02460159|101505723|FG000|NOT COMPLETED|Overall Study||6||
48476938|NCT02460159|101505724|FG001|NOT COMPLETED|Overall Study||1||
48476939|NCT01355081|101505725|FG000|STARTED|Overall Study||119||
48476940|NCT01355081|101505726|FG001|STARTED|Overall Study||123||
48476941|NCT01355081|101505727|FG002|STARTED|Overall Study||124||
48476942|NCT01355081|101505725|FG000|COMPLETED|Overall Study||112||
48476943|NCT01355081|101505726|FG001|COMPLETED|Overall Study||113||
48476944|NCT01355081|101505727|FG002|COMPLETED|Overall Study||113||
48476945|NCT01355081|101505725|FG000|NOT COMPLETED|Overall Study||7||
48476946|NCT01355081|101505726|FG001|NOT COMPLETED|Overall Study||10||
48476947|NCT01355081|101505727|FG002|NOT COMPLETED|Overall Study||11||
48476948|NCT00324168|101505728|FG000|STARTED|Overall Study||250||
48476949|NCT00324168|101505729|FG001|STARTED|Overall Study||250||
48476950|NCT00324168|101505728|FG000|COMPLETED|Overall Study||222||
48476951|NCT00324168|101505729|FG001|COMPLETED|Overall Study||220||
48476952|NCT00324168|101505728|FG000|NOT COMPLETED|Overall Study||28||
48476953|NCT00324168|101505729|FG001|NOT COMPLETED|Overall Study||30||
48476954|NCT03025880|101505730|FG000|STARTED|Overall Study||14||
48476955|NCT03025880|101505731|FG001|STARTED|Overall Study||22||
48476956|NCT03025880|101505730|FG000|COMPLETED|Overall Study||0||
48476957|NCT03025880|101505731|FG001|COMPLETED|Overall Study||0||
48476958|NCT03025880|101505730|FG000|NOT COMPLETED|Overall Study||14||
48476959|NCT03025880|101505731|FG001|NOT COMPLETED|Overall Study||22||
48476960|NCT00389064|101505732|FG000|STARTED|Overall Study||223||
48476961|NCT00389064|101505733|FG001|STARTED|Overall Study||227||
48476962|NCT00389064|101505732|FG000|COMPLETED|Overall Study||178||
48476963|NCT00389064|101505733|FG001|COMPLETED|Overall Study||168||
48476964|NCT00389064|101505732|FG000|NOT COMPLETED|Overall Study||45||
48476965|NCT00389064|101505733|FG001|NOT COMPLETED|Overall Study||59||
48476966|NCT00214422|101505734|FG000|STARTED|Overall Study||12||
48476967|NCT00214422|101505735|FG001|STARTED|Overall Study||3||
48476968|NCT00214422|101505736|FG002|STARTED|Overall Study||4||
48476969|NCT00214422|101505734|FG000|COMPLETED|Overall Study||7||
48476970|NCT00214422|101505735|FG001|COMPLETED|Overall Study||2||
48476971|NCT00214422|101505736|FG002|COMPLETED|Overall Study||3||
48193783|NCT03441984|100797060|FG007|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
48193784|NCT03441984|100797061|FG008|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
48193785|NCT03441984|100797062|FG009|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
48193786|NCT03441984|100797063|FG010|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
48193787|NCT03441984|100797064|FG011|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
48193788|NCT03441984|100797053|FG000|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
48193789|NCT03441984|100797054|FG001|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
48193790|NCT03441984|100797055|FG002|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
48193791|NCT03441984|100797056|FG003|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
48193792|NCT03441984|100797057|FG004|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
48193793|NCT03441984|100797058|FG005|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
48193794|NCT03441984|100797059|FG006|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
48193795|NCT03441984|100797060|FG007|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
48193796|NCT03441984|100797061|FG008|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
48193797|NCT03441984|100797062|FG009|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
48193798|NCT03441984|100797063|FG010|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
48193799|NCT03441984|100797064|FG011|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
48193800|NCT03441984|100797053|FG000|STARTED|Part 1: Period 3 (Up to Day 4 )||3||
48193801|NCT03441984|100797054|FG001|STARTED|Part 1: Period 3 (Up to Day 4 )||3||
48193802|NCT03441984|100797055|FG002|STARTED|Part 1: Period 3 (Up to Day 4 )||2||
48193803|NCT03441984|100797056|FG003|STARTED|Part 1: Period 3 (Up to Day 4 )||3||
48193804|NCT03441984|100797057|FG004|STARTED|Part 1: Period 3 (Up to Day 4 )||3||
48193805|NCT03441984|100797058|FG005|STARTED|Part 1: Period 3 (Up to Day 4 )||3||
48193806|NCT03441984|100797059|FG006|STARTED|Part 1: Period 3 (Up to Day 4 )||0||
48193807|NCT03441984|100797060|FG007|STARTED|Part 1: Period 3 (Up to Day 4 )||0||
48193808|NCT03441984|100797061|FG008|STARTED|Part 1: Period 3 (Up to Day 4 )||0||
48193809|NCT03441984|100797062|FG009|STARTED|Part 1: Period 3 (Up to Day 4 )||0||
48193810|NCT03441984|100797063|FG010|STARTED|Part 1: Period 3 (Up to Day 4 )||0||
48193811|NCT03441984|100797064|FG011|STARTED|Part 1: Period 3 (Up to Day 4 )||0||
48193812|NCT03441984|100797053|FG000|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3||
48193813|NCT03441984|100797054|FG001|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3||
48193814|NCT03441984|100797055|FG002|COMPLETED|Part 1: Period 3 (Up to Day 4 )||2||
48193815|NCT03441984|100797056|FG003|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3||
48193816|NCT03441984|100797057|FG004|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3||
48193817|NCT03441984|100797058|FG005|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3||
48193818|NCT03441984|100797059|FG006|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
48193819|NCT03441984|100797060|FG007|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
48193820|NCT03441984|100797061|FG008|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
48193821|NCT03441984|100797062|FG009|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
48193822|NCT03441984|100797063|FG010|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
48193823|NCT03441984|100797064|FG011|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
48193824|NCT03441984|100797053|FG000|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
48193825|NCT03441984|100797054|FG001|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
48193826|NCT03441984|100797055|FG002|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
48193827|NCT03441984|100797056|FG003|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
48193828|NCT03441984|100797057|FG004|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
48193829|NCT03441984|100797058|FG005|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
48193830|NCT03441984|100797059|FG006|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
48193831|NCT03441984|100797060|FG007|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
48193832|NCT03441984|100797061|FG008|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
48193833|NCT03441984|100797062|FG009|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
48193834|NCT03441984|100797063|FG010|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
48193835|NCT03441984|100797064|FG011|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
48193836|NCT03441984|100797053|FG000|STARTED|Part 2: Period 1(Up to Day 4)||0||
48476972|NCT00214422|101505734|FG000|NOT COMPLETED|Overall Study||5||
48193837|NCT03441984|100797054|FG001|STARTED|Part 2: Period 1(Up to Day 4)||0||
48193838|NCT03441984|100797055|FG002|STARTED|Part 2: Period 1(Up to Day 4)||0||
48193839|NCT03441984|100797056|FG003|STARTED|Part 2: Period 1(Up to Day 4)||0||
48193840|NCT03441984|100797057|FG004|STARTED|Part 2: Period 1(Up to Day 4)||0||
48193841|NCT03441984|100797058|FG005|STARTED|Part 2: Period 1(Up to Day 4)||0||
48193842|NCT03441984|100797059|FG006|STARTED|Part 2: Period 1(Up to Day 4)||3||
48476973|NCT00214422|101505735|FG001|NOT COMPLETED|Overall Study||1||
48476974|NCT00214422|101505736|FG002|NOT COMPLETED|Overall Study||1||
48476975|NCT00385593|101505737|FG000|STARTED|Overall Study||328||
48476976|NCT00385593|101505738|FG001|STARTED|Overall Study||326||
48476977|NCT00385593|101505737|FG000|COMPLETED|Overall Study||270||
48476978|NCT00385593|101505738|FG001|COMPLETED|Overall Study||289||
48193843|NCT03441984|100797060|FG007|STARTED|Part 2: Period 1(Up to Day 4)||3||
48476979|NCT00385593|101505737|FG000|NOT COMPLETED|Overall Study||58||
48476980|NCT00385593|101505738|FG001|NOT COMPLETED|Overall Study||37||
48476981|NCT03991494|101505739|FG000|STARTED|Overall Study||4||
48476982|NCT03991494|101505739|FG000|COMPLETED|Overall Study||0||
48476983|NCT03991494|101505739|FG000|NOT COMPLETED|Overall Study||4||
48476984|NCT02032888|101505740|FG000|STARTED|Treatment Period||101||
48476985|NCT02032888|101505741|FG001|STARTED|Treatment Period||50||
48476986|NCT02032888|101505742|FG002|STARTED|Treatment Period||52||
48476987|NCT02032888|101505740|FG000|COMPLETED|Treatment Period||99||
48476988|NCT02032888|101505741|FG001|COMPLETED|Treatment Period||48||
48476989|NCT02032888|101505742|FG002|COMPLETED|Treatment Period||52||
48476990|NCT02032888|101505740|FG000|NOT COMPLETED|Treatment Period||2||
48476991|NCT02032888|101505741|FG001|NOT COMPLETED|Treatment Period||2||
48476992|NCT02032888|101505742|FG002|NOT COMPLETED|Treatment Period||0||
48476993|NCT02032888|101505740|FG000|STARTED|Follow-up Period||100||
48476994|NCT02032888|101505741|FG001|STARTED|Follow-up Period||49||
48476995|NCT02032888|101505742|FG002|STARTED|Follow-up Period||52||
48476996|NCT02032888|101505740|FG000|COMPLETED|Follow-up Period||97||
48476997|NCT02032888|101505741|FG001|COMPLETED|Follow-up Period||47||
48476998|NCT02032888|101505742|FG002|COMPLETED|Follow-up Period||52||
48476999|NCT02032888|101505740|FG000|NOT COMPLETED|Follow-up Period||3||
48477000|NCT02032888|101505741|FG001|NOT COMPLETED|Follow-up Period||2||
48477001|NCT02032888|101505742|FG002|NOT COMPLETED|Follow-up Period||0||
48477002|NCT01474122|101505743|FG000|STARTED|Period 1: Baseline to Week 16||88||
48477003|NCT01474122|101505744|FG001|STARTED|Period 1: Baseline to Week 16||88||
48477004|NCT01474122|101505745|FG002|STARTED|Period 1: Baseline to Week 16||89||
48477005|NCT01474122|101505743|FG000|COMPLETED|Period 1: Baseline to Week 16||87||
48477006|NCT01474122|101505744|FG001|COMPLETED|Period 1: Baseline to Week 16||86||
48477007|NCT01474122|101505745|FG002|COMPLETED|Period 1: Baseline to Week 16||88||
48477008|NCT01474122|101505743|FG000|NOT COMPLETED|Period 1: Baseline to Week 16||1||
48477009|NCT01474122|101505744|FG001|NOT COMPLETED|Period 1: Baseline to Week 16||2||
48477010|NCT01474122|101505745|FG002|NOT COMPLETED|Period 1: Baseline to Week 16||1||
48477011|NCT01474122|101505743|FG000|STARTED|Period 2: Week 16 to End of Study||87||
48477012|NCT01474122|101505744|FG001|STARTED|Period 2: Week 16 to End of Study||86||
48477013|NCT01474122|101505745|FG002|STARTED|Period 2: Week 16 to End of Study||88||
48477014|NCT01474122|101505743|FG000|COMPLETED|Period 2: Week 16 to End of Study||70||
48477015|NCT01474122|101505744|FG001|COMPLETED|Period 2: Week 16 to End of Study||73||
48477016|NCT01474122|101505745|FG002|COMPLETED|Period 2: Week 16 to End of Study||73||
48477017|NCT01474122|101505743|FG000|NOT COMPLETED|Period 2: Week 16 to End of Study||17||
48477018|NCT01474122|101505744|FG001|NOT COMPLETED|Period 2: Week 16 to End of Study||13||
48477019|NCT01474122|101505745|FG002|NOT COMPLETED|Period 2: Week 16 to End of Study||15||
48477020|NCT02086188|101505746|FG000|STARTED|Overall Study||14||
48477021|NCT02086188|101505747|FG001|STARTED|Overall Study||14||
48477022|NCT02086188|101505746|FG000|COMPLETED|Overall Study||14||
48477023|NCT02086188|101505747|FG001|COMPLETED|Overall Study||14||
48477024|NCT02086188|101505746|FG000|NOT COMPLETED|Overall Study||0||
48477025|NCT02086188|101505747|FG001|NOT COMPLETED|Overall Study||0||
48477026|NCT02495857|101505748|FG000|STARTED|Overall Study||200||
48477027|NCT02495857|101505749|FG001|STARTED|Overall Study||200||
48477028|NCT02495857|101505750|FG002|STARTED|Overall Study||199||
48477029|NCT02495857|101505748|FG000|COMPLETED|Overall Study||178||
48477030|NCT02495857|101505749|FG001|COMPLETED|Overall Study||184||
48477031|NCT02495857|101505750|FG002|COMPLETED|Overall Study||181||
48477032|NCT02495857|101505748|FG000|NOT COMPLETED|Overall Study||22||
48477033|NCT02495857|101505749|FG001|NOT COMPLETED|Overall Study||16||
48477034|NCT02495857|101505750|FG002|NOT COMPLETED|Overall Study||18||
48477035|NCT00322465|101505751|FG000|STARTED|Overall Study||76||
48477036|NCT00322465|101505752|FG001|STARTED|Overall Study||73||
48477037|NCT00322465|101505753|FG002|STARTED|Overall Study||77||
48477038|NCT00322465|101505754|FG003|STARTED|Overall Study||79||
48477039|NCT00322465|101505751|FG000|COMPLETED|Overall Study||56||
48477040|NCT00322465|101505752|FG001|COMPLETED|Overall Study||49||
48477041|NCT00322465|101505753|FG002|COMPLETED|Overall Study||51||
48477042|NCT00322465|101505754|FG003|COMPLETED|Overall Study||53||
48477043|NCT00322465|101505751|FG000|NOT COMPLETED|Overall Study||20||
48477044|NCT00322465|101505752|FG001|NOT COMPLETED|Overall Study||24||
48477045|NCT00322465|101505753|FG002|NOT COMPLETED|Overall Study||26||
48477046|NCT00322465|101505754|FG003|NOT COMPLETED|Overall Study||26||
48477047|NCT00304083|101505755|FG000|STARTED|Overall Study||34||
48477048|NCT00304083|101505756|FG001|STARTED|Overall Study||14||
48477049|NCT00304083|101505755|FG000|Completed 4 Cycles|Overall Study||22||
48477050|NCT00304083|101505756|FG001|Completed 4 Cycles|Overall Study||7||
48477051|NCT00304083|101505755|FG000|Patients Treated With Surgery|Overall Study||7||
48477052|NCT00304083|101505756|FG001|Patients Treated With Surgery|Overall Study||3||
48477053|NCT00304083|101505755|FG000|Patients Treated With Surgery and RT|Overall Study||5||
48477054|NCT00304083|101505756|FG001|Patients Treated With Surgery and RT|Overall Study||1||
48477055|NCT00304083|101505755|FG000|Patients Treated With RT Only|Overall Study||4||
48477056|NCT00304083|101505756|FG001|Patients Treated With RT Only|Overall Study||2||
48477057|NCT00304083|101505755|FG000|Patients Had Neither RT or Surgery|Overall Study||6||
48477058|NCT00304083|101505756|FG001|Patients Had Neither RT or Surgery|Overall Study||1||
48477059|NCT00304083|101505755|FG000|COMPLETED|Overall Study||12||
48477060|NCT00304083|101505756|FG001|COMPLETED|Overall Study||6||
48477061|NCT00304083|101505755|FG000|NOT COMPLETED|Overall Study||22||
48666315|NCT01148771|101967553|FG001|COMPLETED|Second Intervention||5||
48666316|NCT01148771|101967552|FG000|NOT COMPLETED|Second Intervention||0||
48477062|NCT00304083|101505756|FG001|NOT COMPLETED|Overall Study||8||
48477063|NCT00617305|101505757|FG000|STARTED|Overall Study||33||
48477064|NCT00617305|101505758|FG001|STARTED|Overall Study||4||
48477065|NCT00617305|101505759|FG002|STARTED|Overall Study||1||
48666317|NCT01148771|101967553|FG001|NOT COMPLETED|Second Intervention||0||
48666318|NCT03801993|101967554|FG000|STARTED|Overall Study||402|With 400 subjects, this study will allow estimation of variability (between and within subject) in 160 pediatric subjects and 240 adult subjects.|
48666319|NCT03801993|101967554|FG000|Week 1|Overall Study||329|At least one fully completed ePRO at Week 1|
48666320|NCT03801993|101967554|FG000|Week 2|Overall Study||324|At least one fully completed ePRO at Week 2|
48666321|NCT03801993|101967554|FG000|Week 4|Overall Study||312|At least one fully completed ePRO at Week 4|
48193844|NCT03441984|100797061|FG008|STARTED|Part 2: Period 1(Up to Day 4)||3||
48193845|NCT03441984|100797062|FG009|STARTED|Part 2: Period 1(Up to Day 4)||3||
48477066|NCT00617305|101505757|FG000|Completed 24-week Primary Analysis|Overall Study||31||
48477067|NCT00617305|101505758|FG001|Completed 24-week Primary Analysis|Overall Study||4||
48477068|NCT00617305|101505759|FG002|Completed 24-week Primary Analysis|Overall Study||0||
48477069|NCT00617305|101505757|FG000|COMPLETED|Overall Study||25||
48477070|NCT00617305|101505758|FG001|COMPLETED|Overall Study||4||
48477071|NCT00617305|101505759|FG002|COMPLETED|Overall Study||0||
48477072|NCT00617305|101505757|FG000|NOT COMPLETED|Overall Study||8||
48477073|NCT00617305|101505758|FG001|NOT COMPLETED|Overall Study||0||
48477074|NCT00617305|101505759|FG002|NOT COMPLETED|Overall Study||1||
48477075|NCT00176306|101505760|FG000|STARTED|Overall Study||15||
48477076|NCT00176306|101505760|FG000|COMPLETED|Overall Study||15||
48477077|NCT00176306|101505760|FG000|NOT COMPLETED|Overall Study||0||
48477078|NCT00360360|101505761|FG000|STARTED|Overall Study||60||
48477079|NCT00360360|101505761|FG000|COMPLETED|Overall Study||54||
48477080|NCT00360360|101505761|FG000|NOT COMPLETED|Overall Study||6||
48477081|NCT02359305|101505762|FG000|STARTED|Overall Study||34||
48477082|NCT02359305|101505763|FG001|STARTED|Overall Study||34||
48477083|NCT02359305|101505762|FG000|COMPLETED|Overall Study||34||
48477084|NCT02359305|101505763|FG001|COMPLETED|Overall Study||34||
48477085|NCT02359305|101505762|FG000|NOT COMPLETED|Overall Study||0||
48477086|NCT02359305|101505763|FG001|NOT COMPLETED|Overall Study||0||
48477087|NCT01954264|101505764|FG000|STARTED|Overall Study||2421||
48477088|NCT01954264|101505764|FG000|COMPLETED|Overall Study||2421||
48477089|NCT01954264|101505764|FG000|NOT COMPLETED|Overall Study||0||
48477090|NCT04185909|101505765|FG000|STARTED|Overall Study||55||
48477091|NCT04185909|101505765|FG000|COMPLETED|Overall Study||54||
48477092|NCT04185909|101505765|FG000|NOT COMPLETED|Overall Study||1||
48477093|NCT04190693|101505766|FG000|STARTED|Overall Study||4||
48477094|NCT04190693|101505767|FG001|STARTED|Overall Study||7||
48477095|NCT04190693|101505768|FG002|STARTED|Overall Study||12||
48477096|NCT04190693|101505769|FG003|STARTED|Overall Study||7||
48477097|NCT04190693|101505766|FG000|COMPLETED|Overall Study||4||
48477098|NCT04190693|101505767|FG001|COMPLETED|Overall Study||7||
48477099|NCT04190693|101505768|FG002|COMPLETED|Overall Study||12||
48477100|NCT04190693|101505769|FG003|COMPLETED|Overall Study||7||
48477101|NCT04190693|101505766|FG000|NOT COMPLETED|Overall Study||0||
48477102|NCT04190693|101505767|FG001|NOT COMPLETED|Overall Study||0||
48477103|NCT04190693|101505768|FG002|NOT COMPLETED|Overall Study||0||
48477104|NCT04190693|101505769|FG003|NOT COMPLETED|Overall Study||0||
48477105|NCT01469767|101505770|FG000|STARTED|Overall Study||10||
48477106|NCT01469767|101505770|FG000|COMPLETED|Overall Study||10||
48477107|NCT01469767|101505770|FG000|NOT COMPLETED|Overall Study||0||
48477108|NCT03005522|101505771|FG000|STARTED|Overall Study||36||
48477109|NCT03005522|101505772|FG001|STARTED|Overall Study||37||
48477110|NCT03005522|101505771|FG000|COMPLETED|Overall Study||25||
48477111|NCT03005522|101505772|FG001|COMPLETED|Overall Study||27||
48477112|NCT03005522|101505771|FG000|NOT COMPLETED|Overall Study||11||
48477113|NCT03005522|101505772|FG001|NOT COMPLETED|Overall Study||10||
48477114|NCT00262964|101505773|FG000|STARTED|Overall Study||11||
48477115|NCT00262964|101505774|FG001|STARTED|Overall Study||11||
48477116|NCT00262964|101505775|FG002|STARTED|Overall Study||17||
48477117|NCT00262964|101505776|FG003|STARTED|Overall Study||12||
48477118|NCT00262964|101505773|FG000|COMPLETED|Overall Study||11||
48477119|NCT00262964|101505774|FG001|COMPLETED|Overall Study||11||
48477120|NCT00262964|101505775|FG002|COMPLETED|Overall Study||17||
48477121|NCT00262964|101505776|FG003|COMPLETED|Overall Study||12||
48477122|NCT00262964|101505773|FG000|NOT COMPLETED|Overall Study||0||
48477123|NCT00262964|101505774|FG001|NOT COMPLETED|Overall Study||0||
48477124|NCT00262964|101505775|FG002|NOT COMPLETED|Overall Study||0||
48477125|NCT00262964|101505776|FG003|NOT COMPLETED|Overall Study||0||
48477126|NCT00615069|101505777|FG000|STARTED|Overall Study||35||
48477127|NCT00615069|101505777|FG000|COMPLETED|Overall Study||19||
48477128|NCT00615069|101505777|FG000|NOT COMPLETED|Overall Study||16||
48477129|NCT03657160|101505778|FG000|STARTED|Overall Study||169||
48477130|NCT03657160|101505779|FG001|STARTED|Overall Study||174||
48477131|NCT03657160|101505778|FG000|Safety Analysis Set|Overall Study||165|Safety Analysis Set included all participants who received at least 1 dose of study drug.|
48477132|NCT03657160|101505779|FG001|Safety Analysis Set|Overall Study||169|Safety Analysis Set included all participants who received at least 1 dose of study drug.|
48477133|NCT03657160|101505778|FG000|Full Analysis Set|Overall Study||165|Full Analysis Set included all participants who were randomized, received at least 1 dose of the treatment, and under-went allo-HSCT.|
48477134|NCT03657160|101505779|FG001|Full Analysis Set|Overall Study||168|Full Analysis Set included all participants who were randomized, received at least 1 dose of the treatment, and under-went allo-HSCT.|
48477135|NCT03657160|101505778|FG000|COMPLETED|Overall Study||98|Participants who completed the 182 days treatment period and the long term follow-up (6 months after the last dose of study drug).|
48477136|NCT03657160|101505779|FG001|COMPLETED|Overall Study||117|Participants who completed the 182 days treatment period and the long term follow-up (6 months after the last dose of study drug).|
48477137|NCT03657160|101505778|FG000|NOT COMPLETED|Overall Study||71||
48477138|NCT03657160|101505779|FG001|NOT COMPLETED|Overall Study||57||
48477139|NCT01395030|101505780|FG000|STARTED|Overall Study||64||
48477140|NCT01395030|101505780|FG000|Complete FCH PET/CT|Overall Study||57||
48477141|NCT01395030|101505780|FG000|Adequate Tissue for Analysis|Overall Study||50||
48477142|NCT01395030|101505780|FG000|COMPLETED|Overall Study||57||
48477143|NCT01395030|101505780|FG000|NOT COMPLETED|Overall Study||7||
48477144|NCT02272777|101505781|FG000|STARTED|Overall Study||112|All enrolled subjects were included in the Safety Set|
48477145|NCT02272777|101505782|FG001|STARTED|Overall Study||113|All enrolled subjects were included in the Safety Set|
48477146|NCT02272777|101505781|FG000|COMPLETED|Overall Study||108||
48477147|NCT02272777|101505782|FG001|COMPLETED|Overall Study||109||
48477148|NCT02272777|101505781|FG000|NOT COMPLETED|Overall Study||4||
48477149|NCT02272777|101505782|FG001|NOT COMPLETED|Overall Study||4||
48477150|NCT03900624|101505783|FG000|STARTED|Overall Study||61||
48477151|NCT03900624|101505784|FG001|STARTED|Overall Study||31||
48477152|NCT03900624|101505783|FG000|COMPLETED|Overall Study||61||
48477153|NCT03900624|101505784|FG001|COMPLETED|Overall Study||31||
48477154|NCT03900624|101505783|FG000|NOT COMPLETED|Overall Study||0||
48477155|NCT03900624|101505784|FG001|NOT COMPLETED|Overall Study||0||
48477156|NCT00320112|101505785|FG000|STARTED|Overall Study||125||
48477157|NCT00320112|101505786|FG001|STARTED|Overall Study||119||
48477158|NCT00320112|101505785|FG000|COMPLETED|Overall Study||117||
48477159|NCT00320112|101505786|FG001|COMPLETED|Overall Study||114||
48477160|NCT00320112|101505785|FG000|NOT COMPLETED|Overall Study||8||
48477161|NCT00320112|101505786|FG001|NOT COMPLETED|Overall Study||5||
48477162|NCT02109042|101505787|FG000|STARTED|Overall Study||15||
48477163|NCT02109042|101505787|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15||
48477164|NCT02109042|101505787|FG000|Received 180 mg Loading Dose|Overall Study||15||
48477165|NCT02109042|101505787|FG000|Receive at Least 1 Subsequent 90 mg Dose|Overall Study||15||
48477166|NCT02109042|101505787|FG000|COMPLETED|Overall Study||0||
48477167|NCT02109042|101505787|FG000|NOT COMPLETED|Overall Study||15||
48477168|NCT02127281|101505788|FG000|STARTED|Overall Study||80||
48477169|NCT02127281|101505789|FG001|STARTED|Overall Study||80||
48477170|NCT02127281|101505788|FG000|COMPLETED|Overall Study||79||
48477171|NCT02127281|101505789|FG001|COMPLETED|Overall Study||80||
48477172|NCT02127281|101505788|FG000|NOT COMPLETED|Overall Study||1||
48477173|NCT02127281|101505789|FG001|NOT COMPLETED|Overall Study||0||
48477174|NCT00863746|101505790|FG000|STARTED|Treatment||350||
48477175|NCT00863746|101505791|FG001|STARTED|Treatment||353||
48477176|NCT00863746|101505790|FG000|Participants Received Treatment|Treatment||346||
48477177|NCT00863746|101505791|FG001|Participants Received Treatment|Treatment||351||
48477178|NCT00863746|101505790|FG000|COMPLETED|Treatment||279||
48477179|NCT00863746|101505791|FG001|COMPLETED|Treatment||318||
48477180|NCT00863746|101505790|FG000|NOT COMPLETED|Treatment||71||
48477181|NCT00863746|101505791|FG001|NOT COMPLETED|Treatment||35||
48477182|NCT00863746|101505790|FG000|STARTED|Survival Follow up||298||
48477183|NCT00863746|101505791|FG001|STARTED|Survival Follow up||331||
48477184|NCT00863746|101505790|FG000|COMPLETED|Survival Follow up||45||
48477185|NCT00863746|101505791|FG001|COMPLETED|Survival Follow up||51||
48477186|NCT00863746|101505790|FG000|NOT COMPLETED|Survival Follow up||253||
48477187|NCT00863746|101505791|FG001|NOT COMPLETED|Survival Follow up||280||
48477188|NCT01059903|101505792|FG000|STARTED|Period 1: First Intervention- 24 Hours||25||
48477189|NCT01059903|101505793|FG001|STARTED|Period 1: First Intervention- 24 Hours||25||
48477190|NCT01059903|101505792|FG000|COMPLETED|Period 1: First Intervention- 24 Hours||24||
48477191|NCT01059903|101505793|FG001|COMPLETED|Period 1: First Intervention- 24 Hours||24||
48477192|NCT01059903|101505792|FG000|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1||
48477193|NCT01059903|101505793|FG001|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1||
48477194|NCT01059903|101505792|FG000|STARTED|Period 2: Washout Period (>= 5 Days)||24||
48477195|NCT01059903|101505793|FG001|STARTED|Period 2: Washout Period (>= 5 Days)||24||
48477196|NCT01059903|101505792|FG000|COMPLETED|Period 2: Washout Period (>= 5 Days)||24||
48477197|NCT01059903|101505793|FG001|COMPLETED|Period 2: Washout Period (>= 5 Days)||24||
48477198|NCT01059903|101505792|FG000|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0||
48477199|NCT01059903|101505793|FG001|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0||
48477200|NCT01059903|101505792|FG000|STARTED|Period 3: Second Intervention- 24 Hours||24||
48477201|NCT01059903|101505793|FG001|STARTED|Period 3: Second Intervention- 24 Hours||24||
48477202|NCT01059903|101505792|FG000|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours||18||
48477203|NCT01059903|101505793|FG001|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours||22||
48477204|NCT01059903|101505792|FG000|COMPLETED|Period 3: Second Intervention- 24 Hours||24||
48477205|NCT01059903|101505793|FG001|COMPLETED|Period 3: Second Intervention- 24 Hours||24||
48477206|NCT01059903|101505792|FG000|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0||
48477207|NCT01059903|101505793|FG001|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0||
48477208|NCT02674477|101505794|FG000|STARTED|Overall Study||48||
48477209|NCT02674477|101505795|FG001|STARTED|Overall Study||47||
48477210|NCT02674477|101505794|FG000|COMPLETED|Overall Study||40||
48477211|NCT02674477|101505795|FG001|COMPLETED|Overall Study||45||
48477212|NCT02674477|101505794|FG000|NOT COMPLETED|Overall Study||8||
48477213|NCT02674477|101505795|FG001|NOT COMPLETED|Overall Study||2||
48477214|NCT02222155|101505796|FG000|STARTED|Overall Study||13||
48477215|NCT02222155|101505797|FG001|STARTED|Overall Study||13||
48477216|NCT02222155|101505798|FG002|STARTED|Overall Study||16||
48477217|NCT02222155|101505796|FG000|COMPLETED|Overall Study||13||
48477218|NCT02222155|101505797|FG001|COMPLETED|Overall Study||12||
48477219|NCT02222155|101505798|FG002|COMPLETED|Overall Study||15||
48477220|NCT02222155|101505796|FG000|NOT COMPLETED|Overall Study||0||
48477221|NCT02222155|101505797|FG001|NOT COMPLETED|Overall Study||1||
48477222|NCT02222155|101505798|FG002|NOT COMPLETED|Overall Study||1||
48477223|NCT01085825|101505799|FG000|STARTED|Overall Study||252||
48477224|NCT01085825|101505800|FG001|STARTED|Overall Study||248||
48477225|NCT01085825|101505799|FG000|COMPLETED|Overall Study||251||
48477226|NCT01085825|101505800|FG001|COMPLETED|Overall Study||247||
48477227|NCT01085825|101505799|FG000|NOT COMPLETED|Overall Study||1||
48477228|NCT01085825|101505800|FG001|NOT COMPLETED|Overall Study||1||
48477229|NCT04526210|101505801|FG000|STARTED|Overall Study||27||
48477230|NCT04526210|101505802|FG001|STARTED|Overall Study||27||
48477231|NCT04526210|101505801|FG000|Received at Least 1 Dose of Stud Drug|Overall Study||27||
48477232|NCT04526210|101505802|FG001|Received at Least 1 Dose of Stud Drug|Overall Study||27||
48477233|NCT04526210|101505801|FG000|COMPLETED|Overall Study||17||
48477234|NCT04526210|101505802|FG001|COMPLETED|Overall Study||20||
48477235|NCT04526210|101505801|FG000|NOT COMPLETED|Overall Study||10||
48477236|NCT04526210|101505802|FG001|NOT COMPLETED|Overall Study||7||
48477237|NCT01822548|101505803|FG000|STARTED|Overall Study||40||
48477238|NCT01822548|101505804|FG001|STARTED|Overall Study||24||
48477239|NCT01822548|101505803|FG000|Discontinued Intervention|Overall Study||0||
48477240|NCT01822548|101505804|FG001|Discontinued Intervention|Overall Study||5||
48477241|NCT01822548|101505803|FG000|COMPLETED|Overall Study||40||
48477242|NCT01822548|101505804|FG001|COMPLETED|Overall Study||24||
48477243|NCT01822548|101505803|FG000|NOT COMPLETED|Overall Study||0||
48477244|NCT01822548|101505804|FG001|NOT COMPLETED|Overall Study||0||
48477245|NCT00735904|101505805|FG000|STARTED|Overall Study||38||
48477246|NCT00735904|101505805|FG000|COMPLETED|Overall Study||0||
48477247|NCT00735904|101505805|FG000|NOT COMPLETED|Overall Study||38||
48477248|NCT03546842|101505806|FG000|STARTED|Overall Study||201||
48477249|NCT03546842|101505806|FG000|Vaccination 1|Overall Study||200||
48477250|NCT03546842|101505806|FG000|Vaccination 2|Overall Study||200||
48477251|NCT03546842|101505806|FG000|Vaccination 3|Overall Study||198||
48477252|NCT03546842|101505806|FG000|COMPLETED|Overall Study||198||
48477253|NCT03546842|101505806|FG000|NOT COMPLETED|Overall Study||3||
48477254|NCT01374919|101505807|FG000|STARTED|Overall Study||60||
48477255|NCT01374919|101505807|FG000|COMPLETED|Overall Study||58||
48477256|NCT01374919|101505807|FG000|NOT COMPLETED|Overall Study||2||
48477257|NCT01434121|101505808|FG000|STARTED|Overall Study||8||
48477258|NCT01434121|101505809|FG001|STARTED|Overall Study||8||
48477259|NCT01434121|101505810|FG002|STARTED|Overall Study||8||
48477260|NCT01434121|101505808|FG000|COMPLETED|Overall Study||8||
48477261|NCT01434121|101505809|FG001|COMPLETED|Overall Study||8||
48477262|NCT01434121|101505810|FG002|COMPLETED|Overall Study||8||
48477263|NCT01434121|101505808|FG000|NOT COMPLETED|Overall Study||0||
48477264|NCT01434121|101505809|FG001|NOT COMPLETED|Overall Study||0||
48477265|NCT01434121|101505810|FG002|NOT COMPLETED|Overall Study||0||
48477266|NCT03480425|101505811|FG000|STARTED|Overall Study||11||
48477267|NCT03480425|101505811|FG000|COMPLETED|Overall Study||10||
48477268|NCT03480425|101505811|FG000|NOT COMPLETED|Overall Study||1||
48477269|NCT01598701|101505812|FG000|STARTED|Overall Study||50||
48477270|NCT01598701|101505813|FG001|STARTED|Overall Study||50||
48477271|NCT01598701|101505812|FG000|COMPLETED|Overall Study||45||
48477272|NCT01598701|101505813|FG001|COMPLETED|Overall Study||41||
48477273|NCT01598701|101505812|FG000|NOT COMPLETED|Overall Study||5||
48477274|NCT01598701|101505813|FG001|NOT COMPLETED|Overall Study||9||
48477275|NCT01239121|101505814|FG000|STARTED|Overall Study||188||
48477276|NCT01239121|101505815|FG001|STARTED|Overall Study||199||
48477277|NCT01239121|101505816|FG002|STARTED|Overall Study||15||
48477278|NCT01239121|101505814|FG000|COMPLETED|Overall Study||186||
48477279|NCT01239121|101505815|FG001|COMPLETED|Overall Study||195||
48477280|NCT01239121|101505816|FG002|COMPLETED|Overall Study||15||
48477281|NCT01239121|101505814|FG000|NOT COMPLETED|Overall Study||2||
48477282|NCT01239121|101505815|FG001|NOT COMPLETED|Overall Study||4||
48477283|NCT01239121|101505816|FG002|NOT COMPLETED|Overall Study||0||
48477284|NCT02120443|101505817|FG000|STARTED|Overall Study||43||
48477285|NCT02120443|101505817|FG000|COMPLETED|Overall Study||43||
48477286|NCT02120443|101505817|FG000|NOT COMPLETED|Overall Study||0||
48477287|NCT02087904|101505818|FG000|STARTED|Overall Study||85||
48477288|NCT02087904|101505819|FG001|STARTED|Overall Study||89||
48477289|NCT02087904|101505820|FG002|STARTED|Overall Study||87||
48477290|NCT02087904|101505821|FG003|STARTED|Overall Study||89||
48477291|NCT02087904|101505818|FG000|COMPLETED|Overall Study||60||
48477292|NCT02087904|101505819|FG001|COMPLETED|Overall Study||70||
48477293|NCT02087904|101505820|FG002|COMPLETED|Overall Study||65||
48477294|NCT02087904|101505821|FG003|COMPLETED|Overall Study||64||
48477295|NCT02087904|101505818|FG000|NOT COMPLETED|Overall Study||25||
48477296|NCT02087904|101505819|FG001|NOT COMPLETED|Overall Study||19||
48477297|NCT02087904|101505820|FG002|NOT COMPLETED|Overall Study||22||
48477298|NCT02087904|101505821|FG003|NOT COMPLETED|Overall Study||25||
48477299|NCT05233163|101505822|FG000|STARTED|Overall Study||15||
48477300|NCT05233163|101505822|FG000|COMPLETED|Overall Study||15||
48477301|NCT05233163|101505822|FG000|NOT COMPLETED|Overall Study||0||
48477302|NCT04753437|101505823|FG000|STARTED|Overall Study||22||
48477303|NCT04753437|101505824|FG001|STARTED|Overall Study||22||
48477304|NCT04753437|101505823|FG000|COMPLETED|Overall Study||20||
48477305|NCT04753437|101505824|FG001|COMPLETED|Overall Study||17||
48477306|NCT04753437|101505823|FG000|NOT COMPLETED|Overall Study||2||
48477307|NCT04753437|101505824|FG001|NOT COMPLETED|Overall Study||5||
48477308|NCT03164772|101505825|FG000|STARTED|Overall Study||23|Started is defined as started treatment.|
48477309|NCT03164772|101505826|FG001|STARTED|Overall Study||34|Started is defined as started treatment.|
48477310|NCT03164772|101505825|FG000|COMPLETED|Overall Study||5|Completed is defined as completed all 12 cycles of study treatment.|
48477311|NCT03164772|101505826|FG001|COMPLETED|Overall Study||3|Completed is defined as completed all 12 cycles of study treatment.|
48477312|NCT03164772|101505825|FG000|NOT COMPLETED|Overall Study||18||
48477313|NCT03164772|101505826|FG001|NOT COMPLETED|Overall Study||31||
48477314|NCT02924038|101505827|FG000|STARTED|Overall Study||8||
48477315|NCT02924038|101505828|FG001|STARTED|Overall Study||6||
48477316|NCT02924038|101505827|FG000|Included in Biological Analysis|Overall Study||6||
48477317|NCT02924038|101505828|FG001|Included in Biological Analysis|Overall Study||5||
48477318|NCT02924038|101505827|FG000|COMPLETED|Overall Study||6||
48477319|NCT02924038|101505828|FG001|COMPLETED|Overall Study||4||
48670436|NCT02460458|101974944|FG000|COMPLETED|Confirmation of Clinical Phase Data||92||
48670437|NCT02460458|101974944|FG000|NOT COMPLETED|Confirmation of Clinical Phase Data||34||
48670438|NCT01733316|101974945|FG000|STARTED|Cystagon® Phase||41||
48670439|NCT01733316|101974945|FG000|COMPLETED|Cystagon® Phase||41||
48670440|NCT01733316|101974945|FG000|NOT COMPLETED|Cystagon® Phase||0||
48670441|NCT01733316|101974945|FG000|STARTED|RP103 Phase||41||
48670442|NCT01733316|101974945|FG000|COMPLETED|RP103 Phase||40||
48670443|NCT01733316|101974945|FG000|NOT COMPLETED|RP103 Phase||1||
48670444|NCT01733316|101974945|FG000|STARTED|Long Term Extension Phase||38||
48670445|NCT01733316|101974945|FG000|COMPLETED|Long Term Extension Phase||33||
48193846|NCT03441984|100797063|FG010|STARTED|Part 2: Period 1(Up to Day 4)||3||
48193847|NCT03441984|100797064|FG011|STARTED|Part 2: Period 1(Up to Day 4)||3||
48193848|NCT03441984|100797053|FG000|COMPLETED|Part 2: Period 1(Up to Day 4)||0||
48193849|NCT03441984|100797054|FG001|COMPLETED|Part 2: Period 1(Up to Day 4)||0||
48193850|NCT03441984|100797055|FG002|COMPLETED|Part 2: Period 1(Up to Day 4)||0||
48193851|NCT03441984|100797056|FG003|COMPLETED|Part 2: Period 1(Up to Day 4)||0||
48193852|NCT03441984|100797057|FG004|COMPLETED|Part 2: Period 1(Up to Day 4)||0||
48193853|NCT03441984|100797058|FG005|COMPLETED|Part 2: Period 1(Up to Day 4)||0||
48193854|NCT03441984|100797059|FG006|COMPLETED|Part 2: Period 1(Up to Day 4)||3||
48193855|NCT03441984|100797060|FG007|COMPLETED|Part 2: Period 1(Up to Day 4)||3||
48193856|NCT03441984|100797061|FG008|COMPLETED|Part 2: Period 1(Up to Day 4)||3||
48193857|NCT03441984|100797062|FG009|COMPLETED|Part 2: Period 1(Up to Day 4)||3||
48193858|NCT03441984|100797063|FG010|COMPLETED|Part 2: Period 1(Up to Day 4)||3||
48193859|NCT03441984|100797064|FG011|COMPLETED|Part 2: Period 1(Up to Day 4)||3||
48193860|NCT03441984|100797053|FG000|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0||
48193861|NCT03441984|100797054|FG001|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0||
48193862|NCT03441984|100797055|FG002|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0||
48193863|NCT03441984|100797056|FG003|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0||
48193864|NCT03441984|100797057|FG004|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0||
48193865|NCT03441984|100797058|FG005|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0||
48193866|NCT03441984|100797059|FG006|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0||
48193867|NCT03441984|100797060|FG007|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0||
48193868|NCT03441984|100797061|FG008|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0||
48193869|NCT03441984|100797062|FG009|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0||
48193870|NCT03441984|100797063|FG010|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0||
48193871|NCT03441984|100797064|FG011|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0||
48193872|NCT03441984|100797053|FG000|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
48193873|NCT03441984|100797054|FG001|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
48193874|NCT03441984|100797055|FG002|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
48193875|NCT03441984|100797056|FG003|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
48193876|NCT03441984|100797057|FG004|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
48193877|NCT03441984|100797058|FG005|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
48193878|NCT03441984|100797059|FG006|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3||
48193879|NCT03441984|100797060|FG007|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3||
48193880|NCT03441984|100797061|FG008|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3||
48193881|NCT03441984|100797062|FG009|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3||
48193882|NCT03441984|100797063|FG010|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3||
48193883|NCT03441984|100797064|FG011|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3||
48193884|NCT03441984|100797053|FG000|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
48193885|NCT03441984|100797054|FG001|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
48193886|NCT03441984|100797055|FG002|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
48193887|NCT03441984|100797056|FG003|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
48193888|NCT03441984|100797057|FG004|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
48193889|NCT03441984|100797058|FG005|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
48193890|NCT03441984|100797059|FG006|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3||
48193891|NCT03441984|100797060|FG007|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3||
48193892|NCT03441984|100797061|FG008|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3||
48193893|NCT03441984|100797062|FG009|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3||
48193894|NCT03441984|100797063|FG010|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3||
48193895|NCT03441984|100797064|FG011|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3||
48193896|NCT03441984|100797053|FG000|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
48193897|NCT03441984|100797054|FG001|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
48193898|NCT03441984|100797055|FG002|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
48193899|NCT03441984|100797056|FG003|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
48193900|NCT03441984|100797057|FG004|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
48193901|NCT03441984|100797058|FG005|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
48193902|NCT03441984|100797059|FG006|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
48193903|NCT03441984|100797060|FG007|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
48193904|NCT03441984|100797061|FG008|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
48193905|NCT03441984|100797062|FG009|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
48193906|NCT03441984|100797063|FG010|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
48193907|NCT03441984|100797064|FG011|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
48193908|NCT03441984|100797053|FG000|STARTED|Part 2: Period 2 (Up to Day 4)||0||
48193909|NCT03441984|100797054|FG001|STARTED|Part 2: Period 2 (Up to Day 4)||0||
48193910|NCT03441984|100797055|FG002|STARTED|Part 2: Period 2 (Up to Day 4)||0||
48193911|NCT03441984|100797056|FG003|STARTED|Part 2: Period 2 (Up to Day 4)||0||
48193912|NCT03441984|100797057|FG004|STARTED|Part 2: Period 2 (Up to Day 4)||0||
48193913|NCT03441984|100797058|FG005|STARTED|Part 2: Period 2 (Up to Day 4)||0||
48193914|NCT03441984|100797059|FG006|STARTED|Part 2: Period 2 (Up to Day 4)||3||
48193915|NCT03441984|100797060|FG007|STARTED|Part 2: Period 2 (Up to Day 4)||3||
48193916|NCT03441984|100797061|FG008|STARTED|Part 2: Period 2 (Up to Day 4)||3||
48193917|NCT03441984|100797062|FG009|STARTED|Part 2: Period 2 (Up to Day 4)||3||
48193918|NCT03441984|100797063|FG010|STARTED|Part 2: Period 2 (Up to Day 4)||3||
48193919|NCT03441984|100797064|FG011|STARTED|Part 2: Period 2 (Up to Day 4)||3||
48193920|NCT03441984|100797053|FG000|COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
48193921|NCT03441984|100797054|FG001|COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
48193922|NCT03441984|100797055|FG002|COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
48193923|NCT03441984|100797056|FG003|COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
48193924|NCT03441984|100797057|FG004|COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
48193925|NCT03441984|100797058|FG005|COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
48193926|NCT03441984|100797059|FG006|COMPLETED|Part 2: Period 2 (Up to Day 4)||3||
48193927|NCT03441984|100797060|FG007|COMPLETED|Part 2: Period 2 (Up to Day 4)||3||
48193928|NCT03441984|100797061|FG008|COMPLETED|Part 2: Period 2 (Up to Day 4)||3||
48193929|NCT03441984|100797062|FG009|COMPLETED|Part 2: Period 2 (Up to Day 4)||3||
48193930|NCT03441984|100797063|FG010|COMPLETED|Part 2: Period 2 (Up to Day 4)||3||
48193931|NCT03441984|100797064|FG011|COMPLETED|Part 2: Period 2 (Up to Day 4)||3||
48193932|NCT03441984|100797053|FG000|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
48193933|NCT03441984|100797054|FG001|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
48193934|NCT03441984|100797055|FG002|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
48193935|NCT03441984|100797056|FG003|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
48193936|NCT03441984|100797057|FG004|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
48193937|NCT03441984|100797058|FG005|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
48193938|NCT03441984|100797059|FG006|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
48193939|NCT03441984|100797060|FG007|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
48477320|NCT02924038|101505827|FG000|NOT COMPLETED|Overall Study||2||
48477321|NCT02924038|101505828|FG001|NOT COMPLETED|Overall Study||2||
48477322|NCT01884740|101505829|FG000|STARTED|Overall Study||13||
48477323|NCT01884740|101505829|FG000|COMPLETED|Overall Study||13||
48477324|NCT01884740|101505829|FG000|NOT COMPLETED|Overall Study||0||
48477325|NCT00723528|101505830|FG000|STARTED|Period 1: Controlled Period (CP)||32||
48477326|NCT00723528|101505831|FG001|STARTED|Period 1: Controlled Period (CP)||64||
48477327|NCT00723528|101505832|FG002|STARTED|Period 1: Controlled Period (CP)||62||
48477328|NCT00723528|101505833|FG003|STARTED|Period 1: Controlled Period (CP)||0||
48477329|NCT00723528|101505834|FG004|STARTED|Period 1: Controlled Period (CP)||0||
48193940|NCT03441984|100797061|FG008|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
48193941|NCT03441984|100797062|FG009|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
48193942|NCT03441984|100797063|FG010|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
48193943|NCT03441984|100797064|FG011|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
48193944|NCT03441984|100797053|FG000|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
48193945|NCT03441984|100797054|FG001|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
48193946|NCT03441984|100797055|FG002|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
48193947|NCT03441984|100797056|FG003|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
48193948|NCT03441984|100797057|FG004|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
48193949|NCT03441984|100797058|FG005|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
48193950|NCT03441984|100797059|FG006|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3||
48193951|NCT03441984|100797060|FG007|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3||
48193952|NCT03441984|100797061|FG008|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3||
48193953|NCT03441984|100797062|FG009|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3||
48193954|NCT03441984|100797063|FG010|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3||
48193955|NCT03441984|100797064|FG011|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3||
48193956|NCT03441984|100797053|FG000|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
48193957|NCT03441984|100797054|FG001|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
48193958|NCT03441984|100797055|FG002|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
48193959|NCT03441984|100797056|FG003|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
48193960|NCT03441984|100797057|FG004|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
48193961|NCT03441984|100797058|FG005|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
48193962|NCT03441984|100797059|FG006|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3||
48193963|NCT03441984|100797060|FG007|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3||
48193964|NCT03441984|100797061|FG008|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3||
48193965|NCT03441984|100797062|FG009|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3||
48193966|NCT03441984|100797063|FG010|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3||
48193967|NCT03441984|100797064|FG011|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3||
48193968|NCT03441984|100797053|FG000|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
48193969|NCT03441984|100797054|FG001|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
48193970|NCT03441984|100797055|FG002|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
48193971|NCT03441984|100797056|FG003|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
48193972|NCT03441984|100797057|FG004|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
48193973|NCT03441984|100797058|FG005|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
48193974|NCT03441984|100797059|FG006|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
48193975|NCT03441984|100797060|FG007|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
48193976|NCT03441984|100797061|FG008|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
48193977|NCT03441984|100797062|FG009|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
48193978|NCT03441984|100797063|FG010|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
48193979|NCT03441984|100797064|FG011|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
48193980|NCT03441984|100797053|FG000|STARTED|Part 2: Period 3 (Up to Day 4)||0||
48477330|NCT00723528|101505835|FG005|STARTED|Period 1: Controlled Period (CP)||0||
48477331|NCT00723528|101505836|FG006|STARTED|Period 1: Controlled Period (CP)||0||
48477332|NCT00723528|101505830|FG000|COMPLETED|Period 1: Controlled Period (CP)||28||
48477333|NCT00723528|101505831|FG001|COMPLETED|Period 1: Controlled Period (CP)||64||
48477334|NCT00723528|101505832|FG002|COMPLETED|Period 1: Controlled Period (CP)||58||
48477335|NCT00723528|101505833|FG003|COMPLETED|Period 1: Controlled Period (CP)||0||
48477336|NCT00723528|101505834|FG004|COMPLETED|Period 1: Controlled Period (CP)||0||
48477337|NCT00723528|101505835|FG005|COMPLETED|Period 1: Controlled Period (CP)||0||
48477338|NCT00723528|101505836|FG006|COMPLETED|Period 1: Controlled Period (CP)||0||
48477339|NCT00723528|101505830|FG000|NOT COMPLETED|Period 1: Controlled Period (CP)||4||
48193981|NCT03441984|100797054|FG001|STARTED|Part 2: Period 3 (Up to Day 4)||0||
48193982|NCT03441984|100797055|FG002|STARTED|Part 2: Period 3 (Up to Day 4)||0||
48193983|NCT03441984|100797056|FG003|STARTED|Part 2: Period 3 (Up to Day 4)||0||
48193984|NCT03441984|100797057|FG004|STARTED|Part 2: Period 3 (Up to Day 4)||0||
48193985|NCT03441984|100797058|FG005|STARTED|Part 2: Period 3 (Up to Day 4)||0||
48193986|NCT03441984|100797059|FG006|STARTED|Part 2: Period 3 (Up to Day 4)||3||
48193987|NCT03441984|100797060|FG007|STARTED|Part 2: Period 3 (Up to Day 4)||3||
48193988|NCT03441984|100797061|FG008|STARTED|Part 2: Period 3 (Up to Day 4)||3||
48477340|NCT00723528|101505831|FG001|NOT COMPLETED|Period 1: Controlled Period (CP)||0||
48477341|NCT00723528|101505832|FG002|NOT COMPLETED|Period 1: Controlled Period (CP)||4||
48193989|NCT03441984|100797062|FG009|STARTED|Part 2: Period 3 (Up to Day 4)||3||
48193990|NCT03441984|100797063|FG010|STARTED|Part 2: Period 3 (Up to Day 4)||3||
48193991|NCT03441984|100797064|FG011|STARTED|Part 2: Period 3 (Up to Day 4)||3||
48193992|NCT03441984|100797053|FG000|COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
48193993|NCT03441984|100797054|FG001|COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
48193994|NCT03441984|100797055|FG002|COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
48193995|NCT03441984|100797056|FG003|COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
48193996|NCT03441984|100797057|FG004|COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
48193997|NCT03441984|100797058|FG005|COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
48193998|NCT03441984|100797059|FG006|COMPLETED|Part 2: Period 3 (Up to Day 4)||3||
48193999|NCT03441984|100797060|FG007|COMPLETED|Part 2: Period 3 (Up to Day 4)||3||
48194000|NCT03441984|100797061|FG008|COMPLETED|Part 2: Period 3 (Up to Day 4)||3||
48194001|NCT03441984|100797062|FG009|COMPLETED|Part 2: Period 3 (Up to Day 4)||3||
48194002|NCT03441984|100797063|FG010|COMPLETED|Part 2: Period 3 (Up to Day 4)||3||
48194003|NCT03441984|100797064|FG011|COMPLETED|Part 2: Period 3 (Up to Day 4)||3||
48194004|NCT03441984|100797053|FG000|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
48194005|NCT03441984|100797054|FG001|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
48194006|NCT03441984|100797055|FG002|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
48194007|NCT03441984|100797056|FG003|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
48194008|NCT03441984|100797057|FG004|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
48194009|NCT03441984|100797058|FG005|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
48194010|NCT03441984|100797059|FG006|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
48194011|NCT03441984|100797060|FG007|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
48194012|NCT03441984|100797061|FG008|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
48194013|NCT03441984|100797062|FG009|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
48194014|NCT03441984|100797063|FG010|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
48194015|NCT03441984|100797064|FG011|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
48194016|NCT03141788|100797065|FG000|STARTED|Overall Study||52||
48194017|NCT03141788|100797065|FG000|COMPLETED|Overall Study||44||
48194018|NCT03141788|100797065|FG000|NOT COMPLETED|Overall Study||8||
48194019|NCT03303105|100797066|FG000|STARTED|Overall Study||25||
48194020|NCT03303105|100797067|FG001|STARTED|Overall Study||25||
48194021|NCT03303105|100797066|FG000|COMPLETED|Overall Study||23||
48194022|NCT03303105|100797067|FG001|COMPLETED|Overall Study||21||
48194023|NCT03303105|100797066|FG000|NOT COMPLETED|Overall Study||2||
48194024|NCT03303105|100797067|FG001|NOT COMPLETED|Overall Study||4||
48194025|NCT01278862|100797068|FG000|STARTED|Overall Study||45|Total # of participants equaled 77; Some subjects received more than one crown (max, of 2).|50
48194026|NCT01278862|100797069|FG001|STARTED|Overall Study||43|Total # of participants equaled 77; Some subjects received more than one crown (max, of 2).|50
48194027|NCT01278862|100797068|FG000|COMPLETED|Overall Study||44|1 subject with one of each crown placed was lost follow-up|49
48194028|NCT01278862|100797069|FG001|COMPLETED|Overall Study||42|1 subject with one of each crown placed was lost follow-up|49
48194029|NCT01278862|100797068|FG000|NOT COMPLETED|Overall Study||1||1
48194030|NCT01278862|100797069|FG001|NOT COMPLETED|Overall Study||1||1
48194031|NCT02403323|100797070|FG000|STARTED|Part 1: Open Label Extension Period||431||
48194032|NCT02403323|100797071|FG001|STARTED|Part 1: Open Label Extension Period||320||
48194033|NCT02403323|100797072|FG002|STARTED|Part 1: Open Label Extension Period||0||
48194034|NCT02403323|100797070|FG000|COMPLETED|Part 1: Open Label Extension Period||5||
48194035|NCT02403323|100797071|FG001|COMPLETED|Part 1: Open Label Extension Period||320||
48194036|NCT02403323|100797072|FG002|COMPLETED|Part 1: Open Label Extension Period||0||
48194037|NCT02403323|100797070|FG000|NOT COMPLETED|Part 1: Open Label Extension Period||426||
48194038|NCT02403323|100797071|FG001|NOT COMPLETED|Part 1: Open Label Extension Period||0||
48194039|NCT02403323|100797072|FG002|NOT COMPLETED|Part 1: Open Label Extension Period||0||
48194040|NCT02403323|100797070|FG000|STARTED|Part 2: PML Safety Monitoring Period||0||
48194041|NCT02403323|100797071|FG001|STARTED|Part 2: PML Safety Monitoring Period||320||
48194042|NCT02403323|100797072|FG002|STARTED|Part 2: PML Safety Monitoring Period||39||
48194043|NCT02403323|100797070|FG000|COMPLETED|Part 2: PML Safety Monitoring Period||0||
48194044|NCT02403323|100797071|FG001|COMPLETED|Part 2: PML Safety Monitoring Period||112||
48194045|NCT02403323|100797072|FG002|COMPLETED|Part 2: PML Safety Monitoring Period||33||
48194046|NCT02403323|100797070|FG000|NOT COMPLETED|Part 2: PML Safety Monitoring Period||0||
48477342|NCT00723528|101505833|FG003|NOT COMPLETED|Period 1: Controlled Period (CP)||0||
48477343|NCT00723528|101505834|FG004|NOT COMPLETED|Period 1: Controlled Period (CP)||0||
48477344|NCT00723528|101505835|FG005|NOT COMPLETED|Period 1: Controlled Period (CP)||0||
48477345|NCT00723528|101505836|FG006|NOT COMPLETED|Period 1: Controlled Period (CP)||0||
48477346|NCT00723528|101505830|FG000|STARTED|Period 2: After Controlled Period||0||
48477347|NCT00723528|101505831|FG001|STARTED|Period 2: After Controlled Period||0||
48477348|NCT00723528|101505832|FG002|STARTED|Period 2: After Controlled Period||0||
48477349|NCT00723528|101505833|FG003|STARTED|Period 2: After Controlled Period||15||
48194047|NCT02403323|100797071|FG001|NOT COMPLETED|Part 2: PML Safety Monitoring Period||208||
48194048|NCT02403323|100797072|FG002|NOT COMPLETED|Part 2: PML Safety Monitoring Period||6||
48194049|NCT03120676|100797073|FG000|STARTED|Overall Study||3||
48194050|NCT03120676|100797073|FG000|COMPLETED|Overall Study||2||
48194051|NCT03120676|100797073|FG000|NOT COMPLETED|Overall Study||1||
48194052|NCT03468920|100797074|FG000|STARTED|Overall Study||60||
48194053|NCT03468920|100797075|FG001|STARTED|Overall Study||60||
48194054|NCT03468920|100797074|FG000|COMPLETED|Overall Study||60||
48670446|NCT01733316|101974945|FG000|NOT COMPLETED|Long Term Extension Phase||5||
48194055|NCT03468920|100797075|FG001|COMPLETED|Overall Study||60||
48194056|NCT03468920|100797074|FG000|NOT COMPLETED|Overall Study||0||
48194057|NCT03468920|100797075|FG001|NOT COMPLETED|Overall Study||0||
48194058|NCT00672256|100797076|FG000|STARTED|Overall Study||62||
48194059|NCT00672256|100797076|FG000|COMPLETED|Overall Study||18||
48194060|NCT00672256|100797076|FG000|NOT COMPLETED|Overall Study||44||
48194061|NCT01833065|100797077|FG000|STARTED|Overall Study||65||
48194062|NCT01833065|100797078|FG001|STARTED|Overall Study||53||
48194063|NCT01833065|100797079|FG002|STARTED|Overall Study||35||
48194064|NCT01833065|100797080|FG003|STARTED|Overall Study||50||
48194065|NCT01833065|100797081|FG004|STARTED|Overall Study||110||
48194066|NCT01833065|100797077|FG000|Intention-to-treat Analysis Set|Overall Study||50||
48194067|NCT01833065|100797078|FG001|Intention-to-treat Analysis Set|Overall Study||53||
48194068|NCT01833065|100797079|FG002|Intention-to-treat Analysis Set|Overall Study||50||
48194069|NCT01833065|100797080|FG003|Intention-to-treat Analysis Set|Overall Study||50||
48194070|NCT01833065|100797081|FG004|Intention-to-treat Analysis Set|Overall Study||111||
48194071|NCT01833065|100797077|FG000|COMPLETED|Overall Study||41||
48194072|NCT01833065|100797078|FG001|COMPLETED|Overall Study||40||
48194073|NCT01833065|100797079|FG002|COMPLETED|Overall Study||23||
48194074|NCT01833065|100797080|FG003|COMPLETED|Overall Study||41||
48194075|NCT01833065|100797081|FG004|COMPLETED|Overall Study||74||
48194076|NCT01833065|100797077|FG000|NOT COMPLETED|Overall Study||24||
48194077|NCT01833065|100797078|FG001|NOT COMPLETED|Overall Study||13||
48194078|NCT01833065|100797079|FG002|NOT COMPLETED|Overall Study||12||
48670447|NCT02587403|101974946|FG000|STARTED|Overall Study||60||
48670448|NCT02587403|101974947|FG001|STARTED|Overall Study||60||
48670449|NCT02587403|101974946|FG000|COMPLETED|Overall Study||51||
48670450|NCT02587403|101974947|FG001|COMPLETED|Overall Study||44||
48670451|NCT02587403|101974946|FG000|NOT COMPLETED|Overall Study||9||
48670452|NCT02587403|101974947|FG001|NOT COMPLETED|Overall Study||16||
48670453|NCT01674140|101974948|FG000|STARTED|Overall Study||968||
48670454|NCT01674140|101974949|FG001|STARTED|Overall Study||971||
48670455|NCT01674140|101974948|FG000|COMPLETED|Overall Study||896||
48670456|NCT01674140|101974949|FG001|COMPLETED|Overall Study||896||
48670457|NCT01674140|101974948|FG000|NOT COMPLETED|Overall Study||72||
48670458|NCT01674140|101974949|FG001|NOT COMPLETED|Overall Study||75||
48670459|NCT01197378|101974950|FG000|STARTED|Overall Study||60||
48670460|NCT01197378|101974950|FG000|Received Treatment|Overall Study||59||
48670461|NCT01197378|101974950|FG000|COMPLETED|Overall Study||53||
48670462|NCT01197378|101974950|FG000|NOT COMPLETED|Overall Study||7||
48670463|NCT00098475|101974951|FG000|STARTED|Step 1||223||
48670464|NCT00098475|101974952|FG001|STARTED|Step 1||222||
48670465|NCT00098475|101974953|FG002|STARTED|Step 1||4||
48670466|NCT00098475|101974954|FG003|STARTED|Step 1||3||
48670467|NCT00098475|101974951|FG000|Treated|Step 1||223||
48670468|NCT00098475|101974952|FG001|Treated|Step 1||220||
48670469|NCT00098475|101974953|FG002|Treated|Step 1||4||
48670470|NCT00098475|101974954|FG003|Treated|Step 1||3||
48670471|NCT00098475|101974951|FG000|Eligible|Step 1||214||
48670472|NCT00098475|101974952|FG001|Eligible|Step 1||208||
48670473|NCT00098475|101974953|FG002|Eligible|Step 1||4||
48670474|NCT00098475|101974954|FG003|Eligible|Step 1||3||
48670475|NCT00098475|101974951|FG000|COMPLETED|Step 1||52||
48670476|NCT00098475|101974952|FG001|COMPLETED|Step 1||49||
48670477|NCT00098475|101974953|FG002|COMPLETED|Step 1||0||
48670478|NCT00098475|101974954|FG003|COMPLETED|Step 1||0||
48670479|NCT00098475|101974951|FG000|NOT COMPLETED|Step 1||171||
48670480|NCT00098475|101974952|FG001|NOT COMPLETED|Step 1||173||
48670481|NCT00098475|101974953|FG002|NOT COMPLETED|Step 1||4||
48670482|NCT00098475|101974954|FG003|NOT COMPLETED|Step 1||3||
48670483|NCT00098475|101974951|FG000|STARTED|Step 2||5||
48670484|NCT00098475|101974952|FG001|STARTED|Step 2||15||
48670485|NCT00098475|101974953|FG002|STARTED|Step 2||0||
48670486|NCT00098475|101974954|FG003|STARTED|Step 2||0||
48670487|NCT00098475|101974951|FG000|Treated|Step 2||4||
48670488|NCT00098475|101974952|FG001|Treated|Step 2||14||
48670489|NCT00098475|101974953|FG002|Treated|Step 2||0||
48670490|NCT00098475|101974954|FG003|Treated|Step 2||0||
48670491|NCT00098475|101974951|FG000|Eligible|Step 2||2||
48477350|NCT00723528|101505834|FG004|STARTED|Period 2: After Controlled Period||13||
48477351|NCT00723528|101505835|FG005|STARTED|Period 2: After Controlled Period||64||
48477352|NCT00723528|101505836|FG006|STARTED|Period 2: After Controlled Period||58||
48477353|NCT00723528|101505830|FG000|COMPLETED|Period 2: After Controlled Period||0||
48477354|NCT00723528|101505831|FG001|COMPLETED|Period 2: After Controlled Period||0||
48477355|NCT00723528|101505832|FG002|COMPLETED|Period 2: After Controlled Period||0||
48477356|NCT00723528|101505833|FG003|COMPLETED|Period 2: After Controlled Period||14||
48477357|NCT00723528|101505834|FG004|COMPLETED|Period 2: After Controlled Period||11||
48477358|NCT00723528|101505835|FG005|COMPLETED|Period 2: After Controlled Period||58||
48477359|NCT00723528|101505836|FG006|COMPLETED|Period 2: After Controlled Period||54||
48477360|NCT00723528|101505830|FG000|NOT COMPLETED|Period 2: After Controlled Period||0||
48477361|NCT00723528|101505831|FG001|NOT COMPLETED|Period 2: After Controlled Period||0||
48477362|NCT00723528|101505832|FG002|NOT COMPLETED|Period 2: After Controlled Period||0||
48477363|NCT00723528|101505833|FG003|NOT COMPLETED|Period 2: After Controlled Period||1||
48477364|NCT00723528|101505834|FG004|NOT COMPLETED|Period 2: After Controlled Period||2||
48477365|NCT00723528|101505835|FG005|NOT COMPLETED|Period 2: After Controlled Period||6||
48477366|NCT00723528|101505836|FG006|NOT COMPLETED|Period 2: After Controlled Period||4||
48477367|NCT04885296|101505837|FG000|STARTED|Period 1||117||
48477368|NCT04885296|101505838|FG001|STARTED|Period 1||110||
48477369|NCT04885296|101505837|FG000|COMPLETED|Period 1||112||
48477370|NCT04885296|101505838|FG001|COMPLETED|Period 1||108||
48477371|NCT04885296|101505837|FG000|NOT COMPLETED|Period 1||5||
48477372|NCT04885296|101505838|FG001|NOT COMPLETED|Period 1||2||
48477373|NCT04885296|101505837|FG000|STARTED|Period 2||112||
48477374|NCT04885296|101505838|FG001|STARTED|Period 2||108||
48477375|NCT04885296|101505837|FG000|COMPLETED|Period 2||112||
48477376|NCT04885296|101505838|FG001|COMPLETED|Period 2||107||
48477377|NCT04885296|101505837|FG000|NOT COMPLETED|Period 2||0||
48477378|NCT04885296|101505838|FG001|NOT COMPLETED|Period 2||1||
48477379|NCT04257474|101505839|FG000|STARTED|Overall Study||172||
48477380|NCT04257474|101505840|FG001|STARTED|Overall Study||63||
48477381|NCT04257474|101505839|FG000|COMPLETED|Overall Study||172||
48477382|NCT04257474|101505840|FG001|COMPLETED|Overall Study||63||
48477383|NCT04257474|101505839|FG000|NOT COMPLETED|Overall Study||0||
48477384|NCT04257474|101505840|FG001|NOT COMPLETED|Overall Study||0||
48477385|NCT02648880|101505841|FG000|STARTED|Overall Study||3||
48477386|NCT02648880|101505841|FG000|COMPLETED|Overall Study||3||
48477387|NCT02648880|101505841|FG000|NOT COMPLETED|Overall Study||0||
48477388|NCT01700621|101505842|FG000|STARTED|Received Study Vaccines||240||
48477389|NCT01700621|101505843|FG001|STARTED|Received Study Vaccines||240||
48477390|NCT01700621|101505842|FG000|COMPLETED|Received Study Vaccines||240||
48477391|NCT01700621|101505843|FG001|COMPLETED|Received Study Vaccines||240||
48477392|NCT01700621|101505842|FG000|NOT COMPLETED|Received Study Vaccines||0||
48477393|NCT01700621|101505843|FG001|NOT COMPLETED|Received Study Vaccines||0||
48477394|NCT01700621|101505842|FG000|STARTED|Analyzed for Immunogenicity||240||
48477395|NCT01700621|101505843|FG001|STARTED|Analyzed for Immunogenicity||240||
48477396|NCT01700621|101505842|FG000|COMPLETED|Analyzed for Immunogenicity||227||
48477397|NCT01700621|101505843|FG001|COMPLETED|Analyzed for Immunogenicity||233||
48477398|NCT01700621|101505842|FG000|NOT COMPLETED|Analyzed for Immunogenicity||13||
48477399|NCT01700621|101505843|FG001|NOT COMPLETED|Analyzed for Immunogenicity||7||
48477400|NCT00259012|101505844|FG000|STARTED|Overall Study||33||
48477401|NCT00259012|101505845|FG001|STARTED|Overall Study||34||
48477402|NCT00259012|101505844|FG000|COMPLETED|Overall Study||31||
48477403|NCT00259012|101505845|FG001|COMPLETED|Overall Study||30||
48477404|NCT00259012|101505844|FG000|NOT COMPLETED|Overall Study||2||
48477405|NCT00259012|101505845|FG001|NOT COMPLETED|Overall Study||4||
48477406|NCT00893464|101505846|FG000|STARTED|Overall Study||1||
48477407|NCT00893464|101505847|FG001|STARTED|Overall Study||1||
48477408|NCT00893464|101505848|FG002|STARTED|Overall Study||1||
48477409|NCT00893464|101505849|FG003|STARTED|Overall Study||1||
48477410|NCT00893464|101505850|FG004|STARTED|Overall Study||4||
48477411|NCT00893464|101505851|FG005|STARTED|Overall Study||7||
48477412|NCT00893464|101505852|FG006|STARTED|Overall Study||10||
48477413|NCT00893464|101505853|FG007|STARTED|Overall Study||5||
48477414|NCT00893464|101505846|FG000|COMPLETED|Overall Study||1||
48477415|NCT00893464|101505847|FG001|COMPLETED|Overall Study||1||
48477416|NCT00893464|101505848|FG002|COMPLETED|Overall Study||1||
48477417|NCT00893464|101505849|FG003|COMPLETED|Overall Study||1||
48477418|NCT00893464|101505850|FG004|COMPLETED|Overall Study||4||
48477419|NCT00893464|101505851|FG005|COMPLETED|Overall Study||7||
48477420|NCT00893464|101505852|FG006|COMPLETED|Overall Study||8||
48477421|NCT00893464|101505853|FG007|COMPLETED|Overall Study||3||
48477422|NCT00893464|101505846|FG000|NOT COMPLETED|Overall Study||0||
48477423|NCT00893464|101505847|FG001|NOT COMPLETED|Overall Study||0||
48477424|NCT00893464|101505848|FG002|NOT COMPLETED|Overall Study||0||
48477425|NCT00893464|101505849|FG003|NOT COMPLETED|Overall Study||0||
48477426|NCT00893464|101505850|FG004|NOT COMPLETED|Overall Study||0||
48477427|NCT00893464|101505851|FG005|NOT COMPLETED|Overall Study||0||
48477428|NCT00893464|101505852|FG006|NOT COMPLETED|Overall Study||2||
48477429|NCT00893464|101505853|FG007|NOT COMPLETED|Overall Study||2||
48477430|NCT01722877|101505854|FG000|STARTED|Overall Study||29||32
48477431|NCT01722877|101505854|FG000|COMPLETED|Overall Study||27||29
48194079|NCT01833065|100797080|FG003|NOT COMPLETED|Overall Study||9||
48194080|NCT01833065|100797081|FG004|NOT COMPLETED|Overall Study||36||
48194081|NCT02306161|100797082|FG000|STARTED|Overall Study||157||
48194082|NCT02306161|100797083|FG001|STARTED|Overall Study||155||
48194083|NCT02306161|100797082|FG000|COMPLETED|Overall Study||93||
48194084|NCT02306161|100797083|FG001|COMPLETED|Overall Study||86||
48194085|NCT02306161|100797082|FG000|NOT COMPLETED|Overall Study||64||
48477432|NCT01722877|101505854|FG000|NOT COMPLETED|Overall Study||2||3
48477433|NCT01244126|101505855|FG000|STARTED|Overall Study||59||
48477434|NCT01244126|101505856|FG001|STARTED|Overall Study||55||
48477435|NCT01244126|101505857|FG002|STARTED|Overall Study||57||
48477436|NCT01244126|101505855|FG000|COMPLETED|Overall Study||56||
48477437|NCT01244126|101505856|FG001|COMPLETED|Overall Study||52||
48477438|NCT01244126|101505857|FG002|COMPLETED|Overall Study||48||
48477439|NCT01244126|101505855|FG000|NOT COMPLETED|Overall Study||3||
48477440|NCT01244126|101505856|FG001|NOT COMPLETED|Overall Study||3||
48477441|NCT01244126|101505857|FG002|NOT COMPLETED|Overall Study||9||
48477442|NCT02193178|101505858|FG000|STARTED|Overall Study||15||
48477443|NCT02193178|101505858|FG000|COMPLETED|Overall Study||13||
48477444|NCT02193178|101505858|FG000|NOT COMPLETED|Overall Study||2||
48477445|NCT02008565|101505859|FG000|STARTED|Overall Study||86||
48477446|NCT02008565|101505860|FG001|STARTED|Overall Study||84||
48477447|NCT02008565|101505861|FG002|STARTED|Overall Study||88||
48477448|NCT02008565|101505862|FG003|STARTED|Overall Study||42||
48477449|NCT02008565|101505859|FG000|COMPLETED|Overall Study||85||
48477450|NCT02008565|101505860|FG001|COMPLETED|Overall Study||83||
48477451|NCT02008565|101505861|FG002|COMPLETED|Overall Study||86||
48477452|NCT02008565|101505862|FG003|COMPLETED|Overall Study||42||
48477453|NCT02008565|101505859|FG000|NOT COMPLETED|Overall Study||1||
48477454|NCT02008565|101505860|FG001|NOT COMPLETED|Overall Study||1||
48477455|NCT02008565|101505861|FG002|NOT COMPLETED|Overall Study||2||
48477456|NCT02008565|101505862|FG003|NOT COMPLETED|Overall Study||0||
48477457|NCT03581448|101505863|FG000|STARTED|Overall Study||21||
48477458|NCT03581448|101505863|FG000|COMPLETED|Overall Study||21||
48477459|NCT03581448|101505863|FG000|NOT COMPLETED|Overall Study||0||
48477460|NCT00366899|101505864|FG000|STARTED|Infant Series||303||
48477461|NCT00366899|101505865|FG001|STARTED|Infant Series||303||
48477462|NCT00366899|101505864|FG000|Vaccinated Dose 1|Infant Series||302||
48477463|NCT00366899|101505865|FG001|Vaccinated Dose 1|Infant Series||302||
48477464|NCT00366899|101505864|FG000|Vaccinated Dose 2|Infant Series||296||
48477465|NCT00366899|101505865|FG001|Vaccinated Dose 2|Infant Series||293||
48477466|NCT00366899|101505864|FG000|COMPLETED|Infant Series||294||
48477467|NCT00366899|101505865|FG001|COMPLETED|Infant Series||291||
48477468|NCT00366899|101505864|FG000|NOT COMPLETED|Infant Series||9||
48477469|NCT00366899|101505865|FG001|NOT COMPLETED|Infant Series||12||
48477470|NCT00366899|101505864|FG000|STARTED|After Infant Series||294||
48477471|NCT00366899|101505865|FG001|STARTED|After Infant Series||291||
48477472|NCT00366899|101505864|FG000|COMPLETED|After Infant Series||287||
48477473|NCT00366899|101505865|FG001|COMPLETED|After Infant Series||282||
48477474|NCT00366899|101505864|FG000|NOT COMPLETED|After Infant Series||7||
48477475|NCT00366899|101505865|FG001|NOT COMPLETED|After Infant Series||9||
48477476|NCT00366899|101505864|FG000|STARTED|Toddler Dose||287||
48477477|NCT00366899|101505865|FG001|STARTED|Toddler Dose||282||
48477478|NCT00366899|101505864|FG000|COMPLETED|Toddler Dose||285||
48477479|NCT00366899|101505865|FG001|COMPLETED|Toddler Dose||281||
48477480|NCT00366899|101505864|FG000|NOT COMPLETED|Toddler Dose||2||
48477481|NCT00366899|101505865|FG001|NOT COMPLETED|Toddler Dose||1||
48477482|NCT03049488|101505866|FG000|STARTED|Overall Study||15||
48477483|NCT03049488|101505867|FG001|STARTED|Overall Study||15||
48477484|NCT03049488|101505868|FG002|STARTED|Overall Study||20||
48477485|NCT03049488|101505869|FG003|STARTED|Overall Study||15||
48477486|NCT03049488|101505870|FG004|STARTED|Overall Study||15||
48477487|NCT03049488|101505871|FG005|STARTED|Overall Study||15||
48477488|NCT03049488|101505866|FG000|Received First Product Administration|Overall Study||15||
48477489|NCT03049488|101505867|FG001|Received First Product Administration|Overall Study||15||
48477490|NCT03049488|101505868|FG002|Received First Product Administration|Overall Study||20||
48477491|NCT03049488|101505869|FG003|Received First Product Administration|Overall Study||15||
48194086|NCT02306161|100797083|FG001|NOT COMPLETED|Overall Study||69||
48194087|NCT00868231|100797084|FG000|STARTED|Treatment Period 1||5||
48194088|NCT00868231|100797085|FG001|STARTED|Treatment Period 1||5||
48194089|NCT00868231|100797086|FG002|STARTED|Treatment Period 1||5||
48194090|NCT00868231|100797087|FG003|STARTED|Treatment Period 1||5||
48194091|NCT00868231|100797088|FG004|STARTED|Treatment Period 1||5||
48194092|NCT00868231|100797089|FG005|STARTED|Treatment Period 1||5||
48194093|NCT00868231|100797084|FG000|COMPLETED|Treatment Period 1||5||
48194094|NCT00868231|100797085|FG001|COMPLETED|Treatment Period 1||5||
48194095|NCT00868231|100797086|FG002|COMPLETED|Treatment Period 1||5||
48194096|NCT00868231|100797087|FG003|COMPLETED|Treatment Period 1||5||
48194097|NCT00868231|100797088|FG004|COMPLETED|Treatment Period 1||4||
48194098|NCT00868231|100797089|FG005|COMPLETED|Treatment Period 1||5||
48194099|NCT00868231|100797084|FG000|NOT COMPLETED|Treatment Period 1||0||
48194100|NCT00868231|100797085|FG001|NOT COMPLETED|Treatment Period 1||0||
48194101|NCT00868231|100797086|FG002|NOT COMPLETED|Treatment Period 1||0||
48477492|NCT03049488|101505870|FG004|Received First Product Administration|Overall Study||15||
48477493|NCT03049488|101505871|FG005|Received First Product Administration|Overall Study||15||
48477494|NCT03049488|101505866|FG000|Received Optional Second Dose|Overall Study||10||
48477495|NCT03049488|101505867|FG001|Received Optional Second Dose|Overall Study||11||
48477496|NCT03049488|101505868|FG002|Received Optional Second Dose|Overall Study||11||
48477497|NCT03049488|101505869|FG003|Received Optional Second Dose|Overall Study||9||
48477498|NCT03049488|101505870|FG004|Received Optional Second Dose|Overall Study||11||
48477499|NCT03049488|101505871|FG005|Received Optional Second Dose|Overall Study||10||
48477500|NCT03049488|101505866|FG000|COMPLETED|Overall Study||13||
48477501|NCT03049488|101505867|FG001|COMPLETED|Overall Study||13||
48477502|NCT03049488|101505868|FG002|COMPLETED|Overall Study||20||
48194102|NCT00868231|100797087|FG003|NOT COMPLETED|Treatment Period 1||0||
48194103|NCT00868231|100797088|FG004|NOT COMPLETED|Treatment Period 1||1||
48477503|NCT03049488|101505869|FG003|COMPLETED|Overall Study||13||
48477504|NCT03049488|101505870|FG004|COMPLETED|Overall Study||13||
48477505|NCT03049488|101505871|FG005|COMPLETED|Overall Study||15||
48477506|NCT03049488|101505866|FG000|NOT COMPLETED|Overall Study||2||
48477507|NCT03049488|101505867|FG001|NOT COMPLETED|Overall Study||2||
48477508|NCT03049488|101505868|FG002|NOT COMPLETED|Overall Study||0||
48477509|NCT03049488|101505869|FG003|NOT COMPLETED|Overall Study||2||
48477510|NCT03049488|101505870|FG004|NOT COMPLETED|Overall Study||2||
48477511|NCT03049488|101505871|FG005|NOT COMPLETED|Overall Study||0||
48477512|NCT01449266|101505872|FG000|STARTED|Overall Study||10||
48477513|NCT01449266|101505872|FG000|COMPLETED|Overall Study||10||
48477514|NCT01449266|101505872|FG000|NOT COMPLETED|Overall Study||0||
48477515|NCT00976664|101505873|FG000|STARTED|Overall Study||25||
48477516|NCT00976664|101505874|FG001|STARTED|Overall Study||25||
48477517|NCT00976664|101505873|FG000|COMPLETED|Overall Study||22||
48477518|NCT00976664|101505874|FG001|COMPLETED|Overall Study||24||
48477519|NCT00976664|101505873|FG000|NOT COMPLETED|Overall Study||3||
48477520|NCT00976664|101505874|FG001|NOT COMPLETED|Overall Study||1||
48477521|NCT02506309|101505875|FG000|STARTED|Overall Study||84||
48477522|NCT02506309|101505876|FG001|STARTED|Overall Study||84||
48477523|NCT02506309|101505875|FG000|COMPLETED|Overall Study||66||
48477524|NCT02506309|101505876|FG001|COMPLETED|Overall Study||64||
48477525|NCT02506309|101505875|FG000|NOT COMPLETED|Overall Study||18||
48477526|NCT02506309|101505876|FG001|NOT COMPLETED|Overall Study||20||
48477527|NCT03639311|101505877|FG000|STARTED|Maintenance Phase||90||
48477528|NCT03639311|101505878|FG001|STARTED|Maintenance Phase||7||
48477529|NCT03639311|101505879|FG002|STARTED|Maintenance Phase||0||
48477530|NCT03639311|101505877|FG000|COMPLETED|Maintenance Phase||76||
48477531|NCT03639311|101505878|FG001|COMPLETED|Maintenance Phase||7||
48477532|NCT03639311|101505879|FG002|COMPLETED|Maintenance Phase||0||
48477533|NCT03639311|101505877|FG000|NOT COMPLETED|Maintenance Phase||14||
48477534|NCT03639311|101505878|FG001|NOT COMPLETED|Maintenance Phase||0||
48477535|NCT03639311|101505879|FG002|NOT COMPLETED|Maintenance Phase||0||
48477536|NCT03639311|101505877|FG000|STARTED|Long-term Follow-up Phase (LTFU Phase)||0|70 participants from CAB LA + RPV LA Q2M arm who completed the Maintenance Phase did not enter LTFU Phase as they completed the study and transitioned off CAB LA + RPV LA Q2M regimen to other options. DTG + RPV arm was not considered for LTFU Phase.|
48477537|NCT03639311|101505878|FG001|STARTED|Long-term Follow-up Phase (LTFU Phase)||0|70 participants from CAB LA + RPV LA Q2M arm who completed the Maintenance Phase did not enter LTFU Phase as they completed the study and transitioned off CAB LA + RPV LA Q2M regimen to other options. DTG + RPV arm was not considered for LTFU Phase.|
48477538|NCT03639311|101505879|FG002|STARTED|Long-term Follow-up Phase (LTFU Phase)||6|70 participants from CAB LA + RPV LA Q2M arm who completed the Maintenance Phase did not enter LTFU Phase as they completed the study and transitioned off CAB LA + RPV LA Q2M regimen to other options. DTG + RPV arm was not considered for LTFU Phase.|
48477539|NCT03639311|101505877|FG000|COMPLETED|Long-term Follow-up Phase (LTFU Phase)||0|70 participants from CAB LA + RPV LA Q2M arm who completed the Maintenance Phase did not enter LTFU Phase as they completed the study and transitioned off CAB LA + RPV LA Q2M regimen to other options. DTG + RPV arm was not considered for LTFU Phase.|
48477540|NCT03639311|101505878|FG001|COMPLETED|Long-term Follow-up Phase (LTFU Phase)||0|70 participants from CAB LA + RPV LA Q2M arm who completed the Maintenance Phase did not enter LTFU Phase as they completed the study and transitioned off CAB LA + RPV LA Q2M regimen to other options. DTG + RPV arm was not considered for LTFU Phase.|
48477541|NCT03639311|101505879|FG002|COMPLETED|Long-term Follow-up Phase (LTFU Phase)||6|70 participants from CAB LA + RPV LA Q2M arm who completed the Maintenance Phase did not enter LTFU Phase as they completed the study and transitioned off CAB LA + RPV LA Q2M regimen to other options. DTG + RPV arm was not considered for LTFU Phase.|
48477542|NCT03639311|101505877|FG000|NOT COMPLETED|Long-term Follow-up Phase (LTFU Phase)||0||
48670492|NCT00098475|101974952|FG001|Eligible|Step 2||9||
48194104|NCT00868231|100797089|FG005|NOT COMPLETED|Treatment Period 1||0||
48194105|NCT00868231|100797084|FG000|STARTED|Treatment Period 2||5||
48194106|NCT00868231|100797085|FG001|STARTED|Treatment Period 2||5||
48194107|NCT00868231|100797086|FG002|STARTED|Treatment Period 2||5||
48194108|NCT00868231|100797087|FG003|STARTED|Treatment Period 2||5||
48477543|NCT03639311|101505878|FG001|NOT COMPLETED|Long-term Follow-up Phase (LTFU Phase)||0||
48477544|NCT03639311|101505879|FG002|NOT COMPLETED|Long-term Follow-up Phase (LTFU Phase)||0||
48477545|NCT01312922|101505880|FG000|STARTED|Overall Study||185||
48477546|NCT01312922|101505881|FG001|STARTED|Overall Study||185||
48477547|NCT01312922|101505882|FG002|STARTED|Overall Study||185||
48477548|NCT01312922|101505880|FG000|COMPLETED|Overall Study||117||
48477549|NCT01312922|101505881|FG001|COMPLETED|Overall Study||131||
48477550|NCT01312922|101505882|FG002|COMPLETED|Overall Study||135||
48477551|NCT01312922|101505880|FG000|NOT COMPLETED|Overall Study||68||
48477552|NCT01312922|101505881|FG001|NOT COMPLETED|Overall Study||54||
48477553|NCT01312922|101505882|FG002|NOT COMPLETED|Overall Study||50||
48477554|NCT03329027|101505883|FG000|STARTED|Overall Study||21||
48477555|NCT03329027|101505884|FG001|STARTED|Overall Study||22||
48477556|NCT03329027|101505885|FG002|STARTED|Overall Study||24||
48477557|NCT03329027|101505883|FG000|COMPLETED|Overall Study||11||
48477558|NCT03329027|101505884|FG001|COMPLETED|Overall Study||17||
48477559|NCT03329027|101505885|FG002|COMPLETED|Overall Study||16||
48477560|NCT03329027|101505883|FG000|NOT COMPLETED|Overall Study||10||
48477561|NCT03329027|101505884|FG001|NOT COMPLETED|Overall Study||5||
48477562|NCT03329027|101505885|FG002|NOT COMPLETED|Overall Study||8||
48477563|NCT00208026|101505886|FG000|STARTED|Overall Study||3||
48477564|NCT00208026|101505886|FG000|COMPLETED|Overall Study||3||
48477565|NCT00208026|101505886|FG000|NOT COMPLETED|Overall Study||0||
48477566|NCT03693430|101505887|FG000|STARTED|Overall Study||152||
48477567|NCT03693430|101505888|FG001|STARTED|Overall Study||152||
48477568|NCT03693430|101505887|FG000|Full Analysis Set (FAS)|Overall Study||152||
48194109|NCT00868231|100797088|FG004|STARTED|Treatment Period 2||4||
48477569|NCT03693430|101505888|FG001|Full Analysis Set (FAS)|Overall Study||152||
48477570|NCT03693430|101505887|FG000|Safety Analysis Set (SAS)|Overall Study||152||
48477571|NCT03693430|101505888|FG001|Safety Analysis Set (SAS)|Overall Study||152||
48477572|NCT03693430|101505887|FG000|COMPLETED|Overall Study||148||
48477573|NCT03693430|101505888|FG001|COMPLETED|Overall Study||134||
48477574|NCT03693430|101505887|FG000|NOT COMPLETED|Overall Study||4||
48477575|NCT03693430|101505888|FG001|NOT COMPLETED|Overall Study||18||
48477576|NCT00150462|101505889|FG000|STARTED|Overall Study||3||
48477577|NCT00150462|101505890|FG001|STARTED|Overall Study||3||
48477578|NCT00150462|101505891|FG002|STARTED|Overall Study||4||
48477579|NCT00150462|101505892|FG003|STARTED|Overall Study||3||
48477580|NCT00150462|101505893|FG004|STARTED|Overall Study||3||
48477581|NCT00150462|101505894|FG005|STARTED|Overall Study||4||
48477582|NCT00150462|101505895|FG006|STARTED|Overall Study||3||
48477583|NCT00150462|101505896|FG007|STARTED|Overall Study||8||
48477584|NCT00150462|101505897|FG008|STARTED|Overall Study||6||
48477585|NCT00150462|101505898|FG009|STARTED|Overall Study||7||
48477586|NCT00150462|101505899|FG010|STARTED|Overall Study||4||
48477587|NCT00150462|101505889|FG000|COMPLETED|Overall Study||0||
48477588|NCT00150462|101505890|FG001|COMPLETED|Overall Study||0||
48477589|NCT00150462|101505891|FG002|COMPLETED|Overall Study||0||
48477590|NCT00150462|101505892|FG003|COMPLETED|Overall Study||0||
48477591|NCT00150462|101505893|FG004|COMPLETED|Overall Study||0||
48477592|NCT00150462|101505894|FG005|COMPLETED|Overall Study||0||
48477593|NCT00150462|101505895|FG006|COMPLETED|Overall Study||0||
48477594|NCT00150462|101505896|FG007|COMPLETED|Overall Study||0||
48477595|NCT00150462|101505897|FG008|COMPLETED|Overall Study||0||
48477596|NCT00150462|101505898|FG009|COMPLETED|Overall Study||1||
48477597|NCT00150462|101505899|FG010|COMPLETED|Overall Study||1||
48477598|NCT00150462|101505889|FG000|NOT COMPLETED|Overall Study||3||
48477599|NCT00150462|101505890|FG001|NOT COMPLETED|Overall Study||3||
48477600|NCT00150462|101505891|FG002|NOT COMPLETED|Overall Study||4||
48477601|NCT00150462|101505892|FG003|NOT COMPLETED|Overall Study||3||
48477602|NCT00150462|101505893|FG004|NOT COMPLETED|Overall Study||3||
48477603|NCT00150462|101505894|FG005|NOT COMPLETED|Overall Study||4||
48477604|NCT00150462|101505895|FG006|NOT COMPLETED|Overall Study||3||
48477605|NCT00150462|101505896|FG007|NOT COMPLETED|Overall Study||8||
48477606|NCT00150462|101505897|FG008|NOT COMPLETED|Overall Study||6||
48477607|NCT00150462|101505898|FG009|NOT COMPLETED|Overall Study||6||
48477608|NCT00150462|101505899|FG010|NOT COMPLETED|Overall Study||3||
48477609|NCT02421952|101505900|FG000|STARTED|Overall Study||208||
48666322|NCT03801993|101967554|FG000|COMPLETED|Overall Study||254|Fully completed at least one ePRO at all Follow-up Weeks|
48194110|NCT00868231|100797089|FG005|STARTED|Treatment Period 2||5||
48477610|NCT02421952|101505900|FG000|Excluded From PACU and Post-Analysis|Overall Study||16|Reasons itemized below|
48194111|NCT00868231|100797084|FG000|COMPLETED|Treatment Period 2||4||
48477611|NCT02421952|101505900|FG000|Included in PACU Analysis|Overall Study||192||
48477612|NCT02421952|101505900|FG000|COMPLETED|Overall Study||99|Diary returned|
48477613|NCT02421952|101505900|FG000|NOT COMPLETED|Overall Study||109||
48477614|NCT01076452|101505901|FG000|STARTED|Overall Study||147||
48477615|NCT01076452|101505902|FG001|STARTED|Overall Study||152||
48477616|NCT01076452|101505901|FG000|COMPLETED|Overall Study||123||
48477617|NCT01076452|101505902|FG001|COMPLETED|Overall Study||138||
48477618|NCT01076452|101505901|FG000|NOT COMPLETED|Overall Study||24||
48477619|NCT01076452|101505902|FG001|NOT COMPLETED|Overall Study||14||
48477620|NCT02202850|101505903|FG000|STARTED|Overall Study||70||
48477621|NCT02202850|101505904|FG001|STARTED|Overall Study||14||
48477622|NCT02202850|101505903|FG000|COMPLETED|Overall Study||46||
48477623|NCT02202850|101505904|FG001|COMPLETED|Overall Study||8||
48477624|NCT02202850|101505903|FG000|NOT COMPLETED|Overall Study||24||
48477625|NCT02202850|101505904|FG001|NOT COMPLETED|Overall Study||6||
48477626|NCT01697696|101505905|FG000|STARTED|Overall Study||254||
48477627|NCT01697696|101505906|FG001|STARTED|Overall Study||257||
48477628|NCT01697696|101505905|FG000|Safety Set|Overall Study||251||
48477629|NCT01697696|101505906|FG001|Safety Set|Overall Study||256||
48477630|NCT01697696|101505905|FG000|Full Analysis Set (FAS)|Overall Study||251||
48477631|NCT01697696|101505906|FG001|Full Analysis Set (FAS)|Overall Study||255||
48477632|NCT01697696|101505905|FG000|COMPLETED|Overall Study||207||
48477633|NCT01697696|101505906|FG001|COMPLETED|Overall Study||210||
48477634|NCT01697696|101505905|FG000|NOT COMPLETED|Overall Study||47||
48477635|NCT01697696|101505906|FG001|NOT COMPLETED|Overall Study||47||
48477636|NCT05350137|101505907|FG000|STARTED|Overall Study||26||
48477637|NCT05350137|101505908|FG001|STARTED|Overall Study||26||
48477638|NCT05350137|101505907|FG000|COMPLETED|Overall Study||23||
48477639|NCT05350137|101505908|FG001|COMPLETED|Overall Study||18||
48477640|NCT05350137|101505907|FG000|NOT COMPLETED|Overall Study||3||
48477641|NCT05350137|101505908|FG001|NOT COMPLETED|Overall Study||8||
48477642|NCT03203447|101505909|FG000|STARTED|Overall Study||162||
48477643|NCT03203447|101505910|FG001|STARTED|Overall Study||163||
48477644|NCT03203447|101505909|FG000|COMPLETED|Overall Study||0||
48477645|NCT03203447|101505910|FG001|COMPLETED|Overall Study||0||
48477646|NCT03203447|101505909|FG000|NOT COMPLETED|Overall Study||162||
48477647|NCT03203447|101505910|FG001|NOT COMPLETED|Overall Study||163||
48477648|NCT00854308|101505911|FG000|STARTED|Overall Study||69||
48477649|NCT00854308|101505912|FG001|STARTED|Overall Study||68||
48477650|NCT00854308|101505911|FG000|Received Study Drug|Overall Study||69||
48477651|NCT00854308|101505912|FG001|Received Study Drug|Overall Study||67||
48477652|NCT00854308|101505911|FG000|COMPLETED|Overall Study||7||
48477653|NCT00854308|101505912|FG001|COMPLETED|Overall Study||1||
48477654|NCT00854308|101505911|FG000|NOT COMPLETED|Overall Study||62||
48477655|NCT00854308|101505912|FG001|NOT COMPLETED|Overall Study||67||
48477656|NCT02079766|101505913|FG000|STARTED|Overall Study||30||
48477657|NCT02079766|101505914|FG001|STARTED|Overall Study||11||
48477658|NCT02079766|101505913|FG000|COMPLETED|Overall Study||28||
48477659|NCT02079766|101505914|FG001|COMPLETED|Overall Study||11||
48477660|NCT02079766|101505913|FG000|NOT COMPLETED|Overall Study||2||
48477661|NCT02079766|101505914|FG001|NOT COMPLETED|Overall Study||0||
48477662|NCT03733925|101505915|FG000|STARTED|Overall Study||100||
48477663|NCT03733925|101505915|FG000|Participants With Psoriatic Arthritis (PsA)|Overall Study||50||
48477664|NCT03733925|101505915|FG000|Participants With Ankylosing Spondylitis (AS)|Overall Study||50||
48477665|NCT03733925|101505915|FG000|COMPLETED|Overall Study||94||
48477666|NCT03733925|101505915|FG000|NOT COMPLETED|Overall Study||6||
48477667|NCT01033565|101505916|FG000|STARTED|Overall Study||1||
48477668|NCT01033565|101505916|FG000|COMPLETED|Overall Study||1||
48477669|NCT01033565|101505916|FG000|NOT COMPLETED|Overall Study||0||
48477670|NCT00440297|101505917|FG000|STARTED|Overall Study||139||
48477671|NCT00440297|101505918|FG001|STARTED|Overall Study||138||
48477672|NCT00440297|101505917|FG000|Vaccination Visit 1|Overall Study||138||
48477673|NCT00440297|101505918|FG001|Vaccination Visit 1|Overall Study||138||
48477674|NCT00440297|101505917|FG000|Vaccination Visit 2|Overall Study||136||
48477675|NCT00440297|101505918|FG001|Vaccination Visit 2|Overall Study||134||
48477676|NCT00440297|101505917|FG000|Vaccination Visit 3|Overall Study||124||
48477677|NCT00440297|101505918|FG001|Vaccination Visit 3|Overall Study||125||
48477678|NCT00440297|101505917|FG000|Vaccination Visit 4|Overall Study||116||
48477679|NCT00440297|101505918|FG001|Vaccination Visit 4|Overall Study||122||
48477680|NCT00440297|101505917|FG000|COMPLETED|Overall Study||116||
48477681|NCT00440297|101505918|FG001|COMPLETED|Overall Study||120||
48477682|NCT00440297|101505917|FG000|NOT COMPLETED|Overall Study||23||
48477683|NCT00440297|101505918|FG001|NOT COMPLETED|Overall Study||18||
48477684|NCT00686959|101505919|FG000|STARTED|Overall Study||301||
48477685|NCT00686959|101505920|FG001|STARTED|Overall Study||297||
48477686|NCT00686959|101505919|FG000|Received at Least One Dose of Study Drug|Overall Study||283||
48477687|NCT00686959|101505920|FG001|Received at Least One Dose of Study Drug|Overall Study||272||
48477688|NCT00686959|101505919|FG000|Entered Consolidation Phase|Overall Study||229||
48477689|NCT00686959|101505920|FG001|Entered Consolidation Phase|Overall Study||202||
48477690|NCT00686959|101505919|FG000|COMPLETED|Overall Study||177||
48194112|NCT00868231|100797085|FG001|COMPLETED|Treatment Period 2||5||
48194113|NCT00868231|100797086|FG002|COMPLETED|Treatment Period 2||5||
48477691|NCT00686959|101505920|FG001|COMPLETED|Overall Study||180||
48477692|NCT00686959|101505919|FG000|NOT COMPLETED|Overall Study||124||
48194114|NCT00868231|100797087|FG003|COMPLETED|Treatment Period 2||5||
48194115|NCT00868231|100797088|FG004|COMPLETED|Treatment Period 2||4||
48194116|NCT00868231|100797089|FG005|COMPLETED|Treatment Period 2||5||
48194117|NCT00868231|100797084|FG000|NOT COMPLETED|Treatment Period 2||1||
48194118|NCT00868231|100797085|FG001|NOT COMPLETED|Treatment Period 2||0||
48194119|NCT00868231|100797086|FG002|NOT COMPLETED|Treatment Period 2||0||
48194120|NCT00868231|100797087|FG003|NOT COMPLETED|Treatment Period 2||0||
48477693|NCT00686959|101505920|FG001|NOT COMPLETED|Overall Study||117||
48477694|NCT01709474|101505921|FG000|STARTED|Overall Study||3||
48477695|NCT01709474|101505922|FG001|STARTED|Overall Study||4||
48477696|NCT01709474|101505921|FG000|COMPLETED|Overall Study||3||
48194121|NCT00868231|100797088|FG004|NOT COMPLETED|Treatment Period 2||0||
48477697|NCT01709474|101505922|FG001|COMPLETED|Overall Study||4||
48477698|NCT01709474|101505921|FG000|NOT COMPLETED|Overall Study||0||
48477699|NCT01709474|101505922|FG001|NOT COMPLETED|Overall Study||0||
48477700|NCT03151057|101505923|FG000|STARTED|Overall Study||9||
48477701|NCT03151057|101505924|FG001|STARTED|Overall Study||7||
48477702|NCT03151057|101505923|FG000|COMPLETED|Overall Study||9||
48477703|NCT03151057|101505924|FG001|COMPLETED|Overall Study||7||
48477704|NCT03151057|101505923|FG000|NOT COMPLETED|Overall Study||0||
48477705|NCT03151057|101505924|FG001|NOT COMPLETED|Overall Study||0||
48477706|NCT00998374|101505925|FG000|STARTED|Overall Study||39||
48477707|NCT00998374|101505926|FG001|STARTED|Overall Study||23||
48477708|NCT00998374|101505925|FG000|COMPLETED|Overall Study||27||
48477709|NCT00998374|101505926|FG001|COMPLETED|Overall Study||12||
48477710|NCT00998374|101505925|FG000|NOT COMPLETED|Overall Study||12||
48477711|NCT00998374|101505926|FG001|NOT COMPLETED|Overall Study||11||
48477712|NCT02719522|101505927|FG000|STARTED|Overall Study||204||
48477713|NCT02719522|101505927|FG000|COMPLETED|Overall Study||193||
48477714|NCT02719522|101505927|FG000|NOT COMPLETED|Overall Study||11||
48477715|NCT01307098|101505928|FG000|STARTED|Overall Study||3||
48477716|NCT01307098|101505929|FG001|STARTED|Overall Study||3||
48477717|NCT01307098|101505930|FG002|STARTED|Overall Study||3||
48477718|NCT01307098|101505928|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
48477719|NCT01307098|101505929|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3||
48477720|NCT01307098|101505930|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
48477721|NCT01307098|101505928|FG000|COMPLETED|Overall Study||3||
48477722|NCT01307098|101505929|FG001|COMPLETED|Overall Study||3||
48477723|NCT01307098|101505930|FG002|COMPLETED|Overall Study||3||
48477724|NCT01307098|101505928|FG000|NOT COMPLETED|Overall Study||0||
48477725|NCT01307098|101505929|FG001|NOT COMPLETED|Overall Study||0||
48477726|NCT01307098|101505930|FG002|NOT COMPLETED|Overall Study||0||
48477727|NCT02781727|101505931|FG000|STARTED|Pre-dosing Period||106||
48477728|NCT02781727|101505932|FG001|STARTED|Pre-dosing Period||56||
48477729|NCT02781727|101505931|FG000|COMPLETED|Pre-dosing Period||105||
48477730|NCT02781727|101505932|FG001|COMPLETED|Pre-dosing Period||56||
48477731|NCT02781727|101505931|FG000|NOT COMPLETED|Pre-dosing Period||1||
48477732|NCT02781727|101505932|FG001|NOT COMPLETED|Pre-dosing Period||0||
48477733|NCT02781727|101505931|FG000|STARTED|Treatment Period||105||
48477734|NCT02781727|101505932|FG001|STARTED|Treatment Period||56||
48477735|NCT02781727|101505931|FG000|COMPLETED|Treatment Period||104||
48477736|NCT02781727|101505932|FG001|COMPLETED|Treatment Period||55||
48477737|NCT02781727|101505931|FG000|NOT COMPLETED|Treatment Period||1||
48477738|NCT02781727|101505932|FG001|NOT COMPLETED|Treatment Period||1||
48477739|NCT02637232|101505933|FG000|STARTED|Overall Study||301||
48477740|NCT02637232|101505933|FG000|COMPLETED|Overall Study||246||
48477741|NCT02637232|101505933|FG000|NOT COMPLETED|Overall Study||55||
48477742|NCT02441309|101505934|FG000|STARTED|Overall Study||3||
48477743|NCT02441309|101505935|FG001|STARTED|Overall Study||2||
48477744|NCT02441309|101505936|FG002|STARTED|Overall Study||3||
48477745|NCT02441309|101505934|FG000|Received Allocated Intervention|Overall Study||1||
48477746|NCT02441309|101505935|FG001|Received Allocated Intervention|Overall Study||2||
48477747|NCT02441309|101505936|FG002|Received Allocated Intervention|Overall Study||3||
48477748|NCT02441309|101505934|FG000|COMPLETED|Overall Study||0||
48477749|NCT02441309|101505935|FG001|COMPLETED|Overall Study||0||
48477750|NCT02441309|101505936|FG002|COMPLETED|Overall Study||0||
48477751|NCT02441309|101505934|FG000|NOT COMPLETED|Overall Study||3||
48477752|NCT02441309|101505935|FG001|NOT COMPLETED|Overall Study||2||
48477753|NCT02441309|101505936|FG002|NOT COMPLETED|Overall Study||3||
48477754|NCT03583606|101505937|FG000|STARTED|Overall Study||22||
48477755|NCT03583606|101505938|FG001|STARTED|Overall Study||20||
48666323|NCT03801993|101967554|FG000|NOT COMPLETED|Overall Study||148||
48194122|NCT00868231|100797089|FG005|NOT COMPLETED|Treatment Period 2||0||
48194123|NCT00868231|100797084|FG000|STARTED|Treatment Period 3||4||
48194124|NCT00868231|100797085|FG001|STARTED|Treatment Period 3||5||
48194125|NCT00868231|100797086|FG002|STARTED|Treatment Period 3||5||
48477756|NCT03583606|101505939|FG002|STARTED|Overall Study||19||
48477757|NCT03583606|101505937|FG000|COMPLETED|Overall Study||21||
48477758|NCT03583606|101505938|FG001|COMPLETED|Overall Study||19||
48477759|NCT03583606|101505939|FG002|COMPLETED|Overall Study||19||
48477760|NCT03583606|101505937|FG000|NOT COMPLETED|Overall Study||1||
48477761|NCT03583606|101505938|FG001|NOT COMPLETED|Overall Study||1||
48477762|NCT03583606|101505939|FG002|NOT COMPLETED|Overall Study||0||
48477763|NCT01682083|101505940|FG000|STARTED|Overall Study||438||
48477764|NCT01682083|101505941|FG001|STARTED|Overall Study||432||
48477765|NCT01682083|101505940|FG000|COMPLETED|Overall Study||331||
48477766|NCT01682083|101505941|FG001|COMPLETED|Overall Study||277||
48194126|NCT00868231|100797087|FG003|STARTED|Treatment Period 3||5||
48194127|NCT00868231|100797088|FG004|STARTED|Treatment Period 3||4||
48194128|NCT00868231|100797089|FG005|STARTED|Treatment Period 3||5||
48477767|NCT01682083|101505940|FG000|NOT COMPLETED|Overall Study||107||
48477768|NCT01682083|101505941|FG001|NOT COMPLETED|Overall Study||155||
48477769|NCT02732210|101505942|FG000|STARTED|Overall Study||303||
48477770|NCT02732210|101505943|FG001|STARTED|Overall Study||632||
48477771|NCT02732210|101505942|FG000|COMPLETED|Overall Study||218||
48477772|NCT02732210|101505943|FG001|COMPLETED|Overall Study||338||
48194129|NCT00868231|100797084|FG000|COMPLETED|Treatment Period 3||4||
48194130|NCT00868231|100797085|FG001|COMPLETED|Treatment Period 3||5||
48477773|NCT02732210|101505942|FG000|NOT COMPLETED|Overall Study||85||
48477774|NCT02732210|101505943|FG001|NOT COMPLETED|Overall Study||294||
48477775|NCT01807637|101505944|FG000|STARTED|Baseline||4||
48477776|NCT01807637|101505945|FG001|STARTED|Baseline||2||
48477777|NCT01807637|101505944|FG000|COMPLETED|Baseline||4||
48477778|NCT01807637|101505945|FG001|COMPLETED|Baseline||2||
48477779|NCT01807637|101505944|FG000|NOT COMPLETED|Baseline||0||
48477780|NCT01807637|101505945|FG001|NOT COMPLETED|Baseline||0||
48477781|NCT01807637|101505944|FG000|STARTED|One Week||4||
48477782|NCT01807637|101505945|FG001|STARTED|One Week||2||
48477783|NCT01807637|101505944|FG000|COMPLETED|One Week||4||
48477784|NCT01807637|101505945|FG001|COMPLETED|One Week||2||
48477785|NCT01807637|101505944|FG000|NOT COMPLETED|One Week||0||
48477786|NCT01807637|101505945|FG001|NOT COMPLETED|One Week||0||
48477787|NCT01807637|101505944|FG000|STARTED|One Month||4||
48477788|NCT01807637|101505945|FG001|STARTED|One Month||2||
48477789|NCT01807637|101505944|FG000|COMPLETED|One Month||4||
48477790|NCT01807637|101505945|FG001|COMPLETED|One Month||2||
48477791|NCT01807637|101505944|FG000|NOT COMPLETED|One Month||0||
48477792|NCT01807637|101505945|FG001|NOT COMPLETED|One Month||0||
48477793|NCT02731157|101505946|FG000|STARTED|First Standard RCE||4||
48477794|NCT02731157|101505946|FG000|COMPLETED|First Standard RCE||4||
48477795|NCT02731157|101505946|FG000|NOT COMPLETED|First Standard RCE||0||
48477796|NCT02731157|101505946|FG000|STARTED|First Rejuvenated RCE||4||
48477797|NCT02731157|101505946|FG000|COMPLETED|First Rejuvenated RCE||3||
48477798|NCT02731157|101505946|FG000|NOT COMPLETED|First Rejuvenated RCE||1||
48477799|NCT02731157|101505946|FG000|STARTED|Second Rejuvenated RCE||3||
48477800|NCT02731157|101505946|FG000|COMPLETED|Second Rejuvenated RCE||3||
48477801|NCT02731157|101505946|FG000|NOT COMPLETED|Second Rejuvenated RCE||0||
48477802|NCT02731157|101505946|FG000|STARTED|Third Rejuvenated RCE||3||
48477803|NCT02731157|101505946|FG000|COMPLETED|Third Rejuvenated RCE||3||
48477804|NCT02731157|101505946|FG000|NOT COMPLETED|Third Rejuvenated RCE||0||
48477805|NCT02731157|101505946|FG000|STARTED|Second Standard RCE||3||
48666324|NCT01230060|101967555|FG000|STARTED|Overall Study||122||
48477806|NCT02731157|101505946|FG000|COMPLETED|Second Standard RCE||3||
48477807|NCT02731157|101505946|FG000|NOT COMPLETED|Second Standard RCE||0||
48477808|NCT02731157|101505946|FG000|STARTED|Third Standard RCE||3||
48477809|NCT02731157|101505946|FG000|COMPLETED|Third Standard RCE||3||
48477810|NCT02731157|101505946|FG000|NOT COMPLETED|Third Standard RCE||0||
48477811|NCT03629249|101505947|FG000|STARTED|Overall Study||201|All patients who were randomized|
48477812|NCT03629249|101505948|FG001|STARTED|Overall Study||201|All patients who were randomized|
48477813|NCT03629249|101505949|FG002|STARTED|Overall Study||202|All patients who were randomized|
48477814|NCT03629249|101505947|FG000|Full Analysis Set (FAS)|Overall Study||201|All randomized patients who received at least one dose of study medication|
48477815|NCT03629249|101505948|FG001|Full Analysis Set (FAS)|Overall Study||200|All randomized patients who received at least one dose of study medication|
48477816|NCT03629249|101505949|FG002|Full Analysis Set (FAS)|Overall Study||201|All randomized patients who received at least one dose of study medication|
48477817|NCT03629249|101505947|FG000|Safety Set (SAF)|Overall Study||201|all patients who received at least one dose of double-blind study drug|
48477818|NCT03629249|101505948|FG001|Safety Set (SAF)|Overall Study||200|all patients who received at least one dose of double-blind study drug|
48477819|NCT03629249|101505949|FG002|Safety Set (SAF)|Overall Study||201|all patients who received at least one dose of double-blind study drug|
48477820|NCT03629249|101505947|FG000|COMPLETED|Overall Study||0||
48477821|NCT03629249|101505948|FG001|COMPLETED|Overall Study||0||
48477822|NCT03629249|101505949|FG002|COMPLETED|Overall Study||0||
48477823|NCT03629249|101505947|FG000|NOT COMPLETED|Overall Study||201||
48477824|NCT03629249|101505948|FG001|NOT COMPLETED|Overall Study||201||
48477825|NCT03629249|101505949|FG002|NOT COMPLETED|Overall Study||202||
48477826|NCT00056160|101505950|FG000|STARTED|Up to Unblinding (07 Jun 2005)||177||
48477827|NCT00056160|101505951|FG001|STARTED|Up to Unblinding (07 Jun 2005)||176||
48477828|NCT00056160|101505950|FG000|COMPLETED|Up to Unblinding (07 Jun 2005)||64||
48477829|NCT00056160|101505951|FG001|COMPLETED|Up to Unblinding (07 Jun 2005)||13||
48477830|NCT00056160|101505950|FG000|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||113||
48477831|NCT00056160|101505951|FG001|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||163||
48477832|NCT00056160|101505950|FG000|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||177||
48477833|NCT00056160|101505951|FG001|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||0||
48477834|NCT00056160|101505950|FG000|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||6||
48477835|NCT00056160|101505951|FG001|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0||
48477836|NCT00056160|101505950|FG000|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||171||
48477837|NCT00056160|101505951|FG001|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0||
48477838|NCT00056160|101505950|FG000|STARTED|Final Follow-up||6||
48666325|NCT01230060|101967555|FG000|COMPLETED|Overall Study||121||
48477839|NCT00056160|101505951|FG001|STARTED|Final Follow-up||0||
48477840|NCT00056160|101505950|FG000|COMPLETED|Final Follow-up||0||
48477841|NCT00056160|101505951|FG001|COMPLETED|Final Follow-up||0||
48477842|NCT00056160|101505950|FG000|NOT COMPLETED|Final Follow-up||6||
48666326|NCT01230060|101967555|FG000|NOT COMPLETED|Overall Study||1||
48194131|NCT00868231|100797086|FG002|COMPLETED|Treatment Period 3||4||
48194132|NCT00868231|100797087|FG003|COMPLETED|Treatment Period 3||5||
48194133|NCT00868231|100797088|FG004|COMPLETED|Treatment Period 3||4||
48194134|NCT00868231|100797089|FG005|COMPLETED|Treatment Period 3||5||
48194135|NCT00868231|100797084|FG000|NOT COMPLETED|Treatment Period 3||0||
48194136|NCT00868231|100797085|FG001|NOT COMPLETED|Treatment Period 3||0||
48194137|NCT00868231|100797086|FG002|NOT COMPLETED|Treatment Period 3||1||
48477843|NCT00056160|101505951|FG001|NOT COMPLETED|Final Follow-up||0||
48477844|NCT00855738|101505952|FG000|STARTED|Overall Study||111||
48477845|NCT00855738|101505952|FG000|At Least 1 Dose and 1 Endpoint|Overall Study||108||
48477846|NCT00855738|101505952|FG000|COMPLETED|Overall Study||106||
48477847|NCT00855738|101505952|FG000|NOT COMPLETED|Overall Study||5||
48477848|NCT04089982|101505953|FG000|STARTED|Overall Study||6||
48477849|NCT04089982|101505954|FG001|STARTED|Overall Study||5||
48194138|NCT00868231|100797087|FG003|NOT COMPLETED|Treatment Period 3||0||
48194139|NCT00868231|100797088|FG004|NOT COMPLETED|Treatment Period 3||0||
48194140|NCT00868231|100797089|FG005|NOT COMPLETED|Treatment Period 3||0||
48194141|NCT03643965|100797090|FG000|STARTED|Part A||182||
48194142|NCT03643965|100797091|FG001|STARTED|Part A||182||
48194143|NCT03643965|100797090|FG000|COMPLETED|Part A||175||
48194144|NCT03643965|100797091|FG001|COMPLETED|Part A||174||
48194145|NCT03643965|100797090|FG000|NOT COMPLETED|Part A||7||
48194146|NCT03643965|100797091|FG001|NOT COMPLETED|Part A||8||
48194147|NCT03643965|100797090|FG000|STARTED|Part B||175||
48194148|NCT03643965|100797091|FG001|STARTED|Part B||174||
48194149|NCT03643965|100797090|FG000|COMPLETED|Part B||161||
48194150|NCT03643965|100797091|FG001|COMPLETED|Part B||165||
48194151|NCT03643965|100797090|FG000|NOT COMPLETED|Part B||14||
48194152|NCT03643965|100797091|FG001|NOT COMPLETED|Part B||9||
48477850|NCT04089982|101505953|FG000|COMPLETED|Overall Study||6||
48477851|NCT04089982|101505954|FG001|COMPLETED|Overall Study||5||
48477852|NCT04089982|101505953|FG000|NOT COMPLETED|Overall Study||0||
48477853|NCT04089982|101505954|FG001|NOT COMPLETED|Overall Study||0||
48477854|NCT04322500|101505955|FG000|STARTED|Overall Study||13||
48477855|NCT04322500|101505956|FG001|STARTED|Overall Study||13||
48477856|NCT04322500|101505955|FG000|COMPLETED|Overall Study||13||
48477857|NCT04322500|101505956|FG001|COMPLETED|Overall Study||13||
48477858|NCT04322500|101505955|FG000|NOT COMPLETED|Overall Study||0||
48477859|NCT04322500|101505956|FG001|NOT COMPLETED|Overall Study||0||
48477860|NCT03100903|101505957|FG000|STARTED|Overall Study||12||
48477861|NCT03100903|101505958|FG001|STARTED|Overall Study||12||
48477862|NCT03100903|101505959|FG002|STARTED|Overall Study||12||
48477863|NCT03100903|101505957|FG000|COMPLETED|Overall Study||12||
48477864|NCT03100903|101505958|FG001|COMPLETED|Overall Study||12||
48477865|NCT03100903|101505959|FG002|COMPLETED|Overall Study||11||
48477866|NCT03100903|101505957|FG000|NOT COMPLETED|Overall Study||0||
48477867|NCT03100903|101505958|FG001|NOT COMPLETED|Overall Study||0||
48477868|NCT03100903|101505959|FG002|NOT COMPLETED|Overall Study||1||
48477869|NCT00280904|101505960|FG000|STARTED|Overall Study||433||
48477870|NCT00280904|101505960|FG000|COMPLETED|Overall Study||433||
48194153|NCT02596906|100797092|FG000|STARTED|Overall Study||12|The units assigned is indeed the participants|
48194154|NCT02596906|100797093|FG001|STARTED|Overall Study||10|The units assigned is indeed the participants|
48194155|NCT02596906|100797092|FG000|COMPLETED|Overall Study||8|3-month follow-up|
48194156|NCT02596906|100797093|FG001|COMPLETED|Overall Study||7|3-month follow-up|
48194157|NCT02596906|100797092|FG000|NOT COMPLETED|Overall Study||4||
48194158|NCT02596906|100797093|FG001|NOT COMPLETED|Overall Study||3||
48194159|NCT01684046|100797094|FG000|STARTED|Period 1, First 30 Days||97||
48194160|NCT01684046|100797095|FG001|STARTED|Period 1, First 30 Days||95||
48194161|NCT01684046|100797094|FG000|COMPLETED|Period 1, First 30 Days||97||
48194162|NCT01684046|100797095|FG001|COMPLETED|Period 1, First 30 Days||93||
48194163|NCT01684046|100797094|FG000|NOT COMPLETED|Period 1, First 30 Days||0||
48194164|NCT01684046|100797095|FG001|NOT COMPLETED|Period 1, First 30 Days||2||
48194165|NCT01684046|100797094|FG000|STARTED|Period 2, Second 30 Days||97||
48194166|NCT01684046|100797095|FG001|STARTED|Period 2, Second 30 Days||93||
48194167|NCT01684046|100797094|FG000|COMPLETED|Period 2, Second 30 Days||97||
48194168|NCT01684046|100797095|FG001|COMPLETED|Period 2, Second 30 Days||93||
48194169|NCT01684046|100797094|FG000|NOT COMPLETED|Period 2, Second 30 Days||0||
48194170|NCT01684046|100797095|FG001|NOT COMPLETED|Period 2, Second 30 Days||0||
48194171|NCT05516342|100797096|FG000|STARTED|Baseline||54||5
48194172|NCT05516342|100797097|FG001|STARTED|Baseline||41||4
48194173|NCT05516342|100797096|FG000|COMPLETED|Baseline||54||5
48477871|NCT00280904|101505960|FG000|NOT COMPLETED|Overall Study||0||
48477872|NCT01973348|101505961|FG000|STARTED|Overall Study||27||
48477873|NCT01973348|101505962|FG001|STARTED|Overall Study||18||
48477874|NCT01973348|101505963|FG002|STARTED|Overall Study||0||
48477875|NCT01973348|101505964|FG003|STARTED|Overall Study||0||
48477876|NCT01973348|101505961|FG000|COMPLETED|Overall Study||19||
48477877|NCT01973348|101505962|FG001|COMPLETED|Overall Study||15||
48477878|NCT01973348|101505963|FG002|COMPLETED|Overall Study||0||
48477879|NCT01973348|101505964|FG003|COMPLETED|Overall Study||0||
48477880|NCT01973348|101505961|FG000|NOT COMPLETED|Overall Study||8||
48477881|NCT01973348|101505962|FG001|NOT COMPLETED|Overall Study||3||
48477882|NCT01973348|101505963|FG002|NOT COMPLETED|Overall Study||0||
48477883|NCT01973348|101505964|FG003|NOT COMPLETED|Overall Study||0||
48477884|NCT04510285|101505965|FG000|STARTED|Overall Study||1||
48477885|NCT04510285|101505965|FG000|COMPLETED|Overall Study||0||
48477886|NCT04510285|101505965|FG000|NOT COMPLETED|Overall Study||1||
48477887|NCT02682602|101505966|FG000|STARTED|Pre-operative Diseased & Normal Hips||11||
48477888|NCT02682602|101505967|FG001|STARTED|Pre-operative Diseased & Normal Hips||10||
48477889|NCT02682602|101505966|FG000|COMPLETED|Pre-operative Diseased & Normal Hips||10||
48477890|NCT02682602|101505967|FG001|COMPLETED|Pre-operative Diseased & Normal Hips||10||
48477891|NCT02682602|101505966|FG000|NOT COMPLETED|Pre-operative Diseased & Normal Hips||1||
48477892|NCT02682602|101505967|FG001|NOT COMPLETED|Pre-operative Diseased & Normal Hips||0||
48477893|NCT02682602|101505966|FG000|STARTED|Post-operative Fluoroscopy for Implanted||10||
48477894|NCT02682602|101505967|FG001|STARTED|Post-operative Fluoroscopy for Implanted||0||
48666327|NCT04849897|101967556|FG000|STARTED|Overall Study||24||
48194174|NCT05516342|100797097|FG001|COMPLETED|Baseline||41||4
48194175|NCT05516342|100797096|FG000|NOT COMPLETED|Baseline||0||0
48194176|NCT05516342|100797097|FG001|NOT COMPLETED|Baseline||0||0
48194177|NCT05516342|100797096|FG000|STARTED|Treatment||54||5
48194178|NCT05516342|100797097|FG001|STARTED|Treatment||41||4
48194179|NCT05516342|100797096|FG000|COMPLETED|Treatment||51||5
48194180|NCT05516342|100797097|FG001|COMPLETED|Treatment||37||4
48194181|NCT05516342|100797096|FG000|NOT COMPLETED|Treatment||3||0
48194182|NCT05516342|100797097|FG001|NOT COMPLETED|Treatment||4||0
48194183|NCT05516342|100797096|FG000|STARTED|Post Treatment||51||5
48194184|NCT05516342|100797097|FG001|STARTED|Post Treatment||37||4
48194185|NCT05516342|100797096|FG000|COMPLETED|Post Treatment||47||5
48194186|NCT05516342|100797097|FG001|COMPLETED|Post Treatment||35||4
48194187|NCT05516342|100797096|FG000|NOT COMPLETED|Post Treatment||4||0
48194188|NCT05516342|100797097|FG001|NOT COMPLETED|Post Treatment||2||0
48194189|NCT03861728|100797098|FG000|STARTED|Overall Study||6||
48194190|NCT03861728|100797099|FG001|STARTED|Overall Study||5||
48194191|NCT03861728|100797098|FG000|COMPLETED|Overall Study||6||
48194192|NCT03861728|100797099|FG001|COMPLETED|Overall Study||5||
48194193|NCT03861728|100797098|FG000|NOT COMPLETED|Overall Study||0||
48194194|NCT03861728|100797099|FG001|NOT COMPLETED|Overall Study||0||
48194195|NCT02040844|100797100|FG000|STARTED|Overall Study||138||
48194196|NCT02040844|100797101|FG001|STARTED|Overall Study||148||
48194197|NCT02040844|100797102|FG002|STARTED|Overall Study||144||
48194198|NCT02040844|100797100|FG000|COMPLETED|Overall Study||88||
48194199|NCT02040844|100797101|FG001|COMPLETED|Overall Study||109||
48194200|NCT02040844|100797102|FG002|COMPLETED|Overall Study||97||
48194201|NCT02040844|100797100|FG000|NOT COMPLETED|Overall Study||50||
48194202|NCT02040844|100797101|FG001|NOT COMPLETED|Overall Study||39||
48194203|NCT02040844|100797102|FG002|NOT COMPLETED|Overall Study||47||
48194204|NCT02374957|100797103|FG000|STARTED|Overall Study||11||
48194205|NCT02374957|100797104|FG001|STARTED|Overall Study||9||
48194206|NCT02374957|100797103|FG000|COMPLETED|Overall Study||10||
48194207|NCT02374957|100797104|FG001|COMPLETED|Overall Study||9||
48194208|NCT02374957|100797103|FG000|NOT COMPLETED|Overall Study||1||
48477895|NCT02682602|101505966|FG000|COMPLETED|Post-operative Fluoroscopy for Implanted||7||
48477896|NCT02682602|101505967|FG001|COMPLETED|Post-operative Fluoroscopy for Implanted||0||
48477897|NCT02682602|101505966|FG000|NOT COMPLETED|Post-operative Fluoroscopy for Implanted||3||
48477898|NCT02682602|101505967|FG001|NOT COMPLETED|Post-operative Fluoroscopy for Implanted||0||
48477899|NCT01771965|101505968|FG000|STARTED|Overall Study||10||
48477900|NCT01771965|101505969|FG001|STARTED|Overall Study||9||
48477901|NCT01771965|101505968|FG000|COMPLETED|Overall Study||7||
48477902|NCT01771965|101505969|FG001|COMPLETED|Overall Study||4||
48477903|NCT01771965|101505968|FG000|NOT COMPLETED|Overall Study||3||
48477904|NCT01771965|101505969|FG001|NOT COMPLETED|Overall Study||5||
48477905|NCT03205553|101505970|FG000|STARTED|Overall Study||2||
48477906|NCT03205553|101505971|FG001|STARTED|Overall Study||1||
48477907|NCT03205553|101505970|FG000|COMPLETED|Overall Study||2||
48477908|NCT03205553|101505971|FG001|COMPLETED|Overall Study||1||
48477909|NCT03205553|101505970|FG000|NOT COMPLETED|Overall Study||0||
48477910|NCT03205553|101505971|FG001|NOT COMPLETED|Overall Study||0||
48477911|NCT03555305|101508977|FG000|STARTED|Period 1||29||
48477912|NCT03555305|101508978|FG001|STARTED|Period 1||29||
48477913|NCT03555305|101508977|FG000|Received at Least 1 Dose of Study Drug|Period 1||29||
48477914|NCT03555305|101508978|FG001|Received at Least 1 Dose of Study Drug|Period 1||29||
48477915|NCT03555305|101508977|FG000|COMPLETED|Period 1||29||
48477916|NCT03555305|101508978|FG001|COMPLETED|Period 1||27||
48477917|NCT03555305|101508977|FG000|NOT COMPLETED|Period 1||0||
48477918|NCT03555305|101508978|FG001|NOT COMPLETED|Period 1||2||
48477919|NCT03555305|101508977|FG000|STARTED|Period 2||29||
48477920|NCT03555305|101508978|FG001|STARTED|Period 2||27||
48477921|NCT03555305|101508977|FG000|COMPLETED|Period 2||29||
48477922|NCT03555305|101508978|FG001|COMPLETED|Period 2||27||
48477923|NCT03555305|101508977|FG000|NOT COMPLETED|Period 2||0||
48477924|NCT03555305|101508978|FG001|NOT COMPLETED|Period 2||0||
48477925|NCT03252353|101508979|FG000|STARTED|Overall Study||28||
48477926|NCT03252353|101508980|FG001|STARTED|Overall Study||28||
48477927|NCT03252353|101508979|FG000|COMPLETED|Overall Study||28||
48477928|NCT03252353|101508980|FG001|COMPLETED|Overall Study||28||
48477929|NCT03252353|101508979|FG000|NOT COMPLETED|Overall Study||0||
48477930|NCT03252353|101508980|FG001|NOT COMPLETED|Overall Study||0||
48477931|NCT03618147|101508981|FG000|STARTED|Overall Study||314||
48477932|NCT03618147|101508981|FG000|COMPLETED|Overall Study||314||
48477933|NCT03618147|101508981|FG000|NOT COMPLETED|Overall Study||0||
48477934|NCT01346397|101508982|FG000|STARTED|Overall Study||85||
48477935|NCT01346397|101508983|FG001|STARTED|Overall Study||85||
48477936|NCT01346397|101508982|FG000|COMPLETED|Overall Study||85||
48477937|NCT01346397|101508983|FG001|COMPLETED|Overall Study||85||
48477938|NCT01346397|101508982|FG000|NOT COMPLETED|Overall Study||0||
48477939|NCT01346397|101508983|FG001|NOT COMPLETED|Overall Study||0||
48477940|NCT01389102|101508984|FG000|STARTED|Overall Study||75||
48477941|NCT01389102|101508985|FG001|STARTED|Overall Study||76||
48477942|NCT01389102|101508986|FG002|STARTED|Overall Study||77||
48477943|NCT01389102|101508987|FG003|STARTED|Overall Study||76||
48477944|NCT01389102|101508988|FG004|STARTED|Overall Study||74||
48477945|NCT01389102|101508989|FG005|STARTED|Overall Study||76||
48477946|NCT01389102|101508984|FG000|COMPLETED|Overall Study||57||
48477947|NCT01389102|101508985|FG001|COMPLETED|Overall Study||64||
48477948|NCT01389102|101508986|FG002|COMPLETED|Overall Study||58||
48477949|NCT01389102|101508987|FG003|COMPLETED|Overall Study||69||
48477950|NCT01389102|101508988|FG004|COMPLETED|Overall Study||61||
48477951|NCT01389102|101508989|FG005|COMPLETED|Overall Study||68||
48477952|NCT01389102|101508984|FG000|NOT COMPLETED|Overall Study||18||
48477953|NCT01389102|101508985|FG001|NOT COMPLETED|Overall Study||12||
48477954|NCT01389102|101508986|FG002|NOT COMPLETED|Overall Study||19||
48477955|NCT01389102|101508987|FG003|NOT COMPLETED|Overall Study||7||
48477956|NCT01389102|101508988|FG004|NOT COMPLETED|Overall Study||13||
48477957|NCT01389102|101508989|FG005|NOT COMPLETED|Overall Study||8||
48477958|NCT04657770|101508990|FG000|STARTED|Overall Study||19||
48477959|NCT04657770|101508990|FG000|COMPLETED|Overall Study||15||
48477960|NCT04657770|101508990|FG000|NOT COMPLETED|Overall Study||4||
48477961|NCT00397488|101508991|FG000|STARTED|Overall Study||78||
48477962|NCT00397488|101508991|FG000|COMPLETED|Overall Study||71||
48477963|NCT00397488|101508991|FG000|NOT COMPLETED|Overall Study||7||
48194209|NCT02374957|100797104|FG001|NOT COMPLETED|Overall Study||0||
48477964|NCT02377947|101508992|FG000|STARTED|Overall Study||50||
48477965|NCT02377947|101508992|FG000|COMPLETED|Overall Study||50||
48477966|NCT02377947|101508992|FG000|NOT COMPLETED|Overall Study||0||
48477967|NCT03206177|101508993|FG000|STARTED|Overall Study||24||
48477968|NCT03206177|101508993|FG000|COMPLETED|Overall Study||23||
48477969|NCT03206177|101508993|FG000|NOT COMPLETED|Overall Study||1||
48477970|NCT03952143|101508994|FG000|STARTED|Lead-In Period||628||
48477971|NCT03952143|101508995|FG001|STARTED|Lead-In Period||0||
48477972|NCT03952143|101508996|FG002|STARTED|Lead-In Period||0||
48477973|NCT03952143|101508994|FG000|Participants Who Received at Least One Dose|Lead-In Period||628||
48477974|NCT03952143|101508995|FG001|Participants Who Received at Least One Dose|Lead-In Period||0||
48477975|NCT03952143|101508996|FG002|Participants Who Received at Least One Dose|Lead-In Period||0||
48194210|NCT04269889|100797105|FG000|STARTED|Initial Phase (Day 0 to Month 6)||15||
48477976|NCT03952143|101508994|FG000|COMPLETED|Lead-In Period||595||
48477977|NCT03952143|101508995|FG001|COMPLETED|Lead-In Period||0||
48477978|NCT03952143|101508996|FG002|COMPLETED|Lead-In Period||0||
48477979|NCT03952143|101508994|FG000|NOT COMPLETED|Lead-In Period||33||
48477980|NCT03952143|101508995|FG001|NOT COMPLETED|Lead-In Period||0||
48477981|NCT03952143|101508996|FG002|NOT COMPLETED|Lead-In Period||0||
48477982|NCT03952143|101508994|FG000|STARTED|Treatment Period||0||
48477983|NCT03952143|101508995|FG001|STARTED|Treatment Period||200||
48477984|NCT03952143|101508996|FG002|STARTED|Treatment Period||395||
48477985|NCT03952143|101508994|FG000|Participants Who Received at Least One Dose|Treatment Period||0||
48477986|NCT03952143|101508995|FG001|Participants Who Received at Least One Dose|Treatment Period||200||
48477987|NCT03952143|101508996|FG002|Participants Who Received at Least One Dose|Treatment Period||395||
48477988|NCT03952143|101508994|FG000|COMPLETED|Treatment Period||0||
48477989|NCT03952143|101508995|FG001|COMPLETED|Treatment Period||191||
48477990|NCT03952143|101508996|FG002|COMPLETED|Treatment Period||359||
48477991|NCT03952143|101508994|FG000|NOT COMPLETED|Treatment Period||0||
48477992|NCT03952143|101508995|FG001|NOT COMPLETED|Treatment Period||9||
48194211|NCT04269889|100797105|FG000|COMPLETED|Initial Phase (Day 0 to Month 6)||14||
48194212|NCT04269889|100797105|FG000|NOT COMPLETED|Initial Phase (Day 0 to Month 6)||1||
48194213|NCT04269889|100797105|FG000|STARTED|Extended Phase (6 Months to Year 3)||14||
48194214|NCT04269889|100797105|FG000|COMPLETED|Extended Phase (6 Months to Year 3)||1||
48194215|NCT04269889|100797105|FG000|NOT COMPLETED|Extended Phase (6 Months to Year 3)||13||
48194216|NCT00498186|100797106|FG000|STARTED|Overall Study||295||
48194217|NCT00498186|100797106|FG000|COMPLETED|Overall Study||122||
48194218|NCT00498186|100797106|FG000|NOT COMPLETED|Overall Study||173||
48194219|NCT03425643|100797107|FG000|STARTED|Overall Study||397||
48194220|NCT03425643|100797108|FG001|STARTED|Overall Study||400||
48194221|NCT03425643|100797107|FG000|Treated|Overall Study||396||
48194222|NCT03425643|100797108|FG001|Treated|Overall Study||399||
48194223|NCT03425643|100797107|FG000|COMPLETED|Overall Study||0||
48194224|NCT03425643|100797108|FG001|COMPLETED|Overall Study||0||
48194225|NCT03425643|100797107|FG000|NOT COMPLETED|Overall Study||397||
48194226|NCT03425643|100797108|FG001|NOT COMPLETED|Overall Study||400||
48194227|NCT00507208|100797109|FG000|STARTED|Overall Study||27||
48194228|NCT00507208|100797110|FG001|STARTED|Overall Study||26||
48194229|NCT00507208|100797109|FG000|Received Dynasplint in Crossover|Overall Study||0||
48194230|NCT00507208|100797110|FG001|Received Dynasplint in Crossover|Overall Study||3||
48194231|NCT00507208|100797109|FG000|COMPLETED|Overall Study||27||
48477993|NCT03952143|101508996|FG002|NOT COMPLETED|Treatment Period||36||
48477994|NCT01544127|101508997|FG000|STARTED|Overall Study||33||
48666328|NCT04849897|101967557|FG001|STARTED|Overall Study||12||
48666329|NCT04849897|101967556|FG000|COMPLETED|Overall Study||21||
48666330|NCT04849897|101967557|FG001|COMPLETED|Overall Study||11||
48666331|NCT04849897|101967556|FG000|NOT COMPLETED|Overall Study||3||
48666332|NCT04849897|101967557|FG001|NOT COMPLETED|Overall Study||1||
48666333|NCT00105066|101967558|FG000|STARTED|Overall Study||27||
48666334|NCT00105066|101967559|FG001|STARTED|Overall Study||50||
48666335|NCT00105066|101967558|FG000|COMPLETED|Overall Study||25||
48666336|NCT00105066|101967559|FG001|COMPLETED|Overall Study||45||
48666337|NCT00105066|101967558|FG000|NOT COMPLETED|Overall Study||2||
48666338|NCT00105066|101967559|FG001|NOT COMPLETED|Overall Study||5||
48666339|NCT00652834|101967560|FG000|STARTED|Overall Study||23||
48666340|NCT00652834|101967560|FG000|COMPLETED|Overall Study||18||
48666341|NCT00652834|101967560|FG000|NOT COMPLETED|Overall Study||5||
48666342|NCT03289039|101967561|FG000|STARTED|Overall Study||11||
48666343|NCT03289039|101967562|FG001|STARTED|Overall Study||10||
48194232|NCT00507208|100797110|FG001|COMPLETED|Overall Study||26||
48194233|NCT00507208|100797109|FG000|NOT COMPLETED|Overall Study||0||
48194234|NCT00507208|100797110|FG001|NOT COMPLETED|Overall Study||0||
48194235|NCT01366196|100797111|FG000|STARTED|Overall Study||43||
48194236|NCT01366196|100797112|FG001|STARTED|Overall Study||43||
48194237|NCT01366196|100797111|FG000|COMPLETED|Overall Study||43||
48194238|NCT01366196|100797112|FG001|COMPLETED|Overall Study||43||
48194239|NCT01366196|100797111|FG000|NOT COMPLETED|Overall Study||0||
48194240|NCT01366196|100797112|FG001|NOT COMPLETED|Overall Study||0||
48194241|NCT02148809|100797113|FG000|STARTED|Overall Study||14||
48194242|NCT02148809|100797113|FG000|COMPLETED|Overall Study||14||
48194243|NCT02148809|100797113|FG000|NOT COMPLETED|Overall Study||0||
48194244|NCT00828919|100797114|FG000|STARTED|Overall Study||7||
48194245|NCT00828919|100797115|FG001|STARTED|Overall Study||9||
48194246|NCT00828919|100797116|FG002|STARTED|Overall Study||20||
48194247|NCT00828919|100797117|FG003|STARTED|Overall Study||2||
48194248|NCT00828919|100797118|FG004|STARTED|Overall Study||11||
48194249|NCT00828919|100797114|FG000|COMPLETED|Overall Study||0||
48194250|NCT00828919|100797115|FG001|COMPLETED|Overall Study||0||
48194251|NCT00828919|100797116|FG002|COMPLETED|Overall Study||0||
48194252|NCT00828919|100797117|FG003|COMPLETED|Overall Study||0||
48194253|NCT00828919|100797118|FG004|COMPLETED|Overall Study||0||
48194254|NCT00828919|100797114|FG000|NOT COMPLETED|Overall Study||7||
48194255|NCT00828919|100797115|FG001|NOT COMPLETED|Overall Study||9||
48194256|NCT00828919|100797116|FG002|NOT COMPLETED|Overall Study||20||
48194257|NCT00828919|100797117|FG003|NOT COMPLETED|Overall Study||2||
48194258|NCT00828919|100797118|FG004|NOT COMPLETED|Overall Study||11||
48477995|NCT01544127|101508998|FG001|STARTED|Overall Study||33||
48477996|NCT01544127|101508999|FG002|STARTED|Overall Study||66||
48477997|NCT01544127|101508997|FG000|COMPLETED|Overall Study||22||
48477998|NCT01544127|101508998|FG001|COMPLETED|Overall Study||27||
48477999|NCT01544127|101508999|FG002|COMPLETED|Overall Study||52||
48478000|NCT01544127|101508997|FG000|NOT COMPLETED|Overall Study||11||
48478001|NCT01544127|101508998|FG001|NOT COMPLETED|Overall Study||6||
48478002|NCT01544127|101508999|FG002|NOT COMPLETED|Overall Study||14||
48478003|NCT04786184|101509000|FG000|STARTED|Overall Study||20||
48478004|NCT04786184|101509001|FG001|STARTED|Overall Study||22||
48478005|NCT04786184|101509000|FG000|Randomized|Overall Study||20||
48478006|NCT04786184|101509001|FG001|Randomized|Overall Study||22||
48478007|NCT04786184|101509000|FG000|Started Pulmonary Rehab|Overall Study||11||
48478008|NCT04786184|101509001|FG001|Started Pulmonary Rehab|Overall Study||18||
48478009|NCT04786184|101509000|FG000|COMPLETED|Overall Study||9|Refers to the completion of the study and not the pulmonary rehab.|
48478010|NCT04786184|101509001|FG001|COMPLETED|Overall Study||19|Refers to the completion of the study and not the pulmonary rehab.|
48478011|NCT04786184|101509000|FG000|NOT COMPLETED|Overall Study||11||
48478012|NCT04786184|101509001|FG001|NOT COMPLETED|Overall Study||3||
48478013|NCT03785548|101509002|FG000|STARTED|Overall Study||73||
48478014|NCT03785548|101509003|FG001|STARTED|Overall Study||74||
48478015|NCT03785548|101509002|FG000|COMPLETED|Overall Study||71||
48478016|NCT03785548|101509003|FG001|COMPLETED|Overall Study||74||
48478017|NCT03785548|101509002|FG000|NOT COMPLETED|Overall Study||2||
48478018|NCT03785548|101509003|FG001|NOT COMPLETED|Overall Study||0||
48478019|NCT00959660|101509004|FG000|STARTED|Overall Study||26||
48478020|NCT00959660|101509005|FG001|STARTED|Overall Study||24||
48478021|NCT00959660|101509006|FG002|STARTED|Overall Study||25||
48478022|NCT00959660|101509007|FG003|STARTED|Overall Study||25||
48478023|NCT00959660|101509004|FG000|COMPLETED|Overall Study||24||
48478024|NCT00959660|101509005|FG001|COMPLETED|Overall Study||24||
48478025|NCT00959660|101509006|FG002|COMPLETED|Overall Study||22||
48478026|NCT00959660|101509007|FG003|COMPLETED|Overall Study||22||
48478027|NCT00959660|101509004|FG000|NOT COMPLETED|Overall Study||2||
48478028|NCT00959660|101509005|FG001|NOT COMPLETED|Overall Study||0||
48478029|NCT00959660|101509006|FG002|NOT COMPLETED|Overall Study||3||
48478030|NCT00959660|101509007|FG003|NOT COMPLETED|Overall Study||3||
48478031|NCT05194722|101509008|FG000|STARTED|Overall Study||30||
48478032|NCT05194722|101509008|FG000|COMPLETED|Overall Study||30||
48478033|NCT05194722|101509008|FG000|NOT COMPLETED|Overall Study||0||
48478034|NCT00874237|101509009|FG000|STARTED|Overall Study||8||
48478035|NCT00874237|101509010|FG001|STARTED|Overall Study||8||
48478036|NCT00874237|101509011|FG002|STARTED|Overall Study||8||
48478037|NCT00874237|101509012|FG003|STARTED|Overall Study||8||
48478038|NCT00874237|101509013|FG004|STARTED|Overall Study||8||
48478039|NCT00874237|101509014|FG005|STARTED|Overall Study||8||
48478040|NCT00874237|101509009|FG000|COMPLETED|Overall Study||8||
48478041|NCT00874237|101509010|FG001|COMPLETED|Overall Study||7||
48478042|NCT00874237|101509011|FG002|COMPLETED|Overall Study||7||
48478043|NCT00874237|101509012|FG003|COMPLETED|Overall Study||8||
48478044|NCT00874237|101509013|FG004|COMPLETED|Overall Study||8||
48478045|NCT00874237|101509014|FG005|COMPLETED|Overall Study||8||
48478046|NCT00874237|101509009|FG000|NOT COMPLETED|Overall Study||0||
48478047|NCT00874237|101509010|FG001|NOT COMPLETED|Overall Study||1||
48478048|NCT00874237|101509011|FG002|NOT COMPLETED|Overall Study||1||
48478049|NCT00874237|101509012|FG003|NOT COMPLETED|Overall Study||0||
48478050|NCT00874237|101509013|FG004|NOT COMPLETED|Overall Study||0||
48478051|NCT00874237|101509014|FG005|NOT COMPLETED|Overall Study||0||
48478052|NCT00672178|101509015|FG000|STARTED|Overall Study||1||
48478053|NCT00672178|101509015|FG000|COMPLETED|Overall Study||1||
48478054|NCT00672178|101509015|FG000|NOT COMPLETED|Overall Study||0||
48478055|NCT03828734|101509016|FG000|STARTED|Baseline||32||
48478056|NCT03828734|101509017|FG001|STARTED|Baseline||26||
48478057|NCT03828734|101509016|FG000|COMPLETED|Baseline||32||
48478058|NCT03828734|101509017|FG001|COMPLETED|Baseline||26||
48478059|NCT03828734|101509016|FG000|NOT COMPLETED|Baseline||0||
48478060|NCT03828734|101509017|FG001|NOT COMPLETED|Baseline||0||
48478061|NCT03828734|101509016|FG000|STARTED|Pre-Randomization (1 Week)||32||
48478062|NCT03828734|101509017|FG001|STARTED|Pre-Randomization (1 Week)||26||
48478063|NCT03828734|101509016|FG000|COMPLETED|Pre-Randomization (1 Week)||29||
48478064|NCT03828734|101509017|FG001|COMPLETED|Pre-Randomization (1 Week)||25||
48478065|NCT03828734|101509016|FG000|NOT COMPLETED|Pre-Randomization (1 Week)||3||
48478066|NCT03828734|101509017|FG001|NOT COMPLETED|Pre-Randomization (1 Week)||1||
48478067|NCT03828734|101509016|FG000|STARTED|First Intervention||29||
48478068|NCT03828734|101509017|FG001|STARTED|First Intervention||25||
48478069|NCT03828734|101509016|FG000|COMPLETED|First Intervention||25||
48478070|NCT03828734|101509017|FG001|COMPLETED|First Intervention||25||
48478071|NCT03828734|101509016|FG000|NOT COMPLETED|First Intervention||4||
48478072|NCT03828734|101509017|FG001|NOT COMPLETED|First Intervention||0||
48478073|NCT03828734|101509016|FG000|STARTED|First Washout (1 Week)||25||
48478074|NCT03828734|101509017|FG001|STARTED|First Washout (1 Week)||25||
48478075|NCT03828734|101509016|FG000|COMPLETED|First Washout (1 Week)||25||
48478076|NCT03828734|101509017|FG001|COMPLETED|First Washout (1 Week)||24||
48478077|NCT03828734|101509016|FG000|NOT COMPLETED|First Washout (1 Week)||0||
48478078|NCT03828734|101509017|FG001|NOT COMPLETED|First Washout (1 Week)||1||
48478079|NCT03828734|101509016|FG000|STARTED|Second Intervention||25||
48478080|NCT03828734|101509017|FG001|STARTED|Second Intervention||24||
48478081|NCT03828734|101509016|FG000|COMPLETED|Second Intervention||25||
48478082|NCT03828734|101509017|FG001|COMPLETED|Second Intervention||24||
48478083|NCT03828734|101509016|FG000|NOT COMPLETED|Second Intervention||0||
48478084|NCT03828734|101509017|FG001|NOT COMPLETED|Second Intervention||0||
48478085|NCT00819741|101509018|FG000|STARTED|Overall Study||218||
48478086|NCT00819741|101509019|FG001|STARTED|Overall Study||215||
48478087|NCT00819741|101509018|FG000|Exposed to Drug|Overall Study||218||
48478088|NCT00819741|101509019|FG001|Exposed to Drug|Overall Study||214||
48478089|NCT00819741|101509018|FG000|COMPLETED|Overall Study||196||
48478090|NCT00819741|101509019|FG001|COMPLETED|Overall Study||201||
48478091|NCT00819741|101509018|FG000|NOT COMPLETED|Overall Study||22||
48478092|NCT00819741|101509019|FG001|NOT COMPLETED|Overall Study||14||
48478093|NCT00488865|101509020|FG000|STARTED|Overall Study||100||
48478094|NCT00488865|101509020|FG000|COMPLETED|Overall Study||100||
48478095|NCT00488865|101509020|FG000|NOT COMPLETED|Overall Study||0||
48478096|NCT00814463|101509021|FG000|STARTED|Overall Study||1||
48478097|NCT00814463|101509021|FG000|COMPLETED|Overall Study||0||
48478098|NCT00814463|101509021|FG000|NOT COMPLETED|Overall Study||1||
48478099|NCT01085045|101509022|FG000|STARTED|Part A||122||
48478100|NCT01085045|101509022|FG000|GFF MDI 72/9.6mcg|Part A||40||
48478101|NCT01085045|101509022|FG000|GFF MDI 36/9.6 µg (PT003)|Part A||42||
48478102|NCT01085045|101509022|FG000|GP MDI 36 µg (PT001)|Part A||40||
48478103|NCT01085045|101509022|FG000|Spiriva 18 µg|Part A||58||
48478104|NCT01085045|101509022|FG000|FF MDI 9.6 µg (PT005)|Part A||20||
48478105|NCT01085045|101509022|FG000|FF MDI 7.2 µg (PT005)|Part A||21||
48478106|NCT01085045|101509022|FG000|Placebo MDI|Part A||5||
48478107|NCT01085045|101509022|FG000|Foradil 12 µg|Part A||14||
48478108|NCT01085045|101509022|FG000|COMPLETED|Part A||104||
48478109|NCT01085045|101509022|FG000|NOT COMPLETED|Part A||18||
48478110|NCT01085045|101509022|FG000|STARTED|Part B||104||
48478111|NCT01085045|101509022|FG000|GFF MDI 72/9.6mcg (PT003)|Part B||0||
48478112|NCT01085045|101509022|FG000|GFF MDI 36/9.6 µg|Part B||0||
48478113|NCT01085045|101509022|FG000|Spiriva 18 µg|Part B||0||
48478114|NCT01085045|101509022|FG000|FF MDI 9.6 µg (PT005)|Part B||43||
48478115|NCT01085045|101509022|FG000|FF MDI 7.2 µg (PT005)|Part B||43||
48478116|NCT01085045|101509022|FG000|Placebo MDI|Part B||47||
48478117|NCT01085045|101509022|FG000|Foradil 12 µg|Part B||41||
48478118|NCT01085045|101509022|FG000|GP MDI 36 µg (PT001)|Part B||0||
48478119|NCT01085045|101509022|FG000|COMPLETED|Part B||89||
48478120|NCT01085045|101509022|FG000|NOT COMPLETED|Part B||15||
48478121|NCT01351506|101509023|FG000|STARTED|Overall Study||602||
48478122|NCT01351506|101509023|FG000|COMPLETED|Overall Study||465||
48478123|NCT01351506|101509023|FG000|NOT COMPLETED|Overall Study||137||
48478124|NCT02648347|101509024|FG000|STARTED|Overall Study||879||
48478125|NCT02648347|101509025|FG001|STARTED|Overall Study||872||
48478126|NCT02648347|101509024|FG000|COMPLETED|Overall Study||670||
48478127|NCT02648347|101509025|FG001|COMPLETED|Overall Study||675||
48478128|NCT02648347|101509024|FG000|NOT COMPLETED|Overall Study||209||
48478129|NCT02648347|101509025|FG001|NOT COMPLETED|Overall Study||197||
48478130|NCT03966365|101509026|FG000|STARTED|Overall Study||12||
48478131|NCT03966365|101509027|FG001|STARTED|Overall Study||12||
48478132|NCT03966365|101509026|FG000|COMPLETED|Overall Study||11||
48478133|NCT03966365|101509027|FG001|COMPLETED|Overall Study||12||
48478134|NCT03966365|101509026|FG000|NOT COMPLETED|Overall Study||1||
48478135|NCT03966365|101509027|FG001|NOT COMPLETED|Overall Study||0||
48478136|NCT01701024|101509028|FG000|STARTED|Overall Study||253||
48478137|NCT01701024|101509029|FG001|STARTED|Overall Study||245||
48478138|NCT01701024|101509028|FG000|COMPLETED|Overall Study||243||
48478139|NCT01701024|101509029|FG001|COMPLETED|Overall Study||236||
48478140|NCT01701024|101509028|FG000|NOT COMPLETED|Overall Study||10||
48478141|NCT01701024|101509029|FG001|NOT COMPLETED|Overall Study||9||
48478142|NCT00819507|101509030|FG000|STARTED|Overall Study||25||
48478143|NCT00819507|101509030|FG000|COMPLETED|Overall Study||25||
48478144|NCT00819507|101509030|FG000|NOT COMPLETED|Overall Study||0||
48478145|NCT02932878|101509031|FG000|STARTED|Overall Study||15||
48478146|NCT02932878|101509032|FG001|STARTED|Overall Study||1||
48478147|NCT02932878|101509031|FG000|COMPLETED|Overall Study||13||
48478148|NCT02932878|101509032|FG001|COMPLETED|Overall Study||0||
48478149|NCT02932878|101509031|FG000|NOT COMPLETED|Overall Study||2||
48478150|NCT02932878|101509032|FG001|NOT COMPLETED|Overall Study||1||
48478151|NCT03616106|101509033|FG000|STARTED|Overall Study||56||
48478152|NCT03616106|101509034|FG001|STARTED|Overall Study||3||
48478153|NCT03616106|101509033|FG000|COMPLETED|Overall Study||42||
48478154|NCT03616106|101509034|FG001|COMPLETED|Overall Study||2||
48478155|NCT03616106|101509033|FG000|NOT COMPLETED|Overall Study||14||
48478156|NCT03616106|101509034|FG001|NOT COMPLETED|Overall Study||1||
48478157|NCT01390844|101509035|FG000|STARTED|Treatment Phase||133||
48478158|NCT01390844|101509036|FG001|STARTED|Treatment Phase||65||
48478159|NCT01390844|101509037|FG002|STARTED|Treatment Phase||57||
48478160|NCT01390844|101509038|FG003|STARTED|Treatment Phase||27||
48478161|NCT01390844|101509035|FG000|Followed Good Clinical Practice (GCP)|Treatment Phase||133||
48478162|NCT01390844|101509036|FG001|Followed Good Clinical Practice (GCP)|Treatment Phase||65||
48478163|NCT01390844|101509037|FG002|Followed Good Clinical Practice (GCP)|Treatment Phase||47||
48478164|NCT01390844|101509038|FG003|Followed Good Clinical Practice (GCP)|Treatment Phase||24||
48478165|NCT01390844|101509035|FG000|COMPLETED|Treatment Phase||93||
48478166|NCT01390844|101509036|FG001|COMPLETED|Treatment Phase||37||
48478167|NCT01390844|101509037|FG002|COMPLETED|Treatment Phase||26||
48478168|NCT01390844|101509038|FG003|COMPLETED|Treatment Phase||8||
48478169|NCT01390844|101509035|FG000|NOT COMPLETED|Treatment Phase||40||
48478170|NCT01390844|101509036|FG001|NOT COMPLETED|Treatment Phase||28||
48478171|NCT01390844|101509037|FG002|NOT COMPLETED|Treatment Phase||31||
48478172|NCT01390844|101509038|FG003|NOT COMPLETED|Treatment Phase||19||
48478173|NCT01390844|101509035|FG000|STARTED|Follow-Up Phase||93||
48478174|NCT01390844|101509036|FG001|STARTED|Follow-Up Phase||37||
48478175|NCT01390844|101509037|FG002|STARTED|Follow-Up Phase||26||
48478176|NCT01390844|101509038|FG003|STARTED|Follow-Up Phase||8||
48478177|NCT01390844|101509035|FG000|COMPLETED|Follow-Up Phase||92||
48478178|NCT01390844|101509036|FG001|COMPLETED|Follow-Up Phase||36||
48478179|NCT01390844|101509037|FG002|COMPLETED|Follow-Up Phase||25||
48478180|NCT01390844|101509038|FG003|COMPLETED|Follow-Up Phase||8||
48478181|NCT01390844|101509035|FG000|NOT COMPLETED|Follow-Up Phase||1||
48478182|NCT01390844|101509036|FG001|NOT COMPLETED|Follow-Up Phase||1||
48478183|NCT01390844|101509037|FG002|NOT COMPLETED|Follow-Up Phase||1||
48478184|NCT01390844|101509038|FG003|NOT COMPLETED|Follow-Up Phase||0||
48478185|NCT00336479|101509039|FG000|STARTED|Overall Study||75||
48478186|NCT00336479|101509040|FG001|STARTED|Overall Study||79||
48478187|NCT00336479|101509041|FG002|STARTED|Overall Study||79||
48478188|NCT00336479|101509042|FG003|STARTED|Overall Study||17||
48478189|NCT00336479|101509039|FG000|COMPLETED|Overall Study||38||
48478190|NCT00336479|101509040|FG001|COMPLETED|Overall Study||54||
48478191|NCT00336479|101509041|FG002|COMPLETED|Overall Study||53||
48478192|NCT00336479|101509042|FG003|COMPLETED|Overall Study||13||
48478193|NCT00336479|101509039|FG000|NOT COMPLETED|Overall Study||37||
48478194|NCT00336479|101509040|FG001|NOT COMPLETED|Overall Study||25||
48478195|NCT00336479|101509041|FG002|NOT COMPLETED|Overall Study||26||
48478196|NCT00336479|101509042|FG003|NOT COMPLETED|Overall Study||4||
48478197|NCT01870856|101509043|FG000|STARTED|Overall Study||25||
48478198|NCT01870856|101509044|FG001|STARTED|Overall Study||27||
48478199|NCT01870856|101509043|FG000|COMPLETED|Overall Study||25||
48478200|NCT01870856|101509044|FG001|COMPLETED|Overall Study||27||
48478201|NCT01870856|101509043|FG000|NOT COMPLETED|Overall Study||0||
48478202|NCT01870856|101509044|FG001|NOT COMPLETED|Overall Study||0||
48478203|NCT02726581|101509045|FG000|STARTED|Pre-Treatment Period||75||
48478204|NCT02726581|101509046|FG001|STARTED|Pre-Treatment Period||71||
48478205|NCT02726581|101509047|FG002|STARTED|Pre-Treatment Period||24||
48478206|NCT02726581|101509045|FG000|COMPLETED|Pre-Treatment Period||72||
48478207|NCT02726581|101509046|FG001|COMPLETED|Pre-Treatment Period||70||
48478208|NCT02726581|101509047|FG002|COMPLETED|Pre-Treatment Period||24||
48478209|NCT02726581|101509045|FG000|NOT COMPLETED|Pre-Treatment Period||3||
48478210|NCT02726581|101509046|FG001|NOT COMPLETED|Pre-Treatment Period||1||
48478211|NCT02726581|101509047|FG002|NOT COMPLETED|Pre-Treatment Period||0||
48478212|NCT02726581|101509045|FG000|STARTED|Treatment Period||72||
48478213|NCT02726581|101509046|FG001|STARTED|Treatment Period||70||
48478214|NCT02726581|101509047|FG002|STARTED|Treatment Period||24||
48478215|NCT02726581|101509045|FG000|NE-Pd Crossover|Treatment Period||0||
48478216|NCT02726581|101509046|FG001|NE-Pd Crossover|Treatment Period||8||
48478217|NCT02726581|101509047|FG002|NE-Pd Crossover|Treatment Period||0||
48478218|NCT02726581|101509045|FG000|COMPLETED|Treatment Period||0|Completed treatment|
48478219|NCT02726581|101509046|FG001|COMPLETED|Treatment Period||0|Completed treatment|
48478220|NCT02726581|101509047|FG002|COMPLETED|Treatment Period||0|Completed treatment|
48478221|NCT02726581|101509045|FG000|NOT COMPLETED|Treatment Period||72||
48478222|NCT02726581|101509046|FG001|NOT COMPLETED|Treatment Period||70||
48478223|NCT02726581|101509047|FG002|NOT COMPLETED|Treatment Period||24||
48478224|NCT02472366|101509048|FG000|STARTED|Overall Study||6||
48478225|NCT02472366|101509049|FG001|STARTED|Overall Study||10||
48478226|NCT02472366|101509048|FG000|COMPLETED|Overall Study||5||
48478227|NCT02472366|101509049|FG001|COMPLETED|Overall Study||10||
48478228|NCT02472366|101509048|FG000|NOT COMPLETED|Overall Study||1||
48478229|NCT02472366|101509049|FG001|NOT COMPLETED|Overall Study||0||
48478230|NCT02605395|101509050|FG000|STARTED|Period 1, Day 1||35||
48478231|NCT02605395|101509051|FG001|STARTED|Period 1, Day 1||35||
48478232|NCT02605395|101509050|FG000|COMPLETED|Period 1, Day 1||35||
48478233|NCT02605395|101509051|FG001|COMPLETED|Period 1, Day 1||35||
48478234|NCT02605395|101509050|FG000|NOT COMPLETED|Period 1, Day 1||0||
48478235|NCT02605395|101509051|FG001|NOT COMPLETED|Period 1, Day 1||0||
48478236|NCT02605395|101509050|FG000|STARTED|Washout Period, Day 2 to Day 7||35||
48478237|NCT02605395|101509051|FG001|STARTED|Washout Period, Day 2 to Day 7||35||
48478238|NCT02605395|101509050|FG000|COMPLETED|Washout Period, Day 2 to Day 7||35||
48478239|NCT02605395|101509051|FG001|COMPLETED|Washout Period, Day 2 to Day 7||35||
48478240|NCT02605395|101509050|FG000|NOT COMPLETED|Washout Period, Day 2 to Day 7||0||
48478241|NCT02605395|101509051|FG001|NOT COMPLETED|Washout Period, Day 2 to Day 7||0||
48478242|NCT02605395|101509050|FG000|STARTED|Period 2, Day 8||35||
48478243|NCT02605395|101509051|FG001|STARTED|Period 2, Day 8||35||
48478244|NCT02605395|101509050|FG000|COMPLETED|Period 2, Day 8||35||
48478245|NCT02605395|101509051|FG001|COMPLETED|Period 2, Day 8||35||
48478246|NCT02605395|101509050|FG000|NOT COMPLETED|Period 2, Day 8||0||
48478247|NCT02605395|101509051|FG001|NOT COMPLETED|Period 2, Day 8||0||
48478248|NCT02131129|101509052|FG000|STARTED|Overall Study||10||
48478249|NCT02131129|101509053|FG001|STARTED|Overall Study||10||
48478250|NCT02131129|101509052|FG000|COMPLETED|Overall Study||9||
48478251|NCT02131129|101509053|FG001|COMPLETED|Overall Study||10||
48478252|NCT02131129|101509052|FG000|NOT COMPLETED|Overall Study||1||
48478253|NCT02131129|101509053|FG001|NOT COMPLETED|Overall Study||0||
48478254|NCT05067647|101509054|FG000|STARTED|Overall Study||94||
48478255|NCT05067647|101509054|FG000|COMPLETED|Overall Study||93||
48478256|NCT05067647|101509054|FG000|NOT COMPLETED|Overall Study||1||
48478257|NCT02457520|101509055|FG000|STARTED|Active Treatment Phase||201||
48478258|NCT02457520|101509055|FG000|COMPLETED|Active Treatment Phase||167|Subjects Completing Treatment Phase, n (%)|
48478259|NCT02457520|101509055|FG000|NOT COMPLETED|Active Treatment Phase||34||
48478260|NCT02457520|101509055|FG000|STARTED|Post-treatment Period||167||
48478261|NCT02457520|101509055|FG000|COMPLETED|Post-treatment Period||119||
48478262|NCT02457520|101509055|FG000|NOT COMPLETED|Post-treatment Period||48||
48478263|NCT02612337|101509056|FG000|STARTED|Overall Study||83||
48478264|NCT02612337|101509057|FG001|STARTED|Overall Study||83||
48478265|NCT02612337|101509056|FG000|Received Study Drug|Overall Study||83||
48478266|NCT02612337|101509057|FG001|Received Study Drug|Overall Study||82||
48478267|NCT02612337|101509056|FG000|COMPLETED|Overall Study||80||
48478268|NCT02612337|101509057|FG001|COMPLETED|Overall Study||80||
48478269|NCT02612337|101509056|FG000|NOT COMPLETED|Overall Study||3||
48478270|NCT02612337|101509057|FG001|NOT COMPLETED|Overall Study||3||
48478271|NCT00711464|101509058|FG000|STARTED|Overall Study||29||
48478272|NCT00711464|101509058|FG000|COMPLETED|Overall Study||29||
48478273|NCT00711464|101509058|FG000|NOT COMPLETED|Overall Study||0||
48478274|NCT01837654|101509059|FG000|STARTED|Overall Study||11||
48478275|NCT01837654|101509060|FG001|STARTED|Overall Study||11||
48478276|NCT01837654|101509059|FG000|COMPLETED|Overall Study||11||
48478277|NCT01837654|101509060|FG001|COMPLETED|Overall Study||11||
48478278|NCT01837654|101509059|FG000|NOT COMPLETED|Overall Study||0||
48478279|NCT01837654|101509060|FG001|NOT COMPLETED|Overall Study||0||
48478280|NCT00784823|101509061|FG000|STARTED|Overall Study||6||
48478281|NCT00784823|101509062|FG001|STARTED|Overall Study||3||
48478282|NCT00784823|101509063|FG002|STARTED|Overall Study||3||
48478283|NCT00784823|101509064|FG003|STARTED|Overall Study||20||
48478284|NCT00784823|101509061|FG000|COMPLETED|Overall Study||6||
48478285|NCT00784823|101509062|FG001|COMPLETED|Overall Study||3||
48478286|NCT00784823|101509063|FG002|COMPLETED|Overall Study||3||
48478287|NCT00784823|101509064|FG003|COMPLETED|Overall Study||20||
48478288|NCT00784823|101509061|FG000|NOT COMPLETED|Overall Study||0||
48478289|NCT00784823|101509062|FG001|NOT COMPLETED|Overall Study||0||
48478290|NCT00784823|101509063|FG002|NOT COMPLETED|Overall Study||0||
48478291|NCT00784823|101509064|FG003|NOT COMPLETED|Overall Study||0||
48478292|NCT01370408|101509065|FG000|STARTED|Overall Study||85||
48478293|NCT01370408|101509065|FG000|COMPLETED|Overall Study||76||
48478294|NCT01370408|101509065|FG000|NOT COMPLETED|Overall Study||9||
48478295|NCT04274686|101509066|FG000|STARTED|Overall Study||13||
48478296|NCT04274686|101509067|FG001|STARTED|Overall Study||12||
48478297|NCT04274686|101509066|FG000|COMPLETED|Overall Study||12||
48478298|NCT04274686|101509067|FG001|COMPLETED|Overall Study||12||
48478299|NCT04274686|101509066|FG000|NOT COMPLETED|Overall Study||1||
48478300|NCT04274686|101509067|FG001|NOT COMPLETED|Overall Study||0||
48478301|NCT05342597|101509068|FG000|STARTED|Period 1||4||
48478302|NCT05342597|101509069|FG001|STARTED|Period 1||4||
48478303|NCT05342597|101509070|FG002|STARTED|Period 1||4||
48478304|NCT05342597|101509071|FG003|STARTED|Period 1||4||
48478305|NCT05342597|101509068|FG000|COMPLETED|Period 1||4||
48478306|NCT05342597|101509069|FG001|COMPLETED|Period 1||4||
48478307|NCT05342597|101509070|FG002|COMPLETED|Period 1||4||
48478308|NCT05342597|101509071|FG003|COMPLETED|Period 1||4||
48478309|NCT05342597|101509068|FG000|NOT COMPLETED|Period 1||0||
48478310|NCT05342597|101509069|FG001|NOT COMPLETED|Period 1||0||
48478311|NCT05342597|101509070|FG002|NOT COMPLETED|Period 1||0||
48478312|NCT05342597|101509071|FG003|NOT COMPLETED|Period 1||0||
48478313|NCT05342597|101509068|FG000|STARTED|Period 2||4||
48478314|NCT05342597|101509069|FG001|STARTED|Period 2||4||
48478315|NCT05342597|101509070|FG002|STARTED|Period 2||4||
48478316|NCT05342597|101509071|FG003|STARTED|Period 2||4||
48478317|NCT05342597|101509068|FG000|COMPLETED|Period 2||4||
48478318|NCT05342597|101509069|FG001|COMPLETED|Period 2||4||
48478319|NCT05342597|101509070|FG002|COMPLETED|Period 2||4||
48478320|NCT05342597|101509071|FG003|COMPLETED|Period 2||4||
48478321|NCT05342597|101509068|FG000|NOT COMPLETED|Period 2||0||
48478322|NCT05342597|101509069|FG001|NOT COMPLETED|Period 2||0||
48478323|NCT05342597|101509070|FG002|NOT COMPLETED|Period 2||0||
48478324|NCT05342597|101509071|FG003|NOT COMPLETED|Period 2||0||
48478325|NCT05342597|101509068|FG000|STARTED|Period 3||4||
48478326|NCT05342597|101509069|FG001|STARTED|Period 3||4||
48478327|NCT05342597|101509070|FG002|STARTED|Period 3||4||
48478328|NCT05342597|101509071|FG003|STARTED|Period 3||4||
48478329|NCT05342597|101509068|FG000|COMPLETED|Period 3||4||
48478330|NCT05342597|101509069|FG001|COMPLETED|Period 3||4||
48478331|NCT05342597|101509070|FG002|COMPLETED|Period 3||4||
48478332|NCT05342597|101509071|FG003|COMPLETED|Period 3||4||
48478333|NCT05342597|101509068|FG000|NOT COMPLETED|Period 3||0||
48478334|NCT05342597|101509069|FG001|NOT COMPLETED|Period 3||0||
48478335|NCT05342597|101509070|FG002|NOT COMPLETED|Period 3||0||
48478336|NCT05342597|101509071|FG003|NOT COMPLETED|Period 3||0||
48478337|NCT05342597|101509068|FG000|STARTED|Period 4||4||
48478338|NCT05342597|101509069|FG001|STARTED|Period 4||4||
48478339|NCT05342597|101509070|FG002|STARTED|Period 4||4||
48478340|NCT05342597|101509071|FG003|STARTED|Period 4||4||
48478341|NCT05342597|101509068|FG000|COMPLETED|Period 4||4||
48478342|NCT05342597|101509069|FG001|COMPLETED|Period 4||4||
48478343|NCT05342597|101509070|FG002|COMPLETED|Period 4||4||
48478344|NCT05342597|101509071|FG003|COMPLETED|Period 4||4||
48478345|NCT05342597|101509068|FG000|NOT COMPLETED|Period 4||0||
48478346|NCT05342597|101509069|FG001|NOT COMPLETED|Period 4||0||
48478347|NCT05342597|101509070|FG002|NOT COMPLETED|Period 4||0||
48478348|NCT05342597|101509071|FG003|NOT COMPLETED|Period 4||0||
48478349|NCT05342597|101509068|FG000|STARTED|Period 5||4||
48478350|NCT05342597|101509069|FG001|STARTED|Period 5||4||
48478351|NCT05342597|101509070|FG002|STARTED|Period 5||4||
48478352|NCT05342597|101509071|FG003|STARTED|Period 5||4||
48478353|NCT05342597|101509068|FG000|COMPLETED|Period 5||4||
48478354|NCT05342597|101509069|FG001|COMPLETED|Period 5||4||
48478355|NCT05342597|101509070|FG002|COMPLETED|Period 5||4||
48478356|NCT05342597|101509071|FG003|COMPLETED|Period 5||4||
48478357|NCT05342597|101509068|FG000|NOT COMPLETED|Period 5||0||
48478358|NCT05342597|101509069|FG001|NOT COMPLETED|Period 5||0||
48478359|NCT05342597|101509070|FG002|NOT COMPLETED|Period 5||0||
48478360|NCT05342597|101509071|FG003|NOT COMPLETED|Period 5||0||
48478361|NCT02770625|101509072|FG000|STARTED|Overall Study||8||
48478362|NCT02770625|101509072|FG000|COMPLETED|Overall Study||8||
48478363|NCT02770625|101509072|FG000|NOT COMPLETED|Overall Study||0||
48478364|NCT01157091|101509073|FG000|STARTED|Overall Study||28||
48478365|NCT01157091|101509073|FG000|COMPLETED|Overall Study||28||
48478366|NCT01157091|101509073|FG000|NOT COMPLETED|Overall Study||0||
48478367|NCT02468778|101509074|FG000|STARTED|Overall Study||18||
48478368|NCT02468778|101509075|FG001|STARTED|Overall Study||26||
48478369|NCT02468778|101509076|FG002|STARTED|Overall Study||10||
48478370|NCT02468778|101509074|FG000|COMPLETED|Overall Study||15||
48478371|NCT02468778|101509075|FG001|COMPLETED|Overall Study||22||
48478372|NCT02468778|101509076|FG002|COMPLETED|Overall Study||7||
48478373|NCT02468778|101509074|FG000|NOT COMPLETED|Overall Study||3||
48478374|NCT02468778|101509075|FG001|NOT COMPLETED|Overall Study||4||
48478375|NCT02468778|101509076|FG002|NOT COMPLETED|Overall Study||3||
48478376|NCT03025945|101509077|FG000|STARTED|Overall Study||331||
48478377|NCT03025945|101509078|FG001|STARTED|Overall Study||331||
48478378|NCT03025945|101509077|FG000|COMPLETED|Overall Study||331||
48478379|NCT03025945|101509078|FG001|COMPLETED|Overall Study||331||
48478380|NCT03025945|101509077|FG000|NOT COMPLETED|Overall Study||0||
48478381|NCT03025945|101509078|FG001|NOT COMPLETED|Overall Study||0||
48478382|NCT02883452|101509079|FG000|STARTED|Overall Study||13||
48478383|NCT02883452|101509080|FG001|STARTED|Overall Study||11||
48478384|NCT02883452|101509081|FG002|STARTED|Overall Study||12||
48478385|NCT02883452|101509082|FG003|STARTED|Overall Study||8||
48478386|NCT02883452|101509083|FG004|STARTED|Overall Study||66||
48478387|NCT02883452|101509084|FG005|STARTED|Overall Study||65||
48478388|NCT02883452|101509079|FG000|COMPLETED|Overall Study||8||
48478389|NCT02883452|101509080|FG001|COMPLETED|Overall Study||9||
48478390|NCT02883452|101509081|FG002|COMPLETED|Overall Study||7||
48478391|NCT02883452|101509082|FG003|COMPLETED|Overall Study||6||
48478392|NCT02883452|101509083|FG004|COMPLETED|Overall Study||55||
48478393|NCT02883452|101509084|FG005|COMPLETED|Overall Study||50||
48478394|NCT02883452|101509079|FG000|NOT COMPLETED|Overall Study||5||
48478395|NCT02883452|101509080|FG001|NOT COMPLETED|Overall Study||2||
48478396|NCT02883452|101509081|FG002|NOT COMPLETED|Overall Study||5||
48478397|NCT02883452|101509082|FG003|NOT COMPLETED|Overall Study||2||
48478398|NCT02883452|101509083|FG004|NOT COMPLETED|Overall Study||11||
48478399|NCT02883452|101509084|FG005|NOT COMPLETED|Overall Study||15||
48478400|NCT02349893|101509085|FG000|STARTED|Overall Study||56||
48478401|NCT02349893|101509085|FG000|COMPLETED|Overall Study||43||
48478402|NCT02349893|101509085|FG000|NOT COMPLETED|Overall Study||13||
48478403|NCT04611789|101509086|FG000|STARTED|Overall Study||4||
48478404|NCT04611789|101509087|FG001|STARTED|Overall Study||7||
48478405|NCT04611789|101509088|FG002|STARTED|Overall Study||7||
48478406|NCT04611789|101509086|FG000|COMPLETED|Overall Study||3||
48478407|NCT04611789|101509087|FG001|COMPLETED|Overall Study||7||
48478408|NCT04611789|101509088|FG002|COMPLETED|Overall Study||7||
48478409|NCT04611789|101509086|FG000|NOT COMPLETED|Overall Study||1||
48478410|NCT04611789|101509087|FG001|NOT COMPLETED|Overall Study||0||
48478411|NCT04611789|101509088|FG002|NOT COMPLETED|Overall Study||0||
48478412|NCT02152566|101509089|FG000|STARTED|Overall Study||6||
48478413|NCT02152566|101509089|FG000|COMPLETED|Overall Study||3||
48478414|NCT02152566|101509089|FG000|NOT COMPLETED|Overall Study||3||
48478415|NCT00667862|101509090|FG000|STARTED|Overall Study||35||
48478416|NCT00667862|101509090|FG000|COMPLETED|Overall Study||0|Completed here refers to participants who completed study treatment.|
48478417|NCT00667862|101509090|FG000|NOT COMPLETED|Overall Study||35||
48478418|NCT02924883|101509091|FG000|STARTED|Overall Study||133||
48478419|NCT02924883|101509092|FG001|STARTED|Overall Study||69||
48478420|NCT02924883|101509091|FG000|COMPLETED|Overall Study||0||
48478421|NCT02924883|101509092|FG001|COMPLETED|Overall Study||0||
48194259|NCT03354390|100797119|FG000|STARTED|Level 1||3||
48194260|NCT03354390|100797120|FG001|STARTED|Level 1||0||
48194261|NCT03354390|100797121|FG002|STARTED|Level 1||0||
48478422|NCT02924883|101509091|FG000|NOT COMPLETED|Overall Study||133||
48478423|NCT02924883|101509092|FG001|NOT COMPLETED|Overall Study||69||
48478424|NCT01944930|101509093|FG000|STARTED|Overall Study||12||
48478425|NCT01944930|101509094|FG001|STARTED|Overall Study||11||
48478426|NCT01944930|101509093|FG000|COMPLETED|Overall Study||10||
48478427|NCT01944930|101509094|FG001|COMPLETED|Overall Study||10||
48478428|NCT01944930|101509093|FG000|NOT COMPLETED|Overall Study||2||
48478429|NCT01944930|101509094|FG001|NOT COMPLETED|Overall Study||1||
48478430|NCT03262012|101509095|FG000|STARTED|Overall Study||139||
48478431|NCT03262012|101509096|FG001|STARTED|Overall Study||138||
48478432|NCT03262012|101509097|FG002|STARTED|Overall Study||70||
48478433|NCT03262012|101509098|FG003|STARTED|Overall Study||69||
48478434|NCT03262012|101509095|FG000|COMPLETED|Overall Study||112||
48478435|NCT03262012|101509096|FG001|COMPLETED|Overall Study||102||
48478436|NCT03262012|101509097|FG002|COMPLETED|Overall Study||56||
48478437|NCT03262012|101509098|FG003|COMPLETED|Overall Study||54||
48478438|NCT03262012|101509095|FG000|NOT COMPLETED|Overall Study||27||
48478439|NCT03262012|101509096|FG001|NOT COMPLETED|Overall Study||36||
48194262|NCT03354390|100797122|FG003|STARTED|Level 1||0||
48478440|NCT03262012|101509097|FG002|NOT COMPLETED|Overall Study||14||
48478441|NCT03262012|101509098|FG003|NOT COMPLETED|Overall Study||15||
48478442|NCT01269801|101509099|FG000|STARTED|Overall Study||74||
48478443|NCT01269801|101509100|FG001|STARTED|Overall Study||80||
48478444|NCT01269801|101509099|FG000|COMPLETED|Overall Study||74||
48478445|NCT01269801|101509100|FG001|COMPLETED|Overall Study||77||
48478446|NCT01269801|101509099|FG000|NOT COMPLETED|Overall Study||0||
48478447|NCT01269801|101509100|FG001|NOT COMPLETED|Overall Study||3||
48478448|NCT02076022|101509101|FG000|STARTED|Overall Study||7||
48478449|NCT02076022|101509102|FG001|STARTED|Overall Study||3||
48478450|NCT02076022|101509101|FG000|COMPLETED|Overall Study||5||
48478451|NCT02076022|101509102|FG001|COMPLETED|Overall Study||3||
48478452|NCT02076022|101509101|FG000|NOT COMPLETED|Overall Study||2||
48478453|NCT02076022|101509102|FG001|NOT COMPLETED|Overall Study||0||
48478454|NCT02563808|101509103|FG000|STARTED|Overall Study||96|A total of 5 participants enrolled were not included in final data due to data collection error|
48666344|NCT03289039|101967561|FG000|COMPLETED|Overall Study||10||
48194263|NCT03354390|100797119|FG000|Treatment Completed|Level 1||3||
48478455|NCT02563808|101509104|FG001|STARTED|Overall Study||88|A total of 5 participants enrolled were not included in final data due to data collection error|
48478456|NCT02563808|101509103|FG000|COMPLETED|Overall Study||96||
48478457|NCT02563808|101509104|FG001|COMPLETED|Overall Study||88||
48478458|NCT02563808|101509103|FG000|NOT COMPLETED|Overall Study||0||
48478459|NCT02563808|101509104|FG001|NOT COMPLETED|Overall Study||0||
48478460|NCT01263704|101509105|FG000|STARTED|Overall Study||42||
48478461|NCT01263704|101509105|FG000|COMPLETED|Overall Study||13||
48478462|NCT01263704|101509105|FG000|NOT COMPLETED|Overall Study||29||
48478463|NCT00880568|101509106|FG000|STARTED|Overall Study||3||
48478464|NCT00880568|101509107|FG001|STARTED|Overall Study||3||
48478465|NCT00880568|101509108|FG002|STARTED|Overall Study||3||
48478466|NCT00880568|101509109|FG003|STARTED|Overall Study||1||
48478467|NCT00880568|101509110|FG004|STARTED|Overall Study||3||
48478468|NCT00880568|101509111|FG005|STARTED|Overall Study||3||
48478469|NCT00880568|101509112|FG006|STARTED|Overall Study||6||
48478470|NCT00880568|101509113|FG007|STARTED|Overall Study||2||
48478471|NCT00880568|101509114|FG008|STARTED|Overall Study||3||
48478472|NCT00880568|101509106|FG000|COMPLETED|Overall Study||0||
48478473|NCT00880568|101509107|FG001|COMPLETED|Overall Study||0||
48478474|NCT00880568|101509108|FG002|COMPLETED|Overall Study||0||
48478475|NCT00880568|101509109|FG003|COMPLETED|Overall Study||0||
48478476|NCT00880568|101509110|FG004|COMPLETED|Overall Study||0||
48478477|NCT00880568|101509111|FG005|COMPLETED|Overall Study||0||
48478478|NCT00880568|101509112|FG006|COMPLETED|Overall Study||0||
48478479|NCT00880568|101509113|FG007|COMPLETED|Overall Study||0||
48478480|NCT00880568|101509114|FG008|COMPLETED|Overall Study||0||
48478481|NCT00880568|101509106|FG000|NOT COMPLETED|Overall Study||3||
48478482|NCT00880568|101509107|FG001|NOT COMPLETED|Overall Study||3||
48194264|NCT03354390|100797120|FG001|Treatment Completed|Level 1||0||
48194265|NCT03354390|100797121|FG002|Treatment Completed|Level 1||0||
48478483|NCT00880568|101509108|FG002|NOT COMPLETED|Overall Study||3||
48478484|NCT00880568|101509109|FG003|NOT COMPLETED|Overall Study||1||
48478485|NCT00880568|101509110|FG004|NOT COMPLETED|Overall Study||3||
48478486|NCT00880568|101509111|FG005|NOT COMPLETED|Overall Study||3||
48478487|NCT00880568|101509112|FG006|NOT COMPLETED|Overall Study||6||
48478488|NCT00880568|101509113|FG007|NOT COMPLETED|Overall Study||2||
48478489|NCT00880568|101509114|FG008|NOT COMPLETED|Overall Study||3||
48478490|NCT02461771|101509115|FG000|STARTED|Overall Study||3||
48478491|NCT02461771|101509116|FG001|STARTED|Overall Study||3||
48194266|NCT03354390|100797122|FG003|Treatment Completed|Level 1||0||
48478492|NCT02461771|101509117|FG002|STARTED|Overall Study||7||
48478493|NCT02461771|101509115|FG000|COMPLETED|Overall Study||3|Completed acute safety observation period (up to Day 15) and follow-up visits up to Day 113.|
48478494|NCT02461771|101509116|FG001|COMPLETED|Overall Study||3|Completed acute safety observation period (up to Day 15) and follow-up visits up to Day 113.|
48478495|NCT02461771|101509117|FG002|COMPLETED|Overall Study||7|Completed acute safety observation period (up to Day 15) and follow-up visits up to Day 113.|
48194267|NCT03354390|100797119|FG000|COMPLETED|Level 1||0||
48478496|NCT02461771|101509115|FG000|NOT COMPLETED|Overall Study||0||
48478497|NCT02461771|101509116|FG001|NOT COMPLETED|Overall Study||0||
48194268|NCT03354390|100797120|FG001|COMPLETED|Level 1||0||
48194269|NCT03354390|100797121|FG002|COMPLETED|Level 1||0||
48194270|NCT03354390|100797122|FG003|COMPLETED|Level 1||0||
48194271|NCT03354390|100797119|FG000|NOT COMPLETED|Level 1||3||
48194272|NCT03354390|100797120|FG001|NOT COMPLETED|Level 1||0||
48194273|NCT03354390|100797121|FG002|NOT COMPLETED|Level 1||0||
48194274|NCT03354390|100797122|FG003|NOT COMPLETED|Level 1||0||
48194275|NCT03354390|100797119|FG000|STARTED|Level 2||0||
48194276|NCT03354390|100797120|FG001|STARTED|Level 2||4||
48194277|NCT03354390|100797121|FG002|STARTED|Level 2||0||
48194278|NCT03354390|100797122|FG003|STARTED|Level 2||0||
48194279|NCT03354390|100797119|FG000|Treatment Completed|Level 2||0||
48194280|NCT03354390|100797120|FG001|Treatment Completed|Level 2||4||
48194281|NCT03354390|100797121|FG002|Treatment Completed|Level 2||0||
48194282|NCT03354390|100797122|FG003|Treatment Completed|Level 2||0||
48478498|NCT02461771|101509117|FG002|NOT COMPLETED|Overall Study||0||
48478499|NCT01964092|101509118|FG000|STARTED|Overall Study||229||
48478500|NCT01964092|101509119|FG001|STARTED|Overall Study||181||
48478501|NCT01964092|101509118|FG000|COMPLETED|Overall Study||227||
48478502|NCT01964092|101509119|FG001|COMPLETED|Overall Study||181||
48478503|NCT01964092|101509118|FG000|NOT COMPLETED|Overall Study||2||
48478504|NCT01964092|101509119|FG001|NOT COMPLETED|Overall Study||0||
48478505|NCT02828917|101509120|FG000|STARTED|Overall Study||104||
48478506|NCT02828917|101509120|FG000|COMPLETED|Overall Study||104||
48478507|NCT02828917|101509120|FG000|NOT COMPLETED|Overall Study||0||
48478508|NCT03292653|101509121|FG000|STARTED|Overall Study||11||
48478509|NCT03292653|101509122|FG001|STARTED|Overall Study||10||
48194283|NCT03354390|100797119|FG000|COMPLETED|Level 2||0||
48194284|NCT03354390|100797120|FG001|COMPLETED|Level 2||0||
48194285|NCT03354390|100797121|FG002|COMPLETED|Level 2||0||
48194286|NCT03354390|100797122|FG003|COMPLETED|Level 2||0||
48194287|NCT03354390|100797119|FG000|NOT COMPLETED|Level 2||0||
48194288|NCT03354390|100797120|FG001|NOT COMPLETED|Level 2||4||
48194289|NCT03354390|100797121|FG002|NOT COMPLETED|Level 2||0||
48194290|NCT03354390|100797122|FG003|NOT COMPLETED|Level 2||0||
48194291|NCT03354390|100797119|FG000|STARTED|Level 3||0||
48194292|NCT03354390|100797120|FG001|STARTED|Level 3||0||
48194293|NCT03354390|100797121|FG002|STARTED|Level 3||3||
48194294|NCT03354390|100797122|FG003|STARTED|Level 3||0||
48194295|NCT03354390|100797119|FG000|Treatment Completed|Level 3||0||
48194296|NCT03354390|100797120|FG001|Treatment Completed|Level 3||0||
48194297|NCT03354390|100797121|FG002|Treatment Completed|Level 3||3||
48194298|NCT03354390|100797122|FG003|Treatment Completed|Level 3||0||
48194299|NCT03354390|100797119|FG000|COMPLETED|Level 3||0||
48194300|NCT03354390|100797120|FG001|COMPLETED|Level 3||0||
48194301|NCT03354390|100797121|FG002|COMPLETED|Level 3||0||
48194302|NCT03354390|100797122|FG003|COMPLETED|Level 3||0||
48194303|NCT03354390|100797119|FG000|NOT COMPLETED|Level 3||0||
48194304|NCT03354390|100797120|FG001|NOT COMPLETED|Level 3||0||
48194305|NCT03354390|100797121|FG002|NOT COMPLETED|Level 3||3||
48194306|NCT03354390|100797122|FG003|NOT COMPLETED|Level 3||0||
48478510|NCT03292653|101509123|FG002|STARTED|Overall Study||11||
48478511|NCT03292653|101509121|FG000|COMPLETED|Overall Study||10||
48478512|NCT03292653|101509122|FG001|COMPLETED|Overall Study||10||
48478513|NCT03292653|101509123|FG002|COMPLETED|Overall Study||10||
48478514|NCT03292653|101509121|FG000|NOT COMPLETED|Overall Study||1||
48478515|NCT03292653|101509122|FG001|NOT COMPLETED|Overall Study||0||
48478516|NCT03292653|101509123|FG002|NOT COMPLETED|Overall Study||1||
48478517|NCT04188106|101509124|FG000|STARTED|Overall Study||26||
48478518|NCT04188106|101509124|FG000|COMPLETED|Overall Study||20||
48478519|NCT04188106|101509124|FG000|NOT COMPLETED|Overall Study||6||
48478520|NCT01010542|101509125|FG000|STARTED|Overall Study||1||
48478521|NCT01010542|101509126|FG001|STARTED|Overall Study||30||
48478522|NCT01010542|101509127|FG002|STARTED|Overall Study||8||
48478523|NCT01010542|101509125|FG000|COMPLETED|Overall Study||1||
48478524|NCT01010542|101509126|FG001|COMPLETED|Overall Study||25||
48478525|NCT01010542|101509127|FG002|COMPLETED|Overall Study||6||
48478526|NCT01010542|101509125|FG000|NOT COMPLETED|Overall Study||0||
48478527|NCT01010542|101509126|FG001|NOT COMPLETED|Overall Study||5||
48478528|NCT01010542|101509127|FG002|NOT COMPLETED|Overall Study||2||
48478529|NCT02747615|101509128|FG000|STARTED|Overall Study||30||
48478530|NCT02747615|101509129|FG001|STARTED|Overall Study||30||
48478531|NCT02747615|101509128|FG000|COMPLETED|Overall Study||30||
48478532|NCT02747615|101509129|FG001|COMPLETED|Overall Study||30||
48478533|NCT02747615|101509128|FG000|NOT COMPLETED|Overall Study||0||
48478534|NCT02747615|101509129|FG001|NOT COMPLETED|Overall Study||0||
48478535|NCT00773422|101509130|FG000|STARTED|Overall Study||11||
48478536|NCT00773422|101509131|FG001|STARTED|Overall Study||9||
48478537|NCT00773422|101509132|FG002|STARTED|Overall Study||10||
48478538|NCT00773422|101509130|FG000|COMPLETED|Overall Study||11||
48478539|NCT00773422|101509131|FG001|COMPLETED|Overall Study||9||
48478540|NCT00773422|101509132|FG002|COMPLETED|Overall Study||10||
48478541|NCT00773422|101509130|FG000|NOT COMPLETED|Overall Study||0||
48478542|NCT00773422|101509131|FG001|NOT COMPLETED|Overall Study||0||
48478543|NCT00773422|101509132|FG002|NOT COMPLETED|Overall Study||0||
48478544|NCT00685477|101509133|FG000|STARTED|Overall Study||10||
48478545|NCT00685477|101509134|FG001|STARTED|Overall Study||10||
48478546|NCT00685477|101509135|FG002|STARTED|Overall Study||10||
48478547|NCT00685477|101509136|FG003|STARTED|Overall Study||10||
48478548|NCT00685477|101509137|FG004|STARTED|Overall Study||10||
48478549|NCT00685477|101509138|FG005|STARTED|Overall Study||10||
48478550|NCT00685477|101509133|FG000|COMPLETED|Overall Study||10||
48478551|NCT00685477|101509134|FG001|COMPLETED|Overall Study||10||
48478552|NCT00685477|101509135|FG002|COMPLETED|Overall Study||10||
48478553|NCT00685477|101509136|FG003|COMPLETED|Overall Study||10||
48478554|NCT00685477|101509137|FG004|COMPLETED|Overall Study||10||
48478555|NCT00685477|101509138|FG005|COMPLETED|Overall Study||10||
48478556|NCT00685477|101509133|FG000|NOT COMPLETED|Overall Study||0||
48478557|NCT00685477|101509134|FG001|NOT COMPLETED|Overall Study||0||
48478558|NCT00685477|101509135|FG002|NOT COMPLETED|Overall Study||0||
48478559|NCT00685477|101509136|FG003|NOT COMPLETED|Overall Study||0||
48478560|NCT00685477|101509137|FG004|NOT COMPLETED|Overall Study||0||
48478561|NCT00685477|101509138|FG005|NOT COMPLETED|Overall Study||0||
48478562|NCT00050778|101509139|FG000|STARTED|Overall Study||111||
48478563|NCT00050778|101509140|FG001|STARTED|Overall Study||113||
48478564|NCT00050778|101509141|FG002|STARTED|Overall Study||110||
48478565|NCT00050778|101509139|FG000|Treated|Overall Study||107||
48478566|NCT00050778|101509140|FG001|Treated|Overall Study||108||
48478567|NCT00050778|101509141|FG002|Treated|Overall Study||108||
48478568|NCT00050778|101509139|FG000|COMPLETED|Overall Study||66||
48478569|NCT00050778|101509140|FG001|COMPLETED|Overall Study||92||
48478570|NCT00050778|101509141|FG002|COMPLETED|Overall Study||92||
48478571|NCT00050778|101509139|FG000|NOT COMPLETED|Overall Study||45||
48478572|NCT00050778|101509140|FG001|NOT COMPLETED|Overall Study||21||
48478573|NCT00050778|101509141|FG002|NOT COMPLETED|Overall Study||18||
48478574|NCT02865538|101509142|FG000|STARTED|Overall Study||18|76|
48478575|NCT02865538|101509143|FG001|STARTED|Overall Study||15|76|
48478576|NCT02865538|101509144|FG002|STARTED|Overall Study||15|76|
48478577|NCT02865538|101509145|FG003|STARTED|Overall Study||15|76|
48478578|NCT02865538|101509146|FG004|STARTED|Overall Study||13|76|
48478579|NCT02865538|101509142|FG000|COMPLETED|Overall Study||17|74|
48478580|NCT02865538|101509143|FG001|COMPLETED|Overall Study||15|74|
48478581|NCT02865538|101509144|FG002|COMPLETED|Overall Study||14|74|
48478582|NCT02865538|101509145|FG003|COMPLETED|Overall Study||15|74|
48478583|NCT02865538|101509146|FG004|COMPLETED|Overall Study||13|74|
48478584|NCT02865538|101509142|FG000|NOT COMPLETED|Overall Study||1||
48478585|NCT02865538|101509143|FG001|NOT COMPLETED|Overall Study||0||
48478586|NCT02865538|101509144|FG002|NOT COMPLETED|Overall Study||1||
48478587|NCT02865538|101509145|FG003|NOT COMPLETED|Overall Study||0||
48478588|NCT02865538|101509146|FG004|NOT COMPLETED|Overall Study||0||
48478589|NCT03335761|101509147|FG000|STARTED|Overall Study||19||
48478590|NCT03335761|101509148|FG001|STARTED|Overall Study||14||
48478591|NCT03335761|101509149|FG002|STARTED|Overall Study||15||
48478592|NCT03335761|101509147|FG000|Implanted With a Neurostimulator Device|Overall Study||18||
48194307|NCT03354390|100797119|FG000|STARTED|Level 4||0||
48478593|NCT03335761|101509148|FG001|Implanted With a Neurostimulator Device|Overall Study||14||
48478594|NCT03335761|101509149|FG002|Implanted With a Neurostimulator Device|Overall Study||14||
48478595|NCT03335761|101509147|FG000|COMPLETED|Overall Study||17||
48478596|NCT03335761|101509148|FG001|COMPLETED|Overall Study||13||
48478597|NCT03335761|101509149|FG002|COMPLETED|Overall Study||13||
48478598|NCT03335761|101509147|FG000|NOT COMPLETED|Overall Study||2||
48478599|NCT03335761|101509148|FG001|NOT COMPLETED|Overall Study||1||
48478600|NCT03335761|101509149|FG002|NOT COMPLETED|Overall Study||2||
48478601|NCT04121364|101509150|FG000|STARTED|Overall Study||20||
48478602|NCT04121364|101509150|FG000|COMPLETED|Overall Study||6||
48478603|NCT04121364|101509150|FG000|NOT COMPLETED|Overall Study||14||
48478604|NCT02870920|101509151|FG000|STARTED|Overall Study||61||
48478605|NCT02870920|101509152|FG001|STARTED|Overall Study||119||
48478606|NCT02870920|101509151|FG000|COMPLETED|Overall Study||61||
48478607|NCT02870920|101509152|FG001|COMPLETED|Overall Study||119||
48478608|NCT02870920|101509151|FG000|NOT COMPLETED|Overall Study||0||
48478609|NCT02870920|101509152|FG001|NOT COMPLETED|Overall Study||0||
48478610|NCT02910037|101509153|FG000|STARTED|Overall Study||214||
48478611|NCT02910037|101509153|FG000|COMPLETED|Overall Study||204||
48478612|NCT02910037|101509153|FG000|NOT COMPLETED|Overall Study||10||
48478613|NCT00436553|101509154|FG000|STARTED|Overall Study||104||
48478614|NCT00436553|101509155|FG001|STARTED|Overall Study||105||
48478615|NCT00436553|101509156|FG002|STARTED|Overall Study||112||
48478616|NCT00436553|101509154|FG000|COMPLETED|Overall Study||91||
48478617|NCT00436553|101509155|FG001|COMPLETED|Overall Study||93||
48478618|NCT00436553|101509156|FG002|COMPLETED|Overall Study||102||
48478619|NCT00436553|101509154|FG000|NOT COMPLETED|Overall Study||13||
48478620|NCT00436553|101509155|FG001|NOT COMPLETED|Overall Study||12||
48478621|NCT00436553|101509156|FG002|NOT COMPLETED|Overall Study||10||
48478622|NCT01318499|101509157|FG000|STARTED|Overall Study||540||
48478623|NCT01318499|101509158|FG001|STARTED|Overall Study||534||
48478624|NCT01318499|101509159|FG002|STARTED|Overall Study||268||
48478625|NCT01318499|101509157|FG000|COMPLETED|Overall Study||475||
48478626|NCT01318499|101509158|FG001|COMPLETED|Overall Study||458||
48478627|NCT01318499|101509159|FG002|COMPLETED|Overall Study||121||
48478628|NCT01318499|101509157|FG000|NOT COMPLETED|Overall Study||65||
48478629|NCT01318499|101509158|FG001|NOT COMPLETED|Overall Study||76||
48478630|NCT01318499|101509159|FG002|NOT COMPLETED|Overall Study||147||
48478631|NCT02627924|101509160|FG000|STARTED|Overall Study||91||
48478632|NCT02627924|101509160|FG000|COMPLETED|Overall Study||79||
48478633|NCT02627924|101509160|FG000|NOT COMPLETED|Overall Study||12||
48478634|NCT04869787|101509161|FG000|STARTED|Screening||7||
48478635|NCT04869787|101509161|FG000|COMPLETED|Screening||6||
48478636|NCT04869787|101509161|FG000|NOT COMPLETED|Screening||1||
48478637|NCT04869787|101509161|FG000|STARTED|SCD Treatment Period (up to 10 Days)||6||
48478638|NCT04869787|101509161|FG000|COMPLETED|SCD Treatment Period (up to 10 Days)||5||
48478639|NCT04869787|101509161|FG000|NOT COMPLETED|SCD Treatment Period (up to 10 Days)||1||
48478640|NCT04869787|101509161|FG000|STARTED|Observational Follow Up Period (90 Days)||5||
48478641|NCT04869787|101509161|FG000|COMPLETED|Observational Follow Up Period (90 Days)||5||
48478642|NCT04869787|101509161|FG000|NOT COMPLETED|Observational Follow Up Period (90 Days)||0||
48478643|NCT01077596|101509162|FG000|STARTED|Overall Study||350||
48478644|NCT01077596|101509163|FG001|STARTED|Overall Study||1050||
48478645|NCT01077596|101509164|FG002|STARTED|Overall Study||457||
48478646|NCT01077596|101509165|FG003|STARTED|Overall Study||1370||
48478647|NCT01077596|101509166|FG004|STARTED|Overall Study||294||
48478648|NCT01077596|101509167|FG005|STARTED|Overall Study||882||
48478649|NCT01077596|101509168|FG006|STARTED|Overall Study||308||
48478650|NCT01077596|101509169|FG007|STARTED|Overall Study||837||
48478651|NCT01077596|101509170|FG008|STARTED|Overall Study||2842||
48478652|NCT01077596|101509171|FG009|STARTED|Overall Study||28420||
48478653|NCT01077596|101509172|FG010|STARTED|Overall Study||2215||
48478654|NCT01077596|101509173|FG011|STARTED|Overall Study||22150||
48478655|NCT01077596|101509162|FG000|COMPLETED|Overall Study||350||
48478656|NCT01077596|101509163|FG001|COMPLETED|Overall Study||1050||
48478657|NCT01077596|101509164|FG002|COMPLETED|Overall Study||457||
48478658|NCT01077596|101509165|FG003|COMPLETED|Overall Study||1370||
48478659|NCT01077596|101509166|FG004|COMPLETED|Overall Study||294||
48478660|NCT01077596|101509167|FG005|COMPLETED|Overall Study||882||
48478661|NCT01077596|101509168|FG006|COMPLETED|Overall Study||308||
48478662|NCT01077596|101509169|FG007|COMPLETED|Overall Study||837||
48478663|NCT01077596|101509170|FG008|COMPLETED|Overall Study||2842||
48478664|NCT01077596|101509171|FG009|COMPLETED|Overall Study||28420||
48478665|NCT01077596|101509172|FG010|COMPLETED|Overall Study||2215||
48478666|NCT01077596|101509173|FG011|COMPLETED|Overall Study||22150||
48478667|NCT01077596|101509162|FG000|NOT COMPLETED|Overall Study||0||
48478668|NCT01077596|101509163|FG001|NOT COMPLETED|Overall Study||0||
48478669|NCT01077596|101509164|FG002|NOT COMPLETED|Overall Study||0||
48478670|NCT01077596|101509165|FG003|NOT COMPLETED|Overall Study||0||
48478671|NCT01077596|101509166|FG004|NOT COMPLETED|Overall Study||0||
48478672|NCT01077596|101509167|FG005|NOT COMPLETED|Overall Study||0||
48478673|NCT01077596|101509168|FG006|NOT COMPLETED|Overall Study||0||
48478674|NCT01077596|101509169|FG007|NOT COMPLETED|Overall Study||0||
48478675|NCT01077596|101509170|FG008|NOT COMPLETED|Overall Study||0||
48478676|NCT01077596|101509171|FG009|NOT COMPLETED|Overall Study||0||
48478677|NCT01077596|101509172|FG010|NOT COMPLETED|Overall Study||0||
48478678|NCT01077596|101509173|FG011|NOT COMPLETED|Overall Study||0||
48478679|NCT01536405|101509174|FG000|STARTED|Randomization to Visit 1 (Vaccination 1)||706||
48478680|NCT01536405|101509175|FG001|STARTED|Randomization to Visit 1 (Vaccination 1)||706||
48478681|NCT01536405|101509174|FG000|COMPLETED|Randomization to Visit 1 (Vaccination 1)||698||
48478682|NCT01536405|101509175|FG001|COMPLETED|Randomization to Visit 1 (Vaccination 1)||702||
48478683|NCT01536405|101509174|FG000|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||8||
48478684|NCT01536405|101509175|FG001|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||4||
48478685|NCT01536405|101509174|FG000|STARTED|Visit 1 (Vaccination 1) to Visit 2||698||
48478686|NCT01536405|101509175|FG001|STARTED|Visit 1 (Vaccination 1) to Visit 2||702||
48478687|NCT01536405|101509174|FG000|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||698||
48478688|NCT01536405|101509175|FG001|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||702||
48478689|NCT01536405|101509174|FG000|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||666||
48478690|NCT01536405|101509175|FG001|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||662||
48478691|NCT01536405|101509174|FG000|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||32||
48478692|NCT01536405|101509175|FG001|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||40||
48478693|NCT01536405|101509174|FG000|STARTED|Visit 2 to Visit 3 (Vaccination 2)||666||
48478694|NCT01536405|101509175|FG001|STARTED|Visit 2 to Visit 3 (Vaccination 2)||662||
48478695|NCT01536405|101509174|FG000|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||635||
48478696|NCT01536405|101509175|FG001|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||634||
48478697|NCT01536405|101509174|FG000|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||31||
48478698|NCT01536405|101509175|FG001|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||28||
48478699|NCT01536405|101509174|FG000|STARTED|Visit 3 (Vaccination 2) to Visit 4||635||
48478700|NCT01536405|101509175|FG001|STARTED|Visit 3 (Vaccination 2) to Visit 4||634||
48478701|NCT01536405|101509174|FG000|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||634||
48478702|NCT01536405|101509175|FG001|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||632||
48478703|NCT01536405|101509174|FG000|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||615||
48478704|NCT01536405|101509175|FG001|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||618||
48478705|NCT01536405|101509174|FG000|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||20||
48478706|NCT01536405|101509175|FG001|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||16||
48478707|NCT01536405|101509174|FG000|STARTED|Visit 4 to Extended Study Follow-up||615||
48478708|NCT01536405|101509175|FG001|STARTED|Visit 4 to Extended Study Follow-up||618||
48666345|NCT03289039|101967562|FG001|COMPLETED|Overall Study||8||
48194308|NCT03354390|100797120|FG001|STARTED|Level 4||0||
48478709|NCT01536405|101509174|FG000|COMPLETED|Visit 4 to Extended Study Follow-up||595||
48478710|NCT01536405|101509175|FG001|COMPLETED|Visit 4 to Extended Study Follow-up||595||
48478711|NCT01536405|101509174|FG000|NOT COMPLETED|Visit 4 to Extended Study Follow-up||20||
48478712|NCT01536405|101509175|FG001|NOT COMPLETED|Visit 4 to Extended Study Follow-up||23||
48478713|NCT02100228|101509176|FG000|STARTED|Overall Study||753||
48478714|NCT02100228|101509177|FG001|STARTED|Overall Study||747||
48478715|NCT02100228|101509176|FG000|COMPLETED|Overall Study||678||
48478716|NCT02100228|101509177|FG001|COMPLETED|Overall Study||657||
48478717|NCT02100228|101509176|FG000|NOT COMPLETED|Overall Study||75||
48194309|NCT03354390|100797121|FG002|STARTED|Level 4||0||
48194310|NCT03354390|100797122|FG003|STARTED|Level 4||7||
48194311|NCT03354390|100797119|FG000|Completed Treatment|Level 4||0||
48478718|NCT02100228|101509177|FG001|NOT COMPLETED|Overall Study||90||
48478719|NCT01866319|101509178|FG000|STARTED|Overall Study||278||
48478720|NCT01866319|101509179|FG001|STARTED|Overall Study||279||
48478721|NCT01866319|101509180|FG002|STARTED|Overall Study||277||
48478722|NCT01866319|101509178|FG000|Treated|Overall Study||256||
48478723|NCT01866319|101509179|FG001|Treated|Overall Study||278||
48478724|NCT01866319|101509180|FG002|Treated|Overall Study||277||
48478725|NCT01866319|101509178|FG000|COMPLETED|Overall Study||71||
48478726|NCT01866319|101509179|FG001|COMPLETED|Overall Study||101||
48478727|NCT01866319|101509180|FG002|COMPLETED|Overall Study||97||
48478728|NCT01866319|101509178|FG000|NOT COMPLETED|Overall Study||207||
48478729|NCT01866319|101509179|FG001|NOT COMPLETED|Overall Study||178||
48478730|NCT01866319|101509180|FG002|NOT COMPLETED|Overall Study||180||
48478731|NCT00533273|101509181|FG000|STARTED|Double-blind||45||
48478732|NCT00533273|101509182|FG001|STARTED|Double-blind||21||
48478733|NCT00533273|101509181|FG000|COMPLETED|Double-blind||45||
48478734|NCT00533273|101509182|FG001|COMPLETED|Double-blind||19||
48478735|NCT00533273|101509181|FG000|NOT COMPLETED|Double-blind||0||
48478736|NCT00533273|101509182|FG001|NOT COMPLETED|Double-blind||2||
48478737|NCT00533273|101509181|FG000|STARTED|Open-label||64||
48478738|NCT00533273|101509182|FG001|STARTED|Open-label||0||
48478739|NCT00533273|101509181|FG000|COMPLETED|Open-label||58||
48478740|NCT00533273|101509182|FG001|COMPLETED|Open-label||0||
48478741|NCT00533273|101509181|FG000|NOT COMPLETED|Open-label||6||
48478742|NCT00533273|101509182|FG001|NOT COMPLETED|Open-label||0||
48478743|NCT00906165|101509183|FG000|STARTED|Overall Study||14||
48478744|NCT00906165|101509184|FG001|STARTED|Overall Study||14||
48478745|NCT00906165|101509183|FG000|COMPLETED|Overall Study||10||
48478746|NCT00906165|101509184|FG001|COMPLETED|Overall Study||14||
48478747|NCT00906165|101509183|FG000|NOT COMPLETED|Overall Study||4||
48478748|NCT00906165|101509184|FG001|NOT COMPLETED|Overall Study||0||
48478749|NCT05612724|101509185|FG000|STARTED|Overall Study||14||
48478750|NCT05612724|101509185|FG000|COMPLETED|Overall Study||10||
48478751|NCT05612724|101509185|FG000|NOT COMPLETED|Overall Study||4||
48478752|NCT01314417|101509186|FG000|STARTED|Overall Study||2||
48478753|NCT01314417|101509186|FG000|COMPLETED|Overall Study||2||
48478754|NCT01314417|101509186|FG000|NOT COMPLETED|Overall Study||0||
48478755|NCT00862979|101509187|FG000|STARTED|Overall Study||84||
48478756|NCT00862979|101509188|FG001|STARTED|Overall Study||78||
48478757|NCT00862979|101509187|FG000|Full Analysis Set (FAS)|Overall Study||74||
48478758|NCT00862979|101509188|FG001|Full Analysis Set (FAS)|Overall Study||71||
48478759|NCT00862979|101509187|FG000|COMPLETED|Overall Study||76||
48478760|NCT00862979|101509188|FG001|COMPLETED|Overall Study||71||
48478761|NCT00862979|101509187|FG000|NOT COMPLETED|Overall Study||8||
48478762|NCT00862979|101509188|FG001|NOT COMPLETED|Overall Study||7||
48478763|NCT01248247|101509189|FG000|STARTED|Overall Study||22||
48478764|NCT01248247|101509190|FG001|STARTED|Overall Study||42||
48478765|NCT01248247|101509191|FG002|STARTED|Overall Study||75||
48478766|NCT01248247|101509192|FG003|STARTED|Overall Study||61||
48478767|NCT01248247|101509189|FG000|COMPLETED|Overall Study||0||
48478768|NCT01248247|101509190|FG001|COMPLETED|Overall Study||0||
48478769|NCT01248247|101509191|FG002|COMPLETED|Overall Study||0||
48478770|NCT01248247|101509192|FG003|COMPLETED|Overall Study||0||
48478771|NCT01248247|101509189|FG000|NOT COMPLETED|Overall Study||22||
48478772|NCT01248247|101509190|FG001|NOT COMPLETED|Overall Study||42||
48478773|NCT01248247|101509191|FG002|NOT COMPLETED|Overall Study||75||
48478774|NCT01248247|101509192|FG003|NOT COMPLETED|Overall Study||61||
48478775|NCT00667095|101509193|FG000|STARTED|Overall Study||11||
48478776|NCT00667095|101509194|FG001|STARTED|Overall Study||10||
48478777|NCT00667095|101509193|FG000|COMPLETED|Overall Study||11||
48478778|NCT00667095|101509194|FG001|COMPLETED|Overall Study||9||
48478779|NCT00667095|101509193|FG000|NOT COMPLETED|Overall Study||0||
48478780|NCT00667095|101509194|FG001|NOT COMPLETED|Overall Study||1||
48478781|NCT03435081|101509195|FG000|STARTED|Week 0 to Week 16||147||
48478782|NCT03435081|101509196|FG001|STARTED|Week 0 to Week 16||147||
48478783|NCT03435081|101509197|FG002|STARTED|Week 0 to Week 16||146||
48478784|NCT03435081|101509195|FG000|Received at Least One Dose of Study Drug|Week 0 to Week 16||147||
48478785|NCT03435081|101509196|FG001|Received at Least One Dose of Study Drug|Week 0 to Week 16||147||
48478786|NCT03435081|101509197|FG002|Received at Least One Dose of Study Drug|Week 0 to Week 16||146||
48478787|NCT03435081|101509195|FG000|Completed Week 16 and Entered JAIX Study|Week 0 to Week 16||111||
48478788|NCT03435081|101509196|FG001|Completed Week 16 and Entered JAIX Study|Week 0 to Week 16||112||
48478789|NCT03435081|101509197|FG002|Completed Week 16 and Entered JAIX Study|Week 0 to Week 16||96||
48478790|NCT03435081|101509195|FG000|COMPLETED|Week 0 to Week 16||126||
48478791|NCT03435081|101509196|FG001|COMPLETED|Week 0 to Week 16||131||
48478792|NCT03435081|101509197|FG002|COMPLETED|Week 0 to Week 16||127||
48478793|NCT03435081|101509195|FG000|NOT COMPLETED|Week 0 to Week 16||21||
48478794|NCT03435081|101509196|FG001|NOT COMPLETED|Week 0 to Week 16||16||
48478795|NCT03435081|101509197|FG002|NOT COMPLETED|Week 0 to Week 16||19||
48478796|NCT03435081|101509195|FG000|STARTED|Week 16 to Week 104||8||
48478797|NCT03435081|101509196|FG001|STARTED|Week 16 to Week 104||19||
48478798|NCT03435081|101509197|FG002|STARTED|Week 16 to Week 104||35||
48478799|NCT03435081|101509195|FG000|Rolled Over Into the Open-Label Extension Study JAIX.|Week 16 to Week 104||6||
48478800|NCT03435081|101509196|FG001|Rolled Over Into the Open-Label Extension Study JAIX.|Week 16 to Week 104||14||
48478801|NCT03435081|101509197|FG002|Rolled Over Into the Open-Label Extension Study JAIX.|Week 16 to Week 104||19||
48478802|NCT03435081|101509195|FG000|COMPLETED|Week 16 to Week 104||5||
48478803|NCT03435081|101509196|FG001|COMPLETED|Week 16 to Week 104||6||
48478804|NCT03435081|101509197|FG002|COMPLETED|Week 16 to Week 104||16||
48478805|NCT03435081|101509195|FG000|NOT COMPLETED|Week 16 to Week 104||3||
48478806|NCT03435081|101509196|FG001|NOT COMPLETED|Week 16 to Week 104||13||
48478807|NCT03435081|101509197|FG002|NOT COMPLETED|Week 16 to Week 104||19||
48478808|NCT00874887|101509198|FG000|STARTED|Overall Study||32||
48478809|NCT00874887|101509199|FG001|STARTED|Overall Study||34||
48478810|NCT00874887|101509198|FG000|COMPLETED|Overall Study||32||
48478811|NCT00874887|101509199|FG001|COMPLETED|Overall Study||34||
48478812|NCT00874887|101509198|FG000|NOT COMPLETED|Overall Study||0||
48478813|NCT00874887|101509199|FG001|NOT COMPLETED|Overall Study||0||
48478814|NCT01270919|101509200|FG000|STARTED|Overall Study||0||
48478815|NCT01270919|101509200|FG000|COMPLETED|Overall Study||0||
48478816|NCT01270919|101509200|FG000|NOT COMPLETED|Overall Study||0||
48478817|NCT04753710|101509201|FG000|STARTED|Overall||67||
48666346|NCT03289039|101967561|FG000|NOT COMPLETED|Overall Study||1||
48478818|NCT04753710|101509202|FG001|STARTED|Overall||29||
48478819|NCT04753710|101509201|FG000|COMPLETED|Overall||67||
48478820|NCT04753710|101509202|FG001|COMPLETED|Overall||29||
48478821|NCT04753710|101509201|FG000|NOT COMPLETED|Overall||0||
48478822|NCT04753710|101509202|FG001|NOT COMPLETED|Overall||0||
48478823|NCT04753710|101509201|FG000|STARTED|First Phase||27||
48478824|NCT04753710|101509202|FG001|STARTED|First Phase||9||
48478825|NCT04753710|101509201|FG000|COMPLETED|First Phase||27||
48478826|NCT04753710|101509202|FG001|COMPLETED|First Phase||9||
48478827|NCT04753710|101509201|FG000|NOT COMPLETED|First Phase||0||
48478828|NCT04753710|101509202|FG001|NOT COMPLETED|First Phase||0||
48478829|NCT04753710|101509201|FG000|STARTED|Second Phase||40||
48478830|NCT04753710|101509202|FG001|STARTED|Second Phase||20||
48478831|NCT04753710|101509201|FG000|COMPLETED|Second Phase||40||
48478832|NCT04753710|101509202|FG001|COMPLETED|Second Phase||20||
48478833|NCT04753710|101509201|FG000|NOT COMPLETED|Second Phase||0||
48478834|NCT04753710|101509202|FG001|NOT COMPLETED|Second Phase||0||
48478835|NCT01520909|101509203|FG000|STARTED|Part 1 (Randomized Period)||29||
48478836|NCT01520909|101509204|FG001|STARTED|Part 1 (Randomized Period)||63||
48478837|NCT01520909|101509205|FG002|STARTED|Part 1 (Randomized Period)||0||
48478838|NCT01520909|101509203|FG000|COMPLETED|Part 1 (Randomized Period)||28||
48478839|NCT01520909|101509204|FG001|COMPLETED|Part 1 (Randomized Period)||61||
48478840|NCT01520909|101509205|FG002|COMPLETED|Part 1 (Randomized Period)||0||
48478841|NCT01520909|101509203|FG000|NOT COMPLETED|Part 1 (Randomized Period)||1||
48478842|NCT01520909|101509204|FG001|NOT COMPLETED|Part 1 (Randomized Period)||2||
48478843|NCT01520909|101509205|FG002|NOT COMPLETED|Part 1 (Randomized Period)||0||
48478844|NCT01520909|101509203|FG000|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0||
48478845|NCT01520909|101509204|FG001|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0||
48478846|NCT01520909|101509205|FG002|STARTED|Part 2 (Open-Label Period)-Eltrombopag||87||
48478847|NCT01520909|101509203|FG000|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0||
48478848|NCT01520909|101509204|FG001|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0||
48478849|NCT01520909|101509205|FG002|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||80||
48478850|NCT01520909|101509203|FG000|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0||
48478851|NCT01520909|101509204|FG001|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0||
48478852|NCT01520909|101509205|FG002|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||7||
48478853|NCT03138330|101509206|FG000|STARTED|Overall Study||95||
48478854|NCT03138330|101509206|FG000|COMPLETED|Overall Study||91||
48478855|NCT03138330|101509206|FG000|NOT COMPLETED|Overall Study||4||
48478856|NCT02728102|101509207|FG000|STARTED|Overall Study||68||
48478857|NCT02728102|101509208|FG001|STARTED|Overall Study||37||
48478858|NCT02728102|101509209|FG002|STARTED|Overall Study||35||
48478859|NCT02728102|101509207|FG000|COMPLETED|Overall Study||61||
48478860|NCT02728102|101509208|FG001|COMPLETED|Overall Study||33||
48478861|NCT02728102|101509209|FG002|COMPLETED|Overall Study||30||
48478862|NCT02728102|101509207|FG000|NOT COMPLETED|Overall Study||7||
48478863|NCT02728102|101509208|FG001|NOT COMPLETED|Overall Study||4||
48478864|NCT02728102|101509209|FG002|NOT COMPLETED|Overall Study||5||
48478865|NCT00765648|101509210|FG000|STARTED|Overall Study||110||
48478866|NCT00765648|101509211|FG001|STARTED|Overall Study||116||
48478867|NCT00765648|101509210|FG000|COMPLETED|Overall Study||109||
48478868|NCT00765648|101509211|FG001|COMPLETED|Overall Study||114||
48478869|NCT00765648|101509210|FG000|NOT COMPLETED|Overall Study||1||
48478870|NCT00765648|101509211|FG001|NOT COMPLETED|Overall Study||2||
48478871|NCT04213326|101509212|FG000|STARTED|Overall Study||937||
48478872|NCT04213326|101509213|FG001|STARTED|Overall Study||5463||
48478873|NCT04213326|101509212|FG000|COMPLETED|Overall Study||727||
48478874|NCT04213326|101509213|FG001|COMPLETED|Overall Study||3893||
48478875|NCT04213326|101509212|FG000|NOT COMPLETED|Overall Study||210||
48478876|NCT04213326|101509213|FG001|NOT COMPLETED|Overall Study||1570||
48478877|NCT01691508|101509214|FG000|STARTED|Overall Study||66||
48478878|NCT01691508|101509215|FG001|STARTED|Overall Study||69||
48478879|NCT01691508|101509214|FG000|COMPLETED|Overall Study||62||
48478880|NCT01691508|101509215|FG001|COMPLETED|Overall Study||66||
48478881|NCT01691508|101509214|FG000|NOT COMPLETED|Overall Study||4||
48478882|NCT01691508|101509215|FG001|NOT COMPLETED|Overall Study||3||
48478883|NCT02019940|101509216|FG000|STARTED|Overall Study||18||
48478884|NCT02019940|101509216|FG000|COMPLETED|Overall Study||8||
48478885|NCT02019940|101509216|FG000|NOT COMPLETED|Overall Study||10||
48478886|NCT01027143|101509217|FG000|STARTED|Overall Study||77||
48478887|NCT01027143|101509218|FG001|STARTED|Overall Study||21||
48478888|NCT01027143|101509217|FG000|COMPLETED|Overall Study||68||
48478889|NCT01027143|101509218|FG001|COMPLETED|Overall Study||17||
48478890|NCT01027143|101509217|FG000|NOT COMPLETED|Overall Study||9||
48478891|NCT01027143|101509218|FG001|NOT COMPLETED|Overall Study||4||
48478892|NCT03687736|101509219|FG000|STARTED|Overall Study||120||
48478893|NCT03687736|101509219|FG000|COMPLETED|Overall Study||110||
48478894|NCT03687736|101509219|FG000|NOT COMPLETED|Overall Study||10||
48478895|NCT02405325|101509220|FG000|STARTED|Overall Study||267||
48478896|NCT02405325|101509221|FG001|STARTED|Overall Study||209||
48478897|NCT02405325|101509220|FG000|COMPLETED|Overall Study||203||
48478898|NCT02405325|101509221|FG001|COMPLETED|Overall Study||175||
48478899|NCT02405325|101509220|FG000|NOT COMPLETED|Overall Study||64||
48478900|NCT02405325|101509221|FG001|NOT COMPLETED|Overall Study||34||
48478901|NCT01026623|101509222|FG000|STARTED|Overall Study||6||
48478902|NCT01026623|101509223|FG001|STARTED|Overall Study||5||
48478903|NCT01026623|101509224|FG002|STARTED|Overall Study||5||
48478904|NCT01026623|101509222|FG000|COMPLETED|Overall Study||6||
48478905|NCT01026623|101509223|FG001|COMPLETED|Overall Study||5||
48478906|NCT01026623|101509224|FG002|COMPLETED|Overall Study||5||
48478907|NCT01026623|101509222|FG000|NOT COMPLETED|Overall Study||0||
48478908|NCT01026623|101509223|FG001|NOT COMPLETED|Overall Study||0||
48478909|NCT01026623|101509224|FG002|NOT COMPLETED|Overall Study||0||
48478910|NCT01853553|101509225|FG000|STARTED|Overall Study||29||
48478911|NCT01853553|101509226|FG001|STARTED|Overall Study||32||
48478912|NCT01853553|101509225|FG000|COMPLETED|Overall Study||28||
48478913|NCT01853553|101509226|FG001|COMPLETED|Overall Study||32||
48478914|NCT01853553|101509225|FG000|NOT COMPLETED|Overall Study||1||
48478915|NCT01853553|101509226|FG001|NOT COMPLETED|Overall Study||0||
48478916|NCT01270503|101509227|FG000|STARTED|Overall Study||538||
48478917|NCT01270503|101509227|FG000|COMPLETED|Overall Study||537||
48478918|NCT01270503|101509227|FG000|NOT COMPLETED|Overall Study||1||
48478919|NCT04567186|101509228|FG000|STARTED|Period 1||38||
48478920|NCT04567186|101509229|FG001|STARTED|Period 1||40||
48478921|NCT04567186|101509228|FG000|COMPLETED|Period 1||37||
48478922|NCT04567186|101509229|FG001|COMPLETED|Period 1||37||
48478923|NCT04567186|101509228|FG000|NOT COMPLETED|Period 1||1||
48478924|NCT04567186|101509229|FG001|NOT COMPLETED|Period 1||3||
48478925|NCT04567186|101509228|FG000|STARTED|Period 2||37||
48478926|NCT04567186|101509229|FG001|STARTED|Period 2||37||
48478927|NCT04567186|101509228|FG000|COMPLETED|Period 2||37||
48478928|NCT04567186|101509229|FG001|COMPLETED|Period 2||34||
48478929|NCT04567186|101509228|FG000|NOT COMPLETED|Period 2||0||
48478930|NCT04567186|101509229|FG001|NOT COMPLETED|Period 2||3||
48478931|NCT04567186|101509228|FG000|STARTED|Period 3||37||
48478932|NCT04567186|101509229|FG001|STARTED|Period 3||34||
48478933|NCT04567186|101509228|FG000|COMPLETED|Period 3||36||
48478934|NCT04567186|101509229|FG001|COMPLETED|Period 3||34||
48478935|NCT04567186|101509228|FG000|NOT COMPLETED|Period 3||1||
48478936|NCT04567186|101509229|FG001|NOT COMPLETED|Period 3||0||
48478937|NCT01768858|101509230|FG000|STARTED|Overall Study||96||
48478938|NCT01768858|101509230|FG000|COMPLETED|Overall Study||74||
48478939|NCT01768858|101509230|FG000|NOT COMPLETED|Overall Study||22||
48478940|NCT01297348|101509231|FG000|STARTED|Overall Study||12281||
48194312|NCT03354390|100797120|FG001|Completed Treatment|Level 4||0||
48194313|NCT03354390|100797121|FG002|Completed Treatment|Level 4||0||
48478941|NCT01297348|101509232|FG001|STARTED|Overall Study||586401||
48478942|NCT01297348|101509231|FG000|COMPLETED|Overall Study||12281||
48478943|NCT01297348|101509232|FG001|COMPLETED|Overall Study||586401||
48478944|NCT01297348|101509231|FG000|NOT COMPLETED|Overall Study||0||
48478945|NCT01297348|101509232|FG001|NOT COMPLETED|Overall Study||0||
48478946|NCT00119379|101509233|FG000|STARTED|Overall Study||26||
48478947|NCT00119379|101509234|FG001|STARTED|Overall Study||24||
48478948|NCT00119379|101509233|FG000|COMPLETED|Overall Study||22||
48478949|NCT00119379|101509234|FG001|COMPLETED|Overall Study||23||
48478950|NCT00119379|101509233|FG000|NOT COMPLETED|Overall Study||4||
48478951|NCT00119379|101509234|FG001|NOT COMPLETED|Overall Study||1||
48478952|NCT00939003|101509235|FG000|STARTED|Double-blind Treatment Period||97||
48478953|NCT00939003|101509236|FG001|STARTED|Double-blind Treatment Period||95||
48478954|NCT00939003|101509235|FG000|COMPLETED|Double-blind Treatment Period||95||
48478955|NCT00939003|101509236|FG001|COMPLETED|Double-blind Treatment Period||91||
48478956|NCT00939003|101509235|FG000|NOT COMPLETED|Double-blind Treatment Period||2||
48478957|NCT00939003|101509236|FG001|NOT COMPLETED|Double-blind Treatment Period||4||
48478958|NCT00939003|101509235|FG000|STARTED|Open-label Treatment Period||95||
48478959|NCT00939003|101509236|FG001|STARTED|Open-label Treatment Period||91||
48478960|NCT00939003|101509235|FG000|COMPLETED|Open-label Treatment Period||66||
48478961|NCT00939003|101509236|FG001|COMPLETED|Open-label Treatment Period||62||
48478962|NCT00939003|101509235|FG000|NOT COMPLETED|Open-label Treatment Period||29||
48478963|NCT00939003|101509236|FG001|NOT COMPLETED|Open-label Treatment Period||29||
48478964|NCT02711852|101509237|FG000|STARTED|Overall Study||19||
48478965|NCT02711852|101509237|FG000|Received At Least 1 Dose of Study Drug|Overall Study||19||
48478966|NCT02711852|101509237|FG000|COMPLETED|Overall Study||9||
48478967|NCT02711852|101509237|FG000|NOT COMPLETED|Overall Study||10||
48478968|NCT00860405|101509238|FG000|STARTED|Overall Study||31||
48478969|NCT00860405|101509239|FG001|STARTED|Overall Study||30||
48478970|NCT00860405|101509238|FG000|Completed Treatment|Overall Study||31||
48478971|NCT00860405|101509239|FG001|Completed Treatment|Overall Study||29||
48478972|NCT00860405|101509238|FG000|Day 28 Follow-up Performed|Overall Study||31||
48478973|NCT00860405|101509239|FG001|Day 28 Follow-up Performed|Overall Study||29||
48478974|NCT00860405|101509238|FG000|COMPLETED|Overall Study||26||
48478975|NCT00860405|101509239|FG001|COMPLETED|Overall Study||26||
48478976|NCT00860405|101509238|FG000|NOT COMPLETED|Overall Study||5||
48478977|NCT00860405|101509239|FG001|NOT COMPLETED|Overall Study||4||
48478978|NCT01185821|101509240|FG000|STARTED|Overall Study||33||
48478979|NCT01185821|101509241|FG001|STARTED|Overall Study||29||
48478980|NCT01185821|101509242|FG002|STARTED|Overall Study||43||
48478981|NCT01185821|101509243|FG003|STARTED|Overall Study||29||
48478982|NCT01185821|101509244|FG004|STARTED|Overall Study||50||
48478983|NCT01185821|101509240|FG000|Patients With Washout|Overall Study||33||
48478984|NCT01185821|101509241|FG001|Patients With Washout|Overall Study||29||
48478985|NCT01185821|101509242|FG002|Patients With Washout|Overall Study||39||
48478986|NCT01185821|101509243|FG003|Patients With Washout|Overall Study||29||
48478987|NCT01185821|101509244|FG004|Patients With Washout|Overall Study||33||
48478988|NCT01185821|101509240|FG000|Patients Without Washout|Overall Study||0||
48478989|NCT01185821|101509241|FG001|Patients Without Washout|Overall Study||0||
48478990|NCT01185821|101509242|FG002|Patients Without Washout|Overall Study||4||
48478991|NCT01185821|101509243|FG003|Patients Without Washout|Overall Study||0||
48478992|NCT01185821|101509244|FG004|Patients Without Washout|Overall Study||17||
48478993|NCT01185821|101509240|FG000|Patients on Placebo in Core|Overall Study||8||
48478994|NCT01185821|101509241|FG001|Patients on Placebo in Core|Overall Study||7||
48478995|NCT01185821|101509242|FG002|Patients on Placebo in Core|Overall Study||9||
48478996|NCT01185821|101509243|FG003|Patients on Placebo in Core|Overall Study||8||
48478997|NCT01185821|101509244|FG004|Patients on Placebo in Core|Overall Study||2||
48478998|NCT01185821|101509240|FG000|COMPLETED|Overall Study||26||
48478999|NCT01185821|101509241|FG001|COMPLETED|Overall Study||20||
48479000|NCT01185821|101509242|FG002|COMPLETED|Overall Study||33||
48479001|NCT01185821|101509243|FG003|COMPLETED|Overall Study||23||
48479002|NCT01185821|101509244|FG004|COMPLETED|Overall Study||26||
48479003|NCT01185821|101509240|FG000|NOT COMPLETED|Overall Study||7||
48479004|NCT01185821|101509241|FG001|NOT COMPLETED|Overall Study||9||
48479005|NCT01185821|101509242|FG002|NOT COMPLETED|Overall Study||10||
48479006|NCT01185821|101509243|FG003|NOT COMPLETED|Overall Study||6||
48479007|NCT01185821|101509244|FG004|NOT COMPLETED|Overall Study||24||
48479008|NCT00488774|101509245|FG000|STARTED|Overall Study||77||
48479009|NCT00488774|101509246|FG001|STARTED|Overall Study||62||
48479010|NCT00488774|101509247|FG002|STARTED|Overall Study||75||
48479011|NCT00488774|101509248|FG003|STARTED|Overall Study||77||
48479012|NCT00488774|101509245|FG000|COMPLETED|Overall Study||69||
48479013|NCT00488774|101509246|FG001|COMPLETED|Overall Study||57||
48479014|NCT00488774|101509247|FG002|COMPLETED|Overall Study||70||
48479015|NCT00488774|101509248|FG003|COMPLETED|Overall Study||74||
48479016|NCT00488774|101509245|FG000|NOT COMPLETED|Overall Study||8||
48479017|NCT00488774|101509246|FG001|NOT COMPLETED|Overall Study||5||
48479018|NCT00488774|101509247|FG002|NOT COMPLETED|Overall Study||5||
48479019|NCT00488774|101509248|FG003|NOT COMPLETED|Overall Study||3||
48479020|NCT02763865|101509249|FG000|STARTED|Overall Study||5||
48479021|NCT02763865|101509250|FG001|STARTED|Overall Study||5||
48479022|NCT02763865|101509249|FG000|COMPLETED|Overall Study||5||
48479023|NCT02763865|101509250|FG001|COMPLETED|Overall Study||5||
48479024|NCT02763865|101509249|FG000|NOT COMPLETED|Overall Study||0||
48479025|NCT02763865|101509250|FG001|NOT COMPLETED|Overall Study||0||
48479026|NCT01110005|101509251|FG000|STARTED|Overall Study||157||
48479027|NCT01110005|101509252|FG001|STARTED|Overall Study||161||
48479028|NCT01110005|101509251|FG000|COMPLETED|Overall Study||153||
48479029|NCT01110005|101509252|FG001|COMPLETED|Overall Study||156||
48479030|NCT01110005|101509251|FG000|NOT COMPLETED|Overall Study||4||
48479031|NCT01110005|101509252|FG001|NOT COMPLETED|Overall Study||5||
48479032|NCT02024646|101509253|FG000|STARTED|Overall Study||163||
48479033|NCT02024646|101509254|FG001|STARTED|Overall Study||160||
48479034|NCT02024646|101509255|FG002|STARTED|Overall Study||161||
48479035|NCT02024646|101509253|FG000|COMPLETED|Overall Study||131||
48479036|NCT02024646|101509254|FG001|COMPLETED|Overall Study||135||
48479037|NCT02024646|101509255|FG002|COMPLETED|Overall Study||133||
48479038|NCT02024646|101509253|FG000|NOT COMPLETED|Overall Study||32||
48479039|NCT02024646|101509254|FG001|NOT COMPLETED|Overall Study||25||
48479040|NCT02024646|101509255|FG002|NOT COMPLETED|Overall Study||28||
48479041|NCT01530880|101509256|FG000|STARTED|Overall Study||35||
48479042|NCT01530880|101509256|FG000|COMPLETED|Overall Study||35||
48479043|NCT01530880|101509256|FG000|NOT COMPLETED|Overall Study||0||
48479044|NCT00487669|101509257|FG000|STARTED|Overall Study||12||
48479045|NCT00487669|101509257|FG000|COMPLETED|Overall Study||12||
48479046|NCT00487669|101509257|FG000|NOT COMPLETED|Overall Study||0||
48479047|NCT00620022|101509258|FG000|STARTED|Treatment Period 1||46||
48479048|NCT00620022|101509259|FG001|STARTED|Treatment Period 1||43||
48479049|NCT00620022|101509258|FG000|COMPLETED|Treatment Period 1||41||
48479050|NCT00620022|101509259|FG001|COMPLETED|Treatment Period 1||37||
48479051|NCT00620022|101509258|FG000|NOT COMPLETED|Treatment Period 1||5||
48479052|NCT00620022|101509259|FG001|NOT COMPLETED|Treatment Period 1||6||
48479053|NCT00620022|101509258|FG000|STARTED|Treatment Period 2||41||
48479054|NCT00620022|101509259|FG001|STARTED|Treatment Period 2||37||
48479055|NCT00620022|101509258|FG000|COMPLETED|Treatment Period 2||39||
48479056|NCT00620022|101509259|FG001|COMPLETED|Treatment Period 2||35||
48479057|NCT00620022|101509258|FG000|NOT COMPLETED|Treatment Period 2||2||
48194314|NCT03354390|100797122|FG003|Completed Treatment|Level 4||7||
48194315|NCT03354390|100797119|FG000|COMPLETED|Level 4||0||
48194316|NCT03354390|100797120|FG001|COMPLETED|Level 4||0||
48194317|NCT03354390|100797121|FG002|COMPLETED|Level 4||0||
48194318|NCT03354390|100797122|FG003|COMPLETED|Level 4||4||
48194319|NCT03354390|100797119|FG000|NOT COMPLETED|Level 4||0||
48194320|NCT03354390|100797120|FG001|NOT COMPLETED|Level 4||0||
48194321|NCT03354390|100797121|FG002|NOT COMPLETED|Level 4||0||
48194322|NCT03354390|100797122|FG003|NOT COMPLETED|Level 4||3||
48194323|NCT02397889|100797123|FG000|STARTED|Overall Study||15||
48194324|NCT02397889|100797124|FG001|STARTED|Overall Study||15||
48194325|NCT02397889|100797123|FG000|COMPLETED|Overall Study||14||
48194326|NCT02397889|100797124|FG001|COMPLETED|Overall Study||15||
48194327|NCT02397889|100797123|FG000|NOT COMPLETED|Overall Study||1||
48194328|NCT02397889|100797124|FG001|NOT COMPLETED|Overall Study||0||
48479058|NCT00620022|101509259|FG001|NOT COMPLETED|Treatment Period 2||2||
48479059|NCT05275205|101509260|FG000|STARTED|Overall Study||25||
48479060|NCT05275205|101509261|FG001|STARTED|Overall Study||26||
48479061|NCT05275205|101509260|FG000|COMPLETED|Overall Study||19||
48479062|NCT05275205|101509261|FG001|COMPLETED|Overall Study||20||
48666347|NCT03289039|101967562|FG001|NOT COMPLETED|Overall Study||2||
48194329|NCT04807517|100797125|FG000|STARTED|Overall Study||20||
48194330|NCT04807517|100797125|FG000|Started Taking Medication After Baseline|Overall Study||19||
48194331|NCT04807517|100797125|FG000|Remained in Study at Week 12|Overall Study||18||
48194332|NCT04807517|100797125|FG000|Remained in Study at Week 16|Overall Study||18||
48194333|NCT04807517|100797125|FG000|COMPLETED|Overall Study||18||
48194334|NCT04807517|100797125|FG000|NOT COMPLETED|Overall Study||2||
48194335|NCT05541497|100797126|FG000|STARTED|Overall Study||20||
48194336|NCT05541497|100797127|FG001|STARTED|Overall Study||20||
48194337|NCT05541497|100797126|FG000|Completed 8 Weeks of Treatment|Overall Study||18||
48194338|NCT05541497|100797127|FG001|Completed 8 Weeks of Treatment|Overall Study||17||
48479063|NCT05275205|101509260|FG000|NOT COMPLETED|Overall Study||6||
48666348|NCT00104884|101967563|FG000|STARTED|Overall Study||4||
48666349|NCT00104884|101967563|FG000|COMPLETED|Overall Study||0||
48666350|NCT00104884|101967563|FG000|NOT COMPLETED|Overall Study||4||
48666351|NCT03257657|101967564|FG000|STARTED|Overall Study||22||
48666352|NCT03257657|101967565|FG001|STARTED|Overall Study||20||
48666353|NCT03257657|101967564|FG000|COMPLETED|Overall Study||22||
48666354|NCT03257657|101967565|FG001|COMPLETED|Overall Study||15||
48666355|NCT03257657|101967564|FG000|NOT COMPLETED|Overall Study||0||
48666356|NCT03257657|101967565|FG001|NOT COMPLETED|Overall Study||5||
48666357|NCT04576455|101967566|FG000|STARTED|Overall Study||151||
48666358|NCT04576455|101967567|FG001|STARTED|Overall Study||152||
48666359|NCT04576455|101967566|FG000|Safety-Evaluable Population|Overall Study||150|Safety-Evaluable Population included all participants who received at least one dose of the study treatment (giredestrant or PCET).|
48666360|NCT04576455|101967567|FG001|Safety-Evaluable Population|Overall Study||152|Safety-Evaluable Population included all participants who received at least one dose of the study treatment (giredestrant or PCET).|
48666361|NCT04576455|101967566|FG000|COMPLETED|Overall Study||0||
48666362|NCT04576455|101967567|FG001|COMPLETED|Overall Study||0||
48666363|NCT04576455|101967566|FG000|NOT COMPLETED|Overall Study||151||
48479064|NCT05275205|101509261|FG001|NOT COMPLETED|Overall Study||6||
48479065|NCT01035060|101509262|FG000|STARTED|Overall Study||39||
48479066|NCT01035060|101509263|FG001|STARTED|Overall Study||29||
48479067|NCT01035060|101509262|FG000|COMPLETED|Overall Study||15||
48479068|NCT01035060|101509263|FG001|COMPLETED|Overall Study||15||
48479069|NCT01035060|101509262|FG000|NOT COMPLETED|Overall Study||24||
48479070|NCT01035060|101509263|FG001|NOT COMPLETED|Overall Study||14||
48479071|NCT00234078|101509264|FG000|STARTED|Overall Study||72||
48479072|NCT00234078|101509265|FG001|STARTED|Overall Study||72||
48479073|NCT00234078|101509266|FG002|STARTED|Overall Study||74||
48479074|NCT00234078|101509267|FG003|STARTED|Overall Study||72||
48479075|NCT00234078|101509264|FG000|COMPLETED|Overall Study||66||
48479076|NCT00234078|101509265|FG001|COMPLETED|Overall Study||63||
48479077|NCT00234078|101509266|FG002|COMPLETED|Overall Study||64||
48479078|NCT00234078|101509267|FG003|COMPLETED|Overall Study||68||
48479079|NCT00234078|101509264|FG000|NOT COMPLETED|Overall Study||6||
48479080|NCT00234078|101509265|FG001|NOT COMPLETED|Overall Study||9||
48479081|NCT00234078|101509266|FG002|NOT COMPLETED|Overall Study||10||
48479082|NCT00234078|101509267|FG003|NOT COMPLETED|Overall Study||4||
48479083|NCT03314688|101509268|FG000|STARTED|Overall Study||87||
48479084|NCT03314688|101509269|FG001|STARTED|Overall Study||86||
48479085|NCT03314688|101509268|FG000|Eligible for Endocrine Therapy|Overall Study||40||
48479086|NCT03314688|101509269|FG001|Eligible for Endocrine Therapy|Overall Study||37||
48479087|NCT03314688|101509268|FG000|COMPLETED|Overall Study||87||
48479088|NCT03314688|101509269|FG001|COMPLETED|Overall Study||86||
48479089|NCT03314688|101509268|FG000|NOT COMPLETED|Overall Study||0||
48479090|NCT03314688|101509269|FG001|NOT COMPLETED|Overall Study||0||
48479091|NCT00856388|101509270|FG000|STARTED|Overall Study||62||
48479092|NCT00856388|101509270|FG000|COMPLETED|Overall Study||61||
48479093|NCT00856388|101509270|FG000|NOT COMPLETED|Overall Study||1||
48479094|NCT00096265|101509271|FG000|STARTED|Overall Study||45||
48479095|NCT00096265|101509272|FG001|STARTED|Overall Study||40||
48479096|NCT00096265|101509273|FG002|STARTED|Overall Study||41||
48479097|NCT00096265|101509271|FG000|COMPLETED|Overall Study||44||
48479098|NCT00096265|101509272|FG001|COMPLETED|Overall Study||40||
48479099|NCT00096265|101509273|FG002|COMPLETED|Overall Study||41||
48479100|NCT00096265|101509271|FG000|NOT COMPLETED|Overall Study||1||
48479101|NCT00096265|101509272|FG001|NOT COMPLETED|Overall Study||0||
48479102|NCT00096265|101509273|FG002|NOT COMPLETED|Overall Study||0||
48479103|NCT03929393|101509274|FG000|STARTED|Overall Study||86||
48479104|NCT03929393|101509275|FG001|STARTED|Overall Study||90||
48479105|NCT03929393|101509274|FG000|COMPLETED|Overall Study||82||
48479106|NCT03929393|101509275|FG001|COMPLETED|Overall Study||80||
48479107|NCT03929393|101509274|FG000|NOT COMPLETED|Overall Study||4||
48479108|NCT03929393|101509275|FG001|NOT COMPLETED|Overall Study||10||
48479109|NCT05341622|101509276|FG000|STARTED|Overall Study||682||
48479110|NCT05341622|101509277|FG001|STARTED|Overall Study||683||
48479111|NCT05341622|101509278|FG002|STARTED|Overall Study||681||
48479112|NCT05341622|101509279|FG003|STARTED|Overall Study||685||
48479113|NCT05341622|101509280|FG004|STARTED|Overall Study||685||
48479114|NCT05341622|101509281|FG005|STARTED|Overall Study||687||
48479115|NCT05341622|101509282|FG006|STARTED|Overall Study||681||
48479116|NCT05341622|101509283|FG007|STARTED|Overall Study||676||
48479117|NCT05341622|101509276|FG000|COMPLETED|Overall Study||656||
48479118|NCT05341622|101509277|FG001|COMPLETED|Overall Study||661||
48479119|NCT05341622|101509278|FG002|COMPLETED|Overall Study||653||
48479120|NCT05341622|101509279|FG003|COMPLETED|Overall Study||661||
48479121|NCT05341622|101509280|FG004|COMPLETED|Overall Study||655||
48479122|NCT05341622|101509281|FG005|COMPLETED|Overall Study||656||
48479123|NCT05341622|101509282|FG006|COMPLETED|Overall Study||653||
48479124|NCT05341622|101509283|FG007|COMPLETED|Overall Study||649||
48479125|NCT05341622|101509276|FG000|NOT COMPLETED|Overall Study||26||
48479126|NCT05341622|101509277|FG001|NOT COMPLETED|Overall Study||22||
48479127|NCT05341622|101509278|FG002|NOT COMPLETED|Overall Study||28||
48479128|NCT05341622|101509279|FG003|NOT COMPLETED|Overall Study||24||
48479129|NCT05341622|101509280|FG004|NOT COMPLETED|Overall Study||30||
48479130|NCT05341622|101509281|FG005|NOT COMPLETED|Overall Study||31||
48479131|NCT05341622|101509282|FG006|NOT COMPLETED|Overall Study||28||
48479132|NCT05341622|101509283|FG007|NOT COMPLETED|Overall Study||27||
48479133|NCT02327130|101509284|FG000|STARTED|Overall Study||32||
48479134|NCT02327130|101509284|FG000|COMPLETED|Overall Study||20||
48479135|NCT02327130|101509284|FG000|NOT COMPLETED|Overall Study||12||
48479136|NCT00445003|101509285|FG000|STARTED|Overall Study||123||
48479137|NCT00445003|101509286|FG001|STARTED|Overall Study||113||
48479138|NCT00445003|101509287|FG002|STARTED|Overall Study||109||
48479139|NCT00445003|101509285|FG000|COMPLETED|Overall Study||118||
48479140|NCT00445003|101509286|FG001|COMPLETED|Overall Study||103||
48479141|NCT00445003|101509287|FG002|COMPLETED|Overall Study||105||
48479142|NCT00445003|101509285|FG000|NOT COMPLETED|Overall Study||5||
48479143|NCT00445003|101509286|FG001|NOT COMPLETED|Overall Study||10||
48479144|NCT00445003|101509287|FG002|NOT COMPLETED|Overall Study||4||
48479145|NCT03603314|101509288|FG000|STARTED|Overall Study||38||
48479146|NCT03603314|101509289|FG001|STARTED|Overall Study||39||
48479147|NCT03603314|101509290|FG002|STARTED|Overall Study||38||
48479148|NCT03603314|101509288|FG000|COMPLETED|Overall Study||31||
48479149|NCT03603314|101509289|FG001|COMPLETED|Overall Study||28||
48479150|NCT03603314|101509290|FG002|COMPLETED|Overall Study||35||
48479151|NCT03603314|101509288|FG000|NOT COMPLETED|Overall Study||7||
48479152|NCT03603314|101509289|FG001|NOT COMPLETED|Overall Study||11||
48479153|NCT03603314|101509290|FG002|NOT COMPLETED|Overall Study||3||
48479154|NCT02934347|101509291|FG000|STARTED|Overall Study||374||
48479155|NCT02934347|101509292|FG001|STARTED|Overall Study||407||
48479156|NCT02934347|101509291|FG000|COMPLETED|Overall Study||374||
48479157|NCT02934347|101509292|FG001|COMPLETED|Overall Study||407||
48479158|NCT02934347|101509291|FG000|NOT COMPLETED|Overall Study||0||
48479159|NCT02934347|101509292|FG001|NOT COMPLETED|Overall Study||0||
48479160|NCT02512393|101509293|FG000|STARTED|Overall Study||21||
48479161|NCT02512393|101509294|FG001|STARTED|Overall Study||20||
48479162|NCT02512393|101509293|FG000|COMPLETED|Overall Study||20||
48479163|NCT02512393|101509294|FG001|COMPLETED|Overall Study||20||
48479164|NCT02512393|101509293|FG000|NOT COMPLETED|Overall Study||1||
48479165|NCT02512393|101509294|FG001|NOT COMPLETED|Overall Study||0||
48479166|NCT00911898|101509295|FG000|STARTED|Overall Study||20||
48479167|NCT00911898|101509295|FG000|COMPLETED|Overall Study||20||
48479168|NCT00911898|101509295|FG000|NOT COMPLETED|Overall Study||0||
48479169|NCT00720330|101509296|FG000|STARTED|Overall Study||5||
48479170|NCT00720330|101509297|FG001|STARTED|Overall Study||4||
48479171|NCT00720330|101509298|FG002|STARTED|Overall Study||3||
48479172|NCT00720330|101509296|FG000|COMPLETED|Overall Study||5||
48479173|NCT00720330|101509297|FG001|COMPLETED|Overall Study||4||
48479174|NCT00720330|101509298|FG002|COMPLETED|Overall Study||3||
48479175|NCT00720330|101509296|FG000|NOT COMPLETED|Overall Study||0||
48479176|NCT00720330|101509297|FG001|NOT COMPLETED|Overall Study||0||
48479177|NCT00720330|101509298|FG002|NOT COMPLETED|Overall Study||0||
48479178|NCT00528606|101509299|FG000|STARTED|Overall Study||204||
48479179|NCT00528606|101509300|FG001|STARTED|Overall Study||104||
48479180|NCT00528606|101509299|FG000|COMPLETED|Overall Study||191||
48479181|NCT00528606|101509300|FG001|COMPLETED|Overall Study||100||
48479182|NCT00528606|101509299|FG000|NOT COMPLETED|Overall Study||13||
48479183|NCT00528606|101509300|FG001|NOT COMPLETED|Overall Study||4||
48479184|NCT01772537|101509301|FG000|STARTED|Overall Study||5||
48479185|NCT01772537|101509302|FG001|STARTED|Overall Study||3||
48479186|NCT01772537|101509303|FG002|STARTED|Overall Study||6||
48479187|NCT01772537|101509301|FG000|COMPLETED|Overall Study||4||
48479188|NCT01772537|101509302|FG001|COMPLETED|Overall Study||3||
48479189|NCT01772537|101509303|FG002|COMPLETED|Overall Study||6||
48479190|NCT01772537|101509301|FG000|NOT COMPLETED|Overall Study||1||
48479191|NCT01772537|101509302|FG001|NOT COMPLETED|Overall Study||0||
48479192|NCT01772537|101509303|FG002|NOT COMPLETED|Overall Study||0||
48479193|NCT00584922|101509304|FG000|STARTED|Overall Study||175||
48479194|NCT00584922|101509304|FG000|COMPLETED|Overall Study||175||
48479195|NCT00584922|101509304|FG000|NOT COMPLETED|Overall Study||0||
48479196|NCT00724477|101509305|FG000|STARTED|Overall Study||1663||
48479197|NCT00724477|101509305|FG000|COMPLETED|Overall Study||1663||
48479198|NCT00724477|101509305|FG000|NOT COMPLETED|Overall Study||0||
48479199|NCT00408070|101509306|FG000|STARTED|Overall Study||5||
48479200|NCT00408070|101509306|FG000|COMPLETED|Overall Study||5||
48479201|NCT00408070|101509306|FG000|NOT COMPLETED|Overall Study||0||
48479202|NCT01658228|101509307|FG000|STARTED|Overall Study||30||
48479203|NCT01658228|101509308|FG001|STARTED|Overall Study||31||
48479204|NCT01658228|101509307|FG000|COMPLETED|Overall Study||23||
48479205|NCT01658228|101509308|FG001|COMPLETED|Overall Study||23||
48479206|NCT01658228|101509307|FG000|NOT COMPLETED|Overall Study||7||
48479207|NCT01658228|101509308|FG001|NOT COMPLETED|Overall Study||8||
48479208|NCT04646213|101511940|FG000|STARTED|Overall Study||14||
48479209|NCT04646213|101511940|FG000|COMPLETED|Overall Study||9||
48479210|NCT04646213|101511940|FG000|NOT COMPLETED|Overall Study||5||
48479211|NCT03136380|101511941|FG000|STARTED|Part 1, Period 1 (3 Days)||6||
48479212|NCT03136380|101511942|FG001|STARTED|Part 1, Period 1 (3 Days)||6||
48479213|NCT03136380|101511943|FG002|STARTED|Part 1, Period 1 (3 Days)||6||
48479214|NCT03136380|101511944|FG003|STARTED|Part 1, Period 1 (3 Days)||0||
48479215|NCT03136380|101511945|FG004|STARTED|Part 1, Period 1 (3 Days)||0||
48479216|NCT03136380|101511941|FG000|COMPLETED|Part 1, Period 1 (3 Days)||6||
48479217|NCT03136380|101511942|FG001|COMPLETED|Part 1, Period 1 (3 Days)||6||
48479218|NCT03136380|101511943|FG002|COMPLETED|Part 1, Period 1 (3 Days)||6||
48479219|NCT03136380|101511944|FG003|COMPLETED|Part 1, Period 1 (3 Days)||0||
48479220|NCT03136380|101511945|FG004|COMPLETED|Part 1, Period 1 (3 Days)||0||
48479221|NCT03136380|101511941|FG000|NOT COMPLETED|Part 1, Period 1 (3 Days)||0||
48479222|NCT03136380|101511942|FG001|NOT COMPLETED|Part 1, Period 1 (3 Days)||0||
48479223|NCT03136380|101511943|FG002|NOT COMPLETED|Part 1, Period 1 (3 Days)||0||
48479224|NCT03136380|101511944|FG003|NOT COMPLETED|Part 1, Period 1 (3 Days)||0||
48479225|NCT03136380|101511945|FG004|NOT COMPLETED|Part 1, Period 1 (3 Days)||0||
48479226|NCT03136380|101511941|FG000|STARTED|Part 1, Washout Period 1 (7 Days)||6||
48479227|NCT03136380|101511942|FG001|STARTED|Part 1, Washout Period 1 (7 Days)||6||
48479228|NCT03136380|101511943|FG002|STARTED|Part 1, Washout Period 1 (7 Days)||6||
48479229|NCT03136380|101511944|FG003|STARTED|Part 1, Washout Period 1 (7 Days)||0||
48479230|NCT03136380|101511945|FG004|STARTED|Part 1, Washout Period 1 (7 Days)||0||
48479231|NCT03136380|101511941|FG000|COMPLETED|Part 1, Washout Period 1 (7 Days)||6||
48479232|NCT03136380|101511942|FG001|COMPLETED|Part 1, Washout Period 1 (7 Days)||6||
48479233|NCT03136380|101511943|FG002|COMPLETED|Part 1, Washout Period 1 (7 Days)||6||
48479234|NCT03136380|101511944|FG003|COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48479235|NCT03136380|101511945|FG004|COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48479236|NCT03136380|101511941|FG000|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48479237|NCT03136380|101511942|FG001|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48479238|NCT03136380|101511943|FG002|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48479239|NCT03136380|101511944|FG003|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48479240|NCT03136380|101511945|FG004|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48479241|NCT03136380|101511941|FG000|STARTED|Part 1, Period 2 (3 Days)||6||
48479242|NCT03136380|101511942|FG001|STARTED|Part 1, Period 2 (3 Days)||6||
48479243|NCT03136380|101511943|FG002|STARTED|Part 1, Period 2 (3 Days)||6||
48479244|NCT03136380|101511944|FG003|STARTED|Part 1, Period 2 (3 Days)||0||
48479245|NCT03136380|101511945|FG004|STARTED|Part 1, Period 2 (3 Days)||0||
48479246|NCT03136380|101511941|FG000|COMPLETED|Part 1, Period 2 (3 Days)||6||
48479247|NCT03136380|101511942|FG001|COMPLETED|Part 1, Period 2 (3 Days)||6||
48479248|NCT03136380|101511943|FG002|COMPLETED|Part 1, Period 2 (3 Days)||6||
48479249|NCT03136380|101511944|FG003|COMPLETED|Part 1, Period 2 (3 Days)||0||
48479250|NCT03136380|101511945|FG004|COMPLETED|Part 1, Period 2 (3 Days)||0||
48479251|NCT03136380|101511941|FG000|NOT COMPLETED|Part 1, Period 2 (3 Days)||0||
48479252|NCT03136380|101511942|FG001|NOT COMPLETED|Part 1, Period 2 (3 Days)||0||
48479253|NCT03136380|101511943|FG002|NOT COMPLETED|Part 1, Period 2 (3 Days)||0||
48479254|NCT03136380|101511944|FG003|NOT COMPLETED|Part 1, Period 2 (3 Days)||0||
48479255|NCT03136380|101511945|FG004|NOT COMPLETED|Part 1, Period 2 (3 Days)||0||
48479256|NCT03136380|101511941|FG000|STARTED|Part 1, Washout Period 2 (7 Days)||6||
48479257|NCT03136380|101511942|FG001|STARTED|Part 1, Washout Period 2 (7 Days)||6||
48479258|NCT03136380|101511943|FG002|STARTED|Part 1, Washout Period 2 (7 Days)||6||
48479259|NCT03136380|101511944|FG003|STARTED|Part 1, Washout Period 2 (7 Days)||0||
48479260|NCT03136380|101511945|FG004|STARTED|Part 1, Washout Period 2 (7 Days)||0||
48479261|NCT03136380|101511941|FG000|COMPLETED|Part 1, Washout Period 2 (7 Days)||6||
48479262|NCT03136380|101511942|FG001|COMPLETED|Part 1, Washout Period 2 (7 Days)||5||
48479263|NCT03136380|101511943|FG002|COMPLETED|Part 1, Washout Period 2 (7 Days)||6||
48479264|NCT03136380|101511944|FG003|COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48479265|NCT03136380|101511945|FG004|COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48479266|NCT03136380|101511941|FG000|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48479267|NCT03136380|101511942|FG001|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||1||
48479268|NCT03136380|101511943|FG002|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48479269|NCT03136380|101511944|FG003|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48479270|NCT03136380|101511945|FG004|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48479271|NCT03136380|101511941|FG000|STARTED|Part 1, Period 3 (4 Days)||6||
48479272|NCT03136380|101511942|FG001|STARTED|Part 1, Period 3 (4 Days)||5||
48479273|NCT03136380|101511943|FG002|STARTED|Part 1, Period 3 (4 Days)||6||
48479274|NCT03136380|101511944|FG003|STARTED|Part 1, Period 3 (4 Days)||0||
48479275|NCT03136380|101511945|FG004|STARTED|Part 1, Period 3 (4 Days)||0||
48479276|NCT03136380|101511941|FG000|COMPLETED|Part 1, Period 3 (4 Days)||6||
48479277|NCT03136380|101511942|FG001|COMPLETED|Part 1, Period 3 (4 Days)||5||
48479278|NCT03136380|101511943|FG002|COMPLETED|Part 1, Period 3 (4 Days)||6||
48479279|NCT03136380|101511944|FG003|COMPLETED|Part 1, Period 3 (4 Days)||0||
48479280|NCT03136380|101511945|FG004|COMPLETED|Part 1, Period 3 (4 Days)||0||
48479281|NCT03136380|101511941|FG000|NOT COMPLETED|Part 1, Period 3 (4 Days)||0||
48479282|NCT03136380|101511942|FG001|NOT COMPLETED|Part 1, Period 3 (4 Days)||0||
48479283|NCT03136380|101511943|FG002|NOT COMPLETED|Part 1, Period 3 (4 Days)||0||
48479284|NCT03136380|101511944|FG003|NOT COMPLETED|Part 1, Period 3 (4 Days)||0||
48479285|NCT03136380|101511945|FG004|NOT COMPLETED|Part 1, Period 3 (4 Days)||0||
48479286|NCT03136380|101511941|FG000|STARTED|Part 2, Period 1 (3 Days)||0||
48479287|NCT03136380|101511942|FG001|STARTED|Part 2, Period 1 (3 Days)||0||
48479288|NCT03136380|101511943|FG002|STARTED|Part 2, Period 1 (3 Days)||0||
48479289|NCT03136380|101511944|FG003|STARTED|Part 2, Period 1 (3 Days)||8||
48479290|NCT03136380|101511945|FG004|STARTED|Part 2, Period 1 (3 Days)||8||
48479291|NCT03136380|101511941|FG000|COMPLETED|Part 2, Period 1 (3 Days)||0||
48479292|NCT03136380|101511942|FG001|COMPLETED|Part 2, Period 1 (3 Days)||0||
48479293|NCT03136380|101511943|FG002|COMPLETED|Part 2, Period 1 (3 Days)||0||
48479294|NCT03136380|101511944|FG003|COMPLETED|Part 2, Period 1 (3 Days)||8||
48479295|NCT03136380|101511945|FG004|COMPLETED|Part 2, Period 1 (3 Days)||8||
48479296|NCT03136380|101511941|FG000|NOT COMPLETED|Part 2, Period 1 (3 Days)||0||
48479297|NCT03136380|101511942|FG001|NOT COMPLETED|Part 2, Period 1 (3 Days)||0||
48479298|NCT03136380|101511943|FG002|NOT COMPLETED|Part 2, Period 1 (3 Days)||0||
48479299|NCT03136380|101511944|FG003|NOT COMPLETED|Part 2, Period 1 (3 Days)||0||
48479300|NCT03136380|101511945|FG004|NOT COMPLETED|Part 2, Period 1 (3 Days)||0||
48479301|NCT03136380|101511941|FG000|STARTED|Part 2, Washout Period 1 (7 Days)||0||
48479302|NCT03136380|101511942|FG001|STARTED|Part 2, Washout Period 1 (7 Days)||0||
48479303|NCT03136380|101511943|FG002|STARTED|Part 2, Washout Period 1 (7 Days)||0||
48479304|NCT03136380|101511944|FG003|STARTED|Part 2, Washout Period 1 (7 Days)||8||
48479305|NCT03136380|101511945|FG004|STARTED|Part 2, Washout Period 1 (7 Days)||8||
48479306|NCT03136380|101511941|FG000|COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
48479307|NCT03136380|101511942|FG001|COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
48479308|NCT03136380|101511943|FG002|COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
48479309|NCT03136380|101511944|FG003|COMPLETED|Part 2, Washout Period 1 (7 Days)||8||
48479310|NCT03136380|101511945|FG004|COMPLETED|Part 2, Washout Period 1 (7 Days)||8||
48479311|NCT03136380|101511941|FG000|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
48479312|NCT03136380|101511942|FG001|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
48479313|NCT03136380|101511943|FG002|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
48479314|NCT03136380|101511944|FG003|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
48479315|NCT03136380|101511945|FG004|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
48479316|NCT03136380|101511941|FG000|STARTED|Part 2, Period 2 (3 Days)||0||
48479317|NCT03136380|101511942|FG001|STARTED|Part 2, Period 2 (3 Days)||0||
48479318|NCT03136380|101511943|FG002|STARTED|Part 2, Period 2 (3 Days)||0||
48479319|NCT03136380|101511944|FG003|STARTED|Part 2, Period 2 (3 Days)||8||
48479320|NCT03136380|101511945|FG004|STARTED|Part 2, Period 2 (3 Days)||8||
48479321|NCT03136380|101511941|FG000|COMPLETED|Part 2, Period 2 (3 Days)||0||
48479322|NCT03136380|101511942|FG001|COMPLETED|Part 2, Period 2 (3 Days)||0||
48479323|NCT03136380|101511943|FG002|COMPLETED|Part 2, Period 2 (3 Days)||0||
48479324|NCT03136380|101511944|FG003|COMPLETED|Part 2, Period 2 (3 Days)||8||
48479325|NCT03136380|101511945|FG004|COMPLETED|Part 2, Period 2 (3 Days)||8||
48479326|NCT03136380|101511941|FG000|NOT COMPLETED|Part 2, Period 2 (3 Days)||0||
48479327|NCT03136380|101511942|FG001|NOT COMPLETED|Part 2, Period 2 (3 Days)||0||
48479328|NCT03136380|101511943|FG002|NOT COMPLETED|Part 2, Period 2 (3 Days)||0||
48479329|NCT03136380|101511944|FG003|NOT COMPLETED|Part 2, Period 2 (3 Days)||0||
48479330|NCT03136380|101511945|FG004|NOT COMPLETED|Part 2, Period 2 (3 Days)||0||
48479331|NCT03686033|101511946|FG000|STARTED|Treatment Period 1 (1 Day)||1||
48479332|NCT03686033|101511947|FG001|STARTED|Treatment Period 1 (1 Day)||1||
48479333|NCT03686033|101511948|FG002|STARTED|Treatment Period 1 (1 Day)||1||
48479334|NCT03686033|101511949|FG003|STARTED|Treatment Period 1 (1 Day)||1||
48479335|NCT03686033|101511950|FG004|STARTED|Treatment Period 1 (1 Day)||1||
48479336|NCT03686033|101511951|FG005|STARTED|Treatment Period 1 (1 Day)||0||
48479337|NCT03686033|101511946|FG000|COMPLETED|Treatment Period 1 (1 Day)||1||
48479338|NCT03686033|101511947|FG001|COMPLETED|Treatment Period 1 (1 Day)||1||
48479339|NCT03686033|101511948|FG002|COMPLETED|Treatment Period 1 (1 Day)||1||
48479340|NCT03686033|101511949|FG003|COMPLETED|Treatment Period 1 (1 Day)||1||
48666364|NCT04576455|101967567|FG001|NOT COMPLETED|Overall Study||152||
48479341|NCT03686033|101511950|FG004|COMPLETED|Treatment Period 1 (1 Day)||1||
48479342|NCT03686033|101511951|FG005|COMPLETED|Treatment Period 1 (1 Day)||0||
48479343|NCT03686033|101511946|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
48479344|NCT03686033|101511947|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
48479345|NCT03686033|101511948|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
48479346|NCT03686033|101511949|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
48479347|NCT03686033|101511950|FG004|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
48479348|NCT03686033|101511951|FG005|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
48479349|NCT03686033|101511946|FG000|STARTED|Washout Phase (at Least 2 Weeks)||1||
48479350|NCT03686033|101511947|FG001|STARTED|Washout Phase (at Least 2 Weeks)||1||
48479351|NCT03686033|101511948|FG002|STARTED|Washout Phase (at Least 2 Weeks)||1||
48479352|NCT03686033|101511949|FG003|STARTED|Washout Phase (at Least 2 Weeks)||1||
48479353|NCT03686033|101511950|FG004|STARTED|Washout Phase (at Least 2 Weeks)||1||
48479354|NCT03686033|101511951|FG005|STARTED|Washout Phase (at Least 2 Weeks)||0||
48479355|NCT03686033|101511946|FG000|COMPLETED|Washout Phase (at Least 2 Weeks)||1||
48479356|NCT03686033|101511947|FG001|COMPLETED|Washout Phase (at Least 2 Weeks)||1||
48479357|NCT03686033|101511948|FG002|COMPLETED|Washout Phase (at Least 2 Weeks)||1||
48479358|NCT03686033|101511949|FG003|COMPLETED|Washout Phase (at Least 2 Weeks)||1||
48479359|NCT03686033|101511950|FG004|COMPLETED|Washout Phase (at Least 2 Weeks)||1||
48479360|NCT03686033|101511951|FG005|COMPLETED|Washout Phase (at Least 2 Weeks)||0||
48479361|NCT03686033|101511946|FG000|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
48479362|NCT03686033|101511947|FG001|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
48479363|NCT03686033|101511948|FG002|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
48479364|NCT03686033|101511949|FG003|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
48479365|NCT03686033|101511950|FG004|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
48479366|NCT03686033|101511951|FG005|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
48479367|NCT03686033|101511946|FG000|STARTED|Treatment Period 2 (1 Day)||1||
48479368|NCT03686033|101511947|FG001|STARTED|Treatment Period 2 (1 Day)||1||
48479369|NCT03686033|101511948|FG002|STARTED|Treatment Period 2 (1 Day)||1||
48479370|NCT03686033|101511949|FG003|STARTED|Treatment Period 2 (1 Day)||1||
48479371|NCT03686033|101511950|FG004|STARTED|Treatment Period 2 (1 Day)||1||
48479372|NCT03686033|101511951|FG005|STARTED|Treatment Period 2 (1 Day)||0||
48479373|NCT03686033|101511946|FG000|COMPLETED|Treatment Period 2 (1 Day)||1||
48479374|NCT03686033|101511947|FG001|COMPLETED|Treatment Period 2 (1 Day)||1||
48479375|NCT03686033|101511948|FG002|COMPLETED|Treatment Period 2 (1 Day)||1||
48479376|NCT03686033|101511949|FG003|COMPLETED|Treatment Period 2 (1 Day)||1||
48479377|NCT03686033|101511950|FG004|COMPLETED|Treatment Period 2 (1 Day)||0||
48479378|NCT03686033|101511951|FG005|COMPLETED|Treatment Period 2 (1 Day)||0||
48479379|NCT03686033|101511946|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
48479380|NCT03686033|101511947|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
48479381|NCT03686033|101511948|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
48479382|NCT03686033|101511949|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
48479383|NCT03686033|101511950|FG004|NOT COMPLETED|Treatment Period 2 (1 Day)||1||
48479384|NCT03686033|101511951|FG005|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
48479385|NCT03686033|101511946|FG000|STARTED|Washout Phase (at Least 2 Weeks)||1||
48479386|NCT03686033|101511947|FG001|STARTED|Washout Phase (at Least 2 Weeks)||1||
48479387|NCT03686033|101511948|FG002|STARTED|Washout Phase (at Least 2 Weeks)||1||
48479388|NCT03686033|101511949|FG003|STARTED|Washout Phase (at Least 2 Weeks)||1||
48479389|NCT03686033|101511950|FG004|STARTED|Washout Phase (at Least 2 Weeks)||0||
48479390|NCT03686033|101511951|FG005|STARTED|Washout Phase (at Least 2 Weeks)||0||
48479391|NCT03686033|101511946|FG000|COMPLETED|Washout Phase (at Least 2 Weeks)||1||
48479392|NCT03686033|101511947|FG001|COMPLETED|Washout Phase (at Least 2 Weeks)||1||
48479393|NCT03686033|101511948|FG002|COMPLETED|Washout Phase (at Least 2 Weeks)||1||
48479394|NCT03686033|101511949|FG003|COMPLETED|Washout Phase (at Least 2 Weeks)||1||
48479395|NCT03686033|101511950|FG004|COMPLETED|Washout Phase (at Least 2 Weeks)||0||
48479396|NCT03686033|101511951|FG005|COMPLETED|Washout Phase (at Least 2 Weeks)||0||
48479397|NCT03686033|101511946|FG000|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
48479398|NCT03686033|101511947|FG001|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
48479399|NCT03686033|101511948|FG002|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
48479400|NCT03686033|101511949|FG003|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
48479401|NCT03686033|101511950|FG004|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
48479402|NCT03686033|101511951|FG005|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
48479403|NCT03686033|101511946|FG000|STARTED|Treatment Period 3 (1 Day)||1||
48479404|NCT03686033|101511947|FG001|STARTED|Treatment Period 3 (1 Day)||1||
48479405|NCT03686033|101511948|FG002|STARTED|Treatment Period 3 (1 Day)||1||
48479406|NCT03686033|101511949|FG003|STARTED|Treatment Period 3 (1 Day)||1||
48479407|NCT03686033|101511950|FG004|STARTED|Treatment Period 3 (1 Day)||0||
48479408|NCT03686033|101511951|FG005|STARTED|Treatment Period 3 (1 Day)||0||
48479409|NCT03686033|101511946|FG000|COMPLETED|Treatment Period 3 (1 Day)||1||
48479410|NCT03686033|101511947|FG001|COMPLETED|Treatment Period 3 (1 Day)||1||
48479411|NCT03686033|101511948|FG002|COMPLETED|Treatment Period 3 (1 Day)||1||
48194339|NCT05541497|100797126|FG000|Completed 12 Week Follow up|Overall Study||18||
48194340|NCT05541497|100797127|FG001|Completed 12 Week Follow up|Overall Study||15||
48194341|NCT05541497|100797126|FG000|COMPLETED|Overall Study||18||
48194342|NCT05541497|100797127|FG001|COMPLETED|Overall Study||15||
48194343|NCT05541497|100797126|FG000|NOT COMPLETED|Overall Study||2||
48194344|NCT05541497|100797127|FG001|NOT COMPLETED|Overall Study||5||
48479412|NCT03686033|101511949|FG003|COMPLETED|Treatment Period 3 (1 Day)||1||
48479413|NCT03686033|101511950|FG004|COMPLETED|Treatment Period 3 (1 Day)||0||
48479414|NCT03686033|101511951|FG005|COMPLETED|Treatment Period 3 (1 Day)||0||
48479415|NCT03686033|101511946|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
48479416|NCT03686033|101511947|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
48479417|NCT03686033|101511948|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
48479418|NCT03686033|101511949|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
48479419|NCT03686033|101511950|FG004|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
48479420|NCT03686033|101511951|FG005|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
48479421|NCT03686033|101511946|FG000|STARTED|Washout Phase (at Least 2 Weeks)||1||
48479422|NCT03686033|101511947|FG001|STARTED|Washout Phase (at Least 2 Weeks)||1||
48479423|NCT03686033|101511948|FG002|STARTED|Washout Phase (at Least 2 Weeks)||1||
48479424|NCT03686033|101511949|FG003|STARTED|Washout Phase (at Least 2 Weeks)||1||
48479425|NCT03686033|101511950|FG004|STARTED|Washout Phase (at Least 2 Weeks)||0||
48479426|NCT03686033|101511951|FG005|STARTED|Washout Phase (at Least 2 Weeks)||0||
48479427|NCT03686033|101511946|FG000|COMPLETED|Washout Phase (at Least 2 Weeks)||1||
48479428|NCT03686033|101511947|FG001|COMPLETED|Washout Phase (at Least 2 Weeks)||1||
48479429|NCT03686033|101511948|FG002|COMPLETED|Washout Phase (at Least 2 Weeks)||1||
48479430|NCT03686033|101511949|FG003|COMPLETED|Washout Phase (at Least 2 Weeks)||1||
48479431|NCT03686033|101511950|FG004|COMPLETED|Washout Phase (at Least 2 Weeks)||0||
48479432|NCT03686033|101511951|FG005|COMPLETED|Washout Phase (at Least 2 Weeks)||0||
48479433|NCT03686033|101511946|FG000|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
48479434|NCT03686033|101511947|FG001|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
48479435|NCT03686033|101511948|FG002|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
48479436|NCT03686033|101511949|FG003|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
48479437|NCT03686033|101511950|FG004|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
48479438|NCT03686033|101511951|FG005|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
48479439|NCT03686033|101511946|FG000|STARTED|Treatment Period 4 (1 Day)||1||
48479440|NCT03686033|101511947|FG001|STARTED|Treatment Period 4 (1 Day)||1||
48479441|NCT03686033|101511948|FG002|STARTED|Treatment Period 4 (1 Day)||1||
48479442|NCT03686033|101511949|FG003|STARTED|Treatment Period 4 (1 Day)||1||
48479443|NCT03686033|101511950|FG004|STARTED|Treatment Period 4 (1 Day)||0||
48479444|NCT03686033|101511951|FG005|STARTED|Treatment Period 4 (1 Day)||0||
48479445|NCT03686033|101511946|FG000|COMPLETED|Treatment Period 4 (1 Day)||1||
48479446|NCT03686033|101511947|FG001|COMPLETED|Treatment Period 4 (1 Day)||1||
48479447|NCT03686033|101511948|FG002|COMPLETED|Treatment Period 4 (1 Day)||1||
48479448|NCT03686033|101511949|FG003|COMPLETED|Treatment Period 4 (1 Day)||1||
48479449|NCT03686033|101511950|FG004|COMPLETED|Treatment Period 4 (1 Day)||0||
48479450|NCT03686033|101511951|FG005|COMPLETED|Treatment Period 4 (1 Day)||0||
48479451|NCT03686033|101511946|FG000|NOT COMPLETED|Treatment Period 4 (1 Day)||0||
48479452|NCT03686033|101511947|FG001|NOT COMPLETED|Treatment Period 4 (1 Day)||0||
48479453|NCT03686033|101511948|FG002|NOT COMPLETED|Treatment Period 4 (1 Day)||0||
48479454|NCT03686033|101511949|FG003|NOT COMPLETED|Treatment Period 4 (1 Day)||0||
48479455|NCT03686033|101511950|FG004|NOT COMPLETED|Treatment Period 4 (1 Day)||0||
48479456|NCT03686033|101511951|FG005|NOT COMPLETED|Treatment Period 4 (1 Day)||0||
48479457|NCT02419937|101511952|FG000|STARTED|Overall Study||12||
48479458|NCT02419937|101511953|FG001|STARTED|Overall Study||16||
48479459|NCT02419937|101511952|FG000|COMPLETED|Overall Study||11||
48479460|NCT02419937|101511953|FG001|COMPLETED|Overall Study||16||
48479461|NCT02419937|101511952|FG000|NOT COMPLETED|Overall Study||1||
48479462|NCT02419937|101511953|FG001|NOT COMPLETED|Overall Study||0||
48479463|NCT01423760|101511954|FG000|STARTED|Overall Study||14||
48479464|NCT01423760|101511955|FG001|STARTED|Overall Study||13||
48479465|NCT01423760|101511954|FG000|Number of Tecemotide Subjects|Overall Study||12||
48479466|NCT01423760|101511955|FG001|Number of Tecemotide Subjects|Overall Study||8||
48479467|NCT01423760|101511954|FG000|Number of Non-treatment Subjects|Overall Study||2||
48479468|NCT01423760|101511955|FG001|Number of Non-treatment Subjects|Overall Study||5||
48479469|NCT01423760|101511954|FG000|Safety Analysis Set|Overall Study||12||
48479470|NCT01423760|101511955|FG001|Safety Analysis Set|Overall Study||8||
48479471|NCT01423760|101511954|FG000|COMPLETED|Overall Study||14||
48479472|NCT01423760|101511955|FG001|COMPLETED|Overall Study||13||
48479473|NCT01423760|101511954|FG000|NOT COMPLETED|Overall Study||0||
48479474|NCT01423760|101511955|FG001|NOT COMPLETED|Overall Study||0||
48479475|NCT02794974|101511956|FG000|STARTED|Overall Study||14||
48479476|NCT02794974|101511957|FG001|STARTED|Overall Study||15||
48479477|NCT02794974|101511956|FG000|COMPLETED|Overall Study||14||
48479478|NCT02794974|101511957|FG001|COMPLETED|Overall Study||14||
48479479|NCT02794974|101511956|FG000|NOT COMPLETED|Overall Study||0||
48479480|NCT02794974|101511957|FG001|NOT COMPLETED|Overall Study||1||
48479481|NCT02865122|101511958|FG000|STARTED|Overall Study||1||
48479482|NCT02865122|101511959|FG001|STARTED|Overall Study||1||
48479483|NCT02865122|101511960|FG002|STARTED|Overall Study||0||
48479484|NCT02865122|101511958|FG000|COMPLETED|Overall Study||0||
48479485|NCT02865122|101511959|FG001|COMPLETED|Overall Study||1||
48479486|NCT02865122|101511960|FG002|COMPLETED|Overall Study||0||
48479487|NCT02865122|101511958|FG000|NOT COMPLETED|Overall Study||1||
48479488|NCT02865122|101511959|FG001|NOT COMPLETED|Overall Study||0||
48479489|NCT02865122|101511960|FG002|NOT COMPLETED|Overall Study||0||
48479490|NCT01576042|101511961|FG000|STARTED|Overall Study||13||
48479491|NCT01576042|101511962|FG001|STARTED|Overall Study||14||
48479492|NCT01576042|101511961|FG000|Switched to the Other Arm|Overall Study||5||
48479493|NCT01576042|101511962|FG001|Switched to the Other Arm|Overall Study||1||
48479494|NCT01576042|101511961|FG000|COMPLETED|Overall Study||11||
48479495|NCT01576042|101511962|FG001|COMPLETED|Overall Study||14||
48479496|NCT01576042|101511961|FG000|NOT COMPLETED|Overall Study||2||
48479497|NCT01576042|101511962|FG001|NOT COMPLETED|Overall Study||0||
48479498|NCT00468286|101511963|FG000|STARTED|Overall Study||67||
48479499|NCT00468286|101511964|FG001|STARTED|Overall Study||66||
48479500|NCT00468286|101511963|FG000|COMPLETED|Overall Study||60||
48479501|NCT00468286|101511964|FG001|COMPLETED|Overall Study||54||
48479502|NCT00468286|101511963|FG000|NOT COMPLETED|Overall Study||7||
48479503|NCT00468286|101511964|FG001|NOT COMPLETED|Overall Study||12||
48479504|NCT02337218|101511965|FG000|STARTED|Overall Study||17||
48479505|NCT02337218|101511966|FG001|STARTED|Overall Study||11||
48479506|NCT02337218|101511965|FG000|COMPLETED|Overall Study||17||
48479507|NCT02337218|101511966|FG001|COMPLETED|Overall Study||11||
48479508|NCT02337218|101511965|FG000|NOT COMPLETED|Overall Study||0||
48479509|NCT02337218|101511966|FG001|NOT COMPLETED|Overall Study||0||
48479510|NCT03962348|101511967|FG000|STARTED|Overall Study||8||
48479511|NCT03962348|101511967|FG000|COMPLETED|Overall Study||8||
48479512|NCT03962348|101511967|FG000|NOT COMPLETED|Overall Study||0||
48479513|NCT04320849|101511968|FG000|STARTED|Overall Study||117||
48479514|NCT04320849|101511968|FG000|COMPLETED|Overall Study||109||
48479515|NCT04320849|101511968|FG000|NOT COMPLETED|Overall Study||8||
48479516|NCT00585689|101511969|FG000|STARTED|Overall Study||29||
48479517|NCT00585689|101511969|FG000|COMPLETED|Overall Study||22||
48479518|NCT00585689|101511969|FG000|NOT COMPLETED|Overall Study||7||
48479519|NCT01641380|101511970|FG000|STARTED|First Injection Cycle||50||
48479520|NCT01641380|101511971|FG001|STARTED|First Injection Cycle||50||
48479521|NCT01641380|101511970|FG000|COMPLETED|First Injection Cycle||43||
48479522|NCT01641380|101511971|FG001|COMPLETED|First Injection Cycle||44||
48479523|NCT01641380|101511970|FG000|NOT COMPLETED|First Injection Cycle||7||
48479524|NCT01641380|101511971|FG001|NOT COMPLETED|First Injection Cycle||6||
48479525|NCT01641380|101511970|FG000|STARTED|Second Injection Cycle||43||
48479526|NCT01641380|101511971|FG001|STARTED|Second Injection Cycle||44||
48479527|NCT01641380|101511970|FG000|COMPLETED|Second Injection Cycle||39||
48479528|NCT01641380|101511971|FG001|COMPLETED|Second Injection Cycle||38||
48479529|NCT01641380|101511970|FG000|NOT COMPLETED|Second Injection Cycle||4||
48479530|NCT01641380|101511971|FG001|NOT COMPLETED|Second Injection Cycle||6||
48479531|NCT01641380|101511970|FG000|STARTED|Third Injection Cycle||39||
48479532|NCT01641380|101511971|FG001|STARTED|Third Injection Cycle||38||
48479533|NCT01641380|101511970|FG000|COMPLETED|Third Injection Cycle||36||
48479534|NCT01641380|101511971|FG001|COMPLETED|Third Injection Cycle||33||
48479535|NCT01641380|101511970|FG000|NOT COMPLETED|Third Injection Cycle||3||
48479536|NCT01641380|101511971|FG001|NOT COMPLETED|Third Injection Cycle||5||
48479537|NCT01544361|101511972|FG000|STARTED|Overall Study||8||
48479538|NCT01544361|101511973|FG001|STARTED|Overall Study||6||
48479539|NCT01544361|101511974|FG002|STARTED|Overall Study||6||
48479540|NCT01544361|101511975|FG003|STARTED|Overall Study||6||
48479541|NCT01544361|101511976|FG004|STARTED|Overall Study||6||
48479542|NCT01544361|101511972|FG000|COMPLETED|Overall Study||8||
48479543|NCT01544361|101511973|FG001|COMPLETED|Overall Study||6||
48479544|NCT01544361|101511974|FG002|COMPLETED|Overall Study||6||
48479545|NCT01544361|101511975|FG003|COMPLETED|Overall Study||6||
48479546|NCT01544361|101511976|FG004|COMPLETED|Overall Study||6||
48479547|NCT01544361|101511972|FG000|NOT COMPLETED|Overall Study||0||
48479548|NCT01544361|101511973|FG001|NOT COMPLETED|Overall Study||0||
48479549|NCT01544361|101511974|FG002|NOT COMPLETED|Overall Study||0||
48479550|NCT01544361|101511975|FG003|NOT COMPLETED|Overall Study||0||
48479551|NCT01544361|101511976|FG004|NOT COMPLETED|Overall Study||0||
48479552|NCT04000815|101511977|FG000|STARTED|Overall Study||29||
48479553|NCT04000815|101511978|FG001|STARTED|Overall Study||20||
48479554|NCT04000815|101511979|FG002|STARTED|Overall Study||22||
48479555|NCT04000815|101511977|FG000|COMPLETED|Overall Study||15||
48479556|NCT04000815|101511978|FG001|COMPLETED|Overall Study||15||
48479557|NCT04000815|101511979|FG002|COMPLETED|Overall Study||15||
48479558|NCT04000815|101511977|FG000|NOT COMPLETED|Overall Study||14||
48479559|NCT04000815|101511978|FG001|NOT COMPLETED|Overall Study||5||
48479560|NCT04000815|101511979|FG002|NOT COMPLETED|Overall Study||7||
48479561|NCT00086996|101511980|FG000|STARTED|Overall Study||98||
48479562|NCT00086996|101511980|FG000|Eligible|Overall Study||93||
48479563|NCT00086996|101511980|FG000|Eligible and Began Protocol Therapy|Overall Study||93||
48479564|NCT00086996|101511980|FG000|COMPLETED|Overall Study||34||
48479565|NCT00086996|101511980|FG000|NOT COMPLETED|Overall Study||64||
48479566|NCT01591785|101511981|FG000|STARTED|Overall Study||30||
48479567|NCT01591785|101511982|FG001|STARTED|Overall Study||30||
48479568|NCT01591785|101511981|FG000|COMPLETED|Overall Study||26||
48479569|NCT01591785|101511982|FG001|COMPLETED|Overall Study||28||
48479570|NCT01591785|101511981|FG000|NOT COMPLETED|Overall Study||4||
48479571|NCT01591785|101511982|FG001|NOT COMPLETED|Overall Study||2||
48479572|NCT02678286|101511983|FG000|STARTED|Treatment Phase (48 Hours Post-Dose 1)||110||
48479573|NCT02678286|101511984|FG001|STARTED|Treatment Phase (48 Hours Post-Dose 1)||109||
48479574|NCT02678286|101511983|FG000|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||108||
48479575|NCT02678286|101511984|FG001|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||107||
48479576|NCT02678286|101511983|FG000|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2||
48479577|NCT02678286|101511984|FG001|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2||
48479578|NCT02678286|101511983|FG000|STARTED|Study Overall (28 Day Follow-Up)||110||
48479579|NCT02678286|101511984|FG001|STARTED|Study Overall (28 Day Follow-Up)||109||
48479580|NCT02678286|101511983|FG000|COMPLETED|Study Overall (28 Day Follow-Up)||104||
48479581|NCT02678286|101511984|FG001|COMPLETED|Study Overall (28 Day Follow-Up)||105||
48479582|NCT02678286|101511983|FG000|NOT COMPLETED|Study Overall (28 Day Follow-Up)||6||
48479583|NCT02678286|101511984|FG001|NOT COMPLETED|Study Overall (28 Day Follow-Up)||4||
48479584|NCT03020641|101511985|FG000|STARTED|Overall Study||50||
48479585|NCT03020641|101511986|FG001|STARTED|Overall Study||50||
48479586|NCT03020641|101511985|FG000|COMPLETED|Overall Study||48||
48479587|NCT03020641|101511986|FG001|COMPLETED|Overall Study||47||
48479588|NCT03020641|101511985|FG000|NOT COMPLETED|Overall Study||2||
48479589|NCT03020641|101511986|FG001|NOT COMPLETED|Overall Study||3||
48479590|NCT03123471|101511987|FG000|STARTED|Placebo-controlled Phase||102||
48479591|NCT03123471|101511988|FG001|STARTED|Placebo-controlled Phase||201||
48479592|NCT03123471|101511987|FG000|Received at Least 1 Dose of Study Drug|Placebo-controlled Phase||102||
48479593|NCT03123471|101511988|FG001|Received at Least 1 Dose of Study Drug|Placebo-controlled Phase||200||
48479594|NCT03123471|101511987|FG000|COMPLETED|Placebo-controlled Phase||84||
48479595|NCT03123471|101511988|FG001|COMPLETED|Placebo-controlled Phase||168||
48479596|NCT03123471|101511987|FG000|NOT COMPLETED|Placebo-controlled Phase||18||
48479597|NCT03123471|101511988|FG001|NOT COMPLETED|Placebo-controlled Phase||33||
48479598|NCT03123471|101511987|FG000|STARTED|Apremilast Extension Phase||84||
48479599|NCT03123471|101511988|FG001|STARTED|Apremilast Extension Phase||165||
48479600|NCT03123471|101511987|FG000|Received at Least 1 Dose of Study Drug|Apremilast Extension Phase||84||
48479601|NCT03123471|101511988|FG001|Received at Least 1 Dose of Study Drug|Apremilast Extension Phase||163||
48479602|NCT03123471|101511987|FG000|COMPLETED|Apremilast Extension Phase||76||
48479603|NCT03123471|101511988|FG001|COMPLETED|Apremilast Extension Phase||140||
48479604|NCT03123471|101511987|FG000|NOT COMPLETED|Apremilast Extension Phase||8||
48479605|NCT03123471|101511988|FG001|NOT COMPLETED|Apremilast Extension Phase||25||
48479606|NCT00857623|101511989|FG000|STARTED|Overall Study||62||
48479607|NCT00857623|101511990|FG001|STARTED|Overall Study||65||
48479608|NCT00857623|101511989|FG000|COMPLETED|Overall Study||48||
48479609|NCT00857623|101511990|FG001|COMPLETED|Overall Study||55||
48479610|NCT00857623|101511989|FG000|NOT COMPLETED|Overall Study||14||
48479611|NCT00857623|101511990|FG001|NOT COMPLETED|Overall Study||10||
48479612|NCT03410862|101511991|FG000|STARTED|Overall Study||43||
48479613|NCT03410862|101511992|FG001|STARTED|Overall Study||44||
48479614|NCT03410862|101511991|FG000|COMPLETED|Overall Study||41||
48479615|NCT03410862|101511992|FG001|COMPLETED|Overall Study||42||
48479616|NCT03410862|101511991|FG000|NOT COMPLETED|Overall Study||2||
48479617|NCT03410862|101511992|FG001|NOT COMPLETED|Overall Study||2||
48479618|NCT00416520|101511993|FG000|STARTED|Open-label Period||165||
48479619|NCT00416520|101511994|FG001|STARTED|Open-label Period||171||
48479620|NCT00416520|101511995|FG002|STARTED|Open-label Period||0||
48479621|NCT00416520|101511996|FG003|STARTED|Open-label Period||0||
48479622|NCT00416520|101511993|FG000|COMPLETED|Open-label Period||105||
48479623|NCT00416520|101511994|FG001|COMPLETED|Open-label Period||139||
48194345|NCT05824351|100797128|FG000|STARTED|Overall Study||50||
48479624|NCT00416520|101511995|FG002|COMPLETED|Open-label Period||0||
48479625|NCT00416520|101511996|FG003|COMPLETED|Open-label Period||0||
48479626|NCT00416520|101511993|FG000|NOT COMPLETED|Open-label Period||60||
48479627|NCT00416520|101511994|FG001|NOT COMPLETED|Open-label Period||32||
48479628|NCT00416520|101511995|FG002|NOT COMPLETED|Open-label Period||0||
48479629|NCT00416520|101511996|FG003|NOT COMPLETED|Open-label Period||0||
48479630|NCT00416520|101511993|FG000|STARTED|Placebo-controlled Withdrawal Period||0||
48479631|NCT00416520|101511994|FG001|STARTED|Placebo-controlled Withdrawal Period||0||
48479632|NCT00416520|101511995|FG002|STARTED|Placebo-controlled Withdrawal Period||50||
48479633|NCT00416520|101511996|FG003|STARTED|Placebo-controlled Withdrawal Period||54||
48479634|NCT00416520|101511993|FG000|COMPLETED|Placebo-controlled Withdrawal Period||0||
48479635|NCT00416520|101511994|FG001|COMPLETED|Placebo-controlled Withdrawal Period||0||
48194346|NCT05824351|100797128|FG000|COMPLETED|Overall Study||44||
48479636|NCT00416520|101511995|FG002|COMPLETED|Placebo-controlled Withdrawal Period||49||
48479637|NCT00416520|101511996|FG003|COMPLETED|Placebo-controlled Withdrawal Period||49||
48479638|NCT00416520|101511993|FG000|NOT COMPLETED|Placebo-controlled Withdrawal Period||0||
48479639|NCT00416520|101511994|FG001|NOT COMPLETED|Placebo-controlled Withdrawal Period||0||
48479640|NCT00416520|101511995|FG002|NOT COMPLETED|Placebo-controlled Withdrawal Period||1||
48479641|NCT00416520|101511996|FG003|NOT COMPLETED|Placebo-controlled Withdrawal Period||5||
48479642|NCT01529060|101511997|FG000|STARTED|Overall Study||10||
48479643|NCT01529060|101511998|FG001|STARTED|Overall Study||10||
48479644|NCT01529060|101511997|FG000|COMPLETED|Overall Study||10||
48479645|NCT01529060|101511998|FG001|COMPLETED|Overall Study||10||
48479646|NCT01529060|101511997|FG000|NOT COMPLETED|Overall Study||0||
48479647|NCT01529060|101511998|FG001|NOT COMPLETED|Overall Study||0||
48479648|NCT01661114|101511999|FG000|STARTED|Overall Study||39||
48479649|NCT01661114|101511999|FG000|COMPLETED|Overall Study||39||
48479650|NCT01661114|101511999|FG000|NOT COMPLETED|Overall Study||0||
48479651|NCT02336165|101512000|FG000|STARTED|Overall Study||40||
48479652|NCT02336165|101512001|FG001|STARTED|Overall Study||31||
48479653|NCT02336165|101512002|FG002|STARTED|Overall Study||33||
48479654|NCT02336165|101512003|FG003|STARTED|Overall Study||33||
48479655|NCT02336165|101512004|FG004|STARTED|Overall Study||22||
48666365|NCT04704193|101967568|FG000|STARTED|Overall Study||93||
48479656|NCT02336165|101512000|FG000|COMPLETED|Overall Study||6||
48479657|NCT02336165|101512001|FG001|COMPLETED|Overall Study||6||
48479658|NCT02336165|101512002|FG002|COMPLETED|Overall Study||2||
48479659|NCT02336165|101512003|FG003|COMPLETED|Overall Study||2||
48666366|NCT04704193|101967568|FG000|COMPLETED|Overall Study||92||
48666367|NCT04704193|101967568|FG000|NOT COMPLETED|Overall Study||1||
48666368|NCT05112640|101967569|FG000|STARTED|Overall Study||59||
48666369|NCT05112640|101967570|FG001|STARTED|Overall Study||56||
48666370|NCT05112640|101967569|FG000|COMPLETED|Overall Study||59||
48666371|NCT05112640|101967570|FG001|COMPLETED|Overall Study||56||
48666372|NCT05112640|101967569|FG000|NOT COMPLETED|Overall Study||0||
48666373|NCT05112640|101967570|FG001|NOT COMPLETED|Overall Study||0||
48666374|NCT01088906|101967571|FG000|STARTED|Overall Study||57||
48666375|NCT01088906|101967571|FG000|COMPLETED|Overall Study||52||
48666376|NCT01088906|101967571|FG000|NOT COMPLETED|Overall Study||5||
48666377|NCT02038036|101967572|FG000|STARTED|Core Study||74||
48666378|NCT02038036|101967573|FG001|STARTED|Core Study||75||
48666379|NCT02038036|101967572|FG000|Full Analysis Set|Core Study||74|comprised of all patients to whom study treatment was assigned by randomization.|
48670493|NCT00098475|101974953|FG002|Eligible|Step 2||0||
48194347|NCT05824351|100797128|FG000|NOT COMPLETED|Overall Study||6||
48194348|NCT05096884|100797129|FG000|STARTED|Overall Study||14||
48194349|NCT05096884|100797129|FG000|COMPLETED|Overall Study||10||
48194350|NCT05096884|100797129|FG000|NOT COMPLETED|Overall Study||4||
48479660|NCT02336165|101512004|FG004|COMPLETED|Overall Study||0||
48479661|NCT02336165|101512000|FG000|NOT COMPLETED|Overall Study||34||
48479662|NCT02336165|101512001|FG001|NOT COMPLETED|Overall Study||25||
48479663|NCT02336165|101512002|FG002|NOT COMPLETED|Overall Study||31||
48479664|NCT02336165|101512003|FG003|NOT COMPLETED|Overall Study||31||
48479665|NCT02336165|101512004|FG004|NOT COMPLETED|Overall Study||22||
48479666|NCT00262223|101512005|FG000|STARTED|Treatment Phase||32||
48479667|NCT00262223|101512006|FG001|STARTED|Treatment Phase||37||
48479668|NCT00262223|101512005|FG000|COMPLETED|Treatment Phase||28||
48479669|NCT00262223|101512006|FG001|COMPLETED|Treatment Phase||29||
48479670|NCT00262223|101512005|FG000|NOT COMPLETED|Treatment Phase||4||
48479671|NCT00262223|101512006|FG001|NOT COMPLETED|Treatment Phase||8||
48479672|NCT00262223|101512005|FG000|STARTED|1-week Post-treatment Follow-up||28||
48479673|NCT00262223|101512006|FG001|STARTED|1-week Post-treatment Follow-up||29||
48479674|NCT00262223|101512005|FG000|COMPLETED|1-week Post-treatment Follow-up||24||
48479675|NCT00262223|101512006|FG001|COMPLETED|1-week Post-treatment Follow-up||25||
48479676|NCT00262223|101512005|FG000|NOT COMPLETED|1-week Post-treatment Follow-up||4||
48479677|NCT00262223|101512006|FG001|NOT COMPLETED|1-week Post-treatment Follow-up||4||
48479678|NCT00262223|101512005|FG000|STARTED|6-month Post-treatment Follow-up||28||
48479679|NCT00262223|101512006|FG001|STARTED|6-month Post-treatment Follow-up||29||
48479680|NCT00262223|101512005|FG000|COMPLETED|6-month Post-treatment Follow-up||22||
48479681|NCT00262223|101512006|FG001|COMPLETED|6-month Post-treatment Follow-up||28||
48479682|NCT00262223|101512005|FG000|NOT COMPLETED|6-month Post-treatment Follow-up||6||
48479683|NCT00262223|101512006|FG001|NOT COMPLETED|6-month Post-treatment Follow-up||1||
48479684|NCT00262223|101512005|FG000|STARTED|12-month Post-treatment Follow-up||28||
48479685|NCT00262223|101512006|FG001|STARTED|12-month Post-treatment Follow-up||29||
48479686|NCT00262223|101512005|FG000|COMPLETED|12-month Post-treatment Follow-up||21||
48479687|NCT00262223|101512006|FG001|COMPLETED|12-month Post-treatment Follow-up||22||
48479688|NCT00262223|101512005|FG000|NOT COMPLETED|12-month Post-treatment Follow-up||7||
48479689|NCT00262223|101512006|FG001|NOT COMPLETED|12-month Post-treatment Follow-up||7||
48479690|NCT00537030|101512007|FG000|STARTED|Overall Study||59||
48479691|NCT00537030|101512007|FG000|COMPLETED|Overall Study||43||
48479692|NCT00537030|101512007|FG000|NOT COMPLETED|Overall Study||16||
48479693|NCT00986245|101512008|FG000|STARTED|First Intervention||41||
48479694|NCT00986245|101512009|FG001|STARTED|First Intervention||41||
48479695|NCT00986245|101512008|FG000|COMPLETED|First Intervention||31||
48479696|NCT00986245|101512009|FG001|COMPLETED|First Intervention||33||
48479697|NCT00986245|101512008|FG000|NOT COMPLETED|First Intervention||10||
48479698|NCT00986245|101512009|FG001|NOT COMPLETED|First Intervention||8||
48479699|NCT00986245|101512008|FG000|STARTED|Second Intervention||31||
48479700|NCT00986245|101512009|FG001|STARTED|Second Intervention||33||
48479701|NCT00986245|101512008|FG000|COMPLETED|Second Intervention||29||
48479702|NCT00986245|101512009|FG001|COMPLETED|Second Intervention||32||
48479703|NCT00986245|101512008|FG000|NOT COMPLETED|Second Intervention||2||
48479704|NCT00986245|101512009|FG001|NOT COMPLETED|Second Intervention||1||
48479705|NCT02189941|101512010|FG000|STARTED|Overall Study||4||
48479706|NCT02189941|101512011|FG001|STARTED|Overall Study||4||
48479707|NCT02189941|101512012|FG002|STARTED|Overall Study||3||
48479708|NCT02189941|101512010|FG000|COMPLETED|Overall Study||4||
48479709|NCT02189941|101512011|FG001|COMPLETED|Overall Study||4||
48479710|NCT02189941|101512012|FG002|COMPLETED|Overall Study||2||
48479711|NCT02189941|101512010|FG000|NOT COMPLETED|Overall Study||0||
48479712|NCT02189941|101512011|FG001|NOT COMPLETED|Overall Study||0||
48479713|NCT02189941|101512012|FG002|NOT COMPLETED|Overall Study||1||
48479714|NCT00830232|101512013|FG000|STARTED|Overall Study||20||
48479715|NCT00830232|101512014|FG001|STARTED|Overall Study||20||
48479716|NCT00830232|101512013|FG000|COMPLETED|Overall Study||20||
48479717|NCT00830232|101512014|FG001|COMPLETED|Overall Study||20||
48479718|NCT00830232|101512013|FG000|NOT COMPLETED|Overall Study||0||
48479719|NCT00830232|101512014|FG001|NOT COMPLETED|Overall Study||0||
48479720|NCT04037969|101512015|FG000|STARTED|Overall Study||10||
48479721|NCT04037969|101512016|FG001|STARTED|Overall Study||10||
48479722|NCT04037969|101512015|FG000|COMPLETED|Overall Study||10||
48479723|NCT04037969|101512016|FG001|COMPLETED|Overall Study||10||
48479724|NCT04037969|101512015|FG000|NOT COMPLETED|Overall Study||0||
48479725|NCT04037969|101512016|FG001|NOT COMPLETED|Overall Study||0||
48479726|NCT00699491|101512017|FG000|STARTED|Overall Study||3||
48479727|NCT00699491|101512018|FG001|STARTED|Overall Study||2||
48479728|NCT00699491|101512019|FG002|STARTED|Overall Study||7||
48479729|NCT00699491|101512020|FG003|STARTED|Overall Study||6||
48479730|NCT00699491|101512021|FG004|STARTED|Overall Study||8||
48479731|NCT00699491|101512022|FG005|STARTED|Overall Study||22||
48479732|NCT00699491|101512017|FG000|COMPLETED|Overall Study||3||
48479733|NCT00699491|101512018|FG001|COMPLETED|Overall Study||2||
48479734|NCT00699491|101512019|FG002|COMPLETED|Overall Study||7||
48479735|NCT00699491|101512020|FG003|COMPLETED|Overall Study||6||
48479736|NCT00699491|101512021|FG004|COMPLETED|Overall Study||8||
48479737|NCT00699491|101512022|FG005|COMPLETED|Overall Study||22||
48194351|NCT04917757|100797130|FG000|STARTED|Overall Study||2089||
48194352|NCT04917757|100797131|FG001|STARTED|Overall Study||1320||
48194353|NCT04917757|100797132|FG002|STARTED|Overall Study||247||
48479738|NCT00699491|101512017|FG000|NOT COMPLETED|Overall Study||0||
48479739|NCT00699491|101512018|FG001|NOT COMPLETED|Overall Study||0||
48479740|NCT00699491|101512019|FG002|NOT COMPLETED|Overall Study||0||
48479741|NCT00699491|101512020|FG003|NOT COMPLETED|Overall Study||0||
48479742|NCT00699491|101512021|FG004|NOT COMPLETED|Overall Study||0||
48479743|NCT00699491|101512022|FG005|NOT COMPLETED|Overall Study||0||
48479744|NCT00374335|101512023|FG000|STARTED|Overall Study||261||
48479745|NCT00374335|101512023|FG000|COMPLETED|Overall Study||261||
48479746|NCT00374335|101512023|FG000|NOT COMPLETED|Overall Study||0||
48479747|NCT00727961|101512024|FG000|STARTED|Overall Study||58||
48479748|NCT00727961|101512024|FG000|COMPLETED|Overall Study||21||
48479749|NCT00727961|101512024|FG000|NOT COMPLETED|Overall Study||37||
48479750|NCT02780687|101512025|FG000|STARTED|Overall Study||34||
48479751|NCT02780687|101512026|FG001|STARTED|Overall Study||8||
48194354|NCT04917757|100797130|FG000|COMPLETED|Overall Study||2089||
48194355|NCT04917757|100797131|FG001|COMPLETED|Overall Study||1320||
48194356|NCT04917757|100797132|FG002|COMPLETED|Overall Study||247||
48194357|NCT04917757|100797130|FG000|NOT COMPLETED|Overall Study||0||
48194358|NCT04917757|100797131|FG001|NOT COMPLETED|Overall Study||0||
48194359|NCT04917757|100797132|FG002|NOT COMPLETED|Overall Study||0||
48194360|NCT01744691|100797133|FG000|STARTED|Overall Study||144||
48194361|NCT01744691|100797133|FG000|COMPLETED|Overall Study||101||
48194362|NCT01744691|100797133|FG000|NOT COMPLETED|Overall Study||43||
48194363|NCT04411940|100797134|FG000|STARTED|Treatment Period 1 (8 Days)||16||
48194364|NCT04411940|100797135|FG001|STARTED|Treatment Period 1 (8 Days)||16||
48194365|NCT04411940|100797134|FG000|COMPLETED|Treatment Period 1 (8 Days)||16||
48194366|NCT04411940|100797135|FG001|COMPLETED|Treatment Period 1 (8 Days)||16||
48194367|NCT04411940|100797134|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
48479752|NCT02780687|101512025|FG000|COMPLETED|Overall Study||0||
48479753|NCT02780687|101512026|FG001|COMPLETED|Overall Study||0||
48479754|NCT02780687|101512025|FG000|NOT COMPLETED|Overall Study||34||
48479755|NCT02780687|101512026|FG001|NOT COMPLETED|Overall Study||8||
48479756|NCT01985308|101512027|FG000|STARTED|Overall Study||14||
48479757|NCT01985308|101512028|FG001|STARTED|Overall Study||14||
48479758|NCT01985308|101512027|FG000|COMPLETED|Overall Study||14||
48479759|NCT01985308|101512028|FG001|COMPLETED|Overall Study||14||
48194368|NCT04411940|100797135|FG001|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
48194369|NCT04411940|100797134|FG000|STARTED|Washout Period (14 Days)||16||
48194370|NCT04411940|100797135|FG001|STARTED|Washout Period (14 Days)||16||
48194371|NCT04411940|100797134|FG000|COMPLETED|Washout Period (14 Days)||16||
48194372|NCT04411940|100797135|FG001|COMPLETED|Washout Period (14 Days)||16||
48479760|NCT01985308|101512027|FG000|NOT COMPLETED|Overall Study||0||
48479761|NCT01985308|101512028|FG001|NOT COMPLETED|Overall Study||0||
48479762|NCT00890981|101512029|FG000|STARTED|Overall Study||39||
48194373|NCT04411940|100797134|FG000|NOT COMPLETED|Washout Period (14 Days)||0||
48194374|NCT04411940|100797135|FG001|NOT COMPLETED|Washout Period (14 Days)||0||
48194375|NCT04411940|100797134|FG000|STARTED|Treatment Period 2 (8 Days)||16||
48194376|NCT04411940|100797135|FG001|STARTED|Treatment Period 2 (8 Days)||16||
48479763|NCT00890981|101512030|FG001|STARTED|Overall Study||40||
48479764|NCT00890981|101512029|FG000|COMPLETED|Overall Study||39||
48479765|NCT00890981|101512030|FG001|COMPLETED|Overall Study||40||
48479766|NCT00890981|101512029|FG000|NOT COMPLETED|Overall Study||0||
48479767|NCT00890981|101512030|FG001|NOT COMPLETED|Overall Study||0||
48479768|NCT00301366|101512031|FG000|STARTED|Overall Study||38||
48194377|NCT04411940|100797134|FG000|COMPLETED|Treatment Period 2 (8 Days)||16||
48479769|NCT00301366|101512031|FG000|COMPLETED|Overall Study||37||
48479770|NCT00301366|101512031|FG000|NOT COMPLETED|Overall Study||1||
48479771|NCT00624065|101512032|FG000|STARTED|Overall Study||216||
48479772|NCT00624065|101512033|FG001|STARTED|Overall Study||216||
48479773|NCT00624065|101512032|FG000|COMPLETED|Overall Study||197||
48194378|NCT04411940|100797135|FG001|COMPLETED|Treatment Period 2 (8 Days)||16||
48194379|NCT04411940|100797134|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
48194380|NCT04411940|100797135|FG001|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
48194381|NCT02501629|100797136|FG000|STARTED|Overall Study||89||
48194382|NCT02501629|100797137|FG001|STARTED|Overall Study||88||
48194383|NCT02501629|100797136|FG000|COMPLETED|Overall Study||84|Participants who completed the 8-week follow-up visit or enrolled in NCT03052725|
48194384|NCT02501629|100797137|FG001|COMPLETED|Overall Study||81|Participants who completed the 8-week follow-up visit or enrolled in NCT03052725|
48194385|NCT02501629|100797136|FG000|NOT COMPLETED|Overall Study||5||
48194386|NCT02501629|100797137|FG001|NOT COMPLETED|Overall Study||7||
48194387|NCT01474538|100797138|FG000|STARTED|Treatment Period 1||60||
48194388|NCT01474538|100797139|FG001|STARTED|Treatment Period 1||62||
48194389|NCT01474538|100797138|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||60||
48194390|NCT01474538|100797139|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||62||
48194391|NCT01474538|100797138|FG000|COMPLETED|Treatment Period 1||57||
48194392|NCT01474538|100797139|FG001|COMPLETED|Treatment Period 1||58||
48194393|NCT01474538|100797138|FG000|NOT COMPLETED|Treatment Period 1||3||
48194394|NCT01474538|100797139|FG001|NOT COMPLETED|Treatment Period 1||4||
48194395|NCT01474538|100797138|FG000|STARTED|Treatment Period 2||57||
48194396|NCT01474538|100797139|FG001|STARTED|Treatment Period 2||58||
48194397|NCT01474538|100797138|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||57||
48194398|NCT01474538|100797139|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2||58||
48194399|NCT01474538|100797138|FG000|COMPLETED|Treatment Period 2||51||
48479774|NCT00624065|101512033|FG001|COMPLETED|Overall Study||192||
48479775|NCT00624065|101512032|FG000|NOT COMPLETED|Overall Study||19||
48479776|NCT00624065|101512033|FG001|NOT COMPLETED|Overall Study||24||
48479777|NCT02248597|101512034|FG000|STARTED|Overall Study||27||
48479778|NCT02248597|101512034|FG000|COMPLETED|Overall Study||27||
48479779|NCT02248597|101512034|FG000|NOT COMPLETED|Overall Study||0||
48479780|NCT01974141|101512035|FG000|STARTED|Overall Study||1044||
48479781|NCT01974141|101512036|FG001|STARTED|Overall Study||1058||
48479782|NCT01974141|101512035|FG000|COMPLETED|Overall Study||948||
48479783|NCT01974141|101512036|FG001|COMPLETED|Overall Study||976||
48479784|NCT01974141|101512035|FG000|NOT COMPLETED|Overall Study||96||
48194400|NCT01474538|100797139|FG001|COMPLETED|Treatment Period 2||56||
48194401|NCT01474538|100797138|FG000|NOT COMPLETED|Treatment Period 2||6||
48194402|NCT01474538|100797139|FG001|NOT COMPLETED|Treatment Period 2||2||
48194403|NCT01773122|100797140|FG000|STARTED|Overall Study||20||
48194404|NCT01773122|100797141|FG001|STARTED|Overall Study||19||
48479785|NCT01974141|101512036|FG001|NOT COMPLETED|Overall Study||82||
48479786|NCT04006171|101512037|FG000|STARTED|Overall Study||48||
48479787|NCT04006171|101512038|FG001|STARTED|Overall Study||42||
48479788|NCT04006171|101512037|FG000|COMPLETED|Overall Study||36||
48479789|NCT04006171|101512038|FG001|COMPLETED|Overall Study||30||
48479790|NCT04006171|101512037|FG000|NOT COMPLETED|Overall Study||12||
48479791|NCT04006171|101512038|FG001|NOT COMPLETED|Overall Study||12||
48479792|NCT02475954|101512039|FG000|STARTED|Overall Study||87||
48479793|NCT02475954|101512040|FG001|STARTED|Overall Study||87||
48479794|NCT02475954|101512039|FG000|COMPLETED|Overall Study||73||
48194405|NCT01773122|100797142|FG002|STARTED|Overall Study||19||
48479795|NCT02475954|101512040|FG001|COMPLETED|Overall Study||75||
48479796|NCT02475954|101512039|FG000|NOT COMPLETED|Overall Study||14||
48479797|NCT02475954|101512040|FG001|NOT COMPLETED|Overall Study||12||
48479798|NCT01474551|101512041|FG000|STARTED|Overall Study||2||
48479799|NCT01474551|101512041|FG000|COMPLETED|Overall Study||1||
48479800|NCT01474551|101512041|FG000|NOT COMPLETED|Overall Study||1||
48479801|NCT00846495|101512042|FG000|STARTED|Overall Study||28||
48479802|NCT00846495|101512043|FG001|STARTED|Overall Study||27||
48479803|NCT00846495|101512042|FG000|COMPLETED|Overall Study||20||
48479804|NCT00846495|101512043|FG001|COMPLETED|Overall Study||24||
48479805|NCT00846495|101512042|FG000|NOT COMPLETED|Overall Study||8||
48479806|NCT00846495|101512043|FG001|NOT COMPLETED|Overall Study||3||
48479807|NCT01371786|101512044|FG000|STARTED|Overall Study||7||
48479808|NCT01371786|101512045|FG001|STARTED|Overall Study||7||
48479809|NCT01371786|101512044|FG000|COMPLETED|Overall Study||7||
48479810|NCT01371786|101512045|FG001|COMPLETED|Overall Study||7||
48479811|NCT01371786|101512044|FG000|NOT COMPLETED|Overall Study||0||
48479812|NCT01371786|101512045|FG001|NOT COMPLETED|Overall Study||0||
48479813|NCT00319735|101512046|FG000|STARTED|Overall Study||41||
48479814|NCT00319735|101512046|FG000|COMPLETED|Overall Study||39||
48479815|NCT00319735|101512046|FG000|NOT COMPLETED|Overall Study||2||
48479816|NCT00119015|101512047|FG000|STARTED|Open-Label Phase (2 Weeks)||102||
48479817|NCT00119015|101512048|FG001|STARTED|Open-Label Phase (2 Weeks)||0||
48479818|NCT00119015|101512049|FG002|STARTED|Open-Label Phase (2 Weeks)||0||
48479819|NCT00119015|101512047|FG000|COMPLETED|Open-Label Phase (2 Weeks)||54||
48479820|NCT00119015|101512048|FG001|COMPLETED|Open-Label Phase (2 Weeks)||0||
48479821|NCT00119015|101512049|FG002|COMPLETED|Open-Label Phase (2 Weeks)||0||
48479822|NCT00119015|101512047|FG000|NOT COMPLETED|Open-Label Phase (2 Weeks)||48||
48479823|NCT00119015|101512048|FG001|NOT COMPLETED|Open-Label Phase (2 Weeks)||0||
48479824|NCT00119015|101512049|FG002|NOT COMPLETED|Open-Label Phase (2 Weeks)||0||
48479825|NCT00119015|101512047|FG000|STARTED|Double-Blind, Randomized Phase (2 Weeks)||0||
48479826|NCT00119015|101512048|FG001|STARTED|Double-Blind, Randomized Phase (2 Weeks)||28||
48479827|NCT00119015|101512049|FG002|STARTED|Double-Blind, Randomized Phase (2 Weeks)||26||
48479828|NCT00119015|101512047|FG000|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0||
48479829|NCT00119015|101512048|FG001|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||28||
48479830|NCT00119015|101512049|FG002|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||26||
48479831|NCT00119015|101512047|FG000|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0||
48479832|NCT00119015|101512048|FG001|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0||
48479833|NCT00119015|101512049|FG002|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0||
48479834|NCT03099538|101512050|FG000|STARTED|Overall Study||4||
48479835|NCT03099538|101512050|FG000|COMPLETED|Overall Study||1||
48479836|NCT03099538|101512050|FG000|NOT COMPLETED|Overall Study||3||
48479837|NCT02506933|101512051|FG000|STARTED|Overall Study||51||
48479838|NCT02506933|101512052|FG001|STARTED|Overall Study||51||
48479839|NCT02506933|101512051|FG000|COMPLETED|Overall Study||51||
48479840|NCT02506933|101512052|FG001|COMPLETED|Overall Study||51||
48479841|NCT02506933|101512051|FG000|NOT COMPLETED|Overall Study||0||
48479842|NCT02506933|101512052|FG001|NOT COMPLETED|Overall Study||0||
48479843|NCT02140060|101512053|FG000|STARTED|Overall Study||44||
48479844|NCT02140060|101512054|FG001|STARTED|Overall Study||44||
48479845|NCT02140060|101512055|FG002|STARTED|Overall Study||44||
48479846|NCT02140060|101512056|FG003|STARTED|Overall Study||45||
48479847|NCT02140060|101512057|FG004|STARTED|Overall Study||45||
48479848|NCT02140060|101512058|FG005|STARTED|Overall Study||44||
48479849|NCT02140060|101512053|FG000|COMPLETED|Overall Study||44||
48479850|NCT02140060|101512054|FG001|COMPLETED|Overall Study||44||
48479851|NCT02140060|101512055|FG002|COMPLETED|Overall Study||44||
48479852|NCT02140060|101512056|FG003|COMPLETED|Overall Study||43||
48479853|NCT02140060|101512057|FG004|COMPLETED|Overall Study||44||
48479854|NCT02140060|101512058|FG005|COMPLETED|Overall Study||43||
48479855|NCT02140060|101512053|FG000|NOT COMPLETED|Overall Study||0||
48479856|NCT02140060|101512054|FG001|NOT COMPLETED|Overall Study||0||
48479857|NCT02140060|101512055|FG002|NOT COMPLETED|Overall Study||0||
48479858|NCT02140060|101512056|FG003|NOT COMPLETED|Overall Study||2||
48479859|NCT02140060|101512057|FG004|NOT COMPLETED|Overall Study||1||
48479860|NCT02140060|101512058|FG005|NOT COMPLETED|Overall Study||1||
48479861|NCT00905840|101512059|FG000|STARTED|Overall Study||91||
48479862|NCT00905840|101512059|FG000|COMPLETED|Overall Study||75||
48479863|NCT00905840|101512059|FG000|NOT COMPLETED|Overall Study||16||
48479864|NCT03496623|101512060|FG000|STARTED|Run-In Period (2 Weeks)||108||
48479865|NCT03496623|101512061|FG001|STARTED|Run-In Period (2 Weeks)||0||
48479866|NCT03496623|101512062|FG002|STARTED|Run-In Period (2 Weeks)||0||
48479867|NCT03496623|101512063|FG003|STARTED|Run-In Period (2 Weeks)||0||
48479868|NCT03496623|101512064|FG004|STARTED|Run-In Period (2 Weeks)||0||
48479869|NCT03496623|101512060|FG000|Received At Least 1 Dose of Study Drug|Run-In Period (2 Weeks)||108||
48479870|NCT03496623|101512061|FG001|Received At Least 1 Dose of Study Drug|Run-In Period (2 Weeks)||0||
48479871|NCT03496623|101512062|FG002|Received At Least 1 Dose of Study Drug|Run-In Period (2 Weeks)||0||
48479872|NCT03496623|101512063|FG003|Received At Least 1 Dose of Study Drug|Run-In Period (2 Weeks)||0||
48479873|NCT03496623|101512064|FG004|Received At Least 1 Dose of Study Drug|Run-In Period (2 Weeks)||0||
48479874|NCT03496623|101512060|FG000|COMPLETED|Run-In Period (2 Weeks)||76||
48479875|NCT03496623|101512061|FG001|COMPLETED|Run-In Period (2 Weeks)||0||
48479876|NCT03496623|101512062|FG002|COMPLETED|Run-In Period (2 Weeks)||0||
48479877|NCT03496623|101512063|FG003|COMPLETED|Run-In Period (2 Weeks)||0||
48479878|NCT03496623|101512064|FG004|COMPLETED|Run-In Period (2 Weeks)||0||
48479879|NCT03496623|101512060|FG000|NOT COMPLETED|Run-In Period (2 Weeks)||32||
48479880|NCT03496623|101512061|FG001|NOT COMPLETED|Run-In Period (2 Weeks)||0||
48479881|NCT03496623|101512062|FG002|NOT COMPLETED|Run-In Period (2 Weeks)||0||
48479882|NCT03496623|101512063|FG003|NOT COMPLETED|Run-In Period (2 Weeks)||0||
48479883|NCT03496623|101512064|FG004|NOT COMPLETED|Run-In Period (2 Weeks)||0||
48479884|NCT03496623|101512060|FG000|STARTED|Period 1 (12 Weeks)||0||
48479885|NCT03496623|101512061|FG001|STARTED|Period 1 (12 Weeks)||32||
48479886|NCT03496623|101512062|FG002|STARTED|Period 1 (12 Weeks)||32||
48479887|NCT03496623|101512063|FG003|STARTED|Period 1 (12 Weeks)||6||
48479888|NCT03496623|101512064|FG004|STARTED|Period 1 (12 Weeks)||6||
48479889|NCT03496623|101512060|FG000|Received At Least 1 Dose of Study Drug|Period 1 (12 Weeks)||0||
48479890|NCT03496623|101512061|FG001|Received At Least 1 Dose of Study Drug|Period 1 (12 Weeks)||32||
48479891|NCT03496623|101512062|FG002|Received At Least 1 Dose of Study Drug|Period 1 (12 Weeks)||32||
48479892|NCT03496623|101512063|FG003|Received At Least 1 Dose of Study Drug|Period 1 (12 Weeks)||6||
48479893|NCT03496623|101512064|FG004|Received At Least 1 Dose of Study Drug|Period 1 (12 Weeks)||6||
48479894|NCT03496623|101512060|FG000|COMPLETED|Period 1 (12 Weeks)||0||
48479895|NCT03496623|101512061|FG001|COMPLETED|Period 1 (12 Weeks)||26||
48479896|NCT03496623|101512062|FG002|COMPLETED|Period 1 (12 Weeks)||29||
48479897|NCT03496623|101512063|FG003|COMPLETED|Period 1 (12 Weeks)||5||
48479898|NCT03496623|101512064|FG004|COMPLETED|Period 1 (12 Weeks)||4||
48479899|NCT03496623|101512060|FG000|NOT COMPLETED|Period 1 (12 Weeks)||0||
48479900|NCT03496623|101512061|FG001|NOT COMPLETED|Period 1 (12 Weeks)||6||
48479901|NCT03496623|101512062|FG002|NOT COMPLETED|Period 1 (12 Weeks)||3||
48479902|NCT03496623|101512063|FG003|NOT COMPLETED|Period 1 (12 Weeks)||1||
48479903|NCT03496623|101512064|FG004|NOT COMPLETED|Period 1 (12 Weeks)||2||
48479904|NCT03496623|101512060|FG000|STARTED|Period 2 (12 Weeks)||0||
48479905|NCT03496623|101512061|FG001|STARTED|Period 2 (12 Weeks)||26||
48479906|NCT03496623|101512062|FG002|STARTED|Period 2 (12 Weeks)||29||
48479907|NCT03496623|101512063|FG003|STARTED|Period 2 (12 Weeks)||0||
48479908|NCT03496623|101512064|FG004|STARTED|Period 2 (12 Weeks)||0||
48479909|NCT03496623|101512060|FG000|Received At Least 1 Dose of Study Drug|Period 2 (12 Weeks)||0||
48479910|NCT03496623|101512061|FG001|Received At Least 1 Dose of Study Drug|Period 2 (12 Weeks)||20||
48479911|NCT03496623|101512062|FG002|Received At Least 1 Dose of Study Drug|Period 2 (12 Weeks)||28||
48479912|NCT03496623|101512063|FG003|Received At Least 1 Dose of Study Drug|Period 2 (12 Weeks)||0||
48479913|NCT03496623|101512064|FG004|Received At Least 1 Dose of Study Drug|Period 2 (12 Weeks)||0||
48479914|NCT03496623|101512060|FG000|COMPLETED|Period 2 (12 Weeks)||0||
48479915|NCT03496623|101512061|FG001|COMPLETED|Period 2 (12 Weeks)||19||
48479916|NCT03496623|101512062|FG002|COMPLETED|Period 2 (12 Weeks)||21||
48479917|NCT03496623|101512063|FG003|COMPLETED|Period 2 (12 Weeks)||0||
48479918|NCT03496623|101512064|FG004|COMPLETED|Period 2 (12 Weeks)||0||
48479919|NCT03496623|101512060|FG000|NOT COMPLETED|Period 2 (12 Weeks)||0||
48479920|NCT03496623|101512061|FG001|NOT COMPLETED|Period 2 (12 Weeks)||7||
48479921|NCT03496623|101512062|FG002|NOT COMPLETED|Period 2 (12 Weeks)||8||
48479922|NCT03496623|101512063|FG003|NOT COMPLETED|Period 2 (12 Weeks)||0||
48479923|NCT03496623|101512064|FG004|NOT COMPLETED|Period 2 (12 Weeks)||0||
48479924|NCT02511782|101512065|FG000|STARTED|Overall Study||51||
48479925|NCT02511782|101512066|FG001|STARTED|Overall Study||2||
48479926|NCT02511782|101512067|FG002|STARTED|Overall Study||10||
48479927|NCT02511782|101512065|FG000|COMPLETED|Overall Study||50||
48479928|NCT02511782|101512066|FG001|COMPLETED|Overall Study||2||
48479929|NCT02511782|101512067|FG002|COMPLETED|Overall Study||10||
48479930|NCT02511782|101512065|FG000|NOT COMPLETED|Overall Study||1||
48479931|NCT02511782|101512066|FG001|NOT COMPLETED|Overall Study||0||
48479932|NCT02511782|101512067|FG002|NOT COMPLETED|Overall Study||0||
48479933|NCT03122457|101512068|FG000|STARTED|Overall Study||22||
48479934|NCT03122457|101512068|FG000|COMPLETED|Overall Study||16||
48479935|NCT03122457|101512068|FG000|NOT COMPLETED|Overall Study||6||
48479936|NCT03861845|101512069|FG000|STARTED|Overall Study||6||
48479937|NCT03861845|101512070|FG001|STARTED|Overall Study||5||
48479938|NCT03861845|101512071|FG002|STARTED|Overall Study||4||
48479939|NCT03861845|101512069|FG000|COMPLETED|Overall Study||6||
48479940|NCT03861845|101512070|FG001|COMPLETED|Overall Study||5||
48479941|NCT03861845|101512071|FG002|COMPLETED|Overall Study||4||
48479942|NCT03861845|101512069|FG000|NOT COMPLETED|Overall Study||0||
48479943|NCT03861845|101512070|FG001|NOT COMPLETED|Overall Study||0||
48479944|NCT03861845|101512071|FG002|NOT COMPLETED|Overall Study||0||
48479945|NCT02325531|101512072|FG000|STARTED|Overall Study||0||9
48479946|NCT02325531|101512073|FG001|STARTED|Overall Study||0||11
48479947|NCT02325531|101512074|FG002|STARTED|Overall Study||0||9
48479948|NCT02325531|101512075|FG003|STARTED|Overall Study||0||137
48479949|NCT02325531|101512072|FG000|COMPLETED|Overall Study||0||9
48479950|NCT02325531|101512073|FG001|COMPLETED|Overall Study||0||11
48479951|NCT02325531|101512074|FG002|COMPLETED|Overall Study||0||7
48479952|NCT02325531|101512075|FG003|COMPLETED|Overall Study||0||137
48479953|NCT02325531|101512072|FG000|NOT COMPLETED|Overall Study||0||0
48479954|NCT02325531|101512073|FG001|NOT COMPLETED|Overall Study||0||0
48479955|NCT02325531|101512074|FG002|NOT COMPLETED|Overall Study||0||2
48479956|NCT02325531|101512075|FG003|NOT COMPLETED|Overall Study||0||0
48479957|NCT01532141|101512076|FG000|STARTED|Overall Study||9||
48479958|NCT01532141|101512077|FG001|STARTED|Overall Study||8||
48479959|NCT01532141|101512078|FG002|STARTED|Overall Study||8||
48479960|NCT01532141|101512076|FG000|Period 1|Overall Study||9||
48479961|NCT01532141|101512077|FG001|Period 1|Overall Study||8||
48479962|NCT01532141|101512078|FG002|Period 1|Overall Study||8||
48479963|NCT01532141|101512076|FG000|Period 2|Overall Study||8||
48479964|NCT01532141|101512077|FG001|Period 2|Overall Study||8||
48479965|NCT01532141|101512078|FG002|Period 2|Overall Study||8||
48479966|NCT01532141|101512076|FG000|Period 3|Overall Study||8||
48479967|NCT01532141|101512077|FG001|Period 3|Overall Study||8||
48479968|NCT01532141|101512078|FG002|Period 3|Overall Study||8||
48479969|NCT01532141|101512076|FG000|COMPLETED|Overall Study||8||
48479970|NCT01532141|101512077|FG001|COMPLETED|Overall Study||8||
48479971|NCT01532141|101512078|FG002|COMPLETED|Overall Study||8||
48479972|NCT01532141|101512076|FG000|NOT COMPLETED|Overall Study||1||
48479973|NCT01532141|101512077|FG001|NOT COMPLETED|Overall Study||0||
48479974|NCT01532141|101512078|FG002|NOT COMPLETED|Overall Study||0||
48479975|NCT00183794|101512079|FG000|STARTED|Overall Study||20||
48479976|NCT00183794|101512079|FG000|COMPLETED|Overall Study||20||
48479977|NCT00183794|101512079|FG000|NOT COMPLETED|Overall Study||0||
48479978|NCT01874756|101512080|FG000|STARTED|Overall Study||29||
48479979|NCT01874756|101512081|FG001|STARTED|Overall Study||10||
48479980|NCT01874756|101512082|FG002|STARTED|Overall Study||29||
48479981|NCT01874756|101512083|FG003|STARTED|Overall Study||27||
48479982|NCT01874756|101512080|FG000|COMPLETED|Overall Study||28||
48479983|NCT01874756|101512081|FG001|COMPLETED|Overall Study||10||
48479984|NCT01874756|101512082|FG002|COMPLETED|Overall Study||27||
48479985|NCT01874756|101512083|FG003|COMPLETED|Overall Study||21||
48479986|NCT01874756|101512080|FG000|NOT COMPLETED|Overall Study||1||
48479987|NCT01874756|101512081|FG001|NOT COMPLETED|Overall Study||0||
48479988|NCT01874756|101512082|FG002|NOT COMPLETED|Overall Study||2||
48194406|NCT01773122|100797143|FG003|STARTED|Overall Study||19||
48479989|NCT01874756|101512083|FG003|NOT COMPLETED|Overall Study||6||
48479990|NCT00323882|101512084|FG000|STARTED|Overall Study||8||
48479991|NCT00323882|101512085|FG001|STARTED|Overall Study||6||
48479992|NCT00323882|101512086|FG002|STARTED|Overall Study||16||
48479993|NCT00323882|101512087|FG003|STARTED|Overall Study||7||
48479994|NCT00323882|101512088|FG004|STARTED|Overall Study||34||
48479995|NCT00323882|101512084|FG000|COMPLETED|Overall Study||0||
48479996|NCT00323882|101512085|FG001|COMPLETED|Overall Study||0||
48479997|NCT00323882|101512086|FG002|COMPLETED|Overall Study||3||
48479998|NCT00323882|101512087|FG003|COMPLETED|Overall Study||0||
48479999|NCT00323882|101512088|FG004|COMPLETED|Overall Study||2||
48480000|NCT00323882|101512084|FG000|NOT COMPLETED|Overall Study||8||
48480001|NCT00323882|101512085|FG001|NOT COMPLETED|Overall Study||6||
48480002|NCT00323882|101512086|FG002|NOT COMPLETED|Overall Study||13||
48480003|NCT00323882|101512087|FG003|NOT COMPLETED|Overall Study||7||
48480004|NCT00323882|101512088|FG004|NOT COMPLETED|Overall Study||32||
48480005|NCT01949662|101512089|FG000|STARTED|Overall Study||47||
48480006|NCT01949662|101512090|FG001|STARTED|Overall Study||43||
48480007|NCT01949662|101512089|FG000|COMPLETED|Overall Study||29||
48480008|NCT01949662|101512090|FG001|COMPLETED|Overall Study||29||
48480009|NCT01949662|101512089|FG000|NOT COMPLETED|Overall Study||18||
48480010|NCT01949662|101512090|FG001|NOT COMPLETED|Overall Study||14||
48194407|NCT01773122|100797140|FG000|COMPLETED|Overall Study||17||
48194408|NCT01773122|100797141|FG001|COMPLETED|Overall Study||18||
48480011|NCT03834870|101512091|FG000|STARTED|Overall Study||1012||
48480012|NCT03834870|101512091|FG000|COMPLETED|Overall Study||1002||
48480013|NCT03834870|101512091|FG000|NOT COMPLETED|Overall Study||10||
48480014|NCT05194839|101512092|FG000|STARTED|Overall Study||27||
48194409|NCT01773122|100797142|FG002|COMPLETED|Overall Study||19||
48194410|NCT01773122|100797143|FG003|COMPLETED|Overall Study||18||
48194411|NCT01773122|100797140|FG000|NOT COMPLETED|Overall Study||3||
48194412|NCT01773122|100797141|FG001|NOT COMPLETED|Overall Study||1||
48194413|NCT01773122|100797142|FG002|NOT COMPLETED|Overall Study||0||
48480015|NCT05194839|101512093|FG001|STARTED|Overall Study||26||
48480016|NCT05194839|101512094|FG002|STARTED|Overall Study||26||
48480017|NCT05194839|101512092|FG000|COMPLETED|Overall Study||12||
48480018|NCT05194839|101512093|FG001|COMPLETED|Overall Study||13||
48480019|NCT05194839|101512094|FG002|COMPLETED|Overall Study||12||
48480020|NCT05194839|101512092|FG000|NOT COMPLETED|Overall Study||15||
48480021|NCT05194839|101512093|FG001|NOT COMPLETED|Overall Study||13||
48480022|NCT05194839|101512094|FG002|NOT COMPLETED|Overall Study||14||
48480023|NCT02661295|101512095|FG000|STARTED|Overall Study||38||
48480024|NCT02661295|101512095|FG000|COMPLETED|Overall Study||19||
48480025|NCT02661295|101512095|FG000|NOT COMPLETED|Overall Study||19||
48480026|NCT03097783|101512096|FG000|STARTED|Overall Study||132||
48480027|NCT03097783|101512097|FG001|STARTED|Overall Study||37||
48480028|NCT03097783|101512096|FG000|COMPLETED|Overall Study||123||
48480029|NCT03097783|101512097|FG001|COMPLETED|Overall Study||31||
48194414|NCT01773122|100797143|FG003|NOT COMPLETED|Overall Study||1||
48480030|NCT03097783|101512096|FG000|NOT COMPLETED|Overall Study||9||
48480031|NCT03097783|101512097|FG001|NOT COMPLETED|Overall Study||6||
48480032|NCT03124966|101512098|FG000|STARTED|Overall Study||118||
48480033|NCT03124966|101512098|FG000|COMPLETED|Overall Study||118||
48480034|NCT03124966|101512098|FG000|NOT COMPLETED|Overall Study||0||
48480035|NCT01457053|101512099|FG000|STARTED|Overall Study||2||
48480036|NCT01457053|101512100|FG001|STARTED|Overall Study||2||
48480037|NCT01457053|101512099|FG000|COMPLETED|Overall Study||1||
48480038|NCT01457053|101512100|FG001|COMPLETED|Overall Study||1||
48480039|NCT01457053|101512099|FG000|NOT COMPLETED|Overall Study||1||
48480040|NCT01457053|101512100|FG001|NOT COMPLETED|Overall Study||1||
48480041|NCT03257722|101512101|FG000|STARTED|Overall Study||2||
48480042|NCT03257722|101512101|FG000|COMPLETED|Overall Study||0||
48480043|NCT03257722|101512101|FG000|NOT COMPLETED|Overall Study||2||
48480044|NCT04419311|101512102|FG000|STARTED|Overall Study||33||
48480045|NCT04419311|101512103|FG001|STARTED|Overall Study||33||
48480046|NCT04419311|101512102|FG000|COMPLETED|Overall Study||32||
48480047|NCT04419311|101512103|FG001|COMPLETED|Overall Study||33||
48480048|NCT04419311|101512102|FG000|NOT COMPLETED|Overall Study||1||
48480049|NCT04419311|101512103|FG001|NOT COMPLETED|Overall Study||0||
48480050|NCT01496183|101512104|FG000|STARTED|Overall Study||9||
48480051|NCT01496183|101512105|FG001|STARTED|Overall Study||15||
48480052|NCT01496183|101512104|FG000|COMPLETED|Overall Study||6||
48480053|NCT01496183|101512105|FG001|COMPLETED|Overall Study||13||
48480054|NCT01496183|101512104|FG000|NOT COMPLETED|Overall Study||3||
48480055|NCT01496183|101512105|FG001|NOT COMPLETED|Overall Study||2||
48480056|NCT02724462|101512106|FG000|STARTED|3 Month Follow-up Survey||1254||
48480057|NCT02724462|101512107|FG001|STARTED|3 Month Follow-up Survey||1249||
48480058|NCT02724462|101512106|FG000|COMPLETED|3 Month Follow-up Survey||1043||
48480059|NCT02724462|101512107|FG001|COMPLETED|3 Month Follow-up Survey||1050||
48480060|NCT02724462|101512106|FG000|NOT COMPLETED|3 Month Follow-up Survey||211||
48480061|NCT02724462|101512107|FG001|NOT COMPLETED|3 Month Follow-up Survey||199||
48480062|NCT02724462|101512106|FG000|STARTED|6 Month Follow-up Survey||1254||
48480063|NCT02724462|101512107|FG001|STARTED|6 Month Follow-up Survey||1249||
48480064|NCT02724462|101512106|FG000|COMPLETED|6 Month Follow-up Survey||1058||
48480065|NCT02724462|101512107|FG001|COMPLETED|6 Month Follow-up Survey||1078||
48480066|NCT02724462|101512106|FG000|NOT COMPLETED|6 Month Follow-up Survey||196||
48480067|NCT02724462|101512107|FG001|NOT COMPLETED|6 Month Follow-up Survey||171||
48480068|NCT02724462|101512106|FG000|STARTED|12 Month Follow-up Survey||1254||
48480069|NCT02724462|101512107|FG001|STARTED|12 Month Follow-up Survey||1249||
48480070|NCT02724462|101512106|FG000|COMPLETED|12 Month Follow-up Survey||1040||
48480071|NCT02724462|101512107|FG001|COMPLETED|12 Month Follow-up Survey||1067||
48480072|NCT02724462|101512106|FG000|NOT COMPLETED|12 Month Follow-up Survey||214||
48480073|NCT02724462|101512107|FG001|NOT COMPLETED|12 Month Follow-up Survey||182||
48480074|NCT01878825|101512108|FG000|STARTED|Overall Study||60||
48480075|NCT01878825|101512109|FG001|STARTED|Overall Study||60||
48480076|NCT01878825|101512108|FG000|COMPLETED|Overall Study||60||
48480077|NCT01878825|101512109|FG001|COMPLETED|Overall Study||60||
48480078|NCT01878825|101512108|FG000|NOT COMPLETED|Overall Study||0||
48480079|NCT01878825|101512109|FG001|NOT COMPLETED|Overall Study||0||
48480080|NCT01792635|101512110|FG000|STARTED|Part A||6||
48480081|NCT01792635|101512111|FG001|STARTED|Part A||0||
48480082|NCT01792635|101512112|FG002|STARTED|Part A||0||
48480083|NCT01792635|101512110|FG000|COMPLETED|Part A||6||
48480084|NCT01792635|101512111|FG001|COMPLETED|Part A||0||
48480085|NCT01792635|101512112|FG002|COMPLETED|Part A||0||
48480086|NCT01792635|101512110|FG000|NOT COMPLETED|Part A||0||
48480087|NCT01792635|101512111|FG001|NOT COMPLETED|Part A||0||
48480088|NCT01792635|101512112|FG002|NOT COMPLETED|Part A||0||
48480089|NCT01792635|101512110|FG000|STARTED|Part B||0||
48480090|NCT01792635|101512111|FG001|STARTED|Part B||6||
48480091|NCT01792635|101512112|FG002|STARTED|Part B||7||
48480092|NCT01792635|101512110|FG000|COMPLETED|Part B||0||
48480093|NCT01792635|101512111|FG001|COMPLETED|Part B||2||
48480094|NCT01792635|101512112|FG002|COMPLETED|Part B||3||
48480095|NCT01792635|101512110|FG000|NOT COMPLETED|Part B||0||
48480096|NCT01792635|101512111|FG001|NOT COMPLETED|Part B||4||
48480097|NCT01792635|101512112|FG002|NOT COMPLETED|Part B||4||
48480098|NCT01667679|101512113|FG000|STARTED|Treatment Period 1 (<=12 Weeks)||138||
48480099|NCT01667679|101512114|FG001|STARTED|Treatment Period 1 (<=12 Weeks)||137||
48480100|NCT01667679|101512113|FG000|COMPLETED|Treatment Period 1 (<=12 Weeks)||122||
48480101|NCT01667679|101512114|FG001|COMPLETED|Treatment Period 1 (<=12 Weeks)||107||
48480102|NCT01667679|101512113|FG000|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||16||
48480103|NCT01667679|101512114|FG001|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||30||
48480104|NCT01667679|101512113|FG000|STARTED|Treatment Period 2 (<=12 Weeks)||122||
48480105|NCT01667679|101512114|FG001|STARTED|Treatment Period 2 (<=12 Weeks)||107||
48480106|NCT01667679|101512113|FG000|COMPLETED|Treatment Period 2 (<=12 Weeks)||100||
48480107|NCT01667679|101512114|FG001|COMPLETED|Treatment Period 2 (<=12 Weeks)||85||
48480108|NCT01667679|101512113|FG000|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22||
48480109|NCT01667679|101512114|FG001|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22||
48480110|NCT03880266|101512115|FG000|STARTED|Overall Study||12||
48480111|NCT03880266|101512116|FG001|STARTED|Overall Study||6||
48480112|NCT03880266|101512117|FG002|STARTED|Overall Study||12||
48480113|NCT03880266|101512118|FG003|STARTED|Overall Study||4||
48480114|NCT03880266|101512119|FG004|STARTED|Overall Study||12||
48480115|NCT03880266|101512120|FG005|STARTED|Overall Study||6||
48480116|NCT03880266|101512121|FG006|STARTED|Overall Study||13||
48480117|NCT03880266|101512122|FG007|STARTED|Overall Study||7||
48480118|NCT03880266|101512115|FG000|COMPLETED|Overall Study||12||
48670494|NCT00098475|101974954|FG003|Eligible|Step 2||0||
48480119|NCT03880266|101512116|FG001|COMPLETED|Overall Study||5||
48666380|NCT02038036|101967573|FG001|Full Analysis Set|Core Study||75|comprised of all patients to whom study treatment was assigned by randomization.|
48194415|NCT01018511|100797144|FG000|STARTED|Overall Study||341||
48670495|NCT00098475|101974951|FG000|COMPLETED|Step 2||0||
48670496|NCT00098475|101974952|FG001|COMPLETED|Step 2||5||
48480120|NCT03880266|101512117|FG002|COMPLETED|Overall Study||11||
48480121|NCT03880266|101512118|FG003|COMPLETED|Overall Study||4||
48480122|NCT03880266|101512119|FG004|COMPLETED|Overall Study||12||
48480123|NCT03880266|101512120|FG005|COMPLETED|Overall Study||6||
48480124|NCT03880266|101512121|FG006|COMPLETED|Overall Study||13||
48480125|NCT03880266|101512122|FG007|COMPLETED|Overall Study||7||
48480126|NCT03880266|101512115|FG000|NOT COMPLETED|Overall Study||0||
48480127|NCT03880266|101512116|FG001|NOT COMPLETED|Overall Study||1||
48480128|NCT03880266|101512117|FG002|NOT COMPLETED|Overall Study||1||
48480129|NCT03880266|101512118|FG003|NOT COMPLETED|Overall Study||0||
48480130|NCT03880266|101512119|FG004|NOT COMPLETED|Overall Study||0||
48480131|NCT03880266|101512120|FG005|NOT COMPLETED|Overall Study||0||
48480132|NCT03880266|101512121|FG006|NOT COMPLETED|Overall Study||0||
48480133|NCT03880266|101512122|FG007|NOT COMPLETED|Overall Study||0||
48480134|NCT03471078|101512123|FG000|STARTED|Overall Study||82||
48480135|NCT03471078|101512124|FG001|STARTED|Overall Study||40||
48480136|NCT03471078|101512123|FG000|COMPLETED|Overall Study||61||
48480137|NCT03471078|101512124|FG001|COMPLETED|Overall Study||34||
48480138|NCT03471078|101512123|FG000|NOT COMPLETED|Overall Study||21||
48480139|NCT03471078|101512124|FG001|NOT COMPLETED|Overall Study||6||
48480140|NCT03497897|101512125|FG000|STARTED|Overall Study||26||
48480141|NCT03497897|101512126|FG001|STARTED|Overall Study||11||
48480142|NCT03497897|101512127|FG002|STARTED|Overall Study||29||
48480143|NCT03497897|101512125|FG000|Completed Treatment Period|Overall Study||23||
48480144|NCT03497897|101512126|FG001|Completed Treatment Period|Overall Study||9||
48480145|NCT03497897|101512127|FG002|Completed Treatment Period|Overall Study||24||
48480146|NCT03497897|101512125|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||24|The PD analysis set included all participants with available PD data who received any study drug and with no protocol deviations with relevant impact on PD data.|
48480147|NCT03497897|101512126|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||11|The PD analysis set included all participants with available PD data who received any study drug and with no protocol deviations with relevant impact on PD data.|
48480148|NCT03497897|101512127|FG002|Pharmacodynamic (PD) Analysis Set|Overall Study||28|The PD analysis set included all participants with available PD data who received any study drug and with no protocol deviations with relevant impact on PD data.|
48480149|NCT03497897|101512125|FG000|COMPLETED|Overall Study||20|Participants who completed the study|
48480150|NCT03497897|101512126|FG001|COMPLETED|Overall Study||9|Participants who completed the study|
48480151|NCT03497897|101512127|FG002|COMPLETED|Overall Study||23|Participants who completed the study|
48480152|NCT03497897|101512125|FG000|NOT COMPLETED|Overall Study||6||
48480153|NCT03497897|101512126|FG001|NOT COMPLETED|Overall Study||2||
48480154|NCT03497897|101512127|FG002|NOT COMPLETED|Overall Study||6||
48480155|NCT03334825|101512128|FG000|STARTED|Overall Study||119||
48480156|NCT03334825|101512129|FG001|STARTED|Overall Study||117||
48480157|NCT03334825|101512128|FG000|COMPLETED|Overall Study||112||
48480158|NCT03334825|101512129|FG001|COMPLETED|Overall Study||113||
48480159|NCT03334825|101512128|FG000|NOT COMPLETED|Overall Study||7||
48480160|NCT03334825|101512129|FG001|NOT COMPLETED|Overall Study||4||
48480161|NCT00550537|101512130|FG000|STARTED|Overall Study||116||
48480162|NCT00550537|101512130|FG000|COMPLETED|Overall Study||12||
48480163|NCT00550537|101512130|FG000|NOT COMPLETED|Overall Study||104||
48480164|NCT00004562|101512131|FG000|STARTED|Overall Study||1101||
48480165|NCT00004562|101512132|FG001|STARTED|Overall Study||1100||
48480166|NCT00004562|101512131|FG000|COMPLETED|Overall Study||999||
48480167|NCT00004562|101512132|FG001|COMPLETED|Overall Study||1009||
48480168|NCT00004562|101512131|FG000|NOT COMPLETED|Overall Study||102||
48480169|NCT00004562|101512132|FG001|NOT COMPLETED|Overall Study||91||
48480170|NCT05214560|101512133|FG000|STARTED|Overall Study||160||
48480171|NCT05214560|101512133|FG000|Enrolled Set|Overall Study||160||
48480172|NCT05214560|101512133|FG000|Evaluable Set|Overall Study||144||
48480173|NCT05214560|101512133|FG000|Safety Set|Overall Study||142||
48480174|NCT05214560|101512133|FG000|COMPLETED|Overall Study||142||
48480175|NCT05214560|101512133|FG000|NOT COMPLETED|Overall Study||18||
48480176|NCT02039908|101512134|FG000|STARTED|Phase 1-Summer||129||
48480177|NCT02039908|101512135|FG001|STARTED|Phase 1-Summer||138||
48480178|NCT02039908|101512136|FG002|STARTED|Phase 1-Summer||0||
48480179|NCT02039908|101512137|FG003|STARTED|Phase 1-Summer||0||
48480180|NCT02039908|101512134|FG000|COMPLETED|Phase 1-Summer||116||
48480181|NCT02039908|101512135|FG001|COMPLETED|Phase 1-Summer||132||
48480182|NCT02039908|101512136|FG002|COMPLETED|Phase 1-Summer||0||
48480183|NCT02039908|101512137|FG003|COMPLETED|Phase 1-Summer||0||
48480184|NCT02039908|101512134|FG000|NOT COMPLETED|Phase 1-Summer||13||
48480185|NCT02039908|101512135|FG001|NOT COMPLETED|Phase 1-Summer||6||
48480186|NCT02039908|101512136|FG002|NOT COMPLETED|Phase 1-Summer||0||
48480187|NCT02039908|101512137|FG003|NOT COMPLETED|Phase 1-Summer||0||
48480188|NCT02039908|101512134|FG000|STARTED|Phase 2-School Year||0|Three participants elected not to continue in the study for the school -year phase.|
48480189|NCT02039908|101512135|FG001|STARTED|Phase 2-School Year||0|Three participants elected not to continue in the study for the school -year phase.|
48480190|NCT02039908|101512136|FG002|STARTED|Phase 2-School Year||121|Three participants elected not to continue in the study for the school -year phase.|
48194416|NCT01018511|100797145|FG001|STARTED|Overall Study||327||
48194417|NCT01018511|100797146|FG002|STARTED|Overall Study||339||
48194418|NCT01018511|100797147|FG003|STARTED|Overall Study||327||
48194419|NCT01018511|100797144|FG000|Randomized and Treated|Overall Study||341||
48194420|NCT01018511|100797145|FG001|Randomized and Treated|Overall Study||326||
48194421|NCT01018511|100797146|FG002|Randomized and Treated|Overall Study||338||
48194422|NCT01018511|100797147|FG003|Randomized and Treated|Overall Study||324||
48194423|NCT01018511|100797144|FG000|COMPLETED|Overall Study||315||
48194424|NCT01018511|100797145|FG001|COMPLETED|Overall Study||295||
48194425|NCT01018511|100797146|FG002|COMPLETED|Overall Study||299||
48194426|NCT01018511|100797147|FG003|COMPLETED|Overall Study||294||
48194427|NCT01018511|100797144|FG000|NOT COMPLETED|Overall Study||26||
48194428|NCT01018511|100797145|FG001|NOT COMPLETED|Overall Study||32||
48194429|NCT01018511|100797146|FG002|NOT COMPLETED|Overall Study||40||
48194430|NCT01018511|100797147|FG003|NOT COMPLETED|Overall Study||33||
48194431|NCT02465359|100797148|FG000|STARTED|Overall Study||15||
48194432|NCT02465359|100797148|FG000|COMPLETED|Overall Study||12||
48194433|NCT02465359|100797148|FG000|NOT COMPLETED|Overall Study||3||
48194434|NCT00072475|100800067|FG000|STARTED|Overall Study||142||
48194435|NCT00072475|100800067|FG000|COMPLETED|Overall Study||45||
48194436|NCT00072475|100800067|FG000|NOT COMPLETED|Overall Study||97||
48194437|NCT01893320|100800068|FG000|STARTED|Overall Study||7||
48194438|NCT01893320|100800069|FG001|STARTED|Overall Study||59||
48194439|NCT01893320|100800068|FG000|COMPLETED|Overall Study||7||
48194440|NCT01893320|100800069|FG001|COMPLETED|Overall Study||59||
48194441|NCT01893320|100800068|FG000|NOT COMPLETED|Overall Study||0||
48194442|NCT01893320|100800069|FG001|NOT COMPLETED|Overall Study||0||
48194443|NCT01674569|100800070|FG000|STARTED|Overall Study||3||
48194444|NCT01674569|100800071|FG001|STARTED|Overall Study||8||
48194445|NCT01674569|100800072|FG002|STARTED|Overall Study||4||
48194446|NCT01674569|100800073|FG003|STARTED|Overall Study||10||
48194447|NCT01674569|100800074|FG004|STARTED|Overall Study||7||
48194448|NCT01674569|100800075|FG005|STARTED|Overall Study||3||
48194449|NCT01674569|100800070|FG000|COMPLETED|Overall Study||3||
48194450|NCT01674569|100800071|FG001|COMPLETED|Overall Study||5||
48194451|NCT01674569|100800072|FG002|COMPLETED|Overall Study||2||
48194452|NCT01674569|100800073|FG003|COMPLETED|Overall Study||9||
48194453|NCT01674569|100800074|FG004|COMPLETED|Overall Study||5||
48194454|NCT01674569|100800075|FG005|COMPLETED|Overall Study||1||
48194455|NCT01674569|100800070|FG000|NOT COMPLETED|Overall Study||0||
48480191|NCT02039908|101512137|FG003|STARTED|Phase 2-School Year||124|Three participants elected not to continue in the study for the school -year phase.|
48480192|NCT02039908|101512134|FG000|COMPLETED|Phase 2-School Year||0||
48194456|NCT01674569|100800071|FG001|NOT COMPLETED|Overall Study||3||
48194457|NCT01674569|100800072|FG002|NOT COMPLETED|Overall Study||2||
48194458|NCT01674569|100800073|FG003|NOT COMPLETED|Overall Study||1||
48194459|NCT01674569|100800074|FG004|NOT COMPLETED|Overall Study||2||
48194460|NCT01674569|100800075|FG005|NOT COMPLETED|Overall Study||2||
48194461|NCT03298113|100800076|FG000|STARTED|Overall Study||10||
48480193|NCT02039908|101512135|FG001|COMPLETED|Phase 2-School Year||0||
48480194|NCT02039908|101512136|FG002|COMPLETED|Phase 2-School Year||109||
48480195|NCT02039908|101512137|FG003|COMPLETED|Phase 2-School Year||116||
48480196|NCT02039908|101512134|FG000|NOT COMPLETED|Phase 2-School Year||0||
48480197|NCT02039908|101512135|FG001|NOT COMPLETED|Phase 2-School Year||0||
48480198|NCT02039908|101512136|FG002|NOT COMPLETED|Phase 2-School Year||12||
48480199|NCT02039908|101512137|FG003|NOT COMPLETED|Phase 2-School Year||8||
48480200|NCT03351335|101512138|FG000|STARTED|Overall Study||21||
48480201|NCT03351335|101512139|FG001|STARTED|Overall Study||19||
48480202|NCT03351335|101512140|FG002|STARTED|Overall Study||20||
48480203|NCT03351335|101512138|FG000|COMPLETED|Overall Study||21||
48480204|NCT03351335|101512139|FG001|COMPLETED|Overall Study||19||
48480205|NCT03351335|101512140|FG002|COMPLETED|Overall Study||16||
48480206|NCT03351335|101512138|FG000|NOT COMPLETED|Overall Study||0||
48480207|NCT03351335|101512139|FG001|NOT COMPLETED|Overall Study||0||
48480208|NCT03351335|101512140|FG002|NOT COMPLETED|Overall Study||4||
48480209|NCT01832259|101512141|FG000|STARTED|Overall Study||15||
48480210|NCT01832259|101512142|FG001|STARTED|Overall Study||15||
48480211|NCT01832259|101512141|FG000|COMPLETED|Overall Study||15||
48480212|NCT01832259|101512142|FG001|COMPLETED|Overall Study||15||
48480213|NCT01832259|101512141|FG000|NOT COMPLETED|Overall Study||0||
48480214|NCT01832259|101512142|FG001|NOT COMPLETED|Overall Study||0||
48480215|NCT00501345|101512143|FG000|STARTED|Overall Study||5||
48480216|NCT00501345|101512143|FG000|COMPLETED|Overall Study||5||
48480217|NCT00501345|101512143|FG000|NOT COMPLETED|Overall Study||0||
48480218|NCT02129426|101512144|FG000|STARTED|Overall Study||7||
48480219|NCT02129426|101512145|FG001|STARTED|Overall Study||13||
48480220|NCT02129426|101512144|FG000|COMPLETED|Overall Study||0||
48480221|NCT02129426|101512145|FG001|COMPLETED|Overall Study||0||
48480222|NCT02129426|101512144|FG000|NOT COMPLETED|Overall Study||7||
48480223|NCT02129426|101512145|FG001|NOT COMPLETED|Overall Study||13||
48480224|NCT01363765|101512146|FG000|STARTED|Overall Study||18322||
48480225|NCT01363765|101512147|FG001|STARTED|Overall Study||16436||
48480226|NCT01363765|101512146|FG000|COMPLETED|Overall Study||12522||
48480227|NCT01363765|101512147|FG001|COMPLETED|Overall Study||11705||
48480228|NCT01363765|101512146|FG000|NOT COMPLETED|Overall Study||5800||
48480229|NCT01363765|101512147|FG001|NOT COMPLETED|Overall Study||4731||
48480230|NCT02817841|101512148|FG000|STARTED|Overall Study||1864||
48480231|NCT02817841|101512148|FG000|COMPLETED|Overall Study||1016||
48480232|NCT02817841|101512148|FG000|NOT COMPLETED|Overall Study||848||
48480233|NCT01639222|101512149|FG000|STARTED|Overall Study||55||
48480234|NCT01639222|101512149|FG000|COMPLETED|Overall Study||55||
48480235|NCT01639222|101512149|FG000|NOT COMPLETED|Overall Study||0||
48480236|NCT02006160|101512150|FG000|STARTED|Overall Study||45||
48480237|NCT02006160|101512151|FG001|STARTED|Overall Study||16||
48480238|NCT02006160|101512150|FG000|COMPLETED|Overall Study||41||
48480239|NCT02006160|101512151|FG001|COMPLETED|Overall Study||16||
48480240|NCT02006160|101512150|FG000|NOT COMPLETED|Overall Study||4||
48194462|NCT03298113|100800077|FG001|STARTED|Overall Study||10||
48480241|NCT02006160|101512151|FG001|NOT COMPLETED|Overall Study||0||
48480242|NCT03018249|101512152|FG000|STARTED|Overall Study||25||
48480243|NCT03018249|101512153|FG001|STARTED|Overall Study||25||
48480244|NCT03018249|101512152|FG000|COMPLETED|Overall Study||23||
48480245|NCT03018249|101512153|FG001|COMPLETED|Overall Study||23||
48480246|NCT03018249|101512152|FG000|NOT COMPLETED|Overall Study||2||
48480247|NCT03018249|101512153|FG001|NOT COMPLETED|Overall Study||2||
48480248|NCT01607645|101512154|FG000|STARTED|Overall Study||4||
48480249|NCT01607645|101512155|FG001|STARTED|Overall Study||3||
48480250|NCT01607645|101512154|FG000|COMPLETED|Overall Study||4||
48480251|NCT01607645|101512155|FG001|COMPLETED|Overall Study||3||
48480252|NCT01607645|101512154|FG000|NOT COMPLETED|Overall Study||0||
48480253|NCT01607645|101512155|FG001|NOT COMPLETED|Overall Study||0||
48480254|NCT00987948|101512156|FG000|STARTED|Overall Study||15||
48480255|NCT00987948|101512156|FG000|COMPLETED|Overall Study||12||
48480256|NCT00987948|101512156|FG000|NOT COMPLETED|Overall Study||3||
48480257|NCT02089997|101512157|FG000|STARTED|Overall Study||3304||
48480258|NCT02089997|101512157|FG000|COMPLETED|Overall Study||3058||
48480259|NCT02089997|101512157|FG000|NOT COMPLETED|Overall Study||246||
48480260|NCT02374853|101512158|FG000|STARTED|Overall Study||517||
48480261|NCT02374853|101512159|FG001|STARTED|Overall Study||520||
48480262|NCT02374853|101512158|FG000|COMPLETED|Overall Study||512||
48480263|NCT02374853|101512159|FG001|COMPLETED|Overall Study||509||
48194463|NCT03298113|100800076|FG000|IAD 1A|Overall Study||3||
48480264|NCT02374853|101512158|FG000|NOT COMPLETED|Overall Study||5||
48480265|NCT02374853|101512159|FG001|NOT COMPLETED|Overall Study||11||
48480266|NCT02413320|101512160|FG000|STARTED|Overall Study||49||
48480267|NCT02413320|101512161|FG001|STARTED|Overall Study||52||
48480268|NCT02413320|101512160|FG000|COMPLETED|Overall Study||48||
48480269|NCT02413320|101512161|FG001|COMPLETED|Overall Study||52||
48480270|NCT02413320|101512160|FG000|NOT COMPLETED|Overall Study||1||
48480271|NCT02413320|101512161|FG001|NOT COMPLETED|Overall Study||0||
48194464|NCT03298113|100800077|FG001|IAD 1A|Overall Study||4||
48480272|NCT00282048|101512162|FG000|STARTED|Overall Study||62||
48480273|NCT00282048|101512162|FG000|COMPLETED|Overall Study||0||
48480274|NCT00282048|101512162|FG000|NOT COMPLETED|Overall Study||62||
48480275|NCT04384978|101512163|FG000|STARTED|Overall Study||4||
48480276|NCT04384978|101512164|FG001|STARTED|Overall Study||18||
48480277|NCT04384978|101512163|FG000|COMPLETED|Overall Study||0||
48480278|NCT04384978|101512164|FG001|COMPLETED|Overall Study||18||
48480279|NCT04384978|101512163|FG000|NOT COMPLETED|Overall Study||4||
48480280|NCT04384978|101512164|FG001|NOT COMPLETED|Overall Study||0||
48480281|NCT03195491|101512165|FG000|STARTED|Overall Study||383||
48480282|NCT03195491|101512166|FG001|STARTED|Overall Study||17||
48480283|NCT03195491|101512165|FG000|COMPLETED|Overall Study||36||
48480284|NCT03195491|101512166|FG001|COMPLETED|Overall Study||2||
48480285|NCT03195491|101512165|FG000|NOT COMPLETED|Overall Study||347||
48480286|NCT03195491|101512166|FG001|NOT COMPLETED|Overall Study||15||
48480287|NCT03699020|101512167|FG000|STARTED|Overall Study||7||
48480288|NCT03699020|101512168|FG001|STARTED|Overall Study||5||
48480289|NCT03699020|101512167|FG000|Intervention Attendance Completion|Overall Study||4||
48480290|NCT03699020|101512168|FG001|Intervention Attendance Completion|Overall Study||3||
48480291|NCT03699020|101512167|FG000|COMPLETED|Overall Study||4||
48480292|NCT03699020|101512168|FG001|COMPLETED|Overall Study||3||
48480293|NCT03699020|101512167|FG000|NOT COMPLETED|Overall Study||3||
48480294|NCT03699020|101512168|FG001|NOT COMPLETED|Overall Study||2||
48480295|NCT00524264|101512169|FG000|STARTED|Overall Study||164||
48480296|NCT00524264|101512170|FG001|STARTED|Overall Study||84||
48480297|NCT00524264|101512169|FG000|COMPLETED|Overall Study||144||
48480298|NCT00524264|101512170|FG001|COMPLETED|Overall Study||57||
48480299|NCT00524264|101512169|FG000|NOT COMPLETED|Overall Study||20||
48480300|NCT00524264|101512170|FG001|NOT COMPLETED|Overall Study||27||
48480301|NCT01416584|101512171|FG000|STARTED|Overall Study||30||
48480302|NCT01416584|101512172|FG001|STARTED|Overall Study||35||
48480303|NCT01416584|101512173|FG002|STARTED|Overall Study||33||
48480304|NCT01416584|101512171|FG000|COMPLETED|Overall Study||27||
48480305|NCT01416584|101512172|FG001|COMPLETED|Overall Study||33||
48480306|NCT01416584|101512173|FG002|COMPLETED|Overall Study||32||
48480307|NCT01416584|101512171|FG000|NOT COMPLETED|Overall Study||3||
48480308|NCT01416584|101512172|FG001|NOT COMPLETED|Overall Study||2||
48480309|NCT01416584|101512173|FG002|NOT COMPLETED|Overall Study||1||
48480310|NCT00633399|101512174|FG000|STARTED|Overall Study||71||
48480311|NCT00633399|101512175|FG001|STARTED|Overall Study||68||
48480312|NCT00633399|101512174|FG000|COMPLETED|Overall Study||49||
48480313|NCT00633399|101512175|FG001|COMPLETED|Overall Study||53||
48480314|NCT00633399|101512174|FG000|NOT COMPLETED|Overall Study||22||
48480315|NCT00633399|101512175|FG001|NOT COMPLETED|Overall Study||15||
48480316|NCT03002597|101512176|FG000|STARTED|Overall Study||9||
48480317|NCT03002597|101512176|FG000|COMPLETED|Overall Study||9||
48480318|NCT03002597|101512176|FG000|NOT COMPLETED|Overall Study||0||
48480319|NCT00184600|101512177|FG000|STARTED|Overall Study||234||
48480320|NCT00184600|101512178|FG001|STARTED|Overall Study||239||
48480321|NCT00184600|101512179|FG002|STARTED|Overall Study||235||
48480322|NCT00184600|101512177|FG000|COMPLETED|Overall Study||189||
48480323|NCT00184600|101512178|FG001|COMPLETED|Overall Study||188||
48480324|NCT00184600|101512179|FG002|COMPLETED|Overall Study||201||
48480325|NCT00184600|101512177|FG000|NOT COMPLETED|Overall Study||45||
48480326|NCT00184600|101512178|FG001|NOT COMPLETED|Overall Study||51||
48480327|NCT00184600|101512179|FG002|NOT COMPLETED|Overall Study||34||
48480328|NCT00099047|101512180|FG000|STARTED|Overall Study||11||
48480329|NCT00099047|101512181|FG001|STARTED|Overall Study||12||
48480330|NCT00099047|101512180|FG000|COMPLETED|Overall Study||11||
48670497|NCT00098475|101974953|FG002|COMPLETED|Step 2||0||
48480331|NCT00099047|101512181|FG001|COMPLETED|Overall Study||12||
48480332|NCT00099047|101512180|FG000|NOT COMPLETED|Overall Study||0||
48480333|NCT00099047|101512181|FG001|NOT COMPLETED|Overall Study||0||
48480334|NCT01387022|101512182|FG000|STARTED|Overall Study||29||
48480335|NCT01387022|101512183|FG001|STARTED|Overall Study||30||
48480336|NCT01387022|101512182|FG000|COMPLETED|Overall Study||28||
48670498|NCT00098475|101974954|FG003|COMPLETED|Step 2||0||
48670499|NCT00098475|101974951|FG000|NOT COMPLETED|Step 2||5||
48670500|NCT00098475|101974952|FG001|NOT COMPLETED|Step 2||10||
48670501|NCT00098475|101974953|FG002|NOT COMPLETED|Step 2||0||
48670502|NCT00098475|101974954|FG003|NOT COMPLETED|Step 2||0||
48670503|NCT02709161|101974955|FG000|STARTED|Overall Study||19||
48670504|NCT02709161|101974956|FG001|STARTED|Overall Study||17||
48670505|NCT02709161|101974955|FG000|COMPLETED|Overall Study||18||
48670506|NCT02709161|101974956|FG001|COMPLETED|Overall Study||17||
48670507|NCT02709161|101974955|FG000|NOT COMPLETED|Overall Study||1||
48670508|NCT02709161|101974956|FG001|NOT COMPLETED|Overall Study||0||
48670509|NCT02466971|101974957|FG000|STARTED|Overall Study||225||
48670510|NCT02466971|101974958|FG001|STARTED|Overall Study||225||
48670511|NCT02466971|101974957|FG000|COMPLETED|Overall Study||207||
48670512|NCT02466971|101974958|FG001|COMPLETED|Overall Study||202||
48670513|NCT02466971|101974957|FG000|NOT COMPLETED|Overall Study||18||
48480337|NCT01387022|101512183|FG001|COMPLETED|Overall Study||26||
48480338|NCT01387022|101512182|FG000|NOT COMPLETED|Overall Study||1||
48480339|NCT01387022|101512183|FG001|NOT COMPLETED|Overall Study||4||
48480340|NCT03707912|101512184|FG000|STARTED|Overall Study||104||
48480341|NCT03707912|101512185|FG001|STARTED|Overall Study||100||
48480342|NCT03707912|101512184|FG000|COMPLETED|Overall Study||103||
48480343|NCT03707912|101512185|FG001|COMPLETED|Overall Study||100||
48480344|NCT03707912|101512184|FG000|NOT COMPLETED|Overall Study||1||
48480345|NCT03707912|101512185|FG001|NOT COMPLETED|Overall Study||0||
48480346|NCT03447262|101512186|FG000|STARTED|Overall Study||481||
48480347|NCT03447262|101512186|FG000|COMPLETED|Overall Study||2||
48480348|NCT03447262|101512186|FG000|NOT COMPLETED|Overall Study||479||
48480349|NCT03600376|101512187|FG000|STARTED|Overall Study||9||
48480350|NCT03600376|101512188|FG001|STARTED|Overall Study||8||
48480351|NCT03600376|101512187|FG000|COMPLETED|Overall Study||7||
48480352|NCT03600376|101512188|FG001|COMPLETED|Overall Study||2||
48480353|NCT03600376|101512187|FG000|NOT COMPLETED|Overall Study||2||
48480354|NCT03600376|101512188|FG001|NOT COMPLETED|Overall Study||6||
48480355|NCT01918397|101512189|FG000|STARTED|Overall Study||27||
48480356|NCT01918397|101512190|FG001|STARTED|Overall Study||29||
48480357|NCT01918397|101512191|FG002|STARTED|Overall Study||28||
48480358|NCT01918397|101512192|FG003|STARTED|Overall Study||27||
48480359|NCT01918397|101512189|FG000|COMPLETED|Overall Study||16||
48480360|NCT01918397|101512190|FG001|COMPLETED|Overall Study||21||
48194465|NCT03298113|100800076|FG000|IAD 2A|Overall Study||7||
48194466|NCT03298113|100800077|FG001|IAD 2A|Overall Study||6||
48194467|NCT03298113|100800076|FG000|COMPLETED|Overall Study||10||
48194468|NCT03298113|100800077|FG001|COMPLETED|Overall Study||10||
48194469|NCT03298113|100800076|FG000|NOT COMPLETED|Overall Study||0||
48194470|NCT03298113|100800077|FG001|NOT COMPLETED|Overall Study||0||
48194471|NCT03675737|100800078|FG000|STARTED|Overall Study||790||
48194472|NCT03675737|100800079|FG001|STARTED|Overall Study||789||
48194473|NCT03675737|100800078|FG000|Treated|Overall Study||785||
48194474|NCT03675737|100800079|FG001|Treated|Overall Study||787||
48194475|NCT03675737|100800078|FG000|COMPLETED|Overall Study||0||
48194476|NCT03675737|100800079|FG001|COMPLETED|Overall Study||0||
48194477|NCT03675737|100800078|FG000|NOT COMPLETED|Overall Study||790||
48194478|NCT03675737|100800079|FG001|NOT COMPLETED|Overall Study||789||
48194479|NCT02419521|100800080|FG000|STARTED|Overall Study||75||
48480361|NCT01918397|101512191|FG002|COMPLETED|Overall Study||20||
48480362|NCT01918397|101512192|FG003|COMPLETED|Overall Study||20||
48480363|NCT01918397|101512189|FG000|NOT COMPLETED|Overall Study||11||
48480364|NCT01918397|101512190|FG001|NOT COMPLETED|Overall Study||8||
48480365|NCT01918397|101512191|FG002|NOT COMPLETED|Overall Study||8||
48480366|NCT01918397|101512192|FG003|NOT COMPLETED|Overall Study||7||
48194480|NCT02419521|100800080|FG000|COMPLETED|Overall Study||74||
48194481|NCT02419521|100800080|FG000|NOT COMPLETED|Overall Study||1||
48194482|NCT02405390|100800081|FG000|STARTED|Overall Study||46||
48194483|NCT02405390|100800082|FG001|STARTED|Overall Study||46||
48194484|NCT02405390|100800081|FG000|COMPLETED|Overall Study||46||
48194485|NCT02405390|100800082|FG001|COMPLETED|Overall Study||46||
48194486|NCT02405390|100800081|FG000|NOT COMPLETED|Overall Study||0||
48194487|NCT02405390|100800082|FG001|NOT COMPLETED|Overall Study||0||
48194488|NCT00543725|100800083|FG000|STARTED|Overall Study||340||
48194489|NCT00543725|100800084|FG001|STARTED|Overall Study||338||
48480367|NCT03161405|101512193|FG000|STARTED|First Intervention Period (3 Days)||12||
48480368|NCT03161405|101512193|FG000|COMPLETED|First Intervention Period (3 Days)||12||
48480369|NCT03161405|101512193|FG000|NOT COMPLETED|First Intervention Period (3 Days)||0||
48480370|NCT03161405|101512193|FG000|STARTED|Washout Period (at Least 4 Days)||12||
48480371|NCT03161405|101512193|FG000|COMPLETED|Washout Period (at Least 4 Days)||12||
48480372|NCT03161405|101512193|FG000|NOT COMPLETED|Washout Period (at Least 4 Days)||0||
48480373|NCT03161405|101512193|FG000|STARTED|Second Intervention Period (6 Days)||12||
48480374|NCT03161405|101512193|FG000|COMPLETED|Second Intervention Period (6 Days)||11||
48480375|NCT03161405|101512193|FG000|NOT COMPLETED|Second Intervention Period (6 Days)||1||
48480376|NCT01273805|101512194|FG000|STARTED|Overall Study||10||
48480377|NCT01273805|101512195|FG001|STARTED|Overall Study||10||
48480378|NCT01273805|101512194|FG000|COMPLETED|Overall Study||0||
48480379|NCT01273805|101512195|FG001|COMPLETED|Overall Study||0||
48480380|NCT01273805|101512194|FG000|NOT COMPLETED|Overall Study||10||
48480381|NCT01273805|101512195|FG001|NOT COMPLETED|Overall Study||10||
48480382|NCT02414152|101512196|FG000|STARTED|Overall Study||2||
48480383|NCT02414152|101512196|FG000|COMPLETED|Overall Study||0||
48480384|NCT02414152|101512196|FG000|NOT COMPLETED|Overall Study||2||
48480385|NCT01448057|101512197|FG000|STARTED|Overall Study||170||
48480386|NCT01448057|101512198|FG001|STARTED|Overall Study||171||
48480387|NCT01448057|101512197|FG000|COMPLETED|Overall Study||162||
48480388|NCT01448057|101512198|FG001|COMPLETED|Overall Study||167||
48480389|NCT01448057|101512197|FG000|NOT COMPLETED|Overall Study||8||
48480390|NCT01448057|101512198|FG001|NOT COMPLETED|Overall Study||4||
48480391|NCT01061866|101512199|FG000|STARTED|Overall Study||7||
48480392|NCT01061866|101512199|FG000|COMPLETED|Overall Study||5||
48480393|NCT01061866|101512199|FG000|NOT COMPLETED|Overall Study||2||
48480394|NCT02937701|101512200|FG000|STARTED|Day 1 to Week 22||279||
48480395|NCT02937701|101512201|FG001|STARTED|Day 1 to Week 22||279||
48480396|NCT02937701|101512202|FG002|STARTED|Day 1 to Week 22||0||
48480397|NCT02937701|101512203|FG003|STARTED|Day 1 to Week 22||0||
48480398|NCT02937701|101512204|FG004|STARTED|Day 1 to Week 22||0||
48480399|NCT02937701|101512200|FG000|Received Treatment|Day 1 to Week 22||278||
48480400|NCT02937701|101512201|FG001|Received Treatment|Day 1 to Week 22||278||
48480401|NCT02937701|101512202|FG002|Received Treatment|Day 1 to Week 22||0||
48480402|NCT02937701|101512203|FG003|Received Treatment|Day 1 to Week 22||0||
48480403|NCT02937701|101512204|FG004|Received Treatment|Day 1 to Week 22||0||
48480404|NCT02937701|101512200|FG000|COMPLETED|Day 1 to Week 22||244||
48480405|NCT02937701|101512201|FG001|COMPLETED|Day 1 to Week 22||240||
48480406|NCT02937701|101512202|FG002|COMPLETED|Day 1 to Week 22||0||
48480407|NCT02937701|101512203|FG003|COMPLETED|Day 1 to Week 22||0||
48480408|NCT02937701|101512204|FG004|COMPLETED|Day 1 to Week 22||0||
48480409|NCT02937701|101512200|FG000|NOT COMPLETED|Day 1 to Week 22||35||
48480410|NCT02937701|101512201|FG001|NOT COMPLETED|Day 1 to Week 22||39||
48480411|NCT02937701|101512202|FG002|NOT COMPLETED|Day 1 to Week 22||0||
48480412|NCT02937701|101512203|FG003|NOT COMPLETED|Day 1 to Week 22||0||
48480413|NCT02937701|101512204|FG004|NOT COMPLETED|Day 1 to Week 22||0||
48480414|NCT02937701|101512200|FG000|STARTED|Week 22 to Week 50||0||
48480415|NCT02937701|101512201|FG001|STARTED|Week 22 to Week 50||0||
48480416|NCT02937701|101512202|FG002|STARTED|Week 22 to Week 50||244||
48480417|NCT02937701|101512203|FG003|STARTED|Week 22 to Week 50||121||
48480418|NCT02937701|101512204|FG004|STARTED|Week 22 to Week 50||119||
48480419|NCT02937701|101512200|FG000|COMPLETED|Week 22 to Week 50||0||
48480420|NCT02937701|101512201|FG001|COMPLETED|Week 22 to Week 50||0||
48194490|NCT00543725|100800083|FG000|COMPLETED|Overall Study||272||
48194491|NCT00543725|100800084|FG001|COMPLETED|Overall Study||264||
48194492|NCT00543725|100800083|FG000|NOT COMPLETED|Overall Study||68||
48480421|NCT02937701|101512202|FG002|COMPLETED|Week 22 to Week 50||212||
48480422|NCT02937701|101512203|FG003|COMPLETED|Week 22 to Week 50||113||
48480423|NCT02937701|101512204|FG004|COMPLETED|Week 22 to Week 50||110||
48480424|NCT02937701|101512200|FG000|NOT COMPLETED|Week 22 to Week 50||0||
48480425|NCT02937701|101512201|FG001|NOT COMPLETED|Week 22 to Week 50||0||
48480426|NCT02937701|101512202|FG002|NOT COMPLETED|Week 22 to Week 50||32||
48480427|NCT02937701|101512203|FG003|NOT COMPLETED|Week 22 to Week 50||8||
48480428|NCT02937701|101512204|FG004|NOT COMPLETED|Week 22 to Week 50||9||
48480429|NCT00985257|101512205|FG000|STARTED|Overall Study||123||
48480430|NCT00985257|101512205|FG000|COMPLETED|Overall Study||123||
48480431|NCT00985257|101512205|FG000|NOT COMPLETED|Overall Study||0||
48480432|NCT02597101|101512206|FG000|STARTED|Overall Study||4||
48480433|NCT02597101|101512207|FG001|STARTED|Overall Study||5||
48480434|NCT02597101|101512206|FG000|COMPLETED|Overall Study||4||
48480435|NCT02597101|101512207|FG001|COMPLETED|Overall Study||5||
48480436|NCT02597101|101512206|FG000|NOT COMPLETED|Overall Study||0||
48480437|NCT02597101|101512207|FG001|NOT COMPLETED|Overall Study||0||
48194493|NCT00543725|100800084|FG001|NOT COMPLETED|Overall Study||74||
48194494|NCT01134575|100800085|FG000|STARTED|Overall Study||3||
48194495|NCT01134575|100800086|FG001|STARTED|Overall Study||45||
48194496|NCT01134575|100800087|FG002|STARTED|Overall Study||42||
48194497|NCT01134575|100800085|FG000|COMPLETED|Overall Study||3||
48194498|NCT01134575|100800086|FG001|COMPLETED|Overall Study||45||
48194499|NCT01134575|100800087|FG002|COMPLETED|Overall Study||42||
48194500|NCT01134575|100800085|FG000|NOT COMPLETED|Overall Study||0||
48480438|NCT03601637|101512208|FG000|STARTED|Overall Study||14||
48480439|NCT03601637|101512209|FG001|STARTED|Overall Study||46||
48194501|NCT01134575|100800086|FG001|NOT COMPLETED|Overall Study||0||
48194502|NCT01134575|100800087|FG002|NOT COMPLETED|Overall Study||0||
48480440|NCT03601637|101512208|FG000|COMPLETED|Overall Study||13||
48480441|NCT03601637|101512209|FG001|COMPLETED|Overall Study||43||
48194503|NCT04511650|100800088|FG000|STARTED|Overall Study||10||
48194504|NCT04511650|100800089|FG001|STARTED|Overall Study||10||
48194505|NCT04511650|100800090|FG002|STARTED|Overall Study||11||
48194506|NCT04511650|100800088|FG000|Subjects Treated|Overall Study||9||
48194507|NCT04511650|100800089|FG001|Subjects Treated|Overall Study||10||
48194508|NCT04511650|100800090|FG002|Subjects Treated|Overall Study||10||
48194509|NCT04511650|100800088|FG000|Subjects Randomized But Not Treated|Overall Study||1||
48194510|NCT04511650|100800089|FG001|Subjects Randomized But Not Treated|Overall Study||0||
48194511|NCT04511650|100800090|FG002|Subjects Randomized But Not Treated|Overall Study||1||
48194512|NCT04511650|100800088|FG000|COMPLETED|Overall Study||7||
48194513|NCT04511650|100800089|FG001|COMPLETED|Overall Study||9||
48194514|NCT04511650|100800090|FG002|COMPLETED|Overall Study||9||
48194515|NCT04511650|100800088|FG000|NOT COMPLETED|Overall Study||3||
48194516|NCT04511650|100800089|FG001|NOT COMPLETED|Overall Study||1||
48194517|NCT04511650|100800090|FG002|NOT COMPLETED|Overall Study||2||
48194518|NCT02028884|100800091|FG000|STARTED|Double-blind Period||42||
48194519|NCT02028884|100800092|FG001|STARTED|Double-blind Period||42||
48194520|NCT02028884|100800093|FG002|STARTED|Double-blind Period||0||
48194521|NCT02028884|100800091|FG000|COMPLETED|Double-blind Period||32|Double-blind period|
48194522|NCT02028884|100800092|FG001|COMPLETED|Double-blind Period||39|Double-blind period|
48194523|NCT02028884|100800093|FG002|COMPLETED|Double-blind Period||0|Double-blind period|
48194524|NCT02028884|100800091|FG000|NOT COMPLETED|Double-blind Period||10||
48194525|NCT02028884|100800092|FG001|NOT COMPLETED|Double-blind Period||3||
48194526|NCT02028884|100800093|FG002|NOT COMPLETED|Double-blind Period||0||
48194527|NCT02028884|100800091|FG000|STARTED|Open-label Extension Period||32||
48194528|NCT02028884|100800092|FG001|STARTED|Open-label Extension Period||39||
48194529|NCT02028884|100800093|FG002|STARTED|Open-label Extension Period||1||
48194530|NCT02028884|100800091|FG000|COMPLETED|Open-label Extension Period||23|Open-label extension period|
48194531|NCT02028884|100800092|FG001|COMPLETED|Open-label Extension Period||31|Open-label extension period|
48194532|NCT02028884|100800093|FG002|COMPLETED|Open-label Extension Period||1|Open-label extension period|
48194533|NCT02028884|100800091|FG000|NOT COMPLETED|Open-label Extension Period||9||
48194534|NCT02028884|100800092|FG001|NOT COMPLETED|Open-label Extension Period||8||
48194535|NCT02028884|100800093|FG002|NOT COMPLETED|Open-label Extension Period||0||
48194536|NCT01560143|100800094|FG000|STARTED|Overall Study||12||
48194537|NCT01560143|100800094|FG000|COMPLETED|Overall Study||12||
48194538|NCT01560143|100800094|FG000|NOT COMPLETED|Overall Study||0||
48194539|NCT02266810|100800095|FG000|STARTED|Overall Study||80||160
48194540|NCT02266810|100800096|FG001|STARTED|Overall Study||80||160
48194541|NCT02266810|100800095|FG000|COMPLETED|Overall Study||79||158
48194542|NCT02266810|100800096|FG001|COMPLETED|Overall Study||79||158
48480442|NCT03601637|101512208|FG000|NOT COMPLETED|Overall Study||1||
48480443|NCT03601637|101512209|FG001|NOT COMPLETED|Overall Study||3||
48480444|NCT00318812|101512210|FG000|STARTED|Overall Study||18||
48480445|NCT00318812|101512211|FG001|STARTED|Overall Study||22||
48480446|NCT00318812|101512210|FG000|COMPLETED|Overall Study||18||
48480447|NCT00318812|101512211|FG001|COMPLETED|Overall Study||22||
48480448|NCT00318812|101512210|FG000|NOT COMPLETED|Overall Study||0||
48480449|NCT00318812|101512211|FG001|NOT COMPLETED|Overall Study||0||
48480450|NCT01029340|101512212|FG000|STARTED|Part A Treatment Period||14||
48480451|NCT01029340|101512213|FG001|STARTED|Part A Treatment Period||14||
48480452|NCT01029340|101512214|FG002|STARTED|Part A Treatment Period||0||
48480453|NCT01029340|101512215|FG003|STARTED|Part A Treatment Period||0||
48670514|NCT02466971|101974958|FG001|NOT COMPLETED|Overall Study||23||
48480454|NCT01029340|101512216|FG004|STARTED|Part A Treatment Period||0||
48480455|NCT01029340|101512217|FG005|STARTED|Part A Treatment Period||0||
48480456|NCT01029340|101512212|FG000|Participants Received Treatment|Part A Treatment Period||14||
48480457|NCT01029340|101512213|FG001|Participants Received Treatment|Part A Treatment Period||14||
48670515|NCT02891603|101974959|FG000|STARTED|Overall Study||10||
48670516|NCT02891603|101974960|FG001|STARTED|Overall Study||8||
48670517|NCT02891603|101974961|FG002|STARTED|Overall Study||22||
48670518|NCT02891603|101974959|FG000|COMPLETED|Overall Study||10||
48670519|NCT02891603|101974960|FG001|COMPLETED|Overall Study||8||
48670520|NCT02891603|101974961|FG002|COMPLETED|Overall Study||22||
48670521|NCT02891603|101974959|FG000|NOT COMPLETED|Overall Study||0||
48670522|NCT02891603|101974960|FG001|NOT COMPLETED|Overall Study||0||
48670523|NCT02891603|101974961|FG002|NOT COMPLETED|Overall Study||0||
48670524|NCT04980248|101974962|FG000|STARTED|Overall Study||5||
48670525|NCT04980248|101974963|FG001|STARTED|Overall Study||5||
48670526|NCT04980248|101974964|FG002|STARTED|Overall Study||5||
48670527|NCT04980248|101974962|FG000|Received at Least 1 Dose of Study Drug|Overall Study||5||
48670528|NCT04980248|101974963|FG001|Received at Least 1 Dose of Study Drug|Overall Study||5||
48670529|NCT04980248|101974964|FG002|Received at Least 1 Dose of Study Drug|Overall Study||5||
48670530|NCT04980248|101974962|FG000|COMPLETED|Overall Study||5||
48670531|NCT04980248|101974963|FG001|COMPLETED|Overall Study||5||
48670532|NCT04980248|101974964|FG002|COMPLETED|Overall Study||5||
48670533|NCT04980248|101974962|FG000|NOT COMPLETED|Overall Study||0||
48670534|NCT04980248|101974963|FG001|NOT COMPLETED|Overall Study||0||
48670535|NCT04980248|101974964|FG002|NOT COMPLETED|Overall Study||0||
48670536|NCT03314454|101974965|FG000|STARTED|Overall Study||11||
48670537|NCT03314454|101974965|FG000|COMPLETED|Overall Study||10||
48670538|NCT03314454|101974965|FG000|NOT COMPLETED|Overall Study||1||
48480458|NCT01029340|101512214|FG002|Participants Received Treatment|Part A Treatment Period||0||
48480459|NCT01029340|101512215|FG003|Participants Received Treatment|Part A Treatment Period||0||
48480460|NCT01029340|101512216|FG004|Participants Received Treatment|Part A Treatment Period||0||
48480461|NCT01029340|101512217|FG005|Participants Received Treatment|Part A Treatment Period||0||
48480462|NCT01029340|101512212|FG000|Safety Population|Part A Treatment Period||13||
48480463|NCT01029340|101512213|FG001|Safety Population|Part A Treatment Period||14||
48480464|NCT01029340|101512214|FG002|Safety Population|Part A Treatment Period||0||
48480465|NCT01029340|101512215|FG003|Safety Population|Part A Treatment Period||0||
48480466|NCT01029340|101512216|FG004|Safety Population|Part A Treatment Period||0||
48480467|NCT01029340|101512217|FG005|Safety Population|Part A Treatment Period||0||
48480468|NCT01029340|101512212|FG000|COMPLETED|Part A Treatment Period||14||
48480469|NCT01029340|101512213|FG001|COMPLETED|Part A Treatment Period||14||
48480470|NCT01029340|101512214|FG002|COMPLETED|Part A Treatment Period||0||
48480471|NCT01029340|101512215|FG003|COMPLETED|Part A Treatment Period||0||
48480472|NCT01029340|101512216|FG004|COMPLETED|Part A Treatment Period||0||
48480473|NCT01029340|101512217|FG005|COMPLETED|Part A Treatment Period||0||
48480474|NCT01029340|101512212|FG000|NOT COMPLETED|Part A Treatment Period||0||
48480475|NCT01029340|101512213|FG001|NOT COMPLETED|Part A Treatment Period||0||
48480476|NCT01029340|101512214|FG002|NOT COMPLETED|Part A Treatment Period||0||
48480477|NCT01029340|101512215|FG003|NOT COMPLETED|Part A Treatment Period||0||
48480478|NCT01029340|101512216|FG004|NOT COMPLETED|Part A Treatment Period||0||
48480479|NCT01029340|101512217|FG005|NOT COMPLETED|Part A Treatment Period||0||
48480480|NCT01029340|101512212|FG000|STARTED|Part A Follow up Period||14||
48480481|NCT01029340|101512213|FG001|STARTED|Part A Follow up Period||14||
48480482|NCT01029340|101512214|FG002|STARTED|Part A Follow up Period||0||
48480483|NCT01029340|101512215|FG003|STARTED|Part A Follow up Period||0||
48194543|NCT02266810|100800095|FG000|NOT COMPLETED|Overall Study||1||2
48480484|NCT01029340|101512216|FG004|STARTED|Part A Follow up Period||0||
48480485|NCT01029340|101512217|FG005|STARTED|Part A Follow up Period||0||
48480486|NCT01029340|101512212|FG000|COMPLETED|Part A Follow up Period||14||
48480487|NCT01029340|101512213|FG001|COMPLETED|Part A Follow up Period||14||
48480488|NCT01029340|101512214|FG002|COMPLETED|Part A Follow up Period||0||
48480489|NCT01029340|101512215|FG003|COMPLETED|Part A Follow up Period||0||
48194544|NCT02266810|100800096|FG001|NOT COMPLETED|Overall Study||1||2
48194545|NCT00536380|100800097|FG000|STARTED|Overall Study||106||
48194546|NCT00536380|100800098|FG001|STARTED|Overall Study||104||
48194547|NCT00536380|100800099|FG002|STARTED|Overall Study||104||
48194548|NCT00536380|100800097|FG000|COMPLETED|Overall Study||94||
48194549|NCT00536380|100800098|FG001|COMPLETED|Overall Study||95||
48194550|NCT00536380|100800099|FG002|COMPLETED|Overall Study||94||
48194551|NCT00536380|100800097|FG000|NOT COMPLETED|Overall Study||12||
48194552|NCT00536380|100800098|FG001|NOT COMPLETED|Overall Study||9||
48194553|NCT00536380|100800099|FG002|NOT COMPLETED|Overall Study||10||
48194554|NCT01656304|100800100|FG000|STARTED|Overall Study||16||
48194555|NCT01656304|100800100|FG000|COMPLETED|Overall Study||15||
48194556|NCT01656304|100800100|FG000|NOT COMPLETED|Overall Study||1||
48194557|NCT01168401|100800101|FG000|STARTED|Overall Study||10||
48194558|NCT01168401|100800102|FG001|STARTED|Overall Study||10||
48194559|NCT01168401|100800103|FG002|STARTED|Overall Study||10||
48194560|NCT01168401|100800104|FG003|STARTED|Overall Study||9||
48480490|NCT01029340|101512216|FG004|COMPLETED|Part A Follow up Period||0||
48194561|NCT01168401|100800105|FG004|STARTED|Overall Study||9||
48194562|NCT01168401|100800106|FG005|STARTED|Overall Study||9||
48194563|NCT01168401|100800107|FG006|STARTED|Overall Study||10||
48194564|NCT01168401|100800108|FG007|STARTED|Overall Study||10||
48194565|NCT01168401|100800109|FG008|STARTED|Overall Study||9||
48194566|NCT01168401|100800110|FG009|STARTED|Overall Study||8||
48194567|NCT01168401|100800111|FG010|STARTED|Overall Study||8||
48194568|NCT01168401|100800101|FG000|COMPLETED|Overall Study||9||
48194569|NCT01168401|100800102|FG001|COMPLETED|Overall Study||9||
48194570|NCT01168401|100800103|FG002|COMPLETED|Overall Study||8||
48194571|NCT01168401|100800104|FG003|COMPLETED|Overall Study||7||
48194572|NCT01168401|100800105|FG004|COMPLETED|Overall Study||9||
48480491|NCT01029340|101512217|FG005|COMPLETED|Part A Follow up Period||0||
48480492|NCT01029340|101512212|FG000|NOT COMPLETED|Part A Follow up Period||0||
48480493|NCT01029340|101512213|FG001|NOT COMPLETED|Part A Follow up Period||0||
48480494|NCT01029340|101512214|FG002|NOT COMPLETED|Part A Follow up Period||0||
48480495|NCT01029340|101512215|FG003|NOT COMPLETED|Part A Follow up Period||0||
48480496|NCT01029340|101512216|FG004|NOT COMPLETED|Part A Follow up Period||0||
48480497|NCT01029340|101512217|FG005|NOT COMPLETED|Part A Follow up Period||0||
48480498|NCT01029340|101512212|FG000|STARTED|Part B Treatment Period||0||
48480499|NCT01029340|101512213|FG001|STARTED|Part B Treatment Period||0||
48480500|NCT01029340|101512214|FG002|STARTED|Part B Treatment Period||31||
48480501|NCT01029340|101512215|FG003|STARTED|Part B Treatment Period||32||
48480502|NCT01029340|101512216|FG004|STARTED|Part B Treatment Period||0||
48480503|NCT01029340|101512217|FG005|STARTED|Part B Treatment Period||0||
48480504|NCT01029340|101512212|FG000|Participants Received Treatment|Part B Treatment Period||0||
48480505|NCT01029340|101512213|FG001|Participants Received Treatment|Part B Treatment Period||0||
48480506|NCT01029340|101512214|FG002|Participants Received Treatment|Part B Treatment Period||30||
48480507|NCT01029340|101512215|FG003|Participants Received Treatment|Part B Treatment Period||32||
48480508|NCT01029340|101512216|FG004|Participants Received Treatment|Part B Treatment Period||0||
48480509|NCT01029340|101512217|FG005|Participants Received Treatment|Part B Treatment Period||0||
48480510|NCT01029340|101512212|FG000|COMPLETED|Part B Treatment Period||0||
48480511|NCT01029340|101512213|FG001|COMPLETED|Part B Treatment Period||0||
48480512|NCT01029340|101512214|FG002|COMPLETED|Part B Treatment Period||29||
48194573|NCT01168401|100800106|FG005|COMPLETED|Overall Study||9||
48480513|NCT01029340|101512215|FG003|COMPLETED|Part B Treatment Period||32||
48194574|NCT01168401|100800107|FG006|COMPLETED|Overall Study||10||
48194575|NCT01168401|100800108|FG007|COMPLETED|Overall Study||10||
48194576|NCT01168401|100800109|FG008|COMPLETED|Overall Study||9||
48480514|NCT01029340|101512216|FG004|COMPLETED|Part B Treatment Period||0||
48480515|NCT01029340|101512217|FG005|COMPLETED|Part B Treatment Period||0||
48480516|NCT01029340|101512212|FG000|NOT COMPLETED|Part B Treatment Period||0||
48480517|NCT01029340|101512213|FG001|NOT COMPLETED|Part B Treatment Period||0||
48480518|NCT01029340|101512214|FG002|NOT COMPLETED|Part B Treatment Period||2||
48480519|NCT01029340|101512215|FG003|NOT COMPLETED|Part B Treatment Period||0||
48480520|NCT01029340|101512216|FG004|NOT COMPLETED|Part B Treatment Period||0||
48480521|NCT01029340|101512217|FG005|NOT COMPLETED|Part B Treatment Period||0||
48480522|NCT01029340|101512212|FG000|STARTED|Part B Follow up Period||0||
48480523|NCT01029340|101512213|FG001|STARTED|Part B Follow up Period||0||
48480524|NCT01029340|101512214|FG002|STARTED|Part B Follow up Period||29||
48480525|NCT01029340|101512215|FG003|STARTED|Part B Follow up Period||32||
48480526|NCT01029340|101512216|FG004|STARTED|Part B Follow up Period||0||
48480527|NCT01029340|101512217|FG005|STARTED|Part B Follow up Period||0||
48480528|NCT01029340|101512212|FG000|COMPLETED|Part B Follow up Period||0||
48480529|NCT01029340|101512213|FG001|COMPLETED|Part B Follow up Period||0||
48480530|NCT01029340|101512214|FG002|COMPLETED|Part B Follow up Period||29||
48480531|NCT01029340|101512215|FG003|COMPLETED|Part B Follow up Period||32||
48480532|NCT01029340|101512216|FG004|COMPLETED|Part B Follow up Period||0||
48480533|NCT01029340|101512217|FG005|COMPLETED|Part B Follow up Period||0||
48480534|NCT01029340|101512212|FG000|NOT COMPLETED|Part B Follow up Period||0||
48480535|NCT01029340|101512213|FG001|NOT COMPLETED|Part B Follow up Period||0||
48480536|NCT01029340|101512214|FG002|NOT COMPLETED|Part B Follow up Period||0||
48480537|NCT01029340|101512215|FG003|NOT COMPLETED|Part B Follow up Period||0||
48480538|NCT01029340|101512216|FG004|NOT COMPLETED|Part B Follow up Period||0||
48480539|NCT01029340|101512217|FG005|NOT COMPLETED|Part B Follow up Period||0||
48480540|NCT01029340|101512212|FG000|STARTED|Extension Period||0||
48480541|NCT01029340|101512213|FG001|STARTED|Extension Period||0||
48480542|NCT01029340|101512214|FG002|STARTED|Extension Period||0||
48480543|NCT01029340|101512215|FG003|STARTED|Extension Period||0||
48480544|NCT01029340|101512216|FG004|STARTED|Extension Period||0||
48480545|NCT01029340|101512217|FG005|STARTED|Extension Period||55||
48480546|NCT01029340|101512212|FG000|COMPLETED|Extension Period||0||
48480547|NCT01029340|101512213|FG001|COMPLETED|Extension Period||0||
48480548|NCT01029340|101512214|FG002|COMPLETED|Extension Period||0||
48480549|NCT01029340|101512215|FG003|COMPLETED|Extension Period||0||
48480550|NCT01029340|101512216|FG004|COMPLETED|Extension Period||0||
48480551|NCT01029340|101512217|FG005|COMPLETED|Extension Period||43||
48480552|NCT01029340|101512212|FG000|NOT COMPLETED|Extension Period||0||
48480553|NCT01029340|101512213|FG001|NOT COMPLETED|Extension Period||0||
48480554|NCT01029340|101512214|FG002|NOT COMPLETED|Extension Period||0||
48480555|NCT01029340|101512215|FG003|NOT COMPLETED|Extension Period||0||
48480556|NCT01029340|101512216|FG004|NOT COMPLETED|Extension Period||0||
48480557|NCT01029340|101512217|FG005|NOT COMPLETED|Extension Period||12||
48480558|NCT01029340|101512212|FG000|STARTED|Part C Treatment Period||0||
48480559|NCT01029340|101512213|FG001|STARTED|Part C Treatment Period||0||
48480560|NCT01029340|101512214|FG002|STARTED|Part C Treatment Period||0||
48480561|NCT01029340|101512215|FG003|STARTED|Part C Treatment Period||0||
48480562|NCT01029340|101512216|FG004|STARTED|Part C Treatment Period||5||
48480563|NCT01029340|101512217|FG005|STARTED|Part C Treatment Period||0||
48480564|NCT01029340|101512212|FG000|Participants Received Treatment|Part C Treatment Period||0||
48480565|NCT01029340|101512213|FG001|Participants Received Treatment|Part C Treatment Period||0||
48480566|NCT01029340|101512214|FG002|Participants Received Treatment|Part C Treatment Period||0||
48480567|NCT01029340|101512215|FG003|Participants Received Treatment|Part C Treatment Period||0||
48480568|NCT01029340|101512216|FG004|Participants Received Treatment|Part C Treatment Period||5||
48480569|NCT01029340|101512217|FG005|Participants Received Treatment|Part C Treatment Period||0||
48480570|NCT01029340|101512212|FG000|COMPLETED|Part C Treatment Period||0||
48480571|NCT01029340|101512213|FG001|COMPLETED|Part C Treatment Period||0||
48480572|NCT01029340|101512214|FG002|COMPLETED|Part C Treatment Period||0||
48480573|NCT01029340|101512215|FG003|COMPLETED|Part C Treatment Period||0||
48480574|NCT01029340|101512216|FG004|COMPLETED|Part C Treatment Period||5||
48480575|NCT01029340|101512217|FG005|COMPLETED|Part C Treatment Period||0||
48480576|NCT01029340|101512212|FG000|NOT COMPLETED|Part C Treatment Period||0||
48480577|NCT01029340|101512213|FG001|NOT COMPLETED|Part C Treatment Period||0||
48480578|NCT01029340|101512214|FG002|NOT COMPLETED|Part C Treatment Period||0||
48480579|NCT01029340|101512215|FG003|NOT COMPLETED|Part C Treatment Period||0||
48480580|NCT01029340|101512216|FG004|NOT COMPLETED|Part C Treatment Period||0||
48480581|NCT01029340|101512217|FG005|NOT COMPLETED|Part C Treatment Period||0||
48480582|NCT01029340|101512212|FG000|STARTED|Part C Follow up Period||0||
48480583|NCT01029340|101512213|FG001|STARTED|Part C Follow up Period||0||
48480584|NCT01029340|101512214|FG002|STARTED|Part C Follow up Period||0||
48480585|NCT01029340|101512215|FG003|STARTED|Part C Follow up Period||0||
48480586|NCT01029340|101512216|FG004|STARTED|Part C Follow up Period||5||
48480587|NCT01029340|101512217|FG005|STARTED|Part C Follow up Period||0||
48480588|NCT01029340|101512212|FG000|COMPLETED|Part C Follow up Period||0||
48480589|NCT01029340|101512213|FG001|COMPLETED|Part C Follow up Period||0||
48480590|NCT01029340|101512214|FG002|COMPLETED|Part C Follow up Period||0||
48480591|NCT01029340|101512215|FG003|COMPLETED|Part C Follow up Period||0||
48480592|NCT01029340|101512216|FG004|COMPLETED|Part C Follow up Period||5||
48480593|NCT01029340|101512217|FG005|COMPLETED|Part C Follow up Period||0||
48480594|NCT01029340|101512212|FG000|NOT COMPLETED|Part C Follow up Period||0||
48480595|NCT01029340|101512213|FG001|NOT COMPLETED|Part C Follow up Period||0||
48480596|NCT01029340|101512214|FG002|NOT COMPLETED|Part C Follow up Period||0||
48480597|NCT01029340|101512215|FG003|NOT COMPLETED|Part C Follow up Period||0||
48480598|NCT01029340|101512216|FG004|NOT COMPLETED|Part C Follow up Period||0||
48480599|NCT01029340|101512217|FG005|NOT COMPLETED|Part C Follow up Period||0||
48480600|NCT00576056|101512218|FG000|STARTED|Overall Study||19||
48480601|NCT00576056|101512218|FG000|COMPLETED|Overall Study||5||
48480602|NCT00576056|101512218|FG000|NOT COMPLETED|Overall Study||14||
48480603|NCT05087524|101512219|FG000|STARTED|Overall Study||65||
48480604|NCT05087524|101512219|FG000|COMPLETED|Overall Study||65||
48480605|NCT05087524|101512219|FG000|NOT COMPLETED|Overall Study||0||
48480606|NCT04605094|101512220|FG000|STARTED|Overall Study||96||
48480607|NCT04605094|101512221|FG001|STARTED|Overall Study||98||
48480608|NCT04605094|101512220|FG000|COMPLETED|Overall Study||37||
48480609|NCT04605094|101512221|FG001|COMPLETED|Overall Study||37||
48480610|NCT04605094|101512220|FG000|NOT COMPLETED|Overall Study||59||
48480611|NCT04605094|101512221|FG001|NOT COMPLETED|Overall Study||61||
48480612|NCT01185548|101512222|FG000|STARTED|Period 1 : Tolbutamide||4||
48480613|NCT01185548|101512222|FG000|COMPLETED|Period 1 : Tolbutamide||4||
48480614|NCT01185548|101512222|FG000|NOT COMPLETED|Period 1 : Tolbutamide||0||
48480615|NCT01185548|101512222|FG000|STARTED|Period 2: Tasisulam and Tolbutamide||4||
48480616|NCT01185548|101512222|FG000|COMPLETED|Period 2: Tasisulam and Tolbutamide||2||
48480617|NCT01185548|101512222|FG000|NOT COMPLETED|Period 2: Tasisulam and Tolbutamide||2||
48480618|NCT01185548|101512222|FG000|STARTED|Period 3: Tasisulam and Tolbutamide||2||
48480619|NCT01185548|101512222|FG000|COMPLETED|Period 3: Tasisulam and Tolbutamide||2||
48480620|NCT01185548|101512222|FG000|NOT COMPLETED|Period 3: Tasisulam and Tolbutamide||0||
48480621|NCT02770820|101512223|FG000|STARTED|Overall Study||7||
48480622|NCT02770820|101512223|FG000|COMPLETED|Overall Study||4||
48480623|NCT02770820|101512223|FG000|NOT COMPLETED|Overall Study||3||
48480624|NCT02196675|101512224|FG000|STARTED|Overall Study||27||
48480625|NCT02196675|101512225|FG001|STARTED|Overall Study||70||
48480626|NCT02196675|101512226|FG002|STARTED|Overall Study||8||
48480627|NCT02196675|101512224|FG000|COMPLETED|Overall Study||25||
48480628|NCT02196675|101512225|FG001|COMPLETED|Overall Study||68||
48480629|NCT02196675|101512226|FG002|COMPLETED|Overall Study||7||
48480630|NCT02196675|101512224|FG000|NOT COMPLETED|Overall Study||2||
48480631|NCT02196675|101512225|FG001|NOT COMPLETED|Overall Study||2||
48480632|NCT02196675|101512226|FG002|NOT COMPLETED|Overall Study||1||
48480633|NCT03586726|101512227|FG000|STARTED|Overall Study||16||
48480634|NCT03586726|101512227|FG000|COMPLETED|Overall Study||15||
48480635|NCT03586726|101512227|FG000|NOT COMPLETED|Overall Study||1||
48480636|NCT02058498|101512228|FG000|STARTED|Overall Study||12||
48480637|NCT02058498|101512228|FG000|6 Weeks|Overall Study||8||
48480638|NCT02058498|101512228|FG000|COMPLETED|Overall Study||8||
48480639|NCT02058498|101512228|FG000|NOT COMPLETED|Overall Study||4||
48480640|NCT02392000|101512229|FG000|STARTED|Overall Study||38||
48480641|NCT02392000|101512229|FG000|COMPLETED|Overall Study||11||
48480642|NCT02392000|101512229|FG000|NOT COMPLETED|Overall Study||27||
48480643|NCT01038856|101512230|FG000|STARTED|Overall Study||5||
48480644|NCT01038856|101512230|FG000|COMPLETED|Overall Study||3||
48480645|NCT01038856|101512230|FG000|NOT COMPLETED|Overall Study||2||
48480646|NCT01275586|101512231|FG000|STARTED|Overall Study||6||
48480647|NCT01275586|101512231|FG000|COMPLETED|Overall Study||3||
48480648|NCT01275586|101512231|FG000|NOT COMPLETED|Overall Study||3||
48480649|NCT04720664|101512232|FG000|STARTED|Overall Study||11||
48480650|NCT04720664|101512232|FG000|COMPLETED|Overall Study||0||
48480651|NCT04720664|101512232|FG000|NOT COMPLETED|Overall Study||11||
48194577|NCT01168401|100800110|FG009|COMPLETED|Overall Study||8||
48480652|NCT00705536|101512233|FG000|STARTED|Start Period 1||6||
48480653|NCT00705536|101512234|FG001|STARTED|Start Period 1||6||
48480654|NCT00705536|101512235|FG002|STARTED|Start Period 1||7||
48480655|NCT00705536|101512236|FG003|STARTED|Start Period 1||7||
48480656|NCT00705536|101512233|FG000|Received at Least 1 Dose of Study Drug|Start Period 1||6||
48480657|NCT00705536|101512234|FG001|Received at Least 1 Dose of Study Drug|Start Period 1||6||
48480658|NCT00705536|101512235|FG002|Received at Least 1 Dose of Study Drug|Start Period 1||7||
48480659|NCT00705536|101512236|FG003|Received at Least 1 Dose of Study Drug|Start Period 1||7||
48194578|NCT01168401|100800111|FG010|COMPLETED|Overall Study||8||
48194579|NCT01168401|100800101|FG000|NOT COMPLETED|Overall Study||1||
48194580|NCT01168401|100800102|FG001|NOT COMPLETED|Overall Study||1||
48194581|NCT01168401|100800103|FG002|NOT COMPLETED|Overall Study||2||
48194582|NCT01168401|100800104|FG003|NOT COMPLETED|Overall Study||2||
48194583|NCT01168401|100800105|FG004|NOT COMPLETED|Overall Study||0||
48194584|NCT01168401|100800106|FG005|NOT COMPLETED|Overall Study||0||
48194585|NCT01168401|100800107|FG006|NOT COMPLETED|Overall Study||0||
48194586|NCT01168401|100800108|FG007|NOT COMPLETED|Overall Study||0||
48480660|NCT00705536|101512233|FG000|COMPLETED|Start Period 1||6||
48480661|NCT00705536|101512234|FG001|COMPLETED|Start Period 1||6||
48480662|NCT00705536|101512235|FG002|COMPLETED|Start Period 1||7||
48480663|NCT00705536|101512236|FG003|COMPLETED|Start Period 1||6||
48480664|NCT00705536|101512233|FG000|NOT COMPLETED|Start Period 1||0||
48480665|NCT00705536|101512234|FG001|NOT COMPLETED|Start Period 1||0||
48480666|NCT00705536|101512235|FG002|NOT COMPLETED|Start Period 1||0||
48480667|NCT00705536|101512236|FG003|NOT COMPLETED|Start Period 1||1||
48480668|NCT00705536|101512233|FG000|STARTED|Washout Period of at Least 6 Days||6||
48480669|NCT00705536|101512234|FG001|STARTED|Washout Period of at Least 6 Days||6||
48480670|NCT00705536|101512235|FG002|STARTED|Washout Period of at Least 6 Days||7||
48480671|NCT00705536|101512236|FG003|STARTED|Washout Period of at Least 6 Days||6||
48480672|NCT00705536|101512233|FG000|COMPLETED|Washout Period of at Least 6 Days||6||
48480673|NCT00705536|101512234|FG001|COMPLETED|Washout Period of at Least 6 Days||6||
48480674|NCT00705536|101512235|FG002|COMPLETED|Washout Period of at Least 6 Days||7||
48480675|NCT00705536|101512236|FG003|COMPLETED|Washout Period of at Least 6 Days||6||
48480676|NCT00705536|101512233|FG000|NOT COMPLETED|Washout Period of at Least 6 Days||0||
48480677|NCT00705536|101512234|FG001|NOT COMPLETED|Washout Period of at Least 6 Days||0||
48480678|NCT00705536|101512235|FG002|NOT COMPLETED|Washout Period of at Least 6 Days||0||
48480679|NCT00705536|101512236|FG003|NOT COMPLETED|Washout Period of at Least 6 Days||0||
48480680|NCT00705536|101512233|FG000|STARTED|Start Period 2||6||
48480681|NCT00705536|101512234|FG001|STARTED|Start Period 2||6||
48480682|NCT00705536|101512235|FG002|STARTED|Start Period 2||7||
48480683|NCT00705536|101512236|FG003|STARTED|Start Period 2||6||
48480684|NCT00705536|101512233|FG000|COMPLETED|Start Period 2||6||
48480685|NCT00705536|101512234|FG001|COMPLETED|Start Period 2||6||
48480686|NCT00705536|101512235|FG002|COMPLETED|Start Period 2||7||
48480687|NCT00705536|101512236|FG003|COMPLETED|Start Period 2||6||
48194587|NCT01168401|100800109|FG008|NOT COMPLETED|Overall Study||0||
48480688|NCT00705536|101512233|FG000|NOT COMPLETED|Start Period 2||0||
48480689|NCT00705536|101512234|FG001|NOT COMPLETED|Start Period 2||0||
48480690|NCT00705536|101512235|FG002|NOT COMPLETED|Start Period 2||0||
48480691|NCT00705536|101512236|FG003|NOT COMPLETED|Start Period 2||0||
48480692|NCT00705536|101512233|FG000|STARTED|Completed Study||6||
48480693|NCT00705536|101512234|FG001|STARTED|Completed Study||6||
48480694|NCT00705536|101512235|FG002|STARTED|Completed Study||7||
48480695|NCT00705536|101512236|FG003|STARTED|Completed Study||6||
48194588|NCT01168401|100800110|FG009|NOT COMPLETED|Overall Study||0||
48194589|NCT01168401|100800111|FG010|NOT COMPLETED|Overall Study||0||
48480696|NCT00705536|101512233|FG000|COMPLETED|Completed Study||6||
48480697|NCT00705536|101512234|FG001|COMPLETED|Completed Study||6||
48480698|NCT00705536|101512235|FG002|COMPLETED|Completed Study||7||
48194590|NCT04888585|100800112|FG000|STARTED|Placebo-Controlled (Baseline-Week 12)||96||
48194591|NCT04888585|100800113|FG001|STARTED|Placebo-Controlled (Baseline-Week 12)||98||
48194592|NCT04888585|100800114|FG002|STARTED|Placebo-Controlled (Baseline-Week 12)||95||
48480699|NCT00705536|101512236|FG003|COMPLETED|Completed Study||6||
48480700|NCT00705536|101512233|FG000|NOT COMPLETED|Completed Study||0||
48480701|NCT00705536|101512234|FG001|NOT COMPLETED|Completed Study||0||
48480702|NCT00705536|101512235|FG002|NOT COMPLETED|Completed Study||0||
48480703|NCT00705536|101512236|FG003|NOT COMPLETED|Completed Study||0||
48480704|NCT01367457|101512237|FG000|STARTED|Overall Study||193||
48480705|NCT01367457|101512238|FG001|STARTED|Overall Study||23||
48480706|NCT01367457|101512239|FG002|STARTED|Overall Study||26||
48480707|NCT01367457|101512237|FG000|COMPLETED|Overall Study||5||
48480708|NCT01367457|101512238|FG001|COMPLETED|Overall Study||23||
48480709|NCT01367457|101512239|FG002|COMPLETED|Overall Study||26||
48480710|NCT01367457|101512237|FG000|NOT COMPLETED|Overall Study||188||
48480711|NCT01367457|101512238|FG001|NOT COMPLETED|Overall Study||0||
48480712|NCT01367457|101512239|FG002|NOT COMPLETED|Overall Study||0||
48480713|NCT01199848|101512240|FG000|STARTED|Placebo Arm||29||
48480714|NCT01199848|101512240|FG000|COMPLETED|Placebo Arm||21||
48480715|NCT01199848|101512240|FG000|NOT COMPLETED|Placebo Arm||8||
48480716|NCT01199848|101512240|FG000|STARTED|10g STR Arm||21||
48480717|NCT01199848|101512240|FG000|COMPLETED|10g STR Arm||21||
48480718|NCT01199848|101512240|FG000|NOT COMPLETED|10g STR Arm||0||
48480719|NCT01199848|101512240|FG000|STARTED|20G STRB Arm||21||
48480720|NCT01199848|101512240|FG000|COMPLETED|20G STRB Arm||21||
48480721|NCT01199848|101512240|FG000|NOT COMPLETED|20G STRB Arm||0||
48480722|NCT01199848|101512240|FG000|STARTED|40G STRB Arm||21||
48480723|NCT01199848|101512240|FG000|COMPLETED|40G STRB Arm||21||
48480724|NCT01199848|101512240|FG000|NOT COMPLETED|40G STRB Arm||0||
48480725|NCT00414765|101512241|FG000|STARTED|Overall Study||7||
48480726|NCT00414765|101512242|FG001|STARTED|Overall Study||19||
48480727|NCT00414765|101512241|FG000|Completed Study|Overall Study||7|A participant was considered a completer when the participant did not die or have disease progression at the end of treatment.|
48480728|NCT00414765|101512242|FG001|Completed Study|Overall Study||18|A participant was considered a completer when the participant did not die or have disease progression at the end of treatment.|
48480729|NCT00414765|101512241|FG000|Completed Cycle 1|Overall Study||7|Completion of a cycle was defined as any participant who received at least seven IV infusions during the cycle.|
48194593|NCT04888585|100800115|FG003|STARTED|Placebo-Controlled (Baseline-Week 12)||90||
48194594|NCT04888585|100800116|FG004|STARTED|Placebo-Controlled (Baseline-Week 12)||94||
48194595|NCT04888585|100800117|FG005|STARTED|Placebo-Controlled (Baseline-Week 12)||0||
48194596|NCT04888585|100800118|FG006|STARTED|Placebo-Controlled (Baseline-Week 12)||0||
48194597|NCT04888585|100800119|FG007|STARTED|Placebo-Controlled (Baseline-Week 12)||0||
48480730|NCT00414765|101512242|FG001|Completed Cycle 1|Overall Study||19|Completion of a cycle was defined as any participant who received at least seven IV infusions during the cycle.|
48480731|NCT00414765|101512241|FG000|Completed Cycle 2|Overall Study||4|Completion of a cycle was defined as any participant who received at least seven IV infusions during the cycle.|
48480732|NCT00414765|101512242|FG001|Completed Cycle 2|Overall Study||16|Completion of a cycle was defined as any participant who received at least seven IV infusions during the cycle.|
48480733|NCT00414765|101512241|FG000|COMPLETED|Overall Study||1||
48480734|NCT00414765|101512242|FG001|COMPLETED|Overall Study||8||
48480735|NCT00414765|101512241|FG000|NOT COMPLETED|Overall Study||6||
48480736|NCT00414765|101512242|FG001|NOT COMPLETED|Overall Study||11||
48480737|NCT01546545|101512243|FG000|STARTED|Overall Study||11||
48480738|NCT01546545|101512243|FG000|COMPLETED|Overall Study||10||
48480739|NCT01546545|101512243|FG000|NOT COMPLETED|Overall Study||1||
48480740|NCT01281501|101512244|FG000|STARTED|Overall Study||44||
48480741|NCT01281501|101512245|FG001|STARTED|Overall Study||43||
48480742|NCT01281501|101512244|FG000|COMPLETED|Overall Study||44||
48480743|NCT01281501|101512245|FG001|COMPLETED|Overall Study||43||
48480744|NCT01281501|101512244|FG000|NOT COMPLETED|Overall Study||0||
48480745|NCT01281501|101512245|FG001|NOT COMPLETED|Overall Study||0||
48480746|NCT02215161|101512246|FG000|STARTED|Overall Study||14||
48480747|NCT02215161|101512246|FG000|COMPLETED|Overall Study||14||
48480748|NCT02215161|101512246|FG000|NOT COMPLETED|Overall Study||0||
48480749|NCT00038675|101512247|FG000|STARTED|Overall Study||125||
48480750|NCT00038675|101512247|FG000|COMPLETED|Overall Study||125||
48480751|NCT00038675|101512247|FG000|NOT COMPLETED|Overall Study||0||
48480752|NCT03627091|101512248|FG000|STARTED|Overall Study||19||
48480753|NCT03627091|101512249|FG001|STARTED|Overall Study||10||
48480754|NCT03627091|101512250|FG002|STARTED|Overall Study||11||
48480755|NCT03627091|101512248|FG000|COMPLETED|Overall Study||7||
48480756|NCT03627091|101512249|FG001|COMPLETED|Overall Study||4||
48480757|NCT03627091|101512250|FG002|COMPLETED|Overall Study||6||
48480758|NCT03627091|101512248|FG000|NOT COMPLETED|Overall Study||12||
48480759|NCT03627091|101512249|FG001|NOT COMPLETED|Overall Study||6||
48480760|NCT03627091|101512250|FG002|NOT COMPLETED|Overall Study||5||
48480761|NCT00877032|101512251|FG000|STARTED|Overall Study||6||
48480762|NCT00877032|101512252|FG001|STARTED|Overall Study||6||
48480763|NCT00877032|101512253|FG002|STARTED|Overall Study||6||
48480764|NCT00877032|101512254|FG003|STARTED|Overall Study||7||
48194598|NCT04888585|100800120|FG008|STARTED|Placebo-Controlled (Baseline-Week 12)||0||
48480765|NCT00877032|101512255|FG004|STARTED|Overall Study||6||
48480766|NCT00877032|101512256|FG005|STARTED|Overall Study||6||
48480767|NCT00877032|101512257|FG006|STARTED|Overall Study||20||
48480768|NCT00877032|101512251|FG000|Treated|Overall Study||6||
48480769|NCT00877032|101512252|FG001|Treated|Overall Study||6||
48480770|NCT00877032|101512253|FG002|Treated|Overall Study||6||
48480771|NCT00877032|101512254|FG003|Treated|Overall Study||6||
48194599|NCT04888585|100800121|FG009|STARTED|Placebo-Controlled (Baseline-Week 12)||0||
48194600|NCT04888585|100800122|FG010|STARTED|Placebo-Controlled (Baseline-Week 12)||0||
48194601|NCT04888585|100800112|FG000|COMPLETED|Placebo-Controlled (Baseline-Week 12)||92||
48194602|NCT04888585|100800113|FG001|COMPLETED|Placebo-Controlled (Baseline-Week 12)||93||
48194603|NCT04888585|100800114|FG002|COMPLETED|Placebo-Controlled (Baseline-Week 12)||86||
48194604|NCT04888585|100800115|FG003|COMPLETED|Placebo-Controlled (Baseline-Week 12)||85||
48194605|NCT04888585|100800116|FG004|COMPLETED|Placebo-Controlled (Baseline-Week 12)||89||
48194606|NCT04888585|100800117|FG005|COMPLETED|Placebo-Controlled (Baseline-Week 12)||0||
48194607|NCT04888585|100800118|FG006|COMPLETED|Placebo-Controlled (Baseline-Week 12)||0||
48194608|NCT04888585|100800119|FG007|COMPLETED|Placebo-Controlled (Baseline-Week 12)||0||
48194609|NCT04888585|100800120|FG008|COMPLETED|Placebo-Controlled (Baseline-Week 12)||0||
48194610|NCT04888585|100800121|FG009|COMPLETED|Placebo-Controlled (Baseline-Week 12)||0||
48194611|NCT04888585|100800122|FG010|COMPLETED|Placebo-Controlled (Baseline-Week 12)||0||
48194612|NCT04888585|100800112|FG000|NOT COMPLETED|Placebo-Controlled (Baseline-Week 12)||4||
48194613|NCT04888585|100800113|FG001|NOT COMPLETED|Placebo-Controlled (Baseline-Week 12)||5||
48480772|NCT00877032|101512255|FG004|Treated|Overall Study||6||
48480773|NCT00877032|101512256|FG005|Treated|Overall Study||6||
48480774|NCT00877032|101512257|FG006|Treated|Overall Study||18||
48480775|NCT00877032|101512251|FG000|COMPLETED|Overall Study||6||
48480776|NCT00877032|101512252|FG001|COMPLETED|Overall Study||6||
48480777|NCT00877032|101512253|FG002|COMPLETED|Overall Study||6||
48480778|NCT00877032|101512254|FG003|COMPLETED|Overall Study||6||
48480779|NCT00877032|101512255|FG004|COMPLETED|Overall Study||6||
48480780|NCT00877032|101512256|FG005|COMPLETED|Overall Study||6||
48480781|NCT00877032|101512257|FG006|COMPLETED|Overall Study||18||
48480782|NCT00877032|101512251|FG000|NOT COMPLETED|Overall Study||0||
48480783|NCT00877032|101512252|FG001|NOT COMPLETED|Overall Study||0||
48480784|NCT00877032|101512253|FG002|NOT COMPLETED|Overall Study||0||
48194614|NCT04888585|100800114|FG002|NOT COMPLETED|Placebo-Controlled (Baseline-Week 12)||9||
48194615|NCT04888585|100800115|FG003|NOT COMPLETED|Placebo-Controlled (Baseline-Week 12)||5||
48194616|NCT04888585|100800116|FG004|NOT COMPLETED|Placebo-Controlled (Baseline-Week 12)||5||
48194617|NCT04888585|100800117|FG005|NOT COMPLETED|Placebo-Controlled (Baseline-Week 12)||0||
48194618|NCT04888585|100800118|FG006|NOT COMPLETED|Placebo-Controlled (Baseline-Week 12)||0||
48194619|NCT04888585|100800119|FG007|NOT COMPLETED|Placebo-Controlled (Baseline-Week 12)||0||
48194620|NCT04888585|100800120|FG008|NOT COMPLETED|Placebo-Controlled (Baseline-Week 12)||0||
48194621|NCT04888585|100800121|FG009|NOT COMPLETED|Placebo-Controlled (Baseline-Week 12)||0||
48194622|NCT04888585|100800122|FG010|NOT COMPLETED|Placebo-Controlled (Baseline-Week 12)||0||
48194623|NCT04888585|100800112|FG000|STARTED|Long Term Extension (Wk 13-End of Study)||0||
48194624|NCT04888585|100800113|FG001|STARTED|Long Term Extension (Wk 13-End of Study)||0||
48194625|NCT04888585|100800114|FG002|STARTED|Long Term Extension (Wk 13-End of Study)||0||
48194626|NCT04888585|100800115|FG003|STARTED|Long Term Extension (Wk 13-End of Study)||0||
48194627|NCT04888585|100800116|FG004|STARTED|Long Term Extension (Wk 13-End of Study)||0||
48194628|NCT04888585|100800117|FG005|STARTED|Long Term Extension (Wk 13-End of Study)||45||
48194629|NCT04888585|100800118|FG006|STARTED|Long Term Extension (Wk 13-End of Study)||46||
48194630|NCT04888585|100800119|FG007|STARTED|Long Term Extension (Wk 13-End of Study)||93||
48194631|NCT04888585|100800120|FG008|STARTED|Long Term Extension (Wk 13-End of Study)||86||
48194632|NCT04888585|100800121|FG009|STARTED|Long Term Extension (Wk 13-End of Study)||85||
48194633|NCT04888585|100800122|FG010|STARTED|Long Term Extension (Wk 13-End of Study)||89||
48194634|NCT04888585|100800112|FG000|COMPLETED|Long Term Extension (Wk 13-End of Study)||0||
48194635|NCT04888585|100800113|FG001|COMPLETED|Long Term Extension (Wk 13-End of Study)||0||
48194636|NCT04888585|100800114|FG002|COMPLETED|Long Term Extension (Wk 13-End of Study)||0||
48194637|NCT04888585|100800115|FG003|COMPLETED|Long Term Extension (Wk 13-End of Study)||0||
48194638|NCT04888585|100800116|FG004|COMPLETED|Long Term Extension (Wk 13-End of Study)||0||
48480785|NCT00877032|101512254|FG003|NOT COMPLETED|Overall Study||1||
48480786|NCT00877032|101512255|FG004|NOT COMPLETED|Overall Study||0||
48480787|NCT00877032|101512256|FG005|NOT COMPLETED|Overall Study||0||
48480788|NCT00877032|101512257|FG006|NOT COMPLETED|Overall Study||2||
48480789|NCT01037114|101515438|FG000|STARTED|Year 16||49||
48480790|NCT01037114|101515438|FG000|COMPLETED|Year 16||49||
48480791|NCT01037114|101515438|FG000|NOT COMPLETED|Year 16||0||
48480792|NCT01037114|101515438|FG000|STARTED|Year 17||48||
48480793|NCT01037114|101515438|FG000|COMPLETED|Year 17||48||
48480794|NCT01037114|101515438|FG000|NOT COMPLETED|Year 17||0||
48194639|NCT04888585|100800117|FG005|COMPLETED|Long Term Extension (Wk 13-End of Study)||0||
48194640|NCT04888585|100800118|FG006|COMPLETED|Long Term Extension (Wk 13-End of Study)||0||
48194641|NCT04888585|100800119|FG007|COMPLETED|Long Term Extension (Wk 13-End of Study)||0||
48194642|NCT04888585|100800120|FG008|COMPLETED|Long Term Extension (Wk 13-End of Study)||0||
48194643|NCT04888585|100800121|FG009|COMPLETED|Long Term Extension (Wk 13-End of Study)||0||
48194644|NCT04888585|100800122|FG010|COMPLETED|Long Term Extension (Wk 13-End of Study)||0||
48194645|NCT04888585|100800112|FG000|NOT COMPLETED|Long Term Extension (Wk 13-End of Study)||0||
48194646|NCT04888585|100800113|FG001|NOT COMPLETED|Long Term Extension (Wk 13-End of Study)||0||
48194647|NCT04888585|100800114|FG002|NOT COMPLETED|Long Term Extension (Wk 13-End of Study)||0||
48194648|NCT04888585|100800115|FG003|NOT COMPLETED|Long Term Extension (Wk 13-End of Study)||0||
48194649|NCT04888585|100800116|FG004|NOT COMPLETED|Long Term Extension (Wk 13-End of Study)||0||
48194650|NCT04888585|100800117|FG005|NOT COMPLETED|Long Term Extension (Wk 13-End of Study)||45||
48480795|NCT01037114|101515438|FG000|STARTED|Year 18||44||
48480796|NCT01037114|101515438|FG000|COMPLETED|Year 18||44||
48480797|NCT01037114|101515438|FG000|NOT COMPLETED|Year 18||0||
48194651|NCT04888585|100800118|FG006|NOT COMPLETED|Long Term Extension (Wk 13-End of Study)||46||
48194652|NCT04888585|100800119|FG007|NOT COMPLETED|Long Term Extension (Wk 13-End of Study)||93||
48194653|NCT04888585|100800120|FG008|NOT COMPLETED|Long Term Extension (Wk 13-End of Study)||86||
48194654|NCT04888585|100800121|FG009|NOT COMPLETED|Long Term Extension (Wk 13-End of Study)||85||
48194655|NCT04888585|100800122|FG010|NOT COMPLETED|Long Term Extension (Wk 13-End of Study)||89||
48194656|NCT04759131|100800123|FG000|STARTED|Overall Study||38||
48194657|NCT04759131|100800124|FG001|STARTED|Overall Study||36||
48194658|NCT04759131|100800123|FG000|COMPLETED|Overall Study||36||
48194659|NCT04759131|100800124|FG001|COMPLETED|Overall Study||36||
48194660|NCT04759131|100800123|FG000|NOT COMPLETED|Overall Study||2||
48194661|NCT04759131|100800124|FG001|NOT COMPLETED|Overall Study||0||
48194662|NCT01599325|100800125|FG000|STARTED|Primary Parent Phase||72||
48194663|NCT01599325|100800125|FG000|Intent to Treat (ITT) Population|Primary Parent Phase||72||
48194664|NCT01599325|100800125|FG000|Pharmacokinetic (PK) Population|Primary Parent Phase||12||
48194665|NCT01599325|100800125|FG000|COMPLETED|Primary Parent Phase||15||
48194666|NCT01599325|100800125|FG000|NOT COMPLETED|Primary Parent Phase||57||
48194667|NCT01599325|100800125|FG000|STARTED|Extension Phase||15||
48194668|NCT01599325|100800125|FG000|COMPLETED|Extension Phase||0||
48194669|NCT01599325|100800125|FG000|NOT COMPLETED|Extension Phase||15||
48194670|NCT00906698|100800126|FG000|STARTED|Overall Study||3||
48194671|NCT00906698|100800127|FG001|STARTED|Overall Study||19||
48194672|NCT00906698|100800128|FG002|STARTED|Overall Study||6||
48194673|NCT00906698|100800129|FG003|STARTED|Overall Study||4||
48194674|NCT00906698|100800130|FG004|STARTED|Overall Study||18||
48194675|NCT00906698|100800131|FG005|STARTED|Overall Study||5||
48194676|NCT00906698|100800126|FG000|COMPLETED|Overall Study||0||
48194677|NCT00906698|100800127|FG001|COMPLETED|Overall Study||0||
48194678|NCT00906698|100800128|FG002|COMPLETED|Overall Study||0||
48194679|NCT00906698|100800129|FG003|COMPLETED|Overall Study||0||
48194680|NCT00906698|100800130|FG004|COMPLETED|Overall Study||0||
48194681|NCT00906698|100800131|FG005|COMPLETED|Overall Study||0||
48194682|NCT00906698|100800126|FG000|NOT COMPLETED|Overall Study||3||
48194683|NCT00906698|100800127|FG001|NOT COMPLETED|Overall Study||19||
48194684|NCT00906698|100800128|FG002|NOT COMPLETED|Overall Study||6||
48194685|NCT00906698|100800129|FG003|NOT COMPLETED|Overall Study||4||
48194686|NCT00906698|100800130|FG004|NOT COMPLETED|Overall Study||18||
48194687|NCT00906698|100800131|FG005|NOT COMPLETED|Overall Study||5||
48194688|NCT01124162|100800132|FG000|STARTED|First Intervention||40||
48194689|NCT01124162|100800133|FG001|STARTED|First Intervention||40||
48194690|NCT01124162|100800132|FG000|COMPLETED|First Intervention||38||
48194691|NCT01124162|100800133|FG001|COMPLETED|First Intervention||40||
48194692|NCT01124162|100800132|FG000|NOT COMPLETED|First Intervention||2||
48194693|NCT01124162|100800133|FG001|NOT COMPLETED|First Intervention||0||
48194694|NCT01124162|100800132|FG000|STARTED|Washout of 7 Days||38||
48194695|NCT01124162|100800133|FG001|STARTED|Washout of 7 Days||40||
48194696|NCT01124162|100800132|FG000|COMPLETED|Washout of 7 Days||37||
48194697|NCT01124162|100800133|FG001|COMPLETED|Washout of 7 Days||40||
48194698|NCT01124162|100800132|FG000|NOT COMPLETED|Washout of 7 Days||1||
48480798|NCT01037114|101515438|FG000|STARTED|Year 19||45||
48194699|NCT01124162|100800133|FG001|NOT COMPLETED|Washout of 7 Days||0||
48194700|NCT01124162|100800132|FG000|STARTED|Second Intervention||37||
48194701|NCT01124162|100800133|FG001|STARTED|Second Intervention||40||
48194702|NCT01124162|100800132|FG000|COMPLETED|Second Intervention||37||
48194703|NCT01124162|100800133|FG001|COMPLETED|Second Intervention||40||
48194704|NCT01124162|100800132|FG000|NOT COMPLETED|Second Intervention||0||
48194705|NCT01124162|100800133|FG001|NOT COMPLETED|Second Intervention||0||
48194706|NCT01670019|100800134|FG000|STARTED|Overall Study||23||
48194707|NCT01670019|100800135|FG001|STARTED|Overall Study||23||
48194708|NCT01670019|100800134|FG000|COMPLETED|Overall Study||14||
48194709|NCT01670019|100800135|FG001|COMPLETED|Overall Study||23||
48194710|NCT01670019|100800134|FG000|NOT COMPLETED|Overall Study||9||
48194711|NCT01670019|100800135|FG001|NOT COMPLETED|Overall Study||0||
48194712|NCT01414166|100800136|FG000|STARTED|Overall Study||122||
48194713|NCT01414166|100800137|FG001|STARTED|Overall Study||122||
48194714|NCT01414166|100800136|FG000|Treated|Overall Study||120||
48194715|NCT01414166|100800137|FG001|Treated|Overall Study||121||
48194716|NCT01414166|100800136|FG000|COMPLETED|Overall Study||31||
48194717|NCT01414166|100800137|FG001|COMPLETED|Overall Study||39||
48194718|NCT01414166|100800136|FG000|NOT COMPLETED|Overall Study||91||
48194719|NCT01414166|100800137|FG001|NOT COMPLETED|Overall Study||83||
48194720|NCT00603447|100800138|FG000|STARTED|Overall Study||6||
48194721|NCT00603447|100800139|FG001|STARTED|Overall Study||6||
48194722|NCT00603447|100800140|FG002|STARTED|Overall Study||8||
48194723|NCT00603447|100800141|FG003|STARTED|Overall Study||6||
48194724|NCT00603447|100800142|FG004|STARTED|Overall Study||6||
48194725|NCT00603447|100800143|FG005|STARTED|Overall Study||8||
48194726|NCT00603447|100800144|FG006|STARTED|Overall Study||44||
48194727|NCT00603447|100800138|FG000|COMPLETED|Overall Study||6||
48194728|NCT00603447|100800139|FG001|COMPLETED|Overall Study||3||
48194729|NCT00603447|100800140|FG002|COMPLETED|Overall Study||6||
48194730|NCT00603447|100800141|FG003|COMPLETED|Overall Study||4||
48194731|NCT00603447|100800142|FG004|COMPLETED|Overall Study||1||
48194732|NCT00603447|100800143|FG005|COMPLETED|Overall Study||6||
48194733|NCT00603447|100800144|FG006|COMPLETED|Overall Study||20||
48194734|NCT00603447|100800138|FG000|NOT COMPLETED|Overall Study||0||
48194735|NCT00603447|100800139|FG001|NOT COMPLETED|Overall Study||3||
48194736|NCT00603447|100800140|FG002|NOT COMPLETED|Overall Study||2||
48194737|NCT00603447|100800141|FG003|NOT COMPLETED|Overall Study||2||
48194738|NCT00603447|100800142|FG004|NOT COMPLETED|Overall Study||5||
48194739|NCT00603447|100800143|FG005|NOT COMPLETED|Overall Study||2||
48194740|NCT00603447|100800144|FG006|NOT COMPLETED|Overall Study||24||
48194741|NCT05967442|100800145|FG000|STARTED|Overall Study||61||
48194742|NCT05967442|100800146|FG001|STARTED|Overall Study||44||
48194743|NCT05967442|100800147|FG002|STARTED|Overall Study||52||
48194744|NCT05967442|100800145|FG000|COMPLETED|Overall Study||61||
48194745|NCT05967442|100800146|FG001|COMPLETED|Overall Study||44||
48194746|NCT05967442|100800147|FG002|COMPLETED|Overall Study||52||
48194747|NCT05967442|100800145|FG000|NOT COMPLETED|Overall Study||0||
48194748|NCT05967442|100800146|FG001|NOT COMPLETED|Overall Study||0||
48194749|NCT05967442|100800147|FG002|NOT COMPLETED|Overall Study||0||
48194750|NCT04188288|100800148|FG000|STARTED|Overall Study||8||
48194751|NCT04188288|100800149|FG001|STARTED|Overall Study||3||
48194752|NCT04188288|100800148|FG000|Completed Scan Day 1|Overall Study||7||
48194753|NCT04188288|100800149|FG001|Completed Scan Day 1|Overall Study||3||
48194754|NCT04188288|100800148|FG000|Completed Scan Day 2|Overall Study||5||
48194755|NCT04188288|100800149|FG001|Completed Scan Day 2|Overall Study||3||
48194756|NCT04188288|100800148|FG000|Completed Scan Day 3|Overall Study||4||
48194757|NCT04188288|100800149|FG001|Completed Scan Day 3|Overall Study||3||
48194758|NCT04188288|100800148|FG000|Completed Scan Day 4|Overall Study||4||
48194759|NCT04188288|100800149|FG001|Completed Scan Day 4|Overall Study||3||
48194760|NCT04188288|100800148|FG000|Completed Scan Day 5|Overall Study||2||
48194761|NCT04188288|100800149|FG001|Completed Scan Day 5|Overall Study||3||
48194762|NCT04188288|100800148|FG000|Completed 1 Month Follow up|Overall Study||3||
48194763|NCT04188288|100800149|FG001|Completed 1 Month Follow up|Overall Study||3||
48194764|NCT04188288|100800148|FG000|COMPLETED|Overall Study||3||
48194765|NCT04188288|100800149|FG001|COMPLETED|Overall Study||3||
48194766|NCT04188288|100800148|FG000|NOT COMPLETED|Overall Study||5||
48194767|NCT04188288|100800149|FG001|NOT COMPLETED|Overall Study||0||
48194768|NCT02121418|100800150|FG000|STARTED|Overall Study||12||
48194769|NCT02121418|100800150|FG000|COMPLETED|Overall Study||12||
48480799|NCT01037114|101515438|FG000|COMPLETED|Year 19||45||
48194770|NCT02121418|100800150|FG000|NOT COMPLETED|Overall Study||0||
48194771|NCT02359435|100800151|FG000|STARTED|Overall Study||220||
48194772|NCT02359435|100800152|FG001|STARTED|Overall Study||220||
48194773|NCT02359435|100800151|FG000|COMPLETED|Overall Study||216||
48194774|NCT02359435|100800152|FG001|COMPLETED|Overall Study||216||
48194775|NCT02359435|100800151|FG000|NOT COMPLETED|Overall Study||4||
48194776|NCT02359435|100800152|FG001|NOT COMPLETED|Overall Study||4||
48194777|NCT05526911|100800153|FG000|STARTED|Overall Study||28||
48194778|NCT05526911|100800153|FG000|COMPLETED|Overall Study||26||
48194779|NCT05526911|100800153|FG000|NOT COMPLETED|Overall Study||2||
48194780|NCT03568162|100800154|FG000|STARTED|Overall Study||76||
48194781|NCT03568162|100800155|FG001|STARTED|Overall Study||80||
48194782|NCT03568162|100800156|FG002|STARTED|Overall Study||77||
48194783|NCT03568162|100800157|FG003|STARTED|Overall Study||80||
48194784|NCT03568162|100800158|FG004|STARTED|Overall Study||75||
48194785|NCT03568162|100800159|FG005|STARTED|Overall Study||74||
48194786|NCT03568162|100800154|FG000|COMPLETED|Overall Study||54||
48194787|NCT03568162|100800155|FG001|COMPLETED|Overall Study||57||
48194788|NCT03568162|100800156|FG002|COMPLETED|Overall Study||42||
48194789|NCT03568162|100800157|FG003|COMPLETED|Overall Study||50||
48194790|NCT03568162|100800158|FG004|COMPLETED|Overall Study||61||
48194791|NCT03568162|100800159|FG005|COMPLETED|Overall Study||60||
48194792|NCT03568162|100800154|FG000|NOT COMPLETED|Overall Study||22||
48194793|NCT03568162|100800155|FG001|NOT COMPLETED|Overall Study||23||
48194794|NCT03568162|100800156|FG002|NOT COMPLETED|Overall Study||35||
48194795|NCT03568162|100800157|FG003|NOT COMPLETED|Overall Study||30||
48194796|NCT03568162|100800158|FG004|NOT COMPLETED|Overall Study||14||
48194797|NCT03568162|100800159|FG005|NOT COMPLETED|Overall Study||14||
48194798|NCT00751036|100800160|FG000|STARTED|Overall Study||48||
48194799|NCT00751036|100800161|FG001|STARTED|Overall Study||46||
48194800|NCT00751036|100800160|FG000|COMPLETED|Overall Study||0||
48194801|NCT00751036|100800161|FG001|COMPLETED|Overall Study||0||
48194802|NCT00751036|100800160|FG000|NOT COMPLETED|Overall Study||48||
48194803|NCT00751036|100800161|FG001|NOT COMPLETED|Overall Study||46||
48194804|NCT03532178|100800162|FG000|STARTED|First Period||23||
48480800|NCT01037114|101515438|FG000|NOT COMPLETED|Year 19||0||
48480801|NCT01037114|101515438|FG000|STARTED|Year 20||45||
48194805|NCT03532178|100800163|FG001|STARTED|First Period||21||
48194806|NCT03532178|100800162|FG000|COMPLETED|First Period||22||
48194807|NCT03532178|100800163|FG001|COMPLETED|First Period||17||
48480802|NCT01037114|101515438|FG000|COMPLETED|Year 20||44||
48480803|NCT01037114|101515438|FG000|NOT COMPLETED|Year 20||1||
48480804|NCT05452798|101515439|FG000|STARTED|Overall Study||1054||
48480805|NCT05452798|101515439|FG000|COMPLETED|Overall Study||1054||
48480806|NCT05452798|101515439|FG000|NOT COMPLETED|Overall Study||0||
48480807|NCT00358449|101515440|FG000|STARTED|Overall Study||19||
48480808|NCT00358449|101515441|FG001|STARTED|Overall Study||20||
48480809|NCT00358449|101515442|FG002|STARTED|Overall Study||20||
48480810|NCT00358449|101515440|FG000|COMPLETED|Overall Study||15||
48480811|NCT00358449|101515441|FG001|COMPLETED|Overall Study||19||
48480812|NCT00358449|101515442|FG002|COMPLETED|Overall Study||18||
48480813|NCT00358449|101515440|FG000|NOT COMPLETED|Overall Study||4||
48480814|NCT00358449|101515441|FG001|NOT COMPLETED|Overall Study||1||
48480815|NCT00358449|101515442|FG002|NOT COMPLETED|Overall Study||2||
48480816|NCT01938066|101515443|FG000|STARTED|Overall Study||15||
48194808|NCT03532178|100800162|FG000|NOT COMPLETED|First Period||1||
48194809|NCT03532178|100800163|FG001|NOT COMPLETED|First Period||4||
48194810|NCT03532178|100800162|FG000|STARTED|Second Period||22||
48480817|NCT01938066|101515444|FG001|STARTED|Overall Study||15||
48194811|NCT03532178|100800163|FG001|STARTED|Second Period||17||
48480818|NCT01938066|101515443|FG000|COMPLETED|Overall Study||14||
48480819|NCT01938066|101515444|FG001|COMPLETED|Overall Study||13||
48480820|NCT01938066|101515443|FG000|NOT COMPLETED|Overall Study||1||
48480821|NCT01938066|101515444|FG001|NOT COMPLETED|Overall Study||2||
48480822|NCT03433430|101515445|FG000|STARTED|Overall Study||9||
48480823|NCT03433430|101515445|FG000|COMPLETED|Overall Study||8||
48480824|NCT03433430|101515445|FG000|NOT COMPLETED|Overall Study||1||
48480825|NCT04166032|101515446|FG000|STARTED|Overall Study||15||
48480826|NCT04166032|101515446|FG000|COMPLETED|Overall Study||14||
48480827|NCT04166032|101515446|FG000|NOT COMPLETED|Overall Study||1||
48480828|NCT02683083|101515447|FG000|STARTED|Overall Study||9||
48480829|NCT02683083|101515447|FG000|COMPLETED|Overall Study||9||
48480830|NCT02683083|101515447|FG000|NOT COMPLETED|Overall Study||0||
48480831|NCT02017223|101515448|FG000|STARTED|Overall Study||12||
48480832|NCT02017223|101515448|FG000|COMPLETED|Overall Study||10||
48480833|NCT02017223|101515448|FG000|NOT COMPLETED|Overall Study||2||
48480834|NCT01049334|101515449|FG000|STARTED|Overall Study||102||
48480835|NCT01049334|101515450|FG001|STARTED|Overall Study||102||
48480836|NCT01049334|101515449|FG000|COMPLETED|Overall Study||93||
48480837|NCT01049334|101515450|FG001|COMPLETED|Overall Study||95||
48480838|NCT01049334|101515449|FG000|NOT COMPLETED|Overall Study||9||
48480839|NCT01049334|101515450|FG001|NOT COMPLETED|Overall Study||7||
48480840|NCT04005859|101515451|FG000|STARTED|Overall Study||32||
48480841|NCT04005859|101515452|FG001|STARTED|Overall Study||29||
48480842|NCT04005859|101515451|FG000|COMPLETED|Overall Study||28||
48480843|NCT04005859|101515452|FG001|COMPLETED|Overall Study||25||
48480844|NCT04005859|101515451|FG000|NOT COMPLETED|Overall Study||4||
48480845|NCT04005859|101515452|FG001|NOT COMPLETED|Overall Study||4||
48480846|NCT00420238|101515453|FG000|STARTED|12 Week Double-Blind Treatment Period 1||39||
48480847|NCT00420238|101515454|FG001|STARTED|12 Week Double-Blind Treatment Period 1||43||
48480848|NCT00420238|101515453|FG000|COMPLETED|12 Week Double-Blind Treatment Period 1||38||
48480849|NCT00420238|101515454|FG001|COMPLETED|12 Week Double-Blind Treatment Period 1||39||
48480850|NCT00420238|101515453|FG000|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||1||
48480851|NCT00420238|101515454|FG001|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||4||
48480852|NCT00420238|101515453|FG000|STARTED|12 Week Open-Label Treatment Period 2||38||
48480853|NCT00420238|101515454|FG001|STARTED|12 Week Open-Label Treatment Period 2||39||
48480854|NCT00420238|101515453|FG000|COMPLETED|12 Week Open-Label Treatment Period 2||36||
48480855|NCT00420238|101515454|FG001|COMPLETED|12 Week Open-Label Treatment Period 2||38||
48480856|NCT00420238|101515453|FG000|NOT COMPLETED|12 Week Open-Label Treatment Period 2||2||
48480857|NCT00420238|101515454|FG001|NOT COMPLETED|12 Week Open-Label Treatment Period 2||1||
48480858|NCT00485472|101515455|FG000|STARTED|Overall Study||73||
48480859|NCT00485472|101515456|FG001|STARTED|Overall Study||76||
48480860|NCT00485472|101515455|FG000|Entered Maintenance Phase|Overall Study||65||
48480861|NCT00485472|101515456|FG001|Entered Maintenance Phase|Overall Study||67||
48480862|NCT00485472|101515455|FG000|COMPLETED|Overall Study||57||
48480863|NCT00485472|101515456|FG001|COMPLETED|Overall Study||64||
48480864|NCT00485472|101515455|FG000|NOT COMPLETED|Overall Study||16||
48480865|NCT00485472|101515456|FG001|NOT COMPLETED|Overall Study||12||
48480866|NCT00465270|101515457|FG000|STARTED|Overall Study||499||
48480867|NCT00465270|101515458|FG001|STARTED|Overall Study||481||
48480868|NCT00465270|101515457|FG000|COMPLETED|Overall Study||395||
48480869|NCT00465270|101515458|FG001|COMPLETED|Overall Study||321||
48480870|NCT00465270|101515457|FG000|NOT COMPLETED|Overall Study||104||
48480871|NCT00465270|101515458|FG001|NOT COMPLETED|Overall Study||160||
48480872|NCT00978822|101515459|FG000|STARTED|Overall Study||5||
48480873|NCT00978822|101515459|FG000|COMPLETED|Overall Study||5||
48194812|NCT03532178|100800162|FG000|COMPLETED|Second Period||21||
48194813|NCT03532178|100800163|FG001|COMPLETED|Second Period||15||
48194814|NCT03532178|100800162|FG000|NOT COMPLETED|Second Period||1||
48194815|NCT03532178|100800163|FG001|NOT COMPLETED|Second Period||2||
48194816|NCT00151996|100800164|FG000|STARTED|Overall Study||42||
48194817|NCT00151996|100800165|FG001|STARTED|Overall Study||33||
48194818|NCT00151996|100800164|FG000|COMPLETED|Overall Study||37||
48194819|NCT00151996|100800165|FG001|COMPLETED|Overall Study||26||
48194820|NCT00151996|100800164|FG000|NOT COMPLETED|Overall Study||5||
48194821|NCT00151996|100800165|FG001|NOT COMPLETED|Overall Study||7||
48194822|NCT00941031|100800166|FG000|STARTED|Induction Period||66||
48194823|NCT00941031|100800167|FG001|STARTED|Induction Period||138||
48194824|NCT00941031|100800168|FG002|STARTED|Induction Period||133||
48194825|NCT00941031|100800169|FG003|STARTED|Induction Period||67||
48194826|NCT00941031|100800170|FG004|STARTED|Induction Period||0||
48194827|NCT00941031|100800171|FG005|STARTED|Induction Period||0||
48194828|NCT00941031|100800172|FG006|STARTED|Induction Period||0||
48194829|NCT00941031|100800166|FG000|COMPLETED|Induction Period||61||
48194830|NCT00941031|100800167|FG001|COMPLETED|Induction Period||134||
48194831|NCT00941031|100800168|FG002|COMPLETED|Induction Period||127||
48194832|NCT00941031|100800169|FG003|COMPLETED|Induction Period||58||
48194833|NCT00941031|100800170|FG004|COMPLETED|Induction Period||0||
48194834|NCT00941031|100800171|FG005|COMPLETED|Induction Period||0||
48194835|NCT00941031|100800172|FG006|COMPLETED|Induction Period||0||
48194836|NCT00941031|100800166|FG000|NOT COMPLETED|Induction Period||5||
48194837|NCT00941031|100800167|FG001|NOT COMPLETED|Induction Period||4||
48194838|NCT00941031|100800168|FG002|NOT COMPLETED|Induction Period||6||
48194839|NCT00941031|100800169|FG003|NOT COMPLETED|Induction Period||9||
48194840|NCT00941031|100800170|FG004|NOT COMPLETED|Induction Period||0||
48194841|NCT00941031|100800171|FG005|NOT COMPLETED|Induction Period||0||
48194842|NCT00941031|100800172|FG006|NOT COMPLETED|Induction Period||0||
48194843|NCT00941031|100800166|FG000|STARTED|Maintenance Period||0||
48194844|NCT00941031|100800167|FG001|STARTED|Maintenance Period||0||
48194845|NCT00941031|100800168|FG002|STARTED|Maintenance Period||0||
48194846|NCT00941031|100800169|FG003|STARTED|Maintenance Period||0||
48194847|NCT00941031|100800170|FG004|STARTED|Maintenance Period||65||
48194848|NCT00941031|100800171|FG005|STARTED|Maintenance Period||67||
48194849|NCT00941031|100800172|FG006|STARTED|Maintenance Period||247||
48194850|NCT00941031|100800166|FG000|COMPLETED|Maintenance Period||0||
48194851|NCT00941031|100800167|FG001|COMPLETED|Maintenance Period||0||
48194852|NCT00941031|100800168|FG002|COMPLETED|Maintenance Period||0||
48194853|NCT00941031|100800169|FG003|COMPLETED|Maintenance Period||0||
48194854|NCT00941031|100800170|FG004|COMPLETED|Maintenance Period||56||
48194855|NCT00941031|100800171|FG005|COMPLETED|Maintenance Period||61||
48194856|NCT00941031|100800172|FG006|COMPLETED|Maintenance Period||204||
48194857|NCT00941031|100800166|FG000|NOT COMPLETED|Maintenance Period||0||
48194858|NCT00941031|100800167|FG001|NOT COMPLETED|Maintenance Period||0||
48194859|NCT00941031|100800168|FG002|NOT COMPLETED|Maintenance Period||0||
48480874|NCT00978822|101515459|FG000|NOT COMPLETED|Overall Study||0||
48480875|NCT03478397|101515460|FG000|STARTED|Overall Study||3272|Eligible women invited|
48480876|NCT03478397|101515461|FG001|STARTED|Overall Study||2117|Eligible women invited|
48480877|NCT03478397|101515460|FG000|Women Accepted to Participate|Overall Study||3241||
48480878|NCT03478397|101515461|FG001|Women Accepted to Participate|Overall Study||2110||
48480879|NCT03478397|101515460|FG000|COMPLETED|Overall Study||3241||
48480880|NCT03478397|101515461|FG001|COMPLETED|Overall Study||2110||
48480881|NCT03478397|101515460|FG000|NOT COMPLETED|Overall Study||31||
48480882|NCT03478397|101515461|FG001|NOT COMPLETED|Overall Study||7||
48194860|NCT00941031|100800169|FG003|NOT COMPLETED|Maintenance Period||0||
48480883|NCT02918877|101515462|FG000|STARTED|Overall Study||24||
48480884|NCT02918877|101515463|FG001|STARTED|Overall Study||25||
48480885|NCT02918877|101515462|FG000|COMPLETED|Overall Study||18||
48480886|NCT02918877|101515463|FG001|COMPLETED|Overall Study||22||
48480887|NCT02918877|101515462|FG000|NOT COMPLETED|Overall Study||6||
48480888|NCT02918877|101515463|FG001|NOT COMPLETED|Overall Study||3||
48480889|NCT01675622|101515464|FG000|STARTED|Overall Study||122||
48480890|NCT01675622|101515465|FG001|STARTED|Overall Study||120||
48480891|NCT01675622|101515464|FG000|COMPLETED|Overall Study||96||
48194861|NCT00941031|100800170|FG004|NOT COMPLETED|Maintenance Period||9||
48194862|NCT00941031|100800171|FG005|NOT COMPLETED|Maintenance Period||6||
48194863|NCT00941031|100800172|FG006|NOT COMPLETED|Maintenance Period||43||
48194864|NCT03586167|100800173|FG000|STARTED|Overall Study||58|Randomized and Treated|116
48480892|NCT01675622|101515465|FG001|COMPLETED|Overall Study||96||
48480893|NCT01675622|101515464|FG000|NOT COMPLETED|Overall Study||26||
48480894|NCT01675622|101515465|FG001|NOT COMPLETED|Overall Study||24||
48480895|NCT02062580|101515466|FG000|STARTED|Overall Study||71||
48480896|NCT02062580|101515467|FG001|STARTED|Overall Study||78||
48480897|NCT02062580|101515466|FG000|COMPLETED|Overall Study||59||
48480898|NCT02062580|101515467|FG001|COMPLETED|Overall Study||65||
48480899|NCT02062580|101515466|FG000|NOT COMPLETED|Overall Study||12||
48480900|NCT02062580|101515467|FG001|NOT COMPLETED|Overall Study||13||
48480901|NCT02438722|101515468|FG000|STARTED|Overall Study||83||
48480902|NCT02438722|101515469|FG001|STARTED|Overall Study||85||
48480903|NCT02438722|101515468|FG000|Participants Evaluable for Adverse Events|Overall Study||78||
48480904|NCT02438722|101515469|FG001|Participants Evaluable for Adverse Events|Overall Study||85||
48480905|NCT02438722|101515468|FG000|COMPLETED|Overall Study||0||
48480906|NCT02438722|101515469|FG001|COMPLETED|Overall Study||0||
48480907|NCT02438722|101515468|FG000|NOT COMPLETED|Overall Study||83||
48480908|NCT02438722|101515469|FG001|NOT COMPLETED|Overall Study||85||
48480909|NCT03567174|101515470|FG000|STARTED|Overall Study||360||6
48480910|NCT03567174|101515471|FG001|STARTED|Overall Study||360||6
48480911|NCT03567174|101515470|FG000|V7 Follow-up|Overall Study||268||6
48480912|NCT03567174|101515471|FG001|V7 Follow-up|Overall Study||243||6
48480913|NCT03567174|101515470|FG000|V14 Follow-up (Pre-COVID)|Overall Study||79||2
48480914|NCT03567174|101515471|FG001|V14 Follow-up (Pre-COVID)|Overall Study||70||2
48480915|NCT03567174|101515470|FG000|COVID Phone Surveys|Overall Study||164||6
48480916|NCT03567174|101515471|FG001|COVID Phone Surveys|Overall Study||155||6
48480917|NCT03567174|101515470|FG000|V14 Follow-up (Post-COVID)|Overall Study||92||4
48480918|NCT03567174|101515471|FG001|V14 Follow-up (Post-COVID)|Overall Study||85||4
48480919|NCT03567174|101515470|FG000|COMPLETED|Overall Study||171||6
48480920|NCT03567174|101515471|FG001|COMPLETED|Overall Study||155||6
48480921|NCT03567174|101515470|FG000|NOT COMPLETED|Overall Study||189||0
48480922|NCT03567174|101515471|FG001|NOT COMPLETED|Overall Study||205||0
48480923|NCT00696020|101515472|FG000|STARTED|Overall Study||90||
48480924|NCT00696020|101515473|FG001|STARTED|Overall Study||89||
48480925|NCT00696020|101515474|FG002|STARTED|Overall Study||93||
48480926|NCT00696020|101515475|FG003|STARTED|Overall Study||88||
48480927|NCT00696020|101515472|FG000|COMPLETED|Overall Study||86||
48480928|NCT00696020|101515473|FG001|COMPLETED|Overall Study||87||
48480929|NCT00696020|101515474|FG002|COMPLETED|Overall Study||90||
48480930|NCT00696020|101515475|FG003|COMPLETED|Overall Study||84||
48480931|NCT00696020|101515472|FG000|NOT COMPLETED|Overall Study||4||
48480932|NCT00696020|101515473|FG001|NOT COMPLETED|Overall Study||2||
48480933|NCT00696020|101515474|FG002|NOT COMPLETED|Overall Study||3||
48480934|NCT00696020|101515475|FG003|NOT COMPLETED|Overall Study||4||
48480935|NCT00267644|101515476|FG000|STARTED|Overall Study||13||
48480936|NCT00267644|101515477|FG001|STARTED|Overall Study||63||
48480937|NCT00267644|101515476|FG000|COMPLETED|Overall Study||13||
48480938|NCT00267644|101515477|FG001|COMPLETED|Overall Study||63||
48480939|NCT00267644|101515476|FG000|NOT COMPLETED|Overall Study||0||
48480940|NCT00267644|101515477|FG001|NOT COMPLETED|Overall Study||0||
48480941|NCT00318461|101515478|FG000|STARTED|Double-Blind, 6 Months||242||
48480942|NCT00318461|101515479|FG001|STARTED|Double-Blind, 6 Months||241||
48480943|NCT00318461|101515480|FG002|STARTED|Double-Blind, 6 Months||242||
48480944|NCT00318461|101515481|FG003|STARTED|Double-Blind, 6 Months||122||
48194865|NCT03586167|100800174|FG001|STARTED|Overall Study||28|Randomized and Treated|56
48194866|NCT03586167|100800173|FG000|COMPLETED|Overall Study||57||114
48194867|NCT03586167|100800174|FG001|COMPLETED|Overall Study||28||56
48194868|NCT03586167|100800173|FG000|NOT COMPLETED|Overall Study||1||2
48194869|NCT03586167|100800174|FG001|NOT COMPLETED|Overall Study||0||0
48194870|NCT04798521|100800175|FG000|STARTED|Overall Study||100||
48194871|NCT04798521|100800176|FG001|STARTED|Overall Study||103||
48194872|NCT04798521|100800175|FG000|COMPLETED|Overall Study||63||
48194873|NCT04798521|100800176|FG001|COMPLETED|Overall Study||16||
48194874|NCT04798521|100800175|FG000|NOT COMPLETED|Overall Study||37||
48194875|NCT04798521|100800176|FG001|NOT COMPLETED|Overall Study||87||
48194876|NCT00984282|100800177|FG000|STARTED|Double Blind Treatment||207||
48194877|NCT00984282|100800178|FG001|STARTED|Double Blind Treatment||210||
48194878|NCT00984282|100800177|FG000|Received Treatment|Double Blind Treatment||207||
48194879|NCT00984282|100800178|FG001|Received Treatment|Double Blind Treatment||209||
48194880|NCT00984282|100800177|FG000|COMPLETED|Double Blind Treatment||103||
48194881|NCT00984282|100800178|FG001|COMPLETED|Double Blind Treatment||172||
48194882|NCT00984282|100800177|FG000|NOT COMPLETED|Double Blind Treatment||104||
48194883|NCT00984282|100800178|FG001|NOT COMPLETED|Double Blind Treatment||38||
48194884|NCT00984282|100800177|FG000|STARTED|Open-label Treatment||86||
48194885|NCT00984282|100800178|FG001|STARTED|Open-label Treatment||161||
48194886|NCT00984282|100800177|FG000|Received Treatment|Open-label Treatment||86||
48194887|NCT00984282|100800178|FG001|Received Treatment|Open-label Treatment||161||
48194888|NCT00984282|100800177|FG000|COMPLETED|Open-label Treatment||0||
48194889|NCT00984282|100800178|FG001|COMPLETED|Open-label Treatment||0||
48194890|NCT00984282|100800177|FG000|NOT COMPLETED|Open-label Treatment||86||
48194891|NCT00984282|100800178|FG001|NOT COMPLETED|Open-label Treatment||161||
48194892|NCT00984282|100800177|FG000|STARTED|Long Term Follow-up||72||
48194893|NCT00984282|100800178|FG001|STARTED|Long Term Follow-up||124||
48194894|NCT00984282|100800177|FG000|COMPLETED|Long Term Follow-up||3||
48194895|NCT00984282|100800178|FG001|COMPLETED|Long Term Follow-up||4||
48194896|NCT00984282|100800177|FG000|NOT COMPLETED|Long Term Follow-up||69||
48194897|NCT00984282|100800178|FG001|NOT COMPLETED|Long Term Follow-up||120||
48194898|NCT02757885|100800179|FG000|STARTED|Overall Study||10||
48194899|NCT02757885|100800179|FG000|COMPLETED|Overall Study||6||
48194900|NCT02757885|100800179|FG000|NOT COMPLETED|Overall Study||4||
48194901|NCT00515086|100800180|FG000|STARTED|Overall Study||24||
48194902|NCT00515086|100800181|FG001|STARTED|Overall Study||6||
48194903|NCT00515086|100800182|FG002|STARTED|Overall Study||5||
48194904|NCT00515086|100800183|FG003|STARTED|Overall Study||6||
48194905|NCT00515086|100800180|FG000|COMPLETED|Overall Study||0||
48194906|NCT00515086|100800181|FG001|COMPLETED|Overall Study||0||
48194907|NCT00515086|100800182|FG002|COMPLETED|Overall Study||0||
48194908|NCT00515086|100800183|FG003|COMPLETED|Overall Study||0||
48194909|NCT00515086|100800180|FG000|NOT COMPLETED|Overall Study||24||
48194910|NCT00515086|100800181|FG001|NOT COMPLETED|Overall Study||6||
48194911|NCT00515086|100800182|FG002|NOT COMPLETED|Overall Study||5||
48194912|NCT00515086|100800183|FG003|NOT COMPLETED|Overall Study||6||
48194913|NCT02004613|100800184|FG000|STARTED|Overall Study||400||
48194914|NCT02004613|100800185|FG001|STARTED|Overall Study||398||
48194915|NCT02004613|100800184|FG000|COMPLETED|Overall Study||398||
48194916|NCT02004613|100800185|FG001|COMPLETED|Overall Study||396||
48194917|NCT02004613|100800184|FG000|NOT COMPLETED|Overall Study||2||
48194918|NCT02004613|100800185|FG001|NOT COMPLETED|Overall Study||2||
48194919|NCT03618095|100800186|FG000|STARTED|Overall Study||274||
48194920|NCT03618095|100800187|FG001|STARTED|Overall Study||63||
48194921|NCT03618095|100800188|FG002|STARTED|Overall Study||45||
48194922|NCT03618095|100800186|FG000|COMPLETED|Overall Study||0||
48194923|NCT03618095|100800187|FG001|COMPLETED|Overall Study||0||
48194924|NCT03618095|100800188|FG002|COMPLETED|Overall Study||0||
48194925|NCT03618095|100800186|FG000|NOT COMPLETED|Overall Study||274||
48194926|NCT03618095|100800187|FG001|NOT COMPLETED|Overall Study||63||
48194927|NCT03618095|100800188|FG002|NOT COMPLETED|Overall Study||45||
48194928|NCT04886596|100800189|FG000|STARTED|Overall Study||12467||
48194929|NCT04886596|100800190|FG001|STARTED|Overall Study||12499||
48194930|NCT04886596|100800189|FG000|COMPLETED|Overall Study||0||
48194931|NCT04886596|100800190|FG001|COMPLETED|Overall Study||0||
48194932|NCT04886596|100800189|FG000|NOT COMPLETED|Overall Study||12467||
48194933|NCT04886596|100800190|FG001|NOT COMPLETED|Overall Study||12499||
48194934|NCT00823979|100800191|FG000|STARTED|Overall Study||35||
48194935|NCT00823979|100800192|FG001|STARTED|Overall Study||35||
48194936|NCT00823979|100800193|FG002|STARTED|Overall Study||35||
48194937|NCT00823979|100800191|FG000|Treated|Overall Study||31||
48194938|NCT00823979|100800192|FG001|Treated|Overall Study||32||
48194939|NCT00823979|100800193|FG002|Treated|Overall Study||34||
48194940|NCT00823979|100800191|FG000|COMPLETED|Overall Study||6||
48194941|NCT00823979|100800192|FG001|COMPLETED|Overall Study||3||
48194942|NCT00823979|100800193|FG002|COMPLETED|Overall Study||11||
48194943|NCT00823979|100800191|FG000|NOT COMPLETED|Overall Study||29||
48194944|NCT00823979|100800192|FG001|NOT COMPLETED|Overall Study||32||
48194945|NCT00823979|100800193|FG002|NOT COMPLETED|Overall Study||24||
48194946|NCT04984876|100800194|FG000|STARTED|Overall Study||47||
48194947|NCT04984876|100800195|FG001|STARTED|Overall Study||51||
48194948|NCT04984876|100800196|FG002|STARTED|Overall Study||46||
48194949|NCT04984876|100800197|FG003|STARTED|Overall Study||44||
48194950|NCT04984876|100800198|FG004|STARTED|Overall Study||11||
48194951|NCT04984876|100800199|FG005|STARTED|Overall Study||12||
48480945|NCT00318461|101515482|FG004|STARTED|Double-Blind, 6 Months||244||
48480946|NCT00318461|101515478|FG000|Exposed to Study Drug|Double-Blind, 6 Months||242||
48194952|NCT04984876|100800194|FG000|Randomized Analysis Set (RAS)|Overall Study||47|All randomized participants, regardless of whether or not they receive a dose of study drug|
48194953|NCT04984876|100800195|FG001|Randomized Analysis Set (RAS)|Overall Study||51|All randomized participants, regardless of whether or not they receive a dose of study drug|
48194954|NCT04984876|100800196|FG002|Randomized Analysis Set (RAS)|Overall Study||46|All randomized participants, regardless of whether or not they receive a dose of study drug|
48194955|NCT04984876|100800197|FG003|Randomized Analysis Set (RAS)|Overall Study||44|All randomized participants, regardless of whether or not they receive a dose of study drug|
48194956|NCT04984876|100800198|FG004|Randomized Analysis Set (RAS)|Overall Study||11|All randomized participants, regardless of whether or not they receive a dose of study drug|
48194957|NCT04984876|100800199|FG005|Randomized Analysis Set (RAS)|Overall Study||12|All randomized participants, regardless of whether or not they receive a dose of study drug|
48194958|NCT04984876|100800194|FG000|Full Analysis Set (FAS)|Overall Study||47|All participants who received at least one dose of study treatment. Mis-randomized patients (mis-randomized in IRT) will be excluded from FAS|
48194959|NCT04984876|100800195|FG001|Full Analysis Set (FAS)|Overall Study||51|All participants who received at least one dose of study treatment. Mis-randomized patients (mis-randomized in IRT) will be excluded from FAS|
48194960|NCT04984876|100800196|FG002|Full Analysis Set (FAS)|Overall Study||46|All participants who received at least one dose of study treatment. Mis-randomized patients (mis-randomized in IRT) will be excluded from FAS|
48194961|NCT04984876|100800197|FG003|Full Analysis Set (FAS)|Overall Study||44|All participants who received at least one dose of study treatment. Mis-randomized patients (mis-randomized in IRT) will be excluded from FAS|
48194962|NCT04984876|100800198|FG004|Full Analysis Set (FAS)|Overall Study||11|All participants who received at least one dose of study treatment. Mis-randomized patients (mis-randomized in IRT) will be excluded from FAS|
48480947|NCT00318461|101515479|FG001|Exposed to Study Drug|Double-Blind, 6 Months||240||
48480948|NCT00318461|101515480|FG002|Exposed to Study Drug|Double-Blind, 6 Months||242||
48480949|NCT00318461|101515481|FG003|Exposed to Study Drug|Double-Blind, 6 Months||121||
48194963|NCT04984876|100800199|FG005|Full Analysis Set (FAS)|Overall Study||12|All participants who received at least one dose of study treatment. Mis-randomized patients (mis-randomized in IRT) will be excluded from FAS|
48194964|NCT04984876|100800194|FG000|Safety Set (SAF)|Overall Study||47|All participants who received at least one dose of study treatment whether or not being randomized|
48194965|NCT04984876|100800195|FG001|Safety Set (SAF)|Overall Study||51|All participants who received at least one dose of study treatment whether or not being randomized|
48194966|NCT04984876|100800196|FG002|Safety Set (SAF)|Overall Study||46|All participants who received at least one dose of study treatment whether or not being randomized|
48194967|NCT04984876|100800197|FG003|Safety Set (SAF)|Overall Study||44|All participants who received at least one dose of study treatment whether or not being randomized|
48194968|NCT04984876|100800198|FG004|Safety Set (SAF)|Overall Study||11|All participants who received at least one dose of study treatment whether or not being randomized|
48194969|NCT04984876|100800199|FG005|Safety Set (SAF)|Overall Study||12|All participants who received at least one dose of study treatment whether or not being randomized|
48194970|NCT04984876|100800194|FG000|COMPLETED|Overall Study||44||
48194971|NCT04984876|100800195|FG001|COMPLETED|Overall Study||40||
48194972|NCT04984876|100800196|FG002|COMPLETED|Overall Study||41||
48194973|NCT04984876|100800197|FG003|COMPLETED|Overall Study||37||
48194974|NCT04984876|100800198|FG004|COMPLETED|Overall Study||8||
48194975|NCT04984876|100800199|FG005|COMPLETED|Overall Study||11||
48194976|NCT04984876|100800194|FG000|NOT COMPLETED|Overall Study||3||
48194977|NCT04984876|100800195|FG001|NOT COMPLETED|Overall Study||11||
48194978|NCT04984876|100800196|FG002|NOT COMPLETED|Overall Study||5||
48194979|NCT04984876|100800197|FG003|NOT COMPLETED|Overall Study||7||
48194980|NCT04984876|100800198|FG004|NOT COMPLETED|Overall Study||3||
48194981|NCT04984876|100800199|FG005|NOT COMPLETED|Overall Study||1||
48194982|NCT04222660|100800200|FG000|STARTED|Overall Study||28||
48194983|NCT04222660|100800201|FG001|STARTED|Overall Study||16||
48194984|NCT04222660|100800200|FG000|COMPLETED|Overall Study||28||
48194985|NCT04222660|100800201|FG001|COMPLETED|Overall Study||16||
48480950|NCT00318461|101515482|FG004|Exposed to Study Drug|Double-Blind, 6 Months||242||
48480951|NCT00318461|101515478|FG000|COMPLETED|Double-Blind, 6 Months||208||
48194986|NCT04222660|100800200|FG000|NOT COMPLETED|Overall Study||0||
48194987|NCT04222660|100800201|FG001|NOT COMPLETED|Overall Study||0||
48194988|NCT01240356|100800202|FG000|STARTED|Overall Study||18||
48194989|NCT01240356|100800203|FG001|STARTED|Overall Study||20||
48194990|NCT01240356|100800202|FG000|COMPLETED|Overall Study||15||
48194991|NCT01240356|100800203|FG001|COMPLETED|Overall Study||20||
48480952|NCT00318461|101515479|FG001|COMPLETED|Double-Blind, 6 Months||197||
48480953|NCT00318461|101515480|FG002|COMPLETED|Double-Blind, 6 Months||191||
48480954|NCT00318461|101515481|FG003|COMPLETED|Double-Blind, 6 Months||74||
48480955|NCT00318461|101515482|FG004|COMPLETED|Double-Blind, 6 Months||210||
48480956|NCT00318461|101515478|FG000|NOT COMPLETED|Double-Blind, 6 Months||34||
48480957|NCT00318461|101515479|FG001|NOT COMPLETED|Double-Blind, 6 Months||44||
48480958|NCT00318461|101515480|FG002|NOT COMPLETED|Double-Blind, 6 Months||51||
48480959|NCT00318461|101515481|FG003|NOT COMPLETED|Double-Blind, 6 Months||48||
48480960|NCT00318461|101515482|FG004|NOT COMPLETED|Double-Blind, 6 Months||34||
48480961|NCT00318461|101515478|FG000|STARTED|Open-Label Extension, 18 Months||208||
48480962|NCT00318461|101515479|FG001|STARTED|Open-Label Extension, 18 Months||197||
48480963|NCT00318461|101515480|FG002|STARTED|Open-Label Extension, 18 Months||191||
48480964|NCT00318461|101515481|FG003|STARTED|Open-Label Extension, 18 Months||74||
48480965|NCT00318461|101515482|FG004|STARTED|Open-Label Extension, 18 Months||210||
48480966|NCT00318461|101515478|FG000|COMPLETED|Open-Label Extension, 18 Months||130||
48480967|NCT00318461|101515479|FG001|COMPLETED|Open-Label Extension, 18 Months||137||
48480968|NCT00318461|101515480|FG002|COMPLETED|Open-Label Extension, 18 Months||118||
48480969|NCT00318461|101515481|FG003|COMPLETED|Open-Label Extension, 18 Months||31||
48480970|NCT00318461|101515482|FG004|COMPLETED|Open-Label Extension, 18 Months||113||
48480971|NCT00318461|101515478|FG000|NOT COMPLETED|Open-Label Extension, 18 Months||78||
48480972|NCT00318461|101515479|FG001|NOT COMPLETED|Open-Label Extension, 18 Months||60||
48480973|NCT00318461|101515480|FG002|NOT COMPLETED|Open-Label Extension, 18 Months||73||
48480974|NCT00318461|101515481|FG003|NOT COMPLETED|Open-Label Extension, 18 Months||43||
48480975|NCT00318461|101515482|FG004|NOT COMPLETED|Open-Label Extension, 18 Months||97||
48480976|NCT04089735|101515483|FG000|STARTED|Overall Study||22||
48480977|NCT04089735|101515484|FG001|STARTED|Overall Study||23||
48480978|NCT04089735|101515485|FG002|STARTED|Overall Study||22||
48480979|NCT04089735|101515486|FG003|STARTED|Overall Study||22||
48480980|NCT04089735|101515487|FG004|STARTED|Overall Study||22||
48480981|NCT04089735|101515488|FG005|STARTED|Overall Study||21||
48480982|NCT04089735|101515483|FG000|COMPLETED|Overall Study||21||
48480983|NCT04089735|101515484|FG001|COMPLETED|Overall Study||17||
48480984|NCT04089735|101515485|FG002|COMPLETED|Overall Study||20||
48480985|NCT04089735|101515486|FG003|COMPLETED|Overall Study||16||
48480986|NCT04089735|101515487|FG004|COMPLETED|Overall Study||21||
48480987|NCT04089735|101515488|FG005|COMPLETED|Overall Study||15||
48480988|NCT04089735|101515483|FG000|NOT COMPLETED|Overall Study||1||
48480989|NCT04089735|101515484|FG001|NOT COMPLETED|Overall Study||6||
48480990|NCT04089735|101515485|FG002|NOT COMPLETED|Overall Study||2||
48480991|NCT04089735|101515486|FG003|NOT COMPLETED|Overall Study||6||
48480992|NCT04089735|101515487|FG004|NOT COMPLETED|Overall Study||1||
48480993|NCT04089735|101515488|FG005|NOT COMPLETED|Overall Study||6||
48480994|NCT01880593|101515489|FG000|STARTED|Overall Study||18||
48480995|NCT01880593|101515490|FG001|STARTED|Overall Study||16||
48480996|NCT01880593|101515489|FG000|COMPLETED|Overall Study||10||
48480997|NCT01880593|101515490|FG001|COMPLETED|Overall Study||10||
48480998|NCT01880593|101515489|FG000|NOT COMPLETED|Overall Study||8||
48480999|NCT01880593|101515490|FG001|NOT COMPLETED|Overall Study||6||
48481000|NCT01182415|101515491|FG000|STARTED|Overall Study||30||
48481001|NCT01182415|101515491|FG000|COMPLETED|Overall Study||29||
48481002|NCT01182415|101515491|FG000|NOT COMPLETED|Overall Study||1||
48481003|NCT00830206|101515492|FG000|STARTED|First Intervention||40||
48481004|NCT00830206|101515493|FG001|STARTED|First Intervention||40||
48481005|NCT00830206|101515492|FG000|COMPLETED|First Intervention||40||
48666381|NCT02038036|101967572|FG000|Crossover Set|Core Study||0|consisted of all patients randomized to the BAT arm, who crossed over and received at least one dose of ruxolitinib.|
48666382|NCT02038036|101967573|FG001|Crossover Set|Core Study||58|consisted of all patients randomized to the BAT arm, who crossed over and received at least one dose of ruxolitinib.|
48666383|NCT02038036|101967572|FG000|COMPLETED|Core Study||59||
48481006|NCT00830206|101515493|FG001|COMPLETED|First Intervention||40||
48481007|NCT00830206|101515492|FG000|NOT COMPLETED|First Intervention||0||
48481008|NCT00830206|101515493|FG001|NOT COMPLETED|First Intervention||0||
48481009|NCT00830206|101515492|FG000|STARTED|Washout: 21 Days||40||
48481010|NCT00830206|101515493|FG001|STARTED|Washout: 21 Days||40||
48481011|NCT00830206|101515492|FG000|COMPLETED|Washout: 21 Days||39||
48481012|NCT00830206|101515493|FG001|COMPLETED|Washout: 21 Days||39||
48481013|NCT00830206|101515492|FG000|NOT COMPLETED|Washout: 21 Days||1||
48481014|NCT00830206|101515493|FG001|NOT COMPLETED|Washout: 21 Days||1||
48666384|NCT02038036|101967573|FG001|COMPLETED|Core Study||61||
48666385|NCT02038036|101967572|FG000|NOT COMPLETED|Core Study||15||
48666386|NCT02038036|101967573|FG001|NOT COMPLETED|Core Study||14||
48666387|NCT02038036|101967572|FG000|STARTED|Crossover Period||0||
48666388|NCT02038036|101967573|FG001|STARTED|Crossover Period||58||
48666389|NCT02038036|101967572|FG000|COMPLETED|Crossover Period||0||
48481015|NCT00830206|101515492|FG000|STARTED|Second Intervention||39||
48666390|NCT02038036|101967573|FG001|COMPLETED|Crossover Period||38||
48666391|NCT02038036|101967572|FG000|NOT COMPLETED|Crossover Period||0||
48666392|NCT02038036|101967573|FG001|NOT COMPLETED|Crossover Period||20||
48666393|NCT03566732|101967574|FG000|STARTED|Overall Study||914||
48481016|NCT00830206|101515493|FG001|STARTED|Second Intervention||39||
48481017|NCT00830206|101515492|FG000|COMPLETED|Second Intervention||39||
48481018|NCT00830206|101515493|FG001|COMPLETED|Second Intervention||39||
48481019|NCT00830206|101515492|FG000|NOT COMPLETED|Second Intervention||0||
48481020|NCT00830206|101515493|FG001|NOT COMPLETED|Second Intervention||0||
48481021|NCT02739997|101515494|FG000|STARTED|Overall Study||100||
48481022|NCT02739997|101515494|FG000|COMPLETED|Overall Study||98||
48481023|NCT02739997|101515494|FG000|NOT COMPLETED|Overall Study||2||
48481024|NCT01929642|101515495|FG000|STARTED|Overall Study||3||
48481025|NCT01929642|101515495|FG000|COMPLETED|Overall Study||1||
48481026|NCT01929642|101515495|FG000|NOT COMPLETED|Overall Study||2||
48481027|NCT01511939|101515496|FG000|STARTED|Overall Study||9||
48481028|NCT01511939|101515497|FG001|STARTED|Overall Study||5||
48481029|NCT01511939|101515498|FG002|STARTED|Overall Study||8||
48481030|NCT01511939|101515496|FG000|COMPLETED|Overall Study||7||
48481031|NCT01511939|101515497|FG001|COMPLETED|Overall Study||4||
48481032|NCT01511939|101515498|FG002|COMPLETED|Overall Study||8||
48481033|NCT01511939|101515496|FG000|NOT COMPLETED|Overall Study||2||
48481034|NCT01511939|101515497|FG001|NOT COMPLETED|Overall Study||1||
48481035|NCT01511939|101515498|FG002|NOT COMPLETED|Overall Study||0||
48481036|NCT00864097|101515499|FG000|STARTED|Overall Study||154||
48481037|NCT00864097|101515500|FG001|STARTED|Overall Study||157||
48481038|NCT00864097|101515501|FG002|STARTED|Overall Study||151||
48481039|NCT00864097|101515502|FG003|STARTED|Overall Study||145||
48481040|NCT00864097|101515499|FG000|Treated|Overall Study||152||
48481041|NCT00864097|101515500|FG001|Treated|Overall Study||157||
48481042|NCT00864097|101515501|FG002|Treated|Overall Study||150||
48481043|NCT00864097|101515502|FG003|Treated|Overall Study||145||
48481044|NCT00864097|101515499|FG000|COMPLETED|Overall Study||15||
48481045|NCT00864097|101515500|FG001|COMPLETED|Overall Study||20||
48481046|NCT00864097|101515501|FG002|COMPLETED|Overall Study||19||
48481047|NCT00864097|101515502|FG003|COMPLETED|Overall Study||20||
48481048|NCT00864097|101515499|FG000|NOT COMPLETED|Overall Study||139||
48481049|NCT00864097|101515500|FG001|NOT COMPLETED|Overall Study||137||
48481050|NCT00864097|101515501|FG002|NOT COMPLETED|Overall Study||132||
48481051|NCT00864097|101515502|FG003|NOT COMPLETED|Overall Study||125||
48481052|NCT00373217|101515503|FG000|STARTED|Overall Study||3||
48481053|NCT00373217|101515504|FG001|STARTED|Overall Study||3||
48481054|NCT00373217|101515503|FG000|COMPLETED|Overall Study||2||
48481055|NCT00373217|101515504|FG001|COMPLETED|Overall Study||3||
48481056|NCT00373217|101515503|FG000|NOT COMPLETED|Overall Study||1||
48481057|NCT00373217|101515504|FG001|NOT COMPLETED|Overall Study||0||
48481058|NCT01864174|101515505|FG000|STARTED|Double Blind Treatment - All Treated||283||
48481059|NCT01864174|101515506|FG001|STARTED|Double Blind Treatment - All Treated||285||
48481060|NCT01864174|101515505|FG000|COMPLETED|Double Blind Treatment - All Treated||268||
48481061|NCT01864174|101515506|FG001|COMPLETED|Double Blind Treatment - All Treated||271||
48481062|NCT01864174|101515505|FG000|NOT COMPLETED|Double Blind Treatment - All Treated||15||
48481063|NCT01864174|101515506|FG001|NOT COMPLETED|Double Blind Treatment - All Treated||14||
48481064|NCT01864174|101515505|FG000|STARTED|Double Blind - Compliant Randomized||268||
48481065|NCT01864174|101515506|FG001|STARTED|Double Blind - Compliant Randomized||271||
48481066|NCT01864174|101515505|FG000|COMPLETED|Double Blind - Compliant Randomized||245||
48481067|NCT01864174|101515506|FG001|COMPLETED|Double Blind - Compliant Randomized||245||
48481068|NCT01864174|101515505|FG000|NOT COMPLETED|Double Blind - Compliant Randomized||23||
48481069|NCT01864174|101515506|FG001|NOT COMPLETED|Double Blind - Compliant Randomized||26||
48481070|NCT01864174|101515505|FG000|STARTED|Off Treatment Follow-Up||9||
48481071|NCT01864174|101515506|FG001|STARTED|Off Treatment Follow-Up||1||
48481072|NCT01864174|101515505|FG000|COMPLETED|Off Treatment Follow-Up||6||
48481073|NCT01864174|101515506|FG001|COMPLETED|Off Treatment Follow-Up||1||
48481074|NCT01864174|101515505|FG000|NOT COMPLETED|Off Treatment Follow-Up||3||
48481075|NCT01864174|101515506|FG001|NOT COMPLETED|Off Treatment Follow-Up||0||
48481076|NCT00075478|101515507|FG000|STARTED|Overall Study||42||
48481077|NCT00075478|101515508|FG001|STARTED|Overall Study||45||
48481078|NCT00075478|101515507|FG000|COMPLETED|Overall Study||41||
48481079|NCT00075478|101515508|FG001|COMPLETED|Overall Study||44||
48481080|NCT00075478|101515507|FG000|NOT COMPLETED|Overall Study||1||
48481081|NCT00075478|101515508|FG001|NOT COMPLETED|Overall Study||1||
48481082|NCT00635492|101515509|FG000|STARTED|Overall Study||1114||
48481083|NCT00635492|101515510|FG001|STARTED|Overall Study||1274||
48481084|NCT00635492|101515509|FG000|COMPLETED|Overall Study||835||
48481085|NCT00635492|101515510|FG001|COMPLETED|Overall Study||992||
48481086|NCT00635492|101515509|FG000|NOT COMPLETED|Overall Study||279||
48481087|NCT00635492|101515510|FG001|NOT COMPLETED|Overall Study||282||
48481088|NCT02629094|101515511|FG000|STARTED|Overall Study||5||
48481089|NCT02629094|101515511|FG000|COMPLETED|Overall Study||5||
48481090|NCT02629094|101515511|FG000|NOT COMPLETED|Overall Study||0||
48481091|NCT03020615|101515512|FG000|STARTED|Overall Study||26||
48481092|NCT03020615|101515513|FG001|STARTED|Overall Study||25||
48481093|NCT03020615|101515514|FG002|STARTED|Overall Study||7||
48481094|NCT03020615|101515512|FG000|COMPLETED|Overall Study||19||
48481095|NCT03020615|101515513|FG001|COMPLETED|Overall Study||23||
48481096|NCT03020615|101515514|FG002|COMPLETED|Overall Study||0||
48481097|NCT03020615|101515512|FG000|NOT COMPLETED|Overall Study||7||
48481098|NCT03020615|101515513|FG001|NOT COMPLETED|Overall Study||2||
48481099|NCT03020615|101515514|FG002|NOT COMPLETED|Overall Study||7||
48481100|NCT03503578|101515515|FG000|STARTED|Overall Study||12||
48481101|NCT03503578|101515515|FG000|COMPLETED|Overall Study||12||
48481102|NCT03503578|101515515|FG000|NOT COMPLETED|Overall Study||0||
48481103|NCT00517530|101515516|FG000|STARTED|Overall Study||21||
48481104|NCT00517530|101515517|FG001|STARTED|Overall Study||13||
48481105|NCT00517530|101515518|FG002|STARTED|Overall Study||18||
48481106|NCT00517530|101515519|FG003|STARTED|Overall Study||22||
48481107|NCT00517530|101515520|FG004|STARTED|Overall Study||21||
48481108|NCT00517530|101515521|FG005|STARTED|Overall Study||19||
48481109|NCT00517530|101515522|FG006|STARTED|Overall Study||20||
48481110|NCT00517530|101515516|FG000|Completed Treatment|Overall Study||11||
48481111|NCT00517530|101515517|FG001|Completed Treatment|Overall Study||13||
48481112|NCT00517530|101515518|FG002|Completed Treatment|Overall Study||13||
48481113|NCT00517530|101515519|FG003|Completed Treatment|Overall Study||18||
48481114|NCT00517530|101515520|FG004|Completed Treatment|Overall Study||9||
48481115|NCT00517530|101515521|FG005|Completed Treatment|Overall Study||9||
48481116|NCT00517530|101515522|FG006|Completed Treatment|Overall Study||13||
48481117|NCT00517530|101515516|FG000|Started Follow-up|Overall Study||20||
48481118|NCT00517530|101515517|FG001|Started Follow-up|Overall Study||13||
48481119|NCT00517530|101515518|FG002|Started Follow-up|Overall Study||17||
48481120|NCT00517530|101515519|FG003|Started Follow-up|Overall Study||21||
48481121|NCT00517530|101515520|FG004|Started Follow-up|Overall Study||17||
48481122|NCT00517530|101515521|FG005|Started Follow-up|Overall Study||16||
48481123|NCT00517530|101515522|FG006|Started Follow-up|Overall Study||19||
48481124|NCT00517530|101515516|FG000|Completed Follow-up|Overall Study||2||
48481125|NCT00517530|101515517|FG001|Completed Follow-up|Overall Study||0||
48481126|NCT00517530|101515518|FG002|Completed Follow-up|Overall Study||0||
48481127|NCT00517530|101515519|FG003|Completed Follow-up|Overall Study||1||
48481128|NCT00517530|101515520|FG004|Completed Follow-up|Overall Study||0||
48481129|NCT00517530|101515521|FG005|Completed Follow-up|Overall Study||0||
48481130|NCT00517530|101515522|FG006|Completed Follow-up|Overall Study||1||
48481131|NCT00517530|101515516|FG000|Retreated Population|Overall Study||2||
48481132|NCT00517530|101515517|FG001|Retreated Population|Overall Study||2||
48481133|NCT00517530|101515518|FG002|Retreated Population|Overall Study||1||
48481134|NCT00517530|101515519|FG003|Retreated Population|Overall Study||4||
48481135|NCT00517530|101515520|FG004|Retreated Population|Overall Study||2||
48481136|NCT00517530|101515521|FG005|Retreated Population|Overall Study||2||
48481137|NCT00517530|101515522|FG006|Retreated Population|Overall Study||0||
48481138|NCT00517530|101515516|FG000|COMPLETED|Overall Study||2||
48481139|NCT00517530|101515517|FG001|COMPLETED|Overall Study||0||
48481140|NCT00517530|101515518|FG002|COMPLETED|Overall Study||0||
48481141|NCT00517530|101515519|FG003|COMPLETED|Overall Study||1||
48481142|NCT00517530|101515520|FG004|COMPLETED|Overall Study||1||
48481143|NCT00517530|101515521|FG005|COMPLETED|Overall Study||0||
48481144|NCT00517530|101515522|FG006|COMPLETED|Overall Study||1||
48481145|NCT00517530|101515516|FG000|NOT COMPLETED|Overall Study||19||
48481146|NCT00517530|101515517|FG001|NOT COMPLETED|Overall Study||13||
48481147|NCT00517530|101515518|FG002|NOT COMPLETED|Overall Study||18||
48481148|NCT00517530|101515519|FG003|NOT COMPLETED|Overall Study||21||
48481149|NCT00517530|101515520|FG004|NOT COMPLETED|Overall Study||20||
48481150|NCT00517530|101515521|FG005|NOT COMPLETED|Overall Study||19||
48481151|NCT00517530|101515522|FG006|NOT COMPLETED|Overall Study||19||
48481152|NCT01361048|101515523|FG000|STARTED|Overall Study||20||
48481153|NCT01361048|101515524|FG001|STARTED|Overall Study||10||
48481154|NCT01361048|101515525|FG002|STARTED|Overall Study||10||
48481155|NCT01361048|101515523|FG000|COMPLETED|Overall Study||20||
48481156|NCT01361048|101515524|FG001|COMPLETED|Overall Study||10||
48481157|NCT01361048|101515525|FG002|COMPLETED|Overall Study||9||
48481158|NCT01361048|101515523|FG000|NOT COMPLETED|Overall Study||0||
48481159|NCT01361048|101515524|FG001|NOT COMPLETED|Overall Study||0||
48481160|NCT01361048|101515525|FG002|NOT COMPLETED|Overall Study||1||
48481161|NCT03617523|101515526|FG000|STARTED|Overall Study||30||
48481162|NCT03617523|101515527|FG001|STARTED|Overall Study||30||
48481163|NCT03617523|101515528|FG002|STARTED|Overall Study||61||
48481164|NCT03617523|101515529|FG003|STARTED|Overall Study||59||
48481165|NCT03617523|101515530|FG004|STARTED|Overall Study||60||
48481166|NCT03617523|101515526|FG000|COMPLETED|Overall Study||30||
48481167|NCT03617523|101515527|FG001|COMPLETED|Overall Study||30||
48481168|NCT03617523|101515528|FG002|COMPLETED|Overall Study||61||
48481169|NCT03617523|101515529|FG003|COMPLETED|Overall Study||59||
48481170|NCT03617523|101515530|FG004|COMPLETED|Overall Study||60||
48481171|NCT03617523|101515526|FG000|NOT COMPLETED|Overall Study||0||
48481172|NCT03617523|101515527|FG001|NOT COMPLETED|Overall Study||0||
48481173|NCT03617523|101515528|FG002|NOT COMPLETED|Overall Study||0||
48481174|NCT03617523|101515529|FG003|NOT COMPLETED|Overall Study||0||
48481175|NCT03617523|101515530|FG004|NOT COMPLETED|Overall Study||0||
48481176|NCT02605928|101515531|FG000|STARTED|Overall Study||79||132
48481177|NCT02605928|101515531|FG000|Pivotal Phase, Statistical Phase|Overall Study||51|First punctures utilized for model tuning. Performance of the device was evaluated after tuning.|80
48481178|NCT02605928|101515531|FG000|COMPLETED|Overall Study||46|Included to statistical analysis|72
48481179|NCT02605928|101515531|FG000|NOT COMPLETED|Overall Study||33||60
48481180|NCT03233724|101515532|FG000|STARTED|Phase I Dose Escalation||2||
48481181|NCT03233724|101515533|FG001|STARTED|Phase I Dose Escalation||2||
48481182|NCT03233724|101515534|FG002|STARTED|Phase I Dose Escalation||4||
48481183|NCT03233724|101515535|FG003|STARTED|Phase I Dose Escalation||0||
48481184|NCT03233724|101515536|FG004|STARTED|Phase I Dose Escalation||1||
48481185|NCT03233724|101515532|FG000|COMPLETED|Phase I Dose Escalation||1||
48666394|NCT03566732|101967574|FG000|COMPLETED|Overall Study||914||
48666395|NCT03566732|101967574|FG000|NOT COMPLETED|Overall Study||0||
48481186|NCT03233724|101515533|FG001|COMPLETED|Phase I Dose Escalation||1||
48481187|NCT03233724|101515534|FG002|COMPLETED|Phase I Dose Escalation||1||
48481188|NCT03233724|101515535|FG003|COMPLETED|Phase I Dose Escalation||0||
48481189|NCT03233724|101515536|FG004|COMPLETED|Phase I Dose Escalation||0||
48666396|NCT02853136|101967575|FG000|STARTED|Period 1||2||
48666397|NCT02853136|101967576|FG001|STARTED|Period 1||2||
48666398|NCT02853136|101967577|FG002|STARTED|Period 1||7||
48666399|NCT02853136|101967578|FG003|STARTED|Period 1||7||
48666400|NCT02853136|101967575|FG000|COMPLETED|Period 1||2||
48666401|NCT02853136|101967576|FG001|COMPLETED|Period 1||2||
48666402|NCT02853136|101967577|FG002|COMPLETED|Period 1||7||
48666403|NCT02853136|101967578|FG003|COMPLETED|Period 1||7||
48666404|NCT02853136|101967575|FG000|NOT COMPLETED|Period 1||0||
48666405|NCT02853136|101967576|FG001|NOT COMPLETED|Period 1||0||
48666406|NCT02853136|101967577|FG002|NOT COMPLETED|Period 1||0||
48666407|NCT02853136|101967578|FG003|NOT COMPLETED|Period 1||0||
48666408|NCT02853136|101967575|FG000|STARTED|Wash-out||2||
48666409|NCT02853136|101967576|FG001|STARTED|Wash-out||2||
48481190|NCT03233724|101515532|FG000|NOT COMPLETED|Phase I Dose Escalation||1||
48481191|NCT03233724|101515533|FG001|NOT COMPLETED|Phase I Dose Escalation||1||
48481192|NCT03233724|101515534|FG002|NOT COMPLETED|Phase I Dose Escalation||3||
48481193|NCT03233724|101515535|FG003|NOT COMPLETED|Phase I Dose Escalation||0||
48481194|NCT03233724|101515536|FG004|NOT COMPLETED|Phase I Dose Escalation||1||
48481195|NCT03233724|101515532|FG000|STARTED|Phase II Dose Expansion||0||
48481196|NCT03233724|101515533|FG001|STARTED|Phase II Dose Expansion||0||
48481197|NCT03233724|101515534|FG002|STARTED|Phase II Dose Expansion||0||
48481198|NCT03233724|101515535|FG003|STARTED|Phase II Dose Expansion||0||
48481199|NCT03233724|101515536|FG004|STARTED|Phase II Dose Expansion||0||
48481200|NCT03233724|101515532|FG000|COMPLETED|Phase II Dose Expansion||0||
48481201|NCT03233724|101515533|FG001|COMPLETED|Phase II Dose Expansion||0||
48481202|NCT03233724|101515534|FG002|COMPLETED|Phase II Dose Expansion||0||
48481203|NCT03233724|101515535|FG003|COMPLETED|Phase II Dose Expansion||0||
48481204|NCT03233724|101515536|FG004|COMPLETED|Phase II Dose Expansion||0||
48481205|NCT03233724|101515532|FG000|NOT COMPLETED|Phase II Dose Expansion||0||
48481206|NCT03233724|101515533|FG001|NOT COMPLETED|Phase II Dose Expansion||0||
48481207|NCT03233724|101515534|FG002|NOT COMPLETED|Phase II Dose Expansion||0||
48481208|NCT03233724|101515535|FG003|NOT COMPLETED|Phase II Dose Expansion||0||
48481209|NCT03233724|101515536|FG004|NOT COMPLETED|Phase II Dose Expansion||0||
48481210|NCT01435265|101515537|FG000|STARTED|Overall Study||3||
48481211|NCT01435265|101515538|FG001|STARTED|Overall Study||4||
48481212|NCT01435265|101515537|FG000|COMPLETED|Overall Study||3||
48481213|NCT01435265|101515538|FG001|COMPLETED|Overall Study||3||
48481214|NCT01435265|101515537|FG000|NOT COMPLETED|Overall Study||0||
48481215|NCT01435265|101515538|FG001|NOT COMPLETED|Overall Study||1||
48481216|NCT01536574|101515539|FG000|STARTED|Overall Study||162||
48481217|NCT01536574|101515540|FG001|STARTED|Overall Study||133||
48481218|NCT01536574|101515539|FG000|COMPLETED|Overall Study||156||
48481219|NCT01536574|101515540|FG001|COMPLETED|Overall Study||126||
48481220|NCT01536574|101515539|FG000|NOT COMPLETED|Overall Study||6||
48481221|NCT01536574|101515540|FG001|NOT COMPLETED|Overall Study||7||
48481222|NCT01661686|101515541|FG000|STARTED|Overall Study||49||
48481223|NCT01661686|101515542|FG001|STARTED|Overall Study||49||
48481224|NCT01661686|101515541|FG000|COMPLETED|Overall Study||47||
48481225|NCT01661686|101515542|FG001|COMPLETED|Overall Study||47||
48481226|NCT01661686|101515541|FG000|NOT COMPLETED|Overall Study||2||
48481227|NCT01661686|101515542|FG001|NOT COMPLETED|Overall Study||2||
48481228|NCT00746798|101515543|FG000|STARTED|Overall Study||122||
48481229|NCT00746798|101515544|FG001|STARTED|Overall Study||124||
48481230|NCT00746798|101515545|FG002|STARTED|Overall Study||113||
48481231|NCT00746798|101515546|FG003|STARTED|Overall Study||120||
48481232|NCT00746798|101515543|FG000|COMPLETED|Overall Study||121||
48481233|NCT00746798|101515544|FG001|COMPLETED|Overall Study||122||
48481234|NCT00746798|101515545|FG002|COMPLETED|Overall Study||110||
48481235|NCT00746798|101515546|FG003|COMPLETED|Overall Study||120||
48481236|NCT00746798|101515543|FG000|NOT COMPLETED|Overall Study||1||
48481237|NCT00746798|101515544|FG001|NOT COMPLETED|Overall Study||2||
48481238|NCT00746798|101515545|FG002|NOT COMPLETED|Overall Study||3||
48481239|NCT00746798|101515546|FG003|NOT COMPLETED|Overall Study||0||
48481240|NCT02107092|101515547|FG000|STARTED|Overall Study||123||
48194992|NCT01240356|100800202|FG000|NOT COMPLETED|Overall Study||3||
48481241|NCT02107092|101515547|FG000|COMPLETED|Overall Study||79||
48481242|NCT02107092|101515547|FG000|NOT COMPLETED|Overall Study||44||
48481243|NCT02549092|101515548|FG000|STARTED|Treatment Period||44|Randomized|
48481244|NCT02549092|101515549|FG001|STARTED|Treatment Period||45|Randomized|
48666410|NCT02853136|101967577|FG002|STARTED|Wash-out||7||
48481245|NCT02549092|101515548|FG000|COMPLETED|Treatment Period||41|Completed 26-week Treatment Period|
48481246|NCT02549092|101515549|FG001|COMPLETED|Treatment Period||38|Completed 26-week Treatment Period|
48481247|NCT02549092|101515548|FG000|NOT COMPLETED|Treatment Period||3||
48481248|NCT02549092|101515549|FG001|NOT COMPLETED|Treatment Period||7||
48481249|NCT02549092|101515548|FG000|STARTED|Extension/Transition Period||10||
48481250|NCT02549092|101515549|FG001|STARTED|Extension/Transition Period||14||
48481251|NCT02549092|101515548|FG000|Transitioned to Commercial LCIG|Extension/Transition Period||5||
48481252|NCT02549092|101515549|FG001|Transitioned to Commercial LCIG|Extension/Transition Period||7||
48481253|NCT02549092|101515548|FG000|COMPLETED|Extension/Transition Period||5||
48481254|NCT02549092|101515549|FG001|COMPLETED|Extension/Transition Period||10||
48481255|NCT02549092|101515548|FG000|NOT COMPLETED|Extension/Transition Period||5||
48481256|NCT02549092|101515549|FG001|NOT COMPLETED|Extension/Transition Period||4||
48481257|NCT02024932|101515550|FG000|STARTED|Overall Study||2||
48481258|NCT02024932|101515551|FG001|STARTED|Overall Study||4||
48481259|NCT02024932|101515552|FG002|STARTED|Overall Study||2||
48481260|NCT02024932|101515553|FG003|STARTED|Overall Study||2||
48481261|NCT02024932|101515554|FG004|STARTED|Overall Study||18||
48481262|NCT02024932|101515555|FG005|STARTED|Overall Study||9||
48481263|NCT02024932|101515550|FG000|Safety Analysis Set|Overall Study||2||
48481264|NCT02024932|101515551|FG001|Safety Analysis Set|Overall Study||4||
48481265|NCT02024932|101515552|FG002|Safety Analysis Set|Overall Study||2||
48481266|NCT02024932|101515553|FG003|Safety Analysis Set|Overall Study||2||
48481267|NCT02024932|101515554|FG004|Safety Analysis Set|Overall Study||18||
48481268|NCT02024932|101515555|FG005|Safety Analysis Set|Overall Study||9||
48481269|NCT02024932|101515550|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||2||
48481270|NCT02024932|101515551|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||4||
48481271|NCT02024932|101515552|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||0||
48481272|NCT02024932|101515553|FG003|Pharmacokinetic (PK) Analysis Set|Overall Study||2||
48481273|NCT02024932|101515554|FG004|Pharmacokinetic (PK) Analysis Set|Overall Study||18||
48481274|NCT02024932|101515555|FG005|Pharmacokinetic (PK) Analysis Set|Overall Study||0||
48481275|NCT02024932|101515550|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||2||
48481276|NCT02024932|101515551|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||4||
48481277|NCT02024932|101515552|FG002|Pharmacodynamic (PD) Analysis Set|Overall Study||2||
48481278|NCT02024932|101515553|FG003|Pharmacodynamic (PD) Analysis Set|Overall Study||2||
48481279|NCT02024932|101515554|FG004|Pharmacodynamic (PD) Analysis Set|Overall Study||18||
48481280|NCT02024932|101515555|FG005|Pharmacodynamic (PD) Analysis Set|Overall Study||9||
48481281|NCT02024932|101515550|FG000|COMPLETED|Overall Study||0||
48481282|NCT02024932|101515551|FG001|COMPLETED|Overall Study||1||
48481283|NCT02024932|101515552|FG002|COMPLETED|Overall Study||2||
48481284|NCT02024932|101515553|FG003|COMPLETED|Overall Study||0||
48481285|NCT02024932|101515554|FG004|COMPLETED|Overall Study||16||
48481286|NCT02024932|101515555|FG005|COMPLETED|Overall Study||9||
48666411|NCT02853136|101967578|FG003|STARTED|Wash-out||7||
48481287|NCT02024932|101515550|FG000|NOT COMPLETED|Overall Study||2||
48666412|NCT02853136|101967575|FG000|COMPLETED|Wash-out||2||
48666413|NCT02853136|101967576|FG001|COMPLETED|Wash-out||2||
48666414|NCT02853136|101967577|FG002|COMPLETED|Wash-out||7||
48666415|NCT02853136|101967578|FG003|COMPLETED|Wash-out||6||
48666416|NCT02853136|101967575|FG000|NOT COMPLETED|Wash-out||0||
48666417|NCT02853136|101967576|FG001|NOT COMPLETED|Wash-out||0||
48666418|NCT02853136|101967577|FG002|NOT COMPLETED|Wash-out||0||
48666419|NCT02853136|101967578|FG003|NOT COMPLETED|Wash-out||1||
48666420|NCT02853136|101967575|FG000|STARTED|Period 2||2||
48666421|NCT02853136|101967576|FG001|STARTED|Period 2||2||
48666422|NCT02853136|101967577|FG002|STARTED|Period 2||7||
48666423|NCT02853136|101967578|FG003|STARTED|Period 2||6||
48666424|NCT02853136|101967575|FG000|COMPLETED|Period 2||2||
48666425|NCT02853136|101967576|FG001|COMPLETED|Period 2||2||
48666426|NCT02853136|101967577|FG002|COMPLETED|Period 2||7||
48666427|NCT02853136|101967578|FG003|COMPLETED|Period 2||6||
48666428|NCT02853136|101967575|FG000|NOT COMPLETED|Period 2||0||
48666429|NCT02853136|101967576|FG001|NOT COMPLETED|Period 2||0||
48481288|NCT02024932|101515551|FG001|NOT COMPLETED|Overall Study||3||
48481289|NCT02024932|101515552|FG002|NOT COMPLETED|Overall Study||0||
48481290|NCT02024932|101515553|FG003|NOT COMPLETED|Overall Study||2||
48481291|NCT02024932|101515554|FG004|NOT COMPLETED|Overall Study||2||
48481292|NCT02024932|101515555|FG005|NOT COMPLETED|Overall Study||0||
48481293|NCT01981720|101515556|FG000|STARTED|Overall Study||15||
48481294|NCT01981720|101515556|FG000|COMPLETED|Overall Study||10||
48481295|NCT01981720|101515556|FG000|NOT COMPLETED|Overall Study||5||
48481296|NCT01848938|101515557|FG000|STARTED|Overall Study||62||
48481297|NCT01848938|101515558|FG001|STARTED|Overall Study||61||
48481298|NCT01848938|101515557|FG000|COMPLETED|Overall Study||61||
48481299|NCT01848938|101515558|FG001|COMPLETED|Overall Study||60||
48481300|NCT01848938|101515557|FG000|NOT COMPLETED|Overall Study||1||
48481301|NCT01848938|101515558|FG001|NOT COMPLETED|Overall Study||1||
48194993|NCT01240356|100800203|FG001|NOT COMPLETED|Overall Study||0||
48194994|NCT02242942|100800204|FG000|STARTED|Overall Study||216||
48194995|NCT02242942|100800205|FG001|STARTED|Overall Study||216||
48194996|NCT02242942|100800206|FG002|STARTED|Overall Study||13||
48481302|NCT03752528|101515559|FG000|STARTED|Part A||53||
48481303|NCT03752528|101515559|FG000|COMPLETED|Part A||51||
48481304|NCT03752528|101515559|FG000|NOT COMPLETED|Part A||2||
48481305|NCT03752528|101515559|FG000|STARTED|Part B||24|Requirement: positive for buprenorphine and/or norbuprenorphine and negative for naloxone in Part A|
48481306|NCT03752528|101515559|FG000|COMPLETED|Part B||20||
48481307|NCT03752528|101515559|FG000|NOT COMPLETED|Part B||4||
48481308|NCT00286754|101515560|FG000|STARTED|Overall Study||176||
48194997|NCT02242942|100800204|FG000|Treated|Overall Study||214||
48481309|NCT00286754|101515561|FG001|STARTED|Overall Study||177||
48666430|NCT02853136|101967577|FG002|NOT COMPLETED|Period 2||0||
48194998|NCT02242942|100800205|FG001|Treated|Overall Study||212||
48481310|NCT00286754|101515562|FG002|STARTED|Overall Study||180||
48481311|NCT00286754|101515560|FG000|COMPLETED|Overall Study||156||
48666431|NCT02853136|101967578|FG003|NOT COMPLETED|Period 2||0||
48666432|NCT01190527|101967579|FG000|STARTED|Overall Study||42||
48666433|NCT01190527|101967579|FG000|COMPLETED|Overall Study||42||
48666434|NCT01190527|101967579|FG000|NOT COMPLETED|Overall Study||0||
48666435|NCT02367456|101967580|FG000|STARTED|Overall Study||12||
48666436|NCT02367456|101967581|FG001|STARTED|Overall Study||30||
48194999|NCT02242942|100800206|FG002|Treated|Overall Study||13||
48195000|NCT02242942|100800204|FG000|COMPLETED|Overall Study||0||
48195001|NCT02242942|100800205|FG001|COMPLETED|Overall Study||0||
48195002|NCT02242942|100800206|FG002|COMPLETED|Overall Study||0||
48195003|NCT02242942|100800204|FG000|NOT COMPLETED|Overall Study||216||
48195004|NCT02242942|100800205|FG001|NOT COMPLETED|Overall Study||216||
48195005|NCT02242942|100800206|FG002|NOT COMPLETED|Overall Study||13||
48195006|NCT02054247|100800207|FG000|STARTED|Overall Study||15||
48195007|NCT02054247|100800208|FG001|STARTED|Overall Study||16||
48195008|NCT02054247|100800209|FG002|STARTED|Overall Study||15||
48195009|NCT02054247|100800207|FG000|COMPLETED|Overall Study||15||
48195010|NCT02054247|100800208|FG001|COMPLETED|Overall Study||16||
48195011|NCT02054247|100800209|FG002|COMPLETED|Overall Study||15||
48195012|NCT02054247|100800207|FG000|NOT COMPLETED|Overall Study||0||
48195013|NCT02054247|100800208|FG001|NOT COMPLETED|Overall Study||0||
48195014|NCT02054247|100800209|FG002|NOT COMPLETED|Overall Study||0||
48195015|NCT04109118|100800210|FG000|STARTED|Overall Study||4||
48195016|NCT04109118|100800210|FG000|COMPLETED|Overall Study||1||
48195017|NCT04109118|100800210|FG000|NOT COMPLETED|Overall Study||3||
48195018|NCT05074498|100800211|FG000|STARTED|Part 1 (Upto Day 104)||7||
48195019|NCT05074498|100800212|FG001|STARTED|Part 1 (Upto Day 104)||6||
48195020|NCT05074498|100800213|FG002|STARTED|Part 1 (Upto Day 104)||6||
48195021|NCT05074498|100800214|FG003|STARTED|Part 1 (Upto Day 104)||6||
48195022|NCT05074498|100800215|FG004|STARTED|Part 1 (Upto Day 104)||0||
48195023|NCT05074498|100800216|FG005|STARTED|Part 1 (Upto Day 104)||0||
48195024|NCT05074498|100800211|FG000|COMPLETED|Part 1 (Upto Day 104)||6||
48195025|NCT05074498|100800212|FG001|COMPLETED|Part 1 (Upto Day 104)||6||
48195026|NCT05074498|100800213|FG002|COMPLETED|Part 1 (Upto Day 104)||6||
48195027|NCT05074498|100800214|FG003|COMPLETED|Part 1 (Upto Day 104)||5||
48195028|NCT05074498|100800215|FG004|COMPLETED|Part 1 (Upto Day 104)||0||
48195029|NCT05074498|100800216|FG005|COMPLETED|Part 1 (Upto Day 104)||0||
48195030|NCT05074498|100800211|FG000|NOT COMPLETED|Part 1 (Upto Day 104)||1||
48195031|NCT05074498|100800212|FG001|NOT COMPLETED|Part 1 (Upto Day 104)||0||
48195032|NCT05074498|100800213|FG002|NOT COMPLETED|Part 1 (Upto Day 104)||0||
48195033|NCT05074498|100800214|FG003|NOT COMPLETED|Part 1 (Upto Day 104)||1||
48195034|NCT05074498|100800215|FG004|NOT COMPLETED|Part 1 (Upto Day 104)||0||
48195035|NCT05074498|100800216|FG005|NOT COMPLETED|Part 1 (Upto Day 104)||0||
48195036|NCT05074498|100800211|FG000|STARTED|Part 2 (Upto Day 104)||0||
48195037|NCT05074498|100800212|FG001|STARTED|Part 2 (Upto Day 104)||0||
48195038|NCT05074498|100800213|FG002|STARTED|Part 2 (Upto Day 104)||0||
48195039|NCT05074498|100800214|FG003|STARTED|Part 2 (Upto Day 104)||0||
48195040|NCT05074498|100800215|FG004|STARTED|Part 2 (Upto Day 104)||63||
48195041|NCT05074498|100800216|FG005|STARTED|Part 2 (Upto Day 104)||66||
48195042|NCT05074498|100800211|FG000|COMPLETED|Part 2 (Upto Day 104)||0||
48195043|NCT05074498|100800212|FG001|COMPLETED|Part 2 (Upto Day 104)||0||
48195044|NCT05074498|100800213|FG002|COMPLETED|Part 2 (Upto Day 104)||0||
48195045|NCT05074498|100800214|FG003|COMPLETED|Part 2 (Upto Day 104)||0||
48195046|NCT05074498|100800215|FG004|COMPLETED|Part 2 (Upto Day 104)||58||
48195047|NCT05074498|100800216|FG005|COMPLETED|Part 2 (Upto Day 104)||64||
48195048|NCT05074498|100800211|FG000|NOT COMPLETED|Part 2 (Upto Day 104)||0||
48195049|NCT05074498|100800212|FG001|NOT COMPLETED|Part 2 (Upto Day 104)||0||
48195050|NCT05074498|100800213|FG002|NOT COMPLETED|Part 2 (Upto Day 104)||0||
48195051|NCT05074498|100800214|FG003|NOT COMPLETED|Part 2 (Upto Day 104)||0||
48195052|NCT05074498|100800215|FG004|NOT COMPLETED|Part 2 (Upto Day 104)||5||
48195053|NCT05074498|100800216|FG005|NOT COMPLETED|Part 2 (Upto Day 104)||2||
48195054|NCT03719677|100800217|FG000|STARTED|Overall Study||7||
48195055|NCT03719677|100800217|FG000|COMPLETED|Overall Study||7||
48195056|NCT03719677|100800217|FG000|NOT COMPLETED|Overall Study||0||
48195057|NCT00635817|100800218|FG000|STARTED|Overall Study||21||
48195058|NCT00635817|100800219|FG001|STARTED|Overall Study||21||
48195059|NCT00635817|100800220|FG002|STARTED|Overall Study||21||
48195060|NCT00635817|100800221|FG003|STARTED|Overall Study||21||
48195061|NCT00635817|100800218|FG000|COMPLETED|Overall Study||15||
48195062|NCT00635817|100800219|FG001|COMPLETED|Overall Study||19||
48195063|NCT00635817|100800220|FG002|COMPLETED|Overall Study||19||
48195064|NCT00635817|100800221|FG003|COMPLETED|Overall Study||21||
48195065|NCT00635817|100800218|FG000|NOT COMPLETED|Overall Study||6||
48195066|NCT00635817|100800219|FG001|NOT COMPLETED|Overall Study||2||
48195067|NCT00635817|100800220|FG002|NOT COMPLETED|Overall Study||2||
48195068|NCT00635817|100800221|FG003|NOT COMPLETED|Overall Study||0||
48195069|NCT01385280|100800222|FG000|STARTED|Overall Study||13||
48195070|NCT01385280|100800222|FG000|COMPLETED|Overall Study||13||
48195071|NCT01385280|100800222|FG000|NOT COMPLETED|Overall Study||0||
48195072|NCT01450943|100800223|FG000|STARTED|Overall Study||28||
48195073|NCT01450943|100800224|FG001|STARTED|Overall Study||42||
48195074|NCT01450943|100800225|FG002|STARTED|Overall Study||48||
48195075|NCT01450943|100800223|FG000|COMPLETED|Overall Study||26||
48195076|NCT01450943|100800224|FG001|COMPLETED|Overall Study||35||
48195077|NCT01450943|100800225|FG002|COMPLETED|Overall Study||42||
48195078|NCT01450943|100800223|FG000|NOT COMPLETED|Overall Study||2||
48481312|NCT00286754|101515561|FG001|COMPLETED|Overall Study||159||
48195079|NCT01450943|100800224|FG001|NOT COMPLETED|Overall Study||7||
48195080|NCT01450943|100800225|FG002|NOT COMPLETED|Overall Study||6||
48195081|NCT00938340|100800226|FG000|STARTED|Overall Study||20||
48195082|NCT00938340|100800226|FG000|Received Whole Walnut Intervention|Overall Study||16||
48195083|NCT00938340|100800226|FG000|Received Walnut Nutmeat Intervention|Overall Study||19||
48195084|NCT00938340|100800226|FG000|Received Walnut Skins Intervention|Overall Study||15||
48195085|NCT00938340|100800226|FG000|Received Walnut Oil Intervention|Overall Study||15||
48195086|NCT00938340|100800226|FG000|COMPLETED|Overall Study||15||
48195087|NCT00938340|100800226|FG000|NOT COMPLETED|Overall Study||5||
48195088|NCT01444287|100800227|FG000|STARTED|Period 1||22||
48195089|NCT01444287|100800227|FG000|COMPLETED|Period 1||22||
48195090|NCT01444287|100800227|FG000|NOT COMPLETED|Period 1||0||
48481313|NCT00286754|101515562|FG002|COMPLETED|Overall Study||170||
48481314|NCT00286754|101515560|FG000|NOT COMPLETED|Overall Study||20||
48195091|NCT01444287|100800227|FG000|STARTED|Period 2||22||
48195092|NCT01444287|100800227|FG000|COMPLETED|Period 2||22||
48195093|NCT01444287|100800227|FG000|NOT COMPLETED|Period 2||0||
48195094|NCT01444287|100800227|FG000|STARTED|Period 3||22||
48195095|NCT01444287|100800227|FG000|COMPLETED|Period 3||22||
48195096|NCT01444287|100800227|FG000|NOT COMPLETED|Period 3||0||
48195097|NCT01444287|100800227|FG000|STARTED|Period 4||22||
48195098|NCT01444287|100800227|FG000|COMPLETED|Period 4||22||
48195099|NCT01444287|100800227|FG000|NOT COMPLETED|Period 4||0||
48195100|NCT02027935|100800228|FG000|STARTED|Overall Study||7||
48195101|NCT02027935|100800228|FG000|COMPLETED|Overall Study||0||
48195102|NCT02027935|100800228|FG000|NOT COMPLETED|Overall Study||7||
48195103|NCT02334306|100800229|FG000|STARTED|Double-blind Period||16||
48195104|NCT02334306|100800230|FG001|STARTED|Double-blind Period||16||
48195105|NCT02334306|100800229|FG000|COMPLETED|Double-blind Period||15||
48195106|NCT02334306|100800230|FG001|COMPLETED|Double-blind Period||14||
48195107|NCT02334306|100800229|FG000|NOT COMPLETED|Double-blind Period||1||
48195108|NCT02334306|100800230|FG001|NOT COMPLETED|Double-blind Period||2||
48195109|NCT02334306|100800229|FG000|STARTED|Open-label Period||15||
48195110|NCT02334306|100800230|FG001|STARTED|Open-label Period||14||
48195111|NCT02334306|100800229|FG000|COMPLETED|Open-label Period||15||
48195112|NCT02334306|100800230|FG001|COMPLETED|Open-label Period||14||
48195113|NCT02334306|100800229|FG000|NOT COMPLETED|Open-label Period||0||
48195114|NCT02334306|100800230|FG001|NOT COMPLETED|Open-label Period||0||
48195115|NCT02430532|100800231|FG000|STARTED|Overall Study||30||
48195116|NCT02430532|100800232|FG001|STARTED|Overall Study||28||
48195117|NCT02430532|100800231|FG000|COMPLETED|Overall Study||0||
48195118|NCT02430532|100800232|FG001|COMPLETED|Overall Study||0||
48195119|NCT02430532|100800231|FG000|NOT COMPLETED|Overall Study||30||
48195120|NCT02430532|100800232|FG001|NOT COMPLETED|Overall Study||28||
48195121|NCT03582956|100800233|FG000|STARTED|Overall Study||13||
48195122|NCT03582956|100800234|FG001|STARTED|Overall Study||7||
48195123|NCT03582956|100800235|FG002|STARTED|Overall Study||2||
48195124|NCT03582956|100800233|FG000|COMPLETED|Overall Study||13||
48195125|NCT03582956|100800234|FG001|COMPLETED|Overall Study||7||
48195126|NCT03582956|100800235|FG002|COMPLETED|Overall Study||2||
48195127|NCT03582956|100800233|FG000|NOT COMPLETED|Overall Study||0||
48195128|NCT03582956|100800234|FG001|NOT COMPLETED|Overall Study||0||
48195129|NCT03582956|100800235|FG002|NOT COMPLETED|Overall Study||0||
48195130|NCT01447914|100800236|FG000|STARTED|Overall Study||16||
48195131|NCT01447914|100800236|FG000|COMPLETED|Overall Study||16||
48195132|NCT01447914|100800236|FG000|NOT COMPLETED|Overall Study||0||
48195133|NCT01506362|100800237|FG000|STARTED|Overall Study||22||
48195134|NCT01506362|100800237|FG000|COMPLETED|Overall Study||16||
48481315|NCT00286754|101515561|FG001|NOT COMPLETED|Overall Study||18||
48481316|NCT00286754|101515562|FG002|NOT COMPLETED|Overall Study||10||
48195135|NCT01506362|100800237|FG000|NOT COMPLETED|Overall Study||6||
48195136|NCT00785772|100800238|FG000|STARTED|Overall Study||1||
48195137|NCT00785772|100800238|FG000|COMPLETED|Overall Study||1||
48195138|NCT00785772|100800238|FG000|NOT COMPLETED|Overall Study||0||
48195139|NCT03772964|100800239|FG000|STARTED|Overall Study||8||
48195140|NCT03772964|100800240|FG001|STARTED|Overall Study||8||
48195141|NCT03772964|100800241|FG002|STARTED|Overall Study||8||
48195142|NCT03772964|100800242|FG003|STARTED|Overall Study||8||
48195143|NCT03772964|100800239|FG000|COMPLETED|Overall Study||7||
48195144|NCT03772964|100800240|FG001|COMPLETED|Overall Study||8||
48195145|NCT03772964|100800241|FG002|COMPLETED|Overall Study||8||
48195146|NCT03772964|100800242|FG003|COMPLETED|Overall Study||8||
48195147|NCT03772964|100800239|FG000|NOT COMPLETED|Overall Study||1||
48195148|NCT03772964|100800240|FG001|NOT COMPLETED|Overall Study||0||
48481317|NCT00669942|101515563|FG000|STARTED|Part 1||6||
48481318|NCT00669942|101515564|FG001|STARTED|Part 1||6||
48481319|NCT00669942|101515565|FG002|STARTED|Part 1||6||
48481320|NCT00669942|101515566|FG003|STARTED|Part 1||6||
48481321|NCT00669942|101515567|FG004|STARTED|Part 1||8||
48481322|NCT00669942|101515568|FG005|STARTED|Part 1||0||
48481323|NCT00669942|101515569|FG006|STARTED|Part 1||0||
48481324|NCT00669942|101515570|FG007|STARTED|Part 1||0||
48481325|NCT00669942|101515571|FG008|STARTED|Part 1||0||
48481326|NCT00669942|101515572|FG009|STARTED|Part 1||0||
48481327|NCT00669942|101515573|FG010|STARTED|Part 1||0||
48481328|NCT00669942|101515574|FG011|STARTED|Part 1||0||
48481329|NCT00669942|101515563|FG000|COMPLETED|Part 1||6||
48481330|NCT00669942|101515564|FG001|COMPLETED|Part 1||6||
48481331|NCT00669942|101515565|FG002|COMPLETED|Part 1||6||
48481332|NCT00669942|101515566|FG003|COMPLETED|Part 1||6||
48481333|NCT00669942|101515567|FG004|COMPLETED|Part 1||8||
48481334|NCT00669942|101515568|FG005|COMPLETED|Part 1||0||
48481335|NCT00669942|101515569|FG006|COMPLETED|Part 1||0||
48481336|NCT00669942|101515570|FG007|COMPLETED|Part 1||0||
48481337|NCT00669942|101515571|FG008|COMPLETED|Part 1||0||
48481338|NCT00669942|101515572|FG009|COMPLETED|Part 1||0||
48481339|NCT00669942|101515573|FG010|COMPLETED|Part 1||0||
48481340|NCT00669942|101515574|FG011|COMPLETED|Part 1||0||
48481341|NCT00669942|101515563|FG000|NOT COMPLETED|Part 1||0||
48481342|NCT00669942|101515564|FG001|NOT COMPLETED|Part 1||0||
48481343|NCT00669942|101515565|FG002|NOT COMPLETED|Part 1||0||
48481344|NCT00669942|101515566|FG003|NOT COMPLETED|Part 1||0||
48481345|NCT00669942|101515567|FG004|NOT COMPLETED|Part 1||0||
48481346|NCT00669942|101515568|FG005|NOT COMPLETED|Part 1||0||
48481347|NCT00669942|101515569|FG006|NOT COMPLETED|Part 1||0||
48481348|NCT00669942|101515570|FG007|NOT COMPLETED|Part 1||0||
48481349|NCT00669942|101515571|FG008|NOT COMPLETED|Part 1||0||
48481350|NCT00669942|101515572|FG009|NOT COMPLETED|Part 1||0||
48481351|NCT00669942|101515573|FG010|NOT COMPLETED|Part 1||0||
48481352|NCT00669942|101515574|FG011|NOT COMPLETED|Part 1||0||
48481353|NCT00669942|101515563|FG000|STARTED|Parts 2 and 3||0||
48481354|NCT00669942|101515564|FG001|STARTED|Parts 2 and 3||0||
48481355|NCT00669942|101515565|FG002|STARTED|Parts 2 and 3||0||
48481356|NCT00669942|101515566|FG003|STARTED|Parts 2 and 3||0||
48481357|NCT00669942|101515567|FG004|STARTED|Parts 2 and 3||0||
48481358|NCT00669942|101515568|FG005|STARTED|Parts 2 and 3||6||
48195149|NCT03772964|100800241|FG002|NOT COMPLETED|Overall Study||0||
48195150|NCT03772964|100800242|FG003|NOT COMPLETED|Overall Study||0||
48195151|NCT01333514|100800243|FG000|STARTED|Overall Study||8||
48195152|NCT01333514|100800244|FG001|STARTED|Overall Study||6||
48195153|NCT01333514|100800243|FG000|COMPLETED|Overall Study||7|One subject refused to participate after enrolling because he was not allowed to snack in between meals.|
48195154|NCT01333514|100800244|FG001|COMPLETED|Overall Study||6|One subject refused to participate after enrolling because he was not allowed to snack in between meals.|
48195155|NCT01333514|100800243|FG000|NOT COMPLETED|Overall Study||1||
48195156|NCT01333514|100800244|FG001|NOT COMPLETED|Overall Study||0||
48195157|NCT04469218|100800245|FG000|STARTED|Overall Study||74||
48195158|NCT04469218|100800246|FG001|STARTED|Overall Study||74||
48195159|NCT04469218|100800245|FG000|COMPLETED|Overall Study||69||
48195160|NCT04469218|100800246|FG001|COMPLETED|Overall Study||70||
48195161|NCT04469218|100800245|FG000|NOT COMPLETED|Overall Study||5||
48195162|NCT04469218|100800246|FG001|NOT COMPLETED|Overall Study||4||
48195163|NCT03310983|100800247|FG000|STARTED|Overall Study||126||
48195164|NCT03310983|100800248|FG001|STARTED|Overall Study||128||
48195165|NCT03310983|100800247|FG000|COMPLETED|Overall Study||111||
48195166|NCT03310983|100800248|FG001|COMPLETED|Overall Study||111||
48195167|NCT03310983|100800247|FG000|NOT COMPLETED|Overall Study||15||
48195168|NCT03310983|100800248|FG001|NOT COMPLETED|Overall Study||17||
48195169|NCT01605136|100800249|FG000|STARTED|Study Period||48||
48195170|NCT01605136|100800250|FG001|STARTED|Study Period||45||
48195171|NCT01605136|100800249|FG000|COMPLETED|Study Period||45||
48195172|NCT01605136|100800250|FG001|COMPLETED|Study Period||42||
48195173|NCT01605136|100800249|FG000|NOT COMPLETED|Study Period||3||
48195174|NCT01605136|100800250|FG001|NOT COMPLETED|Study Period||3||
48481359|NCT00669942|101515569|FG006|STARTED|Parts 2 and 3||6||
48481360|NCT00669942|101515570|FG007|STARTED|Parts 2 and 3||26||
48481361|NCT00669942|101515571|FG008|STARTED|Parts 2 and 3||26||
48481362|NCT00669942|101515572|FG009|STARTED|Parts 2 and 3||0||
48481363|NCT00669942|101515573|FG010|STARTED|Parts 2 and 3||0||
48481364|NCT00669942|101515574|FG011|STARTED|Parts 2 and 3||0||
48481365|NCT00669942|101515563|FG000|COMPLETED|Parts 2 and 3||0||
48481366|NCT00669942|101515564|FG001|COMPLETED|Parts 2 and 3||0||
48481367|NCT00669942|101515565|FG002|COMPLETED|Parts 2 and 3||0||
48481368|NCT00669942|101515566|FG003|COMPLETED|Parts 2 and 3||0||
48481369|NCT00669942|101515567|FG004|COMPLETED|Parts 2 and 3||0||
48481370|NCT00669942|101515568|FG005|COMPLETED|Parts 2 and 3||4||
48481371|NCT00669942|101515569|FG006|COMPLETED|Parts 2 and 3||6||
48481372|NCT00669942|101515570|FG007|COMPLETED|Parts 2 and 3||24||
48481373|NCT00669942|101515571|FG008|COMPLETED|Parts 2 and 3||23||
48481374|NCT00669942|101515572|FG009|COMPLETED|Parts 2 and 3||0||
48481375|NCT00669942|101515573|FG010|COMPLETED|Parts 2 and 3||0||
48481376|NCT00669942|101515574|FG011|COMPLETED|Parts 2 and 3||0||
48481377|NCT00669942|101515563|FG000|NOT COMPLETED|Parts 2 and 3||0||
48481378|NCT00669942|101515564|FG001|NOT COMPLETED|Parts 2 and 3||0||
48481379|NCT00669942|101515565|FG002|NOT COMPLETED|Parts 2 and 3||0||
48481380|NCT00669942|101515566|FG003|NOT COMPLETED|Parts 2 and 3||0||
48481381|NCT00669942|101515567|FG004|NOT COMPLETED|Parts 2 and 3||0||
48481382|NCT00669942|101515568|FG005|NOT COMPLETED|Parts 2 and 3||2||
48481383|NCT00669942|101515569|FG006|NOT COMPLETED|Parts 2 and 3||0||
48481384|NCT00669942|101515570|FG007|NOT COMPLETED|Parts 2 and 3||2||
48481385|NCT00669942|101515571|FG008|NOT COMPLETED|Parts 2 and 3||3||
48481386|NCT00669942|101515572|FG009|NOT COMPLETED|Parts 2 and 3||0||
48481387|NCT00669942|101515573|FG010|NOT COMPLETED|Parts 2 and 3||0||
48481388|NCT00669942|101515574|FG011|NOT COMPLETED|Parts 2 and 3||0||
48481389|NCT00669942|101515563|FG000|STARTED|Healthy Volunteers||0||
48481390|NCT00669942|101515564|FG001|STARTED|Healthy Volunteers||0||
48481391|NCT00669942|101515565|FG002|STARTED|Healthy Volunteers||0||
48481392|NCT00669942|101515566|FG003|STARTED|Healthy Volunteers||0||
48481393|NCT00669942|101515567|FG004|STARTED|Healthy Volunteers||0||
48481394|NCT00669942|101515568|FG005|STARTED|Healthy Volunteers||0||
48481395|NCT00669942|101515569|FG006|STARTED|Healthy Volunteers||0||
48195175|NCT01605136|100800249|FG000|STARTED|Safety Follow-Up Period||45||
48195176|NCT01605136|100800250|FG001|STARTED|Safety Follow-Up Period||42||
48195177|NCT01605136|100800249|FG000|COMPLETED|Safety Follow-Up Period||44||
48195178|NCT01605136|100800250|FG001|COMPLETED|Safety Follow-Up Period||40||
48195179|NCT01605136|100800249|FG000|NOT COMPLETED|Safety Follow-Up Period||1||
48481396|NCT00669942|101515570|FG007|STARTED|Healthy Volunteers||0||
48481397|NCT00669942|101515571|FG008|STARTED|Healthy Volunteers||0||
48481398|NCT00669942|101515572|FG009|STARTED|Healthy Volunteers||3||
48481399|NCT00669942|101515573|FG010|STARTED|Healthy Volunteers||3||
48481400|NCT00669942|101515574|FG011|STARTED|Healthy Volunteers||2||
48481401|NCT00669942|101515563|FG000|COMPLETED|Healthy Volunteers||0||
48481402|NCT00669942|101515564|FG001|COMPLETED|Healthy Volunteers||0||
48481403|NCT00669942|101515565|FG002|COMPLETED|Healthy Volunteers||0||
48481404|NCT00669942|101515566|FG003|COMPLETED|Healthy Volunteers||0||
48195180|NCT01605136|100800250|FG001|NOT COMPLETED|Safety Follow-Up Period||2||
48195181|NCT00886613|100800251|FG000|STARTED|Overall Study||41||
48195182|NCT00886613|100800252|FG001|STARTED|Overall Study||39||
48195183|NCT00886613|100800253|FG002|STARTED|Overall Study||40||
48195184|NCT00886613|100800251|FG000|COMPLETED|Overall Study||39||
48195185|NCT00886613|100800252|FG001|COMPLETED|Overall Study||39||
48195186|NCT00886613|100800253|FG002|COMPLETED|Overall Study||37||
48195187|NCT00886613|100800251|FG000|NOT COMPLETED|Overall Study||2||
48195188|NCT00886613|100800252|FG001|NOT COMPLETED|Overall Study||0||
48195189|NCT00886613|100800253|FG002|NOT COMPLETED|Overall Study||3||
48195190|NCT02908620|100800254|FG000|STARTED|Overall Study||10||
48195191|NCT02908620|100800255|FG001|STARTED|Overall Study||10||
48195192|NCT02908620|100800256|FG002|STARTED|Overall Study||10||
48195193|NCT02908620|100800257|FG003|STARTED|Overall Study||10||
48195194|NCT02908620|100800254|FG000|COMPLETED|Overall Study||10||
48195195|NCT02908620|100800255|FG001|COMPLETED|Overall Study||10||
48195196|NCT02908620|100800256|FG002|COMPLETED|Overall Study||10||
48195197|NCT02908620|100800257|FG003|COMPLETED|Overall Study||10||
48195198|NCT02908620|100800254|FG000|NOT COMPLETED|Overall Study||0||
48195199|NCT02908620|100800255|FG001|NOT COMPLETED|Overall Study||0||
48195200|NCT02908620|100800256|FG002|NOT COMPLETED|Overall Study||0||
48195201|NCT02908620|100800257|FG003|NOT COMPLETED|Overall Study||0||
48195202|NCT03368001|100800258|FG000|STARTED|Allocation||144||
48195203|NCT03368001|100800259|FG001|STARTED|Allocation||146||
48195204|NCT03368001|100800258|FG000|COMPLETED|Allocation||120||
48195205|NCT03368001|100800259|FG001|COMPLETED|Allocation||112||
48195206|NCT03368001|100800258|FG000|NOT COMPLETED|Allocation||24||
48195207|NCT03368001|100800259|FG001|NOT COMPLETED|Allocation||34||
48195208|NCT03368001|100800258|FG000|STARTED|Posttest||114||
48195209|NCT03368001|100800259|FG001|STARTED|Posttest||93||
48195210|NCT03368001|100800258|FG000|COMPLETED|Posttest||101||
48195211|NCT03368001|100800259|FG001|COMPLETED|Posttest||63||
48195212|NCT03368001|100800258|FG000|NOT COMPLETED|Posttest||13||
48195213|NCT03368001|100800259|FG001|NOT COMPLETED|Posttest||30||
48195214|NCT03368001|100800258|FG000|STARTED|Follow-up||101||
48195215|NCT03368001|100800259|FG001|STARTED|Follow-up||63||
48195216|NCT03368001|100800258|FG000|COMPLETED|Follow-up||95||
48195217|NCT03368001|100800259|FG001|COMPLETED|Follow-up||60||
48195218|NCT03368001|100800258|FG000|NOT COMPLETED|Follow-up||6||
48195219|NCT03368001|100800259|FG001|NOT COMPLETED|Follow-up||3||
48195220|NCT03557333|100800260|FG000|STARTED|Overall Study||354||
48195221|NCT03557333|100800260|FG000|COMPLETED|Overall Study||262||
48195222|NCT03557333|100800260|FG000|NOT COMPLETED|Overall Study||92||
48195223|NCT04034121|100800261|FG000|STARTED|European Cohort||30||
48195224|NCT04034121|100800261|FG000|COMPLETED|European Cohort||30||
48195225|NCT04034121|100800261|FG000|NOT COMPLETED|European Cohort||0||
48195226|NCT04034121|100800261|FG000|STARTED|Brazil Cohort||20|20 patients enrolled in Brazil continued follow-up through 3 years|
48195227|NCT04034121|100800261|FG000|COMPLETED|Brazil Cohort||20||
48195228|NCT04034121|100800261|FG000|NOT COMPLETED|Brazil Cohort||0||
48195229|NCT02624778|100800262|FG000|STARTED|Overall Study||7||
48195230|NCT02624778|100800263|FG001|STARTED|Overall Study||7||
48195231|NCT02624778|100800264|FG002|STARTED|Overall Study||7||
48195232|NCT02624778|100800265|FG003|STARTED|Overall Study||4||
48195233|NCT02624778|100800266|FG004|STARTED|Overall Study||3||
48195234|NCT02624778|100800267|FG005|STARTED|Overall Study||10||
48195235|NCT02624778|100800268|FG006|STARTED|Overall Study||5||
48195236|NCT02624778|100800269|FG007|STARTED|Overall Study||8||
48195237|NCT02624778|100800270|FG008|STARTED|Overall Study||10||
48195238|NCT02624778|100800262|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7||
48195239|NCT02624778|100800263|FG001|Received at Least 1 Dose of Study Drug|Overall Study||7||
48195240|NCT02624778|100800264|FG002|Received at Least 1 Dose of Study Drug|Overall Study||7||
48195241|NCT02624778|100800265|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4||
48195242|NCT02624778|100800266|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3||
48195243|NCT02624778|100800267|FG005|Received at Least 1 Dose of Study Drug|Overall Study||10||
48195244|NCT02624778|100800268|FG006|Received at Least 1 Dose of Study Drug|Overall Study||5||
48195245|NCT02624778|100800269|FG007|Received at Least 1 Dose of Study Drug|Overall Study||8||
48195246|NCT02624778|100800270|FG008|Received at Least 1 Dose of Study Drug|Overall Study||10||
48195247|NCT02624778|100800262|FG000|COMPLETED|Overall Study||7||
48195248|NCT02624778|100800263|FG001|COMPLETED|Overall Study||6||
48481405|NCT00669942|101515567|FG004|COMPLETED|Healthy Volunteers||0||
48481406|NCT00669942|101515568|FG005|COMPLETED|Healthy Volunteers||0||
48195249|NCT02624778|100800264|FG002|COMPLETED|Overall Study||6||
48195250|NCT02624778|100800265|FG003|COMPLETED|Overall Study||4||
48195251|NCT02624778|100800266|FG004|COMPLETED|Overall Study||3||
48195252|NCT02624778|100800267|FG005|COMPLETED|Overall Study||9||
48195253|NCT02624778|100800268|FG006|COMPLETED|Overall Study||3||
48195254|NCT02624778|100800269|FG007|COMPLETED|Overall Study||4||
48195255|NCT02624778|100800270|FG008|COMPLETED|Overall Study||4||
48195256|NCT02624778|100800262|FG000|NOT COMPLETED|Overall Study||0||
48195257|NCT02624778|100800263|FG001|NOT COMPLETED|Overall Study||1||
48195258|NCT02624778|100800264|FG002|NOT COMPLETED|Overall Study||1||
48195259|NCT02624778|100800265|FG003|NOT COMPLETED|Overall Study||0||
48195260|NCT02624778|100800266|FG004|NOT COMPLETED|Overall Study||0||
48195261|NCT02624778|100800267|FG005|NOT COMPLETED|Overall Study||1||
48195262|NCT02624778|100800268|FG006|NOT COMPLETED|Overall Study||2||
48195263|NCT02624778|100800269|FG007|NOT COMPLETED|Overall Study||4||
48195264|NCT02624778|100800270|FG008|NOT COMPLETED|Overall Study||6||
48481407|NCT00669942|101515569|FG006|COMPLETED|Healthy Volunteers||0||
48481408|NCT00669942|101515570|FG007|COMPLETED|Healthy Volunteers||0||
48481409|NCT00669942|101515571|FG008|COMPLETED|Healthy Volunteers||0||
48481410|NCT00669942|101515572|FG009|COMPLETED|Healthy Volunteers||3||
48195265|NCT00926393|100800271|FG000|STARTED|Overall Study||69||
48481411|NCT00669942|101515573|FG010|COMPLETED|Healthy Volunteers||2||
48481412|NCT00669942|101515574|FG011|COMPLETED|Healthy Volunteers||2||
48481413|NCT00669942|101515563|FG000|NOT COMPLETED|Healthy Volunteers||0||
48481414|NCT00669942|101515564|FG001|NOT COMPLETED|Healthy Volunteers||0||
48481415|NCT00669942|101515565|FG002|NOT COMPLETED|Healthy Volunteers||0||
48481416|NCT00669942|101515566|FG003|NOT COMPLETED|Healthy Volunteers||0||
48481417|NCT00669942|101515567|FG004|NOT COMPLETED|Healthy Volunteers||0||
48481418|NCT00669942|101515568|FG005|NOT COMPLETED|Healthy Volunteers||0||
48481419|NCT00669942|101515569|FG006|NOT COMPLETED|Healthy Volunteers||0||
48481420|NCT00669942|101515570|FG007|NOT COMPLETED|Healthy Volunteers||0||
48481421|NCT00669942|101515571|FG008|NOT COMPLETED|Healthy Volunteers||0||
48481422|NCT00669942|101515572|FG009|NOT COMPLETED|Healthy Volunteers||0||
48481423|NCT00669942|101515573|FG010|NOT COMPLETED|Healthy Volunteers||1||
48481424|NCT00669942|101515574|FG011|NOT COMPLETED|Healthy Volunteers||0||
48481425|NCT01054586|101515575|FG000|STARTED|Overall Study||43||
48481426|NCT01054586|101515576|FG001|STARTED|Overall Study||15||
48481427|NCT01054586|101515577|FG002|STARTED|Overall Study||8||
48195266|NCT00926393|100800272|FG001|STARTED|Overall Study||70||
48481428|NCT01054586|101515578|FG003|STARTED|Overall Study||101||
48481429|NCT01054586|101515575|FG000|COMPLETED|Overall Study||43||
48481430|NCT01054586|101515576|FG001|COMPLETED|Overall Study||15||
48481431|NCT01054586|101515577|FG002|COMPLETED|Overall Study||8||
48481432|NCT01054586|101515578|FG003|COMPLETED|Overall Study||101||
48195267|NCT00926393|100800271|FG000|COMPLETED|Overall Study||67||
48481433|NCT01054586|101515575|FG000|NOT COMPLETED|Overall Study||0||
48481434|NCT01054586|101515576|FG001|NOT COMPLETED|Overall Study||0||
48481435|NCT01054586|101515577|FG002|NOT COMPLETED|Overall Study||0||
48481436|NCT01054586|101515578|FG003|NOT COMPLETED|Overall Study||0||
48481437|NCT01710657|101515579|FG000|STARTED|Overall Study||184||
48481438|NCT01710657|101515580|FG001|STARTED|Overall Study||183||
48481439|NCT01710657|101515581|FG002|STARTED|Overall Study||180||
48481440|NCT01710657|101515579|FG000|Titration Period (4 Weeks)|Overall Study||184||
48481441|NCT01710657|101515580|FG001|Titration Period (4 Weeks)|Overall Study||183||
48481442|NCT01710657|101515581|FG002|Titration Period (4 Weeks)|Overall Study||180||
48481443|NCT01710657|101515579|FG000|Maintenance Period (12 Weeks)|Overall Study||176||
48481444|NCT01710657|101515580|FG001|Maintenance Period (12 Weeks)|Overall Study||175||
48481445|NCT01710657|101515581|FG002|Maintenance Period (12 Weeks)|Overall Study||168||
48481446|NCT01710657|101515579|FG000|COMPLETED|Overall Study||166||
48195268|NCT00926393|100800272|FG001|COMPLETED|Overall Study||67||
48195269|NCT00926393|100800271|FG000|NOT COMPLETED|Overall Study||2||
48481447|NCT01710657|101515580|FG001|COMPLETED|Overall Study||171||
48481448|NCT01710657|101515581|FG002|COMPLETED|Overall Study||148||
48481449|NCT01710657|101515579|FG000|NOT COMPLETED|Overall Study||18||
48481450|NCT01710657|101515580|FG001|NOT COMPLETED|Overall Study||12||
48481451|NCT01710657|101515581|FG002|NOT COMPLETED|Overall Study||32||
48481452|NCT04314362|101515582|FG000|STARTED|Overall Study||21|The results with and without Hylo-Forte were to be combined if Hylo-Forte did not significantly impact safety or efficacy results. The groups were combined for presentation of the results as Hylo-Forte did not significantly impact the observed safety or efficacy results.|
48481453|NCT04314362|101515583|FG001|STARTED|Overall Study||11|The results with and without Hylo-Forte were to be combined if Hylo-Forte did not significantly impact safety or efficacy results. The groups were combined for presentation of the results as Hylo-Forte did not significantly impact the observed safety or efficacy results.|
48481454|NCT04314362|101515582|FG000|COMPLETED|Overall Study||12||
48481455|NCT04314362|101515583|FG001|COMPLETED|Overall Study||10||
48481456|NCT04314362|101515582|FG000|NOT COMPLETED|Overall Study||9||
48481457|NCT04314362|101515583|FG001|NOT COMPLETED|Overall Study||1||
48481458|NCT02373098|101515584|FG000|STARTED|Overall Study||66||
48481459|NCT02373098|101515585|FG001|STARTED|Overall Study||60||
48195270|NCT00926393|100800272|FG001|NOT COMPLETED|Overall Study||3||
48481460|NCT02373098|101515584|FG000|COMPLETED|Overall Study||54||
48481461|NCT02373098|101515585|FG001|COMPLETED|Overall Study||60||
48481462|NCT02373098|101515584|FG000|NOT COMPLETED|Overall Study||12||
48481463|NCT02373098|101515585|FG001|NOT COMPLETED|Overall Study||0||
48481464|NCT01993030|101515586|FG000|STARTED|Overall Study||36||
48195271|NCT02534896|100800273|FG000|STARTED|Overall Study||49||
48481465|NCT01993030|101515587|FG001|STARTED|Overall Study||35||
48481466|NCT01993030|101515586|FG000|COMPLETED|Overall Study||36||
48481467|NCT01993030|101515587|FG001|COMPLETED|Overall Study||31||
48481468|NCT01993030|101515586|FG000|NOT COMPLETED|Overall Study||0||
48481469|NCT01993030|101515587|FG001|NOT COMPLETED|Overall Study||4||
48481470|NCT03286465|101515588|FG000|STARTED|Overall Study||100||
48481471|NCT03286465|101515589|FG001|STARTED|Overall Study||100||
48481472|NCT03286465|101515588|FG000|COMPLETED|Overall Study||100||
48481473|NCT03286465|101515589|FG001|COMPLETED|Overall Study||100||
48481474|NCT03286465|101515588|FG000|NOT COMPLETED|Overall Study||0||
48481475|NCT03286465|101515589|FG001|NOT COMPLETED|Overall Study||0||
48481476|NCT02703948|101515590|FG000|STARTED|Overall Study||60||
48481477|NCT02703948|101515590|FG000|COMPLETED|Overall Study||57||
48481478|NCT02703948|101515590|FG000|NOT COMPLETED|Overall Study||3||
48481479|NCT02098876|101515591|FG000|STARTED|Overall Study||45||
48481480|NCT02098876|101515592|FG001|STARTED|Overall Study||41||
48481481|NCT02098876|101515591|FG000|COMPLETED|Overall Study||40||
48481482|NCT02098876|101515592|FG001|COMPLETED|Overall Study||36||
48481483|NCT02098876|101515591|FG000|NOT COMPLETED|Overall Study||5||
48481484|NCT02098876|101515592|FG001|NOT COMPLETED|Overall Study||5||
48481485|NCT01379222|101515593|FG000|STARTED|Overall Study||178||
48481486|NCT01379222|101515593|FG000|COMPLETED|Overall Study||105||
48481487|NCT01379222|101515593|FG000|NOT COMPLETED|Overall Study||73||
48481488|NCT04544787|101515594|FG000|STARTED|Overall Study||50||
48481489|NCT04544787|101515595|FG001|STARTED|Overall Study||50||
48481490|NCT04544787|101515596|FG002|STARTED|Overall Study||50||
48481491|NCT04544787|101515597|FG003|STARTED|Overall Study||50||
48481492|NCT04544787|101515598|FG004|STARTED|Overall Study||17||
48481493|NCT04544787|101515599|FG005|STARTED|Overall Study||16||
48481494|NCT04544787|101515600|FG006|STARTED|Overall Study||17||
48481495|NCT04544787|101515594|FG000|Received First Dose of Vaccine|Overall Study||50||
48481496|NCT04544787|101515595|FG001|Received First Dose of Vaccine|Overall Study||50||
48481497|NCT04544787|101515596|FG002|Received First Dose of Vaccine|Overall Study||50||
48481498|NCT04544787|101515597|FG003|Received First Dose of Vaccine|Overall Study||50||
48481499|NCT04544787|101515598|FG004|Received First Dose of Vaccine|Overall Study||17||
48481500|NCT04544787|101515599|FG005|Received First Dose of Vaccine|Overall Study||16||
48481501|NCT04544787|101515600|FG006|Received First Dose of Vaccine|Overall Study||17||
48481502|NCT04544787|101515594|FG000|Received Second Dose of Vaccine|Overall Study||0||
48481503|NCT04544787|101515595|FG001|Received Second Dose of Vaccine|Overall Study||49||
48481504|NCT04544787|101515596|FG002|Received Second Dose of Vaccine|Overall Study||0||
48481505|NCT04544787|101515597|FG003|Received Second Dose of Vaccine|Overall Study||49||
48481506|NCT04544787|101515598|FG004|Received Second Dose of Vaccine|Overall Study||17||
48481507|NCT04544787|101515599|FG005|Received Second Dose of Vaccine|Overall Study||15||
48481508|NCT04544787|101515600|FG006|Received Second Dose of Vaccine|Overall Study||16||
48481509|NCT04544787|101515594|FG000|COMPLETED|Overall Study||50|defined as completing the last study visit (Day 70)|
48481510|NCT04544787|101515595|FG001|COMPLETED|Overall Study||50|defined as completing the last study visit (Day 70)|
48481511|NCT04544787|101515596|FG002|COMPLETED|Overall Study||50|defined as completing the last study visit (Day 70)|
48481512|NCT04544787|101515597|FG003|COMPLETED|Overall Study||50|defined as completing the last study visit (Day 70)|
48666437|NCT02367456|101967582|FG002|STARTED|Overall Study||30||
48481513|NCT04544787|101515598|FG004|COMPLETED|Overall Study||17|defined as completing the last study visit (Day 70)|
48481514|NCT04544787|101515599|FG005|COMPLETED|Overall Study||16|defined as completing the last study visit (Day 70)|
48481515|NCT04544787|101515600|FG006|COMPLETED|Overall Study||17|defined as completing the last study visit (Day 70)|
48481516|NCT04544787|101515594|FG000|NOT COMPLETED|Overall Study||0||
48481517|NCT04544787|101515595|FG001|NOT COMPLETED|Overall Study||0||
48481518|NCT04544787|101515596|FG002|NOT COMPLETED|Overall Study||0||
48481519|NCT04544787|101515597|FG003|NOT COMPLETED|Overall Study||0||
48481520|NCT04544787|101515598|FG004|NOT COMPLETED|Overall Study||0||
48481521|NCT04544787|101515599|FG005|NOT COMPLETED|Overall Study||0||
48481522|NCT04544787|101515600|FG006|NOT COMPLETED|Overall Study||0||
48481523|NCT01565902|101515601|FG000|STARTED|Overall Study||8||
48481524|NCT01565902|101515602|FG001|STARTED|Overall Study||8||
48481525|NCT01565902|101515603|FG002|STARTED|Overall Study||8||
48481526|NCT01565902|101515604|FG003|STARTED|Overall Study||16||
48481527|NCT01565902|101515601|FG000|COMPLETED|Overall Study||8||
48481528|NCT01565902|101515602|FG001|COMPLETED|Overall Study||8||
48481529|NCT01565902|101515603|FG002|COMPLETED|Overall Study||8||
48481530|NCT01565902|101515604|FG003|COMPLETED|Overall Study||16||
48481531|NCT01565902|101515601|FG000|NOT COMPLETED|Overall Study||0||
48481532|NCT01565902|101515602|FG001|NOT COMPLETED|Overall Study||0||
48481533|NCT01565902|101515603|FG002|NOT COMPLETED|Overall Study||0||
48481534|NCT01565902|101515604|FG003|NOT COMPLETED|Overall Study||0||
48481535|NCT00453362|101515605|FG000|STARTED|Overall Study||88||
48481536|NCT00453362|101515605|FG000|Treated With Erlotinib|Overall Study||74||
48481537|NCT00453362|101515605|FG000|FDG-PET Evaluable|Overall Study||51||
48481538|NCT00453362|101515605|FG000|FLT-PET Evaluable|Overall Study||50||
48481539|NCT00453362|101515605|FG000|COMPLETED|Overall Study||1||
48481540|NCT00453362|101515605|FG000|NOT COMPLETED|Overall Study||87||
48481541|NCT03002077|101515606|FG000|STARTED|Overall Study||617||
48481542|NCT03002077|101515606|FG000|COMPLETED|Overall Study||179||
48481543|NCT03002077|101515606|FG000|NOT COMPLETED|Overall Study||438||
48481544|NCT02841033|101515607|FG000|STARTED|Overall Study||22||
48481545|NCT02841033|101515607|FG000|COMPLETED|Overall Study||22||
48481546|NCT02841033|101515607|FG000|NOT COMPLETED|Overall Study||0||
48481547|NCT02562378|101515608|FG000|STARTED|Overall Study||3||
48481548|NCT02562378|101515609|FG001|STARTED|Overall Study||3||
48481549|NCT02562378|101515610|FG002|STARTED|Overall Study||9||
48481550|NCT02562378|101515608|FG000|COMPLETED|Overall Study||3||
48481551|NCT02562378|101515609|FG001|COMPLETED|Overall Study||3||
48481552|NCT02562378|101515610|FG002|COMPLETED|Overall Study||9||
48481553|NCT02562378|101515608|FG000|NOT COMPLETED|Overall Study||0||
48481554|NCT02562378|101515609|FG001|NOT COMPLETED|Overall Study||0||
48481555|NCT02562378|101515610|FG002|NOT COMPLETED|Overall Study||0||
48481556|NCT03649841|101515611|FG000|STARTED|Overall Study||6||
48481557|NCT03649841|101515612|FG001|STARTED|Overall Study||4||
48481558|NCT03649841|101515611|FG000|COMPLETED|Overall Study||6||
48481559|NCT03649841|101515612|FG001|COMPLETED|Overall Study||4||
48481560|NCT03649841|101515611|FG000|NOT COMPLETED|Overall Study||0||
48481561|NCT03649841|101515612|FG001|NOT COMPLETED|Overall Study||0||
48481562|NCT02087514|101515613|FG000|STARTED|Overall Study||10||
48481563|NCT02087514|101515614|FG001|STARTED|Overall Study||10||
48481564|NCT02087514|101515615|FG002|STARTED|Overall Study||10||
48481565|NCT02087514|101515616|FG003|STARTED|Overall Study||10||
48481566|NCT02087514|101515617|FG004|STARTED|Overall Study||10||
48481567|NCT02087514|101515618|FG005|STARTED|Overall Study||10||
48481568|NCT02087514|101515613|FG000|COMPLETED|Overall Study||8||
48481569|NCT02087514|101515614|FG001|COMPLETED|Overall Study||10||
48481570|NCT02087514|101515615|FG002|COMPLETED|Overall Study||7||
48481571|NCT02087514|101515616|FG003|COMPLETED|Overall Study||8||
48481572|NCT02087514|101515617|FG004|COMPLETED|Overall Study||10||
48481573|NCT02087514|101515618|FG005|COMPLETED|Overall Study||9||
48481574|NCT02087514|101515613|FG000|NOT COMPLETED|Overall Study||2||
48481575|NCT02087514|101515614|FG001|NOT COMPLETED|Overall Study||0||
48481576|NCT02087514|101515615|FG002|NOT COMPLETED|Overall Study||3||
48481577|NCT02087514|101515616|FG003|NOT COMPLETED|Overall Study||2||
48481578|NCT02087514|101515617|FG004|NOT COMPLETED|Overall Study||0||
48195272|NCT02534896|100800274|FG001|STARTED|Overall Study||52||
48195273|NCT02534896|100800275|FG002|STARTED|Overall Study||49||
48195274|NCT02534896|100800273|FG000|COMPLETED|Overall Study||45||
48195275|NCT02534896|100800274|FG001|COMPLETED|Overall Study||51||
48481579|NCT02087514|101515618|FG005|NOT COMPLETED|Overall Study||1||
48481580|NCT00433147|101515619|FG000|STARTED|Overall Study||7||
48481581|NCT00433147|101515620|FG001|STARTED|Overall Study||7||
48481582|NCT00433147|101515621|FG002|STARTED|Overall Study||9||
48481583|NCT00433147|101515622|FG003|STARTED|Overall Study||7||
48481584|NCT00433147|101515619|FG000|Safety Population|Overall Study||7|All participants who received at least 1 dose of study drug.|
48481585|NCT00433147|101515620|FG001|Safety Population|Overall Study||7|All participants who received at least 1 dose of study drug.|
48481586|NCT00433147|101515621|FG002|Safety Population|Overall Study||9|All participants who received at least 1 dose of study drug.|
48195276|NCT02534896|100800275|FG002|COMPLETED|Overall Study||48||
48195277|NCT02534896|100800273|FG000|NOT COMPLETED|Overall Study||4||
48195278|NCT02534896|100800274|FG001|NOT COMPLETED|Overall Study||1||
48195279|NCT02534896|100800275|FG002|NOT COMPLETED|Overall Study||1||
48195280|NCT02540213|100800276|FG000|STARTED|Overall Study||240||
48195281|NCT02540213|100800276|FG000|COMPLETED|Overall Study||201||
48195282|NCT02540213|100800276|FG000|NOT COMPLETED|Overall Study||39||
48481587|NCT00433147|101515622|FG003|Safety Population|Overall Study||7|All participants who received at least 1 dose of study drug.|
48195283|NCT03201757|100800277|FG000|STARTED|Overall Study||523||
48666438|NCT02367456|101967580|FG000|COMPLETED|Overall Study||0||
48666439|NCT02367456|101967581|FG001|COMPLETED|Overall Study||0||
48195284|NCT03201757|100800277|FG000|COMPLETED|Overall Study||188||
48195285|NCT03201757|100800277|FG000|NOT COMPLETED|Overall Study||335||
48195286|NCT04454567|100800278|FG000|STARTED|Overall Study||1||
48195287|NCT04454567|100800279|FG001|STARTED|Overall Study||1||
48195288|NCT04454567|100800278|FG000|COMPLETED|Overall Study||0||
48195289|NCT04454567|100800279|FG001|COMPLETED|Overall Study||0||
48195290|NCT04454567|100800278|FG000|NOT COMPLETED|Overall Study||1||
48195291|NCT04454567|100800279|FG001|NOT COMPLETED|Overall Study||1||
48195292|NCT01823341|100800280|FG000|STARTED|Overall Study||97||
48195293|NCT01823341|100800280|FG000|COMPLETED|Overall Study||82||
48195294|NCT01823341|100800280|FG000|NOT COMPLETED|Overall Study||15||
48195295|NCT03158948|100800281|FG000|STARTED|Overall Study||13||
48195296|NCT03158948|100800282|FG001|STARTED|Overall Study||12||
48195297|NCT03158948|100800283|FG002|STARTED|Overall Study||12||
48195298|NCT03158948|100800284|FG003|STARTED|Overall Study||12||
48195299|NCT03158948|100800281|FG000|COMPLETED|Overall Study||12||
48195300|NCT03158948|100800282|FG001|COMPLETED|Overall Study||11||
48195301|NCT03158948|100800283|FG002|COMPLETED|Overall Study||9||
48195302|NCT03158948|100800284|FG003|COMPLETED|Overall Study||9||
48195303|NCT03158948|100800281|FG000|NOT COMPLETED|Overall Study||1||
48195304|NCT03158948|100800282|FG001|NOT COMPLETED|Overall Study||1||
48195305|NCT03158948|100800283|FG002|NOT COMPLETED|Overall Study||3||
48195306|NCT03158948|100800284|FG003|NOT COMPLETED|Overall Study||3||
48195307|NCT02933320|100800285|FG000|STARTED|Overall Study||13||
48195308|NCT02933320|100800286|FG001|STARTED|Overall Study||1||
48195309|NCT02933320|100800287|FG002|STARTED|Overall Study||0||
48195310|NCT02933320|100800288|FG003|STARTED|Overall Study||0||
48195311|NCT02933320|100800285|FG000|COMPLETED|Overall Study||13||
48195312|NCT02933320|100800286|FG001|COMPLETED|Overall Study||1||
48195313|NCT02933320|100800287|FG002|COMPLETED|Overall Study||0||
48195314|NCT02933320|100800288|FG003|COMPLETED|Overall Study||0||
48195315|NCT02933320|100800285|FG000|NOT COMPLETED|Overall Study||0||
48195316|NCT02933320|100800286|FG001|NOT COMPLETED|Overall Study||0||
48195317|NCT02933320|100800287|FG002|NOT COMPLETED|Overall Study||0||
48195318|NCT02933320|100800288|FG003|NOT COMPLETED|Overall Study||0||
48195319|NCT00864682|100800289|FG000|STARTED|Overall Study||52||
48195320|NCT00864682|100800290|FG001|STARTED|Overall Study||51||
48195321|NCT00864682|100800291|FG002|STARTED|Overall Study||53||
48195322|NCT00864682|100800289|FG000|COMPLETED|Overall Study||50||
48195323|NCT00864682|100800290|FG001|COMPLETED|Overall Study||50||
48195324|NCT00864682|100800291|FG002|COMPLETED|Overall Study||51||
48195325|NCT00864682|100800289|FG000|NOT COMPLETED|Overall Study||2||
48195326|NCT00864682|100800290|FG001|NOT COMPLETED|Overall Study||1||
48195327|NCT00864682|100800291|FG002|NOT COMPLETED|Overall Study||2||
48195328|NCT01391013|100800292|FG000|STARTED|Overall Study||15||
48195329|NCT01391013|100800293|FG001|STARTED|Overall Study||15||
48195330|NCT01391013|100800292|FG000|COMPLETED|Overall Study||15||
48481588|NCT00433147|101515619|FG000|PD Population|Overall Study||7|Participants in the Safety Population with a baseline and at least 1 post-baseline PD measurement.|
48481589|NCT00433147|101515620|FG001|PD Population|Overall Study||6|Participants in the Safety Population with a baseline and at least 1 post-baseline PD measurement.|
48481590|NCT00433147|101515621|FG002|PD Population|Overall Study||9|Participants in the Safety Population with a baseline and at least 1 post-baseline PD measurement.|
48481591|NCT00433147|101515622|FG003|PD Population|Overall Study||7|Participants in the Safety Population with a baseline and at least 1 post-baseline PD measurement.|
48481592|NCT00433147|101515619|FG000|Received at Least One Dose of Study Drug|Overall Study||7||
48481593|NCT00433147|101515620|FG001|Received at Least One Dose of Study Drug|Overall Study||7||
48481594|NCT00433147|101515621|FG002|Received at Least One Dose of Study Drug|Overall Study||9||
48481595|NCT00433147|101515622|FG003|Received at Least One Dose of Study Drug|Overall Study||7||
48481596|NCT00433147|101515619|FG000|COMPLETED|Overall Study||7||
48481597|NCT00433147|101515620|FG001|COMPLETED|Overall Study||6||
48481598|NCT00433147|101515621|FG002|COMPLETED|Overall Study||9||
48481599|NCT00433147|101515622|FG003|COMPLETED|Overall Study||7||
48481600|NCT00433147|101515619|FG000|NOT COMPLETED|Overall Study||0||
48195331|NCT01391013|100800293|FG001|COMPLETED|Overall Study||15||
48195332|NCT01391013|100800292|FG000|NOT COMPLETED|Overall Study||0||
48195333|NCT01391013|100800293|FG001|NOT COMPLETED|Overall Study||0||
48195334|NCT01311713|100800294|FG000|STARTED|Overall Study||3||
48195335|NCT01311713|100800295|FG001|STARTED|Overall Study||7||
48195336|NCT01311713|100800296|FG002|STARTED|Overall Study||9||
48195337|NCT01311713|100800297|FG003|STARTED|Overall Study||6||
48195338|NCT01311713|100800298|FG004|STARTED|Overall Study||5||
48195339|NCT01311713|100800299|FG005|STARTED|Overall Study||6||
48195340|NCT01311713|100800300|FG006|STARTED|Overall Study||9||
48195341|NCT01311713|100800294|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
48195342|NCT01311713|100800295|FG001|Received at Least 1 Dose of Study Drug|Overall Study||7||
48195343|NCT01311713|100800296|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8||
48195344|NCT01311713|100800297|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6||
48195345|NCT01311713|100800298|FG004|Received at Least 1 Dose of Study Drug|Overall Study||5||
48195346|NCT01311713|100800299|FG005|Received at Least 1 Dose of Study Drug|Overall Study||6||
48195347|NCT01311713|100800300|FG006|Received at Least 1 Dose of Study Drug|Overall Study||9||
48195348|NCT01311713|100800294|FG000|COMPLETED|Overall Study||0||
48195349|NCT01311713|100800295|FG001|COMPLETED|Overall Study||0||
48195350|NCT01311713|100800296|FG002|COMPLETED|Overall Study||0||
48195351|NCT01311713|100800297|FG003|COMPLETED|Overall Study||0||
48195352|NCT01311713|100800298|FG004|COMPLETED|Overall Study||0||
48195353|NCT01311713|100800299|FG005|COMPLETED|Overall Study||0||
48195354|NCT01311713|100800300|FG006|COMPLETED|Overall Study||0||
48195355|NCT01311713|100800294|FG000|NOT COMPLETED|Overall Study||3||
48195356|NCT01311713|100800295|FG001|NOT COMPLETED|Overall Study||7||
48195357|NCT01311713|100800296|FG002|NOT COMPLETED|Overall Study||9||
48195358|NCT01311713|100800297|FG003|NOT COMPLETED|Overall Study||6||
48195359|NCT01311713|100800298|FG004|NOT COMPLETED|Overall Study||5||
48195360|NCT01311713|100800299|FG005|NOT COMPLETED|Overall Study||6||
48195361|NCT01311713|100800300|FG006|NOT COMPLETED|Overall Study||9||
48195362|NCT02062827|100800301|FG000|STARTED|Overall Study||4||
48195363|NCT02062827|100800302|FG001|STARTED|Overall Study||1||
48195364|NCT02062827|100800303|FG002|STARTED|Overall Study||1||
48195365|NCT02062827|100800304|FG003|STARTED|Overall Study||2||
48195366|NCT02062827|100800305|FG004|STARTED|Overall Study||6||
48195367|NCT02062827|100800306|FG005|STARTED|Overall Study||1||
48195368|NCT02062827|100800307|FG006|STARTED|Overall Study||6||
48195369|NCT02062827|100800308|FG007|STARTED|Overall Study||8||
48195370|NCT02062827|100800301|FG000|COMPLETED|Overall Study||0||
48195371|NCT02062827|100800302|FG001|COMPLETED|Overall Study||0||
48195372|NCT02062827|100800303|FG002|COMPLETED|Overall Study||0||
48481601|NCT00433147|101515620|FG001|NOT COMPLETED|Overall Study||1||
48481602|NCT00433147|101515621|FG002|NOT COMPLETED|Overall Study||0||
48481603|NCT00433147|101515622|FG003|NOT COMPLETED|Overall Study||0||
48481604|NCT02231749|101515623|FG000|STARTED|Overall Study||550|Started = Randomized|
48481605|NCT02231749|101515624|FG001|STARTED|Overall Study||546|Started = Randomized|
48481606|NCT02231749|101515623|FG000|Received Treatment|Overall Study||547||
48481607|NCT02231749|101515624|FG001|Received Treatment|Overall Study||535||
48481608|NCT02231749|101515623|FG000|COMPLETED|Overall Study||128|Completed = Continuing in the Treatment Period|
48195373|NCT02062827|100800304|FG003|COMPLETED|Overall Study||0||
48195374|NCT02062827|100800305|FG004|COMPLETED|Overall Study||0||
48195375|NCT02062827|100800306|FG005|COMPLETED|Overall Study||1||
48195376|NCT02062827|100800307|FG006|COMPLETED|Overall Study||1||
48195377|NCT02062827|100800308|FG007|COMPLETED|Overall Study||0||
48195378|NCT02062827|100800301|FG000|NOT COMPLETED|Overall Study||4||
48195379|NCT02062827|100800302|FG001|NOT COMPLETED|Overall Study||1||
48195380|NCT02062827|100800303|FG002|NOT COMPLETED|Overall Study||1||
48195381|NCT02062827|100800304|FG003|NOT COMPLETED|Overall Study||2||
48195382|NCT02062827|100800305|FG004|NOT COMPLETED|Overall Study||6||
48195383|NCT02062827|100800306|FG005|NOT COMPLETED|Overall Study||0||
48195384|NCT02062827|100800307|FG006|NOT COMPLETED|Overall Study||5||
48195385|NCT02062827|100800308|FG007|NOT COMPLETED|Overall Study||8||
48195386|NCT04181632|100800309|FG000|STARTED|Overall Study||12||
48195387|NCT04181632|100800310|FG001|STARTED|Overall Study||9||
48195388|NCT04181632|100800311|FG002|STARTED|Overall Study||8||
48195389|NCT04181632|100800312|FG003|STARTED|Overall Study||11||
48195390|NCT04181632|100800309|FG000|COMPLETED|Overall Study||12||
48195391|NCT04181632|100800310|FG001|COMPLETED|Overall Study||9||
48195392|NCT04181632|100800311|FG002|COMPLETED|Overall Study||8||
48195393|NCT04181632|100800312|FG003|COMPLETED|Overall Study||11||
48195394|NCT04181632|100800309|FG000|NOT COMPLETED|Overall Study||0||
48195395|NCT04181632|100800310|FG001|NOT COMPLETED|Overall Study||0||
48195396|NCT04181632|100800311|FG002|NOT COMPLETED|Overall Study||0||
48195397|NCT04181632|100800312|FG003|NOT COMPLETED|Overall Study||0||
48481609|NCT02231749|101515624|FG001|COMPLETED|Overall Study||97|Completed = Continuing in the Treatment Period|
48481610|NCT02231749|101515623|FG000|NOT COMPLETED|Overall Study||422||
48195398|NCT03732820|100800313|FG000|STARTED|Overall Study||399||
48195399|NCT03732820|100800314|FG001|STARTED|Overall Study||397||
48195400|NCT03732820|100800313|FG000|COMPLETED|Overall Study||0||
48195401|NCT03732820|100800314|FG001|COMPLETED|Overall Study||0||
48195402|NCT03732820|100800313|FG000|NOT COMPLETED|Overall Study||399||
48195403|NCT03732820|100800314|FG001|NOT COMPLETED|Overall Study||397||
48195404|NCT01253824|100800315|FG000|STARTED|Overall Study||7||
48195405|NCT01253824|100800316|FG001|STARTED|Overall Study||7||
48195406|NCT01253824|100800315|FG000|COMPLETED|Overall Study||7||
48195407|NCT01253824|100800316|FG001|COMPLETED|Overall Study||7||
48195408|NCT01253824|100800315|FG000|NOT COMPLETED|Overall Study||0||
48195409|NCT01253824|100800316|FG001|NOT COMPLETED|Overall Study||0||
48195410|NCT00097253|100800317|FG000|STARTED|Lavender||56||
48481611|NCT02231749|101515624|FG001|NOT COMPLETED|Overall Study||449||
48195411|NCT00097253|100800317|FG000|COMPLETED|Lavender||56||
48195412|NCT00097253|100800317|FG000|NOT COMPLETED|Lavender||0||
48195413|NCT00097253|100800317|FG000|STARTED|Lemon||56||
48195414|NCT00097253|100800317|FG000|COMPLETED|Lemon||56||
48195415|NCT00097253|100800317|FG000|NOT COMPLETED|Lemon||0||
48195416|NCT00097253|100800317|FG000|STARTED|Water (Control)||56||
48195417|NCT00097253|100800317|FG000|COMPLETED|Water (Control)||56||
48195418|NCT00097253|100800317|FG000|NOT COMPLETED|Water (Control)||0||
48195419|NCT02735187|100800318|FG000|STARTED|Overall Study||25||
48195420|NCT02735187|100800319|FG001|STARTED|Overall Study||26||
48195421|NCT02735187|100800318|FG000|COMPLETED|Overall Study||21||
48195422|NCT02735187|100800319|FG001|COMPLETED|Overall Study||25||
48195423|NCT02735187|100800318|FG000|NOT COMPLETED|Overall Study||4||
48195424|NCT02735187|100800319|FG001|NOT COMPLETED|Overall Study||1||
48195425|NCT05419557|100800320|FG000|STARTED|Overall Study||22||
48195426|NCT05419557|100800321|FG001|STARTED|Overall Study||20||
48195427|NCT05419557|100800320|FG000|COMPLETED|Overall Study||11||
48195428|NCT05419557|100800321|FG001|COMPLETED|Overall Study||16||
48195429|NCT05419557|100800320|FG000|NOT COMPLETED|Overall Study||11||
48195430|NCT05419557|100800321|FG001|NOT COMPLETED|Overall Study||4||
48195431|NCT01119703|100800322|FG000|STARTED|Overall Study||30||
48195432|NCT01119703|100800323|FG001|STARTED|Overall Study||144||
48195433|NCT01119703|100800322|FG000|COMPLETED|Overall Study||30||
48195434|NCT01119703|100800323|FG001|COMPLETED|Overall Study||143||
48195435|NCT01119703|100800322|FG000|NOT COMPLETED|Overall Study||0||
48195436|NCT01119703|100800323|FG001|NOT COMPLETED|Overall Study||1||
48195437|NCT02952261|100800324|FG000|STARTED|Overall Study||100||
48195438|NCT02952261|100800325|FG001|STARTED|Overall Study||100||
48195439|NCT02952261|100800324|FG000|COMPLETED|Overall Study||95||
48195440|NCT02952261|100800325|FG001|COMPLETED|Overall Study||95||
48195441|NCT02952261|100800324|FG000|NOT COMPLETED|Overall Study||5||
48195442|NCT02952261|100800325|FG001|NOT COMPLETED|Overall Study||5||
48195443|NCT01843465|100800326|FG000|STARTED|Overall Study||34||
48195444|NCT01843465|100800326|FG000|COMPLETED|Overall Study||34||
48195445|NCT01843465|100800326|FG000|NOT COMPLETED|Overall Study||0||
48195446|NCT02781584|100800327|FG000|STARTED|Pre-treatment Phase||0||
48195447|NCT02781584|100800328|FG001|STARTED|Pre-treatment Phase||0||
48195448|NCT02781584|100800329|FG002|STARTED|Pre-treatment Phase||0||
48195449|NCT02781584|100800330|FG003|STARTED|Pre-treatment Phase||0||
48195450|NCT02781584|100800331|FG004|STARTED|Pre-treatment Phase||0||
48195451|NCT02781584|100800332|FG005|STARTED|Pre-treatment Phase||0||
48195452|NCT02781584|100800333|FG006|STARTED|Pre-treatment Phase||0||
48195453|NCT02781584|100800334|FG007|STARTED|Pre-treatment Phase||0||
48195454|NCT02781584|100800335|FG008|STARTED|Pre-treatment Phase||0||
48195455|NCT02781584|100800336|FG009|STARTED|Pre-treatment Phase||15||
48195456|NCT02781584|100800337|FG010|STARTED|Pre-treatment Phase||16||
48195457|NCT02781584|100800338|FG011|STARTED|Pre-treatment Phase||33||
48195458|NCT02781584|100800339|FG012|STARTED|Pre-treatment Phase||33||
48195459|NCT02781584|100800327|FG000|COMPLETED|Pre-treatment Phase||0||
48195460|NCT02781584|100800328|FG001|COMPLETED|Pre-treatment Phase||0||
48195461|NCT02781584|100800329|FG002|COMPLETED|Pre-treatment Phase||0||
48195462|NCT02781584|100800330|FG003|COMPLETED|Pre-treatment Phase||0||
48195463|NCT02781584|100800331|FG004|COMPLETED|Pre-treatment Phase||0||
48195464|NCT02781584|100800332|FG005|COMPLETED|Pre-treatment Phase||0||
48195465|NCT02781584|100800333|FG006|COMPLETED|Pre-treatment Phase||0||
48195466|NCT02781584|100800334|FG007|COMPLETED|Pre-treatment Phase||0||
48195467|NCT02781584|100800335|FG008|COMPLETED|Pre-treatment Phase||0||
48195468|NCT02781584|100800336|FG009|COMPLETED|Pre-treatment Phase||15||
48195469|NCT02781584|100800337|FG010|COMPLETED|Pre-treatment Phase||16||
48195470|NCT02781584|100800338|FG011|COMPLETED|Pre-treatment Phase||30||
48195471|NCT02781584|100800339|FG012|COMPLETED|Pre-treatment Phase||32||
48195472|NCT02781584|100800327|FG000|NOT COMPLETED|Pre-treatment Phase||0||
48195473|NCT02781584|100800328|FG001|NOT COMPLETED|Pre-treatment Phase||0||
48195474|NCT02781584|100800329|FG002|NOT COMPLETED|Pre-treatment Phase||0||
48195475|NCT02781584|100800330|FG003|NOT COMPLETED|Pre-treatment Phase||0||
48195476|NCT02781584|100800331|FG004|NOT COMPLETED|Pre-treatment Phase||0||
48195477|NCT02781584|100800332|FG005|NOT COMPLETED|Pre-treatment Phase||0||
48195478|NCT02781584|100800333|FG006|NOT COMPLETED|Pre-treatment Phase||0||
48195479|NCT02781584|100800334|FG007|NOT COMPLETED|Pre-treatment Phase||0||
48195480|NCT02781584|100800335|FG008|NOT COMPLETED|Pre-treatment Phase||0||
48195481|NCT02781584|100800336|FG009|NOT COMPLETED|Pre-treatment Phase||0||
48195482|NCT02781584|100800337|FG010|NOT COMPLETED|Pre-treatment Phase||0||
48195483|NCT02781584|100800338|FG011|NOT COMPLETED|Pre-treatment Phase||3||
48195484|NCT02781584|100800339|FG012|NOT COMPLETED|Pre-treatment Phase||1||
48195485|NCT02781584|100800327|FG000|STARTED|Treatment Phase||10||
48195486|NCT02781584|100800328|FG001|STARTED|Treatment Phase||10||
48195487|NCT02781584|100800329|FG002|STARTED|Treatment Phase||10||
48195488|NCT02781584|100800330|FG003|STARTED|Treatment Phase||20||
48195489|NCT02781584|100800331|FG004|STARTED|Treatment Phase||20||
48195490|NCT02781584|100800332|FG005|STARTED|Treatment Phase||20||
48195491|NCT02781584|100800333|FG006|STARTED|Treatment Phase||10||
48195492|NCT02781584|100800334|FG007|STARTED|Treatment Phase||10||
48195493|NCT02781584|100800335|FG008|STARTED|Treatment Phase||13||
48195494|NCT02781584|100800336|FG009|STARTED|Treatment Phase||15||
48195495|NCT02781584|100800337|FG010|STARTED|Treatment Phase||16||
48195496|NCT02781584|100800338|FG011|STARTED|Treatment Phase||30||
48195497|NCT02781584|100800339|FG012|STARTED|Treatment Phase||32||
48195498|NCT02781584|100800327|FG000|COMPLETED|Treatment Phase||10||
48195499|NCT02781584|100800328|FG001|COMPLETED|Treatment Phase||10||
48195500|NCT02781584|100800329|FG002|COMPLETED|Treatment Phase||10||
48195501|NCT02781584|100800330|FG003|COMPLETED|Treatment Phase||20||
48195502|NCT02781584|100800331|FG004|COMPLETED|Treatment Phase||20||
48195503|NCT02781584|100800332|FG005|COMPLETED|Treatment Phase||19||
48195504|NCT02781584|100800333|FG006|COMPLETED|Treatment Phase||10||
48195505|NCT02781584|100800334|FG007|COMPLETED|Treatment Phase||9||
48195506|NCT02781584|100800335|FG008|COMPLETED|Treatment Phase||13||
48195507|NCT02781584|100800336|FG009|COMPLETED|Treatment Phase||15||
48195508|NCT02781584|100800337|FG010|COMPLETED|Treatment Phase||15||
48195509|NCT02781584|100800338|FG011|COMPLETED|Treatment Phase||28||
48195510|NCT02781584|100800339|FG012|COMPLETED|Treatment Phase||32||
48195511|NCT02781584|100800327|FG000|NOT COMPLETED|Treatment Phase||0||
48195512|NCT02781584|100800328|FG001|NOT COMPLETED|Treatment Phase||0||
48195513|NCT02781584|100800329|FG002|NOT COMPLETED|Treatment Phase||0||
48195514|NCT02781584|100800330|FG003|NOT COMPLETED|Treatment Phase||0||
48195515|NCT02781584|100800331|FG004|NOT COMPLETED|Treatment Phase||0||
48195516|NCT02781584|100800332|FG005|NOT COMPLETED|Treatment Phase||1||
48195517|NCT02781584|100800333|FG006|NOT COMPLETED|Treatment Phase||0||
48195518|NCT02781584|100800334|FG007|NOT COMPLETED|Treatment Phase||1||
48195519|NCT02781584|100800335|FG008|NOT COMPLETED|Treatment Phase||0||
48195520|NCT02781584|100800336|FG009|NOT COMPLETED|Treatment Phase||0||
48195521|NCT02781584|100800337|FG010|NOT COMPLETED|Treatment Phase||1||
48195522|NCT02781584|100800338|FG011|NOT COMPLETED|Treatment Phase||2||
48195523|NCT02781584|100800339|FG012|NOT COMPLETED|Treatment Phase||0||
48195524|NCT01323660|100800340|FG000|STARTED|Treatment Period 1 (12 Weeks)||84||
48195525|NCT01323660|100800341|FG001|STARTED|Treatment Period 1 (12 Weeks)||22||
48195526|NCT01323660|100800342|FG002|STARTED|Treatment Period 1 (12 Weeks)||24||
48195527|NCT01323660|100800343|FG003|STARTED|Treatment Period 1 (12 Weeks)||36||
48195528|NCT01323660|100800344|FG004|STARTED|Treatment Period 1 (12 Weeks)||71||
48195529|NCT01323660|100800345|FG005|STARTED|Treatment Period 1 (12 Weeks)||70||
48195530|NCT01323660|100800340|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||65||
48195531|NCT01323660|100800341|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||21||
48481612|NCT03703791|101515625|FG000|STARTED|Overall Study||0||
48481613|NCT03703791|101515626|FG001|STARTED|Overall Study||1||
48481614|NCT03703791|101515625|FG000|COMPLETED|Overall Study||0||
48481615|NCT03703791|101515626|FG001|COMPLETED|Overall Study||0||
48481616|NCT03703791|101515625|FG000|NOT COMPLETED|Overall Study||0||
48481617|NCT03703791|101515626|FG001|NOT COMPLETED|Overall Study||1||
48481618|NCT00089661|101515627|FG000|STARTED|Overall Study||127||
48481619|NCT00089661|101515628|FG001|STARTED|Overall Study||125||
48481620|NCT00089661|101515627|FG000|COMPLETED|Overall Study||106||
48481621|NCT00089661|101515628|FG001|COMPLETED|Overall Study||99||
48195532|NCT01323660|100800342|FG002|COMPLETED|Treatment Period 1 (12 Weeks)||19||
48195533|NCT01323660|100800343|FG003|COMPLETED|Treatment Period 1 (12 Weeks)||31||
48195534|NCT01323660|100800344|FG004|COMPLETED|Treatment Period 1 (12 Weeks)||61||
48195535|NCT01323660|100800345|FG005|COMPLETED|Treatment Period 1 (12 Weeks)||61||
48481622|NCT00089661|101515627|FG000|NOT COMPLETED|Overall Study||21||
48481623|NCT00089661|101515628|FG001|NOT COMPLETED|Overall Study||26||
48481624|NCT01246076|101515629|FG000|STARTED|Overall Study||24||
48481625|NCT01246076|101515629|FG000|COMPLETED|Overall Study||24||
48481626|NCT01246076|101515629|FG000|NOT COMPLETED|Overall Study||0||
48481627|NCT02631772|101515630|FG000|STARTED|Overall Study||16||
48481628|NCT02631772|101515631|FG001|STARTED|Overall Study||16||
48481629|NCT02631772|101515630|FG000|COMPLETED|Overall Study||16||
48195536|NCT01323660|100800340|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||19||
48195537|NCT01323660|100800341|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||1||
48195538|NCT01323660|100800342|FG002|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5||
48195539|NCT01323660|100800343|FG003|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5||
48195540|NCT01323660|100800344|FG004|NOT COMPLETED|Treatment Period 1 (12 Weeks)||10||
48195541|NCT01323660|100800345|FG005|NOT COMPLETED|Treatment Period 1 (12 Weeks)||9||
48195542|NCT01323660|100800340|FG000|STARTED|Washout Period (14 Days)||65||
48195543|NCT01323660|100800341|FG001|STARTED|Washout Period (14 Days)||21||
48195544|NCT01323660|100800342|FG002|STARTED|Washout Period (14 Days)||19||
48195545|NCT01323660|100800343|FG003|STARTED|Washout Period (14 Days)||31||
48195546|NCT01323660|100800344|FG004|STARTED|Washout Period (14 Days)||61||
48195547|NCT01323660|100800345|FG005|STARTED|Washout Period (14 Days)||61||
48195548|NCT01323660|100800340|FG000|COMPLETED|Washout Period (14 Days)||65||
48195549|NCT01323660|100800341|FG001|COMPLETED|Washout Period (14 Days)||21||
48195550|NCT01323660|100800342|FG002|COMPLETED|Washout Period (14 Days)||18||
48195551|NCT01323660|100800343|FG003|COMPLETED|Washout Period (14 Days)||28||
48195552|NCT01323660|100800344|FG004|COMPLETED|Washout Period (14 Days)||58||
48481630|NCT02631772|101515631|FG001|COMPLETED|Overall Study||16||
48481631|NCT02631772|101515630|FG000|NOT COMPLETED|Overall Study||0||
48481632|NCT02631772|101515631|FG001|NOT COMPLETED|Overall Study||0||
48481633|NCT00520130|101515632|FG000|STARTED|Overall Study||44||
48481634|NCT00520130|101515633|FG001|STARTED|Overall Study||45||
48481635|NCT00520130|101515632|FG000|COMPLETED|Overall Study||39||
48481636|NCT00520130|101515633|FG001|COMPLETED|Overall Study||44||
48481637|NCT00520130|101515632|FG000|NOT COMPLETED|Overall Study||5||
48481638|NCT00520130|101515633|FG001|NOT COMPLETED|Overall Study||1||
48195553|NCT01323660|100800345|FG005|COMPLETED|Washout Period (14 Days)||59||
48195554|NCT01323660|100800340|FG000|NOT COMPLETED|Washout Period (14 Days)||0||
48481639|NCT01375660|101515634|FG000|STARTED|Overall Study||102||
48481640|NCT01375660|101515635|FG001|STARTED|Overall Study||103||
48481641|NCT01375660|101515634|FG000|COMPLETED|Overall Study||86||
48195555|NCT01323660|100800341|FG001|NOT COMPLETED|Washout Period (14 Days)||0||
48195556|NCT01323660|100800342|FG002|NOT COMPLETED|Washout Period (14 Days)||1||
48195557|NCT01323660|100800343|FG003|NOT COMPLETED|Washout Period (14 Days)||3||
48195558|NCT01323660|100800344|FG004|NOT COMPLETED|Washout Period (14 Days)||3||
48195559|NCT01323660|100800345|FG005|NOT COMPLETED|Washout Period (14 Days)||2||
48195560|NCT01323660|100800340|FG000|STARTED|Treatment Period 2 (12 Weeks)||67||
48195561|NCT01323660|100800341|FG001|STARTED|Treatment Period 2 (12 Weeks)||18||
48195562|NCT01323660|100800342|FG002|STARTED|Treatment Period 2 (12 Weeks)||17||
48195563|NCT01323660|100800343|FG003|STARTED|Treatment Period 2 (12 Weeks)||28||
48195564|NCT01323660|100800344|FG004|STARTED|Treatment Period 2 (12 Weeks)||59||
48195565|NCT01323660|100800345|FG005|STARTED|Treatment Period 2 (12 Weeks)||58||
48195566|NCT01323660|100800340|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||55||
48195567|NCT01323660|100800341|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||17||
48195568|NCT01323660|100800342|FG002|COMPLETED|Treatment Period 2 (12 Weeks)||14||
48195569|NCT01323660|100800343|FG003|COMPLETED|Treatment Period 2 (12 Weeks)||25||
48195570|NCT01323660|100800344|FG004|COMPLETED|Treatment Period 2 (12 Weeks)||55||
48195571|NCT01323660|100800345|FG005|COMPLETED|Treatment Period 2 (12 Weeks)||51||
48195572|NCT01323660|100800340|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||12||
48195573|NCT01323660|100800341|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1||
48195574|NCT01323660|100800342|FG002|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3||
48195575|NCT01323660|100800343|FG003|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3||
48481642|NCT01375660|101515635|FG001|COMPLETED|Overall Study||87||
48481643|NCT01375660|101515634|FG000|NOT COMPLETED|Overall Study||16||
48481644|NCT01375660|101515635|FG001|NOT COMPLETED|Overall Study||16||
48481645|NCT04627038|101515636|FG000|STARTED|Overall Study||135||
48481646|NCT04627038|101515637|FG001|STARTED|Overall Study||67||
48481647|NCT04627038|101515636|FG000|Received at Least One Dose of Study Drug|Overall Study||135||
48195576|NCT01323660|100800344|FG004|NOT COMPLETED|Treatment Period 2 (12 Weeks)||4||
48481648|NCT04627038|101515637|FG001|Received at Least One Dose of Study Drug|Overall Study||66||
48481649|NCT04627038|101515636|FG000|COMPLETED|Overall Study||81||
48195577|NCT01323660|100800345|FG005|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7||
48195578|NCT04133363|100800346|FG000|STARTED|Overall Study||10||
48195579|NCT04133363|100800347|FG001|STARTED|Overall Study||10||
48195580|NCT04133363|100800348|FG002|STARTED|Overall Study||10||
48195581|NCT04133363|100800346|FG000|COMPLETED|Overall Study||8||
48195582|NCT04133363|100800347|FG001|COMPLETED|Overall Study||9||
48481650|NCT04627038|101515637|FG001|COMPLETED|Overall Study||53||
48481651|NCT04627038|101515636|FG000|NOT COMPLETED|Overall Study||54||
48481652|NCT04627038|101515637|FG001|NOT COMPLETED|Overall Study||14||
48481653|NCT00274937|101515638|FG000|STARTED|Overall Study||111||
48481654|NCT00274937|101515638|FG000|COMPLETED|Overall Study||91||
48481655|NCT00274937|101515638|FG000|NOT COMPLETED|Overall Study||20||
48481656|NCT01882257|101515639|FG000|STARTED|Study Origination to Beginning Therapy||11||
48481657|NCT01882257|101515640|FG001|STARTED|Study Origination to Beginning Therapy||40||
48481658|NCT01882257|101515641|FG002|STARTED|Study Origination to Beginning Therapy||23||
48481659|NCT01882257|101515639|FG000|Started Therapy Using Device|Study Origination to Beginning Therapy||11||
48481660|NCT01882257|101515640|FG001|Started Therapy Using Device|Study Origination to Beginning Therapy||38||
48481661|NCT01882257|101515641|FG002|Started Therapy Using Device|Study Origination to Beginning Therapy||22||
48481662|NCT01882257|101515639|FG000|COMPLETED|Study Origination to Beginning Therapy||11|Month 0 Visit Attended|
48481663|NCT01882257|101515640|FG001|COMPLETED|Study Origination to Beginning Therapy||38|Month 0 Visit Attended|
48481664|NCT01882257|101515641|FG002|COMPLETED|Study Origination to Beginning Therapy||22|Month 0 Visit Attended|
48481665|NCT01882257|101515639|FG000|NOT COMPLETED|Study Origination to Beginning Therapy||0||
48481666|NCT01882257|101515640|FG001|NOT COMPLETED|Study Origination to Beginning Therapy||2||
48481667|NCT01882257|101515641|FG002|NOT COMPLETED|Study Origination to Beginning Therapy||1||
48481668|NCT01882257|101515639|FG000|STARTED|Therapy Portion of Study (12 Months)||11||
48481669|NCT01882257|101515640|FG001|STARTED|Therapy Portion of Study (12 Months)||38||
48481670|NCT01882257|101515641|FG002|STARTED|Therapy Portion of Study (12 Months)||22||
48481671|NCT01882257|101515639|FG000|COMPLETED|Therapy Portion of Study (12 Months)||11|Completed Study, Month 12 Final Visit|
48481672|NCT01882257|101515640|FG001|COMPLETED|Therapy Portion of Study (12 Months)||27|Completed Study, Month 12 Final Visit|
48481673|NCT01882257|101515641|FG002|COMPLETED|Therapy Portion of Study (12 Months)||18|Completed Study, Month 12 Final Visit|
48481674|NCT01882257|101515639|FG000|NOT COMPLETED|Therapy Portion of Study (12 Months)||0||
48481675|NCT01882257|101515640|FG001|NOT COMPLETED|Therapy Portion of Study (12 Months)||11||
48481676|NCT01882257|101515641|FG002|NOT COMPLETED|Therapy Portion of Study (12 Months)||4||
48481677|NCT01304641|101515642|FG000|STARTED|Overall Study||11470||
48481678|NCT01304641|101515643|FG001|STARTED|Overall Study||20132||
48481679|NCT01304641|101515642|FG000|COMPLETED|Overall Study||11470||
48481680|NCT01304641|101515643|FG001|COMPLETED|Overall Study||20132||
48481681|NCT01304641|101515642|FG000|NOT COMPLETED|Overall Study||0||
48481682|NCT01304641|101515643|FG001|NOT COMPLETED|Overall Study||0||
48481683|NCT02495467|101515644|FG000|STARTED|First Intervention (4 Weeks)||114||
48481684|NCT02495467|101515645|FG001|STARTED|First Intervention (4 Weeks)||118||
48481685|NCT02495467|101515644|FG000|COMPLETED|First Intervention (4 Weeks)||114||
48481686|NCT02495467|101515645|FG001|COMPLETED|First Intervention (4 Weeks)||118||
48481687|NCT02495467|101515644|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0||
48481688|NCT02495467|101515645|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0||
48481689|NCT02495467|101515644|FG000|STARTED|Washout (1 Week)||114||
48481690|NCT02495467|101515645|FG001|STARTED|Washout (1 Week)||118||
48481691|NCT02495467|101515644|FG000|COMPLETED|Washout (1 Week)||112||
48481692|NCT02495467|101515645|FG001|COMPLETED|Washout (1 Week)||116||
48481693|NCT02495467|101515644|FG000|NOT COMPLETED|Washout (1 Week)||2||
48481694|NCT02495467|101515645|FG001|NOT COMPLETED|Washout (1 Week)||2||
48481695|NCT02495467|101515644|FG000|STARTED|Second Intervention (4 Weeks)||112||
48481696|NCT02495467|101515645|FG001|STARTED|Second Intervention (4 Weeks)||116||
48481697|NCT02495467|101515644|FG000|COMPLETED|Second Intervention (4 Weeks)||112||
48481698|NCT02495467|101515645|FG001|COMPLETED|Second Intervention (4 Weeks)||113||
48481699|NCT02495467|101515644|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0||
48481700|NCT02495467|101515645|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||3||
48481701|NCT00251979|101515646|FG000|STARTED|Overall Study||375||
48481702|NCT00251979|101515647|FG001|STARTED|Overall Study||389||
48481703|NCT00251979|101515646|FG000|COMPLETED|Overall Study||337||
48481704|NCT00251979|101515647|FG001|COMPLETED|Overall Study||349||
48481705|NCT00251979|101515646|FG000|NOT COMPLETED|Overall Study||38||
48481706|NCT00251979|101515647|FG001|NOT COMPLETED|Overall Study||40||
48481707|NCT00783367|101515648|FG000|STARTED|Overall Study||27||
48481708|NCT00783367|101515649|FG001|STARTED|Overall Study||23||
48481709|NCT00783367|101515648|FG000|COMPLETED|Overall Study||27||
48481710|NCT00783367|101515649|FG001|COMPLETED|Overall Study||23||
48481711|NCT00783367|101515648|FG000|NOT COMPLETED|Overall Study||0||
48481712|NCT00783367|101515649|FG001|NOT COMPLETED|Overall Study||0||
48481713|NCT02458469|101515650|FG000|STARTED|First Intervention (2 Weeks)||3||
48481714|NCT02458469|101515651|FG001|STARTED|First Intervention (2 Weeks)||2||
48481715|NCT02458469|101515652|FG002|STARTED|First Intervention (2 Weeks)||3||
48481716|NCT02458469|101515653|FG003|STARTED|First Intervention (2 Weeks)||0||
48481717|NCT02458469|101515654|FG004|STARTED|First Intervention (2 Weeks)||1||
48481718|NCT02458469|101515655|FG005|STARTED|First Intervention (2 Weeks)||2||
48481719|NCT02458469|101515650|FG000|COMPLETED|First Intervention (2 Weeks)||2||
48481720|NCT02458469|101515651|FG001|COMPLETED|First Intervention (2 Weeks)||2||
48481721|NCT02458469|101515652|FG002|COMPLETED|First Intervention (2 Weeks)||2||
48481722|NCT02458469|101515653|FG003|COMPLETED|First Intervention (2 Weeks)||0||
48481723|NCT02458469|101515654|FG004|COMPLETED|First Intervention (2 Weeks)||1||
48481724|NCT02458469|101515655|FG005|COMPLETED|First Intervention (2 Weeks)||2||
48481725|NCT02458469|101515650|FG000|NOT COMPLETED|First Intervention (2 Weeks)||1||
48481726|NCT02458469|101515651|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0||
48481727|NCT02458469|101515652|FG002|NOT COMPLETED|First Intervention (2 Weeks)||1||
48481728|NCT02458469|101515653|FG003|NOT COMPLETED|First Intervention (2 Weeks)||0||
48481729|NCT02458469|101515654|FG004|NOT COMPLETED|First Intervention (2 Weeks)||0||
48481730|NCT02458469|101515655|FG005|NOT COMPLETED|First Intervention (2 Weeks)||0||
48481731|NCT02458469|101515650|FG000|STARTED|First Washout (2 Weeks)||2||
48481732|NCT02458469|101515651|FG001|STARTED|First Washout (2 Weeks)||2||
48481733|NCT02458469|101515652|FG002|STARTED|First Washout (2 Weeks)||2||
48481734|NCT02458469|101515653|FG003|STARTED|First Washout (2 Weeks)||0||
48481735|NCT02458469|101515654|FG004|STARTED|First Washout (2 Weeks)||1||
48481736|NCT02458469|101515655|FG005|STARTED|First Washout (2 Weeks)||2||
48481737|NCT02458469|101515650|FG000|COMPLETED|First Washout (2 Weeks)||2||
48481738|NCT02458469|101515651|FG001|COMPLETED|First Washout (2 Weeks)||2||
48481739|NCT02458469|101515652|FG002|COMPLETED|First Washout (2 Weeks)||2||
48481740|NCT02458469|101515653|FG003|COMPLETED|First Washout (2 Weeks)||0||
48481741|NCT02458469|101515654|FG004|COMPLETED|First Washout (2 Weeks)||1||
48481742|NCT02458469|101515655|FG005|COMPLETED|First Washout (2 Weeks)||2||
48481743|NCT02458469|101515650|FG000|NOT COMPLETED|First Washout (2 Weeks)||0||
48481744|NCT02458469|101515651|FG001|NOT COMPLETED|First Washout (2 Weeks)||0||
48481745|NCT02458469|101515652|FG002|NOT COMPLETED|First Washout (2 Weeks)||0||
48481746|NCT02458469|101515653|FG003|NOT COMPLETED|First Washout (2 Weeks)||0||
48481747|NCT02458469|101515654|FG004|NOT COMPLETED|First Washout (2 Weeks)||0||
48481748|NCT02458469|101515655|FG005|NOT COMPLETED|First Washout (2 Weeks)||0||
48481749|NCT02458469|101515650|FG000|STARTED|Second Intervention (2 Weeks)||2||
48481750|NCT02458469|101515651|FG001|STARTED|Second Intervention (2 Weeks)||2||
48481751|NCT02458469|101515652|FG002|STARTED|Second Intervention (2 Weeks)||2||
48481752|NCT02458469|101515653|FG003|STARTED|Second Intervention (2 Weeks)||0||
48481753|NCT02458469|101515654|FG004|STARTED|Second Intervention (2 Weeks)||1||
48481754|NCT02458469|101515655|FG005|STARTED|Second Intervention (2 Weeks)||2||
48481755|NCT02458469|101515650|FG000|COMPLETED|Second Intervention (2 Weeks)||2||
48481756|NCT02458469|101515651|FG001|COMPLETED|Second Intervention (2 Weeks)||2||
48481757|NCT02458469|101515652|FG002|COMPLETED|Second Intervention (2 Weeks)||2||
48481758|NCT02458469|101515653|FG003|COMPLETED|Second Intervention (2 Weeks)||0||
48481759|NCT02458469|101515654|FG004|COMPLETED|Second Intervention (2 Weeks)||1||
48481760|NCT02458469|101515655|FG005|COMPLETED|Second Intervention (2 Weeks)||1||
48481761|NCT02458469|101515650|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48481762|NCT02458469|101515651|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48481763|NCT02458469|101515652|FG002|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48481764|NCT02458469|101515653|FG003|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48481765|NCT02458469|101515654|FG004|NOT COMPLETED|Second Intervention (2 Weeks)||0||
48481766|NCT02458469|101515655|FG005|NOT COMPLETED|Second Intervention (2 Weeks)||1||
48481767|NCT02458469|101515650|FG000|STARTED|Second Washout (2 Weeks)||2||
48481768|NCT02458469|101515651|FG001|STARTED|Second Washout (2 Weeks)||2||
48481769|NCT02458469|101515652|FG002|STARTED|Second Washout (2 Weeks)||2||
48481770|NCT02458469|101515653|FG003|STARTED|Second Washout (2 Weeks)||0||
48481771|NCT02458469|101515654|FG004|STARTED|Second Washout (2 Weeks)||1||
48481772|NCT02458469|101515655|FG005|STARTED|Second Washout (2 Weeks)||1||
48481773|NCT02458469|101515650|FG000|COMPLETED|Second Washout (2 Weeks)||2||
48481774|NCT02458469|101515651|FG001|COMPLETED|Second Washout (2 Weeks)||2||
48481775|NCT02458469|101515652|FG002|COMPLETED|Second Washout (2 Weeks)||2||
48481776|NCT02458469|101515653|FG003|COMPLETED|Second Washout (2 Weeks)||0||
48481777|NCT02458469|101515654|FG004|COMPLETED|Second Washout (2 Weeks)||1||
48481778|NCT02458469|101515655|FG005|COMPLETED|Second Washout (2 Weeks)||1||
48481779|NCT02458469|101515650|FG000|NOT COMPLETED|Second Washout (2 Weeks)||0||
48481780|NCT02458469|101515651|FG001|NOT COMPLETED|Second Washout (2 Weeks)||0||
48481781|NCT02458469|101515652|FG002|NOT COMPLETED|Second Washout (2 Weeks)||0||
48481782|NCT02458469|101515653|FG003|NOT COMPLETED|Second Washout (2 Weeks)||0||
48481783|NCT02458469|101515654|FG004|NOT COMPLETED|Second Washout (2 Weeks)||0||
48481784|NCT02458469|101515655|FG005|NOT COMPLETED|Second Washout (2 Weeks)||0||
48481785|NCT02458469|101515650|FG000|STARTED|Third Intervention (2 Weeks)||2||
48481786|NCT02458469|101515651|FG001|STARTED|Third Intervention (2 Weeks)||2||
48481787|NCT02458469|101515652|FG002|STARTED|Third Intervention (2 Weeks)||2||
48481788|NCT02458469|101515653|FG003|STARTED|Third Intervention (2 Weeks)||0||
48481789|NCT02458469|101515654|FG004|STARTED|Third Intervention (2 Weeks)||1||
48481790|NCT02458469|101515655|FG005|STARTED|Third Intervention (2 Weeks)||1||
48481791|NCT02458469|101515650|FG000|COMPLETED|Third Intervention (2 Weeks)||2||
48481792|NCT02458469|101515651|FG001|COMPLETED|Third Intervention (2 Weeks)||2||
48481793|NCT02458469|101515652|FG002|COMPLETED|Third Intervention (2 Weeks)||2||
48481794|NCT02458469|101515653|FG003|COMPLETED|Third Intervention (2 Weeks)||0||
48481795|NCT02458469|101515654|FG004|COMPLETED|Third Intervention (2 Weeks)||1||
48481796|NCT02458469|101515655|FG005|COMPLETED|Third Intervention (2 Weeks)||1||
48481797|NCT02458469|101515650|FG000|NOT COMPLETED|Third Intervention (2 Weeks)||0||
48481798|NCT02458469|101515651|FG001|NOT COMPLETED|Third Intervention (2 Weeks)||0||
48481799|NCT02458469|101515652|FG002|NOT COMPLETED|Third Intervention (2 Weeks)||0||
48481800|NCT02458469|101515653|FG003|NOT COMPLETED|Third Intervention (2 Weeks)||0||
48481801|NCT02458469|101515654|FG004|NOT COMPLETED|Third Intervention (2 Weeks)||0||
48481802|NCT02458469|101515655|FG005|NOT COMPLETED|Third Intervention (2 Weeks)||0||
48481803|NCT02057458|101515656|FG000|STARTED|Recruited for Participation||8||
48481804|NCT02057458|101515657|FG001|STARTED|Recruited for Participation||8||
48481805|NCT02057458|101515658|FG002|STARTED|Recruited for Participation||3||
48481806|NCT02057458|101515656|FG000|COMPLETED|Recruited for Participation||8||
48481807|NCT02057458|101515657|FG001|COMPLETED|Recruited for Participation||8||
48481808|NCT02057458|101515658|FG002|COMPLETED|Recruited for Participation||3||
48481809|NCT02057458|101515656|FG000|NOT COMPLETED|Recruited for Participation||0||
48481810|NCT02057458|101515657|FG001|NOT COMPLETED|Recruited for Participation||0||
48481811|NCT02057458|101515658|FG002|NOT COMPLETED|Recruited for Participation||0||
48481812|NCT02057458|101515656|FG000|STARTED|Met Inclusion Criteria||8||
48481813|NCT02057458|101515657|FG001|STARTED|Met Inclusion Criteria||8||
48481814|NCT02057458|101515658|FG002|STARTED|Met Inclusion Criteria||3||
48481815|NCT02057458|101515656|FG000|COMPLETED|Met Inclusion Criteria||8||
48481816|NCT02057458|101515657|FG001|COMPLETED|Met Inclusion Criteria||7||
48481817|NCT02057458|101515658|FG002|COMPLETED|Met Inclusion Criteria||3||
48481818|NCT02057458|101515656|FG000|NOT COMPLETED|Met Inclusion Criteria||0||
48481819|NCT02057458|101515657|FG001|NOT COMPLETED|Met Inclusion Criteria||1||
48481820|NCT02057458|101515658|FG002|NOT COMPLETED|Met Inclusion Criteria||0||
48481821|NCT02057458|101515656|FG000|STARTED|Acute Study (1 Hour): First Intervention||8||
48481822|NCT02057458|101515657|FG001|STARTED|Acute Study (1 Hour): First Intervention||7||
48481823|NCT02057458|101515658|FG002|STARTED|Acute Study (1 Hour): First Intervention||0||
48481824|NCT02057458|101515656|FG000|COMPLETED|Acute Study (1 Hour): First Intervention||6||
48481825|NCT02057458|101515657|FG001|COMPLETED|Acute Study (1 Hour): First Intervention||7||
48481826|NCT02057458|101515658|FG002|COMPLETED|Acute Study (1 Hour): First Intervention||0||
48481827|NCT02057458|101515656|FG000|NOT COMPLETED|Acute Study (1 Hour): First Intervention||2||
48481828|NCT02057458|101515657|FG001|NOT COMPLETED|Acute Study (1 Hour): First Intervention||0||
48481829|NCT02057458|101515658|FG002|NOT COMPLETED|Acute Study (1 Hour): First Intervention||0||
48481830|NCT02057458|101515656|FG000|STARTED|Acute Study (1 Hour): Second Int.||6||
48481831|NCT02057458|101515657|FG001|STARTED|Acute Study (1 Hour): Second Int.||7||
48481832|NCT02057458|101515658|FG002|STARTED|Acute Study (1 Hour): Second Int.||0||
48481833|NCT02057458|101515656|FG000|COMPLETED|Acute Study (1 Hour): Second Int.||6||
48481834|NCT02057458|101515657|FG001|COMPLETED|Acute Study (1 Hour): Second Int.||7||
48481835|NCT02057458|101515658|FG002|COMPLETED|Acute Study (1 Hour): Second Int.||0||
48481836|NCT02057458|101515656|FG000|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0||
48481837|NCT02057458|101515657|FG001|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0||
48481838|NCT02057458|101515658|FG002|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0||
48481839|NCT02057458|101515656|FG000|STARTED|Sub-Chronic Study (4 Weeks)||6||
48481840|NCT02057458|101515657|FG001|STARTED|Sub-Chronic Study (4 Weeks)||7||
48481841|NCT02057458|101515658|FG002|STARTED|Sub-Chronic Study (4 Weeks)||3||
48481842|NCT02057458|101515656|FG000|COMPLETED|Sub-Chronic Study (4 Weeks)||5||
48481843|NCT02057458|101515657|FG001|COMPLETED|Sub-Chronic Study (4 Weeks)||7||
48481844|NCT02057458|101515658|FG002|COMPLETED|Sub-Chronic Study (4 Weeks)||3||
48481845|NCT02057458|101515656|FG000|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||1||
48481846|NCT02057458|101515657|FG001|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||0||
48481847|NCT02057458|101515658|FG002|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||0||
48481848|NCT00794963|101515659|FG000|STARTED|Overall Study||4||
48481849|NCT00794963|101515660|FG001|STARTED|Overall Study||4||
48481850|NCT00794963|101515659|FG000|COMPLETED|Overall Study||3||
48481851|NCT00794963|101515660|FG001|COMPLETED|Overall Study||0||
48481852|NCT00794963|101515659|FG000|NOT COMPLETED|Overall Study||1||
48481853|NCT00794963|101515660|FG001|NOT COMPLETED|Overall Study||4||
48481854|NCT01499147|101515661|FG000|STARTED|Overall Study||33||
48481855|NCT01499147|101515662|FG001|STARTED|Overall Study||17||
48481856|NCT01499147|101515661|FG000|COMPLETED|Overall Study||18||
48481857|NCT01499147|101515662|FG001|COMPLETED|Overall Study||12||
48481858|NCT01499147|101515661|FG000|NOT COMPLETED|Overall Study||15||
48481859|NCT01499147|101515662|FG001|NOT COMPLETED|Overall Study||5||
48481860|NCT03041025|101515663|FG000|STARTED|Overall Study||8||
48481861|NCT03041025|101515664|FG001|STARTED|Overall Study||3||
48481862|NCT03041025|101515665|FG002|STARTED|Overall Study||24||
48481863|NCT03041025|101515663|FG000|COMPLETED|Overall Study||7||
48481864|NCT03041025|101515664|FG001|COMPLETED|Overall Study||3||
48481865|NCT03041025|101515665|FG002|COMPLETED|Overall Study||22||
48481866|NCT03041025|101515663|FG000|NOT COMPLETED|Overall Study||1||
48481867|NCT03041025|101515664|FG001|NOT COMPLETED|Overall Study||0||
48481868|NCT03041025|101515665|FG002|NOT COMPLETED|Overall Study||2||
48481869|NCT00396279|101515666|FG000|STARTED|Overall Study||37||
48481870|NCT00396279|101515666|FG000|COMPLETED|Overall Study||7||
48481871|NCT00396279|101515666|FG000|NOT COMPLETED|Overall Study||30||
48481872|NCT01313273|101515667|FG000|STARTED|Overall Study||2||
48481873|NCT01313273|101515668|FG001|STARTED|Overall Study||1||
48481874|NCT01313273|101515667|FG000|COMPLETED|Overall Study||0||
48481875|NCT01313273|101515668|FG001|COMPLETED|Overall Study||0||
48481876|NCT01313273|101515667|FG000|NOT COMPLETED|Overall Study||2||
48481877|NCT01313273|101515668|FG001|NOT COMPLETED|Overall Study||1||
48481878|NCT01108094|101515669|FG000|STARTED|Overall Study||12||
48481879|NCT01108094|101515670|FG001|STARTED|Overall Study||3||
48481880|NCT01108094|101515671|FG002|STARTED|Overall Study||4||
48481881|NCT01108094|101515672|FG003|STARTED|Overall Study||10||
48481882|NCT01108094|101515669|FG000|COMPLETED|Overall Study||9||
48481883|NCT01108094|101515670|FG001|COMPLETED|Overall Study||3||
48481884|NCT01108094|101515671|FG002|COMPLETED|Overall Study||4||
48481885|NCT01108094|101515672|FG003|COMPLETED|Overall Study||10||
48481886|NCT01108094|101515669|FG000|NOT COMPLETED|Overall Study||3||
48481887|NCT01108094|101515670|FG001|NOT COMPLETED|Overall Study||0||
48481888|NCT01108094|101515671|FG002|NOT COMPLETED|Overall Study||0||
48481889|NCT01108094|101515672|FG003|NOT COMPLETED|Overall Study||0||
48481890|NCT00424047|101515673|FG000|STARTED|Blinded Treatment (Up to 03 Aug 2005)||176||
48481891|NCT00424047|101515674|FG001|STARTED|Blinded Treatment (Up to 03 Aug 2005)||175||
48481892|NCT00424047|101515673|FG000|Safety Population|Blinded Treatment (Up to 03 Aug 2005)||176||
48481893|NCT00424047|101515674|FG001|Safety Population|Blinded Treatment (Up to 03 Aug 2005)||175||
48481894|NCT00424047|101515673|FG000|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)||175||
48481895|NCT00424047|101515674|FG001|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)||171||
48481896|NCT00424047|101515673|FG000|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||54||
48481897|NCT00424047|101515674|FG001|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||19||
48481898|NCT00424047|101515673|FG000|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||122||
48481899|NCT00424047|101515674|FG001|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||156||
48481900|NCT00424047|101515673|FG000|STARTED|On Study at Time of Unblinding||176||
48481901|NCT00424047|101515674|FG001|STARTED|On Study at Time of Unblinding||175||
48481902|NCT00424047|101515673|FG000|COMPLETED|On Study at Time of Unblinding||21||
48481903|NCT00424047|101515674|FG001|COMPLETED|On Study at Time of Unblinding||8||
48481904|NCT00424047|101515673|FG000|NOT COMPLETED|On Study at Time of Unblinding||155||
48481905|NCT00424047|101515674|FG001|NOT COMPLETED|On Study at Time of Unblinding||167||
48481906|NCT00424047|101515673|FG000|STARTED|Long Term Extension (Up to 25 Jun 2013)||21||
48481907|NCT00424047|101515674|FG001|STARTED|Long Term Extension (Up to 25 Jun 2013)||8||
48481908|NCT00424047|101515673|FG000|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0||
48481909|NCT00424047|101515674|FG001|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0||
48481910|NCT00424047|101515673|FG000|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||21||
48481911|NCT00424047|101515674|FG001|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||8||
48481912|NCT00717405|101515675|FG000|STARTED|Overall Study||52||
48481913|NCT00717405|101515675|FG000|COMPLETED|Overall Study||52||
48481914|NCT00717405|101515675|FG000|NOT COMPLETED|Overall Study||0||
48481915|NCT02331394|101515676|FG000|STARTED|Overall Study||15|In the absence of prior data to guide formal power calculations, a sample size of 15 was chosen.|
48481916|NCT02331394|101515676|FG000|COMPLETED|Overall Study||14||
48481917|NCT02331394|101515676|FG000|NOT COMPLETED|Overall Study||1||
48481918|NCT04060147|101515677|FG000|STARTED|Overall Study||11||
48481919|NCT04060147|101515677|FG000|COMPLETED|Overall Study||10||
48481920|NCT04060147|101515677|FG000|NOT COMPLETED|Overall Study||1||
48481921|NCT04503174|101515678|FG000|STARTED|Overall Study||3061||
48481922|NCT04503174|101515678|FG000|COMPLETED|Overall Study||2998||
48481923|NCT04503174|101515678|FG000|NOT COMPLETED|Overall Study||63||
48481924|NCT00076622|101515679|FG000|STARTED|Overall Study||23||
48481925|NCT00076622|101515680|FG001|STARTED|Overall Study||13||
48481926|NCT00076622|101515681|FG002|STARTED|Overall Study||40||
48481927|NCT00076622|101515682|FG003|STARTED|Overall Study||18||
48195583|NCT04133363|100800348|FG002|COMPLETED|Overall Study||6||
48481928|NCT00076622|101515679|FG000|COMPLETED|Overall Study||23||
48481929|NCT00076622|101515680|FG001|COMPLETED|Overall Study||13||
48481930|NCT00076622|101515681|FG002|COMPLETED|Overall Study||40||
48481931|NCT00076622|101515682|FG003|COMPLETED|Overall Study||18||
48481932|NCT00076622|101515679|FG000|NOT COMPLETED|Overall Study||0||
48481933|NCT00076622|101515680|FG001|NOT COMPLETED|Overall Study||0||
48481934|NCT00076622|101515681|FG002|NOT COMPLETED|Overall Study||0||
48481935|NCT00076622|101515682|FG003|NOT COMPLETED|Overall Study||0||
48481936|NCT00496964|101515683|FG000|STARTED|Overall Study||1||
48481937|NCT00496964|101515684|FG001|STARTED|Overall Study||4||
48481938|NCT00496964|101515683|FG000|COMPLETED|Overall Study||1||
48481939|NCT00496964|101515684|FG001|COMPLETED|Overall Study||3||
48481940|NCT00496964|101515683|FG000|NOT COMPLETED|Overall Study||0||
48481941|NCT00496964|101515684|FG001|NOT COMPLETED|Overall Study||1||
48481942|NCT00726739|101515685|FG000|STARTED|Overall Study||11||
48481943|NCT00726739|101515686|FG001|STARTED|Overall Study||10||
48481944|NCT00726739|101515685|FG000|COMPLETED|Overall Study||10||
48481945|NCT00726739|101515686|FG001|COMPLETED|Overall Study||10||
48481946|NCT00726739|101515685|FG000|NOT COMPLETED|Overall Study||1||
48481947|NCT00726739|101515686|FG001|NOT COMPLETED|Overall Study||0||
48195584|NCT04133363|100800346|FG000|NOT COMPLETED|Overall Study||2||
48195585|NCT04133363|100800347|FG001|NOT COMPLETED|Overall Study||1||
48481948|NCT00831428|101515687|FG000|STARTED|Overall Study||97||
48195586|NCT04133363|100800348|FG002|NOT COMPLETED|Overall Study||4||
48481949|NCT00831428|101515687|FG000|COMPLETED|Overall Study||97||
48481950|NCT00831428|101515687|FG000|NOT COMPLETED|Overall Study||0||
48481951|NCT00772941|101515688|FG000|STARTED|Overall Study||3939||
48195587|NCT03109015|100800349|FG000|STARTED|Overall Study||4||
48195588|NCT03109015|100800350|FG001|STARTED|Overall Study||3||
48195589|NCT03109015|100800349|FG000|COMPLETED|Overall Study||4||
48195590|NCT03109015|100800350|FG001|COMPLETED|Overall Study||3||
48195591|NCT03109015|100800349|FG000|NOT COMPLETED|Overall Study||0||
48195592|NCT03109015|100800350|FG001|NOT COMPLETED|Overall Study||0||
48195593|NCT04060355|100800351|FG000|STARTED|Overall Study||120||
48195594|NCT04060355|100800351|FG000|COMPLETED|Overall Study||79||
48195595|NCT04060355|100800351|FG000|NOT COMPLETED|Overall Study||41||
48195596|NCT05025449|100800352|FG000|STARTED|Overall Study||267||
48195597|NCT05025449|100800352|FG000|COMPLETED|Overall Study||265||
48195598|NCT05025449|100800352|FG000|NOT COMPLETED|Overall Study||2||
48195599|NCT05457491|100800353|FG000|STARTED|Overall Study||56||
48195600|NCT05457491|100800353|FG000|COMPLETED|Overall Study||56||
48195601|NCT05457491|100800353|FG000|NOT COMPLETED|Overall Study||0||
48195602|NCT05349864|100800354|FG000|STARTED|Period 1 (5 Days)||6||
48195603|NCT05349864|100800355|FG001|STARTED|Period 1 (5 Days)||6||
48195604|NCT05349864|100800354|FG000|COMPLETED|Period 1 (5 Days)||6||
48195605|NCT05349864|100800355|FG001|COMPLETED|Period 1 (5 Days)||6||
48195606|NCT05349864|100800354|FG000|NOT COMPLETED|Period 1 (5 Days)||0||
48195607|NCT05349864|100800355|FG001|NOT COMPLETED|Period 1 (5 Days)||0||
48195608|NCT05349864|100800354|FG000|STARTED|Period 2 (5 Days)||6||
48195609|NCT05349864|100800355|FG001|STARTED|Period 2 (5 Days)||6||
48195610|NCT05349864|100800354|FG000|COMPLETED|Period 2 (5 Days)||5||
48195611|NCT05349864|100800355|FG001|COMPLETED|Period 2 (5 Days)||5||
48195612|NCT05349864|100800354|FG000|NOT COMPLETED|Period 2 (5 Days)||1||
48195613|NCT05349864|100800355|FG001|NOT COMPLETED|Period 2 (5 Days)||1||
48195614|NCT05349864|100800354|FG000|STARTED|Period 3 (5 Days)||5||
48195615|NCT05349864|100800355|FG001|STARTED|Period 3 (5 Days)||5||
48195616|NCT05349864|100800354|FG000|COMPLETED|Period 3 (5 Days)||5||
48195617|NCT05349864|100800355|FG001|COMPLETED|Period 3 (5 Days)||5||
48195618|NCT05349864|100800354|FG000|NOT COMPLETED|Period 3 (5 Days)||0||
48195619|NCT05349864|100800355|FG001|NOT COMPLETED|Period 3 (5 Days)||0||
48195620|NCT02606734|100800356|FG000|STARTED|Overall Study||44||
48195621|NCT02606734|100800356|FG000|COMPLETED|Overall Study||44||
48195622|NCT02606734|100800356|FG000|NOT COMPLETED|Overall Study||0||
48195623|NCT00587132|100800357|FG000|STARTED|Overall Study||4||
48195624|NCT00587132|100800358|FG001|STARTED|Overall Study||0||
48195625|NCT00587132|100800359|FG002|STARTED|Overall Study||0||
48195626|NCT00587132|100800360|FG003|STARTED|Overall Study||0||
48195627|NCT00587132|100800357|FG000|COMPLETED|Overall Study||4||
48195628|NCT00587132|100800358|FG001|COMPLETED|Overall Study||0||
48195629|NCT00587132|100800359|FG002|COMPLETED|Overall Study||0||
48195630|NCT00587132|100800360|FG003|COMPLETED|Overall Study||0||
48195631|NCT00587132|100800357|FG000|NOT COMPLETED|Overall Study||0||
48481952|NCT00772941|101515688|FG000|COMPLETED|Overall Study||3257||
48481953|NCT00772941|101515688|FG000|NOT COMPLETED|Overall Study||682||
48481954|NCT02287675|101515689|FG000|STARTED|Overall Study||22||
48481955|NCT02287675|101515690|FG001|STARTED|Overall Study||18||
48481956|NCT02287675|101515689|FG000|COMPLETED|Overall Study||22||
48481957|NCT02287675|101515690|FG001|COMPLETED|Overall Study||18||
48481958|NCT02287675|101515689|FG000|NOT COMPLETED|Overall Study||0||
48195632|NCT00587132|100800358|FG001|NOT COMPLETED|Overall Study||0||
48481959|NCT02287675|101515690|FG001|NOT COMPLETED|Overall Study||0||
48481960|NCT01789905|101515691|FG000|STARTED|Overall Study||116||
48481961|NCT01789905|101515691|FG000|COMPLETED|Overall Study||116||
48481962|NCT01789905|101515691|FG000|NOT COMPLETED|Overall Study||0||
48481963|NCT01513174|101515692|FG000|STARTED|Overall Study||94||
48481964|NCT01513174|101515693|FG001|STARTED|Overall Study||92||
48481965|NCT01513174|101515692|FG000|COMPLETED|Overall Study||90||
48481966|NCT01513174|101515693|FG001|COMPLETED|Overall Study||84||
48481967|NCT01513174|101515692|FG000|NOT COMPLETED|Overall Study||4||
48195633|NCT00587132|100800359|FG002|NOT COMPLETED|Overall Study||0||
48481968|NCT01513174|101515693|FG001|NOT COMPLETED|Overall Study||8||
48481969|NCT03375463|101515694|FG000|STARTED|Period 1||10||
48481970|NCT03375463|101515695|FG001|STARTED|Period 1||10||
48481971|NCT03375463|101515696|FG002|STARTED|Period 1||8||
48481972|NCT03375463|101515697|FG003|STARTED|Period 1||4||
48481973|NCT03375463|101515698|FG004|STARTED|Period 1||12||
48481974|NCT03375463|101515699|FG005|STARTED|Period 1||8||
48481975|NCT03375463|101515694|FG000|Received at Least 1 Dose of Study Drug|Period 1||10||
48481976|NCT03375463|101515695|FG001|Received at Least 1 Dose of Study Drug|Period 1||10||
48481977|NCT03375463|101515696|FG002|Received at Least 1 Dose of Study Drug|Period 1||8||
48481978|NCT03375463|101515697|FG003|Received at Least 1 Dose of Study Drug|Period 1||4||
48481979|NCT03375463|101515698|FG004|Received at Least 1 Dose of Study Drug|Period 1||12||
48481980|NCT03375463|101515699|FG005|Received at Least 1 Dose of Study Drug|Period 1||8||
48481981|NCT03375463|101515694|FG000|COMPLETED|Period 1||10||
48481982|NCT03375463|101515695|FG001|COMPLETED|Period 1||10||
48481983|NCT03375463|101515696|FG002|COMPLETED|Period 1||7||
48481984|NCT03375463|101515697|FG003|COMPLETED|Period 1||4||
48481985|NCT03375463|101515698|FG004|COMPLETED|Period 1||11||
48481986|NCT03375463|101515699|FG005|COMPLETED|Period 1||8||
48481987|NCT03375463|101515694|FG000|NOT COMPLETED|Period 1||0||
48481988|NCT03375463|101515695|FG001|NOT COMPLETED|Period 1||0||
48481989|NCT03375463|101515696|FG002|NOT COMPLETED|Period 1||1||
48481990|NCT03375463|101515697|FG003|NOT COMPLETED|Period 1||0||
48481991|NCT03375463|101515698|FG004|NOT COMPLETED|Period 1||1||
48481992|NCT03375463|101515699|FG005|NOT COMPLETED|Period 1||0||
48195634|NCT00587132|100800360|FG003|NOT COMPLETED|Overall Study||0||
48195635|NCT02377362|100803695|FG000|STARTED|Part A First Treatment||4||
48195636|NCT02377362|100803696|FG001|STARTED|Part A First Treatment||4||
48481993|NCT03375463|101515694|FG000|STARTED|Period 2||10||
48481994|NCT03375463|101515695|FG001|STARTED|Period 2||10||
48481995|NCT03375463|101515696|FG002|STARTED|Period 2||0||
48481996|NCT03375463|101515697|FG003|STARTED|Period 2||0||
48481997|NCT03375463|101515698|FG004|STARTED|Period 2||0||
48481998|NCT03375463|101515699|FG005|STARTED|Period 2||0||
48481999|NCT03375463|101515694|FG000|Received at Least 1 Dose of Study Drug|Period 2||10||
48482000|NCT03375463|101515695|FG001|Received at Least 1 Dose of Study Drug|Period 2||10||
48482001|NCT03375463|101515696|FG002|Received at Least 1 Dose of Study Drug|Period 2||0||
48482002|NCT03375463|101515697|FG003|Received at Least 1 Dose of Study Drug|Period 2||0||
48482003|NCT03375463|101515698|FG004|Received at Least 1 Dose of Study Drug|Period 2||0||
48482004|NCT03375463|101515699|FG005|Received at Least 1 Dose of Study Drug|Period 2||0||
48482005|NCT03375463|101515694|FG000|COMPLETED|Period 2||9||
48482006|NCT03375463|101515695|FG001|COMPLETED|Period 2||9||
48482007|NCT03375463|101515696|FG002|COMPLETED|Period 2||0||
48482008|NCT03375463|101515697|FG003|COMPLETED|Period 2||0||
48482009|NCT03375463|101515698|FG004|COMPLETED|Period 2||0||
48482010|NCT03375463|101515699|FG005|COMPLETED|Period 2||0||
48482011|NCT03375463|101515694|FG000|NOT COMPLETED|Period 2||1||
48482012|NCT03375463|101515695|FG001|NOT COMPLETED|Period 2||1||
48195637|NCT02377362|100803697|FG002|STARTED|Part A First Treatment||4||
48195638|NCT02377362|100803698|FG003|STARTED|Part A First Treatment||4||
48195639|NCT02377362|100803699|FG004|STARTED|Part A First Treatment||4||
48195640|NCT02377362|100803700|FG005|STARTED|Part A First Treatment||4||
48195641|NCT02377362|100803701|FG006|STARTED|Part A First Treatment||0||
48482013|NCT03375463|101515696|FG002|NOT COMPLETED|Period 2||0||
48482014|NCT03375463|101515697|FG003|NOT COMPLETED|Period 2||0||
48482015|NCT03375463|101515698|FG004|NOT COMPLETED|Period 2||0||
48482016|NCT03375463|101515699|FG005|NOT COMPLETED|Period 2||0||
48482017|NCT00493831|101515700|FG000|STARTED|Overall Study||20||
48482018|NCT00493831|101515700|FG000|COMPLETED|Overall Study||12||
48482019|NCT00493831|101515700|FG000|NOT COMPLETED|Overall Study||8||
48482020|NCT00495222|101515701|FG000|STARTED|Overall Study||9||
48482021|NCT00495222|101515701|FG000|COMPLETED|Overall Study||9||
48482022|NCT00495222|101515701|FG000|NOT COMPLETED|Overall Study||0||
48482023|NCT02760368|101515702|FG000|STARTED|Overall Study||142||
48482024|NCT02760368|101515703|FG001|STARTED|Overall Study||143||
48482025|NCT02760368|101515704|FG002|STARTED|Overall Study||143||
48482026|NCT02760368|101515702|FG000|COMPLETED|Overall Study||134||
48482027|NCT02760368|101515703|FG001|COMPLETED|Overall Study||130||
48482028|NCT02760368|101515704|FG002|COMPLETED|Overall Study||132||
48482029|NCT02760368|101515702|FG000|NOT COMPLETED|Overall Study||8||
48482030|NCT02760368|101515703|FG001|NOT COMPLETED|Overall Study||13||
48482031|NCT02760368|101515704|FG002|NOT COMPLETED|Overall Study||11||
48482032|NCT01390233|101515705|FG000|STARTED|Overall Study||35||
48482033|NCT01390233|101515706|FG001|STARTED|Overall Study||31||
48482034|NCT01390233|101515707|FG002|STARTED|Overall Study||36||
48482035|NCT01390233|101515705|FG000|COMPLETED|Overall Study||30||
48482036|NCT01390233|101515706|FG001|COMPLETED|Overall Study||29||
48482037|NCT01390233|101515707|FG002|COMPLETED|Overall Study||30||
48482038|NCT01390233|101515705|FG000|NOT COMPLETED|Overall Study||5||
48482039|NCT01390233|101515706|FG001|NOT COMPLETED|Overall Study||2||
48482040|NCT01390233|101515707|FG002|NOT COMPLETED|Overall Study||6||
48482041|NCT03645785|101515708|FG000|STARTED|Day 1 (Normal Fluid Intake and Diet)||23||
48482042|NCT03645785|101515708|FG000|COMPLETED|Day 1 (Normal Fluid Intake and Diet)||23||
48482043|NCT03645785|101515708|FG000|NOT COMPLETED|Day 1 (Normal Fluid Intake and Diet)||0||
48482044|NCT03645785|101515708|FG000|STARTED|Day 2-4 (Double Fluid and Add Citrate)||23||
48482045|NCT03645785|101515708|FG000|COMPLETED|Day 2-4 (Double Fluid and Add Citrate)||23||
48482046|NCT03645785|101515708|FG000|NOT COMPLETED|Day 2-4 (Double Fluid and Add Citrate)||0||
48482047|NCT03552393|101515709|FG000|STARTED|Core Period||40||
48482048|NCT03552393|101515709|FG000|COMPLETED|Core Period||38||
48482049|NCT03552393|101515709|FG000|NOT COMPLETED|Core Period||2||
48482050|NCT03552393|101515709|FG000|STARTED|Safety Extension Period||25||
48482051|NCT03552393|101515709|FG000|COMPLETED|Safety Extension Period||21||
48482052|NCT03552393|101515709|FG000|NOT COMPLETED|Safety Extension Period||4||
48482053|NCT01279486|101515710|FG000|STARTED|Overall Study||120||
48482054|NCT01279486|101515710|FG000|COMPLETED|Overall Study||119||
48482055|NCT01279486|101515710|FG000|NOT COMPLETED|Overall Study||1||
48482056|NCT01954394|101515711|FG000|STARTED|Overall Study||331||
48482057|NCT01954394|101515712|FG001|STARTED|Overall Study||655||
48195642|NCT02377362|100803702|FG007|STARTED|Part A First Treatment||0||
48482058|NCT01954394|101515711|FG000|Treated|Overall Study||330||
48482059|NCT01954394|101515712|FG001|Treated|Overall Study||655||
48482060|NCT01954394|101515711|FG000|COMPLETED|Overall Study||301||
48482061|NCT01954394|101515712|FG001|COMPLETED|Overall Study||598||
48482062|NCT01954394|101515711|FG000|NOT COMPLETED|Overall Study||30||
48482063|NCT01954394|101515712|FG001|NOT COMPLETED|Overall Study||57||
48482064|NCT00102440|101515713|FG000|STARTED|Overall Study||256||
48482065|NCT00102440|101515714|FG001|STARTED|Overall Study||251||
48482066|NCT00102440|101515715|FG002|STARTED|Overall Study||253||
48482067|NCT00102440|101515713|FG000|COMPLETED|Overall Study||168||
48482068|NCT00102440|101515714|FG001|COMPLETED|Overall Study||153||
48482069|NCT00102440|101515715|FG002|COMPLETED|Overall Study||187||
48482070|NCT00102440|101515713|FG000|NOT COMPLETED|Overall Study||88||
48195643|NCT02377362|100803703|FG008|STARTED|Part A First Treatment||0||
48195644|NCT02377362|100803704|FG009|STARTED|Part A First Treatment||0||
48195645|NCT02377362|100803705|FG010|STARTED|Part A First Treatment||0||
48195646|NCT02377362|100803706|FG011|STARTED|Part A First Treatment||0||
48482071|NCT00102440|101515714|FG001|NOT COMPLETED|Overall Study||98||
48195647|NCT02377362|100803707|FG012|STARTED|Part A First Treatment||0||
48195648|NCT02377362|100803695|FG000|COMPLETED|Part A First Treatment||4||
48195649|NCT02377362|100803696|FG001|COMPLETED|Part A First Treatment||4||
48195650|NCT02377362|100803697|FG002|COMPLETED|Part A First Treatment||4||
48195651|NCT02377362|100803698|FG003|COMPLETED|Part A First Treatment||4||
48195652|NCT02377362|100803699|FG004|COMPLETED|Part A First Treatment||4||
48195653|NCT02377362|100803700|FG005|COMPLETED|Part A First Treatment||4||
48195654|NCT02377362|100803701|FG006|COMPLETED|Part A First Treatment||0||
48195655|NCT02377362|100803702|FG007|COMPLETED|Part A First Treatment||0||
48195656|NCT02377362|100803703|FG008|COMPLETED|Part A First Treatment||0||
48195657|NCT02377362|100803704|FG009|COMPLETED|Part A First Treatment||0||
48195658|NCT02377362|100803705|FG010|COMPLETED|Part A First Treatment||0||
48195659|NCT02377362|100803706|FG011|COMPLETED|Part A First Treatment||0||
48195660|NCT02377362|100803707|FG012|COMPLETED|Part A First Treatment||0||
48195661|NCT02377362|100803695|FG000|NOT COMPLETED|Part A First Treatment||0||
48195662|NCT02377362|100803696|FG001|NOT COMPLETED|Part A First Treatment||0||
48195663|NCT02377362|100803697|FG002|NOT COMPLETED|Part A First Treatment||0||
48195664|NCT02377362|100803698|FG003|NOT COMPLETED|Part A First Treatment||0||
48195665|NCT02377362|100803699|FG004|NOT COMPLETED|Part A First Treatment||0||
48195666|NCT02377362|100803700|FG005|NOT COMPLETED|Part A First Treatment||0||
48195667|NCT02377362|100803701|FG006|NOT COMPLETED|Part A First Treatment||0||
48195668|NCT02377362|100803702|FG007|NOT COMPLETED|Part A First Treatment||0||
48195669|NCT02377362|100803703|FG008|NOT COMPLETED|Part A First Treatment||0||
48195670|NCT02377362|100803704|FG009|NOT COMPLETED|Part A First Treatment||0||
48195671|NCT02377362|100803705|FG010|NOT COMPLETED|Part A First Treatment||0||
48195672|NCT02377362|100803706|FG011|NOT COMPLETED|Part A First Treatment||0||
48482072|NCT00102440|101515715|FG002|NOT COMPLETED|Overall Study||66||
48195673|NCT02377362|100803707|FG012|NOT COMPLETED|Part A First Treatment||0||
48482073|NCT02155465|101515716|FG000|STARTED|Overall Study||3||
48482074|NCT02155465|101515717|FG001|STARTED|Overall Study||3||
48482075|NCT02155465|101515718|FG002|STARTED|Overall Study||6||
48482076|NCT02155465|101515719|FG003|STARTED|Overall Study||2||
48482077|NCT02155465|101515720|FG004|STARTED|Overall Study||1||
48482078|NCT02155465|101515721|FG005|STARTED|Overall Study||2||
48482079|NCT02155465|101515722|FG006|STARTED|Overall Study||5||
48482080|NCT02155465|101515716|FG000|COMPLETED|Overall Study||3||
48482081|NCT02155465|101515717|FG001|COMPLETED|Overall Study||3||
48482082|NCT02155465|101515718|FG002|COMPLETED|Overall Study||6||
48482083|NCT02155465|101515719|FG003|COMPLETED|Overall Study||2||
48482084|NCT02155465|101515720|FG004|COMPLETED|Overall Study||1||
48482085|NCT02155465|101515721|FG005|COMPLETED|Overall Study||2||
48195674|NCT02377362|100803695|FG000|STARTED|Part A Second Treatment||4||
48482086|NCT02155465|101515722|FG006|COMPLETED|Overall Study||5||
48482087|NCT02155465|101515716|FG000|NOT COMPLETED|Overall Study||0||
48195675|NCT02377362|100803696|FG001|STARTED|Part A Second Treatment||4||
48482088|NCT02155465|101515717|FG001|NOT COMPLETED|Overall Study||0||
48482089|NCT02155465|101515718|FG002|NOT COMPLETED|Overall Study||0||
48482090|NCT02155465|101515719|FG003|NOT COMPLETED|Overall Study||0||
48482091|NCT02155465|101515720|FG004|NOT COMPLETED|Overall Study||0||
48482092|NCT02155465|101515721|FG005|NOT COMPLETED|Overall Study||0||
48482093|NCT02155465|101515722|FG006|NOT COMPLETED|Overall Study||0||
48482094|NCT03113422|101515723|FG000|STARTED|Overall Study||56||
48482095|NCT03113422|101515723|FG000|COMPLETED|Overall Study||56||
48482096|NCT03113422|101515723|FG000|NOT COMPLETED|Overall Study||0||
48482097|NCT02543203|101515724|FG000|STARTED|Overall Study||13||
48482098|NCT02543203|101515725|FG001|STARTED|Overall Study||15||
48482099|NCT02543203|101515724|FG000|COMPLETED|Overall Study||7||
48482100|NCT02543203|101515725|FG001|COMPLETED|Overall Study||10||
48195676|NCT02377362|100803697|FG002|STARTED|Part A Second Treatment||4||
48482101|NCT02543203|101515724|FG000|NOT COMPLETED|Overall Study||6||
48482102|NCT02543203|101515725|FG001|NOT COMPLETED|Overall Study||5||
48482103|NCT02055963|101515726|FG000|STARTED|Overall Study||14||
48482104|NCT02055963|101515727|FG001|STARTED|Overall Study||16||
48482105|NCT02055963|101515726|FG000|COMPLETED|Overall Study||14||
48482106|NCT02055963|101515727|FG001|COMPLETED|Overall Study||16||
48195677|NCT02377362|100803698|FG003|STARTED|Part A Second Treatment||4||
48195678|NCT02377362|100803699|FG004|STARTED|Part A Second Treatment||4||
48195679|NCT02377362|100803700|FG005|STARTED|Part A Second Treatment||4||
48195680|NCT02377362|100803701|FG006|STARTED|Part A Second Treatment||0||
48195681|NCT02377362|100803702|FG007|STARTED|Part A Second Treatment||0||
48195682|NCT02377362|100803703|FG008|STARTED|Part A Second Treatment||0||
48195683|NCT02377362|100803704|FG009|STARTED|Part A Second Treatment||0||
48195684|NCT02377362|100803705|FG010|STARTED|Part A Second Treatment||0||
48195685|NCT02377362|100803706|FG011|STARTED|Part A Second Treatment||0||
48195686|NCT02377362|100803707|FG012|STARTED|Part A Second Treatment||0||
48195687|NCT02377362|100803695|FG000|COMPLETED|Part A Second Treatment||4||
48195688|NCT02377362|100803696|FG001|COMPLETED|Part A Second Treatment||4||
48195689|NCT02377362|100803697|FG002|COMPLETED|Part A Second Treatment||4||
48195690|NCT02377362|100803698|FG003|COMPLETED|Part A Second Treatment||4||
48195691|NCT02377362|100803699|FG004|COMPLETED|Part A Second Treatment||3||
48195692|NCT02377362|100803700|FG005|COMPLETED|Part A Second Treatment||4||
48195693|NCT02377362|100803701|FG006|COMPLETED|Part A Second Treatment||0||
48195694|NCT02377362|100803702|FG007|COMPLETED|Part A Second Treatment||0||
48195695|NCT02377362|100803703|FG008|COMPLETED|Part A Second Treatment||0||
48195696|NCT02377362|100803704|FG009|COMPLETED|Part A Second Treatment||0||
48195697|NCT02377362|100803705|FG010|COMPLETED|Part A Second Treatment||0||
48195698|NCT02377362|100803706|FG011|COMPLETED|Part A Second Treatment||0||
48195699|NCT02377362|100803707|FG012|COMPLETED|Part A Second Treatment||0||
48195700|NCT02377362|100803695|FG000|NOT COMPLETED|Part A Second Treatment||0||
48195701|NCT02377362|100803696|FG001|NOT COMPLETED|Part A Second Treatment||0||
48195702|NCT02377362|100803697|FG002|NOT COMPLETED|Part A Second Treatment||0||
48195703|NCT02377362|100803698|FG003|NOT COMPLETED|Part A Second Treatment||0||
48195704|NCT02377362|100803699|FG004|NOT COMPLETED|Part A Second Treatment||1||
48195705|NCT02377362|100803700|FG005|NOT COMPLETED|Part A Second Treatment||0||
48195706|NCT02377362|100803701|FG006|NOT COMPLETED|Part A Second Treatment||0||
48195707|NCT02377362|100803702|FG007|NOT COMPLETED|Part A Second Treatment||0||
48195708|NCT02377362|100803703|FG008|NOT COMPLETED|Part A Second Treatment||0||
48195709|NCT02377362|100803704|FG009|NOT COMPLETED|Part A Second Treatment||0||
48195710|NCT02377362|100803705|FG010|NOT COMPLETED|Part A Second Treatment||0||
48195711|NCT02377362|100803706|FG011|NOT COMPLETED|Part A Second Treatment||0||
48195712|NCT02377362|100803707|FG012|NOT COMPLETED|Part A Second Treatment||0||
48195713|NCT02377362|100803695|FG000|STARTED|Part A Third Treatment||4||
48195714|NCT02377362|100803696|FG001|STARTED|Part A Third Treatment||4||
48195715|NCT02377362|100803697|FG002|STARTED|Part A Third Treatment||4||
48195716|NCT02377362|100803698|FG003|STARTED|Part A Third Treatment||4||
48195717|NCT02377362|100803699|FG004|STARTED|Part A Third Treatment||3||
48195718|NCT02377362|100803700|FG005|STARTED|Part A Third Treatment||4||
48195719|NCT02377362|100803701|FG006|STARTED|Part A Third Treatment||0||
48195720|NCT02377362|100803702|FG007|STARTED|Part A Third Treatment||0||
48195721|NCT02377362|100803703|FG008|STARTED|Part A Third Treatment||0||
48195722|NCT02377362|100803704|FG009|STARTED|Part A Third Treatment||0||
48195723|NCT02377362|100803705|FG010|STARTED|Part A Third Treatment||0||
48195724|NCT02377362|100803706|FG011|STARTED|Part A Third Treatment||0||
48195725|NCT02377362|100803707|FG012|STARTED|Part A Third Treatment||0||
48195726|NCT02377362|100803695|FG000|COMPLETED|Part A Third Treatment||4||
48195727|NCT02377362|100803696|FG001|COMPLETED|Part A Third Treatment||4||
48195728|NCT02377362|100803697|FG002|COMPLETED|Part A Third Treatment||4||
48195729|NCT02377362|100803698|FG003|COMPLETED|Part A Third Treatment||0||
48195730|NCT02377362|100803699|FG004|COMPLETED|Part A Third Treatment||0||
48195731|NCT02377362|100803700|FG005|COMPLETED|Part A Third Treatment||0||
48195732|NCT02377362|100803701|FG006|COMPLETED|Part A Third Treatment||0||
48195733|NCT02377362|100803702|FG007|COMPLETED|Part A Third Treatment||0||
48195734|NCT02377362|100803703|FG008|COMPLETED|Part A Third Treatment||0||
48195735|NCT02377362|100803704|FG009|COMPLETED|Part A Third Treatment||0||
48195736|NCT02377362|100803705|FG010|COMPLETED|Part A Third Treatment||0||
48195737|NCT02377362|100803706|FG011|COMPLETED|Part A Third Treatment||0||
48195738|NCT02377362|100803707|FG012|COMPLETED|Part A Third Treatment||0||
48195739|NCT02377362|100803695|FG000|NOT COMPLETED|Part A Third Treatment||0||
48195740|NCT02377362|100803696|FG001|NOT COMPLETED|Part A Third Treatment||0||
48195741|NCT02377362|100803697|FG002|NOT COMPLETED|Part A Third Treatment||0||
48195742|NCT02377362|100803698|FG003|NOT COMPLETED|Part A Third Treatment||4||
48195743|NCT02377362|100803699|FG004|NOT COMPLETED|Part A Third Treatment||3||
48195744|NCT02377362|100803700|FG005|NOT COMPLETED|Part A Third Treatment||4||
48195745|NCT02377362|100803701|FG006|NOT COMPLETED|Part A Third Treatment||0||
48195746|NCT02377362|100803702|FG007|NOT COMPLETED|Part A Third Treatment||0||
48195747|NCT02377362|100803703|FG008|NOT COMPLETED|Part A Third Treatment||0||
48195748|NCT02377362|100803704|FG009|NOT COMPLETED|Part A Third Treatment||0||
48195749|NCT02377362|100803705|FG010|NOT COMPLETED|Part A Third Treatment||0||
48195750|NCT02377362|100803706|FG011|NOT COMPLETED|Part A Third Treatment||0||
48195751|NCT02377362|100803707|FG012|NOT COMPLETED|Part A Third Treatment||0||
48195752|NCT02377362|100803695|FG000|STARTED|Part B Overall||0|Part A was a 3-period crossover study (2 escalating doses of GLWL and 1 dose of placebo)|
48195753|NCT02377362|100803696|FG001|STARTED|Part B Overall||0|Part A was a 3-period crossover study (2 escalating doses of GLWL and 1 dose of placebo)|
48482107|NCT02055963|101515726|FG000|NOT COMPLETED|Overall Study||0||
48195754|NCT02377362|100803697|FG002|STARTED|Part B Overall||0|Part A was a 3-period crossover study (2 escalating doses of GLWL and 1 dose of placebo)|
48195755|NCT02377362|100803698|FG003|STARTED|Part B Overall||0|Part A was a 3-period crossover study (2 escalating doses of GLWL and 1 dose of placebo)|
48195756|NCT02377362|100803699|FG004|STARTED|Part B Overall||0|Part A was a 3-period crossover study (2 escalating doses of GLWL and 1 dose of placebo)|
48482108|NCT02055963|101515727|FG001|NOT COMPLETED|Overall Study||0||
48482109|NCT04349917|101515728|FG000|STARTED|First Intervention (2-4 Hours)||19||
48482110|NCT04349917|101515729|FG001|STARTED|First Intervention (2-4 Hours)||18||
48482111|NCT04349917|101515728|FG000|Received Intervention|First Intervention (2-4 Hours)||19||
48482112|NCT04349917|101515729|FG001|Received Intervention|First Intervention (2-4 Hours)||17||
48482113|NCT04349917|101515728|FG000|COMPLETED|First Intervention (2-4 Hours)||19||
48482114|NCT04349917|101515729|FG001|COMPLETED|First Intervention (2-4 Hours)||16||
48482115|NCT04349917|101515728|FG000|NOT COMPLETED|First Intervention (2-4 Hours)||0||
48482116|NCT04349917|101515729|FG001|NOT COMPLETED|First Intervention (2-4 Hours)||2||
48482117|NCT04349917|101515728|FG000|STARTED|Washout Period (4-20 Days)||19||
48482118|NCT04349917|101515729|FG001|STARTED|Washout Period (4-20 Days)||16||
48482119|NCT04349917|101515728|FG000|COMPLETED|Washout Period (4-20 Days)||19||
48482120|NCT04349917|101515729|FG001|COMPLETED|Washout Period (4-20 Days)||16||
48482121|NCT04349917|101515728|FG000|NOT COMPLETED|Washout Period (4-20 Days)||0||
48482122|NCT04349917|101515729|FG001|NOT COMPLETED|Washout Period (4-20 Days)||0||
48482123|NCT04349917|101515728|FG000|STARTED|Second Intervention (2-4 Hours)||19||
48482124|NCT04349917|101515729|FG001|STARTED|Second Intervention (2-4 Hours)||16||
48482125|NCT04349917|101515728|FG000|Received Intervention|Second Intervention (2-4 Hours)||19||
48482126|NCT04349917|101515729|FG001|Received Intervention|Second Intervention (2-4 Hours)||16||
48482127|NCT04349917|101515728|FG000|COMPLETED|Second Intervention (2-4 Hours)||19||
48482128|NCT04349917|101515729|FG001|COMPLETED|Second Intervention (2-4 Hours)||16||
48482129|NCT04349917|101515728|FG000|NOT COMPLETED|Second Intervention (2-4 Hours)||0||
48482130|NCT04349917|101515729|FG001|NOT COMPLETED|Second Intervention (2-4 Hours)||0||
48482131|NCT00537979|101515730|FG000|STARTED|Overall Study||38||
48482132|NCT00537979|101515731|FG001|STARTED|Overall Study||109||
48482133|NCT00537979|101515730|FG000|COMPLETED|Overall Study||32||
48482134|NCT00537979|101515731|FG001|COMPLETED|Overall Study||89||
48482135|NCT00537979|101515730|FG000|NOT COMPLETED|Overall Study||6||
48482136|NCT00537979|101515731|FG001|NOT COMPLETED|Overall Study||20||
48482137|NCT04078022|101515732|FG000|STARTED|Vaccination Phase||29||
48482138|NCT04078022|101515733|FG001|STARTED|Vaccination Phase||29||
48195757|NCT02377362|100803700|FG005|STARTED|Part B Overall||0|Part A was a 3-period crossover study (2 escalating doses of GLWL and 1 dose of placebo)|
48195758|NCT02377362|100803701|FG006|STARTED|Part B Overall||6|Part A was a 3-period crossover study (2 escalating doses of GLWL and 1 dose of placebo)|
48195759|NCT02377362|100803702|FG007|STARTED|Part B Overall||6|Part A was a 3-period crossover study (2 escalating doses of GLWL and 1 dose of placebo)|
48195760|NCT02377362|100803703|FG008|STARTED|Part B Overall||6|Part A was a 3-period crossover study (2 escalating doses of GLWL and 1 dose of placebo)|
48195761|NCT02377362|100803704|FG009|STARTED|Part B Overall||7|Part A was a 3-period crossover study (2 escalating doses of GLWL and 1 dose of placebo)|
48195762|NCT02377362|100803705|FG010|STARTED|Part B Overall||6|Part A was a 3-period crossover study (2 escalating doses of GLWL and 1 dose of placebo)|
48195763|NCT02377362|100803706|FG011|STARTED|Part B Overall||7|Part A was a 3-period crossover study (2 escalating doses of GLWL and 1 dose of placebo)|
48195764|NCT02377362|100803707|FG012|STARTED|Part B Overall||12|Part A was a 3-period crossover study (2 escalating doses of GLWL and 1 dose of placebo)|
48195765|NCT02377362|100803695|FG000|COMPLETED|Part B Overall||0||
48482139|NCT04078022|101515732|FG000|COMPLETED|Vaccination Phase||27||
48482140|NCT04078022|101515733|FG001|COMPLETED|Vaccination Phase||26||
48482141|NCT04078022|101515732|FG000|NOT COMPLETED|Vaccination Phase||2||
48482142|NCT04078022|101515733|FG001|NOT COMPLETED|Vaccination Phase||3||
48482143|NCT04078022|101515732|FG000|STARTED|Challenge Phase||22||
48482144|NCT04078022|101515733|FG001|STARTED|Challenge Phase||22||
48482145|NCT04078022|101515732|FG000|COMPLETED|Challenge Phase||21||
48482146|NCT04078022|101515733|FG001|COMPLETED|Challenge Phase||22||
48482147|NCT04078022|101515732|FG000|NOT COMPLETED|Challenge Phase||1||
48666440|NCT02367456|101967582|FG002|COMPLETED|Overall Study||0||
48666441|NCT02367456|101967580|FG000|NOT COMPLETED|Overall Study||12||
48666442|NCT02367456|101967581|FG001|NOT COMPLETED|Overall Study||30||
48666443|NCT02367456|101967582|FG002|NOT COMPLETED|Overall Study||30||
48666444|NCT04110145|101967583|FG000|STARTED|Double-Blind Treatment Period (4 Weeks)||7||
48666445|NCT04110145|101967584|FG001|STARTED|Double-Blind Treatment Period (4 Weeks)||7||
48666446|NCT04110145|101967585|FG002|STARTED|Double-Blind Treatment Period (4 Weeks)||6||
48666447|NCT04110145|101967586|FG003|STARTED|Double-Blind Treatment Period (4 Weeks)||7||
48666448|NCT04110145|101967587|FG004|STARTED|Double-Blind Treatment Period (4 Weeks)||8||
48666449|NCT04110145|101967583|FG000|COMPLETED|Double-Blind Treatment Period (4 Weeks)||7|Completed= Participants who completed the Double-Blind Treatment Period|
48666450|NCT04110145|101967584|FG001|COMPLETED|Double-Blind Treatment Period (4 Weeks)||7|Completed= Participants who completed the Double-Blind Treatment Period|
48666451|NCT04110145|101967585|FG002|COMPLETED|Double-Blind Treatment Period (4 Weeks)||6|Completed= Participants who completed the Double-Blind Treatment Period|
48666452|NCT04110145|101967586|FG003|COMPLETED|Double-Blind Treatment Period (4 Weeks)||6|Completed= Participants who completed the Double-Blind Treatment Period|
48666453|NCT04110145|101967587|FG004|COMPLETED|Double-Blind Treatment Period (4 Weeks)||8|Completed= Participants who completed the Double-Blind Treatment Period|
48666454|NCT04110145|101967583|FG000|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||0||
48195766|NCT02377362|100803696|FG001|COMPLETED|Part B Overall||0||
48195767|NCT02377362|100803697|FG002|COMPLETED|Part B Overall||0||
48195768|NCT02377362|100803698|FG003|COMPLETED|Part B Overall||0||
48195769|NCT02377362|100803699|FG004|COMPLETED|Part B Overall||0||
48195770|NCT02377362|100803700|FG005|COMPLETED|Part B Overall||0||
48195771|NCT02377362|100803701|FG006|COMPLETED|Part B Overall||4||
48195772|NCT02377362|100803702|FG007|COMPLETED|Part B Overall||5||
48195773|NCT02377362|100803703|FG008|COMPLETED|Part B Overall||6||
48482148|NCT04078022|101515733|FG001|NOT COMPLETED|Challenge Phase||0||
48482149|NCT00546897|101515734|FG000|STARTED|Overall Study||15||
48482150|NCT00546897|101515735|FG001|STARTED|Overall Study||33||
48195774|NCT02377362|100803704|FG009|COMPLETED|Part B Overall||6||
48195775|NCT02377362|100803705|FG010|COMPLETED|Part B Overall||6||
48195776|NCT02377362|100803706|FG011|COMPLETED|Part B Overall||6||
48195777|NCT02377362|100803707|FG012|COMPLETED|Part B Overall||12||
48195778|NCT02377362|100803695|FG000|NOT COMPLETED|Part B Overall||0||
48195779|NCT02377362|100803696|FG001|NOT COMPLETED|Part B Overall||0||
48195780|NCT02377362|100803697|FG002|NOT COMPLETED|Part B Overall||0||
48195781|NCT02377362|100803698|FG003|NOT COMPLETED|Part B Overall||0||
48195782|NCT02377362|100803699|FG004|NOT COMPLETED|Part B Overall||0||
48195783|NCT02377362|100803700|FG005|NOT COMPLETED|Part B Overall||0||
48195784|NCT02377362|100803701|FG006|NOT COMPLETED|Part B Overall||2||
48195785|NCT02377362|100803702|FG007|NOT COMPLETED|Part B Overall||1||
48195786|NCT02377362|100803703|FG008|NOT COMPLETED|Part B Overall||0||
48195787|NCT02377362|100803704|FG009|NOT COMPLETED|Part B Overall||1||
48195788|NCT02377362|100803705|FG010|NOT COMPLETED|Part B Overall||0||
48195789|NCT02377362|100803706|FG011|NOT COMPLETED|Part B Overall||1||
48195790|NCT02377362|100803707|FG012|NOT COMPLETED|Part B Overall||0||
48195791|NCT03681691|100803708|FG000|STARTED|Overall Study||8||
48195792|NCT03681691|100803709|FG001|STARTED|Overall Study||4||
48195793|NCT03681691|100803708|FG000|COMPLETED|Overall Study||6||
48195794|NCT03681691|100803709|FG001|COMPLETED|Overall Study||3||
48195795|NCT03681691|100803708|FG000|NOT COMPLETED|Overall Study||2||
48195796|NCT03681691|100803709|FG001|NOT COMPLETED|Overall Study||1||
48195797|NCT04084769|100803710|FG000|STARTED|Overall Study||191||
48195798|NCT04084769|100803711|FG001|STARTED|Overall Study||190||
48195799|NCT04084769|100803712|FG002|STARTED|Overall Study||95||
48195800|NCT04084769|100803713|FG003|STARTED|Overall Study||94||
48195801|NCT04084769|100803710|FG000|Safety Analysis Set (SAfAS)|Overall Study||186|Participants who had received at least one dose of study vaccine in MET59 and had available safety data.|
48195802|NCT04084769|100803711|FG001|Safety Analysis Set (SAfAS)|Overall Study||184|Participants who had received at least one dose of study vaccine in MET59 and had available safety data.|
48195803|NCT04084769|100803712|FG002|Safety Analysis Set (SAfAS)|Overall Study||93|Participants who had received at least one dose of study vaccine in MET59 and had available safety data.|
48195804|NCT04084769|100803713|FG003|Safety Analysis Set (SAfAS)|Overall Study||92|Participants who had received at least one dose of study vaccine in MET59 and had available safety data.|
48195805|NCT04084769|100803710|FG000|Full Analysis Set|Overall Study||191|Participants who had a valid pre-vaccination serology result.|
48482151|NCT00546897|101515734|FG000|COMPLETED|Overall Study||15||
48482152|NCT00546897|101515735|FG001|COMPLETED|Overall Study||33||
48482153|NCT00546897|101515734|FG000|NOT COMPLETED|Overall Study||0||
48482154|NCT00546897|101515735|FG001|NOT COMPLETED|Overall Study||0||
48482155|NCT00722124|101515736|FG000|STARTED|Overall Study||40||
48482156|NCT00722124|101515737|FG001|STARTED|Overall Study||40||
48482157|NCT00722124|101515738|FG002|STARTED|Overall Study||40||
48195806|NCT04084769|100803711|FG001|Full Analysis Set|Overall Study||190|Participants who had a valid pre-vaccination serology result.|
48195807|NCT04084769|100803712|FG002|Full Analysis Set|Overall Study||95|Participants who had a valid pre-vaccination serology result.|
48195808|NCT04084769|100803713|FG003|Full Analysis Set|Overall Study||94|Participants who had a valid pre-vaccination serology result.|
48195809|NCT04084769|100803710|FG000|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||46|Participants who received at least 1 dose of the study vaccine in MET59 and had a valid post-vaccination serology result with no relevant protocol deviation; defined for evaluating the immune response of MenACYW vaccine measured by serum bactericidal assay using human complement (hSBA) assessed at Day 06 after vaccination in Groups 1 and 2.|
48482158|NCT00722124|101515736|FG000|COMPLETED|Overall Study||23||
48482159|NCT00722124|101515737|FG001|COMPLETED|Overall Study||26||
48482160|NCT00722124|101515738|FG002|COMPLETED|Overall Study||20||
48195810|NCT04084769|100803711|FG001|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||45|Participants who received at least 1 dose of the study vaccine in MET59 and had a valid post-vaccination serology result with no relevant protocol deviation; defined for evaluating the immune response of MenACYW vaccine measured by serum bactericidal assay using human complement (hSBA) assessed at Day 06 after vaccination in Groups 1 and 2.|
48195811|NCT04084769|100803712|FG002|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||0|Participants who received at least 1 dose of the study vaccine in MET59 and had a valid post-vaccination serology result with no relevant protocol deviation; defined for evaluating the immune response of MenACYW vaccine measured by serum bactericidal assay using human complement (hSBA) assessed at Day 06 after vaccination in Groups 1 and 2.|
48195812|NCT04084769|100803713|FG003|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||0|Participants who received at least 1 dose of the study vaccine in MET59 and had a valid post-vaccination serology result with no relevant protocol deviation; defined for evaluating the immune response of MenACYW vaccine measured by serum bactericidal assay using human complement (hSBA) assessed at Day 06 after vaccination in Groups 1 and 2.|
48195813|NCT04084769|100803710|FG000|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||174|Participants who received at least 1 dose of the study vaccine in MET59 and had a valid post-vaccination serology result with no relevant protocol deviation; defined for evaluating the immune response of MenACYW vaccine measured by hSBA or serum bactericidal assay using baby rabbit complement (rSBA) assessed at Day 30 after vaccination.|
48195814|NCT04084769|100803711|FG001|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||176|Participants who received at least 1 dose of the study vaccine in MET59 and had a valid post-vaccination serology result with no relevant protocol deviation; defined for evaluating the immune response of MenACYW vaccine measured by hSBA or serum bactericidal assay using baby rabbit complement (rSBA) assessed at Day 30 after vaccination.|
48195815|NCT04084769|100803712|FG002|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||90|Participants who received at least 1 dose of the study vaccine in MET59 and had a valid post-vaccination serology result with no relevant protocol deviation; defined for evaluating the immune response of MenACYW vaccine measured by hSBA or serum bactericidal assay using baby rabbit complement (rSBA) assessed at Day 30 after vaccination.|
48195816|NCT04084769|100803713|FG003|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||89|Participants who received at least 1 dose of the study vaccine in MET59 and had a valid post-vaccination serology result with no relevant protocol deviation; defined for evaluating the immune response of MenACYW vaccine measured by hSBA or serum bactericidal assay using baby rabbit complement (rSBA) assessed at Day 30 after vaccination.|
48195817|NCT04084769|100803710|FG000|COMPLETED|Overall Study||187||
48195818|NCT04084769|100803711|FG001|COMPLETED|Overall Study||186||
48195819|NCT04084769|100803712|FG002|COMPLETED|Overall Study||95||
48195820|NCT04084769|100803713|FG003|COMPLETED|Overall Study||92||
48195821|NCT04084769|100803710|FG000|NOT COMPLETED|Overall Study||4||
48195822|NCT04084769|100803711|FG001|NOT COMPLETED|Overall Study||4||
48195823|NCT04084769|100803712|FG002|NOT COMPLETED|Overall Study||0||
48195824|NCT04084769|100803713|FG003|NOT COMPLETED|Overall Study||2||
48195825|NCT02435901|100803714|FG000|STARTED|Overall Study||29||
48195826|NCT02435901|100803714|FG000|COMPLETED|Overall Study||29||
48195827|NCT02435901|100803714|FG000|NOT COMPLETED|Overall Study||0||
48195828|NCT00542386|100803715|FG000|STARTED|Overall Study||104||
48195829|NCT00542386|100803716|FG001|STARTED|Overall Study||102||
48195830|NCT00542386|100803717|FG002|STARTED|Overall Study||99||
48195831|NCT00542386|100803718|FG003|STARTED|Overall Study||103||
48195832|NCT00542386|100803719|FG004|STARTED|Overall Study||102||
48195833|NCT00542386|100803720|FG005|STARTED|Overall Study||132||
48195834|NCT00542386|100803715|FG000|COMPLETED|Overall Study||61||
48195835|NCT00542386|100803716|FG001|COMPLETED|Overall Study||74||
48195836|NCT00542386|100803717|FG002|COMPLETED|Overall Study||66||
48195837|NCT00542386|100803718|FG003|COMPLETED|Overall Study||65||
48195838|NCT00542386|100803719|FG004|COMPLETED|Overall Study||62||
48195839|NCT00542386|100803720|FG005|COMPLETED|Overall Study||82||
48195840|NCT00542386|100803715|FG000|NOT COMPLETED|Overall Study||43||
48195841|NCT00542386|100803716|FG001|NOT COMPLETED|Overall Study||28||
48195842|NCT00542386|100803717|FG002|NOT COMPLETED|Overall Study||33||
48195843|NCT00542386|100803718|FG003|NOT COMPLETED|Overall Study||38||
48195844|NCT00542386|100803719|FG004|NOT COMPLETED|Overall Study||40||
48195845|NCT00542386|100803720|FG005|NOT COMPLETED|Overall Study||50||
48195846|NCT01242085|100803721|FG000|STARTED|Overall Study||30||
48195847|NCT01242085|100803722|FG001|STARTED|Overall Study||33||
48195848|NCT01242085|100803723|FG002|STARTED|Overall Study||1||
48195849|NCT01242085|100803721|FG000|COMPLETED|Overall Study||22||
48195850|NCT01242085|100803722|FG001|COMPLETED|Overall Study||26||
48195851|NCT01242085|100803723|FG002|COMPLETED|Overall Study||1||
48195852|NCT01242085|100803721|FG000|NOT COMPLETED|Overall Study||8||
48195853|NCT01242085|100803722|FG001|NOT COMPLETED|Overall Study||7||
48195854|NCT01242085|100803723|FG002|NOT COMPLETED|Overall Study||0||
48195855|NCT01171924|100803724|FG000|STARTED|Overall Study||23||
48195856|NCT01171924|100803725|FG001|STARTED|Overall Study||23||
48195857|NCT01171924|100803724|FG000|COMPLETED|Overall Study||0||
48195858|NCT01171924|100803725|FG001|COMPLETED|Overall Study||0||
48195859|NCT01171924|100803724|FG000|NOT COMPLETED|Overall Study||23||
48195860|NCT01171924|100803725|FG001|NOT COMPLETED|Overall Study||23||
48195861|NCT03181724|100803726|FG000|STARTED|Overall Study||45||
48195862|NCT03181724|100803727|FG001|STARTED|Overall Study||45||
48195863|NCT03181724|100803726|FG000|COMPLETED|Overall Study||45||
48195864|NCT03181724|100803727|FG001|COMPLETED|Overall Study||45||
48195865|NCT03181724|100803726|FG000|NOT COMPLETED|Overall Study||0||
48195866|NCT03181724|100803727|FG001|NOT COMPLETED|Overall Study||0||
48195867|NCT00715390|100803728|FG000|STARTED|Overall Study||234||
48195868|NCT00715390|100803728|FG000|Eligible|Overall Study||234||
48195869|NCT00715390|100803728|FG000|COMPLETED|Overall Study||234||
48195870|NCT00715390|100803728|FG000|NOT COMPLETED|Overall Study||0||
48195871|NCT00631917|100803729|FG000|STARTED|Overall Study||375||
48195872|NCT00631917|100803730|FG001|STARTED|Overall Study||399||
48195873|NCT00631917|100803729|FG000|COMPLETED|Overall Study||287||
48195874|NCT00631917|100803730|FG001|COMPLETED|Overall Study||291||
48195875|NCT00631917|100803729|FG000|NOT COMPLETED|Overall Study||88||
48195876|NCT00631917|100803730|FG001|NOT COMPLETED|Overall Study||108||
48195877|NCT00106431|100803731|FG000|STARTED|Overall Study||102||
48195878|NCT00106431|100803731|FG000|COMPLETED|Overall Study||37||
48195879|NCT00106431|100803731|FG000|NOT COMPLETED|Overall Study||65||
48195880|NCT05650333|100803732|FG000|STARTED|Treatment Period (7 Days)||15||
48195881|NCT05650333|100803732|FG000|COMPLETED|Treatment Period (7 Days)||14||
48195882|NCT05650333|100803732|FG000|NOT COMPLETED|Treatment Period (7 Days)||1||
48195883|NCT05650333|100803732|FG000|STARTED|Follow-up (35 Days After Last Dose)||15||
48195884|NCT05650333|100803732|FG000|COMPLETED|Follow-up (35 Days After Last Dose)||15||
48195885|NCT05650333|100803732|FG000|NOT COMPLETED|Follow-up (35 Days After Last Dose)||0||
48195886|NCT02095158|100803733|FG000|STARTED|Overall Study||440||
48195887|NCT02095158|100803733|FG000|COMPLETED|Overall Study||365||
48195888|NCT02095158|100803733|FG000|NOT COMPLETED|Overall Study||75||
48195889|NCT01311648|100803734|FG000|STARTED|Main Study||51||
48195890|NCT01311648|100803735|FG001|STARTED|Main Study||43||
48195891|NCT01311648|100803734|FG000|Started 0-<6 Years|Main Study||25||
48195892|NCT01311648|100803735|FG001|Started 0-<6 Years|Main Study||43||
48195893|NCT01311648|100803734|FG000|Started 6-12 Years|Main Study||26||
48195894|NCT01311648|100803735|FG001|Started 6-12 Years|Main Study||0||
48195895|NCT01311648|100803734|FG000|COMPLETED|Main Study||51||
48195896|NCT01311648|100803735|FG001|COMPLETED|Main Study||22||
48195897|NCT01311648|100803734|FG000|NOT COMPLETED|Main Study||0||
48195898|NCT01311648|100803735|FG001|NOT COMPLETED|Main Study||21||
48195899|NCT01311648|100803734|FG000|STARTED|Extension Study||46||
48195900|NCT01311648|100803735|FG001|STARTED|Extension Study||36||
48195901|NCT01311648|100803734|FG000|COMPLETED|Extension Study||45||
48195902|NCT01311648|100803735|FG001|COMPLETED|Extension Study||25||
48195903|NCT01311648|100803734|FG000|NOT COMPLETED|Extension Study||1||
48195904|NCT01311648|100803735|FG001|NOT COMPLETED|Extension Study||11||
48195905|NCT00567879|100803736|FG000|STARTED|Overall Study||7||
48195906|NCT00567879|100803737|FG001|STARTED|Overall Study||7||
48195907|NCT00567879|100803738|FG002|STARTED|Overall Study||21||
48195908|NCT00567879|100803739|FG003|STARTED|Overall Study||6||
48195909|NCT00567879|100803740|FG004|STARTED|Overall Study||12||
48195910|NCT00567879|100803741|FG005|STARTED|Overall Study||3||
48195911|NCT00567879|100803736|FG000|Maximum Tolerated Dose Determining Set|Overall Study||5||
48195912|NCT00567879|100803737|FG001|Maximum Tolerated Dose Determining Set|Overall Study||7||
48195913|NCT00567879|100803738|FG002|Maximum Tolerated Dose Determining Set|Overall Study||18||
48195914|NCT00567879|100803739|FG003|Maximum Tolerated Dose Determining Set|Overall Study||6||
48195915|NCT00567879|100803740|FG004|Maximum Tolerated Dose Determining Set|Overall Study||12||
48195916|NCT00567879|100803741|FG005|Maximum Tolerated Dose Determining Set|Overall Study||3||
48195917|NCT00567879|100803736|FG000|COMPLETED|Overall Study||0||
48195918|NCT00567879|100803737|FG001|COMPLETED|Overall Study||0||
48195919|NCT00567879|100803738|FG002|COMPLETED|Overall Study||0||
48195920|NCT00567879|100803739|FG003|COMPLETED|Overall Study||0||
48482161|NCT00722124|101515736|FG000|NOT COMPLETED|Overall Study||17||
48482162|NCT00722124|101515737|FG001|NOT COMPLETED|Overall Study||14||
48482163|NCT00722124|101515738|FG002|NOT COMPLETED|Overall Study||20||
48482164|NCT02996682|101515739|FG000|STARTED|Overall Study||51||
48482165|NCT02996682|101515740|FG001|STARTED|Overall Study||51||
48482166|NCT02996682|101515739|FG000|COMPLETED|Overall Study||51||
48666455|NCT04110145|101967584|FG001|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||0||
48195921|NCT00567879|100803740|FG004|COMPLETED|Overall Study||0||
48482167|NCT02996682|101515740|FG001|COMPLETED|Overall Study||48||
48482168|NCT02996682|101515739|FG000|NOT COMPLETED|Overall Study||0||
48482169|NCT02996682|101515740|FG001|NOT COMPLETED|Overall Study||3||
48482170|NCT03979079|101515741|FG000|STARTED|Overall Study||2384||
48482171|NCT03979079|101515741|FG000|COMPLETED|Overall Study||2384||
48195922|NCT00567879|100803741|FG005|COMPLETED|Overall Study||0||
48195923|NCT00567879|100803736|FG000|NOT COMPLETED|Overall Study||7||
48195924|NCT00567879|100803737|FG001|NOT COMPLETED|Overall Study||7||
48195925|NCT00567879|100803738|FG002|NOT COMPLETED|Overall Study||21||
48195926|NCT00567879|100803739|FG003|NOT COMPLETED|Overall Study||6||
48195927|NCT00567879|100803740|FG004|NOT COMPLETED|Overall Study||12||
48195928|NCT00567879|100803741|FG005|NOT COMPLETED|Overall Study||3||
48195929|NCT00295867|100803742|FG000|STARTED|Overall Study||45||
48482172|NCT03979079|101515741|FG000|NOT COMPLETED|Overall Study||0||
48195930|NCT00295867|100803742|FG000|COMPLETED|Overall Study||34||
48195931|NCT00295867|100803742|FG000|NOT COMPLETED|Overall Study||11||
48195932|NCT04011033|100803743|FG000|STARTED|Overall Study||30||
48195933|NCT04011033|100803744|FG001|STARTED|Overall Study||30||
48195934|NCT04011033|100803743|FG000|COMPLETED|Overall Study||27||
48195935|NCT04011033|100803744|FG001|COMPLETED|Overall Study||27||
48195936|NCT04011033|100803743|FG000|NOT COMPLETED|Overall Study||3||
48195937|NCT04011033|100803744|FG001|NOT COMPLETED|Overall Study||3||
48195938|NCT00058058|100803745|FG000|STARTED|Overall Study||1007|Enrolled|
48195939|NCT00058058|100803745|FG000|COMPLETED|Overall Study||969|Completed MRI|
48195940|NCT00058058|100803745|FG000|NOT COMPLETED|Overall Study||38||
48195941|NCT03419780|100803746|FG000|STARTED|Overall Study||33||
48195942|NCT03419780|100803747|FG001|STARTED|Overall Study||33||
48195943|NCT03419780|100803746|FG000|COMPLETED|Overall Study||33||
48195944|NCT03419780|100803747|FG001|COMPLETED|Overall Study||33||
48195945|NCT03419780|100803746|FG000|NOT COMPLETED|Overall Study||0||
48195946|NCT03419780|100803747|FG001|NOT COMPLETED|Overall Study||0||
48195947|NCT03643211|100803748|FG000|STARTED|Overall Study||2016||
48195948|NCT03643211|100803748|FG000|COMPLETED|Overall Study||1995||
48195949|NCT03643211|100803748|FG000|NOT COMPLETED|Overall Study||21||
48195950|NCT00777556|100803749|FG000|STARTED|Overall Study||343||
48195951|NCT00777556|100803749|FG000|Dispensed Product|Overall Study||307||
48195952|NCT00777556|100803749|FG000|Safety Population|Overall Study||299||
48195953|NCT00777556|100803749|FG000|Used Product|Overall Study||297||
48195954|NCT00777556|100803749|FG000|COMPLETED|Overall Study||277||
48195955|NCT00777556|100803749|FG000|NOT COMPLETED|Overall Study||66||
48195956|NCT04088188|100803750|FG000|STARTED|Overall Study||6||
48195957|NCT04088188|100803751|FG001|STARTED|Overall Study||1||
48195958|NCT04088188|100803750|FG000|COMPLETED|Overall Study||2||
48195959|NCT04088188|100803751|FG001|COMPLETED|Overall Study||1||
48195960|NCT04088188|100803750|FG000|NOT COMPLETED|Overall Study||4||
48195961|NCT04088188|100803751|FG001|NOT COMPLETED|Overall Study||0||
48195962|NCT03761784|100803752|FG000|STARTED|Overall Study||281||
48195963|NCT03761784|100803753|FG001|STARTED|Overall Study||143||
48195964|NCT03761784|100803752|FG000|Received at Least 1 Dose of Study Drug|Overall Study||274||
48195965|NCT03761784|100803753|FG001|Received at Least 1 Dose of Study Drug|Overall Study||139||
48195966|NCT03761784|100803752|FG000|COMPLETED|Overall Study||249||
48195967|NCT03761784|100803753|FG001|COMPLETED|Overall Study||131||
48195968|NCT03761784|100803752|FG000|NOT COMPLETED|Overall Study||32||
48195969|NCT03761784|100803753|FG001|NOT COMPLETED|Overall Study||12||
48195970|NCT05819190|100803754|FG000|STARTED|Overall Study||100||
48195971|NCT05819190|100803755|FG001|STARTED|Overall Study||100||
48195972|NCT05819190|100803754|FG000|COMPLETED|Overall Study||100||
48195973|NCT05819190|100803755|FG001|COMPLETED|Overall Study||100||
48195974|NCT05819190|100803754|FG000|NOT COMPLETED|Overall Study||0||
48195975|NCT05819190|100803755|FG001|NOT COMPLETED|Overall Study||0||
48195976|NCT05080192|100803756|FG000|STARTED|Overall Study||7||
48195977|NCT05080192|100803757|FG001|STARTED|Overall Study||5||
48195978|NCT05080192|100803756|FG000|COMPLETED|Overall Study||7||
48195979|NCT05080192|100803757|FG001|COMPLETED|Overall Study||5||
48195980|NCT05080192|100803756|FG000|NOT COMPLETED|Overall Study||0||
48195981|NCT05080192|100803757|FG001|NOT COMPLETED|Overall Study||0||
48195982|NCT03722446|100803758|FG000|STARTED|Overall Study||135||
48195983|NCT03722446|100803759|FG001|STARTED|Overall Study||122||
48195984|NCT03722446|100803758|FG000|COMPLETED|Overall Study||120||
48195985|NCT03722446|100803759|FG001|COMPLETED|Overall Study||120||
48195986|NCT03722446|100803758|FG000|NOT COMPLETED|Overall Study||15||
48195987|NCT03722446|100803759|FG001|NOT COMPLETED|Overall Study||2||
48195988|NCT05487703|100803760|FG000|STARTED|Overall Study||318||
48195989|NCT05487703|100803760|FG000|Subset With 6 Month Visit|Overall Study||232||
48195990|NCT05487703|100803760|FG000|COMPLETED|Overall Study||209||
48195991|NCT05487703|100803760|FG000|NOT COMPLETED|Overall Study||109||
48195992|NCT03105128|100803761|FG000|STARTED|Period 1||373|Randomized|
48195993|NCT03105128|100803762|FG001|STARTED|Period 1||372|Randomized|
48195994|NCT03105128|100803763|FG002|STARTED|Period 1||186|Randomized|
48195995|NCT03105128|100803764|FG003|STARTED|Period 1||0|Randomized|
48195996|NCT03105128|100803765|FG004|STARTED|Period 1||0|Randomized|
48482173|NCT01707420|101515742|FG000|STARTED|Overall Study||18||
48195997|NCT03105128|100803766|FG005|STARTED|Period 1||0|Randomized|
48482174|NCT01707420|101515743|FG001|STARTED|Overall Study||18||
48482175|NCT01707420|101515742|FG000|COMPLETED|Overall Study||18||
48195998|NCT03105128|100803767|FG006|STARTED|Period 1||0|Randomized|
48195999|NCT03105128|100803761|FG000|COMPLETED|Period 1||365|Completed Period 1|
48196000|NCT03105128|100803762|FG001|COMPLETED|Period 1||366|Completed Period 1|
48196001|NCT03105128|100803763|FG002|COMPLETED|Period 1||163|Completed Period 1|
48196002|NCT03105128|100803764|FG003|COMPLETED|Period 1||0|Completed Period 1|
48196003|NCT03105128|100803765|FG004|COMPLETED|Period 1||0|Completed Period 1|
48196004|NCT03105128|100803766|FG005|COMPLETED|Period 1||0|Completed Period 1|
48196005|NCT03105128|100803767|FG006|COMPLETED|Period 1||0|Completed Period 1|
48196006|NCT03105128|100803761|FG000|NOT COMPLETED|Period 1||8||
48196007|NCT03105128|100803762|FG001|NOT COMPLETED|Period 1||6||
48196008|NCT03105128|100803763|FG002|NOT COMPLETED|Period 1||23||
48196009|NCT03105128|100803764|FG003|NOT COMPLETED|Period 1||0||
48482176|NCT01707420|101515743|FG001|COMPLETED|Overall Study||18||
48482177|NCT01707420|101515742|FG000|NOT COMPLETED|Overall Study||0||
48482178|NCT01707420|101515743|FG001|NOT COMPLETED|Overall Study||0||
48482179|NCT03656783|101515744|FG000|STARTED|Overall Study||25||
48482180|NCT03656783|101515744|FG000|COMPLETED|Overall Study||25||
48482181|NCT03656783|101515744|FG000|NOT COMPLETED|Overall Study||0||
48482182|NCT00581971|101515745|FG000|STARTED|Overall Study||30||
48482183|NCT00581971|101515745|FG000|COMPLETED|Overall Study||30||
48482184|NCT00581971|101515745|FG000|NOT COMPLETED|Overall Study||0||
48482185|NCT02433977|101515746|FG000|STARTED|Overall Study||6||
48482186|NCT02433977|101515746|FG000|COMPLETED|Overall Study||6||
48482187|NCT02433977|101515746|FG000|NOT COMPLETED|Overall Study||0||
48482188|NCT00312663|101515747|FG000|STARTED|Immunization Phase||5||
48482189|NCT00312663|101515748|FG001|STARTED|Immunization Phase||13||
48482190|NCT00312663|101515749|FG002|STARTED|Immunization Phase||0||
48482191|NCT00312663|101515747|FG000|COMPLETED|Immunization Phase||5||
48482192|NCT00312663|101515748|FG001|COMPLETED|Immunization Phase||12||
48482193|NCT00312663|101515749|FG002|COMPLETED|Immunization Phase||0||
48482194|NCT00312663|101515747|FG000|NOT COMPLETED|Immunization Phase||0||
48482195|NCT00312663|101515748|FG001|NOT COMPLETED|Immunization Phase||1||
48482196|NCT00312663|101515749|FG002|NOT COMPLETED|Immunization Phase||0||
48482197|NCT00312663|101515747|FG000|STARTED|Challenge Phase||0||
48482198|NCT00312663|101515748|FG001|STARTED|Challenge Phase||10||
48482199|NCT00312663|101515749|FG002|STARTED|Challenge Phase||6||
48482200|NCT00312663|101515747|FG000|COMPLETED|Challenge Phase||0||
48482201|NCT00312663|101515748|FG001|COMPLETED|Challenge Phase||10||
48482202|NCT00312663|101515749|FG002|COMPLETED|Challenge Phase||6||
48482203|NCT00312663|101515747|FG000|NOT COMPLETED|Challenge Phase||0||
48482204|NCT00312663|101515748|FG001|NOT COMPLETED|Challenge Phase||0||
48482205|NCT00312663|101515749|FG002|NOT COMPLETED|Challenge Phase||0||
48482206|NCT01873586|101515750|FG000|STARTED|Overall Study||29||54
48482207|NCT01873586|101515750|FG000|COMPLETED|Overall Study||26||47
48482208|NCT01873586|101515750|FG000|NOT COMPLETED|Overall Study||3||7
48482209|NCT04056182|101515751|FG000|STARTED|Overall Study||20||
48482210|NCT04056182|101515751|FG000|COMPLETED|Overall Study||3||
48482211|NCT04056182|101515751|FG000|NOT COMPLETED|Overall Study||17||
48482212|NCT00925119|101518805|FG000|STARTED|Overall Study||31||
48482213|NCT00925119|101518805|FG000|COMPLETED|Overall Study||19||
48482214|NCT00925119|101518805|FG000|NOT COMPLETED|Overall Study||12||
48482215|NCT03348423|101518806|FG000|STARTED|Overall Study||15||
48482216|NCT03348423|101518807|FG001|STARTED|Overall Study||15||
48482217|NCT03348423|101518808|FG002|STARTED|Overall Study||15||
48482218|NCT03348423|101518806|FG000|COMPLETED|Overall Study||15||
48482219|NCT03348423|101518807|FG001|COMPLETED|Overall Study||15||
48482220|NCT03348423|101518808|FG002|COMPLETED|Overall Study||15||
48482221|NCT03348423|101518806|FG000|NOT COMPLETED|Overall Study||0||
48482222|NCT03348423|101518807|FG001|NOT COMPLETED|Overall Study||0||
48482223|NCT03348423|101518808|FG002|NOT COMPLETED|Overall Study||0||
48482224|NCT02962934|101518809|FG000|STARTED|Overall Study||12||
48482225|NCT02962934|101518810|FG001|STARTED|Overall Study||6||
48482226|NCT02962934|101518809|FG000|COMPLETED|Overall Study||12||
48482227|NCT02962934|101518810|FG001|COMPLETED|Overall Study||6||
48482228|NCT02962934|101518809|FG000|NOT COMPLETED|Overall Study||0||
48482229|NCT02962934|101518810|FG001|NOT COMPLETED|Overall Study||0||
48482230|NCT01066143|101518811|FG000|STARTED|Overall Study||8||
48482231|NCT01066143|101518811|FG000|COMPLETED|Overall Study||0||
48482232|NCT01066143|101518811|FG000|NOT COMPLETED|Overall Study||8||
48482233|NCT01404988|101518812|FG000|STARTED|Overall Study||33||
48482234|NCT01404988|101518813|FG001|STARTED|Overall Study||33||
48482235|NCT01404988|101518814|FG002|STARTED|Overall Study||33||
48482236|NCT01404988|101518812|FG000|COMPLETED|Overall Study||27||
48482237|NCT01404988|101518813|FG001|COMPLETED|Overall Study||29||
48482238|NCT01404988|101518814|FG002|COMPLETED|Overall Study||30||
48482239|NCT01404988|101518812|FG000|NOT COMPLETED|Overall Study||6||
48482240|NCT01404988|101518813|FG001|NOT COMPLETED|Overall Study||4||
48482241|NCT01404988|101518814|FG002|NOT COMPLETED|Overall Study||3||
48482242|NCT01534520|101518815|FG000|STARTED|Overall Study||30||
48482243|NCT01534520|101518816|FG001|STARTED|Overall Study||29||
48482244|NCT01534520|101518815|FG000|COMPLETED|Overall Study||30||
48482245|NCT01534520|101518816|FG001|COMPLETED|Overall Study||28||
48482246|NCT01534520|101518815|FG000|NOT COMPLETED|Overall Study||0||
48482247|NCT01534520|101518816|FG001|NOT COMPLETED|Overall Study||1||
48482248|NCT02281591|101518817|FG000|STARTED|Overall Study||8||
48482249|NCT02281591|101518818|FG001|STARTED|Overall Study||8||
48482250|NCT02281591|101518819|FG002|STARTED|Overall Study||8||
48482251|NCT02281591|101518820|FG003|STARTED|Overall Study||8||
48482252|NCT02281591|101518817|FG000|COMPLETED|Overall Study||8||
48482253|NCT02281591|101518818|FG001|COMPLETED|Overall Study||8||
48482254|NCT02281591|101518819|FG002|COMPLETED|Overall Study||8||
48482255|NCT02281591|101518820|FG003|COMPLETED|Overall Study||8||
48482256|NCT02281591|101518817|FG000|NOT COMPLETED|Overall Study||0||
48482257|NCT02281591|101518818|FG001|NOT COMPLETED|Overall Study||0||
48482258|NCT02281591|101518819|FG002|NOT COMPLETED|Overall Study||0||
48482259|NCT02281591|101518820|FG003|NOT COMPLETED|Overall Study||0||
48482260|NCT00567320|101518821|FG000|STARTED|Overall Study||13||
48482261|NCT00567320|101518822|FG001|STARTED|Overall Study||18||
48482262|NCT00567320|101518821|FG000|COMPLETED|Overall Study||13||
48482263|NCT00567320|101518822|FG001|COMPLETED|Overall Study||18||
48482264|NCT00567320|101518821|FG000|NOT COMPLETED|Overall Study||0||
48482265|NCT00567320|101518822|FG001|NOT COMPLETED|Overall Study||0||
48482266|NCT01042522|101518823|FG000|STARTED|Overall Study||31||
48482267|NCT01042522|101518824|FG001|STARTED|Overall Study||32||
48482268|NCT01042522|101518823|FG000|COMPLETED|Overall Study||23||
48482269|NCT01042522|101518824|FG001|COMPLETED|Overall Study||26||
48482270|NCT01042522|101518823|FG000|NOT COMPLETED|Overall Study||8||
48482271|NCT01042522|101518824|FG001|NOT COMPLETED|Overall Study||6||
48482272|NCT02943447|101518825|FG000|STARTED|Blinded Study Phase||28||
48482273|NCT02943447|101518826|FG001|STARTED|Blinded Study Phase||30||
48482274|NCT02943447|101518827|FG002|STARTED|Blinded Study Phase||13||
48482275|NCT02943447|101518825|FG000|COMPLETED|Blinded Study Phase||23||
48482276|NCT02943447|101518826|FG001|COMPLETED|Blinded Study Phase||28||
48482277|NCT02943447|101518827|FG002|COMPLETED|Blinded Study Phase||12||
48482278|NCT02943447|101518825|FG000|NOT COMPLETED|Blinded Study Phase||5||
48482279|NCT02943447|101518826|FG001|NOT COMPLETED|Blinded Study Phase||2||
48482280|NCT02943447|101518827|FG002|NOT COMPLETED|Blinded Study Phase||1||
48482281|NCT02943447|101518825|FG000|STARTED|Open-Label Extension Phase||23||
48482282|NCT02943447|101518826|FG001|STARTED|Open-Label Extension Phase||28||
48482283|NCT02943447|101518827|FG002|STARTED|Open-Label Extension Phase||12||
48482284|NCT02943447|101518825|FG000|COMPLETED|Open-Label Extension Phase||5||
48482285|NCT02943447|101518826|FG001|COMPLETED|Open-Label Extension Phase||3||
48482286|NCT02943447|101518827|FG002|COMPLETED|Open-Label Extension Phase||2||
48482287|NCT02943447|101518825|FG000|NOT COMPLETED|Open-Label Extension Phase||18||
48482288|NCT02943447|101518826|FG001|NOT COMPLETED|Open-Label Extension Phase||25||
48482289|NCT02943447|101518827|FG002|NOT COMPLETED|Open-Label Extension Phase||10||
48482290|NCT03290781|101518828|FG000|STARTED|Overall Study||73||
48482291|NCT03290781|101518829|FG001|STARTED|Overall Study||71||
48482292|NCT03290781|101518830|FG002|STARTED|Overall Study||86||
48482293|NCT03290781|101518831|FG003|STARTED|Overall Study||82||
48482294|NCT03290781|101518832|FG004|STARTED|Overall Study||11||
48482295|NCT03290781|101518833|FG005|STARTED|Overall Study||22||
48482296|NCT03290781|101518834|FG006|STARTED|Overall Study||21||
48482297|NCT03290781|101518828|FG000|COMPLETED|Overall Study||24||
48482298|NCT03290781|101518829|FG001|COMPLETED|Overall Study||53||
48482299|NCT03290781|101518830|FG002|COMPLETED|Overall Study||30||
48482300|NCT03290781|101518831|FG003|COMPLETED|Overall Study||59||
48482301|NCT03290781|101518832|FG004|COMPLETED|Overall Study||6||
48482302|NCT03290781|101518833|FG005|COMPLETED|Overall Study||19||
48482303|NCT03290781|101518834|FG006|COMPLETED|Overall Study||17||
48482304|NCT03290781|101518828|FG000|NOT COMPLETED|Overall Study||49||
48482305|NCT03290781|101518829|FG001|NOT COMPLETED|Overall Study||18||
48482306|NCT03290781|101518830|FG002|NOT COMPLETED|Overall Study||56||
48482307|NCT03290781|101518831|FG003|NOT COMPLETED|Overall Study||23||
48482308|NCT03290781|101518832|FG004|NOT COMPLETED|Overall Study||5||
48482309|NCT03290781|101518833|FG005|NOT COMPLETED|Overall Study||3||
48482310|NCT03290781|101518834|FG006|NOT COMPLETED|Overall Study||4||
48482311|NCT01878292|101518835|FG000|STARTED|Randomized||174||
48482312|NCT01878292|101518836|FG001|STARTED|Randomized||175||
48482313|NCT01878292|101518837|FG002|STARTED|Randomized||180||
48482314|NCT01878292|101518835|FG000|COMPLETED|Randomized||171||
48482315|NCT01878292|101518836|FG001|COMPLETED|Randomized||175||
48482316|NCT01878292|101518837|FG002|COMPLETED|Randomized||180||
48482317|NCT01878292|101518835|FG000|NOT COMPLETED|Randomized||3||
48482318|NCT01878292|101518836|FG001|NOT COMPLETED|Randomized||0||
48482319|NCT01878292|101518837|FG002|NOT COMPLETED|Randomized||0||
48482320|NCT01878292|101518835|FG000|STARTED|Double-blind Treatment Period||171||
48196010|NCT03105128|100803765|FG004|NOT COMPLETED|Period 1||0||
48482321|NCT01878292|101518836|FG001|STARTED|Double-blind Treatment Period||175||
48482322|NCT01878292|101518837|FG002|STARTED|Double-blind Treatment Period||180||
48482323|NCT01878292|101518835|FG000|COMPLETED|Double-blind Treatment Period||142||
48482324|NCT01878292|101518836|FG001|COMPLETED|Double-blind Treatment Period||149||
48482325|NCT01878292|101518837|FG002|COMPLETED|Double-blind Treatment Period||161||
48482326|NCT01878292|101518835|FG000|NOT COMPLETED|Double-blind Treatment Period||29||
48482327|NCT01878292|101518836|FG001|NOT COMPLETED|Double-blind Treatment Period||26||
48482328|NCT01878292|101518837|FG002|NOT COMPLETED|Double-blind Treatment Period||19||
48482329|NCT01878292|101518835|FG000|STARTED|Double-blind Down-Taper Period||127||
48482330|NCT01878292|101518836|FG001|STARTED|Double-blind Down-Taper Period||140||
48482331|NCT01878292|101518837|FG002|STARTED|Double-blind Down-Taper Period||146||
48482332|NCT01878292|101518835|FG000|COMPLETED|Double-blind Down-Taper Period||122||
48482333|NCT01878292|101518836|FG001|COMPLETED|Double-blind Down-Taper Period||132||
48482334|NCT01878292|101518837|FG002|COMPLETED|Double-blind Down-Taper Period||142||
48482335|NCT01878292|101518835|FG000|NOT COMPLETED|Double-blind Down-Taper Period||5||
48482336|NCT01878292|101518836|FG001|NOT COMPLETED|Double-blind Down-Taper Period||8||
48482337|NCT01878292|101518837|FG002|NOT COMPLETED|Double-blind Down-Taper Period||4||
48482338|NCT00965185|101518838|FG000|STARTED|Overall Study||19||
48482339|NCT00965185|101518839|FG001|STARTED|Overall Study||21||
48482340|NCT00965185|101518838|FG000|1 Month Visit|Overall Study||18||
48482341|NCT00965185|101518839|FG001|1 Month Visit|Overall Study||21||
48482342|NCT00965185|101518838|FG000|3 Month Visit|Overall Study||18||
48482343|NCT00965185|101518839|FG001|3 Month Visit|Overall Study||21||
48482344|NCT00965185|101518838|FG000|6 Month Visit|Overall Study||18||
48482345|NCT00965185|101518839|FG001|6 Month Visit|Overall Study||21||
48482346|NCT00965185|101518838|FG000|9 Month Visit|Overall Study||18||
48482347|NCT00965185|101518839|FG001|9 Month Visit|Overall Study||21||
48482348|NCT00965185|101518838|FG000|COMPLETED|Overall Study||17||
48482349|NCT00965185|101518839|FG001|COMPLETED|Overall Study||20||
48482350|NCT00965185|101518838|FG000|NOT COMPLETED|Overall Study||2||
48482351|NCT00965185|101518839|FG001|NOT COMPLETED|Overall Study||1||
48482352|NCT01518972|101518840|FG000|STARTED|Overall Study||15||
48482353|NCT01518972|101518841|FG001|STARTED|Overall Study||15||
48482354|NCT01518972|101518840|FG000|COMPLETED|Overall Study||9||
48482355|NCT01518972|101518841|FG001|COMPLETED|Overall Study||11||
48482356|NCT01518972|101518840|FG000|NOT COMPLETED|Overall Study||6||
48482357|NCT01518972|101518841|FG001|NOT COMPLETED|Overall Study||4||
48482358|NCT03401918|101518842|FG000|STARTED|Overall Study||25||
48482359|NCT03401918|101518843|FG001|STARTED|Overall Study||16||
48482360|NCT03401918|101518842|FG000|COMPLETED|Overall Study||25||
48482361|NCT03401918|101518843|FG001|COMPLETED|Overall Study||16||
48482362|NCT03401918|101518842|FG000|NOT COMPLETED|Overall Study||0||
48482363|NCT03401918|101518843|FG001|NOT COMPLETED|Overall Study||0||
48482364|NCT02169115|101518844|FG000|STARTED|Overall Study||19||
48482365|NCT02169115|101518845|FG001|STARTED|Overall Study||21||
48482366|NCT02169115|101518846|FG002|STARTED|Overall Study||21||
48482367|NCT02169115|101518844|FG000|COMPLETED|Overall Study||19||
48482368|NCT02169115|101518845|FG001|COMPLETED|Overall Study||21||
48482369|NCT02169115|101518846|FG002|COMPLETED|Overall Study||21||
48482370|NCT02169115|101518844|FG000|NOT COMPLETED|Overall Study||0||
48482371|NCT02169115|101518845|FG001|NOT COMPLETED|Overall Study||0||
48482372|NCT02169115|101518846|FG002|NOT COMPLETED|Overall Study||0||
48482373|NCT02851992|101518847|FG000|STARTED|Overall Study||303||
48482374|NCT02851992|101518847|FG000|COMPLETED|Overall Study||41||
48482375|NCT02851992|101518847|FG000|NOT COMPLETED|Overall Study||262||
48482376|NCT01841554|101518848|FG000|STARTED|Overall Study||61||
48482377|NCT01841554|101518848|FG000|Implanted|Overall Study||60||
48482378|NCT01841554|101518848|FG000|1 Year Follow Up|Overall Study||42||
48482379|NCT01841554|101518848|FG000|COMPLETED|Overall Study||42||
48482380|NCT01841554|101518848|FG000|NOT COMPLETED|Overall Study||19||
48482381|NCT00473330|101518849|FG000|STARTED|Core Study||125||
48482382|NCT00473330|101518850|FG001|STARTED|Core Study||125||
48482383|NCT00473330|101518851|FG002|STARTED|Core Study||127||
48482384|NCT00473330|101518849|FG000|COMPLETED|Core Study||98||
48482385|NCT00473330|101518850|FG001|COMPLETED|Core Study||100||
48482386|NCT00473330|101518851|FG002|COMPLETED|Core Study||86||
48482387|NCT00473330|101518849|FG000|NOT COMPLETED|Core Study||27||
48482388|NCT00473330|101518850|FG001|NOT COMPLETED|Core Study||25||
48482389|NCT00473330|101518851|FG002|NOT COMPLETED|Core Study||41||
48482390|NCT00473330|101518849|FG000|STARTED|Open-label Extension Through Month 48||89||
48482391|NCT00473330|101518850|FG001|STARTED|Open-label Extension Through Month 48||79||
48482392|NCT00473330|101518851|FG002|STARTED|Open-label Extension Through Month 48||77||
48482393|NCT00473330|101518849|FG000|COMPLETED|Open-label Extension Through Month 48||63||
48196011|NCT03105128|100803766|FG005|NOT COMPLETED|Period 1||0||
48196012|NCT03105128|100803767|FG006|NOT COMPLETED|Period 1||0||
48196013|NCT03105128|100803761|FG000|STARTED|Period 2||0||
48196014|NCT03105128|100803762|FG001|STARTED|Period 2||0||
48196015|NCT03105128|100803763|FG002|STARTED|Period 2||0||
48196016|NCT03105128|100803764|FG003|STARTED|Period 2||67||
48196017|NCT03105128|100803765|FG004|STARTED|Period 2||68||
48196018|NCT03105128|100803766|FG005|STARTED|Period 2||67||
48196019|NCT03105128|100803767|FG006|STARTED|Period 2||76||
48196020|NCT03105128|100803761|FG000|COMPLETED|Period 2||0|Completed study|
48196021|NCT03105128|100803762|FG001|COMPLETED|Period 2||0|Completed study|
48196022|NCT03105128|100803763|FG002|COMPLETED|Period 2||0|Completed study|
48196023|NCT03105128|100803764|FG003|COMPLETED|Period 2||62|Completed study|
48196024|NCT03105128|100803765|FG004|COMPLETED|Period 2||65|Completed study|
48196025|NCT03105128|100803766|FG005|COMPLETED|Period 2||64|Completed study|
48196026|NCT03105128|100803767|FG006|COMPLETED|Period 2||74|Completed study|
48196027|NCT03105128|100803761|FG000|NOT COMPLETED|Period 2||0||
48196028|NCT03105128|100803762|FG001|NOT COMPLETED|Period 2||0||
48196029|NCT03105128|100803763|FG002|NOT COMPLETED|Period 2||0||
48196030|NCT03105128|100803764|FG003|NOT COMPLETED|Period 2||5||
48196031|NCT03105128|100803765|FG004|NOT COMPLETED|Period 2||3||
48196032|NCT03105128|100803766|FG005|NOT COMPLETED|Period 2||3||
48196033|NCT03105128|100803767|FG006|NOT COMPLETED|Period 2||2||
48196034|NCT03771898|100803768|FG000|STARTED|Overall Study||15||
48196035|NCT03771898|100803769|FG001|STARTED|Overall Study||5||
48196036|NCT03771898|100803770|FG002|STARTED|Overall Study||6||
48196037|NCT03771898|100803771|FG003|STARTED|Overall Study||9||
48196038|NCT03771898|100803772|FG004|STARTED|Overall Study||33||
48196039|NCT03771898|100803768|FG000|COMPLETED|Overall Study||12||
48196040|NCT03771898|100803769|FG001|COMPLETED|Overall Study||3||
48196041|NCT03771898|100803770|FG002|COMPLETED|Overall Study||5||
48196042|NCT03771898|100803771|FG003|COMPLETED|Overall Study||9||
48196043|NCT03771898|100803772|FG004|COMPLETED|Overall Study||0||
48196044|NCT03771898|100803768|FG000|NOT COMPLETED|Overall Study||3||
48196045|NCT03771898|100803769|FG001|NOT COMPLETED|Overall Study||2||
48196046|NCT03771898|100803770|FG002|NOT COMPLETED|Overall Study||1||
48196047|NCT03771898|100803771|FG003|NOT COMPLETED|Overall Study||0||
48196048|NCT03771898|100803772|FG004|NOT COMPLETED|Overall Study||33||
48196049|NCT05097573|100803773|FG000|STARTED|Overall Study||17||
48196050|NCT05097573|100803773|FG000|COMPLETED|Overall Study||15||
48196051|NCT05097573|100803773|FG000|NOT COMPLETED|Overall Study||2||
48196052|NCT03835546|100803774|FG000|STARTED|Overall Study||15||
48196053|NCT03835546|100803775|FG001|STARTED|Overall Study||15||
48196054|NCT03835546|100803776|FG002|STARTED|Overall Study||15||
48196055|NCT03835546|100803774|FG000|COMPLETED|Overall Study||12||
48196056|NCT03835546|100803775|FG001|COMPLETED|Overall Study||15||
48196057|NCT03835546|100803776|FG002|COMPLETED|Overall Study||15||
48196058|NCT03835546|100803774|FG000|NOT COMPLETED|Overall Study||3||
48196059|NCT03835546|100803775|FG001|NOT COMPLETED|Overall Study||0||
48196060|NCT03835546|100803776|FG002|NOT COMPLETED|Overall Study||0||
48196061|NCT01207908|100803777|FG000|STARTED|Overall Study||22||
48196062|NCT01207908|100803778|FG001|STARTED|Overall Study||22||
48196063|NCT01207908|100803777|FG000|COMPLETED|Overall Study||17||
48196064|NCT01207908|100803778|FG001|COMPLETED|Overall Study||21||
48196065|NCT01207908|100803777|FG000|NOT COMPLETED|Overall Study||5||
48196066|NCT01207908|100803778|FG001|NOT COMPLETED|Overall Study||1||
48196067|NCT00849147|100803779|FG000|STARTED|Overall Study||55||
48196068|NCT00849147|100803779|FG000|COMPLETED|Overall Study||50||
48196069|NCT00849147|100803779|FG000|NOT COMPLETED|Overall Study||5||
48196070|NCT04927975|100803780|FG000|STARTED|Period 1 (Baseline-Week 24)||46||
48196071|NCT04927975|100803781|FG001|STARTED|Period 1 (Baseline-Week 24)||0||
48196072|NCT04927975|100803782|FG002|STARTED|Period 1 (Baseline-Week 24)||0||
48196073|NCT04927975|100803783|FG003|STARTED|Period 1 (Baseline-Week 24)||49||
48196074|NCT04927975|100803784|FG004|STARTED|Period 1 (Baseline-Week 24)||47||
48196075|NCT04927975|100803785|FG005|STARTED|Period 1 (Baseline-Week 24)||43||
48196076|NCT04927975|100803780|FG000|COMPLETED|Period 1 (Baseline-Week 24)||44||
48196077|NCT04927975|100803781|FG001|COMPLETED|Period 1 (Baseline-Week 24)||0||
48196078|NCT04927975|100803782|FG002|COMPLETED|Period 1 (Baseline-Week 24)||0||
48196079|NCT04927975|100803783|FG003|COMPLETED|Period 1 (Baseline-Week 24)||46||
48196080|NCT04927975|100803784|FG004|COMPLETED|Period 1 (Baseline-Week 24)||45||
48196081|NCT04927975|100803785|FG005|COMPLETED|Period 1 (Baseline-Week 24)||38||
48196082|NCT04927975|100803780|FG000|NOT COMPLETED|Period 1 (Baseline-Week 24)||2||
48196083|NCT04927975|100803781|FG001|NOT COMPLETED|Period 1 (Baseline-Week 24)||0||
48196084|NCT04927975|100803782|FG002|NOT COMPLETED|Period 1 (Baseline-Week 24)||0||
48196085|NCT04927975|100803783|FG003|NOT COMPLETED|Period 1 (Baseline-Week 24)||3||
48196086|NCT04927975|100803784|FG004|NOT COMPLETED|Period 1 (Baseline-Week 24)||2||
48196087|NCT04927975|100803785|FG005|NOT COMPLETED|Period 1 (Baseline-Week 24)||5||
48196088|NCT04927975|100803780|FG000|STARTED|Period 2 (Week 24-52)||0||
48196089|NCT04927975|100803781|FG001|STARTED|Period 2 (Week 24-52)||21||
48196090|NCT04927975|100803782|FG002|STARTED|Period 2 (Week 24-52)||22||
48196091|NCT04927975|100803783|FG003|STARTED|Period 2 (Week 24-52)||45||
48196092|NCT04927975|100803784|FG004|STARTED|Period 2 (Week 24-52)||45||
48196093|NCT04927975|100803785|FG005|STARTED|Period 2 (Week 24-52)||33||
48196094|NCT04927975|100803780|FG000|COMPLETED|Period 2 (Week 24-52)||0||
48196095|NCT04927975|100803781|FG001|COMPLETED|Period 2 (Week 24-52)||19||
48196096|NCT04927975|100803782|FG002|COMPLETED|Period 2 (Week 24-52)||21||
48196097|NCT04927975|100803783|FG003|COMPLETED|Period 2 (Week 24-52)||39||
48196098|NCT04927975|100803784|FG004|COMPLETED|Period 2 (Week 24-52)||38||
48196099|NCT04927975|100803785|FG005|COMPLETED|Period 2 (Week 24-52)||30||
48196100|NCT04927975|100803780|FG000|NOT COMPLETED|Period 2 (Week 24-52)||0||
48196101|NCT04927975|100803781|FG001|NOT COMPLETED|Period 2 (Week 24-52)||2||
48196102|NCT04927975|100803782|FG002|NOT COMPLETED|Period 2 (Week 24-52)||1||
48196103|NCT04927975|100803783|FG003|NOT COMPLETED|Period 2 (Week 24-52)||6||
48196104|NCT04927975|100803784|FG004|NOT COMPLETED|Period 2 (Week 24-52)||7||
48196105|NCT04927975|100803785|FG005|NOT COMPLETED|Period 2 (Week 24-52)||3||
48196106|NCT00569946|100803786|FG000|STARTED|Overall Study||64||
48196107|NCT00569946|100803786|FG000|COMPLETED|Overall Study||5||
48196108|NCT00569946|100803786|FG000|NOT COMPLETED|Overall Study||59||
48196109|NCT02132702|100803787|FG000|STARTED|Overall Study||60||
48196110|NCT02132702|100803787|FG000|COMPLETED|Overall Study||52||
48196111|NCT02132702|100803787|FG000|NOT COMPLETED|Overall Study||8||
48196112|NCT00502593|100803788|FG000|STARTED|Overall Study||51||
48196113|NCT00502593|100803789|FG001|STARTED|Overall Study||18||
48196114|NCT00502593|100803790|FG002|STARTED|Overall Study||51||
48196115|NCT00502593|100803791|FG003|STARTED|Overall Study||18||
48196116|NCT00502593|100803792|FG004|STARTED|Overall Study||51||
48196117|NCT00502593|100803793|FG005|STARTED|Overall Study||17||
48196118|NCT00502593|100803794|FG006|STARTED|Overall Study||49||
48196119|NCT00502593|100803795|FG007|STARTED|Overall Study||17||
48196120|NCT00502593|100803796|FG008|STARTED|Overall Study||49||
48196121|NCT00502593|100803797|FG009|STARTED|Overall Study||17||
48196122|NCT00502593|100803798|FG010|STARTED|Overall Study||49||
48196123|NCT00502593|100803799|FG011|STARTED|Overall Study||18||
48196124|NCT00502593|100803788|FG000|COMPLETED|Overall Study||48||
48196125|NCT00502593|100803789|FG001|COMPLETED|Overall Study||16||
48196126|NCT00502593|100803790|FG002|COMPLETED|Overall Study||41||
48196127|NCT00502593|100803791|FG003|COMPLETED|Overall Study||14||
48196128|NCT00502593|100803792|FG004|COMPLETED|Overall Study||47||
48196129|NCT00502593|100803793|FG005|COMPLETED|Overall Study||17||
48196130|NCT00502593|100803794|FG006|COMPLETED|Overall Study||44||
48196131|NCT00502593|100803795|FG007|COMPLETED|Overall Study||17||
48196132|NCT00502593|100803796|FG008|COMPLETED|Overall Study||43||
48196133|NCT00502593|100803797|FG009|COMPLETED|Overall Study||17||
48196134|NCT00502593|100803798|FG010|COMPLETED|Overall Study||47||
48196135|NCT00502593|100803799|FG011|COMPLETED|Overall Study||18||
48196136|NCT00502593|100803788|FG000|NOT COMPLETED|Overall Study||3||
48196137|NCT00502593|100803789|FG001|NOT COMPLETED|Overall Study||2||
48196138|NCT00502593|100803790|FG002|NOT COMPLETED|Overall Study||10||
48196139|NCT00502593|100803791|FG003|NOT COMPLETED|Overall Study||4||
48196140|NCT00502593|100803792|FG004|NOT COMPLETED|Overall Study||4||
48196141|NCT00502593|100803793|FG005|NOT COMPLETED|Overall Study||0||
48196142|NCT00502593|100803794|FG006|NOT COMPLETED|Overall Study||5||
48196143|NCT00502593|100803795|FG007|NOT COMPLETED|Overall Study||0||
48196144|NCT00502593|100803796|FG008|NOT COMPLETED|Overall Study||6||
48196145|NCT00502593|100803797|FG009|NOT COMPLETED|Overall Study||0||
48196146|NCT00502593|100803798|FG010|NOT COMPLETED|Overall Study||2||
48196147|NCT00502593|100803799|FG011|NOT COMPLETED|Overall Study||0||
48196148|NCT03615001|100803800|FG000|STARTED|Overall Study||20||
48196149|NCT03615001|100803800|FG000|COMPLETED|Overall Study||20||
48196150|NCT03615001|100803800|FG000|NOT COMPLETED|Overall Study||0||
48196151|NCT03781804|100803801|FG000|STARTED|Overall Study||111||
48196152|NCT03781804|100803802|FG001|STARTED|Overall Study||109||
48196153|NCT03781804|100803803|FG002|STARTED|Overall Study||112||
48196154|NCT03781804|100803801|FG000|COMPLETED|Overall Study||102||
48196155|NCT03781804|100803802|FG001|COMPLETED|Overall Study||101||
48196156|NCT03781804|100803803|FG002|COMPLETED|Overall Study||96||
48196157|NCT03781804|100803801|FG000|NOT COMPLETED|Overall Study||9||
48482394|NCT00473330|101518850|FG001|COMPLETED|Open-label Extension Through Month 48||59||
48196158|NCT03781804|100803802|FG001|NOT COMPLETED|Overall Study||8||
48196159|NCT03781804|100803803|FG002|NOT COMPLETED|Overall Study||16||
48196160|NCT01913340|100803804|FG000|STARTED|Overall Study||24||
48196161|NCT01913340|100803805|FG001|STARTED|Overall Study||26||
48196162|NCT01913340|100803804|FG000|COMPLETED|Overall Study||21||
48196163|NCT01913340|100803805|FG001|COMPLETED|Overall Study||20||
48196164|NCT01913340|100803804|FG000|NOT COMPLETED|Overall Study||3||
48196165|NCT01913340|100803805|FG001|NOT COMPLETED|Overall Study||6||
48196166|NCT02086708|100803806|FG000|STARTED|Overall Study||24||
48196167|NCT02086708|100803806|FG000|COMPLETED|Overall Study||24||
48196168|NCT02086708|100803806|FG000|NOT COMPLETED|Overall Study||0||
48196169|NCT03822351|100803807|FG000|STARTED|Overall Study||67||
48196170|NCT03822351|100803808|FG001|STARTED|Overall Study||60||
48196171|NCT03822351|100803809|FG002|STARTED|Overall Study||62||
48196172|NCT03822351|100803807|FG000|COMPLETED|Overall Study||21||
48196173|NCT03822351|100803808|FG001|COMPLETED|Overall Study||29||
48196174|NCT03822351|100803809|FG002|COMPLETED|Overall Study||30||
48196175|NCT03822351|100803807|FG000|NOT COMPLETED|Overall Study||46||
48196176|NCT03822351|100803808|FG001|NOT COMPLETED|Overall Study||31||
48196177|NCT03822351|100803809|FG002|NOT COMPLETED|Overall Study||32||
48196178|NCT03383887|100803810|FG000|STARTED|Overall Study||5||
48196179|NCT03383887|100803811|FG001|STARTED|Overall Study||6||
48196180|NCT03383887|100803810|FG000|COMPLETED|Overall Study||5||
48196181|NCT03383887|100803811|FG001|COMPLETED|Overall Study||5||
48196182|NCT03383887|100803810|FG000|NOT COMPLETED|Overall Study||0||
48196183|NCT03383887|100803811|FG001|NOT COMPLETED|Overall Study||1||
48196184|NCT01250002|100803812|FG000|STARTED|Overall Study||35||
48196185|NCT01250002|100803813|FG001|STARTED|Overall Study||35||
48196186|NCT01250002|100803812|FG000|COMPLETED|Overall Study||31||
48196187|NCT01250002|100803813|FG001|COMPLETED|Overall Study||32||
48196188|NCT01250002|100803812|FG000|NOT COMPLETED|Overall Study||4||
48196189|NCT01250002|100803813|FG001|NOT COMPLETED|Overall Study||3||
48196190|NCT01740557|100803814|FG000|STARTED|Overall Study||10||
48196191|NCT01740557|100803814|FG000|COMPLETED|Overall Study||8||
48196192|NCT01740557|100803814|FG000|NOT COMPLETED|Overall Study||2||
48196193|NCT01721564|100803815|FG000|STARTED|Overall Study||8||
48196194|NCT01721564|100803815|FG000|COMPLETED|Overall Study||8||
48196195|NCT01721564|100803815|FG000|NOT COMPLETED|Overall Study||0||
48196196|NCT04163458|100803816|FG000|STARTED|Overall Study||204||
48196197|NCT04163458|100803817|FG001|STARTED|Overall Study||201||
48196198|NCT04163458|100803816|FG000|mITT|Overall Study||202||
48196199|NCT04163458|100803817|FG001|mITT|Overall Study||199||
48196200|NCT04163458|100803816|FG000|COMPLETED|Overall Study||180||
48196201|NCT04163458|100803817|FG001|COMPLETED|Overall Study||171||
48196202|NCT04163458|100803816|FG000|NOT COMPLETED|Overall Study||24||
48196203|NCT04163458|100803817|FG001|NOT COMPLETED|Overall Study||30||
48196204|NCT01501929|100803818|FG000|STARTED|First Intervention||8||
48196205|NCT01501929|100803819|FG001|STARTED|First Intervention||17||
48196206|NCT01501929|100803818|FG000|COMPLETED|First Intervention||8||
48196207|NCT01501929|100803819|FG001|COMPLETED|First Intervention||17||
48196208|NCT01501929|100803818|FG000|NOT COMPLETED|First Intervention||0||
48196209|NCT01501929|100803819|FG001|NOT COMPLETED|First Intervention||0||
48196210|NCT01501929|100803818|FG000|STARTED|Second Intervention||8||
48196211|NCT01501929|100803819|FG001|STARTED|Second Intervention||17||
48196212|NCT01501929|100803818|FG000|COMPLETED|Second Intervention||8||
48196213|NCT01501929|100803819|FG001|COMPLETED|Second Intervention||17||
48196214|NCT01501929|100803818|FG000|NOT COMPLETED|Second Intervention||0||
48196215|NCT01501929|100803819|FG001|NOT COMPLETED|Second Intervention||0||
48196216|NCT01007149|100803820|FG000|STARTED|Overall Study||20||
48196217|NCT01007149|100803821|FG001|STARTED|Overall Study||21||
48196218|NCT01007149|100803820|FG000|COMPLETED|Overall Study||20||
48482395|NCT00473330|101518851|FG002|COMPLETED|Open-label Extension Through Month 48||50||
48196219|NCT01007149|100803821|FG001|COMPLETED|Overall Study||20||
48196220|NCT01007149|100803820|FG000|NOT COMPLETED|Overall Study||0||
48482396|NCT00473330|101518849|FG000|NOT COMPLETED|Open-label Extension Through Month 48||26||
48482397|NCT00473330|101518850|FG001|NOT COMPLETED|Open-label Extension Through Month 48||20||
48482398|NCT00473330|101518851|FG002|NOT COMPLETED|Open-label Extension Through Month 48||27||
48482399|NCT00473330|101518849|FG000|STARTED|Open-label Extension Through Month 60||89||
48196221|NCT01007149|100803821|FG001|NOT COMPLETED|Overall Study||1||
48196222|NCT04622527|100803822|FG000|STARTED|Overall Study||6||
48196223|NCT04622527|100803823|FG001|STARTED|Overall Study||6||
48196224|NCT04622527|100803824|FG002|STARTED|Overall Study||6||
48196225|NCT04622527|100803825|FG003|STARTED|Overall Study||6||
48196226|NCT04622527|100803822|FG000|COMPLETED|Overall Study||6||
48196227|NCT04622527|100803823|FG001|COMPLETED|Overall Study||6||
48196228|NCT04622527|100803824|FG002|COMPLETED|Overall Study||6||
48196229|NCT04622527|100803825|FG003|COMPLETED|Overall Study||6||
48196230|NCT04622527|100803822|FG000|NOT COMPLETED|Overall Study||0||
48196231|NCT04622527|100803823|FG001|NOT COMPLETED|Overall Study||0||
48196232|NCT04622527|100803824|FG002|NOT COMPLETED|Overall Study||0||
48196233|NCT04622527|100803825|FG003|NOT COMPLETED|Overall Study||0||
48482400|NCT00473330|101518850|FG001|STARTED|Open-label Extension Through Month 60||79||
48482401|NCT00473330|101518851|FG002|STARTED|Open-label Extension Through Month 60||77||
48482402|NCT00473330|101518849|FG000|COMPLETED|Open-label Extension Through Month 60||1||
48482403|NCT00473330|101518850|FG001|COMPLETED|Open-label Extension Through Month 60||1||
48482404|NCT00473330|101518851|FG002|COMPLETED|Open-label Extension Through Month 60||0||
48482405|NCT00473330|101518849|FG000|NOT COMPLETED|Open-label Extension Through Month 60||88||
48482406|NCT00473330|101518850|FG001|NOT COMPLETED|Open-label Extension Through Month 60||78||
48196234|NCT03006341|100803826|FG000|STARTED|Overall Study||26199|Eligible in the claims database|
48482407|NCT00473330|101518851|FG002|NOT COMPLETED|Open-label Extension Through Month 60||77||
48482408|NCT03585790|101518852|FG000|STARTED|First Intervention (1 Week)||23|First intervention|
48482409|NCT03585790|101518853|FG001|STARTED|First Intervention (1 Week)||22|First intervention|
48482410|NCT03585790|101518852|FG000|COMPLETED|First Intervention (1 Week)||23||
48482411|NCT03585790|101518853|FG001|COMPLETED|First Intervention (1 Week)||22||
48482412|NCT03585790|101518852|FG000|NOT COMPLETED|First Intervention (1 Week)||0||
48482413|NCT03585790|101518853|FG001|NOT COMPLETED|First Intervention (1 Week)||0||
48196235|NCT03006341|100803827|FG001|STARTED|Overall Study||70071|Eligible in the claims database|
48196236|NCT03006341|100803828|FG002|STARTED|Overall Study||32595|Eligible in the claims database|
48196237|NCT03006341|100803829|FG003|STARTED|Overall Study||11322|Eligible in the claims database|
48196238|NCT03006341|100803826|FG000|COMPLETED|Overall Study||1130|Successfully linked in the EMR but not necessarily propensity score matched|
48196239|NCT03006341|100803827|FG001|COMPLETED|Overall Study||2566|Successfully linked in the EMR but not necessarily propensity score matched|
48196240|NCT03006341|100803828|FG002|COMPLETED|Overall Study||1602|Successfully linked in the EMR but not necessarily propensity score matched|
48196241|NCT03006341|100803829|FG003|COMPLETED|Overall Study||637|Successfully linked in the EMR but not necessarily propensity score matched|
48196242|NCT03006341|100803826|FG000|NOT COMPLETED|Overall Study||25069||
48196243|NCT03006341|100803827|FG001|NOT COMPLETED|Overall Study||67505||
48196244|NCT03006341|100803828|FG002|NOT COMPLETED|Overall Study||30993||
48196245|NCT03006341|100803829|FG003|NOT COMPLETED|Overall Study||10685||
48196246|NCT00100659|100803830|FG000|STARTED|Overall Study||55||
48196247|NCT00100659|100803831|FG001|STARTED|Overall Study||59||
48196248|NCT00100659|100803830|FG000|COMPLETED|Overall Study||52||
48196249|NCT00100659|100803831|FG001|COMPLETED|Overall Study||57||
48196250|NCT00100659|100803830|FG000|NOT COMPLETED|Overall Study||3||
48196251|NCT00100659|100803831|FG001|NOT COMPLETED|Overall Study||2||
48196252|NCT04697069|100803832|FG000|STARTED|Overall Study||2||
48196253|NCT04697069|100803833|FG001|STARTED|Overall Study||2||
48196254|NCT04697069|100803832|FG000|COMPLETED|Overall Study||0||
48196255|NCT04697069|100803833|FG001|COMPLETED|Overall Study||0||
48196256|NCT04697069|100803832|FG000|NOT COMPLETED|Overall Study||2||
48196257|NCT04697069|100803833|FG001|NOT COMPLETED|Overall Study||2||
48196258|NCT02162667|100803834|FG000|STARTED|Neoadjuvant Period||278||
48196259|NCT02162667|100803835|FG001|STARTED|Neoadjuvant Period||284||
48196260|NCT02162667|100803834|FG000|COMPLETED|Neoadjuvant Period||264|the number of patients who completed 8 cycles of the Neoadjuvant Period and underwent surgery.|
48196261|NCT02162667|100803835|FG001|COMPLETED|Neoadjuvant Period||267|the number of patients who completed 8 cycles of the Neoadjuvant Period and underwent surgery.|
48196262|NCT02162667|100803834|FG000|NOT COMPLETED|Neoadjuvant Period||14||
48196263|NCT02162667|100803835|FG001|NOT COMPLETED|Neoadjuvant Period||17||
48196264|NCT02162667|100803834|FG000|STARTED|Adjuvant Period||260||
48196265|NCT02162667|100803835|FG001|STARTED|Adjuvant Period||268||
48196266|NCT02162667|100803834|FG000|COMPLETED|Adjuvant Period||248||
48196267|NCT02162667|100803835|FG001|COMPLETED|Adjuvant Period||255||
48196268|NCT02162667|100803834|FG000|NOT COMPLETED|Adjuvant Period||12||
48196269|NCT02162667|100803835|FG001|NOT COMPLETED|Adjuvant Period||13||
48196270|NCT01704846|100803836|FG000|STARTED|Treatment Period 1||30||
48196271|NCT01704846|100803837|FG001|STARTED|Treatment Period 1||30||
48196272|NCT01704846|100803836|FG000|COMPLETED|Treatment Period 1||30||
48196273|NCT01704846|100803837|FG001|COMPLETED|Treatment Period 1||30||
48196274|NCT01704846|100803836|FG000|NOT COMPLETED|Treatment Period 1||0||
48196275|NCT01704846|100803837|FG001|NOT COMPLETED|Treatment Period 1||0||
48196276|NCT01704846|100803836|FG000|STARTED|Treatment Period 2||30||
48196277|NCT01704846|100803837|FG001|STARTED|Treatment Period 2||30||
48196278|NCT01704846|100803836|FG000|COMPLETED|Treatment Period 2||30||
48196279|NCT01704846|100803837|FG001|COMPLETED|Treatment Period 2||29||
48196280|NCT01704846|100803836|FG000|NOT COMPLETED|Treatment Period 2||0||
48196281|NCT01704846|100803837|FG001|NOT COMPLETED|Treatment Period 2||1||
48196282|NCT01704846|100803836|FG000|STARTED|Treatment Period 3||30||
48196283|NCT01704846|100803837|FG001|STARTED|Treatment Period 3||29||
48196284|NCT01704846|100803836|FG000|COMPLETED|Treatment Period 3||30||
48196285|NCT01704846|100803837|FG001|COMPLETED|Treatment Period 3||29||
48196286|NCT01704846|100803836|FG000|NOT COMPLETED|Treatment Period 3||0||
48196287|NCT01704846|100803837|FG001|NOT COMPLETED|Treatment Period 3||0||
48196288|NCT01704846|100803836|FG000|STARTED|Treatment Period 4||30||
48196289|NCT01704846|100803837|FG001|STARTED|Treatment Period 4||29||
48196290|NCT01704846|100803836|FG000|COMPLETED|Treatment Period 4||30||
48196291|NCT01704846|100803837|FG001|COMPLETED|Treatment Period 4||29||
48482414|NCT03585790|101518852|FG000|STARTED|Second Intervention (1 Week)||23||
48482415|NCT03585790|101518853|FG001|STARTED|Second Intervention (1 Week)||22||
48482416|NCT03585790|101518852|FG000|COMPLETED|Second Intervention (1 Week)||23||
48482417|NCT03585790|101518853|FG001|COMPLETED|Second Intervention (1 Week)||22||
48482418|NCT03585790|101518852|FG000|NOT COMPLETED|Second Intervention (1 Week)||0||
48196292|NCT01704846|100803836|FG000|NOT COMPLETED|Treatment Period 4||0||
48196293|NCT01704846|100803837|FG001|NOT COMPLETED|Treatment Period 4||0||
48196294|NCT03213678|100803838|FG000|STARTED|Overall Study||18||
48196295|NCT03213678|100803838|FG000|COMPLETED|Overall Study||0||
48196296|NCT03213678|100803838|FG000|NOT COMPLETED|Overall Study||18||
48482419|NCT03585790|101518853|FG001|NOT COMPLETED|Second Intervention (1 Week)||0||
48482420|NCT00837486|101518854|FG000|STARTED|Blinded-treatment Phase||16||
48196297|NCT03360396|100803839|FG000|STARTED|Overall Study||80||
48196298|NCT03360396|100803840|FG001|STARTED|Overall Study||40||
48196299|NCT03360396|100803839|FG000|COMPLETED|Overall Study||0||
48196300|NCT03360396|100803840|FG001|COMPLETED|Overall Study||0||
48196301|NCT03360396|100803839|FG000|NOT COMPLETED|Overall Study||80||
48196302|NCT03360396|100803840|FG001|NOT COMPLETED|Overall Study||40||
48196303|NCT02467491|100803841|FG000|STARTED|Overall Study||12||
48196304|NCT02467491|100803841|FG000|COMPLETED|Overall Study||12||
48196305|NCT02467491|100803841|FG000|NOT COMPLETED|Overall Study||0||
48196306|NCT03098030|100803842|FG000|STARTED|Overall Study||12||
48196307|NCT03098030|100803843|FG001|STARTED|Overall Study||187||
48196308|NCT03098030|100803844|FG002|STARTED|Overall Study||190||
48196309|NCT03098030|100803845|FG003|STARTED|Overall Study||94||
48196310|NCT03098030|100803842|FG000|COMPLETED|Overall Study||2||
48196311|NCT03098030|100803843|FG001|COMPLETED|Overall Study||24||
48196312|NCT03098030|100803844|FG002|COMPLETED|Overall Study||24||
48196313|NCT03098030|100803845|FG003|COMPLETED|Overall Study||9||
48196314|NCT03098030|100803842|FG000|NOT COMPLETED|Overall Study||10||
48196315|NCT03098030|100803843|FG001|NOT COMPLETED|Overall Study||163||
48196316|NCT03098030|100803844|FG002|NOT COMPLETED|Overall Study||166||
48196317|NCT03098030|100803845|FG003|NOT COMPLETED|Overall Study||85||
48196318|NCT03210402|100803846|FG000|STARTED|Overall Study||9|(Randomization after baseline period)|
48196319|NCT03210402|100803847|FG001|STARTED|Overall Study||5|(Randomization after baseline period)|
48196320|NCT03210402|100803846|FG000|COMPLETED|Overall Study||9||
48196321|NCT03210402|100803847|FG001|COMPLETED|Overall Study||4||
48196322|NCT03210402|100803846|FG000|NOT COMPLETED|Overall Study||0||
48196323|NCT03210402|100803847|FG001|NOT COMPLETED|Overall Study||1||
48196324|NCT02322216|100803848|FG000|STARTED|Overall Study||126||
48196325|NCT02322216|100803849|FG001|STARTED|Overall Study||127||
48196326|NCT02322216|100803848|FG000|Treated (Safety Set)|Overall Study||126||
48196327|NCT02322216|100803849|FG001|Treated (Safety Set)|Overall Study||126||
48196328|NCT02322216|100803848|FG000|Per Protocol Set (PPS)|Overall Study||123||
48196329|NCT02322216|100803849|FG001|Per Protocol Set (PPS)|Overall Study||122||
48482421|NCT00837486|101518855|FG001|STARTED|Blinded-treatment Phase||14||
48482422|NCT00837486|101518854|FG000|COMPLETED|Blinded-treatment Phase||15||
48482423|NCT00837486|101518855|FG001|COMPLETED|Blinded-treatment Phase||14||
48482424|NCT00837486|101518854|FG000|NOT COMPLETED|Blinded-treatment Phase||1||
48482425|NCT00837486|101518855|FG001|NOT COMPLETED|Blinded-treatment Phase||0||
48482426|NCT00837486|101518854|FG000|STARTED|Long-term Follow-up Phase - Open Label||29||
48482427|NCT00837486|101518855|FG001|STARTED|Long-term Follow-up Phase - Open Label||0||
48482428|NCT00837486|101518854|FG000|COMPLETED|Long-term Follow-up Phase - Open Label||24||
48482429|NCT00837486|101518855|FG001|COMPLETED|Long-term Follow-up Phase - Open Label||0||
48482430|NCT00837486|101518854|FG000|NOT COMPLETED|Long-term Follow-up Phase - Open Label||5||
48482431|NCT00837486|101518855|FG001|NOT COMPLETED|Long-term Follow-up Phase - Open Label||0||
48482432|NCT01439880|101518856|FG000|STARTED|SOC-controlled Period (Year 1)||442||
48196330|NCT02322216|100803848|FG000|COMPLETED|Overall Study||124||
48196331|NCT02322216|100803849|FG001|COMPLETED|Overall Study||123||
48196332|NCT02322216|100803848|FG000|NOT COMPLETED|Overall Study||2||
48196333|NCT02322216|100803849|FG001|NOT COMPLETED|Overall Study||4||
48196334|NCT01560949|100803850|FG000|STARTED|Systemic Phase: mFOLFIRINOX||33||
48196335|NCT01560949|100803850|FG000|COMPLETED|Systemic Phase: mFOLFIRINOX||27||
48196336|NCT01560949|100803850|FG000|NOT COMPLETED|Systemic Phase: mFOLFIRINOX||6||
48196337|NCT01560949|100803850|FG000|STARTED|Chemoradiation Phase: With Gemcitabine||23||
48196338|NCT01560949|100803850|FG000|COMPLETED|Chemoradiation Phase: With Gemcitabine||23||
48482433|NCT01439880|101518857|FG001|STARTED|SOC-controlled Period (Year 1)||882||
48482434|NCT01439880|101518856|FG000|Received Evolocumab|SOC-controlled Period (Year 1)||0||
48482435|NCT01439880|101518857|FG001|Received Evolocumab|SOC-controlled Period (Year 1)||881||
48482436|NCT01439880|101518856|FG000|COMPLETED|SOC-controlled Period (Year 1)||398||
48482437|NCT01439880|101518857|FG001|COMPLETED|SOC-controlled Period (Year 1)||822||
48482438|NCT01439880|101518856|FG000|NOT COMPLETED|SOC-controlled Period (Year 1)||44||
48482439|NCT01439880|101518857|FG001|NOT COMPLETED|SOC-controlled Period (Year 1)||60||
48482440|NCT01439880|101518856|FG000|STARTED|All-IP Period (Years 2 to 5)||398||
48482441|NCT01439880|101518857|FG001|STARTED|All-IP Period (Years 2 to 5)||822||
48482442|NCT01439880|101518856|FG000|Received Evolocumab|All-IP Period (Years 2 to 5)||374||
48482443|NCT01439880|101518857|FG001|Received Evolocumab|All-IP Period (Years 2 to 5)||777||
48482444|NCT01439880|101518856|FG000|COMPLETED|All-IP Period (Years 2 to 5)||328||
48482445|NCT01439880|101518857|FG001|COMPLETED|All-IP Period (Years 2 to 5)||682||
48482446|NCT01439880|101518856|FG000|NOT COMPLETED|All-IP Period (Years 2 to 5)||70||
48482447|NCT01439880|101518857|FG001|NOT COMPLETED|All-IP Period (Years 2 to 5)||140||
48482448|NCT00355797|101518858|FG000|STARTED|Overall Study||741||
48482449|NCT00355797|101518859|FG001|STARTED|Overall Study||369||
48482450|NCT00355797|101518860|FG002|STARTED|Overall Study||381||
48482451|NCT00355797|101518858|FG000|COMPLETED|Overall Study||501||
48482452|NCT00355797|101518859|FG001|COMPLETED|Overall Study||221||
48482453|NCT00355797|101518860|FG002|COMPLETED|Overall Study||239||
48482454|NCT00355797|101518858|FG000|NOT COMPLETED|Overall Study||240||
48482455|NCT00355797|101518859|FG001|NOT COMPLETED|Overall Study||148||
48196339|NCT01560949|100803850|FG000|NOT COMPLETED|Chemoradiation Phase: With Gemcitabine||0||
48196340|NCT01560949|100803850|FG000|STARTED|Surgery Phase||18||
48196341|NCT01560949|100803850|FG000|COMPLETED|Surgery Phase||15||
48196342|NCT01560949|100803850|FG000|NOT COMPLETED|Surgery Phase||3||
48196343|NCT05887323|100803851|FG000|STARTED|Overall Study||221||
48196344|NCT05887323|100803851|FG000|Implant Attempt|Overall Study||221||
48196345|NCT05887323|100803851|FG000|6-Month|Overall Study||221||
48196346|NCT05887323|100803851|FG000|COMPLETED|Overall Study||221||
48196347|NCT05887323|100803851|FG000|NOT COMPLETED|Overall Study||0||
48196348|NCT03766438|100803852|FG000|STARTED|Overall Study||227||
48196349|NCT03766438|100803853|FG001|STARTED|Overall Study||224||
48196350|NCT03766438|100803852|FG000|COMPLETED|Overall Study||191||
48196351|NCT03766438|100803853|FG001|COMPLETED|Overall Study||199||
48196352|NCT03766438|100803852|FG000|NOT COMPLETED|Overall Study||36||
48196353|NCT03766438|100803853|FG001|NOT COMPLETED|Overall Study||25||
48196354|NCT03028363|100803854|FG000|STARTED|Overall Study||498||
48196355|NCT03028363|100803855|FG001|STARTED|Overall Study||261||
48196356|NCT03028363|100803854|FG000|COMPLETED|Overall Study||420||
48196357|NCT03028363|100803855|FG001|COMPLETED|Overall Study||228||
48196358|NCT03028363|100803854|FG000|NOT COMPLETED|Overall Study||78||
48196359|NCT03028363|100803855|FG001|NOT COMPLETED|Overall Study||33||
48196360|NCT01335789|100803856|FG000|STARTED|Overall Study||8||
48196361|NCT01335789|100803857|FG001|STARTED|Overall Study||8||
48196362|NCT01335789|100803856|FG000|COMPLETED|Overall Study||8||
48196363|NCT01335789|100803857|FG001|COMPLETED|Overall Study||8||
48196364|NCT01335789|100803856|FG000|NOT COMPLETED|Overall Study||0||
48196365|NCT01335789|100803857|FG001|NOT COMPLETED|Overall Study||0||
48196366|NCT00360126|100803858|FG000|STARTED|Overall Study||11||
48196367|NCT00360126|100803858|FG000|COMPLETED|Overall Study||11||
48196368|NCT00360126|100803858|FG000|NOT COMPLETED|Overall Study||0||
48196369|NCT01720446|100803859|FG000|STARTED|Overall Study||826||
48196370|NCT01720446|100803860|FG001|STARTED|Overall Study||822||
48196371|NCT01720446|100803861|FG002|STARTED|Overall Study||824||
48196372|NCT01720446|100803862|FG003|STARTED|Overall Study||825||
48196373|NCT01720446|100803859|FG000|Premature Treatment Discontinuers|Overall Study||164||
48196374|NCT01720446|100803860|FG001|Premature Treatment Discontinuers|Overall Study||186||
48196375|NCT01720446|100803861|FG002|Premature Treatment Discontinuers|Overall Study||151||
48196376|NCT01720446|100803862|FG003|Premature Treatment Discontinuers|Overall Study||159||
48196377|NCT01720446|100803859|FG000|COMPLETED|Overall Study||812||
48196378|NCT01720446|100803860|FG001|COMPLETED|Overall Study||811||
48196379|NCT01720446|100803861|FG002|COMPLETED|Overall Study||804||
48196380|NCT01720446|100803862|FG003|COMPLETED|Overall Study||805||
48196381|NCT01720446|100803859|FG000|NOT COMPLETED|Overall Study||14||
48196382|NCT01720446|100803860|FG001|NOT COMPLETED|Overall Study||11||
48196383|NCT01720446|100803861|FG002|NOT COMPLETED|Overall Study||20||
48196384|NCT01720446|100803862|FG003|NOT COMPLETED|Overall Study||20||
48196385|NCT01195675|100803863|FG000|STARTED|Overall Study||30||
48196386|NCT01195675|100803863|FG000|Received Empa 25mg|Overall Study||28||
48196387|NCT01195675|100803863|FG000|Received Empa 200mg|Overall Study||30||
48196388|NCT01195675|100803863|FG000|Received Moxifloxacin|Overall Study||29||
48196389|NCT01195675|100803863|FG000|Received Placebo 1|Overall Study||29||
48196390|NCT01195675|100803863|FG000|Received Placebo 2|Overall Study||28||
48196391|NCT01195675|100803863|FG000|COMPLETED|Overall Study||27||
48196392|NCT01195675|100803863|FG000|NOT COMPLETED|Overall Study||3||
48196393|NCT03721016|100803864|FG000|STARTED|Overall Study||82||
48196394|NCT03721016|100803865|FG001|STARTED|Overall Study||173||
48196395|NCT03721016|100803866|FG002|STARTED|Overall Study||160||
48196396|NCT03721016|100803864|FG000|COMPLETED|Overall Study||66||
48196397|NCT03721016|100803865|FG001|COMPLETED|Overall Study||141||
48196398|NCT03721016|100803866|FG002|COMPLETED|Overall Study||133||
48196399|NCT03721016|100803864|FG000|NOT COMPLETED|Overall Study||16||
48482456|NCT00355797|101518860|FG002|NOT COMPLETED|Overall Study||142||
48482457|NCT03912337|101518861|FG000|STARTED|Overall Study||15||
48196400|NCT03721016|100803865|FG001|NOT COMPLETED|Overall Study||32||
48196401|NCT03721016|100803866|FG002|NOT COMPLETED|Overall Study||27||
48196402|NCT03593070|100803867|FG000|STARTED|Overall Study||50||
48196403|NCT03593070|100803868|FG001|STARTED|Overall Study||49||
48196404|NCT03593070|100803867|FG000|COMPLETED|Overall Study||49||
48196405|NCT03593070|100803868|FG001|COMPLETED|Overall Study||48||
48196406|NCT03593070|100803867|FG000|NOT COMPLETED|Overall Study||1||
48196407|NCT03593070|100803868|FG001|NOT COMPLETED|Overall Study||1||
48196408|NCT03586544|100803869|FG000|STARTED|First Intervention||6||
48196409|NCT03586544|100803870|FG001|STARTED|First Intervention||12||
48196410|NCT03586544|100803869|FG000|COMPLETED|First Intervention||6||
48196411|NCT03586544|100803870|FG001|COMPLETED|First Intervention||11||
48196412|NCT03586544|100803869|FG000|NOT COMPLETED|First Intervention||0||
48196413|NCT03586544|100803870|FG001|NOT COMPLETED|First Intervention||1||
48196414|NCT03586544|100803869|FG000|STARTED|Second Intervention||6||
48196415|NCT03586544|100803870|FG001|STARTED|Second Intervention||11||
48196416|NCT03586544|100803869|FG000|COMPLETED|Second Intervention||6||
48196417|NCT03586544|100803870|FG001|COMPLETED|Second Intervention||10||
48196418|NCT03586544|100803869|FG000|NOT COMPLETED|Second Intervention||0||
48196419|NCT03586544|100803870|FG001|NOT COMPLETED|Second Intervention||1||
48196420|NCT02824432|100803871|FG000|STARTED|Overall Study||18||
48196421|NCT02824432|100803872|FG001|STARTED|Overall Study||19||
48196422|NCT02824432|100803871|FG000|COMPLETED|Overall Study||17||
48196423|NCT02824432|100803872|FG001|COMPLETED|Overall Study||19||
48196424|NCT02824432|100803871|FG000|NOT COMPLETED|Overall Study||1||
48482458|NCT03912337|101518862|FG001|STARTED|Overall Study||14||
48482459|NCT03912337|101518861|FG000|COMPLETED|Overall Study||13||
48482460|NCT03912337|101518862|FG001|COMPLETED|Overall Study||13||
48482461|NCT03912337|101518861|FG000|NOT COMPLETED|Overall Study||2||
48482462|NCT03912337|101518862|FG001|NOT COMPLETED|Overall Study||1||
48482463|NCT03287310|101518863|FG000|STARTED|Overall Study||12||
48482464|NCT03287310|101518864|FG001|STARTED|Overall Study||6||
48482465|NCT03287310|101518865|FG002|STARTED|Overall Study||6||
48482466|NCT03287310|101518866|FG003|STARTED|Overall Study||9||
48482467|NCT03287310|101518867|FG004|STARTED|Overall Study||9||
48482468|NCT03287310|101518868|FG005|STARTED|Overall Study||6||
48482469|NCT03287310|101518863|FG000|COMPLETED|Overall Study||12||
48482470|NCT03287310|101518864|FG001|COMPLETED|Overall Study||6||
48482471|NCT03287310|101518865|FG002|COMPLETED|Overall Study||6||
48482472|NCT03287310|101518866|FG003|COMPLETED|Overall Study||9||
48482473|NCT03287310|101518867|FG004|COMPLETED|Overall Study||9||
48482474|NCT03287310|101518868|FG005|COMPLETED|Overall Study||6||
48482475|NCT03287310|101518863|FG000|NOT COMPLETED|Overall Study||0||
48482476|NCT03287310|101518864|FG001|NOT COMPLETED|Overall Study||0||
48482477|NCT03287310|101518865|FG002|NOT COMPLETED|Overall Study||0||
48482478|NCT03287310|101518866|FG003|NOT COMPLETED|Overall Study||0||
48482479|NCT03287310|101518867|FG004|NOT COMPLETED|Overall Study||0||
48482480|NCT03287310|101518868|FG005|NOT COMPLETED|Overall Study||0||
48482481|NCT03988803|101518869|FG000|STARTED|Screening||16||
48482482|NCT03988803|101518869|FG000|COMPLETED|Screening||16||
48482483|NCT03988803|101518869|FG000|NOT COMPLETED|Screening||0||
48482484|NCT03988803|101518869|FG000|STARTED|Period 1||16||
48482485|NCT03988803|101518869|FG000|COMPLETED|Period 1||16||
48482486|NCT03988803|101518869|FG000|NOT COMPLETED|Period 1||0||
48482487|NCT03988803|101518869|FG000|STARTED|Period 2||16||
48482488|NCT03988803|101518869|FG000|Treated|Period 2||15||
48482489|NCT03988803|101518869|FG000|Started Days 1 - 7: Multiple Doses of 5 mg Memantine qd|Period 2||15||
48482490|NCT03988803|101518869|FG000|Started Days 8 - 14: Multiple Doses of 10 mg Memantine qd|Period 2||14||
48482491|NCT03988803|101518869|FG000|Started Days 15 - 21: Multiple Doses of 15 mg Memantine qd|Period 2||13||
48482492|NCT03988803|101518869|FG000|Started Days 22 - 35: Multiple Doses of 20 mg Memantine qd|Period 2||13||
48482493|NCT03988803|101518869|FG000|COMPLETED|Period 2||13||
48482494|NCT03988803|101518869|FG000|NOT COMPLETED|Period 2||3||
48482495|NCT03988803|101518869|FG000|STARTED|Period 3||13||
48482496|NCT03988803|101518869|FG000|COMPLETED|Period 3||13||
48482497|NCT03988803|101518869|FG000|NOT COMPLETED|Period 3||0||
48482498|NCT04860804|101518870|FG000|STARTED|Overall Study||30||
48482499|NCT04860804|101518871|FG001|STARTED|Overall Study||30||
48482500|NCT04860804|101518870|FG000|COMPLETED|Overall Study||28||
48482501|NCT04860804|101518871|FG001|COMPLETED|Overall Study||28||
48482502|NCT04860804|101518870|FG000|NOT COMPLETED|Overall Study||2||
48482503|NCT04860804|101518871|FG001|NOT COMPLETED|Overall Study||2||
48482504|NCT01624363|101518872|FG000|STARTED|Overall Study||341||
48482505|NCT01624363|101518872|FG000|COMPLETED|Overall Study||341||
48482506|NCT01624363|101518872|FG000|NOT COMPLETED|Overall Study||0||
48482507|NCT00603187|101518873|FG000|STARTED|Overall Study||4||
48482508|NCT00603187|101518873|FG000|COMPLETED|Overall Study||4||
48482509|NCT00603187|101518873|FG000|NOT COMPLETED|Overall Study||0||
48482510|NCT02350647|101518874|FG000|STARTED|Overall Study||32||
48196425|NCT02824432|100803872|FG001|NOT COMPLETED|Overall Study||0||
48196426|NCT01234532|100803873|FG000|STARTED|Overall Study||5||
48196427|NCT01234532|100803873|FG000|COMPLETED|Overall Study||5||
48196428|NCT01234532|100803873|FG000|NOT COMPLETED|Overall Study||0||
48482511|NCT02350647|101518875|FG001|STARTED|Overall Study||32||
48482512|NCT02350647|101518874|FG000|COMPLETED|Overall Study||26||
48482513|NCT02350647|101518875|FG001|COMPLETED|Overall Study||26||
48482514|NCT02350647|101518874|FG000|NOT COMPLETED|Overall Study||6||
48482515|NCT02350647|101518875|FG001|NOT COMPLETED|Overall Study||6||
48482516|NCT02979522|101518876|FG000|STARTED|Overall Study||8||
48482517|NCT02979522|101518877|FG001|STARTED|Overall Study||51||
48482518|NCT02979522|101518876|FG000|COMPLETED|Overall Study||0||
48482519|NCT02979522|101518877|FG001|COMPLETED|Overall Study||0||
48482520|NCT02979522|101518876|FG000|NOT COMPLETED|Overall Study||8||
48482521|NCT02979522|101518877|FG001|NOT COMPLETED|Overall Study||51||
48482522|NCT04881968|101518878|FG000|STARTED|Overall Study||1261||
48482523|NCT04881968|101518878|FG000|COMPLETED|Overall Study||1261||
48482524|NCT04881968|101518878|FG000|NOT COMPLETED|Overall Study||0||
48482525|NCT02942264|101518879|FG000|STARTED|Phase 1 MTD Finding Stage||6||
48482526|NCT02942264|101518880|FG001|STARTED|Phase 1 MTD Finding Stage||13||
48482527|NCT02942264|101518881|FG002|STARTED|Phase 1 MTD Finding Stage||3||
48482528|NCT02942264|101518882|FG003|STARTED|Phase 1 MTD Finding Stage||6||
48482529|NCT02942264|101518883|FG004|STARTED|Phase 1 MTD Finding Stage||3||
48482530|NCT02942264|101518884|FG005|STARTED|Phase 1 MTD Finding Stage||2||
48482531|NCT02942264|101518885|FG006|STARTED|Phase 1 MTD Finding Stage||7||
48482532|NCT02942264|101518886|FG007|STARTED|Phase 1 MTD Finding Stage||0||
48482533|NCT02942264|101518887|FG008|STARTED|Phase 1 MTD Finding Stage||0||
48482534|NCT02942264|101518879|FG000|COMPLETED|Phase 1 MTD Finding Stage||6||
48482535|NCT02942264|101518880|FG001|COMPLETED|Phase 1 MTD Finding Stage||12||
48482536|NCT02942264|101518881|FG002|COMPLETED|Phase 1 MTD Finding Stage||3||
48482537|NCT02942264|101518882|FG003|COMPLETED|Phase 1 MTD Finding Stage||6||
48482538|NCT02942264|101518883|FG004|COMPLETED|Phase 1 MTD Finding Stage||3||
48482539|NCT02942264|101518884|FG005|COMPLETED|Phase 1 MTD Finding Stage||2||
48482540|NCT02942264|101518885|FG006|COMPLETED|Phase 1 MTD Finding Stage||6||
48482541|NCT02942264|101518886|FG007|COMPLETED|Phase 1 MTD Finding Stage||0||
48482542|NCT02942264|101518887|FG008|COMPLETED|Phase 1 MTD Finding Stage||0||
48482543|NCT02942264|101518879|FG000|NOT COMPLETED|Phase 1 MTD Finding Stage||0||
48482544|NCT02942264|101518880|FG001|NOT COMPLETED|Phase 1 MTD Finding Stage||1||
48482545|NCT02942264|101518881|FG002|NOT COMPLETED|Phase 1 MTD Finding Stage||0||
48482546|NCT02942264|101518882|FG003|NOT COMPLETED|Phase 1 MTD Finding Stage||0||
48482547|NCT02942264|101518883|FG004|NOT COMPLETED|Phase 1 MTD Finding Stage||0||
48482548|NCT02942264|101518884|FG005|NOT COMPLETED|Phase 1 MTD Finding Stage||0||
48482549|NCT02942264|101518885|FG006|NOT COMPLETED|Phase 1 MTD Finding Stage||1||
48482550|NCT02942264|101518886|FG007|NOT COMPLETED|Phase 1 MTD Finding Stage||0||
48482551|NCT02942264|101518887|FG008|NOT COMPLETED|Phase 1 MTD Finding Stage||0||
48482552|NCT02942264|101518879|FG000|STARTED|Phase 1 Cohort Expansion Stage||0||
48482553|NCT02942264|101518880|FG001|STARTED|Phase 1 Cohort Expansion Stage||0||
48482554|NCT02942264|101518881|FG002|STARTED|Phase 1 Cohort Expansion Stage||0||
48482555|NCT02942264|101518882|FG003|STARTED|Phase 1 Cohort Expansion Stage||0||
48482556|NCT02942264|101518883|FG004|STARTED|Phase 1 Cohort Expansion Stage||0||
48482557|NCT02942264|101518884|FG005|STARTED|Phase 1 Cohort Expansion Stage||0||
48482558|NCT02942264|101518885|FG006|STARTED|Phase 1 Cohort Expansion Stage||0||
48482559|NCT02942264|101518886|FG007|STARTED|Phase 1 Cohort Expansion Stage||6||
48482560|NCT02942264|101518887|FG008|STARTED|Phase 1 Cohort Expansion Stage||7||
48482561|NCT02942264|101518879|FG000|COMPLETED|Phase 1 Cohort Expansion Stage||0||
48482562|NCT02942264|101518880|FG001|COMPLETED|Phase 1 Cohort Expansion Stage||0||
48482563|NCT02942264|101518881|FG002|COMPLETED|Phase 1 Cohort Expansion Stage||0||
48482564|NCT02942264|101518882|FG003|COMPLETED|Phase 1 Cohort Expansion Stage||0||
48482565|NCT02942264|101518883|FG004|COMPLETED|Phase 1 Cohort Expansion Stage||0||
48482566|NCT02942264|101518884|FG005|COMPLETED|Phase 1 Cohort Expansion Stage||0||
48482567|NCT02942264|101518885|FG006|COMPLETED|Phase 1 Cohort Expansion Stage||0||
48482568|NCT02942264|101518886|FG007|COMPLETED|Phase 1 Cohort Expansion Stage||6||
48482569|NCT02942264|101518887|FG008|COMPLETED|Phase 1 Cohort Expansion Stage||6||
48482570|NCT02942264|101518879|FG000|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0||
48482571|NCT02942264|101518880|FG001|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0||
48482572|NCT02942264|101518881|FG002|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0||
48482573|NCT02942264|101518882|FG003|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0||
48482574|NCT02942264|101518883|FG004|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0||
48482575|NCT02942264|101518884|FG005|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0||
48482576|NCT02942264|101518885|FG006|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0||
48482577|NCT02942264|101518886|FG007|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0||
48482578|NCT02942264|101518887|FG008|NOT COMPLETED|Phase 1 Cohort Expansion Stage||1||
48482579|NCT02682784|101518888|FG000|STARTED|Overall Study||40||
48482580|NCT02682784|101518889|FG001|STARTED|Overall Study||37||
48482581|NCT02682784|101518890|FG002|STARTED|Overall Study||29||
48482582|NCT02682784|101518891|FG003|STARTED|Overall Study||32||
48482583|NCT02682784|101518888|FG000|COMPLETED|Overall Study||39||
48482584|NCT02682784|101518889|FG001|COMPLETED|Overall Study||35||
48482585|NCT02682784|101518890|FG002|COMPLETED|Overall Study||27||
48482586|NCT02682784|101518891|FG003|COMPLETED|Overall Study||29||
48482587|NCT02682784|101518888|FG000|NOT COMPLETED|Overall Study||1||
48482588|NCT02682784|101518889|FG001|NOT COMPLETED|Overall Study||2||
48482589|NCT02682784|101518890|FG002|NOT COMPLETED|Overall Study||2||
48482590|NCT02682784|101518891|FG003|NOT COMPLETED|Overall Study||3||
48482591|NCT01629381|101518892|FG000|STARTED|Overall Study||122||
48482592|NCT01629381|101518893|FG001|STARTED|Overall Study||119||
48482593|NCT01629381|101518892|FG000|COMPLETED|Overall Study||120||
48482594|NCT01629381|101518893|FG001|COMPLETED|Overall Study||114||
48482595|NCT01629381|101518892|FG000|NOT COMPLETED|Overall Study||2||
48482596|NCT01629381|101518893|FG001|NOT COMPLETED|Overall Study||5||
48482597|NCT02453386|101518894|FG000|STARTED|Overall Study||151||
48482598|NCT02453386|101518895|FG001|STARTED|Overall Study||149||
48482599|NCT02453386|101518896|FG002|STARTED|Overall Study||149||
48482600|NCT02453386|101518894|FG000|COMPLETED|Overall Study||102||
48482601|NCT02453386|101518895|FG001|COMPLETED|Overall Study||100||
48482602|NCT02453386|101518896|FG002|COMPLETED|Overall Study||108||
48482603|NCT02453386|101518894|FG000|NOT COMPLETED|Overall Study||49||
48482604|NCT02453386|101518895|FG001|NOT COMPLETED|Overall Study||49||
48482605|NCT02453386|101518896|FG002|NOT COMPLETED|Overall Study||41||
48482606|NCT02196766|101518897|FG000|STARTED|First Intervention (7 Days)||15||
48482607|NCT02196766|101518898|FG001|STARTED|First Intervention (7 Days)||15||
48482608|NCT02196766|101518897|FG000|COMPLETED|First Intervention (7 Days)||15||
48482609|NCT02196766|101518898|FG001|COMPLETED|First Intervention (7 Days)||15||
48482610|NCT02196766|101518897|FG000|NOT COMPLETED|First Intervention (7 Days)||0||
48482611|NCT02196766|101518898|FG001|NOT COMPLETED|First Intervention (7 Days)||0||
48482612|NCT02196766|101518897|FG000|STARTED|Second Intervention (7 Days)||15||
48482613|NCT02196766|101518898|FG001|STARTED|Second Intervention (7 Days)||15||
48482614|NCT02196766|101518897|FG000|COMPLETED|Second Intervention (7 Days)||15||
48482615|NCT02196766|101518898|FG001|COMPLETED|Second Intervention (7 Days)||15||
48482616|NCT02196766|101518897|FG000|NOT COMPLETED|Second Intervention (7 Days)||0||
48482617|NCT02196766|101518898|FG001|NOT COMPLETED|Second Intervention (7 Days)||0||
48482618|NCT00934934|101518899|FG000|STARTED|Overall Study||30||
48482619|NCT00934934|101518900|FG001|STARTED|Overall Study||31||
48482620|NCT00934934|101518899|FG000|COMPLETED|Overall Study||29||
48482621|NCT00934934|101518900|FG001|COMPLETED|Overall Study||31||
48482622|NCT00934934|101518899|FG000|NOT COMPLETED|Overall Study||1||
48482623|NCT00934934|101518900|FG001|NOT COMPLETED|Overall Study||0||
48482624|NCT00316186|101518901|FG000|STARTED|Overall Study||33||
48482625|NCT00316186|101518901|FG000|COMPLETED|Overall Study||21||
48482626|NCT00316186|101518901|FG000|NOT COMPLETED|Overall Study||12||
48482627|NCT00834795|101518902|FG000|STARTED|First Intervention||18||
48482628|NCT00834795|101518903|FG001|STARTED|First Intervention||18||
48482629|NCT00834795|101518902|FG000|COMPLETED|First Intervention||18||
48482630|NCT00834795|101518903|FG001|COMPLETED|First Intervention||18||
48482631|NCT00834795|101518902|FG000|NOT COMPLETED|First Intervention||0||
48482632|NCT00834795|101518903|FG001|NOT COMPLETED|First Intervention||0||
48482633|NCT00834795|101518902|FG000|STARTED|Washout: 7 Days||18||
48482634|NCT00834795|101518903|FG001|STARTED|Washout: 7 Days||18||
48482635|NCT00834795|101518902|FG000|COMPLETED|Washout: 7 Days||18||
48482636|NCT00834795|101518903|FG001|COMPLETED|Washout: 7 Days||17||
48482637|NCT00834795|101518902|FG000|NOT COMPLETED|Washout: 7 Days||0||
48482638|NCT00834795|101518903|FG001|NOT COMPLETED|Washout: 7 Days||1||
48482639|NCT00834795|101518902|FG000|STARTED|Second Intervention||18||
48482640|NCT00834795|101518903|FG001|STARTED|Second Intervention||17||
48482641|NCT00834795|101518902|FG000|COMPLETED|Second Intervention||17||
48482642|NCT00834795|101518903|FG001|COMPLETED|Second Intervention||17||
48482643|NCT00834795|101518902|FG000|NOT COMPLETED|Second Intervention||1||
48482644|NCT00834795|101518903|FG001|NOT COMPLETED|Second Intervention||0||
48482645|NCT01190930|101518904|FG000|STARTED|Induction||9298||
48482646|NCT01190930|101518905|FG001|STARTED|Induction||52||
48482647|NCT01190930|101518906|FG002|STARTED|Induction||0||
48482648|NCT01190930|101518907|FG003|STARTED|Induction||0||
48482649|NCT01190930|101518908|FG004|STARTED|Induction||0||
48482650|NCT01190930|101518909|FG005|STARTED|Induction||0||
48482651|NCT01190930|101518910|FG006|STARTED|Induction||0||
48482652|NCT01190930|101518911|FG007|STARTED|Induction||0||
48482653|NCT01190930|101518912|FG008|STARTED|Induction||0||
48482654|NCT01190930|101518913|FG009|STARTED|Induction||0||
48482655|NCT01190930|101518904|FG000|COMPLETED|Induction||3949||
48482656|NCT01190930|101518905|FG001|COMPLETED|Induction||43||
48482657|NCT01190930|101518906|FG002|COMPLETED|Induction||0||
48482658|NCT01190930|101518907|FG003|COMPLETED|Induction||0||
48482659|NCT01190930|101518908|FG004|COMPLETED|Induction||0||
48482660|NCT01190930|101518909|FG005|COMPLETED|Induction||0||
48482661|NCT01190930|101518910|FG006|COMPLETED|Induction||0||
48482662|NCT01190930|101518911|FG007|COMPLETED|Induction||0||
48482663|NCT01190930|101518912|FG008|COMPLETED|Induction||0||
48482664|NCT01190930|101518913|FG009|COMPLETED|Induction||0||
48482665|NCT01190930|101518904|FG000|NOT COMPLETED|Induction||5349||
48482666|NCT01190930|101518905|FG001|NOT COMPLETED|Induction||9||
48482667|NCT01190930|101518906|FG002|NOT COMPLETED|Induction||0||
48482668|NCT01190930|101518907|FG003|NOT COMPLETED|Induction||0||
48482669|NCT01190930|101518908|FG004|NOT COMPLETED|Induction||0||
48482670|NCT01190930|101518909|FG005|NOT COMPLETED|Induction||0||
48482671|NCT01190930|101518910|FG006|NOT COMPLETED|Induction||0||
48482672|NCT01190930|101518911|FG007|NOT COMPLETED|Induction||0||
48482673|NCT01190930|101518912|FG008|NOT COMPLETED|Induction||0||
48482674|NCT01190930|101518913|FG009|NOT COMPLETED|Induction||0||
48482675|NCT01190930|101518904|FG000|STARTED|Post Induction Pre-Maintenance||0||
48482676|NCT01190930|101518905|FG001|STARTED|Post Induction Pre-Maintenance||43||
48482677|NCT01190930|101518906|FG002|STARTED|Post Induction Pre-Maintenance||3122||
48482678|NCT01190930|101518907|FG003|STARTED|Post Induction Pre-Maintenance||224||
48482679|NCT01190930|101518908|FG004|STARTED|Post Induction Pre-Maintenance||301||
48482680|NCT01190930|101518909|FG005|STARTED|Post Induction Pre-Maintenance||302||
48482681|NCT01190930|101518910|FG006|STARTED|Post Induction Pre-Maintenance||0||
48482682|NCT01190930|101518911|FG007|STARTED|Post Induction Pre-Maintenance||0||
48482683|NCT01190930|101518912|FG008|STARTED|Post Induction Pre-Maintenance||0||
48482684|NCT01190930|101518913|FG009|STARTED|Post Induction Pre-Maintenance||0||
48482685|NCT01190930|101518904|FG000|COMPLETED|Post Induction Pre-Maintenance||0||
48482686|NCT01190930|101518905|FG001|COMPLETED|Post Induction Pre-Maintenance||37||
48482687|NCT01190930|101518906|FG002|COMPLETED|Post Induction Pre-Maintenance||2364||
48482688|NCT01190930|101518907|FG003|COMPLETED|Post Induction Pre-Maintenance||207||
48482689|NCT01190930|101518908|FG004|COMPLETED|Post Induction Pre-Maintenance||296||
48482690|NCT01190930|101518909|FG005|COMPLETED|Post Induction Pre-Maintenance||296||
48482691|NCT01190930|101518910|FG006|COMPLETED|Post Induction Pre-Maintenance||0||
48482692|NCT01190930|101518911|FG007|COMPLETED|Post Induction Pre-Maintenance||0||
48482693|NCT01190930|101518912|FG008|COMPLETED|Post Induction Pre-Maintenance||0||
48482694|NCT01190930|101518913|FG009|COMPLETED|Post Induction Pre-Maintenance||0||
48482695|NCT01190930|101518904|FG000|NOT COMPLETED|Post Induction Pre-Maintenance||0||
48482696|NCT01190930|101518905|FG001|NOT COMPLETED|Post Induction Pre-Maintenance||6||
48482697|NCT01190930|101518906|FG002|NOT COMPLETED|Post Induction Pre-Maintenance||758||
48482698|NCT01190930|101518907|FG003|NOT COMPLETED|Post Induction Pre-Maintenance||17||
48482699|NCT01190930|101518908|FG004|NOT COMPLETED|Post Induction Pre-Maintenance||5||
48482700|NCT01190930|101518909|FG005|NOT COMPLETED|Post Induction Pre-Maintenance||6||
48482701|NCT01190930|101518910|FG006|NOT COMPLETED|Post Induction Pre-Maintenance||0||
48482702|NCT01190930|101518911|FG007|NOT COMPLETED|Post Induction Pre-Maintenance||0||
48482703|NCT01190930|101518912|FG008|NOT COMPLETED|Post Induction Pre-Maintenance||0||
48482704|NCT01190930|101518913|FG009|NOT COMPLETED|Post Induction Pre-Maintenance||0||
48482705|NCT01190930|101518904|FG000|STARTED|Maintenance||0||
48482706|NCT01190930|101518905|FG001|STARTED|Maintenance||37||
48482707|NCT01190930|101518906|FG002|STARTED|Maintenance||0||
48482708|NCT01190930|101518907|FG003|STARTED|Maintenance||207||
48482709|NCT01190930|101518908|FG004|STARTED|Maintenance||296||
48482710|NCT01190930|101518909|FG005|STARTED|Maintenance||296||
48482711|NCT01190930|101518910|FG006|STARTED|Maintenance||600||
48482712|NCT01190930|101518911|FG007|STARTED|Maintenance||586||
48482713|NCT01190930|101518912|FG008|STARTED|Maintenance||586||
48482714|NCT01190930|101518913|FG009|STARTED|Maintenance||592||
48482715|NCT01190930|101518904|FG000|COMPLETED|Maintenance||0||
48482716|NCT01190930|101518905|FG001|COMPLETED|Maintenance||27||
48482717|NCT01190930|101518906|FG002|COMPLETED|Maintenance||0||
48482718|NCT01190930|101518907|FG003|COMPLETED|Maintenance||167||
48482719|NCT01190930|101518908|FG004|COMPLETED|Maintenance||287||
48482720|NCT01190930|101518909|FG005|COMPLETED|Maintenance||284||
48482721|NCT01190930|101518910|FG006|COMPLETED|Maintenance||574||
48482722|NCT01190930|101518911|FG007|COMPLETED|Maintenance||540||
48482723|NCT01190930|101518912|FG008|COMPLETED|Maintenance||540||
48482724|NCT01190930|101518913|FG009|COMPLETED|Maintenance||555||
48482725|NCT01190930|101518904|FG000|NOT COMPLETED|Maintenance||0||
48482726|NCT01190930|101518905|FG001|NOT COMPLETED|Maintenance||10||
48482727|NCT01190930|101518906|FG002|NOT COMPLETED|Maintenance||0||
48482728|NCT01190930|101518907|FG003|NOT COMPLETED|Maintenance||40||
48482729|NCT01190930|101518908|FG004|NOT COMPLETED|Maintenance||9||
48482730|NCT01190930|101518909|FG005|NOT COMPLETED|Maintenance||12||
48482731|NCT01190930|101518910|FG006|NOT COMPLETED|Maintenance||26||
48482732|NCT01190930|101518911|FG007|NOT COMPLETED|Maintenance||46||
48482733|NCT01190930|101518912|FG008|NOT COMPLETED|Maintenance||46||
48482734|NCT01190930|101518913|FG009|NOT COMPLETED|Maintenance||37||
48482735|NCT02096718|101518914|FG000|STARTED|Overall Study||8||
48482736|NCT02096718|101518915|FG001|STARTED|Overall Study||8||
48482737|NCT02096718|101518916|FG002|STARTED|Overall Study||14||
48482738|NCT02096718|101518914|FG000|COMPLETED|Overall Study||8||
48482739|NCT02096718|101518915|FG001|COMPLETED|Overall Study||8||
48482740|NCT02096718|101518916|FG002|COMPLETED|Overall Study||14||
48482741|NCT02096718|101518914|FG000|NOT COMPLETED|Overall Study||0||
48482742|NCT02096718|101518915|FG001|NOT COMPLETED|Overall Study||0||
48482743|NCT02096718|101518916|FG002|NOT COMPLETED|Overall Study||0||
48482744|NCT05763147|101518917|FG000|STARTED|Overall Study||189||
48482745|NCT05763147|101518918|FG001|STARTED|Overall Study||189||
48482746|NCT05763147|101518917|FG000|COMPLETED|Overall Study||188||
48482747|NCT05763147|101518918|FG001|COMPLETED|Overall Study||187||
48482748|NCT05763147|101518917|FG000|NOT COMPLETED|Overall Study||1||
48482749|NCT05763147|101518918|FG001|NOT COMPLETED|Overall Study||2||
48482750|NCT02363803|101518919|FG000|STARTED|Period 1||17||
48482751|NCT02363803|101518920|FG001|STARTED|Period 1||17||
48482752|NCT02363803|101518919|FG000|COMPLETED|Period 1||17||
48482753|NCT02363803|101518920|FG001|COMPLETED|Period 1||17||
48482754|NCT02363803|101518919|FG000|NOT COMPLETED|Period 1||0||
48482755|NCT02363803|101518920|FG001|NOT COMPLETED|Period 1||0||
48482756|NCT02363803|101518919|FG000|STARTED|Period 2||17||
48482757|NCT02363803|101518920|FG001|STARTED|Period 2||16||
48482758|NCT02363803|101518919|FG000|COMPLETED|Period 2||17||
48482759|NCT02363803|101518920|FG001|COMPLETED|Period 2||16||
48482760|NCT02363803|101518919|FG000|NOT COMPLETED|Period 2||0||
48482761|NCT02363803|101518920|FG001|NOT COMPLETED|Period 2||0||
48482762|NCT02589808|101518921|FG000|STARTED|Overall Study||76||
48482763|NCT02589808|101518921|FG000|COMPLETED|Overall Study||76||
48482764|NCT02589808|101518921|FG000|NOT COMPLETED|Overall Study||0||
48482765|NCT02865850|101518922|FG000|STARTED|Overall Study||181||
48482766|NCT02865850|101518923|FG001|STARTED|Overall Study||188||
48482767|NCT02865850|101518922|FG000|COMPLETED|Overall Study||160||
48482768|NCT02865850|101518923|FG001|COMPLETED|Overall Study||165||
48482769|NCT02865850|101518922|FG000|NOT COMPLETED|Overall Study||21||
48482770|NCT02865850|101518923|FG001|NOT COMPLETED|Overall Study||23||
48482771|NCT00984126|101518924|FG000|STARTED|Overall Study||27||
48196429|NCT01129778|100803874|FG000|STARTED|Overall Study||22||
48482772|NCT00984126|101518925|FG001|STARTED|Overall Study||28||
48482773|NCT00984126|101518926|FG002|STARTED|Overall Study||23||
48482774|NCT00984126|101518927|FG003|STARTED|Overall Study||135||
48482775|NCT00984126|101518924|FG000|COMPLETED|Overall Study||20||
48482776|NCT00984126|101518925|FG001|COMPLETED|Overall Study||20||
48482777|NCT00984126|101518926|FG002|COMPLETED|Overall Study||16||
48482778|NCT00984126|101518927|FG003|COMPLETED|Overall Study||76||
48482779|NCT00984126|101518924|FG000|NOT COMPLETED|Overall Study||7||
48482780|NCT00984126|101518925|FG001|NOT COMPLETED|Overall Study||8||
48482781|NCT00984126|101518926|FG002|NOT COMPLETED|Overall Study||7||
48482782|NCT00984126|101518927|FG003|NOT COMPLETED|Overall Study||59||
48482783|NCT00312897|101518928|FG000|STARTED|Overall Study||27||
48482784|NCT00312897|101518929|FG001|STARTED|Overall Study||24||
48482785|NCT00312897|101518928|FG000|COMPLETED|Overall Study||21||
48482786|NCT00312897|101518929|FG001|COMPLETED|Overall Study||18||
48482787|NCT00312897|101518928|FG000|NOT COMPLETED|Overall Study||6||
48482788|NCT00312897|101518929|FG001|NOT COMPLETED|Overall Study||6||
48196430|NCT01129778|100803874|FG000|COMPLETED|Overall Study||15||
48482789|NCT02445339|101518930|FG000|STARTED|Overall Study||25||
48482790|NCT02445339|101518931|FG001|STARTED|Overall Study||25||
48482791|NCT02445339|101518930|FG000|COMPLETED|Overall Study||13||
48482792|NCT02445339|101518931|FG001|COMPLETED|Overall Study||10||
48482793|NCT02445339|101518930|FG000|NOT COMPLETED|Overall Study||12||
48196431|NCT01129778|100803874|FG000|NOT COMPLETED|Overall Study||7||
48196432|NCT02954055|100803875|FG000|STARTED|Overall Study||69||
48196433|NCT02954055|100803876|FG001|STARTED|Overall Study||71||
48196434|NCT02954055|100803875|FG000|COMPLETED|Overall Study||63||
48196435|NCT02954055|100803876|FG001|COMPLETED|Overall Study||70||
48196436|NCT02954055|100803875|FG000|NOT COMPLETED|Overall Study||6||
48196437|NCT02954055|100803876|FG001|NOT COMPLETED|Overall Study||1||
48196438|NCT02974010|100803877|FG000|STARTED|Overall Study||12||
48196439|NCT02974010|100803878|FG001|STARTED|Overall Study||5||
48196440|NCT02974010|100803879|FG002|STARTED|Overall Study||4||
48196441|NCT02974010|100803880|FG003|STARTED|Overall Study||1||
48482794|NCT02445339|101518931|FG001|NOT COMPLETED|Overall Study||15||
48482795|NCT01348789|101518932|FG000|STARTED|Overall Study||37||
48482796|NCT01348789|101518932|FG000|COMPLETED|Overall Study||33||
48482797|NCT01348789|101518932|FG000|NOT COMPLETED|Overall Study||4||
48482798|NCT01969747|101518933|FG000|STARTED|Overall Study||19||
48482799|NCT01969747|101518934|FG001|STARTED|Overall Study||19||
48482800|NCT01969747|101518935|FG002|STARTED|Overall Study||19||
48482801|NCT01969747|101518936|FG003|STARTED|Overall Study||18||
48482802|NCT01969747|101518933|FG000|COMPLETED|Overall Study||19||
48482803|NCT01969747|101518934|FG001|COMPLETED|Overall Study||19||
48482804|NCT01969747|101518935|FG002|COMPLETED|Overall Study||19||
48482805|NCT01969747|101518936|FG003|COMPLETED|Overall Study||18||
48482806|NCT01969747|101518933|FG000|NOT COMPLETED|Overall Study||0||
48482807|NCT01969747|101518934|FG001|NOT COMPLETED|Overall Study||0||
48482808|NCT01969747|101518935|FG002|NOT COMPLETED|Overall Study||0||
48196442|NCT02974010|100803877|FG000|COMPLETED|Overall Study||6||
48196443|NCT02974010|100803878|FG001|COMPLETED|Overall Study||2||
48482809|NCT01969747|101518936|FG003|NOT COMPLETED|Overall Study||0||
48482810|NCT01921062|101518937|FG000|STARTED|Overall Study||28||
48482811|NCT01921062|101518938|FG001|STARTED|Overall Study||38||
48196444|NCT02974010|100803879|FG002|COMPLETED|Overall Study||2||
48196445|NCT02974010|100803880|FG003|COMPLETED|Overall Study||1||
48196446|NCT02974010|100803877|FG000|NOT COMPLETED|Overall Study||6||
48482812|NCT01921062|101518937|FG000|COMPLETED|Overall Study||19||
48482813|NCT01921062|101518938|FG001|COMPLETED|Overall Study||22||
48482814|NCT01921062|101518937|FG000|NOT COMPLETED|Overall Study||9||
48482815|NCT01921062|101518938|FG001|NOT COMPLETED|Overall Study||16||
48482816|NCT01118312|101518939|FG000|STARTED|Overall Study||189||
48482817|NCT01118312|101518940|FG001|STARTED|Overall Study||199||
48482818|NCT01118312|101518939|FG000|COMPLETED|Overall Study||155||
48482819|NCT01118312|101518940|FG001|COMPLETED|Overall Study||164||
48482820|NCT01118312|101518939|FG000|NOT COMPLETED|Overall Study||34||
48482821|NCT01118312|101518940|FG001|NOT COMPLETED|Overall Study||35||
48482822|NCT00441467|101518941|FG000|STARTED|Overall Study||22||
48482823|NCT00441467|101518941|FG000|2 Cycles|Overall Study||17||
48482824|NCT00441467|101518941|FG000|4 Cycles|Overall Study||7||
48482825|NCT00441467|101518941|FG000|COMPLETED|Overall Study||4||
48482826|NCT00441467|101518941|FG000|NOT COMPLETED|Overall Study||18||
48482827|NCT00415363|101518942|FG000|STARTED|Overall Study||55||
48482828|NCT00415363|101518943|FG001|STARTED|Overall Study||54||
48482829|NCT00415363|101518942|FG000|Safety Population|Overall Study||54||
48482830|NCT00415363|101518943|FG001|Safety Population|Overall Study||53||
48482831|NCT00415363|101518942|FG000|COMPLETED|Overall Study||0||
48482832|NCT00415363|101518943|FG001|COMPLETED|Overall Study||0||
48482833|NCT00415363|101518942|FG000|NOT COMPLETED|Overall Study||55||
48482834|NCT00415363|101518943|FG001|NOT COMPLETED|Overall Study||54||
48482835|NCT01882647|101518944|FG000|STARTED|Overall Study||110||
48482836|NCT01882647|101518945|FG001|STARTED|Overall Study||112||
48482837|NCT01882647|101518944|FG000|COMPLETED|Overall Study||108||
48482838|NCT01882647|101518945|FG001|COMPLETED|Overall Study||106||
48482839|NCT01882647|101518944|FG000|NOT COMPLETED|Overall Study||2||
48482840|NCT01882647|101518945|FG001|NOT COMPLETED|Overall Study||6||
48482841|NCT01819597|101518946|FG000|STARTED|Overall Study||52||
48482842|NCT01819597|101518946|FG000|COMPLETED|Overall Study||52||
48482843|NCT01819597|101518946|FG000|NOT COMPLETED|Overall Study||0||
48482844|NCT02543554|101518947|FG000|STARTED|Overall Study||1192||
48482845|NCT02543554|101518948|FG001|STARTED|Overall Study||513||
48482846|NCT02543554|101518947|FG000|COMPLETED|Overall Study||1192||
48482847|NCT02543554|101518948|FG001|COMPLETED|Overall Study||513||
48482848|NCT02543554|101518947|FG000|NOT COMPLETED|Overall Study||0||
48482849|NCT02543554|101518948|FG001|NOT COMPLETED|Overall Study||0||
48482850|NCT03243630|101518949|FG000|STARTED|Overall Study||24||
48482851|NCT03243630|101518949|FG000|Menthol E-liquid Saline|Overall Study||22||
48482852|NCT03243630|101518949|FG000|Menthol E-liquid Higher|Overall Study||22||
48482853|NCT03243630|101518949|FG000|Menthol E-liquid Lower|Overall Study||22||
48482854|NCT03243630|101518949|FG000|Green Apple E-liquid Saline|Overall Study||20||
48482855|NCT03243630|101518949|FG000|Green Apple E-liquid Higher|Overall Study||20||
48482856|NCT03243630|101518949|FG000|Green Apple E-liquid Lower|Overall Study||20||
48482857|NCT03243630|101518949|FG000|Green Apple and Menthol E-liquid Saline|Overall Study||21||
48482858|NCT03243630|101518949|FG000|Green Apple and Menthol E-liquid Higher|Overall Study||21||
48482859|NCT03243630|101518949|FG000|Green Apple and Menthol E-liquid Lower|Overall Study||21||
48482860|NCT03243630|101518949|FG000|COMPLETED|Overall Study||22||
48482861|NCT03243630|101518949|FG000|NOT COMPLETED|Overall Study||2||
48482862|NCT02645409|101518950|FG000|STARTED|Overall Study||14||
48482863|NCT02645409|101518951|FG001|STARTED|Overall Study||0||
48482864|NCT02645409|101518950|FG000|COMPLETED|Overall Study||10||
48482865|NCT02645409|101518951|FG001|COMPLETED|Overall Study||0||
48482866|NCT02645409|101518950|FG000|NOT COMPLETED|Overall Study||4||
48482867|NCT02645409|101518951|FG001|NOT COMPLETED|Overall Study||0||
48482868|NCT00578552|101518952|FG000|STARTED|Overall Study||27||
48482869|NCT00578552|101518953|FG001|STARTED|Overall Study||27||
48482870|NCT00578552|101518954|FG002|STARTED|Overall Study||26||
48482871|NCT00578552|101518952|FG000|COMPLETED|Overall Study||12||
48482872|NCT00578552|101518953|FG001|COMPLETED|Overall Study||13||
48482873|NCT00578552|101518954|FG002|COMPLETED|Overall Study||11||
48482874|NCT00578552|101518952|FG000|NOT COMPLETED|Overall Study||15||
48482875|NCT00578552|101518953|FG001|NOT COMPLETED|Overall Study||14||
48482876|NCT00578552|101518954|FG002|NOT COMPLETED|Overall Study||15||
48482877|NCT01471041|101518955|FG000|STARTED|Overall Study||54||
48482878|NCT01471041|101518955|FG000|COMPLETED|Overall Study||47||
48482879|NCT01471041|101518955|FG000|NOT COMPLETED|Overall Study||7||
48482880|NCT00527098|101518956|FG000|STARTED|Overall Study||36||
48482881|NCT00527098|101518957|FG001|STARTED|Overall Study||83||
48482882|NCT00527098|101518956|FG000|COMPLETED|Overall Study||36||
48482883|NCT00527098|101518957|FG001|COMPLETED|Overall Study||83||
48196447|NCT02974010|100803878|FG001|NOT COMPLETED|Overall Study||3||
48196448|NCT02974010|100803879|FG002|NOT COMPLETED|Overall Study||2||
48482884|NCT00527098|101518956|FG000|NOT COMPLETED|Overall Study||0||
48482885|NCT00527098|101518957|FG001|NOT COMPLETED|Overall Study||0||
48196449|NCT02974010|100803880|FG003|NOT COMPLETED|Overall Study||0||
48196450|NCT00711646|100803881|FG000|STARTED|Overall Study||124||
48482886|NCT04407806|101518958|FG000|STARTED|Overall Study||3||
48482887|NCT04407806|101518959|FG001|STARTED|Overall Study||3||
48482888|NCT04407806|101518958|FG000|COMPLETED|Overall Study||2||
48196451|NCT00711646|100803882|FG001|STARTED|Overall Study||65||
48196452|NCT00711646|100803881|FG000|COMPLETED|Overall Study||112||
48196453|NCT00711646|100803882|FG001|COMPLETED|Overall Study||62||
48196454|NCT00711646|100803881|FG000|NOT COMPLETED|Overall Study||12||
48196455|NCT00711646|100803882|FG001|NOT COMPLETED|Overall Study||3||
48196456|NCT03852433|100803883|FG000|STARTED|Overall Study||25||
48482889|NCT04407806|101518959|FG001|COMPLETED|Overall Study||1||
48482890|NCT04407806|101518958|FG000|NOT COMPLETED|Overall Study||1||
48482891|NCT04407806|101518959|FG001|NOT COMPLETED|Overall Study||2||
48482892|NCT03119025|101518960|FG000|STARTED|Overall Study||10||
48482893|NCT03119025|101518960|FG000|COMPLETED|Overall Study||10||
48482894|NCT03119025|101518960|FG000|NOT COMPLETED|Overall Study||0||
48482895|NCT00657553|101518961|FG000|STARTED|Overall Study||5||
48482896|NCT00657553|101518962|FG001|STARTED|Overall Study||5||
48482897|NCT00657553|101518961|FG000|COMPLETED|Overall Study||0||
48482898|NCT00657553|101518962|FG001|COMPLETED|Overall Study||0||
48482899|NCT00657553|101518961|FG000|NOT COMPLETED|Overall Study||5||
48482900|NCT00657553|101518962|FG001|NOT COMPLETED|Overall Study||5||
48482901|NCT02289963|101518963|FG000|STARTED|Overall Study||102||
48482902|NCT02289963|101518964|FG001|STARTED|Overall Study||97||
48482903|NCT02289963|101518963|FG000|Treated|Overall Study||102||
48482904|NCT02289963|101518964|FG001|Treated|Overall Study||97||
48482905|NCT02289963|101518963|FG000|COMPLETED|Overall Study||97||
48482906|NCT02289963|101518964|FG001|COMPLETED|Overall Study||87||
48482907|NCT02289963|101518963|FG000|NOT COMPLETED|Overall Study||5||
48482908|NCT02289963|101518964|FG001|NOT COMPLETED|Overall Study||10||
48482909|NCT04395222|101518965|FG000|STARTED|Overall Study||10||
48196457|NCT03852433|100803884|FG001|STARTED|Overall Study||50||
48196458|NCT03852433|100803885|FG002|STARTED|Overall Study||50||
48482910|NCT04395222|101518966|FG001|STARTED|Overall Study||10||
48482911|NCT04395222|101518967|FG002|STARTED|Overall Study||1||
48482912|NCT04395222|101518968|FG003|STARTED|Overall Study||0||
48196459|NCT03852433|100803886|FG003|STARTED|Overall Study||50||
48196460|NCT03852433|100803883|FG000|COMPLETED|Overall Study||17||
48482913|NCT04395222|101518965|FG000|COMPLETED|Overall Study||10||
48482914|NCT04395222|101518966|FG001|COMPLETED|Overall Study||10||
48482915|NCT04395222|101518967|FG002|COMPLETED|Overall Study||1||
48482916|NCT04395222|101518968|FG003|COMPLETED|Overall Study||0||
48196461|NCT03852433|100803884|FG001|COMPLETED|Overall Study||38||
48196462|NCT03852433|100803885|FG002|COMPLETED|Overall Study||45||
48482917|NCT04395222|101518965|FG000|NOT COMPLETED|Overall Study||0||
48482918|NCT04395222|101518966|FG001|NOT COMPLETED|Overall Study||0||
48482919|NCT04395222|101518967|FG002|NOT COMPLETED|Overall Study||0||
48482920|NCT04395222|101518968|FG003|NOT COMPLETED|Overall Study||0||
48482921|NCT01688609|101518969|FG000|STARTED|Overall Study||18||
48482922|NCT01688609|101518969|FG000|COMPLETED|Overall Study||18||
48482923|NCT01688609|101518969|FG000|NOT COMPLETED|Overall Study||0||
48482924|NCT02914600|101518970|FG000|STARTED|Overall Study||945||
48482925|NCT02914600|101518971|FG001|STARTED|Overall Study||119||
48482926|NCT02914600|101518972|FG002|STARTED|Overall Study||124||
48482927|NCT02914600|101518970|FG000|Treated|Overall Study||944||
48482928|NCT02914600|101518971|FG001|Treated|Overall Study||119||
48482929|NCT02914600|101518972|FG002|Treated|Overall Study||124||
48482930|NCT02914600|101518970|FG000|COMPLETED|Overall Study||0||
48482931|NCT02914600|101518971|FG001|COMPLETED|Overall Study||0||
48482932|NCT02914600|101518972|FG002|COMPLETED|Overall Study||0||
48482933|NCT02914600|101518970|FG000|NOT COMPLETED|Overall Study||945||
48482934|NCT02914600|101518971|FG001|NOT COMPLETED|Overall Study||119||
48482935|NCT02914600|101518972|FG002|NOT COMPLETED|Overall Study||124||
48482936|NCT02089685|101518973|FG000|STARTED|Overall Study||23||
48482937|NCT02089685|101518974|FG001|STARTED|Overall Study||14||
48482938|NCT02089685|101518975|FG002|STARTED|Overall Study||3||
48482939|NCT02089685|101518976|FG003|STARTED|Overall Study||153||
48482940|NCT02089685|101518977|FG004|STARTED|Overall Study||51||
48482941|NCT02089685|101518978|FG005|STARTED|Overall Study||51||
48482942|NCT02089685|101518973|FG000|Treated|Overall Study||22||
48482943|NCT02089685|101518974|FG001|Treated|Overall Study||14||
48482944|NCT02089685|101518975|FG002|Treated|Overall Study||3||
48482945|NCT02089685|101518976|FG003|Treated|Overall Study||153||
48482946|NCT02089685|101518977|FG004|Treated|Overall Study||51||
48482947|NCT02089685|101518978|FG005|Treated|Overall Study||51||
48482948|NCT02089685|101518973|FG000|COMPLETED|Overall Study||0||
48482949|NCT02089685|101518974|FG001|COMPLETED|Overall Study||0||
48482950|NCT02089685|101518975|FG002|COMPLETED|Overall Study||0||
48482951|NCT02089685|101518976|FG003|COMPLETED|Overall Study||0||
48482952|NCT02089685|101518977|FG004|COMPLETED|Overall Study||0||
48482953|NCT02089685|101518978|FG005|COMPLETED|Overall Study||0||
48482954|NCT02089685|101518973|FG000|NOT COMPLETED|Overall Study||23||
48482955|NCT02089685|101518974|FG001|NOT COMPLETED|Overall Study||14||
48482956|NCT02089685|101518975|FG002|NOT COMPLETED|Overall Study||3||
48482957|NCT02089685|101518976|FG003|NOT COMPLETED|Overall Study||153||
48482958|NCT02089685|101518977|FG004|NOT COMPLETED|Overall Study||51||
48482959|NCT02089685|101518978|FG005|NOT COMPLETED|Overall Study||51||
48482960|NCT02561585|101518979|FG000|STARTED|Overall Study||20||
48482961|NCT02561585|101518980|FG001|STARTED|Overall Study||11||
48482962|NCT02561585|101518979|FG000|COMPLETED|Overall Study||17||
48482963|NCT02561585|101518980|FG001|COMPLETED|Overall Study||6||
48482964|NCT02561585|101518979|FG000|NOT COMPLETED|Overall Study||3||
48482965|NCT02561585|101518980|FG001|NOT COMPLETED|Overall Study||5||
48482966|NCT02459951|101518981|FG000|STARTED|Overall Study||10||
48482967|NCT02459951|101518981|FG000|COMPLETED|Overall Study||9||
48482968|NCT02459951|101518981|FG000|NOT COMPLETED|Overall Study||1||
48482969|NCT00773253|101518982|FG000|STARTED|First Intervention (Week 0-24)||5||
48482970|NCT00773253|101518983|FG001|STARTED|First Intervention (Week 0-24)||5||
48482971|NCT00773253|101518982|FG000|COMPLETED|First Intervention (Week 0-24)||5||
48482972|NCT00773253|101518983|FG001|COMPLETED|First Intervention (Week 0-24)||4||
48482973|NCT00773253|101518982|FG000|NOT COMPLETED|First Intervention (Week 0-24)||0||
48482974|NCT00773253|101518983|FG001|NOT COMPLETED|First Intervention (Week 0-24)||1||
48482975|NCT00773253|101518982|FG000|STARTED|Second Intervention (Week 24-48)||5||
48482976|NCT00773253|101518983|FG001|STARTED|Second Intervention (Week 24-48)||4||
48482977|NCT00773253|101518982|FG000|COMPLETED|Second Intervention (Week 24-48)||5||
48482978|NCT00773253|101518983|FG001|COMPLETED|Second Intervention (Week 24-48)||4||
48482979|NCT00773253|101518982|FG000|NOT COMPLETED|Second Intervention (Week 24-48)||0||
48196463|NCT03852433|100803886|FG003|COMPLETED|Overall Study||45||
48196464|NCT03852433|100803883|FG000|NOT COMPLETED|Overall Study||8||
48196465|NCT03852433|100803884|FG001|NOT COMPLETED|Overall Study||12||
48196466|NCT03852433|100803885|FG002|NOT COMPLETED|Overall Study||5||
48196467|NCT03852433|100803886|FG003|NOT COMPLETED|Overall Study||5||
48196468|NCT00763282|100803887|FG000|STARTED|Overall Study||72||
48196469|NCT00763282|100803888|FG001|STARTED|Overall Study||72||
48196470|NCT00763282|100803887|FG000|COMPLETED|Overall Study||40||
48196471|NCT00763282|100803888|FG001|COMPLETED|Overall Study||38||
48482980|NCT00773253|101518983|FG001|NOT COMPLETED|Second Intervention (Week 24-48)||0||
48482981|NCT00448019|101518984|FG000|STARTED|Overall Study||64||
48482982|NCT00448019|101518984|FG000|COMPLETED|Overall Study||57||
48482983|NCT00448019|101518984|FG000|NOT COMPLETED|Overall Study||7||
48482984|NCT02214615|101518985|FG000|STARTED|First Intervention||1||
48196472|NCT00763282|100803887|FG000|NOT COMPLETED|Overall Study||32||
48196473|NCT00763282|100803888|FG001|NOT COMPLETED|Overall Study||34||
48196474|NCT02702921|100803889|FG000|STARTED|Overall Study||98|February 2017|
48196475|NCT02702921|100803890|FG001|STARTED|Overall Study||103|February 2017|
48482985|NCT02214615|101518986|FG001|STARTED|First Intervention||1||
48482986|NCT02214615|101518985|FG000|COMPLETED|First Intervention||1||
48482987|NCT02214615|101518986|FG001|COMPLETED|First Intervention||1||
48482988|NCT02214615|101518985|FG000|NOT COMPLETED|First Intervention||0||
48482989|NCT02214615|101518986|FG001|NOT COMPLETED|First Intervention||0||
48482990|NCT02214615|101518985|FG000|STARTED|Washout||1||
48482991|NCT02214615|101518986|FG001|STARTED|Washout||1||
48482992|NCT02214615|101518985|FG000|COMPLETED|Washout||1||
48482993|NCT02214615|101518986|FG001|COMPLETED|Washout||1||
48482994|NCT02214615|101518985|FG000|NOT COMPLETED|Washout||0||
48482995|NCT02214615|101518986|FG001|NOT COMPLETED|Washout||0||
48482996|NCT02214615|101518985|FG000|STARTED|Second Intervention||1||
48482997|NCT02214615|101518986|FG001|STARTED|Second Intervention||1||
48482998|NCT02214615|101518985|FG000|COMPLETED|Second Intervention||1||
48482999|NCT02214615|101518986|FG001|COMPLETED|Second Intervention||1||
48483000|NCT02214615|101518985|FG000|NOT COMPLETED|Second Intervention||0||
48483001|NCT02214615|101518986|FG001|NOT COMPLETED|Second Intervention||0||
48483002|NCT00651820|101518987|FG000|STARTED|Overall Study||28||
48483003|NCT00651820|101518987|FG000|COMPLETED|Overall Study||26||
48483004|NCT00651820|101518987|FG000|NOT COMPLETED|Overall Study||2||
48483005|NCT02600403|101518988|FG000|STARTED|Overall Study||44||
48483006|NCT02600403|101518989|FG001|STARTED|Overall Study||6||
48483007|NCT02600403|101518990|FG002|STARTED|Overall Study||11||
48483008|NCT02600403|101518988|FG000|COMPLETED|Overall Study||44||
48483009|NCT02600403|101518989|FG001|COMPLETED|Overall Study||6||
48483010|NCT02600403|101518990|FG002|COMPLETED|Overall Study||11||
48483011|NCT02600403|101518988|FG000|NOT COMPLETED|Overall Study||0||
48196476|NCT02702921|100803889|FG000|COMPLETED|Overall Study||84|March 2017|
48196477|NCT02702921|100803890|FG001|COMPLETED|Overall Study||95|March 2017|
48196478|NCT02702921|100803889|FG000|NOT COMPLETED|Overall Study||14||
48196479|NCT02702921|100803890|FG001|NOT COMPLETED|Overall Study||8||
48196480|NCT03223883|100803891|FG000|STARTED|Overall Study||45||
48196481|NCT03223883|100803892|FG001|STARTED|Overall Study||43||
48196482|NCT03223883|100803891|FG000|COMPLETED|Overall Study||37||
48196483|NCT03223883|100803892|FG001|COMPLETED|Overall Study||38||
48196484|NCT03223883|100803891|FG000|NOT COMPLETED|Overall Study||8||
48196485|NCT03223883|100803892|FG001|NOT COMPLETED|Overall Study||5||
48483012|NCT02600403|101518989|FG001|NOT COMPLETED|Overall Study||0||
48483013|NCT02600403|101518990|FG002|NOT COMPLETED|Overall Study||0||
48483014|NCT03135834|101518991|FG000|STARTED|Stage 1||272||
48483015|NCT03135834|101518992|FG001|STARTED|Stage 1||537||
48196486|NCT01348087|100803893|FG000|STARTED|Overall Study||148||
48196487|NCT01348087|100803893|FG000|COMPLETED|Overall Study||0||
48196488|NCT01348087|100803893|FG000|NOT COMPLETED|Overall Study||148||
48483016|NCT03135834|101518993|FG002|STARTED|Stage 1||272||
48483017|NCT03135834|101518994|FG003|STARTED|Stage 1||529||
48483018|NCT03135834|101518991|FG000|Vaccination 1 at Month 0|Stage 1||272||
48483019|NCT03135834|101518992|FG001|Vaccination 1 at Month 0|Stage 1||534||
48483020|NCT03135834|101518993|FG002|Vaccination 1 at Month 0|Stage 1||271||
48483021|NCT03135834|101518994|FG003|Vaccination 1 at Month 0|Stage 1||523||
48196489|NCT00802919|100803894|FG000|STARTED|Overall Study||45||
48196490|NCT00802919|100803895|FG001|STARTED|Overall Study||46||
48483022|NCT03135834|101518991|FG000|Vaccination 2 at Month 6|Stage 1||242||
48483023|NCT03135834|101518992|FG001|Vaccination 2 at Month 6|Stage 1||469||
48483024|NCT03135834|101518993|FG002|Vaccination 2 at Month 6|Stage 1||244||
48483025|NCT03135834|101518994|FG003|Vaccination 2 at Month 6|Stage 1||477||
48483026|NCT03135834|101518991|FG000|COMPLETED|Stage 1||233||
48483027|NCT03135834|101518992|FG001|COMPLETED|Stage 1||462||
48483028|NCT03135834|101518993|FG002|COMPLETED|Stage 1||232||
48483029|NCT03135834|101518994|FG003|COMPLETED|Stage 1||463||
48483030|NCT03135834|101518991|FG000|NOT COMPLETED|Stage 1||39||
48483031|NCT03135834|101518992|FG001|NOT COMPLETED|Stage 1||75||
48483032|NCT03135834|101518993|FG002|NOT COMPLETED|Stage 1||40||
48483033|NCT03135834|101518994|FG003|NOT COMPLETED|Stage 1||66||
48483034|NCT03135834|101518991|FG000|STARTED|Stage 2||114||
48483035|NCT03135834|101518992|FG001|STARTED|Stage 2||65||
48483036|NCT03135834|101518993|FG002|STARTED|Stage 2||101||
48483037|NCT03135834|101518994|FG003|STARTED|Stage 2||73||
48483038|NCT03135834|101518991|FG000|Antibody Persistence: Blood Draw Month18|Stage 2||114||
48483039|NCT03135834|101518992|FG001|Antibody Persistence: Blood Draw Month18|Stage 2||63||
48483040|NCT03135834|101518993|FG002|Antibody Persistence: Blood Draw Month18|Stage 2||53||
48196491|NCT00802919|100803894|FG000|COMPLETED|Overall Study||42||
48196492|NCT00802919|100803895|FG001|COMPLETED|Overall Study||45||
48196493|NCT00802919|100803894|FG000|NOT COMPLETED|Overall Study||3||
48483041|NCT03135834|101518994|FG003|Antibody Persistence: Blood Draw Month18|Stage 2||23||
48483042|NCT03135834|101518991|FG000|Antibody Persistence: Blood Draw Month 30|Stage 2||104||
48483043|NCT03135834|101518992|FG001|Antibody Persistence: Blood Draw Month 30|Stage 2||61||
48483044|NCT03135834|101518993|FG002|Antibody Persistence: Blood Draw Month 30|Stage 2||96||
48483045|NCT03135834|101518994|FG003|Antibody Persistence: Blood Draw Month 30|Stage 2||71||
48483046|NCT03135834|101518991|FG000|Antibody Persistence: Blood Draw Month 42|Stage 2||97||
48483047|NCT03135834|101518992|FG001|Antibody Persistence: Blood Draw Month 42|Stage 2||55||
48483048|NCT03135834|101518993|FG002|Antibody Persistence: Blood Draw Month 42|Stage 2||97||
48483049|NCT03135834|101518994|FG003|Antibody Persistence: Blood Draw Month 42|Stage 2||68||
48483050|NCT03135834|101518991|FG000|Received Booster Vaccination|Stage 2||67||
48483051|NCT03135834|101518992|FG001|Received Booster Vaccination|Stage 2||40||
48483052|NCT03135834|101518993|FG002|Received Booster Vaccination|Stage 2||77||
48483053|NCT03135834|101518994|FG003|Received Booster Vaccination|Stage 2||58||
48483054|NCT03135834|101518991|FG000|COMPLETED|Stage 2||67|Completed Stage 2|
48483055|NCT03135834|101518992|FG001|COMPLETED|Stage 2||38|Completed Stage 2|
48483056|NCT03135834|101518993|FG002|COMPLETED|Stage 2||77|Completed Stage 2|
48483057|NCT03135834|101518994|FG003|COMPLETED|Stage 2||58|Completed Stage 2|
48483058|NCT03135834|101518991|FG000|NOT COMPLETED|Stage 2||47||
48483059|NCT03135834|101518992|FG001|NOT COMPLETED|Stage 2||27||
48483060|NCT03135834|101518993|FG002|NOT COMPLETED|Stage 2||24||
48483061|NCT03135834|101518994|FG003|NOT COMPLETED|Stage 2||15||
48483062|NCT01804270|101518995|FG000|STARTED|Overall Study||2||
48483063|NCT01804270|101518996|FG001|STARTED|Overall Study||4||
48483064|NCT01804270|101518995|FG000|COMPLETED|Overall Study||1||
48483065|NCT01804270|101518996|FG001|COMPLETED|Overall Study||3||
48483066|NCT01804270|101518995|FG000|NOT COMPLETED|Overall Study||1||
48483067|NCT01804270|101518996|FG001|NOT COMPLETED|Overall Study||1||
48483068|NCT01940341|101518997|FG000|STARTED|Period 1: Double-blind Phase||285||
48483069|NCT01940341|101518998|FG001|STARTED|Period 1: Double-blind Phase||141||
48483070|NCT01940341|101518999|FG002|STARTED|Period 1: Double-blind Phase||0||
48483071|NCT01940341|101519000|FG003|STARTED|Period 1: Double-blind Phase||0||
48483072|NCT01940341|101518997|FG000|COMPLETED|Period 1: Double-blind Phase||261||
48483073|NCT01940341|101518998|FG001|COMPLETED|Period 1: Double-blind Phase||129||
48483074|NCT01940341|101518999|FG002|COMPLETED|Period 1: Double-blind Phase||0||
48483075|NCT01940341|101519000|FG003|COMPLETED|Period 1: Double-blind Phase||0||
48483076|NCT01940341|101518997|FG000|NOT COMPLETED|Period 1: Double-blind Phase||24||
48483077|NCT01940341|101518998|FG001|NOT COMPLETED|Period 1: Double-blind Phase||12||
48196494|NCT00802919|100803895|FG001|NOT COMPLETED|Overall Study||1||
48196495|NCT03503773|100803896|FG000|STARTED|Overall Study||56||
48483078|NCT01940341|101518999|FG002|NOT COMPLETED|Period 1: Double-blind Phase||0||
48483079|NCT01940341|101519000|FG003|NOT COMPLETED|Period 1: Double-blind Phase||0||
48483080|NCT01940341|101518997|FG000|STARTED|Period 2: Open-Label TAF Extension Phase||0|At the end of Double-blind Phase, participants were given the option to receive TAF in an OL TAF Extension Phase for up to 240 or 288 weeks.|
48666456|NCT04110145|101967585|FG002|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||0||
48666457|NCT04110145|101967586|FG003|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||1||
48196496|NCT03503773|100803897|FG001|STARTED|Overall Study||50||
48483081|NCT01940341|101518998|FG001|STARTED|Period 2: Open-Label TAF Extension Phase||0|At the end of Double-blind Phase, participants were given the option to receive TAF in an OL TAF Extension Phase for up to 240 or 288 weeks.|
48483082|NCT01940341|101518999|FG002|STARTED|Period 2: Open-Label TAF Extension Phase||261|At the end of Double-blind Phase, participants were given the option to receive TAF in an OL TAF Extension Phase for up to 240 or 288 weeks.|
48483083|NCT01940341|101519000|FG003|STARTED|Period 2: Open-Label TAF Extension Phase||129|At the end of Double-blind Phase, participants were given the option to receive TAF in an OL TAF Extension Phase for up to 240 or 288 weeks.|
48196497|NCT03503773|100803896|FG000|COMPLETED|Overall Study||44||
48196498|NCT03503773|100803897|FG001|COMPLETED|Overall Study||43||
48196499|NCT03503773|100803896|FG000|NOT COMPLETED|Overall Study||12||
48196500|NCT03503773|100803897|FG001|NOT COMPLETED|Overall Study||7||
48196501|NCT02317705|100803898|FG000|STARTED|Overall Study||48||
48196502|NCT02317705|100803898|FG000|Safety Population|Overall Study||44|All patients who received OTL38.|
48196503|NCT02317705|100803898|FG000|Modified Intent-to-Treat (mITT)|Overall Study||29|All patients who received OTL38, underwent cytoreductive surgery, were exposed to fluorescent light using the imaging system, and had at least one Folate Receptor-alpha positive target ovarian cancer lesion. Patients enrolled after protocol amendment 4 will not be included in the mITT population.|
48483084|NCT01940341|101518997|FG000|COMPLETED|Period 2: Open-Label TAF Extension Phase||0||
48483085|NCT01940341|101518998|FG001|COMPLETED|Period 2: Open-Label TAF Extension Phase||0||
48483086|NCT01940341|101518999|FG002|COMPLETED|Period 2: Open-Label TAF Extension Phase||227||
48483087|NCT01940341|101519000|FG003|COMPLETED|Period 2: Open-Label TAF Extension Phase||118||
48483088|NCT01940341|101518997|FG000|NOT COMPLETED|Period 2: Open-Label TAF Extension Phase||0||
48483089|NCT01940341|101518998|FG001|NOT COMPLETED|Period 2: Open-Label TAF Extension Phase||0||
48483090|NCT01940341|101518999|FG002|NOT COMPLETED|Period 2: Open-Label TAF Extension Phase||34||
48483091|NCT01940341|101519000|FG003|NOT COMPLETED|Period 2: Open-Label TAF Extension Phase||11||
48196504|NCT02317705|100803898|FG000|COMPLETED|Overall Study||43|Four subjects were screen failures and did not receive treatment; one subject who received treatment did not complete the study|
48196505|NCT02317705|100803898|FG000|NOT COMPLETED|Overall Study||5||
48196506|NCT02533167|100803899|FG000|STARTED|Overall Study||70||
48196507|NCT02533167|100803899|FG000|COMPLETED|Overall Study||55||
48196508|NCT02533167|100803899|FG000|NOT COMPLETED|Overall Study||15||
48196509|NCT01981356|100803900|FG000|STARTED|Overall Study||12||
48196510|NCT01981356|100803901|FG001|STARTED|Overall Study||6||
48196511|NCT01981356|100803900|FG000|COMPLETED|Overall Study||5||
48196512|NCT01981356|100803901|FG001|COMPLETED|Overall Study||4||
48196513|NCT01981356|100803900|FG000|NOT COMPLETED|Overall Study||7||
48196514|NCT01981356|100803901|FG001|NOT COMPLETED|Overall Study||2||
48196515|NCT03425539|100803902|FG000|STARTED|Overall Study||80||
48196516|NCT03425539|100803903|FG001|STARTED|Overall Study||38||
48196517|NCT03425539|100803902|FG000|Treated|Overall Study||80||
48196518|NCT03425539|100803903|FG001|Treated|Overall Study||37||
48196519|NCT03425539|100803902|FG000|COMPLETED|Overall Study||75||
48196520|NCT03425539|100803903|FG001|COMPLETED|Overall Study||34||
48196521|NCT03425539|100803902|FG000|NOT COMPLETED|Overall Study||5||
48196522|NCT03425539|100803903|FG001|NOT COMPLETED|Overall Study||4||
48196523|NCT02289560|100803904|FG000|STARTED|Overall Study||61||
48196524|NCT02289560|100803904|FG000|COMPLETED|Overall Study||26||
48196525|NCT02289560|100803904|FG000|NOT COMPLETED|Overall Study||35||
48196526|NCT00712166|100803905|FG000|STARTED|Overall Study||81||
48483092|NCT01244620|101519001|FG000|STARTED|Overall Study||4||
48483093|NCT01244620|101519002|FG001|STARTED|Overall Study||4||
48483094|NCT01244620|101519003|FG002|STARTED|Overall Study||4||
48483095|NCT01244620|101519004|FG003|STARTED|Overall Study||4||
48483096|NCT01244620|101519001|FG000|COMPLETED|Overall Study||0||
48483097|NCT01244620|101519002|FG001|COMPLETED|Overall Study||0||
48483098|NCT01244620|101519003|FG002|COMPLETED|Overall Study||0||
48483099|NCT01244620|101519004|FG003|COMPLETED|Overall Study||0||
48483100|NCT01244620|101519001|FG000|NOT COMPLETED|Overall Study||4||
48483101|NCT01244620|101519002|FG001|NOT COMPLETED|Overall Study||4||
48483102|NCT01244620|101519003|FG002|NOT COMPLETED|Overall Study||4||
48483103|NCT01244620|101519004|FG003|NOT COMPLETED|Overall Study||4||
48483104|NCT00868374|101519005|FG000|STARTED|Overall Study||12||
48483105|NCT00868374|101519006|FG001|STARTED|Overall Study||11||
48483106|NCT00868374|101519005|FG000|COMPLETED|Overall Study||5||
48483107|NCT00868374|101519006|FG001|COMPLETED|Overall Study||4||
48483108|NCT00868374|101519005|FG000|NOT COMPLETED|Overall Study||7||
48483109|NCT00868374|101519006|FG001|NOT COMPLETED|Overall Study||7||
48483110|NCT05844553|101519007|FG000|STARTED|Overall Study||20||
48483111|NCT05844553|101519007|FG000|COMPLETED|Overall Study||20||
48196527|NCT00712166|100803906|FG001|STARTED|Overall Study||76||
48196528|NCT00712166|100803905|FG000|COMPLETED|Overall Study||81||
48196529|NCT00712166|100803906|FG001|COMPLETED|Overall Study||75||
48483112|NCT05844553|101519007|FG000|NOT COMPLETED|Overall Study||0||
48483113|NCT03190005|101519008|FG000|STARTED|Overall Study||5||
48483114|NCT03190005|101519009|FG001|STARTED|Overall Study||5||
48483115|NCT03190005|101519010|FG002|STARTED|Overall Study||5||
48483116|NCT03190005|101519011|FG003|STARTED|Overall Study||5||
48483117|NCT03190005|101519012|FG004|STARTED|Overall Study||5||
48483118|NCT03190005|101519013|FG005|STARTED|Overall Study||5||
48483119|NCT03190005|101519014|FG006|STARTED|Overall Study||5||
48483120|NCT03190005|101519008|FG000|COMPLETED|Overall Study||5||
48483121|NCT03190005|101519009|FG001|COMPLETED|Overall Study||5||
48483122|NCT03190005|101519010|FG002|COMPLETED|Overall Study||5||
48483123|NCT03190005|101519011|FG003|COMPLETED|Overall Study||5||
48483124|NCT03190005|101519012|FG004|COMPLETED|Overall Study||5||
48483125|NCT03190005|101519013|FG005|COMPLETED|Overall Study||5||
48196530|NCT00712166|100803905|FG000|NOT COMPLETED|Overall Study||0||
48196531|NCT00712166|100803906|FG001|NOT COMPLETED|Overall Study||1||
48196532|NCT02359838|100803907|FG000|STARTED|Overall Study||100||
48483126|NCT03190005|101519014|FG006|COMPLETED|Overall Study||5||
48483127|NCT03190005|101519008|FG000|NOT COMPLETED|Overall Study||0||
48483128|NCT03190005|101519009|FG001|NOT COMPLETED|Overall Study||0||
48196533|NCT02359838|100803908|FG001|STARTED|Overall Study||60||
48196534|NCT02359838|100803907|FG000|COMPLETED|Overall Study||100||
48196535|NCT02359838|100803908|FG001|COMPLETED|Overall Study||48||
48196536|NCT02359838|100803907|FG000|NOT COMPLETED|Overall Study||0||
48196537|NCT02359838|100803908|FG001|NOT COMPLETED|Overall Study||12||
48196538|NCT04091672|100803909|FG000|STARTED|Overall Study||65||65
48196539|NCT04091672|100803910|FG001|STARTED|Overall Study||65||65
48196540|NCT04091672|100803909|FG000|COMPLETED|Overall Study||47||47
48196541|NCT04091672|100803910|FG001|COMPLETED|Overall Study||47||47
48196542|NCT04091672|100803909|FG000|NOT COMPLETED|Overall Study||18||18
48196543|NCT04091672|100803910|FG001|NOT COMPLETED|Overall Study||18||18
48196544|NCT01867580|100803911|FG000|STARTED|Overall Study||93||
48483129|NCT03190005|101519010|FG002|NOT COMPLETED|Overall Study||0||
48483130|NCT03190005|101519011|FG003|NOT COMPLETED|Overall Study||0||
48483131|NCT03190005|101519012|FG004|NOT COMPLETED|Overall Study||0||
48483132|NCT03190005|101519013|FG005|NOT COMPLETED|Overall Study||0||
48483133|NCT03190005|101519014|FG006|NOT COMPLETED|Overall Study||0||
48483134|NCT00950989|101519015|FG000|STARTED|Overall Study||63||
48483135|NCT00950989|101519016|FG001|STARTED|Overall Study||63||
48483136|NCT00950989|101519017|FG002|STARTED|Overall Study||63||
48483137|NCT00950989|101519018|FG003|STARTED|Overall Study||63||
48483138|NCT00950989|101519015|FG000|COMPLETED|Overall Study||59||
48483139|NCT00950989|101519016|FG001|COMPLETED|Overall Study||60||
48483140|NCT00950989|101519017|FG002|COMPLETED|Overall Study||60||
48483141|NCT00950989|101519018|FG003|COMPLETED|Overall Study||63||
48483142|NCT00950989|101519015|FG000|NOT COMPLETED|Overall Study||4||
48483143|NCT00950989|101519016|FG001|NOT COMPLETED|Overall Study||3||
48483144|NCT00950989|101519017|FG002|NOT COMPLETED|Overall Study||3||
48483145|NCT00950989|101519018|FG003|NOT COMPLETED|Overall Study||0||
48483146|NCT03075553|101519019|FG000|STARTED|Overall Study||12||
48483147|NCT03075553|101519019|FG000|COMPLETED|Overall Study||12||
48483148|NCT03075553|101519019|FG000|NOT COMPLETED|Overall Study||0||
48483149|NCT02481830|101519020|FG000|STARTED|Pre-treatment||284|Randomized|
48483150|NCT02481830|101519021|FG001|STARTED|Pre-treatment||285|Randomized|
48483151|NCT02481830|101519020|FG000|COMPLETED|Pre-treatment||282|Treated|
48483152|NCT02481830|101519021|FG001|COMPLETED|Pre-treatment||265|Treated|
48483153|NCT02481830|101519020|FG000|NOT COMPLETED|Pre-treatment||2||
48483154|NCT02481830|101519021|FG001|NOT COMPLETED|Pre-treatment||20||
48483155|NCT02481830|101519020|FG000|STARTED|Treatment||282|Treated|
48483156|NCT02481830|101519021|FG001|STARTED|Treatment||265|Treated|
48483157|NCT02481830|101519020|FG000|COMPLETED|Treatment||0||
48483158|NCT02481830|101519021|FG001|COMPLETED|Treatment||0||
48483159|NCT02481830|101519020|FG000|NOT COMPLETED|Treatment||282||
48483160|NCT02481830|101519021|FG001|NOT COMPLETED|Treatment||265||
48483161|NCT01884519|101519022|FG000|STARTED|Overall Study||60||
48483162|NCT01884519|101519023|FG001|STARTED|Overall Study||60||
48483163|NCT01884519|101519022|FG000|COMPLETED|Overall Study||60||
48483164|NCT01884519|101519023|FG001|COMPLETED|Overall Study||60||
48483165|NCT01884519|101519022|FG000|NOT COMPLETED|Overall Study||0||
48483166|NCT01884519|101519023|FG001|NOT COMPLETED|Overall Study||0||
48483167|NCT00328926|101519024|FG000|STARTED|Overall Study||5||
48483168|NCT00328926|101519025|FG001|STARTED|Overall Study||3||
48483169|NCT00328926|101519026|FG002|STARTED|Overall Study||3||
48483170|NCT00328926|101519024|FG000|COMPLETED|Overall Study||3||
48483171|NCT00328926|101519025|FG001|COMPLETED|Overall Study||0||
48483172|NCT00328926|101519026|FG002|COMPLETED|Overall Study||1||
48483173|NCT00328926|101519024|FG000|NOT COMPLETED|Overall Study||2||
48483174|NCT00328926|101519025|FG001|NOT COMPLETED|Overall Study||3||
48483175|NCT00328926|101519026|FG002|NOT COMPLETED|Overall Study||2||
48483176|NCT04742283|101519027|FG000|STARTED|Overall Study||161||
48483177|NCT04742283|101519028|FG001|STARTED|Overall Study||162||
48483178|NCT04742283|101519027|FG000|COMPLETED|Overall Study||148||
48483179|NCT04742283|101519028|FG001|COMPLETED|Overall Study||158||
48483180|NCT04742283|101519027|FG000|NOT COMPLETED|Overall Study||13||
48483181|NCT04742283|101519028|FG001|NOT COMPLETED|Overall Study||4||
48483182|NCT01218672|101519029|FG000|STARTED|Overall Study||139||
48483183|NCT01218672|101519030|FG001|STARTED|Overall Study||142||
48483184|NCT01218672|101519029|FG000|Treated|Overall Study||136||
48483185|NCT01218672|101519030|FG001|Treated|Overall Study||133||
48483186|NCT01218672|101519029|FG000|COMPLETED|Overall Study||128||
48483187|NCT01218672|101519030|FG001|COMPLETED|Overall Study||121||
48483188|NCT01218672|101519029|FG000|NOT COMPLETED|Overall Study||11||
48483189|NCT01218672|101519030|FG001|NOT COMPLETED|Overall Study||21||
48483190|NCT01328093|101519031|FG000|STARTED|Double-Blind Phase||516||
48483191|NCT01328093|101519032|FG001|STARTED|Double-Blind Phase||162||
48483192|NCT01328093|101519031|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Phase||514||
48483193|NCT01328093|101519032|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Phase||161||
48666458|NCT04110145|101967587|FG004|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||0||
48483194|NCT01328093|101519031|FG000|Modified Intent-To-Treat (mITT)|Double-Blind Phase||511||
48483195|NCT01328093|101519032|FG001|Modified Intent-To-Treat (mITT)|Double-Blind Phase||161||
48483196|NCT01328093|101519031|FG000|COMPLETED|Double-Blind Phase||231||
48483197|NCT01328093|101519032|FG001|COMPLETED|Double-Blind Phase||84||
48483198|NCT01328093|101519031|FG000|NOT COMPLETED|Double-Blind Phase||285||
48483199|NCT01328093|101519032|FG001|NOT COMPLETED|Double-Blind Phase||78||
48483200|NCT01328093|101519031|FG000|STARTED|Open-Label Phase||200||
48483201|NCT01328093|101519032|FG001|STARTED|Open-Label Phase||73||
48483202|NCT01328093|101519031|FG000|Received at Least 1 Dose of Study Drug|Open-Label Phase||198||
48483203|NCT01328093|101519032|FG001|Received at Least 1 Dose of Study Drug|Open-Label Phase||73||
48483204|NCT01328093|101519031|FG000|Modified Intent-To-Treat (mITT)|Open-Label Phase||197||
48483205|NCT01328093|101519032|FG001|Modified Intent-To-Treat (mITT)|Open-Label Phase||73||
48483206|NCT01328093|101519031|FG000|COMPLETED|Open-Label Phase||60||
48483207|NCT01328093|101519032|FG001|COMPLETED|Open-Label Phase||23||
48483208|NCT01328093|101519031|FG000|NOT COMPLETED|Open-Label Phase||140||
48483209|NCT01328093|101519032|FG001|NOT COMPLETED|Open-Label Phase||50||
48483210|NCT02388191|101519033|FG000|STARTED|Overall Study||59||
48483211|NCT02388191|101519034|FG001|STARTED|Overall Study||60||
48483212|NCT02388191|101519033|FG000|COMPLETED|Overall Study||58||
48483213|NCT02388191|101519034|FG001|COMPLETED|Overall Study||60||
48483214|NCT02388191|101519033|FG000|NOT COMPLETED|Overall Study||1||
48483215|NCT02388191|101519034|FG001|NOT COMPLETED|Overall Study||0||
48483216|NCT01376167|101519035|FG000|STARTED|Overall Study||133||
48483217|NCT01376167|101519036|FG001|STARTED|Overall Study||260||
48483218|NCT01376167|101519037|FG002|STARTED|Overall Study||129||
48483219|NCT01376167|101519035|FG000|COMPLETED|Overall Study||129||
48483220|NCT01376167|101519036|FG001|COMPLETED|Overall Study||250||
48483221|NCT01376167|101519037|FG002|COMPLETED|Overall Study||123||
48196545|NCT01867580|100803912|FG001|STARTED|Overall Study||88||
48483222|NCT01376167|101519035|FG000|NOT COMPLETED|Overall Study||4||
48483223|NCT01376167|101519036|FG001|NOT COMPLETED|Overall Study||10||
48483224|NCT01376167|101519037|FG002|NOT COMPLETED|Overall Study||6||
48483225|NCT00437658|101519038|FG000|STARTED|Treatment Period (24 Weeks)||84||
48483226|NCT00437658|101519039|FG001|STARTED|Treatment Period (24 Weeks)||84||
48483227|NCT00437658|101519040|FG002|STARTED|Treatment Period (24 Weeks)||84||
48483228|NCT00437658|101519038|FG000|Received Study Drug|Treatment Period (24 Weeks)||84||
48483229|NCT00437658|101519039|FG001|Received Study Drug|Treatment Period (24 Weeks)||84||
48483230|NCT00437658|101519040|FG002|Received Study Drug|Treatment Period (24 Weeks)||84||
48483231|NCT00437658|101519038|FG000|COMPLETED|Treatment Period (24 Weeks)||56||
48483232|NCT00437658|101519039|FG001|COMPLETED|Treatment Period (24 Weeks)||62||
48483233|NCT00437658|101519040|FG002|COMPLETED|Treatment Period (24 Weeks)||51||
48483234|NCT00437658|101519038|FG000|NOT COMPLETED|Treatment Period (24 Weeks)||28||
48483235|NCT00437658|101519039|FG001|NOT COMPLETED|Treatment Period (24 Weeks)||22||
48483236|NCT00437658|101519040|FG002|NOT COMPLETED|Treatment Period (24 Weeks)||33||
48483237|NCT00437658|101519038|FG000|STARTED|Post-treatment Period (24 Weeks)||56||
48483238|NCT00437658|101519039|FG001|STARTED|Post-treatment Period (24 Weeks)||62||
48483239|NCT00437658|101519040|FG002|STARTED|Post-treatment Period (24 Weeks)||51||
48483240|NCT00437658|101519038|FG000|COMPLETED|Post-treatment Period (24 Weeks)||32||
48483241|NCT00437658|101519039|FG001|COMPLETED|Post-treatment Period (24 Weeks)||54||
48483242|NCT00437658|101519040|FG002|COMPLETED|Post-treatment Period (24 Weeks)||37||
48483243|NCT00437658|101519038|FG000|NOT COMPLETED|Post-treatment Period (24 Weeks)||24||
48483244|NCT00437658|101519039|FG001|NOT COMPLETED|Post-treatment Period (24 Weeks)||8||
48483245|NCT00437658|101519040|FG002|NOT COMPLETED|Post-treatment Period (24 Weeks)||14||
48483246|NCT04459585|101519041|FG000|STARTED|Period 1 (Day 1 to Day 5)||20||
48483247|NCT04459585|101519041|FG000|COMPLETED|Period 1 (Day 1 to Day 5)||20||
48483248|NCT04459585|101519041|FG000|NOT COMPLETED|Period 1 (Day 1 to Day 5)||0||
48196546|NCT01867580|100803911|FG000|COMPLETED|Overall Study||65||
48483249|NCT04459585|101519041|FG000|STARTED|Period 2 (Day 5 to Day 12)||20||
48483250|NCT04459585|101519041|FG000|COMPLETED|Period 2 (Day 5 to Day 12)||20||
48483251|NCT04459585|101519041|FG000|NOT COMPLETED|Period 2 (Day 5 to Day 12)||0||
48483252|NCT04920929|101519042|FG000|STARTED|Overall Study||3||
48483253|NCT04920929|101519043|FG001|STARTED|Overall Study||4||
48483254|NCT04920929|101519042|FG000|COMPLETED|Overall Study||3||
48483255|NCT04920929|101519043|FG001|COMPLETED|Overall Study||4||
48483256|NCT04920929|101519042|FG000|NOT COMPLETED|Overall Study||0||
48483257|NCT04920929|101519043|FG001|NOT COMPLETED|Overall Study||0||
48483258|NCT03459807|101519044|FG000|STARTED|Overall Study||25||
48483259|NCT03459807|101519045|FG001|STARTED|Overall Study||25||
48483260|NCT03459807|101519044|FG000|COMPLETED|Overall Study||25||
48483261|NCT03459807|101519045|FG001|COMPLETED|Overall Study||24||
48483262|NCT03459807|101519044|FG000|NOT COMPLETED|Overall Study||0||
48483263|NCT03459807|101519045|FG001|NOT COMPLETED|Overall Study||1||
48483264|NCT03226522|101519046|FG000|STARTED|Overall Study||159||
48483265|NCT03226522|101519047|FG001|STARTED|Overall Study||49||
48483266|NCT03226522|101519048|FG002|STARTED|Overall Study||158||
48483267|NCT03226522|101519046|FG000|Safety Population|Overall Study||159||
48483268|NCT03226522|101519047|FG001|Safety Population|Overall Study||49||
48483269|NCT03226522|101519048|FG002|Safety Population|Overall Study||158||
48483270|NCT03226522|101519046|FG000|mITT Population|Overall Study||152||
48483271|NCT03226522|101519047|FG001|mITT Population|Overall Study||49||
48483272|NCT03226522|101519048|FG002|mITT Population|Overall Study||156||
48483273|NCT03226522|101519046|FG000|COMPLETED|Overall Study||137||
48483274|NCT03226522|101519047|FG001|COMPLETED|Overall Study||48||
48483275|NCT03226522|101519048|FG002|COMPLETED|Overall Study||136||
48483276|NCT03226522|101519046|FG000|NOT COMPLETED|Overall Study||22||
48483277|NCT03226522|101519047|FG001|NOT COMPLETED|Overall Study||1||
48483278|NCT03226522|101519048|FG002|NOT COMPLETED|Overall Study||22||
48483279|NCT00849901|101519049|FG000|STARTED|Acute Treatment Phase||117||
48483280|NCT00849901|101519050|FG001|STARTED|Acute Treatment Phase||117||
48483281|NCT00849901|101519051|FG002|STARTED|Acute Treatment Phase||103||
48483282|NCT00849901|101519049|FG000|COMPLETED|Acute Treatment Phase||87||
48483283|NCT00849901|101519050|FG001|COMPLETED|Acute Treatment Phase||91||
48483284|NCT00849901|101519051|FG002|COMPLETED|Acute Treatment Phase||87||
48483285|NCT00849901|101519049|FG000|NOT COMPLETED|Acute Treatment Phase||30||
48483286|NCT00849901|101519050|FG001|NOT COMPLETED|Acute Treatment Phase||26||
48483287|NCT00849901|101519051|FG002|NOT COMPLETED|Acute Treatment Phase||16||
48483288|NCT00849901|101519049|FG000|STARTED|Extension Phase||83||
48483289|NCT00849901|101519050|FG001|STARTED|Extension Phase||91||
48483290|NCT00849901|101519051|FG002|STARTED|Extension Phase||86||
48483291|NCT00849901|101519049|FG000|COMPLETED|Extension Phase||56||
48483292|NCT00849901|101519050|FG001|COMPLETED|Extension Phase||65||
48483293|NCT00849901|101519051|FG002|COMPLETED|Extension Phase||69||
48483294|NCT00849901|101519049|FG000|NOT COMPLETED|Extension Phase||27||
48483295|NCT00849901|101519050|FG001|NOT COMPLETED|Extension Phase||26||
48483296|NCT00849901|101519051|FG002|NOT COMPLETED|Extension Phase||17||
48483297|NCT02422264|101519052|FG000|STARTED|Overall Study||296||
48483298|NCT02422264|101519053|FG001|STARTED|Overall Study||305||
48483299|NCT02422264|101519052|FG000|COMPLETED|Overall Study||291||
48483300|NCT02422264|101519053|FG001|COMPLETED|Overall Study||301||
48483301|NCT02422264|101519052|FG000|NOT COMPLETED|Overall Study||5||
48483302|NCT02422264|101519053|FG001|NOT COMPLETED|Overall Study||4||
48483303|NCT00234286|101519054|FG000|STARTED|Overall Study||6066||
48483304|NCT00234286|101519054|FG000|COMPLETED|Overall Study||6066||
48483305|NCT00234286|101519054|FG000|NOT COMPLETED|Overall Study||0||
48483306|NCT00436163|101519055|FG000|STARTED|Overall Study||39||
48483307|NCT00436163|101519055|FG000|COMPLETED|Overall Study||36||
48483308|NCT00436163|101519055|FG000|NOT COMPLETED|Overall Study||3||
48483309|NCT03620747|101519056|FG000|STARTED|Overall Study||393||
48483310|NCT03620747|101519056|FG000|COMPLETED|Overall Study||374||
48483311|NCT03620747|101519056|FG000|NOT COMPLETED|Overall Study||19||
48483312|NCT01900626|101519057|FG000|STARTED|Overall Study||1||
48483313|NCT01900626|101519058|FG001|STARTED|Overall Study||1||
48483314|NCT01900626|101519057|FG000|COMPLETED|Overall Study||0||
48483315|NCT01900626|101519058|FG001|COMPLETED|Overall Study||0||
48483316|NCT01900626|101519057|FG000|NOT COMPLETED|Overall Study||1||
48483317|NCT01900626|101519058|FG001|NOT COMPLETED|Overall Study||1||
48483318|NCT02265783|101519059|FG000|STARTED|Overall Study||20||
48196547|NCT01867580|100803912|FG001|COMPLETED|Overall Study||64||
48196548|NCT01867580|100803911|FG000|NOT COMPLETED|Overall Study||28||
48196549|NCT01867580|100803912|FG001|NOT COMPLETED|Overall Study||24||
48483319|NCT02265783|101519059|FG000|COMPLETED|Overall Study||20||
48483320|NCT02265783|101519059|FG000|NOT COMPLETED|Overall Study||0||
48483321|NCT01602419|101519060|FG000|STARTED|Overall Study||120||
48483322|NCT01602419|101519060|FG000|SAF Population|Overall Study||111||
48483323|NCT01602419|101519060|FG000|ITT Population|Overall Study||102||
48483324|NCT01602419|101519060|FG000|EFF Population|Overall Study||91||
48483325|NCT01602419|101519060|FG000|COMPLETED|Overall Study||91||
48483326|NCT01602419|101519060|FG000|NOT COMPLETED|Overall Study||29||
48483327|NCT02424097|101519061|FG000|STARTED|Overall Study||20||
48483328|NCT02424097|101519062|FG001|STARTED|Overall Study||20||
48483329|NCT02424097|101519061|FG000|COMPLETED|Overall Study||19||
48483330|NCT02424097|101519062|FG001|COMPLETED|Overall Study||18||
48483331|NCT02424097|101519061|FG000|NOT COMPLETED|Overall Study||1||
48483332|NCT02424097|101519062|FG001|NOT COMPLETED|Overall Study||2||
48483333|NCT03541941|101519063|FG000|STARTED|Overall Study||57||
48483334|NCT03541941|101519064|FG001|STARTED|Overall Study||55||
48483335|NCT03541941|101519065|FG002|STARTED|Overall Study||52||
48483336|NCT03541941|101519063|FG000|COMPLETED|Overall Study||57||
48483337|NCT03541941|101519064|FG001|COMPLETED|Overall Study||55||
48483338|NCT03541941|101519065|FG002|COMPLETED|Overall Study||52||
48483339|NCT03541941|101519063|FG000|NOT COMPLETED|Overall Study||0||
48483340|NCT03541941|101519064|FG001|NOT COMPLETED|Overall Study||0||
48483341|NCT03541941|101519065|FG002|NOT COMPLETED|Overall Study||0||
48483342|NCT01370317|101519066|FG000|STARTED|Overall Study||18||
48483343|NCT01370317|101519067|FG001|STARTED|Overall Study||9||
48483344|NCT01370317|101519066|FG000|COMPLETED|Overall Study||17||
48196550|NCT01359371|100803913|FG000|STARTED|Overall Study||131||
48483345|NCT01370317|101519067|FG001|COMPLETED|Overall Study||8||
48483346|NCT01370317|101519066|FG000|NOT COMPLETED|Overall Study||1||
48483347|NCT01370317|101519067|FG001|NOT COMPLETED|Overall Study||1||
48483348|NCT03921294|101519068|FG000|STARTED|Overall Study||1||
48483349|NCT03921294|101519068|FG000|Enrolled|Overall Study||1||
48483350|NCT03921294|101519068|FG000|Completed Treatment|Overall Study||1||
48483351|NCT03921294|101519068|FG000|COMPLETED|Overall Study||1||
48483352|NCT03921294|101519068|FG000|NOT COMPLETED|Overall Study||0||
48483353|NCT00091260|101519069|FG000|STARTED|Overall Study||82||
48483354|NCT00091260|101519069|FG000|COMPLETED|Overall Study||82||
48483355|NCT00091260|101519069|FG000|NOT COMPLETED|Overall Study||0||
48483356|NCT01615198|101519070|FG000|STARTED|Overall Study||296||
48483357|NCT01615198|101519071|FG001|STARTED|Overall Study||292||
48483358|NCT01615198|101519070|FG000|Full Analysis Set|Overall Study||296||
48483359|NCT01615198|101519071|FG001|Full Analysis Set|Overall Study||292||
48483360|NCT01615198|101519070|FG000|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||154||
48483361|NCT01615198|101519071|FG001|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||157||
48483362|NCT01615198|101519070|FG000|Safety Set|Overall Study||296||
48483363|NCT01615198|101519071|FG001|Safety Set|Overall Study||292||
48483364|NCT01615198|101519070|FG000|ABPM Dipper Status Subset|Overall Study||82||
48483365|NCT01615198|101519071|FG001|ABPM Dipper Status Subset|Overall Study||84||
48483366|NCT01615198|101519070|FG000|COMPLETED|Overall Study||272||
48483367|NCT01615198|101519071|FG001|COMPLETED|Overall Study||273||
48483368|NCT01615198|101519070|FG000|NOT COMPLETED|Overall Study||24||
48196551|NCT01359371|100803913|FG000|COMPLETED|Overall Study||131||
48196552|NCT01359371|100803913|FG000|NOT COMPLETED|Overall Study||0||
48196553|NCT02047461|100803914|FG000|STARTED|Overall Study||8||
48196554|NCT02047461|100803914|FG000|COMPLETED|Overall Study||8||
48196555|NCT02047461|100803914|FG000|NOT COMPLETED|Overall Study||0||
48196556|NCT00404079|100803915|FG000|STARTED|Overall Study||125||
48483369|NCT01615198|101519071|FG001|NOT COMPLETED|Overall Study||19||
48483370|NCT00813592|101519072|FG000|STARTED|Overall Study||2||
48483371|NCT00813592|101519072|FG000|Treated|Overall Study||2||
48483372|NCT00813592|101519072|FG000|Response Assessment|Overall Study||1||
48483373|NCT00813592|101519072|FG000|COMPLETED|Overall Study||0||
48483374|NCT00813592|101519072|FG000|NOT COMPLETED|Overall Study||2||
48196557|NCT00404079|100803916|FG001|STARTED|Overall Study||125||
48196558|NCT00404079|100803915|FG000|COMPLETED|Overall Study||103||
48483375|NCT01045161|101519073|FG000|STARTED|Part A - 12 Weeks Double Blind Treatment||182||
48483376|NCT01045161|101519074|FG001|STARTED|Part A - 12 Weeks Double Blind Treatment||184||
48196559|NCT00404079|100803916|FG001|COMPLETED|Overall Study||105||
48196560|NCT00404079|100803915|FG000|NOT COMPLETED|Overall Study||22||
48196561|NCT00404079|100803916|FG001|NOT COMPLETED|Overall Study||20||
48196562|NCT03538054|100803917|FG000|STARTED|Baseline Phase (2 Weeks)||19||
48196563|NCT03538054|100803917|FG000|COMPLETED|Baseline Phase (2 Weeks)||18||
48196564|NCT03538054|100803917|FG000|NOT COMPLETED|Baseline Phase (2 Weeks)||1||
48196565|NCT03538054|100803917|FG000|STARTED|Placebo Phase (5 Weeks)||18||
48483377|NCT01045161|101519075|FG002|STARTED|Part A - 12 Weeks Double Blind Treatment||178||
48483378|NCT01045161|101519073|FG000|COMPLETED|Part A - 12 Weeks Double Blind Treatment||151||
48483379|NCT01045161|101519074|FG001|COMPLETED|Part A - 12 Weeks Double Blind Treatment||155||
48483380|NCT01045161|101519075|FG002|COMPLETED|Part A - 12 Weeks Double Blind Treatment||148||
48483381|NCT01045161|101519073|FG000|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||31||
48483382|NCT01045161|101519074|FG001|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||29||
48483383|NCT01045161|101519075|FG002|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||30||
48483384|NCT01045161|101519073|FG000|STARTED|Part B - 40 Additional Weeks Open Label||147||
48483385|NCT01045161|101519074|FG001|STARTED|Part B - 40 Additional Weeks Open Label||154||
48483386|NCT01045161|101519075|FG002|STARTED|Part B - 40 Additional Weeks Open Label||147||
48483387|NCT01045161|101519073|FG000|COMPLETED|Part B - 40 Additional Weeks Open Label||111||
48483388|NCT01045161|101519074|FG001|COMPLETED|Part B - 40 Additional Weeks Open Label||118||
48483389|NCT01045161|101519075|FG002|COMPLETED|Part B - 40 Additional Weeks Open Label||115||
48483390|NCT01045161|101519073|FG000|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36||
48483391|NCT01045161|101519074|FG001|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36||
48483392|NCT01045161|101519075|FG002|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||32||
48483393|NCT02159183|101519076|FG000|STARTED|Analysis After the 36 Months Follow-up||22||
48483394|NCT02159183|101519077|FG001|STARTED|Analysis After the 36 Months Follow-up||21||
48483395|NCT02159183|101519076|FG000|COMPLETED|Analysis After the 36 Months Follow-up||19||
48483396|NCT02159183|101519077|FG001|COMPLETED|Analysis After the 36 Months Follow-up||19||
48483397|NCT02159183|101519076|FG000|NOT COMPLETED|Analysis After the 36 Months Follow-up||3||
48483398|NCT02159183|101519077|FG001|NOT COMPLETED|Analysis After the 36 Months Follow-up||2||
48483399|NCT02159183|101519076|FG000|STARTED|Analysis of Primary Endpoint (12 Mts)||22||
48483400|NCT02159183|101519077|FG001|STARTED|Analysis of Primary Endpoint (12 Mts)||21||
48483401|NCT02159183|101519076|FG000|COMPLETED|Analysis of Primary Endpoint (12 Mts)||19||
48483402|NCT02159183|101519077|FG001|COMPLETED|Analysis of Primary Endpoint (12 Mts)||20||
48483403|NCT02159183|101519076|FG000|NOT COMPLETED|Analysis of Primary Endpoint (12 Mts)||3||
48483404|NCT02159183|101519077|FG001|NOT COMPLETED|Analysis of Primary Endpoint (12 Mts)||1||
48483405|NCT00979303|101519078|FG000|STARTED|Overall Study||37||
48483406|NCT00979303|101519079|FG001|STARTED|Overall Study||37||
48483407|NCT00979303|101519078|FG000|COMPLETED|Overall Study||37||
48483408|NCT00979303|101519079|FG001|COMPLETED|Overall Study||37||
48483409|NCT00979303|101519078|FG000|NOT COMPLETED|Overall Study||0||
48483410|NCT00979303|101519079|FG001|NOT COMPLETED|Overall Study||0||
48483411|NCT03325426|101519080|FG000|STARTED|Overall Study||21||
48483412|NCT03325426|101519081|FG001|STARTED|Overall Study||42||
48196566|NCT03538054|100803917|FG000|COMPLETED|Placebo Phase (5 Weeks)||16||
48196567|NCT03538054|100803917|FG000|NOT COMPLETED|Placebo Phase (5 Weeks)||2||
48196568|NCT03538054|100803917|FG000|STARTED|Dextromethorphan Phase (10 Weeks)||16||
48196569|NCT03538054|100803917|FG000|COMPLETED|Dextromethorphan Phase (10 Weeks)||14||
48196570|NCT03538054|100803917|FG000|NOT COMPLETED|Dextromethorphan Phase (10 Weeks)||2||
48196571|NCT00995709|100803918|FG000|STARTED|Overall Study||39||
48196572|NCT00995709|100803919|FG001|STARTED|Overall Study||40||
48196573|NCT00995709|100803920|FG002|STARTED|Overall Study||39||
48196574|NCT00995709|100803918|FG000|COMPLETED|Overall Study||32||
48196575|NCT00995709|100803919|FG001|COMPLETED|Overall Study||31||
48196576|NCT00995709|100803920|FG002|COMPLETED|Overall Study||34||
48196577|NCT00995709|100803918|FG000|NOT COMPLETED|Overall Study||7||
48196578|NCT00995709|100803919|FG001|NOT COMPLETED|Overall Study||9||
48196579|NCT00995709|100803920|FG002|NOT COMPLETED|Overall Study||5||
48196580|NCT03768206|100803921|FG000|STARTED|Overall Study||24||
48196581|NCT03768206|100803922|FG001|STARTED|Overall Study||21||
48196582|NCT03768206|100803921|FG000|COMPLETED|Overall Study||22||
48483413|NCT03325426|101519080|FG000|COMPLETED|Overall Study||11||
48483414|NCT03325426|101519081|FG001|COMPLETED|Overall Study||18||
48483415|NCT03325426|101519080|FG000|NOT COMPLETED|Overall Study||10||
48483416|NCT03325426|101519081|FG001|NOT COMPLETED|Overall Study||24||
48483417|NCT02188303|101519082|FG000|STARTED|Overall Study||6||
48483418|NCT02188303|101519083|FG001|STARTED|Overall Study||6||
48196583|NCT03768206|100803922|FG001|COMPLETED|Overall Study||19||
48196584|NCT03768206|100803921|FG000|NOT COMPLETED|Overall Study||2||
48196585|NCT03768206|100803922|FG001|NOT COMPLETED|Overall Study||2||
48196586|NCT03102242|100803923|FG000|STARTED|Overall Study||64||
48196587|NCT03102242|100803923|FG000|COMPLETED|Overall Study||62||
48196588|NCT03102242|100803923|FG000|NOT COMPLETED|Overall Study||2||
48196589|NCT01027286|100803924|FG000|STARTED|Overall Study||50||
48196590|NCT01027286|100803925|FG001|STARTED|Overall Study||50||
48196591|NCT01027286|100803924|FG000|Preoperative|Overall Study||50||
48196592|NCT01027286|100803925|FG001|Preoperative|Overall Study||50||
48196593|NCT01027286|100803924|FG000|Day of Surgery|Overall Study||50||
48196594|NCT01027286|100803925|FG001|Day of Surgery|Overall Study||50||
48196595|NCT01027286|100803924|FG000|4 Week Postoperative|Overall Study||49||
48196596|NCT01027286|100803925|FG001|4 Week Postoperative|Overall Study||50||
48196597|NCT01027286|100803924|FG000|12 Week Postoperative|Overall Study||49||
48196598|NCT01027286|100803925|FG001|12 Week Postoperative|Overall Study||49||
48196599|NCT01027286|100803924|FG000|COMPLETED|Overall Study||49||
48483419|NCT02188303|101519084|FG002|STARTED|Overall Study||6||
48483420|NCT02188303|101519085|FG003|STARTED|Overall Study||6||
48196600|NCT01027286|100803925|FG001|COMPLETED|Overall Study||49||
48196601|NCT01027286|100803924|FG000|NOT COMPLETED|Overall Study||1||
48196602|NCT01027286|100803925|FG001|NOT COMPLETED|Overall Study||1||
48483421|NCT02188303|101519086|FG004|STARTED|Overall Study||4||
48483422|NCT02188303|101519087|FG005|STARTED|Overall Study||12||
48483423|NCT02188303|101519088|FG006|STARTED|Overall Study||2||
48483424|NCT02188303|101519089|FG007|STARTED|Overall Study||6||
48483425|NCT02188303|101519082|FG000|COMPLETED|Overall Study||6||
48483426|NCT02188303|101519083|FG001|COMPLETED|Overall Study||6||
48483427|NCT02188303|101519084|FG002|COMPLETED|Overall Study||6||
48196603|NCT01211665|100803926|FG000|STARTED|Overall Study||2||
48196604|NCT01211665|100803927|FG001|STARTED|Overall Study||1||
48196605|NCT01211665|100803926|FG000|COMPLETED|Overall Study||0||
48196606|NCT01211665|100803927|FG001|COMPLETED|Overall Study||1||
48483428|NCT02188303|101519085|FG003|COMPLETED|Overall Study||6||
48196607|NCT01211665|100803926|FG000|NOT COMPLETED|Overall Study||2||
48196608|NCT01211665|100803927|FG001|NOT COMPLETED|Overall Study||0||
48196609|NCT00425503|100803928|FG000|STARTED|Overall Study||40||
48196610|NCT00425503|100803928|FG000|COMPLETED|Overall Study||37||
48483429|NCT02188303|101519086|FG004|COMPLETED|Overall Study||4||
48483430|NCT02188303|101519087|FG005|COMPLETED|Overall Study||10||
48483431|NCT02188303|101519088|FG006|COMPLETED|Overall Study||0||
48196611|NCT00425503|100803928|FG000|NOT COMPLETED|Overall Study||3||
48196612|NCT03563053|100803929|FG000|STARTED|Overall Study||104||
48196613|NCT03563053|100803929|FG000|Total Set|Overall Study||104||
48483432|NCT02188303|101519089|FG007|COMPLETED|Overall Study||0||
48196614|NCT03563053|100803929|FG000|Safety Set|Overall Study||104||
48196615|NCT03563053|100803929|FG000|Full Analysis Set|Overall Study||80||
48196616|NCT03563053|100803929|FG000|Month 12|Overall Study||64||
48196617|NCT03563053|100803929|FG000|Month 24|Overall Study||33||
48196618|NCT03563053|100803929|FG000|Month 36|Overall Study||21||
48196619|NCT03563053|100803929|FG000|Month 48|Overall Study||7||
48196620|NCT03563053|100803929|FG000|Month 50.5|Overall Study||1||
48196621|NCT03563053|100803929|FG000|COMPLETED|Overall Study||0||
48196622|NCT03563053|100803929|FG000|NOT COMPLETED|Overall Study||104||
48196623|NCT03404843|100803930|FG000|STARTED|Overall Study||17||
48196624|NCT03404843|100803931|FG001|STARTED|Overall Study||14||
48196625|NCT03404843|100803930|FG000|COMPLETED|Overall Study||13||
48196626|NCT03404843|100803931|FG001|COMPLETED|Overall Study||13||
48196627|NCT03404843|100803930|FG000|NOT COMPLETED|Overall Study||4||
48196628|NCT03404843|100803931|FG001|NOT COMPLETED|Overall Study||1||
48483433|NCT02188303|101519082|FG000|NOT COMPLETED|Overall Study||0||
48483434|NCT02188303|101519083|FG001|NOT COMPLETED|Overall Study||0||
48483435|NCT02188303|101519084|FG002|NOT COMPLETED|Overall Study||0||
48483436|NCT02188303|101519085|FG003|NOT COMPLETED|Overall Study||0||
48483437|NCT02188303|101519086|FG004|NOT COMPLETED|Overall Study||0||
48483438|NCT02188303|101519087|FG005|NOT COMPLETED|Overall Study||2||
48483439|NCT02188303|101519088|FG006|NOT COMPLETED|Overall Study||2||
48483440|NCT02188303|101519089|FG007|NOT COMPLETED|Overall Study||6||
48483441|NCT00520234|101519090|FG000|STARTED|Overall Study||118||
48483442|NCT00520234|101519091|FG001|STARTED|Overall Study||104||
48483443|NCT00520234|101519090|FG000|COMPLETED|Overall Study||117||
48483444|NCT00520234|101519091|FG001|COMPLETED|Overall Study||102||
48483445|NCT00520234|101519090|FG000|NOT COMPLETED|Overall Study||1||
48483446|NCT00520234|101519091|FG001|NOT COMPLETED|Overall Study||2||
48483447|NCT00904345|101519092|FG000|STARTED|Overall Study||21||
48483448|NCT00904345|101519092|FG000|Stopped or Modified Treatment Due to Toxicity|Overall Study||3||
48483449|NCT00904345|101519092|FG000|COMPLETED|Overall Study||18|18 completed treatment with RT + Cetuximab|
48483450|NCT00904345|101519092|FG000|NOT COMPLETED|Overall Study||3||
48483451|NCT01424293|101519093|FG000|STARTED|Overall Study||7||
48483452|NCT01424293|101519093|FG000|COMPLETED|Overall Study||7||
48483453|NCT01424293|101519093|FG000|NOT COMPLETED|Overall Study||0||
48483454|NCT00925054|101519094|FG000|STARTED|Overall Study||7||
48483455|NCT00925054|101519095|FG001|STARTED|Overall Study||9||
48483456|NCT00925054|101519096|FG002|STARTED|Overall Study||13||
48483457|NCT00925054|101519097|FG003|STARTED|Overall Study||1||
48483458|NCT00925054|101519098|FG004|STARTED|Overall Study||10||
48483459|NCT00925054|101519094|FG000|COMPLETED|Overall Study||7||
48483460|NCT00925054|101519095|FG001|COMPLETED|Overall Study||8||
48483461|NCT00925054|101519096|FG002|COMPLETED|Overall Study||12||
48483462|NCT00925054|101519097|FG003|COMPLETED|Overall Study||0||
48483463|NCT00925054|101519098|FG004|COMPLETED|Overall Study||10||
48483464|NCT00925054|101519094|FG000|NOT COMPLETED|Overall Study||0||
48196629|NCT01107626|100803932|FG000|STARTED|Step 1: Induction Therapy||642||
48196630|NCT01107626|100803933|FG001|STARTED|Step 1: Induction Therapy||287||
48196631|NCT01107626|100803934|FG002|STARTED|Step 1: Induction Therapy||294||
48196632|NCT01107626|100803935|FG003|STARTED|Step 1: Induction Therapy||293||
48196633|NCT01107626|100803932|FG000|COMPLETED|Step 1: Induction Therapy||65||
48196634|NCT01107626|100803933|FG001|COMPLETED|Step 1: Induction Therapy||287||
48196635|NCT01107626|100803934|FG002|COMPLETED|Step 1: Induction Therapy||294||
48196636|NCT01107626|100803935|FG003|COMPLETED|Step 1: Induction Therapy||293||
48196637|NCT01107626|100803932|FG000|NOT COMPLETED|Step 1: Induction Therapy||577||
48196638|NCT01107626|100803933|FG001|NOT COMPLETED|Step 1: Induction Therapy||0||
48196639|NCT01107626|100803934|FG002|NOT COMPLETED|Step 1: Induction Therapy||0||
48196640|NCT01107626|100803935|FG003|NOT COMPLETED|Step 1: Induction Therapy||0||
48196641|NCT01107626|100803932|FG000|STARTED|Step 2: Maintenance Therapy||0||
48196642|NCT01107626|100803933|FG001|STARTED|Step 2: Maintenance Therapy||287||
48196643|NCT01107626|100803934|FG002|STARTED|Step 2: Maintenance Therapy||294||
48196644|NCT01107626|100803935|FG003|STARTED|Step 2: Maintenance Therapy||293||
48196645|NCT01107626|100803932|FG000|COMPLETED|Step 2: Maintenance Therapy||0||
48196646|NCT01107626|100803933|FG001|COMPLETED|Step 2: Maintenance Therapy||1||
48196647|NCT01107626|100803934|FG002|COMPLETED|Step 2: Maintenance Therapy||0||
48196648|NCT01107626|100803935|FG003|COMPLETED|Step 2: Maintenance Therapy||1||
48196649|NCT01107626|100803932|FG000|NOT COMPLETED|Step 2: Maintenance Therapy||0||
48196650|NCT01107626|100803933|FG001|NOT COMPLETED|Step 2: Maintenance Therapy||286||
48196651|NCT01107626|100803934|FG002|NOT COMPLETED|Step 2: Maintenance Therapy||294||
48196652|NCT01107626|100803935|FG003|NOT COMPLETED|Step 2: Maintenance Therapy||292||
48196653|NCT01219855|100803936|FG000|STARTED|Overall Study||17||
48196654|NCT01219855|100803937|FG001|STARTED|Overall Study||17||
48196655|NCT01219855|100803938|FG002|STARTED|Overall Study||17||
48196656|NCT01219855|100803939|FG003|STARTED|Overall Study||13||
48196657|NCT01219855|100803940|FG004|STARTED|Overall Study||14||
48196658|NCT01219855|100803936|FG000|COMPLETED|Overall Study||16||
48196659|NCT01219855|100803937|FG001|COMPLETED|Overall Study||12||
48196660|NCT01219855|100803938|FG002|COMPLETED|Overall Study||16||
48196661|NCT01219855|100803939|FG003|COMPLETED|Overall Study||12||
48196662|NCT01219855|100803940|FG004|COMPLETED|Overall Study||13||
48196663|NCT01219855|100803936|FG000|NOT COMPLETED|Overall Study||1||
48196664|NCT01219855|100803937|FG001|NOT COMPLETED|Overall Study||5||
48196665|NCT01219855|100803938|FG002|NOT COMPLETED|Overall Study||1||
48196666|NCT01219855|100803939|FG003|NOT COMPLETED|Overall Study||1||
48196667|NCT01219855|100803940|FG004|NOT COMPLETED|Overall Study||1||
48196668|NCT00465985|100803941|FG000|STARTED|Part I - Open-label Treatment Period||35||
48196669|NCT00465985|100803942|FG001|STARTED|Part I - Open-label Treatment Period||0||
48196670|NCT00465985|100803941|FG000|COMPLETED|Part I - Open-label Treatment Period||31||
48196671|NCT00465985|100803942|FG001|COMPLETED|Part I - Open-label Treatment Period||0||
48196672|NCT00465985|100803941|FG000|NOT COMPLETED|Part I - Open-label Treatment Period||4||
48196673|NCT00465985|100803942|FG001|NOT COMPLETED|Part I - Open-label Treatment Period||0||
48196674|NCT00465985|100803941|FG000|STARTED|Part II - 1:1 ACZ885:Placebo||15||
48196675|NCT00465985|100803942|FG001|STARTED|Part II - 1:1 ACZ885:Placebo||16||
48196676|NCT00465985|100803941|FG000|COMPLETED|Part II - 1:1 ACZ885:Placebo||15||
48196677|NCT00465985|100803942|FG001|COMPLETED|Part II - 1:1 ACZ885:Placebo||4||
48196678|NCT00465985|100803941|FG000|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||0||
48196679|NCT00465985|100803942|FG001|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||12||
48196680|NCT00465985|100803941|FG000|STARTED|Part III - Open-label Treatment Period||31||
48196681|NCT00465985|100803942|FG001|STARTED|Part III - Open-label Treatment Period||0||
48196682|NCT00465985|100803941|FG000|COMPLETED|Part III - Open-label Treatment Period||29||
48196683|NCT00465985|100803942|FG001|COMPLETED|Part III - Open-label Treatment Period||0||
48196684|NCT00465985|100803941|FG000|NOT COMPLETED|Part III - Open-label Treatment Period||2||
48196685|NCT00465985|100803942|FG001|NOT COMPLETED|Part III - Open-label Treatment Period||0||
48483465|NCT00925054|101519095|FG001|NOT COMPLETED|Overall Study||1||
48483466|NCT00925054|101519096|FG002|NOT COMPLETED|Overall Study||1||
48483467|NCT00925054|101519097|FG003|NOT COMPLETED|Overall Study||1||
48483468|NCT00925054|101519098|FG004|NOT COMPLETED|Overall Study||0||
48483469|NCT03925532|101522431|FG000|STARTED|Overall Study||30||
48483470|NCT03925532|101522431|FG000|COMPLETED|Overall Study||29||
48483471|NCT03925532|101522431|FG000|NOT COMPLETED|Overall Study||1||
48483472|NCT02308475|101522432|FG000|STARTED|Overall Study||2||
48483473|NCT02308475|101522432|FG000|COMPLETED|Overall Study||2||
48483474|NCT02308475|101522432|FG000|NOT COMPLETED|Overall Study||0||
48483475|NCT00392665|101522433|FG000|STARTED|Overall Study||18||
48483476|NCT00392665|101522434|FG001|STARTED|Overall Study||18||
48483477|NCT00392665|101522433|FG000|COMPLETED|Overall Study||1||
48483478|NCT00392665|101522434|FG001|COMPLETED|Overall Study||3||
48483479|NCT00392665|101522433|FG000|NOT COMPLETED|Overall Study||17||
48483480|NCT00392665|101522434|FG001|NOT COMPLETED|Overall Study||15||
48483481|NCT02255097|101522435|FG000|STARTED|Overall Study||172||
48483482|NCT02255097|101522435|FG000|Treated|Overall Study||171||
48196686|NCT03686813|100803943|FG000|STARTED|Overall Study||10||
48196687|NCT03686813|100803944|FG001|STARTED|Overall Study||8||
48196688|NCT03686813|100803943|FG000|COMPLETED|Overall Study||10||
48196689|NCT03686813|100803944|FG001|COMPLETED|Overall Study||8||
48196690|NCT03686813|100803943|FG000|NOT COMPLETED|Overall Study||0||
48196691|NCT03686813|100803944|FG001|NOT COMPLETED|Overall Study||0||
48196692|NCT01345292|100803945|FG000|STARTED|Overall Study||75||
48196693|NCT01345292|100803946|FG001|STARTED|Overall Study||76||
48196694|NCT01345292|100803947|FG002|STARTED|Overall Study||75||
48196695|NCT01345292|100803945|FG000|COMPLETED|Overall Study||73||
48196696|NCT01345292|100803946|FG001|COMPLETED|Overall Study||76||
48196697|NCT01345292|100803947|FG002|COMPLETED|Overall Study||74||
48196698|NCT01345292|100803945|FG000|NOT COMPLETED|Overall Study||2||
48196699|NCT01345292|100803946|FG001|NOT COMPLETED|Overall Study||0||
48196700|NCT01345292|100803947|FG002|NOT COMPLETED|Overall Study||1||
48196701|NCT03396913|100803948|FG000|STARTED|Overall Study||43||
48196702|NCT03396913|100803949|FG001|STARTED|Overall Study||45||
48196703|NCT03396913|100803948|FG000|COMPLETED|Overall Study||43||
48196704|NCT03396913|100803949|FG001|COMPLETED|Overall Study||39||
48196705|NCT03396913|100803948|FG000|NOT COMPLETED|Overall Study||0||
48196706|NCT03396913|100803949|FG001|NOT COMPLETED|Overall Study||6||
48196707|NCT00567164|100803950|FG000|STARTED|Overall Study||1421||
48196708|NCT00567164|100803951|FG001|STARTED|Overall Study||234||
48196709|NCT00567164|100803952|FG002|STARTED|Overall Study||232||
48483483|NCT02255097|101522435|FG000|Received Second Course of Pembrolizumab|Overall Study||3||
48483484|NCT02255097|101522435|FG000|COMPLETED|Overall Study||0||
48483485|NCT02255097|101522435|FG000|NOT COMPLETED|Overall Study||172||
48196710|NCT00567164|100803950|FG000|Subjects Received Treatment|Overall Study||1406||
48196711|NCT00567164|100803951|FG001|Subjects Received Treatment|Overall Study||232||
48196712|NCT00567164|100803952|FG002|Subjects Received Treatment|Overall Study||226||
48196713|NCT00567164|100803950|FG000|COMPLETED|Overall Study||875||
48196714|NCT00567164|100803951|FG001|COMPLETED|Overall Study||161||
48196715|NCT00567164|100803952|FG002|COMPLETED|Overall Study||160||
48196716|NCT00567164|100803950|FG000|NOT COMPLETED|Overall Study||546||
48196717|NCT00567164|100803951|FG001|NOT COMPLETED|Overall Study||73||
48196718|NCT00567164|100803952|FG002|NOT COMPLETED|Overall Study||72||
48196719|NCT02701361|100803953|FG000|STARTED|Overall Study||31||
48196720|NCT02701361|100803954|FG001|STARTED|Overall Study||31||
48196721|NCT02701361|100803955|FG002|STARTED|Overall Study||18||
48196722|NCT02701361|100803953|FG000|COMPLETED|Overall Study||22||
48196723|NCT02701361|100803954|FG001|COMPLETED|Overall Study||28||
48196724|NCT02701361|100803955|FG002|COMPLETED|Overall Study||16||
48196725|NCT02701361|100803953|FG000|NOT COMPLETED|Overall Study||9||
48196726|NCT02701361|100803954|FG001|NOT COMPLETED|Overall Study||3||
48196727|NCT02701361|100803955|FG002|NOT COMPLETED|Overall Study||2||
48196728|NCT00578214|100803956|FG000|STARTED|Overall Study||22||
48196729|NCT00578214|100803957|FG001|STARTED|Overall Study||22||
48196730|NCT00578214|100803958|FG002|STARTED|Overall Study||31||
48196731|NCT00578214|100803956|FG000|COMPLETED|Overall Study||22||
48196732|NCT00578214|100803957|FG001|COMPLETED|Overall Study||22||
48196733|NCT00578214|100803958|FG002|COMPLETED|Overall Study||31||
48196734|NCT00578214|100803956|FG000|NOT COMPLETED|Overall Study||0||
48196735|NCT00578214|100803957|FG001|NOT COMPLETED|Overall Study||0||
48196736|NCT00578214|100803958|FG002|NOT COMPLETED|Overall Study||0||
48196737|NCT03085017|100803959|FG000|STARTED|Overall Study||30||
48196738|NCT03085017|100803960|FG001|STARTED|Overall Study||27||
48196739|NCT03085017|100803959|FG000|COMPLETED|Overall Study||30||
48196740|NCT03085017|100803960|FG001|COMPLETED|Overall Study||24||
48196741|NCT03085017|100803959|FG000|NOT COMPLETED|Overall Study||0||
48196742|NCT03085017|100803960|FG001|NOT COMPLETED|Overall Study||3||
48196743|NCT00742573|100803961|FG000|STARTED|Overall Study||83||
48196744|NCT00742573|100803962|FG001|STARTED|Overall Study||87||
48196745|NCT00742573|100803961|FG000|Week 12|Overall Study||46||
48196746|NCT00742573|100803962|FG001|Week 12|Overall Study||51||
48196747|NCT00742573|100803961|FG000|Week 24|Overall Study||39||
48196748|NCT00742573|100803962|FG001|Week 24|Overall Study||37||
48196749|NCT00742573|100803961|FG000|Week 52|Overall Study||26||
48196750|NCT00742573|100803962|FG001|Week 52|Overall Study||25||
48196751|NCT00742573|100803961|FG000|COMPLETED|Overall Study||26||
48196752|NCT00742573|100803962|FG001|COMPLETED|Overall Study||25||
48196753|NCT00742573|100803961|FG000|NOT COMPLETED|Overall Study||57||
48196754|NCT00742573|100803962|FG001|NOT COMPLETED|Overall Study||62||
48196755|NCT01286402|100803963|FG000|STARTED|Overall Study||5||
48196756|NCT01286402|100803964|FG001|STARTED|Overall Study||6||
48196757|NCT01286402|100803963|FG000|COMPLETED|Overall Study||5||
48196758|NCT01286402|100803964|FG001|COMPLETED|Overall Study||6||
48196759|NCT01286402|100803963|FG000|NOT COMPLETED|Overall Study||0||
48196760|NCT01286402|100803964|FG001|NOT COMPLETED|Overall Study||0||
48196761|NCT00631475|100803965|FG000|STARTED|Overall Study||128||
48196762|NCT00631475|100803965|FG000|COMPLETED|Overall Study||83||
48196763|NCT00631475|100803965|FG000|NOT COMPLETED|Overall Study||45||
48196764|NCT04337489|100803966|FG000|STARTED|Overall Study||15||
48196765|NCT04337489|100803966|FG000|COMPLETED|Overall Study||14||
48196766|NCT04337489|100803966|FG000|NOT COMPLETED|Overall Study||1||
48196767|NCT00422201|100803967|FG000|STARTED|Overall Study||18||
48196768|NCT00422201|100803967|FG000|COMPLETED|Overall Study||7||
48196769|NCT00422201|100803967|FG000|NOT COMPLETED|Overall Study||11||
48196770|NCT02140554|100803968|FG000|STARTED|Overall Study||9||
48483486|NCT02477202|101522436|FG000|STARTED|Overall Study||7||
48483487|NCT02477202|101522436|FG000|COMPLETED|Overall Study||7||
48483488|NCT02477202|101522436|FG000|NOT COMPLETED|Overall Study||0||
48483489|NCT02911792|101522437|FG000|STARTED|Overall Study||18||
48196771|NCT02140554|100803969|FG001|STARTED|Overall Study||2||
48483490|NCT02911792|101522438|FG001|STARTED|Overall Study||18||
48196772|NCT02140554|100803970|FG002|STARTED|Overall Study||43||
48196773|NCT02140554|100803968|FG000|Transplant Population (TP)|Overall Study||7|TP included participants who received lovo-cel (45 TP participants).|
48196774|NCT02140554|100803969|FG001|Transplant Population (TP)|Overall Study||2|TP included participants who received lovo-cel (45 TP participants).|
48196775|NCT02140554|100803970|FG002|Transplant Population (TP)|Overall Study||36|TP included participants who received lovo-cel (45 TP participants).|
48196776|NCT02140554|100803968|FG000|Transplant Population for VOE (TPVOE)|Overall Study||6|TPVOE is subset of TP participants who had at least 4 protocol VOEs in the 24 months prior to Informed Consent (40 TPVOE participants).|
48196777|NCT02140554|100803969|FG001|Transplant Population for VOE (TPVOE)|Overall Study||2|TPVOE is subset of TP participants who had at least 4 protocol VOEs in the 24 months prior to Informed Consent (40 TPVOE participants).|
48483491|NCT02911792|101522439|FG002|STARTED|Overall Study||18||
48483492|NCT02911792|101522440|FG003|STARTED|Overall Study||18||
48483493|NCT02911792|101522437|FG000|COMPLETED|Overall Study||15||
48196778|NCT02140554|100803970|FG002|Transplant Population for VOE (TPVOE)|Overall Study||32|TPVOE is subset of TP participants who had at least 4 protocol VOEs in the 24 months prior to Informed Consent (40 TPVOE participants).|
48196779|NCT02140554|100803968|FG000|COMPLETED|Overall Study||7||
48196780|NCT02140554|100803969|FG001|COMPLETED|Overall Study||2||
48196781|NCT02140554|100803970|FG002|COMPLETED|Overall Study||35||
48196782|NCT02140554|100803968|FG000|NOT COMPLETED|Overall Study||2||
48196783|NCT02140554|100803969|FG001|NOT COMPLETED|Overall Study||0||
48196784|NCT02140554|100803970|FG002|NOT COMPLETED|Overall Study||8||
48196785|NCT02282527|100803971|FG000|STARTED|Overall Study||16||
48196786|NCT02282527|100803972|FG001|STARTED|Overall Study||16||
48196787|NCT02282527|100803971|FG000|COMPLETED|Overall Study||15||
48196788|NCT02282527|100803972|FG001|COMPLETED|Overall Study||15||
48196789|NCT02282527|100803971|FG000|NOT COMPLETED|Overall Study||1||
48196790|NCT02282527|100803972|FG001|NOT COMPLETED|Overall Study||1||
48196791|NCT00282438|100803973|FG000|STARTED|Overall Study||1||
48196792|NCT00282438|100803974|FG001|STARTED|Overall Study||1||
48196793|NCT00282438|100803973|FG000|COMPLETED|Overall Study||0||
48196794|NCT00282438|100803974|FG001|COMPLETED|Overall Study||0||
48196795|NCT00282438|100803973|FG000|NOT COMPLETED|Overall Study||1||
48196796|NCT00282438|100803974|FG001|NOT COMPLETED|Overall Study||1||
48196797|NCT02469064|100803975|FG000|STARTED|Overall Study||64||
48196798|NCT02469064|100803976|FG001|STARTED|Overall Study||62||
48196799|NCT02469064|100803975|FG000|COMPLETED|Overall Study||63||
48196800|NCT02469064|100803976|FG001|COMPLETED|Overall Study||59||
48196801|NCT02469064|100803975|FG000|NOT COMPLETED|Overall Study||1||
48196802|NCT02469064|100803976|FG001|NOT COMPLETED|Overall Study||3||
48196803|NCT03736785|100803977|FG000|STARTED|Overall Study||135||
48196804|NCT03736785|100803978|FG001|STARTED|Overall Study||132||
48196805|NCT03736785|100803979|FG002|STARTED|Overall Study||132||
48196806|NCT03736785|100803977|FG000|COMPLETED|Overall Study||118||
48196807|NCT03736785|100803978|FG001|COMPLETED|Overall Study||115||
48196808|NCT03736785|100803979|FG002|COMPLETED|Overall Study||118||
48196809|NCT03736785|100803977|FG000|NOT COMPLETED|Overall Study||17||
48196810|NCT03736785|100803978|FG001|NOT COMPLETED|Overall Study||17||
48196811|NCT03736785|100803979|FG002|NOT COMPLETED|Overall Study||14||
48196812|NCT01068249|100803980|FG000|STARTED|Overall Study||39||
48196813|NCT01068249|100803980|FG000|COMPLETED|Overall Study||35||
48196814|NCT01068249|100803980|FG000|NOT COMPLETED|Overall Study||4||
48196815|NCT02664220|100803981|FG000|STARTED|Overall Study||50||
48196816|NCT02664220|100803982|FG001|STARTED|Overall Study||50||
48196817|NCT02664220|100803981|FG000|COMPLETED|Overall Study||50||
48196818|NCT02664220|100803982|FG001|COMPLETED|Overall Study||50||
48196819|NCT02664220|100803981|FG000|NOT COMPLETED|Overall Study||0||
48196820|NCT02664220|100803982|FG001|NOT COMPLETED|Overall Study||0||
48196821|NCT01982643|100806536|FG000|STARTED|Overall Study||49||
48196822|NCT01982643|100806536|FG000|COMPLETED|Overall Study||37||
48483494|NCT02911792|101522438|FG001|COMPLETED|Overall Study||15||
48483495|NCT02911792|101522439|FG002|COMPLETED|Overall Study||15||
48483496|NCT02911792|101522440|FG003|COMPLETED|Overall Study||15||
48483497|NCT02911792|101522437|FG000|NOT COMPLETED|Overall Study||3||
48483498|NCT02911792|101522438|FG001|NOT COMPLETED|Overall Study||3||
48483499|NCT02911792|101522439|FG002|NOT COMPLETED|Overall Study||3||
48483500|NCT02911792|101522440|FG003|NOT COMPLETED|Overall Study||3||
48483501|NCT00752973|101522441|FG000|STARTED|Overall Study||12||
48483502|NCT00752973|101522441|FG000|COMPLETED|Overall Study||12||
48483503|NCT00752973|101522441|FG000|NOT COMPLETED|Overall Study||0||
48483504|NCT04408794|101522442|FG000|STARTED|Overall Study||608|Participants in the enrolled analysis set who participated in the LTT phase, that is, non-missing interactive web response system baseline visit date.|
48483505|NCT04408794|101522442|FG000|Treated/Safety Analysis Set|Overall Study||603|Participants in the enrolled analysis set who took study drug, that is, non-missing study drug start date/time.|
48483506|NCT04408794|101522442|FG000|COMPLETED|Overall Study||341||
48483507|NCT04408794|101522442|FG000|NOT COMPLETED|Overall Study||267||
48483508|NCT00001703|101522443|FG000|STARTED|Overall Study||6||
48483509|NCT00001703|101522443|FG000|Peptide Stock Completed|Overall Study||3||
48483510|NCT00001703|101522443|FG000|COMPLETED|Overall Study||1||
48483511|NCT00001703|101522443|FG000|NOT COMPLETED|Overall Study||5||
48483512|NCT00450190|101522444|FG000|STARTED|Overall Study||20||
48483513|NCT00450190|101522444|FG000|COMPLETED|Overall Study||18||
48196823|NCT01982643|100806536|FG000|NOT COMPLETED|Overall Study||12||
48196824|NCT01549652|100806537|FG000|STARTED|Overall Study||27||
48196825|NCT01549652|100806538|FG001|STARTED|Overall Study||30||
48196826|NCT01549652|100806539|FG002|STARTED|Overall Study||40||
48196827|NCT01549652|100806540|FG003|STARTED|Overall Study||36||
48196828|NCT01549652|100806537|FG000|COMPLETED|Overall Study||15||
48196829|NCT01549652|100806538|FG001|COMPLETED|Overall Study||18||
48196830|NCT01549652|100806539|FG002|COMPLETED|Overall Study||23||
48196831|NCT01549652|100806540|FG003|COMPLETED|Overall Study||25||
48196832|NCT01549652|100806537|FG000|NOT COMPLETED|Overall Study||12||
48196833|NCT01549652|100806538|FG001|NOT COMPLETED|Overall Study||12||
48196834|NCT01549652|100806539|FG002|NOT COMPLETED|Overall Study||17||
48483514|NCT00450190|101522444|FG000|NOT COMPLETED|Overall Study||2||
48483515|NCT02847650|101522445|FG000|STARTED|Overall Study||29||
48483516|NCT02847650|101522446|FG001|STARTED|Overall Study||28||
48483517|NCT02847650|101522445|FG000|COMPLETED|Overall Study||25||
48483518|NCT02847650|101522446|FG001|COMPLETED|Overall Study||22||
48483519|NCT02847650|101522445|FG000|NOT COMPLETED|Overall Study||4||
48196835|NCT01549652|100806540|FG003|NOT COMPLETED|Overall Study||11||
48196836|NCT03302156|100806541|FG000|STARTED|Overall Study||2||
48196837|NCT03302156|100806542|FG001|STARTED|Overall Study||13||
48196838|NCT03302156|100806543|FG002|STARTED|Overall Study||0||
48196839|NCT03302156|100806541|FG000|Analysis Population|Overall Study||2||
48196840|NCT03302156|100806542|FG001|Analysis Population|Overall Study||12||
48196841|NCT03302156|100806543|FG002|Analysis Population|Overall Study||0||
48196842|NCT03302156|100806541|FG000|Participants With Confirmed Ovarian Cancer With PSMA Uptake|Overall Study||0||
48196843|NCT03302156|100806542|FG001|Participants With Confirmed Ovarian Cancer With PSMA Uptake|Overall Study||1||
48196844|NCT03302156|100806543|FG002|Participants With Confirmed Ovarian Cancer With PSMA Uptake|Overall Study||0||
48196845|NCT03302156|100806541|FG000|COMPLETED|Overall Study||2||
48196846|NCT03302156|100806542|FG001|COMPLETED|Overall Study||12||
48196847|NCT03302156|100806543|FG002|COMPLETED|Overall Study||0||
48196848|NCT03302156|100806541|FG000|NOT COMPLETED|Overall Study||0||
48196849|NCT03302156|100806542|FG001|NOT COMPLETED|Overall Study||1||
48196850|NCT03302156|100806543|FG002|NOT COMPLETED|Overall Study||0||
48196851|NCT01726023|100806544|FG000|STARTED|Overall Study||219||
48196852|NCT01726023|100806545|FG001|STARTED|Overall Study||222||
48196853|NCT01726023|100806544|FG000|COMPLETED|Overall Study||190||
48196854|NCT01726023|100806545|FG001|COMPLETED|Overall Study||196||
48196855|NCT01726023|100806544|FG000|NOT COMPLETED|Overall Study||29||
48196856|NCT01726023|100806545|FG001|NOT COMPLETED|Overall Study||26||
48196857|NCT02718118|100806546|FG000|STARTED|Overall Study||30||
48196858|NCT02718118|100806547|FG001|STARTED|Overall Study||30||
48196859|NCT02718118|100806546|FG000|COMPLETED|Overall Study||28||
48196860|NCT02718118|100806547|FG001|COMPLETED|Overall Study||29||
48196861|NCT02718118|100806546|FG000|NOT COMPLETED|Overall Study||2||
48196862|NCT02718118|100806547|FG001|NOT COMPLETED|Overall Study||1||
48483520|NCT02847650|101522446|FG001|NOT COMPLETED|Overall Study||6||
48483521|NCT00487565|101522447|FG000|STARTED|Overall Study||210||
48483522|NCT00487565|101522447|FG000|COMPLETED|Overall Study||182||
48483523|NCT00487565|101522447|FG000|NOT COMPLETED|Overall Study||28||
48483524|NCT02937870|101522448|FG000|STARTED|Overall Study||23||
48196863|NCT03972813|100806548|FG000|STARTED|Overall Study||85||
48483525|NCT02937870|101522448|FG000|Received Test Adhesive 1|Overall Study||21||
48483526|NCT02937870|101522448|FG000|Received Test Adhesive 2|Overall Study||22||
48483527|NCT02937870|101522448|FG000|Received Positive Control Adhesive|Overall Study||21||
48196864|NCT03972813|100806549|FG001|STARTED|Overall Study||49||
48196865|NCT03972813|100806550|FG002|STARTED|Overall Study||58||
48196866|NCT03972813|100806551|FG003|STARTED|Overall Study||55||
48196867|NCT03972813|100806552|FG004|STARTED|Overall Study||52||
48196868|NCT03972813|100806553|FG005|STARTED|Overall Study||51||
48196869|NCT03972813|100806554|FG006|STARTED|Overall Study||53||
48196870|NCT03972813|100806555|FG007|STARTED|Overall Study||55||
48196871|NCT03972813|100806556|FG008|STARTED|Overall Study||58||
48196872|NCT03972813|100806557|FG009|STARTED|Overall Study||60||
48196873|NCT03972813|100806558|FG010|STARTED|Overall Study||62||
48196874|NCT03972813|100806559|FG011|STARTED|Overall Study||55||
48196875|NCT03972813|100806560|FG012|STARTED|Overall Study||58||
48196876|NCT03972813|100806561|FG013|STARTED|Overall Study||55||
48196877|NCT03972813|100806562|FG014|STARTED|Overall Study||58||
48196878|NCT03972813|100806563|FG015|STARTED|Overall Study||56||
48196879|NCT03972813|100806564|FG016|STARTED|Overall Study||51||
48196880|NCT03972813|100806565|FG017|STARTED|Overall Study||50||
48196881|NCT03972813|100806548|FG000|COMPLETED|Overall Study||79|68 individuals completed the survey but did not answer the outcome|
48196882|NCT03972813|100806549|FG001|COMPLETED|Overall Study||45|68 individuals completed the survey but did not answer the outcome|
48196883|NCT03972813|100806550|FG002|COMPLETED|Overall Study||52|68 individuals completed the survey but did not answer the outcome|
48483528|NCT02937870|101522448|FG000|Received no Adhesive|Overall Study||20||
48483529|NCT02937870|101522448|FG000|COMPLETED|Overall Study||20||
48483530|NCT02937870|101522448|FG000|NOT COMPLETED|Overall Study||3||
48483531|NCT00579670|101522449|FG000|STARTED|Overall Study||15||
48483532|NCT00579670|101522450|FG001|STARTED|Overall Study||57||
48483533|NCT00579670|101522451|FG002|STARTED|Overall Study||88||
48483534|NCT00579670|101522452|FG003|STARTED|Overall Study||285||
48483535|NCT00579670|101522453|FG004|STARTED|Overall Study||5||
48483536|NCT00579670|101522449|FG000|Population: Within SmPC (Started)|Overall Study||15||
48483537|NCT00579670|101522450|FG001|Population: Within SmPC (Started)|Overall Study||56||
48483538|NCT00579670|101522451|FG002|Population: Within SmPC (Started)|Overall Study||83||
48483539|NCT00579670|101522452|FG003|Population: Within SmPC (Started)|Overall Study||159||
48483540|NCT00579670|101522453|FG004|Population: Within SmPC (Started)|Overall Study||0||
48483541|NCT00579670|101522449|FG000|Population: Within SmPC (Completed)|Overall Study||13||
48483542|NCT00579670|101522450|FG001|Population: Within SmPC (Completed)|Overall Study||55||
48483543|NCT00579670|101522451|FG002|Population: Within SmPC (Completed)|Overall Study||79||
48483544|NCT00579670|101522452|FG003|Population: Within SmPC (Completed)|Overall Study||147||
48483545|NCT00579670|101522453|FG004|Population: Within SmPC (Completed)|Overall Study||0||
48483546|NCT00579670|101522449|FG000|COMPLETED|Overall Study||13||
48483547|NCT00579670|101522450|FG001|COMPLETED|Overall Study||56||
48483548|NCT00579670|101522451|FG002|COMPLETED|Overall Study||84||
48483549|NCT00579670|101522452|FG003|COMPLETED|Overall Study||263||
48483550|NCT00579670|101522453|FG004|COMPLETED|Overall Study||5||
48483551|NCT00579670|101522449|FG000|NOT COMPLETED|Overall Study||2||
48483552|NCT00579670|101522450|FG001|NOT COMPLETED|Overall Study||1||
48483553|NCT00579670|101522451|FG002|NOT COMPLETED|Overall Study||4||
48483554|NCT00579670|101522452|FG003|NOT COMPLETED|Overall Study||22||
48483555|NCT00579670|101522453|FG004|NOT COMPLETED|Overall Study||0||
48483556|NCT02159950|101522454|FG000|STARTED|Overall Study||0||
48483557|NCT02159950|101522455|FG001|STARTED|Overall Study||2||
48483558|NCT02159950|101522454|FG000|COMPLETED|Overall Study||0||
48483559|NCT02159950|101522455|FG001|COMPLETED|Overall Study||0||
48483560|NCT02159950|101522454|FG000|NOT COMPLETED|Overall Study||0||
48483561|NCT02159950|101522455|FG001|NOT COMPLETED|Overall Study||2||
48483562|NCT02128997|101522456|FG000|STARTED|Overall Study||67||
48483563|NCT02128997|101522457|FG001|STARTED|Overall Study||69||
48483564|NCT02128997|101522456|FG000|COMPLETED|Overall Study||61||
48483565|NCT02128997|101522457|FG001|COMPLETED|Overall Study||58||
48483566|NCT02128997|101522456|FG000|NOT COMPLETED|Overall Study||6||
48483567|NCT02128997|101522457|FG001|NOT COMPLETED|Overall Study||11||
48483568|NCT03514420|101522458|FG000|STARTED|Overall Study||4||
48483569|NCT03514420|101522458|FG000|COMPLETED|Overall Study||4||
48483570|NCT03514420|101522458|FG000|NOT COMPLETED|Overall Study||0||
48483571|NCT01289262|101522459|FG000|STARTED|Overall Study||84||
48483572|NCT01289262|101522460|FG001|STARTED|Overall Study||84||
48483573|NCT01289262|101522459|FG000|COMPLETED|Overall Study||51||
48483574|NCT01289262|101522460|FG001|COMPLETED|Overall Study||65||
48483575|NCT01289262|101522459|FG000|NOT COMPLETED|Overall Study||33||
48483576|NCT01289262|101522460|FG001|NOT COMPLETED|Overall Study||19||
48483577|NCT02393417|101522461|FG000|STARTED|Overall Study||43|Subjects Randomized|
48483578|NCT02393417|101522462|FG001|STARTED|Overall Study||45|Subjects Randomized|
48483579|NCT02393417|101522463|FG002|STARTED|Overall Study||40|Subjects Randomized|
48483580|NCT02393417|101522464|FG003|STARTED|Overall Study||41|Subjects Randomized|
48483581|NCT02393417|101522461|FG000|Completed Treatment|Overall Study||30||
48483582|NCT02393417|101522462|FG001|Completed Treatment|Overall Study||34||
48483583|NCT02393417|101522463|FG002|Completed Treatment|Overall Study||32||
48483584|NCT02393417|101522464|FG003|Completed Treatment|Overall Study||30||
48483585|NCT02393417|101522461|FG000|COMPLETED|Overall Study||28|Completed Treatment and both follow up visits|
48483586|NCT02393417|101522462|FG001|COMPLETED|Overall Study||32|Completed Treatment and both follow up visits|
48483587|NCT02393417|101522463|FG002|COMPLETED|Overall Study||30|Completed Treatment and both follow up visits|
48483588|NCT02393417|101522464|FG003|COMPLETED|Overall Study||29|Completed Treatment and both follow up visits|
48483589|NCT02393417|101522461|FG000|NOT COMPLETED|Overall Study||15||
48483590|NCT02393417|101522462|FG001|NOT COMPLETED|Overall Study||13||
48483591|NCT02393417|101522463|FG002|NOT COMPLETED|Overall Study||10||
48483592|NCT02393417|101522464|FG003|NOT COMPLETED|Overall Study||12||
48483593|NCT03673670|101522465|FG000|STARTED|Treatment Period 1 (3 Days)||14||
48483594|NCT03673670|101522466|FG001|STARTED|Treatment Period 1 (3 Days)||14||
48483595|NCT03673670|101522467|FG002|STARTED|Treatment Period 1 (3 Days)||13||
48483596|NCT03673670|101522468|FG003|STARTED|Treatment Period 1 (3 Days)||12||
48483597|NCT03673670|101522469|FG004|STARTED|Treatment Period 1 (3 Days)||13||
48483598|NCT03673670|101522470|FG005|STARTED|Treatment Period 1 (3 Days)||13||
48483599|NCT03673670|101522465|FG000|COMPLETED|Treatment Period 1 (3 Days)||13||
48483600|NCT03673670|101522466|FG001|COMPLETED|Treatment Period 1 (3 Days)||14||
48483601|NCT03673670|101522467|FG002|COMPLETED|Treatment Period 1 (3 Days)||12||
48483602|NCT03673670|101522468|FG003|COMPLETED|Treatment Period 1 (3 Days)||12||
48483603|NCT03673670|101522469|FG004|COMPLETED|Treatment Period 1 (3 Days)||13||
48483604|NCT03673670|101522470|FG005|COMPLETED|Treatment Period 1 (3 Days)||11||
48483605|NCT03673670|101522465|FG000|NOT COMPLETED|Treatment Period 1 (3 Days)||1||
48483606|NCT03673670|101522466|FG001|NOT COMPLETED|Treatment Period 1 (3 Days)||0||
48483607|NCT03673670|101522467|FG002|NOT COMPLETED|Treatment Period 1 (3 Days)||1||
48483608|NCT03673670|101522468|FG003|NOT COMPLETED|Treatment Period 1 (3 Days)||0||
48483609|NCT03673670|101522469|FG004|NOT COMPLETED|Treatment Period 1 (3 Days)||0||
48483610|NCT03673670|101522470|FG005|NOT COMPLETED|Treatment Period 1 (3 Days)||2||
48483611|NCT03673670|101522465|FG000|STARTED|Washout Period 1 (7-14 Days)||13||
48483612|NCT03673670|101522466|FG001|STARTED|Washout Period 1 (7-14 Days)||14||
48483613|NCT03673670|101522467|FG002|STARTED|Washout Period 1 (7-14 Days)||12||
48483614|NCT03673670|101522468|FG003|STARTED|Washout Period 1 (7-14 Days)||12||
48483615|NCT03673670|101522469|FG004|STARTED|Washout Period 1 (7-14 Days)||13||
48483616|NCT03673670|101522470|FG005|STARTED|Washout Period 1 (7-14 Days)||11||
48483617|NCT03673670|101522465|FG000|COMPLETED|Washout Period 1 (7-14 Days)||13||
48483618|NCT03673670|101522466|FG001|COMPLETED|Washout Period 1 (7-14 Days)||14||
48483619|NCT03673670|101522467|FG002|COMPLETED|Washout Period 1 (7-14 Days)||12||
48483620|NCT03673670|101522468|FG003|COMPLETED|Washout Period 1 (7-14 Days)||12||
48483621|NCT03673670|101522469|FG004|COMPLETED|Washout Period 1 (7-14 Days)||13||
48483622|NCT03673670|101522470|FG005|COMPLETED|Washout Period 1 (7-14 Days)||11||
48483623|NCT03673670|101522465|FG000|NOT COMPLETED|Washout Period 1 (7-14 Days)||0||
48483624|NCT03673670|101522466|FG001|NOT COMPLETED|Washout Period 1 (7-14 Days)||0||
48483625|NCT03673670|101522467|FG002|NOT COMPLETED|Washout Period 1 (7-14 Days)||0||
48483626|NCT03673670|101522468|FG003|NOT COMPLETED|Washout Period 1 (7-14 Days)||0||
48483627|NCT03673670|101522469|FG004|NOT COMPLETED|Washout Period 1 (7-14 Days)||0||
48483628|NCT03673670|101522470|FG005|NOT COMPLETED|Washout Period 1 (7-14 Days)||0||
48483629|NCT03673670|101522465|FG000|STARTED|Treatment Period 2 (3 Days)||13||
48483630|NCT03673670|101522466|FG001|STARTED|Treatment Period 2 (3 Days)||14||
48483631|NCT03673670|101522467|FG002|STARTED|Treatment Period 2 (3 Days)||12||
48483632|NCT03673670|101522468|FG003|STARTED|Treatment Period 2 (3 Days)||12||
48483633|NCT03673670|101522469|FG004|STARTED|Treatment Period 2 (3 Days)||13||
48483634|NCT03673670|101522470|FG005|STARTED|Treatment Period 2 (3 Days)||11||
48483635|NCT03673670|101522465|FG000|COMPLETED|Treatment Period 2 (3 Days)||13||
48483636|NCT03673670|101522466|FG001|COMPLETED|Treatment Period 2 (3 Days)||14||
48483637|NCT03673670|101522467|FG002|COMPLETED|Treatment Period 2 (3 Days)||11||
48483638|NCT03673670|101522468|FG003|COMPLETED|Treatment Period 2 (3 Days)||12||
48483639|NCT03673670|101522469|FG004|COMPLETED|Treatment Period 2 (3 Days)||12||
48196884|NCT03972813|100806551|FG003|COMPLETED|Overall Study||51|68 individuals completed the survey but did not answer the outcome|
48196885|NCT03972813|100806552|FG004|COMPLETED|Overall Study||48|68 individuals completed the survey but did not answer the outcome|
48196886|NCT03972813|100806553|FG005|COMPLETED|Overall Study||49|68 individuals completed the survey but did not answer the outcome|
48483640|NCT03673670|101522470|FG005|COMPLETED|Treatment Period 2 (3 Days)||11||
48483641|NCT03673670|101522465|FG000|NOT COMPLETED|Treatment Period 2 (3 Days)||0||
48483642|NCT03673670|101522466|FG001|NOT COMPLETED|Treatment Period 2 (3 Days)||0||
48483643|NCT03673670|101522467|FG002|NOT COMPLETED|Treatment Period 2 (3 Days)||1||
48483644|NCT03673670|101522468|FG003|NOT COMPLETED|Treatment Period 2 (3 Days)||0||
48483645|NCT03673670|101522469|FG004|NOT COMPLETED|Treatment Period 2 (3 Days)||1||
48483646|NCT03673670|101522470|FG005|NOT COMPLETED|Treatment Period 2 (3 Days)||0||
48483647|NCT03673670|101522465|FG000|STARTED|Washout Period 2 (7-14 Days)||13||
48483648|NCT03673670|101522466|FG001|STARTED|Washout Period 2 (7-14 Days)||14||
48483649|NCT03673670|101522467|FG002|STARTED|Washout Period 2 (7-14 Days)||11||
48483650|NCT03673670|101522468|FG003|STARTED|Washout Period 2 (7-14 Days)||12||
48483651|NCT03673670|101522469|FG004|STARTED|Washout Period 2 (7-14 Days)||12||
48483652|NCT03673670|101522470|FG005|STARTED|Washout Period 2 (7-14 Days)||11||
48483653|NCT03673670|101522465|FG000|COMPLETED|Washout Period 2 (7-14 Days)||13||
48483654|NCT03673670|101522466|FG001|COMPLETED|Washout Period 2 (7-14 Days)||14||
48483655|NCT03673670|101522467|FG002|COMPLETED|Washout Period 2 (7-14 Days)||11||
48483656|NCT03673670|101522468|FG003|COMPLETED|Washout Period 2 (7-14 Days)||12||
48483657|NCT03673670|101522469|FG004|COMPLETED|Washout Period 2 (7-14 Days)||11||
48483658|NCT03673670|101522470|FG005|COMPLETED|Washout Period 2 (7-14 Days)||11||
48483659|NCT03673670|101522465|FG000|NOT COMPLETED|Washout Period 2 (7-14 Days)||0||
48483660|NCT03673670|101522466|FG001|NOT COMPLETED|Washout Period 2 (7-14 Days)||0||
48483661|NCT03673670|101522467|FG002|NOT COMPLETED|Washout Period 2 (7-14 Days)||0||
48483662|NCT03673670|101522468|FG003|NOT COMPLETED|Washout Period 2 (7-14 Days)||0||
48483663|NCT03673670|101522469|FG004|NOT COMPLETED|Washout Period 2 (7-14 Days)||1||
48483664|NCT03673670|101522470|FG005|NOT COMPLETED|Washout Period 2 (7-14 Days)||0||
48483665|NCT03673670|101522465|FG000|STARTED|Treatment Period 3 (3 Days)||13||
48483666|NCT03673670|101522466|FG001|STARTED|Treatment Period 3 (3 Days)||14||
48483667|NCT03673670|101522467|FG002|STARTED|Treatment Period 3 (3 Days)||11||
48483668|NCT03673670|101522468|FG003|STARTED|Treatment Period 3 (3 Days)||12||
48483669|NCT03673670|101522469|FG004|STARTED|Treatment Period 3 (3 Days)||11||
48483670|NCT03673670|101522470|FG005|STARTED|Treatment Period 3 (3 Days)||11||
48483671|NCT03673670|101522465|FG000|COMPLETED|Treatment Period 3 (3 Days)||13||
48483672|NCT03673670|101522466|FG001|COMPLETED|Treatment Period 3 (3 Days)||14||
48483673|NCT03673670|101522467|FG002|COMPLETED|Treatment Period 3 (3 Days)||11||
48483674|NCT03673670|101522468|FG003|COMPLETED|Treatment Period 3 (3 Days)||12||
48483675|NCT03673670|101522469|FG004|COMPLETED|Treatment Period 3 (3 Days)||10||
48483676|NCT03673670|101522470|FG005|COMPLETED|Treatment Period 3 (3 Days)||11||
48483677|NCT03673670|101522465|FG000|NOT COMPLETED|Treatment Period 3 (3 Days)||0||
48483678|NCT03673670|101522466|FG001|NOT COMPLETED|Treatment Period 3 (3 Days)||0||
48483679|NCT03673670|101522467|FG002|NOT COMPLETED|Treatment Period 3 (3 Days)||0||
48483680|NCT03673670|101522468|FG003|NOT COMPLETED|Treatment Period 3 (3 Days)||0||
48483681|NCT03673670|101522469|FG004|NOT COMPLETED|Treatment Period 3 (3 Days)||1||
48483682|NCT03673670|101522470|FG005|NOT COMPLETED|Treatment Period 3 (3 Days)||0||
48483683|NCT01353664|101522471|FG000|STARTED|Overall Study||19||
48483684|NCT01353664|101522471|FG000|COMPLETED|Overall Study||0||
48483685|NCT01353664|101522471|FG000|NOT COMPLETED|Overall Study||19||
48483686|NCT00479258|101522472|FG000|STARTED|Overall Study||0||
48483687|NCT00479258|101522473|FG001|STARTED|Overall Study||0||
48483688|NCT00479258|101522472|FG000|COMPLETED|Overall Study||0||
48483689|NCT00479258|101522473|FG001|COMPLETED|Overall Study||0||
48483690|NCT00479258|101522472|FG000|NOT COMPLETED|Overall Study||0||
48483691|NCT00479258|101522473|FG001|NOT COMPLETED|Overall Study||0||
48483692|NCT01401647|101522474|FG000|STARTED|Overall Study||972||
48483693|NCT01401647|101522475|FG001|STARTED|Overall Study||993||
48483694|NCT01401647|101522476|FG002|STARTED|Overall Study||1059||
48483695|NCT01401647|101522474|FG000|COMPLETED|Overall Study||968||
48483696|NCT01401647|101522475|FG001|COMPLETED|Overall Study||985||
48483697|NCT01401647|101522476|FG002|COMPLETED|Overall Study||1056||
48483698|NCT01401647|101522474|FG000|NOT COMPLETED|Overall Study||4||
48483699|NCT01401647|101522475|FG001|NOT COMPLETED|Overall Study||8||
48483700|NCT01401647|101522476|FG002|NOT COMPLETED|Overall Study||3||
48483701|NCT03965091|101522477|FG000|STARTED|Overall Study||64||
48483702|NCT03965091|101522478|FG001|STARTED|Overall Study||62||
48483703|NCT03965091|101522479|FG002|STARTED|Overall Study||63||
48483704|NCT03965091|101522477|FG000|Received at Least 1 Dose of Study Drug|Overall Study||64||
48483705|NCT03965091|101522478|FG001|Received at Least 1 Dose of Study Drug|Overall Study||62||
48483706|NCT03965091|101522479|FG002|Received at Least 1 Dose of Study Drug|Overall Study||63||
48483707|NCT03965091|101522477|FG000|COMPLETED|Overall Study||41||
48483708|NCT03965091|101522478|FG001|COMPLETED|Overall Study||45||
48483709|NCT03965091|101522479|FG002|COMPLETED|Overall Study||45||
48196887|NCT03972813|100806554|FG006|COMPLETED|Overall Study||49|68 individuals completed the survey but did not answer the outcome|
48483710|NCT03965091|101522477|FG000|NOT COMPLETED|Overall Study||23||
48483711|NCT03965091|101522478|FG001|NOT COMPLETED|Overall Study||17||
48483712|NCT03965091|101522479|FG002|NOT COMPLETED|Overall Study||18||
48483713|NCT01746017|101522480|FG000|STARTED|Period 1||2||
48483714|NCT01746017|101522481|FG001|STARTED|Period 1||2||
48483715|NCT01746017|101522482|FG002|STARTED|Period 1||2||
48483716|NCT01746017|101522483|FG003|STARTED|Period 1||2||
48483717|NCT01746017|101522484|FG004|STARTED|Period 1||2||
48483718|NCT01746017|101522485|FG005|STARTED|Period 1||2||
48483719|NCT01746017|101522486|FG006|STARTED|Period 1||3||
48483720|NCT01746017|101522487|FG007|STARTED|Period 1||2||
48483721|NCT01746017|101522488|FG008|STARTED|Period 1||3||
48483722|NCT01746017|101522489|FG009|STARTED|Period 1||3||
48483723|NCT01746017|101522490|FG010|STARTED|Period 1||3||
48196888|NCT03972813|100806555|FG007|COMPLETED|Overall Study||52|68 individuals completed the survey but did not answer the outcome|
48196889|NCT03972813|100806556|FG008|COMPLETED|Overall Study||53|68 individuals completed the survey but did not answer the outcome|
48196890|NCT03972813|100806557|FG009|COMPLETED|Overall Study||58|68 individuals completed the survey but did not answer the outcome|
48483724|NCT01746017|101522480|FG000|Received at Least 1 Dose of Study Drug|Period 1||2||
48483725|NCT01746017|101522481|FG001|Received at Least 1 Dose of Study Drug|Period 1||2||
48483726|NCT01746017|101522482|FG002|Received at Least 1 Dose of Study Drug|Period 1||2||
48483727|NCT01746017|101522483|FG003|Received at Least 1 Dose of Study Drug|Period 1||2||
48483728|NCT01746017|101522484|FG004|Received at Least 1 Dose of Study Drug|Period 1||2||
48483729|NCT01746017|101522485|FG005|Received at Least 1 Dose of Study Drug|Period 1||2||
48483730|NCT01746017|101522486|FG006|Received at Least 1 Dose of Study Drug|Period 1||3||
48483731|NCT01746017|101522487|FG007|Received at Least 1 Dose of Study Drug|Period 1||2||
48483732|NCT01746017|101522488|FG008|Received at Least 1 Dose of Study Drug|Period 1||3||
48483733|NCT01746017|101522489|FG009|Received at Least 1 Dose of Study Drug|Period 1||3||
48483734|NCT01746017|101522490|FG010|Received at Least 1 Dose of Study Drug|Period 1||3||
48483735|NCT01746017|101522480|FG000|COMPLETED|Period 1||2||
48483736|NCT01746017|101522481|FG001|COMPLETED|Period 1||2||
48483737|NCT01746017|101522482|FG002|COMPLETED|Period 1||2||
48483738|NCT01746017|101522483|FG003|COMPLETED|Period 1||2||
48483739|NCT01746017|101522484|FG004|COMPLETED|Period 1||2||
48483740|NCT01746017|101522485|FG005|COMPLETED|Period 1||2||
48483741|NCT01746017|101522486|FG006|COMPLETED|Period 1||2||
48483742|NCT01746017|101522487|FG007|COMPLETED|Period 1||2||
48483743|NCT01746017|101522488|FG008|COMPLETED|Period 1||3||
48483744|NCT01746017|101522489|FG009|COMPLETED|Period 1||3||
48483745|NCT01746017|101522490|FG010|COMPLETED|Period 1||3||
48483746|NCT01746017|101522480|FG000|NOT COMPLETED|Period 1||0||
48483747|NCT01746017|101522481|FG001|NOT COMPLETED|Period 1||0||
48483748|NCT01746017|101522482|FG002|NOT COMPLETED|Period 1||0||
48483749|NCT01746017|101522483|FG003|NOT COMPLETED|Period 1||0||
48483750|NCT01746017|101522484|FG004|NOT COMPLETED|Period 1||0||
48483751|NCT01746017|101522485|FG005|NOT COMPLETED|Period 1||0||
48483752|NCT01746017|101522486|FG006|NOT COMPLETED|Period 1||1||
48483753|NCT01746017|101522487|FG007|NOT COMPLETED|Period 1||0||
48483754|NCT01746017|101522488|FG008|NOT COMPLETED|Period 1||0||
48483755|NCT01746017|101522489|FG009|NOT COMPLETED|Period 1||0||
48483756|NCT01746017|101522490|FG010|NOT COMPLETED|Period 1||0||
48483757|NCT01746017|101522480|FG000|STARTED|Period 2||2||
48483758|NCT01746017|101522481|FG001|STARTED|Period 2||2||
48483759|NCT01746017|101522482|FG002|STARTED|Period 2||2||
48483760|NCT01746017|101522483|FG003|STARTED|Period 2||2||
48483761|NCT01746017|101522484|FG004|STARTED|Period 2||2||
48483762|NCT01746017|101522485|FG005|STARTED|Period 2||2||
48483763|NCT01746017|101522486|FG006|STARTED|Period 2||2||
48483764|NCT01746017|101522487|FG007|STARTED|Period 2||2||
48483765|NCT01746017|101522488|FG008|STARTED|Period 2||3||
48483766|NCT01746017|101522489|FG009|STARTED|Period 2||3||
48483767|NCT01746017|101522490|FG010|STARTED|Period 2||3||
48483768|NCT01746017|101522480|FG000|COMPLETED|Period 2||2||
48483769|NCT01746017|101522481|FG001|COMPLETED|Period 2||2||
48483770|NCT01746017|101522482|FG002|COMPLETED|Period 2||2||
48483771|NCT01746017|101522483|FG003|COMPLETED|Period 2||2||
48483772|NCT01746017|101522484|FG004|COMPLETED|Period 2||2||
48483773|NCT01746017|101522485|FG005|COMPLETED|Period 2||2||
48483774|NCT01746017|101522486|FG006|COMPLETED|Period 2||2||
48483775|NCT01746017|101522487|FG007|COMPLETED|Period 2||2||
48483776|NCT01746017|101522488|FG008|COMPLETED|Period 2||3||
48483777|NCT01746017|101522489|FG009|COMPLETED|Period 2||3||
48483778|NCT01746017|101522490|FG010|COMPLETED|Period 2||3||
48483779|NCT01746017|101522480|FG000|NOT COMPLETED|Period 2||0||
48483780|NCT01746017|101522481|FG001|NOT COMPLETED|Period 2||0||
48483781|NCT01746017|101522482|FG002|NOT COMPLETED|Period 2||0||
48483782|NCT01746017|101522483|FG003|NOT COMPLETED|Period 2||0||
48483783|NCT01746017|101522484|FG004|NOT COMPLETED|Period 2||0||
48483784|NCT01746017|101522485|FG005|NOT COMPLETED|Period 2||0||
48483785|NCT01746017|101522486|FG006|NOT COMPLETED|Period 2||0||
48483786|NCT01746017|101522487|FG007|NOT COMPLETED|Period 2||0||
48483787|NCT01746017|101522488|FG008|NOT COMPLETED|Period 2||0||
48483788|NCT01746017|101522489|FG009|NOT COMPLETED|Period 2||0||
48483789|NCT01746017|101522490|FG010|NOT COMPLETED|Period 2||0||
48483790|NCT01746017|101522480|FG000|STARTED|Period 3||2||
48483791|NCT01746017|101522481|FG001|STARTED|Period 3||2||
48483792|NCT01746017|101522482|FG002|STARTED|Period 3||2||
48483793|NCT01746017|101522483|FG003|STARTED|Period 3||2||
48483794|NCT01746017|101522484|FG004|STARTED|Period 3||2||
48483795|NCT01746017|101522485|FG005|STARTED|Period 3||2||
48483796|NCT01746017|101522486|FG006|STARTED|Period 3||2||
48483797|NCT01746017|101522487|FG007|STARTED|Period 3||2||
48483798|NCT01746017|101522488|FG008|STARTED|Period 3||3||
48483799|NCT01746017|101522489|FG009|STARTED|Period 3||3||
48483800|NCT01746017|101522490|FG010|STARTED|Period 3||3||
48483801|NCT01746017|101522480|FG000|COMPLETED|Period 3||2||
48483802|NCT01746017|101522481|FG001|COMPLETED|Period 3||2||
48483803|NCT01746017|101522482|FG002|COMPLETED|Period 3||2||
48483804|NCT01746017|101522483|FG003|COMPLETED|Period 3||2||
48483805|NCT01746017|101522484|FG004|COMPLETED|Period 3||2||
48483806|NCT01746017|101522485|FG005|COMPLETED|Period 3||1||
48483807|NCT01746017|101522486|FG006|COMPLETED|Period 3||2||
48483808|NCT01746017|101522487|FG007|COMPLETED|Period 3||2||
48483809|NCT01746017|101522488|FG008|COMPLETED|Period 3||3||
48483810|NCT01746017|101522489|FG009|COMPLETED|Period 3||3||
48483811|NCT01746017|101522490|FG010|COMPLETED|Period 3||3||
48483812|NCT01746017|101522480|FG000|NOT COMPLETED|Period 3||0||
48483813|NCT01746017|101522481|FG001|NOT COMPLETED|Period 3||0||
48483814|NCT01746017|101522482|FG002|NOT COMPLETED|Period 3||0||
48483815|NCT01746017|101522483|FG003|NOT COMPLETED|Period 3||0||
48483816|NCT01746017|101522484|FG004|NOT COMPLETED|Period 3||0||
48483817|NCT01746017|101522485|FG005|NOT COMPLETED|Period 3||1||
48483818|NCT01746017|101522486|FG006|NOT COMPLETED|Period 3||0||
48483819|NCT01746017|101522487|FG007|NOT COMPLETED|Period 3||0||
48483820|NCT01746017|101522488|FG008|NOT COMPLETED|Period 3||0||
48483821|NCT01746017|101522489|FG009|NOT COMPLETED|Period 3||0||
48483822|NCT01746017|101522490|FG010|NOT COMPLETED|Period 3||0||
48483823|NCT01746017|101522480|FG000|STARTED|Period 4||2||
48483824|NCT01746017|101522481|FG001|STARTED|Period 4||2||
48196891|NCT03972813|100806558|FG010|COMPLETED|Overall Study||57|68 individuals completed the survey but did not answer the outcome|
48196892|NCT03972813|100806559|FG011|COMPLETED|Overall Study||51|68 individuals completed the survey but did not answer the outcome|
48483825|NCT01746017|101522482|FG002|STARTED|Period 4||2||
48483826|NCT01746017|101522483|FG003|STARTED|Period 4||2||
48483827|NCT01746017|101522484|FG004|STARTED|Period 4||2||
48483828|NCT01746017|101522485|FG005|STARTED|Period 4||1||
48483829|NCT01746017|101522486|FG006|STARTED|Period 4||2||
48483830|NCT01746017|101522487|FG007|STARTED|Period 4||2||
48483831|NCT01746017|101522488|FG008|STARTED|Period 4||0||
48483832|NCT01746017|101522489|FG009|STARTED|Period 4||0||
48483833|NCT01746017|101522490|FG010|STARTED|Period 4||0||
48483834|NCT01746017|101522480|FG000|COMPLETED|Period 4||2||
48483835|NCT01746017|101522481|FG001|COMPLETED|Period 4||2||
48483836|NCT01746017|101522482|FG002|COMPLETED|Period 4||2||
48483837|NCT01746017|101522483|FG003|COMPLETED|Period 4||2||
48196893|NCT03972813|100806560|FG012|COMPLETED|Overall Study||55|68 individuals completed the survey but did not answer the outcome|
48196894|NCT03972813|100806561|FG013|COMPLETED|Overall Study||52|68 individuals completed the survey but did not answer the outcome|
48196895|NCT03972813|100806562|FG014|COMPLETED|Overall Study||56|68 individuals completed the survey but did not answer the outcome|
48196896|NCT03972813|100806563|FG015|COMPLETED|Overall Study||50|68 individuals completed the survey but did not answer the outcome|
48196897|NCT03972813|100806564|FG016|COMPLETED|Overall Study||48|68 individuals completed the survey but did not answer the outcome|
48196898|NCT03972813|100806565|FG017|COMPLETED|Overall Study||48|68 individuals completed the survey but did not answer the outcome|
48196899|NCT03972813|100806548|FG000|NOT COMPLETED|Overall Study||6||
48196900|NCT03972813|100806549|FG001|NOT COMPLETED|Overall Study||4||
48196901|NCT03972813|100806550|FG002|NOT COMPLETED|Overall Study||6||
48196902|NCT03972813|100806551|FG003|NOT COMPLETED|Overall Study||4||
48196903|NCT03972813|100806552|FG004|NOT COMPLETED|Overall Study||4||
48196904|NCT03972813|100806553|FG005|NOT COMPLETED|Overall Study||2||
48196905|NCT03972813|100806554|FG006|NOT COMPLETED|Overall Study||4||
48196906|NCT03972813|100806555|FG007|NOT COMPLETED|Overall Study||3||
48196907|NCT03972813|100806556|FG008|NOT COMPLETED|Overall Study||5||
48196908|NCT03972813|100806557|FG009|NOT COMPLETED|Overall Study||2||
48196909|NCT03972813|100806558|FG010|NOT COMPLETED|Overall Study||5||
48196910|NCT03972813|100806559|FG011|NOT COMPLETED|Overall Study||4||
48196911|NCT03972813|100806560|FG012|NOT COMPLETED|Overall Study||3||
48196912|NCT03972813|100806561|FG013|NOT COMPLETED|Overall Study||3||
48196913|NCT03972813|100806562|FG014|NOT COMPLETED|Overall Study||2||
48196914|NCT03972813|100806563|FG015|NOT COMPLETED|Overall Study||6||
48196915|NCT03972813|100806564|FG016|NOT COMPLETED|Overall Study||3||
48196916|NCT03972813|100806565|FG017|NOT COMPLETED|Overall Study||2||
48196917|NCT00099437|100806566|FG000|STARTED|Overall Study||374||
48196918|NCT00099437|100806567|FG001|STARTED|Overall Study||362||
48196919|NCT00099437|100806566|FG000|COMPLETED|Overall Study||8||
48196920|NCT00099437|100806567|FG001|COMPLETED|Overall Study||13||
48196921|NCT00099437|100806566|FG000|NOT COMPLETED|Overall Study||366||
48196922|NCT00099437|100806567|FG001|NOT COMPLETED|Overall Study||349||
48196923|NCT04716933|100806568|FG000|STARTED|Overall Study||101||
48196924|NCT04716933|100806569|FG001|STARTED|Overall Study||100||
48196925|NCT04716933|100806568|FG000|COMPLETED|Overall Study||0||
48196926|NCT04716933|100806569|FG001|COMPLETED|Overall Study||0||
48196927|NCT04716933|100806568|FG000|NOT COMPLETED|Overall Study||101||
48196928|NCT04716933|100806569|FG001|NOT COMPLETED|Overall Study||100||
48196929|NCT01280591|100806570|FG000|STARTED|Overall Study||203||
48196930|NCT01280591|100806571|FG001|STARTED|Overall Study||204||
48196931|NCT01280591|100806572|FG002|STARTED|Overall Study||203||
48196932|NCT01280591|100806573|FG003|STARTED|Overall Study||102||
48196933|NCT01280591|100806570|FG000|COMPLETED|Overall Study||203||
48196934|NCT01280591|100806571|FG001|COMPLETED|Overall Study||204||
48196935|NCT01280591|100806572|FG002|COMPLETED|Overall Study||203||
48196936|NCT01280591|100806573|FG003|COMPLETED|Overall Study||99||
48196937|NCT01280591|100806570|FG000|NOT COMPLETED|Overall Study||0||
48196938|NCT01280591|100806571|FG001|NOT COMPLETED|Overall Study||0||
48196939|NCT01280591|100806572|FG002|NOT COMPLETED|Overall Study||0||
48196940|NCT01280591|100806573|FG003|NOT COMPLETED|Overall Study||3||
48196941|NCT01678196|100806574|FG000|STARTED|Overall Study||34||
48196942|NCT01678196|100806575|FG001|STARTED|Overall Study||32||
48196943|NCT01678196|100806574|FG000|COMPLETED|Overall Study||34||
48196944|NCT01678196|100806575|FG001|COMPLETED|Overall Study||32||
48196945|NCT01678196|100806574|FG000|NOT COMPLETED|Overall Study||0||
48196946|NCT01678196|100806575|FG001|NOT COMPLETED|Overall Study||0||
48196947|NCT00908947|100806576|FG000|STARTED|Overall Study||173||
48196948|NCT00908947|100806576|FG000|COMPLETED|Overall Study||83||
48196949|NCT00908947|100806576|FG000|NOT COMPLETED|Overall Study||90||
48196950|NCT02512042|100806577|FG000|STARTED|Overall Study||495||
48483838|NCT01746017|101522484|FG004|COMPLETED|Period 4||2||
48483839|NCT01746017|101522485|FG005|COMPLETED|Period 4||1||
48196951|NCT02512042|100806578|FG001|STARTED|Overall Study||478||
48196952|NCT02512042|100806577|FG000|COMPLETED|Overall Study||472||
48196953|NCT02512042|100806578|FG001|COMPLETED|Overall Study||453||
48196954|NCT02512042|100806577|FG000|NOT COMPLETED|Overall Study||23||
48196955|NCT02512042|100806578|FG001|NOT COMPLETED|Overall Study||25||
48196956|NCT01511250|100806579|FG000|STARTED|Overall Study||24||
48196957|NCT01511250|100806580|FG001|STARTED|Overall Study||14||
48196958|NCT01511250|100806581|FG002|STARTED|Overall Study||22||
48196959|NCT01511250|100806582|FG003|STARTED|Overall Study||14||
48196960|NCT01511250|100806583|FG004|STARTED|Overall Study||21||
48196961|NCT01511250|100806584|FG005|STARTED|Overall Study||17||
48196962|NCT01511250|100806585|FG006|STARTED|Overall Study||23||
48483840|NCT01746017|101522486|FG006|COMPLETED|Period 4||2||
48196963|NCT01511250|100806586|FG007|STARTED|Overall Study||13||
48196964|NCT01511250|100806587|FG008|STARTED|Overall Study||159||
48196965|NCT01511250|100806588|FG009|STARTED|Overall Study||53||
48196966|NCT01511250|100806579|FG000|COMPLETED|Overall Study||15||
48483841|NCT01746017|101522487|FG007|COMPLETED|Period 4||2||
48483842|NCT01746017|101522488|FG008|COMPLETED|Period 4||0||
48483843|NCT01746017|101522489|FG009|COMPLETED|Period 4||0||
48483844|NCT01746017|101522490|FG010|COMPLETED|Period 4||0||
48483845|NCT01746017|101522480|FG000|NOT COMPLETED|Period 4||0||
48483846|NCT01746017|101522481|FG001|NOT COMPLETED|Period 4||0||
48483847|NCT01746017|101522482|FG002|NOT COMPLETED|Period 4||0||
48483848|NCT01746017|101522483|FG003|NOT COMPLETED|Period 4||0||
48483849|NCT01746017|101522484|FG004|NOT COMPLETED|Period 4||0||
48483850|NCT01746017|101522485|FG005|NOT COMPLETED|Period 4||0||
48483851|NCT01746017|101522486|FG006|NOT COMPLETED|Period 4||0||
48483852|NCT01746017|101522487|FG007|NOT COMPLETED|Period 4||0||
48483853|NCT01746017|101522488|FG008|NOT COMPLETED|Period 4||0||
48483854|NCT01746017|101522489|FG009|NOT COMPLETED|Period 4||0||
48196967|NCT01511250|100806580|FG001|COMPLETED|Overall Study||9||
48196968|NCT01511250|100806581|FG002|COMPLETED|Overall Study||18||
48196969|NCT01511250|100806582|FG003|COMPLETED|Overall Study||11||
48196970|NCT01511250|100806583|FG004|COMPLETED|Overall Study||21||
48196971|NCT01511250|100806584|FG005|COMPLETED|Overall Study||17||
48196972|NCT01511250|100806585|FG006|COMPLETED|Overall Study||21||
48196973|NCT01511250|100806586|FG007|COMPLETED|Overall Study||9||
48196974|NCT01511250|100806587|FG008|COMPLETED|Overall Study||145||
48483855|NCT01746017|101522490|FG010|NOT COMPLETED|Period 4||0||
48483856|NCT02440308|101522491|FG000|STARTED|Overall Study||10||
48483857|NCT02440308|101522491|FG000|COMPLETED|Overall Study||10||
48196975|NCT01511250|100806588|FG009|COMPLETED|Overall Study||48||
48196976|NCT01511250|100806579|FG000|NOT COMPLETED|Overall Study||9||
48196977|NCT01511250|100806580|FG001|NOT COMPLETED|Overall Study||5||
48196978|NCT01511250|100806581|FG002|NOT COMPLETED|Overall Study||4||
48196979|NCT01511250|100806582|FG003|NOT COMPLETED|Overall Study||3||
48196980|NCT01511250|100806583|FG004|NOT COMPLETED|Overall Study||0||
48483858|NCT02440308|101522491|FG000|NOT COMPLETED|Overall Study||0||
48483859|NCT03155425|101522492|FG000|STARTED|Overall Study||75||
48483860|NCT03155425|101522492|FG000|COMPLETED|Overall Study||75||
48196981|NCT01511250|100806584|FG005|NOT COMPLETED|Overall Study||0||
48196982|NCT01511250|100806585|FG006|NOT COMPLETED|Overall Study||2||
48196983|NCT01511250|100806586|FG007|NOT COMPLETED|Overall Study||4||
48196984|NCT01511250|100806587|FG008|NOT COMPLETED|Overall Study||14||
48196985|NCT01511250|100806588|FG009|NOT COMPLETED|Overall Study||5||
48196986|NCT01325870|100806589|FG000|STARTED|Overall Study||18||
48196987|NCT01325870|100806590|FG001|STARTED|Overall Study||16||
48196988|NCT01325870|100806591|FG002|STARTED|Overall Study||14||
48196989|NCT01325870|100806589|FG000|COMPLETED|Overall Study||7||
48196990|NCT01325870|100806590|FG001|COMPLETED|Overall Study||3||
48196991|NCT01325870|100806591|FG002|COMPLETED|Overall Study||6||
48196992|NCT01325870|100806589|FG000|NOT COMPLETED|Overall Study||11||
48196993|NCT01325870|100806590|FG001|NOT COMPLETED|Overall Study||13||
48196994|NCT01325870|100806591|FG002|NOT COMPLETED|Overall Study||8||
48196995|NCT00286741|100806592|FG000|STARTED|Overall Study||133||
48196996|NCT00286741|100806593|FG001|STARTED|Overall Study||106||
48196997|NCT00286741|100806592|FG000|COMPLETED|Overall Study||122||
48196998|NCT00286741|100806593|FG001|COMPLETED|Overall Study||89||
48196999|NCT00286741|100806592|FG000|NOT COMPLETED|Overall Study||11||
48197000|NCT00286741|100806593|FG001|NOT COMPLETED|Overall Study||17||
48197001|NCT02430181|100806594|FG000|STARTED|Overall Study||3||
48197002|NCT02430181|100806595|FG001|STARTED|Overall Study||3||
48197003|NCT02430181|100806596|FG002|STARTED|Overall Study||3||
48197004|NCT02430181|100806597|FG003|STARTED|Overall Study||3||
48197005|NCT02430181|100806598|FG004|STARTED|Overall Study||3||
48197006|NCT02430181|100806599|FG005|STARTED|Overall Study||2||
48197007|NCT02430181|100806600|FG006|STARTED|Overall Study||3||
48483861|NCT03155425|101522492|FG000|NOT COMPLETED|Overall Study||0||
48483862|NCT00933686|101522493|FG000|STARTED|Overall Study||55||
48483863|NCT00933686|101522494|FG001|STARTED|Overall Study||58||
48483864|NCT00933686|101522493|FG000|COMPLETED|Overall Study||45||
48483865|NCT00933686|101522494|FG001|COMPLETED|Overall Study||47||
48483866|NCT00933686|101522493|FG000|NOT COMPLETED|Overall Study||10||
48483867|NCT00933686|101522494|FG001|NOT COMPLETED|Overall Study||11||
48483868|NCT00239577|101522495|FG000|STARTED|Primary Phase||22||
48197008|NCT02430181|100806594|FG000|COMPLETED|Overall Study||3||
48197009|NCT02430181|100806595|FG001|COMPLETED|Overall Study||3||
48197010|NCT02430181|100806596|FG002|COMPLETED|Overall Study||2||
48483869|NCT00239577|101522496|FG001|STARTED|Primary Phase||22||
48197011|NCT02430181|100806597|FG003|COMPLETED|Overall Study||3||
48197012|NCT02430181|100806598|FG004|COMPLETED|Overall Study||3||
48197013|NCT02430181|100806599|FG005|COMPLETED|Overall Study||0||
48197014|NCT02430181|100806600|FG006|COMPLETED|Overall Study||0||
48197015|NCT02430181|100806594|FG000|NOT COMPLETED|Overall Study||0||
48197016|NCT02430181|100806595|FG001|NOT COMPLETED|Overall Study||0||
48197017|NCT02430181|100806596|FG002|NOT COMPLETED|Overall Study||1||
48197018|NCT02430181|100806597|FG003|NOT COMPLETED|Overall Study||0||
48483870|NCT00239577|101522497|FG002|STARTED|Primary Phase||21||
48483871|NCT00239577|101522498|FG003|STARTED|Primary Phase||21||
48197019|NCT02430181|100806598|FG004|NOT COMPLETED|Overall Study||0||
48197020|NCT02430181|100806599|FG005|NOT COMPLETED|Overall Study||2||
48483872|NCT00239577|101522495|FG000|COMPLETED|Primary Phase||17||
48483873|NCT00239577|101522496|FG001|COMPLETED|Primary Phase||19||
48197021|NCT02430181|100806600|FG006|NOT COMPLETED|Overall Study||3||
48197022|NCT04094064|100806601|FG000|STARTED|Overall Study||20||
48197023|NCT04094064|100806601|FG000|COMPLETED|Overall Study||20||
48197024|NCT04094064|100806601|FG000|NOT COMPLETED|Overall Study||0||
48197025|NCT02759731|100806602|FG000|STARTED|Overall Study||24||
48197026|NCT02759731|100806602|FG000|COMPLETED|Overall Study||16||
48197027|NCT02759731|100806602|FG000|NOT COMPLETED|Overall Study||8||
48197028|NCT00588965|100806603|FG000|STARTED|Overall Study||35||
48197029|NCT00588965|100806603|FG000|COMPLETED|Overall Study||35||
48197030|NCT00588965|100806603|FG000|NOT COMPLETED|Overall Study||0||
48197031|NCT04310579|100806604|FG000|STARTED|Overall Study||10||
48197032|NCT04310579|100806605|FG001|STARTED|Overall Study||5||
48197033|NCT04310579|100806606|FG002|STARTED|Overall Study||5||
48197034|NCT04310579|100806607|FG003|STARTED|Overall Study||5||
48197035|NCT04310579|100806608|FG004|STARTED|Overall Study||5||
48197036|NCT04310579|100806609|FG005|STARTED|Overall Study||4||
48197037|NCT04310579|100806610|FG006|STARTED|Overall Study||5||
48197038|NCT04310579|100806611|FG007|STARTED|Overall Study||3||
48197039|NCT04310579|100806612|FG008|STARTED|Overall Study||4||
48197040|NCT04310579|100806613|FG009|STARTED|Overall Study||4||
48197041|NCT04310579|100806614|FG010|STARTED|Overall Study||5||
48197042|NCT04310579|100806604|FG000|COMPLETED|Overall Study||10||
48197043|NCT04310579|100806605|FG001|COMPLETED|Overall Study||5||
48197044|NCT04310579|100806606|FG002|COMPLETED|Overall Study||5||
48197045|NCT04310579|100806607|FG003|COMPLETED|Overall Study||5||
48197046|NCT04310579|100806608|FG004|COMPLETED|Overall Study||5||
48197047|NCT04310579|100806609|FG005|COMPLETED|Overall Study||3||
48197048|NCT04310579|100806610|FG006|COMPLETED|Overall Study||3||
48197049|NCT04310579|100806611|FG007|COMPLETED|Overall Study||3||
48197050|NCT04310579|100806612|FG008|COMPLETED|Overall Study||3||
48197051|NCT04310579|100806613|FG009|COMPLETED|Overall Study||3||
48197052|NCT04310579|100806614|FG010|COMPLETED|Overall Study||4||
48197053|NCT04310579|100806604|FG000|NOT COMPLETED|Overall Study||0||
48197054|NCT04310579|100806605|FG001|NOT COMPLETED|Overall Study||0||
48197055|NCT04310579|100806606|FG002|NOT COMPLETED|Overall Study||0||
48197056|NCT04310579|100806607|FG003|NOT COMPLETED|Overall Study||0||
48197057|NCT04310579|100806608|FG004|NOT COMPLETED|Overall Study||0||
48197058|NCT04310579|100806609|FG005|NOT COMPLETED|Overall Study||1||
48197059|NCT04310579|100806610|FG006|NOT COMPLETED|Overall Study||2||
48197060|NCT04310579|100806611|FG007|NOT COMPLETED|Overall Study||0||
48197061|NCT04310579|100806612|FG008|NOT COMPLETED|Overall Study||1||
48197062|NCT04310579|100806613|FG009|NOT COMPLETED|Overall Study||1||
48197063|NCT04310579|100806614|FG010|NOT COMPLETED|Overall Study||1||
48197064|NCT00751790|100806615|FG000|STARTED|Overall Study||120||
48197065|NCT00751790|100806615|FG000|COMPLETED|Overall Study||115||
48197066|NCT00751790|100806615|FG000|NOT COMPLETED|Overall Study||5||
48197067|NCT01227707|100806616|FG000|STARTED|Overall Study||43||
48197068|NCT01227707|100806616|FG000|COMPLETED|Overall Study||19||
48197069|NCT01227707|100806616|FG000|NOT COMPLETED|Overall Study||24||
48197070|NCT02380742|100806617|FG000|STARTED|Overall Study||28||
48197071|NCT02380742|100806618|FG001|STARTED|Overall Study||26||
48197072|NCT02380742|100806617|FG000|COMPLETED|Overall Study||27||
48197073|NCT02380742|100806618|FG001|COMPLETED|Overall Study||26||
48197074|NCT02380742|100806617|FG000|NOT COMPLETED|Overall Study||1||
48197075|NCT02380742|100806618|FG001|NOT COMPLETED|Overall Study||0||
48197076|NCT05386758|100806619|FG000|STARTED|Overall Study||8||
48197077|NCT05386758|100806620|FG001|STARTED|Overall Study||8||
48197078|NCT05386758|100806619|FG000|COMPLETED|Overall Study||8||
48197079|NCT05386758|100806620|FG001|COMPLETED|Overall Study||8||
48197080|NCT05386758|100806619|FG000|NOT COMPLETED|Overall Study||0||
48197081|NCT05386758|100806620|FG001|NOT COMPLETED|Overall Study||0||
48197082|NCT00554801|100806621|FG000|STARTED|Overall Study||55||
48197083|NCT00554801|100806622|FG001|STARTED|Overall Study||29||
48483874|NCT00239577|101522497|FG002|COMPLETED|Primary Phase||18||
48483875|NCT00239577|101522498|FG003|COMPLETED|Primary Phase||21||
48483876|NCT00239577|101522495|FG000|NOT COMPLETED|Primary Phase||5||
48483877|NCT00239577|101522496|FG001|NOT COMPLETED|Primary Phase||3||
48483878|NCT00239577|101522497|FG002|NOT COMPLETED|Primary Phase||3||
48483879|NCT00239577|101522498|FG003|NOT COMPLETED|Primary Phase||0||
48483880|NCT00239577|101522495|FG000|STARTED|Booster Phase||0||
48197084|NCT00554801|100806621|FG000|COMPLETED|Overall Study||36||
48197085|NCT00554801|100806622|FG001|COMPLETED|Overall Study||29||
48197086|NCT00554801|100806621|FG000|NOT COMPLETED|Overall Study||19||
48197087|NCT00554801|100806622|FG001|NOT COMPLETED|Overall Study||0||
48197088|NCT03635567|100806623|FG000|STARTED|Overall Study||308||
48197089|NCT03635567|100806624|FG001|STARTED|Overall Study||309||
48197090|NCT03635567|100806623|FG000|Treated|Overall Study||307||
48197091|NCT03635567|100806624|FG001|Treated|Overall Study||309||
48197092|NCT03635567|100806623|FG000|Received Second Course of Pembrolizumab|Overall Study||8||
48197093|NCT03635567|100806624|FG001|Received Second Course of Pembrolizumab|Overall Study||0||
48197094|NCT03635567|100806623|FG000|COMPLETED|Overall Study||0||
48197095|NCT03635567|100806624|FG001|COMPLETED|Overall Study||0||
48197096|NCT03635567|100806623|FG000|NOT COMPLETED|Overall Study||308||
48197097|NCT03635567|100806624|FG001|NOT COMPLETED|Overall Study||309||
48483881|NCT00239577|101522496|FG001|STARTED|Booster Phase||9||
48483882|NCT00239577|101522497|FG002|STARTED|Booster Phase||12||
48483883|NCT00239577|101522498|FG003|STARTED|Booster Phase||0||
48483884|NCT00239577|101522495|FG000|COMPLETED|Booster Phase||0||
48483885|NCT00239577|101522496|FG001|COMPLETED|Booster Phase||9||
48483886|NCT00239577|101522497|FG002|COMPLETED|Booster Phase||12||
48483887|NCT00239577|101522498|FG003|COMPLETED|Booster Phase||0||
48483888|NCT00239577|101522495|FG000|NOT COMPLETED|Booster Phase||0||
48483889|NCT00239577|101522496|FG001|NOT COMPLETED|Booster Phase||0||
48483890|NCT00239577|101522497|FG002|NOT COMPLETED|Booster Phase||0||
48483891|NCT00239577|101522498|FG003|NOT COMPLETED|Booster Phase||0||
48483892|NCT01450189|101522499|FG000|STARTED|Overall Study||9||
48483893|NCT01450189|101522500|FG001|STARTED|Overall Study||18||
48483894|NCT01450189|101522501|FG002|STARTED|Overall Study||19||
48483895|NCT01450189|101522499|FG000|COMPLETED|Overall Study||9||
48483896|NCT01450189|101522500|FG001|COMPLETED|Overall Study||18||
48483897|NCT01450189|101522501|FG002|COMPLETED|Overall Study||19||
48483898|NCT01450189|101522499|FG000|NOT COMPLETED|Overall Study||0||
48483899|NCT01450189|101522500|FG001|NOT COMPLETED|Overall Study||0||
48483900|NCT01450189|101522501|FG002|NOT COMPLETED|Overall Study||0||
48483901|NCT02294253|101522502|FG000|STARTED|Overall Study||30||
48483902|NCT02294253|101522502|FG000|COMPLETED|Overall Study||15||
48483903|NCT02294253|101522502|FG000|NOT COMPLETED|Overall Study||15||
48483904|NCT00581139|101522503|FG000|STARTED|Overall Study||61||
48483905|NCT00581139|101522504|FG001|STARTED|Overall Study||68||
48483906|NCT00581139|101522505|FG002|STARTED|Overall Study||54||
48483907|NCT00581139|101522506|FG003|STARTED|Overall Study||58||
48483908|NCT00581139|101522503|FG000|COMPLETED|Overall Study||61||
48483909|NCT00581139|101522504|FG001|COMPLETED|Overall Study||68||
48483910|NCT00581139|101522505|FG002|COMPLETED|Overall Study||54||
48483911|NCT00581139|101522506|FG003|COMPLETED|Overall Study||58||
48483912|NCT00581139|101522503|FG000|NOT COMPLETED|Overall Study||0||
48483913|NCT00581139|101522504|FG001|NOT COMPLETED|Overall Study||0||
48483914|NCT00581139|101522505|FG002|NOT COMPLETED|Overall Study||0||
48483915|NCT00581139|101522506|FG003|NOT COMPLETED|Overall Study||0||
48483916|NCT04175808|101522507|FG000|STARTED|Part A||70||
48483917|NCT04175808|101522508|FG001|STARTED|Part A||0||
48483918|NCT04175808|101522509|FG002|STARTED|Part A||0||
48483919|NCT04175808|101522510|FG003|STARTED|Part A||0||
48483920|NCT04175808|101522511|FG004|STARTED|Part A||0||
48483921|NCT04175808|101522512|FG005|STARTED|Part A||0||
48483922|NCT04175808|101522513|FG006|STARTED|Part A||0||
48483923|NCT04175808|101522507|FG000|COMPLETED|Part A||68||
48483924|NCT04175808|101522508|FG001|COMPLETED|Part A||0||
48483925|NCT04175808|101522509|FG002|COMPLETED|Part A||0||
48483926|NCT04175808|101522510|FG003|COMPLETED|Part A||0||
48483927|NCT04175808|101522511|FG004|COMPLETED|Part A||0||
48483928|NCT04175808|101522512|FG005|COMPLETED|Part A||0||
48483929|NCT04175808|101522513|FG006|COMPLETED|Part A||0||
48483930|NCT04175808|101522507|FG000|NOT COMPLETED|Part A||2||
48483931|NCT04175808|101522508|FG001|NOT COMPLETED|Part A||0||
48483932|NCT04175808|101522509|FG002|NOT COMPLETED|Part A||0||
48483933|NCT04175808|101522510|FG003|NOT COMPLETED|Part A||0||
48483934|NCT04175808|101522511|FG004|NOT COMPLETED|Part A||0||
48483935|NCT04175808|101522512|FG005|NOT COMPLETED|Part A||0||
48483936|NCT04175808|101522513|FG006|NOT COMPLETED|Part A||0||
48483937|NCT04175808|101522507|FG000|STARTED|Part B||0||
48483938|NCT04175808|101522508|FG001|STARTED|Part B||10||
48483939|NCT04175808|101522509|FG002|STARTED|Part B||10||
48483940|NCT04175808|101522510|FG003|STARTED|Part B||10||
48483941|NCT04175808|101522511|FG004|STARTED|Part B||10||
48483942|NCT04175808|101522512|FG005|STARTED|Part B||10||
48483943|NCT04175808|101522513|FG006|STARTED|Part B||10||
48483944|NCT04175808|101522507|FG000|COMPLETED|Part B||0||
48483945|NCT04175808|101522508|FG001|COMPLETED|Part B||10||
48483946|NCT04175808|101522509|FG002|COMPLETED|Part B||10||
48483947|NCT04175808|101522510|FG003|COMPLETED|Part B||10||
48483948|NCT04175808|101522511|FG004|COMPLETED|Part B||10||
48483949|NCT04175808|101522512|FG005|COMPLETED|Part B||10||
48483950|NCT04175808|101522513|FG006|COMPLETED|Part B||10||
48483951|NCT04175808|101522507|FG000|NOT COMPLETED|Part B||0||
48483952|NCT04175808|101522508|FG001|NOT COMPLETED|Part B||0||
48483953|NCT04175808|101522509|FG002|NOT COMPLETED|Part B||0||
48483954|NCT04175808|101522510|FG003|NOT COMPLETED|Part B||0||
48483955|NCT04175808|101522511|FG004|NOT COMPLETED|Part B||0||
48483956|NCT04175808|101522512|FG005|NOT COMPLETED|Part B||0||
48483957|NCT04175808|101522513|FG006|NOT COMPLETED|Part B||0||
48483958|NCT01838941|101522514|FG000|STARTED|Overall Study||12||
48483959|NCT01838941|101522514|FG000|COMPLETED|Overall Study||10||
48483960|NCT01838941|101522514|FG000|NOT COMPLETED|Overall Study||2||
48483961|NCT01581658|101522515|FG000|STARTED|Overall Study||8||
48483962|NCT01581658|101522516|FG001|STARTED|Overall Study||8||
48483963|NCT01581658|101522517|FG002|STARTED|Overall Study||8||
48483964|NCT01581658|101522518|FG003|STARTED|Overall Study||8||
48483965|NCT01581658|101522515|FG000|COMPLETED|Overall Study||8||
48483966|NCT01581658|101522516|FG001|COMPLETED|Overall Study||8||
48483967|NCT01581658|101522517|FG002|COMPLETED|Overall Study||8||
48483968|NCT01581658|101522518|FG003|COMPLETED|Overall Study||8||
48483969|NCT01581658|101522515|FG000|NOT COMPLETED|Overall Study||0||
48483970|NCT01581658|101522516|FG001|NOT COMPLETED|Overall Study||0||
48483971|NCT01581658|101522517|FG002|NOT COMPLETED|Overall Study||0||
48483972|NCT01581658|101522518|FG003|NOT COMPLETED|Overall Study||0||
48483973|NCT02646124|101522519|FG000|STARTED|Overall Study||57||
48483974|NCT02646124|101522520|FG001|STARTED|Overall Study||57||
48483975|NCT02646124|101522519|FG000|COMPLETED|Overall Study||57||
48483976|NCT02646124|101522520|FG001|COMPLETED|Overall Study||55||
48483977|NCT02646124|101522519|FG000|NOT COMPLETED|Overall Study||0||
48483978|NCT02646124|101522520|FG001|NOT COMPLETED|Overall Study||2||
48483979|NCT01780870|101522521|FG000|STARTED|Overall Study||0||
48483980|NCT01780870|101522522|FG001|STARTED|Overall Study||5||
48483981|NCT01780870|101522521|FG000|COMPLETED|Overall Study||0||
48483982|NCT01780870|101522522|FG001|COMPLETED|Overall Study||5||
48483983|NCT01780870|101522521|FG000|NOT COMPLETED|Overall Study||0||
48483984|NCT01780870|101522522|FG001|NOT COMPLETED|Overall Study||0||
48483985|NCT01648582|101522523|FG000|STARTED|Overall Study||258||
48483986|NCT01648582|101522524|FG001|STARTED|Overall Study||257||
48483987|NCT01648582|101522525|FG002|STARTED|Overall Study||259||
48483988|NCT01648582|101522523|FG000|Received at Least One Dose of Study Drug|Overall Study||258||
48483989|NCT01648582|101522524|FG001|Received at Least One Dose of Study Drug|Overall Study||257||
48483990|NCT01648582|101522525|FG002|Received at Least One Dose of Study Drug|Overall Study||259||
48483991|NCT01648582|101522523|FG000|Modified Intent-to-Treat Population|Overall Study||253||
48483992|NCT01648582|101522524|FG001|Modified Intent-to-Treat Population|Overall Study||252||
48483993|NCT01648582|101522525|FG002|Modified Intent-to-Treat Population|Overall Study||250||
48483994|NCT01648582|101522523|FG000|COMPLETED|Overall Study||226||
48483995|NCT01648582|101522524|FG001|COMPLETED|Overall Study||219||
48483996|NCT01648582|101522525|FG002|COMPLETED|Overall Study||227||
48483997|NCT01648582|101522523|FG000|NOT COMPLETED|Overall Study||32||
48483998|NCT01648582|101522524|FG001|NOT COMPLETED|Overall Study||38||
48483999|NCT01648582|101522525|FG002|NOT COMPLETED|Overall Study||32||
48484000|NCT02059070|101522526|FG000|STARTED|Overall Study||19||
48484001|NCT02059070|101522527|FG001|STARTED|Overall Study||20||
48484002|NCT02059070|101522526|FG000|COMPLETED|Overall Study||14||
48484003|NCT02059070|101522527|FG001|COMPLETED|Overall Study||16||
48484004|NCT02059070|101522526|FG000|NOT COMPLETED|Overall Study||5||
48484005|NCT02059070|101522527|FG001|NOT COMPLETED|Overall Study||4||
48484006|NCT01215981|101522528|FG000|STARTED|Overall Study||35||
48484007|NCT01215981|101522529|FG001|STARTED|Overall Study||33||
48484008|NCT01215981|101522528|FG000|COMPLETED|Overall Study||33||
48484009|NCT01215981|101522529|FG001|COMPLETED|Overall Study||32||
48484010|NCT01215981|101522528|FG000|NOT COMPLETED|Overall Study||2||
48484011|NCT01215981|101522529|FG001|NOT COMPLETED|Overall Study||1||
48484012|NCT02909907|101522530|FG000|STARTED|Overall Study||10||
48484013|NCT02909907|101522531|FG001|STARTED|Overall Study||10||
48484014|NCT02909907|101522530|FG000|COMPLETED|Overall Study||10||
48484015|NCT02909907|101522531|FG001|COMPLETED|Overall Study||9||
48484016|NCT02909907|101522530|FG000|NOT COMPLETED|Overall Study||0||
48484017|NCT02909907|101522531|FG001|NOT COMPLETED|Overall Study||1||
48484018|NCT02303405|101522532|FG000|STARTED|Overall Study||15||
48484019|NCT02303405|101522533|FG001|STARTED|Overall Study||7||
48484020|NCT02303405|101522532|FG000|COMPLETED|Overall Study||15||
48484021|NCT02303405|101522533|FG001|COMPLETED|Overall Study||7||
48484022|NCT02303405|101522532|FG000|NOT COMPLETED|Overall Study||0||
48484023|NCT02303405|101522533|FG001|NOT COMPLETED|Overall Study||0||
48484024|NCT01173692|101522534|FG000|STARTED|Overall Study||22||
48484025|NCT01173692|101522535|FG001|STARTED|Overall Study||25||
48484026|NCT01173692|101522534|FG000|COMPLETED|Overall Study||20||
48484027|NCT01173692|101522535|FG001|COMPLETED|Overall Study||20||
48484028|NCT01173692|101522534|FG000|NOT COMPLETED|Overall Study||2||
48484029|NCT01173692|101522535|FG001|NOT COMPLETED|Overall Study||5||
48484030|NCT02246166|101522536|FG000|STARTED|Overall Study||26||
48484031|NCT02246166|101522537|FG001|STARTED|Overall Study||27||
48484032|NCT02246166|101522536|FG000|COMPLETED|Overall Study||25||
48484033|NCT02246166|101522537|FG001|COMPLETED|Overall Study||27||
48484034|NCT02246166|101522536|FG000|NOT COMPLETED|Overall Study||1||
48484035|NCT02246166|101522537|FG001|NOT COMPLETED|Overall Study||0||
48484036|NCT02566239|101522538|FG000|STARTED|Overall Study||43||
48484037|NCT02566239|101522539|FG001|STARTED|Overall Study||48||
48484038|NCT02566239|101522538|FG000|COMPLETED|Overall Study||39||
48484039|NCT02566239|101522539|FG001|COMPLETED|Overall Study||44||
48484040|NCT02566239|101522538|FG000|NOT COMPLETED|Overall Study||4||
48484041|NCT02566239|101522539|FG001|NOT COMPLETED|Overall Study||4||
48484042|NCT00909610|101522540|FG000|STARTED|Period: First Intervention||40||
48484043|NCT00909610|101522541|FG001|STARTED|Period: First Intervention||40||
48484044|NCT00909610|101522540|FG000|COMPLETED|Period: First Intervention||40||
48484045|NCT00909610|101522541|FG001|COMPLETED|Period: First Intervention||39||
48484046|NCT00909610|101522540|FG000|NOT COMPLETED|Period: First Intervention||0||
48484047|NCT00909610|101522541|FG001|NOT COMPLETED|Period: First Intervention||1||
48484048|NCT00909610|101522540|FG000|STARTED|Period: Washout of 28 Days||40||
48484049|NCT00909610|101522541|FG001|STARTED|Period: Washout of 28 Days||39||
48484050|NCT00909610|101522540|FG000|COMPLETED|Period: Washout of 28 Days||37||
48484051|NCT00909610|101522541|FG001|COMPLETED|Period: Washout of 28 Days||33||
48484052|NCT00909610|101522540|FG000|NOT COMPLETED|Period: Washout of 28 Days||3||
48484053|NCT00909610|101522541|FG001|NOT COMPLETED|Period: Washout of 28 Days||6||
48484054|NCT00909610|101522540|FG000|STARTED|Period: Second Intervention||37||
48484055|NCT00909610|101522541|FG001|STARTED|Period: Second Intervention||33||
48484056|NCT00909610|101522540|FG000|COMPLETED|Period: Second Intervention||36||
48484057|NCT00909610|101522541|FG001|COMPLETED|Period: Second Intervention||33||
48484058|NCT00909610|101522540|FG000|NOT COMPLETED|Period: Second Intervention||1||
48484059|NCT00909610|101522541|FG001|NOT COMPLETED|Period: Second Intervention||0||
48484060|NCT01294917|101522542|FG000|STARTED|Overall Study||42||
48484061|NCT01294917|101522542|FG000|Received Investigational MPS|Overall Study||36||
48484062|NCT01294917|101522542|FG000|Received Clear Care|Overall Study||36||
48484063|NCT01294917|101522542|FG000|Received OptiFree RepleniSH MPS|Overall Study||36||
48484064|NCT01294917|101522542|FG000|COMPLETED|Overall Study||36||
48484065|NCT01294917|101522542|FG000|NOT COMPLETED|Overall Study||6||
48484066|NCT02252133|101522543|FG000|STARTED|Period 1||23||
48484067|NCT02252133|101522544|FG001|STARTED|Period 1||24||
48484068|NCT02252133|101522543|FG000|COMPLETED|Period 1||23||
48484069|NCT02252133|101522544|FG001|COMPLETED|Period 1||24||
48484070|NCT02252133|101522543|FG000|NOT COMPLETED|Period 1||0||
48484071|NCT02252133|101522544|FG001|NOT COMPLETED|Period 1||0||
48484072|NCT02252133|101522543|FG000|STARTED|Period 2||23||
48484073|NCT02252133|101522544|FG001|STARTED|Period 2||24||
48484074|NCT02252133|101522543|FG000|COMPLETED|Period 2||23||
48484075|NCT02252133|101522544|FG001|COMPLETED|Period 2||24||
48484076|NCT02252133|101522543|FG000|NOT COMPLETED|Period 2||0||
48484077|NCT02252133|101522544|FG001|NOT COMPLETED|Period 2||0||
48484078|NCT05025345|101522545|FG000|STARTED|Overall Study||107||
48484079|NCT05025345|101522546|FG001|STARTED|Overall Study||107||
48484080|NCT05025345|101522545|FG000|COMPLETED|Overall Study||103||
48484081|NCT05025345|101522546|FG001|COMPLETED|Overall Study||107||
48484082|NCT05025345|101522545|FG000|NOT COMPLETED|Overall Study||4||
48484083|NCT05025345|101522546|FG001|NOT COMPLETED|Overall Study||0||
48484084|NCT03197883|101522547|FG000|STARTED|Overall Study||50||
48484085|NCT03197883|101522548|FG001|STARTED|Overall Study||50||
48484086|NCT03197883|101522547|FG000|COMPLETED|Overall Study||47||
48484087|NCT03197883|101522548|FG001|COMPLETED|Overall Study||44||
48484088|NCT03197883|101522547|FG000|NOT COMPLETED|Overall Study||3||
48484089|NCT03197883|101522548|FG001|NOT COMPLETED|Overall Study||6||
48484090|NCT03959683|101522549|FG000|STARTED|Overall Study||49||
48484091|NCT03959683|101522550|FG001|STARTED|Overall Study||51||
48484092|NCT03959683|101522549|FG000|COMPLETED|Overall Study||49||
48484093|NCT03959683|101522550|FG001|COMPLETED|Overall Study||51||
48484094|NCT03959683|101522549|FG000|NOT COMPLETED|Overall Study||0||
48484095|NCT03959683|101522550|FG001|NOT COMPLETED|Overall Study||0||
48484096|NCT01204294|101522551|FG000|STARTED|Overall Study||82||
48484097|NCT01204294|101522552|FG001|STARTED|Overall Study||66||
48484098|NCT01204294|101522553|FG002|STARTED|Overall Study||74||
48484099|NCT01204294|101522554|FG003|STARTED|Overall Study||143||
48484100|NCT01204294|101522555|FG004|STARTED|Overall Study||85||
48484101|NCT01204294|101522556|FG005|STARTED|Overall Study||63||
48484102|NCT01204294|101522557|FG006|STARTED|Overall Study||61||
48484103|NCT01204294|101522551|FG000|COMPLETED|Overall Study||79||
48484104|NCT01204294|101522552|FG001|COMPLETED|Overall Study||58||
48484105|NCT01204294|101522553|FG002|COMPLETED|Overall Study||69||
48197098|NCT03784963|100806625|FG000|STARTED|Overall Study||12||
48197099|NCT03784963|100806626|FG001|STARTED|Overall Study||10||
48197100|NCT03784963|100806627|FG002|STARTED|Overall Study||1||
48484106|NCT01204294|101522554|FG003|COMPLETED|Overall Study||132||
48484107|NCT01204294|101522555|FG004|COMPLETED|Overall Study||83||
48484108|NCT01204294|101522556|FG005|COMPLETED|Overall Study||58||
48484109|NCT01204294|101522557|FG006|COMPLETED|Overall Study||59||
48484110|NCT01204294|101522551|FG000|NOT COMPLETED|Overall Study||3||
48484111|NCT01204294|101522552|FG001|NOT COMPLETED|Overall Study||8||
48484112|NCT01204294|101522553|FG002|NOT COMPLETED|Overall Study||5||
48484113|NCT01204294|101522554|FG003|NOT COMPLETED|Overall Study||11||
48484114|NCT01204294|101522555|FG004|NOT COMPLETED|Overall Study||2||
48484115|NCT01204294|101522556|FG005|NOT COMPLETED|Overall Study||5||
48484116|NCT01204294|101522557|FG006|NOT COMPLETED|Overall Study||2||
48484117|NCT00296647|101522558|FG000|STARTED|Overall Study||282||
48484118|NCT00296647|101522559|FG001|STARTED|Overall Study||261||
48484119|NCT00296647|101522560|FG002|STARTED|Overall Study||256||
48484120|NCT00296647|101522561|FG003|STARTED|Overall Study||279||
48484121|NCT00296647|101522562|FG004|STARTED|Overall Study||268||
48484122|NCT00296647|101522558|FG000|COMPLETED|Overall Study||250||
48484123|NCT00296647|101522559|FG001|COMPLETED|Overall Study||233||
48484124|NCT00296647|101522560|FG002|COMPLETED|Overall Study||222||
48197101|NCT03784963|100806628|FG003|STARTED|Overall Study||0||
48197102|NCT03784963|100806625|FG000|COMPLETED|Overall Study||0||
48484125|NCT00296647|101522561|FG003|COMPLETED|Overall Study||262||
48484126|NCT00296647|101522562|FG004|COMPLETED|Overall Study||248||
48484127|NCT00296647|101522558|FG000|NOT COMPLETED|Overall Study||32||
48484128|NCT00296647|101522559|FG001|NOT COMPLETED|Overall Study||28||
48484129|NCT00296647|101522560|FG002|NOT COMPLETED|Overall Study||34||
48484130|NCT00296647|101522561|FG003|NOT COMPLETED|Overall Study||17||
48484131|NCT00296647|101522562|FG004|NOT COMPLETED|Overall Study||20||
48484132|NCT00467896|101522563|FG000|STARTED|Overall Study||62||
48484133|NCT00467896|101522563|FG000|COMPLETED|Overall Study||11||
48484134|NCT00467896|101522563|FG000|NOT COMPLETED|Overall Study||51||
48484135|NCT02444715|101522564|FG000|STARTED|Overall Study||46||
48484136|NCT02444715|101522565|FG001|STARTED|Overall Study||48||
48484137|NCT02444715|101522564|FG000|COMPLETED|Overall Study||36||
48484138|NCT02444715|101522565|FG001|COMPLETED|Overall Study||32||
48484139|NCT02444715|101522564|FG000|NOT COMPLETED|Overall Study||10||
48484140|NCT02444715|101522565|FG001|NOT COMPLETED|Overall Study||16||
48484141|NCT02301975|101522566|FG000|STARTED|Overall Study||504||
48484142|NCT02301975|101522567|FG001|STARTED|Overall Study||501||
48484143|NCT02301975|101522568|FG002|STARTED|Overall Study||499||
48484144|NCT02301975|101522566|FG000|COMPLETED|Overall Study||473||
48197103|NCT03784963|100806626|FG001|COMPLETED|Overall Study||0||
48484145|NCT02301975|101522567|FG001|COMPLETED|Overall Study||476||
48484146|NCT02301975|101522568|FG002|COMPLETED|Overall Study||477||
48484147|NCT02301975|101522566|FG000|NOT COMPLETED|Overall Study||31||
48484148|NCT02301975|101522567|FG001|NOT COMPLETED|Overall Study||25||
48484149|NCT02301975|101522568|FG002|NOT COMPLETED|Overall Study||22||
48484150|NCT04405570|101522569|FG000|STARTED|Overall Study||23||
48484151|NCT04405570|101522570|FG001|STARTED|Overall Study||64||
48484152|NCT04405570|101522571|FG002|STARTED|Overall Study||55||
48484153|NCT04405570|101522572|FG003|STARTED|Overall Study||62||
48484154|NCT04405570|101522569|FG000|Number of Subjects Randomized Not Dosed|Overall Study||0||
48484155|NCT04405570|101522570|FG001|Number of Subjects Randomized Not Dosed|Overall Study||2||
48197104|NCT03784963|100806627|FG002|COMPLETED|Overall Study||0||
48484156|NCT04405570|101522571|FG002|Number of Subjects Randomized Not Dosed|Overall Study||0||
48484157|NCT04405570|101522572|FG003|Number of Subjects Randomized Not Dosed|Overall Study||0||
48484158|NCT04405570|101522569|FG000|Number of Subjects in the Safety Population|Overall Study||23||
48484159|NCT04405570|101522570|FG001|Number of Subjects in the Safety Population|Overall Study||62||
48484160|NCT04405570|101522571|FG002|Number of Subjects in the Safety Population|Overall Study||55||
48484161|NCT04405570|101522572|FG003|Number of Subjects in the Safety Population|Overall Study||62||
48484162|NCT04405570|101522569|FG000|Number of Subjects in the mITT Population|Overall Study||23||
48484163|NCT04405570|101522570|FG001|Number of Subjects in the mITT Population|Overall Study||61||
48484164|NCT04405570|101522571|FG002|Number of Subjects in the mITT Population|Overall Study||53||
48484165|NCT04405570|101522572|FG003|Number of Subjects in the mITT Population|Overall Study||61||
48484166|NCT04405570|101522569|FG000|COMPLETED|Overall Study||23||
48484167|NCT04405570|101522570|FG001|COMPLETED|Overall Study||59||
48484168|NCT04405570|101522571|FG002|COMPLETED|Overall Study||52||
48484169|NCT04405570|101522572|FG003|COMPLETED|Overall Study||61||
48484170|NCT04405570|101522569|FG000|NOT COMPLETED|Overall Study||0||
48484171|NCT04405570|101522570|FG001|NOT COMPLETED|Overall Study||5||
48484172|NCT04405570|101522571|FG002|NOT COMPLETED|Overall Study||3||
48484173|NCT04405570|101522572|FG003|NOT COMPLETED|Overall Study||1||
48484174|NCT02158663|101522573|FG000|STARTED|Overall Study||22||
48484175|NCT02158663|101522574|FG001|STARTED|Overall Study||22||
48484176|NCT02158663|101522573|FG000|COMPLETED|Overall Study||17||
48484177|NCT02158663|101522574|FG001|COMPLETED|Overall Study||18||
48484178|NCT02158663|101522573|FG000|NOT COMPLETED|Overall Study||5||
48484179|NCT02158663|101522574|FG001|NOT COMPLETED|Overall Study||4||
48484180|NCT00469417|101522575|FG000|STARTED|Overall Study||62||
48484181|NCT00469417|101522576|FG001|STARTED|Overall Study||58||
48484182|NCT00469417|101522575|FG000|Treated|Overall Study||60||
48484183|NCT00469417|101522576|FG001|Treated|Overall Study||58||
48484184|NCT00469417|101522575|FG000|COMPLETED|Overall Study||32||
48484185|NCT00469417|101522576|FG001|COMPLETED|Overall Study||41||
48484186|NCT00469417|101522575|FG000|NOT COMPLETED|Overall Study||30||
48484187|NCT00469417|101522576|FG001|NOT COMPLETED|Overall Study||17||
48484188|NCT01136382|101522577|FG000|STARTED|Overall Study||152||
48484189|NCT01136382|101522578|FG001|STARTED|Overall Study||152||
48484190|NCT01136382|101522577|FG000|COMPLETED|Overall Study||92||
48484191|NCT01136382|101522578|FG001|COMPLETED|Overall Study||121||
48484192|NCT01136382|101522577|FG000|NOT COMPLETED|Overall Study||60||
48484193|NCT01136382|101522578|FG001|NOT COMPLETED|Overall Study||31||
48484194|NCT03084471|101522579|FG000|STARTED|Overall Study||867||
48484195|NCT03084471|101522579|FG000|COMPLETED|Overall Study||0||
48484196|NCT03084471|101522579|FG000|NOT COMPLETED|Overall Study||867||
48484197|NCT01745120|101522580|FG000|STARTED|Overall Study||11|Started = ITT|
48484198|NCT01745120|101522581|FG001|STARTED|Overall Study||8|Started = ITT|
48484199|NCT01745120|101522580|FG000|COMPLETED|Overall Study||10||
48484200|NCT01745120|101522581|FG001|COMPLETED|Overall Study||8||
48484201|NCT01745120|101522580|FG000|NOT COMPLETED|Overall Study||1||
48484202|NCT01745120|101522581|FG001|NOT COMPLETED|Overall Study||0||
48484203|NCT02819323|101522582|FG000|STARTED|Overall Study||31|Safety population - all subjects that took preparation.|
48484204|NCT02819323|101522583|FG001|STARTED|Overall Study||28|Safety population - all subjects that took preparation.|
48484205|NCT02819323|101522584|FG002|STARTED|Overall Study||32|Safety population - all subjects that took preparation.|
48484206|NCT02819323|101522582|FG000|COMPLETED|Overall Study||26||
48484207|NCT02819323|101522583|FG001|COMPLETED|Overall Study||26||
48484208|NCT02819323|101522584|FG002|COMPLETED|Overall Study||31||
48484209|NCT02819323|101522582|FG000|NOT COMPLETED|Overall Study||5||
48484210|NCT02819323|101522583|FG001|NOT COMPLETED|Overall Study||2||
48484211|NCT02819323|101522584|FG002|NOT COMPLETED|Overall Study||1||
48484212|NCT02077465|101522585|FG000|STARTED|Overall Study||8||
48484213|NCT02077465|101522586|FG001|STARTED|Overall Study||3||
48484214|NCT02077465|101522585|FG000|COMPLETED|Overall Study||7||
48484215|NCT02077465|101522586|FG001|COMPLETED|Overall Study||2||
48484216|NCT02077465|101522585|FG000|NOT COMPLETED|Overall Study||1||
48484217|NCT02077465|101522586|FG001|NOT COMPLETED|Overall Study||1||
48484218|NCT02530905|101522587|FG000|STARTED|Double-Blind Period (12 Weeks)||4||
48484219|NCT02530905|101522588|FG001|STARTED|Double-Blind Period (12 Weeks)||8||
48484220|NCT02530905|101522589|FG002|STARTED|Double-Blind Period (12 Weeks)||0||
48484221|NCT02530905|101522587|FG000|Received 4 mg/kg|Double-Blind Period (12 Weeks)||0||
48484222|NCT02530905|101522588|FG001|Received 4 mg/kg|Double-Blind Period (12 Weeks)||8||
48484223|NCT02530905|101522589|FG002|Received 4 mg/kg|Double-Blind Period (12 Weeks)||0||
48484224|NCT02530905|101522587|FG000|Received 10 mg/kg|Double-Blind Period (12 Weeks)||0||
48484225|NCT02530905|101522588|FG001|Received 10 mg/kg|Double-Blind Period (12 Weeks)||8||
48484226|NCT02530905|101522589|FG002|Received 10 mg/kg|Double-Blind Period (12 Weeks)||0||
48484227|NCT02530905|101522587|FG000|Received 20 mg/kg|Double-Blind Period (12 Weeks)||0||
48484228|NCT02530905|101522588|FG001|Received 20 mg/kg|Double-Blind Period (12 Weeks)||8||
48484229|NCT02530905|101522589|FG002|Received 20 mg/kg|Double-Blind Period (12 Weeks)||0||
48484230|NCT02530905|101522587|FG000|Received 30 mg/kg|Double-Blind Period (12 Weeks)||0||
48484231|NCT02530905|101522588|FG001|Received 30 mg/kg|Double-Blind Period (12 Weeks)||8||
48484232|NCT02530905|101522589|FG002|Received 30 mg/kg|Double-Blind Period (12 Weeks)||0||
48484233|NCT02530905|101522587|FG000|COMPLETED|Double-Blind Period (12 Weeks)||4||
48484234|NCT02530905|101522588|FG001|COMPLETED|Double-Blind Period (12 Weeks)||8||
48484235|NCT02530905|101522589|FG002|COMPLETED|Double-Blind Period (12 Weeks)||0||
48484236|NCT02530905|101522587|FG000|NOT COMPLETED|Double-Blind Period (12 Weeks)||0||
48484237|NCT02530905|101522588|FG001|NOT COMPLETED|Double-Blind Period (12 Weeks)||0||
48484238|NCT02530905|101522589|FG002|NOT COMPLETED|Double-Blind Period (12 Weeks)||0||
48484239|NCT02530905|101522587|FG000|STARTED|Open Label Extension Period (132 Weeks)||0||
48484240|NCT02530905|101522588|FG001|STARTED|Open Label Extension Period (132 Weeks)||0||
48484241|NCT02530905|101522589|FG002|STARTED|Open Label Extension Period (132 Weeks)||12||
48484242|NCT02530905|101522587|FG000|COMPLETED|Open Label Extension Period (132 Weeks)||0||
48484243|NCT02530905|101522588|FG001|COMPLETED|Open Label Extension Period (132 Weeks)||0||
48484244|NCT02530905|101522589|FG002|COMPLETED|Open Label Extension Period (132 Weeks)||11||
48484245|NCT02530905|101522587|FG000|NOT COMPLETED|Open Label Extension Period (132 Weeks)||0||
48484246|NCT02530905|101522588|FG001|NOT COMPLETED|Open Label Extension Period (132 Weeks)||0||
48484247|NCT02530905|101522589|FG002|NOT COMPLETED|Open Label Extension Period (132 Weeks)||1||
48484248|NCT01265056|101522590|FG000|STARTED|Initial Study Period||26||
48484249|NCT01265056|101522591|FG001|STARTED|Initial Study Period||27||
48484250|NCT01265056|101522590|FG000|COMPLETED|Initial Study Period||24||
48484251|NCT01265056|101522591|FG001|COMPLETED|Initial Study Period||25||
48484252|NCT01265056|101522590|FG000|NOT COMPLETED|Initial Study Period||2||
48484253|NCT01265056|101522591|FG001|NOT COMPLETED|Initial Study Period||2||
48484254|NCT01265056|101522590|FG000|STARTED|Follow up||26||
48484255|NCT01265056|101522591|FG001|STARTED|Follow up||27||
48484256|NCT01265056|101522590|FG000|COMPLETED|Follow up||19||
48484257|NCT01265056|101522591|FG001|COMPLETED|Follow up||24||
48484258|NCT01265056|101522590|FG000|NOT COMPLETED|Follow up||7||
48484259|NCT01265056|101522591|FG001|NOT COMPLETED|Follow up||3||
48484260|NCT01854047|101522592|FG000|STARTED|Overall Study||158|Started = Randomized|
48484261|NCT01854047|101522593|FG001|STARTED|Overall Study||157|Started = Randomized|
48484262|NCT01854047|101522594|FG002|STARTED|Overall Study||150|Started = Randomized|
48484263|NCT01854047|101522595|FG003|STARTED|Overall Study||157|Started = Randomized|
48484264|NCT01854047|101522596|FG004|STARTED|Overall Study||154|Started = Randomized|
48484265|NCT01854047|101522592|FG000|Treated|Overall Study||158||
48484266|NCT01854047|101522593|FG001|Treated|Overall Study||156||
48484267|NCT01854047|101522594|FG002|Treated|Overall Study||148||
48484268|NCT01854047|101522595|FG003|Treated|Overall Study||157||
48484269|NCT01854047|101522596|FG004|Treated|Overall Study||150||
48484270|NCT01854047|101522592|FG000|Completed 12-week Study Treatment|Overall Study||153||
48484271|NCT01854047|101522593|FG001|Completed 12-week Study Treatment|Overall Study||149||
48484272|NCT01854047|101522594|FG002|Completed 12-week Study Treatment|Overall Study||141||
48484273|NCT01854047|101522595|FG003|Completed 12-week Study Treatment|Overall Study||146||
48484274|NCT01854047|101522596|FG004|Completed 12-week Study Treatment|Overall Study||143||
48484275|NCT01854047|101522592|FG000|COMPLETED|Overall Study||146|Completed = Completed study treatment period.|
48484276|NCT01854047|101522593|FG001|COMPLETED|Overall Study||149|Completed = Completed study treatment period.|
48484277|NCT01854047|101522594|FG002|COMPLETED|Overall Study||137|Completed = Completed study treatment period.|
48484278|NCT01854047|101522595|FG003|COMPLETED|Overall Study||142|Completed = Completed study treatment period.|
48484279|NCT01854047|101522596|FG004|COMPLETED|Overall Study||135|Completed = Completed study treatment period.|
48484280|NCT01854047|101522592|FG000|NOT COMPLETED|Overall Study||12||
48484281|NCT01854047|101522593|FG001|NOT COMPLETED|Overall Study||8||
48484282|NCT01854047|101522594|FG002|NOT COMPLETED|Overall Study||13||
48484283|NCT01854047|101522595|FG003|NOT COMPLETED|Overall Study||15||
48484284|NCT01854047|101522596|FG004|NOT COMPLETED|Overall Study||19||
48484285|NCT01171989|101522597|FG000|STARTED|Overall Study||137||
48484286|NCT01171989|101522598|FG001|STARTED|Overall Study||133||
48484287|NCT01171989|101522599|FG002|STARTED|Overall Study||121||
48484288|NCT01171989|101522597|FG000|COMPLETED|Overall Study||137||
48484289|NCT01171989|101522598|FG001|COMPLETED|Overall Study||133||
48484290|NCT01171989|101522599|FG002|COMPLETED|Overall Study||120||
48484291|NCT01171989|101522597|FG000|NOT COMPLETED|Overall Study||0||
48484292|NCT01171989|101522598|FG001|NOT COMPLETED|Overall Study||0||
48484293|NCT01171989|101522599|FG002|NOT COMPLETED|Overall Study||1||
48484294|NCT00910663|101522600|FG000|STARTED|Period 1||30||
48484295|NCT00910663|101522601|FG001|STARTED|Period 1||30||
48484296|NCT00910663|101522600|FG000|COMPLETED|Period 1||30||
48484297|NCT00910663|101522601|FG001|COMPLETED|Period 1||29||
48484298|NCT00910663|101522600|FG000|NOT COMPLETED|Period 1||0||
48484299|NCT00910663|101522601|FG001|NOT COMPLETED|Period 1||1||
48484300|NCT00910663|101522600|FG000|STARTED|Period 2||30||
48484301|NCT00910663|101522601|FG001|STARTED|Period 2||29||
48484302|NCT00910663|101522600|FG000|COMPLETED|Period 2||30||
48484303|NCT00910663|101522601|FG001|COMPLETED|Period 2||29||
48484304|NCT00910663|101522600|FG000|NOT COMPLETED|Period 2||0||
48484305|NCT00910663|101522601|FG001|NOT COMPLETED|Period 2||0||
48484306|NCT02139826|101522602|FG000|STARTED|Overall Study||12||
48484307|NCT02139826|101522602|FG000|COMPLETED|Overall Study||11||
48484308|NCT02139826|101522602|FG000|NOT COMPLETED|Overall Study||1||
48484309|NCT01972204|101522603|FG000|STARTED|Overall Study||62||
48484310|NCT01972204|101522604|FG001|STARTED|Overall Study||63||
48484311|NCT01972204|101522603|FG000|COMPLETED|Overall Study||58||
48484312|NCT01972204|101522604|FG001|COMPLETED|Overall Study||59||
48484313|NCT01972204|101522603|FG000|NOT COMPLETED|Overall Study||4||
48484314|NCT01972204|101522604|FG001|NOT COMPLETED|Overall Study||4||
48484315|NCT00803686|101522605|FG000|STARTED|Part 1, Period 1||6||
48484316|NCT00803686|101522606|FG001|STARTED|Part 1, Period 1||6||
48484317|NCT00803686|101522607|FG002|STARTED|Part 1, Period 1||0||
48484318|NCT00803686|101522608|FG003|STARTED|Part 1, Period 1||0||
48484319|NCT00803686|101522605|FG000|COMPLETED|Part 1, Period 1||6||
48484320|NCT00803686|101522606|FG001|COMPLETED|Part 1, Period 1||6||
48484321|NCT00803686|101522607|FG002|COMPLETED|Part 1, Period 1||0||
48484322|NCT00803686|101522608|FG003|COMPLETED|Part 1, Period 1||0||
48484323|NCT00803686|101522605|FG000|NOT COMPLETED|Part 1, Period 1||0||
48484324|NCT00803686|101522606|FG001|NOT COMPLETED|Part 1, Period 1||0||
48484325|NCT00803686|101522607|FG002|NOT COMPLETED|Part 1, Period 1||0||
48484326|NCT00803686|101522608|FG003|NOT COMPLETED|Part 1, Period 1||0||
48484327|NCT00803686|101522605|FG000|STARTED|Part 1, Period 2||6||
48484328|NCT00803686|101522606|FG001|STARTED|Part 1, Period 2||6||
48484329|NCT00803686|101522607|FG002|STARTED|Part 1, Period 2||0||
48484330|NCT00803686|101522608|FG003|STARTED|Part 1, Period 2||0||
48484331|NCT00803686|101522605|FG000|COMPLETED|Part 1, Period 2||6||
48484332|NCT00803686|101522606|FG001|COMPLETED|Part 1, Period 2||6||
48484333|NCT00803686|101522607|FG002|COMPLETED|Part 1, Period 2||0||
48484334|NCT00803686|101522608|FG003|COMPLETED|Part 1, Period 2||0||
48484335|NCT00803686|101522605|FG000|NOT COMPLETED|Part 1, Period 2||0||
48484336|NCT00803686|101522606|FG001|NOT COMPLETED|Part 1, Period 2||0||
48484337|NCT00803686|101522607|FG002|NOT COMPLETED|Part 1, Period 2||0||
48484338|NCT00803686|101522608|FG003|NOT COMPLETED|Part 1, Period 2||0||
48484339|NCT00803686|101522605|FG000|STARTED|Part 2, Period 3||0||
48484340|NCT00803686|101522606|FG001|STARTED|Part 2, Period 3||0||
48484341|NCT00803686|101522607|FG002|STARTED|Part 2, Period 3||5||
48484342|NCT00803686|101522608|FG003|STARTED|Part 2, Period 3||4||
48484343|NCT00803686|101522605|FG000|COMPLETED|Part 2, Period 3||0||
48484344|NCT00803686|101522606|FG001|COMPLETED|Part 2, Period 3||0||
48484345|NCT00803686|101522607|FG002|COMPLETED|Part 2, Period 3||5||
48484346|NCT00803686|101522608|FG003|COMPLETED|Part 2, Period 3||4||
48484347|NCT00803686|101522605|FG000|NOT COMPLETED|Part 2, Period 3||0||
48484348|NCT00803686|101522606|FG001|NOT COMPLETED|Part 2, Period 3||0||
48484349|NCT00803686|101522607|FG002|NOT COMPLETED|Part 2, Period 3||0||
48484350|NCT00803686|101522608|FG003|NOT COMPLETED|Part 2, Period 3||0||
48484351|NCT00633256|101522609|FG000|STARTED|Overall Study||12||
48484352|NCT00633256|101522610|FG001|STARTED|Overall Study||13||
48484353|NCT00633256|101522609|FG000|COMPLETED|Overall Study||8||
48484354|NCT00633256|101522610|FG001|COMPLETED|Overall Study||10||
48484355|NCT00633256|101522609|FG000|NOT COMPLETED|Overall Study||4||
48484356|NCT00633256|101522610|FG001|NOT COMPLETED|Overall Study||3||
48484357|NCT00561834|101522611|FG000|STARTED|Overall Study||2||
48484358|NCT00561834|101522611|FG000|COMPLETED|Overall Study||2||
48484359|NCT00561834|101522611|FG000|NOT COMPLETED|Overall Study||0||
48484360|NCT01214850|101522612|FG000|STARTED|Overall Study||979||
48484361|NCT01214850|101522613|FG001|STARTED|Overall Study||988||
48484362|NCT01214850|101522614|FG002|STARTED|Overall Study||987||
48484363|NCT01214850|101522612|FG000|COMPLETED|Overall Study||796||
48484364|NCT01214850|101522613|FG001|COMPLETED|Overall Study||844||
48484365|NCT01214850|101522614|FG002|COMPLETED|Overall Study||826||
48484366|NCT01214850|101522612|FG000|NOT COMPLETED|Overall Study||183||
48484367|NCT01214850|101522613|FG001|NOT COMPLETED|Overall Study||144||
48484368|NCT01214850|101522614|FG002|NOT COMPLETED|Overall Study||161||
48484369|NCT03503318|101522615|FG000|STARTED|Overall Study||181||
48484370|NCT03503318|101522616|FG001|STARTED|Overall Study||183||
48484371|NCT03503318|101522617|FG002|STARTED|Overall Study||180||
48484372|NCT03503318|101522615|FG000|Received at Least 1 Dose of Study Drug|Overall Study||179||
48484373|NCT03503318|101522616|FG001|Received at Least 1 Dose of Study Drug|Overall Study||183||
48484374|NCT03503318|101522617|FG002|Received at Least 1 Dose of Study Drug|Overall Study||180||
48484375|NCT03503318|101522615|FG000|COMPLETED|Overall Study||142||
48484376|NCT03503318|101522616|FG001|COMPLETED|Overall Study||144||
48484377|NCT03503318|101522617|FG002|COMPLETED|Overall Study||140||
48484378|NCT03503318|101522615|FG000|NOT COMPLETED|Overall Study||39||
48484379|NCT03503318|101522616|FG001|NOT COMPLETED|Overall Study||39||
48484380|NCT03503318|101522617|FG002|NOT COMPLETED|Overall Study||40||
48484381|NCT00656305|101522618|FG000|STARTED|Overall Study||87||
48484382|NCT00656305|101522619|FG001|STARTED|Overall Study||28||
48484383|NCT00656305|101522618|FG000|COMPLETED|Overall Study||65||
48484384|NCT00656305|101522619|FG001|COMPLETED|Overall Study||21||
48484385|NCT00656305|101522618|FG000|NOT COMPLETED|Overall Study||22||
48484386|NCT00656305|101522619|FG001|NOT COMPLETED|Overall Study||7||
48484387|NCT01907334|101522620|FG000|STARTED|Overall Study||6||
48484388|NCT01907334|101522621|FG001|STARTED|Overall Study||4||
48484389|NCT01907334|101522620|FG000|COMPLETED|Overall Study||6||
48484390|NCT01907334|101522621|FG001|COMPLETED|Overall Study||4||
48484391|NCT01907334|101522620|FG000|NOT COMPLETED|Overall Study||0||
48484392|NCT01907334|101522621|FG001|NOT COMPLETED|Overall Study||0||
48484393|NCT01278953|101522622|FG000|STARTED|Overall Study||155||
48484394|NCT01278953|101522623|FG001|STARTED|Overall Study||145||
48484395|NCT01278953|101522622|FG000|COMPLETED|Overall Study||146||
48484396|NCT01278953|101522623|FG001|COMPLETED|Overall Study||134||
48484397|NCT01278953|101522622|FG000|NOT COMPLETED|Overall Study||9||
48484398|NCT01278953|101522623|FG001|NOT COMPLETED|Overall Study||11||
48484399|NCT01668602|101522624|FG000|STARTED|Overall Study||2||
48484400|NCT01668602|101522625|FG001|STARTED|Overall Study||22||
48484401|NCT01668602|101522624|FG000|Cohort 2 - Began FastFES Sessions|Overall Study||0||
48484402|NCT01668602|101522625|FG001|Cohort 2 - Began FastFES Sessions|Overall Study||20||
48484403|NCT01668602|101522624|FG000|Cohort 2 - Completed 3 Sessions of FastFES|Overall Study||0||
48484404|NCT01668602|101522625|FG001|Cohort 2 - Completed 3 Sessions of FastFES|Overall Study||19||
48484405|NCT01668602|101522624|FG000|Cohort 2 - Began Fast Walking Sessions|Overall Study||0||
48484406|NCT01668602|101522625|FG001|Cohort 2 - Began Fast Walking Sessions|Overall Study||20||
48484407|NCT01668602|101522624|FG000|Cohort 2 - Completed 3 Sessions of Fast Walking|Overall Study||0||
48484408|NCT01668602|101522625|FG001|Cohort 2 - Completed 3 Sessions of Fast Walking|Overall Study||18||
48484409|NCT01668602|101522624|FG000|COMPLETED|Overall Study||2||
48484410|NCT01668602|101522625|FG001|COMPLETED|Overall Study||18||
48484411|NCT01668602|101522624|FG000|NOT COMPLETED|Overall Study||0||
48484412|NCT01668602|101522625|FG001|NOT COMPLETED|Overall Study||4||
48484413|NCT03466866|101522626|FG000|STARTED|Overall Study||78||
48484414|NCT03466866|101522627|FG001|STARTED|Overall Study||78||
48484415|NCT03466866|101522626|FG000|COMPLETED|Overall Study||62||
48484416|NCT03466866|101522627|FG001|COMPLETED|Overall Study||62||
48484417|NCT03466866|101522626|FG000|NOT COMPLETED|Overall Study||16||
48484418|NCT03466866|101522627|FG001|NOT COMPLETED|Overall Study||16||
48484419|NCT02659150|101522628|FG000|STARTED|Subject Enrollment||16||
48484420|NCT02659150|101522628|FG000|COMPLETED|Subject Enrollment||11||
48484421|NCT02659150|101522628|FG000|NOT COMPLETED|Subject Enrollment||5||
48484422|NCT02659150|101522628|FG000|STARTED|Baseline Imaging||11||
48484423|NCT02659150|101522628|FG000|COMPLETED|Baseline Imaging||9||
48484424|NCT02659150|101522628|FG000|NOT COMPLETED|Baseline Imaging||2||
48484425|NCT02659150|101522628|FG000|STARTED|Study Drug Dosing||9||
48484426|NCT02659150|101522628|FG000|COMPLETED|Study Drug Dosing||8||
48484427|NCT02659150|101522628|FG000|NOT COMPLETED|Study Drug Dosing||1||
48484428|NCT02659150|101522628|FG000|STARTED|Follow-up Imaging||8||
48484429|NCT02659150|101522628|FG000|COMPLETED|Follow-up Imaging||8||
48484430|NCT02659150|101522628|FG000|NOT COMPLETED|Follow-up Imaging||0||
48484431|NCT00268905|101522629|FG000|STARTED|Overall Study||43||
48484432|NCT00268905|101522630|FG001|STARTED|Overall Study||9||
48484433|NCT00268905|101522631|FG002|STARTED|Overall Study||12||
48484434|NCT00268905|101522629|FG000|COMPLETED|Overall Study||0||
48484435|NCT00268905|101522630|FG001|COMPLETED|Overall Study||0||
48484436|NCT00268905|101522631|FG002|COMPLETED|Overall Study||0||
48484437|NCT00268905|101522629|FG000|NOT COMPLETED|Overall Study||43||
48484438|NCT00268905|101522630|FG001|NOT COMPLETED|Overall Study||9||
48484439|NCT00268905|101522631|FG002|NOT COMPLETED|Overall Study||12||
48484440|NCT00322439|101522632|FG000|STARTED|Overall Study||2511||
48484441|NCT00322439|101522632|FG000|Received at Least 1 Dose of Etanercept|Overall Study||2510||
48484442|NCT00322439|101522632|FG000|COMPLETED|Overall Study||1455||
48484443|NCT00322439|101522632|FG000|NOT COMPLETED|Overall Study||1056||
48484444|NCT00519194|101522633|FG000|STARTED|Overall Study||112||
48484445|NCT00519194|101522633|FG000|COMPLETED|Overall Study||91||
48484446|NCT00519194|101522633|FG000|NOT COMPLETED|Overall Study||21||
48484447|NCT02682238|101522634|FG000|STARTED|Overall Study||25||
48484448|NCT02682238|101522635|FG001|STARTED|Overall Study||25||
48484449|NCT02682238|101522634|FG000|COMPLETED|Overall Study||22||
48484450|NCT02682238|101522635|FG001|COMPLETED|Overall Study||21||
48484451|NCT02682238|101522634|FG000|NOT COMPLETED|Overall Study||3||
48484452|NCT02682238|101522635|FG001|NOT COMPLETED|Overall Study||4||
48484453|NCT00428298|101522636|FG000|STARTED|Overall Study||30||
48484454|NCT00428298|101522637|FG001|STARTED|Overall Study||30||
48484455|NCT00428298|101522636|FG000|Second RBANS at Study Exit|Overall Study||3||
48484456|NCT00428298|101522637|FG001|Second RBANS at Study Exit|Overall Study||3||
48484457|NCT00428298|101522636|FG000|COMPLETED|Overall Study||16||
48484458|NCT00428298|101522637|FG001|COMPLETED|Overall Study||19||
48484459|NCT00428298|101522636|FG000|NOT COMPLETED|Overall Study||14||
48484460|NCT00428298|101522637|FG001|NOT COMPLETED|Overall Study||11||
48484461|NCT03804983|101522638|FG000|STARTED|Overall Study||10||
48484462|NCT03804983|101522639|FG001|STARTED|Overall Study||10||
48484463|NCT03804983|101522638|FG000|COMPLETED|Overall Study||9||
48484464|NCT03804983|101522639|FG001|COMPLETED|Overall Study||9||
48484465|NCT03804983|101522638|FG000|NOT COMPLETED|Overall Study||1||
48484466|NCT03804983|101522639|FG001|NOT COMPLETED|Overall Study||1||
48484467|NCT00609674|101522640|FG000|STARTED|Overall Study||155||
48484468|NCT00609674|101522641|FG001|STARTED|Overall Study||160||
48484469|NCT00609674|101522640|FG000|COMPLETED|Overall Study||148||
48484470|NCT00609674|101522641|FG001|COMPLETED|Overall Study||153||
48484471|NCT00609674|101522640|FG000|NOT COMPLETED|Overall Study||7||
48484472|NCT00609674|101522641|FG001|NOT COMPLETED|Overall Study||7||
48484473|NCT03382925|101522642|FG000|STARTED|Overall Study||10||
48484474|NCT03382925|101522643|FG001|STARTED|Overall Study||6||
48484475|NCT03382925|101522642|FG000|COMPLETED|Overall Study||10||
48484476|NCT03382925|101522643|FG001|COMPLETED|Overall Study||6||
48484477|NCT03382925|101522642|FG000|NOT COMPLETED|Overall Study||0||
48484478|NCT03382925|101522643|FG001|NOT COMPLETED|Overall Study||0||
48484479|NCT02412852|101522644|FG000|STARTED|Overall Study||4||
48484480|NCT02412852|101522645|FG001|STARTED|Overall Study||8||
48484481|NCT02412852|101522646|FG002|STARTED|Overall Study||5||
48484482|NCT02412852|101522647|FG003|STARTED|Overall Study||9||
48484483|NCT02412852|101522644|FG000|COMPLETED|Overall Study||4||
48484484|NCT02412852|101522645|FG001|COMPLETED|Overall Study||7||
48484485|NCT02412852|101522646|FG002|COMPLETED|Overall Study||5||
48484486|NCT02412852|101522647|FG003|COMPLETED|Overall Study||8||
48484487|NCT02412852|101522644|FG000|NOT COMPLETED|Overall Study||0||
48484488|NCT02412852|101522645|FG001|NOT COMPLETED|Overall Study||1||
48484489|NCT02412852|101522646|FG002|NOT COMPLETED|Overall Study||0||
48484490|NCT02412852|101522647|FG003|NOT COMPLETED|Overall Study||1||
48484491|NCT01172145|101522648|FG000|STARTED|Overall Study||11||
48484492|NCT01172145|101522649|FG001|STARTED|Overall Study||11||
48484493|NCT01172145|101522648|FG000|COMPLETED|Overall Study||11||
48484494|NCT01172145|101522649|FG001|COMPLETED|Overall Study||11||
48484495|NCT01172145|101522648|FG000|NOT COMPLETED|Overall Study||0||
48484496|NCT01172145|101522649|FG001|NOT COMPLETED|Overall Study||0||
48484497|NCT01844375|101522650|FG000|STARTED|Overall Study||35||
48484498|NCT01844375|101522651|FG001|STARTED|Overall Study||35||
48484499|NCT01844375|101522650|FG000|COMPLETED|Overall Study||34||
48484500|NCT01844375|101522651|FG001|COMPLETED|Overall Study||34||
48484501|NCT01844375|101522650|FG000|NOT COMPLETED|Overall Study||1||
48484502|NCT01844375|101522651|FG001|NOT COMPLETED|Overall Study||1||
48484503|NCT00594685|101522652|FG000|STARTED|Overall Study||10||
48484504|NCT00594685|101522652|FG000|COMPLETED|Overall Study||10||
48484505|NCT00594685|101522652|FG000|NOT COMPLETED|Overall Study||0||
48484506|NCT00610363|101522653|FG000|STARTED|Overall Study||42||
48484507|NCT00610363|101522654|FG001|STARTED|Overall Study||41||
48484508|NCT00610363|101522653|FG000|COMPLETED|Overall Study||31||
48484509|NCT00610363|101522654|FG001|COMPLETED|Overall Study||38||
48484510|NCT00610363|101522653|FG000|NOT COMPLETED|Overall Study||11||
48484511|NCT00610363|101522654|FG001|NOT COMPLETED|Overall Study||3||
48484512|NCT03236311|101522655|FG000|STARTED|Overall Study||5||
48484513|NCT03236311|101522656|FG001|STARTED|Overall Study||5||
48484514|NCT03236311|101522655|FG000|COMPLETED|Overall Study||5||
48484515|NCT03236311|101522656|FG001|COMPLETED|Overall Study||2||
48484516|NCT03236311|101522655|FG000|NOT COMPLETED|Overall Study||0||
48484517|NCT03236311|101522656|FG001|NOT COMPLETED|Overall Study||3||
48484518|NCT04541147|101522657|FG000|STARTED|Overall Study||16||
48484519|NCT04541147|101522658|FG001|STARTED|Overall Study||8||
48484520|NCT04541147|101522657|FG000|COMPLETED|Overall Study||14||
48484521|NCT04541147|101522658|FG001|COMPLETED|Overall Study||7||
48484522|NCT04541147|101522657|FG000|NOT COMPLETED|Overall Study||2||
48484523|NCT04541147|101522658|FG001|NOT COMPLETED|Overall Study||1||
48484524|NCT01597245|101522659|FG000|STARTED|Induction Period (Week 0 - Week 12)||168||
48484525|NCT01597245|101522660|FG001|STARTED|Induction Period (Week 0 - Week 12)||358||
48484526|NCT01597245|101522661|FG002|STARTED|Induction Period (Week 0 - Week 12)||347||
48484527|NCT01597245|101522662|FG003|STARTED|Induction Period (Week 0 - Week 12)||351||
48484528|NCT01597245|101522663|FG004|STARTED|Induction Period (Week 0 - Week 12)||0||
48484529|NCT01597245|101522664|FG005|STARTED|Induction Period (Week 0 - Week 12)||0||
48484530|NCT01597245|101522665|FG006|STARTED|Induction Period (Week 0 - Week 12)||0||
48484531|NCT01597245|101522666|FG007|STARTED|Induction Period (Week 0 - Week 12)||0||
48484532|NCT01597245|101522667|FG008|STARTED|Induction Period (Week 0 - Week 12)||0||
48484533|NCT01597245|101522668|FG009|STARTED|Induction Period (Week 0 - Week 12)||0||
48484534|NCT01597245|101522669|FG010|STARTED|Induction Period (Week 0 - Week 12)||0||
48484535|NCT01597245|101522670|FG011|STARTED|Induction Period (Week 0 - Week 12)||0||
48484536|NCT01597245|101522671|FG012|STARTED|Induction Period (Week 0 - Week 12)||0||
48484537|NCT01597245|101522672|FG013|STARTED|Induction Period (Week 0 - Week 12)||0||
48484538|NCT01597245|101522673|FG014|STARTED|Induction Period (Week 0 - Week 12)||0||
48484539|NCT01597245|101522674|FG015|STARTED|Induction Period (Week 0 - Week 12)||0||
48484540|NCT01597245|101522675|FG016|STARTED|Induction Period (Week 0 - Week 12)||0||
48484541|NCT01597245|101522676|FG017|STARTED|Induction Period (Week 0 - Week 12)||0||
48484542|NCT01597245|101522677|FG018|STARTED|Induction Period (Week 0 - Week 12)||0||
48484543|NCT01597245|101522678|FG019|STARTED|Induction Period (Week 0 - Week 12)||0||
48484544|NCT01597245|101522679|FG020|STARTED|Induction Period (Week 0 - Week 12)||0||
48484545|NCT01597245|101522659|FG000|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||167||
48484546|NCT01597245|101522660|FG001|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||357||
48484547|NCT01597245|101522661|FG002|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||347||
48484548|NCT01597245|101522662|FG003|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||350||
48484549|NCT01597245|101522663|FG004|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0||
48484550|NCT01597245|101522664|FG005|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0||
48484551|NCT01597245|101522665|FG006|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0||
48484552|NCT01597245|101522666|FG007|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0||
48484553|NCT01597245|101522667|FG008|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0||
48484554|NCT01597245|101522668|FG009|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0||
48484555|NCT01597245|101522669|FG010|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0||
48484556|NCT01597245|101522670|FG011|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0||
48484557|NCT01597245|101522671|FG012|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0||
48484558|NCT01597245|101522672|FG013|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0||
48484559|NCT01597245|101522673|FG014|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0||
48484560|NCT01597245|101522674|FG015|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0||
48484561|NCT01597245|101522675|FG016|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0||
48484562|NCT01597245|101522676|FG017|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0||
48484563|NCT01597245|101522677|FG018|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0||
48484564|NCT01597245|101522678|FG019|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0||
48484565|NCT01597245|101522679|FG020|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0||
48484566|NCT01597245|101522659|FG000|COMPLETED|Induction Period (Week 0 - Week 12)||158||
48484567|NCT01597245|101522660|FG001|COMPLETED|Induction Period (Week 0 - Week 12)||333||
48484568|NCT01597245|101522661|FG002|COMPLETED|Induction Period (Week 0 - Week 12)||328||
48484569|NCT01597245|101522662|FG003|COMPLETED|Induction Period (Week 0 - Week 12)||342||
48484570|NCT01597245|101522663|FG004|COMPLETED|Induction Period (Week 0 - Week 12)||0||
48484571|NCT01597245|101522664|FG005|COMPLETED|Induction Period (Week 0 - Week 12)||0||
48484572|NCT01597245|101522665|FG006|COMPLETED|Induction Period (Week 0 - Week 12)||0||
48484573|NCT01597245|101522666|FG007|COMPLETED|Induction Period (Week 0 - Week 12)||0||
48484574|NCT01597245|101522667|FG008|COMPLETED|Induction Period (Week 0 - Week 12)||0||
48484575|NCT01597245|101522668|FG009|COMPLETED|Induction Period (Week 0 - Week 12)||0||
48484576|NCT01597245|101522669|FG010|COMPLETED|Induction Period (Week 0 - Week 12)||0||
48484577|NCT01597245|101522670|FG011|COMPLETED|Induction Period (Week 0 - Week 12)||0||
48484578|NCT01597245|101522671|FG012|COMPLETED|Induction Period (Week 0 - Week 12)||0||
48484579|NCT01597245|101522672|FG013|COMPLETED|Induction Period (Week 0 - Week 12)||0||
48484580|NCT01597245|101522673|FG014|COMPLETED|Induction Period (Week 0 - Week 12)||0||
48484581|NCT01597245|101522674|FG015|COMPLETED|Induction Period (Week 0 - Week 12)||0||
48484582|NCT01597245|101522675|FG016|COMPLETED|Induction Period (Week 0 - Week 12)||0||
48484583|NCT01597245|101522676|FG017|COMPLETED|Induction Period (Week 0 - Week 12)||0||
48484584|NCT01597245|101522677|FG018|COMPLETED|Induction Period (Week 0 - Week 12)||0||
48484585|NCT01597245|101522678|FG019|COMPLETED|Induction Period (Week 0 - Week 12)||0||
48484586|NCT01597245|101522679|FG020|COMPLETED|Induction Period (Week 0 - Week 12)||0||
48484587|NCT01597245|101522659|FG000|NOT COMPLETED|Induction Period (Week 0 - Week 12)||10||
48484588|NCT01597245|101522660|FG001|NOT COMPLETED|Induction Period (Week 0 - Week 12)||25||
48484589|NCT01597245|101522661|FG002|NOT COMPLETED|Induction Period (Week 0 - Week 12)||19||
48484590|NCT01597245|101522662|FG003|NOT COMPLETED|Induction Period (Week 0 - Week 12)||9||
48484591|NCT01597245|101522663|FG004|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0||
48484592|NCT01597245|101522664|FG005|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0||
48484593|NCT01597245|101522665|FG006|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0||
48484594|NCT01597245|101522666|FG007|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0||
48484595|NCT01597245|101522667|FG008|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0||
48484596|NCT01597245|101522668|FG009|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0||
48484597|NCT01597245|101522669|FG010|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0||
48484598|NCT01597245|101522670|FG011|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0||
48484599|NCT01597245|101522671|FG012|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0||
48484600|NCT01597245|101522672|FG013|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0||
48484601|NCT01597245|101522673|FG014|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0||
48484602|NCT01597245|101522674|FG015|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0||
48484603|NCT01597245|101522675|FG016|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0||
48484604|NCT01597245|101522676|FG017|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0||
48484605|NCT01597245|101522677|FG018|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0||
48484606|NCT01597245|101522678|FG019|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0||
48484607|NCT01597245|101522679|FG020|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0||
48484608|NCT01597245|101522659|FG000|STARTED|Maintenance Period (Week 12 to Week 60)||0||
48484609|NCT01597245|101522660|FG001|STARTED|Maintenance Period (Week 12 to Week 60)||0||
48484610|NCT01597245|101522661|FG002|STARTED|Maintenance Period (Week 12 to Week 60)||0||
48484611|NCT01597245|101522662|FG003|STARTED|Maintenance Period (Week 12 to Week 60)||0||
48484612|NCT01597245|101522663|FG004|STARTED|Maintenance Period (Week 12 to Week 60)||176||
48484613|NCT01597245|101522664|FG005|STARTED|Maintenance Period (Week 12 to Week 60)||187||
48484614|NCT01597245|101522665|FG006|STARTED|Maintenance Period (Week 12 to Week 60)||181||
48484615|NCT01597245|101522666|FG007|STARTED|Maintenance Period (Week 12 to Week 60)||3||
48484616|NCT01597245|101522667|FG008|STARTED|Maintenance Period (Week 12 to Week 60)||155||
48484617|NCT01597245|101522668|FG009|STARTED|Maintenance Period (Week 12 to Week 60)||132||
48484618|NCT01597245|101522669|FG010|STARTED|Maintenance Period (Week 12 to Week 60)||200||
48484619|NCT01597245|101522670|FG011|STARTED|Maintenance Period (Week 12 to Week 60)||75||
48484620|NCT01597245|101522671|FG012|STARTED|Maintenance Period (Week 12 to Week 60)||49||
48484621|NCT01597245|101522672|FG013|STARTED|Maintenance Period (Week 12 to Week 60)||0||
48484622|NCT01597245|101522673|FG014|STARTED|Maintenance Period (Week 12 to Week 60)||0||
48484623|NCT01597245|101522674|FG015|STARTED|Maintenance Period (Week 12 to Week 60)||0||
48484624|NCT01597245|101522675|FG016|STARTED|Maintenance Period (Week 12 to Week 60)||0||
48484625|NCT01597245|101522676|FG017|STARTED|Maintenance Period (Week 12 to Week 60)||0||
48484626|NCT01597245|101522677|FG018|STARTED|Maintenance Period (Week 12 to Week 60)||0||
48484627|NCT01597245|101522678|FG019|STARTED|Maintenance Period (Week 12 to Week 60)||0||
48484628|NCT01597245|101522679|FG020|STARTED|Maintenance Period (Week 12 to Week 60)||0||
48484629|NCT01597245|101522659|FG000|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0||
48484630|NCT01597245|101522660|FG001|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0||
48484631|NCT01597245|101522661|FG002|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0||
48484632|NCT01597245|101522662|FG003|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0||
48484633|NCT01597245|101522663|FG004|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||176||
48484634|NCT01597245|101522664|FG005|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||187||
48484635|NCT01597245|101522665|FG006|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||181||
48484636|NCT01597245|101522666|FG007|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||3||
48484637|NCT01597245|101522667|FG008|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||155||
48484638|NCT01597245|101522668|FG009|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||132||
48484639|NCT01597245|101522669|FG010|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||200||
48484640|NCT01597245|101522670|FG011|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||75||
48484641|NCT01597245|101522671|FG012|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||49||
48484642|NCT01597245|101522672|FG013|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0||
48484643|NCT01597245|101522673|FG014|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0||
48484644|NCT01597245|101522674|FG015|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0||
48484645|NCT01597245|101522675|FG016|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0||
48484646|NCT01597245|101522676|FG017|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0||
48484647|NCT01597245|101522677|FG018|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0||
48484648|NCT01597245|101522678|FG019|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0||
48197105|NCT03784963|100806628|FG003|COMPLETED|Overall Study||0||
48484649|NCT01597245|101522679|FG020|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0||
48484650|NCT01597245|101522659|FG000|COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
48484651|NCT01597245|101522660|FG001|COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
48484652|NCT01597245|101522661|FG002|COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
48484653|NCT01597245|101522662|FG003|COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
48484654|NCT01597245|101522663|FG004|COMPLETED|Maintenance Period (Week 12 to Week 60)||15||
48484655|NCT01597245|101522664|FG005|COMPLETED|Maintenance Period (Week 12 to Week 60)||149||
48484656|NCT01597245|101522665|FG006|COMPLETED|Maintenance Period (Week 12 to Week 60)||92||
48484657|NCT01597245|101522666|FG007|COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
48484658|NCT01597245|101522667|FG008|COMPLETED|Maintenance Period (Week 12 to Week 60)||135||
48484659|NCT01597245|101522668|FG009|COMPLETED|Maintenance Period (Week 12 to Week 60)||11||
48484660|NCT01597245|101522669|FG010|COMPLETED|Maintenance Period (Week 12 to Week 60)||178||
48484661|NCT01597245|101522670|FG011|COMPLETED|Maintenance Period (Week 12 to Week 60)||56||
48484662|NCT01597245|101522671|FG012|COMPLETED|Maintenance Period (Week 12 to Week 60)||37||
48484663|NCT01597245|101522672|FG013|COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
48484664|NCT01597245|101522673|FG014|COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
48484665|NCT01597245|101522674|FG015|COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
48484666|NCT01597245|101522675|FG016|COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
48484667|NCT01597245|101522676|FG017|COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
48484668|NCT01597245|101522677|FG018|COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
48484669|NCT01597245|101522678|FG019|COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
48484670|NCT01597245|101522679|FG020|COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
48484671|NCT01597245|101522659|FG000|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
48484672|NCT01597245|101522660|FG001|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
48484673|NCT01597245|101522661|FG002|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
48484674|NCT01597245|101522662|FG003|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
48484675|NCT01597245|101522663|FG004|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||161||
48484676|NCT01597245|101522664|FG005|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||38||
48484677|NCT01597245|101522665|FG006|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||89||
48484678|NCT01597245|101522666|FG007|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||3||
48484679|NCT01597245|101522667|FG008|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||20||
48484680|NCT01597245|101522668|FG009|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||121||
48484681|NCT01597245|101522669|FG010|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||22||
48484682|NCT01597245|101522670|FG011|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||19||
48484683|NCT01597245|101522671|FG012|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||12||
48484684|NCT01597245|101522672|FG013|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
48484685|NCT01597245|101522673|FG014|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
48484686|NCT01597245|101522674|FG015|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
48484687|NCT01597245|101522675|FG016|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
48484688|NCT01597245|101522676|FG017|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
48484689|NCT01597245|101522677|FG018|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
48484690|NCT01597245|101522678|FG019|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
48484691|NCT01597245|101522679|FG020|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
48484692|NCT01597245|101522659|FG000|STARTED|Long Term Extension (Week 60 - Week 264)||0||
48484693|NCT01597245|101522660|FG001|STARTED|Long Term Extension (Week 60 - Week 264)||0||
48484694|NCT01597245|101522661|FG002|STARTED|Long Term Extension (Week 60 - Week 264)||0||
48484695|NCT01597245|101522662|FG003|STARTED|Long Term Extension (Week 60 - Week 264)||0||
48484696|NCT01597245|101522663|FG004|STARTED|Long Term Extension (Week 60 - Week 264)||0||
48484697|NCT01597245|101522664|FG005|STARTED|Long Term Extension (Week 60 - Week 264)||0||
48484698|NCT01597245|101522665|FG006|STARTED|Long Term Extension (Week 60 - Week 264)||0||
48484699|NCT01597245|101522666|FG007|STARTED|Long Term Extension (Week 60 - Week 264)||0||
48484700|NCT01597245|101522667|FG008|STARTED|Long Term Extension (Week 60 - Week 264)||0||
48484701|NCT01597245|101522668|FG009|STARTED|Long Term Extension (Week 60 - Week 264)||0||
48484702|NCT01597245|101522669|FG010|STARTED|Long Term Extension (Week 60 - Week 264)||0||
48484703|NCT01597245|101522670|FG011|STARTED|Long Term Extension (Week 60 - Week 264)||0||
48484704|NCT01597245|101522671|FG012|STARTED|Long Term Extension (Week 60 - Week 264)||0||
48484705|NCT01597245|101522672|FG013|STARTED|Long Term Extension (Week 60 - Week 264)||26||
48484706|NCT01597245|101522673|FG014|STARTED|Long Term Extension (Week 60 - Week 264)||979||
48484707|NCT01597245|101522674|FG015|STARTED|Long Term Extension (Week 60 - Week 264)||1002||
48484708|NCT01597245|101522675|FG016|STARTED|Long Term Extension (Week 60 - Week 264)||0||
48484709|NCT01597245|101522676|FG017|STARTED|Long Term Extension (Week 60 - Week 264)||0||
48484710|NCT01597245|101522677|FG018|STARTED|Long Term Extension (Week 60 - Week 264)||0||
48484711|NCT01597245|101522678|FG019|STARTED|Long Term Extension (Week 60 - Week 264)||0||
48484712|NCT01597245|101522679|FG020|STARTED|Long Term Extension (Week 60 - Week 264)||0||
48484713|NCT01597245|101522659|FG000|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484714|NCT01597245|101522660|FG001|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484715|NCT01597245|101522661|FG002|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48666459|NCT04110145|101967583|FG000|STARTED|Post-Treatment Period (1 Week)||7|Started=Participants who entered the Post-Treatment Period|
48484716|NCT01597245|101522662|FG003|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484717|NCT01597245|101522663|FG004|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484718|NCT01597245|101522664|FG005|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484719|NCT01597245|101522665|FG006|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484720|NCT01597245|101522666|FG007|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484721|NCT01597245|101522667|FG008|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484722|NCT01597245|101522668|FG009|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484723|NCT01597245|101522669|FG010|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484724|NCT01597245|101522670|FG011|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484725|NCT01597245|101522671|FG012|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484726|NCT01597245|101522672|FG013|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484727|NCT01597245|101522673|FG014|COMPLETED|Long Term Extension (Week 60 - Week 264)||754||
48484728|NCT01597245|101522674|FG015|COMPLETED|Long Term Extension (Week 60 - Week 264)||774||
48484729|NCT01597245|101522675|FG016|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484730|NCT01597245|101522676|FG017|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484731|NCT01597245|101522677|FG018|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484732|NCT01597245|101522678|FG019|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484733|NCT01597245|101522679|FG020|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484734|NCT01597245|101522659|FG000|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484735|NCT01597245|101522660|FG001|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484736|NCT01597245|101522661|FG002|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484737|NCT01597245|101522662|FG003|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484738|NCT01597245|101522663|FG004|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484739|NCT01597245|101522664|FG005|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484740|NCT01597245|101522665|FG006|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484741|NCT01597245|101522666|FG007|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484742|NCT01597245|101522667|FG008|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484743|NCT01597245|101522668|FG009|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484744|NCT01597245|101522669|FG010|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484745|NCT01597245|101522670|FG011|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484746|NCT01597245|101522671|FG012|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484747|NCT01597245|101522672|FG013|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||26||
48197106|NCT03784963|100806625|FG000|NOT COMPLETED|Overall Study||12||
48197107|NCT03784963|100806626|FG001|NOT COMPLETED|Overall Study||10||
48197108|NCT03784963|100806627|FG002|NOT COMPLETED|Overall Study||1||
48197109|NCT03784963|100806628|FG003|NOT COMPLETED|Overall Study||0||
48197110|NCT01939158|100806629|FG000|STARTED|Overall Study||203||
48197111|NCT01939158|100806630|FG001|STARTED|Overall Study||198||
48197112|NCT01939158|100806631|FG002|STARTED|Overall Study||201||
48197113|NCT01939158|100806632|FG003|STARTED|Overall Study||201||
48197114|NCT01939158|100806629|FG000|Vaccinated|Overall Study||203||
48197115|NCT01939158|100806630|FG001|Vaccinated|Overall Study||197||
48197116|NCT01939158|100806631|FG002|Vaccinated|Overall Study||201||
48197117|NCT01939158|100806632|FG003|Vaccinated|Overall Study||201||
48197118|NCT01939158|100806629|FG000|COMPLETED|Overall Study||156||
48197119|NCT01939158|100806630|FG001|COMPLETED|Overall Study||146||
48197120|NCT01939158|100806631|FG002|COMPLETED|Overall Study||160||
48197121|NCT01939158|100806632|FG003|COMPLETED|Overall Study||157||
48197122|NCT01939158|100806629|FG000|NOT COMPLETED|Overall Study||47||
48197123|NCT01939158|100806630|FG001|NOT COMPLETED|Overall Study||52||
48197124|NCT01939158|100806631|FG002|NOT COMPLETED|Overall Study||41||
48197125|NCT01939158|100806632|FG003|NOT COMPLETED|Overall Study||44||
48197126|NCT04565249|100806633|FG000|STARTED|Overall Study||5||
48197127|NCT04565249|100806634|FG001|STARTED|Overall Study||0||
48197128|NCT04565249|100806635|FG002|STARTED|Overall Study||0||
48197129|NCT04565249|100806636|FG003|STARTED|Overall Study||1||
48197130|NCT04565249|100806633|FG000|COMPLETED|Overall Study||5||
48197131|NCT04565249|100806634|FG001|COMPLETED|Overall Study||0||
48197132|NCT04565249|100806635|FG002|COMPLETED|Overall Study||0||
48197133|NCT04565249|100806636|FG003|COMPLETED|Overall Study||0||
48197134|NCT04565249|100806633|FG000|NOT COMPLETED|Overall Study||0||
48197135|NCT04565249|100806634|FG001|NOT COMPLETED|Overall Study||0||
48197136|NCT04565249|100806635|FG002|NOT COMPLETED|Overall Study||0||
48197137|NCT04565249|100806636|FG003|NOT COMPLETED|Overall Study||1||
48197138|NCT00996372|100806637|FG000|STARTED|Overall Study||468||
48197139|NCT00996372|100806638|FG001|STARTED|Overall Study||481||
48197140|NCT00996372|100806637|FG000|COMPLETED|Overall Study||365||
48197141|NCT00996372|100806638|FG001|COMPLETED|Overall Study||397||
48197142|NCT00996372|100806637|FG000|NOT COMPLETED|Overall Study||103||
48197143|NCT00996372|100806638|FG001|NOT COMPLETED|Overall Study||84||
48197144|NCT01582945|100806639|FG000|STARTED|Overall Study||14||
48197145|NCT01582945|100806639|FG000|COMPLETED|Overall Study||12||
48197146|NCT01582945|100806639|FG000|NOT COMPLETED|Overall Study||2||
48197147|NCT04495634|100806640|FG000|STARTED|Overall Study||17||
48197148|NCT04495634|100806640|FG000|COMPLETED|Overall Study||17||
48197149|NCT04495634|100806640|FG000|NOT COMPLETED|Overall Study||0||
48197150|NCT04520165|100806641|FG000|STARTED|Overall Study||52||
48197151|NCT04520165|100806641|FG000|COMPLETED|Overall Study||52||
48197152|NCT04520165|100806641|FG000|NOT COMPLETED|Overall Study||0||
48197153|NCT00545844|100806642|FG000|STARTED|Overall Study||313||
48197154|NCT00545844|100806642|FG000|COMPLETED|Overall Study||301||
48197155|NCT00545844|100806642|FG000|NOT COMPLETED|Overall Study||12||
48197156|NCT03557385|100806643|FG000|STARTED|aFFR||201||
48197157|NCT03557385|100806643|FG000|COMPLETED|aFFR||201||
48197158|NCT03557385|100806643|FG000|NOT COMPLETED|aFFR||0||
48197159|NCT03557385|100806643|FG000|STARTED|cFFR||201||
48197160|NCT03557385|100806643|FG000|COMPLETED|cFFR||201||
48197161|NCT03557385|100806643|FG000|NOT COMPLETED|cFFR||0||
48197162|NCT00530335|100806644|FG000|STARTED|Overall Study||45||
48197163|NCT00530335|100806644|FG000|COMPLETED|Overall Study||39||
48197164|NCT00530335|100806644|FG000|NOT COMPLETED|Overall Study||6||
48197165|NCT02680756|100806645|FG000|STARTED|Overall Study||125||
48197166|NCT02680756|100806646|FG001|STARTED|Overall Study||125||
48197167|NCT02680756|100806645|FG000|Received Treatment|Overall Study||127|3 pts randomised to IV were given FM instead in error. Some pts in each arm were not treated.|
48197168|NCT02680756|100806646|FG001|Received Treatment|Overall Study||120|3 pts randomised to IV were given FM instead in error. Some pts in each arm were not treated.|
48197169|NCT02680756|100806645|FG000|COMPLETED|Overall Study||93||
48197170|NCT02680756|100806646|FG001|COMPLETED|Overall Study||106||
48197171|NCT02680756|100806645|FG000|NOT COMPLETED|Overall Study||32||
48197172|NCT02680756|100806646|FG001|NOT COMPLETED|Overall Study||19||
48197173|NCT01249092|100806647|FG000|STARTED|Overall Study||20||
48197174|NCT01249092|100806647|FG000|COMPLETED|Overall Study||18||
48197175|NCT01249092|100806647|FG000|NOT COMPLETED|Overall Study||2||
48197176|NCT00657280|100806648|FG000|STARTED|Overall Study||16||
48197177|NCT00657280|100806648|FG000|COMPLETED|Overall Study||16||
48484748|NCT01597245|101522673|FG014|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||225||
48484749|NCT01597245|101522674|FG015|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||228||
48484750|NCT01597245|101522675|FG016|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484751|NCT01597245|101522676|FG017|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484752|NCT01597245|101522677|FG018|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484753|NCT01597245|101522678|FG019|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484754|NCT01597245|101522679|FG020|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
48484755|NCT01597245|101522659|FG000|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484756|NCT01597245|101522660|FG001|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484757|NCT01597245|101522661|FG002|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484758|NCT01597245|101522662|FG003|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484759|NCT01597245|101522663|FG004|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484760|NCT01597245|101522664|FG005|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484761|NCT01597245|101522665|FG006|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484762|NCT01597245|101522666|FG007|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484763|NCT01597245|101522667|FG008|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484764|NCT01597245|101522668|FG009|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484765|NCT01597245|101522669|FG010|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484766|NCT01597245|101522670|FG011|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484767|NCT01597245|101522671|FG012|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484768|NCT01597245|101522672|FG013|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484769|NCT01597245|101522673|FG014|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48197178|NCT00657280|100806648|FG000|NOT COMPLETED|Overall Study||0||
48197179|NCT01760291|100806649|FG000|STARTED|Overall Study||576||
48484770|NCT01597245|101522674|FG015|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48197180|NCT01760291|100806649|FG000|COMPLETED|Overall Study||340||
48197181|NCT01760291|100806649|FG000|NOT COMPLETED|Overall Study||236||
48197182|NCT01191788|100806650|FG000|STARTED|Overall Study||140||
48197183|NCT01191788|100806651|FG001|STARTED|Overall Study||159||
48197184|NCT01191788|100806650|FG000|COMPLETED|Overall Study||119||
48197185|NCT01191788|100806651|FG001|COMPLETED|Overall Study||137||
48484771|NCT01597245|101522675|FG016|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||16||
48197186|NCT01191788|100806650|FG000|NOT COMPLETED|Overall Study||21||
48197187|NCT01191788|100806651|FG001|NOT COMPLETED|Overall Study||22||
48197188|NCT01516892|100806652|FG000|STARTED|Overall Study||716||
48197189|NCT01516892|100806652|FG000|COMPLETED|Overall Study||373||
48197190|NCT01516892|100806652|FG000|NOT COMPLETED|Overall Study||343||
48197191|NCT00349908|100806653|FG000|STARTED|Overall Study||10||
48197192|NCT00349908|100806654|FG001|STARTED|Overall Study||10||
48197193|NCT00349908|100806653|FG000|COMPLETED|Overall Study||10||
48197194|NCT00349908|100806654|FG001|COMPLETED|Overall Study||6||
48197195|NCT00349908|100806653|FG000|NOT COMPLETED|Overall Study||0||
48197196|NCT00349908|100806654|FG001|NOT COMPLETED|Overall Study||4||
48197197|NCT02387749|100806655|FG000|STARTED|Overall Study||10||
48197198|NCT02387749|100806655|FG000|COMPLETED|Overall Study||10||
48197199|NCT02387749|100806655|FG000|NOT COMPLETED|Overall Study||0||
48197200|NCT02175212|100806656|FG000|STARTED|Overall Study||177||
48197201|NCT02175212|100806657|FG001|STARTED|Overall Study||178||
48484772|NCT01597245|101522676|FG017|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||6||
48484773|NCT01597245|101522677|FG018|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||24||
48484774|NCT01597245|101522678|FG019|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||656||
48197202|NCT02175212|100806656|FG000|COMPLETED|Overall Study||14||
48197203|NCT02175212|100806657|FG001|COMPLETED|Overall Study||31||
48197204|NCT02175212|100806656|FG000|NOT COMPLETED|Overall Study||163||
48197205|NCT02175212|100806657|FG001|NOT COMPLETED|Overall Study||147||
48197206|NCT01710514|100806658|FG000|STARTED|Overall Study||54||
48197207|NCT01710514|100806659|FG001|STARTED|Overall Study||54||
48197208|NCT01710514|100806658|FG000|Intent-To-Treat (ITT) Analysis Set|Overall Study||54||
48197209|NCT01710514|100806659|FG001|Intent-To-Treat (ITT) Analysis Set|Overall Study||54||
48197210|NCT01710514|100806658|FG000|Full Analysis Set (FAS)|Overall Study||46||
48197211|NCT01710514|100806659|FG001|Full Analysis Set (FAS)|Overall Study||48||
48197212|NCT01710514|100806658|FG000|FAS With Embryo Transfer (ET)|Overall Study||43||
48197213|NCT01710514|100806659|FG001|FAS With Embryo Transfer (ET)|Overall Study||47||
48197214|NCT01710514|100806658|FG000|Safety Analysis Set|Overall Study||54||
48197215|NCT01710514|100806659|FG001|Safety Analysis Set|Overall Study||54||
48197216|NCT01710514|100806658|FG000|COMPLETED|Overall Study||47||
48197217|NCT01710514|100806659|FG001|COMPLETED|Overall Study||47||
48197218|NCT01710514|100806658|FG000|NOT COMPLETED|Overall Study||7||
48484775|NCT01597245|101522679|FG020|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||248||
48197219|NCT01710514|100806659|FG001|NOT COMPLETED|Overall Study||7||
48197220|NCT02735915|100806660|FG000|STARTED|Overall Study||70|Started=Number of subjects enrolled into the study (Total enrolled cohort for persistence phase)|
48197221|NCT02735915|100806660|FG000|Vaccinated|Overall Study||62|Vaccinated=Number of subjects that started the Total Vaccinated Cohort (TVc) for revaccination phase|
48197222|NCT02735915|100806660|FG000|COMPLETED|Overall Study||59||
48197223|NCT02735915|100806660|FG000|NOT COMPLETED|Overall Study||11||
48197224|NCT00359619|100806661|FG000|STARTED|Overall Study||88||
48197225|NCT00359619|100806662|FG001|STARTED|Overall Study||50||
48197226|NCT00359619|100806663|FG002|STARTED|Overall Study||49||
48197227|NCT00359619|100806664|FG003|STARTED|Overall Study||48||
48197228|NCT00359619|100806665|FG004|STARTED|Overall Study||48||
48197229|NCT00359619|100806666|FG005|STARTED|Overall Study||50||
48197230|NCT00359619|100806667|FG006|STARTED|Overall Study||50||
48197231|NCT00359619|100806661|FG000|COMPLETED|Overall Study||80||
48197232|NCT00359619|100806662|FG001|COMPLETED|Overall Study||45||
48197233|NCT00359619|100806663|FG002|COMPLETED|Overall Study||42||
48197234|NCT00359619|100806664|FG003|COMPLETED|Overall Study||45||
48197235|NCT00359619|100806665|FG004|COMPLETED|Overall Study||45||
48197236|NCT00359619|100806666|FG005|COMPLETED|Overall Study||45||
48197237|NCT00359619|100806667|FG006|COMPLETED|Overall Study||46||
48197238|NCT00359619|100806661|FG000|NOT COMPLETED|Overall Study||8||
48197239|NCT00359619|100806662|FG001|NOT COMPLETED|Overall Study||5||
48197240|NCT00359619|100806663|FG002|NOT COMPLETED|Overall Study||7||
48197241|NCT00359619|100806664|FG003|NOT COMPLETED|Overall Study||3||
48197242|NCT00359619|100806665|FG004|NOT COMPLETED|Overall Study||3||
48197243|NCT00359619|100806666|FG005|NOT COMPLETED|Overall Study||5||
48197244|NCT00359619|100806667|FG006|NOT COMPLETED|Overall Study||4||
48197245|NCT03601507|100806668|FG000|STARTED|Overall Study||6||
48197246|NCT03601507|100806668|FG000|COMPLETED|Overall Study||5||
48197247|NCT03601507|100806668|FG000|NOT COMPLETED|Overall Study||1||
48197248|NCT03113487|100806669|FG000|STARTED|Overall Study||29||
48197249|NCT03113487|100806669|FG000|COMPLETED|Overall Study||28||
48197250|NCT03113487|100806669|FG000|NOT COMPLETED|Overall Study||1||
48197251|NCT04304534|100806670|FG000|STARTED|Overall Study||397|Full analysis set (FAS)|
48197252|NCT04304534|100806671|FG001|STARTED|Overall Study||401|Full analysis set (FAS)|
48197253|NCT04304534|100806672|FG002|STARTED|Overall Study||402|Full analysis set (FAS)|
48484776|NCT01597245|101522659|FG000|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484777|NCT01597245|101522660|FG001|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48197254|NCT04304534|100806673|FG003|STARTED|Overall Study||401|Full analysis set (FAS)|
48197255|NCT04304534|100806670|FG000|Treated|Overall Study||395|Safety analysis set (SAF)|
48197256|NCT04304534|100806671|FG001|Treated|Overall Study||397|Safety analysis set (SAF)|
48197257|NCT04304534|100806672|FG002|Treated|Overall Study||402|Safety analysis set (SAF)|
48197258|NCT04304534|100806673|FG003|Treated|Overall Study||399|Safety analysis set (SAF)|
48197259|NCT04304534|100806670|FG000|COMPLETED|Overall Study||303||
48197260|NCT04304534|100806671|FG001|COMPLETED|Overall Study||317||
48197261|NCT04304534|100806672|FG002|COMPLETED|Overall Study||309||
48197262|NCT04304534|100806673|FG003|COMPLETED|Overall Study||309||
48197263|NCT04304534|100806670|FG000|NOT COMPLETED|Overall Study||94||
48197264|NCT04304534|100806671|FG001|NOT COMPLETED|Overall Study||84||
48197265|NCT04304534|100806672|FG002|NOT COMPLETED|Overall Study||93||
48197266|NCT04304534|100806673|FG003|NOT COMPLETED|Overall Study||92||
48197267|NCT03189134|100806674|FG000|STARTED|Overall Study||6||
48197268|NCT03189134|100806674|FG000|COMPLETED|Overall Study||6||
48197269|NCT03189134|100806674|FG000|NOT COMPLETED|Overall Study||0||
48197270|NCT02451943|100806675|FG000|STARTED|Overall Study||258||
48197271|NCT02451943|100806676|FG001|STARTED|Overall Study||251||
48197272|NCT02451943|100806675|FG000|Received at Least One Dose of Study Drug|Overall Study||257||
48197273|NCT02451943|100806676|FG001|Received at Least One Dose of Study Drug|Overall Study||249||
48197274|NCT02451943|100806675|FG000|Leiomyosarcoma (LMS) Population|Overall Study||119||
48197275|NCT02451943|100806676|FG001|Leiomyosarcoma (LMS) Population|Overall Study||115||
48197276|NCT02451943|100806675|FG000|COMPLETED|Overall Study||238||
48197277|NCT02451943|100806676|FG001|COMPLETED|Overall Study||227||
48197278|NCT02451943|100806675|FG000|NOT COMPLETED|Overall Study||20||
48197279|NCT02451943|100806676|FG001|NOT COMPLETED|Overall Study||24||
48197280|NCT00771667|100806677|FG000|STARTED|Induction Phase||132||
48197281|NCT00771667|100806678|FG001|STARTED|Induction Phase||131||
48197282|NCT00771667|100806679|FG002|STARTED|Induction Phase||132||
48197283|NCT00771667|100806680|FG003|STARTED|Induction Phase||131||
48197284|NCT00771667|100806681|FG004|STARTED|Induction Phase||0||
48197285|NCT00771667|100806682|FG005|STARTED|Induction Phase||0||
48197286|NCT00771667|100806683|FG006|STARTED|Induction Phase||0||
48197287|NCT00771667|100806684|FG007|STARTED|Induction Phase||0||
48197288|NCT00771667|100806685|FG008|STARTED|Induction Phase||0||
48197289|NCT00771667|100806686|FG009|STARTED|Induction Phase||0||
48197290|NCT00771667|100806677|FG000|COMPLETED|Induction Phase||113||
48197291|NCT00771667|100806678|FG001|COMPLETED|Induction Phase||121||
48197292|NCT00771667|100806679|FG002|COMPLETED|Induction Phase||120||
48197293|NCT00771667|100806680|FG003|COMPLETED|Induction Phase||123||
48197294|NCT00771667|100806681|FG004|COMPLETED|Induction Phase||0||
48197295|NCT00771667|100806682|FG005|COMPLETED|Induction Phase||0||
48197296|NCT00771667|100806683|FG006|COMPLETED|Induction Phase||0||
48197297|NCT00771667|100806684|FG007|COMPLETED|Induction Phase||0||
48197298|NCT00771667|100806685|FG008|COMPLETED|Induction Phase||0||
48197299|NCT00771667|100806686|FG009|COMPLETED|Induction Phase||0||
48197300|NCT00771667|100806677|FG000|NOT COMPLETED|Induction Phase||19||
48197301|NCT00771667|100806678|FG001|NOT COMPLETED|Induction Phase||10||
48197302|NCT00771667|100806679|FG002|NOT COMPLETED|Induction Phase||12||
48197303|NCT00771667|100806680|FG003|NOT COMPLETED|Induction Phase||8||
48197304|NCT00771667|100806681|FG004|NOT COMPLETED|Induction Phase||0||
48197305|NCT00771667|100806682|FG005|NOT COMPLETED|Induction Phase||0||
48197306|NCT00771667|100806683|FG006|NOT COMPLETED|Induction Phase||0||
48197307|NCT00771667|100806684|FG007|NOT COMPLETED|Induction Phase||0||
48197308|NCT00771667|100806685|FG008|NOT COMPLETED|Induction Phase||0||
48197309|NCT00771667|100806686|FG009|NOT COMPLETED|Induction Phase||0||
48197310|NCT00771667|100806677|FG000|STARTED|Maintenance Phase||0||
48197311|NCT00771667|100806678|FG001|STARTED|Maintenance Phase||0||
48197312|NCT00771667|100806679|FG002|STARTED|Maintenance Phase||0||
48197313|NCT00771667|100806680|FG003|STARTED|Maintenance Phase||0||
48197314|NCT00771667|100806681|FG004|STARTED|Maintenance Phase||28||
48197315|NCT00771667|100806682|FG005|STARTED|Maintenance Phase||85||
48197316|NCT00771667|100806683|FG006|STARTED|Maintenance Phase||73||
48197317|NCT00771667|100806684|FG007|STARTED|Maintenance Phase||72||
48197318|NCT00771667|100806685|FG008|STARTED|Maintenance Phase||110||
48197319|NCT00771667|100806686|FG009|STARTED|Maintenance Phase||109||
48197320|NCT00771667|100806677|FG000|COMPLETED|Maintenance Phase||0||
48197321|NCT00771667|100806678|FG001|COMPLETED|Maintenance Phase||0||
48197322|NCT00771667|100806679|FG002|COMPLETED|Maintenance Phase||0||
48197323|NCT00771667|100806680|FG003|COMPLETED|Maintenance Phase||0||
48484778|NCT01597245|101522661|FG002|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484779|NCT01597245|101522662|FG003|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484780|NCT01597245|101522663|FG004|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484781|NCT01597245|101522664|FG005|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484782|NCT01597245|101522665|FG006|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484783|NCT01597245|101522666|FG007|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48197324|NCT00771667|100806681|FG004|COMPLETED|Maintenance Phase||26||
48484784|NCT01597245|101522667|FG008|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484785|NCT01597245|101522668|FG009|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48197325|NCT00771667|100806682|FG005|COMPLETED|Maintenance Phase||78||
48484786|NCT01597245|101522669|FG010|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484787|NCT01597245|101522670|FG011|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484788|NCT01597245|101522671|FG012|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484789|NCT01597245|101522672|FG013|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484790|NCT01597245|101522673|FG014|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484791|NCT01597245|101522674|FG015|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484792|NCT01597245|101522675|FG016|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484793|NCT01597245|101522676|FG017|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484794|NCT01597245|101522677|FG018|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||14||
48484795|NCT01597245|101522678|FG019|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||489||
48484796|NCT01597245|101522679|FG020|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||212||
48484797|NCT01597245|101522659|FG000|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484798|NCT01597245|101522660|FG001|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484799|NCT01597245|101522661|FG002|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484800|NCT01597245|101522662|FG003|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484801|NCT01597245|101522663|FG004|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484802|NCT01597245|101522664|FG005|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484803|NCT01597245|101522665|FG006|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484804|NCT01597245|101522666|FG007|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484805|NCT01597245|101522667|FG008|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484806|NCT01597245|101522668|FG009|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484807|NCT01597245|101522669|FG010|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484808|NCT01597245|101522670|FG011|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48197326|NCT00771667|100806683|FG006|COMPLETED|Maintenance Phase||63||
48484809|NCT01597245|101522671|FG012|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484810|NCT01597245|101522672|FG013|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484811|NCT01597245|101522673|FG014|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484812|NCT01597245|101522674|FG015|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
48484813|NCT01597245|101522675|FG016|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||16||
48484814|NCT01597245|101522676|FG017|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||6||
48484815|NCT01597245|101522677|FG018|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||10||
48484816|NCT01597245|101522678|FG019|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||167||
48484817|NCT01597245|101522679|FG020|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||36||
48484818|NCT01839279|101522680|FG000|STARTED|Overall Study||72||
48484819|NCT01839279|101522681|FG001|STARTED|Overall Study||32||
48484820|NCT01839279|101522682|FG002|STARTED|Overall Study||32||
48197327|NCT00771667|100806684|FG007|COMPLETED|Maintenance Phase||67||
48197328|NCT00771667|100806685|FG008|COMPLETED|Maintenance Phase||88||
48197329|NCT00771667|100806686|FG009|COMPLETED|Maintenance Phase||92||
48197330|NCT00771667|100806677|FG000|NOT COMPLETED|Maintenance Phase||0||
48484821|NCT01839279|101522680|FG000|QT/QTc Analysis Set|Overall Study||72||
48484822|NCT01839279|101522681|FG001|QT/QTc Analysis Set|Overall Study||32||
48484823|NCT01839279|101522682|FG002|QT/QTc Analysis Set|Overall Study||32||
48484824|NCT01839279|101522680|FG000|PK Analysis Set|Overall Study||70||
48484825|NCT01839279|101522681|FG001|PK Analysis Set|Overall Study||0||
48484826|NCT01839279|101522682|FG002|PK Analysis Set|Overall Study||0||
48484827|NCT01839279|101522680|FG000|Moxifloxacin/Placebo Analysis Set|Overall Study||0||
48484828|NCT01839279|101522681|FG001|Moxifloxacin/Placebo Analysis Set|Overall Study||31||
48484829|NCT01839279|101522682|FG002|Moxifloxacin/Placebo Analysis Set|Overall Study||30||
48484830|NCT01839279|101522680|FG000|PK/QTc Analysis Set|Overall Study||70||
48484831|NCT01839279|101522681|FG001|PK/QTc Analysis Set|Overall Study||0||
48484832|NCT01839279|101522682|FG002|PK/QTc Analysis Set|Overall Study||0||
48484833|NCT01839279|101522680|FG000|COMPLETED|Overall Study||59||
48484834|NCT01839279|101522681|FG001|COMPLETED|Overall Study||30||
48484835|NCT01839279|101522682|FG002|COMPLETED|Overall Study||30||
48484836|NCT01839279|101522680|FG000|NOT COMPLETED|Overall Study||13||
48484837|NCT01839279|101522681|FG001|NOT COMPLETED|Overall Study||2||
48484838|NCT01839279|101522682|FG002|NOT COMPLETED|Overall Study||2||
48484839|NCT01541891|101522683|FG000|STARTED|Overall Study||15||
48484840|NCT01541891|101522684|FG001|STARTED|Overall Study||15||
48484841|NCT01541891|101522683|FG000|COMPLETED|Overall Study||14||
48484842|NCT01541891|101522684|FG001|COMPLETED|Overall Study||14||
48484843|NCT01541891|101522683|FG000|NOT COMPLETED|Overall Study||1||
48484844|NCT01541891|101522684|FG001|NOT COMPLETED|Overall Study||1||
48484845|NCT05376319|101522685|FG000|STARTED|Overall Study||2||
48484846|NCT05376319|101522686|FG001|STARTED|Overall Study||4||
48484847|NCT05376319|101522685|FG000|COMPLETED|Overall Study||0||
48484848|NCT05376319|101522686|FG001|COMPLETED|Overall Study||0||
48484849|NCT05376319|101522685|FG000|NOT COMPLETED|Overall Study||2||
48484850|NCT05376319|101522686|FG001|NOT COMPLETED|Overall Study||4||
48484851|NCT00878878|101522687|FG000|STARTED|Overall Study||15||
48484852|NCT00878878|101522688|FG001|STARTED|Overall Study||15||
48484853|NCT00878878|101522687|FG000|COMPLETED|Overall Study||15||
48484854|NCT00878878|101522688|FG001|COMPLETED|Overall Study||15||
48484855|NCT00878878|101522687|FG000|NOT COMPLETED|Overall Study||0||
48484856|NCT00878878|101522688|FG001|NOT COMPLETED|Overall Study||0||
48484857|NCT03792477|101522689|FG000|STARTED|Overall Study||6||
48484858|NCT03792477|101522690|FG001|STARTED|Overall Study||6||
48484859|NCT03792477|101522691|FG002|STARTED|Overall Study||21||
48484860|NCT03792477|101522692|FG003|STARTED|Overall Study||21||
48484861|NCT03792477|101522693|FG004|STARTED|Overall Study||20||
48484862|NCT03792477|101522689|FG000|COMPLETED|Overall Study||6||
48484863|NCT03792477|101522690|FG001|COMPLETED|Overall Study||6||
48484864|NCT03792477|101522691|FG002|COMPLETED|Overall Study||19||
48484865|NCT03792477|101522692|FG003|COMPLETED|Overall Study||20||
48484866|NCT03792477|101522693|FG004|COMPLETED|Overall Study||19||
48484867|NCT03792477|101522689|FG000|NOT COMPLETED|Overall Study||0||
48484868|NCT03792477|101522690|FG001|NOT COMPLETED|Overall Study||0||
48484869|NCT03792477|101522691|FG002|NOT COMPLETED|Overall Study||2||
48484870|NCT03792477|101522692|FG003|NOT COMPLETED|Overall Study||1||
48484871|NCT03792477|101522693|FG004|NOT COMPLETED|Overall Study||1||
48484872|NCT02514122|101522694|FG000|STARTED|Overall Study||32||
48484873|NCT02514122|101522695|FG001|STARTED|Overall Study||29||
48484874|NCT02514122|101522694|FG000|COMPLETED|Overall Study||30||
48484875|NCT02514122|101522695|FG001|COMPLETED|Overall Study||29||
48484876|NCT02514122|101522694|FG000|NOT COMPLETED|Overall Study||2||
48484877|NCT02514122|101522695|FG001|NOT COMPLETED|Overall Study||0||
48484878|NCT03204539|101522696|FG000|STARTED|Overall Study||0||
48484879|NCT03204539|101522697|FG001|STARTED|Overall Study||1||
48484880|NCT03204539|101522696|FG000|COMPLETED|Overall Study||0||
48484881|NCT03204539|101522697|FG001|COMPLETED|Overall Study||0||
48484882|NCT03204539|101522696|FG000|NOT COMPLETED|Overall Study||0||
48484883|NCT03204539|101522697|FG001|NOT COMPLETED|Overall Study||1||
48484884|NCT03522675|101522698|FG000|STARTED|Overall Study||22||
48484885|NCT03522675|101522698|FG000|COMPLETED|Overall Study||20||
48484886|NCT03522675|101522698|FG000|NOT COMPLETED|Overall Study||2||
48484887|NCT03247972|101522699|FG000|STARTED|High Dose Statin Run-In Period (8 Weeks)||30||
48484888|NCT03247972|101522699|FG000|COMPLETED|High Dose Statin Run-In Period (8 Weeks)||26||
48484889|NCT03247972|101522699|FG000|NOT COMPLETED|High Dose Statin Run-In Period (8 Weeks)||4||
48484890|NCT03247972|101522699|FG000|STARTED|High Dose Statins + Evolocumab (8 Weeks)||26||
48484891|NCT03247972|101522699|FG000|COMPLETED|High Dose Statins + Evolocumab (8 Weeks)||24||
48484892|NCT03247972|101522699|FG000|NOT COMPLETED|High Dose Statins + Evolocumab (8 Weeks)||2||
48484893|NCT04239872|101522700|FG000|STARTED|Overall Study||11||
48484894|NCT04239872|101522701|FG001|STARTED|Overall Study||9||
48484895|NCT04239872|101522700|FG000|COMPLETED|Overall Study||11||
48484896|NCT04239872|101522701|FG001|COMPLETED|Overall Study||8||
48484897|NCT04239872|101522700|FG000|NOT COMPLETED|Overall Study||0||
48484898|NCT04239872|101522701|FG001|NOT COMPLETED|Overall Study||1||
48484899|NCT02314403|101522702|FG000|STARTED|Overall Study||2||
48484900|NCT02314403|101522702|FG000|COMPLETED|Overall Study||2||
48484901|NCT02314403|101522702|FG000|NOT COMPLETED|Overall Study||0||
48484902|NCT01675765|101522703|FG000|STARTED|Overall Study||38||
48484903|NCT01675765|101522704|FG001|STARTED|Overall Study||22||
48484904|NCT01675765|101522703|FG000|COMPLETED|Overall Study||27||
48484905|NCT01675765|101522704|FG001|COMPLETED|Overall Study||14||
48484906|NCT01675765|101522703|FG000|NOT COMPLETED|Overall Study||11||
48484907|NCT01675765|101522704|FG001|NOT COMPLETED|Overall Study||8||
48484908|NCT02178787|101522705|FG000|STARTED|Overall Study||35||
48484909|NCT02178787|101522706|FG001|STARTED|Overall Study||39||
48484910|NCT02178787|101522705|FG000|COMPLETED|Overall Study||30||
48484911|NCT02178787|101522706|FG001|COMPLETED|Overall Study||30||
48484912|NCT02178787|101522705|FG000|NOT COMPLETED|Overall Study||5||
48484913|NCT02178787|101522706|FG001|NOT COMPLETED|Overall Study||9||
48484914|NCT02519491|101522707|FG000|STARTED|Overall Study||219||
48484915|NCT02519491|101522708|FG001|STARTED|Overall Study||219||
48484916|NCT02519491|101522707|FG000|COMPLETED|Overall Study||219||
48484917|NCT02519491|101522708|FG001|COMPLETED|Overall Study||219||
48484918|NCT02519491|101522707|FG000|NOT COMPLETED|Overall Study||0||
48484919|NCT02519491|101522708|FG001|NOT COMPLETED|Overall Study||0||
48484920|NCT03373162|101522709|FG000|STARTED|Overall Study||10||
48484921|NCT03373162|101522709|FG000|COMPLETED|Overall Study||10||
48484922|NCT03373162|101522709|FG000|NOT COMPLETED|Overall Study||0||
48484923|NCT01963728|101522710|FG000|STARTED|Overall Study||0||
48484924|NCT01963728|101522711|FG001|STARTED|Overall Study||1||
48484925|NCT01963728|101522710|FG000|COMPLETED|Overall Study||0||
48484926|NCT01963728|101522711|FG001|COMPLETED|Overall Study||0||
48484927|NCT01963728|101522710|FG000|NOT COMPLETED|Overall Study||0||
48484928|NCT01963728|101522711|FG001|NOT COMPLETED|Overall Study||1||
48484929|NCT00207090|101522712|FG000|STARTED|Overall Study||15||
48484930|NCT00207090|101522712|FG000|COMPLETED|Overall Study||8||
48484931|NCT00207090|101522712|FG000|NOT COMPLETED|Overall Study||7||
48484932|NCT00834522|101522713|FG000|STARTED|First Intervention||40||
48484933|NCT00834522|101522714|FG001|STARTED|First Intervention||40||
48484934|NCT00834522|101522713|FG000|COMPLETED|First Intervention||40||
48484935|NCT00834522|101522714|FG001|COMPLETED|First Intervention||40||
48484936|NCT00834522|101522713|FG000|NOT COMPLETED|First Intervention||0||
48484937|NCT00834522|101522714|FG001|NOT COMPLETED|First Intervention||0||
48484938|NCT00834522|101522713|FG000|STARTED|Washout||40||
48484939|NCT00834522|101522714|FG001|STARTED|Washout||40||
48484940|NCT00834522|101522713|FG000|COMPLETED|Washout||37||
48484941|NCT00834522|101522714|FG001|COMPLETED|Washout||39||
48484942|NCT00834522|101522713|FG000|NOT COMPLETED|Washout||3||
48484943|NCT00834522|101522714|FG001|NOT COMPLETED|Washout||1||
48484944|NCT00834522|101522713|FG000|STARTED|Second Intervention||37||
48484945|NCT00834522|101522714|FG001|STARTED|Second Intervention||39||
48484946|NCT00834522|101522713|FG000|COMPLETED|Second Intervention||37||
48484947|NCT00834522|101522714|FG001|COMPLETED|Second Intervention||39||
48484948|NCT00834522|101522713|FG000|NOT COMPLETED|Second Intervention||0||
48484949|NCT00834522|101522714|FG001|NOT COMPLETED|Second Intervention||0||
48484950|NCT03235739|101522715|FG000|STARTED|Overall Study||69||
48484951|NCT03235739|101522716|FG001|STARTED|Overall Study||67||
48484952|NCT03235739|101522715|FG000|COMPLETED|Overall Study||67||
48484953|NCT03235739|101522716|FG001|COMPLETED|Overall Study||64||
48484954|NCT03235739|101522715|FG000|NOT COMPLETED|Overall Study||2||
48484955|NCT03235739|101522716|FG001|NOT COMPLETED|Overall Study||3||
48197331|NCT00771667|100806678|FG001|NOT COMPLETED|Maintenance Phase||0||
48197332|NCT00771667|100806679|FG002|NOT COMPLETED|Maintenance Phase||0||
48197333|NCT00771667|100806680|FG003|NOT COMPLETED|Maintenance Phase||0||
48197334|NCT00771667|100806681|FG004|NOT COMPLETED|Maintenance Phase||2||
48197335|NCT00771667|100806682|FG005|NOT COMPLETED|Maintenance Phase||7||
48197336|NCT00771667|100806683|FG006|NOT COMPLETED|Maintenance Phase||10||
48197337|NCT00771667|100806684|FG007|NOT COMPLETED|Maintenance Phase||5||
48484956|NCT03021018|101522717|FG000|STARTED|Overall Study||16||
48484957|NCT03021018|101522718|FG001|STARTED|Overall Study||15||
48197338|NCT00771667|100806685|FG008|NOT COMPLETED|Maintenance Phase||22||
48197339|NCT00771667|100806686|FG009|NOT COMPLETED|Maintenance Phase||17||
48197340|NCT00608907|100806687|FG000|STARTED|Overall Study||30||
48197341|NCT00608907|100806688|FG001|STARTED|Overall Study||13||
48197342|NCT00608907|100806689|FG002|STARTED|Overall Study||18||
48197343|NCT00608907|100806687|FG000|COMPLETED|Overall Study||18||
48197344|NCT00608907|100806688|FG001|COMPLETED|Overall Study||13||
48197345|NCT00608907|100806689|FG002|COMPLETED|Overall Study||17||
48197346|NCT00608907|100806687|FG000|NOT COMPLETED|Overall Study||12||
48197347|NCT00608907|100806688|FG001|NOT COMPLETED|Overall Study||0||
48197348|NCT00608907|100806689|FG002|NOT COMPLETED|Overall Study||1||
48197349|NCT00816829|100806690|FG000|STARTED|Overall Study||16||
48197350|NCT00816829|100806691|FG001|STARTED|Overall Study||18||
48197351|NCT00816829|100806690|FG000|COMPLETED|Overall Study||16||
48197352|NCT00816829|100806691|FG001|COMPLETED|Overall Study||18||
48197353|NCT00816829|100806690|FG000|NOT COMPLETED|Overall Study||0||
48197354|NCT00816829|100806691|FG001|NOT COMPLETED|Overall Study||0||
48197355|NCT01649791|100806692|FG000|STARTED|Overall Study||8||
48197356|NCT01649791|100806692|FG000|COMPLETED|Overall Study||5||
48197357|NCT01649791|100806692|FG000|NOT COMPLETED|Overall Study||3||
48197358|NCT02689349|100806693|FG000|STARTED|Overall Study||59||
48197359|NCT02689349|100806694|FG001|STARTED|Overall Study||58||
48197360|NCT02689349|100806693|FG000|COMPLETED|Overall Study||46||
48197361|NCT02689349|100806694|FG001|COMPLETED|Overall Study||58||
48197362|NCT02689349|100806693|FG000|NOT COMPLETED|Overall Study||13||
48197363|NCT02689349|100806694|FG001|NOT COMPLETED|Overall Study||0||
48197364|NCT01664104|100806695|FG000|STARTED|Overall Study||136||
48197365|NCT01664104|100806695|FG000|COMPLETED|Overall Study||120||
48197366|NCT01664104|100806695|FG000|NOT COMPLETED|Overall Study||16||
48197367|NCT02013037|100806696|FG000|STARTED|Overall Study||36||
48197368|NCT02013037|100806696|FG000|COMPLETED|Overall Study||20||
48197369|NCT02013037|100806696|FG000|NOT COMPLETED|Overall Study||16||
48197370|NCT02908464|100806697|FG000|STARTED|Overall Study||22||
48197371|NCT02908464|100806698|FG001|STARTED|Overall Study||23||
48197372|NCT02908464|100806697|FG000|COMPLETED|Overall Study||20||
48197373|NCT02908464|100806698|FG001|COMPLETED|Overall Study||20||
48197374|NCT02908464|100806697|FG000|NOT COMPLETED|Overall Study||2||
48197375|NCT02908464|100806698|FG001|NOT COMPLETED|Overall Study||3||
48197376|NCT00093795|100806699|FG000|STARTED|Overall Study||1630||
48197377|NCT00093795|100806700|FG001|STARTED|Overall Study||1634||
48197378|NCT00093795|100806701|FG002|STARTED|Overall Study||1630||
48197379|NCT00093795|100806699|FG000|COMPLETED|Overall Study||1610||
48197380|NCT00093795|100806700|FG001|COMPLETED|Overall Study||1618||
48197381|NCT00093795|100806701|FG002|COMPLETED|Overall Study||1613||
48197382|NCT00093795|100806699|FG000|NOT COMPLETED|Overall Study||20||
48197383|NCT00093795|100806700|FG001|NOT COMPLETED|Overall Study||16||
48197384|NCT00093795|100806701|FG002|NOT COMPLETED|Overall Study||17||
48197385|NCT00669461|100806702|FG000|STARTED|Overall Study||1||
48197386|NCT00669461|100806702|FG000|COMPLETED|Overall Study||1||
48197387|NCT00669461|100806702|FG000|NOT COMPLETED|Overall Study||0||
48484958|NCT03021018|101522719|FG002|STARTED|Overall Study||15||
48484959|NCT03021018|101522717|FG000|COMPLETED|Overall Study||14||
48484960|NCT03021018|101522718|FG001|COMPLETED|Overall Study||15||
48484961|NCT03021018|101522719|FG002|COMPLETED|Overall Study||15||
48484962|NCT03021018|101522717|FG000|NOT COMPLETED|Overall Study||2||
48484963|NCT03021018|101522718|FG001|NOT COMPLETED|Overall Study||0||
48484964|NCT03021018|101522719|FG002|NOT COMPLETED|Overall Study||0||
48484965|NCT04134091|101522720|FG000|STARTED|Overall Study||18||
48484966|NCT04134091|101522721|FG001|STARTED|Overall Study||19||
48484967|NCT04134091|101522722|FG002|STARTED|Overall Study||19||
48484968|NCT04134091|101522720|FG000|Completed Week 12|Overall Study||18||
48484969|NCT04134091|101522721|FG001|Completed Week 12|Overall Study||19||
48484970|NCT04134091|101522722|FG002|Completed Week 12|Overall Study||18||
48197388|NCT01769391|100806703|FG000|STARTED|Overall Study||110||
48197389|NCT01769391|100806704|FG001|STARTED|Overall Study||57||
48197390|NCT01769391|100806703|FG000|Received at Least One Dose of Study Drug|Overall Study||106||
48197391|NCT01769391|100806704|FG001|Received at Least One Dose of Study Drug|Overall Study||55||
48197392|NCT01769391|100806703|FG000|COMPLETED|Overall Study||93||
48197393|NCT01769391|100806704|FG001|COMPLETED|Overall Study||48||
48197394|NCT01769391|100806703|FG000|NOT COMPLETED|Overall Study||17||
48484971|NCT04134091|101522720|FG000|COMPLETED|Overall Study||18||
48484972|NCT04134091|101522721|FG001|COMPLETED|Overall Study||17||
48484973|NCT04134091|101522722|FG002|COMPLETED|Overall Study||17||
48484974|NCT04134091|101522720|FG000|NOT COMPLETED|Overall Study||0||
48197395|NCT01769391|100806704|FG001|NOT COMPLETED|Overall Study||9||
48197396|NCT03608670|100806705|FG000|STARTED|Overall Study||26||
48197397|NCT03608670|100806705|FG000|Implant Attempted|Overall Study||21||
48197398|NCT03608670|100806705|FG000|Successfully Implanted|Overall Study||17||
48197399|NCT03608670|100806705|FG000|2-week Follow-up|Overall Study||17||
48197400|NCT03608670|100806705|FG000|4-6 Weeks Follow-up|Overall Study||17||
48197401|NCT03608670|100806705|FG000|COMPLETED|Overall Study||16|Completed 3 Months follow-up for primary safety objective.|
48197402|NCT03608670|100806705|FG000|NOT COMPLETED|Overall Study||10||
48197403|NCT02903836|100806706|FG000|STARTED|Overall Study||74||
48197404|NCT02903836|100806707|FG001|STARTED|Overall Study||73||
48197405|NCT02903836|100806708|FG002|STARTED|Overall Study||77||
48197406|NCT02903836|100806706|FG000|COMPLETED|Overall Study||71||
48197407|NCT02903836|100806707|FG001|COMPLETED|Overall Study||69||
48197408|NCT02903836|100806708|FG002|COMPLETED|Overall Study||73||
48197409|NCT02903836|100806706|FG000|NOT COMPLETED|Overall Study||3||
48197410|NCT02903836|100806707|FG001|NOT COMPLETED|Overall Study||4||
48197411|NCT02903836|100806708|FG002|NOT COMPLETED|Overall Study||4||
48197412|NCT03523962|100806709|FG000|STARTED|Closed Fractures||2748||12
48197413|NCT03523962|100806710|FG001|STARTED|Closed Fractures||4037||11
48197414|NCT03523962|100806711|FG002|STARTED|Closed Fractures||0||0
48197415|NCT03523962|100806712|FG003|STARTED|Closed Fractures||0||0
48197416|NCT03523962|100806709|FG000|Iodine Povacrylex|Closed Fractures||1405||12
48197417|NCT03523962|100806710|FG001|Iodine Povacrylex|Closed Fractures||1955||11
48197418|NCT03523962|100806711|FG002|Iodine Povacrylex|Closed Fractures||0||0
48197419|NCT03523962|100806712|FG003|Iodine Povacrylex|Closed Fractures||0||0
48197420|NCT03523962|100806709|FG000|Chlorhexidine Gluconate|Closed Fractures||1343||12
48197421|NCT03523962|100806710|FG001|Chlorhexidine Gluconate|Closed Fractures||2082||11
48197422|NCT03523962|100806711|FG002|Chlorhexidine Gluconate|Closed Fractures||0||0
48197423|NCT03523962|100806712|FG003|Chlorhexidine Gluconate|Closed Fractures||0||0
48197424|NCT03523962|100806709|FG000|COMPLETED|Closed Fractures||2580||12
48197425|NCT03523962|100806710|FG001|COMPLETED|Closed Fractures||3897||11
48197426|NCT03523962|100806711|FG002|COMPLETED|Closed Fractures||0||0
48197427|NCT03523962|100806712|FG003|COMPLETED|Closed Fractures||0||0
48197428|NCT03523962|100806709|FG000|NOT COMPLETED|Closed Fractures||168||0
48197429|NCT03523962|100806710|FG001|NOT COMPLETED|Closed Fractures||140||0
48197430|NCT03523962|100806711|FG002|NOT COMPLETED|Closed Fractures||0||0
48197431|NCT03523962|100806712|FG003|NOT COMPLETED|Closed Fractures||0||0
48197432|NCT03523962|100806709|FG000|STARTED|Open Fractures||0||0
48197433|NCT03523962|100806710|FG001|STARTED|Open Fractures||0||0
48484975|NCT04134091|101522721|FG001|NOT COMPLETED|Overall Study||2||
48484976|NCT04134091|101522722|FG002|NOT COMPLETED|Overall Study||2||
48484977|NCT03393208|101522723|FG000|STARTED|Treatment Period 1 (Day 1-Day 3)||13||
48197434|NCT03523962|100806711|FG002|STARTED|Open Fractures||987||11
48197435|NCT03523962|100806712|FG003|STARTED|Open Fractures||713||11
48197436|NCT03523962|100806709|FG000|Iodine Povacrylex|Open Fractures||0||0
48197437|NCT03523962|100806710|FG001|Iodine Povacrylex|Open Fractures||0||0
48197438|NCT03523962|100806711|FG002|Iodine Povacrylex|Open Fractures||503||11
48197439|NCT03523962|100806712|FG003|Iodine Povacrylex|Open Fractures||351||11
48197440|NCT03523962|100806709|FG000|Chlorhexidine Gluconate|Open Fractures||0||0
48197441|NCT03523962|100806710|FG001|Chlorhexidine Gluconate|Open Fractures||0||0
48197442|NCT03523962|100806711|FG002|Chlorhexidine Gluconate|Open Fractures||484||11
48197443|NCT03523962|100806712|FG003|Chlorhexidine Gluconate|Open Fractures||362||11
48197444|NCT03523962|100806709|FG000|COMPLETED|Open Fractures||0||0
48197445|NCT03523962|100806710|FG001|COMPLETED|Open Fractures||0||0
48197446|NCT03523962|100806711|FG002|COMPLETED|Open Fractures||954||11
48197447|NCT03523962|100806712|FG003|COMPLETED|Open Fractures||697||11
48197448|NCT03523962|100806709|FG000|NOT COMPLETED|Open Fractures||0||0
48197449|NCT03523962|100806710|FG001|NOT COMPLETED|Open Fractures||0||0
48197450|NCT03523962|100806711|FG002|NOT COMPLETED|Open Fractures||33||0
48197451|NCT03523962|100806712|FG003|NOT COMPLETED|Open Fractures||16||0
48197452|NCT00290706|100806713|FG000|STARTED|Overall Study||5||
48197453|NCT00290706|100806714|FG001|STARTED|Overall Study||6||
48484978|NCT03393208|101522724|FG001|STARTED|Treatment Period 1 (Day 1-Day 3)||13||
48484979|NCT03393208|101522725|FG002|STARTED|Treatment Period 1 (Day 1-Day 3)||9||
48197454|NCT00290706|100806715|FG002|STARTED|Overall Study||7||
48197455|NCT00290706|100806716|FG003|STARTED|Overall Study||14||
48197456|NCT00290706|100806713|FG000|Attempted1st Cycle|Overall Study||5|DLT period in phase I (Cohort 1 and Cohort 2) =20 days post Cycle 1|
48197457|NCT00290706|100806714|FG001|Attempted1st Cycle|Overall Study||6|DLT period in phase I (Cohort 1 and Cohort 2) =20 days post Cycle 1|
48197458|NCT00290706|100806715|FG002|Attempted1st Cycle|Overall Study||7|DLT period in phase I (Cohort 1 and Cohort 2) =20 days post Cycle 1|
48197459|NCT00290706|100806716|FG003|Attempted1st Cycle|Overall Study||14|DLT period in phase I (Cohort 1 and Cohort 2) =20 days post Cycle 1|
48197460|NCT00290706|100806713|FG000|Reached 1st Response/Cycle 3|Overall Study||0||
48197461|NCT00290706|100806714|FG001|Reached 1st Response/Cycle 3|Overall Study||0||
48197462|NCT00290706|100806715|FG002|Reached 1st Response/Cycle 3|Overall Study||1||
48197463|NCT00290706|100806716|FG003|Reached 1st Response/Cycle 3|Overall Study||2||
48197464|NCT00290706|100806713|FG000|COMPLETED|Overall Study||0||
48197465|NCT00290706|100806714|FG001|COMPLETED|Overall Study||0||
48197466|NCT00290706|100806715|FG002|COMPLETED|Overall Study||1||
48197467|NCT00290706|100806716|FG003|COMPLETED|Overall Study||2||
48197468|NCT00290706|100806713|FG000|NOT COMPLETED|Overall Study||5||
48197469|NCT00290706|100806714|FG001|NOT COMPLETED|Overall Study||6||
48197470|NCT00290706|100806715|FG002|NOT COMPLETED|Overall Study||6||
48197471|NCT00290706|100806716|FG003|NOT COMPLETED|Overall Study||12||
48197472|NCT01695317|100806717|FG000|STARTED|Period 1 in the Cross-over Design||36||
48197473|NCT01695317|100806718|FG001|STARTED|Period 1 in the Cross-over Design||36||
48197474|NCT01695317|100806717|FG000|COMPLETED|Period 1 in the Cross-over Design||34||
48197475|NCT01695317|100806718|FG001|COMPLETED|Period 1 in the Cross-over Design||35||
48197476|NCT01695317|100806717|FG000|NOT COMPLETED|Period 1 in the Cross-over Design||2||
48197477|NCT01695317|100806718|FG001|NOT COMPLETED|Period 1 in the Cross-over Design||1||
48197478|NCT01695317|100806717|FG000|STARTED|Cross-over to Period 2||34||
48197479|NCT01695317|100806718|FG001|STARTED|Cross-over to Period 2||35||
48197480|NCT01695317|100806717|FG000|COMPLETED|Cross-over to Period 2||30||
48197481|NCT01695317|100806718|FG001|COMPLETED|Cross-over to Period 2||1||
48197482|NCT01695317|100806717|FG000|NOT COMPLETED|Cross-over to Period 2||4||
48197483|NCT01695317|100806718|FG001|NOT COMPLETED|Cross-over to Period 2||34||
48197484|NCT05737550|100806719|FG000|STARTED|Overall Study||24||
48197485|NCT05737550|100806719|FG000|Visit 2 (Follow-up Visit 1)|Overall Study||11|Optional visit|
48197486|NCT05737550|100806719|FG000|Visit 3 (Follow-up Visit 2)|Overall Study||5|Optional visit|
48197487|NCT05737550|100806719|FG000|COMPLETED|Overall Study||24||
48197488|NCT05737550|100806719|FG000|NOT COMPLETED|Overall Study||0||
48197489|NCT03058783|100806720|FG000|STARTED|Overall Study||216||
48197490|NCT03058783|100806721|FG001|STARTED|Overall Study||110||
48197491|NCT03058783|100806720|FG000|COMPLETED|Overall Study||180||
48197492|NCT03058783|100806721|FG001|COMPLETED|Overall Study||80||
48197493|NCT03058783|100806720|FG000|NOT COMPLETED|Overall Study||36||
48197494|NCT03058783|100806721|FG001|NOT COMPLETED|Overall Study||30||
48197495|NCT03237936|100806722|FG000|STARTED|Overall Study||17||
48197496|NCT03237936|100806722|FG000|COMPLETED|Overall Study||16||
48197497|NCT03237936|100806722|FG000|NOT COMPLETED|Overall Study||1||
48197498|NCT01912495|100806723|FG000|STARTED|Overall Study||57||
48197499|NCT01912495|100806723|FG000|COMPLETED|Overall Study||57||
48197500|NCT01912495|100806723|FG000|NOT COMPLETED|Overall Study||0||
48197501|NCT02750709|100806724|FG000|STARTED|Treatment Period 1||4||
48197502|NCT02750709|100806725|FG001|STARTED|Treatment Period 1||4||
48197503|NCT02750709|100806726|FG002|STARTED|Treatment Period 1||4||
48197504|NCT02750709|100806727|FG003|STARTED|Treatment Period 1||4||
48197505|NCT02750709|100806728|FG004|STARTED|Treatment Period 1||4||
48197506|NCT02750709|100806729|FG005|STARTED|Treatment Period 1||4||
48197507|NCT02750709|100806724|FG000|COMPLETED|Treatment Period 1||4||
48197508|NCT02750709|100806725|FG001|COMPLETED|Treatment Period 1||4||
48197509|NCT02750709|100806726|FG002|COMPLETED|Treatment Period 1||4||
48484980|NCT03393208|101522726|FG003|STARTED|Treatment Period 1 (Day 1-Day 3)||9||
48197510|NCT02750709|100806727|FG003|COMPLETED|Treatment Period 1||4||
48197511|NCT02750709|100806728|FG004|COMPLETED|Treatment Period 1||4||
48197512|NCT02750709|100806729|FG005|COMPLETED|Treatment Period 1||3||
48197513|NCT02750709|100806724|FG000|NOT COMPLETED|Treatment Period 1||0||
48197514|NCT02750709|100806725|FG001|NOT COMPLETED|Treatment Period 1||0||
48197515|NCT02750709|100806726|FG002|NOT COMPLETED|Treatment Period 1||0||
48197516|NCT02750709|100806727|FG003|NOT COMPLETED|Treatment Period 1||0||
48197517|NCT02750709|100806728|FG004|NOT COMPLETED|Treatment Period 1||0||
48197518|NCT02750709|100806729|FG005|NOT COMPLETED|Treatment Period 1||1||
48197519|NCT02750709|100806724|FG000|STARTED|Treatment Period 2||4||
48484981|NCT03393208|101522723|FG000|COMPLETED|Treatment Period 1 (Day 1-Day 3)||13||
48484982|NCT03393208|101522724|FG001|COMPLETED|Treatment Period 1 (Day 1-Day 3)||13||
48197520|NCT02750709|100806725|FG001|STARTED|Treatment Period 2||4||
48197521|NCT02750709|100806726|FG002|STARTED|Treatment Period 2||4||
48197522|NCT02750709|100806727|FG003|STARTED|Treatment Period 2||4||
48197523|NCT02750709|100806728|FG004|STARTED|Treatment Period 2||4||
48197524|NCT02750709|100806729|FG005|STARTED|Treatment Period 2||3||
48197525|NCT02750709|100806724|FG000|COMPLETED|Treatment Period 2||4||
48197526|NCT02750709|100806725|FG001|COMPLETED|Treatment Period 2||4||
48197527|NCT02750709|100806726|FG002|COMPLETED|Treatment Period 2||4||
48197528|NCT02750709|100806727|FG003|COMPLETED|Treatment Period 2||4||
48197529|NCT02750709|100806728|FG004|COMPLETED|Treatment Period 2||4||
48197530|NCT02750709|100806729|FG005|COMPLETED|Treatment Period 2||3||
48197531|NCT02750709|100806724|FG000|NOT COMPLETED|Treatment Period 2||0||
48197532|NCT02750709|100806725|FG001|NOT COMPLETED|Treatment Period 2||0||
48197533|NCT02750709|100806726|FG002|NOT COMPLETED|Treatment Period 2||0||
48197534|NCT02750709|100806727|FG003|NOT COMPLETED|Treatment Period 2||0||
48197535|NCT02750709|100806728|FG004|NOT COMPLETED|Treatment Period 2||0||
48197536|NCT02750709|100806729|FG005|NOT COMPLETED|Treatment Period 2||0||
48197537|NCT02750709|100806724|FG000|STARTED|Treatment Period 3||4||
48197538|NCT02750709|100806725|FG001|STARTED|Treatment Period 3||4||
48197539|NCT02750709|100806726|FG002|STARTED|Treatment Period 3||4||
48197540|NCT02750709|100806727|FG003|STARTED|Treatment Period 3||4||
48197541|NCT02750709|100806728|FG004|STARTED|Treatment Period 3||4||
48197542|NCT02750709|100806729|FG005|STARTED|Treatment Period 3||3||
48197543|NCT02750709|100806724|FG000|COMPLETED|Treatment Period 3||4||
48197544|NCT02750709|100806725|FG001|COMPLETED|Treatment Period 3||4||
48197545|NCT02750709|100806726|FG002|COMPLETED|Treatment Period 3||4||
48197546|NCT02750709|100806727|FG003|COMPLETED|Treatment Period 3||4||
48197547|NCT02750709|100806728|FG004|COMPLETED|Treatment Period 3||4||
48197548|NCT02750709|100806729|FG005|COMPLETED|Treatment Period 3||3||
48197549|NCT02750709|100806724|FG000|NOT COMPLETED|Treatment Period 3||0||
48197550|NCT02750709|100806725|FG001|NOT COMPLETED|Treatment Period 3||0||
48197551|NCT02750709|100806726|FG002|NOT COMPLETED|Treatment Period 3||0||
48197552|NCT02750709|100806727|FG003|NOT COMPLETED|Treatment Period 3||0||
48197553|NCT02750709|100806728|FG004|NOT COMPLETED|Treatment Period 3||0||
48197554|NCT02750709|100806729|FG005|NOT COMPLETED|Treatment Period 3||0||
48197555|NCT04663802|100806730|FG000|STARTED|Step 1: 2/22/2021 to 5/16/2021||85||1
48197556|NCT04663802|100806731|FG001|STARTED|Step 1: 2/22/2021 to 5/16/2021||91||1
48197557|NCT04663802|100806732|FG002|STARTED|Step 1: 2/22/2021 to 5/16/2021||30||1
48197558|NCT04663802|100806733|FG003|STARTED|Step 1: 2/22/2021 to 5/16/2021||28||1
48197559|NCT04663802|100806734|FG004|STARTED|Step 1: 2/22/2021 to 5/16/2021||73||1
48197560|NCT04663802|100806735|FG005|STARTED|Step 1: 2/22/2021 to 5/16/2021||53||1
48197561|NCT04663802|100806736|FG006|STARTED|Step 1: 2/22/2021 to 5/16/2021||104||1
48197562|NCT04663802|100806737|FG007|STARTED|Step 1: 2/22/2021 to 5/16/2021||66||1
48197563|NCT04663802|100806738|FG008|STARTED|Step 1: 2/22/2021 to 5/16/2021||141||1
48197564|NCT04663802|100806739|FG009|STARTED|Step 1: 2/22/2021 to 5/16/2021||55||1
48197565|NCT04663802|100806740|FG010|STARTED|Step 1: 2/22/2021 to 5/16/2021||58||1
48197566|NCT04663802|100806741|FG011|STARTED|Step 1: 2/22/2021 to 5/16/2021||40||1
48197567|NCT04663802|100806730|FG000|COMPLETED|Step 1: 2/22/2021 to 5/16/2021||85||1
48197568|NCT04663802|100806731|FG001|COMPLETED|Step 1: 2/22/2021 to 5/16/2021||91||1
48197569|NCT04663802|100806732|FG002|COMPLETED|Step 1: 2/22/2021 to 5/16/2021||30||1
48197570|NCT04663802|100806733|FG003|COMPLETED|Step 1: 2/22/2021 to 5/16/2021||28||1
48197571|NCT04663802|100806734|FG004|COMPLETED|Step 1: 2/22/2021 to 5/16/2021||73||1
48197572|NCT04663802|100806735|FG005|COMPLETED|Step 1: 2/22/2021 to 5/16/2021||53||1
48197573|NCT04663802|100806736|FG006|COMPLETED|Step 1: 2/22/2021 to 5/16/2021||104||1
48197574|NCT04663802|100806737|FG007|COMPLETED|Step 1: 2/22/2021 to 5/16/2021||66||1
48197575|NCT04663802|100806738|FG008|COMPLETED|Step 1: 2/22/2021 to 5/16/2021||141||1
48197576|NCT04663802|100806739|FG009|COMPLETED|Step 1: 2/22/2021 to 5/16/2021||55||1
48197577|NCT04663802|100806740|FG010|COMPLETED|Step 1: 2/22/2021 to 5/16/2021||58||1
48197578|NCT04663802|100806741|FG011|COMPLETED|Step 1: 2/22/2021 to 5/16/2021||40||1
48197579|NCT04663802|100806730|FG000|NOT COMPLETED|Step 1: 2/22/2021 to 5/16/2021||0||0
48197580|NCT04663802|100806731|FG001|NOT COMPLETED|Step 1: 2/22/2021 to 5/16/2021||0||0
48197581|NCT04663802|100806732|FG002|NOT COMPLETED|Step 1: 2/22/2021 to 5/16/2021||0||0
48197582|NCT04663802|100806733|FG003|NOT COMPLETED|Step 1: 2/22/2021 to 5/16/2021||0||0
48197583|NCT04663802|100806734|FG004|NOT COMPLETED|Step 1: 2/22/2021 to 5/16/2021||0||0
48197584|NCT04663802|100806735|FG005|NOT COMPLETED|Step 1: 2/22/2021 to 5/16/2021||0||0
48197585|NCT04663802|100806736|FG006|NOT COMPLETED|Step 1: 2/22/2021 to 5/16/2021||0||0
48197586|NCT04663802|100806737|FG007|NOT COMPLETED|Step 1: 2/22/2021 to 5/16/2021||0||0
48197587|NCT04663802|100806738|FG008|NOT COMPLETED|Step 1: 2/22/2021 to 5/16/2021||0||0
48197588|NCT04663802|100806739|FG009|NOT COMPLETED|Step 1: 2/22/2021 to 5/16/2021||0||0
48197589|NCT04663802|100806740|FG010|NOT COMPLETED|Step 1: 2/22/2021 to 5/16/2021||0||0
48197590|NCT04663802|100806741|FG011|NOT COMPLETED|Step 1: 2/22/2021 to 5/16/2021||0||0
48197591|NCT04663802|100806730|FG000|STARTED|Step 2: 5/17/2021 to 8/15/2021||64||1
48484983|NCT03393208|101522725|FG002|COMPLETED|Treatment Period 1 (Day 1-Day 3)||9||
48484984|NCT03393208|101522726|FG003|COMPLETED|Treatment Period 1 (Day 1-Day 3)||9||
48484985|NCT03393208|101522723|FG000|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0||
48484986|NCT03393208|101522724|FG001|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0||
48484987|NCT03393208|101522725|FG002|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0||
48484988|NCT03393208|101522726|FG003|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0||
48484989|NCT03393208|101522723|FG000|STARTED|Treatment Period 2 (Day 8- Day 10)||13||
48484990|NCT03393208|101522724|FG001|STARTED|Treatment Period 2 (Day 8- Day 10)||13||
48484991|NCT03393208|101522725|FG002|STARTED|Treatment Period 2 (Day 8- Day 10)||9||
48484992|NCT03393208|101522726|FG003|STARTED|Treatment Period 2 (Day 8- Day 10)||9||
48484993|NCT03393208|101522723|FG000|COMPLETED|Treatment Period 2 (Day 8- Day 10)||13||
48484994|NCT03393208|101522724|FG001|COMPLETED|Treatment Period 2 (Day 8- Day 10)||13||
48484995|NCT03393208|101522725|FG002|COMPLETED|Treatment Period 2 (Day 8- Day 10)||9||
48484996|NCT03393208|101522726|FG003|COMPLETED|Treatment Period 2 (Day 8- Day 10)||9||
48484997|NCT03393208|101522723|FG000|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0||
48484998|NCT03393208|101522724|FG001|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0||
48484999|NCT03393208|101522725|FG002|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0||
48485000|NCT03393208|101522726|FG003|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0||
48197592|NCT04663802|100806731|FG001|STARTED|Step 2: 5/17/2021 to 8/15/2021||99||1
48197593|NCT04663802|100806732|FG002|STARTED|Step 2: 5/17/2021 to 8/15/2021||39||1
48485001|NCT01175018|101522727|FG000|STARTED|Overall Study||15||
48197594|NCT04663802|100806733|FG003|STARTED|Step 2: 5/17/2021 to 8/15/2021||24||1
48485002|NCT01175018|101522728|FG001|STARTED|Overall Study||15||
48485003|NCT01175018|101522727|FG000|COMPLETED|Overall Study||12||
48485004|NCT01175018|101522728|FG001|COMPLETED|Overall Study||14||
48485005|NCT01175018|101522727|FG000|NOT COMPLETED|Overall Study||3||
48485006|NCT01175018|101522728|FG001|NOT COMPLETED|Overall Study||1||
48485007|NCT01237054|101522729|FG000|STARTED|Overall Study||31||
48485008|NCT01237054|101522729|FG000|COMPLETED|Overall Study||30||
48485009|NCT01237054|101522729|FG000|NOT COMPLETED|Overall Study||1||
48485010|NCT02124122|101522730|FG000|STARTED|Overall Study||41||
48485011|NCT02124122|101522731|FG001|STARTED|Overall Study||19||
48485012|NCT02124122|101522730|FG000|COMPLETED|Overall Study||41||
48485013|NCT02124122|101522731|FG001|COMPLETED|Overall Study||19||
48485014|NCT02124122|101522730|FG000|NOT COMPLETED|Overall Study||0||
48485015|NCT02124122|101522731|FG001|NOT COMPLETED|Overall Study||0||
48485016|NCT00073307|101522732|FG000|STARTED|Double-Blind (DB, as of ~31May2005)||451||
48485017|NCT00073307|101522733|FG001|STARTED|Double-Blind (DB, as of ~31May2005)||452||
48485018|NCT00073307|101522734|FG002|STARTED|Double-Blind (DB, as of ~31May2005)||0||
48485019|NCT00073307|101522732|FG000|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451||
48485020|NCT00073307|101522733|FG001|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451||
48485021|NCT00073307|101522734|FG002|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||0||
48485022|NCT00073307|101522732|FG000|COMPLETED|Double-Blind (DB, as of ~31May2005)||254||
48485023|NCT00073307|101522733|FG001|COMPLETED|Double-Blind (DB, as of ~31May2005)||299||
48485024|NCT00073307|101522734|FG002|COMPLETED|Double-Blind (DB, as of ~31May2005)||0||
48485025|NCT00073307|101522732|FG000|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||197||
48485026|NCT00073307|101522733|FG001|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||153||
48485027|NCT00073307|101522734|FG002|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||0||
48485028|NCT00073307|101522732|FG000|STARTED|Open Label-Sorafenib Only [30Jun2008]||254||
48485029|NCT00073307|101522733|FG001|STARTED|Open Label-Sorafenib Only [30Jun2008]||0||
48485030|NCT00073307|101522734|FG002|STARTED|Open Label-Sorafenib Only [30Jun2008]||299||
48485031|NCT00073307|101522732|FG000|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||219||
48485032|NCT00073307|101522733|FG001|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||0||
48485033|NCT00073307|101522734|FG002|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||216||
48485034|NCT00073307|101522732|FG000|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||120||
48485035|NCT00073307|101522733|FG001|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0||
48485036|NCT00073307|101522734|FG002|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||143||
48485037|NCT00073307|101522732|FG000|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||134||
48485038|NCT00073307|101522733|FG001|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0||
48485039|NCT00073307|101522734|FG002|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||156||
48485040|NCT04107675|101522735|FG000|STARTED|Overall Study||2||
48485041|NCT04107675|101522736|FG001|STARTED|Overall Study||2||
48485042|NCT04107675|101522737|FG002|STARTED|Overall Study||2||
48485043|NCT04107675|101522735|FG000|COMPLETED|Overall Study||2||
48485044|NCT04107675|101522736|FG001|COMPLETED|Overall Study||2||
48485045|NCT04107675|101522737|FG002|COMPLETED|Overall Study||2||
48485046|NCT04107675|101522735|FG000|NOT COMPLETED|Overall Study||0||
48485047|NCT04107675|101522736|FG001|NOT COMPLETED|Overall Study||0||
48485048|NCT04107675|101522737|FG002|NOT COMPLETED|Overall Study||0||
48485049|NCT02352259|101522738|FG000|STARTED|Overall Study||23||
48485050|NCT02352259|101522738|FG000|COMPLETED|Overall Study||23||
48485051|NCT02352259|101522738|FG000|NOT COMPLETED|Overall Study||0||
48485052|NCT04263649|101522739|FG000|STARTED|Overall Study||450|"A total of 451 patients signed the ICF. As 1 patient was a screening failure, the study device was attempted to be placed in 450 patients (safety set). The study device could not be placed in 2 patients and in 1 patient the study device was placed but could not be used for the intended treatment.~Hence, 447 patients received treatment via the study device (evaluable set)."|
48666460|NCT04110145|101967584|FG001|STARTED|Post-Treatment Period (1 Week)||7|Started=Participants who entered the Post-Treatment Period|
48485053|NCT04263649|101522739|FG000|Receive Treatment Via the Study Device|Overall Study||447||
48485054|NCT04263649|101522739|FG000|COMPLETED|Overall Study||335|In the end of eCRF study form, 335 patients were documented as having completed the therapy via study device (device either removed because therapy was completed, changed, or cancelled or still in place at 180 days) and 115 patients were documented as non-completed.|
48485055|NCT04263649|101522739|FG000|NOT COMPLETED|Overall Study||115||
48485056|NCT04405765|101522740|FG000|STARTED|Overall Study||22||
48485057|NCT04405765|101522741|FG001|STARTED|Overall Study||20||
48485058|NCT04405765|101522740|FG000|COMPLETED|Overall Study||21||
48485059|NCT04405765|101522741|FG001|COMPLETED|Overall Study||19||
48485060|NCT04405765|101522740|FG000|NOT COMPLETED|Overall Study||1||
48485061|NCT04405765|101522741|FG001|NOT COMPLETED|Overall Study||1||
48485062|NCT01900691|101522742|FG000|STARTED|Overall Study||130||
48485063|NCT01900691|101522742|FG000|COMPLETED|Overall Study||111||
48485064|NCT01900691|101522742|FG000|NOT COMPLETED|Overall Study||19||
48485065|NCT01702987|101522743|FG000|STARTED|Overall Study||10||
48485066|NCT01702987|101522744|FG001|STARTED|Overall Study||12||
48485067|NCT01702987|101522743|FG000|COMPLETED|Overall Study||9||
48485068|NCT01702987|101522744|FG001|COMPLETED|Overall Study||12||
48485069|NCT01702987|101522743|FG000|NOT COMPLETED|Overall Study||1||
48485070|NCT01702987|101522744|FG001|NOT COMPLETED|Overall Study||0||
48485071|NCT01473953|101522745|FG000|STARTED|Overall Study||6||
48485072|NCT01473953|101522746|FG001|STARTED|Overall Study||6||
48485073|NCT01473953|101522747|FG002|STARTED|Overall Study||6||
48485074|NCT01473953|101522748|FG003|STARTED|Overall Study||5||
48485075|NCT01473953|101522749|FG004|STARTED|Overall Study||8||
48485076|NCT01473953|101522745|FG000|COMPLETED|Overall Study||5||
48485077|NCT01473953|101522746|FG001|COMPLETED|Overall Study||6||
48485078|NCT01473953|101522747|FG002|COMPLETED|Overall Study||6||
48485079|NCT01473953|101522748|FG003|COMPLETED|Overall Study||5||
48485080|NCT01473953|101522749|FG004|COMPLETED|Overall Study||8||
48485081|NCT01473953|101522745|FG000|NOT COMPLETED|Overall Study||1||
48485082|NCT01473953|101522746|FG001|NOT COMPLETED|Overall Study||0||
48485083|NCT01473953|101522747|FG002|NOT COMPLETED|Overall Study||0||
48485084|NCT01473953|101522748|FG003|NOT COMPLETED|Overall Study||0||
48485085|NCT01473953|101522749|FG004|NOT COMPLETED|Overall Study||0||
48485086|NCT02286739|101522750|FG000|STARTED|Overall Study||170||
48485087|NCT02286739|101522751|FG001|STARTED|Overall Study||162||
48485088|NCT02286739|101522750|FG000|COMPLETED|Overall Study||46||
48485089|NCT02286739|101522751|FG001|COMPLETED|Overall Study||9||
48485090|NCT02286739|101522750|FG000|NOT COMPLETED|Overall Study||124||
48485091|NCT02286739|101522751|FG001|NOT COMPLETED|Overall Study||153||
48485092|NCT01458561|101522752|FG000|STARTED|Overall Study||0||
48485093|NCT01458561|101522753|FG001|STARTED|Overall Study||1||
48485094|NCT01458561|101522752|FG000|COMPLETED|Overall Study||0||
48197595|NCT04663802|100806734|FG004|STARTED|Step 2: 5/17/2021 to 8/15/2021||64||1
48485095|NCT01458561|101522753|FG001|COMPLETED|Overall Study||1||
48485096|NCT01458561|101522752|FG000|NOT COMPLETED|Overall Study||0||
48485097|NCT01458561|101522753|FG001|NOT COMPLETED|Overall Study||0||
48485098|NCT00163657|101522754|FG000|STARTED|Overall Study||80||
48485099|NCT00163657|101522755|FG001|STARTED|Overall Study||79||
48485100|NCT00163657|101522756|FG002|STARTED|Overall Study||153||
48485101|NCT00163657|101522754|FG000|COMPLETED|Overall Study||60||
48485102|NCT00163657|101522755|FG001|COMPLETED|Overall Study||56||
48485103|NCT00163657|101522756|FG002|COMPLETED|Overall Study||116||
48485104|NCT00163657|101522754|FG000|NOT COMPLETED|Overall Study||20||
48485105|NCT00163657|101522755|FG001|NOT COMPLETED|Overall Study||23||
48485106|NCT00163657|101522756|FG002|NOT COMPLETED|Overall Study||37||
48485107|NCT02152163|101522757|FG000|STARTED|Overall Study||51||
48485108|NCT02152163|101522758|FG001|STARTED|Overall Study||48||
48485109|NCT02152163|101522757|FG000|COMPLETED|Overall Study||39||
48485110|NCT02152163|101522758|FG001|COMPLETED|Overall Study||35||
48485111|NCT02152163|101522757|FG000|NOT COMPLETED|Overall Study||12||
48485112|NCT02152163|101522758|FG001|NOT COMPLETED|Overall Study||13||
48485113|NCT01863030|101522759|FG000|STARTED|Baseline||31||
48485114|NCT01863030|101522759|FG000|COMPLETED|Baseline||31||
48485115|NCT01863030|101522759|FG000|NOT COMPLETED|Baseline||0||
48485116|NCT01863030|101522759|FG000|STARTED|Follow up||31||
48485117|NCT01863030|101522759|FG000|2 Weeks|Follow up||31||
48485118|NCT01863030|101522759|FG000|3 Months|Follow up||28||
48485119|NCT01863030|101522759|FG000|6 Months|Follow up||29||
48485120|NCT01863030|101522759|FG000|12 Months|Follow up||26||
48485121|NCT01863030|101522759|FG000|24 Months|Follow up||13||
48485122|NCT01863030|101522759|FG000|COMPLETED|Follow up||13||
48485123|NCT01863030|101522759|FG000|NOT COMPLETED|Follow up||18||
48485124|NCT03112863|101522760|FG000|STARTED|Overall Study||21||
48485125|NCT03112863|101522761|FG001|STARTED|Overall Study||23||
48485126|NCT03112863|101522760|FG000|COMPLETED|Overall Study||21||
48485127|NCT03112863|101522761|FG001|COMPLETED|Overall Study||23||
48485128|NCT03112863|101522760|FG000|NOT COMPLETED|Overall Study||0||
48485129|NCT03112863|101522761|FG001|NOT COMPLETED|Overall Study||0||
48485130|NCT02996591|101525324|FG000|STARTED|Overall Study||18||
48485131|NCT02996591|101525325|FG001|STARTED|Overall Study||18||
48485132|NCT02996591|101525324|FG000|COMPLETED|Overall Study||18||
48485133|NCT02996591|101525325|FG001|COMPLETED|Overall Study||18||
48485134|NCT02996591|101525324|FG000|NOT COMPLETED|Overall Study||0||
48485135|NCT02996591|101525325|FG001|NOT COMPLETED|Overall Study||0||
48485136|NCT01783561|101525326|FG000|STARTED|Overall Study||11||
48485137|NCT01783561|101525327|FG001|STARTED|Overall Study||10||
48485138|NCT01783561|101525326|FG000|COMPLETED|Overall Study||11||
48485139|NCT01783561|101525327|FG001|COMPLETED|Overall Study||10||
48485140|NCT01783561|101525326|FG000|NOT COMPLETED|Overall Study||0||
48485141|NCT01783561|101525327|FG001|NOT COMPLETED|Overall Study||0||
48485142|NCT01415232|101525328|FG000|STARTED|Overall Study||160||
48485143|NCT01415232|101525328|FG000|COMPLETED|Overall Study||160||
48485144|NCT01415232|101525328|FG000|NOT COMPLETED|Overall Study||0||
48485145|NCT00905346|101525329|FG000|STARTED|Period 1||12||
48485146|NCT00905346|101525330|FG001|STARTED|Period 1||12||
48485147|NCT00905346|101525329|FG000|COMPLETED|Period 1||11||
48485148|NCT00905346|101525330|FG001|COMPLETED|Period 1||12||
48485149|NCT00905346|101525329|FG000|NOT COMPLETED|Period 1||1||
48485150|NCT00905346|101525330|FG001|NOT COMPLETED|Period 1||0||
48485151|NCT00905346|101525329|FG000|STARTED|Period 2||10||
48485152|NCT00905346|101525330|FG001|STARTED|Period 2||11||
48485153|NCT00905346|101525329|FG000|COMPLETED|Period 2||10||
48485154|NCT00905346|101525330|FG001|COMPLETED|Period 2||11||
48485155|NCT00905346|101525329|FG000|NOT COMPLETED|Period 2||0||
48485156|NCT00905346|101525330|FG001|NOT COMPLETED|Period 2||0||
48485157|NCT00858845|101525331|FG000|STARTED|Overall Study||5||
48485158|NCT00858845|101525332|FG001|STARTED|Overall Study||6||
48485159|NCT00858845|101525331|FG000|COMPLETED|Overall Study||5||
48485160|NCT00858845|101525332|FG001|COMPLETED|Overall Study||5||
48485161|NCT00858845|101525331|FG000|NOT COMPLETED|Overall Study||0||
48485162|NCT00858845|101525332|FG001|NOT COMPLETED|Overall Study||1||
48485163|NCT00834340|101525333|FG000|STARTED|First Intervention||16||
48485164|NCT00834340|101525334|FG001|STARTED|First Intervention||16||
48485165|NCT00834340|101525333|FG000|COMPLETED|First Intervention||16||
48485166|NCT00834340|101525334|FG001|COMPLETED|First Intervention||16||
48485167|NCT00834340|101525333|FG000|NOT COMPLETED|First Intervention||0||
48485168|NCT00834340|101525334|FG001|NOT COMPLETED|First Intervention||0||
48485169|NCT00834340|101525333|FG000|STARTED|Washout||16||
48485170|NCT00834340|101525334|FG001|STARTED|Washout||16||
48485171|NCT00834340|101525333|FG000|COMPLETED|Washout||14||
48485172|NCT00834340|101525334|FG001|COMPLETED|Washout||16||
48485173|NCT00834340|101525333|FG000|NOT COMPLETED|Washout||2||
48485174|NCT00834340|101525334|FG001|NOT COMPLETED|Washout||0||
48485175|NCT00834340|101525333|FG000|STARTED|Second Intervention||14||
48485176|NCT00834340|101525334|FG001|STARTED|Second Intervention||16||
48485177|NCT00834340|101525333|FG000|COMPLETED|Second Intervention||14||
48485178|NCT00834340|101525334|FG001|COMPLETED|Second Intervention||16||
48485179|NCT00834340|101525333|FG000|NOT COMPLETED|Second Intervention||0||
48197596|NCT04663802|100806735|FG005|STARTED|Step 2: 5/17/2021 to 8/15/2021||40||1
48197597|NCT04663802|100806736|FG006|STARTED|Step 2: 5/17/2021 to 8/15/2021||95||1
48197598|NCT04663802|100806737|FG007|STARTED|Step 2: 5/17/2021 to 8/15/2021||61||1
48197599|NCT04663802|100806738|FG008|STARTED|Step 2: 5/17/2021 to 8/15/2021||132||1
48197600|NCT04663802|100806739|FG009|STARTED|Step 2: 5/17/2021 to 8/15/2021||46||1
48197601|NCT04663802|100806740|FG010|STARTED|Step 2: 5/17/2021 to 8/15/2021||62||1
48197602|NCT04663802|100806741|FG011|STARTED|Step 2: 5/17/2021 to 8/15/2021||40||1
48197603|NCT04663802|100806730|FG000|COMPLETED|Step 2: 5/17/2021 to 8/15/2021||64||1
48197604|NCT04663802|100806731|FG001|COMPLETED|Step 2: 5/17/2021 to 8/15/2021||99||1
48197605|NCT04663802|100806732|FG002|COMPLETED|Step 2: 5/17/2021 to 8/15/2021||39||1
48197606|NCT04663802|100806733|FG003|COMPLETED|Step 2: 5/17/2021 to 8/15/2021||24||1
48485180|NCT00834340|101525334|FG001|NOT COMPLETED|Second Intervention||0||
48485181|NCT02431494|101525335|FG000|STARTED|Overall Study||0||
48485182|NCT02431494|101525336|FG001|STARTED|Overall Study||0||
48485183|NCT02431494|101525337|FG002|STARTED|Overall Study||0||
48485184|NCT02431494|101525335|FG000|COMPLETED|Overall Study||0||
48485185|NCT02431494|101525336|FG001|COMPLETED|Overall Study||0||
48197607|NCT04663802|100806734|FG004|COMPLETED|Step 2: 5/17/2021 to 8/15/2021||64||1
48197608|NCT04663802|100806735|FG005|COMPLETED|Step 2: 5/17/2021 to 8/15/2021||40||1
48197609|NCT04663802|100806736|FG006|COMPLETED|Step 2: 5/17/2021 to 8/15/2021||95||1
48197610|NCT04663802|100806737|FG007|COMPLETED|Step 2: 5/17/2021 to 8/15/2021||61||1
48197611|NCT04663802|100806738|FG008|COMPLETED|Step 2: 5/17/2021 to 8/15/2021||132||1
48197612|NCT04663802|100806739|FG009|COMPLETED|Step 2: 5/17/2021 to 8/15/2021||46||1
48197613|NCT04663802|100806740|FG010|COMPLETED|Step 2: 5/17/2021 to 8/15/2021||62||1
48485186|NCT02431494|101525337|FG002|COMPLETED|Overall Study||0||
48197614|NCT04663802|100806741|FG011|COMPLETED|Step 2: 5/17/2021 to 8/15/2021||40||1
48197615|NCT04663802|100806730|FG000|NOT COMPLETED|Step 2: 5/17/2021 to 8/15/2021||0||0
48197616|NCT04663802|100806731|FG001|NOT COMPLETED|Step 2: 5/17/2021 to 8/15/2021||0||0
48197617|NCT04663802|100806732|FG002|NOT COMPLETED|Step 2: 5/17/2021 to 8/15/2021||0||0
48197618|NCT04663802|100806733|FG003|NOT COMPLETED|Step 2: 5/17/2021 to 8/15/2021||0||0
48197619|NCT04663802|100806734|FG004|NOT COMPLETED|Step 2: 5/17/2021 to 8/15/2021||0||0
48197620|NCT04663802|100806735|FG005|NOT COMPLETED|Step 2: 5/17/2021 to 8/15/2021||0||0
48197621|NCT04663802|100806736|FG006|NOT COMPLETED|Step 2: 5/17/2021 to 8/15/2021||0||0
48197622|NCT04663802|100806737|FG007|NOT COMPLETED|Step 2: 5/17/2021 to 8/15/2021||0||0
48485187|NCT02431494|101525335|FG000|NOT COMPLETED|Overall Study||0||
48485188|NCT02431494|101525336|FG001|NOT COMPLETED|Overall Study||0||
48485189|NCT02431494|101525337|FG002|NOT COMPLETED|Overall Study||0||
48485190|NCT03165994|101525338|FG000|STARTED|Overall Study||33||
48485191|NCT03165994|101525338|FG000|COMPLETED|Overall Study||13||
48485192|NCT03165994|101525338|FG000|NOT COMPLETED|Overall Study||20||
48485193|NCT01757392|101525339|FG000|STARTED|Overall Study||39|Number of participants who were screened|
48485194|NCT01757392|101525339|FG000|COMPLETED|Overall Study||35|Number of participants who received at least one wart injection|
48485195|NCT01757392|101525339|FG000|NOT COMPLETED|Overall Study||4||
48485196|NCT04129346|101525340|FG000|STARTED|Overall Study||25||
48485197|NCT04129346|101525341|FG001|STARTED|Overall Study||24||
48485198|NCT04129346|101525340|FG000|COMPLETED|Overall Study||24||
48485199|NCT04129346|101525341|FG001|COMPLETED|Overall Study||24||
48485200|NCT04129346|101525340|FG000|NOT COMPLETED|Overall Study||1||
48485201|NCT04129346|101525341|FG001|NOT COMPLETED|Overall Study||0||
48485202|NCT00834756|101525342|FG000|STARTED|First Intervention||18||
48485203|NCT00834756|101525343|FG001|STARTED|First Intervention||18||
48485204|NCT00834756|101525342|FG000|COMPLETED|First Intervention||17||
48485205|NCT00834756|101525343|FG001|COMPLETED|First Intervention||18||
48485206|NCT00834756|101525342|FG000|NOT COMPLETED|First Intervention||1||
48485207|NCT00834756|101525343|FG001|NOT COMPLETED|First Intervention||0||
48485208|NCT00834756|101525342|FG000|STARTED|Washout: 21 Days||17||
48485209|NCT00834756|101525343|FG001|STARTED|Washout: 21 Days||18||
48485210|NCT00834756|101525342|FG000|COMPLETED|Washout: 21 Days||16||
48485211|NCT00834756|101525343|FG001|COMPLETED|Washout: 21 Days||18||
48485212|NCT00834756|101525342|FG000|NOT COMPLETED|Washout: 21 Days||1||
48485213|NCT00834756|101525343|FG001|NOT COMPLETED|Washout: 21 Days||0||
48485214|NCT00834756|101525342|FG000|STARTED|Second Intervention||16||
48485215|NCT00834756|101525343|FG001|STARTED|Second Intervention||18||
48485216|NCT00834756|101525342|FG000|COMPLETED|Second Intervention||16||
48485217|NCT00834756|101525343|FG001|COMPLETED|Second Intervention||18||
48485218|NCT00834756|101525342|FG000|NOT COMPLETED|Second Intervention||0||
48485219|NCT00834756|101525343|FG001|NOT COMPLETED|Second Intervention||0||
48485220|NCT00252720|101525344|FG000|STARTED|Overall Study||951||
48485221|NCT00252720|101525345|FG001|STARTED|Overall Study||954||
48485222|NCT00252720|101525344|FG000|COMPLETED|Overall Study||819||
48485223|NCT00252720|101525345|FG001|COMPLETED|Overall Study||789||
48485224|NCT00252720|101525344|FG000|NOT COMPLETED|Overall Study||132||
48485225|NCT00252720|101525345|FG001|NOT COMPLETED|Overall Study||165||
48485226|NCT03331289|101525346|FG000|STARTED|Overall Study||30||
48485227|NCT03331289|101525347|FG001|STARTED|Overall Study||23||
48485228|NCT03331289|101525348|FG002|STARTED|Overall Study||28||
48485229|NCT03331289|101525349|FG003|STARTED|Overall Study||26||
48485230|NCT03331289|101525346|FG000|COMPLETED|Overall Study||25||
48485231|NCT03331289|101525347|FG001|COMPLETED|Overall Study||15||
48485232|NCT03331289|101525348|FG002|COMPLETED|Overall Study||25||
48485233|NCT03331289|101525349|FG003|COMPLETED|Overall Study||25||
48485234|NCT03331289|101525346|FG000|NOT COMPLETED|Overall Study||5||
48485235|NCT03331289|101525347|FG001|NOT COMPLETED|Overall Study||8||
48485236|NCT03331289|101525348|FG002|NOT COMPLETED|Overall Study||3||
48485237|NCT03331289|101525349|FG003|NOT COMPLETED|Overall Study||1||
48485238|NCT02106156|101525350|FG000|STARTED|Overall Study||9620||
48485239|NCT02106156|101525351|FG001|STARTED|Overall Study||90||
48197623|NCT04663802|100806738|FG008|NOT COMPLETED|Step 2: 5/17/2021 to 8/15/2021||0||0
48197624|NCT04663802|100806739|FG009|NOT COMPLETED|Step 2: 5/17/2021 to 8/15/2021||0||0
48485240|NCT02106156|101525352|FG002|STARTED|Overall Study||518||
48485241|NCT02106156|101525350|FG000|COMPLETED|Overall Study||7071||
48485242|NCT02106156|101525351|FG001|COMPLETED|Overall Study||50||
48485243|NCT02106156|101525352|FG002|COMPLETED|Overall Study||518||
48197625|NCT04663802|100806740|FG010|NOT COMPLETED|Step 2: 5/17/2021 to 8/15/2021||0||0
48197626|NCT04663802|100806741|FG011|NOT COMPLETED|Step 2: 5/17/2021 to 8/15/2021||0||0
48197627|NCT04663802|100806730|FG000|STARTED|Step 3: 8/16/2021 to 11/14/2021||88||1
48197628|NCT04663802|100806731|FG001|STARTED|Step 3: 8/16/2021 to 11/14/2021||76||1
48197629|NCT04663802|100806732|FG002|STARTED|Step 3: 8/16/2021 to 11/14/2021||38||1
48197630|NCT04663802|100806733|FG003|STARTED|Step 3: 8/16/2021 to 11/14/2021||21||1
48197631|NCT04663802|100806734|FG004|STARTED|Step 3: 8/16/2021 to 11/14/2021||67||1
48197632|NCT04663802|100806735|FG005|STARTED|Step 3: 8/16/2021 to 11/14/2021||38||1
48197633|NCT04663802|100806736|FG006|STARTED|Step 3: 8/16/2021 to 11/14/2021||91||1
48197634|NCT04663802|100806737|FG007|STARTED|Step 3: 8/16/2021 to 11/14/2021||66||1
48197635|NCT04663802|100806738|FG008|STARTED|Step 3: 8/16/2021 to 11/14/2021||124||1
48197636|NCT04663802|100806739|FG009|STARTED|Step 3: 8/16/2021 to 11/14/2021||52||1
48197637|NCT04663802|100806740|FG010|STARTED|Step 3: 8/16/2021 to 11/14/2021||73||1
48197638|NCT04663802|100806741|FG011|STARTED|Step 3: 8/16/2021 to 11/14/2021||53||1
48197639|NCT04663802|100806730|FG000|COMPLETED|Step 3: 8/16/2021 to 11/14/2021||88||1
48197640|NCT04663802|100806731|FG001|COMPLETED|Step 3: 8/16/2021 to 11/14/2021||76||1
48197641|NCT04663802|100806732|FG002|COMPLETED|Step 3: 8/16/2021 to 11/14/2021||38||1
48197642|NCT04663802|100806733|FG003|COMPLETED|Step 3: 8/16/2021 to 11/14/2021||21||1
48197643|NCT04663802|100806734|FG004|COMPLETED|Step 3: 8/16/2021 to 11/14/2021||67||1
48197644|NCT04663802|100806735|FG005|COMPLETED|Step 3: 8/16/2021 to 11/14/2021||38||1
48197645|NCT04663802|100806736|FG006|COMPLETED|Step 3: 8/16/2021 to 11/14/2021||91||1
48197646|NCT04663802|100806737|FG007|COMPLETED|Step 3: 8/16/2021 to 11/14/2021||66||1
48197647|NCT04663802|100806738|FG008|COMPLETED|Step 3: 8/16/2021 to 11/14/2021||124||1
48197648|NCT04663802|100806739|FG009|COMPLETED|Step 3: 8/16/2021 to 11/14/2021||52||1
48197649|NCT04663802|100806740|FG010|COMPLETED|Step 3: 8/16/2021 to 11/14/2021||73||1
48197650|NCT04663802|100806741|FG011|COMPLETED|Step 3: 8/16/2021 to 11/14/2021||53||1
48197651|NCT04663802|100806730|FG000|NOT COMPLETED|Step 3: 8/16/2021 to 11/14/2021||0||0
48197652|NCT04663802|100806731|FG001|NOT COMPLETED|Step 3: 8/16/2021 to 11/14/2021||0||0
48197653|NCT04663802|100806732|FG002|NOT COMPLETED|Step 3: 8/16/2021 to 11/14/2021||0||0
48197654|NCT04663802|100806733|FG003|NOT COMPLETED|Step 3: 8/16/2021 to 11/14/2021||0||0
48197655|NCT04663802|100806734|FG004|NOT COMPLETED|Step 3: 8/16/2021 to 11/14/2021||0||0
48197656|NCT04663802|100806735|FG005|NOT COMPLETED|Step 3: 8/16/2021 to 11/14/2021||0||0
48197657|NCT04663802|100806736|FG006|NOT COMPLETED|Step 3: 8/16/2021 to 11/14/2021||0||0
48197658|NCT04663802|100806737|FG007|NOT COMPLETED|Step 3: 8/16/2021 to 11/14/2021||0||0
48197659|NCT04663802|100806738|FG008|NOT COMPLETED|Step 3: 8/16/2021 to 11/14/2021||0||0
48197660|NCT04663802|100806739|FG009|NOT COMPLETED|Step 3: 8/16/2021 to 11/14/2021||0||0
48197661|NCT04663802|100806740|FG010|NOT COMPLETED|Step 3: 8/16/2021 to 11/14/2021||0||0
48197662|NCT04663802|100806741|FG011|NOT COMPLETED|Step 3: 8/16/2021 to 11/14/2021||0||0
48197663|NCT04663802|100806730|FG000|STARTED|Step 4: 11/15/2021 to 2/20/2022||76||1
48197664|NCT04663802|100806731|FG001|STARTED|Step 4: 11/15/2021 to 2/20/2022||86||1
48197665|NCT04663802|100806732|FG002|STARTED|Step 4: 11/15/2021 to 2/20/2022||56||1
48197666|NCT04663802|100806733|FG003|STARTED|Step 4: 11/15/2021 to 2/20/2022||49||1
48197667|NCT04663802|100806734|FG004|STARTED|Step 4: 11/15/2021 to 2/20/2022||71||1
48197668|NCT04663802|100806735|FG005|STARTED|Step 4: 11/15/2021 to 2/20/2022||47||1
48197669|NCT04663802|100806736|FG006|STARTED|Step 4: 11/15/2021 to 2/20/2022||97||1
48197670|NCT04663802|100806737|FG007|STARTED|Step 4: 11/15/2021 to 2/20/2022||68||1
48197671|NCT04663802|100806738|FG008|STARTED|Step 4: 11/15/2021 to 2/20/2022||151||1
48197672|NCT04663802|100806739|FG009|STARTED|Step 4: 11/15/2021 to 2/20/2022||69||1
48197673|NCT04663802|100806740|FG010|STARTED|Step 4: 11/15/2021 to 2/20/2022||83||1
48197674|NCT04663802|100806741|FG011|STARTED|Step 4: 11/15/2021 to 2/20/2022||82||1
48197675|NCT04663802|100806730|FG000|COMPLETED|Step 4: 11/15/2021 to 2/20/2022||76||1
48197676|NCT04663802|100806731|FG001|COMPLETED|Step 4: 11/15/2021 to 2/20/2022||86||1
48197677|NCT04663802|100806732|FG002|COMPLETED|Step 4: 11/15/2021 to 2/20/2022||56||1
48197678|NCT04663802|100806733|FG003|COMPLETED|Step 4: 11/15/2021 to 2/20/2022||49||1
48197679|NCT04663802|100806734|FG004|COMPLETED|Step 4: 11/15/2021 to 2/20/2022||71||1
48197680|NCT04663802|100806735|FG005|COMPLETED|Step 4: 11/15/2021 to 2/20/2022||47||1
48197681|NCT04663802|100806736|FG006|COMPLETED|Step 4: 11/15/2021 to 2/20/2022||97||1
48197682|NCT04663802|100806737|FG007|COMPLETED|Step 4: 11/15/2021 to 2/20/2022||68||1
48485244|NCT02106156|101525350|FG000|NOT COMPLETED|Overall Study||2549||
48485245|NCT02106156|101525351|FG001|NOT COMPLETED|Overall Study||40||
48485246|NCT02106156|101525352|FG002|NOT COMPLETED|Overall Study||0||
48485247|NCT04499963|101525353|FG000|STARTED|Overall Study||50||
48485248|NCT04499963|101525354|FG001|STARTED|Overall Study||50||
48485249|NCT04499963|101525353|FG000|COMPLETED|Overall Study||35||
48485250|NCT04499963|101525354|FG001|COMPLETED|Overall Study||50||
48485251|NCT04499963|101525353|FG000|NOT COMPLETED|Overall Study||15||
48485252|NCT04499963|101525354|FG001|NOT COMPLETED|Overall Study||0||
48485253|NCT01173211|101525355|FG000|STARTED|Overall Study||48||
48485254|NCT01173211|101525356|FG001|STARTED|Overall Study||45||
48485255|NCT01173211|101525357|FG002|STARTED|Overall Study||46||
48485256|NCT01173211|101525358|FG003|STARTED|Overall Study||15||
48485257|NCT01173211|101525359|FG004|STARTED|Overall Study||16||
48485258|NCT01173211|101525360|FG005|STARTED|Overall Study||13||
48485259|NCT01173211|101525355|FG000|COMPLETED|Overall Study||46||
48485260|NCT01173211|101525356|FG001|COMPLETED|Overall Study||44||
48485261|NCT01173211|101525357|FG002|COMPLETED|Overall Study||44||
48485262|NCT01173211|101525358|FG003|COMPLETED|Overall Study||15||
48485263|NCT01173211|101525359|FG004|COMPLETED|Overall Study||16||
48485264|NCT01173211|101525360|FG005|COMPLETED|Overall Study||13||
48485265|NCT01173211|101525355|FG000|NOT COMPLETED|Overall Study||2||
48485266|NCT01173211|101525356|FG001|NOT COMPLETED|Overall Study||1||
48485267|NCT01173211|101525357|FG002|NOT COMPLETED|Overall Study||2||
48485268|NCT01173211|101525358|FG003|NOT COMPLETED|Overall Study||0||
48485269|NCT01173211|101525359|FG004|NOT COMPLETED|Overall Study||0||
48485270|NCT01173211|101525360|FG005|NOT COMPLETED|Overall Study||0||
48485271|NCT00851877|101525361|FG000|STARTED|Phase I-1||7||
48485272|NCT00851877|101525362|FG001|STARTED|Phase I-1||0||
48485273|NCT00851877|101525363|FG002|STARTED|Phase I-1||0||
48485274|NCT00851877|101525361|FG000|COMPLETED|Phase I-1||6||
48485275|NCT00851877|101525362|FG001|COMPLETED|Phase I-1||0||
48485276|NCT00851877|101525363|FG002|COMPLETED|Phase I-1||0||
48485277|NCT00851877|101525361|FG000|NOT COMPLETED|Phase I-1||1||
48485278|NCT00851877|101525362|FG001|NOT COMPLETED|Phase I-1||0||
48485279|NCT00851877|101525363|FG002|NOT COMPLETED|Phase I-1||0||
48485280|NCT00851877|101525361|FG000|STARTED|Phase I-2||0||
48485281|NCT00851877|101525362|FG001|STARTED|Phase I-2||5||
48485282|NCT00851877|101525363|FG002|STARTED|Phase I-2||0||
48485283|NCT00851877|101525361|FG000|COMPLETED|Phase I-2||0||
48485284|NCT00851877|101525362|FG001|COMPLETED|Phase I-2||5||
48485285|NCT00851877|101525363|FG002|COMPLETED|Phase I-2||0||
48485286|NCT00851877|101525361|FG000|NOT COMPLETED|Phase I-2||0||
48485287|NCT00851877|101525362|FG001|NOT COMPLETED|Phase I-2||0||
48485288|NCT00851877|101525363|FG002|NOT COMPLETED|Phase I-2||0||
48485289|NCT00851877|101525361|FG000|STARTED|Phase II||0||
48485290|NCT00851877|101525362|FG001|STARTED|Phase II||0||
48485291|NCT00851877|101525363|FG002|STARTED|Phase II||25||
48485292|NCT00851877|101525361|FG000|COMPLETED|Phase II||0||
48485293|NCT00851877|101525362|FG001|COMPLETED|Phase II||0||
48485294|NCT00851877|101525363|FG002|COMPLETED|Phase II||22||
48485295|NCT00851877|101525361|FG000|NOT COMPLETED|Phase II||0||
48485296|NCT00851877|101525362|FG001|NOT COMPLETED|Phase II||0||
48485297|NCT00851877|101525363|FG002|NOT COMPLETED|Phase II||3||
48485298|NCT00263588|101525364|FG000|STARTED|Overall Study||95||
48485299|NCT00263588|101525365|FG001|STARTED|Overall Study||147||
48485300|NCT00263588|101525364|FG000|COMPLETED|Overall Study||14||
48485301|NCT00263588|101525365|FG001|COMPLETED|Overall Study||15||
48485302|NCT00263588|101525364|FG000|NOT COMPLETED|Overall Study||81||
48485303|NCT00263588|101525365|FG001|NOT COMPLETED|Overall Study||132||
48485304|NCT00747565|101525366|FG000|STARTED|Overall Study||347||
48485305|NCT00747565|101525367|FG001|STARTED|Overall Study||123||
48485306|NCT00747565|101525366|FG000|COMPLETED|Overall Study||333||
48485307|NCT00747565|101525367|FG001|COMPLETED|Overall Study||116||
48485308|NCT00747565|101525366|FG000|NOT COMPLETED|Overall Study||14||
48485309|NCT00747565|101525367|FG001|NOT COMPLETED|Overall Study||7||
48485310|NCT01114893|101525368|FG000|STARTED|Overall Study||14||
48485311|NCT01114893|101525369|FG001|STARTED|Overall Study||14||
48485312|NCT01114893|101525370|FG002|STARTED|Overall Study||14||
48485313|NCT01114893|101525371|FG003|STARTED|Overall Study||13||
48485314|NCT01114893|101525372|FG004|STARTED|Overall Study||12||
48485315|NCT01114893|101525368|FG000|COMPLETED|Overall Study||14||
48485316|NCT01114893|101525369|FG001|COMPLETED|Overall Study||14||
48485317|NCT01114893|101525370|FG002|COMPLETED|Overall Study||14||
48485318|NCT01114893|101525371|FG003|COMPLETED|Overall Study||13||
48485319|NCT01114893|101525372|FG004|COMPLETED|Overall Study||12||
48485320|NCT01114893|101525368|FG000|NOT COMPLETED|Overall Study||0||
48485321|NCT01114893|101525369|FG001|NOT COMPLETED|Overall Study||0||
48197683|NCT04663802|100806738|FG008|COMPLETED|Step 4: 11/15/2021 to 2/20/2022||151||1
48197684|NCT04663802|100806739|FG009|COMPLETED|Step 4: 11/15/2021 to 2/20/2022||69||1
48197685|NCT04663802|100806740|FG010|COMPLETED|Step 4: 11/15/2021 to 2/20/2022||83||1
48485322|NCT01114893|101525370|FG002|NOT COMPLETED|Overall Study||0||
48485323|NCT01114893|101525371|FG003|NOT COMPLETED|Overall Study||0||
48485324|NCT01114893|101525372|FG004|NOT COMPLETED|Overall Study||0||
48485325|NCT01097577|101525373|FG000|STARTED|Overall Study||67||
48485326|NCT01097577|101525374|FG001|STARTED|Overall Study||63||
48485327|NCT01097577|101525373|FG000|COMPLETED|Overall Study||67||
48485328|NCT01097577|101525374|FG001|COMPLETED|Overall Study||62||
48197686|NCT04663802|100806741|FG011|COMPLETED|Step 4: 11/15/2021 to 2/20/2022||82||1
48197687|NCT04663802|100806730|FG000|NOT COMPLETED|Step 4: 11/15/2021 to 2/20/2022||0||0
48197688|NCT04663802|100806731|FG001|NOT COMPLETED|Step 4: 11/15/2021 to 2/20/2022||0||0
48197689|NCT04663802|100806732|FG002|NOT COMPLETED|Step 4: 11/15/2021 to 2/20/2022||0||0
48197690|NCT04663802|100806733|FG003|NOT COMPLETED|Step 4: 11/15/2021 to 2/20/2022||0||0
48485329|NCT01097577|101525373|FG000|NOT COMPLETED|Overall Study||0||
48485330|NCT01097577|101525374|FG001|NOT COMPLETED|Overall Study||1||
48197691|NCT04663802|100806734|FG004|NOT COMPLETED|Step 4: 11/15/2021 to 2/20/2022||0||0
48197692|NCT04663802|100806735|FG005|NOT COMPLETED|Step 4: 11/15/2021 to 2/20/2022||0||0
48197693|NCT04663802|100806736|FG006|NOT COMPLETED|Step 4: 11/15/2021 to 2/20/2022||0||0
48485331|NCT03733730|101525375|FG000|STARTED|Overall Study||453|All subjects/eyes with attempted implantation|706
48485332|NCT03733730|101525376|FG001|STARTED|Overall Study||1827|All subjects/eyes with attempted implantation|3417
48485333|NCT03733730|101525375|FG000|First Eye Attempted Implantation|Overall Study||453||453
48197694|NCT04663802|100806737|FG007|NOT COMPLETED|Step 4: 11/15/2021 to 2/20/2022||0||0
48197695|NCT04663802|100806738|FG008|NOT COMPLETED|Step 4: 11/15/2021 to 2/20/2022||0||0
48197696|NCT04663802|100806739|FG009|NOT COMPLETED|Step 4: 11/15/2021 to 2/20/2022||0||0
48485334|NCT03733730|101525376|FG001|First Eye Attempted Implantation|Overall Study||1827||1827
48485335|NCT03733730|101525375|FG000|First Eye Successful Implantation|Overall Study||453||453
48485336|NCT03733730|101525376|FG001|First Eye Successful Implantation|Overall Study||1827||1827
48485337|NCT03733730|101525375|FG000|Second Eye Attempted Implantation|Overall Study||453||253
48485338|NCT03733730|101525376|FG001|Second Eye Attempted Implantation|Overall Study||1827||1590
48485339|NCT03733730|101525375|FG000|Second Eye Successful Implantation|Overall Study||453||253
48666461|NCT04110145|101967585|FG002|STARTED|Post-Treatment Period (1 Week)||5|Started=Participants who entered the Post-Treatment Period|
48666462|NCT04110145|101967586|FG003|STARTED|Post-Treatment Period (1 Week)||6|Started=Participants who entered the Post-Treatment Period|
48666463|NCT04110145|101967587|FG004|STARTED|Post-Treatment Period (1 Week)||8|Started=Participants who entered the Post-Treatment Period|
48666464|NCT04110145|101967583|FG000|COMPLETED|Post-Treatment Period (1 Week)||7||
48666465|NCT04110145|101967584|FG001|COMPLETED|Post-Treatment Period (1 Week)||7||
48666466|NCT04110145|101967585|FG002|COMPLETED|Post-Treatment Period (1 Week)||5||
48666467|NCT04110145|101967586|FG003|COMPLETED|Post-Treatment Period (1 Week)||6||
48666468|NCT04110145|101967587|FG004|COMPLETED|Post-Treatment Period (1 Week)||8||
48666469|NCT04110145|101967583|FG000|NOT COMPLETED|Post-Treatment Period (1 Week)||0||
48666470|NCT04110145|101967584|FG001|NOT COMPLETED|Post-Treatment Period (1 Week)||0||
48666471|NCT04110145|101967585|FG002|NOT COMPLETED|Post-Treatment Period (1 Week)||0||
48485340|NCT03733730|101525376|FG001|Second Eye Successful Implantation|Overall Study||1827||1589
48485341|NCT03733730|101525375|FG000|Safety Analysis Set|Overall Study||453||706
48485342|NCT03733730|101525376|FG001|Safety Analysis Set|Overall Study||1827||3417
48485343|NCT03733730|101525375|FG000|COMPLETED|Overall Study||451||703
48485344|NCT03733730|101525376|FG001|COMPLETED|Overall Study||1778||3334
48666472|NCT04110145|101967586|FG003|NOT COMPLETED|Post-Treatment Period (1 Week)||0||
48666473|NCT04110145|101967587|FG004|NOT COMPLETED|Post-Treatment Period (1 Week)||0||
48666474|NCT02474498|101967588|FG000|STARTED|Overall Study||13||
48666475|NCT02474498|101967589|FG001|STARTED|Overall Study||14||
48666476|NCT02474498|101967590|FG002|STARTED|Overall Study||14||
48666477|NCT02474498|101967588|FG000|COMPLETED|Overall Study||13||
48666478|NCT02474498|101967589|FG001|COMPLETED|Overall Study||14||
48666479|NCT02474498|101967590|FG002|COMPLETED|Overall Study||14||
48666480|NCT02474498|101967588|FG000|NOT COMPLETED|Overall Study||0||
48666481|NCT02474498|101967589|FG001|NOT COMPLETED|Overall Study||0||
48666482|NCT02474498|101967590|FG002|NOT COMPLETED|Overall Study||0||
48666483|NCT00836706|101967591|FG000|STARTED|First Intervention||11||
48666484|NCT00836706|101967592|FG001|STARTED|First Intervention||12||
48666485|NCT00836706|101967591|FG000|COMPLETED|First Intervention||11||
48666486|NCT00836706|101967592|FG001|COMPLETED|First Intervention||12||
48666487|NCT00836706|101967591|FG000|NOT COMPLETED|First Intervention||0||
48666488|NCT00836706|101967592|FG001|NOT COMPLETED|First Intervention||0||
48666489|NCT00836706|101967591|FG000|STARTED|Washout: 7 Days||11||
48666490|NCT00836706|101967592|FG001|STARTED|Washout: 7 Days||12||
48666491|NCT00836706|101967591|FG000|COMPLETED|Washout: 7 Days||11||
48666492|NCT00836706|101967592|FG001|COMPLETED|Washout: 7 Days||11||
48666493|NCT00836706|101967591|FG000|NOT COMPLETED|Washout: 7 Days||0||
48666494|NCT00836706|101967592|FG001|NOT COMPLETED|Washout: 7 Days||1||
48666495|NCT00836706|101967591|FG000|STARTED|Second Intervention||11||
48666496|NCT00836706|101967592|FG001|STARTED|Second Intervention||11||
48666497|NCT00836706|101967591|FG000|COMPLETED|Second Intervention||11||
48666498|NCT00836706|101967592|FG001|COMPLETED|Second Intervention||11||
48666499|NCT00836706|101967591|FG000|NOT COMPLETED|Second Intervention||0||
48666500|NCT00836706|101967592|FG001|NOT COMPLETED|Second Intervention||0||
48666501|NCT04164901|101967593|FG000|STARTED|Overall Study||168|The participant flow data is based on the Full Analysis Set (FAS) which includes all subjects randomized, classified according to the randomized treatment arm.|
48666502|NCT04164901|101967594|FG001|STARTED|Overall Study||163|The participant flow data is based on the Full Analysis Set (FAS) which includes all subjects randomized, classified according to the randomized treatment arm.|
48670066|NCT02626533|101974882|FG000|3 Month Post-op|Overall Study||162|Participants who were successfully contacted for 3 months post-operation follow up.|
48485345|NCT03733730|101525375|FG000|NOT COMPLETED|Overall Study||2||3
48485346|NCT03733730|101525376|FG001|NOT COMPLETED|Overall Study||49||83
48485347|NCT03134222|101525377|FG000|STARTED|Treatment Period (Up to Week 12)||19||
48485348|NCT03134222|101525378|FG001|STARTED|Treatment Period (Up to Week 12)||18||
48485349|NCT03134222|101525379|FG002|STARTED|Treatment Period (Up to Week 12)||10||
48485350|NCT03134222|101525380|FG003|STARTED|Treatment Period (Up to Week 12)||0||
48485351|NCT03134222|101525381|FG004|STARTED|Treatment Period (Up to Week 12)||0||
48485352|NCT03134222|101525377|FG000|COMPLETED|Treatment Period (Up to Week 12)||14||
48485353|NCT03134222|101525378|FG001|COMPLETED|Treatment Period (Up to Week 12)||14||
48485354|NCT03134222|101525379|FG002|COMPLETED|Treatment Period (Up to Week 12)||8||
48485355|NCT03134222|101525380|FG003|COMPLETED|Treatment Period (Up to Week 12)||0||
48485356|NCT03134222|101525381|FG004|COMPLETED|Treatment Period (Up to Week 12)||0||
48485357|NCT03134222|101525377|FG000|NOT COMPLETED|Treatment Period (Up to Week 12)||5||
48485358|NCT03134222|101525378|FG001|NOT COMPLETED|Treatment Period (Up to Week 12)||4||
48485359|NCT03134222|101525379|FG002|NOT COMPLETED|Treatment Period (Up to Week 12)||2||
48485360|NCT03134222|101525380|FG003|NOT COMPLETED|Treatment Period (Up to Week 12)||0||
48485361|NCT03134222|101525381|FG004|NOT COMPLETED|Treatment Period (Up to Week 12)||0||
48485362|NCT03134222|101525377|FG000|STARTED|Treatment Period (Week 12 to 48)||14||
48485363|NCT03134222|101525378|FG001|STARTED|Treatment Period (Week 12 to 48)||14||
48485364|NCT03134222|101525379|FG002|STARTED|Treatment Period (Week 12 to 48)||0||
48485365|NCT03134222|101525380|FG003|STARTED|Treatment Period (Week 12 to 48)||4||
48485366|NCT03134222|101525381|FG004|STARTED|Treatment Period (Week 12 to 48)||4||
48485367|NCT03134222|101525377|FG000|COMPLETED|Treatment Period (Week 12 to 48)||12||
48485368|NCT03134222|101525378|FG001|COMPLETED|Treatment Period (Week 12 to 48)||11||
48485369|NCT03134222|101525379|FG002|COMPLETED|Treatment Period (Week 12 to 48)||0||
48485370|NCT03134222|101525380|FG003|COMPLETED|Treatment Period (Week 12 to 48)||3||
48485371|NCT03134222|101525381|FG004|COMPLETED|Treatment Period (Week 12 to 48)||3||
48485372|NCT03134222|101525377|FG000|NOT COMPLETED|Treatment Period (Week 12 to 48)||2||
48485373|NCT03134222|101525378|FG001|NOT COMPLETED|Treatment Period (Week 12 to 48)||3||
48485374|NCT03134222|101525379|FG002|NOT COMPLETED|Treatment Period (Week 12 to 48)||0||
48485375|NCT03134222|101525380|FG003|NOT COMPLETED|Treatment Period (Week 12 to 48)||1||
48485376|NCT03134222|101525381|FG004|NOT COMPLETED|Treatment Period (Week 12 to 48)||1||
48485377|NCT01139047|101525382|FG000|STARTED|Overall Study||77||
48485378|NCT01139047|101525382|FG000|COMPLETED|Overall Study||76||
48485379|NCT01139047|101525382|FG000|NOT COMPLETED|Overall Study||1||
48485380|NCT02713425|101525383|FG000|STARTED|Overall Study||20||
48485381|NCT02713425|101525383|FG000|COMPLETED|Overall Study||20||
48485382|NCT02713425|101525383|FG000|NOT COMPLETED|Overall Study||0||
48485383|NCT00738049|101525384|FG000|STARTED|1st Intervention(14 Days)||13||
48485384|NCT00738049|101525385|FG001|STARTED|1st Intervention(14 Days)||7||
48485385|NCT00738049|101525384|FG000|COMPLETED|1st Intervention(14 Days)||13||
48485386|NCT00738049|101525385|FG001|COMPLETED|1st Intervention(14 Days)||7||
48485387|NCT00738049|101525384|FG000|NOT COMPLETED|1st Intervention(14 Days)||0||
48485388|NCT00738049|101525385|FG001|NOT COMPLETED|1st Intervention(14 Days)||0||
48485389|NCT00738049|101525384|FG000|STARTED|2nd Intervention(14 Days)||13||
48485390|NCT00738049|101525385|FG001|STARTED|2nd Intervention(14 Days)||7||
48485391|NCT00738049|101525384|FG000|COMPLETED|2nd Intervention(14 Days)||13||
48485392|NCT00738049|101525385|FG001|COMPLETED|2nd Intervention(14 Days)||7||
48485393|NCT00738049|101525384|FG000|NOT COMPLETED|2nd Intervention(14 Days)||0||
48485394|NCT00738049|101525385|FG001|NOT COMPLETED|2nd Intervention(14 Days)||0||
48485395|NCT00738049|101525384|FG000|STARTED|Washout||13||
48485396|NCT00738049|101525385|FG001|STARTED|Washout||7||
48485397|NCT00738049|101525384|FG000|COMPLETED|Washout||13||
48485398|NCT00738049|101525385|FG001|COMPLETED|Washout||7||
48485399|NCT00738049|101525384|FG000|NOT COMPLETED|Washout||0||
48197697|NCT04663802|100806740|FG010|NOT COMPLETED|Step 4: 11/15/2021 to 2/20/2022||0||0
48197698|NCT04663802|100806741|FG011|NOT COMPLETED|Step 4: 11/15/2021 to 2/20/2022||0||0
48485400|NCT00738049|101525385|FG001|NOT COMPLETED|Washout||0||
48485401|NCT01313780|101525386|FG000|STARTED|Overall Study||58||
48485402|NCT01313780|101525387|FG001|STARTED|Overall Study||59||
48197699|NCT04663802|100806730|FG000|STARTED|Step 5: 2/21/2022 to 5/15/2022||71||1
48485403|NCT01313780|101525386|FG000|COMPLETED|Overall Study||33||
48485404|NCT01313780|101525387|FG001|COMPLETED|Overall Study||31||
48485405|NCT01313780|101525386|FG000|NOT COMPLETED|Overall Study||25||
48485406|NCT01313780|101525387|FG001|NOT COMPLETED|Overall Study||28||
48485407|NCT02409355|101525388|FG000|STARTED|Overall Study||4||
48485408|NCT02409355|101525389|FG001|STARTED|Overall Study||4||
48485409|NCT02409355|101525388|FG000|COMPLETED|Overall Study||0||
48485410|NCT02409355|101525389|FG001|COMPLETED|Overall Study||0||
48485411|NCT02409355|101525388|FG000|NOT COMPLETED|Overall Study||4||
48197700|NCT04663802|100806731|FG001|STARTED|Step 5: 2/21/2022 to 5/15/2022||71||1
48485412|NCT02409355|101525389|FG001|NOT COMPLETED|Overall Study||4||
48197701|NCT04663802|100806732|FG002|STARTED|Step 5: 2/21/2022 to 5/15/2022||41||1
48197702|NCT04663802|100806733|FG003|STARTED|Step 5: 2/21/2022 to 5/15/2022||32||1
48197703|NCT04663802|100806734|FG004|STARTED|Step 5: 2/21/2022 to 5/15/2022||73||1
48485413|NCT02538523|101525390|FG000|STARTED|Overall Study||29||
48485414|NCT02538523|101525391|FG001|STARTED|Overall Study||29||
48485415|NCT02538523|101525390|FG000|COMPLETED|Overall Study||29||
48485416|NCT02538523|101525391|FG001|COMPLETED|Overall Study||29||
48485417|NCT02538523|101525390|FG000|NOT COMPLETED|Overall Study||0||
48197704|NCT04663802|100806735|FG005|STARTED|Step 5: 2/21/2022 to 5/15/2022||27||1
48197705|NCT04663802|100806736|FG006|STARTED|Step 5: 2/21/2022 to 5/15/2022||73||1
48197706|NCT04663802|100806737|FG007|STARTED|Step 5: 2/21/2022 to 5/15/2022||58||1
48197707|NCT04663802|100806738|FG008|STARTED|Step 5: 2/21/2022 to 5/15/2022||132||1
48197708|NCT04663802|100806739|FG009|STARTED|Step 5: 2/21/2022 to 5/15/2022||48||1
48197709|NCT04663802|100806740|FG010|STARTED|Step 5: 2/21/2022 to 5/15/2022||70||1
48197710|NCT04663802|100806741|FG011|STARTED|Step 5: 2/21/2022 to 5/15/2022||51||1
48197711|NCT04663802|100806730|FG000|COMPLETED|Step 5: 2/21/2022 to 5/15/2022||71||1
48197712|NCT04663802|100806731|FG001|COMPLETED|Step 5: 2/21/2022 to 5/15/2022||71||1
48197713|NCT04663802|100806732|FG002|COMPLETED|Step 5: 2/21/2022 to 5/15/2022||41||1
48197714|NCT04663802|100806733|FG003|COMPLETED|Step 5: 2/21/2022 to 5/15/2022||32||1
48197715|NCT04663802|100806734|FG004|COMPLETED|Step 5: 2/21/2022 to 5/15/2022||73||1
48197716|NCT04663802|100806735|FG005|COMPLETED|Step 5: 2/21/2022 to 5/15/2022||27||1
48197717|NCT04663802|100806736|FG006|COMPLETED|Step 5: 2/21/2022 to 5/15/2022||73||1
48197718|NCT04663802|100806737|FG007|COMPLETED|Step 5: 2/21/2022 to 5/15/2022||58||1
48197719|NCT04663802|100806738|FG008|COMPLETED|Step 5: 2/21/2022 to 5/15/2022||132||1
48197720|NCT04663802|100806739|FG009|COMPLETED|Step 5: 2/21/2022 to 5/15/2022||48||1
48197721|NCT04663802|100806740|FG010|COMPLETED|Step 5: 2/21/2022 to 5/15/2022||70||1
48197722|NCT04663802|100806741|FG011|COMPLETED|Step 5: 2/21/2022 to 5/15/2022||51||1
48197723|NCT04663802|100806730|FG000|NOT COMPLETED|Step 5: 2/21/2022 to 5/15/2022||0||0
48197724|NCT04663802|100806731|FG001|NOT COMPLETED|Step 5: 2/21/2022 to 5/15/2022||0||0
48197725|NCT04663802|100806732|FG002|NOT COMPLETED|Step 5: 2/21/2022 to 5/15/2022||0||0
48197726|NCT04663802|100806733|FG003|NOT COMPLETED|Step 5: 2/21/2022 to 5/15/2022||0||0
48197727|NCT04663802|100806734|FG004|NOT COMPLETED|Step 5: 2/21/2022 to 5/15/2022||0||0
48197728|NCT04663802|100806735|FG005|NOT COMPLETED|Step 5: 2/21/2022 to 5/15/2022||0||0
48197729|NCT04663802|100806736|FG006|NOT COMPLETED|Step 5: 2/21/2022 to 5/15/2022||0||0
48197730|NCT04663802|100806737|FG007|NOT COMPLETED|Step 5: 2/21/2022 to 5/15/2022||0||0
48197731|NCT04663802|100806738|FG008|NOT COMPLETED|Step 5: 2/21/2022 to 5/15/2022||0||0
48197732|NCT04663802|100806739|FG009|NOT COMPLETED|Step 5: 2/21/2022 to 5/15/2022||0||0
48197733|NCT04663802|100806740|FG010|NOT COMPLETED|Step 5: 2/21/2022 to 5/15/2022||0||0
48197734|NCT04663802|100806741|FG011|NOT COMPLETED|Step 5: 2/21/2022 to 5/15/2022||0||0
48485418|NCT02538523|101525391|FG001|NOT COMPLETED|Overall Study||0||
48485419|NCT03173547|101525392|FG000|STARTED|Overall Study||40||
48485420|NCT03173547|101525393|FG001|STARTED|Overall Study||40||
48485421|NCT03173547|101525392|FG000|COMPLETED|Overall Study||36||
48197735|NCT04663802|100806730|FG000|STARTED|Step 6: 5/16/2022 to 8/21/2022||66||1
48197736|NCT04663802|100806731|FG001|STARTED|Step 6: 5/16/2022 to 8/21/2022||74||1
48197737|NCT04663802|100806732|FG002|STARTED|Step 6: 5/16/2022 to 8/21/2022||39||1
48197738|NCT04663802|100806733|FG003|STARTED|Step 6: 5/16/2022 to 8/21/2022||38||1
48197739|NCT04663802|100806734|FG004|STARTED|Step 6: 5/16/2022 to 8/21/2022||71||1
48197740|NCT04663802|100806735|FG005|STARTED|Step 6: 5/16/2022 to 8/21/2022||36||1
48197741|NCT04663802|100806736|FG006|STARTED|Step 6: 5/16/2022 to 8/21/2022||76||1
48485422|NCT03173547|101525393|FG001|COMPLETED|Overall Study||38||
48485423|NCT03173547|101525392|FG000|NOT COMPLETED|Overall Study||4||
48485424|NCT03173547|101525393|FG001|NOT COMPLETED|Overall Study||2||
48485425|NCT00934050|101525394|FG000|STARTED|Enrolled Prior to 15 Dec 2009||12||
48485426|NCT00934050|101525395|FG001|STARTED|Enrolled Prior to 15 Dec 2009||12||
48485427|NCT00934050|101525396|FG002|STARTED|Enrolled Prior to 15 Dec 2009||12||
48485428|NCT00934050|101525397|FG003|STARTED|Enrolled Prior to 15 Dec 2009||14||
48485429|NCT00934050|101525398|FG004|STARTED|Enrolled Prior to 15 Dec 2009||0||
48485430|NCT00934050|101525399|FG005|STARTED|Enrolled Prior to 15 Dec 2009||0||
48485431|NCT00934050|101525394|FG000|COMPLETED|Enrolled Prior to 15 Dec 2009||0||
48485432|NCT00934050|101525395|FG001|COMPLETED|Enrolled Prior to 15 Dec 2009||0||
48485433|NCT00934050|101525396|FG002|COMPLETED|Enrolled Prior to 15 Dec 2009||0||
48485434|NCT00934050|101525397|FG003|COMPLETED|Enrolled Prior to 15 Dec 2009||0||
48485435|NCT00934050|101525398|FG004|COMPLETED|Enrolled Prior to 15 Dec 2009||0||
48485436|NCT00934050|101525399|FG005|COMPLETED|Enrolled Prior to 15 Dec 2009||0||
48485437|NCT00934050|101525394|FG000|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12||
48485438|NCT00934050|101525395|FG001|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12||
48485439|NCT00934050|101525396|FG002|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12||
48485440|NCT00934050|101525397|FG003|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||14||
48485441|NCT00934050|101525398|FG004|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0||
48485442|NCT00934050|101525399|FG005|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0||
48485443|NCT00934050|101525394|FG000|STARTED|Enrolled After 15 Dec 2009||0||
48670067|NCT02626533|101974882|FG000|6 Months Post-op|Overall Study||162|Participants who were successfully contacted for 6 months post-operation follow up.|
48485444|NCT00934050|101525395|FG001|STARTED|Enrolled After 15 Dec 2009||0||
48485445|NCT00934050|101525396|FG002|STARTED|Enrolled After 15 Dec 2009||0||
48485446|NCT00934050|101525397|FG003|STARTED|Enrolled After 15 Dec 2009||0||
48485447|NCT00934050|101525398|FG004|STARTED|Enrolled After 15 Dec 2009||26||
48197742|NCT04663802|100806737|FG007|STARTED|Step 6: 5/16/2022 to 8/21/2022||67||1
48197743|NCT04663802|100806738|FG008|STARTED|Step 6: 5/16/2022 to 8/21/2022||128||1
48197744|NCT04663802|100806739|FG009|STARTED|Step 6: 5/16/2022 to 8/21/2022||67||1
48197745|NCT04663802|100806740|FG010|STARTED|Step 6: 5/16/2022 to 8/21/2022||63||1
48197746|NCT04663802|100806741|FG011|STARTED|Step 6: 5/16/2022 to 8/21/2022||59||1
48485448|NCT00934050|101525399|FG005|STARTED|Enrolled After 15 Dec 2009||27||
48197747|NCT04663802|100806730|FG000|COMPLETED|Step 6: 5/16/2022 to 8/21/2022||66||1
48197748|NCT04663802|100806731|FG001|COMPLETED|Step 6: 5/16/2022 to 8/21/2022||74||1
48197749|NCT04663802|100806732|FG002|COMPLETED|Step 6: 5/16/2022 to 8/21/2022||39||1
48197750|NCT04663802|100806733|FG003|COMPLETED|Step 6: 5/16/2022 to 8/21/2022||38||1
48197751|NCT04663802|100806734|FG004|COMPLETED|Step 6: 5/16/2022 to 8/21/2022||71||1
48197752|NCT04663802|100806735|FG005|COMPLETED|Step 6: 5/16/2022 to 8/21/2022||36||1
48197753|NCT04663802|100806736|FG006|COMPLETED|Step 6: 5/16/2022 to 8/21/2022||76||1
48197754|NCT04663802|100806737|FG007|COMPLETED|Step 6: 5/16/2022 to 8/21/2022||67||1
48197755|NCT04663802|100806738|FG008|COMPLETED|Step 6: 5/16/2022 to 8/21/2022||128||1
48197756|NCT04663802|100806739|FG009|COMPLETED|Step 6: 5/16/2022 to 8/21/2022||67||1
48197757|NCT04663802|100806740|FG010|COMPLETED|Step 6: 5/16/2022 to 8/21/2022||63||1
48197758|NCT04663802|100806741|FG011|COMPLETED|Step 6: 5/16/2022 to 8/21/2022||59||1
48197759|NCT04663802|100806730|FG000|NOT COMPLETED|Step 6: 5/16/2022 to 8/21/2022||0||0
48197760|NCT04663802|100806731|FG001|NOT COMPLETED|Step 6: 5/16/2022 to 8/21/2022||0||0
48197761|NCT04663802|100806732|FG002|NOT COMPLETED|Step 6: 5/16/2022 to 8/21/2022||0||0
48197762|NCT04663802|100806733|FG003|NOT COMPLETED|Step 6: 5/16/2022 to 8/21/2022||0||0
48197763|NCT04663802|100806734|FG004|NOT COMPLETED|Step 6: 5/16/2022 to 8/21/2022||0||0
48197764|NCT04663802|100806735|FG005|NOT COMPLETED|Step 6: 5/16/2022 to 8/21/2022||0||0
48197765|NCT04663802|100806736|FG006|NOT COMPLETED|Step 6: 5/16/2022 to 8/21/2022||0||0
48197766|NCT04663802|100806737|FG007|NOT COMPLETED|Step 6: 5/16/2022 to 8/21/2022||0||0
48197767|NCT04663802|100806738|FG008|NOT COMPLETED|Step 6: 5/16/2022 to 8/21/2022||0||0
48197768|NCT04663802|100806739|FG009|NOT COMPLETED|Step 6: 5/16/2022 to 8/21/2022||0||0
48197769|NCT04663802|100806740|FG010|NOT COMPLETED|Step 6: 5/16/2022 to 8/21/2022||0||0
48197770|NCT04663802|100806741|FG011|NOT COMPLETED|Step 6: 5/16/2022 to 8/21/2022||0||0
48197771|NCT04663802|100806730|FG000|STARTED|Step 7: 8/22/2022 to11/20/2022||78||1
48197772|NCT04663802|100806731|FG001|STARTED|Step 7: 8/22/2022 to11/20/2022||75||1
48197773|NCT04663802|100806732|FG002|STARTED|Step 7: 8/22/2022 to11/20/2022||51||1
48197774|NCT04663802|100806733|FG003|STARTED|Step 7: 8/22/2022 to11/20/2022||48||1
48197775|NCT04663802|100806734|FG004|STARTED|Step 7: 8/22/2022 to11/20/2022||73||1
48197776|NCT04663802|100806735|FG005|STARTED|Step 7: 8/22/2022 to11/20/2022||37||1
48197777|NCT04663802|100806736|FG006|STARTED|Step 7: 8/22/2022 to11/20/2022||86||1
48197778|NCT04663802|100806737|FG007|STARTED|Step 7: 8/22/2022 to11/20/2022||78||1
48197779|NCT04663802|100806738|FG008|STARTED|Step 7: 8/22/2022 to11/20/2022||159||1
48197780|NCT04663802|100806739|FG009|STARTED|Step 7: 8/22/2022 to11/20/2022||70||1
48197781|NCT04663802|100806740|FG010|STARTED|Step 7: 8/22/2022 to11/20/2022||77||1
48197782|NCT04663802|100806741|FG011|STARTED|Step 7: 8/22/2022 to11/20/2022||64||1
48197783|NCT04663802|100806730|FG000|COMPLETED|Step 7: 8/22/2022 to11/20/2022||78||1
48197784|NCT04663802|100806731|FG001|COMPLETED|Step 7: 8/22/2022 to11/20/2022||75||1
48197785|NCT04663802|100806732|FG002|COMPLETED|Step 7: 8/22/2022 to11/20/2022||51||1
48197786|NCT04663802|100806733|FG003|COMPLETED|Step 7: 8/22/2022 to11/20/2022||48||1
48197787|NCT04663802|100806734|FG004|COMPLETED|Step 7: 8/22/2022 to11/20/2022||73||1
48197788|NCT04663802|100806735|FG005|COMPLETED|Step 7: 8/22/2022 to11/20/2022||37||1
48197789|NCT04663802|100806736|FG006|COMPLETED|Step 7: 8/22/2022 to11/20/2022||86||1
48197790|NCT04663802|100806737|FG007|COMPLETED|Step 7: 8/22/2022 to11/20/2022||78||1
48197791|NCT04663802|100806738|FG008|COMPLETED|Step 7: 8/22/2022 to11/20/2022||159||1
48197792|NCT04663802|100806739|FG009|COMPLETED|Step 7: 8/22/2022 to11/20/2022||70||1
48197793|NCT04663802|100806740|FG010|COMPLETED|Step 7: 8/22/2022 to11/20/2022||77||1
48197794|NCT04663802|100806741|FG011|COMPLETED|Step 7: 8/22/2022 to11/20/2022||64||1
48197795|NCT04663802|100806730|FG000|NOT COMPLETED|Step 7: 8/22/2022 to11/20/2022||0||0
48197796|NCT04663802|100806731|FG001|NOT COMPLETED|Step 7: 8/22/2022 to11/20/2022||0||0
48197797|NCT04663802|100806732|FG002|NOT COMPLETED|Step 7: 8/22/2022 to11/20/2022||0||0
48197798|NCT04663802|100806733|FG003|NOT COMPLETED|Step 7: 8/22/2022 to11/20/2022||0||0
48197799|NCT04663802|100806734|FG004|NOT COMPLETED|Step 7: 8/22/2022 to11/20/2022||0||0
48197800|NCT04663802|100806735|FG005|NOT COMPLETED|Step 7: 8/22/2022 to11/20/2022||0||0
48197801|NCT04663802|100806736|FG006|NOT COMPLETED|Step 7: 8/22/2022 to11/20/2022||0||0
48197802|NCT04663802|100806737|FG007|NOT COMPLETED|Step 7: 8/22/2022 to11/20/2022||0||0
48197803|NCT04663802|100806738|FG008|NOT COMPLETED|Step 7: 8/22/2022 to11/20/2022||0||0
48197804|NCT04663802|100806739|FG009|NOT COMPLETED|Step 7: 8/22/2022 to11/20/2022||0||0
48197805|NCT04663802|100806740|FG010|NOT COMPLETED|Step 7: 8/22/2022 to11/20/2022||0||0
48197806|NCT04663802|100806741|FG011|NOT COMPLETED|Step 7: 8/22/2022 to11/20/2022||0||0
48197807|NCT04663802|100806730|FG000|STARTED|Step 8: 11/21/2022 to 2/19/2023||71||1
48485449|NCT00934050|101525394|FG000|COMPLETED|Enrolled After 15 Dec 2009||0||
48485450|NCT00934050|101525395|FG001|COMPLETED|Enrolled After 15 Dec 2009||0||
48197808|NCT04663802|100806731|FG001|STARTED|Step 8: 11/21/2022 to 2/19/2023||88||1
48197809|NCT04663802|100806732|FG002|STARTED|Step 8: 11/21/2022 to 2/19/2023||41||1
48197810|NCT04663802|100806733|FG003|STARTED|Step 8: 11/21/2022 to 2/19/2023||46||1
48197811|NCT04663802|100806734|FG004|STARTED|Step 8: 11/21/2022 to 2/19/2023||80||1
48485451|NCT00934050|101525396|FG002|COMPLETED|Enrolled After 15 Dec 2009||0||
48197812|NCT04663802|100806735|FG005|STARTED|Step 8: 11/21/2022 to 2/19/2023||48||1
48197813|NCT04663802|100806736|FG006|STARTED|Step 8: 11/21/2022 to 2/19/2023||103||1
48197814|NCT04663802|100806737|FG007|STARTED|Step 8: 11/21/2022 to 2/19/2023||67||1
48197815|NCT04663802|100806738|FG008|STARTED|Step 8: 11/21/2022 to 2/19/2023||117||1
48197816|NCT04663802|100806739|FG009|STARTED|Step 8: 11/21/2022 to 2/19/2023||80||1
48197817|NCT04663802|100806740|FG010|STARTED|Step 8: 11/21/2022 to 2/19/2023||55||1
48197818|NCT04663802|100806741|FG011|STARTED|Step 8: 11/21/2022 to 2/19/2023||86||1
48197819|NCT04663802|100806730|FG000|COMPLETED|Step 8: 11/21/2022 to 2/19/2023||71||1
48197820|NCT04663802|100806731|FG001|COMPLETED|Step 8: 11/21/2022 to 2/19/2023||88||1
48197821|NCT04663802|100806732|FG002|COMPLETED|Step 8: 11/21/2022 to 2/19/2023||41||1
48197822|NCT04663802|100806733|FG003|COMPLETED|Step 8: 11/21/2022 to 2/19/2023||46||1
48197823|NCT04663802|100806734|FG004|COMPLETED|Step 8: 11/21/2022 to 2/19/2023||80||1
48197824|NCT04663802|100806735|FG005|COMPLETED|Step 8: 11/21/2022 to 2/19/2023||48||1
48197825|NCT04663802|100806736|FG006|COMPLETED|Step 8: 11/21/2022 to 2/19/2023||103||1
48197826|NCT04663802|100806737|FG007|COMPLETED|Step 8: 11/21/2022 to 2/19/2023||67||1
48197827|NCT04663802|100806738|FG008|COMPLETED|Step 8: 11/21/2022 to 2/19/2023||117||1
48197828|NCT04663802|100806739|FG009|COMPLETED|Step 8: 11/21/2022 to 2/19/2023||80||1
48197829|NCT04663802|100806740|FG010|COMPLETED|Step 8: 11/21/2022 to 2/19/2023||55||1
48197830|NCT04663802|100806741|FG011|COMPLETED|Step 8: 11/21/2022 to 2/19/2023||86||1
48197831|NCT04663802|100806730|FG000|NOT COMPLETED|Step 8: 11/21/2022 to 2/19/2023||0||0
48197832|NCT04663802|100806731|FG001|NOT COMPLETED|Step 8: 11/21/2022 to 2/19/2023||0||0
48197833|NCT04663802|100806732|FG002|NOT COMPLETED|Step 8: 11/21/2022 to 2/19/2023||0||0
48197834|NCT04663802|100806733|FG003|NOT COMPLETED|Step 8: 11/21/2022 to 2/19/2023||0||0
48197835|NCT04663802|100806734|FG004|NOT COMPLETED|Step 8: 11/21/2022 to 2/19/2023||0||0
48197836|NCT04663802|100806735|FG005|NOT COMPLETED|Step 8: 11/21/2022 to 2/19/2023||0||0
48197837|NCT04663802|100806736|FG006|NOT COMPLETED|Step 8: 11/21/2022 to 2/19/2023||0||0
48197838|NCT04663802|100806737|FG007|NOT COMPLETED|Step 8: 11/21/2022 to 2/19/2023||0||0
48197839|NCT04663802|100806738|FG008|NOT COMPLETED|Step 8: 11/21/2022 to 2/19/2023||0||0
48197840|NCT04663802|100806739|FG009|NOT COMPLETED|Step 8: 11/21/2022 to 2/19/2023||0||0
48197841|NCT04663802|100806740|FG010|NOT COMPLETED|Step 8: 11/21/2022 to 2/19/2023||0||0
48197842|NCT04663802|100806741|FG011|NOT COMPLETED|Step 8: 11/21/2022 to 2/19/2023||0||0
48197843|NCT04663802|100806730|FG000|STARTED|Step 9: 2/20/2023 to 5/15/2023||72||1
48197844|NCT04663802|100806731|FG001|STARTED|Step 9: 2/20/2023 to 5/15/2023||65||1
48197845|NCT04663802|100806732|FG002|STARTED|Step 9: 2/20/2023 to 5/15/2023||35||1
48197846|NCT04663802|100806733|FG003|STARTED|Step 9: 2/20/2023 to 5/15/2023||38||1
48197847|NCT04663802|100806734|FG004|STARTED|Step 9: 2/20/2023 to 5/15/2023||73||1
48197848|NCT04663802|100806735|FG005|STARTED|Step 9: 2/20/2023 to 5/15/2023||43||1
48197849|NCT04663802|100806736|FG006|STARTED|Step 9: 2/20/2023 to 5/15/2023||85||1
48197850|NCT04663802|100806737|FG007|STARTED|Step 9: 2/20/2023 to 5/15/2023||56||1
48197851|NCT04663802|100806738|FG008|STARTED|Step 9: 2/20/2023 to 5/15/2023||103||1
48197852|NCT04663802|100806739|FG009|STARTED|Step 9: 2/20/2023 to 5/15/2023||55||1
48197853|NCT04663802|100806740|FG010|STARTED|Step 9: 2/20/2023 to 5/15/2023||53||1
48197854|NCT04663802|100806741|FG011|STARTED|Step 9: 2/20/2023 to 5/15/2023||43||1
48197855|NCT04663802|100806730|FG000|COMPLETED|Step 9: 2/20/2023 to 5/15/2023||72||1
48197856|NCT04663802|100806731|FG001|COMPLETED|Step 9: 2/20/2023 to 5/15/2023||65||1
48197857|NCT04663802|100806732|FG002|COMPLETED|Step 9: 2/20/2023 to 5/15/2023||35||1
48197858|NCT04663802|100806733|FG003|COMPLETED|Step 9: 2/20/2023 to 5/15/2023||38||1
48197859|NCT04663802|100806734|FG004|COMPLETED|Step 9: 2/20/2023 to 5/15/2023||73||1
48197860|NCT04663802|100806735|FG005|COMPLETED|Step 9: 2/20/2023 to 5/15/2023||43||1
48197861|NCT04663802|100806736|FG006|COMPLETED|Step 9: 2/20/2023 to 5/15/2023||85||1
48197862|NCT04663802|100806737|FG007|COMPLETED|Step 9: 2/20/2023 to 5/15/2023||56||1
48197863|NCT04663802|100806738|FG008|COMPLETED|Step 9: 2/20/2023 to 5/15/2023||103||1
48197864|NCT04663802|100806739|FG009|COMPLETED|Step 9: 2/20/2023 to 5/15/2023||55||1
48197865|NCT04663802|100806740|FG010|COMPLETED|Step 9: 2/20/2023 to 5/15/2023||53||1
48197866|NCT04663802|100806741|FG011|COMPLETED|Step 9: 2/20/2023 to 5/15/2023||43||1
48197867|NCT04663802|100806730|FG000|NOT COMPLETED|Step 9: 2/20/2023 to 5/15/2023||0||0
48197868|NCT04663802|100806731|FG001|NOT COMPLETED|Step 9: 2/20/2023 to 5/15/2023||0||0
48197869|NCT04663802|100806732|FG002|NOT COMPLETED|Step 9: 2/20/2023 to 5/15/2023||0||0
48197870|NCT04663802|100806733|FG003|NOT COMPLETED|Step 9: 2/20/2023 to 5/15/2023||0||0
48197871|NCT04663802|100806734|FG004|NOT COMPLETED|Step 9: 2/20/2023 to 5/15/2023||0||0
48197872|NCT04663802|100806735|FG005|NOT COMPLETED|Step 9: 2/20/2023 to 5/15/2023||0||0
48197873|NCT04663802|100806736|FG006|NOT COMPLETED|Step 9: 2/20/2023 to 5/15/2023||0||0
48197874|NCT04663802|100806737|FG007|NOT COMPLETED|Step 9: 2/20/2023 to 5/15/2023||0||0
48197875|NCT04663802|100806738|FG008|NOT COMPLETED|Step 9: 2/20/2023 to 5/15/2023||0||0
48197876|NCT04663802|100806739|FG009|NOT COMPLETED|Step 9: 2/20/2023 to 5/15/2023||0||0
48197877|NCT04663802|100806740|FG010|NOT COMPLETED|Step 9: 2/20/2023 to 5/15/2023||0||0
48197878|NCT04663802|100806741|FG011|NOT COMPLETED|Step 9: 2/20/2023 to 5/15/2023||0||0
48197879|NCT00427557|100806742|FG000|STARTED|Overall Study||30||
48197880|NCT00427557|100806742|FG000|COMPLETED|Overall Study||30||
48197881|NCT00427557|100806742|FG000|NOT COMPLETED|Overall Study||0||
48197882|NCT00683410|100806743|FG000|STARTED|Overall Study||3366||
48197883|NCT00683410|100806743|FG000|Vaccinated Dose 1|Overall Study||3240||
48197884|NCT00683410|100806743|FG000|Vaccinated Dose 2|Overall Study||1623||
48197885|NCT00683410|100806743|FG000|Vaccinated Dose 3|Overall Study||817||
48197886|NCT00683410|100806743|FG000|Vaccinated Dose 4|Overall Study||175||
48197887|NCT00683410|100806743|FG000|COMPLETED|Overall Study||3366||
48197888|NCT00683410|100806743|FG000|NOT COMPLETED|Overall Study||0||
48197889|NCT02107014|100806744|FG000|STARTED|Overall Study||9||
48197890|NCT02107014|100806744|FG000|COMPLETED|Overall Study||8||
48197891|NCT02107014|100806744|FG000|NOT COMPLETED|Overall Study||1||
48197892|NCT00434278|100806745|FG000|STARTED|Overall Study||14||
48197893|NCT00434278|100806746|FG001|STARTED|Overall Study||13||
48197894|NCT00434278|100806745|FG000|COMPLETED|Overall Study||12||
48197895|NCT00434278|100806746|FG001|COMPLETED|Overall Study||13||
48197896|NCT00434278|100806745|FG000|NOT COMPLETED|Overall Study||2||
48197897|NCT00434278|100806746|FG001|NOT COMPLETED|Overall Study||0||
48197898|NCT00371566|100806747|FG000|STARTED|Treatment Phase||36||
48197899|NCT00371566|100806748|FG001|STARTED|Treatment Phase||71||
48197900|NCT00371566|100806747|FG000|COMPLETED|Treatment Phase||36||
48197901|NCT00371566|100806748|FG001|COMPLETED|Treatment Phase||68||
48197902|NCT00371566|100806747|FG000|NOT COMPLETED|Treatment Phase||0||
48197903|NCT00371566|100806748|FG001|NOT COMPLETED|Treatment Phase||3||
48197904|NCT00371566|100806747|FG000|STARTED|Chemoradiation Phase||36||
48197905|NCT00371566|100806748|FG001|STARTED|Chemoradiation Phase||68||
48197906|NCT00371566|100806747|FG000|COMPLETED|Chemoradiation Phase||31||
48197907|NCT00371566|100806748|FG001|COMPLETED|Chemoradiation Phase||65||
48197908|NCT00371566|100806747|FG000|NOT COMPLETED|Chemoradiation Phase||5||
48197909|NCT00371566|100806748|FG001|NOT COMPLETED|Chemoradiation Phase||3||
48197910|NCT00371566|100806747|FG000|STARTED|Follow Up Phase||31||
48197911|NCT00371566|100806748|FG001|STARTED|Follow Up Phase||65||
48197912|NCT00371566|100806747|FG000|COMPLETED|Follow Up Phase||28||
48197913|NCT00371566|100806748|FG001|COMPLETED|Follow Up Phase||58||
48197914|NCT00371566|100806747|FG000|NOT COMPLETED|Follow Up Phase||3||
48197915|NCT00371566|100806748|FG001|NOT COMPLETED|Follow Up Phase||7||
48197916|NCT03124108|100806749|FG000|STARTED|Overall Study||15||
48197917|NCT03124108|100806750|FG001|STARTED|Overall Study||15||
48197918|NCT03124108|100806751|FG002|STARTED|Overall Study||15||
48197919|NCT03124108|100806749|FG000|COMPLETED|Overall Study||15||
48197920|NCT03124108|100806750|FG001|COMPLETED|Overall Study||14||
48197921|NCT03124108|100806751|FG002|COMPLETED|Overall Study||15||
48197922|NCT03124108|100806749|FG000|NOT COMPLETED|Overall Study||0||
48197923|NCT03124108|100806750|FG001|NOT COMPLETED|Overall Study||1||
48197924|NCT03124108|100806751|FG002|NOT COMPLETED|Overall Study||0||
48197925|NCT02057718|100806752|FG000|STARTED|Completed Study Treatment Through Wk. 72||8||
48197926|NCT02057718|100806753|FG001|STARTED|Completed Study Treatment Through Wk. 72||25||
48197927|NCT02057718|100806752|FG000|Completed Study Treatment Through Week 72|Completed Study Treatment Through Wk. 72||6||
48197928|NCT02057718|100806753|FG001|Completed Study Treatment Through Week 72|Completed Study Treatment Through Wk. 72||16||
48197929|NCT02057718|100806752|FG000|COMPLETED|Completed Study Treatment Through Wk. 72||6||
48197930|NCT02057718|100806753|FG001|COMPLETED|Completed Study Treatment Through Wk. 72||16||
48197931|NCT02057718|100806752|FG000|NOT COMPLETED|Completed Study Treatment Through Wk. 72||2||
48197932|NCT02057718|100806753|FG001|NOT COMPLETED|Completed Study Treatment Through Wk. 72||9||
48197933|NCT02057718|100806752|FG000|STARTED|Optional Follow-up Treatment Period||6||
48197934|NCT02057718|100806753|FG001|STARTED|Optional Follow-up Treatment Period||16||
48197935|NCT02057718|100806752|FG000|COMPLETED|Optional Follow-up Treatment Period||4||
48197936|NCT02057718|100806753|FG001|COMPLETED|Optional Follow-up Treatment Period||8||
48197937|NCT02057718|100806752|FG000|NOT COMPLETED|Optional Follow-up Treatment Period||2||
48197938|NCT02057718|100806753|FG001|NOT COMPLETED|Optional Follow-up Treatment Period||8||
48197939|NCT03095508|100806754|FG000|STARTED|Overall Study||114||
48197940|NCT03095508|100806755|FG001|STARTED|Overall Study||115||
48197941|NCT03095508|100806754|FG000|Per Protocol Population|Overall Study||112||
48197942|NCT03095508|100806755|FG001|Per Protocol Population|Overall Study||111||
48197943|NCT03095508|100806754|FG000|Safety Population|Overall Study||114||
48197944|NCT03095508|100806755|FG001|Safety Population|Overall Study||115||
48197945|NCT03095508|100806754|FG000|ITT Population|Overall Study||114||
48197946|NCT03095508|100806755|FG001|ITT Population|Overall Study||115||
48197947|NCT03095508|100806754|FG000|COMPLETED|Overall Study||114||
48197948|NCT03095508|100806755|FG001|COMPLETED|Overall Study||114||
48197949|NCT03095508|100806754|FG000|NOT COMPLETED|Overall Study||0||
48197950|NCT03095508|100806755|FG001|NOT COMPLETED|Overall Study||1||
48197951|NCT00667693|100806756|FG000|STARTED|Overall Study||49||
48197952|NCT00667693|100806757|FG001|STARTED|Overall Study||52||
48197953|NCT00667693|100806756|FG000|COMPLETED|Overall Study||49||
48197954|NCT00667693|100806757|FG001|COMPLETED|Overall Study||50||
48197955|NCT00667693|100806756|FG000|NOT COMPLETED|Overall Study||0||
48197956|NCT00667693|100806757|FG001|NOT COMPLETED|Overall Study||2||
48197957|NCT04536077|100806758|FG000|STARTED|Overall Study||8||
48197958|NCT04536077|100806759|FG001|STARTED|Overall Study||8||
48197959|NCT04536077|100806758|FG000|COMPLETED|Overall Study||7||
48197960|NCT04536077|100806759|FG001|COMPLETED|Overall Study||7||
48197961|NCT04536077|100806758|FG000|NOT COMPLETED|Overall Study||1||
48197962|NCT04536077|100806759|FG001|NOT COMPLETED|Overall Study||1||
48197963|NCT01839877|100806760|FG000|STARTED|Overall Study||58||
48197964|NCT01839877|100806760|FG000|COMPLETED|Overall Study||57||
48197965|NCT01839877|100806760|FG000|NOT COMPLETED|Overall Study||1||
48197966|NCT01565928|100806761|FG000|STARTED|Overall Study||22||
48197967|NCT01565928|100806761|FG000|COMPLETED|Overall Study||0||
48197968|NCT01565928|100806761|FG000|NOT COMPLETED|Overall Study||22||
48197969|NCT00603538|100806762|FG000|STARTED|Overall Study||6||
48197970|NCT00603538|100806763|FG001|STARTED|Overall Study||7||
48197971|NCT00603538|100806764|FG002|STARTED|Overall Study||6||
48197972|NCT00603538|100806762|FG000|COMPLETED|Overall Study||3||
48197973|NCT00603538|100806763|FG001|COMPLETED|Overall Study||3||
48197974|NCT00603538|100806764|FG002|COMPLETED|Overall Study||4||
48485452|NCT00934050|101525397|FG003|COMPLETED|Enrolled After 15 Dec 2009||0||
48485453|NCT00934050|101525398|FG004|COMPLETED|Enrolled After 15 Dec 2009||19||
48485454|NCT00934050|101525399|FG005|COMPLETED|Enrolled After 15 Dec 2009||23||
48485455|NCT00934050|101525394|FG000|NOT COMPLETED|Enrolled After 15 Dec 2009||0||
48485456|NCT00934050|101525395|FG001|NOT COMPLETED|Enrolled After 15 Dec 2009||0||
48485457|NCT00934050|101525396|FG002|NOT COMPLETED|Enrolled After 15 Dec 2009||0||
48485458|NCT00934050|101525397|FG003|NOT COMPLETED|Enrolled After 15 Dec 2009||0||
48485459|NCT00934050|101525398|FG004|NOT COMPLETED|Enrolled After 15 Dec 2009||7||
48485460|NCT00934050|101525399|FG005|NOT COMPLETED|Enrolled After 15 Dec 2009||4||
48485461|NCT03670017|101525400|FG000|STARTED|Overall Study||68||
48485462|NCT03670017|101525400|FG000|COMPLETED|Overall Study||50||
48485463|NCT03670017|101525400|FG000|NOT COMPLETED|Overall Study||18||
48485464|NCT03547622|101525401|FG000|STARTED|Overall Study||3||
48485465|NCT03547622|101525402|FG001|STARTED|Overall Study||3||
48485466|NCT03547622|101525401|FG000|COMPLETED|Overall Study||3||
48485467|NCT03547622|101525402|FG001|COMPLETED|Overall Study||2||
48485468|NCT03547622|101525401|FG000|NOT COMPLETED|Overall Study||0||
48485469|NCT03547622|101525402|FG001|NOT COMPLETED|Overall Study||1||
48485470|NCT00185458|101525403|FG000|STARTED|Contraception Phase||394||
48485471|NCT00185458|101525403|FG000|COMPLETED|Contraception Phase||336||
48485472|NCT00185458|101525403|FG000|NOT COMPLETED|Contraception Phase||58||
48485473|NCT00185458|101525403|FG000|STARTED|HRT Phase||168||
48485474|NCT00185458|101525403|FG000|COMPLETED|HRT Phase||141||
48485475|NCT00185458|101525403|FG000|NOT COMPLETED|HRT Phase||27||
48485476|NCT01370733|101525404|FG000|STARTED|Overall Study||103||
48485477|NCT01370733|101525405|FG001|STARTED|Overall Study||99||
48485478|NCT01370733|101525404|FG000|COMPLETED|Overall Study||86||
48485479|NCT01370733|101525405|FG001|COMPLETED|Overall Study||77||
48485480|NCT01370733|101525404|FG000|NOT COMPLETED|Overall Study||17||
48485481|NCT01370733|101525405|FG001|NOT COMPLETED|Overall Study||22||
48485482|NCT00359281|101525406|FG000|STARTED|Overall Study||16||
48485483|NCT00359281|101525407|FG001|STARTED|Overall Study||15||
48485484|NCT00359281|101525408|FG002|STARTED|Overall Study||10||
48485485|NCT00359281|101525409|FG003|STARTED|Overall Study||10||
48485486|NCT00359281|101525410|FG004|STARTED|Overall Study||10||
48485487|NCT00359281|101525411|FG005|STARTED|Overall Study||15||
48485488|NCT00359281|101525412|FG006|STARTED|Overall Study||18||
48485489|NCT00359281|101525413|FG007|STARTED|Overall Study||15||
48485490|NCT00359281|101525414|FG008|STARTED|Overall Study||20||
48485491|NCT00359281|101525406|FG000|COMPLETED|Overall Study||15||
48485492|NCT00359281|101525407|FG001|COMPLETED|Overall Study||15||
48485493|NCT00359281|101525408|FG002|COMPLETED|Overall Study||10||
48485494|NCT00359281|101525409|FG003|COMPLETED|Overall Study||10||
48485495|NCT00359281|101525410|FG004|COMPLETED|Overall Study||10||
48485496|NCT00359281|101525411|FG005|COMPLETED|Overall Study||15||
48485497|NCT00359281|101525412|FG006|COMPLETED|Overall Study||16||
48485498|NCT00359281|101525413|FG007|COMPLETED|Overall Study||15||
48485499|NCT00359281|101525414|FG008|COMPLETED|Overall Study||20||
48485500|NCT00359281|101525406|FG000|NOT COMPLETED|Overall Study||1||
48485501|NCT00359281|101525407|FG001|NOT COMPLETED|Overall Study||0||
48485502|NCT00359281|101525408|FG002|NOT COMPLETED|Overall Study||0||
48485503|NCT00359281|101525409|FG003|NOT COMPLETED|Overall Study||0||
48485504|NCT00359281|101525410|FG004|NOT COMPLETED|Overall Study||0||
48485505|NCT00359281|101525411|FG005|NOT COMPLETED|Overall Study||0||
48485506|NCT00359281|101525412|FG006|NOT COMPLETED|Overall Study||2||
48485507|NCT00359281|101525413|FG007|NOT COMPLETED|Overall Study||0||
48485508|NCT00359281|101525414|FG008|NOT COMPLETED|Overall Study||0||
48485509|NCT01879345|101525415|FG000|STARTED|Single-dose Period||6||
48485510|NCT01879345|101525416|FG001|STARTED|Single-dose Period||6||
48485511|NCT01879345|101525417|FG002|STARTED|Single-dose Period||6||
48485512|NCT01879345|101525415|FG000|COMPLETED|Single-dose Period||6||
48485513|NCT01879345|101525416|FG001|COMPLETED|Single-dose Period||6||
48485514|NCT01879345|101525417|FG002|COMPLETED|Single-dose Period||6||
48485515|NCT01879345|101525415|FG000|NOT COMPLETED|Single-dose Period||0||
48485516|NCT01879345|101525416|FG001|NOT COMPLETED|Single-dose Period||0||
48485517|NCT01879345|101525417|FG002|NOT COMPLETED|Single-dose Period||0||
48485518|NCT01879345|101525415|FG000|STARTED|7-day Multiple-dose Period||6||
48485519|NCT01879345|101525416|FG001|STARTED|7-day Multiple-dose Period||6||
48485520|NCT01879345|101525417|FG002|STARTED|7-day Multiple-dose Period||6||
48485521|NCT01879345|101525415|FG000|COMPLETED|7-day Multiple-dose Period||6||
48485522|NCT01879345|101525416|FG001|COMPLETED|7-day Multiple-dose Period||6||
48485523|NCT01879345|101525417|FG002|COMPLETED|7-day Multiple-dose Period||6||
48485524|NCT01879345|101525415|FG000|NOT COMPLETED|7-day Multiple-dose Period||0||
48485525|NCT01879345|101525416|FG001|NOT COMPLETED|7-day Multiple-dose Period||0||
48485526|NCT01879345|101525417|FG002|NOT COMPLETED|7-day Multiple-dose Period||0||
48485527|NCT00549718|101525418|FG000|STARTED|Overall Study||125||
48485528|NCT00549718|101525419|FG001|STARTED|Overall Study||123||
48485529|NCT00549718|101525420|FG002|STARTED|Overall Study||124||
48485530|NCT00549718|101525421|FG003|STARTED|Overall Study||128||
48485531|NCT00549718|101525418|FG000|COMPLETED|Overall Study||84||
48485532|NCT00549718|101525419|FG001|COMPLETED|Overall Study||86||
48485533|NCT00549718|101525420|FG002|COMPLETED|Overall Study||85||
48485534|NCT00549718|101525421|FG003|COMPLETED|Overall Study||73||
48485535|NCT00549718|101525418|FG000|NOT COMPLETED|Overall Study||41||
48485536|NCT00549718|101525419|FG001|NOT COMPLETED|Overall Study||37||
48485537|NCT00549718|101525420|FG002|NOT COMPLETED|Overall Study||39||
48485538|NCT00549718|101525421|FG003|NOT COMPLETED|Overall Study||55||
48485539|NCT00645762|101525422|FG000|STARTED|Overall Study||71||
48485540|NCT00645762|101525422|FG000|COMPLETED|Overall Study||67||
48485541|NCT00645762|101525422|FG000|NOT COMPLETED|Overall Study||4||
48485542|NCT03666026|101525423|FG000|STARTED|Overall Study||41070||
48485543|NCT03666026|101525424|FG001|STARTED|Overall Study||41055||
48485544|NCT03666026|101525425|FG002|STARTED|Overall Study||41046||
48485545|NCT03666026|101525426|FG003|STARTED|Overall Study||41034||
48485546|NCT03666026|101525423|FG000|COMPLETED|Overall Study||41070||
48485547|NCT03666026|101525424|FG001|COMPLETED|Overall Study||41055||
48485548|NCT03666026|101525425|FG002|COMPLETED|Overall Study||41046||
48485549|NCT03666026|101525426|FG003|COMPLETED|Overall Study||41034||
48485550|NCT03666026|101525423|FG000|NOT COMPLETED|Overall Study||0||
48485551|NCT03666026|101525424|FG001|NOT COMPLETED|Overall Study||0||
48485552|NCT03666026|101525425|FG002|NOT COMPLETED|Overall Study||0||
48485553|NCT03666026|101525426|FG003|NOT COMPLETED|Overall Study||0||
48485554|NCT01383486|101525427|FG000|STARTED|Overall Study||253||
48485555|NCT01383486|101525427|FG000|Treated|Overall Study||237||
48485556|NCT01383486|101525427|FG000|COMPLETED|Overall Study||235||
48485557|NCT01383486|101525427|FG000|NOT COMPLETED|Overall Study||18||
48485558|NCT05041361|101525428|FG000|STARTED|Overall Study||6||
48485559|NCT05041361|101525429|FG001|STARTED|Overall Study||10||
48485560|NCT05041361|101525428|FG000|COMPLETED|Overall Study||5||
48485561|NCT05041361|101525429|FG001|COMPLETED|Overall Study||7||
48485562|NCT05041361|101525428|FG000|NOT COMPLETED|Overall Study||1||
48485563|NCT05041361|101525429|FG001|NOT COMPLETED|Overall Study||3||
48485564|NCT01721681|101525430|FG000|STARTED|Overall Study||9||
48485565|NCT01721681|101525430|FG000|COMPLETED|Overall Study||9||
48485566|NCT01721681|101525430|FG000|NOT COMPLETED|Overall Study||0||
48485567|NCT02146105|101525431|FG000|STARTED|Overall Study||45||
48485568|NCT02146105|101525431|FG000|COMPLETED|Overall Study||39||
48485569|NCT02146105|101525431|FG000|NOT COMPLETED|Overall Study||6||
48485570|NCT00214097|101525432|FG000|STARTED|Overall Study||101||
48485571|NCT00214097|101525433|FG001|STARTED|Overall Study||111||
48485572|NCT00214097|101525434|FG002|STARTED|Overall Study||135||
48485573|NCT00214097|101525432|FG000|COMPLETED|Overall Study||101||
48485574|NCT00214097|101525433|FG001|COMPLETED|Overall Study||111||
48485575|NCT00214097|101525434|FG002|COMPLETED|Overall Study||135||
48485576|NCT00214097|101525432|FG000|NOT COMPLETED|Overall Study||0||
48485577|NCT00214097|101525433|FG001|NOT COMPLETED|Overall Study||0||
48485578|NCT00214097|101525434|FG002|NOT COMPLETED|Overall Study||0||
48485579|NCT03682653|101525435|FG000|STARTED|Overall Study||10898||
48485580|NCT03682653|101525436|FG001|STARTED|Overall Study||10934||
48485581|NCT03682653|101525435|FG000|Received Allocated Treatment|Overall Study||10898||
48485582|NCT03682653|101525436|FG001|Received Allocated Treatment|Overall Study||10928||
48485583|NCT03682653|101525435|FG000|Day 21|Overall Study||10069||
48197975|NCT00603538|100806762|FG000|NOT COMPLETED|Overall Study||3||
48197976|NCT00603538|100806763|FG001|NOT COMPLETED|Overall Study||4||
48485584|NCT03682653|101525436|FG001|Day 21|Overall Study||10119||
48485585|NCT03682653|101525435|FG000|3 Months|Overall Study||10273||
48485586|NCT03682653|101525436|FG001|3 Months|Overall Study||10356||
48485587|NCT03682653|101525435|FG000|COMPLETED|Overall Study||9606|6 Months (primary endpoint)|
48485588|NCT03682653|101525436|FG001|COMPLETED|Overall Study||9684|6 Months (primary endpoint)|
48485589|NCT03682653|101525435|FG000|NOT COMPLETED|Overall Study||1292||
48485590|NCT03682653|101525436|FG001|NOT COMPLETED|Overall Study||1250||
48485591|NCT02834663|101525437|FG000|STARTED|Overall Study||25||25
48485592|NCT02834663|101525437|FG000|COMPLETED|Overall Study||25||25
48485593|NCT02834663|101525437|FG000|NOT COMPLETED|Overall Study||0||0
48485594|NCT05428020|101525438|FG000|STARTED|Overall Study||194||
48485595|NCT05428020|101525439|FG001|STARTED|Overall Study||194||
48485596|NCT05428020|101525438|FG000|COMPLETED|Overall Study||194||
48485597|NCT05428020|101525439|FG001|COMPLETED|Overall Study||194||
48485598|NCT05428020|101525438|FG000|NOT COMPLETED|Overall Study||0||
48197977|NCT00603538|100806764|FG002|NOT COMPLETED|Overall Study||2||
48485599|NCT05428020|101525439|FG001|NOT COMPLETED|Overall Study||0||
48485600|NCT01136174|101525440|FG000|STARTED|Overall Study||12||
48485601|NCT01136174|101525441|FG001|STARTED|Overall Study||6||
48485602|NCT01136174|101525442|FG002|STARTED|Overall Study||8||
48485603|NCT01136174|101525443|FG003|STARTED|Overall Study||24||
48485604|NCT01136174|101525440|FG000|COMPLETED|Overall Study||12||
48485605|NCT01136174|101525441|FG001|COMPLETED|Overall Study||6||
48485606|NCT01136174|101525442|FG002|COMPLETED|Overall Study||8||
48485607|NCT01136174|101525443|FG003|COMPLETED|Overall Study||20||
48485608|NCT01136174|101525440|FG000|NOT COMPLETED|Overall Study||0||
48485609|NCT01136174|101525441|FG001|NOT COMPLETED|Overall Study||0||
48485610|NCT01136174|101525442|FG002|NOT COMPLETED|Overall Study||0||
48485611|NCT01136174|101525443|FG003|NOT COMPLETED|Overall Study||4||
48485612|NCT00420303|101525444|FG000|STARTED|Overall Study||12||
48485613|NCT00420303|101525445|FG001|STARTED|Overall Study||12||
48485614|NCT00420303|101525444|FG000|COMPLETED|Overall Study||11||
48197978|NCT02410291|100806765|FG000|STARTED|Overall Study||29||
48485615|NCT00420303|101525445|FG001|COMPLETED|Overall Study||8||
48485616|NCT00420303|101525444|FG000|NOT COMPLETED|Overall Study||1||
48485617|NCT00420303|101525445|FG001|NOT COMPLETED|Overall Study||4||
48485618|NCT02632344|101525446|FG000|STARTED|Overall Study||21||
48485619|NCT02632344|101525446|FG000|COMPLETED|Overall Study||13||
48485620|NCT02632344|101525446|FG000|NOT COMPLETED|Overall Study||8||
48485621|NCT01456221|101525447|FG000|STARTED|Overall Study||183||
48485622|NCT01456221|101525448|FG001|STARTED|Overall Study||183||
48485623|NCT01456221|101525447|FG000|COMPLETED|Overall Study||119||
48485624|NCT01456221|101525448|FG001|COMPLETED|Overall Study||126||
48485625|NCT01456221|101525447|FG000|NOT COMPLETED|Overall Study||64||
48485626|NCT01456221|101525448|FG001|NOT COMPLETED|Overall Study||57||
48485627|NCT04298918|101525449|FG000|STARTED|Overall Study||0||
48485628|NCT04298918|101525450|FG001|STARTED|Overall Study||0||
48485629|NCT04298918|101525451|FG002|STARTED|Overall Study||0||
48485630|NCT04298918|101525452|FG003|STARTED|Overall Study||0||
48485631|NCT04298918|101525449|FG000|COMPLETED|Overall Study||0||
48485632|NCT04298918|101525450|FG001|COMPLETED|Overall Study||0||
48485633|NCT04298918|101525451|FG002|COMPLETED|Overall Study||0||
48485634|NCT04298918|101525452|FG003|COMPLETED|Overall Study||0||
48485635|NCT04298918|101525449|FG000|NOT COMPLETED|Overall Study||0||
48485636|NCT04298918|101525450|FG001|NOT COMPLETED|Overall Study||0||
48197979|NCT02410291|100806766|FG001|STARTED|Overall Study||29||
48197980|NCT02410291|100806765|FG000|COMPLETED|Overall Study||29||
48197981|NCT02410291|100806766|FG001|COMPLETED|Overall Study||29||
48197982|NCT02410291|100806765|FG000|NOT COMPLETED|Overall Study||0||
48197983|NCT02410291|100806766|FG001|NOT COMPLETED|Overall Study||0||
48197984|NCT00281918|100806767|FG000|STARTED|Overall Study||409||
48197985|NCT00281918|100806768|FG001|STARTED|Overall Study||408||
48197986|NCT00281918|100806767|FG000|Safety Population; Received Study Drug|Overall Study||398||
48197987|NCT00281918|100806768|FG001|Safety Population; Received Study Drug|Overall Study||402||
48197988|NCT00281918|100806767|FG000|COMPLETED|Overall Study||267||
48197989|NCT00281918|100806768|FG001|COMPLETED|Overall Study||300||
48197990|NCT00281918|100806767|FG000|NOT COMPLETED|Overall Study||142||
48197991|NCT00281918|100806768|FG001|NOT COMPLETED|Overall Study||108||
48197992|NCT03879642|100806769|FG000|STARTED|Overall Study||22||
48197993|NCT03879642|100806770|FG001|STARTED|Overall Study||21||
48197994|NCT03879642|100806769|FG000|COMPLETED|Overall Study||19||
48197995|NCT03879642|100806770|FG001|COMPLETED|Overall Study||18||
48197996|NCT03879642|100806769|FG000|NOT COMPLETED|Overall Study||3||
48197997|NCT03879642|100806770|FG001|NOT COMPLETED|Overall Study||3||
48197998|NCT00580801|100806771|FG000|STARTED|Overall Study||8||
48197999|NCT00580801|100806772|FG001|STARTED|Overall Study||8||
48198000|NCT00580801|100806773|FG002|STARTED|Overall Study||8||
48198001|NCT00580801|100806771|FG000|COMPLETED|Overall Study||2||
48198002|NCT00580801|100806772|FG001|COMPLETED|Overall Study||7||
48198003|NCT00580801|100806773|FG002|COMPLETED|Overall Study||5||
48198004|NCT00580801|100806771|FG000|NOT COMPLETED|Overall Study||6||
48198005|NCT00580801|100806772|FG001|NOT COMPLETED|Overall Study||1||
48198006|NCT00580801|100806773|FG002|NOT COMPLETED|Overall Study||3||
48485637|NCT04298918|101525451|FG002|NOT COMPLETED|Overall Study||0||
48485638|NCT04298918|101525452|FG003|NOT COMPLETED|Overall Study||0||
48485639|NCT02071108|101525453|FG000|STARTED|Overall Study||35||
48485640|NCT02071108|101525453|FG000|COMPLETED|Overall Study||35||
48485641|NCT02071108|101525453|FG000|NOT COMPLETED|Overall Study||0||
48485642|NCT01802320|101525454|FG000|STARTED|Overall Study||18||
48485643|NCT01802320|101525454|FG000|COMPLETED|Overall Study||16||
48485644|NCT01802320|101525454|FG000|NOT COMPLETED|Overall Study||2||
48485645|NCT02335658|101525455|FG000|STARTED|Overall Study||97||
48485646|NCT02335658|101525456|FG001|STARTED|Overall Study||103||
48485647|NCT02335658|101525455|FG000|COMPLETED|Overall Study||57||
48485648|NCT02335658|101525456|FG001|COMPLETED|Overall Study||59||
48485649|NCT02335658|101525455|FG000|NOT COMPLETED|Overall Study||40||
48485650|NCT02335658|101525456|FG001|NOT COMPLETED|Overall Study||44||
48485651|NCT01636661|101525457|FG000|STARTED|Overall Study||5||
48198007|NCT03256344|100806774|FG000|STARTED|Overall Study||11||
48198008|NCT03256344|100806775|FG001|STARTED|Overall Study||25||
48198009|NCT03256344|100806774|FG000|Received Talimogene Laherparepvec|Overall Study||8||
48198010|NCT03256344|100806775|FG001|Received Talimogene Laherparepvec|Overall Study||23||
48198011|NCT03256344|100806774|FG000|Received Atezolizumab|Overall Study||10||
48198012|NCT03256344|100806775|FG001|Received Atezolizumab|Overall Study||24||
48198013|NCT03256344|100806774|FG000|Safety Analysis Set|Overall Study||10|All participants who received at least 1 dose of talimogene laherparepvec or atezolizumab.|
48198014|NCT03256344|100806775|FG001|Safety Analysis Set|Overall Study||24|All participants who received at least 1 dose of talimogene laherparepvec or atezolizumab.|
48198015|NCT03256344|100806774|FG000|COMPLETED|Overall Study||1||
48198016|NCT03256344|100806775|FG001|COMPLETED|Overall Study||0||
48198017|NCT03256344|100806774|FG000|NOT COMPLETED|Overall Study||10||
48198018|NCT03256344|100806775|FG001|NOT COMPLETED|Overall Study||25||
48198019|NCT02485834|100806776|FG000|STARTED|Overall Study||3|Randomized|
48198020|NCT02485834|100806777|FG001|STARTED|Overall Study||2|Randomized|
48198021|NCT02485834|100806776|FG000|COMPLETED|Overall Study||3||
48198022|NCT02485834|100806777|FG001|COMPLETED|Overall Study||2||
48198023|NCT02485834|100806776|FG000|NOT COMPLETED|Overall Study||0||
48198024|NCT02485834|100806777|FG001|NOT COMPLETED|Overall Study||0||
48198025|NCT03646669|100806778|FG000|STARTED|Overall Study||33||
48198026|NCT03646669|100806779|FG001|STARTED|Overall Study||25||
48198027|NCT03646669|100806778|FG000|COMPLETED|Overall Study||28||
48198028|NCT03646669|100806779|FG001|COMPLETED|Overall Study||25||
48198029|NCT03646669|100806778|FG000|NOT COMPLETED|Overall Study||5||
48198030|NCT03646669|100806779|FG001|NOT COMPLETED|Overall Study||0||
48198031|NCT01645111|100806780|FG000|STARTED|Overall Study||50||
48198032|NCT01645111|100806780|FG000|COMPLETED|Overall Study||35||
48198033|NCT01645111|100806780|FG000|NOT COMPLETED|Overall Study||15||
48198034|NCT03631199|100806781|FG000|STARTED|Overall Study||10||
48198035|NCT03631199|100806782|FG001|STARTED|Overall Study||11||
48198036|NCT03631199|100806783|FG002|STARTED|Overall Study||9||
48198037|NCT03631199|100806784|FG003|STARTED|Overall Study||320||
48198038|NCT03631199|100806785|FG004|STARTED|Overall Study||323||
48198039|NCT03631199|100806781|FG000|COMPLETED|Overall Study||0||
48198040|NCT03631199|100806782|FG001|COMPLETED|Overall Study||0||
48198041|NCT03631199|100806783|FG002|COMPLETED|Overall Study||0||
48198042|NCT03631199|100806784|FG003|COMPLETED|Overall Study||0||
48198043|NCT03631199|100806785|FG004|COMPLETED|Overall Study||0||
48198044|NCT03631199|100806781|FG000|NOT COMPLETED|Overall Study||10||
48198045|NCT03631199|100806782|FG001|NOT COMPLETED|Overall Study||11||
48198046|NCT03631199|100806783|FG002|NOT COMPLETED|Overall Study||9||
48198047|NCT03631199|100806784|FG003|NOT COMPLETED|Overall Study||320||
48198048|NCT03631199|100806785|FG004|NOT COMPLETED|Overall Study||323||
48198049|NCT04858425|100806786|FG000|STARTED|Overall Study||84||
48198050|NCT04858425|100806787|FG001|STARTED|Overall Study||82||
48198051|NCT04858425|100806786|FG000|COMPLETED|Overall Study||74||
48198052|NCT04858425|100806787|FG001|COMPLETED|Overall Study||77||
48198053|NCT04858425|100806786|FG000|NOT COMPLETED|Overall Study||10||
48198054|NCT04858425|100806787|FG001|NOT COMPLETED|Overall Study||5||
48198055|NCT01155869|100806788|FG000|STARTED|Overall Study||3||
48198056|NCT01155869|100806789|FG001|STARTED|Overall Study||4||
48198057|NCT01155869|100806788|FG000|COMPLETED|Overall Study||0||
48198058|NCT01155869|100806789|FG001|COMPLETED|Overall Study||3||
48198059|NCT01155869|100806788|FG000|NOT COMPLETED|Overall Study||3||
48198060|NCT01155869|100806789|FG001|NOT COMPLETED|Overall Study||1||
48198061|NCT01972152|100806790|FG000|STARTED|First Treatment Visit||5||
48198062|NCT01972152|100806791|FG001|STARTED|First Treatment Visit||5||
48198063|NCT01972152|100806792|FG002|STARTED|First Treatment Visit||5||
48198064|NCT01972152|100806793|FG003|STARTED|First Treatment Visit||5||
48198065|NCT01972152|100806794|FG004|STARTED|First Treatment Visit||5||
48198066|NCT01972152|100806795|FG005|STARTED|First Treatment Visit||5||
48198067|NCT01972152|100806790|FG000|COMPLETED|First Treatment Visit||5||
48198068|NCT01972152|100806791|FG001|COMPLETED|First Treatment Visit||4||
48198069|NCT01972152|100806792|FG002|COMPLETED|First Treatment Visit||5||
48198070|NCT01972152|100806793|FG003|COMPLETED|First Treatment Visit||5||
48198071|NCT01972152|100806794|FG004|COMPLETED|First Treatment Visit||5||
48198072|NCT01972152|100806795|FG005|COMPLETED|First Treatment Visit||5||
48198073|NCT01972152|100806790|FG000|NOT COMPLETED|First Treatment Visit||0||
48198074|NCT01972152|100806791|FG001|NOT COMPLETED|First Treatment Visit||1||
48198075|NCT01972152|100806792|FG002|NOT COMPLETED|First Treatment Visit||0||
48198076|NCT01972152|100806793|FG003|NOT COMPLETED|First Treatment Visit||0||
48198077|NCT01972152|100806794|FG004|NOT COMPLETED|First Treatment Visit||0||
48198078|NCT01972152|100806795|FG005|NOT COMPLETED|First Treatment Visit||0||
48198079|NCT01972152|100806790|FG000|STARTED|Second Treatment Visit||5||
48198080|NCT01972152|100806791|FG001|STARTED|Second Treatment Visit||4||
48198081|NCT01972152|100806792|FG002|STARTED|Second Treatment Visit||5||
48198082|NCT01972152|100806793|FG003|STARTED|Second Treatment Visit||5||
48198083|NCT01972152|100806794|FG004|STARTED|Second Treatment Visit||5||
48198084|NCT01972152|100806795|FG005|STARTED|Second Treatment Visit||5||
48198085|NCT01972152|100806790|FG000|COMPLETED|Second Treatment Visit||5||
48198086|NCT01972152|100806791|FG001|COMPLETED|Second Treatment Visit||3||
48198087|NCT01972152|100806792|FG002|COMPLETED|Second Treatment Visit||5||
48198088|NCT01972152|100806793|FG003|COMPLETED|Second Treatment Visit||5||
48198089|NCT01972152|100806794|FG004|COMPLETED|Second Treatment Visit||5||
48198090|NCT01972152|100806795|FG005|COMPLETED|Second Treatment Visit||5||
48198091|NCT01972152|100806790|FG000|NOT COMPLETED|Second Treatment Visit||0||
48198092|NCT01972152|100806791|FG001|NOT COMPLETED|Second Treatment Visit||1||
48198093|NCT01972152|100806792|FG002|NOT COMPLETED|Second Treatment Visit||0||
48198094|NCT01972152|100806793|FG003|NOT COMPLETED|Second Treatment Visit||0||
48198095|NCT01972152|100806794|FG004|NOT COMPLETED|Second Treatment Visit||0||
48198096|NCT01972152|100806795|FG005|NOT COMPLETED|Second Treatment Visit||0||
48198097|NCT01972152|100806790|FG000|STARTED|Third Treatment Visit||5||
48198098|NCT01972152|100806791|FG001|STARTED|Third Treatment Visit||3||
48198099|NCT01972152|100806792|FG002|STARTED|Third Treatment Visit||5||
48198100|NCT01972152|100806793|FG003|STARTED|Third Treatment Visit||5||
48198101|NCT01972152|100806794|FG004|STARTED|Third Treatment Visit||5||
48198102|NCT01972152|100806795|FG005|STARTED|Third Treatment Visit||5||
48198103|NCT01972152|100806790|FG000|COMPLETED|Third Treatment Visit||5||
48198104|NCT01972152|100806791|FG001|COMPLETED|Third Treatment Visit||3||
48198105|NCT01972152|100806792|FG002|COMPLETED|Third Treatment Visit||5||
48198106|NCT01972152|100806793|FG003|COMPLETED|Third Treatment Visit||5||
48198107|NCT01972152|100806794|FG004|COMPLETED|Third Treatment Visit||5||
48198108|NCT01972152|100806795|FG005|COMPLETED|Third Treatment Visit||5||
48198109|NCT01972152|100806790|FG000|NOT COMPLETED|Third Treatment Visit||0||
48198110|NCT01972152|100806791|FG001|NOT COMPLETED|Third Treatment Visit||0||
48198111|NCT01972152|100806792|FG002|NOT COMPLETED|Third Treatment Visit||0||
48198112|NCT01972152|100806793|FG003|NOT COMPLETED|Third Treatment Visit||0||
48198113|NCT01972152|100806794|FG004|NOT COMPLETED|Third Treatment Visit||0||
48198114|NCT01972152|100806795|FG005|NOT COMPLETED|Third Treatment Visit||0||
48198115|NCT01494662|100810096|FG000|STARTED|Overall Study||40||
48198116|NCT01494662|100810097|FG001|STARTED|Overall Study||5||
48198117|NCT01494662|100810098|FG002|STARTED|Overall Study||39||
48198118|NCT01494662|100810099|FG003|STARTED|Overall Study||12||
48198119|NCT01494662|100810100|FG004|STARTED|Overall Study||6||
48198120|NCT01494662|100810101|FG005|STARTED|Overall Study||17||
48198121|NCT01494662|100810102|FG006|STARTED|Overall Study||21||
48198122|NCT01494662|100810096|FG000|COMPLETED|Overall Study||40||
48198123|NCT01494662|100810097|FG001|COMPLETED|Overall Study||5||
48198124|NCT01494662|100810098|FG002|COMPLETED|Overall Study||37||
48198125|NCT01494662|100810099|FG003|COMPLETED|Overall Study||12||
48198126|NCT01494662|100810100|FG004|COMPLETED|Overall Study||6||
48198127|NCT01494662|100810101|FG005|COMPLETED|Overall Study||17||
48198128|NCT01494662|100810102|FG006|COMPLETED|Overall Study||21||
48198129|NCT01494662|100810096|FG000|NOT COMPLETED|Overall Study||0||
48198130|NCT01494662|100810097|FG001|NOT COMPLETED|Overall Study||0||
48198131|NCT01494662|100810098|FG002|NOT COMPLETED|Overall Study||2||
48198132|NCT01494662|100810099|FG003|NOT COMPLETED|Overall Study||0||
48198133|NCT01494662|100810100|FG004|NOT COMPLETED|Overall Study||0||
48198134|NCT01494662|100810101|FG005|NOT COMPLETED|Overall Study||0||
48198135|NCT01494662|100810102|FG006|NOT COMPLETED|Overall Study||0||
48198136|NCT03523091|100810103|FG000|STARTED|Overall Study||1||
48198137|NCT03523091|100810104|FG001|STARTED|Overall Study||5||
48198138|NCT03523091|100810103|FG000|COMPLETED|Overall Study||0||
48198139|NCT03523091|100810104|FG001|COMPLETED|Overall Study||1||
48198140|NCT03523091|100810103|FG000|NOT COMPLETED|Overall Study||1||
48198141|NCT03523091|100810104|FG001|NOT COMPLETED|Overall Study||4||
48198142|NCT00768066|100810105|FG000|STARTED|Overall Study||22||
48198143|NCT00768066|100810106|FG001|STARTED|Overall Study||22||
48198144|NCT00768066|100810107|FG002|STARTED|Overall Study||21||
48198145|NCT00768066|100810105|FG000|COMPLETED|Overall Study||19||
48198146|NCT00768066|100810106|FG001|COMPLETED|Overall Study||19||
48198147|NCT00768066|100810107|FG002|COMPLETED|Overall Study||21||
48198148|NCT00768066|100810105|FG000|NOT COMPLETED|Overall Study||3||
48198149|NCT00768066|100810106|FG001|NOT COMPLETED|Overall Study||3||
48198150|NCT00768066|100810107|FG002|NOT COMPLETED|Overall Study||0||
48198151|NCT01183533|100810108|FG000|STARTED|Overall Study||40||
48198152|NCT01183533|100810108|FG000|COMPLETED|Overall Study||40||
48198153|NCT01183533|100810108|FG000|NOT COMPLETED|Overall Study||0||
48198154|NCT02020018|100810109|FG000|STARTED|Overall Study||272||
48198155|NCT02020018|100810110|FG001|STARTED|Overall Study||1597||
48198156|NCT02020018|100810109|FG000|COMPLETED|Overall Study||272||
48198157|NCT02020018|100810110|FG001|COMPLETED|Overall Study||1597||
48198158|NCT02020018|100810109|FG000|NOT COMPLETED|Overall Study||0||
48198159|NCT02020018|100810110|FG001|NOT COMPLETED|Overall Study||0||
48198160|NCT04208243|100810111|FG000|STARTED|Overall Study||83||
48198161|NCT04208243|100810111|FG000|COMPLETED|Overall Study||83||
48198162|NCT04208243|100810111|FG000|NOT COMPLETED|Overall Study||0||
48198163|NCT01245439|100810112|FG000|STARTED|Overall Study||65||
48198164|NCT01245439|100810112|FG000|COMPLETED|Overall Study||65||
48198165|NCT01245439|100810112|FG000|NOT COMPLETED|Overall Study||0||
48198166|NCT00964366|100810113|FG000|STARTED|Overall Study||28||
48198167|NCT00964366|100810114|FG001|STARTED|Overall Study||25||
48198168|NCT00964366|100810113|FG000|COMPLETED|Overall Study||27||
48198169|NCT00964366|100810114|FG001|COMPLETED|Overall Study||24||
48198170|NCT00964366|100810113|FG000|NOT COMPLETED|Overall Study||1||
48198171|NCT00964366|100810114|FG001|NOT COMPLETED|Overall Study||1||
48198172|NCT05579886|100810115|FG000|STARTED|Period 1: Control Lens, 2 Weeks||60||
48198173|NCT05579886|100810116|FG001|STARTED|Period 1: Control Lens, 2 Weeks||0||
48198174|NCT05579886|100810115|FG000|COMPLETED|Period 1: Control Lens, 2 Weeks||60||
48198175|NCT05579886|100810116|FG001|COMPLETED|Period 1: Control Lens, 2 Weeks||0||
48198176|NCT05579886|100810115|FG000|NOT COMPLETED|Period 1: Control Lens, 2 Weeks||0||
48198177|NCT05579886|100810116|FG001|NOT COMPLETED|Period 1: Control Lens, 2 Weeks||0||
48198178|NCT05579886|100810115|FG000|STARTED|Period 2: Test Lens, 2 Weeks||0||
48198179|NCT05579886|100810116|FG001|STARTED|Period 2: Test Lens, 2 Weeks||60||
48198180|NCT05579886|100810115|FG000|COMPLETED|Period 2: Test Lens, 2 Weeks||0||
48198181|NCT05579886|100810116|FG001|COMPLETED|Period 2: Test Lens, 2 Weeks||60||
48198182|NCT05579886|100810115|FG000|NOT COMPLETED|Period 2: Test Lens, 2 Weeks||0||
48198183|NCT05579886|100810116|FG001|NOT COMPLETED|Period 2: Test Lens, 2 Weeks||0||
48198184|NCT00003656|100810117|FG000|STARTED|Overall Study||12||
48198185|NCT00003656|100810118|FG001|STARTED|Overall Study||14||
48198186|NCT00003656|100810117|FG000|COMPLETED|Overall Study||12||
48198187|NCT00003656|100810118|FG001|COMPLETED|Overall Study||13||
48198188|NCT00003656|100810117|FG000|NOT COMPLETED|Overall Study||0||
48198189|NCT00003656|100810118|FG001|NOT COMPLETED|Overall Study||1||
48198190|NCT00197015|100810119|FG000|STARTED|Overall Study||324||
48198191|NCT00197015|100810120|FG001|STARTED|Overall Study||455||
48198192|NCT00197015|100810121|FG002|STARTED|Overall Study||462||
48198193|NCT00197015|100810119|FG000|COMPLETED|Overall Study||274||
48198194|NCT00197015|100810120|FG001|COMPLETED|Overall Study||366||
48198195|NCT00197015|100810121|FG002|COMPLETED|Overall Study||385||
48198196|NCT00197015|100810119|FG000|NOT COMPLETED|Overall Study||50||
48198197|NCT00197015|100810120|FG001|NOT COMPLETED|Overall Study||89||
48198198|NCT00197015|100810121|FG002|NOT COMPLETED|Overall Study||77||
48198199|NCT04044664|100810122|FG000|STARTED|Stage 1||103||
48198200|NCT04044664|100810123|FG001|STARTED|Stage 1||26||
48198201|NCT04044664|100810124|FG002|STARTED|Stage 1||23||
48198202|NCT04044664|100810122|FG000|COMPLETED|Stage 1||86||
48198203|NCT04044664|100810123|FG001|COMPLETED|Stage 1||19||
48198204|NCT04044664|100810124|FG002|COMPLETED|Stage 1||20||
48198205|NCT04044664|100810122|FG000|NOT COMPLETED|Stage 1||17||
48198206|NCT04044664|100810123|FG001|NOT COMPLETED|Stage 1||7||
48198207|NCT04044664|100810124|FG002|NOT COMPLETED|Stage 1||3||
48198208|NCT04044664|100810122|FG000|STARTED|Stage 2||76||
48198209|NCT04044664|100810123|FG001|STARTED|Stage 2||26||
48198210|NCT04044664|100810124|FG002|STARTED|Stage 2||22||
48198211|NCT04044664|100810122|FG000|From Placebo, Responder|Stage 2||20||
48198212|NCT04044664|100810123|FG001|From Placebo, Responder|Stage 2||13||
48198213|NCT04044664|100810124|FG002|From Placebo, Responder|Stage 2||11||
48198214|NCT04044664|100810122|FG000|From Placebo, Non-Responder|Stage 2||18||
48198215|NCT04044664|100810123|FG001|From Placebo, Non-Responder|Stage 2||13||
48198216|NCT04044664|100810124|FG002|From Placebo, Non-Responder|Stage 2||11||
48198217|NCT04044664|100810122|FG000|From NYX-783 (10 mg or 50 mg)|Stage 2||38||
48198218|NCT04044664|100810123|FG001|From NYX-783 (10 mg or 50 mg)|Stage 2||0||
48198219|NCT04044664|100810124|FG002|From NYX-783 (10 mg or 50 mg)|Stage 2||0||
48198220|NCT04044664|100810122|FG000|COMPLETED|Stage 2||67||
48198221|NCT04044664|100810123|FG001|COMPLETED|Stage 2||24||
48198222|NCT04044664|100810124|FG002|COMPLETED|Stage 2||21||
48198223|NCT04044664|100810122|FG000|NOT COMPLETED|Stage 2||9||
48198224|NCT04044664|100810123|FG001|NOT COMPLETED|Stage 2||2||
48198225|NCT04044664|100810124|FG002|NOT COMPLETED|Stage 2||1||
48198226|NCT01636206|100810125|FG000|STARTED|Overall Study||111||
48198227|NCT01636206|100810126|FG001|STARTED|Overall Study||221||
48198228|NCT01636206|100810125|FG000|COMPLETED|Overall Study||92||
48198229|NCT01636206|100810126|FG001|COMPLETED|Overall Study||170||
48198230|NCT01636206|100810125|FG000|NOT COMPLETED|Overall Study||19||
48198231|NCT01636206|100810126|FG001|NOT COMPLETED|Overall Study||51||
48198232|NCT02716324|100810127|FG000|STARTED|Overall Study||149||
48198233|NCT02716324|100810128|FG001|STARTED|Overall Study||154||
48198234|NCT02716324|100810127|FG000|COMPLETED|Overall Study||130||
48198235|NCT02716324|100810128|FG001|COMPLETED|Overall Study||143||
48198236|NCT02716324|100810127|FG000|NOT COMPLETED|Overall Study||19||
48198237|NCT02716324|100810128|FG001|NOT COMPLETED|Overall Study||11||
48198238|NCT03982199|100810129|FG000|STARTED|Main Cohorts (Day 1 up to Day 1095)||2909||
48198239|NCT03982199|100810130|FG001|STARTED|Main Cohorts (Day 1 up to Day 1095)||2906||
48198240|NCT03982199|100810131|FG002|STARTED|Main Cohorts (Day 1 up to Day 1095)||0||
48198241|NCT03982199|100810132|FG003|STARTED|Main Cohorts (Day 1 up to Day 1095)||0||
48198242|NCT03982199|100810133|FG004|STARTED|Main Cohorts (Day 1 up to Day 1095)||0||
48198243|NCT03982199|100810134|FG005|STARTED|Main Cohorts (Day 1 up to Day 1095)||0||
48485652|NCT01636661|101525458|FG001|STARTED|Overall Study||6||
48485653|NCT01636661|101525457|FG000|COMPLETED|Overall Study||5||
48485654|NCT01636661|101525458|FG001|COMPLETED|Overall Study||6||
48198244|NCT03982199|100810135|FG006|STARTED|Main Cohorts (Day 1 up to Day 1095)||0||
48198245|NCT03982199|100810136|FG007|STARTED|Main Cohorts (Day 1 up to Day 1095)||0||
48198246|NCT03982199|100810137|FG008|STARTED|Main Cohorts (Day 1 up to Day 1095)||0||
48198247|NCT03982199|100810138|FG009|STARTED|Main Cohorts (Day 1 up to Day 1095)||0||
48198248|NCT03982199|100810139|FG010|STARTED|Main Cohorts (Day 1 up to Day 1095)||0||
48485655|NCT01636661|101525457|FG000|NOT COMPLETED|Overall Study||0||
48485656|NCT01636661|101525458|FG001|NOT COMPLETED|Overall Study||0||
48485657|NCT02608177|101525459|FG000|STARTED|Overall Study||2||
48485658|NCT02608177|101525460|FG001|STARTED|Overall Study||1||
48485659|NCT02608177|101525459|FG000|COMPLETED|Overall Study||2||
48485660|NCT02608177|101525460|FG001|COMPLETED|Overall Study||1||
48485661|NCT02608177|101525459|FG000|NOT COMPLETED|Overall Study||0||
48485662|NCT02608177|101525460|FG001|NOT COMPLETED|Overall Study||0||
48485663|NCT03359356|101525461|FG000|STARTED|Overall Study||20||
48485664|NCT03359356|101525462|FG001|STARTED|Overall Study||40||
48485665|NCT03359356|101525461|FG000|COMPLETED|Overall Study||20||
48485666|NCT03359356|101525462|FG001|COMPLETED|Overall Study||40||
48485667|NCT03359356|101525461|FG000|NOT COMPLETED|Overall Study||0||
48485668|NCT03359356|101525462|FG001|NOT COMPLETED|Overall Study||0||
48485669|NCT01111461|101525463|FG000|STARTED|Overall Study||133||
48485670|NCT01111461|101525463|FG000|COMPLETED|Overall Study||82||
48485671|NCT01111461|101525463|FG000|NOT COMPLETED|Overall Study||51||
48485672|NCT03663179|101525464|FG000|STARTED|Overall Study||18||
48485673|NCT03663179|101525465|FG001|STARTED|Overall Study||14||
48485674|NCT03663179|101525464|FG000|COMPLETED|Overall Study||14||
48485675|NCT03663179|101525465|FG001|COMPLETED|Overall Study||13||
48485676|NCT03663179|101525464|FG000|NOT COMPLETED|Overall Study||4||
48485677|NCT03663179|101525465|FG001|NOT COMPLETED|Overall Study||1||
48485678|NCT02563561|101525466|FG000|STARTED|Overall Study||19||
48485679|NCT02563561|101525467|FG001|STARTED|Overall Study||23||
48485680|NCT02563561|101525468|FG002|STARTED|Overall Study||20||
48485681|NCT02563561|101525466|FG000|Safety Population|Overall Study||19||
48485682|NCT02563561|101525467|FG001|Safety Population|Overall Study||21||
48485683|NCT02563561|101525468|FG002|Safety Population|Overall Study||17||
48485684|NCT02563561|101525466|FG000|COMPLETED|Overall Study||1||
48485685|NCT02563561|101525467|FG001|COMPLETED|Overall Study||2||
48485686|NCT02563561|101525468|FG002|COMPLETED|Overall Study||3||
48485687|NCT02563561|101525466|FG000|NOT COMPLETED|Overall Study||18||
48485688|NCT02563561|101525467|FG001|NOT COMPLETED|Overall Study||21||
48485689|NCT02563561|101525468|FG002|NOT COMPLETED|Overall Study||17||
48485690|NCT01188681|101525469|FG000|STARTED|Overall Study||6||
48485691|NCT01188681|101525470|FG001|STARTED|Overall Study||6||
48485692|NCT01188681|101525471|FG002|STARTED|Overall Study||33||
48485693|NCT01188681|101525472|FG003|STARTED|Overall Study||34||
48485694|NCT01188681|101525469|FG000|COMPLETED|Overall Study||6||
48485695|NCT01188681|101525470|FG001|COMPLETED|Overall Study||6||
48485696|NCT01188681|101525471|FG002|COMPLETED|Overall Study||32||
48485697|NCT01188681|101525472|FG003|COMPLETED|Overall Study||33||
48485698|NCT01188681|101525469|FG000|NOT COMPLETED|Overall Study||0||
48485699|NCT01188681|101525470|FG001|NOT COMPLETED|Overall Study||0||
48485700|NCT01188681|101525471|FG002|NOT COMPLETED|Overall Study||1||
48485701|NCT01188681|101525472|FG003|NOT COMPLETED|Overall Study||1||
48485702|NCT02068820|101525473|FG000|STARTED|Overall Study||20||
48485703|NCT02068820|101525474|FG001|STARTED|Overall Study||180||
48485704|NCT02068820|101525473|FG000|COMPLETED|Overall Study||20||
48485705|NCT02068820|101525474|FG001|COMPLETED|Overall Study||180||
48485706|NCT02068820|101525473|FG000|NOT COMPLETED|Overall Study||0||
48485707|NCT02068820|101525474|FG001|NOT COMPLETED|Overall Study||0||
48485708|NCT01472341|101525475|FG000|STARTED|Overall Study||507||
48485709|NCT01472341|101525475|FG000|COMPLETED|Overall Study||235||
48485710|NCT01472341|101525475|FG000|NOT COMPLETED|Overall Study||272||
48485711|NCT02880761|101525476|FG000|STARTED|Overall Study||103||
48485712|NCT02880761|101525477|FG001|STARTED|Overall Study||106||
48485713|NCT02880761|101525476|FG000|COMPLETED|Overall Study||87||
48485714|NCT02880761|101525477|FG001|COMPLETED|Overall Study||85||
48485715|NCT02880761|101525476|FG000|NOT COMPLETED|Overall Study||16||
48485716|NCT02880761|101525477|FG001|NOT COMPLETED|Overall Study||21||
48485717|NCT00859430|101525478|FG000|STARTED|First Intervention||11||
48485718|NCT00859430|101525479|FG001|STARTED|First Intervention||11||
48485719|NCT00859430|101525478|FG000|COMPLETED|First Intervention||11||
48485720|NCT00859430|101525479|FG001|COMPLETED|First Intervention||10||
48485721|NCT00859430|101525478|FG000|NOT COMPLETED|First Intervention||0||
48485722|NCT00859430|101525479|FG001|NOT COMPLETED|First Intervention||1||
48485723|NCT00859430|101525478|FG000|STARTED|Second Intervention||11||
48485724|NCT00859430|101525479|FG001|STARTED|Second Intervention||10||
48485725|NCT00859430|101525478|FG000|COMPLETED|Second Intervention||11||
48485726|NCT00859430|101525479|FG001|COMPLETED|Second Intervention||10||
48485727|NCT00859430|101525478|FG000|NOT COMPLETED|Second Intervention||0||
48485728|NCT00859430|101525479|FG001|NOT COMPLETED|Second Intervention||0||
48485729|NCT00440518|101525480|FG000|STARTED|Randomized /Titration Period||72||
48485730|NCT00440518|101525481|FG001|STARTED|Randomized /Titration Period||72||
48485731|NCT00440518|101525482|FG002|STARTED|Randomized /Titration Period||74||
48485732|NCT00440518|101525480|FG000|COMPLETED|Randomized /Titration Period||59||
48485733|NCT00440518|101525481|FG001|COMPLETED|Randomized /Titration Period||63||
48485734|NCT00440518|101525482|FG002|COMPLETED|Randomized /Titration Period||70||
48485735|NCT00440518|101525480|FG000|NOT COMPLETED|Randomized /Titration Period||13||
48485736|NCT00440518|101525481|FG001|NOT COMPLETED|Randomized /Titration Period||9||
48485737|NCT00440518|101525482|FG002|NOT COMPLETED|Randomized /Titration Period||4||
48485738|NCT00440518|101525480|FG000|STARTED|Maintenance and Safety Follow-up Periods||59||
48485739|NCT00440518|101525481|FG001|STARTED|Maintenance and Safety Follow-up Periods||63||
48485740|NCT00440518|101525482|FG002|STARTED|Maintenance and Safety Follow-up Periods||70||
48485741|NCT00440518|101525480|FG000|COMPLETED|Maintenance and Safety Follow-up Periods||52||
48485742|NCT00440518|101525481|FG001|COMPLETED|Maintenance and Safety Follow-up Periods||51||
48198249|NCT03982199|100810140|FG011|STARTED|Main Cohorts (Day 1 up to Day 1095)||0||
48198250|NCT03982199|100810141|FG012|STARTED|Main Cohorts (Day 1 up to Day 1095)||0||
48198251|NCT03982199|100810142|FG013|STARTED|Main Cohorts (Day 1 up to Day 1095)||0||
48198252|NCT03982199|100810129|FG000|Vaccinated|Main Cohorts (Day 1 up to Day 1095)||2891||
48198253|NCT03982199|100810130|FG001|Vaccinated|Main Cohorts (Day 1 up to Day 1095)||2891||
48198254|NCT03982199|100810131|FG002|Vaccinated|Main Cohorts (Day 1 up to Day 1095)||0||
48485743|NCT00440518|101525482|FG002|COMPLETED|Maintenance and Safety Follow-up Periods||55||
48485744|NCT00440518|101525480|FG000|NOT COMPLETED|Maintenance and Safety Follow-up Periods||7||
48198255|NCT03982199|100810132|FG003|Vaccinated|Main Cohorts (Day 1 up to Day 1095)||0||
48485745|NCT00440518|101525481|FG001|NOT COMPLETED|Maintenance and Safety Follow-up Periods||12||
48485746|NCT00440518|101525482|FG002|NOT COMPLETED|Maintenance and Safety Follow-up Periods||15||
48485747|NCT03117296|101525483|FG000|STARTED|Overall Study||74||
48485748|NCT03117296|101525484|FG001|STARTED|Overall Study||115||
48485749|NCT03117296|101525483|FG000|COMPLETED|Overall Study||74||
48485750|NCT03117296|101525484|FG001|COMPLETED|Overall Study||115||
48485751|NCT03117296|101525483|FG000|NOT COMPLETED|Overall Study||0||
48485752|NCT03117296|101525484|FG001|NOT COMPLETED|Overall Study||0||
48485753|NCT03270462|101525485|FG000|STARTED|Overall Study||20||
48485754|NCT03270462|101525485|FG000|COMPLETED|Overall Study||20||
48485755|NCT03270462|101525485|FG000|NOT COMPLETED|Overall Study||0||
48485756|NCT05017480|101525486|FG000|STARTED|Stage 1 Study||219||
48485757|NCT05017480|101525487|FG001|STARTED|Stage 1 Study||111||
48485758|NCT05017480|101525488|FG002|STARTED|Stage 1 Study||0||
48485759|NCT05017480|101525489|FG003|STARTED|Stage 1 Study||0||
48485760|NCT05017480|101525490|FG004|STARTED|Stage 1 Study||0||
48485761|NCT05017480|101525486|FG000|COMPLETED|Stage 1 Study||209||
48485762|NCT05017480|101525487|FG001|COMPLETED|Stage 1 Study||102||
48485763|NCT05017480|101525488|FG002|COMPLETED|Stage 1 Study||0||
48485764|NCT05017480|101525489|FG003|COMPLETED|Stage 1 Study||0||
48485765|NCT05017480|101525490|FG004|COMPLETED|Stage 1 Study||0||
48485766|NCT05017480|101525486|FG000|NOT COMPLETED|Stage 1 Study||10||
48485767|NCT05017480|101525487|FG001|NOT COMPLETED|Stage 1 Study||9||
48485768|NCT05017480|101525488|FG002|NOT COMPLETED|Stage 1 Study||0||
48485769|NCT05017480|101525489|FG003|NOT COMPLETED|Stage 1 Study||0||
48485770|NCT05017480|101525490|FG004|NOT COMPLETED|Stage 1 Study||0||
48485771|NCT05017480|101525486|FG000|STARTED|Stage 2 Study||0||
48485772|NCT05017480|101525487|FG001|STARTED|Stage 2 Study||0||
48485773|NCT05017480|101525488|FG002|STARTED|Stage 2 Study||113||
48485774|NCT05017480|101525489|FG003|STARTED|Stage 2 Study||112||
48485775|NCT05017480|101525490|FG004|STARTED|Stage 2 Study||86||
48485776|NCT05017480|101525486|FG000|COMPLETED|Stage 2 Study||0||
48485777|NCT05017480|101525487|FG001|COMPLETED|Stage 2 Study||0||
48485778|NCT05017480|101525488|FG002|COMPLETED|Stage 2 Study||107||
48485779|NCT05017480|101525489|FG003|COMPLETED|Stage 2 Study||99||
48485780|NCT05017480|101525490|FG004|COMPLETED|Stage 2 Study||73||
48485781|NCT05017480|101525486|FG000|NOT COMPLETED|Stage 2 Study||0||
48670251|NCT01928394|101974930|FG009|STARTED|Treatment Period||18|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
48670252|NCT01928394|101974931|FG010|STARTED|Treatment Period||30|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
48670253|NCT01928394|101974932|FG011|STARTED|Treatment Period||98|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
48670254|NCT01928394|101974933|FG012|STARTED|Treatment Period||61|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
48670255|NCT01928394|101974934|FG013|STARTED|Treatment Period||147|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
48670256|NCT01928394|101974935|FG014|STARTED|Treatment Period||96|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
48670257|NCT01928394|101974936|FG015|STARTED|Treatment Period||3|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
48670258|NCT01928394|101974937|FG016|STARTED|Treatment Period||55|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
48670259|NCT01928394|101974938|FG017|STARTED|Treatment Period||78|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
48670260|NCT01928394|101974939|FG018|STARTED|Treatment Period||92|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
48670261|NCT01928394|101974940|FG019|STARTED|Treatment Period||104|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
48670262|NCT01928394|101974941|FG020|STARTED|Treatment Period||41|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
48670263|NCT01928394|101974942|FG021|STARTED|Treatment Period||43|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
48670264|NCT01928394|101974943|FG022|STARTED|Treatment Period||42|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
48198256|NCT03982199|100810133|FG004|Vaccinated|Main Cohorts (Day 1 up to Day 1095)||0||
48198257|NCT03982199|100810134|FG005|Vaccinated|Main Cohorts (Day 1 up to Day 1095)||0||
48485782|NCT05017480|101525487|FG001|NOT COMPLETED|Stage 2 Study||0||
48485783|NCT05017480|101525488|FG002|NOT COMPLETED|Stage 2 Study||6||
48485784|NCT05017480|101525489|FG003|NOT COMPLETED|Stage 2 Study||13||
48485785|NCT05017480|101525490|FG004|NOT COMPLETED|Stage 2 Study||13||
48485786|NCT01921894|101525491|FG000|STARTED|Overall Study||8||
48485787|NCT01921894|101525492|FG001|STARTED|Overall Study||8||
48485788|NCT01921894|101525493|FG002|STARTED|Overall Study||8||
48485789|NCT01921894|101525491|FG000|COMPLETED|Overall Study||8||
48485790|NCT01921894|101525492|FG001|COMPLETED|Overall Study||8||
48485791|NCT01921894|101525493|FG002|COMPLETED|Overall Study||8||
48485792|NCT01921894|101525491|FG000|NOT COMPLETED|Overall Study||0||
48485793|NCT01921894|101525492|FG001|NOT COMPLETED|Overall Study||0||
48485794|NCT01921894|101525493|FG002|NOT COMPLETED|Overall Study||0||
48485795|NCT00731783|101525494|FG000|STARTED|One Month Follow-Up Visit||92||
48485796|NCT00731783|101525495|FG001|STARTED|One Month Follow-Up Visit||91||
48485797|NCT00731783|101525494|FG000|COMPLETED|One Month Follow-Up Visit||78||
48485798|NCT00731783|101525495|FG001|COMPLETED|One Month Follow-Up Visit||69||
48485799|NCT00731783|101525494|FG000|NOT COMPLETED|One Month Follow-Up Visit||14||
48485800|NCT00731783|101525495|FG001|NOT COMPLETED|One Month Follow-Up Visit||22||
48485801|NCT00731783|101525494|FG000|STARTED|Three Month Follow-Up Visit||79||
48485802|NCT00731783|101525495|FG001|STARTED|Three Month Follow-Up Visit||73||
48485803|NCT00731783|101525494|FG000|COMPLETED|Three Month Follow-Up Visit||72||
48485804|NCT00731783|101525495|FG001|COMPLETED|Three Month Follow-Up Visit||57||
48485805|NCT00731783|101525494|FG000|NOT COMPLETED|Three Month Follow-Up Visit||7||
48485806|NCT00731783|101525495|FG001|NOT COMPLETED|Three Month Follow-Up Visit||16||
48485807|NCT00731783|101525494|FG000|STARTED|Six Month Follow-Up Visit||77||
48485808|NCT00731783|101525495|FG001|STARTED|Six Month Follow-Up Visit||67||
48485809|NCT00731783|101525494|FG000|COMPLETED|Six Month Follow-Up Visit||71||
48485810|NCT00731783|101525495|FG001|COMPLETED|Six Month Follow-Up Visit||64||
48485811|NCT00731783|101525494|FG000|NOT COMPLETED|Six Month Follow-Up Visit||6||
48485812|NCT00731783|101525495|FG001|NOT COMPLETED|Six Month Follow-Up Visit||3||
48485813|NCT00731783|101525494|FG000|STARTED|12 Month Follow-Up Visit||74||
48485814|NCT00731783|101525495|FG001|STARTED|12 Month Follow-Up Visit||65||
48485815|NCT00731783|101525494|FG000|COMPLETED|12 Month Follow-Up Visit||68||
48485816|NCT00731783|101525495|FG001|COMPLETED|12 Month Follow-Up Visit||58||
48485817|NCT00731783|101525494|FG000|NOT COMPLETED|12 Month Follow-Up Visit||6||
48485818|NCT00731783|101525495|FG001|NOT COMPLETED|12 Month Follow-Up Visit||7||
48485819|NCT01959672|101525496|FG000|STARTED|Overall Study||11||
48485820|NCT01959672|101525496|FG000|COMPLETED|Overall Study||10||
48485821|NCT01959672|101525496|FG000|NOT COMPLETED|Overall Study||1||
48485822|NCT00365846|101525497|FG000|STARTED|Overall Study||29||
48485823|NCT00365846|101525497|FG000|COMPLETED|Overall Study||28||
48485824|NCT00365846|101525497|FG000|NOT COMPLETED|Overall Study||1||
48485825|NCT00707161|101525498|FG000|STARTED|Overall Study||6||
48485826|NCT00707161|101525498|FG000|COMPLETED|Overall Study||0||
48485827|NCT00707161|101525498|FG000|NOT COMPLETED|Overall Study||6||
48485828|NCT01860521|101525499|FG000|STARTED|Overall Study||52||
48485829|NCT01860521|101525500|FG001|STARTED|Overall Study||52||
48485830|NCT01860521|101525499|FG000|COMPLETED|Overall Study||52||
48485831|NCT01860521|101525500|FG001|COMPLETED|Overall Study||52||
48485832|NCT01860521|101525499|FG000|NOT COMPLETED|Overall Study||0||
48485833|NCT01860521|101525500|FG001|NOT COMPLETED|Overall Study||0||
48485834|NCT01403194|101525501|FG000|STARTED|Overall Study||11||
48485835|NCT01403194|101525501|FG000|COMPLETED|Overall Study||1||
48485836|NCT01403194|101525501|FG000|NOT COMPLETED|Overall Study||10||
48485837|NCT02655679|101525502|FG000|STARTED|Overall Study||21||
48485838|NCT02655679|101525503|FG001|STARTED|Overall Study||19||
48485839|NCT02655679|101525504|FG002|STARTED|Overall Study||20||
48485840|NCT02655679|101525505|FG003|STARTED|Overall Study||24||
48485841|NCT02655679|101525506|FG004|STARTED|Overall Study||20||
48485842|NCT02655679|101525502|FG000|Received Study Drug (Safety Population)|Overall Study||20||
48485843|NCT02655679|101525503|FG001|Received Study Drug (Safety Population)|Overall Study||19||
48485844|NCT02655679|101525504|FG002|Received Study Drug (Safety Population)|Overall Study||20||
48485845|NCT02655679|101525505|FG003|Received Study Drug (Safety Population)|Overall Study||24||
48485846|NCT02655679|101525506|FG004|Received Study Drug (Safety Population)|Overall Study||20||
48485847|NCT02655679|101525502|FG000|COMPLETED|Overall Study||18||
48485848|NCT02655679|101525503|FG001|COMPLETED|Overall Study||16||
48485849|NCT02655679|101525504|FG002|COMPLETED|Overall Study||19||
48485850|NCT02655679|101525505|FG003|COMPLETED|Overall Study||20||
48485851|NCT02655679|101525506|FG004|COMPLETED|Overall Study||19||
48485852|NCT02655679|101525502|FG000|NOT COMPLETED|Overall Study||3||
48198258|NCT03982199|100810135|FG006|Vaccinated|Main Cohorts (Day 1 up to Day 1095)||0||
48198259|NCT03982199|100810136|FG007|Vaccinated|Main Cohorts (Day 1 up to Day 1095)||0||
48198260|NCT03982199|100810137|FG008|Vaccinated|Main Cohorts (Day 1 up to Day 1095)||0||
48485853|NCT02655679|101525503|FG001|NOT COMPLETED|Overall Study||3||
48485854|NCT02655679|101525504|FG002|NOT COMPLETED|Overall Study||1||
48485855|NCT02655679|101525505|FG003|NOT COMPLETED|Overall Study||4||
48485856|NCT02655679|101525506|FG004|NOT COMPLETED|Overall Study||1||
48485857|NCT02598089|101525507|FG000|STARTED|Overall Study||30||
48485858|NCT02598089|101525508|FG001|STARTED|Overall Study||30||
48485859|NCT02598089|101525507|FG000|COMPLETED|Overall Study||30||
48485860|NCT02598089|101525508|FG001|COMPLETED|Overall Study||30||
48485861|NCT02598089|101525507|FG000|NOT COMPLETED|Overall Study||0||
48198261|NCT03982199|100810138|FG009|Vaccinated|Main Cohorts (Day 1 up to Day 1095)||0||
48198262|NCT03982199|100810139|FG010|Vaccinated|Main Cohorts (Day 1 up to Day 1095)||0||
48485862|NCT02598089|101525508|FG001|NOT COMPLETED|Overall Study||0||
48485863|NCT01190865|101525509|FG000|STARTED|Overall Study||28||
48485864|NCT01190865|101525509|FG000|COMPLETED|Overall Study||25||
48485865|NCT01190865|101525509|FG000|NOT COMPLETED|Overall Study||3||
48485866|NCT04032977|101525510|FG000|STARTED|Overall Study||80||
48485867|NCT04032977|101525511|FG001|STARTED|Overall Study||78||
48485868|NCT04032977|101525510|FG000|COMPLETED|Overall Study||71||
48485869|NCT04032977|101525511|FG001|COMPLETED|Overall Study||70||
48485870|NCT04032977|101525510|FG000|NOT COMPLETED|Overall Study||9||
48485871|NCT04032977|101525511|FG001|NOT COMPLETED|Overall Study||8||
48485872|NCT03238781|101525512|FG000|STARTED|Overall Study||137||
48485873|NCT03238781|101525513|FG001|STARTED|Overall Study||104||
48485874|NCT03238781|101525514|FG002|STARTED|Overall Study||102||
48485875|NCT03238781|101525512|FG000|COMPLETED|Overall Study||111||
48485876|NCT03238781|101525513|FG001|COMPLETED|Overall Study||87||
48485877|NCT03238781|101525514|FG002|COMPLETED|Overall Study||82||
48485878|NCT03238781|101525512|FG000|NOT COMPLETED|Overall Study||26||
48485879|NCT03238781|101525513|FG001|NOT COMPLETED|Overall Study||17||
48485880|NCT03238781|101525514|FG002|NOT COMPLETED|Overall Study||20||
48485881|NCT02193165|101525515|FG000|STARTED|4 Week Product Use||40||
48485882|NCT02193165|101525516|FG001|STARTED|4 Week Product Use||40||
48485883|NCT02193165|101525517|FG002|STARTED|4 Week Product Use||40||
48485884|NCT02193165|101525515|FG000|COMPLETED|4 Week Product Use||39||
48485885|NCT02193165|101525516|FG001|COMPLETED|4 Week Product Use||39||
48485886|NCT02193165|101525517|FG002|COMPLETED|4 Week Product Use||39||
48485887|NCT02193165|101525515|FG000|NOT COMPLETED|4 Week Product Use||1||
48485888|NCT02193165|101525516|FG001|NOT COMPLETED|4 Week Product Use||1||
48485889|NCT02193165|101525517|FG002|NOT COMPLETED|4 Week Product Use||1||
48485890|NCT02193165|101525515|FG000|STARTED|6 Week Product Use||39||
48485891|NCT02193165|101525516|FG001|STARTED|6 Week Product Use||39||
48485892|NCT02193165|101525517|FG002|STARTED|6 Week Product Use||39||
48485893|NCT02193165|101525515|FG000|COMPLETED|6 Week Product Use||39||
48485894|NCT02193165|101525516|FG001|COMPLETED|6 Week Product Use||38||
48485895|NCT02193165|101525517|FG002|COMPLETED|6 Week Product Use||39||
48485896|NCT02193165|101525515|FG000|NOT COMPLETED|6 Week Product Use||0||
48485897|NCT02193165|101525516|FG001|NOT COMPLETED|6 Week Product Use||1||
48485898|NCT02193165|101525517|FG002|NOT COMPLETED|6 Week Product Use||0||
48198263|NCT03982199|100810140|FG011|Vaccinated|Main Cohorts (Day 1 up to Day 1095)||0||
48198264|NCT03982199|100810141|FG012|Vaccinated|Main Cohorts (Day 1 up to Day 1095)||0||
48198265|NCT03982199|100810142|FG013|Vaccinated|Main Cohorts (Day 1 up to Day 1095)||0||
48198266|NCT03982199|100810129|FG000|COMPLETED|Main Cohorts (Day 1 up to Day 1095)||1875||
48198267|NCT03982199|100810130|FG001|COMPLETED|Main Cohorts (Day 1 up to Day 1095)||1897||
48198268|NCT03982199|100810131|FG002|COMPLETED|Main Cohorts (Day 1 up to Day 1095)||0||
48198269|NCT03982199|100810132|FG003|COMPLETED|Main Cohorts (Day 1 up to Day 1095)||0||
48198270|NCT03982199|100810133|FG004|COMPLETED|Main Cohorts (Day 1 up to Day 1095)||0||
48198271|NCT03982199|100810134|FG005|COMPLETED|Main Cohorts (Day 1 up to Day 1095)||0||
48198272|NCT03982199|100810135|FG006|COMPLETED|Main Cohorts (Day 1 up to Day 1095)||0||
48198273|NCT03982199|100810136|FG007|COMPLETED|Main Cohorts (Day 1 up to Day 1095)||0||
48198274|NCT03982199|100810137|FG008|COMPLETED|Main Cohorts (Day 1 up to Day 1095)||0||
48198275|NCT03982199|100810138|FG009|COMPLETED|Main Cohorts (Day 1 up to Day 1095)||0||
48198276|NCT03982199|100810139|FG010|COMPLETED|Main Cohorts (Day 1 up to Day 1095)||0||
48198277|NCT03982199|100810140|FG011|COMPLETED|Main Cohorts (Day 1 up to Day 1095)||0||
48198278|NCT03982199|100810141|FG012|COMPLETED|Main Cohorts (Day 1 up to Day 1095)||0||
48198279|NCT03982199|100810142|FG013|COMPLETED|Main Cohorts (Day 1 up to Day 1095)||0||
48198280|NCT03982199|100810129|FG000|NOT COMPLETED|Main Cohorts (Day 1 up to Day 1095)||1034||
48198281|NCT03982199|100810130|FG001|NOT COMPLETED|Main Cohorts (Day 1 up to Day 1095)||1009||
48198282|NCT03982199|100810131|FG002|NOT COMPLETED|Main Cohorts (Day 1 up to Day 1095)||0||
48198283|NCT03982199|100810132|FG003|NOT COMPLETED|Main Cohorts (Day 1 up to Day 1095)||0||
48198284|NCT03982199|100810133|FG004|NOT COMPLETED|Main Cohorts (Day 1 up to Day 1095)||0||
48198285|NCT03982199|100810134|FG005|NOT COMPLETED|Main Cohorts (Day 1 up to Day 1095)||0||
48198286|NCT03982199|100810135|FG006|NOT COMPLETED|Main Cohorts (Day 1 up to Day 1095)||0||
48198287|NCT03982199|100810136|FG007|NOT COMPLETED|Main Cohorts (Day 1 up to Day 1095)||0||
48198288|NCT03982199|100810137|FG008|NOT COMPLETED|Main Cohorts (Day 1 up to Day 1095)||0||
48198289|NCT03982199|100810138|FG009|NOT COMPLETED|Main Cohorts (Day 1 up to Day 1095)||0||
48198290|NCT03982199|100810139|FG010|NOT COMPLETED|Main Cohorts (Day 1 up to Day 1095)||0||
48198291|NCT03982199|100810140|FG011|NOT COMPLETED|Main Cohorts (Day 1 up to Day 1095)||0||
48198292|NCT03982199|100810141|FG012|NOT COMPLETED|Main Cohorts (Day 1 up to Day 1095)||0||
48198293|NCT03982199|100810142|FG013|NOT COMPLETED|Main Cohorts (Day 1 up to Day 1095)||0||
48198294|NCT03982199|100810129|FG000|STARTED|Revacc Subcohorts (From Day 365 to 730)||0||
48198295|NCT03982199|100810130|FG001|STARTED|Revacc Subcohorts (From Day 365 to 730)||0||
48198296|NCT03982199|100810131|FG002|STARTED|Revacc Subcohorts (From Day 365 to 730)||120||
48198297|NCT03982199|100810132|FG003|STARTED|Revacc Subcohorts (From Day 365 to 730)||126||
48198298|NCT03982199|100810133|FG004|STARTED|Revacc Subcohorts (From Day 365 to 730)||0||
48198299|NCT03982199|100810134|FG005|STARTED|Revacc Subcohorts (From Day 365 to 730)||0||
48198300|NCT03982199|100810135|FG006|STARTED|Revacc Subcohorts (From Day 365 to 730)||0||
48198301|NCT03982199|100810136|FG007|STARTED|Revacc Subcohorts (From Day 365 to 730)||0||
48198302|NCT03982199|100810137|FG008|STARTED|Revacc Subcohorts (From Day 365 to 730)||0||
48198303|NCT03982199|100810138|FG009|STARTED|Revacc Subcohorts (From Day 365 to 730)||0||
48198304|NCT03982199|100810139|FG010|STARTED|Revacc Subcohorts (From Day 365 to 730)||0||
48198305|NCT03982199|100810140|FG011|STARTED|Revacc Subcohorts (From Day 365 to 730)||0||
48198306|NCT03982199|100810141|FG012|STARTED|Revacc Subcohorts (From Day 365 to 730)||0||
48198307|NCT03982199|100810142|FG013|STARTED|Revacc Subcohorts (From Day 365 to 730)||0||
48198308|NCT03982199|100810129|FG000|COMPLETED|Revacc Subcohorts (From Day 365 to 730)||0||
48198309|NCT03982199|100810130|FG001|COMPLETED|Revacc Subcohorts (From Day 365 to 730)||0||
48198310|NCT03982199|100810131|FG002|COMPLETED|Revacc Subcohorts (From Day 365 to 730)||94||
48198311|NCT03982199|100810132|FG003|COMPLETED|Revacc Subcohorts (From Day 365 to 730)||102||
48198312|NCT03982199|100810133|FG004|COMPLETED|Revacc Subcohorts (From Day 365 to 730)||0||
48198313|NCT03982199|100810134|FG005|COMPLETED|Revacc Subcohorts (From Day 365 to 730)||0||
48198314|NCT03982199|100810135|FG006|COMPLETED|Revacc Subcohorts (From Day 365 to 730)||0||
48198315|NCT03982199|100810136|FG007|COMPLETED|Revacc Subcohorts (From Day 365 to 730)||0||
48198316|NCT03982199|100810137|FG008|COMPLETED|Revacc Subcohorts (From Day 365 to 730)||0||
48198317|NCT03982199|100810138|FG009|COMPLETED|Revacc Subcohorts (From Day 365 to 730)||0||
48198318|NCT03982199|100810139|FG010|COMPLETED|Revacc Subcohorts (From Day 365 to 730)||0||
48198319|NCT03982199|100810140|FG011|COMPLETED|Revacc Subcohorts (From Day 365 to 730)||0||
48198320|NCT03982199|100810141|FG012|COMPLETED|Revacc Subcohorts (From Day 365 to 730)||0||
48198321|NCT03982199|100810142|FG013|COMPLETED|Revacc Subcohorts (From Day 365 to 730)||0||
48485899|NCT01723397|101525518|FG000|STARTED|Study Period 1||7||
48485900|NCT01723397|101525519|FG001|STARTED|Study Period 1||7||
48198322|NCT03982199|100810129|FG000|NOT COMPLETED|Revacc Subcohorts (From Day 365 to 730)||0||
48198323|NCT03982199|100810130|FG001|NOT COMPLETED|Revacc Subcohorts (From Day 365 to 730)||0||
48485901|NCT01723397|101525518|FG000|COMPLETED|Study Period 1||7||
48485902|NCT01723397|101525519|FG001|COMPLETED|Study Period 1||6||
48485903|NCT01723397|101525518|FG000|NOT COMPLETED|Study Period 1||0||
48485904|NCT01723397|101525519|FG001|NOT COMPLETED|Study Period 1||1||
48485905|NCT01723397|101525518|FG000|STARTED|Washout||7||
48485906|NCT01723397|101525519|FG001|STARTED|Washout||6||
48198324|NCT03982199|100810131|FG002|NOT COMPLETED|Revacc Subcohorts (From Day 365 to 730)||26||
48198325|NCT03982199|100810132|FG003|NOT COMPLETED|Revacc Subcohorts (From Day 365 to 730)||24||
48198326|NCT03982199|100810133|FG004|NOT COMPLETED|Revacc Subcohorts (From Day 365 to 730)||0||
48198327|NCT03982199|100810134|FG005|NOT COMPLETED|Revacc Subcohorts (From Day 365 to 730)||0||
48198328|NCT03982199|100810135|FG006|NOT COMPLETED|Revacc Subcohorts (From Day 365 to 730)||0||
48485907|NCT01723397|101525518|FG000|COMPLETED|Washout||7||
48485908|NCT01723397|101525519|FG001|COMPLETED|Washout||6||
48485909|NCT01723397|101525518|FG000|NOT COMPLETED|Washout||0||
48198329|NCT03982199|100810136|FG007|NOT COMPLETED|Revacc Subcohorts (From Day 365 to 730)||0||
48198330|NCT03982199|100810137|FG008|NOT COMPLETED|Revacc Subcohorts (From Day 365 to 730)||0||
48198331|NCT03982199|100810138|FG009|NOT COMPLETED|Revacc Subcohorts (From Day 365 to 730)||0||
48198332|NCT03982199|100810139|FG010|NOT COMPLETED|Revacc Subcohorts (From Day 365 to 730)||0||
48198333|NCT03982199|100810140|FG011|NOT COMPLETED|Revacc Subcohorts (From Day 365 to 730)||0||
48198334|NCT03982199|100810141|FG012|NOT COMPLETED|Revacc Subcohorts (From Day 365 to 730)||0||
48198335|NCT03982199|100810142|FG013|NOT COMPLETED|Revacc Subcohorts (From Day 365 to 730)||0||
48198336|NCT03982199|100810129|FG000|STARTED|Revacc Subcohorts (From Day 730 to 1095)||0||
48198337|NCT03982199|100810130|FG001|STARTED|Revacc Subcohorts (From Day 730 to 1095)||0||
48198338|NCT03982199|100810131|FG002|STARTED|Revacc Subcohorts (From Day 730 to 1095)||0||
48198339|NCT03982199|100810132|FG003|STARTED|Revacc Subcohorts (From Day 730 to 1095)||0||
48198340|NCT03982199|100810133|FG004|STARTED|Revacc Subcohorts (From Day 730 to 1095)||28||
48198341|NCT03982199|100810134|FG005|STARTED|Revacc Subcohorts (From Day 730 to 1095)||28||
48198342|NCT03982199|100810135|FG006|STARTED|Revacc Subcohorts (From Day 730 to 1095)||28||
48198343|NCT03982199|100810136|FG007|STARTED|Revacc Subcohorts (From Day 730 to 1095)||137||
48198344|NCT03982199|100810137|FG008|STARTED|Revacc Subcohorts (From Day 730 to 1095)||149||
48198345|NCT03982199|100810138|FG009|STARTED|Revacc Subcohorts (From Day 730 to 1095)||0||
48198346|NCT03982199|100810139|FG010|STARTED|Revacc Subcohorts (From Day 730 to 1095)||0||
48198347|NCT03982199|100810140|FG011|STARTED|Revacc Subcohorts (From Day 730 to 1095)||0||
48198348|NCT03982199|100810141|FG012|STARTED|Revacc Subcohorts (From Day 730 to 1095)||0||
48198349|NCT03982199|100810142|FG013|STARTED|Revacc Subcohorts (From Day 730 to 1095)||0||
48198350|NCT03982199|100810129|FG000|COMPLETED|Revacc Subcohorts (From Day 730 to 1095)||0||
48198351|NCT03982199|100810130|FG001|COMPLETED|Revacc Subcohorts (From Day 730 to 1095)||0||
48198352|NCT03982199|100810131|FG002|COMPLETED|Revacc Subcohorts (From Day 730 to 1095)||0||
48198353|NCT03982199|100810132|FG003|COMPLETED|Revacc Subcohorts (From Day 730 to 1095)||0||
48198354|NCT03982199|100810133|FG004|COMPLETED|Revacc Subcohorts (From Day 730 to 1095)||28||
48198355|NCT03982199|100810134|FG005|COMPLETED|Revacc Subcohorts (From Day 730 to 1095)||24||
48198356|NCT03982199|100810135|FG006|COMPLETED|Revacc Subcohorts (From Day 730 to 1095)||28||
48198357|NCT03982199|100810136|FG007|COMPLETED|Revacc Subcohorts (From Day 730 to 1095)||127||
48198358|NCT03982199|100810137|FG008|COMPLETED|Revacc Subcohorts (From Day 730 to 1095)||3||
48198359|NCT03982199|100810138|FG009|COMPLETED|Revacc Subcohorts (From Day 730 to 1095)||0||
48198360|NCT03982199|100810139|FG010|COMPLETED|Revacc Subcohorts (From Day 730 to 1095)||0||
48198361|NCT03982199|100810140|FG011|COMPLETED|Revacc Subcohorts (From Day 730 to 1095)||0||
48198362|NCT03982199|100810141|FG012|COMPLETED|Revacc Subcohorts (From Day 730 to 1095)||0||
48198363|NCT03982199|100810142|FG013|COMPLETED|Revacc Subcohorts (From Day 730 to 1095)||0||
48198364|NCT03982199|100810129|FG000|NOT COMPLETED|Revacc Subcohorts (From Day 730 to 1095)||0||
48198365|NCT03982199|100810130|FG001|NOT COMPLETED|Revacc Subcohorts (From Day 730 to 1095)||0||
48198366|NCT03982199|100810131|FG002|NOT COMPLETED|Revacc Subcohorts (From Day 730 to 1095)||0||
48198367|NCT03982199|100810132|FG003|NOT COMPLETED|Revacc Subcohorts (From Day 730 to 1095)||0||
48198368|NCT03982199|100810133|FG004|NOT COMPLETED|Revacc Subcohorts (From Day 730 to 1095)||0||
48198369|NCT03982199|100810134|FG005|NOT COMPLETED|Revacc Subcohorts (From Day 730 to 1095)||4||
48198370|NCT03982199|100810135|FG006|NOT COMPLETED|Revacc Subcohorts (From Day 730 to 1095)||0||
48198371|NCT03982199|100810136|FG007|NOT COMPLETED|Revacc Subcohorts (From Day 730 to 1095)||10||
48198372|NCT03982199|100810137|FG008|NOT COMPLETED|Revacc Subcohorts (From Day 730 to 1095)||146||
48198373|NCT03982199|100810138|FG009|NOT COMPLETED|Revacc Subcohorts (From Day 730 to 1095)||0||
48198374|NCT03982199|100810139|FG010|NOT COMPLETED|Revacc Subcohorts (From Day 730 to 1095)||0||
48198375|NCT03982199|100810140|FG011|NOT COMPLETED|Revacc Subcohorts (From Day 730 to 1095)||0||
48198376|NCT03982199|100810141|FG012|NOT COMPLETED|Revacc Subcohorts (From Day 730 to 1095)||0||
48198377|NCT03982199|100810142|FG013|NOT COMPLETED|Revacc Subcohorts (From Day 730 to 1095)||0||
48485910|NCT01723397|101525519|FG001|NOT COMPLETED|Washout||0||
48485911|NCT01723397|101525518|FG000|STARTED|Study Period 2||7||
48485912|NCT01723397|101525519|FG001|STARTED|Study Period 2||6||
48485913|NCT01723397|101525518|FG000|COMPLETED|Study Period 2||7||
48485914|NCT01723397|101525519|FG001|COMPLETED|Study Period 2||5||
48485915|NCT01723397|101525518|FG000|NOT COMPLETED|Study Period 2||0||
48485916|NCT01723397|101525519|FG001|NOT COMPLETED|Study Period 2||1||
48485917|NCT00505622|101525520|FG000|STARTED|Overall Study||121||
48485918|NCT00505622|101525521|FG001|STARTED|Overall Study||108||
48198378|NCT03982199|100810129|FG000|STARTED|Revacc Subcohort (From Day 1095 to 1460)||0||
48198379|NCT03982199|100810130|FG001|STARTED|Revacc Subcohort (From Day 1095 to 1460)||0||
48198380|NCT03982199|100810131|FG002|STARTED|Revacc Subcohort (From Day 1095 to 1460)||0||
48198381|NCT03982199|100810132|FG003|STARTED|Revacc Subcohort (From Day 1095 to 1460)||0||
48198382|NCT03982199|100810133|FG004|STARTED|Revacc Subcohort (From Day 1095 to 1460)||0||
48198383|NCT03982199|100810134|FG005|STARTED|Revacc Subcohort (From Day 1095 to 1460)||0||
48198384|NCT03982199|100810135|FG006|STARTED|Revacc Subcohort (From Day 1095 to 1460)||0||
48198385|NCT03982199|100810136|FG007|STARTED|Revacc Subcohort (From Day 1095 to 1460)||0||
48198386|NCT03982199|100810137|FG008|STARTED|Revacc Subcohort (From Day 1095 to 1460)||0||
48198387|NCT03982199|100810138|FG009|STARTED|Revacc Subcohort (From Day 1095 to 1460)||37||
48198388|NCT03982199|100810139|FG010|STARTED|Revacc Subcohort (From Day 1095 to 1460)||37||
48198389|NCT03982199|100810140|FG011|STARTED|Revacc Subcohort (From Day 1095 to 1460)||37||
48198390|NCT03982199|100810141|FG012|STARTED|Revacc Subcohort (From Day 1095 to 1460)||131||
48198391|NCT03982199|100810142|FG013|STARTED|Revacc Subcohort (From Day 1095 to 1460)||119||
48198392|NCT03982199|100810129|FG000|COMPLETED|Revacc Subcohort (From Day 1095 to 1460)||0||
48198393|NCT03982199|100810130|FG001|COMPLETED|Revacc Subcohort (From Day 1095 to 1460)||0||
48198394|NCT03982199|100810131|FG002|COMPLETED|Revacc Subcohort (From Day 1095 to 1460)||0||
48198395|NCT03982199|100810132|FG003|COMPLETED|Revacc Subcohort (From Day 1095 to 1460)||0||
48485919|NCT00505622|101525522|FG002|STARTED|Overall Study||96||
48485920|NCT00505622|101525520|FG000|COMPLETED|Overall Study||0||
48485921|NCT00505622|101525521|FG001|COMPLETED|Overall Study||0||
48485922|NCT00505622|101525522|FG002|COMPLETED|Overall Study||0||
48485923|NCT00505622|101525520|FG000|NOT COMPLETED|Overall Study||121||
48485924|NCT00505622|101525521|FG001|NOT COMPLETED|Overall Study||108||
48485925|NCT00505622|101525522|FG002|NOT COMPLETED|Overall Study||96||
48485926|NCT00088829|101525523|FG000|STARTED|Overall Study||22||
48485927|NCT00088829|101525523|FG000|COMPLETED|Overall Study||0||
48485928|NCT00088829|101525523|FG000|NOT COMPLETED|Overall Study||22||
48485929|NCT01929863|101525524|FG000|STARTED|Period 1:Intervention Period 1 (7 Days)||7||
48485930|NCT01929863|101525525|FG001|STARTED|Period 1:Intervention Period 1 (7 Days)||8||
48485931|NCT01929863|101525524|FG000|COMPLETED|Period 1:Intervention Period 1 (7 Days)||6||
48485932|NCT01929863|101525525|FG001|COMPLETED|Period 1:Intervention Period 1 (7 Days)||7||
48485933|NCT01929863|101525524|FG000|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1||
48485934|NCT01929863|101525525|FG001|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1||
48485935|NCT01929863|101525524|FG000|STARTED|Period 2:Washout Period (13-15 Days)||6||
48485936|NCT01929863|101525525|FG001|STARTED|Period 2:Washout Period (13-15 Days)||7||
48485937|NCT01929863|101525524|FG000|COMPLETED|Period 2:Washout Period (13-15 Days)||6||
48485938|NCT01929863|101525525|FG001|COMPLETED|Period 2:Washout Period (13-15 Days)||7||
48198396|NCT03982199|100810133|FG004|COMPLETED|Revacc Subcohort (From Day 1095 to 1460)||0||
48198397|NCT03982199|100810134|FG005|COMPLETED|Revacc Subcohort (From Day 1095 to 1460)||0||
48485939|NCT01929863|101525524|FG000|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0||
48485940|NCT01929863|101525525|FG001|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0||
48485941|NCT01929863|101525524|FG000|STARTED|Period 3:Intervention Period 2 (7 Days)||6||
48485942|NCT01929863|101525525|FG001|STARTED|Period 3:Intervention Period 2 (7 Days)||7||
48485943|NCT01929863|101525524|FG000|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6||
48485944|NCT01929863|101525525|FG001|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6||
48485945|NCT01929863|101525524|FG000|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||0||
48485946|NCT01929863|101525525|FG001|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||1||
48485947|NCT01929863|101525524|FG000|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6||
48485948|NCT01929863|101525525|FG001|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6||
48485949|NCT01929863|101525524|FG000|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0||
48485950|NCT01929863|101525525|FG001|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0||
48485951|NCT01929863|101525524|FG000|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6||
48485952|NCT01929863|101525525|FG001|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6||
48485953|NCT02294786|101525526|FG000|STARTED|Overall Study||30||
48485954|NCT02294786|101525527|FG001|STARTED|Overall Study||32||
48485955|NCT02294786|101525526|FG000|Safety Population|Overall Study||29|All randomized subjects who received at least one dose of study treatment.|
48198398|NCT03982199|100810135|FG006|COMPLETED|Revacc Subcohort (From Day 1095 to 1460)||0||
48485956|NCT02294786|101525527|FG001|Safety Population|Overall Study||33|All randomized subjects who received at least one dose of study treatment.|
48485957|NCT02294786|101525526|FG000|ITT Population|Overall Study||30|All randomized subjects regardless of whether or not treatment was administered.|
48485958|NCT02294786|101525527|FG001|ITT Population|Overall Study||32|All randomized subjects regardless of whether or not treatment was administered.|
48485959|NCT02294786|101525526|FG000|COMPLETED|Overall Study||19||
48485960|NCT02294786|101525527|FG001|COMPLETED|Overall Study||18||
48485961|NCT02294786|101525526|FG000|NOT COMPLETED|Overall Study||11||
48485962|NCT02294786|101525527|FG001|NOT COMPLETED|Overall Study||14||
48485963|NCT03649477|101525528|FG000|STARTED|Overall Study||44||
48485964|NCT03649477|101525529|FG001|STARTED|Overall Study||43||
48485965|NCT03649477|101525530|FG002|STARTED|Overall Study||43||
48485966|NCT03649477|101525528|FG000|COMPLETED|Overall Study||42||
48485967|NCT03649477|101525529|FG001|COMPLETED|Overall Study||43||
48485968|NCT03649477|101525530|FG002|COMPLETED|Overall Study||43||
48485969|NCT03649477|101525528|FG000|NOT COMPLETED|Overall Study||2||
48485970|NCT03649477|101525529|FG001|NOT COMPLETED|Overall Study||0||
48485971|NCT03649477|101525530|FG002|NOT COMPLETED|Overall Study||0||
48485972|NCT00850174|101525531|FG000|STARTED|First Intervention||30||
48485973|NCT00850174|101525532|FG001|STARTED|First Intervention||30||
48485974|NCT00850174|101525531|FG000|COMPLETED|First Intervention||30||
48485975|NCT00850174|101525532|FG001|COMPLETED|First Intervention||30||
48485976|NCT00850174|101525531|FG000|NOT COMPLETED|First Intervention||0||
48485977|NCT00850174|101525532|FG001|NOT COMPLETED|First Intervention||0||
48485978|NCT00850174|101525531|FG000|STARTED|Washout: One Week||30||
48485979|NCT00850174|101525532|FG001|STARTED|Washout: One Week||30||
48485980|NCT00850174|101525531|FG000|COMPLETED|Washout: One Week||30||
48485981|NCT00850174|101525532|FG001|COMPLETED|Washout: One Week||28||
48485982|NCT00850174|101525531|FG000|NOT COMPLETED|Washout: One Week||0||
48485983|NCT00850174|101525532|FG001|NOT COMPLETED|Washout: One Week||2||
48485984|NCT00850174|101525531|FG000|STARTED|Second Intervention||30||
48485985|NCT00850174|101525532|FG001|STARTED|Second Intervention||28||
48485986|NCT00850174|101525531|FG000|COMPLETED|Second Intervention||29||
48485987|NCT00850174|101525532|FG001|COMPLETED|Second Intervention||28||
48485988|NCT00850174|101525531|FG000|NOT COMPLETED|Second Intervention||1||
48485989|NCT00850174|101525532|FG001|NOT COMPLETED|Second Intervention||0||
48485990|NCT02476994|101525533|FG000|STARTED|Overall Study||1||
48485991|NCT02476994|101525534|FG001|STARTED|Overall Study||0||
48485992|NCT02476994|101525533|FG000|COMPLETED|Overall Study||0||
48485993|NCT02476994|101525534|FG001|COMPLETED|Overall Study||0||
48485994|NCT02476994|101525533|FG000|NOT COMPLETED|Overall Study||1||
48485995|NCT02476994|101525534|FG001|NOT COMPLETED|Overall Study||0||
48485996|NCT00202722|101525535|FG000|STARTED|Overall Study||41||
48485997|NCT00202722|101525535|FG000|COMPLETED|Overall Study||41||
48485998|NCT00202722|101525535|FG000|NOT COMPLETED|Overall Study||0||
48485999|NCT00836758|101525536|FG000|STARTED|Overall Study||115||148
48486000|NCT00836758|101525536|FG000|COMPLETED|Overall Study||115||148
48486001|NCT00836758|101525536|FG000|NOT COMPLETED|Overall Study||0||0
48486002|NCT02624050|101525537|FG000|STARTED|Overall Study||26||
48486003|NCT02624050|101525538|FG001|STARTED|Overall Study||25||
48486004|NCT02624050|101525537|FG000|COMPLETED|Overall Study||20||
48486005|NCT02624050|101525538|FG001|COMPLETED|Overall Study||25||
48486006|NCT02624050|101525537|FG000|NOT COMPLETED|Overall Study||6||
48486007|NCT02624050|101525538|FG001|NOT COMPLETED|Overall Study||0||
48486008|NCT00539110|101525539|FG000|STARTED|Overall Study||5||
48486009|NCT00539110|101525540|FG001|STARTED|Overall Study||5||
48486010|NCT00539110|101525539|FG000|COMPLETED|Overall Study||5||
48486011|NCT00539110|101525540|FG001|COMPLETED|Overall Study||5||
48486012|NCT00539110|101525539|FG000|NOT COMPLETED|Overall Study||0||
48486013|NCT00539110|101525540|FG001|NOT COMPLETED|Overall Study||0||
48486014|NCT01149473|101525541|FG000|STARTED|First Intervention||40||
48486015|NCT01149473|101525542|FG001|STARTED|First Intervention||40||
48486016|NCT01149473|101525541|FG000|COMPLETED|First Intervention||39||
48486017|NCT01149473|101525542|FG001|COMPLETED|First Intervention||39||
48486018|NCT01149473|101525541|FG000|NOT COMPLETED|First Intervention||1||
48486019|NCT01149473|101525542|FG001|NOT COMPLETED|First Intervention||1||
48486020|NCT01149473|101525541|FG000|STARTED|Washout of 7 Days||39||
48486021|NCT01149473|101525542|FG001|STARTED|Washout of 7 Days||39||
48486022|NCT01149473|101525541|FG000|COMPLETED|Washout of 7 Days||38||
48486023|NCT01149473|101525542|FG001|COMPLETED|Washout of 7 Days||38||
48486024|NCT01149473|101525541|FG000|NOT COMPLETED|Washout of 7 Days||1||
48486025|NCT01149473|101525542|FG001|NOT COMPLETED|Washout of 7 Days||1||
48486026|NCT01149473|101525541|FG000|STARTED|Second Intervention||38||
48486027|NCT01149473|101525542|FG001|STARTED|Second Intervention||38||
48486028|NCT01149473|101525541|FG000|COMPLETED|Second Intervention||38||
48486029|NCT01149473|101525542|FG001|COMPLETED|Second Intervention||38||
48486030|NCT01149473|101525541|FG000|NOT COMPLETED|Second Intervention||0||
48486031|NCT01149473|101525542|FG001|NOT COMPLETED|Second Intervention||0||
48486032|NCT03075761|101525543|FG000|STARTED|Overall Study||11||
48486033|NCT03075761|101525544|FG001|STARTED|Overall Study||12||
48486034|NCT03075761|101525543|FG000|COMPLETED|Overall Study||10||
48486035|NCT03075761|101525544|FG001|COMPLETED|Overall Study||6||
48486036|NCT03075761|101525543|FG000|NOT COMPLETED|Overall Study||1||
48486037|NCT03075761|101525544|FG001|NOT COMPLETED|Overall Study||6||
48486038|NCT04608188|101525545|FG000|STARTED|Overall Study||21||
48486039|NCT04608188|101525546|FG001|STARTED|Overall Study||68||
48486040|NCT04608188|101525545|FG000|COMPLETED|Overall Study||17||
48486041|NCT04608188|101525546|FG001|COMPLETED|Overall Study||60||
48486042|NCT04608188|101525545|FG000|NOT COMPLETED|Overall Study||4||
48486043|NCT04608188|101525546|FG001|NOT COMPLETED|Overall Study||8||
48486044|NCT01494532|101525547|FG000|STARTED|Overall Study||75||
48486045|NCT01494532|101525548|FG001|STARTED|Overall Study||25||
48486046|NCT01494532|101525549|FG002|STARTED|Overall Study||76||
48486047|NCT01494532|101525550|FG003|STARTED|Overall Study||75||
48486048|NCT01494532|101525551|FG004|STARTED|Overall Study||76||
48486049|NCT01494532|101525552|FG005|STARTED|Overall Study||25||
48486050|NCT01494532|101525547|FG000|COMPLETED|Overall Study||65||
48486051|NCT01494532|101525548|FG001|COMPLETED|Overall Study||21||
48486052|NCT01494532|101525549|FG002|COMPLETED|Overall Study||59||
48486053|NCT01494532|101525550|FG003|COMPLETED|Overall Study||60||
48486054|NCT01494532|101525551|FG004|COMPLETED|Overall Study||64||
48486055|NCT01494532|101525552|FG005|COMPLETED|Overall Study||25||
48486056|NCT01494532|101525547|FG000|NOT COMPLETED|Overall Study||10||
48486057|NCT01494532|101525548|FG001|NOT COMPLETED|Overall Study||4||
48486058|NCT01494532|101525549|FG002|NOT COMPLETED|Overall Study||17||
48486059|NCT01494532|101525550|FG003|NOT COMPLETED|Overall Study||15||
48486060|NCT01494532|101525551|FG004|NOT COMPLETED|Overall Study||12||
48486061|NCT01494532|101525552|FG005|NOT COMPLETED|Overall Study||0||
48486062|NCT01650350|101525553|FG000|STARTED|Overall Study||7||
48486063|NCT01650350|101525553|FG000|COMPLETED|Overall Study||7||
48486064|NCT01650350|101525553|FG000|NOT COMPLETED|Overall Study||0||
48486065|NCT00002601|101525554|FG000|STARTED|Overall Study||13||
48486066|NCT00002601|101525554|FG000|COMPLETED|Overall Study||13||
48486067|NCT00002601|101525554|FG000|NOT COMPLETED|Overall Study||0||
48486068|NCT03999684|101525555|FG000|STARTED|Overall Study||18||
48486069|NCT03999684|101525555|FG000|COMPLETED|Overall Study||18||
48486070|NCT03999684|101525555|FG000|NOT COMPLETED|Overall Study||0||
48486071|NCT01827163|101525556|FG000|STARTED|Overall Study||20||
48486072|NCT01827163|101525556|FG000|COMPLETED|Overall Study||9||
48486073|NCT01827163|101525556|FG000|NOT COMPLETED|Overall Study||11||
48486074|NCT02009163|101525557|FG000|STARTED|Open-label Period (Non-randomized)||418||
48486075|NCT02009163|101525558|FG001|STARTED|Open-label Period (Non-randomized)||0||
48486076|NCT02009163|101525559|FG002|STARTED|Open-label Period (Non-randomized)||0||
48486077|NCT02009163|101525557|FG000|COMPLETED|Open-label Period (Non-randomized)||275||
48486078|NCT02009163|101525558|FG001|COMPLETED|Open-label Period (Non-randomized)||0||
48486079|NCT02009163|101525559|FG002|COMPLETED|Open-label Period (Non-randomized)||0||
48486080|NCT02009163|101525557|FG000|NOT COMPLETED|Open-label Period (Non-randomized)||143||
48486081|NCT02009163|101525558|FG001|NOT COMPLETED|Open-label Period (Non-randomized)||0||
48486082|NCT02009163|101525559|FG002|NOT COMPLETED|Open-label Period (Non-randomized)||0||
48486083|NCT02009163|101525557|FG000|STARTED|Randomized-withdrawal Period||0||
48486084|NCT02009163|101525558|FG001|STARTED|Randomized-withdrawal Period||138||
48486085|NCT02009163|101525559|FG002|STARTED|Randomized-withdrawal Period||137||
48486086|NCT02009163|101525557|FG000|COMPLETED|Randomized-withdrawal Period||0||
48486087|NCT02009163|101525558|FG001|COMPLETED|Randomized-withdrawal Period||50||
48486088|NCT02009163|101525559|FG002|COMPLETED|Randomized-withdrawal Period||102||
48486089|NCT02009163|101525557|FG000|NOT COMPLETED|Randomized-withdrawal Period||0||
48486090|NCT02009163|101525558|FG001|NOT COMPLETED|Randomized-withdrawal Period||88||
48486091|NCT02009163|101525559|FG002|NOT COMPLETED|Randomized-withdrawal Period||35||
48486092|NCT01808794|101525560|FG000|STARTED|Overall Study||0||
48486093|NCT01808794|101525561|FG001|STARTED|Overall Study||0||
48486094|NCT01808794|101525560|FG000|COMPLETED|Overall Study||0||
48486095|NCT01808794|101525561|FG001|COMPLETED|Overall Study||0||
48486096|NCT01808794|101525560|FG000|NOT COMPLETED|Overall Study||0||
48486097|NCT01808794|101525561|FG001|NOT COMPLETED|Overall Study||0||
48486098|NCT02075463|101525562|FG000|STARTED|Overall Study||15||
48486099|NCT02075463|101525562|FG000|COMPLETED|Overall Study||7||
48486100|NCT02075463|101525562|FG000|NOT COMPLETED|Overall Study||8||
48486101|NCT03194217|101525563|FG000|STARTED|Overall Study||60||
48486102|NCT03194217|101525564|FG001|STARTED|Overall Study||60||
48486103|NCT03194217|101525565|FG002|STARTED|Overall Study||60||
48486104|NCT03194217|101525566|FG003|STARTED|Overall Study||64||
48486105|NCT03194217|101525563|FG000|COMPLETED|Overall Study||60||
48486106|NCT03194217|101525564|FG001|COMPLETED|Overall Study||57||
48486107|NCT03194217|101525565|FG002|COMPLETED|Overall Study||56||
48486108|NCT03194217|101525566|FG003|COMPLETED|Overall Study||60||
48486109|NCT03194217|101525563|FG000|NOT COMPLETED|Overall Study||0||
48486110|NCT03194217|101525564|FG001|NOT COMPLETED|Overall Study||3||
48486111|NCT03194217|101525565|FG002|NOT COMPLETED|Overall Study||4||
48486112|NCT03194217|101525566|FG003|NOT COMPLETED|Overall Study||4||
48486113|NCT00840411|101525567|FG000|STARTED|First Intervention||33||
48486114|NCT00840411|101525568|FG001|STARTED|First Intervention||33||
48486115|NCT00840411|101525567|FG000|COMPLETED|First Intervention||32||
48486116|NCT00840411|101525568|FG001|COMPLETED|First Intervention||33||
48486117|NCT00840411|101525567|FG000|NOT COMPLETED|First Intervention||1||
48486118|NCT00840411|101525568|FG001|NOT COMPLETED|First Intervention||0||
48486119|NCT00840411|101525567|FG000|STARTED|Washout||32||
48486120|NCT00840411|101525568|FG001|STARTED|Washout||33||
48486121|NCT00840411|101525567|FG000|COMPLETED|Washout||31||
48486122|NCT00840411|101525568|FG001|COMPLETED|Washout||33||
48486123|NCT00840411|101525567|FG000|NOT COMPLETED|Washout||1||
48486124|NCT00840411|101525568|FG001|NOT COMPLETED|Washout||0||
48486125|NCT00840411|101525567|FG000|STARTED|Second Intervention||31||
48486126|NCT00840411|101525568|FG001|STARTED|Second Intervention||33||
48486127|NCT00840411|101525567|FG000|COMPLETED|Second Intervention||31||
48486128|NCT00840411|101525568|FG001|COMPLETED|Second Intervention||33||
48486129|NCT00840411|101525567|FG000|NOT COMPLETED|Second Intervention||0||
48486130|NCT00840411|101525568|FG001|NOT COMPLETED|Second Intervention||0||
48486131|NCT03818581|101525569|FG000|STARTED|Overall Study||23||
48486132|NCT03818581|101525570|FG001|STARTED|Overall Study||7||
48486133|NCT03818581|101525571|FG002|STARTED|Overall Study||16||
48486134|NCT03818581|101525572|FG003|STARTED|Overall Study||18||
48486135|NCT03818581|101525573|FG004|STARTED|Overall Study||3||
48486136|NCT03818581|101525569|FG000|COMPLETED|Overall Study||20||
48486137|NCT03818581|101525570|FG001|COMPLETED|Overall Study||7||
48486138|NCT03818581|101525571|FG002|COMPLETED|Overall Study||16||
48486139|NCT03818581|101525572|FG003|COMPLETED|Overall Study||18||
48486140|NCT03818581|101525573|FG004|COMPLETED|Overall Study||0||
48486141|NCT03818581|101525569|FG000|NOT COMPLETED|Overall Study||3||
48486142|NCT03818581|101525570|FG001|NOT COMPLETED|Overall Study||0||
48486143|NCT03818581|101525571|FG002|NOT COMPLETED|Overall Study||0||
48486144|NCT03818581|101525572|FG003|NOT COMPLETED|Overall Study||0||
48486145|NCT03818581|101525573|FG004|NOT COMPLETED|Overall Study||3||
48486146|NCT02082392|101525574|FG000|STARTED|Overall Study||2||
48486147|NCT02082392|101525575|FG001|STARTED|Overall Study||1||
48486148|NCT02082392|101525574|FG000|COMPLETED|Overall Study||2||
48486149|NCT02082392|101525575|FG001|COMPLETED|Overall Study||1||
48486150|NCT02082392|101525574|FG000|NOT COMPLETED|Overall Study||0||
48486151|NCT02082392|101525575|FG001|NOT COMPLETED|Overall Study||0||
48486152|NCT00204373|101525576|FG000|STARTED|Overall Study||72||
48486153|NCT00204373|101525576|FG000|COMPLETED|Overall Study||72||
48486154|NCT00204373|101525576|FG000|NOT COMPLETED|Overall Study||0||
48486155|NCT01498120|101525577|FG000|STARTED|Overall Study||14||
48486156|NCT01498120|101525577|FG000|COMPLETED|Overall Study||1||
48486157|NCT01498120|101525577|FG000|NOT COMPLETED|Overall Study||13||
48486158|NCT00794547|101525578|FG000|STARTED|Overall Study||18||
48486159|NCT00794547|101525579|FG001|STARTED|Overall Study||16||
48486160|NCT00794547|101525578|FG000|COMPLETED|Overall Study||18||
48486161|NCT00794547|101525579|FG001|COMPLETED|Overall Study||16||
48486162|NCT00794547|101525578|FG000|NOT COMPLETED|Overall Study||0||
48486163|NCT00794547|101525579|FG001|NOT COMPLETED|Overall Study||0||
48486164|NCT00395694|101525580|FG000|STARTED|Escalation Phase + Maintenance Phase||51||
48486165|NCT00395694|101525581|FG001|STARTED|Escalation Phase + Maintenance Phase||51||
48486166|NCT00395694|101525580|FG000|COMPLETED|Escalation Phase + Maintenance Phase||50||
48486167|NCT00395694|101525581|FG001|COMPLETED|Escalation Phase + Maintenance Phase||49||
48486168|NCT00395694|101525580|FG000|NOT COMPLETED|Escalation Phase + Maintenance Phase||1||
48486169|NCT00395694|101525581|FG001|NOT COMPLETED|Escalation Phase + Maintenance Phase||2||
48486170|NCT00395694|101525580|FG000|STARTED|Continuation Phase||49||
48486171|NCT00395694|101525581|FG001|STARTED|Continuation Phase||48||
48486172|NCT00395694|101525580|FG000|COMPLETED|Continuation Phase||34||
48486173|NCT00395694|101525581|FG001|COMPLETED|Continuation Phase||35||
48486174|NCT00395694|101525580|FG000|NOT COMPLETED|Continuation Phase||15||
48486175|NCT00395694|101525581|FG001|NOT COMPLETED|Continuation Phase||13||
48486176|NCT03181594|101525582|FG000|STARTED|Initial Study Protocol (12-month FU)||100||
48486177|NCT03181594|101525582|FG000|30-day Follow-up|Initial Study Protocol (12-month FU)||99|1 participant missed the 30-day visit but continued in later follow-up visits.|
48486178|NCT03181594|101525582|FG000|90-day Follow-up|Initial Study Protocol (12-month FU)||98||
48486179|NCT03181594|101525582|FG000|6-month Follow-up|Initial Study Protocol (12-month FU)||98||
48486180|NCT03181594|101525582|FG000|9-month Follow-up|Initial Study Protocol (12-month FU)||95||
48486181|NCT03181594|101525582|FG000|12-month Follow-up|Initial Study Protocol (12-month FU)||91||
48486182|NCT03181594|101525582|FG000|COMPLETED|Initial Study Protocol (12-month FU)||91||
48486183|NCT03181594|101525582|FG000|NOT COMPLETED|Initial Study Protocol (12-month FU)||9||
48486184|NCT03181594|101525582|FG000|STARTED|Long-term Extension (15-24 Month FU)||62||
48486185|NCT03181594|101525582|FG000|15-month Follow-up|Long-term Extension (15-24 Month FU)||56|Of the 91 participants who completed the 12-month visit, 28 did not consent to the long-term follow-up and 1 participant died before the long-term follow-up started resulting in 62 participants being eligible for long-term follow-up . 6/62 participants missed the 15-month missed visit.|
48486186|NCT03181594|101525582|FG000|18-month Follow-up|Long-term Extension (15-24 Month FU)||57|5/62 participants missed the 18-month visit.|
48486187|NCT03181594|101525582|FG000|21-month Follow-up|Long-term Extension (15-24 Month FU)||55|6 participants missed the 21-month visit.|
48486188|NCT03181594|101525582|FG000|24-month Follow-up|Long-term Extension (15-24 Month FU)||57||
48486189|NCT03181594|101525582|FG000|COMPLETED|Long-term Extension (15-24 Month FU)||57||
48486190|NCT03181594|101525582|FG000|NOT COMPLETED|Long-term Extension (15-24 Month FU)||5||
48486191|NCT01010555|101525583|FG000|STARTED|First Four Weeks of Wear||11||
48486192|NCT01010555|101525584|FG001|STARTED|First Four Weeks of Wear||10||
48486193|NCT01010555|101525583|FG000|COMPLETED|First Four Weeks of Wear||11||
48486194|NCT01010555|101525584|FG001|COMPLETED|First Four Weeks of Wear||10||
48486195|NCT01010555|101525583|FG000|NOT COMPLETED|First Four Weeks of Wear||0||
48486196|NCT01010555|101525584|FG001|NOT COMPLETED|First Four Weeks of Wear||0||
48486197|NCT01010555|101525583|FG000|STARTED|Second Four Weeks of Wear||10||
48486198|NCT01010555|101525584|FG001|STARTED|Second Four Weeks of Wear||9||
48486199|NCT01010555|101525583|FG000|COMPLETED|Second Four Weeks of Wear||10||
48486200|NCT01010555|101525584|FG001|COMPLETED|Second Four Weeks of Wear||9||
48486201|NCT01010555|101525583|FG000|NOT COMPLETED|Second Four Weeks of Wear||0||
48486202|NCT01010555|101525584|FG001|NOT COMPLETED|Second Four Weeks of Wear||0||
48486203|NCT00787254|101525585|FG000|STARTED|Overall Study||185||
48486204|NCT00787254|101525586|FG001|STARTED|Overall Study||181||
48486205|NCT00787254|101525585|FG000|COMPLETED|Overall Study||109||
48486206|NCT00787254|101525586|FG001|COMPLETED|Overall Study||99||
48486207|NCT00787254|101525585|FG000|NOT COMPLETED|Overall Study||76||
48486208|NCT00787254|101525586|FG001|NOT COMPLETED|Overall Study||82||
48486209|NCT00834405|101525587|FG000|STARTED|Overall Study||20||
48486210|NCT00834405|101525588|FG001|STARTED|Overall Study||17||
48486211|NCT00834405|101525587|FG000|COMPLETED|Overall Study||20||
48486212|NCT00834405|101525588|FG001|COMPLETED|Overall Study||17||
48486213|NCT00834405|101525587|FG000|NOT COMPLETED|Overall Study||0||
48486214|NCT00834405|101525588|FG001|NOT COMPLETED|Overall Study||0||
48486215|NCT02642835|101525589|FG000|STARTED|Overall Study||48||
48486216|NCT02642835|101525589|FG000|COMPLETED|Overall Study||48||
48486217|NCT02642835|101525589|FG000|NOT COMPLETED|Overall Study||0||
48486218|NCT03429712|101525590|FG000|STARTED|Overall Study||19||
48486219|NCT03429712|101525590|FG000|COMPLETED|Overall Study||10||
48486220|NCT03429712|101525590|FG000|NOT COMPLETED|Overall Study||9||
48486221|NCT01727180|101525591|FG000|STARTED|Overall Study||108||
48486222|NCT01727180|101525591|FG000|COMPLETED|Overall Study||108||
48486223|NCT01727180|101525591|FG000|NOT COMPLETED|Overall Study||0||
48486224|NCT03987191|101525592|FG000|STARTED|Overall Study||17||
48486225|NCT03987191|101525593|FG001|STARTED|Overall Study||15||
48486226|NCT03987191|101525592|FG000|Data Collected|Overall Study||17||
48486227|NCT03987191|101525593|FG001|Data Collected|Overall Study||13||
48486228|NCT03987191|101525592|FG000|COMPLETED|Overall Study||17||
48486229|NCT03987191|101525593|FG001|COMPLETED|Overall Study||13||
48486230|NCT03987191|101525592|FG000|NOT COMPLETED|Overall Study||0||
48486231|NCT03987191|101525593|FG001|NOT COMPLETED|Overall Study||2||
48486232|NCT02355886|101525594|FG000|STARTED|Overall Study||13||
48486233|NCT02355886|101525595|FG001|STARTED|Overall Study||12||
48486234|NCT02355886|101525594|FG000|COMPLETED|Overall Study||13||
48486235|NCT02355886|101525595|FG001|COMPLETED|Overall Study||12||
48486236|NCT02355886|101525594|FG000|NOT COMPLETED|Overall Study||0||
48486237|NCT02355886|101525595|FG001|NOT COMPLETED|Overall Study||0||
48486238|NCT01010932|101525596|FG000|STARTED|Overall Study||222||
48486239|NCT01010932|101525596|FG000|COMPLETED|Overall Study||200||
48486240|NCT01010932|101525596|FG000|NOT COMPLETED|Overall Study||22||
48486241|NCT01577381|101525597|FG000|STARTED|Overall Study||2||
48486242|NCT01577381|101525598|FG001|STARTED|Overall Study||3||
48486243|NCT01577381|101525599|FG002|STARTED|Overall Study||3||
48486244|NCT01577381|101525600|FG003|STARTED|Overall Study||2||
48486245|NCT01577381|101525597|FG000|COMPLETED|Overall Study||0||
48486246|NCT01577381|101525598|FG001|COMPLETED|Overall Study||0||
48486247|NCT01577381|101525599|FG002|COMPLETED|Overall Study||0||
48486248|NCT01577381|101525600|FG003|COMPLETED|Overall Study||0||
48486249|NCT01577381|101525597|FG000|NOT COMPLETED|Overall Study||2||
48486250|NCT01577381|101525598|FG001|NOT COMPLETED|Overall Study||3||
48486251|NCT01577381|101525599|FG002|NOT COMPLETED|Overall Study||3||
48486252|NCT01577381|101525600|FG003|NOT COMPLETED|Overall Study||2||
48486253|NCT00982397|101525601|FG000|STARTED|Phase I||236||
48486254|NCT00982397|101525602|FG001|STARTED|Phase I||0||
48486255|NCT00982397|101525601|FG000|COMPLETED|Phase I||236||
48486256|NCT00982397|101525602|FG001|COMPLETED|Phase I||0||
48486257|NCT00982397|101525601|FG000|NOT COMPLETED|Phase I||0||
48486258|NCT00982397|101525602|FG001|NOT COMPLETED|Phase I||0||
48486259|NCT00982397|101525601|FG000|STARTED|Phase II/Overall Study||2019|Note additional subjects were enrolled for Phase II|
48486260|NCT00982397|101525602|FG001|STARTED|Phase II/Overall Study||751|Note additional subjects were enrolled for Phase II|
48486261|NCT00982397|101525601|FG000|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||231|NID=number of intervals to detect prior to therapy delivery|
48486262|NCT00982397|101525602|FG001|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||122|NID=number of intervals to detect prior to therapy delivery|
48486263|NCT00982397|101525601|FG000|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||221|NID=number of intervals to detect prior to therapy delivery|
48486264|NCT00982397|101525602|FG001|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||131|NID=number of intervals to detect prior to therapy delivery|
48486265|NCT00982397|101525601|FG000|COMPLETED|Phase II/Overall Study||2019||
48486266|NCT00982397|101525602|FG001|COMPLETED|Phase II/Overall Study||751||
48486267|NCT00982397|101525601|FG000|NOT COMPLETED|Phase II/Overall Study||0||
48486268|NCT00982397|101525602|FG001|NOT COMPLETED|Phase II/Overall Study||0||
48486269|NCT01644058|101525603|FG000|STARTED|Overall Study||18||
48486270|NCT01644058|101525603|FG000|COMPLETED|Overall Study||18||
48486271|NCT01644058|101525603|FG000|NOT COMPLETED|Overall Study||0||
48486272|NCT00244764|101525604|FG000|STARTED|Overall Study||225||
48486273|NCT00244764|101525604|FG000|COMPLETED|Overall Study||129||
48486274|NCT00244764|101525604|FG000|NOT COMPLETED|Overall Study||96||
48666503|NCT04164901|101967593|FG000|COMPLETED|Overall Study||164|"As the study is still ongoing, the number of participants Completed reflects the number of participants who were still on study at the time of data collection for the purposes of this results submission."|
48666504|NCT04164901|101967594|FG001|COMPLETED|Overall Study||159|"As the study is still ongoing, the number of participants Completed reflects the number of participants who were still on study at the time of data collection for the purposes of this results submission."|
48666505|NCT04164901|101967593|FG000|NOT COMPLETED|Overall Study||4||
48666506|NCT04164901|101967594|FG001|NOT COMPLETED|Overall Study||4||
48666507|NCT02495883|101967595|FG000|STARTED|Overall Study||32||
48666508|NCT02495883|101967596|FG001|STARTED|Overall Study||24||
48666509|NCT02495883|101967595|FG000|COMPLETED|Overall Study||31||
48666510|NCT02495883|101967596|FG001|COMPLETED|Overall Study||24||
48666511|NCT02495883|101967595|FG000|NOT COMPLETED|Overall Study||1||
48666512|NCT02495883|101967596|FG001|NOT COMPLETED|Overall Study||0||
48666513|NCT03639935|101967597|FG000|STARTED|Overall Study||31||
48666514|NCT03639935|101967597|FG000|COMPLETED|Overall Study||27||
48666515|NCT03639935|101967597|FG000|NOT COMPLETED|Overall Study||4||
48666516|NCT01370551|101967598|FG000|STARTED|Overall Study||16||
48666517|NCT01370551|101967598|FG000|COMPLETED|Overall Study||16||
48666518|NCT01370551|101967598|FG000|NOT COMPLETED|Overall Study||0||
48666519|NCT00455702|101967599|FG000|STARTED|Overall Study||19||
48666520|NCT00455702|101967600|FG001|STARTED|Overall Study||19||
48666521|NCT00455702|101967599|FG000|COMPLETED|Overall Study||16||
48666522|NCT00455702|101967600|FG001|COMPLETED|Overall Study||16||
48666523|NCT00455702|101967599|FG000|NOT COMPLETED|Overall Study||3||
48666524|NCT00455702|101967600|FG001|NOT COMPLETED|Overall Study||3||
48666525|NCT01377402|101967601|FG000|STARTED|Overall Study||982||
48666526|NCT01377402|101967601|FG000|COMPLETED|Overall Study||982||
48666527|NCT01377402|101967601|FG000|NOT COMPLETED|Overall Study||0||
48666528|NCT02943473|101967602|FG000|STARTED|Overall Study||9||
48666529|NCT02943473|101967602|FG000|COMPLETED|Overall Study||3||
48666530|NCT02943473|101967602|FG000|NOT COMPLETED|Overall Study||6||
48666531|NCT00404248|101967603|FG000|STARTED|Overall Study||3||
48666532|NCT00404248|101967604|FG001|STARTED|Overall Study||4||
48666533|NCT00404248|101967605|FG002|STARTED|Overall Study||5||
48666534|NCT00404248|101967606|FG003|STARTED|Overall Study||2||
48666535|NCT00404248|101967607|FG004|STARTED|Overall Study||3||
48666536|NCT00404248|101967608|FG005|STARTED|Overall Study||3||
48666537|NCT00404248|101967609|FG006|STARTED|Overall Study||6||
48666538|NCT00404248|101967610|FG007|STARTED|Overall Study||6||
48666539|NCT00404248|101967611|FG008|STARTED|Overall Study||3||
48666540|NCT00404248|101967603|FG000|COMPLETED|Overall Study||3||
48666541|NCT00404248|101967604|FG001|COMPLETED|Overall Study||3||
48666542|NCT00404248|101967605|FG002|COMPLETED|Overall Study||5||
48666543|NCT00404248|101967606|FG003|COMPLETED|Overall Study||2||
48666544|NCT00404248|101967607|FG004|COMPLETED|Overall Study||3||
48666545|NCT00404248|101967608|FG005|COMPLETED|Overall Study||3||
48666546|NCT00404248|101967609|FG006|COMPLETED|Overall Study||6||
48666547|NCT00404248|101967610|FG007|COMPLETED|Overall Study||6||
48666548|NCT00404248|101967611|FG008|COMPLETED|Overall Study||3||
48666549|NCT00404248|101967603|FG000|NOT COMPLETED|Overall Study||0||
48666550|NCT00404248|101967604|FG001|NOT COMPLETED|Overall Study||1||
48666551|NCT00404248|101967605|FG002|NOT COMPLETED|Overall Study||0||
48666552|NCT00404248|101967606|FG003|NOT COMPLETED|Overall Study||0||
48486275|NCT04841317|101528958|FG000|STARTED|Overall Study||30||
48486276|NCT04841317|101528958|FG000|COMPLETED|Overall Study||30||
48486277|NCT04841317|101528958|FG000|NOT COMPLETED|Overall Study||0||
48486278|NCT05099380|101528959|FG000|STARTED|Overall Study||150||
48486279|NCT05099380|101528960|FG001|STARTED|Overall Study||145||
48486280|NCT05099380|101528959|FG000|COMPLETED|Overall Study||145||
48486281|NCT05099380|101528960|FG001|COMPLETED|Overall Study||144||
48486282|NCT05099380|101528959|FG000|NOT COMPLETED|Overall Study||5||
48486283|NCT05099380|101528960|FG001|NOT COMPLETED|Overall Study||1||
48486284|NCT02399917|101528961|FG000|STARTED|Overall Study||6||
48198399|NCT03982199|100810136|FG007|COMPLETED|Revacc Subcohort (From Day 1095 to 1460)||0||
48198400|NCT03982199|100810137|FG008|COMPLETED|Revacc Subcohort (From Day 1095 to 1460)||0||
48198401|NCT03982199|100810138|FG009|COMPLETED|Revacc Subcohort (From Day 1095 to 1460)||0||
48198402|NCT03982199|100810139|FG010|COMPLETED|Revacc Subcohort (From Day 1095 to 1460)||0||
48198403|NCT03982199|100810140|FG011|COMPLETED|Revacc Subcohort (From Day 1095 to 1460)||0||
48198404|NCT03982199|100810141|FG012|COMPLETED|Revacc Subcohort (From Day 1095 to 1460)||0||
48198405|NCT03982199|100810142|FG013|COMPLETED|Revacc Subcohort (From Day 1095 to 1460)||0||
48198406|NCT03982199|100810129|FG000|NOT COMPLETED|Revacc Subcohort (From Day 1095 to 1460)||0||
48198407|NCT03982199|100810130|FG001|NOT COMPLETED|Revacc Subcohort (From Day 1095 to 1460)||0||
48198408|NCT03982199|100810131|FG002|NOT COMPLETED|Revacc Subcohort (From Day 1095 to 1460)||0||
48198409|NCT03982199|100810132|FG003|NOT COMPLETED|Revacc Subcohort (From Day 1095 to 1460)||0||
48198410|NCT03982199|100810133|FG004|NOT COMPLETED|Revacc Subcohort (From Day 1095 to 1460)||0||
48198411|NCT03982199|100810134|FG005|NOT COMPLETED|Revacc Subcohort (From Day 1095 to 1460)||0||
48198412|NCT03982199|100810135|FG006|NOT COMPLETED|Revacc Subcohort (From Day 1095 to 1460)||0||
48198413|NCT03982199|100810136|FG007|NOT COMPLETED|Revacc Subcohort (From Day 1095 to 1460)||0||
48486285|NCT02399917|101528962|FG001|STARTED|Overall Study||6||
48486286|NCT02399917|101528963|FG002|STARTED|Overall Study||24||
48486287|NCT02399917|101528961|FG000|COMPLETED|Overall Study||6||
48486288|NCT02399917|101528962|FG001|COMPLETED|Overall Study||6||
48486289|NCT02399917|101528963|FG002|COMPLETED|Overall Study||24||
48486290|NCT02399917|101528961|FG000|NOT COMPLETED|Overall Study||0||
48486291|NCT02399917|101528962|FG001|NOT COMPLETED|Overall Study||0||
48198414|NCT03982199|100810137|FG008|NOT COMPLETED|Revacc Subcohort (From Day 1095 to 1460)||0||
48198415|NCT03982199|100810138|FG009|NOT COMPLETED|Revacc Subcohort (From Day 1095 to 1460)||37||
48198416|NCT03982199|100810139|FG010|NOT COMPLETED|Revacc Subcohort (From Day 1095 to 1460)||37||
48198417|NCT03982199|100810140|FG011|NOT COMPLETED|Revacc Subcohort (From Day 1095 to 1460)||37||
48198418|NCT03982199|100810141|FG012|NOT COMPLETED|Revacc Subcohort (From Day 1095 to 1460)||131||
48198419|NCT03982199|100810142|FG013|NOT COMPLETED|Revacc Subcohort (From Day 1095 to 1460)||119||
48198420|NCT01186848|100810143|FG000|STARTED|Overall Study||30||
48198421|NCT01186848|100810143|FG000|COMPLETED|Overall Study||22||
48198422|NCT01186848|100810143|FG000|NOT COMPLETED|Overall Study||8||
48486292|NCT02399917|101528963|FG002|NOT COMPLETED|Overall Study||0||
48486293|NCT00904423|101528964|FG000|STARTED|Overall Study||8||
48486294|NCT00904423|101528964|FG000|COMPLETED|Overall Study||8||
48486295|NCT00904423|101528964|FG000|NOT COMPLETED|Overall Study||0||
48486296|NCT03128723|101528965|FG000|STARTED|Overall Study||45||
48486297|NCT03128723|101528965|FG000|COMPLETED|Overall Study||43||
48486298|NCT03128723|101528965|FG000|NOT COMPLETED|Overall Study||2||
48486299|NCT00486863|101528966|FG000|STARTED|Overall Study||184||
48486300|NCT00486863|101528967|FG001|STARTED|Overall Study||186||
48486301|NCT00486863|101528966|FG000|COMPLETED|Overall Study||183||
48486302|NCT00486863|101528967|FG001|COMPLETED|Overall Study||183||
48486303|NCT00486863|101528966|FG000|NOT COMPLETED|Overall Study||1||
48486304|NCT00486863|101528967|FG001|NOT COMPLETED|Overall Study||3||
48486305|NCT01681745|101528968|FG000|STARTED|Overall Study||0||
48486306|NCT01681745|101528968|FG000|COMPLETED|Overall Study||0||
48486307|NCT01681745|101528968|FG000|NOT COMPLETED|Overall Study||0||
48486308|NCT00461786|101528969|FG000|STARTED|Overall Study||51||
48486309|NCT00461786|101528969|FG000|COMPLETED|Overall Study||48||
48486310|NCT00461786|101528969|FG000|NOT COMPLETED|Overall Study||3||
48486311|NCT02664961|101528970|FG000|STARTED|Overall Study||3||
48486312|NCT02664961|101528970|FG000|COMPLETED|Overall Study||3||
48486313|NCT02664961|101528970|FG000|NOT COMPLETED|Overall Study||0||
48486314|NCT01642277|101528971|FG000|STARTED|Overall Study||74||
48486315|NCT01642277|101528972|FG001|STARTED|Overall Study||60||
48486316|NCT01642277|101528971|FG000|COMPLETED|Overall Study||50||
48486317|NCT01642277|101528972|FG001|COMPLETED|Overall Study||60||
48486318|NCT01642277|101528971|FG000|NOT COMPLETED|Overall Study||24||
48486319|NCT01642277|101528972|FG001|NOT COMPLETED|Overall Study||0||
48486320|NCT00113386|101528973|FG000|STARTED|Overall Study||10||
48486321|NCT00113386|101528974|FG001|STARTED|Overall Study||9||
48486322|NCT00113386|101528973|FG000|COMPLETED|Overall Study||3||
48486323|NCT00113386|101528974|FG001|COMPLETED|Overall Study||5||
48486324|NCT00113386|101528973|FG000|NOT COMPLETED|Overall Study||7||
48486325|NCT00113386|101528974|FG001|NOT COMPLETED|Overall Study||4||
48486326|NCT03435835|101528975|FG000|STARTED|First Intervention||8||
48486327|NCT03435835|101528976|FG001|STARTED|First Intervention||8||
48198423|NCT00942149|100810144|FG000|STARTED|Overall Study||20||
48198424|NCT00942149|100810144|FG000|COMPLETED|Overall Study||20||
48198425|NCT00942149|100810144|FG000|NOT COMPLETED|Overall Study||0||
48198426|NCT01193153|100810145|FG000|STARTED|Open-label Lead in Period||667||
48198427|NCT01193153|100810146|FG001|STARTED|Open-label Lead in Period||0||
48198428|NCT01193153|100810145|FG000|COMPLETED|Open-label Lead in Period||432||
48198429|NCT01193153|100810146|FG001|COMPLETED|Open-label Lead in Period||0||
48198430|NCT01193153|100810145|FG000|NOT COMPLETED|Open-label Lead in Period||235||
48198431|NCT01193153|100810146|FG001|NOT COMPLETED|Open-label Lead in Period||0||
48198432|NCT01193153|100810145|FG000|STARTED|Open-label Stabilization Period||432||
48198433|NCT01193153|100810146|FG001|STARTED|Open-label Stabilization Period||0||
48198434|NCT01193153|100810145|FG000|COMPLETED|Open-label Stabilization Period||334||
48198435|NCT01193153|100810146|FG001|COMPLETED|Open-label Stabilization Period||0||
48198436|NCT01193153|100810145|FG000|NOT COMPLETED|Open-label Stabilization Period||98||
48198437|NCT01193153|100810146|FG001|NOT COMPLETED|Open-label Stabilization Period||0||
48198438|NCT01193153|100810145|FG000|STARTED|Double Blind Relapse Prevention Period||164||
48198439|NCT01193153|100810146|FG001|STARTED|Double Blind Relapse Prevention Period||170||
48198440|NCT01193153|100810145|FG000|COMPLETED|Double Blind Relapse Prevention Period||100||
48198441|NCT01193153|100810146|FG001|COMPLETED|Double Blind Relapse Prevention Period||65||
48198442|NCT01193153|100810145|FG000|NOT COMPLETED|Double Blind Relapse Prevention Period||64||
48198443|NCT01193153|100810146|FG001|NOT COMPLETED|Double Blind Relapse Prevention Period||105||
48198444|NCT04460898|100810147|FG000|STARTED|Overall Study||195||
48198445|NCT04460898|100810147|FG000|COMPLETED|Overall Study||195||
48198446|NCT04460898|100810147|FG000|NOT COMPLETED|Overall Study||0||
48198447|NCT00464672|100810148|FG000|STARTED|Overall Study||460||
48486328|NCT03435835|101528975|FG000|COMPLETED|First Intervention||8||
48198448|NCT00464672|100810149|FG001|STARTED|Overall Study||232||
48198449|NCT00464672|100810150|FG002|STARTED|Overall Study||400||
48198450|NCT00464672|100810151|FG003|STARTED|Overall Study||200||
48198451|NCT00464672|100810152|FG004|STARTED|Overall Study||402||
48486329|NCT03435835|101528976|FG001|COMPLETED|First Intervention||8||
48486330|NCT03435835|101528975|FG000|NOT COMPLETED|First Intervention||0||
48486331|NCT03435835|101528976|FG001|NOT COMPLETED|First Intervention||0||
48486332|NCT03435835|101528975|FG000|STARTED|Washout||8||
48198452|NCT00464672|100810153|FG005|STARTED|Overall Study||199||
48198453|NCT00464672|100810148|FG000|COMPLETED|Overall Study||435||
48198454|NCT00464672|100810149|FG001|COMPLETED|Overall Study||222||
48198455|NCT00464672|100810150|FG002|COMPLETED|Overall Study||400||
48198456|NCT00464672|100810151|FG003|COMPLETED|Overall Study||199||
48198457|NCT00464672|100810152|FG004|COMPLETED|Overall Study||392||
48198458|NCT00464672|100810153|FG005|COMPLETED|Overall Study||195||
48198459|NCT00464672|100810148|FG000|NOT COMPLETED|Overall Study||25||
48198460|NCT00464672|100810149|FG001|NOT COMPLETED|Overall Study||10||
48198461|NCT00464672|100810150|FG002|NOT COMPLETED|Overall Study||0||
48198462|NCT00464672|100810151|FG003|NOT COMPLETED|Overall Study||1||
48198463|NCT00464672|100810152|FG004|NOT COMPLETED|Overall Study||10||
48666553|NCT00404248|101967607|FG004|NOT COMPLETED|Overall Study||0||
48198464|NCT00464672|100810153|FG005|NOT COMPLETED|Overall Study||4||
48198465|NCT02280655|100810154|FG000|STARTED|Overall Study||25||
48198466|NCT02280655|100810155|FG001|STARTED|Overall Study||18||
48198467|NCT02280655|100810154|FG000|COMPLETED|Overall Study||25||
48198468|NCT02280655|100810155|FG001|COMPLETED|Overall Study||18||
48198469|NCT02280655|100810154|FG000|NOT COMPLETED|Overall Study||0||
48198470|NCT02280655|100810155|FG001|NOT COMPLETED|Overall Study||0||
48198471|NCT00470106|100810156|FG000|STARTED|Overall Study||19||
48198472|NCT00470106|100810157|FG001|STARTED|Overall Study||24||
48198473|NCT00470106|100810158|FG002|STARTED|Overall Study||21||
48198474|NCT00470106|100810159|FG003|STARTED|Overall Study||21||
48198475|NCT00470106|100810156|FG000|COMPLETED|Overall Study||16||
48198476|NCT00470106|100810157|FG001|COMPLETED|Overall Study||19||
48198477|NCT00470106|100810158|FG002|COMPLETED|Overall Study||14||
48198478|NCT00470106|100810159|FG003|COMPLETED|Overall Study||19||
48198479|NCT00470106|100810156|FG000|NOT COMPLETED|Overall Study||3||
48198480|NCT00470106|100810157|FG001|NOT COMPLETED|Overall Study||5||
48198481|NCT00470106|100810158|FG002|NOT COMPLETED|Overall Study||7||
48198482|NCT00470106|100810159|FG003|NOT COMPLETED|Overall Study||2||
48198483|NCT00943605|100810160|FG000|STARTED|Overall Study||30||
48198484|NCT00943605|100810161|FG001|STARTED|Overall Study||30||
48198485|NCT00943605|100810160|FG000|COMPLETED|Overall Study||0||
48198486|NCT00943605|100810161|FG001|COMPLETED|Overall Study||0||
48198487|NCT00943605|100810160|FG000|NOT COMPLETED|Overall Study||30||
48198488|NCT00943605|100810161|FG001|NOT COMPLETED|Overall Study||30||
48486333|NCT03435835|101528976|FG001|STARTED|Washout||8||
48486334|NCT03435835|101528975|FG000|COMPLETED|Washout||8||
48486335|NCT03435835|101528976|FG001|COMPLETED|Washout||8||
48486336|NCT03435835|101528975|FG000|NOT COMPLETED|Washout||0||
48486337|NCT03435835|101528976|FG001|NOT COMPLETED|Washout||0||
48486338|NCT03435835|101528975|FG000|STARTED|Second Intervention||8||
48486339|NCT03435835|101528976|FG001|STARTED|Second Intervention||8||
48486340|NCT03435835|101528975|FG000|COMPLETED|Second Intervention||8||
48486341|NCT03435835|101528976|FG001|COMPLETED|Second Intervention||8||
48486342|NCT03435835|101528975|FG000|NOT COMPLETED|Second Intervention||0||
48486343|NCT03435835|101528976|FG001|NOT COMPLETED|Second Intervention||0||
48486344|NCT02043132|101528977|FG000|STARTED|Overall Study||58||
48486345|NCT02043132|101528978|FG001|STARTED|Overall Study||58||
48486346|NCT02043132|101528977|FG000|COMPLETED|Overall Study||53||
48486347|NCT02043132|101528978|FG001|COMPLETED|Overall Study||49||
48486348|NCT02043132|101528977|FG000|NOT COMPLETED|Overall Study||5||
48486349|NCT02043132|101528978|FG001|NOT COMPLETED|Overall Study||9||
48486350|NCT00252967|101528979|FG000|STARTED|Overall Study||31||
48486351|NCT00252967|101528980|FG001|STARTED|Overall Study||33||
48486352|NCT00252967|101528979|FG000|COMPLETED|Overall Study||31||
48486353|NCT00252967|101528980|FG001|COMPLETED|Overall Study||33||
48486354|NCT00252967|101528979|FG000|NOT COMPLETED|Overall Study||0||
48486355|NCT00252967|101528980|FG001|NOT COMPLETED|Overall Study||0||
48486356|NCT01319383|101528981|FG000|STARTED|Overall Study||12||
48198489|NCT01156116|100810162|FG000|STARTED|Overall Study||26||
48198490|NCT01156116|100810163|FG001|STARTED|Overall Study||13||
48198491|NCT01156116|100810162|FG000|COMPLETED|Overall Study||21||
48198492|NCT01156116|100810163|FG001|COMPLETED|Overall Study||12||
48198493|NCT01156116|100810162|FG000|NOT COMPLETED|Overall Study||5||
48198494|NCT01156116|100810163|FG001|NOT COMPLETED|Overall Study||1||
48198495|NCT00975806|100810164|FG000|STARTED|Overall Study||5||
48198496|NCT00975806|100810165|FG001|STARTED|Overall Study||7||
48198497|NCT00975806|100810166|FG002|STARTED|Overall Study||4||
48198498|NCT00975806|100810164|FG000|COMPLETED|Overall Study||0||
48198499|NCT00975806|100810165|FG001|COMPLETED|Overall Study||0||
48198500|NCT00975806|100810166|FG002|COMPLETED|Overall Study||0||
48198501|NCT00975806|100810164|FG000|NOT COMPLETED|Overall Study||5||
48486357|NCT01319383|101528982|FG001|STARTED|Overall Study||13||
48486358|NCT01319383|101528981|FG000|Step 1|Overall Study||8|Demonstrating an ex vivo response to VOR, measured in research lab, permitted study advancement|
48486359|NCT01319383|101528982|FG001|Step 1|Overall Study||11|Demonstrating an ex vivo response to VOR, measured in research lab, permitted study advancement|
48486360|NCT01319383|101528981|FG000|Step 2|Overall Study||8|Demonstrated an in vivo response to a single VOR 400 mg PO in Step 2|
48486361|NCT01319383|101528982|FG001|Step 2|Overall Study||4|Demonstrated an in vivo response to a single VOR 400 mg PO in Step 2|
48486362|NCT01319383|101528981|FG000|Step 2|Overall Study||4|Did not demonstrate an in vivo response to VOR 400 mg PO|
48486363|NCT01319383|101528982|FG001|Step 2|Overall Study||0|Did not demonstrate an in vivo response to VOR 400 mg PO|
48486364|NCT01319383|101528981|FG000|Step 3|Overall Study||0|Demonstrated an in vivo response to multiple doses of VOR 400 mg PO|
48486365|NCT01319383|101528982|FG001|Step 3|Overall Study||6|Demonstrated an in vivo response to multiple doses of VOR 400 mg PO|
48486366|NCT01319383|101528981|FG000|Step 4|Overall Study||0|Demonstrated an in vivo response to 10 doses taken a designated intervals|
48486367|NCT01319383|101528982|FG001|Step 4|Overall Study||3|Demonstrated an in vivo response to 10 doses taken a designated intervals|
48486368|NCT01319383|101528981|FG000|COMPLETED|Overall Study||0||
48486369|NCT01319383|101528982|FG001|COMPLETED|Overall Study||3||
48486370|NCT01319383|101528981|FG000|NOT COMPLETED|Overall Study||12||
48486371|NCT01319383|101528982|FG001|NOT COMPLETED|Overall Study||10||
48486372|NCT02158572|101528983|FG000|STARTED|Overall Study||2032||
48486373|NCT02158572|101528983|FG000|COMPLETED|Overall Study||989||
48486374|NCT02158572|101528983|FG000|NOT COMPLETED|Overall Study||1043||
48198502|NCT00975806|100810165|FG001|NOT COMPLETED|Overall Study||7||
48198503|NCT00975806|100810166|FG002|NOT COMPLETED|Overall Study||4||
48198504|NCT05512949|100810167|FG000|STARTED|Overall Study||75||
48198505|NCT05512949|100810168|FG001|STARTED|Overall Study||78||
48198506|NCT05512949|100810169|FG002|STARTED|Overall Study||76||
48486375|NCT00579345|101528984|FG000|STARTED|Overall Study||549||
48486376|NCT00579345|101528985|FG001|STARTED|Overall Study||169||
48486377|NCT00579345|101528986|FG002|STARTED|Overall Study||391||
48486378|NCT00579345|101528987|FG003|STARTED|Overall Study||144||
48486379|NCT00579345|101528988|FG004|STARTED|Overall Study||90||
48486380|NCT00579345|101528989|FG005|STARTED|Overall Study||78||
48486381|NCT00579345|101528990|FG006|STARTED|Overall Study||57||
48486382|NCT00579345|101528991|FG007|STARTED|Overall Study||44||
48486383|NCT00579345|101528984|FG000|COMPLETED|Overall Study||544||
48486384|NCT00579345|101528985|FG001|COMPLETED|Overall Study||168||
48486385|NCT00579345|101528986|FG002|COMPLETED|Overall Study||389||
48486386|NCT00579345|101528987|FG003|COMPLETED|Overall Study||143||
48486387|NCT00579345|101528988|FG004|COMPLETED|Overall Study||90||
48486388|NCT00579345|101528989|FG005|COMPLETED|Overall Study||78||
48486389|NCT00579345|101528990|FG006|COMPLETED|Overall Study||57||
48486390|NCT00579345|101528991|FG007|COMPLETED|Overall Study||42||
48486391|NCT00579345|101528984|FG000|NOT COMPLETED|Overall Study||5||
48486392|NCT00579345|101528985|FG001|NOT COMPLETED|Overall Study||1||
48486393|NCT00579345|101528986|FG002|NOT COMPLETED|Overall Study||2||
48486394|NCT00579345|101528987|FG003|NOT COMPLETED|Overall Study||1||
48486395|NCT00579345|101528988|FG004|NOT COMPLETED|Overall Study||0||
48486396|NCT00579345|101528989|FG005|NOT COMPLETED|Overall Study||0||
48486397|NCT00579345|101528990|FG006|NOT COMPLETED|Overall Study||0||
48486398|NCT00579345|101528991|FG007|NOT COMPLETED|Overall Study||2||
48486399|NCT01891994|101528992|FG000|STARTED|Overall Study||40||
48486400|NCT01891994|101528992|FG000|COMPLETED|Overall Study||40||
48486401|NCT01891994|101528992|FG000|NOT COMPLETED|Overall Study||0||
48486402|NCT02820350|101528993|FG000|STARTED|Overall Study||19||
48486403|NCT02820350|101528993|FG000|COMPLETED|Overall Study||12||
48486404|NCT02820350|101528993|FG000|NOT COMPLETED|Overall Study||7||
48486405|NCT01032083|101528994|FG000|STARTED|Overall Study||30||
48486406|NCT01032083|101528995|FG001|STARTED|Overall Study||32||
48486407|NCT01032083|101528994|FG000|COMPLETED|Overall Study||19||
48486408|NCT01032083|101528995|FG001|COMPLETED|Overall Study||23||
48486409|NCT01032083|101528994|FG000|NOT COMPLETED|Overall Study||11||
48486410|NCT01032083|101528995|FG001|NOT COMPLETED|Overall Study||9||
48486411|NCT05956925|101528996|FG000|STARTED|Overall Study||14||
48486412|NCT05956925|101528997|FG001|STARTED|Overall Study||15||
48486413|NCT05956925|101528996|FG000|COMPLETED|Overall Study||14||
48486414|NCT05956925|101528997|FG001|COMPLETED|Overall Study||15||
48486415|NCT05956925|101528996|FG000|NOT COMPLETED|Overall Study||0||
48486416|NCT05956925|101528997|FG001|NOT COMPLETED|Overall Study||0||
48486417|NCT05038293|101528998|FG000|STARTED|Overall Study||24||
48486418|NCT05038293|101528999|FG001|STARTED|Overall Study||18||
48486419|NCT05038293|101528998|FG000|COMPLETED|Overall Study||22||
48486420|NCT05038293|101528999|FG001|COMPLETED|Overall Study||18||
48486421|NCT05038293|101528998|FG000|NOT COMPLETED|Overall Study||2||
48486422|NCT05038293|101528999|FG001|NOT COMPLETED|Overall Study||0||
48486423|NCT04206332|101529000|FG000|STARTED|Part A||4||
48198507|NCT05512949|100810167|FG000|COMPLETED|Overall Study||69||
48198508|NCT05512949|100810168|FG001|COMPLETED|Overall Study||68||
48198509|NCT05512949|100810169|FG002|COMPLETED|Overall Study||71||
48198510|NCT05512949|100810167|FG000|NOT COMPLETED|Overall Study||6||
48486424|NCT04206332|101529001|FG001|STARTED|Part A||4||
48486425|NCT04206332|101529002|FG002|STARTED|Part A||5||
48486426|NCT04206332|101529003|FG003|STARTED|Part A||5||
48486427|NCT04206332|101529004|FG004|STARTED|Part A||3||
48486428|NCT04206332|101529005|FG005|STARTED|Part A||8||
48486429|NCT04206332|101529006|FG006|STARTED|Part A||0||
48486430|NCT04206332|101529007|FG007|STARTED|Part A||0||
48486431|NCT04206332|101529008|FG008|STARTED|Part A||0||
48486432|NCT04206332|101529009|FG009|STARTED|Part A||0||
48486433|NCT04206332|101529010|FG010|STARTED|Part A||0||
48486434|NCT04206332|101529011|FG011|STARTED|Part A||0||
48486435|NCT04206332|101529012|FG012|STARTED|Part A||0||
48486436|NCT04206332|101529013|FG013|STARTED|Part A||0||
48486437|NCT04206332|101529014|FG014|STARTED|Part A||0||
48486438|NCT04206332|101529015|FG015|STARTED|Part A||0||
48486439|NCT04206332|101529016|FG016|STARTED|Part A||0||
48486440|NCT04206332|101529000|FG000|Received Product Administration|Part A||4||
48486441|NCT04206332|101529001|FG001|Received Product Administration|Part A||4||
48666554|NCT00404248|101967608|FG005|NOT COMPLETED|Overall Study||0||
48666555|NCT00404248|101967609|FG006|NOT COMPLETED|Overall Study||0||
48486442|NCT04206332|101529002|FG002|Received Product Administration|Part A||5||
48486443|NCT04206332|101529003|FG003|Received Product Administration|Part A||5||
48486444|NCT04206332|101529004|FG004|Received Product Administration|Part A||3||
48486445|NCT04206332|101529005|FG005|Received Product Administration|Part A||0||
48486446|NCT04206332|101529006|FG006|Received Product Administration|Part A||0||
48486447|NCT04206332|101529007|FG007|Received Product Administration|Part A||0||
48486448|NCT04206332|101529008|FG008|Received Product Administration|Part A||0||
48486449|NCT04206332|101529009|FG009|Received Product Administration|Part A||0||
48486450|NCT04206332|101529010|FG010|Received Product Administration|Part A||0||
48486451|NCT04206332|101529011|FG011|Received Product Administration|Part A||0||
48486452|NCT04206332|101529012|FG012|Received Product Administration|Part A||0||
48486453|NCT04206332|101529013|FG013|Received Product Administration|Part A||0||
48486454|NCT04206332|101529014|FG014|Received Product Administration|Part A||0||
48486455|NCT04206332|101529015|FG015|Received Product Administration|Part A||0||
48486456|NCT04206332|101529016|FG016|Received Product Administration|Part A||0||
48486457|NCT04206332|101529000|FG000|Completed Controlled Human Malaria Infection (CHMI)|Part A||0||
48486458|NCT04206332|101529001|FG001|Completed Controlled Human Malaria Infection (CHMI)|Part A||0||
48486459|NCT04206332|101529002|FG002|Completed Controlled Human Malaria Infection (CHMI)|Part A||0||
48486460|NCT04206332|101529003|FG003|Completed Controlled Human Malaria Infection (CHMI)|Part A||0||
48486461|NCT04206332|101529004|FG004|Completed Controlled Human Malaria Infection (CHMI)|Part A||0||
48486462|NCT04206332|101529005|FG005|Completed Controlled Human Malaria Infection (CHMI)|Part A||0||
48486463|NCT04206332|101529006|FG006|Completed Controlled Human Malaria Infection (CHMI)|Part A||0||
48486464|NCT04206332|101529007|FG007|Completed Controlled Human Malaria Infection (CHMI)|Part A||0||
48486465|NCT04206332|101529008|FG008|Completed Controlled Human Malaria Infection (CHMI)|Part A||0||
48486466|NCT04206332|101529009|FG009|Completed Controlled Human Malaria Infection (CHMI)|Part A||0||
48486467|NCT04206332|101529010|FG010|Completed Controlled Human Malaria Infection (CHMI)|Part A||0||
48486468|NCT04206332|101529011|FG011|Completed Controlled Human Malaria Infection (CHMI)|Part A||0||
48486469|NCT04206332|101529012|FG012|Completed Controlled Human Malaria Infection (CHMI)|Part A||0||
48486470|NCT04206332|101529013|FG013|Completed Controlled Human Malaria Infection (CHMI)|Part A||0||
48486471|NCT04206332|101529014|FG014|Completed Controlled Human Malaria Infection (CHMI)|Part A||0||
48486472|NCT04206332|101529015|FG015|Completed Controlled Human Malaria Infection (CHMI)|Part A||0||
48486473|NCT04206332|101529016|FG016|Completed Controlled Human Malaria Infection (CHMI)|Part A||0||
48486474|NCT04206332|101529000|FG000|COMPLETED|Part A||4||
48486475|NCT04206332|101529001|FG001|COMPLETED|Part A||3||
48486476|NCT04206332|101529002|FG002|COMPLETED|Part A||5||
48486477|NCT04206332|101529003|FG003|COMPLETED|Part A||5||
48486478|NCT04206332|101529004|FG004|COMPLETED|Part A||3||
48486479|NCT04206332|101529005|FG005|COMPLETED|Part A||0||
48486480|NCT04206332|101529006|FG006|COMPLETED|Part A||0||
48486481|NCT04206332|101529007|FG007|COMPLETED|Part A||0||
48486482|NCT04206332|101529008|FG008|COMPLETED|Part A||0||
48486483|NCT04206332|101529009|FG009|COMPLETED|Part A||0||
48486484|NCT04206332|101529010|FG010|COMPLETED|Part A||0||
48486485|NCT04206332|101529011|FG011|COMPLETED|Part A||0||
48486486|NCT04206332|101529012|FG012|COMPLETED|Part A||0||
48486487|NCT04206332|101529013|FG013|COMPLETED|Part A||0||
48486488|NCT04206332|101529014|FG014|COMPLETED|Part A||0||
48486489|NCT04206332|101529015|FG015|COMPLETED|Part A||0||
48486490|NCT04206332|101529016|FG016|COMPLETED|Part A||0||
48486491|NCT04206332|101529000|FG000|NOT COMPLETED|Part A||0||
48486492|NCT04206332|101529001|FG001|NOT COMPLETED|Part A||1||
48486493|NCT04206332|101529002|FG002|NOT COMPLETED|Part A||0||
48486494|NCT04206332|101529003|FG003|NOT COMPLETED|Part A||0||
48486495|NCT04206332|101529004|FG004|NOT COMPLETED|Part A||0||
48486496|NCT04206332|101529005|FG005|NOT COMPLETED|Part A||8||
48486497|NCT04206332|101529006|FG006|NOT COMPLETED|Part A||0||
48486498|NCT04206332|101529007|FG007|NOT COMPLETED|Part A||0||
48486499|NCT04206332|101529008|FG008|NOT COMPLETED|Part A||0||
48486500|NCT04206332|101529009|FG009|NOT COMPLETED|Part A||0||
48486501|NCT04206332|101529010|FG010|NOT COMPLETED|Part A||0||
48486502|NCT04206332|101529011|FG011|NOT COMPLETED|Part A||0||
48486503|NCT04206332|101529012|FG012|NOT COMPLETED|Part A||0||
48486504|NCT04206332|101529013|FG013|NOT COMPLETED|Part A||0||
48486505|NCT04206332|101529014|FG014|NOT COMPLETED|Part A||0||
48486506|NCT04206332|101529015|FG015|NOT COMPLETED|Part A||0||
48486507|NCT04206332|101529016|FG016|NOT COMPLETED|Part A||0||
48486508|NCT04206332|101529000|FG000|STARTED|Part B||0||
48486509|NCT04206332|101529001|FG001|STARTED|Part B||0||
48486510|NCT04206332|101529002|FG002|STARTED|Part B||0||
48486511|NCT04206332|101529003|FG003|STARTED|Part B||0||
48486512|NCT04206332|101529004|FG004|STARTED|Part B||0||
48486513|NCT04206332|101529005|FG005|STARTED|Part B||0||
48486514|NCT04206332|101529006|FG006|STARTED|Part B||0||
48486515|NCT04206332|101529007|FG007|STARTED|Part B||7||
48486516|NCT04206332|101529008|FG008|STARTED|Part B||2||
48486517|NCT04206332|101529009|FG009|STARTED|Part B||4||
48486518|NCT04206332|101529010|FG010|STARTED|Part B||8||
48486519|NCT04206332|101529011|FG011|STARTED|Part B||0||
48486520|NCT04206332|101529012|FG012|STARTED|Part B||0||
48486521|NCT04206332|101529013|FG013|STARTED|Part B||0||
48486522|NCT04206332|101529014|FG014|STARTED|Part B||0||
48486523|NCT04206332|101529015|FG015|STARTED|Part B||0||
48486524|NCT04206332|101529016|FG016|STARTED|Part B||0||
48486525|NCT04206332|101529000|FG000|Received Product Administration|Part B||0||
48486526|NCT04206332|101529001|FG001|Received Product Administration|Part B||0||
48486527|NCT04206332|101529002|FG002|Received Product Administration|Part B||0||
48486528|NCT04206332|101529003|FG003|Received Product Administration|Part B||0||
48486529|NCT04206332|101529004|FG004|Received Product Administration|Part B||0||
48486530|NCT04206332|101529005|FG005|Received Product Administration|Part B||0||
48486531|NCT04206332|101529006|FG006|Received Product Administration|Part B||0||
48486532|NCT04206332|101529007|FG007|Received Product Administration|Part B||4||
48486533|NCT04206332|101529008|FG008|Received Product Administration|Part B||0||
48486534|NCT04206332|101529009|FG009|Received Product Administration|Part B||4||
48198511|NCT05512949|100810168|FG001|NOT COMPLETED|Overall Study||10||
48198512|NCT05512949|100810169|FG002|NOT COMPLETED|Overall Study||5||
48198513|NCT01190150|100810170|FG000|STARTED|First Treatment||11||
48198514|NCT01190150|100810171|FG001|STARTED|First Treatment||9||
48198515|NCT01190150|100810170|FG000|COMPLETED|First Treatment||10||
48198516|NCT01190150|100810171|FG001|COMPLETED|First Treatment||9||
48198517|NCT01190150|100810170|FG000|NOT COMPLETED|First Treatment||1||
48198518|NCT01190150|100810171|FG001|NOT COMPLETED|First Treatment||0||
48198519|NCT01190150|100810170|FG000|STARTED|Washout||10||
48198520|NCT01190150|100810171|FG001|STARTED|Washout||9||
48198521|NCT01190150|100810170|FG000|COMPLETED|Washout||10||
48198522|NCT01190150|100810171|FG001|COMPLETED|Washout||7||
48198523|NCT01190150|100810170|FG000|NOT COMPLETED|Washout||0||
48198524|NCT01190150|100810171|FG001|NOT COMPLETED|Washout||2||
48198525|NCT01190150|100810170|FG000|STARTED|Second Treatment||10||
48198526|NCT01190150|100810171|FG001|STARTED|Second Treatment||7||
48198527|NCT01190150|100810170|FG000|COMPLETED|Second Treatment||10||
48198528|NCT01190150|100810171|FG001|COMPLETED|Second Treatment||7||
48198529|NCT01190150|100810170|FG000|NOT COMPLETED|Second Treatment||0||
48486535|NCT04206332|101529010|FG010|Received Product Administration|Part B||0||
48198530|NCT01190150|100810171|FG001|NOT COMPLETED|Second Treatment||0||
48486536|NCT04206332|101529011|FG011|Received Product Administration|Part B||0||
48486537|NCT04206332|101529012|FG012|Received Product Administration|Part B||0||
48486538|NCT04206332|101529013|FG013|Received Product Administration|Part B||0||
48198531|NCT03942042|100810172|FG000|STARTED|Induction Dosing Period (12 Weeks)||7||
48198532|NCT03942042|100810173|FG001|STARTED|Induction Dosing Period (12 Weeks)||5||
48486539|NCT04206332|101529014|FG014|Received Product Administration|Part B||0||
48486540|NCT04206332|101529015|FG015|Received Product Administration|Part B||0||
48486541|NCT04206332|101529016|FG016|Received Product Administration|Part B||0||
48198533|NCT03942042|100810172|FG000|Received at Least One Dose of Study Drug|Induction Dosing Period (12 Weeks)||7||
48198534|NCT03942042|100810173|FG001|Received at Least One Dose of Study Drug|Induction Dosing Period (12 Weeks)||5||
48198535|NCT03942042|100810172|FG000|Participants With GIS=1 at Week 12|Induction Dosing Period (12 Weeks)||4||
48198536|NCT03942042|100810173|FG001|Participants With GIS=1 at Week 12|Induction Dosing Period (12 Weeks)||0||
48198537|NCT03942042|100810172|FG000|Participants Who Completed Week 12 With GIS >= 2|Induction Dosing Period (12 Weeks)||2||
48198538|NCT03942042|100810173|FG001|Participants Who Completed Week 12 With GIS >= 2|Induction Dosing Period (12 Weeks)||4||
48198539|NCT03942042|100810172|FG000|COMPLETED|Induction Dosing Period (12 Weeks)||6||
48198540|NCT03942042|100810173|FG001|COMPLETED|Induction Dosing Period (12 Weeks)||4||
48198541|NCT03942042|100810172|FG000|NOT COMPLETED|Induction Dosing Period (12 Weeks)||1||
48198542|NCT03942042|100810173|FG001|NOT COMPLETED|Induction Dosing Period (12 Weeks)||1||
48198543|NCT03942042|100810172|FG000|STARTED|Maintenance Dosing Period (8 Weeks)||2||
48198544|NCT03942042|100810173|FG001|STARTED|Maintenance Dosing Period (8 Weeks)||4||
48198545|NCT03942042|100810172|FG000|COMPLETED|Maintenance Dosing Period (8 Weeks)||2||
48198546|NCT03942042|100810173|FG001|COMPLETED|Maintenance Dosing Period (8 Weeks)||4||
48198547|NCT03942042|100810172|FG000|NOT COMPLETED|Maintenance Dosing Period (8 Weeks)||0||
48198548|NCT03942042|100810173|FG001|NOT COMPLETED|Maintenance Dosing Period (8 Weeks)||0||
48198549|NCT00016913|100810174|FG000|STARTED|Overall Study||27||
48198550|NCT00016913|100810174|FG000|COMPLETED|Overall Study||27||
48198551|NCT00016913|100810174|FG000|NOT COMPLETED|Overall Study||0||
48198552|NCT02596035|100810175|FG000|STARTED|Overall Study||97||
48198553|NCT02596035|100810176|FG001|STARTED|Overall Study||44||
48198554|NCT02596035|100810177|FG002|STARTED|Overall Study||1||
48198555|NCT02596035|100810175|FG000|COMPLETED|Overall Study||0||
48198556|NCT02596035|100810176|FG001|COMPLETED|Overall Study||0||
48198557|NCT02596035|100810177|FG002|COMPLETED|Overall Study||0||
48198558|NCT02596035|100810175|FG000|NOT COMPLETED|Overall Study||97||
48486542|NCT04206332|101529000|FG000|Completed Controlled Human Malaria Infection (CHMI)|Part B||0||
48486543|NCT04206332|101529001|FG001|Completed Controlled Human Malaria Infection (CHMI)|Part B||0||
48198559|NCT02596035|100810176|FG001|NOT COMPLETED|Overall Study||44||
48486544|NCT04206332|101529002|FG002|Completed Controlled Human Malaria Infection (CHMI)|Part B||0||
48486545|NCT04206332|101529003|FG003|Completed Controlled Human Malaria Infection (CHMI)|Part B||0||
48486546|NCT04206332|101529004|FG004|Completed Controlled Human Malaria Infection (CHMI)|Part B||0||
48486547|NCT04206332|101529005|FG005|Completed Controlled Human Malaria Infection (CHMI)|Part B||0||
48486548|NCT04206332|101529006|FG006|Completed Controlled Human Malaria Infection (CHMI)|Part B||0||
48486549|NCT04206332|101529007|FG007|Completed Controlled Human Malaria Infection (CHMI)|Part B||4||
48486550|NCT04206332|101529008|FG008|Completed Controlled Human Malaria Infection (CHMI)|Part B||2||
48486551|NCT04206332|101529009|FG009|Completed Controlled Human Malaria Infection (CHMI)|Part B||3||
48486552|NCT04206332|101529010|FG010|Completed Controlled Human Malaria Infection (CHMI)|Part B||6||
48486553|NCT04206332|101529011|FG011|Completed Controlled Human Malaria Infection (CHMI)|Part B||0||
48486554|NCT04206332|101529012|FG012|Completed Controlled Human Malaria Infection (CHMI)|Part B||0||
48486555|NCT04206332|101529013|FG013|Completed Controlled Human Malaria Infection (CHMI)|Part B||0||
48486556|NCT04206332|101529014|FG014|Completed Controlled Human Malaria Infection (CHMI)|Part B||0||
48486557|NCT04206332|101529015|FG015|Completed Controlled Human Malaria Infection (CHMI)|Part B||0||
48486558|NCT04206332|101529016|FG016|Completed Controlled Human Malaria Infection (CHMI)|Part B||0||
48486559|NCT04206332|101529000|FG000|COMPLETED|Part B||0||
48486560|NCT04206332|101529001|FG001|COMPLETED|Part B||0||
48486561|NCT04206332|101529002|FG002|COMPLETED|Part B||0||
48486562|NCT04206332|101529003|FG003|COMPLETED|Part B||0||
48486563|NCT04206332|101529004|FG004|COMPLETED|Part B||0||
48486564|NCT04206332|101529005|FG005|COMPLETED|Part B||0||
48486565|NCT04206332|101529006|FG006|COMPLETED|Part B||0||
48486566|NCT04206332|101529007|FG007|COMPLETED|Part B||4||
48486567|NCT04206332|101529008|FG008|COMPLETED|Part B||2||
48198560|NCT02596035|100810177|FG002|NOT COMPLETED|Overall Study||1||
48486568|NCT04206332|101529009|FG009|COMPLETED|Part B||4||
48486569|NCT04206332|101529010|FG010|COMPLETED|Part B||6||
48198561|NCT01191086|100810178|FG000|STARTED|Overall Study||210||
48198562|NCT01191086|100810178|FG000|COMPLETED|Overall Study||148||
48486570|NCT04206332|101529011|FG011|COMPLETED|Part B||0||
48486571|NCT04206332|101529012|FG012|COMPLETED|Part B||0||
48486572|NCT04206332|101529013|FG013|COMPLETED|Part B||0||
48486573|NCT04206332|101529014|FG014|COMPLETED|Part B||0||
48486574|NCT04206332|101529015|FG015|COMPLETED|Part B||0||
48486575|NCT04206332|101529016|FG016|COMPLETED|Part B||0||
48486576|NCT04206332|101529000|FG000|NOT COMPLETED|Part B||0||
48486577|NCT04206332|101529001|FG001|NOT COMPLETED|Part B||0||
48486578|NCT04206332|101529002|FG002|NOT COMPLETED|Part B||0||
48486579|NCT04206332|101529003|FG003|NOT COMPLETED|Part B||0||
48486580|NCT04206332|101529004|FG004|NOT COMPLETED|Part B||0||
48198563|NCT01191086|100810178|FG000|NOT COMPLETED|Overall Study||62||
48198564|NCT03613129|100810179|FG000|STARTED|Pre-treatment Assessment||3||
48198565|NCT03613129|100810180|FG001|STARTED|Pre-treatment Assessment||3||
48198566|NCT03613129|100810181|FG002|STARTED|Pre-treatment Assessment||7||
48198567|NCT03613129|100810182|FG003|STARTED|Pre-treatment Assessment||2||
48198568|NCT03613129|100810183|FG004|STARTED|Pre-treatment Assessment||2||
48198569|NCT03613129|100810179|FG000|COMPLETED|Pre-treatment Assessment||0||
48198570|NCT03613129|100810180|FG001|COMPLETED|Pre-treatment Assessment||3||
48198571|NCT03613129|100810181|FG002|COMPLETED|Pre-treatment Assessment||7||
48198572|NCT03613129|100810182|FG003|COMPLETED|Pre-treatment Assessment||2||
48198573|NCT03613129|100810183|FG004|COMPLETED|Pre-treatment Assessment||2||
48198574|NCT03613129|100810179|FG000|NOT COMPLETED|Pre-treatment Assessment||3||
48198575|NCT03613129|100810180|FG001|NOT COMPLETED|Pre-treatment Assessment||0||
48198576|NCT03613129|100810181|FG002|NOT COMPLETED|Pre-treatment Assessment||0||
48198577|NCT03613129|100810182|FG003|NOT COMPLETED|Pre-treatment Assessment||0||
48198578|NCT03613129|100810183|FG004|NOT COMPLETED|Pre-treatment Assessment||0||
48198579|NCT03613129|100810179|FG000|STARTED|Treatment||0||
48198580|NCT03613129|100810180|FG001|STARTED|Treatment||3||
48198581|NCT03613129|100810181|FG002|STARTED|Treatment||7||
48198582|NCT03613129|100810182|FG003|STARTED|Treatment||2||
48198583|NCT03613129|100810183|FG004|STARTED|Treatment||2||
48198584|NCT03613129|100810179|FG000|COMPLETED|Treatment||0||
48198585|NCT03613129|100810180|FG001|COMPLETED|Treatment||3||
48198586|NCT03613129|100810181|FG002|COMPLETED|Treatment||7||
48198587|NCT03613129|100810182|FG003|COMPLETED|Treatment||2||
48198588|NCT03613129|100810183|FG004|COMPLETED|Treatment||2||
48198589|NCT03613129|100810179|FG000|NOT COMPLETED|Treatment||0||
48198590|NCT03613129|100810180|FG001|NOT COMPLETED|Treatment||0||
48198591|NCT03613129|100810181|FG002|NOT COMPLETED|Treatment||0||
48486581|NCT04206332|101529005|FG005|NOT COMPLETED|Part B||0||
48198592|NCT03613129|100810182|FG003|NOT COMPLETED|Treatment||0||
48486582|NCT04206332|101529006|FG006|NOT COMPLETED|Part B||0||
48486583|NCT04206332|101529007|FG007|NOT COMPLETED|Part B||3||
48486584|NCT04206332|101529008|FG008|NOT COMPLETED|Part B||0||
48198593|NCT03613129|100810183|FG004|NOT COMPLETED|Treatment||0||
48486585|NCT04206332|101529009|FG009|NOT COMPLETED|Part B||0||
48198594|NCT03613129|100810179|FG000|STARTED|Post-treatment Assessment||0||
48198595|NCT03613129|100810180|FG001|STARTED|Post-treatment Assessment||3||
48198596|NCT03613129|100810181|FG002|STARTED|Post-treatment Assessment||7||
48486586|NCT04206332|101529010|FG010|NOT COMPLETED|Part B||2||
48486587|NCT04206332|101529011|FG011|NOT COMPLETED|Part B||0||
48486588|NCT04206332|101529012|FG012|NOT COMPLETED|Part B||0||
48486589|NCT04206332|101529013|FG013|NOT COMPLETED|Part B||0||
48486590|NCT04206332|101529014|FG014|NOT COMPLETED|Part B||0||
48486591|NCT04206332|101529015|FG015|NOT COMPLETED|Part B||0||
48486592|NCT04206332|101529016|FG016|NOT COMPLETED|Part B||0||
48486593|NCT04206332|101529000|FG000|STARTED|Part C||0||
48486594|NCT04206332|101529001|FG001|STARTED|Part C||0||
48486595|NCT04206332|101529002|FG002|STARTED|Part C||0||
48486596|NCT04206332|101529003|FG003|STARTED|Part C||0||
48486597|NCT04206332|101529004|FG004|STARTED|Part C||0||
48486598|NCT04206332|101529005|FG005|STARTED|Part C||0||
48486599|NCT04206332|101529006|FG006|STARTED|Part C||0||
48486600|NCT04206332|101529007|FG007|STARTED|Part C||0||
48486601|NCT04206332|101529008|FG008|STARTED|Part C||0||
48486602|NCT04206332|101529009|FG009|STARTED|Part C||0||
48486603|NCT04206332|101529010|FG010|STARTED|Part C||0||
48486604|NCT04206332|101529011|FG011|STARTED|Part C||7||
48486605|NCT04206332|101529012|FG012|STARTED|Part C||4||
48486606|NCT04206332|101529013|FG013|STARTED|Part C||4||
48486607|NCT04206332|101529014|FG014|STARTED|Part C||4||
48486608|NCT04206332|101529015|FG015|STARTED|Part C||4||
48486609|NCT04206332|101529016|FG016|STARTED|Part C||8||
48486610|NCT04206332|101529000|FG000|Received Product Administration|Part C||0||
48486611|NCT04206332|101529001|FG001|Received Product Administration|Part C||0||
48486612|NCT04206332|101529002|FG002|Received Product Administration|Part C||0||
48198597|NCT03613129|100810182|FG003|STARTED|Post-treatment Assessment||2||
48198598|NCT03613129|100810183|FG004|STARTED|Post-treatment Assessment||2||
48198599|NCT03613129|100810179|FG000|COMPLETED|Post-treatment Assessment||0||
48198600|NCT03613129|100810180|FG001|COMPLETED|Post-treatment Assessment||3||
48198601|NCT03613129|100810181|FG002|COMPLETED|Post-treatment Assessment||7||
48198602|NCT03613129|100810182|FG003|COMPLETED|Post-treatment Assessment||2||
48666556|NCT00404248|101967610|FG007|NOT COMPLETED|Overall Study||0||
48198603|NCT03613129|100810183|FG004|COMPLETED|Post-treatment Assessment||2||
48198604|NCT03613129|100810179|FG000|NOT COMPLETED|Post-treatment Assessment||0||
48198605|NCT03613129|100810180|FG001|NOT COMPLETED|Post-treatment Assessment||0||
48198606|NCT03613129|100810181|FG002|NOT COMPLETED|Post-treatment Assessment||0||
48198607|NCT03613129|100810182|FG003|NOT COMPLETED|Post-treatment Assessment||0||
48198608|NCT03613129|100810183|FG004|NOT COMPLETED|Post-treatment Assessment||0||
48198609|NCT02968004|100810184|FG000|STARTED|Overall Study||109||
48198610|NCT02968004|100810185|FG001|STARTED|Overall Study||115||
48198611|NCT02968004|100810184|FG000|COMPLETED|Overall Study||108||
48198612|NCT02968004|100810185|FG001|COMPLETED|Overall Study||114||
48198613|NCT02968004|100810184|FG000|NOT COMPLETED|Overall Study||1||
48198614|NCT02968004|100810185|FG001|NOT COMPLETED|Overall Study||1||
48198615|NCT01103973|100810186|FG000|STARTED|Overall Study||51||
48198616|NCT01103973|100810187|FG001|STARTED|Overall Study||46||
48198617|NCT01103973|100810186|FG000|COMPLETED|Overall Study||51||
48486613|NCT04206332|101529003|FG003|Received Product Administration|Part C||0||
48486614|NCT04206332|101529004|FG004|Received Product Administration|Part C||0||
48198618|NCT01103973|100810187|FG001|COMPLETED|Overall Study||46||
48198619|NCT01103973|100810186|FG000|NOT COMPLETED|Overall Study||0||
48198620|NCT01103973|100810187|FG001|NOT COMPLETED|Overall Study||0||
48486615|NCT04206332|101529005|FG005|Received Product Administration|Part C||0||
48198621|NCT01190566|100810188|FG000|STARTED|Overall Study||6||
48666557|NCT00404248|101967611|FG008|NOT COMPLETED|Overall Study||0||
48198622|NCT01190566|100810189|FG001|STARTED|Overall Study||42||
48198623|NCT01190566|100810188|FG000|COMPLETED|Overall Study||6||
48198624|NCT01190566|100810189|FG001|COMPLETED|Overall Study||42||
48198625|NCT01190566|100810188|FG000|NOT COMPLETED|Overall Study||0||
48198626|NCT01190566|100810189|FG001|NOT COMPLETED|Overall Study||0||
48486616|NCT04206332|101529006|FG006|Received Product Administration|Part C||0||
48198627|NCT02570295|100810190|FG000|STARTED|Overall Study||375||
48486617|NCT04206332|101529007|FG007|Received Product Administration|Part C||0||
48486618|NCT04206332|101529008|FG008|Received Product Administration|Part C||0||
48486619|NCT04206332|101529009|FG009|Received Product Administration|Part C||0||
48486620|NCT04206332|101529010|FG010|Received Product Administration|Part C||0||
48486621|NCT04206332|101529011|FG011|Received Product Administration|Part C||7||
48486622|NCT04206332|101529012|FG012|Received Product Administration|Part C||4||
48486623|NCT04206332|101529013|FG013|Received Product Administration|Part C||4||
48486624|NCT04206332|101529014|FG014|Received Product Administration|Part C||3||
48486625|NCT04206332|101529015|FG015|Received Product Administration|Part C||4||
48486626|NCT04206332|101529016|FG016|Received Product Administration|Part C||0||
48486627|NCT04206332|101529000|FG000|Completed Controlled Human Malaria Infection (CHMI)|Part C||0||
48486628|NCT04206332|101529001|FG001|Completed Controlled Human Malaria Infection (CHMI)|Part C||0||
48486629|NCT04206332|101529002|FG002|Completed Controlled Human Malaria Infection (CHMI)|Part C||0||
48486630|NCT04206332|101529003|FG003|Completed Controlled Human Malaria Infection (CHMI)|Part C||0||
48486631|NCT04206332|101529004|FG004|Completed Controlled Human Malaria Infection (CHMI)|Part C||0||
48486632|NCT04206332|101529005|FG005|Completed Controlled Human Malaria Infection (CHMI)|Part C||0||
48486633|NCT04206332|101529006|FG006|Completed Controlled Human Malaria Infection (CHMI)|Part C||0||
48486634|NCT04206332|101529007|FG007|Completed Controlled Human Malaria Infection (CHMI)|Part C||0||
48486635|NCT04206332|101529008|FG008|Completed Controlled Human Malaria Infection (CHMI)|Part C||0||
48486636|NCT04206332|101529009|FG009|Completed Controlled Human Malaria Infection (CHMI)|Part C||0||
48486637|NCT04206332|101529010|FG010|Completed Controlled Human Malaria Infection (CHMI)|Part C||0||
48486638|NCT04206332|101529011|FG011|Completed Controlled Human Malaria Infection (CHMI)|Part C||7||
48486639|NCT04206332|101529012|FG012|Completed Controlled Human Malaria Infection (CHMI)|Part C||4||
48198628|NCT02570295|100810191|FG001|STARTED|Overall Study||347||
48198629|NCT02570295|100810190|FG000|COMPLETED|Overall Study||364||
48486640|NCT04206332|101529013|FG013|Completed Controlled Human Malaria Infection (CHMI)|Part C||4||
48486641|NCT04206332|101529014|FG014|Completed Controlled Human Malaria Infection (CHMI)|Part C||3||
48666558|NCT01051661|101967612|FG000|STARTED|Overall Study||610||
48198630|NCT02570295|100810191|FG001|COMPLETED|Overall Study||289||
48486642|NCT04206332|101529015|FG015|Completed Controlled Human Malaria Infection (CHMI)|Part C||4||
48486643|NCT04206332|101529016|FG016|Completed Controlled Human Malaria Infection (CHMI)|Part C||6||
48486644|NCT04206332|101529000|FG000|COMPLETED|Part C||0||
48486645|NCT04206332|101529001|FG001|COMPLETED|Part C||0||
48486646|NCT04206332|101529002|FG002|COMPLETED|Part C||0||
48486647|NCT04206332|101529003|FG003|COMPLETED|Part C||0||
48486648|NCT04206332|101529004|FG004|COMPLETED|Part C||0||
48486649|NCT04206332|101529005|FG005|COMPLETED|Part C||0||
48486650|NCT04206332|101529006|FG006|COMPLETED|Part C||0||
48486651|NCT04206332|101529007|FG007|COMPLETED|Part C||0||
48486652|NCT04206332|101529008|FG008|COMPLETED|Part C||0||
48486653|NCT04206332|101529009|FG009|COMPLETED|Part C||0||
48486654|NCT04206332|101529010|FG010|COMPLETED|Part C||0||
48486655|NCT04206332|101529011|FG011|COMPLETED|Part C||7||
48486656|NCT04206332|101529012|FG012|COMPLETED|Part C||4||
48486657|NCT04206332|101529013|FG013|COMPLETED|Part C||4||
48486658|NCT04206332|101529014|FG014|COMPLETED|Part C||2||
48486659|NCT04206332|101529015|FG015|COMPLETED|Part C||4||
48486660|NCT04206332|101529016|FG016|COMPLETED|Part C||6||
48486661|NCT04206332|101529000|FG000|NOT COMPLETED|Part C||0||
48486662|NCT04206332|101529001|FG001|NOT COMPLETED|Part C||0||
48486663|NCT04206332|101529002|FG002|NOT COMPLETED|Part C||0||
48486664|NCT04206332|101529003|FG003|NOT COMPLETED|Part C||0||
48486665|NCT04206332|101529004|FG004|NOT COMPLETED|Part C||0||
48486666|NCT04206332|101529005|FG005|NOT COMPLETED|Part C||0||
48486667|NCT04206332|101529006|FG006|NOT COMPLETED|Part C||0||
48486668|NCT04206332|101529007|FG007|NOT COMPLETED|Part C||0||
48486669|NCT04206332|101529008|FG008|NOT COMPLETED|Part C||0||
48486670|NCT04206332|101529009|FG009|NOT COMPLETED|Part C||0||
48486671|NCT04206332|101529010|FG010|NOT COMPLETED|Part C||0||
48486672|NCT04206332|101529011|FG011|NOT COMPLETED|Part C||0||
48486673|NCT04206332|101529012|FG012|NOT COMPLETED|Part C||0||
48486674|NCT04206332|101529013|FG013|NOT COMPLETED|Part C||0||
48486675|NCT04206332|101529014|FG014|NOT COMPLETED|Part C||2||
48486676|NCT04206332|101529015|FG015|NOT COMPLETED|Part C||0||
48486677|NCT04206332|101529016|FG016|NOT COMPLETED|Part C||2||
48486678|NCT03422653|101529017|FG000|STARTED|Period 1: Double-blind Phase||189||
48486679|NCT03422653|101529018|FG001|STARTED|Period 1: Double-blind Phase||189||
48486680|NCT03422653|101529019|FG002|STARTED|Period 1: Double-blind Phase||0||
48486681|NCT03422653|101529017|FG000|COMPLETED|Period 1: Double-blind Phase||162||
48486682|NCT03422653|101529018|FG001|COMPLETED|Period 1: Double-blind Phase||170||
48486683|NCT03422653|101529019|FG002|COMPLETED|Period 1: Double-blind Phase||0||
48486684|NCT03422653|101529017|FG000|NOT COMPLETED|Period 1: Double-blind Phase||27||
48486685|NCT03422653|101529018|FG001|NOT COMPLETED|Period 1: Double-blind Phase||19||
48486686|NCT03422653|101529019|FG002|NOT COMPLETED|Period 1: Double-blind Phase||0||
48486687|NCT03422653|101529017|FG000|STARTED|Period 2: Open-label Phase||0||
48486688|NCT03422653|101529018|FG001|STARTED|Period 2: Open-label Phase||0||
48486689|NCT03422653|101529019|FG002|STARTED|Period 2: Open-label Phase||313||
48486690|NCT03422653|101529017|FG000|COMPLETED|Period 2: Open-label Phase||0||
48486691|NCT03422653|101529018|FG001|COMPLETED|Period 2: Open-label Phase||0||
48486692|NCT03422653|101529019|FG002|COMPLETED|Period 2: Open-label Phase||189||
48486693|NCT03422653|101529017|FG000|NOT COMPLETED|Period 2: Open-label Phase||0||
48486694|NCT03422653|101529018|FG001|NOT COMPLETED|Period 2: Open-label Phase||0||
48486695|NCT03422653|101529019|FG002|NOT COMPLETED|Period 2: Open-label Phase||124||
48486696|NCT01566721|101529020|FG000|STARTED|Treatment Period||1867||
48486697|NCT01566721|101529021|FG001|STARTED|Treatment Period||710||
48486698|NCT01566721|101529020|FG000|COMPLETED|Treatment Period||1670||
48486699|NCT01566721|101529021|FG001|COMPLETED|Treatment Period||652||
48486700|NCT01566721|101529020|FG000|NOT COMPLETED|Treatment Period||197||
48486701|NCT01566721|101529021|FG001|NOT COMPLETED|Treatment Period||58||
48486702|NCT01566721|101529020|FG000|STARTED|Safety Follow-up||1865||
48486703|NCT01566721|101529021|FG001|STARTED|Safety Follow-up||708||
48486704|NCT01566721|101529020|FG000|COMPLETED|Safety Follow-up||1318||
48486705|NCT01566721|101529021|FG001|COMPLETED|Safety Follow-up||501||
48486706|NCT01566721|101529020|FG000|NOT COMPLETED|Safety Follow-up||547||
48486707|NCT01566721|101529021|FG001|NOT COMPLETED|Safety Follow-up||207||
48486708|NCT02305732|101529022|FG000|STARTED|Overall Study||90||
48486709|NCT02305732|101529022|FG000|COMPLETED|Overall Study||72||
48486710|NCT02305732|101529022|FG000|NOT COMPLETED|Overall Study||18||
48486711|NCT02294604|101529023|FG000|STARTED|Overall Study||80||
48486712|NCT02294604|101529024|FG001|STARTED|Overall Study||80||
48486713|NCT02294604|101529025|FG002|STARTED|Overall Study||80||
48486714|NCT02294604|101529023|FG000|COMPLETED|Overall Study||79||
48486715|NCT02294604|101529024|FG001|COMPLETED|Overall Study||77||
48486716|NCT02294604|101529025|FG002|COMPLETED|Overall Study||80||
48486717|NCT02294604|101529023|FG000|NOT COMPLETED|Overall Study||1||
48486718|NCT02294604|101529024|FG001|NOT COMPLETED|Overall Study||3||
48486719|NCT02294604|101529025|FG002|NOT COMPLETED|Overall Study||0||
48486720|NCT03450057|101529026|FG000|STARTED|Overall Study||38||
48486721|NCT03450057|101529026|FG000|COMPLETED|Overall Study||15||
48486722|NCT03450057|101529026|FG000|NOT COMPLETED|Overall Study||23||
48486723|NCT00462228|101529027|FG000|STARTED|Memantine or Placebo 12 Weeks||11||
48486724|NCT00462228|101529027|FG000|COMPLETED|Memantine or Placebo 12 Weeks||11||
48486725|NCT00462228|101529027|FG000|NOT COMPLETED|Memantine or Placebo 12 Weeks||0||
48486726|NCT00462228|101529027|FG000|STARTED|No Treatment (Washout) 4 Weeks||11||
48486727|NCT00462228|101529027|FG000|COMPLETED|No Treatment (Washout) 4 Weeks||11||
48486728|NCT00462228|101529027|FG000|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0||
48486729|NCT00462228|101529027|FG000|STARTED|Placebo or Memantine 12 Weeks||11||
48486730|NCT00462228|101529027|FG000|COMPLETED|Placebo or Memantine 12 Weeks||11||
48486731|NCT00462228|101529027|FG000|NOT COMPLETED|Placebo or Memantine 12 Weeks||0||
48486732|NCT00462228|101529027|FG000|STARTED|No Treatment (Washout) 4 Weeks||11||
48486733|NCT00462228|101529027|FG000|COMPLETED|No Treatment (Washout) 4 Weeks||11||
48486734|NCT00462228|101529027|FG000|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0||
48486735|NCT00836056|101529028|FG000|STARTED|First Intervention||12||
48486736|NCT00836056|101529029|FG001|STARTED|First Intervention||12||
48486737|NCT00836056|101529028|FG000|COMPLETED|First Intervention||11||
48486738|NCT00836056|101529029|FG001|COMPLETED|First Intervention||12||
48486739|NCT00836056|101529028|FG000|NOT COMPLETED|First Intervention||1||
48486740|NCT00836056|101529029|FG001|NOT COMPLETED|First Intervention||0||
48486741|NCT00836056|101529028|FG000|STARTED|Washout: 7 Days||11||
48486742|NCT00836056|101529029|FG001|STARTED|Washout: 7 Days||12||
48486743|NCT00836056|101529028|FG000|COMPLETED|Washout: 7 Days||11||
48486744|NCT00836056|101529029|FG001|COMPLETED|Washout: 7 Days||12||
48486745|NCT00836056|101529028|FG000|NOT COMPLETED|Washout: 7 Days||0||
48486746|NCT00836056|101529029|FG001|NOT COMPLETED|Washout: 7 Days||0||
48486747|NCT00836056|101529028|FG000|STARTED|Second Intervention||11||
48486748|NCT00836056|101529029|FG001|STARTED|Second Intervention||12||
48486749|NCT00836056|101529028|FG000|COMPLETED|Second Intervention||11||
48486750|NCT00836056|101529029|FG001|COMPLETED|Second Intervention||12||
48486751|NCT00836056|101529028|FG000|NOT COMPLETED|Second Intervention||0||
48486752|NCT00836056|101529029|FG001|NOT COMPLETED|Second Intervention||0||
48486753|NCT00840099|101529030|FG000|STARTED|Period 1||24||
48486754|NCT00840099|101529031|FG001|STARTED|Period 1||24||
48486755|NCT00840099|101529030|FG000|COMPLETED|Period 1||24||
48486756|NCT00840099|101529031|FG001|COMPLETED|Period 1||24||
48486757|NCT00840099|101529030|FG000|NOT COMPLETED|Period 1||0||
48486758|NCT00840099|101529031|FG001|NOT COMPLETED|Period 1||0||
48486759|NCT00840099|101529030|FG000|STARTED|Period 2||21||
48198631|NCT02570295|100810190|FG000|NOT COMPLETED|Overall Study||11||
48486760|NCT00840099|101529031|FG001|STARTED|Period 2||24||
48486761|NCT00840099|101529030|FG000|COMPLETED|Period 2||21||
48486762|NCT00840099|101529031|FG001|COMPLETED|Period 2||24||
48486763|NCT00840099|101529030|FG000|NOT COMPLETED|Period 2||0||
48486764|NCT00840099|101529031|FG001|NOT COMPLETED|Period 2||0||
48486765|NCT02493868|101529032|FG000|STARTED|Induction Phase: DE Participants||437||
48198632|NCT02570295|100810191|FG001|NOT COMPLETED|Overall Study||58||
48486766|NCT02493868|101529033|FG001|STARTED|Induction Phase: DE Participants||0||
48486767|NCT02493868|101529032|FG000|COMPLETED|Induction Phase: DE Participants||273||
48486768|NCT02493868|101529033|FG001|COMPLETED|Induction Phase: DE Participants||0||
48486769|NCT02493868|101529032|FG000|NOT COMPLETED|Induction Phase: DE Participants||164||
48486770|NCT02493868|101529033|FG001|NOT COMPLETED|Induction Phase: DE Participants||0||
48486771|NCT02493868|101529032|FG000|STARTED|Optimization Phase: DE+TE Participants||455||
48486772|NCT02493868|101529033|FG001|STARTED|Optimization Phase: DE+TE Participants||86||
48486773|NCT02493868|101529032|FG000|COMPLETED|Optimization Phase: DE+TE Participants||297||
48486774|NCT02493868|101529033|FG001|COMPLETED|Optimization Phase: DE+TE Participants||54||
48486775|NCT02493868|101529032|FG000|NOT COMPLETED|Optimization Phase: DE+TE Participants||158||
48486776|NCT02493868|101529033|FG001|NOT COMPLETED|Optimization Phase: DE+TE Participants||32||
48486777|NCT02493868|101529032|FG000|STARTED|Maintenance Phase: DE+TE Participants||152||
48486778|NCT02493868|101529033|FG001|STARTED|Maintenance Phase: DE+TE Participants||199||
48486779|NCT02493868|101529032|FG000|Stable Remitters|Maintenance Phase: DE+TE Participants||90||
48486780|NCT02493868|101529033|FG001|Stable Remitters|Maintenance Phase: DE+TE Participants||86||
48486781|NCT02493868|101529032|FG000|Stable Responders|Maintenance Phase: DE+TE Participants||62||
48486782|NCT02493868|101529033|FG001|Stable Responders|Maintenance Phase: DE+TE Participants||59||
48486783|NCT02493868|101529032|FG000|COMPLETED|Maintenance Phase: DE+TE Participants||139||
48486784|NCT02493868|101529033|FG001|COMPLETED|Maintenance Phase: DE+TE Participants||177||
48486785|NCT02493868|101529032|FG000|NOT COMPLETED|Maintenance Phase: DE+TE Participants||13||
48486786|NCT02493868|101529033|FG001|NOT COMPLETED|Maintenance Phase: DE+TE Participants||22||
48486787|NCT02493868|101529032|FG000|STARTED|Follow-up Phase||481||
48486788|NCT02493868|101529033|FG001|STARTED|Follow-up Phase||64||
48198633|NCT01175707|100810192|FG000|STARTED|Overall Study||40||
48198634|NCT01175707|100810193|FG001|STARTED|Overall Study||40||
48198635|NCT01175707|100810192|FG000|COMPLETED|Overall Study||36||
48198636|NCT01175707|100810193|FG001|COMPLETED|Overall Study||34||
48198637|NCT01175707|100810192|FG000|NOT COMPLETED|Overall Study||4||
48486789|NCT02493868|101529032|FG000|COMPLETED|Follow-up Phase||470||
48486790|NCT02493868|101529033|FG001|COMPLETED|Follow-up Phase||62||
48198638|NCT01175707|100810193|FG001|NOT COMPLETED|Overall Study||6||
48198639|NCT02321748|100810194|FG000|STARTED|Overall Study||12||
48198640|NCT02321748|100810195|FG001|STARTED|Overall Study||12||
48486791|NCT02493868|101529032|FG000|NOT COMPLETED|Follow-up Phase||11||
48198641|NCT02321748|100810194|FG000|First Intervention (4 Days)|Overall Study||12||
48198642|NCT02321748|100810195|FG001|First Intervention (4 Days)|Overall Study||12||
48198643|NCT02321748|100810194|FG000|Wasout (2weeks)|Overall Study||12||
48198644|NCT02321748|100810195|FG001|Wasout (2weeks)|Overall Study||12||
48198645|NCT02321748|100810194|FG000|Second Intervention (4 Days)|Overall Study||12||
48198646|NCT02321748|100810195|FG001|Second Intervention (4 Days)|Overall Study||12||
48198647|NCT02321748|100810194|FG000|COMPLETED|Overall Study||12||
48198648|NCT02321748|100810195|FG001|COMPLETED|Overall Study||12||
48198649|NCT02321748|100810194|FG000|NOT COMPLETED|Overall Study||0||
48198650|NCT02321748|100810195|FG001|NOT COMPLETED|Overall Study||0||
48198651|NCT00728845|100810196|FG000|STARTED|Overall Study||8||
48198652|NCT00728845|100810197|FG001|STARTED|Overall Study||0||
48198653|NCT00728845|100810196|FG000|COMPLETED|Overall Study||8||
48198654|NCT00728845|100810197|FG001|COMPLETED|Overall Study||0||
48198655|NCT00728845|100810196|FG000|NOT COMPLETED|Overall Study||0||
48198656|NCT00728845|100810197|FG001|NOT COMPLETED|Overall Study||0||
48198657|NCT00315055|100810198|FG000|STARTED|Overall Study||155||
48198658|NCT00315055|100810199|FG001|STARTED|Overall Study||155||
48198659|NCT00315055|100810198|FG000|COMPLETED|Overall Study||152||
48198660|NCT00315055|100810199|FG001|COMPLETED|Overall Study||150||
48198661|NCT00315055|100810198|FG000|NOT COMPLETED|Overall Study||3||
48198662|NCT00315055|100810199|FG001|NOT COMPLETED|Overall Study||5||
48198663|NCT02145182|100810200|FG000|STARTED|Overall Study||142||
48198664|NCT02145182|100810201|FG001|STARTED|Overall Study||146||
48198665|NCT02145182|100810200|FG000|Received at Least 1 Dose of Study Drug|Overall Study||142||
48198666|NCT02145182|100810201|FG001|Received at Least 1 Dose of Study Drug|Overall Study||146||
48198667|NCT02145182|100810200|FG000|COMPLETED|Overall Study||124||
48198668|NCT02145182|100810201|FG001|COMPLETED|Overall Study||130||
48198669|NCT02145182|100810200|FG000|NOT COMPLETED|Overall Study||18||
48198670|NCT02145182|100810201|FG001|NOT COMPLETED|Overall Study||16||
48198671|NCT01909336|100810202|FG000|STARTED|Overall Study||53||
48198672|NCT01909336|100810203|FG001|STARTED|Overall Study||53||
48198673|NCT01909336|100810204|FG002|STARTED|Overall Study||55||
48198674|NCT01909336|100810202|FG000|COMPLETED|Overall Study||49||
48198675|NCT01909336|100810203|FG001|COMPLETED|Overall Study||50||
48198676|NCT01909336|100810204|FG002|COMPLETED|Overall Study||52||
48198677|NCT01909336|100810202|FG000|NOT COMPLETED|Overall Study||4||
48198678|NCT01909336|100810203|FG001|NOT COMPLETED|Overall Study||3||
48198679|NCT01909336|100810204|FG002|NOT COMPLETED|Overall Study||3||
48198680|NCT01090024|100810205|FG000|STARTED|Period 1||6||
48198681|NCT01090024|100810206|FG001|STARTED|Period 1||6||
48198682|NCT01090024|100810207|FG002|STARTED|Period 1||6||
48198683|NCT01090024|100810208|FG003|STARTED|Period 1||6||
48198684|NCT01090024|100810209|FG004|STARTED|Period 1||6||
48198685|NCT01090024|100810210|FG005|STARTED|Period 1||6||
48198686|NCT01090024|100810211|FG006|STARTED|Period 1||6||
48198687|NCT01090024|100810212|FG007|STARTED|Period 1||6||
48198688|NCT01090024|100810213|FG008|STARTED|Period 1||6||
48198689|NCT01090024|100810214|FG009|STARTED|Period 1||6||
48198690|NCT01090024|100810215|FG010|STARTED|Period 1||6||
48198691|NCT01090024|100810216|FG011|STARTED|Period 1||6||
48198692|NCT01090024|100810217|FG012|STARTED|Period 1||6||
48198693|NCT01090024|100810218|FG013|STARTED|Period 1||6||
48486792|NCT02493868|101529033|FG001|NOT COMPLETED|Follow-up Phase||2||
48486793|NCT03298880|101529034|FG000|STARTED|Overall Study||75||
48486794|NCT03298880|101529034|FG000|COMPLETED|Overall Study||75||
48486795|NCT03298880|101529034|FG000|NOT COMPLETED|Overall Study||0||
48198694|NCT01090024|100810219|FG014|STARTED|Period 1||6||
48198695|NCT01090024|100810220|FG015|STARTED|Period 1||6||
48198696|NCT01090024|100810221|FG016|STARTED|Period 1||6||
48198697|NCT01090024|100810222|FG017|STARTED|Period 1||6||
48198698|NCT01090024|100810205|FG000|COMPLETED|Period 1||6||
48198699|NCT01090024|100810206|FG001|COMPLETED|Period 1||5||
48198700|NCT01090024|100810207|FG002|COMPLETED|Period 1||6||
48198701|NCT01090024|100810208|FG003|COMPLETED|Period 1||5||
48198702|NCT01090024|100810209|FG004|COMPLETED|Period 1||6||
48198703|NCT01090024|100810210|FG005|COMPLETED|Period 1||6||
48198704|NCT01090024|100810211|FG006|COMPLETED|Period 1||6||
48198705|NCT01090024|100810212|FG007|COMPLETED|Period 1||6||
48486796|NCT03769025|101529035|FG000|STARTED|Overall Study||8||
48198706|NCT01090024|100810213|FG008|COMPLETED|Period 1||6||
48198707|NCT01090024|100810214|FG009|COMPLETED|Period 1||5||
48198708|NCT01090024|100810215|FG010|COMPLETED|Period 1||6||
48198709|NCT01090024|100810216|FG011|COMPLETED|Period 1||5||
48198710|NCT01090024|100810217|FG012|COMPLETED|Period 1||6||
48198711|NCT01090024|100810218|FG013|COMPLETED|Period 1||6||
48198712|NCT01090024|100810219|FG014|COMPLETED|Period 1||5||
48198713|NCT01090024|100810220|FG015|COMPLETED|Period 1||6||
48198714|NCT01090024|100810221|FG016|COMPLETED|Period 1||6||
48198715|NCT01090024|100810222|FG017|COMPLETED|Period 1||5||
48198716|NCT01090024|100810205|FG000|NOT COMPLETED|Period 1||0||
48198717|NCT01090024|100810206|FG001|NOT COMPLETED|Period 1||1||
48198718|NCT01090024|100810207|FG002|NOT COMPLETED|Period 1||0||
48198719|NCT01090024|100810208|FG003|NOT COMPLETED|Period 1||1||
48198720|NCT01090024|100810209|FG004|NOT COMPLETED|Period 1||0||
48198721|NCT01090024|100810210|FG005|NOT COMPLETED|Period 1||0||
48198722|NCT01090024|100810211|FG006|NOT COMPLETED|Period 1||0||
48198723|NCT01090024|100810212|FG007|NOT COMPLETED|Period 1||0||
48198724|NCT01090024|100810213|FG008|NOT COMPLETED|Period 1||0||
48198725|NCT01090024|100810214|FG009|NOT COMPLETED|Period 1||1||
48198726|NCT01090024|100810215|FG010|NOT COMPLETED|Period 1||0||
48198727|NCT01090024|100810216|FG011|NOT COMPLETED|Period 1||1||
48198728|NCT01090024|100810217|FG012|NOT COMPLETED|Period 1||0||
48198729|NCT01090024|100810218|FG013|NOT COMPLETED|Period 1||0||
48198730|NCT01090024|100810219|FG014|NOT COMPLETED|Period 1||1||
48198731|NCT01090024|100810220|FG015|NOT COMPLETED|Period 1||0||
48198732|NCT01090024|100810221|FG016|NOT COMPLETED|Period 1||0||
48486797|NCT03769025|101529036|FG001|STARTED|Overall Study||8||
48486798|NCT03769025|101529035|FG000|COMPLETED|Overall Study||3||
48486799|NCT03769025|101529036|FG001|COMPLETED|Overall Study||4||
48486800|NCT03769025|101529035|FG000|NOT COMPLETED|Overall Study||5||
48198733|NCT01090024|100810222|FG017|NOT COMPLETED|Period 1||1||
48198734|NCT01090024|100810205|FG000|STARTED|Period 2||6||
48198735|NCT01090024|100810206|FG001|STARTED|Period 2||5||
48198736|NCT01090024|100810207|FG002|STARTED|Period 2||6||
48198737|NCT01090024|100810208|FG003|STARTED|Period 2||5||
48198738|NCT01090024|100810209|FG004|STARTED|Period 2||6||
48198739|NCT01090024|100810210|FG005|STARTED|Period 2||6||
48198740|NCT01090024|100810211|FG006|STARTED|Period 2||6||
48198741|NCT01090024|100810212|FG007|STARTED|Period 2||6||
48198742|NCT01090024|100810213|FG008|STARTED|Period 2||6||
48198743|NCT01090024|100810214|FG009|STARTED|Period 2||5||
48198744|NCT01090024|100810215|FG010|STARTED|Period 2||6||
48198745|NCT01090024|100810216|FG011|STARTED|Period 2||5||
48198746|NCT01090024|100810217|FG012|STARTED|Period 2||6||
48486801|NCT03769025|101529036|FG001|NOT COMPLETED|Overall Study||4||
48486802|NCT02729714|101529037|FG000|STARTED|Treatment Period 1 (4 Weeks)||11||
48198747|NCT01090024|100810218|FG013|STARTED|Period 2||6||
48198748|NCT01090024|100810219|FG014|STARTED|Period 2||5||
48198749|NCT01090024|100810220|FG015|STARTED|Period 2||6||
48198750|NCT01090024|100810221|FG016|STARTED|Period 2||6||
48198751|NCT01090024|100810222|FG017|STARTED|Period 2||5||
48198752|NCT01090024|100810205|FG000|COMPLETED|Period 2||5||
48198753|NCT01090024|100810206|FG001|COMPLETED|Period 2||5||
48666559|NCT01051661|101967613|FG001|STARTED|Overall Study||1438||
48198754|NCT01090024|100810207|FG002|COMPLETED|Period 2||6||
48198755|NCT01090024|100810208|FG003|COMPLETED|Period 2||4||
48198756|NCT01090024|100810209|FG004|COMPLETED|Period 2||6||
48198757|NCT01090024|100810210|FG005|COMPLETED|Period 2||6||
48198758|NCT01090024|100810211|FG006|COMPLETED|Period 2||6||
48666560|NCT01051661|101967614|FG002|STARTED|Overall Study||612||
48666561|NCT01051661|101967615|FG003|STARTED|Overall Study||1436||
48666562|NCT01051661|101967616|FG004|STARTED|Overall Study||613||
48666563|NCT01051661|101967617|FG005|STARTED|Overall Study||1436||
48666564|NCT01051661|101967612|FG000|COMPLETED|Overall Study||576||
48666565|NCT01051661|101967613|FG001|COMPLETED|Overall Study||1375||
48666566|NCT01051661|101967614|FG002|COMPLETED|Overall Study||573||
48666567|NCT01051661|101967615|FG003|COMPLETED|Overall Study||1380||
48666568|NCT01051661|101967616|FG004|COMPLETED|Overall Study||578||
48666569|NCT01051661|101967617|FG005|COMPLETED|Overall Study||1369||
48666570|NCT01051661|101967612|FG000|NOT COMPLETED|Overall Study||34||
48666571|NCT01051661|101967613|FG001|NOT COMPLETED|Overall Study||63||
48666572|NCT01051661|101967614|FG002|NOT COMPLETED|Overall Study||39||
48666573|NCT01051661|101967615|FG003|NOT COMPLETED|Overall Study||56||
48666574|NCT01051661|101967616|FG004|NOT COMPLETED|Overall Study||35||
48666575|NCT01051661|101967617|FG005|NOT COMPLETED|Overall Study||67||
48666576|NCT01467557|101967618|FG000|STARTED|Overall Study||601||
48666577|NCT01467557|101967619|FG001|STARTED|Overall Study||570||
48666578|NCT01467557|101967618|FG000|2 Week Survey Completed|Overall Study||551||
48666579|NCT01467557|101967619|FG001|2 Week Survey Completed|Overall Study||522||
48666580|NCT01467557|101967618|FG000|4 Month Survey Completed|Overall Study||533||
48666581|NCT01467557|101967619|FG001|4 Month Survey Completed|Overall Study||493||
48666582|NCT01467557|101967618|FG000|12 Month Survey Completed|Overall Study||502||
48666583|NCT01467557|101967619|FG001|12 Month Survey Completed|Overall Study||463||
48198759|NCT01090024|100810212|FG007|COMPLETED|Period 2||6||
48486803|NCT02729714|101529038|FG001|STARTED|Treatment Period 1 (4 Weeks)||10||
48486804|NCT02729714|101529037|FG000|COMPLETED|Treatment Period 1 (4 Weeks)||11||
48486805|NCT02729714|101529038|FG001|COMPLETED|Treatment Period 1 (4 Weeks)||10||
48486806|NCT02729714|101529037|FG000|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0||
48486807|NCT02729714|101529038|FG001|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0||
48486808|NCT02729714|101529037|FG000|STARTED|Washout Period (2 Weeks)||11||
48486809|NCT02729714|101529038|FG001|STARTED|Washout Period (2 Weeks)||10||
48486810|NCT02729714|101529037|FG000|COMPLETED|Washout Period (2 Weeks)||11||
48486811|NCT02729714|101529038|FG001|COMPLETED|Washout Period (2 Weeks)||9||
48486812|NCT02729714|101529037|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0||
48486813|NCT02729714|101529038|FG001|NOT COMPLETED|Washout Period (2 Weeks)||1||
48486814|NCT02729714|101529037|FG000|STARTED|Treatment Period 2 (4 Weeks)||11||
48198760|NCT01090024|100810213|FG008|COMPLETED|Period 2||6||
48198761|NCT01090024|100810214|FG009|COMPLETED|Period 2||5||
48198762|NCT01090024|100810215|FG010|COMPLETED|Period 2||6||
48198763|NCT01090024|100810216|FG011|COMPLETED|Period 2||5||
48198764|NCT01090024|100810217|FG012|COMPLETED|Period 2||6||
48198765|NCT01090024|100810218|FG013|COMPLETED|Period 2||6||
48198766|NCT01090024|100810219|FG014|COMPLETED|Period 2||5||
48486815|NCT02729714|101529038|FG001|STARTED|Treatment Period 2 (4 Weeks)||9||
48486816|NCT02729714|101529037|FG000|COMPLETED|Treatment Period 2 (4 Weeks)||11||
48486817|NCT02729714|101529038|FG001|COMPLETED|Treatment Period 2 (4 Weeks)||8||
48486818|NCT02729714|101529037|FG000|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0||
48486819|NCT02729714|101529038|FG001|NOT COMPLETED|Treatment Period 2 (4 Weeks)||1||
48486820|NCT03749252|101529039|FG000|STARTED|Overall Study||26||
48198767|NCT01090024|100810220|FG015|COMPLETED|Period 2||6||
48198768|NCT01090024|100810221|FG016|COMPLETED|Period 2||6||
48486821|NCT03749252|101529040|FG001|STARTED|Overall Study||23||
48486822|NCT03749252|101529041|FG002|STARTED|Overall Study||31||
48486823|NCT03749252|101529039|FG000|COMPLETED|Overall Study||26||
48198769|NCT01090024|100810222|FG017|COMPLETED|Period 2||5||
48198770|NCT01090024|100810205|FG000|NOT COMPLETED|Period 2||1||
48486824|NCT03749252|101529040|FG001|COMPLETED|Overall Study||23||
48486825|NCT03749252|101529041|FG002|COMPLETED|Overall Study||31||
48198771|NCT01090024|100810206|FG001|NOT COMPLETED|Period 2||0||
48198772|NCT01090024|100810207|FG002|NOT COMPLETED|Period 2||0||
48198773|NCT01090024|100810208|FG003|NOT COMPLETED|Period 2||1||
48486826|NCT03749252|101529039|FG000|NOT COMPLETED|Overall Study||0||
48486827|NCT03749252|101529040|FG001|NOT COMPLETED|Overall Study||0||
48486828|NCT03749252|101529041|FG002|NOT COMPLETED|Overall Study||0||
48486829|NCT00033917|101529042|FG000|STARTED|Overall Study||209||
48486830|NCT00033917|101529043|FG001|STARTED|Overall Study||222||
48486831|NCT00033917|101529042|FG000|COMPLETED|Overall Study||209||
48486832|NCT00033917|101529043|FG001|COMPLETED|Overall Study||222||
48486833|NCT00033917|101529042|FG000|NOT COMPLETED|Overall Study||0||
48486834|NCT00033917|101529043|FG001|NOT COMPLETED|Overall Study||0||
48486835|NCT00573066|101529044|FG000|STARTED|Overall Study||56||
48486836|NCT00573066|101529044|FG000|COMPLETED|Overall Study||36||
48486837|NCT00573066|101529044|FG000|NOT COMPLETED|Overall Study||20||
48486838|NCT01421277|101529045|FG000|STARTED|Overall Study||25||
48486839|NCT01421277|101529046|FG001|STARTED|Overall Study||191||
48486840|NCT01421277|101529045|FG000|COMPLETED|Overall Study||25||
48486841|NCT01421277|101529046|FG001|COMPLETED|Overall Study||99||
48486842|NCT01421277|101529045|FG000|NOT COMPLETED|Overall Study||0||
48486843|NCT01421277|101529046|FG001|NOT COMPLETED|Overall Study||92||
48486844|NCT03161158|101529047|FG000|STARTED|Overall Study||18|Patients in the FAS|
48486845|NCT03161158|101529048|FG001|STARTED|Overall Study||19|Patients in the FAS|
48486846|NCT03161158|101529047|FG000|COMPLETED|Overall Study||9|Patients in the FAS|
48486847|NCT03161158|101529048|FG001|COMPLETED|Overall Study||13|Patients in the FAS|
48486848|NCT03161158|101529047|FG000|NOT COMPLETED|Overall Study||9||
48486849|NCT03161158|101529048|FG001|NOT COMPLETED|Overall Study||6||
48486850|NCT01759277|101529049|FG000|STARTED|Overall Study||41||
48486851|NCT01759277|101529050|FG001|STARTED|Overall Study||39||
48486852|NCT01759277|101529049|FG000|COMPLETED|Overall Study||41||
48486853|NCT01759277|101529050|FG001|COMPLETED|Overall Study||39||
48486854|NCT01759277|101529049|FG000|NOT COMPLETED|Overall Study||0||
48486855|NCT01759277|101529050|FG001|NOT COMPLETED|Overall Study||0||
48486856|NCT03874715|101529051|FG000|STARTED|Overall Study||104||
48486857|NCT03874715|101529052|FG001|STARTED|Overall Study||106||
48486858|NCT03874715|101529051|FG000|Treated|Overall Study||104||
48486859|NCT03874715|101529052|FG001|Treated|Overall Study||106||
48486860|NCT03874715|101529051|FG000|Safety Population|Overall Study||99|Safety population included all randomized participants who received at least one dose of investigational medicinal product (IMP) and analyzed according to the treatment actually received.|
48486861|NCT03874715|101529052|FG001|Safety Population|Overall Study||111|Safety population included all randomized participants who received at least one dose of investigational medicinal product (IMP) and analyzed according to the treatment actually received.|
48486862|NCT03874715|101529051|FG000|Anti-insulin Antibody (AIA) Population|Overall Study||98|AIA population included all participants who received at least one dose of IMP and with at least one AIA sample available for analysis, and were analyzed according to the treatment actually received|
48486863|NCT03874715|101529052|FG001|Anti-insulin Antibody (AIA) Population|Overall Study||107|AIA population included all participants who received at least one dose of IMP and with at least one AIA sample available for analysis, and were analyzed according to the treatment actually received|
48486864|NCT03874715|101529051|FG000|COMPLETED|Overall Study||95||
48486865|NCT03874715|101529052|FG001|COMPLETED|Overall Study||105||
48486866|NCT03874715|101529051|FG000|NOT COMPLETED|Overall Study||9||
48486867|NCT03874715|101529052|FG001|NOT COMPLETED|Overall Study||1||
48486868|NCT01794039|101529053|FG000|STARTED|Overall Study||5||
48486869|NCT01794039|101529054|FG001|STARTED|Overall Study||4||
48486870|NCT01794039|101529053|FG000|COMPLETED|Overall Study||5||
48198774|NCT01090024|100810209|FG004|NOT COMPLETED|Period 2||0||
48486871|NCT01794039|101529054|FG001|COMPLETED|Overall Study||4||
48486872|NCT01794039|101529053|FG000|NOT COMPLETED|Overall Study||0||
48486873|NCT01794039|101529054|FG001|NOT COMPLETED|Overall Study||0||
48486874|NCT02777372|101529055|FG000|STARTED|Overall Study||43||
48198775|NCT01090024|100810210|FG005|NOT COMPLETED|Period 2||0||
48198776|NCT01090024|100810211|FG006|NOT COMPLETED|Period 2||0||
48198777|NCT01090024|100810212|FG007|NOT COMPLETED|Period 2||0||
48486875|NCT02777372|101529056|FG001|STARTED|Overall Study||41||
48486876|NCT02777372|101529055|FG000|COMPLETED|Overall Study||24||
48486877|NCT02777372|101529056|FG001|COMPLETED|Overall Study||23||
48486878|NCT02777372|101529055|FG000|NOT COMPLETED|Overall Study||19||
48486879|NCT02777372|101529056|FG001|NOT COMPLETED|Overall Study||18||
48486880|NCT01001403|101529057|FG000|STARTED|Overall Study||31||
48486881|NCT01001403|101529058|FG001|STARTED|Overall Study||31||
48198778|NCT01090024|100810213|FG008|NOT COMPLETED|Period 2||0||
48486882|NCT01001403|101529057|FG000|COMPLETED|Overall Study||31||
48486883|NCT01001403|101529058|FG001|COMPLETED|Overall Study||31||
48486884|NCT01001403|101529057|FG000|NOT COMPLETED|Overall Study||0||
48486885|NCT01001403|101529058|FG001|NOT COMPLETED|Overall Study||0||
48486886|NCT00654030|101529059|FG000|STARTED|Overall Study||12||
48486887|NCT00654030|101529059|FG000|COMPLETED|Overall Study||11||
48486888|NCT00654030|101529059|FG000|NOT COMPLETED|Overall Study||1||
48486889|NCT03733444|101529060|FG000|STARTED|Overall Study||260||
48486890|NCT03733444|101529061|FG001|STARTED|Overall Study||262||
48486891|NCT03733444|101529062|FG002|STARTED|Overall Study||259||
48486892|NCT03733444|101529060|FG000|Treated|Overall Study||259||
48486893|NCT03733444|101529061|FG001|Treated|Overall Study||260||
48486894|NCT03733444|101529062|FG002|Treated|Overall Study||258||
48486895|NCT03733444|101529060|FG000|COMPLETED|Overall Study||0||
48486896|NCT03733444|101529061|FG001|COMPLETED|Overall Study||0||
48486897|NCT03733444|101529062|FG002|COMPLETED|Overall Study||0||
48486898|NCT03733444|101529060|FG000|NOT COMPLETED|Overall Study||260||
48486899|NCT03733444|101529061|FG001|NOT COMPLETED|Overall Study||262||
48486900|NCT03733444|101529062|FG002|NOT COMPLETED|Overall Study||259||
48486901|NCT02319824|101529063|FG000|STARTED|Overall Study||2||2
48486902|NCT02319824|101529063|FG000|COMPLETED|Overall Study||2||2
48198779|NCT01090024|100810214|FG009|NOT COMPLETED|Period 2||0||
48198780|NCT01090024|100810215|FG010|NOT COMPLETED|Period 2||0||
48198781|NCT01090024|100810216|FG011|NOT COMPLETED|Period 2||0||
48198782|NCT01090024|100810217|FG012|NOT COMPLETED|Period 2||0||
48486903|NCT02319824|101529063|FG000|NOT COMPLETED|Overall Study||0||0
48486904|NCT03810703|101529064|FG000|STARTED|Overall Study||31||
48486905|NCT03810703|101529065|FG001|STARTED|Overall Study||31||
48486906|NCT03810703|101529066|FG002|STARTED|Overall Study||31||
48486907|NCT03810703|101529064|FG000|COMPLETED|Overall Study||31||
48486908|NCT03810703|101529065|FG001|COMPLETED|Overall Study||31||
48486909|NCT03810703|101529066|FG002|COMPLETED|Overall Study||31||
48486910|NCT03810703|101529064|FG000|NOT COMPLETED|Overall Study||0||
48486911|NCT03810703|101529065|FG001|NOT COMPLETED|Overall Study||0||
48486912|NCT03810703|101529066|FG002|NOT COMPLETED|Overall Study||0||
48486913|NCT00838630|101529067|FG000|STARTED|First Intervention||18||
48486914|NCT00838630|101529068|FG001|STARTED|First Intervention||18||
48486915|NCT00838630|101529067|FG000|COMPLETED|First Intervention||17||
48486916|NCT00838630|101529068|FG001|COMPLETED|First Intervention||18||
48198783|NCT01090024|100810218|FG013|NOT COMPLETED|Period 2||0||
48486917|NCT00838630|101529067|FG000|NOT COMPLETED|First Intervention||1||
48486918|NCT00838630|101529068|FG001|NOT COMPLETED|First Intervention||0||
48486919|NCT00838630|101529067|FG000|STARTED|Washout: 7 Days||17||
48486920|NCT00838630|101529068|FG001|STARTED|Washout: 7 Days||18||
48486921|NCT00838630|101529067|FG000|COMPLETED|Washout: 7 Days||16||
48486922|NCT00838630|101529068|FG001|COMPLETED|Washout: 7 Days||18||
48486923|NCT00838630|101529067|FG000|NOT COMPLETED|Washout: 7 Days||1||
48486924|NCT00838630|101529068|FG001|NOT COMPLETED|Washout: 7 Days||0||
48486925|NCT00838630|101529067|FG000|STARTED|Second Intervention||16||
48486926|NCT00838630|101529068|FG001|STARTED|Second Intervention||18||
48486927|NCT00838630|101529067|FG000|COMPLETED|Second Intervention||16||
48486928|NCT00838630|101529068|FG001|COMPLETED|Second Intervention||18||
48486929|NCT00838630|101529067|FG000|NOT COMPLETED|Second Intervention||0||
48486930|NCT00838630|101529068|FG001|NOT COMPLETED|Second Intervention||0||
48486931|NCT00811655|101529069|FG000|STARTED|Overall Study||6||
48486932|NCT00811655|101529069|FG000|COMPLETED|Overall Study||5||
48486933|NCT00811655|101529069|FG000|NOT COMPLETED|Overall Study||1||
48486934|NCT02115347|101529070|FG000|STARTED|Overall Study||8||
48486935|NCT02115347|101529071|FG001|STARTED|Overall Study||8||
48486936|NCT02115347|101529072|FG002|STARTED|Overall Study||0||
48486937|NCT02115347|101529070|FG000|COMPLETED|Overall Study||8||
48486938|NCT02115347|101529071|FG001|COMPLETED|Overall Study||8||
48486939|NCT02115347|101529072|FG002|COMPLETED|Overall Study||0||
48486940|NCT02115347|101529070|FG000|NOT COMPLETED|Overall Study||0||
48486941|NCT02115347|101529071|FG001|NOT COMPLETED|Overall Study||0||
48486942|NCT02115347|101529072|FG002|NOT COMPLETED|Overall Study||0||
48486943|NCT00829673|101529073|FG000|STARTED|First Intervention||12||
48486944|NCT00829673|101529074|FG001|STARTED|First Intervention||12||
48486945|NCT00829673|101529073|FG000|COMPLETED|First Intervention||12||
48198784|NCT01090024|100810219|FG014|NOT COMPLETED|Period 2||0||
48486946|NCT00829673|101529074|FG001|COMPLETED|First Intervention||12||
48486947|NCT00829673|101529073|FG000|NOT COMPLETED|First Intervention||0||
48486948|NCT00829673|101529074|FG001|NOT COMPLETED|First Intervention||0||
48486949|NCT00829673|101529073|FG000|STARTED|Washout of 7 Days||12||
48486950|NCT00829673|101529074|FG001|STARTED|Washout of 7 Days||12||
48486951|NCT00829673|101529073|FG000|COMPLETED|Washout of 7 Days||11||
48486952|NCT00829673|101529074|FG001|COMPLETED|Washout of 7 Days||12||
48486953|NCT00829673|101529073|FG000|NOT COMPLETED|Washout of 7 Days||1||
48486954|NCT00829673|101529074|FG001|NOT COMPLETED|Washout of 7 Days||0||
48486955|NCT00829673|101529073|FG000|STARTED|Second Intervention||11||
48486956|NCT00829673|101529074|FG001|STARTED|Second Intervention||12||
48486957|NCT00829673|101529073|FG000|COMPLETED|Second Intervention||11||
48486958|NCT00829673|101529074|FG001|COMPLETED|Second Intervention||12||
48486959|NCT00829673|101529073|FG000|NOT COMPLETED|Second Intervention||0||
48486960|NCT00829673|101529074|FG001|NOT COMPLETED|Second Intervention||0||
48486961|NCT01068821|101529075|FG000|STARTED|Overall Study||31||
48486962|NCT01068821|101529076|FG001|STARTED|Overall Study||29||
48486963|NCT01068821|101529075|FG000|COMPLETED|Overall Study||30||
48486964|NCT01068821|101529076|FG001|COMPLETED|Overall Study||29||
48486965|NCT01068821|101529075|FG000|NOT COMPLETED|Overall Study||1||
48486966|NCT01068821|101529076|FG001|NOT COMPLETED|Overall Study||0||
48486967|NCT01913405|101529077|FG000|STARTED|Overall Study||22||
48486968|NCT01913405|101529077|FG000|COMPLETED|Overall Study||20||
48486969|NCT01913405|101529077|FG000|NOT COMPLETED|Overall Study||2||
48486970|NCT02181140|101529078|FG000|STARTED|Overall Study||56||
48486971|NCT02181140|101529078|FG000|COMPLETED|Overall Study||56||
48486972|NCT02181140|101529078|FG000|NOT COMPLETED|Overall Study||0||
48486973|NCT00467363|101529079|FG000|STARTED|Overall Study||615||
48486974|NCT00467363|101529080|FG001|STARTED|Overall Study||613||
48486975|NCT00467363|101529079|FG000|COMPLETED|Overall Study||535||
48486976|NCT00467363|101529080|FG001|COMPLETED|Overall Study||543||
48486977|NCT00467363|101529079|FG000|NOT COMPLETED|Overall Study||80||
48486978|NCT00467363|101529080|FG001|NOT COMPLETED|Overall Study||70||
48486979|NCT04852978|101529081|FG000|STARTED|Overall Study||48||
48486980|NCT04852978|101529082|FG001|STARTED|Overall Study||28||
48486981|NCT04852978|101529083|FG002|STARTED|Overall Study||29||
48486982|NCT04852978|101529084|FG003|STARTED|Overall Study||28||
48486983|NCT04852978|101529085|FG004|STARTED|Overall Study||33||
48486984|NCT04852978|101529086|FG005|STARTED|Overall Study||31||
48486985|NCT04852978|101529087|FG006|STARTED|Overall Study||26||
48486986|NCT04852978|101529088|FG007|STARTED|Overall Study||35||
48486987|NCT04852978|101529089|FG008|STARTED|Overall Study||35||
48486988|NCT04852978|101529081|FG000|COMPLETED|Overall Study||41||
48486989|NCT04852978|101529082|FG001|COMPLETED|Overall Study||23||
48486990|NCT04852978|101529083|FG002|COMPLETED|Overall Study||24||
48486991|NCT04852978|101529084|FG003|COMPLETED|Overall Study||27||
48486992|NCT04852978|101529085|FG004|COMPLETED|Overall Study||26||
48486993|NCT04852978|101529086|FG005|COMPLETED|Overall Study||24||
48486994|NCT04852978|101529087|FG006|COMPLETED|Overall Study||22||
48486995|NCT04852978|101529088|FG007|COMPLETED|Overall Study||29||
48486996|NCT04852978|101529089|FG008|COMPLETED|Overall Study||32||
48486997|NCT04852978|101529081|FG000|NOT COMPLETED|Overall Study||7||
48486998|NCT04852978|101529082|FG001|NOT COMPLETED|Overall Study||5||
48486999|NCT04852978|101529083|FG002|NOT COMPLETED|Overall Study||5||
48487000|NCT04852978|101529084|FG003|NOT COMPLETED|Overall Study||1||
48487001|NCT04852978|101529085|FG004|NOT COMPLETED|Overall Study||7||
48487002|NCT04852978|101529086|FG005|NOT COMPLETED|Overall Study||7||
48198785|NCT01090024|100810220|FG015|NOT COMPLETED|Period 2||0||
48487003|NCT04852978|101529087|FG006|NOT COMPLETED|Overall Study||4||
48487004|NCT04852978|101529088|FG007|NOT COMPLETED|Overall Study||6||
48487005|NCT04852978|101529089|FG008|NOT COMPLETED|Overall Study||3||
48487006|NCT02687126|101529090|FG000|STARTED|Data Collection||106||
48487007|NCT02687126|101529090|FG000|COMPLETED|Data Collection||106||
48487008|NCT02687126|101529090|FG000|NOT COMPLETED|Data Collection||0||
48487009|NCT02687126|101529090|FG000|STARTED|Data Analysis||106||
48487010|NCT02687126|101529090|FG000|COMPLETED|Data Analysis||106||
48487011|NCT02687126|101529090|FG000|NOT COMPLETED|Data Analysis||0||
48487012|NCT02157623|101529091|FG000|STARTED|Overall Study||3||
48487013|NCT02157623|101529091|FG000|COMPLETED|Overall Study||3||
48487014|NCT02157623|101529091|FG000|NOT COMPLETED|Overall Study||0||
48487015|NCT03772522|101529092|FG000|STARTED|Pre-intervention||12||
48487016|NCT03772522|101529093|FG001|STARTED|Pre-intervention||15||
48198786|NCT01090024|100810221|FG016|NOT COMPLETED|Period 2||0||
48487017|NCT03772522|101529092|FG000|COMPLETED|Pre-intervention||9||
48487018|NCT03772522|101529093|FG001|COMPLETED|Pre-intervention||11||
48487019|NCT03772522|101529092|FG000|NOT COMPLETED|Pre-intervention||3||
48487020|NCT03772522|101529093|FG001|NOT COMPLETED|Pre-intervention||4||
48487021|NCT03772522|101529092|FG000|STARTED|Intervention||9||
48487022|NCT03772522|101529093|FG001|STARTED|Intervention||11||
48487023|NCT03772522|101529092|FG000|COMPLETED|Intervention||8||
48487024|NCT03772522|101529093|FG001|COMPLETED|Intervention||11||
48487025|NCT03772522|101529092|FG000|NOT COMPLETED|Intervention||1||
48487026|NCT03772522|101529093|FG001|NOT COMPLETED|Intervention||0||
48487027|NCT03772522|101529092|FG000|STARTED|Post-intervention Follow-up||8||
48487028|NCT03772522|101529093|FG001|STARTED|Post-intervention Follow-up||11||
48487029|NCT03772522|101529092|FG000|COMPLETED|Post-intervention Follow-up||7||
48487030|NCT03772522|101529093|FG001|COMPLETED|Post-intervention Follow-up||11||
48487031|NCT03772522|101529092|FG000|NOT COMPLETED|Post-intervention Follow-up||1||
48487032|NCT03772522|101529093|FG001|NOT COMPLETED|Post-intervention Follow-up||0||
48487033|NCT02535611|101529094|FG000|STARTED|Overall Study||27||
48487034|NCT02535611|101529095|FG001|STARTED|Overall Study||20||
48487035|NCT02535611|101529094|FG000|COMPLETED|Overall Study||27||
48487036|NCT02535611|101529095|FG001|COMPLETED|Overall Study||20||
48487037|NCT02535611|101529094|FG000|NOT COMPLETED|Overall Study||0||
48487038|NCT02535611|101529095|FG001|NOT COMPLETED|Overall Study||0||
48487039|NCT00448591|101529096|FG000|STARTED|Overall Study||2296||
48487040|NCT00448591|101529096|FG000|COMPLETED|Overall Study||0||
48487041|NCT00448591|101529096|FG000|NOT COMPLETED|Overall Study||2296||
48487042|NCT01507051|101529097|FG000|STARTED|Overall Study||29||
48487043|NCT01507051|101529098|FG001|STARTED|Overall Study||31||
48487044|NCT01507051|101529099|FG002|STARTED|Overall Study||29||
48487045|NCT01507051|101529100|FG003|STARTED|Overall Study||7||
48487046|NCT01507051|101529097|FG000|Warfarin run-in Phase|Overall Study||28||
48487047|NCT01507051|101529098|FG001|Warfarin run-in Phase|Overall Study||28||
48487048|NCT01507051|101529099|FG002|Warfarin run-in Phase|Overall Study||0||
48487049|NCT01507051|101529100|FG003|Warfarin run-in Phase|Overall Study||7||
48487050|NCT01507051|101529097|FG000|Received Placebo or Rivaroxaban|Overall Study||28||
48487051|NCT01507051|101529098|FG001|Received Placebo or Rivaroxaban|Overall Study||28||
48487052|NCT01507051|101529099|FG002|Received Placebo or Rivaroxaban|Overall Study||28||
48487053|NCT01507051|101529100|FG003|Received Placebo or Rivaroxaban|Overall Study||0||
48487054|NCT01507051|101529097|FG000|COMPLETED|Overall Study||27||
48487055|NCT01507051|101529098|FG001|COMPLETED|Overall Study||28||
48487056|NCT01507051|101529099|FG002|COMPLETED|Overall Study||28||
48487057|NCT01507051|101529100|FG003|COMPLETED|Overall Study||0||
48487058|NCT01507051|101529097|FG000|NOT COMPLETED|Overall Study||2||
48487059|NCT01507051|101529098|FG001|NOT COMPLETED|Overall Study||3||
48487060|NCT01507051|101529099|FG002|NOT COMPLETED|Overall Study||1||
48487061|NCT01507051|101529100|FG003|NOT COMPLETED|Overall Study||7||
48487062|NCT03290326|101529101|FG000|STARTED|Overall Study||10||
48487063|NCT03290326|101529101|FG000|COMPLETED|Overall Study||10||
48487064|NCT03290326|101529101|FG000|NOT COMPLETED|Overall Study||0||
48487065|NCT01705574|101529102|FG000|STARTED|Double-Blind Phase||293||
48487066|NCT01705574|101529103|FG001|STARTED|Double-Blind Phase||290||
48487067|NCT01705574|101529104|FG002|STARTED|Double-Blind Phase||0||
48487068|NCT01705574|101529105|FG003|STARTED|Double-Blind Phase||0||
48487069|NCT01705574|101529102|FG000|COMPLETED|Double-Blind Phase||260||
48487070|NCT01705574|101529103|FG001|COMPLETED|Double-Blind Phase||249||
48487071|NCT01705574|101529104|FG002|COMPLETED|Double-Blind Phase||0||
48487072|NCT01705574|101529105|FG003|COMPLETED|Double-Blind Phase||0||
48487073|NCT01705574|101529102|FG000|NOT COMPLETED|Double-Blind Phase||33||
48487074|NCT01705574|101529103|FG001|NOT COMPLETED|Double-Blind Phase||41||
48487075|NCT01705574|101529104|FG002|NOT COMPLETED|Double-Blind Phase||0||
48487076|NCT01705574|101529105|FG003|NOT COMPLETED|Double-Blind Phase||0||
48487077|NCT01705574|101529102|FG000|STARTED|Open-Label Extension Phase||246|14 participants did not enter the OLE STB arm.|
48487078|NCT01705574|101529103|FG001|STARTED|Open-Label Extension Phase||0|14 participants did not enter the OLE STB arm.|
48487079|NCT01705574|101529104|FG002|STARTED|Open-Label Extension Phase||159|14 participants did not enter the OLE STB arm.|
48487080|NCT01705574|101529105|FG003|STARTED|Open-Label Extension Phase||53|14 participants did not enter the OLE STB arm.|
48487081|NCT01705574|101529102|FG000|COMPLETED|Open-Label Extension Phase||231||
48487082|NCT01705574|101529103|FG001|COMPLETED|Open-Label Extension Phase||0||
48487083|NCT01705574|101529104|FG002|COMPLETED|Open-Label Extension Phase||148||
48487084|NCT01705574|101529105|FG003|COMPLETED|Open-Label Extension Phase||48||
48487085|NCT01705574|101529102|FG000|NOT COMPLETED|Open-Label Extension Phase||15||
48487086|NCT01705574|101529103|FG001|NOT COMPLETED|Open-Label Extension Phase||0||
48487087|NCT01705574|101529104|FG002|NOT COMPLETED|Open-Label Extension Phase||11||
48487088|NCT01705574|101529105|FG003|NOT COMPLETED|Open-Label Extension Phase||5||
48487089|NCT04400890|101529106|FG000|STARTED|Overall Study||53|Intent-to-treat Population|
48487090|NCT04400890|101529107|FG001|STARTED|Overall Study||52|Intent-to-treat Population|
48487091|NCT04400890|101529106|FG000|Treated Per Protocol Population|Overall Study||50|Completed participation through 21-day primary outcome measures.|
48487092|NCT04400890|101529107|FG001|Treated Per Protocol Population|Overall Study||50|Completed participation through 21-day primary outcome measures.|
48487093|NCT04400890|101529106|FG000|COMPLETED|Overall Study||50||
48487094|NCT04400890|101529107|FG001|COMPLETED|Overall Study||50||
48487095|NCT04400890|101529106|FG000|NOT COMPLETED|Overall Study||3||
48487096|NCT04400890|101529107|FG001|NOT COMPLETED|Overall Study||2||
48487097|NCT03956862|101529108|FG000|STARTED|Overall Study||50||
48198787|NCT01090024|100810222|FG017|NOT COMPLETED|Period 2||0||
48198788|NCT01090024|100810205|FG000|STARTED|Period 3||5||
48487098|NCT03956862|101529109|FG001|STARTED|Overall Study||47||
48198789|NCT01090024|100810206|FG001|STARTED|Period 3||5||
48198790|NCT01090024|100810207|FG002|STARTED|Period 3||6||
48198791|NCT01090024|100810208|FG003|STARTED|Period 3||4||
48198792|NCT01090024|100810209|FG004|STARTED|Period 3||6||
48198793|NCT01090024|100810210|FG005|STARTED|Period 3||6||
48198794|NCT01090024|100810211|FG006|STARTED|Period 3||6||
48198795|NCT01090024|100810212|FG007|STARTED|Period 3||6||
48198796|NCT01090024|100810213|FG008|STARTED|Period 3||6||
48198797|NCT01090024|100810214|FG009|STARTED|Period 3||5||
48198798|NCT01090024|100810215|FG010|STARTED|Period 3||6||
48198799|NCT01090024|100810216|FG011|STARTED|Period 3||5||
48198800|NCT01090024|100810217|FG012|STARTED|Period 3||6||
48198801|NCT01090024|100810218|FG013|STARTED|Period 3||6||
48198802|NCT01090024|100810219|FG014|STARTED|Period 3||5||
48198803|NCT01090024|100810220|FG015|STARTED|Period 3||6||
48198804|NCT01090024|100810221|FG016|STARTED|Period 3||6||
48198805|NCT01090024|100810222|FG017|STARTED|Period 3||5||
48198806|NCT01090024|100810205|FG000|Treated|Period 3||5||
48198807|NCT01090024|100810206|FG001|Treated|Period 3||5||
48198808|NCT01090024|100810207|FG002|Treated|Period 3||6||
48198809|NCT01090024|100810208|FG003|Treated|Period 3||4||
48198810|NCT01090024|100810209|FG004|Treated|Period 3||6||
48198811|NCT01090024|100810210|FG005|Treated|Period 3||6||
48198812|NCT01090024|100810211|FG006|Treated|Period 3||6||
48198813|NCT01090024|100810212|FG007|Treated|Period 3||6||
48198814|NCT01090024|100810213|FG008|Treated|Period 3||6||
48198815|NCT01090024|100810214|FG009|Treated|Period 3||5||
48198816|NCT01090024|100810215|FG010|Treated|Period 3||6||
48198817|NCT01090024|100810216|FG011|Treated|Period 3||5||
48198818|NCT01090024|100810217|FG012|Treated|Period 3||6||
48198819|NCT01090024|100810218|FG013|Treated|Period 3||6||
48198820|NCT01090024|100810219|FG014|Treated|Period 3||5||
48198821|NCT01090024|100810220|FG015|Treated|Period 3||5||
48198822|NCT01090024|100810221|FG016|Treated|Period 3||6||
48198823|NCT01090024|100810222|FG017|Treated|Period 3||5||
48198824|NCT01090024|100810205|FG000|COMPLETED|Period 3||5||
48487099|NCT03956862|101529108|FG000|COMPLETED|Overall Study||48||
48487100|NCT03956862|101529109|FG001|COMPLETED|Overall Study||45||
48487101|NCT03956862|101529108|FG000|NOT COMPLETED|Overall Study||2||
48487102|NCT03956862|101529109|FG001|NOT COMPLETED|Overall Study||2||
48487103|NCT02606708|101529110|FG000|STARTED|Overall Study||314||
48487104|NCT02606708|101529110|FG000|COMPLETED|Overall Study||314||
48487105|NCT02606708|101529110|FG000|NOT COMPLETED|Overall Study||0||
48487106|NCT03506386|101529111|FG000|STARTED|Overall Study||943||
48487107|NCT03506386|101529111|FG000|COMPLETED|Overall Study||943||
48487108|NCT03506386|101529111|FG000|NOT COMPLETED|Overall Study||0||
48487109|NCT00960297|101529112|FG000|STARTED|Overall Study||4||
48487110|NCT00960297|101529112|FG000|COMPLETED|Overall Study||1||
48487111|NCT00960297|101529112|FG000|NOT COMPLETED|Overall Study||3||
48487112|NCT03098394|101529113|FG000|STARTED|Overall Study||30||
48487113|NCT03098394|101529114|FG001|STARTED|Overall Study||34||
48487114|NCT03098394|101529113|FG000|COMPLETED|Overall Study||30||
48487115|NCT03098394|101529114|FG001|COMPLETED|Overall Study||33||
48487116|NCT03098394|101529113|FG000|NOT COMPLETED|Overall Study||0||
48487117|NCT03098394|101529114|FG001|NOT COMPLETED|Overall Study||1||
48487118|NCT00833937|101529115|FG000|STARTED|First Intervention||12||
48487119|NCT00833937|101529116|FG001|STARTED|First Intervention||12||
48487120|NCT00833937|101529115|FG000|COMPLETED|First Intervention||12||
48487121|NCT00833937|101529116|FG001|COMPLETED|First Intervention||12||
48487122|NCT00833937|101529115|FG000|NOT COMPLETED|First Intervention||0||
48487123|NCT00833937|101529116|FG001|NOT COMPLETED|First Intervention||0||
48487124|NCT00833937|101529115|FG000|STARTED|Washout||12||
48487125|NCT00833937|101529116|FG001|STARTED|Washout||12||
48487126|NCT00833937|101529115|FG000|COMPLETED|Washout||11||
48487127|NCT00833937|101529116|FG001|COMPLETED|Washout||12||
48487128|NCT00833937|101529115|FG000|NOT COMPLETED|Washout||1||
48487129|NCT00833937|101529116|FG001|NOT COMPLETED|Washout||0||
48487130|NCT00833937|101529115|FG000|STARTED|Second Intervention||11||
48487131|NCT00833937|101529116|FG001|STARTED|Second Intervention||12||
48487132|NCT00833937|101529115|FG000|COMPLETED|Second Intervention||11||
48487133|NCT00833937|101529116|FG001|COMPLETED|Second Intervention||12||
48487134|NCT00833937|101529115|FG000|NOT COMPLETED|Second Intervention||0||
48487135|NCT00833937|101529116|FG001|NOT COMPLETED|Second Intervention||0||
48487136|NCT02714062|101529117|FG000|STARTED|Overall Study||14||
48487137|NCT02714062|101529118|FG001|STARTED|Overall Study||15||
48487138|NCT02714062|101529119|FG002|STARTED|Overall Study||13||
48487139|NCT02714062|101529117|FG000|COMPLETED|Overall Study||13||
48487140|NCT02714062|101529118|FG001|COMPLETED|Overall Study||14||
48487141|NCT02714062|101529119|FG002|COMPLETED|Overall Study||10||
48487142|NCT02714062|101529117|FG000|NOT COMPLETED|Overall Study||1||
48487143|NCT02714062|101529118|FG001|NOT COMPLETED|Overall Study||1||
48487144|NCT02714062|101529119|FG002|NOT COMPLETED|Overall Study||3||
48487145|NCT00840632|101529120|FG000|STARTED|First Intervention||20||
48487146|NCT00840632|101529121|FG001|STARTED|First Intervention||20||
48487147|NCT00840632|101529120|FG000|COMPLETED|First Intervention||20||
48487148|NCT00840632|101529121|FG001|COMPLETED|First Intervention||19||
48487149|NCT00840632|101529120|FG000|NOT COMPLETED|First Intervention||0||
48487150|NCT00840632|101529121|FG001|NOT COMPLETED|First Intervention||1||
48487151|NCT00840632|101529120|FG000|STARTED|Washout||20||
48487152|NCT00840632|101529121|FG001|STARTED|Washout||19||
48487153|NCT00840632|101529120|FG000|COMPLETED|Washout||19||
48487154|NCT00840632|101529121|FG001|COMPLETED|Washout||18||
48487155|NCT00840632|101529120|FG000|NOT COMPLETED|Washout||1||
48487156|NCT00840632|101529121|FG001|NOT COMPLETED|Washout||1||
48487157|NCT00840632|101529120|FG000|STARTED|Second Intervention||19||
48487158|NCT00840632|101529121|FG001|STARTED|Second Intervention||18||
48487159|NCT00840632|101529120|FG000|COMPLETED|Second Intervention||19||
48487160|NCT00840632|101529121|FG001|COMPLETED|Second Intervention||18||
48487161|NCT00840632|101529120|FG000|NOT COMPLETED|Second Intervention||0||
48487162|NCT00840632|101529121|FG001|NOT COMPLETED|Second Intervention||0||
48487163|NCT03380845|101529122|FG000|STARTED|Overall Study||4||8
48487164|NCT03380845|101529122|FG000|COMPLETED|Overall Study||4||8
48487165|NCT03380845|101529122|FG000|NOT COMPLETED|Overall Study||0||0
48487166|NCT00834067|101529123|FG000|STARTED|First Intervention||30||
48487167|NCT00834067|101529124|FG001|STARTED|First Intervention||30||
48487168|NCT00834067|101529123|FG000|COMPLETED|First Intervention||30||
48487169|NCT00834067|101529124|FG001|COMPLETED|First Intervention||30||
48487170|NCT00834067|101529123|FG000|NOT COMPLETED|First Intervention||0||
48487171|NCT00834067|101529124|FG001|NOT COMPLETED|First Intervention||0||
48487172|NCT00834067|101529123|FG000|STARTED|Washout of 21 Days||30||
48487173|NCT00834067|101529124|FG001|STARTED|Washout of 21 Days||30||
48487174|NCT00834067|101529123|FG000|COMPLETED|Washout of 21 Days||30||
48487175|NCT00834067|101529124|FG001|COMPLETED|Washout of 21 Days||29||
48487176|NCT00834067|101529123|FG000|NOT COMPLETED|Washout of 21 Days||0||
48487177|NCT00834067|101529124|FG001|NOT COMPLETED|Washout of 21 Days||1||
48487178|NCT00834067|101529123|FG000|STARTED|Second Intervention||30||
48487179|NCT00834067|101529124|FG001|STARTED|Second Intervention||29||
48487180|NCT00834067|101529123|FG000|COMPLETED|Second Intervention||30||
48487181|NCT00834067|101529124|FG001|COMPLETED|Second Intervention||29||
48487182|NCT00834067|101529123|FG000|NOT COMPLETED|Second Intervention||0||
48487183|NCT00834067|101529124|FG001|NOT COMPLETED|Second Intervention||0||
48487184|NCT03447353|101529125|FG000|STARTED|Overall Study||18||
48487185|NCT03447353|101529125|FG000|COMPLETED|Overall Study||8||
48487186|NCT03447353|101529125|FG000|NOT COMPLETED|Overall Study||10||
48487187|NCT01250912|101529126|FG000|STARTED|Overall Study||20||
48487188|NCT01250912|101529126|FG000|COMPLETED|Overall Study||19||
48198825|NCT01090024|100810206|FG001|COMPLETED|Period 3||5||
48198826|NCT01090024|100810207|FG002|COMPLETED|Period 3||6||
48198827|NCT01090024|100810208|FG003|COMPLETED|Period 3||4||
48198828|NCT01090024|100810209|FG004|COMPLETED|Period 3||6||
48198829|NCT01090024|100810210|FG005|COMPLETED|Period 3||5||
48198830|NCT01090024|100810211|FG006|COMPLETED|Period 3||6||
48198831|NCT01090024|100810212|FG007|COMPLETED|Period 3||6||
48198832|NCT01090024|100810213|FG008|COMPLETED|Period 3||5||
48487189|NCT01250912|101529126|FG000|NOT COMPLETED|Overall Study||1||
48487190|NCT00446563|101529127|FG000|STARTED|Overall Study||43||
48487191|NCT00446563|101529128|FG001|STARTED|Overall Study||47||
48487192|NCT00446563|101529127|FG000|COMPLETED|Overall Study||36||
48487193|NCT00446563|101529128|FG001|COMPLETED|Overall Study||38||
48487194|NCT00446563|101529127|FG000|NOT COMPLETED|Overall Study||7||
48487195|NCT00446563|101529128|FG001|NOT COMPLETED|Overall Study||9||
48487196|NCT03199872|101529129|FG000|STARTED|Overall Study||22||
48487197|NCT03199872|101529129|FG000|COMPLETED|Overall Study||22||
48487198|NCT03199872|101529129|FG000|NOT COMPLETED|Overall Study||0||
48487199|NCT03017885|101529130|FG000|STARTED|Overall Study||9||
48487200|NCT03017885|101529131|FG001|STARTED|Overall Study||5||
48487201|NCT03017885|101529132|FG002|STARTED|Overall Study||9||
48198833|NCT01090024|100810214|FG009|COMPLETED|Period 3||5||
48198834|NCT01090024|100810215|FG010|COMPLETED|Period 3||6||
48198835|NCT01090024|100810216|FG011|COMPLETED|Period 3||5||
48487202|NCT03017885|101529133|FG003|STARTED|Overall Study||1||
48487203|NCT03017885|101529134|FG004|STARTED|Overall Study||3||
48198836|NCT01090024|100810217|FG012|COMPLETED|Period 3||6||
48487204|NCT03017885|101529135|FG005|STARTED|Overall Study||1||
48487205|NCT03017885|101529130|FG000|COMPLETED|Overall Study||0|Completed treatment|
48487206|NCT03017885|101529131|FG001|COMPLETED|Overall Study||0|Completed treatment|
48487207|NCT03017885|101529132|FG002|COMPLETED|Overall Study||0|Completed treatment|
48487208|NCT03017885|101529133|FG003|COMPLETED|Overall Study||1|Completed treatment|
48487209|NCT03017885|101529134|FG004|COMPLETED|Overall Study||3|Completed treatment|
48487210|NCT03017885|101529135|FG005|COMPLETED|Overall Study||1|Completed treatment|
48487211|NCT03017885|101529130|FG000|NOT COMPLETED|Overall Study||9||
48487212|NCT03017885|101529131|FG001|NOT COMPLETED|Overall Study||5||
48487213|NCT03017885|101529132|FG002|NOT COMPLETED|Overall Study||9||
48487214|NCT03017885|101529133|FG003|NOT COMPLETED|Overall Study||0||
48487215|NCT03017885|101529134|FG004|NOT COMPLETED|Overall Study||0||
48487216|NCT03017885|101529135|FG005|NOT COMPLETED|Overall Study||0||
48487217|NCT00096447|101529136|FG000|STARTED|Overall Study||31||
48487218|NCT00096447|101529136|FG000|COMPLETED|Overall Study||30||
48487219|NCT00096447|101529136|FG000|NOT COMPLETED|Overall Study||1||
48487220|NCT03114891|101529137|FG000|STARTED|First Treatment Round||12||
48487221|NCT03114891|101529138|FG001|STARTED|First Treatment Round||14||
48487222|NCT03114891|101529139|FG002|STARTED|First Treatment Round||11||
48487223|NCT03114891|101529140|FG003|STARTED|First Treatment Round||13||
48487224|NCT03114891|101529137|FG000|COMPLETED|First Treatment Round||12||
48487225|NCT03114891|101529138|FG001|COMPLETED|First Treatment Round||11||
48198837|NCT01090024|100810218|FG013|COMPLETED|Period 3||6||
48198838|NCT01090024|100810219|FG014|COMPLETED|Period 3||5||
48198839|NCT01090024|100810220|FG015|COMPLETED|Period 3||5||
48198840|NCT01090024|100810221|FG016|COMPLETED|Period 3||6||
48198841|NCT01090024|100810222|FG017|COMPLETED|Period 3||5||
48198842|NCT01090024|100810205|FG000|NOT COMPLETED|Period 3||0||
48198843|NCT01090024|100810206|FG001|NOT COMPLETED|Period 3||0||
48198844|NCT01090024|100810207|FG002|NOT COMPLETED|Period 3||0||
48198845|NCT01090024|100810208|FG003|NOT COMPLETED|Period 3||0||
48198846|NCT01090024|100810209|FG004|NOT COMPLETED|Period 3||0||
48198847|NCT01090024|100810210|FG005|NOT COMPLETED|Period 3||1||
48198848|NCT01090024|100810211|FG006|NOT COMPLETED|Period 3||0||
48198849|NCT01090024|100810212|FG007|NOT COMPLETED|Period 3||0||
48198850|NCT01090024|100810213|FG008|NOT COMPLETED|Period 3||1||
48198851|NCT01090024|100810214|FG009|NOT COMPLETED|Period 3||0||
48487226|NCT03114891|101529139|FG002|COMPLETED|First Treatment Round||10||
48487227|NCT03114891|101529140|FG003|COMPLETED|First Treatment Round||12||
48487228|NCT03114891|101529137|FG000|NOT COMPLETED|First Treatment Round||0||
48487229|NCT03114891|101529138|FG001|NOT COMPLETED|First Treatment Round||3||
48487230|NCT03114891|101529139|FG002|NOT COMPLETED|First Treatment Round||1||
48487231|NCT03114891|101529140|FG003|NOT COMPLETED|First Treatment Round||1||
48487232|NCT03114891|101529137|FG000|STARTED|3 Week Break||12||
48487233|NCT03114891|101529138|FG001|STARTED|3 Week Break||11||
48198852|NCT01090024|100810215|FG010|NOT COMPLETED|Period 3||0||
48198853|NCT01090024|100810216|FG011|NOT COMPLETED|Period 3||0||
48198854|NCT01090024|100810217|FG012|NOT COMPLETED|Period 3||0||
48198855|NCT01090024|100810218|FG013|NOT COMPLETED|Period 3||0||
48198856|NCT01090024|100810219|FG014|NOT COMPLETED|Period 3||0||
48198857|NCT01090024|100810220|FG015|NOT COMPLETED|Period 3||1||
48198858|NCT01090024|100810221|FG016|NOT COMPLETED|Period 3||0||
48198859|NCT01090024|100810222|FG017|NOT COMPLETED|Period 3||0||
48198860|NCT01352507|100810223|FG000|STARTED|Treatment Period 1||190||
48198861|NCT01352507|100810224|FG001|STARTED|Treatment Period 1||193||
48198862|NCT01352507|100810223|FG000|Received Treatment|Treatment Period 1||182||
48198863|NCT01352507|100810224|FG001|Received Treatment|Treatment Period 1||188||
48198864|NCT01352507|100810223|FG000|COMPLETED|Treatment Period 1||176||
48198865|NCT01352507|100810224|FG001|COMPLETED|Treatment Period 1||184||
48198866|NCT01352507|100810223|FG000|NOT COMPLETED|Treatment Period 1||14||
48198867|NCT01352507|100810224|FG001|NOT COMPLETED|Treatment Period 1||9||
48198868|NCT01352507|100810223|FG000|STARTED|Washout Period||176||
48198869|NCT01352507|100810224|FG001|STARTED|Washout Period||184||
48198870|NCT01352507|100810223|FG000|COMPLETED|Washout Period||176||
48198871|NCT01352507|100810224|FG001|COMPLETED|Washout Period||183||
48198872|NCT01352507|100810223|FG000|NOT COMPLETED|Washout Period||0||
48198873|NCT01352507|100810224|FG001|NOT COMPLETED|Washout Period||1||
48198874|NCT01352507|100810223|FG000|STARTED|Treatment Period 2||176||
48198875|NCT01352507|100810224|FG001|STARTED|Treatment Period 2||183||
48198876|NCT01352507|100810223|FG000|Received Treatment|Treatment Period 2||173||
48198877|NCT01352507|100810224|FG001|Received Treatment|Treatment Period 2||181||
48198878|NCT01352507|100810223|FG000|COMPLETED|Treatment Period 2||170||
48198879|NCT01352507|100810224|FG001|COMPLETED|Treatment Period 2||180||
48198880|NCT01352507|100810223|FG000|NOT COMPLETED|Treatment Period 2||6||
48198881|NCT01352507|100810224|FG001|NOT COMPLETED|Treatment Period 2||3||
48198882|NCT01352507|100810223|FG000|STARTED|Extension Phase||164||
48198883|NCT01352507|100810224|FG001|STARTED|Extension Phase||173||
48198884|NCT01352507|100810223|FG000|COMPLETED|Extension Phase||164||
48487234|NCT03114891|101529139|FG002|STARTED|3 Week Break||10||
48198885|NCT01352507|100810224|FG001|COMPLETED|Extension Phase||173||
48198886|NCT01352507|100810223|FG000|NOT COMPLETED|Extension Phase||0||
48198887|NCT01352507|100810224|FG001|NOT COMPLETED|Extension Phase||0||
48198888|NCT05012644|100810225|FG000|STARTED|Overall Study||116||
48198889|NCT05012644|100810226|FG001|STARTED|Overall Study||80||
48198890|NCT05012644|100810225|FG000|Discontinued|Overall Study||64|Included first line metastatic treatment only|
48198891|NCT05012644|100810226|FG001|Discontinued|Overall Study||67|Included first line metastatic treatment only|
48198892|NCT05012644|100810225|FG000|Ongoing|Overall Study||51|Included first line metastatic treatment only|
48198893|NCT05012644|100810226|FG001|Ongoing|Overall Study||13|Included first line metastatic treatment only|
48198894|NCT05012644|100810225|FG000|COMPLETED|Overall Study||1|Included first line metastatic treatment only|
48198895|NCT05012644|100810226|FG001|COMPLETED|Overall Study||0|Included first line metastatic treatment only|
48198896|NCT05012644|100810225|FG000|NOT COMPLETED|Overall Study||115||
48198897|NCT05012644|100810226|FG001|NOT COMPLETED|Overall Study||80||
48198898|NCT01213706|100810227|FG000|STARTED|Sham WBPA||45||
48198899|NCT01213706|100810227|FG000|COMPLETED|Sham WBPA||45||
48198900|NCT01213706|100810227|FG000|NOT COMPLETED|Sham WBPA||0||
48198901|NCT01213706|100810227|FG000|STARTED|Washout (1 Hour)||45||
48198902|NCT01213706|100810227|FG000|COMPLETED|Washout (1 Hour)||45||
48198903|NCT01213706|100810227|FG000|NOT COMPLETED|Washout (1 Hour)||0||
48198904|NCT01213706|100810227|FG000|STARTED|WBPA||45||
48198905|NCT01213706|100810227|FG000|COMPLETED|WBPA||45||
48198906|NCT01213706|100810227|FG000|NOT COMPLETED|WBPA||0||
48198907|NCT02885350|100810228|FG000|STARTED|Overall Study||20||
48198908|NCT02885350|100810229|FG001|STARTED|Overall Study||20||
48198909|NCT02885350|100810230|FG002|STARTED|Overall Study||20||
48198910|NCT02885350|100810231|FG003|STARTED|Overall Study||20||
48198911|NCT02885350|100810228|FG000|COMPLETED|Overall Study||20||
48198912|NCT02885350|100810229|FG001|COMPLETED|Overall Study||20||
48198913|NCT02885350|100810230|FG002|COMPLETED|Overall Study||20||
48198914|NCT02885350|100810231|FG003|COMPLETED|Overall Study||20||
48198915|NCT02885350|100810228|FG000|NOT COMPLETED|Overall Study||0||
48198916|NCT02885350|100810229|FG001|NOT COMPLETED|Overall Study||0||
48198917|NCT02885350|100810230|FG002|NOT COMPLETED|Overall Study||0||
48198918|NCT02885350|100810231|FG003|NOT COMPLETED|Overall Study||0||
48198919|NCT03107611|100810232|FG000|STARTED|Overall Study||217||
48198920|NCT03107611|100810233|FG001|STARTED|Overall Study||216||
48198921|NCT03107611|100810234|FG002|STARTED|Overall Study||221||
48198922|NCT03107611|100810232|FG000|Dosed|Overall Study||215|2 Test, 2 Reference, and 1 Placebo Subjects are not known to have dosed|
48198923|NCT03107611|100810233|FG001|Dosed|Overall Study||214|2 Test, 2 Reference, and 1 Placebo Subjects are not known to have dosed|
48198924|NCT03107611|100810234|FG002|Dosed|Overall Study||220|2 Test, 2 Reference, and 1 Placebo Subjects are not known to have dosed|
48198925|NCT03107611|100810232|FG000|COMPLETED|Overall Study||210||
48198926|NCT03107611|100810233|FG001|COMPLETED|Overall Study||212||
48198927|NCT03107611|100810234|FG002|COMPLETED|Overall Study||212||
48198928|NCT03107611|100810232|FG000|NOT COMPLETED|Overall Study||7||
48198929|NCT03107611|100810233|FG001|NOT COMPLETED|Overall Study||4||
48198930|NCT03107611|100810234|FG002|NOT COMPLETED|Overall Study||9||
48198931|NCT05567952|100810235|FG000|STARTED|Overall Study||292||
48198932|NCT05567952|100810236|FG001|STARTED|Overall Study||144||
48198933|NCT05567952|100810235|FG000|COMPLETED|Overall Study||280||
48198934|NCT05567952|100810236|FG001|COMPLETED|Overall Study||138||
48198935|NCT05567952|100810235|FG000|NOT COMPLETED|Overall Study||12||
48198936|NCT05567952|100810236|FG001|NOT COMPLETED|Overall Study||6||
48198937|NCT00605033|100810237|FG000|STARTED|Overall Study||143||
48198938|NCT00605033|100810238|FG001|STARTED|Overall Study||98||
48198939|NCT00605033|100810237|FG000|COMPLETED|Overall Study||136||
48198940|NCT00605033|100810238|FG001|COMPLETED|Overall Study||90||
48198941|NCT00605033|100810237|FG000|NOT COMPLETED|Overall Study||7||
48198942|NCT00605033|100810238|FG001|NOT COMPLETED|Overall Study||8||
48198943|NCT03235349|100810239|FG000|STARTED|Overall Study||160||
48198944|NCT03235349|100810239|FG000|COMPLETED|Overall Study||158||
48198945|NCT03235349|100810239|FG000|NOT COMPLETED|Overall Study||2||
48198946|NCT02987335|100810240|FG000|STARTED|Overall Study||20||
48198947|NCT02987335|100810241|FG001|STARTED|Overall Study||13||
48198948|NCT02987335|100810242|FG002|STARTED|Overall Study||15||
48198949|NCT02987335|100810243|FG003|STARTED|Overall Study||16||
48198950|NCT02987335|100810244|FG004|STARTED|Overall Study||9||
48198951|NCT02987335|100810240|FG000|COMPLETED|Overall Study||20||
48198952|NCT02987335|100810241|FG001|COMPLETED|Overall Study||13||
48198953|NCT02987335|100810242|FG002|COMPLETED|Overall Study||15||
48198954|NCT02987335|100810243|FG003|COMPLETED|Overall Study||16||
48198955|NCT02987335|100810244|FG004|COMPLETED|Overall Study||9||
48198956|NCT02987335|100810240|FG000|NOT COMPLETED|Overall Study||0||
48198957|NCT02987335|100810241|FG001|NOT COMPLETED|Overall Study||0||
48198958|NCT02987335|100810242|FG002|NOT COMPLETED|Overall Study||0||
48198959|NCT02987335|100810243|FG003|NOT COMPLETED|Overall Study||0||
48198960|NCT02987335|100810244|FG004|NOT COMPLETED|Overall Study||0||
48198961|NCT00946114|100810245|FG000|STARTED|Overall Study||20||
48198962|NCT00946114|100810246|FG001|STARTED|Overall Study||12||
48198963|NCT00946114|100810245|FG000|COMPLETED|Overall Study||12||
48198964|NCT00946114|100810246|FG001|COMPLETED|Overall Study||10||
48198965|NCT00946114|100810245|FG000|NOT COMPLETED|Overall Study||8||
48198966|NCT00946114|100810246|FG001|NOT COMPLETED|Overall Study||2||
48198967|NCT00731211|100810247|FG000|STARTED|Overall Study||55||
48198968|NCT00731211|100810247|FG000|COMPLETED|Overall Study||55||
48198969|NCT00731211|100810247|FG000|NOT COMPLETED|Overall Study||0||
48198970|NCT01303835|100810248|FG000|STARTED|Overall Study||54||
48198971|NCT01303835|100810249|FG001|STARTED|Overall Study||56||
48198972|NCT01303835|100810248|FG000|COMPLETED|Overall Study||35||
48198973|NCT01303835|100810249|FG001|COMPLETED|Overall Study||31||
48198974|NCT01303835|100810248|FG000|NOT COMPLETED|Overall Study||19||
48198975|NCT01303835|100810249|FG001|NOT COMPLETED|Overall Study||25||
48198976|NCT02165605|100810250|FG000|STARTED|Overall Study||28||
48198977|NCT02165605|100810250|FG000|COMPLETED|Overall Study||28||
48198978|NCT02165605|100810250|FG000|NOT COMPLETED|Overall Study||0||
48198979|NCT03061513|100810251|FG000|STARTED|Overall Study||6||
48198980|NCT03061513|100810252|FG001|STARTED|Overall Study||5||
48198981|NCT03061513|100810251|FG000|COMPLETED|Overall Study||6||
48198982|NCT03061513|100810252|FG001|COMPLETED|Overall Study||4||
48198983|NCT03061513|100810251|FG000|NOT COMPLETED|Overall Study||0||
48198984|NCT03061513|100810252|FG001|NOT COMPLETED|Overall Study||1||
48198985|NCT00149630|100810253|FG000|STARTED|Overall Study||34||
48198986|NCT00149630|100810254|FG001|STARTED|Overall Study||40||
48198987|NCT00149630|100810253|FG000|COMPLETED|Overall Study||26||
48198988|NCT00149630|100810254|FG001|COMPLETED|Overall Study||35||
48198989|NCT00149630|100810253|FG000|NOT COMPLETED|Overall Study||8||
48198990|NCT00149630|100810254|FG001|NOT COMPLETED|Overall Study||5||
48198991|NCT04470193|100810255|FG000|STARTED|Overall Study||24||
48198992|NCT04470193|100810256|FG001|STARTED|Overall Study||26||
48198993|NCT04470193|100810255|FG000|COMPLETED|Overall Study||19||
48198994|NCT04470193|100810256|FG001|COMPLETED|Overall Study||26||
48198995|NCT04470193|100810255|FG000|NOT COMPLETED|Overall Study||5||
48198996|NCT04470193|100810256|FG001|NOT COMPLETED|Overall Study||0||
48198997|NCT00336232|100810257|FG000|STARTED|Baseline (200mcg Daily)||59||
48198998|NCT00336232|100810257|FG000|COMPLETED|Baseline (200mcg Daily)||42||
48198999|NCT00336232|100810257|FG000|NOT COMPLETED|Baseline (200mcg Daily)||17||
48199000|NCT00336232|100810257|FG000|STARTED|Low Vitamin K (10mcg Daily)||42||
48199001|NCT00336232|100810257|FG000|COMPLETED|Low Vitamin K (10mcg Daily)||42||
48199002|NCT00336232|100810257|FG000|NOT COMPLETED|Low Vitamin K (10mcg Daily)||0||
48199003|NCT00336232|100810257|FG000|STARTED|High Vitamin K (500mcg Daily)||42||
48199004|NCT00336232|100810257|FG000|COMPLETED|High Vitamin K (500mcg Daily)||42||
48199005|NCT00336232|100810257|FG000|NOT COMPLETED|High Vitamin K (500mcg Daily)||0||
48199006|NCT01360840|100810258|FG000|STARTED|Overall Study||60||
48199007|NCT01360840|100810259|FG001|STARTED|Overall Study||60||
48199008|NCT01360840|100810260|FG002|STARTED|Overall Study||60||
48199009|NCT01360840|100810258|FG000|COMPLETED|Overall Study||50||
48199010|NCT01360840|100810259|FG001|COMPLETED|Overall Study||50||
48199011|NCT01360840|100810260|FG002|COMPLETED|Overall Study||51||
48199012|NCT01360840|100810258|FG000|NOT COMPLETED|Overall Study||10||
48199013|NCT01360840|100810259|FG001|NOT COMPLETED|Overall Study||10||
48487235|NCT03114891|101529140|FG003|STARTED|3 Week Break||12||
48487236|NCT03114891|101529137|FG000|COMPLETED|3 Week Break||11||
48487237|NCT03114891|101529138|FG001|COMPLETED|3 Week Break||10||
48487238|NCT03114891|101529139|FG002|COMPLETED|3 Week Break||10||
48487239|NCT03114891|101529140|FG003|COMPLETED|3 Week Break||11||
48487240|NCT03114891|101529137|FG000|NOT COMPLETED|3 Week Break||1||
48487241|NCT03114891|101529138|FG001|NOT COMPLETED|3 Week Break||1||
48487242|NCT03114891|101529139|FG002|NOT COMPLETED|3 Week Break||0||
48487243|NCT03114891|101529140|FG003|NOT COMPLETED|3 Week Break||1||
48487244|NCT03114891|101529137|FG000|STARTED|Second Treatment Round||11||
48487245|NCT03114891|101529138|FG001|STARTED|Second Treatment Round||10||
48487246|NCT03114891|101529139|FG002|STARTED|Second Treatment Round||10||
48487247|NCT03114891|101529140|FG003|STARTED|Second Treatment Round||11||
48487248|NCT03114891|101529137|FG000|COMPLETED|Second Treatment Round||9||
48487249|NCT03114891|101529138|FG001|COMPLETED|Second Treatment Round||10||
48487250|NCT03114891|101529139|FG002|COMPLETED|Second Treatment Round||10||
48487251|NCT03114891|101529140|FG003|COMPLETED|Second Treatment Round||11||
48487252|NCT03114891|101529137|FG000|NOT COMPLETED|Second Treatment Round||2||
48487253|NCT03114891|101529138|FG001|NOT COMPLETED|Second Treatment Round||0||
48487254|NCT03114891|101529139|FG002|NOT COMPLETED|Second Treatment Round||0||
48487255|NCT03114891|101529140|FG003|NOT COMPLETED|Second Treatment Round||0||
48487256|NCT01171963|101529141|FG000|STARTED|Overall Study||1666||
48487257|NCT01171963|101529142|FG001|STARTED|Overall Study||1667||
48487258|NCT01171963|101529141|FG000|COMPLETED|Overall Study||1518||
48487259|NCT01171963|101529142|FG001|COMPLETED|Overall Study||1499||
48487260|NCT01171963|101529141|FG000|NOT COMPLETED|Overall Study||148||
48487261|NCT01171963|101529142|FG001|NOT COMPLETED|Overall Study||168||
48487262|NCT00796653|101529143|FG000|STARTED|Overall Study||235||
48487263|NCT00796653|101529144|FG001|STARTED|Overall Study||232||
48487264|NCT00796653|101529145|FG002|STARTED|Overall Study||234||
48487265|NCT00796653|101529146|FG003|STARTED|Overall Study||233||
48487266|NCT00796653|101529143|FG000|COMPLETED|Overall Study||184||
48487267|NCT00796653|101529144|FG001|COMPLETED|Overall Study||195||
48487268|NCT00796653|101529145|FG002|COMPLETED|Overall Study||198||
48487269|NCT00796653|101529146|FG003|COMPLETED|Overall Study||193||
48487270|NCT00796653|101529143|FG000|NOT COMPLETED|Overall Study||51||
48487271|NCT00796653|101529144|FG001|NOT COMPLETED|Overall Study||37||
48487272|NCT00796653|101529145|FG002|NOT COMPLETED|Overall Study||36||
48487273|NCT00796653|101529146|FG003|NOT COMPLETED|Overall Study||40||
48487274|NCT02832063|101529147|FG000|STARTED|Overall Study||186||
48487275|NCT02832063|101529148|FG001|STARTED|Overall Study||186||
48487276|NCT02832063|101529147|FG000|COMPLETED|Overall Study||152||
48487277|NCT02832063|101529148|FG001|COMPLETED|Overall Study||148||
48487278|NCT02832063|101529147|FG000|NOT COMPLETED|Overall Study||34||
48487279|NCT02832063|101529148|FG001|NOT COMPLETED|Overall Study||38||
48487280|NCT01767103|101529149|FG000|STARTED|Overall Study||7||
48487281|NCT01767103|101529150|FG001|STARTED|Overall Study||7||
48487282|NCT01767103|101529151|FG002|STARTED|Overall Study||7||
48487283|NCT01767103|101529149|FG000|COMPLETED|Overall Study||7||
48487284|NCT01767103|101529150|FG001|COMPLETED|Overall Study||7||
48487285|NCT01767103|101529151|FG002|COMPLETED|Overall Study||7||
48487286|NCT01767103|101529149|FG000|NOT COMPLETED|Overall Study||0||
48487287|NCT01767103|101529150|FG001|NOT COMPLETED|Overall Study||0||
48487288|NCT01767103|101529151|FG002|NOT COMPLETED|Overall Study||0||
48487289|NCT02392195|101529152|FG000|STARTED|Overall Study||10||
48487290|NCT02392195|101529152|FG000|COMPLETED|Overall Study||2||
48487291|NCT02392195|101529152|FG000|NOT COMPLETED|Overall Study||8||
48487292|NCT02154672|101529153|FG000|STARTED|Overall Study||1||
48487293|NCT02154672|101529153|FG000|COMPLETED|Overall Study||1||
48487294|NCT02154672|101529153|FG000|NOT COMPLETED|Overall Study||0||
48487295|NCT03444090|101529154|FG000|STARTED|Overall Study||214||
48487296|NCT03444090|101529155|FG001|STARTED|Overall Study||214||
48487297|NCT03444090|101529154|FG000|COMPLETED|Overall Study||211||
48487298|NCT03444090|101529155|FG001|COMPLETED|Overall Study||210||
48487299|NCT03444090|101529154|FG000|NOT COMPLETED|Overall Study||3||
48487300|NCT03444090|101529155|FG001|NOT COMPLETED|Overall Study||4||
48487301|NCT03351244|101529156|FG000|STARTED|Overall Study||89||
48487302|NCT03351244|101529157|FG001|STARTED|Overall Study||88||
48487303|NCT03351244|101529158|FG002|STARTED|Overall Study||87||
48487304|NCT03351244|101529156|FG000|COMPLETED|Overall Study||62||
48487305|NCT03351244|101529157|FG001|COMPLETED|Overall Study||48||
48487306|NCT03351244|101529158|FG002|COMPLETED|Overall Study||53||
48487307|NCT03351244|101529156|FG000|NOT COMPLETED|Overall Study||27||
48487308|NCT03351244|101529157|FG001|NOT COMPLETED|Overall Study||40||
48487309|NCT03351244|101529158|FG002|NOT COMPLETED|Overall Study||34||
48487310|NCT04533594|101529159|FG000|STARTED|Overall Study||59||
48487311|NCT04533594|101529159|FG000|Started Intervention|Overall Study||53|N=6 participants had their loved one died before being able to start intervention|
48487312|NCT04533594|101529159|FG000|Completed Final Survey|Overall Study||44||
48487313|NCT04533594|101529159|FG000|COMPLETED|Overall Study||33|N=20 participants had their loved one died before being able to complete the intervention.|
48487314|NCT04533594|101529159|FG000|NOT COMPLETED|Overall Study||26||
48487315|NCT00545506|101529160|FG000|STARTED|Overall Study||3||
48487316|NCT00545506|101529161|FG001|STARTED|Overall Study||3||
48487317|NCT00545506|101529160|FG000|COMPLETED|Overall Study||3||
48487318|NCT00545506|101529161|FG001|COMPLETED|Overall Study||3||
48487319|NCT00545506|101529160|FG000|NOT COMPLETED|Overall Study||0||
48487320|NCT00545506|101529161|FG001|NOT COMPLETED|Overall Study||0||
48487321|NCT01124175|101529162|FG000|STARTED|First Intervention||40||
48487322|NCT01124175|101529163|FG001|STARTED|First Intervention||40||
48487323|NCT01124175|101529162|FG000|COMPLETED|First Intervention||40||
48487324|NCT01124175|101529163|FG001|COMPLETED|First Intervention||40||
48487325|NCT01124175|101529162|FG000|NOT COMPLETED|First Intervention||0||
48487326|NCT01124175|101529163|FG001|NOT COMPLETED|First Intervention||0||
48487327|NCT01124175|101529162|FG000|STARTED|Washout of 7 Days||40||
48666584|NCT01467557|101967618|FG000|COMPLETED|Overall Study||502||
48666585|NCT01467557|101967619|FG001|COMPLETED|Overall Study||463||
48487328|NCT01124175|101529163|FG001|STARTED|Washout of 7 Days||40||
48487329|NCT01124175|101529162|FG000|COMPLETED|Washout of 7 Days||40||
48487330|NCT01124175|101529163|FG001|COMPLETED|Washout of 7 Days||38||
48487331|NCT01124175|101529162|FG000|NOT COMPLETED|Washout of 7 Days||0||
48487332|NCT01124175|101529163|FG001|NOT COMPLETED|Washout of 7 Days||2||
48487333|NCT01124175|101529162|FG000|STARTED|Second Intervention||40||
48487334|NCT01124175|101529163|FG001|STARTED|Second Intervention||38||
48487335|NCT01124175|101529162|FG000|COMPLETED|Second Intervention||40||
48487336|NCT01124175|101529163|FG001|COMPLETED|Second Intervention||38||
48487337|NCT01124175|101529162|FG000|NOT COMPLETED|Second Intervention||0||
48487338|NCT01124175|101529163|FG001|NOT COMPLETED|Second Intervention||0||
48487339|NCT04166630|101529164|FG000|STARTED|Overall Study||5||
48487340|NCT04166630|101529165|FG001|STARTED|Overall Study||17||
48487341|NCT04166630|101529164|FG000|COMPLETED|Overall Study||5||
48487342|NCT04166630|101529165|FG001|COMPLETED|Overall Study||16||
48487343|NCT04166630|101529164|FG000|NOT COMPLETED|Overall Study||0||
48487344|NCT04166630|101529165|FG001|NOT COMPLETED|Overall Study||1||
48487345|NCT05327491|101529166|FG000|STARTED|Periods 1 & 2||73||
48487346|NCT05327491|101529167|FG001|STARTED|Periods 1 & 2||73||
48487347|NCT05327491|101529168|FG002|STARTED|Periods 1 & 2||0||
48487348|NCT05327491|101529169|FG003|STARTED|Periods 1 & 2||0||
48487349|NCT05327491|101529166|FG000|Received at Least 1 Dose|Periods 1 & 2||73||
48487350|NCT05327491|101529167|FG001|Received at Least 1 Dose|Periods 1 & 2||73||
48487351|NCT05327491|101529168|FG002|Received at Least 1 Dose|Periods 1 & 2||0||
48487352|NCT05327491|101529169|FG003|Received at Least 1 Dose|Periods 1 & 2||0||
48487353|NCT05327491|101529166|FG000|COMPLETED|Periods 1 & 2||72||
48487354|NCT05327491|101529167|FG001|COMPLETED|Periods 1 & 2||72||
48487355|NCT05327491|101529168|FG002|COMPLETED|Periods 1 & 2||0||
48487356|NCT05327491|101529169|FG003|COMPLETED|Periods 1 & 2||0||
48487357|NCT05327491|101529166|FG000|NOT COMPLETED|Periods 1 & 2||1||
48487358|NCT05327491|101529167|FG001|NOT COMPLETED|Periods 1 & 2||1||
48487359|NCT05327491|101529168|FG002|NOT COMPLETED|Periods 1 & 2||0||
48487360|NCT05327491|101529169|FG003|NOT COMPLETED|Periods 1 & 2||0||
48487361|NCT05327491|101529166|FG000|STARTED|Period 3 (Food Effect Substudy)||0||
48487362|NCT05327491|101529167|FG001|STARTED|Period 3 (Food Effect Substudy)||0||
48487363|NCT05327491|101529168|FG002|STARTED|Period 3 (Food Effect Substudy)||7||
48487364|NCT05327491|101529169|FG003|STARTED|Period 3 (Food Effect Substudy)||7||
48487365|NCT05327491|101529166|FG000|COMPLETED|Period 3 (Food Effect Substudy)||0||
48487366|NCT05327491|101529167|FG001|COMPLETED|Period 3 (Food Effect Substudy)||0||
48487367|NCT05327491|101529168|FG002|COMPLETED|Period 3 (Food Effect Substudy)||7||
48487368|NCT05327491|101529169|FG003|COMPLETED|Period 3 (Food Effect Substudy)||7||
48487369|NCT05327491|101529166|FG000|NOT COMPLETED|Period 3 (Food Effect Substudy)||0||
48487370|NCT05327491|101529167|FG001|NOT COMPLETED|Period 3 (Food Effect Substudy)||0||
48487371|NCT05327491|101529168|FG002|NOT COMPLETED|Period 3 (Food Effect Substudy)||0||
48487372|NCT05327491|101529169|FG003|NOT COMPLETED|Period 3 (Food Effect Substudy)||0||
48487373|NCT04827394|101529170|FG000|STARTED|Overall Study||25||
48487374|NCT04827394|101529171|FG001|STARTED|Overall Study||27||
48487375|NCT04827394|101529170|FG000|COMPLETED|Overall Study||25||
48487376|NCT04827394|101529171|FG001|COMPLETED|Overall Study||25||
48487377|NCT04827394|101529170|FG000|NOT COMPLETED|Overall Study||0||
48487378|NCT04827394|101529171|FG001|NOT COMPLETED|Overall Study||2||
48487379|NCT01987765|101529172|FG000|STARTED|Overall Study||847||
48487380|NCT01987765|101529172|FG000|COMPLETED|Overall Study||745||
48487381|NCT01987765|101529172|FG000|NOT COMPLETED|Overall Study||102||
48487382|NCT01073657|101529173|FG000|STARTED|Overall Study||17||
48487383|NCT01073657|101529174|FG001|STARTED|Overall Study||16||
48487384|NCT01073657|101529173|FG000|COMPLETED|Overall Study||17||
48487385|NCT01073657|101529174|FG001|COMPLETED|Overall Study||16||
48487386|NCT01073657|101529173|FG000|NOT COMPLETED|Overall Study||0||
48487387|NCT01073657|101529174|FG001|NOT COMPLETED|Overall Study||0||
48487388|NCT01137539|101529175|FG000|STARTED|Overall Study||50||
48487389|NCT01137539|101529175|FG000|COMPLETED|Overall Study||50||
48487390|NCT01137539|101529175|FG000|NOT COMPLETED|Overall Study||0||
48487391|NCT01519661|101529176|FG000|STARTED|Overall Study||157||
48487392|NCT01519661|101529176|FG000|COMPLETED|Overall Study||96||
48487393|NCT01519661|101529176|FG000|NOT COMPLETED|Overall Study||61||
48487394|NCT00633594|101529177|FG000|STARTED|Overall Study||5||
48487395|NCT00633594|101529178|FG001|STARTED|Overall Study||8||
48487396|NCT00633594|101529179|FG002|STARTED|Overall Study||26||
48487397|NCT00633594|101529177|FG000|COMPLETED|Overall Study||5||
48487398|NCT00633594|101529178|FG001|COMPLETED|Overall Study||3||
48487399|NCT00633594|101529179|FG002|COMPLETED|Overall Study||16||
48487400|NCT00633594|101529177|FG000|NOT COMPLETED|Overall Study||0||
48487401|NCT00633594|101529178|FG001|NOT COMPLETED|Overall Study||5||
48487402|NCT00633594|101529179|FG002|NOT COMPLETED|Overall Study||10||
48487403|NCT00908128|101529180|FG000|STARTED|Period 1||20||
48487404|NCT00908128|101529181|FG001|STARTED|Period 1||20||
48199014|NCT01360840|100810260|FG002|NOT COMPLETED|Overall Study||9||
48199015|NCT00470626|100810261|FG000|STARTED|Overall Study||129||
48199016|NCT00470626|100810261|FG000|COMPLETED|Overall Study||112||
48199017|NCT00470626|100810261|FG000|NOT COMPLETED|Overall Study||17||
48199018|NCT03467724|100810262|FG000|STARTED|Overall Study||51||
48199019|NCT03467724|100810262|FG000|COMPLETED|Overall Study||43||
48199020|NCT03467724|100810262|FG000|NOT COMPLETED|Overall Study||8||
48199021|NCT02030028|100810263|FG000|STARTED|Overall Study||18||
48199022|NCT02030028|100810263|FG000|COMPLETED|Overall Study||13||
48199023|NCT02030028|100810263|FG000|NOT COMPLETED|Overall Study||5||
48199024|NCT00587288|100810264|FG000|STARTED|Overall Study||53||
48199025|NCT00587288|100810265|FG001|STARTED|Overall Study||53||
48199026|NCT00587288|100810264|FG000|COMPLETED|Overall Study||50||
48199027|NCT00587288|100810265|FG001|COMPLETED|Overall Study||44||
48199028|NCT00587288|100810264|FG000|NOT COMPLETED|Overall Study||3||
48199029|NCT00587288|100810265|FG001|NOT COMPLETED|Overall Study||9||
48199030|NCT00614406|100810266|FG000|STARTED|Overall Study||7||
48199031|NCT00614406|100810267|FG001|STARTED|Overall Study||4||
48199032|NCT00614406|100810266|FG000|COMPLETED|Overall Study||7||
48199033|NCT00614406|100810267|FG001|COMPLETED|Overall Study||4||
48199034|NCT00614406|100810266|FG000|NOT COMPLETED|Overall Study||0||
48199035|NCT00614406|100810267|FG001|NOT COMPLETED|Overall Study||0||
48199036|NCT04490148|100810268|FG000|STARTED|Overall Study||12||
48199037|NCT04490148|100810269|FG001|STARTED|Overall Study||17||
48199038|NCT04490148|100810268|FG000|COMPLETED|Overall Study||11||
48199039|NCT04490148|100810269|FG001|COMPLETED|Overall Study||12||
48199040|NCT04490148|100810268|FG000|NOT COMPLETED|Overall Study||1||
48199041|NCT04490148|100810269|FG001|NOT COMPLETED|Overall Study||5||
48199042|NCT02357784|100810270|FG000|STARTED|Overall Study||1||
48199043|NCT02357784|100810270|FG000|COMPLETED|Overall Study||0||
48199044|NCT02357784|100810270|FG000|NOT COMPLETED|Overall Study||1||
48199045|NCT02930343|100810271|FG000|STARTED|Overall Study||68||
48199046|NCT02930343|100810272|FG001|STARTED|Overall Study||68||
48199047|NCT02930343|100810271|FG000|COMPLETED|Overall Study||59||
48199048|NCT02930343|100810272|FG001|COMPLETED|Overall Study||61||
48199049|NCT02930343|100810271|FG000|NOT COMPLETED|Overall Study||9||
48199050|NCT02930343|100810272|FG001|NOT COMPLETED|Overall Study||7||
48199051|NCT02837237|100810273|FG000|STARTED|Overall Study||11||
48199052|NCT02837237|100810273|FG000|COMPLETED|Overall Study||11||
48199053|NCT02837237|100810273|FG000|NOT COMPLETED|Overall Study||0||
48199054|NCT01975467|100810274|FG000|STARTED|Overall Study||0||
48199055|NCT01975467|100810275|FG001|STARTED|Overall Study||0||
48199056|NCT01975467|100810274|FG000|COMPLETED|Overall Study||0||
48199057|NCT01975467|100810275|FG001|COMPLETED|Overall Study||0||
48199058|NCT01975467|100810274|FG000|NOT COMPLETED|Overall Study||0||
48199059|NCT01975467|100810275|FG001|NOT COMPLETED|Overall Study||0||
48199060|NCT00927823|100810276|FG000|STARTED|Lead-In Period||3||
48199061|NCT00927823|100810277|FG001|STARTED|Lead-In Period||3||
48199062|NCT00927823|100810278|FG002|STARTED|Lead-In Period||26||
48199063|NCT00927823|100810279|FG003|STARTED|Lead-In Period||5||
48199064|NCT00927823|100810276|FG000|COMPLETED|Lead-In Period||3||
48199065|NCT00927823|100810277|FG001|COMPLETED|Lead-In Period||3||
48199066|NCT00927823|100810278|FG002|COMPLETED|Lead-In Period||26||
48199067|NCT00927823|100810279|FG003|COMPLETED|Lead-In Period||5||
48199068|NCT00927823|100810276|FG000|NOT COMPLETED|Lead-In Period||0||
48199069|NCT00927823|100810277|FG001|NOT COMPLETED|Lead-In Period||0||
48199070|NCT00927823|100810278|FG002|NOT COMPLETED|Lead-In Period||0||
48199071|NCT00927823|100810279|FG003|NOT COMPLETED|Lead-In Period||0||
48199072|NCT00927823|100810276|FG000|STARTED|Continuous Dosing Period||3||
48199073|NCT00927823|100810277|FG001|STARTED|Continuous Dosing Period||3||
48199074|NCT00927823|100810278|FG002|STARTED|Continuous Dosing Period||26||
48199075|NCT00927823|100810279|FG003|STARTED|Continuous Dosing Period||5||
48199076|NCT00927823|100810276|FG000|Treated|Continuous Dosing Period||3||
48199077|NCT00927823|100810277|FG001|Treated|Continuous Dosing Period||3||
48199078|NCT00927823|100810278|FG002|Treated|Continuous Dosing Period||23||
48199079|NCT00927823|100810279|FG003|Treated|Continuous Dosing Period||5||
48199080|NCT00927823|100810276|FG000|COMPLETED|Continuous Dosing Period||0||
48199081|NCT00927823|100810277|FG001|COMPLETED|Continuous Dosing Period||0||
48199082|NCT00927823|100810278|FG002|COMPLETED|Continuous Dosing Period||0||
48199083|NCT00927823|100810279|FG003|COMPLETED|Continuous Dosing Period||0||
48199084|NCT00927823|100810276|FG000|NOT COMPLETED|Continuous Dosing Period||3||
48199085|NCT00927823|100810277|FG001|NOT COMPLETED|Continuous Dosing Period||3||
48199086|NCT00927823|100810278|FG002|NOT COMPLETED|Continuous Dosing Period||26||
48487405|NCT00908128|101529180|FG000|COMPLETED|Period 1||20||
48487406|NCT00908128|101529181|FG001|COMPLETED|Period 1||20||
48487407|NCT00908128|101529180|FG000|NOT COMPLETED|Period 1||0||
48487408|NCT00908128|101529181|FG001|NOT COMPLETED|Period 1||0||
48487409|NCT00908128|101529180|FG000|STARTED|Period 2||20||
48487410|NCT00908128|101529181|FG001|STARTED|Period 2||20||
48487411|NCT00908128|101529180|FG000|COMPLETED|Period 2||20||
48487412|NCT00908128|101529181|FG001|COMPLETED|Period 2||20||
48487413|NCT00908128|101529180|FG000|NOT COMPLETED|Period 2||0||
48487414|NCT00908128|101529181|FG001|NOT COMPLETED|Period 2||0||
48487415|NCT00908128|101529180|FG000|STARTED|Period 3||20||
48487416|NCT00908128|101529181|FG001|STARTED|Period 3||20||
48487417|NCT00908128|101529180|FG000|COMPLETED|Period 3||20||
48487418|NCT00908128|101529181|FG001|COMPLETED|Period 3||20||
48487419|NCT00908128|101529180|FG000|NOT COMPLETED|Period 3||0||
48487420|NCT00908128|101529181|FG001|NOT COMPLETED|Period 3||0||
48487421|NCT00908128|101529180|FG000|STARTED|Period 4||20||
48487422|NCT00908128|101529181|FG001|STARTED|Period 4||19||
48487423|NCT00908128|101529180|FG000|COMPLETED|Period 4||20||
48487424|NCT00908128|101529181|FG001|COMPLETED|Period 4||19||
48487425|NCT00908128|101529180|FG000|NOT COMPLETED|Period 4||0||
48487426|NCT00908128|101529181|FG001|NOT COMPLETED|Period 4||0||
48487427|NCT00958334|101529182|FG000|STARTED|Overall Study||22||
48487428|NCT00958334|101529183|FG001|STARTED|Overall Study||22||
48487429|NCT00958334|101529184|FG002|STARTED|Overall Study||21||
48487430|NCT00958334|101529182|FG000|COMPLETED|Overall Study||8||
48487431|NCT00958334|101529183|FG001|COMPLETED|Overall Study||5||
48487432|NCT00958334|101529184|FG002|COMPLETED|Overall Study||8||
48487433|NCT00958334|101529182|FG000|NOT COMPLETED|Overall Study||14||
48487434|NCT00958334|101529183|FG001|NOT COMPLETED|Overall Study||17||
48487435|NCT00958334|101529184|FG002|NOT COMPLETED|Overall Study||13||
48487436|NCT05093205|101529185|FG000|STARTED|Part A Period 1 - Treatment||18||
48487437|NCT05093205|101529186|FG001|STARTED|Part A Period 1 - Treatment||0||
48487438|NCT05093205|101529187|FG002|STARTED|Part A Period 1 - Treatment||0||
48487439|NCT05093205|101529188|FG003|STARTED|Part A Period 1 - Treatment||0||
48487440|NCT05093205|101529189|FG004|STARTED|Part A Period 1 - Treatment||0||
48487441|NCT05093205|101529190|FG005|STARTED|Part A Period 1 - Treatment||0||
48487442|NCT05093205|101529191|FG006|STARTED|Part A Period 1 - Treatment||0||
48487443|NCT05093205|101529192|FG007|STARTED|Part A Period 1 - Treatment||0||
48487444|NCT05093205|101529193|FG008|STARTED|Part A Period 1 - Treatment||0||
48487445|NCT05093205|101529194|FG009|STARTED|Part A Period 1 - Treatment||0||
48487446|NCT05093205|101529195|FG010|STARTED|Part A Period 1 - Treatment||0||
48487447|NCT05093205|101529196|FG011|STARTED|Part A Period 1 - Treatment||0||
48487448|NCT05093205|101529197|FG012|STARTED|Part A Period 1 - Treatment||0||
48487449|NCT05093205|101529185|FG000|COMPLETED|Part A Period 1 - Treatment||18||
48487450|NCT05093205|101529186|FG001|COMPLETED|Part A Period 1 - Treatment||0||
48487451|NCT05093205|101529187|FG002|COMPLETED|Part A Period 1 - Treatment||0||
48487452|NCT05093205|101529188|FG003|COMPLETED|Part A Period 1 - Treatment||0||
48487453|NCT05093205|101529189|FG004|COMPLETED|Part A Period 1 - Treatment||0||
48487454|NCT05093205|101529190|FG005|COMPLETED|Part A Period 1 - Treatment||0||
48487455|NCT05093205|101529191|FG006|COMPLETED|Part A Period 1 - Treatment||0||
48487456|NCT05093205|101529192|FG007|COMPLETED|Part A Period 1 - Treatment||0||
48487457|NCT05093205|101529193|FG008|COMPLETED|Part A Period 1 - Treatment||0||
48487458|NCT05093205|101529194|FG009|COMPLETED|Part A Period 1 - Treatment||0||
48487459|NCT05093205|101529195|FG010|COMPLETED|Part A Period 1 - Treatment||0||
48487460|NCT05093205|101529196|FG011|COMPLETED|Part A Period 1 - Treatment||0||
48487461|NCT05093205|101529197|FG012|COMPLETED|Part A Period 1 - Treatment||0||
48487462|NCT05093205|101529185|FG000|NOT COMPLETED|Part A Period 1 - Treatment||0||
48487463|NCT05093205|101529186|FG001|NOT COMPLETED|Part A Period 1 - Treatment||0||
48487464|NCT05093205|101529187|FG002|NOT COMPLETED|Part A Period 1 - Treatment||0||
48487465|NCT05093205|101529188|FG003|NOT COMPLETED|Part A Period 1 - Treatment||0||
48487466|NCT05093205|101529189|FG004|NOT COMPLETED|Part A Period 1 - Treatment||0||
48487467|NCT05093205|101529190|FG005|NOT COMPLETED|Part A Period 1 - Treatment||0||
48487468|NCT05093205|101529191|FG006|NOT COMPLETED|Part A Period 1 - Treatment||0||
48487469|NCT05093205|101529192|FG007|NOT COMPLETED|Part A Period 1 - Treatment||0||
48487470|NCT05093205|101529193|FG008|NOT COMPLETED|Part A Period 1 - Treatment||0||
48487471|NCT05093205|101529194|FG009|NOT COMPLETED|Part A Period 1 - Treatment||0||
48487472|NCT05093205|101529195|FG010|NOT COMPLETED|Part A Period 1 - Treatment||0||
48487473|NCT05093205|101529196|FG011|NOT COMPLETED|Part A Period 1 - Treatment||0||
48487474|NCT05093205|101529197|FG012|NOT COMPLETED|Part A Period 1 - Treatment||0||
48487475|NCT05093205|101529185|FG000|STARTED|Part A Period 1 - Follow-Up||15||
48487476|NCT05093205|101529186|FG001|STARTED|Part A Period 1 - Follow-Up||0||
48487477|NCT05093205|101529187|FG002|STARTED|Part A Period 1 - Follow-Up||0||
48487478|NCT05093205|101529188|FG003|STARTED|Part A Period 1 - Follow-Up||0||
48487479|NCT05093205|101529189|FG004|STARTED|Part A Period 1 - Follow-Up||0||
48487480|NCT05093205|101529190|FG005|STARTED|Part A Period 1 - Follow-Up||0||
48487481|NCT05093205|101529191|FG006|STARTED|Part A Period 1 - Follow-Up||0||
48487482|NCT05093205|101529192|FG007|STARTED|Part A Period 1 - Follow-Up||0||
48487483|NCT05093205|101529193|FG008|STARTED|Part A Period 1 - Follow-Up||0||
48487484|NCT05093205|101529194|FG009|STARTED|Part A Period 1 - Follow-Up||0||
48487485|NCT05093205|101529195|FG010|STARTED|Part A Period 1 - Follow-Up||0||
48487486|NCT05093205|101529196|FG011|STARTED|Part A Period 1 - Follow-Up||0||
48487487|NCT05093205|101529197|FG012|STARTED|Part A Period 1 - Follow-Up||0||
48487488|NCT05093205|101529185|FG000|COMPLETED|Part A Period 1 - Follow-Up||15||
48487489|NCT05093205|101529186|FG001|COMPLETED|Part A Period 1 - Follow-Up||0||
48487490|NCT05093205|101529187|FG002|COMPLETED|Part A Period 1 - Follow-Up||0||
48487491|NCT05093205|101529188|FG003|COMPLETED|Part A Period 1 - Follow-Up||0||
48487492|NCT05093205|101529189|FG004|COMPLETED|Part A Period 1 - Follow-Up||0||
48487493|NCT05093205|101529190|FG005|COMPLETED|Part A Period 1 - Follow-Up||0||
48487494|NCT05093205|101529191|FG006|COMPLETED|Part A Period 1 - Follow-Up||0||
48487495|NCT05093205|101529192|FG007|COMPLETED|Part A Period 1 - Follow-Up||0||
48487496|NCT05093205|101529193|FG008|COMPLETED|Part A Period 1 - Follow-Up||0||
48487497|NCT05093205|101529194|FG009|COMPLETED|Part A Period 1 - Follow-Up||0||
48487498|NCT05093205|101529195|FG010|COMPLETED|Part A Period 1 - Follow-Up||0||
48487499|NCT05093205|101529196|FG011|COMPLETED|Part A Period 1 - Follow-Up||0||
48487500|NCT05093205|101529197|FG012|COMPLETED|Part A Period 1 - Follow-Up||0||
48487501|NCT05093205|101529185|FG000|NOT COMPLETED|Part A Period 1 - Follow-Up||0||
48487502|NCT05093205|101529186|FG001|NOT COMPLETED|Part A Period 1 - Follow-Up||0||
48487503|NCT05093205|101529187|FG002|NOT COMPLETED|Part A Period 1 - Follow-Up||0||
48487504|NCT05093205|101529188|FG003|NOT COMPLETED|Part A Period 1 - Follow-Up||0||
48487505|NCT05093205|101529189|FG004|NOT COMPLETED|Part A Period 1 - Follow-Up||0||
48487506|NCT05093205|101529190|FG005|NOT COMPLETED|Part A Period 1 - Follow-Up||0||
48487507|NCT05093205|101529191|FG006|NOT COMPLETED|Part A Period 1 - Follow-Up||0||
48487508|NCT05093205|101529192|FG007|NOT COMPLETED|Part A Period 1 - Follow-Up||0||
48487509|NCT05093205|101529193|FG008|NOT COMPLETED|Part A Period 1 - Follow-Up||0||
48487510|NCT05093205|101529194|FG009|NOT COMPLETED|Part A Period 1 - Follow-Up||0||
48487511|NCT05093205|101529195|FG010|NOT COMPLETED|Part A Period 1 - Follow-Up||0||
48487512|NCT05093205|101529196|FG011|NOT COMPLETED|Part A Period 1 - Follow-Up||0||
48487513|NCT05093205|101529197|FG012|NOT COMPLETED|Part A Period 1 - Follow-Up||0||
48487514|NCT05093205|101529185|FG000|STARTED|Part A Period 2 - Treatment||0||
48487515|NCT05093205|101529186|FG001|STARTED|Part A Period 2 - Treatment||18||
48487516|NCT05093205|101529187|FG002|STARTED|Part A Period 2 - Treatment||0||
48487517|NCT05093205|101529188|FG003|STARTED|Part A Period 2 - Treatment||0||
48487518|NCT05093205|101529189|FG004|STARTED|Part A Period 2 - Treatment||0||
48199087|NCT00927823|100810279|FG003|NOT COMPLETED|Continuous Dosing Period||5||
48199088|NCT02246621|100810280|FG000|STARTED|Overall Study||328||
48487519|NCT05093205|101529190|FG005|STARTED|Part A Period 2 - Treatment||0||
48487520|NCT05093205|101529191|FG006|STARTED|Part A Period 2 - Treatment||0||
48487521|NCT05093205|101529192|FG007|STARTED|Part A Period 2 - Treatment||0||
48487522|NCT05093205|101529193|FG008|STARTED|Part A Period 2 - Treatment||0||
48487523|NCT05093205|101529194|FG009|STARTED|Part A Period 2 - Treatment||0||
48487524|NCT05093205|101529195|FG010|STARTED|Part A Period 2 - Treatment||0||
48487525|NCT05093205|101529196|FG011|STARTED|Part A Period 2 - Treatment||0||
48487526|NCT05093205|101529197|FG012|STARTED|Part A Period 2 - Treatment||0||
48487527|NCT05093205|101529185|FG000|COMPLETED|Part A Period 2 - Treatment||0||
48487528|NCT05093205|101529186|FG001|COMPLETED|Part A Period 2 - Treatment||17||
48487529|NCT05093205|101529187|FG002|COMPLETED|Part A Period 2 - Treatment||0||
48487530|NCT05093205|101529188|FG003|COMPLETED|Part A Period 2 - Treatment||0||
48487531|NCT05093205|101529189|FG004|COMPLETED|Part A Period 2 - Treatment||0||
48487532|NCT05093205|101529190|FG005|COMPLETED|Part A Period 2 - Treatment||0||
48487533|NCT05093205|101529191|FG006|COMPLETED|Part A Period 2 - Treatment||0||
48487534|NCT05093205|101529192|FG007|COMPLETED|Part A Period 2 - Treatment||0||
48487535|NCT05093205|101529193|FG008|COMPLETED|Part A Period 2 - Treatment||0||
48487536|NCT05093205|101529194|FG009|COMPLETED|Part A Period 2 - Treatment||0||
48487537|NCT05093205|101529195|FG010|COMPLETED|Part A Period 2 - Treatment||0||
48487538|NCT05093205|101529196|FG011|COMPLETED|Part A Period 2 - Treatment||0||
48487539|NCT05093205|101529197|FG012|COMPLETED|Part A Period 2 - Treatment||0||
48487540|NCT05093205|101529185|FG000|NOT COMPLETED|Part A Period 2 - Treatment||0||
48487541|NCT05093205|101529186|FG001|NOT COMPLETED|Part A Period 2 - Treatment||1||
48487542|NCT05093205|101529187|FG002|NOT COMPLETED|Part A Period 2 - Treatment||0||
48487543|NCT05093205|101529188|FG003|NOT COMPLETED|Part A Period 2 - Treatment||0||
48487544|NCT05093205|101529189|FG004|NOT COMPLETED|Part A Period 2 - Treatment||0||
48487545|NCT05093205|101529190|FG005|NOT COMPLETED|Part A Period 2 - Treatment||0||
48199089|NCT02246621|100810281|FG001|STARTED|Overall Study||165||
48487546|NCT05093205|101529191|FG006|NOT COMPLETED|Part A Period 2 - Treatment||0||
48487547|NCT05093205|101529192|FG007|NOT COMPLETED|Part A Period 2 - Treatment||0||
48199090|NCT02246621|100810280|FG000|Received At Least One Dose of Study Drug|Overall Study||327||
48487548|NCT05093205|101529193|FG008|NOT COMPLETED|Part A Period 2 - Treatment||0||
48487549|NCT05093205|101529194|FG009|NOT COMPLETED|Part A Period 2 - Treatment||0||
48487550|NCT05093205|101529195|FG010|NOT COMPLETED|Part A Period 2 - Treatment||0||
48487551|NCT05093205|101529196|FG011|NOT COMPLETED|Part A Period 2 - Treatment||0||
48487552|NCT05093205|101529197|FG012|NOT COMPLETED|Part A Period 2 - Treatment||0||
48487553|NCT05093205|101529185|FG000|STARTED|Part A Period 2 - Follow-Up||0||
48487554|NCT05093205|101529186|FG001|STARTED|Part A Period 2 - Follow-Up||15||
48487555|NCT05093205|101529187|FG002|STARTED|Part A Period 2 - Follow-Up||0||
48487556|NCT05093205|101529188|FG003|STARTED|Part A Period 2 - Follow-Up||0||
48487557|NCT05093205|101529189|FG004|STARTED|Part A Period 2 - Follow-Up||0||
48487558|NCT05093205|101529190|FG005|STARTED|Part A Period 2 - Follow-Up||0||
48487559|NCT05093205|101529191|FG006|STARTED|Part A Period 2 - Follow-Up||0||
48487560|NCT05093205|101529192|FG007|STARTED|Part A Period 2 - Follow-Up||0||
48487561|NCT05093205|101529193|FG008|STARTED|Part A Period 2 - Follow-Up||0||
48199091|NCT02246621|100810281|FG001|Received At Least One Dose of Study Drug|Overall Study||161||
48199092|NCT02246621|100810280|FG000|COMPLETED|Overall Study||63||
48199093|NCT02246621|100810281|FG001|COMPLETED|Overall Study||30||
48199094|NCT02246621|100810280|FG000|NOT COMPLETED|Overall Study||265||
48199095|NCT02246621|100810281|FG001|NOT COMPLETED|Overall Study||135||
48199096|NCT04148937|100810282|FG000|STARTED|Overall Study||4||
48199097|NCT04148937|100810283|FG001|STARTED|Overall Study||6||
48199098|NCT04148937|100810284|FG002|STARTED|Overall Study||6||
48199099|NCT04148937|100810285|FG003|STARTED|Overall Study||4||
48199100|NCT04148937|100810286|FG004|STARTED|Overall Study||3||
48199101|NCT04148937|100810287|FG005|STARTED|Overall Study||11||
48199102|NCT04148937|100810288|FG006|STARTED|Overall Study||1||
48199103|NCT04148937|100810289|FG007|STARTED|Overall Study||17||
48199104|NCT04148937|100810282|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4||
48199105|NCT04148937|100810283|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
48199106|NCT04148937|100810284|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
48199107|NCT04148937|100810285|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4||
48199108|NCT04148937|100810286|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3||
48199109|NCT04148937|100810287|FG005|Received at Least 1 Dose of Study Drug|Overall Study||11||
48199110|NCT04148937|100810288|FG006|Received at Least 1 Dose of Study Drug|Overall Study||1||
48199111|NCT04148937|100810289|FG007|Received at Least 1 Dose of Study Drug|Overall Study||17||
48199112|NCT04148937|100810282|FG000|COMPLETED|Overall Study||4|Completers include participants who were observed until event (progressive disease or death) or had discontinued study treatment and was in follow up at the time of the final analysis.|
48199113|NCT04148937|100810283|FG001|COMPLETED|Overall Study||6|Completers include participants who were observed until event (progressive disease or death) or had discontinued study treatment and was in follow up at the time of the final analysis.|
48199114|NCT04148937|100810284|FG002|COMPLETED|Overall Study||5|Completers include participants who were observed until event (progressive disease or death) or had discontinued study treatment and was in follow up at the time of the final analysis.|
48199115|NCT04148937|100810285|FG003|COMPLETED|Overall Study||3|Completers include participants who were observed until event (progressive disease or death) or had discontinued study treatment and was in follow up at the time of the final analysis.|
48199116|NCT04148937|100810286|FG004|COMPLETED|Overall Study||3|Completers include participants who were observed until event (progressive disease or death) or had discontinued study treatment and was in follow up at the time of the final analysis.|
48199117|NCT04148937|100810287|FG005|COMPLETED|Overall Study||8|Completers include participants who were observed until event (progressive disease or death) or had discontinued study treatment and was in follow up at the time of the final analysis.|
48199118|NCT04148937|100810288|FG006|COMPLETED|Overall Study||0|Completers include participants who were observed until event (progressive disease or death) or had discontinued study treatment and was in follow up at the time of the final analysis.|
48199119|NCT04148937|100810289|FG007|COMPLETED|Overall Study||17|Completers include participants who were observed until event (progressive disease or death) or had discontinued study treatment and was in follow up at the time of the final analysis.|
48199120|NCT04148937|100810282|FG000|NOT COMPLETED|Overall Study||0||
48199121|NCT04148937|100810283|FG001|NOT COMPLETED|Overall Study||0||
48199122|NCT04148937|100810284|FG002|NOT COMPLETED|Overall Study||1||
48199123|NCT04148937|100810285|FG003|NOT COMPLETED|Overall Study||1||
48199124|NCT04148937|100810286|FG004|NOT COMPLETED|Overall Study||0||
48487562|NCT05093205|101529194|FG009|STARTED|Part A Period 2 - Follow-Up||0||
48487563|NCT05093205|101529195|FG010|STARTED|Part A Period 2 - Follow-Up||0||
48487564|NCT05093205|101529196|FG011|STARTED|Part A Period 2 - Follow-Up||0||
48487565|NCT05093205|101529197|FG012|STARTED|Part A Period 2 - Follow-Up||0||
48487566|NCT05093205|101529185|FG000|COMPLETED|Part A Period 2 - Follow-Up||0||
48487567|NCT05093205|101529186|FG001|COMPLETED|Part A Period 2 - Follow-Up||15||
48487568|NCT05093205|101529187|FG002|COMPLETED|Part A Period 2 - Follow-Up||0||
48487569|NCT05093205|101529188|FG003|COMPLETED|Part A Period 2 - Follow-Up||0||
48487570|NCT05093205|101529189|FG004|COMPLETED|Part A Period 2 - Follow-Up||0||
48487571|NCT05093205|101529190|FG005|COMPLETED|Part A Period 2 - Follow-Up||0||
48487572|NCT05093205|101529191|FG006|COMPLETED|Part A Period 2 - Follow-Up||0||
48487573|NCT05093205|101529192|FG007|COMPLETED|Part A Period 2 - Follow-Up||0||
48487574|NCT05093205|101529193|FG008|COMPLETED|Part A Period 2 - Follow-Up||0||
48487575|NCT05093205|101529194|FG009|COMPLETED|Part A Period 2 - Follow-Up||0||
48487576|NCT05093205|101529195|FG010|COMPLETED|Part A Period 2 - Follow-Up||0||
48487577|NCT05093205|101529196|FG011|COMPLETED|Part A Period 2 - Follow-Up||0||
48487578|NCT05093205|101529197|FG012|COMPLETED|Part A Period 2 - Follow-Up||0||
48487579|NCT05093205|101529185|FG000|NOT COMPLETED|Part A Period 2 - Follow-Up||0||
48487580|NCT05093205|101529186|FG001|NOT COMPLETED|Part A Period 2 - Follow-Up||0||
48487581|NCT05093205|101529187|FG002|NOT COMPLETED|Part A Period 2 - Follow-Up||0||
48487582|NCT05093205|101529188|FG003|NOT COMPLETED|Part A Period 2 - Follow-Up||0||
48487583|NCT05093205|101529189|FG004|NOT COMPLETED|Part A Period 2 - Follow-Up||0||
48487584|NCT05093205|101529190|FG005|NOT COMPLETED|Part A Period 2 - Follow-Up||0||
48487585|NCT05093205|101529191|FG006|NOT COMPLETED|Part A Period 2 - Follow-Up||0||
48487586|NCT05093205|101529192|FG007|NOT COMPLETED|Part A Period 2 - Follow-Up||0||
48487587|NCT05093205|101529193|FG008|NOT COMPLETED|Part A Period 2 - Follow-Up||0||
48487588|NCT05093205|101529194|FG009|NOT COMPLETED|Part A Period 2 - Follow-Up||0||
48487589|NCT05093205|101529195|FG010|NOT COMPLETED|Part A Period 2 - Follow-Up||0||
48487590|NCT05093205|101529196|FG011|NOT COMPLETED|Part A Period 2 - Follow-Up||0||
48487591|NCT05093205|101529197|FG012|NOT COMPLETED|Part A Period 2 - Follow-Up||0||
48487592|NCT05093205|101529185|FG000|STARTED|Part A Period 3 - Treatment||0||
48487593|NCT05093205|101529186|FG001|STARTED|Part A Period 3 - Treatment||0||
48487594|NCT05093205|101529187|FG002|STARTED|Part A Period 3 - Treatment||17||
48487595|NCT05093205|101529188|FG003|STARTED|Part A Period 3 - Treatment||0||
48666586|NCT01467557|101967618|FG000|NOT COMPLETED|Overall Study||99||
48199125|NCT04148937|100810287|FG005|NOT COMPLETED|Overall Study||3||
48199126|NCT04148937|100810288|FG006|NOT COMPLETED|Overall Study||1||
48199127|NCT04148937|100810289|FG007|NOT COMPLETED|Overall Study||0||
48199128|NCT02784704|100810290|FG000|STARTED|Overall Study||250||
48199129|NCT02784704|100810291|FG001|STARTED|Overall Study||250||
48199130|NCT02784704|100810290|FG000|Treated|Overall Study||250||
48199131|NCT02784704|100810291|FG001|Treated|Overall Study||249||
48199132|NCT02784704|100810290|FG000|COMPLETED|Overall Study||237||
48199133|NCT02784704|100810291|FG001|COMPLETED|Overall Study||241||
48199134|NCT02784704|100810290|FG000|NOT COMPLETED|Overall Study||13||
48199135|NCT02784704|100810291|FG001|NOT COMPLETED|Overall Study||9||
48199136|NCT02155829|100810292|FG000|STARTED|Overall Study||37||
48199137|NCT02155829|100810293|FG001|STARTED|Overall Study||38||
48199138|NCT02155829|100810292|FG000|COMPLETED|Overall Study||31||
48199139|NCT02155829|100810293|FG001|COMPLETED|Overall Study||35||
48487596|NCT05093205|101529189|FG004|STARTED|Part A Period 3 - Treatment||0||
48487597|NCT05093205|101529190|FG005|STARTED|Part A Period 3 - Treatment||0||
48487598|NCT05093205|101529191|FG006|STARTED|Part A Period 3 - Treatment||0||
48487599|NCT05093205|101529192|FG007|STARTED|Part A Period 3 - Treatment||0||
48487600|NCT05093205|101529193|FG008|STARTED|Part A Period 3 - Treatment||0||
48487601|NCT05093205|101529194|FG009|STARTED|Part A Period 3 - Treatment||0||
48199140|NCT02155829|100810292|FG000|NOT COMPLETED|Overall Study||6||
48199141|NCT02155829|100810293|FG001|NOT COMPLETED|Overall Study||3||
48199142|NCT01673113|100810294|FG000|STARTED|Overall Study||11||11
48199143|NCT01673113|100810295|FG001|STARTED|Overall Study||11||11
48199144|NCT01673113|100810294|FG000|COMPLETED|Overall Study||11||11
48199145|NCT01673113|100810295|FG001|COMPLETED|Overall Study||11||11
48199146|NCT01673113|100810294|FG000|NOT COMPLETED|Overall Study||0||0
48199147|NCT01673113|100810295|FG001|NOT COMPLETED|Overall Study||0||0
48199148|NCT01559506|100810296|FG000|STARTED|Overall Study||20||
48199149|NCT01559506|100810297|FG001|STARTED|Overall Study||21||
48199150|NCT01559506|100810296|FG000|COMPLETED|Overall Study||20||
48199151|NCT01559506|100810297|FG001|COMPLETED|Overall Study||18||
48199152|NCT01559506|100810296|FG000|NOT COMPLETED|Overall Study||0||
48199153|NCT01559506|100810297|FG001|NOT COMPLETED|Overall Study||3||
48199154|NCT00094809|100810298|FG000|STARTED|Overall Study||126||
48199155|NCT00094809|100810299|FG001|STARTED|Overall Study||126||
48199156|NCT00094809|100810298|FG000|Received Study Drug|Overall Study||124||
48199157|NCT00094809|100810299|FG001|Received Study Drug|Overall Study||118||
48487602|NCT05093205|101529195|FG010|STARTED|Part A Period 3 - Treatment||0||
48487603|NCT05093205|101529196|FG011|STARTED|Part A Period 3 - Treatment||0||
48487604|NCT05093205|101529197|FG012|STARTED|Part A Period 3 - Treatment||0||
48487605|NCT05093205|101529185|FG000|COMPLETED|Part A Period 3 - Treatment||0||
48487606|NCT05093205|101529186|FG001|COMPLETED|Part A Period 3 - Treatment||0||
48487607|NCT05093205|101529187|FG002|COMPLETED|Part A Period 3 - Treatment||13||
48487608|NCT05093205|101529188|FG003|COMPLETED|Part A Period 3 - Treatment||0||
48666587|NCT01467557|101967619|FG001|NOT COMPLETED|Overall Study||107||
48199158|NCT00094809|100810298|FG000|Properly Consented; Received Study Drug|Overall Study||123||
48199159|NCT00094809|100810299|FG001|Properly Consented; Received Study Drug|Overall Study||118||
48199160|NCT00094809|100810298|FG000|Completed All 4 Cycles of Treatment|Overall Study||98||
48199161|NCT00094809|100810299|FG001|Completed All 4 Cycles of Treatment|Overall Study||90||
48199162|NCT00094809|100810298|FG000|COMPLETED|Overall Study||74||
48199163|NCT00094809|100810299|FG001|COMPLETED|Overall Study||61||
48199164|NCT00094809|100810298|FG000|NOT COMPLETED|Overall Study||52||
48199165|NCT00094809|100810299|FG001|NOT COMPLETED|Overall Study||65||
48199166|NCT03121950|100810300|FG000|STARTED|Overall Study||17||
48199167|NCT03121950|100810301|FG001|STARTED|Overall Study||3||
48199168|NCT03121950|100810300|FG000|COMPLETED|Overall Study||6||
48199169|NCT03121950|100810301|FG001|COMPLETED|Overall Study||1||
48199170|NCT03121950|100810300|FG000|NOT COMPLETED|Overall Study||11||
48199171|NCT03121950|100810301|FG001|NOT COMPLETED|Overall Study||2||
48199172|NCT01076335|100810302|FG000|STARTED|Overall Study||40||
48199173|NCT01076335|100810302|FG000|COMPLETED|Overall Study||36||
48199174|NCT01076335|100810302|FG000|NOT COMPLETED|Overall Study||4||
48199175|NCT03034915|100810303|FG000|STARTED|Overall Study||812||
48199176|NCT03034915|100810304|FG001|STARTED|Overall Study||804||
48199177|NCT03034915|100810305|FG002|STARTED|Overall Study||809||
48199178|NCT03034915|100810303|FG000|COMPLETED|Overall Study||717||
48199179|NCT03034915|100810304|FG001|COMPLETED|Overall Study||650||
48199180|NCT03034915|100810305|FG002|COMPLETED|Overall Study||683||
48199181|NCT03034915|100810303|FG000|NOT COMPLETED|Overall Study||95||
48199182|NCT03034915|100810304|FG001|NOT COMPLETED|Overall Study||154||
48199183|NCT03034915|100810305|FG002|NOT COMPLETED|Overall Study||126||
48199184|NCT00300456|100810306|FG000|STARTED|Overall Study||119||
48199185|NCT00300456|100810307|FG001|STARTED|Overall Study||118||
48199186|NCT00300456|100810308|FG002|STARTED|Overall Study||119||
48199187|NCT00300456|100810309|FG003|STARTED|Overall Study||119||
48199188|NCT00300456|100810310|FG004|STARTED|Overall Study||116||
48199189|NCT00300456|100810311|FG005|STARTED|Overall Study||59||
48199190|NCT00300456|100810306|FG000|COMPLETED|Overall Study||103||
48199191|NCT00300456|100810307|FG001|COMPLETED|Overall Study||102||
48199192|NCT00300456|100810308|FG002|COMPLETED|Overall Study||98||
48199193|NCT00300456|100810309|FG003|COMPLETED|Overall Study||105||
48199194|NCT00300456|100810310|FG004|COMPLETED|Overall Study||99||
48199195|NCT00300456|100810311|FG005|COMPLETED|Overall Study||48||
48199196|NCT00300456|100810306|FG000|NOT COMPLETED|Overall Study||16||
48487609|NCT05093205|101529189|FG004|COMPLETED|Part A Period 3 - Treatment||0||
48487610|NCT05093205|101529190|FG005|COMPLETED|Part A Period 3 - Treatment||0||
48487611|NCT05093205|101529191|FG006|COMPLETED|Part A Period 3 - Treatment||0||
48487612|NCT05093205|101529192|FG007|COMPLETED|Part A Period 3 - Treatment||0||
48487613|NCT05093205|101529193|FG008|COMPLETED|Part A Period 3 - Treatment||0||
48487614|NCT05093205|101529194|FG009|COMPLETED|Part A Period 3 - Treatment||0||
48487615|NCT05093205|101529195|FG010|COMPLETED|Part A Period 3 - Treatment||0||
48487616|NCT05093205|101529196|FG011|COMPLETED|Part A Period 3 - Treatment||0||
48487617|NCT05093205|101529197|FG012|COMPLETED|Part A Period 3 - Treatment||0||
48487618|NCT05093205|101529185|FG000|NOT COMPLETED|Part A Period 3 - Treatment||0||
48487619|NCT05093205|101529186|FG001|NOT COMPLETED|Part A Period 3 - Treatment||0||
48487620|NCT05093205|101529187|FG002|NOT COMPLETED|Part A Period 3 - Treatment||4||
48487621|NCT05093205|101529188|FG003|NOT COMPLETED|Part A Period 3 - Treatment||0||
48199197|NCT00300456|100810307|FG001|NOT COMPLETED|Overall Study||16||
48199198|NCT00300456|100810308|FG002|NOT COMPLETED|Overall Study||21||
48199199|NCT00300456|100810309|FG003|NOT COMPLETED|Overall Study||14||
48199200|NCT00300456|100810310|FG004|NOT COMPLETED|Overall Study||17||
48199201|NCT00300456|100810311|FG005|NOT COMPLETED|Overall Study||11||
48487622|NCT05093205|101529189|FG004|NOT COMPLETED|Part A Period 3 - Treatment||0||
48487623|NCT05093205|101529190|FG005|NOT COMPLETED|Part A Period 3 - Treatment||0||
48487624|NCT05093205|101529191|FG006|NOT COMPLETED|Part A Period 3 - Treatment||0||
48487625|NCT05093205|101529192|FG007|NOT COMPLETED|Part A Period 3 - Treatment||0||
48487626|NCT05093205|101529193|FG008|NOT COMPLETED|Part A Period 3 - Treatment||0||
48199202|NCT04335591|100810312|FG000|STARTED|Overall Study||119||
48199203|NCT04335591|100810313|FG001|STARTED|Overall Study||122||
48199204|NCT04335591|100810314|FG002|STARTED|Overall Study||58||
48487627|NCT05093205|101529194|FG009|NOT COMPLETED|Part A Period 3 - Treatment||0||
48487628|NCT05093205|101529195|FG010|NOT COMPLETED|Part A Period 3 - Treatment||0||
48487629|NCT05093205|101529196|FG011|NOT COMPLETED|Part A Period 3 - Treatment||0||
48487630|NCT05093205|101529197|FG012|NOT COMPLETED|Part A Period 3 - Treatment||0||
48199205|NCT04335591|100810315|FG003|STARTED|Overall Study||57||
48199206|NCT04335591|100810312|FG000|COMPLETED|Overall Study||101||
48487631|NCT05093205|101529185|FG000|STARTED|Part A Period 3 - Follow-Up||0||
48487632|NCT05093205|101529186|FG001|STARTED|Part A Period 3 - Follow-Up||0||
48487633|NCT05093205|101529187|FG002|STARTED|Part A Period 3 - Follow-Up||15||
48487634|NCT05093205|101529188|FG003|STARTED|Part A Period 3 - Follow-Up||0||
48487635|NCT05093205|101529189|FG004|STARTED|Part A Period 3 - Follow-Up||0||
48487636|NCT05093205|101529190|FG005|STARTED|Part A Period 3 - Follow-Up||0||
48487637|NCT05093205|101529191|FG006|STARTED|Part A Period 3 - Follow-Up||0||
48487638|NCT05093205|101529192|FG007|STARTED|Part A Period 3 - Follow-Up||0||
48487639|NCT05093205|101529193|FG008|STARTED|Part A Period 3 - Follow-Up||0||
48487640|NCT05093205|101529194|FG009|STARTED|Part A Period 3 - Follow-Up||0||
48487641|NCT05093205|101529195|FG010|STARTED|Part A Period 3 - Follow-Up||0||
48487642|NCT05093205|101529196|FG011|STARTED|Part A Period 3 - Follow-Up||0||
48487643|NCT05093205|101529197|FG012|STARTED|Part A Period 3 - Follow-Up||0||
48487644|NCT05093205|101529185|FG000|COMPLETED|Part A Period 3 - Follow-Up||0||
48487645|NCT05093205|101529186|FG001|COMPLETED|Part A Period 3 - Follow-Up||0||
48487646|NCT05093205|101529187|FG002|COMPLETED|Part A Period 3 - Follow-Up||15||
48487647|NCT05093205|101529188|FG003|COMPLETED|Part A Period 3 - Follow-Up||0||
48487648|NCT05093205|101529189|FG004|COMPLETED|Part A Period 3 - Follow-Up||0||
48487649|NCT05093205|101529190|FG005|COMPLETED|Part A Period 3 - Follow-Up||0||
48487650|NCT05093205|101529191|FG006|COMPLETED|Part A Period 3 - Follow-Up||0||
48487651|NCT05093205|101529192|FG007|COMPLETED|Part A Period 3 - Follow-Up||0||
48487652|NCT05093205|101529193|FG008|COMPLETED|Part A Period 3 - Follow-Up||0||
48487653|NCT05093205|101529194|FG009|COMPLETED|Part A Period 3 - Follow-Up||0||
48487654|NCT05093205|101529195|FG010|COMPLETED|Part A Period 3 - Follow-Up||0||
48487655|NCT05093205|101529196|FG011|COMPLETED|Part A Period 3 - Follow-Up||0||
48487656|NCT05093205|101529197|FG012|COMPLETED|Part A Period 3 - Follow-Up||0||
48487657|NCT05093205|101529185|FG000|NOT COMPLETED|Part A Period 3 - Follow-Up||0||
48487658|NCT05093205|101529186|FG001|NOT COMPLETED|Part A Period 3 - Follow-Up||0||
48487659|NCT05093205|101529187|FG002|NOT COMPLETED|Part A Period 3 - Follow-Up||0||
48487660|NCT05093205|101529188|FG003|NOT COMPLETED|Part A Period 3 - Follow-Up||0||
48487661|NCT05093205|101529189|FG004|NOT COMPLETED|Part A Period 3 - Follow-Up||0||
48487662|NCT05093205|101529190|FG005|NOT COMPLETED|Part A Period 3 - Follow-Up||0||
48487663|NCT05093205|101529191|FG006|NOT COMPLETED|Part A Period 3 - Follow-Up||0||
48487664|NCT05093205|101529192|FG007|NOT COMPLETED|Part A Period 3 - Follow-Up||0||
48487665|NCT05093205|101529193|FG008|NOT COMPLETED|Part A Period 3 - Follow-Up||0||
48487666|NCT05093205|101529194|FG009|NOT COMPLETED|Part A Period 3 - Follow-Up||0||
48487667|NCT05093205|101529195|FG010|NOT COMPLETED|Part A Period 3 - Follow-Up||0||
48487668|NCT05093205|101529196|FG011|NOT COMPLETED|Part A Period 3 - Follow-Up||0||
48487669|NCT05093205|101529197|FG012|NOT COMPLETED|Part A Period 3 - Follow-Up||0||
48487670|NCT05093205|101529185|FG000|STARTED|Part A Period 4 - Treatment||0||
48487671|NCT05093205|101529186|FG001|STARTED|Part A Period 4 - Treatment||0||
48487672|NCT05093205|101529187|FG002|STARTED|Part A Period 4 - Treatment||0||
48487673|NCT05093205|101529188|FG003|STARTED|Part A Period 4 - Treatment||13||
48487674|NCT05093205|101529189|FG004|STARTED|Part A Period 4 - Treatment||0||
48487675|NCT05093205|101529190|FG005|STARTED|Part A Period 4 - Treatment||0||
48666588|NCT02374255|101967620|FG000|STARTED|Overall Study||155||
48487676|NCT05093205|101529191|FG006|STARTED|Part A Period 4 - Treatment||0||
48487677|NCT05093205|101529192|FG007|STARTED|Part A Period 4 - Treatment||0||
48487678|NCT05093205|101529193|FG008|STARTED|Part A Period 4 - Treatment||0||
48487679|NCT05093205|101529194|FG009|STARTED|Part A Period 4 - Treatment||0||
48487680|NCT05093205|101529195|FG010|STARTED|Part A Period 4 - Treatment||0||
48487681|NCT05093205|101529196|FG011|STARTED|Part A Period 4 - Treatment||0||
48487682|NCT05093205|101529197|FG012|STARTED|Part A Period 4 - Treatment||0||
48487683|NCT05093205|101529185|FG000|COMPLETED|Part A Period 4 - Treatment||0||
48487684|NCT05093205|101529186|FG001|COMPLETED|Part A Period 4 - Treatment||0||
48487685|NCT05093205|101529187|FG002|COMPLETED|Part A Period 4 - Treatment||0||
48487686|NCT05093205|101529188|FG003|COMPLETED|Part A Period 4 - Treatment||13||
48487687|NCT05093205|101529189|FG004|COMPLETED|Part A Period 4 - Treatment||0||
48487688|NCT05093205|101529190|FG005|COMPLETED|Part A Period 4 - Treatment||0||
48487689|NCT05093205|101529191|FG006|COMPLETED|Part A Period 4 - Treatment||0||
48487690|NCT05093205|101529192|FG007|COMPLETED|Part A Period 4 - Treatment||0||
48487691|NCT05093205|101529193|FG008|COMPLETED|Part A Period 4 - Treatment||0||
48487692|NCT05093205|101529194|FG009|COMPLETED|Part A Period 4 - Treatment||0||
48487693|NCT05093205|101529195|FG010|COMPLETED|Part A Period 4 - Treatment||0||
48487694|NCT05093205|101529196|FG011|COMPLETED|Part A Period 4 - Treatment||0||
48487695|NCT05093205|101529197|FG012|COMPLETED|Part A Period 4 - Treatment||0||
48487696|NCT05093205|101529185|FG000|NOT COMPLETED|Part A Period 4 - Treatment||0||
48487697|NCT05093205|101529186|FG001|NOT COMPLETED|Part A Period 4 - Treatment||0||
48487698|NCT05093205|101529187|FG002|NOT COMPLETED|Part A Period 4 - Treatment||0||
48487699|NCT05093205|101529188|FG003|NOT COMPLETED|Part A Period 4 - Treatment||0||
48487700|NCT05093205|101529189|FG004|NOT COMPLETED|Part A Period 4 - Treatment||0||
48487701|NCT05093205|101529190|FG005|NOT COMPLETED|Part A Period 4 - Treatment||0||
48487702|NCT05093205|101529191|FG006|NOT COMPLETED|Part A Period 4 - Treatment||0||
48487703|NCT05093205|101529192|FG007|NOT COMPLETED|Part A Period 4 - Treatment||0||
48487704|NCT05093205|101529193|FG008|NOT COMPLETED|Part A Period 4 - Treatment||0||
48487705|NCT05093205|101529194|FG009|NOT COMPLETED|Part A Period 4 - Treatment||0||
48487706|NCT05093205|101529195|FG010|NOT COMPLETED|Part A Period 4 - Treatment||0||
48487707|NCT05093205|101529196|FG011|NOT COMPLETED|Part A Period 4 - Treatment||0||
48487708|NCT05093205|101529197|FG012|NOT COMPLETED|Part A Period 4 - Treatment||0||
48487709|NCT05093205|101529185|FG000|STARTED|Part A Period 4 - Follow-Up||0||
48487710|NCT05093205|101529186|FG001|STARTED|Part A Period 4 - Follow-Up||0||
48487711|NCT05093205|101529187|FG002|STARTED|Part A Period 4 - Follow-Up||0||
48487712|NCT05093205|101529188|FG003|STARTED|Part A Period 4 - Follow-Up||13||
48487713|NCT05093205|101529189|FG004|STARTED|Part A Period 4 - Follow-Up||0||
48487714|NCT05093205|101529190|FG005|STARTED|Part A Period 4 - Follow-Up||0||
48487715|NCT05093205|101529191|FG006|STARTED|Part A Period 4 - Follow-Up||0||
48487716|NCT05093205|101529192|FG007|STARTED|Part A Period 4 - Follow-Up||0||
48487717|NCT05093205|101529193|FG008|STARTED|Part A Period 4 - Follow-Up||0||
48487718|NCT05093205|101529194|FG009|STARTED|Part A Period 4 - Follow-Up||0||
48487719|NCT05093205|101529195|FG010|STARTED|Part A Period 4 - Follow-Up||0||
48487720|NCT05093205|101529196|FG011|STARTED|Part A Period 4 - Follow-Up||0||
48487721|NCT05093205|101529197|FG012|STARTED|Part A Period 4 - Follow-Up||0||
48487722|NCT05093205|101529185|FG000|COMPLETED|Part A Period 4 - Follow-Up||0||
48199207|NCT04335591|100810313|FG001|COMPLETED|Overall Study||110||
48487723|NCT05093205|101529186|FG001|COMPLETED|Part A Period 4 - Follow-Up||0||
48487724|NCT05093205|101529187|FG002|COMPLETED|Part A Period 4 - Follow-Up||0||
48487725|NCT05093205|101529188|FG003|COMPLETED|Part A Period 4 - Follow-Up||13||
48487726|NCT05093205|101529189|FG004|COMPLETED|Part A Period 4 - Follow-Up||0||
48487727|NCT05093205|101529190|FG005|COMPLETED|Part A Period 4 - Follow-Up||0||
48487728|NCT05093205|101529191|FG006|COMPLETED|Part A Period 4 - Follow-Up||0||
48487729|NCT05093205|101529192|FG007|COMPLETED|Part A Period 4 - Follow-Up||0||
48487730|NCT05093205|101529193|FG008|COMPLETED|Part A Period 4 - Follow-Up||0||
48487731|NCT05093205|101529194|FG009|COMPLETED|Part A Period 4 - Follow-Up||0||
48487732|NCT05093205|101529195|FG010|COMPLETED|Part A Period 4 - Follow-Up||0||
48487733|NCT05093205|101529196|FG011|COMPLETED|Part A Period 4 - Follow-Up||0||
48487734|NCT05093205|101529197|FG012|COMPLETED|Part A Period 4 - Follow-Up||0||
48487735|NCT05093205|101529185|FG000|NOT COMPLETED|Part A Period 4 - Follow-Up||0||
48487736|NCT05093205|101529186|FG001|NOT COMPLETED|Part A Period 4 - Follow-Up||0||
48487737|NCT05093205|101529187|FG002|NOT COMPLETED|Part A Period 4 - Follow-Up||0||
48487738|NCT05093205|101529188|FG003|NOT COMPLETED|Part A Period 4 - Follow-Up||0||
48487739|NCT05093205|101529189|FG004|NOT COMPLETED|Part A Period 4 - Follow-Up||0||
48487740|NCT05093205|101529190|FG005|NOT COMPLETED|Part A Period 4 - Follow-Up||0||
48487741|NCT05093205|101529191|FG006|NOT COMPLETED|Part A Period 4 - Follow-Up||0||
48487742|NCT05093205|101529192|FG007|NOT COMPLETED|Part A Period 4 - Follow-Up||0||
48487743|NCT05093205|101529193|FG008|NOT COMPLETED|Part A Period 4 - Follow-Up||0||
48487744|NCT05093205|101529194|FG009|NOT COMPLETED|Part A Period 4 - Follow-Up||0||
48199208|NCT04335591|100810314|FG002|COMPLETED|Overall Study||49||
48487745|NCT05093205|101529195|FG010|NOT COMPLETED|Part A Period 4 - Follow-Up||0||
48666589|NCT02374255|101967621|FG001|STARTED|Overall Study||110||
48487746|NCT05093205|101529196|FG011|NOT COMPLETED|Part A Period 4 - Follow-Up||0||
48487747|NCT05093205|101529197|FG012|NOT COMPLETED|Part A Period 4 - Follow-Up||0||
48487748|NCT05093205|101529185|FG000|STARTED|Part A Period 5 - Treatment||0||
48487749|NCT05093205|101529186|FG001|STARTED|Part A Period 5 - Treatment||0||
48487750|NCT05093205|101529187|FG002|STARTED|Part A Period 5 - Treatment||0||
48487751|NCT05093205|101529188|FG003|STARTED|Part A Period 5 - Treatment||0||
48487752|NCT05093205|101529189|FG004|STARTED|Part A Period 5 - Treatment||13||
48487753|NCT05093205|101529190|FG005|STARTED|Part A Period 5 - Treatment||0||
48487754|NCT05093205|101529191|FG006|STARTED|Part A Period 5 - Treatment||0||
48487755|NCT05093205|101529192|FG007|STARTED|Part A Period 5 - Treatment||0||
48487756|NCT05093205|101529193|FG008|STARTED|Part A Period 5 - Treatment||0||
48487757|NCT05093205|101529194|FG009|STARTED|Part A Period 5 - Treatment||0||
48487758|NCT05093205|101529195|FG010|STARTED|Part A Period 5 - Treatment||0||
48487759|NCT05093205|101529196|FG011|STARTED|Part A Period 5 - Treatment||0||
48487760|NCT05093205|101529197|FG012|STARTED|Part A Period 5 - Treatment||0||
48487761|NCT05093205|101529185|FG000|COMPLETED|Part A Period 5 - Treatment||0||
48487762|NCT05093205|101529186|FG001|COMPLETED|Part A Period 5 - Treatment||0||
48487763|NCT05093205|101529187|FG002|COMPLETED|Part A Period 5 - Treatment||0||
48487764|NCT05093205|101529188|FG003|COMPLETED|Part A Period 5 - Treatment||0||
48487765|NCT05093205|101529189|FG004|COMPLETED|Part A Period 5 - Treatment||13||
48487766|NCT05093205|101529190|FG005|COMPLETED|Part A Period 5 - Treatment||0||
48487767|NCT05093205|101529191|FG006|COMPLETED|Part A Period 5 - Treatment||0||
48487768|NCT05093205|101529192|FG007|COMPLETED|Part A Period 5 - Treatment||0||
48487769|NCT05093205|101529193|FG008|COMPLETED|Part A Period 5 - Treatment||0||
48487770|NCT05093205|101529194|FG009|COMPLETED|Part A Period 5 - Treatment||0||
48487771|NCT05093205|101529195|FG010|COMPLETED|Part A Period 5 - Treatment||0||
48487772|NCT05093205|101529196|FG011|COMPLETED|Part A Period 5 - Treatment||0||
48487773|NCT05093205|101529197|FG012|COMPLETED|Part A Period 5 - Treatment||0||
48487774|NCT05093205|101529185|FG000|NOT COMPLETED|Part A Period 5 - Treatment||0||
48487775|NCT05093205|101529186|FG001|NOT COMPLETED|Part A Period 5 - Treatment||0||
48487776|NCT05093205|101529187|FG002|NOT COMPLETED|Part A Period 5 - Treatment||0||
48487777|NCT05093205|101529188|FG003|NOT COMPLETED|Part A Period 5 - Treatment||0||
48487778|NCT05093205|101529189|FG004|NOT COMPLETED|Part A Period 5 - Treatment||0||
48487779|NCT05093205|101529190|FG005|NOT COMPLETED|Part A Period 5 - Treatment||0||
48487780|NCT05093205|101529191|FG006|NOT COMPLETED|Part A Period 5 - Treatment||0||
48487781|NCT05093205|101529192|FG007|NOT COMPLETED|Part A Period 5 - Treatment||0||
48487782|NCT05093205|101529193|FG008|NOT COMPLETED|Part A Period 5 - Treatment||0||
48487783|NCT05093205|101529194|FG009|NOT COMPLETED|Part A Period 5 - Treatment||0||
48487784|NCT05093205|101529195|FG010|NOT COMPLETED|Part A Period 5 - Treatment||0||
48487785|NCT05093205|101529196|FG011|NOT COMPLETED|Part A Period 5 - Treatment||0||
48487786|NCT05093205|101529197|FG012|NOT COMPLETED|Part A Period 5 - Treatment||0||
48487787|NCT05093205|101529185|FG000|STARTED|Part A Period 5 - Follow-Up||0||
48487788|NCT05093205|101529186|FG001|STARTED|Part A Period 5 - Follow-Up||0||
48487789|NCT05093205|101529187|FG002|STARTED|Part A Period 5 - Follow-Up||0||
48487790|NCT05093205|101529188|FG003|STARTED|Part A Period 5 - Follow-Up||0||
48487791|NCT05093205|101529189|FG004|STARTED|Part A Period 5 - Follow-Up||13||
48487792|NCT05093205|101529190|FG005|STARTED|Part A Period 5 - Follow-Up||0||
48487793|NCT05093205|101529191|FG006|STARTED|Part A Period 5 - Follow-Up||0||
48487794|NCT05093205|101529192|FG007|STARTED|Part A Period 5 - Follow-Up||0||
48487795|NCT05093205|101529193|FG008|STARTED|Part A Period 5 - Follow-Up||0||
48487796|NCT05093205|101529194|FG009|STARTED|Part A Period 5 - Follow-Up||0||
48487797|NCT05093205|101529195|FG010|STARTED|Part A Period 5 - Follow-Up||0||
48487798|NCT05093205|101529196|FG011|STARTED|Part A Period 5 - Follow-Up||0||
48487799|NCT05093205|101529197|FG012|STARTED|Part A Period 5 - Follow-Up||0||
48487800|NCT05093205|101529185|FG000|COMPLETED|Part A Period 5 - Follow-Up||0||
48487801|NCT05093205|101529186|FG001|COMPLETED|Part A Period 5 - Follow-Up||0||
48487802|NCT05093205|101529187|FG002|COMPLETED|Part A Period 5 - Follow-Up||0||
48487803|NCT05093205|101529188|FG003|COMPLETED|Part A Period 5 - Follow-Up||0||
48487804|NCT05093205|101529189|FG004|COMPLETED|Part A Period 5 - Follow-Up||13||
48487805|NCT05093205|101529190|FG005|COMPLETED|Part A Period 5 - Follow-Up||0||
48487806|NCT05093205|101529191|FG006|COMPLETED|Part A Period 5 - Follow-Up||0||
48487807|NCT05093205|101529192|FG007|COMPLETED|Part A Period 5 - Follow-Up||0||
48487808|NCT05093205|101529193|FG008|COMPLETED|Part A Period 5 - Follow-Up||0||
48487809|NCT05093205|101529194|FG009|COMPLETED|Part A Period 5 - Follow-Up||0||
48487810|NCT05093205|101529195|FG010|COMPLETED|Part A Period 5 - Follow-Up||0||
48487811|NCT05093205|101529196|FG011|COMPLETED|Part A Period 5 - Follow-Up||0||
48487812|NCT05093205|101529197|FG012|COMPLETED|Part A Period 5 - Follow-Up||0||
48487813|NCT05093205|101529185|FG000|NOT COMPLETED|Part A Period 5 - Follow-Up||0||
48487814|NCT05093205|101529186|FG001|NOT COMPLETED|Part A Period 5 - Follow-Up||0||
48487815|NCT05093205|101529187|FG002|NOT COMPLETED|Part A Period 5 - Follow-Up||0||
48487816|NCT05093205|101529188|FG003|NOT COMPLETED|Part A Period 5 - Follow-Up||0||
48487817|NCT05093205|101529189|FG004|NOT COMPLETED|Part A Period 5 - Follow-Up||0||
48487818|NCT05093205|101529190|FG005|NOT COMPLETED|Part A Period 5 - Follow-Up||0||
48487819|NCT05093205|101529191|FG006|NOT COMPLETED|Part A Period 5 - Follow-Up||0||
48487820|NCT05093205|101529192|FG007|NOT COMPLETED|Part A Period 5 - Follow-Up||0||
48487821|NCT05093205|101529193|FG008|NOT COMPLETED|Part A Period 5 - Follow-Up||0||
48487822|NCT05093205|101529194|FG009|NOT COMPLETED|Part A Period 5 - Follow-Up||0||
48487823|NCT05093205|101529195|FG010|NOT COMPLETED|Part A Period 5 - Follow-Up||0||
48487824|NCT05093205|101529196|FG011|NOT COMPLETED|Part A Period 5 - Follow-Up||0||
48487825|NCT05093205|101529197|FG012|NOT COMPLETED|Part A Period 5 - Follow-Up||0||
48487826|NCT05093205|101529185|FG000|STARTED|Part A Period 6 - Treatment||0||
48487827|NCT05093205|101529186|FG001|STARTED|Part A Period 6 - Treatment||0||
48487828|NCT05093205|101529187|FG002|STARTED|Part A Period 6 - Treatment||0||
48487829|NCT05093205|101529188|FG003|STARTED|Part A Period 6 - Treatment||0||
48487830|NCT05093205|101529189|FG004|STARTED|Part A Period 6 - Treatment||0||
48487831|NCT05093205|101529190|FG005|STARTED|Part A Period 6 - Treatment||13||
48487832|NCT05093205|101529191|FG006|STARTED|Part A Period 6 - Treatment||0||
48487833|NCT05093205|101529192|FG007|STARTED|Part A Period 6 - Treatment||0||
48487834|NCT05093205|101529193|FG008|STARTED|Part A Period 6 - Treatment||0||
48487835|NCT05093205|101529194|FG009|STARTED|Part A Period 6 - Treatment||0||
48487836|NCT05093205|101529195|FG010|STARTED|Part A Period 6 - Treatment||0||
48487837|NCT05093205|101529196|FG011|STARTED|Part A Period 6 - Treatment||0||
48487838|NCT05093205|101529197|FG012|STARTED|Part A Period 6 - Treatment||0||
48487839|NCT05093205|101529185|FG000|COMPLETED|Part A Period 6 - Treatment||0||
48487840|NCT05093205|101529186|FG001|COMPLETED|Part A Period 6 - Treatment||0||
48487841|NCT05093205|101529187|FG002|COMPLETED|Part A Period 6 - Treatment||0||
48487842|NCT05093205|101529188|FG003|COMPLETED|Part A Period 6 - Treatment||0||
48487843|NCT05093205|101529189|FG004|COMPLETED|Part A Period 6 - Treatment||0||
48487844|NCT05093205|101529190|FG005|COMPLETED|Part A Period 6 - Treatment||6||
48487845|NCT05093205|101529191|FG006|COMPLETED|Part A Period 6 - Treatment||0||
48487846|NCT05093205|101529192|FG007|COMPLETED|Part A Period 6 - Treatment||0||
48487847|NCT05093205|101529193|FG008|COMPLETED|Part A Period 6 - Treatment||0||
48487848|NCT05093205|101529194|FG009|COMPLETED|Part A Period 6 - Treatment||0||
48487849|NCT05093205|101529195|FG010|COMPLETED|Part A Period 6 - Treatment||0||
48487850|NCT05093205|101529196|FG011|COMPLETED|Part A Period 6 - Treatment||0||
48487851|NCT05093205|101529197|FG012|COMPLETED|Part A Period 6 - Treatment||0||
48487852|NCT05093205|101529185|FG000|NOT COMPLETED|Part A Period 6 - Treatment||0||
48487853|NCT05093205|101529186|FG001|NOT COMPLETED|Part A Period 6 - Treatment||0||
48487854|NCT05093205|101529187|FG002|NOT COMPLETED|Part A Period 6 - Treatment||0||
48487855|NCT05093205|101529188|FG003|NOT COMPLETED|Part A Period 6 - Treatment||0||
48487856|NCT05093205|101529189|FG004|NOT COMPLETED|Part A Period 6 - Treatment||0||
48487857|NCT05093205|101529190|FG005|NOT COMPLETED|Part A Period 6 - Treatment||7||
48487858|NCT05093205|101529191|FG006|NOT COMPLETED|Part A Period 6 - Treatment||0||
48487859|NCT05093205|101529192|FG007|NOT COMPLETED|Part A Period 6 - Treatment||0||
48199209|NCT04335591|100810315|FG003|COMPLETED|Overall Study||50||
48199210|NCT04335591|100810312|FG000|NOT COMPLETED|Overall Study||18||
48199211|NCT04335591|100810313|FG001|NOT COMPLETED|Overall Study||12||
48199212|NCT04335591|100810314|FG002|NOT COMPLETED|Overall Study||9||
48199213|NCT04335591|100810315|FG003|NOT COMPLETED|Overall Study||7||
48199214|NCT01368406|100810316|FG000|STARTED|Overall Study||81||
48199215|NCT01368406|100810317|FG001|STARTED|Overall Study||79||
48199216|NCT01368406|100810316|FG000|COMPLETED|Overall Study||60||
48199217|NCT01368406|100810317|FG001|COMPLETED|Overall Study||66||
48199218|NCT01368406|100810316|FG000|NOT COMPLETED|Overall Study||21||
48199219|NCT01368406|100810317|FG001|NOT COMPLETED|Overall Study||13||
48199220|NCT03328949|100810318|FG000|STARTED|Overall Study||120||
48199221|NCT03328949|100810318|FG000|COMPLETED|Overall Study||120||
48199222|NCT03328949|100810318|FG000|NOT COMPLETED|Overall Study||0||
48199223|NCT01837641|100810319|FG000|STARTED|Overall Study||12||
48199224|NCT01837641|100810320|FG001|STARTED|Overall Study||4||
48199225|NCT01837641|100810321|FG002|STARTED|Overall Study||7||
48199226|NCT01837641|100810322|FG003|STARTED|Overall Study||6||
48199227|NCT01837641|100810323|FG004|STARTED|Overall Study||9||
48199228|NCT01837641|100810324|FG005|STARTED|Overall Study||11||
48199229|NCT01837641|100810325|FG006|STARTED|Overall Study||6||
48199230|NCT01837641|100810326|FG007|STARTED|Overall Study||8||
48199231|NCT01837641|100810319|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12||
48199232|NCT01837641|100810320|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4||
48199233|NCT01837641|100810321|FG002|Received at Least 1 Dose of Study Drug|Overall Study||7||
48199234|NCT01837641|100810322|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6||
48199235|NCT01837641|100810323|FG004|Received at Least 1 Dose of Study Drug|Overall Study||9||
48199236|NCT01837641|100810324|FG005|Received at Least 1 Dose of Study Drug|Overall Study||11||
48199237|NCT01837641|100810325|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6||
48199238|NCT01837641|100810326|FG007|Received at Least 1 Dose of Study Drug|Overall Study||8||
48199239|NCT01837641|100810319|FG000|COMPLETED|Overall Study||11||
48199240|NCT01837641|100810320|FG001|COMPLETED|Overall Study||4||
48199241|NCT01837641|100810321|FG002|COMPLETED|Overall Study||7||
48199242|NCT01837641|100810322|FG003|COMPLETED|Overall Study||6||
48199243|NCT01837641|100810323|FG004|COMPLETED|Overall Study||8||
48199244|NCT01837641|100810324|FG005|COMPLETED|Overall Study||9||
48199245|NCT01837641|100810325|FG006|COMPLETED|Overall Study||5||
48199246|NCT01837641|100810326|FG007|COMPLETED|Overall Study||8||
48199247|NCT01837641|100810319|FG000|NOT COMPLETED|Overall Study||1||
48199248|NCT01837641|100810320|FG001|NOT COMPLETED|Overall Study||0||
48199249|NCT01837641|100810321|FG002|NOT COMPLETED|Overall Study||0||
48199250|NCT01837641|100810322|FG003|NOT COMPLETED|Overall Study||0||
48199251|NCT01837641|100810323|FG004|NOT COMPLETED|Overall Study||1||
48487860|NCT05093205|101529193|FG008|NOT COMPLETED|Part A Period 6 - Treatment||0||
48666590|NCT02374255|101967622|FG002|STARTED|Overall Study||11||
48199252|NCT01837641|100810324|FG005|NOT COMPLETED|Overall Study||2||
48199253|NCT01837641|100810325|FG006|NOT COMPLETED|Overall Study||1||
48199254|NCT01837641|100810326|FG007|NOT COMPLETED|Overall Study||0||
48199255|NCT00290732|100810327|FG000|STARTED|Overall Study||3||
48199256|NCT00290732|100810328|FG001|STARTED|Overall Study||4||
48199257|NCT00290732|100810329|FG002|STARTED|Overall Study||4||
48199258|NCT00290732|100810330|FG003|STARTED|Overall Study||6||
48199259|NCT00290732|100810331|FG004|STARTED|Overall Study||3||
48199260|NCT00290732|100810327|FG000|COMPLETED|Overall Study||3||
48199261|NCT00290732|100810328|FG001|COMPLETED|Overall Study||3||
48199262|NCT00290732|100810329|FG002|COMPLETED|Overall Study||3||
48199263|NCT00290732|100810330|FG003|COMPLETED|Overall Study||6||
48199264|NCT00290732|100810331|FG004|COMPLETED|Overall Study||3||
48199265|NCT00290732|100810327|FG000|NOT COMPLETED|Overall Study||0||
48199266|NCT00290732|100810328|FG001|NOT COMPLETED|Overall Study||1||
48199267|NCT00290732|100810329|FG002|NOT COMPLETED|Overall Study||1||
48199268|NCT00290732|100810330|FG003|NOT COMPLETED|Overall Study||0||
48199269|NCT00290732|100810331|FG004|NOT COMPLETED|Overall Study||0||
48199270|NCT03360422|100810332|FG000|STARTED|Survey||673||
48199271|NCT03360422|100810332|FG000|COMPLETED|Survey||673||
48199272|NCT03360422|100810332|FG000|NOT COMPLETED|Survey||0||
48199273|NCT03360422|100810332|FG000|STARTED|Focus Group/Individual Interview||24||
48199274|NCT03360422|100810332|FG000|COMPLETED|Focus Group/Individual Interview||24||
48199275|NCT03360422|100810332|FG000|NOT COMPLETED|Focus Group/Individual Interview||0||
48199276|NCT03360422|100810332|FG000|STARTED|Usability Study||10||
48199277|NCT03360422|100810332|FG000|COMPLETED|Usability Study||10||
48199278|NCT03360422|100810332|FG000|NOT COMPLETED|Usability Study||0||
48199279|NCT00782639|100810333|FG000|STARTED|Overall Study||12||
48199280|NCT00782639|100810334|FG001|STARTED|Overall Study||11||
48199281|NCT00782639|100810333|FG000|COMPLETED|Overall Study||12||
48199282|NCT00782639|100810334|FG001|COMPLETED|Overall Study||11||
48199283|NCT00782639|100810333|FG000|NOT COMPLETED|Overall Study||0||
48199284|NCT00782639|100810334|FG001|NOT COMPLETED|Overall Study||0||
48199285|NCT00392678|100810335|FG000|STARTED|Overall Study||27||
48199286|NCT00392678|100810336|FG001|STARTED|Overall Study||27||
48199287|NCT00392678|100810337|FG002|STARTED|Overall Study||27||
48199288|NCT00392678|100810338|FG003|STARTED|Overall Study||27||
48199289|NCT00392678|100810335|FG000|COMPLETED|Overall Study||27||
48199290|NCT00392678|100810336|FG001|COMPLETED|Overall Study||26||
48199291|NCT00392678|100810337|FG002|COMPLETED|Overall Study||25||
48199292|NCT00392678|100810338|FG003|COMPLETED|Overall Study||26||
48199293|NCT00392678|100810335|FG000|NOT COMPLETED|Overall Study||0||
48199294|NCT00392678|100810336|FG001|NOT COMPLETED|Overall Study||1||
48199295|NCT00392678|100810337|FG002|NOT COMPLETED|Overall Study||2||
48199296|NCT00392678|100810338|FG003|NOT COMPLETED|Overall Study||1||
48199297|NCT00831792|100810339|FG000|STARTED|Overall Study||46||
48199298|NCT00831792|100810339|FG000|COMPLETED|Overall Study||40||
48199299|NCT00831792|100810339|FG000|NOT COMPLETED|Overall Study||6||
48199300|NCT00613301|100810340|FG000|STARTED|Overall Study||416||
48199301|NCT00613301|100810340|FG000|COMPLETED|Overall Study||188||
48199302|NCT00613301|100810340|FG000|NOT COMPLETED|Overall Study||228||
48199303|NCT03408860|100810341|FG000|STARTED|Overall Study||4||
48199304|NCT03408860|100810342|FG001|STARTED|Overall Study||4||
48199305|NCT03408860|100810341|FG000|COMPLETED|Overall Study||4||
48199306|NCT03408860|100810342|FG001|COMPLETED|Overall Study||4||
48199307|NCT03408860|100810341|FG000|NOT COMPLETED|Overall Study||0||
48199308|NCT03408860|100810342|FG001|NOT COMPLETED|Overall Study||0||
48199309|NCT00586339|100810343|FG000|STARTED|Overall Study||61||
48199310|NCT00586339|100810344|FG001|STARTED|Overall Study||59||
48199311|NCT00586339|100810345|FG002|STARTED|Overall Study||30||
48199312|NCT00586339|100810343|FG000|COMPLETED|Overall Study||54||
48199313|NCT00586339|100810344|FG001|COMPLETED|Overall Study||52||
48199314|NCT00586339|100810345|FG002|COMPLETED|Overall Study||24||
48199315|NCT00586339|100810343|FG000|NOT COMPLETED|Overall Study||7||
48199316|NCT00586339|100810344|FG001|NOT COMPLETED|Overall Study||7||
48199317|NCT00586339|100810345|FG002|NOT COMPLETED|Overall Study||6||
48199318|NCT01167426|100810346|FG000|STARTED|Overall Study||148||
48199319|NCT01167426|100810346|FG000|COMPLETED|Overall Study||138||
48199320|NCT01167426|100810346|FG000|NOT COMPLETED|Overall Study||10||
48199321|NCT02085356|100810347|FG000|STARTED|Overall Study||577||
48199322|NCT02085356|100810348|FG001|STARTED|Overall Study||348||
48199323|NCT02085356|100810349|FG002|STARTED|Overall Study||681||
48199324|NCT02085356|100810350|FG003|STARTED|Overall Study||361||
48199325|NCT02085356|100810347|FG000|COMPLETED|Overall Study||577||
48199326|NCT02085356|100810348|FG001|COMPLETED|Overall Study||348||
48199327|NCT02085356|100810349|FG002|COMPLETED|Overall Study||681||
48199328|NCT02085356|100810350|FG003|COMPLETED|Overall Study||361||
48199329|NCT02085356|100810347|FG000|NOT COMPLETED|Overall Study||0||
48199330|NCT02085356|100810348|FG001|NOT COMPLETED|Overall Study||0||
48199331|NCT02085356|100810349|FG002|NOT COMPLETED|Overall Study||0||
48199332|NCT02085356|100810350|FG003|NOT COMPLETED|Overall Study||0||
48199333|NCT01670110|100810351|FG000|STARTED|Overall Study||33||
48199334|NCT01670110|100810352|FG001|STARTED|Overall Study||15||
48199335|NCT01670110|100810351|FG000|COMPLETED|Overall Study||29||
48199336|NCT01670110|100810352|FG001|COMPLETED|Overall Study||12||
48199337|NCT01670110|100810351|FG000|NOT COMPLETED|Overall Study||4||
48199338|NCT01670110|100810352|FG001|NOT COMPLETED|Overall Study||3||
48199339|NCT03999554|100810353|FG000|STARTED|Overall Study||42||
48199340|NCT03999554|100810354|FG001|STARTED|Overall Study||41||
48199341|NCT03999554|100810355|FG002|STARTED|Overall Study||40||
48199342|NCT03999554|100810356|FG003|STARTED|Overall Study||42||
48199343|NCT03999554|100810357|FG004|STARTED|Overall Study||41||
48199344|NCT03999554|100810353|FG000|COMPLETED|Overall Study||36||
48199345|NCT03999554|100810354|FG001|COMPLETED|Overall Study||34||
48199346|NCT03999554|100810355|FG002|COMPLETED|Overall Study||28||
48199347|NCT03999554|100810356|FG003|COMPLETED|Overall Study||35||
48199348|NCT03999554|100810357|FG004|COMPLETED|Overall Study||32||
48199349|NCT03999554|100810353|FG000|NOT COMPLETED|Overall Study||6||
48199350|NCT03999554|100810354|FG001|NOT COMPLETED|Overall Study||7||
48199351|NCT03999554|100810355|FG002|NOT COMPLETED|Overall Study||12||
48199352|NCT03999554|100810356|FG003|NOT COMPLETED|Overall Study||7||
48199353|NCT03999554|100810357|FG004|NOT COMPLETED|Overall Study||9||
48199354|NCT04880733|100810358|FG000|STARTED|Participants in the RCT (Overall Study)||83||
48199355|NCT04880733|100810359|FG001|STARTED|Participants in the RCT (Overall Study)||82||
48199356|NCT04880733|100810360|FG002|STARTED|Participants in the RCT (Overall Study)||0||
48199357|NCT04880733|100810358|FG000|Received Acupuncture|Participants in the RCT (Overall Study)||79||
48199358|NCT04880733|100810359|FG001|Received Acupuncture|Participants in the RCT (Overall Study)||0||
48199359|NCT04880733|100810360|FG002|Received Acupuncture|Participants in the RCT (Overall Study)||0||
48199360|NCT04880733|100810358|FG000|Received Usual Care|Participants in the RCT (Overall Study)||0||
48199361|NCT04880733|100810359|FG001|Received Usual Care|Participants in the RCT (Overall Study)||82||
48199362|NCT04880733|100810360|FG002|Received Usual Care|Participants in the RCT (Overall Study)||0||
48199363|NCT04880733|100810358|FG000|COMPLETED|Participants in the RCT (Overall Study)||76||
48199364|NCT04880733|100810359|FG001|COMPLETED|Participants in the RCT (Overall Study)||75||
48199365|NCT04880733|100810360|FG002|COMPLETED|Participants in the RCT (Overall Study)||0||
48199366|NCT04880733|100810358|FG000|NOT COMPLETED|Participants in the RCT (Overall Study)||7||
48199367|NCT04880733|100810359|FG001|NOT COMPLETED|Participants in the RCT (Overall Study)||7||
48199368|NCT04880733|100810360|FG002|NOT COMPLETED|Participants in the RCT (Overall Study)||0||
48199369|NCT04880733|100810358|FG000|STARTED|ED Staff/Providers 6 Month Assessment||0||
48199370|NCT04880733|100810359|FG001|STARTED|ED Staff/Providers 6 Month Assessment||0||
48199371|NCT04880733|100810360|FG002|STARTED|ED Staff/Providers 6 Month Assessment||125||
48199372|NCT04880733|100810358|FG000|Completed Question 1|ED Staff/Providers 6 Month Assessment||0||
48199373|NCT04880733|100810359|FG001|Completed Question 1|ED Staff/Providers 6 Month Assessment||0||
48199374|NCT04880733|100810360|FG002|Completed Question 1|ED Staff/Providers 6 Month Assessment||125||
48199375|NCT04880733|100810358|FG000|Completed Question 2|ED Staff/Providers 6 Month Assessment||0||
48199376|NCT04880733|100810359|FG001|Completed Question 2|ED Staff/Providers 6 Month Assessment||0||
48199377|NCT04880733|100810360|FG002|Completed Question 2|ED Staff/Providers 6 Month Assessment||124||
48199378|NCT04880733|100810358|FG000|Completed Question 3|ED Staff/Providers 6 Month Assessment||0||
48199379|NCT04880733|100810359|FG001|Completed Question 3|ED Staff/Providers 6 Month Assessment||0||
48199380|NCT04880733|100810360|FG002|Completed Question 3|ED Staff/Providers 6 Month Assessment||32||
48199381|NCT04880733|100810358|FG000|Completed Question 4|ED Staff/Providers 6 Month Assessment||0||
48199382|NCT04880733|100810359|FG001|Completed Question 4|ED Staff/Providers 6 Month Assessment||0||
48199383|NCT04880733|100810360|FG002|Completed Question 4|ED Staff/Providers 6 Month Assessment||32||
48199384|NCT04880733|100810358|FG000|COMPLETED|ED Staff/Providers 6 Month Assessment||0||
48199385|NCT04880733|100810359|FG001|COMPLETED|ED Staff/Providers 6 Month Assessment||0||
48199386|NCT04880733|100810360|FG002|COMPLETED|ED Staff/Providers 6 Month Assessment||124||
48199387|NCT04880733|100810358|FG000|NOT COMPLETED|ED Staff/Providers 6 Month Assessment||0||
48199388|NCT04880733|100810359|FG001|NOT COMPLETED|ED Staff/Providers 6 Month Assessment||0||
48199389|NCT04880733|100810360|FG002|NOT COMPLETED|ED Staff/Providers 6 Month Assessment||1||
48199390|NCT04381494|100810361|FG000|STARTED|Overall Study||40||
48199391|NCT04381494|100810361|FG000|COMPLETED|Overall Study||5||
48199392|NCT04381494|100810361|FG000|NOT COMPLETED|Overall Study||35||
48199393|NCT02891629|100810362|FG000|STARTED|Overall Study||10||
48199394|NCT02891629|100810363|FG001|STARTED|Overall Study||5||
48199395|NCT02891629|100810362|FG000|COMPLETED|Overall Study||10||
48199396|NCT02891629|100810363|FG001|COMPLETED|Overall Study||4||
48199397|NCT02891629|100810362|FG000|NOT COMPLETED|Overall Study||0||
48199398|NCT02891629|100810363|FG001|NOT COMPLETED|Overall Study||1||
48199399|NCT05302791|100810364|FG000|STARTED|Overall Study||12||24
48199400|NCT05302791|100810364|FG000|Experimental (Cooling)|Overall Study||12||12
48199401|NCT05302791|100810364|FG000|Control (no Cooling)|Overall Study||12||12
48199402|NCT05302791|100810364|FG000|COMPLETED|Overall Study||12||24
48487861|NCT05093205|101529194|FG009|NOT COMPLETED|Part A Period 6 - Treatment||0||
48487862|NCT05093205|101529195|FG010|NOT COMPLETED|Part A Period 6 - Treatment||0||
48487863|NCT05093205|101529196|FG011|NOT COMPLETED|Part A Period 6 - Treatment||0||
48487864|NCT05093205|101529197|FG012|NOT COMPLETED|Part A Period 6 - Treatment||0||
48199403|NCT05302791|100810364|FG000|NOT COMPLETED|Overall Study||0||0
48487865|NCT05093205|101529185|FG000|STARTED|Part A Period 6 - Follow-Up||0||
48199404|NCT03636451|100810365|FG000|STARTED|Overall Study||57||
48199405|NCT03636451|100810366|FG001|STARTED|Overall Study||57||
48199406|NCT03636451|100810365|FG000|COMPLETED|Overall Study||57||
48199407|NCT03636451|100810366|FG001|COMPLETED|Overall Study||57||
48199408|NCT03636451|100810365|FG000|NOT COMPLETED|Overall Study||0||
48199409|NCT03636451|100810366|FG001|NOT COMPLETED|Overall Study||0||
48199410|NCT00605904|100810367|FG000|STARTED|Baseline Data Collection and Dosing||13||
48487866|NCT05093205|101529186|FG001|STARTED|Part A Period 6 - Follow-Up||0||
48666591|NCT02374255|101967623|FG003|STARTED|Overall Study||11||
48666592|NCT02374255|101967620|FG000|COMPLETED|Overall Study||153||
48199411|NCT00605904|100810368|FG001|STARTED|Baseline Data Collection and Dosing||21||
48199412|NCT00605904|100810367|FG000|COMPLETED|Baseline Data Collection and Dosing||13||
48199413|NCT00605904|100810368|FG001|COMPLETED|Baseline Data Collection and Dosing||16||
48199414|NCT00605904|100810367|FG000|NOT COMPLETED|Baseline Data Collection and Dosing||0||
48199415|NCT00605904|100810368|FG001|NOT COMPLETED|Baseline Data Collection and Dosing||5||
48199416|NCT00605904|100810367|FG000|STARTED|Infusion Sessions||13||
48199417|NCT00605904|100810368|FG001|STARTED|Infusion Sessions||16||
48487867|NCT05093205|101529187|FG002|STARTED|Part A Period 6 - Follow-Up||0||
48199418|NCT00605904|100810367|FG000|Saline Infusion|Infusion Sessions||13||
48199419|NCT00605904|100810368|FG001|Saline Infusion|Infusion Sessions||14||
48199420|NCT00605904|100810367|FG000|mCPP Infusion|Infusion Sessions||12||
48199421|NCT00605904|100810368|FG001|mCPP Infusion|Infusion Sessions||13||
48199422|NCT00605904|100810367|FG000|Yohimbine Infusion|Infusion Sessions||12||
48199423|NCT00605904|100810368|FG001|Yohimbine Infusion|Infusion Sessions||15||
48199424|NCT00605904|100810367|FG000|COMPLETED|Infusion Sessions||12||
48199425|NCT00605904|100810368|FG001|COMPLETED|Infusion Sessions||13||
48199426|NCT00605904|100810367|FG000|NOT COMPLETED|Infusion Sessions||1||
48199427|NCT00605904|100810368|FG001|NOT COMPLETED|Infusion Sessions||3||
48199428|NCT00887640|100810369|FG000|STARTED|Overall Study||11||
48199429|NCT00887640|100810369|FG000|COMPLETED|Overall Study||11||
48199430|NCT00887640|100810369|FG000|NOT COMPLETED|Overall Study||0||
48199431|NCT03700658|100810370|FG000|STARTED|Overall Study||27||
48199432|NCT03700658|100810370|FG000|Received at Least 1 Dose of Study Drug|Overall Study||27||
48199433|NCT03700658|100810370|FG000|COMPLETED|Overall Study||27||
48199434|NCT03700658|100810370|FG000|NOT COMPLETED|Overall Study||0||
48199435|NCT02163915|100810371|FG000|STARTED|Overall Study||10||
48199436|NCT02163915|100810372|FG001|STARTED|Overall Study||8||
48199437|NCT02163915|100810373|FG002|STARTED|Overall Study||10||
48199438|NCT02163915|100810374|FG003|STARTED|Overall Study||9||
48199439|NCT02163915|100810375|FG004|STARTED|Overall Study||10||
48199440|NCT02163915|100810371|FG000|COMPLETED|Overall Study||7||
48199441|NCT02163915|100810372|FG001|COMPLETED|Overall Study||8||
48199442|NCT02163915|100810373|FG002|COMPLETED|Overall Study||8||
48199443|NCT02163915|100810374|FG003|COMPLETED|Overall Study||6||
48199444|NCT02163915|100810375|FG004|COMPLETED|Overall Study||6||
48199445|NCT02163915|100810371|FG000|NOT COMPLETED|Overall Study||3||
48199446|NCT02163915|100810372|FG001|NOT COMPLETED|Overall Study||0||
48199447|NCT02163915|100810373|FG002|NOT COMPLETED|Overall Study||2||
48199448|NCT02163915|100810374|FG003|NOT COMPLETED|Overall Study||3||
48487868|NCT05093205|101529188|FG003|STARTED|Part A Period 6 - Follow-Up||0||
48487869|NCT05093205|101529189|FG004|STARTED|Part A Period 6 - Follow-Up||0||
48487870|NCT05093205|101529190|FG005|STARTED|Part A Period 6 - Follow-Up||13||
48487871|NCT05093205|101529191|FG006|STARTED|Part A Period 6 - Follow-Up||0||
48487872|NCT05093205|101529192|FG007|STARTED|Part A Period 6 - Follow-Up||0||
48487873|NCT05093205|101529193|FG008|STARTED|Part A Period 6 - Follow-Up||0||
48487874|NCT05093205|101529194|FG009|STARTED|Part A Period 6 - Follow-Up||0||
48487875|NCT05093205|101529195|FG010|STARTED|Part A Period 6 - Follow-Up||0||
48487876|NCT05093205|101529196|FG011|STARTED|Part A Period 6 - Follow-Up||0||
48487877|NCT05093205|101529197|FG012|STARTED|Part A Period 6 - Follow-Up||0||
48487878|NCT05093205|101529185|FG000|COMPLETED|Part A Period 6 - Follow-Up||0||
48487879|NCT05093205|101529186|FG001|COMPLETED|Part A Period 6 - Follow-Up||0||
48487880|NCT05093205|101529187|FG002|COMPLETED|Part A Period 6 - Follow-Up||0||
48487881|NCT05093205|101529188|FG003|COMPLETED|Part A Period 6 - Follow-Up||0||
48487882|NCT05093205|101529189|FG004|COMPLETED|Part A Period 6 - Follow-Up||0||
48487883|NCT05093205|101529190|FG005|COMPLETED|Part A Period 6 - Follow-Up||13||
48487884|NCT05093205|101529191|FG006|COMPLETED|Part A Period 6 - Follow-Up||0||
48487885|NCT05093205|101529192|FG007|COMPLETED|Part A Period 6 - Follow-Up||0||
48487886|NCT05093205|101529193|FG008|COMPLETED|Part A Period 6 - Follow-Up||0||
48487887|NCT05093205|101529194|FG009|COMPLETED|Part A Period 6 - Follow-Up||0||
48487888|NCT05093205|101529195|FG010|COMPLETED|Part A Period 6 - Follow-Up||0||
48487889|NCT05093205|101529196|FG011|COMPLETED|Part A Period 6 - Follow-Up||0||
48487890|NCT05093205|101529197|FG012|COMPLETED|Part A Period 6 - Follow-Up||0||
48199449|NCT02163915|100810375|FG004|NOT COMPLETED|Overall Study||4||
48199450|NCT00130637|100810376|FG000|STARTED|Overall Study||6||
48199451|NCT00130637|100810376|FG000|COMPLETED|Overall Study||3||
48199452|NCT00130637|100810376|FG000|NOT COMPLETED|Overall Study||3||
48199453|NCT01514734|100810377|FG000|STARTED|Overall Study||9||
48199454|NCT01514734|100810377|FG000|COMPLETED|Overall Study||9||
48199455|NCT01514734|100810377|FG000|NOT COMPLETED|Overall Study||0||
48199456|NCT00906282|100810378|FG000|STARTED|Preoperative Chemotherapy||46||
48199457|NCT00906282|100810378|FG000|COMPLETED|Preoperative Chemotherapy||27||
48487891|NCT05093205|101529185|FG000|NOT COMPLETED|Part A Period 6 - Follow-Up||0||
48487892|NCT05093205|101529186|FG001|NOT COMPLETED|Part A Period 6 - Follow-Up||0||
48199458|NCT00906282|100810378|FG000|NOT COMPLETED|Preoperative Chemotherapy||19||
48199459|NCT00906282|100810378|FG000|STARTED|Surgical Resection||27||
48199460|NCT00906282|100810378|FG000|COMPLETED|Surgical Resection||27||
48199461|NCT00906282|100810378|FG000|NOT COMPLETED|Surgical Resection||0||
48199462|NCT05252871|100810379|FG000|STARTED|Overall Study||40||
48199463|NCT05252871|100810380|FG001|STARTED|Overall Study||40||
48199464|NCT05252871|100810379|FG000|COMPLETED|Overall Study||40||
48199465|NCT05252871|100810380|FG001|COMPLETED|Overall Study||40||
48199466|NCT05252871|100810379|FG000|NOT COMPLETED|Overall Study||0||
48199467|NCT05252871|100810380|FG001|NOT COMPLETED|Overall Study||0||
48199468|NCT02979899|100810381|FG000|STARTED|Overall Study||64||
48199469|NCT02979899|100810382|FG001|STARTED|Overall Study||64||
48199470|NCT02979899|100810381|FG000|COMPLETED|Overall Study||64||
48199471|NCT02979899|100810382|FG001|COMPLETED|Overall Study||64||
48199472|NCT02979899|100810381|FG000|NOT COMPLETED|Overall Study||0||
48199473|NCT02979899|100810382|FG001|NOT COMPLETED|Overall Study||0||
48199474|NCT04555044|100810383|FG000|STARTED|Overall Study||50||
48199475|NCT04555044|100810384|FG001|STARTED|Overall Study||51||
48199476|NCT04555044|100810383|FG000|COMPLETED|Overall Study||50||
48199477|NCT04555044|100810384|FG001|COMPLETED|Overall Study||50||
48199478|NCT04555044|100810383|FG000|NOT COMPLETED|Overall Study||0||
48199479|NCT04555044|100810384|FG001|NOT COMPLETED|Overall Study||1||
48199480|NCT02526680|100810385|FG000|STARTED|Overall Study||27||
48199481|NCT02526680|100810385|FG000|COMPLETED|Overall Study||27||
48199482|NCT02526680|100810385|FG000|NOT COMPLETED|Overall Study||0||
48199483|NCT05460663|100810386|FG000|STARTED|Overall Study||32||
48199484|NCT05460663|100810387|FG001|STARTED|Overall Study||24||
48199485|NCT05460663|100810386|FG000|COMPLETED|Overall Study||30||
48199486|NCT05460663|100810387|FG001|COMPLETED|Overall Study||19||
48199487|NCT05460663|100810386|FG000|NOT COMPLETED|Overall Study||2||
48199488|NCT05460663|100810387|FG001|NOT COMPLETED|Overall Study||5||
48199489|NCT00299702|100810388|FG000|STARTED|Overall Study||179||
48199490|NCT00299702|100810389|FG001|STARTED|Overall Study||176||
48199491|NCT00299702|100810388|FG000|COMPLETED|Overall Study||126||
48199492|NCT00299702|100810389|FG001|COMPLETED|Overall Study||126||
48199493|NCT00299702|100810388|FG000|NOT COMPLETED|Overall Study||53||
48199494|NCT00299702|100810389|FG001|NOT COMPLETED|Overall Study||50||
48199495|NCT03255018|100810390|FG000|STARTED|Overall Study||2||
48199496|NCT03255018|100810391|FG001|STARTED|Overall Study||10||
48199497|NCT03255018|100810390|FG000|COMPLETED|Overall Study||2||
48199498|NCT03255018|100810391|FG001|COMPLETED|Overall Study||3||
48199499|NCT03255018|100810390|FG000|NOT COMPLETED|Overall Study||0||
48199500|NCT03255018|100810391|FG001|NOT COMPLETED|Overall Study||7||
48199501|NCT00957229|100810392|FG000|STARTED|Study Start||15||
48199502|NCT00957229|100810393|FG001|STARTED|Study Start||26||
48199503|NCT00957229|100810392|FG000|COMPLETED|Study Start||14||
48199504|NCT00957229|100810393|FG001|COMPLETED|Study Start||23||
48199505|NCT00957229|100810392|FG000|NOT COMPLETED|Study Start||1||
48199506|NCT00957229|100810393|FG001|NOT COMPLETED|Study Start||3||
48487893|NCT05093205|101529187|FG002|NOT COMPLETED|Part A Period 6 - Follow-Up||0||
48199507|NCT00957229|100810392|FG000|STARTED|Reallocated to or Continued Vismodegib||14||
48199508|NCT00957229|100810393|FG001|STARTED|Reallocated to or Continued Vismodegib||23||
48199509|NCT00957229|100810392|FG000|COMPLETED|Reallocated to or Continued Vismodegib||11||
48199510|NCT00957229|100810393|FG001|COMPLETED|Reallocated to or Continued Vismodegib||21||
48199511|NCT00957229|100810392|FG000|NOT COMPLETED|Reallocated to or Continued Vismodegib||3||
48199512|NCT00957229|100810393|FG001|NOT COMPLETED|Reallocated to or Continued Vismodegib||2||
48199513|NCT01467700|100810394|FG000|STARTED|Overall Study||115||
48199514|NCT01467700|100810395|FG001|STARTED|Overall Study||128||
48199515|NCT01467700|100810396|FG002|STARTED|Overall Study||124||
48199516|NCT01467700|100810397|FG003|STARTED|Overall Study||123||
48487894|NCT05093205|101529188|FG003|NOT COMPLETED|Part A Period 6 - Follow-Up||0||
48487895|NCT05093205|101529189|FG004|NOT COMPLETED|Part A Period 6 - Follow-Up||0||
48199517|NCT01467700|100810394|FG000|Safety Set - Received Treatment|Overall Study||115||
48199518|NCT01467700|100810395|FG001|Safety Set - Received Treatment|Overall Study||127||
48199519|NCT01467700|100810396|FG002|Safety Set - Received Treatment|Overall Study||124||
48199520|NCT01467700|100810397|FG003|Safety Set - Received Treatment|Overall Study||123||
48199521|NCT01467700|100810394|FG000|COMPLETED|Overall Study||86||
48199522|NCT01467700|100810395|FG001|COMPLETED|Overall Study||100||
48199523|NCT01467700|100810396|FG002|COMPLETED|Overall Study||97||
48199524|NCT01467700|100810397|FG003|COMPLETED|Overall Study||96||
48199525|NCT01467700|100810394|FG000|NOT COMPLETED|Overall Study||29||
48199526|NCT01467700|100810395|FG001|NOT COMPLETED|Overall Study||28||
48199527|NCT01467700|100810396|FG002|NOT COMPLETED|Overall Study||27||
48199528|NCT01467700|100810397|FG003|NOT COMPLETED|Overall Study||27||
48199529|NCT01489176|100810398|FG000|STARTED|Overall Study||50||
48199530|NCT01489176|100810398|FG000|COMPLETED|Overall Study||50||
48199531|NCT01489176|100810398|FG000|NOT COMPLETED|Overall Study||0||
48199532|NCT02503202|100810399|FG000|STARTED|Base Study: Up to Month 6||266||
48199533|NCT02503202|100810400|FG001|STARTED|Base Study: Up to Month 6||265||
48199534|NCT02503202|100810401|FG002|STARTED|Base Study: Up to Month 6||267||
48199535|NCT02503202|100810402|FG003|STARTED|Base Study: Up to Month 6||266||
48199536|NCT02503202|100810403|FG004|STARTED|Base Study: Up to Month 6||133||
48487896|NCT05093205|101529190|FG005|NOT COMPLETED|Part A Period 6 - Follow-Up||0||
48487897|NCT05093205|101529191|FG006|NOT COMPLETED|Part A Period 6 - Follow-Up||0||
48487898|NCT05093205|101529192|FG007|NOT COMPLETED|Part A Period 6 - Follow-Up||0||
48487899|NCT05093205|101529193|FG008|NOT COMPLETED|Part A Period 6 - Follow-Up||0||
48487900|NCT05093205|101529194|FG009|NOT COMPLETED|Part A Period 6 - Follow-Up||0||
48487901|NCT05093205|101529195|FG010|NOT COMPLETED|Part A Period 6 - Follow-Up||0||
48487902|NCT05093205|101529196|FG011|NOT COMPLETED|Part A Period 6 - Follow-Up||0||
48487903|NCT05093205|101529197|FG012|NOT COMPLETED|Part A Period 6 - Follow-Up||0||
48487904|NCT05093205|101529185|FG000|STARTED|Part A Period 7 - Treatment||0||
48487905|NCT05093205|101529186|FG001|STARTED|Part A Period 7 - Treatment||0||
48487906|NCT05093205|101529187|FG002|STARTED|Part A Period 7 - Treatment||0||
48487907|NCT05093205|101529188|FG003|STARTED|Part A Period 7 - Treatment||0||
48487908|NCT05093205|101529189|FG004|STARTED|Part A Period 7 - Treatment||0||
48487909|NCT05093205|101529190|FG005|STARTED|Part A Period 7 - Treatment||0||
48487910|NCT05093205|101529191|FG006|STARTED|Part A Period 7 - Treatment||5||
48487911|NCT05093205|101529192|FG007|STARTED|Part A Period 7 - Treatment||0||
48487912|NCT05093205|101529193|FG008|STARTED|Part A Period 7 - Treatment||0||
48487913|NCT05093205|101529194|FG009|STARTED|Part A Period 7 - Treatment||0||
48487914|NCT05093205|101529195|FG010|STARTED|Part A Period 7 - Treatment||0||
48487915|NCT05093205|101529196|FG011|STARTED|Part A Period 7 - Treatment||0||
48487916|NCT05093205|101529197|FG012|STARTED|Part A Period 7 - Treatment||0||
48487917|NCT05093205|101529185|FG000|COMPLETED|Part A Period 7 - Treatment||0||
48487918|NCT05093205|101529186|FG001|COMPLETED|Part A Period 7 - Treatment||0||
48487919|NCT05093205|101529187|FG002|COMPLETED|Part A Period 7 - Treatment||0||
48487920|NCT05093205|101529188|FG003|COMPLETED|Part A Period 7 - Treatment||0||
48487921|NCT05093205|101529189|FG004|COMPLETED|Part A Period 7 - Treatment||0||
48487922|NCT05093205|101529190|FG005|COMPLETED|Part A Period 7 - Treatment||0||
48487923|NCT05093205|101529191|FG006|COMPLETED|Part A Period 7 - Treatment||5||
48487924|NCT05093205|101529192|FG007|COMPLETED|Part A Period 7 - Treatment||0||
48487925|NCT05093205|101529193|FG008|COMPLETED|Part A Period 7 - Treatment||0||
48487926|NCT05093205|101529194|FG009|COMPLETED|Part A Period 7 - Treatment||0||
48487927|NCT05093205|101529195|FG010|COMPLETED|Part A Period 7 - Treatment||0||
48487928|NCT05093205|101529196|FG011|COMPLETED|Part A Period 7 - Treatment||0||
48487929|NCT05093205|101529197|FG012|COMPLETED|Part A Period 7 - Treatment||0||
48487930|NCT05093205|101529185|FG000|NOT COMPLETED|Part A Period 7 - Treatment||0||
48487931|NCT05093205|101529186|FG001|NOT COMPLETED|Part A Period 7 - Treatment||0||
48487932|NCT05093205|101529187|FG002|NOT COMPLETED|Part A Period 7 - Treatment||0||
48487933|NCT05093205|101529188|FG003|NOT COMPLETED|Part A Period 7 - Treatment||0||
48487934|NCT05093205|101529189|FG004|NOT COMPLETED|Part A Period 7 - Treatment||0||
48487935|NCT05093205|101529190|FG005|NOT COMPLETED|Part A Period 7 - Treatment||0||
48487936|NCT05093205|101529191|FG006|NOT COMPLETED|Part A Period 7 - Treatment||0||
48487937|NCT05093205|101529192|FG007|NOT COMPLETED|Part A Period 7 - Treatment||0||
48487938|NCT05093205|101529193|FG008|NOT COMPLETED|Part A Period 7 - Treatment||0||
48487939|NCT05093205|101529194|FG009|NOT COMPLETED|Part A Period 7 - Treatment||0||
48487940|NCT05093205|101529195|FG010|NOT COMPLETED|Part A Period 7 - Treatment||0||
48487941|NCT05093205|101529196|FG011|NOT COMPLETED|Part A Period 7 - Treatment||0||
48487942|NCT05093205|101529197|FG012|NOT COMPLETED|Part A Period 7 - Treatment||0||
48487943|NCT05093205|101529185|FG000|STARTED|Part A Period 7 - Follow-Up||0||
48487944|NCT05093205|101529186|FG001|STARTED|Part A Period 7 - Follow-Up||0||
48487945|NCT05093205|101529187|FG002|STARTED|Part A Period 7 - Follow-Up||0||
48487946|NCT05093205|101529188|FG003|STARTED|Part A Period 7 - Follow-Up||0||
48487947|NCT05093205|101529189|FG004|STARTED|Part A Period 7 - Follow-Up||0||
48487948|NCT05093205|101529190|FG005|STARTED|Part A Period 7 - Follow-Up||0||
48487949|NCT05093205|101529191|FG006|STARTED|Part A Period 7 - Follow-Up||5||
48487950|NCT05093205|101529192|FG007|STARTED|Part A Period 7 - Follow-Up||0||
48487951|NCT05093205|101529193|FG008|STARTED|Part A Period 7 - Follow-Up||0||
48487952|NCT05093205|101529194|FG009|STARTED|Part A Period 7 - Follow-Up||0||
48487953|NCT05093205|101529195|FG010|STARTED|Part A Period 7 - Follow-Up||0||
48487954|NCT05093205|101529196|FG011|STARTED|Part A Period 7 - Follow-Up||0||
48487955|NCT05093205|101529197|FG012|STARTED|Part A Period 7 - Follow-Up||0||
48487956|NCT05093205|101529185|FG000|COMPLETED|Part A Period 7 - Follow-Up||0||
48487957|NCT05093205|101529186|FG001|COMPLETED|Part A Period 7 - Follow-Up||0||
48487958|NCT05093205|101529187|FG002|COMPLETED|Part A Period 7 - Follow-Up||0||
48487959|NCT05093205|101529188|FG003|COMPLETED|Part A Period 7 - Follow-Up||0||
48487960|NCT05093205|101529189|FG004|COMPLETED|Part A Period 7 - Follow-Up||0||
48487961|NCT05093205|101529190|FG005|COMPLETED|Part A Period 7 - Follow-Up||0||
48487962|NCT05093205|101529191|FG006|COMPLETED|Part A Period 7 - Follow-Up||5||
48487963|NCT05093205|101529192|FG007|COMPLETED|Part A Period 7 - Follow-Up||0||
48487964|NCT05093205|101529193|FG008|COMPLETED|Part A Period 7 - Follow-Up||0||
48487965|NCT05093205|101529194|FG009|COMPLETED|Part A Period 7 - Follow-Up||0||
48487966|NCT05093205|101529195|FG010|COMPLETED|Part A Period 7 - Follow-Up||0||
48487967|NCT05093205|101529196|FG011|COMPLETED|Part A Period 7 - Follow-Up||0||
48487968|NCT05093205|101529197|FG012|COMPLETED|Part A Period 7 - Follow-Up||0||
48487969|NCT05093205|101529185|FG000|NOT COMPLETED|Part A Period 7 - Follow-Up||0||
48487970|NCT05093205|101529186|FG001|NOT COMPLETED|Part A Period 7 - Follow-Up||0||
48487971|NCT05093205|101529187|FG002|NOT COMPLETED|Part A Period 7 - Follow-Up||0||
48487972|NCT05093205|101529188|FG003|NOT COMPLETED|Part A Period 7 - Follow-Up||0||
48487973|NCT05093205|101529189|FG004|NOT COMPLETED|Part A Period 7 - Follow-Up||0||
48487974|NCT05093205|101529190|FG005|NOT COMPLETED|Part A Period 7 - Follow-Up||0||
48487975|NCT05093205|101529191|FG006|NOT COMPLETED|Part A Period 7 - Follow-Up||0||
48487976|NCT05093205|101529192|FG007|NOT COMPLETED|Part A Period 7 - Follow-Up||0||
48487977|NCT05093205|101529193|FG008|NOT COMPLETED|Part A Period 7 - Follow-Up||0||
48487978|NCT05093205|101529194|FG009|NOT COMPLETED|Part A Period 7 - Follow-Up||0||
48487979|NCT05093205|101529195|FG010|NOT COMPLETED|Part A Period 7 - Follow-Up||0||
48487980|NCT05093205|101529196|FG011|NOT COMPLETED|Part A Period 7 - Follow-Up||0||
48487981|NCT05093205|101529197|FG012|NOT COMPLETED|Part A Period 7 - Follow-Up||0||
48487982|NCT05093205|101529185|FG000|STARTED|Part A Period 8 - Treatment||0||
48487983|NCT05093205|101529186|FG001|STARTED|Part A Period 8 - Treatment||0||
48487984|NCT05093205|101529187|FG002|STARTED|Part A Period 8 - Treatment||0||
48487985|NCT05093205|101529188|FG003|STARTED|Part A Period 8 - Treatment||0||
48487986|NCT05093205|101529189|FG004|STARTED|Part A Period 8 - Treatment||0||
48487987|NCT05093205|101529190|FG005|STARTED|Part A Period 8 - Treatment||0||
48487988|NCT05093205|101529191|FG006|STARTED|Part A Period 8 - Treatment||0||
48487989|NCT05093205|101529192|FG007|STARTED|Part A Period 8 - Treatment||6||
48487990|NCT05093205|101529193|FG008|STARTED|Part A Period 8 - Treatment||0||
48487991|NCT05093205|101529194|FG009|STARTED|Part A Period 8 - Treatment||0||
48487992|NCT05093205|101529195|FG010|STARTED|Part A Period 8 - Treatment||0||
48487993|NCT05093205|101529196|FG011|STARTED|Part A Period 8 - Treatment||0||
48487994|NCT05093205|101529197|FG012|STARTED|Part A Period 8 - Treatment||0||
48487995|NCT05093205|101529185|FG000|COMPLETED|Part A Period 8 - Treatment||0||
48487996|NCT05093205|101529186|FG001|COMPLETED|Part A Period 8 - Treatment||0||
48487997|NCT05093205|101529187|FG002|COMPLETED|Part A Period 8 - Treatment||0||
48487998|NCT05093205|101529188|FG003|COMPLETED|Part A Period 8 - Treatment||0||
48487999|NCT05093205|101529189|FG004|COMPLETED|Part A Period 8 - Treatment||0||
48488000|NCT05093205|101529190|FG005|COMPLETED|Part A Period 8 - Treatment||0||
48488001|NCT05093205|101529191|FG006|COMPLETED|Part A Period 8 - Treatment||0||
48488002|NCT05093205|101529192|FG007|COMPLETED|Part A Period 8 - Treatment||5||
48199537|NCT02503202|100810399|FG000|Vaccinated|Base Study: Up to Month 6||266||
48199538|NCT02503202|100810400|FG001|Vaccinated|Base Study: Up to Month 6||265||
48199539|NCT02503202|100810401|FG002|Vaccinated|Base Study: Up to Month 6||266||
48199540|NCT02503202|100810402|FG003|Vaccinated|Base Study: Up to Month 6||264||
48199541|NCT02503202|100810403|FG004|Vaccinated|Base Study: Up to Month 6||133||
48199542|NCT02503202|100810399|FG000|COMPLETED|Base Study: Up to Month 6||248||
48488003|NCT05093205|101529193|FG008|COMPLETED|Part A Period 8 - Treatment||0||
48488004|NCT05093205|101529194|FG009|COMPLETED|Part A Period 8 - Treatment||0||
48488005|NCT05093205|101529195|FG010|COMPLETED|Part A Period 8 - Treatment||0||
48488006|NCT05093205|101529196|FG011|COMPLETED|Part A Period 8 - Treatment||0||
48488007|NCT05093205|101529197|FG012|COMPLETED|Part A Period 8 - Treatment||0||
48488008|NCT05093205|101529185|FG000|NOT COMPLETED|Part A Period 8 - Treatment||0||
48488009|NCT05093205|101529186|FG001|NOT COMPLETED|Part A Period 8 - Treatment||0||
48488010|NCT05093205|101529187|FG002|NOT COMPLETED|Part A Period 8 - Treatment||0||
48488011|NCT05093205|101529188|FG003|NOT COMPLETED|Part A Period 8 - Treatment||0||
48488012|NCT05093205|101529189|FG004|NOT COMPLETED|Part A Period 8 - Treatment||0||
48488013|NCT05093205|101529190|FG005|NOT COMPLETED|Part A Period 8 - Treatment||0||
48488014|NCT05093205|101529191|FG006|NOT COMPLETED|Part A Period 8 - Treatment||0||
48488015|NCT05093205|101529192|FG007|NOT COMPLETED|Part A Period 8 - Treatment||1||
48488016|NCT05093205|101529193|FG008|NOT COMPLETED|Part A Period 8 - Treatment||0||
48488017|NCT05093205|101529194|FG009|NOT COMPLETED|Part A Period 8 - Treatment||0||
48488018|NCT05093205|101529195|FG010|NOT COMPLETED|Part A Period 8 - Treatment||0||
48488019|NCT05093205|101529196|FG011|NOT COMPLETED|Part A Period 8 - Treatment||0||
48488020|NCT05093205|101529197|FG012|NOT COMPLETED|Part A Period 8 - Treatment||0||
48488021|NCT05093205|101529185|FG000|STARTED|Part A Period 8 - Follow-Up||0||
48488022|NCT05093205|101529186|FG001|STARTED|Part A Period 8 - Follow-Up||0||
48488023|NCT05093205|101529187|FG002|STARTED|Part A Period 8 - Follow-Up||0||
48488024|NCT05093205|101529188|FG003|STARTED|Part A Period 8 - Follow-Up||0||
48488025|NCT05093205|101529189|FG004|STARTED|Part A Period 8 - Follow-Up||0||
48488026|NCT05093205|101529190|FG005|STARTED|Part A Period 8 - Follow-Up||0||
48488027|NCT05093205|101529191|FG006|STARTED|Part A Period 8 - Follow-Up||0||
48488028|NCT05093205|101529192|FG007|STARTED|Part A Period 8 - Follow-Up||6||
48488029|NCT05093205|101529193|FG008|STARTED|Part A Period 8 - Follow-Up||0||
48488030|NCT05093205|101529194|FG009|STARTED|Part A Period 8 - Follow-Up||0||
48488031|NCT05093205|101529195|FG010|STARTED|Part A Period 8 - Follow-Up||0||
48488032|NCT05093205|101529196|FG011|STARTED|Part A Period 8 - Follow-Up||0||
48488033|NCT05093205|101529197|FG012|STARTED|Part A Period 8 - Follow-Up||0||
48488034|NCT05093205|101529185|FG000|COMPLETED|Part A Period 8 - Follow-Up||0||
48488035|NCT05093205|101529186|FG001|COMPLETED|Part A Period 8 - Follow-Up||0||
48488036|NCT05093205|101529187|FG002|COMPLETED|Part A Period 8 - Follow-Up||0||
48488037|NCT05093205|101529188|FG003|COMPLETED|Part A Period 8 - Follow-Up||0||
48488038|NCT05093205|101529189|FG004|COMPLETED|Part A Period 8 - Follow-Up||0||
48488039|NCT05093205|101529190|FG005|COMPLETED|Part A Period 8 - Follow-Up||0||
48488040|NCT05093205|101529191|FG006|COMPLETED|Part A Period 8 - Follow-Up||0||
48488041|NCT05093205|101529192|FG007|COMPLETED|Part A Period 8 - Follow-Up||6||
48199543|NCT02503202|100810400|FG001|COMPLETED|Base Study: Up to Month 6||253||
48199544|NCT02503202|100810401|FG002|COMPLETED|Base Study: Up to Month 6||252||
48488042|NCT05093205|101529193|FG008|COMPLETED|Part A Period 8 - Follow-Up||0||
48488043|NCT05093205|101529194|FG009|COMPLETED|Part A Period 8 - Follow-Up||0||
48488044|NCT05093205|101529195|FG010|COMPLETED|Part A Period 8 - Follow-Up||0||
48488045|NCT05093205|101529196|FG011|COMPLETED|Part A Period 8 - Follow-Up||0||
48488046|NCT05093205|101529197|FG012|COMPLETED|Part A Period 8 - Follow-Up||0||
48488047|NCT05093205|101529185|FG000|NOT COMPLETED|Part A Period 8 - Follow-Up||0||
48488048|NCT05093205|101529186|FG001|NOT COMPLETED|Part A Period 8 - Follow-Up||0||
48488049|NCT05093205|101529187|FG002|NOT COMPLETED|Part A Period 8 - Follow-Up||0||
48488050|NCT05093205|101529188|FG003|NOT COMPLETED|Part A Period 8 - Follow-Up||0||
48488051|NCT05093205|101529189|FG004|NOT COMPLETED|Part A Period 8 - Follow-Up||0||
48488052|NCT05093205|101529190|FG005|NOT COMPLETED|Part A Period 8 - Follow-Up||0||
48488053|NCT05093205|101529191|FG006|NOT COMPLETED|Part A Period 8 - Follow-Up||0||
48488054|NCT05093205|101529192|FG007|NOT COMPLETED|Part A Period 8 - Follow-Up||0||
48488055|NCT05093205|101529193|FG008|NOT COMPLETED|Part A Period 8 - Follow-Up||0||
48488056|NCT05093205|101529194|FG009|NOT COMPLETED|Part A Period 8 - Follow-Up||0||
48488057|NCT05093205|101529195|FG010|NOT COMPLETED|Part A Period 8 - Follow-Up||0||
48488058|NCT05093205|101529196|FG011|NOT COMPLETED|Part A Period 8 - Follow-Up||0||
48488059|NCT05093205|101529197|FG012|NOT COMPLETED|Part A Period 8 - Follow-Up||0||
48488060|NCT05093205|101529185|FG000|STARTED|Part B Period 1 - Treatment||0||
48488061|NCT05093205|101529186|FG001|STARTED|Part B Period 1 - Treatment||0||
48488062|NCT05093205|101529187|FG002|STARTED|Part B Period 1 - Treatment||0||
48488063|NCT05093205|101529188|FG003|STARTED|Part B Period 1 - Treatment||0||
48488064|NCT05093205|101529189|FG004|STARTED|Part B Period 1 - Treatment||0||
48488065|NCT05093205|101529190|FG005|STARTED|Part B Period 1 - Treatment||0||
48488066|NCT05093205|101529191|FG006|STARTED|Part B Period 1 - Treatment||0||
48488067|NCT05093205|101529192|FG007|STARTED|Part B Period 1 - Treatment||0||
48488068|NCT05093205|101529193|FG008|STARTED|Part B Period 1 - Treatment||17||
48488069|NCT05093205|101529194|FG009|STARTED|Part B Period 1 - Treatment||0||
48488070|NCT05093205|101529195|FG010|STARTED|Part B Period 1 - Treatment||0||
48488071|NCT05093205|101529196|FG011|STARTED|Part B Period 1 - Treatment||0||
48488072|NCT05093205|101529197|FG012|STARTED|Part B Period 1 - Treatment||0||
48488073|NCT05093205|101529185|FG000|COMPLETED|Part B Period 1 - Treatment||0||
48488074|NCT05093205|101529186|FG001|COMPLETED|Part B Period 1 - Treatment||0||
48488075|NCT05093205|101529187|FG002|COMPLETED|Part B Period 1 - Treatment||0||
48488076|NCT05093205|101529188|FG003|COMPLETED|Part B Period 1 - Treatment||0||
48488077|NCT05093205|101529189|FG004|COMPLETED|Part B Period 1 - Treatment||0||
48488078|NCT05093205|101529190|FG005|COMPLETED|Part B Period 1 - Treatment||0||
48488079|NCT05093205|101529191|FG006|COMPLETED|Part B Period 1 - Treatment||0||
48488080|NCT05093205|101529192|FG007|COMPLETED|Part B Period 1 - Treatment||0||
48488081|NCT05093205|101529193|FG008|COMPLETED|Part B Period 1 - Treatment||16||
48488082|NCT05093205|101529194|FG009|COMPLETED|Part B Period 1 - Treatment||0||
48488083|NCT05093205|101529195|FG010|COMPLETED|Part B Period 1 - Treatment||0||
48488084|NCT05093205|101529196|FG011|COMPLETED|Part B Period 1 - Treatment||0||
48488085|NCT05093205|101529197|FG012|COMPLETED|Part B Period 1 - Treatment||0||
48488086|NCT05093205|101529185|FG000|NOT COMPLETED|Part B Period 1 - Treatment||0||
48488087|NCT05093205|101529186|FG001|NOT COMPLETED|Part B Period 1 - Treatment||0||
48488088|NCT05093205|101529187|FG002|NOT COMPLETED|Part B Period 1 - Treatment||0||
48488089|NCT05093205|101529188|FG003|NOT COMPLETED|Part B Period 1 - Treatment||0||
48488090|NCT05093205|101529189|FG004|NOT COMPLETED|Part B Period 1 - Treatment||0||
48488091|NCT05093205|101529190|FG005|NOT COMPLETED|Part B Period 1 - Treatment||0||
48488092|NCT05093205|101529191|FG006|NOT COMPLETED|Part B Period 1 - Treatment||0||
48488093|NCT05093205|101529192|FG007|NOT COMPLETED|Part B Period 1 - Treatment||0||
48488094|NCT05093205|101529193|FG008|NOT COMPLETED|Part B Period 1 - Treatment||1||
48199545|NCT02503202|100810402|FG003|COMPLETED|Base Study: Up to Month 6||255||
48488095|NCT05093205|101529194|FG009|NOT COMPLETED|Part B Period 1 - Treatment||0||
48488096|NCT05093205|101529195|FG010|NOT COMPLETED|Part B Period 1 - Treatment||0||
48488097|NCT05093205|101529196|FG011|NOT COMPLETED|Part B Period 1 - Treatment||0||
48488098|NCT05093205|101529197|FG012|NOT COMPLETED|Part B Period 1 - Treatment||0||
48488099|NCT05093205|101529185|FG000|STARTED|Part B Period 1 - Follow-Up||0||
48488100|NCT05093205|101529186|FG001|STARTED|Part B Period 1 - Follow-Up||0||
48488101|NCT05093205|101529187|FG002|STARTED|Part B Period 1 - Follow-Up||0||
48488102|NCT05093205|101529188|FG003|STARTED|Part B Period 1 - Follow-Up||0||
48488103|NCT05093205|101529189|FG004|STARTED|Part B Period 1 - Follow-Up||0||
48488104|NCT05093205|101529190|FG005|STARTED|Part B Period 1 - Follow-Up||0||
48488105|NCT05093205|101529191|FG006|STARTED|Part B Period 1 - Follow-Up||0||
48488106|NCT05093205|101529192|FG007|STARTED|Part B Period 1 - Follow-Up||0||
48488107|NCT05093205|101529193|FG008|STARTED|Part B Period 1 - Follow-Up||15||
48488108|NCT05093205|101529194|FG009|STARTED|Part B Period 1 - Follow-Up||0||
48488109|NCT05093205|101529195|FG010|STARTED|Part B Period 1 - Follow-Up||0||
48488110|NCT05093205|101529196|FG011|STARTED|Part B Period 1 - Follow-Up||0||
48488111|NCT05093205|101529197|FG012|STARTED|Part B Period 1 - Follow-Up||0||
48488112|NCT05093205|101529185|FG000|COMPLETED|Part B Period 1 - Follow-Up||0||
48488113|NCT05093205|101529186|FG001|COMPLETED|Part B Period 1 - Follow-Up||0||
48488114|NCT05093205|101529187|FG002|COMPLETED|Part B Period 1 - Follow-Up||0||
48488115|NCT05093205|101529188|FG003|COMPLETED|Part B Period 1 - Follow-Up||0||
48488116|NCT05093205|101529189|FG004|COMPLETED|Part B Period 1 - Follow-Up||0||
48488117|NCT05093205|101529190|FG005|COMPLETED|Part B Period 1 - Follow-Up||0||
48488118|NCT05093205|101529191|FG006|COMPLETED|Part B Period 1 - Follow-Up||0||
48488119|NCT05093205|101529192|FG007|COMPLETED|Part B Period 1 - Follow-Up||0||
48488120|NCT05093205|101529193|FG008|COMPLETED|Part B Period 1 - Follow-Up||15||
48488121|NCT05093205|101529194|FG009|COMPLETED|Part B Period 1 - Follow-Up||0||
48488122|NCT05093205|101529195|FG010|COMPLETED|Part B Period 1 - Follow-Up||0||
48488123|NCT05093205|101529196|FG011|COMPLETED|Part B Period 1 - Follow-Up||0||
48488124|NCT05093205|101529197|FG012|COMPLETED|Part B Period 1 - Follow-Up||0||
48488125|NCT05093205|101529185|FG000|NOT COMPLETED|Part B Period 1 - Follow-Up||0||
48488126|NCT05093205|101529186|FG001|NOT COMPLETED|Part B Period 1 - Follow-Up||0||
48488127|NCT05093205|101529187|FG002|NOT COMPLETED|Part B Period 1 - Follow-Up||0||
48488128|NCT05093205|101529188|FG003|NOT COMPLETED|Part B Period 1 - Follow-Up||0||
48488129|NCT05093205|101529189|FG004|NOT COMPLETED|Part B Period 1 - Follow-Up||0||
48488130|NCT05093205|101529190|FG005|NOT COMPLETED|Part B Period 1 - Follow-Up||0||
48488131|NCT05093205|101529191|FG006|NOT COMPLETED|Part B Period 1 - Follow-Up||0||
48488132|NCT05093205|101529192|FG007|NOT COMPLETED|Part B Period 1 - Follow-Up||0||
48488133|NCT05093205|101529193|FG008|NOT COMPLETED|Part B Period 1 - Follow-Up||0||
48488134|NCT05093205|101529194|FG009|NOT COMPLETED|Part B Period 1 - Follow-Up||0||
48488135|NCT05093205|101529195|FG010|NOT COMPLETED|Part B Period 1 - Follow-Up||0||
48488136|NCT05093205|101529196|FG011|NOT COMPLETED|Part B Period 1 - Follow-Up||0||
48488137|NCT05093205|101529197|FG012|NOT COMPLETED|Part B Period 1 - Follow-Up||0||
48488138|NCT05093205|101529185|FG000|STARTED|Part B Period 2 - Treatment||0||
48488139|NCT05093205|101529186|FG001|STARTED|Part B Period 2 - Treatment||0||
48488140|NCT05093205|101529187|FG002|STARTED|Part B Period 2 - Treatment||0||
48488141|NCT05093205|101529188|FG003|STARTED|Part B Period 2 - Treatment||0||
48488142|NCT05093205|101529189|FG004|STARTED|Part B Period 2 - Treatment||0||
48488143|NCT05093205|101529190|FG005|STARTED|Part B Period 2 - Treatment||0||
48488144|NCT05093205|101529191|FG006|STARTED|Part B Period 2 - Treatment||0||
48488145|NCT05093205|101529192|FG007|STARTED|Part B Period 2 - Treatment||0||
48488146|NCT05093205|101529193|FG008|STARTED|Part B Period 2 - Treatment||0||
48488147|NCT05093205|101529194|FG009|STARTED|Part B Period 2 - Treatment||16||
48488148|NCT05093205|101529195|FG010|STARTED|Part B Period 2 - Treatment||0||
48488149|NCT05093205|101529196|FG011|STARTED|Part B Period 2 - Treatment||0||
48488150|NCT05093205|101529197|FG012|STARTED|Part B Period 2 - Treatment||0||
48199546|NCT02503202|100810403|FG004|COMPLETED|Base Study: Up to Month 6||130||
48199547|NCT02503202|100810399|FG000|NOT COMPLETED|Base Study: Up to Month 6||18||
48199548|NCT02503202|100810400|FG001|NOT COMPLETED|Base Study: Up to Month 6||12||
48199549|NCT02503202|100810401|FG002|NOT COMPLETED|Base Study: Up to Month 6||15||
48199550|NCT02503202|100810402|FG003|NOT COMPLETED|Base Study: Up to Month 6||11||
48199551|NCT02503202|100810403|FG004|NOT COMPLETED|Base Study: Up to Month 6||3||
48199552|NCT02503202|100810399|FG000|STARTED|Extension: Month 6 to 24||119|A subset of US participants enrolled in Extension Study|
48199553|NCT02503202|100810400|FG001|STARTED|Extension: Month 6 to 24||130|A subset of US participants enrolled in Extension Study|
48199554|NCT02503202|100810401|FG002|STARTED|Extension: Month 6 to 24||112|A subset of US participants enrolled in Extension Study|
48199555|NCT02503202|100810402|FG003|STARTED|Extension: Month 6 to 24||137|A subset of US participants enrolled in Extension Study|
48199556|NCT02503202|100810403|FG004|STARTED|Extension: Month 6 to 24||68|A subset of US participants enrolled in Extension Study|
48199557|NCT02503202|100810399|FG000|COMPLETED|Extension: Month 6 to 24||108||
48199558|NCT02503202|100810400|FG001|COMPLETED|Extension: Month 6 to 24||114||
48199559|NCT02503202|100810401|FG002|COMPLETED|Extension: Month 6 to 24||103||
48488151|NCT05093205|101529185|FG000|COMPLETED|Part B Period 2 - Treatment||0||
48488152|NCT05093205|101529186|FG001|COMPLETED|Part B Period 2 - Treatment||0||
48488153|NCT05093205|101529187|FG002|COMPLETED|Part B Period 2 - Treatment||0||
48488154|NCT05093205|101529188|FG003|COMPLETED|Part B Period 2 - Treatment||0||
48488155|NCT05093205|101529189|FG004|COMPLETED|Part B Period 2 - Treatment||0||
48488156|NCT05093205|101529190|FG005|COMPLETED|Part B Period 2 - Treatment||0||
48488157|NCT05093205|101529191|FG006|COMPLETED|Part B Period 2 - Treatment||0||
48488158|NCT05093205|101529192|FG007|COMPLETED|Part B Period 2 - Treatment||0||
48488159|NCT05093205|101529193|FG008|COMPLETED|Part B Period 2 - Treatment||0||
48199560|NCT02503202|100810402|FG003|COMPLETED|Extension: Month 6 to 24||119||
48199561|NCT02503202|100810403|FG004|COMPLETED|Extension: Month 6 to 24||67||
48199562|NCT02503202|100810399|FG000|NOT COMPLETED|Extension: Month 6 to 24||11||
48488160|NCT05093205|101529194|FG009|COMPLETED|Part B Period 2 - Treatment||14||
48199563|NCT02503202|100810400|FG001|NOT COMPLETED|Extension: Month 6 to 24||16||
48199564|NCT02503202|100810401|FG002|NOT COMPLETED|Extension: Month 6 to 24||9||
48199565|NCT02503202|100810402|FG003|NOT COMPLETED|Extension: Month 6 to 24||18||
48199566|NCT02503202|100810403|FG004|NOT COMPLETED|Extension: Month 6 to 24||1||
48199567|NCT03667547|100810404|FG000|STARTED|Overall Study||12||
48199568|NCT03667547|100810404|FG000|COMPLETED|Overall Study||12||
48199569|NCT03667547|100810404|FG000|NOT COMPLETED|Overall Study||0||
48199570|NCT01549314|100810405|FG000|STARTED|Overall Study||27||
48199571|NCT01549314|100810406|FG001|STARTED|Overall Study||26||
48199572|NCT01549314|100810407|FG002|STARTED|Overall Study||26||
48199573|NCT01549314|100810405|FG000|COMPLETED|Overall Study||23||
48199574|NCT01549314|100810406|FG001|COMPLETED|Overall Study||21||
48199575|NCT01549314|100810407|FG002|COMPLETED|Overall Study||24||
48199576|NCT01549314|100810405|FG000|NOT COMPLETED|Overall Study||4||
48199577|NCT01549314|100810406|FG001|NOT COMPLETED|Overall Study||5||
48488161|NCT05093205|101529195|FG010|COMPLETED|Part B Period 2 - Treatment||0||
48488162|NCT05093205|101529196|FG011|COMPLETED|Part B Period 2 - Treatment||0||
48488163|NCT05093205|101529197|FG012|COMPLETED|Part B Period 2 - Treatment||0||
48488164|NCT05093205|101529185|FG000|NOT COMPLETED|Part B Period 2 - Treatment||0||
48488165|NCT05093205|101529186|FG001|NOT COMPLETED|Part B Period 2 - Treatment||0||
48488166|NCT05093205|101529187|FG002|NOT COMPLETED|Part B Period 2 - Treatment||0||
48488167|NCT05093205|101529188|FG003|NOT COMPLETED|Part B Period 2 - Treatment||0||
48488168|NCT05093205|101529189|FG004|NOT COMPLETED|Part B Period 2 - Treatment||0||
48488169|NCT05093205|101529190|FG005|NOT COMPLETED|Part B Period 2 - Treatment||0||
48488170|NCT05093205|101529191|FG006|NOT COMPLETED|Part B Period 2 - Treatment||0||
48488171|NCT05093205|101529192|FG007|NOT COMPLETED|Part B Period 2 - Treatment||0||
48488172|NCT05093205|101529193|FG008|NOT COMPLETED|Part B Period 2 - Treatment||0||
48488173|NCT05093205|101529194|FG009|NOT COMPLETED|Part B Period 2 - Treatment||2||
48488174|NCT05093205|101529195|FG010|NOT COMPLETED|Part B Period 2 - Treatment||0||
48488175|NCT05093205|101529196|FG011|NOT COMPLETED|Part B Period 2 - Treatment||0||
48488176|NCT05093205|101529197|FG012|NOT COMPLETED|Part B Period 2 - Treatment||0||
48488177|NCT05093205|101529185|FG000|STARTED|Part B Period 2 - Follow-Up||0||
48488178|NCT05093205|101529186|FG001|STARTED|Part B Period 2 - Follow-Up||0||
48488179|NCT05093205|101529187|FG002|STARTED|Part B Period 2 - Follow-Up||0||
48488180|NCT05093205|101529188|FG003|STARTED|Part B Period 2 - Follow-Up||0||
48488181|NCT05093205|101529189|FG004|STARTED|Part B Period 2 - Follow-Up||0||
48488182|NCT05093205|101529190|FG005|STARTED|Part B Period 2 - Follow-Up||0||
48488183|NCT05093205|101529191|FG006|STARTED|Part B Period 2 - Follow-Up||0||
48488184|NCT05093205|101529192|FG007|STARTED|Part B Period 2 - Follow-Up||0||
48488185|NCT05093205|101529193|FG008|STARTED|Part B Period 2 - Follow-Up||0||
48488186|NCT05093205|101529194|FG009|STARTED|Part B Period 2 - Follow-Up||15||
48488187|NCT05093205|101529195|FG010|STARTED|Part B Period 2 - Follow-Up||0||
48488188|NCT05093205|101529196|FG011|STARTED|Part B Period 2 - Follow-Up||0||
48488189|NCT05093205|101529197|FG012|STARTED|Part B Period 2 - Follow-Up||0||
48199578|NCT01549314|100810407|FG002|NOT COMPLETED|Overall Study||2||
48199579|NCT00496379|100810408|FG000|STARTED|Overall Study||15||
48199580|NCT00496379|100810408|FG000|COMPLETED|Overall Study||15||
48199581|NCT00496379|100810408|FG000|NOT COMPLETED|Overall Study||0||
48199582|NCT01119950|100810409|FG000|STARTED|Overall Study||388||
48199583|NCT01119950|100810409|FG000|NVA237 12.5 ug q.d.|Overall Study||96||
48488190|NCT05093205|101529185|FG000|COMPLETED|Part B Period 2 - Follow-Up||0||
48488191|NCT05093205|101529186|FG001|COMPLETED|Part B Period 2 - Follow-Up||0||
48488192|NCT05093205|101529187|FG002|COMPLETED|Part B Period 2 - Follow-Up||0||
48488193|NCT05093205|101529188|FG003|COMPLETED|Part B Period 2 - Follow-Up||0||
48488194|NCT05093205|101529189|FG004|COMPLETED|Part B Period 2 - Follow-Up||0||
48488195|NCT05093205|101529190|FG005|COMPLETED|Part B Period 2 - Follow-Up||0||
48488196|NCT05093205|101529191|FG006|COMPLETED|Part B Period 2 - Follow-Up||0||
48488197|NCT05093205|101529192|FG007|COMPLETED|Part B Period 2 - Follow-Up||0||
48488198|NCT05093205|101529193|FG008|COMPLETED|Part B Period 2 - Follow-Up||0||
48488199|NCT05093205|101529194|FG009|COMPLETED|Part B Period 2 - Follow-Up||14||
48488200|NCT05093205|101529195|FG010|COMPLETED|Part B Period 2 - Follow-Up||0||
48488201|NCT05093205|101529196|FG011|COMPLETED|Part B Period 2 - Follow-Up||0||
48488202|NCT05093205|101529197|FG012|COMPLETED|Part B Period 2 - Follow-Up||0||
48488203|NCT05093205|101529185|FG000|NOT COMPLETED|Part B Period 2 - Follow-Up||0||
48488204|NCT05093205|101529186|FG001|NOT COMPLETED|Part B Period 2 - Follow-Up||0||
48488205|NCT05093205|101529187|FG002|NOT COMPLETED|Part B Period 2 - Follow-Up||0||
48488206|NCT05093205|101529188|FG003|NOT COMPLETED|Part B Period 2 - Follow-Up||0||
48488207|NCT05093205|101529189|FG004|NOT COMPLETED|Part B Period 2 - Follow-Up||0||
48488208|NCT05093205|101529190|FG005|NOT COMPLETED|Part B Period 2 - Follow-Up||0||
48488209|NCT05093205|101529191|FG006|NOT COMPLETED|Part B Period 2 - Follow-Up||0||
48488210|NCT05093205|101529192|FG007|NOT COMPLETED|Part B Period 2 - Follow-Up||0||
48488211|NCT05093205|101529193|FG008|NOT COMPLETED|Part B Period 2 - Follow-Up||0||
48488212|NCT05093205|101529194|FG009|NOT COMPLETED|Part B Period 2 - Follow-Up||1||
48488213|NCT05093205|101529195|FG010|NOT COMPLETED|Part B Period 2 - Follow-Up||0||
48488214|NCT05093205|101529196|FG011|NOT COMPLETED|Part B Period 2 - Follow-Up||0||
48488215|NCT05093205|101529197|FG012|NOT COMPLETED|Part B Period 2 - Follow-Up||0||
48666593|NCT02374255|101967621|FG001|COMPLETED|Overall Study||110||
48666594|NCT02374255|101967622|FG002|COMPLETED|Overall Study||11||
48199584|NCT01119950|100810409|FG000|NVA237 25 ug q.d.|Overall Study||99||
48199585|NCT01119950|100810409|FG000|NVA237 12.5 ug b.i.d.|Overall Study||99||
48199586|NCT01119950|100810409|FG000|NVA237 50 ug q.d.|Overall Study||96||
48199587|NCT01119950|100810409|FG000|NVA237 25 ug b.i.d.|Overall Study||100||
48199588|NCT01119950|100810409|FG000|NVA237 100 ug q.d.|Overall Study||98||
48199589|NCT01119950|100810409|FG000|NVA237 50 ug b.i.d.|Overall Study||94||
48199590|NCT01119950|100810409|FG000|Placebo|Overall Study||94||
48199591|NCT01119950|100810409|FG000|COMPLETED|Overall Study||341||
48199592|NCT01119950|100810409|FG000|NOT COMPLETED|Overall Study||47||
48199593|NCT02749045|100810410|FG000|STARTED|Overall Study||27||
48199594|NCT02749045|100810410|FG000|COMPLETED|Overall Study||27||
48199595|NCT02749045|100810410|FG000|NOT COMPLETED|Overall Study||0||
48199596|NCT04173572|100810411|FG000|STARTED|Overall Study||24||
48199597|NCT04173572|100810412|FG001|STARTED|Overall Study||26||
48199598|NCT04173572|100810411|FG000|Cohort 1|Overall Study||7||
48199599|NCT04173572|100810412|FG001|Cohort 1|Overall Study||6||
48199600|NCT04173572|100810411|FG000|Cohort 2|Overall Study||8||
48199601|NCT04173572|100810412|FG001|Cohort 2|Overall Study||12||
48199602|NCT04173572|100810411|FG000|Cohort 3|Overall Study||9||
48199603|NCT04173572|100810412|FG001|Cohort 3|Overall Study||8||
48199604|NCT04173572|100810411|FG000|COMPLETED|Overall Study||20||
48199605|NCT04173572|100810412|FG001|COMPLETED|Overall Study||20||
48199606|NCT04173572|100810411|FG000|NOT COMPLETED|Overall Study||4||
48199607|NCT04173572|100810412|FG001|NOT COMPLETED|Overall Study||6||
48488216|NCT05093205|101529185|FG000|STARTED|Part B Period 3 - Treatment||0||
48488217|NCT05093205|101529186|FG001|STARTED|Part B Period 3 - Treatment||0||
48488218|NCT05093205|101529187|FG002|STARTED|Part B Period 3 - Treatment||0||
48199608|NCT03386929|100810413|FG000|STARTED|Overall Study||6||
48199609|NCT03386929|100810414|FG001|STARTED|Overall Study||6||
48199610|NCT03386929|100810415|FG002|STARTED|Overall Study||3||
48199611|NCT03386929|100810413|FG000|COMPLETED|Overall Study||0||
48199612|NCT03386929|100810414|FG001|COMPLETED|Overall Study||0||
48199613|NCT03386929|100810415|FG002|COMPLETED|Overall Study||0||
48199614|NCT03386929|100810413|FG000|NOT COMPLETED|Overall Study||6||
48199615|NCT03386929|100810414|FG001|NOT COMPLETED|Overall Study||6||
48199616|NCT03386929|100810415|FG002|NOT COMPLETED|Overall Study||3||
48199617|NCT02577523|100810416|FG000|STARTED|Overall Study||19||
48199618|NCT02577523|100810417|FG001|STARTED|Overall Study||19||
48199619|NCT02577523|100810416|FG000|COMPLETED|Overall Study||16||
48199620|NCT02577523|100810417|FG001|COMPLETED|Overall Study||17||
48199621|NCT02577523|100810416|FG000|NOT COMPLETED|Overall Study||3||
48199622|NCT02577523|100810417|FG001|NOT COMPLETED|Overall Study||2||
48199623|NCT00109967|100810418|FG000|STARTED|Overall Study||50||
48199624|NCT00109967|100810419|FG001|STARTED|Overall Study||21||
48199625|NCT00109967|100810418|FG000|COMPLETED|Overall Study||30||
48199626|NCT00109967|100810419|FG001|COMPLETED|Overall Study||15||
48199627|NCT00109967|100810418|FG000|NOT COMPLETED|Overall Study||20||
48199628|NCT00109967|100810419|FG001|NOT COMPLETED|Overall Study||6||
48199629|NCT02699970|100810420|FG000|STARTED|Overall Study||399||420
48199630|NCT02699970|100810420|FG000|Intra-system|Overall Study||399||420
48199631|NCT02699970|100810420|FG000|Inter-system|Overall Study||399||420
48199632|NCT02699970|100810420|FG000|COMPLETED|Overall Study||399||420
48199633|NCT02699970|100810420|FG000|NOT COMPLETED|Overall Study||0||0
48199634|NCT01859312|100810421|FG000|STARTED|Overall Study||8||
48199635|NCT01859312|100810421|FG000|COMPLETED|Overall Study||8||
48199636|NCT01859312|100810421|FG000|NOT COMPLETED|Overall Study||0||
48199637|NCT00920686|100810422|FG000|STARTED|Overall Study||82||
48199638|NCT00920686|100810423|FG001|STARTED|Overall Study||82||
48488219|NCT05093205|101529188|FG003|STARTED|Part B Period 3 - Treatment||0||
48199639|NCT00920686|100810424|FG002|STARTED|Overall Study||75||
48199640|NCT00920686|100810422|FG000|COMPLETED|Overall Study||63||
48199641|NCT00920686|100810423|FG001|COMPLETED|Overall Study||60||
48199642|NCT00920686|100810424|FG002|COMPLETED|Overall Study||62||
48199643|NCT00920686|100810422|FG000|NOT COMPLETED|Overall Study||19||
48199644|NCT00920686|100810423|FG001|NOT COMPLETED|Overall Study||22||
48199645|NCT00920686|100810424|FG002|NOT COMPLETED|Overall Study||13||
48199646|NCT03603717|100810425|FG000|STARTED|Overall Study||98||
48199647|NCT03603717|100810426|FG001|STARTED|Overall Study||96||
48199648|NCT03603717|100810425|FG000|COMPLETED|Overall Study||62||
48199649|NCT03603717|100810426|FG001|COMPLETED|Overall Study||66||
48199650|NCT03603717|100810425|FG000|NOT COMPLETED|Overall Study||36||
48199651|NCT03603717|100810426|FG001|NOT COMPLETED|Overall Study||30||
48199652|NCT03396835|100810427|FG000|STARTED|Overall Study||16||
48199653|NCT03396835|100810427|FG000|COMPLETED|Overall Study||14||
48199654|NCT03396835|100810427|FG000|NOT COMPLETED|Overall Study||2||
48199655|NCT00580073|100810428|FG000|STARTED|Overall Study||6||
48199656|NCT00580073|100810428|FG000|COMPLETED|Overall Study||6||
48199657|NCT00580073|100810428|FG000|NOT COMPLETED|Overall Study||0||
48199658|NCT01178762|100810429|FG000|STARTED|Overall Study||42||
48199659|NCT01178762|100810429|FG000|COMPLETED|Overall Study||27||
48199660|NCT01178762|100810429|FG000|NOT COMPLETED|Overall Study||15||
48199661|NCT02317016|100810430|FG000|STARTED|Part A: Day 1-3 (Rosuvastatin Alone)||44||
48199662|NCT02317016|100810430|FG000|COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||44||
48199663|NCT02317016|100810430|FG000|NOT COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||0||
48199664|NCT02317016|100810430|FG000|STARTED|Part A: Day 4-31 (AZD9291 Alone)||44||
48199665|NCT02317016|100810430|FG000|COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||43||
48199666|NCT02317016|100810430|FG000|NOT COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||1||
48199667|NCT02317016|100810430|FG000|STARTED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||43||
48199668|NCT02317016|100810430|FG000|COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||41||
48199669|NCT02317016|100810430|FG000|NOT COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||2||
48199670|NCT02317016|100810430|FG000|STARTED|Part B: Day 35 to End Part B (AZD9291)||42||
48199671|NCT02317016|100810430|FG000|COMPLETED|Part B: Day 35 to End Part B (AZD9291)||11||
48199672|NCT02317016|100810430|FG000|NOT COMPLETED|Part B: Day 35 to End Part B (AZD9291)||31||
48199673|NCT02390557|100810431|FG000|STARTED|Wave 1||160||9
48199674|NCT02390557|100810432|FG001|STARTED|Wave 1||156||9
48199675|NCT02390557|100810433|FG002|STARTED|Wave 1||135||9
48199676|NCT02390557|100810431|FG000|COMPLETED|Wave 1||160||9
48199677|NCT02390557|100810432|FG001|COMPLETED|Wave 1||156||9
48199678|NCT02390557|100810433|FG002|COMPLETED|Wave 1||135||9
48199679|NCT02390557|100810431|FG000|NOT COMPLETED|Wave 1||0||0
48199680|NCT02390557|100810432|FG001|NOT COMPLETED|Wave 1||0||0
48199681|NCT02390557|100810433|FG002|NOT COMPLETED|Wave 1||0||0
48199682|NCT02390557|100810431|FG000|STARTED|Wave 2||160||9
48199683|NCT02390557|100810432|FG001|STARTED|Wave 2||156||9
48199684|NCT02390557|100810433|FG002|STARTED|Wave 2||135||9
48199685|NCT02390557|100810431|FG000|COMPLETED|Wave 2||88||9
48199686|NCT02390557|100810432|FG001|COMPLETED|Wave 2||115||9
48199687|NCT02390557|100810433|FG002|COMPLETED|Wave 2||112||9
48199688|NCT02390557|100810431|FG000|NOT COMPLETED|Wave 2||72||0
48199689|NCT02390557|100810432|FG001|NOT COMPLETED|Wave 2||41||0
48199690|NCT02390557|100810433|FG002|NOT COMPLETED|Wave 2||23||0
48199691|NCT02333630|100810434|FG000|STARTED|Overall Study||100||
48199692|NCT02333630|100810435|FG001|STARTED|Overall Study||100||
48199693|NCT02333630|100810434|FG000|COMPLETED|Overall Study||95||
48199694|NCT02333630|100810435|FG001|COMPLETED|Overall Study||98||
48488220|NCT05093205|101529189|FG004|STARTED|Part B Period 3 - Treatment||0||
48488221|NCT05093205|101529190|FG005|STARTED|Part B Period 3 - Treatment||0||
48488222|NCT05093205|101529191|FG006|STARTED|Part B Period 3 - Treatment||0||
48488223|NCT05093205|101529192|FG007|STARTED|Part B Period 3 - Treatment||0||
48488224|NCT05093205|101529193|FG008|STARTED|Part B Period 3 - Treatment||0||
48488225|NCT05093205|101529194|FG009|STARTED|Part B Period 3 - Treatment||0||
48488226|NCT05093205|101529195|FG010|STARTED|Part B Period 3 - Treatment||14||
48488227|NCT05093205|101529196|FG011|STARTED|Part B Period 3 - Treatment||0||
48488228|NCT05093205|101529197|FG012|STARTED|Part B Period 3 - Treatment||0||
48488229|NCT05093205|101529185|FG000|COMPLETED|Part B Period 3 - Treatment||0||
48488230|NCT05093205|101529186|FG001|COMPLETED|Part B Period 3 - Treatment||0||
48488231|NCT05093205|101529187|FG002|COMPLETED|Part B Period 3 - Treatment||0||
48488232|NCT05093205|101529188|FG003|COMPLETED|Part B Period 3 - Treatment||0||
48488233|NCT05093205|101529189|FG004|COMPLETED|Part B Period 3 - Treatment||0||
48488234|NCT05093205|101529190|FG005|COMPLETED|Part B Period 3 - Treatment||0||
48488235|NCT05093205|101529191|FG006|COMPLETED|Part B Period 3 - Treatment||0||
48488236|NCT05093205|101529192|FG007|COMPLETED|Part B Period 3 - Treatment||0||
48488237|NCT05093205|101529193|FG008|COMPLETED|Part B Period 3 - Treatment||0||
48488238|NCT05093205|101529194|FG009|COMPLETED|Part B Period 3 - Treatment||0||
48488239|NCT05093205|101529195|FG010|COMPLETED|Part B Period 3 - Treatment||12||
48488240|NCT05093205|101529196|FG011|COMPLETED|Part B Period 3 - Treatment||0||
48488241|NCT05093205|101529197|FG012|COMPLETED|Part B Period 3 - Treatment||0||
48199695|NCT02333630|100810434|FG000|NOT COMPLETED|Overall Study||5||
48199696|NCT02333630|100810435|FG001|NOT COMPLETED|Overall Study||2||
48199697|NCT00329732|100810436|FG000|STARTED|Overall Study||2||
48199698|NCT00329732|100810437|FG001|STARTED|Overall Study||0||
48199699|NCT00329732|100810436|FG000|COMPLETED|Overall Study||2||
48199700|NCT00329732|100810437|FG001|COMPLETED|Overall Study||0||
48199701|NCT00329732|100810436|FG000|NOT COMPLETED|Overall Study||0||
48199702|NCT00329732|100810437|FG001|NOT COMPLETED|Overall Study||0||
48199703|NCT03357341|100810438|FG000|STARTED|Overall Study||96||
48199704|NCT03357341|100810439|FG001|STARTED|Overall Study||98||
48199705|NCT03357341|100810438|FG000|COMPLETED|Overall Study||89||
48199706|NCT03357341|100810439|FG001|COMPLETED|Overall Study||86||
48199707|NCT03357341|100810438|FG000|NOT COMPLETED|Overall Study||7||
48199708|NCT03357341|100810439|FG001|NOT COMPLETED|Overall Study||12||
48199709|NCT01608971|100810440|FG000|STARTED|Overall Study||15||
48199710|NCT01608971|100810441|FG001|STARTED|Overall Study||15||
48199711|NCT01608971|100810440|FG000|COMPLETED|Overall Study||15||
48199712|NCT01608971|100810441|FG001|COMPLETED|Overall Study||15||
48488242|NCT05093205|101529185|FG000|NOT COMPLETED|Part B Period 3 - Treatment||0||
48488243|NCT05093205|101529186|FG001|NOT COMPLETED|Part B Period 3 - Treatment||0||
48488244|NCT05093205|101529187|FG002|NOT COMPLETED|Part B Period 3 - Treatment||0||
48488245|NCT05093205|101529188|FG003|NOT COMPLETED|Part B Period 3 - Treatment||0||
48488246|NCT05093205|101529189|FG004|NOT COMPLETED|Part B Period 3 - Treatment||0||
48488247|NCT05093205|101529190|FG005|NOT COMPLETED|Part B Period 3 - Treatment||0||
48488248|NCT05093205|101529191|FG006|NOT COMPLETED|Part B Period 3 - Treatment||0||
48488249|NCT05093205|101529192|FG007|NOT COMPLETED|Part B Period 3 - Treatment||0||
48488250|NCT05093205|101529193|FG008|NOT COMPLETED|Part B Period 3 - Treatment||0||
48488251|NCT05093205|101529194|FG009|NOT COMPLETED|Part B Period 3 - Treatment||0||
48488252|NCT05093205|101529195|FG010|NOT COMPLETED|Part B Period 3 - Treatment||2||
48488253|NCT05093205|101529196|FG011|NOT COMPLETED|Part B Period 3 - Treatment||0||
48488254|NCT05093205|101529197|FG012|NOT COMPLETED|Part B Period 3 - Treatment||0||
48488255|NCT05093205|101529185|FG000|STARTED|Part B Period 3 - Follow-Up||0||
48488256|NCT05093205|101529186|FG001|STARTED|Part B Period 3 - Follow-Up||0||
48488257|NCT05093205|101529187|FG002|STARTED|Part B Period 3 - Follow-Up||0||
48488258|NCT05093205|101529188|FG003|STARTED|Part B Period 3 - Follow-Up||0||
48488259|NCT05093205|101529189|FG004|STARTED|Part B Period 3 - Follow-Up||0||
48488260|NCT05093205|101529190|FG005|STARTED|Part B Period 3 - Follow-Up||0||
48488261|NCT05093205|101529191|FG006|STARTED|Part B Period 3 - Follow-Up||0||
48488262|NCT05093205|101529192|FG007|STARTED|Part B Period 3 - Follow-Up||0||
48488263|NCT05093205|101529193|FG008|STARTED|Part B Period 3 - Follow-Up||0||
48488264|NCT05093205|101529194|FG009|STARTED|Part B Period 3 - Follow-Up||0||
48488265|NCT05093205|101529195|FG010|STARTED|Part B Period 3 - Follow-Up||13||
48488266|NCT05093205|101529196|FG011|STARTED|Part B Period 3 - Follow-Up||0||
48488267|NCT05093205|101529197|FG012|STARTED|Part B Period 3 - Follow-Up||0||
48488268|NCT05093205|101529185|FG000|COMPLETED|Part B Period 3 - Follow-Up||0||
48488269|NCT05093205|101529186|FG001|COMPLETED|Part B Period 3 - Follow-Up||0||
48488270|NCT05093205|101529187|FG002|COMPLETED|Part B Period 3 - Follow-Up||0||
48488271|NCT05093205|101529188|FG003|COMPLETED|Part B Period 3 - Follow-Up||0||
48488272|NCT05093205|101529189|FG004|COMPLETED|Part B Period 3 - Follow-Up||0||
48488273|NCT05093205|101529190|FG005|COMPLETED|Part B Period 3 - Follow-Up||0||
48488274|NCT05093205|101529191|FG006|COMPLETED|Part B Period 3 - Follow-Up||0||
48488275|NCT05093205|101529192|FG007|COMPLETED|Part B Period 3 - Follow-Up||0||
48488276|NCT05093205|101529193|FG008|COMPLETED|Part B Period 3 - Follow-Up||0||
48488277|NCT05093205|101529194|FG009|COMPLETED|Part B Period 3 - Follow-Up||0||
48488278|NCT05093205|101529195|FG010|COMPLETED|Part B Period 3 - Follow-Up||11||
48488279|NCT05093205|101529196|FG011|COMPLETED|Part B Period 3 - Follow-Up||0||
48488280|NCT05093205|101529197|FG012|COMPLETED|Part B Period 3 - Follow-Up||0||
48488281|NCT05093205|101529185|FG000|NOT COMPLETED|Part B Period 3 - Follow-Up||0||
48488282|NCT05093205|101529186|FG001|NOT COMPLETED|Part B Period 3 - Follow-Up||0||
48488283|NCT05093205|101529187|FG002|NOT COMPLETED|Part B Period 3 - Follow-Up||0||
48488284|NCT05093205|101529188|FG003|NOT COMPLETED|Part B Period 3 - Follow-Up||0||
48488285|NCT05093205|101529189|FG004|NOT COMPLETED|Part B Period 3 - Follow-Up||0||
48488286|NCT05093205|101529190|FG005|NOT COMPLETED|Part B Period 3 - Follow-Up||0||
48488287|NCT05093205|101529191|FG006|NOT COMPLETED|Part B Period 3 - Follow-Up||0||
48488288|NCT05093205|101529192|FG007|NOT COMPLETED|Part B Period 3 - Follow-Up||0||
48488289|NCT05093205|101529193|FG008|NOT COMPLETED|Part B Period 3 - Follow-Up||0||
48488290|NCT05093205|101529194|FG009|NOT COMPLETED|Part B Period 3 - Follow-Up||0||
48488291|NCT05093205|101529195|FG010|NOT COMPLETED|Part B Period 3 - Follow-Up||2||
48488292|NCT05093205|101529196|FG011|NOT COMPLETED|Part B Period 3 - Follow-Up||0||
48488293|NCT05093205|101529197|FG012|NOT COMPLETED|Part B Period 3 - Follow-Up||0||
48488294|NCT05093205|101529185|FG000|STARTED|Part B Period 4 - Treatment||0||
48488295|NCT05093205|101529186|FG001|STARTED|Part B Period 4 - Treatment||0||
48488296|NCT05093205|101529187|FG002|STARTED|Part B Period 4 - Treatment||0||
48488297|NCT05093205|101529188|FG003|STARTED|Part B Period 4 - Treatment||0||
48488298|NCT05093205|101529189|FG004|STARTED|Part B Period 4 - Treatment||0||
48488299|NCT05093205|101529190|FG005|STARTED|Part B Period 4 - Treatment||0||
48488300|NCT05093205|101529191|FG006|STARTED|Part B Period 4 - Treatment||0||
48488301|NCT05093205|101529192|FG007|STARTED|Part B Period 4 - Treatment||0||
48488302|NCT05093205|101529193|FG008|STARTED|Part B Period 4 - Treatment||0||
48488303|NCT05093205|101529194|FG009|STARTED|Part B Period 4 - Treatment||0||
48488304|NCT05093205|101529195|FG010|STARTED|Part B Period 4 - Treatment||0||
48488305|NCT05093205|101529196|FG011|STARTED|Part B Period 4 - Treatment||12||
48488306|NCT05093205|101529197|FG012|STARTED|Part B Period 4 - Treatment||0||
48488307|NCT05093205|101529185|FG000|COMPLETED|Part B Period 4 - Treatment||0||
48488308|NCT05093205|101529186|FG001|COMPLETED|Part B Period 4 - Treatment||0||
48488309|NCT05093205|101529187|FG002|COMPLETED|Part B Period 4 - Treatment||0||
48488310|NCT05093205|101529188|FG003|COMPLETED|Part B Period 4 - Treatment||0||
48488311|NCT05093205|101529189|FG004|COMPLETED|Part B Period 4 - Treatment||0||
48488312|NCT05093205|101529190|FG005|COMPLETED|Part B Period 4 - Treatment||0||
48488313|NCT05093205|101529191|FG006|COMPLETED|Part B Period 4 - Treatment||0||
48488314|NCT05093205|101529192|FG007|COMPLETED|Part B Period 4 - Treatment||0||
48488315|NCT05093205|101529193|FG008|COMPLETED|Part B Period 4 - Treatment||0||
48488316|NCT05093205|101529194|FG009|COMPLETED|Part B Period 4 - Treatment||0||
48488317|NCT05093205|101529195|FG010|COMPLETED|Part B Period 4 - Treatment||0||
48488318|NCT05093205|101529196|FG011|COMPLETED|Part B Period 4 - Treatment||9||
48488319|NCT05093205|101529197|FG012|COMPLETED|Part B Period 4 - Treatment||0||
48488320|NCT05093205|101529185|FG000|NOT COMPLETED|Part B Period 4 - Treatment||0||
48488321|NCT05093205|101529186|FG001|NOT COMPLETED|Part B Period 4 - Treatment||0||
48488322|NCT05093205|101529187|FG002|NOT COMPLETED|Part B Period 4 - Treatment||0||
48488323|NCT05093205|101529188|FG003|NOT COMPLETED|Part B Period 4 - Treatment||0||
48488324|NCT05093205|101529189|FG004|NOT COMPLETED|Part B Period 4 - Treatment||0||
48488325|NCT05093205|101529190|FG005|NOT COMPLETED|Part B Period 4 - Treatment||0||
48488326|NCT05093205|101529191|FG006|NOT COMPLETED|Part B Period 4 - Treatment||0||
48488327|NCT05093205|101529192|FG007|NOT COMPLETED|Part B Period 4 - Treatment||0||
48488328|NCT05093205|101529193|FG008|NOT COMPLETED|Part B Period 4 - Treatment||0||
48488329|NCT05093205|101529194|FG009|NOT COMPLETED|Part B Period 4 - Treatment||0||
48488330|NCT05093205|101529195|FG010|NOT COMPLETED|Part B Period 4 - Treatment||0||
48488331|NCT05093205|101529196|FG011|NOT COMPLETED|Part B Period 4 - Treatment||3||
48488332|NCT05093205|101529197|FG012|NOT COMPLETED|Part B Period 4 - Treatment||0||
48488333|NCT05093205|101529185|FG000|STARTED|Part B Period 4 - Follow-Up||0||
48488334|NCT05093205|101529186|FG001|STARTED|Part B Period 4 - Follow-Up||0||
48488335|NCT05093205|101529187|FG002|STARTED|Part B Period 4 - Follow-Up||0||
48488336|NCT05093205|101529188|FG003|STARTED|Part B Period 4 - Follow-Up||0||
48488337|NCT05093205|101529189|FG004|STARTED|Part B Period 4 - Follow-Up||0||
48488338|NCT05093205|101529190|FG005|STARTED|Part B Period 4 - Follow-Up||0||
48488339|NCT05093205|101529191|FG006|STARTED|Part B Period 4 - Follow-Up||0||
48488340|NCT05093205|101529192|FG007|STARTED|Part B Period 4 - Follow-Up||0||
48488341|NCT05093205|101529193|FG008|STARTED|Part B Period 4 - Follow-Up||0||
48488342|NCT05093205|101529194|FG009|STARTED|Part B Period 4 - Follow-Up||0||
48488343|NCT05093205|101529195|FG010|STARTED|Part B Period 4 - Follow-Up||0||
48488344|NCT05093205|101529196|FG011|STARTED|Part B Period 4 - Follow-Up||11||
48488345|NCT05093205|101529197|FG012|STARTED|Part B Period 4 - Follow-Up||0||
48488346|NCT05093205|101529185|FG000|COMPLETED|Part B Period 4 - Follow-Up||0||
48488347|NCT05093205|101529186|FG001|COMPLETED|Part B Period 4 - Follow-Up||0||
48488348|NCT05093205|101529187|FG002|COMPLETED|Part B Period 4 - Follow-Up||0||
48488349|NCT05093205|101529188|FG003|COMPLETED|Part B Period 4 - Follow-Up||0||
48488350|NCT05093205|101529189|FG004|COMPLETED|Part B Period 4 - Follow-Up||0||
48488351|NCT05093205|101529190|FG005|COMPLETED|Part B Period 4 - Follow-Up||0||
48488352|NCT05093205|101529191|FG006|COMPLETED|Part B Period 4 - Follow-Up||0||
48488353|NCT05093205|101529192|FG007|COMPLETED|Part B Period 4 - Follow-Up||0||
48488354|NCT05093205|101529193|FG008|COMPLETED|Part B Period 4 - Follow-Up||0||
48488355|NCT05093205|101529194|FG009|COMPLETED|Part B Period 4 - Follow-Up||0||
48488356|NCT05093205|101529195|FG010|COMPLETED|Part B Period 4 - Follow-Up||0||
48488357|NCT05093205|101529196|FG011|COMPLETED|Part B Period 4 - Follow-Up||10||
48488358|NCT05093205|101529197|FG012|COMPLETED|Part B Period 4 - Follow-Up||0||
48488359|NCT05093205|101529185|FG000|NOT COMPLETED|Part B Period 4 - Follow-Up||0||
48488360|NCT05093205|101529186|FG001|NOT COMPLETED|Part B Period 4 - Follow-Up||0||
48488361|NCT05093205|101529187|FG002|NOT COMPLETED|Part B Period 4 - Follow-Up||0||
48488362|NCT05093205|101529188|FG003|NOT COMPLETED|Part B Period 4 - Follow-Up||0||
48488363|NCT05093205|101529189|FG004|NOT COMPLETED|Part B Period 4 - Follow-Up||0||
48488364|NCT05093205|101529190|FG005|NOT COMPLETED|Part B Period 4 - Follow-Up||0||
48488365|NCT05093205|101529191|FG006|NOT COMPLETED|Part B Period 4 - Follow-Up||0||
48488366|NCT05093205|101529192|FG007|NOT COMPLETED|Part B Period 4 - Follow-Up||0||
48488367|NCT05093205|101529193|FG008|NOT COMPLETED|Part B Period 4 - Follow-Up||0||
48488368|NCT05093205|101529194|FG009|NOT COMPLETED|Part B Period 4 - Follow-Up||0||
48488369|NCT05093205|101529195|FG010|NOT COMPLETED|Part B Period 4 - Follow-Up||0||
48488370|NCT05093205|101529196|FG011|NOT COMPLETED|Part B Period 4 - Follow-Up||1||
48488371|NCT05093205|101529197|FG012|NOT COMPLETED|Part B Period 4 - Follow-Up||0||
48488372|NCT05093205|101529185|FG000|STARTED|Part B Period 5 - Treatment||0||
48488373|NCT05093205|101529186|FG001|STARTED|Part B Period 5 - Treatment||0||
48488374|NCT05093205|101529187|FG002|STARTED|Part B Period 5 - Treatment||0||
48488375|NCT05093205|101529188|FG003|STARTED|Part B Period 5 - Treatment||0||
48488376|NCT05093205|101529189|FG004|STARTED|Part B Period 5 - Treatment||0||
48488377|NCT05093205|101529190|FG005|STARTED|Part B Period 5 - Treatment||0||
48488378|NCT05093205|101529191|FG006|STARTED|Part B Period 5 - Treatment||0||
48488379|NCT05093205|101529192|FG007|STARTED|Part B Period 5 - Treatment||0||
48488380|NCT05093205|101529193|FG008|STARTED|Part B Period 5 - Treatment||0||
48488381|NCT05093205|101529194|FG009|STARTED|Part B Period 5 - Treatment||0||
48488382|NCT05093205|101529195|FG010|STARTED|Part B Period 5 - Treatment||0||
48488383|NCT05093205|101529196|FG011|STARTED|Part B Period 5 - Treatment||0||
48488384|NCT05093205|101529197|FG012|STARTED|Part B Period 5 - Treatment||9||
48488385|NCT05093205|101529185|FG000|COMPLETED|Part B Period 5 - Treatment||0||
48488386|NCT05093205|101529186|FG001|COMPLETED|Part B Period 5 - Treatment||0||
48488387|NCT05093205|101529187|FG002|COMPLETED|Part B Period 5 - Treatment||0||
48488388|NCT05093205|101529188|FG003|COMPLETED|Part B Period 5 - Treatment||0||
48488389|NCT05093205|101529189|FG004|COMPLETED|Part B Period 5 - Treatment||0||
48488390|NCT05093205|101529190|FG005|COMPLETED|Part B Period 5 - Treatment||0||
48488391|NCT05093205|101529191|FG006|COMPLETED|Part B Period 5 - Treatment||0||
48488392|NCT05093205|101529192|FG007|COMPLETED|Part B Period 5 - Treatment||0||
48488393|NCT05093205|101529193|FG008|COMPLETED|Part B Period 5 - Treatment||0||
48488394|NCT05093205|101529194|FG009|COMPLETED|Part B Period 5 - Treatment||0||
48488395|NCT05093205|101529195|FG010|COMPLETED|Part B Period 5 - Treatment||0||
48488396|NCT05093205|101529196|FG011|COMPLETED|Part B Period 5 - Treatment||0||
48488397|NCT05093205|101529197|FG012|COMPLETED|Part B Period 5 - Treatment||9||
48488398|NCT05093205|101529185|FG000|NOT COMPLETED|Part B Period 5 - Treatment||0||
48488399|NCT05093205|101529186|FG001|NOT COMPLETED|Part B Period 5 - Treatment||0||
48488400|NCT05093205|101529187|FG002|NOT COMPLETED|Part B Period 5 - Treatment||0||
48488401|NCT05093205|101529188|FG003|NOT COMPLETED|Part B Period 5 - Treatment||0||
48488402|NCT05093205|101529189|FG004|NOT COMPLETED|Part B Period 5 - Treatment||0||
48488403|NCT05093205|101529190|FG005|NOT COMPLETED|Part B Period 5 - Treatment||0||
48488404|NCT05093205|101529191|FG006|NOT COMPLETED|Part B Period 5 - Treatment||0||
48488405|NCT05093205|101529192|FG007|NOT COMPLETED|Part B Period 5 - Treatment||0||
48488406|NCT05093205|101529193|FG008|NOT COMPLETED|Part B Period 5 - Treatment||0||
48488407|NCT05093205|101529194|FG009|NOT COMPLETED|Part B Period 5 - Treatment||0||
48488408|NCT05093205|101529195|FG010|NOT COMPLETED|Part B Period 5 - Treatment||0||
48488409|NCT05093205|101529196|FG011|NOT COMPLETED|Part B Period 5 - Treatment||0||
48488410|NCT05093205|101529197|FG012|NOT COMPLETED|Part B Period 5 - Treatment||0||
48488411|NCT05093205|101529185|FG000|STARTED|Part B Period 5 - Follow-Up||0||
48488412|NCT05093205|101529186|FG001|STARTED|Part B Period 5 - Follow-Up||0||
48488413|NCT05093205|101529187|FG002|STARTED|Part B Period 5 - Follow-Up||0||
48488414|NCT05093205|101529188|FG003|STARTED|Part B Period 5 - Follow-Up||0||
48488415|NCT05093205|101529189|FG004|STARTED|Part B Period 5 - Follow-Up||0||
48488416|NCT05093205|101529190|FG005|STARTED|Part B Period 5 - Follow-Up||0||
48488417|NCT05093205|101529191|FG006|STARTED|Part B Period 5 - Follow-Up||0||
48488418|NCT05093205|101529192|FG007|STARTED|Part B Period 5 - Follow-Up||0||
48488419|NCT05093205|101529193|FG008|STARTED|Part B Period 5 - Follow-Up||0||
48488420|NCT05093205|101529194|FG009|STARTED|Part B Period 5 - Follow-Up||0||
48488421|NCT05093205|101529195|FG010|STARTED|Part B Period 5 - Follow-Up||0||
48488422|NCT05093205|101529196|FG011|STARTED|Part B Period 5 - Follow-Up||0||
48488423|NCT05093205|101529197|FG012|STARTED|Part B Period 5 - Follow-Up||9||
48488424|NCT05093205|101529185|FG000|COMPLETED|Part B Period 5 - Follow-Up||0||
48488425|NCT05093205|101529186|FG001|COMPLETED|Part B Period 5 - Follow-Up||0||
48488426|NCT05093205|101529187|FG002|COMPLETED|Part B Period 5 - Follow-Up||0||
48488427|NCT05093205|101529188|FG003|COMPLETED|Part B Period 5 - Follow-Up||0||
48488428|NCT05093205|101529189|FG004|COMPLETED|Part B Period 5 - Follow-Up||0||
48488429|NCT05093205|101529190|FG005|COMPLETED|Part B Period 5 - Follow-Up||0||
48488430|NCT05093205|101529191|FG006|COMPLETED|Part B Period 5 - Follow-Up||0||
48488431|NCT05093205|101529192|FG007|COMPLETED|Part B Period 5 - Follow-Up||0||
48488432|NCT05093205|101529193|FG008|COMPLETED|Part B Period 5 - Follow-Up||0||
48488433|NCT05093205|101529194|FG009|COMPLETED|Part B Period 5 - Follow-Up||0||
48488434|NCT05093205|101529195|FG010|COMPLETED|Part B Period 5 - Follow-Up||0||
48488435|NCT05093205|101529196|FG011|COMPLETED|Part B Period 5 - Follow-Up||0||
48488436|NCT05093205|101529197|FG012|COMPLETED|Part B Period 5 - Follow-Up||9||
48488437|NCT05093205|101529185|FG000|NOT COMPLETED|Part B Period 5 - Follow-Up||0||
48488438|NCT05093205|101529186|FG001|NOT COMPLETED|Part B Period 5 - Follow-Up||0||
48488439|NCT05093205|101529187|FG002|NOT COMPLETED|Part B Period 5 - Follow-Up||0||
48488440|NCT05093205|101529188|FG003|NOT COMPLETED|Part B Period 5 - Follow-Up||0||
48488441|NCT05093205|101529189|FG004|NOT COMPLETED|Part B Period 5 - Follow-Up||0||
48488442|NCT05093205|101529190|FG005|NOT COMPLETED|Part B Period 5 - Follow-Up||0||
48488443|NCT05093205|101529191|FG006|NOT COMPLETED|Part B Period 5 - Follow-Up||0||
48488444|NCT05093205|101529192|FG007|NOT COMPLETED|Part B Period 5 - Follow-Up||0||
48488445|NCT05093205|101529193|FG008|NOT COMPLETED|Part B Period 5 - Follow-Up||0||
48488446|NCT05093205|101529194|FG009|NOT COMPLETED|Part B Period 5 - Follow-Up||0||
48488447|NCT05093205|101529195|FG010|NOT COMPLETED|Part B Period 5 - Follow-Up||0||
48488448|NCT05093205|101529196|FG011|NOT COMPLETED|Part B Period 5 - Follow-Up||0||
48488449|NCT05093205|101529197|FG012|NOT COMPLETED|Part B Period 5 - Follow-Up||0||
48488450|NCT00817219|101529198|FG000|STARTED|Overall Study||33||
48488451|NCT00817219|101529198|FG000|COMPLETED|Overall Study||33||
48488452|NCT00817219|101529198|FG000|NOT COMPLETED|Overall Study||0||
48488453|NCT01978743|101529199|FG000|STARTED|Overall Study||10||
48488454|NCT01978743|101529199|FG000|COMPLETED|Overall Study||10||
48488455|NCT01978743|101529199|FG000|NOT COMPLETED|Overall Study||0||
48488456|NCT01462279|101529200|FG000|STARTED|Overall Study||20||
48488457|NCT01462279|101529200|FG000|COMPLETED|Overall Study||17||
48488458|NCT01462279|101529200|FG000|NOT COMPLETED|Overall Study||3||
48488459|NCT05704426|101529201|FG000|STARTED|Overall Study||2||
48488460|NCT05704426|101529201|FG000|COMPLETED|Overall Study||2||
48488461|NCT05704426|101529201|FG000|NOT COMPLETED|Overall Study||0||
48488462|NCT01144494|101529202|FG000|STARTED|Overall Study||15||
48488463|NCT01144494|101529203|FG001|STARTED|Overall Study||18||
48488464|NCT01144494|101529202|FG000|COMPLETED|Overall Study||15||
48488465|NCT01144494|101529203|FG001|COMPLETED|Overall Study||14||
48488466|NCT01144494|101529202|FG000|NOT COMPLETED|Overall Study||0||
48488467|NCT01144494|101529203|FG001|NOT COMPLETED|Overall Study||4||
48488468|NCT03276754|101529204|FG000|STARTED|Overall Study||530||
48488469|NCT03276754|101529204|FG000|Without Pneumococcal Vaccination|Overall Study||126||
48488470|NCT03276754|101529204|FG000|With Pneumococcal Vaccination|Overall Study||404||
48488471|NCT03276754|101529204|FG000|13-Valent Pneumococcal Conjugate Vaccine (PCV13) Population|Overall Study||114||
48488472|NCT03276754|101529204|FG000|COMPLETED|Overall Study||421||
48488473|NCT03276754|101529204|FG000|NOT COMPLETED|Overall Study||109||
48488474|NCT02849457|101529205|FG000|STARTED|Enrolled, Pre-randomized Period||0||
48488475|NCT02849457|101529206|FG001|STARTED|Enrolled, Pre-randomized Period||0||
48488476|NCT02849457|101529207|FG002|STARTED|Enrolled, Pre-randomized Period||84||
48488477|NCT02849457|101529208|FG003|STARTED|Enrolled, Pre-randomized Period||0||
48488478|NCT02849457|101529205|FG000|COMPLETED|Enrolled, Pre-randomized Period||0||
48488479|NCT02849457|101529206|FG001|COMPLETED|Enrolled, Pre-randomized Period||0||
48488480|NCT02849457|101529207|FG002|COMPLETED|Enrolled, Pre-randomized Period||72||
48488481|NCT02849457|101529208|FG003|COMPLETED|Enrolled, Pre-randomized Period||0||
48666595|NCT02374255|101967623|FG003|COMPLETED|Overall Study||11||
48488482|NCT02849457|101529205|FG000|NOT COMPLETED|Enrolled, Pre-randomized Period||0||
48488483|NCT02849457|101529206|FG001|NOT COMPLETED|Enrolled, Pre-randomized Period||0||
48488484|NCT02849457|101529207|FG002|NOT COMPLETED|Enrolled, Pre-randomized Period||12||
48488485|NCT02849457|101529208|FG003|NOT COMPLETED|Enrolled, Pre-randomized Period||0||
48488486|NCT02849457|101529205|FG000|STARTED|Randomized Period||27||
48488487|NCT02849457|101529206|FG001|STARTED|Randomized Period||29||
48488488|NCT02849457|101529207|FG002|STARTED|Randomized Period||12||
48488489|NCT02849457|101529208|FG003|STARTED|Randomized Period||4||
48488490|NCT02849457|101529205|FG000|COMPLETED|Randomized Period||22||
48488491|NCT02849457|101529206|FG001|COMPLETED|Randomized Period||29||
48488492|NCT02849457|101529207|FG002|COMPLETED|Randomized Period||11||
48488493|NCT02849457|101529208|FG003|COMPLETED|Randomized Period||4||
48488494|NCT02849457|101529205|FG000|NOT COMPLETED|Randomized Period||5||
48488495|NCT02849457|101529206|FG001|NOT COMPLETED|Randomized Period||0||
48488496|NCT02849457|101529207|FG002|NOT COMPLETED|Randomized Period||1||
48488497|NCT02849457|101529208|FG003|NOT COMPLETED|Randomized Period||0||
48488498|NCT04123548|101529209|FG000|STARTED|Overall Study||52||
48488499|NCT04123548|101529209|FG000|COMPLETED|Overall Study||38||
48488500|NCT04123548|101529209|FG000|NOT COMPLETED|Overall Study||14||
48488501|NCT00824291|101529210|FG000|STARTED|Overall Study||285||
48488502|NCT00824291|101529211|FG001|STARTED|Overall Study||142||
48488503|NCT00824291|101529210|FG000|COMPLETED|Overall Study||231||
48488504|NCT00824291|101529211|FG001|COMPLETED|Overall Study||107||
48488505|NCT00824291|101529210|FG000|NOT COMPLETED|Overall Study||54||
48488506|NCT00824291|101529211|FG001|NOT COMPLETED|Overall Study||35||
48488507|NCT01339247|101529212|FG000|STARTED|Period 1||30||
48488508|NCT01339247|101529213|FG001|STARTED|Period 1||30||
48488509|NCT01339247|101529212|FG000|COMPLETED|Period 1||30||
48488510|NCT01339247|101529213|FG001|COMPLETED|Period 1||30||
48488511|NCT01339247|101529212|FG000|NOT COMPLETED|Period 1||0||
48488512|NCT01339247|101529213|FG001|NOT COMPLETED|Period 1||0||
48488513|NCT01339247|101529212|FG000|STARTED|Period 2||30||
48488514|NCT01339247|101529213|FG001|STARTED|Period 2||30||
48488515|NCT01339247|101529212|FG000|COMPLETED|Period 2||30||
48488516|NCT01339247|101529213|FG001|COMPLETED|Period 2||30||
48488517|NCT01339247|101529212|FG000|NOT COMPLETED|Period 2||0||
48488518|NCT01339247|101529213|FG001|NOT COMPLETED|Period 2||0||
48488519|NCT02354339|101529214|FG000|STARTED|Overall Study||12||
48488520|NCT02354339|101529215|FG001|STARTED|Overall Study||12||
48488521|NCT02354339|101529214|FG000|COMPLETED|Overall Study||12||
48488522|NCT02354339|101529215|FG001|COMPLETED|Overall Study||12||
48488523|NCT02354339|101529214|FG000|NOT COMPLETED|Overall Study||0||
48488524|NCT02354339|101529215|FG001|NOT COMPLETED|Overall Study||0||
48488525|NCT04238754|101529216|FG000|STARTED|First Intervention||2||
48488526|NCT04238754|101529217|FG001|STARTED|First Intervention||1||
48488527|NCT04238754|101529216|FG000|COMPLETED|First Intervention||2||
48488528|NCT04238754|101529217|FG001|COMPLETED|First Intervention||1||
48488529|NCT04238754|101529216|FG000|NOT COMPLETED|First Intervention||0||
48488530|NCT04238754|101529217|FG001|NOT COMPLETED|First Intervention||0||
48488531|NCT04238754|101529216|FG000|STARTED|Washout - 1 Week||2||
48488532|NCT04238754|101529217|FG001|STARTED|Washout - 1 Week||1||
48488533|NCT04238754|101529216|FG000|COMPLETED|Washout - 1 Week||1||
48488534|NCT04238754|101529217|FG001|COMPLETED|Washout - 1 Week||1||
48488535|NCT04238754|101529216|FG000|NOT COMPLETED|Washout - 1 Week||1||
48488536|NCT04238754|101529217|FG001|NOT COMPLETED|Washout - 1 Week||0||
48488537|NCT04238754|101529216|FG000|STARTED|Second Intervention||1||
48488538|NCT04238754|101529217|FG001|STARTED|Second Intervention||1||
48488539|NCT04238754|101529216|FG000|COMPLETED|Second Intervention||1||
48488540|NCT04238754|101529217|FG001|COMPLETED|Second Intervention||1||
48488541|NCT04238754|101529216|FG000|NOT COMPLETED|Second Intervention||0||
48488542|NCT04238754|101529217|FG001|NOT COMPLETED|Second Intervention||0||
48488543|NCT04365153|101529218|FG000|STARTED|Overall Study||15||
48488544|NCT04365153|101529219|FG001|STARTED|Overall Study||14||
48488545|NCT04365153|101529220|FG002|STARTED|Overall Study||16||
48488546|NCT04365153|101529218|FG000|COMPLETED|Overall Study||15||
48488547|NCT04365153|101529219|FG001|COMPLETED|Overall Study||14||
48488548|NCT04365153|101529220|FG002|COMPLETED|Overall Study||16||
48488549|NCT04365153|101529218|FG000|NOT COMPLETED|Overall Study||0||
48488550|NCT04365153|101529219|FG001|NOT COMPLETED|Overall Study||0||
48488551|NCT04365153|101529220|FG002|NOT COMPLETED|Overall Study||0||
48488552|NCT00963482|101529221|FG000|STARTED|Overall Study||53||
48488553|NCT00963482|101529222|FG001|STARTED|Overall Study||50||
48488554|NCT00963482|101529221|FG000|COMPLETED|Overall Study||25||
48488555|NCT00963482|101529222|FG001|COMPLETED|Overall Study||33||
48488556|NCT00963482|101529221|FG000|NOT COMPLETED|Overall Study||28||
48488557|NCT00963482|101529222|FG001|NOT COMPLETED|Overall Study||17||
48488558|NCT01593852|101529223|FG000|STARTED|Overall Study||68||
48488559|NCT01593852|101529224|FG001|STARTED|Overall Study||68||
48488560|NCT01593852|101529223|FG000|COMPLETED|Overall Study||68||
48488561|NCT01593852|101529224|FG001|COMPLETED|Overall Study||68||
48488562|NCT01593852|101529223|FG000|NOT COMPLETED|Overall Study||0||
48488563|NCT01593852|101529224|FG001|NOT COMPLETED|Overall Study||0||
48488564|NCT02902211|101529225|FG000|STARTED|First Three Months||12||
48488565|NCT02902211|101529226|FG001|STARTED|First Three Months||21||
48488566|NCT02902211|101529225|FG000|COMPLETED|First Three Months||5||
48488567|NCT02902211|101529226|FG001|COMPLETED|First Three Months||18||
48488568|NCT02902211|101529225|FG000|NOT COMPLETED|First Three Months||7||
48488569|NCT02902211|101529226|FG001|NOT COMPLETED|First Three Months||3||
48488570|NCT02902211|101529225|FG000|STARTED|Second Three Months||5||
48488571|NCT02902211|101529226|FG001|STARTED|Second Three Months||18||
48488572|NCT02902211|101529225|FG000|COMPLETED|Second Three Months||2||
48199713|NCT01608971|100810440|FG000|NOT COMPLETED|Overall Study||0||
48488573|NCT02902211|101529226|FG001|COMPLETED|Second Three Months||13||
48488574|NCT02902211|101529225|FG000|NOT COMPLETED|Second Three Months||3||
48488575|NCT02902211|101529226|FG001|NOT COMPLETED|Second Three Months||5||
48488576|NCT01867164|101529227|FG000|STARTED|Overall Study||81||
48488577|NCT01867164|101529228|FG001|STARTED|Overall Study||79||
48488578|NCT01867164|101529227|FG000|COMPLETED|Overall Study||81||
48488579|NCT01867164|101529228|FG001|COMPLETED|Overall Study||79||
48488580|NCT01867164|101529227|FG000|NOT COMPLETED|Overall Study||0||
48488581|NCT01867164|101529228|FG001|NOT COMPLETED|Overall Study||0||
48488582|NCT01794845|101529229|FG000|STARTED|Overall Study||5||
48488583|NCT01794845|101529229|FG000|COMPLETED|Overall Study||4||
48488584|NCT01794845|101529229|FG000|NOT COMPLETED|Overall Study||1||
48488585|NCT02233985|101529230|FG000|STARTED|Overall Study||33||
48488586|NCT02233985|101529231|FG001|STARTED|Overall Study||31||
48488587|NCT02233985|101529230|FG000|COMPLETED|Overall Study||33||
48488588|NCT02233985|101529231|FG001|COMPLETED|Overall Study||31||
48488589|NCT02233985|101529230|FG000|NOT COMPLETED|Overall Study||0||
48488590|NCT02233985|101529231|FG001|NOT COMPLETED|Overall Study||0||
48488591|NCT03611608|101529232|FG000|STARTED|Overall Study||4||
48488592|NCT03611608|101529233|FG001|STARTED|Overall Study||12||
48488593|NCT03611608|101529232|FG000|Received at Least One Dose/Injection|Overall Study||4||
48666596|NCT02374255|101967620|FG000|NOT COMPLETED|Overall Study||2||
48488594|NCT03611608|101529233|FG001|Received at Least One Dose/Injection|Overall Study||12||
48488595|NCT03611608|101529232|FG000|COMPLETED|Overall Study||4||
48488596|NCT03611608|101529233|FG001|COMPLETED|Overall Study||12||
48488597|NCT03611608|101529232|FG000|NOT COMPLETED|Overall Study||0||
48488598|NCT03611608|101529233|FG001|NOT COMPLETED|Overall Study||0||
48488599|NCT00187720|101529234|FG000|STARTED|Overall Study||9||
48488600|NCT00187720|101529235|FG001|STARTED|Overall Study||14||
48488601|NCT00187720|101529234|FG000|COMPLETED|Overall Study||9||
48488602|NCT00187720|101529235|FG001|COMPLETED|Overall Study||14||
48488603|NCT00187720|101529234|FG000|NOT COMPLETED|Overall Study||0||
48488604|NCT00187720|101529235|FG001|NOT COMPLETED|Overall Study||0||
48488605|NCT01528150|101529236|FG000|STARTED|Overall Study||466||
48488606|NCT01528150|101529236|FG000|COMPLETED|Overall Study||422||
48488607|NCT01528150|101529236|FG000|NOT COMPLETED|Overall Study||44||
48488608|NCT00927069|101529237|FG000|STARTED|Week 0 to Week 12||50||
48488609|NCT00927069|101529238|FG001|STARTED|Week 0 to Week 12||35||
48488610|NCT00927069|101529239|FG002|STARTED|Week 0 to Week 12||0||
48488611|NCT00927069|101529240|FG003|STARTED|Week 0 to Week 12||0||
48488612|NCT00927069|101529237|FG000|COMPLETED|Week 0 to Week 12||49||
48488613|NCT00927069|101529238|FG001|COMPLETED|Week 0 to Week 12||34||
48488614|NCT00927069|101529239|FG002|COMPLETED|Week 0 to Week 12||0||
48488615|NCT00927069|101529240|FG003|COMPLETED|Week 0 to Week 12||0||
48488616|NCT00927069|101529237|FG000|NOT COMPLETED|Week 0 to Week 12||1||
48488617|NCT00927069|101529238|FG001|NOT COMPLETED|Week 0 to Week 12||1||
48488618|NCT00927069|101529239|FG002|NOT COMPLETED|Week 0 to Week 12||0||
48488619|NCT00927069|101529240|FG003|NOT COMPLETED|Week 0 to Week 12||0||
48488620|NCT00927069|101529237|FG000|STARTED|Week 12 to Week 24||18||
48488621|NCT00927069|101529238|FG001|STARTED|Week 12 to Week 24||11||
48488622|NCT00927069|101529239|FG002|STARTED|Week 12 to Week 24||31||
48488623|NCT00927069|101529240|FG003|STARTED|Week 12 to Week 24||23||
48488624|NCT00927069|101529237|FG000|COMPLETED|Week 12 to Week 24||16||
48488625|NCT00927069|101529238|FG001|COMPLETED|Week 12 to Week 24||11||
48488626|NCT00927069|101529239|FG002|COMPLETED|Week 12 to Week 24||28||
48488627|NCT00927069|101529240|FG003|COMPLETED|Week 12 to Week 24||20||
48488628|NCT00927069|101529237|FG000|NOT COMPLETED|Week 12 to Week 24||2||
48488629|NCT00927069|101529238|FG001|NOT COMPLETED|Week 12 to Week 24||0||
48488630|NCT00927069|101529239|FG002|NOT COMPLETED|Week 12 to Week 24||3||
48488631|NCT00927069|101529240|FG003|NOT COMPLETED|Week 12 to Week 24||3||
48488632|NCT03040362|101529241|FG000|STARTED|Overall Study||8||
48488633|NCT03040362|101529241|FG000|Received at Least 1dose of Study Drug|Overall Study||8||
48488634|NCT03040362|101529241|FG000|COMPLETED|Overall Study||8||
48488635|NCT03040362|101529241|FG000|NOT COMPLETED|Overall Study||0||
48488636|NCT02197481|101529242|FG000|STARTED|Overall Study||43||
48488637|NCT02197481|101529243|FG001|STARTED|Overall Study||43||
48488638|NCT02197481|101529242|FG000|COMPLETED|Overall Study||43||
48488639|NCT02197481|101529243|FG001|COMPLETED|Overall Study||43||
48488640|NCT02197481|101529242|FG000|NOT COMPLETED|Overall Study||0||
48488641|NCT02197481|101529243|FG001|NOT COMPLETED|Overall Study||0||
48488642|NCT01527006|101529244|FG000|STARTED|Core Study||22||
48488643|NCT01527006|101529245|FG001|STARTED|Core Study||28||
48488644|NCT01527006|101529244|FG000|COMPLETED|Core Study||20||
48488645|NCT01527006|101529245|FG001|COMPLETED|Core Study||22||
48488646|NCT01527006|101529244|FG000|NOT COMPLETED|Core Study||2||
48488647|NCT01527006|101529245|FG001|NOT COMPLETED|Core Study||6||
48488648|NCT01527006|101529244|FG000|STARTED|Extension Phase||19||
48488649|NCT01527006|101529245|FG001|STARTED|Extension Phase||22||
48488650|NCT01527006|101529244|FG000|COMPLETED|Extension Phase||13||
48488651|NCT01527006|101529245|FG001|COMPLETED|Extension Phase||14||
48488652|NCT01527006|101529244|FG000|NOT COMPLETED|Extension Phase||6||
48488653|NCT01527006|101529245|FG001|NOT COMPLETED|Extension Phase||8||
48488654|NCT00875550|101529246|FG000|STARTED|Overall Study||89||
48488655|NCT00875550|101529247|FG001|STARTED|Overall Study||86||
48488656|NCT00875550|101529246|FG000|COMPLETED|Overall Study||77||
48488657|NCT00875550|101529247|FG001|COMPLETED|Overall Study||76||
48488658|NCT00875550|101529246|FG000|NOT COMPLETED|Overall Study||12||
48488659|NCT00875550|101529247|FG001|NOT COMPLETED|Overall Study||10||
48488660|NCT03115177|101529248|FG000|STARTED|Overall Study||27||
48488661|NCT03115177|101529249|FG001|STARTED|Overall Study||29||
48488662|NCT03115177|101529248|FG000|COMPLETED|Overall Study||27||
48488663|NCT03115177|101529249|FG001|COMPLETED|Overall Study||29||
48488664|NCT03115177|101529248|FG000|NOT COMPLETED|Overall Study||0||
48488665|NCT03115177|101529249|FG001|NOT COMPLETED|Overall Study||0||
48488666|NCT01686451|101529250|FG000|STARTED|Overall Study||33||
48488667|NCT01686451|101529251|FG001|STARTED|Overall Study||27||
48488668|NCT01686451|101529250|FG000|COMPLETED|Overall Study||33||
48488669|NCT01686451|101529251|FG001|COMPLETED|Overall Study||27||
48666597|NCT02374255|101967621|FG001|NOT COMPLETED|Overall Study||0||
48488670|NCT01686451|101529250|FG000|NOT COMPLETED|Overall Study||0||
48488671|NCT01686451|101529251|FG001|NOT COMPLETED|Overall Study||0||
48488672|NCT00804856|101529252|FG000|STARTED|Overall Study||4||
48488673|NCT00804856|101529253|FG001|STARTED|Overall Study||3||
48488674|NCT00804856|101529254|FG002|STARTED|Overall Study||5||
48488675|NCT00804856|101529255|FG003|STARTED|Overall Study||9||
48488676|NCT00804856|101529256|FG004|STARTED|Overall Study||8||
48488677|NCT00804856|101529257|FG005|STARTED|Overall Study||3||
48488678|NCT00804856|101529258|FG006|STARTED|Overall Study||11||
48488679|NCT00804856|101529259|FG007|STARTED|Overall Study||2||
48488680|NCT00804856|101529260|FG008|STARTED|Overall Study||5||
48488681|NCT00804856|101529261|FG009|STARTED|Overall Study||6||
48488682|NCT00804856|101529262|FG010|STARTED|Overall Study||23||
48488683|NCT00804856|101529263|FG011|STARTED|Overall Study||5||
48488684|NCT00804856|101529264|FG012|STARTED|Overall Study||4||
48199714|NCT01608971|100810441|FG001|NOT COMPLETED|Overall Study||0||
48488685|NCT00804856|101529265|FG013|STARTED|Overall Study||45||
48488686|NCT00804856|101529266|FG014|STARTED|Overall Study||42||
48488687|NCT00804856|101529252|FG000|COMPLETED|Overall Study||0||
48488688|NCT00804856|101529253|FG001|COMPLETED|Overall Study||0||
48488689|NCT00804856|101529254|FG002|COMPLETED|Overall Study||0||
48488690|NCT00804856|101529255|FG003|COMPLETED|Overall Study||0||
48488691|NCT00804856|101529256|FG004|COMPLETED|Overall Study||0||
48488692|NCT00804856|101529257|FG005|COMPLETED|Overall Study||0||
48488693|NCT00804856|101529258|FG006|COMPLETED|Overall Study||0||
48488694|NCT00804856|101529259|FG007|COMPLETED|Overall Study||0||
48488695|NCT00804856|101529260|FG008|COMPLETED|Overall Study||0||
48488696|NCT00804856|101529261|FG009|COMPLETED|Overall Study||0||
48488697|NCT00804856|101529262|FG010|COMPLETED|Overall Study||0||
48488698|NCT00804856|101529263|FG011|COMPLETED|Overall Study||0||
48488699|NCT00804856|101529264|FG012|COMPLETED|Overall Study||0||
48488700|NCT00804856|101529265|FG013|COMPLETED|Overall Study||0||
48488701|NCT00804856|101529266|FG014|COMPLETED|Overall Study||0||
48488702|NCT00804856|101529252|FG000|NOT COMPLETED|Overall Study||4||
48488703|NCT00804856|101529253|FG001|NOT COMPLETED|Overall Study||3||
48488704|NCT00804856|101529254|FG002|NOT COMPLETED|Overall Study||5||
48488705|NCT00804856|101529255|FG003|NOT COMPLETED|Overall Study||9||
48488706|NCT00804856|101529256|FG004|NOT COMPLETED|Overall Study||8||
48488707|NCT00804856|101529257|FG005|NOT COMPLETED|Overall Study||3||
48488708|NCT00804856|101529258|FG006|NOT COMPLETED|Overall Study||11||
48488709|NCT00804856|101529259|FG007|NOT COMPLETED|Overall Study||2||
48488710|NCT00804856|101529260|FG008|NOT COMPLETED|Overall Study||5||
48488711|NCT00804856|101529261|FG009|NOT COMPLETED|Overall Study||6||
48488712|NCT00804856|101529262|FG010|NOT COMPLETED|Overall Study||23||
48488713|NCT00804856|101529263|FG011|NOT COMPLETED|Overall Study||5||
48488714|NCT00804856|101529264|FG012|NOT COMPLETED|Overall Study||4||
48488715|NCT00804856|101529265|FG013|NOT COMPLETED|Overall Study||45||
48488716|NCT00804856|101529266|FG014|NOT COMPLETED|Overall Study||42||
48488717|NCT02944617|101529267|FG000|STARTED|Overall Study||11||
48488718|NCT02944617|101529268|FG001|STARTED|Overall Study||10||
48199715|NCT01362491|100810442|FG000|STARTED|Overall Study||91||
48199716|NCT01362491|100810443|FG001|STARTED|Overall Study||89||
48199717|NCT01362491|100810444|FG002|STARTED|Overall Study||46||
48488719|NCT02944617|101529267|FG000|COMPLETED|Overall Study||10||
48488720|NCT02944617|101529268|FG001|COMPLETED|Overall Study||10||
48488721|NCT02944617|101529267|FG000|NOT COMPLETED|Overall Study||1||
48488722|NCT02944617|101529268|FG001|NOT COMPLETED|Overall Study||0||
48488723|NCT02186821|101529269|FG000|STARTED|Overall Study||47||
48488724|NCT02186821|101529269|FG000|COMPLETED|Overall Study||0||
48488725|NCT02186821|101529269|FG000|NOT COMPLETED|Overall Study||47||
48488726|NCT04421508|101529270|FG000|STARTED|Overall Study||95||
48488727|NCT04421508|101529271|FG001|STARTED|Overall Study||96||
48488728|NCT04421508|101529270|FG000|COMPLETED|Overall Study||91||
48488729|NCT04421508|101529271|FG001|COMPLETED|Overall Study||95||
48488730|NCT04421508|101529270|FG000|NOT COMPLETED|Overall Study||4||
48488731|NCT04421508|101529271|FG001|NOT COMPLETED|Overall Study||1||
48199718|NCT01362491|100810442|FG000|COMPLETED|Overall Study||90||
48199719|NCT01362491|100810443|FG001|COMPLETED|Overall Study||89||
48488732|NCT02890992|101529272|FG000|STARTED|12 Weeks Open-Label Dose Finding Period||4||
48199720|NCT01362491|100810444|FG002|COMPLETED|Overall Study||46||
48488733|NCT02890992|101529273|FG001|STARTED|12 Weeks Open-Label Dose Finding Period||6||
48199721|NCT01362491|100810442|FG000|NOT COMPLETED|Overall Study||1||
48199722|NCT01362491|100810443|FG001|NOT COMPLETED|Overall Study||0||
48199723|NCT01362491|100810444|FG002|NOT COMPLETED|Overall Study||0||
48199724|NCT02487056|100810445|FG000|STARTED|Overall Study||1622||
48199725|NCT02487056|100810445|FG000|COMPLETED|Overall Study||1606||
48199726|NCT02487056|100810445|FG000|NOT COMPLETED|Overall Study||16||
48199727|NCT03635112|100810446|FG000|STARTED|Overall Study||38||
48199728|NCT03635112|100810447|FG001|STARTED|Overall Study||58||
48488734|NCT02890992|101529274|FG002|STARTED|12 Weeks Open-Label Dose Finding Period||4||
48488735|NCT02890992|101529275|FG003|STARTED|12 Weeks Open-Label Dose Finding Period||6||
48488736|NCT02890992|101529276|FG004|STARTED|12 Weeks Open-Label Dose Finding Period||6||
48488737|NCT02890992|101529277|FG005|STARTED|12 Weeks Open-Label Dose Finding Period||5||
48488738|NCT02890992|101529278|FG006|STARTED|12 Weeks Open-Label Dose Finding Period||6||
48488739|NCT02890992|101529279|FG007|STARTED|12 Weeks Open-Label Dose Finding Period||5||
48488740|NCT02890992|101529272|FG000|Treated|12 Weeks Open-Label Dose Finding Period||4||
48488741|NCT02890992|101529273|FG001|Treated|12 Weeks Open-Label Dose Finding Period||6||
48488742|NCT02890992|101529274|FG002|Treated|12 Weeks Open-Label Dose Finding Period||4||
48488743|NCT02890992|101529275|FG003|Treated|12 Weeks Open-Label Dose Finding Period||6||
48488744|NCT02890992|101529276|FG004|Treated|12 Weeks Open-Label Dose Finding Period||6||
48488745|NCT02890992|101529277|FG005|Treated|12 Weeks Open-Label Dose Finding Period||5||
48199729|NCT03635112|100810448|FG002|STARTED|Overall Study||63||
48199730|NCT03635112|100810446|FG000|Completed Week 12 Visit|Overall Study||33||
48199731|NCT03635112|100810447|FG001|Completed Week 12 Visit|Overall Study||48||
48199732|NCT03635112|100810448|FG002|Completed Week 12 Visit|Overall Study||49||
48199733|NCT03635112|100810446|FG000|Switched From Placebo to TD-1473 80 mg|Overall Study||33||
48199734|NCT03635112|100810447|FG001|Switched From Placebo to TD-1473 80 mg|Overall Study||0||
48199735|NCT03635112|100810448|FG002|Switched From Placebo to TD-1473 80 mg|Overall Study||0||
48199736|NCT03635112|100810446|FG000|COMPLETED|Overall Study||12||
48199737|NCT03635112|100810447|FG001|COMPLETED|Overall Study||16||
48199738|NCT03635112|100810448|FG002|COMPLETED|Overall Study||13||
48199739|NCT03635112|100810446|FG000|NOT COMPLETED|Overall Study||26||
48199740|NCT03635112|100810447|FG001|NOT COMPLETED|Overall Study||42||
48199741|NCT03635112|100810448|FG002|NOT COMPLETED|Overall Study||50||
48199742|NCT01306331|100810449|FG000|STARTED|Overall Study||1659||
48199743|NCT01306331|100810450|FG001|STARTED|Overall Study||1665||
48199744|NCT01306331|100810449|FG000|COMPLETED|Overall Study||758||
48199745|NCT01306331|100810450|FG001|COMPLETED|Overall Study||788||
48199746|NCT01306331|100810449|FG000|NOT COMPLETED|Overall Study||901||
48199747|NCT01306331|100810450|FG001|NOT COMPLETED|Overall Study||877||
48199748|NCT00015457|100810451|FG000|STARTED|First Intervention||8||
48199749|NCT00015457|100810452|FG001|STARTED|First Intervention||8||
48199750|NCT00015457|100810451|FG000|COMPLETED|First Intervention||8||
48199751|NCT00015457|100810452|FG001|COMPLETED|First Intervention||5||
48199752|NCT00015457|100810451|FG000|NOT COMPLETED|First Intervention||0||
48199753|NCT00015457|100810452|FG001|NOT COMPLETED|First Intervention||3||
48199754|NCT00015457|100810451|FG000|STARTED|Second Intervention||8||
48199755|NCT00015457|100810452|FG001|STARTED|Second Intervention||5||
48199756|NCT00015457|100810451|FG000|COMPLETED|Second Intervention||7||
48199757|NCT00015457|100810452|FG001|COMPLETED|Second Intervention||5||
48199758|NCT00015457|100810451|FG000|NOT COMPLETED|Second Intervention||1||
48199759|NCT00015457|100810452|FG001|NOT COMPLETED|Second Intervention||0||
48199760|NCT00208507|100810453|FG000|STARTED|Overall Study||177||
48199761|NCT00208507|100810454|FG001|STARTED|Overall Study||87||
48199762|NCT00208507|100810453|FG000|COMPLETED|Overall Study||163||
48199763|NCT00208507|100810454|FG001|COMPLETED|Overall Study||79||
48199764|NCT00208507|100810453|FG000|NOT COMPLETED|Overall Study||14||
48199765|NCT00208507|100810454|FG001|NOT COMPLETED|Overall Study||8||
48199766|NCT00383188|100810455|FG000|STARTED|Overall Study||69||
48488746|NCT02890992|101529278|FG006|Treated|12 Weeks Open-Label Dose Finding Period||6||
48488747|NCT02890992|101529279|FG007|Treated|12 Weeks Open-Label Dose Finding Period||5||
48488748|NCT02890992|101529272|FG000|COMPLETED|12 Weeks Open-Label Dose Finding Period||4||
48488749|NCT02890992|101529273|FG001|COMPLETED|12 Weeks Open-Label Dose Finding Period||6||
48488750|NCT02890992|101529274|FG002|COMPLETED|12 Weeks Open-Label Dose Finding Period||4||
48488751|NCT02890992|101529275|FG003|COMPLETED|12 Weeks Open-Label Dose Finding Period||6||
48488752|NCT02890992|101529276|FG004|COMPLETED|12 Weeks Open-Label Dose Finding Period||6||
48488753|NCT02890992|101529277|FG005|COMPLETED|12 Weeks Open-Label Dose Finding Period||5||
48488754|NCT02890992|101529278|FG006|COMPLETED|12 Weeks Open-Label Dose Finding Period||6||
48488755|NCT02890992|101529279|FG007|COMPLETED|12 Weeks Open-Label Dose Finding Period||5||
48488756|NCT02890992|101529272|FG000|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0||
48488757|NCT02890992|101529273|FG001|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0||
48488758|NCT02890992|101529274|FG002|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0||
48488759|NCT02890992|101529275|FG003|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0||
48488760|NCT02890992|101529276|FG004|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0||
48488761|NCT02890992|101529277|FG005|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0||
48488762|NCT02890992|101529278|FG006|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0||
48488763|NCT02890992|101529279|FG007|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0||
48488764|NCT02890992|101529272|FG000|STARTED|130 Weeks Open-Label Extension Period||3||
48488765|NCT02890992|101529273|FG001|STARTED|130 Weeks Open-Label Extension Period||6||
48488766|NCT02890992|101529274|FG002|STARTED|130 Weeks Open-Label Extension Period||4||
48488767|NCT02890992|101529275|FG003|STARTED|130 Weeks Open-Label Extension Period||6||
48488768|NCT02890992|101529276|FG004|STARTED|130 Weeks Open-Label Extension Period||6||
48488769|NCT02890992|101529277|FG005|STARTED|130 Weeks Open-Label Extension Period||5||
48488770|NCT02890992|101529278|FG006|STARTED|130 Weeks Open-Label Extension Period||6||
48488771|NCT02890992|101529279|FG007|STARTED|130 Weeks Open-Label Extension Period||5||
48488772|NCT02890992|101529272|FG000|Treated|130 Weeks Open-Label Extension Period||3||
48488773|NCT02890992|101529273|FG001|Treated|130 Weeks Open-Label Extension Period||6||
48488774|NCT02890992|101529274|FG002|Treated|130 Weeks Open-Label Extension Period||4||
48488775|NCT02890992|101529275|FG003|Treated|130 Weeks Open-Label Extension Period||6||
48488776|NCT02890992|101529276|FG004|Treated|130 Weeks Open-Label Extension Period||6||
48488777|NCT02890992|101529277|FG005|Treated|130 Weeks Open-Label Extension Period||5||
48488778|NCT02890992|101529278|FG006|Treated|130 Weeks Open-Label Extension Period||5||
48488779|NCT02890992|101529279|FG007|Treated|130 Weeks Open-Label Extension Period||4||
48488780|NCT02890992|101529272|FG000|COMPLETED|130 Weeks Open-Label Extension Period||3||
48488781|NCT02890992|101529273|FG001|COMPLETED|130 Weeks Open-Label Extension Period||3||
48199767|NCT00383188|100810456|FG001|STARTED|Overall Study||74||
48199768|NCT00383188|100810457|FG002|STARTED|Overall Study||44||
48199769|NCT00383188|100810458|FG003|STARTED|Overall Study||40||
48488782|NCT02890992|101529274|FG002|COMPLETED|130 Weeks Open-Label Extension Period||4||
48488783|NCT02890992|101529275|FG003|COMPLETED|130 Weeks Open-Label Extension Period||6||
48488784|NCT02890992|101529276|FG004|COMPLETED|130 Weeks Open-Label Extension Period||6||
48488785|NCT02890992|101529277|FG005|COMPLETED|130 Weeks Open-Label Extension Period||5||
48488786|NCT02890992|101529278|FG006|COMPLETED|130 Weeks Open-Label Extension Period||5||
48488787|NCT02890992|101529279|FG007|COMPLETED|130 Weeks Open-Label Extension Period||4||
48488788|NCT02890992|101529272|FG000|NOT COMPLETED|130 Weeks Open-Label Extension Period||0||
48488789|NCT02890992|101529273|FG001|NOT COMPLETED|130 Weeks Open-Label Extension Period||3||
48488790|NCT02890992|101529274|FG002|NOT COMPLETED|130 Weeks Open-Label Extension Period||0||
48488791|NCT02890992|101529275|FG003|NOT COMPLETED|130 Weeks Open-Label Extension Period||0||
48488792|NCT02890992|101529276|FG004|NOT COMPLETED|130 Weeks Open-Label Extension Period||0||
48488793|NCT02890992|101529277|FG005|NOT COMPLETED|130 Weeks Open-Label Extension Period||0||
48199770|NCT00383188|100810459|FG004|STARTED|Overall Study||75||
48199771|NCT00383188|100810455|FG000|COMPLETED|Overall Study||52||
48199772|NCT00383188|100810456|FG001|COMPLETED|Overall Study||63||
48199773|NCT00383188|100810457|FG002|COMPLETED|Overall Study||31||
48199774|NCT00383188|100810458|FG003|COMPLETED|Overall Study||28||
48199775|NCT00383188|100810459|FG004|COMPLETED|Overall Study||52||
48199776|NCT00383188|100810455|FG000|NOT COMPLETED|Overall Study||17||
48199777|NCT00383188|100810456|FG001|NOT COMPLETED|Overall Study||11||
48199778|NCT00383188|100810457|FG002|NOT COMPLETED|Overall Study||13||
48199779|NCT00383188|100810458|FG003|NOT COMPLETED|Overall Study||12||
48199780|NCT00383188|100810459|FG004|NOT COMPLETED|Overall Study||23||
48199781|NCT03038399|100810460|FG000|STARTED|Overall Study||11||
48199782|NCT03038399|100810461|FG001|STARTED|Overall Study||12||
48199783|NCT03038399|100810462|FG002|STARTED|Overall Study||12||
48488794|NCT02890992|101529278|FG006|NOT COMPLETED|130 Weeks Open-Label Extension Period||1||
48488795|NCT02890992|101529279|FG007|NOT COMPLETED|130 Weeks Open-Label Extension Period||1||
48488796|NCT00693628|101529280|FG000|STARTED|Overall Study||0||
48488797|NCT00693628|101529281|FG001|STARTED|Overall Study||0||
48488798|NCT00693628|101529280|FG000|COMPLETED|Overall Study||0||
48488799|NCT00693628|101529281|FG001|COMPLETED|Overall Study||0||
48488800|NCT00693628|101529280|FG000|NOT COMPLETED|Overall Study||0||
48488801|NCT00693628|101529281|FG001|NOT COMPLETED|Overall Study||0||
48488802|NCT02545283|101532502|FG000|STARTED|Overall Study||149||
48488803|NCT02545283|101532503|FG001|STARTED|Overall Study||298||
48488804|NCT02545283|101532502|FG000|Received Treatment|Overall Study||149||
48488805|NCT02545283|101532503|FG001|Received Treatment|Overall Study||292||
48488806|NCT02545283|101532502|FG000|Safety Follow Up|Overall Study||149||
48488807|NCT02545283|101532503|FG001|Safety Follow Up|Overall Study||292||
48488808|NCT02545283|101532502|FG000|COMPLETED|Overall Study||0||
48488809|NCT02545283|101532503|FG001|COMPLETED|Overall Study||0||
48488810|NCT02545283|101532502|FG000|NOT COMPLETED|Overall Study||149||
48488811|NCT02545283|101532503|FG001|NOT COMPLETED|Overall Study||298||
48488812|NCT03154047|101532504|FG000|STARTED|Overall Study||80||
48488813|NCT03154047|101532504|FG000|Number of Patients Dosed|Overall Study||80||
48488814|NCT03154047|101532504|FG000|COMPLETED|Overall Study||0||
48488815|NCT03154047|101532504|FG000|NOT COMPLETED|Overall Study||80||
48199784|NCT03038399|100810463|FG003|STARTED|Overall Study||11||
48199785|NCT03038399|100810460|FG000|COMPLETED|Overall Study||10||
48199786|NCT03038399|100810461|FG001|COMPLETED|Overall Study||11||
48199787|NCT03038399|100810462|FG002|COMPLETED|Overall Study||11||
48199788|NCT03038399|100810463|FG003|COMPLETED|Overall Study||9||
48199789|NCT03038399|100810460|FG000|NOT COMPLETED|Overall Study||1||
48199790|NCT03038399|100810461|FG001|NOT COMPLETED|Overall Study||1||
48199791|NCT03038399|100810462|FG002|NOT COMPLETED|Overall Study||1||
48199792|NCT03038399|100810463|FG003|NOT COMPLETED|Overall Study||2||
48488816|NCT00003659|101532505|FG000|STARTED|Overall Study||39||
48488817|NCT00003659|101532505|FG000|COMPLETED|Overall Study||36||
48488818|NCT00003659|101532505|FG000|NOT COMPLETED|Overall Study||3||
48488819|NCT01948258|101532506|FG000|STARTED|Overall Study||395||
48488820|NCT01948258|101532506|FG000|COMPLETED|Overall Study||233||
48488821|NCT01948258|101532506|FG000|NOT COMPLETED|Overall Study||162||
48488822|NCT00834418|101532507|FG000|STARTED|Overall Study||42||
48488823|NCT00834418|101532508|FG001|STARTED|Overall Study||42||
48488824|NCT00834418|101532507|FG000|COMPLETED|Overall Study||42||
48488825|NCT00834418|101532508|FG001|COMPLETED|Overall Study||40||
48488826|NCT00834418|101532507|FG000|NOT COMPLETED|Overall Study||0||
48488827|NCT00834418|101532508|FG001|NOT COMPLETED|Overall Study||2||
48488828|NCT00968812|101532509|FG000|STARTED|Overall Study||483||
48488829|NCT00968812|101532510|FG001|STARTED|Overall Study||485||
48488830|NCT00968812|101532511|FG002|STARTED|Overall Study||482||
48488831|NCT00968812|101532509|FG000|COMPLETED|Overall Study||343||
48488832|NCT00968812|101532510|FG001|COMPLETED|Overall Study||323||
48488833|NCT00968812|101532511|FG002|COMPLETED|Overall Study||314||
48488834|NCT00968812|101532509|FG000|NOT COMPLETED|Overall Study||140||
48199793|NCT03055767|100810464|FG000|STARTED|Double-Blind Period||9||
48199794|NCT03055767|100810465|FG001|STARTED|Double-Blind Period||6||
48199795|NCT03055767|100810466|FG002|STARTED|Double-Blind Period||0||
48199796|NCT03055767|100810467|FG003|STARTED|Double-Blind Period||0||
48199797|NCT03055767|100810464|FG000|COMPLETED|Double-Blind Period||9||
48199798|NCT03055767|100810465|FG001|COMPLETED|Double-Blind Period||6||
48199799|NCT03055767|100810466|FG002|COMPLETED|Double-Blind Period||0||
48199800|NCT03055767|100810467|FG003|COMPLETED|Double-Blind Period||0||
48199801|NCT03055767|100810464|FG000|NOT COMPLETED|Double-Blind Period||0||
48199802|NCT03055767|100810465|FG001|NOT COMPLETED|Double-Blind Period||0||
48199803|NCT03055767|100810466|FG002|NOT COMPLETED|Double-Blind Period||0||
48199804|NCT03055767|100810467|FG003|NOT COMPLETED|Double-Blind Period||0||
48199805|NCT03055767|100810464|FG000|STARTED|Open-Label Period||0||
48199806|NCT03055767|100810465|FG001|STARTED|Open-Label Period||0||
48199807|NCT03055767|100810466|FG002|STARTED|Open-Label Period||11||
48199808|NCT03055767|100810467|FG003|STARTED|Open-Label Period||4||
48199809|NCT03055767|100810464|FG000|COMPLETED|Open-Label Period||0||
48199810|NCT03055767|100810465|FG001|COMPLETED|Open-Label Period||0||
48199811|NCT03055767|100810466|FG002|COMPLETED|Open-Label Period||9||
48199812|NCT03055767|100810467|FG003|COMPLETED|Open-Label Period||3||
48199813|NCT03055767|100810464|FG000|NOT COMPLETED|Open-Label Period||0||
48199814|NCT03055767|100810465|FG001|NOT COMPLETED|Open-Label Period||0||
48199815|NCT03055767|100810466|FG002|NOT COMPLETED|Open-Label Period||2||
48199816|NCT03055767|100810467|FG003|NOT COMPLETED|Open-Label Period||1||
48199817|NCT02857283|100810468|FG000|STARTED|First Exposure||8||
48199818|NCT02857283|100810469|FG001|STARTED|First Exposure||7||
48199819|NCT02857283|100810468|FG000|COMPLETED|First Exposure||7||
48199820|NCT02857283|100810469|FG001|COMPLETED|First Exposure||7||
48199821|NCT02857283|100810468|FG000|NOT COMPLETED|First Exposure||1||
48199822|NCT02857283|100810469|FG001|NOT COMPLETED|First Exposure||0||
48199823|NCT02857283|100810468|FG000|STARTED|Washout (2 Weeks)||7||
48199824|NCT02857283|100810469|FG001|STARTED|Washout (2 Weeks)||7||
48199825|NCT02857283|100810468|FG000|COMPLETED|Washout (2 Weeks)||7||
48199826|NCT02857283|100810469|FG001|COMPLETED|Washout (2 Weeks)||7||
48199827|NCT02857283|100810468|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
48199828|NCT02857283|100810469|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
48199829|NCT02857283|100810468|FG000|STARTED|Second Exposure||7||
48199830|NCT02857283|100810469|FG001|STARTED|Second Exposure||7||
48199831|NCT02857283|100810468|FG000|COMPLETED|Second Exposure||7||
48199832|NCT02857283|100810469|FG001|COMPLETED|Second Exposure||7||
48199833|NCT02857283|100810468|FG000|NOT COMPLETED|Second Exposure||0||
48199834|NCT02857283|100810469|FG001|NOT COMPLETED|Second Exposure||0||
48199835|NCT01451814|100810470|FG000|STARTED|Overall Study||35||
48199836|NCT01451814|100810471|FG001|STARTED|Overall Study||31||
48199837|NCT01451814|100810470|FG000|Attended a Session|Overall Study||35||
48199838|NCT01451814|100810471|FG001|Attended a Session|Overall Study||31||
48488835|NCT00968812|101532510|FG001|NOT COMPLETED|Overall Study||162||
48488836|NCT00968812|101532511|FG002|NOT COMPLETED|Overall Study||168||
48199839|NCT01451814|100810470|FG000|COMPLETED|Overall Study||29||
48199840|NCT01451814|100810471|FG001|COMPLETED|Overall Study||26||
48199841|NCT01451814|100810470|FG000|NOT COMPLETED|Overall Study||6||
48199842|NCT01451814|100810471|FG001|NOT COMPLETED|Overall Study||5||
48199843|NCT03533036|100810472|FG000|STARTED|Overall Study||15||
48199844|NCT03533036|100810473|FG001|STARTED|Overall Study||15||
48199845|NCT03533036|100810472|FG000|COMPLETED|Overall Study||15||
48488837|NCT00112463|101532512|FG000|STARTED|Overall Study||40||
48488838|NCT00112463|101532512|FG000|COMPLETED|Overall Study||1||
48199846|NCT03533036|100810473|FG001|COMPLETED|Overall Study||15||
48488839|NCT00112463|101532512|FG000|NOT COMPLETED|Overall Study||39||
48488840|NCT00834964|101532513|FG000|STARTED|First Intervention||15||
48488841|NCT00834964|101532514|FG001|STARTED|First Intervention||15||
48488842|NCT00834964|101532513|FG000|COMPLETED|First Intervention||15||
48488843|NCT00834964|101532514|FG001|COMPLETED|First Intervention||15||
48488844|NCT00834964|101532513|FG000|NOT COMPLETED|First Intervention||0||
48488845|NCT00834964|101532514|FG001|NOT COMPLETED|First Intervention||0||
48488846|NCT00834964|101532513|FG000|STARTED|Washout: 7 Days||15||
48488847|NCT00834964|101532514|FG001|STARTED|Washout: 7 Days||15||
48488848|NCT00834964|101532513|FG000|COMPLETED|Washout: 7 Days||15||
48488849|NCT00834964|101532514|FG001|COMPLETED|Washout: 7 Days||15||
48488850|NCT00834964|101532513|FG000|NOT COMPLETED|Washout: 7 Days||0||
48488851|NCT00834964|101532514|FG001|NOT COMPLETED|Washout: 7 Days||0||
48488852|NCT00834964|101532513|FG000|STARTED|Second Intervention||15||
48488853|NCT00834964|101532514|FG001|STARTED|Second Intervention||15||
48488854|NCT00834964|101532513|FG000|COMPLETED|Second Intervention||15||
48488855|NCT00834964|101532514|FG001|COMPLETED|Second Intervention||15||
48488856|NCT00834964|101532513|FG000|NOT COMPLETED|Second Intervention||0||
48666598|NCT02374255|101967622|FG002|NOT COMPLETED|Overall Study||0||
48199847|NCT03533036|100810472|FG000|NOT COMPLETED|Overall Study||0||
48199848|NCT03533036|100810473|FG001|NOT COMPLETED|Overall Study||0||
48488857|NCT00834964|101532514|FG001|NOT COMPLETED|Second Intervention||0||
48488858|NCT01415986|101532515|FG000|STARTED|Overall Study||1||
48488859|NCT01415986|101532515|FG000|COMPLETED|Overall Study||0||
48488860|NCT01415986|101532515|FG000|NOT COMPLETED|Overall Study||1||
48488861|NCT01299454|101532516|FG000|STARTED|Overall Study||8||
48488862|NCT01299454|101532517|FG001|STARTED|Overall Study||8||
48488863|NCT01299454|101532518|FG002|STARTED|Overall Study||6||
48488864|NCT01299454|101532519|FG003|STARTED|Overall Study||23||
48199849|NCT05372094|100814397|FG000|STARTED|Overall Study||18||
48199850|NCT05372094|100814397|FG000|COMPLETED|Overall Study||18||
48199851|NCT05372094|100814397|FG000|NOT COMPLETED|Overall Study||0||
48199852|NCT03518112|100814398|FG000|STARTED|Overall Study||6||
48199853|NCT03518112|100814398|FG000|COMPLETED|Overall Study||5||
48199854|NCT03518112|100814398|FG000|NOT COMPLETED|Overall Study||1||
48199855|NCT02299635|100814399|FG000|STARTED|Overall Study||19||
48199856|NCT02299635|100814399|FG000|COMPLETED|Overall Study||0||
48199857|NCT02299635|100814399|FG000|NOT COMPLETED|Overall Study||19||
48199858|NCT00516503|100814400|FG000|STARTED|Overall Study||101||
48199859|NCT00516503|100814401|FG001|STARTED|Overall Study||102||
48199860|NCT00516503|100814400|FG000|COMPLETED|Overall Study||101||
48199861|NCT00516503|100814401|FG001|COMPLETED|Overall Study||102||
48199862|NCT00516503|100814400|FG000|NOT COMPLETED|Overall Study||0||
48199863|NCT00516503|100814401|FG001|NOT COMPLETED|Overall Study||0||
48199864|NCT04026620|100814402|FG000|STARTED|Overall Study||82||
48199865|NCT04026620|100814403|FG001|STARTED|Overall Study||85||
48199866|NCT04026620|100814402|FG000|COMPLETED|Overall Study||71||
48199867|NCT04026620|100814403|FG001|COMPLETED|Overall Study||68||
48199868|NCT04026620|100814402|FG000|NOT COMPLETED|Overall Study||11||
48199869|NCT04026620|100814403|FG001|NOT COMPLETED|Overall Study||17||
48199870|NCT00907218|100814404|FG000|STARTED|Overall Study||2||
48199871|NCT00907218|100814404|FG000|COMPLETED|Overall Study||2||
48199872|NCT00907218|100814404|FG000|NOT COMPLETED|Overall Study||0||
48199873|NCT01597128|100814405|FG000|STARTED|Overall Study||18||
48199874|NCT01597128|100814406|FG001|STARTED|Overall Study||17||
48199875|NCT01597128|100814405|FG000|COMPLETED|Overall Study||18||
48199876|NCT01597128|100814406|FG001|COMPLETED|Overall Study||17||
48199877|NCT01597128|100814405|FG000|NOT COMPLETED|Overall Study||0||
48199878|NCT01597128|100814406|FG001|NOT COMPLETED|Overall Study||0||
48199879|NCT02247063|100814407|FG000|STARTED|Overall Study||12||
48199880|NCT02247063|100814408|FG001|STARTED|Overall Study||12||
48199881|NCT02247063|100814407|FG000|COMPLETED|Overall Study||12||
48199882|NCT02247063|100814408|FG001|COMPLETED|Overall Study||12||
48199883|NCT02247063|100814407|FG000|NOT COMPLETED|Overall Study||0||
48199884|NCT02247063|100814408|FG001|NOT COMPLETED|Overall Study||0||
48199885|NCT03621761|100814409|FG000|STARTED|Overall Study||114||
48199886|NCT03621761|100814410|FG001|STARTED|Overall Study||114||
48199887|NCT03621761|100814411|FG002|STARTED|Overall Study||108||
48199888|NCT03621761|100814409|FG000|Week 8 Follow-up Timepoint|Overall Study||111||
48199889|NCT03621761|100814410|FG001|Week 8 Follow-up Timepoint|Overall Study||111||
48199890|NCT03621761|100814411|FG002|Week 8 Follow-up Timepoint|Overall Study||105||
48199891|NCT03621761|100814409|FG000|Week 12 Follow-up Timepoint|Overall Study||111||
48199892|NCT03621761|100814410|FG001|Week 12 Follow-up Timepoint|Overall Study||110||
48199893|NCT03621761|100814411|FG002|Week 12 Follow-up Timepoint|Overall Study||105||
48199894|NCT03621761|100814409|FG000|Week 24 Survey Timepoint|Overall Study||111||
48199895|NCT03621761|100814410|FG001|Week 24 Survey Timepoint|Overall Study||110||
48199896|NCT03621761|100814411|FG002|Week 24 Survey Timepoint|Overall Study||105||
48199897|NCT03621761|100814409|FG000|COMPLETED|Overall Study||111||
48199898|NCT03621761|100814410|FG001|COMPLETED|Overall Study||110||
48488865|NCT01299454|101532516|FG000|COMPLETED|Overall Study||8||
48488866|NCT01299454|101532517|FG001|COMPLETED|Overall Study||8||
48488867|NCT01299454|101532518|FG002|COMPLETED|Overall Study||6||
48488868|NCT01299454|101532519|FG003|COMPLETED|Overall Study||23||
48488869|NCT01299454|101532516|FG000|NOT COMPLETED|Overall Study||0||
48488870|NCT01299454|101532517|FG001|NOT COMPLETED|Overall Study||0||
48488871|NCT01299454|101532518|FG002|NOT COMPLETED|Overall Study||0||
48488872|NCT01299454|101532519|FG003|NOT COMPLETED|Overall Study||0||
48488873|NCT00272779|101532520|FG000|STARTED|Baseline Through Week 48||440||
48488874|NCT00272779|101532521|FG001|STARTED|Baseline Through Week 48||443||
48199899|NCT03621761|100814411|FG002|COMPLETED|Overall Study||105||
48199900|NCT03621761|100814409|FG000|NOT COMPLETED|Overall Study||3||
48199901|NCT03621761|100814410|FG001|NOT COMPLETED|Overall Study||4||
48199902|NCT03621761|100814411|FG002|NOT COMPLETED|Overall Study||3||
48199903|NCT00959920|100814412|FG000|STARTED|Overall Study||72||
48199904|NCT00959920|100814413|FG001|STARTED|Overall Study||67||
48199905|NCT00959920|100814412|FG000|COMPLETED|Overall Study||72||
48199906|NCT00959920|100814413|FG001|COMPLETED|Overall Study||66||
48199907|NCT00959920|100814412|FG000|NOT COMPLETED|Overall Study||0||
48199908|NCT00959920|100814413|FG001|NOT COMPLETED|Overall Study||1||
48199909|NCT03693742|100814414|FG000|STARTED|Overall Study||7||
48199910|NCT03693742|100814415|FG001|STARTED|Overall Study||3||
48199911|NCT03693742|100814414|FG000|COMPLETED|Overall Study||7||
48199912|NCT03693742|100814415|FG001|COMPLETED|Overall Study||3||
48199913|NCT03693742|100814414|FG000|NOT COMPLETED|Overall Study||0||
48199914|NCT03693742|100814415|FG001|NOT COMPLETED|Overall Study||0||
48199915|NCT02982213|100814416|FG000|STARTED|Overall Study||75||
48199916|NCT02982213|100814417|FG001|STARTED|Overall Study||75||
48199917|NCT02982213|100814416|FG000|COMPLETED|Overall Study||70||
48199918|NCT02982213|100814417|FG001|COMPLETED|Overall Study||74||
48199919|NCT02982213|100814416|FG000|NOT COMPLETED|Overall Study||5||
48199920|NCT02982213|100814417|FG001|NOT COMPLETED|Overall Study||1||
48199921|NCT00001575|100814418|FG000|STARTED|Overall Study||87||
48199922|NCT00001575|100814418|FG000|Treated|Overall Study||65||
48199923|NCT00001575|100814418|FG000|COMPLETED|Overall Study||42||
48199924|NCT00001575|100814418|FG000|NOT COMPLETED|Overall Study||45||
48199925|NCT01648140|100814419|FG000|STARTED|Overall Study||41||
48199926|NCT01648140|100814420|FG001|STARTED|Overall Study||40||
48199927|NCT01648140|100814421|FG002|STARTED|Overall Study||17||
48199928|NCT01648140|100814422|FG003|STARTED|Overall Study||13||
48199929|NCT01648140|100814419|FG000|COMPLETED|Overall Study||29||
48199930|NCT01648140|100814420|FG001|COMPLETED|Overall Study||28||
48199931|NCT01648140|100814421|FG002|COMPLETED|Overall Study||9||
48199932|NCT01648140|100814422|FG003|COMPLETED|Overall Study||11||
48199933|NCT01648140|100814419|FG000|NOT COMPLETED|Overall Study||12||
48199934|NCT01648140|100814420|FG001|NOT COMPLETED|Overall Study||12||
48199935|NCT01648140|100814421|FG002|NOT COMPLETED|Overall Study||8||
48199936|NCT01648140|100814422|FG003|NOT COMPLETED|Overall Study||2||
48199937|NCT02087306|100814423|FG000|STARTED|Overall Study||65||
48199938|NCT02087306|100814424|FG001|STARTED|Overall Study||93||
48199939|NCT02087306|100814425|FG002|STARTED|Overall Study||43||
48199940|NCT02087306|100814423|FG000|COMPLETED|Overall Study||29||
48199941|NCT02087306|100814424|FG001|COMPLETED|Overall Study||29||
48199942|NCT02087306|100814425|FG002|COMPLETED|Overall Study||16||
48199943|NCT02087306|100814423|FG000|NOT COMPLETED|Overall Study||36||
48199944|NCT02087306|100814424|FG001|NOT COMPLETED|Overall Study||64||
48199945|NCT02087306|100814425|FG002|NOT COMPLETED|Overall Study||27||
48199946|NCT02488317|100814426|FG000|STARTED|Overall Study||117||
48488875|NCT00272779|101532520|FG000|RECEIVED ANY TREATMENT|Baseline Through Week 48||441||
48488876|NCT00272779|101532521|FG001|RECEIVED ANY TREATMENT|Baseline Through Week 48||437||
48488877|NCT00272779|101532520|FG000|TREATED AS RANDOMIZED|Baseline Through Week 48||438||
48488878|NCT00272779|101532521|FG001|TREATED AS RANDOMIZED|Baseline Through Week 48||440||
48199947|NCT02488317|100814427|FG001|STARTED|Overall Study||117||
48199948|NCT02488317|100814426|FG000|COMPLETED|Overall Study||63||
48199949|NCT02488317|100814427|FG001|COMPLETED|Overall Study||70||
48199950|NCT02488317|100814426|FG000|NOT COMPLETED|Overall Study||54||
48199951|NCT02488317|100814427|FG001|NOT COMPLETED|Overall Study||47||
48199952|NCT03663101|100814428|FG000|STARTED|Overall Study||4||
48199953|NCT03663101|100814429|FG001|STARTED|Overall Study||3||
48199954|NCT03663101|100814430|FG002|STARTED|Overall Study||5||
48199955|NCT03663101|100814431|FG003|STARTED|Overall Study||4||
48199956|NCT03663101|100814428|FG000|COMPLETED|Overall Study||4||
48199957|NCT03663101|100814429|FG001|COMPLETED|Overall Study||3||
48199958|NCT03663101|100814430|FG002|COMPLETED|Overall Study||5||
48199959|NCT03663101|100814431|FG003|COMPLETED|Overall Study||4||
48199960|NCT03663101|100814428|FG000|NOT COMPLETED|Overall Study||0||
48199961|NCT03663101|100814429|FG001|NOT COMPLETED|Overall Study||0||
48199962|NCT03663101|100814430|FG002|NOT COMPLETED|Overall Study||0||
48199963|NCT03663101|100814431|FG003|NOT COMPLETED|Overall Study||0||
48488879|NCT00272779|101532520|FG000|Discontinued Before Week 48|Baseline Through Week 48||39||
48488880|NCT00272779|101532521|FG001|Discontinued Before Week 48|Baseline Through Week 48||58||
48488881|NCT00272779|101532520|FG000|Discontinued on or After Week 48|Baseline Through Week 48||14||
48488882|NCT00272779|101532521|FG001|Discontinued on or After Week 48|Baseline Through Week 48||14||
48488883|NCT00272779|101532520|FG000|STILL ON TREATMENT|Baseline Through Week 48||385||
48488884|NCT00272779|101532521|FG001|STILL ON TREATMENT|Baseline Through Week 48||368||
48488885|NCT00272779|101532520|FG000|COMPLETED|Baseline Through Week 48||0||
48488886|NCT00272779|101532521|FG001|COMPLETED|Baseline Through Week 48||0||
48488887|NCT00272779|101532520|FG000|NOT COMPLETED|Baseline Through Week 48||440||
48488888|NCT00272779|101532521|FG001|NOT COMPLETED|Baseline Through Week 48||443||
48488889|NCT00272779|101532520|FG000|STARTED|Baseline Through Week 96||440||
48488890|NCT00272779|101532521|FG001|STARTED|Baseline Through Week 96||443||
48488891|NCT00272779|101532520|FG000|RECEIVED ANY TREATMENT|Baseline Through Week 96||441||
48488892|NCT00272779|101532521|FG001|RECEIVED ANY TREATMENT|Baseline Through Week 96||437||
48199964|NCT00145041|100814432|FG000|STARTED|Overall Study||7||
48488893|NCT00272779|101532520|FG000|COMPLETED|Baseline Through Week 96||301||
48488894|NCT00272779|101532521|FG001|COMPLETED|Baseline Through Week 96||307||
48488895|NCT00272779|101532520|FG000|NOT COMPLETED|Baseline Through Week 96||139||
48488896|NCT00272779|101532521|FG001|NOT COMPLETED|Baseline Through Week 96||136||
48488897|NCT01141374|101532522|FG000|STARTED|Overall Study||26||
48488898|NCT01141374|101532523|FG001|STARTED|Overall Study||27||
48488899|NCT01141374|101532524|FG002|STARTED|Overall Study||22||
48488900|NCT01141374|101532522|FG000|COMPLETED|Overall Study||26||
48488901|NCT01141374|101532523|FG001|COMPLETED|Overall Study||27||
48488902|NCT01141374|101532524|FG002|COMPLETED|Overall Study||22||
48488903|NCT01141374|101532522|FG000|NOT COMPLETED|Overall Study||0||
48488904|NCT01141374|101532523|FG001|NOT COMPLETED|Overall Study||0||
48488905|NCT01141374|101532524|FG002|NOT COMPLETED|Overall Study||0||
48488906|NCT00840476|101532525|FG000|STARTED|First Intervention||14||
48488907|NCT00840476|101532526|FG001|STARTED|First Intervention||14||
48488908|NCT00840476|101532525|FG000|COMPLETED|First Intervention||14||
48488909|NCT00840476|101532526|FG001|COMPLETED|First Intervention||14||
48488910|NCT00840476|101532525|FG000|NOT COMPLETED|First Intervention||0||
48488911|NCT00840476|101532526|FG001|NOT COMPLETED|First Intervention||0||
48488912|NCT00840476|101532525|FG000|STARTED|Washout: 14 Days||14||
48488913|NCT00840476|101532526|FG001|STARTED|Washout: 14 Days||14||
48488914|NCT00840476|101532525|FG000|COMPLETED|Washout: 14 Days||14||
48488915|NCT00840476|101532526|FG001|COMPLETED|Washout: 14 Days||14||
48488916|NCT00840476|101532525|FG000|NOT COMPLETED|Washout: 14 Days||0||
48488917|NCT00840476|101532526|FG001|NOT COMPLETED|Washout: 14 Days||0||
48488918|NCT00840476|101532525|FG000|STARTED|Second Intervention||14||
48488919|NCT00840476|101532526|FG001|STARTED|Second Intervention||14||
48488920|NCT00840476|101532525|FG000|COMPLETED|Second Intervention||14||
48488921|NCT00840476|101532526|FG001|COMPLETED|Second Intervention||14||
48488922|NCT00840476|101532525|FG000|NOT COMPLETED|Second Intervention||0||
48488923|NCT00840476|101532526|FG001|NOT COMPLETED|Second Intervention||0||
48488924|NCT04859517|101532527|FG000|STARTED|Overall Study||245||
48488925|NCT04859517|101532528|FG001|STARTED|Overall Study||242||
48488926|NCT04859517|101532529|FG002|STARTED|Overall Study||1048||
48488927|NCT04859517|101532530|FG003|STARTED|Overall Study||1047||
48488928|NCT04859517|101532527|FG000|COMPLETED|Overall Study||32||
48488929|NCT04859517|101532528|FG001|COMPLETED|Overall Study||35||
48488930|NCT04859517|101532529|FG002|COMPLETED|Overall Study||226||
48488931|NCT04859517|101532530|FG003|COMPLETED|Overall Study||236||
48488932|NCT04859517|101532527|FG000|NOT COMPLETED|Overall Study||213||
48488933|NCT04859517|101532528|FG001|NOT COMPLETED|Overall Study||207||
48488934|NCT04859517|101532529|FG002|NOT COMPLETED|Overall Study||822||
48488935|NCT04859517|101532530|FG003|NOT COMPLETED|Overall Study||811||
48488936|NCT04813354|101532531|FG000|STARTED|Overall Study||29||
48488937|NCT04813354|101532532|FG001|STARTED|Overall Study||29||
48488938|NCT04813354|101532533|FG002|STARTED|Overall Study||28||
48488939|NCT04813354|101532534|FG003|STARTED|Overall Study||28||
48488940|NCT04813354|101532531|FG000|COMPLETED|Overall Study||29||
48488941|NCT04813354|101532532|FG001|COMPLETED|Overall Study||29||
48488942|NCT04813354|101532533|FG002|COMPLETED|Overall Study||28||
48488943|NCT04813354|101532534|FG003|COMPLETED|Overall Study||28||
48488944|NCT04813354|101532531|FG000|NOT COMPLETED|Overall Study||0||
48488945|NCT04813354|101532532|FG001|NOT COMPLETED|Overall Study||0||
48488946|NCT04813354|101532533|FG002|NOT COMPLETED|Overall Study||0||
48488947|NCT04813354|101532534|FG003|NOT COMPLETED|Overall Study||0||
48488948|NCT00840073|101532535|FG000|STARTED|First Intervention||25||
48488949|NCT00840073|101532536|FG001|STARTED|First Intervention||25||
48488950|NCT00840073|101532535|FG000|COMPLETED|First Intervention||25||
48488951|NCT00840073|101532536|FG001|COMPLETED|First Intervention||25||
48488952|NCT00840073|101532535|FG000|NOT COMPLETED|First Intervention||0||
48488953|NCT00840073|101532536|FG001|NOT COMPLETED|First Intervention||0||
48488954|NCT00840073|101532535|FG000|STARTED|Second Intervention||25||
48488955|NCT00840073|101532536|FG001|STARTED|Second Intervention||25||
48488956|NCT00840073|101532535|FG000|COMPLETED|Second Intervention||24||
48488957|NCT00840073|101532536|FG001|COMPLETED|Second Intervention||24||
48488958|NCT00840073|101532535|FG000|NOT COMPLETED|Second Intervention||1||
48488959|NCT00840073|101532536|FG001|NOT COMPLETED|Second Intervention||1||
48488960|NCT02362997|101532537|FG000|STARTED|Overall Study||31||
48488961|NCT02362997|101532538|FG001|STARTED|Overall Study||30||
48488962|NCT02362997|101532539|FG002|STARTED|Overall Study||21||
48488963|NCT02362997|101532537|FG000|COMPLETED|Overall Study||31||
48488964|NCT02362997|101532538|FG001|COMPLETED|Overall Study||30||
48488965|NCT02362997|101532539|FG002|COMPLETED|Overall Study||21||
48488966|NCT02362997|101532537|FG000|NOT COMPLETED|Overall Study||0||
48488967|NCT02362997|101532538|FG001|NOT COMPLETED|Overall Study||0||
48488968|NCT02362997|101532539|FG002|NOT COMPLETED|Overall Study||0||
48488969|NCT04194801|101532540|FG000|STARTED|Part Ib/II End Of Treatment-BLU554||4||
48488970|NCT04194801|101532541|FG001|STARTED|Part Ib/II End Of Treatment-BLU554||7||
48488971|NCT04194801|101532542|FG002|STARTED|Part Ib/II End Of Treatment-BLU554||15||
48488972|NCT04194801|101532540|FG000|COMPLETED|Part Ib/II End Of Treatment-BLU554||0||
48488973|NCT04194801|101532541|FG001|COMPLETED|Part Ib/II End Of Treatment-BLU554||0||
48488974|NCT04194801|101532542|FG002|COMPLETED|Part Ib/II End Of Treatment-BLU554||0||
48488975|NCT04194801|101532540|FG000|NOT COMPLETED|Part Ib/II End Of Treatment-BLU554||4||
48488976|NCT04194801|101532541|FG001|NOT COMPLETED|Part Ib/II End Of Treatment-BLU554||7||
48488977|NCT04194801|101532542|FG002|NOT COMPLETED|Part Ib/II End Of Treatment-BLU554||15||
48488978|NCT04194801|101532540|FG000|STARTED|Part Ib/II End Of Treatment-CS1001||4||
48488979|NCT04194801|101532541|FG001|STARTED|Part Ib/II End Of Treatment-CS1001||7||
48488980|NCT04194801|101532542|FG002|STARTED|Part Ib/II End Of Treatment-CS1001||15||
48488981|NCT04194801|101532540|FG000|COMPLETED|Part Ib/II End Of Treatment-CS1001||0||
48488982|NCT04194801|101532541|FG001|COMPLETED|Part Ib/II End Of Treatment-CS1001||0||
48488983|NCT04194801|101532542|FG002|COMPLETED|Part Ib/II End Of Treatment-CS1001||0||
48488984|NCT04194801|101532540|FG000|NOT COMPLETED|Part Ib/II End Of Treatment-CS1001||4||
48488985|NCT04194801|101532541|FG001|NOT COMPLETED|Part Ib/II End Of Treatment-CS1001||7||
48488986|NCT04194801|101532542|FG002|NOT COMPLETED|Part Ib/II End Of Treatment-CS1001||15||
48488987|NCT04194801|101532540|FG000|STARTED|Part Ib/II End of Study||4||
48488988|NCT04194801|101532541|FG001|STARTED|Part Ib/II End of Study||7||
48488989|NCT04194801|101532542|FG002|STARTED|Part Ib/II End of Study||15||
48488990|NCT04194801|101532540|FG000|COMPLETED|Part Ib/II End of Study||0||
48488991|NCT04194801|101532541|FG001|COMPLETED|Part Ib/II End of Study||0||
48488992|NCT04194801|101532542|FG002|COMPLETED|Part Ib/II End of Study||0||
48488993|NCT04194801|101532540|FG000|NOT COMPLETED|Part Ib/II End of Study||4||
48488994|NCT04194801|101532541|FG001|NOT COMPLETED|Part Ib/II End of Study||7||
48488995|NCT04194801|101532542|FG002|NOT COMPLETED|Part Ib/II End of Study||15||
48488996|NCT01926119|101532543|FG000|STARTED|Overall Study||4||
48488997|NCT01926119|101532543|FG000|COMPLETED|Overall Study||3||
48488998|NCT01926119|101532543|FG000|NOT COMPLETED|Overall Study||1||
48488999|NCT00477594|101532544|FG000|STARTED|Year 1 and Year 2||16||
48489000|NCT00477594|101532545|FG001|STARTED|Year 1 and Year 2||5||
48489001|NCT00477594|101532544|FG000|COMPLETED|Year 1 and Year 2||7||
48489002|NCT00477594|101532545|FG001|COMPLETED|Year 1 and Year 2||1||
48489003|NCT00477594|101532544|FG000|NOT COMPLETED|Year 1 and Year 2||9||
48489004|NCT00477594|101532545|FG001|NOT COMPLETED|Year 1 and Year 2||4||
48489005|NCT00477594|101532544|FG000|STARTED|Year 3||4||
48489006|NCT00477594|101532545|FG001|STARTED|Year 3||0||
48489007|NCT00477594|101532544|FG000|COMPLETED|Year 3||2||
48489008|NCT00477594|101532545|FG001|COMPLETED|Year 3||0||
48489009|NCT00477594|101532544|FG000|NOT COMPLETED|Year 3||2||
48489010|NCT00477594|101532545|FG001|NOT COMPLETED|Year 3||0||
48489011|NCT00477594|101532544|FG000|STARTED|Follow-up Period||16||
48489012|NCT00477594|101532545|FG001|STARTED|Follow-up Period||5||
48489013|NCT00477594|101532544|FG000|COMPLETED|Follow-up Period||13||
48489014|NCT00477594|101532545|FG001|COMPLETED|Follow-up Period||4||
48489015|NCT00477594|101532544|FG000|NOT COMPLETED|Follow-up Period||3||
48489016|NCT00477594|101532545|FG001|NOT COMPLETED|Follow-up Period||1||
48489017|NCT00829764|101532546|FG000|STARTED|First Intervention||15||
48489018|NCT00829764|101532547|FG001|STARTED|First Intervention||15||
48489019|NCT00829764|101532546|FG000|COMPLETED|First Intervention||13||
48489020|NCT00829764|101532547|FG001|COMPLETED|First Intervention||14||
48489021|NCT00829764|101532546|FG000|NOT COMPLETED|First Intervention||2||
48489022|NCT00829764|101532547|FG001|NOT COMPLETED|First Intervention||1||
48489023|NCT00829764|101532546|FG000|STARTED|Washout of 14 Days||13||
48489024|NCT00829764|101532547|FG001|STARTED|Washout of 14 Days||14||
48489025|NCT00829764|101532546|FG000|COMPLETED|Washout of 14 Days||13||
48489026|NCT00829764|101532547|FG001|COMPLETED|Washout of 14 Days||14||
48489027|NCT00829764|101532546|FG000|NOT COMPLETED|Washout of 14 Days||0||
48489028|NCT00829764|101532547|FG001|NOT COMPLETED|Washout of 14 Days||0||
48489029|NCT00829764|101532546|FG000|STARTED|Second Intervention||13||
48489030|NCT00829764|101532547|FG001|STARTED|Second Intervention||14||
48489031|NCT00829764|101532546|FG000|COMPLETED|Second Intervention||13||
48489032|NCT00829764|101532547|FG001|COMPLETED|Second Intervention||14||
48489033|NCT00829764|101532546|FG000|NOT COMPLETED|Second Intervention||0||
48489034|NCT00829764|101532547|FG001|NOT COMPLETED|Second Intervention||0||
48489035|NCT00556322|101532548|FG000|STARTED|Overall Study||221||
48489036|NCT00556322|101532549|FG001|STARTED|Overall Study||203||
48489037|NCT00556322|101532548|FG000|COMPLETED|Overall Study||0||
48489038|NCT00556322|101532549|FG001|COMPLETED|Overall Study||0||
48489039|NCT00556322|101532548|FG000|NOT COMPLETED|Overall Study||221||
48489040|NCT00556322|101532549|FG001|NOT COMPLETED|Overall Study||203||
48489041|NCT00147498|101532550|FG000|STARTED|Overall Study||61||
48489042|NCT00147498|101532551|FG001|STARTED|Overall Study||69||
48489043|NCT00147498|101532552|FG002|STARTED|Overall Study||69||
48489044|NCT00147498|101532553|FG003|STARTED|Overall Study||65||
48489045|NCT00147498|101532550|FG000|COMPLETED|Overall Study||58||
48489046|NCT00147498|101532551|FG001|COMPLETED|Overall Study||60||
48489047|NCT00147498|101532552|FG002|COMPLETED|Overall Study||52||
48489048|NCT00147498|101532553|FG003|COMPLETED|Overall Study||48||
48489049|NCT00147498|101532550|FG000|NOT COMPLETED|Overall Study||3||
48489050|NCT00147498|101532551|FG001|NOT COMPLETED|Overall Study||9||
48489051|NCT00147498|101532552|FG002|NOT COMPLETED|Overall Study||17||
48489052|NCT00147498|101532553|FG003|NOT COMPLETED|Overall Study||17||
48489053|NCT00723710|101532554|FG000|STARTED|Overall Study||294||
48489054|NCT00723710|101532554|FG000|COMPLETED|Overall Study||120||
48489055|NCT00723710|101532554|FG000|NOT COMPLETED|Overall Study||174||
48489056|NCT00836004|101532555|FG000|STARTED|First Intervention||12||
48489057|NCT00836004|101532556|FG001|STARTED|First Intervention||12||
48489058|NCT00836004|101532555|FG000|COMPLETED|First Intervention||12||
48489059|NCT00836004|101532556|FG001|COMPLETED|First Intervention||12||
48489060|NCT00836004|101532555|FG000|NOT COMPLETED|First Intervention||0||
48489061|NCT00836004|101532556|FG001|NOT COMPLETED|First Intervention||0||
48489062|NCT00836004|101532555|FG000|STARTED|Washout: 7 Days||12||
48489063|NCT00836004|101532556|FG001|STARTED|Washout: 7 Days||12||
48489064|NCT00836004|101532555|FG000|COMPLETED|Washout: 7 Days||12||
48489065|NCT00836004|101532556|FG001|COMPLETED|Washout: 7 Days||12||
48489066|NCT00836004|101532555|FG000|NOT COMPLETED|Washout: 7 Days||0||
48489067|NCT00836004|101532556|FG001|NOT COMPLETED|Washout: 7 Days||0||
48489068|NCT00836004|101532555|FG000|STARTED|Second Intervention||12||
48489069|NCT00836004|101532556|FG001|STARTED|Second Intervention||12||
48489070|NCT00836004|101532555|FG000|COMPLETED|Second Intervention||12||
48489071|NCT00836004|101532556|FG001|COMPLETED|Second Intervention||12||
48489072|NCT00836004|101532555|FG000|NOT COMPLETED|Second Intervention||0||
48489073|NCT00836004|101532556|FG001|NOT COMPLETED|Second Intervention||0||
48489074|NCT03803774|101532557|FG000|STARTED|Dose Escalation||0||
48489075|NCT03803774|101532558|FG001|STARTED|Dose Escalation||3||
48489076|NCT03803774|101532559|FG002|STARTED|Dose Escalation||3||
48489077|NCT03803774|101532560|FG003|STARTED|Dose Escalation||4||
48489078|NCT03803774|101532561|FG004|STARTED|Dose Escalation||3||
48489079|NCT03803774|101532557|FG000|COMPLETED|Dose Escalation||0||
48489080|NCT03803774|101532558|FG001|COMPLETED|Dose Escalation||3||
48489081|NCT03803774|101532559|FG002|COMPLETED|Dose Escalation||3||
48489082|NCT03803774|101532560|FG003|COMPLETED|Dose Escalation||3||
48489083|NCT03803774|101532561|FG004|COMPLETED|Dose Escalation||3||
48489084|NCT03803774|101532557|FG000|NOT COMPLETED|Dose Escalation||0||
48489085|NCT03803774|101532558|FG001|NOT COMPLETED|Dose Escalation||0||
48489086|NCT03803774|101532559|FG002|NOT COMPLETED|Dose Escalation||0||
48489087|NCT03803774|101532560|FG003|NOT COMPLETED|Dose Escalation||1||
48489088|NCT03803774|101532561|FG004|NOT COMPLETED|Dose Escalation||0||
48489089|NCT03803774|101532557|FG000|STARTED|Dose Expansion||0||
48489090|NCT03803774|101532558|FG001|STARTED|Dose Expansion||0||
48489091|NCT03803774|101532559|FG002|STARTED|Dose Expansion||0||
48489092|NCT03803774|101532560|FG003|STARTED|Dose Expansion||0||
48489093|NCT03803774|101532561|FG004|STARTED|Dose Expansion||0||
48489094|NCT03803774|101532557|FG000|COMPLETED|Dose Expansion||0||
48489095|NCT03803774|101532558|FG001|COMPLETED|Dose Expansion||0||
48489096|NCT03803774|101532559|FG002|COMPLETED|Dose Expansion||0||
48489097|NCT03803774|101532560|FG003|COMPLETED|Dose Expansion||0||
48489098|NCT03803774|101532561|FG004|COMPLETED|Dose Expansion||0||
48489099|NCT03803774|101532557|FG000|NOT COMPLETED|Dose Expansion||0||
48199965|NCT00145041|100814432|FG000|COMPLETED|Overall Study||7||
48489100|NCT03803774|101532558|FG001|NOT COMPLETED|Dose Expansion||0||
48489101|NCT03803774|101532559|FG002|NOT COMPLETED|Dose Expansion||0||
48489102|NCT03803774|101532560|FG003|NOT COMPLETED|Dose Expansion||0||
48489103|NCT03803774|101532561|FG004|NOT COMPLETED|Dose Expansion||0||
48489104|NCT00678639|101532562|FG000|STARTED|Overall Study||53||
48489105|NCT00678639|101532563|FG001|STARTED|Overall Study||57||
48489106|NCT00678639|101532562|FG000|Hospital Discharge|Overall Study||53||
48489107|NCT00678639|101532563|FG001|Hospital Discharge|Overall Study||57||
48489108|NCT00678639|101532562|FG000|COMPLETED|Overall Study||51||
48489109|NCT00678639|101532563|FG001|COMPLETED|Overall Study||57||
48489110|NCT00678639|101532562|FG000|NOT COMPLETED|Overall Study||2||
48489111|NCT00678639|101532563|FG001|NOT COMPLETED|Overall Study||0||
48489112|NCT00834743|101532564|FG000|STARTED|First Intervention||16||
48489113|NCT00834743|101532565|FG001|STARTED|First Intervention||16||
48489114|NCT00834743|101532564|FG000|COMPLETED|First Intervention||16||
48489115|NCT00834743|101532565|FG001|COMPLETED|First Intervention||16||
48489116|NCT00834743|101532564|FG000|NOT COMPLETED|First Intervention||0||
48489117|NCT00834743|101532565|FG001|NOT COMPLETED|First Intervention||0||
48489118|NCT00834743|101532564|FG000|STARTED|Washout of 7 Days||16||
48489119|NCT00834743|101532565|FG001|STARTED|Washout of 7 Days||16||
48489120|NCT00834743|101532564|FG000|COMPLETED|Washout of 7 Days||16||
48489121|NCT00834743|101532565|FG001|COMPLETED|Washout of 7 Days||16||
48489122|NCT00834743|101532564|FG000|NOT COMPLETED|Washout of 7 Days||0||
48489123|NCT00834743|101532565|FG001|NOT COMPLETED|Washout of 7 Days||0||
48489124|NCT00834743|101532564|FG000|STARTED|Second Intervention||16||
48489125|NCT00834743|101532565|FG001|STARTED|Second Intervention||16||
48489126|NCT00834743|101532564|FG000|COMPLETED|Second Intervention||15||
48489127|NCT00834743|101532565|FG001|COMPLETED|Second Intervention||16||
48489128|NCT00834743|101532564|FG000|NOT COMPLETED|Second Intervention||1||
48489129|NCT00834743|101532565|FG001|NOT COMPLETED|Second Intervention||0||
48489130|NCT00123734|101532566|FG000|STARTED|Overall Study||82||
48666599|NCT02374255|101967623|FG003|NOT COMPLETED|Overall Study||0||
48666600|NCT04743011|101967624|FG000|STARTED|Overall Study||14||
48666601|NCT04743011|101967625|FG001|STARTED|Overall Study||13||
48666602|NCT04743011|101967624|FG000|COMPLETED|Overall Study||14||
48666603|NCT04743011|101967625|FG001|COMPLETED|Overall Study||13||
48666604|NCT04743011|101967624|FG000|NOT COMPLETED|Overall Study||0||
48666605|NCT04743011|101967625|FG001|NOT COMPLETED|Overall Study||0||
48666606|NCT01537432|101967626|FG000|STARTED|Overall Study||24||
48666607|NCT01537432|101967627|FG001|STARTED|Overall Study||12||
48489131|NCT00123734|101532566|FG000|COMPLETED|Overall Study||74||
48489132|NCT00123734|101532566|FG000|NOT COMPLETED|Overall Study||8||
48489133|NCT02738086|101532567|FG000|STARTED|Overall Study||16||
48489134|NCT02738086|101532568|FG001|STARTED|Overall Study||15||
48489135|NCT02738086|101532567|FG000|COMPLETED|Overall Study||14||
48489136|NCT02738086|101532568|FG001|COMPLETED|Overall Study||13||
48489137|NCT02738086|101532567|FG000|NOT COMPLETED|Overall Study||2||
48489138|NCT02738086|101532568|FG001|NOT COMPLETED|Overall Study||2||
48489139|NCT00561015|101532569|FG000|STARTED|Overall Study||9||
48489140|NCT00561015|101532570|FG001|STARTED|Overall Study||5||
48489141|NCT00561015|101532571|FG002|STARTED|Overall Study||9||
48489142|NCT00561015|101532572|FG003|STARTED|Overall Study||8||
48489143|NCT00561015|101532573|FG004|STARTED|Overall Study||9||
48489144|NCT00561015|101532574|FG005|STARTED|Overall Study||9||
48489145|NCT00561015|101532569|FG000|COMPLETED|Overall Study||5||
48489146|NCT00561015|101532570|FG001|COMPLETED|Overall Study||5||
48489147|NCT00561015|101532571|FG002|COMPLETED|Overall Study||9||
48489148|NCT00561015|101532572|FG003|COMPLETED|Overall Study||7||
48489149|NCT00561015|101532573|FG004|COMPLETED|Overall Study||8||
48489150|NCT00561015|101532574|FG005|COMPLETED|Overall Study||6||
48489151|NCT00561015|101532569|FG000|NOT COMPLETED|Overall Study||4||
48489152|NCT00561015|101532570|FG001|NOT COMPLETED|Overall Study||0||
48489153|NCT00561015|101532571|FG002|NOT COMPLETED|Overall Study||0||
48489154|NCT00561015|101532572|FG003|NOT COMPLETED|Overall Study||1||
48489155|NCT00561015|101532573|FG004|NOT COMPLETED|Overall Study||1||
48489156|NCT00561015|101532574|FG005|NOT COMPLETED|Overall Study||3||
48489157|NCT02281084|101532575|FG000|STARTED|Overall Study||32||
48489158|NCT02281084|101532576|FG001|STARTED|Overall Study||22||
48489159|NCT02281084|101532577|FG002|STARTED|Overall Study||6||
48489160|NCT02281084|101532578|FG003|STARTED|Overall Study||5||
48489161|NCT02281084|101532575|FG000|COMPLETED|Overall Study||3||
48489162|NCT02281084|101532576|FG001|COMPLETED|Overall Study||1||
48489163|NCT02281084|101532577|FG002|COMPLETED|Overall Study||1||
48489164|NCT02281084|101532578|FG003|COMPLETED|Overall Study||0||
48489165|NCT02281084|101532575|FG000|NOT COMPLETED|Overall Study||29||
48489166|NCT02281084|101532576|FG001|NOT COMPLETED|Overall Study||21||
48489167|NCT02281084|101532577|FG002|NOT COMPLETED|Overall Study||5||
48489168|NCT02281084|101532578|FG003|NOT COMPLETED|Overall Study||5||
48489169|NCT03702608|101532579|FG000|STARTED|Overall Study||50||
48489170|NCT03702608|101532579|FG000|COMPLETED|Overall Study||50||
48489171|NCT03702608|101532579|FG000|NOT COMPLETED|Overall Study||0||
48489172|NCT00905606|101532580|FG000|STARTED|Period 1||15||
48489173|NCT00905606|101532581|FG001|STARTED|Period 1||15||
48489174|NCT00905606|101532580|FG000|COMPLETED|Period 1||15||
48489175|NCT00905606|101532581|FG001|COMPLETED|Period 1||14||
48489176|NCT00905606|101532580|FG000|NOT COMPLETED|Period 1||0||
48489177|NCT00905606|101532581|FG001|NOT COMPLETED|Period 1||1||
48489178|NCT00905606|101532580|FG000|STARTED|Washout||15||
48489179|NCT00905606|101532581|FG001|STARTED|Washout||14||
48489180|NCT00905606|101532580|FG000|COMPLETED|Washout||14||
48489181|NCT00905606|101532581|FG001|COMPLETED|Washout||14||
48489182|NCT00905606|101532580|FG000|NOT COMPLETED|Washout||1||
48489183|NCT00905606|101532581|FG001|NOT COMPLETED|Washout||0||
48489184|NCT00905606|101532580|FG000|STARTED|Period 2||14||
48489185|NCT00905606|101532581|FG001|STARTED|Period 2||14||
48489186|NCT00905606|101532580|FG000|COMPLETED|Period 2||14||
48489187|NCT00905606|101532581|FG001|COMPLETED|Period 2||14||
48489188|NCT00905606|101532580|FG000|NOT COMPLETED|Period 2||0||
48489189|NCT00905606|101532581|FG001|NOT COMPLETED|Period 2||0||
48489190|NCT00741858|101532582|FG000|STARTED|Overall Study||16||
48489191|NCT00741858|101532583|FG001|STARTED|Overall Study||18||
48489192|NCT00741858|101532582|FG000|COMPLETED|Overall Study||16||
48489193|NCT00741858|101532583|FG001|COMPLETED|Overall Study||18||
48489194|NCT00741858|101532582|FG000|NOT COMPLETED|Overall Study||0||
48489195|NCT00741858|101532583|FG001|NOT COMPLETED|Overall Study||0||
48489196|NCT02601560|101532584|FG000|STARTED|Overall Study||8||
48489197|NCT02601560|101532585|FG001|STARTED|Overall Study||6||
48489198|NCT02601560|101532586|FG002|STARTED|Overall Study||6||
48489199|NCT02601560|101532587|FG003|STARTED|Overall Study||6||
48489200|NCT02601560|101532588|FG004|STARTED|Overall Study||6||
48489201|NCT02601560|101532589|FG005|STARTED|Overall Study||4||
48489202|NCT02601560|101532590|FG006|STARTED|Overall Study||6||
48489203|NCT02601560|101532591|FG007|STARTED|Overall Study||6||
48489204|NCT02601560|101532584|FG000|COMPLETED|Overall Study||8||
48489205|NCT02601560|101532585|FG001|COMPLETED|Overall Study||6||
48489206|NCT02601560|101532586|FG002|COMPLETED|Overall Study||6||
48489207|NCT02601560|101532587|FG003|COMPLETED|Overall Study||6||
48489208|NCT02601560|101532588|FG004|COMPLETED|Overall Study||6||
48489209|NCT02601560|101532589|FG005|COMPLETED|Overall Study||4||
48489210|NCT02601560|101532590|FG006|COMPLETED|Overall Study||5||
48489211|NCT02601560|101532591|FG007|COMPLETED|Overall Study||6||
48489212|NCT02601560|101532584|FG000|NOT COMPLETED|Overall Study||0||
48489213|NCT02601560|101532585|FG001|NOT COMPLETED|Overall Study||0||
48489214|NCT02601560|101532586|FG002|NOT COMPLETED|Overall Study||0||
48489215|NCT02601560|101532587|FG003|NOT COMPLETED|Overall Study||0||
48489216|NCT02601560|101532588|FG004|NOT COMPLETED|Overall Study||0||
48489217|NCT02601560|101532589|FG005|NOT COMPLETED|Overall Study||0||
48489218|NCT02601560|101532590|FG006|NOT COMPLETED|Overall Study||1||
48489219|NCT02601560|101532591|FG007|NOT COMPLETED|Overall Study||0||
48489220|NCT01247701|101532592|FG000|STARTED|Overall Study||16||
48489221|NCT01247701|101532592|FG000|COMPLETED|Overall Study||6||
48489222|NCT01247701|101532592|FG000|NOT COMPLETED|Overall Study||10||
48199966|NCT00145041|100814432|FG000|NOT COMPLETED|Overall Study||0||
48199967|NCT00762619|100814433|FG000|STARTED|Overall Study||55||
48199968|NCT00762619|100814434|FG001|STARTED|Overall Study||50||
48489223|NCT01911676|101532593|FG000|STARTED|Period 1 of Study||23||
48489224|NCT01911676|101532594|FG001|STARTED|Period 1 of Study||23||
48489225|NCT01911676|101532595|FG002|STARTED|Period 1 of Study||12||
48489226|NCT01911676|101532596|FG003|STARTED|Period 1 of Study||13||
48489227|NCT01911676|101532593|FG000|COMPLETED|Period 1 of Study||17||
48199969|NCT00762619|100814433|FG000|COMPLETED|Overall Study||55||
48199970|NCT00762619|100814434|FG001|COMPLETED|Overall Study||50||
48199971|NCT00762619|100814433|FG000|NOT COMPLETED|Overall Study||0||
48199972|NCT00762619|100814434|FG001|NOT COMPLETED|Overall Study||0||
48199973|NCT02476890|100814435|FG000|STARTED|Overall Study||6||
48199974|NCT02476890|100814436|FG001|STARTED|Overall Study||6||
48199975|NCT02476890|100814437|FG002|STARTED|Overall Study||12||
48489228|NCT01911676|101532594|FG001|COMPLETED|Period 1 of Study||21||
48489229|NCT01911676|101532595|FG002|COMPLETED|Period 1 of Study||11||
48489230|NCT01911676|101532596|FG003|COMPLETED|Period 1 of Study||10||
48489231|NCT01911676|101532593|FG000|NOT COMPLETED|Period 1 of Study||6||
48489232|NCT01911676|101532594|FG001|NOT COMPLETED|Period 1 of Study||2||
48489233|NCT01911676|101532595|FG002|NOT COMPLETED|Period 1 of Study||1||
48489234|NCT01911676|101532596|FG003|NOT COMPLETED|Period 1 of Study||3||
48489235|NCT01911676|101532593|FG000|STARTED|Period 2 of Study||17||
48489236|NCT01911676|101532594|FG001|STARTED|Period 2 of Study||21||
48489237|NCT01911676|101532595|FG002|STARTED|Period 2 of Study||11||
48489238|NCT01911676|101532596|FG003|STARTED|Period 2 of Study||10||
48489239|NCT01911676|101532593|FG000|COMPLETED|Period 2 of Study||15||
48489240|NCT01911676|101532594|FG001|COMPLETED|Period 2 of Study||21||
48489241|NCT01911676|101532595|FG002|COMPLETED|Period 2 of Study||11||
48199976|NCT02476890|100814438|FG003|STARTED|Overall Study||12||
48489242|NCT01911676|101532596|FG003|COMPLETED|Period 2 of Study||8||
48489243|NCT01911676|101532593|FG000|NOT COMPLETED|Period 2 of Study||2||
48489244|NCT01911676|101532594|FG001|NOT COMPLETED|Period 2 of Study||0||
48489245|NCT01911676|101532595|FG002|NOT COMPLETED|Period 2 of Study||0||
48489246|NCT01911676|101532596|FG003|NOT COMPLETED|Period 2 of Study||2||
48489247|NCT00834249|101532597|FG000|STARTED|First Intervention||9||
48489248|NCT00834249|101532598|FG001|STARTED|First Intervention||9||
48489249|NCT00834249|101532597|FG000|COMPLETED|First Intervention||9||
48489250|NCT00834249|101532598|FG001|COMPLETED|First Intervention||9||
48489251|NCT00834249|101532597|FG000|NOT COMPLETED|First Intervention||0||
48199977|NCT02476890|100814435|FG000|Washout|Overall Study||6||
48199978|NCT02476890|100814436|FG001|Washout|Overall Study||6||
48199979|NCT02476890|100814437|FG002|Washout|Overall Study||12||
48199980|NCT02476890|100814438|FG003|Washout|Overall Study||12||
48199981|NCT02476890|100814435|FG000|COMPLETED|Overall Study||6||
48199982|NCT02476890|100814436|FG001|COMPLETED|Overall Study||6||
48199983|NCT02476890|100814437|FG002|COMPLETED|Overall Study||12||
48489252|NCT00834249|101532598|FG001|NOT COMPLETED|First Intervention||0||
48489253|NCT00834249|101532597|FG000|STARTED|Washout: 7 Days||9||
48489254|NCT00834249|101532598|FG001|STARTED|Washout: 7 Days||9||
48489255|NCT00834249|101532597|FG000|COMPLETED|Washout: 7 Days||8||
48489256|NCT00834249|101532598|FG001|COMPLETED|Washout: 7 Days||8||
48489257|NCT00834249|101532597|FG000|NOT COMPLETED|Washout: 7 Days||1||
48489258|NCT00834249|101532598|FG001|NOT COMPLETED|Washout: 7 Days||1||
48489259|NCT00834249|101532597|FG000|STARTED|Second Intervention||8||
48489260|NCT00834249|101532598|FG001|STARTED|Second Intervention||8||
48489261|NCT00834249|101532597|FG000|COMPLETED|Second Intervention||7||
48489262|NCT00834249|101532598|FG001|COMPLETED|Second Intervention||8||
48199984|NCT02476890|100814438|FG003|COMPLETED|Overall Study||12||
48199985|NCT02476890|100814435|FG000|NOT COMPLETED|Overall Study||0||
48489263|NCT00834249|101532597|FG000|NOT COMPLETED|Second Intervention||1||
48199986|NCT02476890|100814436|FG001|NOT COMPLETED|Overall Study||0||
48489264|NCT00834249|101532598|FG001|NOT COMPLETED|Second Intervention||0||
48489265|NCT01725529|101532599|FG000|STARTED|Overall Study||152||
48489266|NCT01725529|101532600|FG001|STARTED|Overall Study||153||
48489267|NCT01725529|101532601|FG002|STARTED|Overall Study||152||
48489268|NCT01725529|101532599|FG000|COMPLETED|Overall Study||137||
48489269|NCT01725529|101532600|FG001|COMPLETED|Overall Study||137||
48489270|NCT01725529|101532601|FG002|COMPLETED|Overall Study||142||
48489271|NCT01725529|101532599|FG000|NOT COMPLETED|Overall Study||15||
48489272|NCT01725529|101532600|FG001|NOT COMPLETED|Overall Study||16||
48489273|NCT01725529|101532601|FG002|NOT COMPLETED|Overall Study||10||
48489274|NCT00101647|101532602|FG000|STARTED|Overall Study||13||
48489275|NCT00101647|101532603|FG001|STARTED|Overall Study||161||
48489276|NCT00101647|101532602|FG000|COMPLETED|Overall Study||13||
48489277|NCT00101647|101532603|FG001|COMPLETED|Overall Study||161||
48489278|NCT00101647|101532602|FG000|NOT COMPLETED|Overall Study||0||
48489279|NCT00101647|101532603|FG001|NOT COMPLETED|Overall Study||0||
48489280|NCT02392286|101532604|FG000|STARTED|Overall Study||7||
48489281|NCT02392286|101532605|FG001|STARTED|Overall Study||8||
48489282|NCT02392286|101532604|FG000|COMPLETED|Overall Study||4||
48489283|NCT02392286|101532605|FG001|COMPLETED|Overall Study||6||
48489284|NCT02392286|101532604|FG000|NOT COMPLETED|Overall Study||3||
48489285|NCT02392286|101532605|FG001|NOT COMPLETED|Overall Study||2||
48489286|NCT00906399|101532606|FG000|STARTED|Year 1||500||
48489287|NCT00906399|101532607|FG001|STARTED|Year 1||501||
48489288|NCT00906399|101532608|FG002|STARTED|Year 1||515||
48489289|NCT00906399|101532609|FG003|STARTED|Year 1||0||
48489290|NCT00906399|101532610|FG004|STARTED|Year 1||0||
48489291|NCT00906399|101532611|FG005|STARTED|Year 1||0||
48489292|NCT00906399|101532612|FG006|STARTED|Year 1||0||
48489293|NCT00906399|101532606|FG000|Completed Year 1 Study Treatment|Year 1||456||
48489294|NCT00906399|101532607|FG001|Completed Year 1 Study Treatment|Year 1||438||
48489295|NCT00906399|101532608|FG002|Completed Year 1 Study Treatment|Year 1||438||
48489296|NCT00906399|101532609|FG003|Completed Year 1 Study Treatment|Year 1||0||
48489297|NCT00906399|101532610|FG004|Completed Year 1 Study Treatment|Year 1||0||
48489298|NCT00906399|101532611|FG005|Completed Year 1 Study Treatment|Year 1||0||
48489299|NCT00906399|101532612|FG006|Completed Year 1 Study Treatment|Year 1||0||
48489300|NCT00906399|101532606|FG000|COMPLETED|Year 1||456||
48489301|NCT00906399|101532607|FG001|COMPLETED|Year 1||438||
48489302|NCT00906399|101532608|FG002|COMPLETED|Year 1||439||
48489303|NCT00906399|101532609|FG003|COMPLETED|Year 1||0||
48489304|NCT00906399|101532610|FG004|COMPLETED|Year 1||0||
48489305|NCT00906399|101532611|FG005|COMPLETED|Year 1||0||
48489306|NCT00906399|101532612|FG006|COMPLETED|Year 1||0||
48489307|NCT00906399|101532606|FG000|NOT COMPLETED|Year 1||44||
48489308|NCT00906399|101532607|FG001|NOT COMPLETED|Year 1||63||
48489309|NCT00906399|101532608|FG002|NOT COMPLETED|Year 1||76||
48489310|NCT00906399|101532609|FG003|NOT COMPLETED|Year 1||0||
48489311|NCT00906399|101532610|FG004|NOT COMPLETED|Year 1||0||
48489312|NCT00906399|101532611|FG005|NOT COMPLETED|Year 1||0||
48489313|NCT00906399|101532612|FG006|NOT COMPLETED|Year 1||0||
48489314|NCT00906399|101532606|FG000|STARTED|Year 2||0||
48489315|NCT00906399|101532607|FG001|STARTED|Year 2||0||
48489316|NCT00906399|101532608|FG002|STARTED|Year 2||0||
48489317|NCT00906399|101532609|FG003|STARTED|Year 2||228||
48489318|NCT00906399|101532610|FG004|STARTED|Year 2||228||
48489319|NCT00906399|101532611|FG005|STARTED|Year 2||438||
48489320|NCT00906399|101532612|FG006|STARTED|Year 2||438||
48199987|NCT02476890|100814437|FG002|NOT COMPLETED|Overall Study||0||
48489321|NCT00906399|101532606|FG000|Completed Year 2 Study Treatment|Year 2||0||
48666608|NCT01537432|101967626|FG000|COMPLETED|Overall Study||18||
48489322|NCT00906399|101532607|FG001|Completed Year 2 Study Treatment|Year 2||0||
48489323|NCT00906399|101532608|FG002|Completed Year 2 Study Treatment|Year 2||0||
48489324|NCT00906399|101532609|FG003|Completed Year 2 Study Treatment|Year 2||200||
48489325|NCT00906399|101532610|FG004|Completed Year 2 Study Treatment|Year 2||196||
48489326|NCT00906399|101532611|FG005|Completed Year 2 Study Treatment|Year 2||391||
48489327|NCT00906399|101532612|FG006|Completed Year 2 Study Treatment|Year 2||411||
48489328|NCT00906399|101532606|FG000|COMPLETED|Year 2||0||
48489329|NCT00906399|101532607|FG001|COMPLETED|Year 2||0||
48489330|NCT00906399|101532608|FG002|COMPLETED|Year 2||0||
48489331|NCT00906399|101532609|FG003|COMPLETED|Year 2||198||
48489332|NCT00906399|101532610|FG004|COMPLETED|Year 2||193||
48489333|NCT00906399|101532611|FG005|COMPLETED|Year 2||391||
48489334|NCT00906399|101532612|FG006|COMPLETED|Year 2||409||
48489335|NCT00906399|101532606|FG000|NOT COMPLETED|Year 2||0||
48489336|NCT00906399|101532607|FG001|NOT COMPLETED|Year 2||0||
48489337|NCT00906399|101532608|FG002|NOT COMPLETED|Year 2||0||
48489338|NCT00906399|101532609|FG003|NOT COMPLETED|Year 2||30||
48489339|NCT00906399|101532610|FG004|NOT COMPLETED|Year 2||35||
48489340|NCT00906399|101532611|FG005|NOT COMPLETED|Year 2||47||
48489341|NCT00906399|101532612|FG006|NOT COMPLETED|Year 2||29||
48489342|NCT02473718|101532613|FG000|STARTED|Overall Study||41||
48489343|NCT02473718|101532614|FG001|STARTED|Overall Study||41||
48489344|NCT02473718|101532613|FG000|COMPLETED|Overall Study||41||
48489345|NCT02473718|101532614|FG001|COMPLETED|Overall Study||41||
48489346|NCT02473718|101532613|FG000|NOT COMPLETED|Overall Study||0||
48489347|NCT02473718|101532614|FG001|NOT COMPLETED|Overall Study||0||
48489348|NCT04870606|101532615|FG000|STARTED|Overall Study||366||
48489349|NCT04870606|101532616|FG001|STARTED|Overall Study||367||
48489350|NCT04870606|101532615|FG000|Received at Least One Dose of Treatment After Randomised|Overall Study||365||
48199988|NCT02476890|100814438|FG003|NOT COMPLETED|Overall Study||0||
48199989|NCT00930813|100814439|FG000|STARTED|Overall Study||49||
48199990|NCT00930813|100814440|FG001|STARTED|Overall Study||52||
48199991|NCT00930813|100814439|FG000|COMPLETED|Overall Study||41||
48199992|NCT00930813|100814440|FG001|COMPLETED|Overall Study||38||
48199993|NCT00930813|100814439|FG000|NOT COMPLETED|Overall Study||8||
48199994|NCT00930813|100814440|FG001|NOT COMPLETED|Overall Study||14||
48199995|NCT03264456|100814441|FG000|STARTED|Overall Study||18||
48199996|NCT03264456|100814441|FG000|COMPLETED|Overall Study||14||
48199997|NCT03264456|100814441|FG000|NOT COMPLETED|Overall Study||4||
48199998|NCT02232178|100814442|FG000|STARTED|Overall Study||26||
48199999|NCT02232178|100814443|FG001|STARTED|Overall Study||25||
48200000|NCT02232178|100814444|FG002|STARTED|Overall Study||13||
48200001|NCT02232178|100814442|FG000|Per Protocol PK Population|Overall Study||26||
48200002|NCT02232178|100814443|FG001|Per Protocol PK Population|Overall Study||24||
48200003|NCT02232178|100814444|FG002|Per Protocol PK Population|Overall Study||11||
48200004|NCT02232178|100814442|FG000|Safety Population|Overall Study||26||
48200005|NCT02232178|100814443|FG001|Safety Population|Overall Study||24||
48200006|NCT02232178|100814444|FG002|Safety Population|Overall Study||12||
48200007|NCT02232178|100814442|FG000|COMPLETED|Overall Study||25||
48200008|NCT02232178|100814443|FG001|COMPLETED|Overall Study||24||
48200009|NCT02232178|100814444|FG002|COMPLETED|Overall Study||12||
48200010|NCT02232178|100814442|FG000|NOT COMPLETED|Overall Study||1||
48200011|NCT02232178|100814443|FG001|NOT COMPLETED|Overall Study||1||
48200012|NCT02232178|100814444|FG002|NOT COMPLETED|Overall Study||1||
48200013|NCT00269399|100814445|FG000|STARTED|Overall Study||119||
48200014|NCT00269399|100814446|FG001|STARTED|Overall Study||118||
48200015|NCT00269399|100814445|FG000|COMPLETED|Overall Study||78||
48200016|NCT00269399|100814446|FG001|COMPLETED|Overall Study||91||
48200017|NCT00269399|100814445|FG000|NOT COMPLETED|Overall Study||41||
48200018|NCT00269399|100814446|FG001|NOT COMPLETED|Overall Study||27||
48200019|NCT00494442|100814447|FG000|STARTED|Overall Study||24||
48489351|NCT04870606|101532616|FG001|Received at Least One Dose of Treatment After Randomised|Overall Study||365||
48489352|NCT04870606|101532615|FG000|COMPLETED|Overall Study||354||
48489353|NCT04870606|101532616|FG001|COMPLETED|Overall Study||359||
48489354|NCT04870606|101532615|FG000|NOT COMPLETED|Overall Study||12||
48489355|NCT04870606|101532616|FG001|NOT COMPLETED|Overall Study||8||
48489356|NCT00365365|101532617|FG000|STARTED|Overall Study||78||
48489357|NCT00365365|101532618|FG001|STARTED|Overall Study||77||
48489358|NCT00365365|101532619|FG002|STARTED|Overall Study||59||
48489359|NCT00365365|101532617|FG000|TREATED (SAFETY POPULATION)|Overall Study||78||
48489360|NCT00365365|101532618|FG001|TREATED (SAFETY POPULATION)|Overall Study||75||
48489361|NCT00365365|101532619|FG002|TREATED (SAFETY POPULATION)|Overall Study||59||
48489362|NCT00365365|101532617|FG000|COMPLETED TREATMENT|Overall Study||38||
48489363|NCT00365365|101532618|FG001|COMPLETED TREATMENT|Overall Study||36||
48489364|NCT00365365|101532619|FG002|COMPLETED TREATMENT|Overall Study||45||
48489365|NCT00365365|101532617|FG000|COMPLETED|Overall Study||44||
48489366|NCT00365365|101532618|FG001|COMPLETED|Overall Study||41||
48200020|NCT00494442|100814448|FG001|STARTED|Overall Study||33||
48200021|NCT00494442|100814447|FG000|COMPLETED|Overall Study||7||
48200022|NCT00494442|100814448|FG001|COMPLETED|Overall Study||17||
48200023|NCT00494442|100814447|FG000|NOT COMPLETED|Overall Study||17||
48200024|NCT00494442|100814448|FG001|NOT COMPLETED|Overall Study||16||
48200025|NCT02987543|100814449|FG000|STARTED|Overall Study||162||
48200026|NCT02987543|100814450|FG001|STARTED|Overall Study||83||
48200027|NCT02987543|100814451|FG002|STARTED|Overall Study||94||
48489367|NCT00365365|101532619|FG002|COMPLETED|Overall Study||44||
48489368|NCT00365365|101532617|FG000|NOT COMPLETED|Overall Study||34||
48489369|NCT00365365|101532618|FG001|NOT COMPLETED|Overall Study||36||
48489370|NCT00365365|101532619|FG002|NOT COMPLETED|Overall Study||15||
48489371|NCT01163461|101532620|FG000|STARTED|Overall Study||14||
48489372|NCT01163461|101532621|FG001|STARTED|Overall Study||14||
48489373|NCT01163461|101532620|FG000|COMPLETED|Overall Study||14||
48489374|NCT01163461|101532621|FG001|COMPLETED|Overall Study||14||
48489375|NCT01163461|101532620|FG000|NOT COMPLETED|Overall Study||0||
48200028|NCT02987543|100814452|FG003|STARTED|Overall Study||48||
48489376|NCT01163461|101532621|FG001|NOT COMPLETED|Overall Study||0||
48489377|NCT03962439|101532622|FG000|STARTED|Overall Study||17||
48489378|NCT03962439|101532623|FG001|STARTED|Overall Study||15||
48489379|NCT03962439|101532624|FG002|STARTED|Overall Study||18||
48489380|NCT03962439|101532622|FG000|COMPLETED|Overall Study||17||
48489381|NCT03962439|101532623|FG001|COMPLETED|Overall Study||15||
48489382|NCT03962439|101532624|FG002|COMPLETED|Overall Study||18||
48489383|NCT03962439|101532622|FG000|NOT COMPLETED|Overall Study||0||
48489384|NCT03962439|101532623|FG001|NOT COMPLETED|Overall Study||0||
48489385|NCT03962439|101532624|FG002|NOT COMPLETED|Overall Study||0||
48489386|NCT02251886|101532625|FG000|STARTED|Overall Study||48||
48489387|NCT02251886|101532626|FG001|STARTED|Overall Study||54||
48489388|NCT02251886|101532627|FG002|STARTED|Overall Study||44||
48489389|NCT02251886|101532628|FG003|STARTED|Overall Study||54||
48489390|NCT02251886|101532625|FG000|COMPLETED|Overall Study||48||
48489391|NCT02251886|101532626|FG001|COMPLETED|Overall Study||54||
48489392|NCT02251886|101532627|FG002|COMPLETED|Overall Study||44||
48489393|NCT02251886|101532628|FG003|COMPLETED|Overall Study||54||
48489394|NCT02251886|101532625|FG000|NOT COMPLETED|Overall Study||0||
48489395|NCT02251886|101532626|FG001|NOT COMPLETED|Overall Study||0||
48489396|NCT02251886|101532627|FG002|NOT COMPLETED|Overall Study||0||
48489397|NCT02251886|101532628|FG003|NOT COMPLETED|Overall Study||0||
48489398|NCT04246476|101532629|FG000|STARTED|Overall Study||29||
48489399|NCT04246476|101532630|FG001|STARTED|Overall Study||29||
48489400|NCT04246476|101532629|FG000|COMPLETED|Overall Study||29||
48489401|NCT04246476|101532630|FG001|COMPLETED|Overall Study||29||
48489402|NCT04246476|101532629|FG000|NOT COMPLETED|Overall Study||0||
48489403|NCT04246476|101532630|FG001|NOT COMPLETED|Overall Study||0||
48489404|NCT03500341|101532631|FG000|STARTED|Overall Study||16||
48489405|NCT03500341|101532631|FG000|COMPLETED|Overall Study||14||
48489406|NCT03500341|101532631|FG000|NOT COMPLETED|Overall Study||2||
48489407|NCT02601625|101532632|FG000|STARTED|Overall Study||6|Participants|
48489408|NCT02601625|101532633|FG001|STARTED|Overall Study||6|Participants|
48489409|NCT02601625|101532634|FG002|STARTED|Overall Study||6|Participants|
48489410|NCT02601625|101532635|FG003|STARTED|Overall Study||12|Participants|
48489411|NCT02601625|101532632|FG000|COMPLETED|Overall Study||6|Participants|
48489412|NCT02601625|101532633|FG001|COMPLETED|Overall Study||6|Participants|
48489413|NCT02601625|101532634|FG002|COMPLETED|Overall Study||5|Participants|
48489414|NCT02601625|101532635|FG003|COMPLETED|Overall Study||11|Participants|
48489415|NCT02601625|101532632|FG000|NOT COMPLETED|Overall Study||0||
48489416|NCT02601625|101532633|FG001|NOT COMPLETED|Overall Study||0||
48489417|NCT02601625|101532634|FG002|NOT COMPLETED|Overall Study||1||
48489418|NCT02601625|101532635|FG003|NOT COMPLETED|Overall Study||1||
48489419|NCT03797872|101532636|FG000|STARTED|Overall Study||1||
48489420|NCT03797872|101532637|FG001|STARTED|Overall Study||0||
48489421|NCT03797872|101532636|FG000|COMPLETED|Overall Study||0||
48489422|NCT03797872|101532637|FG001|COMPLETED|Overall Study||0||
48489423|NCT03797872|101532636|FG000|NOT COMPLETED|Overall Study||1||
48489424|NCT03797872|101532637|FG001|NOT COMPLETED|Overall Study||0||
48489425|NCT00124618|101532638|FG000|STARTED|Overall Study||58||
48489426|NCT00124618|101532638|FG000|COMPLETED|Overall Study||57||
48489427|NCT00124618|101532638|FG000|NOT COMPLETED|Overall Study||1||
48489428|NCT01309672|101532639|FG000|STARTED|Overall Study||41||
48489429|NCT01309672|101532639|FG000|Received Protocol Treatment|Overall Study||40||
48489430|NCT01309672|101532639|FG000|COMPLETED|Overall Study||4||
48489431|NCT01309672|101532639|FG000|NOT COMPLETED|Overall Study||37||
48489432|NCT02321098|101532640|FG000|STARTED|12 Weeks Treament||26||
48489433|NCT02321098|101532641|FG001|STARTED|12 Weeks Treament||24||
48489434|NCT02321098|101532642|FG002|STARTED|12 Weeks Treament||0||
48489435|NCT02321098|101532640|FG000|COMPLETED|12 Weeks Treament||25||
48489436|NCT02321098|101532641|FG001|COMPLETED|12 Weeks Treament||23||
48489437|NCT02321098|101532642|FG002|COMPLETED|12 Weeks Treament||0||
48489438|NCT02321098|101532640|FG000|NOT COMPLETED|12 Weeks Treament||1||
48489439|NCT02321098|101532641|FG001|NOT COMPLETED|12 Weeks Treament||1||
48489440|NCT02321098|101532642|FG002|NOT COMPLETED|12 Weeks Treament||0||
48489441|NCT02321098|101532640|FG000|STARTED|Additional 15 Months Treatment||0||
48489442|NCT02321098|101532641|FG001|STARTED|Additional 15 Months Treatment||0||
48489443|NCT02321098|101532642|FG002|STARTED|Additional 15 Months Treatment||29||
48489444|NCT02321098|101532640|FG000|COMPLETED|Additional 15 Months Treatment||0||
48489445|NCT02321098|101532641|FG001|COMPLETED|Additional 15 Months Treatment||0||
48489446|NCT02321098|101532642|FG002|COMPLETED|Additional 15 Months Treatment||21||
48489447|NCT02321098|101532640|FG000|NOT COMPLETED|Additional 15 Months Treatment||0||
48489448|NCT02321098|101532641|FG001|NOT COMPLETED|Additional 15 Months Treatment||0||
48489449|NCT02321098|101532642|FG002|NOT COMPLETED|Additional 15 Months Treatment||8||
48489450|NCT03342157|101532643|FG000|STARTED|Overall Study||1||
48489451|NCT03342157|101532644|FG001|STARTED|Overall Study||1||
48489452|NCT03342157|101532643|FG000|COMPLETED|Overall Study||1||
48489453|NCT03342157|101532644|FG001|COMPLETED|Overall Study||1||
48489454|NCT03342157|101532643|FG000|NOT COMPLETED|Overall Study||0||
48489455|NCT03342157|101532644|FG001|NOT COMPLETED|Overall Study||0||
48489456|NCT01036009|101532645|FG000|STARTED|Overall Study||17||
48489457|NCT01036009|101532646|FG001|STARTED|Overall Study||26||
48489458|NCT01036009|101532645|FG000|COMPLETED|Overall Study||17||
48489459|NCT01036009|101532646|FG001|COMPLETED|Overall Study||26||
48489460|NCT01036009|101532645|FG000|NOT COMPLETED|Overall Study||0||
48489461|NCT01036009|101532646|FG001|NOT COMPLETED|Overall Study||0||
48489462|NCT01910688|101532647|FG000|STARTED|Overall Study||25||
48489463|NCT01910688|101532647|FG000|3.5month|Overall Study||25||
48489464|NCT01910688|101532647|FG000|2nd RFA Treatment|Overall Study||22||
48489465|NCT01910688|101532647|FG000|7.5months|Overall Study||24||
48489466|NCT01910688|101532647|FG000|3rd RFA Treatment|Overall Study||18||
48489467|NCT01910688|101532647|FG000|12months|Overall Study||22||
48489468|NCT01910688|101532647|FG000|COMPLETED|Overall Study||20||
48489469|NCT01910688|101532647|FG000|NOT COMPLETED|Overall Study||5||
48489470|NCT01149733|101532648|FG000|STARTED|Overall Study||16||
48489471|NCT01149733|101532649|FG001|STARTED|Overall Study||16||
48489472|NCT01149733|101532648|FG000|COMPLETED|Overall Study||16||
48489473|NCT01149733|101532649|FG001|COMPLETED|Overall Study||16||
48489474|NCT01149733|101532648|FG000|NOT COMPLETED|Overall Study||0||
48489475|NCT01149733|101532649|FG001|NOT COMPLETED|Overall Study||0||
48489476|NCT03100344|101532650|FG000|STARTED|Overall Study||57||
48489477|NCT03100344|101532651|FG001|STARTED|Overall Study||55||
48489478|NCT03100344|101532652|FG002|STARTED|Overall Study||57||
48489479|NCT03100344|101532653|FG003|STARTED|Overall Study||57||
48489480|NCT03100344|101532650|FG000|COMPLETED|Overall Study||43||
48489481|NCT03100344|101532651|FG001|COMPLETED|Overall Study||44||
48489482|NCT03100344|101532652|FG002|COMPLETED|Overall Study||50||
48489483|NCT03100344|101532653|FG003|COMPLETED|Overall Study||45||
48489484|NCT03100344|101532650|FG000|NOT COMPLETED|Overall Study||14||
48489485|NCT03100344|101532651|FG001|NOT COMPLETED|Overall Study||11||
48489486|NCT03100344|101532652|FG002|NOT COMPLETED|Overall Study||7||
48489487|NCT03100344|101532653|FG003|NOT COMPLETED|Overall Study||12||
48489488|NCT01414153|101532654|FG000|STARTED|Overall Study||38||
48489489|NCT01414153|101532655|FG001|STARTED|Overall Study||40||
48200029|NCT02987543|100814449|FG000|COMPLETED|Overall Study||0||
48489490|NCT01414153|101532656|FG002|STARTED|Overall Study||39||
48200030|NCT02987543|100814450|FG001|COMPLETED|Overall Study||0||
48489491|NCT01414153|101532657|FG003|STARTED|Overall Study||41||
48489492|NCT01414153|101532654|FG000|COMPLETED|Overall Study||30||
48489493|NCT01414153|101532655|FG001|COMPLETED|Overall Study||38||
48489494|NCT01414153|101532656|FG002|COMPLETED|Overall Study||35||
48489495|NCT01414153|101532657|FG003|COMPLETED|Overall Study||37||
48489496|NCT01414153|101532654|FG000|NOT COMPLETED|Overall Study||8||
48489497|NCT01414153|101532655|FG001|NOT COMPLETED|Overall Study||2||
48489498|NCT01414153|101532656|FG002|NOT COMPLETED|Overall Study||4||
48489499|NCT01414153|101532657|FG003|NOT COMPLETED|Overall Study||4||
48489500|NCT00828295|101532658|FG000|STARTED|Overall Study||75||
48489501|NCT00828295|101532659|FG001|STARTED|Overall Study||75||
48489502|NCT00828295|101532658|FG000|COMPLETED|Overall Study||75||
48489503|NCT00828295|101532659|FG001|COMPLETED|Overall Study||75||
48489504|NCT00828295|101532658|FG000|NOT COMPLETED|Overall Study||0||
48489505|NCT00828295|101532659|FG001|NOT COMPLETED|Overall Study||0||
48489506|NCT01341730|101532660|FG000|STARTED|Overall Study||20||
48489507|NCT01341730|101532661|FG001|STARTED|Overall Study||21||
48489508|NCT01341730|101532660|FG000|COMPLETED|Overall Study||16||
48489509|NCT01341730|101532661|FG001|COMPLETED|Overall Study||17||
48489510|NCT01341730|101532660|FG000|NOT COMPLETED|Overall Study||4||
48489511|NCT01341730|101532661|FG001|NOT COMPLETED|Overall Study||4||
48489512|NCT01980771|101532662|FG000|STARTED|Overall Study||436||
48489513|NCT01980771|101532663|FG001|STARTED|Overall Study||424||
48489514|NCT01980771|101532662|FG000|COMPLETED|Overall Study||352||
48489515|NCT01980771|101532663|FG001|COMPLETED|Overall Study||305||
48489516|NCT01980771|101532662|FG000|NOT COMPLETED|Overall Study||84||
48489517|NCT01980771|101532663|FG001|NOT COMPLETED|Overall Study||119||
48489518|NCT01124305|101532664|FG000|STARTED|Overall Study||34||
48489519|NCT01124305|101532665|FG001|STARTED|Overall Study||36||
48489520|NCT01124305|101532664|FG000|COMPLETED|Overall Study||26||
48489521|NCT01124305|101532665|FG001|COMPLETED|Overall Study||26||
48489522|NCT01124305|101532664|FG000|NOT COMPLETED|Overall Study||8||
48489523|NCT01124305|101532665|FG001|NOT COMPLETED|Overall Study||10||
48489524|NCT00838279|101532666|FG000|STARTED|First Intervention||16||
48489525|NCT00838279|101532667|FG001|STARTED|First Intervention||16||
48489526|NCT00838279|101532666|FG000|COMPLETED|First Intervention||16||
48489527|NCT00838279|101532667|FG001|COMPLETED|First Intervention||16||
48489528|NCT00838279|101532666|FG000|NOT COMPLETED|First Intervention||0||
48489529|NCT00838279|101532667|FG001|NOT COMPLETED|First Intervention||0||
48489530|NCT00838279|101532666|FG000|STARTED|Washout||16||
48489531|NCT00838279|101532667|FG001|STARTED|Washout||16||
48489532|NCT00838279|101532666|FG000|COMPLETED|Washout||15||
48489533|NCT00838279|101532667|FG001|COMPLETED|Washout||15||
48489534|NCT00838279|101532666|FG000|NOT COMPLETED|Washout||1||
48489535|NCT00838279|101532667|FG001|NOT COMPLETED|Washout||1||
48489536|NCT00838279|101532666|FG000|STARTED|Second Intervention||15||
48489537|NCT00838279|101532667|FG001|STARTED|Second Intervention||15||
48489538|NCT00838279|101532666|FG000|COMPLETED|Second Intervention||15||
48489539|NCT00838279|101532667|FG001|COMPLETED|Second Intervention||15||
48489540|NCT00838279|101532666|FG000|NOT COMPLETED|Second Intervention||0||
48489541|NCT00838279|101532667|FG001|NOT COMPLETED|Second Intervention||0||
48489542|NCT00834535|101532668|FG000|STARTED|First Intervention||16||
48489543|NCT00834535|101532669|FG001|STARTED|First Intervention||16||
48489544|NCT00834535|101532668|FG000|COMPLETED|First Intervention||16||
48489545|NCT00834535|101532669|FG001|COMPLETED|First Intervention||16||
48489546|NCT00834535|101532668|FG000|NOT COMPLETED|First Intervention||0||
48489547|NCT00834535|101532669|FG001|NOT COMPLETED|First Intervention||0||
48489548|NCT00834535|101532668|FG000|STARTED|Washout of 7 Days||16||
48489549|NCT00834535|101532669|FG001|STARTED|Washout of 7 Days||16||
48489550|NCT00834535|101532668|FG000|COMPLETED|Washout of 7 Days||16||
48489551|NCT00834535|101532669|FG001|COMPLETED|Washout of 7 Days||16||
48489552|NCT00834535|101532668|FG000|NOT COMPLETED|Washout of 7 Days||0||
48489553|NCT00834535|101532669|FG001|NOT COMPLETED|Washout of 7 Days||0||
48489554|NCT00834535|101532668|FG000|STARTED|Second Intervention||16||
48489555|NCT00834535|101532669|FG001|STARTED|Second Intervention||16||
48200031|NCT02987543|100814451|FG002|COMPLETED|Overall Study||0||
48200032|NCT02987543|100814452|FG003|COMPLETED|Overall Study||0||
48489556|NCT00834535|101532668|FG000|COMPLETED|Second Intervention||16||
48489557|NCT00834535|101532669|FG001|COMPLETED|Second Intervention||16||
48489558|NCT00834535|101532668|FG000|NOT COMPLETED|Second Intervention||0||
48489559|NCT00834535|101532669|FG001|NOT COMPLETED|Second Intervention||0||
48489560|NCT02926677|101532670|FG000|STARTED|Overall Study||25||
48489561|NCT02926677|101532671|FG001|STARTED|Overall Study||22||
48489562|NCT02926677|101532672|FG002|STARTED|Overall Study||26||
48489563|NCT02926677|101532670|FG000|COMPLETED|Overall Study||8||
48489564|NCT02926677|101532671|FG001|COMPLETED|Overall Study||8||
48489565|NCT02926677|101532672|FG002|COMPLETED|Overall Study||6||
48489566|NCT02926677|101532670|FG000|NOT COMPLETED|Overall Study||17||
48489567|NCT02926677|101532671|FG001|NOT COMPLETED|Overall Study||14||
48489568|NCT02926677|101532672|FG002|NOT COMPLETED|Overall Study||20||
48489569|NCT01294787|101532673|FG000|STARTED|Period 1||12||
48489570|NCT01294787|101532674|FG001|STARTED|Period 1||16||
48489571|NCT01294787|101532675|FG002|STARTED|Period 1||14||
48489572|NCT01294787|101532676|FG003|STARTED|Period 1||12||
48489573|NCT01294787|101532677|FG004|STARTED|Period 1||16||
48489574|NCT01294787|101532678|FG005|STARTED|Period 1||15||
48489575|NCT01294787|101532673|FG000|COMPLETED|Period 1||12||
48489576|NCT01294787|101532674|FG001|COMPLETED|Period 1||16||
48489577|NCT01294787|101532675|FG002|COMPLETED|Period 1||13||
48489578|NCT01294787|101532676|FG003|COMPLETED|Period 1||11||
48489579|NCT01294787|101532677|FG004|COMPLETED|Period 1||14||
48489580|NCT01294787|101532678|FG005|COMPLETED|Period 1||13||
48489581|NCT01294787|101532673|FG000|NOT COMPLETED|Period 1||0||
48489582|NCT01294787|101532674|FG001|NOT COMPLETED|Period 1||0||
48489583|NCT01294787|101532675|FG002|NOT COMPLETED|Period 1||1||
48489584|NCT01294787|101532676|FG003|NOT COMPLETED|Period 1||1||
48489585|NCT01294787|101532677|FG004|NOT COMPLETED|Period 1||2||
48489586|NCT01294787|101532678|FG005|NOT COMPLETED|Period 1||2||
48489587|NCT01294787|101532673|FG000|STARTED|Period 2||12||
48489588|NCT01294787|101532674|FG001|STARTED|Period 2||16||
48489589|NCT01294787|101532675|FG002|STARTED|Period 2||13||
48489590|NCT01294787|101532676|FG003|STARTED|Period 2||11||
48489591|NCT01294787|101532677|FG004|STARTED|Period 2||14||
48489592|NCT01294787|101532678|FG005|STARTED|Period 2||13||
48489593|NCT01294787|101532673|FG000|COMPLETED|Period 2||12||
48489594|NCT01294787|101532674|FG001|COMPLETED|Period 2||13||
48489595|NCT01294787|101532675|FG002|COMPLETED|Period 2||13||
48489596|NCT01294787|101532676|FG003|COMPLETED|Period 2||9||
48489597|NCT01294787|101532677|FG004|COMPLETED|Period 2||14||
48489598|NCT01294787|101532678|FG005|COMPLETED|Period 2||13||
48489599|NCT01294787|101532673|FG000|NOT COMPLETED|Period 2||0||
48489600|NCT01294787|101532674|FG001|NOT COMPLETED|Period 2||3||
48489601|NCT01294787|101532675|FG002|NOT COMPLETED|Period 2||0||
48489602|NCT01294787|101532676|FG003|NOT COMPLETED|Period 2||2||
48489603|NCT01294787|101532677|FG004|NOT COMPLETED|Period 2||0||
48489604|NCT01294787|101532678|FG005|NOT COMPLETED|Period 2||0||
48489605|NCT01294787|101532673|FG000|STARTED|Period 3||12||
48489606|NCT01294787|101532674|FG001|STARTED|Period 3||13||
48489607|NCT01294787|101532675|FG002|STARTED|Period 3||13||
48489608|NCT01294787|101532676|FG003|STARTED|Period 3||9||
48489609|NCT01294787|101532677|FG004|STARTED|Period 3||14||
48489610|NCT01294787|101532678|FG005|STARTED|Period 3||13||
48489611|NCT01294787|101532673|FG000|COMPLETED|Period 3||12||
48489612|NCT01294787|101532674|FG001|COMPLETED|Period 3||13||
48489613|NCT01294787|101532675|FG002|COMPLETED|Period 3||13||
48200033|NCT02987543|100814449|FG000|NOT COMPLETED|Overall Study||162||
48200034|NCT02987543|100814450|FG001|NOT COMPLETED|Overall Study||83||
48489614|NCT01294787|101532676|FG003|COMPLETED|Period 3||9||
48489615|NCT01294787|101532677|FG004|COMPLETED|Period 3||13||
48489616|NCT01294787|101532678|FG005|COMPLETED|Period 3||13||
48489617|NCT01294787|101532673|FG000|NOT COMPLETED|Period 3||0||
48489618|NCT01294787|101532674|FG001|NOT COMPLETED|Period 3||0||
48489619|NCT01294787|101532675|FG002|NOT COMPLETED|Period 3||0||
48489620|NCT01294787|101532676|FG003|NOT COMPLETED|Period 3||0||
48489621|NCT01294787|101532677|FG004|NOT COMPLETED|Period 3||1||
48489622|NCT01294787|101532678|FG005|NOT COMPLETED|Period 3||0||
48489623|NCT02701556|101532679|FG000|STARTED|Overall Study||198||
48489624|NCT02701556|101532680|FG001|STARTED|Overall Study||198||
48489625|NCT02701556|101532679|FG000|COMPLETED|Overall Study||175||
48489626|NCT02701556|101532680|FG001|COMPLETED|Overall Study||178||
48489627|NCT02701556|101532679|FG000|NOT COMPLETED|Overall Study||23||
48489628|NCT02701556|101532680|FG001|NOT COMPLETED|Overall Study||20||
48489629|NCT02642653|101532681|FG000|STARTED|Overall Study||14||
48489630|NCT02642653|101532682|FG001|STARTED|Overall Study||16||
48489631|NCT02642653|101532681|FG000|COMPLETED|Overall Study||12||
48489632|NCT02642653|101532682|FG001|COMPLETED|Overall Study||16||
48489633|NCT02642653|101532681|FG000|NOT COMPLETED|Overall Study||2||
48489634|NCT02642653|101532682|FG001|NOT COMPLETED|Overall Study||0||
48489635|NCT01776190|101532683|FG000|STARTED|Overall Study||6||
48489636|NCT01776190|101532683|FG000|COMPLETED|Overall Study||5||
48489637|NCT01776190|101532683|FG000|NOT COMPLETED|Overall Study||1||
48489638|NCT04708028|101532684|FG000|STARTED|Overall Study||22||
48489639|NCT04708028|101532685|FG001|STARTED|Overall Study||18||
48489640|NCT04708028|101532684|FG000|COMPLETED|Overall Study||21||
48489641|NCT04708028|101532685|FG001|COMPLETED|Overall Study||18||
48489642|NCT04708028|101532684|FG000|NOT COMPLETED|Overall Study||1||
48489643|NCT04708028|101532685|FG001|NOT COMPLETED|Overall Study||0||
48489644|NCT02651272|101532686|FG000|STARTED|Overall Study||4||
48489645|NCT02651272|101532686|FG000|COMPLETED|Overall Study||1||
48489646|NCT02651272|101532686|FG000|NOT COMPLETED|Overall Study||3||
48489647|NCT00835081|101532687|FG000|STARTED|First Intervention||13||
48489648|NCT00835081|101532688|FG001|STARTED|First Intervention||13||
48489649|NCT00835081|101532687|FG000|COMPLETED|First Intervention||13||
48489650|NCT00835081|101532688|FG001|COMPLETED|First Intervention||13||
48489651|NCT00835081|101532687|FG000|NOT COMPLETED|First Intervention||0||
48489652|NCT00835081|101532688|FG001|NOT COMPLETED|First Intervention||0||
48489653|NCT00835081|101532687|FG000|STARTED|Washout of 7 Days||13||
48489654|NCT00835081|101532688|FG001|STARTED|Washout of 7 Days||13||
48489655|NCT00835081|101532687|FG000|COMPLETED|Washout of 7 Days||12||
48489656|NCT00835081|101532688|FG001|COMPLETED|Washout of 7 Days||13||
48489657|NCT00835081|101532687|FG000|NOT COMPLETED|Washout of 7 Days||1||
48489658|NCT00835081|101532688|FG001|NOT COMPLETED|Washout of 7 Days||0||
48489659|NCT00835081|101532687|FG000|STARTED|Second Intervention||12||
48489660|NCT00835081|101532688|FG001|STARTED|Second Intervention||13||
48489661|NCT00835081|101532687|FG000|COMPLETED|Second Intervention||12||
48489662|NCT00835081|101532688|FG001|COMPLETED|Second Intervention||13||
48489663|NCT00835081|101532687|FG000|NOT COMPLETED|Second Intervention||0||
48489664|NCT00835081|101532688|FG001|NOT COMPLETED|Second Intervention||0||
48489665|NCT01534663|101532689|FG000|STARTED|Overall Study||14||
48489666|NCT01534663|101532690|FG001|STARTED|Overall Study||17||
48489667|NCT01534663|101532689|FG000|COMPLETED|Overall Study||12||
48489668|NCT01534663|101532690|FG001|COMPLETED|Overall Study||14||
48489669|NCT01534663|101532689|FG000|NOT COMPLETED|Overall Study||2||
48489670|NCT01534663|101532690|FG001|NOT COMPLETED|Overall Study||3||
48489671|NCT04278560|101532691|FG000|STARTED|Overall Study||16||
48489672|NCT04278560|101532692|FG001|STARTED|Overall Study||16||
48489673|NCT04278560|101532691|FG000|COMPLETED|Overall Study||15||
48489674|NCT04278560|101532692|FG001|COMPLETED|Overall Study||13||
48489675|NCT04278560|101532691|FG000|NOT COMPLETED|Overall Study||1||
48489676|NCT04278560|101532692|FG001|NOT COMPLETED|Overall Study||3||
48489677|NCT00829452|101532693|FG000|STARTED|First Intervention||20||
48489678|NCT00829452|101532694|FG001|STARTED|First Intervention||20||
48489679|NCT00829452|101532693|FG000|COMPLETED|First Intervention||20||
48489680|NCT00829452|101532694|FG001|COMPLETED|First Intervention||19||
48489681|NCT00829452|101532693|FG000|NOT COMPLETED|First Intervention||0||
48489682|NCT00829452|101532694|FG001|NOT COMPLETED|First Intervention||1||
48489683|NCT00829452|101532693|FG000|STARTED|Washout of 42 Days||20||
48489684|NCT00829452|101532694|FG001|STARTED|Washout of 42 Days||19||
48489685|NCT00829452|101532693|FG000|COMPLETED|Washout of 42 Days||20||
48489686|NCT00829452|101532694|FG001|COMPLETED|Washout of 42 Days||18||
48489687|NCT00829452|101532693|FG000|NOT COMPLETED|Washout of 42 Days||0||
48489688|NCT00829452|101532694|FG001|NOT COMPLETED|Washout of 42 Days||1||
48489689|NCT00829452|101532693|FG000|STARTED|Second Intervention||20||
48489690|NCT00829452|101532694|FG001|STARTED|Second Intervention||18||
48489691|NCT00829452|101532693|FG000|COMPLETED|Second Intervention||20||
48489692|NCT00829452|101532694|FG001|COMPLETED|Second Intervention||17||
48489693|NCT00829452|101532693|FG000|NOT COMPLETED|Second Intervention||0||
48489694|NCT00829452|101532694|FG001|NOT COMPLETED|Second Intervention||1||
48489695|NCT02956460|101532695|FG000|STARTED|Lens 1||30||
48489696|NCT02956460|101532696|FG001|STARTED|Lens 1||34||
48489697|NCT02956460|101532695|FG000|COMPLETED|Lens 1||29||
48489698|NCT02956460|101532696|FG001|COMPLETED|Lens 1||34||
48489699|NCT02956460|101532695|FG000|NOT COMPLETED|Lens 1||1||
48489700|NCT02956460|101532696|FG001|NOT COMPLETED|Lens 1||0||
48489701|NCT02956460|101532695|FG000|STARTED|Lens 2||29||
48489702|NCT02956460|101532696|FG001|STARTED|Lens 2||34||
48489703|NCT02956460|101532695|FG000|COMPLETED|Lens 2||29||
48489704|NCT02956460|101532696|FG001|COMPLETED|Lens 2||34||
48489705|NCT02956460|101532695|FG000|NOT COMPLETED|Lens 2||0||
48489706|NCT02956460|101532696|FG001|NOT COMPLETED|Lens 2||0||
48489707|NCT00904215|101532697|FG000|STARTED|Overall Study||1095||
48489708|NCT00904215|101532697|FG000|COMPLETED|Overall Study||960||
48489709|NCT00904215|101532697|FG000|NOT COMPLETED|Overall Study||135||
48489710|NCT03868891|101532698|FG000|STARTED|Overall Study||8||
48489711|NCT03868891|101532699|FG001|STARTED|Overall Study||3||
48666609|NCT01537432|101967627|FG001|COMPLETED|Overall Study||10||
48666610|NCT01537432|101967626|FG000|NOT COMPLETED|Overall Study||6||
48666611|NCT01537432|101967627|FG001|NOT COMPLETED|Overall Study||2||
48666612|NCT03359161|101967628|FG000|STARTED|Overall Study||9||
48666613|NCT03359161|101967628|FG000|Pilot Phase|Overall Study||9|Pilot Phase|
48666614|NCT03359161|101967628|FG000|COMPLETED|Overall Study||9||
48666615|NCT03359161|101967628|FG000|NOT COMPLETED|Overall Study||0||
48666616|NCT03961672|101967629|FG000|STARTED|Overall Study||15||
48666617|NCT03961672|101967629|FG000|COMPLETED|Overall Study||15||
48666618|NCT03961672|101967629|FG000|NOT COMPLETED|Overall Study||0||
48666619|NCT02784587|101967630|FG000|STARTED|Overall Study||25||
48666620|NCT02784587|101967630|FG000|COMPLETED|Overall Study||25||
48666621|NCT02784587|101967630|FG000|NOT COMPLETED|Overall Study||0||
48666622|NCT00770679|101967631|FG000|STARTED|Overall Study||16||
48666623|NCT00770679|101967631|FG000|COMPLETED|Overall Study||10||
48666624|NCT00770679|101967631|FG000|NOT COMPLETED|Overall Study||6||
48666625|NCT03423979|101967632|FG000|STARTED|Overall Study||80||
48666626|NCT03423979|101967632|FG000|COMPLETED|Overall Study||79||
48666627|NCT03423979|101967632|FG000|NOT COMPLETED|Overall Study||1||
48666628|NCT02997202|101967633|FG000|STARTED|Overall Study||178||
48666629|NCT02997202|101967634|FG001|STARTED|Overall Study||178||
48666630|NCT02997202|101967633|FG000|Safety Analysis Population|Overall Study||178||
48666631|NCT02997202|101967634|FG001|Safety Analysis Population|Overall Study||177||
48666632|NCT02997202|101967633|FG000|Intent to Treat (ITT) Population|Overall Study||178||
48666633|NCT02997202|101967634|FG001|Intent to Treat (ITT) Population|Overall Study||178||
48666634|NCT02997202|101967633|FG000|COMPLETED|Overall Study||122||
48666635|NCT02997202|101967634|FG001|COMPLETED|Overall Study||116||
48666636|NCT02997202|101967633|FG000|NOT COMPLETED|Overall Study||56||
48666637|NCT02997202|101967634|FG001|NOT COMPLETED|Overall Study||62||
48666638|NCT01085214|101967635|FG000|STARTED|Overall Study||37||
48666639|NCT01085214|101967635|FG000|COMPLETED|Overall Study||36||
48666640|NCT01085214|101967635|FG000|NOT COMPLETED|Overall Study||1||
48666641|NCT02263547|101967636|FG000|STARTED|Overall Study||14||
48666642|NCT02263547|101967636|FG000|COMPLETED|Overall Study||11||
48666643|NCT02263547|101967636|FG000|NOT COMPLETED|Overall Study||3||
48666644|NCT02296125|101970449|FG000|STARTED|Overall Study||279|There were 19 participants double counted which shows the total participants of 692.|
48489712|NCT03868891|101532698|FG000|Visit 2|Overall Study||7||
48489713|NCT03868891|101532699|FG001|Visit 2|Overall Study||1||
48489714|NCT03868891|101532698|FG000|Visit 3|Overall Study||4||
48200035|NCT02987543|100814451|FG002|NOT COMPLETED|Overall Study||94||
48200036|NCT02987543|100814452|FG003|NOT COMPLETED|Overall Study||48||
48489715|NCT03868891|101532699|FG001|Visit 3|Overall Study||0||
48489716|NCT03868891|101532698|FG000|COMPLETED|Overall Study||4||
48489717|NCT03868891|101532699|FG001|COMPLETED|Overall Study||0||
48489718|NCT03868891|101532698|FG000|NOT COMPLETED|Overall Study||4||
48489719|NCT03868891|101532699|FG001|NOT COMPLETED|Overall Study||3||
48489720|NCT01058668|101532700|FG000|STARTED|Double-blind Treatment Phase||161||
48489721|NCT01058668|101532701|FG001|STARTED|Double-blind Treatment Phase||167||
48489722|NCT01058668|101532702|FG002|STARTED|Double-blind Treatment Phase||169||
48489723|NCT01058668|101532700|FG000|COMPLETED|Double-blind Treatment Phase||122||
48489724|NCT01058668|101532701|FG001|COMPLETED|Double-blind Treatment Phase||129||
48489725|NCT01058668|101532702|FG002|COMPLETED|Double-blind Treatment Phase||119||
48489726|NCT01058668|101532700|FG000|NOT COMPLETED|Double-blind Treatment Phase||39||
48489727|NCT01058668|101532701|FG001|NOT COMPLETED|Double-blind Treatment Phase||38||
48489728|NCT01058668|101532702|FG002|NOT COMPLETED|Double-blind Treatment Phase||50||
48489729|NCT01058668|101532700|FG000|STARTED|Safety Follow-up||144||
48200037|NCT02628093|100814453|FG000|STARTED|Overall Study||31||
48200038|NCT02628093|100814454|FG001|STARTED|Overall Study||29||
48200039|NCT02628093|100814453|FG000|COMPLETED|Overall Study||31||
48200040|NCT02628093|100814454|FG001|COMPLETED|Overall Study||29||
48200041|NCT02628093|100814453|FG000|NOT COMPLETED|Overall Study||0||
48200042|NCT02628093|100814454|FG001|NOT COMPLETED|Overall Study||0||
48200043|NCT01872819|100814455|FG000|STARTED|Overall Study||14||
48489730|NCT01058668|101532701|FG001|STARTED|Safety Follow-up||146||
48489731|NCT01058668|101532702|FG002|STARTED|Safety Follow-up||148||
48489732|NCT01058668|101532700|FG000|COMPLETED|Safety Follow-up||139||
48489733|NCT01058668|101532701|FG001|COMPLETED|Safety Follow-up||146||
48489734|NCT01058668|101532702|FG002|COMPLETED|Safety Follow-up||141||
48489735|NCT01058668|101532700|FG000|NOT COMPLETED|Safety Follow-up||5||
48489736|NCT01058668|101532701|FG001|NOT COMPLETED|Safety Follow-up||0||
48489737|NCT01058668|101532702|FG002|NOT COMPLETED|Safety Follow-up||7||
48489738|NCT06195579|101532703|FG000|STARTED|Overall Study||6||
48489739|NCT06195579|101532703|FG000|COMPLETED|Overall Study||5||
48489740|NCT06195579|101532703|FG000|NOT COMPLETED|Overall Study||1||
48489741|NCT01208337|101532704|FG000|STARTED|Overall Study||23||
48489742|NCT01208337|101532704|FG000|One-year Follow-up|Overall Study||23||
48489743|NCT01208337|101532704|FG000|Five-year Follow-up|Overall Study||20||
48489744|NCT01208337|101532704|FG000|COMPLETED|Overall Study||20||
48489745|NCT01208337|101532704|FG000|NOT COMPLETED|Overall Study||3||
48489746|NCT02968992|101532705|FG000|STARTED|Overall Study||18||
48489747|NCT02968992|101532706|FG001|STARTED|Overall Study||18||
48489748|NCT02968992|101532705|FG000|COMPLETED|Overall Study||18||
48489749|NCT02968992|101532706|FG001|COMPLETED|Overall Study||17||
48489750|NCT02968992|101532705|FG000|NOT COMPLETED|Overall Study||0||
48489751|NCT02968992|101532706|FG001|NOT COMPLETED|Overall Study||1||
48489752|NCT02324660|101532707|FG000|STARTED|Overall Study||169||
48489753|NCT02324660|101532707|FG000|COMPLETED|Overall Study||137||
48489754|NCT02324660|101532707|FG000|NOT COMPLETED|Overall Study||32||
48489755|NCT04594252|101532708|FG000|STARTED|Overall Study||6||
48489756|NCT04594252|101532709|FG001|STARTED|Overall Study||11||
48489757|NCT04594252|101532708|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
48489758|NCT04594252|101532709|FG001|Received at Least 1 Dose of Study Drug|Overall Study||11||
48489759|NCT04594252|101532708|FG000|COMPLETED|Overall Study||6||
48489760|NCT04594252|101532709|FG001|COMPLETED|Overall Study||9||
48489761|NCT04594252|101532708|FG000|NOT COMPLETED|Overall Study||0||
48489762|NCT04594252|101532709|FG001|NOT COMPLETED|Overall Study||2||
48489763|NCT00857454|101532710|FG000|STARTED|Overall Study||71||
48489764|NCT00857454|101532710|FG000|COMPLETED|Overall Study||51||
48489765|NCT00857454|101532710|FG000|NOT COMPLETED|Overall Study||20||
48489766|NCT00245063|101532711|FG000|STARTED|Overall Study||12||
48489767|NCT00245063|101532712|FG001|STARTED|Overall Study||13||
48489768|NCT00245063|101532711|FG000|COMPLETED|Overall Study||5||
48489769|NCT00245063|101532712|FG001|COMPLETED|Overall Study||8||
48489770|NCT00245063|101532711|FG000|NOT COMPLETED|Overall Study||7||
48489771|NCT00245063|101532712|FG001|NOT COMPLETED|Overall Study||5||
48489772|NCT02213263|101532713|FG000|STARTED|Overall Study||198||
48489773|NCT02213263|101532714|FG001|STARTED|Overall Study||196||
48489774|NCT02213263|101532713|FG000|Treated|Overall Study||197||
48489775|NCT02213263|101532714|FG001|Treated|Overall Study||196||
48489776|NCT02213263|101532713|FG000|COMPLETED|Overall Study||170||
48489777|NCT02213263|101532714|FG001|COMPLETED|Overall Study||170||
48489778|NCT02213263|101532713|FG000|NOT COMPLETED|Overall Study||28||
48489779|NCT02213263|101532714|FG001|NOT COMPLETED|Overall Study||26||
48489780|NCT01975948|101532715|FG000|STARTED|Overall Study||56||
48489781|NCT01975948|101532716|FG001|STARTED|Overall Study||55||
48489782|NCT01975948|101532717|FG002|STARTED|Overall Study||72||
48489783|NCT01975948|101532718|FG003|STARTED|Overall Study||57||
48489784|NCT01975948|101532715|FG000|COMPLETED|Overall Study||39||
48489785|NCT01975948|101532716|FG001|COMPLETED|Overall Study||34||
48489786|NCT01975948|101532717|FG002|COMPLETED|Overall Study||65||
48489787|NCT01975948|101532718|FG003|COMPLETED|Overall Study||51||
48489788|NCT01975948|101532715|FG000|NOT COMPLETED|Overall Study||17||
48489789|NCT01975948|101532716|FG001|NOT COMPLETED|Overall Study||21||
48489790|NCT01975948|101532717|FG002|NOT COMPLETED|Overall Study||7||
48489791|NCT01975948|101532718|FG003|NOT COMPLETED|Overall Study||6||
48489792|NCT00665470|101532719|FG000|STARTED|Overall Study||10||
48489793|NCT00665470|101532720|FG001|STARTED|Overall Study||0||
48489794|NCT00665470|101532719|FG000|COMPLETED|Overall Study||10||
48489795|NCT00665470|101532720|FG001|COMPLETED|Overall Study||0||
48489796|NCT00665470|101532719|FG000|NOT COMPLETED|Overall Study||0||
48489797|NCT00665470|101532720|FG001|NOT COMPLETED|Overall Study||0||
48489798|NCT03517085|101532721|FG000|STARTED|Overall Study||3||
48489799|NCT03517085|101532722|FG001|STARTED|Overall Study||3||
48489800|NCT03517085|101532723|FG002|STARTED|Overall Study||3||
48489801|NCT03517085|101532724|FG003|STARTED|Overall Study||3||
48489802|NCT03517085|101532721|FG000|COMPLETED|Overall Study||3||
48489803|NCT03517085|101532722|FG001|COMPLETED|Overall Study||3||
48489804|NCT03517085|101532723|FG002|COMPLETED|Overall Study||3||
48489805|NCT03517085|101532724|FG003|COMPLETED|Overall Study||3||
48489806|NCT03517085|101532721|FG000|NOT COMPLETED|Overall Study||0||
48489807|NCT03517085|101532722|FG001|NOT COMPLETED|Overall Study||0||
48489808|NCT03517085|101532723|FG002|NOT COMPLETED|Overall Study||0||
48489809|NCT03517085|101532724|FG003|NOT COMPLETED|Overall Study||0||
48489810|NCT01380782|101532725|FG000|STARTED|Overall Study||12||
48489811|NCT01380782|101532726|FG001|STARTED|Overall Study||10||
48489812|NCT01380782|101532727|FG002|STARTED|Overall Study||11||
48489813|NCT01380782|101532728|FG003|STARTED|Overall Study||4||
48489814|NCT01380782|101532725|FG000|COMPLETED|Overall Study||0||
48489815|NCT01380782|101532726|FG001|COMPLETED|Overall Study||0||
48489816|NCT01380782|101532727|FG002|COMPLETED|Overall Study||0||
48489817|NCT01380782|101532728|FG003|COMPLETED|Overall Study||0||
48489818|NCT01380782|101532725|FG000|NOT COMPLETED|Overall Study||12||
48489819|NCT01380782|101532726|FG001|NOT COMPLETED|Overall Study||10||
48489820|NCT01380782|101532727|FG002|NOT COMPLETED|Overall Study||11||
48489821|NCT01380782|101532728|FG003|NOT COMPLETED|Overall Study||4||
48489822|NCT00833586|101532729|FG000|STARTED|First Intervention||14||
48489823|NCT00833586|101532730|FG001|STARTED|First Intervention||14||
48489824|NCT00833586|101532729|FG000|COMPLETED|First Intervention||14||
48489825|NCT00833586|101532730|FG001|COMPLETED|First Intervention||14||
48489826|NCT00833586|101532729|FG000|NOT COMPLETED|First Intervention||0||
48489827|NCT00833586|101532730|FG001|NOT COMPLETED|First Intervention||0||
48489828|NCT00833586|101532729|FG000|STARTED|Washout: 14 Days||14||
48489829|NCT00833586|101532730|FG001|STARTED|Washout: 14 Days||14||
48489830|NCT00833586|101532729|FG000|COMPLETED|Washout: 14 Days||14||
48489831|NCT00833586|101532730|FG001|COMPLETED|Washout: 14 Days||14||
48489832|NCT00833586|101532729|FG000|NOT COMPLETED|Washout: 14 Days||0||
48489833|NCT00833586|101532730|FG001|NOT COMPLETED|Washout: 14 Days||0||
48489834|NCT00833586|101532729|FG000|STARTED|Second Intervention||14||
48489835|NCT00833586|101532730|FG001|STARTED|Second Intervention||14||
48489836|NCT00833586|101532729|FG000|COMPLETED|Second Intervention||14||
48489837|NCT00833586|101532730|FG001|COMPLETED|Second Intervention||14||
48489838|NCT00833586|101532729|FG000|NOT COMPLETED|Second Intervention||0||
48200044|NCT01872819|100814455|FG000|COMPLETED|Overall Study||14||
48200045|NCT01872819|100814455|FG000|NOT COMPLETED|Overall Study||0||
48200046|NCT00741988|100814456|FG000|STARTED|Overall Study||42||
48200047|NCT00741988|100814457|FG001|STARTED|Overall Study||40||
48200048|NCT00741988|100814456|FG000|COMPLETED|Overall Study||38||
48200049|NCT00741988|100814457|FG001|COMPLETED|Overall Study||36||
48200050|NCT00741988|100814456|FG000|NOT COMPLETED|Overall Study||4||
48200051|NCT00741988|100814457|FG001|NOT COMPLETED|Overall Study||4||
48200052|NCT01570751|100814458|FG000|STARTED|Period A (16 Weeks)||73||
48200053|NCT01570751|100814459|FG001|STARTED|Period A (16 Weeks)||72||
48200054|NCT01570751|100814458|FG000|Exposed|Period A (16 Weeks)||73||
48200055|NCT01570751|100814459|FG001|Exposed|Period A (16 Weeks)||72||
48200056|NCT01570751|100814458|FG000|COMPLETED|Period A (16 Weeks)||70||
48200057|NCT01570751|100814459|FG001|COMPLETED|Period A (16 Weeks)||67||
48200058|NCT01570751|100814458|FG000|NOT COMPLETED|Period A (16 Weeks)||3||
48200059|NCT01570751|100814459|FG001|NOT COMPLETED|Period A (16 Weeks)||5||
48200060|NCT01570751|100814458|FG000|STARTED|Period B (16 Weeks)||70||
48200061|NCT01570751|100814459|FG001|STARTED|Period B (16 Weeks)||67||
48200062|NCT01570751|100814458|FG000|Exposed|Period B (16 Weeks)||70||
48200063|NCT01570751|100814459|FG001|Exposed|Period B (16 Weeks)||67||
48489839|NCT00833586|101532730|FG001|NOT COMPLETED|Second Intervention||0||
48489840|NCT04267276|101532731|FG000|STARTED|Overall Study||7||
48489841|NCT04267276|101532731|FG000|Treated|Overall Study||7||
48489842|NCT04267276|101532731|FG000|COMPLETED|Overall Study||7||
48489843|NCT04267276|101532731|FG000|NOT COMPLETED|Overall Study||0||
48489844|NCT01686477|101532732|FG000|STARTED|Feeding Intervention||35||
48489845|NCT01686477|101532733|FG001|STARTED|Feeding Intervention||34||
48489846|NCT01686477|101532734|FG002|STARTED|Feeding Intervention||34||
48489847|NCT01686477|101532732|FG000|COMPLETED|Feeding Intervention||32||
48489848|NCT01686477|101532733|FG001|COMPLETED|Feeding Intervention||25||
48200064|NCT01570751|100814458|FG000|COMPLETED|Period B (16 Weeks)||69||
48200065|NCT01570751|100814459|FG001|COMPLETED|Period B (16 Weeks)||66||
48489849|NCT01686477|101532734|FG002|COMPLETED|Feeding Intervention||31||
48489850|NCT01686477|101532732|FG000|NOT COMPLETED|Feeding Intervention||3||
48489851|NCT01686477|101532733|FG001|NOT COMPLETED|Feeding Intervention||9||
48489852|NCT01686477|101532734|FG002|NOT COMPLETED|Feeding Intervention||3||
48489853|NCT01686477|101532732|FG000|STARTED|Primary Outcome Term Scan||30||
48489854|NCT01686477|101532733|FG001|STARTED|Primary Outcome Term Scan||25||
48489855|NCT01686477|101532734|FG002|STARTED|Primary Outcome Term Scan||30||
48489856|NCT01686477|101532732|FG000|COMPLETED|Primary Outcome Term Scan||21||
48489857|NCT01686477|101532733|FG001|COMPLETED|Primary Outcome Term Scan||19||
48489858|NCT01686477|101532734|FG002|COMPLETED|Primary Outcome Term Scan||24||
48489859|NCT01686477|101532732|FG000|NOT COMPLETED|Primary Outcome Term Scan||9||
48200066|NCT01570751|100814458|FG000|NOT COMPLETED|Period B (16 Weeks)||1||
48200067|NCT01570751|100814459|FG001|NOT COMPLETED|Period B (16 Weeks)||1||
48200068|NCT00768651|100814460|FG000|STARTED|Overall Study||8||
48200069|NCT00768651|100814460|FG000|COMPLETED|Overall Study||7||
48200070|NCT00768651|100814460|FG000|NOT COMPLETED|Overall Study||1||
48200071|NCT00828672|100814461|FG000|STARTED|Pre-treatment (Baseline)||43||
48200072|NCT00828672|100814462|FG001|STARTED|Pre-treatment (Baseline)||41||
48489860|NCT01686477|101532733|FG001|NOT COMPLETED|Primary Outcome Term Scan||6||
48489861|NCT01686477|101532734|FG002|NOT COMPLETED|Primary Outcome Term Scan||6||
48489862|NCT01686477|101532732|FG000|STARTED|Term Plus 6 Week Scan (End of Study)||21||
48489863|NCT01686477|101532733|FG001|STARTED|Term Plus 6 Week Scan (End of Study)||19||
48489864|NCT01686477|101532734|FG002|STARTED|Term Plus 6 Week Scan (End of Study)||24||
48489865|NCT01686477|101532732|FG000|COMPLETED|Term Plus 6 Week Scan (End of Study)||14||
48489866|NCT01686477|101532733|FG001|COMPLETED|Term Plus 6 Week Scan (End of Study)||5||
48489867|NCT01686477|101532734|FG002|COMPLETED|Term Plus 6 Week Scan (End of Study)||19||
48489868|NCT01686477|101532732|FG000|NOT COMPLETED|Term Plus 6 Week Scan (End of Study)||7||
48489869|NCT01686477|101532733|FG001|NOT COMPLETED|Term Plus 6 Week Scan (End of Study)||14||
48489870|NCT01686477|101532734|FG002|NOT COMPLETED|Term Plus 6 Week Scan (End of Study)||5||
48489871|NCT00274651|101532735|FG000|STARTED|Overall Study||29||
48489872|NCT00274651|101532736|FG001|STARTED|Overall Study||24||
48489873|NCT00274651|101532735|FG000|COMPLETED|Overall Study||1||
48489874|NCT00274651|101532736|FG001|COMPLETED|Overall Study||4||
48489875|NCT00274651|101532735|FG000|NOT COMPLETED|Overall Study||28||
48489876|NCT00274651|101532736|FG001|NOT COMPLETED|Overall Study||20||
48489877|NCT02647944|101532737|FG000|STARTED|Overall Study||19||
48489878|NCT02647944|101532738|FG001|STARTED|Overall Study||21||
48489879|NCT02647944|101532737|FG000|COMPLETED|Overall Study||17||
48489880|NCT02647944|101532738|FG001|COMPLETED|Overall Study||18||
48489881|NCT02647944|101532737|FG000|NOT COMPLETED|Overall Study||2||
48489882|NCT02647944|101532738|FG001|NOT COMPLETED|Overall Study||3||
48489883|NCT04916548|101532739|FG000|STARTED|Overall Study||15||
48489884|NCT04916548|101532739|FG000|COMPLETED|Overall Study||15||
48489885|NCT04916548|101532739|FG000|NOT COMPLETED|Overall Study||0||
48489886|NCT01218867|101532740|FG000|STARTED|Overall Study||1||
48489887|NCT01218867|101532741|FG001|STARTED|Overall Study||1||
48489888|NCT01218867|101532742|FG002|STARTED|Overall Study||3||
48489889|NCT01218867|101532743|FG003|STARTED|Overall Study||1||
48489890|NCT01218867|101532744|FG004|STARTED|Overall Study||1||
48489891|NCT01218867|101532745|FG005|STARTED|Overall Study||1||
48489892|NCT01218867|101532746|FG006|STARTED|Overall Study||4||
48489893|NCT01218867|101532747|FG007|STARTED|Overall Study||3||
48489894|NCT01218867|101532748|FG008|STARTED|Overall Study||3||
48489895|NCT01218867|101532749|FG009|STARTED|Overall Study||4||
48489896|NCT01218867|101532750|FG010|STARTED|Overall Study||2||
48489897|NCT01218867|101532740|FG000|COMPLETED|Overall Study||1||
48489898|NCT01218867|101532741|FG001|COMPLETED|Overall Study||1||
48489899|NCT01218867|101532742|FG002|COMPLETED|Overall Study||3||
48489900|NCT01218867|101532743|FG003|COMPLETED|Overall Study||1||
48489901|NCT01218867|101532744|FG004|COMPLETED|Overall Study||1||
48489902|NCT01218867|101532745|FG005|COMPLETED|Overall Study||1||
48489903|NCT01218867|101532746|FG006|COMPLETED|Overall Study||3||
48489904|NCT01218867|101532747|FG007|COMPLETED|Overall Study||3||
48489905|NCT01218867|101532748|FG008|COMPLETED|Overall Study||3||
48489906|NCT01218867|101532749|FG009|COMPLETED|Overall Study||4||
48489907|NCT01218867|101532750|FG010|COMPLETED|Overall Study||2||
48489908|NCT01218867|101532740|FG000|NOT COMPLETED|Overall Study||0||
48489909|NCT01218867|101532741|FG001|NOT COMPLETED|Overall Study||0||
48489910|NCT01218867|101532742|FG002|NOT COMPLETED|Overall Study||0||
48489911|NCT01218867|101532743|FG003|NOT COMPLETED|Overall Study||0||
48489912|NCT01218867|101532744|FG004|NOT COMPLETED|Overall Study||0||
48489913|NCT01218867|101532745|FG005|NOT COMPLETED|Overall Study||0||
48489914|NCT01218867|101532746|FG006|NOT COMPLETED|Overall Study||1||
48489915|NCT01218867|101532747|FG007|NOT COMPLETED|Overall Study||0||
48489916|NCT01218867|101532748|FG008|NOT COMPLETED|Overall Study||0||
48489917|NCT01218867|101532749|FG009|NOT COMPLETED|Overall Study||0||
48489918|NCT01218867|101532750|FG010|NOT COMPLETED|Overall Study||0||
48489919|NCT04044521|101532751|FG000|STARTED|Overall Study||60||8
48489920|NCT04044521|101532752|FG001|STARTED|Overall Study||65||8
48489921|NCT04044521|101532753|FG002|STARTED|Overall Study||66||8
48489922|NCT04044521|101532754|FG003|STARTED|Overall Study||77||8
48489923|NCT04044521|101532751|FG000|COMPLETED|Overall Study||60||8
48489924|NCT04044521|101532752|FG001|COMPLETED|Overall Study||65||8
48489925|NCT04044521|101532753|FG002|COMPLETED|Overall Study||66||8
48489926|NCT04044521|101532754|FG003|COMPLETED|Overall Study||77||8
48489927|NCT04044521|101532751|FG000|NOT COMPLETED|Overall Study||0||0
48489928|NCT04044521|101532752|FG001|NOT COMPLETED|Overall Study||0||0
48489929|NCT04044521|101532753|FG002|NOT COMPLETED|Overall Study||0||0
48489930|NCT04044521|101532754|FG003|NOT COMPLETED|Overall Study||0||0
48489931|NCT00772603|101532755|FG000|STARTED|Overall Study||123||
48489932|NCT00772603|101532756|FG001|STARTED|Overall Study||122||
48489933|NCT00772603|101532757|FG002|STARTED|Overall Study||121||
48489934|NCT00772603|101532755|FG000|COMPLETED|Overall Study||71||
48489935|NCT00772603|101532756|FG001|COMPLETED|Overall Study||82||
48489936|NCT00772603|101532757|FG002|COMPLETED|Overall Study||95||
48489937|NCT00772603|101532755|FG000|NOT COMPLETED|Overall Study||52||
48489938|NCT00772603|101532756|FG001|NOT COMPLETED|Overall Study||40||
48489939|NCT00772603|101532757|FG002|NOT COMPLETED|Overall Study||26||
48489940|NCT01030133|101532758|FG000|STARTED|Overall Study||14||
48489941|NCT01030133|101532759|FG001|STARTED|Overall Study||14||
48489942|NCT01030133|101532758|FG000|COMPLETED|Overall Study||12||
48489943|NCT01030133|101532759|FG001|COMPLETED|Overall Study||12||
48489944|NCT01030133|101532758|FG000|NOT COMPLETED|Overall Study||2||
48489945|NCT01030133|101532759|FG001|NOT COMPLETED|Overall Study||2||
48489946|NCT01316055|101532760|FG000|STARTED|Overall Study||13||
48489947|NCT01316055|101532761|FG001|STARTED|Overall Study||17||
48489948|NCT01316055|101532762|FG002|STARTED|Overall Study||12||
48489949|NCT01316055|101532760|FG000|COMPLETED|Overall Study||12||
48489950|NCT01316055|101532761|FG001|COMPLETED|Overall Study||17||
48489951|NCT01316055|101532762|FG002|COMPLETED|Overall Study||12||
48489952|NCT01316055|101532760|FG000|NOT COMPLETED|Overall Study||1||
48489953|NCT01316055|101532761|FG001|NOT COMPLETED|Overall Study||0||
48489954|NCT01316055|101532762|FG002|NOT COMPLETED|Overall Study||0||
48489955|NCT00431041|101532763|FG000|STARTED|Overall Study||68||
48489956|NCT00431041|101532764|FG001|STARTED|Overall Study||64||
48489957|NCT00431041|101532763|FG000|COMPLETED|Overall Study||52||
48489958|NCT00431041|101532764|FG001|COMPLETED|Overall Study||40||
48489959|NCT00431041|101532763|FG000|NOT COMPLETED|Overall Study||16||
48489960|NCT00431041|101532764|FG001|NOT COMPLETED|Overall Study||24||
48489961|NCT00575159|101532765|FG000|STARTED|Overall Study||10||
48489962|NCT00575159|101532765|FG000|COMPLETED|Overall Study||10||
48489963|NCT00575159|101532765|FG000|NOT COMPLETED|Overall Study||0||
48489964|NCT02284867|101532766|FG000|STARTED|Overall Study||30||
48489965|NCT02284867|101532767|FG001|STARTED|Overall Study||30||
48489966|NCT02284867|101532766|FG000|COMPLETED|Overall Study||30||
48489967|NCT02284867|101532767|FG001|COMPLETED|Overall Study||30||
48489968|NCT02284867|101532766|FG000|NOT COMPLETED|Overall Study||0||
48489969|NCT02284867|101532767|FG001|NOT COMPLETED|Overall Study||0||
48489970|NCT04887415|101532768|FG000|STARTED|Overall Study||25||
48489971|NCT04887415|101532768|FG000|COMPLETED|Overall Study||23||
48489972|NCT04887415|101532768|FG000|NOT COMPLETED|Overall Study||2||
48489973|NCT00152451|101532769|FG000|STARTED|Overall Study||31||
48489974|NCT00152451|101532769|FG000|COMPLETED|Overall Study||27||
48489975|NCT00152451|101532769|FG000|NOT COMPLETED|Overall Study||4||
48489976|NCT04173247|101532770|FG000|STARTED|Overall Study||14||
48489977|NCT04173247|101532771|FG001|STARTED|Overall Study||14||
48489978|NCT04173247|101532770|FG000|COMPLETED|Overall Study||12||
48489979|NCT04173247|101532771|FG001|COMPLETED|Overall Study||12||
48489980|NCT04173247|101532770|FG000|NOT COMPLETED|Overall Study||2||
48489981|NCT04173247|101532771|FG001|NOT COMPLETED|Overall Study||2||
48489982|NCT04927013|101532772|FG000|STARTED|Overall Study||969|Cancer survivors considered as starting the study are individuals from the GCR who were randomized to a study arm. Close relatives who started the study are individuals who were identified by survivors who used their unique login code to access the study website.|
48489983|NCT04927013|101532773|FG001|STARTED|Overall Study||969|Cancer survivors considered as starting the study are individuals from the GCR who were randomized to a study arm. Close relatives who started the study are individuals who were identified by survivors who used their unique login code to access the study website.|
48489984|NCT04927013|101532774|FG002|STARTED|Overall Study||152|Cancer survivors considered as starting the study are individuals from the GCR who were randomized to a study arm. Close relatives who started the study are individuals who were identified by survivors who used their unique login code to access the study website.|
48489985|NCT04927013|101532775|FG003|STARTED|Overall Study||241|Cancer survivors considered as starting the study are individuals from the GCR who were randomized to a study arm. Close relatives who started the study are individuals who were identified by survivors who used their unique login code to access the study website.|
48489986|NCT04927013|101532772|FG000|COMPLETED|Overall Study||130|Individuals who started the study are considered as completing the study if they consented to participate while they were using the website.|
48489987|NCT04927013|101532773|FG001|COMPLETED|Overall Study||184|Individuals who started the study are considered as completing the study if they consented to participate while they were using the website.|
48489988|NCT04927013|101532774|FG002|COMPLETED|Overall Study||19|Individuals who started the study are considered as completing the study if they consented to participate while they were using the website.|
48489989|NCT04927013|101532775|FG003|COMPLETED|Overall Study||1|Individuals who started the study are considered as completing the study if they consented to participate while they were using the website.|
48489990|NCT04927013|101532772|FG000|NOT COMPLETED|Overall Study||839||
48489991|NCT04927013|101532773|FG001|NOT COMPLETED|Overall Study||785||
48489992|NCT04927013|101532774|FG002|NOT COMPLETED|Overall Study||133||
48489993|NCT04927013|101532775|FG003|NOT COMPLETED|Overall Study||240||
48489994|NCT00041392|101532776|FG000|STARTED|Overall Study||198||
48489995|NCT00041392|101532777|FG001|STARTED|Overall Study||191||
48489996|NCT00041392|101532776|FG000|COMPLETED|Overall Study||198||
48489997|NCT00041392|101532777|FG001|COMPLETED|Overall Study||191||
48489998|NCT00041392|101532776|FG000|NOT COMPLETED|Overall Study||0||
48489999|NCT00041392|101532777|FG001|NOT COMPLETED|Overall Study||0||
48490000|NCT00841698|101532778|FG000|STARTED|First Intervention||25||
48490001|NCT00841698|101532779|FG001|STARTED|First Intervention||25||
48490002|NCT00841698|101532778|FG000|COMPLETED|First Intervention||24||
48490003|NCT00841698|101532779|FG001|COMPLETED|First Intervention||25||
48490004|NCT00841698|101532778|FG000|NOT COMPLETED|First Intervention||1||
48490005|NCT00841698|101532779|FG001|NOT COMPLETED|First Intervention||0||
48490006|NCT00841698|101532778|FG000|STARTED|Washout: 2 Weeks||24||
48490007|NCT00841698|101532779|FG001|STARTED|Washout: 2 Weeks||25||
48490008|NCT00841698|101532778|FG000|COMPLETED|Washout: 2 Weeks||24||
48490009|NCT00841698|101532779|FG001|COMPLETED|Washout: 2 Weeks||25||
48490010|NCT00841698|101532778|FG000|NOT COMPLETED|Washout: 2 Weeks||0||
48490011|NCT00841698|101532779|FG001|NOT COMPLETED|Washout: 2 Weeks||0||
48490012|NCT00841698|101532778|FG000|STARTED|Second Intervention||24||
48490013|NCT00841698|101532779|FG001|STARTED|Second Intervention||25||
48490014|NCT00841698|101532778|FG000|COMPLETED|Second Intervention||24||
48490015|NCT00841698|101532779|FG001|COMPLETED|Second Intervention||25||
48490016|NCT00841698|101532778|FG000|NOT COMPLETED|Second Intervention||0||
48490017|NCT00841698|101532779|FG001|NOT COMPLETED|Second Intervention||0||
48490018|NCT02158494|101532780|FG000|STARTED|Overall Study||22||
48490019|NCT02158494|101532781|FG001|STARTED|Overall Study||22||
48490020|NCT02158494|101532780|FG000|COMPLETED|Overall Study||22||
48490021|NCT02158494|101532781|FG001|COMPLETED|Overall Study||21||
48490022|NCT02158494|101532780|FG000|NOT COMPLETED|Overall Study||0||
48490023|NCT02158494|101532781|FG001|NOT COMPLETED|Overall Study||1||
48490024|NCT03612960|101532782|FG000|STARTED|Overall Study||21||
48490025|NCT03612960|101532783|FG001|STARTED|Overall Study||13||
48490026|NCT03612960|101532782|FG000|COMPLETED|Overall Study||20||
48490027|NCT03612960|101532783|FG001|COMPLETED|Overall Study||10||
48490028|NCT03612960|101532782|FG000|NOT COMPLETED|Overall Study||1||
48490029|NCT03612960|101532783|FG001|NOT COMPLETED|Overall Study||3||
48490030|NCT00218257|101532784|FG000|STARTED|Intervention 1||23||
48490031|NCT00218257|101532785|FG001|STARTED|Intervention 1||22||
48490032|NCT00218257|101532784|FG000|COMPLETED|Intervention 1||23||
48490033|NCT00218257|101532785|FG001|COMPLETED|Intervention 1||22||
48490034|NCT00218257|101532784|FG000|NOT COMPLETED|Intervention 1||0||
48490035|NCT00218257|101532785|FG001|NOT COMPLETED|Intervention 1||0||
48490036|NCT00218257|101532784|FG000|STARTED|Period Between Visit 1 and 2||23||
48490037|NCT00218257|101532785|FG001|STARTED|Period Between Visit 1 and 2||22||
48490038|NCT00218257|101532784|FG000|COMPLETED|Period Between Visit 1 and 2||19||
48490039|NCT00218257|101532785|FG001|COMPLETED|Period Between Visit 1 and 2||19||
48490040|NCT00218257|101532784|FG000|NOT COMPLETED|Period Between Visit 1 and 2||4||
48490041|NCT00218257|101532785|FG001|NOT COMPLETED|Period Between Visit 1 and 2||3||
48490042|NCT00218257|101532784|FG000|STARTED|Intervention 2||19||
48490043|NCT00218257|101532785|FG001|STARTED|Intervention 2||19||
48490044|NCT00218257|101532784|FG000|COMPLETED|Intervention 2||19||
48490045|NCT00218257|101532785|FG001|COMPLETED|Intervention 2||19||
48490046|NCT00218257|101532784|FG000|NOT COMPLETED|Intervention 2||0||
48490047|NCT00218257|101532785|FG001|NOT COMPLETED|Intervention 2||0||
48490048|NCT03527485|101532786|FG000|STARTED|Overall Study||15||
48490049|NCT03527485|101532787|FG001|STARTED|Overall Study||26||
48490050|NCT03527485|101532786|FG000|COMPLETED|Overall Study||15||
48490051|NCT03527485|101532787|FG001|COMPLETED|Overall Study||26||
48490052|NCT03527485|101532786|FG000|NOT COMPLETED|Overall Study||0||
48490053|NCT03527485|101532787|FG001|NOT COMPLETED|Overall Study||0||
48490054|NCT04503603|101532788|FG000|STARTED|Overall Study||9||
48490055|NCT04503603|101532789|FG001|STARTED|Overall Study||3||
48490056|NCT04503603|101532788|FG000|COMPLETED|Overall Study||9||
48490057|NCT04503603|101532789|FG001|COMPLETED|Overall Study||3||
48490058|NCT04503603|101532788|FG000|NOT COMPLETED|Overall Study||0||
48490059|NCT04503603|101532789|FG001|NOT COMPLETED|Overall Study||0||
48490060|NCT01466166|101532790|FG000|STARTED|Overall Study||188||
48490061|NCT01466166|101532790|FG000|Received Treatment|Overall Study||188||
48490062|NCT01466166|101532790|FG000|Completed 24 Weeks of Treatment|Overall Study||55||
48490063|NCT01466166|101532790|FG000|COMPLETED|Overall Study||25|Patients completed the treatment phase of the study (on study for 52 weeks)|
48490064|NCT01466166|101532790|FG000|NOT COMPLETED|Overall Study||163||
48490065|NCT00640562|101532791|FG000|STARTED|Overall Study||109||
48490066|NCT00640562|101532792|FG001|STARTED|Overall Study||107||
48490067|NCT00640562|101532791|FG000|COMPLETED|Overall Study||91||
48490068|NCT00640562|101532792|FG001|COMPLETED|Overall Study||81||
48490069|NCT00640562|101532791|FG000|NOT COMPLETED|Overall Study||18||
48490070|NCT00640562|101532792|FG001|NOT COMPLETED|Overall Study||26||
48490071|NCT02554890|101532793|FG000|STARTED|Double-blind||444|Randomized|
48490072|NCT02554890|101532794|FG001|STARTED|Double-blind||443|Randomized|
48490073|NCT02554890|101532793|FG000|Treated Patients|Double-blind||436|Treated|
48490074|NCT02554890|101532794|FG001|Treated Patients|Double-blind||439|Treated|
48490075|NCT02554890|101532793|FG000|COMPLETED|Double-blind||348|Continued study treatment during double-blind phase|
48490076|NCT02554890|101532794|FG001|COMPLETED|Double-blind||352|Continued study treatment during double-blind phase|
48490077|NCT02554890|101532793|FG000|NOT COMPLETED|Double-blind||96||
48490078|NCT02554890|101532794|FG001|NOT COMPLETED|Double-blind||91||
48490079|NCT02554890|101532793|FG000|STARTED|Open-label||0|Randomized|
48490080|NCT02554890|101532794|FG001|STARTED|Open-label||887|Randomized|
48490081|NCT02554890|101532793|FG000|COMPLETED|Open-label||0|Continued study treatment during open-label phase|
48490082|NCT02554890|101532794|FG001|COMPLETED|Open-label||835|Continued study treatment during open-label phase|
48490083|NCT02554890|101532793|FG000|NOT COMPLETED|Open-label||0||
48490084|NCT02554890|101532794|FG001|NOT COMPLETED|Open-label||52||
48490085|NCT02963259|101532795|FG000|STARTED|Overall Study||17||
48490086|NCT02963259|101532795|FG000|COMPLETED|Overall Study||12||
48490087|NCT02963259|101532795|FG000|NOT COMPLETED|Overall Study||5||
48490088|NCT01631331|101532796|FG000|STARTED|Overall Study||15||76
48490089|NCT01631331|101532796|FG000|COMPLETED|Overall Study||11||43
48490090|NCT01631331|101532796|FG000|NOT COMPLETED|Overall Study||4||33
48490091|NCT03597256|101532797|FG000|STARTED|Overall Study||111||
48490092|NCT03597256|101532798|FG001|STARTED|Overall Study||37||
48490093|NCT03597256|101532797|FG000|Treated|Overall Study||111||
48490094|NCT03597256|101532798|FG001|Treated|Overall Study||34||
48490095|NCT03597256|101532797|FG000|COMPLETED|Overall Study||108||
48490096|NCT03597256|101532798|FG001|COMPLETED|Overall Study||32||
48490097|NCT03597256|101532797|FG000|NOT COMPLETED|Overall Study||3||
48490098|NCT03597256|101532798|FG001|NOT COMPLETED|Overall Study||5||
48490099|NCT03437265|101532799|FG000|STARTED|Overall Study||19||
48490100|NCT03437265|101532799|FG000|COMPLETED|Overall Study||13||
48490101|NCT03437265|101532799|FG000|NOT COMPLETED|Overall Study||6||
48490102|NCT01686438|101532800|FG000|STARTED|Overall Study||15||
48490103|NCT01686438|101532801|FG001|STARTED|Overall Study||35||
48490104|NCT01686438|101532802|FG002|STARTED|Overall Study||37||
48490105|NCT01686438|101532800|FG000|2-Week Follow Up|Overall Study||12||
48490106|NCT01686438|101532801|FG001|2-Week Follow Up|Overall Study||31||
48490107|NCT01686438|101532802|FG002|2-Week Follow Up|Overall Study||27||
48200073|NCT00828672|100814461|FG000|COMPLETED|Pre-treatment (Baseline)||43||
48200074|NCT00828672|100814462|FG001|COMPLETED|Pre-treatment (Baseline)||41||
48200075|NCT00828672|100814461|FG000|NOT COMPLETED|Pre-treatment (Baseline)||0||
48490108|NCT01686438|101532800|FG000|3-Month Follow Up|Overall Study||7||
48490109|NCT01686438|101532801|FG001|3-Month Follow Up|Overall Study||21||
48490110|NCT01686438|101532802|FG002|3-Month Follow Up|Overall Study||17||
48490111|NCT01686438|101532800|FG000|6-Month Follow Up|Overall Study||7||
48490112|NCT01686438|101532801|FG001|6-Month Follow Up|Overall Study||26||
48200076|NCT00828672|100814462|FG001|NOT COMPLETED|Pre-treatment (Baseline)||0||
48200077|NCT00828672|100814461|FG000|STARTED|Study Treatment||43||
48200078|NCT00828672|100814462|FG001|STARTED|Study Treatment||41||
48200079|NCT00828672|100814461|FG000|COMPLETED|Study Treatment||41||
48200080|NCT00828672|100814462|FG001|COMPLETED|Study Treatment||39||
48490113|NCT01686438|101532802|FG002|6-Month Follow Up|Overall Study||24||
48490114|NCT01686438|101532800|FG000|COMPLETED|Overall Study||7||
48490115|NCT01686438|101532801|FG001|COMPLETED|Overall Study||26||
48490116|NCT01686438|101532802|FG002|COMPLETED|Overall Study||24||
48490117|NCT01686438|101532800|FG000|NOT COMPLETED|Overall Study||8||
48490118|NCT01686438|101532801|FG001|NOT COMPLETED|Overall Study||9||
48490119|NCT01686438|101532802|FG002|NOT COMPLETED|Overall Study||13||
48490120|NCT01863745|101532803|FG000|STARTED|Overall Study||15||
48490121|NCT01863745|101532803|FG000|COMPLETED|Overall Study||2||
48490122|NCT01863745|101532803|FG000|NOT COMPLETED|Overall Study||13||
48490123|NCT03256695|101532804|FG000|STARTED|Overall Study||405||
48490124|NCT03256695|101532804|FG000|Used ABS eMDPI at Least Once|Overall Study||390||
48490125|NCT03256695|101532804|FG000|COMPLETED|Overall Study||366||
48490126|NCT03256695|101532804|FG000|NOT COMPLETED|Overall Study||39||
48490127|NCT00003470|101532805|FG000|STARTED|Overall Study||27||
48490128|NCT00003470|101532805|FG000|COMPLETED|Overall Study||21||
48490129|NCT00003470|101532805|FG000|NOT COMPLETED|Overall Study||6||
48490130|NCT01015625|101535873|FG000|STARTED|Overall Study||45||
48490131|NCT01015625|101535874|FG001|STARTED|Overall Study||45||
48490132|NCT01015625|101535873|FG000|COMPLETED|Overall Study||8||
48490133|NCT01015625|101535874|FG001|COMPLETED|Overall Study||19||
48490134|NCT01015625|101535873|FG000|NOT COMPLETED|Overall Study||37||
48490135|NCT01015625|101535874|FG001|NOT COMPLETED|Overall Study||26||
48490136|NCT01384591|101535875|FG000|STARTED|Overall Study||2||
48490137|NCT01384591|101535876|FG001|STARTED|Overall Study||2||
48490138|NCT01384591|101535877|FG002|STARTED|Overall Study||2||
48490139|NCT01384591|101535875|FG000|COMPLETED|Overall Study||2||
48490140|NCT01384591|101535876|FG001|COMPLETED|Overall Study||2||
48490141|NCT01384591|101535877|FG002|COMPLETED|Overall Study||2||
48490142|NCT01384591|101535875|FG000|NOT COMPLETED|Overall Study||0||
48490143|NCT01384591|101535876|FG001|NOT COMPLETED|Overall Study||0||
48490144|NCT01384591|101535877|FG002|NOT COMPLETED|Overall Study||0||
48490145|NCT03682601|101535878|FG000|STARTED|Overall Study||12||
48490146|NCT03682601|101535879|FG001|STARTED|Overall Study||7||
48490147|NCT03682601|101535880|FG002|STARTED|Overall Study||13||
48490148|NCT03682601|101535878|FG000|COMPLETED|Overall Study||12||
48490149|NCT03682601|101535879|FG001|COMPLETED|Overall Study||7||
48490150|NCT03682601|101535880|FG002|COMPLETED|Overall Study||13||
48490151|NCT03682601|101535878|FG000|NOT COMPLETED|Overall Study||0||
48490152|NCT03682601|101535879|FG001|NOT COMPLETED|Overall Study||0||
48490153|NCT03682601|101535880|FG002|NOT COMPLETED|Overall Study||0||
48490154|NCT02622386|101535881|FG000|STARTED|First Assignment||12||
48490155|NCT02622386|101535882|FG001|STARTED|First Assignment||11||
48490156|NCT02622386|101535881|FG000|COMPLETED|First Assignment||9||
48490157|NCT02622386|101535882|FG001|COMPLETED|First Assignment||9||
48490158|NCT02622386|101535881|FG000|NOT COMPLETED|First Assignment||3||
48490159|NCT02622386|101535882|FG001|NOT COMPLETED|First Assignment||2||
48490160|NCT02622386|101535881|FG000|STARTED|Washout||9||
48490161|NCT02622386|101535882|FG001|STARTED|Washout||9||
48490162|NCT02622386|101535881|FG000|COMPLETED|Washout||5||
48490163|NCT02622386|101535882|FG001|COMPLETED|Washout||5||
48490164|NCT02622386|101535881|FG000|NOT COMPLETED|Washout||4||
48490165|NCT02622386|101535882|FG001|NOT COMPLETED|Washout||4||
48490166|NCT02622386|101535881|FG000|STARTED|Second Assignment||5||
48490167|NCT02622386|101535882|FG001|STARTED|Second Assignment||5||
48490168|NCT02622386|101535881|FG000|COMPLETED|Second Assignment||5||
48490169|NCT02622386|101535882|FG001|COMPLETED|Second Assignment||3||
48490170|NCT02622386|101535881|FG000|NOT COMPLETED|Second Assignment||0||
48490171|NCT02622386|101535882|FG001|NOT COMPLETED|Second Assignment||2||
48490172|NCT01796171|101535883|FG000|STARTED|Enrolled||4||
48490173|NCT01796171|101535884|FG001|STARTED|Enrolled||36||
48490174|NCT01796171|101535885|FG002|STARTED|Enrolled||3||
48490175|NCT01796171|101535886|FG003|STARTED|Enrolled||1||
48490176|NCT01796171|101535887|FG004|STARTED|Enrolled||2||
48490177|NCT01796171|101535888|FG005|STARTED|Enrolled||3||
48490178|NCT01796171|101535889|FG006|STARTED|Enrolled||3||
48490179|NCT01796171|101535890|FG007|STARTED|Enrolled||18||
48490180|NCT01796171|101535891|FG008|STARTED|Enrolled||4||
48490181|NCT01796171|101535892|FG009|STARTED|Enrolled||2||
48490182|NCT01796171|101535893|FG010|STARTED|Enrolled||76||
48490183|NCT01796171|101535894|FG011|STARTED|Enrolled||28||
48490184|NCT01796171|101535895|FG012|STARTED|Enrolled||9||
48490185|NCT01796171|101535896|FG013|STARTED|Enrolled||1||
48490186|NCT01796171|101535897|FG014|STARTED|Enrolled||1||
48490187|NCT01796171|101535883|FG000|COMPLETED|Enrolled||4||
48490188|NCT01796171|101535884|FG001|COMPLETED|Enrolled||36||
48490189|NCT01796171|101535885|FG002|COMPLETED|Enrolled||3||
48490190|NCT01796171|101535886|FG003|COMPLETED|Enrolled||1||
48490191|NCT01796171|101535887|FG004|COMPLETED|Enrolled||2||
48490192|NCT01796171|101535888|FG005|COMPLETED|Enrolled||3||
48490193|NCT01796171|101535889|FG006|COMPLETED|Enrolled||3||
48490194|NCT01796171|101535890|FG007|COMPLETED|Enrolled||18||
48490195|NCT01796171|101535891|FG008|COMPLETED|Enrolled||4||
48490196|NCT01796171|101535892|FG009|COMPLETED|Enrolled||2||
48490197|NCT01796171|101535893|FG010|COMPLETED|Enrolled||76||
48490198|NCT01796171|101535894|FG011|COMPLETED|Enrolled||28||
48490199|NCT01796171|101535895|FG012|COMPLETED|Enrolled||9||
48490200|NCT01796171|101535896|FG013|COMPLETED|Enrolled||1||
48490201|NCT01796171|101535897|FG014|COMPLETED|Enrolled||0||
48490202|NCT01796171|101535883|FG000|NOT COMPLETED|Enrolled||0||
48490203|NCT01796171|101535884|FG001|NOT COMPLETED|Enrolled||0||
48490204|NCT01796171|101535885|FG002|NOT COMPLETED|Enrolled||0||
48490205|NCT01796171|101535886|FG003|NOT COMPLETED|Enrolled||0||
48490206|NCT01796171|101535887|FG004|NOT COMPLETED|Enrolled||0||
48490207|NCT01796171|101535888|FG005|NOT COMPLETED|Enrolled||0||
48490208|NCT01796171|101535889|FG006|NOT COMPLETED|Enrolled||0||
48490209|NCT01796171|101535890|FG007|NOT COMPLETED|Enrolled||0||
48490210|NCT01796171|101535891|FG008|NOT COMPLETED|Enrolled||0||
48490211|NCT01796171|101535892|FG009|NOT COMPLETED|Enrolled||0||
48490212|NCT01796171|101535893|FG010|NOT COMPLETED|Enrolled||0||
48490213|NCT01796171|101535894|FG011|NOT COMPLETED|Enrolled||0||
48490214|NCT01796171|101535895|FG012|NOT COMPLETED|Enrolled||0||
48490215|NCT01796171|101535896|FG013|NOT COMPLETED|Enrolled||0||
48490216|NCT01796171|101535897|FG014|NOT COMPLETED|Enrolled||1||
48490217|NCT01796171|101535883|FG000|STARTED|Pre-reatment With Rituximab||4|Started pre-treatment with rituximab|
48490218|NCT01796171|101535884|FG001|STARTED|Pre-reatment With Rituximab||36|Started pre-treatment with rituximab|
48490219|NCT01796171|101535885|FG002|STARTED|Pre-reatment With Rituximab||3|Started pre-treatment with rituximab|
48490220|NCT01796171|101535886|FG003|STARTED|Pre-reatment With Rituximab||1|Started pre-treatment with rituximab|
48490221|NCT01796171|101535887|FG004|STARTED|Pre-reatment With Rituximab||2|Started pre-treatment with rituximab|
48490222|NCT01796171|101535888|FG005|STARTED|Pre-reatment With Rituximab||3|Started pre-treatment with rituximab|
48490223|NCT01796171|101535889|FG006|STARTED|Pre-reatment With Rituximab||3|Started pre-treatment with rituximab|
48490224|NCT01796171|101535890|FG007|STARTED|Pre-reatment With Rituximab||18|Started pre-treatment with rituximab|
48490225|NCT01796171|101535891|FG008|STARTED|Pre-reatment With Rituximab||4|Started pre-treatment with rituximab|
48490226|NCT01796171|101535892|FG009|STARTED|Pre-reatment With Rituximab||2|Started pre-treatment with rituximab|
48490227|NCT01796171|101535893|FG010|STARTED|Pre-reatment With Rituximab||76|Started pre-treatment with rituximab|
48490228|NCT01796171|101535894|FG011|STARTED|Pre-reatment With Rituximab||28|Started pre-treatment with rituximab|
48490229|NCT01796171|101535895|FG012|STARTED|Pre-reatment With Rituximab||9|Started pre-treatment with rituximab|
48490230|NCT01796171|101535896|FG013|STARTED|Pre-reatment With Rituximab||1|Started pre-treatment with rituximab|
48490231|NCT01796171|101535897|FG014|STARTED|Pre-reatment With Rituximab||0|Started pre-treatment with rituximab|
48490232|NCT01796171|101535883|FG000|COMPLETED|Pre-reatment With Rituximab||4||
48490233|NCT01796171|101535884|FG001|COMPLETED|Pre-reatment With Rituximab||36||
48490234|NCT01796171|101535885|FG002|COMPLETED|Pre-reatment With Rituximab||3||
48490235|NCT01796171|101535886|FG003|COMPLETED|Pre-reatment With Rituximab||1||
48490236|NCT01796171|101535887|FG004|COMPLETED|Pre-reatment With Rituximab||2||
48490237|NCT01796171|101535888|FG005|COMPLETED|Pre-reatment With Rituximab||3||
48490238|NCT01796171|101535889|FG006|COMPLETED|Pre-reatment With Rituximab||3||
48490239|NCT01796171|101535890|FG007|COMPLETED|Pre-reatment With Rituximab||18||
48490240|NCT01796171|101535891|FG008|COMPLETED|Pre-reatment With Rituximab||4||
48490241|NCT01796171|101535892|FG009|COMPLETED|Pre-reatment With Rituximab||0||
48490242|NCT01796171|101535893|FG010|COMPLETED|Pre-reatment With Rituximab||76||
48490243|NCT01796171|101535894|FG011|COMPLETED|Pre-reatment With Rituximab||28||
48490244|NCT01796171|101535895|FG012|COMPLETED|Pre-reatment With Rituximab||9||
48490245|NCT01796171|101535896|FG013|COMPLETED|Pre-reatment With Rituximab||0||
48490246|NCT01796171|101535897|FG014|COMPLETED|Pre-reatment With Rituximab||0||
48490247|NCT01796171|101535883|FG000|NOT COMPLETED|Pre-reatment With Rituximab||0||
48490248|NCT01796171|101535884|FG001|NOT COMPLETED|Pre-reatment With Rituximab||0||
48490249|NCT01796171|101535885|FG002|NOT COMPLETED|Pre-reatment With Rituximab||0||
48490250|NCT01796171|101535886|FG003|NOT COMPLETED|Pre-reatment With Rituximab||0||
48490251|NCT01796171|101535887|FG004|NOT COMPLETED|Pre-reatment With Rituximab||0||
48490252|NCT01796171|101535888|FG005|NOT COMPLETED|Pre-reatment With Rituximab||0||
48490253|NCT01796171|101535889|FG006|NOT COMPLETED|Pre-reatment With Rituximab||0||
48490254|NCT01796171|101535890|FG007|NOT COMPLETED|Pre-reatment With Rituximab||0||
48490255|NCT01796171|101535891|FG008|NOT COMPLETED|Pre-reatment With Rituximab||0||
48490256|NCT01796171|101535892|FG009|NOT COMPLETED|Pre-reatment With Rituximab||2||
48490257|NCT01796171|101535893|FG010|NOT COMPLETED|Pre-reatment With Rituximab||0||
48490258|NCT01796171|101535894|FG011|NOT COMPLETED|Pre-reatment With Rituximab||0||
48490259|NCT01796171|101535895|FG012|NOT COMPLETED|Pre-reatment With Rituximab||0||
48490260|NCT01796171|101535896|FG013|NOT COMPLETED|Pre-reatment With Rituximab||1||
48490261|NCT01796171|101535897|FG014|NOT COMPLETED|Pre-reatment With Rituximab||0||
48490262|NCT01796171|101535883|FG000|STARTED|Treatment Period With Betalutin||4||
48490263|NCT01796171|101535884|FG001|STARTED|Treatment Period With Betalutin||36||
48490264|NCT01796171|101535885|FG002|STARTED|Treatment Period With Betalutin||3||
48490265|NCT01796171|101535886|FG003|STARTED|Treatment Period With Betalutin||1||
48490266|NCT01796171|101535887|FG004|STARTED|Treatment Period With Betalutin||2||
48490267|NCT01796171|101535888|FG005|STARTED|Treatment Period With Betalutin||3||
48490268|NCT01796171|101535889|FG006|STARTED|Treatment Period With Betalutin||3||
48490269|NCT01796171|101535890|FG007|STARTED|Treatment Period With Betalutin||18||
48490270|NCT01796171|101535891|FG008|STARTED|Treatment Period With Betalutin||4||
48490271|NCT01796171|101535892|FG009|STARTED|Treatment Period With Betalutin||0||
48490272|NCT01796171|101535893|FG010|STARTED|Treatment Period With Betalutin||76||
48490273|NCT01796171|101535894|FG011|STARTED|Treatment Period With Betalutin||28||
48490274|NCT01796171|101535895|FG012|STARTED|Treatment Period With Betalutin||9||
48490275|NCT01796171|101535896|FG013|STARTED|Treatment Period With Betalutin||0||
48490276|NCT01796171|101535897|FG014|STARTED|Treatment Period With Betalutin||0||
48490277|NCT01796171|101535883|FG000|COMPLETED|Treatment Period With Betalutin||4||
48490278|NCT01796171|101535884|FG001|COMPLETED|Treatment Period With Betalutin||35||
48490279|NCT01796171|101535885|FG002|COMPLETED|Treatment Period With Betalutin||3||
48490280|NCT01796171|101535886|FG003|COMPLETED|Treatment Period With Betalutin||1||
48490281|NCT01796171|101535887|FG004|COMPLETED|Treatment Period With Betalutin||2||
48490282|NCT01796171|101535888|FG005|COMPLETED|Treatment Period With Betalutin||3||
48490283|NCT01796171|101535889|FG006|COMPLETED|Treatment Period With Betalutin||3||
48490284|NCT01796171|101535890|FG007|COMPLETED|Treatment Period With Betalutin||18||
48490285|NCT01796171|101535891|FG008|COMPLETED|Treatment Period With Betalutin||3||
48490286|NCT01796171|101535892|FG009|COMPLETED|Treatment Period With Betalutin||0||
48490287|NCT01796171|101535893|FG010|COMPLETED|Treatment Period With Betalutin||65||
48490288|NCT01796171|101535894|FG011|COMPLETED|Treatment Period With Betalutin||25||
48490289|NCT01796171|101535895|FG012|COMPLETED|Treatment Period With Betalutin||8||
48490290|NCT01796171|101535896|FG013|COMPLETED|Treatment Period With Betalutin||0||
48490291|NCT01796171|101535897|FG014|COMPLETED|Treatment Period With Betalutin||0||
48490292|NCT01796171|101535883|FG000|NOT COMPLETED|Treatment Period With Betalutin||0||
48490293|NCT01796171|101535884|FG001|NOT COMPLETED|Treatment Period With Betalutin||1||
48490294|NCT01796171|101535885|FG002|NOT COMPLETED|Treatment Period With Betalutin||0||
48490295|NCT01796171|101535886|FG003|NOT COMPLETED|Treatment Period With Betalutin||0||
48490296|NCT01796171|101535887|FG004|NOT COMPLETED|Treatment Period With Betalutin||0||
48490297|NCT01796171|101535888|FG005|NOT COMPLETED|Treatment Period With Betalutin||0||
48490298|NCT01796171|101535889|FG006|NOT COMPLETED|Treatment Period With Betalutin||0||
48490299|NCT01796171|101535890|FG007|NOT COMPLETED|Treatment Period With Betalutin||0||
48490300|NCT01796171|101535891|FG008|NOT COMPLETED|Treatment Period With Betalutin||1||
48490301|NCT01796171|101535892|FG009|NOT COMPLETED|Treatment Period With Betalutin||0||
48490302|NCT01796171|101535893|FG010|NOT COMPLETED|Treatment Period With Betalutin||11||
48490303|NCT01796171|101535894|FG011|NOT COMPLETED|Treatment Period With Betalutin||3||
48490304|NCT01796171|101535895|FG012|NOT COMPLETED|Treatment Period With Betalutin||1||
48490305|NCT01796171|101535896|FG013|NOT COMPLETED|Treatment Period With Betalutin||0||
48490306|NCT01796171|101535897|FG014|NOT COMPLETED|Treatment Period With Betalutin||0||
48490307|NCT01796171|101535883|FG000|STARTED|Follow-up Period||4||
48490308|NCT01796171|101535884|FG001|STARTED|Follow-up Period||35||
48490309|NCT01796171|101535885|FG002|STARTED|Follow-up Period||3||
48490310|NCT01796171|101535886|FG003|STARTED|Follow-up Period||1||
48490311|NCT01796171|101535887|FG004|STARTED|Follow-up Period||2||
48490312|NCT01796171|101535888|FG005|STARTED|Follow-up Period||3||
48490313|NCT01796171|101535889|FG006|STARTED|Follow-up Period||3||
48490314|NCT01796171|101535890|FG007|STARTED|Follow-up Period||18||
48490315|NCT01796171|101535891|FG008|STARTED|Follow-up Period||3||
48200081|NCT00828672|100814461|FG000|NOT COMPLETED|Study Treatment||2||
48200082|NCT00828672|100814462|FG001|NOT COMPLETED|Study Treatment||2||
48200083|NCT00828672|100814461|FG000|STARTED|Post-surgery (<30 Days)||41||
48200084|NCT00828672|100814462|FG001|STARTED|Post-surgery (<30 Days)||39||
48490316|NCT01796171|101535892|FG009|STARTED|Follow-up Period||0||
48490317|NCT01796171|101535893|FG010|STARTED|Follow-up Period||65||
48490318|NCT01796171|101535894|FG011|STARTED|Follow-up Period||25||
48490319|NCT01796171|101535895|FG012|STARTED|Follow-up Period||8||
48490320|NCT01796171|101535896|FG013|STARTED|Follow-up Period||0||
48490321|NCT01796171|101535897|FG014|STARTED|Follow-up Period||0||
48490322|NCT01796171|101535883|FG000|COMPLETED|Follow-up Period||0||
48490323|NCT01796171|101535884|FG001|COMPLETED|Follow-up Period||5||
48200085|NCT00828672|100814461|FG000|COMPLETED|Post-surgery (<30 Days)||41||
48200086|NCT00828672|100814462|FG001|COMPLETED|Post-surgery (<30 Days)||38||
48200087|NCT00828672|100814461|FG000|NOT COMPLETED|Post-surgery (<30 Days)||0||
48200088|NCT00828672|100814462|FG001|NOT COMPLETED|Post-surgery (<30 Days)||1||
48200089|NCT00828672|100814461|FG000|STARTED|Follow-up||42|Pt with compl response\&no surgery and pts with no central review material and with AEs joined in FU|
48200090|NCT00828672|100814462|FG001|STARTED|Follow-up||41|Pt with compl response\&no surgery and pts with no central review material and with AEs joined in FU|
48490324|NCT01796171|101535885|FG002|COMPLETED|Follow-up Period||1||
48490325|NCT01796171|101535886|FG003|COMPLETED|Follow-up Period||0||
48490326|NCT01796171|101535887|FG004|COMPLETED|Follow-up Period||0||
48490327|NCT01796171|101535888|FG005|COMPLETED|Follow-up Period||0||
48490328|NCT01796171|101535889|FG006|COMPLETED|Follow-up Period||1||
48490329|NCT01796171|101535890|FG007|COMPLETED|Follow-up Period||0||
48490330|NCT01796171|101535891|FG008|COMPLETED|Follow-up Period||1||
48490331|NCT01796171|101535892|FG009|COMPLETED|Follow-up Period||0||
48490332|NCT01796171|101535893|FG010|COMPLETED|Follow-up Period||0||
48490333|NCT01796171|101535894|FG011|COMPLETED|Follow-up Period||0||
48490334|NCT01796171|101535895|FG012|COMPLETED|Follow-up Period||0||
48490335|NCT01796171|101535896|FG013|COMPLETED|Follow-up Period||0||
48490336|NCT01796171|101535897|FG014|COMPLETED|Follow-up Period||0||
48490337|NCT01796171|101535883|FG000|NOT COMPLETED|Follow-up Period||4||
48490338|NCT01796171|101535884|FG001|NOT COMPLETED|Follow-up Period||30||
48200091|NCT00828672|100814461|FG000|COMPLETED|Follow-up||42||
48200092|NCT00828672|100814462|FG001|COMPLETED|Follow-up||41||
48200093|NCT00828672|100814461|FG000|NOT COMPLETED|Follow-up||0||
48200094|NCT00828672|100814462|FG001|NOT COMPLETED|Follow-up||0||
48200095|NCT02770248|100814463|FG000|STARTED|Overall Study||62||
48200096|NCT02770248|100814464|FG001|STARTED|Overall Study||63||
48200097|NCT02770248|100814463|FG000|COMPLETED|Overall Study||62||
48200098|NCT02770248|100814464|FG001|COMPLETED|Overall Study||61||
48200099|NCT02770248|100814463|FG000|NOT COMPLETED|Overall Study||0||
48200100|NCT02770248|100814464|FG001|NOT COMPLETED|Overall Study||2||
48200101|NCT02555631|100814465|FG000|STARTED|Overall Study||29||
48200102|NCT02555631|100814465|FG000|COMPLETED|Overall Study||25||
48200103|NCT02555631|100814465|FG000|NOT COMPLETED|Overall Study||4||
48200104|NCT01616654|100814466|FG000|STARTED|Overall Study||61||
48490339|NCT01796171|101535885|FG002|NOT COMPLETED|Follow-up Period||2||
48490340|NCT01796171|101535886|FG003|NOT COMPLETED|Follow-up Period||1||
48490341|NCT01796171|101535887|FG004|NOT COMPLETED|Follow-up Period||2||
48490342|NCT01796171|101535888|FG005|NOT COMPLETED|Follow-up Period||3||
48490343|NCT01796171|101535889|FG006|NOT COMPLETED|Follow-up Period||2||
48490344|NCT01796171|101535890|FG007|NOT COMPLETED|Follow-up Period||18||
48200105|NCT01616654|100814467|FG001|STARTED|Overall Study||61||
48200106|NCT01616654|100814468|FG002|STARTED|Overall Study||60||
48200107|NCT01616654|100814469|FG003|STARTED|Overall Study||61||
48490345|NCT01796171|101535891|FG008|NOT COMPLETED|Follow-up Period||2||
48490346|NCT01796171|101535892|FG009|NOT COMPLETED|Follow-up Period||0||
48490347|NCT01796171|101535893|FG010|NOT COMPLETED|Follow-up Period||65||
48490348|NCT01796171|101535894|FG011|NOT COMPLETED|Follow-up Period||25||
48490349|NCT01796171|101535895|FG012|NOT COMPLETED|Follow-up Period||8||
48490350|NCT01796171|101535896|FG013|NOT COMPLETED|Follow-up Period||0||
48490351|NCT01796171|101535897|FG014|NOT COMPLETED|Follow-up Period||0||
48490352|NCT01249651|101535898|FG000|STARTED|Overall Study||101||
48200108|NCT01616654|100814470|FG004|STARTED|Overall Study||61||
48200109|NCT01616654|100814466|FG000|COMPLETED|Overall Study||56||
48200110|NCT01616654|100814467|FG001|COMPLETED|Overall Study||53||
48200111|NCT01616654|100814468|FG002|COMPLETED|Overall Study||50||
48490353|NCT01249651|101535898|FG000|COMPLETED|Overall Study||94||
48490354|NCT01249651|101535898|FG000|NOT COMPLETED|Overall Study||7||
48490355|NCT02822235|101535899|FG000|STARTED|Cross-sectional Phase (Day 1)||264||
48200112|NCT01616654|100814469|FG003|COMPLETED|Overall Study||53||
48200113|NCT01616654|100814470|FG004|COMPLETED|Overall Study||49||
48200114|NCT01616654|100814466|FG000|NOT COMPLETED|Overall Study||5||
48200115|NCT01616654|100814467|FG001|NOT COMPLETED|Overall Study||8||
48490356|NCT02822235|101535900|FG001|STARTED|Cross-sectional Phase (Day 1)||143||
48490357|NCT02822235|101535899|FG000|COMPLETED|Cross-sectional Phase (Day 1)||118|Participants with moderate to severe IBD at Day 1|
48490358|NCT02822235|101535900|FG001|COMPLETED|Cross-sectional Phase (Day 1)||36|Participants with moderate to severe IBD at Day 1|
48490359|NCT02822235|101535899|FG000|NOT COMPLETED|Cross-sectional Phase (Day 1)||146||
48490360|NCT02822235|101535900|FG001|NOT COMPLETED|Cross-sectional Phase (Day 1)||107||
48490361|NCT02822235|101535899|FG000|STARTED|Prospective Phase (Day 1 up to Month 12)||118||
48490362|NCT02822235|101535900|FG001|STARTED|Prospective Phase (Day 1 up to Month 12)||36||
48490363|NCT02822235|101535899|FG000|COMPLETED|Prospective Phase (Day 1 up to Month 12)||107||
48200116|NCT01616654|100814468|FG002|NOT COMPLETED|Overall Study||10||
48490364|NCT02822235|101535900|FG001|COMPLETED|Prospective Phase (Day 1 up to Month 12)||34||
48490365|NCT02822235|101535899|FG000|NOT COMPLETED|Prospective Phase (Day 1 up to Month 12)||11||
48490366|NCT02822235|101535900|FG001|NOT COMPLETED|Prospective Phase (Day 1 up to Month 12)||2||
48490367|NCT01919112|101535901|FG000|STARTED|Primary Analysis-day 5 of Intervention||14||
48490368|NCT01919112|101535902|FG001|STARTED|Primary Analysis-day 5 of Intervention||13||
48200117|NCT01616654|100814469|FG003|NOT COMPLETED|Overall Study||8||
48200118|NCT01616654|100814470|FG004|NOT COMPLETED|Overall Study||12||
48200119|NCT05565391|100814471|FG000|STARTED|Overall Study||123||
48200120|NCT05565391|100814472|FG001|STARTED|Overall Study||233||
48200121|NCT05565391|100814473|FG002|STARTED|Overall Study||152||
48200122|NCT05565391|100814471|FG000|COMPLETED|Overall Study||123||
48200123|NCT05565391|100814472|FG001|COMPLETED|Overall Study||233||
48200124|NCT05565391|100814473|FG002|COMPLETED|Overall Study||152||
48200125|NCT05565391|100814471|FG000|NOT COMPLETED|Overall Study||0||
48200126|NCT05565391|100814472|FG001|NOT COMPLETED|Overall Study||0||
48490369|NCT01919112|101535903|FG002|STARTED|Primary Analysis-day 5 of Intervention||15||
48490370|NCT01919112|101535901|FG000|COMPLETED|Primary Analysis-day 5 of Intervention||14||
48490371|NCT01919112|101535902|FG001|COMPLETED|Primary Analysis-day 5 of Intervention||13||
48490372|NCT01919112|101535903|FG002|COMPLETED|Primary Analysis-day 5 of Intervention||15||
48490373|NCT01919112|101535901|FG000|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0||
48490374|NCT01919112|101535902|FG001|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0||
48490375|NCT01919112|101535903|FG002|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0||
48490376|NCT01919112|101535901|FG000|STARTED|Secondary Analysis-day 30||14||
48490377|NCT01919112|101535902|FG001|STARTED|Secondary Analysis-day 30||13||
48490378|NCT01919112|101535903|FG002|STARTED|Secondary Analysis-day 30||15||
48490379|NCT01919112|101535901|FG000|COMPLETED|Secondary Analysis-day 30||12||
48490380|NCT01919112|101535902|FG001|COMPLETED|Secondary Analysis-day 30||12||
48490381|NCT01919112|101535903|FG002|COMPLETED|Secondary Analysis-day 30||14||
48490382|NCT01919112|101535901|FG000|NOT COMPLETED|Secondary Analysis-day 30||2||
48490383|NCT01919112|101535902|FG001|NOT COMPLETED|Secondary Analysis-day 30||1||
48490384|NCT01919112|101535903|FG002|NOT COMPLETED|Secondary Analysis-day 30||1||
48490385|NCT00682461|101535904|FG000|STARTED|Overall Study||100||
48490386|NCT00682461|101535905|FG001|STARTED|Overall Study||100||
48490387|NCT00682461|101535904|FG000|COMPLETED|Overall Study||75||
48490388|NCT00682461|101535905|FG001|COMPLETED|Overall Study||69||
48490389|NCT00682461|101535904|FG000|NOT COMPLETED|Overall Study||25||
48490390|NCT00682461|101535905|FG001|NOT COMPLETED|Overall Study||31||
48490391|NCT02517294|101535906|FG000|STARTED|Overall Study||38||
48490392|NCT02517294|101535907|FG001|STARTED|Overall Study||35||
48490393|NCT02517294|101535906|FG000|COMPLETED|Overall Study||38||
48200127|NCT05565391|100814473|FG002|NOT COMPLETED|Overall Study||0||
48200128|NCT02639429|100814474|FG000|STARTED|Overall Study||113||
48200129|NCT02639429|100814475|FG001|STARTED|Overall Study||123||
48200130|NCT02639429|100814474|FG000|COMPLETED|Overall Study||113||
48490394|NCT02517294|101535907|FG001|COMPLETED|Overall Study||35||
48490395|NCT02517294|101535906|FG000|NOT COMPLETED|Overall Study||0||
48490396|NCT02517294|101535907|FG001|NOT COMPLETED|Overall Study||0||
48200131|NCT02639429|100814475|FG001|COMPLETED|Overall Study||123||
48200132|NCT02639429|100814474|FG000|NOT COMPLETED|Overall Study||0||
48200133|NCT02639429|100814475|FG001|NOT COMPLETED|Overall Study||0||
48200134|NCT01524536|100814476|FG000|STARTED|Overall Study||23||
48200135|NCT01524536|100814476|FG000|COMPLETED|Overall Study||23||
48200136|NCT01524536|100814476|FG000|NOT COMPLETED|Overall Study||0||
48200137|NCT02385669|100814477|FG000|STARTED|Overall Study||3||
48200138|NCT02385669|100814477|FG000|COMPLETED|Overall Study||1|Closed early due to slow enrollment.|
48200139|NCT02385669|100814477|FG000|NOT COMPLETED|Overall Study||2||
48200140|NCT00531518|100814478|FG000|STARTED|Overall Study||87||
48200141|NCT00531518|100814479|FG001|STARTED|Overall Study||205||
48200142|NCT00531518|100814478|FG000|COMPLETED|Overall Study||55||
48200143|NCT00531518|100814479|FG001|COMPLETED|Overall Study||134||
48200144|NCT00531518|100814478|FG000|NOT COMPLETED|Overall Study||32||
48490397|NCT00571064|101535908|FG000|STARTED|Overall Study||97||
48490398|NCT00571064|101535908|FG000|COMPLETED|Overall Study||76||
48490399|NCT00571064|101535908|FG000|NOT COMPLETED|Overall Study||21||
48490400|NCT01547286|101535909|FG000|STARTED|Overall Study||7||
48490401|NCT01547286|101535909|FG000|COMPLETED|Overall Study||5||
48490402|NCT01547286|101535909|FG000|NOT COMPLETED|Overall Study||2||
48490403|NCT00840216|101535910|FG000|STARTED|First Intervention||11||
48490404|NCT00840216|101535911|FG001|STARTED|First Intervention||11||
48490405|NCT00840216|101535910|FG000|COMPLETED|First Intervention||11||
48490406|NCT00840216|101535911|FG001|COMPLETED|First Intervention||11||
48490407|NCT00840216|101535910|FG000|NOT COMPLETED|First Intervention||0||
48490408|NCT00840216|101535911|FG001|NOT COMPLETED|First Intervention||0||
48490409|NCT00840216|101535910|FG000|STARTED|Washout: 7 Days||11||
48490410|NCT00840216|101535911|FG001|STARTED|Washout: 7 Days||11||
48490411|NCT00840216|101535910|FG000|COMPLETED|Washout: 7 Days||10||
48490412|NCT00840216|101535911|FG001|COMPLETED|Washout: 7 Days||11||
48490413|NCT00840216|101535910|FG000|NOT COMPLETED|Washout: 7 Days||1||
48490414|NCT00840216|101535911|FG001|NOT COMPLETED|Washout: 7 Days||0||
48490415|NCT00840216|101535910|FG000|STARTED|Second Intervention||10||
48490416|NCT00840216|101535911|FG001|STARTED|Second Intervention||11||
48490417|NCT00840216|101535910|FG000|COMPLETED|Second Intervention||10||
48490418|NCT00840216|101535911|FG001|COMPLETED|Second Intervention||11||
48490419|NCT00840216|101535910|FG000|NOT COMPLETED|Second Intervention||0||
48490420|NCT00840216|101535911|FG001|NOT COMPLETED|Second Intervention||0||
48490421|NCT00418145|101535912|FG000|STARTED|Overall Study||16||
48200145|NCT00531518|100814479|FG001|NOT COMPLETED|Overall Study||71||
48200146|NCT04588480|100814480|FG000|STARTED|Blinded Phase: Up to 6 Months||119||
48490422|NCT00418145|101535912|FG000|COMPLETED|Overall Study||10||
48490423|NCT00418145|101535912|FG000|NOT COMPLETED|Overall Study||6||
48490424|NCT02300103|101535913|FG000|STARTED|Overall Study||69||
48490425|NCT02300103|101535913|FG000|COMPLETED|Overall Study||63||
48490426|NCT02300103|101535913|FG000|NOT COMPLETED|Overall Study||6||
48490427|NCT01855750|101535914|FG000|STARTED|Overall Study||419||
48490428|NCT01855750|101535915|FG001|STARTED|Overall Study||419||
48490429|NCT01855750|101535914|FG000|Treated|Overall Study||416||
48490430|NCT01855750|101535915|FG001|Treated|Overall Study||418||
48490431|NCT01855750|101535914|FG000|COMPLETED|Overall Study||0||
48490432|NCT01855750|101535915|FG001|COMPLETED|Overall Study||0||
48490433|NCT01855750|101535914|FG000|NOT COMPLETED|Overall Study||419||
48490434|NCT01855750|101535915|FG001|NOT COMPLETED|Overall Study||419||
48490435|NCT02576938|101535916|FG000|STARTED|Overall Study||49||
48490436|NCT02576938|101535917|FG001|STARTED|Overall Study||37||
48490437|NCT02576938|101535918|FG002|STARTED|Overall Study||38||
48490438|NCT02576938|101535916|FG000|Received at Least One Dose of Study Drug|Overall Study||49||
48490439|NCT02576938|101535917|FG001|Received at Least One Dose of Study Drug|Overall Study||37||
48490440|NCT02576938|101535918|FG002|Received at Least One Dose of Study Drug|Overall Study||38||
48490441|NCT02576938|101535916|FG000|COMPLETED|Overall Study||29||
48490442|NCT02576938|101535917|FG001|COMPLETED|Overall Study||25||
48490443|NCT02576938|101535918|FG002|COMPLETED|Overall Study||26||
48490444|NCT02576938|101535916|FG000|NOT COMPLETED|Overall Study||20||
48490445|NCT02576938|101535917|FG001|NOT COMPLETED|Overall Study||12||
48200147|NCT04588480|100814481|FG001|STARTED|Blinded Phase: Up to 6 Months||41||
48200148|NCT04588480|100814482|FG002|STARTED|Blinded Phase: Up to 6 Months||0||
48200149|NCT04588480|100814480|FG000|COMPLETED|Blinded Phase: Up to 6 Months||119||
48200150|NCT04588480|100814481|FG001|COMPLETED|Blinded Phase: Up to 6 Months||41||
48200151|NCT04588480|100814482|FG002|COMPLETED|Blinded Phase: Up to 6 Months||0||
48200152|NCT04588480|100814480|FG000|NOT COMPLETED|Blinded Phase: Up to 6 Months||0||
48200153|NCT04588480|100814481|FG001|NOT COMPLETED|Blinded Phase: Up to 6 Months||0||
48200154|NCT04588480|100814482|FG002|NOT COMPLETED|Blinded Phase: Up to 6 Months||0||
48200155|NCT04588480|100814480|FG000|STARTED|Unblinded Phase: From 6 to 12 Months||119||
48200156|NCT04588480|100814481|FG001|STARTED|Unblinded Phase: From 6 to 12 Months||6||
48200157|NCT04588480|100814482|FG002|STARTED|Unblinded Phase: From 6 to 12 Months||35||
48200158|NCT04588480|100814480|FG000|COMPLETED|Unblinded Phase: From 6 to 12 Months||117||
48200159|NCT04588480|100814481|FG001|COMPLETED|Unblinded Phase: From 6 to 12 Months||3||
48200160|NCT04588480|100814482|FG002|COMPLETED|Unblinded Phase: From 6 to 12 Months||35||
48200161|NCT04588480|100814480|FG000|NOT COMPLETED|Unblinded Phase: From 6 to 12 Months||2||
48200162|NCT04588480|100814481|FG001|NOT COMPLETED|Unblinded Phase: From 6 to 12 Months||3||
48200163|NCT04588480|100814482|FG002|NOT COMPLETED|Unblinded Phase: From 6 to 12 Months||0||
48200164|NCT00324038|100814483|FG000|STARTED|Overall Study||110||
48200165|NCT00324038|100814484|FG001|STARTED|Overall Study||109||
48200166|NCT00324038|100814483|FG000|COMPLETED|Overall Study||61||
48200167|NCT00324038|100814484|FG001|COMPLETED|Overall Study||58||
48200168|NCT00324038|100814483|FG000|NOT COMPLETED|Overall Study||49||
48200169|NCT00324038|100814484|FG001|NOT COMPLETED|Overall Study||51||
48200170|NCT01651949|100814485|FG000|STARTED|Overall Study||1106||
48200171|NCT01651949|100814486|FG001|STARTED|Overall Study||1101||
48200172|NCT01651949|100814487|FG002|STARTED|Overall Study||313||
48200173|NCT01651949|100814485|FG000|Vaccination 1|Overall Study||1103||
48200174|NCT01651949|100814486|FG001|Vaccination 1|Overall Study||1099||
48200175|NCT01651949|100814487|FG002|Vaccination 1|Overall Study||313||
48200176|NCT01651949|100814485|FG000|Vaccination 2|Overall Study||1089||
48490446|NCT02576938|101535918|FG002|NOT COMPLETED|Overall Study||12||
48490447|NCT00745420|101535919|FG000|STARTED|Overall Study||30||
48490448|NCT00745420|101535919|FG000|COMPLETED|Overall Study||29||
48490449|NCT00745420|101535919|FG000|NOT COMPLETED|Overall Study||1||
48490450|NCT04306952|101535920|FG000|STARTED|Overall Study||20||
48490451|NCT04306952|101535921|FG001|STARTED|Overall Study||20||
48200177|NCT01651949|100814486|FG001|Vaccination 2|Overall Study||1069||
48200178|NCT01651949|100814487|FG002|Vaccination 2|Overall Study||298||
48200179|NCT01651949|100814485|FG000|Vaccination 3|Overall Study||1067||
48200180|NCT01651949|100814486|FG001|Vaccination 3|Overall Study||1037||
48490452|NCT04306952|101535922|FG002|STARTED|Overall Study||20||
48490453|NCT04306952|101535920|FG000|COMPLETED|Overall Study||20||
48490454|NCT04306952|101535921|FG001|COMPLETED|Overall Study||16||
48490455|NCT04306952|101535922|FG002|COMPLETED|Overall Study||19||
48490456|NCT04306952|101535920|FG000|NOT COMPLETED|Overall Study||0||
48490457|NCT04306952|101535921|FG001|NOT COMPLETED|Overall Study||4||
48490458|NCT04306952|101535922|FG002|NOT COMPLETED|Overall Study||1||
48490459|NCT03679598|101535923|FG000|STARTED|Overall Study||32||
48490460|NCT03679598|101535924|FG001|STARTED|Overall Study||31||
48490461|NCT03679598|101535923|FG000|COMPLETED|Overall Study||30||
48490462|NCT03679598|101535924|FG001|COMPLETED|Overall Study||31||
48490463|NCT03679598|101535923|FG000|NOT COMPLETED|Overall Study||2||
48490464|NCT03679598|101535924|FG001|NOT COMPLETED|Overall Study||0||
48490465|NCT04198363|101535925|FG000|STARTED|Overall Study||256||
48490466|NCT04198363|101535926|FG001|STARTED|Overall Study||254||
48490467|NCT04198363|101535925|FG000|COMPLETED|Overall Study||254||
48490468|NCT04198363|101535926|FG001|COMPLETED|Overall Study||252||
48490469|NCT04198363|101535925|FG000|NOT COMPLETED|Overall Study||2||
48490470|NCT04198363|101535926|FG001|NOT COMPLETED|Overall Study||2||
48490471|NCT02757105|101535927|FG000|STARTED|Overall Study||75||
48490472|NCT02757105|101535928|FG001|STARTED|Overall Study||52||
48490473|NCT02757105|101535927|FG000|Treated|Overall Study||75|1 patient in the placebo group was randomized and not treated.|
48490474|NCT02757105|101535928|FG001|Treated|Overall Study||51|1 patient in the placebo group was randomized and not treated.|
48490475|NCT02757105|101535927|FG000|COMPLETED|Overall Study||63|At least 7.6 weeks of treatment \& end of study visit 28 +/- 11 days after last intake of study drug.|
48490476|NCT02757105|101535928|FG001|COMPLETED|Overall Study||41|At least 7.6 weeks of treatment \& end of study visit 28 +/- 11 days after last intake of study drug.|
48490477|NCT02757105|101535927|FG000|NOT COMPLETED|Overall Study||12||
48490478|NCT02757105|101535928|FG001|NOT COMPLETED|Overall Study||11||
48490479|NCT03107091|101535929|FG000|STARTED|Overall Study||6||
48490480|NCT03107091|101535929|FG000|COMPLETED|Overall Study||5||
48490481|NCT03107091|101535929|FG000|NOT COMPLETED|Overall Study||1||
48490482|NCT02378935|101535930|FG000|STARTED|Overall Study||34||
48490483|NCT02378935|101535931|FG001|STARTED|Overall Study||36||
48490484|NCT02378935|101535932|FG002|STARTED|Overall Study||33||
48490485|NCT02378935|101535933|FG003|STARTED|Overall Study||31||
48490486|NCT02378935|101535934|FG004|STARTED|Overall Study||31||
48490487|NCT02378935|101535935|FG005|STARTED|Overall Study||32||
48490488|NCT02378935|101535936|FG006|STARTED|Overall Study||8||
48490489|NCT02378935|101535930|FG000|COMPLETED|Overall Study||24||
48490490|NCT02378935|101535931|FG001|COMPLETED|Overall Study||36||
48490491|NCT02378935|101535932|FG002|COMPLETED|Overall Study||30||
48490492|NCT02378935|101535933|FG003|COMPLETED|Overall Study||25||
48490493|NCT02378935|101535934|FG004|COMPLETED|Overall Study||31||
48490494|NCT02378935|101535935|FG005|COMPLETED|Overall Study||32||
48490495|NCT02378935|101535936|FG006|COMPLETED|Overall Study||8||
48490496|NCT02378935|101535930|FG000|NOT COMPLETED|Overall Study||10||
48490497|NCT02378935|101535931|FG001|NOT COMPLETED|Overall Study||0||
48490498|NCT02378935|101535932|FG002|NOT COMPLETED|Overall Study||3||
48490499|NCT02378935|101535933|FG003|NOT COMPLETED|Overall Study||6||
48490500|NCT02378935|101535934|FG004|NOT COMPLETED|Overall Study||0||
48490501|NCT02378935|101535935|FG005|NOT COMPLETED|Overall Study||0||
48490502|NCT02378935|101535936|FG006|NOT COMPLETED|Overall Study||0||
48490503|NCT00835991|101535937|FG000|STARTED|First Intervention||30||
48490504|NCT00835991|101535938|FG001|STARTED|First Intervention||30||
48490505|NCT00835991|101535937|FG000|COMPLETED|First Intervention||30||
48490506|NCT00835991|101535938|FG001|COMPLETED|First Intervention||29||
48490507|NCT00835991|101535937|FG000|NOT COMPLETED|First Intervention||0||
48490508|NCT00835991|101535938|FG001|NOT COMPLETED|First Intervention||1||
48490509|NCT00835991|101535937|FG000|STARTED|Washout||30||
48490510|NCT00835991|101535938|FG001|STARTED|Washout||29||
48490511|NCT00835991|101535937|FG000|COMPLETED|Washout||27||
48490512|NCT00835991|101535938|FG001|COMPLETED|Washout||26||
48490513|NCT00835991|101535937|FG000|NOT COMPLETED|Washout||3||
48490514|NCT00835991|101535938|FG001|NOT COMPLETED|Washout||3||
48490515|NCT00835991|101535937|FG000|STARTED|Second Intervention||27||
48490516|NCT00835991|101535938|FG001|STARTED|Second Intervention||26||
48490517|NCT00835991|101535937|FG000|COMPLETED|Second Intervention||27||
48490518|NCT00835991|101535938|FG001|COMPLETED|Second Intervention||26||
48490519|NCT00835991|101535937|FG000|NOT COMPLETED|Second Intervention||0||
48490520|NCT00835991|101535938|FG001|NOT COMPLETED|Second Intervention||0||
48490521|NCT01838681|101535939|FG000|STARTED|Period A||1986||
48490522|NCT01838681|101535940|FG001|STARTED|Period A||0||
48490523|NCT01838681|101535941|FG002|STARTED|Period A||0||
48490524|NCT01838681|101535942|FG003|STARTED|Period A||0||
48490525|NCT01838681|101535939|FG000|COMPLETED|Period A||1661||
48490526|NCT01838681|101535940|FG001|COMPLETED|Period A||0||
48490527|NCT01838681|101535941|FG002|COMPLETED|Period A||0||
48490528|NCT01838681|101535942|FG003|COMPLETED|Period A||0||
48490529|NCT01838681|101535939|FG000|NOT COMPLETED|Period A||325||
48490530|NCT01838681|101535940|FG001|NOT COMPLETED|Period A||0||
48490531|NCT01838681|101535941|FG002|NOT COMPLETED|Period A||0||
48490532|NCT01838681|101535942|FG003|NOT COMPLETED|Period A||0||
48490533|NCT01838681|101535939|FG000|STARTED|Period B/A+||0||
48490534|NCT01838681|101535940|FG001|STARTED|Period B/A+||442||
48490535|NCT01838681|101535941|FG002|STARTED|Period B/A+||444||
48490536|NCT01838681|101535942|FG003|STARTED|Period B/A+||770||
48490537|NCT01838681|101535939|FG000|COMPLETED|Period B/A+||0||
48490538|NCT01838681|101535940|FG001|COMPLETED|Period B/A+||380||
48490539|NCT01838681|101535941|FG002|COMPLETED|Period B/A+||349||
48490540|NCT01838681|101535942|FG003|COMPLETED|Period B/A+||653||
48490541|NCT01838681|101535939|FG000|NOT COMPLETED|Period B/A+||0||
48490542|NCT01838681|101535940|FG001|NOT COMPLETED|Period B/A+||62||
48490543|NCT01838681|101535941|FG002|NOT COMPLETED|Period B/A+||95||
48490544|NCT01838681|101535942|FG003|NOT COMPLETED|Period B/A+||117||
48490545|NCT02440711|101535943|FG000|STARTED|First Intervention||16||
48490546|NCT02440711|101535944|FG001|STARTED|First Intervention||20||
48490547|NCT02440711|101535943|FG000|Unilateral Amputation|First Intervention||14||
48490548|NCT02440711|101535944|FG001|Unilateral Amputation|First Intervention||17||
48490549|NCT02440711|101535943|FG000|Bilateral Amputation|First Intervention||2||
48490550|NCT02440711|101535944|FG001|Bilateral Amputation|First Intervention||3||
48490551|NCT02440711|101535943|FG000|COMPLETED|First Intervention||16||
48490552|NCT02440711|101535944|FG001|COMPLETED|First Intervention||20||
48490553|NCT02440711|101535943|FG000|NOT COMPLETED|First Intervention||0||
48490554|NCT02440711|101535944|FG001|NOT COMPLETED|First Intervention||0||
48490555|NCT02440711|101535943|FG000|STARTED|Second Intervention||16||
48490556|NCT02440711|101535944|FG001|STARTED|Second Intervention||20||
48490557|NCT02440711|101535943|FG000|Unilateral Amputation|Second Intervention||14||
48490558|NCT02440711|101535944|FG001|Unilateral Amputation|Second Intervention||17||
48490559|NCT02440711|101535943|FG000|Bilateral Amputation|Second Intervention||2||
48490560|NCT02440711|101535944|FG001|Bilateral Amputation|Second Intervention||3||
48490561|NCT02440711|101535943|FG000|COMPLETED|Second Intervention||15||
48490562|NCT02440711|101535944|FG001|COMPLETED|Second Intervention||20||
48490563|NCT02440711|101535943|FG000|NOT COMPLETED|Second Intervention||1||
48490564|NCT02440711|101535944|FG001|NOT COMPLETED|Second Intervention||0||
48490565|NCT03867838|101535945|FG000|STARTED|Overall Study||6||
48490566|NCT03867838|101535945|FG000|COMPLETED|Overall Study||6||
48490567|NCT03867838|101535945|FG000|NOT COMPLETED|Overall Study||0||
48490568|NCT00085293|101535946|FG000|STARTED|Overall Study||12||
48490569|NCT00085293|101535946|FG000|COMPLETED|Overall Study||12||
48490570|NCT00085293|101535946|FG000|NOT COMPLETED|Overall Study||0||
48490571|NCT03707587|101535947|FG000|STARTED|Overall Study||7||
48490572|NCT03707587|101535948|FG001|STARTED|Overall Study||2||
48490573|NCT03707587|101535947|FG000|COMPLETED|Overall Study||7||
48490574|NCT03707587|101535948|FG001|COMPLETED|Overall Study||1||
48490575|NCT03707587|101535947|FG000|NOT COMPLETED|Overall Study||0||
48490576|NCT03707587|101535948|FG001|NOT COMPLETED|Overall Study||1||
48490577|NCT02057835|101535949|FG000|STARTED|Overall Study||8||
48490578|NCT02057835|101535950|FG001|STARTED|Overall Study||6||
48490579|NCT02057835|101535951|FG002|STARTED|Overall Study||6||
48490580|NCT02057835|101535952|FG003|STARTED|Overall Study||6||
48490581|NCT02057835|101535953|FG004|STARTED|Overall Study||6||
48490582|NCT02057835|101535954|FG005|STARTED|Overall Study||8||
48490583|NCT02057835|101535955|FG006|STARTED|Overall Study||6||
48490584|NCT02057835|101535956|FG007|STARTED|Overall Study||6||
48490585|NCT02057835|101535957|FG008|STARTED|Overall Study||6||
48490586|NCT02057835|101535958|FG009|STARTED|Overall Study||6||
48490587|NCT02057835|101535949|FG000|COMPLETED|Overall Study||8||
48490588|NCT02057835|101535950|FG001|COMPLETED|Overall Study||4||
48490589|NCT02057835|101535951|FG002|COMPLETED|Overall Study||6||
48490590|NCT02057835|101535952|FG003|COMPLETED|Overall Study||6||
48490591|NCT02057835|101535953|FG004|COMPLETED|Overall Study||6||
48490592|NCT02057835|101535954|FG005|COMPLETED|Overall Study||8||
48490593|NCT02057835|101535955|FG006|COMPLETED|Overall Study||6||
48490594|NCT02057835|101535956|FG007|COMPLETED|Overall Study||6||
48490595|NCT02057835|101535957|FG008|COMPLETED|Overall Study||6||
48490596|NCT02057835|101535958|FG009|COMPLETED|Overall Study||6||
48490597|NCT02057835|101535949|FG000|NOT COMPLETED|Overall Study||0||
48490598|NCT02057835|101535950|FG001|NOT COMPLETED|Overall Study||2||
48490599|NCT02057835|101535951|FG002|NOT COMPLETED|Overall Study||0||
48490600|NCT02057835|101535952|FG003|NOT COMPLETED|Overall Study||0||
48490601|NCT02057835|101535953|FG004|NOT COMPLETED|Overall Study||0||
48490602|NCT02057835|101535954|FG005|NOT COMPLETED|Overall Study||0||
48490603|NCT02057835|101535955|FG006|NOT COMPLETED|Overall Study||0||
48490604|NCT02057835|101535956|FG007|NOT COMPLETED|Overall Study||0||
48490605|NCT02057835|101535957|FG008|NOT COMPLETED|Overall Study||0||
48490606|NCT02057835|101535958|FG009|NOT COMPLETED|Overall Study||0||
48490607|NCT05439252|101535959|FG000|STARTED|Overall Study||21||
48490608|NCT05439252|101535959|FG000|COMPLETED|Overall Study||18||
48490609|NCT05439252|101535959|FG000|NOT COMPLETED|Overall Study||3||
48490610|NCT01631552|101535960|FG000|STARTED|Overall Study||83||
48490611|NCT01631552|101535961|FG001|STARTED|Overall Study||420||
48490612|NCT01631552|101535962|FG002|STARTED|Overall Study||9||
48490613|NCT01631552|101535963|FG003|STARTED|Overall Study||3||
48490614|NCT01631552|101535960|FG000|Enrolled and Treated|Overall Study||81||
48490615|NCT01631552|101535961|FG001|Enrolled and Treated|Overall Study||402||
48490616|NCT01631552|101535962|FG002|Enrolled and Treated|Overall Study||9||
48490617|NCT01631552|101535963|FG003|Enrolled and Treated|Overall Study||3||
48490618|NCT01631552|101535960|FG000|COMPLETED|Overall Study||81||
48490619|NCT01631552|101535961|FG001|COMPLETED|Overall Study||400||
48490620|NCT01631552|101535962|FG002|COMPLETED|Overall Study||9||
48490621|NCT01631552|101535963|FG003|COMPLETED|Overall Study||3||
48490622|NCT01631552|101535960|FG000|NOT COMPLETED|Overall Study||2||
48490623|NCT01631552|101535961|FG001|NOT COMPLETED|Overall Study||20||
48490624|NCT01631552|101535962|FG002|NOT COMPLETED|Overall Study||0||
48200181|NCT01651949|100814487|FG002|Vaccination 3|Overall Study||291||
48200182|NCT01651949|100814485|FG000|COMPLETED|Overall Study||1053||
48200183|NCT01651949|100814486|FG001|COMPLETED|Overall Study||1015||
48490625|NCT01631552|101535963|FG003|NOT COMPLETED|Overall Study||0||
48490626|NCT03502148|101535964|FG000|STARTED|Overall Study||10||
48490627|NCT03502148|101535964|FG000|COMPLETED|Overall Study||10||
48490628|NCT03502148|101535964|FG000|NOT COMPLETED|Overall Study||0||
48490629|NCT01104025|101535965|FG000|STARTED|Treatment Period||31||
48490630|NCT01104025|101535965|FG000|COMPLETED|Treatment Period||25||
48490631|NCT01104025|101535965|FG000|NOT COMPLETED|Treatment Period||6||
48490632|NCT01104025|101535965|FG000|STARTED|Follow up Until BMT OR 6 Months||25||
48490633|NCT01104025|101535965|FG000|COMPLETED|Follow up Until BMT OR 6 Months||22||
48490634|NCT01104025|101535965|FG000|NOT COMPLETED|Follow up Until BMT OR 6 Months||3||
48490635|NCT01104025|101535965|FG000|STARTED|Follow up Until Day 100 Post BMT||11||
48490636|NCT01104025|101535965|FG000|COMPLETED|Follow up Until Day 100 Post BMT||9||
48490637|NCT01104025|101535965|FG000|NOT COMPLETED|Follow up Until Day 100 Post BMT||2||
48490638|NCT00270634|101535966|FG000|STARTED|Overall Study||87||
48490639|NCT00270634|101535967|FG001|STARTED|Overall Study||77||
48490640|NCT00270634|101535968|FG002|STARTED|Overall Study||84||
48490641|NCT00270634|101535969|FG003|STARTED|Overall Study||86||
48490642|NCT00270634|101535966|FG000|COMPLETED|Overall Study||70||
48490643|NCT00270634|101535967|FG001|COMPLETED|Overall Study||64||
48490644|NCT00270634|101535968|FG002|COMPLETED|Overall Study||62||
48490645|NCT00270634|101535969|FG003|COMPLETED|Overall Study||81||
48490646|NCT00270634|101535966|FG000|NOT COMPLETED|Overall Study||17||
48490647|NCT00270634|101535967|FG001|NOT COMPLETED|Overall Study||13||
48490648|NCT00270634|101535968|FG002|NOT COMPLETED|Overall Study||22||
48490649|NCT00270634|101535969|FG003|NOT COMPLETED|Overall Study||5||
48200184|NCT01651949|100814487|FG002|COMPLETED|Overall Study||282||
48200185|NCT01651949|100814485|FG000|NOT COMPLETED|Overall Study||53||
48490650|NCT00629122|101535970|FG000|STARTED|First Period: Day 1- 3 (Sublingual)||2||
48490651|NCT00629122|101535971|FG001|STARTED|First Period: Day 1- 3 (Sublingual)||3||
48490652|NCT00629122|101535970|FG000|COMPLETED|First Period: Day 1- 3 (Sublingual)||2||
48490653|NCT00629122|101535971|FG001|COMPLETED|First Period: Day 1- 3 (Sublingual)||3||
48200186|NCT01651949|100814486|FG001|NOT COMPLETED|Overall Study||86||
48490654|NCT00629122|101535970|FG000|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0||
48490655|NCT00629122|101535971|FG001|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0||
48490656|NCT00629122|101535970|FG000|STARTED|Second Period: Day 3-5 (Washout)||2||
48200187|NCT01651949|100814487|FG002|NOT COMPLETED|Overall Study||31||
48200188|NCT00606580|100814488|FG000|STARTED|Overall Study||125||
48200189|NCT00606580|100814489|FG001|STARTED|Overall Study||125||
48490657|NCT00629122|101535971|FG001|STARTED|Second Period: Day 3-5 (Washout)||3||
48490658|NCT00629122|101535970|FG000|COMPLETED|Second Period: Day 3-5 (Washout)||2||
48490659|NCT00629122|101535971|FG001|COMPLETED|Second Period: Day 3-5 (Washout)||3||
48490660|NCT00629122|101535970|FG000|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0||
48490661|NCT00629122|101535971|FG001|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0||
48490662|NCT00629122|101535970|FG000|STARTED|Third Period: Day 6-8 (Oral)||2||
48490663|NCT00629122|101535971|FG001|STARTED|Third Period: Day 6-8 (Oral)||3||
48490664|NCT00629122|101535970|FG000|COMPLETED|Third Period: Day 6-8 (Oral)||2||
48490665|NCT00629122|101535971|FG001|COMPLETED|Third Period: Day 6-8 (Oral)||3||
48490666|NCT00629122|101535970|FG000|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0||
48490667|NCT00629122|101535971|FG001|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0||
48490668|NCT05178927|101535972|FG000|STARTED|First Intervention (Treatments 1-5)||13||
48490669|NCT05178927|101535973|FG001|STARTED|First Intervention (Treatments 1-5)||14||
48490670|NCT05178927|101535972|FG000|COMPLETED|First Intervention (Treatments 1-5)||8||
48490671|NCT05178927|101535973|FG001|COMPLETED|First Intervention (Treatments 1-5)||12||
48490672|NCT05178927|101535972|FG000|NOT COMPLETED|First Intervention (Treatments 1-5)||5||
48490673|NCT05178927|101535973|FG001|NOT COMPLETED|First Intervention (Treatments 1-5)||2||
48490674|NCT05178927|101535972|FG000|STARTED|Second Intervention (Treatments 6-10)||8||
48490675|NCT05178927|101535973|FG001|STARTED|Second Intervention (Treatments 6-10)||12||
48490676|NCT05178927|101535972|FG000|COMPLETED|Second Intervention (Treatments 6-10)||8||
48200190|NCT00606580|100814490|FG002|STARTED|Overall Study||125||
48200191|NCT00606580|100814488|FG000|COMPLETED|Overall Study||123||
48200192|NCT00606580|100814489|FG001|COMPLETED|Overall Study||122||
48200193|NCT00606580|100814490|FG002|COMPLETED|Overall Study||103||
48200194|NCT00606580|100814488|FG000|NOT COMPLETED|Overall Study||2||
48200195|NCT00606580|100814489|FG001|NOT COMPLETED|Overall Study||3||
48200196|NCT00606580|100814490|FG002|NOT COMPLETED|Overall Study||22||
48200197|NCT01137292|100814491|FG000|STARTED|Overall Study||177||
48200198|NCT01137292|100814491|FG000|COMPLETED|Overall Study||123||
48200199|NCT01137292|100814491|FG000|NOT COMPLETED|Overall Study||54||
48200200|NCT00344019|100814492|FG000|STARTED|Overall Study||12||
48200201|NCT00344019|100814493|FG001|STARTED|Overall Study||11||
48200202|NCT00344019|100814494|FG002|STARTED|Overall Study||74||
48200203|NCT00344019|100814492|FG000|COMPLETED|Overall Study||12||
48200204|NCT00344019|100814493|FG001|COMPLETED|Overall Study||11||
48200205|NCT00344019|100814494|FG002|COMPLETED|Overall Study||0||
48200206|NCT00344019|100814492|FG000|NOT COMPLETED|Overall Study||0||
48200207|NCT00344019|100814493|FG001|NOT COMPLETED|Overall Study||0||
48200208|NCT00344019|100814494|FG002|NOT COMPLETED|Overall Study||74||
48200209|NCT01833832|100814495|FG000|STARTED|Overall Study||11||
48200210|NCT01833832|100814495|FG000|COMPLETED|Overall Study||10||
48200211|NCT01833832|100814495|FG000|NOT COMPLETED|Overall Study||1||
48200212|NCT00686517|100814496|FG000|STARTED|Treatment||44||
48200213|NCT00686517|100814497|FG001|STARTED|Treatment||43||
48200214|NCT00686517|100814498|FG002|STARTED|Treatment||43||
48200215|NCT00686517|100814496|FG000|Completed Final Treatment Visit|Treatment||44||
48200216|NCT00686517|100814497|FG001|Completed Final Treatment Visit|Treatment||43||
48200217|NCT00686517|100814498|FG002|Completed Final Treatment Visit|Treatment||43||
48200218|NCT00686517|100814496|FG000|COMPLETED|Treatment||38||
48200219|NCT00686517|100814497|FG001|COMPLETED|Treatment||40||
48490677|NCT05178927|101535973|FG001|COMPLETED|Second Intervention (Treatments 6-10)||12||
48490678|NCT05178927|101535972|FG000|NOT COMPLETED|Second Intervention (Treatments 6-10)||0||
48490679|NCT05178927|101535973|FG001|NOT COMPLETED|Second Intervention (Treatments 6-10)||0||
48490680|NCT00316277|101535974|FG000|STARTED|Phase 1 (12 Weeks)||329||
48490681|NCT00316277|101535975|FG001|STARTED|Phase 1 (12 Weeks)||324||
48490682|NCT00316277|101535974|FG000|COMPLETED|Phase 1 (12 Weeks)||19||
48490683|NCT00316277|101535975|FG001|COMPLETED|Phase 1 (12 Weeks)||24||
48490684|NCT00316277|101535974|FG000|NOT COMPLETED|Phase 1 (12 Weeks)||310||
48490685|NCT00316277|101535975|FG001|NOT COMPLETED|Phase 1 (12 Weeks)||300||
48200220|NCT00686517|100814498|FG002|COMPLETED|Treatment||42||
48200221|NCT00686517|100814496|FG000|NOT COMPLETED|Treatment||6||
48200222|NCT00686517|100814497|FG001|NOT COMPLETED|Treatment||3||
48200223|NCT00686517|100814498|FG002|NOT COMPLETED|Treatment||1||
48200224|NCT00686517|100814496|FG000|STARTED|Follow-up||37||
48200225|NCT00686517|100814497|FG001|STARTED|Follow-up||38||
48200226|NCT00686517|100814498|FG002|STARTED|Follow-up||39||
48200227|NCT00686517|100814496|FG000|COMPLETED|Follow-up||29||
48200228|NCT00686517|100814497|FG001|COMPLETED|Follow-up||28||
48200229|NCT00686517|100814498|FG002|COMPLETED|Follow-up||29||
48200230|NCT00686517|100814496|FG000|NOT COMPLETED|Follow-up||8||
48200231|NCT00686517|100814497|FG001|NOT COMPLETED|Follow-up||10||
48200232|NCT00686517|100814498|FG002|NOT COMPLETED|Follow-up||10||
48200233|NCT03673943|100814499|FG000|STARTED|Overall Study||63||
48490686|NCT00316277|101535974|FG000|STARTED|Phase 2 (24 Weeks)||180||
48490687|NCT00316277|101535975|FG001|STARTED|Phase 2 (24 Weeks)||180||
48490688|NCT00316277|101535974|FG000|COMPLETED|Phase 2 (24 Weeks)||161||
48490689|NCT00316277|101535975|FG001|COMPLETED|Phase 2 (24 Weeks)||161||
48490690|NCT00316277|101535974|FG000|NOT COMPLETED|Phase 2 (24 Weeks)||19||
48490691|NCT00316277|101535975|FG001|NOT COMPLETED|Phase 2 (24 Weeks)||19||
48490692|NCT00545792|101535976|FG000|STARTED|Overall Study||21||
48490693|NCT00545792|101535976|FG000|COMPLETED|Overall Study||20||
48490694|NCT00545792|101535976|FG000|NOT COMPLETED|Overall Study||1||
48490695|NCT00617396|101535977|FG000|STARTED|Overall Study||25||
48490696|NCT00617396|101535977|FG000|COMPLETED|Overall Study||25||
48490697|NCT00617396|101535977|FG000|NOT COMPLETED|Overall Study||0||
48490698|NCT02436005|101535978|FG000|STARTED|First Intervention||12||
48490699|NCT02436005|101535979|FG001|STARTED|First Intervention||13||
48490700|NCT02436005|101535978|FG000|COMPLETED|First Intervention||12||
48490701|NCT02436005|101535979|FG001|COMPLETED|First Intervention||13||
48490702|NCT02436005|101535978|FG000|NOT COMPLETED|First Intervention||0||
48490703|NCT02436005|101535979|FG001|NOT COMPLETED|First Intervention||0||
48490704|NCT02436005|101535978|FG000|STARTED|Second Intervention||12||
48490705|NCT02436005|101535979|FG001|STARTED|Second Intervention||13||
48490706|NCT02436005|101535978|FG000|COMPLETED|Second Intervention||12||
48490707|NCT02436005|101535979|FG001|COMPLETED|Second Intervention||12||
48490708|NCT02436005|101535978|FG000|NOT COMPLETED|Second Intervention||0||
48490709|NCT02436005|101535979|FG001|NOT COMPLETED|Second Intervention||1||
48490710|NCT02339558|101535980|FG000|STARTED|Overall Study||45||
48490711|NCT02339558|101535980|FG000|COMPLETED|Overall Study||45||
48490712|NCT02339558|101535980|FG000|NOT COMPLETED|Overall Study||0||
48490713|NCT01535222|101535981|FG000|STARTED|Overall Study||3||
48490714|NCT01535222|101535982|FG001|STARTED|Overall Study||3||
48490715|NCT01535222|101535983|FG002|STARTED|Overall Study||7||
48490716|NCT01535222|101535984|FG003|STARTED|Overall Study||6||
48490717|NCT01535222|101535985|FG004|STARTED|Overall Study||6||
48490718|NCT01535222|101535986|FG005|STARTED|Overall Study||8||
48490719|NCT01535222|101535981|FG000|COMPLETED|Overall Study||3||
48490720|NCT01535222|101535982|FG001|COMPLETED|Overall Study||3||
48490721|NCT01535222|101535983|FG002|COMPLETED|Overall Study||6||
48490722|NCT01535222|101535984|FG003|COMPLETED|Overall Study||6||
48490723|NCT01535222|101535985|FG004|COMPLETED|Overall Study||6||
48490724|NCT01535222|101535986|FG005|COMPLETED|Overall Study||8||
48490725|NCT01535222|101535981|FG000|NOT COMPLETED|Overall Study||0||
48490726|NCT01535222|101535982|FG001|NOT COMPLETED|Overall Study||0||
48490727|NCT01535222|101535983|FG002|NOT COMPLETED|Overall Study||1||
48490728|NCT01535222|101535984|FG003|NOT COMPLETED|Overall Study||0||
48490729|NCT01535222|101535985|FG004|NOT COMPLETED|Overall Study||0||
48490730|NCT01535222|101535986|FG005|NOT COMPLETED|Overall Study||0||
48490731|NCT01531894|101535987|FG000|STARTED|Overall Study||11||
48490732|NCT01531894|101535987|FG000|COMPLETED|Overall Study||2||
48490733|NCT01531894|101535987|FG000|NOT COMPLETED|Overall Study||9||
48490734|NCT00748072|101535988|FG000|STARTED|Overall Study||82||
48490735|NCT00748072|101535989|FG001|STARTED|Overall Study||80||
48490736|NCT00748072|101535988|FG000|COMPLETED|Overall Study||82||
48490737|NCT00748072|101535989|FG001|COMPLETED|Overall Study||80||
48490738|NCT00748072|101535988|FG000|NOT COMPLETED|Overall Study||0||
48490739|NCT00748072|101535989|FG001|NOT COMPLETED|Overall Study||0||
48490740|NCT01101022|101535990|FG000|STARTED|Overall Study||79||
48490741|NCT01101022|101535991|FG001|STARTED|Overall Study||80||
48490742|NCT01101022|101535990|FG000|COMPLETED|Overall Study||62||
48490743|NCT01101022|101535991|FG001|COMPLETED|Overall Study||53||
48490744|NCT01101022|101535990|FG000|NOT COMPLETED|Overall Study||17||
48490745|NCT01101022|101535991|FG001|NOT COMPLETED|Overall Study||27||
48490746|NCT00529464|101535992|FG000|STARTED|Overall Study||0||
48490747|NCT00529464|101535993|FG001|STARTED|Overall Study||0||
48490748|NCT00529464|101535994|FG002|STARTED|Overall Study||0||
48490749|NCT00529464|101535992|FG000|COMPLETED|Overall Study||0||
48490750|NCT00529464|101535993|FG001|COMPLETED|Overall Study||0||
48490751|NCT00529464|101535994|FG002|COMPLETED|Overall Study||0||
48490752|NCT00529464|101535992|FG000|NOT COMPLETED|Overall Study||0||
48490753|NCT00529464|101535993|FG001|NOT COMPLETED|Overall Study||0||
48490754|NCT00529464|101535994|FG002|NOT COMPLETED|Overall Study||0||
48490755|NCT02777580|101535995|FG000|STARTED|Overall Study||405||
48490756|NCT02777580|101535996|FG001|STARTED|Overall Study||204||
48490757|NCT02777580|101535995|FG000|COMPLETED|Overall Study||401||
48490758|NCT02777580|101535996|FG001|COMPLETED|Overall Study||203||
48490759|NCT02777580|101535995|FG000|NOT COMPLETED|Overall Study||4||
48490760|NCT02777580|101535996|FG001|NOT COMPLETED|Overall Study||1||
48490761|NCT01391273|101535997|FG000|STARTED|Overall Study||88||
48490762|NCT01391273|101535998|FG001|STARTED|Overall Study||85||
48490763|NCT01391273|101535997|FG000|COMPLETED|Overall Study||84||
48490764|NCT01391273|101535998|FG001|COMPLETED|Overall Study||83||
48490765|NCT01391273|101535997|FG000|NOT COMPLETED|Overall Study||4||
48490766|NCT01391273|101535998|FG001|NOT COMPLETED|Overall Study||2||
48490767|NCT00834431|101535999|FG000|STARTED|First Intervention||18||
48490768|NCT00834431|101536000|FG001|STARTED|First Intervention||18||
48490769|NCT00834431|101535999|FG000|COMPLETED|First Intervention||18||
48490770|NCT00834431|101536000|FG001|COMPLETED|First Intervention||17||
48490771|NCT00834431|101535999|FG000|NOT COMPLETED|First Intervention||0||
48490772|NCT00834431|101536000|FG001|NOT COMPLETED|First Intervention||1||
48490773|NCT00834431|101535999|FG000|STARTED|Washout of 7 Days||18||
48490774|NCT00834431|101536000|FG001|STARTED|Washout of 7 Days||17||
48490775|NCT00834431|101535999|FG000|COMPLETED|Washout of 7 Days||18||
48490776|NCT00834431|101536000|FG001|COMPLETED|Washout of 7 Days||16||
48490777|NCT00834431|101535999|FG000|NOT COMPLETED|Washout of 7 Days||0||
48490778|NCT00834431|101536000|FG001|NOT COMPLETED|Washout of 7 Days||1||
48490779|NCT00834431|101535999|FG000|STARTED|Second Intervention||18||
48490780|NCT00834431|101536000|FG001|STARTED|Second Intervention||16||
48490781|NCT00834431|101535999|FG000|COMPLETED|Second Intervention||18||
48490782|NCT00834431|101536000|FG001|COMPLETED|Second Intervention||16||
48490783|NCT00834431|101535999|FG000|NOT COMPLETED|Second Intervention||0||
48490784|NCT00834431|101536000|FG001|NOT COMPLETED|Second Intervention||0||
48490785|NCT01125163|101536001|FG000|STARTED|Overall Study||76||
48490786|NCT01125163|101536002|FG001|STARTED|Overall Study||74||
48490787|NCT01125163|101536001|FG000|COMPLETED|Overall Study||76||
48490788|NCT01125163|101536002|FG001|COMPLETED|Overall Study||74||
48490789|NCT01125163|101536001|FG000|NOT COMPLETED|Overall Study||0||
48490790|NCT01125163|101536002|FG001|NOT COMPLETED|Overall Study||0||
48490791|NCT03600805|101536003|FG000|STARTED|Overall Study||28||
48490792|NCT03600805|101536004|FG001|STARTED|Overall Study||14||
48490793|NCT03600805|101536005|FG002|STARTED|Overall Study||14||
48490794|NCT03600805|101536006|FG003|STARTED|Overall Study||27||
48490795|NCT03600805|101536003|FG000|Week 52 Analysis Set Population|Overall Study||10|Randomized participants who had opportunity to complete the 52-week treatment period (randomized prior to October 16th, 2019).|
48490796|NCT03600805|101536004|FG001|Week 52 Analysis Set Population|Overall Study||6|Randomized participants who had opportunity to complete the 52-week treatment period (randomized prior to October 16th, 2019).|
48490797|NCT03600805|101536005|FG002|Week 52 Analysis Set Population|Overall Study||7|Randomized participants who had opportunity to complete the 52-week treatment period (randomized prior to October 16th, 2019).|
48490798|NCT03600805|101536006|FG003|Week 52 Analysis Set Population|Overall Study||13|Randomized participants who had opportunity to complete the 52-week treatment period (randomized prior to October 16th, 2019).|
48490799|NCT03600805|101536003|FG000|COMPLETED|Overall Study||9||
48490800|NCT03600805|101536004|FG001|COMPLETED|Overall Study||6||
48490801|NCT03600805|101536005|FG002|COMPLETED|Overall Study||6||
48490802|NCT03600805|101536006|FG003|COMPLETED|Overall Study||8||
48490803|NCT03600805|101536003|FG000|NOT COMPLETED|Overall Study||19||
48490804|NCT03600805|101536004|FG001|NOT COMPLETED|Overall Study||8||
48490805|NCT03600805|101536005|FG002|NOT COMPLETED|Overall Study||8||
48490806|NCT03600805|101536006|FG003|NOT COMPLETED|Overall Study||19||
48490807|NCT00907907|101536007|FG000|STARTED|Period 1||20||
48490808|NCT00907907|101536008|FG001|STARTED|Period 1||20||
48490809|NCT00907907|101536007|FG000|COMPLETED|Period 1||20||
48490810|NCT00907907|101536008|FG001|COMPLETED|Period 1||20||
48490811|NCT00907907|101536007|FG000|NOT COMPLETED|Period 1||0||
48490812|NCT00907907|101536008|FG001|NOT COMPLETED|Period 1||0||
48490813|NCT00907907|101536007|FG000|STARTED|Period 2||20||
48490814|NCT00907907|101536008|FG001|STARTED|Period 2||20||
48490815|NCT00907907|101536007|FG000|COMPLETED|Period 2||20||
48490816|NCT00907907|101536008|FG001|COMPLETED|Period 2||20||
48490817|NCT00907907|101536007|FG000|NOT COMPLETED|Period 2||0||
48490818|NCT00907907|101536008|FG001|NOT COMPLETED|Period 2||0||
48490819|NCT00907907|101536007|FG000|STARTED|Period 3||20||
48490820|NCT00907907|101536008|FG001|STARTED|Period 3||20||
48490821|NCT00907907|101536007|FG000|COMPLETED|Period 3||20||
48490822|NCT00907907|101536008|FG001|COMPLETED|Period 3||20||
48490823|NCT00907907|101536007|FG000|NOT COMPLETED|Period 3||0||
48490824|NCT00907907|101536008|FG001|NOT COMPLETED|Period 3||0||
48200234|NCT03673943|100814499|FG000|COMPLETED|Overall Study||63||
48200235|NCT03673943|100814499|FG000|NOT COMPLETED|Overall Study||0||
48200236|NCT00320489|100814500|FG000|STARTED|Overall Study||264||
48200237|NCT00320489|100814501|FG001|STARTED|Overall Study||260||
48200238|NCT00320489|100814500|FG000|COMPLETED|Overall Study||119||
48200239|NCT00320489|100814501|FG001|COMPLETED|Overall Study||124||
48200240|NCT00320489|100814500|FG000|NOT COMPLETED|Overall Study||145||
48490825|NCT00907907|101536007|FG000|STARTED|Period 4||19||
48490826|NCT00907907|101536008|FG001|STARTED|Period 4||18||
48490827|NCT00907907|101536007|FG000|COMPLETED|Period 4||19||
48490828|NCT00907907|101536008|FG001|COMPLETED|Period 4||18||
48490829|NCT00907907|101536007|FG000|NOT COMPLETED|Period 4||0||
48490830|NCT00907907|101536008|FG001|NOT COMPLETED|Period 4||0||
48490831|NCT00835536|101536009|FG000|STARTED|First Intervention||13||
48490832|NCT00835536|101536010|FG001|STARTED|First Intervention||14||
48490833|NCT00835536|101536009|FG000|COMPLETED|First Intervention||13||
48490834|NCT00835536|101536010|FG001|COMPLETED|First Intervention||14||
48490835|NCT00835536|101536009|FG000|NOT COMPLETED|First Intervention||0||
48490836|NCT00835536|101536010|FG001|NOT COMPLETED|First Intervention||0||
48490837|NCT00835536|101536009|FG000|STARTED|Washout of 5 Weeks||13||
48490838|NCT00835536|101536010|FG001|STARTED|Washout of 5 Weeks||14||
48490839|NCT00835536|101536009|FG000|COMPLETED|Washout of 5 Weeks||12||
48490840|NCT00835536|101536010|FG001|COMPLETED|Washout of 5 Weeks||14||
48490841|NCT00835536|101536009|FG000|NOT COMPLETED|Washout of 5 Weeks||1||
48490842|NCT00835536|101536010|FG001|NOT COMPLETED|Washout of 5 Weeks||0||
48490843|NCT00835536|101536009|FG000|STARTED|Second Intervention||12||
48490844|NCT00835536|101536010|FG001|STARTED|Second Intervention||14||
48490845|NCT00835536|101536009|FG000|COMPLETED|Second Intervention||12||
48490846|NCT00835536|101536010|FG001|COMPLETED|Second Intervention||14||
48490847|NCT00835536|101536009|FG000|NOT COMPLETED|Second Intervention||0||
48490848|NCT00835536|101536010|FG001|NOT COMPLETED|Second Intervention||0||
48490849|NCT00573443|101536011|FG000|STARTED|Double-Blind Phase||110||
48490850|NCT00573443|101536012|FG001|STARTED|Double-Blind Phase||107||
48490851|NCT00573443|101536013|FG002|STARTED|Double-Blind Phase||109||
48490852|NCT00573443|101536011|FG000|Subjects With PBA Secondary to ALS|Double-Blind Phase||65||
48490853|NCT00573443|101536012|FG001|Subjects With PBA Secondary to ALS|Double-Blind Phase||68||
48200241|NCT00320489|100814501|FG001|NOT COMPLETED|Overall Study||136||
48200242|NCT02046616|100814502|FG000|STARTED|24-Week Treatment Period||133||
48490854|NCT00573443|101536013|FG002|Subjects With PBA Secondary to ALS|Double-Blind Phase||64||
48490855|NCT00573443|101536011|FG000|Subjects With PBA Secondary to MS|Double-Blind Phase||45||
48490856|NCT00573443|101536012|FG001|Subjects With PBA Secondary to MS|Double-Blind Phase||39||
48490857|NCT00573443|101536013|FG002|Subjects With PBA Secondary to MS|Double-Blind Phase||45||
48490858|NCT00573443|101536011|FG000|COMPLETED|Double-Blind Phase||101||
48490859|NCT00573443|101536012|FG001|COMPLETED|Double-Blind Phase||88||
48490860|NCT00573443|101536013|FG002|COMPLETED|Double-Blind Phase||94||
48490861|NCT00573443|101536011|FG000|NOT COMPLETED|Double-Blind Phase||9||
48490862|NCT00573443|101536012|FG001|NOT COMPLETED|Double-Blind Phase||19||
48490863|NCT00573443|101536013|FG002|NOT COMPLETED|Double-Blind Phase||15||
48490864|NCT00573443|101536011|FG000|STARTED|Open-Label Extension Phase||253||
48490865|NCT00573443|101536012|FG001|STARTED|Open-Label Extension Phase||0||
48490866|NCT00573443|101536013|FG002|STARTED|Open-Label Extension Phase||0||
48490867|NCT00573443|101536011|FG000|Subjects With PBA Secondary to ALS|Open-Label Extension Phase||146||
48490868|NCT00573443|101536012|FG001|Subjects With PBA Secondary to ALS|Open-Label Extension Phase||0||
48490869|NCT00573443|101536013|FG002|Subjects With PBA Secondary to ALS|Open-Label Extension Phase||0||
48490870|NCT00573443|101536011|FG000|Subjects With PBA Secondary to MS|Open-Label Extension Phase||107||
48490871|NCT00573443|101536012|FG001|Subjects With PBA Secondary to MS|Open-Label Extension Phase||0||
48490872|NCT00573443|101536013|FG002|Subjects With PBA Secondary to MS|Open-Label Extension Phase||0||
48490873|NCT00573443|101536011|FG000|COMPLETED|Open-Label Extension Phase||235||
48490874|NCT00573443|101536012|FG001|COMPLETED|Open-Label Extension Phase||0||
48490875|NCT00573443|101536013|FG002|COMPLETED|Open-Label Extension Phase||0||
48490876|NCT00573443|101536011|FG000|NOT COMPLETED|Open-Label Extension Phase||18||
48490877|NCT00573443|101536012|FG001|NOT COMPLETED|Open-Label Extension Phase||0||
48490878|NCT00573443|101536013|FG002|NOT COMPLETED|Open-Label Extension Phase||0||
48490879|NCT05086835|101536014|FG000|STARTED|Overall Study||10||
48490880|NCT05086835|101536014|FG000|COMPLETED|Overall Study||10||
48490881|NCT05086835|101536014|FG000|NOT COMPLETED|Overall Study||0||
48490882|NCT01370369|101536015|FG000|STARTED|Overall Study||20||
48490883|NCT01370369|101536015|FG000|COMPLETED|Overall Study||20||
48490884|NCT01370369|101536015|FG000|NOT COMPLETED|Overall Study||0||
48490885|NCT03031847|101536016|FG000|STARTED|Overall Study||22||
48490886|NCT03031847|101536017|FG001|STARTED|Overall Study||20||
48490887|NCT03031847|101536018|FG002|STARTED|Overall Study||18||
48490888|NCT03031847|101536019|FG003|STARTED|Overall Study||42||
48490889|NCT03031847|101536016|FG000|COMPLETED|Overall Study||20||
48490890|NCT03031847|101536017|FG001|COMPLETED|Overall Study||18||
48490891|NCT03031847|101536018|FG002|COMPLETED|Overall Study||14||
48490892|NCT03031847|101536019|FG003|COMPLETED|Overall Study||36||
48490893|NCT03031847|101536016|FG000|NOT COMPLETED|Overall Study||2||
48490894|NCT03031847|101536017|FG001|NOT COMPLETED|Overall Study||2||
48490895|NCT03031847|101536018|FG002|NOT COMPLETED|Overall Study||4||
48490896|NCT03031847|101536019|FG003|NOT COMPLETED|Overall Study||6||
48490897|NCT01020474|101536020|FG000|STARTED|Overall Study||54||
48490898|NCT01020474|101536021|FG001|STARTED|Overall Study||53||
48490899|NCT01020474|101536020|FG000|COMPLETED|Overall Study||44||
48490900|NCT01020474|101536021|FG001|COMPLETED|Overall Study||36||
48490901|NCT01020474|101536020|FG000|NOT COMPLETED|Overall Study||10||
48490902|NCT01020474|101536021|FG001|NOT COMPLETED|Overall Study||17||
48490903|NCT02566850|101536022|FG000|STARTED|Overall Study||4||
48490904|NCT02566850|101536022|FG000|COMPLETED|Overall Study||3||
48490905|NCT02566850|101536022|FG000|NOT COMPLETED|Overall Study||1||
48490906|NCT00777023|101536023|FG000|STARTED|Overall Study||186||
48490907|NCT00777023|101536024|FG001|STARTED|Overall Study||190||
48490908|NCT00777023|101536025|FG002|STARTED|Overall Study||183||
48490909|NCT00777023|101536023|FG000|COMPLETED|Overall Study||151||
48490910|NCT00777023|101536024|FG001|COMPLETED|Overall Study||149||
48490911|NCT00777023|101536025|FG002|COMPLETED|Overall Study||146||
48490912|NCT00777023|101536023|FG000|NOT COMPLETED|Overall Study||35||
48490913|NCT00777023|101536024|FG001|NOT COMPLETED|Overall Study||41||
48490914|NCT00777023|101536025|FG002|NOT COMPLETED|Overall Study||37||
48490915|NCT04313751|101536026|FG000|STARTED|Overall Study||26||
48490916|NCT04313751|101536027|FG001|STARTED|Overall Study||23||
48490917|NCT04313751|101536026|FG000|COMPLETED|Overall Study||21||
48490918|NCT04313751|101536027|FG001|COMPLETED|Overall Study||16||
48490919|NCT04313751|101536026|FG000|NOT COMPLETED|Overall Study||5||
48490920|NCT04313751|101536027|FG001|NOT COMPLETED|Overall Study||7||
48490921|NCT01370083|101536028|FG000|STARTED|Overall Study||7||
48490922|NCT01370083|101536029|FG001|STARTED|Overall Study||7||
48490923|NCT01370083|101536028|FG000|COMPLETED|Overall Study||5||
48490924|NCT01370083|101536029|FG001|COMPLETED|Overall Study||6||
48490925|NCT01370083|101536028|FG000|NOT COMPLETED|Overall Study||2||
48490926|NCT01370083|101536029|FG001|NOT COMPLETED|Overall Study||1||
48490927|NCT02736721|101536030|FG000|STARTED|Overall Study||41||
48490928|NCT02736721|101536030|FG000|COMPLETED|Overall Study||25||
48490929|NCT02736721|101536030|FG000|NOT COMPLETED|Overall Study||16||
48490930|NCT03214952|101536031|FG000|STARTED|Overall Study||3183||
48490931|NCT03214952|101536031|FG000|COMPLETED|Overall Study||3125||
48490932|NCT03214952|101536031|FG000|NOT COMPLETED|Overall Study||58||
48490933|NCT03086460|101536032|FG000|STARTED|Study Participants||67|"Due to an error in the randomization system during the trial, some patients received the same treatment in several treatment intervals. The error was recognized after the database lock and unblinding. Patients were analyzed according to the treatments assigned by the Interactive Response Technology (IRT) system.~For statistical analyses as randomized corresponds to as actually allocated by the IRT that was used for efficacy analyses not according to those which were originally planned."|
48490934|NCT03086460|101536032|FG000|Treatment A|Study Participants||39|Number of patients who received Treatment A.|
48490935|NCT03086460|101536032|FG000|Treatment B|Study Participants||35|Number of patients who received Treatment B.|
48490936|NCT03086460|101536032|FG000|Treatment C|Study Participants||37|Number of patients who received Treatment C.|
48490937|NCT03086460|101536032|FG000|Treatment D|Study Participants||40|Number of patients who received Treatment D.|
48490938|NCT03086460|101536032|FG000|Treatment E|Study Participants||40|Number of patients who received Treatment E.|
48490939|NCT03086460|101536032|FG000|Treatment F|Study Participants||41|Number of patients who received Treatment F.|
48490940|NCT03086460|101536032|FG000|COMPLETED|Study Participants||58|"Patients who received the same treatment during two treatment intervals were considered twice in the corresponding group (once for each treatment interval).~The table above presents the number of patients receiving each treatment in at least one treatment interval."|
48490941|NCT03086460|101536032|FG000|NOT COMPLETED|Study Participants||9||
48490942|NCT03086460|101536032|FG000|STARTED|Treatment A||39||
48490943|NCT03086460|101536032|FG000|COMPLETED|Treatment A||35||
48490944|NCT03086460|101536032|FG000|NOT COMPLETED|Treatment A||4||
48490945|NCT03086460|101536032|FG000|STARTED|Treatment B||35||
48490946|NCT03086460|101536032|FG000|COMPLETED|Treatment B||35||
48490947|NCT03086460|101536032|FG000|NOT COMPLETED|Treatment B||0||
48490948|NCT03086460|101536032|FG000|STARTED|Treatment C||37||
48490949|NCT03086460|101536032|FG000|COMPLETED|Treatment C||35||
48490950|NCT03086460|101536032|FG000|NOT COMPLETED|Treatment C||2||
48490951|NCT03086460|101536032|FG000|STARTED|Treatment D||40||
48490952|NCT03086460|101536032|FG000|COMPLETED|Treatment D||40||
48490953|NCT03086460|101536032|FG000|NOT COMPLETED|Treatment D||0||
48490954|NCT03086460|101536032|FG000|STARTED|Treatment E||40||
48490955|NCT03086460|101536032|FG000|COMPLETED|Treatment E||36||
48490956|NCT03086460|101536032|FG000|NOT COMPLETED|Treatment E||4||
48490957|NCT03086460|101536032|FG000|STARTED|Treatment F||41||
48490958|NCT03086460|101536032|FG000|COMPLETED|Treatment F||41||
48490959|NCT03086460|101536032|FG000|NOT COMPLETED|Treatment F||0||
48490960|NCT01034358|101536033|FG000|STARTED|Overall Study||15||
48490961|NCT01034358|101536033|FG000|COMPLETED|Overall Study||13||
48490962|NCT01034358|101536033|FG000|NOT COMPLETED|Overall Study||2||
48490963|NCT00620074|101536034|FG000|STARTED|Overall Study||6||
48490964|NCT00620074|101536034|FG000|COMPLETED|Overall Study||5||
48490965|NCT00620074|101536034|FG000|NOT COMPLETED|Overall Study||1||
48490966|NCT01200810|101536035|FG000|STARTED|Overall Study||5||
48490967|NCT01200810|101536036|FG001|STARTED|Overall Study||5||
48490968|NCT01200810|101536035|FG000|COMPLETED|Overall Study||0||
48490969|NCT01200810|101536036|FG001|COMPLETED|Overall Study||0||
48490970|NCT01200810|101536035|FG000|NOT COMPLETED|Overall Study||5||
48490971|NCT01200810|101536036|FG001|NOT COMPLETED|Overall Study||5||
48490972|NCT00926887|101536037|FG000|STARTED|Overall Study||54||
48490973|NCT00926887|101536038|FG001|STARTED|Overall Study||50||
48490974|NCT00926887|101536037|FG000|COMPLETED|Overall Study||54||
48490975|NCT00926887|101536038|FG001|COMPLETED|Overall Study||50||
48490976|NCT00926887|101536037|FG000|NOT COMPLETED|Overall Study||0||
48490977|NCT00926887|101536038|FG001|NOT COMPLETED|Overall Study||0||
48490978|NCT02149420|101536039|FG000|STARTED|Core Study||9||
48490979|NCT02149420|101536040|FG001|STARTED|Core Study||6||
48490980|NCT02149420|101536041|FG002|STARTED|Core Study||12||
48490981|NCT02149420|101536039|FG000|Safety Analysis Set|Core Study||9|all patients that received study drug|
48490982|NCT02149420|101536040|FG001|Safety Analysis Set|Core Study||6|all patients that received study drug|
48490983|NCT02149420|101536041|FG002|Safety Analysis Set|Core Study||12|all patients that received study drug|
48490984|NCT02149420|101536039|FG000|PK Analysis Set|Core Study||5|at least one valid PK concentration measurement|
48490985|NCT02149420|101536040|FG001|PK Analysis Set|Core Study||6|at least one valid PK concentration measurement|
48490986|NCT02149420|101536041|FG002|PK Analysis Set|Core Study||12|at least one valid PK concentration measurement|
48490987|NCT02149420|101536039|FG000|PD (Pharmacodynamics) Analysis Set|Core Study||9|all patients with PD data, who received at least one dose of study drug.|
48490988|NCT02149420|101536040|FG001|PD (Pharmacodynamics) Analysis Set|Core Study||6|all patients with PD data, who received at least one dose of study drug.|
48490989|NCT02149420|101536041|FG002|PD (Pharmacodynamics) Analysis Set|Core Study||12|all patients with PD data, who received at least one dose of study drug.|
48490990|NCT02149420|101536039|FG000|COMPLETED|Core Study||9||
48490991|NCT02149420|101536040|FG001|COMPLETED|Core Study||5||
48490992|NCT02149420|101536041|FG002|COMPLETED|Core Study||10||
48490993|NCT02149420|101536039|FG000|NOT COMPLETED|Core Study||0||
48490994|NCT02149420|101536040|FG001|NOT COMPLETED|Core Study||1||
48490995|NCT02149420|101536041|FG002|NOT COMPLETED|Core Study||2||
48490996|NCT02149420|101536039|FG000|STARTED|Open Label VAY736 10 mg/kg Extension||5||
48490997|NCT02149420|101536040|FG001|STARTED|Open Label VAY736 10 mg/kg Extension||0||
48490998|NCT02149420|101536041|FG002|STARTED|Open Label VAY736 10 mg/kg Extension||0||
48490999|NCT02149420|101536039|FG000|COMPLETED|Open Label VAY736 10 mg/kg Extension||4||
48491000|NCT02149420|101536040|FG001|COMPLETED|Open Label VAY736 10 mg/kg Extension||0||
48491001|NCT02149420|101536041|FG002|COMPLETED|Open Label VAY736 10 mg/kg Extension||0||
48491002|NCT02149420|101536039|FG000|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||1||
48491003|NCT02149420|101536040|FG001|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||0||
48491004|NCT02149420|101536041|FG002|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||0||
48491005|NCT02903407|101536042|FG000|STARTED|Overall Study||4||
48491006|NCT02903407|101536043|FG001|STARTED|Overall Study||3||
48491007|NCT02903407|101536042|FG000|COMPLETED|Overall Study||4||
48491008|NCT02903407|101536043|FG001|COMPLETED|Overall Study||3||
48491009|NCT02903407|101536042|FG000|NOT COMPLETED|Overall Study||0||
48491010|NCT02903407|101536043|FG001|NOT COMPLETED|Overall Study||0||
48491011|NCT04757298|101536044|FG000|STARTED|Stage 1: First Intervention||328|In Stage 1, participants were randomized to receive either Navigation Services or a Digital Brochure|
48491012|NCT04757298|101536045|FG001|STARTED|Stage 1: First Intervention||0|In Stage 1, participants were randomized to receive either Navigation Services or a Digital Brochure|
48491013|NCT04757298|101536046|FG002|STARTED|Stage 1: First Intervention||0|In Stage 1, participants were randomized to receive either Navigation Services or a Digital Brochure|
48491014|NCT04757298|101536047|FG003|STARTED|Stage 1: First Intervention||0|In Stage 1, participants were randomized to receive either Navigation Services or a Digital Brochure|
48491015|NCT04757298|101536048|FG004|STARTED|Stage 1: First Intervention||340|In Stage 1, participants were randomized to receive either Navigation Services or a Digital Brochure|
48491016|NCT04757298|101536049|FG005|STARTED|Stage 1: First Intervention||0|In Stage 1, participants were randomized to receive either Navigation Services or a Digital Brochure|
48491017|NCT04757298|101536050|FG006|STARTED|Stage 1: First Intervention||0|In Stage 1, participants were randomized to receive either Navigation Services or a Digital Brochure|
48491018|NCT04757298|101536051|FG007|STARTED|Stage 1: First Intervention||0|In Stage 1, participants were randomized to receive either Navigation Services or a Digital Brochure|
48491019|NCT04757298|101536044|FG000|COMPLETED|Stage 1: First Intervention||160||
48491020|NCT04757298|101536045|FG001|COMPLETED|Stage 1: First Intervention||0||
48491021|NCT04757298|101536046|FG002|COMPLETED|Stage 1: First Intervention||0||
48491022|NCT04757298|101536047|FG003|COMPLETED|Stage 1: First Intervention||0||
48491023|NCT04757298|101536048|FG004|COMPLETED|Stage 1: First Intervention||165||
48491024|NCT04757298|101536049|FG005|COMPLETED|Stage 1: First Intervention||0||
48491025|NCT04757298|101536050|FG006|COMPLETED|Stage 1: First Intervention||0||
48491026|NCT04757298|101536051|FG007|COMPLETED|Stage 1: First Intervention||0||
48491027|NCT04757298|101536044|FG000|NOT COMPLETED|Stage 1: First Intervention||168||
48491028|NCT04757298|101536045|FG001|NOT COMPLETED|Stage 1: First Intervention||0||
48491029|NCT04757298|101536046|FG002|NOT COMPLETED|Stage 1: First Intervention||0||
48491030|NCT04757298|101536047|FG003|NOT COMPLETED|Stage 1: First Intervention||0||
48491031|NCT04757298|101536048|FG004|NOT COMPLETED|Stage 1: First Intervention||175||
48491032|NCT04757298|101536049|FG005|NOT COMPLETED|Stage 1: First Intervention||0||
48491033|NCT04757298|101536050|FG006|NOT COMPLETED|Stage 1: First Intervention||0||
48491034|NCT04757298|101536051|FG007|NOT COMPLETED|Stage 1: First Intervention||0||
48491035|NCT04757298|101536044|FG000|STARTED|Second Intervention||0|After initial randomization into either Navigation or Brochure in Stage 1, participants were again randomized to receive Brief Counseling or Critical Dialogue in Stage 2|
48491036|NCT04757298|101536045|FG001|STARTED|Second Intervention||160|After initial randomization into either Navigation or Brochure in Stage 1, participants were again randomized to receive Brief Counseling or Critical Dialogue in Stage 2|
48491037|NCT04757298|101536046|FG002|STARTED|Second Intervention||36|After initial randomization into either Navigation or Brochure in Stage 1, participants were again randomized to receive Brief Counseling or Critical Dialogue in Stage 2|
48491038|NCT04757298|101536047|FG003|STARTED|Second Intervention||126|After initial randomization into either Navigation or Brochure in Stage 1, participants were again randomized to receive Brief Counseling or Critical Dialogue in Stage 2|
48491039|NCT04757298|101536048|FG004|STARTED|Second Intervention||0|After initial randomization into either Navigation or Brochure in Stage 1, participants were again randomized to receive Brief Counseling or Critical Dialogue in Stage 2|
48491040|NCT04757298|101536049|FG005|STARTED|Second Intervention||165|After initial randomization into either Navigation or Brochure in Stage 1, participants were again randomized to receive Brief Counseling or Critical Dialogue in Stage 2|
48491041|NCT04757298|101536050|FG006|STARTED|Second Intervention||32|After initial randomization into either Navigation or Brochure in Stage 1, participants were again randomized to receive Brief Counseling or Critical Dialogue in Stage 2|
48491042|NCT04757298|101536051|FG007|STARTED|Second Intervention||137|After initial randomization into either Navigation or Brochure in Stage 1, participants were again randomized to receive Brief Counseling or Critical Dialogue in Stage 2|
48491043|NCT04757298|101536044|FG000|COMPLETED|Second Intervention||0||
48491044|NCT04757298|101536045|FG001|COMPLETED|Second Intervention||96||
48491045|NCT04757298|101536046|FG002|COMPLETED|Second Intervention||16||
48491046|NCT04757298|101536047|FG003|COMPLETED|Second Intervention||16||
48491047|NCT04757298|101536048|FG004|COMPLETED|Second Intervention||0||
48491048|NCT04757298|101536049|FG005|COMPLETED|Second Intervention||164||
48491049|NCT04757298|101536050|FG006|COMPLETED|Second Intervention||19||
48491050|NCT04757298|101536051|FG007|COMPLETED|Second Intervention||19||
48491051|NCT04757298|101536044|FG000|NOT COMPLETED|Second Intervention||0||
48491052|NCT04757298|101536045|FG001|NOT COMPLETED|Second Intervention||64||
48491053|NCT04757298|101536046|FG002|NOT COMPLETED|Second Intervention||20||
48491054|NCT04757298|101536047|FG003|NOT COMPLETED|Second Intervention||110||
48491055|NCT04757298|101536048|FG004|NOT COMPLETED|Second Intervention||0||
48491056|NCT04757298|101536049|FG005|NOT COMPLETED|Second Intervention||1||
48491057|NCT04757298|101536050|FG006|NOT COMPLETED|Second Intervention||13||
48491058|NCT04757298|101536051|FG007|NOT COMPLETED|Second Intervention||118||
48491059|NCT01471353|101536052|FG000|STARTED|Overall Study||42||
48491060|NCT01471353|101536052|FG000|COMPLETED|Overall Study||39||
48491061|NCT01471353|101536052|FG000|NOT COMPLETED|Overall Study||3||
48491062|NCT03935880|101536053|FG000|STARTED|Overall Study||9||
48491063|NCT03935880|101536054|FG001|STARTED|Overall Study||11||
48491064|NCT03935880|101536053|FG000|Completed Surgery|Overall Study||9||
48491065|NCT03935880|101536054|FG001|Completed Surgery|Overall Study||10||
48491066|NCT03935880|101536053|FG000|COMPLETED|Overall Study||9||
48200243|NCT02046616|100814502|FG000|COMPLETED|24-Week Treatment Period||114||
48200244|NCT02046616|100814502|FG000|NOT COMPLETED|24-Week Treatment Period||19||
48200245|NCT02046616|100814502|FG000|STARTED|8-Week FU Period||114||
48200246|NCT02046616|100814502|FG000|COMPLETED|8-Week FU Period||113||
48200247|NCT02046616|100814502|FG000|NOT COMPLETED|8-Week FU Period||1||
48200248|NCT01803646|100814503|FG000|STARTED|Overall Study||204||
48491067|NCT03935880|101536054|FG001|COMPLETED|Overall Study||10||
48491068|NCT03935880|101536053|FG000|NOT COMPLETED|Overall Study||0||
48491069|NCT03935880|101536054|FG001|NOT COMPLETED|Overall Study||1||
48491070|NCT02269657|101536055|FG000|STARTED|Overall Study||40||
48491071|NCT02269657|101536055|FG000|COMPLETED|Overall Study||37||
48491072|NCT02269657|101536055|FG000|NOT COMPLETED|Overall Study||3||
48491073|NCT03719040|101536056|FG000|STARTED|Overall Study||870||
48491074|NCT03719040|101536056|FG000|Attempted Implant|Overall Study||849||
48491075|NCT03719040|101536056|FG000|1-Month Follow up|Overall Study||731||
48491076|NCT03719040|101536056|FG000|6-Month Follow up|Overall Study||667||
48491077|NCT03719040|101536056|FG000|COMPLETED|Overall Study||667||
48491078|NCT03719040|101536056|FG000|NOT COMPLETED|Overall Study||203||
48491079|NCT03872128|101536057|FG000|STARTED|Overall Study||30|Participants randomized|
48491080|NCT03872128|101536058|FG001|STARTED|Overall Study||30|Participants randomized|
48491081|NCT03872128|101536059|FG002|STARTED|Overall Study||31|Participants randomized|
48491082|NCT03872128|101536057|FG000|Began Treatment|Overall Study||29||
48491083|NCT03872128|101536058|FG001|Began Treatment|Overall Study||30||
48491084|NCT03872128|101536059|FG002|Began Treatment|Overall Study||27||
48491085|NCT03872128|101536057|FG000|COMPLETED|Overall Study||27||
48491086|NCT03872128|101536058|FG001|COMPLETED|Overall Study||25||
48491087|NCT03872128|101536059|FG002|COMPLETED|Overall Study||19||
48491088|NCT03872128|101536057|FG000|NOT COMPLETED|Overall Study||3||
48491089|NCT03872128|101536058|FG001|NOT COMPLETED|Overall Study||5||
48491090|NCT03872128|101536059|FG002|NOT COMPLETED|Overall Study||12||
48491091|NCT00830258|101536060|FG000|STARTED|First Intervention||30||
48491092|NCT00830258|101536061|FG001|STARTED|First Intervention||30||
48491093|NCT00830258|101536060|FG000|COMPLETED|First Intervention||29||
48491094|NCT00830258|101536061|FG001|COMPLETED|First Intervention||30||
48491095|NCT00830258|101536060|FG000|NOT COMPLETED|First Intervention||1||
48491096|NCT00830258|101536061|FG001|NOT COMPLETED|First Intervention||0||
48491097|NCT00830258|101536060|FG000|STARTED|Washout: 7 Days||29||
48491098|NCT00830258|101536061|FG001|STARTED|Washout: 7 Days||30||
48491099|NCT00830258|101536060|FG000|COMPLETED|Washout: 7 Days||28||
48200249|NCT01803646|100814504|FG001|STARTED|Overall Study||139||
48200250|NCT01803646|100814503|FG000|COMPLETED|Overall Study||187||
48491100|NCT00830258|101536061|FG001|COMPLETED|Washout: 7 Days||30||
48491101|NCT00830258|101536060|FG000|NOT COMPLETED|Washout: 7 Days||1||
48491102|NCT00830258|101536061|FG001|NOT COMPLETED|Washout: 7 Days||0||
48491103|NCT00830258|101536060|FG000|STARTED|Second Intervention||28||
48491104|NCT00830258|101536061|FG001|STARTED|Second Intervention||30||
48491105|NCT00830258|101536060|FG000|COMPLETED|Second Intervention||28||
48491106|NCT00830258|101536061|FG001|COMPLETED|Second Intervention||30||
48491107|NCT00830258|101536060|FG000|NOT COMPLETED|Second Intervention||0||
48491108|NCT00830258|101536061|FG001|NOT COMPLETED|Second Intervention||0||
48491109|NCT00620711|101536062|FG000|STARTED|Overall Study||4||
48491110|NCT00620711|101536062|FG000|COMPLETED|Overall Study||4||
48491111|NCT00620711|101536062|FG000|NOT COMPLETED|Overall Study||0||
48491112|NCT03158727|101536063|FG000|STARTED|Overall Study||42||
48491113|NCT03158727|101536064|FG001|STARTED|Overall Study||42||
48491114|NCT03158727|101536063|FG000|Enrolled, Not Treated|Overall Study||1||
48491115|NCT03158727|101536064|FG001|Enrolled, Not Treated|Overall Study||0||
48491116|NCT03158727|101536063|FG000|COMPLETED|Overall Study||25||
48491117|NCT03158727|101536064|FG001|COMPLETED|Overall Study||23||
48491118|NCT03158727|101536063|FG000|NOT COMPLETED|Overall Study||17||
48491119|NCT03158727|101536064|FG001|NOT COMPLETED|Overall Study||19||
48491120|NCT01312844|101536065|FG000|STARTED|Overall Study||4||
48491121|NCT01312844|101536066|FG001|STARTED|Overall Study||3||
48491122|NCT01312844|101536065|FG000|COMPLETED|Overall Study||4||
48491123|NCT01312844|101536066|FG001|COMPLETED|Overall Study||3||
48491124|NCT01312844|101536065|FG000|NOT COMPLETED|Overall Study||0||
48491125|NCT01312844|101536066|FG001|NOT COMPLETED|Overall Study||0||
48491126|NCT00354835|101536067|FG000|STARTED|Overall Study||239||
48491127|NCT00354835|101536068|FG001|STARTED|Overall Study||242||
48491128|NCT00354835|101536067|FG000|COMPLETED|Overall Study||187||
48491129|NCT00354835|101536068|FG001|COMPLETED|Overall Study||181||
48200251|NCT01803646|100814504|FG001|COMPLETED|Overall Study||129||
48200252|NCT01803646|100814503|FG000|NOT COMPLETED|Overall Study||17||
48200253|NCT01803646|100814504|FG001|NOT COMPLETED|Overall Study||10||
48200254|NCT02274493|100814505|FG000|STARTED|Overall Study||15||
48200255|NCT02274493|100814505|FG000|COMPLETED|Overall Study||14||
48200256|NCT02274493|100814505|FG000|NOT COMPLETED|Overall Study||1||
48200257|NCT02633358|100814506|FG000|STARTED|Overall Study||87||
48200258|NCT02633358|100814507|FG001|STARTED|Overall Study||54||
48200259|NCT02633358|100814506|FG000|COMPLETED|Overall Study||87||
48200260|NCT02633358|100814507|FG001|COMPLETED|Overall Study||54||
48200261|NCT02633358|100814506|FG000|NOT COMPLETED|Overall Study||0||
48200262|NCT02633358|100814507|FG001|NOT COMPLETED|Overall Study||0||
48200263|NCT00139737|100814508|FG000|STARTED|Overall Study||344||
48200264|NCT00139737|100814508|FG000|Received Treatment|Overall Study||331||
48200265|NCT00139737|100814508|FG000|COMPLETED|Overall Study||3||
48200266|NCT00139737|100814508|FG000|NOT COMPLETED|Overall Study||341||
48200267|NCT03036735|100814509|FG000|STARTED|Overall Study||10||
48200268|NCT03036735|100814509|FG000|COMPLETED|Overall Study||0||
48200269|NCT03036735|100814509|FG000|NOT COMPLETED|Overall Study||10||
48200270|NCT01072357|100814510|FG000|STARTED|Overall Study||15||
48200271|NCT01072357|100814511|FG001|STARTED|Overall Study||15||
48200272|NCT01072357|100814510|FG000|COMPLETED|Overall Study||15||
48200273|NCT01072357|100814511|FG001|COMPLETED|Overall Study||14||
48200274|NCT01072357|100814510|FG000|NOT COMPLETED|Overall Study||0||
48200275|NCT01072357|100814511|FG001|NOT COMPLETED|Overall Study||1||
48200276|NCT01212757|100814512|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||162||
48200277|NCT01212757|100814513|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||163||
48200278|NCT01212757|100814514|FG002|STARTED|Placebo-controlled Phase (Week 0 - 24)||163||
48200279|NCT01212757|100814515|FG003|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
48200280|NCT01212757|100814516|FG004|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
48200281|NCT01212757|100814517|FG005|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
48200282|NCT01212757|100814518|FG006|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
48200283|NCT01212757|100814519|FG007|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
48200284|NCT01212757|100814520|FG008|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
48200285|NCT01212757|100814512|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||159||
48200286|NCT01212757|100814513|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||163||
48200287|NCT01212757|100814514|FG002|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||162||
48200288|NCT01212757|100814515|FG003|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
48200289|NCT01212757|100814516|FG004|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
48200290|NCT01212757|100814517|FG005|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
48200291|NCT01212757|100814518|FG006|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
48200292|NCT01212757|100814519|FG007|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
48200293|NCT01212757|100814520|FG008|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
48200294|NCT01212757|100814512|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||148||
48200295|NCT01212757|100814513|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||151||
48200296|NCT01212757|100814514|FG002|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||149||
48200297|NCT01212757|100814515|FG003|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48200298|NCT01212757|100814516|FG004|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48200299|NCT01212757|100814517|FG005|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48200300|NCT01212757|100814518|FG006|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48200301|NCT01212757|100814519|FG007|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48200302|NCT01212757|100814520|FG008|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48200303|NCT01212757|100814512|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||88||
48200304|NCT01212757|100814513|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||59||
48200305|NCT01212757|100814514|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||64||
48200306|NCT01212757|100814515|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48200307|NCT01212757|100814516|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48200308|NCT01212757|100814517|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48200309|NCT01212757|100814518|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48200310|NCT01212757|100814519|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48200311|NCT01212757|100814520|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
48200312|NCT01212757|100814512|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||143||
48200313|NCT01212757|100814513|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||143||
48200314|NCT01212757|100814514|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||142||
48200315|NCT01212757|100814515|FG003|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48200316|NCT01212757|100814516|FG004|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48200317|NCT01212757|100814517|FG005|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48200318|NCT01212757|100814518|FG006|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48200319|NCT01212757|100814519|FG007|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48200320|NCT01212757|100814520|FG008|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48200321|NCT01212757|100814512|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||19||
48200322|NCT01212757|100814513|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20||
48200323|NCT01212757|100814514|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||21||
48200324|NCT01212757|100814515|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48200325|NCT01212757|100814516|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48200326|NCT01212757|100814517|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48200327|NCT01212757|100814518|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48200328|NCT01212757|100814519|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48200329|NCT01212757|100814520|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
48200330|NCT01212757|100814512|FG000|STARTED|Active Treatment Phase (Weeks 24 - 52)||0||
48200331|NCT01212757|100814513|FG001|STARTED|Active Treatment Phase (Weeks 24 - 52)||137||
48200332|NCT01212757|100814514|FG002|STARTED|Active Treatment Phase (Weeks 24 - 52)||134||
48200333|NCT01212757|100814515|FG003|STARTED|Active Treatment Phase (Weeks 24 - 52)||43||
48200334|NCT01212757|100814516|FG004|STARTED|Active Treatment Phase (Weeks 24 - 52)||27||
48200335|NCT01212757|100814517|FG005|STARTED|Active Treatment Phase (Weeks 24 - 52)||41||
48200336|NCT01212757|100814518|FG006|STARTED|Active Treatment Phase (Weeks 24 - 52)||28||
48200337|NCT01212757|100814519|FG007|STARTED|Active Treatment Phase (Weeks 24 - 52)||0||
48200338|NCT01212757|100814520|FG008|STARTED|Active Treatment Phase (Weeks 24 - 52)||0||
48200339|NCT01212757|100814512|FG000|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0||
48200340|NCT01212757|100814513|FG001|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||125||
48200341|NCT01212757|100814514|FG002|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||114||
48200342|NCT01212757|100814515|FG003|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||35||
48200343|NCT01212757|100814516|FG004|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||25||
48200344|NCT01212757|100814517|FG005|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||34||
48200345|NCT01212757|100814518|FG006|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||28||
48200346|NCT01212757|100814519|FG007|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0||
48200347|NCT01212757|100814520|FG008|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0||
48200348|NCT01212757|100814512|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0||
48200349|NCT01212757|100814513|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12||
48200350|NCT01212757|100814514|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||20||
48200351|NCT01212757|100814515|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||8||
48200352|NCT01212757|100814516|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||2||
48200353|NCT01212757|100814517|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||7||
48200354|NCT01212757|100814518|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0||
48200355|NCT01212757|100814519|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0||
48200356|NCT01212757|100814520|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0||
48200357|NCT01212757|100814512|FG000|STARTED|Long-Term Safety Phase (Year 2)||0||
48200358|NCT01212757|100814513|FG001|STARTED|Long-Term Safety Phase (Year 2)||119||
48200359|NCT01212757|100814514|FG002|STARTED|Long-Term Safety Phase (Year 2)||109||
48200360|NCT01212757|100814515|FG003|STARTED|Long-Term Safety Phase (Year 2)||0||
48200361|NCT01212757|100814516|FG004|STARTED|Long-Term Safety Phase (Year 2)||0||
48200362|NCT01212757|100814517|FG005|STARTED|Long-Term Safety Phase (Year 2)||0||
48200363|NCT01212757|100814518|FG006|STARTED|Long-Term Safety Phase (Year 2)||0||
48200364|NCT01212757|100814519|FG007|STARTED|Long-Term Safety Phase (Year 2)||58||
48200365|NCT01212757|100814520|FG008|STARTED|Long-Term Safety Phase (Year 2)||60||
48200366|NCT01212757|100814512|FG000|COMPLETED|Long-Term Safety Phase (Year 2)||0||
48200367|NCT01212757|100814513|FG001|COMPLETED|Long-Term Safety Phase (Year 2)||107||
48200368|NCT01212757|100814514|FG002|COMPLETED|Long-Term Safety Phase (Year 2)||95||
48200369|NCT01212757|100814515|FG003|COMPLETED|Long-Term Safety Phase (Year 2)||0||
48200370|NCT01212757|100814516|FG004|COMPLETED|Long-Term Safety Phase (Year 2)||0||
48200371|NCT01212757|100814517|FG005|COMPLETED|Long-Term Safety Phase (Year 2)||0||
48200372|NCT01212757|100814518|FG006|COMPLETED|Long-Term Safety Phase (Year 2)||0||
48200373|NCT01212757|100814519|FG007|COMPLETED|Long-Term Safety Phase (Year 2)||48||
48200374|NCT01212757|100814520|FG008|COMPLETED|Long-Term Safety Phase (Year 2)||51||
48200375|NCT01212757|100814512|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0||
48200376|NCT01212757|100814513|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 2)||12||
48200377|NCT01212757|100814514|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 2)||14||
48200378|NCT01212757|100814515|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0||
48200379|NCT01212757|100814516|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0||
48200380|NCT01212757|100814517|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0||
48200381|NCT01212757|100814518|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0||
48200382|NCT01212757|100814519|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 2)||10||
48200383|NCT01212757|100814520|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 2)||9||
48200384|NCT01212757|100814512|FG000|STARTED|Long-Term Safety Phase (Year 3)||0||
48200385|NCT01212757|100814513|FG001|STARTED|Long-Term Safety Phase (Year 3)||107||
48200386|NCT01212757|100814514|FG002|STARTED|Long-Term Safety Phase (Year 3)||95||
48200387|NCT01212757|100814515|FG003|STARTED|Long-Term Safety Phase (Year 3)||0||
48200388|NCT01212757|100814516|FG004|STARTED|Long-Term Safety Phase (Year 3)||0||
48200389|NCT01212757|100814517|FG005|STARTED|Long-Term Safety Phase (Year 3)||0||
48200390|NCT01212757|100814518|FG006|STARTED|Long-Term Safety Phase (Year 3)||0||
48200391|NCT01212757|100814519|FG007|STARTED|Long-Term Safety Phase (Year 3)||48||
48200392|NCT01212757|100814520|FG008|STARTED|Long-Term Safety Phase (Year 3)||51||
48200393|NCT01212757|100814512|FG000|COMPLETED|Long-Term Safety Phase (Year 3)||0||
48200394|NCT01212757|100814513|FG001|COMPLETED|Long-Term Safety Phase (Year 3)||89||
48200395|NCT01212757|100814514|FG002|COMPLETED|Long-Term Safety Phase (Year 3)||84||
48200396|NCT01212757|100814515|FG003|COMPLETED|Long-Term Safety Phase (Year 3)||0||
48200397|NCT01212757|100814516|FG004|COMPLETED|Long-Term Safety Phase (Year 3)||0||
48200398|NCT01212757|100814517|FG005|COMPLETED|Long-Term Safety Phase (Year 3)||0||
48200399|NCT01212757|100814518|FG006|COMPLETED|Long-Term Safety Phase (Year 3)||0||
48200400|NCT01212757|100814519|FG007|COMPLETED|Long-Term Safety Phase (Year 3)||42||
48200401|NCT01212757|100814520|FG008|COMPLETED|Long-Term Safety Phase (Year 3)||46||
48200402|NCT01212757|100814512|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0||
48200403|NCT01212757|100814513|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 3)||18||
48200404|NCT01212757|100814514|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 3)||11||
48200405|NCT01212757|100814515|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0||
48200406|NCT01212757|100814516|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0||
48200407|NCT01212757|100814517|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0||
48200408|NCT01212757|100814518|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0||
48200409|NCT01212757|100814519|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 3)||6||
48200410|NCT01212757|100814520|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 3)||5||
48200411|NCT01212757|100814512|FG000|STARTED|Long-Term Safety Phase (Year 4)||0||
48200412|NCT01212757|100814513|FG001|STARTED|Long-Term Safety Phase (Year 4)||89||
48200413|NCT01212757|100814514|FG002|STARTED|Long-Term Safety Phase (Year 4)||84||
48200414|NCT01212757|100814515|FG003|STARTED|Long-Term Safety Phase (Year 4)||0||
48200415|NCT01212757|100814516|FG004|STARTED|Long-Term Safety Phase (Year 4)||0||
48200416|NCT01212757|100814517|FG005|STARTED|Long-Term Safety Phase (Year 4)||0||
48200417|NCT01212757|100814518|FG006|STARTED|Long-Term Safety Phase (Year 4)||0||
48200418|NCT01212757|100814519|FG007|STARTED|Long-Term Safety Phase (Year 4)||41||
48200419|NCT01212757|100814520|FG008|STARTED|Long-Term Safety Phase (Year 4)||46||
48200420|NCT01212757|100814512|FG000|COMPLETED|Long-Term Safety Phase (Year 4)||0||
48200421|NCT01212757|100814513|FG001|COMPLETED|Long-Term Safety Phase (Year 4)||80||
48200422|NCT01212757|100814514|FG002|COMPLETED|Long-Term Safety Phase (Year 4)||77||
48200423|NCT01212757|100814515|FG003|COMPLETED|Long-Term Safety Phase (Year 4)||0||
48200424|NCT01212757|100814516|FG004|COMPLETED|Long-Term Safety Phase (Year 4)||0||
48200425|NCT01212757|100814517|FG005|COMPLETED|Long-Term Safety Phase (Year 4)||0||
48200426|NCT01212757|100814518|FG006|COMPLETED|Long-Term Safety Phase (Year 4)||0||
48200427|NCT01212757|100814519|FG007|COMPLETED|Long-Term Safety Phase (Year 4)||37||
48200428|NCT01212757|100814520|FG008|COMPLETED|Long-Term Safety Phase (Year 4)||39||
48200429|NCT01212757|100814512|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0||
48200430|NCT01212757|100814513|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 4)||9||
48200431|NCT01212757|100814514|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7||
48200432|NCT01212757|100814515|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0||
48200433|NCT01212757|100814516|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0||
48200434|NCT01212757|100814517|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0||
48200435|NCT01212757|100814518|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0||
48200436|NCT01212757|100814519|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 4)||4||
48200437|NCT01212757|100814520|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7||
48200438|NCT01212757|100814512|FG000|STARTED|Long-Term Safety Phase (Year 5)||0||
48200439|NCT01212757|100814513|FG001|STARTED|Long-Term Safety Phase (Year 5)||80||
48200440|NCT01212757|100814514|FG002|STARTED|Long-Term Safety Phase (Year 5)||77||
48200441|NCT01212757|100814515|FG003|STARTED|Long-Term Safety Phase (Year 5)||0||
48200442|NCT01212757|100814516|FG004|STARTED|Long-Term Safety Phase (Year 5)||0||
48491130|NCT00354835|101536067|FG000|NOT COMPLETED|Overall Study||52||
48200443|NCT01212757|100814517|FG005|STARTED|Long-Term Safety Phase (Year 5)||0||
48200444|NCT01212757|100814518|FG006|STARTED|Long-Term Safety Phase (Year 5)||0||
48200445|NCT01212757|100814519|FG007|STARTED|Long-Term Safety Phase (Year 5)||38||
48200446|NCT01212757|100814520|FG008|STARTED|Long-Term Safety Phase (Year 5)||39||
48491131|NCT00354835|101536068|FG001|NOT COMPLETED|Overall Study||61||
48491132|NCT04347018|101536069|FG000|STARTED|Overall Study||7||
48491133|NCT04347018|101536070|FG001|STARTED|Overall Study||6||
48200447|NCT01212757|100814512|FG000|COMPLETED|Long-Term Safety Phase (Year 5)||0||
48200448|NCT01212757|100814513|FG001|COMPLETED|Long-Term Safety Phase (Year 5)||72||
48200449|NCT01212757|100814514|FG002|COMPLETED|Long-Term Safety Phase (Year 5)||69||
48200450|NCT01212757|100814515|FG003|COMPLETED|Long-Term Safety Phase (Year 5)||0||
48200451|NCT01212757|100814516|FG004|COMPLETED|Long-Term Safety Phase (Year 5)||0||
48200452|NCT01212757|100814517|FG005|COMPLETED|Long-Term Safety Phase (Year 5)||0||
48200453|NCT01212757|100814518|FG006|COMPLETED|Long-Term Safety Phase (Year 5)||0||
48200454|NCT01212757|100814519|FG007|COMPLETED|Long-Term Safety Phase (Year 5)||33||
48200455|NCT01212757|100814520|FG008|COMPLETED|Long-Term Safety Phase (Year 5)||37||
48200456|NCT01212757|100814512|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0||
48200457|NCT01212757|100814513|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8||
48200458|NCT01212757|100814514|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8||
48491134|NCT04347018|101536069|FG000|COMPLETED|Overall Study||7||
48491135|NCT04347018|101536070|FG001|COMPLETED|Overall Study||6||
48491136|NCT04347018|101536069|FG000|NOT COMPLETED|Overall Study||0||
48491137|NCT04347018|101536070|FG001|NOT COMPLETED|Overall Study||0||
48491138|NCT00089011|101536071|FG000|STARTED|Overall Study||100||
48491139|NCT00089011|101536072|FG001|STARTED|Overall Study||50||
48491140|NCT00089011|101536071|FG000|COMPLETED|Overall Study||100||
48491141|NCT00089011|101536072|FG001|COMPLETED|Overall Study||50||
48491142|NCT00089011|101536071|FG000|NOT COMPLETED|Overall Study||0||
48491143|NCT00089011|101536072|FG001|NOT COMPLETED|Overall Study||0||
48491144|NCT02163837|101536073|FG000|STARTED|Before Rifaximin||15||
48491145|NCT02163837|101536073|FG000|COMPLETED|Before Rifaximin||15||
48491146|NCT02163837|101536073|FG000|NOT COMPLETED|Before Rifaximin||0||
48491147|NCT02163837|101536073|FG000|STARTED|Day 28 of Rifaximin Treatment||15||
48491148|NCT02163837|101536073|FG000|COMPLETED|Day 28 of Rifaximin Treatment||15||
48491149|NCT02163837|101536073|FG000|NOT COMPLETED|Day 28 of Rifaximin Treatment||0||
48491150|NCT01168856|101536074|FG000|STARTED|Overall Study||176||
48491151|NCT01168856|101536075|FG001|STARTED|Overall Study||558||
48491152|NCT01168856|101536074|FG000|COMPLETED|Overall Study||158||
48491153|NCT01168856|101536075|FG001|COMPLETED|Overall Study||215||
48491154|NCT01168856|101536074|FG000|NOT COMPLETED|Overall Study||18||
48491155|NCT01168856|101536075|FG001|NOT COMPLETED|Overall Study||343||
48491156|NCT01895335|101536076|FG000|STARTED|Overall Study||1001||
48491157|NCT01895335|101536076|FG000|Treated|Overall Study||1000||
48491158|NCT01895335|101536076|FG000|COMPLETED|Overall Study||786||
48491159|NCT01895335|101536076|FG000|NOT COMPLETED|Overall Study||215||
48491160|NCT00526188|101536077|FG000|STARTED|Overall Study||234||
48491161|NCT00526188|101536077|FG000|COMPLETED|Overall Study||234||
48491162|NCT00526188|101536077|FG000|NOT COMPLETED|Overall Study||0||
48491163|NCT00838539|101536078|FG000|STARTED|Overall Study||3||
48491164|NCT00838539|101536079|FG001|STARTED|Overall Study||6||
48491165|NCT00838539|101536080|FG002|STARTED|Overall Study||5||
48491166|NCT00838539|101536081|FG003|STARTED|Overall Study||4||
48491167|NCT00838539|101536082|FG004|STARTED|Overall Study||6||
48491168|NCT00838539|101536083|FG005|STARTED|Overall Study||4||
48491169|NCT00838539|101536084|FG006|STARTED|Overall Study||7||
48491170|NCT00838539|101536085|FG007|STARTED|Overall Study||6||
48491171|NCT00838539|101536086|FG008|STARTED|Overall Study||5||
48491172|NCT00838539|101536087|FG009|STARTED|Overall Study||8||
48491173|NCT00838539|101536088|FG010|STARTED|Overall Study||5||
48491174|NCT00838539|101536089|FG011|STARTED|Overall Study||4||
48491175|NCT00838539|101536078|FG000|Received Treatment|Overall Study||3||
48491176|NCT00838539|101536079|FG001|Received Treatment|Overall Study||5||
48491177|NCT00838539|101536080|FG002|Received Treatment|Overall Study||5||
48491178|NCT00838539|101536081|FG003|Received Treatment|Overall Study||4||
48491179|NCT00838539|101536082|FG004|Received Treatment|Overall Study||4||
48491180|NCT00838539|101536083|FG005|Received Treatment|Overall Study||4||
48491181|NCT00838539|101536084|FG006|Received Treatment|Overall Study||7||
48491182|NCT00838539|101536085|FG007|Received Treatment|Overall Study||6||
48491183|NCT00838539|101536086|FG008|Received Treatment|Overall Study||5||
48491184|NCT00838539|101536087|FG009|Received Treatment|Overall Study||8||
48491185|NCT00838539|101536088|FG010|Received Treatment|Overall Study||5||
48491186|NCT00838539|101536089|FG011|Received Treatment|Overall Study||4||
48491187|NCT00838539|101536078|FG000|COMPLETED|Overall Study||0||
48491188|NCT00838539|101536079|FG001|COMPLETED|Overall Study||0||
48491189|NCT00838539|101536080|FG002|COMPLETED|Overall Study||0||
48491190|NCT00838539|101536081|FG003|COMPLETED|Overall Study||0||
48491191|NCT00838539|101536082|FG004|COMPLETED|Overall Study||0||
48491192|NCT00838539|101536083|FG005|COMPLETED|Overall Study||0||
48491193|NCT00838539|101536084|FG006|COMPLETED|Overall Study||2||
48491194|NCT00838539|101536085|FG007|COMPLETED|Overall Study||0||
48491195|NCT00838539|101536086|FG008|COMPLETED|Overall Study||0||
48491196|NCT00838539|101536087|FG009|COMPLETED|Overall Study||0||
48491197|NCT00838539|101536088|FG010|COMPLETED|Overall Study||0||
48491198|NCT00838539|101536089|FG011|COMPLETED|Overall Study||0||
48491199|NCT00838539|101536078|FG000|NOT COMPLETED|Overall Study||3||
48491200|NCT00838539|101536079|FG001|NOT COMPLETED|Overall Study||6||
48491201|NCT00838539|101536080|FG002|NOT COMPLETED|Overall Study||5||
48491202|NCT00838539|101536081|FG003|NOT COMPLETED|Overall Study||4||
48491203|NCT00838539|101536082|FG004|NOT COMPLETED|Overall Study||6||
48491204|NCT00838539|101536083|FG005|NOT COMPLETED|Overall Study||4||
48491205|NCT00838539|101536084|FG006|NOT COMPLETED|Overall Study||5||
48491206|NCT00838539|101536085|FG007|NOT COMPLETED|Overall Study||6||
48491207|NCT00838539|101536086|FG008|NOT COMPLETED|Overall Study||5||
48491208|NCT00838539|101536087|FG009|NOT COMPLETED|Overall Study||8||
48491209|NCT00838539|101536088|FG010|NOT COMPLETED|Overall Study||5||
48491210|NCT00838539|101536089|FG011|NOT COMPLETED|Overall Study||4||
48491211|NCT00418561|101536090|FG000|STARTED|Overall Study||4||
48491212|NCT00418561|101536091|FG001|STARTED|Overall Study||5||
48491213|NCT00418561|101536092|FG002|STARTED|Overall Study||4||
48491214|NCT00418561|101536090|FG000|COMPLETED|Overall Study||4||
48200459|NCT01212757|100814515|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0||
48666645|NCT02296125|101970450|FG001|STARTED|Overall Study||277|There were 19 participants double counted which shows the total participants of 692.|
48200460|NCT01212757|100814516|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0||
48491215|NCT00418561|101536091|FG001|COMPLETED|Overall Study||4||
48491216|NCT00418561|101536092|FG002|COMPLETED|Overall Study||4||
48666646|NCT02296125|101970451|FG002|STARTED|Overall Study||71|There were 19 participants double counted which shows the total participants of 692.|
48666647|NCT02296125|101970452|FG003|STARTED|Overall Study||65|There were 19 participants double counted which shows the total participants of 692.|
48666648|NCT02296125|101970449|FG000|COMPLETED|Overall Study||61|Participants ongoing study treatment at data cut-off|
48666649|NCT02296125|101970450|FG001|COMPLETED|Overall Study||13|Participants ongoing study treatment at data cut-off|
48666650|NCT02296125|101970451|FG002|COMPLETED|Overall Study||15|Participants ongoing study treatment at data cut-off|
48666651|NCT02296125|101970452|FG003|COMPLETED|Overall Study||3|Participants ongoing study treatment at data cut-off|
48666652|NCT02296125|101970449|FG000|NOT COMPLETED|Overall Study||218||
48666653|NCT02296125|101970450|FG001|NOT COMPLETED|Overall Study||264||
48666654|NCT02296125|101970451|FG002|NOT COMPLETED|Overall Study||56||
48666655|NCT02296125|101970452|FG003|NOT COMPLETED|Overall Study||62||
48666656|NCT01129206|101970453|FG000|STARTED|Overall Study||6||
48491217|NCT00418561|101536090|FG000|NOT COMPLETED|Overall Study||0||
48200461|NCT01212757|100814517|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0||
48200462|NCT01212757|100814518|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0||
48200463|NCT01212757|100814519|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 5)||5||
48200464|NCT01212757|100814520|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 5)||2||
48491218|NCT00418561|101536091|FG001|NOT COMPLETED|Overall Study||1||
48491219|NCT00418561|101536092|FG002|NOT COMPLETED|Overall Study||0||
48491220|NCT01701063|101536093|FG000|STARTED|Overall Study||13||
48491221|NCT01701063|101536094|FG001|STARTED|Overall Study||19||
48491222|NCT01701063|101536095|FG002|STARTED|Overall Study||10||
48491223|NCT01701063|101536093|FG000|COMPLETED|Overall Study||13||
48491224|NCT01701063|101536094|FG001|COMPLETED|Overall Study||18||
48491225|NCT01701063|101536095|FG002|COMPLETED|Overall Study||8||
48491226|NCT01701063|101536093|FG000|NOT COMPLETED|Overall Study||0||
48491227|NCT01701063|101536094|FG001|NOT COMPLETED|Overall Study||1||
48491228|NCT01701063|101536095|FG002|NOT COMPLETED|Overall Study||2||
48491229|NCT00942968|101536096|FG000|STARTED|Overall Study||338||
48491230|NCT00942968|101536096|FG000|Treated|Overall Study||334||
48491231|NCT00942968|101536096|FG000|COMPLETED|Overall Study||109||
48491232|NCT00942968|101536096|FG000|NOT COMPLETED|Overall Study||229||
48491233|NCT00462345|101536097|FG000|STARTED|Overall Study||40||
48491234|NCT00462345|101536097|FG000|Completed First Course|Overall Study||38||
48491235|NCT00462345|101536097|FG000|COMPLETED|Overall Study||37||
48491236|NCT00462345|101536097|FG000|NOT COMPLETED|Overall Study||3||
48491237|NCT03302780|101536098|FG000|STARTED|Overall Study||3||
48491238|NCT03302780|101536099|FG001|STARTED|Overall Study||3||
48491239|NCT03302780|101536098|FG000|COMPLETED|Overall Study||3||
48491240|NCT03302780|101536099|FG001|COMPLETED|Overall Study||3||
48491241|NCT03302780|101536098|FG000|NOT COMPLETED|Overall Study||0||
48491242|NCT03302780|101536099|FG001|NOT COMPLETED|Overall Study||0||
48491243|NCT02599558|101536100|FG000|STARTED|Overall Study||22||
48491244|NCT02599558|101536100|FG000|COMPLETED|Overall Study||22||
48491245|NCT02599558|101536100|FG000|NOT COMPLETED|Overall Study||0||
48200465|NCT00367055|100814521|FG000|STARTED|Overall Study||43||
48200466|NCT00367055|100814522|FG001|STARTED|Overall Study||41||
48491246|NCT04216329|101536101|FG000|STARTED|Overall Study||0||
48491247|NCT04216329|101536102|FG001|STARTED|Overall Study||3||
48491248|NCT04216329|101536103|FG002|STARTED|Overall Study||6||
48491249|NCT04216329|101536104|FG003|STARTED|Overall Study||2||
48491250|NCT04216329|101536101|FG000|COMPLETED|Overall Study||0||
48491251|NCT04216329|101536102|FG001|COMPLETED|Overall Study||3||
48491252|NCT04216329|101536103|FG002|COMPLETED|Overall Study||6||
48491253|NCT04216329|101536104|FG003|COMPLETED|Overall Study||2||
48491254|NCT04216329|101536101|FG000|NOT COMPLETED|Overall Study||0||
48491255|NCT04216329|101536102|FG001|NOT COMPLETED|Overall Study||0||
48491256|NCT04216329|101536103|FG002|NOT COMPLETED|Overall Study||0||
48491257|NCT04216329|101536104|FG003|NOT COMPLETED|Overall Study||0||
48491258|NCT02157974|101536105|FG000|STARTED|Overall Study||24||
48491259|NCT02157974|101536106|FG001|STARTED|Overall Study||42||
48491260|NCT02157974|101536107|FG002|STARTED|Overall Study||10||
48491261|NCT02157974|101536108|FG003|STARTED|Overall Study||10||
48491262|NCT02157974|101536109|FG004|STARTED|Overall Study||6||
48491263|NCT02157974|101536105|FG000|COMPLETED|Overall Study||24||
48491264|NCT02157974|101536106|FG001|COMPLETED|Overall Study||39||
48491265|NCT02157974|101536107|FG002|COMPLETED|Overall Study||10||
48491266|NCT02157974|101536108|FG003|COMPLETED|Overall Study||10||
48491267|NCT02157974|101536109|FG004|COMPLETED|Overall Study||6||
48491268|NCT02157974|101536105|FG000|NOT COMPLETED|Overall Study||0||
48491269|NCT02157974|101536106|FG001|NOT COMPLETED|Overall Study||3||
48491270|NCT02157974|101536107|FG002|NOT COMPLETED|Overall Study||0||
48491271|NCT02157974|101536108|FG003|NOT COMPLETED|Overall Study||0||
48491272|NCT02157974|101536109|FG004|NOT COMPLETED|Overall Study||0||
48491273|NCT02067611|101536110|FG000|STARTED|Overall Study||72||
48491274|NCT02067611|101536111|FG001|STARTED|Overall Study||72||
48491275|NCT02067611|101536112|FG002|STARTED|Overall Study||72||
48491276|NCT02067611|101536110|FG000|COMPLETED|Overall Study||66||
48491277|NCT02067611|101536111|FG001|COMPLETED|Overall Study||66||
48491278|NCT02067611|101536112|FG002|COMPLETED|Overall Study||68||
48491279|NCT02067611|101536110|FG000|NOT COMPLETED|Overall Study||6||
48491280|NCT02067611|101536111|FG001|NOT COMPLETED|Overall Study||6||
48491281|NCT02067611|101536112|FG002|NOT COMPLETED|Overall Study||4||
48491282|NCT02358538|101536113|FG000|STARTED|Through Week 26||7||
48491283|NCT02358538|101536114|FG001|STARTED|Through Week 26||2||
48491284|NCT02358538|101536115|FG002|STARTED|Through Week 26||10||
48491285|NCT02358538|101536116|FG003|STARTED|Through Week 26||11||
48491286|NCT02358538|101536113|FG000|COMPLETED|Through Week 26||4||
48491287|NCT02358538|101536114|FG001|COMPLETED|Through Week 26||0||
48491288|NCT02358538|101536115|FG002|COMPLETED|Through Week 26||5||
48491289|NCT02358538|101536116|FG003|COMPLETED|Through Week 26||6||
48491290|NCT02358538|101536113|FG000|NOT COMPLETED|Through Week 26||3||
48491291|NCT02358538|101536114|FG001|NOT COMPLETED|Through Week 26||2||
48491292|NCT02358538|101536115|FG002|NOT COMPLETED|Through Week 26||5||
48491293|NCT02358538|101536116|FG003|NOT COMPLETED|Through Week 26||5||
48491294|NCT02358538|101536113|FG000|STARTED|52 Week Extension Period||4||
48491295|NCT02358538|101536114|FG001|STARTED|52 Week Extension Period||0||
48491296|NCT02358538|101536115|FG002|STARTED|52 Week Extension Period||4||
48491297|NCT02358538|101536116|FG003|STARTED|52 Week Extension Period||6||
48491298|NCT02358538|101536113|FG000|COMPLETED|52 Week Extension Period||4||
48491299|NCT02358538|101536114|FG001|COMPLETED|52 Week Extension Period||0||
48491300|NCT02358538|101536115|FG002|COMPLETED|52 Week Extension Period||2||
48491301|NCT02358538|101536116|FG003|COMPLETED|52 Week Extension Period||2||
48491302|NCT02358538|101536113|FG000|NOT COMPLETED|52 Week Extension Period||0||
48491303|NCT02358538|101536114|FG001|NOT COMPLETED|52 Week Extension Period||0||
48491304|NCT02358538|101536115|FG002|NOT COMPLETED|52 Week Extension Period||2||
48491305|NCT02358538|101536116|FG003|NOT COMPLETED|52 Week Extension Period||4||
48491306|NCT00583453|101536117|FG000|STARTED|Overall Study||9||
48491307|NCT00583453|101536118|FG001|STARTED|Overall Study||8||
48491308|NCT00583453|101536117|FG000|COMPLETED|Overall Study||9||
48491309|NCT00583453|101536118|FG001|COMPLETED|Overall Study||6||
48491310|NCT00583453|101536117|FG000|NOT COMPLETED|Overall Study||0||
48491311|NCT00583453|101536118|FG001|NOT COMPLETED|Overall Study||2||
48491312|NCT02488408|101536119|FG000|STARTED|Part A||6||
48491313|NCT02488408|101536120|FG001|STARTED|Part A||14||
48491314|NCT02488408|101536121|FG002|STARTED|Part A||5||
48491315|NCT02488408|101536122|FG003|STARTED|Part A||4||
48491316|NCT02488408|101536123|FG004|STARTED|Part A||7||
48491317|NCT02488408|101536124|FG005|STARTED|Part A||0||
48491318|NCT02488408|101536125|FG006|STARTED|Part A||0||
48491319|NCT02488408|101536126|FG007|STARTED|Part A||0||
48491320|NCT02488408|101536127|FG008|STARTED|Part A||0||
48491321|NCT02488408|101536128|FG009|STARTED|Part A||0||
48491322|NCT02488408|101536119|FG000|COMPLETED|Part A||0||
48491323|NCT02488408|101536120|FG001|COMPLETED|Part A||0||
48491324|NCT02488408|101536121|FG002|COMPLETED|Part A||0||
48491325|NCT02488408|101536122|FG003|COMPLETED|Part A||0||
48491326|NCT02488408|101536123|FG004|COMPLETED|Part A||0||
48200467|NCT00367055|100814521|FG000|COMPLETED|Overall Study||32||
48200468|NCT00367055|100814522|FG001|COMPLETED|Overall Study||30||
48491327|NCT02488408|101536124|FG005|COMPLETED|Part A||0||
48491328|NCT02488408|101536125|FG006|COMPLETED|Part A||0||
48491329|NCT02488408|101536126|FG007|COMPLETED|Part A||0||
48491330|NCT02488408|101536127|FG008|COMPLETED|Part A||0||
48491331|NCT02488408|101536128|FG009|COMPLETED|Part A||0||
48491332|NCT02488408|101536119|FG000|NOT COMPLETED|Part A||6||
48491333|NCT02488408|101536120|FG001|NOT COMPLETED|Part A||14||
48491334|NCT02488408|101536121|FG002|NOT COMPLETED|Part A||5||
48491335|NCT02488408|101536122|FG003|NOT COMPLETED|Part A||4||
48491336|NCT02488408|101536123|FG004|NOT COMPLETED|Part A||7||
48491337|NCT02488408|101536124|FG005|NOT COMPLETED|Part A||0||
48491338|NCT02488408|101536125|FG006|NOT COMPLETED|Part A||0||
48491339|NCT02488408|101536126|FG007|NOT COMPLETED|Part A||0||
48491340|NCT02488408|101536127|FG008|NOT COMPLETED|Part A||0||
48491341|NCT02488408|101536128|FG009|NOT COMPLETED|Part A||0||
48491342|NCT02488408|101536119|FG000|STARTED|Part B||0||
48491343|NCT02488408|101536120|FG001|STARTED|Part B||0||
48491344|NCT02488408|101536121|FG002|STARTED|Part B||0||
48491345|NCT02488408|101536122|FG003|STARTED|Part B||0||
48491346|NCT02488408|101536123|FG004|STARTED|Part B||0||
48491347|NCT02488408|101536124|FG005|STARTED|Part B||14||
48491348|NCT02488408|101536125|FG006|STARTED|Part B||16||
48491349|NCT02488408|101536126|FG007|STARTED|Part B||18||
48491350|NCT02488408|101536127|FG008|STARTED|Part B||18||
48491351|NCT02488408|101536128|FG009|STARTED|Part B||20||
48491352|NCT02488408|101536119|FG000|COMPLETED|Part B||0||
48491353|NCT02488408|101536120|FG001|COMPLETED|Part B||0||
48200469|NCT00367055|100814521|FG000|NOT COMPLETED|Overall Study||11||
48200470|NCT00367055|100814522|FG001|NOT COMPLETED|Overall Study||11||
48200471|NCT01020838|100814523|FG000|STARTED|Overall Study||218||
48200472|NCT01020838|100814523|FG000|Safety Analysis Set|Overall Study||216||
48200473|NCT01020838|100814523|FG000|Interim Analysis Set (Primary Efficacy)|Overall Study||41||
48491354|NCT02488408|101536121|FG002|COMPLETED|Part B||0||
48491355|NCT02488408|101536122|FG003|COMPLETED|Part B||0||
48491356|NCT02488408|101536123|FG004|COMPLETED|Part B||0||
48491357|NCT02488408|101536124|FG005|COMPLETED|Part B||0||
48491358|NCT02488408|101536125|FG006|COMPLETED|Part B||0||
48491359|NCT02488408|101536126|FG007|COMPLETED|Part B||0||
48491360|NCT02488408|101536127|FG008|COMPLETED|Part B||0||
48491361|NCT02488408|101536128|FG009|COMPLETED|Part B||0||
48491362|NCT02488408|101536119|FG000|NOT COMPLETED|Part B||0||
48491363|NCT02488408|101536120|FG001|NOT COMPLETED|Part B||0||
48491364|NCT02488408|101536121|FG002|NOT COMPLETED|Part B||0||
48491365|NCT02488408|101536122|FG003|NOT COMPLETED|Part B||0||
48491366|NCT02488408|101536123|FG004|NOT COMPLETED|Part B||0||
48491367|NCT02488408|101536124|FG005|NOT COMPLETED|Part B||14||
48491368|NCT02488408|101536125|FG006|NOT COMPLETED|Part B||16||
48491369|NCT02488408|101536126|FG007|NOT COMPLETED|Part B||18||
48491370|NCT02488408|101536127|FG008|NOT COMPLETED|Part B||18||
48491371|NCT02488408|101536128|FG009|NOT COMPLETED|Part B||20||
48491372|NCT04076059|101536129|FG000|STARTED|Double Blind Phase||120||
48491373|NCT04076059|101536130|FG001|STARTED|Double Blind Phase||60||
48491374|NCT04076059|101536131|FG002|STARTED|Double Blind Phase||0||
48491375|NCT04076059|101536129|FG000|Ongoing Participants|Double Blind Phase||82||
48491376|NCT04076059|101536130|FG001|Ongoing Participants|Double Blind Phase||18||
48491377|NCT04076059|101536131|FG002|Ongoing Participants|Double Blind Phase||0||
48491378|NCT04076059|101536129|FG000|Participants Who Received at Least One Dose of Study Drug|Double Blind Phase||119||
48491379|NCT04076059|101536130|FG001|Participants Who Received at Least One Dose of Study Drug|Double Blind Phase||59||
48491380|NCT04076059|101536131|FG002|Participants Who Received at Least One Dose of Study Drug|Double Blind Phase||0||
48491381|NCT04076059|101536129|FG000|COMPLETED|Double Blind Phase||0||
48491382|NCT04076059|101536130|FG001|COMPLETED|Double Blind Phase||0||
48491383|NCT04076059|101536131|FG002|COMPLETED|Double Blind Phase||0||
48200474|NCT01020838|100814523|FG000|Final Analysis Set (Whole Brain)|Overall Study||97||
48200475|NCT01020838|100814523|FG000|First Annual Repeat Injection|Overall Study||91||
48491384|NCT04076059|101536129|FG000|NOT COMPLETED|Double Blind Phase||120||
48491385|NCT04076059|101536130|FG001|NOT COMPLETED|Double Blind Phase||60||
48491386|NCT04076059|101536131|FG002|NOT COMPLETED|Double Blind Phase||0||
48491387|NCT04076059|101536129|FG000|STARTED|Open Label Phase||0||
48491388|NCT04076059|101536130|FG001|STARTED|Open Label Phase||0||
48491389|NCT04076059|101536131|FG002|STARTED|Open Label Phase||23||
48491390|NCT04076059|101536129|FG000|COMPLETED|Open Label Phase||0||
48491391|NCT04076059|101536130|FG001|COMPLETED|Open Label Phase||0||
48491392|NCT04076059|101536131|FG002|COMPLETED|Open Label Phase||0||
48491393|NCT04076059|101536129|FG000|NOT COMPLETED|Open Label Phase||0||
48491394|NCT04076059|101536130|FG001|NOT COMPLETED|Open Label Phase||0||
48491395|NCT04076059|101536131|FG002|NOT COMPLETED|Open Label Phase||23||
48491396|NCT01528696|101536132|FG000|STARTED|Overall Study||18||
48491397|NCT01528696|101536133|FG001|STARTED|Overall Study||19||
48491398|NCT01528696|101536132|FG000|Hospital Stay (2-5 Days)|Overall Study||18||
48491399|NCT01528696|101536133|FG001|Hospital Stay (2-5 Days)|Overall Study||19||
48491400|NCT01528696|101536132|FG000|COMPLETED|Overall Study||0||
48491401|NCT01528696|101536133|FG001|COMPLETED|Overall Study||0||
48491402|NCT01528696|101536132|FG000|NOT COMPLETED|Overall Study||18||
48491403|NCT01528696|101536133|FG001|NOT COMPLETED|Overall Study||19||
48491404|NCT02101788|101536134|FG000|STARTED|Overall Study||130||
48491405|NCT02101788|101536135|FG001|STARTED|Overall Study||130||
48491406|NCT02101788|101536134|FG000|Crossover From Arm A to Arm B|Overall Study||88||
48491407|NCT02101788|101536135|FG001|Crossover From Arm A to Arm B|Overall Study||0||
48491408|NCT02101788|101536134|FG000|COMPLETED|Overall Study||120||
48491409|NCT02101788|101536135|FG001|COMPLETED|Overall Study||116||
48491410|NCT02101788|101536134|FG000|NOT COMPLETED|Overall Study||10||
48491411|NCT02101788|101536135|FG001|NOT COMPLETED|Overall Study||14||
48491412|NCT02861300|101536136|FG000|STARTED|Overall Study||0||
48491413|NCT02861300|101536137|FG001|STARTED|Overall Study||3||
48491414|NCT02861300|101536138|FG002|STARTED|Overall Study||3||
48491415|NCT02861300|101536139|FG003|STARTED|Overall Study||3||
48491416|NCT02861300|101536140|FG004|STARTED|Overall Study||0||
48491417|NCT02861300|101536141|FG005|STARTED|Overall Study||7||
48491418|NCT02861300|101536142|FG006|STARTED|Overall Study||32||
48491419|NCT02861300|101536136|FG000|COMPLETED|Overall Study||0||
48491420|NCT02861300|101536137|FG001|COMPLETED|Overall Study||2||
48491421|NCT02861300|101536138|FG002|COMPLETED|Overall Study||3||
48491422|NCT02861300|101536139|FG003|COMPLETED|Overall Study||3||
48491423|NCT02861300|101536140|FG004|COMPLETED|Overall Study||0||
48491424|NCT02861300|101536141|FG005|COMPLETED|Overall Study||6||
48491425|NCT02861300|101536142|FG006|COMPLETED|Overall Study||3||
48491426|NCT02861300|101536136|FG000|NOT COMPLETED|Overall Study||0||
48491427|NCT02861300|101536137|FG001|NOT COMPLETED|Overall Study||1||
48491428|NCT02861300|101536138|FG002|NOT COMPLETED|Overall Study||0||
48200476|NCT01020838|100814523|FG000|Second Annual Repeat Injection|Overall Study||34||
48200477|NCT01020838|100814523|FG000|COMPLETED|Overall Study||35||
48491429|NCT02861300|101536139|FG003|NOT COMPLETED|Overall Study||0||
48491430|NCT02861300|101536140|FG004|NOT COMPLETED|Overall Study||0||
48491431|NCT02861300|101536141|FG005|NOT COMPLETED|Overall Study||1||
48491432|NCT02861300|101536142|FG006|NOT COMPLETED|Overall Study||29||
48491433|NCT00829530|101536143|FG000|STARTED|First Intervention||20||
48491434|NCT00829530|101536144|FG001|STARTED|First Intervention||20||
48491435|NCT00829530|101536143|FG000|COMPLETED|First Intervention||20||
48491436|NCT00829530|101536144|FG001|COMPLETED|First Intervention||18||
48491437|NCT00829530|101536143|FG000|NOT COMPLETED|First Intervention||0||
48491438|NCT00829530|101536144|FG001|NOT COMPLETED|First Intervention||2||
48491439|NCT00829530|101536143|FG000|STARTED|Washout of 42 Days||20||
48491440|NCT00829530|101536144|FG001|STARTED|Washout of 42 Days||18||
48491441|NCT00829530|101536143|FG000|COMPLETED|Washout of 42 Days||20||
48491442|NCT00829530|101536144|FG001|COMPLETED|Washout of 42 Days||18||
48491443|NCT00829530|101536143|FG000|NOT COMPLETED|Washout of 42 Days||0||
48491444|NCT00829530|101536144|FG001|NOT COMPLETED|Washout of 42 Days||0||
48491445|NCT00829530|101536143|FG000|STARTED|Second Intervention||20||
48491446|NCT00829530|101536144|FG001|STARTED|Second Intervention||18||
48491447|NCT00829530|101536143|FG000|COMPLETED|Second Intervention||19||
48491448|NCT00829530|101536144|FG001|COMPLETED|Second Intervention||18||
48491449|NCT00829530|101536143|FG000|NOT COMPLETED|Second Intervention||1||
48491450|NCT00829530|101536144|FG001|NOT COMPLETED|Second Intervention||0||
48491451|NCT01718873|101536145|FG000|STARTED|Overall Study||115||
48491452|NCT01718873|101536146|FG001|STARTED|Overall Study||115||
48491453|NCT01718873|101536145|FG000|COMPLETED|Overall Study||115||
48491454|NCT01718873|101536146|FG001|COMPLETED|Overall Study||115||
48491455|NCT01718873|101536145|FG000|NOT COMPLETED|Overall Study||0||
48491456|NCT01718873|101536146|FG001|NOT COMPLETED|Overall Study||0||
48491457|NCT00909753|101536147|FG000|STARTED|Period: First Intervention||46||
48491458|NCT00909753|101536148|FG001|STARTED|Period: First Intervention||46||
48491459|NCT00909753|101536147|FG000|COMPLETED|Period: First Intervention||46||
48491460|NCT00909753|101536148|FG001|COMPLETED|Period: First Intervention||46||
48491461|NCT00909753|101536147|FG000|NOT COMPLETED|Period: First Intervention||0||
48491462|NCT00909753|101536148|FG001|NOT COMPLETED|Period: First Intervention||0||
48200478|NCT01020838|100814523|FG000|NOT COMPLETED|Overall Study||183||
48200479|NCT03888755|100814524|FG000|STARTED|Overall Study||8||
48200480|NCT03888755|100814524|FG000|COMPLETED|Overall Study||8||
48200481|NCT03888755|100814524|FG000|NOT COMPLETED|Overall Study||0||
48200482|NCT02517307|100814525|FG000|STARTED|Overall Study||11||
48200483|NCT02517307|100814526|FG001|STARTED|Overall Study||8||
48200484|NCT02517307|100814527|FG002|STARTED|Overall Study||11||
48200485|NCT02517307|100814528|FG003|STARTED|Overall Study||11||
48200486|NCT02517307|100814525|FG000|COMPLETED|Overall Study||10||
48200487|NCT02517307|100814526|FG001|COMPLETED|Overall Study||8||
48200488|NCT02517307|100814527|FG002|COMPLETED|Overall Study||9||
48200489|NCT02517307|100814528|FG003|COMPLETED|Overall Study||10||
48200490|NCT02517307|100814525|FG000|NOT COMPLETED|Overall Study||1||
48200491|NCT02517307|100814526|FG001|NOT COMPLETED|Overall Study||0||
48200492|NCT02517307|100814527|FG002|NOT COMPLETED|Overall Study||2||
48491463|NCT00909753|101536147|FG000|STARTED|Period: Washout of 28 Days||46||
48200493|NCT02517307|100814528|FG003|NOT COMPLETED|Overall Study||1||
48200494|NCT03612804|100814529|FG000|STARTED|Overall Study||47||
48200495|NCT03612804|100814530|FG001|STARTED|Overall Study||422||
48200496|NCT03612804|100814531|FG002|STARTED|Overall Study||69||
48200497|NCT03612804|100814532|FG003|STARTED|Overall Study||406||
48200498|NCT03612804|100814529|FG000|COMPLETED|Overall Study||46||
48200499|NCT03612804|100814530|FG001|COMPLETED|Overall Study||412||
48200500|NCT03612804|100814531|FG002|COMPLETED|Overall Study||60||
48200501|NCT03612804|100814532|FG003|COMPLETED|Overall Study||378||
48200502|NCT03612804|100814529|FG000|NOT COMPLETED|Overall Study||1||
48200503|NCT03612804|100814530|FG001|NOT COMPLETED|Overall Study||10||
48491464|NCT00909753|101536148|FG001|STARTED|Period: Washout of 28 Days||46||
48491465|NCT00909753|101536147|FG000|COMPLETED|Period: Washout of 28 Days||44||
48491466|NCT00909753|101536148|FG001|COMPLETED|Period: Washout of 28 Days||43||
48491467|NCT00909753|101536147|FG000|NOT COMPLETED|Period: Washout of 28 Days||2||
48491468|NCT00909753|101536148|FG001|NOT COMPLETED|Period: Washout of 28 Days||3||
48491469|NCT00909753|101536147|FG000|STARTED|Period: Second Intervention||44||
48491470|NCT00909753|101536148|FG001|STARTED|Period: Second Intervention||43||
48491471|NCT00909753|101536147|FG000|COMPLETED|Period: Second Intervention||43||
48491472|NCT00909753|101536148|FG001|COMPLETED|Period: Second Intervention||43||
48491473|NCT00909753|101536147|FG000|NOT COMPLETED|Period: Second Intervention||1||
48491474|NCT00909753|101536148|FG001|NOT COMPLETED|Period: Second Intervention||0||
48491475|NCT02554877|101536149|FG000|STARTED|Overall Study||51||
48491476|NCT02554877|101536150|FG001|STARTED|Overall Study||51||
48666657|NCT01129206|101970453|FG000|COMPLETED|Overall Study||6||
48666658|NCT01129206|101970453|FG000|NOT COMPLETED|Overall Study||0||
48491477|NCT02554877|101536151|FG002|STARTED|Overall Study||52||
48491478|NCT02554877|101536152|FG003|STARTED|Overall Study||52||
48491479|NCT02554877|101536149|FG000|COMPLETED|Overall Study||39||
48491480|NCT02554877|101536150|FG001|COMPLETED|Overall Study||44||
48491481|NCT02554877|101536151|FG002|COMPLETED|Overall Study||46||
48491482|NCT02554877|101536152|FG003|COMPLETED|Overall Study||45||
48491483|NCT02554877|101536149|FG000|NOT COMPLETED|Overall Study||12||
48491484|NCT02554877|101536150|FG001|NOT COMPLETED|Overall Study||7||
48491485|NCT02554877|101536151|FG002|NOT COMPLETED|Overall Study||6||
48491486|NCT02554877|101536152|FG003|NOT COMPLETED|Overall Study||7||
48491487|NCT02334722|101536153|FG000|STARTED|Overall Study||40||
48491488|NCT02334722|101536154|FG001|STARTED|Overall Study||41||
48491489|NCT02334722|101536153|FG000|COMPLETED|Overall Study||33||
48491490|NCT02334722|101536154|FG001|COMPLETED|Overall Study||34||
48491491|NCT02334722|101536153|FG000|NOT COMPLETED|Overall Study||7||
48491492|NCT02334722|101536154|FG001|NOT COMPLETED|Overall Study||7||
48491493|NCT01552317|101536155|FG000|STARTED|Overall Study||96||
48491494|NCT01552317|101536156|FG001|STARTED|Overall Study||97||
48491495|NCT01552317|101536155|FG000|COMPLETED|Overall Study||77||
48491496|NCT01552317|101536156|FG001|COMPLETED|Overall Study||81||
48491497|NCT01552317|101536155|FG000|NOT COMPLETED|Overall Study||19||
48491498|NCT01552317|101536156|FG001|NOT COMPLETED|Overall Study||16||
48491499|NCT00875524|101536157|FG000|STARTED|Overall Study||120||
48491500|NCT00875524|101536158|FG001|STARTED|Overall Study||60||
48491501|NCT00875524|101536157|FG000|Received Vaccination 1|Overall Study||120||
48491502|NCT00875524|101536158|FG001|Received Vaccination 1|Overall Study||60||
48491503|NCT00875524|101536157|FG000|Received Vaccination 2|Overall Study||116||
48491504|NCT00875524|101536158|FG001|Received Vaccination 2|Overall Study||58||
48491505|NCT00875524|101536157|FG000|Received Vaccination 3|Overall Study||114||
48491506|NCT00875524|101536158|FG001|Received Vaccination 3|Overall Study||58||
48491507|NCT00875524|101536157|FG000|COMPLETED|Overall Study||112||
48491508|NCT00875524|101536158|FG001|COMPLETED|Overall Study||54||
48491509|NCT00875524|101536157|FG000|NOT COMPLETED|Overall Study||8||
48491510|NCT00875524|101536158|FG001|NOT COMPLETED|Overall Study||6||
48491511|NCT00883233|101536159|FG000|STARTED|Overall Study||32||
48491512|NCT00883233|101536160|FG001|STARTED|Overall Study||32||
48491513|NCT00883233|101536161|FG002|STARTED|Overall Study||29||
48491514|NCT00883233|101536162|FG003|STARTED|Overall Study||30||
48491515|NCT00883233|101536159|FG000|COMPLETED|Overall Study||27||
48491516|NCT00883233|101536160|FG001|COMPLETED|Overall Study||28||
48491517|NCT00883233|101536161|FG002|COMPLETED|Overall Study||25||
48491518|NCT00883233|101536162|FG003|COMPLETED|Overall Study||25||
48491519|NCT00883233|101536159|FG000|NOT COMPLETED|Overall Study||5||
48491520|NCT00883233|101536160|FG001|NOT COMPLETED|Overall Study||4||
48491521|NCT00883233|101536161|FG002|NOT COMPLETED|Overall Study||4||
48491522|NCT00883233|101536162|FG003|NOT COMPLETED|Overall Study||5||
48491523|NCT02393885|101536163|FG000|STARTED|Overall Study||90||
48491524|NCT02393885|101536163|FG000|COMPLETED|Overall Study||85||
48491525|NCT02393885|101536163|FG000|NOT COMPLETED|Overall Study||5||
48491526|NCT02927639|101536164|FG000|STARTED|Overall Study||83||
48491527|NCT02927639|101536165|FG001|STARTED|Overall Study||82||
48491528|NCT02927639|101536164|FG000|COMPLETED|Overall Study||10||
48491529|NCT02927639|101536165|FG001|COMPLETED|Overall Study||13||
48491530|NCT02927639|101536164|FG000|NOT COMPLETED|Overall Study||73||
48491531|NCT02927639|101536165|FG001|NOT COMPLETED|Overall Study||69||
48491532|NCT01663233|101536166|FG000|STARTED|Overall Study||130||
48491533|NCT01663233|101536167|FG001|STARTED|Overall Study||136||
48491534|NCT01663233|101536166|FG000|COMPLETED|Overall Study||126||
48491535|NCT01663233|101536167|FG001|COMPLETED|Overall Study||129||
48491536|NCT01663233|101536166|FG000|NOT COMPLETED|Overall Study||4||
48491537|NCT01663233|101536167|FG001|NOT COMPLETED|Overall Study||7||
48491538|NCT03032107|101536168|FG000|STARTED|Dose De-escalation (Dose-finding)||6||
48491539|NCT03032107|101536168|FG000|COMPLETED|Dose De-escalation (Dose-finding)||6||
48491540|NCT03032107|101536168|FG000|NOT COMPLETED|Dose De-escalation (Dose-finding)||0||
48491541|NCT03032107|101536168|FG000|STARTED|Recommended Phase 2 Dose Expansion||14||
48491542|NCT03032107|101536168|FG000|COMPLETED|Recommended Phase 2 Dose Expansion||14||
48491543|NCT03032107|101536168|FG000|NOT COMPLETED|Recommended Phase 2 Dose Expansion||0||
48491544|NCT00834561|101536169|FG000|STARTED|First Intervention||16||
48491545|NCT00834561|101536170|FG001|STARTED|First Intervention||16||
48491546|NCT00834561|101536169|FG000|COMPLETED|First Intervention||16||
48491547|NCT00834561|101536170|FG001|COMPLETED|First Intervention||16||
48491548|NCT00834561|101536169|FG000|NOT COMPLETED|First Intervention||0||
48491549|NCT00834561|101536170|FG001|NOT COMPLETED|First Intervention||0||
48491550|NCT00834561|101536169|FG000|STARTED|Second Intervention||16||
48491551|NCT00834561|101536170|FG001|STARTED|Second Intervention||16||
48491552|NCT00834561|101536169|FG000|COMPLETED|Second Intervention||16||
48491553|NCT00834561|101536170|FG001|COMPLETED|Second Intervention||16||
48491554|NCT00834561|101536169|FG000|NOT COMPLETED|Second Intervention||0||
48491555|NCT00834561|101536170|FG001|NOT COMPLETED|Second Intervention||0||
48491556|NCT05755282|101536171|FG000|STARTED|Overall Study||19||
48491557|NCT05755282|101536172|FG001|STARTED|Overall Study||27||
48491558|NCT05755282|101536171|FG000|COMPLETED|Overall Study||19||
48491559|NCT05755282|101536172|FG001|COMPLETED|Overall Study||26||
48491560|NCT05755282|101536171|FG000|NOT COMPLETED|Overall Study||0||
48491561|NCT05755282|101536172|FG001|NOT COMPLETED|Overall Study||1||
48491562|NCT00627016|101536173|FG000|STARTED|Overall Study||153||
48491563|NCT00627016|101536174|FG001|STARTED|Overall Study||152||
48491564|NCT00627016|101536173|FG000|COMPLETED|Overall Study||147||
48491565|NCT00627016|101536174|FG001|COMPLETED|Overall Study||146||
48491566|NCT00627016|101536173|FG000|NOT COMPLETED|Overall Study||6||
48491567|NCT00627016|101536174|FG001|NOT COMPLETED|Overall Study||6||
48491568|NCT00829790|101536175|FG000|STARTED|First Intervention||15||
48491569|NCT00829790|101536176|FG001|STARTED|First Intervention||15||
48491570|NCT00829790|101536175|FG000|COMPLETED|First Intervention||15||
48491571|NCT00829790|101536176|FG001|COMPLETED|First Intervention||15||
48200504|NCT03612804|100814531|FG002|NOT COMPLETED|Overall Study||9||
48491572|NCT00829790|101536175|FG000|NOT COMPLETED|First Intervention||0||
48491573|NCT00829790|101536176|FG001|NOT COMPLETED|First Intervention||0||
48491574|NCT00829790|101536175|FG000|STARTED|Washout of 14 Days||15||
48491575|NCT00829790|101536176|FG001|STARTED|Washout of 14 Days||15||
48491576|NCT00829790|101536175|FG000|COMPLETED|Washout of 14 Days||15||
48491577|NCT00829790|101536176|FG001|COMPLETED|Washout of 14 Days||14||
48491578|NCT00829790|101536175|FG000|NOT COMPLETED|Washout of 14 Days||0||
48491579|NCT00829790|101536176|FG001|NOT COMPLETED|Washout of 14 Days||1||
48491580|NCT00829790|101536175|FG000|STARTED|Second Intervention||15||
48491581|NCT00829790|101536176|FG001|STARTED|Second Intervention||14||
48491582|NCT00829790|101536175|FG000|COMPLETED|Second Intervention||15||
48491583|NCT00829790|101536176|FG001|COMPLETED|Second Intervention||14||
48491584|NCT00829790|101536175|FG000|NOT COMPLETED|Second Intervention||0||
48491585|NCT00829790|101536176|FG001|NOT COMPLETED|Second Intervention||0||
48491586|NCT01778010|101536177|FG000|STARTED|Overall Study||13||
48491587|NCT01778010|101536177|FG000|COMPLETED|Overall Study||8||
48491588|NCT01778010|101536177|FG000|NOT COMPLETED|Overall Study||5||
48491589|NCT00443651|101538649|FG000|STARTED|Overall Study||401||
48491590|NCT00443651|101538650|FG001|STARTED|Overall Study||176||
48491591|NCT00443651|101538649|FG000|Week 24|Overall Study||376||
48491592|NCT00443651|101538650|FG001|Week 24|Overall Study||160||
48491593|NCT00443651|101538649|FG000|Week 48|Overall Study||338||
48491594|NCT00443651|101538650|FG001|Week 48|Overall Study||134||
48491595|NCT00443651|101538649|FG000|COMPLETED|Overall Study||306||
48491596|NCT00443651|101538650|FG001|COMPLETED|Overall Study||118||
48491597|NCT00443651|101538649|FG000|NOT COMPLETED|Overall Study||95||
48491598|NCT00443651|101538650|FG001|NOT COMPLETED|Overall Study||58||
48491599|NCT04132518|101538651|FG000|STARTED|Overall Study||16||
48491600|NCT04132518|101538652|FG001|STARTED|Overall Study||126||
48491601|NCT04132518|101538653|FG002|STARTED|Overall Study||63||
48491602|NCT04132518|101538651|FG000|Treated|Overall Study||16||
48491603|NCT04132518|101538652|FG001|Treated|Overall Study||124||
48491604|NCT04132518|101538653|FG002|Treated|Overall Study||0||
48491605|NCT04132518|101538651|FG000|COMPLETED|Overall Study||16||
48491606|NCT04132518|101538652|FG001|COMPLETED|Overall Study||117||
48491607|NCT04132518|101538653|FG002|COMPLETED|Overall Study||62||
48491608|NCT04132518|101538651|FG000|NOT COMPLETED|Overall Study||0||
48491609|NCT04132518|101538652|FG001|NOT COMPLETED|Overall Study||9||
48491610|NCT04132518|101538653|FG002|NOT COMPLETED|Overall Study||1||
48491611|NCT03713086|101538654|FG000|STARTED|Overall Study||16||
48491612|NCT03713086|101538655|FG001|STARTED|Overall Study||16||
48491613|NCT03713086|101538656|FG002|STARTED|Overall Study||10||
48491614|NCT03713086|101538657|FG003|STARTED|Overall Study||11||
48491615|NCT03713086|101538654|FG000|Received Dose at Day 1|Overall Study||16||
48491616|NCT03713086|101538655|FG001|Received Dose at Day 1|Overall Study||16||
48491617|NCT03713086|101538656|FG002|Received Dose at Day 1|Overall Study||10||
48491618|NCT03713086|101538657|FG003|Received Dose at Day 1|Overall Study||11||
48491619|NCT03713086|101538654|FG000|Received Dose at Day 8|Overall Study||0||
48491620|NCT03713086|101538655|FG001|Received Dose at Day 8|Overall Study||0||
48491621|NCT03713086|101538656|FG002|Received Dose at Day 8|Overall Study||0||
48491622|NCT03713086|101538657|FG003|Received Dose at Day 8|Overall Study||11||
48491623|NCT03713086|101538654|FG000|Received Dose at Day 29|Overall Study||8||
48491624|NCT03713086|101538655|FG001|Received Dose at Day 29|Overall Study||8||
48491625|NCT03713086|101538656|FG002|Received Dose at Day 29|Overall Study||0||
48491626|NCT03713086|101538657|FG003|Received Dose at Day 29|Overall Study||11||
48491627|NCT03713086|101538654|FG000|COMPLETED|Overall Study||16||
48491628|NCT03713086|101538655|FG001|COMPLETED|Overall Study||13||
48491629|NCT03713086|101538656|FG002|COMPLETED|Overall Study||9||
48491630|NCT03713086|101538657|FG003|COMPLETED|Overall Study||10||
48491631|NCT03713086|101538654|FG000|NOT COMPLETED|Overall Study||0||
48491632|NCT03713086|101538655|FG001|NOT COMPLETED|Overall Study||3||
48491633|NCT03713086|101538656|FG002|NOT COMPLETED|Overall Study||1||
48491634|NCT03713086|101538657|FG003|NOT COMPLETED|Overall Study||1||
48491635|NCT03938246|101538658|FG000|STARTED|Overall Study||33||
48491636|NCT03938246|101538659|FG001|STARTED|Overall Study||35||
48491637|NCT03938246|101538660|FG002|STARTED|Overall Study||31||
48491638|NCT03938246|101538661|FG003|STARTED|Overall Study||21||
48491639|NCT03938246|101538662|FG004|STARTED|Overall Study||9||
48491640|NCT03938246|101538663|FG005|STARTED|Overall Study||13||
48491641|NCT03938246|101538658|FG000|COMPLETED|Overall Study||27||
48491642|NCT03938246|101538659|FG001|COMPLETED|Overall Study||30||
48491643|NCT03938246|101538660|FG002|COMPLETED|Overall Study||31||
48491644|NCT03938246|101538661|FG003|COMPLETED|Overall Study||20||
48491645|NCT03938246|101538662|FG004|COMPLETED|Overall Study||9||
48491646|NCT03938246|101538663|FG005|COMPLETED|Overall Study||11||
48491647|NCT03938246|101538658|FG000|NOT COMPLETED|Overall Study||6||
48491648|NCT03938246|101538659|FG001|NOT COMPLETED|Overall Study||5||
48491649|NCT03938246|101538660|FG002|NOT COMPLETED|Overall Study||0||
48491650|NCT03938246|101538661|FG003|NOT COMPLETED|Overall Study||1||
48491651|NCT03938246|101538662|FG004|NOT COMPLETED|Overall Study||0||
48491652|NCT03938246|101538663|FG005|NOT COMPLETED|Overall Study||2||
48491653|NCT05184894|101538664|FG000|STARTED|Overall Study||25||
48491654|NCT05184894|101538665|FG001|STARTED|Overall Study||25||
48491655|NCT05184894|101538664|FG000|COMPLETED|Overall Study||25||
48491656|NCT05184894|101538665|FG001|COMPLETED|Overall Study||25||
48491657|NCT05184894|101538664|FG000|NOT COMPLETED|Overall Study||0||
48200505|NCT03612804|100814532|FG003|NOT COMPLETED|Overall Study||28||
48491658|NCT05184894|101538665|FG001|NOT COMPLETED|Overall Study||0||
48491659|NCT03199963|101538666|FG000|STARTED|Blinded Phase - Overall Study||149||
48491660|NCT03199963|101538667|FG001|STARTED|Blinded Phase - Overall Study||74||
48491661|NCT03199963|101538666|FG000|Received at Least 1 Gel Application|Blinded Phase - Overall Study||149||
48491662|NCT03199963|101538667|FG001|Received at Least 1 Gel Application|Blinded Phase - Overall Study||73||
48491663|NCT03199963|101538666|FG000|COMPLETED|Blinded Phase - Overall Study||16|Completed 52 week visit|
48491664|NCT03199963|101538667|FG001|COMPLETED|Blinded Phase - Overall Study||8|Completed 52 week visit|
48491665|NCT03199963|101538666|FG000|NOT COMPLETED|Blinded Phase - Overall Study||133||
48491666|NCT03199963|101538667|FG001|NOT COMPLETED|Blinded Phase - Overall Study||66||
48491667|NCT03199963|101538666|FG000|STARTED|Optional Open-Label Phase - BHR-700||7||
48491668|NCT03199963|101538667|FG001|STARTED|Optional Open-Label Phase - BHR-700||6||
48491669|NCT03199963|101538666|FG000|COMPLETED|Optional Open-Label Phase - BHR-700||0||
48491670|NCT03199963|101538667|FG001|COMPLETED|Optional Open-Label Phase - BHR-700||0||
48491671|NCT03199963|101538666|FG000|NOT COMPLETED|Optional Open-Label Phase - BHR-700||7||
48491672|NCT03199963|101538667|FG001|NOT COMPLETED|Optional Open-Label Phase - BHR-700||6||
48491673|NCT01340495|101538668|FG000|STARTED|Overall Study||70||
48491674|NCT01340495|101538668|FG000|COMPLETED|Overall Study||69||
48491675|NCT01340495|101538668|FG000|NOT COMPLETED|Overall Study||1||
48491676|NCT05143801|101538669|FG000|STARTED|Overall Study||10||
48491677|NCT05143801|101538669|FG000|COMPLETED|Overall Study||10||
48491678|NCT05143801|101538669|FG000|NOT COMPLETED|Overall Study||0||
48491679|NCT00984022|101538670|FG000|STARTED|Overall Study||43||
48491680|NCT00984022|101538671|FG001|STARTED|Overall Study||49||
48491681|NCT00984022|101538670|FG000|COMPLETED|Overall Study||33||
48491682|NCT00984022|101538671|FG001|COMPLETED|Overall Study||35||
48491683|NCT00984022|101538670|FG000|NOT COMPLETED|Overall Study||10||
48491684|NCT00984022|101538671|FG001|NOT COMPLETED|Overall Study||14||
48491685|NCT01857934|101538672|FG000|STARTED|Overall Study||64||
48491686|NCT01857934|101538672|FG000|COMPLETED|Overall Study||54||
48491687|NCT01857934|101538672|FG000|NOT COMPLETED|Overall Study||10||
48491688|NCT05456360|101538673|FG000|STARTED|Overall Study||52||
48491689|NCT05456360|101538674|FG001|STARTED|Overall Study||37||
48491690|NCT05456360|101538673|FG000|COMPLETED|Overall Study||16||
48491691|NCT05456360|101538674|FG001|COMPLETED|Overall Study||9||
48491692|NCT05456360|101538673|FG000|NOT COMPLETED|Overall Study||36||
48491693|NCT05456360|101538674|FG001|NOT COMPLETED|Overall Study||28||
48491694|NCT03606174|101538675|FG000|STARTED|Overall Study||49||
48491695|NCT03606174|101538676|FG001|STARTED|Overall Study||23||
48491696|NCT03606174|101538677|FG002|STARTED|Overall Study||18||
48491697|NCT03606174|101538678|FG003|STARTED|Overall Study||9||
48491698|NCT03606174|101538679|FG004|STARTED|Overall Study||53||
48491699|NCT03606174|101538680|FG005|STARTED|Overall Study||27||
48491700|NCT03606174|101538681|FG006|STARTED|Overall Study||56||
48491701|NCT03606174|101538682|FG007|STARTED|Overall Study||9||
48491702|NCT03606174|101538683|FG008|STARTED|Overall Study||8||
48491703|NCT03606174|101538684|FG009|STARTED|Overall Study||4||
48491704|NCT03606174|101538685|FG010|STARTED|Overall Study||4||
48491705|NCT03606174|101538675|FG000|Started Cohort 9 Lead-in Dose-escalation Part|Overall Study||0||
48491706|NCT03606174|101538676|FG001|Started Cohort 9 Lead-in Dose-escalation Part|Overall Study||0||
48491707|NCT03606174|101538677|FG002|Started Cohort 9 Lead-in Dose-escalation Part|Overall Study||0||
48491708|NCT03606174|101538678|FG003|Started Cohort 9 Lead-in Dose-escalation Part|Overall Study||0||
48491709|NCT03606174|101538679|FG004|Started Cohort 9 Lead-in Dose-escalation Part|Overall Study||0||
48666659|NCT00567502|101970454|FG000|STARTED|Overall Study||804||
48666660|NCT00567502|101970455|FG001|STARTED|Overall Study||141||
48666661|NCT00567502|101970456|FG002|STARTED|Overall Study||2666||
48666662|NCT00567502|101970457|FG003|STARTED|Overall Study||110||
48666663|NCT00567502|101970454|FG000|Initiated Treatment|Overall Study||804||
48666664|NCT00567502|101970455|FG001|Initiated Treatment|Overall Study||141||
48666665|NCT00567502|101970456|FG002|Initiated Treatment|Overall Study||2666||
48666666|NCT00567502|101970457|FG003|Initiated Treatment|Overall Study||38||
48666667|NCT00567502|101970454|FG000|COMPLETED|Overall Study||563||
48666668|NCT00567502|101970455|FG001|COMPLETED|Overall Study||108||
48666669|NCT00567502|101970456|FG002|COMPLETED|Overall Study||1758||
48666670|NCT00567502|101970457|FG003|COMPLETED|Overall Study||23||
48666671|NCT00567502|101970454|FG000|NOT COMPLETED|Overall Study||241||
48666672|NCT00567502|101970455|FG001|NOT COMPLETED|Overall Study||33||
48666673|NCT00567502|101970456|FG002|NOT COMPLETED|Overall Study||908||
48200506|NCT00430300|100814533|FG000|STARTED|Overall Study||17||
48200507|NCT00430300|100814534|FG001|STARTED|Overall Study||18||
48491710|NCT03606174|101538680|FG005|Started Cohort 9 Lead-in Dose-escalation Part|Overall Study||0||
48491711|NCT03606174|101538681|FG006|Started Cohort 9 Lead-in Dose-escalation Part|Overall Study||0||
48491712|NCT03606174|101538682|FG007|Started Cohort 9 Lead-in Dose-escalation Part|Overall Study||0||
48491713|NCT03606174|101538683|FG008|Started Cohort 9 Lead-in Dose-escalation Part|Overall Study||8||
48491714|NCT03606174|101538684|FG009|Started Cohort 9 Lead-in Dose-escalation Part|Overall Study||4||
48491715|NCT03606174|101538685|FG010|Started Cohort 9 Lead-in Dose-escalation Part|Overall Study||4||
48491716|NCT03606174|101538675|FG000|Started Cohort 9 Dose-expansion Part|Overall Study||0||
48491717|NCT03606174|101538676|FG001|Started Cohort 9 Dose-expansion Part|Overall Study||0||
48491718|NCT03606174|101538677|FG002|Started Cohort 9 Dose-expansion Part|Overall Study||0||
48491719|NCT03606174|101538678|FG003|Started Cohort 9 Dose-expansion Part|Overall Study||0||
48491720|NCT03606174|101538679|FG004|Started Cohort 9 Dose-expansion Part|Overall Study||0||
48491721|NCT03606174|101538680|FG005|Started Cohort 9 Dose-expansion Part|Overall Study||0||
48491722|NCT03606174|101538681|FG006|Started Cohort 9 Dose-expansion Part|Overall Study||0||
48491723|NCT03606174|101538682|FG007|Started Cohort 9 Dose-expansion Part|Overall Study||0||
48491724|NCT03606174|101538683|FG008|Started Cohort 9 Dose-expansion Part|Overall Study||0||
48491725|NCT03606174|101538684|FG009|Started Cohort 9 Dose-expansion Part|Overall Study||0||
48491726|NCT03606174|101538685|FG010|Started Cohort 9 Dose-expansion Part|Overall Study||0||
48491727|NCT03606174|101538675|FG000|COMPLETED|Overall Study||0||
48491728|NCT03606174|101538676|FG001|COMPLETED|Overall Study||0||
48491729|NCT03606174|101538677|FG002|COMPLETED|Overall Study||0||
48491730|NCT03606174|101538678|FG003|COMPLETED|Overall Study||0||
48491731|NCT03606174|101538679|FG004|COMPLETED|Overall Study||0||
48491732|NCT03606174|101538680|FG005|COMPLETED|Overall Study||0||
48491733|NCT03606174|101538681|FG006|COMPLETED|Overall Study||0||
48491734|NCT03606174|101538682|FG007|COMPLETED|Overall Study||0||
48491735|NCT03606174|101538683|FG008|COMPLETED|Overall Study||0||
48491736|NCT03606174|101538684|FG009|COMPLETED|Overall Study||0||
48491737|NCT03606174|101538685|FG010|COMPLETED|Overall Study||0||
48491738|NCT03606174|101538675|FG000|NOT COMPLETED|Overall Study||49||
48491739|NCT03606174|101538676|FG001|NOT COMPLETED|Overall Study||23||
48491740|NCT03606174|101538677|FG002|NOT COMPLETED|Overall Study||18||
48491741|NCT03606174|101538678|FG003|NOT COMPLETED|Overall Study||9||
48491742|NCT03606174|101538679|FG004|NOT COMPLETED|Overall Study||53||
48491743|NCT03606174|101538680|FG005|NOT COMPLETED|Overall Study||27||
48491744|NCT03606174|101538681|FG006|NOT COMPLETED|Overall Study||56||
48491745|NCT03606174|101538682|FG007|NOT COMPLETED|Overall Study||9||
48491746|NCT03606174|101538683|FG008|NOT COMPLETED|Overall Study||8||
48491747|NCT03606174|101538684|FG009|NOT COMPLETED|Overall Study||4||
48491748|NCT03606174|101538685|FG010|NOT COMPLETED|Overall Study||4||
48491749|NCT01447017|101538686|FG000|STARTED|Overall Study||45||
48491750|NCT01447017|101538687|FG001|STARTED|Overall Study||24||
48491751|NCT01447017|101538686|FG000|Performed Visit 2|Overall Study||43||
48491752|NCT01447017|101538687|FG001|Performed Visit 2|Overall Study||24||
48491753|NCT01447017|101538686|FG000|COMPLETED|Overall Study||35||
48491754|NCT01447017|101538687|FG001|COMPLETED|Overall Study||14||
48491755|NCT01447017|101538686|FG000|NOT COMPLETED|Overall Study||10||
48491756|NCT01447017|101538687|FG001|NOT COMPLETED|Overall Study||10||
48491757|NCT00574847|101538688|FG000|STARTED|Overall Study||64||
48491758|NCT00574847|101538689|FG001|STARTED|Overall Study||63||
48491759|NCT00574847|101538688|FG000|COMPLETED|Overall Study||56||
48491760|NCT00574847|101538689|FG001|COMPLETED|Overall Study||56||
48491761|NCT00574847|101538688|FG000|NOT COMPLETED|Overall Study||8||
48491762|NCT00574847|101538689|FG001|NOT COMPLETED|Overall Study||7||
48491763|NCT00841542|101538690|FG000|STARTED|Period 1||14||
48491764|NCT00841542|101538691|FG001|STARTED|Period 1||14||
48491765|NCT00841542|101538690|FG000|COMPLETED|Period 1||13||
48491766|NCT00841542|101538691|FG001|COMPLETED|Period 1||14||
48491767|NCT00841542|101538690|FG000|NOT COMPLETED|Period 1||1||
48491768|NCT00841542|101538691|FG001|NOT COMPLETED|Period 1||0||
48200508|NCT00430300|100814535|FG002|STARTED|Overall Study||35||
48491769|NCT00841542|101538690|FG000|STARTED|Period 2||13||
48491770|NCT00841542|101538691|FG001|STARTED|Period 2||14||
48491771|NCT00841542|101538690|FG000|COMPLETED|Period 2||13||
48491772|NCT00841542|101538691|FG001|COMPLETED|Period 2||14||
48491773|NCT00841542|101538690|FG000|NOT COMPLETED|Period 2||0||
48491774|NCT00841542|101538691|FG001|NOT COMPLETED|Period 2||0||
48491775|NCT03122535|101538692|FG000|STARTED|Overall Study||115||115
48491776|NCT03122535|101538693|FG001|STARTED|Overall Study||115||115
48491777|NCT03122535|101538692|FG000|3 Months|Overall Study||92||92
48491778|NCT03122535|101538693|FG001|3 Months|Overall Study||92||92
48491779|NCT03122535|101538692|FG000|12 Months|Overall Study||42||42
48491780|NCT03122535|101538693|FG001|12 Months|Overall Study||42||42
48491781|NCT03122535|101538692|FG000|COMPLETED|Overall Study||42||42
48491782|NCT03122535|101538693|FG001|COMPLETED|Overall Study||42||42
48491783|NCT03122535|101538692|FG000|NOT COMPLETED|Overall Study||73||73
48491784|NCT03122535|101538693|FG001|NOT COMPLETED|Overall Study||73||73
48491785|NCT06044090|101538694|FG000|STARTED|First Intervention (5 Days)||4||
48491786|NCT06044090|101538695|FG001|STARTED|First Intervention (5 Days)||6||
48491787|NCT06044090|101538694|FG000|COMPLETED|First Intervention (5 Days)||4||
48491788|NCT06044090|101538695|FG001|COMPLETED|First Intervention (5 Days)||6||
48491789|NCT06044090|101538694|FG000|NOT COMPLETED|First Intervention (5 Days)||0||
48491790|NCT06044090|101538695|FG001|NOT COMPLETED|First Intervention (5 Days)||0||
48491791|NCT06044090|101538694|FG000|STARTED|Washout (14 Days)||4||
48491792|NCT06044090|101538695|FG001|STARTED|Washout (14 Days)||6||
48491793|NCT06044090|101538694|FG000|COMPLETED|Washout (14 Days)||4||
48491794|NCT06044090|101538695|FG001|COMPLETED|Washout (14 Days)||6||
48491795|NCT06044090|101538694|FG000|NOT COMPLETED|Washout (14 Days)||0||
48491796|NCT06044090|101538695|FG001|NOT COMPLETED|Washout (14 Days)||0||
48491797|NCT06044090|101538694|FG000|STARTED|Second Intervention (5 Days)||4||
48491798|NCT06044090|101538695|FG001|STARTED|Second Intervention (5 Days)||4||
48491799|NCT06044090|101538694|FG000|COMPLETED|Second Intervention (5 Days)||4||
48491800|NCT06044090|101538695|FG001|COMPLETED|Second Intervention (5 Days)||4||
48491801|NCT06044090|101538694|FG000|NOT COMPLETED|Second Intervention (5 Days)||0||
48491802|NCT06044090|101538695|FG001|NOT COMPLETED|Second Intervention (5 Days)||0||
48491803|NCT02311361|101538696|FG000|STARTED|Overall Study||14||
48491804|NCT02311361|101538697|FG001|STARTED|Overall Study||11||
48491805|NCT02311361|101538698|FG002|STARTED|Overall Study||19||
48200509|NCT00430300|100814536|FG003|STARTED|Overall Study||17||
48200510|NCT00430300|100814533|FG000|COMPLETED|Overall Study||15||
48200511|NCT00430300|100814534|FG001|COMPLETED|Overall Study||16||
48200512|NCT00430300|100814535|FG002|COMPLETED|Overall Study||29||
48200513|NCT00430300|100814536|FG003|COMPLETED|Overall Study||15||
48491806|NCT02311361|101538699|FG003|STARTED|Overall Study||21||
48491807|NCT02311361|101538696|FG000|Received Radiation Therapy Only|Overall Study||0||
48491808|NCT02311361|101538697|FG001|Received Radiation Therapy Only|Overall Study||1||
48491809|NCT02311361|101538698|FG002|Received Radiation Therapy Only|Overall Study||1||
48491810|NCT02311361|101538699|FG003|Received Radiation Therapy Only|Overall Study||1||
48491811|NCT02311361|101538696|FG000|COMPLETED|Overall Study||14||
48491812|NCT02311361|101538697|FG001|COMPLETED|Overall Study||10||
48491813|NCT02311361|101538698|FG002|COMPLETED|Overall Study||19||
48200514|NCT00430300|100814533|FG000|NOT COMPLETED|Overall Study||2||
48491814|NCT02311361|101538699|FG003|COMPLETED|Overall Study||20||
48491815|NCT02311361|101538696|FG000|NOT COMPLETED|Overall Study||0||
48491816|NCT02311361|101538697|FG001|NOT COMPLETED|Overall Study||1||
48491817|NCT02311361|101538698|FG002|NOT COMPLETED|Overall Study||0||
48491818|NCT02311361|101538699|FG003|NOT COMPLETED|Overall Study||1||
48491819|NCT02588339|101538700|FG000|STARTED|Overall Study||42||
48491820|NCT02588339|101538700|FG000|COMPLETED|Overall Study||39||
48491821|NCT02588339|101538700|FG000|NOT COMPLETED|Overall Study||3||
48491822|NCT03346902|101538701|FG000|STARTED|Overall Study||4||
48491823|NCT03346902|101538702|FG001|STARTED|Overall Study||8||
48491824|NCT03346902|101538701|FG000|COMPLETED|Overall Study||4||
48491825|NCT03346902|101538702|FG001|COMPLETED|Overall Study||8||
48491826|NCT03346902|101538701|FG000|NOT COMPLETED|Overall Study||0||
48491827|NCT03346902|101538702|FG001|NOT COMPLETED|Overall Study||0||
48491828|NCT00702377|101538703|FG000|STARTED|Overall Study||53||
48491829|NCT00702377|101538704|FG001|STARTED|Overall Study||56||
48491830|NCT00702377|101538703|FG000|COMPLETED|Overall Study||52||
48491831|NCT00702377|101538704|FG001|COMPLETED|Overall Study||53||
48491832|NCT00702377|101538703|FG000|NOT COMPLETED|Overall Study||1||
48491833|NCT00702377|101538704|FG001|NOT COMPLETED|Overall Study||3||
48491834|NCT00463684|101538705|FG000|STARTED|Overall Study||278||
48491835|NCT00463684|101538705|FG000|COMPLETED|Overall Study||274||
48491836|NCT00463684|101538705|FG000|NOT COMPLETED|Overall Study||4||
48491837|NCT00398983|101538706|FG000|STARTED|Overall Study||20||
48491838|NCT00398983|101538707|FG001|STARTED|Overall Study||25||
48491839|NCT00398983|101538706|FG000|COMPLETED|Overall Study||20||
48491840|NCT00398983|101538707|FG001|COMPLETED|Overall Study||25||
48491841|NCT00398983|101538706|FG000|NOT COMPLETED|Overall Study||0||
48491842|NCT00398983|101538707|FG001|NOT COMPLETED|Overall Study||0||
48491843|NCT04547192|101538708|FG000|STARTED|Period 1: 0-14 Weeks||377||2
48491844|NCT04547192|101538709|FG001|STARTED|Period 1: 0-14 Weeks||270||2
48491845|NCT04547192|101538710|FG002|STARTED|Period 1: 0-14 Weeks||235||2
48491846|NCT04547192|101538711|FG003|STARTED|Period 1: 0-14 Weeks||107||2
48491847|NCT04547192|101538708|FG000|COMPLETED|Period 1: 0-14 Weeks||370||2
48491848|NCT04547192|101538709|FG001|COMPLETED|Period 1: 0-14 Weeks||268||2
48491849|NCT04547192|101538710|FG002|COMPLETED|Period 1: 0-14 Weeks||230||2
48491850|NCT04547192|101538711|FG003|COMPLETED|Period 1: 0-14 Weeks||106||2
48491851|NCT04547192|101538708|FG000|NOT COMPLETED|Period 1: 0-14 Weeks||7||0
48491852|NCT04547192|101538709|FG001|NOT COMPLETED|Period 1: 0-14 Weeks||2||0
48491853|NCT04547192|101538710|FG002|NOT COMPLETED|Period 1: 0-14 Weeks||5||0
48491854|NCT04547192|101538711|FG003|NOT COMPLETED|Period 1: 0-14 Weeks||1||0
48491855|NCT04547192|101538708|FG000|STARTED|Period 2: 14-28 Weeks||186||2
48491856|NCT04547192|101538709|FG001|STARTED|Period 2: 14-28 Weeks||279||2
48491857|NCT04547192|101538710|FG002|STARTED|Period 2: 14-28 Weeks||265||2
48491858|NCT04547192|101538711|FG003|STARTED|Period 2: 14-28 Weeks||79||2
48491859|NCT04547192|101538708|FG000|COMPLETED|Period 2: 14-28 Weeks||186||2
48491860|NCT04547192|101538709|FG001|COMPLETED|Period 2: 14-28 Weeks||278||2
48491861|NCT04547192|101538710|FG002|COMPLETED|Period 2: 14-28 Weeks||264||2
48491862|NCT04547192|101538711|FG003|COMPLETED|Period 2: 14-28 Weeks||79||2
48491863|NCT04547192|101538708|FG000|NOT COMPLETED|Period 2: 14-28 Weeks||0||0
48491864|NCT04547192|101538709|FG001|NOT COMPLETED|Period 2: 14-28 Weeks||1||0
48491865|NCT04547192|101538710|FG002|NOT COMPLETED|Period 2: 14-28 Weeks||1||0
48491866|NCT04547192|101538711|FG003|NOT COMPLETED|Period 2: 14-28 Weeks||0||0
48491867|NCT04547192|101538708|FG000|STARTED|Period 3: 28-42 Weeks||261||2
48491868|NCT04547192|101538709|FG001|STARTED|Period 3: 28-42 Weeks||274||2
48491869|NCT04547192|101538710|FG002|STARTED|Period 3: 28-42 Weeks||287||2
48491870|NCT04547192|101538711|FG003|STARTED|Period 3: 28-42 Weeks||104||2
48491871|NCT04547192|101538708|FG000|COMPLETED|Period 3: 28-42 Weeks||259||2
48491872|NCT04547192|101538709|FG001|COMPLETED|Period 3: 28-42 Weeks||274||2
48491873|NCT04547192|101538710|FG002|COMPLETED|Period 3: 28-42 Weeks||281||2
48491874|NCT04547192|101538711|FG003|COMPLETED|Period 3: 28-42 Weeks||104||2
48491875|NCT04547192|101538708|FG000|NOT COMPLETED|Period 3: 28-42 Weeks||2||0
48491876|NCT04547192|101538709|FG001|NOT COMPLETED|Period 3: 28-42 Weeks||0||0
48491877|NCT04547192|101538710|FG002|NOT COMPLETED|Period 3: 28-42 Weeks||6||0
48491878|NCT04547192|101538711|FG003|NOT COMPLETED|Period 3: 28-42 Weeks||0||0
48491879|NCT04547192|101538708|FG000|STARTED|Period 4: 42-56 Weeks||250||2
48491880|NCT04547192|101538709|FG001|STARTED|Period 4: 42-56 Weeks||186||2
48491881|NCT04547192|101538710|FG002|STARTED|Period 4: 42-56 Weeks||169||2
48491882|NCT04547192|101538711|FG003|STARTED|Period 4: 42-56 Weeks||87||2
48491883|NCT04547192|101538708|FG000|COMPLETED|Period 4: 42-56 Weeks||248||2
48491884|NCT04547192|101538709|FG001|COMPLETED|Period 4: 42-56 Weeks||186||2
48491885|NCT04547192|101538710|FG002|COMPLETED|Period 4: 42-56 Weeks||169||2
48491886|NCT04547192|101538711|FG003|COMPLETED|Period 4: 42-56 Weeks||87||2
48491887|NCT04547192|101538708|FG000|NOT COMPLETED|Period 4: 42-56 Weeks||2||0
48491888|NCT04547192|101538709|FG001|NOT COMPLETED|Period 4: 42-56 Weeks||0||0
48491889|NCT04547192|101538710|FG002|NOT COMPLETED|Period 4: 42-56 Weeks||0||0
48491890|NCT04547192|101538711|FG003|NOT COMPLETED|Period 4: 42-56 Weeks||0||0
48491891|NCT04547192|101538708|FG000|STARTED|Period 5: 56-70 Weeks||227||2
48491892|NCT04547192|101538709|FG001|STARTED|Period 5: 56-70 Weeks||182||2
48491893|NCT04547192|101538710|FG002|STARTED|Period 5: 56-70 Weeks||226||2
48491894|NCT04547192|101538711|FG003|STARTED|Period 5: 56-70 Weeks||54||2
48491895|NCT04547192|101538708|FG000|COMPLETED|Period 5: 56-70 Weeks||227||2
48491896|NCT04547192|101538709|FG001|COMPLETED|Period 5: 56-70 Weeks||182||2
48491897|NCT04547192|101538710|FG002|COMPLETED|Period 5: 56-70 Weeks||225||2
48491898|NCT04547192|101538711|FG003|COMPLETED|Period 5: 56-70 Weeks||54||2
48491899|NCT04547192|101538708|FG000|NOT COMPLETED|Period 5: 56-70 Weeks||0||0
48491900|NCT04547192|101538709|FG001|NOT COMPLETED|Period 5: 56-70 Weeks||0||0
48491901|NCT04547192|101538710|FG002|NOT COMPLETED|Period 5: 56-70 Weeks||1||0
48491902|NCT04547192|101538711|FG003|NOT COMPLETED|Period 5: 56-70 Weeks||0||0
48491903|NCT00429416|101538712|FG000|STARTED|Overall Study||14||
48491904|NCT00429416|101538712|FG000|COMPLETED|Overall Study||13||
48491905|NCT00429416|101538712|FG000|NOT COMPLETED|Overall Study||1||
48491906|NCT05746455|101538713|FG000|STARTED|Overall Study||8||
48491907|NCT05746455|101538713|FG000|COMPLETED|Overall Study||6||
48491908|NCT05746455|101538713|FG000|NOT COMPLETED|Overall Study||2||
48491909|NCT02561611|101538714|FG000|STARTED|Overall Study||20||
48491910|NCT02561611|101538715|FG001|STARTED|Overall Study||20||
48491911|NCT02561611|101538714|FG000|COMPLETED|Overall Study||20||
48491912|NCT02561611|101538715|FG001|COMPLETED|Overall Study||20||
48491913|NCT02561611|101538714|FG000|NOT COMPLETED|Overall Study||0||
48491914|NCT02561611|101538715|FG001|NOT COMPLETED|Overall Study||0||
48491915|NCT00835666|101538716|FG000|STARTED|First Intervention||16||
48491916|NCT00835666|101538717|FG001|STARTED|First Intervention||16||
48491917|NCT00835666|101538716|FG000|COMPLETED|First Intervention||16||
48491918|NCT00835666|101538717|FG001|COMPLETED|First Intervention||16||
48491919|NCT00835666|101538716|FG000|NOT COMPLETED|First Intervention||0||
48491920|NCT00835666|101538717|FG001|NOT COMPLETED|First Intervention||0||
48491921|NCT00835666|101538716|FG000|STARTED|Washout||16||
48491922|NCT00835666|101538717|FG001|STARTED|Washout||16||
48491923|NCT00835666|101538716|FG000|COMPLETED|Washout||14||
48491924|NCT00835666|101538717|FG001|COMPLETED|Washout||16||
48491925|NCT00835666|101538716|FG000|NOT COMPLETED|Washout||2||
48491926|NCT00835666|101538717|FG001|NOT COMPLETED|Washout||0||
48491927|NCT00835666|101538716|FG000|STARTED|Second Intervention||14||
48491928|NCT00835666|101538717|FG001|STARTED|Second Intervention||16||
48491929|NCT00835666|101538716|FG000|COMPLETED|Second Intervention||14||
48491930|NCT00835666|101538717|FG001|COMPLETED|Second Intervention||16||
48491931|NCT00835666|101538716|FG000|NOT COMPLETED|Second Intervention||0||
48491932|NCT00835666|101538717|FG001|NOT COMPLETED|Second Intervention||0||
48491933|NCT01564394|101538718|FG000|STARTED|Overall Study||30||
48491934|NCT01564394|101538719|FG001|STARTED|Overall Study||30||
48491935|NCT01564394|101538718|FG000|COMPLETED|Overall Study||24||
48491936|NCT01564394|101538719|FG001|COMPLETED|Overall Study||20||
48491937|NCT01564394|101538718|FG000|NOT COMPLETED|Overall Study||6||
48491938|NCT01564394|101538719|FG001|NOT COMPLETED|Overall Study||10||
48491939|NCT02257528|101538720|FG000|STARTED|Overall Study||26||
48491940|NCT02257528|101538720|FG000|COMPLETED|Overall Study||25||
48491941|NCT02257528|101538720|FG000|NOT COMPLETED|Overall Study||1||
48491942|NCT02151981|101538721|FG000|STARTED|Overall Study||279||
48491943|NCT02151981|101538722|FG001|STARTED|Overall Study||140||
48491944|NCT02151981|101538721|FG000|Received Randomised Treatment Only|Overall Study||279||
48491945|NCT02151981|101538722|FG001|Received Randomised Treatment Only|Overall Study||136||
48491946|NCT02151981|101538721|FG000|Did Not Receive Treatment|Overall Study||0||
48491947|NCT02151981|101538722|FG001|Did Not Receive Treatment|Overall Study||4||
48491948|NCT02151981|101538721|FG000|Crossed Over Osimertinib|Overall Study||0||
48491949|NCT02151981|101538722|FG001|Crossed Over Osimertinib|Overall Study||99||
48491950|NCT02151981|101538721|FG000|COMPLETED|Overall Study||0||
48491951|NCT02151981|101538722|FG001|COMPLETED|Overall Study||0||
48491952|NCT02151981|101538721|FG000|NOT COMPLETED|Overall Study||279||
48491953|NCT02151981|101538722|FG001|NOT COMPLETED|Overall Study||140||
48491954|NCT03249454|101538723|FG000|STARTED|Overall Study||1||
48491955|NCT03249454|101538724|FG001|STARTED|Overall Study||1||
48491956|NCT03249454|101538725|FG002|STARTED|Overall Study||2||
48491957|NCT03249454|101538726|FG003|STARTED|Overall Study||1||
48491958|NCT03249454|101538727|FG004|STARTED|Overall Study||1||
48491959|NCT03249454|101538728|FG005|STARTED|Overall Study||2||
48491960|NCT03249454|101538729|FG006|STARTED|Overall Study||1||
48491961|NCT03249454|101538730|FG007|STARTED|Overall Study||1||
48491962|NCT03249454|101538731|FG008|STARTED|Overall Study||1||
48491963|NCT03249454|101538732|FG009|STARTED|Overall Study||1||
48491964|NCT03249454|101538733|FG010|STARTED|Overall Study||1||
48491965|NCT03249454|101538723|FG000|First Intervention (1 Day)|Overall Study||1||
48491966|NCT03249454|101538724|FG001|First Intervention (1 Day)|Overall Study||1||
48491967|NCT03249454|101538725|FG002|First Intervention (1 Day)|Overall Study||2||
48491968|NCT03249454|101538726|FG003|First Intervention (1 Day)|Overall Study||1||
48491969|NCT03249454|101538727|FG004|First Intervention (1 Day)|Overall Study||1||
48491970|NCT03249454|101538728|FG005|First Intervention (1 Day)|Overall Study||2||
48491971|NCT03249454|101538729|FG006|First Intervention (1 Day)|Overall Study||1||
48491972|NCT03249454|101538730|FG007|First Intervention (1 Day)|Overall Study||1||
48491973|NCT03249454|101538731|FG008|First Intervention (1 Day)|Overall Study||1||
48491974|NCT03249454|101538732|FG009|First Intervention (1 Day)|Overall Study||0||
48491975|NCT03249454|101538733|FG010|First Intervention (1 Day)|Overall Study||0||
48491976|NCT03249454|101538723|FG000|Washout (1 Week)|Overall Study||1||
48491977|NCT03249454|101538724|FG001|Washout (1 Week)|Overall Study||1||
48491978|NCT03249454|101538725|FG002|Washout (1 Week)|Overall Study||2||
48491979|NCT03249454|101538726|FG003|Washout (1 Week)|Overall Study||1||
48491980|NCT03249454|101538727|FG004|Washout (1 Week)|Overall Study||1||
48491981|NCT03249454|101538728|FG005|Washout (1 Week)|Overall Study||2||
48491982|NCT03249454|101538729|FG006|Washout (1 Week)|Overall Study||1||
48491983|NCT03249454|101538730|FG007|Washout (1 Week)|Overall Study||1||
48491984|NCT03249454|101538731|FG008|Washout (1 Week)|Overall Study||1||
48491985|NCT03249454|101538732|FG009|Washout (1 Week)|Overall Study||0||
48491986|NCT03249454|101538733|FG010|Washout (1 Week)|Overall Study||0||
48491987|NCT03249454|101538723|FG000|Second Intervention (1 Day)|Overall Study||1||
48491988|NCT03249454|101538724|FG001|Second Intervention (1 Day)|Overall Study||1||
48200515|NCT00430300|100814534|FG001|NOT COMPLETED|Overall Study||2||
48200516|NCT00430300|100814535|FG002|NOT COMPLETED|Overall Study||6||
48491989|NCT03249454|101538725|FG002|Second Intervention (1 Day)|Overall Study||2||
48491990|NCT03249454|101538726|FG003|Second Intervention (1 Day)|Overall Study||1||
48491991|NCT03249454|101538727|FG004|Second Intervention (1 Day)|Overall Study||1||
48491992|NCT03249454|101538728|FG005|Second Intervention (1 Day)|Overall Study||2||
48491993|NCT03249454|101538729|FG006|Second Intervention (1 Day)|Overall Study||1||
48491994|NCT03249454|101538730|FG007|Second Intervention (1 Day)|Overall Study||1||
48491995|NCT03249454|101538731|FG008|Second Intervention (1 Day)|Overall Study||1||
48491996|NCT03249454|101538732|FG009|Second Intervention (1 Day)|Overall Study||0||
48491997|NCT03249454|101538733|FG010|Second Intervention (1 Day)|Overall Study||0||
48491998|NCT03249454|101538723|FG000|Washout (1 Week)|Overall Study||1||
48491999|NCT03249454|101538724|FG001|Washout (1 Week)|Overall Study||1||
48492000|NCT03249454|101538725|FG002|Washout (1 Week)|Overall Study||2||
48492001|NCT03249454|101538726|FG003|Washout (1 Week)|Overall Study||1||
48492002|NCT03249454|101538727|FG004|Washout (1 Week)|Overall Study||1||
48492003|NCT03249454|101538728|FG005|Washout (1 Week)|Overall Study||2||
48492004|NCT03249454|101538729|FG006|Washout (1 Week)|Overall Study||1||
48200517|NCT00430300|100814536|FG003|NOT COMPLETED|Overall Study||2||
48200518|NCT00880906|100814537|FG000|STARTED|Overall Study||29||
48200519|NCT00880906|100814538|FG001|STARTED|Overall Study||21||
48200520|NCT00880906|100814537|FG000|COMPLETED|Overall Study||17||
48200521|NCT00880906|100814538|FG001|COMPLETED|Overall Study||14||
48200522|NCT00880906|100814537|FG000|NOT COMPLETED|Overall Study||12||
48200523|NCT00880906|100814538|FG001|NOT COMPLETED|Overall Study||7||
48200524|NCT02351180|100814539|FG000|STARTED|Overall Study||8||
48200525|NCT02351180|100814540|FG001|STARTED|Overall Study||8||
48200526|NCT02351180|100814539|FG000|COMPLETED|Overall Study||7||
48200527|NCT02351180|100814540|FG001|COMPLETED|Overall Study||8||
48200528|NCT02351180|100814539|FG000|NOT COMPLETED|Overall Study||1||
48200529|NCT02351180|100814540|FG001|NOT COMPLETED|Overall Study||0||
48200530|NCT01145885|100814541|FG000|STARTED|Overall Study||7||
48200531|NCT01145885|100814541|FG000|COMPLETED|Overall Study||0||
48200532|NCT01145885|100814541|FG000|NOT COMPLETED|Overall Study||7||
48200533|NCT02236559|100814542|FG000|STARTED|Overall Study||112||
48200534|NCT02236559|100814543|FG001|STARTED|Overall Study||116||
48200535|NCT02236559|100814542|FG000|COMPLETED|Overall Study||100||
48200536|NCT02236559|100814543|FG001|COMPLETED|Overall Study||104||
48200537|NCT02236559|100814542|FG000|NOT COMPLETED|Overall Study||12||
48200538|NCT02236559|100814543|FG001|NOT COMPLETED|Overall Study||12||
48200539|NCT00387465|100814544|FG000|STARTED|Overall Study||3||
48200540|NCT00387465|100814545|FG001|STARTED|Overall Study||7||
48200541|NCT00387465|100814546|FG002|STARTED|Overall Study||35||
48200542|NCT00387465|100814544|FG000|COMPLETED|Overall Study||3||
48200543|NCT00387465|100814545|FG001|COMPLETED|Overall Study||6||
48200544|NCT00387465|100814546|FG002|COMPLETED|Overall Study||35||
48200545|NCT00387465|100814544|FG000|NOT COMPLETED|Overall Study||0||
48200546|NCT00387465|100814545|FG001|NOT COMPLETED|Overall Study||1||
48492005|NCT03249454|101538730|FG007|Washout (1 Week)|Overall Study||1||
48492006|NCT03249454|101538731|FG008|Washout (1 Week)|Overall Study||1||
48200547|NCT00387465|100814546|FG002|NOT COMPLETED|Overall Study||0||
48200548|NCT03264248|100814547|FG000|STARTED|Overall Study||9||
48200549|NCT03264248|100814547|FG000|COMPLETED|Overall Study||9||
48200550|NCT03264248|100814547|FG000|NOT COMPLETED|Overall Study||0||
48200551|NCT02228408|100814548|FG000|STARTED|Overall Study||7||
48200552|NCT02228408|100814549|FG001|STARTED|Overall Study||10||
48200553|NCT02228408|100814548|FG000|COMPLETED|Overall Study||7||
48200554|NCT02228408|100814549|FG001|COMPLETED|Overall Study||10||
48200555|NCT02228408|100814548|FG000|NOT COMPLETED|Overall Study||0||
48200556|NCT02228408|100814549|FG001|NOT COMPLETED|Overall Study||0||
48200557|NCT01235949|100814550|FG000|STARTED|Primary Phase||198||
48200558|NCT01235949|100814551|FG001|STARTED|Primary Phase||198||
48200559|NCT01235949|100814552|FG002|STARTED|Primary Phase||199||
48200560|NCT01235949|100814553|FG003|STARTED|Primary Phase||71||
48492007|NCT03249454|101538732|FG009|Washout (1 Week)|Overall Study||0||
48492008|NCT03249454|101538733|FG010|Washout (1 Week)|Overall Study||0||
48492009|NCT03249454|101538723|FG000|Third Intervention (1 Day)|Overall Study||1||
48492010|NCT03249454|101538724|FG001|Third Intervention (1 Day)|Overall Study||1||
48492011|NCT03249454|101538725|FG002|Third Intervention (1 Day)|Overall Study||2||
48492012|NCT03249454|101538726|FG003|Third Intervention (1 Day)|Overall Study||1||
48492013|NCT03249454|101538727|FG004|Third Intervention (1 Day)|Overall Study||1||
48492014|NCT03249454|101538728|FG005|Third Intervention (1 Day)|Overall Study||2||
48492015|NCT03249454|101538729|FG006|Third Intervention (1 Day)|Overall Study||1||
48492016|NCT03249454|101538730|FG007|Third Intervention (1 Day)|Overall Study||1||
48492017|NCT03249454|101538731|FG008|Third Intervention (1 Day)|Overall Study||1||
48492018|NCT03249454|101538732|FG009|Third Intervention (1 Day)|Overall Study||0||
48492019|NCT03249454|101538733|FG010|Third Intervention (1 Day)|Overall Study||0||
48492020|NCT03249454|101538723|FG000|Washout (1 Week)|Overall Study||1||
48492021|NCT03249454|101538724|FG001|Washout (1 Week)|Overall Study||1||
48492022|NCT03249454|101538725|FG002|Washout (1 Week)|Overall Study||2||
48200561|NCT01235949|100814554|FG004|STARTED|Primary Phase||72||
48200562|NCT01235949|100814555|FG005|STARTED|Primary Phase||74||
48200563|NCT01235949|100814556|FG006|STARTED|Primary Phase||0||
48200564|NCT01235949|100814557|FG007|STARTED|Primary Phase||0||
48200565|NCT01235949|100814558|FG008|STARTED|Primary Phase||0||
48200566|NCT01235949|100814559|FG009|STARTED|Primary Phase||0||
48200567|NCT01235949|100814560|FG010|STARTED|Primary Phase||0||
48200568|NCT01235949|100814561|FG011|STARTED|Primary Phase||0||
48200569|NCT01235949|100814562|FG012|STARTED|Primary Phase||0||
48200570|NCT01235949|100814563|FG013|STARTED|Primary Phase||0||
48200571|NCT01235949|100814564|FG014|STARTED|Primary Phase||0||
48200572|NCT01235949|100814565|FG015|STARTED|Primary Phase||0||
48200573|NCT01235949|100814566|FG016|STARTED|Primary Phase||0||
48200574|NCT01235949|100814567|FG017|STARTED|Primary Phase||0||
48200575|NCT01235949|100814550|FG000|COMPLETED|Primary Phase||194||
48200576|NCT01235949|100814551|FG001|COMPLETED|Primary Phase||195||
48200577|NCT01235949|100814552|FG002|COMPLETED|Primary Phase||196||
48200578|NCT01235949|100814553|FG003|COMPLETED|Primary Phase||69||
48200579|NCT01235949|100814554|FG004|COMPLETED|Primary Phase||71||
48200580|NCT01235949|100814555|FG005|COMPLETED|Primary Phase||67||
48200581|NCT01235949|100814556|FG006|COMPLETED|Primary Phase||0||
48200582|NCT01235949|100814557|FG007|COMPLETED|Primary Phase||0||
48200583|NCT01235949|100814558|FG008|COMPLETED|Primary Phase||0||
48200584|NCT01235949|100814559|FG009|COMPLETED|Primary Phase||0||
48200585|NCT01235949|100814560|FG010|COMPLETED|Primary Phase||0||
48492023|NCT03249454|101538726|FG003|Washout (1 Week)|Overall Study||1||
48492024|NCT03249454|101538727|FG004|Washout (1 Week)|Overall Study||1||
48492025|NCT03249454|101538728|FG005|Washout (1 Week)|Overall Study||2||
48492026|NCT03249454|101538729|FG006|Washout (1 Week)|Overall Study||1||
48492027|NCT03249454|101538730|FG007|Washout (1 Week)|Overall Study||1||
48492028|NCT03249454|101538731|FG008|Washout (1 Week)|Overall Study||1||
48492029|NCT03249454|101538732|FG009|Washout (1 Week)|Overall Study||0||
48492030|NCT03249454|101538733|FG010|Washout (1 Week)|Overall Study||0||
48492031|NCT03249454|101538723|FG000|Fourth Intervention (1 Day)|Overall Study||1||
48492032|NCT03249454|101538724|FG001|Fourth Intervention (1 Day)|Overall Study||1||
48492033|NCT03249454|101538725|FG002|Fourth Intervention (1 Day)|Overall Study||2||
48492034|NCT03249454|101538726|FG003|Fourth Intervention (1 Day)|Overall Study||1||
48492035|NCT03249454|101538727|FG004|Fourth Intervention (1 Day)|Overall Study||1||
48492036|NCT03249454|101538728|FG005|Fourth Intervention (1 Day)|Overall Study||2||
48492037|NCT03249454|101538729|FG006|Fourth Intervention (1 Day)|Overall Study||1||
48492038|NCT03249454|101538730|FG007|Fourth Intervention (1 Day)|Overall Study||1||
48492039|NCT03249454|101538731|FG008|Fourth Intervention (1 Day)|Overall Study||1||
48492040|NCT03249454|101538732|FG009|Fourth Intervention (1 Day)|Overall Study||0||
48492041|NCT03249454|101538733|FG010|Fourth Intervention (1 Day)|Overall Study||0||
48492042|NCT03249454|101538723|FG000|Washout (1 Week)|Overall Study||1||
48492043|NCT03249454|101538724|FG001|Washout (1 Week)|Overall Study||1||
48492044|NCT03249454|101538725|FG002|Washout (1 Week)|Overall Study||2||
48492045|NCT03249454|101538726|FG003|Washout (1 Week)|Overall Study||1||
48492046|NCT03249454|101538727|FG004|Washout (1 Week)|Overall Study||1||
48492047|NCT03249454|101538728|FG005|Washout (1 Week)|Overall Study||2||
48492048|NCT03249454|101538729|FG006|Washout (1 Week)|Overall Study||1||
48492049|NCT03249454|101538730|FG007|Washout (1 Week)|Overall Study||1||
48492050|NCT03249454|101538731|FG008|Washout (1 Week)|Overall Study||1||
48492051|NCT03249454|101538732|FG009|Washout (1 Week)|Overall Study||0||
48492052|NCT03249454|101538733|FG010|Washout (1 Week)|Overall Study||0||
48492053|NCT03249454|101538723|FG000|Fifth Intervention (1 Day)|Overall Study||1||
48492054|NCT03249454|101538724|FG001|Fifth Intervention (1 Day)|Overall Study||1||
48492055|NCT03249454|101538725|FG002|Fifth Intervention (1 Day)|Overall Study||2||
48492056|NCT03249454|101538726|FG003|Fifth Intervention (1 Day)|Overall Study||1||
48492057|NCT03249454|101538727|FG004|Fifth Intervention (1 Day)|Overall Study||1||
48200586|NCT01235949|100814561|FG011|COMPLETED|Primary Phase||0||
48200587|NCT01235949|100814562|FG012|COMPLETED|Primary Phase||0||
48200588|NCT01235949|100814563|FG013|COMPLETED|Primary Phase||0||
48492058|NCT03249454|101538728|FG005|Fifth Intervention (1 Day)|Overall Study||2||
48492059|NCT03249454|101538729|FG006|Fifth Intervention (1 Day)|Overall Study||1||
48492060|NCT03249454|101538730|FG007|Fifth Intervention (1 Day)|Overall Study||1||
48492061|NCT03249454|101538731|FG008|Fifth Intervention (1 Day)|Overall Study||1||
48492062|NCT03249454|101538732|FG009|Fifth Intervention (1 Day)|Overall Study||0||
48200589|NCT01235949|100814564|FG014|COMPLETED|Primary Phase||0||
48200590|NCT01235949|100814565|FG015|COMPLETED|Primary Phase||0||
48492063|NCT03249454|101538733|FG010|Fifth Intervention (1 Day)|Overall Study||0||
48492064|NCT03249454|101538723|FG000|COMPLETED|Overall Study||1||
48200591|NCT01235949|100814566|FG016|COMPLETED|Primary Phase||0||
48200592|NCT01235949|100814567|FG017|COMPLETED|Primary Phase||0||
48492065|NCT03249454|101538724|FG001|COMPLETED|Overall Study||1||
48492066|NCT03249454|101538725|FG002|COMPLETED|Overall Study||2||
48492067|NCT03249454|101538726|FG003|COMPLETED|Overall Study||1||
48492068|NCT03249454|101538727|FG004|COMPLETED|Overall Study||1||
48200593|NCT01235949|100814550|FG000|NOT COMPLETED|Primary Phase||4||
48200594|NCT01235949|100814551|FG001|NOT COMPLETED|Primary Phase||3||
48492069|NCT03249454|101538728|FG005|COMPLETED|Overall Study||2||
48492070|NCT03249454|101538729|FG006|COMPLETED|Overall Study||1||
48492071|NCT03249454|101538730|FG007|COMPLETED|Overall Study||1||
48492072|NCT03249454|101538731|FG008|COMPLETED|Overall Study||1||
48492073|NCT03249454|101538732|FG009|COMPLETED|Overall Study||0||
48492074|NCT03249454|101538733|FG010|COMPLETED|Overall Study||0||
48492075|NCT03249454|101538723|FG000|NOT COMPLETED|Overall Study||0||
48492076|NCT03249454|101538724|FG001|NOT COMPLETED|Overall Study||0||
48492077|NCT03249454|101538725|FG002|NOT COMPLETED|Overall Study||0||
48492078|NCT03249454|101538726|FG003|NOT COMPLETED|Overall Study||0||
48492079|NCT03249454|101538727|FG004|NOT COMPLETED|Overall Study||0||
48492080|NCT03249454|101538728|FG005|NOT COMPLETED|Overall Study||0||
48492081|NCT03249454|101538729|FG006|NOT COMPLETED|Overall Study||0||
48492082|NCT03249454|101538730|FG007|NOT COMPLETED|Overall Study||0||
48492083|NCT03249454|101538731|FG008|NOT COMPLETED|Overall Study||0||
48492084|NCT03249454|101538732|FG009|NOT COMPLETED|Overall Study||1||
48492085|NCT03249454|101538733|FG010|NOT COMPLETED|Overall Study||1||
48492086|NCT03285594|101538734|FG000|STARTED|Overall Study||144||
48492087|NCT03285594|101538735|FG001|STARTED|Overall Study||141||
48492088|NCT03285594|101538736|FG002|STARTED|Overall Study||286||
48492089|NCT03285594|101538734|FG000|Treated|Overall Study||144||
48492090|NCT03285594|101538735|FG001|Treated|Overall Study||141||
48492091|NCT03285594|101538736|FG002|Treated|Overall Study||285||
48492092|NCT03285594|101538734|FG000|COMPLETED|Overall Study||129||
48492093|NCT03285594|101538735|FG001|COMPLETED|Overall Study||130||
48492094|NCT03285594|101538736|FG002|COMPLETED|Overall Study||249||
48492095|NCT03285594|101538734|FG000|NOT COMPLETED|Overall Study||15||
48492096|NCT03285594|101538735|FG001|NOT COMPLETED|Overall Study||11||
48492097|NCT03285594|101538736|FG002|NOT COMPLETED|Overall Study||37||
48492098|NCT02642042|101538737|FG000|STARTED|Overall Study||54||
48492099|NCT02642042|101538737|FG000|COMPLETED|Overall Study||0||
48492100|NCT02642042|101538737|FG000|NOT COMPLETED|Overall Study||54||
48492101|NCT00840866|101538738|FG000|STARTED|First Intervention||20||
48492102|NCT00840866|101538739|FG001|STARTED|First Intervention||19||
48200595|NCT01235949|100814552|FG002|NOT COMPLETED|Primary Phase||3||
48200596|NCT01235949|100814553|FG003|NOT COMPLETED|Primary Phase||2||
48200597|NCT01235949|100814554|FG004|NOT COMPLETED|Primary Phase||1||
48200598|NCT01235949|100814555|FG005|NOT COMPLETED|Primary Phase||7||
48200599|NCT01235949|100814556|FG006|NOT COMPLETED|Primary Phase||0||
48200600|NCT01235949|100814557|FG007|NOT COMPLETED|Primary Phase||0||
48200601|NCT01235949|100814558|FG008|NOT COMPLETED|Primary Phase||0||
48200602|NCT01235949|100814559|FG009|NOT COMPLETED|Primary Phase||0||
48492103|NCT00840866|101538738|FG000|COMPLETED|First Intervention||20||
48492104|NCT00840866|101538739|FG001|COMPLETED|First Intervention||19||
48492105|NCT00840866|101538738|FG000|NOT COMPLETED|First Intervention||0||
48492106|NCT00840866|101538739|FG001|NOT COMPLETED|First Intervention||0||
48492107|NCT00840866|101538738|FG000|STARTED|Washout of 7 Days||20||
48492108|NCT00840866|101538739|FG001|STARTED|Washout of 7 Days||19||
48492109|NCT00840866|101538738|FG000|COMPLETED|Washout of 7 Days||20||
48492110|NCT00840866|101538739|FG001|COMPLETED|Washout of 7 Days||19||
48492111|NCT00840866|101538738|FG000|NOT COMPLETED|Washout of 7 Days||0||
48492112|NCT00840866|101538739|FG001|NOT COMPLETED|Washout of 7 Days||0||
48492113|NCT00840866|101538738|FG000|STARTED|Second Intervention||20||
48492114|NCT00840866|101538739|FG001|STARTED|Second Intervention||19||
48492115|NCT00840866|101538738|FG000|COMPLETED|Second Intervention||20||
48492116|NCT00840866|101538739|FG001|COMPLETED|Second Intervention||19||
48492117|NCT00840866|101538738|FG000|NOT COMPLETED|Second Intervention||0||
48492118|NCT00840866|101538739|FG001|NOT COMPLETED|Second Intervention||0||
48492119|NCT03909607|101538740|FG000|STARTED|Overall Study||40||
48492120|NCT03909607|101538741|FG001|STARTED|Overall Study||40||
48492121|NCT03909607|101538742|FG002|STARTED|Overall Study||40||
48492122|NCT03909607|101538740|FG000|COMPLETED|Overall Study||35||
48492123|NCT03909607|101538741|FG001|COMPLETED|Overall Study||36||
48492124|NCT03909607|101538742|FG002|COMPLETED|Overall Study||38||
48492125|NCT03909607|101538740|FG000|NOT COMPLETED|Overall Study||5||
48492126|NCT03909607|101538741|FG001|NOT COMPLETED|Overall Study||4||
48492127|NCT03909607|101538742|FG002|NOT COMPLETED|Overall Study||2||
48492128|NCT01505933|101538743|FG000|STARTED|Overall Study||10||
48492129|NCT01505933|101538744|FG001|STARTED|Overall Study||14||
48492130|NCT01505933|101538743|FG000|COMPLETED|Overall Study||10||
48492131|NCT01505933|101538744|FG001|COMPLETED|Overall Study||14||
48200603|NCT01235949|100814560|FG010|NOT COMPLETED|Primary Phase||0||
48492132|NCT01505933|101538743|FG000|NOT COMPLETED|Overall Study||0||
48492133|NCT01505933|101538744|FG001|NOT COMPLETED|Overall Study||0||
48492134|NCT03343535|101538745|FG000|STARTED|Overall Study||46|Donor Lungs Transplanted|
48492135|NCT03343535|101538745|FG000|COMPLETED|Overall Study||32|36-month follow-up completed|
48492136|NCT03343535|101538745|FG000|NOT COMPLETED|Overall Study||14||
48492137|NCT04523168|101538746|FG000|STARTED|Overall Study||30||
48492138|NCT04523168|101538746|FG000|COMPLETED|Overall Study||30||
48492139|NCT04523168|101538746|FG000|NOT COMPLETED|Overall Study||0||
48492140|NCT01444378|101538747|FG000|STARTED|Overall Study||141||
48492141|NCT01444378|101538747|FG000|COMPLETED|Overall Study||124||
48492142|NCT01444378|101538747|FG000|NOT COMPLETED|Overall Study||17||
48492143|NCT00834275|101538748|FG000|STARTED|First Intervention||13||
48492144|NCT00834275|101538749|FG001|STARTED|First Intervention||13||
48492145|NCT00834275|101538748|FG000|COMPLETED|First Intervention||13||
48492146|NCT00834275|101538749|FG001|COMPLETED|First Intervention||13||
48492147|NCT00834275|101538748|FG000|NOT COMPLETED|First Intervention||0||
48492148|NCT00834275|101538749|FG001|NOT COMPLETED|First Intervention||0||
48492149|NCT00834275|101538748|FG000|STARTED|Washout of 7 Days||13||
48492150|NCT00834275|101538749|FG001|STARTED|Washout of 7 Days||13||
48492151|NCT00834275|101538748|FG000|COMPLETED|Washout of 7 Days||13||
48492152|NCT00834275|101538749|FG001|COMPLETED|Washout of 7 Days||13||
48492153|NCT00834275|101538748|FG000|NOT COMPLETED|Washout of 7 Days||0||
48492154|NCT00834275|101538749|FG001|NOT COMPLETED|Washout of 7 Days||0||
48492155|NCT00834275|101538748|FG000|STARTED|Second Intervention||13||
48492156|NCT00834275|101538749|FG001|STARTED|Second Intervention||13||
48492157|NCT00834275|101538748|FG000|COMPLETED|Second Intervention||13||
48492158|NCT00834275|101538749|FG001|COMPLETED|Second Intervention||13||
48492159|NCT00834275|101538748|FG000|NOT COMPLETED|Second Intervention||0||
48492160|NCT00834275|101538749|FG001|NOT COMPLETED|Second Intervention||0||
48492161|NCT03677141|101538750|FG000|STARTED|Overall Study||3||
48492162|NCT03677141|101538751|FG001|STARTED|Overall Study||4||
48492163|NCT03677141|101538752|FG002|STARTED|Overall Study||8||
48492164|NCT03677141|101538753|FG003|STARTED|Overall Study||40||
48492165|NCT03677141|101538754|FG004|STARTED|Overall Study||40||
48492166|NCT03677141|101538755|FG005|STARTED|Overall Study||22||
48492167|NCT03677141|101538750|FG000|COMPLETED|Overall Study||1||
48492168|NCT03677141|101538751|FG001|COMPLETED|Overall Study||3||
48492169|NCT03677141|101538752|FG002|COMPLETED|Overall Study||1||
48492170|NCT03677141|101538753|FG003|COMPLETED|Overall Study||28||
48492171|NCT03677141|101538754|FG004|COMPLETED|Overall Study||31||
48492172|NCT03677141|101538755|FG005|COMPLETED|Overall Study||19||
48492173|NCT03677141|101538750|FG000|NOT COMPLETED|Overall Study||2||
48492174|NCT03677141|101538751|FG001|NOT COMPLETED|Overall Study||1||
48492175|NCT03677141|101538752|FG002|NOT COMPLETED|Overall Study||7||
48492176|NCT03677141|101538753|FG003|NOT COMPLETED|Overall Study||12||
48492177|NCT03677141|101538754|FG004|NOT COMPLETED|Overall Study||9||
48492178|NCT03677141|101538755|FG005|NOT COMPLETED|Overall Study||3||
48492179|NCT02718326|101538756|FG000|STARTED|Overall Study||133||133
48492180|NCT02718326|101538757|FG001|STARTED|Overall Study||135||135
48492181|NCT02718326|101538758|FG002|STARTED|Overall Study||134||134
48492182|NCT02718326|101538756|FG000|Completed Week 52|Overall Study||109||109
48492183|NCT02718326|101538757|FG001|Completed Week 52|Overall Study||122||122
48492184|NCT02718326|101538758|FG002|Completed Week 52|Overall Study||124||124
48492185|NCT02718326|101538756|FG000|COMPLETED|Overall Study||97|Week 100 (End of Study)|97
48492186|NCT02718326|101538757|FG001|COMPLETED|Overall Study||111|Week 100 (End of Study)|111
48492187|NCT02718326|101538758|FG002|COMPLETED|Overall Study||112|Week 100 (End of Study)|112
48492188|NCT02718326|101538756|FG000|NOT COMPLETED|Overall Study||36||36
48492189|NCT02718326|101538757|FG001|NOT COMPLETED|Overall Study||24||24
48492190|NCT02718326|101538758|FG002|NOT COMPLETED|Overall Study||22||22
48492191|NCT03556618|101538759|FG000|STARTED|Overall Study||0||
48492192|NCT03556618|101538760|FG001|STARTED|Overall Study||19||
48492193|NCT03556618|101538759|FG000|COMPLETED|Overall Study||0||
48492194|NCT03556618|101538760|FG001|COMPLETED|Overall Study||5||
48492195|NCT03556618|101538759|FG000|NOT COMPLETED|Overall Study||0||
48492196|NCT03556618|101538760|FG001|NOT COMPLETED|Overall Study||14||
48492197|NCT04639219|101538761|FG000|STARTED|Overall Study||102|Participants assigned to treatment and received treatment|
48492198|NCT04639219|101538761|FG000|COMPLETED|Overall Study||33||
48492199|NCT04639219|101538761|FG000|NOT COMPLETED|Overall Study||69||
48492200|NCT01180634|101538762|FG000|STARTED|Overall Study||220||
48492201|NCT01180634|101538763|FG001|STARTED|Overall Study||110||
48492202|NCT01180634|101538762|FG000|COMPLETED|Overall Study||210||
48492203|NCT01180634|101538763|FG001|COMPLETED|Overall Study||109||
48492204|NCT01180634|101538762|FG000|NOT COMPLETED|Overall Study||10||
48492205|NCT01180634|101538763|FG001|NOT COMPLETED|Overall Study||1||
48492206|NCT01442155|101538764|FG000|STARTED|Overall Study||74||
48492207|NCT01442155|101538764|FG000|COMPLETED|Overall Study||9||
48492208|NCT01442155|101538764|FG000|NOT COMPLETED|Overall Study||65||
48492209|NCT01788423|101538765|FG000|STARTED|Overall Study||53||
48492210|NCT01788423|101538766|FG001|STARTED|Overall Study||55||
48492211|NCT01788423|101538767|FG002|STARTED|Overall Study||55||
48492212|NCT01788423|101538765|FG000|COMPLETED|Overall Study||53||
48492213|NCT01788423|101538766|FG001|COMPLETED|Overall Study||51||
48492214|NCT01788423|101538767|FG002|COMPLETED|Overall Study||50||
48492215|NCT01788423|101538765|FG000|NOT COMPLETED|Overall Study||0||
48492216|NCT01788423|101538766|FG001|NOT COMPLETED|Overall Study||4||
48492217|NCT01788423|101538767|FG002|NOT COMPLETED|Overall Study||5||
48492218|NCT02558491|101538768|FG000|STARTED|First Invention||19||
48492219|NCT02558491|101538769|FG001|STARTED|First Invention||14||
48492220|NCT02558491|101538768|FG000|COMPLETED|First Invention||14||
48492221|NCT02558491|101538769|FG001|COMPLETED|First Invention||12||
48492222|NCT02558491|101538768|FG000|NOT COMPLETED|First Invention||5||
48492223|NCT02558491|101538769|FG001|NOT COMPLETED|First Invention||2||
48492224|NCT02558491|101538768|FG000|STARTED|Second Intervention||14||
48492225|NCT02558491|101538769|FG001|STARTED|Second Intervention||12||
48492226|NCT02558491|101538768|FG000|COMPLETED|Second Intervention||12||
48492227|NCT02558491|101538769|FG001|COMPLETED|Second Intervention||12||
48492228|NCT02558491|101538768|FG000|NOT COMPLETED|Second Intervention||2||
48492229|NCT02558491|101538769|FG001|NOT COMPLETED|Second Intervention||0||
48492230|NCT02558491|101538768|FG000|STARTED|Third Intervention||12||
48492231|NCT02558491|101538769|FG001|STARTED|Third Intervention||12||
48492232|NCT02558491|101538768|FG000|COMPLETED|Third Intervention||12||
48492233|NCT02558491|101538769|FG001|COMPLETED|Third Intervention||12||
48492234|NCT02558491|101538768|FG000|NOT COMPLETED|Third Intervention||0||
48492235|NCT02558491|101538769|FG001|NOT COMPLETED|Third Intervention||0||
48492236|NCT02243579|101538770|FG000|STARTED|Overall Study||24||
48492237|NCT02243579|101538770|FG000|COMPLETED|Overall Study||4||
48492238|NCT02243579|101538770|FG000|NOT COMPLETED|Overall Study||20||
48492239|NCT04022954|101538771|FG000|STARTED|Consented to Completed Procedure||201||
48492240|NCT04022954|101538771|FG000|COMPLETED|Consented to Completed Procedure||200||
48492241|NCT04022954|101538771|FG000|NOT COMPLETED|Consented to Completed Procedure||1||
48492242|NCT04022954|101538771|FG000|STARTED|Completed 12-month Follow-up||200||
48492243|NCT04022954|101538771|FG000|COMPLETED|Completed 12-month Follow-up||192||
48492244|NCT04022954|101538771|FG000|NOT COMPLETED|Completed 12-month Follow-up||8||
48492245|NCT03322267|101538772|FG000|STARTED|Overall Study||25||
48492246|NCT03322267|101538772|FG000|COMPLETED|Overall Study||11||
48492247|NCT03322267|101538772|FG000|NOT COMPLETED|Overall Study||14||
48492248|NCT03873272|101538773|FG000|STARTED|Overall Study||20||
48492249|NCT03873272|101538774|FG001|STARTED|Overall Study||22||
48200604|NCT01235949|100814561|FG011|NOT COMPLETED|Primary Phase||0||
48200605|NCT01235949|100814562|FG012|NOT COMPLETED|Primary Phase||0||
48492250|NCT03873272|101538775|FG002|STARTED|Overall Study||21||
48200606|NCT01235949|100814563|FG013|NOT COMPLETED|Primary Phase||0||
48492251|NCT03873272|101538773|FG000|COMPLETED|Overall Study||18||
48492252|NCT03873272|101538774|FG001|COMPLETED|Overall Study||20||
48492253|NCT03873272|101538775|FG002|COMPLETED|Overall Study||19||
48492254|NCT03873272|101538773|FG000|NOT COMPLETED|Overall Study||2||
48492255|NCT03873272|101538774|FG001|NOT COMPLETED|Overall Study||2||
48492256|NCT03873272|101538775|FG002|NOT COMPLETED|Overall Study||2||
48492257|NCT02842853|101538776|FG000|STARTED|Overall Study||902||
48492258|NCT02842853|101538777|FG001|STARTED|Overall Study||895||
48492259|NCT02842853|101538778|FG002|STARTED|Overall Study||906||
48492260|NCT02842853|101538779|FG003|STARTED|Overall Study||641||
48492261|NCT02842853|101538776|FG000|Vaccinated|Overall Study||895||
48492262|NCT02842853|101538777|FG001|Vaccinated|Overall Study||886||
48492263|NCT02842853|101538778|FG002|Vaccinated|Overall Study||900||
48492264|NCT02842853|101538779|FG003|Vaccinated|Overall Study||636||
48492265|NCT02842853|101538776|FG000|Safety Analysis Set (SafAS)|Overall Study||895|SafAS: participants who received at least 1 dose of study vaccine \& had any safety data available.|
48492266|NCT02842853|101538777|FG001|Safety Analysis Set (SafAS)|Overall Study||883|SafAS: participants who received at least 1 dose of study vaccine \& had any safety data available.|
48492267|NCT02842853|101538778|FG002|Safety Analysis Set (SafAS)|Overall Study||898|SafAS: participants who received at least 1 dose of study vaccine \& had any safety data available.|
48492268|NCT02842853|101538779|FG003|Safety Analysis Set (SafAS)|Overall Study||635|SafAS: participants who received at least 1 dose of study vaccine \& had any safety data available.|
48492269|NCT02842853|101538776|FG000|COMPLETED|Overall Study||879||
48492270|NCT02842853|101538777|FG001|COMPLETED|Overall Study||861||
48492271|NCT02842853|101538778|FG002|COMPLETED|Overall Study||885||
48492272|NCT02842853|101538779|FG003|COMPLETED|Overall Study||617||
48492273|NCT02842853|101538776|FG000|NOT COMPLETED|Overall Study||23||
48492274|NCT02842853|101538777|FG001|NOT COMPLETED|Overall Study||34||
48492275|NCT02842853|101538778|FG002|NOT COMPLETED|Overall Study||21||
48492276|NCT02842853|101538779|FG003|NOT COMPLETED|Overall Study||24||
48492277|NCT04974684|101538780|FG000|STARTED|3 Months||16||
48492278|NCT04974684|101538781|FG001|STARTED|3 Months||15||
48492279|NCT04974684|101538782|FG002|STARTED|3 Months||14||
48492280|NCT04974684|101538780|FG000|COMPLETED|3 Months||15||
48492281|NCT04974684|101538781|FG001|COMPLETED|3 Months||13||
48492282|NCT04974684|101538782|FG002|COMPLETED|3 Months||13||
48492283|NCT04974684|101538780|FG000|NOT COMPLETED|3 Months||1||
48492284|NCT04974684|101538781|FG001|NOT COMPLETED|3 Months||2||
48492285|NCT04974684|101538782|FG002|NOT COMPLETED|3 Months||1||
48492286|NCT04974684|101538780|FG000|STARTED|6 Months||15||
48492287|NCT04974684|101538781|FG001|STARTED|6 Months||13||
48492288|NCT04974684|101538782|FG002|STARTED|6 Months||13||
48492289|NCT04974684|101538780|FG000|COMPLETED|6 Months||13||
48492290|NCT04974684|101538781|FG001|COMPLETED|6 Months||9||
48492291|NCT04974684|101538782|FG002|COMPLETED|6 Months||12||
48492292|NCT04974684|101538780|FG000|NOT COMPLETED|6 Months||2||
48492293|NCT04974684|101538781|FG001|NOT COMPLETED|6 Months||4||
48492294|NCT04974684|101538782|FG002|NOT COMPLETED|6 Months||1||
48492295|NCT04739800|101538783|FG000|STARTED|Overall Study||18||
48492296|NCT04739800|101538784|FG001|STARTED|Overall Study||33||
48492297|NCT04739800|101538785|FG002|STARTED|Overall Study||34||
48492298|NCT04739800|101538786|FG003|STARTED|Overall Study||35||
48492299|NCT04739800|101538783|FG000|COMPLETED|Overall Study||6||
48492300|NCT04739800|101538784|FG001|COMPLETED|Overall Study||17||
48492301|NCT04739800|101538785|FG002|COMPLETED|Overall Study||11||
48492302|NCT04739800|101538786|FG003|COMPLETED|Overall Study||13||
48492303|NCT04739800|101538783|FG000|NOT COMPLETED|Overall Study||12||
48492304|NCT04739800|101538784|FG001|NOT COMPLETED|Overall Study||16||
48492305|NCT04739800|101538785|FG002|NOT COMPLETED|Overall Study||23||
48492306|NCT04739800|101538786|FG003|NOT COMPLETED|Overall Study||22||
48492307|NCT02322593|101538787|FG000|STARTED|Overall Study||356||
48492308|NCT02322593|101538788|FG001|STARTED|Overall Study||355||
48492309|NCT02322593|101538787|FG000|COMPLETED|Overall Study||356||
48492310|NCT02322593|101538788|FG001|COMPLETED|Overall Study||355||
48492311|NCT02322593|101538787|FG000|NOT COMPLETED|Overall Study||0||
48492312|NCT02322593|101538788|FG001|NOT COMPLETED|Overall Study||0||
48492313|NCT00191815|101538789|FG000|STARTED|Overall Study||70||
48492314|NCT00191815|101538789|FG000|Treated|Overall Study||67||
48492315|NCT00191815|101538789|FG000|COMPLETED|Overall Study||30||
48492316|NCT00191815|101538789|FG000|NOT COMPLETED|Overall Study||40||
48492317|NCT03292484|101538790|FG000|STARTED|Overall Study||911||
48492318|NCT03292484|101538790|FG000|Safety Population|Overall Study||908|The safety population consisted of all participants who received AR101 during ARC008.|
48492319|NCT03292484|101538790|FG000|Participants Who Had an Open-label Food Challenge (OLFC)|Overall Study||517|At Month 12 and yearly thereafter, up to 58 months.|
48492320|NCT03292484|101538790|FG000|Participants Who Had a Double-blind, Placebo-Controlled Food Challenge (DBPCFC)|Overall Study||211|At end of treatment (Month 58).|
48492321|NCT03292484|101538790|FG000|COMPLETED|Overall Study||18||
48492322|NCT03292484|101538790|FG000|NOT COMPLETED|Overall Study||893||
48492323|NCT01171898|101538791|FG000|STARTED|Overall Study||30||
48492324|NCT01171898|101538792|FG001|STARTED|Overall Study||51||
48492325|NCT01171898|101538793|FG002|STARTED|Overall Study||25||
48492326|NCT01171898|101538794|FG003|STARTED|Overall Study||21||
48492327|NCT01171898|101538791|FG000|COMPLETED|Overall Study||26||
48492328|NCT01171898|101538792|FG001|COMPLETED|Overall Study||32||
48492329|NCT01171898|101538793|FG002|COMPLETED|Overall Study||13||
48492330|NCT01171898|101538794|FG003|COMPLETED|Overall Study||15||
48492331|NCT01171898|101538791|FG000|NOT COMPLETED|Overall Study||4||
48492332|NCT01171898|101538792|FG001|NOT COMPLETED|Overall Study||19||
48492333|NCT01171898|101538793|FG002|NOT COMPLETED|Overall Study||12||
48492334|NCT01171898|101538794|FG003|NOT COMPLETED|Overall Study||6||
48492335|NCT04408586|101538795|FG000|STARTED|Overall Study||42||
48492336|NCT04408586|101538796|FG001|STARTED|Overall Study||38||
48492337|NCT04408586|101538795|FG000|COMPLETED|Overall Study||42||
48492338|NCT04408586|101538796|FG001|COMPLETED|Overall Study||38||
48492339|NCT04408586|101538795|FG000|NOT COMPLETED|Overall Study||0||
48492340|NCT04408586|101538796|FG001|NOT COMPLETED|Overall Study||0||
48492341|NCT00835692|101538797|FG000|STARTED|First Intervention||28||
48492342|NCT00835692|101538798|FG001|STARTED|First Intervention||28||
48492343|NCT00835692|101538797|FG000|COMPLETED|First Intervention||27||
48492344|NCT00835692|101538798|FG001|COMPLETED|First Intervention||28||
48492345|NCT00835692|101538797|FG000|NOT COMPLETED|First Intervention||1||
48492346|NCT00835692|101538798|FG001|NOT COMPLETED|First Intervention||0||
48492347|NCT00835692|101538797|FG000|STARTED|Washout||27||
48492348|NCT00835692|101538798|FG001|STARTED|Washout||28||
48492349|NCT00835692|101538797|FG000|COMPLETED|Washout||27||
48492350|NCT00835692|101538798|FG001|COMPLETED|Washout||28||
48492351|NCT00835692|101538797|FG000|NOT COMPLETED|Washout||0||
48492352|NCT00835692|101538798|FG001|NOT COMPLETED|Washout||0||
48492353|NCT00835692|101538797|FG000|STARTED|Second Intervention||27||
48492354|NCT00835692|101538798|FG001|STARTED|Second Intervention||28||
48492355|NCT00835692|101538797|FG000|COMPLETED|Second Intervention||27||
48492356|NCT00835692|101538798|FG001|COMPLETED|Second Intervention||28||
48492357|NCT00835692|101538797|FG000|NOT COMPLETED|Second Intervention||0||
48492358|NCT00835692|101538798|FG001|NOT COMPLETED|Second Intervention||0||
48492359|NCT03605342|101538799|FG000|STARTED|Overall Study||20||
48492360|NCT03605342|101538800|FG001|STARTED|Overall Study||18||
48492361|NCT03605342|101538799|FG000|COMPLETED|Overall Study||10||
48492362|NCT03605342|101538800|FG001|COMPLETED|Overall Study||10||
48492363|NCT03605342|101538799|FG000|NOT COMPLETED|Overall Study||10||
48492364|NCT03605342|101538800|FG001|NOT COMPLETED|Overall Study||8||
48492365|NCT02760927|101538801|FG000|STARTED|Overall Study||4||
48492366|NCT02760927|101538801|FG000|COMPLETED|Overall Study||3||
48492367|NCT02760927|101538801|FG000|NOT COMPLETED|Overall Study||1||
48200607|NCT01235949|100814564|FG014|NOT COMPLETED|Primary Phase||0||
48200608|NCT01235949|100814565|FG015|NOT COMPLETED|Primary Phase||0||
48200609|NCT01235949|100814566|FG016|NOT COMPLETED|Primary Phase||0||
48200610|NCT01235949|100814567|FG017|NOT COMPLETED|Primary Phase||0||
48200611|NCT01235949|100814550|FG000|STARTED|Booster Phase||0|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
48200612|NCT01235949|100814551|FG001|STARTED|Booster Phase||0|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
48200613|NCT01235949|100814552|FG002|STARTED|Booster Phase||0|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
48200614|NCT01235949|100814553|FG003|STARTED|Booster Phase||0|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
48200615|NCT01235949|100814554|FG004|STARTED|Booster Phase||0|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
48200616|NCT01235949|100814555|FG005|STARTED|Booster Phase||0|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
48200617|NCT01235949|100814556|FG006|STARTED|Booster Phase||64|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
48200618|NCT01235949|100814557|FG007|STARTED|Booster Phase||60|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
48200619|NCT01235949|100814558|FG008|STARTED|Booster Phase||63|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
48492368|NCT02993159|101538802|FG000|STARTED|Overall Study||47||
48492369|NCT02993159|101538803|FG001|STARTED|Overall Study||53||
48492370|NCT02993159|101538802|FG000|COMPLETED|Overall Study||42||
48492371|NCT02993159|101538803|FG001|COMPLETED|Overall Study||48||
48492372|NCT02993159|101538802|FG000|NOT COMPLETED|Overall Study||5||
48492373|NCT02993159|101538803|FG001|NOT COMPLETED|Overall Study||5||
48492374|NCT00455312|101538804|FG000|STARTED|Overall Study||15||
48492375|NCT00455312|101538805|FG001|STARTED|Overall Study||21||
48492376|NCT00455312|101538804|FG000|COMPLETED|Overall Study||15||
48492377|NCT00455312|101538805|FG001|COMPLETED|Overall Study||20||
48492378|NCT00455312|101538804|FG000|NOT COMPLETED|Overall Study||0||
48492379|NCT00455312|101538805|FG001|NOT COMPLETED|Overall Study||1||
48492380|NCT01010503|101538806|FG000|STARTED|Overall Study||32||
48492381|NCT01010503|101538806|FG000|COMPLETED|Overall Study||30||
48492382|NCT01010503|101538806|FG000|NOT COMPLETED|Overall Study||2||
48492383|NCT05292365|101538807|FG000|STARTED|Overall Study||36||
48492384|NCT05292365|101538808|FG001|STARTED|Overall Study||35||
48492385|NCT05292365|101538809|FG002|STARTED|Overall Study||24||
48492386|NCT05292365|101538810|FG003|STARTED|Overall Study||24||
48492387|NCT05292365|101538807|FG000|COMPLETED|Overall Study||35||
48492388|NCT05292365|101538808|FG001|COMPLETED|Overall Study||34||
48492389|NCT05292365|101538809|FG002|COMPLETED|Overall Study||24||
48492390|NCT05292365|101538810|FG003|COMPLETED|Overall Study||24||
48492391|NCT05292365|101538807|FG000|NOT COMPLETED|Overall Study||1||
48492392|NCT05292365|101538808|FG001|NOT COMPLETED|Overall Study||1||
48492393|NCT05292365|101538809|FG002|NOT COMPLETED|Overall Study||0||
48492394|NCT05292365|101538810|FG003|NOT COMPLETED|Overall Study||0||
48492395|NCT01272037|101538811|FG000|STARTED|Overall Study||2511||
48492396|NCT01272037|101538812|FG001|STARTED|Overall Study||2507||
48492397|NCT01272037|101538811|FG000|COMPLETED|Overall Study||1504||
48492398|NCT01272037|101538812|FG001|COMPLETED|Overall Study||1547||
48492399|NCT01272037|101538811|FG000|NOT COMPLETED|Overall Study||1007||
48492400|NCT01272037|101538812|FG001|NOT COMPLETED|Overall Study||960||
48492401|NCT00835575|101538813|FG000|STARTED|First Intervention||16||
48492402|NCT00835575|101538814|FG001|STARTED|First Intervention||16||
48492403|NCT00835575|101538813|FG000|COMPLETED|First Intervention||16||
48492404|NCT00835575|101538814|FG001|COMPLETED|First Intervention||16||
48492405|NCT00835575|101538813|FG000|NOT COMPLETED|First Intervention||0||
48492406|NCT00835575|101538814|FG001|NOT COMPLETED|First Intervention||0||
48492407|NCT00835575|101538813|FG000|STARTED|Washout of 14 Days||16||
48492408|NCT00835575|101538814|FG001|STARTED|Washout of 14 Days||16||
48492409|NCT00835575|101538813|FG000|COMPLETED|Washout of 14 Days||15||
48492410|NCT00835575|101538814|FG001|COMPLETED|Washout of 14 Days||16||
48492411|NCT00835575|101538813|FG000|NOT COMPLETED|Washout of 14 Days||1||
48492412|NCT00835575|101538814|FG001|NOT COMPLETED|Washout of 14 Days||0||
48492413|NCT00835575|101538813|FG000|STARTED|Second Intervention||15||
48492414|NCT00835575|101538814|FG001|STARTED|Second Intervention||16||
48492415|NCT00835575|101538813|FG000|COMPLETED|Second Intervention||15||
48492416|NCT00835575|101538814|FG001|COMPLETED|Second Intervention||16||
48492417|NCT00835575|101538813|FG000|NOT COMPLETED|Second Intervention||0||
48492418|NCT00835575|101538814|FG001|NOT COMPLETED|Second Intervention||0||
48492419|NCT01246258|101538815|FG000|STARTED|Overall Study||5||
48492420|NCT01246258|101538815|FG000|COMPLETED|Overall Study||5||
48492421|NCT01246258|101538815|FG000|NOT COMPLETED|Overall Study||0||
48492422|NCT01811953|101538816|FG000|STARTED|Overall Study||6||
48492423|NCT01811953|101538817|FG001|STARTED|Overall Study||6||
48492424|NCT01811953|101538818|FG002|STARTED|Overall Study||6||
48492425|NCT01811953|101538819|FG003|STARTED|Overall Study||6||
48492426|NCT01811953|101538820|FG004|STARTED|Overall Study||12||
48492427|NCT01811953|101538821|FG005|STARTED|Overall Study||12||
48492428|NCT01811953|101538816|FG000|COMPLETED|Overall Study||6||
48492429|NCT01811953|101538817|FG001|COMPLETED|Overall Study||6||
48492430|NCT01811953|101538818|FG002|COMPLETED|Overall Study||6||
48492431|NCT01811953|101538819|FG003|COMPLETED|Overall Study||5||
48492432|NCT01811953|101538820|FG004|COMPLETED|Overall Study||11||
48492433|NCT01811953|101538821|FG005|COMPLETED|Overall Study||11||
48492434|NCT01811953|101538816|FG000|NOT COMPLETED|Overall Study||0||
48492435|NCT01811953|101538817|FG001|NOT COMPLETED|Overall Study||0||
48492436|NCT01811953|101538818|FG002|NOT COMPLETED|Overall Study||0||
48492437|NCT01811953|101538819|FG003|NOT COMPLETED|Overall Study||1||
48492438|NCT01811953|101538820|FG004|NOT COMPLETED|Overall Study||1||
48492439|NCT01811953|101538821|FG005|NOT COMPLETED|Overall Study||1||
48492440|NCT00919113|101538822|FG000|STARTED|Overall Study||50||
48492441|NCT00919113|101538823|FG001|STARTED|Overall Study||48||
48492442|NCT00919113|101538822|FG000|Received Uracyst|Overall Study||49||
48492443|NCT00919113|101538823|FG001|Received Uracyst|Overall Study||0||
48492444|NCT00919113|101538822|FG000|Received Placebo|Overall Study||0||
48492445|NCT00919113|101538823|FG001|Received Placebo|Overall Study||49||
48492446|NCT00919113|101538822|FG000|COMPLETED|Overall Study||41||
48492447|NCT00919113|101538823|FG001|COMPLETED|Overall Study||40||
48492448|NCT00919113|101538822|FG000|NOT COMPLETED|Overall Study||9||
48492449|NCT00919113|101538823|FG001|NOT COMPLETED|Overall Study||8||
48492450|NCT01463423|101538824|FG000|STARTED|Overall Study||84||
48492451|NCT01463423|101538825|FG001|STARTED|Overall Study||87||
48492452|NCT01463423|101538826|FG002|STARTED|Overall Study||85||
48492453|NCT01463423|101538824|FG000|COMPLETED|Overall Study||79||
48492454|NCT01463423|101538825|FG001|COMPLETED|Overall Study||82||
48492455|NCT01463423|101538826|FG002|COMPLETED|Overall Study||79||
48492456|NCT01463423|101538824|FG000|NOT COMPLETED|Overall Study||5||
48492457|NCT01463423|101538825|FG001|NOT COMPLETED|Overall Study||5||
48492458|NCT01463423|101538826|FG002|NOT COMPLETED|Overall Study||6||
48492459|NCT04678856|101538827|FG000|STARTED|Overall Study||33||
48492460|NCT04678856|101538828|FG001|STARTED|Overall Study||38||
48492461|NCT04678856|101538827|FG000|COMPLETED|Overall Study||25||
48492462|NCT04678856|101538828|FG001|COMPLETED|Overall Study||37||
48492463|NCT04678856|101538827|FG000|NOT COMPLETED|Overall Study||8||
48492464|NCT04678856|101538828|FG001|NOT COMPLETED|Overall Study||1||
48492465|NCT01222234|101538829|FG000|STARTED|Overall Study||15||
48492466|NCT01222234|101538830|FG001|STARTED|Overall Study||17||
48492467|NCT01222234|101538831|FG002|STARTED|Overall Study||24||
48492468|NCT01222234|101538829|FG000|COMPLETED|Overall Study||15||
48492469|NCT01222234|101538830|FG001|COMPLETED|Overall Study||15||
48492470|NCT01222234|101538831|FG002|COMPLETED|Overall Study||22||
48492471|NCT01222234|101538829|FG000|NOT COMPLETED|Overall Study||0||
48492472|NCT01222234|101538830|FG001|NOT COMPLETED|Overall Study||2||
48492473|NCT01222234|101538831|FG002|NOT COMPLETED|Overall Study||2||
48492474|NCT05015751|101538832|FG000|STARTED|Overall Study||44||
48492475|NCT05015751|101538832|FG000|COMPLETED|Overall Study||40||
48492476|NCT05015751|101538832|FG000|NOT COMPLETED|Overall Study||4||
48492477|NCT03769896|101538833|FG000|STARTED|Open-label Phase||47||
48492478|NCT03769896|101538834|FG001|STARTED|Open-label Phase||0||
48492479|NCT03769896|101538833|FG000|COMPLETED|Open-label Phase||38||
48492480|NCT03769896|101538834|FG001|COMPLETED|Open-label Phase||0||
48492481|NCT03769896|101538833|FG000|NOT COMPLETED|Open-label Phase||9||
48492482|NCT03769896|101538834|FG001|NOT COMPLETED|Open-label Phase||0||
48492483|NCT03769896|101538833|FG000|STARTED|Double-blind Treatment Phase||19|refers to the double-blind treatment phase|
48492484|NCT03769896|101538834|FG001|STARTED|Double-blind Treatment Phase||19|refers to the double-blind treatment phase|
48492485|NCT03769896|101538833|FG000|COMPLETED|Double-blind Treatment Phase||19|refers to the double-blind treatment phase|
48492486|NCT03769896|101538834|FG001|COMPLETED|Double-blind Treatment Phase||19|refers to the double-blind treatment phase|
48492487|NCT03769896|101538833|FG000|NOT COMPLETED|Double-blind Treatment Phase||0||
48492488|NCT03769896|101538834|FG001|NOT COMPLETED|Double-blind Treatment Phase||0||
48492489|NCT00679081|101538835|FG000|STARTED|Overall Study||15||
48492490|NCT00679081|101538835|FG000|COMPLETED|Overall Study||14||
48492491|NCT00679081|101538835|FG000|NOT COMPLETED|Overall Study||1||
48492492|NCT04236596|101538836|FG000|STARTED|Overall Study||22||
48492493|NCT04236596|101538836|FG000|COMPLETED|Overall Study||14||
48492494|NCT04236596|101538836|FG000|NOT COMPLETED|Overall Study||8||
48492495|NCT02635750|101538837|FG000|STARTED|Part 1, Period 1||18||
48492496|NCT02635750|101538838|FG001|STARTED|Part 1, Period 1||0||
48492497|NCT02635750|101538839|FG002|STARTED|Part 1, Period 1||0||
48492498|NCT02635750|101538837|FG000|COMPLETED|Part 1, Period 1||18||
48492499|NCT02635750|101538838|FG001|COMPLETED|Part 1, Period 1||0||
48492500|NCT02635750|101538839|FG002|COMPLETED|Part 1, Period 1||0||
48492501|NCT02635750|101538837|FG000|NOT COMPLETED|Part 1, Period 1||0||
48492502|NCT02635750|101538838|FG001|NOT COMPLETED|Part 1, Period 1||0||
48492503|NCT02635750|101538839|FG002|NOT COMPLETED|Part 1, Period 1||0||
48492504|NCT02635750|101538837|FG000|STARTED|Part 1, Period 2||18||
48492505|NCT02635750|101538838|FG001|STARTED|Part 1, Period 2||0||
48492506|NCT02635750|101538839|FG002|STARTED|Part 1, Period 2||0||
48492507|NCT02635750|101538837|FG000|COMPLETED|Part 1, Period 2||17||
48492508|NCT02635750|101538838|FG001|COMPLETED|Part 1, Period 2||0||
48492509|NCT02635750|101538839|FG002|COMPLETED|Part 1, Period 2||0||
48492510|NCT02635750|101538837|FG000|NOT COMPLETED|Part 1, Period 2||1||
48492511|NCT02635750|101538838|FG001|NOT COMPLETED|Part 1, Period 2||0||
48492512|NCT02635750|101538839|FG002|NOT COMPLETED|Part 1, Period 2||0||
48492513|NCT02635750|101538837|FG000|STARTED|Part 1, Period 3||17||
48492514|NCT02635750|101538838|FG001|STARTED|Part 1, Period 3||0||
48492515|NCT02635750|101538839|FG002|STARTED|Part 1, Period 3||0||
48492516|NCT02635750|101538837|FG000|COMPLETED|Part 1, Period 3||17||
48492517|NCT02635750|101538838|FG001|COMPLETED|Part 1, Period 3||0||
48492518|NCT02635750|101538839|FG002|COMPLETED|Part 1, Period 3||0||
48492519|NCT02635750|101538837|FG000|NOT COMPLETED|Part 1, Period 3||0||
48492520|NCT02635750|101538838|FG001|NOT COMPLETED|Part 1, Period 3||0||
48492521|NCT02635750|101538839|FG002|NOT COMPLETED|Part 1, Period 3||0||
48492522|NCT02635750|101538837|FG000|STARTED|Part 2, Period 1||0||
48492523|NCT02635750|101538838|FG001|STARTED|Part 2, Period 1||7||
48492524|NCT02635750|101538839|FG002|STARTED|Part 2, Period 1||7||
48492525|NCT02635750|101538837|FG000|COMPLETED|Part 2, Period 1||0||
48492526|NCT02635750|101538838|FG001|COMPLETED|Part 2, Period 1||7||
48492527|NCT02635750|101538839|FG002|COMPLETED|Part 2, Period 1||7||
48492528|NCT02635750|101538837|FG000|NOT COMPLETED|Part 2, Period 1||0||
48492529|NCT02635750|101538838|FG001|NOT COMPLETED|Part 2, Period 1||0||
48492530|NCT02635750|101538839|FG002|NOT COMPLETED|Part 2, Period 1||0||
48492531|NCT02635750|101538837|FG000|STARTED|Part 2, Washout||0||
48492532|NCT02635750|101538838|FG001|STARTED|Part 2, Washout||7||
48492533|NCT02635750|101538839|FG002|STARTED|Part 2, Washout||7||
48492534|NCT02635750|101538837|FG000|COMPLETED|Part 2, Washout||0||
48492535|NCT02635750|101538838|FG001|COMPLETED|Part 2, Washout||7||
48492536|NCT02635750|101538839|FG002|COMPLETED|Part 2, Washout||7||
48492537|NCT02635750|101538837|FG000|NOT COMPLETED|Part 2, Washout||0||
48492538|NCT02635750|101538838|FG001|NOT COMPLETED|Part 2, Washout||0||
48492539|NCT02635750|101538839|FG002|NOT COMPLETED|Part 2, Washout||0||
48492540|NCT02635750|101538837|FG000|STARTED|Part 2, Period 2||0||
48492541|NCT02635750|101538838|FG001|STARTED|Part 2, Period 2||7||
48492542|NCT02635750|101538839|FG002|STARTED|Part 2, Period 2||7||
48492543|NCT02635750|101538837|FG000|COMPLETED|Part 2, Period 2||0||
48492544|NCT02635750|101538838|FG001|COMPLETED|Part 2, Period 2||7||
48492545|NCT02635750|101538839|FG002|COMPLETED|Part 2, Period 2||7||
48492546|NCT02635750|101538837|FG000|NOT COMPLETED|Part 2, Period 2||0||
48492547|NCT02635750|101538838|FG001|NOT COMPLETED|Part 2, Period 2||0||
48492548|NCT02635750|101538839|FG002|NOT COMPLETED|Part 2, Period 2||0||
48492549|NCT01169558|101538840|FG000|STARTED|Overall Study||162||
48492550|NCT01169558|101538840|FG000|COMPLETED|Overall Study||6||
48492551|NCT01169558|101538840|FG000|NOT COMPLETED|Overall Study||156||
48492552|NCT01013649|101538841|FG000|STARTED|First Step||379||
48492553|NCT01013649|101538842|FG001|STARTED|First Step||167||
48492554|NCT01013649|101538843|FG002|STARTED|First Step||0||
48492555|NCT01013649|101538844|FG003|STARTED|First Step||0||
48492556|NCT01013649|101538841|FG000|Randomized to Arm I or Arm II|First Step||169|Closed 02-28-2014.|
48492557|NCT01013649|101538842|FG001|Randomized to Arm I or Arm II|First Step||167|Closed 02-28-2014.|
48492558|NCT01013649|101538843|FG002|Randomized to Arm I or Arm II|First Step||0|Closed 02-28-2014.|
48492559|NCT01013649|101538844|FG003|Randomized to Arm I or Arm II|First Step||0|Closed 02-28-2014.|
48492560|NCT01013649|101538841|FG000|Registered to Arm 1 Only|First Step||210|Started 04-02-2014, and as of 06-28-2016, combination chemotherapy was allowed.|
48492561|NCT01013649|101538842|FG001|Registered to Arm 1 Only|First Step||0|Started 04-02-2014, and as of 06-28-2016, combination chemotherapy was allowed.|
48492562|NCT01013649|101538843|FG002|Registered to Arm 1 Only|First Step||0|Started 04-02-2014, and as of 06-28-2016, combination chemotherapy was allowed.|
48492563|NCT01013649|101538844|FG003|Registered to Arm 1 Only|First Step||0|Started 04-02-2014, and as of 06-28-2016, combination chemotherapy was allowed.|
48492564|NCT01013649|101538841|FG000|Eligible|First Step||363||
48492565|NCT01013649|101538842|FG001|Eligible|First Step||159||
48492566|NCT01013649|101538843|FG002|Eligible|First Step||0||
48492567|NCT01013649|101538844|FG003|Eligible|First Step||0||
48492568|NCT01013649|101538841|FG000|Phase II Analysis Population|First Step||163|Randomized to first step and eligible.|
48492569|NCT01013649|101538842|FG001|Phase II Analysis Population|First Step||159|Randomized to first step and eligible.|
48492570|NCT01013649|101538843|FG002|Phase II Analysis Population|First Step||0|Randomized to first step and eligible.|
48492571|NCT01013649|101538844|FG003|Phase II Analysis Population|First Step||0|Randomized to first step and eligible.|
48666674|NCT00567502|101970457|FG003|NOT COMPLETED|Overall Study||87||
48200620|NCT01235949|100814559|FG009|STARTED|Booster Phase||63|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
48200621|NCT01235949|100814560|FG010|STARTED|Booster Phase||63|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
48200622|NCT01235949|100814561|FG011|STARTED|Booster Phase||63|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
48200623|NCT01235949|100814562|FG012|STARTED|Booster Phase||63|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
48200624|NCT01235949|100814563|FG013|STARTED|Booster Phase||65|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
48200625|NCT01235949|100814564|FG014|STARTED|Booster Phase||62|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
48200626|NCT01235949|100814565|FG015|STARTED|Booster Phase||67|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
48200627|NCT01235949|100814566|FG016|STARTED|Booster Phase||68|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
48200628|NCT01235949|100814567|FG017|STARTED|Booster Phase||67|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
48200629|NCT01235949|100814550|FG000|COMPLETED|Booster Phase||0||
48200630|NCT01235949|100814551|FG001|COMPLETED|Booster Phase||0||
48200631|NCT01235949|100814552|FG002|COMPLETED|Booster Phase||0||
48200632|NCT01235949|100814553|FG003|COMPLETED|Booster Phase||0||
48200633|NCT01235949|100814554|FG004|COMPLETED|Booster Phase||0||
48200634|NCT01235949|100814555|FG005|COMPLETED|Booster Phase||0||
48200635|NCT01235949|100814556|FG006|COMPLETED|Booster Phase||64||
48200636|NCT01235949|100814557|FG007|COMPLETED|Booster Phase||59||
48200637|NCT01235949|100814558|FG008|COMPLETED|Booster Phase||61||
48200638|NCT01235949|100814559|FG009|COMPLETED|Booster Phase||62||
48200639|NCT01235949|100814560|FG010|COMPLETED|Booster Phase||61||
48200640|NCT01235949|100814561|FG011|COMPLETED|Booster Phase||60||
48200641|NCT01235949|100814562|FG012|COMPLETED|Booster Phase||60||
48200642|NCT01235949|100814563|FG013|COMPLETED|Booster Phase||65||
48200643|NCT01235949|100814564|FG014|COMPLETED|Booster Phase||60||
48200644|NCT01235949|100814565|FG015|COMPLETED|Booster Phase||66||
48200645|NCT01235949|100814566|FG016|COMPLETED|Booster Phase||68||
48200646|NCT01235949|100814567|FG017|COMPLETED|Booster Phase||65||
48200647|NCT01235949|100814550|FG000|NOT COMPLETED|Booster Phase||0||
48200648|NCT01235949|100814551|FG001|NOT COMPLETED|Booster Phase||0||
48200649|NCT01235949|100814552|FG002|NOT COMPLETED|Booster Phase||0||
48200650|NCT01235949|100814553|FG003|NOT COMPLETED|Booster Phase||0||
48200651|NCT01235949|100814554|FG004|NOT COMPLETED|Booster Phase||0||
48200652|NCT01235949|100814555|FG005|NOT COMPLETED|Booster Phase||0||
48200653|NCT01235949|100814556|FG006|NOT COMPLETED|Booster Phase||0||
48492572|NCT01013649|101538841|FG000|Phase II AE Population|First Step||160|Randomized to first step, eligible, and started protocol treatment.|
48492573|NCT01013649|101538842|FG001|Phase II AE Population|First Step||158|Randomized to first step, eligible, and started protocol treatment.|
48200654|NCT01235949|100814557|FG007|NOT COMPLETED|Booster Phase||1||
48200655|NCT01235949|100814558|FG008|NOT COMPLETED|Booster Phase||2||
48200656|NCT01235949|100814559|FG009|NOT COMPLETED|Booster Phase||1||
48200657|NCT01235949|100814560|FG010|NOT COMPLETED|Booster Phase||2||
48200658|NCT01235949|100814561|FG011|NOT COMPLETED|Booster Phase||3||
48492574|NCT01013649|101538843|FG002|Phase II AE Population|First Step||0|Randomized to first step, eligible, and started protocol treatment.|
48492575|NCT01013649|101538844|FG003|Phase II AE Population|First Step||0|Randomized to first step, eligible, and started protocol treatment.|
48492576|NCT01013649|101538841|FG000|Randomized to Arm III|First Step||124||
48492577|NCT01013649|101538842|FG001|Randomized to Arm III|First Step||50||
48492578|NCT01013649|101538843|FG002|Randomized to Arm III|First Step||0||
48492579|NCT01013649|101538844|FG003|Randomized to Arm III|First Step||0||
48492580|NCT01013649|101538841|FG000|Randomized to Arm IV|First Step||130||
48492581|NCT01013649|101538842|FG001|Randomized to Arm IV|First Step||50||
48492582|NCT01013649|101538843|FG002|Randomized to Arm IV|First Step||0||
48492583|NCT01013649|101538844|FG003|Randomized to Arm IV|First Step||0||
48492584|NCT01013649|101538841|FG000|COMPLETED|First Step||254|Participants who continued to second step randomization, which requires starting the 5th cycle of the first step treatment and having no progression detected on the 5th cycle CT/MRI.|
48492585|NCT01013649|101538842|FG001|COMPLETED|First Step||100|Participants who continued to second step randomization, which requires starting the 5th cycle of the first step treatment and having no progression detected on the 5th cycle CT/MRI.|
48492586|NCT01013649|101538843|FG002|COMPLETED|First Step||0|Participants who continued to second step randomization, which requires starting the 5th cycle of the first step treatment and having no progression detected on the 5th cycle CT/MRI.|
48492587|NCT01013649|101538844|FG003|COMPLETED|First Step||0|Participants who continued to second step randomization, which requires starting the 5th cycle of the first step treatment and having no progression detected on the 5th cycle CT/MRI.|
48492588|NCT01013649|101538841|FG000|NOT COMPLETED|First Step||125||
48492589|NCT01013649|101538842|FG001|NOT COMPLETED|First Step||67||
48492590|NCT01013649|101538843|FG002|NOT COMPLETED|First Step||0||
48492591|NCT01013649|101538844|FG003|NOT COMPLETED|First Step||0||
48492592|NCT01013649|101538841|FG000|STARTED|Second Step||0||
48492593|NCT01013649|101538842|FG001|STARTED|Second Step||0||
48492594|NCT01013649|101538843|FG002|STARTED|Second Step||174||
48492595|NCT01013649|101538844|FG003|STARTED|Second Step||180||
48492596|NCT01013649|101538841|FG000|Phase III Analysis Population|Second Step||0|Randomized to second step (Arm III and Arm IV).|
48492597|NCT01013649|101538842|FG001|Phase III Analysis Population|Second Step||0|Randomized to second step (Arm III and Arm IV).|
48200659|NCT01235949|100814562|FG012|NOT COMPLETED|Booster Phase||3||
48200660|NCT01235949|100814563|FG013|NOT COMPLETED|Booster Phase||0||
48200661|NCT01235949|100814564|FG014|NOT COMPLETED|Booster Phase||2||
48492598|NCT01013649|101538843|FG002|Phase III Analysis Population|Second Step||174|Randomized to second step (Arm III and Arm IV).|
48492599|NCT01013649|101538844|FG003|Phase III Analysis Population|Second Step||180|Randomized to second step (Arm III and Arm IV).|
48492600|NCT01013649|101538841|FG000|Phase III AE Population|Second Step||0|Randomized to second step, and started protocol treatment.|
48492601|NCT01013649|101538842|FG001|Phase III AE Population|Second Step||0|Randomized to second step, and started protocol treatment.|
48492602|NCT01013649|101538843|FG002|Phase III AE Population|Second Step||174|Randomized to second step, and started protocol treatment.|
48492603|NCT01013649|101538844|FG003|Phase III AE Population|Second Step||180|Randomized to second step, and started protocol treatment.|
48492604|NCT01013649|101538841|FG000|COMPLETED|Second Step||0|Contributed any data to phase III analysis or adverse event reporting.|
48492605|NCT01013649|101538842|FG001|COMPLETED|Second Step||0|Contributed any data to phase III analysis or adverse event reporting.|
48492606|NCT01013649|101538843|FG002|COMPLETED|Second Step||174|Contributed any data to phase III analysis or adverse event reporting.|
48492607|NCT01013649|101538844|FG003|COMPLETED|Second Step||180|Contributed any data to phase III analysis or adverse event reporting.|
48492608|NCT01013649|101538841|FG000|NOT COMPLETED|Second Step||0||
48492609|NCT01013649|101538842|FG001|NOT COMPLETED|Second Step||0||
48492610|NCT01013649|101538843|FG002|NOT COMPLETED|Second Step||0||
48200662|NCT01235949|100814565|FG015|NOT COMPLETED|Booster Phase||1||
48200663|NCT01235949|100814566|FG016|NOT COMPLETED|Booster Phase||0||
48492611|NCT01013649|101538844|FG003|NOT COMPLETED|Second Step||0||
48492612|NCT01056484|101538845|FG000|STARTED|Randomized Controlled Trial||64||
48492613|NCT01056484|101538846|FG001|STARTED|Randomized Controlled Trial||59||
48492614|NCT01056484|101538845|FG000|COMPLETED|Randomized Controlled Trial||57||
48492615|NCT01056484|101538846|FG001|COMPLETED|Randomized Controlled Trial||58||
48492616|NCT01056484|101538845|FG000|NOT COMPLETED|Randomized Controlled Trial||7||
48492617|NCT01056484|101538846|FG001|NOT COMPLETED|Randomized Controlled Trial||1||
48492618|NCT01056484|101538845|FG000|STARTED|Follow up - Non-randomized||57||
48492619|NCT01056484|101538846|FG001|STARTED|Follow up - Non-randomized||58||
48492620|NCT01056484|101538845|FG000|COMPLETED|Follow up - Non-randomized||57||
48492621|NCT01056484|101538846|FG001|COMPLETED|Follow up - Non-randomized||56||
48492622|NCT01056484|101538845|FG000|NOT COMPLETED|Follow up - Non-randomized||0||
48492623|NCT01056484|101538846|FG001|NOT COMPLETED|Follow up - Non-randomized||2||
48492624|NCT03374176|101538847|FG000|STARTED|Overall Study||21||
48492625|NCT03374176|101538848|FG001|STARTED|Overall Study||21||
48492626|NCT03374176|101538847|FG000|COMPLETED|Overall Study||21||
48492627|NCT03374176|101538848|FG001|COMPLETED|Overall Study||21||
48492628|NCT03374176|101538847|FG000|NOT COMPLETED|Overall Study||0||
48492629|NCT03374176|101538848|FG001|NOT COMPLETED|Overall Study||0||
48492630|NCT00840879|101538849|FG000|STARTED|First Intervention||14||
48492631|NCT00840879|101538850|FG001|STARTED|First Intervention||14||
48492632|NCT00840879|101538849|FG000|COMPLETED|First Intervention||14||
48492633|NCT00840879|101538850|FG001|COMPLETED|First Intervention||14||
48492634|NCT00840879|101538849|FG000|NOT COMPLETED|First Intervention||0||
48492635|NCT00840879|101538850|FG001|NOT COMPLETED|First Intervention||0||
48492636|NCT00840879|101538849|FG000|STARTED|Washout: 14 Days||14||
48492637|NCT00840879|101538850|FG001|STARTED|Washout: 14 Days||14||
48492638|NCT00840879|101538849|FG000|COMPLETED|Washout: 14 Days||14||
48492639|NCT00840879|101538850|FG001|COMPLETED|Washout: 14 Days||14||
48492640|NCT00840879|101538849|FG000|NOT COMPLETED|Washout: 14 Days||0||
48492641|NCT00840879|101538850|FG001|NOT COMPLETED|Washout: 14 Days||0||
48492642|NCT00840879|101538849|FG000|STARTED|Second Intervention||14||
48492643|NCT00840879|101538850|FG001|STARTED|Second Intervention||14||
48492644|NCT00840879|101538849|FG000|COMPLETED|Second Intervention||13||
48492645|NCT00840879|101538850|FG001|COMPLETED|Second Intervention||14||
48492646|NCT00840879|101538849|FG000|NOT COMPLETED|Second Intervention||1||
48492647|NCT00840879|101538850|FG001|NOT COMPLETED|Second Intervention||0||
48492648|NCT02267187|101538851|FG000|STARTED|Overall Study||15||
48492649|NCT02267187|101538851|FG000|COMPLETED|Overall Study||10||
48492650|NCT02267187|101538851|FG000|NOT COMPLETED|Overall Study||5||
48492651|NCT01537887|101538852|FG000|STARTED|Period 1||12||
48492652|NCT01537887|101538853|FG001|STARTED|Period 1||12||
48492653|NCT01537887|101538854|FG002|STARTED|Period 1||12||
48492654|NCT01537887|101538855|FG003|STARTED|Period 1||12||
48492655|NCT01537887|101538856|FG004|STARTED|Period 1||12||
48492656|NCT01537887|101538857|FG005|STARTED|Period 1||12||
48492657|NCT01537887|101538852|FG000|Received at Least 1 Dose of Study Drug|Period 1||12||
48492658|NCT01537887|101538853|FG001|Received at Least 1 Dose of Study Drug|Period 1||12||
48492659|NCT01537887|101538854|FG002|Received at Least 1 Dose of Study Drug|Period 1||11||
48492660|NCT01537887|101538855|FG003|Received at Least 1 Dose of Study Drug|Period 1||12||
48492661|NCT01537887|101538856|FG004|Received at Least 1 Dose of Study Drug|Period 1||12||
48492662|NCT01537887|101538857|FG005|Received at Least 1 Dose of Study Drug|Period 1||12||
48492663|NCT01537887|101538852|FG000|COMPLETED|Period 1||12||
48492664|NCT01537887|101538853|FG001|COMPLETED|Period 1||12||
48492665|NCT01537887|101538854|FG002|COMPLETED|Period 1||11||
48492666|NCT01537887|101538855|FG003|COMPLETED|Period 1||12||
48492667|NCT01537887|101538856|FG004|COMPLETED|Period 1||11||
48492668|NCT01537887|101538857|FG005|COMPLETED|Period 1||11||
48492669|NCT01537887|101538852|FG000|NOT COMPLETED|Period 1||0||
48492670|NCT01537887|101538853|FG001|NOT COMPLETED|Period 1||0||
48492671|NCT01537887|101538854|FG002|NOT COMPLETED|Period 1||1||
48492672|NCT01537887|101538855|FG003|NOT COMPLETED|Period 1||0||
48492673|NCT01537887|101538856|FG004|NOT COMPLETED|Period 1||1||
48492674|NCT01537887|101538857|FG005|NOT COMPLETED|Period 1||1||
48492675|NCT01537887|101538852|FG000|STARTED|Period 2||12||
48492676|NCT01537887|101538853|FG001|STARTED|Period 2||12||
48492677|NCT01537887|101538854|FG002|STARTED|Period 2||11||
48492678|NCT01537887|101538855|FG003|STARTED|Period 2||12||
48200664|NCT01235949|100814567|FG017|NOT COMPLETED|Booster Phase||2||
48200665|NCT03254394|100814568|FG000|STARTED|Overall Study||12||
48200666|NCT03254394|100814569|FG001|STARTED|Overall Study||14||
48492679|NCT01537887|101538856|FG004|STARTED|Period 2||11||
48200667|NCT03254394|100814568|FG000|COMPLETED|Overall Study||12||
48200668|NCT03254394|100814569|FG001|COMPLETED|Overall Study||12||
48200669|NCT03254394|100814568|FG000|NOT COMPLETED|Overall Study||0||
48200670|NCT03254394|100814569|FG001|NOT COMPLETED|Overall Study||2||
48200671|NCT01806714|100814570|FG000|STARTED|Overall Study||2093||
48200672|NCT01806714|100814571|FG001|STARTED|Overall Study||2089||
48200673|NCT01806714|100814570|FG000|COMPLETED|Overall Study||1893||
48200674|NCT01806714|100814571|FG001|COMPLETED|Overall Study||1919||
48492680|NCT01537887|101538857|FG005|STARTED|Period 2||11||
48492681|NCT01537887|101538852|FG000|COMPLETED|Period 2||12||
48200675|NCT01806714|100814570|FG000|NOT COMPLETED|Overall Study||200||
48200676|NCT01806714|100814571|FG001|NOT COMPLETED|Overall Study||170||
48200677|NCT01689519|100814572|FG000|STARTED|Intent to Treat||247||
48200678|NCT01689519|100814573|FG001|STARTED|Intent to Treat||248||
48200679|NCT01689519|100814572|FG000|COMPLETED|Intent to Treat||0||
48200680|NCT01689519|100814573|FG001|COMPLETED|Intent to Treat||0||
48492682|NCT01537887|101538853|FG001|COMPLETED|Period 2||11||
48492683|NCT01537887|101538854|FG002|COMPLETED|Period 2||11||
48492684|NCT01537887|101538855|FG003|COMPLETED|Period 2||12||
48492685|NCT01537887|101538856|FG004|COMPLETED|Period 2||11||
48492686|NCT01537887|101538857|FG005|COMPLETED|Period 2||11||
48492687|NCT01537887|101538852|FG000|NOT COMPLETED|Period 2||0||
48492688|NCT01537887|101538853|FG001|NOT COMPLETED|Period 2||1||
48492689|NCT01537887|101538854|FG002|NOT COMPLETED|Period 2||0||
48492690|NCT01537887|101538855|FG003|NOT COMPLETED|Period 2||0||
48492691|NCT01537887|101538856|FG004|NOT COMPLETED|Period 2||0||
48492692|NCT01537887|101538857|FG005|NOT COMPLETED|Period 2||0||
48492693|NCT01537887|101538852|FG000|STARTED|Period 3||12||
48492694|NCT01537887|101538853|FG001|STARTED|Period 3||11||
48492695|NCT01537887|101538854|FG002|STARTED|Period 3||11||
48492696|NCT01537887|101538855|FG003|STARTED|Period 3||12||
48200681|NCT01689519|100814572|FG000|NOT COMPLETED|Intent to Treat||247||
48200682|NCT01689519|100814573|FG001|NOT COMPLETED|Intent to Treat||248||
48492697|NCT01537887|101538856|FG004|STARTED|Period 3||11||
48200683|NCT01689519|100814572|FG000|STARTED|Safety Population||248||
48200684|NCT01689519|100814573|FG001|STARTED|Safety Population||245||
48492698|NCT01537887|101538857|FG005|STARTED|Period 3||11||
48492699|NCT01537887|101538852|FG000|COMPLETED|Period 3||12||
48492700|NCT01537887|101538853|FG001|COMPLETED|Period 3||10||
48492701|NCT01537887|101538854|FG002|COMPLETED|Period 3||10||
48492702|NCT01537887|101538855|FG003|COMPLETED|Period 3||12||
48492703|NCT01537887|101538856|FG004|COMPLETED|Period 3||11||
48492704|NCT01537887|101538857|FG005|COMPLETED|Period 3||11||
48492705|NCT01537887|101538852|FG000|NOT COMPLETED|Period 3||0||
48492706|NCT01537887|101538853|FG001|NOT COMPLETED|Period 3||1||
48492707|NCT01537887|101538854|FG002|NOT COMPLETED|Period 3||1||
48492708|NCT01537887|101538855|FG003|NOT COMPLETED|Period 3||0||
48492709|NCT01537887|101538856|FG004|NOT COMPLETED|Period 3||0||
48492710|NCT01537887|101538857|FG005|NOT COMPLETED|Period 3||0||
48492711|NCT00840281|101538858|FG000|STARTED|First Intervention||19||
48492712|NCT00840281|101538859|FG001|STARTED|First Intervention||19||
48492713|NCT00840281|101538858|FG000|COMPLETED|First Intervention||19||
48492714|NCT00840281|101538859|FG001|COMPLETED|First Intervention||19||
48492715|NCT00840281|101538858|FG000|NOT COMPLETED|First Intervention||0||
48492716|NCT00840281|101538859|FG001|NOT COMPLETED|First Intervention||0||
48492717|NCT00840281|101538858|FG000|STARTED|Washout of 7 Days||19||
48492718|NCT00840281|101538859|FG001|STARTED|Washout of 7 Days||19||
48492719|NCT00840281|101538858|FG000|COMPLETED|Washout of 7 Days||19||
48492720|NCT00840281|101538859|FG001|COMPLETED|Washout of 7 Days||19||
48492721|NCT00840281|101538858|FG000|NOT COMPLETED|Washout of 7 Days||0||
48492722|NCT00840281|101538859|FG001|NOT COMPLETED|Washout of 7 Days||0||
48492723|NCT00840281|101538858|FG000|STARTED|Second Intervention||19||
48492724|NCT00840281|101538859|FG001|STARTED|Second Intervention||19||
48492725|NCT00840281|101538858|FG000|COMPLETED|Second Intervention||19||
48492726|NCT00840281|101538859|FG001|COMPLETED|Second Intervention||19||
48492727|NCT00840281|101538858|FG000|NOT COMPLETED|Second Intervention||0||
48492728|NCT00840281|101538859|FG001|NOT COMPLETED|Second Intervention||0||
48492729|NCT05168735|101538860|FG000|STARTED|Overall Study||22||
48492730|NCT05168735|101538861|FG001|STARTED|Overall Study||21||
48492731|NCT05168735|101538860|FG000|COMPLETED|Overall Study||22||
48492732|NCT05168735|101538861|FG001|COMPLETED|Overall Study||21||
48492733|NCT05168735|101538860|FG000|NOT COMPLETED|Overall Study||0||
48492734|NCT05168735|101538861|FG001|NOT COMPLETED|Overall Study||0||
48492735|NCT00489307|101538862|FG000|STARTED|Overall Study||67||
48492736|NCT00489307|101538863|FG001|STARTED|Overall Study||65||
48492737|NCT00489307|101538862|FG000|COMPLETED|Overall Study||43||
48492738|NCT00489307|101538863|FG001|COMPLETED|Overall Study||41||
48492739|NCT00489307|101538862|FG000|NOT COMPLETED|Overall Study||24||
48492740|NCT00489307|101538863|FG001|NOT COMPLETED|Overall Study||24||
48492741|NCT00418938|101538864|FG000|STARTED|Overall Study||133||
48492742|NCT00418938|101538865|FG001|STARTED|Overall Study||131||
48492743|NCT00418938|101538864|FG000|COMPLETED|Overall Study||109||
48492744|NCT00418938|101538865|FG001|COMPLETED|Overall Study||108||
48492745|NCT00418938|101538864|FG000|NOT COMPLETED|Overall Study||24||
48492746|NCT00418938|101538865|FG001|NOT COMPLETED|Overall Study||23||
48492747|NCT03939897|101538866|FG000|STARTED|Overall Study||7||
48492748|NCT03939897|101538867|FG001|STARTED|Overall Study||3||
48492749|NCT03939897|101538868|FG002|STARTED|Overall Study||7||
48492750|NCT03939897|101538869|FG003|STARTED|Overall Study||7||
48492751|NCT03939897|101538870|FG004|STARTED|Overall Study||0||
48492752|NCT03939897|101538871|FG005|STARTED|Overall Study||0||
48492753|NCT03939897|101538866|FG000|COMPLETED|Overall Study||7||
48492754|NCT03939897|101538867|FG001|COMPLETED|Overall Study||3||
48492755|NCT03939897|101538868|FG002|COMPLETED|Overall Study||6||
48492756|NCT03939897|101538869|FG003|COMPLETED|Overall Study||7||
48492757|NCT03939897|101538870|FG004|COMPLETED|Overall Study||0||
48492758|NCT03939897|101538871|FG005|COMPLETED|Overall Study||0||
48492759|NCT03939897|101538866|FG000|NOT COMPLETED|Overall Study||0||
48492760|NCT03939897|101538867|FG001|NOT COMPLETED|Overall Study||0||
48492761|NCT03939897|101538868|FG002|NOT COMPLETED|Overall Study||1||
48492762|NCT03939897|101538869|FG003|NOT COMPLETED|Overall Study||0||
48492763|NCT03939897|101538870|FG004|NOT COMPLETED|Overall Study||0||
48492764|NCT03939897|101538871|FG005|NOT COMPLETED|Overall Study||0||
48492765|NCT03106415|101538872|FG000|STARTED|Phase 1||5||
48492766|NCT03106415|101538873|FG001|STARTED|Phase 1||8||
48492767|NCT03106415|101538874|FG002|STARTED|Phase 1||0||
48492768|NCT03106415|101538872|FG000|COMPLETED|Phase 1||3||
48492769|NCT03106415|101538873|FG001|COMPLETED|Phase 1||6||
48492770|NCT03106415|101538874|FG002|COMPLETED|Phase 1||0||
48492771|NCT03106415|101538872|FG000|NOT COMPLETED|Phase 1||2||
48492772|NCT03106415|101538873|FG001|NOT COMPLETED|Phase 1||2||
48492773|NCT03106415|101538874|FG002|NOT COMPLETED|Phase 1||0||
48492774|NCT03106415|101538872|FG000|STARTED|Phase 2||0||
48492775|NCT03106415|101538873|FG001|STARTED|Phase 2||8||
48492776|NCT03106415|101538874|FG002|STARTED|Phase 2||10||
48492777|NCT03106415|101538872|FG000|COMPLETED|Phase 2||0||
48492778|NCT03106415|101538873|FG001|COMPLETED|Phase 2||8||
48492779|NCT03106415|101538874|FG002|COMPLETED|Phase 2||10||
48200685|NCT01689519|100814572|FG000|COMPLETED|Safety Population||0||
48492780|NCT03106415|101538872|FG000|NOT COMPLETED|Phase 2||0||
48492781|NCT03106415|101538873|FG001|NOT COMPLETED|Phase 2||0||
48492782|NCT03106415|101538874|FG002|NOT COMPLETED|Phase 2||0||
48492783|NCT04512781|101538875|FG000|STARTED|Overall Study||15||
48492784|NCT04512781|101538876|FG001|STARTED|Overall Study||11||
48200686|NCT01689519|100814573|FG001|COMPLETED|Safety Population||0||
48492785|NCT04512781|101538875|FG000|COMPLETED|Overall Study||15||
48492786|NCT04512781|101538876|FG001|COMPLETED|Overall Study||11||
48492787|NCT04512781|101538875|FG000|NOT COMPLETED|Overall Study||0||
48492788|NCT04512781|101538876|FG001|NOT COMPLETED|Overall Study||0||
48492789|NCT00835588|101538877|FG000|STARTED|First Intervention||50||
48492790|NCT00835588|101538878|FG001|STARTED|First Intervention||50||
48492791|NCT00835588|101538877|FG000|COMPLETED|First Intervention||50||
48492792|NCT00835588|101538878|FG001|COMPLETED|First Intervention||50||
48492793|NCT00835588|101538877|FG000|NOT COMPLETED|First Intervention||0||
48492794|NCT00835588|101538878|FG001|NOT COMPLETED|First Intervention||0||
48492795|NCT00835588|101538877|FG000|STARTED|Washout: 5 Days||50||
48492796|NCT00835588|101538878|FG001|STARTED|Washout: 5 Days||50||
48200687|NCT01689519|100814572|FG000|NOT COMPLETED|Safety Population||248||
48492797|NCT00835588|101538877|FG000|COMPLETED|Washout: 5 Days||50||
48492798|NCT00835588|101538878|FG001|COMPLETED|Washout: 5 Days||50||
48492799|NCT00835588|101538877|FG000|NOT COMPLETED|Washout: 5 Days||0||
48492800|NCT00835588|101538878|FG001|NOT COMPLETED|Washout: 5 Days||0||
48492801|NCT00835588|101538877|FG000|STARTED|Second Intervention||50||
48492802|NCT00835588|101538878|FG001|STARTED|Second Intervention||50||
48492803|NCT00835588|101538877|FG000|COMPLETED|Second Intervention||50||
48492804|NCT00835588|101538878|FG001|COMPLETED|Second Intervention||50||
48492805|NCT00835588|101538877|FG000|NOT COMPLETED|Second Intervention||0||
48492806|NCT00835588|101538878|FG001|NOT COMPLETED|Second Intervention||0||
48492807|NCT03325881|101538879|FG000|STARTED|Overall Study||44||
48492808|NCT03325881|101538880|FG001|STARTED|Overall Study||45||
48492809|NCT03325881|101538879|FG000|Treated|Overall Study||43||
48492810|NCT03325881|101538880|FG001|Treated|Overall Study||45||
48492811|NCT03325881|101538879|FG000|COMPLETED|Overall Study||41||
48492812|NCT03325881|101538880|FG001|COMPLETED|Overall Study||42||
48492813|NCT03325881|101538879|FG000|NOT COMPLETED|Overall Study||3||
48492814|NCT03325881|101538880|FG001|NOT COMPLETED|Overall Study||3||
48492815|NCT05757453|101538881|FG000|STARTED|Overall Study||43||
48492816|NCT05757453|101538881|FG000|COMPLETED|Overall Study||21||
48492817|NCT05757453|101538881|FG000|NOT COMPLETED|Overall Study||22||
48492818|NCT02960295|101538882|FG000|STARTED|Overall Study||10||
48492819|NCT02960295|101538882|FG000|COMPLETED|Overall Study||10||
48492820|NCT02960295|101538882|FG000|NOT COMPLETED|Overall Study||0||
48492821|NCT02709018|101538883|FG000|STARTED|Overall Study||75||
48492822|NCT02709018|101538884|FG001|STARTED|Overall Study||74||
48492823|NCT02709018|101538883|FG000|COMPLETED|Overall Study||59||
48492824|NCT02709018|101538884|FG001|COMPLETED|Overall Study||58||
48492825|NCT02709018|101538883|FG000|NOT COMPLETED|Overall Study||16||
48492826|NCT02709018|101538884|FG001|NOT COMPLETED|Overall Study||16||
48492827|NCT01983969|101538885|FG000|STARTED|Overall Study||37||
48492828|NCT01983969|101538886|FG001|STARTED|Overall Study||19||
48492829|NCT01983969|101538887|FG002|STARTED|Overall Study||5||
48492830|NCT01983969|101538885|FG000|COMPLETED|Overall Study||37||
48492831|NCT01983969|101538886|FG001|COMPLETED|Overall Study||18||
48492832|NCT01983969|101538887|FG002|COMPLETED|Overall Study||5||
48492833|NCT01983969|101538885|FG000|NOT COMPLETED|Overall Study||0||
48492834|NCT01983969|101538886|FG001|NOT COMPLETED|Overall Study||1||
48492835|NCT01983969|101538887|FG002|NOT COMPLETED|Overall Study||0||
48492836|NCT00377260|101538888|FG000|STARTED|Overall Study||144||
48492837|NCT00377260|101538889|FG001|STARTED|Overall Study||147||
48492838|NCT00377260|101538888|FG000|COMPLETED|Overall Study||142||
48492839|NCT00377260|101538889|FG001|COMPLETED|Overall Study||142||
48492840|NCT00377260|101538888|FG000|NOT COMPLETED|Overall Study||2||
48492841|NCT00377260|101538889|FG001|NOT COMPLETED|Overall Study||5||
48492842|NCT00304187|101538890|FG000|STARTED|Overall Study||15||
48492843|NCT00304187|101538891|FG001|STARTED|Overall Study||14||
48492844|NCT00304187|101538890|FG000|COMPLETED|Overall Study||13||
48492845|NCT00304187|101538891|FG001|COMPLETED|Overall Study||13||
48492846|NCT00304187|101538890|FG000|NOT COMPLETED|Overall Study||2||
48492847|NCT00304187|101538891|FG001|NOT COMPLETED|Overall Study||1||
48492848|NCT02272803|101538892|FG000|STARTED|Overall Study||40||
48492849|NCT02272803|101538893|FG001|STARTED|Overall Study||42||
48492850|NCT02272803|101538892|FG000|COMPLETED|Overall Study||0||
48492851|NCT02272803|101538893|FG001|COMPLETED|Overall Study||0||
48492852|NCT02272803|101538892|FG000|NOT COMPLETED|Overall Study||40||
48492853|NCT02272803|101538893|FG001|NOT COMPLETED|Overall Study||42||
48492854|NCT04089917|101538894|FG000|STARTED|Overall Study||45||
48492855|NCT04089917|101538894|FG000|COMPLETED|Overall Study||45||
48492856|NCT04089917|101538894|FG000|NOT COMPLETED|Overall Study||0||
48492857|NCT01165450|101538895|FG000|STARTED|Overall Study||2||
48492858|NCT01165450|101538895|FG000|COMPLETED|Overall Study||2||
48492859|NCT01165450|101538895|FG000|NOT COMPLETED|Overall Study||0||
48492860|NCT03427463|101538896|FG000|STARTED|Overall Study||115||
48492861|NCT03427463|101538897|FG001|STARTED|Overall Study||114||
48492862|NCT03427463|101538896|FG000|COMPLETED|Overall Study||101||
48492863|NCT03427463|101538897|FG001|COMPLETED|Overall Study||100||
48492864|NCT03427463|101538896|FG000|NOT COMPLETED|Overall Study||14||
48492865|NCT03427463|101538897|FG001|NOT COMPLETED|Overall Study||14||
48492866|NCT00470704|101538898|FG000|STARTED|Overall Study||41||
48492867|NCT00470704|101538899|FG001|STARTED|Overall Study||46||
48492868|NCT00470704|101538898|FG000|Safety Population|Overall Study||41||
48492869|NCT00470704|101538899|FG001|Safety Population|Overall Study||45||
48492870|NCT00470704|101538898|FG000|Treated|Overall Study||40||
48492871|NCT00470704|101538899|FG001|Treated|Overall Study||45||
48492872|NCT00470704|101538898|FG000|COMPLETED|Overall Study||0||
48492873|NCT00470704|101538899|FG001|COMPLETED|Overall Study||0||
48492874|NCT00470704|101538898|FG000|NOT COMPLETED|Overall Study||41||
48492875|NCT00470704|101538899|FG001|NOT COMPLETED|Overall Study||46||
48492876|NCT02815566|101538900|FG000|STARTED|Overall Study||19||
48492877|NCT02815566|101538901|FG001|STARTED|Overall Study||15||
48492878|NCT02815566|101538900|FG000|COMPLETED|Overall Study||17||
48492879|NCT02815566|101538901|FG001|COMPLETED|Overall Study||13||
48492880|NCT02815566|101538900|FG000|NOT COMPLETED|Overall Study||2||
48492881|NCT02815566|101538901|FG001|NOT COMPLETED|Overall Study||2||
48492882|NCT03904147|101538902|FG000|STARTED|Overall Study||175||
48492883|NCT03904147|101538903|FG001|STARTED|Overall Study||175||
48492884|NCT03904147|101538904|FG002|STARTED|Overall Study||100||
48492885|NCT03904147|101538902|FG000|COMPLETED|Overall Study||152||
48492886|NCT03904147|101538903|FG001|COMPLETED|Overall Study||149||
48492887|NCT03904147|101538904|FG002|COMPLETED|Overall Study||84||
48492888|NCT03904147|101538902|FG000|NOT COMPLETED|Overall Study||23||
48492889|NCT03904147|101538903|FG001|NOT COMPLETED|Overall Study||26||
48492890|NCT03904147|101538904|FG002|NOT COMPLETED|Overall Study||16||
48492891|NCT02890355|101538905|FG000|STARTED|Overall Study||59||
48492892|NCT02890355|101538906|FG001|STARTED|Overall Study||58||
48492893|NCT02890355|101538905|FG000|Treated & Assessed for AEs|Overall Study||56||
48492894|NCT02890355|101538906|FG001|Treated & Assessed for AEs|Overall Study||50||
48492895|NCT02890355|101538905|FG000|COMPLETED|Overall Study||0||
48492896|NCT02890355|101538906|FG001|COMPLETED|Overall Study||0||
48492897|NCT02890355|101538905|FG000|NOT COMPLETED|Overall Study||59||
48492898|NCT02890355|101538906|FG001|NOT COMPLETED|Overall Study||58||
48492899|NCT04660201|101538907|FG000|STARTED|Overall Study||21||
48492900|NCT04660201|101538908|FG001|STARTED|Overall Study||20||
48492901|NCT04660201|101538907|FG000|COMPLETED|Overall Study||21||
48492902|NCT04660201|101538908|FG001|COMPLETED|Overall Study||20||
48492903|NCT04660201|101538907|FG000|NOT COMPLETED|Overall Study||0||
48492904|NCT04660201|101538908|FG001|NOT COMPLETED|Overall Study||0||
48492905|NCT02476916|101538909|FG000|STARTED|Core Period||27||
48492906|NCT02476916|101538910|FG001|STARTED|Core Period||25||
48492907|NCT02476916|101538909|FG000|COMPLETED|Core Period||21||
48492908|NCT02476916|101538910|FG001|COMPLETED|Core Period||22||
48492909|NCT02476916|101538909|FG000|NOT COMPLETED|Core Period||6||
48492910|NCT02476916|101538910|FG001|NOT COMPLETED|Core Period||3||
48492911|NCT02476916|101538909|FG000|STARTED|Extension Period||18|A total of 36 participants who had clinical activity and tolerated dose entered Extension Period.|
48492912|NCT02476916|101538910|FG001|STARTED|Extension Period||18|A total of 36 participants who had clinical activity and tolerated dose entered Extension Period.|
48492913|NCT02476916|101538909|FG000|COMPLETED|Extension Period||0||
48492914|NCT02476916|101538910|FG001|COMPLETED|Extension Period||0||
48492915|NCT02476916|101538909|FG000|NOT COMPLETED|Extension Period||18||
48492916|NCT02476916|101538910|FG001|NOT COMPLETED|Extension Period||18||
48492917|NCT03569631|101538911|FG000|STARTED|Period 1 (12 Weeks)||15||
48492918|NCT03569631|101538912|FG001|STARTED|Period 1 (12 Weeks)||15||
48492919|NCT03569631|101538911|FG000|Received At Least 1 Dose of Study Drug|Period 1 (12 Weeks)||15||
48492920|NCT03569631|101538912|FG001|Received At Least 1 Dose of Study Drug|Period 1 (12 Weeks)||15||
48492921|NCT03569631|101538911|FG000|COMPLETED|Period 1 (12 Weeks)||15||
48492922|NCT03569631|101538912|FG001|COMPLETED|Period 1 (12 Weeks)||15||
48492923|NCT03569631|101538911|FG000|NOT COMPLETED|Period 1 (12 Weeks)||0||
48492924|NCT03569631|101538912|FG001|NOT COMPLETED|Period 1 (12 Weeks)||0||
48492925|NCT03569631|101538911|FG000|STARTED|Period 2 (12 Weeks)||15||
48492926|NCT03569631|101538912|FG001|STARTED|Period 2 (12 Weeks)||15||
48492927|NCT03569631|101538911|FG000|Received At Least 1 Dose of Study Drug|Period 2 (12 Weeks)||15||
48492928|NCT03569631|101538912|FG001|Received At Least 1 Dose of Study Drug|Period 2 (12 Weeks)||15||
48492929|NCT03569631|101538911|FG000|COMPLETED|Period 2 (12 Weeks)||15||
48492930|NCT03569631|101538912|FG001|COMPLETED|Period 2 (12 Weeks)||15||
48492931|NCT03569631|101538911|FG000|NOT COMPLETED|Period 2 (12 Weeks)||0||
48492932|NCT03569631|101538912|FG001|NOT COMPLETED|Period 2 (12 Weeks)||0||
48492933|NCT03307343|101538913|FG000|STARTED|Overall Study||136||
48492934|NCT03307343|101538914|FG001|STARTED|Overall Study||135||
48492935|NCT03307343|101538913|FG000|COMPLETED|Overall Study||134||
48492936|NCT03307343|101538914|FG001|COMPLETED|Overall Study||129||
48492937|NCT03307343|101538913|FG000|NOT COMPLETED|Overall Study||2||
48492938|NCT03307343|101538914|FG001|NOT COMPLETED|Overall Study||6||
48492939|NCT03671213|101538915|FG000|STARTED|Overall Study||81||
48492940|NCT03671213|101538916|FG001|STARTED|Overall Study||81||
48492941|NCT03671213|101538915|FG000|COMPLETED|Overall Study||73||
48492942|NCT03671213|101538916|FG001|COMPLETED|Overall Study||65||
48492943|NCT03671213|101538915|FG000|NOT COMPLETED|Overall Study||8||
48492944|NCT03671213|101538916|FG001|NOT COMPLETED|Overall Study||16||
48492945|NCT01501955|101538917|FG000|STARTED|Overall Study||11||
48492946|NCT01501955|101538918|FG001|STARTED|Overall Study||9||
48492947|NCT01501955|101538917|FG000|Surgery|Overall Study||11||
48492948|NCT01501955|101538918|FG001|Surgery|Overall Study||9||
48492949|NCT01501955|101538917|FG000|6 Weeks Postop|Overall Study||10||
48492950|NCT01501955|101538918|FG001|6 Weeks Postop|Overall Study||9||
48492951|NCT01501955|101538917|FG000|1 Year Postop|Overall Study||9||
48492952|NCT01501955|101538918|FG001|1 Year Postop|Overall Study||7||
48492953|NCT01501955|101538917|FG000|2 Years Postop|Overall Study||9||
48492954|NCT01501955|101538918|FG001|2 Years Postop|Overall Study||6||
48492955|NCT01501955|101538917|FG000|COMPLETED|Overall Study||9|Primary endpoint at 2 years postop. All active patients will be followed further until 10 years.|
48492956|NCT01501955|101538918|FG001|COMPLETED|Overall Study||6|Primary endpoint at 2 years postop. All active patients will be followed further until 10 years.|
48492957|NCT01501955|101538917|FG000|NOT COMPLETED|Overall Study||2||
48492958|NCT01501955|101538918|FG001|NOT COMPLETED|Overall Study||3||
48492959|NCT03279978|101538919|FG000|STARTED|Overall Study||11||
48492960|NCT03279978|101538920|FG001|STARTED|Overall Study||9||
48492961|NCT03279978|101538921|FG002|STARTED|Overall Study||9||
48492962|NCT03279978|101538922|FG003|STARTED|Overall Study||9||
48492963|NCT03279978|101538923|FG004|STARTED|Overall Study||1||
48492964|NCT03279978|101538924|FG005|STARTED|Overall Study||8||
48492965|NCT03279978|101538925|FG006|STARTED|Overall Study||9||
48492966|NCT03279978|101538926|FG007|STARTED|Overall Study||9||
48492967|NCT03279978|101538927|FG008|STARTED|Overall Study||9||
48492968|NCT03279978|101538928|FG009|STARTED|Overall Study||9||
48492969|NCT03279978|101538919|FG000|COMPLETED|Overall Study||10||
48492970|NCT03279978|101538920|FG001|COMPLETED|Overall Study||8||
48492971|NCT03279978|101538921|FG002|COMPLETED|Overall Study||8||
48492972|NCT03279978|101538922|FG003|COMPLETED|Overall Study||9||
48492973|NCT03279978|101538923|FG004|COMPLETED|Overall Study||1||
48492974|NCT03279978|101538924|FG005|COMPLETED|Overall Study||8||
48492975|NCT03279978|101538925|FG006|COMPLETED|Overall Study||8||
48492976|NCT03279978|101538926|FG007|COMPLETED|Overall Study||9||
48492977|NCT03279978|101538927|FG008|COMPLETED|Overall Study||9||
48492978|NCT03279978|101538928|FG009|COMPLETED|Overall Study||8||
48492979|NCT03279978|101538919|FG000|NOT COMPLETED|Overall Study||1||
48492980|NCT03279978|101538920|FG001|NOT COMPLETED|Overall Study||1||
48492981|NCT03279978|101538921|FG002|NOT COMPLETED|Overall Study||1||
48492982|NCT03279978|101538922|FG003|NOT COMPLETED|Overall Study||0||
48492983|NCT03279978|101538923|FG004|NOT COMPLETED|Overall Study||0||
48492984|NCT03279978|101538924|FG005|NOT COMPLETED|Overall Study||0||
48492985|NCT03279978|101538925|FG006|NOT COMPLETED|Overall Study||1||
48492986|NCT03279978|101538926|FG007|NOT COMPLETED|Overall Study||0||
48492987|NCT03279978|101538927|FG008|NOT COMPLETED|Overall Study||0||
48492988|NCT03279978|101538928|FG009|NOT COMPLETED|Overall Study||1||
48492989|NCT00243347|101541630|FG000|STARTED|Overall Study||19||
48492990|NCT00243347|101541630|FG000|COMPLETED|Overall Study||0||
48492991|NCT00243347|101541630|FG000|NOT COMPLETED|Overall Study||19||
48492992|NCT02511535|101541631|FG000|STARTED|Overall Study||49||
48492993|NCT02511535|101541632|FG001|STARTED|Overall Study||21||
48492994|NCT02511535|101541633|FG002|STARTED|Overall Study||49||
48492995|NCT02511535|101541631|FG000|COMPLETED|Overall Study||49||
48492996|NCT02511535|101541632|FG001|COMPLETED|Overall Study||21||
48492997|NCT02511535|101541633|FG002|COMPLETED|Overall Study||49||
48492998|NCT02511535|101541631|FG000|NOT COMPLETED|Overall Study||0||
48492999|NCT02511535|101541632|FG001|NOT COMPLETED|Overall Study||0||
48493000|NCT02511535|101541633|FG002|NOT COMPLETED|Overall Study||0||
48493001|NCT01044537|101541634|FG000|STARTED|Overall Study||6||
48493002|NCT01044537|101541635|FG001|STARTED|Overall Study||6||
48493003|NCT01044537|101541636|FG002|STARTED|Overall Study||6||
48493004|NCT01044537|101541637|FG003|STARTED|Overall Study||6||
48493005|NCT01044537|101541638|FG004|STARTED|Overall Study||5||
48493006|NCT01044537|101541639|FG005|STARTED|Overall Study||5||
48493007|NCT01044537|101541640|FG006|STARTED|Overall Study||16||
48493008|NCT01044537|101541634|FG000|COMPLETED|Overall Study||6||
48493009|NCT01044537|101541635|FG001|COMPLETED|Overall Study||6||
48493010|NCT01044537|101541636|FG002|COMPLETED|Overall Study||6||
48493011|NCT01044537|101541637|FG003|COMPLETED|Overall Study||6||
48493012|NCT01044537|101541638|FG004|COMPLETED|Overall Study||5||
48493013|NCT01044537|101541639|FG005|COMPLETED|Overall Study||5||
48493014|NCT01044537|101541640|FG006|COMPLETED|Overall Study||16||
48493015|NCT01044537|101541634|FG000|NOT COMPLETED|Overall Study||0||
48493016|NCT01044537|101541635|FG001|NOT COMPLETED|Overall Study||0||
48493017|NCT01044537|101541636|FG002|NOT COMPLETED|Overall Study||0||
48493018|NCT01044537|101541637|FG003|NOT COMPLETED|Overall Study||0||
48493019|NCT01044537|101541638|FG004|NOT COMPLETED|Overall Study||0||
48493020|NCT01044537|101541639|FG005|NOT COMPLETED|Overall Study||0||
48493021|NCT01044537|101541640|FG006|NOT COMPLETED|Overall Study||0||
48493022|NCT00798603|101541641|FG000|STARTED|Overall Study||62||
48493023|NCT00798603|101541641|FG000|COMPLETED|Overall Study||27||
48493024|NCT00798603|101541641|FG000|NOT COMPLETED|Overall Study||35||
48493025|NCT01532635|101541642|FG000|STARTED|Overall Study||4||
48493026|NCT01532635|101541642|FG000|COMPLETED|Overall Study||4||
48493027|NCT01532635|101541642|FG000|NOT COMPLETED|Overall Study||0||
48493028|NCT03273153|101541643|FG000|STARTED|Overall Study||224||
48493029|NCT03273153|101541644|FG001|STARTED|Overall Study||222||
48493030|NCT03273153|101541643|FG000|COMPLETED|Overall Study||0||
48493031|NCT03273153|101541644|FG001|COMPLETED|Overall Study||0||
48493032|NCT03273153|101541643|FG000|NOT COMPLETED|Overall Study||224||
48493033|NCT03273153|101541644|FG001|NOT COMPLETED|Overall Study||222||
48493034|NCT00960414|101541645|FG000|STARTED|Overall Study||100||
48493035|NCT00960414|101541646|FG001|STARTED|Overall Study||94||
48493036|NCT00960414|101541645|FG000|COMPLETED|Overall Study||81||
48493037|NCT00960414|101541646|FG001|COMPLETED|Overall Study||67||
48493038|NCT00960414|101541645|FG000|NOT COMPLETED|Overall Study||19||
48493039|NCT00960414|101541646|FG001|NOT COMPLETED|Overall Study||27||
48493040|NCT02110277|101541647|FG000|STARTED|Overall Study||2|Two participants enrolled and started but did not complete due to study premature termination.|
48200688|NCT01689519|100814573|FG001|NOT COMPLETED|Safety Population||245||
48200689|NCT05298111|100814574|FG000|STARTED|First Intervention||18||
48200690|NCT05298111|100814575|FG001|STARTED|First Intervention||18||
48200691|NCT05298111|100814574|FG000|COMPLETED|First Intervention||18||
48200692|NCT05298111|100814575|FG001|COMPLETED|First Intervention||18||
48200693|NCT05298111|100814574|FG000|NOT COMPLETED|First Intervention||0||
48200694|NCT05298111|100814575|FG001|NOT COMPLETED|First Intervention||0||
48200695|NCT05298111|100814574|FG000|STARTED|Washout (3 Days)||18||
48200696|NCT05298111|100814575|FG001|STARTED|Washout (3 Days)||18||
48200697|NCT05298111|100814574|FG000|COMPLETED|Washout (3 Days)||15||
48200698|NCT05298111|100814575|FG001|COMPLETED|Washout (3 Days)||15||
48200699|NCT05298111|100814574|FG000|NOT COMPLETED|Washout (3 Days)||3||
48200700|NCT05298111|100814575|FG001|NOT COMPLETED|Washout (3 Days)||3||
48200701|NCT05298111|100814574|FG000|STARTED|Second Intervention||15||
48200702|NCT05298111|100814575|FG001|STARTED|Second Intervention||15||
48200703|NCT05298111|100814574|FG000|COMPLETED|Second Intervention||15||
48200704|NCT05298111|100814575|FG001|COMPLETED|Second Intervention||15||
48200705|NCT05298111|100814574|FG000|NOT COMPLETED|Second Intervention||0||
48200706|NCT05298111|100814575|FG001|NOT COMPLETED|Second Intervention||0||
48200707|NCT02943993|100814576|FG000|STARTED|Overall Study||2655||
48200708|NCT02943993|100814576|FG000|COMPLETED|Overall Study||2325||
48200709|NCT02943993|100814576|FG000|NOT COMPLETED|Overall Study||330||
48200710|NCT05380505|100814577|FG000|STARTED|Overall Study||588||
48200711|NCT05380505|100814578|FG001|STARTED|Overall Study||550||
48200712|NCT05380505|100814577|FG000|COMPLETED|Overall Study||588||
48200713|NCT05380505|100814578|FG001|COMPLETED|Overall Study||550||
48200714|NCT05380505|100814577|FG000|NOT COMPLETED|Overall Study||0||
48200715|NCT05380505|100814578|FG001|NOT COMPLETED|Overall Study||0||
48200716|NCT03743246|100814579|FG000|STARTED|Pre-Treatment Period||9|Leukapheresed|
48200717|NCT03743246|100814580|FG001|STARTED|Pre-Treatment Period||8|Leukapheresed|
48200718|NCT03743246|100814581|FG002|STARTED|Pre-Treatment Period||3|Leukapheresed|
48200719|NCT03743246|100814582|FG003|STARTED|Pre-Treatment Period||1|Leukapheresed|
48493041|NCT02110277|101541647|FG000|COMPLETED|Overall Study||0|no results obtained. study terminated prematurely.|
48493042|NCT02110277|101541647|FG000|NOT COMPLETED|Overall Study||2||
48200720|NCT03743246|100814579|FG000|COMPLETED|Pre-Treatment Period||8||
48200721|NCT03743246|100814580|FG001|COMPLETED|Pre-Treatment Period||7||
48493043|NCT00665925|101541648|FG000|STARTED|Overall Study||77||
48493044|NCT00665925|101541649|FG001|STARTED|Overall Study||76||
48493045|NCT00665925|101541650|FG002|STARTED|Overall Study||152||
48493046|NCT00665925|101541651|FG003|STARTED|Overall Study||152||
48493047|NCT00665925|101541648|FG000|COMPLETED|Overall Study||62||
48493048|NCT00665925|101541649|FG001|COMPLETED|Overall Study||59||
48200722|NCT03743246|100814581|FG002|COMPLETED|Pre-Treatment Period||1||
48200723|NCT03743246|100814582|FG003|COMPLETED|Pre-Treatment Period||0||
48200724|NCT03743246|100814579|FG000|NOT COMPLETED|Pre-Treatment Period||1||
48200725|NCT03743246|100814580|FG001|NOT COMPLETED|Pre-Treatment Period||1||
48493049|NCT00665925|101541650|FG002|COMPLETED|Overall Study||126||
48493050|NCT00665925|101541651|FG003|COMPLETED|Overall Study||131||
48493051|NCT00665925|101541648|FG000|NOT COMPLETED|Overall Study||15||
48493052|NCT00665925|101541649|FG001|NOT COMPLETED|Overall Study||17||
48200726|NCT03743246|100814581|FG002|NOT COMPLETED|Pre-Treatment Period||2||
48200727|NCT03743246|100814582|FG003|NOT COMPLETED|Pre-Treatment Period||1||
48493053|NCT00665925|101541650|FG002|NOT COMPLETED|Overall Study||26||
48493054|NCT00665925|101541651|FG003|NOT COMPLETED|Overall Study||21||
48493055|NCT00860938|101541652|FG000|STARTED|Overall Study||45||
48493056|NCT00860938|101541653|FG001|STARTED|Overall Study||45||
48493057|NCT00860938|101541652|FG000|COMPLETED|Overall Study||31||
48493058|NCT00860938|101541653|FG001|COMPLETED|Overall Study||37||
48493059|NCT00860938|101541652|FG000|NOT COMPLETED|Overall Study||14||
48493060|NCT00860938|101541653|FG001|NOT COMPLETED|Overall Study||8||
48493061|NCT00911274|101541654|FG000|STARTED|Period 1||27||
48493062|NCT00911274|101541655|FG001|STARTED|Period 1||26||
48493063|NCT00911274|101541654|FG000|COMPLETED|Period 1||27||
48493064|NCT00911274|101541655|FG001|COMPLETED|Period 1||26||
48493065|NCT00911274|101541654|FG000|NOT COMPLETED|Period 1||0||
48493066|NCT00911274|101541655|FG001|NOT COMPLETED|Period 1||0||
48493067|NCT00911274|101541654|FG000|STARTED|Period 2||27||
48493068|NCT00911274|101541655|FG001|STARTED|Period 2||26||
48493069|NCT00911274|101541654|FG000|COMPLETED|Period 2||27||
48493070|NCT00911274|101541655|FG001|COMPLETED|Period 2||26||
48200728|NCT03743246|100814579|FG000|STARTED|Lymphodepleting Chemotherapy||8||
48200729|NCT03743246|100814580|FG001|STARTED|Lymphodepleting Chemotherapy||7||
48200730|NCT03743246|100814581|FG002|STARTED|Lymphodepleting Chemotherapy||1||
48200731|NCT03743246|100814582|FG003|STARTED|Lymphodepleting Chemotherapy||0||
48200732|NCT03743246|100814579|FG000|COMPLETED|Lymphodepleting Chemotherapy||7||
48200733|NCT03743246|100814580|FG001|COMPLETED|Lymphodepleting Chemotherapy||7||
48493071|NCT00911274|101541654|FG000|NOT COMPLETED|Period 2||0||
48493072|NCT00911274|101541655|FG001|NOT COMPLETED|Period 2||0||
48493073|NCT00672984|101541656|FG000|STARTED|First Intervention||31||
48493074|NCT00672984|101541657|FG001|STARTED|First Intervention||25||
48493075|NCT00672984|101541658|FG002|STARTED|First Intervention||27||
48493076|NCT00672984|101541656|FG000|COMPLETED|First Intervention||22||
48493077|NCT00672984|101541657|FG001|COMPLETED|First Intervention||23||
48493078|NCT00672984|101541658|FG002|COMPLETED|First Intervention||25||
48493079|NCT00672984|101541656|FG000|NOT COMPLETED|First Intervention||9||
48493080|NCT00672984|101541657|FG001|NOT COMPLETED|First Intervention||2||
48493081|NCT00672984|101541658|FG002|NOT COMPLETED|First Intervention||2||
48200734|NCT03743246|100814581|FG002|COMPLETED|Lymphodepleting Chemotherapy||1||
48200735|NCT03743246|100814582|FG003|COMPLETED|Lymphodepleting Chemotherapy||0||
48200736|NCT03743246|100814579|FG000|NOT COMPLETED|Lymphodepleting Chemotherapy||1||
48493082|NCT00672984|101541656|FG000|STARTED|Second Intervention||22||
48493083|NCT00672984|101541657|FG001|STARTED|Second Intervention||23||
48493084|NCT00672984|101541658|FG002|STARTED|Second Intervention||25||
48493085|NCT00672984|101541656|FG000|COMPLETED|Second Intervention||22||
48493086|NCT00672984|101541657|FG001|COMPLETED|Second Intervention||17||
48493087|NCT00672984|101541658|FG002|COMPLETED|Second Intervention||24||
48493088|NCT00672984|101541656|FG000|NOT COMPLETED|Second Intervention||0||
48493089|NCT00672984|101541657|FG001|NOT COMPLETED|Second Intervention||6||
48200737|NCT03743246|100814580|FG001|NOT COMPLETED|Lymphodepleting Chemotherapy||0||
48200738|NCT03743246|100814581|FG002|NOT COMPLETED|Lymphodepleting Chemotherapy||0||
48200739|NCT03743246|100814582|FG003|NOT COMPLETED|Lymphodepleting Chemotherapy||0||
48200740|NCT03743246|100814579|FG000|STARTED|Treatment Period (JCAR017 Infusion)||7||
48200741|NCT03743246|100814580|FG001|STARTED|Treatment Period (JCAR017 Infusion)||7||
48200742|NCT03743246|100814581|FG002|STARTED|Treatment Period (JCAR017 Infusion)||1||
48200743|NCT03743246|100814582|FG003|STARTED|Treatment Period (JCAR017 Infusion)||0||
48200744|NCT03743246|100814579|FG000|COMPLETED|Treatment Period (JCAR017 Infusion)||3||
48200745|NCT03743246|100814580|FG001|COMPLETED|Treatment Period (JCAR017 Infusion)||6||
48200746|NCT03743246|100814581|FG002|COMPLETED|Treatment Period (JCAR017 Infusion)||1||
48200747|NCT03743246|100814582|FG003|COMPLETED|Treatment Period (JCAR017 Infusion)||0||
48200748|NCT03743246|100814579|FG000|NOT COMPLETED|Treatment Period (JCAR017 Infusion)||4||
48200749|NCT03743246|100814580|FG001|NOT COMPLETED|Treatment Period (JCAR017 Infusion)||1||
48200750|NCT03743246|100814581|FG002|NOT COMPLETED|Treatment Period (JCAR017 Infusion)||0||
48200751|NCT03743246|100814582|FG003|NOT COMPLETED|Treatment Period (JCAR017 Infusion)||0||
48493090|NCT00672984|101541658|FG002|NOT COMPLETED|Second Intervention||1||
48200752|NCT03478696|100814583|FG000|STARTED|Overall Study||366||
48200753|NCT03478696|100814584|FG001|STARTED|Overall Study||366||
48200754|NCT03478696|100814583|FG000|COMPLETED|Overall Study||349||
48200755|NCT03478696|100814584|FG001|COMPLETED|Overall Study||354||
48200756|NCT03478696|100814583|FG000|NOT COMPLETED|Overall Study||17||
48493091|NCT00672984|101541656|FG000|STARTED|Third Intervention||22||
48493092|NCT00672984|101541657|FG001|STARTED|Third Intervention||17||
48493093|NCT00672984|101541658|FG002|STARTED|Third Intervention||24||
48493094|NCT00672984|101541656|FG000|COMPLETED|Third Intervention||21||
48493095|NCT00672984|101541657|FG001|COMPLETED|Third Intervention||17||
48493096|NCT00672984|101541658|FG002|COMPLETED|Third Intervention||23||
48493097|NCT00672984|101541656|FG000|NOT COMPLETED|Third Intervention||1||
48493098|NCT00672984|101541657|FG001|NOT COMPLETED|Third Intervention||0||
48200757|NCT03478696|100814584|FG001|NOT COMPLETED|Overall Study||12||
48200758|NCT02967016|100814585|FG000|STARTED|Overall Study||25||
48200759|NCT02967016|100814586|FG001|STARTED|Overall Study||25||
48493099|NCT00672984|101541658|FG002|NOT COMPLETED|Third Intervention||1||
48493100|NCT02854800|101541659|FG000|STARTED|Overall Study||32||
48493101|NCT02854800|101541660|FG001|STARTED|Overall Study||28||
48200760|NCT02967016|100814585|FG000|COMPLETED|Overall Study||25||
48200761|NCT02967016|100814586|FG001|COMPLETED|Overall Study||25||
48493102|NCT02854800|101541661|FG002|STARTED|Overall Study||14||
48493103|NCT02854800|101541659|FG000|COMPLETED|Overall Study||12||
48493104|NCT02854800|101541660|FG001|COMPLETED|Overall Study||15||
48493105|NCT02854800|101541661|FG002|COMPLETED|Overall Study||8||
48493106|NCT02854800|101541659|FG000|NOT COMPLETED|Overall Study||20||
48493107|NCT02854800|101541660|FG001|NOT COMPLETED|Overall Study||13||
48493108|NCT02854800|101541661|FG002|NOT COMPLETED|Overall Study||6||
48493109|NCT05216315|101541662|FG000|STARTED|Overall Study||19||
48493110|NCT05216315|101541663|FG001|STARTED|Overall Study||19||
48493111|NCT05216315|101541662|FG000|COMPLETED|Overall Study||17||
48493112|NCT05216315|101541663|FG001|COMPLETED|Overall Study||16||
48493113|NCT05216315|101541662|FG000|NOT COMPLETED|Overall Study||2||
48493114|NCT05216315|101541663|FG001|NOT COMPLETED|Overall Study||3||
48493115|NCT02722239|101541664|FG000|STARTED|Overall Study||20||
48493116|NCT02722239|101541665|FG001|STARTED|Overall Study||20||
48493117|NCT02722239|101541664|FG000|First Intervention (1 Day)|Overall Study||20||
48493118|NCT02722239|101541665|FG001|First Intervention (1 Day)|Overall Study||20||
48493119|NCT02722239|101541664|FG000|Washout (7 Days)|Overall Study||20||
48493120|NCT02722239|101541665|FG001|Washout (7 Days)|Overall Study||20||
48493121|NCT02722239|101541664|FG000|Second Intervention (1 Day)|Overall Study||20||
48493122|NCT02722239|101541665|FG001|Second Intervention (1 Day)|Overall Study||20||
48493123|NCT02722239|101541664|FG000|COMPLETED|Overall Study||20||
48493124|NCT02722239|101541665|FG001|COMPLETED|Overall Study||20||
48493125|NCT02722239|101541664|FG000|NOT COMPLETED|Overall Study||0||
48493126|NCT02722239|101541665|FG001|NOT COMPLETED|Overall Study||0||
48493127|NCT02826694|101541666|FG000|STARTED|Overall Study||61||
48493128|NCT02826694|101541667|FG001|STARTED|Overall Study||45||
48493129|NCT02826694|101541666|FG000|Decision Group|Overall Study||41||
48200762|NCT02967016|100814585|FG000|NOT COMPLETED|Overall Study||0||
48200763|NCT02967016|100814586|FG001|NOT COMPLETED|Overall Study||0||
48493130|NCT02826694|101541667|FG001|Decision Group|Overall Study||30||
48493131|NCT02826694|101541666|FG000|Control Group|Overall Study||20||
48493132|NCT02826694|101541667|FG001|Control Group|Overall Study||15||
48493133|NCT02826694|101541666|FG000|COMPLETED|Overall Study||61||
48493134|NCT02826694|101541667|FG001|COMPLETED|Overall Study||45||
48493135|NCT02826694|101541666|FG000|NOT COMPLETED|Overall Study||0||
48493136|NCT02826694|101541667|FG001|NOT COMPLETED|Overall Study||0||
48493137|NCT02311933|101541668|FG000|STARTED|Overall Study||41||
48493138|NCT02311933|101541669|FG001|STARTED|Overall Study||40||
48493139|NCT02311933|101541668|FG000|COMPLETED|Overall Study||41||
48493140|NCT02311933|101541669|FG001|COMPLETED|Overall Study||40||
48493141|NCT02311933|101541668|FG000|NOT COMPLETED|Overall Study||0||
48493142|NCT02311933|101541669|FG001|NOT COMPLETED|Overall Study||0||
48493143|NCT06185088|101541670|FG000|STARTED|Overall Study||1||
48493144|NCT06185088|101541670|FG000|COMPLETED|Overall Study||1||
48493145|NCT06185088|101541670|FG000|NOT COMPLETED|Overall Study||0||
48493146|NCT03945773|101541671|FG000|STARTED|Overall Study||85||
48493147|NCT03945773|101541672|FG001|STARTED|Overall Study||42||
48493148|NCT03945773|101541671|FG000|COMPLETED|Overall Study||31||
48493149|NCT03945773|101541672|FG001|COMPLETED|Overall Study||16||
48493150|NCT03945773|101541671|FG000|NOT COMPLETED|Overall Study||54||
48493151|NCT03945773|101541672|FG001|NOT COMPLETED|Overall Study||26||
48493152|NCT03637764|101541673|FG000|STARTED|Overall Study||27||
48493153|NCT03637764|101541674|FG001|STARTED|Overall Study||29||
48493154|NCT03637764|101541675|FG002|STARTED|Overall Study||18||
48493155|NCT03637764|101541676|FG003|STARTED|Overall Study||33||
48493156|NCT03637764|101541673|FG000|COMPLETED|Overall Study||1|Participants who completed the study treatment duration.|
48493157|NCT03637764|101541674|FG001|COMPLETED|Overall Study||3|Participants who completed the study treatment duration.|
48493158|NCT03637764|101541675|FG002|COMPLETED|Overall Study||0|Participants who completed the study treatment duration.|
48493159|NCT03637764|101541676|FG003|COMPLETED|Overall Study||0|Participants who completed the study treatment duration.|
48493160|NCT03637764|101541673|FG000|NOT COMPLETED|Overall Study||26||
48493161|NCT03637764|101541674|FG001|NOT COMPLETED|Overall Study||26||
48493162|NCT03637764|101541675|FG002|NOT COMPLETED|Overall Study||18||
48493163|NCT03637764|101541676|FG003|NOT COMPLETED|Overall Study||33||
48493164|NCT02891863|101541677|FG000|STARTED|Overall Study||9||
48493165|NCT02891863|101541677|FG000|COMPLETED|Overall Study||9||
48493166|NCT02891863|101541677|FG000|NOT COMPLETED|Overall Study||0||
48493167|NCT02087423|101541678|FG000|STARTED|Overall Study||111||
48493168|NCT02087423|101541679|FG001|STARTED|Overall Study||265||
48493169|NCT02087423|101541680|FG002|STARTED|Overall Study||68||
48493170|NCT02087423|101541678|FG000|Completed 12 Months of Treatment|Overall Study||18||
48493171|NCT02087423|101541679|FG001|Completed 12 Months of Treatment|Overall Study||60||
48493172|NCT02087423|101541680|FG002|Completed 12 Months of Treatment|Overall Study||26||
48493173|NCT02087423|101541678|FG000|COMPLETED|Overall Study||0||
48493174|NCT02087423|101541679|FG001|COMPLETED|Overall Study||0||
48493175|NCT02087423|101541680|FG002|COMPLETED|Overall Study||0||
48493176|NCT02087423|101541678|FG000|NOT COMPLETED|Overall Study||111||
48493177|NCT02087423|101541679|FG001|NOT COMPLETED|Overall Study||265||
48493178|NCT02087423|101541680|FG002|NOT COMPLETED|Overall Study||68||
48493179|NCT02222818|101541681|FG000|STARTED|Period 1||33||
48493180|NCT02222818|101541682|FG001|STARTED|Period 1||33||
48493181|NCT02222818|101541681|FG000|COMPLETED|Period 1||33||
48493182|NCT02222818|101541682|FG001|COMPLETED|Period 1||30||
48493183|NCT02222818|101541681|FG000|NOT COMPLETED|Period 1||0||
48493184|NCT02222818|101541682|FG001|NOT COMPLETED|Period 1||3||
48493185|NCT02222818|101541681|FG000|STARTED|Period 2||33||
48493186|NCT02222818|101541682|FG001|STARTED|Period 2||30||
48493187|NCT02222818|101541681|FG000|COMPLETED|Period 2||33||
48493188|NCT02222818|101541682|FG001|COMPLETED|Period 2||30||
48493189|NCT02222818|101541681|FG000|NOT COMPLETED|Period 2||0||
48493190|NCT02222818|101541682|FG001|NOT COMPLETED|Period 2||0||
48493191|NCT03913377|101541683|FG000|STARTED|Period 1||21||
48493192|NCT03913377|101541684|FG001|STARTED|Period 1||22||
48493193|NCT03913377|101541685|FG002|STARTED|Period 1||22||
48493194|NCT03913377|101541683|FG000|COMPLETED|Period 1||21||
48493195|NCT03913377|101541684|FG001|COMPLETED|Period 1||21||
48493196|NCT03913377|101541685|FG002|COMPLETED|Period 1||21||
48493197|NCT03913377|101541683|FG000|NOT COMPLETED|Period 1||0||
48493198|NCT03913377|101541684|FG001|NOT COMPLETED|Period 1||1||
48493199|NCT03913377|101541685|FG002|NOT COMPLETED|Period 1||1||
48493200|NCT03913377|101541683|FG000|STARTED|Period 2||0||
48493201|NCT03913377|101541684|FG001|STARTED|Period 2||21||
48493202|NCT03913377|101541685|FG002|STARTED|Period 2||21||
48493203|NCT03913377|101541683|FG000|COMPLETED|Period 2||0||
48493204|NCT03913377|101541684|FG001|COMPLETED|Period 2||21||
48493205|NCT03913377|101541685|FG002|COMPLETED|Period 2||21||
48493206|NCT03913377|101541683|FG000|NOT COMPLETED|Period 2||0||
48493207|NCT03913377|101541684|FG001|NOT COMPLETED|Period 2||0||
48200764|NCT00117988|100814587|FG000|STARTED|Overall Study||22||
48200765|NCT00117988|100814587|FG000|COMPLETED|Overall Study||18||
48200766|NCT00117988|100814587|FG000|NOT COMPLETED|Overall Study||4||
48200767|NCT03265210|100814588|FG000|STARTED|Overall Study||50||
48493208|NCT03913377|101541685|FG002|NOT COMPLETED|Period 2||0||
48493209|NCT04230681|101541686|FG000|STARTED|Overall Study||93||
48493210|NCT04230681|101541687|FG001|STARTED|Overall Study||95||
48493211|NCT04230681|101541686|FG000|COMPLETED|Overall Study||90||
48493212|NCT04230681|101541687|FG001|COMPLETED|Overall Study||90||
48493213|NCT04230681|101541686|FG000|NOT COMPLETED|Overall Study||3||
48493214|NCT04230681|101541687|FG001|NOT COMPLETED|Overall Study||5||
48493215|NCT02593773|101541688|FG000|STARTED|Overall Study||86||
48493216|NCT02593773|101541688|FG000|COMPLETED|Overall Study||51||
48493217|NCT02593773|101541688|FG000|NOT COMPLETED|Overall Study||35||
48493218|NCT05600322|101541689|FG000|STARTED|Overall Study||158||
48493219|NCT05600322|101541689|FG000|COMPLETED|Overall Study||157||
48493220|NCT05600322|101541689|FG000|NOT COMPLETED|Overall Study||1||
48493221|NCT00761813|101541690|FG000|STARTED|Overall Study||557||
48493222|NCT00761813|101541691|FG001|STARTED|Overall Study||551||
48493223|NCT00761813|101541690|FG000|COMPLETED|Overall Study||542||
48493224|NCT00761813|101541691|FG001|COMPLETED|Overall Study||537||
48493225|NCT00761813|101541690|FG000|NOT COMPLETED|Overall Study||15||
48493226|NCT00761813|101541691|FG001|NOT COMPLETED|Overall Study||14||
48493227|NCT02905435|101541692|FG000|STARTED|Overall Study||14||
48493228|NCT02905435|101541692|FG000|COMPLETED|Overall Study||7||
48200768|NCT03265210|100814589|FG001|STARTED|Overall Study||23||
48200769|NCT03265210|100814588|FG000|COMPLETED|Overall Study||38||
48200770|NCT03265210|100814589|FG001|COMPLETED|Overall Study||14||
48200771|NCT03265210|100814588|FG000|NOT COMPLETED|Overall Study||12||
48493229|NCT02905435|101541692|FG000|NOT COMPLETED|Overall Study||7||
48493230|NCT00979147|101541693|FG000|STARTED|Overall Study||0||
48493231|NCT00979147|101541694|FG001|STARTED|Overall Study||0||
48493232|NCT00979147|101541693|FG000|COMPLETED|Overall Study||0||
48493233|NCT00979147|101541694|FG001|COMPLETED|Overall Study||0||
48493234|NCT00979147|101541693|FG000|NOT COMPLETED|Overall Study||0||
48493235|NCT00979147|101541694|FG001|NOT COMPLETED|Overall Study||0||
48493236|NCT01000961|101541695|FG000|STARTED|Run-in Period of 2-3 Weeks on Cystagon||21||
48493237|NCT01000961|101541696|FG001|STARTED|Run-in Period of 2-3 Weeks on Cystagon||22||
48493238|NCT01000961|101541695|FG000|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||21||
48493239|NCT01000961|101541696|FG001|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||22||
48493240|NCT01000961|101541695|FG000|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0||
48493241|NCT01000961|101541696|FG001|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0||
48493242|NCT01000961|101541695|FG000|STARTED|First Intervention (3 Weeks)||21||
48493243|NCT01000961|101541696|FG001|STARTED|First Intervention (3 Weeks)||22||
48493244|NCT01000961|101541695|FG000|COMPLETED|First Intervention (3 Weeks)||21||
48493245|NCT01000961|101541696|FG001|COMPLETED|First Intervention (3 Weeks)||20||
48493246|NCT01000961|101541695|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0||
48493247|NCT01000961|101541696|FG001|NOT COMPLETED|First Intervention (3 Weeks)||2||
48493248|NCT01000961|101541695|FG000|STARTED|Second Intervention (3 Weeks)||21||
48493249|NCT01000961|101541696|FG001|STARTED|Second Intervention (3 Weeks)||20||
48493250|NCT01000961|101541695|FG000|COMPLETED|Second Intervention (3 Weeks)||21||
48493251|NCT01000961|101541696|FG001|COMPLETED|Second Intervention (3 Weeks)||20||
48493252|NCT01000961|101541695|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0||
48493253|NCT01000961|101541696|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0||
48493254|NCT03399500|101541697|FG000|STARTED|Overall Study||136||
48493255|NCT03399500|101541698|FG001|STARTED|Overall Study||134||
48493256|NCT03399500|101541699|FG002|STARTED|Overall Study||133||
48493257|NCT03399500|101541697|FG000|COMPLETED|Overall Study||64||
48493258|NCT03399500|101541698|FG001|COMPLETED|Overall Study||72||
48493259|NCT03399500|101541699|FG002|COMPLETED|Overall Study||81||
48493260|NCT03399500|101541697|FG000|NOT COMPLETED|Overall Study||72||
48493261|NCT03399500|101541698|FG001|NOT COMPLETED|Overall Study||62||
48493262|NCT03399500|101541699|FG002|NOT COMPLETED|Overall Study||52||
48493263|NCT00540995|101541700|FG000|STARTED|Overall Study||23||
48493264|NCT00540995|101541701|FG001|STARTED|Overall Study||2||
48493265|NCT00540995|101541700|FG000|COMPLETED|Overall Study||23||
48493266|NCT00540995|101541701|FG001|COMPLETED|Overall Study||2||
48493267|NCT00540995|101541700|FG000|NOT COMPLETED|Overall Study||0||
48493268|NCT00540995|101541701|FG001|NOT COMPLETED|Overall Study||0||
48493269|NCT00872729|101541702|FG000|STARTED|Overall Study||9||
48493270|NCT00872729|101541702|FG000|COMPLETED|Overall Study||9||
48493271|NCT00872729|101541702|FG000|NOT COMPLETED|Overall Study||0||
48493272|NCT05032807|101541703|FG000|STARTED|Treatment 1||7||
48493273|NCT05032807|101541704|FG001|STARTED|Treatment 1||7||
48493274|NCT05032807|101541703|FG000|COMPLETED|Treatment 1||7||
48493275|NCT05032807|101541704|FG001|COMPLETED|Treatment 1||7||
48493276|NCT05032807|101541703|FG000|NOT COMPLETED|Treatment 1||0||
48493277|NCT05032807|101541704|FG001|NOT COMPLETED|Treatment 1||0||
48493278|NCT05032807|101541703|FG000|STARTED|Treatment 2||7||
48493279|NCT05032807|101541704|FG001|STARTED|Treatment 2||7||
48493280|NCT05032807|101541703|FG000|COMPLETED|Treatment 2||7||
48493281|NCT05032807|101541704|FG001|COMPLETED|Treatment 2||7||
48493282|NCT05032807|101541703|FG000|NOT COMPLETED|Treatment 2||0||
48493283|NCT05032807|101541704|FG001|NOT COMPLETED|Treatment 2||0||
48493284|NCT01988376|101541705|FG000|STARTED|Overall Study||129||
48493285|NCT01988376|101541706|FG001|STARTED|Overall Study||129||
48493286|NCT01988376|101541705|FG000|COMPLETED|Overall Study||129||
48493287|NCT01988376|101541706|FG001|COMPLETED|Overall Study||129||
48493288|NCT01988376|101541705|FG000|NOT COMPLETED|Overall Study||0||
48493289|NCT01988376|101541706|FG001|NOT COMPLETED|Overall Study||0||
48493290|NCT02475681|101541707|FG000|STARTED|Overall Study||177|Randomized|
48493291|NCT02475681|101541708|FG001|STARTED|Overall Study||179|Randomized|
48493292|NCT02475681|101541709|FG002|STARTED|Overall Study||179|Randomized|
48493293|NCT02475681|101541707|FG000|Crossed Over From Arm A to Arm C|Overall Study||45||
48493294|NCT02475681|101541708|FG001|Crossed Over From Arm A to Arm C|Overall Study||0||
48493295|NCT02475681|101541709|FG002|Crossed Over From Arm A to Arm C|Overall Study||0||
48493296|NCT02475681|101541707|FG000|COMPLETED|Overall Study||145||
48493297|NCT02475681|101541708|FG001|COMPLETED|Overall Study||0||
48493298|NCT02475681|101541709|FG002|COMPLETED|Overall Study||0||
48493299|NCT02475681|101541707|FG000|NOT COMPLETED|Overall Study||32||
48493300|NCT02475681|101541708|FG001|NOT COMPLETED|Overall Study||179||
48493301|NCT02475681|101541709|FG002|NOT COMPLETED|Overall Study||179||
48493302|NCT02977403|101541710|FG000|STARTED|Overall Study||36||
48493303|NCT02977403|101541711|FG001|STARTED|Overall Study||32||
48493304|NCT02977403|101541710|FG000|COMPLETED|Overall Study||29||
48493305|NCT02977403|101541711|FG001|COMPLETED|Overall Study||29||
48493306|NCT02977403|101541710|FG000|NOT COMPLETED|Overall Study||7||
48493307|NCT02977403|101541711|FG001|NOT COMPLETED|Overall Study||3||
48493308|NCT04196907|101541712|FG000|STARTED|Overall Study||20||
48200772|NCT03265210|100814589|FG001|NOT COMPLETED|Overall Study||9||
48493309|NCT04196907|101541712|FG000|COMPLETED|Overall Study||20||
48493310|NCT04196907|101541712|FG000|NOT COMPLETED|Overall Study||0||
48493311|NCT01410227|101541713|FG000|STARTED|Overall Study||8||
48200773|NCT01959412|100814590|FG000|STARTED|Overall Study||15||
48200774|NCT01959412|100814591|FG001|STARTED|Overall Study||15||
48200775|NCT01959412|100814592|FG002|STARTED|Overall Study||15||
48666675|NCT04129398|101970458|FG000|STARTED|Overall Study||22||
48493312|NCT01410227|101541714|FG001|STARTED|Overall Study||8||
48493313|NCT01410227|101541715|FG002|STARTED|Overall Study||15||
48493314|NCT01410227|101541716|FG003|STARTED|Overall Study||6||
48493315|NCT01410227|101541713|FG000|COMPLETED|Overall Study||4||
48493316|NCT01410227|101541714|FG001|COMPLETED|Overall Study||8||
48493317|NCT01410227|101541715|FG002|COMPLETED|Overall Study||13||
48493318|NCT01410227|101541716|FG003|COMPLETED|Overall Study||5||
48493319|NCT01410227|101541713|FG000|NOT COMPLETED|Overall Study||4||
48493320|NCT01410227|101541714|FG001|NOT COMPLETED|Overall Study||0||
48493321|NCT01410227|101541715|FG002|NOT COMPLETED|Overall Study||2||
48493322|NCT01410227|101541716|FG003|NOT COMPLETED|Overall Study||1||
48493323|NCT00835263|101541717|FG000|STARTED|First Intervention||16||
48493324|NCT00835263|101541718|FG001|STARTED|First Intervention||16||
48493325|NCT00835263|101541717|FG000|COMPLETED|First Intervention||16||
48493326|NCT00835263|101541718|FG001|COMPLETED|First Intervention||16||
48493327|NCT00835263|101541717|FG000|NOT COMPLETED|First Intervention||0||
48493328|NCT00835263|101541718|FG001|NOT COMPLETED|First Intervention||0||
48493329|NCT00835263|101541717|FG000|STARTED|Second Intervention||16||
48493330|NCT00835263|101541718|FG001|STARTED|Second Intervention||16||
48493331|NCT00835263|101541717|FG000|COMPLETED|Second Intervention||15||
48493332|NCT00835263|101541718|FG001|COMPLETED|Second Intervention||16||
48493333|NCT00835263|101541717|FG000|NOT COMPLETED|Second Intervention||1||
48493334|NCT00835263|101541718|FG001|NOT COMPLETED|Second Intervention||0||
48493335|NCT00115063|101541719|FG000|STARTED|Overall Study||200||
48493336|NCT00115063|101541720|FG001|STARTED|Overall Study||190||
48493337|NCT00115063|101541719|FG000|COMPLETED|Overall Study||101||
48493338|NCT00115063|101541720|FG001|COMPLETED|Overall Study||86||
48493339|NCT00115063|101541719|FG000|NOT COMPLETED|Overall Study||99||
48493340|NCT00115063|101541720|FG001|NOT COMPLETED|Overall Study||104||
48493341|NCT05387408|101541721|FG000|STARTED|Overall Study||4939||
48493342|NCT05387408|101541721|FG000|COMPLETED|Overall Study||0||
48493343|NCT05387408|101541721|FG000|NOT COMPLETED|Overall Study||4939||
48493344|NCT00294047|101541722|FG000|STARTED|Month 48||2881||
48493345|NCT00294047|101541723|FG001|STARTED|Month 48||2871||
48493346|NCT00294047|101541722|FG000|Participated up to Month 48|Month 48||2305||
48493347|NCT00294047|101541723|FG001|Participated up to Month 48|Month 48||2281||
48493348|NCT00294047|101541722|FG000|COMPLETED|Month 48||2456||
48493349|NCT00294047|101541723|FG001|COMPLETED|Month 48||2438||
48493350|NCT00294047|101541722|FG000|NOT COMPLETED|Month 48||425||
48493351|NCT00294047|101541723|FG001|NOT COMPLETED|Month 48||433||
48493352|NCT00294047|101541722|FG000|STARTED|Month 84||2877||
48493353|NCT00294047|101541723|FG001|STARTED|Month 84||2870||
48493354|NCT00294047|101541722|FG000|COMPLETED|Month 84||1904||
48493355|NCT00294047|101541723|FG001|COMPLETED|Month 84||1881||
48493356|NCT00294047|101541722|FG000|NOT COMPLETED|Month 84||973||
48493357|NCT00294047|101541723|FG001|NOT COMPLETED|Month 84||989||
48493358|NCT03629054|101541724|FG000|STARTED|Period 1 (4 Days)||15|Started are treated|
48493359|NCT03629054|101541725|FG001|STARTED|Period 1 (4 Days)||15|Started are treated|
48493360|NCT03629054|101541724|FG000|COMPLETED|Period 1 (4 Days)||15||
48493361|NCT03629054|101541725|FG001|COMPLETED|Period 1 (4 Days)||15||
48493362|NCT03629054|101541724|FG000|NOT COMPLETED|Period 1 (4 Days)||0||
48493363|NCT03629054|101541725|FG001|NOT COMPLETED|Period 1 (4 Days)||0||
48493364|NCT03629054|101541724|FG000|STARTED|Wasout Period (35 Days)||15|Started are treated|
48493365|NCT03629054|101541725|FG001|STARTED|Wasout Period (35 Days)||15|Started are treated|
48493366|NCT03629054|101541724|FG000|COMPLETED|Wasout Period (35 Days)||15||
48493367|NCT03629054|101541725|FG001|COMPLETED|Wasout Period (35 Days)||15||
48493368|NCT03629054|101541724|FG000|NOT COMPLETED|Wasout Period (35 Days)||0||
48493369|NCT03629054|101541725|FG001|NOT COMPLETED|Wasout Period (35 Days)||0||
48493370|NCT03629054|101541724|FG000|STARTED|Period 2 (4 Days)||15||
48493371|NCT03629054|101541725|FG001|STARTED|Period 2 (4 Days)||15||
48493372|NCT03629054|101541724|FG000|Treated|Period 2 (4 Days)||15||
48493373|NCT03629054|101541725|FG001|Treated|Period 2 (4 Days)||14||
48493374|NCT03629054|101541724|FG000|COMPLETED|Period 2 (4 Days)||15||
48493375|NCT03629054|101541725|FG001|COMPLETED|Period 2 (4 Days)||14||
48493376|NCT03629054|101541724|FG000|NOT COMPLETED|Period 2 (4 Days)||0||
48493377|NCT03629054|101541725|FG001|NOT COMPLETED|Period 2 (4 Days)||1||
48493378|NCT02415127|101541726|FG000|STARTED|Overall Study||47||
48493379|NCT02415127|101541727|FG001|STARTED|Overall Study||45||
48493380|NCT02415127|101541726|FG000|COMPLETED|Overall Study||46||
48493381|NCT02415127|101541727|FG001|COMPLETED|Overall Study||45||
48493382|NCT02415127|101541726|FG000|NOT COMPLETED|Overall Study||1||
48493383|NCT02415127|101541727|FG001|NOT COMPLETED|Overall Study||0||
48200776|NCT01959412|100814593|FG003|STARTED|Overall Study||15||
48200777|NCT01959412|100814594|FG004|STARTED|Overall Study||16||
48493384|NCT03606408|101541728|FG000|STARTED|Overall Study||127||
48493385|NCT03606408|101541728|FG000|COMPLETED|Overall Study||99||
48493386|NCT03606408|101541728|FG000|NOT COMPLETED|Overall Study||28||
48493387|NCT02498600|101541729|FG000|STARTED|Overall Study||49||
48493388|NCT02498600|101541730|FG001|STARTED|Overall Study||51||
48493389|NCT02498600|101541729|FG000|COMPLETED|Overall Study||49||
48493390|NCT02498600|101541730|FG001|COMPLETED|Overall Study||51||
48493391|NCT02498600|101541729|FG000|NOT COMPLETED|Overall Study||0||
48493392|NCT02498600|101541730|FG001|NOT COMPLETED|Overall Study||0||
48493393|NCT02264977|101541731|FG000|STARTED|Overall Study||9||
48493394|NCT02264977|101541731|FG000|COMPLETED|Overall Study||4||
48493395|NCT02264977|101541731|FG000|NOT COMPLETED|Overall Study||5||
48493396|NCT05239195|101541732|FG000|STARTED|Overall Study||707||
48493397|NCT05239195|101541733|FG001|STARTED|Overall Study||713||
48493398|NCT05239195|101541732|FG000|COMPLETED|Overall Study||705||
48493399|NCT05239195|101541733|FG001|COMPLETED|Overall Study||712||
48493400|NCT05239195|101541732|FG000|NOT COMPLETED|Overall Study||2||
48493401|NCT05239195|101541733|FG001|NOT COMPLETED|Overall Study||1||
48493402|NCT04975880|101541734|FG000|STARTED|Clinic Training Phase||43||
48493403|NCT04975880|101541734|FG000|Evaluable Population|Clinic Training Phase||35||
48493404|NCT04975880|101541734|FG000|COMPLETED|Clinic Training Phase||35||
48493405|NCT04975880|101541734|FG000|NOT COMPLETED|Clinic Training Phase||8||
48493406|NCT04975880|101541734|FG000|STARTED|Transition Phase||35||
48493407|NCT04975880|101541734|FG000|Evaluable Population|Transition Phase||35||
48493408|NCT04975880|101541734|FG000|COMPLETED|Transition Phase||35||
48493409|NCT04975880|101541734|FG000|NOT COMPLETED|Transition Phase||0||
48493410|NCT04975880|101541734|FG000|STARTED|Home Hemodialysis Phase||35||
48493411|NCT04975880|101541734|FG000|Evaluable Population|Home Hemodialysis Phase||34||
48493412|NCT04975880|101541734|FG000|COMPLETED|Home Hemodialysis Phase||31||
48493413|NCT04975880|101541734|FG000|NOT COMPLETED|Home Hemodialysis Phase||4||
48493414|NCT03532282|101541735|FG000|STARTED|Overall Study||121||
48493415|NCT03532282|101541736|FG001|STARTED|Overall Study||124||
48493416|NCT03532282|101541735|FG000|Triaged Checklist YES|Overall Study||69|met at least one of 5 checklist criteria|
48493417|NCT03532282|101541736|FG001|Triaged Checklist YES|Overall Study||68|met at least one of 5 checklist criteria|
48493418|NCT03532282|101541735|FG000|COMPLETED|Overall Study||102||
48493419|NCT03532282|101541736|FG001|COMPLETED|Overall Study||108||
48493420|NCT03532282|101541735|FG000|NOT COMPLETED|Overall Study||19||
48493421|NCT03532282|101541736|FG001|NOT COMPLETED|Overall Study||16||
48493422|NCT00830024|101541737|FG000|STARTED|First Intervention||18||
48493423|NCT00830024|101541738|FG001|STARTED|First Intervention||18||
48493424|NCT00830024|101541737|FG000|COMPLETED|First Intervention||18||
48493425|NCT00830024|101541738|FG001|COMPLETED|First Intervention||18||
48493426|NCT00830024|101541737|FG000|NOT COMPLETED|First Intervention||0||
48493427|NCT00830024|101541738|FG001|NOT COMPLETED|First Intervention||0||
48493428|NCT00830024|101541737|FG000|STARTED|Washout: 7 Days||18||
48493429|NCT00830024|101541738|FG001|STARTED|Washout: 7 Days||18||
48493430|NCT00830024|101541737|FG000|COMPLETED|Washout: 7 Days||17||
48493431|NCT00830024|101541738|FG001|COMPLETED|Washout: 7 Days||18||
48493432|NCT00830024|101541737|FG000|NOT COMPLETED|Washout: 7 Days||1||
48493433|NCT00830024|101541738|FG001|NOT COMPLETED|Washout: 7 Days||0||
48493434|NCT00830024|101541737|FG000|STARTED|Second Intervention||17||
48493435|NCT00830024|101541738|FG001|STARTED|Second Intervention||18||
48493436|NCT00830024|101541737|FG000|COMPLETED|Second Intervention||17||
48493437|NCT00830024|101541738|FG001|COMPLETED|Second Intervention||18||
48493438|NCT00830024|101541737|FG000|NOT COMPLETED|Second Intervention||0||
48493439|NCT00830024|101541738|FG001|NOT COMPLETED|Second Intervention||0||
48493440|NCT00746421|101541739|FG000|STARTED|Overall Study||12||
48493441|NCT00746421|101541740|FG001|STARTED|Overall Study||11||
48493442|NCT00746421|101541739|FG000|COMPLETED|Overall Study||5||
48493443|NCT00746421|101541740|FG001|COMPLETED|Overall Study||9||
48493444|NCT00746421|101541739|FG000|NOT COMPLETED|Overall Study||7||
48493445|NCT00746421|101541740|FG001|NOT COMPLETED|Overall Study||2||
48493446|NCT02875392|101541741|FG000|STARTED|Overall Study||28||
48493447|NCT02875392|101541742|FG001|STARTED|Overall Study||29||
48493448|NCT02875392|101541741|FG000|COMPLETED|Overall Study||21||
48493449|NCT02875392|101541742|FG001|COMPLETED|Overall Study||21||
48493450|NCT02875392|101541741|FG000|NOT COMPLETED|Overall Study||7||
48493451|NCT02875392|101541742|FG001|NOT COMPLETED|Overall Study||8||
48493452|NCT01274338|101541743|FG000|STARTED|Overall Study||511||
48493453|NCT01274338|101541744|FG001|STARTED|Overall Study||636||
48493454|NCT01274338|101541745|FG002|STARTED|Overall Study||523||
48493455|NCT01274338|101541746|FG003|STARTED|Overall Study||1||
48493456|NCT01274338|101541747|FG004|STARTED|Overall Study||1||
48493457|NCT01274338|101541748|FG005|STARTED|Overall Study||1||
48493458|NCT01274338|101541743|FG000|Received Treatment|Overall Study||503||
48493459|NCT01274338|101541744|FG001|Received Treatment|Overall Study||520||
48493460|NCT01274338|101541745|FG002|Received Treatment|Overall Study||516||
48493461|NCT01274338|101541746|FG003|Received Treatment|Overall Study||1||
48493462|NCT01274338|101541747|FG004|Received Treatment|Overall Study||1||
48493463|NCT01274338|101541748|FG005|Received Treatment|Overall Study||1||
48493464|NCT01274338|101541743|FG000|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||110||
48493465|NCT01274338|101541744|FG001|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||114||
48493466|NCT01274338|101541745|FG002|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||97||
48493467|NCT01274338|101541746|FG003|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||0||
48493468|NCT01274338|101541747|FG004|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||0||
48493469|NCT01274338|101541748|FG005|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||0||
48493470|NCT01274338|101541743|FG000|Data Available for FACIT-D Analysis|Overall Study||109||
48493471|NCT01274338|101541744|FG001|Data Available for FACIT-D Analysis|Overall Study||114||
48493472|NCT01274338|101541745|FG002|Data Available for FACIT-D Analysis|Overall Study||97||
48493473|NCT01274338|101541746|FG003|Data Available for FACIT-D Analysis|Overall Study||0||
48493474|NCT01274338|101541747|FG004|Data Available for FACIT-D Analysis|Overall Study||0||
48493475|NCT01274338|101541748|FG005|Data Available for FACIT-D Analysis|Overall Study||0||
48493476|NCT01274338|101541743|FG000|COMPLETED|Overall Study||108||
48493477|NCT01274338|101541744|FG001|COMPLETED|Overall Study||182||
48493478|NCT01274338|101541745|FG002|COMPLETED|Overall Study||198||
48493479|NCT01274338|101541746|FG003|COMPLETED|Overall Study||0||
48493480|NCT01274338|101541747|FG004|COMPLETED|Overall Study||0||
48493481|NCT01274338|101541748|FG005|COMPLETED|Overall Study||1||
48493482|NCT01274338|101541743|FG000|NOT COMPLETED|Overall Study||403||
48493483|NCT01274338|101541744|FG001|NOT COMPLETED|Overall Study||454||
48493484|NCT01274338|101541745|FG002|NOT COMPLETED|Overall Study||325||
48493485|NCT01274338|101541746|FG003|NOT COMPLETED|Overall Study||1||
48493486|NCT01274338|101541747|FG004|NOT COMPLETED|Overall Study||1||
48493487|NCT01274338|101541748|FG005|NOT COMPLETED|Overall Study||0||
48493488|NCT05752721|101541749|FG000|STARTED|Overall Study||114||
48493489|NCT05752721|101541750|FG001|STARTED|Overall Study||90||
48493490|NCT05752721|101541749|FG000|COMPLETED|Overall Study||77||
48493491|NCT05752721|101541750|FG001|COMPLETED|Overall Study||58||
48493492|NCT05752721|101541749|FG000|NOT COMPLETED|Overall Study||37||
48493493|NCT05752721|101541750|FG001|NOT COMPLETED|Overall Study||32||
48493494|NCT03734861|101541751|FG000|STARTED|Overall Study||50||
48493495|NCT03734861|101541752|FG001|STARTED|Overall Study||25||
48493496|NCT03734861|101541751|FG000|COMPLETED|Overall Study||50||
48493497|NCT03734861|101541752|FG001|COMPLETED|Overall Study||25||
48493498|NCT03734861|101541751|FG000|NOT COMPLETED|Overall Study||0||
48493499|NCT03734861|101541752|FG001|NOT COMPLETED|Overall Study||0||
48493500|NCT02648438|101541753|FG000|STARTED|Overall Study||12||
48493501|NCT02648438|101541754|FG001|STARTED|Overall Study||12||
48493502|NCT02648438|101541755|FG002|STARTED|Overall Study||6||
48493503|NCT02648438|101541753|FG000|COMPLETED|Overall Study||9||
48200778|NCT01959412|100814595|FG005|STARTED|Overall Study||15||
48493504|NCT02648438|101541754|FG001|COMPLETED|Overall Study||9||
48493505|NCT02648438|101541755|FG002|COMPLETED|Overall Study||6||
48493506|NCT02648438|101541753|FG000|NOT COMPLETED|Overall Study||3||
48493507|NCT02648438|101541754|FG001|NOT COMPLETED|Overall Study||3||
48493508|NCT02648438|101541755|FG002|NOT COMPLETED|Overall Study||0||
48493509|NCT03364192|101541756|FG000|STARTED|Overall Study||28||
48493510|NCT03364192|101541756|FG000|COMPLETED|Overall Study||12||
48493511|NCT03364192|101541756|FG000|NOT COMPLETED|Overall Study||16||
48493512|NCT04633564|101541757|FG000|STARTED|Period 1||335||
48493513|NCT04633564|101541758|FG001|STARTED|Period 1||329||
48493514|NCT04633564|101541757|FG000|COMPLETED|Period 1||227||
48493515|NCT04633564|101541758|FG001|COMPLETED|Period 1||220||
48493516|NCT04633564|101541757|FG000|NOT COMPLETED|Period 1||108||
48493517|NCT04633564|101541758|FG001|NOT COMPLETED|Period 1||109||
48493518|NCT04633564|101541757|FG000|STARTED|Period 2||200||
48493519|NCT04633564|101541758|FG001|STARTED|Period 2||199||
48493520|NCT04633564|101541757|FG000|COMPLETED|Period 2||107||
48493521|NCT04633564|101541758|FG001|COMPLETED|Period 2||102||
48493522|NCT04633564|101541757|FG000|NOT COMPLETED|Period 2||93||
48493523|NCT04633564|101541758|FG001|NOT COMPLETED|Period 2||97||
48493524|NCT01018862|101541759|FG000|STARTED|Overall Study||161||
48493525|NCT01018862|101541760|FG001|STARTED|Overall Study||166||
48493526|NCT01018862|101541761|FG002|STARTED|Overall Study||162||
48493527|NCT01018862|101541759|FG000|COMPLETED|Overall Study||148||
48493528|NCT01018862|101541760|FG001|COMPLETED|Overall Study||156||
48493529|NCT01018862|101541761|FG002|COMPLETED|Overall Study||146||
48493530|NCT01018862|101541759|FG000|NOT COMPLETED|Overall Study||13||
48493531|NCT01018862|101541760|FG001|NOT COMPLETED|Overall Study||10||
48493532|NCT01018862|101541761|FG002|NOT COMPLETED|Overall Study||16||
48493533|NCT03053362|101541762|FG000|STARTED|Overall Study||100||
48493534|NCT03053362|101541763|FG001|STARTED|Overall Study||58||
48493535|NCT03053362|101541762|FG000|COMPLETED|Overall Study||83||
48493536|NCT03053362|101541763|FG001|COMPLETED|Overall Study||50||
48493537|NCT03053362|101541762|FG000|NOT COMPLETED|Overall Study||17||
48493538|NCT03053362|101541763|FG001|NOT COMPLETED|Overall Study||8||
48493539|NCT00421304|101541764|FG000|STARTED|Overall Study||40||
48493540|NCT00421304|101541765|FG001|STARTED|Overall Study||39||
48493541|NCT00421304|101541766|FG002|STARTED|Overall Study||39||
48493542|NCT00421304|101541764|FG000|COMPLETED|Overall Study||32||
48493543|NCT00421304|101541765|FG001|COMPLETED|Overall Study||35||
48493544|NCT00421304|101541766|FG002|COMPLETED|Overall Study||31||
48493545|NCT00421304|101541764|FG000|NOT COMPLETED|Overall Study||8||
48493546|NCT00421304|101541765|FG001|NOT COMPLETED|Overall Study||4||
48493547|NCT00421304|101541766|FG002|NOT COMPLETED|Overall Study||8||
48493548|NCT01302548|101541767|FG000|STARTED|Overall Study||14||
48493549|NCT01302548|101541768|FG001|STARTED|Overall Study||19||
48493550|NCT01302548|101541767|FG000|COMPLETED|Overall Study||12||
48493551|NCT01302548|101541768|FG001|COMPLETED|Overall Study||18||
48493552|NCT01302548|101541767|FG000|NOT COMPLETED|Overall Study||2||
48493553|NCT01302548|101541768|FG001|NOT COMPLETED|Overall Study||1||
48493554|NCT01609257|101541769|FG000|STARTED|Overall Study||67||
48493555|NCT01609257|101541770|FG001|STARTED|Overall Study||65||
48493556|NCT01609257|101541769|FG000|Received 2 Doses|Overall Study||63||
48493557|NCT01609257|101541770|FG001|Received 2 Doses|Overall Study||64||
48493558|NCT01609257|101541769|FG000|Received Challenge Product|Overall Study||56||
48493559|NCT01609257|101541770|FG001|Received Challenge Product|Overall Study||53||
48493560|NCT01609257|101541769|FG000|COMPLETED|Overall Study||61||
48493561|NCT01609257|101541770|FG001|COMPLETED|Overall Study||57||
48493562|NCT01609257|101541769|FG000|NOT COMPLETED|Overall Study||6||
48493563|NCT01609257|101541770|FG001|NOT COMPLETED|Overall Study||8||
48493564|NCT00402103|101541771|FG000|STARTED|Overall Study||470||
48493565|NCT00402103|101541772|FG001|STARTED|Overall Study||86||
48493566|NCT00402103|101541771|FG000|COMPLETED|Overall Study||379||
48493567|NCT00402103|101541772|FG001|COMPLETED|Overall Study||73||
48493568|NCT00402103|101541771|FG000|NOT COMPLETED|Overall Study||91||
48493569|NCT00402103|101541772|FG001|NOT COMPLETED|Overall Study||13||
48493570|NCT02332863|101541773|FG000|STARTED|Overall Study||22||
48493571|NCT02332863|101541774|FG001|STARTED|Overall Study||22||
48493572|NCT02332863|101541773|FG000|COMPLETED|Overall Study||22||
48493573|NCT02332863|101541774|FG001|COMPLETED|Overall Study||22||
48493574|NCT02332863|101541773|FG000|NOT COMPLETED|Overall Study||0||
48493575|NCT02332863|101541774|FG001|NOT COMPLETED|Overall Study||0||
48493576|NCT00787124|101541775|FG000|STARTED|Overall Study||4||
48493577|NCT00787124|101541776|FG001|STARTED|Overall Study||4||
48493578|NCT00787124|101541775|FG000|COMPLETED|Overall Study||4||
48493579|NCT00787124|101541776|FG001|COMPLETED|Overall Study||4||
48493580|NCT00787124|101541775|FG000|NOT COMPLETED|Overall Study||0||
48493581|NCT00787124|101541776|FG001|NOT COMPLETED|Overall Study||0||
48493582|NCT00216736|101541777|FG000|STARTED|Overall Study||32||
48493583|NCT00216736|101541778|FG001|STARTED|Overall Study||31||
48493584|NCT00216736|101541777|FG000|COMPLETED|Overall Study||31||
48493585|NCT00216736|101541778|FG001|COMPLETED|Overall Study||30||
48493586|NCT00216736|101541777|FG000|NOT COMPLETED|Overall Study||1||
48493587|NCT00216736|101541778|FG001|NOT COMPLETED|Overall Study||1||
48493588|NCT00746395|101541779|FG000|STARTED|Overall Study||20||
48493589|NCT00746395|101541780|FG001|STARTED|Overall Study||20||
48493590|NCT00746395|101541779|FG000|COMPLETED|Overall Study||20||
48493591|NCT00746395|101541780|FG001|COMPLETED|Overall Study||20||
48493592|NCT00746395|101541779|FG000|NOT COMPLETED|Overall Study||0||
48493593|NCT00746395|101541780|FG001|NOT COMPLETED|Overall Study||0||
48493594|NCT00371839|101541781|FG000|STARTED|Overall Study||49||
48493595|NCT00371839|101541782|FG001|STARTED|Overall Study||20||
48493596|NCT00371839|101541783|FG002|STARTED|Overall Study||9||
48493597|NCT00371839|101541781|FG000|COMPLETED|Overall Study||32||
48493598|NCT00371839|101541782|FG001|COMPLETED|Overall Study||13||
48493599|NCT00371839|101541783|FG002|COMPLETED|Overall Study||7||
48493600|NCT00371839|101541781|FG000|NOT COMPLETED|Overall Study||17||
48493601|NCT00371839|101541782|FG001|NOT COMPLETED|Overall Study||7||
48493602|NCT00371839|101541783|FG002|NOT COMPLETED|Overall Study||2||
48493603|NCT04116957|101541784|FG000|STARTED|Overall Study||9||
48493604|NCT04116957|101541785|FG001|STARTED|Overall Study||10||
48493605|NCT04116957|101541784|FG000|COMPLETED|Overall Study||9||
48493606|NCT04116957|101541785|FG001|COMPLETED|Overall Study||10||
48493607|NCT04116957|101541784|FG000|NOT COMPLETED|Overall Study||0||
48493608|NCT04116957|101541785|FG001|NOT COMPLETED|Overall Study||0||
48493609|NCT02679729|101541786|FG000|STARTED|Overall Study||6||
48493610|NCT02679729|101541787|FG001|STARTED|Overall Study||7||
48493611|NCT02679729|101541788|FG002|STARTED|Overall Study||6||
48493612|NCT02679729|101541789|FG003|STARTED|Overall Study||6||
48493613|NCT02679729|101541790|FG004|STARTED|Overall Study||6||
48493614|NCT02679729|101541791|FG005|STARTED|Overall Study||6||
48493615|NCT02679729|101541792|FG006|STARTED|Overall Study||6||
48493616|NCT02679729|101541793|FG007|STARTED|Overall Study||14||
48493617|NCT02679729|101541794|FG008|STARTED|Overall Study||6||
48493618|NCT02679729|101541786|FG000|COMPLETED|Overall Study||6||
48493619|NCT02679729|101541787|FG001|COMPLETED|Overall Study||5||
48493620|NCT02679729|101541788|FG002|COMPLETED|Overall Study||6||
48493621|NCT02679729|101541789|FG003|COMPLETED|Overall Study||6||
48493622|NCT02679729|101541790|FG004|COMPLETED|Overall Study||5||
48493623|NCT02679729|101541791|FG005|COMPLETED|Overall Study||6||
48493624|NCT02679729|101541792|FG006|COMPLETED|Overall Study||5||
48493625|NCT02679729|101541793|FG007|COMPLETED|Overall Study||14||
48493626|NCT02679729|101541794|FG008|COMPLETED|Overall Study||6||
48493627|NCT02679729|101541786|FG000|NOT COMPLETED|Overall Study||0||
48493628|NCT02679729|101541787|FG001|NOT COMPLETED|Overall Study||2||
48200779|NCT01959412|100814590|FG000|COMPLETED|Overall Study||14||
48493629|NCT02679729|101541788|FG002|NOT COMPLETED|Overall Study||0||
48493630|NCT02679729|101541789|FG003|NOT COMPLETED|Overall Study||0||
48493631|NCT02679729|101541790|FG004|NOT COMPLETED|Overall Study||1||
48493632|NCT02679729|101541791|FG005|NOT COMPLETED|Overall Study||0||
48493633|NCT02679729|101541792|FG006|NOT COMPLETED|Overall Study||1||
48493634|NCT02679729|101541793|FG007|NOT COMPLETED|Overall Study||0||
48493635|NCT02679729|101541794|FG008|NOT COMPLETED|Overall Study||0||
48493636|NCT02615249|101541795|FG000|STARTED|Overall Study||122||
48493637|NCT02615249|101541795|FG000|COMPLETED|Overall Study||121||
48493638|NCT02615249|101541795|FG000|NOT COMPLETED|Overall Study||1||
48493639|NCT02518945|101541796|FG000|STARTED|Overall Study||9||
48493640|NCT02518945|101541797|FG001|STARTED|Overall Study||17||
48493641|NCT02518945|101541796|FG000|COMPLETED|Overall Study||9||
48493642|NCT02518945|101541797|FG001|COMPLETED|Overall Study||17||
48493643|NCT02518945|101541796|FG000|NOT COMPLETED|Overall Study||0||
48493644|NCT02518945|101541797|FG001|NOT COMPLETED|Overall Study||0||
48493645|NCT01576705|101541798|FG000|STARTED|Overall Study||43||
48493646|NCT01576705|101541799|FG001|STARTED|Overall Study||45||
48493647|NCT01576705|101541800|FG002|STARTED|Overall Study||43||
48493648|NCT01576705|101541801|FG003|STARTED|Overall Study||44||
48493649|NCT01576705|101541798|FG000|COMPLETED|Overall Study||40||
48493650|NCT01576705|101541799|FG001|COMPLETED|Overall Study||37||
48493651|NCT01576705|101541800|FG002|COMPLETED|Overall Study||38||
48493652|NCT01576705|101541801|FG003|COMPLETED|Overall Study||41||
48493653|NCT01576705|101541798|FG000|NOT COMPLETED|Overall Study||3||
48493654|NCT01576705|101541799|FG001|NOT COMPLETED|Overall Study||8||
48493655|NCT01576705|101541800|FG002|NOT COMPLETED|Overall Study||5||
48493656|NCT01576705|101541801|FG003|NOT COMPLETED|Overall Study||3||
48493657|NCT00834717|101541802|FG000|STARTED|First Intervention||20||
48493658|NCT00834717|101541803|FG001|STARTED|First Intervention||20||
48493659|NCT00834717|101541802|FG000|COMPLETED|First Intervention||19||
48493660|NCT00834717|101541803|FG001|COMPLETED|First Intervention||19||
48493661|NCT00834717|101541802|FG000|NOT COMPLETED|First Intervention||1||
48493662|NCT00834717|101541803|FG001|NOT COMPLETED|First Intervention||1||
48493663|NCT00834717|101541802|FG000|STARTED|Second Intervention||19||
48493664|NCT00834717|101541803|FG001|STARTED|Second Intervention||19||
48493665|NCT00834717|101541802|FG000|COMPLETED|Second Intervention||19||
48493666|NCT00834717|101541803|FG001|COMPLETED|Second Intervention||19||
48493667|NCT00834717|101541802|FG000|NOT COMPLETED|Second Intervention||0||
48493668|NCT00834717|101541803|FG001|NOT COMPLETED|Second Intervention||0||
48493669|NCT04035187|101541804|FG000|STARTED|Overall Study||4||
48493670|NCT04035187|101541805|FG001|STARTED|Overall Study||4||
48493671|NCT04035187|101541806|FG002|STARTED|Overall Study||4||
48493672|NCT04035187|101541807|FG003|STARTED|Overall Study||5||
48493673|NCT04035187|101541804|FG000|COMPLETED|Overall Study||2||
48493674|NCT04035187|101541805|FG001|COMPLETED|Overall Study||2||
48493675|NCT04035187|101541806|FG002|COMPLETED|Overall Study||4||
48493676|NCT04035187|101541807|FG003|COMPLETED|Overall Study||4||
48493677|NCT04035187|101541804|FG000|NOT COMPLETED|Overall Study||2||
48493678|NCT04035187|101541805|FG001|NOT COMPLETED|Overall Study||2||
48493679|NCT04035187|101541806|FG002|NOT COMPLETED|Overall Study||0||
48493680|NCT04035187|101541807|FG003|NOT COMPLETED|Overall Study||1||
48493681|NCT00859521|101541808|FG000|STARTED|First Intervention||15||
48493682|NCT00859521|101541809|FG001|STARTED|First Intervention||15||
48493683|NCT00859521|101541808|FG000|COMPLETED|First Intervention||15||
48493684|NCT00859521|101541809|FG001|COMPLETED|First Intervention||15||
48493685|NCT00859521|101541808|FG000|NOT COMPLETED|First Intervention||0||
48493686|NCT00859521|101541809|FG001|NOT COMPLETED|First Intervention||0||
48493687|NCT00859521|101541808|FG000|STARTED|Washout||15||
48493688|NCT00859521|101541809|FG001|STARTED|Washout||15||
48493689|NCT00859521|101541808|FG000|COMPLETED|Washout||15||
48493690|NCT00859521|101541809|FG001|COMPLETED|Washout||14||
48493691|NCT00859521|101541808|FG000|NOT COMPLETED|Washout||0||
48493692|NCT00859521|101541809|FG001|NOT COMPLETED|Washout||1||
48493693|NCT00859521|101541808|FG000|STARTED|Second Intervention||15||
48493694|NCT00859521|101541809|FG001|STARTED|Second Intervention||14||
48493695|NCT00859521|101541808|FG000|COMPLETED|Second Intervention||15||
48493696|NCT00859521|101541809|FG001|COMPLETED|Second Intervention||14||
48493697|NCT00859521|101541808|FG000|NOT COMPLETED|Second Intervention||0||
48493698|NCT00859521|101541809|FG001|NOT COMPLETED|Second Intervention||0||
48493699|NCT04667338|101541810|FG000|STARTED|Overall Study||157||
48493700|NCT04667338|101541811|FG001|STARTED|Overall Study||53||
48493701|NCT04667338|101541810|FG000|Naive: Untreated|Overall Study||8|Participants with narcolepsy who were not treated with any pharmacological treatment from diagnosis to study visit (up to 12 months).|
48200780|NCT01959412|100814591|FG001|COMPLETED|Overall Study||14||
48493702|NCT04667338|101541811|FG001|Naive: Untreated|Overall Study||4|Participants with narcolepsy who were not treated with any pharmacological treatment from diagnosis to study visit (up to 12 months).|
48493703|NCT04667338|101541810|FG000|Treated|Overall Study||149|Participants with narcolepsy who were treated with any pharmacological treatment from diagnosis to study visit (up to 12 months).|
48493704|NCT04667338|101541811|FG001|Treated|Overall Study||49|Participants with narcolepsy who were treated with any pharmacological treatment from diagnosis to study visit (up to 12 months).|
48493705|NCT04667338|101541810|FG000|COMPLETED|Overall Study||157||
48493706|NCT04667338|101541811|FG001|COMPLETED|Overall Study||53||
48493707|NCT04667338|101541810|FG000|NOT COMPLETED|Overall Study||0||
48493708|NCT04667338|101541811|FG001|NOT COMPLETED|Overall Study||0||
48493709|NCT02557035|101541812|FG000|STARTED|Overall Study||225||
48493710|NCT02557035|101541813|FG001|STARTED|Overall Study||215||
48200781|NCT01959412|100814592|FG002|COMPLETED|Overall Study||15||
48200782|NCT01959412|100814593|FG003|COMPLETED|Overall Study||13||
48200783|NCT01959412|100814594|FG004|COMPLETED|Overall Study||13||
48493711|NCT02557035|101541812|FG000|COMPLETED|Overall Study||218||
48493712|NCT02557035|101541813|FG001|COMPLETED|Overall Study||206||
48493713|NCT02557035|101541812|FG000|NOT COMPLETED|Overall Study||7||
48493714|NCT02557035|101541813|FG001|NOT COMPLETED|Overall Study||9||
48493715|NCT02448862|101541814|FG000|STARTED|Overall Study||4525||
48493716|NCT02448862|101541815|FG001|STARTED|Overall Study||6050||
48493717|NCT02448862|101541814|FG000|COMPLETED|Overall Study||4525||
48493718|NCT02448862|101541815|FG001|COMPLETED|Overall Study||6050||
48493719|NCT02448862|101541814|FG000|NOT COMPLETED|Overall Study||0||
48493720|NCT02448862|101541815|FG001|NOT COMPLETED|Overall Study||0||
48493721|NCT02957942|101541816|FG000|STARTED|Overall Study||7||
48493722|NCT02957942|101541817|FG001|STARTED|Overall Study||13||
48493723|NCT02957942|101541816|FG000|COMPLETED|Overall Study||7||
48493724|NCT02957942|101541817|FG001|COMPLETED|Overall Study||6||
48493725|NCT02957942|101541816|FG000|NOT COMPLETED|Overall Study||0||
48493726|NCT02957942|101541817|FG001|NOT COMPLETED|Overall Study||7||
48493727|NCT04377087|101541818|FG000|STARTED|Overall Study||3||
48493728|NCT04377087|101541818|FG000|COMPLETED|Overall Study||3||
48493729|NCT04377087|101541818|FG000|NOT COMPLETED|Overall Study||0||
48493730|NCT03635320|101541819|FG000|STARTED|Overall Study||94|Participated in randomization|
48493731|NCT03635320|101541820|FG001|STARTED|Overall Study||94|Participated in randomization|
48493732|NCT03635320|101541819|FG000|FAS|Overall Study||93|Full Analysis Set (FAS): The data set constituted by all subjects who participate in the randomized study and receive the product (implant).|
48493733|NCT03635320|101541820|FG001|FAS|Overall Study||92|Full Analysis Set (FAS): The data set constituted by all subjects who participate in the randomized study and receive the product (implant).|
48493734|NCT03635320|101541819|FG000|PPS|Overall Study||81|Per Protocol Set (PPS): A set of subjects that complete the trial, excluding those with serious protocol violation affecting the primary efficacy endpoints.|
48493735|NCT03635320|101541820|FG001|PPS|Overall Study||83|Per Protocol Set (PPS): A set of subjects that complete the trial, excluding those with serious protocol violation affecting the primary efficacy endpoints.|
48493736|NCT03635320|101541819|FG000|COMPLETED|Overall Study||82|Completed the study visits|
48493737|NCT03635320|101541820|FG001|COMPLETED|Overall Study||86|Completed the study visits|
48493738|NCT03635320|101541819|FG000|NOT COMPLETED|Overall Study||12||
48200784|NCT01959412|100814595|FG005|COMPLETED|Overall Study||15||
48200785|NCT01959412|100814590|FG000|NOT COMPLETED|Overall Study||1||
48200786|NCT01959412|100814591|FG001|NOT COMPLETED|Overall Study||1||
48200787|NCT01959412|100814592|FG002|NOT COMPLETED|Overall Study||0||
48200788|NCT01959412|100814593|FG003|NOT COMPLETED|Overall Study||2||
48200789|NCT01959412|100814594|FG004|NOT COMPLETED|Overall Study||3||
48493739|NCT03635320|101541820|FG001|NOT COMPLETED|Overall Study||8||
48493740|NCT02179788|101541821|FG000|STARTED|Overall Study||10||
48493741|NCT02179788|101541822|FG001|STARTED|Overall Study||5||
48493742|NCT02179788|101541821|FG000|COMPLETED|Overall Study||10||
48493743|NCT02179788|101541822|FG001|COMPLETED|Overall Study||5||
48493744|NCT02179788|101541821|FG000|NOT COMPLETED|Overall Study||0||
48493745|NCT02179788|101541822|FG001|NOT COMPLETED|Overall Study||0||
48493746|NCT01015703|101541823|FG000|STARTED|Overall Study||10||
48493747|NCT01015703|101541824|FG001|STARTED|Overall Study||10||
48493748|NCT01015703|101541825|FG002|STARTED|Overall Study||10||
48493749|NCT01015703|101541826|FG003|STARTED|Overall Study||10||
48493750|NCT01015703|101541827|FG004|STARTED|Overall Study||10||
48493751|NCT01015703|101541823|FG000|COMPLETED|Overall Study||8||
48493752|NCT01015703|101541824|FG001|COMPLETED|Overall Study||9||
48493753|NCT01015703|101541825|FG002|COMPLETED|Overall Study||10||
48493754|NCT01015703|101541826|FG003|COMPLETED|Overall Study||10||
48493755|NCT01015703|101541827|FG004|COMPLETED|Overall Study||10||
48493756|NCT01015703|101541823|FG000|NOT COMPLETED|Overall Study||2||
48493757|NCT01015703|101541824|FG001|NOT COMPLETED|Overall Study||1||
48493758|NCT01015703|101541825|FG002|NOT COMPLETED|Overall Study||0||
48493759|NCT01015703|101541826|FG003|NOT COMPLETED|Overall Study||0||
48493760|NCT01015703|101541827|FG004|NOT COMPLETED|Overall Study||0||
48493761|NCT02055547|101541828|FG000|STARTED|Overall Study||2||
48493762|NCT02055547|101541829|FG001|STARTED|Overall Study||2||
48493763|NCT02055547|101541830|FG002|STARTED|Overall Study||5||
48493764|NCT02055547|101541831|FG003|STARTED|Overall Study||2||
48493765|NCT02055547|101541832|FG004|STARTED|Overall Study||2||
48493766|NCT02055547|101541833|FG005|STARTED|Overall Study||2||
48493767|NCT02055547|101541834|FG006|STARTED|Overall Study||2||
48493768|NCT02055547|101541835|FG007|STARTED|Overall Study||6||
48493769|NCT02055547|101541836|FG008|STARTED|Overall Study||6||
48493770|NCT02055547|101541837|FG009|STARTED|Overall Study||6||
48493771|NCT02055547|101541838|FG010|STARTED|Overall Study||6||
48493772|NCT02055547|101541839|FG011|STARTED|Overall Study||6||
48493773|NCT02055547|101541840|FG012|STARTED|Overall Study||2||
48493774|NCT02055547|101541841|FG013|STARTED|Overall Study||2||
48493775|NCT02055547|101541842|FG014|STARTED|Overall Study||2||
48493776|NCT02055547|101541843|FG015|STARTED|Overall Study||2||
48493777|NCT02055547|101541844|FG016|STARTED|Overall Study||2||
48493778|NCT02055547|101541845|FG017|STARTED|Overall Study||2||
48493779|NCT02055547|101541846|FG018|STARTED|Overall Study||2||
48493780|NCT02055547|101541828|FG000|COMPLETED|Overall Study||2||
48493781|NCT02055547|101541829|FG001|COMPLETED|Overall Study||1||
48493782|NCT02055547|101541830|FG002|COMPLETED|Overall Study||2||
48493783|NCT02055547|101541831|FG003|COMPLETED|Overall Study||2||
48493784|NCT02055547|101541832|FG004|COMPLETED|Overall Study||1||
48493785|NCT02055547|101541833|FG005|COMPLETED|Overall Study||1||
48493786|NCT02055547|101541834|FG006|COMPLETED|Overall Study||0||
48200790|NCT01959412|100814595|FG005|NOT COMPLETED|Overall Study||0||
48200791|NCT00646451|100814596|FG000|STARTED|Overall Study||10||
48200792|NCT00646451|100814597|FG001|STARTED|Overall Study||10||
48493787|NCT02055547|101541835|FG007|COMPLETED|Overall Study||6||
48493788|NCT02055547|101541836|FG008|COMPLETED|Overall Study||4||
48200793|NCT00646451|100814596|FG000|COMPLETED|Overall Study||6||
48200794|NCT00646451|100814597|FG001|COMPLETED|Overall Study||10||
48200795|NCT00646451|100814596|FG000|NOT COMPLETED|Overall Study||4||
48200796|NCT00646451|100814597|FG001|NOT COMPLETED|Overall Study||0||
48200797|NCT02993471|100814598|FG000|STARTED|Period 1 (Drug Cocktail)||28||
48200798|NCT02993471|100814598|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Drug Cocktail)||28||
48200799|NCT02993471|100814598|FG000|COMPLETED|Period 1 (Drug Cocktail)||28||
48200800|NCT02993471|100814598|FG000|NOT COMPLETED|Period 1 (Drug Cocktail)||0||
48200801|NCT02993471|100814598|FG000|STARTED|Period 2 (Drug Cocktail + Ixekizumab)||28||
48200802|NCT02993471|100814598|FG000|Received at Least 1 Dose of Study Drug|Period 2 (Drug Cocktail + Ixekizumab)||27||
48200803|NCT02993471|100814598|FG000|COMPLETED|Period 2 (Drug Cocktail + Ixekizumab)||26||
48200804|NCT02993471|100814598|FG000|NOT COMPLETED|Period 2 (Drug Cocktail + Ixekizumab)||2||
48200805|NCT00578617|100814599|FG000|STARTED|Overall Study||31||
48200806|NCT00578617|100814600|FG001|STARTED|Overall Study||29||
48200807|NCT00578617|100814599|FG000|COMPLETED|Overall Study||31||
48200808|NCT00578617|100814600|FG001|COMPLETED|Overall Study||29||
48200809|NCT00578617|100814599|FG000|NOT COMPLETED|Overall Study||0||
48200810|NCT00578617|100814600|FG001|NOT COMPLETED|Overall Study||0||
48200811|NCT00591838|100814601|FG000|STARTED|Overall Study||5||
48200812|NCT00591838|100814602|FG001|STARTED|Overall Study||6||
48200813|NCT00591838|100814603|FG002|STARTED|Overall Study||6||
48200814|NCT00591838|100814604|FG003|STARTED|Overall Study||6||
48200815|NCT00591838|100814605|FG004|STARTED|Overall Study||51||
48200816|NCT00591838|100814601|FG000|COMPLETED|Overall Study||5||
48200817|NCT00591838|100814602|FG001|COMPLETED|Overall Study||6||
48200818|NCT00591838|100814603|FG002|COMPLETED|Overall Study||6||
48200819|NCT00591838|100814604|FG003|COMPLETED|Overall Study||5||
48200820|NCT00591838|100814605|FG004|COMPLETED|Overall Study||51||
48200821|NCT00591838|100814601|FG000|NOT COMPLETED|Overall Study||0||
48200822|NCT00591838|100814602|FG001|NOT COMPLETED|Overall Study||0||
48200823|NCT00591838|100814603|FG002|NOT COMPLETED|Overall Study||0||
48493789|NCT02055547|101541837|FG009|COMPLETED|Overall Study||5||
48493790|NCT02055547|101541838|FG010|COMPLETED|Overall Study||5||
48493791|NCT02055547|101541839|FG011|COMPLETED|Overall Study||6||
48493792|NCT02055547|101541840|FG012|COMPLETED|Overall Study||2||
48493793|NCT02055547|101541841|FG013|COMPLETED|Overall Study||1||
48493794|NCT02055547|101541842|FG014|COMPLETED|Overall Study||2||
48493795|NCT02055547|101541843|FG015|COMPLETED|Overall Study||1||
48493796|NCT02055547|101541844|FG016|COMPLETED|Overall Study||2||
48493797|NCT02055547|101541845|FG017|COMPLETED|Overall Study||2||
48200824|NCT00591838|100814604|FG003|NOT COMPLETED|Overall Study||1||
48200825|NCT00591838|100814605|FG004|NOT COMPLETED|Overall Study||0||
48493798|NCT02055547|101541846|FG018|COMPLETED|Overall Study||2||
48493799|NCT02055547|101541828|FG000|NOT COMPLETED|Overall Study||0||
48493800|NCT02055547|101541829|FG001|NOT COMPLETED|Overall Study||1||
48493801|NCT02055547|101541830|FG002|NOT COMPLETED|Overall Study||3||
48493802|NCT02055547|101541831|FG003|NOT COMPLETED|Overall Study||0||
48493803|NCT02055547|101541832|FG004|NOT COMPLETED|Overall Study||1||
48493804|NCT02055547|101541833|FG005|NOT COMPLETED|Overall Study||1||
48493805|NCT02055547|101541834|FG006|NOT COMPLETED|Overall Study||2||
48493806|NCT02055547|101541835|FG007|NOT COMPLETED|Overall Study||0||
48493807|NCT02055547|101541836|FG008|NOT COMPLETED|Overall Study||2||
48493808|NCT02055547|101541837|FG009|NOT COMPLETED|Overall Study||1||
48493809|NCT02055547|101541838|FG010|NOT COMPLETED|Overall Study||1||
48493810|NCT02055547|101541839|FG011|NOT COMPLETED|Overall Study||0||
48493811|NCT02055547|101541840|FG012|NOT COMPLETED|Overall Study||0||
48493812|NCT02055547|101541841|FG013|NOT COMPLETED|Overall Study||1||
48493813|NCT02055547|101541842|FG014|NOT COMPLETED|Overall Study||0||
48493814|NCT02055547|101541843|FG015|NOT COMPLETED|Overall Study||1||
48493815|NCT02055547|101541844|FG016|NOT COMPLETED|Overall Study||0||
48493816|NCT02055547|101541845|FG017|NOT COMPLETED|Overall Study||0||
48493817|NCT02055547|101541846|FG018|NOT COMPLETED|Overall Study||0||
48493818|NCT01343004|101541847|FG000|STARTED|Overall Study||821||
48493819|NCT01343004|101541848|FG001|STARTED|Overall Study||824||
48493820|NCT01343004|101541849|FG002|STARTED|Overall Study||818||
48493821|NCT01343004|101541847|FG000|COMPLETED|Overall Study||637||
48493822|NCT01343004|101541848|FG001|COMPLETED|Overall Study||606||
48493823|NCT01343004|101541849|FG002|COMPLETED|Overall Study||658||
48493824|NCT01343004|101541847|FG000|NOT COMPLETED|Overall Study||184||
48493825|NCT01343004|101541848|FG001|NOT COMPLETED|Overall Study||218||
48493826|NCT01343004|101541849|FG002|NOT COMPLETED|Overall Study||160||
48493827|NCT01885117|101541850|FG000|STARTED|Overall Study||61||
48493828|NCT01885117|101541851|FG001|STARTED|Overall Study||64||
48493829|NCT01885117|101541850|FG000|COMPLETED|Overall Study||61||
48493830|NCT01885117|101541851|FG001|COMPLETED|Overall Study||64||
48493831|NCT01885117|101541850|FG000|NOT COMPLETED|Overall Study||0||
48493832|NCT01885117|101541851|FG001|NOT COMPLETED|Overall Study||0||
48493833|NCT00496860|101541852|FG000|STARTED|Overall Study||4||
48493834|NCT00496860|101541853|FG001|STARTED|Overall Study||16||
48493835|NCT00496860|101541854|FG002|STARTED|Overall Study||6||
48493836|NCT00496860|101541852|FG000|COMPLETED|Overall Study||3||
48493837|NCT00496860|101541853|FG001|COMPLETED|Overall Study||15||
48493838|NCT00496860|101541854|FG002|COMPLETED|Overall Study||6||
48493839|NCT00496860|101541852|FG000|NOT COMPLETED|Overall Study||1||
48493840|NCT00496860|101541853|FG001|NOT COMPLETED|Overall Study||1||
48493841|NCT00496860|101541854|FG002|NOT COMPLETED|Overall Study||0||
48493842|NCT02028715|101541855|FG000|STARTED|Overall Study||34||
48493843|NCT02028715|101541856|FG001|STARTED|Overall Study||34||
48493844|NCT02028715|101541855|FG000|COMPLETED|Overall Study||29||
48493845|NCT02028715|101541856|FG001|COMPLETED|Overall Study||30||
48493846|NCT02028715|101541855|FG000|NOT COMPLETED|Overall Study||5||
48493847|NCT02028715|101541856|FG001|NOT COMPLETED|Overall Study||4||
48493848|NCT01153503|101541857|FG000|STARTED|Overall Study||25||
48493849|NCT01153503|101541858|FG001|STARTED|Overall Study||25||
48493850|NCT01153503|101541859|FG002|STARTED|Overall Study||25||
48493851|NCT01153503|101541857|FG000|COMPLETED|Overall Study||25||
48493852|NCT01153503|101541858|FG001|COMPLETED|Overall Study||24||
48493853|NCT01153503|101541859|FG002|COMPLETED|Overall Study||25||
48493854|NCT01153503|101541857|FG000|NOT COMPLETED|Overall Study||0||
48493855|NCT01153503|101541858|FG001|NOT COMPLETED|Overall Study||1||
48493856|NCT01153503|101541859|FG002|NOT COMPLETED|Overall Study||0||
48666676|NCT04129398|101970458|FG000|COMPLETED|Overall Study||20||
48666677|NCT04129398|101970458|FG000|NOT COMPLETED|Overall Study||2||
48666678|NCT00209131|101970459|FG000|STARTED|Overall Study||15||
48666679|NCT00209131|101970460|FG001|STARTED|Overall Study||11||
48666680|NCT00209131|101970459|FG000|COMPLETED|Overall Study||0||
48666681|NCT00209131|101970460|FG001|COMPLETED|Overall Study||0||
48666682|NCT00209131|101970459|FG000|NOT COMPLETED|Overall Study||15||
48666683|NCT00209131|101970460|FG001|NOT COMPLETED|Overall Study||11||
48666684|NCT00863304|101970461|FG000|STARTED|Overall Study||212||
48666685|NCT00863304|101970462|FG001|STARTED|Overall Study||212||
48666686|NCT00863304|101970463|FG002|STARTED|Overall Study||213||
48666687|NCT00863304|101970464|FG003|STARTED|Overall Study||212||
48666688|NCT00863304|101970461|FG000|Treated|Overall Study||209||
48666689|NCT00863304|101970462|FG001|Treated|Overall Study||211||
48666690|NCT00863304|101970463|FG002|Treated|Overall Study||209||
48666691|NCT00863304|101970464|FG003|Treated|Overall Study||211||
48666692|NCT00863304|101970461|FG000|COMPLETED|Overall Study||18||
48666693|NCT00863304|101970462|FG001|COMPLETED|Overall Study||27||
48666694|NCT00863304|101970463|FG002|COMPLETED|Overall Study||26||
48666695|NCT00863304|101970464|FG003|COMPLETED|Overall Study||21||
48666696|NCT00863304|101970461|FG000|NOT COMPLETED|Overall Study||194||
48666697|NCT00863304|101970462|FG001|NOT COMPLETED|Overall Study||185||
48666698|NCT00863304|101970463|FG002|NOT COMPLETED|Overall Study||187||
48666699|NCT00863304|101970464|FG003|NOT COMPLETED|Overall Study||191||
48666700|NCT03391882|101970465|FG000|STARTED|Study Overall||20||
48666701|NCT03391882|101970466|FG001|STARTED|Study Overall||19||
48666702|NCT03391882|101970467|FG002|STARTED|Study Overall||19||
48666703|NCT03391882|101970468|FG003|STARTED|Study Overall||18||
48666704|NCT03391882|101970469|FG004|STARTED|Study Overall||18||
48666705|NCT03391882|101970470|FG005|STARTED|Study Overall||19||
48666706|NCT03391882|101970465|FG000|Safety Population|Study Overall||20||
48666707|NCT03391882|101970466|FG001|Safety Population|Study Overall||18||
48666708|NCT03391882|101970467|FG002|Safety Population|Study Overall||19||
48666709|NCT03391882|101970468|FG003|Safety Population|Study Overall||18||
48666710|NCT03391882|101970469|FG004|Safety Population|Study Overall||18||
48666711|NCT03391882|101970470|FG005|Safety Population|Study Overall||19||
48666712|NCT03391882|101970465|FG000|Modified Intent-to-Treat Population|Study Overall||20||
48666713|NCT03391882|101970466|FG001|Modified Intent-to-Treat Population|Study Overall||18||
48666714|NCT03391882|101970467|FG002|Modified Intent-to-Treat Population|Study Overall||19||
48666715|NCT03391882|101970468|FG003|Modified Intent-to-Treat Population|Study Overall||18||
48666716|NCT03391882|101970469|FG004|Modified Intent-to-Treat Population|Study Overall||18||
48666717|NCT03391882|101970470|FG005|Modified Intent-to-Treat Population|Study Overall||19||
48666718|NCT03391882|101970465|FG000|COMPLETED|Study Overall||0|The study|
48666719|NCT03391882|101970466|FG001|COMPLETED|Study Overall||0|The study|
48666720|NCT03391882|101970467|FG002|COMPLETED|Study Overall||16|The study|
48666721|NCT03391882|101970468|FG003|COMPLETED|Study Overall||15|The study|
48666722|NCT03391882|101970469|FG004|COMPLETED|Study Overall||14|The study|
48666723|NCT03391882|101970470|FG005|COMPLETED|Study Overall||15|The study|
48666724|NCT03391882|101970465|FG000|NOT COMPLETED|Study Overall||20||
48666725|NCT03391882|101970466|FG001|NOT COMPLETED|Study Overall||19||
48666726|NCT03391882|101970467|FG002|NOT COMPLETED|Study Overall||3||
48666727|NCT03391882|101970468|FG003|NOT COMPLETED|Study Overall||3||
48666728|NCT03391882|101970469|FG004|NOT COMPLETED|Study Overall||4||
48666729|NCT03391882|101970470|FG005|NOT COMPLETED|Study Overall||4||
48666730|NCT03391882|101970465|FG000|STARTED|Part A - Titration Phase||20||
48666731|NCT03391882|101970466|FG001|STARTED|Part A - Titration Phase||19||
48666732|NCT03391882|101970467|FG002|STARTED|Part A - Titration Phase||19||
48493857|NCT02699463|101545008|FG000|STARTED|Overall Study||115||
48200826|NCT03140176|100814606|FG000|STARTED|Overall Study||74||
48200827|NCT03140176|100814606|FG000|COMPLETED|Overall Study||0||
48493858|NCT02699463|101545009|FG001|STARTED|Overall Study||118||
48493859|NCT02699463|101545008|FG000|COMPLETED|Overall Study||100||
48200828|NCT03140176|100814606|FG000|NOT COMPLETED|Overall Study||74||
48493860|NCT02699463|101545009|FG001|COMPLETED|Overall Study||109||
48493861|NCT02699463|101545008|FG000|NOT COMPLETED|Overall Study||15||
48493862|NCT02699463|101545009|FG001|NOT COMPLETED|Overall Study||9||
48200829|NCT05019729|100814607|FG000|STARTED|Overall Study||5||
48493863|NCT00841659|101545010|FG000|STARTED|First Intervention||12||
48493864|NCT00841659|101545011|FG001|STARTED|First Intervention||12||
48493865|NCT00841659|101545010|FG000|COMPLETED|First Intervention||12||
48493866|NCT00841659|101545011|FG001|COMPLETED|First Intervention||12||
48493867|NCT00841659|101545010|FG000|NOT COMPLETED|First Intervention||0||
48493868|NCT00841659|101545011|FG001|NOT COMPLETED|First Intervention||0||
48493869|NCT00841659|101545010|FG000|STARTED|Washout: 2 Weeks||12||
48493870|NCT00841659|101545011|FG001|STARTED|Washout: 2 Weeks||12||
48493871|NCT00841659|101545010|FG000|COMPLETED|Washout: 2 Weeks||11||
48493872|NCT00841659|101545011|FG001|COMPLETED|Washout: 2 Weeks||12||
48493873|NCT00841659|101545010|FG000|NOT COMPLETED|Washout: 2 Weeks||1||
48493874|NCT00841659|101545011|FG001|NOT COMPLETED|Washout: 2 Weeks||0||
48493875|NCT00841659|101545010|FG000|STARTED|Second Intervention||11||
48493876|NCT00841659|101545011|FG001|STARTED|Second Intervention||12||
48493877|NCT00841659|101545010|FG000|COMPLETED|Second Intervention||11||
48493878|NCT00841659|101545011|FG001|COMPLETED|Second Intervention||12||
48493879|NCT00841659|101545010|FG000|NOT COMPLETED|Second Intervention||0||
48493880|NCT00841659|101545011|FG001|NOT COMPLETED|Second Intervention||0||
48493881|NCT03581097|101545012|FG000|STARTED|Overall Study||46||
48493882|NCT03581097|101545013|FG001|STARTED|Overall Study||47||
48493883|NCT03581097|101545012|FG000|COMPLETED|Overall Study||46||
48493884|NCT03581097|101545013|FG001|COMPLETED|Overall Study||47||
48493885|NCT03581097|101545012|FG000|NOT COMPLETED|Overall Study||0||
48493886|NCT03581097|101545013|FG001|NOT COMPLETED|Overall Study||0||
48493887|NCT03442322|101545014|FG000|STARTED|Overall Study||1291||17
48493888|NCT03442322|101545015|FG001|STARTED|Overall Study||3206||36
48493889|NCT03442322|101545014|FG000|6-month Outcome|Overall Study||793||17
48493890|NCT03442322|101545015|FG001|6-month Outcome|Overall Study||1905||36
48493891|NCT03442322|101545014|FG000|12-month Outcome|Overall Study||658||16
48493892|NCT03442322|101545015|FG001|12-month Outcome|Overall Study||1693||36
48493893|NCT03442322|101545014|FG000|COMPLETED|Overall Study||526|This is the 18-month outcome|16
48493894|NCT03442322|101545015|FG001|COMPLETED|Overall Study||1420|This is the 18-month outcome|36
48200830|NCT05019729|100814608|FG001|STARTED|Overall Study||4||
48493895|NCT03442322|101545014|FG000|NOT COMPLETED|Overall Study||765||1
48493896|NCT03442322|101545015|FG001|NOT COMPLETED|Overall Study||1786||0
48493897|NCT02645253|101545016|FG000|STARTED|Overall Study||7||
48493898|NCT02645253|101545017|FG001|STARTED|Overall Study||7||
48493899|NCT02645253|101545018|FG002|STARTED|Overall Study||7||
48493900|NCT02645253|101545019|FG003|STARTED|Overall Study||6||
48493901|NCT02645253|101545016|FG000|COMPLETED|Overall Study||7||
48493902|NCT02645253|101545017|FG001|COMPLETED|Overall Study||7||
48493903|NCT02645253|101545018|FG002|COMPLETED|Overall Study||7||
48493904|NCT02645253|101545019|FG003|COMPLETED|Overall Study||6||
48493905|NCT02645253|101545016|FG000|NOT COMPLETED|Overall Study||0||
48493906|NCT02645253|101545017|FG001|NOT COMPLETED|Overall Study||0||
48493907|NCT02645253|101545018|FG002|NOT COMPLETED|Overall Study||0||
48493908|NCT02645253|101545019|FG003|NOT COMPLETED|Overall Study||0||
48493909|NCT03393754|101545020|FG000|STARTED|Overall Study||811||
48493910|NCT03393754|101545021|FG001|STARTED|Overall Study||796||
48493911|NCT03393754|101545020|FG000|COMPLETED|Overall Study||785||
48493912|NCT03393754|101545021|FG001|COMPLETED|Overall Study||758||
48493913|NCT03393754|101545020|FG000|NOT COMPLETED|Overall Study||26||
48493914|NCT03393754|101545021|FG001|NOT COMPLETED|Overall Study||38||
48493915|NCT04342663|101545022|FG000|STARTED|Overall Study||80||
48493916|NCT04342663|101545023|FG001|STARTED|Overall Study||72||
48493917|NCT04342663|101545022|FG000|COMPLETED|Overall Study||62||
48200831|NCT05019729|100814609|FG002|STARTED|Overall Study||5||
48200832|NCT05019729|100814610|FG003|STARTED|Overall Study||4||
48200833|NCT05019729|100814611|FG004|STARTED|Overall Study||9||
48200834|NCT05019729|100814612|FG005|STARTED|Overall Study||5||
48200835|NCT05019729|100814607|FG000|Received Product Administration|Overall Study||5||
48200836|NCT05019729|100814608|FG001|Received Product Administration|Overall Study||4||
48200837|NCT05019729|100814609|FG002|Received Product Administration|Overall Study||5||
48200838|NCT05019729|100814610|FG003|Received Product Administration|Overall Study||4||
48200839|NCT05019729|100814611|FG004|Received Product Administration|Overall Study||0||
48200840|NCT05019729|100814612|FG005|Received Product Administration|Overall Study||5||
48200841|NCT05019729|100814607|FG000|Completed Controlled Human Malaria Infection (CHMI)|Overall Study||5||
48200842|NCT05019729|100814608|FG001|Completed Controlled Human Malaria Infection (CHMI)|Overall Study||3||
48200843|NCT05019729|100814609|FG002|Completed Controlled Human Malaria Infection (CHMI)|Overall Study||5||
48200844|NCT05019729|100814610|FG003|Completed Controlled Human Malaria Infection (CHMI)|Overall Study||4||
48493918|NCT04342663|101545023|FG001|COMPLETED|Overall Study||53||
48493919|NCT04342663|101545022|FG000|NOT COMPLETED|Overall Study||18||
48493920|NCT04342663|101545023|FG001|NOT COMPLETED|Overall Study||19||
48493921|NCT01640197|101545024|FG000|STARTED|Overall Study||30||
48493922|NCT01640197|101545025|FG001|STARTED|Overall Study||30||
48493923|NCT01640197|101545024|FG000|COMPLETED|Overall Study||30||
48493924|NCT01640197|101545025|FG001|COMPLETED|Overall Study||30||
48493925|NCT01640197|101545024|FG000|NOT COMPLETED|Overall Study||0||
48493926|NCT01640197|101545025|FG001|NOT COMPLETED|Overall Study||0||
48493927|NCT01604941|101545026|FG000|STARTED|Overall Study||11||
48493928|NCT01604941|101545027|FG001|STARTED|Overall Study||4||
48493929|NCT01604941|101545028|FG002|STARTED|Overall Study||3||
48493930|NCT01604941|101545029|FG003|STARTED|Overall Study||3||
48493931|NCT01604941|101545030|FG004|STARTED|Overall Study||4||
48493932|NCT01604941|101545031|FG005|STARTED|Overall Study||7||
48493933|NCT01604941|101545026|FG000|COMPLETED|Overall Study||0||
48493934|NCT01604941|101545027|FG001|COMPLETED|Overall Study||0||
48493935|NCT01604941|101545028|FG002|COMPLETED|Overall Study||0||
48493936|NCT01604941|101545029|FG003|COMPLETED|Overall Study||0||
48493937|NCT01604941|101545030|FG004|COMPLETED|Overall Study||3||
48493938|NCT01604941|101545031|FG005|COMPLETED|Overall Study||0||
48493939|NCT01604941|101545026|FG000|NOT COMPLETED|Overall Study||11||
48493940|NCT01604941|101545027|FG001|NOT COMPLETED|Overall Study||4||
48493941|NCT01604941|101545028|FG002|NOT COMPLETED|Overall Study||3||
48493942|NCT01604941|101545029|FG003|NOT COMPLETED|Overall Study||3||
48493943|NCT01604941|101545030|FG004|NOT COMPLETED|Overall Study||1||
48493944|NCT01604941|101545031|FG005|NOT COMPLETED|Overall Study||7||
48493945|NCT03138967|101545032|FG000|STARTED|Overall Study||26||
48493946|NCT03138967|101545033|FG001|STARTED|Overall Study||28||
48493947|NCT03138967|101545032|FG000|Post-operative Day(POD) 1 Follow-up|Overall Study||25||
48493948|NCT03138967|101545033|FG001|Post-operative Day(POD) 1 Follow-up|Overall Study||25||
48493949|NCT03138967|101545032|FG000|Post-operative Day(POD) 7 Follow-up|Overall Study||25||
48493950|NCT03138967|101545033|FG001|Post-operative Day(POD) 7 Follow-up|Overall Study||24||
48493951|NCT03138967|101545032|FG000|COMPLETED|Overall Study||25||
48493952|NCT03138967|101545033|FG001|COMPLETED|Overall Study||24||
48493953|NCT03138967|101545032|FG000|NOT COMPLETED|Overall Study||1||
48493954|NCT03138967|101545033|FG001|NOT COMPLETED|Overall Study||4||
48493955|NCT04281472|101545034|FG000|STARTED|Stage A||322||
48493956|NCT04281472|101545035|FG001|STARTED|Stage A||0||
48493957|NCT04281472|101545036|FG002|STARTED|Stage A||0||
48493958|NCT04281472|101545034|FG000|COMPLETED|Stage A||221||
48493959|NCT04281472|101545035|FG001|COMPLETED|Stage A||0||
48493960|NCT04281472|101545036|FG002|COMPLETED|Stage A||0||
48493961|NCT04281472|101545034|FG000|NOT COMPLETED|Stage A||101||
48493962|NCT04281472|101545035|FG001|NOT COMPLETED|Stage A||0||
48493963|NCT04281472|101545036|FG002|NOT COMPLETED|Stage A||0||
48493964|NCT04281472|101545034|FG000|STARTED|Stage B||0||
48493965|NCT04281472|101545035|FG001|STARTED|Stage B||111||
48493966|NCT04281472|101545036|FG002|STARTED|Stage B||110||
48493967|NCT04281472|101545034|FG000|COMPLETED|Stage B||0||
48493968|NCT04281472|101545035|FG001|COMPLETED|Stage B||64||
48493969|NCT04281472|101545036|FG002|COMPLETED|Stage B||74||
48493970|NCT04281472|101545034|FG000|NOT COMPLETED|Stage B||0||
48493971|NCT04281472|101545035|FG001|NOT COMPLETED|Stage B||47||
48493972|NCT04281472|101545036|FG002|NOT COMPLETED|Stage B||36||
48493973|NCT01960296|101545037|FG000|STARTED|Overall Study||23||
48493974|NCT01960296|101545038|FG001|STARTED|Overall Study||25||
48493975|NCT01960296|101545037|FG000|COMPLETED|Overall Study||21||
48493976|NCT01960296|101545038|FG001|COMPLETED|Overall Study||22||
48493977|NCT01960296|101545037|FG000|NOT COMPLETED|Overall Study||2||
48493978|NCT01960296|101545038|FG001|NOT COMPLETED|Overall Study||3||
48493979|NCT00836472|101545039|FG000|STARTED|First Intervention||30||
48493980|NCT00836472|101545040|FG001|STARTED|First Intervention||30||
48493981|NCT00836472|101545039|FG000|COMPLETED|First Intervention||30||
48493982|NCT00836472|101545040|FG001|COMPLETED|First Intervention||30||
48493983|NCT00836472|101545039|FG000|NOT COMPLETED|First Intervention||0||
48493984|NCT00836472|101545040|FG001|NOT COMPLETED|First Intervention||0||
48493985|NCT00836472|101545039|FG000|STARTED|Washout||30||
48493986|NCT00836472|101545040|FG001|STARTED|Washout||30||
48493987|NCT00836472|101545039|FG000|COMPLETED|Washout||28||
48493988|NCT00836472|101545040|FG001|COMPLETED|Washout||27||
48493989|NCT00836472|101545039|FG000|NOT COMPLETED|Washout||2||
48493990|NCT00836472|101545040|FG001|NOT COMPLETED|Washout||3||
48493991|NCT00836472|101545039|FG000|STARTED|Second Intervention||28||
48493992|NCT00836472|101545040|FG001|STARTED|Second Intervention||27||
48493993|NCT00836472|101545039|FG000|COMPLETED|Second Intervention||28||
48493994|NCT00836472|101545040|FG001|COMPLETED|Second Intervention||27||
48493995|NCT00836472|101545039|FG000|NOT COMPLETED|Second Intervention||0||
48493996|NCT00836472|101545040|FG001|NOT COMPLETED|Second Intervention||0||
48493997|NCT01693523|101545041|FG000|STARTED|Overall Study||23||
48493998|NCT01693523|101545042|FG001|STARTED|Overall Study||21||
48493999|NCT01693523|101545043|FG002|STARTED|Overall Study||35||
48494000|NCT01693523|101545041|FG000|COMPLETED|Overall Study||18||
48494001|NCT01693523|101545042|FG001|COMPLETED|Overall Study||13||
48494002|NCT01693523|101545043|FG002|COMPLETED|Overall Study||27||
48494003|NCT01693523|101545041|FG000|NOT COMPLETED|Overall Study||5||
48494004|NCT01693523|101545042|FG001|NOT COMPLETED|Overall Study||8||
48494005|NCT01693523|101545043|FG002|NOT COMPLETED|Overall Study||8||
48494006|NCT00107991|101545044|FG000|STARTED|Eligibility Assessment||38||
48494007|NCT00107991|101545044|FG000|COMPLETED|Eligibility Assessment||15||
48494008|NCT00107991|101545044|FG000|NOT COMPLETED|Eligibility Assessment||23||
48494009|NCT00107991|101545044|FG000|STARTED|12 Week Treatment Period||15||
48494010|NCT00107991|101545044|FG000|COMPLETED|12 Week Treatment Period||10||
48494011|NCT00107991|101545044|FG000|NOT COMPLETED|12 Week Treatment Period||5||
48494012|NCT00107991|101545044|FG000|STARTED|18-Week Post Treatment Assessment||10||
48494013|NCT00107991|101545044|FG000|COMPLETED|18-Week Post Treatment Assessment||8||
48494014|NCT00107991|101545044|FG000|NOT COMPLETED|18-Week Post Treatment Assessment||2||
48494015|NCT00446966|101545045|FG000|STARTED|Overall Study||130||
48494016|NCT00446966|101545046|FG001|STARTED|Overall Study||130||
48494017|NCT00446966|101545045|FG000|COMPLETED|Overall Study||120||
48494018|NCT00446966|101545046|FG001|COMPLETED|Overall Study||123||
48494019|NCT00446966|101545045|FG000|NOT COMPLETED|Overall Study||10||
48494020|NCT00446966|101545046|FG001|NOT COMPLETED|Overall Study||7||
48200845|NCT05019729|100814611|FG004|Completed Controlled Human Malaria Infection (CHMI)|Overall Study||6||
48494021|NCT02316223|101545047|FG000|STARTED|Overall Study||134||
48494022|NCT02316223|101545048|FG001|STARTED|Overall Study||133||
48494023|NCT02316223|101545049|FG002|STARTED|Overall Study||139||
48494024|NCT02316223|101545047|FG000|COMPLETED|Overall Study||90||
48494025|NCT02316223|101545048|FG001|COMPLETED|Overall Study||76||
48494026|NCT02316223|101545049|FG002|COMPLETED|Overall Study||95||
48494027|NCT02316223|101545047|FG000|NOT COMPLETED|Overall Study||44||
48494028|NCT02316223|101545048|FG001|NOT COMPLETED|Overall Study||57||
48494029|NCT02316223|101545049|FG002|NOT COMPLETED|Overall Study||44||
48494030|NCT00835484|101545050|FG000|STARTED|First Intervention||16||
48494031|NCT00835484|101545051|FG001|STARTED|First Intervention||16||
48200846|NCT05019729|100814612|FG005|Completed Controlled Human Malaria Infection (CHMI)|Overall Study||0||
48494032|NCT00835484|101545050|FG000|COMPLETED|First Intervention||16||
48494033|NCT00835484|101545051|FG001|COMPLETED|First Intervention||16||
48494034|NCT00835484|101545050|FG000|NOT COMPLETED|First Intervention||0||
48494035|NCT00835484|101545051|FG001|NOT COMPLETED|First Intervention||0||
48494036|NCT00835484|101545050|FG000|STARTED|Washout of 7 Days||16||
48494037|NCT00835484|101545051|FG001|STARTED|Washout of 7 Days||16||
48494038|NCT00835484|101545050|FG000|COMPLETED|Washout of 7 Days||16||
48494039|NCT00835484|101545051|FG001|COMPLETED|Washout of 7 Days||16||
48494040|NCT00835484|101545050|FG000|NOT COMPLETED|Washout of 7 Days||0||
48494041|NCT00835484|101545051|FG001|NOT COMPLETED|Washout of 7 Days||0||
48494042|NCT00835484|101545050|FG000|STARTED|Second Intervention||16||
48494043|NCT00835484|101545051|FG001|STARTED|Second Intervention||16||
48494044|NCT00835484|101545050|FG000|COMPLETED|Second Intervention||16||
48494045|NCT00835484|101545051|FG001|COMPLETED|Second Intervention||16||
48494046|NCT00835484|101545050|FG000|NOT COMPLETED|Second Intervention||0||
48494047|NCT00835484|101545051|FG001|NOT COMPLETED|Second Intervention||0||
48494048|NCT01117623|101545052|FG000|STARTED|Overall Study||3||
48494049|NCT01117623|101545053|FG001|STARTED|Overall Study||8||
48494050|NCT01117623|101545054|FG002|STARTED|Overall Study||11||
48494051|NCT01117623|101545055|FG003|STARTED|Overall Study||6||
48494052|NCT01117623|101545056|FG004|STARTED|Overall Study||10||
48494053|NCT01117623|101545057|FG005|STARTED|Overall Study||16||
48494054|NCT01117623|101545058|FG006|STARTED|Overall Study||6||
48494055|NCT01117623|101545059|FG007|STARTED|Overall Study||26||
48494056|NCT01117623|101545052|FG000|ITT Efficacy Analysis Population|Overall Study||3||
48494057|NCT01117623|101545053|FG001|ITT Efficacy Analysis Population|Overall Study||8||
48494058|NCT01117623|101545054|FG002|ITT Efficacy Analysis Population|Overall Study||11||
48494059|NCT01117623|101545055|FG003|ITT Efficacy Analysis Population|Overall Study||5||
48494060|NCT01117623|101545056|FG004|ITT Efficacy Analysis Population|Overall Study||10||
48494061|NCT01117623|101545057|FG005|ITT Efficacy Analysis Population|Overall Study||16||
48494062|NCT01117623|101545058|FG006|ITT Efficacy Analysis Population|Overall Study||6||
48494063|NCT01117623|101545059|FG007|ITT Efficacy Analysis Population|Overall Study||22||
48494064|NCT01117623|101545052|FG000|PK Population|Overall Study||3||
48494065|NCT01117623|101545053|FG001|PK Population|Overall Study||8||
48494066|NCT01117623|101545054|FG002|PK Population|Overall Study||10||
48494067|NCT01117623|101545055|FG003|PK Population|Overall Study||6||
48494068|NCT01117623|101545056|FG004|PK Population|Overall Study||10||
48494069|NCT01117623|101545057|FG005|PK Population|Overall Study||14||
48494070|NCT01117623|101545058|FG006|PK Population|Overall Study||6||
48494071|NCT01117623|101545059|FG007|PK Population|Overall Study||24||
48494072|NCT01117623|101545052|FG000|COMPLETED|Overall Study||0||
48494073|NCT01117623|101545053|FG001|COMPLETED|Overall Study||0||
48494074|NCT01117623|101545054|FG002|COMPLETED|Overall Study||0||
48494075|NCT01117623|101545055|FG003|COMPLETED|Overall Study||0||
48494076|NCT01117623|101545056|FG004|COMPLETED|Overall Study||0||
48494077|NCT01117623|101545057|FG005|COMPLETED|Overall Study||0||
48494078|NCT01117623|101545058|FG006|COMPLETED|Overall Study||0||
48494079|NCT01117623|101545059|FG007|COMPLETED|Overall Study||0||
48494080|NCT01117623|101545052|FG000|NOT COMPLETED|Overall Study||3||
48494081|NCT01117623|101545053|FG001|NOT COMPLETED|Overall Study||8||
48494082|NCT01117623|101545054|FG002|NOT COMPLETED|Overall Study||11||
48494083|NCT01117623|101545055|FG003|NOT COMPLETED|Overall Study||6||
48494084|NCT01117623|101545056|FG004|NOT COMPLETED|Overall Study||10||
48494085|NCT01117623|101545057|FG005|NOT COMPLETED|Overall Study||16||
48494086|NCT01117623|101545058|FG006|NOT COMPLETED|Overall Study||6||
48494087|NCT01117623|101545059|FG007|NOT COMPLETED|Overall Study||26||
48494088|NCT03077451|101545060|FG000|STARTED|Overall Study||36||
48494089|NCT03077451|101545060|FG000|COMPLETED|Overall Study||20||
48494090|NCT03077451|101545060|FG000|NOT COMPLETED|Overall Study||16||
48494091|NCT00351039|101545061|FG000|STARTED|Overall Study||8||
48494092|NCT00351039|101545061|FG000|COMPLETED|Overall Study||8||
48494093|NCT00351039|101545061|FG000|NOT COMPLETED|Overall Study||0||
48494094|NCT01798264|101545062|FG000|STARTED|Overall Study||12||
48494095|NCT01798264|101545063|FG001|STARTED|Overall Study||11||
48494096|NCT01798264|101545064|FG002|STARTED|Overall Study||10||
48494097|NCT01798264|101545065|FG003|STARTED|Overall Study||11||
48494098|NCT01798264|101545062|FG000|COMPLETED|Overall Study||11||
48494099|NCT01798264|101545063|FG001|COMPLETED|Overall Study||11||
48494100|NCT01798264|101545064|FG002|COMPLETED|Overall Study||10||
48494101|NCT01798264|101545065|FG003|COMPLETED|Overall Study||7||
48494102|NCT01798264|101545062|FG000|NOT COMPLETED|Overall Study||1||
48494103|NCT01798264|101545063|FG001|NOT COMPLETED|Overall Study||0||
48200847|NCT05019729|100814607|FG000|COMPLETED|Overall Study||5||
48494104|NCT01798264|101545064|FG002|NOT COMPLETED|Overall Study||0||
48494105|NCT01798264|101545065|FG003|NOT COMPLETED|Overall Study||4||
48494106|NCT03060486|101545066|FG000|STARTED|Overall Study||15||15
48494107|NCT03060486|101545066|FG000|COMPLETED|Overall Study||15||15
48494108|NCT03060486|101545066|FG000|NOT COMPLETED|Overall Study||0||0
48494109|NCT02121067|101545067|FG000|STARTED|Overall Study||50||
48494110|NCT02121067|101545067|FG000|COMPLETED|Overall Study||50||
48494111|NCT02121067|101545067|FG000|NOT COMPLETED|Overall Study||0||
48494112|NCT00903877|101545068|FG000|STARTED|Overall Study||51||
48494113|NCT00903877|101545068|FG000|COMPLETED|Overall Study||8||
48494114|NCT00903877|101545068|FG000|NOT COMPLETED|Overall Study||43||
48494115|NCT05068284|101545069|FG000|STARTED|Double-Blind Induction (12 Weeks)||21||
48494116|NCT05068284|101545070|FG001|STARTED|Double-Blind Induction (12 Weeks)||20||
48494117|NCT05068284|101545071|FG002|STARTED|Double-Blind Induction (12 Weeks)||22||
48494118|NCT05068284|101545072|FG003|STARTED|Double-Blind Induction (12 Weeks)||20||
48494119|NCT05068284|101545073|FG004|STARTED|Double-Blind Induction (12 Weeks)||23||
48494120|NCT05068284|101545074|FG005|STARTED|Double-Blind Induction (12 Weeks)||0||
48494121|NCT05068284|101545075|FG006|STARTED|Double-Blind Induction (12 Weeks)||0||
48494122|NCT05068284|101545076|FG007|STARTED|Double-Blind Induction (12 Weeks)||0||
48200848|NCT05019729|100814608|FG001|COMPLETED|Overall Study||4||
48200849|NCT05019729|100814609|FG002|COMPLETED|Overall Study||5||
48494123|NCT05068284|101545069|FG000|COMPLETED|Double-Blind Induction (12 Weeks)||12||
48494124|NCT05068284|101545070|FG001|COMPLETED|Double-Blind Induction (12 Weeks)||15||
48494125|NCT05068284|101545071|FG002|COMPLETED|Double-Blind Induction (12 Weeks)||12||
48494126|NCT05068284|101545072|FG003|COMPLETED|Double-Blind Induction (12 Weeks)||15||
48494127|NCT05068284|101545073|FG004|COMPLETED|Double-Blind Induction (12 Weeks)||12||
48494128|NCT05068284|101545074|FG005|COMPLETED|Double-Blind Induction (12 Weeks)||0||
48494129|NCT05068284|101545075|FG006|COMPLETED|Double-Blind Induction (12 Weeks)||0||
48494130|NCT05068284|101545076|FG007|COMPLETED|Double-Blind Induction (12 Weeks)||0||
48494131|NCT05068284|101545069|FG000|NOT COMPLETED|Double-Blind Induction (12 Weeks)||9||
48494132|NCT05068284|101545070|FG001|NOT COMPLETED|Double-Blind Induction (12 Weeks)||5||
48494133|NCT05068284|101545071|FG002|NOT COMPLETED|Double-Blind Induction (12 Weeks)||10||
48494134|NCT05068284|101545072|FG003|NOT COMPLETED|Double-Blind Induction (12 Weeks)||5||
48494135|NCT05068284|101545073|FG004|NOT COMPLETED|Double-Blind Induction (12 Weeks)||11||
48494136|NCT05068284|101545074|FG005|NOT COMPLETED|Double-Blind Induction (12 Weeks)||0||
48494137|NCT05068284|101545075|FG006|NOT COMPLETED|Double-Blind Induction (12 Weeks)||0||
48494138|NCT05068284|101545076|FG007|NOT COMPLETED|Double-Blind Induction (12 Weeks)||0||
48494139|NCT05068284|101545069|FG000|STARTED|Double-Blind Re-Induction (12 Weeks)||0||
48494140|NCT05068284|101545070|FG001|STARTED|Double-Blind Re-Induction (12 Weeks)||0||
48494141|NCT05068284|101545071|FG002|STARTED|Double-Blind Re-Induction (12 Weeks)||12||
48494142|NCT05068284|101545072|FG003|STARTED|Double-Blind Re-Induction (12 Weeks)||12||
48494143|NCT05068284|101545073|FG004|STARTED|Double-Blind Re-Induction (12 Weeks)||0||
48494144|NCT05068284|101545074|FG005|STARTED|Double-Blind Re-Induction (12 Weeks)||0||
48494145|NCT05068284|101545075|FG006|STARTED|Double-Blind Re-Induction (12 Weeks)||0||
48494146|NCT05068284|101545076|FG007|STARTED|Double-Blind Re-Induction (12 Weeks)||0||
48494147|NCT05068284|101545069|FG000|COMPLETED|Double-Blind Re-Induction (12 Weeks)||0||
48494148|NCT05068284|101545070|FG001|COMPLETED|Double-Blind Re-Induction (12 Weeks)||0||
48494149|NCT05068284|101545071|FG002|COMPLETED|Double-Blind Re-Induction (12 Weeks)||9||
48494150|NCT05068284|101545072|FG003|COMPLETED|Double-Blind Re-Induction (12 Weeks)||6||
48494151|NCT05068284|101545073|FG004|COMPLETED|Double-Blind Re-Induction (12 Weeks)||0||
48494152|NCT05068284|101545074|FG005|COMPLETED|Double-Blind Re-Induction (12 Weeks)||0||
48494153|NCT05068284|101545075|FG006|COMPLETED|Double-Blind Re-Induction (12 Weeks)||0||
48494154|NCT05068284|101545076|FG007|COMPLETED|Double-Blind Re-Induction (12 Weeks)||0||
48494155|NCT05068284|101545069|FG000|NOT COMPLETED|Double-Blind Re-Induction (12 Weeks)||0||
48494156|NCT05068284|101545070|FG001|NOT COMPLETED|Double-Blind Re-Induction (12 Weeks)||0||
48494157|NCT05068284|101545071|FG002|NOT COMPLETED|Double-Blind Re-Induction (12 Weeks)||3||
48494158|NCT05068284|101545072|FG003|NOT COMPLETED|Double-Blind Re-Induction (12 Weeks)||6||
48494159|NCT05068284|101545073|FG004|NOT COMPLETED|Double-Blind Re-Induction (12 Weeks)||0||
48494160|NCT05068284|101545074|FG005|NOT COMPLETED|Double-Blind Re-Induction (12 Weeks)||0||
48494161|NCT05068284|101545075|FG006|NOT COMPLETED|Double-Blind Re-Induction (12 Weeks)||0||
48494162|NCT05068284|101545076|FG007|NOT COMPLETED|Double-Blind Re-Induction (12 Weeks)||0||
48494163|NCT05068284|101545069|FG000|STARTED|Double-Blind Maintenance (40 Weeks)||18||
48494164|NCT05068284|101545070|FG001|STARTED|Double-Blind Maintenance (40 Weeks)||0||
48494165|NCT05068284|101545071|FG002|STARTED|Double-Blind Maintenance (40 Weeks)||0||
48494166|NCT05068284|101545072|FG003|STARTED|Double-Blind Maintenance (40 Weeks)||0||
48494167|NCT05068284|101545073|FG004|STARTED|Double-Blind Maintenance (40 Weeks)||0||
48494168|NCT05068284|101545074|FG005|STARTED|Double-Blind Maintenance (40 Weeks)||14||
48494169|NCT05068284|101545075|FG006|STARTED|Double-Blind Maintenance (40 Weeks)||13||
48494170|NCT05068284|101545076|FG007|STARTED|Double-Blind Maintenance (40 Weeks)||4||
48494171|NCT05068284|101545069|FG000|COMPLETED|Double-Blind Maintenance (40 Weeks)||0||
48494172|NCT05068284|101545070|FG001|COMPLETED|Double-Blind Maintenance (40 Weeks)||0||
48494173|NCT05068284|101545071|FG002|COMPLETED|Double-Blind Maintenance (40 Weeks)||0||
48494174|NCT05068284|101545072|FG003|COMPLETED|Double-Blind Maintenance (40 Weeks)||0||
48494175|NCT05068284|101545073|FG004|COMPLETED|Double-Blind Maintenance (40 Weeks)||0||
48494176|NCT05068284|101545074|FG005|COMPLETED|Double-Blind Maintenance (40 Weeks)||1||
48494177|NCT05068284|101545075|FG006|COMPLETED|Double-Blind Maintenance (40 Weeks)||0||
48494178|NCT05068284|101545076|FG007|COMPLETED|Double-Blind Maintenance (40 Weeks)||0||
48494179|NCT05068284|101545069|FG000|NOT COMPLETED|Double-Blind Maintenance (40 Weeks)||18||
48494180|NCT05068284|101545070|FG001|NOT COMPLETED|Double-Blind Maintenance (40 Weeks)||0||
48494181|NCT05068284|101545071|FG002|NOT COMPLETED|Double-Blind Maintenance (40 Weeks)||0||
48494182|NCT05068284|101545072|FG003|NOT COMPLETED|Double-Blind Maintenance (40 Weeks)||0||
48494183|NCT05068284|101545073|FG004|NOT COMPLETED|Double-Blind Maintenance (40 Weeks)||0||
48494184|NCT05068284|101545074|FG005|NOT COMPLETED|Double-Blind Maintenance (40 Weeks)||13||
48494185|NCT05068284|101545075|FG006|NOT COMPLETED|Double-Blind Maintenance (40 Weeks)||13||
48494186|NCT05068284|101545076|FG007|NOT COMPLETED|Double-Blind Maintenance (40 Weeks)||4||
48494187|NCT02825680|101545077|FG000|STARTED|Overall Study||82||
48494188|NCT02825680|101545078|FG001|STARTED|Overall Study||55||
48494189|NCT02825680|101545077|FG000|COMPLETED|Overall Study||82||
48494190|NCT02825680|101545078|FG001|COMPLETED|Overall Study||39||
48494191|NCT02825680|101545077|FG000|NOT COMPLETED|Overall Study||0||
48200850|NCT05019729|100814610|FG003|COMPLETED|Overall Study||4||
48200851|NCT05019729|100814611|FG004|COMPLETED|Overall Study||6||
48200852|NCT05019729|100814612|FG005|COMPLETED|Overall Study||5||
48200853|NCT05019729|100814607|FG000|NOT COMPLETED|Overall Study||0||
48200854|NCT05019729|100814608|FG001|NOT COMPLETED|Overall Study||0||
48200855|NCT05019729|100814609|FG002|NOT COMPLETED|Overall Study||0||
48200856|NCT05019729|100814610|FG003|NOT COMPLETED|Overall Study||0||
48200857|NCT05019729|100814611|FG004|NOT COMPLETED|Overall Study||3||
48200858|NCT05019729|100814612|FG005|NOT COMPLETED|Overall Study||0||
48200859|NCT00891618|100814613|FG000|STARTED|Overall Study||21||
48200860|NCT00891618|100814613|FG000|COMPLETED|Overall Study||20||
48200861|NCT00891618|100814613|FG000|NOT COMPLETED|Overall Study||1||
48200862|NCT01992354|100814614|FG000|STARTED|Overall Study||4||
48200863|NCT01992354|100814614|FG000|COMPLETED|Overall Study||4||
48200864|NCT01992354|100814614|FG000|NOT COMPLETED|Overall Study||0||
48200865|NCT01585038|100814615|FG000|STARTED|Overall Study||20||
48494192|NCT02825680|101545078|FG001|NOT COMPLETED|Overall Study||16||
48494193|NCT01322633|101545079|FG000|STARTED|Overall Study||34178||
48494194|NCT01322633|101545080|FG001|STARTED|Overall Study||27686||
48494195|NCT01322633|101545079|FG000|COMPLETED|Overall Study||34178||
48494196|NCT01322633|101545080|FG001|COMPLETED|Overall Study||27686||
48494197|NCT01322633|101545079|FG000|NOT COMPLETED|Overall Study||0||
48494198|NCT01322633|101545080|FG001|NOT COMPLETED|Overall Study||0||
48494199|NCT01440803|101545081|FG000|STARTED|Overall Study||13||
48666733|NCT03391882|101970468|FG003|STARTED|Part A - Titration Phase||18||
48200866|NCT01585038|100814616|FG001|STARTED|Overall Study||20||
48200867|NCT01585038|100814615|FG000|COMPLETED|Overall Study||18||
48200868|NCT01585038|100814616|FG001|COMPLETED|Overall Study||18||
48494200|NCT01440803|101545082|FG001|STARTED|Overall Study||28||
48200869|NCT01585038|100814615|FG000|NOT COMPLETED|Overall Study||2||
48200870|NCT01585038|100814616|FG001|NOT COMPLETED|Overall Study||2||
48200871|NCT00530842|100814617|FG000|STARTED|Overall Study||172||
48200872|NCT00530842|100814618|FG001|STARTED|Overall Study||172||
48200873|NCT00530842|100814617|FG000|COMPLETED|Overall Study||149||
48200874|NCT00530842|100814618|FG001|COMPLETED|Overall Study||151||
48200875|NCT00530842|100814617|FG000|NOT COMPLETED|Overall Study||23||
48494201|NCT01440803|101545081|FG000|Period 1 - Forteo/Placebo|Overall Study||13||
48494202|NCT01440803|101545082|FG001|Period 1 - Forteo/Placebo|Overall Study||28||
48494203|NCT01440803|101545081|FG000|Period 2 - Forteo/Forteo|Overall Study||13||
48494204|NCT01440803|101545082|FG001|Period 2 - Forteo/Forteo|Overall Study||28||
48494205|NCT01440803|101545081|FG000|Period 3 - Forteo Open Label|Overall Study||13||
48494206|NCT01440803|101545082|FG001|Period 3 - Forteo Open Label|Overall Study||27||
48494207|NCT01440803|101545081|FG000|COMPLETED|Overall Study||11||
48494208|NCT01440803|101545082|FG001|COMPLETED|Overall Study||24||
48494209|NCT01440803|101545081|FG000|NOT COMPLETED|Overall Study||2||
48494210|NCT01440803|101545082|FG001|NOT COMPLETED|Overall Study||4||
48494211|NCT02175095|101545083|FG000|STARTED|Overall Study||68||
48494212|NCT02175095|101545083|FG000|COMPLETED|Overall Study||65||
48200876|NCT00530842|100814618|FG001|NOT COMPLETED|Overall Study||21||
48200877|NCT00530842|100814617|FG000|STARTED|Period 1||172||
48200878|NCT00530842|100814618|FG001|STARTED|Period 1||172||
48200879|NCT00530842|100814617|FG000|COMPLETED|Period 1||158||
48200880|NCT00530842|100814618|FG001|COMPLETED|Period 1||161||
48200881|NCT00530842|100814617|FG000|NOT COMPLETED|Period 1||14||
48200882|NCT00530842|100814618|FG001|NOT COMPLETED|Period 1||11||
48200883|NCT00530842|100814617|FG000|STARTED|Period 2||157||
48200884|NCT00530842|100814618|FG001|STARTED|Period 2||160||
48200885|NCT00530842|100814617|FG000|COMPLETED|Period 2||149||
48200886|NCT00530842|100814618|FG001|COMPLETED|Period 2||151||
48494213|NCT02175095|101545083|FG000|NOT COMPLETED|Overall Study||3||
48494214|NCT00957021|101545084|FG000|STARTED|Overall Study||354||
48494215|NCT00957021|101545084|FG000|COMPLETED|Overall Study||237||
48494216|NCT00957021|101545084|FG000|NOT COMPLETED|Overall Study||117||
48494217|NCT00227370|101545085|FG000|STARTED|Overall Study||66||
48494218|NCT00227370|101545086|FG001|STARTED|Overall Study||70||
48494219|NCT00227370|101545085|FG000|COMPLETED|Overall Study||45||
48494220|NCT00227370|101545086|FG001|COMPLETED|Overall Study||46||
48494221|NCT00227370|101545085|FG000|NOT COMPLETED|Overall Study||21||
48494222|NCT00227370|101545086|FG001|NOT COMPLETED|Overall Study||24||
48494223|NCT01116739|101545087|FG000|STARTED|Overall Study||1056||
48494224|NCT01116739|101545088|FG001|STARTED|Overall Study||1004||
48494225|NCT01116739|101545087|FG000|COMPLETED|Overall Study||926||
48494226|NCT01116739|101545088|FG001|COMPLETED|Overall Study||868||
48494227|NCT01116739|101545087|FG000|NOT COMPLETED|Overall Study||130||
48494228|NCT01116739|101545088|FG001|NOT COMPLETED|Overall Study||136||
48494229|NCT04112823|101545089|FG000|STARTED|Overall Study||104||
48200887|NCT00530842|100814617|FG000|NOT COMPLETED|Period 2||8||
48200888|NCT00530842|100814618|FG001|NOT COMPLETED|Period 2||9||
48200889|NCT04107805|100814619|FG000|STARTED|Overall Study||22||
48200890|NCT04107805|100814620|FG001|STARTED|Overall Study||9||
48200891|NCT04107805|100814621|FG002|STARTED|Overall Study||5||
48200892|NCT04107805|100814622|FG003|STARTED|Overall Study||9||
48200893|NCT04107805|100814623|FG004|STARTED|Overall Study||6||
48200894|NCT04107805|100814624|FG005|STARTED|Overall Study||9||
48494230|NCT04112823|101545090|FG001|STARTED|Overall Study||105||
48494231|NCT04112823|101545089|FG000|COMPLETED|Overall Study||102||
48494232|NCT04112823|101545090|FG001|COMPLETED|Overall Study||102||
48200895|NCT04107805|100814625|FG006|STARTED|Overall Study||9||
48200896|NCT04107805|100814626|FG007|STARTED|Overall Study||9||
48200897|NCT04107805|100814627|FG008|STARTED|Overall Study||9||
48200898|NCT04107805|100814619|FG000|COMPLETED|Overall Study||22|Not prematurely discontinued trial medication|
48200899|NCT04107805|100814620|FG001|COMPLETED|Overall Study||9|Not prematurely discontinued trial medication|
48200900|NCT04107805|100814621|FG002|COMPLETED|Overall Study||5|Not prematurely discontinued trial medication|
48200901|NCT04107805|100814622|FG003|COMPLETED|Overall Study||8|Not prematurely discontinued trial medication|
48494233|NCT04112823|101545089|FG000|NOT COMPLETED|Overall Study||2||
48494234|NCT04112823|101545090|FG001|NOT COMPLETED|Overall Study||3||
48494235|NCT01545193|101545091|FG000|STARTED|Overall Study||150||
48494236|NCT01545193|101545092|FG001|STARTED|Overall Study||150||
48494237|NCT01545193|101545091|FG000|COMPLETED|Overall Study||150||
48494238|NCT01545193|101545092|FG001|COMPLETED|Overall Study||149||
48200902|NCT04107805|100814623|FG004|COMPLETED|Overall Study||6|Not prematurely discontinued trial medication|
48200903|NCT04107805|100814624|FG005|COMPLETED|Overall Study||8|Not prematurely discontinued trial medication|
48200904|NCT04107805|100814625|FG006|COMPLETED|Overall Study||9|Not prematurely discontinued trial medication|
48200905|NCT04107805|100814626|FG007|COMPLETED|Overall Study||9|Not prematurely discontinued trial medication|
48200906|NCT04107805|100814627|FG008|COMPLETED|Overall Study||8|Not prematurely discontinued trial medication|
48200907|NCT04107805|100814619|FG000|NOT COMPLETED|Overall Study||0||
48200908|NCT04107805|100814620|FG001|NOT COMPLETED|Overall Study||0||
48200909|NCT04107805|100814621|FG002|NOT COMPLETED|Overall Study||0||
48200910|NCT04107805|100814622|FG003|NOT COMPLETED|Overall Study||1||
48494239|NCT01545193|101545091|FG000|NOT COMPLETED|Overall Study||0||
48494240|NCT01545193|101545092|FG001|NOT COMPLETED|Overall Study||1||
48494241|NCT01175135|101545093|FG000|STARTED|Overall Study||74||
48494242|NCT01175135|101545094|FG001|STARTED|Overall Study||74||
48494243|NCT01175135|101545095|FG002|STARTED|Overall Study||37||
48494244|NCT01175135|101545096|FG003|STARTED|Overall Study||74||
48494245|NCT01175135|101545093|FG000|Treated|Overall Study||74||
48494246|NCT01175135|101545094|FG001|Treated|Overall Study||74||
48494247|NCT01175135|101545095|FG002|Treated|Overall Study||36||
48494248|NCT01175135|101545096|FG003|Treated|Overall Study||74||
48494249|NCT01175135|101545093|FG000|Analyzed for Efficacy|Overall Study||74||
48494250|NCT01175135|101545094|FG001|Analyzed for Efficacy|Overall Study||73||
48494251|NCT01175135|101545095|FG002|Analyzed for Efficacy|Overall Study||34||
48494252|NCT01175135|101545096|FG003|Analyzed for Efficacy|Overall Study||73||
48494253|NCT01175135|101545093|FG000|COMPLETED|Overall Study||58||
48494254|NCT01175135|101545094|FG001|COMPLETED|Overall Study||52||
48494255|NCT01175135|101545095|FG002|COMPLETED|Overall Study||25||
48494256|NCT01175135|101545096|FG003|COMPLETED|Overall Study||60||
48494257|NCT01175135|101545093|FG000|NOT COMPLETED|Overall Study||16||
48494258|NCT01175135|101545094|FG001|NOT COMPLETED|Overall Study||22||
48494259|NCT01175135|101545095|FG002|NOT COMPLETED|Overall Study||12||
48494260|NCT01175135|101545096|FG003|NOT COMPLETED|Overall Study||14||
48494261|NCT02625974|101545097|FG000|STARTED|Part 1||219||
48494262|NCT02625974|101545098|FG001|STARTED|Part 1||111||
48494263|NCT02625974|101545097|FG000|Received Treatment|Part 1||219||
48494264|NCT02625974|101545098|FG001|Received Treatment|Part 1||111||
48494265|NCT02625974|101545097|FG000|COMPLETED|Part 1||210||
48494266|NCT02625974|101545098|FG001|COMPLETED|Part 1||108||
48494267|NCT02625974|101545097|FG000|NOT COMPLETED|Part 1||9||
48494268|NCT02625974|101545098|FG001|NOT COMPLETED|Part 1||3||
48494269|NCT02625974|101545097|FG000|STARTED|Part 2||197||
48494270|NCT02625974|101545098|FG001|STARTED|Part 2||98||
48494271|NCT02625974|101545097|FG000|COMPLETED|Part 2||191||
48494272|NCT02625974|101545098|FG001|COMPLETED|Part 2||91||
48494273|NCT02625974|101545097|FG000|NOT COMPLETED|Part 2||6||
48494274|NCT02625974|101545098|FG001|NOT COMPLETED|Part 2||7||
48494275|NCT04223791|101545099|FG000|STARTED|Overall Study||322||
48494276|NCT04223791|101545100|FG001|STARTED|Overall Study||321||
48494277|NCT04223791|101545099|FG000|Treated|Overall Study||322||
48494278|NCT04223791|101545100|FG001|Treated|Overall Study||319||
48494279|NCT04223791|101545099|FG000|COMPLETED|Overall Study||0||
48494280|NCT04223791|101545100|FG001|COMPLETED|Overall Study||0||
48494281|NCT04223791|101545099|FG000|NOT COMPLETED|Overall Study||322||
48494282|NCT04223791|101545100|FG001|NOT COMPLETED|Overall Study||321||
48494283|NCT03423654|101545101|FG000|STARTED|Overall Study||3||
48494284|NCT03423654|101545102|FG001|STARTED|Overall Study||3||
48494285|NCT03423654|101545101|FG000|COMPLETED|Overall Study||3||
48494286|NCT03423654|101545102|FG001|COMPLETED|Overall Study||3||
48494287|NCT03423654|101545101|FG000|NOT COMPLETED|Overall Study||0||
48494288|NCT03423654|101545102|FG001|NOT COMPLETED|Overall Study||0||
48494289|NCT05315713|101545103|FG000|STARTED|Overall Study||8||
48494290|NCT05315713|101545103|FG000|COMPLETED|Overall Study||0||
48494291|NCT05315713|101545103|FG000|NOT COMPLETED|Overall Study||8||
48494292|NCT00881751|101545104|FG000|STARTED|Overall Study||47||
48494293|NCT00881751|101545105|FG001|STARTED|Overall Study||48||
48494294|NCT00881751|101545104|FG000|COMPLETED|Overall Study||47||
48494295|NCT00881751|101545105|FG001|COMPLETED|Overall Study||43||
48494296|NCT00881751|101545104|FG000|NOT COMPLETED|Overall Study||0||
48494297|NCT00881751|101545105|FG001|NOT COMPLETED|Overall Study||5||
48494298|NCT00932477|101545106|FG000|STARTED|Treatment 1||7||
48494299|NCT00932477|101545107|FG001|STARTED|Treatment 1||8||
48200911|NCT04107805|100814623|FG004|NOT COMPLETED|Overall Study||0||
48200912|NCT04107805|100814624|FG005|NOT COMPLETED|Overall Study||1||
48200913|NCT04107805|100814625|FG006|NOT COMPLETED|Overall Study||0||
48200914|NCT04107805|100814626|FG007|NOT COMPLETED|Overall Study||0||
48494300|NCT00932477|101545108|FG002|STARTED|Treatment 1||9||
48494301|NCT00932477|101545109|FG003|STARTED|Treatment 1||7||
48494302|NCT00932477|101545110|FG004|STARTED|Treatment 1||8||
48200915|NCT04107805|100814627|FG008|NOT COMPLETED|Overall Study||1||
48200916|NCT00678795|100814628|FG000|STARTED|Overall Study||67||
48494303|NCT00932477|101545111|FG005|STARTED|Treatment 1||8||
48494304|NCT00932477|101545106|FG000|COMPLETED|Treatment 1||7||
48494305|NCT00932477|101545107|FG001|COMPLETED|Treatment 1||8||
48494306|NCT00932477|101545108|FG002|COMPLETED|Treatment 1||9||
48494307|NCT00932477|101545109|FG003|COMPLETED|Treatment 1||7||
48494308|NCT00932477|101545110|FG004|COMPLETED|Treatment 1||8||
48494309|NCT00932477|101545111|FG005|COMPLETED|Treatment 1||8||
48494310|NCT00932477|101545106|FG000|NOT COMPLETED|Treatment 1||0||
48494311|NCT00932477|101545107|FG001|NOT COMPLETED|Treatment 1||0||
48494312|NCT00932477|101545108|FG002|NOT COMPLETED|Treatment 1||0||
48494313|NCT00932477|101545109|FG003|NOT COMPLETED|Treatment 1||0||
48494314|NCT00932477|101545110|FG004|NOT COMPLETED|Treatment 1||0||
48494315|NCT00932477|101545111|FG005|NOT COMPLETED|Treatment 1||0||
48494316|NCT00932477|101545106|FG000|STARTED|Treatment 2||7||
48494317|NCT00932477|101545107|FG001|STARTED|Treatment 2||8||
48200917|NCT00678795|100814629|FG001|STARTED|Overall Study||68||
48200918|NCT00678795|100814628|FG000|COMPLETED|Overall Study||56||
48200919|NCT00678795|100814629|FG001|COMPLETED|Overall Study||62||
48200920|NCT00678795|100814628|FG000|NOT COMPLETED|Overall Study||11||
48200921|NCT00678795|100814629|FG001|NOT COMPLETED|Overall Study||6||
48200922|NCT02595398|100814630|FG000|STARTED|Overall Study||96||
48200923|NCT02595398|100814631|FG001|STARTED|Overall Study||64||
48200924|NCT02595398|100814630|FG000|Intention-to-Treat (ITT) Population|Overall Study||96|Defined as all randomized subjects who received at least one study treatment. Subjects analyzed as originally allocated after randomization.|
48200925|NCT02595398|100814631|FG001|Intention-to-Treat (ITT) Population|Overall Study||64|Defined as all randomized subjects who received at least one study treatment. Subjects analyzed as originally allocated after randomization.|
48200926|NCT02595398|100814630|FG000|Safety Population|Overall Study||96|Defined as all randomized subjects who were administered at least one dose of study drug.|
48200927|NCT02595398|100814631|FG001|Safety Population|Overall Study||64|Defined as all randomized subjects who were administered at least one dose of study drug.|
48200928|NCT02595398|100814630|FG000|COMPLETED|Overall Study||92||
48200929|NCT02595398|100814631|FG001|COMPLETED|Overall Study||63||
48200930|NCT02595398|100814630|FG000|NOT COMPLETED|Overall Study||4||
48200931|NCT02595398|100814631|FG001|NOT COMPLETED|Overall Study||1||
48200932|NCT00619645|100814632|FG000|STARTED|Overall Study||8||
48200933|NCT00619645|100814632|FG000|COMPLETED|Overall Study||7||
48200934|NCT00619645|100814632|FG000|NOT COMPLETED|Overall Study||1||
48200935|NCT01729819|100814633|FG000|STARTED|Overall Study||49|The ITT comprised of all randomised patients (49 in combination group and 57 in tolterodine group)|
48200936|NCT01729819|100814634|FG001|STARTED|Overall Study||57|The ITT comprised of all randomised patients (49 in combination group and 57 in tolterodine group)|
48200937|NCT01729819|100814633|FG000|COMPLETED|Overall Study||43||
48200938|NCT01729819|100814634|FG001|COMPLETED|Overall Study||50||
48200939|NCT01729819|100814633|FG000|NOT COMPLETED|Overall Study||6||
48200940|NCT01729819|100814634|FG001|NOT COMPLETED|Overall Study||7||
48200941|NCT02711826|100814635|FG000|STARTED|Overall Study||3||
48200942|NCT02711826|100814636|FG001|STARTED|Overall Study||9||
48200943|NCT02711826|100814637|FG002|STARTED|Overall Study||6||
48200944|NCT02711826|100814638|FG003|STARTED|Overall Study||9||
48200945|NCT02711826|100814639|FG004|STARTED|Overall Study||5||
48200946|NCT02711826|100814635|FG000|COMPLETED|Overall Study||3||
48200947|NCT02711826|100814636|FG001|COMPLETED|Overall Study||7||
48200948|NCT02711826|100814637|FG002|COMPLETED|Overall Study||1||
48200949|NCT02711826|100814638|FG003|COMPLETED|Overall Study||0||
48200950|NCT02711826|100814639|FG004|COMPLETED|Overall Study||5||
48200951|NCT02711826|100814635|FG000|NOT COMPLETED|Overall Study||0||
48200952|NCT02711826|100814636|FG001|NOT COMPLETED|Overall Study||2||
48200953|NCT02711826|100814637|FG002|NOT COMPLETED|Overall Study||5||
48200954|NCT02711826|100814638|FG003|NOT COMPLETED|Overall Study||9||
48200955|NCT02711826|100814639|FG004|NOT COMPLETED|Overall Study||0||
48494318|NCT00932477|101545108|FG002|STARTED|Treatment 2||9||
48494319|NCT00932477|101545109|FG003|STARTED|Treatment 2||7||
48494320|NCT00932477|101545110|FG004|STARTED|Treatment 2||8||
48200956|NCT04673851|100814640|FG000|STARTED|Overall Study||25||
48200957|NCT04673851|100814641|FG001|STARTED|Overall Study||37||
48200958|NCT04673851|100814642|FG002|STARTED|Overall Study||12||
48200959|NCT04673851|100814643|FG003|STARTED|Overall Study||11||
48200960|NCT04673851|100814640|FG000|COMPLETED|Overall Study||20||
48200961|NCT04673851|100814641|FG001|COMPLETED|Overall Study||27||
48200962|NCT04673851|100814642|FG002|COMPLETED|Overall Study||12||
48200963|NCT04673851|100814643|FG003|COMPLETED|Overall Study||11||
48200964|NCT04673851|100814640|FG000|NOT COMPLETED|Overall Study||5||
48200965|NCT04673851|100814641|FG001|NOT COMPLETED|Overall Study||10||
48494321|NCT00932477|101545111|FG005|STARTED|Treatment 2||8||
48494322|NCT00932477|101545106|FG000|COMPLETED|Treatment 2||7||
48494323|NCT00932477|101545107|FG001|COMPLETED|Treatment 2||8||
48494324|NCT00932477|101545108|FG002|COMPLETED|Treatment 2||9||
48494325|NCT00932477|101545109|FG003|COMPLETED|Treatment 2||7||
48494326|NCT00932477|101545110|FG004|COMPLETED|Treatment 2||8||
48494327|NCT00932477|101545111|FG005|COMPLETED|Treatment 2||8||
48494328|NCT00932477|101545106|FG000|NOT COMPLETED|Treatment 2||0||
48494329|NCT00932477|101545107|FG001|NOT COMPLETED|Treatment 2||0||
48494330|NCT00932477|101545108|FG002|NOT COMPLETED|Treatment 2||0||
48494331|NCT00932477|101545109|FG003|NOT COMPLETED|Treatment 2||0||
48494332|NCT00932477|101545110|FG004|NOT COMPLETED|Treatment 2||0||
48494333|NCT00932477|101545111|FG005|NOT COMPLETED|Treatment 2||0||
48494334|NCT00932477|101545106|FG000|STARTED|Treatment 3||7||
48494335|NCT00932477|101545107|FG001|STARTED|Treatment 3||8||
48494336|NCT00932477|101545108|FG002|STARTED|Treatment 3||9||
48494337|NCT00932477|101545109|FG003|STARTED|Treatment 3||7||
48494338|NCT00932477|101545110|FG004|STARTED|Treatment 3||8||
48494339|NCT00932477|101545111|FG005|STARTED|Treatment 3||8||
48494340|NCT00932477|101545106|FG000|COMPLETED|Treatment 3||7||
48494341|NCT00932477|101545107|FG001|COMPLETED|Treatment 3||8||
48494342|NCT00932477|101545108|FG002|COMPLETED|Treatment 3||9||
48494343|NCT00932477|101545109|FG003|COMPLETED|Treatment 3||7||
48494344|NCT00932477|101545110|FG004|COMPLETED|Treatment 3||8||
48494345|NCT00932477|101545111|FG005|COMPLETED|Treatment 3||8||
48494346|NCT00932477|101545106|FG000|NOT COMPLETED|Treatment 3||0||
48494347|NCT00932477|101545107|FG001|NOT COMPLETED|Treatment 3||0||
48494348|NCT00932477|101545108|FG002|NOT COMPLETED|Treatment 3||0||
48494349|NCT00932477|101545109|FG003|NOT COMPLETED|Treatment 3||0||
48494350|NCT00932477|101545110|FG004|NOT COMPLETED|Treatment 3||0||
48494351|NCT00932477|101545111|FG005|NOT COMPLETED|Treatment 3||0||
48494352|NCT00935012|101545112|FG000|STARTED|Overall Study||31||
48494353|NCT00935012|101545112|FG000|COMPLETED|Overall Study||2||
48494354|NCT00935012|101545112|FG000|NOT COMPLETED|Overall Study||29||
48494355|NCT05143047|101545113|FG000|STARTED|Overall Study||99||
48494356|NCT05143047|101545114|FG001|STARTED|Overall Study||99||
48494357|NCT05143047|101545113|FG000|COMPLETED|Overall Study||72||
48494358|NCT05143047|101545114|FG001|COMPLETED|Overall Study||79||
48494359|NCT05143047|101545113|FG000|NOT COMPLETED|Overall Study||27||
48494360|NCT05143047|101545114|FG001|NOT COMPLETED|Overall Study||20||
48494361|NCT00205777|101545115|FG000|STARTED|Core Study (Up to 3 Years)||1907||
48494362|NCT00205777|101545116|FG001|STARTED|Core Study (Up to 3 Years)||1904||
48494363|NCT00205777|101545117|FG002|STARTED|Core Study (Up to 3 Years)||1884||
48494364|NCT00205777|101545118|FG003|STARTED|Core Study (Up to 3 Years)||1914||
48494365|NCT00205777|101545119|FG004|STARTED|Core Study (Up to 3 Years)||0||
48494366|NCT00205777|101545120|FG005|STARTED|Core Study (Up to 3 Years)||0||
48494367|NCT00205777|101545115|FG000|TREATED|Core Study (Up to 3 Years)||1886||
48494368|NCT00205777|101545116|FG001|TREATED|Core Study (Up to 3 Years)||1872||
48494369|NCT00205777|101545117|FG002|TREATED|Core Study (Up to 3 Years)||1849||
48494370|NCT00205777|101545118|FG003|TREATED|Core Study (Up to 3 Years)||1885||
48494371|NCT00205777|101545119|FG004|TREATED|Core Study (Up to 3 Years)||0||
48494372|NCT00205777|101545120|FG005|TREATED|Core Study (Up to 3 Years)||0||
48494373|NCT00205777|101545115|FG000|COMPLETED|Core Study (Up to 3 Years)||1279||
48494374|NCT00205777|101545116|FG001|COMPLETED|Core Study (Up to 3 Years)||1245||
48494375|NCT00205777|101545117|FG002|COMPLETED|Core Study (Up to 3 Years)||1277||
48494376|NCT00205777|101545118|FG003|COMPLETED|Core Study (Up to 3 Years)||1282||
48494377|NCT00205777|101545119|FG004|COMPLETED|Core Study (Up to 3 Years)||0||
48494378|NCT00205777|101545120|FG005|COMPLETED|Core Study (Up to 3 Years)||0||
48494379|NCT00205777|101545115|FG000|NOT COMPLETED|Core Study (Up to 3 Years)||628||
48494380|NCT00205777|101545116|FG001|NOT COMPLETED|Core Study (Up to 3 Years)||659||
48494381|NCT00205777|101545117|FG002|NOT COMPLETED|Core Study (Up to 3 Years)||607||
48494382|NCT00205777|101545118|FG003|NOT COMPLETED|Core Study (Up to 3 Years)||632||
48494383|NCT00205777|101545119|FG004|NOT COMPLETED|Core Study (Up to 3 Years)||0||
48494384|NCT00205777|101545120|FG005|NOT COMPLETED|Core Study (Up to 3 Years)||0||
48494385|NCT00205777|101545115|FG000|STARTED|Completed Core Study, Entered SE I||1279||
48494386|NCT00205777|101545116|FG001|STARTED|Completed Core Study, Entered SE I||1245||
48494387|NCT00205777|101545117|FG002|STARTED|Completed Core Study, Entered SE I||1277||
48494388|NCT00205777|101545118|FG003|STARTED|Completed Core Study, Entered SE I||1282||
48494389|NCT00205777|101545119|FG004|STARTED|Completed Core Study, Entered SE I||0||
48494390|NCT00205777|101545120|FG005|STARTED|Completed Core Study, Entered SE I||0||
48666734|NCT03391882|101970469|FG004|STARTED|Part A - Titration Phase||18||
48200966|NCT04673851|100814642|FG002|NOT COMPLETED|Overall Study||0||
48200967|NCT04673851|100814643|FG003|NOT COMPLETED|Overall Study||0||
48200968|NCT02446223|100814644|FG000|STARTED|Overall Study||21||
48200969|NCT02446223|100814644|FG000|COMPLETED|Overall Study||20||
48200970|NCT02446223|100814644|FG000|NOT COMPLETED|Overall Study||1||
48200971|NCT01891968|100814645|FG000|STARTED|Overall Study||15||
48200972|NCT01891968|100814645|FG000|COMPLETED|Overall Study||15||
48200973|NCT01891968|100814645|FG000|NOT COMPLETED|Overall Study||0||
48200974|NCT02076919|100814646|FG000|STARTED|Overall Study||24||
48200975|NCT02076919|100814647|FG001|STARTED|Overall Study||8||
48200976|NCT02076919|100814648|FG002|STARTED|Overall Study||36||
48200977|NCT02076919|100814649|FG003|STARTED|Overall Study||12||
48200978|NCT02076919|100814646|FG000|COMPLETED|Overall Study||24||
48200979|NCT02076919|100814647|FG001|COMPLETED|Overall Study||8||
48494391|NCT00205777|101545115|FG000|COMPLETED|Completed Core Study, Entered SE I||1047||
48494392|NCT00205777|101545116|FG001|COMPLETED|Completed Core Study, Entered SE I||1041||
48494393|NCT00205777|101545117|FG002|COMPLETED|Completed Core Study, Entered SE I||1070||
48200980|NCT02076919|100814648|FG002|COMPLETED|Overall Study||36||
48200981|NCT02076919|100814649|FG003|COMPLETED|Overall Study||12||
48200982|NCT02076919|100814646|FG000|NOT COMPLETED|Overall Study||0||
48200983|NCT02076919|100814647|FG001|NOT COMPLETED|Overall Study||0||
48200984|NCT02076919|100814648|FG002|NOT COMPLETED|Overall Study||0||
48494394|NCT00205777|101545118|FG003|COMPLETED|Completed Core Study, Entered SE I||1058||
48494395|NCT00205777|101545119|FG004|COMPLETED|Completed Core Study, Entered SE I||0||
48494396|NCT00205777|101545120|FG005|COMPLETED|Completed Core Study, Entered SE I||0||
48494397|NCT00205777|101545115|FG000|NOT COMPLETED|Completed Core Study, Entered SE I||232||
48494398|NCT00205777|101545116|FG001|NOT COMPLETED|Completed Core Study, Entered SE I||204||
48666735|NCT03391882|101970470|FG005|STARTED|Part A - Titration Phase||19||
48200985|NCT02076919|100814649|FG003|NOT COMPLETED|Overall Study||0||
48200986|NCT00377455|100814650|FG000|STARTED|Overall Study||5||
48494399|NCT00205777|101545117|FG002|NOT COMPLETED|Completed Core Study, Entered SE I||207||
48494400|NCT00205777|101545118|FG003|NOT COMPLETED|Completed Core Study, Entered SE I||224||
48494401|NCT00205777|101545119|FG004|NOT COMPLETED|Completed Core Study, Entered SE I||0||
48200987|NCT00377455|100814650|FG000|COMPLETED|Overall Study||4||
48200988|NCT00377455|100814650|FG000|NOT COMPLETED|Overall Study||1||
48200989|NCT03525119|100814651|FG000|STARTED|Overall Study||300||
48200990|NCT03525119|100814652|FG001|STARTED|Overall Study||300||
48200991|NCT03525119|100814653|FG002|STARTED|Overall Study||300||
48200992|NCT03525119|100814651|FG000|Safety Population|Overall Study||299|Received at Least 1 Vaccination with Investigational Products (IPs) i.e. HAV vaccine/placebo/TDV|
48200993|NCT03525119|100814652|FG001|Safety Population|Overall Study||300|Received at Least 1 Vaccination with Investigational Products (IPs) i.e. HAV vaccine/placebo/TDV|
48200994|NCT03525119|100814653|FG002|Safety Population|Overall Study||298|Received at Least 1 Vaccination with Investigational Products (IPs) i.e. HAV vaccine/placebo/TDV|
48494402|NCT00205777|101545120|FG005|NOT COMPLETED|Completed Core Study, Entered SE I||0||
48494403|NCT00205777|101545115|FG000|STARTED|Study Extension I||1047||
48494404|NCT00205777|101545116|FG001|STARTED|Study Extension I||0||
48494405|NCT00205777|101545117|FG002|STARTED|Study Extension I||1070||
48494406|NCT00205777|101545118|FG003|STARTED|Study Extension I||1058||
48494407|NCT00205777|101545119|FG004|STARTED|Study Extension I||1041||
48200995|NCT03525119|100814651|FG000|COMPLETED|Overall Study||260||
48200996|NCT03525119|100814652|FG001|COMPLETED|Overall Study||261||
48200997|NCT03525119|100814653|FG002|COMPLETED|Overall Study||257||
48200998|NCT03525119|100814651|FG000|NOT COMPLETED|Overall Study||40||
48200999|NCT03525119|100814652|FG001|NOT COMPLETED|Overall Study||39||
48201000|NCT03525119|100814653|FG002|NOT COMPLETED|Overall Study||43||
48494408|NCT00205777|101545120|FG005|STARTED|Study Extension I||0||
48494409|NCT00205777|101545115|FG000|COMPLETED|Study Extension I||833||
48494410|NCT00205777|101545116|FG001|COMPLETED|Study Extension I||0||
48494411|NCT00205777|101545117|FG002|COMPLETED|Study Extension I||0||
48494412|NCT00205777|101545118|FG003|COMPLETED|Study Extension I||830||
48494413|NCT00205777|101545119|FG004|COMPLETED|Study Extension I||840||
48201001|NCT00837616|100814654|FG000|STARTED|Overall Study||20||
48201002|NCT00837616|100814655|FG001|STARTED|Overall Study||21||
48201003|NCT00837616|100814654|FG000|COMPLETED|Overall Study||20||
48201004|NCT00837616|100814655|FG001|COMPLETED|Overall Study||20||
48201005|NCT00837616|100814654|FG000|NOT COMPLETED|Overall Study||0||
48494414|NCT00205777|101545120|FG005|COMPLETED|Study Extension I||0||
48201006|NCT00837616|100814655|FG001|NOT COMPLETED|Overall Study||1||
48494415|NCT00205777|101545115|FG000|NOT COMPLETED|Study Extension I||214||
48494416|NCT00205777|101545116|FG001|NOT COMPLETED|Study Extension I||0||
48494417|NCT00205777|101545117|FG002|NOT COMPLETED|Study Extension I||1070||
48494418|NCT00205777|101545118|FG003|NOT COMPLETED|Study Extension I||228||
48494419|NCT00205777|101545119|FG004|NOT COMPLETED|Study Extension I||201||
48201007|NCT01196988|100814656|FG000|STARTED|Overall Study||915||
48201008|NCT01196988|100814657|FG001|STARTED|Overall Study||912||
48494420|NCT00205777|101545120|FG005|NOT COMPLETED|Study Extension I||0||
48494421|NCT00205777|101545115|FG000|STARTED|Completed SE I, Entered Extension SE II||833||
48494422|NCT00205777|101545116|FG001|STARTED|Completed SE I, Entered Extension SE II||0||
48494423|NCT00205777|101545117|FG002|STARTED|Completed SE I, Entered Extension SE II||0||
48494424|NCT00205777|101545118|FG003|STARTED|Completed SE I, Entered Extension SE II||830||
48494425|NCT00205777|101545119|FG004|STARTED|Completed SE I, Entered Extension SE II||840||
48494426|NCT00205777|101545120|FG005|STARTED|Completed SE I, Entered Extension SE II||0||
48494427|NCT00205777|101545115|FG000|COMPLETED|Completed SE I, Entered Extension SE II||560||
48494428|NCT00205777|101545116|FG001|COMPLETED|Completed SE I, Entered Extension SE II||0||
48494429|NCT00205777|101545117|FG002|COMPLETED|Completed SE I, Entered Extension SE II||0||
48494430|NCT00205777|101545118|FG003|COMPLETED|Completed SE I, Entered Extension SE II||590||
48494431|NCT00205777|101545119|FG004|COMPLETED|Completed SE I, Entered Extension SE II||582||
48494432|NCT00205777|101545120|FG005|COMPLETED|Completed SE I, Entered Extension SE II||0||
48494433|NCT00205777|101545115|FG000|NOT COMPLETED|Completed SE I, Entered Extension SE II||273||
48494434|NCT00205777|101545116|FG001|NOT COMPLETED|Completed SE I, Entered Extension SE II||0||
48494435|NCT00205777|101545117|FG002|NOT COMPLETED|Completed SE I, Entered Extension SE II||0||
48494436|NCT00205777|101545118|FG003|NOT COMPLETED|Completed SE I, Entered Extension SE II||240||
48494437|NCT00205777|101545119|FG004|NOT COMPLETED|Completed SE I, Entered Extension SE II||258||
48494438|NCT00205777|101545120|FG005|NOT COMPLETED|Completed SE I, Entered Extension SE II||0||
48494439|NCT00205777|101545115|FG000|STARTED|Study Extension II||0||
48201009|NCT01196988|100814658|FG002|STARTED|Overall Study||911||
48201010|NCT01196988|100814659|FG003|STARTED|Overall Study||277||
48201011|NCT01196988|100814656|FG000|COMPLETED|Overall Study||891||
48201012|NCT01196988|100814657|FG001|COMPLETED|Overall Study||880||
48201013|NCT01196988|100814658|FG002|COMPLETED|Overall Study||886||
48494440|NCT00205777|101545116|FG001|STARTED|Study Extension II||0||
48494441|NCT00205777|101545117|FG002|STARTED|Study Extension II||0||
48201014|NCT01196988|100814659|FG003|COMPLETED|Overall Study||276||
48201015|NCT01196988|100814656|FG000|NOT COMPLETED|Overall Study||24||
48494442|NCT00205777|101545118|FG003|STARTED|Study Extension II||590||
48494443|NCT00205777|101545119|FG004|STARTED|Study Extension II||0||
48494444|NCT00205777|101545120|FG005|STARTED|Study Extension II||1142||
48494445|NCT00205777|101545115|FG000|TREATED|Study Extension II||0||
48201016|NCT01196988|100814657|FG001|NOT COMPLETED|Overall Study||32||
48201017|NCT01196988|100814658|FG002|NOT COMPLETED|Overall Study||25||
48201018|NCT01196988|100814659|FG003|NOT COMPLETED|Overall Study||1||
48201019|NCT01801930|100814660|FG000|STARTED|Overall Study||6||
48201020|NCT01801930|100814661|FG001|STARTED|Overall Study||6||
48201021|NCT01801930|100814662|FG002|STARTED|Overall Study||6||
48201022|NCT01801930|100814663|FG003|STARTED|Overall Study||6||
48201023|NCT01801930|100814660|FG000|COMPLETED|Overall Study||0||
48494446|NCT00205777|101545116|FG001|TREATED|Study Extension II||0||
48494447|NCT00205777|101545117|FG002|TREATED|Study Extension II||0||
48494448|NCT00205777|101545118|FG003|TREATED|Study Extension II||519||
48494449|NCT00205777|101545119|FG004|TREATED|Study Extension II||0||
48494450|NCT00205777|101545120|FG005|TREATED|Study Extension II||1011||
48494451|NCT00205777|101545115|FG000|COMPLETED|Study Extension II||0||
48494452|NCT00205777|101545116|FG001|COMPLETED|Study Extension II||0||
48494453|NCT00205777|101545117|FG002|COMPLETED|Study Extension II||0||
48201024|NCT01801930|100814661|FG001|COMPLETED|Overall Study||0||
48201025|NCT01801930|100814662|FG002|COMPLETED|Overall Study||0||
48494454|NCT00205777|101545118|FG003|COMPLETED|Study Extension II||441||
48494455|NCT00205777|101545119|FG004|COMPLETED|Study Extension II||0||
48494456|NCT00205777|101545120|FG005|COMPLETED|Study Extension II||860||
48494457|NCT00205777|101545115|FG000|NOT COMPLETED|Study Extension II||0||
48494458|NCT00205777|101545116|FG001|NOT COMPLETED|Study Extension II||0||
48494459|NCT00205777|101545117|FG002|NOT COMPLETED|Study Extension II||0||
48494460|NCT00205777|101545118|FG003|NOT COMPLETED|Study Extension II||149||
48494461|NCT00205777|101545119|FG004|NOT COMPLETED|Study Extension II||0||
48494462|NCT00205777|101545120|FG005|NOT COMPLETED|Study Extension II||282||
48494463|NCT01484912|101545121|FG000|STARTED|Overall Study||39||
48494464|NCT01484912|101545122|FG001|STARTED|Overall Study||40||
48494465|NCT01484912|101545121|FG000|COMPLETED|Overall Study||38||
48494466|NCT01484912|101545122|FG001|COMPLETED|Overall Study||39||
48494467|NCT01484912|101545121|FG000|NOT COMPLETED|Overall Study||1||
48494468|NCT01484912|101545122|FG001|NOT COMPLETED|Overall Study||1||
48494469|NCT02072096|101545123|FG000|STARTED|Overall Study||99||
48494470|NCT02072096|101545124|FG001|STARTED|Overall Study||93||
48494471|NCT02072096|101545123|FG000|Received at Least One Dose of Study Drug|Overall Study||98||
48494472|NCT02072096|101545124|FG001|Received at Least One Dose of Study Drug|Overall Study||93||
48494473|NCT02072096|101545123|FG000|COMPLETED|Overall Study||14||
48494474|NCT02072096|101545124|FG001|COMPLETED|Overall Study||15||
48494475|NCT02072096|101545123|FG000|NOT COMPLETED|Overall Study||85||
48494476|NCT02072096|101545124|FG001|NOT COMPLETED|Overall Study||78||
48494477|NCT00838136|101545125|FG000|STARTED|First Intervention||16||
48494478|NCT00838136|101545126|FG001|STARTED|First Intervention||16||
48494479|NCT00838136|101545125|FG000|COMPLETED|First Intervention||16||
48494480|NCT00838136|101545126|FG001|COMPLETED|First Intervention||16||
48494481|NCT00838136|101545125|FG000|NOT COMPLETED|First Intervention||0||
48494482|NCT00838136|101545126|FG001|NOT COMPLETED|First Intervention||0||
48494483|NCT00838136|101545125|FG000|STARTED|Second Intervention||16||
48494484|NCT00838136|101545126|FG001|STARTED|Second Intervention||16||
48494485|NCT00838136|101545125|FG000|COMPLETED|Second Intervention||16||
48494486|NCT00838136|101545126|FG001|COMPLETED|Second Intervention||15||
48494487|NCT00838136|101545125|FG000|NOT COMPLETED|Second Intervention||0||
48494488|NCT00838136|101545126|FG001|NOT COMPLETED|Second Intervention||1||
48494489|NCT02125461|101545127|FG000|STARTED|Overall Study||476|Randomized|
48494490|NCT02125461|101545128|FG001|STARTED|Overall Study||237|Randomized|
48494491|NCT02125461|101545127|FG000|Full Analysis Set (FAS)|Overall Study||476||
48494492|NCT02125461|101545128|FG001|Full Analysis Set (FAS)|Overall Study||237||
48494493|NCT02125461|101545127|FG000|Received Treatment|Overall Study||473||
48494494|NCT02125461|101545128|FG001|Received Treatment|Overall Study||236||
48494495|NCT02125461|101545127|FG000|Safety Analysis Set|Overall Study||475||
48494496|NCT02125461|101545128|FG001|Safety Analysis Set|Overall Study||234||
48201026|NCT01801930|100814663|FG003|COMPLETED|Overall Study||0||
48201027|NCT01801930|100814660|FG000|NOT COMPLETED|Overall Study||6||
48201028|NCT01801930|100814661|FG001|NOT COMPLETED|Overall Study||6||
48201029|NCT01801930|100814662|FG002|NOT COMPLETED|Overall Study||6||
48201030|NCT01801930|100814663|FG003|NOT COMPLETED|Overall Study||6||
48201031|NCT04364269|100814664|FG000|STARTED|Overall Study||9||
48201032|NCT04364269|100814665|FG001|STARTED|Overall Study||12||
48201033|NCT04364269|100814666|FG002|STARTED|Overall Study||4||
48201034|NCT04364269|100814664|FG000|COMPLETED|Overall Study||8||
48201035|NCT04364269|100814665|FG001|COMPLETED|Overall Study||11||
48201036|NCT04364269|100814666|FG002|COMPLETED|Overall Study||4||
48201037|NCT04364269|100814664|FG000|NOT COMPLETED|Overall Study||1||
48494497|NCT02125461|101545127|FG000|Completed 12 Months of Treatment|Overall Study||232||
48494498|NCT02125461|101545128|FG001|Completed 12 Months of Treatment|Overall Study||82||
48494499|NCT02125461|101545127|FG000|COMPLETED|Overall Study||178|Ongoing study at final DCO (study complete)|
48494500|NCT02125461|101545128|FG001|COMPLETED|Overall Study||68|Ongoing study at final DCO (study complete)|
48494501|NCT02125461|101545127|FG000|NOT COMPLETED|Overall Study||298||
48201038|NCT04364269|100814665|FG001|NOT COMPLETED|Overall Study||1||
48201039|NCT04364269|100814666|FG002|NOT COMPLETED|Overall Study||0||
48201040|NCT02930590|100814667|FG000|STARTED|First Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48494502|NCT02125461|101545128|FG001|NOT COMPLETED|Overall Study||169||
48494503|NCT03889639|101545129|FG000|STARTED|Overall Study||16||
48494504|NCT03889639|101545130|FG001|STARTED|Overall Study||16||
48494505|NCT03889639|101545131|FG002|STARTED|Overall Study||16||
48494506|NCT03889639|101545132|FG003|STARTED|Overall Study||16||
48494507|NCT03889639|101545133|FG004|STARTED|Overall Study||17||
48494508|NCT03889639|101545134|FG005|STARTED|Overall Study||16||
48494509|NCT03889639|101545135|FG006|STARTED|Overall Study||17||
48494510|NCT03889639|101545136|FG007|STARTED|Overall Study||16||
48494511|NCT03889639|101545129|FG000|COMPLETED|Overall Study||16||
48494512|NCT03889639|101545130|FG001|COMPLETED|Overall Study||16||
48494513|NCT03889639|101545131|FG002|COMPLETED|Overall Study||16||
48494514|NCT03889639|101545132|FG003|COMPLETED|Overall Study||16||
48494515|NCT03889639|101545133|FG004|COMPLETED|Overall Study||17||
48494516|NCT03889639|101545134|FG005|COMPLETED|Overall Study||16||
48494517|NCT03889639|101545135|FG006|COMPLETED|Overall Study||17||
48494518|NCT03889639|101545136|FG007|COMPLETED|Overall Study||15||
48494519|NCT03889639|101545129|FG000|NOT COMPLETED|Overall Study||0||
48494520|NCT03889639|101545130|FG001|NOT COMPLETED|Overall Study||0||
48494521|NCT03889639|101545131|FG002|NOT COMPLETED|Overall Study||0||
48494522|NCT03889639|101545132|FG003|NOT COMPLETED|Overall Study||0||
48494523|NCT03889639|101545133|FG004|NOT COMPLETED|Overall Study||0||
48494524|NCT03889639|101545134|FG005|NOT COMPLETED|Overall Study||0||
48494525|NCT03889639|101545135|FG006|NOT COMPLETED|Overall Study||0||
48494526|NCT03889639|101545136|FG007|NOT COMPLETED|Overall Study||1||
48494527|NCT02974621|101545137|FG000|STARTED|Overall Study||35||
48494528|NCT02974621|101545138|FG001|STARTED|Overall Study||35||
48494529|NCT02974621|101545137|FG000|COMPLETED|Overall Study||34||
48494530|NCT02974621|101545138|FG001|COMPLETED|Overall Study||25||
48494531|NCT02974621|101545137|FG000|NOT COMPLETED|Overall Study||1||
48494532|NCT02974621|101545138|FG001|NOT COMPLETED|Overall Study||10||
48494533|NCT02479763|101545139|FG000|STARTED|Overall Study||53||
48494534|NCT02479763|101545140|FG001|STARTED|Overall Study||53||
48494535|NCT02479763|101545139|FG000|COMPLETED|Overall Study||50||
48494536|NCT02479763|101545140|FG001|COMPLETED|Overall Study||50||
48494537|NCT02479763|101545139|FG000|NOT COMPLETED|Overall Study||3||
48494538|NCT02479763|101545140|FG001|NOT COMPLETED|Overall Study||3||
48494539|NCT01876992|101545141|FG000|STARTED|Overall Study||5||
48494540|NCT01876992|101545142|FG001|STARTED|Overall Study||5||
48494541|NCT01876992|101545141|FG000|COMPLETED|Overall Study||5||
48494542|NCT01876992|101545142|FG001|COMPLETED|Overall Study||5||
48494543|NCT01876992|101545141|FG000|NOT COMPLETED|Overall Study||0||
48494544|NCT01876992|101545142|FG001|NOT COMPLETED|Overall Study||0||
48494545|NCT00367133|101545143|FG000|STARTED|2 Years||330||
48494546|NCT00367133|101545144|FG001|STARTED|2 Years||256||
48494547|NCT00367133|101545145|FG002|STARTED|2 Years||254||
48494548|NCT00367133|101545143|FG000|COMPLETED|2 Years||272||
48494549|NCT00367133|101545144|FG001|COMPLETED|2 Years||220||
48494550|NCT00367133|101545145|FG002|COMPLETED|2 Years||205||
48494551|NCT00367133|101545143|FG000|NOT COMPLETED|2 Years||58||
48494552|NCT00367133|101545144|FG001|NOT COMPLETED|2 Years||36||
48494553|NCT00367133|101545145|FG002|NOT COMPLETED|2 Years||49||
48494554|NCT00367133|101545143|FG000|STARTED|3 Years||143||
48494555|NCT00367133|101545144|FG001|STARTED|3 Years||116||
48494556|NCT00367133|101545145|FG002|STARTED|3 Years||116||
48494557|NCT00367133|101545143|FG000|COMPLETED|3 Years||115||
48494558|NCT00367133|101545144|FG001|COMPLETED|3 Years||93||
48494559|NCT00367133|101545145|FG002|COMPLETED|3 Years||98||
48494560|NCT00367133|101545143|FG000|NOT COMPLETED|3 Years||28||
48494561|NCT00367133|101545144|FG001|NOT COMPLETED|3 Years||23||
48494562|NCT00367133|101545145|FG002|NOT COMPLETED|3 Years||18||
48494563|NCT05133180|101545146|FG000|STARTED|Overall Study||52||
48494564|NCT05133180|101545147|FG001|STARTED|Overall Study||52||
48494565|NCT05133180|101545146|FG000|Randomized But Not Treated|Overall Study||0||
48494566|NCT05133180|101545147|FG001|Randomized But Not Treated|Overall Study||1||
48494567|NCT05133180|101545146|FG000|Safety Population (SAF)|Overall Study||52||
48494568|NCT05133180|101545147|FG001|Safety Population (SAF)|Overall Study||51||
48494569|NCT05133180|101545146|FG000|Full Analysis Set Population (FAS)|Overall Study||52||
48494570|NCT05133180|101545147|FG001|Full Analysis Set Population (FAS)|Overall Study||51||
48494571|NCT05133180|101545146|FG000|Per Protocol Population (PP)|Overall Study||46||
48494572|NCT05133180|101545147|FG001|Per Protocol Population (PP)|Overall Study||47||
48494573|NCT05133180|101545146|FG000|Prematurely Study Discontinued|Overall Study||2||
48494574|NCT05133180|101545147|FG001|Prematurely Study Discontinued|Overall Study||3||
48494575|NCT05133180|101545146|FG000|COMPLETED|Overall Study||50|study completed|
48494576|NCT05133180|101545147|FG001|COMPLETED|Overall Study||49|study completed|
48494577|NCT05133180|101545146|FG000|NOT COMPLETED|Overall Study||2||
48494578|NCT05133180|101545147|FG001|NOT COMPLETED|Overall Study||3||
48494579|NCT01075282|101545148|FG000|STARTED|Overall Study||273||
48494580|NCT01075282|101545149|FG001|STARTED|Overall Study||272||
48494581|NCT01075282|101545150|FG002|STARTED|Overall Study||265||
48494582|NCT01075282|101545148|FG000|Received at Least One Dose of Study Drug|Overall Study||273||
48494583|NCT01075282|101545149|FG001|Received at Least One Dose of Study Drug|Overall Study||272||
48494584|NCT01075282|101545150|FG002|Received at Least One Dose of Study Drug|Overall Study||262||
48494585|NCT01075282|101545148|FG000|COMPLETED|Overall Study||242||
48494586|NCT01075282|101545149|FG001|COMPLETED|Overall Study||243||
48494587|NCT01075282|101545150|FG002|COMPLETED|Overall Study||238||
48494588|NCT01075282|101545148|FG000|NOT COMPLETED|Overall Study||31||
48494589|NCT01075282|101545149|FG001|NOT COMPLETED|Overall Study||29||
48494590|NCT01075282|101545150|FG002|NOT COMPLETED|Overall Study||27||
48494591|NCT01161420|101545151|FG000|STARTED|Inspire Therapy||126||
48494592|NCT01161420|101545151|FG000|COMPLETED|Inspire Therapy||124||
48494593|NCT01161420|101545151|FG000|NOT COMPLETED|Inspire Therapy||2||
48494594|NCT01161420|101545151|FG000|STARTED|Withdrawal Study - Maintenance||23||
48494595|NCT01161420|101545151|FG000|COMPLETED|Withdrawal Study - Maintenance||23||
48494596|NCT01161420|101545151|FG000|NOT COMPLETED|Withdrawal Study - Maintenance||0||
48494597|NCT01161420|101545151|FG000|STARTED|Withdrawal Study - Withdrawal||23||
48494598|NCT01161420|101545151|FG000|COMPLETED|Withdrawal Study - Withdrawal||23||
48494599|NCT01161420|101545151|FG000|NOT COMPLETED|Withdrawal Study - Withdrawal||0||
48494600|NCT03681470|101545152|FG000|STARTED|Overall Study||20||
48494601|NCT03681470|101545152|FG000|COMPLETED|Overall Study||12||
48494602|NCT03681470|101545152|FG000|NOT COMPLETED|Overall Study||8||
48494603|NCT00705003|101545153|FG000|STARTED|Enrolled||71||
48494604|NCT00705003|101545154|FG001|STARTED|Enrolled||37||
48494605|NCT00705003|101545155|FG002|STARTED|Enrolled||34||
48494606|NCT00705003|101545153|FG000|COMPLETED|Enrolled||67||
48494607|NCT00705003|101545154|FG001|COMPLETED|Enrolled||34||
48494608|NCT00705003|101545155|FG002|COMPLETED|Enrolled||33||
48494609|NCT00705003|101545153|FG000|NOT COMPLETED|Enrolled||4||
48494610|NCT00705003|101545154|FG001|NOT COMPLETED|Enrolled||3||
48201041|NCT02930590|100814668|FG001|STARTED|First Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48494611|NCT00705003|101545155|FG002|NOT COMPLETED|Enrolled||1||
48494612|NCT00705003|101545153|FG000|STARTED|Treated||67||
48494613|NCT00705003|101545154|FG001|STARTED|Treated||34||
48494614|NCT00705003|101545155|FG002|STARTED|Treated||33||
48494615|NCT00705003|101545153|FG000|COMPLETED|Treated||54||
48494616|NCT00705003|101545154|FG001|COMPLETED|Treated||28||
48494617|NCT00705003|101545155|FG002|COMPLETED|Treated||30||
48494618|NCT00705003|101545153|FG000|NOT COMPLETED|Treated||13||
48494619|NCT00705003|101545154|FG001|NOT COMPLETED|Treated||6||
48494620|NCT00705003|101545155|FG002|NOT COMPLETED|Treated||3||
48494621|NCT04466111|101545156|FG000|STARTED|Prior to Trial Phase||58||
48494622|NCT04466111|101545156|FG000|COMPLETED|Prior to Trial Phase||57||
48494623|NCT04466111|101545156|FG000|NOT COMPLETED|Prior to Trial Phase||1||
48494624|NCT04466111|101545156|FG000|STARTED|Trial Phase||57||
48494625|NCT04466111|101545156|FG000|COMPLETED|Trial Phase||52||
48494626|NCT04466111|101545156|FG000|NOT COMPLETED|Trial Phase||5||
48494627|NCT04466111|101545156|FG000|STARTED|Permanent Implant||52||
48494628|NCT04466111|101545156|FG000|COMPLETED|Permanent Implant||46||
48494629|NCT04466111|101545156|FG000|NOT COMPLETED|Permanent Implant||6||
48494630|NCT04466111|101545156|FG000|STARTED|3 Months||46||
48494631|NCT04466111|101545156|FG000|COMPLETED|3 Months||43||
48494632|NCT04466111|101545156|FG000|NOT COMPLETED|3 Months||3||
48494633|NCT00829309|101545157|FG000|STARTED|First Intervention||8||
48494634|NCT00829309|101545158|FG001|STARTED|First Intervention||8||
48494635|NCT00829309|101545157|FG000|COMPLETED|First Intervention||8||
48494636|NCT00829309|101545158|FG001|COMPLETED|First Intervention||8||
48494637|NCT00829309|101545157|FG000|NOT COMPLETED|First Intervention||0||
48494638|NCT00829309|101545158|FG001|NOT COMPLETED|First Intervention||0||
48494639|NCT00829309|101545157|FG000|STARTED|Washout: 7 Days||8||
48494640|NCT00829309|101545158|FG001|STARTED|Washout: 7 Days||8||
48494641|NCT00829309|101545157|FG000|COMPLETED|Washout: 7 Days||7||
48494642|NCT00829309|101545158|FG001|COMPLETED|Washout: 7 Days||8||
48494643|NCT00829309|101545157|FG000|NOT COMPLETED|Washout: 7 Days||1||
48494644|NCT00829309|101545158|FG001|NOT COMPLETED|Washout: 7 Days||0||
48494645|NCT00829309|101545157|FG000|STARTED|Second Intervention||7||
48494646|NCT00829309|101545158|FG001|STARTED|Second Intervention||8||
48494647|NCT00829309|101545157|FG000|COMPLETED|Second Intervention||7||
48494648|NCT00829309|101545158|FG001|COMPLETED|Second Intervention||8||
48494649|NCT00829309|101545157|FG000|NOT COMPLETED|Second Intervention||0||
48494650|NCT00829309|101545158|FG001|NOT COMPLETED|Second Intervention||0||
48494651|NCT02442687|101545159|FG000|STARTED|Overall Study||21||
48494652|NCT02442687|101545160|FG001|STARTED|Overall Study||22||
48494653|NCT02442687|101545161|FG002|STARTED|Overall Study||22||
48494654|NCT02442687|101545159|FG000|COMPLETED|Overall Study||13||
48494655|NCT02442687|101545160|FG001|COMPLETED|Overall Study||11||
48494656|NCT02442687|101545161|FG002|COMPLETED|Overall Study||19||
48494657|NCT02442687|101545159|FG000|NOT COMPLETED|Overall Study||8||
48494658|NCT02442687|101545160|FG001|NOT COMPLETED|Overall Study||11||
48494659|NCT02442687|101545161|FG002|NOT COMPLETED|Overall Study||3||
48494660|NCT00918645|101545162|FG000|STARTED|Overall Study||13||
48494661|NCT00918645|101545162|FG000|COMPLETED|Overall Study||12||
48494662|NCT00918645|101545162|FG000|NOT COMPLETED|Overall Study||1||
48494663|NCT02258074|101545163|FG000|STARTED|Overall Study||53||
48494664|NCT02258074|101545164|FG001|STARTED|Overall Study||50||
48494665|NCT02258074|101545165|FG002|STARTED|Overall Study||51||
48494666|NCT02258074|101545166|FG003|STARTED|Overall Study||51||
48494667|NCT02258074|101545163|FG000|COMPLETED|Overall Study||52|Completed with data available for the primary serum phosphorus analysis.|
48494668|NCT02258074|101545164|FG001|COMPLETED|Overall Study||50|Completed with data available for the primary serum phosphorus analysis.|
48494669|NCT02258074|101545165|FG002|COMPLETED|Overall Study||51|Completed with data available for the primary serum phosphorus analysis.|
48494670|NCT02258074|101545166|FG003|COMPLETED|Overall Study||51|Completed with data available for the primary serum phosphorus analysis.|
48201042|NCT02930590|100814669|FG002|STARTED|First Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48201043|NCT02930590|100814670|FG003|STARTED|First Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48201044|NCT02930590|100814671|FG004|STARTED|First Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48201045|NCT02930590|100814672|FG005|STARTED|First Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48201046|NCT02930590|100814667|FG000|COMPLETED|First Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48201047|NCT02930590|100814668|FG001|COMPLETED|First Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48201048|NCT02930590|100814669|FG002|COMPLETED|First Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48201049|NCT02930590|100814670|FG003|COMPLETED|First Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48201050|NCT02930590|100814671|FG004|COMPLETED|First Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48201051|NCT02930590|100814672|FG005|COMPLETED|First Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48201052|NCT02930590|100814667|FG000|NOT COMPLETED|First Intervention (2 Hours)||0||
48201053|NCT02930590|100814668|FG001|NOT COMPLETED|First Intervention (2 Hours)||0||
48201054|NCT02930590|100814669|FG002|NOT COMPLETED|First Intervention (2 Hours)||0||
48201055|NCT02930590|100814670|FG003|NOT COMPLETED|First Intervention (2 Hours)||0||
48201056|NCT02930590|100814671|FG004|NOT COMPLETED|First Intervention (2 Hours)||0||
48201057|NCT02930590|100814672|FG005|NOT COMPLETED|First Intervention (2 Hours)||0||
48201058|NCT02930590|100814667|FG000|STARTED|Second Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48201059|NCT02930590|100814668|FG001|STARTED|Second Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48201060|NCT02930590|100814669|FG002|STARTED|Second Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48201061|NCT02930590|100814670|FG003|STARTED|Second Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48201062|NCT02930590|100814671|FG004|STARTED|Second Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48201063|NCT02930590|100814672|FG005|STARTED|Second Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48201064|NCT02930590|100814667|FG000|COMPLETED|Second Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48201065|NCT02930590|100814668|FG001|COMPLETED|Second Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48201066|NCT02930590|100814669|FG002|COMPLETED|Second Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48201067|NCT02930590|100814670|FG003|COMPLETED|Second Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48201068|NCT02930590|100814671|FG004|COMPLETED|Second Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48201069|NCT02930590|100814672|FG005|COMPLETED|Second Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48201070|NCT02930590|100814667|FG000|NOT COMPLETED|Second Intervention (2 Hours)||0||
48201071|NCT02930590|100814668|FG001|NOT COMPLETED|Second Intervention (2 Hours)||0||
48201072|NCT02930590|100814669|FG002|NOT COMPLETED|Second Intervention (2 Hours)||0||
48201073|NCT02930590|100814670|FG003|NOT COMPLETED|Second Intervention (2 Hours)||0||
48201074|NCT02930590|100814671|FG004|NOT COMPLETED|Second Intervention (2 Hours)||0||
48201075|NCT02930590|100814672|FG005|NOT COMPLETED|Second Intervention (2 Hours)||0||
48201076|NCT02930590|100814667|FG000|STARTED|Third Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48201077|NCT02930590|100814668|FG001|STARTED|Third Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48201078|NCT02930590|100814669|FG002|STARTED|Third Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48201079|NCT02930590|100814670|FG003|STARTED|Third Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48201080|NCT02930590|100814671|FG004|STARTED|Third Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48201081|NCT02930590|100814672|FG005|STARTED|Third Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48201082|NCT02930590|100814667|FG000|COMPLETED|Third Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48201083|NCT02930590|100814668|FG001|COMPLETED|Third Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48494671|NCT02258074|101545163|FG000|NOT COMPLETED|Overall Study||1||
48494672|NCT02258074|101545164|FG001|NOT COMPLETED|Overall Study||0||
48494673|NCT02258074|101545165|FG002|NOT COMPLETED|Overall Study||0||
48494674|NCT02258074|101545166|FG003|NOT COMPLETED|Overall Study||0||
48201084|NCT02930590|100814669|FG002|COMPLETED|Third Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48201085|NCT02930590|100814670|FG003|COMPLETED|Third Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48201086|NCT02930590|100814671|FG004|COMPLETED|Third Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48201087|NCT02930590|100814672|FG005|COMPLETED|Third Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
48201088|NCT02930590|100814667|FG000|NOT COMPLETED|Third Intervention (2 Hours)||0||
48201089|NCT02930590|100814668|FG001|NOT COMPLETED|Third Intervention (2 Hours)||0||
48201090|NCT02930590|100814669|FG002|NOT COMPLETED|Third Intervention (2 Hours)||0||
48201091|NCT02930590|100814670|FG003|NOT COMPLETED|Third Intervention (2 Hours)||0||
48201092|NCT02930590|100814671|FG004|NOT COMPLETED|Third Intervention (2 Hours)||0||
48201093|NCT02930590|100814672|FG005|NOT COMPLETED|Third Intervention (2 Hours)||0||
48201094|NCT01080131|100814673|FG000|STARTED|Core Study (0- 12 Weeks)||112||
48201095|NCT01080131|100814674|FG001|STARTED|Core Study (0- 12 Weeks)||114||
48201096|NCT01080131|100814673|FG000|COMPLETED|Core Study (0- 12 Weeks)||99||
48201097|NCT01080131|100814674|FG001|COMPLETED|Core Study (0- 12 Weeks)||103||
48201098|NCT01080131|100814673|FG000|NOT COMPLETED|Core Study (0- 12 Weeks)||13||
48201099|NCT01080131|100814674|FG001|NOT COMPLETED|Core Study (0- 12 Weeks)||11||
48201100|NCT01080131|100814673|FG000|STARTED|Extension Study 1 (12 -24 Weeks)||84||
48201101|NCT01080131|100814674|FG001|STARTED|Extension Study 1 (12 -24 Weeks)||76||
48201102|NCT01080131|100814673|FG000|COMPLETED|Extension Study 1 (12 -24 Weeks)||78||
48201103|NCT01080131|100814674|FG001|COMPLETED|Extension Study 1 (12 -24 Weeks)||72||
48201104|NCT01080131|100814673|FG000|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||6||
48201105|NCT01080131|100814674|FG001|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||4||
48201106|NCT01080131|100814673|FG000|STARTED|Extension Study 2 (25-72 Weeks)||72||
48201107|NCT01080131|100814674|FG001|STARTED|Extension Study 2 (25-72 Weeks)||65||
48201108|NCT01080131|100814673|FG000|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)||62||
48201109|NCT01080131|100814674|FG001|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)||41||
48201110|NCT01080131|100814673|FG000|COMPLETED|Extension Study 2 (25-72 Weeks)||64||
48201111|NCT01080131|100814674|FG001|COMPLETED|Extension Study 2 (25-72 Weeks)||54||
48201112|NCT01080131|100814673|FG000|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||8||
48201113|NCT01080131|100814674|FG001|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||11||
48201114|NCT00395018|100814675|FG000|STARTED|On-Treatment||65||
48201115|NCT00395018|100814675|FG000|DISCONTINUED PRIOR TO WEEK 72 VISIT|On-Treatment||10||
48201116|NCT00395018|100814675|FG000|DISCONTINUED AT OR AFTER WEEK 72 VISIT|On-Treatment||0||
48201117|NCT00395018|100814675|FG000|COMPLETED|On-Treatment||55||
48201118|NCT00395018|100814675|FG000|NOT COMPLETED|On-Treatment||10||
48201119|NCT00395018|100814675|FG000|STARTED|Off-Treatment Follow-up||5||
48201120|NCT00395018|100814675|FG000|COMPLETED|Off-Treatment Follow-up||1||
48201121|NCT00395018|100814675|FG000|NOT COMPLETED|Off-Treatment Follow-up||4||
48201122|NCT02504619|100814676|FG000|STARTED|Overall Study||1||
48201123|NCT02504619|100814676|FG000|COMPLETED|Overall Study||1||
48201124|NCT02504619|100814676|FG000|NOT COMPLETED|Overall Study||0||
48201125|NCT01185522|100814677|FG000|STARTED|Overall Study||693||
48201126|NCT01185522|100814677|FG000|COMPLETED|Overall Study||585||
48201127|NCT01185522|100814677|FG000|NOT COMPLETED|Overall Study||108||
48201128|NCT03987451|100814678|FG000|STARTED|Overall Study||47||
48201129|NCT03987451|100814679|FG001|STARTED|Overall Study||24||
48201130|NCT03987451|100814678|FG000|COMPLETED|Overall Study||45||
48201131|NCT03987451|100814679|FG001|COMPLETED|Overall Study||23||
48201132|NCT03987451|100814678|FG000|NOT COMPLETED|Overall Study||2||
48201133|NCT03987451|100814679|FG001|NOT COMPLETED|Overall Study||1||
48201134|NCT03545984|100814680|FG000|STARTED|Overall Study||24||
48201135|NCT03545984|100814681|FG001|STARTED|Overall Study||24||
48201136|NCT03545984|100814680|FG000|COMPLETED|Overall Study||13||
48201137|NCT03545984|100814681|FG001|COMPLETED|Overall Study||15||
48201138|NCT03545984|100814680|FG000|NOT COMPLETED|Overall Study||11||
48201139|NCT03545984|100814681|FG001|NOT COMPLETED|Overall Study||9||
48201140|NCT00408928|100814682|FG000|STARTED|Overall Study||11||
48201141|NCT00408928|100814682|FG000|COMPLETED|Overall Study||8||
48201142|NCT00408928|100814682|FG000|NOT COMPLETED|Overall Study||3||
48201143|NCT01253226|100814683|FG000|STARTED|Overall Study||6||
48201144|NCT01253226|100814684|FG001|STARTED|Overall Study||6||
48201145|NCT01253226|100814685|FG002|STARTED|Overall Study||6||
48201146|NCT01253226|100814686|FG003|STARTED|Overall Study||6||
48201147|NCT01253226|100814687|FG004|STARTED|Overall Study||8||
48201148|NCT01253226|100814683|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
48201149|NCT01253226|100814684|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
48201150|NCT01253226|100814685|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
48201151|NCT01253226|100814686|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6||
48201152|NCT01253226|100814687|FG004|Received at Least 1 Dose of Study Drug|Overall Study||8||
48201153|NCT01253226|100814683|FG000|COMPLETED|Overall Study||6||
48201154|NCT01253226|100814684|FG001|COMPLETED|Overall Study||5||
48201155|NCT01253226|100814685|FG002|COMPLETED|Overall Study||5||
48201156|NCT01253226|100814686|FG003|COMPLETED|Overall Study||5||
48201157|NCT01253226|100814687|FG004|COMPLETED|Overall Study||6||
48201158|NCT01253226|100814683|FG000|NOT COMPLETED|Overall Study||0||
48201159|NCT01253226|100814684|FG001|NOT COMPLETED|Overall Study||1||
48201160|NCT01253226|100814685|FG002|NOT COMPLETED|Overall Study||1||
48201161|NCT01253226|100814686|FG003|NOT COMPLETED|Overall Study||1||
48201162|NCT01253226|100814687|FG004|NOT COMPLETED|Overall Study||2||
48201163|NCT02954848|100814688|FG000|STARTED|Overall Study||245||
48201164|NCT02954848|100814689|FG001|STARTED|Overall Study||239||
48201165|NCT02954848|100814688|FG000|Treated|Overall Study||245||
48201166|NCT02954848|100814689|FG001|Treated|Overall Study||238||
48201167|NCT02954848|100814688|FG000|COMPLETED|Overall Study||243||
48201168|NCT02954848|100814689|FG001|COMPLETED|Overall Study||234||
48201169|NCT02954848|100814688|FG000|NOT COMPLETED|Overall Study||2||
48201170|NCT02954848|100814689|FG001|NOT COMPLETED|Overall Study||5||
48201171|NCT01460342|100814690|FG000|STARTED|Overall Study||304||
48201172|NCT01460342|100814691|FG001|STARTED|Overall Study||306||
48494675|NCT02653664|101545167|FG000|STARTED|Post-Treatment||110|Fifteen of the 343 enrolled subjects withdrew or were withdrawn from the trial prior to randomization. As a result, 328 of the 343 enrolled subjects were randomized. All randomized subjects were listed as 'started' for all time periods following randomization given we conducted an Intention-to-Treat (ITT) analysis.|
48494676|NCT02653664|101545168|FG001|STARTED|Post-Treatment||110|Fifteen of the 343 enrolled subjects withdrew or were withdrawn from the trial prior to randomization. As a result, 328 of the 343 enrolled subjects were randomized. All randomized subjects were listed as 'started' for all time periods following randomization given we conducted an Intention-to-Treat (ITT) analysis.|
48494677|NCT02653664|101545169|FG002|STARTED|Post-Treatment||108|Fifteen of the 343 enrolled subjects withdrew or were withdrawn from the trial prior to randomization. As a result, 328 of the 343 enrolled subjects were randomized. All randomized subjects were listed as 'started' for all time periods following randomization given we conducted an Intention-to-Treat (ITT) analysis.|
48494678|NCT02653664|101545167|FG000|Primary and Secondary Data|Post-Treatment||93||
48201173|NCT01460342|100814690|FG000|Received at Least 1 Dose of Study Drug|Overall Study||304||
48201174|NCT01460342|100814691|FG001|Received at Least 1 Dose of Study Drug|Overall Study||306||
48494679|NCT02653664|101545168|FG001|Primary and Secondary Data|Post-Treatment||104||
48494680|NCT02653664|101545169|FG002|Primary and Secondary Data|Post-Treatment||91||
48494681|NCT02653664|101545167|FG000|Primary Outcome Data Only|Post-Treatment||3||
48494682|NCT02653664|101545168|FG001|Primary Outcome Data Only|Post-Treatment||0||
48494683|NCT02653664|101545169|FG002|Primary Outcome Data Only|Post-Treatment||3||
48494684|NCT02653664|101545167|FG000|COMPLETED|Post-Treatment||96|Number of subjects who provided average pain intensity data during this assessment period.|
48494685|NCT02653664|101545168|FG001|COMPLETED|Post-Treatment||104|Number of subjects who provided average pain intensity data during this assessment period.|
48494686|NCT02653664|101545169|FG002|COMPLETED|Post-Treatment||94|Number of subjects who provided average pain intensity data during this assessment period.|
48494687|NCT02653664|101545167|FG000|NOT COMPLETED|Post-Treatment||14||
48494688|NCT02653664|101545168|FG001|NOT COMPLETED|Post-Treatment||6||
48494689|NCT02653664|101545169|FG002|NOT COMPLETED|Post-Treatment||14||
48494690|NCT02653664|101545167|FG000|STARTED|3 Month Follow-Up||110|All randomized subjects were listed as 'started' for all time periods following randomization given we conducted an Intention-to-Treat (ITT) analysis.|
48494691|NCT02653664|101545168|FG001|STARTED|3 Month Follow-Up||110|All randomized subjects were listed as 'started' for all time periods following randomization given we conducted an Intention-to-Treat (ITT) analysis.|
48494692|NCT02653664|101545169|FG002|STARTED|3 Month Follow-Up||108|All randomized subjects were listed as 'started' for all time periods following randomization given we conducted an Intention-to-Treat (ITT) analysis.|
48494693|NCT02653664|101545167|FG000|Primary and Secondary Data|3 Month Follow-Up||83||
48494694|NCT02653664|101545168|FG001|Primary and Secondary Data|3 Month Follow-Up||95||
48494695|NCT02653664|101545169|FG002|Primary and Secondary Data|3 Month Follow-Up||82||
48494696|NCT02653664|101545167|FG000|Primary Outcome Data Only|3 Month Follow-Up||6||
48494697|NCT02653664|101545168|FG001|Primary Outcome Data Only|3 Month Follow-Up||0||
48494698|NCT02653664|101545169|FG002|Primary Outcome Data Only|3 Month Follow-Up||1||
48494699|NCT02653664|101545167|FG000|COMPLETED|3 Month Follow-Up||89|Number of subjects who provided average pain intensity data during this assessment period.|
48494700|NCT02653664|101545168|FG001|COMPLETED|3 Month Follow-Up||95|Number of subjects who provided average pain intensity data during this assessment period.|
48494701|NCT02653664|101545169|FG002|COMPLETED|3 Month Follow-Up||83|Number of subjects who provided average pain intensity data during this assessment period.|
48494702|NCT02653664|101545167|FG000|NOT COMPLETED|3 Month Follow-Up||21||
48201175|NCT01460342|100814690|FG000|COMPLETED|Overall Study||293||
48201176|NCT01460342|100814691|FG001|COMPLETED|Overall Study||292||
48201177|NCT01460342|100814690|FG000|NOT COMPLETED|Overall Study||11||
48201178|NCT01460342|100814691|FG001|NOT COMPLETED|Overall Study||14||
48201179|NCT00337818|100814692|FG000|STARTED|Overall Study||458||
48201180|NCT00337818|100814693|FG001|STARTED|Overall Study||154||
48201181|NCT00337818|100814694|FG002|STARTED|Overall Study||158||
48494703|NCT02653664|101545168|FG001|NOT COMPLETED|3 Month Follow-Up||15||
48494704|NCT02653664|101545169|FG002|NOT COMPLETED|3 Month Follow-Up||25||
48494705|NCT02653664|101545167|FG000|STARTED|6 Month Follow-Up||110|All randomized subjects were listed as 'started' for all time periods following randomization given we conducted an Intention-to-Treat (ITT) analysis.|
48494706|NCT02653664|101545168|FG001|STARTED|6 Month Follow-Up||110|All randomized subjects were listed as 'started' for all time periods following randomization given we conducted an Intention-to-Treat (ITT) analysis.|
48494707|NCT02653664|101545169|FG002|STARTED|6 Month Follow-Up||108|All randomized subjects were listed as 'started' for all time periods following randomization given we conducted an Intention-to-Treat (ITT) analysis.|
48494708|NCT02653664|101545167|FG000|Primary and Secondary Outcome Data|6 Month Follow-Up||85||
48494709|NCT02653664|101545168|FG001|Primary and Secondary Outcome Data|6 Month Follow-Up||87||
48494710|NCT02653664|101545169|FG002|Primary and Secondary Outcome Data|6 Month Follow-Up||83||
48494711|NCT02653664|101545167|FG000|Primary Outcome Data Only|6 Month Follow-Up||2||
48494712|NCT02653664|101545168|FG001|Primary Outcome Data Only|6 Month Follow-Up||2||
48494713|NCT02653664|101545169|FG002|Primary Outcome Data Only|6 Month Follow-Up||2||
48494714|NCT02653664|101545167|FG000|COMPLETED|6 Month Follow-Up||87|Number of subjects who provided average pain intensity data during this assessment period.|
48494715|NCT02653664|101545168|FG001|COMPLETED|6 Month Follow-Up||89|Number of subjects who provided average pain intensity data during this assessment period.|
48494716|NCT02653664|101545169|FG002|COMPLETED|6 Month Follow-Up||85|Number of subjects who provided average pain intensity data during this assessment period.|
48494717|NCT02653664|101545167|FG000|NOT COMPLETED|6 Month Follow-Up||23||
48494718|NCT02653664|101545168|FG001|NOT COMPLETED|6 Month Follow-Up||21||
48494719|NCT02653664|101545169|FG002|NOT COMPLETED|6 Month Follow-Up||23||
48494720|NCT03169062|101545170|FG000|STARTED|Overall Study||10||
48494721|NCT03169062|101545170|FG000|COMPLETED|Overall Study||10||
48494722|NCT03169062|101545170|FG000|NOT COMPLETED|Overall Study||0||
48494723|NCT01634139|101545171|FG000|STARTED|Overall Study||132||
48494724|NCT01634139|101545172|FG001|STARTED|Overall Study||136||
48494725|NCT01634139|101545173|FG002|STARTED|Overall Study||135||
48494726|NCT01634139|101545171|FG000|COMPLETED|Overall Study||122||
48494727|NCT01634139|101545172|FG001|COMPLETED|Overall Study||130||
48494728|NCT01634139|101545173|FG002|COMPLETED|Overall Study||130||
48494729|NCT01634139|101545171|FG000|NOT COMPLETED|Overall Study||10||
48494730|NCT01634139|101545172|FG001|NOT COMPLETED|Overall Study||6||
48494731|NCT01634139|101545173|FG002|NOT COMPLETED|Overall Study||5||
48201182|NCT00337818|100814692|FG000|COMPLETED|Overall Study||169||
48494732|NCT04188392|101545174|FG000|STARTED|Overall Study||6||
48494733|NCT04188392|101545174|FG000|Sleep Studies 1 and 2|Overall Study||6||
48494734|NCT04188392|101545174|FG000|Mid-point Visit (Treatment Week-3)|Overall Study||6||
48494735|NCT04188392|101545174|FG000|Sleep Study 3|Overall Study||5||
48494736|NCT04188392|101545174|FG000|COMPLETED|Overall Study||6||
48494737|NCT04188392|101545174|FG000|NOT COMPLETED|Overall Study||0||
48494738|NCT02535923|101545175|FG000|STARTED|Overall Study||26||
48494739|NCT02535923|101545176|FG001|STARTED|Overall Study||21||
48494740|NCT02535923|101545175|FG000|Completed Post Assessment|Overall Study||22||
48494741|NCT02535923|101545176|FG001|Completed Post Assessment|Overall Study||17||
48494742|NCT02535923|101545175|FG000|Completed Follow Up Assessment|Overall Study||17||
48494743|NCT02535923|101545176|FG001|Completed Follow Up Assessment|Overall Study||13||
48494744|NCT02535923|101545175|FG000|COMPLETED|Overall Study||17||
48494745|NCT02535923|101545176|FG001|COMPLETED|Overall Study||13||
48494746|NCT02535923|101545175|FG000|NOT COMPLETED|Overall Study||9||
48494747|NCT02535923|101545176|FG001|NOT COMPLETED|Overall Study||8||
48494748|NCT01167829|101545177|FG000|STARTED|Overall Study||12||
48494749|NCT01167829|101545177|FG000|COMPLETED|Overall Study||12||
48494750|NCT01167829|101545177|FG000|NOT COMPLETED|Overall Study||0||
48494751|NCT03552484|101545178|FG000|STARTED|Overall Study||20||
48494752|NCT03552484|101545179|FG001|STARTED|Overall Study||36||
48494753|NCT03552484|101545178|FG000|COMPLETED|Overall Study||14||
48494754|NCT03552484|101545179|FG001|COMPLETED|Overall Study||16||
48494755|NCT03552484|101545178|FG000|NOT COMPLETED|Overall Study||6||
48494756|NCT03552484|101545179|FG001|NOT COMPLETED|Overall Study||20||
48494757|NCT03123094|101545180|FG000|STARTED|Overall Study||6||
48494758|NCT03123094|101545181|FG001|STARTED|Overall Study||6||
48494759|NCT03123094|101545182|FG002|STARTED|Overall Study||6||
48494760|NCT03123094|101545183|FG003|STARTED|Overall Study||6||
48494761|NCT03123094|101545184|FG004|STARTED|Overall Study||8||
48494762|NCT03123094|101545180|FG000|COMPLETED|Overall Study||6||
48494763|NCT03123094|101545181|FG001|COMPLETED|Overall Study||4||
48494764|NCT03123094|101545182|FG002|COMPLETED|Overall Study||5||
48494765|NCT03123094|101545183|FG003|COMPLETED|Overall Study||6||
48494766|NCT03123094|101545184|FG004|COMPLETED|Overall Study||7||
48494767|NCT03123094|101545180|FG000|NOT COMPLETED|Overall Study||0||
48494768|NCT03123094|101545181|FG001|NOT COMPLETED|Overall Study||2||
48494769|NCT03123094|101545182|FG002|NOT COMPLETED|Overall Study||1||
48494770|NCT03123094|101545183|FG003|NOT COMPLETED|Overall Study||0||
48494771|NCT03123094|101545184|FG004|NOT COMPLETED|Overall Study||1||
48494772|NCT00585286|101545185|FG000|STARTED|Overall Study||15||
48494773|NCT00585286|101545185|FG000|COMPLETED|Overall Study||14||
48494774|NCT00585286|101545185|FG000|NOT COMPLETED|Overall Study||1||
48494775|NCT03446768|101545186|FG000|STARTED|Overall Study||141||
48494776|NCT03446768|101545187|FG001|STARTED|Overall Study||153||
48494777|NCT03446768|101545186|FG000|COMPLETED|Overall Study||141||
48494778|NCT03446768|101545187|FG001|COMPLETED|Overall Study||152||
48494779|NCT03446768|101545186|FG000|NOT COMPLETED|Overall Study||0||
48494780|NCT03446768|101545187|FG001|NOT COMPLETED|Overall Study||1||
48494781|NCT02464657|101545188|FG000|STARTED|Overall Study||3||
48494782|NCT02464657|101545189|FG001|STARTED|Overall Study||2||
48494783|NCT02464657|101545190|FG002|STARTED|Overall Study||39||
48494784|NCT02464657|101545188|FG000|COMPLETED|Overall Study||3||
48494785|NCT02464657|101545189|FG001|COMPLETED|Overall Study||2||
48494786|NCT02464657|101545190|FG002|COMPLETED|Overall Study||39||
48494787|NCT02464657|101545188|FG000|NOT COMPLETED|Overall Study||0||
48494788|NCT02464657|101545189|FG001|NOT COMPLETED|Overall Study||0||
48494789|NCT02464657|101545190|FG002|NOT COMPLETED|Overall Study||0||
48494790|NCT03591458|101545191|FG000|STARTED|Overall Study||1||
48494791|NCT03591458|101545192|FG001|STARTED|Overall Study||1||
48494792|NCT03591458|101545191|FG000|COMPLETED|Overall Study||1||
48494793|NCT03591458|101545192|FG001|COMPLETED|Overall Study||1||
48494794|NCT03591458|101545191|FG000|NOT COMPLETED|Overall Study||0||
48494795|NCT03591458|101545192|FG001|NOT COMPLETED|Overall Study||0||
48666736|NCT03391882|101970465|FG000|Safety Population Part A|Part A - Titration Phase||20||
48494796|NCT04345653|101545193|FG000|STARTED|Overall Study||48||
48494797|NCT04345653|101545193|FG000|COMPLETED|Overall Study||46||
48494798|NCT04345653|101545193|FG000|NOT COMPLETED|Overall Study||2||
48494799|NCT00373256|101545194|FG000|STARTED|Overall Study||241||
48494800|NCT00373256|101545195|FG001|STARTED|Overall Study||247||
48494801|NCT00373256|101545194|FG000|Treated|Overall Study||235||
48494802|NCT00373256|101545195|FG001|Treated|Overall Study||236||
48494803|NCT00373256|101545194|FG000|COMPLETED|Overall Study||0||
48494804|NCT00373256|101545195|FG001|COMPLETED|Overall Study||0||
48494805|NCT00373256|101545194|FG000|NOT COMPLETED|Overall Study||241||
48494806|NCT00373256|101545195|FG001|NOT COMPLETED|Overall Study||247||
48494807|NCT03658954|101545196|FG000|STARTED|Overall Study||30||
48494808|NCT03658954|101545197|FG001|STARTED|Overall Study||30||
48494809|NCT03658954|101545198|FG002|STARTED|Overall Study||60||
48494810|NCT03658954|101545196|FG000|Completed 2 Week Treatment|Overall Study||28||
48494811|NCT03658954|101545197|FG001|Completed 2 Week Treatment|Overall Study||30||
48494812|NCT03658954|101545198|FG002|Completed 2 Week Treatment|Overall Study||60||
48494813|NCT03658954|101545196|FG000|Completed 12 Week Follow-up|Overall Study||27||
48494814|NCT03658954|101545197|FG001|Completed 12 Week Follow-up|Overall Study||30||
48494815|NCT03658954|101545198|FG002|Completed 12 Week Follow-up|Overall Study||57||
48494816|NCT03658954|101545196|FG000|COMPLETED|Overall Study||28||
48494817|NCT03658954|101545197|FG001|COMPLETED|Overall Study||30||
48494818|NCT03658954|101545198|FG002|COMPLETED|Overall Study||60||
48494819|NCT03658954|101545196|FG000|NOT COMPLETED|Overall Study||2||
48494820|NCT03658954|101545197|FG001|NOT COMPLETED|Overall Study||0||
48494821|NCT03658954|101545198|FG002|NOT COMPLETED|Overall Study||0||
48494822|NCT00573313|101545199|FG000|STARTED|Overall Study||18||
48494823|NCT00573313|101545200|FG001|STARTED|Overall Study||28||
48494824|NCT00573313|101545201|FG002|STARTED|Overall Study||19||
48494825|NCT00573313|101545202|FG003|STARTED|Overall Study||26||
48494826|NCT00573313|101545199|FG000|COMPLETED|Overall Study||13||
48494827|NCT00573313|101545200|FG001|COMPLETED|Overall Study||28||
48201183|NCT00337818|100814693|FG001|COMPLETED|Overall Study||63||
48201184|NCT00337818|100814694|FG002|COMPLETED|Overall Study||51||
48201185|NCT00337818|100814692|FG000|NOT COMPLETED|Overall Study||289||
48201186|NCT00337818|100814693|FG001|NOT COMPLETED|Overall Study||91||
48201187|NCT00337818|100814694|FG002|NOT COMPLETED|Overall Study||107||
48201188|NCT01751724|100814695|FG000|STARTED|Overall Study||42||
48201189|NCT01751724|100814696|FG001|STARTED|Overall Study||44||
48201190|NCT01751724|100814695|FG000|COMPLETED|Overall Study||41||
48494828|NCT00573313|101545201|FG002|COMPLETED|Overall Study||13||
48494829|NCT00573313|101545202|FG003|COMPLETED|Overall Study||26||
48494830|NCT00573313|101545199|FG000|NOT COMPLETED|Overall Study||5||
48494831|NCT00573313|101545200|FG001|NOT COMPLETED|Overall Study||0||
48494832|NCT00573313|101545201|FG002|NOT COMPLETED|Overall Study||6||
48494833|NCT00573313|101545202|FG003|NOT COMPLETED|Overall Study||0||
48494834|NCT01108445|101545203|FG000|STARTED|Overall Study||57||
48494835|NCT01108445|101545204|FG001|STARTED|Overall Study||51||
48494836|NCT01108445|101545203|FG000|COMPLETED|Overall Study||1||
48494837|NCT01108445|101545204|FG001|COMPLETED|Overall Study||2||
48494838|NCT01108445|101545203|FG000|NOT COMPLETED|Overall Study||56||
48494839|NCT01108445|101545204|FG001|NOT COMPLETED|Overall Study||49||
48494840|NCT01730846|101545205|FG000|STARTED|Overall Study||11||
48494841|NCT01730846|101545206|FG001|STARTED|Overall Study||11||
48494842|NCT01730846|101545207|FG002|STARTED|Overall Study||13||
48494843|NCT01730846|101545205|FG000|COMPLETED|Overall Study||11||
48494844|NCT01730846|101545206|FG001|COMPLETED|Overall Study||11||
48494845|NCT01730846|101545207|FG002|COMPLETED|Overall Study||13||
48494846|NCT01730846|101545205|FG000|NOT COMPLETED|Overall Study||0||
48494847|NCT01730846|101545206|FG001|NOT COMPLETED|Overall Study||0||
48494848|NCT01730846|101545207|FG002|NOT COMPLETED|Overall Study||0||
48494849|NCT03214588|101545208|FG000|STARTED|Overall Study||27||
48494850|NCT03214588|101545209|FG001|STARTED|Overall Study||14||
48494851|NCT03214588|101545210|FG002|STARTED|Overall Study||26||
48494852|NCT03214588|101545208|FG000|COMPLETED|Overall Study||26||
48494853|NCT03214588|101545209|FG001|COMPLETED|Overall Study||13||
48494854|NCT03214588|101545210|FG002|COMPLETED|Overall Study||24||
48494855|NCT03214588|101545208|FG000|NOT COMPLETED|Overall Study||1||
48494856|NCT03214588|101545209|FG001|NOT COMPLETED|Overall Study||1||
48494857|NCT03214588|101545210|FG002|NOT COMPLETED|Overall Study||2||
48494858|NCT02342535|101545211|FG000|STARTED|Overall Study||68||
48494859|NCT02342535|101545211|FG000|COMPLETED|Overall Study||68||
48494860|NCT02342535|101545211|FG000|NOT COMPLETED|Overall Study||0||
48494861|NCT04474405|101545212|FG000|STARTED|Overall Study||4||
48494862|NCT04474405|101545213|FG001|STARTED|Overall Study||3||
48494863|NCT04474405|101545214|FG002|STARTED|Overall Study||5||
48494864|NCT04474405|101545215|FG003|STARTED|Overall Study||4||
48494865|NCT04474405|101545216|FG004|STARTED|Overall Study||13||
48494866|NCT04474405|101545217|FG005|STARTED|Overall Study||7||
48494867|NCT04474405|101545212|FG000|Flortaucipir PET Scan|Overall Study||4||
48494868|NCT04474405|101545213|FG001|Flortaucipir PET Scan|Overall Study||3||
48494869|NCT04474405|101545214|FG002|Flortaucipir PET Scan|Overall Study||4||
48494870|NCT04474405|101545215|FG003|Flortaucipir PET Scan|Overall Study||4||
48494871|NCT04474405|101545216|FG004|Flortaucipir PET Scan|Overall Study||9||
48494872|NCT04474405|101545217|FG005|Flortaucipir PET Scan|Overall Study||0||
48494873|NCT04474405|101545212|FG000|Florbetapir PET Scan|Overall Study||4||
48494874|NCT04474405|101545213|FG001|Florbetapir PET Scan|Overall Study||3||
48494875|NCT04474405|101545214|FG002|Florbetapir PET Scan|Overall Study||0||
48494876|NCT04474405|101545215|FG003|Florbetapir PET Scan|Overall Study||4||
48494877|NCT04474405|101545216|FG004|Florbetapir PET Scan|Overall Study||0||
48494878|NCT04474405|101545217|FG005|Florbetapir PET Scan|Overall Study||4||
48494879|NCT04474405|101545212|FG000|COMPLETED|Overall Study||4||
48494880|NCT04474405|101545213|FG001|COMPLETED|Overall Study||3||
48494881|NCT04474405|101545214|FG002|COMPLETED|Overall Study||4||
48494882|NCT04474405|101545215|FG003|COMPLETED|Overall Study||4||
48494883|NCT04474405|101545216|FG004|COMPLETED|Overall Study||9||
48494884|NCT04474405|101545217|FG005|COMPLETED|Overall Study||7||
48494885|NCT04474405|101545212|FG000|NOT COMPLETED|Overall Study||0||
48494886|NCT04474405|101545213|FG001|NOT COMPLETED|Overall Study||0||
48494887|NCT04474405|101545214|FG002|NOT COMPLETED|Overall Study||1||
48494888|NCT04474405|101545215|FG003|NOT COMPLETED|Overall Study||0||
48494889|NCT04474405|101545216|FG004|NOT COMPLETED|Overall Study||4||
48494890|NCT04474405|101545217|FG005|NOT COMPLETED|Overall Study||0||
48494891|NCT02047305|101545218|FG000|STARTED|Overall Study||96||
48494892|NCT02047305|101545218|FG000|COMPLETED|Overall Study||96||
48494893|NCT02047305|101545218|FG000|NOT COMPLETED|Overall Study||0||
48494894|NCT03259139|101545219|FG000|STARTED|Overall Study||42||
48494895|NCT03259139|101545220|FG001|STARTED|Overall Study||42||
48494896|NCT03259139|101545221|FG002|STARTED|Overall Study||42||
48494897|NCT03259139|101545222|FG003|STARTED|Overall Study||42||
48494898|NCT03259139|101545223|FG004|STARTED|Overall Study||41||
48494899|NCT03259139|101545224|FG005|STARTED|Overall Study||41||
48494900|NCT03259139|101545219|FG000|Eligible|Overall Study||41||
48494901|NCT03259139|101545220|FG001|Eligible|Overall Study||41||
48494902|NCT03259139|101545221|FG002|Eligible|Overall Study||41||
48494903|NCT03259139|101545222|FG003|Eligible|Overall Study||41||
48494904|NCT03259139|101545223|FG004|Eligible|Overall Study||41||
48494905|NCT03259139|101545224|FG005|Eligible|Overall Study||41||
48494906|NCT03259139|101545219|FG000|Outlier Elimination|Overall Study||41||
48494907|NCT03259139|101545220|FG001|Outlier Elimination|Overall Study||41||
48494908|NCT03259139|101545221|FG002|Outlier Elimination|Overall Study||41||
48494909|NCT03259139|101545222|FG003|Outlier Elimination|Overall Study||41||
48494910|NCT03259139|101545223|FG004|Outlier Elimination|Overall Study||39||
48494911|NCT03259139|101545224|FG005|Outlier Elimination|Overall Study||39||
48494912|NCT03259139|101545219|FG000|Found Handgun|Overall Study||38||
48494913|NCT03259139|101545220|FG001|Found Handgun|Overall Study||38||
48494914|NCT03259139|101545221|FG002|Found Handgun|Overall Study||37||
48494915|NCT03259139|101545222|FG003|Found Handgun|Overall Study||37||
48494916|NCT03259139|101545223|FG004|Found Handgun|Overall Study||35||
48494917|NCT03259139|101545224|FG005|Found Handgun|Overall Study||35||
48494918|NCT03259139|101545219|FG000|COMPLETED|Overall Study||38||
48494919|NCT03259139|101545220|FG001|COMPLETED|Overall Study||38||
48494920|NCT03259139|101545221|FG002|COMPLETED|Overall Study||37||
48494921|NCT03259139|101545222|FG003|COMPLETED|Overall Study||37||
48494922|NCT03259139|101545223|FG004|COMPLETED|Overall Study||35||
48494923|NCT03259139|101545224|FG005|COMPLETED|Overall Study||35||
48494924|NCT03259139|101545219|FG000|NOT COMPLETED|Overall Study||4||
48494925|NCT03259139|101545220|FG001|NOT COMPLETED|Overall Study||4||
48494926|NCT03259139|101545221|FG002|NOT COMPLETED|Overall Study||5||
48494927|NCT03259139|101545222|FG003|NOT COMPLETED|Overall Study||5||
48494928|NCT03259139|101545223|FG004|NOT COMPLETED|Overall Study||6||
48494929|NCT03259139|101545224|FG005|NOT COMPLETED|Overall Study||6||
48494930|NCT02441686|101545225|FG000|STARTED|Induction||46||
48494931|NCT02441686|101545225|FG000|Safety|Induction||42||
48494932|NCT02441686|101545225|FG000|Progression-free Survival Evaluable|Induction||41||
48494933|NCT02441686|101545225|FG000|Evaluable for Induction Response|Induction||40||
48494934|NCT02441686|101545225|FG000|Received Autologous Stem Cell Transplant (ASCT)|Induction||15||
48494935|NCT02441686|101545225|FG000|COMPLETED|Induction||38||
48494936|NCT02441686|101545225|FG000|NOT COMPLETED|Induction||8||
48494937|NCT02441686|101545225|FG000|STARTED|Maintenance||38||
48494938|NCT02441686|101545225|FG000|Safety|Maintenance||35||
48494939|NCT02441686|101545225|FG000|COMPLETED|Maintenance||0|Given treatment duration is not a fixed duration, all participants are considered as 'Not Completed'. Reasons off-treatment are provided for all participants not still on treatment as of the date of data extraction.|
48494940|NCT02441686|101545225|FG000|NOT COMPLETED|Maintenance||38||
48494941|NCT02776774|101545226|FG000|STARTED|Overall Study||91|Total surveys submitted|
48494942|NCT02776774|101545226|FG000|COMPLETED|Overall Study||91||
48494943|NCT02776774|101545226|FG000|NOT COMPLETED|Overall Study||0||
48494944|NCT02450539|101545227|FG000|STARTED|Overall Study||106||
48494945|NCT02450539|101545228|FG001|STARTED|Overall Study||53||
48494946|NCT02450539|101545227|FG000|Received at Least One Dose of Study Drug|Overall Study||106||
48494947|NCT02450539|101545228|FG001|Received at Least One Dose of Study Drug|Overall Study||52||
48494948|NCT02450539|101545227|FG000|COMPLETED|Overall Study||90||
48494949|NCT02450539|101545228|FG001|COMPLETED|Overall Study||46||
48494950|NCT02450539|101545227|FG000|NOT COMPLETED|Overall Study||16||
48494951|NCT02450539|101545228|FG001|NOT COMPLETED|Overall Study||7||
48494952|NCT05616728|101545229|FG000|STARTED|Overall Study||77||
48494953|NCT05616728|101545230|FG001|STARTED|Overall Study||78||
48494954|NCT05616728|101545231|FG002|STARTED|Overall Study||76||
48494955|NCT05616728|101545229|FG000|COMPLETED|Overall Study||75||
48494956|NCT05616728|101545230|FG001|COMPLETED|Overall Study||74||
48494957|NCT05616728|101545231|FG002|COMPLETED|Overall Study||74||
48494958|NCT05616728|101545229|FG000|NOT COMPLETED|Overall Study||2||
48494959|NCT05616728|101545230|FG001|NOT COMPLETED|Overall Study||4||
48494960|NCT05616728|101545231|FG002|NOT COMPLETED|Overall Study||2||
48494961|NCT01735994|101545232|FG000|STARTED|Overall Study||263||13
48494962|NCT01735994|101545233|FG001|STARTED|Overall Study||218||15
48494963|NCT01735994|101545232|FG000|Post Intervention (3 Weeks)|Overall Study||239||13
48494964|NCT01735994|101545233|FG001|Post Intervention (3 Weeks)|Overall Study||198||15
48494965|NCT01735994|101545232|FG000|Follow-Up #1 (6 Months)|Overall Study||213||13
48494966|NCT01735994|101545233|FG001|Follow-Up #1 (6 Months)|Overall Study||163||15
48494967|NCT01735994|101545232|FG000|Follow-Up #2 (12 Months)|Overall Study||212||13
48494968|NCT01735994|101545233|FG001|Follow-Up #2 (12 Months)|Overall Study||174||15
48494969|NCT01735994|101545232|FG000|COMPLETED|Overall Study||200||13
48494970|NCT01735994|101545233|FG001|COMPLETED|Overall Study||152||15
48494971|NCT01735994|101545232|FG000|NOT COMPLETED|Overall Study||63||0
48494972|NCT01735994|101545233|FG001|NOT COMPLETED|Overall Study||66||0
48494973|NCT05740098|101545234|FG000|STARTED|Overall Study||68||
48494974|NCT05740098|101545235|FG001|STARTED|Overall Study||63||
48494975|NCT05740098|101545236|FG002|STARTED|Overall Study||67||
48494976|NCT05740098|101545234|FG000|COMPLETED|Overall Study||42||
48494977|NCT05740098|101545235|FG001|COMPLETED|Overall Study||46||
48494978|NCT05740098|101545236|FG002|COMPLETED|Overall Study||46||
48494979|NCT05740098|101545234|FG000|NOT COMPLETED|Overall Study||26||
48494980|NCT05740098|101545235|FG001|NOT COMPLETED|Overall Study||17||
48494981|NCT05740098|101545236|FG002|NOT COMPLETED|Overall Study||21||
48494982|NCT03140631|101545237|FG000|STARTED|Overall Study||73||
48494983|NCT03140631|101545238|FG001|STARTED|Overall Study||77||
48494984|NCT03140631|101545237|FG000|COMPLETED|Overall Study||73||
48494985|NCT03140631|101545238|FG001|COMPLETED|Overall Study||77||
48494986|NCT03140631|101545237|FG000|NOT COMPLETED|Overall Study||0||
48494987|NCT03140631|101545238|FG001|NOT COMPLETED|Overall Study||0||
48494988|NCT03261167|101545239|FG000|STARTED|Double Blind(Treatment cyc1,Upto Week48)||63||
48494989|NCT03261167|101545240|FG001|STARTED|Double Blind(Treatment cyc1,Upto Week48)||61||
48494990|NCT03261167|101545239|FG000|COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||60||
48494991|NCT03261167|101545240|FG001|COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||57||
48494992|NCT03261167|101545239|FG000|NOT COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||3||
48494993|NCT03261167|101545240|FG001|NOT COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||4||
48494994|NCT03261167|101545239|FG000|STARTED|Open-label(Treatment cycle2,Upto Week48)||60|Participants who met retreatment criteria in Treatment cycle 1 and received second dose|
48494995|NCT03261167|101545240|FG001|STARTED|Open-label(Treatment cycle2,Upto Week48)||57|Participants who met retreatment criteria in Treatment cycle 1 and received second dose|
48494996|NCT03261167|101545239|FG000|COMPLETED|Open-label(Treatment cycle2,Upto Week48)||58||
48494997|NCT03261167|101545240|FG001|COMPLETED|Open-label(Treatment cycle2,Upto Week48)||57||
48494998|NCT03261167|101545239|FG000|NOT COMPLETED|Open-label(Treatment cycle2,Upto Week48)||2||
48494999|NCT03261167|101545240|FG001|NOT COMPLETED|Open-label(Treatment cycle2,Upto Week48)||0||
48201191|NCT01751724|100814696|FG001|COMPLETED|Overall Study||42||
48201192|NCT01751724|100814695|FG000|NOT COMPLETED|Overall Study||1||
48666737|NCT03391882|101970466|FG001|Safety Population Part A|Part A - Titration Phase||18||
48495000|NCT03261167|101545239|FG000|STARTED|Open-label(Treatment cycle3,Upto Week48)||55|Participants who met retreatment criteria in Treatment cycle 2 and received third dose|
48495001|NCT03261167|101545240|FG001|STARTED|Open-label(Treatment cycle3,Upto Week48)||56|Participants who met retreatment criteria in Treatment cycle 2 and received third dose|
48495002|NCT03261167|101545239|FG000|COMPLETED|Open-label(Treatment cycle3,Upto Week48)||54||
48495003|NCT03261167|101545240|FG001|COMPLETED|Open-label(Treatment cycle3,Upto Week48)||55||
48495004|NCT03261167|101545239|FG000|NOT COMPLETED|Open-label(Treatment cycle3,Upto Week48)||1||
48495005|NCT03261167|101545240|FG001|NOT COMPLETED|Open-label(Treatment cycle3,Upto Week48)||1||
48495006|NCT03261167|101545239|FG000|STARTED|Open-label(Treatment cycle4,Upto Week48)||43|Participants who met retreatment criteria in Treatment cycle 3 and received fourth dose|
48495007|NCT03261167|101545240|FG001|STARTED|Open-label(Treatment cycle4,Upto Week48)||40|Participants who met retreatment criteria in Treatment cycle 3 and received fourth dose|
48495008|NCT03261167|101545239|FG000|COMPLETED|Open-label(Treatment cycle4,Upto Week48)||43||
48495009|NCT03261167|101545240|FG001|COMPLETED|Open-label(Treatment cycle4,Upto Week48)||40||
48495010|NCT03261167|101545239|FG000|NOT COMPLETED|Open-label(Treatment cycle4,Upto Week48)||0||
48495011|NCT03261167|101545240|FG001|NOT COMPLETED|Open-label(Treatment cycle4,Upto Week48)||0||
48495012|NCT00815087|101545241|FG000|STARTED|Overall Study||10||
48201193|NCT01751724|100814696|FG001|NOT COMPLETED|Overall Study||2||
48201194|NCT04164563|100814697|FG000|STARTED|Overall Study||3||
48201195|NCT04164563|100814698|FG001|STARTED|Overall Study||3||
48201196|NCT04164563|100814697|FG000|COMPLETED|Overall Study||3||
48201197|NCT04164563|100814698|FG001|COMPLETED|Overall Study||3||
48495013|NCT00815087|101545242|FG001|STARTED|Overall Study||10||
48495014|NCT00815087|101545241|FG000|COMPLETED|Overall Study||10||
48495015|NCT00815087|101545242|FG001|COMPLETED|Overall Study||10||
48201198|NCT04164563|100814697|FG000|NOT COMPLETED|Overall Study||0||
48201199|NCT04164563|100814698|FG001|NOT COMPLETED|Overall Study||0||
48201200|NCT00768664|100814699|FG000|STARTED|Overall Study||69||
48201201|NCT00768664|100814699|FG000|COMPLETED|Overall Study||0||
48201202|NCT00768664|100814699|FG000|NOT COMPLETED|Overall Study||69||
48201203|NCT01329328|100814700|FG000|STARTED|Overall Study||15||
48201204|NCT01329328|100814701|FG001|STARTED|Overall Study||17||
48201205|NCT01329328|100814702|FG002|STARTED|Overall Study||18||
48201206|NCT01329328|100814700|FG000|COMPLETED|Overall Study||13||
48201207|NCT01329328|100814701|FG001|COMPLETED|Overall Study||13||
48201208|NCT01329328|100814702|FG002|COMPLETED|Overall Study||15||
48201209|NCT01329328|100814700|FG000|NOT COMPLETED|Overall Study||2||
48201210|NCT01329328|100814701|FG001|NOT COMPLETED|Overall Study||4||
48201211|NCT01329328|100814702|FG002|NOT COMPLETED|Overall Study||3||
48201212|NCT00197236|100814703|FG000|STARTED|Overall Study||135||
48201213|NCT00197236|100814704|FG001|STARTED|Overall Study||127||
48201214|NCT00197236|100814705|FG002|STARTED|Overall Study||132||
48201215|NCT00197236|100814703|FG000|COMPLETED|Overall Study||121||
48201216|NCT00197236|100814704|FG001|COMPLETED|Overall Study||110||
48201217|NCT00197236|100814705|FG002|COMPLETED|Overall Study||109||
48201218|NCT00197236|100814703|FG000|NOT COMPLETED|Overall Study||14||
48201219|NCT00197236|100814704|FG001|NOT COMPLETED|Overall Study||17||
48201220|NCT00197236|100814705|FG002|NOT COMPLETED|Overall Study||23||
48201221|NCT02537522|100814706|FG000|STARTED|Phase I - Contralateral||34||
48201222|NCT02537522|100814707|FG001|STARTED|Phase I - Contralateral||37||
48201223|NCT02537522|100814708|FG002|STARTED|Phase I - Contralateral||0||
48201224|NCT02537522|100814709|FG003|STARTED|Phase I - Contralateral||0||
48201225|NCT02537522|100814706|FG000|COMPLETED|Phase I - Contralateral||19||
48201226|NCT02537522|100814707|FG001|COMPLETED|Phase I - Contralateral||27||
48201227|NCT02537522|100814708|FG002|COMPLETED|Phase I - Contralateral||0||
48201228|NCT02537522|100814709|FG003|COMPLETED|Phase I - Contralateral||0||
48201229|NCT02537522|100814706|FG000|NOT COMPLETED|Phase I - Contralateral||15||
48201230|NCT02537522|100814707|FG001|NOT COMPLETED|Phase I - Contralateral||10||
48201231|NCT02537522|100814708|FG002|NOT COMPLETED|Phase I - Contralateral||0||
48201232|NCT02537522|100814709|FG003|NOT COMPLETED|Phase I - Contralateral||0||
48201233|NCT02537522|100814706|FG000|STARTED|Phase II - Period 1 Bilateral||0||
48201234|NCT02537522|100814707|FG001|STARTED|Phase II - Period 1 Bilateral||0||
48495016|NCT00815087|101545241|FG000|NOT COMPLETED|Overall Study||0||
48495017|NCT00815087|101545242|FG001|NOT COMPLETED|Overall Study||0||
48495018|NCT03170219|101545243|FG000|STARTED|Overall Study||7||
48495019|NCT03170219|101545244|FG001|STARTED|Overall Study||4||
48495020|NCT03170219|101545243|FG000|COMPLETED|Overall Study||7||
48495021|NCT03170219|101545244|FG001|COMPLETED|Overall Study||4||
48495022|NCT03170219|101545243|FG000|NOT COMPLETED|Overall Study||0||
48495023|NCT03170219|101545244|FG001|NOT COMPLETED|Overall Study||0||
48495024|NCT03419403|101545245|FG000|STARTED|Overall Study||14||
48495025|NCT03419403|101545246|FG001|STARTED|Overall Study||12||
48495026|NCT03419403|101545247|FG002|STARTED|Overall Study||12||
48495027|NCT03419403|101545248|FG003|STARTED|Overall Study||2||
48495028|NCT03419403|101545245|FG000|COMPLETED|Overall Study||2||
48495029|NCT03419403|101545246|FG001|COMPLETED|Overall Study||3||
48495030|NCT03419403|101545247|FG002|COMPLETED|Overall Study||0||
48495031|NCT03419403|101545248|FG003|COMPLETED|Overall Study||0||
48201235|NCT02537522|100814708|FG002|STARTED|Phase II - Period 1 Bilateral||23||
48201236|NCT02537522|100814709|FG003|STARTED|Phase II - Period 1 Bilateral||23||
48201237|NCT02537522|100814706|FG000|COMPLETED|Phase II - Period 1 Bilateral||0||
48201238|NCT02537522|100814707|FG001|COMPLETED|Phase II - Period 1 Bilateral||0||
48201239|NCT02537522|100814708|FG002|COMPLETED|Phase II - Period 1 Bilateral||23||
48495032|NCT03419403|101545245|FG000|NOT COMPLETED|Overall Study||12||
48495033|NCT03419403|101545246|FG001|NOT COMPLETED|Overall Study||9||
48495034|NCT03419403|101545247|FG002|NOT COMPLETED|Overall Study||12||
48495035|NCT03419403|101545248|FG003|NOT COMPLETED|Overall Study||2||
48495036|NCT03049215|101545249|FG000|STARTED|Overall Study||1||
48495037|NCT03049215|101545250|FG001|STARTED|Overall Study||0||
48495038|NCT03049215|101545249|FG000|COMPLETED|Overall Study||1||
48495039|NCT03049215|101545250|FG001|COMPLETED|Overall Study||0||
48495040|NCT03049215|101545249|FG000|NOT COMPLETED|Overall Study||0||
48495041|NCT03049215|101545250|FG001|NOT COMPLETED|Overall Study||0||
48495042|NCT00274781|101545251|FG000|STARTED|Overall Study||30||
48495043|NCT00274781|101545251|FG000|COMPLETED|Overall Study||30||
48495044|NCT00274781|101545251|FG000|NOT COMPLETED|Overall Study||0||
48495045|NCT00624286|101545252|FG000|STARTED|Overall Study||211||
48495046|NCT00624286|101545253|FG001|STARTED|Overall Study||205||
48495047|NCT00624286|101545252|FG000|COMPLETED|Overall Study||186||
48495048|NCT00624286|101545253|FG001|COMPLETED|Overall Study||178||
48495049|NCT00624286|101545252|FG000|NOT COMPLETED|Overall Study||25||
48495050|NCT00624286|101545253|FG001|NOT COMPLETED|Overall Study||27||
48495051|NCT00081653|101545254|FG000|STARTED|Overall Study||358||
48495052|NCT00081653|101545255|FG001|STARTED|Overall Study||361||
48495053|NCT00081653|101545254|FG000|COMPLETED|Overall Study||311||
48495054|NCT00081653|101545255|FG001|COMPLETED|Overall Study||324||
48495055|NCT00081653|101545254|FG000|NOT COMPLETED|Overall Study||47||
48495056|NCT00081653|101545255|FG001|NOT COMPLETED|Overall Study||37||
48495057|NCT04994535|101545256|FG000|STARTED|Overall Study||217|ITT Population|
48495058|NCT04994535|101545257|FG001|STARTED|Overall Study||209|ITT Population|
48495059|NCT04994535|101545256|FG000|COMPLETED|Overall Study||199||
48495060|NCT04994535|101545257|FG001|COMPLETED|Overall Study||194||
48495061|NCT04994535|101545256|FG000|NOT COMPLETED|Overall Study||18||
48495062|NCT04994535|101545257|FG001|NOT COMPLETED|Overall Study||15||
48495063|NCT01521780|101545258|FG000|STARTED|Overall Study||9||
48201240|NCT02537522|100814709|FG003|COMPLETED|Phase II - Period 1 Bilateral||22||
48201241|NCT02537522|100814706|FG000|NOT COMPLETED|Phase II - Period 1 Bilateral||0||
48201242|NCT02537522|100814707|FG001|NOT COMPLETED|Phase II - Period 1 Bilateral||0||
48201243|NCT02537522|100814708|FG002|NOT COMPLETED|Phase II - Period 1 Bilateral||0||
48201244|NCT02537522|100814709|FG003|NOT COMPLETED|Phase II - Period 1 Bilateral||1||
48201245|NCT02537522|100814706|FG000|STARTED|Phase II - Period 2 Bilateral||0||
48201246|NCT02537522|100814707|FG001|STARTED|Phase II - Period 2 Bilateral||0||
48201247|NCT02537522|100814708|FG002|STARTED|Phase II - Period 2 Bilateral||23||
48201248|NCT02537522|100814709|FG003|STARTED|Phase II - Period 2 Bilateral||22||
48201249|NCT02537522|100814706|FG000|COMPLETED|Phase II - Period 2 Bilateral||0||
48201250|NCT02537522|100814707|FG001|COMPLETED|Phase II - Period 2 Bilateral||0||
48201251|NCT02537522|100814708|FG002|COMPLETED|Phase II - Period 2 Bilateral||23||
48201252|NCT02537522|100814709|FG003|COMPLETED|Phase II - Period 2 Bilateral||22||
48201253|NCT02537522|100814706|FG000|NOT COMPLETED|Phase II - Period 2 Bilateral||0||
48201254|NCT02537522|100814707|FG001|NOT COMPLETED|Phase II - Period 2 Bilateral||0||
48201255|NCT02537522|100814708|FG002|NOT COMPLETED|Phase II - Period 2 Bilateral||0||
48201256|NCT02537522|100814709|FG003|NOT COMPLETED|Phase II - Period 2 Bilateral||0||
48201257|NCT04415333|100817760|FG000|STARTED|First Intervention (Single 1-Day Visit)||10|No participants received random assignment to the 80 mmol intervention first.|
48201258|NCT04415333|100817761|FG001|STARTED|First Intervention (Single 1-Day Visit)||0|No participants received random assignment to the 80 mmol intervention first.|
48201259|NCT04415333|100817762|FG002|STARTED|First Intervention (Single 1-Day Visit)||10|No participants received random assignment to the 80 mmol intervention first.|
48201260|NCT04415333|100817760|FG000|COMPLETED|First Intervention (Single 1-Day Visit)||10||
48201261|NCT04415333|100817761|FG001|COMPLETED|First Intervention (Single 1-Day Visit)||0||
48201262|NCT04415333|100817762|FG002|COMPLETED|First Intervention (Single 1-Day Visit)||10||
48201263|NCT04415333|100817760|FG000|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0||
48201264|NCT04415333|100817761|FG001|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0||
48201265|NCT04415333|100817762|FG002|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0||
48201266|NCT04415333|100817760|FG000|STARTED|Washout (1 Week)||10||
48201267|NCT04415333|100817761|FG001|STARTED|Washout (1 Week)||0||
48201268|NCT04415333|100817762|FG002|STARTED|Washout (1 Week)||10||
48201269|NCT04415333|100817760|FG000|COMPLETED|Washout (1 Week)||10||
48201270|NCT04415333|100817761|FG001|COMPLETED|Washout (1 Week)||0||
48201271|NCT04415333|100817762|FG002|COMPLETED|Washout (1 Week)||10||
48201272|NCT04415333|100817760|FG000|NOT COMPLETED|Washout (1 Week)||0||
48201273|NCT04415333|100817761|FG001|NOT COMPLETED|Washout (1 Week)||0||
48201274|NCT04415333|100817762|FG002|NOT COMPLETED|Washout (1 Week)||0||
48201275|NCT04415333|100817760|FG000|STARTED|Second Intervention (Single 1-Day Visit)||10||
48201276|NCT04415333|100817761|FG001|STARTED|Second Intervention (Single 1-Day Visit)||0||
48201277|NCT04415333|100817762|FG002|STARTED|Second Intervention (Single 1-Day Visit)||10||
48201278|NCT04415333|100817760|FG000|COMPLETED|Second Intervention (Single 1-Day Visit)||10||
48201279|NCT04415333|100817761|FG001|COMPLETED|Second Intervention (Single 1-Day Visit)||0||
48201280|NCT04415333|100817762|FG002|COMPLETED|Second Intervention (Single 1-Day Visit)||10||
48201281|NCT04415333|100817760|FG000|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0||
48201282|NCT04415333|100817761|FG001|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0||
48201283|NCT04415333|100817762|FG002|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0||
48201284|NCT05334758|100817763|FG000|STARTED|Overall Study||30||
48201285|NCT05334758|100817764|FG001|STARTED|Overall Study||252||
48201286|NCT05334758|100817763|FG000|COMPLETED|Overall Study||30||
48201287|NCT05334758|100817764|FG001|COMPLETED|Overall Study||252||
48201288|NCT05334758|100817763|FG000|NOT COMPLETED|Overall Study||0||
48201289|NCT05334758|100817764|FG001|NOT COMPLETED|Overall Study||0||
48201290|NCT03184558|100817765|FG000|STARTED|Overall Study||29||
48201291|NCT03184558|100817765|FG000|COMPLETED|Overall Study||0||
48201292|NCT03184558|100817765|FG000|NOT COMPLETED|Overall Study||29||
48201293|NCT00601848|100817766|FG000|STARTED|Overall Study||9||
48201294|NCT00601848|100817766|FG000|COMPLETED|Overall Study||0||
48201295|NCT00601848|100817766|FG000|NOT COMPLETED|Overall Study||9||
48201296|NCT02178540|100817767|FG000|STARTED|Overall Study||45||
48201297|NCT02178540|100817767|FG000|COMPLETED|Overall Study||45||
48201298|NCT02178540|100817767|FG000|NOT COMPLETED|Overall Study||0||
48201299|NCT02072226|100817768|FG000|STARTED|Overall Study||156||
48201300|NCT02072226|100817769|FG001|STARTED|Overall Study||157||
48201301|NCT02072226|100817768|FG000|COMPLETED|Overall Study||141||
48201302|NCT02072226|100817769|FG001|COMPLETED|Overall Study||147||
48201303|NCT02072226|100817768|FG000|NOT COMPLETED|Overall Study||15||
48201304|NCT02072226|100817769|FG001|NOT COMPLETED|Overall Study||10||
48201305|NCT00961636|100817770|FG000|STARTED|Overall Study||463||
48201306|NCT00961636|100817771|FG001|STARTED|Overall Study||456||
48201307|NCT00961636|100817772|FG002|STARTED|Overall Study||233||
48201308|NCT00961636|100817770|FG000|COMPLETED|Overall Study||356||
48201309|NCT00961636|100817771|FG001|COMPLETED|Overall Study||325||
48201310|NCT00961636|100817772|FG002|COMPLETED|Overall Study||201||
48201311|NCT00961636|100817770|FG000|NOT COMPLETED|Overall Study||107||
48201312|NCT00961636|100817771|FG001|NOT COMPLETED|Overall Study||131||
48201313|NCT00961636|100817772|FG002|NOT COMPLETED|Overall Study||32||
48201314|NCT01740817|100817773|FG000|STARTED|First Intervention (48 h)||8||
48201315|NCT01740817|100817774|FG001|STARTED|First Intervention (48 h)||4||
48201316|NCT01740817|100817773|FG000|COMPLETED|First Intervention (48 h)||8||
48201317|NCT01740817|100817774|FG001|COMPLETED|First Intervention (48 h)||4||
48201318|NCT01740817|100817773|FG000|NOT COMPLETED|First Intervention (48 h)||0||
48201319|NCT01740817|100817774|FG001|NOT COMPLETED|First Intervention (48 h)||0||
48201320|NCT01740817|100817773|FG000|STARTED|Washout (4-6 Weeks)||8||
48495064|NCT01521780|101545259|FG001|STARTED|Overall Study||1||
48201321|NCT01740817|100817774|FG001|STARTED|Washout (4-6 Weeks)||4||
48201322|NCT01740817|100817773|FG000|COMPLETED|Washout (4-6 Weeks)||8||
48201323|NCT01740817|100817774|FG001|COMPLETED|Washout (4-6 Weeks)||4||
48495065|NCT01521780|101545260|FG002|STARTED|Overall Study||2||
48495066|NCT01521780|101545258|FG000|COMPLETED|Overall Study||9||
48495067|NCT01521780|101545259|FG001|COMPLETED|Overall Study||1||
48495068|NCT01521780|101545260|FG002|COMPLETED|Overall Study||2||
48201324|NCT01740817|100817773|FG000|NOT COMPLETED|Washout (4-6 Weeks)||0||
48201325|NCT01740817|100817774|FG001|NOT COMPLETED|Washout (4-6 Weeks)||0||
48201326|NCT01740817|100817773|FG000|STARTED|Second Intervention (48 h)||8||
48201327|NCT01740817|100817774|FG001|STARTED|Second Intervention (48 h)||4||
48201328|NCT01740817|100817773|FG000|COMPLETED|Second Intervention (48 h)||8||
48201329|NCT01740817|100817774|FG001|COMPLETED|Second Intervention (48 h)||4||
48495069|NCT01521780|101545258|FG000|NOT COMPLETED|Overall Study||0||
48495070|NCT01521780|101545259|FG001|NOT COMPLETED|Overall Study||0||
48201330|NCT01740817|100817773|FG000|NOT COMPLETED|Second Intervention (48 h)||0||
48201331|NCT01740817|100817774|FG001|NOT COMPLETED|Second Intervention (48 h)||0||
48201332|NCT00487578|100817775|FG000|STARTED|Overall Study||3||
48201333|NCT00487578|100817776|FG001|STARTED|Overall Study||9||
48201334|NCT00487578|100817775|FG000|COMPLETED|Overall Study||2||
48201335|NCT00487578|100817776|FG001|COMPLETED|Overall Study||5||
48201336|NCT00487578|100817775|FG000|NOT COMPLETED|Overall Study||1||
48201337|NCT00487578|100817776|FG001|NOT COMPLETED|Overall Study||4||
48201338|NCT00208767|100817777|FG000|STARTED|Overall Study||80||
48201339|NCT00208767|100817778|FG001|STARTED|Overall Study||40||
48201340|NCT00208767|100817777|FG000|COMPLETED|Overall Study||53||
48201341|NCT00208767|100817778|FG001|COMPLETED|Overall Study||33||
48201342|NCT00208767|100817777|FG000|NOT COMPLETED|Overall Study||27||
48201343|NCT00208767|100817778|FG001|NOT COMPLETED|Overall Study||7||
48201344|NCT01541358|100817779|FG000|STARTED|Overall Study||2||
48201345|NCT01541358|100817779|FG000|COMPLETED|Overall Study||2||
48201346|NCT01541358|100817779|FG000|NOT COMPLETED|Overall Study||0||
48201347|NCT00972504|100817780|FG000|STARTED|Overall Study||54||
48201348|NCT00972504|100817780|FG000|COMPLETED|Overall Study||51||
48201349|NCT00972504|100817780|FG000|NOT COMPLETED|Overall Study||3||
48201350|NCT00434018|100817781|FG000|STARTED|Overall Study||69||
48201351|NCT00434018|100817782|FG001|STARTED|Overall Study||69||
48201352|NCT00434018|100817781|FG000|COMPLETED|Overall Study||52||
48201353|NCT00434018|100817782|FG001|COMPLETED|Overall Study||57||
48201354|NCT00434018|100817781|FG000|NOT COMPLETED|Overall Study||17||
48201355|NCT00434018|100817782|FG001|NOT COMPLETED|Overall Study||12||
48201356|NCT02787694|100817783|FG000|STARTED|Overall Study||22||
48201357|NCT02787694|100817783|FG000|COMPLETED|Overall Study||17||
48201358|NCT02787694|100817783|FG000|NOT COMPLETED|Overall Study||5||
48201359|NCT02674750|100817784|FG000|STARTED|Overall Study||5||
48201360|NCT02674750|100817785|FG001|STARTED|Overall Study||49||
48201361|NCT02674750|100817786|FG002|STARTED|Overall Study||16||
48495071|NCT01521780|101545260|FG002|NOT COMPLETED|Overall Study||0||
48495072|NCT01169753|101545261|FG000|STARTED|Overall Study||0||
48495073|NCT01169753|101545262|FG001|STARTED|Overall Study||1||
48495074|NCT01169753|101545261|FG000|COMPLETED|Overall Study||0||
48495075|NCT01169753|101545262|FG001|COMPLETED|Overall Study||0||
48495076|NCT01169753|101545261|FG000|NOT COMPLETED|Overall Study||0||
48495077|NCT01169753|101545262|FG001|NOT COMPLETED|Overall Study||1||
48495078|NCT02336074|101545263|FG000|STARTED|Overall Study||30||
48495079|NCT02336074|101545264|FG001|STARTED|Overall Study||30||
48201362|NCT02674750|100817784|FG000|COMPLETED|Overall Study||0|Completed = subjects stopped when Sponsor stopped study.|
48495080|NCT02336074|101545263|FG000|COMPLETED|Overall Study||30||
48495081|NCT02336074|101545264|FG001|COMPLETED|Overall Study||28||
48495082|NCT02336074|101545263|FG000|NOT COMPLETED|Overall Study||0||
48495083|NCT02336074|101545264|FG001|NOT COMPLETED|Overall Study||2||
48495084|NCT04577651|101545265|FG000|STARTED|Overall Study||58||
48201363|NCT02674750|100817785|FG001|COMPLETED|Overall Study||4|Completed = subjects stopped when Sponsor stopped study.|
48201364|NCT02674750|100817786|FG002|COMPLETED|Overall Study||4|Completed = subjects stopped when Sponsor stopped study.|
48201365|NCT02674750|100817784|FG000|NOT COMPLETED|Overall Study||5||
48201366|NCT02674750|100817785|FG001|NOT COMPLETED|Overall Study||45||
48201367|NCT02674750|100817786|FG002|NOT COMPLETED|Overall Study||12||
48201368|NCT01123083|100817787|FG000|STARTED|Overall Study||61||
48201369|NCT01123083|100817788|FG001|STARTED|Overall Study||118||
48201370|NCT01123083|100817787|FG000|COMPLETED|Overall Study||50||
48201371|NCT01123083|100817788|FG001|COMPLETED|Overall Study||103||
48201372|NCT01123083|100817787|FG000|NOT COMPLETED|Overall Study||11||
48201373|NCT01123083|100817788|FG001|NOT COMPLETED|Overall Study||15||
48201374|NCT04178941|100817789|FG000|STARTED|Overall Study||1051||
48201375|NCT04178941|100817790|FG001|STARTED|Overall Study||847||
48201376|NCT04178941|100817789|FG000|COMPLETED|Overall Study||1051||
48201377|NCT04178941|100817790|FG001|COMPLETED|Overall Study||847||
48201378|NCT04178941|100817789|FG000|NOT COMPLETED|Overall Study||0||
48201379|NCT04178941|100817790|FG001|NOT COMPLETED|Overall Study||0||
48201380|NCT01910636|100817791|FG000|STARTED|Overall Study||90||
48201381|NCT01910636|100817792|FG001|STARTED|Overall Study||63||
48201382|NCT01910636|100817791|FG000|COMPLETED|Overall Study||90||
48201383|NCT01910636|100817792|FG001|COMPLETED|Overall Study||63||
48201384|NCT01910636|100817791|FG000|NOT COMPLETED|Overall Study||0||
48201385|NCT01910636|100817792|FG001|NOT COMPLETED|Overall Study||0||
48201386|NCT00919763|100817793|FG000|STARTED|Overall Study||53||
48201387|NCT00919763|100817794|FG001|STARTED|Overall Study||49||
48201388|NCT00919763|100817793|FG000|COMPLETED|Overall Study||41||
48201389|NCT00919763|100817794|FG001|COMPLETED|Overall Study||45||
48201390|NCT00919763|100817793|FG000|NOT COMPLETED|Overall Study||12||
48201391|NCT00919763|100817794|FG001|NOT COMPLETED|Overall Study||4||
48201392|NCT00610688|100817795|FG000|STARTED|Overall Study||64||
48201393|NCT00610688|100817796|FG001|STARTED|Overall Study||65||
48201394|NCT00610688|100817797|FG002|STARTED|Overall Study||63||
48201395|NCT00610688|100817795|FG000|COMPLETED|Overall Study||55||
48201396|NCT00610688|100817796|FG001|COMPLETED|Overall Study||52||
48201397|NCT00610688|100817797|FG002|COMPLETED|Overall Study||55||
48201398|NCT00610688|100817795|FG000|NOT COMPLETED|Overall Study||9||
48495085|NCT04577651|101545265|FG000|COMPLETED|Overall Study||45||
48201399|NCT00610688|100817796|FG001|NOT COMPLETED|Overall Study||13||
48201400|NCT00610688|100817797|FG002|NOT COMPLETED|Overall Study||8||
48201401|NCT04860258|100817798|FG000|STARTED|Overall Study||1||
48201402|NCT04860258|100817799|FG001|STARTED|Overall Study||1||
48201403|NCT04860258|100817800|FG002|STARTED|Overall Study||52||
48201404|NCT04860258|100817801|FG003|STARTED|Overall Study||33||
48201405|NCT04860258|100817802|FG004|STARTED|Overall Study||33||
48201406|NCT04860258|100817803|FG005|STARTED|Overall Study||7||
48201407|NCT04860258|100817804|FG006|STARTED|Overall Study||2||
48201408|NCT04860258|100817798|FG000|COMPLETED|Overall Study||1||
48201409|NCT04860258|100817799|FG001|COMPLETED|Overall Study||1||
48201410|NCT04860258|100817800|FG002|COMPLETED|Overall Study||48||
48201411|NCT04860258|100817801|FG003|COMPLETED|Overall Study||32||
48201412|NCT04860258|100817802|FG004|COMPLETED|Overall Study||29||
48201413|NCT04860258|100817803|FG005|COMPLETED|Overall Study||6||
48201414|NCT04860258|100817804|FG006|COMPLETED|Overall Study||2||
48201415|NCT04860258|100817798|FG000|NOT COMPLETED|Overall Study||0||
48201416|NCT04860258|100817799|FG001|NOT COMPLETED|Overall Study||0||
48201417|NCT04860258|100817800|FG002|NOT COMPLETED|Overall Study||4||
48201418|NCT04860258|100817801|FG003|NOT COMPLETED|Overall Study||1||
48201419|NCT04860258|100817802|FG004|NOT COMPLETED|Overall Study||4||
48201420|NCT04860258|100817803|FG005|NOT COMPLETED|Overall Study||1||
48201421|NCT04860258|100817804|FG006|NOT COMPLETED|Overall Study||0||
48201422|NCT02486588|100817805|FG000|STARTED|Overall Study||1188||
48201423|NCT02486588|100817806|FG001|STARTED|Overall Study||1252||
48201424|NCT02486588|100817807|FG002|STARTED|Overall Study||1220||
48201425|NCT02486588|100817808|FG003|STARTED|Overall Study||1206||
48201426|NCT02486588|100817809|FG004|STARTED|Overall Study||1243||
48201427|NCT02486588|100817810|FG005|STARTED|Overall Study||1205||
48201428|NCT02486588|100817805|FG000|COMPLETED|Overall Study||450||
48201429|NCT02486588|100817806|FG001|COMPLETED|Overall Study||502||
48201430|NCT02486588|100817807|FG002|COMPLETED|Overall Study||465||
48201431|NCT02486588|100817808|FG003|COMPLETED|Overall Study||468||
48201432|NCT02486588|100817809|FG004|COMPLETED|Overall Study||497||
48201433|NCT02486588|100817810|FG005|COMPLETED|Overall Study||459||
48201434|NCT02486588|100817805|FG000|NOT COMPLETED|Overall Study||738||
48201435|NCT02486588|100817806|FG001|NOT COMPLETED|Overall Study||750||
48201436|NCT02486588|100817807|FG002|NOT COMPLETED|Overall Study||755||
48201437|NCT02486588|100817808|FG003|NOT COMPLETED|Overall Study||738||
48201438|NCT02486588|100817809|FG004|NOT COMPLETED|Overall Study||746||
48201439|NCT02486588|100817810|FG005|NOT COMPLETED|Overall Study||746||
48201440|NCT02885311|100817811|FG000|STARTED|Overall Study||6||
48201441|NCT02885311|100817812|FG001|STARTED|Overall Study||10||
48201442|NCT02885311|100817813|FG002|STARTED|Overall Study||9||
48201443|NCT02885311|100817814|FG003|STARTED|Overall Study||2||
48201444|NCT02885311|100817811|FG000|COMPLETED|Overall Study||6||
48201445|NCT02885311|100817812|FG001|COMPLETED|Overall Study||9||
48201446|NCT02885311|100817813|FG002|COMPLETED|Overall Study||8||
48201447|NCT02885311|100817814|FG003|COMPLETED|Overall Study||2||
48201448|NCT02885311|100817811|FG000|NOT COMPLETED|Overall Study||0||
48495086|NCT04577651|101545265|FG000|NOT COMPLETED|Overall Study||13||
48495087|NCT00101439|101545266|FG000|STARTED|Period 1||28||
48201449|NCT02885311|100817812|FG001|NOT COMPLETED|Overall Study||1||
48495088|NCT00101439|101545267|FG001|STARTED|Period 1||30||
48495089|NCT00101439|101545266|FG000|COMPLETED|Period 1||28||
48495090|NCT00101439|101545267|FG001|COMPLETED|Period 1||30||
48495091|NCT00101439|101545266|FG000|NOT COMPLETED|Period 1||0||
48495092|NCT00101439|101545267|FG001|NOT COMPLETED|Period 1||0||
48495093|NCT00101439|101545266|FG000|STARTED|Period 2||28||
48495094|NCT00101439|101545267|FG001|STARTED|Period 2||30||
48495095|NCT00101439|101545266|FG000|COMPLETED|Period 2||28||
48495096|NCT00101439|101545267|FG001|COMPLETED|Period 2||28||
48495097|NCT00101439|101545266|FG000|NOT COMPLETED|Period 2||0||
48495098|NCT00101439|101545267|FG001|NOT COMPLETED|Period 2||2||
48495099|NCT00594035|101545268|FG000|STARTED|Overall Study||102||
48495100|NCT00594035|101545269|FG001|STARTED|Overall Study||56||
48495101|NCT00594035|101545268|FG000|COMPLETED|Overall Study||100||
48495102|NCT00594035|101545269|FG001|COMPLETED|Overall Study||53||
48495103|NCT00594035|101545268|FG000|NOT COMPLETED|Overall Study||2||
48495104|NCT00594035|101545269|FG001|NOT COMPLETED|Overall Study||3||
48495105|NCT01103713|101545270|FG000|STARTED|Overall Study||168||
48495106|NCT01103713|101545270|FG000|COMPLETED|Overall Study||155||
48495107|NCT01103713|101545270|FG000|NOT COMPLETED|Overall Study||13||
48495108|NCT03317444|101545271|FG000|STARTED|Overall Study||124||
48495109|NCT03317444|101545272|FG001|STARTED|Overall Study||93||
48495110|NCT03317444|101545271|FG000|COMPLETED|Overall Study||119||
48495111|NCT03317444|101545272|FG001|COMPLETED|Overall Study||89||
48495112|NCT03317444|101545271|FG000|NOT COMPLETED|Overall Study||5||
48495113|NCT03317444|101545272|FG001|NOT COMPLETED|Overall Study||4||
48495114|NCT02911025|101545273|FG000|STARTED|Overall Study||13||
48495115|NCT02911025|101545273|FG000|COMPLETED|Overall Study||10||
48495116|NCT02911025|101545273|FG000|NOT COMPLETED|Overall Study||3||
48495117|NCT00848536|101545274|FG000|STARTED|Overall Study||185||
48495118|NCT00848536|101545275|FG001|STARTED|Overall Study||186||
48495119|NCT00848536|101545274|FG000|COMPLETED|Overall Study||181||
48495120|NCT00848536|101545275|FG001|COMPLETED|Overall Study||179||
48495121|NCT00848536|101545274|FG000|NOT COMPLETED|Overall Study||4||
48201450|NCT02885311|100817813|FG002|NOT COMPLETED|Overall Study||1||
48201451|NCT02885311|100817814|FG003|NOT COMPLETED|Overall Study||0||
48201452|NCT02299336|100817815|FG000|STARTED|Overall Study||60||
48201453|NCT02299336|100817815|FG000|COMPLETED|Overall Study||46||
48201454|NCT02299336|100817815|FG000|NOT COMPLETED|Overall Study||14||
48201455|NCT02498769|100817816|FG000|STARTED|Overall Study||63||
48201456|NCT02498769|100817817|FG001|STARTED|Overall Study||67||
48201457|NCT02498769|100817816|FG000|COMPLETED|Overall Study||63||
48201458|NCT02498769|100817817|FG001|COMPLETED|Overall Study||67||
48201459|NCT02498769|100817816|FG000|NOT COMPLETED|Overall Study||0||
48201460|NCT02498769|100817817|FG001|NOT COMPLETED|Overall Study||0||
48201461|NCT00355914|100817818|FG000|STARTED|Overall Study||60||
48201462|NCT00355914|100817819|FG001|STARTED|Overall Study||60||
48201463|NCT00355914|100817818|FG000|COMPLETED|Overall Study||60||
48201464|NCT00355914|100817819|FG001|COMPLETED|Overall Study||60||
48201465|NCT00355914|100817818|FG000|NOT COMPLETED|Overall Study||0||
48201466|NCT00355914|100817819|FG001|NOT COMPLETED|Overall Study||0||
48201467|NCT04072822|100817820|FG000|STARTED|Treatment||73||
48201468|NCT04072822|100817821|FG001|STARTED|Treatment||74||
48201469|NCT04072822|100817820|FG000|COMPLETED|Treatment||30||
48201470|NCT04072822|100817821|FG001|COMPLETED|Treatment||20||
48201471|NCT04072822|100817820|FG000|NOT COMPLETED|Treatment||43||
48201472|NCT04072822|100817821|FG001|NOT COMPLETED|Treatment||54||
48201473|NCT04072822|100817820|FG000|STARTED|Follow-up||30||
48201474|NCT04072822|100817821|FG001|STARTED|Follow-up||20||
48201475|NCT04072822|100817820|FG000|COMPLETED|Follow-up||24||
48201476|NCT04072822|100817821|FG001|COMPLETED|Follow-up||16||
48201477|NCT04072822|100817820|FG000|NOT COMPLETED|Follow-up||6||
48201478|NCT04072822|100817821|FG001|NOT COMPLETED|Follow-up||4||
48201479|NCT00762463|100817822|FG000|STARTED|Double-blind Phase (Baseline to Week 6)||120||
48201480|NCT00762463|100817823|FG001|STARTED|Double-blind Phase (Baseline to Week 6)||120||
48201481|NCT00762463|100817824|FG002|STARTED|Double-blind Phase (Baseline to Week 6)||0||
48201482|NCT00762463|100817825|FG003|STARTED|Double-blind Phase (Baseline to Week 6)||0||
48201483|NCT00762463|100817822|FG000|COMPLETED|Double-blind Phase (Baseline to Week 6)||113||
48201484|NCT00762463|100817823|FG001|COMPLETED|Double-blind Phase (Baseline to Week 6)||110||
48201485|NCT00762463|100817824|FG002|COMPLETED|Double-blind Phase (Baseline to Week 6)||0||
48201486|NCT00762463|100817825|FG003|COMPLETED|Double-blind Phase (Baseline to Week 6)||0||
48201487|NCT00762463|100817822|FG000|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||7||
48201488|NCT00762463|100817823|FG001|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||10||
48201489|NCT00762463|100817824|FG002|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0||
48201490|NCT00762463|100817825|FG003|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0||
48201491|NCT00762463|100817822|FG000|STARTED|Enrollment in Extension Phase (Week 6)||113||
48201492|NCT00762463|100817823|FG001|STARTED|Enrollment in Extension Phase (Week 6)||110||
48495122|NCT00848536|101545275|FG001|NOT COMPLETED|Overall Study||7||
48201493|NCT00762463|100817824|FG002|STARTED|Enrollment in Extension Phase (Week 6)||0||
48201494|NCT00762463|100817825|FG003|STARTED|Enrollment in Extension Phase (Week 6)||0||
48201495|NCT00762463|100817822|FG000|COMPLETED|Enrollment in Extension Phase (Week 6)||109||
48201496|NCT00762463|100817823|FG001|COMPLETED|Enrollment in Extension Phase (Week 6)||109||
48201497|NCT00762463|100817824|FG002|COMPLETED|Enrollment in Extension Phase (Week 6)||0||
48201498|NCT00762463|100817825|FG003|COMPLETED|Enrollment in Extension Phase (Week 6)||0||
48201499|NCT00762463|100817822|FG000|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||4||
48495123|NCT00268203|101545276|FG000|STARTED|Overall Study||765||
48495124|NCT00268203|101545276|FG000|Completed 2 Years of Follow-up|Overall Study||62||
48495125|NCT00268203|101545276|FG000|COMPLETED|Overall Study||118||
48495126|NCT00268203|101545276|FG000|NOT COMPLETED|Overall Study||647||
48495127|NCT04631562|101545277|FG000|STARTED|Overall Study||5||
48495128|NCT04631562|101545278|FG001|STARTED|Overall Study||6||
48495129|NCT04631562|101545279|FG002|STARTED|Overall Study||5||
48495130|NCT04631562|101545280|FG003|STARTED|Overall Study||5||
48495131|NCT04631562|101545281|FG004|STARTED|Overall Study||5||
48495132|NCT04631562|101545282|FG005|STARTED|Overall Study||6||
48495133|NCT04631562|101545283|FG006|STARTED|Overall Study||7||
48495134|NCT04631562|101545284|FG007|STARTED|Overall Study||6||
48201500|NCT00762463|100817823|FG001|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||1||
48495135|NCT04631562|101545285|FG008|STARTED|Overall Study||15||
48495136|NCT04631562|101545277|FG000|Received at Least 1 Dose of Study Drug|Overall Study||5||
48495137|NCT04631562|101545278|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
48495138|NCT04631562|101545279|FG002|Received at Least 1 Dose of Study Drug|Overall Study||5||
48495139|NCT04631562|101545280|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5||
48495140|NCT04631562|101545281|FG004|Received at Least 1 Dose of Study Drug|Overall Study||5||
48495141|NCT04631562|101545282|FG005|Received at Least 1 Dose of Study Drug|Overall Study||6||
48495142|NCT04631562|101545283|FG006|Received at Least 1 Dose of Study Drug|Overall Study||7||
48495143|NCT04631562|101545284|FG007|Received at Least 1 Dose of Study Drug|Overall Study||6||
48495144|NCT04631562|101545285|FG008|Received at Least 1 Dose of Study Drug|Overall Study||15||
48495145|NCT04631562|101545277|FG000|COMPLETED|Overall Study||5||
48201501|NCT00762463|100817824|FG002|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0||
48201502|NCT00762463|100817825|FG003|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0||
48495146|NCT04631562|101545278|FG001|COMPLETED|Overall Study||6||
48495147|NCT04631562|101545279|FG002|COMPLETED|Overall Study||5||
48495148|NCT04631562|101545280|FG003|COMPLETED|Overall Study||4||
48495149|NCT04631562|101545281|FG004|COMPLETED|Overall Study||5||
48495150|NCT04631562|101545282|FG005|COMPLETED|Overall Study||6||
48495151|NCT04631562|101545283|FG006|COMPLETED|Overall Study||6||
48495152|NCT04631562|101545284|FG007|COMPLETED|Overall Study||5||
48495153|NCT04631562|101545285|FG008|COMPLETED|Overall Study||14||
48495154|NCT04631562|101545277|FG000|NOT COMPLETED|Overall Study||0||
48495155|NCT04631562|101545278|FG001|NOT COMPLETED|Overall Study||0||
48495156|NCT04631562|101545279|FG002|NOT COMPLETED|Overall Study||0||
48201503|NCT00762463|100817822|FG000|STARTED|Extension Phase (Week 6 to Week 12)||55||
48201504|NCT00762463|100817823|FG001|STARTED|Extension Phase (Week 6 to Week 12)||55||
48495157|NCT04631562|101545280|FG003|NOT COMPLETED|Overall Study||1||
48495158|NCT04631562|101545281|FG004|NOT COMPLETED|Overall Study||0||
48495159|NCT04631562|101545282|FG005|NOT COMPLETED|Overall Study||0||
48495160|NCT04631562|101545283|FG006|NOT COMPLETED|Overall Study||1||
48201505|NCT00762463|100817824|FG002|STARTED|Extension Phase (Week 6 to Week 12)||54||
48201506|NCT00762463|100817825|FG003|STARTED|Extension Phase (Week 6 to Week 12)||54||
48201507|NCT00762463|100817822|FG000|COMPLETED|Extension Phase (Week 6 to Week 12)||52||
48201508|NCT00762463|100817823|FG001|COMPLETED|Extension Phase (Week 6 to Week 12)||54||
48201509|NCT00762463|100817824|FG002|COMPLETED|Extension Phase (Week 6 to Week 12)||50||
48201510|NCT00762463|100817825|FG003|COMPLETED|Extension Phase (Week 6 to Week 12)||52||
48201511|NCT00762463|100817822|FG000|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||3||
48201512|NCT00762463|100817823|FG001|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||1||
48201513|NCT00762463|100817824|FG002|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||4||
48201514|NCT00762463|100817825|FG003|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||2||
48201515|NCT00618540|100817826|FG000|STARTED|Overall Study||1||
48201516|NCT00618540|100817826|FG000|COMPLETED|Overall Study||1||
48201517|NCT00618540|100817826|FG000|NOT COMPLETED|Overall Study||0||
48201518|NCT01697319|100817827|FG000|STARTED|Primary Phase||16||
48201519|NCT01697319|100817827|FG000|COMPLETED|Primary Phase||15||
48201520|NCT01697319|100817827|FG000|NOT COMPLETED|Primary Phase||1||
48201521|NCT01697319|100817827|FG000|STARTED|Extension Phase||15||
48201522|NCT01697319|100817827|FG000|COMPLETED|Extension Phase||0||
48201523|NCT01697319|100817827|FG000|NOT COMPLETED|Extension Phase||15||
48201524|NCT02482233|100817828|FG000|STARTED|Overall Study||10||
48201525|NCT02482233|100817829|FG001|STARTED|Overall Study||20||
48201526|NCT02482233|100817828|FG000|COMPLETED|Overall Study||9||
48201527|NCT02482233|100817829|FG001|COMPLETED|Overall Study||19||
48201528|NCT02482233|100817828|FG000|NOT COMPLETED|Overall Study||1||
48201529|NCT02482233|100817829|FG001|NOT COMPLETED|Overall Study||1||
48201530|NCT03418324|100817830|FG000|STARTED|Overall Study||3||
48201531|NCT03418324|100817831|FG001|STARTED|Overall Study||8||
48201532|NCT03418324|100817830|FG000|COMPLETED|Overall Study||2||
48201533|NCT03418324|100817831|FG001|COMPLETED|Overall Study||6||
48201534|NCT03418324|100817830|FG000|NOT COMPLETED|Overall Study||1||
48201535|NCT03418324|100817831|FG001|NOT COMPLETED|Overall Study||2||
48201536|NCT04090190|100817832|FG000|STARTED|Overall Study||20||
48201537|NCT04090190|100817832|FG000|COMPLETED|Overall Study||20||
48201538|NCT04090190|100817832|FG000|NOT COMPLETED|Overall Study||0||
48201539|NCT03861169|100817833|FG000|STARTED|Overall Study||209||
48201540|NCT03861169|100817833|FG000|COMPLETED|Overall Study||149||
48201541|NCT03861169|100817833|FG000|NOT COMPLETED|Overall Study||60||
48201542|NCT01693614|100817834|FG000|STARTED|Overall Study||26||
48201543|NCT01693614|100817835|FG001|STARTED|Overall Study||22||
48201544|NCT01693614|100817836|FG002|STARTED|Overall Study||24||
48201545|NCT01693614|100817834|FG000|COMPLETED|Overall Study||0||
48201546|NCT01693614|100817835|FG001|COMPLETED|Overall Study||0||
48201547|NCT01693614|100817836|FG002|COMPLETED|Overall Study||0||
48201548|NCT01693614|100817834|FG000|NOT COMPLETED|Overall Study||26||
48201549|NCT01693614|100817835|FG001|NOT COMPLETED|Overall Study||22||
48495161|NCT04631562|101545284|FG007|NOT COMPLETED|Overall Study||1||
48201550|NCT01693614|100817836|FG002|NOT COMPLETED|Overall Study||24||
48201551|NCT01981850|100817837|FG000|STARTED|Main Phase Stage 1||8||
48201552|NCT01981850|100817838|FG001|STARTED|Main Phase Stage 1||7||
48201553|NCT01981850|100817839|FG002|STARTED|Main Phase Stage 1||6||
48495162|NCT04631562|101545285|FG008|NOT COMPLETED|Overall Study||1||
48495163|NCT00725322|101545286|FG000|STARTED|First Injection Visit||15||
48495164|NCT00725322|101545287|FG001|STARTED|First Injection Visit||15||
48201554|NCT01981850|100817840|FG003|STARTED|Main Phase Stage 1||6||
48201555|NCT01981850|100817841|FG004|STARTED|Main Phase Stage 1||0||
48201556|NCT01981850|100817842|FG005|STARTED|Main Phase Stage 1||0||
48201557|NCT01981850|100817843|FG006|STARTED|Main Phase Stage 1||0||
48201558|NCT01981850|100817844|FG007|STARTED|Main Phase Stage 1||0||
48201559|NCT01981850|100817845|FG008|STARTED|Main Phase Stage 1||0||
48201560|NCT01981850|100817846|FG009|STARTED|Main Phase Stage 1||0||
48495165|NCT00725322|101545286|FG000|COMPLETED|First Injection Visit||15||
48201561|NCT01981850|100817837|FG000|COMPLETED|Main Phase Stage 1||5|Main Study|
48495166|NCT00725322|101545287|FG001|COMPLETED|First Injection Visit||15||
48495167|NCT00725322|101545286|FG000|NOT COMPLETED|First Injection Visit||0||
48201562|NCT01981850|100817838|FG001|COMPLETED|Main Phase Stage 1||5|Main Study|
48201563|NCT01981850|100817839|FG002|COMPLETED|Main Phase Stage 1||4|Main Study|
48201564|NCT01981850|100817840|FG003|COMPLETED|Main Phase Stage 1||6|Main Study|
48201565|NCT01981850|100817841|FG004|COMPLETED|Main Phase Stage 1||0|Main Study|
48201566|NCT01981850|100817842|FG005|COMPLETED|Main Phase Stage 1||0|Main Study|
48201567|NCT01981850|100817843|FG006|COMPLETED|Main Phase Stage 1||0|Main Study|
48201568|NCT01981850|100817844|FG007|COMPLETED|Main Phase Stage 1||0|Main Study|
48201569|NCT01981850|100817845|FG008|COMPLETED|Main Phase Stage 1||0|Main Study|
48201570|NCT01981850|100817846|FG009|COMPLETED|Main Phase Stage 1||0|Main Study|
48201571|NCT01981850|100817837|FG000|NOT COMPLETED|Main Phase Stage 1||3||
48495168|NCT00725322|101545287|FG001|NOT COMPLETED|First Injection Visit||0||
48495169|NCT00725322|101545286|FG000|STARTED|Washout (28 Days)||15||
48495170|NCT00725322|101545287|FG001|STARTED|Washout (28 Days)||15||
48495171|NCT00725322|101545286|FG000|COMPLETED|Washout (28 Days)||13||
48495172|NCT00725322|101545287|FG001|COMPLETED|Washout (28 Days)||14||
48495173|NCT00725322|101545286|FG000|NOT COMPLETED|Washout (28 Days)||2||
48495174|NCT00725322|101545287|FG001|NOT COMPLETED|Washout (28 Days)||1||
48495175|NCT00725322|101545286|FG000|STARTED|Second Injection Visit||13||
48495176|NCT00725322|101545287|FG001|STARTED|Second Injection Visit||14||
48495177|NCT00725322|101545286|FG000|COMPLETED|Second Injection Visit||13||
48495178|NCT00725322|101545287|FG001|COMPLETED|Second Injection Visit||14||
48495179|NCT00725322|101545286|FG000|NOT COMPLETED|Second Injection Visit||0||
48495180|NCT00725322|101545287|FG001|NOT COMPLETED|Second Injection Visit||0||
48495181|NCT00178178|101545288|FG000|STARTED|Overall Study||24||
48201572|NCT01981850|100817838|FG001|NOT COMPLETED|Main Phase Stage 1||2||
48201573|NCT01981850|100817839|FG002|NOT COMPLETED|Main Phase Stage 1||2||
48201574|NCT01981850|100817840|FG003|NOT COMPLETED|Main Phase Stage 1||0||
48201575|NCT01981850|100817841|FG004|NOT COMPLETED|Main Phase Stage 1||0||
48201576|NCT01981850|100817842|FG005|NOT COMPLETED|Main Phase Stage 1||0||
48201577|NCT01981850|100817843|FG006|NOT COMPLETED|Main Phase Stage 1||0||
48201578|NCT01981850|100817844|FG007|NOT COMPLETED|Main Phase Stage 1||0||
48201579|NCT01981850|100817845|FG008|NOT COMPLETED|Main Phase Stage 1||0||
48201580|NCT01981850|100817846|FG009|NOT COMPLETED|Main Phase Stage 1||0||
48201581|NCT01981850|100817837|FG000|STARTED|Main Phase Stage 2||0||
48201582|NCT01981850|100817838|FG001|STARTED|Main Phase Stage 2||0||
48201583|NCT01981850|100817839|FG002|STARTED|Main Phase Stage 2||0||
48201584|NCT01981850|100817840|FG003|STARTED|Main Phase Stage 2||0||
48201585|NCT01981850|100817841|FG004|STARTED|Main Phase Stage 2||33||
48201586|NCT01981850|100817842|FG005|STARTED|Main Phase Stage 2||32||
48201587|NCT01981850|100817843|FG006|STARTED|Main Phase Stage 2||32||
48201588|NCT01981850|100817844|FG007|STARTED|Main Phase Stage 2||0||
48201589|NCT01981850|100817845|FG008|STARTED|Main Phase Stage 2||0||
48201590|NCT01981850|100817846|FG009|STARTED|Main Phase Stage 2||0||
48201591|NCT01981850|100817837|FG000|COMPLETED|Main Phase Stage 2||0|Main Study|
48201592|NCT01981850|100817838|FG001|COMPLETED|Main Phase Stage 2||0|Main Study|
48201593|NCT01981850|100817839|FG002|COMPLETED|Main Phase Stage 2||0|Main Study|
48201594|NCT01981850|100817840|FG003|COMPLETED|Main Phase Stage 2||0|Main Study|
48201595|NCT01981850|100817841|FG004|COMPLETED|Main Phase Stage 2||20|Main Study|
48201596|NCT01981850|100817842|FG005|COMPLETED|Main Phase Stage 2||16|Main Study|
48201597|NCT01981850|100817843|FG006|COMPLETED|Main Phase Stage 2||15|Main Study|
48201598|NCT01981850|100817844|FG007|COMPLETED|Main Phase Stage 2||0|Main Study|
48201599|NCT01981850|100817845|FG008|COMPLETED|Main Phase Stage 2||0|Main Study|
48201600|NCT01981850|100817846|FG009|COMPLETED|Main Phase Stage 2||0|Main Study|
48201601|NCT01981850|100817837|FG000|NOT COMPLETED|Main Phase Stage 2||0||
48201602|NCT01981850|100817838|FG001|NOT COMPLETED|Main Phase Stage 2||0||
48201603|NCT01981850|100817839|FG002|NOT COMPLETED|Main Phase Stage 2||0||
48201604|NCT01981850|100817840|FG003|NOT COMPLETED|Main Phase Stage 2||0||
48201605|NCT01981850|100817841|FG004|NOT COMPLETED|Main Phase Stage 2||13||
48201606|NCT01981850|100817842|FG005|NOT COMPLETED|Main Phase Stage 2||16||
48201607|NCT01981850|100817843|FG006|NOT COMPLETED|Main Phase Stage 2||17||
48201608|NCT01981850|100817844|FG007|NOT COMPLETED|Main Phase Stage 2||0||
48201609|NCT01981850|100817845|FG008|NOT COMPLETED|Main Phase Stage 2||0||
48201610|NCT01981850|100817846|FG009|NOT COMPLETED|Main Phase Stage 2||0||
48201611|NCT01981850|100817837|FG000|STARTED|Open Label Extension (OLE)||0|Continued in OLE|
48495182|NCT00178178|101545289|FG001|STARTED|Overall Study||24||
48495183|NCT00178178|101545290|FG002|STARTED|Overall Study||24||
48495184|NCT00178178|101545291|FG003|STARTED|Overall Study||24||
48201612|NCT01981850|100817838|FG001|STARTED|Open Label Extension (OLE)||0|Continued in OLE|
48201613|NCT01981850|100817839|FG002|STARTED|Open Label Extension (OLE)||0|Continued in OLE|
48201614|NCT01981850|100817840|FG003|STARTED|Open Label Extension (OLE)||0|Continued in OLE|
48201615|NCT01981850|100817841|FG004|STARTED|Open Label Extension (OLE)||0|Continued in OLE|
48201616|NCT01981850|100817842|FG005|STARTED|Open Label Extension (OLE)||0|Continued in OLE|
48201617|NCT01981850|100817843|FG006|STARTED|Open Label Extension (OLE)||0|Continued in OLE|
48495185|NCT00178178|101545288|FG000|COMPLETED|Overall Study||24||
48495186|NCT00178178|101545289|FG001|COMPLETED|Overall Study||24||
48495187|NCT00178178|101545290|FG002|COMPLETED|Overall Study||24||
48201618|NCT01981850|100817844|FG007|STARTED|Open Label Extension (OLE)||13|Continued in OLE|
48201619|NCT01981850|100817845|FG008|STARTED|Open Label Extension (OLE)||5|Continued in OLE|
48201620|NCT01981850|100817846|FG009|STARTED|Open Label Extension (OLE)||48|Continued in OLE|
48201621|NCT01981850|100817837|FG000|COMPLETED|Open Label Extension (OLE)||0||
48201622|NCT01981850|100817838|FG001|COMPLETED|Open Label Extension (OLE)||0||
48201623|NCT01981850|100817839|FG002|COMPLETED|Open Label Extension (OLE)||0||
48201624|NCT01981850|100817840|FG003|COMPLETED|Open Label Extension (OLE)||0||
48201625|NCT01981850|100817841|FG004|COMPLETED|Open Label Extension (OLE)||0||
48201626|NCT01981850|100817842|FG005|COMPLETED|Open Label Extension (OLE)||0||
48201627|NCT01981850|100817843|FG006|COMPLETED|Open Label Extension (OLE)||0||
48201628|NCT01981850|100817844|FG007|COMPLETED|Open Label Extension (OLE)||1||
48201629|NCT01981850|100817845|FG008|COMPLETED|Open Label Extension (OLE)||0||
48201630|NCT01981850|100817846|FG009|COMPLETED|Open Label Extension (OLE)||0||
48201631|NCT01981850|100817837|FG000|NOT COMPLETED|Open Label Extension (OLE)||0||
48201632|NCT01981850|100817838|FG001|NOT COMPLETED|Open Label Extension (OLE)||0||
48201633|NCT01981850|100817839|FG002|NOT COMPLETED|Open Label Extension (OLE)||0||
48201634|NCT01981850|100817840|FG003|NOT COMPLETED|Open Label Extension (OLE)||0||
48201635|NCT01981850|100817841|FG004|NOT COMPLETED|Open Label Extension (OLE)||0||
48201636|NCT01981850|100817842|FG005|NOT COMPLETED|Open Label Extension (OLE)||0||
48201637|NCT01981850|100817843|FG006|NOT COMPLETED|Open Label Extension (OLE)||0||
48201638|NCT01981850|100817844|FG007|NOT COMPLETED|Open Label Extension (OLE)||12||
48201639|NCT01981850|100817845|FG008|NOT COMPLETED|Open Label Extension (OLE)||5||
48201640|NCT01981850|100817846|FG009|NOT COMPLETED|Open Label Extension (OLE)||48||
48201641|NCT00696618|100817847|FG000|STARTED|Overall Study||3||
48201642|NCT00696618|100817848|FG001|STARTED|Overall Study||3||
48201643|NCT00696618|100817849|FG002|STARTED|Overall Study||3||
48201644|NCT00696618|100817847|FG000|COMPLETED|Overall Study||3||
48201645|NCT00696618|100817848|FG001|COMPLETED|Overall Study||3||
48201646|NCT00696618|100817849|FG002|COMPLETED|Overall Study||3||
48201647|NCT00696618|100817847|FG000|NOT COMPLETED|Overall Study||0||
48201648|NCT00696618|100817848|FG001|NOT COMPLETED|Overall Study||0||
48201649|NCT00696618|100817849|FG002|NOT COMPLETED|Overall Study||0||
48201650|NCT02148133|100817850|FG000|STARTED|Overall Study||21|Full Analysis Set (FAS)|
48201651|NCT02148133|100817850|FG000|Safety Set (SS)|Overall Study||21|All patients who were treated with eltrombopag at least once|
48201652|NCT02148133|100817850|FG000|Pharmacokinetic Analysis Set (PAS)|Overall Study||21|All patients who provided Pharmacokinetics (PK) serum samples|
48201653|NCT02148133|100817850|FG000|COMPLETED|Overall Study||16||
48201654|NCT02148133|100817850|FG000|NOT COMPLETED|Overall Study||5||
48201655|NCT00906035|100817851|FG000|STARTED|Overall Study||8||
48201656|NCT00906035|100817852|FG001|STARTED|Overall Study||9||
48201657|NCT00906035|100817853|FG002|STARTED|Overall Study||8||
48201658|NCT00906035|100817851|FG000|COMPLETED|Overall Study||6||
48201659|NCT00906035|100817852|FG001|COMPLETED|Overall Study||6||
48201660|NCT00906035|100817853|FG002|COMPLETED|Overall Study||8||
48201661|NCT00906035|100817851|FG000|NOT COMPLETED|Overall Study||2||
48201662|NCT00906035|100817852|FG001|NOT COMPLETED|Overall Study||3||
48201663|NCT00906035|100817853|FG002|NOT COMPLETED|Overall Study||0||
48201664|NCT00128193|100817854|FG000|STARTED|Overall Study||5||
48201665|NCT00128193|100817855|FG001|STARTED|Overall Study||5||
48201666|NCT00128193|100817856|FG002|STARTED|Overall Study||45||
48201667|NCT00128193|100817857|FG003|STARTED|Overall Study||45||
48201668|NCT00128193|100817858|FG004|STARTED|Overall Study||20||
48201669|NCT00128193|100817859|FG005|STARTED|Overall Study||20||
48201670|NCT00128193|100817860|FG006|STARTED|Overall Study||20||
48201671|NCT00128193|100817861|FG007|STARTED|Overall Study||20||
48201672|NCT00128193|100817862|FG008|STARTED|Overall Study||20||
48201673|NCT00128193|100817863|FG009|STARTED|Overall Study||20||
48201674|NCT00128193|100817864|FG010|STARTED|Overall Study||20||
48201675|NCT00128193|100817865|FG011|STARTED|Overall Study||20||
48201676|NCT00128193|100817854|FG000|COMPLETED|Overall Study||5||
48201677|NCT00128193|100817855|FG001|COMPLETED|Overall Study||5||
48201678|NCT00128193|100817856|FG002|COMPLETED|Overall Study||42||
48201679|NCT00128193|100817857|FG003|COMPLETED|Overall Study||44||
48201680|NCT00128193|100817858|FG004|COMPLETED|Overall Study||18||
48201681|NCT00128193|100817859|FG005|COMPLETED|Overall Study||17||
48201682|NCT00128193|100817860|FG006|COMPLETED|Overall Study||16||
48201683|NCT00128193|100817861|FG007|COMPLETED|Overall Study||20||
48201684|NCT00128193|100817862|FG008|COMPLETED|Overall Study||18||
48201685|NCT00128193|100817863|FG009|COMPLETED|Overall Study||18||
48201686|NCT00128193|100817864|FG010|COMPLETED|Overall Study||17||
48201687|NCT00128193|100817865|FG011|COMPLETED|Overall Study||18||
48201688|NCT00128193|100817854|FG000|NOT COMPLETED|Overall Study||0||
48201689|NCT00128193|100817855|FG001|NOT COMPLETED|Overall Study||0||
48201690|NCT00128193|100817856|FG002|NOT COMPLETED|Overall Study||3||
48201691|NCT00128193|100817857|FG003|NOT COMPLETED|Overall Study||1||
48201692|NCT00128193|100817858|FG004|NOT COMPLETED|Overall Study||2||
48201693|NCT00128193|100817859|FG005|NOT COMPLETED|Overall Study||3||
48201694|NCT00128193|100817860|FG006|NOT COMPLETED|Overall Study||4||
48201695|NCT00128193|100817861|FG007|NOT COMPLETED|Overall Study||0||
48201696|NCT00128193|100817862|FG008|NOT COMPLETED|Overall Study||2||
48201697|NCT00128193|100817863|FG009|NOT COMPLETED|Overall Study||2||
48201698|NCT00128193|100817864|FG010|NOT COMPLETED|Overall Study||3||
48201699|NCT00128193|100817865|FG011|NOT COMPLETED|Overall Study||2||
48201700|NCT02914522|100817866|FG000|STARTED|Induction Study: Up to Week 11||245||
48201701|NCT02914522|100817867|FG001|STARTED|Induction Study: Up to Week 11||278||
48201702|NCT02914522|100817868|FG002|STARTED|Induction Study: Up to Week 11||137||
48201703|NCT02914522|100817869|FG003|STARTED|Induction Study: Up to Week 11||262||
48201704|NCT02914522|100817870|FG004|STARTED|Induction Study: Up to Week 11||286||
48201705|NCT02914522|100817871|FG005|STARTED|Induction Study: Up to Week 11||143||
48201706|NCT02914522|100817872|FG006|STARTED|Induction Study: Up to Week 11||0||
48201707|NCT02914522|100817873|FG007|STARTED|Induction Study: Up to Week 11||0||
48201708|NCT02914522|100817874|FG008|STARTED|Induction Study: Up to Week 11||0||
48201709|NCT02914522|100817875|FG009|STARTED|Induction Study: Up to Week 11||0||
48201710|NCT02914522|100817876|FG010|STARTED|Induction Study: Up to Week 11||0||
48201711|NCT02914522|100817866|FG000|COMPLETED|Induction Study: Up to Week 11||235||
48201712|NCT02914522|100817867|FG001|COMPLETED|Induction Study: Up to Week 11||256||
48201713|NCT02914522|100817868|FG002|COMPLETED|Induction Study: Up to Week 11||127||
48201714|NCT02914522|100817869|FG003|COMPLETED|Induction Study: Up to Week 11||234||
48201715|NCT02914522|100817870|FG004|COMPLETED|Induction Study: Up to Week 11||262||
48201716|NCT02914522|100817871|FG005|COMPLETED|Induction Study: Up to Week 11||127||
48201717|NCT02914522|100817872|FG006|COMPLETED|Induction Study: Up to Week 11||0||
48201718|NCT02914522|100817873|FG007|COMPLETED|Induction Study: Up to Week 11||0||
48201719|NCT02914522|100817874|FG008|COMPLETED|Induction Study: Up to Week 11||0||
48201720|NCT02914522|100817875|FG009|COMPLETED|Induction Study: Up to Week 11||0||
48201721|NCT02914522|100817876|FG010|COMPLETED|Induction Study: Up to Week 11||0||
48201722|NCT02914522|100817866|FG000|NOT COMPLETED|Induction Study: Up to Week 11||10||
48201723|NCT02914522|100817867|FG001|NOT COMPLETED|Induction Study: Up to Week 11||22||
48201724|NCT02914522|100817868|FG002|NOT COMPLETED|Induction Study: Up to Week 11||10||
48201725|NCT02914522|100817869|FG003|NOT COMPLETED|Induction Study: Up to Week 11||28||
48201726|NCT02914522|100817870|FG004|NOT COMPLETED|Induction Study: Up to Week 11||24||
48201727|NCT02914522|100817871|FG005|NOT COMPLETED|Induction Study: Up to Week 11||16||
48201728|NCT02914522|100817872|FG006|NOT COMPLETED|Induction Study: Up to Week 11||0||
48201729|NCT02914522|100817873|FG007|NOT COMPLETED|Induction Study: Up to Week 11||0||
48495188|NCT00178178|101545291|FG003|COMPLETED|Overall Study||24||
48495189|NCT00178178|101545288|FG000|NOT COMPLETED|Overall Study||0||
48201730|NCT02914522|100817874|FG008|NOT COMPLETED|Induction Study: Up to Week 11||0||
48201731|NCT02914522|100817875|FG009|NOT COMPLETED|Induction Study: Up to Week 11||0||
48201732|NCT02914522|100817876|FG010|NOT COMPLETED|Induction Study: Up to Week 11||0||
48201733|NCT02914522|100817866|FG000|STARTED|Maintenance Study: Week 11 to Week 58||0||
48201734|NCT02914522|100817867|FG001|STARTED|Maintenance Study: Week 11 to Week 58||0||
48201735|NCT02914522|100817868|FG002|STARTED|Maintenance Study: Week 11 to Week 58||0||
48201736|NCT02914522|100817869|FG003|STARTED|Maintenance Study: Week 11 to Week 58||0||
48201737|NCT02914522|100817870|FG004|STARTED|Maintenance Study: Week 11 to Week 58||0||
48495190|NCT00178178|101545289|FG001|NOT COMPLETED|Overall Study||0||
48201738|NCT02914522|100817871|FG005|STARTED|Maintenance Study: Week 11 to Week 58||0||
48201739|NCT02914522|100817872|FG006|STARTED|Maintenance Study: Week 11 to Week 58||202||
48201740|NCT02914522|100817873|FG007|STARTED|Maintenance Study: Week 11 to Week 58||99||
48495191|NCT00178178|101545290|FG002|NOT COMPLETED|Overall Study||0||
48201741|NCT02914522|100817874|FG008|STARTED|Maintenance Study: Week 11 to Week 58||179||
48201742|NCT02914522|100817875|FG009|STARTED|Maintenance Study: Week 11 to Week 58||91||
48201743|NCT02914522|100817876|FG010|STARTED|Maintenance Study: Week 11 to Week 58||93||
48201744|NCT02914522|100817866|FG000|COMPLETED|Maintenance Study: Week 11 to Week 58||0||
48201745|NCT02914522|100817867|FG001|COMPLETED|Maintenance Study: Week 11 to Week 58||0||
48201746|NCT02914522|100817868|FG002|COMPLETED|Maintenance Study: Week 11 to Week 58||0||
48201747|NCT02914522|100817869|FG003|COMPLETED|Maintenance Study: Week 11 to Week 58||0||
48201748|NCT02914522|100817870|FG004|COMPLETED|Maintenance Study: Week 11 to Week 58||0||
48201749|NCT02914522|100817871|FG005|COMPLETED|Maintenance Study: Week 11 to Week 58||0||
48201750|NCT02914522|100817872|FG006|COMPLETED|Maintenance Study: Week 11 to Week 58||150||
48201751|NCT02914522|100817873|FG007|COMPLETED|Maintenance Study: Week 11 to Week 58||41||
48201752|NCT02914522|100817874|FG008|COMPLETED|Maintenance Study: Week 11 to Week 58||104||
48201753|NCT02914522|100817875|FG009|COMPLETED|Maintenance Study: Week 11 to Week 58||42||
48201754|NCT02914522|100817876|FG010|COMPLETED|Maintenance Study: Week 11 to Week 58||64||
48201755|NCT02914522|100817866|FG000|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0||
48201756|NCT02914522|100817867|FG001|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0||
48201757|NCT02914522|100817868|FG002|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0||
48201758|NCT02914522|100817869|FG003|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0||
48201759|NCT02914522|100817870|FG004|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0||
48201760|NCT02914522|100817871|FG005|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0||
48201761|NCT02914522|100817872|FG006|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||52||
48201762|NCT02914522|100817873|FG007|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||58||
48201763|NCT02914522|100817874|FG008|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||75||
48201764|NCT02914522|100817875|FG009|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||49||
48495192|NCT00178178|101545291|FG003|NOT COMPLETED|Overall Study||0||
48201765|NCT02914522|100817876|FG010|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||29||
48201766|NCT00964119|100817877|FG000|STARTED|Overall Study||15||
48495193|NCT03218787|101545292|FG000|STARTED|Overall Study||2047||
48201767|NCT00964119|100817877|FG000|COMPLETED|Overall Study||15||
48201768|NCT00964119|100817877|FG000|NOT COMPLETED|Overall Study||0||
48201769|NCT00385801|100817878|FG000|STARTED|Overall Study||15||
48201770|NCT00385801|100817879|FG001|STARTED|Overall Study||16||
48201771|NCT00385801|100817878|FG000|COMPLETED|Overall Study||6||
48201772|NCT00385801|100817879|FG001|COMPLETED|Overall Study||8||
48201773|NCT00385801|100817878|FG000|NOT COMPLETED|Overall Study||9||
48201774|NCT00385801|100817879|FG001|NOT COMPLETED|Overall Study||8||
48201775|NCT04008836|100817880|FG000|STARTED|Overall Study||384||
48495194|NCT03218787|101545292|FG000|COMPLETED|Overall Study||1841||
48495195|NCT03218787|101545292|FG000|NOT COMPLETED|Overall Study||206||
48495196|NCT02052895|101545293|FG000|STARTED|Overall Study||196||
48201776|NCT04008836|100817880|FG000|COMPLETED|Overall Study||384||
48201777|NCT04008836|100817880|FG000|NOT COMPLETED|Overall Study||0||
48201778|NCT01320072|100817881|FG000|STARTED|Overall Study||16||
48201779|NCT01320072|100817882|FG001|STARTED|Overall Study||13||
48201780|NCT01320072|100817881|FG000|COMPLETED|Overall Study||16||
48495197|NCT02052895|101545294|FG001|STARTED|Overall Study||15||
48495198|NCT02052895|101545295|FG002|STARTED|Overall Study||15||
48495199|NCT02052895|101545293|FG000|COMPLETED|Overall Study||196||
48495200|NCT02052895|101545294|FG001|COMPLETED|Overall Study||15||
48495201|NCT02052895|101545295|FG002|COMPLETED|Overall Study||15||
48495202|NCT02052895|101545293|FG000|NOT COMPLETED|Overall Study||0||
48495203|NCT02052895|101545294|FG001|NOT COMPLETED|Overall Study||0||
48495204|NCT02052895|101545295|FG002|NOT COMPLETED|Overall Study||0||
48495205|NCT00730691|101545296|FG000|STARTED|Overall Study||157||
48495206|NCT00730691|101545297|FG001|STARTED|Overall Study||156||
48201781|NCT01320072|100817882|FG001|COMPLETED|Overall Study||13||
48201782|NCT01320072|100817881|FG000|NOT COMPLETED|Overall Study||0||
48201783|NCT01320072|100817882|FG001|NOT COMPLETED|Overall Study||0||
48201784|NCT01591616|100817883|FG000|STARTED|Overall Study||16||
48201785|NCT01591616|100817883|FG000|COMPLETED|Overall Study||15||
48201786|NCT01591616|100817883|FG000|NOT COMPLETED|Overall Study||1||
48201787|NCT00038103|100817884|FG000|STARTED|Overall Study||55||
48201788|NCT00038103|100817885|FG001|STARTED|Overall Study||56||
48201789|NCT00038103|100817884|FG000|End of Treatment|Overall Study||53||
48201790|NCT00038103|100817885|FG001|End of Treatment|Overall Study||56||
48201791|NCT00038103|100817884|FG000|COMPLETED|Overall Study||0||
48201792|NCT00038103|100817885|FG001|COMPLETED|Overall Study||0||
48201793|NCT00038103|100817884|FG000|NOT COMPLETED|Overall Study||55||
48201794|NCT00038103|100817885|FG001|NOT COMPLETED|Overall Study||56||
48201795|NCT00028093|100817886|FG000|STARTED|Overall Study||25||
48201796|NCT00028093|100817887|FG001|STARTED|Overall Study||25||
48201797|NCT00028093|100817886|FG000|COMPLETED|Overall Study||25||
48201798|NCT00028093|100817887|FG001|COMPLETED|Overall Study||25||
48201799|NCT00028093|100817886|FG000|NOT COMPLETED|Overall Study||0||
48201800|NCT00028093|100817887|FG001|NOT COMPLETED|Overall Study||0||
48201801|NCT02613364|100817888|FG000|STARTED|Overall Study||251||
48201802|NCT02613364|100817889|FG001|STARTED|Overall Study||238||
48201803|NCT02613364|100817890|FG002|STARTED|Overall Study||251||
48201804|NCT02613364|100817888|FG000|COMPLETED|Overall Study||185||
48201805|NCT02613364|100817889|FG001|COMPLETED|Overall Study||148||
48201806|NCT02613364|100817890|FG002|COMPLETED|Overall Study||175||
48201807|NCT02613364|100817888|FG000|NOT COMPLETED|Overall Study||66||
48201808|NCT02613364|100817889|FG001|NOT COMPLETED|Overall Study||90||
48201809|NCT02613364|100817890|FG002|NOT COMPLETED|Overall Study||76||
48201810|NCT01078246|100817891|FG000|STARTED|Overall Study||1041||
48201811|NCT01078246|100817892|FG001|STARTED|Overall Study||405||
48201812|NCT01078246|100817893|FG002|STARTED|Overall Study||1963||
48201813|NCT01078246|100817894|FG003|STARTED|Overall Study||152||
48201814|NCT01078246|100817895|FG004|STARTED|Overall Study||3310||
48201815|NCT01078246|100817896|FG005|STARTED|Overall Study||231||
48201816|NCT01078246|100817897|FG006|STARTED|Overall Study||22||
48201817|NCT01078246|100817891|FG000|COMPLETED|Overall Study||1041||
48201818|NCT01078246|100817892|FG001|COMPLETED|Overall Study||405||
48201819|NCT01078246|100817893|FG002|COMPLETED|Overall Study||1963||
48201820|NCT01078246|100817894|FG003|COMPLETED|Overall Study||152||
48201821|NCT01078246|100817895|FG004|COMPLETED|Overall Study||3310||
48201822|NCT01078246|100817896|FG005|COMPLETED|Overall Study||231||
48201823|NCT01078246|100817897|FG006|COMPLETED|Overall Study||22||
48201824|NCT01078246|100817891|FG000|NOT COMPLETED|Overall Study||0||
48201825|NCT01078246|100817892|FG001|NOT COMPLETED|Overall Study||0||
48201826|NCT01078246|100817893|FG002|NOT COMPLETED|Overall Study||0||
48201827|NCT01078246|100817894|FG003|NOT COMPLETED|Overall Study||0||
48201828|NCT01078246|100817895|FG004|NOT COMPLETED|Overall Study||0||
48201829|NCT01078246|100817896|FG005|NOT COMPLETED|Overall Study||0||
48201830|NCT01078246|100817897|FG006|NOT COMPLETED|Overall Study||0||
48201831|NCT02459899|100817898|FG000|STARTED|Overall Study||36||
48201832|NCT02459899|100817899|FG001|STARTED|Overall Study||35||
48201833|NCT02459899|100817900|FG002|STARTED|Overall Study||35||
48201834|NCT02459899|100817901|FG003|STARTED|Overall Study||35||
48201835|NCT02459899|100817898|FG000|COMPLETED|Overall Study||33||
48201836|NCT02459899|100817899|FG001|COMPLETED|Overall Study||29||
48201837|NCT02459899|100817900|FG002|COMPLETED|Overall Study||35||
48201838|NCT02459899|100817901|FG003|COMPLETED|Overall Study||33||
48201839|NCT02459899|100817898|FG000|NOT COMPLETED|Overall Study||3||
48201840|NCT02459899|100817899|FG001|NOT COMPLETED|Overall Study||6||
48201841|NCT02459899|100817900|FG002|NOT COMPLETED|Overall Study||0||
48201842|NCT02459899|100817901|FG003|NOT COMPLETED|Overall Study||2||
48201843|NCT00771849|100817902|FG000|STARTED|Overall Study||52||
48201844|NCT00771849|100817903|FG001|STARTED|Overall Study||51||
48201845|NCT00771849|100817902|FG000|COMPLETED|Overall Study||50||
48201846|NCT00771849|100817903|FG001|COMPLETED|Overall Study||47||
48201847|NCT00771849|100817902|FG000|NOT COMPLETED|Overall Study||2||
48201848|NCT00771849|100817903|FG001|NOT COMPLETED|Overall Study||4||
48201849|NCT00559949|100817904|FG000|STARTED|Overall Study||39||
48201850|NCT00559949|100817904|FG000|COMPLETED|Overall Study||32||
48201851|NCT00559949|100817904|FG000|NOT COMPLETED|Overall Study||7||
48201852|NCT03537651|100817905|FG000|STARTED|Part A (Up to 96 Weeks)||130||
48201853|NCT03537651|100817905|FG000|113B/116 FAS|Part A (Up to 96 Weeks)||64|All enrolled participants from parent Study 113B who received at least 1 dose of TEZ/IVA in Study 116 and had an eligible genotype.|
48201854|NCT03537651|100817905|FG000|113B/116 LCI FAS|Part A (Up to 96 Weeks)||30|All enrolled participants who participated in the LCI sub study in parent Study 113B and received at least 1 dose of TEZ/IVA in Study 116 and had an eligible genotype.|
48201855|NCT03537651|100817905|FG000|115/116 FAS|Part A (Up to 96 Weeks)||66|All enrolled participants who were randomized to either TEZ/IVA, IVA or placebo treatment group in parent Study 115 and received at least 1 dose of TEZ/IVA in Study 116 and had an eligible genotype.|
48201856|NCT03537651|100817905|FG000|115/116 FAS (TEZ/IVA Group)|Part A (Up to 96 Weeks)||53|All enrolled participants who were randomized to the TEZ/IVA treatment group in parent Study 115 and received at least 1 dose of TEZ/IVA in Study 116 and had an eligible genotype.|
48201857|NCT03537651|100817905|FG000|COMPLETED|Part A (Up to 96 Weeks)||69||
48201858|NCT03537651|100817905|FG000|NOT COMPLETED|Part A (Up to 96 Weeks)||61||
48201859|NCT03537651|100817905|FG000|STARTED|Part B (Up to 192 Weeks)||62||
48201860|NCT03537651|100817905|FG000|113B/116 FAS|Part B (Up to 192 Weeks)||9|All enrolled participants from parent Study 113B who received at least 1 dose of TEZ/IVA in Study 116 and had an eligible genotype.|
48495207|NCT00730691|101545298|FG002|STARTED|Overall Study||156||
48495208|NCT00730691|101545299|FG003|STARTED|Overall Study||156||
48495209|NCT00730691|101545300|FG004|STARTED|Overall Study||156||
48495210|NCT00730691|101545296|FG000|COMPLETED|Overall Study||121||
48495211|NCT00730691|101545297|FG001|COMPLETED|Overall Study||120||
48495212|NCT00730691|101545298|FG002|COMPLETED|Overall Study||117||
48495213|NCT00730691|101545299|FG003|COMPLETED|Overall Study||111||
48495214|NCT00730691|101545300|FG004|COMPLETED|Overall Study||106||
48495215|NCT00730691|101545296|FG000|NOT COMPLETED|Overall Study||36||
48495216|NCT00730691|101545297|FG001|NOT COMPLETED|Overall Study||36||
48495217|NCT00730691|101545298|FG002|NOT COMPLETED|Overall Study||39||
48495218|NCT00730691|101545299|FG003|NOT COMPLETED|Overall Study||45||
48495219|NCT00730691|101545300|FG004|NOT COMPLETED|Overall Study||50||
48495220|NCT00540423|101545301|FG000|STARTED|Double-Blind Treatment Period||8||
48495221|NCT00540423|101545302|FG001|STARTED|Double-Blind Treatment Period||15||
48495222|NCT00540423|101545303|FG002|STARTED|Double-Blind Treatment Period||0||
48201861|NCT03537651|100817905|FG000|115/116 FAS|Part B (Up to 192 Weeks)||53|All enrolled participants who were randomized to either TEZ/IVA, IVA or placebo treatment group in parent Study 115 and received at least 1 dose of TEZ/IVA in Study 116 and had an eligible genotype.|
48201862|NCT03537651|100817905|FG000|COMPLETED|Part B (Up to 192 Weeks)||3||
48201863|NCT03537651|100817905|FG000|NOT COMPLETED|Part B (Up to 192 Weeks)||59||
48201864|NCT02685033|100817906|FG000|STARTED|Overall Study||70||
48201865|NCT02685033|100817907|FG001|STARTED|Overall Study||10||
48201866|NCT02685033|100817906|FG000|COMPLETED|Overall Study||67||
48201867|NCT02685033|100817907|FG001|COMPLETED|Overall Study||8||
48201868|NCT02685033|100817906|FG000|NOT COMPLETED|Overall Study||3||
48201869|NCT02685033|100817907|FG001|NOT COMPLETED|Overall Study||2||
48201870|NCT01490580|100817908|FG000|STARTED|Overall Study||82||
48201871|NCT01490580|100817909|FG001|STARTED|Overall Study||91||
48201872|NCT01490580|100817908|FG000|COMPLETED|Overall Study||82||
48201873|NCT01490580|100817909|FG001|COMPLETED|Overall Study||89||
48201874|NCT01490580|100817908|FG000|NOT COMPLETED|Overall Study||0||
48201875|NCT01490580|100817909|FG001|NOT COMPLETED|Overall Study||2||
48201876|NCT00256243|100817910|FG000|STARTED|Overall Study||48||
48201877|NCT00256243|100817910|FG000|COMPLETED|Overall Study||38||
48201878|NCT00256243|100817910|FG000|NOT COMPLETED|Overall Study||10||
48201879|NCT04059237|100817911|FG000|STARTED|Overall Study||98||
48201880|NCT04059237|100817911|FG000|Completed Baseline Assessment|Overall Study||98||
48201881|NCT04059237|100817911|FG000|Completed 1-month Assessment|Overall Study||78||
48201882|NCT04059237|100817911|FG000|Completed 3-month Assessment|Overall Study||55||
48201883|NCT04059237|100817911|FG000|COMPLETED|Overall Study||55||
48201884|NCT04059237|100817911|FG000|NOT COMPLETED|Overall Study||43||
48201885|NCT00762606|100817912|FG000|STARTED|Overall Study||55||
48201886|NCT00762606|100817913|FG001|STARTED|Overall Study||51||
48201887|NCT00762606|100817912|FG000|COMPLETED|Overall Study||37||
48201888|NCT00762606|100817913|FG001|COMPLETED|Overall Study||38||
48201889|NCT00762606|100817912|FG000|NOT COMPLETED|Overall Study||18||
48201890|NCT00762606|100817913|FG001|NOT COMPLETED|Overall Study||13||
48201891|NCT02001714|100817914|FG000|STARTED|Overall Study||232||
48201892|NCT02001714|100817915|FG001|STARTED|Overall Study||231||
48201893|NCT02001714|100817914|FG000|COMPLETED|Overall Study||210||
48201894|NCT02001714|100817915|FG001|COMPLETED|Overall Study||219||
48201895|NCT02001714|100817914|FG000|NOT COMPLETED|Overall Study||22||
48201896|NCT02001714|100817915|FG001|NOT COMPLETED|Overall Study||12||
48201897|NCT03193619|100817916|FG000|STARTED|Overall Study||350||
48201898|NCT03193619|100817916|FG000|COMPLETED|Overall Study||349||
48201899|NCT03193619|100817916|FG000|NOT COMPLETED|Overall Study||1||
48201900|NCT01192542|100817917|FG000|STARTED|Period 1||18||
48201901|NCT01192542|100817918|FG001|STARTED|Period 1||20||
48201902|NCT01192542|100817917|FG000|COMPLETED|Period 1||18||
48201903|NCT01192542|100817918|FG001|COMPLETED|Period 1||20||
48201904|NCT01192542|100817917|FG000|NOT COMPLETED|Period 1||0||
48201905|NCT01192542|100817918|FG001|NOT COMPLETED|Period 1||0||
48495223|NCT00540423|101545301|FG000|COMPLETED|Double-Blind Treatment Period||8||
48201906|NCT01192542|100817917|FG000|STARTED|Period 2||18||
48201907|NCT01192542|100817918|FG001|STARTED|Period 2||20||
48201908|NCT01192542|100817917|FG000|COMPLETED|Period 2||18||
48201909|NCT01192542|100817918|FG001|COMPLETED|Period 2||20||
48201910|NCT01192542|100817917|FG000|NOT COMPLETED|Period 2||0||
48201911|NCT01192542|100817918|FG001|NOT COMPLETED|Period 2||0||
48495224|NCT00540423|101545302|FG001|COMPLETED|Double-Blind Treatment Period||14||
48201912|NCT03395353|100817919|FG000|STARTED|Overall Study||151||
48201913|NCT03395353|100817919|FG000|Received At Least 1 Dose of Study Drug|Overall Study||150||
48201914|NCT03395353|100817919|FG000|COMPLETED|Overall Study||64||
48201915|NCT03395353|100817919|FG000|NOT COMPLETED|Overall Study||87||
48201916|NCT02975934|100817920|FG000|STARTED|Treatment Phase||270||
48201917|NCT02975934|100817921|FG001|STARTED|Treatment Phase||135||
48201918|NCT02975934|100817920|FG000|COMPLETED|Treatment Phase||237||
48201919|NCT02975934|100817921|FG001|COMPLETED|Treatment Phase||125||
48201920|NCT02975934|100817920|FG000|NOT COMPLETED|Treatment Phase||33||
48201921|NCT02975934|100817921|FG001|NOT COMPLETED|Treatment Phase||10||
48201922|NCT02975934|100817920|FG000|STARTED|Cross-Over Phase||0||
48201923|NCT02975934|100817921|FG001|STARTED|Cross-Over Phase||63||
48201924|NCT02975934|100817920|FG000|COMPLETED|Cross-Over Phase||0||
48201925|NCT02975934|100817921|FG001|COMPLETED|Cross-Over Phase||56||
48201926|NCT02975934|100817920|FG000|NOT COMPLETED|Cross-Over Phase||0||
48201927|NCT02975934|100817921|FG001|NOT COMPLETED|Cross-Over Phase||7||
48201928|NCT04066738|100817922|FG000|STARTED|Overall Study||2||
48201929|NCT04066738|100817922|FG000|COMPLETED|Overall Study||2||
48201930|NCT04066738|100817922|FG000|NOT COMPLETED|Overall Study||0||
48201931|NCT00596167|100817923|FG000|STARTED|Overall Study||6||
48201932|NCT00596167|100817923|FG000|COMPLETED|Overall Study||6||
48201933|NCT00596167|100817923|FG000|NOT COMPLETED|Overall Study||0||
48201934|NCT05193318|100817924|FG000|STARTED|Acute Intervention (Weeks 1-9 of Study)||5||
48201935|NCT05193318|100817924|FG000|COMPLETED|Acute Intervention (Weeks 1-9 of Study)||4||
48201936|NCT05193318|100817924|FG000|NOT COMPLETED|Acute Intervention (Weeks 1-9 of Study)||1||
48201937|NCT05193318|100817924|FG000|STARTED|Follow-up Phase (Through Week 16)||4||
48201938|NCT05193318|100817924|FG000|COMPLETED|Follow-up Phase (Through Week 16)||3||
48201939|NCT05193318|100817924|FG000|NOT COMPLETED|Follow-up Phase (Through Week 16)||1||
48201940|NCT00544440|100817925|FG000|STARTED|Overall Study||57||
48201941|NCT00544440|100817925|FG000|COMPLETED|Overall Study||0||
48201942|NCT00544440|100817925|FG000|NOT COMPLETED|Overall Study||57||
48201943|NCT03505099|100817926|FG000|STARTED|Overall Study||14||
48201944|NCT03505099|100817927|FG001|STARTED|Overall Study||15||
48201945|NCT03505099|100817926|FG000|Received AVXS-101|Overall Study||14||
48201946|NCT03505099|100817927|FG001|Received AVXS-101|Overall Study||15||
48201947|NCT03505099|100817926|FG000|COMPLETED|Overall Study||14||
48201948|NCT03505099|100817927|FG001|COMPLETED|Overall Study||15||
48201949|NCT03505099|100817926|FG000|NOT COMPLETED|Overall Study||0||
48201950|NCT03505099|100817927|FG001|NOT COMPLETED|Overall Study||0||
48201951|NCT01289119|100817928|FG000|STARTED|Overall Study||93||
48201952|NCT01289119|100817929|FG001|STARTED|Overall Study||92||
48201953|NCT01289119|100817930|FG002|STARTED|Overall Study||98||
48201954|NCT01289119|100817931|FG003|STARTED|Overall Study||99||
48201955|NCT01289119|100817932|FG004|STARTED|Overall Study||63||
48201956|NCT01289119|100817933|FG005|STARTED|Overall Study||61||
48201957|NCT01289119|100817928|FG000|Treated|Overall Study||92||
48201958|NCT01289119|100817929|FG001|Treated|Overall Study||92||
48201959|NCT01289119|100817930|FG002|Treated|Overall Study||98||
48201960|NCT01289119|100817931|FG003|Treated|Overall Study||99||
48201961|NCT01289119|100817932|FG004|Treated|Overall Study||63||
48201962|NCT01289119|100817933|FG005|Treated|Overall Study||61||
48201963|NCT01289119|100817928|FG000|COMPLETED|Overall Study||84||
48201964|NCT01289119|100817929|FG001|COMPLETED|Overall Study||83||
48201965|NCT01289119|100817930|FG002|COMPLETED|Overall Study||89||
48201966|NCT01289119|100817931|FG003|COMPLETED|Overall Study||93||
48201967|NCT01289119|100817932|FG004|COMPLETED|Overall Study||58||
48201968|NCT01289119|100817933|FG005|COMPLETED|Overall Study||57||
48201969|NCT01289119|100817928|FG000|NOT COMPLETED|Overall Study||9||
48201970|NCT01289119|100817929|FG001|NOT COMPLETED|Overall Study||9||
48201971|NCT01289119|100817930|FG002|NOT COMPLETED|Overall Study||9||
48201972|NCT01289119|100817931|FG003|NOT COMPLETED|Overall Study||6||
48201973|NCT01289119|100817932|FG004|NOT COMPLETED|Overall Study||5||
48201974|NCT01289119|100817933|FG005|NOT COMPLETED|Overall Study||4||
48201975|NCT01149681|100817934|FG000|STARTED|Overall Study||12||
48201976|NCT01149681|100817934|FG000|COMPLETED|Overall Study||0||
48201977|NCT01149681|100817934|FG000|NOT COMPLETED|Overall Study||12||
48201978|NCT04371536|100817935|FG000|STARTED|Overall Study||1||
48201979|NCT04371536|100817936|FG001|STARTED|Overall Study||0||
48201980|NCT04371536|100817935|FG000|COMPLETED|Overall Study||1||
48201981|NCT04371536|100817936|FG001|COMPLETED|Overall Study||0||
48201982|NCT04371536|100817935|FG000|NOT COMPLETED|Overall Study||0||
48201983|NCT04371536|100817936|FG001|NOT COMPLETED|Overall Study||0||
48201984|NCT05136443|100817937|FG000|STARTED|Overall Study||70||
48201985|NCT05136443|100817937|FG000|COMPLETED|Overall Study||66||
48201986|NCT05136443|100817937|FG000|NOT COMPLETED|Overall Study||4||
48201987|NCT03748433|100817938|FG000|STARTED|Overall Study||17||
48201988|NCT03748433|100817939|FG001|STARTED|Overall Study||18||
48201989|NCT03748433|100817938|FG000|COMPLETED|Overall Study||16||
48201990|NCT03748433|100817939|FG001|COMPLETED|Overall Study||14||
48201991|NCT03748433|100817938|FG000|NOT COMPLETED|Overall Study||1||
48201992|NCT03748433|100817939|FG001|NOT COMPLETED|Overall Study||4||
48201993|NCT00424762|100817940|FG000|STARTED|Overall Study||74||
48201994|NCT00424762|100817941|FG001|STARTED|Overall Study||76||
48201995|NCT00424762|100817940|FG000|COMPLETED|Overall Study||54||
48201996|NCT00424762|100817941|FG001|COMPLETED|Overall Study||54||
48201997|NCT00424762|100817940|FG000|NOT COMPLETED|Overall Study||20||
48201998|NCT00424762|100817941|FG001|NOT COMPLETED|Overall Study||22||
48201999|NCT02955069|100817942|FG000|STARTED|Overall Study||95||
48202000|NCT02955069|100817943|FG001|STARTED|Overall Study||21||
48495225|NCT00540423|101545303|FG002|COMPLETED|Double-Blind Treatment Period||0||
48202001|NCT02955069|100817942|FG000|Full Analysis Set (FAS)|Overall Study||95|All subjects to whom study treatment was assigned and who received at least one dose of PDR001.|
48202002|NCT02955069|100817943|FG001|Full Analysis Set (FAS)|Overall Study||21|All subjects to whom study treatment was assigned and who received at least one dose of PDR001.|
48202003|NCT02955069|100817942|FG000|Safety Set|Overall Study||95|All subjects who received at least one dose of PDR001.|
48495226|NCT00540423|101545301|FG000|NOT COMPLETED|Double-Blind Treatment Period||0||
48495227|NCT00540423|101545302|FG001|NOT COMPLETED|Double-Blind Treatment Period||1||
48202004|NCT02955069|100817943|FG001|Safety Set|Overall Study||21|All subjects who received at least one dose of PDR001.|
48202005|NCT02955069|100817942|FG000|Pharmacokinetic Analysis Set (PAS)|Overall Study||94|All subjects who provide at least one evaluable PDR001 pharmacokinetic (PK) concentration.|
48202006|NCT02955069|100817943|FG001|Pharmacokinetic Analysis Set (PAS)|Overall Study||18|All subjects who provide at least one evaluable PDR001 pharmacokinetic (PK) concentration.|
48202007|NCT02955069|100817942|FG000|Immunogenicity (IG) Prevalence Set|Overall Study||94|All subjects in the FAS with a baseline or at least one post-baseline IG sample.|
48495228|NCT00540423|101545303|FG002|NOT COMPLETED|Double-Blind Treatment Period||0||
48495229|NCT00540423|101545301|FG000|STARTED|Open-Label Treatment Period||0||
48495230|NCT00540423|101545302|FG001|STARTED|Open-Label Treatment Period||0||
48495231|NCT00540423|101545303|FG002|STARTED|Open-Label Treatment Period||22||
48495232|NCT00540423|101545301|FG000|COMPLETED|Open-Label Treatment Period||0||
48495233|NCT00540423|101545302|FG001|COMPLETED|Open-Label Treatment Period||0||
48495234|NCT00540423|101545303|FG002|COMPLETED|Open-Label Treatment Period||20||
48202008|NCT02955069|100817943|FG001|Immunogenicity (IG) Prevalence Set|Overall Study||21|All subjects in the FAS with a baseline or at least one post-baseline IG sample.|
48202009|NCT02955069|100817942|FG000|IG Incidence Set|Overall Study||84|All subjects in the IG prevalence set with a baseline and at least one post-baseline IG sample.|
48202010|NCT02955069|100817943|FG001|IG Incidence Set|Overall Study||17|All subjects in the IG prevalence set with a baseline and at least one post-baseline IG sample.|
48202011|NCT02955069|100817942|FG000|COMPLETED|Overall Study||0||
48202012|NCT02955069|100817943|FG001|COMPLETED|Overall Study||0||
48202013|NCT02955069|100817942|FG000|NOT COMPLETED|Overall Study||95||
48202014|NCT02955069|100817943|FG001|NOT COMPLETED|Overall Study||21||
48202015|NCT00623506|100817944|FG000|STARTED|Overall Study||15||
48202016|NCT00623506|100817945|FG001|STARTED|Overall Study||15||
48202017|NCT00623506|100817944|FG000|Week 4|Overall Study||11||
48202018|NCT00623506|100817945|FG001|Week 4|Overall Study||11||
48202019|NCT00623506|100817944|FG000|COMPLETED|Overall Study||11||
48202020|NCT00623506|100817945|FG001|COMPLETED|Overall Study||11||
48202021|NCT00623506|100817944|FG000|NOT COMPLETED|Overall Study||4||
48202022|NCT00623506|100817945|FG001|NOT COMPLETED|Overall Study||4||
48202023|NCT01419717|100817946|FG000|STARTED|Overall Study||129||
48202024|NCT01419717|100817946|FG000|Received Denosumab|Overall Study||128||
48202025|NCT01419717|100817946|FG000|COMPLETED|Overall Study||4||
48202026|NCT01419717|100817946|FG000|NOT COMPLETED|Overall Study||125||
48202027|NCT00414206|100817947|FG000|STARTED|Overall Study||115||
48202028|NCT00414206|100817948|FG001|STARTED|Overall Study||114||
48202029|NCT00414206|100817949|FG002|STARTED|Overall Study||114||
48202030|NCT00414206|100817947|FG000|COMPLETED|Overall Study||57||
48202031|NCT00414206|100817948|FG001|COMPLETED|Overall Study||58||
48202032|NCT00414206|100817949|FG002|COMPLETED|Overall Study||59||
48202033|NCT00414206|100817947|FG000|NOT COMPLETED|Overall Study||58||
48202034|NCT00414206|100817948|FG001|NOT COMPLETED|Overall Study||56||
48202035|NCT00414206|100817949|FG002|NOT COMPLETED|Overall Study||55||
48202036|NCT03068611|100817950|FG000|STARTED|Overall Study||61||
48202037|NCT03068611|100817951|FG001|STARTED|Overall Study||58||
48202038|NCT03068611|100817950|FG000|COMPLETED|Overall Study||30||
48202039|NCT03068611|100817951|FG001|COMPLETED|Overall Study||33||
48202040|NCT03068611|100817950|FG000|NOT COMPLETED|Overall Study||31||
48202041|NCT03068611|100817951|FG001|NOT COMPLETED|Overall Study||25||
48202042|NCT02962674|100817952|FG000|STARTED|Overall Study||49|All subjects that signed an informed consent form.|
48202043|NCT02962674|100817952|FG000|3 Month Endpoint|Overall Study||46||
48202044|NCT02962674|100817952|FG000|12 Month Durability|Overall Study||46||
48202045|NCT02962674|100817952|FG000|24 Month Durability|Overall Study||32||
48202046|NCT02962674|100817952|FG000|36 Month Durability|Overall Study||18||
48202047|NCT02962674|100817952|FG000|48 Month Durability|Overall Study||4||
48202048|NCT02962674|100817952|FG000|COMPLETED|Overall Study||0||
48202049|NCT02962674|100817952|FG000|NOT COMPLETED|Overall Study||49||
48202050|NCT02023125|100817953|FG000|STARTED|Period 1||9||
48202051|NCT02023125|100817954|FG001|STARTED|Period 1||9||
48202052|NCT02023125|100817955|FG002|STARTED|Period 1||24||
48202053|NCT02023125|100817953|FG000|COMPLETED|Period 1||9||
48202054|NCT02023125|100817954|FG001|COMPLETED|Period 1||9||
48202055|NCT02023125|100817955|FG002|COMPLETED|Period 1||24||
48202056|NCT02023125|100817953|FG000|NOT COMPLETED|Period 1||0||
48202057|NCT02023125|100817954|FG001|NOT COMPLETED|Period 1||0||
48202058|NCT02023125|100817955|FG002|NOT COMPLETED|Period 1||0||
48202059|NCT02023125|100817953|FG000|STARTED|Washout Period||9||
48202060|NCT02023125|100817954|FG001|STARTED|Washout Period||9||
48202061|NCT02023125|100817955|FG002|STARTED|Washout Period||24||
48202062|NCT02023125|100817953|FG000|COMPLETED|Washout Period||9||
48202063|NCT02023125|100817954|FG001|COMPLETED|Washout Period||9||
48202064|NCT02023125|100817955|FG002|COMPLETED|Washout Period||24||
48202065|NCT02023125|100817953|FG000|NOT COMPLETED|Washout Period||0||
48202066|NCT02023125|100817954|FG001|NOT COMPLETED|Washout Period||0||
48202067|NCT02023125|100817955|FG002|NOT COMPLETED|Washout Period||0||
48202068|NCT02023125|100817953|FG000|STARTED|Period 2||9||
48202069|NCT02023125|100817954|FG001|STARTED|Period 2||9||
48202070|NCT02023125|100817955|FG002|STARTED|Period 2||24||
48202071|NCT02023125|100817953|FG000|COMPLETED|Period 2||9||
48202072|NCT02023125|100817954|FG001|COMPLETED|Period 2||9||
48202073|NCT02023125|100817955|FG002|COMPLETED|Period 2||24||
48202074|NCT02023125|100817953|FG000|NOT COMPLETED|Period 2||0||
48202075|NCT02023125|100817954|FG001|NOT COMPLETED|Period 2||0||
48202076|NCT02023125|100817955|FG002|NOT COMPLETED|Period 2||0||
48202077|NCT00939991|100817956|FG000|STARTED|Overall Study||9||
48202078|NCT00939991|100817957|FG001|STARTED|Overall Study||39||
48202079|NCT00939991|100817956|FG000|COMPLETED|Overall Study||9||
48202080|NCT00939991|100817957|FG001|COMPLETED|Overall Study||39||
48202081|NCT00939991|100817956|FG000|NOT COMPLETED|Overall Study||0||
48202082|NCT00939991|100817957|FG001|NOT COMPLETED|Overall Study||0||
48202083|NCT00798096|100817958|FG000|STARTED|Overall Study||18||
48202084|NCT00798096|100817958|FG000|COMPLETED|Overall Study||16||
48202085|NCT00798096|100817958|FG000|NOT COMPLETED|Overall Study||2||
48202086|NCT01499654|100817959|FG000|STARTED|Overall Study||64||
48202087|NCT01499654|100817959|FG000|COMPLETED|Overall Study||64||
48202088|NCT01499654|100817959|FG000|NOT COMPLETED|Overall Study||0||
48202089|NCT01835899|100817960|FG000|STARTED|Overall Study||6||
48202090|NCT01835899|100817961|FG001|STARTED|Overall Study||9||
48202091|NCT01835899|100817962|FG002|STARTED|Overall Study||9||
48202092|NCT01835899|100817960|FG000|COMPLETED|Overall Study||6||
48202093|NCT01835899|100817961|FG001|COMPLETED|Overall Study||8||
48202094|NCT01835899|100817962|FG002|COMPLETED|Overall Study||8||
48202095|NCT01835899|100817960|FG000|NOT COMPLETED|Overall Study||0||
48202096|NCT01835899|100817961|FG001|NOT COMPLETED|Overall Study||1||
48202097|NCT01835899|100817962|FG002|NOT COMPLETED|Overall Study||1||
48202098|NCT00954707|100817963|FG000|STARTED|Overall Study||2509||
48202099|NCT00954707|100817963|FG000|COMPLETED|Overall Study||2342||
48202100|NCT00954707|100817963|FG000|NOT COMPLETED|Overall Study||167||
48202101|NCT00546871|100817964|FG000|STARTED|Part 1 - IV Infusions of IGIV, PK||14||
48202102|NCT00546871|100817965|FG001|STARTED|Part 1 - IV Infusions of IGIV, PK||35||
48202103|NCT00546871|100817964|FG000|COMPLETED|Part 1 - IV Infusions of IGIV, PK||13||
48202104|NCT00546871|100817965|FG001|COMPLETED|Part 1 - IV Infusions of IGIV, PK||35||
48202105|NCT00546871|100817964|FG000|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||1||
48202106|NCT00546871|100817965|FG001|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||0||
48202107|NCT00546871|100817964|FG000|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||13||
48202108|NCT00546871|100817965|FG001|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||35||
48202109|NCT00546871|100817964|FG000|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||12||
48202110|NCT00546871|100817965|FG001|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||32||
48202111|NCT00546871|100817964|FG000|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||1||
48202112|NCT00546871|100817965|FG001|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||3||
48202113|NCT00546871|100817964|FG000|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||12||
48202114|NCT00546871|100817965|FG001|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||32||
48202115|NCT00546871|100817964|FG000|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||12||
48202116|NCT00546871|100817965|FG001|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||32||
48202117|NCT00546871|100817964|FG000|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0||
48202118|NCT00546871|100817965|FG001|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0||
48202119|NCT00546871|100817964|FG000|STARTED|Part 3b - SC IGIV 12 Weeks||12||
48202120|NCT00546871|100817965|FG001|STARTED|Part 3b - SC IGIV 12 Weeks||32||
48202121|NCT00546871|100817964|FG000|COMPLETED|Part 3b - SC IGIV 12 Weeks||12||
48202122|NCT00546871|100817965|FG001|COMPLETED|Part 3b - SC IGIV 12 Weeks||32||
48202123|NCT00546871|100817964|FG000|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0||
48202124|NCT00546871|100817965|FG001|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0||
48202125|NCT00546871|100817964|FG000|STARTED|Study Extension Period||10||
48202126|NCT00546871|100817965|FG001|STARTED|Study Extension Period||26||
48202127|NCT00546871|100817964|FG000|COMPLETED|Study Extension Period||9||
48202128|NCT00546871|100817965|FG001|COMPLETED|Study Extension Period||25||
48202129|NCT00546871|100817964|FG000|NOT COMPLETED|Study Extension Period||1||
48202130|NCT00546871|100817965|FG001|NOT COMPLETED|Study Extension Period||1||
48202131|NCT01377623|100817966|FG000|STARTED|Overall Study||33||
48202132|NCT01377623|100817967|FG001|STARTED|Overall Study||33||
48202133|NCT01377623|100817966|FG000|COMPLETED|Overall Study||26||
48202134|NCT01377623|100817967|FG001|COMPLETED|Overall Study||28||
48202135|NCT01377623|100817966|FG000|NOT COMPLETED|Overall Study||7||
48202136|NCT01377623|100817967|FG001|NOT COMPLETED|Overall Study||5||
48202137|NCT05674370|100817968|FG000|STARTED|Overall Study||45||
48202138|NCT05674370|100817968|FG000|COMPLETED|Overall Study||43||
48202139|NCT05674370|100817968|FG000|NOT COMPLETED|Overall Study||2||
48202140|NCT02763124|100817969|FG000|STARTED|Overall Study||18||28
48202141|NCT02763124|100817969|FG000|COMPLETED|Overall Study||18||28
48202142|NCT02763124|100817969|FG000|NOT COMPLETED|Overall Study||0||0
48202143|NCT00982033|100817970|FG000|STARTED|Overall Study||25||
48202144|NCT00982033|100817971|FG001|STARTED|Overall Study||27||
48202145|NCT00982033|100817970|FG000|COMPLETED|Overall Study||25||
48202146|NCT00982033|100817971|FG001|COMPLETED|Overall Study||27||
48202147|NCT00982033|100817970|FG000|NOT COMPLETED|Overall Study||0||
48202148|NCT00982033|100817971|FG001|NOT COMPLETED|Overall Study||0||
48202149|NCT00853827|100817972|FG000|STARTED|Single Blind Period (1 Week)||652||
48202150|NCT00853827|100817973|FG001|STARTED|Single Blind Period (1 Week)||0||
48202151|NCT00853827|100817972|FG000|COMPLETED|Single Blind Period (1 Week)||613||
48202152|NCT00853827|100817973|FG001|COMPLETED|Single Blind Period (1 Week)||0||
48202153|NCT00853827|100817972|FG000|NOT COMPLETED|Single Blind Period (1 Week)||39||
48202154|NCT00853827|100817973|FG001|NOT COMPLETED|Single Blind Period (1 Week)||0||
48202155|NCT00853827|100817972|FG000|STARTED|Double Blind Period (103 Weeks)||305||
48202156|NCT00853827|100817973|FG001|STARTED|Double Blind Period (103 Weeks)||308||
48202157|NCT00853827|100817972|FG000|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||225||
48202158|NCT00853827|100817973|FG001|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||233||
48202159|NCT00853827|100817972|FG000|COMPLETED|Double Blind Period (103 Weeks)||201||
48202160|NCT00853827|100817973|FG001|COMPLETED|Double Blind Period (103 Weeks)||199||
48202161|NCT00853827|100817972|FG000|NOT COMPLETED|Double Blind Period (103 Weeks)||104||
48202162|NCT00853827|100817973|FG001|NOT COMPLETED|Double Blind Period (103 Weeks)||109||
48202163|NCT03179787|100817974|FG000|STARTED|Overall Study||528||
48202164|NCT03179787|100817974|FG000|COMPLETED|Overall Study||510||
48202165|NCT03179787|100817974|FG000|NOT COMPLETED|Overall Study||18||
48202166|NCT00276250|100817975|FG000|STARTED|Overall Study||4||
48202167|NCT00276250|100817976|FG001|STARTED|Overall Study||1||
48202168|NCT00276250|100817977|FG002|STARTED|Overall Study||0||
48202169|NCT00276250|100817975|FG000|COMPLETED|Overall Study||4||
48495235|NCT00540423|101545301|FG000|NOT COMPLETED|Open-Label Treatment Period||0||
48495236|NCT00540423|101545302|FG001|NOT COMPLETED|Open-Label Treatment Period||0||
48495237|NCT00540423|101545303|FG002|NOT COMPLETED|Open-Label Treatment Period||2||
48495238|NCT01215279|101545304|FG000|STARTED|Overall Study||31||
48495239|NCT01215279|101545305|FG001|STARTED|Overall Study||32||
48495240|NCT01215279|101545304|FG000|COMPLETED|Overall Study||31||
48495241|NCT01215279|101545305|FG001|COMPLETED|Overall Study||32||
48495242|NCT01215279|101545304|FG000|NOT COMPLETED|Overall Study||0||
48202170|NCT00276250|100817976|FG001|COMPLETED|Overall Study||1||
48495243|NCT01215279|101545305|FG001|NOT COMPLETED|Overall Study||0||
48202171|NCT00276250|100817977|FG002|COMPLETED|Overall Study||0||
48495244|NCT03961204|101545306|FG000|STARTED|Overall Study||662||
48495245|NCT03961204|101545306|FG000|COMPLETED|Overall Study||655||
48202172|NCT00276250|100817975|FG000|NOT COMPLETED|Overall Study||0||
48202173|NCT00276250|100817976|FG001|NOT COMPLETED|Overall Study||0||
48202174|NCT00276250|100817977|FG002|NOT COMPLETED|Overall Study||0||
48202175|NCT04889664|100817978|FG000|STARTED|Screen||16||
48202176|NCT04889664|100817978|FG000|COMPLETED|Screen||14||
48202177|NCT04889664|100817978|FG000|NOT COMPLETED|Screen||2||
48202178|NCT04889664|100817978|FG000|STARTED|Study Treatment||14||
48202179|NCT04889664|100817978|FG000|COMPLETED|Study Treatment||13||
48202180|NCT04889664|100817978|FG000|NOT COMPLETED|Study Treatment||1||
48202181|NCT03181958|100817979|FG000|STARTED|Overall Study||497||
48202182|NCT03181958|100817980|FG001|STARTED|Overall Study||501||
48202183|NCT03181958|100817981|FG002|STARTED|Overall Study||495||
48202184|NCT03181958|100817979|FG000|COMPLETED|Overall Study||480||
48202185|NCT03181958|100817980|FG001|COMPLETED|Overall Study||480||
48202186|NCT03181958|100817981|FG002|COMPLETED|Overall Study||480||
48202187|NCT03181958|100817979|FG000|NOT COMPLETED|Overall Study||17||
48202188|NCT03181958|100817980|FG001|NOT COMPLETED|Overall Study||21||
48202189|NCT03181958|100817981|FG002|NOT COMPLETED|Overall Study||15||
48202190|NCT01233050|100817982|FG000|STARTED|Overall Study||400||
48495246|NCT03961204|101545306|FG000|NOT COMPLETED|Overall Study||7||
48202191|NCT01233050|100817983|FG001|STARTED|Overall Study||402||
48202192|NCT01233050|100817982|FG000|COMPLETED|Overall Study||392||
48202193|NCT01233050|100817983|FG001|COMPLETED|Overall Study||396||
48202194|NCT01233050|100817982|FG000|NOT COMPLETED|Overall Study||8||
48202195|NCT01233050|100817983|FG001|NOT COMPLETED|Overall Study||6||
48202196|NCT01048788|100817984|FG000|STARTED|Overall Study||8||
48202197|NCT01048788|100817985|FG001|STARTED|Overall Study||30||
48202198|NCT01048788|100817986|FG002|STARTED|Overall Study||13||
48202199|NCT01048788|100817984|FG000|COMPLETED|Overall Study||3||
48202200|NCT01048788|100817985|FG001|COMPLETED|Overall Study||28||
48202201|NCT01048788|100817986|FG002|COMPLETED|Overall Study||11||
48202202|NCT01048788|100817984|FG000|NOT COMPLETED|Overall Study||5||
48202203|NCT01048788|100817985|FG001|NOT COMPLETED|Overall Study||2||
48202204|NCT01048788|100817986|FG002|NOT COMPLETED|Overall Study||2||
48202205|NCT01544062|100817987|FG000|STARTED|Overall Study||33||
48202206|NCT01544062|100817988|FG001|STARTED|Overall Study||35||
48202207|NCT01544062|100817987|FG000|COMPLETED|Overall Study||33||
48202208|NCT01544062|100817988|FG001|COMPLETED|Overall Study||35||
48202209|NCT01544062|100817987|FG000|NOT COMPLETED|Overall Study||0||
48202210|NCT01544062|100817988|FG001|NOT COMPLETED|Overall Study||0||
48202211|NCT01152190|100817989|FG000|STARTED|Overall Study||50||
48202212|NCT01152190|100817990|FG001|STARTED|Overall Study||47||
48202213|NCT01152190|100817989|FG000|Received at Least 1 Dose of Study Drug|Overall Study||50||
48202214|NCT01152190|100817990|FG001|Received at Least 1 Dose of Study Drug|Overall Study||47||
48202215|NCT01152190|100817989|FG000|COMPLETED|Overall Study||45||
48202216|NCT01152190|100817990|FG001|COMPLETED|Overall Study||39||
48202217|NCT01152190|100817989|FG000|NOT COMPLETED|Overall Study||5||
48202218|NCT01152190|100817990|FG001|NOT COMPLETED|Overall Study||8||
48202219|NCT00957658|100817991|FG000|STARTED|Overall Study||234||
48202220|NCT00957658|100817991|FG000|COMPLETED|Overall Study||169||
48202221|NCT00957658|100817991|FG000|NOT COMPLETED|Overall Study||65||
48202222|NCT00486330|100817992|FG000|STARTED|Overall Study||12||
48202223|NCT00486330|100817992|FG000|COMPLETED|Overall Study||10||
48202224|NCT00486330|100817992|FG000|NOT COMPLETED|Overall Study||2||
48202225|NCT03546608|100817993|FG000|STARTED|Overall Study||6||
48202226|NCT03546608|100817994|FG001|STARTED|Overall Study||6||
48202227|NCT03546608|100817995|FG002|STARTED|Overall Study||6||
48202228|NCT03546608|100817993|FG000|COMPLETED|Overall Study||6||
48202229|NCT03546608|100817994|FG001|COMPLETED|Overall Study||6||
48202230|NCT03546608|100817995|FG002|COMPLETED|Overall Study||6||
48202231|NCT03546608|100817993|FG000|NOT COMPLETED|Overall Study||0||
48202232|NCT03546608|100817994|FG001|NOT COMPLETED|Overall Study||0||
48202233|NCT03546608|100817995|FG002|NOT COMPLETED|Overall Study||0||
48202234|NCT02513238|100817996|FG000|STARTED|Overall Study||15||
48202235|NCT02513238|100817997|FG001|STARTED|Overall Study||15||
48202236|NCT02513238|100817996|FG000|COMPLETED|Overall Study||15||
48202237|NCT02513238|100817997|FG001|COMPLETED|Overall Study||15||
48202238|NCT02513238|100817996|FG000|NOT COMPLETED|Overall Study||0||
48202239|NCT02513238|100817997|FG001|NOT COMPLETED|Overall Study||0||
48202240|NCT01988233|100817998|FG000|STARTED|Overall Study||167||
48202241|NCT01988233|100817999|FG001|STARTED|Overall Study||166||
48202242|NCT01988233|100817998|FG000|COMPLETED|Overall Study||103||
48202243|NCT01988233|100817999|FG001|COMPLETED|Overall Study||115||
48202244|NCT01988233|100817998|FG000|NOT COMPLETED|Overall Study||64||
48202245|NCT01988233|100817999|FG001|NOT COMPLETED|Overall Study||51||
48202246|NCT00817635|100818000|FG000|STARTED|Overall Study||32||
48202247|NCT00817635|100818001|FG001|STARTED|Overall Study||26||
48202248|NCT00817635|100818002|FG002|STARTED|Overall Study||31||
48202249|NCT00817635|100818003|FG003|STARTED|Overall Study||33||
48202250|NCT00817635|100818004|FG004|STARTED|Overall Study||33||
48202251|NCT00817635|100818000|FG000|COMPLETED|Overall Study||23||
48202252|NCT00817635|100818001|FG001|COMPLETED|Overall Study||22||
48202253|NCT00817635|100818002|FG002|COMPLETED|Overall Study||28||
48202254|NCT00817635|100818003|FG003|COMPLETED|Overall Study||28||
48202255|NCT00817635|100818004|FG004|COMPLETED|Overall Study||25||
48202256|NCT00817635|100818000|FG000|NOT COMPLETED|Overall Study||9||
48202257|NCT00817635|100818001|FG001|NOT COMPLETED|Overall Study||4||
48202258|NCT00817635|100818002|FG002|NOT COMPLETED|Overall Study||3||
48202259|NCT00817635|100818003|FG003|NOT COMPLETED|Overall Study||5||
48202260|NCT00817635|100818004|FG004|NOT COMPLETED|Overall Study||8||
48202261|NCT00739102|100818005|FG000|STARTED|Overall Study||250||
48202262|NCT00739102|100818005|FG000|COMPLETED|Overall Study||235||
48202263|NCT00739102|100818005|FG000|NOT COMPLETED|Overall Study||15||
48202264|NCT01908634|100818006|FG000|STARTED|Milk-based Strawberry Beverage With Meal||10||
48202265|NCT01908634|100818006|FG000|COMPLETED|Milk-based Strawberry Beverage With Meal||10|cross over design|
48202266|NCT01908634|100818006|FG000|NOT COMPLETED|Milk-based Strawberry Beverage With Meal||0||
48202267|NCT01908634|100818006|FG000|STARTED|Water-based Strawberry Beverage Wit Meal||10||
48202268|NCT01908634|100818006|FG000|COMPLETED|Water-based Strawberry Beverage Wit Meal||9||
48202269|NCT01908634|100818006|FG000|NOT COMPLETED|Water-based Strawberry Beverage Wit Meal||1||
48495247|NCT03480763|101545307|FG000|STARTED|Overall Study||327||
48202270|NCT01908634|100818006|FG000|STARTED|Milk-based Strawberry Beverage w/o Meal||9||
48202271|NCT01908634|100818006|FG000|COMPLETED|Milk-based Strawberry Beverage w/o Meal||4||
48495248|NCT03480763|101545308|FG001|STARTED|Overall Study||325||
48202272|NCT01908634|100818006|FG000|NOT COMPLETED|Milk-based Strawberry Beverage w/o Meal||5||
48202273|NCT01908634|100818006|FG000|STARTED|Water-based Strawberry Beverage w/o Meal||4||
48202274|NCT01908634|100818006|FG000|COMPLETED|Water-based Strawberry Beverage w/o Meal||4||
48202275|NCT01908634|100818006|FG000|NOT COMPLETED|Water-based Strawberry Beverage w/o Meal||0||
48202276|NCT02002819|100818007|FG000|STARTED|Overall Study||17||
48495249|NCT03480763|101545307|FG000|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||326||
48202277|NCT02002819|100818008|FG001|STARTED|Overall Study||17||
48202278|NCT02002819|100818007|FG000|COMPLETED|Overall Study||13||
48202279|NCT02002819|100818008|FG001|COMPLETED|Overall Study||15||
48202280|NCT02002819|100818007|FG000|NOT COMPLETED|Overall Study||4||
48202281|NCT02002819|100818008|FG001|NOT COMPLETED|Overall Study||2||
48202282|NCT01194258|100818009|FG000|STARTED|Titration Period||132||
48202283|NCT01194258|100818010|FG001|STARTED|Titration Period||0||
48202284|NCT01194258|100818011|FG002|STARTED|Titration Period||0||
48202285|NCT01194258|100818012|FG003|STARTED|Titration Period||0||
48202286|NCT01194258|100818013|FG004|STARTED|Titration Period||0||
48202287|NCT01194258|100818009|FG000|COMPLETED|Titration Period||121||
48202288|NCT01194258|100818010|FG001|COMPLETED|Titration Period||0||
48202289|NCT01194258|100818011|FG002|COMPLETED|Titration Period||0||
48202290|NCT01194258|100818012|FG003|COMPLETED|Titration Period||0||
48202291|NCT01194258|100818013|FG004|COMPLETED|Titration Period||0||
48202292|NCT01194258|100818009|FG000|NOT COMPLETED|Titration Period||11||
48202293|NCT01194258|100818010|FG001|NOT COMPLETED|Titration Period||0||
48202294|NCT01194258|100818011|FG002|NOT COMPLETED|Titration Period||0||
48202295|NCT01194258|100818012|FG003|NOT COMPLETED|Titration Period||0||
48202296|NCT01194258|100818013|FG004|NOT COMPLETED|Titration Period||0||
48202297|NCT01194258|100818009|FG000|STARTED|Period 1 (12 Weeks)||0||
48202298|NCT01194258|100818010|FG001|STARTED|Period 1 (12 Weeks)||29||
48202299|NCT01194258|100818011|FG002|STARTED|Period 1 (12 Weeks)||30||
48202300|NCT01194258|100818012|FG003|STARTED|Period 1 (12 Weeks)||29||
48202301|NCT01194258|100818013|FG004|STARTED|Period 1 (12 Weeks)||33||
48202302|NCT01194258|100818009|FG000|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||0||
48202303|NCT01194258|100818010|FG001|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29||
48202304|NCT01194258|100818011|FG002|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||30||
48202305|NCT01194258|100818012|FG003|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29||
48202306|NCT01194258|100818013|FG004|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||33||
48202307|NCT01194258|100818009|FG000|COMPLETED|Period 1 (12 Weeks)||0||
48202308|NCT01194258|100818010|FG001|COMPLETED|Period 1 (12 Weeks)||29||
48202309|NCT01194258|100818011|FG002|COMPLETED|Period 1 (12 Weeks)||30||
48202310|NCT01194258|100818012|FG003|COMPLETED|Period 1 (12 Weeks)||29||
48202311|NCT01194258|100818013|FG004|COMPLETED|Period 1 (12 Weeks)||32||
48202312|NCT01194258|100818009|FG000|NOT COMPLETED|Period 1 (12 Weeks)||0||
48202313|NCT01194258|100818010|FG001|NOT COMPLETED|Period 1 (12 Weeks)||0||
48202314|NCT01194258|100818011|FG002|NOT COMPLETED|Period 1 (12 Weeks)||0||
48495250|NCT03480763|101545308|FG001|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||325||
48495251|NCT03480763|101545307|FG000|Vaccination 2 - (PNEUMOVAX™23, Month 12)|Overall Study||298||
48202315|NCT01194258|100818012|FG003|NOT COMPLETED|Period 1 (12 Weeks)||0||
48202316|NCT01194258|100818013|FG004|NOT COMPLETED|Period 1 (12 Weeks)||1||
48202317|NCT01194258|100818009|FG000|STARTED|Period 2 (12 Weeks)||0||
48202318|NCT01194258|100818010|FG001|STARTED|Period 2 (12 Weeks)||29||
48202319|NCT01194258|100818011|FG002|STARTED|Period 2 (12 Weeks)||30||
48202320|NCT01194258|100818012|FG003|STARTED|Period 2 (12 Weeks)||29||
48202321|NCT01194258|100818013|FG004|STARTED|Period 2 (12 Weeks)||32||
48202322|NCT01194258|100818009|FG000|COMPLETED|Period 2 (12 Weeks)||0||
48202323|NCT01194258|100818010|FG001|COMPLETED|Period 2 (12 Weeks)||27||
48202324|NCT01194258|100818011|FG002|COMPLETED|Period 2 (12 Weeks)||29||
48202325|NCT01194258|100818012|FG003|COMPLETED|Period 2 (12 Weeks)||29||
48202326|NCT01194258|100818013|FG004|COMPLETED|Period 2 (12 Weeks)||30||
48202327|NCT01194258|100818009|FG000|NOT COMPLETED|Period 2 (12 Weeks)||0||
48202328|NCT01194258|100818010|FG001|NOT COMPLETED|Period 2 (12 Weeks)||2||
48202329|NCT01194258|100818011|FG002|NOT COMPLETED|Period 2 (12 Weeks)||1||
48202330|NCT01194258|100818012|FG003|NOT COMPLETED|Period 2 (12 Weeks)||0||
48202331|NCT01194258|100818013|FG004|NOT COMPLETED|Period 2 (12 Weeks)||2||
48202332|NCT01956669|100818014|FG000|STARTED|Overall Study||12|All enrolled subjects who took 1 dose of medication included in mITT and Safety Sets|
48202333|NCT01956669|100818015|FG001|STARTED|Overall Study||11|All enrolled subjects who took 1 dose of medication included in mITT and Safety Sets|
48202334|NCT01956669|100818016|FG002|STARTED|Overall Study||10|All enrolled subjects who took 1 dose of medication included in mITT and Safety Sets|
48202335|NCT01956669|100818017|FG003|STARTED|Overall Study||10|All enrolled subjects who took 1 dose of medication included in mITT and Safety Sets|
48202336|NCT01956669|100818018|FG004|STARTED|Overall Study||4|All enrolled subjects who took 1 dose of medication included in mITT and Safety Sets|
48202337|NCT01956669|100818019|FG005|STARTED|Overall Study||4|All enrolled subjects who took 1 dose of medication included in mITT and Safety Sets|
48202338|NCT01956669|100818020|FG006|STARTED|Overall Study||6|All enrolled subjects who took 1 dose of medication included in mITT and Safety Sets|
48202339|NCT01956669|100818014|FG000|PK Set|Overall Study||11|All mITT subjects who had at least 1 PK sample analyzed|
48202340|NCT01956669|100818015|FG001|PK Set|Overall Study||11|All mITT subjects who had at least 1 PK sample analyzed|
48202341|NCT01956669|100818016|FG002|PK Set|Overall Study||10|All mITT subjects who had at least 1 PK sample analyzed|
48202342|NCT01956669|100818017|FG003|PK Set|Overall Study||10|All mITT subjects who had at least 1 PK sample analyzed|
48495252|NCT03480763|101545308|FG001|Vaccination 2 - (PNEUMOVAX™23, Month 12)|Overall Study||302||
48202343|NCT01956669|100818018|FG004|PK Set|Overall Study||4|All mITT subjects who had at least 1 PK sample analyzed|
48495253|NCT03480763|101545307|FG000|COMPLETED|Overall Study||303||
48202344|NCT01956669|100818019|FG005|PK Set|Overall Study||4|All mITT subjects who had at least 1 PK sample analyzed|
48202345|NCT01956669|100818020|FG006|PK Set|Overall Study||6|All mITT subjects who had at least 1 PK sample analyzed|
48495254|NCT03480763|101545308|FG001|COMPLETED|Overall Study||306||
48037649|NCT01294098|100413289|FG000|STARTED|Overall Study||0||
48037650|NCT01294098|100413290|FG001|STARTED|Overall Study||1||
48037651|NCT01294098|100413291|FG002|STARTED|Overall Study||1||
48037652|NCT01294098|100413289|FG000|COMPLETED|Overall Study||0||
48037653|NCT01294098|100413290|FG001|COMPLETED|Overall Study||0||
48037654|NCT01294098|100413291|FG002|COMPLETED|Overall Study||0||
48037655|NCT01294098|100413289|FG000|NOT COMPLETED|Overall Study||0||
48037656|NCT01294098|100413290|FG001|NOT COMPLETED|Overall Study||1||
48037657|NCT01294098|100413291|FG002|NOT COMPLETED|Overall Study||1||
48037658|NCT00545272|100413292|FG000|STARTED|Overall Study||61||
48037659|NCT00545272|100413293|FG001|STARTED|Overall Study||68||
48037660|NCT00545272|100413294|FG002|STARTED|Overall Study||65||
48037661|NCT00545272|100413295|FG003|STARTED|Overall Study||72||
48037662|NCT00545272|100413296|FG004|STARTED|Overall Study||64||
48037663|NCT00545272|100413297|FG005|STARTED|Overall Study||62||
48037664|NCT00545272|100413292|FG000|COMPLETED|Overall Study||61||
48037665|NCT00545272|100413293|FG001|COMPLETED|Overall Study||67||
48037666|NCT00545272|100413294|FG002|COMPLETED|Overall Study||64||
48037667|NCT00545272|100413295|FG003|COMPLETED|Overall Study||71||
48037668|NCT00545272|100413296|FG004|COMPLETED|Overall Study||62||
48037669|NCT00545272|100413297|FG005|COMPLETED|Overall Study||59||
48037670|NCT00545272|100413292|FG000|NOT COMPLETED|Overall Study||0||
48037671|NCT00545272|100413293|FG001|NOT COMPLETED|Overall Study||1||
48037672|NCT00545272|100413294|FG002|NOT COMPLETED|Overall Study||1||
48037673|NCT00545272|100413295|FG003|NOT COMPLETED|Overall Study||1||
48037674|NCT00545272|100413296|FG004|NOT COMPLETED|Overall Study||2||
48495255|NCT03480763|101545307|FG000|NOT COMPLETED|Overall Study||24||
48037675|NCT00545272|100413297|FG005|NOT COMPLETED|Overall Study||3||
48037676|NCT01566084|100413298|FG000|STARTED|Overall Study||7||
48037677|NCT01566084|100413299|FG001|STARTED|Overall Study||10||
48037678|NCT01566084|100413298|FG000|COMPLETED|Overall Study||7||
48037679|NCT01566084|100413299|FG001|COMPLETED|Overall Study||10||
48037680|NCT01566084|100413298|FG000|NOT COMPLETED|Overall Study||0||
48037681|NCT01566084|100413299|FG001|NOT COMPLETED|Overall Study||0||
48037682|NCT03718091|100413300|FG000|STARTED|Overall Study||8||
48037683|NCT03718091|100413301|FG001|STARTED|Overall Study||7||
48037684|NCT03718091|100413302|FG002|STARTED|Overall Study||9||
48037685|NCT03718091|100413303|FG003|STARTED|Overall Study||5||
48037686|NCT03718091|100413300|FG000|COMPLETED|Overall Study||8||
48037687|NCT03718091|100413301|FG001|COMPLETED|Overall Study||7||
48037688|NCT03718091|100413302|FG002|COMPLETED|Overall Study||9||
48202346|NCT01956669|100818014|FG000|PKES Set|Overall Study||4|PK subset (received powder suspension and had at least 1 non-predose extended PK sampling)|
48202347|NCT01956669|100818015|FG001|PKES Set|Overall Study||0|PK subset (received powder suspension and had at least 1 non-predose extended PK sampling)|
48202348|NCT01956669|100818016|FG002|PKES Set|Overall Study||3|PK subset (received powder suspension and had at least 1 non-predose extended PK sampling)|
48202349|NCT01956669|100818017|FG003|PKES Set|Overall Study||0|PK subset (received powder suspension and had at least 1 non-predose extended PK sampling)|
48202350|NCT01956669|100818018|FG004|PKES Set|Overall Study||1|PK subset (received powder suspension and had at least 1 non-predose extended PK sampling)|
48202351|NCT01956669|100818019|FG005|PKES Set|Overall Study||1|PK subset (received powder suspension and had at least 1 non-predose extended PK sampling)|
48202352|NCT01956669|100818020|FG006|PKES Set|Overall Study||5|PK subset (received powder suspension and had at least 1 non-predose extended PK sampling)|
48202353|NCT01956669|100818014|FG000|Biomarker Set|Overall Study||12|All mITT subjects who had valid biomarker samples analyzed|
48202354|NCT01956669|100818015|FG001|Biomarker Set|Overall Study||11|All mITT subjects who had valid biomarker samples analyzed|
48202355|NCT01956669|100818016|FG002|Biomarker Set|Overall Study||9|All mITT subjects who had valid biomarker samples analyzed|
48202356|NCT01956669|100818017|FG003|Biomarker Set|Overall Study||9|All mITT subjects who had valid biomarker samples analyzed|
48202357|NCT01956669|100818018|FG004|Biomarker Set|Overall Study||3|All mITT subjects who had valid biomarker samples analyzed|
48202358|NCT01956669|100818019|FG005|Biomarker Set|Overall Study||4|All mITT subjects who had valid biomarker samples analyzed|
48202359|NCT01956669|100818020|FG006|Biomarker Set|Overall Study||3|All mITT subjects who had valid biomarker samples analyzed|
48202360|NCT01956669|100818014|FG000|Per Protocol Set (PP Set)|Overall Study||9||
48202361|NCT01956669|100818015|FG001|Per Protocol Set (PP Set)|Overall Study||10||
48202362|NCT01956669|100818016|FG002|Per Protocol Set (PP Set)|Overall Study||6||
48202363|NCT01956669|100818017|FG003|Per Protocol Set (PP Set)|Overall Study||9||
48202364|NCT01956669|100818018|FG004|Per Protocol Set (PP Set)|Overall Study||4||
48202365|NCT01956669|100818019|FG005|Per Protocol Set (PP Set)|Overall Study||4||
48202366|NCT01956669|100818020|FG006|Per Protocol Set (PP Set)|Overall Study||5||
48202367|NCT01956669|100818014|FG000|COMPLETED|Overall Study||0||
48202368|NCT01956669|100818015|FG001|COMPLETED|Overall Study||0||
48202369|NCT01956669|100818016|FG002|COMPLETED|Overall Study||0||
48202370|NCT01956669|100818017|FG003|COMPLETED|Overall Study||0||
48202371|NCT01956669|100818018|FG004|COMPLETED|Overall Study||0||
48202372|NCT01956669|100818019|FG005|COMPLETED|Overall Study||0||
48202373|NCT01956669|100818020|FG006|COMPLETED|Overall Study||0||
48037689|NCT03718091|100413303|FG003|COMPLETED|Overall Study||5||
48037690|NCT03718091|100413300|FG000|NOT COMPLETED|Overall Study||0||
48037691|NCT03718091|100413301|FG001|NOT COMPLETED|Overall Study||0||
48037692|NCT03718091|100413302|FG002|NOT COMPLETED|Overall Study||0||
48037693|NCT03718091|100413303|FG003|NOT COMPLETED|Overall Study||0||
48037694|NCT04432727|100413304|FG000|STARTED|Overall Study||15||
48037695|NCT04432727|100413305|FG001|STARTED|Overall Study||14||
48037696|NCT04432727|100413304|FG000|COMPLETED|Overall Study||14||
48037697|NCT04432727|100413305|FG001|COMPLETED|Overall Study||11||
48037698|NCT04432727|100413304|FG000|NOT COMPLETED|Overall Study||1||
48037699|NCT04432727|100413305|FG001|NOT COMPLETED|Overall Study||3||
48037700|NCT02520089|100413306|FG000|STARTED|Overall Study||12||
48037701|NCT02520089|100413307|FG001|STARTED|Overall Study||11||
48037702|NCT02520089|100413306|FG000|COMPLETED|Overall Study||9||
48037703|NCT02520089|100413307|FG001|COMPLETED|Overall Study||7||
48037704|NCT02520089|100413306|FG000|NOT COMPLETED|Overall Study||3||
48037705|NCT02520089|100413307|FG001|NOT COMPLETED|Overall Study||4||
48037706|NCT02365233|100413308|FG000|STARTED|Overall Study||1||
48037707|NCT02365233|100413309|FG001|STARTED|Overall Study||2||
48037708|NCT02365233|100413310|FG002|STARTED|Overall Study||2||
48037709|NCT02365233|100413308|FG000|COMPLETED|Overall Study||0||
48037710|NCT02365233|100413309|FG001|COMPLETED|Overall Study||0||
48037711|NCT02365233|100413310|FG002|COMPLETED|Overall Study||0||
48037712|NCT02365233|100413308|FG000|NOT COMPLETED|Overall Study||1||
48037713|NCT02365233|100413309|FG001|NOT COMPLETED|Overall Study||2||
48037714|NCT02365233|100413310|FG002|NOT COMPLETED|Overall Study||2||
48037715|NCT01980589|100413311|FG000|STARTED|Overall Study||3||
48037716|NCT01980589|100413312|FG001|STARTED|Overall Study||3||
48037717|NCT01980589|100413313|FG002|STARTED|Overall Study||16||
48037718|NCT01980589|100413311|FG000|COMPLETED|Overall Study||3||
48037719|NCT01980589|100413312|FG001|COMPLETED|Overall Study||3||
48037720|NCT01980589|100413313|FG002|COMPLETED|Overall Study||16||
48037721|NCT01980589|100413311|FG000|NOT COMPLETED|Overall Study||0||
48037722|NCT01980589|100413312|FG001|NOT COMPLETED|Overall Study||0||
48037723|NCT01980589|100413313|FG002|NOT COMPLETED|Overall Study||0||
48037724|NCT02489422|100413314|FG000|STARTED|Overall Study||23||
48037725|NCT02489422|100413315|FG001|STARTED|Overall Study||21||
48037726|NCT02489422|100413314|FG000|COMPLETED|Overall Study||23||
48202374|NCT01956669|100818014|FG000|NOT COMPLETED|Overall Study||12||
48495256|NCT03480763|101545308|FG001|NOT COMPLETED|Overall Study||19||
48495257|NCT03349567|101545309|FG000|STARTED|Overall Study||2||
48495258|NCT03349567|101545310|FG001|STARTED|Overall Study||2||
48037727|NCT02489422|100413315|FG001|COMPLETED|Overall Study||21||
48037728|NCT02489422|100413314|FG000|NOT COMPLETED|Overall Study||0||
48037729|NCT02489422|100413315|FG001|NOT COMPLETED|Overall Study||0||
48037730|NCT03531632|100413316|FG000|STARTED|Overall Study||5||
48037731|NCT03531632|100413317|FG001|STARTED|Overall Study||3||
48037732|NCT03531632|100413318|FG002|STARTED|Overall Study||28||
48037733|NCT03531632|100413316|FG000|Safety Population|Overall Study||5||
48037734|NCT03531632|100413317|FG001|Safety Population|Overall Study||3||
48037735|NCT03531632|100413318|FG002|Safety Population|Overall Study||28||
48037736|NCT03531632|100413316|FG000|Response Evaluable Population|Overall Study||5||
48037737|NCT03531632|100413317|FG001|Response Evaluable Population|Overall Study||3||
48037738|NCT03531632|100413318|FG002|Response Evaluable Population|Overall Study||24||
48037739|NCT03531632|100413316|FG000|COMPLETED|Overall Study||0||
48037740|NCT03531632|100413317|FG001|COMPLETED|Overall Study||0||
48037741|NCT03531632|100413318|FG002|COMPLETED|Overall Study||2||
48037742|NCT03531632|100413316|FG000|NOT COMPLETED|Overall Study||5||
48037743|NCT03531632|100413317|FG001|NOT COMPLETED|Overall Study||3||
48037744|NCT03531632|100413318|FG002|NOT COMPLETED|Overall Study||26||
48037745|NCT01242813|100413319|FG000|STARTED|Overall Study||20||
48037746|NCT01242813|100413319|FG000|COMPLETED|Overall Study||18||
48037747|NCT01242813|100413319|FG000|NOT COMPLETED|Overall Study||2||
48037748|NCT04620213|100413320|FG000|STARTED|Overall Study||94||
48037749|NCT04620213|100413321|FG001|STARTED|Overall Study||91||
48037750|NCT04620213|100413320|FG000|COMPLETED|Overall Study||94||
48037751|NCT04620213|100413321|FG001|COMPLETED|Overall Study||91||
48037752|NCT04620213|100413320|FG000|NOT COMPLETED|Overall Study||0||
48037753|NCT04620213|100413321|FG001|NOT COMPLETED|Overall Study||0||
48037754|NCT01558128|100413322|FG000|STARTED|Overall Study||1||
48037755|NCT01558128|100413322|FG000|COMPLETED|Overall Study||1||
48037756|NCT01558128|100413322|FG000|NOT COMPLETED|Overall Study||0||
48037757|NCT01395524|100413323|FG000|STARTED|Overall Study||97||
48037758|NCT01395524|100413324|FG001|STARTED|Overall Study||99||
48037759|NCT01395524|100413325|FG002|STARTED|Overall Study||106||
48037760|NCT01395524|100413323|FG000|COMPLETED|Overall Study||79||
48037761|NCT01395524|100413324|FG001|COMPLETED|Overall Study||83||
48037762|NCT01395524|100413325|FG002|COMPLETED|Overall Study||89||
48037763|NCT01395524|100413323|FG000|NOT COMPLETED|Overall Study||18||
48037764|NCT01395524|100413324|FG001|NOT COMPLETED|Overall Study||16||
48037765|NCT01395524|100413325|FG002|NOT COMPLETED|Overall Study||17||
48037766|NCT00612105|100413326|FG000|STARTED|Period Title 1: 6-Week Titration Phase||125||
48037767|NCT00612105|100413327|FG001|STARTED|Period Title 1: 6-Week Titration Phase||62||
48037768|NCT00612105|100413326|FG000|COMPLETED|Period Title 1: 6-Week Titration Phase||89||
48037769|NCT00612105|100413327|FG001|COMPLETED|Period Title 1: 6-Week Titration Phase||57||
48037770|NCT00612105|100413326|FG000|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||36||
48037771|NCT00612105|100413327|FG001|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||5||
48037772|NCT00612105|100413326|FG000|STARTED|Period Title 2: 4-Week Maintenance Phase||89||
48037773|NCT00612105|100413327|FG001|STARTED|Period Title 2: 4-Week Maintenance Phase||57||
48037774|NCT00612105|100413326|FG000|COMPLETED|Period Title 2: 4-Week Maintenance Phase||78||
48037775|NCT00612105|100413327|FG001|COMPLETED|Period Title 2: 4-Week Maintenance Phase||55||
48037776|NCT00612105|100413326|FG000|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||11||
48037777|NCT00612105|100413327|FG001|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||2||
48037778|NCT00612105|100413326|FG000|STARTED|Period Title 3: 3-Week Taper Phase||86||
48037779|NCT00612105|100413327|FG001|STARTED|Period Title 3: 3-Week Taper Phase||58||
48037780|NCT00612105|100413326|FG000|COMPLETED|Period Title 3: 3-Week Taper Phase||85||
48037781|NCT00612105|100413327|FG001|COMPLETED|Period Title 3: 3-Week Taper Phase||58||
48037782|NCT00612105|100413326|FG000|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||1||
48037783|NCT00612105|100413327|FG001|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||0||
48037784|NCT00096356|100413328|FG000|STARTED|Overall Study||122||
48037785|NCT00096356|100413329|FG001|STARTED|Overall Study||114||
48037786|NCT00096356|100413328|FG000|COMPLETED|Overall Study||78||
48037787|NCT00096356|100413329|FG001|COMPLETED|Overall Study||61||
48037788|NCT00096356|100413328|FG000|NOT COMPLETED|Overall Study||44||
48037789|NCT00096356|100413329|FG001|NOT COMPLETED|Overall Study||53||
48037802|NCT01865552|100413334|FG000|STARTED|Period 1||23||
48037803|NCT01865552|100413335|FG001|STARTED|Period 1||23||
48037804|NCT01865552|100413336|FG002|STARTED|Period 1||23||
48037805|NCT01865552|100413337|FG003|STARTED|Period 1||23||
48037806|NCT01865552|100413338|FG004|STARTED|Period 1||23||
48037807|NCT01865552|100413339|FG005|STARTED|Period 1||23||
48037808|NCT01865552|100413334|FG000|Discontinued From Period 1|Period 1||1||
48037809|NCT01865552|100413335|FG001|Discontinued From Period 1|Period 1||0||
48037810|NCT01865552|100413336|FG002|Discontinued From Period 1|Period 1||0||
48037811|NCT01865552|100413337|FG003|Discontinued From Period 1|Period 1||1||
48037812|NCT01865552|100413338|FG004|Discontinued From Period 1|Period 1||3||
48037813|NCT01865552|100413339|FG005|Discontinued From Period 1|Period 1||1||
48037814|NCT01865552|100413334|FG000|COMPLETED|Period 1||22||
48037815|NCT01865552|100413335|FG001|COMPLETED|Period 1||23||
48037816|NCT01865552|100413336|FG002|COMPLETED|Period 1||23||
48037817|NCT01865552|100413337|FG003|COMPLETED|Period 1||22||
48037818|NCT01865552|100413338|FG004|COMPLETED|Period 1||20||
48037819|NCT01865552|100413339|FG005|COMPLETED|Period 1||22||
48037820|NCT01865552|100413334|FG000|NOT COMPLETED|Period 1||1||
48037821|NCT01865552|100413335|FG001|NOT COMPLETED|Period 1||0||
48037822|NCT01865552|100413336|FG002|NOT COMPLETED|Period 1||0||
48037823|NCT01865552|100413337|FG003|NOT COMPLETED|Period 1||1||
48037824|NCT01865552|100413338|FG004|NOT COMPLETED|Period 1||3||
48037825|NCT01865552|100413339|FG005|NOT COMPLETED|Period 1||1||
48037826|NCT01865552|100413334|FG000|STARTED|Period 2||22||
48037827|NCT01865552|100413335|FG001|STARTED|Period 2||23||
48037828|NCT01865552|100413336|FG002|STARTED|Period 2||23||
48037829|NCT01865552|100413337|FG003|STARTED|Period 2||22||
48037830|NCT01865552|100413338|FG004|STARTED|Period 2||20||
48037831|NCT01865552|100413339|FG005|STARTED|Period 2||22||
48037832|NCT01865552|100413334|FG000|COMPLETED|Period 2||22||
48037833|NCT01865552|100413335|FG001|COMPLETED|Period 2||23||
48037834|NCT01865552|100413336|FG002|COMPLETED|Period 2||23||
48037835|NCT01865552|100413337|FG003|COMPLETED|Period 2||22||
48037836|NCT01865552|100413338|FG004|COMPLETED|Period 2||20||
48037837|NCT01865552|100413339|FG005|COMPLETED|Period 2||22||
48037838|NCT01865552|100413334|FG000|NOT COMPLETED|Period 2||0||
48037839|NCT01865552|100413335|FG001|NOT COMPLETED|Period 2||0||
48037840|NCT01865552|100413336|FG002|NOT COMPLETED|Period 2||0||
48037841|NCT01865552|100413337|FG003|NOT COMPLETED|Period 2||0||
48037842|NCT01865552|100413338|FG004|NOT COMPLETED|Period 2||0||
48037843|NCT01865552|100413339|FG005|NOT COMPLETED|Period 2||0||
48202375|NCT01956669|100818015|FG001|NOT COMPLETED|Overall Study||11||
48202376|NCT01956669|100818016|FG002|NOT COMPLETED|Overall Study||10||
48202377|NCT01956669|100818017|FG003|NOT COMPLETED|Overall Study||10||
48202378|NCT01956669|100818018|FG004|NOT COMPLETED|Overall Study||4||
48202379|NCT01956669|100818019|FG005|NOT COMPLETED|Overall Study||4||
48202380|NCT01956669|100818020|FG006|NOT COMPLETED|Overall Study||6||
48202381|NCT00357396|100818021|FG000|STARTED|Overall Study||6||
48202382|NCT00357396|100818022|FG001|STARTED|Overall Study||4||
48202383|NCT00357396|100818021|FG000|COMPLETED|Overall Study||5||
48202384|NCT00357396|100818022|FG001|COMPLETED|Overall Study||4||
48202385|NCT00357396|100818021|FG000|NOT COMPLETED|Overall Study||1||
48202386|NCT00357396|100818022|FG001|NOT COMPLETED|Overall Study||0||
48202387|NCT00940992|100818023|FG000|STARTED|Overall Study||32||
48202388|NCT00940992|100818024|FG001|STARTED|Overall Study||30||
48202389|NCT00940992|100818025|FG002|STARTED|Overall Study||30||
48202390|NCT00940992|100818023|FG000|COMPLETED|Overall Study||28||
48202391|NCT00940992|100818024|FG001|COMPLETED|Overall Study||28||
48202392|NCT00940992|100818025|FG002|COMPLETED|Overall Study||28||
48202393|NCT00940992|100818023|FG000|NOT COMPLETED|Overall Study||4||
48202394|NCT00940992|100818024|FG001|NOT COMPLETED|Overall Study||2||
48202395|NCT00940992|100818025|FG002|NOT COMPLETED|Overall Study||2||
48202396|NCT02174562|100818026|FG000|STARTED|Overall Study||50||
48495259|NCT03349567|101545309|FG000|COMPLETED|Overall Study||2||
48495260|NCT03349567|101545310|FG001|COMPLETED|Overall Study||2||
48202397|NCT02174562|100818027|FG001|STARTED|Overall Study||51||
48202398|NCT02174562|100818026|FG000|COMPLETED|Overall Study||41||
48202399|NCT02174562|100818027|FG001|COMPLETED|Overall Study||46||
48202400|NCT02174562|100818026|FG000|NOT COMPLETED|Overall Study||9||
48202401|NCT02174562|100818027|FG001|NOT COMPLETED|Overall Study||5||
48038036|NCT01146457|100413392|FG000|STARTED|Overall Study||19||
48038037|NCT01146457|100413393|FG001|STARTED|Overall Study||17||
48038038|NCT01146457|100413394|FG002|STARTED|Overall Study||21||
48038039|NCT01146457|100413395|FG003|STARTED|Overall Study||13||
48202402|NCT01199237|100818028|FG000|STARTED|Overall Study||41||
48202403|NCT01199237|100818029|FG001|STARTED|Overall Study||40||
48038040|NCT01146457|100413396|FG004|STARTED|Overall Study||13||
48038041|NCT01146457|100413392|FG000|COMPLETED|Overall Study||19||
48038042|NCT01146457|100413393|FG001|COMPLETED|Overall Study||17||
48038043|NCT01146457|100413394|FG002|COMPLETED|Overall Study||20||
48038044|NCT01146457|100413395|FG003|COMPLETED|Overall Study||13||
48038045|NCT01146457|100413396|FG004|COMPLETED|Overall Study||13||
48038046|NCT01146457|100413392|FG000|NOT COMPLETED|Overall Study||0||
48038047|NCT01146457|100413393|FG001|NOT COMPLETED|Overall Study||0||
48038048|NCT01146457|100413394|FG002|NOT COMPLETED|Overall Study||1||
48038049|NCT01146457|100413395|FG003|NOT COMPLETED|Overall Study||0||
48038050|NCT01146457|100413396|FG004|NOT COMPLETED|Overall Study||0||
48038051|NCT01410357|100413397|FG000|STARTED|Overall Study||100||
48038052|NCT01410357|100413398|FG001|STARTED|Overall Study||100||
48038053|NCT01410357|100413397|FG000|COMPLETED|Overall Study||74||
48038054|NCT01410357|100413398|FG001|COMPLETED|Overall Study||76||
48038055|NCT01410357|100413397|FG000|NOT COMPLETED|Overall Study||26||
48038056|NCT01410357|100413398|FG001|NOT COMPLETED|Overall Study||24||
48038066|NCT01128621|100413402|FG000|STARTED|Part A: GSK1292263 300 mg||6||
48038067|NCT01128621|100413403|FG001|STARTED|Part A: GSK1292263 300 mg||0||
48038068|NCT01128621|100413402|FG000|COMPLETED|Part A: GSK1292263 300 mg||6||
48038069|NCT01128621|100413403|FG001|COMPLETED|Part A: GSK1292263 300 mg||0||
48038070|NCT01128621|100413402|FG000|NOT COMPLETED|Part A: GSK1292263 300 mg||0||
48038071|NCT01128621|100413403|FG001|NOT COMPLETED|Part A: GSK1292263 300 mg||0||
48038072|NCT01128621|100413402|FG000|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0||
48038073|NCT01128621|100413403|FG001|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||67||
48038074|NCT01128621|100413402|FG000|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0||
48038075|NCT01128621|100413403|FG001|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||65||
48038076|NCT01128621|100413402|FG000|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0||
48038077|NCT01128621|100413403|FG001|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||2||
48038078|NCT03632954|100413404|FG000|STARTED|Overall Study||37||
48038079|NCT03632954|100413404|FG000|COMPLETED|Overall Study||3||
48038080|NCT03632954|100413404|FG000|NOT COMPLETED|Overall Study||34||
48038081|NCT00065429|100413405|FG000|STARTED|Phase I - May 2001 - Oct 2002||4||
48038082|NCT00065429|100413406|FG001|STARTED|Phase I - May 2001 - Oct 2002||3||
48038083|NCT00065429|100413407|FG002|STARTED|Phase I - May 2001 - Oct 2002||4||
48038084|NCT00065429|100413408|FG003|STARTED|Phase I - May 2001 - Oct 2002||4||
48038085|NCT00065429|100413409|FG004|STARTED|Phase I - May 2001 - Oct 2002||9||
48038086|NCT00065429|100413410|FG005|STARTED|Phase I - May 2001 - Oct 2002||4||
48038087|NCT00065429|100413411|FG006|STARTED|Phase I - May 2001 - Oct 2002||4||
48038088|NCT00065429|100413405|FG000|COMPLETED|Phase I - May 2001 - Oct 2002||3||
48038089|NCT00065429|100413406|FG001|COMPLETED|Phase I - May 2001 - Oct 2002||3||
48038090|NCT00065429|100413407|FG002|COMPLETED|Phase I - May 2001 - Oct 2002||3||
48038091|NCT00065429|100413408|FG003|COMPLETED|Phase I - May 2001 - Oct 2002||3||
48038092|NCT00065429|100413409|FG004|COMPLETED|Phase I - May 2001 - Oct 2002||8||
48038093|NCT00065429|100413410|FG005|COMPLETED|Phase I - May 2001 - Oct 2002||2||
48038094|NCT00065429|100413411|FG006|COMPLETED|Phase I - May 2001 - Oct 2002||2||
48038095|NCT00065429|100413405|FG000|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1||
48038096|NCT00065429|100413406|FG001|NOT COMPLETED|Phase I - May 2001 - Oct 2002||0||
48038097|NCT00065429|100413407|FG002|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1||
48038098|NCT00065429|100413408|FG003|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1||
48038099|NCT00065429|100413409|FG004|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1||
48038100|NCT00065429|100413410|FG005|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2||
48038101|NCT00065429|100413411|FG006|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2||
48038102|NCT00065429|100413405|FG000|STARTED|Phase II - Apr 2003 - Aug 2008||0||
48038103|NCT00065429|100413406|FG001|STARTED|Phase II - Apr 2003 - Aug 2008||0||
48202404|NCT01199237|100818028|FG000|COMPLETED|Overall Study||41||
48038104|NCT00065429|100413407|FG002|STARTED|Phase II - Apr 2003 - Aug 2008||0||
48038105|NCT00065429|100413408|FG003|STARTED|Phase II - Apr 2003 - Aug 2008||0||
48038106|NCT00065429|100413409|FG004|STARTED|Phase II - Apr 2003 - Aug 2008||32||
48038107|NCT00065429|100413410|FG005|STARTED|Phase II - Apr 2003 - Aug 2008||0||
48038108|NCT00065429|100413411|FG006|STARTED|Phase II - Apr 2003 - Aug 2008||0||
48038109|NCT00065429|100413405|FG000|COMPLETED|Phase II - Apr 2003 - Aug 2008||0||
48038110|NCT00065429|100413406|FG001|COMPLETED|Phase II - Apr 2003 - Aug 2008||0||
48038111|NCT00065429|100413407|FG002|COMPLETED|Phase II - Apr 2003 - Aug 2008||0||
48038112|NCT00065429|100413408|FG003|COMPLETED|Phase II - Apr 2003 - Aug 2008||0||
48038113|NCT00065429|100413409|FG004|COMPLETED|Phase II - Apr 2003 - Aug 2008||26||
48038114|NCT00065429|100413410|FG005|COMPLETED|Phase II - Apr 2003 - Aug 2008||0||
48038115|NCT00065429|100413411|FG006|COMPLETED|Phase II - Apr 2003 - Aug 2008||0||
48038116|NCT00065429|100413405|FG000|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0||
48038117|NCT00065429|100413406|FG001|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0||
48038118|NCT00065429|100413407|FG002|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0||
48038119|NCT00065429|100413408|FG003|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0||
48038120|NCT00065429|100413409|FG004|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||6||
48038121|NCT00065429|100413410|FG005|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0||
48038122|NCT00065429|100413411|FG006|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0||
48038123|NCT02855541|100413412|FG000|STARTED|Overall Study||25||
48038124|NCT02855541|100413412|FG000|COMPLETED|Overall Study||21||
48038125|NCT02855541|100413412|FG000|NOT COMPLETED|Overall Study||4||
48038126|NCT03595618|100413413|FG000|STARTED|Overall Study||234||
48038127|NCT03595618|100413414|FG001|STARTED|Overall Study||231||
48038128|NCT03595618|100413415|FG002|STARTED|Overall Study||233||
48038129|NCT03595618|100413416|FG003|STARTED|Overall Study||234||
48038130|NCT03595618|100413413|FG000|Treated|Overall Study||234|All participants having taken at least one dose of investigational medicinal product (IMP)|
48038131|NCT03595618|100413414|FG001|Treated|Overall Study||231|All participants having taken at least one dose of investigational medicinal product (IMP)|
48038132|NCT03595618|100413415|FG002|Treated|Overall Study||232|All participants having taken at least one dose of investigational medicinal product (IMP)|
48038133|NCT03595618|100413416|FG003|Treated|Overall Study||234|All participants having taken at least one dose of investigational medicinal product (IMP)|
48038134|NCT03595618|100413413|FG000|COMPLETED|Overall Study||191||
48038135|NCT03595618|100413414|FG001|COMPLETED|Overall Study||191||
48038136|NCT03595618|100413415|FG002|COMPLETED|Overall Study||177||
48038137|NCT03595618|100413416|FG003|COMPLETED|Overall Study||200||
48038138|NCT03595618|100413413|FG000|NOT COMPLETED|Overall Study||43||
48038139|NCT03595618|100413414|FG001|NOT COMPLETED|Overall Study||40||
48038140|NCT03595618|100413415|FG002|NOT COMPLETED|Overall Study||56||
48038141|NCT03595618|100413416|FG003|NOT COMPLETED|Overall Study||34||
48038142|NCT00913458|100413417|FG000|STARTED|Phase 1||306||
48038143|NCT00913458|100413418|FG001|STARTED|Phase 1||0||
48038144|NCT00913458|100413419|FG002|STARTED|Phase 1||0||
48038145|NCT00913458|100413420|FG003|STARTED|Phase 1||0||
48038146|NCT00913458|100413421|FG004|STARTED|Phase 1||0||
48038147|NCT00913458|100413422|FG005|STARTED|Phase 1||0||
48038148|NCT00913458|100413423|FG006|STARTED|Phase 1||0||
48038149|NCT00913458|100413417|FG000|COMPLETED|Phase 1||194||
48038150|NCT00913458|100413418|FG001|COMPLETED|Phase 1||0||
48038151|NCT00913458|100413419|FG002|COMPLETED|Phase 1||0||
48038152|NCT00913458|100413420|FG003|COMPLETED|Phase 1||0||
48038153|NCT00913458|100413421|FG004|COMPLETED|Phase 1||0||
48038154|NCT00913458|100413422|FG005|COMPLETED|Phase 1||0||
48038155|NCT00913458|100413423|FG006|COMPLETED|Phase 1||0||
48038156|NCT00913458|100413417|FG000|NOT COMPLETED|Phase 1||112||
48038157|NCT00913458|100413418|FG001|NOT COMPLETED|Phase 1||0||
48038158|NCT00913458|100413419|FG002|NOT COMPLETED|Phase 1||0||
48038159|NCT00913458|100413420|FG003|NOT COMPLETED|Phase 1||0||
48038160|NCT00913458|100413421|FG004|NOT COMPLETED|Phase 1||0||
48038161|NCT00913458|100413422|FG005|NOT COMPLETED|Phase 1||0||
48038162|NCT00913458|100413423|FG006|NOT COMPLETED|Phase 1||0||
48038163|NCT00913458|100413417|FG000|STARTED|Phase 2||0||
48038164|NCT00913458|100413418|FG001|STARTED|Phase 2||63||
48038165|NCT00913458|100413419|FG002|STARTED|Phase 2||65||
48038166|NCT00913458|100413420|FG003|STARTED|Phase 2||65||
48038167|NCT00913458|100413421|FG004|STARTED|Phase 2||0||
48038168|NCT00913458|100413422|FG005|STARTED|Phase 2||0||
48038169|NCT00913458|100413423|FG006|STARTED|Phase 2||0||
48038170|NCT00913458|100413417|FG000|COMPLETED|Phase 2||0||
48038171|NCT00913458|100413418|FG001|COMPLETED|Phase 2||53||
48038172|NCT00913458|100413419|FG002|COMPLETED|Phase 2||46||
48038173|NCT00913458|100413420|FG003|COMPLETED|Phase 2||32||
48038174|NCT00913458|100413421|FG004|COMPLETED|Phase 2||0||
48038175|NCT00913458|100413422|FG005|COMPLETED|Phase 2||0||
48038176|NCT00913458|100413423|FG006|COMPLETED|Phase 2||0||
48038177|NCT00913458|100413417|FG000|NOT COMPLETED|Phase 2||0||
48038178|NCT00913458|100413418|FG001|NOT COMPLETED|Phase 2||10||
48038179|NCT00913458|100413419|FG002|NOT COMPLETED|Phase 2||19||
48038180|NCT00913458|100413420|FG003|NOT COMPLETED|Phase 2||33||
48038181|NCT00913458|100413421|FG004|NOT COMPLETED|Phase 2||0||
48038182|NCT00913458|100413422|FG005|NOT COMPLETED|Phase 2||0||
48038183|NCT00913458|100413423|FG006|NOT COMPLETED|Phase 2||0||
48038184|NCT00913458|100413417|FG000|STARTED|Phase 3||0||
48038185|NCT00913458|100413418|FG001|STARTED|Phase 3||0||
48038186|NCT00913458|100413419|FG002|STARTED|Phase 3||0||
48038187|NCT00913458|100413420|FG003|STARTED|Phase 3||0||
48038188|NCT00913458|100413421|FG004|STARTED|Phase 3||53||
48038189|NCT00913458|100413422|FG005|STARTED|Phase 3||46||
48038190|NCT00913458|100413423|FG006|STARTED|Phase 3||32||
48038191|NCT00913458|100413417|FG000|COMPLETED|Phase 3||0||
48038192|NCT00913458|100413418|FG001|COMPLETED|Phase 3||0||
48038193|NCT00913458|100413419|FG002|COMPLETED|Phase 3||0||
48038194|NCT00913458|100413420|FG003|COMPLETED|Phase 3||0||
48038195|NCT00913458|100413421|FG004|COMPLETED|Phase 3||31||
48038196|NCT00913458|100413422|FG005|COMPLETED|Phase 3||28||
48038197|NCT00913458|100413423|FG006|COMPLETED|Phase 3||24||
48038198|NCT00913458|100413417|FG000|NOT COMPLETED|Phase 3||0||
48038199|NCT00913458|100413418|FG001|NOT COMPLETED|Phase 3||0||
48038200|NCT00913458|100413419|FG002|NOT COMPLETED|Phase 3||0||
48038201|NCT00913458|100413420|FG003|NOT COMPLETED|Phase 3||0||
48038202|NCT00913458|100413421|FG004|NOT COMPLETED|Phase 3||22||
48038203|NCT00913458|100413422|FG005|NOT COMPLETED|Phase 3||18||
48038204|NCT00913458|100413423|FG006|NOT COMPLETED|Phase 3||8||
48038205|NCT02522624|100413424|FG000|STARTED|Overall Study||165||
48038206|NCT02522624|100413425|FG001|STARTED|Overall Study||163||
48038207|NCT02522624|100413424|FG000|COMPLETED|Overall Study||164||
48038208|NCT02522624|100413425|FG001|COMPLETED|Overall Study||163||
48038209|NCT02522624|100413424|FG000|NOT COMPLETED|Overall Study||1||
48038210|NCT02522624|100413425|FG001|NOT COMPLETED|Overall Study||0||
48038217|NCT02338232|100413428|FG000|STARTED|Overall Study||32||
48038218|NCT02338232|100413428|FG000|COMPLETED|Overall Study||21||
48038219|NCT02338232|100413428|FG000|NOT COMPLETED|Overall Study||11||
48038226|NCT01543581|100413431|FG000|STARTED|Overall Study||1||
48038227|NCT01543581|100413432|FG001|STARTED|Overall Study||0||
48038228|NCT01543581|100413431|FG000|COMPLETED|Overall Study||1||
48038229|NCT01543581|100413432|FG001|COMPLETED|Overall Study||0||
48038230|NCT01543581|100413431|FG000|NOT COMPLETED|Overall Study||0||
48038231|NCT01543581|100413432|FG001|NOT COMPLETED|Overall Study||0||
48038232|NCT00486811|100413433|FG000|STARTED|Overall Study||337||
48038233|NCT00486811|100413434|FG001|STARTED|Overall Study||320||
48038234|NCT00486811|100413435|FG002|STARTED|Overall Study||333||
48038235|NCT00486811|100413433|FG000|COMPLETED|Overall Study||215||
48038236|NCT00486811|100413434|FG001|COMPLETED|Overall Study||179||
48038237|NCT00486811|100413435|FG002|COMPLETED|Overall Study||119||
48038238|NCT00486811|100413433|FG000|NOT COMPLETED|Overall Study||122||
48038239|NCT00486811|100413434|FG001|NOT COMPLETED|Overall Study||141||
48038240|NCT00486811|100413435|FG002|NOT COMPLETED|Overall Study||214||
48038241|NCT01596062|100413436|FG000|STARTED|Overall Study||3||
48038242|NCT01596062|100413437|FG001|STARTED|Overall Study||6||
48038243|NCT01596062|100413438|FG002|STARTED|Overall Study||7||
48038244|NCT01596062|100413436|FG000|COMPLETED|Overall Study||2||
48038245|NCT01596062|100413437|FG001|COMPLETED|Overall Study||6||
48038246|NCT01596062|100413438|FG002|COMPLETED|Overall Study||4||
48038247|NCT01596062|100413436|FG000|NOT COMPLETED|Overall Study||1||
48038248|NCT01596062|100413437|FG001|NOT COMPLETED|Overall Study||0||
48038249|NCT01596062|100413438|FG002|NOT COMPLETED|Overall Study||3||
48038250|NCT00514852|100413439|FG000|STARTED|Overall Study||157||
48038251|NCT00514852|100413440|FG001|STARTED|Overall Study||159||
48495261|NCT03349567|101545309|FG000|NOT COMPLETED|Overall Study||0||
48038252|NCT00514852|100413439|FG000|COMPLETED|Overall Study||152||
48038253|NCT00514852|100413440|FG001|COMPLETED|Overall Study||154||
48038254|NCT00514852|100413439|FG000|NOT COMPLETED|Overall Study||5||
48038255|NCT00514852|100413440|FG001|NOT COMPLETED|Overall Study||5||
48495262|NCT03349567|101545310|FG001|NOT COMPLETED|Overall Study||0||
48495263|NCT03406156|101545311|FG000|STARTED|Overall Study||84||
48495264|NCT03406156|101545312|FG001|STARTED|Overall Study||36||
48495265|NCT03406156|101545311|FG000|COMPLETED|Overall Study||0||
48495266|NCT03406156|101545312|FG001|COMPLETED|Overall Study||0||
48495267|NCT03406156|101545311|FG000|NOT COMPLETED|Overall Study||84||
48038259|NCT04693052|100413442|FG000|STARTED|Overall Study||605||
48038260|NCT04693052|100413442|FG000|COMPLETED|Overall Study||605||
48038261|NCT04693052|100413442|FG000|NOT COMPLETED|Overall Study||0||
48038262|NCT01541397|100413443|FG000|STARTED|Overall Study||4||
48038263|NCT01541397|100413444|FG001|STARTED|Overall Study||2||
48038264|NCT01541397|100413443|FG000|COMPLETED|Overall Study||0||
48038265|NCT01541397|100413444|FG001|COMPLETED|Overall Study||0||
48038266|NCT01541397|100413443|FG000|NOT COMPLETED|Overall Study||4||
48038267|NCT01541397|100413444|FG001|NOT COMPLETED|Overall Study||2||
48495268|NCT03406156|101545312|FG001|NOT COMPLETED|Overall Study||36||
48495269|NCT02061280|101545313|FG000|STARTED|Overall Study||71|Individuals who signed informed consent form.|
48495270|NCT02061280|101545314|FG001|STARTED|Overall Study||37|Individuals who signed informed consent form.|
48495271|NCT02061280|101545313|FG000|Randomized to Treatment|Overall Study||54|Individuals randomized to drug treatment at Visit 3.|
48495272|NCT02061280|101545314|FG001|Randomized to Treatment|Overall Study||25|Individuals randomized to drug treatment at Visit 3.|
48038300|NCT01323855|100413451|FG000|STARTED|Overall Study||9||
48038301|NCT01323855|100413452|FG001|STARTED|Overall Study||9||
48038302|NCT01323855|100413453|FG002|STARTED|Overall Study||8||
48038303|NCT01323855|100413454|FG003|STARTED|Overall Study||9||
48038304|NCT01323855|100413455|FG004|STARTED|Overall Study||11||
48038305|NCT01323855|100413451|FG000|COMPLETED|Overall Study||9||
48038306|NCT01323855|100413452|FG001|COMPLETED|Overall Study||9||
48038307|NCT01323855|100413453|FG002|COMPLETED|Overall Study||8||
48038308|NCT01323855|100413454|FG003|COMPLETED|Overall Study||9||
48038309|NCT01323855|100413455|FG004|COMPLETED|Overall Study||11||
48038310|NCT01323855|100413451|FG000|NOT COMPLETED|Overall Study||0||
48038311|NCT01323855|100413452|FG001|NOT COMPLETED|Overall Study||0||
48038312|NCT01323855|100413453|FG002|NOT COMPLETED|Overall Study||0||
48038313|NCT01323855|100413454|FG003|NOT COMPLETED|Overall Study||0||
48038314|NCT01323855|100413455|FG004|NOT COMPLETED|Overall Study||0||
48038315|NCT00717236|100413456|FG000|STARTED|Double-Blind Period||851||
48038316|NCT00717236|100413457|FG001|STARTED|Double-Blind Period||212||
48038317|NCT00717236|100413456|FG000|COMPLETED|Double-Blind Period||771||
48038318|NCT00717236|100413457|FG001|COMPLETED|Double-Blind Period||184||
48038319|NCT00717236|100413456|FG000|NOT COMPLETED|Double-Blind Period||80||
48038320|NCT00717236|100413457|FG001|NOT COMPLETED|Double-Blind Period||28||
48038321|NCT00717236|100413456|FG000|STARTED|Open-Label Period||771||
48038322|NCT00717236|100413457|FG001|STARTED|Open-Label Period||184||
48038323|NCT00717236|100413456|FG000|COMPLETED|Open-Label Period||646||
48038324|NCT00717236|100413457|FG001|COMPLETED|Open-Label Period||163||
48038325|NCT00717236|100413456|FG000|NOT COMPLETED|Open-Label Period||125||
48038326|NCT00717236|100413457|FG001|NOT COMPLETED|Open-Label Period||21||
48038327|NCT04605991|100413458|FG000|STARTED|Overall Study||187||
48038328|NCT04605991|100413458|FG000|Received at Least 1 Dose of Study Drug|Overall Study||176||
48038329|NCT04605991|100413458|FG000|COMPLETED|Overall Study||154||
48038330|NCT04605991|100413458|FG000|NOT COMPLETED|Overall Study||33||
48038331|NCT00910299|100413459|FG000|STARTED|Overall Study||212||
48495273|NCT02061280|101545313|FG000|COMPLETED|Overall Study||53||
48495274|NCT02061280|101545314|FG001|COMPLETED|Overall Study||25||
48495275|NCT02061280|101545313|FG000|NOT COMPLETED|Overall Study||18||
48495276|NCT02061280|101545314|FG001|NOT COMPLETED|Overall Study||12||
48038332|NCT00910299|100413460|FG001|STARTED|Overall Study||211||
48038333|NCT00910299|100413459|FG000|Received at Least 1 Dose of Study Drug|Overall Study||210||
48038334|NCT00910299|100413460|FG001|Received at Least 1 Dose of Study Drug|Overall Study||210||
48666738|NCT03391882|101970467|FG002|Safety Population Part A|Part A - Titration Phase||19||
48038335|NCT00910299|100413459|FG000|COMPLETED|Overall Study||136||
48038336|NCT00910299|100413460|FG001|COMPLETED|Overall Study||137||
48038337|NCT00910299|100413459|FG000|NOT COMPLETED|Overall Study||76||
48038338|NCT00910299|100413460|FG001|NOT COMPLETED|Overall Study||74||
48038366|NCT03598114|100413468|FG000|STARTED|Overall Study||127||11
48038367|NCT03598114|100413469|FG001|STARTED|Overall Study||128||12
48038368|NCT03598114|100413468|FG000|COMPLETED|Overall Study||124||11
48038369|NCT03598114|100413469|FG001|COMPLETED|Overall Study||89||12
48038370|NCT03598114|100413468|FG000|NOT COMPLETED|Overall Study||3||0
48038371|NCT03598114|100413469|FG001|NOT COMPLETED|Overall Study||39||0
48038378|NCT00600119|100413472|FG000|STARTED|Single-blind Placebo run-in Period||36||
48038379|NCT00600119|100413473|FG001|STARTED|Single-blind Placebo run-in Period||35||
48038380|NCT00600119|100413474|FG002|STARTED|Single-blind Placebo run-in Period||29||
48038381|NCT00600119|100413475|FG003|STARTED|Single-blind Placebo run-in Period||31||
48038382|NCT00600119|100413476|FG004|STARTED|Single-blind Placebo run-in Period||39||
48038383|NCT00600119|100413477|FG005|STARTED|Single-blind Placebo run-in Period||37||
48038384|NCT00600119|100413472|FG000|COMPLETED|Single-blind Placebo run-in Period||32||
48038385|NCT00600119|100413473|FG001|COMPLETED|Single-blind Placebo run-in Period||33||
48038386|NCT00600119|100413474|FG002|COMPLETED|Single-blind Placebo run-in Period||27||
48038387|NCT00600119|100413475|FG003|COMPLETED|Single-blind Placebo run-in Period||30||
48038388|NCT00600119|100413476|FG004|COMPLETED|Single-blind Placebo run-in Period||37||
48038389|NCT00600119|100413477|FG005|COMPLETED|Single-blind Placebo run-in Period||35||
48038390|NCT00600119|100413472|FG000|NOT COMPLETED|Single-blind Placebo run-in Period||4||
48038391|NCT00600119|100413473|FG001|NOT COMPLETED|Single-blind Placebo run-in Period||2||
48038392|NCT00600119|100413474|FG002|NOT COMPLETED|Single-blind Placebo run-in Period||2||
48038393|NCT00600119|100413475|FG003|NOT COMPLETED|Single-blind Placebo run-in Period||1||
48038394|NCT00600119|100413476|FG004|NOT COMPLETED|Single-blind Placebo run-in Period||2||
48038395|NCT00600119|100413477|FG005|NOT COMPLETED|Single-blind Placebo run-in Period||2||
48038396|NCT00600119|100413472|FG000|STARTED|Double-blind Treatment Period||32||
48038397|NCT00600119|100413473|FG001|STARTED|Double-blind Treatment Period||33||
48038398|NCT00600119|100413474|FG002|STARTED|Double-blind Treatment Period||27||
48038399|NCT00600119|100413475|FG003|STARTED|Double-blind Treatment Period||30||
48038400|NCT00600119|100413476|FG004|STARTED|Double-blind Treatment Period||37||
48038401|NCT00600119|100413477|FG005|STARTED|Double-blind Treatment Period||35||
48038402|NCT00600119|100413472|FG000|COMPLETED|Double-blind Treatment Period||27||
48038403|NCT00600119|100413473|FG001|COMPLETED|Double-blind Treatment Period||28||
48038404|NCT00600119|100413474|FG002|COMPLETED|Double-blind Treatment Period||27||
48038405|NCT00600119|100413475|FG003|COMPLETED|Double-blind Treatment Period||28||
48038406|NCT00600119|100413476|FG004|COMPLETED|Double-blind Treatment Period||31||
48038407|NCT00600119|100413477|FG005|COMPLETED|Double-blind Treatment Period||21||
48038408|NCT00600119|100413472|FG000|NOT COMPLETED|Double-blind Treatment Period||5||
48038409|NCT00600119|100413473|FG001|NOT COMPLETED|Double-blind Treatment Period||5||
48038410|NCT00600119|100413474|FG002|NOT COMPLETED|Double-blind Treatment Period||0||
48038411|NCT00600119|100413475|FG003|NOT COMPLETED|Double-blind Treatment Period||2||
48038412|NCT00600119|100413476|FG004|NOT COMPLETED|Double-blind Treatment Period||6||
48038413|NCT00600119|100413477|FG005|NOT COMPLETED|Double-blind Treatment Period||14||
48038414|NCT00600119|100413472|FG000|STARTED|Follow-up Period||27||
48038415|NCT00600119|100413473|FG001|STARTED|Follow-up Period||28||
48038416|NCT00600119|100413474|FG002|STARTED|Follow-up Period||27||
48038417|NCT00600119|100413475|FG003|STARTED|Follow-up Period||28||
48038418|NCT00600119|100413476|FG004|STARTED|Follow-up Period||31||
48038419|NCT00600119|100413477|FG005|STARTED|Follow-up Period||21||
48038420|NCT00600119|100413472|FG000|COMPLETED|Follow-up Period||26||
48038421|NCT00600119|100413473|FG001|COMPLETED|Follow-up Period||28||
48038422|NCT00600119|100413474|FG002|COMPLETED|Follow-up Period||27||
48038423|NCT00600119|100413475|FG003|COMPLETED|Follow-up Period||28||
48038424|NCT00600119|100413476|FG004|COMPLETED|Follow-up Period||31||
48038425|NCT00600119|100413477|FG005|COMPLETED|Follow-up Period||20||
48038426|NCT00600119|100413472|FG000|NOT COMPLETED|Follow-up Period||1||
48038427|NCT00600119|100413473|FG001|NOT COMPLETED|Follow-up Period||0||
48038428|NCT00600119|100413474|FG002|NOT COMPLETED|Follow-up Period||0||
48038429|NCT00600119|100413475|FG003|NOT COMPLETED|Follow-up Period||0||
48038430|NCT00600119|100413476|FG004|NOT COMPLETED|Follow-up Period||0||
48038431|NCT00600119|100413477|FG005|NOT COMPLETED|Follow-up Period||1||
48038432|NCT01139008|100413478|FG000|STARTED|Overall Study||80||
48038433|NCT01139008|100413478|FG000|COMPLETED|Overall Study||74||
48038434|NCT01139008|100413478|FG000|NOT COMPLETED|Overall Study||6||
48038435|NCT02255435|100413479|FG000|STARTED|Overall Study||6||
48038436|NCT02255435|100413480|FG001|STARTED|Overall Study||6||
48038437|NCT02255435|100413481|FG002|STARTED|Overall Study||6||
48038438|NCT02255435|100413482|FG003|STARTED|Overall Study||6||
48038439|NCT02255435|100413483|FG004|STARTED|Overall Study||6||
48038440|NCT02255435|100413484|FG005|STARTED|Overall Study||12||
48038441|NCT02255435|100413485|FG006|STARTED|Overall Study||10||
48038442|NCT02255435|100413486|FG007|STARTED|Overall Study||17||
48038443|NCT02255435|100413487|FG008|STARTED|Overall Study||52||
48038444|NCT02255435|100413488|FG009|STARTED|Overall Study||51||
48038445|NCT02255435|100413479|FG000|Number of Participants With Pes Cavus|Overall Study||2||
48038446|NCT02255435|100413480|FG001|Number of Participants With Pes Cavus|Overall Study||2||
48038447|NCT02255435|100413481|FG002|Number of Participants With Pes Cavus|Overall Study||3||
48038448|NCT02255435|100413482|FG003|Number of Participants With Pes Cavus|Overall Study||2||
48038449|NCT02255435|100413483|FG004|Number of Participants With Pes Cavus|Overall Study||2||
48038450|NCT02255435|100413484|FG005|Number of Participants With Pes Cavus|Overall Study||8||
48038451|NCT02255435|100413485|FG006|Number of Participants With Pes Cavus|Overall Study||3||
48038452|NCT02255435|100413486|FG007|Number of Participants With Pes Cavus|Overall Study||10||
48038453|NCT02255435|100413487|FG008|Number of Participants With Pes Cavus|Overall Study||10||
48038454|NCT02255435|100413488|FG009|Number of Participants With Pes Cavus|Overall Study||10||
48038455|NCT02255435|100413479|FG000|COMPLETED|Overall Study||6||
48038456|NCT02255435|100413480|FG001|COMPLETED|Overall Study||6||
48038457|NCT02255435|100413481|FG002|COMPLETED|Overall Study||6||
48038458|NCT02255435|100413482|FG003|COMPLETED|Overall Study||6||
48038459|NCT02255435|100413483|FG004|COMPLETED|Overall Study||6||
48038460|NCT02255435|100413484|FG005|COMPLETED|Overall Study||12||
48038461|NCT02255435|100413485|FG006|COMPLETED|Overall Study||10||
48038462|NCT02255435|100413486|FG007|COMPLETED|Overall Study||16||
48038463|NCT02255435|100413487|FG008|COMPLETED|Overall Study||51||
48038464|NCT02255435|100413488|FG009|COMPLETED|Overall Study||45||
48038465|NCT02255435|100413479|FG000|NOT COMPLETED|Overall Study||0||
48038466|NCT02255435|100413480|FG001|NOT COMPLETED|Overall Study||0||
48038467|NCT02255435|100413481|FG002|NOT COMPLETED|Overall Study||0||
48038468|NCT02255435|100413482|FG003|NOT COMPLETED|Overall Study||0||
48038469|NCT02255435|100413483|FG004|NOT COMPLETED|Overall Study||0||
48038470|NCT02255435|100413484|FG005|NOT COMPLETED|Overall Study||0||
48038471|NCT02255435|100413485|FG006|NOT COMPLETED|Overall Study||0||
48038472|NCT02255435|100413486|FG007|NOT COMPLETED|Overall Study||1||
48038473|NCT02255435|100413487|FG008|NOT COMPLETED|Overall Study||1||
48038474|NCT02255435|100413488|FG009|NOT COMPLETED|Overall Study||6||
48038481|NCT04915950|100413491|FG000|STARTED|Stage A: Treatment Period 1 (1 Day)||2||
48038482|NCT04915950|100413492|FG001|STARTED|Stage A: Treatment Period 1 (1 Day)||2||
48038483|NCT04915950|100413493|FG002|STARTED|Stage A: Treatment Period 1 (1 Day)||2||
48038484|NCT04915950|100413494|FG003|STARTED|Stage A: Treatment Period 1 (1 Day)||2||
48038485|NCT04915950|100413495|FG004|STARTED|Stage A: Treatment Period 1 (1 Day)||3||
48038486|NCT04915950|100413496|FG005|STARTED|Stage A: Treatment Period 1 (1 Day)||2||
48038487|NCT04915950|100413491|FG000|COMPLETED|Stage A: Treatment Period 1 (1 Day)||2||
48038488|NCT04915950|100413492|FG001|COMPLETED|Stage A: Treatment Period 1 (1 Day)||2||
48038489|NCT04915950|100413493|FG002|COMPLETED|Stage A: Treatment Period 1 (1 Day)||2||
48038490|NCT04915950|100413494|FG003|COMPLETED|Stage A: Treatment Period 1 (1 Day)||2||
48038491|NCT04915950|100413495|FG004|COMPLETED|Stage A: Treatment Period 1 (1 Day)||3||
48038492|NCT04915950|100413496|FG005|COMPLETED|Stage A: Treatment Period 1 (1 Day)||2||
48038493|NCT04915950|100413491|FG000|NOT COMPLETED|Stage A: Treatment Period 1 (1 Day)||0||
48038494|NCT04915950|100413492|FG001|NOT COMPLETED|Stage A: Treatment Period 1 (1 Day)||0||
48038495|NCT04915950|100413493|FG002|NOT COMPLETED|Stage A: Treatment Period 1 (1 Day)||0||
48038496|NCT04915950|100413494|FG003|NOT COMPLETED|Stage A: Treatment Period 1 (1 Day)||0||
48038497|NCT04915950|100413495|FG004|NOT COMPLETED|Stage A: Treatment Period 1 (1 Day)||0||
48038498|NCT04915950|100413496|FG005|NOT COMPLETED|Stage A: Treatment Period 1 (1 Day)||0||
48038499|NCT04915950|100413491|FG000|STARTED|Stage A:Washout Period(72hours to 7days)||2||
48038500|NCT04915950|100413492|FG001|STARTED|Stage A:Washout Period(72hours to 7days)||2||
48038501|NCT04915950|100413493|FG002|STARTED|Stage A:Washout Period(72hours to 7days)||2||
48038502|NCT04915950|100413494|FG003|STARTED|Stage A:Washout Period(72hours to 7days)||2||
48038503|NCT04915950|100413495|FG004|STARTED|Stage A:Washout Period(72hours to 7days)||3||
48038504|NCT04915950|100413496|FG005|STARTED|Stage A:Washout Period(72hours to 7days)||2||
48038505|NCT04915950|100413491|FG000|COMPLETED|Stage A:Washout Period(72hours to 7days)||2||
48038506|NCT04915950|100413492|FG001|COMPLETED|Stage A:Washout Period(72hours to 7days)||2||
48038507|NCT04915950|100413493|FG002|COMPLETED|Stage A:Washout Period(72hours to 7days)||2||
48038508|NCT04915950|100413494|FG003|COMPLETED|Stage A:Washout Period(72hours to 7days)||2||
48038509|NCT04915950|100413495|FG004|COMPLETED|Stage A:Washout Period(72hours to 7days)||3||
48038510|NCT04915950|100413496|FG005|COMPLETED|Stage A:Washout Period(72hours to 7days)||2||
48038511|NCT04915950|100413491|FG000|NOT COMPLETED|Stage A:Washout Period(72hours to 7days)||0||
48038512|NCT04915950|100413492|FG001|NOT COMPLETED|Stage A:Washout Period(72hours to 7days)||0||
48038513|NCT04915950|100413493|FG002|NOT COMPLETED|Stage A:Washout Period(72hours to 7days)||0||
48038514|NCT04915950|100413494|FG003|NOT COMPLETED|Stage A:Washout Period(72hours to 7days)||0||
48038515|NCT04915950|100413495|FG004|NOT COMPLETED|Stage A:Washout Period(72hours to 7days)||0||
48038516|NCT04915950|100413496|FG005|NOT COMPLETED|Stage A:Washout Period(72hours to 7days)||0||
48038517|NCT04915950|100413491|FG000|STARTED|Stage A: Treatment Period 2 (1 Day)||2||
48038518|NCT04915950|100413492|FG001|STARTED|Stage A: Treatment Period 2 (1 Day)||2||
48038519|NCT04915950|100413493|FG002|STARTED|Stage A: Treatment Period 2 (1 Day)||2||
48038520|NCT04915950|100413494|FG003|STARTED|Stage A: Treatment Period 2 (1 Day)||2||
48038521|NCT04915950|100413495|FG004|STARTED|Stage A: Treatment Period 2 (1 Day)||3||
48038522|NCT04915950|100413496|FG005|STARTED|Stage A: Treatment Period 2 (1 Day)||2||
48038523|NCT04915950|100413491|FG000|COMPLETED|Stage A: Treatment Period 2 (1 Day)||2||
48038524|NCT04915950|100413492|FG001|COMPLETED|Stage A: Treatment Period 2 (1 Day)||2||
48038525|NCT04915950|100413493|FG002|COMPLETED|Stage A: Treatment Period 2 (1 Day)||2||
48038526|NCT04915950|100413494|FG003|COMPLETED|Stage A: Treatment Period 2 (1 Day)||2||
48038527|NCT04915950|100413495|FG004|COMPLETED|Stage A: Treatment Period 2 (1 Day)||3||
48038528|NCT04915950|100413496|FG005|COMPLETED|Stage A: Treatment Period 2 (1 Day)||2||
48038529|NCT04915950|100413491|FG000|NOT COMPLETED|Stage A: Treatment Period 2 (1 Day)||0||
48038530|NCT04915950|100413492|FG001|NOT COMPLETED|Stage A: Treatment Period 2 (1 Day)||0||
48038531|NCT04915950|100413493|FG002|NOT COMPLETED|Stage A: Treatment Period 2 (1 Day)||0||
48202405|NCT01199237|100818029|FG001|COMPLETED|Overall Study||40||
48202406|NCT01199237|100818028|FG000|NOT COMPLETED|Overall Study||0||
48202407|NCT01199237|100818029|FG001|NOT COMPLETED|Overall Study||0||
48202408|NCT04884737|100818030|FG000|STARTED|Overall Study||50||
48202409|NCT04884737|100818031|FG001|STARTED|Overall Study||57||
48202410|NCT04884737|100818030|FG000|COMPLETED|Overall Study||39||
48202411|NCT04884737|100818031|FG001|COMPLETED|Overall Study||48||
48202412|NCT04884737|100818030|FG000|NOT COMPLETED|Overall Study||11||
48202413|NCT04884737|100818031|FG001|NOT COMPLETED|Overall Study||9||
48202414|NCT01879371|100818032|FG000|STARTED|Overall Study||6||
48202415|NCT01879371|100818033|FG001|STARTED|Overall Study||6||
48202416|NCT01879371|100818034|FG002|STARTED|Overall Study||6||
48202417|NCT01879371|100818035|FG003|STARTED|Overall Study||6||
48202418|NCT01879371|100818036|FG004|STARTED|Overall Study||6||
48202419|NCT01879371|100818037|FG005|STARTED|Overall Study||6||
48202420|NCT01879371|100818032|FG000|COMPLETED|Overall Study||6||
48202421|NCT01879371|100818033|FG001|COMPLETED|Overall Study||6||
48202422|NCT01879371|100818034|FG002|COMPLETED|Overall Study||6||
48202423|NCT01879371|100818035|FG003|COMPLETED|Overall Study||6||
48202424|NCT01879371|100818036|FG004|COMPLETED|Overall Study||6||
48202425|NCT01879371|100818037|FG005|COMPLETED|Overall Study||6||
48038532|NCT04915950|100413494|FG003|NOT COMPLETED|Stage A: Treatment Period 2 (1 Day)||0||
48038533|NCT04915950|100413495|FG004|NOT COMPLETED|Stage A: Treatment Period 2 (1 Day)||0||
48038534|NCT04915950|100413496|FG005|NOT COMPLETED|Stage A: Treatment Period 2 (1 Day)||0||
48202426|NCT01879371|100818032|FG000|NOT COMPLETED|Overall Study||0||
48202427|NCT01879371|100818033|FG001|NOT COMPLETED|Overall Study||0||
48038535|NCT04915950|100413491|FG000|STARTED|Stage A:Washout Period(72hours to 7days)||2||
48038536|NCT04915950|100413492|FG001|STARTED|Stage A:Washout Period(72hours to 7days)||2||
48038537|NCT04915950|100413493|FG002|STARTED|Stage A:Washout Period(72hours to 7days)||2||
48038538|NCT04915950|100413494|FG003|STARTED|Stage A:Washout Period(72hours to 7days)||2||
48038539|NCT04915950|100413495|FG004|STARTED|Stage A:Washout Period(72hours to 7days)||3||
48202428|NCT01879371|100818034|FG002|NOT COMPLETED|Overall Study||0||
48202429|NCT01879371|100818035|FG003|NOT COMPLETED|Overall Study||0||
48202430|NCT01879371|100818036|FG004|NOT COMPLETED|Overall Study||0||
48202431|NCT01879371|100818037|FG005|NOT COMPLETED|Overall Study||0||
48038540|NCT04915950|100413496|FG005|STARTED|Stage A:Washout Period(72hours to 7days)||2||
48038541|NCT04915950|100413491|FG000|COMPLETED|Stage A:Washout Period(72hours to 7days)||2||
48038542|NCT04915950|100413492|FG001|COMPLETED|Stage A:Washout Period(72hours to 7days)||2||
48038543|NCT04915950|100413493|FG002|COMPLETED|Stage A:Washout Period(72hours to 7days)||2||
48038544|NCT04915950|100413494|FG003|COMPLETED|Stage A:Washout Period(72hours to 7days)||2||
48038545|NCT04915950|100413495|FG004|COMPLETED|Stage A:Washout Period(72hours to 7days)||3||
48038546|NCT04915950|100413496|FG005|COMPLETED|Stage A:Washout Period(72hours to 7days)||2||
48038547|NCT04915950|100413491|FG000|NOT COMPLETED|Stage A:Washout Period(72hours to 7days)||0||
48038548|NCT04915950|100413492|FG001|NOT COMPLETED|Stage A:Washout Period(72hours to 7days)||0||
48038549|NCT04915950|100413493|FG002|NOT COMPLETED|Stage A:Washout Period(72hours to 7days)||0||
48038550|NCT04915950|100413494|FG003|NOT COMPLETED|Stage A:Washout Period(72hours to 7days)||0||
48038551|NCT04915950|100413495|FG004|NOT COMPLETED|Stage A:Washout Period(72hours to 7days)||0||
48038552|NCT04915950|100413496|FG005|NOT COMPLETED|Stage A:Washout Period(72hours to 7days)||0||
48038553|NCT04915950|100413491|FG000|STARTED|Stage A: Treatment Period 3 (1 Day)||2||
48038554|NCT04915950|100413492|FG001|STARTED|Stage A: Treatment Period 3 (1 Day)||2||
48038555|NCT04915950|100413493|FG002|STARTED|Stage A: Treatment Period 3 (1 Day)||2||
48038556|NCT04915950|100413494|FG003|STARTED|Stage A: Treatment Period 3 (1 Day)||2||
48038557|NCT04915950|100413495|FG004|STARTED|Stage A: Treatment Period 3 (1 Day)||3||
48038558|NCT04915950|100413496|FG005|STARTED|Stage A: Treatment Period 3 (1 Day)||2||
48495277|NCT00633022|101547819|FG000|STARTED|Overall Study||34||
48495278|NCT00633022|101547820|FG001|STARTED|Overall Study||33||
48038559|NCT04915950|100413491|FG000|COMPLETED|Stage A: Treatment Period 3 (1 Day)||2||
48038560|NCT04915950|100413492|FG001|COMPLETED|Stage A: Treatment Period 3 (1 Day)||2||
48038561|NCT04915950|100413493|FG002|COMPLETED|Stage A: Treatment Period 3 (1 Day)||2||
48038562|NCT04915950|100413494|FG003|COMPLETED|Stage A: Treatment Period 3 (1 Day)||2||
48038563|NCT04915950|100413495|FG004|COMPLETED|Stage A: Treatment Period 3 (1 Day)||3||
48038564|NCT04915950|100413496|FG005|COMPLETED|Stage A: Treatment Period 3 (1 Day)||2||
48038565|NCT04915950|100413491|FG000|NOT COMPLETED|Stage A: Treatment Period 3 (1 Day)||0||
48038566|NCT04915950|100413492|FG001|NOT COMPLETED|Stage A: Treatment Period 3 (1 Day)||0||
48038567|NCT04915950|100413493|FG002|NOT COMPLETED|Stage A: Treatment Period 3 (1 Day)||0||
48038568|NCT04915950|100413494|FG003|NOT COMPLETED|Stage A: Treatment Period 3 (1 Day)||0||
48038569|NCT04915950|100413495|FG004|NOT COMPLETED|Stage A: Treatment Period 3 (1 Day)||0||
48038570|NCT04915950|100413496|FG005|NOT COMPLETED|Stage A: Treatment Period 3 (1 Day)||0||
48038583|NCT02067975|100413501|FG000|STARTED|Overall Study||20||
48038584|NCT02067975|100413502|FG001|STARTED|Overall Study||18||
48038585|NCT02067975|100413503|FG002|STARTED|Overall Study||21||
48038586|NCT02067975|100413504|FG003|STARTED|Overall Study||18||
48038587|NCT02067975|100413505|FG004|STARTED|Overall Study||8||
48038588|NCT02067975|100413506|FG005|STARTED|Overall Study||8||
48038589|NCT02067975|100413501|FG000|COMPLETED|Overall Study||16||
48038590|NCT02067975|100413502|FG001|COMPLETED|Overall Study||16||
48038591|NCT02067975|100413503|FG002|COMPLETED|Overall Study||19||
48038592|NCT02067975|100413504|FG003|COMPLETED|Overall Study||14||
48038593|NCT02067975|100413505|FG004|COMPLETED|Overall Study||0||
48038594|NCT02067975|100413506|FG005|COMPLETED|Overall Study||0||
48038595|NCT02067975|100413501|FG000|NOT COMPLETED|Overall Study||4||
48038596|NCT02067975|100413502|FG001|NOT COMPLETED|Overall Study||2||
48038597|NCT02067975|100413503|FG002|NOT COMPLETED|Overall Study||2||
48038598|NCT02067975|100413504|FG003|NOT COMPLETED|Overall Study||4||
48038599|NCT02067975|100413505|FG004|NOT COMPLETED|Overall Study||8||
48038600|NCT02067975|100413506|FG005|NOT COMPLETED|Overall Study||8||
48038607|NCT01934647|100413509|FG000|STARTED|Overall Study||2||
48038608|NCT01934647|100413510|FG001|STARTED|Overall Study||2||
48038609|NCT01934647|100413511|FG002|STARTED|Overall Study||3||
48038610|NCT01934647|100413509|FG000|COMPLETED|Overall Study||2||
48038611|NCT01934647|100413510|FG001|COMPLETED|Overall Study||2||
48038612|NCT01934647|100413511|FG002|COMPLETED|Overall Study||3||
48038613|NCT01934647|100413509|FG000|NOT COMPLETED|Overall Study||0||
48038614|NCT01934647|100413510|FG001|NOT COMPLETED|Overall Study||0||
48495279|NCT00633022|101547821|FG002|STARTED|Overall Study||32||
48038615|NCT01934647|100413511|FG002|NOT COMPLETED|Overall Study||0||
48202432|NCT04173962|100818038|FG000|STARTED|Overall Study||12||
48202433|NCT04173962|100818039|FG001|STARTED|Overall Study||12||
48202434|NCT04173962|100818038|FG000|COMPLETED|Overall Study||12||
48202435|NCT04173962|100818039|FG001|COMPLETED|Overall Study||12||
48495280|NCT00633022|101547819|FG000|COMPLETED|Overall Study||33||
48038616|NCT03927482|100413512|FG000|STARTED|Overall Study||118||
48038617|NCT03927482|100413513|FG001|STARTED|Overall Study||121||
48038618|NCT03927482|100413512|FG000|COMPLETED|Overall Study||110||
48038619|NCT03927482|100413513|FG001|COMPLETED|Overall Study||115||
48038620|NCT03927482|100413512|FG000|NOT COMPLETED|Overall Study||8||
48038621|NCT03927482|100413513|FG001|NOT COMPLETED|Overall Study||6||
48038622|NCT02674204|100413514|FG000|STARTED|Overall Study||1||
48038623|NCT02674204|100413515|FG001|STARTED|Overall Study||1||
48038624|NCT02674204|100413514|FG000|COMPLETED|Overall Study||0||
48038625|NCT02674204|100413515|FG001|COMPLETED|Overall Study||1||
48038626|NCT02674204|100413514|FG000|NOT COMPLETED|Overall Study||1||
48038627|NCT02674204|100413515|FG001|NOT COMPLETED|Overall Study||0||
48038628|NCT00167778|100413516|FG000|STARTED|Overall Study||11||
48038629|NCT00167778|100413516|FG000|COMPLETED|Overall Study||10||
48038630|NCT00167778|100413516|FG000|NOT COMPLETED|Overall Study||1||
48038631|NCT01737593|100413517|FG000|STARTED|Overall Study||37||
48038632|NCT01737593|100413518|FG001|STARTED|Overall Study||32||
48038633|NCT01737593|100413519|FG002|STARTED|Overall Study||39||
48038634|NCT01737593|100413517|FG000|COMPLETED|Overall Study||37||
48038635|NCT01737593|100413518|FG001|COMPLETED|Overall Study||32||
48038636|NCT01737593|100413519|FG002|COMPLETED|Overall Study||39||
48038637|NCT01737593|100413517|FG000|NOT COMPLETED|Overall Study||0||
48038638|NCT01737593|100413518|FG001|NOT COMPLETED|Overall Study||0||
48038639|NCT01737593|100413519|FG002|NOT COMPLETED|Overall Study||0||
48038640|NCT00798759|100413520|FG000|STARTED|Overall Study||117||
48038641|NCT00798759|100413521|FG001|STARTED|Overall Study||119||
48038642|NCT00798759|100413520|FG000|COMPLETED|Overall Study||109||
48038643|NCT00798759|100413521|FG001|COMPLETED|Overall Study||106||
48038644|NCT00798759|100413520|FG000|NOT COMPLETED|Overall Study||8||
48038645|NCT00798759|100413521|FG001|NOT COMPLETED|Overall Study||13||
48038646|NCT04268823|100413522|FG000|STARTED|Overall Study||26||
48038647|NCT04268823|100413523|FG001|STARTED|Overall Study||28||
48038648|NCT04268823|100413522|FG000|COMPLETED|Overall Study||24||
48038649|NCT04268823|100413523|FG001|COMPLETED|Overall Study||28||
48038650|NCT04268823|100413522|FG000|NOT COMPLETED|Overall Study||2||
48038651|NCT04268823|100413523|FG001|NOT COMPLETED|Overall Study||0||
48038652|NCT03316911|100413524|FG000|STARTED|Overall Study||122||
48038653|NCT03316911|100413525|FG001|STARTED|Overall Study||139||
48038654|NCT03316911|100413524|FG000|3-Month Follow-up Survey|Overall Study||93||
48038655|NCT03316911|100413525|FG001|3-Month Follow-up Survey|Overall Study||112||
48038656|NCT03316911|100413524|FG000|5-Month Follow-up Survey|Overall Study||89||
48038657|NCT03316911|100413525|FG001|5-Month Follow-up Survey|Overall Study||110||
48038658|NCT03316911|100413524|FG000|COMPLETED|Overall Study||89||
48038659|NCT03316911|100413525|FG001|COMPLETED|Overall Study||110||
48038660|NCT03316911|100413524|FG000|NOT COMPLETED|Overall Study||33||
48038661|NCT03316911|100413525|FG001|NOT COMPLETED|Overall Study||29||
48038662|NCT01024309|100413526|FG000|STARTED|Overall Study||35||
48038663|NCT01024309|100413527|FG001|STARTED|Overall Study||31||
48038664|NCT01024309|100413526|FG000|COMPLETED|Overall Study||27||
48038665|NCT01024309|100413527|FG001|COMPLETED|Overall Study||27||
48038666|NCT01024309|100413526|FG000|NOT COMPLETED|Overall Study||8||
48038667|NCT01024309|100413527|FG001|NOT COMPLETED|Overall Study||4||
48038668|NCT03897439|100413528|FG000|STARTED|Randomization (Week 0)||196||
48038669|NCT03897439|100413529|FG001|STARTED|Randomization (Week 0)||196||
48038670|NCT03897439|100413528|FG000|Started on Nicotine Patch|Randomization (Week 0)||196||
48038671|NCT03897439|100413529|FG001|Started on Nicotine Patch|Randomization (Week 0)||196||
48038672|NCT03897439|100413528|FG000|COMPLETED|Randomization (Week 0)||196||
48038673|NCT03897439|100413529|FG001|COMPLETED|Randomization (Week 0)||196||
48038674|NCT03897439|100413528|FG000|NOT COMPLETED|Randomization (Week 0)||0||
48038675|NCT03897439|100413529|FG001|NOT COMPLETED|Randomization (Week 0)||0||
48038676|NCT03897439|100413528|FG000|STARTED|Optimization Point 1 (Week 2)||187||
48038677|NCT03897439|100413529|FG001|STARTED|Optimization Point 1 (Week 2)||187||
48202436|NCT04173962|100818038|FG000|NOT COMPLETED|Overall Study||0||
48202437|NCT04173962|100818039|FG001|NOT COMPLETED|Overall Study||0||
48495281|NCT00633022|101547820|FG001|COMPLETED|Overall Study||32||
48495282|NCT00633022|101547821|FG002|COMPLETED|Overall Study||27||
48495283|NCT00633022|101547819|FG000|NOT COMPLETED|Overall Study||1||
48495284|NCT00633022|101547820|FG001|NOT COMPLETED|Overall Study||1||
48038678|NCT03897439|100413528|FG000|Stayed on Nicotine Patch|Optimization Point 1 (Week 2)||187||
48038679|NCT03897439|100413529|FG001|Stayed on Nicotine Patch|Optimization Point 1 (Week 2)||61||
48038680|NCT03897439|100413528|FG000|Adapted to VAR|Optimization Point 1 (Week 2)||0||
48038681|NCT03897439|100413529|FG001|Adapted to VAR|Optimization Point 1 (Week 2)||126||
48038682|NCT03897439|100413528|FG000|COMPLETED|Optimization Point 1 (Week 2)||187||
48038683|NCT03897439|100413529|FG001|COMPLETED|Optimization Point 1 (Week 2)||187||
48038684|NCT03897439|100413528|FG000|NOT COMPLETED|Optimization Point 1 (Week 2)||0||
48202438|NCT05010304|100818040|FG000|STARTED|Overall Study||23||
48038685|NCT03897439|100413529|FG001|NOT COMPLETED|Optimization Point 1 (Week 2)||0||
48038686|NCT03897439|100413528|FG000|STARTED|Optimization Point 2 (Week 6)||178||
48038687|NCT03897439|100413529|FG001|STARTED|Optimization Point 2 (Week 6)||173||
48038688|NCT03897439|100413528|FG000|Stayed on Nicotine Patch|Optimization Point 2 (Week 6)||178||
48038689|NCT03897439|100413529|FG001|Stayed on Nicotine Patch|Optimization Point 2 (Week 6)||52||
48038690|NCT03897439|100413528|FG000|Stayed on VAR|Optimization Point 2 (Week 6)||0||
48038691|NCT03897439|100413529|FG001|Stayed on VAR|Optimization Point 2 (Week 6)||25||
48038692|NCT03897439|100413528|FG000|Adapted to Varenicline|Optimization Point 2 (Week 6)||0||
48038693|NCT03897439|100413529|FG001|Adapted to Varenicline|Optimization Point 2 (Week 6)||9||
48038694|NCT03897439|100413528|FG000|Adapted to BUP + Nicotine Patch|Optimization Point 2 (Week 6)||0||
48038695|NCT03897439|100413529|FG001|Adapted to BUP + Nicotine Patch|Optimization Point 2 (Week 6)||87||
48038696|NCT03897439|100413528|FG000|COMPLETED|Optimization Point 2 (Week 6)||178||
48202439|NCT05010304|100818040|FG000|COMPLETED|Overall Study||23||
48202440|NCT05010304|100818040|FG000|NOT COMPLETED|Overall Study||0||
48038697|NCT03897439|100413529|FG001|COMPLETED|Optimization Point 2 (Week 6)||173||
48038698|NCT03897439|100413528|FG000|NOT COMPLETED|Optimization Point 2 (Week 6)||0||
48038699|NCT03897439|100413529|FG001|NOT COMPLETED|Optimization Point 2 (Week 6)||0||
48038700|NCT03897439|100413528|FG000|STARTED|Primary Endpoint (Week 12)||174||
48038701|NCT03897439|100413529|FG001|STARTED|Primary Endpoint (Week 12)||165||
48038702|NCT03897439|100413528|FG000|COMPLETED|Primary Endpoint (Week 12)||174||
48038703|NCT03897439|100413529|FG001|COMPLETED|Primary Endpoint (Week 12)||165||
48038704|NCT03897439|100413528|FG000|NOT COMPLETED|Primary Endpoint (Week 12)||0||
48038705|NCT03897439|100413529|FG001|NOT COMPLETED|Primary Endpoint (Week 12)||0||
48038706|NCT03897439|100413528|FG000|STARTED|End of Treatment (Week 18)||170||
48038707|NCT03897439|100413529|FG001|STARTED|End of Treatment (Week 18)||163||
48038708|NCT03897439|100413528|FG000|COMPLETED|End of Treatment (Week 18)||170||
48038709|NCT03897439|100413529|FG001|COMPLETED|End of Treatment (Week 18)||163||
48038710|NCT03897439|100413528|FG000|NOT COMPLETED|End of Treatment (Week 18)||0||
48038711|NCT03897439|100413529|FG001|NOT COMPLETED|End of Treatment (Week 18)||0||
48038712|NCT03897439|100413528|FG000|STARTED|End of Study (Week 26)||162||
48038713|NCT03897439|100413529|FG001|STARTED|End of Study (Week 26)||162||
48038714|NCT03897439|100413528|FG000|COMPLETED|End of Study (Week 26)||162||
48038715|NCT03897439|100413529|FG001|COMPLETED|End of Study (Week 26)||162||
48038716|NCT03897439|100413528|FG000|NOT COMPLETED|End of Study (Week 26)||0||
48038717|NCT03897439|100413529|FG001|NOT COMPLETED|End of Study (Week 26)||0||
48038718|NCT01203644|100413530|FG000|STARTED|Overall Study||26||
48038719|NCT01203644|100413531|FG001|STARTED|Overall Study||50||
48038720|NCT01203644|100413530|FG000|COMPLETED|Overall Study||26||
48038721|NCT01203644|100413531|FG001|COMPLETED|Overall Study||50||
48038722|NCT01203644|100413530|FG000|NOT COMPLETED|Overall Study||0||
48038723|NCT01203644|100413531|FG001|NOT COMPLETED|Overall Study||0||
48038724|NCT03456882|100413532|FG000|STARTED|Overall Study||74||
48038725|NCT03456882|100413533|FG001|STARTED|Overall Study||73||
48038726|NCT03456882|100413532|FG000|COMPLETED|Overall Study||60||
48038727|NCT03456882|100413533|FG001|COMPLETED|Overall Study||50||
48038728|NCT03456882|100413532|FG000|NOT COMPLETED|Overall Study||14||
48038729|NCT03456882|100413533|FG001|NOT COMPLETED|Overall Study||23||
48038739|NCT03836001|100413537|FG000|STARTED|Blinded Phase (2 Months)||12||
48038740|NCT03836001|100413538|FG001|STARTED|Blinded Phase (2 Months)||12||
48038741|NCT03836001|100413539|FG002|STARTED|Blinded Phase (2 Months)||0||
48038742|NCT03836001|100413537|FG000|COMPLETED|Blinded Phase (2 Months)||12||
48038743|NCT03836001|100413538|FG001|COMPLETED|Blinded Phase (2 Months)||10||
48038744|NCT03836001|100413539|FG002|COMPLETED|Blinded Phase (2 Months)||0||
48038745|NCT03836001|100413537|FG000|NOT COMPLETED|Blinded Phase (2 Months)||0||
48038746|NCT03836001|100413538|FG001|NOT COMPLETED|Blinded Phase (2 Months)||2||
48038747|NCT03836001|100413539|FG002|NOT COMPLETED|Blinded Phase (2 Months)||0||
48038748|NCT03836001|100413537|FG000|STARTED|Washout (1 Month)||12||
48038749|NCT03836001|100413538|FG001|STARTED|Washout (1 Month)||10||
48038750|NCT03836001|100413539|FG002|STARTED|Washout (1 Month)||0||
48038751|NCT03836001|100413537|FG000|COMPLETED|Washout (1 Month)||12||
48202441|NCT00315120|100818041|FG000|STARTED|Overall Study||115||
48202442|NCT00315120|100818042|FG001|STARTED|Overall Study||118||
48038752|NCT03836001|100413538|FG001|COMPLETED|Washout (1 Month)||10||
48038753|NCT03836001|100413539|FG002|COMPLETED|Washout (1 Month)||0||
48038754|NCT03836001|100413537|FG000|NOT COMPLETED|Washout (1 Month)||0||
48495285|NCT00633022|101547821|FG002|NOT COMPLETED|Overall Study||5||
48038755|NCT03836001|100413538|FG001|NOT COMPLETED|Washout (1 Month)||0||
48038756|NCT03836001|100413539|FG002|NOT COMPLETED|Washout (1 Month)||0||
48038757|NCT03836001|100413537|FG000|STARTED|Open-label Extension (3 or 12 Months)||0||
48038758|NCT03836001|100413538|FG001|STARTED|Open-label Extension (3 or 12 Months)||0||
48038759|NCT03836001|100413539|FG002|STARTED|Open-label Extension (3 or 12 Months)||10||
48038760|NCT03836001|100413537|FG000|Entered 12-month Follow-up Period|Open-label Extension (3 or 12 Months)||0||
48038761|NCT03836001|100413538|FG001|Entered 12-month Follow-up Period|Open-label Extension (3 or 12 Months)||0||
48038762|NCT03836001|100413539|FG002|Entered 12-month Follow-up Period|Open-label Extension (3 or 12 Months)||2||
48038763|NCT03836001|100413537|FG000|Entered 3-month Follow-up Period|Open-label Extension (3 or 12 Months)||0||
48038764|NCT03836001|100413538|FG001|Entered 3-month Follow-up Period|Open-label Extension (3 or 12 Months)||0||
48038765|NCT03836001|100413539|FG002|Entered 3-month Follow-up Period|Open-label Extension (3 or 12 Months)||8||
48038766|NCT03836001|100413537|FG000|COMPLETED|Open-label Extension (3 or 12 Months)||0||
48038767|NCT03836001|100413538|FG001|COMPLETED|Open-label Extension (3 or 12 Months)||0||
48038768|NCT03836001|100413539|FG002|COMPLETED|Open-label Extension (3 or 12 Months)||8||
48202443|NCT00315120|100818043|FG002|STARTED|Overall Study||115||
48202444|NCT00315120|100818044|FG003|STARTED|Overall Study||107||
48202445|NCT00315120|100818041|FG000|COMPLETED|Overall Study||115||
48038769|NCT03836001|100413537|FG000|NOT COMPLETED|Open-label Extension (3 or 12 Months)||0||
48038770|NCT03836001|100413538|FG001|NOT COMPLETED|Open-label Extension (3 or 12 Months)||0||
48038771|NCT03836001|100413539|FG002|NOT COMPLETED|Open-label Extension (3 or 12 Months)||2||
48202446|NCT00315120|100818042|FG001|COMPLETED|Overall Study||118||
48202447|NCT00315120|100818043|FG002|COMPLETED|Overall Study||115||
48202448|NCT00315120|100818044|FG003|COMPLETED|Overall Study||107||
48202449|NCT00315120|100818041|FG000|NOT COMPLETED|Overall Study||0||
48202450|NCT00315120|100818042|FG001|NOT COMPLETED|Overall Study||0||
48202451|NCT00315120|100818043|FG002|NOT COMPLETED|Overall Study||0||
48202452|NCT00315120|100818044|FG003|NOT COMPLETED|Overall Study||0||
48202453|NCT03557658|100818045|FG000|STARTED|Overall Study||8||
48202454|NCT03557658|100818046|FG001|STARTED|Overall Study||8||
48202455|NCT03557658|100818045|FG000|COMPLETED|Overall Study||8||
48202456|NCT03557658|100818046|FG001|COMPLETED|Overall Study||8||
48038778|NCT02908490|100413542|FG000|STARTED|Overall Study||12||
48038779|NCT02908490|100413543|FG001|STARTED|Overall Study||13||
48038780|NCT02908490|100413542|FG000|COMPLETED|Overall Study||10||
48038781|NCT02908490|100413543|FG001|COMPLETED|Overall Study||11||
48038782|NCT02908490|100413542|FG000|NOT COMPLETED|Overall Study||2||
48038783|NCT02908490|100413543|FG001|NOT COMPLETED|Overall Study||2||
48038784|NCT00361634|100413544|FG000|STARTED|Overall Study||14||
48038785|NCT00361634|100413544|FG000|Treated|Overall Study||13||
48038786|NCT00361634|100413544|FG000|COMPLETED|Overall Study||12||
48038787|NCT00361634|100413544|FG000|NOT COMPLETED|Overall Study||2||
48038788|NCT02410343|100413545|FG000|STARTED|Core Period (24 Weeks)||6||
48038789|NCT02410343|100413546|FG001|STARTED|Core Period (24 Weeks)||8||
48038790|NCT02410343|100413545|FG000|COMPLETED|Core Period (24 Weeks)||1||
48038791|NCT02410343|100413546|FG001|COMPLETED|Core Period (24 Weeks)||1||
48038792|NCT02410343|100413545|FG000|NOT COMPLETED|Core Period (24 Weeks)||5||
48038793|NCT02410343|100413546|FG001|NOT COMPLETED|Core Period (24 Weeks)||7||
48038794|NCT02410343|100413545|FG000|STARTED|Extension Period (12 Months)||1||
48038795|NCT02410343|100413546|FG001|STARTED|Extension Period (12 Months)||1||
48038796|NCT02410343|100413545|FG000|COMPLETED|Extension Period (12 Months)||0||
48038797|NCT02410343|100413546|FG001|COMPLETED|Extension Period (12 Months)||0||
48038798|NCT02410343|100413545|FG000|NOT COMPLETED|Extension Period (12 Months)||1||
48038799|NCT02410343|100413546|FG001|NOT COMPLETED|Extension Period (12 Months)||1||
48038800|NCT02081859|100413547|FG000|STARTED|Overall Study||150||
48038801|NCT02081859|100413548|FG001|STARTED|Overall Study||150||
48038802|NCT02081859|100413547|FG000|COMPLETED|Overall Study||116||
48038803|NCT02081859|100413548|FG001|COMPLETED|Overall Study||119||
48038804|NCT02081859|100413547|FG000|NOT COMPLETED|Overall Study||34||
48038805|NCT02081859|100413548|FG001|NOT COMPLETED|Overall Study||31||
48038806|NCT01996839|100413549|FG000|STARTED|Overall Study||172||
48038807|NCT01996839|100413550|FG001|STARTED|Overall Study||171||
48038808|NCT01996839|100413551|FG002|STARTED|Overall Study||171||
48038809|NCT01996839|100413549|FG000|COMPLETED|Overall Study||80||
48038810|NCT01996839|100413550|FG001|COMPLETED|Overall Study||133||
48038811|NCT01996839|100413551|FG002|COMPLETED|Overall Study||139||
48038812|NCT01996839|100413549|FG000|NOT COMPLETED|Overall Study||92||
48038813|NCT01996839|100413550|FG001|NOT COMPLETED|Overall Study||38||
48038814|NCT01996839|100413551|FG002|NOT COMPLETED|Overall Study||32||
48038815|NCT02395172|100413552|FG000|STARTED|Overall Study||396||
48038816|NCT02395172|100413553|FG001|STARTED|Overall Study||396||
48038817|NCT02395172|100413552|FG000|Treated|Overall Study||393||
48038818|NCT02395172|100413553|FG001|Treated|Overall Study||365||
48202457|NCT03557658|100818045|FG000|NOT COMPLETED|Overall Study||0||
48202458|NCT03557658|100818046|FG001|NOT COMPLETED|Overall Study||0||
48202459|NCT01876511|100818047|FG000|STARTED|Overall Study||41||
48202460|NCT01876511|100818048|FG001|STARTED|Overall Study||25||
48202461|NCT01876511|100818049|FG002|STARTED|Overall Study||47||
48202462|NCT01876511|100818047|FG000|Stages 1 and 2|Overall Study||24||
48202463|NCT01876511|100818048|FG001|Stages 1 and 2|Overall Study||25||
48202464|NCT01876511|100818049|FG002|Stages 1 and 2|Overall Study||21||
48202465|NCT01876511|100818047|FG000|COMPLETED|Overall Study||18||
48202466|NCT01876511|100818048|FG001|COMPLETED|Overall Study||0||
48202467|NCT01876511|100818049|FG002|COMPLETED|Overall Study||16||
48202468|NCT01876511|100818047|FG000|NOT COMPLETED|Overall Study||23||
48202469|NCT01876511|100818048|FG001|NOT COMPLETED|Overall Study||25||
48202470|NCT01876511|100818049|FG002|NOT COMPLETED|Overall Study||31||
48202471|NCT04176458|100818050|FG000|STARTED|Overall Study||4||
48202472|NCT04176458|100818050|FG000|COMPLETED|Overall Study||0||
48202473|NCT04176458|100818050|FG000|NOT COMPLETED|Overall Study||4||
48202474|NCT00305695|100820588|FG000|STARTED|Overall Study||81||
48202475|NCT00305695|100820589|FG001|STARTED|Overall Study||79||
48202476|NCT00305695|100820588|FG000|COMPLETED|Overall Study||40||
48202477|NCT00305695|100820589|FG001|COMPLETED|Overall Study||52||
48202478|NCT00305695|100820588|FG000|NOT COMPLETED|Overall Study||41||
48202479|NCT00305695|100820589|FG001|NOT COMPLETED|Overall Study||27||
48202480|NCT04580303|100820590|FG000|STARTED|Overall Study||7||14
48202481|NCT04580303|100820591|FG001|STARTED|Overall Study||9||18
48202482|NCT04580303|100820592|FG002|STARTED|Overall Study||9||18
48202483|NCT04580303|100820593|FG003|STARTED|Overall Study||10||20
48202484|NCT04580303|100820590|FG000|COMPLETED|Overall Study||7||14
48202485|NCT04580303|100820591|FG001|COMPLETED|Overall Study||8||16
48202486|NCT04580303|100820592|FG002|COMPLETED|Overall Study||8||16
48202487|NCT04580303|100820593|FG003|COMPLETED|Overall Study||10||20
48202488|NCT04580303|100820590|FG000|NOT COMPLETED|Overall Study||0||0
48202489|NCT04580303|100820591|FG001|NOT COMPLETED|Overall Study||1||2
48202490|NCT04580303|100820592|FG002|NOT COMPLETED|Overall Study||1||2
48202491|NCT04580303|100820593|FG003|NOT COMPLETED|Overall Study||0||0
48202492|NCT01830842|100820594|FG000|STARTED|Overall Study||30||
48202493|NCT01830842|100820595|FG001|STARTED|Overall Study||24||
48202494|NCT01830842|100820594|FG000|COMPLETED|Overall Study||25||
48202495|NCT01830842|100820595|FG001|COMPLETED|Overall Study||22||
48202496|NCT01830842|100820594|FG000|NOT COMPLETED|Overall Study||5||
48202497|NCT01830842|100820595|FG001|NOT COMPLETED|Overall Study||2||
48202498|NCT02041104|100820596|FG000|STARTED|Overall Study||28||
48202499|NCT02041104|100820597|FG001|STARTED|Overall Study||23||
48202500|NCT02041104|100820596|FG000|COMPLETED|Overall Study||27||
48202501|NCT02041104|100820597|FG001|COMPLETED|Overall Study||16||
48202502|NCT02041104|100820596|FG000|NOT COMPLETED|Overall Study||1||
48202503|NCT02041104|100820597|FG001|NOT COMPLETED|Overall Study||7||
48038819|NCT02395172|100413552|FG000|COMPLETED|Overall Study||393||
48038820|NCT02395172|100413553|FG001|COMPLETED|Overall Study||365||
48038821|NCT02395172|100413552|FG000|NOT COMPLETED|Overall Study||3||
48038822|NCT02395172|100413553|FG001|NOT COMPLETED|Overall Study||31||
48038829|NCT01473368|100413556|FG000|STARTED|Overall Study||14||
48202504|NCT01254019|100820598|FG000|STARTED|Overall Study||61||
48202505|NCT01254019|100820599|FG001|STARTED|Overall Study||125||
48202506|NCT01254019|100820598|FG000|COMPLETED|Overall Study||60||
48202507|NCT01254019|100820599|FG001|COMPLETED|Overall Study||121||
48495286|NCT00521586|101547822|FG000|STARTED|Initial Vaccination (Year 0)||554||
48038830|NCT01473368|100413557|FG001|STARTED|Overall Study||12||
48038831|NCT01473368|100413558|FG002|STARTED|Overall Study||15||
48038832|NCT01473368|100413559|FG003|STARTED|Overall Study||12||
48038833|NCT01473368|100413556|FG000|COMPLETED|Overall Study||13||
48038834|NCT01473368|100413557|FG001|COMPLETED|Overall Study||12||
48038835|NCT01473368|100413558|FG002|COMPLETED|Overall Study||12||
48038836|NCT01473368|100413559|FG003|COMPLETED|Overall Study||12||
48038837|NCT01473368|100413556|FG000|NOT COMPLETED|Overall Study||1||
48038838|NCT01473368|100413557|FG001|NOT COMPLETED|Overall Study||0||
48038839|NCT01473368|100413558|FG002|NOT COMPLETED|Overall Study||3||
48038840|NCT01473368|100413559|FG003|NOT COMPLETED|Overall Study||0||
48038841|NCT01425463|100413560|FG000|STARTED|Overall Study||130||
48202508|NCT01254019|100820598|FG000|NOT COMPLETED|Overall Study||1||
48202509|NCT01254019|100820599|FG001|NOT COMPLETED|Overall Study||4||
48202510|NCT01977612|100820600|FG000|STARTED|Overall Study||85||
48202511|NCT01977612|100820601|FG001|STARTED|Overall Study||80||
48202512|NCT01977612|100820600|FG000|COMPLETED|Overall Study||84||
48202513|NCT01977612|100820601|FG001|COMPLETED|Overall Study||79||
48038842|NCT01425463|100413561|FG001|STARTED|Overall Study||126||
48038843|NCT01425463|100413560|FG000|Safety Set|Overall Study||126||
48038844|NCT01425463|100413561|FG001|Safety Set|Overall Study||122||
48038845|NCT01425463|100413560|FG000|Full Analysis Set|Overall Study||122||
48038846|NCT01425463|100413561|FG001|Full Analysis Set|Overall Study||116||
48202514|NCT01977612|100820600|FG000|NOT COMPLETED|Overall Study||1||
48202515|NCT01977612|100820601|FG001|NOT COMPLETED|Overall Study||1||
48202516|NCT02918071|100820602|FG000|STARTED|Overall Study||121||
48202517|NCT02918071|100820602|FG000|COMPLETED|Overall Study||118||
48038847|NCT01425463|100413560|FG000|COMPLETED|Overall Study||106||
48038848|NCT01425463|100413561|FG001|COMPLETED|Overall Study||102||
48038849|NCT01425463|100413560|FG000|NOT COMPLETED|Overall Study||24||
48038850|NCT01425463|100413561|FG001|NOT COMPLETED|Overall Study||24||
48038864|NCT02204124|100413565|FG000|STARTED|Overall Study||13||
48038865|NCT02204124|100413566|FG001|STARTED|Overall Study||19||
48038866|NCT02204124|100413565|FG000|COMPLETED|Overall Study||13||
48038867|NCT02204124|100413566|FG001|COMPLETED|Overall Study||19||
48038868|NCT02204124|100413565|FG000|NOT COMPLETED|Overall Study||0||
48038869|NCT02204124|100413566|FG001|NOT COMPLETED|Overall Study||0||
48038870|NCT03126344|100413567|FG000|STARTED|Overall Study||33||
48038871|NCT03126344|100413568|FG001|STARTED|Overall Study||33||
48038872|NCT03126344|100413569|FG002|STARTED|Overall Study||33||
48202518|NCT02918071|100820602|FG000|NOT COMPLETED|Overall Study||3||
48202519|NCT02378714|100820603|FG000|STARTED|Overall Study||68||
48202520|NCT02378714|100820604|FG001|STARTED|Overall Study||68||
48495287|NCT00521586|101547823|FG001|STARTED|Initial Vaccination (Year 0)||562||
48038873|NCT03126344|100413567|FG000|COMPLETED|Overall Study||33||
48038874|NCT03126344|100413568|FG001|COMPLETED|Overall Study||33||
48038875|NCT03126344|100413569|FG002|COMPLETED|Overall Study||28||
48038876|NCT03126344|100413567|FG000|NOT COMPLETED|Overall Study||0||
48038877|NCT03126344|100413568|FG001|NOT COMPLETED|Overall Study||0||
48038878|NCT03126344|100413569|FG002|NOT COMPLETED|Overall Study||5||
48038879|NCT01980485|100413570|FG000|STARTED|Overall Study||120||
48038880|NCT01980485|100413571|FG001|STARTED|Overall Study||105||
48038881|NCT01980485|100413570|FG000|COMPLETED|Overall Study||84||
48038882|NCT01980485|100413571|FG001|COMPLETED|Overall Study||80||
48038883|NCT01980485|100413570|FG000|NOT COMPLETED|Overall Study||36||
48038884|NCT01980485|100413571|FG001|NOT COMPLETED|Overall Study||25||
48202521|NCT02378714|100820605|FG002|STARTED|Overall Study||81||
48202522|NCT02378714|100820606|FG003|STARTED|Overall Study||83||
48202523|NCT02378714|100820603|FG000|COMPLETED|Overall Study||39||
48202524|NCT02378714|100820604|FG001|COMPLETED|Overall Study||29||
48202525|NCT02378714|100820605|FG002|COMPLETED|Overall Study||51||
48202526|NCT02378714|100820606|FG003|COMPLETED|Overall Study||51||
48202527|NCT02378714|100820603|FG000|NOT COMPLETED|Overall Study||29||
48495288|NCT00521586|101547822|FG000|Vaccinated Dose 1|Initial Vaccination (Year 0)||551||
48495289|NCT00521586|101547823|FG001|Vaccinated Dose 1|Initial Vaccination (Year 0)||560||
48202528|NCT02378714|100820604|FG001|NOT COMPLETED|Overall Study||39||
48202529|NCT02378714|100820605|FG002|NOT COMPLETED|Overall Study||30||
48202530|NCT02378714|100820606|FG003|NOT COMPLETED|Overall Study||32||
48202531|NCT00364286|100820607|FG000|STARTED|Overall Study||17||
48202532|NCT00364286|100820607|FG000|COMPLETED|Overall Study||14||
48202533|NCT00364286|100820607|FG000|NOT COMPLETED|Overall Study||3||
48202534|NCT02786771|100820608|FG000|STARTED|Overall Study||63||
48202535|NCT02786771|100820609|FG001|STARTED|Overall Study||62||
48202536|NCT02786771|100820608|FG000|COMPLETED|Overall Study||53||
48202537|NCT02786771|100820609|FG001|COMPLETED|Overall Study||56||
48202538|NCT02786771|100820608|FG000|NOT COMPLETED|Overall Study||10||
48202539|NCT02786771|100820609|FG001|NOT COMPLETED|Overall Study||6||
48202540|NCT00667745|100820610|FG000|STARTED|Overall Study||141||
48202541|NCT00667745|100820611|FG001|STARTED|Overall Study||142||
48202542|NCT00667745|100820610|FG000|COMPLETED|Overall Study||116||
48202543|NCT00667745|100820611|FG001|COMPLETED|Overall Study||121||
48202544|NCT00667745|100820610|FG000|NOT COMPLETED|Overall Study||25||
48202545|NCT00667745|100820611|FG001|NOT COMPLETED|Overall Study||21||
48202546|NCT02311907|100820612|FG000|STARTED|Overall Study||94||
48202547|NCT02311907|100820613|FG001|STARTED|Overall Study||91||
48202548|NCT02311907|100820612|FG000|COMPLETED|Overall Study||94||
48202549|NCT02311907|100820613|FG001|COMPLETED|Overall Study||91||
48202550|NCT02311907|100820612|FG000|NOT COMPLETED|Overall Study||0||
48202551|NCT02311907|100820613|FG001|NOT COMPLETED|Overall Study||0||
48202552|NCT03008915|100820614|FG000|STARTED|Treatment 1||8||
48202553|NCT03008915|100820615|FG001|STARTED|Treatment 1||7||
48202554|NCT03008915|100820614|FG000|COMPLETED|Treatment 1||8||
48202555|NCT03008915|100820615|FG001|COMPLETED|Treatment 1||6||
48202556|NCT03008915|100820614|FG000|NOT COMPLETED|Treatment 1||0||
48202557|NCT03008915|100820615|FG001|NOT COMPLETED|Treatment 1||1||
48202558|NCT03008915|100820614|FG000|STARTED|Treatment 2||8||
48202559|NCT03008915|100820615|FG001|STARTED|Treatment 2||6||
48202560|NCT03008915|100820614|FG000|COMPLETED|Treatment 2||8||
48202561|NCT03008915|100820615|FG001|COMPLETED|Treatment 2||6||
48202562|NCT03008915|100820614|FG000|NOT COMPLETED|Treatment 2||0||
48202563|NCT03008915|100820615|FG001|NOT COMPLETED|Treatment 2||0||
48202564|NCT02131324|100820616|FG000|STARTED|Overall Study||24||
48202565|NCT02131324|100820617|FG001|STARTED|Overall Study||26||
48202566|NCT02131324|100820616|FG000|Analyzed|Overall Study||22||
48202567|NCT02131324|100820617|FG001|Analyzed|Overall Study||24||
48202568|NCT02131324|100820616|FG000|COMPLETED|Overall Study||22||
48202569|NCT02131324|100820617|FG001|COMPLETED|Overall Study||23||
48202570|NCT02131324|100820616|FG000|NOT COMPLETED|Overall Study||2||
48202571|NCT02131324|100820617|FG001|NOT COMPLETED|Overall Study||3||
48202572|NCT01421654|100820618|FG000|STARTED|Overall Study||11||
48202573|NCT01421654|100820619|FG001|STARTED|Overall Study||9||
48202574|NCT01421654|100820618|FG000|COMPLETED|Overall Study||11||
48202575|NCT01421654|100820619|FG001|COMPLETED|Overall Study||9||
48202576|NCT01421654|100820618|FG000|NOT COMPLETED|Overall Study||0||
48202577|NCT01421654|100820619|FG001|NOT COMPLETED|Overall Study||0||
48202578|NCT00432458|100820620|FG000|STARTED|Overall Study||35||
48202579|NCT00432458|100820621|FG001|STARTED|Overall Study||33||
48202580|NCT00432458|100820620|FG000|COMPLETED|Overall Study||30||
48202581|NCT00432458|100820621|FG001|COMPLETED|Overall Study||32||
48202582|NCT00432458|100820620|FG000|NOT COMPLETED|Overall Study||5||
48202583|NCT00432458|100820621|FG001|NOT COMPLETED|Overall Study||1||
48202584|NCT05257798|100820622|FG000|STARTED|Treatment Phase||15||
48202585|NCT05257798|100820623|FG001|STARTED|Treatment Phase||3||
48202586|NCT05257798|100820622|FG000|COMPLETED|Treatment Phase||15||
48202587|NCT05257798|100820623|FG001|COMPLETED|Treatment Phase||3||
48202588|NCT05257798|100820622|FG000|NOT COMPLETED|Treatment Phase||0||
48202589|NCT05257798|100820623|FG001|NOT COMPLETED|Treatment Phase||0||
48202590|NCT05257798|100820622|FG000|STARTED|Follow-up Phase||15||
48202591|NCT05257798|100820623|FG001|STARTED|Follow-up Phase||3||
48202592|NCT05257798|100820622|FG000|COMPLETED|Follow-up Phase||14||
48202593|NCT05257798|100820623|FG001|COMPLETED|Follow-up Phase||3||
48202594|NCT05257798|100820622|FG000|NOT COMPLETED|Follow-up Phase||1||
48202595|NCT05257798|100820623|FG001|NOT COMPLETED|Follow-up Phase||0||
48202596|NCT05046132|100820624|FG000|STARTED|Overall Study||28||
48202597|NCT05046132|100820625|FG001|STARTED|Overall Study||24||
48202598|NCT05046132|100820626|FG002|STARTED|Overall Study||25||
48202599|NCT05046132|100820624|FG000|Received 2 mg Setmelanotide|Overall Study||28||
48202600|NCT05046132|100820625|FG001|Received 2 mg Setmelanotide|Overall Study||0||
48202601|NCT05046132|100820626|FG002|Received 2 mg Setmelanotide|Overall Study||0||
48202602|NCT05046132|100820624|FG000|Received 3 mg Setmelanotide|Overall Study||24||
48202603|NCT05046132|100820625|FG001|Received 3 mg Setmelanotide|Overall Study||0||
48202604|NCT05046132|100820626|FG002|Received 3 mg Setmelanotide|Overall Study||0||
48202605|NCT05046132|100820624|FG000|Received 5 mg Setmelanotide|Overall Study||23||
48202606|NCT05046132|100820625|FG001|Received 5 mg Setmelanotide|Overall Study||0||
48202607|NCT05046132|100820626|FG002|Received 5 mg Setmelanotide|Overall Study||0||
48202608|NCT05046132|100820624|FG000|Received 7 mg Setmelanotide|Overall Study||21||
48202609|NCT05046132|100820625|FG001|Received 7 mg Setmelanotide|Overall Study||0||
48202610|NCT05046132|100820626|FG002|Received 7 mg Setmelanotide|Overall Study||0||
48202611|NCT05046132|100820624|FG000|COMPLETED|Overall Study||21||
48038924|NCT01567839|100417029|FG000|STARTED|Overall Study||60||
48038925|NCT01567839|100417029|FG000|COMPLETED|Overall Study||60||
48038926|NCT01567839|100417029|FG000|NOT COMPLETED|Overall Study||0||
48038927|NCT02881567|100417030|FG000|STARTED|Overall Study||41||
48038928|NCT02881567|100417030|FG000|COMPLETED|Overall Study||23||
48038929|NCT02881567|100417030|FG000|NOT COMPLETED|Overall Study||18||
48038930|NCT04931888|100417031|FG000|STARTED|Overall Study||17|"Unit applied to children for consistency across columns. Although written as 0 units for parents to ensure the total column is correct, each parent is also from one family unit as well, corresponding to their child's family unit."|5
48038931|NCT04931888|100417032|FG001|STARTED|Overall Study||5|"Unit applied to children for consistency across columns. Although written as 0 units for parents to ensure the total column is correct, each parent is also from one family unit as well, corresponding to their child's family unit."|0
48038932|NCT04931888|100417033|FG002|STARTED|Overall Study||6|"Unit applied to children for consistency across columns. Although written as 0 units for parents to ensure the total column is correct, each parent is also from one family unit as well, corresponding to their child's family unit."|3
48038933|NCT04931888|100417034|FG003|STARTED|Overall Study||3|"Unit applied to children for consistency across columns. Although written as 0 units for parents to ensure the total column is correct, each parent is also from one family unit as well, corresponding to their child's family unit."|0
48038934|NCT04931888|100417031|FG000|COMPLETED|Overall Study||13||3
48038935|NCT04931888|100417032|FG001|COMPLETED|Overall Study||3||0
48038936|NCT04931888|100417033|FG002|COMPLETED|Overall Study||6||3
48038937|NCT04931888|100417034|FG003|COMPLETED|Overall Study||3||0
48038938|NCT04931888|100417031|FG000|NOT COMPLETED|Overall Study||4||2
48038939|NCT04931888|100417032|FG001|NOT COMPLETED|Overall Study||2||0
48038940|NCT04931888|100417033|FG002|NOT COMPLETED|Overall Study||0||0
48038941|NCT04931888|100417034|FG003|NOT COMPLETED|Overall Study||0||0
48038942|NCT00156936|100417035|FG000|STARTED|Overall Study||92||
48038943|NCT00156936|100417036|FG001|STARTED|Overall Study||16||
48038944|NCT00156936|100417035|FG000|COMPLETED|Overall Study||20||
48038945|NCT00156936|100417036|FG001|COMPLETED|Overall Study||5||
48038946|NCT00156936|100417035|FG000|NOT COMPLETED|Overall Study||72||
48038947|NCT00156936|100417036|FG001|NOT COMPLETED|Overall Study||11||
48038948|NCT01717053|100417037|FG000|STARTED|Overall Study||37||
48038949|NCT01717053|100417037|FG000|COMPLETED|Overall Study||33||
48038950|NCT01717053|100417037|FG000|NOT COMPLETED|Overall Study||4||
48038951|NCT00123643|100417038|FG000|STARTED|Overall Study||20||
48038952|NCT00123643|100417039|FG001|STARTED|Overall Study||16||
48038953|NCT00123643|100417038|FG000|COMPLETED|Overall Study||20||
48038954|NCT00123643|100417039|FG001|COMPLETED|Overall Study||16||
48038955|NCT00123643|100417038|FG000|NOT COMPLETED|Overall Study||0||
48038956|NCT00123643|100417039|FG001|NOT COMPLETED|Overall Study||0||
48038957|NCT01433250|100417040|FG000|STARTED|Overall Study||22||
48038958|NCT01433250|100417041|FG001|STARTED|Overall Study||17||
48038959|NCT01433250|100417040|FG000|COMPLETED|Overall Study||19||
48038960|NCT01433250|100417041|FG001|COMPLETED|Overall Study||14||
48038961|NCT01433250|100417040|FG000|NOT COMPLETED|Overall Study||3||
48038962|NCT01433250|100417041|FG001|NOT COMPLETED|Overall Study||3||
48038963|NCT04610281|100417042|FG000|STARTED|Overall Study||30||
48038964|NCT04610281|100417043|FG001|STARTED|Overall Study||33||
48038965|NCT04610281|100417042|FG000|COMPLETED|Overall Study||29||
48038966|NCT04610281|100417043|FG001|COMPLETED|Overall Study||29||
48038967|NCT04610281|100417042|FG000|NOT COMPLETED|Overall Study||1||
48038968|NCT04610281|100417043|FG001|NOT COMPLETED|Overall Study||4||
48038969|NCT01883453|100417044|FG000|STARTED|Overall Study||73||
48038970|NCT01883453|100417045|FG001|STARTED|Overall Study||73||
48038971|NCT01883453|100417044|FG000|COMPLETED|Overall Study||48||
48038972|NCT01883453|100417045|FG001|COMPLETED|Overall Study||50||
48038973|NCT01883453|100417044|FG000|NOT COMPLETED|Overall Study||25||
48038974|NCT01883453|100417045|FG001|NOT COMPLETED|Overall Study||23||
48038975|NCT00668733|100417046|FG000|STARTED|Overall Study||89||
48038976|NCT00668733|100417047|FG001|STARTED|Overall Study||90||
48038977|NCT00668733|100417046|FG000|COMPLETED|Overall Study||87||
48038978|NCT00668733|100417047|FG001|COMPLETED|Overall Study||83||
48038979|NCT00668733|100417046|FG000|NOT COMPLETED|Overall Study||2||
48038980|NCT00668733|100417047|FG001|NOT COMPLETED|Overall Study||7||
48038981|NCT02338882|100417048|FG000|STARTED|Overall Study||50||
48038982|NCT02338882|100417049|FG001|STARTED|Overall Study||50||
48038983|NCT02338882|100417048|FG000|COMPLETED|Overall Study||43||
48038984|NCT02338882|100417049|FG001|COMPLETED|Overall Study||47||
48038985|NCT02338882|100417048|FG000|NOT COMPLETED|Overall Study||7||
48038986|NCT02338882|100417049|FG001|NOT COMPLETED|Overall Study||3||
48038987|NCT03390114|100417050|FG000|STARTED|Overall Study||10||
48038988|NCT03390114|100417051|FG001|STARTED|Overall Study||10||
48038989|NCT03390114|100417050|FG000|COMPLETED|Overall Study||6||
48038990|NCT03390114|100417051|FG001|COMPLETED|Overall Study||8||
48202612|NCT05046132|100820625|FG001|COMPLETED|Overall Study||23||
48202613|NCT05046132|100820626|FG002|COMPLETED|Overall Study||25||
48038991|NCT03390114|100417050|FG000|NOT COMPLETED|Overall Study||4||
48038992|NCT03390114|100417051|FG001|NOT COMPLETED|Overall Study||2||
48038993|NCT00311584|100417052|FG000|STARTED|Overall Study||29||
48038994|NCT00311584|100417053|FG001|STARTED|Overall Study||30||
48038995|NCT00311584|100417052|FG000|COMPLETED|Overall Study||9||
48038996|NCT00311584|100417053|FG001|COMPLETED|Overall Study||7||
48038997|NCT00311584|100417052|FG000|NOT COMPLETED|Overall Study||20||
48038998|NCT00311584|100417053|FG001|NOT COMPLETED|Overall Study||23||
48038999|NCT01317550|100417054|FG000|STARTED|Overall Study||5||
48039000|NCT01317550|100417055|FG001|STARTED|Overall Study||3||
48039001|NCT01317550|100417056|FG002|STARTED|Overall Study||3||
48039002|NCT01317550|100417057|FG003|STARTED|Overall Study||3||
48039003|NCT01317550|100417054|FG000|COMPLETED|Overall Study||3||
48039004|NCT01317550|100417055|FG001|COMPLETED|Overall Study||3||
48039005|NCT01317550|100417056|FG002|COMPLETED|Overall Study||3||
48039006|NCT01317550|100417057|FG003|COMPLETED|Overall Study||3||
48039007|NCT01317550|100417054|FG000|NOT COMPLETED|Overall Study||2||
48039008|NCT01317550|100417055|FG001|NOT COMPLETED|Overall Study||0||
48039009|NCT01317550|100417056|FG002|NOT COMPLETED|Overall Study||0||
48039010|NCT01317550|100417057|FG003|NOT COMPLETED|Overall Study||0||
48039011|NCT02923921|100417058|FG000|STARTED|Overall Study||283||
48039012|NCT02923921|100417059|FG001|STARTED|Overall Study||284||
48039013|NCT02923921|100417058|FG000|Received at Least 1 Dose of Study Drug|Overall Study||278||
48039014|NCT02923921|100417059|FG001|Received at Least 1 Dose of Study Drug|Overall Study||251||
48039015|NCT02923921|100417058|FG000|Safety Population|Overall Study||278||
48039016|NCT02923921|100417059|FG001|Safety Population|Overall Study||251||
48039017|NCT02923921|100417058|FG000|COMPLETED|Overall Study||230||
48039018|NCT02923921|100417059|FG001|COMPLETED|Overall Study||227||
48039019|NCT02923921|100417058|FG000|NOT COMPLETED|Overall Study||53||
48039020|NCT02923921|100417059|FG001|NOT COMPLETED|Overall Study||57||
48039021|NCT01381562|100417060|FG000|STARTED|Overall Study||5||
48039022|NCT01381562|100417061|FG001|STARTED|Overall Study||4||
48039023|NCT01381562|100417062|FG002|STARTED|Overall Study||5||
48039024|NCT01381562|100417060|FG000|COMPLETED|Overall Study||5||
48039025|NCT01381562|100417061|FG001|COMPLETED|Overall Study||3||
48039026|NCT01381562|100417062|FG002|COMPLETED|Overall Study||5||
48039027|NCT01381562|100417060|FG000|NOT COMPLETED|Overall Study||0||
48039028|NCT01381562|100417061|FG001|NOT COMPLETED|Overall Study||1||
48039029|NCT01381562|100417062|FG002|NOT COMPLETED|Overall Study||0||
48039030|NCT02123251|100417063|FG000|STARTED|Overall Study||159||
48039031|NCT02123251|100417064|FG001|STARTED|Overall Study||161||
48039032|NCT02123251|100417063|FG000|COMPLETED|Overall Study||125||
48039033|NCT02123251|100417064|FG001|COMPLETED|Overall Study||131||
48039034|NCT02123251|100417063|FG000|NOT COMPLETED|Overall Study||34||
48039035|NCT02123251|100417064|FG001|NOT COMPLETED|Overall Study||30||
48039036|NCT00294762|100417065|FG000|STARTED|Overall Study||72||
48039037|NCT00294762|100417066|FG001|STARTED|Overall Study||71||
48039038|NCT00294762|100417065|FG000|COMPLETED|Overall Study||69||
48039039|NCT00294762|100417066|FG001|COMPLETED|Overall Study||68||
48039040|NCT00294762|100417065|FG000|NOT COMPLETED|Overall Study||3||
48039041|NCT00294762|100417066|FG001|NOT COMPLETED|Overall Study||3||
48039042|NCT03478865|100417067|FG000|STARTED|Overall Study||5||
48039043|NCT03478865|100417068|FG001|STARTED|Overall Study||3||
48039044|NCT03478865|100417067|FG000|Completed Treatment Completion Visit|Overall Study||5||
48039045|NCT03478865|100417068|FG001|Completed Treatment Completion Visit|Overall Study||3||
48039046|NCT03478865|100417067|FG000|COMPLETED|Overall Study||5||
48039047|NCT03478865|100417068|FG001|COMPLETED|Overall Study||3||
48039048|NCT03478865|100417067|FG000|NOT COMPLETED|Overall Study||0||
48039049|NCT03478865|100417068|FG001|NOT COMPLETED|Overall Study||0||
48039050|NCT02603666|100417069|FG000|STARTED|Overall Study||130||
48039051|NCT02603666|100417069|FG000|COMPLETED|Overall Study||130||
48039052|NCT02603666|100417069|FG000|NOT COMPLETED|Overall Study||0||
48039053|NCT03467685|100417070|FG000|STARTED|Overall Study||52||
48039054|NCT03467685|100417071|FG001|STARTED|Overall Study||49||
48039055|NCT03467685|100417070|FG000|COMPLETED|Overall Study||52||
48039056|NCT03467685|100417071|FG001|COMPLETED|Overall Study||49||
48039057|NCT03467685|100417070|FG000|NOT COMPLETED|Overall Study||0||
48039058|NCT03467685|100417071|FG001|NOT COMPLETED|Overall Study||0||
48039059|NCT04644315|100417072|FG000|STARTED|Overall Study||1||
48039060|NCT04644315|100417072|FG000|COMPLETED|Overall Study||0||
48039061|NCT04644315|100417072|FG000|NOT COMPLETED|Overall Study||1||
48039062|NCT00779259|100417073|FG000|STARTED|Theophylline Alone||24||
48039063|NCT00779259|100417073|FG000|COMPLETED|Theophylline Alone||24||
48039064|NCT00779259|100417073|FG000|NOT COMPLETED|Theophylline Alone||0||
48039065|NCT00779259|100417073|FG000|STARTED|4 Day Washout Period||24||
48039066|NCT00779259|100417073|FG000|COMPLETED|4 Day Washout Period||24||
48039067|NCT00779259|100417073|FG000|NOT COMPLETED|4 Day Washout Period||0||
48039068|NCT00779259|100417073|FG000|STARTED|Quinine Alone||24||
48039069|NCT00779259|100417073|FG000|COMPLETED|Quinine Alone||22||
48039070|NCT00779259|100417073|FG000|NOT COMPLETED|Quinine Alone||2||
48039071|NCT00779259|100417073|FG000|STARTED|Theophylline With Quinine||22||
48039072|NCT00779259|100417073|FG000|COMPLETED|Theophylline With Quinine||22||
48039073|NCT00779259|100417073|FG000|NOT COMPLETED|Theophylline With Quinine||0||
48039074|NCT00995566|100417074|FG000|STARTED|Overall Study||54||
48039075|NCT00995566|100417074|FG000|COMPLETED|Overall Study||0||
48039076|NCT00995566|100417074|FG000|NOT COMPLETED|Overall Study||54||
48202614|NCT05046132|100820624|FG000|NOT COMPLETED|Overall Study||7||
48202615|NCT05046132|100820625|FG001|NOT COMPLETED|Overall Study||1||
48202616|NCT05046132|100820626|FG002|NOT COMPLETED|Overall Study||0||
48202617|NCT01393119|100820627|FG000|STARTED|Overall Study||14||
48202618|NCT01393119|100820628|FG001|STARTED|Overall Study||14||
48202619|NCT01393119|100820629|FG002|STARTED|Overall Study||14||
48202620|NCT01393119|100820630|FG003|STARTED|Overall Study||16||
48202621|NCT01393119|100820627|FG000|COMPLETED|Overall Study||0||
48202622|NCT01393119|100820628|FG001|COMPLETED|Overall Study||0||
48202623|NCT01393119|100820629|FG002|COMPLETED|Overall Study||0||
48202624|NCT01393119|100820630|FG003|COMPLETED|Overall Study||0||
48202625|NCT01393119|100820627|FG000|NOT COMPLETED|Overall Study||14||
48202626|NCT01393119|100820628|FG001|NOT COMPLETED|Overall Study||14||
48202627|NCT01393119|100820629|FG002|NOT COMPLETED|Overall Study||14||
48202628|NCT01393119|100820630|FG003|NOT COMPLETED|Overall Study||16||
48202629|NCT01802632|100820631|FG000|STARTED|Overall Study||201||
48202630|NCT01802632|100820632|FG001|STARTED|Overall Study||31||
48202631|NCT01802632|100820633|FG002|STARTED|Overall Study||271||
48202632|NCT01802632|100820634|FG003|STARTED|Overall Study||60||
48202633|NCT01802632|100820635|FG004|STARTED|Overall Study||12||
48202634|NCT01802632|100820636|FG005|STARTED|Overall Study||28||
48202635|NCT01802632|100820631|FG000|COMPLETED|Overall Study||0||
48202636|NCT01802632|100820632|FG001|COMPLETED|Overall Study||0||
48202637|NCT01802632|100820633|FG002|COMPLETED|Overall Study||0||
48202638|NCT01802632|100820634|FG003|COMPLETED|Overall Study||0||
48202639|NCT01802632|100820635|FG004|COMPLETED|Overall Study||0||
48202640|NCT01802632|100820636|FG005|COMPLETED|Overall Study||0||
48202641|NCT01802632|100820631|FG000|NOT COMPLETED|Overall Study||201||
48202642|NCT01802632|100820632|FG001|NOT COMPLETED|Overall Study||31||
48202643|NCT01802632|100820633|FG002|NOT COMPLETED|Overall Study||271||
48202644|NCT01802632|100820634|FG003|NOT COMPLETED|Overall Study||60||
48202645|NCT01802632|100820635|FG004|NOT COMPLETED|Overall Study||12||
48202646|NCT01802632|100820636|FG005|NOT COMPLETED|Overall Study||28||
48202647|NCT03768856|100820637|FG000|STARTED|Overall Study||5||
48202648|NCT03768856|100820637|FG000|COMPLETED|Overall Study||5||
48202649|NCT03768856|100820637|FG000|NOT COMPLETED|Overall Study||0||
48202650|NCT02194933|100820638|FG000|STARTED|Overall Study||19||
48202651|NCT02194933|100820639|FG001|STARTED|Overall Study||19||
48202652|NCT02194933|100820638|FG000|COMPLETED|Overall Study||16||
48202653|NCT02194933|100820639|FG001|COMPLETED|Overall Study||10||
48202654|NCT02194933|100820638|FG000|NOT COMPLETED|Overall Study||3||
48202655|NCT02194933|100820639|FG001|NOT COMPLETED|Overall Study||9||
48202656|NCT01405924|100820640|FG000|STARTED|Overall Study||111||
48202657|NCT01405924|100820640|FG000|COMPLETED|Overall Study||101||
48202658|NCT01405924|100820640|FG000|NOT COMPLETED|Overall Study||10||
48202659|NCT03040661|100820641|FG000|STARTED|Overall Study||35||
48202660|NCT03040661|100820642|FG001|STARTED|Overall Study||35||
48202661|NCT03040661|100820641|FG000|COMPLETED|Overall Study||35||
48202662|NCT03040661|100820642|FG001|COMPLETED|Overall Study||35||
48202663|NCT03040661|100820641|FG000|NOT COMPLETED|Overall Study||0||
48202664|NCT03040661|100820642|FG001|NOT COMPLETED|Overall Study||0||
48202665|NCT00319436|100820643|FG000|STARTED|Overall Study||23||
48202666|NCT00319436|100820644|FG001|STARTED|Overall Study||24||
48202667|NCT00319436|100820643|FG000|COMPLETED|Overall Study||17||
48202668|NCT00319436|100820644|FG001|COMPLETED|Overall Study||17||
48202669|NCT00319436|100820643|FG000|NOT COMPLETED|Overall Study||6||
48202670|NCT00319436|100820644|FG001|NOT COMPLETED|Overall Study||7||
48202671|NCT01510912|100820645|FG000|STARTED|Overall Study||602||
48202672|NCT01510912|100820645|FG000|COMPLETED|Overall Study||360||
48202673|NCT01510912|100820645|FG000|NOT COMPLETED|Overall Study||242||
48202674|NCT00573833|100820646|FG000|STARTED|Overall Study||23||
48202675|NCT00573833|100820646|FG000|COMPLETED|Overall Study||21||
48202676|NCT00573833|100820646|FG000|NOT COMPLETED|Overall Study||2||
48202677|NCT04420195|100820647|FG000|STARTED|Overall Study||40||
48202678|NCT04420195|100820648|FG001|STARTED|Overall Study||24||
48202679|NCT04420195|100820647|FG000|COMPLETED|Overall Study||40||
48202680|NCT04420195|100820648|FG001|COMPLETED|Overall Study||24||
48202681|NCT04420195|100820647|FG000|NOT COMPLETED|Overall Study||0||
48202682|NCT04420195|100820648|FG001|NOT COMPLETED|Overall Study||0||
48202683|NCT00952718|100820649|FG000|STARTED|Overall Study||19||
48202684|NCT00952718|100820650|FG001|STARTED|Overall Study||19||
48202685|NCT00952718|100820649|FG000|COMPLETED|Overall Study||13||
48202686|NCT00952718|100820650|FG001|COMPLETED|Overall Study||13||
48202687|NCT00952718|100820649|FG000|NOT COMPLETED|Overall Study||6||
48202688|NCT00952718|100820650|FG001|NOT COMPLETED|Overall Study||6||
48202689|NCT04141917|100820651|FG000|STARTED|Surveillance Year 1||63|This is all year 1 participants enrolled during standard surveillance months at their shelter of residence|3
48202690|NCT04141917|100820652|FG001|STARTED|Surveillance Year 1||76|This is all year 1 participants enrolled during standard surveillance months at their shelter of residence|2
48202691|NCT04141917|100820653|FG002|STARTED|Surveillance Year 1||81|This is all year 1 participants enrolled during standard surveillance months at their shelter of residence|2
48202692|NCT04141917|100820654|FG003|STARTED|Surveillance Year 1||324|This is all year 1 participants enrolled during standard surveillance months at their shelter of residence|2
48039077|NCT03254459|100417075|FG000|STARTED|Overall Study||50||
48039078|NCT03254459|100417076|FG001|STARTED|Overall Study||50||
48039079|NCT03254459|100417075|FG000|COMPLETED|Overall Study||40||
48039080|NCT03254459|100417076|FG001|COMPLETED|Overall Study||27||
48039081|NCT03254459|100417075|FG000|NOT COMPLETED|Overall Study||10||
48039082|NCT03254459|100417076|FG001|NOT COMPLETED|Overall Study||23||
48039083|NCT02116530|100417077|FG000|STARTED|Overall Study||192||
48039084|NCT02116530|100417078|FG001|STARTED|Overall Study||188||
48039085|NCT02116530|100417077|FG000|COMPLETED|Overall Study||183||
48039086|NCT02116530|100417078|FG001|COMPLETED|Overall Study||184||
48039087|NCT02116530|100417077|FG000|NOT COMPLETED|Overall Study||9||
48039088|NCT02116530|100417078|FG001|NOT COMPLETED|Overall Study||4||
48039089|NCT00934648|100417079|FG000|STARTED|Overall Study||15||
48039090|NCT00934648|100417079|FG000|COMPLETED|Overall Study||6||
48039091|NCT00934648|100417079|FG000|NOT COMPLETED|Overall Study||9||
48039092|NCT04160975|100417080|FG000|STARTED|Overall Study||479||
48039093|NCT04160975|100417081|FG001|STARTED|Overall Study||496||
48039094|NCT04160975|100417082|FG002|STARTED|Overall Study||478||
48039095|NCT04160975|100417083|FG003|STARTED|Overall Study||485||
48039096|NCT04160975|100417084|FG004|STARTED|Overall Study||649||
48039097|NCT04160975|100417085|FG005|STARTED|Overall Study||658||
48039098|NCT04160975|100417080|FG000|COMPLETED|Overall Study||415||
48039099|NCT04160975|100417081|FG001|COMPLETED|Overall Study||430||
48039100|NCT04160975|100417082|FG002|COMPLETED|Overall Study||417||
48039101|NCT04160975|100417083|FG003|COMPLETED|Overall Study||410||
48039102|NCT04160975|100417084|FG004|COMPLETED|Overall Study||614||
48039103|NCT04160975|100417085|FG005|COMPLETED|Overall Study||607||
48039104|NCT04160975|100417080|FG000|NOT COMPLETED|Overall Study||64||
48039105|NCT04160975|100417081|FG001|NOT COMPLETED|Overall Study||66||
48039106|NCT04160975|100417082|FG002|NOT COMPLETED|Overall Study||61||
48039107|NCT04160975|100417083|FG003|NOT COMPLETED|Overall Study||75||
48039108|NCT04160975|100417084|FG004|NOT COMPLETED|Overall Study||35||
48039109|NCT04160975|100417085|FG005|NOT COMPLETED|Overall Study||51||
48039110|NCT03658876|100417086|FG000|STARTED|Overall Study||88||
48039111|NCT03658876|100417087|FG001|STARTED|Overall Study||96||
48039112|NCT03658876|100417086|FG000|COMPLETED|Overall Study||76||
48039113|NCT03658876|100417087|FG001|COMPLETED|Overall Study||84||
48039114|NCT03658876|100417086|FG000|NOT COMPLETED|Overall Study||12||
48039115|NCT03658876|100417087|FG001|NOT COMPLETED|Overall Study||12||
48039116|NCT04144127|100417088|FG000|STARTED|Overall Study||3||
48039117|NCT04144127|100417088|FG000|COMPLETED|Overall Study||3||
48039118|NCT04144127|100417088|FG000|NOT COMPLETED|Overall Study||0||
48039119|NCT00859027|100417089|FG000|STARTED|Overall Study||25||
48039120|NCT00859027|100417090|FG001|STARTED|Overall Study||25||
48039121|NCT00859027|100417089|FG000|COMPLETED|Overall Study||20||
48039122|NCT00859027|100417090|FG001|COMPLETED|Overall Study||20||
48039123|NCT00859027|100417089|FG000|NOT COMPLETED|Overall Study||5||
48039124|NCT00859027|100417090|FG001|NOT COMPLETED|Overall Study||5||
48039125|NCT00732940|100417091|FG000|STARTED|Overall Study||28||
48039126|NCT00732940|100417092|FG001|STARTED|Overall Study||28||
48039127|NCT00732940|100417091|FG000|COMPLETED|Overall Study||26||
48039128|NCT00732940|100417092|FG001|COMPLETED|Overall Study||25||
48039129|NCT00732940|100417091|FG000|NOT COMPLETED|Overall Study||2||
48039130|NCT00732940|100417092|FG001|NOT COMPLETED|Overall Study||3||
48039131|NCT00505778|100417093|FG000|STARTED|Overall Study||514||
48039132|NCT00505778|100417094|FG001|STARTED|Overall Study||513||
48039133|NCT00505778|100417093|FG000|Intent to Treat (ITT) Population|Overall Study||512||
48039134|NCT00505778|100417094|FG001|Intent to Treat (ITT) Population|Overall Study||511||
48039135|NCT00505778|100417093|FG000|COMPLETED|Overall Study||380||
48039136|NCT00505778|100417094|FG001|COMPLETED|Overall Study||378||
48039137|NCT00505778|100417093|FG000|NOT COMPLETED|Overall Study||134||
48039138|NCT00505778|100417094|FG001|NOT COMPLETED|Overall Study||135||
48039139|NCT00955305|100417095|FG000|STARTED|Overall Study||88||
48039140|NCT00955305|100417096|FG001|STARTED|Overall Study||87||
48039141|NCT00955305|100417095|FG000|Treated|Overall Study||83||
48039142|NCT00955305|100417096|FG001|Treated|Overall Study||82||
48039143|NCT00955305|100417095|FG000|Eligible and Treated|Overall Study||78||
48039144|NCT00955305|100417096|FG001|Eligible and Treated|Overall Study||75||
48039145|NCT00955305|100417095|FG000|COMPLETED|Overall Study||0||
48039146|NCT00955305|100417096|FG001|COMPLETED|Overall Study||0||
48039147|NCT00955305|100417095|FG000|NOT COMPLETED|Overall Study||88||
48039148|NCT00955305|100417096|FG001|NOT COMPLETED|Overall Study||87||
48039149|NCT00824733|100417097|FG000|STARTED|Overall Study||6||
48039150|NCT00824733|100417097|FG000|COMPLETED|Overall Study||6||
48039151|NCT00824733|100417097|FG000|NOT COMPLETED|Overall Study||0||
48039152|NCT01295879|100417098|FG000|STARTED|Overall Study||29||
48039153|NCT01295879|100417098|FG000|COMPLETED|Overall Study||29||
48039154|NCT01295879|100417098|FG000|NOT COMPLETED|Overall Study||0||
48039155|NCT04475198|100417099|FG000|STARTED|Overall Study||4||
48039156|NCT04475198|100417100|FG001|STARTED|Overall Study||4||
48039157|NCT04475198|100417101|FG002|STARTED|Overall Study||4||
48039158|NCT04475198|100417102|FG003|STARTED|Overall Study||4||
48039159|NCT04475198|100417103|FG004|STARTED|Overall Study||8||
48039160|NCT04475198|100417099|FG000|COMPLETED|Overall Study||4||
48039161|NCT04475198|100417100|FG001|COMPLETED|Overall Study||4||
48039162|NCT04475198|100417101|FG002|COMPLETED|Overall Study||4||
48039163|NCT04475198|100417102|FG003|COMPLETED|Overall Study||4||
48039164|NCT04475198|100417103|FG004|COMPLETED|Overall Study||8||
48039165|NCT04475198|100417099|FG000|NOT COMPLETED|Overall Study||0||
48039166|NCT04475198|100417100|FG001|NOT COMPLETED|Overall Study||0||
48039167|NCT04475198|100417101|FG002|NOT COMPLETED|Overall Study||0||
48039168|NCT04475198|100417102|FG003|NOT COMPLETED|Overall Study||0||
48039169|NCT04475198|100417103|FG004|NOT COMPLETED|Overall Study||0||
48039170|NCT01261780|100417104|FG000|STARTED|Overall Study||7||
48039171|NCT01261780|100417105|FG001|STARTED|Overall Study||7||
48039172|NCT01261780|100417104|FG000|COMPLETED|Overall Study||5||
48039173|NCT01261780|100417105|FG001|COMPLETED|Overall Study||5||
48039174|NCT01261780|100417104|FG000|NOT COMPLETED|Overall Study||2||
48039175|NCT01261780|100417105|FG001|NOT COMPLETED|Overall Study||2||
48039176|NCT01816945|100417106|FG000|STARTED|Overall Study||23||
48039177|NCT01816945|100417107|FG001|STARTED|Overall Study||24||
48039178|NCT01816945|100417106|FG000|COMPLETED|Overall Study||21|Completed 12 months of the intervention|
48039179|NCT01816945|100417107|FG001|COMPLETED|Overall Study||19|Completed 12 months of the intervention|
48039180|NCT01816945|100417106|FG000|NOT COMPLETED|Overall Study||2||
48039181|NCT01816945|100417107|FG001|NOT COMPLETED|Overall Study||5||
48039182|NCT02660138|100417108|FG000|STARTED|Overall Study||76|Subjects randomised in DBPC cycle|
48039183|NCT02660138|100417109|FG001|STARTED|Overall Study||76|Subjects randomised in DBPC cycle|
48039184|NCT02660138|100417110|FG002|STARTED|Overall Study||75|Subjects randomised in DBPC cycle|
48039185|NCT02660138|100417108|FG000|Subjects Treated in DBPC Cycle|Overall Study||76||
48039186|NCT02660138|100417109|FG001|Subjects Treated in DBPC Cycle|Overall Study||75||
48039187|NCT02660138|100417110|FG002|Subjects Treated in DBPC Cycle|Overall Study||75||
48039188|NCT02660138|100417108|FG000|Subjects Entered in the Dysport Cycles|Overall Study||49||
48039189|NCT02660138|100417109|FG001|Subjects Entered in the Dysport Cycles|Overall Study||75||
48039190|NCT02660138|100417110|FG002|Subjects Entered in the Dysport Cycles|Overall Study||75||
48039191|NCT02660138|100417108|FG000|COMPLETED|Overall Study||6|Subjects completed the study in the Dysport cycles|
48039192|NCT02660138|100417109|FG001|COMPLETED|Overall Study||2|Subjects completed the study in the Dysport cycles|
48039193|NCT02660138|100417110|FG002|COMPLETED|Overall Study||3|Subjects completed the study in the Dysport cycles|
48039194|NCT02660138|100417108|FG000|NOT COMPLETED|Overall Study||70||
48039195|NCT02660138|100417109|FG001|NOT COMPLETED|Overall Study||74||
48039196|NCT02660138|100417110|FG002|NOT COMPLETED|Overall Study||72||
48039197|NCT00966875|100417111|FG000|STARTED|Part A||54||
48039198|NCT00966875|100417112|FG001|STARTED|Part A||40||
48039199|NCT00966875|100417113|FG002|STARTED|Part A||35||
48039200|NCT00966875|100417114|FG003|STARTED|Part A||37||
48039201|NCT00966875|100417115|FG004|STARTED|Part A||57||
48039202|NCT00966875|100417116|FG005|STARTED|Part A||37||
48039203|NCT00966875|100417117|FG006|STARTED|Part A||64||
48039204|NCT00966875|100417118|FG007|STARTED|Part A||65||
48039205|NCT00966875|100417119|FG008|STARTED|Part A||59||
48039206|NCT00966875|100417111|FG000|Received ≥1 Doses of Study Drug|Part A||54||
48039207|NCT00966875|100417112|FG001|Received ≥1 Doses of Study Drug|Part A||40||
48039208|NCT00966875|100417113|FG002|Received ≥1 Doses of Study Drug|Part A||35||
48039209|NCT00966875|100417114|FG003|Received ≥1 Doses of Study Drug|Part A||37||
48039210|NCT00966875|100417115|FG004|Received ≥1 Doses of Study Drug|Part A||57||
48039211|NCT00966875|100417116|FG005|Received ≥1 Doses of Study Drug|Part A||37||
48039212|NCT00966875|100417117|FG006|Received ≥1 Doses of Study Drug|Part A||64||
48039213|NCT00966875|100417118|FG007|Received ≥1 Doses of Study Drug|Part A||65||
48039214|NCT00966875|100417119|FG008|Received ≥1 Doses of Study Drug|Part A||59||
48039215|NCT00966875|100417111|FG000|COMPLETED|Part A||48||
48039216|NCT00966875|100417112|FG001|COMPLETED|Part A||36||
48039217|NCT00966875|100417113|FG002|COMPLETED|Part A||33||
48039218|NCT00966875|100417114|FG003|COMPLETED|Part A||34||
48039219|NCT00966875|100417115|FG004|COMPLETED|Part A||52||
48039220|NCT00966875|100417116|FG005|COMPLETED|Part A||33||
48039221|NCT00966875|100417117|FG006|COMPLETED|Part A||52||
48039222|NCT00966875|100417118|FG007|COMPLETED|Part A||58||
48039223|NCT00966875|100417119|FG008|COMPLETED|Part A||51||
48039224|NCT00966875|100417111|FG000|NOT COMPLETED|Part A||6||
48039225|NCT00966875|100417112|FG001|NOT COMPLETED|Part A||4||
48039226|NCT00966875|100417113|FG002|NOT COMPLETED|Part A||2||
48039227|NCT00966875|100417114|FG003|NOT COMPLETED|Part A||3||
48039228|NCT00966875|100417115|FG004|NOT COMPLETED|Part A||5||
48039229|NCT00966875|100417116|FG005|NOT COMPLETED|Part A||4||
48039230|NCT00966875|100417117|FG006|NOT COMPLETED|Part A||12||
48039231|NCT00966875|100417118|FG007|NOT COMPLETED|Part A||7||
48039232|NCT00966875|100417119|FG008|NOT COMPLETED|Part A||8||
48039233|NCT00966875|100417111|FG000|STARTED|Part B||46||
48039234|NCT00966875|100417112|FG001|STARTED|Part B||36||
48039235|NCT00966875|100417113|FG002|STARTED|Part B||33||
48039236|NCT00966875|100417114|FG003|STARTED|Part B||34||
48039237|NCT00966875|100417115|FG004|STARTED|Part B||51||
48039238|NCT00966875|100417116|FG005|STARTED|Part B||32||
48039239|NCT00966875|100417117|FG006|STARTED|Part B||51||
48039240|NCT00966875|100417118|FG007|STARTED|Part B||57||
48039241|NCT00966875|100417119|FG008|STARTED|Part B||50||
48039242|NCT00966875|100417111|FG000|COMPLETED|Part B||41||
48039243|NCT00966875|100417112|FG001|COMPLETED|Part B||33||
48039244|NCT00966875|100417113|FG002|COMPLETED|Part B||27||
48039245|NCT00966875|100417114|FG003|COMPLETED|Part B||31||
48039246|NCT00966875|100417115|FG004|COMPLETED|Part B||44||
48039247|NCT00966875|100417116|FG005|COMPLETED|Part B||26||
48039248|NCT00966875|100417117|FG006|COMPLETED|Part B||29||
48039249|NCT00966875|100417118|FG007|COMPLETED|Part B||38||
48039250|NCT00966875|100417119|FG008|COMPLETED|Part B||32||
48039251|NCT00966875|100417111|FG000|NOT COMPLETED|Part B||5||
48039252|NCT00966875|100417112|FG001|NOT COMPLETED|Part B||3||
48039253|NCT00966875|100417113|FG002|NOT COMPLETED|Part B||6||
48039254|NCT00966875|100417114|FG003|NOT COMPLETED|Part B||3||
48039255|NCT00966875|100417115|FG004|NOT COMPLETED|Part B||7||
48039256|NCT00966875|100417116|FG005|NOT COMPLETED|Part B||6||
48039257|NCT00966875|100417117|FG006|NOT COMPLETED|Part B||22||
48039258|NCT00966875|100417118|FG007|NOT COMPLETED|Part B||19||
48039259|NCT00966875|100417119|FG008|NOT COMPLETED|Part B||18||
48039260|NCT01206322|100417120|FG000|STARTED|Overall Study||4||
48039261|NCT01206322|100417121|FG001|STARTED|Overall Study||11||
48039262|NCT01206322|100417122|FG002|STARTED|Overall Study||9||
48039263|NCT01206322|100417123|FG003|STARTED|Overall Study||6||
48039264|NCT01206322|100417120|FG000|COMPLETED|Overall Study||4||
48039265|NCT01206322|100417121|FG001|COMPLETED|Overall Study||11||
48039266|NCT01206322|100417122|FG002|COMPLETED|Overall Study||9||
48039267|NCT01206322|100417123|FG003|COMPLETED|Overall Study||5||
48039268|NCT01206322|100417120|FG000|NOT COMPLETED|Overall Study||0||
48039269|NCT01206322|100417121|FG001|NOT COMPLETED|Overall Study||0||
48039270|NCT01206322|100417122|FG002|NOT COMPLETED|Overall Study||0||
48039271|NCT01206322|100417123|FG003|NOT COMPLETED|Overall Study||1||
48039272|NCT01700439|100417124|FG000|STARTED|Overall Study||934||
48039273|NCT01700439|100417124|FG000|Study Valve Group|Overall Study||885||
48039274|NCT01700439|100417124|FG000|Discharge|Overall Study||925||
48039275|NCT01700439|100417124|FG000|3 Month|Overall Study||862||
48039276|NCT01700439|100417124|FG000|1 Year|Overall Study||842||
48039277|NCT01700439|100417124|FG000|2 Year|Overall Study||795||
48039278|NCT01700439|100417124|FG000|3 Year|Overall Study||720||
48039279|NCT01700439|100417124|FG000|4 Year|Overall Study||667||
48039280|NCT01700439|100417124|FG000|5 Year|Overall Study||577||
48039281|NCT01700439|100417124|FG000|6 Year|Overall Study||357||
48039282|NCT01700439|100417124|FG000|7 Year|Overall Study||164||
48039283|NCT01700439|100417124|FG000|8 Year|Overall Study||40||
48039284|NCT01700439|100417124|FG000|COMPLETED|Overall Study||518||
48039285|NCT01700439|100417124|FG000|NOT COMPLETED|Overall Study||416||
48039286|NCT01332461|100417125|FG000|STARTED|Overall Study||1291||
48039287|NCT01332461|100417126|FG001|STARTED|Overall Study||4386||
48039288|NCT01332461|100417125|FG000|COMPLETED|Overall Study||1291||
48039289|NCT01332461|100417126|FG001|COMPLETED|Overall Study||4386||
48039290|NCT01332461|100417125|FG000|NOT COMPLETED|Overall Study||0||
48039291|NCT01332461|100417126|FG001|NOT COMPLETED|Overall Study||0||
48039292|NCT01256190|100417127|FG000|STARTED|Overall Study||39||
48039293|NCT01256190|100417128|FG001|STARTED|Overall Study||17||
48039294|NCT01256190|100417127|FG000|COMPLETED|Overall Study||37||
48039295|NCT01256190|100417128|FG001|COMPLETED|Overall Study||17||
48039296|NCT01256190|100417127|FG000|NOT COMPLETED|Overall Study||2||
48039297|NCT01256190|100417128|FG001|NOT COMPLETED|Overall Study||0||
48039298|NCT02743611|100417129|FG000|STARTED|Overall Study||4|All 4 enrolled subjects were enrolled into Arm 1 and started w/ the 1.25 x 10E6 cells/kg dose.|
48039299|NCT02743611|100417130|FG001|STARTED|Overall Study||0|All 4 enrolled subjects were enrolled into Arm 1 and started w/ the 1.25 x 10E6 cells/kg dose.|
48039300|NCT02743611|100417131|FG002|STARTED|Overall Study||0|All 4 enrolled subjects were enrolled into Arm 1 and started w/ the 1.25 x 10E6 cells/kg dose.|
48039301|NCT02743611|100417132|FG003|STARTED|Overall Study||0|All 4 enrolled subjects were enrolled into Arm 1 and started w/ the 1.25 x 10E6 cells/kg dose.|
48039302|NCT02743611|100417129|FG000|COMPLETED|Overall Study||0||
48039303|NCT02743611|100417130|FG001|COMPLETED|Overall Study||0||
48039304|NCT02743611|100417131|FG002|COMPLETED|Overall Study||0||
48039305|NCT02743611|100417132|FG003|COMPLETED|Overall Study||0||
48039306|NCT02743611|100417129|FG000|NOT COMPLETED|Overall Study||4||
48039307|NCT02743611|100417130|FG001|NOT COMPLETED|Overall Study||0||
48039308|NCT02743611|100417131|FG002|NOT COMPLETED|Overall Study||0||
48039309|NCT02743611|100417132|FG003|NOT COMPLETED|Overall Study||0||
48039310|NCT00978757|100417133|FG000|STARTED|Overall Study||22||
48039311|NCT00978757|100417134|FG001|STARTED|Overall Study||20||
48039312|NCT00978757|100417133|FG000|COMPLETED|Overall Study||21||
48039313|NCT00978757|100417134|FG001|COMPLETED|Overall Study||17||
48039314|NCT00978757|100417133|FG000|NOT COMPLETED|Overall Study||1||
48039315|NCT00978757|100417134|FG001|NOT COMPLETED|Overall Study||3||
48039316|NCT04540510|100417135|FG000|STARTED|Overall Study||5||
48039317|NCT04540510|100417136|FG001|STARTED|Overall Study||6||
48039318|NCT04540510|100417135|FG000|COMPLETED|Overall Study||5||
48039319|NCT04540510|100417136|FG001|COMPLETED|Overall Study||6||
48039320|NCT04540510|100417135|FG000|NOT COMPLETED|Overall Study||0||
48039321|NCT04540510|100417136|FG001|NOT COMPLETED|Overall Study||0||
48039322|NCT01251536|100417137|FG000|STARTED|Overall Study||8||
48039323|NCT01251536|100417138|FG001|STARTED|Overall Study||93||
48039324|NCT01251536|100417139|FG002|STARTED|Overall Study||7||
48039325|NCT01251536|100417137|FG000|COMPLETED|Overall Study||8||
48039326|NCT01251536|100417138|FG001|COMPLETED|Overall Study||93||
48039327|NCT01251536|100417139|FG002|COMPLETED|Overall Study||7||
48039328|NCT01251536|100417137|FG000|NOT COMPLETED|Overall Study||0||
48039329|NCT01251536|100417138|FG001|NOT COMPLETED|Overall Study||0||
48039330|NCT01251536|100417139|FG002|NOT COMPLETED|Overall Study||0||
48039331|NCT00109590|100417140|FG000|STARTED|Overall Study||57||
48039332|NCT00109590|100417141|FG001|STARTED|Overall Study||58||
48039333|NCT00109590|100417142|FG002|STARTED|Overall Study||60||
48039334|NCT00109590|100417140|FG000|RECEIVED TREATMENT|Overall Study||56||
48039335|NCT00109590|100417141|FG001|RECEIVED TREATMENT|Overall Study||56||
48039336|NCT00109590|100417142|FG002|RECEIVED TREATMENT|Overall Study||57||
48039337|NCT00109590|100417140|FG000|COMPLETED|Overall Study||55||
48039338|NCT00109590|100417141|FG001|COMPLETED|Overall Study||56||
48039339|NCT00109590|100417142|FG002|COMPLETED|Overall Study||56||
48039340|NCT00109590|100417140|FG000|NOT COMPLETED|Overall Study||2||
48039341|NCT00109590|100417141|FG001|NOT COMPLETED|Overall Study||2||
48039342|NCT00109590|100417142|FG002|NOT COMPLETED|Overall Study||4||
48039343|NCT03462511|100417143|FG000|STARTED|Overall Study||24||
48039344|NCT03462511|100417144|FG001|STARTED|Overall Study||26||
48039345|NCT03462511|100417143|FG000|COMPLETED|Overall Study||22||
48039346|NCT03462511|100417144|FG001|COMPLETED|Overall Study||23||
48039347|NCT03462511|100417143|FG000|NOT COMPLETED|Overall Study||2||
48039348|NCT03462511|100417144|FG001|NOT COMPLETED|Overall Study||3||
48039349|NCT03179202|100417145|FG000|STARTED|Overall Study||166||
48039350|NCT03179202|100417145|FG000|Enrolled/Received Leads|Overall Study||99|Subjects who were consented, met eligibility criteria, and underwent Lead Placement. Also includes subjects participating in sub-studies with modified eligibility criteria allowing a history of prior radiofrequency ablation or prior lumbar surgery.|
48039351|NCT03179202|100417145|FG000|Protocol Population|Overall Study||91|Subjects who were consented, met eligibility criteria, underwent Lead Placement, and continued to meet eligibility criteria. Also includes subjects participating in sub-studies with modified eligibility criteria allowing a history of prior radiofrequency ablation or prior lumbar surgery.|
48039352|NCT03179202|100417145|FG000|COMPLETED|Overall Study||75||
48039353|NCT03179202|100417145|FG000|NOT COMPLETED|Overall Study||91||
48039354|NCT01221285|100417146|FG000|STARTED|Overall Study||11||
48039355|NCT01221285|100417146|FG000|COMPLETED|Overall Study||10||
48039356|NCT01221285|100417146|FG000|NOT COMPLETED|Overall Study||1||
48039357|NCT03101111|100417147|FG000|STARTED|Overall Study||26||
48039358|NCT03101111|100417148|FG001|STARTED|Overall Study||8||
48039359|NCT03101111|100417147|FG000|COMPLETED|Overall Study||23||
48039360|NCT03101111|100417148|FG001|COMPLETED|Overall Study||7||
48039361|NCT03101111|100417147|FG000|NOT COMPLETED|Overall Study||3||
48039362|NCT03101111|100417148|FG001|NOT COMPLETED|Overall Study||1||
48039363|NCT02043899|100417149|FG000|STARTED|Overall Study||36||
48039364|NCT02043899|100417149|FG000|Underwent Routine [123I]mIBG Planar and SPECT/CT Imaging|Overall Study||32||
48039365|NCT02043899|100417149|FG000|Underwent [124I]mIBG PET/CT Imaging|Overall Study||9||
48039366|NCT02043899|100417149|FG000|COMPLETED|Overall Study||9||
48039367|NCT02043899|100417149|FG000|NOT COMPLETED|Overall Study||27||
48039368|NCT02663934|100417150|FG000|STARTED|Overall Study||45||
48039369|NCT02663934|100417151|FG001|STARTED|Overall Study||20||
48039370|NCT02663934|100417150|FG000|COMPLETED|Overall Study||33||
48039371|NCT02663934|100417151|FG001|COMPLETED|Overall Study||14||
48039372|NCT02663934|100417150|FG000|NOT COMPLETED|Overall Study||12||
48039373|NCT02663934|100417151|FG001|NOT COMPLETED|Overall Study||6||
48039374|NCT05037578|100417152|FG000|STARTED|Overall Study||62||
48039375|NCT05037578|100417153|FG001|STARTED|Overall Study||37||
48039376|NCT05037578|100417152|FG000|COMPLETED|Overall Study||54||
48039377|NCT05037578|100417153|FG001|COMPLETED|Overall Study||33||
48039378|NCT05037578|100417152|FG000|NOT COMPLETED|Overall Study||8||
48039379|NCT05037578|100417153|FG001|NOT COMPLETED|Overall Study||4||
48039380|NCT00870103|100417154|FG000|STARTED|Overall Study||64||
48039381|NCT00870103|100417154|FG000|COMPLETED|Overall Study||60||
48039382|NCT00870103|100417154|FG000|NOT COMPLETED|Overall Study||4||
48039383|NCT00444678|100417155|FG000|STARTED|Overall Study||36||
48039384|NCT00444678|100417155|FG000|COMPLETED|Overall Study||5||
48039385|NCT00444678|100417155|FG000|NOT COMPLETED|Overall Study||31||
48039386|NCT03968939|100417156|FG000|STARTED|Overall Study||15||
48039387|NCT03968939|100417157|FG001|STARTED|Overall Study||26||
48039388|NCT03968939|100417158|FG002|STARTED|Overall Study||14||
48039389|NCT03968939|100417156|FG000|COMPLETED|Overall Study||15||
48039390|NCT03968939|100417157|FG001|COMPLETED|Overall Study||26||
48039391|NCT03968939|100417158|FG002|COMPLETED|Overall Study||14||
48039392|NCT03968939|100417156|FG000|NOT COMPLETED|Overall Study||0||
48039393|NCT03968939|100417157|FG001|NOT COMPLETED|Overall Study||0||
48039394|NCT03968939|100417158|FG002|NOT COMPLETED|Overall Study||0||
48039395|NCT02730195|100417159|FG000|STARTED|Overall Study||9||
48039396|NCT02730195|100417159|FG000|COMPLETED|Overall Study||8||
48039397|NCT02730195|100417159|FG000|NOT COMPLETED|Overall Study||1||
48039398|NCT03148691|100417160|FG000|STARTED|Overall Study||50||
48039399|NCT03148691|100417161|FG001|STARTED|Overall Study||103||
48039400|NCT03148691|100417162|FG002|STARTED|Overall Study||100||
48039401|NCT03148691|100417160|FG000|COMPLETED|Overall Study||47||
48039402|NCT03148691|100417161|FG001|COMPLETED|Overall Study||101||
48039403|NCT03148691|100417162|FG002|COMPLETED|Overall Study||92||
48039404|NCT03148691|100417160|FG000|NOT COMPLETED|Overall Study||3||
48039405|NCT03148691|100417161|FG001|NOT COMPLETED|Overall Study||2||
48039406|NCT03148691|100417162|FG002|NOT COMPLETED|Overall Study||8||
48039407|NCT00608569|100417163|FG000|STARTED|Overall Study||129||
48039408|NCT00608569|100417164|FG001|STARTED|Overall Study||128||
48039409|NCT00608569|100417163|FG000|COMPLETED|Overall Study||119||
48039410|NCT00608569|100417164|FG001|COMPLETED|Overall Study||119||
48039411|NCT00608569|100417163|FG000|NOT COMPLETED|Overall Study||10||
48039412|NCT00608569|100417164|FG001|NOT COMPLETED|Overall Study||9||
48039413|NCT00568633|100417165|FG000|STARTED|Overall Study||25||
48039414|NCT00568633|100417166|FG001|STARTED|Overall Study||33||
48039415|NCT00568633|100417165|FG000|COMPLETED|Overall Study||25||
48039416|NCT00568633|100417166|FG001|COMPLETED|Overall Study||33||
48039417|NCT00568633|100417165|FG000|NOT COMPLETED|Overall Study||0||
48039418|NCT00568633|100417166|FG001|NOT COMPLETED|Overall Study||0||
48039419|NCT03254108|100417167|FG000|STARTED|Overall Study||13||
48039420|NCT03254108|100417168|FG001|STARTED|Overall Study||12||
48039421|NCT03254108|100417169|FG002|STARTED|Overall Study||12||
48039422|NCT03254108|100417170|FG003|STARTED|Overall Study||12||
48039423|NCT03254108|100417171|FG004|STARTED|Overall Study||12||
48039424|NCT03254108|100417167|FG000|Received Treatment|Overall Study||13||
48039425|NCT03254108|100417168|FG001|Received Treatment|Overall Study||12||
48039426|NCT03254108|100417169|FG002|Received Treatment|Overall Study||12||
48039427|NCT03254108|100417170|FG003|Received Treatment|Overall Study||11||
48039428|NCT03254108|100417171|FG004|Received Treatment|Overall Study||12||
48039429|NCT03254108|100417167|FG000|COMPLETED|Overall Study||13||
48039430|NCT03254108|100417168|FG001|COMPLETED|Overall Study||10||
48039431|NCT03254108|100417169|FG002|COMPLETED|Overall Study||12||
48039432|NCT03254108|100417170|FG003|COMPLETED|Overall Study||11||
48039433|NCT03254108|100417171|FG004|COMPLETED|Overall Study||9||
48039434|NCT03254108|100417167|FG000|NOT COMPLETED|Overall Study||0||
48039435|NCT03254108|100417168|FG001|NOT COMPLETED|Overall Study||2||
48039436|NCT03254108|100417169|FG002|NOT COMPLETED|Overall Study||0||
48039437|NCT03254108|100417170|FG003|NOT COMPLETED|Overall Study||1||
48039438|NCT03254108|100417171|FG004|NOT COMPLETED|Overall Study||3||
48039439|NCT00618098|100417172|FG000|STARTED|Overall Study||97||
48039440|NCT00618098|100417173|FG001|STARTED|Overall Study||103||
48039441|NCT00618098|100417172|FG000|COMPLETED|Overall Study||66||
48039442|NCT00618098|100417173|FG001|COMPLETED|Overall Study||69||
48039443|NCT00618098|100417172|FG000|NOT COMPLETED|Overall Study||31||
48039444|NCT00618098|100417173|FG001|NOT COMPLETED|Overall Study||34||
48039445|NCT02971033|100417174|FG000|STARTED|Overall Study||1||
48039446|NCT02971033|100417175|FG001|STARTED|Overall Study||1||
48039447|NCT02971033|100417176|FG002|STARTED|Overall Study||0||
48202693|NCT04141917|100820651|FG000|COMPLETED|Surveillance Year 1||63||3
48202694|NCT04141917|100820652|FG001|COMPLETED|Surveillance Year 1||76||2
48202695|NCT04141917|100820653|FG002|COMPLETED|Surveillance Year 1||81||2
48202696|NCT04141917|100820654|FG003|COMPLETED|Surveillance Year 1||324||2
48202697|NCT04141917|100820651|FG000|NOT COMPLETED|Surveillance Year 1||0||0
48202698|NCT04141917|100820652|FG001|NOT COMPLETED|Surveillance Year 1||0||0
48202699|NCT04141917|100820653|FG002|NOT COMPLETED|Surveillance Year 1||0||0
48039448|NCT02971033|100417174|FG000|COMPLETED|Overall Study||1||
48039449|NCT02971033|100417175|FG001|COMPLETED|Overall Study||1||
48039450|NCT02971033|100417176|FG002|COMPLETED|Overall Study||0||
48039451|NCT02971033|100417174|FG000|NOT COMPLETED|Overall Study||0||
48039452|NCT02971033|100417175|FG001|NOT COMPLETED|Overall Study||0||
48039453|NCT02971033|100417176|FG002|NOT COMPLETED|Overall Study||0||
48039454|NCT01734889|100417177|FG000|STARTED|Overall Study||18||
48039455|NCT01734889|100417177|FG000|COMPLETED|Overall Study||18||
48039456|NCT01734889|100417177|FG000|NOT COMPLETED|Overall Study||0||
48039457|NCT00921895|100417178|FG000|STARTED|Overall Study||128||
48039458|NCT00921895|100417178|FG000|COMPLETED|Overall Study||128||
48202700|NCT04141917|100820654|FG003|NOT COMPLETED|Surveillance Year 1||0||0
48202701|NCT04141917|100820651|FG000|STARTED|Surveillance + Test and Treat Year 1||358|This is all year 1 participants enrolled during standard surveillance + test and treat protocol months at their shelter of residence|3
48039459|NCT00921895|100417178|FG000|NOT COMPLETED|Overall Study||0||
48039460|NCT03560518|100417179|FG000|STARTED|Double Blind Treatment Period||147||
48039461|NCT03560518|100417180|FG001|STARTED|Double Blind Treatment Period||145||
48039462|NCT03560518|100417181|FG002|STARTED|Double Blind Treatment Period||147||
48039463|NCT03560518|100417179|FG000|COMPLETED|Double Blind Treatment Period||122||
48039464|NCT03560518|100417180|FG001|COMPLETED|Double Blind Treatment Period||116||
48039465|NCT03560518|100417181|FG002|COMPLETED|Double Blind Treatment Period||124||
48039466|NCT03560518|100417179|FG000|NOT COMPLETED|Double Blind Treatment Period||25||
48039467|NCT03560518|100417180|FG001|NOT COMPLETED|Double Blind Treatment Period||29||
48039468|NCT03560518|100417181|FG002|NOT COMPLETED|Double Blind Treatment Period||23||
48039469|NCT03560518|100417179|FG000|STARTED|Safety Follow-Up Period||10||
48039470|NCT03560518|100417180|FG001|STARTED|Safety Follow-Up Period||17||
48039471|NCT03560518|100417181|FG002|STARTED|Safety Follow-Up Period||22||
48039472|NCT03560518|100417179|FG000|COMPLETED|Safety Follow-Up Period||10||
48039473|NCT03560518|100417180|FG001|COMPLETED|Safety Follow-Up Period||17||
48039474|NCT03560518|100417181|FG002|COMPLETED|Safety Follow-Up Period||22||
48039475|NCT03560518|100417179|FG000|NOT COMPLETED|Safety Follow-Up Period||0||
48039476|NCT03560518|100417180|FG001|NOT COMPLETED|Safety Follow-Up Period||0||
48039477|NCT03560518|100417181|FG002|NOT COMPLETED|Safety Follow-Up Period||0||
48039478|NCT03059355|100417182|FG000|STARTED|Overall Study||3||
48039479|NCT03059355|100417183|FG001|STARTED|Overall Study||3||
48039480|NCT03059355|100417184|FG002|STARTED|Overall Study||3||
48039481|NCT03059355|100417185|FG003|STARTED|Overall Study||3||
48039482|NCT03059355|100417186|FG004|STARTED|Overall Study||0||
48039483|NCT03059355|100417187|FG005|STARTED|Overall Study||2||
48039484|NCT03059355|100417188|FG006|STARTED|Overall Study||0||
48039485|NCT03059355|100417182|FG000|COMPLETED|Overall Study||3||
48039486|NCT03059355|100417183|FG001|COMPLETED|Overall Study||3||
48039487|NCT03059355|100417184|FG002|COMPLETED|Overall Study||3||
48039488|NCT03059355|100417185|FG003|COMPLETED|Overall Study||3||
48039489|NCT03059355|100417186|FG004|COMPLETED|Overall Study||0||
48039490|NCT03059355|100417187|FG005|COMPLETED|Overall Study||2||
48039491|NCT03059355|100417188|FG006|COMPLETED|Overall Study||0||
48039492|NCT03059355|100417182|FG000|NOT COMPLETED|Overall Study||0||
48039493|NCT03059355|100417183|FG001|NOT COMPLETED|Overall Study||0||
48039494|NCT03059355|100417184|FG002|NOT COMPLETED|Overall Study||0||
48039495|NCT03059355|100417185|FG003|NOT COMPLETED|Overall Study||0||
48039496|NCT03059355|100417186|FG004|NOT COMPLETED|Overall Study||0||
48039497|NCT03059355|100417187|FG005|NOT COMPLETED|Overall Study||0||
48039498|NCT03059355|100417188|FG006|NOT COMPLETED|Overall Study||0||
48039499|NCT05315908|100417189|FG000|STARTED|Overall Study||4489||
48039500|NCT05315908|100417190|FG001|STARTED|Overall Study||4631||
48039501|NCT05315908|100417189|FG000|COMPLETED|Overall Study||12||
48039502|NCT05315908|100417190|FG001|COMPLETED|Overall Study||25||
48039503|NCT05315908|100417189|FG000|NOT COMPLETED|Overall Study||4477||
48039504|NCT05315908|100417190|FG001|NOT COMPLETED|Overall Study||4606||
48039505|NCT02785770|100417191|FG000|STARTED|Intervention Period 1 (1 Day)||11||
48039506|NCT02785770|100417192|FG001|STARTED|Intervention Period 1 (1 Day)||11||
48039507|NCT02785770|100417193|FG002|STARTED|Intervention Period 1 (1 Day)||11||
48039508|NCT02785770|100417194|FG003|STARTED|Intervention Period 1 (1 Day)||11||
48039509|NCT02785770|100417191|FG000|COMPLETED|Intervention Period 1 (1 Day)||11||
48039510|NCT02785770|100417192|FG001|COMPLETED|Intervention Period 1 (1 Day)||11||
48039511|NCT02785770|100417193|FG002|COMPLETED|Intervention Period 1 (1 Day)||11||
48039512|NCT02785770|100417194|FG003|COMPLETED|Intervention Period 1 (1 Day)||11||
48039513|NCT02785770|100417191|FG000|NOT COMPLETED|Intervention Period 1 (1 Day)||0||
48039514|NCT02785770|100417192|FG001|NOT COMPLETED|Intervention Period 1 (1 Day)||0||
48039515|NCT02785770|100417193|FG002|NOT COMPLETED|Intervention Period 1 (1 Day)||0||
48039516|NCT02785770|100417194|FG003|NOT COMPLETED|Intervention Period 1 (1 Day)||0||
48039517|NCT02785770|100417191|FG000|STARTED|Washout Period 1 (7 Days)||11||
48039518|NCT02785770|100417192|FG001|STARTED|Washout Period 1 (7 Days)||11||
48039519|NCT02785770|100417193|FG002|STARTED|Washout Period 1 (7 Days)||11||
48039520|NCT02785770|100417194|FG003|STARTED|Washout Period 1 (7 Days)||11||
48039521|NCT02785770|100417191|FG000|COMPLETED|Washout Period 1 (7 Days)||11||
48039522|NCT02785770|100417192|FG001|COMPLETED|Washout Period 1 (7 Days)||11||
48039523|NCT02785770|100417193|FG002|COMPLETED|Washout Period 1 (7 Days)||11||
48039524|NCT02785770|100417194|FG003|COMPLETED|Washout Period 1 (7 Days)||11||
48039525|NCT02785770|100417191|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48039526|NCT02785770|100417192|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48039527|NCT02785770|100417193|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48039528|NCT02785770|100417194|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0||
48039529|NCT02785770|100417191|FG000|STARTED|Intervention Period 2 (1 Day)||11||
48039530|NCT02785770|100417192|FG001|STARTED|Intervention Period 2 (1 Day)||11||
48039531|NCT02785770|100417193|FG002|STARTED|Intervention Period 2 (1 Day)||11||
48039532|NCT02785770|100417194|FG003|STARTED|Intervention Period 2 (1 Day)||11||
48039533|NCT02785770|100417191|FG000|COMPLETED|Intervention Period 2 (1 Day)||11||
48039534|NCT02785770|100417192|FG001|COMPLETED|Intervention Period 2 (1 Day)||10||
48039535|NCT02785770|100417193|FG002|COMPLETED|Intervention Period 2 (1 Day)||10||
48039536|NCT02785770|100417194|FG003|COMPLETED|Intervention Period 2 (1 Day)||11||
48039537|NCT02785770|100417191|FG000|NOT COMPLETED|Intervention Period 2 (1 Day)||0||
48039538|NCT02785770|100417192|FG001|NOT COMPLETED|Intervention Period 2 (1 Day)||1||
48039539|NCT02785770|100417193|FG002|NOT COMPLETED|Intervention Period 2 (1 Day)||1||
48039540|NCT02785770|100417194|FG003|NOT COMPLETED|Intervention Period 2 (1 Day)||0||
48039541|NCT02785770|100417191|FG000|STARTED|Washout Period 2 (7 Days)||11||
48039542|NCT02785770|100417192|FG001|STARTED|Washout Period 2 (7 Days)||10||
48039543|NCT02785770|100417193|FG002|STARTED|Washout Period 2 (7 Days)||10||
48039544|NCT02785770|100417194|FG003|STARTED|Washout Period 2 (7 Days)||11||
48039545|NCT02785770|100417191|FG000|COMPLETED|Washout Period 2 (7 Days)||11||
48039546|NCT02785770|100417192|FG001|COMPLETED|Washout Period 2 (7 Days)||10||
48039547|NCT02785770|100417193|FG002|COMPLETED|Washout Period 2 (7 Days)||10||
48039548|NCT02785770|100417194|FG003|COMPLETED|Washout Period 2 (7 Days)||11||
48039549|NCT02785770|100417191|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48039550|NCT02785770|100417192|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48039551|NCT02785770|100417193|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48039552|NCT02785770|100417194|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0||
48039553|NCT02785770|100417191|FG000|STARTED|Intervention Period 3 (1 Day)||11||
48039554|NCT02785770|100417192|FG001|STARTED|Intervention Period 3 (1 Day)||10||
48039555|NCT02785770|100417193|FG002|STARTED|Intervention Period 3 (1 Day)||10||
48039556|NCT02785770|100417194|FG003|STARTED|Intervention Period 3 (1 Day)||11||
48039557|NCT02785770|100417191|FG000|COMPLETED|Intervention Period 3 (1 Day)||11||
48039558|NCT02785770|100417192|FG001|COMPLETED|Intervention Period 3 (1 Day)||10||
48039559|NCT02785770|100417193|FG002|COMPLETED|Intervention Period 3 (1 Day)||10||
48039560|NCT02785770|100417194|FG003|COMPLETED|Intervention Period 3 (1 Day)||10||
48039561|NCT02785770|100417191|FG000|NOT COMPLETED|Intervention Period 3 (1 Day)||0||
48039562|NCT02785770|100417192|FG001|NOT COMPLETED|Intervention Period 3 (1 Day)||0||
48039563|NCT02785770|100417193|FG002|NOT COMPLETED|Intervention Period 3 (1 Day)||0||
48039564|NCT02785770|100417194|FG003|NOT COMPLETED|Intervention Period 3 (1 Day)||1||
48039565|NCT02785770|100417191|FG000|STARTED|Washout Period 3 (7 Days)||11||
48039566|NCT02785770|100417192|FG001|STARTED|Washout Period 3 (7 Days)||10||
48039567|NCT02785770|100417193|FG002|STARTED|Washout Period 3 (7 Days)||10||
48039568|NCT02785770|100417194|FG003|STARTED|Washout Period 3 (7 Days)||10||
48039569|NCT02785770|100417191|FG000|COMPLETED|Washout Period 3 (7 Days)||11||
48039570|NCT02785770|100417192|FG001|COMPLETED|Washout Period 3 (7 Days)||10||
48039571|NCT02785770|100417193|FG002|COMPLETED|Washout Period 3 (7 Days)||10||
48039572|NCT02785770|100417194|FG003|COMPLETED|Washout Period 3 (7 Days)||10||
48039573|NCT02785770|100417191|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48039574|NCT02785770|100417192|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48039575|NCT02785770|100417193|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48039576|NCT02785770|100417194|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0||
48039577|NCT02785770|100417191|FG000|STARTED|Intervention Period 4 (1 Day)||11||
48039578|NCT02785770|100417192|FG001|STARTED|Intervention Period 4 (1 Day)||10||
48039579|NCT02785770|100417193|FG002|STARTED|Intervention Period 4 (1 Day)||10||
48039580|NCT02785770|100417194|FG003|STARTED|Intervention Period 4 (1 Day)||10||
48039581|NCT02785770|100417191|FG000|COMPLETED|Intervention Period 4 (1 Day)||11||
48039582|NCT02785770|100417192|FG001|COMPLETED|Intervention Period 4 (1 Day)||10||
48039583|NCT02785770|100417193|FG002|COMPLETED|Intervention Period 4 (1 Day)||10||
48039584|NCT02785770|100417194|FG003|COMPLETED|Intervention Period 4 (1 Day)||10||
48039585|NCT02785770|100417191|FG000|NOT COMPLETED|Intervention Period 4 (1 Day)||0||
48039586|NCT02785770|100417192|FG001|NOT COMPLETED|Intervention Period 4 (1 Day)||0||
48039587|NCT02785770|100417193|FG002|NOT COMPLETED|Intervention Period 4 (1 Day)||0||
48039588|NCT02785770|100417194|FG003|NOT COMPLETED|Intervention Period 4 (1 Day)||0||
48039589|NCT01030666|100417195|FG000|STARTED|Overall Study||28||
48039590|NCT01030666|100417196|FG001|STARTED|Overall Study||33||
48039591|NCT01030666|100417195|FG000|COMPLETED|Overall Study||25||
48039592|NCT01030666|100417196|FG001|COMPLETED|Overall Study||31||
48039593|NCT01030666|100417195|FG000|NOT COMPLETED|Overall Study||3||
48039594|NCT01030666|100417196|FG001|NOT COMPLETED|Overall Study||2||
48039595|NCT01853839|100417197|FG000|STARTED|Overall Study||2092||
48039596|NCT01853839|100417197|FG000|COMPLETED|Overall Study||1663||
48039597|NCT01853839|100417197|FG000|NOT COMPLETED|Overall Study||429||
48039598|NCT00588861|100417198|FG000|STARTED|Pre-Operative||202||
48039599|NCT00588861|100417199|FG001|STARTED|Pre-Operative||200||
48039600|NCT00588861|100417198|FG000|COMPLETED|Pre-Operative||107||
48039601|NCT00588861|100417199|FG001|COMPLETED|Pre-Operative||114||
48039602|NCT00588861|100417198|FG000|NOT COMPLETED|Pre-Operative||95||
48039603|NCT00588861|100417199|FG001|NOT COMPLETED|Pre-Operative||86||
48039604|NCT00588861|100417198|FG000|STARTED|6 Months||107||
48039605|NCT00588861|100417199|FG001|STARTED|6 Months||114||
48039606|NCT00588861|100417198|FG000|COMPLETED|6 Months||9||
48039607|NCT00588861|100417199|FG001|COMPLETED|6 Months||41||
48039608|NCT00588861|100417198|FG000|NOT COMPLETED|6 Months||98||
48039609|NCT00588861|100417199|FG001|NOT COMPLETED|6 Months||73||
48039610|NCT00588861|100417198|FG000|STARTED|1 Year||107||
48039611|NCT00588861|100417199|FG001|STARTED|1 Year||114||
48039612|NCT00588861|100417198|FG000|COMPLETED|1 Year||18||
48039613|NCT00588861|100417199|FG001|COMPLETED|1 Year||32||
48039614|NCT00588861|100417198|FG000|NOT COMPLETED|1 Year||89||
48039615|NCT00588861|100417199|FG001|NOT COMPLETED|1 Year||82||
48039616|NCT00588861|100417198|FG000|STARTED|2 Years||107||
48039617|NCT00588861|100417199|FG001|STARTED|2 Years||114||
48039618|NCT00588861|100417198|FG000|COMPLETED|2 Years||15||
48039619|NCT00588861|100417199|FG001|COMPLETED|2 Years||27||
48039620|NCT00588861|100417198|FG000|NOT COMPLETED|2 Years||92||
48039621|NCT00588861|100417199|FG001|NOT COMPLETED|2 Years||87||
48202702|NCT04141917|100820652|FG001|STARTED|Surveillance + Test and Treat Year 1||153|This is all year 1 participants enrolled during standard surveillance + test and treat protocol months at their shelter of residence|2
48495290|NCT00521586|101547822|FG000|Vaccinated Dose 2|Initial Vaccination (Year 0)||538||
48039622|NCT00588861|100417198|FG000|STARTED|4 Years||107||
48039623|NCT00588861|100417199|FG001|STARTED|4 Years||114||
48039624|NCT00588861|100417198|FG000|COMPLETED|4 Years||16||
48039625|NCT00588861|100417199|FG001|COMPLETED|4 Years||11||
48039626|NCT00588861|100417198|FG000|NOT COMPLETED|4 Years||91||
48039627|NCT00588861|100417199|FG001|NOT COMPLETED|4 Years||103||
48039628|NCT00588861|100417198|FG000|STARTED|6 Years||107||
48039629|NCT00588861|100417199|FG001|STARTED|6 Years||114||
48039630|NCT00588861|100417198|FG000|COMPLETED|6 Years||3||
48039631|NCT00588861|100417199|FG001|COMPLETED|6 Years||5||
48039632|NCT00588861|100417198|FG000|NOT COMPLETED|6 Years||104||
48039633|NCT00588861|100417199|FG001|NOT COMPLETED|6 Years||109||
48039634|NCT00588861|100417198|FG000|STARTED|8 Years||107||
48039635|NCT00588861|100417199|FG001|STARTED|8 Years||114||
48039636|NCT00588861|100417198|FG000|COMPLETED|8 Years||2||
48039637|NCT00588861|100417199|FG001|COMPLETED|8 Years||0||
48039638|NCT00588861|100417198|FG000|NOT COMPLETED|8 Years||105||
48039639|NCT00588861|100417199|FG001|NOT COMPLETED|8 Years||114||
48039640|NCT00588861|100417198|FG000|STARTED|10 Years||107||
48039641|NCT00588861|100417199|FG001|STARTED|10 Years||114||
48039642|NCT00588861|100417198|FG000|COMPLETED|10 Years||0||
48039643|NCT00588861|100417199|FG001|COMPLETED|10 Years||0||
48039644|NCT00588861|100417198|FG000|NOT COMPLETED|10 Years||107||
48039645|NCT00588861|100417199|FG001|NOT COMPLETED|10 Years||114||
48039646|NCT03417713|100417200|FG000|STARTED|Overall Study||33||
48039647|NCT03417713|100417200|FG000|COMPLETED|Overall Study||30||
48039648|NCT03417713|100417200|FG000|NOT COMPLETED|Overall Study||3||
48039649|NCT05525078|100417201|FG000|STARTED|Overall Study||20||
48039650|NCT05525078|100417202|FG001|STARTED|Overall Study||10||
48495291|NCT00521586|101547823|FG001|Vaccinated Dose 2|Initial Vaccination (Year 0)||543||
48039651|NCT05525078|100417201|FG000|COMPLETED|Overall Study||18||
48039652|NCT05525078|100417202|FG001|COMPLETED|Overall Study||10||
48039653|NCT05525078|100417201|FG000|NOT COMPLETED|Overall Study||2||
48039654|NCT05525078|100417202|FG001|NOT COMPLETED|Overall Study||0||
48039655|NCT03700684|100417203|FG000|STARTED|Overall Study||12||
48039656|NCT03700684|100417204|FG001|STARTED|Overall Study||12||
48039657|NCT03700684|100417205|FG002|STARTED|Overall Study||12||
48039658|NCT03700684|100417203|FG000|COMPLETED|Overall Study||12||
48039659|NCT03700684|100417204|FG001|COMPLETED|Overall Study||12||
48039660|NCT03700684|100417205|FG002|COMPLETED|Overall Study||10||
48039661|NCT03700684|100417203|FG000|NOT COMPLETED|Overall Study||0||
48039662|NCT03700684|100417204|FG001|NOT COMPLETED|Overall Study||0||
48039663|NCT03700684|100417205|FG002|NOT COMPLETED|Overall Study||2||
48039664|NCT00495040|100417206|FG000|STARTED|Overall Study||38||
48039665|NCT00495040|100417206|FG000|COMPLETED|Overall Study||35||
48039666|NCT00495040|100417206|FG000|NOT COMPLETED|Overall Study||3||
48039667|NCT01853618|100417207|FG000|STARTED|Overall Study||8||
48039668|NCT01853618|100417208|FG001|STARTED|Overall Study||12||
48039669|NCT01853618|100417209|FG002|STARTED|Overall Study||12||
48039670|NCT01853618|100417210|FG003|STARTED|Overall Study||9||
48039671|NCT01853618|100417211|FG004|STARTED|Overall Study||20||
48039672|NCT01853618|100417207|FG000|COMPLETED|Overall Study||6||
48039673|NCT01853618|100417208|FG001|COMPLETED|Overall Study||10||
48039674|NCT01853618|100417209|FG002|COMPLETED|Overall Study||10||
48039675|NCT01853618|100417210|FG003|COMPLETED|Overall Study||8||
48039676|NCT01853618|100417211|FG004|COMPLETED|Overall Study||17||
48039677|NCT01853618|100417207|FG000|NOT COMPLETED|Overall Study||2||
48039678|NCT01853618|100417208|FG001|NOT COMPLETED|Overall Study||2||
48039679|NCT01853618|100417209|FG002|NOT COMPLETED|Overall Study||2||
48039680|NCT01853618|100417210|FG003|NOT COMPLETED|Overall Study||1||
48039681|NCT01853618|100417211|FG004|NOT COMPLETED|Overall Study||3||
48039682|NCT01989468|100417212|FG000|STARTED|Overall Study||138|All randomized patients were included in the Full Analysis Set (FAS) and Safety Set (SAF).|
48039683|NCT01989468|100417213|FG001|STARTED|Overall Study||139|All randomized patients were included in the Full Analysis Set (FAS) and Safety Set (SAF).|
48039684|NCT01989468|100417214|FG002|STARTED|Overall Study||64|All randomized patients were included in the Full Analysis Set (FAS) and Safety Set (SAF).|
48039685|NCT01989468|100417215|FG003|STARTED|Overall Study||65|All randomized patients were included in the Full Analysis Set (FAS) and Safety Set (SAF).|
48039686|NCT01989468|100417216|FG004|STARTED|Overall Study||8|All randomized patients were included in the Full Analysis Set (FAS) and Safety Set (SAF).|
48039687|NCT01989468|100417212|FG000|COMPLETED|Overall Study||91|Completed Week 156|
48039688|NCT01989468|100417213|FG001|COMPLETED|Overall Study||102|Completed Week 156|
48039689|NCT01989468|100417214|FG002|COMPLETED|Overall Study||45|Completed Week 156|
48039690|NCT01989468|100417215|FG003|COMPLETED|Overall Study||49|Completed Week 156|
48039691|NCT01989468|100417216|FG004|COMPLETED|Overall Study||0|Completed Week 156|
48039692|NCT01989468|100417212|FG000|NOT COMPLETED|Overall Study||47||
48039693|NCT01989468|100417213|FG001|NOT COMPLETED|Overall Study||37||
48039694|NCT01989468|100417214|FG002|NOT COMPLETED|Overall Study||19||
48039695|NCT01989468|100417215|FG003|NOT COMPLETED|Overall Study||16||
48039696|NCT01989468|100417216|FG004|NOT COMPLETED|Overall Study||8||
48039697|NCT00393510|100417217|FG000|STARTED|Overall Study||40||
48039698|NCT00393510|100417218|FG001|STARTED|Overall Study||40||
48039699|NCT00393510|100417217|FG000|COMPLETED|Overall Study||37||
48039700|NCT00393510|100417218|FG001|COMPLETED|Overall Study||31||
48039701|NCT00393510|100417217|FG000|NOT COMPLETED|Overall Study||3||
48039702|NCT00393510|100417218|FG001|NOT COMPLETED|Overall Study||9||
48039703|NCT04586387|100417219|FG000|STARTED|Overall Study||6||
48039704|NCT04586387|100417220|FG001|STARTED|Overall Study||6||
48039705|NCT04586387|100417219|FG000|Sham Stimulation|Overall Study||6|Will occur over biceps or FDI depending on which area is being stimulated first|
48039706|NCT04586387|100417220|FG001|Sham Stimulation|Overall Study||6|Will occur over biceps or FDI depending on which area is being stimulated first|
48039707|NCT04586387|100417219|FG000|Active Stimulation|Overall Study||6|Will occur over biceps or FDI depending on which area is being stimulated first|
48039708|NCT04586387|100417220|FG001|Active Stimulation|Overall Study||6|Will occur over biceps or FDI depending on which area is being stimulated first|
48039709|NCT04586387|100417219|FG000|3 Day Rest|Overall Study||6||
48039710|NCT04586387|100417220|FG001|3 Day Rest|Overall Study||6||
48039711|NCT04586387|100417219|FG000|Sham Stimulation|Overall Study||6|Will occur over biceps or FDI depending on which area is being stimulated second|
48039712|NCT04586387|100417220|FG001|Sham Stimulation|Overall Study||6|Will occur over biceps or FDI depending on which area is being stimulated second|
48039713|NCT04586387|100417219|FG000|Active Stimulation|Overall Study||6|Will occur over biceps or FDI depending on which area is being stimulated second|
48039714|NCT04586387|100417220|FG001|Active Stimulation|Overall Study||6|Will occur over biceps or FDI depending on which area is being stimulated second|
48039715|NCT04586387|100417219|FG000|COMPLETED|Overall Study||6||
48039716|NCT04586387|100417220|FG001|COMPLETED|Overall Study||6||
48039717|NCT04586387|100417219|FG000|NOT COMPLETED|Overall Study||0||
48039718|NCT04586387|100417220|FG001|NOT COMPLETED|Overall Study||0||
48039719|NCT02730793|100417221|FG000|STARTED|Overall Study||2||
48039720|NCT02730793|100417222|FG001|STARTED|Overall Study||3||
48202703|NCT04141917|100820653|FG002|STARTED|Surveillance + Test and Treat Year 1||82|This is all year 1 participants enrolled during standard surveillance + test and treat protocol months at their shelter of residence|2
48202704|NCT04141917|100820654|FG003|STARTED|Surveillance + Test and Treat Year 1||83|This is all year 1 participants enrolled during standard surveillance + test and treat protocol months at their shelter of residence|2
48202705|NCT04141917|100820651|FG000|COMPLETED|Surveillance + Test and Treat Year 1||358||3
48202706|NCT04141917|100820652|FG001|COMPLETED|Surveillance + Test and Treat Year 1||153||2
48202707|NCT04141917|100820653|FG002|COMPLETED|Surveillance + Test and Treat Year 1||82||2
48202708|NCT04141917|100820654|FG003|COMPLETED|Surveillance + Test and Treat Year 1||83||2
48202709|NCT04141917|100820651|FG000|NOT COMPLETED|Surveillance + Test and Treat Year 1||0||0
48202710|NCT04141917|100820652|FG001|NOT COMPLETED|Surveillance + Test and Treat Year 1||0||0
48202711|NCT04141917|100820653|FG002|NOT COMPLETED|Surveillance + Test and Treat Year 1||0||0
48039721|NCT02730793|100417221|FG000|COMPLETED|Overall Study||2||
48039722|NCT02730793|100417222|FG001|COMPLETED|Overall Study||1||
48039723|NCT02730793|100417221|FG000|NOT COMPLETED|Overall Study||0||
48039724|NCT02730793|100417222|FG001|NOT COMPLETED|Overall Study||2||
48039725|NCT01806662|100417223|FG000|STARTED|First Intervention (Weeks 0-16)||16||
48039726|NCT01806662|100417224|FG001|STARTED|First Intervention (Weeks 0-16)||16||
48039727|NCT01806662|100417223|FG000|Received Intervention|First Intervention (Weeks 0-16)||12||
48039728|NCT01806662|100417224|FG001|Received Intervention|First Intervention (Weeks 0-16)||15||
48039729|NCT01806662|100417223|FG000|COMPLETED|First Intervention (Weeks 0-16)||12||
48039730|NCT01806662|100417224|FG001|COMPLETED|First Intervention (Weeks 0-16)||15||
48039731|NCT01806662|100417223|FG000|NOT COMPLETED|First Intervention (Weeks 0-16)||4||
48039732|NCT01806662|100417224|FG001|NOT COMPLETED|First Intervention (Weeks 0-16)||1||
48039733|NCT01806662|100417223|FG000|STARTED|Second Intervention (Weeks 16-32)||12||
48039734|NCT01806662|100417224|FG001|STARTED|Second Intervention (Weeks 16-32)||15||
48039735|NCT01806662|100417223|FG000|COMPLETED|Second Intervention (Weeks 16-32)||10||
48039736|NCT01806662|100417224|FG001|COMPLETED|Second Intervention (Weeks 16-32)||11||
48039737|NCT01806662|100417223|FG000|NOT COMPLETED|Second Intervention (Weeks 16-32)||2||
48039738|NCT01806662|100417224|FG001|NOT COMPLETED|Second Intervention (Weeks 16-32)||4||
48039739|NCT01144299|100417225|FG000|STARTED|Overall Study||60||
48039740|NCT01144299|100417226|FG001|STARTED|Overall Study||54||
48039741|NCT01144299|100417225|FG000|COMPLETED|Overall Study||58||
48039742|NCT01144299|100417226|FG001|COMPLETED|Overall Study||54||
48039743|NCT01144299|100417225|FG000|NOT COMPLETED|Overall Study||2||
48039744|NCT01144299|100417226|FG001|NOT COMPLETED|Overall Study||0||
48039745|NCT00934843|100417227|FG000|STARTED|Overall Study||37||
48039746|NCT00934843|100417228|FG001|STARTED|Overall Study||40||
48039747|NCT00934843|100417227|FG000|COMPLETED|Overall Study||37||
48039748|NCT00934843|100417228|FG001|COMPLETED|Overall Study||39||
48039749|NCT00934843|100417227|FG000|NOT COMPLETED|Overall Study||0||
48039750|NCT00934843|100417228|FG001|NOT COMPLETED|Overall Study||1||
48039751|NCT00357760|100417229|FG000|STARTED|Overall Study||59||
48039752|NCT00357760|100417230|FG001|STARTED|Overall Study||35||
48039753|NCT00357760|100417229|FG000|Patients Who Started Treatment|Overall Study||57||
48039754|NCT00357760|100417230|FG001|Patients Who Started Treatment|Overall Study||34||
48039755|NCT00357760|100417229|FG000|Eligible and Treated Patients|Overall Study||57||
48039756|NCT00357760|100417230|FG001|Eligible and Treated Patients|Overall Study||32||
48039757|NCT00357760|100417229|FG000|Patients Who Undergo Dose Escalation|Overall Study||0||
48039758|NCT00357760|100417230|FG001|Patients Who Undergo Dose Escalation|Overall Study||16||
48039759|NCT00357760|100417229|FG000|COMPLETED|Overall Study||0||
48039760|NCT00357760|100417230|FG001|COMPLETED|Overall Study||0||
48039761|NCT00357760|100417229|FG000|NOT COMPLETED|Overall Study||59||
48039762|NCT00357760|100417230|FG001|NOT COMPLETED|Overall Study||35||
48039763|NCT01037192|100417231|FG000|STARTED|Overall Study||3||
48039764|NCT01037192|100417232|FG001|STARTED|Overall Study||1||
48039765|NCT01037192|100417231|FG000|COMPLETED|Overall Study||3||
48039766|NCT01037192|100417232|FG001|COMPLETED|Overall Study||1||
48039767|NCT01037192|100417231|FG000|NOT COMPLETED|Overall Study||0||
48039768|NCT01037192|100417232|FG001|NOT COMPLETED|Overall Study||0||
48039769|NCT01719744|100417233|FG000|STARTED|Overall Study||25||
48039770|NCT01719744|100417233|FG000|COMPLETED|Overall Study||25||
48039771|NCT01719744|100417233|FG000|NOT COMPLETED|Overall Study||0||
48039772|NCT01217307|100417234|FG000|STARTED|Overall Study||191||
48202712|NCT04141917|100820654|FG003|NOT COMPLETED|Surveillance + Test and Treat Year 1||0||0
48202713|NCT04141917|100820651|FG000|STARTED|Summer Surveillance||73|This is all participants enrolled between 4/1/2020 and 11/1/2020 when only standard surveillance was conducted at all shelters as year 1 of the test and treat protocol took place between 11/15/2019 and 3/31/2020 and year 2 of the protocol took place between 11/2/2020 and 3/31/2021. Enrollments are noted as per their randomized shelter sequence from year 1.|3
48202714|NCT04141917|100820652|FG001|STARTED|Summer Surveillance||39|This is all participants enrolled between 4/1/2020 and 11/1/2020 when only standard surveillance was conducted at all shelters as year 1 of the test and treat protocol took place between 11/15/2019 and 3/31/2020 and year 2 of the protocol took place between 11/2/2020 and 3/31/2021. Enrollments are noted as per their randomized shelter sequence from year 1.|2
48202715|NCT04141917|100820653|FG002|STARTED|Summer Surveillance||54|This is all participants enrolled between 4/1/2020 and 11/1/2020 when only standard surveillance was conducted at all shelters as year 1 of the test and treat protocol took place between 11/15/2019 and 3/31/2020 and year 2 of the protocol took place between 11/2/2020 and 3/31/2021. Enrollments are noted as per their randomized shelter sequence from year 1.|2
48202716|NCT04141917|100820654|FG003|STARTED|Summer Surveillance||20|This is all participants enrolled between 4/1/2020 and 11/1/2020 when only standard surveillance was conducted at all shelters as year 1 of the test and treat protocol took place between 11/15/2019 and 3/31/2020 and year 2 of the protocol took place between 11/2/2020 and 3/31/2021. Enrollments are noted as per their randomized shelter sequence from year 1.|2
48202717|NCT04141917|100820651|FG000|COMPLETED|Summer Surveillance||73||3
48202718|NCT04141917|100820652|FG001|COMPLETED|Summer Surveillance||39||2
48202719|NCT04141917|100820653|FG002|COMPLETED|Summer Surveillance||54||2
48202720|NCT04141917|100820654|FG003|COMPLETED|Summer Surveillance||20||2
48202721|NCT04141917|100820651|FG000|NOT COMPLETED|Summer Surveillance||0||0
48202722|NCT04141917|100820652|FG001|NOT COMPLETED|Summer Surveillance||0||0
48202723|NCT04141917|100820653|FG002|NOT COMPLETED|Summer Surveillance||0||0
48202724|NCT04141917|100820654|FG003|NOT COMPLETED|Summer Surveillance||0||0
48202725|NCT04141917|100820651|FG000|STARTED|Surveillance Year 2||3|This is all year 2 participants enrolled during standard surveillance months at their shelter of residence|3
48202726|NCT04141917|100820652|FG001|STARTED|Surveillance Year 2||3|This is all year 2 participants enrolled during standard surveillance months at their shelter of residence|2
48039773|NCT01217307|100417235|FG001|STARTED|Overall Study||189||
48039774|NCT01217307|100417234|FG000|COMPLETED|Overall Study||191||
48039775|NCT01217307|100417235|FG001|COMPLETED|Overall Study||188||
48039776|NCT01217307|100417234|FG000|NOT COMPLETED|Overall Study||0||
48039777|NCT01217307|100417235|FG001|NOT COMPLETED|Overall Study||1||
48039778|NCT03751657|100417236|FG000|STARTED|Overall Study||125||
48202727|NCT04141917|100820653|FG002|STARTED|Surveillance Year 2||10|This is all year 2 participants enrolled during standard surveillance months at their shelter of residence|2
48202728|NCT04141917|100820654|FG003|STARTED|Surveillance Year 2||7|This is all year 2 participants enrolled during standard surveillance months at their shelter of residence|2
48202729|NCT04141917|100820651|FG000|COMPLETED|Surveillance Year 2||3||3
48202730|NCT04141917|100820652|FG001|COMPLETED|Surveillance Year 2||3||2
48202731|NCT04141917|100820653|FG002|COMPLETED|Surveillance Year 2||10||2
48202732|NCT04141917|100820654|FG003|COMPLETED|Surveillance Year 2||7||2
48202733|NCT04141917|100820651|FG000|NOT COMPLETED|Surveillance Year 2||0||0
48202734|NCT04141917|100820652|FG001|NOT COMPLETED|Surveillance Year 2||0||0
48202735|NCT04141917|100820653|FG002|NOT COMPLETED|Surveillance Year 2||0||0
48202736|NCT04141917|100820654|FG003|NOT COMPLETED|Surveillance Year 2||0||0
48202737|NCT04141917|100820651|FG000|STARTED|Surveillance + Test and Treat Year 2||62|This is all year 1 participants enrolled during standard surveillance + test and treat protocol months at their shelter of residence|3
48202738|NCT04141917|100820652|FG001|STARTED|Surveillance + Test and Treat Year 2||13|This is all year 1 participants enrolled during standard surveillance + test and treat protocol months at their shelter of residence|2
48202739|NCT04141917|100820653|FG002|STARTED|Surveillance + Test and Treat Year 2||3|This is all year 1 participants enrolled during standard surveillance + test and treat protocol months at their shelter of residence|2
48495292|NCT00521586|101547822|FG000|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)||531||
48039779|NCT03751657|100417237|FG001|STARTED|Overall Study||122||
48039780|NCT03751657|100417236|FG000|COMPLETED|Overall Study||122||
48039781|NCT03751657|100417237|FG001|COMPLETED|Overall Study||119||
48039782|NCT03751657|100417236|FG000|NOT COMPLETED|Overall Study||3||
48039783|NCT03751657|100417237|FG001|NOT COMPLETED|Overall Study||3||
48039784|NCT01491113|100417238|FG000|STARTED|Overall Study||6||
48039785|NCT01491113|100417239|FG001|STARTED|Overall Study||6||
48039786|NCT01491113|100417240|FG002|STARTED|Overall Study||6||
48039787|NCT01491113|100417241|FG003|STARTED|Overall Study||6||
48039788|NCT01491113|100417242|FG004|STARTED|Overall Study||6||
48039789|NCT01491113|100417238|FG000|COMPLETED|Overall Study||6||
48039790|NCT01491113|100417239|FG001|COMPLETED|Overall Study||6||
48039791|NCT01491113|100417240|FG002|COMPLETED|Overall Study||6||
48039792|NCT01491113|100417241|FG003|COMPLETED|Overall Study||6||
48039793|NCT01491113|100417242|FG004|COMPLETED|Overall Study||6||
48039794|NCT01491113|100417238|FG000|NOT COMPLETED|Overall Study||0||
48039795|NCT01491113|100417239|FG001|NOT COMPLETED|Overall Study||0||
48039796|NCT01491113|100417240|FG002|NOT COMPLETED|Overall Study||0||
48039797|NCT01491113|100417241|FG003|NOT COMPLETED|Overall Study||0||
48039798|NCT01491113|100417242|FG004|NOT COMPLETED|Overall Study||0||
48039799|NCT02207946|100417243|FG000|STARTED|Overall Study||19||
48039800|NCT02207946|100417244|FG001|STARTED|Overall Study||11||
48039801|NCT02207946|100417243|FG000|COMPLETED|Overall Study||18||
48039802|NCT02207946|100417244|FG001|COMPLETED|Overall Study||10||
48039803|NCT02207946|100417243|FG000|NOT COMPLETED|Overall Study||1||
48039804|NCT02207946|100417244|FG001|NOT COMPLETED|Overall Study||1||
48039805|NCT00924040|100417245|FG000|STARTED|Overall Study||1||
48039806|NCT00924040|100417245|FG000|COMPLETED|Overall Study||1||
48039807|NCT00924040|100417245|FG000|NOT COMPLETED|Overall Study||0||
48039808|NCT02880956|100417246|FG000|STARTED|Overall Study||116||
48039809|NCT02880956|100417247|FG001|STARTED|Overall Study||108||
48039810|NCT02880956|100417248|FG002|STARTED|Overall Study||116||
48039811|NCT02880956|100417249|FG003|STARTED|Overall Study||113||
48039812|NCT02880956|100417246|FG000|COMPLETED|Overall Study||99||
48039813|NCT02880956|100417247|FG001|COMPLETED|Overall Study||93||
48039814|NCT02880956|100417248|FG002|COMPLETED|Overall Study||105||
48039815|NCT02880956|100417249|FG003|COMPLETED|Overall Study||95||
48039816|NCT02880956|100417246|FG000|NOT COMPLETED|Overall Study||17||
48039817|NCT02880956|100417247|FG001|NOT COMPLETED|Overall Study||15||
48039818|NCT02880956|100417248|FG002|NOT COMPLETED|Overall Study||11||
48039819|NCT02880956|100417249|FG003|NOT COMPLETED|Overall Study||18||
48039820|NCT01303224|100417250|FG000|STARTED|Overall Study||141||
48039821|NCT01303224|100417251|FG001|STARTED|Overall Study||142||
48039822|NCT01303224|100417252|FG002|STARTED|Overall Study||139||
48039823|NCT01303224|100417253|FG003|STARTED|Overall Study||143||
48039824|NCT01303224|100417250|FG000|Intention To Treat|Overall Study||140||
48039825|NCT01303224|100417251|FG001|Intention To Treat|Overall Study||138||
48039826|NCT01303224|100417252|FG002|Intention To Treat|Overall Study||139||
48039827|NCT01303224|100417253|FG003|Intention To Treat|Overall Study||142||
48039828|NCT01303224|100417250|FG000|COMPLETED|Overall Study||130||
48039829|NCT01303224|100417251|FG001|COMPLETED|Overall Study||131||
48039830|NCT01303224|100417252|FG002|COMPLETED|Overall Study||133||
48039831|NCT01303224|100417253|FG003|COMPLETED|Overall Study||133||
48039832|NCT01303224|100417250|FG000|NOT COMPLETED|Overall Study||11||
48039833|NCT01303224|100417251|FG001|NOT COMPLETED|Overall Study||11||
48039834|NCT01303224|100417252|FG002|NOT COMPLETED|Overall Study||6||
48039835|NCT01303224|100417253|FG003|NOT COMPLETED|Overall Study||10||
48039836|NCT02491944|100417254|FG000|STARTED|Overall Study||10||
48039837|NCT02491944|100417254|FG000|COMPLETED|Overall Study||10||
48039838|NCT02491944|100417254|FG000|NOT COMPLETED|Overall Study||0||
48039839|NCT00222131|100417255|FG000|STARTED|Overall Study||38||
48039840|NCT00222131|100417256|FG001|STARTED|Overall Study||35||
48039841|NCT00222131|100417255|FG000|COMPLETED|Overall Study||38||
48039842|NCT00222131|100417256|FG001|COMPLETED|Overall Study||35||
48039843|NCT00222131|100417255|FG000|NOT COMPLETED|Overall Study||0||
48039844|NCT00222131|100417256|FG001|NOT COMPLETED|Overall Study||0||
48039845|NCT00308581|100417257|FG000|STARTED|Induction Phase||0||
48039846|NCT00308581|100417258|FG001|STARTED|Induction Phase||0||
48039847|NCT00308581|100417259|FG002|STARTED|Induction Phase||539||
48039848|NCT00308581|100417257|FG000|COMPLETED|Induction Phase||0||
48039849|NCT00308581|100417258|FG001|COMPLETED|Induction Phase||0||
48039850|NCT00308581|100417259|FG002|COMPLETED|Induction Phase||373||
48039851|NCT00308581|100417257|FG000|NOT COMPLETED|Induction Phase||0||
48039852|NCT00308581|100417258|FG001|NOT COMPLETED|Induction Phase||0||
48039853|NCT00308581|100417259|FG002|NOT COMPLETED|Induction Phase||166||
48039854|NCT00308581|100417257|FG000|STARTED|Randomized Maintenance Phase||187||
48039855|NCT00308581|100417258|FG001|STARTED|Randomized Maintenance Phase||186||
48039856|NCT00308581|100417259|FG002|STARTED|Randomized Maintenance Phase||0||
48039857|NCT00308581|100417257|FG000|COMPLETED|Randomized Maintenance Phase||82||
48039858|NCT00308581|100417258|FG001|COMPLETED|Randomized Maintenance Phase||83||
48039859|NCT00308581|100417259|FG002|COMPLETED|Randomized Maintenance Phase||0||
48039860|NCT00308581|100417257|FG000|NOT COMPLETED|Randomized Maintenance Phase||105||
48039861|NCT00308581|100417258|FG001|NOT COMPLETED|Randomized Maintenance Phase||103||
48039862|NCT00308581|100417259|FG002|NOT COMPLETED|Randomized Maintenance Phase||0||
48039863|NCT03353740|100417260|FG000|STARTED|Overall Study||346||
48039864|NCT03353740|100417260|FG000|COMPLETED|Overall Study||294||
48039865|NCT03353740|100417260|FG000|NOT COMPLETED|Overall Study||52||
48039866|NCT02051933|100417261|FG000|STARTED|Overall Study||5||
48039867|NCT02051933|100417262|FG001|STARTED|Overall Study||5||
48039868|NCT02051933|100417261|FG000|COMPLETED|Overall Study||5||
48039869|NCT02051933|100417262|FG001|COMPLETED|Overall Study||4||
48039870|NCT02051933|100417261|FG000|NOT COMPLETED|Overall Study||0||
48039871|NCT02051933|100417262|FG001|NOT COMPLETED|Overall Study||1||
48039872|NCT00864916|100417263|FG000|STARTED|Overall Study||10||
48039873|NCT00864916|100417264|FG001|STARTED|Overall Study||9||
48039874|NCT00864916|100417263|FG000|COMPLETED|Overall Study||4||
48039875|NCT00864916|100417264|FG001|COMPLETED|Overall Study||5||
48039876|NCT00864916|100417263|FG000|NOT COMPLETED|Overall Study||6||
48039877|NCT00864916|100417264|FG001|NOT COMPLETED|Overall Study||4||
48039878|NCT05028361|100417265|FG000|STARTED|Overall Study||169||
48039879|NCT05028361|100417266|FG001|STARTED|Overall Study||166||
48039880|NCT05028361|100417265|FG000|COMPLETED|Overall Study||168||
48039881|NCT05028361|100417266|FG001|COMPLETED|Overall Study||166||
48039882|NCT05028361|100417265|FG000|NOT COMPLETED|Overall Study||1||
48039883|NCT05028361|100417266|FG001|NOT COMPLETED|Overall Study||0||
48039884|NCT02642744|100417267|FG000|STARTED|Overall Study||278||
48039885|NCT02642744|100417268|FG001|STARTED|Overall Study||392||
48039886|NCT02642744|100417267|FG000|COMPLETED|Overall Study||129||
48039887|NCT02642744|100417268|FG001|COMPLETED|Overall Study||169||
48039888|NCT02642744|100417267|FG000|NOT COMPLETED|Overall Study||149||
48039889|NCT02642744|100417268|FG001|NOT COMPLETED|Overall Study||223||
48039890|NCT01239992|100417269|FG000|STARTED|Overall Study||12||
48039891|NCT01239992|100417269|FG000|COMPLETED|Overall Study||10||
48202740|NCT04141917|100820654|FG003|STARTED|Surveillance + Test and Treat Year 2||3|This is all year 1 participants enrolled during standard surveillance + test and treat protocol months at their shelter of residence|2
48202741|NCT04141917|100820651|FG000|COMPLETED|Surveillance + Test and Treat Year 2||62||3
48202742|NCT04141917|100820652|FG001|COMPLETED|Surveillance + Test and Treat Year 2||13||2
48202743|NCT04141917|100820653|FG002|COMPLETED|Surveillance + Test and Treat Year 2||3||2
48202744|NCT04141917|100820654|FG003|COMPLETED|Surveillance + Test and Treat Year 2||3||2
48202745|NCT04141917|100820651|FG000|NOT COMPLETED|Surveillance + Test and Treat Year 2||0||0
48202746|NCT04141917|100820652|FG001|NOT COMPLETED|Surveillance + Test and Treat Year 2||0||0
48202747|NCT04141917|100820653|FG002|NOT COMPLETED|Surveillance + Test and Treat Year 2||0||0
48202748|NCT04141917|100820654|FG003|NOT COMPLETED|Surveillance + Test and Treat Year 2||0||0
48202749|NCT00612586|100820655|FG000|STARTED|Overall Study||58||
48202750|NCT00612586|100820656|FG001|STARTED|Overall Study||59||
48202751|NCT00612586|100820655|FG000|Received at Least 1 Dose|Overall Study||57||
48202752|NCT00612586|100820656|FG001|Received at Least 1 Dose|Overall Study||58||
48202753|NCT00612586|100820655|FG000|COMPLETED|Overall Study||15||
48202754|NCT00612586|100820656|FG001|COMPLETED|Overall Study||18||
48202755|NCT00612586|100820655|FG000|NOT COMPLETED|Overall Study||43||
48202756|NCT00612586|100820656|FG001|NOT COMPLETED|Overall Study||41||
48202757|NCT01546155|100820657|FG000|STARTED|Overall Study||11||
48202758|NCT01546155|100820657|FG000|COMPLETED|Overall Study||8||
48202759|NCT01546155|100820657|FG000|NOT COMPLETED|Overall Study||3||
48202760|NCT01897233|100820658|FG000|STARTED|Part A (14 Days)||10||
48202761|NCT01897233|100820658|FG000|Part A Cohort 1 (6 to 8 Years)|Part A (14 Days)||5||
48202762|NCT01897233|100820658|FG000|Part A Cohort 2 (9 to 11 Years)|Part A (14 Days)||5||
48202763|NCT01897233|100820658|FG000|COMPLETED|Part A (14 Days)||10||
48202764|NCT01897233|100820658|FG000|NOT COMPLETED|Part A (14 Days)||0||
48202765|NCT01897233|100820658|FG000|STARTED|Part B (24 Weeks)||58||
48202766|NCT01897233|100820658|FG000|COMPLETED|Part B (24 Weeks)||54||
48202767|NCT01897233|100820658|FG000|NOT COMPLETED|Part B (24 Weeks)||4||
48202768|NCT00309452|100820659|FG000|STARTED|Overall Study||60||
48202769|NCT00309452|100820660|FG001|STARTED|Overall Study||60||
48202770|NCT00309452|100820659|FG000|COMPLETED|Overall Study||57||
48202771|NCT00309452|100820660|FG001|COMPLETED|Overall Study||60||
48202772|NCT00309452|100820659|FG000|NOT COMPLETED|Overall Study||3||
48202773|NCT00309452|100820660|FG001|NOT COMPLETED|Overall Study||0||
48202774|NCT00831415|100820661|FG000|STARTED|Overall Study||304||
48202775|NCT00831415|100820661|FG000|"Completers for Exposure"|Overall Study||227||
48202776|NCT00831415|100820661|FG000|"Study Completers"|Overall Study||227||
48202777|NCT00831415|100820661|FG000|COMPLETED|Overall Study||229||
48202778|NCT00831415|100820661|FG000|NOT COMPLETED|Overall Study||75||
48202779|NCT00794118|100820662|FG000|STARTED|Overall Study||299||
48202780|NCT00794118|100820662|FG000|COMPLETED|Overall Study||272||
48202781|NCT00794118|100820662|FG000|NOT COMPLETED|Overall Study||27||
48202782|NCT04301986|100820663|FG000|STARTED|Overall Study||0||
48202783|NCT04301986|100820664|FG001|STARTED|Overall Study||24||
48039892|NCT01239992|100417269|FG000|NOT COMPLETED|Overall Study||2||
48039893|NCT02551991|100417270|FG000|STARTED|Overall Study||7||
48039894|NCT02551991|100417271|FG001|STARTED|Overall Study||7||
48202784|NCT04301986|100820663|FG000|COMPLETED|Overall Study||0||
48202785|NCT04301986|100820664|FG001|COMPLETED|Overall Study||24||
48202786|NCT04301986|100820663|FG000|NOT COMPLETED|Overall Study||0||
48202787|NCT04301986|100820664|FG001|NOT COMPLETED|Overall Study||0||
48202788|NCT03906968|100820665|FG000|STARTED|Overall Study||40||
48202789|NCT03906968|100820665|FG000|COMPLETED|Overall Study||40||
48202790|NCT03906968|100820665|FG000|NOT COMPLETED|Overall Study||0||
48202791|NCT01251354|100820666|FG000|STARTED|Overall Study||6||
48202792|NCT01251354|100820666|FG000|COMPLETED|Overall Study||0||
48202793|NCT01251354|100820666|FG000|NOT COMPLETED|Overall Study||6||
48202794|NCT03302741|100820667|FG000|STARTED|Overall Study||8||
48202795|NCT03302741|100820668|FG001|STARTED|Overall Study||9||
48202796|NCT03302741|100820667|FG000|COMPLETED|Overall Study||7||
48202797|NCT03302741|100820668|FG001|COMPLETED|Overall Study||8||
48202798|NCT03302741|100820667|FG000|NOT COMPLETED|Overall Study||1||
48202799|NCT03302741|100820668|FG001|NOT COMPLETED|Overall Study||1||
48202800|NCT01792830|100820669|FG000|STARTED|Overall Study||84||
48202801|NCT01792830|100820670|FG001|STARTED|Overall Study||3||
48202802|NCT01792830|100820671|FG002|STARTED|Overall Study||4||
48202803|NCT01792830|100820672|FG003|STARTED|Overall Study||21||
48202804|NCT01792830|100820673|FG004|STARTED|Overall Study||2||
48039895|NCT02551991|100417272|FG002|STARTED|Overall Study||10||
48039896|NCT02551991|100417273|FG003|STARTED|Overall Study||7||
48039897|NCT02551991|100417274|FG004|STARTED|Overall Study||25||
48202805|NCT01792830|100820674|FG005|STARTED|Overall Study||4||
48039898|NCT02551991|100417270|FG000|COMPLETED|Overall Study||0||
48039899|NCT02551991|100417271|FG001|COMPLETED|Overall Study||0||
48039900|NCT02551991|100417272|FG002|COMPLETED|Overall Study||0||
48039901|NCT02551991|100417273|FG003|COMPLETED|Overall Study||0||
48039902|NCT02551991|100417274|FG004|COMPLETED|Overall Study||0||
48039903|NCT02551991|100417270|FG000|NOT COMPLETED|Overall Study||7||
48039904|NCT02551991|100417271|FG001|NOT COMPLETED|Overall Study||7||
48039905|NCT02551991|100417272|FG002|NOT COMPLETED|Overall Study||10||
48039906|NCT02551991|100417273|FG003|NOT COMPLETED|Overall Study||7||
48202806|NCT01792830|100820675|FG006|STARTED|Overall Study||14||
48202807|NCT01792830|100820676|FG007|STARTED|Overall Study||7||
48202808|NCT01792830|100820677|FG008|STARTED|Overall Study||20||
48202809|NCT01792830|100820678|FG009|STARTED|Overall Study||4||
48202810|NCT01792830|100820679|FG010|STARTED|Overall Study||12||
48202811|NCT01792830|100820669|FG000|COMPLETED|Overall Study||59|Participants who died in the hospital, before follow-up, are considered as not completing the study.|
48202812|NCT01792830|100820670|FG001|COMPLETED|Overall Study||3|Participants who died in the hospital, before follow-up, are considered as not completing the study.|
48202813|NCT01792830|100820671|FG002|COMPLETED|Overall Study||4|Participants who died in the hospital, before follow-up, are considered as not completing the study.|
48202814|NCT01792830|100820672|FG003|COMPLETED|Overall Study||18|Participants who died in the hospital, before follow-up, are considered as not completing the study.|
48202815|NCT01792830|100820673|FG004|COMPLETED|Overall Study||1|Participants who died in the hospital, before follow-up, are considered as not completing the study.|
48202816|NCT01792830|100820674|FG005|COMPLETED|Overall Study||3|Participants who died in the hospital, before follow-up, are considered as not completing the study.|
48202817|NCT01792830|100820675|FG006|COMPLETED|Overall Study||12|Participants who died in the hospital, before follow-up, are considered as not completing the study.|
48202818|NCT01792830|100820676|FG007|COMPLETED|Overall Study||6|Participants who died in the hospital, before follow-up, are considered as not completing the study.|
48202819|NCT01792830|100820677|FG008|COMPLETED|Overall Study||11|Participants who died in the hospital, before follow-up, are considered as not completing the study.|
48202820|NCT01792830|100820678|FG009|COMPLETED|Overall Study||4|Participants who died in the hospital, before follow-up, are considered as not completing the study.|
48202821|NCT01792830|100820679|FG010|COMPLETED|Overall Study||9|Participants who died in the hospital, before follow-up, are considered as not completing the study.|
48202822|NCT01792830|100820669|FG000|NOT COMPLETED|Overall Study||25||
48202823|NCT01792830|100820670|FG001|NOT COMPLETED|Overall Study||0||
48202824|NCT01792830|100820671|FG002|NOT COMPLETED|Overall Study||0||
48202825|NCT01792830|100820672|FG003|NOT COMPLETED|Overall Study||3||
48495293|NCT00521586|101547823|FG001|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)||529||
48495294|NCT00521586|101547822|FG000|COMPLETED|Initial Vaccination (Year 0)||533||
48495295|NCT00521586|101547823|FG001|COMPLETED|Initial Vaccination (Year 0)||533||
48495296|NCT00521586|101547822|FG000|NOT COMPLETED|Initial Vaccination (Year 0)||21||
48495297|NCT00521586|101547823|FG001|NOT COMPLETED|Initial Vaccination (Year 0)||29||
48039907|NCT02551991|100417274|FG004|NOT COMPLETED|Overall Study||25||
48039908|NCT00422084|100417275|FG000|STARTED|Overall Study||849||
48039909|NCT00422084|100417276|FG001|STARTED|Overall Study||423||
48039910|NCT00422084|100417275|FG000|COMPLETED|Overall Study||751||
48039911|NCT00422084|100417276|FG001|COMPLETED|Overall Study||347||
48039912|NCT00422084|100417275|FG000|NOT COMPLETED|Overall Study||98||
48039913|NCT00422084|100417276|FG001|NOT COMPLETED|Overall Study||76||
48039914|NCT01566214|100417277|FG000|STARTED|Overall Study||6||
48039915|NCT01566214|100417278|FG001|STARTED|Overall Study||6||
48039916|NCT01566214|100417277|FG000|COMPLETED|Overall Study||3||
48039917|NCT01566214|100417278|FG001|COMPLETED|Overall Study||6||
48039918|NCT01566214|100417277|FG000|NOT COMPLETED|Overall Study||3||
48039919|NCT01566214|100417278|FG001|NOT COMPLETED|Overall Study||0||
48039920|NCT02745145|100417279|FG000|STARTED|Overall Study||10||
48039921|NCT02745145|100417280|FG001|STARTED|Overall Study||5||
48039922|NCT02745145|100417281|FG002|STARTED|Overall Study||9||
48039923|NCT02745145|100417279|FG000|COMPLETED|Overall Study||0||
48039924|NCT02745145|100417280|FG001|COMPLETED|Overall Study||0||
48039925|NCT02745145|100417281|FG002|COMPLETED|Overall Study||0||
48039926|NCT02745145|100417279|FG000|NOT COMPLETED|Overall Study||10||
48039927|NCT02745145|100417280|FG001|NOT COMPLETED|Overall Study||5||
48039928|NCT02745145|100417281|FG002|NOT COMPLETED|Overall Study||9||
48039929|NCT03758755|100417282|FG000|STARTED|Overall Study||25||
48039930|NCT03758755|100417283|FG001|STARTED|Overall Study||20||
48039931|NCT03758755|100417282|FG000|COMPLETED|Overall Study||25||
48039932|NCT03758755|100417283|FG001|COMPLETED|Overall Study||20||
48039933|NCT03758755|100417282|FG000|NOT COMPLETED|Overall Study||0||
48039934|NCT03758755|100417283|FG001|NOT COMPLETED|Overall Study||0||
48039935|NCT00662532|100417284|FG000|STARTED|Overall Study||22||
48495298|NCT00521586|101547822|FG000|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533||
48495299|NCT00521586|101547823|FG001|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533||
48495300|NCT00521586|101547822|FG000|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||364||
48495301|NCT00521586|101547823|FG001|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||363||
48495302|NCT00521586|101547822|FG000|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||169||
48039936|NCT00662532|100417285|FG001|STARTED|Overall Study||22||
48039937|NCT00662532|100417284|FG000|COMPLETED|Overall Study||22||
48039938|NCT00662532|100417285|FG001|COMPLETED|Overall Study||20||
48039939|NCT00662532|100417284|FG000|NOT COMPLETED|Overall Study||0||
48039940|NCT00662532|100417285|FG001|NOT COMPLETED|Overall Study||2||
48039941|NCT00097981|100417286|FG000|STARTED|Overall Study||113||
48039942|NCT00097981|100417287|FG001|STARTED|Overall Study||112||
48039943|NCT00097981|100417286|FG000|Received Study Medication|Overall Study||110||
48039944|NCT00097981|100417287|FG001|Received Study Medication|Overall Study||106||
48039945|NCT00097981|100417286|FG000|COMPLETED|Overall Study||7||
48039946|NCT00097981|100417287|FG001|COMPLETED|Overall Study||12||
48039947|NCT00097981|100417286|FG000|NOT COMPLETED|Overall Study||106||
48039948|NCT00097981|100417287|FG001|NOT COMPLETED|Overall Study||100||
48039949|NCT02415842|100417288|FG000|STARTED|Overall Study||29||
48039950|NCT02415842|100417289|FG001|STARTED|Overall Study||29||
48039951|NCT02415842|100417290|FG002|STARTED|Overall Study||29||
48039952|NCT02415842|100417291|FG003|STARTED|Overall Study||27||
48039953|NCT02415842|100417292|FG004|STARTED|Overall Study||30||
48039954|NCT02415842|100417293|FG005|STARTED|Overall Study||30||
48039955|NCT02415842|100417294|FG006|STARTED|Overall Study||30||
48039956|NCT02415842|100417295|FG007|STARTED|Overall Study||26||
48039957|NCT02415842|100417296|FG008|STARTED|Overall Study||29||
48039958|NCT02415842|100417297|FG009|STARTED|Overall Study||53||
48039959|NCT02415842|100417298|FG010|STARTED|Overall Study||49||
48039960|NCT02415842|100417299|FG011|STARTED|Overall Study||33||
48039961|NCT02415842|100417300|FG012|STARTED|Overall Study||20||
48039962|NCT02415842|100417288|FG000|COMPLETED|Overall Study||29||
48039963|NCT02415842|100417289|FG001|COMPLETED|Overall Study||29||
48039964|NCT02415842|100417290|FG002|COMPLETED|Overall Study||29||
48039965|NCT02415842|100417291|FG003|COMPLETED|Overall Study||27||
48039966|NCT02415842|100417292|FG004|COMPLETED|Overall Study||30||
48039967|NCT02415842|100417293|FG005|COMPLETED|Overall Study||30||
48039968|NCT02415842|100417294|FG006|COMPLETED|Overall Study||30||
48039969|NCT02415842|100417295|FG007|COMPLETED|Overall Study||26||
48039970|NCT02415842|100417296|FG008|COMPLETED|Overall Study||29||
48039971|NCT02415842|100417297|FG009|COMPLETED|Overall Study||53||
48039972|NCT02415842|100417298|FG010|COMPLETED|Overall Study||49||
48039973|NCT02415842|100417299|FG011|COMPLETED|Overall Study||33||
48039974|NCT02415842|100417300|FG012|COMPLETED|Overall Study||20||
48039975|NCT02415842|100417288|FG000|NOT COMPLETED|Overall Study||0||
48039976|NCT02415842|100417289|FG001|NOT COMPLETED|Overall Study||0||
48039977|NCT02415842|100417290|FG002|NOT COMPLETED|Overall Study||0||
48039978|NCT02415842|100417291|FG003|NOT COMPLETED|Overall Study||0||
48039979|NCT02415842|100417292|FG004|NOT COMPLETED|Overall Study||0||
48039980|NCT02415842|100417293|FG005|NOT COMPLETED|Overall Study||0||
48039981|NCT02415842|100417294|FG006|NOT COMPLETED|Overall Study||0||
48039982|NCT02415842|100417295|FG007|NOT COMPLETED|Overall Study||0||
48039983|NCT02415842|100417296|FG008|NOT COMPLETED|Overall Study||0||
48039984|NCT02415842|100417297|FG009|NOT COMPLETED|Overall Study||0||
48039985|NCT02415842|100417298|FG010|NOT COMPLETED|Overall Study||0||
48039986|NCT02415842|100417299|FG011|NOT COMPLETED|Overall Study||0||
48039987|NCT02415842|100417300|FG012|NOT COMPLETED|Overall Study||0||
48039988|NCT01510457|100417301|FG000|STARTED|Overall Study||17||
48039989|NCT01510457|100417302|FG001|STARTED|Overall Study||29||
48039990|NCT01510457|100417301|FG000|COMPLETED|Overall Study||12||
48039991|NCT01510457|100417302|FG001|COMPLETED|Overall Study||26||
48039992|NCT01510457|100417301|FG000|NOT COMPLETED|Overall Study||5||
48039993|NCT01510457|100417302|FG001|NOT COMPLETED|Overall Study||3||
48039994|NCT03259620|100417303|FG000|STARTED|Overall Study||245||
48039995|NCT03259620|100417304|FG001|STARTED|Overall Study||246||
48039996|NCT03259620|100417303|FG000|Subjects Who Had 1 Wart|Overall Study||112||
48039997|NCT03259620|100417304|FG001|Subjects Who Had 1 Wart|Overall Study||118||
48039998|NCT03259620|100417303|FG000|Subjects Who Had 2 Warts|Overall Study||48||
48039999|NCT03259620|100417304|FG001|Subjects Who Had 2 Warts|Overall Study||40||
48040000|NCT03259620|100417303|FG000|Subjects Who Had 3 Warts|Overall Study||25||
48040001|NCT03259620|100417304|FG001|Subjects Who Had 3 Warts|Overall Study||31||
48040002|NCT03259620|100417303|FG000|Subjects Who Had 4 Warts|Overall Study||13||
48040003|NCT03259620|100417304|FG001|Subjects Who Had 4 Warts|Overall Study||18||
48040004|NCT03259620|100417303|FG000|Subjects Who Had 5 Warts|Overall Study||20||
48040005|NCT03259620|100417304|FG001|Subjects Who Had 5 Warts|Overall Study||20||
48040006|NCT03259620|100417303|FG000|Subjects Who Had 6 Warts|Overall Study||27||
48040007|NCT03259620|100417304|FG001|Subjects Who Had 6 Warts|Overall Study||19||
48040008|NCT03259620|100417303|FG000|COMPLETED|Overall Study||226||
48040009|NCT03259620|100417304|FG001|COMPLETED|Overall Study||217||
48040010|NCT03259620|100417303|FG000|NOT COMPLETED|Overall Study||19||
48040011|NCT03259620|100417304|FG001|NOT COMPLETED|Overall Study||29||
48040012|NCT02788279|100417305|FG000|STARTED|Overall Study||90|Intent to treat (ITT) population|
48040013|NCT02788279|100417306|FG001|STARTED|Overall Study||183|Intent to treat (ITT) population|
48040014|NCT02788279|100417307|FG002|STARTED|Overall Study||90|Intent to treat (ITT) population|
48040015|NCT02788279|100417305|FG000|Received Treatment (Safety Population)|Overall Study||80||
48040016|NCT02788279|100417306|FG001|Received Treatment (Safety Population)|Overall Study||179||
48040017|NCT02788279|100417307|FG002|Received Treatment (Safety Population)|Overall Study||90||
48040018|NCT02788279|100417305|FG000|Modified ITT Population|Overall Study||57|Patient-reported outcome (PRO)|
48040019|NCT02788279|100417306|FG001|Modified ITT Population|Overall Study||125|Patient-reported outcome (PRO)|
48202826|NCT01792830|100820673|FG004|NOT COMPLETED|Overall Study||1||
48040020|NCT02788279|100417307|FG002|Modified ITT Population|Overall Study||61|Patient-reported outcome (PRO)|
48040021|NCT02788279|100417305|FG000|COMPLETED|Overall Study||0||
48040022|NCT02788279|100417306|FG001|COMPLETED|Overall Study||0||
48040023|NCT02788279|100417307|FG002|COMPLETED|Overall Study||0||
48040024|NCT02788279|100417305|FG000|NOT COMPLETED|Overall Study||90||
48040025|NCT02788279|100417306|FG001|NOT COMPLETED|Overall Study||183||
48040026|NCT02788279|100417307|FG002|NOT COMPLETED|Overall Study||90||
48040027|NCT01185353|100417308|FG000|STARTED|Part A (Weeks 0 Through 12)||49||
48040028|NCT01185353|100417309|FG001|STARTED|Part A (Weeks 0 Through 12)||52||
48040029|NCT01185353|100417310|FG002|STARTED|Part A (Weeks 0 Through 12)||52||
48040030|NCT01185353|100417311|FG003|STARTED|Part A (Weeks 0 Through 12)||50||
48040031|NCT01185353|100417312|FG004|STARTED|Part A (Weeks 0 Through 12)||98||
48040032|NCT01185353|100417313|FG005|STARTED|Part A (Weeks 0 Through 12)||0||
48040033|NCT01185353|100417314|FG006|STARTED|Part A (Weeks 0 Through 12)||0||
48040034|NCT01185353|100417315|FG007|STARTED|Part A (Weeks 0 Through 12)||0||
48040035|NCT01185353|100417316|FG008|STARTED|Part A (Weeks 0 Through 12)||0||
48040036|NCT01185353|100417317|FG009|STARTED|Part A (Weeks 0 Through 12)||0||
48040037|NCT01185353|100417308|FG000|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||49||
48040038|NCT01185353|100417309|FG001|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52||
48040039|NCT01185353|100417310|FG002|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52||
48040040|NCT01185353|100417311|FG003|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||50||
48040041|NCT01185353|100417312|FG004|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||98||
48040042|NCT01185353|100417313|FG005|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0||
48040043|NCT01185353|100417314|FG006|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0||
48040044|NCT01185353|100417315|FG007|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0||
48040045|NCT01185353|100417316|FG008|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0||
48040046|NCT01185353|100417317|FG009|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0||
48040047|NCT01185353|100417308|FG000|COMPLETED|Part A (Weeks 0 Through 12)||44||
48040048|NCT01185353|100417309|FG001|COMPLETED|Part A (Weeks 0 Through 12)||51||
48040049|NCT01185353|100417310|FG002|COMPLETED|Part A (Weeks 0 Through 12)||50||
48040050|NCT01185353|100417311|FG003|COMPLETED|Part A (Weeks 0 Through 12)||49||
48040051|NCT01185353|100417312|FG004|COMPLETED|Part A (Weeks 0 Through 12)||82||
48040052|NCT01185353|100417313|FG005|COMPLETED|Part A (Weeks 0 Through 12)||0||
48040053|NCT01185353|100417314|FG006|COMPLETED|Part A (Weeks 0 Through 12)||0||
48040054|NCT01185353|100417315|FG007|COMPLETED|Part A (Weeks 0 Through 12)||0||
48040055|NCT01185353|100417316|FG008|COMPLETED|Part A (Weeks 0 Through 12)||0||
48040056|NCT01185353|100417317|FG009|COMPLETED|Part A (Weeks 0 Through 12)||0||
48040057|NCT01185353|100417308|FG000|NOT COMPLETED|Part A (Weeks 0 Through 12)||5||
48040058|NCT01185353|100417309|FG001|NOT COMPLETED|Part A (Weeks 0 Through 12)||1||
48040059|NCT01185353|100417310|FG002|NOT COMPLETED|Part A (Weeks 0 Through 12)||2||
48040060|NCT01185353|100417311|FG003|NOT COMPLETED|Part A (Weeks 0 Through 12)||1||
48040061|NCT01185353|100417312|FG004|NOT COMPLETED|Part A (Weeks 0 Through 12)||16||
48040062|NCT01185353|100417313|FG005|NOT COMPLETED|Part A (Weeks 0 Through 12)||0||
48040063|NCT01185353|100417314|FG006|NOT COMPLETED|Part A (Weeks 0 Through 12)||0||
48040064|NCT01185353|100417315|FG007|NOT COMPLETED|Part A (Weeks 0 Through 12)||0||
48040065|NCT01185353|100417316|FG008|NOT COMPLETED|Part A (Weeks 0 Through 12)||0||
48040066|NCT01185353|100417317|FG009|NOT COMPLETED|Part A (Weeks 0 Through 12)||0||
48040067|NCT01185353|100417308|FG000|STARTED|Part B (Weeks 12 Through 24)||0||
48040068|NCT01185353|100417309|FG001|STARTED|Part B (Weeks 12 Through 24)||51||
48040069|NCT01185353|100417310|FG002|STARTED|Part B (Weeks 12 Through 24)||50||
48040070|NCT01185353|100417311|FG003|STARTED|Part B (Weeks 12 Through 24)||49||
48040071|NCT01185353|100417312|FG004|STARTED|Part B (Weeks 12 Through 24)||0||
48040072|NCT01185353|100417313|FG005|STARTED|Part B (Weeks 12 Through 24)||63||
48040073|NCT01185353|100417314|FG006|STARTED|Part B (Weeks 12 Through 24)||63||
48040074|NCT01185353|100417315|FG007|STARTED|Part B (Weeks 12 Through 24)||0||
48040075|NCT01185353|100417316|FG008|STARTED|Part B (Weeks 12 Through 24)||0||
48040076|NCT01185353|100417317|FG009|STARTED|Part B (Weeks 12 Through 24)||0||
48040077|NCT01185353|100417308|FG000|COMPLETED|Part B (Weeks 12 Through 24)||0||
48040078|NCT01185353|100417309|FG001|COMPLETED|Part B (Weeks 12 Through 24)||50||
48040079|NCT01185353|100417310|FG002|COMPLETED|Part B (Weeks 12 Through 24)||48||
48040080|NCT01185353|100417311|FG003|COMPLETED|Part B (Weeks 12 Through 24)||45||
48040081|NCT01185353|100417312|FG004|COMPLETED|Part B (Weeks 12 Through 24)||0||
48040082|NCT01185353|100417313|FG005|COMPLETED|Part B (Weeks 12 Through 24)||59||
48040083|NCT01185353|100417314|FG006|COMPLETED|Part B (Weeks 12 Through 24)||57||
48040084|NCT01185353|100417315|FG007|COMPLETED|Part B (Weeks 12 Through 24)||0||
48040085|NCT01185353|100417316|FG008|COMPLETED|Part B (Weeks 12 Through 24)||0||
48040086|NCT01185353|100417317|FG009|COMPLETED|Part B (Weeks 12 Through 24)||0||
48040087|NCT01185353|100417308|FG000|NOT COMPLETED|Part B (Weeks 12 Through 24)||0||
48040088|NCT01185353|100417309|FG001|NOT COMPLETED|Part B (Weeks 12 Through 24)||1||
48040089|NCT01185353|100417310|FG002|NOT COMPLETED|Part B (Weeks 12 Through 24)||2||
48040090|NCT01185353|100417311|FG003|NOT COMPLETED|Part B (Weeks 12 Through 24)||4||
48040091|NCT01185353|100417312|FG004|NOT COMPLETED|Part B (Weeks 12 Through 24)||0||
48040092|NCT01185353|100417313|FG005|NOT COMPLETED|Part B (Weeks 12 Through 24)||4||
48040093|NCT01185353|100417314|FG006|NOT COMPLETED|Part B (Weeks 12 Through 24)||6||
48040094|NCT01185353|100417315|FG007|NOT COMPLETED|Part B (Weeks 12 Through 24)||0||
48040095|NCT01185353|100417316|FG008|NOT COMPLETED|Part B (Weeks 12 Through 24)||0||
48040096|NCT01185353|100417317|FG009|NOT COMPLETED|Part B (Weeks 12 Through 24)||0||
48040097|NCT01185353|100417308|FG000|STARTED|Part C (Weeks 24 Through 76)||0||
48040098|NCT01185353|100417309|FG001|STARTED|Part C (Weeks 24 Through 76)||0||
48040099|NCT01185353|100417310|FG002|STARTED|Part C (Weeks 24 Through 76)||0||
48040100|NCT01185353|100417311|FG003|STARTED|Part C (Weeks 24 Through 76)||0||
48040101|NCT01185353|100417312|FG004|STARTED|Part C (Weeks 24 Through 76)||0||
48040102|NCT01185353|100417313|FG005|STARTED|Part C (Weeks 24 Through 76)||0||
48040103|NCT01185353|100417314|FG006|STARTED|Part C (Weeks 24 Through 76)||0||
48040104|NCT01185353|100417315|FG007|STARTED|Part C (Weeks 24 Through 76)||108||
48040105|NCT01185353|100417316|FG008|STARTED|Part C (Weeks 24 Through 76)||61||
48040106|NCT01185353|100417317|FG009|STARTED|Part C (Weeks 24 Through 76)||32||
48040107|NCT01185353|100417308|FG000|COMPLETED|Part C (Weeks 24 Through 76)||0||
48040108|NCT01185353|100417309|FG001|COMPLETED|Part C (Weeks 24 Through 76)||0||
48040109|NCT01185353|100417310|FG002|COMPLETED|Part C (Weeks 24 Through 76)||0||
48040110|NCT01185353|100417311|FG003|COMPLETED|Part C (Weeks 24 Through 76)||0||
48040111|NCT01185353|100417312|FG004|COMPLETED|Part C (Weeks 24 Through 76)||0||
48040112|NCT01185353|100417313|FG005|COMPLETED|Part C (Weeks 24 Through 76)||0||
48040113|NCT01185353|100417314|FG006|COMPLETED|Part C (Weeks 24 Through 76)||0||
48202827|NCT01792830|100820674|FG005|NOT COMPLETED|Overall Study||1||
48040114|NCT01185353|100417315|FG007|COMPLETED|Part C (Weeks 24 Through 76)||92||
48040115|NCT01185353|100417316|FG008|COMPLETED|Part C (Weeks 24 Through 76)||53||
48040116|NCT01185353|100417317|FG009|COMPLETED|Part C (Weeks 24 Through 76)||24||
48040117|NCT01185353|100417308|FG000|NOT COMPLETED|Part C (Weeks 24 Through 76)||0||
48040118|NCT01185353|100417309|FG001|NOT COMPLETED|Part C (Weeks 24 Through 76)||0||
48040119|NCT01185353|100417310|FG002|NOT COMPLETED|Part C (Weeks 24 Through 76)||0||
48040120|NCT01185353|100417311|FG003|NOT COMPLETED|Part C (Weeks 24 Through 76)||0||
48040121|NCT01185353|100417312|FG004|NOT COMPLETED|Part C (Weeks 24 Through 76)||0||
48040122|NCT01185353|100417313|FG005|NOT COMPLETED|Part C (Weeks 24 Through 76)||0||
48040123|NCT01185353|100417314|FG006|NOT COMPLETED|Part C (Weeks 24 Through 76)||0||
48040124|NCT01185353|100417315|FG007|NOT COMPLETED|Part C (Weeks 24 Through 76)||16||
48040125|NCT01185353|100417316|FG008|NOT COMPLETED|Part C (Weeks 24 Through 76)||8||
48040126|NCT01185353|100417317|FG009|NOT COMPLETED|Part C (Weeks 24 Through 76)||8||
48040127|NCT01185353|100417308|FG000|STARTED|Part D (Weeks 76 Through 128)||0||
48040128|NCT01185353|100417309|FG001|STARTED|Part D (Weeks 76 Through 128)||0||
48040129|NCT01185353|100417310|FG002|STARTED|Part D (Weeks 76 Through 128)||0||
48040130|NCT01185353|100417311|FG003|STARTED|Part D (Weeks 76 Through 128)||0||
48040131|NCT01185353|100417312|FG004|STARTED|Part D (Weeks 76 Through 128)||0||
48040132|NCT01185353|100417313|FG005|STARTED|Part D (Weeks 76 Through 128)||0||
48040133|NCT01185353|100417314|FG006|STARTED|Part D (Weeks 76 Through 128)||0||
48040134|NCT01185353|100417315|FG007|STARTED|Part D (Weeks 76 Through 128)||79||
48040135|NCT01185353|100417316|FG008|STARTED|Part D (Weeks 76 Through 128)||47||
48040136|NCT01185353|100417317|FG009|STARTED|Part D (Weeks 76 Through 128)||18||
48040137|NCT01185353|100417308|FG000|COMPLETED|Part D (Weeks 76 Through 128)||0||
48040138|NCT01185353|100417309|FG001|COMPLETED|Part D (Weeks 76 Through 128)||0||
48040139|NCT01185353|100417310|FG002|COMPLETED|Part D (Weeks 76 Through 128)||0||
48040140|NCT01185353|100417311|FG003|COMPLETED|Part D (Weeks 76 Through 128)||0||
48040141|NCT01185353|100417312|FG004|COMPLETED|Part D (Weeks 76 Through 128)||0||
48040142|NCT01185353|100417313|FG005|COMPLETED|Part D (Weeks 76 Through 128)||0||
48040143|NCT01185353|100417314|FG006|COMPLETED|Part D (Weeks 76 Through 128)||0||
48040144|NCT01185353|100417315|FG007|COMPLETED|Part D (Weeks 76 Through 128)||76||
48040145|NCT01185353|100417316|FG008|COMPLETED|Part D (Weeks 76 Through 128)||40||
48040146|NCT01185353|100417317|FG009|COMPLETED|Part D (Weeks 76 Through 128)||17||
48040147|NCT01185353|100417308|FG000|NOT COMPLETED|Part D (Weeks 76 Through 128)||0||
48040148|NCT01185353|100417309|FG001|NOT COMPLETED|Part D (Weeks 76 Through 128)||0||
48040149|NCT01185353|100417310|FG002|NOT COMPLETED|Part D (Weeks 76 Through 128)||0||
48040150|NCT01185353|100417311|FG003|NOT COMPLETED|Part D (Weeks 76 Through 128)||0||
48040151|NCT01185353|100417312|FG004|NOT COMPLETED|Part D (Weeks 76 Through 128)||0||
48040152|NCT01185353|100417313|FG005|NOT COMPLETED|Part D (Weeks 76 Through 128)||0||
48040153|NCT01185353|100417314|FG006|NOT COMPLETED|Part D (Weeks 76 Through 128)||0||
48040154|NCT01185353|100417315|FG007|NOT COMPLETED|Part D (Weeks 76 Through 128)||3||
48040155|NCT01185353|100417316|FG008|NOT COMPLETED|Part D (Weeks 76 Through 128)||7||
48040156|NCT01185353|100417317|FG009|NOT COMPLETED|Part D (Weeks 76 Through 128)||1||
48040157|NCT06131476|100417318|FG000|STARTED|Period 1||15||
48040158|NCT06131476|100417319|FG001|STARTED|Period 1||16||
48040159|NCT06131476|100417318|FG000|COMPLETED|Period 1||15||
48040160|NCT06131476|100417319|FG001|COMPLETED|Period 1||16||
48040161|NCT06131476|100417318|FG000|NOT COMPLETED|Period 1||0||
48040162|NCT06131476|100417319|FG001|NOT COMPLETED|Period 1||0||
48040163|NCT06131476|100417318|FG000|STARTED|Period 2||15||
48040164|NCT06131476|100417319|FG001|STARTED|Period 2||16||
48040165|NCT06131476|100417318|FG000|COMPLETED|Period 2||15||
48040166|NCT06131476|100417319|FG001|COMPLETED|Period 2||16||
48040167|NCT06131476|100417318|FG000|NOT COMPLETED|Period 2||0||
48040168|NCT06131476|100417319|FG001|NOT COMPLETED|Period 2||0||
48040169|NCT01989208|100417320|FG000|STARTED|200 mg (7 Days)||4||
48040170|NCT01989208|100417321|FG001|STARTED|200 mg (7 Days)||12||
48040171|NCT01989208|100417320|FG000|COMPLETED|200 mg (7 Days)||4||
48040172|NCT01989208|100417321|FG001|COMPLETED|200 mg (7 Days)||11||
48040173|NCT01989208|100417320|FG000|NOT COMPLETED|200 mg (7 Days)||0||
48040174|NCT01989208|100417321|FG001|NOT COMPLETED|200 mg (7 Days)||1||
48040175|NCT01989208|100417320|FG000|STARTED|400 mg (7 Days)||4||
48040176|NCT01989208|100417321|FG001|STARTED|400 mg (7 Days)||11||
48040177|NCT01989208|100417320|FG000|COMPLETED|400 mg (7 Days)||4||
48040178|NCT01989208|100417321|FG001|COMPLETED|400 mg (7 Days)||11||
48040179|NCT01989208|100417320|FG000|NOT COMPLETED|400 mg (7 Days)||0||
48040180|NCT01989208|100417321|FG001|NOT COMPLETED|400 mg (7 Days)||0||
48040181|NCT01989208|100417320|FG000|STARTED|800 mg (7 Days)||4||
48040182|NCT01989208|100417321|FG001|STARTED|800 mg (7 Days)||11||
48040183|NCT01989208|100417320|FG000|COMPLETED|800 mg (7 Days)||4||
48040184|NCT01989208|100417321|FG001|COMPLETED|800 mg (7 Days)||11||
48202828|NCT01792830|100820675|FG006|NOT COMPLETED|Overall Study||2||
48202829|NCT01792830|100820676|FG007|NOT COMPLETED|Overall Study||1||
48202830|NCT01792830|100820677|FG008|NOT COMPLETED|Overall Study||9||
48202831|NCT01792830|100820678|FG009|NOT COMPLETED|Overall Study||0||
48202832|NCT01792830|100820679|FG010|NOT COMPLETED|Overall Study||3||
48202833|NCT02614560|100820680|FG000|STARTED|Overall Study||6||
48202834|NCT02614560|100820681|FG001|STARTED|Overall Study||8||
48202835|NCT02614560|100820680|FG000|COMPLETED|Overall Study||0||
48202836|NCT02614560|100820681|FG001|COMPLETED|Overall Study||6||
48202837|NCT02614560|100820680|FG000|NOT COMPLETED|Overall Study||6||
48202838|NCT02614560|100820681|FG001|NOT COMPLETED|Overall Study||2||
48202839|NCT02698241|100820682|FG000|STARTED|Overall Study||79||
48202840|NCT02698241|100820682|FG000|Baseline & Programming|Overall Study||66|Subject characteristics collected and device diagnostic enabled at baseline and programming visit.|
48202841|NCT02698241|100820682|FG000|COMPLETED|Overall Study||45||
48202842|NCT02698241|100820682|FG000|NOT COMPLETED|Overall Study||34||
48202843|NCT03125382|100820683|FG000|STARTED|Randomization||38|Randomization|
48202844|NCT03125382|100820684|FG001|STARTED|Randomization||32|Randomization|
48202845|NCT03125382|100820685|FG002|STARTED|Randomization||37|Randomization|
48202846|NCT03125382|100820686|FG003|STARTED|Randomization||34|Randomization|
48202847|NCT03125382|100820683|FG000|COMPLETED|Randomization||37||
48202848|NCT03125382|100820684|FG001|COMPLETED|Randomization||28||
48202849|NCT03125382|100820685|FG002|COMPLETED|Randomization||35||
48202850|NCT03125382|100820686|FG003|COMPLETED|Randomization||34||
48202851|NCT03125382|100820683|FG000|NOT COMPLETED|Randomization||1||
48202852|NCT03125382|100820684|FG001|NOT COMPLETED|Randomization||4||
48202853|NCT03125382|100820685|FG002|NOT COMPLETED|Randomization||2||
48202854|NCT03125382|100820686|FG003|NOT COMPLETED|Randomization||0||
48202855|NCT03125382|100820683|FG000|STARTED|Follow-up||37||
48202856|NCT03125382|100820684|FG001|STARTED|Follow-up||28||
48202857|NCT03125382|100820685|FG002|STARTED|Follow-up||35||
48202858|NCT03125382|100820686|FG003|STARTED|Follow-up||34||
48202859|NCT03125382|100820683|FG000|COMPLETED|Follow-up||35||
48202860|NCT03125382|100820684|FG001|COMPLETED|Follow-up||22||
48202861|NCT03125382|100820685|FG002|COMPLETED|Follow-up||31||
48202862|NCT03125382|100820686|FG003|COMPLETED|Follow-up||31||
48202863|NCT03125382|100820683|FG000|NOT COMPLETED|Follow-up||2||
48202864|NCT03125382|100820684|FG001|NOT COMPLETED|Follow-up||6||
48202865|NCT03125382|100820685|FG002|NOT COMPLETED|Follow-up||4||
48202866|NCT03125382|100820686|FG003|NOT COMPLETED|Follow-up||3||
48202867|NCT01351272|100820687|FG000|STARTED|Overall Study||19||
48202868|NCT01351272|100820688|FG001|STARTED|Overall Study||16||
48202869|NCT01351272|100820687|FG000|COMPLETED|Overall Study||14||
48202870|NCT01351272|100820688|FG001|COMPLETED|Overall Study||13||
48202871|NCT01351272|100820687|FG000|NOT COMPLETED|Overall Study||5||
48202872|NCT01351272|100820688|FG001|NOT COMPLETED|Overall Study||3||
48202873|NCT04286529|100820689|FG000|STARTED|Overall Study||4||
48202874|NCT04286529|100820690|FG001|STARTED|Overall Study||4||
48202875|NCT04286529|100820691|FG002|STARTED|Overall Study||5||
48202876|NCT04286529|100820692|FG003|STARTED|Overall Study||4||
48202877|NCT04286529|100820689|FG000|COMPLETED|Overall Study||3||
48202878|NCT04286529|100820690|FG001|COMPLETED|Overall Study||1||
48202879|NCT04286529|100820691|FG002|COMPLETED|Overall Study||3||
48202880|NCT04286529|100820692|FG003|COMPLETED|Overall Study||1||
48202881|NCT04286529|100820689|FG000|NOT COMPLETED|Overall Study||1||
48202882|NCT04286529|100820690|FG001|NOT COMPLETED|Overall Study||3||
48202883|NCT04286529|100820691|FG002|NOT COMPLETED|Overall Study||2||
48202884|NCT04286529|100820692|FG003|NOT COMPLETED|Overall Study||3||
48202885|NCT05200247|100820693|FG000|STARTED|Overall Study||11||
48202886|NCT05200247|100820693|FG000|COMPLETED|Overall Study||11||
48202887|NCT05200247|100820693|FG000|NOT COMPLETED|Overall Study||0||
48040185|NCT01989208|100417320|FG000|NOT COMPLETED|800 mg (7 Days)||0||
48202888|NCT00217672|100820694|FG000|STARTED|Allocation||69||
48202889|NCT00217672|100820695|FG001|STARTED|Allocation||7||
48202890|NCT00217672|100820694|FG000|COMPLETED|Allocation||67||
48202891|NCT00217672|100820695|FG001|COMPLETED|Allocation||7||
48202892|NCT00217672|100820694|FG000|NOT COMPLETED|Allocation||2||
48040186|NCT01989208|100417321|FG001|NOT COMPLETED|800 mg (7 Days)||0||
48040187|NCT00313781|100417322|FG000|STARTED|Before Crossover||102||
48040188|NCT00313781|100417323|FG001|STARTED|Before Crossover||102||
48040189|NCT00313781|100417324|FG002|STARTED|Before Crossover||0||
48040190|NCT00313781|100417322|FG000|Treated|Before Crossover||97||
48040191|NCT00313781|100417323|FG001|Treated|Before Crossover||102||
48040192|NCT00313781|100417324|FG002|Treated|Before Crossover||0||
48040193|NCT00313781|100417322|FG000|COMPLETED|Before Crossover||27||
48040194|NCT00313781|100417323|FG001|COMPLETED|Before Crossover||23||
48040195|NCT00313781|100417324|FG002|COMPLETED|Before Crossover||0||
48040196|NCT00313781|100417322|FG000|NOT COMPLETED|Before Crossover||75||
48040197|NCT00313781|100417323|FG001|NOT COMPLETED|Before Crossover||79||
48040198|NCT00313781|100417324|FG002|NOT COMPLETED|Before Crossover||0||
48040199|NCT00313781|100417322|FG000|STARTED|After Crossover||0||
48040200|NCT00313781|100417323|FG001|STARTED|After Crossover||0||
48040201|NCT00313781|100417324|FG002|STARTED|After Crossover||37||
48040202|NCT00313781|100417322|FG000|COMPLETED|After Crossover||0||
48040203|NCT00313781|100417323|FG001|COMPLETED|After Crossover||0||
48040204|NCT00313781|100417324|FG002|COMPLETED|After Crossover||10||
48040205|NCT00313781|100417322|FG000|NOT COMPLETED|After Crossover||0||
48040206|NCT00313781|100417323|FG001|NOT COMPLETED|After Crossover||0||
48040207|NCT00313781|100417324|FG002|NOT COMPLETED|After Crossover||27||
48040208|NCT03602560|100417325|FG000|STARTED|Overall Study||89||
48040209|NCT03602560|100417326|FG001|STARTED|Overall Study||89||
48040210|NCT03602560|100417327|FG002|STARTED|Overall Study||87||
48040211|NCT03602560|100417325|FG000|COMPLETED|Overall Study||1||
48040212|NCT03602560|100417326|FG001|COMPLETED|Overall Study||1||
48040213|NCT03602560|100417327|FG002|COMPLETED|Overall Study||1||
48040214|NCT03602560|100417325|FG000|NOT COMPLETED|Overall Study||88||
48040215|NCT03602560|100417326|FG001|NOT COMPLETED|Overall Study||88||
48040216|NCT03602560|100417327|FG002|NOT COMPLETED|Overall Study||86||
48040217|NCT01253811|100417328|FG000|STARTED|Overall Study||6||
48040218|NCT01253811|100417328|FG000|Exposed|Overall Study||6||
48040219|NCT01253811|100417328|FG000|COMPLETED|Overall Study||5||
48040220|NCT01253811|100417328|FG000|NOT COMPLETED|Overall Study||1||
48040221|NCT02577887|100417329|FG000|STARTED|Overall Study||2101||
48040222|NCT02577887|100417329|FG000|6 Month Follow-up|Overall Study||1938||
48040223|NCT02577887|100417329|FG000|COMPLETED|Overall Study||1803|The last follow-up was at 12 months post implant.|
48040224|NCT02577887|100417329|FG000|NOT COMPLETED|Overall Study||298||
48040225|NCT01270802|100417330|FG000|STARTED|Overall Study||15||
48040226|NCT01270802|100417331|FG001|STARTED|Overall Study||15||
48040227|NCT01270802|100417330|FG000|COMPLETED|Overall Study||13||
48040228|NCT01270802|100417331|FG001|COMPLETED|Overall Study||14||
48040229|NCT01270802|100417330|FG000|NOT COMPLETED|Overall Study||2||
48040230|NCT01270802|100417331|FG001|NOT COMPLETED|Overall Study||1||
48040231|NCT04129151|100417332|FG000|STARTED|Overall Study||10||
48040232|NCT04129151|100417332|FG000|COMPLETED|Overall Study||1||
48040233|NCT04129151|100417332|FG000|NOT COMPLETED|Overall Study||9||
48040234|NCT03708393|100417333|FG000|STARTED|Overall Study||155||
48040235|NCT03708393|100417333|FG000|COMPLETED|Overall Study||155||
48040236|NCT03708393|100417333|FG000|NOT COMPLETED|Overall Study||0||
48040237|NCT00562315|100417334|FG000|STARTED|Overall Study||93||
48040238|NCT00562315|100417334|FG000|COMPLETED|Overall Study||93||
48040239|NCT00562315|100417334|FG000|NOT COMPLETED|Overall Study||0||
48040240|NCT00870584|100420035|FG000|STARTED|Overall Study||136||
48040241|NCT00870584|100420036|FG001|STARTED|Overall Study||135||
48040242|NCT00870584|100420035|FG000|COMPLETED|Overall Study||120||
48040243|NCT00870584|100420036|FG001|COMPLETED|Overall Study||122||
48040244|NCT00870584|100420035|FG000|NOT COMPLETED|Overall Study||16||
48040245|NCT00870584|100420036|FG001|NOT COMPLETED|Overall Study||13||
48040246|NCT01771809|100420037|FG000|STARTED|Overall Study||164||
48040247|NCT01771809|100420038|FG001|STARTED|Overall Study||166||
48040248|NCT01771809|100420037|FG000|COMPLETED|Overall Study||93||
48040249|NCT01771809|100420038|FG001|COMPLETED|Overall Study||83||
48040250|NCT01771809|100420037|FG000|NOT COMPLETED|Overall Study||71||
48040251|NCT01771809|100420038|FG001|NOT COMPLETED|Overall Study||83||
48040252|NCT02364336|100420039|FG000|STARTED|Overall Study||1||
48040253|NCT02364336|100420040|FG001|STARTED|Overall Study||12||
48040254|NCT02364336|100420039|FG000|6 Hours Post First Peginterferon Inject|Overall Study||1||
48040255|NCT02364336|100420040|FG001|6 Hours Post First Peginterferon Inject|Overall Study||12||
48040256|NCT02364336|100420039|FG000|End of Peginterferon Treatment|Overall Study||1||
48040257|NCT02364336|100420040|FG001|End of Peginterferon Treatment|Overall Study||11||
48040258|NCT02364336|100420039|FG000|24 Weeks After End of Peginterferon|Overall Study||1||
48040259|NCT02364336|100420040|FG001|24 Weeks After End of Peginterferon|Overall Study||11||
48040260|NCT02364336|100420039|FG000|48 Weeks After End of Peginterferon|Overall Study||1||
48040261|NCT02364336|100420040|FG001|48 Weeks After End of Peginterferon|Overall Study||10||
48040262|NCT02364336|100420039|FG000|COMPLETED|Overall Study||1||
48040263|NCT02364336|100420040|FG001|COMPLETED|Overall Study||11||
48040264|NCT02364336|100420039|FG000|NOT COMPLETED|Overall Study||0||
48040265|NCT02364336|100420040|FG001|NOT COMPLETED|Overall Study||1||
48040266|NCT00811642|100420041|FG000|STARTED|Overall Study||62||
48040267|NCT00811642|100420041|FG000|COMPLETED|Overall Study||47||
48040268|NCT00811642|100420041|FG000|NOT COMPLETED|Overall Study||15||
48040269|NCT01248104|100420042|FG000|STARTED|Overall Study||50||
48040270|NCT01248104|100420043|FG001|STARTED|Overall Study||50||
48040271|NCT01248104|100420042|FG000|COMPLETED|Overall Study||40||
48040272|NCT01248104|100420043|FG001|COMPLETED|Overall Study||42||
48040273|NCT01248104|100420042|FG000|NOT COMPLETED|Overall Study||10||
48040274|NCT01248104|100420043|FG001|NOT COMPLETED|Overall Study||8||
48040275|NCT00428584|100420044|FG000|STARTED|Comparative Phase||65||
48040276|NCT00428584|100420045|FG001|STARTED|Comparative Phase||64||
48040277|NCT00428584|100420044|FG000|COMPLETED|Comparative Phase||56||
48040278|NCT00428584|100420045|FG001|COMPLETED|Comparative Phase||63||
48040279|NCT00428584|100420044|FG000|NOT COMPLETED|Comparative Phase||9||
48040280|NCT00428584|100420045|FG001|NOT COMPLETED|Comparative Phase||1||
48040281|NCT00428584|100420044|FG000|STARTED|Extension Phase||56||
48040282|NCT00428584|100420045|FG001|STARTED|Extension Phase||63||
48040283|NCT00428584|100420044|FG000|COMPLETED|Extension Phase||35||
48040284|NCT00428584|100420045|FG001|COMPLETED|Extension Phase||34||
48040285|NCT00428584|100420044|FG000|NOT COMPLETED|Extension Phase||21||
48040286|NCT00428584|100420045|FG001|NOT COMPLETED|Extension Phase||29||
48040287|NCT01049945|100420046|FG000|STARTED|Overall Study||3||
48040288|NCT01049945|100420047|FG001|STARTED|Overall Study||6||
48040289|NCT01049945|100420048|FG002|STARTED|Overall Study||3||
48040290|NCT01049945|100420049|FG003|STARTED|Overall Study||6||
48040291|NCT01049945|100420050|FG004|STARTED|Overall Study||3||
48040292|NCT01049945|100420051|FG005|STARTED|Overall Study||49||
48040293|NCT01049945|100420046|FG000|COMPLETED|Overall Study||3||
48040294|NCT01049945|100420047|FG001|COMPLETED|Overall Study||6||
48040295|NCT01049945|100420048|FG002|COMPLETED|Overall Study||3||
48040296|NCT01049945|100420049|FG003|COMPLETED|Overall Study||6||
48040297|NCT01049945|100420050|FG004|COMPLETED|Overall Study||3||
48040298|NCT01049945|100420051|FG005|COMPLETED|Overall Study||49||
48040299|NCT01049945|100420046|FG000|NOT COMPLETED|Overall Study||0||
48040300|NCT01049945|100420047|FG001|NOT COMPLETED|Overall Study||0||
48040301|NCT01049945|100420048|FG002|NOT COMPLETED|Overall Study||0||
48040302|NCT01049945|100420049|FG003|NOT COMPLETED|Overall Study||0||
48040303|NCT01049945|100420050|FG004|NOT COMPLETED|Overall Study||0||
48040304|NCT01049945|100420051|FG005|NOT COMPLETED|Overall Study||0||
48040305|NCT01087788|100420052|FG000|STARTED|24-weeks Double-blind Period||136||
48040306|NCT01087788|100420053|FG001|STARTED|24-weeks Double-blind Period||138||
48040307|NCT01087788|100420054|FG002|STARTED|24-weeks Double-blind Period||135||
48040308|NCT01087788|100420052|FG000|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period||30||
48040309|NCT01087788|100420053|FG001|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period||0||
48040310|NCT01087788|100420054|FG002|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period||0||
48040311|NCT01087788|100420052|FG000|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period||29||
48040312|NCT01087788|100420053|FG001|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period||0||
48040313|NCT01087788|100420054|FG002|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period||0||
48040314|NCT01087788|100420052|FG000|COMPLETED|24-weeks Double-blind Period||120||
48040315|NCT01087788|100420053|FG001|COMPLETED|24-weeks Double-blind Period||128||
48040316|NCT01087788|100420054|FG002|COMPLETED|24-weeks Double-blind Period||120||
48040317|NCT01087788|100420052|FG000|NOT COMPLETED|24-weeks Double-blind Period||16||
48040318|NCT01087788|100420053|FG001|NOT COMPLETED|24-weeks Double-blind Period||10||
48040319|NCT01087788|100420054|FG002|NOT COMPLETED|24-weeks Double-blind Period||15||
48040320|NCT01087788|100420052|FG000|STARTED|24-weeks Dose-blind Period||120||
48040321|NCT01087788|100420053|FG001|STARTED|24-weeks Dose-blind Period||128||
48040322|NCT01087788|100420054|FG002|STARTED|24-weeks Dose-blind Period||120||
48040323|NCT01087788|100420052|FG000|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period||60||
48040324|NCT01087788|100420053|FG001|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period||0||
48040325|NCT01087788|100420054|FG002|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period||0||
48040326|NCT01087788|100420052|FG000|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period||60||
48040327|NCT01087788|100420053|FG001|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period||0||
48040328|NCT01087788|100420054|FG002|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period||0||
48040329|NCT01087788|100420052|FG000|COMPLETED|24-weeks Dose-blind Period||113||
48040330|NCT01087788|100420053|FG001|COMPLETED|24-weeks Dose-blind Period||123||
48040331|NCT01087788|100420054|FG002|COMPLETED|24-weeks Dose-blind Period||114||
48040332|NCT01087788|100420052|FG000|NOT COMPLETED|24-weeks Dose-blind Period||7||
48040333|NCT01087788|100420053|FG001|NOT COMPLETED|24-weeks Dose-blind Period||5||
48040334|NCT01087788|100420054|FG002|NOT COMPLETED|24-weeks Dose-blind Period||6||
48040335|NCT01087788|100420052|FG000|STARTED|Open-Label Period (OL-P)||111||
48040336|NCT01087788|100420053|FG001|STARTED|Open-Label Period (OL-P)||121||
48040337|NCT01087788|100420054|FG002|STARTED|Open-Label Period (OL-P)||114||
48040338|NCT01087788|100420052|FG000|COMPLETED|Open-Label Period (OL-P)||81||
48040339|NCT01087788|100420053|FG001|COMPLETED|Open-Label Period (OL-P)||97||
48040340|NCT01087788|100420054|FG002|COMPLETED|Open-Label Period (OL-P)||86||
48040341|NCT01087788|100420052|FG000|NOT COMPLETED|Open-Label Period (OL-P)||30||
48040342|NCT01087788|100420053|FG001|NOT COMPLETED|Open-Label Period (OL-P)||24||
48040343|NCT01087788|100420054|FG002|NOT COMPLETED|Open-Label Period (OL-P)||28||
48040344|NCT01022398|100420055|FG000|STARTED|Overall Study||2||
48040345|NCT01022398|100420056|FG001|STARTED|Overall Study||2||
48040346|NCT01022398|100420055|FG000|COMPLETED|Overall Study||0||
48040347|NCT01022398|100420056|FG001|COMPLETED|Overall Study||0||
48040348|NCT01022398|100420055|FG000|NOT COMPLETED|Overall Study||2||
48040349|NCT01022398|100420056|FG001|NOT COMPLETED|Overall Study||2||
48040350|NCT03225859|100420057|FG000|STARTED|Overall Study||12||
48040351|NCT03225859|100420057|FG000|COMPLETED|Overall Study||11||
48040352|NCT03225859|100420057|FG000|NOT COMPLETED|Overall Study||1||
48040353|NCT01431638|100420058|FG000|STARTED|Overall Study||133|Core study|
48040354|NCT01431638|100420059|FG001|STARTED|Overall Study||132|Core study|
48040355|NCT01431638|100420060|FG002|STARTED|Overall Study||132|Core study|
48040356|NCT01431638|100420058|FG000|Completed Core Study|Overall Study||124||
48040357|NCT01431638|100420059|FG001|Completed Core Study|Overall Study||117||
48040358|NCT01431638|100420060|FG002|Completed Core Study|Overall Study||108||
48040359|NCT01431638|100420058|FG000|Entered Extension 1 Study|Overall Study||85||
48040360|NCT01431638|100420059|FG001|Entered Extension 1 Study|Overall Study||71||
48040361|NCT01431638|100420060|FG002|Entered Extension 1 Study|Overall Study||76||
48040362|NCT01431638|100420058|FG000|COMPLETED|Overall Study||67|Completed Extension Study|
48040363|NCT01431638|100420059|FG001|COMPLETED|Overall Study||61|Completed Extension Study|
48040364|NCT01431638|100420060|FG002|COMPLETED|Overall Study||70|Completed Extension Study|
48040365|NCT01431638|100420058|FG000|NOT COMPLETED|Overall Study||66||
48040366|NCT01431638|100420059|FG001|NOT COMPLETED|Overall Study||71||
48040367|NCT01431638|100420060|FG002|NOT COMPLETED|Overall Study||62||
48040368|NCT01790243|100420061|FG000|STARTED|Overall Study||1029||
48040369|NCT01790243|100420062|FG001|STARTED|Overall Study||160||
48040370|NCT01790243|100420061|FG000|COMPLETED|Overall Study||739||
48040371|NCT01790243|100420062|FG001|COMPLETED|Overall Study||117||
48040372|NCT01790243|100420061|FG000|NOT COMPLETED|Overall Study||290||
48040373|NCT01790243|100420062|FG001|NOT COMPLETED|Overall Study||43||
48040374|NCT00883688|100420063|FG000|STARTED|Overall Study||24||
48040375|NCT00883688|100420063|FG000|COMPLETED|Overall Study||22||
48040376|NCT00883688|100420063|FG000|NOT COMPLETED|Overall Study||2||
48040377|NCT05111301|100420064|FG000|STARTED|Overall Study||13||
48040378|NCT05111301|100420065|FG001|STARTED|Overall Study||17||
48040379|NCT05111301|100420064|FG000|COMPLETED|Overall Study||13||
48040380|NCT05111301|100420065|FG001|COMPLETED|Overall Study||17||
48040381|NCT05111301|100420064|FG000|NOT COMPLETED|Overall Study||0||
48040382|NCT05111301|100420065|FG001|NOT COMPLETED|Overall Study||0||
48040383|NCT00689260|100420066|FG000|STARTED|Overall Study||21||
48040384|NCT00689260|100420067|FG001|STARTED|Overall Study||21||
48040385|NCT00689260|100420066|FG000|COMPLETED|Overall Study||19||
48040386|NCT00689260|100420067|FG001|COMPLETED|Overall Study||21||
48040387|NCT00689260|100420066|FG000|NOT COMPLETED|Overall Study||2||
48040388|NCT00689260|100420067|FG001|NOT COMPLETED|Overall Study||0||
48040389|NCT04497883|100420068|FG000|STARTED|Treatment Period 1 (2 Days)||12||
48040390|NCT04497883|100420069|FG001|STARTED|Treatment Period 1 (2 Days)||12||
48040391|NCT04497883|100420070|FG002|STARTED|Treatment Period 1 (2 Days)||0||
48040392|NCT04497883|100420071|FG003|STARTED|Treatment Period 1 (2 Days)||0||
48040393|NCT04497883|100420068|FG000|COMPLETED|Treatment Period 1 (2 Days)||12||
48040394|NCT04497883|100420069|FG001|COMPLETED|Treatment Period 1 (2 Days)||12||
48040395|NCT04497883|100420070|FG002|COMPLETED|Treatment Period 1 (2 Days)||0||
48040396|NCT04497883|100420071|FG003|COMPLETED|Treatment Period 1 (2 Days)||0||
48040397|NCT04497883|100420068|FG000|NOT COMPLETED|Treatment Period 1 (2 Days)||0||
48040398|NCT04497883|100420069|FG001|NOT COMPLETED|Treatment Period 1 (2 Days)||0||
48040399|NCT04497883|100420070|FG002|NOT COMPLETED|Treatment Period 1 (2 Days)||0||
48040400|NCT04497883|100420071|FG003|NOT COMPLETED|Treatment Period 1 (2 Days)||0||
48040401|NCT04497883|100420068|FG000|STARTED|Washout Period 1 (72 Hours)||12||
48040402|NCT04497883|100420069|FG001|STARTED|Washout Period 1 (72 Hours)||12||
48040403|NCT04497883|100420070|FG002|STARTED|Washout Period 1 (72 Hours)||0||
48040404|NCT04497883|100420071|FG003|STARTED|Washout Period 1 (72 Hours)||0||
48040405|NCT04497883|100420068|FG000|COMPLETED|Washout Period 1 (72 Hours)||12||
48040406|NCT04497883|100420069|FG001|COMPLETED|Washout Period 1 (72 Hours)||12||
48040407|NCT04497883|100420070|FG002|COMPLETED|Washout Period 1 (72 Hours)||0||
48040408|NCT04497883|100420071|FG003|COMPLETED|Washout Period 1 (72 Hours)||0||
48040409|NCT04497883|100420068|FG000|NOT COMPLETED|Washout Period 1 (72 Hours)||0||
48040410|NCT04497883|100420069|FG001|NOT COMPLETED|Washout Period 1 (72 Hours)||0||
48040411|NCT04497883|100420070|FG002|NOT COMPLETED|Washout Period 1 (72 Hours)||0||
48040412|NCT04497883|100420071|FG003|NOT COMPLETED|Washout Period 1 (72 Hours)||0||
48040413|NCT04497883|100420068|FG000|STARTED|Treatment Period 2 (2 Days)||0||
48040414|NCT04497883|100420069|FG001|STARTED|Treatment Period 2 (2 Days)||0||
48040415|NCT04497883|100420070|FG002|STARTED|Treatment Period 2 (2 Days)||6||
48040416|NCT04497883|100420071|FG003|STARTED|Treatment Period 2 (2 Days)||6||
48040417|NCT04497883|100420068|FG000|COMPLETED|Treatment Period 2 (2 Days)||0||
48040418|NCT04497883|100420069|FG001|COMPLETED|Treatment Period 2 (2 Days)||0||
48040419|NCT04497883|100420070|FG002|COMPLETED|Treatment Period 2 (2 Days)||6||
48040420|NCT04497883|100420071|FG003|COMPLETED|Treatment Period 2 (2 Days)||6||
48040421|NCT04497883|100420068|FG000|NOT COMPLETED|Treatment Period 2 (2 Days)||0||
48040422|NCT04497883|100420069|FG001|NOT COMPLETED|Treatment Period 2 (2 Days)||0||
48040423|NCT04497883|100420070|FG002|NOT COMPLETED|Treatment Period 2 (2 Days)||0||
48040424|NCT04497883|100420071|FG003|NOT COMPLETED|Treatment Period 2 (2 Days)||0||
48040425|NCT04497883|100420068|FG000|STARTED|Washout Period 2 (72 Hours)||0||
48040426|NCT04497883|100420069|FG001|STARTED|Washout Period 2 (72 Hours)||0||
48040427|NCT04497883|100420070|FG002|STARTED|Washout Period 2 (72 Hours)||6||
48040428|NCT04497883|100420071|FG003|STARTED|Washout Period 2 (72 Hours)||6||
48040429|NCT04497883|100420068|FG000|COMPLETED|Washout Period 2 (72 Hours)||0||
48040430|NCT04497883|100420069|FG001|COMPLETED|Washout Period 2 (72 Hours)||0||
48040431|NCT04497883|100420070|FG002|COMPLETED|Washout Period 2 (72 Hours)||6||
48040432|NCT04497883|100420071|FG003|COMPLETED|Washout Period 2 (72 Hours)||6||
48040433|NCT04497883|100420068|FG000|NOT COMPLETED|Washout Period 2 (72 Hours)||0||
48040434|NCT04497883|100420069|FG001|NOT COMPLETED|Washout Period 2 (72 Hours)||0||
48040435|NCT04497883|100420070|FG002|NOT COMPLETED|Washout Period 2 (72 Hours)||0||
48040436|NCT04497883|100420071|FG003|NOT COMPLETED|Washout Period 2 (72 Hours)||0||
48040437|NCT04497883|100420068|FG000|STARTED|Treatment Period 3 (2 Days)||0||
48040438|NCT04497883|100420069|FG001|STARTED|Treatment Period 3 (2 Days)||0||
48040439|NCT04497883|100420070|FG002|STARTED|Treatment Period 3 (2 Days)||6||
48040440|NCT04497883|100420071|FG003|STARTED|Treatment Period 3 (2 Days)||6||
48040441|NCT04497883|100420068|FG000|COMPLETED|Treatment Period 3 (2 Days)||0||
48040442|NCT04497883|100420069|FG001|COMPLETED|Treatment Period 3 (2 Days)||0||
48040443|NCT04497883|100420070|FG002|COMPLETED|Treatment Period 3 (2 Days)||6||
48040444|NCT04497883|100420071|FG003|COMPLETED|Treatment Period 3 (2 Days)||6||
48040445|NCT04497883|100420068|FG000|NOT COMPLETED|Treatment Period 3 (2 Days)||0||
48040446|NCT04497883|100420069|FG001|NOT COMPLETED|Treatment Period 3 (2 Days)||0||
48040447|NCT04497883|100420070|FG002|NOT COMPLETED|Treatment Period 3 (2 Days)||0||
48040448|NCT04497883|100420071|FG003|NOT COMPLETED|Treatment Period 3 (2 Days)||0||
48040449|NCT02331095|100420072|FG000|STARTED|Overall Study||11||
48040450|NCT02331095|100420073|FG001|STARTED|Overall Study||10||
48040451|NCT02331095|100420072|FG000|COMPLETED|Overall Study||7||
48040452|NCT02331095|100420073|FG001|COMPLETED|Overall Study||9||
48040453|NCT02331095|100420072|FG000|NOT COMPLETED|Overall Study||4||
48040454|NCT02331095|100420073|FG001|NOT COMPLETED|Overall Study||1||
48040455|NCT00906971|100420074|FG000|STARTED|Overall Study||36||
48040456|NCT00906971|100420075|FG001|STARTED|Overall Study||36||
48040457|NCT00906971|100420074|FG000|COMPLETED|Overall Study||28||
48040458|NCT00906971|100420075|FG001|COMPLETED|Overall Study||33||
48040459|NCT00906971|100420074|FG000|NOT COMPLETED|Overall Study||8||
48040460|NCT00906971|100420075|FG001|NOT COMPLETED|Overall Study||3||
48040461|NCT01402427|100420076|FG000|STARTED|Overall Study||297||
48040462|NCT01402427|100420077|FG001|STARTED|Overall Study||294||
48040463|NCT01402427|100420076|FG000|COMPLETED|Overall Study||297||
48040464|NCT01402427|100420077|FG001|COMPLETED|Overall Study||294||
48040465|NCT01402427|100420076|FG000|NOT COMPLETED|Overall Study||0||
48040466|NCT01402427|100420077|FG001|NOT COMPLETED|Overall Study||0||
48040467|NCT01463007|100420078|FG000|STARTED|Overall Study||41||
48040468|NCT01463007|100420078|FG000|COMPLETED|Overall Study||40||
48040469|NCT01463007|100420078|FG000|NOT COMPLETED|Overall Study||1||
48040470|NCT02910505|100420079|FG000|STARTED|Overall Study||8||
48040471|NCT02910505|100420079|FG000|COMPLETED|Overall Study||1||
48040472|NCT02910505|100420079|FG000|NOT COMPLETED|Overall Study||7||
48040473|NCT03459690|100420080|FG000|STARTED|Overall Study||4||
48040474|NCT03459690|100420081|FG001|STARTED|Overall Study||9||
48040475|NCT03459690|100420080|FG000|COMPLETED|Overall Study||3||
48040476|NCT03459690|100420081|FG001|COMPLETED|Overall Study||7||
48040477|NCT03459690|100420080|FG000|NOT COMPLETED|Overall Study||1||
48040478|NCT03459690|100420081|FG001|NOT COMPLETED|Overall Study||2||
48040479|NCT00561977|100420082|FG000|STARTED|Overall Study||12||
48040480|NCT00561977|100420083|FG001|STARTED|Overall Study||12||
48040481|NCT00561977|100420084|FG002|STARTED|Overall Study||12||
48040482|NCT00561977|100420082|FG000|COMPLETED|Overall Study||12||
48040483|NCT00561977|100420083|FG001|COMPLETED|Overall Study||9||
48040484|NCT00561977|100420084|FG002|COMPLETED|Overall Study||10||
48040485|NCT00561977|100420082|FG000|NOT COMPLETED|Overall Study||0||
48040486|NCT00561977|100420083|FG001|NOT COMPLETED|Overall Study||3||
48040487|NCT00561977|100420084|FG002|NOT COMPLETED|Overall Study||2||
48040488|NCT00129311|100420085|FG000|STARTED|Overall Study||51||
48040489|NCT00129311|100420086|FG001|STARTED|Overall Study||50||
48040490|NCT00129311|100420085|FG000|COMPLETED|Overall Study||39||
48040491|NCT00129311|100420086|FG001|COMPLETED|Overall Study||31||
48040492|NCT00129311|100420085|FG000|NOT COMPLETED|Overall Study||12||
48040493|NCT00129311|100420086|FG001|NOT COMPLETED|Overall Study||19||
48040494|NCT01794338|100420087|FG000|STARTED|Overall Study||8||
48040495|NCT01794338|100420088|FG001|STARTED|Overall Study||9||
48040496|NCT01794338|100420087|FG000|Screen Failure|Overall Study||3||
48040497|NCT01794338|100420088|FG001|Screen Failure|Overall Study||3||
48040498|NCT01794338|100420087|FG000|1 Month Follow Up|Overall Study||6||
48040499|NCT01794338|100420088|FG001|1 Month Follow Up|Overall Study||9||
48040500|NCT01794338|100420087|FG000|6 Month Follow Up|Overall Study||0||
48040501|NCT01794338|100420088|FG001|6 Month Follow Up|Overall Study||0||
48040502|NCT01794338|100420087|FG000|12 Month Follow Up|Overall Study||0||
48040503|NCT01794338|100420088|FG001|12 Month Follow Up|Overall Study||0||
48040504|NCT01794338|100420087|FG000|24 Month Follow Up|Overall Study||0||
48040505|NCT01794338|100420088|FG001|24 Month Follow Up|Overall Study||0||
48040506|NCT01794338|100420087|FG000|36 Month Follow Up|Overall Study||0||
48040507|NCT01794338|100420088|FG001|36 Month Follow Up|Overall Study||0||
48040508|NCT01794338|100420087|FG000|COMPLETED|Overall Study||0||
48040509|NCT01794338|100420088|FG001|COMPLETED|Overall Study||0||
48040510|NCT01794338|100420087|FG000|NOT COMPLETED|Overall Study||8||
48040511|NCT01794338|100420088|FG001|NOT COMPLETED|Overall Study||9||
48040512|NCT01395784|100420089|FG000|STARTED|Overall Study||32||
48040513|NCT01395784|100420089|FG000|COMPLETED|Overall Study||17||
48040514|NCT01395784|100420089|FG000|NOT COMPLETED|Overall Study||15||
48040515|NCT00878436|100420090|FG000|STARTED|Overall Study||28||
48040516|NCT00878436|100420091|FG001|STARTED|Overall Study||24||
48040517|NCT00878436|100420090|FG000|Completed 2 Cycles|Overall Study||21||
48040518|NCT00878436|100420091|FG001|Completed 2 Cycles|Overall Study||20||
48040519|NCT00878436|100420090|FG000|6 Months|Overall Study||8||
48040520|NCT00878436|100420091|FG001|6 Months|Overall Study||0||
48040521|NCT00878436|100420090|FG000|COMPLETED|Overall Study||5||
48040522|NCT00878436|100420091|FG001|COMPLETED|Overall Study||0||
48040523|NCT00878436|100420090|FG000|NOT COMPLETED|Overall Study||23||
48040524|NCT00878436|100420091|FG001|NOT COMPLETED|Overall Study||24||
48040525|NCT01888432|100420092|FG000|STARTED|12-month Analysis (FAS)||142||
48040526|NCT01888432|100420093|FG001|STARTED|12-month Analysis (FAS)||142||
48040527|NCT01888432|100420092|FG000|COMPLETED|12-month Analysis (FAS)||131||
48040528|NCT01888432|100420093|FG001|COMPLETED|12-month Analysis (FAS)||133||
48040529|NCT01888432|100420092|FG000|NOT COMPLETED|12-month Analysis (FAS)||11||
48040530|NCT01888432|100420093|FG001|NOT COMPLETED|12-month Analysis (FAS)||9||
48040531|NCT01888432|100420092|FG000|STARTED|24-month Analysis (FAS)||142||
48040532|NCT01888432|100420093|FG001|STARTED|24-month Analysis (FAS)||142||
48040533|NCT01888432|100420092|FG000|COMPLETED|24-month Analysis (FAS)||125||
48040534|NCT01888432|100420093|FG001|COMPLETED|24-month Analysis (FAS)||125||
48040535|NCT01888432|100420092|FG000|NOT COMPLETED|24-month Analysis (FAS)||17||
48040536|NCT01888432|100420093|FG001|NOT COMPLETED|24-month Analysis (FAS)||17||
48040537|NCT01888432|100420092|FG000|STARTED|36-month Analysis (Extension)||13||
48040538|NCT01888432|100420093|FG001|STARTED|36-month Analysis (Extension)||5||
48040539|NCT01888432|100420092|FG000|COMPLETED|36-month Analysis (Extension)||12||
48040540|NCT01888432|100420093|FG001|COMPLETED|36-month Analysis (Extension)||5||
48040541|NCT01888432|100420092|FG000|NOT COMPLETED|36-month Analysis (Extension)||1||
48040542|NCT01888432|100420093|FG001|NOT COMPLETED|36-month Analysis (Extension)||0||
48040543|NCT01713933|100420094|FG000|STARTED|Overall Study||37||
48040544|NCT01713933|100420094|FG000|COMPLETED|Overall Study||31||
48040545|NCT01713933|100420094|FG000|NOT COMPLETED|Overall Study||6||
48040546|NCT00523367|100420095|FG000|STARTED|Overall Study||25||
48040547|NCT00523367|100420095|FG000|COMPLETED|Overall Study||2||
48040548|NCT00523367|100420095|FG000|NOT COMPLETED|Overall Study||23||
48040549|NCT02793622|100420096|FG000|STARTED|Overall Study||391||
48040550|NCT02793622|100420097|FG001|STARTED|Overall Study||391||
48040551|NCT02793622|100420096|FG000|COMPLETED|Overall Study||338||
48040552|NCT02793622|100420097|FG001|COMPLETED|Overall Study||349||
48040553|NCT02793622|100420096|FG000|NOT COMPLETED|Overall Study||53||
48040554|NCT02793622|100420097|FG001|NOT COMPLETED|Overall Study||42||
48040555|NCT03320824|100420098|FG000|STARTED|Overall Study||184||
48040556|NCT03320824|100420099|FG001|STARTED|Overall Study||89||
48040557|NCT03320824|100420098|FG000|COMPLETED|Overall Study||166||
48040558|NCT03320824|100420099|FG001|COMPLETED|Overall Study||85||
48040559|NCT03320824|100420098|FG000|NOT COMPLETED|Overall Study||18||
48040560|NCT03320824|100420099|FG001|NOT COMPLETED|Overall Study||4||
48040561|NCT02720107|100420100|FG000|STARTED|Overall Study||130||
48040562|NCT02720107|100420100|FG000|COMPLETED|Overall Study||130||
48040563|NCT02720107|100420100|FG000|NOT COMPLETED|Overall Study||0||
48040564|NCT02015221|100420101|FG000|STARTED|Overall Study||41||
48040565|NCT02015221|100420102|FG001|STARTED|Overall Study||40||
48040566|NCT02015221|100420101|FG000|COMPLETED|Overall Study||32||
48040567|NCT02015221|100420102|FG001|COMPLETED|Overall Study||34||
48040568|NCT02015221|100420101|FG000|NOT COMPLETED|Overall Study||9||
48040569|NCT02015221|100420102|FG001|NOT COMPLETED|Overall Study||6||
48040570|NCT02387476|100420103|FG000|STARTED|Overall Study||25||
48040571|NCT02387476|100420104|FG001|STARTED|Overall Study||22||
48040572|NCT02387476|100420103|FG000|COMPLETED|Overall Study||19||
48040573|NCT02387476|100420104|FG001|COMPLETED|Overall Study||17||
48040574|NCT02387476|100420103|FG000|NOT COMPLETED|Overall Study||6||
48040575|NCT02387476|100420104|FG001|NOT COMPLETED|Overall Study||5||
48040576|NCT00183729|100420105|FG000|STARTED|Overall Study||17||
48040577|NCT00183729|100420106|FG001|STARTED|Overall Study||18||
48040578|NCT00183729|100420105|FG000|COMPLETED|Overall Study||14||
48040579|NCT00183729|100420106|FG001|COMPLETED|Overall Study||13||
48040580|NCT00183729|100420105|FG000|NOT COMPLETED|Overall Study||3||
48040581|NCT00183729|100420106|FG001|NOT COMPLETED|Overall Study||5||
48040582|NCT02929498|100420107|FG000|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||5||
48040583|NCT02929498|100420108|FG001|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||0||
48040584|NCT02929498|100420109|FG002|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||0||
48040585|NCT02929498|100420107|FG000|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0||
48040586|NCT02929498|100420108|FG001|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0||
48040587|NCT02929498|100420109|FG002|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0||
48040588|NCT02929498|100420107|FG000|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||5||
48040589|NCT02929498|100420108|FG001|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0||
48040590|NCT02929498|100420109|FG002|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0||
48040591|NCT02929498|100420107|FG000|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0||
48040592|NCT02929498|100420108|FG001|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0||
48040593|NCT02929498|100420109|FG002|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0||
48040594|NCT02929498|100420107|FG000|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0||
48040595|NCT02929498|100420108|FG001|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0||
48040596|NCT02929498|100420109|FG002|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0||
48040597|NCT02929498|100420107|FG000|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0||
48040598|NCT02929498|100420108|FG001|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0||
48040599|NCT02929498|100420109|FG002|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0||
48040600|NCT01512667|100420110|FG000|STARTED|Overall Study||13||
48040601|NCT01512667|100420111|FG001|STARTED|Overall Study||12||
48040602|NCT01512667|100420110|FG000|Matched Participants|Overall Study||12||
48040603|NCT01512667|100420111|FG001|Matched Participants|Overall Study||12||
48040604|NCT01512667|100420110|FG000|Unmatched Participants|Overall Study||1||
48040605|NCT01512667|100420111|FG001|Unmatched Participants|Overall Study||0||
48040606|NCT01512667|100420110|FG000|COMPLETED|Overall Study||13||
48040607|NCT01512667|100420111|FG001|COMPLETED|Overall Study||12||
48040608|NCT01512667|100420110|FG000|NOT COMPLETED|Overall Study||0||
48040609|NCT01512667|100420111|FG001|NOT COMPLETED|Overall Study||0||
48040610|NCT04121078|100420112|FG000|STARTED|Study Period 1 (1 Day)||6||
48040611|NCT04121078|100420113|FG001|STARTED|Study Period 1 (1 Day)||6||
48040612|NCT04121078|100420112|FG000|COMPLETED|Study Period 1 (1 Day)||6||
48040613|NCT04121078|100420113|FG001|COMPLETED|Study Period 1 (1 Day)||6||
48040614|NCT04121078|100420112|FG000|NOT COMPLETED|Study Period 1 (1 Day)||0||
48040615|NCT04121078|100420113|FG001|NOT COMPLETED|Study Period 1 (1 Day)||0||
48040616|NCT04121078|100420112|FG000|STARTED|Washout Period (at Least 7 Days)||6||
48040617|NCT04121078|100420113|FG001|STARTED|Washout Period (at Least 7 Days)||6||
48040618|NCT04121078|100420112|FG000|COMPLETED|Washout Period (at Least 7 Days)||6||
48040619|NCT04121078|100420113|FG001|COMPLETED|Washout Period (at Least 7 Days)||6||
48040620|NCT04121078|100420112|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48040621|NCT04121078|100420113|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48040622|NCT04121078|100420112|FG000|STARTED|Study Period 2 (1 Day)||6||
48040623|NCT04121078|100420113|FG001|STARTED|Study Period 2 (1 Day)||6||
48040624|NCT04121078|100420112|FG000|COMPLETED|Study Period 2 (1 Day)||6||
48040625|NCT04121078|100420113|FG001|COMPLETED|Study Period 2 (1 Day)||6||
48040626|NCT04121078|100420112|FG000|NOT COMPLETED|Study Period 2 (1 Day)||0||
48040627|NCT04121078|100420113|FG001|NOT COMPLETED|Study Period 2 (1 Day)||0||
48040628|NCT00270842|100420114|FG000|STARTED|Overall Study||33||
48040629|NCT00270842|100420115|FG001|STARTED|Overall Study||34||
48040630|NCT00270842|100420116|FG002|STARTED|Overall Study||34||
48040631|NCT00270842|100420114|FG000|COMPLETED|Overall Study||18||
48040632|NCT00270842|100420115|FG001|COMPLETED|Overall Study||18||
48040633|NCT00270842|100420116|FG002|COMPLETED|Overall Study||18||
48040634|NCT00270842|100420114|FG000|NOT COMPLETED|Overall Study||15||
48040635|NCT00270842|100420115|FG001|NOT COMPLETED|Overall Study||16||
48040636|NCT00270842|100420116|FG002|NOT COMPLETED|Overall Study||16||
48040637|NCT01155167|100420117|FG000|STARTED|Overall Study||43||
48040638|NCT01155167|100420118|FG001|STARTED|Overall Study||43||
48040639|NCT01155167|100420117|FG000|COMPLETED|Overall Study||40||
48040640|NCT01155167|100420118|FG001|COMPLETED|Overall Study||43||
48040641|NCT01155167|100420117|FG000|NOT COMPLETED|Overall Study||3||
48040642|NCT01155167|100420118|FG001|NOT COMPLETED|Overall Study||0||
48040643|NCT00917644|100420119|FG000|STARTED|Period 1: First Intervention||39||
48040644|NCT00917644|100420120|FG001|STARTED|Period 1: First Intervention||37||
48040645|NCT00917644|100420119|FG000|COMPLETED|Period 1: First Intervention||39||
48040646|NCT00917644|100420120|FG001|COMPLETED|Period 1: First Intervention||37||
48040647|NCT00917644|100420119|FG000|NOT COMPLETED|Period 1: First Intervention||0||
48040648|NCT00917644|100420120|FG001|NOT COMPLETED|Period 1: First Intervention||0||
48040649|NCT00917644|100420119|FG000|STARTED|Period: Washout Period of > = 2 Weeks||39||
48040650|NCT00917644|100420120|FG001|STARTED|Period: Washout Period of > = 2 Weeks||37||
48040651|NCT00917644|100420119|FG000|COMPLETED|Period: Washout Period of > = 2 Weeks||37||
48040652|NCT00917644|100420120|FG001|COMPLETED|Period: Washout Period of > = 2 Weeks||37||
48040653|NCT00917644|100420119|FG000|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||2||
48040654|NCT00917644|100420120|FG001|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||0||
48040655|NCT00917644|100420119|FG000|STARTED|Period 2: Second Intervention||37||
48040656|NCT00917644|100420120|FG001|STARTED|Period 2: Second Intervention||37||
48040657|NCT00917644|100420119|FG000|COMPLETED|Period 2: Second Intervention||36||
48040658|NCT00917644|100420120|FG001|COMPLETED|Period 2: Second Intervention||37||
48040659|NCT00917644|100420119|FG000|NOT COMPLETED|Period 2: Second Intervention||1||
48040660|NCT00917644|100420120|FG001|NOT COMPLETED|Period 2: Second Intervention||0||
48040661|NCT02342418|100420121|FG000|STARTED|Overall Study||9||
48040662|NCT02342418|100420122|FG001|STARTED|Overall Study||10||
48040663|NCT02342418|100420121|FG000|COMPLETED|Overall Study||9||
48040664|NCT02342418|100420122|FG001|COMPLETED|Overall Study||9||
48040665|NCT02342418|100420121|FG000|NOT COMPLETED|Overall Study||0||
48040666|NCT02342418|100420122|FG001|NOT COMPLETED|Overall Study||1||
48040667|NCT01911910|100420123|FG000|STARTED|Overall Study||197||
48040668|NCT01911910|100420124|FG001|STARTED|Overall Study||205||
48040669|NCT01911910|100420123|FG000|COMPLETED|Overall Study||184||
48040670|NCT01911910|100420124|FG001|COMPLETED|Overall Study||194||
48040671|NCT01911910|100420123|FG000|NOT COMPLETED|Overall Study||13||
48040672|NCT01911910|100420124|FG001|NOT COMPLETED|Overall Study||11||
48040673|NCT00095147|100420125|FG000|STARTED|Double-blind Period 1 (Days 1-197)||156||
48040674|NCT00095147|100420126|FG001|STARTED|Double-blind Period 1 (Days 1-197)||165||
48040675|NCT00095147|100420127|FG002|STARTED|Double-blind Period 1 (Days 1-197)||110||
48040676|NCT00095147|100420128|FG003|STARTED|Double-blind Period 1 (Days 1-197)||0||
48040677|NCT00095147|100420129|FG004|STARTED|Double-blind Period 1 (Days 1-197)||0||
48040678|NCT00095147|100420125|FG000|COMPLETED|Double-blind Period 1 (Days 1-197)||147||
48040679|NCT00095147|100420126|FG001|COMPLETED|Double-blind Period 1 (Days 1-197)||152||
48040680|NCT00095147|100420127|FG002|COMPLETED|Double-blind Period 1 (Days 1-197)||107||
48040681|NCT00095147|100420128|FG003|COMPLETED|Double-blind Period 1 (Days 1-197)||0||
48040682|NCT00095147|100420129|FG004|COMPLETED|Double-blind Period 1 (Days 1-197)||0||
48040683|NCT00095147|100420125|FG000|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||9||
48040684|NCT00095147|100420126|FG001|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||13||
48040685|NCT00095147|100420127|FG002|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||3||
48040686|NCT00095147|100420128|FG003|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0||
48040687|NCT00095147|100420129|FG004|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0||
48040688|NCT00095147|100420125|FG000|STARTED|Double-blind Period 2 (Days 198-365)||147||
48040689|NCT00095147|100420126|FG001|STARTED|Double-blind Period 2 (Days 198-365)||152||
48040690|NCT00095147|100420127|FG002|STARTED|Double-blind Period 2 (Days 198-365)||0||
48040691|NCT00095147|100420128|FG003|STARTED|Double-blind Period 2 (Days 198-365)||107||
48040692|NCT00095147|100420129|FG004|STARTED|Double-blind Period 2 (Days 198-365)||0||
48040693|NCT00095147|100420125|FG000|COMPLETED|Double-blind Period 2 (Days 198-365)||139||
48040694|NCT00095147|100420126|FG001|COMPLETED|Double-blind Period 2 (Days 198-365)||141||
48040695|NCT00095147|100420127|FG002|COMPLETED|Double-blind Period 2 (Days 198-365)||0||
48040696|NCT00095147|100420128|FG003|COMPLETED|Double-blind Period 2 (Days 198-365)||104||
48040697|NCT00095147|100420129|FG004|COMPLETED|Double-blind Period 2 (Days 198-365)||0||
48040698|NCT00095147|100420125|FG000|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||8||
48040699|NCT00095147|100420126|FG001|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||11||
48040700|NCT00095147|100420127|FG002|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0||
48040701|NCT00095147|100420128|FG003|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||3||
48040702|NCT00095147|100420129|FG004|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0||
48040703|NCT00095147|100420125|FG000|STARTED|Long-term Extension Period||0||
48040704|NCT00095147|100420126|FG001|STARTED|Long-term Extension Period||0||
48040705|NCT00095147|100420127|FG002|STARTED|Long-term Extension Period||0||
48040706|NCT00095147|100420128|FG003|STARTED|Long-term Extension Period||0||
48040707|NCT00095147|100420129|FG004|STARTED|Long-term Extension Period||372||
48040708|NCT00095147|100420125|FG000|COMPLETED|Long-term Extension Period||0||
48040709|NCT00095147|100420126|FG001|COMPLETED|Long-term Extension Period||0||
48040710|NCT00095147|100420127|FG002|COMPLETED|Long-term Extension Period||0||
48040711|NCT00095147|100420128|FG003|COMPLETED|Long-term Extension Period||0||
48040712|NCT00095147|100420129|FG004|COMPLETED|Long-term Extension Period||327||
48040713|NCT00095147|100420125|FG000|NOT COMPLETED|Long-term Extension Period||0||
48040714|NCT00095147|100420126|FG001|NOT COMPLETED|Long-term Extension Period||0||
48040715|NCT00095147|100420127|FG002|NOT COMPLETED|Long-term Extension Period||0||
48040716|NCT00095147|100420128|FG003|NOT COMPLETED|Long-term Extension Period||0||
48040717|NCT00095147|100420129|FG004|NOT COMPLETED|Long-term Extension Period||45||
48040718|NCT01489813|100420130|FG000|STARTED|Overall Study||16||
48040719|NCT01489813|100420131|FG001|STARTED|Overall Study||20||
48040720|NCT01489813|100420130|FG000|COMPLETED|Overall Study||13||
48040721|NCT01489813|100420131|FG001|COMPLETED|Overall Study||17||
48040722|NCT01489813|100420130|FG000|NOT COMPLETED|Overall Study||3||
48040723|NCT01489813|100420131|FG001|NOT COMPLETED|Overall Study||3||
48040724|NCT02361476|100420132|FG000|STARTED|Overall Study||191||
48040725|NCT02361476|100420133|FG001|STARTED|Overall Study||188||
48040726|NCT02361476|100420132|FG000|COMPLETED|Overall Study||191||
48040727|NCT02361476|100420133|FG001|COMPLETED|Overall Study||188||
48040728|NCT02361476|100420132|FG000|NOT COMPLETED|Overall Study||0||
48040729|NCT02361476|100420133|FG001|NOT COMPLETED|Overall Study||0||
48040730|NCT00510653|100420134|FG000|STARTED|Overall Study||24||
48040731|NCT00510653|100420134|FG000|COMPLETED|Overall Study||13||
48040732|NCT00510653|100420134|FG000|NOT COMPLETED|Overall Study||11||
48040733|NCT01075191|100420135|FG000|STARTED|Overall Study||60||
48040734|NCT01075191|100420135|FG000|Discontinued Year 1|Overall Study||7||
48040735|NCT01075191|100420135|FG000|Discontinued Year 2|Overall Study||6||
48040736|NCT01075191|100420135|FG000|Discontinued Year 3|Overall Study||5||
48040737|NCT01075191|100420135|FG000|COMPLETED|Overall Study||42||
48040738|NCT01075191|100420135|FG000|NOT COMPLETED|Overall Study||18||
48040739|NCT00330161|100420136|FG000|STARTED|Overall Study||29||
48040740|NCT00330161|100420136|FG000|COMPLETED|Overall Study||29||
48202893|NCT00217672|100820695|FG001|NOT COMPLETED|Allocation||0||
48202894|NCT00217672|100820694|FG000|STARTED|Treatment||67||
48202895|NCT00217672|100820695|FG001|STARTED|Treatment||7||
48202896|NCT00217672|100820694|FG000|COMPLETED|Treatment||0||
48202897|NCT00217672|100820695|FG001|COMPLETED|Treatment||0||
48202898|NCT00217672|100820694|FG000|NOT COMPLETED|Treatment||67||
48202899|NCT00217672|100820695|FG001|NOT COMPLETED|Treatment||7||
48202900|NCT00217672|100820694|FG000|STARTED|Follow-up||74||
48202901|NCT00217672|100820695|FG001|STARTED|Follow-up||0||
48202902|NCT00217672|100820694|FG000|COMPLETED|Follow-up||69||
48202903|NCT00217672|100820695|FG001|COMPLETED|Follow-up||0||
48202904|NCT00217672|100820694|FG000|NOT COMPLETED|Follow-up||5||
48202905|NCT00217672|100820695|FG001|NOT COMPLETED|Follow-up||0||
48202906|NCT00233519|100820696|FG000|STARTED|Overall Study||7||
48202907|NCT00233519|100820697|FG001|STARTED|Overall Study||10||
48202908|NCT00233519|100820696|FG000|COMPLETED|Overall Study||6||
48202909|NCT00233519|100820697|FG001|COMPLETED|Overall Study||9||
48202910|NCT00233519|100820696|FG000|NOT COMPLETED|Overall Study||1||
48202911|NCT00233519|100820697|FG001|NOT COMPLETED|Overall Study||1||
48202912|NCT04012853|100820698|FG000|STARTED|Overall Study||13||
48202913|NCT04012853|100820699|FG001|STARTED|Overall Study||13||
48202914|NCT04012853|100820698|FG000|COMPLETED|Overall Study||10||
48202915|NCT04012853|100820699|FG001|COMPLETED|Overall Study||12||
48202916|NCT04012853|100820698|FG000|NOT COMPLETED|Overall Study||3||
48202917|NCT04012853|100820699|FG001|NOT COMPLETED|Overall Study||1||
48202918|NCT00909363|100820700|FG000|STARTED|Overall Study||11||
48202919|NCT00909363|100820701|FG001|STARTED|Overall Study||8||
48202920|NCT00909363|100820702|FG002|STARTED|Overall Study||5||
48202921|NCT00909363|100820700|FG000|COMPLETED|Overall Study||9||
48202922|NCT00909363|100820701|FG001|COMPLETED|Overall Study||8||
48040741|NCT00330161|100420136|FG000|NOT COMPLETED|Overall Study||0||
48040742|NCT04255394|100420137|FG000|STARTED|Overall Study||220||
48040743|NCT04255394|100420138|FG001|STARTED|Overall Study||457||
48040744|NCT04255394|100420137|FG000|Treated|Overall Study||208||
48040745|NCT04255394|100420138|FG001|Treated|Overall Study||449||
48040746|NCT04255394|100420137|FG000|COMPLETED|Overall Study||38||
48040747|NCT04255394|100420138|FG001|COMPLETED|Overall Study||138||
48040748|NCT04255394|100420137|FG000|NOT COMPLETED|Overall Study||182||
48040749|NCT04255394|100420138|FG001|NOT COMPLETED|Overall Study||319||
48040750|NCT01120782|100420139|FG000|STARTED|Overall Study||45||
48040751|NCT01120782|100420139|FG000|COMPLETED|Overall Study||34||
48040752|NCT01120782|100420139|FG000|NOT COMPLETED|Overall Study||11||
48040753|NCT02617901|100420140|FG000|STARTED|Overall Study||20||
48040754|NCT02617901|100420140|FG000|COMPLETED|Overall Study||20||
48040755|NCT02617901|100420140|FG000|NOT COMPLETED|Overall Study||0||
48040756|NCT03579602|100420141|FG000|STARTED|Overall Study||11||
48040757|NCT03579602|100420142|FG001|STARTED|Overall Study||107||
48040758|NCT03579602|100420141|FG000|Subjects Who Received Tozuleristide Retreatment|Overall Study||2||
48040759|NCT03579602|100420142|FG001|Subjects Who Received Tozuleristide Retreatment|Overall Study||2||
48040760|NCT03579602|100420141|FG000|COMPLETED|Overall Study||11||
48040761|NCT03579602|100420142|FG001|COMPLETED|Overall Study||104||
48040762|NCT03579602|100420141|FG000|NOT COMPLETED|Overall Study||0||
48040763|NCT03579602|100420142|FG001|NOT COMPLETED|Overall Study||3||
48040764|NCT04036292|100420143|FG000|STARTED|Overall Study||260||
48040765|NCT04036292|100420144|FG001|STARTED|Overall Study||246||
48040766|NCT04036292|100420145|FG002|STARTED|Overall Study||252||
48040767|NCT04036292|100420143|FG000|COMPLETED|Overall Study||239||
48040768|NCT04036292|100420144|FG001|COMPLETED|Overall Study||212||
48040769|NCT04036292|100420145|FG002|COMPLETED|Overall Study||228||
48040770|NCT04036292|100420143|FG000|NOT COMPLETED|Overall Study||21||
48040771|NCT04036292|100420144|FG001|NOT COMPLETED|Overall Study||34||
48040772|NCT04036292|100420145|FG002|NOT COMPLETED|Overall Study||24||
48040773|NCT02248675|100420146|FG000|STARTED|Overall Study||26||
48040774|NCT02248675|100420147|FG001|STARTED|Overall Study||28||
48040775|NCT02248675|100420146|FG000|COMPLETED|Overall Study||23||
48040776|NCT02248675|100420147|FG001|COMPLETED|Overall Study||27||
48202923|NCT00909363|100820702|FG002|COMPLETED|Overall Study||5||
48202924|NCT00909363|100820700|FG000|NOT COMPLETED|Overall Study||2||
48202925|NCT00909363|100820701|FG001|NOT COMPLETED|Overall Study||0||
48202926|NCT00909363|100820702|FG002|NOT COMPLETED|Overall Study||0||
48202927|NCT04897737|100820703|FG000|STARTED|Overall Study||53||
48202928|NCT04897737|100820704|FG001|STARTED|Overall Study||53||
48202929|NCT04897737|100820703|FG000|COMPLETED|Overall Study||53||
48040777|NCT02248675|100420146|FG000|NOT COMPLETED|Overall Study||3||
48040778|NCT02248675|100420147|FG001|NOT COMPLETED|Overall Study||1||
48202930|NCT04897737|100820704|FG001|COMPLETED|Overall Study||53||
48202931|NCT04897737|100820703|FG000|NOT COMPLETED|Overall Study||0||
48202932|NCT04897737|100820704|FG001|NOT COMPLETED|Overall Study||0||
48202933|NCT02026258|100820705|FG000|STARTED|Randomized||20||
48202934|NCT02026258|100820706|FG001|STARTED|Randomized||21||
48202935|NCT02026258|100820705|FG000|COMPLETED|Randomized||16||
48202936|NCT02026258|100820706|FG001|COMPLETED|Randomized||19||
48202937|NCT02026258|100820705|FG000|NOT COMPLETED|Randomized||4||
48202938|NCT02026258|100820706|FG001|NOT COMPLETED|Randomized||2||
48202939|NCT02026258|100820705|FG000|STARTED|Recieved Allocated Intervention||16||
48202940|NCT02026258|100820706|FG001|STARTED|Recieved Allocated Intervention||19||
48202941|NCT02026258|100820705|FG000|COMPLETED|Recieved Allocated Intervention||15||
48040779|NCT02518464|100420148|FG000|STARTED|Overall Study||40||
48040780|NCT02518464|100420148|FG000|COMPLETED|Overall Study||38||
48040781|NCT02518464|100420148|FG000|NOT COMPLETED|Overall Study||2||
48040782|NCT00958438|100420149|FG000|STARTED|Overall Study||82||
48040783|NCT00958438|100420150|FG001|STARTED|Overall Study||82||
48040784|NCT00958438|100420151|FG002|STARTED|Overall Study||84||
48040785|NCT00958438|100420149|FG000|COMPLETED|Overall Study||72||
48040786|NCT00958438|100420150|FG001|COMPLETED|Overall Study||72||
48040787|NCT00958438|100420151|FG002|COMPLETED|Overall Study||78||
48040788|NCT00958438|100420149|FG000|NOT COMPLETED|Overall Study||10||
48040789|NCT00958438|100420150|FG001|NOT COMPLETED|Overall Study||10||
48040790|NCT00958438|100420151|FG002|NOT COMPLETED|Overall Study||6||
48040791|NCT04565327|100420152|FG000|STARTED|Overall Study||0||
48040792|NCT04565327|100420153|FG001|STARTED|Overall Study||7||
48040793|NCT04565327|100420152|FG000|COMPLETED|Overall Study||0||
48040794|NCT04565327|100420153|FG001|COMPLETED|Overall Study||7||
48040795|NCT04565327|100420152|FG000|NOT COMPLETED|Overall Study||0||
48040796|NCT04565327|100420153|FG001|NOT COMPLETED|Overall Study||0||
48040797|NCT01239732|100420154|FG000|STARTED|Overall Study||1021||
48040798|NCT01239732|100420154|FG000|COMPLETED|Overall Study||0||
48040799|NCT01239732|100420154|FG000|NOT COMPLETED|Overall Study||1021||
48040800|NCT01278927|100420155|FG000|STARTED|Overall Study||180||
48040801|NCT01278927|100420156|FG001|STARTED|Overall Study||178||
48040802|NCT01278927|100420157|FG002|STARTED|Overall Study||178||
48040803|NCT01278927|100420158|FG003|STARTED|Overall Study||175||
48040804|NCT01278927|100420155|FG000|COMPLETED|Overall Study||180||
48040805|NCT01278927|100420156|FG001|COMPLETED|Overall Study||178||
48040806|NCT01278927|100420157|FG002|COMPLETED|Overall Study||178||
48040807|NCT01278927|100420158|FG003|COMPLETED|Overall Study||175||
48040808|NCT01278927|100420155|FG000|NOT COMPLETED|Overall Study||0||
48040809|NCT01278927|100420156|FG001|NOT COMPLETED|Overall Study||0||
48040810|NCT01278927|100420157|FG002|NOT COMPLETED|Overall Study||0||
48040811|NCT01278927|100420158|FG003|NOT COMPLETED|Overall Study||0||
48040812|NCT01576159|100420159|FG000|STARTED|Overall Study||12||
48040813|NCT01576159|100420160|FG001|STARTED|Overall Study||12||
48040814|NCT01576159|100420161|FG002|STARTED|Overall Study||12||
48040815|NCT01576159|100420162|FG003|STARTED|Overall Study||12||
48040816|NCT01576159|100420159|FG000|COMPLETED|Overall Study||11||
48040817|NCT01576159|100420160|FG001|COMPLETED|Overall Study||11||
48040818|NCT01576159|100420161|FG002|COMPLETED|Overall Study||11||
48040819|NCT01576159|100420162|FG003|COMPLETED|Overall Study||11||
48040820|NCT01576159|100420159|FG000|NOT COMPLETED|Overall Study||1||
48040821|NCT01576159|100420160|FG001|NOT COMPLETED|Overall Study||1||
48040822|NCT01576159|100420161|FG002|NOT COMPLETED|Overall Study||1||
48040823|NCT01576159|100420162|FG003|NOT COMPLETED|Overall Study||1||
48040824|NCT01215929|100420163|FG000|STARTED|Overall Study||18||
48040825|NCT01215929|100420164|FG001|STARTED|Overall Study||17||
48040826|NCT01215929|100420163|FG000|COMPLETED|Overall Study||12||
48040827|NCT01215929|100420164|FG001|COMPLETED|Overall Study||12||
48040828|NCT01215929|100420163|FG000|NOT COMPLETED|Overall Study||6||
48040829|NCT01215929|100420164|FG001|NOT COMPLETED|Overall Study||5||
48040830|NCT02617485|100420165|FG000|STARTED|Treatment and Observation Period||100||
48040831|NCT02617485|100420166|FG001|STARTED|Treatment and Observation Period||40||
48040832|NCT02617485|100420165|FG000|COMPLETED|Treatment and Observation Period||85||
48040833|NCT02617485|100420166|FG001|COMPLETED|Treatment and Observation Period||35||
48040834|NCT02617485|100420165|FG000|NOT COMPLETED|Treatment and Observation Period||15||
48040835|NCT02617485|100420166|FG001|NOT COMPLETED|Treatment and Observation Period||5||
48040836|NCT02617485|100420165|FG000|STARTED|Follow-up Period||85||
48040837|NCT02617485|100420166|FG001|STARTED|Follow-up Period||35||
48040838|NCT02617485|100420165|FG000|COMPLETED|Follow-up Period||70||
48040839|NCT02617485|100420166|FG001|COMPLETED|Follow-up Period||29||
48040840|NCT02617485|100420165|FG000|NOT COMPLETED|Follow-up Period||15||
48040841|NCT02617485|100420166|FG001|NOT COMPLETED|Follow-up Period||6||
48040842|NCT03911102|100420167|FG000|STARTED|Overall Study||15||
48040843|NCT03911102|100420168|FG001|STARTED|Overall Study||17||
48040844|NCT03911102|100420169|FG002|STARTED|Overall Study||15||
48040845|NCT03911102|100420170|FG003|STARTED|Overall Study||16||
48040846|NCT03911102|100420167|FG000|COMPLETED|Overall Study||14||
48040847|NCT03911102|100420168|FG001|COMPLETED|Overall Study||16||
48040848|NCT03911102|100420169|FG002|COMPLETED|Overall Study||12||
48040849|NCT03911102|100420170|FG003|COMPLETED|Overall Study||16||
48202942|NCT02026258|100820706|FG001|COMPLETED|Recieved Allocated Intervention||17||
48202943|NCT02026258|100820705|FG000|NOT COMPLETED|Recieved Allocated Intervention||1||
48202944|NCT02026258|100820706|FG001|NOT COMPLETED|Recieved Allocated Intervention||2||
48040850|NCT03911102|100420167|FG000|NOT COMPLETED|Overall Study||1||
48040851|NCT03911102|100420168|FG001|NOT COMPLETED|Overall Study||1||
48040852|NCT03911102|100420169|FG002|NOT COMPLETED|Overall Study||3||
48040853|NCT03911102|100420170|FG003|NOT COMPLETED|Overall Study||0||
48040854|NCT00601952|100420171|FG000|STARTED|Overall Study||14||
48040855|NCT00601952|100420172|FG001|STARTED|Overall Study||17||
48040856|NCT00601952|100420171|FG000|COMPLETED|Overall Study||12||
48202945|NCT03885596|100820707|FG000|STARTED|Overall Study||9||
48202946|NCT03885596|100820708|FG001|STARTED|Overall Study||9||
48202947|NCT03885596|100820709|FG002|STARTED|Overall Study||9||
48202948|NCT03885596|100820710|FG003|STARTED|Overall Study||9||
48202949|NCT03885596|100820707|FG000|COMPLETED|Overall Study||7||
48202950|NCT03885596|100820708|FG001|COMPLETED|Overall Study||8||
48202951|NCT03885596|100820709|FG002|COMPLETED|Overall Study||9||
48202952|NCT03885596|100820710|FG003|COMPLETED|Overall Study||9||
48202953|NCT03885596|100820707|FG000|NOT COMPLETED|Overall Study||2||
48202954|NCT03885596|100820708|FG001|NOT COMPLETED|Overall Study||1||
48202955|NCT03885596|100820709|FG002|NOT COMPLETED|Overall Study||0||
48202956|NCT03885596|100820710|FG003|NOT COMPLETED|Overall Study||0||
48202957|NCT01335932|100820711|FG000|STARTED|Overall Study||84||
48202958|NCT01335932|100820712|FG001|STARTED|Overall Study||76||
48202959|NCT01335932|100820711|FG000|COMPLETED|Overall Study||84||
48202960|NCT01335932|100820712|FG001|COMPLETED|Overall Study||72||
48202961|NCT01335932|100820711|FG000|NOT COMPLETED|Overall Study||0||
48202962|NCT01335932|100820712|FG001|NOT COMPLETED|Overall Study||4||
48202963|NCT02657629|100820713|FG000|STARTED|Overall Study||14||
48202964|NCT02657629|100820714|FG001|STARTED|Overall Study||14||
48202965|NCT02657629|100820713|FG000|COMPLETED|Overall Study||12||
48202966|NCT02657629|100820714|FG001|COMPLETED|Overall Study||14||
48202967|NCT02657629|100820713|FG000|NOT COMPLETED|Overall Study||2||
48202968|NCT02657629|100820714|FG001|NOT COMPLETED|Overall Study||0||
48040857|NCT00601952|100420172|FG001|COMPLETED|Overall Study||17||
48040858|NCT00601952|100420171|FG000|NOT COMPLETED|Overall Study||2||
48040859|NCT00601952|100420172|FG001|NOT COMPLETED|Overall Study||0||
48202969|NCT03061474|100820715|FG000|STARTED|Overall Study||24||
48202970|NCT03061474|100820716|FG001|STARTED|Overall Study||22||
48202971|NCT03061474|100820715|FG000|COMPLETED|Overall Study||22||
48202972|NCT03061474|100820716|FG001|COMPLETED|Overall Study||18||
48202973|NCT03061474|100820715|FG000|NOT COMPLETED|Overall Study||2||
48202974|NCT03061474|100820716|FG001|NOT COMPLETED|Overall Study||4||
48202975|NCT03439124|100820717|FG000|STARTED|Overall Study||94||
48202976|NCT03439124|100820718|FG001|STARTED|Overall Study||44||
48202977|NCT03439124|100820717|FG000|COMPLETED|Overall Study||90||
48202978|NCT03439124|100820718|FG001|COMPLETED|Overall Study||44||
48202979|NCT03439124|100820717|FG000|NOT COMPLETED|Overall Study||4||
48202980|NCT03439124|100820718|FG001|NOT COMPLETED|Overall Study||0||
48202981|NCT02739035|100820719|FG000|STARTED|6 Weeks Post-MUA||59||
48202982|NCT02739035|100820720|FG001|STARTED|6 Weeks Post-MUA||71||
48202983|NCT02739035|100820719|FG000|COMPLETED|6 Weeks Post-MUA||56||
48202984|NCT02739035|100820720|FG001|COMPLETED|6 Weeks Post-MUA||61||
48202985|NCT02739035|100820719|FG000|NOT COMPLETED|6 Weeks Post-MUA||3||
48202986|NCT02739035|100820720|FG001|NOT COMPLETED|6 Weeks Post-MUA||10||
48202987|NCT02739035|100820719|FG000|STARTED|1 Year Post-MUA||56||
48202988|NCT02739035|100820720|FG001|STARTED|1 Year Post-MUA||61||
48202989|NCT02739035|100820719|FG000|COMPLETED|1 Year Post-MUA||46||
48202990|NCT02739035|100820720|FG001|COMPLETED|1 Year Post-MUA||50||
48202991|NCT02739035|100820719|FG000|NOT COMPLETED|1 Year Post-MUA||10||
48202992|NCT02739035|100820720|FG001|NOT COMPLETED|1 Year Post-MUA||11||
48202993|NCT01241292|100820721|FG000|STARTED|Overall Study||3||
48202994|NCT01241292|100820722|FG001|STARTED|Overall Study||3||
48202995|NCT01241292|100820721|FG000|Entered Treatment Period|Overall Study||3||
48202996|NCT01241292|100820722|FG001|Entered Treatment Period|Overall Study||3||
48202997|NCT01241292|100820721|FG000|COMPLETED|Overall Study||0||
48202998|NCT01241292|100820722|FG001|COMPLETED|Overall Study||0||
48202999|NCT01241292|100820721|FG000|NOT COMPLETED|Overall Study||3||
48203000|NCT01241292|100820722|FG001|NOT COMPLETED|Overall Study||3||
48203001|NCT01121549|100820723|FG000|STARTED|Overall Study||378||
48203002|NCT01121549|100820723|FG000|COMPLETED|Overall Study||31||
48203003|NCT01121549|100820723|FG000|NOT COMPLETED|Overall Study||347||
48203004|NCT01852019|100820724|FG000|STARTED|Day 1||3||
48203005|NCT01852019|100820725|FG001|STARTED|Day 1||3||
48203006|NCT01852019|100820726|FG002|STARTED|Day 1||6||
48203007|NCT01852019|100820727|FG003|STARTED|Day 1||0||
48203008|NCT01852019|100820728|FG004|STARTED|Day 1||0||
48203009|NCT01852019|100820724|FG000|COMPLETED|Day 1||3||
48203010|NCT01852019|100820725|FG001|COMPLETED|Day 1||3||
48203011|NCT01852019|100820726|FG002|COMPLETED|Day 1||6||
48203012|NCT01852019|100820727|FG003|COMPLETED|Day 1||0||
48203013|NCT01852019|100820728|FG004|COMPLETED|Day 1||0||
48203014|NCT01852019|100820724|FG000|NOT COMPLETED|Day 1||0||
48203015|NCT01852019|100820725|FG001|NOT COMPLETED|Day 1||0||
48203016|NCT01852019|100820726|FG002|NOT COMPLETED|Day 1||0||
48040860|NCT00796926|100420173|FG000|STARTED|Overall Study||15||
48040861|NCT00796926|100420174|FG001|STARTED|Overall Study||15||
48040862|NCT00796926|100420173|FG000|COMPLETED|Overall Study||14||
48040863|NCT00796926|100420174|FG001|COMPLETED|Overall Study||15||
48040864|NCT00796926|100420173|FG000|NOT COMPLETED|Overall Study||1||
48040865|NCT00796926|100420174|FG001|NOT COMPLETED|Overall Study||0||
48040866|NCT03499964|100420175|FG000|STARTED|Overall Study||79||
48203017|NCT01852019|100820727|FG003|NOT COMPLETED|Day 1||0||
48203018|NCT01852019|100820728|FG004|NOT COMPLETED|Day 1||0||
48203019|NCT01852019|100820724|FG000|STARTED|Day 8||0||
48203020|NCT01852019|100820725|FG001|STARTED|Day 8||0||
48203021|NCT01852019|100820726|FG002|STARTED|Day 8||0||
48203022|NCT01852019|100820727|FG003|STARTED|Day 8||6||
48040867|NCT03499964|100420176|FG001|STARTED|Overall Study||48||
48040868|NCT03499964|100420175|FG000|COMPLETED|Overall Study||68||
48040869|NCT03499964|100420176|FG001|COMPLETED|Overall Study||21||
48040870|NCT03499964|100420175|FG000|NOT COMPLETED|Overall Study||11||
48040871|NCT03499964|100420176|FG001|NOT COMPLETED|Overall Study||27||
48040872|NCT00603642|100420177|FG000|STARTED|Overall Study||12||
48040873|NCT00603642|100420178|FG001|STARTED|Overall Study||22||
48040874|NCT00603642|100420177|FG000|COMPLETED|Overall Study||12||
48040875|NCT00603642|100420178|FG001|COMPLETED|Overall Study||22||
48203023|NCT01852019|100820728|FG004|STARTED|Day 8||6||
48203024|NCT01852019|100820724|FG000|COMPLETED|Day 8||0||
48203025|NCT01852019|100820725|FG001|COMPLETED|Day 8||0||
48203026|NCT01852019|100820726|FG002|COMPLETED|Day 8||0||
48203027|NCT01852019|100820727|FG003|COMPLETED|Day 8||6||
48203028|NCT01852019|100820728|FG004|COMPLETED|Day 8||6||
48203029|NCT01852019|100820724|FG000|NOT COMPLETED|Day 8||0||
48203030|NCT01852019|100820725|FG001|NOT COMPLETED|Day 8||0||
48495303|NCT00521586|101547823|FG001|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||170||
48495304|NCT00521586|101547822|FG000|STARTED|Revaccination With 13vPnC (Year 5)||364||
48040876|NCT00603642|100420177|FG000|NOT COMPLETED|Overall Study||0||
48040877|NCT00603642|100420178|FG001|NOT COMPLETED|Overall Study||0||
48040878|NCT00400803|100420179|FG000|STARTED|Overall Study||35||
48040879|NCT00400803|100420179|FG000|COMPLETED|Overall Study||35||
48040880|NCT00400803|100420179|FG000|NOT COMPLETED|Overall Study||0||
48040881|NCT00710762|100420180|FG000|STARTED|Overall Study||44||
48040882|NCT00710762|100420181|FG001|STARTED|Overall Study||40||
48040883|NCT00710762|100420180|FG000|COMPLETED|Overall Study||5||
48040884|NCT00710762|100420181|FG001|COMPLETED|Overall Study||0||
48203031|NCT01852019|100820726|FG002|NOT COMPLETED|Day 8||0||
48203032|NCT01852019|100820727|FG003|NOT COMPLETED|Day 8||0||
48203033|NCT01852019|100820728|FG004|NOT COMPLETED|Day 8||0||
48203034|NCT03068468|100820729|FG000|STARTED|Placebo-Controlled Period||166||
48495305|NCT00521586|101547823|FG001|STARTED|Revaccination With 13vPnC (Year 5)||363||
48040885|NCT00710762|100420180|FG000|NOT COMPLETED|Overall Study||39||
48040886|NCT00710762|100420181|FG001|NOT COMPLETED|Overall Study||40||
48040887|NCT02285062|100420182|FG000|STARTED|Pre-Treatment Period||285|Started = Randomized|
48040888|NCT02285062|100420183|FG001|STARTED|Pre-Treatment Period||285|Started = Randomized|
48040889|NCT02285062|100420182|FG000|COMPLETED|Pre-Treatment Period||284|Completed = Received StudyTreatment|
48040890|NCT02285062|100420183|FG001|COMPLETED|Pre-Treatment Period||283|Completed = Received StudyTreatment|
48040891|NCT02285062|100420182|FG000|NOT COMPLETED|Pre-Treatment Period||1||
48040892|NCT02285062|100420183|FG001|NOT COMPLETED|Pre-Treatment Period||2||
48040893|NCT02285062|100420182|FG000|STARTED|Treatment Period||283||
48040894|NCT02285062|100420183|FG001|STARTED|Treatment Period||284||
48040895|NCT02285062|100420182|FG000|COMPLETED|Treatment Period||211|Completed = six full cycles of both len/pbo and R-CHOP|
48040896|NCT02285062|100420183|FG001|COMPLETED|Treatment Period||240|Completed = six full cycles of both len/pbo and R-CHOP|
48040897|NCT02285062|100420182|FG000|NOT COMPLETED|Treatment Period||72||
48040898|NCT02285062|100420183|FG001|NOT COMPLETED|Treatment Period||44||
48040899|NCT00853996|100420184|FG000|STARTED|Overall Study||25||
48040900|NCT00853996|100420184|FG000|COMPLETED|Overall Study||25||
48040901|NCT00853996|100420184|FG000|NOT COMPLETED|Overall Study||0||
48040902|NCT02586506|100420185|FG000|STARTED|Overall Study||259||
48040903|NCT02586506|100420185|FG000|COMPLETED|Overall Study||250||
48040904|NCT02586506|100420185|FG000|NOT COMPLETED|Overall Study||9||
48040905|NCT02184455|100420186|FG000|STARTED|Overall Study||11||
48040906|NCT02184455|100420186|FG000|COMPLETED|Overall Study||10||
48040907|NCT02184455|100420186|FG000|NOT COMPLETED|Overall Study||1||
48040908|NCT01213576|100420187|FG000|STARTED|Overall Study||18||
48040909|NCT01213576|100420188|FG001|STARTED|Overall Study||17||
48040910|NCT01213576|100420189|FG002|STARTED|Overall Study||18||
48040911|NCT01213576|100420190|FG003|STARTED|Overall Study||17||
48040912|NCT01213576|100420187|FG000|COMPLETED|Overall Study||15||
48040913|NCT01213576|100420188|FG001|COMPLETED|Overall Study||13||
48040914|NCT01213576|100420189|FG002|COMPLETED|Overall Study||13||
48040915|NCT01213576|100420190|FG003|COMPLETED|Overall Study||13||
48040916|NCT01213576|100420187|FG000|NOT COMPLETED|Overall Study||3||
48040917|NCT01213576|100420188|FG001|NOT COMPLETED|Overall Study||4||
48040918|NCT01213576|100420189|FG002|NOT COMPLETED|Overall Study||5||
48040919|NCT01213576|100420190|FG003|NOT COMPLETED|Overall Study||4||
48040920|NCT01499368|100420191|FG000|STARTED|Overall Study||165||
48040921|NCT01499368|100420192|FG001|STARTED|Overall Study||163||
48040922|NCT01499368|100420193|FG002|STARTED|Overall Study||167||
48040923|NCT01499368|100420191|FG000|COMPLETED|Overall Study||138||
48040924|NCT01499368|100420192|FG001|COMPLETED|Overall Study||145||
48040925|NCT01499368|100420193|FG002|COMPLETED|Overall Study||146||
48040926|NCT01499368|100420191|FG000|NOT COMPLETED|Overall Study||27||
48040927|NCT01499368|100420192|FG001|NOT COMPLETED|Overall Study||18||
48040928|NCT01499368|100420193|FG002|NOT COMPLETED|Overall Study||21||
48040929|NCT00945906|100420194|FG000|STARTED|Overall Study||61||
48040930|NCT00945906|100420194|FG000|COMPLETED|Overall Study||54||
48040931|NCT00945906|100420194|FG000|NOT COMPLETED|Overall Study||7||
48203035|NCT03068468|100820730|FG001|STARTED|Placebo-Controlled Period||324||
48203036|NCT03068468|100820731|FG002|STARTED|Placebo-Controlled Period||0||
48203037|NCT03068468|100820732|FG003|STARTED|Placebo-Controlled Period||0||
48203038|NCT03068468|100820729|FG000|Treated|Placebo-Controlled Period||165||
48203039|NCT03068468|100820730|FG001|Treated|Placebo-Controlled Period||321||
48203040|NCT03068468|100820731|FG002|Treated|Placebo-Controlled Period||0||
48203041|NCT03068468|100820732|FG003|Treated|Placebo-Controlled Period||0||
48203042|NCT03068468|100820729|FG000|COMPLETED|Placebo-Controlled Period||144|Participants who completed the study PC period|
48203043|NCT03068468|100820730|FG001|COMPLETED|Placebo-Controlled Period||279|Participants who completed the study PC period|
48203044|NCT03068468|100820731|FG002|COMPLETED|Placebo-Controlled Period||0|Participants who completed the study PC period|
48203045|NCT03068468|100820732|FG003|COMPLETED|Placebo-Controlled Period||0|Participants who completed the study PC period|
48203046|NCT03068468|100820729|FG000|NOT COMPLETED|Placebo-Controlled Period||22||
48203047|NCT03068468|100820730|FG001|NOT COMPLETED|Placebo-Controlled Period||45||
48203048|NCT03068468|100820731|FG002|NOT COMPLETED|Placebo-Controlled Period||0||
48203049|NCT03068468|100820732|FG003|NOT COMPLETED|Placebo-Controlled Period||0||
48203050|NCT03068468|100820729|FG000|STARTED|Open-Label Extension Period||0||
48203051|NCT03068468|100820730|FG001|STARTED|Open-Label Extension Period||0||
48203052|NCT03068468|100820731|FG002|STARTED|Open-Label Extension Period||140||
48203053|NCT03068468|100820732|FG003|STARTED|Open-Label Extension Period||276||
48203054|NCT03068468|100820729|FG000|COMPLETED|Open-Label Extension Period||0||
48203055|NCT03068468|100820730|FG001|COMPLETED|Open-Label Extension Period||0||
48203056|NCT03068468|100820731|FG002|COMPLETED|Open-Label Extension Period||0||
48203057|NCT03068468|100820732|FG003|COMPLETED|Open-Label Extension Period||0||
48203058|NCT03068468|100820729|FG000|NOT COMPLETED|Open-Label Extension Period||0||
48203059|NCT03068468|100820730|FG001|NOT COMPLETED|Open-Label Extension Period||0||
48203060|NCT03068468|100820731|FG002|NOT COMPLETED|Open-Label Extension Period||140||
48203061|NCT03068468|100820732|FG003|NOT COMPLETED|Open-Label Extension Period||276||
48203062|NCT01986686|100820733|FG000|STARTED|Overall Study||81||
48203063|NCT01986686|100820734|FG001|STARTED|Overall Study||26||
48203064|NCT01986686|100820733|FG000|COMPLETED|Overall Study||81||
48203065|NCT01986686|100820734|FG001|COMPLETED|Overall Study||26||
48203066|NCT01986686|100820733|FG000|NOT COMPLETED|Overall Study||0||
48495306|NCT00521586|101547822|FG000|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||364||
48495307|NCT00521586|101547823|FG001|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||363||
48495308|NCT00521586|101547822|FG000|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||363||
48495309|NCT00521586|101547823|FG001|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||359||
48040932|NCT00345332|100420195|FG000|STARTED|Overall Study||11||
48040933|NCT00345332|100420196|FG001|STARTED|Overall Study||20||
48040934|NCT00345332|100420195|FG000|COMPLETED|Overall Study||11||
48040935|NCT00345332|100420196|FG001|COMPLETED|Overall Study||20||
48040936|NCT00345332|100420195|FG000|NOT COMPLETED|Overall Study||0||
48040937|NCT00345332|100420196|FG001|NOT COMPLETED|Overall Study||0||
48040938|NCT02081248|100420197|FG000|STARTED|Overall Study||98||
48203067|NCT01986686|100820734|FG001|NOT COMPLETED|Overall Study||0||
48203068|NCT00995150|100820735|FG000|STARTED|Overall Study||1600||
48203069|NCT00995150|100820736|FG001|STARTED|Overall Study||159||
48203070|NCT00995150|100820737|FG002|STARTED|Overall Study||151||
48203071|NCT00995150|100820735|FG000|COMPLETED|Overall Study||302||
48495310|NCT00521586|101547822|FG000|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||361||
48495311|NCT00521586|101547823|FG001|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||351||
48495312|NCT00521586|101547822|FG000|COMPLETED|Revaccination With 13vPnC (Year 5)||361||
48203072|NCT00995150|100820736|FG001|COMPLETED|Overall Study||22||
48203073|NCT00995150|100820737|FG002|COMPLETED|Overall Study||41||
48203074|NCT00995150|100820735|FG000|NOT COMPLETED|Overall Study||1298||
48203075|NCT00995150|100820736|FG001|NOT COMPLETED|Overall Study||137||
48203076|NCT00995150|100820737|FG002|NOT COMPLETED|Overall Study||110||
48203077|NCT00758602|100820738|FG000|STARTED|Overall Study||104||
48040939|NCT02081248|100420198|FG001|STARTED|Overall Study||100||
48040940|NCT02081248|100420197|FG000|COMPLETED|Overall Study||76||
48040941|NCT02081248|100420198|FG001|COMPLETED|Overall Study||87||
48040942|NCT02081248|100420197|FG000|NOT COMPLETED|Overall Study||22||
48040943|NCT02081248|100420198|FG001|NOT COMPLETED|Overall Study||13||
48040944|NCT00984620|100420199|FG000|STARTED|Overall Study||81||
48040945|NCT00984620|100420200|FG001|STARTED|Overall Study||79||
48040946|NCT00984620|100420199|FG000|COMPLETED|Overall Study||75||
48040947|NCT00984620|100420200|FG001|COMPLETED|Overall Study||67||
48040948|NCT00984620|100420199|FG000|NOT COMPLETED|Overall Study||6||
48040949|NCT00984620|100420200|FG001|NOT COMPLETED|Overall Study||12||
48040950|NCT00522925|100420201|FG000|STARTED|Overall Study||36||
48040951|NCT00522925|100420202|FG001|STARTED|Overall Study||39||
48040952|NCT00522925|100420203|FG002|STARTED|Overall Study||38||
48040953|NCT00522925|100420201|FG000|COMPLETED|Overall Study||28||
48040954|NCT00522925|100420202|FG001|COMPLETED|Overall Study||38||
48040955|NCT00522925|100420203|FG002|COMPLETED|Overall Study||36||
48040956|NCT00522925|100420201|FG000|NOT COMPLETED|Overall Study||8||
48040957|NCT00522925|100420202|FG001|NOT COMPLETED|Overall Study||1||
48040958|NCT00522925|100420203|FG002|NOT COMPLETED|Overall Study||2||
48040959|NCT03351101|100420204|FG000|STARTED|Overall Study||136||
48040960|NCT03351101|100420205|FG001|STARTED|Overall Study||132||
48040961|NCT03351101|100420204|FG000|COMPLETED|Overall Study||135||
48203078|NCT00758602|100820739|FG001|STARTED|Overall Study||106||
48203079|NCT00758602|100820738|FG000|COMPLETED|Overall Study||85||
48203080|NCT00758602|100820739|FG001|COMPLETED|Overall Study||84||
48203081|NCT00758602|100820738|FG000|NOT COMPLETED|Overall Study||19||
48203082|NCT00758602|100820739|FG001|NOT COMPLETED|Overall Study||22||
48203083|NCT01118338|100820740|FG000|STARTED|Overall Study||185||
48203084|NCT01118338|100820741|FG001|STARTED|Overall Study||183||
48203085|NCT01118338|100820740|FG000|COMPLETED|Overall Study||182||
48203086|NCT01118338|100820741|FG001|COMPLETED|Overall Study||174||
48203087|NCT01118338|100820740|FG000|NOT COMPLETED|Overall Study||3||
48203088|NCT01118338|100820741|FG001|NOT COMPLETED|Overall Study||9||
48203089|NCT01390402|100820742|FG000|STARTED|Overall Study||6||
48203090|NCT01390402|100820742|FG000|COMPLETED|Overall Study||1||
48203091|NCT01390402|100820742|FG000|NOT COMPLETED|Overall Study||5||
48203092|NCT01460290|100820743|FG000|STARTED|Overall Study||15||
48203093|NCT01460290|100820743|FG000|COMPLETED|Overall Study||11||
48203094|NCT01460290|100820743|FG000|NOT COMPLETED|Overall Study||4||
48203095|NCT02057692|100820744|FG000|STARTED|Overall Study||8||
48203096|NCT02057692|100820745|FG001|STARTED|Overall Study||11||
48203097|NCT02057692|100820746|FG002|STARTED|Overall Study||6||
48203098|NCT02057692|100820747|FG003|STARTED|Overall Study||12||
48203099|NCT02057692|100820744|FG000|COMPLETED|Overall Study||7||
48203100|NCT02057692|100820745|FG001|COMPLETED|Overall Study||11||
48203101|NCT02057692|100820746|FG002|COMPLETED|Overall Study||6||
48203102|NCT02057692|100820747|FG003|COMPLETED|Overall Study||11||
48203103|NCT02057692|100820744|FG000|NOT COMPLETED|Overall Study||1||
48203104|NCT02057692|100820745|FG001|NOT COMPLETED|Overall Study||0||
48203105|NCT02057692|100820746|FG002|NOT COMPLETED|Overall Study||0||
48203106|NCT02057692|100820747|FG003|NOT COMPLETED|Overall Study||1||
48203107|NCT04181307|100820748|FG000|STARTED|Overall Study||2986||
48203108|NCT04181307|100820749|FG001|STARTED|Overall Study||4644||
48203109|NCT04181307|100820748|FG000|Assessed at Baseline|Overall Study||1342||
48203110|NCT04181307|100820749|FG001|Assessed at Baseline|Overall Study||2086||
48203111|NCT04181307|100820748|FG000|Assessed at 18 Months|Overall Study||1644||
48203112|NCT04181307|100820749|FG001|Assessed at 18 Months|Overall Study||2558||
48203113|NCT04181307|100820748|FG000|COMPLETED|Overall Study||1342||
48203114|NCT04181307|100820749|FG001|COMPLETED|Overall Study||2086||
48203115|NCT04181307|100820748|FG000|NOT COMPLETED|Overall Study||1644||
48203116|NCT04181307|100820749|FG001|NOT COMPLETED|Overall Study||2558||
48203117|NCT02524288|100820750|FG000|STARTED|Overall Study||1941||
48203118|NCT02524288|100820750|FG000|Treated|Overall Study||1936||
48203119|NCT02524288|100820750|FG000|COMPLETED|Overall Study||0||
48203120|NCT02524288|100820750|FG000|NOT COMPLETED|Overall Study||1941||
48203121|NCT02156687|100820751|FG000|STARTED|Overall Study||30||
48203122|NCT02156687|100820752|FG001|STARTED|Overall Study||29||
48203123|NCT02156687|100820751|FG000|COMPLETED|Overall Study||20||
48203124|NCT02156687|100820752|FG001|COMPLETED|Overall Study||24||
48203125|NCT02156687|100820751|FG000|NOT COMPLETED|Overall Study||10||
48203126|NCT02156687|100820752|FG001|NOT COMPLETED|Overall Study||5||
48203127|NCT04615299|100820753|FG000|STARTED|Overall Study||36||
48203128|NCT04615299|100820754|FG001|STARTED|Overall Study||36||
48203129|NCT04615299|100820753|FG000|COMPLETED|Overall Study||36||
48203130|NCT04615299|100820754|FG001|COMPLETED|Overall Study||36||
48203131|NCT04615299|100820753|FG000|NOT COMPLETED|Overall Study||0||
48203132|NCT04615299|100820754|FG001|NOT COMPLETED|Overall Study||0||
48203133|NCT01713530|100820755|FG000|STARTED|Overall Study||138||
48203134|NCT01713530|100820756|FG001|STARTED|Overall Study||136||
48203135|NCT01713530|100820755|FG000|Exposed|Overall Study||136||
48203136|NCT01713530|100820756|FG001|Exposed|Overall Study||135||
48203137|NCT01713530|100820755|FG000|COMPLETED|Overall Study||113||
48203138|NCT01713530|100820756|FG001|COMPLETED|Overall Study||117||
48203139|NCT01713530|100820755|FG000|NOT COMPLETED|Overall Study||25||
48203140|NCT01713530|100820756|FG001|NOT COMPLETED|Overall Study||19||
48203141|NCT01157182|100820757|FG000|STARTED|First Intervention||18||
48203142|NCT01157182|100820758|FG001|STARTED|First Intervention||18||
48203143|NCT01157182|100820757|FG000|COMPLETED|First Intervention||18||
48203144|NCT01157182|100820758|FG001|COMPLETED|First Intervention||18||
48203145|NCT01157182|100820757|FG000|NOT COMPLETED|First Intervention||0||
48495313|NCT00521586|101547823|FG001|COMPLETED|Revaccination With 13vPnC (Year 5)||351||
48495314|NCT00521586|101547822|FG000|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||3||
48203146|NCT01157182|100820758|FG001|NOT COMPLETED|First Intervention||0||
48203147|NCT01157182|100820757|FG000|STARTED|Washout of 28 Days||18||
48203148|NCT01157182|100820758|FG001|STARTED|Washout of 28 Days||18||
48203149|NCT01157182|100820757|FG000|COMPLETED|Washout of 28 Days||16||
48203150|NCT01157182|100820758|FG001|COMPLETED|Washout of 28 Days||18||
48203151|NCT01157182|100820757|FG000|NOT COMPLETED|Washout of 28 Days||2||
48495315|NCT00521586|101547823|FG001|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||12||
48203152|NCT01157182|100820758|FG001|NOT COMPLETED|Washout of 28 Days||0||
48203153|NCT01157182|100820757|FG000|STARTED|Second Intervention||16||
48203154|NCT01157182|100820758|FG001|STARTED|Second Intervention||18||
48203155|NCT01157182|100820757|FG000|COMPLETED|Second Intervention||16||
48203156|NCT01157182|100820758|FG001|COMPLETED|Second Intervention||18||
48203157|NCT01157182|100820757|FG000|NOT COMPLETED|Second Intervention||0||
48203158|NCT01157182|100820758|FG001|NOT COMPLETED|Second Intervention||0||
48203159|NCT02248480|100820759|FG000|STARTED|Overall Study||178||
48203160|NCT02248480|100820760|FG001|STARTED|Overall Study||176||
48203161|NCT02248480|100820759|FG000|Efficacy Population|Overall Study||177||
48203162|NCT02248480|100820760|FG001|Efficacy Population|Overall Study||176||
48203163|NCT02248480|100820759|FG000|COMPLETED|Overall Study||161||
48203164|NCT02248480|100820760|FG001|COMPLETED|Overall Study||162||
48203165|NCT02248480|100820759|FG000|NOT COMPLETED|Overall Study||17||
48203166|NCT02248480|100820760|FG001|NOT COMPLETED|Overall Study||14||
48203167|NCT01144182|100820761|FG000|STARTED|Overall Study||68||
48203168|NCT01144182|100820762|FG001|STARTED|Overall Study||68||
48203169|NCT01144182|100820761|FG000|COMPLETED|Overall Study||51||
48203170|NCT01144182|100820762|FG001|COMPLETED|Overall Study||47||
48203171|NCT01144182|100820761|FG000|NOT COMPLETED|Overall Study||17||
48203172|NCT01144182|100820762|FG001|NOT COMPLETED|Overall Study||21||
48203173|NCT02873754|100820763|FG000|STARTED|Overall Study||11||
48203174|NCT02873754|100820763|FG000|COMPLETED|Overall Study||5||
48203175|NCT02873754|100820763|FG000|NOT COMPLETED|Overall Study||6||
48203176|NCT03278028|100820764|FG000|STARTED|Overall Study||81||
48203177|NCT03278028|100820765|FG001|STARTED|Overall Study||78||
48203178|NCT03278028|100820764|FG000|COMPLETED|Overall Study||77||
48203179|NCT03278028|100820765|FG001|COMPLETED|Overall Study||76||
48203180|NCT03278028|100820764|FG000|NOT COMPLETED|Overall Study||4||
48203181|NCT03278028|100820765|FG001|NOT COMPLETED|Overall Study||2||
48203182|NCT02052648|100820766|FG000|STARTED|Overall Study||3||
48203183|NCT02052648|100820767|FG001|STARTED|Overall Study||3||
48203184|NCT02052648|100820768|FG002|STARTED|Overall Study||6||
48203185|NCT02052648|100820769|FG003|STARTED|Overall Study||80||
48203186|NCT02052648|100820770|FG004|STARTED|Overall Study||28||
48203187|NCT02052648|100820771|FG005|STARTED|Overall Study||40||
48203188|NCT02052648|100820766|FG000|COMPLETED|Overall Study||3||
48203189|NCT02052648|100820767|FG001|COMPLETED|Overall Study||3||
48203190|NCT02052648|100820768|FG002|COMPLETED|Overall Study||6||
48203191|NCT02052648|100820769|FG003|COMPLETED|Overall Study||80||
48203192|NCT02052648|100820770|FG004|COMPLETED|Overall Study||28||
48203193|NCT02052648|100820771|FG005|COMPLETED|Overall Study||40||
48203194|NCT02052648|100820766|FG000|NOT COMPLETED|Overall Study||0||
48203195|NCT02052648|100820767|FG001|NOT COMPLETED|Overall Study||0||
48203196|NCT02052648|100820768|FG002|NOT COMPLETED|Overall Study||0||
48203197|NCT02052648|100820769|FG003|NOT COMPLETED|Overall Study||0||
48203198|NCT02052648|100820770|FG004|NOT COMPLETED|Overall Study||0||
48203199|NCT02052648|100820771|FG005|NOT COMPLETED|Overall Study||0||
48203200|NCT04678830|100820772|FG000|STARTED|Overall Study||28||
48203201|NCT04678830|100820773|FG001|STARTED|Overall Study||28||
48203202|NCT04678830|100820772|FG000|COMPLETED|Overall Study||26||
48203203|NCT04678830|100820773|FG001|COMPLETED|Overall Study||27||
48203204|NCT04678830|100820772|FG000|NOT COMPLETED|Overall Study||2||
48203205|NCT04678830|100820773|FG001|NOT COMPLETED|Overall Study||1||
48203206|NCT02736799|100820774|FG000|STARTED|Overall Study||6||
48203207|NCT02736799|100820775|FG001|STARTED|Overall Study||6||
48203208|NCT02736799|100820776|FG002|STARTED|Overall Study||6||
48203209|NCT02736799|100820777|FG003|STARTED|Overall Study||6||
48203210|NCT02736799|100820774|FG000|COMPLETED|Overall Study||6||
48203211|NCT02736799|100820775|FG001|COMPLETED|Overall Study||6||
48203212|NCT02736799|100820776|FG002|COMPLETED|Overall Study||6||
48203213|NCT02736799|100820777|FG003|COMPLETED|Overall Study||5||
48203214|NCT02736799|100820774|FG000|NOT COMPLETED|Overall Study||0||
48203215|NCT02736799|100820775|FG001|NOT COMPLETED|Overall Study||0||
48203216|NCT02736799|100820776|FG002|NOT COMPLETED|Overall Study||0||
48203217|NCT02736799|100820777|FG003|NOT COMPLETED|Overall Study||1||
48203218|NCT01624168|100820778|FG000|STARTED|Overall Study||19||
48203219|NCT01624168|100820779|FG001|STARTED|Overall Study||28||
48203220|NCT01624168|100820780|FG002|STARTED|Overall Study||28||
48203221|NCT01624168|100820778|FG000|COMPLETED|Overall Study||15||
48203222|NCT01624168|100820779|FG001|COMPLETED|Overall Study||16||
48203223|NCT01624168|100820780|FG002|COMPLETED|Overall Study||22||
48203224|NCT01624168|100820778|FG000|NOT COMPLETED|Overall Study||4||
48203225|NCT01624168|100820779|FG001|NOT COMPLETED|Overall Study||12||
48203226|NCT01624168|100820780|FG002|NOT COMPLETED|Overall Study||6||
48203227|NCT01810263|100820781|FG000|STARTED|Overall Study||16||
48203228|NCT01810263|100820782|FG001|STARTED|Overall Study||18||
48203229|NCT01810263|100820781|FG000|COMPLETED|Overall Study||8||
48203230|NCT01810263|100820782|FG001|COMPLETED|Overall Study||11||
48203231|NCT01810263|100820781|FG000|NOT COMPLETED|Overall Study||8||
48203232|NCT01810263|100820782|FG001|NOT COMPLETED|Overall Study||7||
48203233|NCT01256034|100820783|FG000|STARTED|Overall Study||25||
48203234|NCT01256034|100820784|FG001|STARTED|Overall Study||25||
48203235|NCT01256034|100820783|FG000|COMPLETED|Overall Study||0||
48203236|NCT01256034|100820784|FG001|COMPLETED|Overall Study||0||
48203237|NCT01256034|100820783|FG000|NOT COMPLETED|Overall Study||25||
48203238|NCT01256034|100820784|FG001|NOT COMPLETED|Overall Study||25||
48203239|NCT01786564|100820785|FG000|STARTED|Overall Study||120||
48203240|NCT01786564|100820785|FG000|COMPLETED|Overall Study||56||
48203241|NCT01786564|100820785|FG000|NOT COMPLETED|Overall Study||64||
48203242|NCT05179837|100820786|FG000|STARTED|Overall Study||36||
48203243|NCT05179837|100820786|FG000|COMPLETED|Overall Study||32||
48203244|NCT05179837|100820786|FG000|NOT COMPLETED|Overall Study||4||
48203245|NCT01499134|100820787|FG000|STARTED|Overall Study||9||
48203246|NCT01499134|100820788|FG001|STARTED|Overall Study||8||
48203247|NCT01499134|100820787|FG000|COMPLETED|Overall Study||9||
48203248|NCT01499134|100820788|FG001|COMPLETED|Overall Study||7||
48203249|NCT01499134|100820787|FG000|NOT COMPLETED|Overall Study||0||
48203250|NCT01499134|100820788|FG001|NOT COMPLETED|Overall Study||1||
48203251|NCT02106442|100820789|FG000|STARTED|Overall Study||579||
48203252|NCT02106442|100820789|FG000|COMPLETED|Overall Study||542||
48203253|NCT02106442|100820789|FG000|NOT COMPLETED|Overall Study||37||
48203254|NCT01838200|100820790|FG000|STARTED|Overall Study||3||
48203255|NCT01838200|100820791|FG001|STARTED|Overall Study||2||
48203256|NCT01838200|100820790|FG000|COMPLETED|Overall Study||0||
48203257|NCT01838200|100820791|FG001|COMPLETED|Overall Study||0||
48203258|NCT01838200|100820790|FG000|NOT COMPLETED|Overall Study||3||
48203259|NCT01838200|100820791|FG001|NOT COMPLETED|Overall Study||2||
48203260|NCT02355158|100820792|FG000|STARTED|Overall Study||197||
48203261|NCT02355158|100820792|FG000|COMPLETED|Overall Study||47||
48203262|NCT02355158|100820792|FG000|NOT COMPLETED|Overall Study||150||
48203263|NCT00517933|100820793|FG000|STARTED|Period 1||89||
48203264|NCT00517933|100820794|FG001|STARTED|Period 1||91||
48203265|NCT00517933|100820793|FG000|COMPLETED|Period 1||81||
48203266|NCT00517933|100820794|FG001|COMPLETED|Period 1||85||
48203267|NCT00517933|100820793|FG000|NOT COMPLETED|Period 1||8||
48203268|NCT00517933|100820794|FG001|NOT COMPLETED|Period 1||6||
48203269|NCT00517933|100820793|FG000|STARTED|Period 2||79||
48203270|NCT00517933|100820794|FG001|STARTED|Period 2||83||
48203271|NCT00517933|100820793|FG000|COMPLETED|Period 2||73||
48203272|NCT00517933|100820794|FG001|COMPLETED|Period 2||70||
48203273|NCT00517933|100820793|FG000|NOT COMPLETED|Period 2||6||
48203274|NCT00517933|100820794|FG001|NOT COMPLETED|Period 2||13||
48203275|NCT01919697|100820795|FG000|STARTED|Overall Study||224||
48203276|NCT01919697|100820796|FG001|STARTED|Overall Study||2146||
48203277|NCT01919697|100820795|FG000|COMPLETED|Overall Study||171||
48203278|NCT01919697|100820796|FG001|COMPLETED|Overall Study||1761||
48203279|NCT01919697|100820795|FG000|NOT COMPLETED|Overall Study||53||
48203280|NCT01919697|100820796|FG001|NOT COMPLETED|Overall Study||385||
48203281|NCT00811057|100820797|FG000|STARTED|Overall Study||90||
48203282|NCT00811057|100820798|FG001|STARTED|Overall Study||114||
48203283|NCT00811057|100820799|FG002|STARTED|Overall Study||97||
48203284|NCT00811057|100820797|FG000|COMPLETED|Overall Study||85||
48203285|NCT00811057|100820798|FG001|COMPLETED|Overall Study||104||
48203286|NCT00811057|100820799|FG002|COMPLETED|Overall Study||87||
48203287|NCT00811057|100820797|FG000|NOT COMPLETED|Overall Study||5||
48203288|NCT00811057|100820798|FG001|NOT COMPLETED|Overall Study||10||
48203289|NCT00811057|100820799|FG002|NOT COMPLETED|Overall Study||10||
48203290|NCT02861937|100820800|FG000|STARTED|Overall Study||10||
48203291|NCT02861937|100820801|FG001|STARTED|Overall Study||12||
48203292|NCT02861937|100820802|FG002|STARTED|Overall Study||12||
48203293|NCT02861937|100820800|FG000|COMPLETED|Overall Study||10||
48203294|NCT02861937|100820801|FG001|COMPLETED|Overall Study||12||
48203295|NCT02861937|100820802|FG002|COMPLETED|Overall Study||12||
48203296|NCT02861937|100820800|FG000|NOT COMPLETED|Overall Study||0||
48203297|NCT02861937|100820801|FG001|NOT COMPLETED|Overall Study||0||
48203298|NCT02861937|100820802|FG002|NOT COMPLETED|Overall Study||0||
48203299|NCT01832506|100820803|FG000|STARTED|Overall Study||3||
48203300|NCT01832506|100820804|FG001|STARTED|Overall Study||3||
48203301|NCT01832506|100820805|FG002|STARTED|Overall Study||6||
48203302|NCT01832506|100820803|FG000|COMPLETED|Overall Study||3||
48203303|NCT01832506|100820804|FG001|COMPLETED|Overall Study||3||
48203304|NCT01832506|100820805|FG002|COMPLETED|Overall Study||6||
48203305|NCT01832506|100820803|FG000|NOT COMPLETED|Overall Study||0||
48203306|NCT01832506|100820804|FG001|NOT COMPLETED|Overall Study||0||
48203307|NCT01832506|100820805|FG002|NOT COMPLETED|Overall Study||0||
48203308|NCT04089488|100820806|FG000|STARTED|Overall Study||175||
48203309|NCT04089488|100820806|FG000|COMPLETED|Overall Study||175||
48203310|NCT04089488|100820806|FG000|NOT COMPLETED|Overall Study||0||
48203311|NCT03394027|100820807|FG000|STARTED|Overall Study||10||
48203312|NCT03394027|100820808|FG001|STARTED|Overall Study||6||
48203313|NCT03394027|100820809|FG002|STARTED|Overall Study||14||
48203314|NCT03394027|100820807|FG000|COMPLETED|Overall Study||7||
48203315|NCT03394027|100820808|FG001|COMPLETED|Overall Study||5||
48203316|NCT03394027|100820809|FG002|COMPLETED|Overall Study||10||
48495316|NCT00835614|101547824|FG000|STARTED|First Intervention||13||
48203317|NCT03394027|100820807|FG000|NOT COMPLETED|Overall Study||3||
48203318|NCT03394027|100820808|FG001|NOT COMPLETED|Overall Study||1||
48203319|NCT03394027|100820809|FG002|NOT COMPLETED|Overall Study||4||
48203320|NCT03949335|100820810|FG000|STARTED|Overall Study||135||
48203321|NCT03949335|100820811|FG001|STARTED|Overall Study||137||
48203322|NCT03949335|100820810|FG000|COMPLETED|Overall Study||132||
48203323|NCT03949335|100820811|FG001|COMPLETED|Overall Study||131||
48203324|NCT03949335|100820810|FG000|NOT COMPLETED|Overall Study||3||
48203325|NCT03949335|100820811|FG001|NOT COMPLETED|Overall Study||6||
48203326|NCT02221219|100820812|FG000|STARTED|Overall Study||36||
48203327|NCT02221219|100820813|FG001|STARTED|Overall Study||87||
48203328|NCT02221219|100820814|FG002|STARTED|Overall Study||41||
48203329|NCT02221219|100820815|FG003|STARTED|Overall Study||92||
48203330|NCT02221219|100820812|FG000|COMPLETED|Overall Study||36||
48203331|NCT02221219|100820813|FG001|COMPLETED|Overall Study||87||
48040962|NCT03351101|100420205|FG001|COMPLETED|Overall Study||129||
48040963|NCT03351101|100420204|FG000|NOT COMPLETED|Overall Study||1||
48040964|NCT03351101|100420205|FG001|NOT COMPLETED|Overall Study||3||
48040965|NCT01193257|100420206|FG000|STARTED|Overall Study||365||
48040966|NCT01193257|100420207|FG001|STARTED|Overall Study||734||
48040967|NCT01193257|100420206|FG000|Treated|Overall Study||363||
48040968|NCT01193257|100420207|FG001|Treated|Overall Study||732||
48040969|NCT01193257|100420206|FG000|COMPLETED|Overall Study||0||
48040970|NCT01193257|100420207|FG001|COMPLETED|Overall Study||0||
48040971|NCT01193257|100420206|FG000|NOT COMPLETED|Overall Study||365||
48040972|NCT01193257|100420207|FG001|NOT COMPLETED|Overall Study||734||
48040973|NCT03051620|100420208|FG000|STARTED|Overall Study||142||
48040974|NCT03051620|100420208|FG000|COMPLETED|Overall Study||124||
48040975|NCT03051620|100420208|FG000|NOT COMPLETED|Overall Study||18||
48040976|NCT03077087|100420209|FG000|STARTED|Overall Study||2||
48040977|NCT03077087|100420209|FG000|COMPLETED|Overall Study||0||
48040978|NCT03077087|100420209|FG000|NOT COMPLETED|Overall Study||2||
48040979|NCT01306929|100420210|FG000|STARTED|Overall Study||134||
48040980|NCT01306929|100420210|FG000|COMPLETED|Overall Study||40||
48040981|NCT01306929|100420210|FG000|NOT COMPLETED|Overall Study||94||
48040982|NCT01836276|100420211|FG000|STARTED|Overall Study||224||
48040983|NCT01836276|100420212|FG001|STARTED|Overall Study||225||
48040984|NCT01836276|100420211|FG000|Week 4|Overall Study||198||
48040985|NCT01836276|100420212|FG001|Week 4|Overall Study||186||
48040986|NCT01836276|100420211|FG000|Week 12|Overall Study||183||
48040987|NCT01836276|100420212|FG001|Week 12|Overall Study||165||
48040988|NCT01836276|100420211|FG000|COMPLETED|Overall Study||196||
48040989|NCT01836276|100420212|FG001|COMPLETED|Overall Study||174||
48040990|NCT01836276|100420211|FG000|NOT COMPLETED|Overall Study||28||
48203332|NCT02221219|100820814|FG002|COMPLETED|Overall Study||41||
48203333|NCT02221219|100820815|FG003|COMPLETED|Overall Study||92||
48203334|NCT02221219|100820812|FG000|NOT COMPLETED|Overall Study||0||
48203335|NCT02221219|100820813|FG001|NOT COMPLETED|Overall Study||0||
48040991|NCT01836276|100420212|FG001|NOT COMPLETED|Overall Study||51||
48040992|NCT05168501|100420213|FG000|STARTED|Overall Study||7||
48040993|NCT05168501|100420213|FG000|COMPLETED|Overall Study||7||
48040994|NCT05168501|100420213|FG000|NOT COMPLETED|Overall Study||0||
48040995|NCT01561898|100420214|FG000|STARTED|Overall Study||7||
48040996|NCT01561898|100420215|FG001|STARTED|Overall Study||92||
48040997|NCT01561898|100420216|FG002|STARTED|Overall Study||97||
48040998|NCT01561898|100420217|FG003|STARTED|Overall Study||32||
48040999|NCT01561898|100420214|FG000|COMPLETED|Overall Study||5||
48041000|NCT01561898|100420215|FG001|COMPLETED|Overall Study||51||
48041001|NCT01561898|100420216|FG002|COMPLETED|Overall Study||53||
48041002|NCT01561898|100420217|FG003|COMPLETED|Overall Study||12||
48041003|NCT01561898|100420214|FG000|NOT COMPLETED|Overall Study||2||
48041004|NCT01561898|100420215|FG001|NOT COMPLETED|Overall Study||41||
48041005|NCT01561898|100420216|FG002|NOT COMPLETED|Overall Study||44||
48041006|NCT01561898|100420217|FG003|NOT COMPLETED|Overall Study||20||
48041007|NCT00329849|100420218|FG000|STARTED|Overall Study||950||
48041008|NCT00329849|100420219|FG001|STARTED|Overall Study||550||
48041009|NCT00329849|100420218|FG000|COMPLETED|Overall Study||944||
48041010|NCT00329849|100420219|FG001|COMPLETED|Overall Study||546||
48041011|NCT00329849|100420218|FG000|NOT COMPLETED|Overall Study||6||
48041012|NCT00329849|100420219|FG001|NOT COMPLETED|Overall Study||4||
48041013|NCT02452931|100420220|FG000|STARTED|Overall Study||64||
48041014|NCT02452931|100420220|FG000|COMPLETED|Overall Study||60||
48041015|NCT02452931|100420220|FG000|NOT COMPLETED|Overall Study||4||
48041016|NCT01027806|100420221|FG000|STARTED|Overall Study||32||
48041017|NCT01027806|100420222|FG001|STARTED|Overall Study||32||
48041018|NCT01027806|100420221|FG000|COMPLETED|Overall Study||28||
48041019|NCT01027806|100420222|FG001|COMPLETED|Overall Study||29||
48041020|NCT01027806|100420221|FG000|NOT COMPLETED|Overall Study||4||
48041021|NCT01027806|100420222|FG001|NOT COMPLETED|Overall Study||3||
48041022|NCT01357850|100420223|FG000|STARTED|Overall Study||30||
48041023|NCT01357850|100420224|FG001|STARTED|Overall Study||12||
48041024|NCT01357850|100420225|FG002|STARTED|Overall Study||13||
48041025|NCT01357850|100420226|FG003|STARTED|Overall Study||27||
48041026|NCT01357850|100420223|FG000|COMPLETED|Overall Study||29||
48041027|NCT01357850|100420224|FG001|COMPLETED|Overall Study||12||
48041028|NCT01357850|100420225|FG002|COMPLETED|Overall Study||13||
48041029|NCT01357850|100420226|FG003|COMPLETED|Overall Study||27||
48041030|NCT01357850|100420223|FG000|NOT COMPLETED|Overall Study||1||
48041031|NCT01357850|100420224|FG001|NOT COMPLETED|Overall Study||0||
48041032|NCT01357850|100420225|FG002|NOT COMPLETED|Overall Study||0||
48041033|NCT01357850|100420226|FG003|NOT COMPLETED|Overall Study||0||
48041034|NCT00802113|100420227|FG000|STARTED|Overall Study||6||
48041035|NCT00802113|100420228|FG001|STARTED|Overall Study||17||
48041036|NCT00802113|100420227|FG000|COMPLETED|Overall Study||6||
48041037|NCT00802113|100420228|FG001|COMPLETED|Overall Study||17||
48041038|NCT00802113|100420227|FG000|NOT COMPLETED|Overall Study||0||
48041039|NCT00802113|100420228|FG001|NOT COMPLETED|Overall Study||0||
48041040|NCT04658940|100420229|FG000|STARTED|Overall Study||115||
48041041|NCT04658940|100420229|FG000|COMPLETED|Overall Study||114||
48041042|NCT04658940|100420229|FG000|NOT COMPLETED|Overall Study||1||
48041043|NCT01982968|100420230|FG000|STARTED|Overall Study||29||
48041044|NCT01982968|100420231|FG001|STARTED|Overall Study||29||
48041045|NCT01982968|100420230|FG000|COMPLETED|Overall Study||21||
48041046|NCT01982968|100420231|FG001|COMPLETED|Overall Study||27||
48041047|NCT01982968|100420230|FG000|NOT COMPLETED|Overall Study||8||
48041048|NCT01982968|100420231|FG001|NOT COMPLETED|Overall Study||2||
48041049|NCT02925416|100420232|FG000|STARTED|Overall Study||17||
48041050|NCT02925416|100420233|FG001|STARTED|Overall Study||5||
48041051|NCT02925416|100420232|FG000|Received at Least 1 Dose of Study Drug|Overall Study||17||
48041052|NCT02925416|100420233|FG001|Received at Least 1 Dose of Study Drug|Overall Study||5||
48041053|NCT02925416|100420232|FG000|COMPLETED|Overall Study||15||
48041054|NCT02925416|100420233|FG001|COMPLETED|Overall Study||5||
48041055|NCT02925416|100420232|FG000|NOT COMPLETED|Overall Study||2||
48041056|NCT02925416|100420233|FG001|NOT COMPLETED|Overall Study||0||
48041057|NCT02726542|100420234|FG000|STARTED|Overall Study||13||
48041058|NCT02726542|100420235|FG001|STARTED|Overall Study||11||
48041059|NCT02726542|100420234|FG000|COMPLETED|Overall Study||10||
48041060|NCT02726542|100420235|FG001|COMPLETED|Overall Study||10||
48041061|NCT02726542|100420234|FG000|NOT COMPLETED|Overall Study||3||
48041062|NCT02726542|100420235|FG001|NOT COMPLETED|Overall Study||1||
48041063|NCT01369329|100420236|FG000|STARTED|Overall Study||256||
48041064|NCT01369329|100420237|FG001|STARTED|Overall Study||254||
48041065|NCT01369329|100420238|FG002|STARTED|Overall Study||259||
48203336|NCT02221219|100820814|FG002|NOT COMPLETED|Overall Study||0||
48203337|NCT02221219|100820815|FG003|NOT COMPLETED|Overall Study||0||
48203338|NCT02251613|100820816|FG000|STARTED|Overall Study||50||
48203339|NCT02251613|100820816|FG000|COMPLETED|Overall Study||50||
48203340|NCT02251613|100820816|FG000|NOT COMPLETED|Overall Study||0||
48203341|NCT01596504|100820817|FG000|STARTED|Overall Study||48||
48203342|NCT01596504|100820818|FG001|STARTED|Overall Study||47||
48203343|NCT01596504|100820819|FG002|STARTED|Overall Study||47||
48203344|NCT01596504|100820817|FG000|COMPLETED|Overall Study||46||
48203345|NCT01596504|100820818|FG001|COMPLETED|Overall Study||44||
48203346|NCT01596504|100820819|FG002|COMPLETED|Overall Study||46||
48203347|NCT01596504|100820817|FG000|NOT COMPLETED|Overall Study||2||
48203348|NCT01596504|100820818|FG001|NOT COMPLETED|Overall Study||3||
48203349|NCT01596504|100820819|FG002|NOT COMPLETED|Overall Study||1||
48041066|NCT01369329|100420236|FG000|COMPLETED|Overall Study||244||
48041067|NCT01369329|100420237|FG001|COMPLETED|Overall Study||243||
48041068|NCT01369329|100420238|FG002|COMPLETED|Overall Study||245||
48041069|NCT01369329|100420236|FG000|NOT COMPLETED|Overall Study||12||
48041070|NCT01369329|100420237|FG001|NOT COMPLETED|Overall Study||11||
48041071|NCT01369329|100420238|FG002|NOT COMPLETED|Overall Study||14||
48041072|NCT02600871|100420239|FG000|STARTED|Overall Study||52||
48041073|NCT02600871|100420240|FG001|STARTED|Overall Study||49||
48041074|NCT02600871|100420239|FG000|COMPLETED|Overall Study||39||
48041075|NCT02600871|100420240|FG001|COMPLETED|Overall Study||39||
48041076|NCT02600871|100420239|FG000|NOT COMPLETED|Overall Study||13||
48041077|NCT02600871|100420240|FG001|NOT COMPLETED|Overall Study||10||
48041078|NCT00843778|100420241|FG000|STARTED|Overall Study||131||
48041079|NCT00843778|100420241|FG000|COMPLETED|Overall Study||96||
48041080|NCT00843778|100420241|FG000|NOT COMPLETED|Overall Study||35||
48041081|NCT00653432|100420242|FG000|STARTED|Overall Study||184|Safety Population|
48041082|NCT00653432|100420243|FG001|STARTED|Overall Study||185|Safety Population|
48041083|NCT00653432|100420242|FG000|Intend-to-treat ITT|Overall Study||181||
48041084|NCT00653432|100420243|FG001|Intend-to-treat ITT|Overall Study||184||
48041085|NCT00653432|100420242|FG000|COMPLETED|Overall Study||162|Completed through 26 weeks follow-up|
48041086|NCT00653432|100420243|FG001|COMPLETED|Overall Study||169|Completed through 26 weeks follow-up|
48041087|NCT00653432|100420242|FG000|NOT COMPLETED|Overall Study||22||
48041088|NCT00653432|100420243|FG001|NOT COMPLETED|Overall Study||16||
48041089|NCT02251548|100420244|FG000|STARTED|Overall Study||85||
48041090|NCT02251548|100420244|FG000|COMPLETED|Overall Study||0||
48041091|NCT02251548|100420244|FG000|NOT COMPLETED|Overall Study||85||
48041092|NCT00727441|100420245|FG000|STARTED|Overall Study||29||
48041093|NCT00727441|100420246|FG001|STARTED|Overall Study||28||
48041094|NCT00727441|100420247|FG002|STARTED|Overall Study||30||
48041095|NCT00727441|100420245|FG000|COMPLETED|Overall Study||11||
48041096|NCT00727441|100420246|FG001|COMPLETED|Overall Study||6||
48041097|NCT00727441|100420247|FG002|COMPLETED|Overall Study||5||
48041098|NCT00727441|100420245|FG000|NOT COMPLETED|Overall Study||18||
48041099|NCT00727441|100420246|FG001|NOT COMPLETED|Overall Study||22||
48041100|NCT00727441|100420247|FG002|NOT COMPLETED|Overall Study||25||
48041101|NCT01375075|100420248|FG000|STARTED|Overall Study||27||
48041102|NCT01375075|100420249|FG001|STARTED|Overall Study||28||
48041103|NCT01375075|100420250|FG002|STARTED|Overall Study||27||
48041104|NCT01375075|100420251|FG003|STARTED|Overall Study||28||
48041105|NCT01375075|100420252|FG004|STARTED|Overall Study||27||
48041106|NCT01375075|100420253|FG005|STARTED|Overall Study||28||
48041107|NCT01375075|100420248|FG000|Received at Least One Dose of Study Drug|Overall Study||27||
48041108|NCT01375075|100420249|FG001|Received at Least One Dose of Study Drug|Overall Study||28||
48041109|NCT01375075|100420250|FG002|Received at Least One Dose of Study Drug|Overall Study||27||
48203350|NCT02053363|100820820|FG000|STARTED|Overall Study||25||
48041110|NCT01375075|100420251|FG003|Received at Least One Dose of Study Drug|Overall Study||28||
48041111|NCT01375075|100420252|FG004|Received at Least One Dose of Study Drug|Overall Study||27||
48041112|NCT01375075|100420253|FG005|Received at Least One Dose of Study Drug|Overall Study||28||
48203351|NCT02053363|100820821|FG001|STARTED|Overall Study||27||
48203352|NCT02053363|100820820|FG000|COMPLETED|Overall Study||25||
48203353|NCT02053363|100820821|FG001|COMPLETED|Overall Study||27||
48203354|NCT02053363|100820820|FG000|NOT COMPLETED|Overall Study||0||
48203355|NCT02053363|100820821|FG001|NOT COMPLETED|Overall Study||0||
48203356|NCT02371746|100820822|FG000|STARTED|Overall Study||7||
48203357|NCT02371746|100820823|FG001|STARTED|Overall Study||10||
48495317|NCT00835614|101547825|FG001|STARTED|First Intervention||13||
48041113|NCT01375075|100420248|FG000|COMPLETED|Overall Study||26||
48041114|NCT01375075|100420249|FG001|COMPLETED|Overall Study||27||
48041115|NCT01375075|100420250|FG002|COMPLETED|Overall Study||24||
48041116|NCT01375075|100420251|FG003|COMPLETED|Overall Study||27||
48041117|NCT01375075|100420252|FG004|COMPLETED|Overall Study||27||
48041118|NCT01375075|100420253|FG005|COMPLETED|Overall Study||25||
48041119|NCT01375075|100420248|FG000|NOT COMPLETED|Overall Study||1||
48041120|NCT01375075|100420249|FG001|NOT COMPLETED|Overall Study||1||
48041121|NCT01375075|100420250|FG002|NOT COMPLETED|Overall Study||3||
48041122|NCT01375075|100420251|FG003|NOT COMPLETED|Overall Study||1||
48041123|NCT01375075|100420252|FG004|NOT COMPLETED|Overall Study||0||
48041124|NCT01375075|100420253|FG005|NOT COMPLETED|Overall Study||3||
48041125|NCT00300742|100420254|FG000|STARTED|Overall Study||5||
48041126|NCT00300742|100420254|FG000|COMPLETED|Overall Study||3||
48041127|NCT00300742|100420254|FG000|NOT COMPLETED|Overall Study||2||
48041128|NCT04075812|100420255|FG000|STARTED|Overall Study||2||
48041129|NCT04075812|100420255|FG000|COMPLETED|Overall Study||2||
48041130|NCT04075812|100420255|FG000|NOT COMPLETED|Overall Study||0||
48041131|NCT00952380|100420256|FG000|STARTED|Overall Study||1||
48041132|NCT00952380|100420257|FG001|STARTED|Overall Study||2||
48041133|NCT00952380|100420258|FG002|STARTED|Overall Study||8||
48041134|NCT00952380|100420259|FG003|STARTED|Overall Study||7||
48203358|NCT02371746|100820824|FG002|STARTED|Overall Study||2||
48203359|NCT02371746|100820825|FG003|STARTED|Overall Study||2||
48203360|NCT02371746|100820826|FG004|STARTED|Overall Study||5||
48203361|NCT02371746|100820827|FG005|STARTED|Overall Study||6||
48203362|NCT02371746|100820828|FG006|STARTED|Overall Study||9||
48203363|NCT02371746|100820822|FG000|COMPLETED|Overall Study||7||
48203364|NCT02371746|100820823|FG001|COMPLETED|Overall Study||10||
48203365|NCT02371746|100820824|FG002|COMPLETED|Overall Study||2||
48203366|NCT02371746|100820825|FG003|COMPLETED|Overall Study||2||
48495318|NCT00835614|101547824|FG000|COMPLETED|First Intervention||13||
48495319|NCT00835614|101547825|FG001|COMPLETED|First Intervention||13||
48495320|NCT00835614|101547824|FG000|NOT COMPLETED|First Intervention||0||
48495321|NCT00835614|101547825|FG001|NOT COMPLETED|First Intervention||0||
48495322|NCT00835614|101547824|FG000|STARTED|Washout of 7 Days||13||
48041135|NCT00952380|100420260|FG004|STARTED|Overall Study||20||
48041136|NCT00952380|100420256|FG000|COMPLETED|Overall Study||1||
48041137|NCT00952380|100420257|FG001|COMPLETED|Overall Study||1||
48041138|NCT00952380|100420258|FG002|COMPLETED|Overall Study||6||
48041139|NCT00952380|100420259|FG003|COMPLETED|Overall Study||4||
48041140|NCT00952380|100420260|FG004|COMPLETED|Overall Study||14||
48041141|NCT00952380|100420256|FG000|NOT COMPLETED|Overall Study||0||
48041142|NCT00952380|100420257|FG001|NOT COMPLETED|Overall Study||1||
48041143|NCT00952380|100420258|FG002|NOT COMPLETED|Overall Study||2||
48041144|NCT00952380|100420259|FG003|NOT COMPLETED|Overall Study||3||
48041145|NCT00952380|100420260|FG004|NOT COMPLETED|Overall Study||6||
48041146|NCT00583713|100420261|FG000|STARTED|Overall Study||6||
48041147|NCT00583713|100420262|FG001|STARTED|Overall Study||6||
48041148|NCT00583713|100420263|FG002|STARTED|Overall Study||6||
48041149|NCT00583713|100420261|FG000|COMPLETED|Overall Study||6||
48041150|NCT00583713|100420262|FG001|COMPLETED|Overall Study||6||
48041151|NCT00583713|100420263|FG002|COMPLETED|Overall Study||6||
48041152|NCT00583713|100420261|FG000|NOT COMPLETED|Overall Study||0||
48041153|NCT00583713|100420262|FG001|NOT COMPLETED|Overall Study||0||
48041154|NCT00583713|100420263|FG002|NOT COMPLETED|Overall Study||0||
48041155|NCT02431260|100420264|FG000|STARTED|Overall Study||4||
48041156|NCT02431260|100420265|FG001|STARTED|Overall Study||5||
48041157|NCT02431260|100420266|FG002|STARTED|Overall Study||6||
48041158|NCT02431260|100420267|FG003|STARTED|Overall Study||5||
48041159|NCT02431260|100420268|FG004|STARTED|Overall Study||3||
48041160|NCT02431260|100420269|FG005|STARTED|Overall Study||4||
48041161|NCT02431260|100420270|FG006|STARTED|Overall Study||4||
48041162|NCT02431260|100420271|FG007|STARTED|Overall Study||3||
48041163|NCT02431260|100420272|FG008|STARTED|Overall Study||8||
48041164|NCT02431260|100420273|FG009|STARTED|Overall Study||8||
48041165|NCT02431260|100420274|FG010|STARTED|Overall Study||4||
48041166|NCT02431260|100420275|FG011|STARTED|Overall Study||4||
48041167|NCT02431260|100420276|FG012|STARTED|Overall Study||10||
48041168|NCT02431260|100420277|FG013|STARTED|Overall Study||1||
48041169|NCT02431260|100420264|FG000|COMPLETED|Overall Study||0||
48041170|NCT02431260|100420265|FG001|COMPLETED|Overall Study||0||
48203367|NCT02371746|100820826|FG004|COMPLETED|Overall Study||5||
48495323|NCT00835614|101547825|FG001|STARTED|Washout of 7 Days||13||
48041171|NCT02431260|100420266|FG002|COMPLETED|Overall Study||0||
48203368|NCT02371746|100820827|FG005|COMPLETED|Overall Study||6||
48203369|NCT02371746|100820828|FG006|COMPLETED|Overall Study||8||
48041172|NCT02431260|100420267|FG003|COMPLETED|Overall Study||0||
48041173|NCT02431260|100420268|FG004|COMPLETED|Overall Study||0||
48041174|NCT02431260|100420269|FG005|COMPLETED|Overall Study||0||
48041175|NCT02431260|100420270|FG006|COMPLETED|Overall Study||0||
48041176|NCT02431260|100420271|FG007|COMPLETED|Overall Study||0||
48041177|NCT02431260|100420272|FG008|COMPLETED|Overall Study||0||
48041178|NCT02431260|100420273|FG009|COMPLETED|Overall Study||0||
48041179|NCT02431260|100420274|FG010|COMPLETED|Overall Study||0||
48041180|NCT02431260|100420275|FG011|COMPLETED|Overall Study||0||
48041181|NCT02431260|100420276|FG012|COMPLETED|Overall Study||0||
48041182|NCT02431260|100420277|FG013|COMPLETED|Overall Study||0||
48041183|NCT02431260|100420264|FG000|NOT COMPLETED|Overall Study||4||
48041184|NCT02431260|100420265|FG001|NOT COMPLETED|Overall Study||5||
48041185|NCT02431260|100420266|FG002|NOT COMPLETED|Overall Study||6||
48041186|NCT02431260|100420267|FG003|NOT COMPLETED|Overall Study||5||
48041187|NCT02431260|100420268|FG004|NOT COMPLETED|Overall Study||3||
48203370|NCT02371746|100820822|FG000|NOT COMPLETED|Overall Study||0||
48203371|NCT02371746|100820823|FG001|NOT COMPLETED|Overall Study||0||
48203372|NCT02371746|100820824|FG002|NOT COMPLETED|Overall Study||0||
48203373|NCT02371746|100820825|FG003|NOT COMPLETED|Overall Study||0||
48203374|NCT02371746|100820826|FG004|NOT COMPLETED|Overall Study||0||
48203375|NCT02371746|100820827|FG005|NOT COMPLETED|Overall Study||0||
48203376|NCT02371746|100820828|FG006|NOT COMPLETED|Overall Study||1||
48495324|NCT00835614|101547824|FG000|COMPLETED|Washout of 7 Days||13||
48495325|NCT00835614|101547825|FG001|COMPLETED|Washout of 7 Days||13||
48495326|NCT00835614|101547824|FG000|NOT COMPLETED|Washout of 7 Days||0||
48495327|NCT00835614|101547825|FG001|NOT COMPLETED|Washout of 7 Days||0||
48495328|NCT00835614|101547824|FG000|STARTED|Second Intervention||13||
48495329|NCT00835614|101547825|FG001|STARTED|Second Intervention||13||
48495330|NCT00835614|101547824|FG000|COMPLETED|Second Intervention||13||
48495331|NCT00835614|101547825|FG001|COMPLETED|Second Intervention||13||
48495332|NCT00835614|101547824|FG000|NOT COMPLETED|Second Intervention||0||
48495333|NCT00835614|101547825|FG001|NOT COMPLETED|Second Intervention||0||
48495334|NCT00606281|101547826|FG000|STARTED|Overall Study||128||
48495335|NCT00606281|101547827|FG001|STARTED|Overall Study||130||
48495336|NCT00606281|101547826|FG000|COMPLETED|Overall Study||72||
48495337|NCT00606281|101547827|FG001|COMPLETED|Overall Study||64||
48495338|NCT00606281|101547826|FG000|NOT COMPLETED|Overall Study||56||
48041188|NCT02431260|100420269|FG005|NOT COMPLETED|Overall Study||4||
48041189|NCT02431260|100420270|FG006|NOT COMPLETED|Overall Study||4||
48041190|NCT02431260|100420271|FG007|NOT COMPLETED|Overall Study||3||
48041191|NCT02431260|100420272|FG008|NOT COMPLETED|Overall Study||8||
48041192|NCT02431260|100420273|FG009|NOT COMPLETED|Overall Study||8||
48041193|NCT02431260|100420274|FG010|NOT COMPLETED|Overall Study||4||
48041194|NCT02431260|100420275|FG011|NOT COMPLETED|Overall Study||4||
48041195|NCT02431260|100420276|FG012|NOT COMPLETED|Overall Study||10||
48041196|NCT02431260|100420277|FG013|NOT COMPLETED|Overall Study||1||
48041197|NCT01816451|100420278|FG000|STARTED|Overall Study||13||
48041198|NCT01816451|100420279|FG001|STARTED|Overall Study||11||
48041199|NCT01816451|100420280|FG002|STARTED|Overall Study||8||
48041200|NCT01816451|100420278|FG000|COMPLETED|Overall Study||13||
48041201|NCT01816451|100420279|FG001|COMPLETED|Overall Study||11||
48041202|NCT01816451|100420280|FG002|COMPLETED|Overall Study||8||
48041203|NCT01816451|100420278|FG000|NOT COMPLETED|Overall Study||0||
48041204|NCT01816451|100420279|FG001|NOT COMPLETED|Overall Study||0||
48041205|NCT01816451|100420280|FG002|NOT COMPLETED|Overall Study||0||
48041206|NCT00985829|100420281|FG000|STARTED|Overall Study||28||
48041207|NCT00985829|100420281|FG000|COMPLETED|Overall Study||28||
48041208|NCT00985829|100420281|FG000|NOT COMPLETED|Overall Study||0||
48041209|NCT02142387|100420282|FG000|STARTED|Overall Study||2551||
48041210|NCT02142387|100420283|FG001|STARTED|Overall Study||16271||
48041211|NCT02142387|100420282|FG000|COMPLETED|Overall Study||1486||
48041212|NCT02142387|100420283|FG001|COMPLETED|Overall Study||8641||
48041213|NCT02142387|100420282|FG000|NOT COMPLETED|Overall Study||1065||
48041214|NCT02142387|100420283|FG001|NOT COMPLETED|Overall Study||7630||
48041215|NCT01453387|100420284|FG000|STARTED|Overall Study||21||
48041216|NCT01453387|100420285|FG001|STARTED|Overall Study||7||
48041217|NCT01453387|100420284|FG000|COMPLETED|Overall Study||21||
48041218|NCT01453387|100420285|FG001|COMPLETED|Overall Study||7||
48041219|NCT01453387|100420284|FG000|NOT COMPLETED|Overall Study||0||
48041220|NCT01453387|100420285|FG001|NOT COMPLETED|Overall Study||0||
48041221|NCT04434846|100420286|FG000|STARTED|Overall Study||300||
48041222|NCT04434846|100420286|FG000|COMPLETED|Overall Study||300||
48041223|NCT04434846|100420286|FG000|NOT COMPLETED|Overall Study||0||
48041224|NCT01012674|100420287|FG000|STARTED|Overall Study||211||
48495339|NCT00606281|101547827|FG001|NOT COMPLETED|Overall Study||66||
48495340|NCT03499353|101547828|FG000|STARTED|Treatment||61||
48495341|NCT03499353|101547828|FG000|COMPLETED|Treatment||45||
48495342|NCT03499353|101547828|FG000|NOT COMPLETED|Treatment||16||
48495343|NCT03499353|101547828|FG000|STARTED|Safety Follow-up||49||
48495344|NCT03499353|101547828|FG000|Received Treatment|Safety Follow-up||0||
48203377|NCT04842604|100820829|FG000|STARTED|Overall Study||9||
48203378|NCT04842604|100820830|FG001|STARTED|Overall Study||5||
48203379|NCT04842604|100820829|FG000|Treated|Overall Study||8||
48203380|NCT04842604|100820830|FG001|Treated|Overall Study||5||
48203381|NCT04842604|100820829|FG000|COMPLETED|Overall Study||3||
48203382|NCT04842604|100820830|FG001|COMPLETED|Overall Study||1||
48203383|NCT04842604|100820829|FG000|NOT COMPLETED|Overall Study||6||
48203384|NCT04842604|100820830|FG001|NOT COMPLETED|Overall Study||4||
48203385|NCT01768676|100820831|FG000|STARTED|Overall Study||90||
48203386|NCT01768676|100820832|FG001|STARTED|Overall Study||91||
48203387|NCT01768676|100820831|FG000|COMPLETED|Overall Study||66||
48203388|NCT01768676|100820832|FG001|COMPLETED|Overall Study||60||
48203389|NCT01768676|100820831|FG000|NOT COMPLETED|Overall Study||24||
48203390|NCT01768676|100820832|FG001|NOT COMPLETED|Overall Study||31||
48203391|NCT04379713|100820833|FG000|STARTED|Overall Study||1006||
48203392|NCT04379713|100820834|FG001|STARTED|Overall Study||505||
48203393|NCT04379713|100820833|FG000|Dose 1|Overall Study||1000||
48203394|NCT04379713|100820834|FG001|Dose 1|Overall Study||504||
48203395|NCT04379713|100820833|FG000|Dose 2|Overall Study||972||
48203396|NCT04379713|100820834|FG001|Dose 2|Overall Study||492||
48203397|NCT04379713|100820833|FG000|Dose 3|Overall Study||964||
48041225|NCT01012674|100420287|FG000|COMPLETED|Overall Study||187||
48041226|NCT01012674|100420287|FG000|NOT COMPLETED|Overall Study||24||
48041227|NCT03005873|100420288|FG000|STARTED|Overall Study||26||
48041228|NCT03005873|100420289|FG001|STARTED|Overall Study||24||
48041229|NCT03005873|100420290|FG002|STARTED|Overall Study||26||
48041230|NCT03005873|100420288|FG000|COMPLETED|Overall Study||25||
48041231|NCT03005873|100420289|FG001|COMPLETED|Overall Study||21||
48041232|NCT03005873|100420290|FG002|COMPLETED|Overall Study||22||
48041233|NCT03005873|100420288|FG000|NOT COMPLETED|Overall Study||1||
48041234|NCT03005873|100420289|FG001|NOT COMPLETED|Overall Study||3||
48041235|NCT03005873|100420290|FG002|NOT COMPLETED|Overall Study||4||
48041236|NCT00043550|100420291|FG000|STARTED|Overall Study||55||
48041237|NCT00043550|100420292|FG001|STARTED|Overall Study||51||
48041238|NCT00043550|100420293|FG002|STARTED|Overall Study||50||
48041239|NCT00043550|100420291|FG000|Week 8 Completed|Overall Study||35||
48041240|NCT00043550|100420292|FG001|Week 8 Completed|Overall Study||40||
48041241|NCT00043550|100420293|FG002|Week 8 Completed|Overall Study||35||
48041242|NCT00043550|100420291|FG000|COMPLETED|Overall Study||33||
48041243|NCT00043550|100420292|FG001|COMPLETED|Overall Study||39||
48041244|NCT00043550|100420293|FG002|COMPLETED|Overall Study||30||
48041245|NCT00043550|100420291|FG000|NOT COMPLETED|Overall Study||22||
48041246|NCT00043550|100420292|FG001|NOT COMPLETED|Overall Study||12||
48041247|NCT00043550|100420293|FG002|NOT COMPLETED|Overall Study||20||
48041248|NCT03608150|100420294|FG000|STARTED|Overall Study||58||
48041249|NCT03608150|100420295|FG001|STARTED|Overall Study||59||
48041250|NCT03608150|100420294|FG000|COMPLETED|Overall Study||47||
48041251|NCT03608150|100420295|FG001|COMPLETED|Overall Study||48||
48041252|NCT03608150|100420294|FG000|NOT COMPLETED|Overall Study||11||
48041253|NCT03608150|100420295|FG001|NOT COMPLETED|Overall Study||11||
48041254|NCT03206788|100420296|FG000|STARTED|Overall Study||2||
48041255|NCT03206788|100420297|FG001|STARTED|Overall Study||5||
48041256|NCT03206788|100420296|FG000|COMPLETED|Overall Study||2||
48041257|NCT03206788|100420297|FG001|COMPLETED|Overall Study||2||
48041258|NCT03206788|100420296|FG000|NOT COMPLETED|Overall Study||0||
48041259|NCT03206788|100420297|FG001|NOT COMPLETED|Overall Study||3||
48041260|NCT00853970|100420298|FG000|STARTED|Overall Study||152||
48041261|NCT00853970|100420299|FG001|STARTED|Overall Study||147||
48041262|NCT00853970|100420298|FG000|COMPLETED|Overall Study||146||
48041263|NCT00853970|100420299|FG001|COMPLETED|Overall Study||144||
48203398|NCT04379713|100820834|FG001|Dose 3|Overall Study||483||
48203399|NCT04379713|100820833|FG000|Dose 4|Overall Study||923||
48203400|NCT04379713|100820834|FG001|Dose 4|Overall Study||462||
48203401|NCT04379713|100820833|FG000|COMPLETED|Overall Study||910||
48203402|NCT04379713|100820834|FG001|COMPLETED|Overall Study||451||
48203403|NCT04379713|100820833|FG000|NOT COMPLETED|Overall Study||96||
48203404|NCT04379713|100820834|FG001|NOT COMPLETED|Overall Study||54||
48041264|NCT00853970|100420298|FG000|NOT COMPLETED|Overall Study||6||
48041265|NCT00853970|100420299|FG001|NOT COMPLETED|Overall Study||3||
48041266|NCT01101308|100420300|FG000|STARTED|Period 1||27||
48041267|NCT01101308|100420301|FG001|STARTED|Period 1||28||
48203405|NCT00770965|100820835|FG000|STARTED|Safety Set||2||
48203406|NCT00770965|100820836|FG001|STARTED|Safety Set||4||
48203407|NCT00770965|100820837|FG002|STARTED|Safety Set||4||
48203408|NCT00770965|100820838|FG003|STARTED|Safety Set||5||
48041268|NCT01101308|100420300|FG000|COMPLETED|Period 1||24||
48041269|NCT01101308|100420301|FG001|COMPLETED|Period 1||27||
48041270|NCT01101308|100420300|FG000|NOT COMPLETED|Period 1||3||
48041271|NCT01101308|100420301|FG001|NOT COMPLETED|Period 1||1||
48041272|NCT01101308|100420300|FG000|STARTED|Period 2||24||
48041273|NCT01101308|100420301|FG001|STARTED|Period 2||27||
48041274|NCT01101308|100420300|FG000|COMPLETED|Period 2||24||
48041275|NCT01101308|100420301|FG001|COMPLETED|Period 2||27||
48041276|NCT01101308|100420300|FG000|NOT COMPLETED|Period 2||0||
48041277|NCT01101308|100420301|FG001|NOT COMPLETED|Period 2||0||
48041278|NCT04656899|100420302|FG000|STARTED|Overall Study||19||
48203409|NCT00770965|100820835|FG000|COMPLETED|Safety Set||2||
48041279|NCT04656899|100420303|FG001|STARTED|Overall Study||22||
48041280|NCT04656899|100420302|FG000|COMPLETED|Overall Study||16||
48041281|NCT04656899|100420303|FG001|COMPLETED|Overall Study||13||
48041282|NCT04656899|100420302|FG000|NOT COMPLETED|Overall Study||3||
48041283|NCT04656899|100420303|FG001|NOT COMPLETED|Overall Study||9||
48041284|NCT03255629|100420304|FG000|STARTED|Overall Study||8||
48041285|NCT03255629|100420305|FG001|STARTED|Overall Study||8||
48041286|NCT03255629|100420304|FG000|COMPLETED|Overall Study||5||
48041287|NCT03255629|100420305|FG001|COMPLETED|Overall Study||7||
48041288|NCT03255629|100420304|FG000|NOT COMPLETED|Overall Study||3||
48041289|NCT03255629|100420305|FG001|NOT COMPLETED|Overall Study||1||
48041290|NCT00813943|100420306|FG000|STARTED|Overall Study||88||
48041291|NCT00813943|100420307|FG001|STARTED|Overall Study||88||
48041292|NCT00813943|100420308|FG002|STARTED|Overall Study||89||
48041293|NCT00813943|100420306|FG000|COMPLETED|Overall Study||83||
48041294|NCT00813943|100420307|FG001|COMPLETED|Overall Study||83||
48041295|NCT00813943|100420308|FG002|COMPLETED|Overall Study||86||
48041296|NCT00813943|100420306|FG000|NOT COMPLETED|Overall Study||5||
48041297|NCT00813943|100420307|FG001|NOT COMPLETED|Overall Study||5||
48041298|NCT00813943|100420308|FG002|NOT COMPLETED|Overall Study||3||
48041299|NCT00368290|100420309|FG000|STARTED|Overall Study||47||
48041300|NCT00368290|100420310|FG001|STARTED|Overall Study||47||
48041301|NCT00368290|100420309|FG000|COMPLETED|Overall Study||34||
48041302|NCT00368290|100420310|FG001|COMPLETED|Overall Study||37||
48041303|NCT00368290|100420309|FG000|NOT COMPLETED|Overall Study||13||
48041304|NCT00368290|100420310|FG001|NOT COMPLETED|Overall Study||10||
48041305|NCT01403948|100420311|FG000|STARTED|Overall Study||1||
48041306|NCT01403948|100420312|FG001|STARTED|Overall Study||4||
48041307|NCT01403948|100420313|FG002|STARTED|Overall Study||3||
48041308|NCT01403948|100420314|FG003|STARTED|Overall Study||4||
48041309|NCT01403948|100420315|FG004|STARTED|Overall Study||6||
48041310|NCT01403948|100420316|FG005|STARTED|Overall Study||7||
48041311|NCT01403948|100420317|FG006|STARTED|Overall Study||6||
48041312|NCT01403948|100420318|FG007|STARTED|Overall Study||4||
48041313|NCT01403948|100420319|FG008|STARTED|Overall Study||6||
48041314|NCT01403948|100420320|FG009|STARTED|Overall Study||7||
48041315|NCT01403948|100420311|FG000|COMPLETED|Overall Study||0||
48041316|NCT01403948|100420312|FG001|COMPLETED|Overall Study||0||
48041317|NCT01403948|100420313|FG002|COMPLETED|Overall Study||0||
48041318|NCT01403948|100420314|FG003|COMPLETED|Overall Study||0||
48041319|NCT01403948|100420315|FG004|COMPLETED|Overall Study||0||
48495345|NCT03499353|101547828|FG000|COMPLETED|Safety Follow-up||49||
48495346|NCT03499353|101547828|FG000|NOT COMPLETED|Safety Follow-up||0||
48041320|NCT01403948|100420316|FG005|COMPLETED|Overall Study||0||
48041321|NCT01403948|100420317|FG006|COMPLETED|Overall Study||0||
48041322|NCT01403948|100420318|FG007|COMPLETED|Overall Study||0||
48041323|NCT01403948|100420319|FG008|COMPLETED|Overall Study||0||
48041324|NCT01403948|100420320|FG009|COMPLETED|Overall Study||0||
48041325|NCT01403948|100420311|FG000|NOT COMPLETED|Overall Study||1||
48041326|NCT01403948|100420312|FG001|NOT COMPLETED|Overall Study||4||
48041327|NCT01403948|100420313|FG002|NOT COMPLETED|Overall Study||3||
48041328|NCT01403948|100420314|FG003|NOT COMPLETED|Overall Study||4||
48041329|NCT01403948|100420315|FG004|NOT COMPLETED|Overall Study||6||
48041330|NCT01403948|100420316|FG005|NOT COMPLETED|Overall Study||7||
48041331|NCT01403948|100420317|FG006|NOT COMPLETED|Overall Study||6||
48041332|NCT01403948|100420318|FG007|NOT COMPLETED|Overall Study||4||
48041333|NCT01403948|100420319|FG008|NOT COMPLETED|Overall Study||6||
48041334|NCT01403948|100420320|FG009|NOT COMPLETED|Overall Study||7||
48041335|NCT01230177|100423758|FG000|STARTED|Overall Study||3||
48041336|NCT01230177|100423758|FG000|COMPLETED|Overall Study||3||
48041337|NCT01230177|100423758|FG000|NOT COMPLETED|Overall Study||0||
48041338|NCT01037088|100423759|FG000|STARTED|Overall Study||39||
48041339|NCT01037088|100423759|FG000|Received 3.53% THC|Overall Study||36||
48041340|NCT01037088|100423759|FG000|Received 1.29% THC|Overall Study||37||
48041341|NCT01037088|100423759|FG000|Received Placebo|Overall Study||38||
48041342|NCT01037088|100423759|FG000|COMPLETED|Overall Study||36||
48041343|NCT01037088|100423759|FG000|NOT COMPLETED|Overall Study||3||
48041344|NCT00833417|100423760|FG000|STARTED|Overall Study||33||
48041345|NCT00833417|100423761|FG001|STARTED|Overall Study||71||
48041346|NCT00833417|100423760|FG000|COMPLETED|Overall Study||0||
48041347|NCT00833417|100423761|FG001|COMPLETED|Overall Study||0||
48041348|NCT00833417|100423760|FG000|NOT COMPLETED|Overall Study||33||
48041349|NCT00833417|100423761|FG001|NOT COMPLETED|Overall Study||71||
48041350|NCT01484288|100423762|FG000|STARTED|Overall Study||11||
48041351|NCT01484288|100423762|FG000|COMPLETED|Overall Study||11||
48041352|NCT01484288|100423762|FG000|NOT COMPLETED|Overall Study||0||
48041353|NCT00787904|100423763|FG000|STARTED|Overall Study||6||
48041354|NCT00787904|100423764|FG001|STARTED|Overall Study||13||
48041355|NCT00787904|100423763|FG000|COMPLETED|Overall Study||6||
48041356|NCT00787904|100423764|FG001|COMPLETED|Overall Study||13||
48041357|NCT00787904|100423763|FG000|NOT COMPLETED|Overall Study||0||
48041358|NCT00787904|100423764|FG001|NOT COMPLETED|Overall Study||0||
48041359|NCT05293392|100423765|FG000|STARTED|Phase 1: Community-Tailored Handouts||268||2
48041360|NCT05293392|100423766|FG001|STARTED|Phase 1: Community-Tailored Handouts||406||2
48203410|NCT00770965|100820836|FG001|COMPLETED|Safety Set||4||
48041361|NCT05293392|100423765|FG000|COMPLETED|Phase 1: Community-Tailored Handouts||268||2
48041362|NCT05293392|100423766|FG001|COMPLETED|Phase 1: Community-Tailored Handouts||406||2
48041363|NCT05293392|100423765|FG000|NOT COMPLETED|Phase 1: Community-Tailored Handouts||0||0
48041364|NCT05293392|100423766|FG001|NOT COMPLETED|Phase 1: Community-Tailored Handouts||0||0
48041365|NCT05293392|100423765|FG000|STARTED|Phase 2: Videos Featuring Local Families||281||2
48041366|NCT05293392|100423766|FG001|STARTED|Phase 2: Videos Featuring Local Families||476||2
48041367|NCT05293392|100423765|FG000|COMPLETED|Phase 2: Videos Featuring Local Families||281||2
48041368|NCT05293392|100423766|FG001|COMPLETED|Phase 2: Videos Featuring Local Families||476||2
48041369|NCT05293392|100423765|FG000|NOT COMPLETED|Phase 2: Videos Featuring Local Families||0||0
48041370|NCT05293392|100423766|FG001|NOT COMPLETED|Phase 2: Videos Featuring Local Families||0||0
48041371|NCT05293392|100423765|FG000|STARTED|Phase 3: Family-Centered Communication||442||2
48041372|NCT05293392|100423766|FG001|STARTED|Phase 3: Family-Centered Communication||628||2
48041373|NCT05293392|100423765|FG000|COMPLETED|Phase 3: Family-Centered Communication||442||2
48041374|NCT05293392|100423766|FG001|COMPLETED|Phase 3: Family-Centered Communication||628||2
48041375|NCT05293392|100423765|FG000|NOT COMPLETED|Phase 3: Family-Centered Communication||0||0
48041376|NCT05293392|100423766|FG001|NOT COMPLETED|Phase 3: Family-Centered Communication||0||0
48041377|NCT05293392|100423765|FG000|STARTED|Phase 4:Community Health Worker Outreach||1230||2
48041378|NCT05293392|100423766|FG001|STARTED|Phase 4:Community Health Worker Outreach||2019||2
48041379|NCT05293392|100423765|FG000|COMPLETED|Phase 4:Community Health Worker Outreach||1230||2
48041380|NCT05293392|100423766|FG001|COMPLETED|Phase 4:Community Health Worker Outreach||2019||2
48041381|NCT05293392|100423765|FG000|NOT COMPLETED|Phase 4:Community Health Worker Outreach||0||0
48041382|NCT05293392|100423766|FG001|NOT COMPLETED|Phase 4:Community Health Worker Outreach||0||0
48041383|NCT02805504|100423767|FG000|STARTED|Overall Study||63||
48041384|NCT02805504|100423768|FG001|STARTED|Overall Study||73||
48041385|NCT02805504|100423767|FG000|COMPLETED|Overall Study||63||
48041386|NCT02805504|100423768|FG001|COMPLETED|Overall Study||73||
48041387|NCT02805504|100423767|FG000|NOT COMPLETED|Overall Study||0||
48041388|NCT02805504|100423768|FG001|NOT COMPLETED|Overall Study||0||
48041389|NCT01147627|100423769|FG000|STARTED|Overall Study||142||
48041390|NCT01147627|100423770|FG001|STARTED|Overall Study||138||
48041391|NCT01147627|100423771|FG002|STARTED|Overall Study||136||
48041392|NCT01147627|100423769|FG000|COMPLETED|Overall Study||110||
48041393|NCT01147627|100423770|FG001|COMPLETED|Overall Study||114||
48041394|NCT01147627|100423771|FG002|COMPLETED|Overall Study||118||
48041395|NCT01147627|100423769|FG000|NOT COMPLETED|Overall Study||32||
48041396|NCT01147627|100423770|FG001|NOT COMPLETED|Overall Study||24||
48041397|NCT01147627|100423771|FG002|NOT COMPLETED|Overall Study||18||
48041398|NCT00734747|100423772|FG000|STARTED|SRS Procedure||72||
48041399|NCT00734747|100423772|FG000|COMPLETED|SRS Procedure||69||
48041400|NCT00734747|100423772|FG000|NOT COMPLETED|SRS Procedure||3||
48041401|NCT00734747|100423772|FG000|STARTED|6 Month Follow-up||69||
48041402|NCT00734747|100423772|FG000|COMPLETED|6 Month Follow-up||66||
48041403|NCT00734747|100423772|FG000|NOT COMPLETED|6 Month Follow-up||3||
48041404|NCT02536404|100423773|FG000|STARTED|Overall Study||112||
48041405|NCT02536404|100423774|FG001|STARTED|Overall Study||6||
48041406|NCT02536404|100423773|FG000|COMPLETED|Overall Study||92||
48041407|NCT02536404|100423774|FG001|COMPLETED|Overall Study||5||
48041408|NCT02536404|100423773|FG000|NOT COMPLETED|Overall Study||20||
48041409|NCT02536404|100423774|FG001|NOT COMPLETED|Overall Study||1||
48041410|NCT02683746|100423775|FG000|STARTED|Overall Study||154||
48041411|NCT02683746|100423776|FG001|STARTED|Overall Study||154||
48041412|NCT02683746|100423775|FG000|COMPLETED|Overall Study||138||
48041413|NCT02683746|100423776|FG001|COMPLETED|Overall Study||140||
48041414|NCT02683746|100423775|FG000|NOT COMPLETED|Overall Study||16||
48041415|NCT02683746|100423776|FG001|NOT COMPLETED|Overall Study||14||
48041416|NCT02208063|100423777|FG000|STARTED|Overall Study||60|All Randomized|
48041417|NCT02208063|100423778|FG001|STARTED|Overall Study||61|All Randomized|
48041418|NCT02208063|100423777|FG000|Randomized and Treated|Overall Study||58||
48041419|NCT02208063|100423778|FG001|Randomized and Treated|Overall Study||60||
48041420|NCT02208063|100423777|FG000|Microbiological All Treated|Overall Study||47|Includes all subjects in the AT population who had a mono-microbial QBC positive for S. aureus.|
48041421|NCT02208063|100423778|FG001|Microbiological All Treated|Overall Study||52|Includes all subjects in the AT population who had a mono-microbial QBC positive for S. aureus.|
48041422|NCT02208063|100423777|FG000|COMPLETED|Overall Study||48||
48041423|NCT02208063|100423778|FG001|COMPLETED|Overall Study||50||
48041424|NCT02208063|100423777|FG000|NOT COMPLETED|Overall Study||12||
48041425|NCT02208063|100423778|FG001|NOT COMPLETED|Overall Study||11||
48041426|NCT00725842|100423779|FG000|STARTED|Overall Study||97||
48041427|NCT00725842|100423779|FG000|Participants Eligible for Analysis|Overall Study||90||
48041428|NCT00725842|100423779|FG000|COMPLETED|Overall Study||57||
48041429|NCT00725842|100423779|FG000|NOT COMPLETED|Overall Study||40||
48041430|NCT00796445|100423780|FG000|STARTED|Overall Study||895||
48041431|NCT00796445|100423781|FG001|STARTED|Overall Study||450||
48041432|NCT00796445|100423780|FG000|COMPLETED|Overall Study||310||
48041433|NCT00796445|100423781|FG001|COMPLETED|Overall Study||158||
48041434|NCT00796445|100423780|FG000|NOT COMPLETED|Overall Study||585||
48041435|NCT00796445|100423781|FG001|NOT COMPLETED|Overall Study||292||
48203411|NCT00770965|100820837|FG002|COMPLETED|Safety Set||3||
48203412|NCT00770965|100820838|FG003|COMPLETED|Safety Set||4||
48203413|NCT00770965|100820835|FG000|NOT COMPLETED|Safety Set||0||
48203414|NCT00770965|100820836|FG001|NOT COMPLETED|Safety Set||0||
48203415|NCT00770965|100820837|FG002|NOT COMPLETED|Safety Set||1||
48203416|NCT00770965|100820838|FG003|NOT COMPLETED|Safety Set||1||
48203417|NCT00770965|100820835|FG000|STARTED|Excluded Set||18||
48203418|NCT00770965|100820836|FG001|STARTED|Excluded Set||16||
48203419|NCT00770965|100820837|FG002|STARTED|Excluded Set||16||
48203420|NCT00770965|100820838|FG003|STARTED|Excluded Set||15||
48203421|NCT00770965|100820835|FG000|COMPLETED|Excluded Set||3||
48203422|NCT00770965|100820836|FG001|COMPLETED|Excluded Set||3||
48203423|NCT00770965|100820837|FG002|COMPLETED|Excluded Set||2||
48203424|NCT00770965|100820838|FG003|COMPLETED|Excluded Set||2||
48203425|NCT00770965|100820835|FG000|NOT COMPLETED|Excluded Set||15||
48203426|NCT00770965|100820836|FG001|NOT COMPLETED|Excluded Set||13||
48203427|NCT00770965|100820837|FG002|NOT COMPLETED|Excluded Set||14||
48203428|NCT00770965|100820838|FG003|NOT COMPLETED|Excluded Set||13||
48203429|NCT01537133|100820839|FG000|STARTED|Overall Study||28||
48203430|NCT01537133|100820840|FG001|STARTED|Overall Study||14||
48203431|NCT01537133|100820841|FG002|STARTED|Overall Study||21||
48203432|NCT01537133|100820842|FG003|STARTED|Overall Study||21||
48203433|NCT01537133|100820839|FG000|COMPLETED|Overall Study||25||
48203434|NCT01537133|100820840|FG001|COMPLETED|Overall Study||14||
48203435|NCT01537133|100820841|FG002|COMPLETED|Overall Study||21||
48203436|NCT01537133|100820842|FG003|COMPLETED|Overall Study||21||
48203437|NCT01537133|100820839|FG000|NOT COMPLETED|Overall Study||3||
48203438|NCT01537133|100820840|FG001|NOT COMPLETED|Overall Study||0||
48495347|NCT03499353|101547828|FG000|STARTED|Long-Term Follow-up||58||
48495348|NCT03499353|101547828|FG000|Received Treatment|Long-Term Follow-up||0||
48041436|NCT00947505|100423782|FG000|STARTED|Overall Study||33||
48041437|NCT00947505|100423783|FG001|STARTED|Overall Study||16||
48041438|NCT00947505|100423782|FG000|COMPLETED|Overall Study||24||
48041439|NCT00947505|100423783|FG001|COMPLETED|Overall Study||14||
48041440|NCT00947505|100423782|FG000|NOT COMPLETED|Overall Study||9||
48041441|NCT00947505|100423783|FG001|NOT COMPLETED|Overall Study||2||
48041442|NCT01328366|100423784|FG000|STARTED|Overall Study||153||
48041443|NCT01328366|100423784|FG000|COMPLETED|Overall Study||143||
48041444|NCT01328366|100423784|FG000|NOT COMPLETED|Overall Study||10||
48041445|NCT02004288|100423785|FG000|STARTED|Overall Study||15||
48041446|NCT02004288|100423786|FG001|STARTED|Overall Study||16||
48041447|NCT02004288|100423785|FG000|COMPLETED|Overall Study||14||
48041448|NCT02004288|100423786|FG001|COMPLETED|Overall Study||15||
48041449|NCT02004288|100423785|FG000|NOT COMPLETED|Overall Study||1||
48041450|NCT02004288|100423786|FG001|NOT COMPLETED|Overall Study||1||
48041451|NCT05277337|100423787|FG000|STARTED|Overall Study||99||
48041452|NCT05277337|100423788|FG001|STARTED|Overall Study||51||
48041453|NCT05277337|100423787|FG000|COMPLETED|Overall Study||96||
48041454|NCT05277337|100423788|FG001|COMPLETED|Overall Study||51||
48041455|NCT05277337|100423787|FG000|NOT COMPLETED|Overall Study||3||
48041456|NCT05277337|100423788|FG001|NOT COMPLETED|Overall Study||0||
48041457|NCT00545129|100423789|FG000|STARTED|Overall Study||29||
48041458|NCT00545129|100423790|FG001|STARTED|Overall Study||30||
48041459|NCT00545129|100423789|FG000|COMPLETED|Overall Study||12||
48041460|NCT00545129|100423790|FG001|COMPLETED|Overall Study||6||
48203439|NCT01537133|100820841|FG002|NOT COMPLETED|Overall Study||0||
48203440|NCT01537133|100820842|FG003|NOT COMPLETED|Overall Study||0||
48203441|NCT01378065|100820843|FG000|STARTED|Overall Study||30||
48203442|NCT01378065|100820843|FG000|6 Week|Overall Study||30||
48203443|NCT01378065|100820843|FG000|3 Months|Overall Study||30||
48203444|NCT01378065|100820843|FG000|6 Months|Overall Study||30||
48203445|NCT01378065|100820843|FG000|12 Months|Overall Study||30||
48203446|NCT01378065|100820843|FG000|COMPLETED|Overall Study||30||
48203447|NCT01378065|100820843|FG000|NOT COMPLETED|Overall Study||0||
48203448|NCT01194154|100820844|FG000|STARTED|Overall Study||117||
48203449|NCT01194154|100820845|FG001|STARTED|Overall Study||124||
48203450|NCT01194154|100820844|FG000|Full Analysis Set|Overall Study||115||
48203451|NCT01194154|100820845|FG001|Full Analysis Set|Overall Study||120||
48203452|NCT01194154|100820844|FG000|Safety Analysis Set|Overall Study||118||
48203453|NCT01194154|100820845|FG001|Safety Analysis Set|Overall Study||117||
48203454|NCT01194154|100820844|FG000|COMPLETED|Overall Study||68||
48203455|NCT01194154|100820845|FG001|COMPLETED|Overall Study||91||
48203456|NCT01194154|100820844|FG000|NOT COMPLETED|Overall Study||49||
48203457|NCT01194154|100820845|FG001|NOT COMPLETED|Overall Study||33||
48203458|NCT01123928|100820846|FG000|STARTED|Overall Study||212||
48203459|NCT01123928|100820847|FG001|STARTED|Overall Study||222||
48203460|NCT01123928|100820846|FG000|COMPLETED|Overall Study||212||
48203461|NCT01123928|100820847|FG001|COMPLETED|Overall Study||222||
48203462|NCT01123928|100820846|FG000|NOT COMPLETED|Overall Study||0||
48041461|NCT00545129|100423789|FG000|NOT COMPLETED|Overall Study||17||
48041462|NCT00545129|100423790|FG001|NOT COMPLETED|Overall Study||24||
48041463|NCT04233918|100423791|FG000|STARTED|Period 1: Part A and B||6||
48041464|NCT04233918|100423792|FG001|STARTED|Period 1: Part A and B||14||
48203463|NCT01123928|100820847|FG001|NOT COMPLETED|Overall Study||0||
48203464|NCT00796068|100820848|FG000|STARTED|Overall Study||66||
48203465|NCT00796068|100820849|FG001|STARTED|Overall Study||64||
48203466|NCT00796068|100820848|FG000|COMPLETED|Overall Study||66||
48203467|NCT00796068|100820849|FG001|COMPLETED|Overall Study||64||
48041465|NCT04233918|100423793|FG002|STARTED|Period 1: Part A and B||0||
48041466|NCT04233918|100423794|FG003|STARTED|Period 1: Part A and B||0||
48041467|NCT04233918|100423791|FG000|COMPLETED|Period 1: Part A and B||6||
48041468|NCT04233918|100423792|FG001|COMPLETED|Period 1: Part A and B||14||
48203468|NCT00796068|100820848|FG000|NOT COMPLETED|Overall Study||0||
48203469|NCT00796068|100820849|FG001|NOT COMPLETED|Overall Study||0||
48203470|NCT00839540|100820850|FG000|STARTED|Overall Study||8||
48203471|NCT00839540|100820851|FG001|STARTED|Overall Study||8||
48203472|NCT00839540|100820852|FG002|STARTED|Overall Study||5||
48203473|NCT00839540|100820850|FG000|COMPLETED|Overall Study||8||
48203474|NCT00839540|100820851|FG001|COMPLETED|Overall Study||8||
48203475|NCT00839540|100820852|FG002|COMPLETED|Overall Study||5||
48203476|NCT00839540|100820850|FG000|NOT COMPLETED|Overall Study||0||
48203477|NCT00839540|100820851|FG001|NOT COMPLETED|Overall Study||0||
48203478|NCT00839540|100820852|FG002|NOT COMPLETED|Overall Study||0||
48203479|NCT00913913|100820853|FG000|STARTED|Overall Study||8||
48203480|NCT00913913|100820853|FG000|COMPLETED|Overall Study||0||
48203481|NCT00913913|100820853|FG000|NOT COMPLETED|Overall Study||8||
48203482|NCT01595321|100820854|FG000|STARTED|Overall Study||3||
48203483|NCT01595321|100820855|FG001|STARTED|Overall Study||4||
48203484|NCT01595321|100820856|FG002|STARTED|Overall Study||12||
48203485|NCT01595321|100820854|FG000|COMPLETED|Overall Study||2|Completed = received all planned doses of SBRT + FOLFIRINOX (Cohorts 1 and 2), or all planned doses of SBRT + FOLFIRINOX and all 5 monthly cycles of Cy and GVAX (Cohort 3)|
48203486|NCT01595321|100820855|FG001|COMPLETED|Overall Study||3|Completed = received all planned doses of SBRT + FOLFIRINOX (Cohorts 1 and 2), or all planned doses of SBRT + FOLFIRINOX and all 5 monthly cycles of Cy and GVAX (Cohort 3)|
48203487|NCT01595321|100820856|FG002|COMPLETED|Overall Study||7|Completed = received all planned doses of SBRT + FOLFIRINOX (Cohorts 1 and 2), or all planned doses of SBRT + FOLFIRINOX and all 5 monthly cycles of Cy and GVAX (Cohort 3)|
48203488|NCT01595321|100820854|FG000|NOT COMPLETED|Overall Study||1||
48203489|NCT01595321|100820855|FG001|NOT COMPLETED|Overall Study||1||
48203490|NCT01595321|100820856|FG002|NOT COMPLETED|Overall Study||5||
48203491|NCT02925195|100820857|FG000|STARTED|Overall Study||499||
48203492|NCT02925195|100820858|FG001|STARTED|Overall Study||167||
48203493|NCT02925195|100820857|FG000|COMPLETED|Overall Study||453||
48203494|NCT02925195|100820858|FG001|COMPLETED|Overall Study||158||
48203495|NCT02925195|100820857|FG000|NOT COMPLETED|Overall Study||46||
48203496|NCT02925195|100820858|FG001|NOT COMPLETED|Overall Study||9||
48203497|NCT00436644|100820859|FG000|STARTED|Overall Study||18||
48203498|NCT00436644|100820859|FG000|COMPLETED|Overall Study||15||
48203499|NCT00436644|100820859|FG000|NOT COMPLETED|Overall Study||3||
48203500|NCT00373269|100820860|FG000|STARTED|Overall Study||11||
48203501|NCT00373269|100820861|FG001|STARTED|Overall Study||10||
48203502|NCT00373269|100820860|FG000|COMPLETED|Overall Study||11||
48203503|NCT00373269|100820861|FG001|COMPLETED|Overall Study||10||
48203504|NCT00373269|100820860|FG000|NOT COMPLETED|Overall Study||0||
48203505|NCT00373269|100820861|FG001|NOT COMPLETED|Overall Study||0||
48203506|NCT03058991|100823520|FG000|STARTED|Overall Study||39||
48203507|NCT03058991|100823521|FG001|STARTED|Overall Study||32||
48203508|NCT03058991|100823522|FG002|STARTED|Overall Study||37||
48203509|NCT03058991|100823520|FG000|1-Week Follow Up|Overall Study||23||
48203510|NCT03058991|100823521|FG001|1-Week Follow Up|Overall Study||27||
48203511|NCT03058991|100823522|FG002|1-Week Follow Up|Overall Study||28||
48203512|NCT03058991|100823520|FG000|COMPLETED|Overall Study||21||
48203513|NCT03058991|100823521|FG001|COMPLETED|Overall Study||20||
48203514|NCT03058991|100823522|FG002|COMPLETED|Overall Study||25||
48203515|NCT03058991|100823520|FG000|NOT COMPLETED|Overall Study||18||
48203516|NCT03058991|100823521|FG001|NOT COMPLETED|Overall Study||12||
48041469|NCT04233918|100423793|FG002|COMPLETED|Period 1: Part A and B||0||
48041470|NCT04233918|100423794|FG003|COMPLETED|Period 1: Part A and B||0||
48041471|NCT04233918|100423791|FG000|NOT COMPLETED|Period 1: Part A and B||0||
48041472|NCT04233918|100423792|FG001|NOT COMPLETED|Period 1: Part A and B||0||
48041473|NCT04233918|100423793|FG002|NOT COMPLETED|Period 1: Part A and B||0||
48041474|NCT04233918|100423794|FG003|NOT COMPLETED|Period 1: Part A and B||0||
48203517|NCT03058991|100823522|FG002|NOT COMPLETED|Overall Study||12||
48203518|NCT00932022|100823523|FG000|STARTED|Overall Study||64||
48203519|NCT00932022|100823524|FG001|STARTED|Overall Study||63||
48203520|NCT00932022|100823523|FG000|COMPLETED|Overall Study||59||
48203521|NCT00932022|100823524|FG001|COMPLETED|Overall Study||59||
48203522|NCT00932022|100823523|FG000|NOT COMPLETED|Overall Study||5||
48203523|NCT00932022|100823524|FG001|NOT COMPLETED|Overall Study||4||
48203524|NCT00547118|100823525|FG000|STARTED|Overall Study||8||
48203525|NCT00547118|100823526|FG001|STARTED|Overall Study||9||
48203526|NCT00547118|100823525|FG000|COMPLETED|Overall Study||0||
48203527|NCT00547118|100823526|FG001|COMPLETED|Overall Study||0||
48203528|NCT00547118|100823525|FG000|NOT COMPLETED|Overall Study||8||
48203529|NCT00547118|100823526|FG001|NOT COMPLETED|Overall Study||9||
48203530|NCT02203630|100823527|FG000|STARTED|Overall Study||8||
48203531|NCT02203630|100823528|FG001|STARTED|Overall Study||9||
48203532|NCT02203630|100823527|FG000|COMPLETED|Overall Study||8||
48203533|NCT02203630|100823528|FG001|COMPLETED|Overall Study||9||
48041475|NCT04233918|100423791|FG000|STARTED|Part C (Extension Period)||0||
48203534|NCT02203630|100823527|FG000|NOT COMPLETED|Overall Study||0||
48203535|NCT02203630|100823528|FG001|NOT COMPLETED|Overall Study||0||
48203536|NCT02311972|100823529|FG000|STARTED|Overall Study||12||
48203537|NCT02311972|100823530|FG001|STARTED|Overall Study||8||
48203538|NCT02311972|100823529|FG000|COMPLETED|Overall Study||12||
48203539|NCT02311972|100823530|FG001|COMPLETED|Overall Study||8||
48203540|NCT02311972|100823529|FG000|NOT COMPLETED|Overall Study||0||
48203541|NCT02311972|100823530|FG001|NOT COMPLETED|Overall Study||0||
48203542|NCT00814346|100823531|FG000|STARTED|Double-blind Phase (4 Weeks)||23||
48203543|NCT00814346|100823532|FG001|STARTED|Double-blind Phase (4 Weeks)||26||
48203544|NCT00814346|100823531|FG000|CNE|Double-blind Phase (4 Weeks)||10||
48203545|NCT00814346|100823532|FG001|CNE|Double-blind Phase (4 Weeks)||13||
48203546|NCT00814346|100823531|FG000|MC|Double-blind Phase (4 Weeks)||10||
48203547|NCT00814346|100823532|FG001|MC|Double-blind Phase (4 Weeks)||11||
48203548|NCT00814346|100823531|FG000|AD|Double-blind Phase (4 Weeks)||3||
48203549|NCT00814346|100823532|FG001|AD|Double-blind Phase (4 Weeks)||2||
48203550|NCT00814346|100823531|FG000|COMPLETED|Double-blind Phase (4 Weeks)||23||
48203551|NCT00814346|100823532|FG001|COMPLETED|Double-blind Phase (4 Weeks)||23||
48203552|NCT00814346|100823531|FG000|NOT COMPLETED|Double-blind Phase (4 Weeks)||0||
48203553|NCT00814346|100823532|FG001|NOT COMPLETED|Double-blind Phase (4 Weeks)||3||
48203554|NCT00814346|100823531|FG000|STARTED|Open Phase (17 Months)||41||
48203555|NCT00814346|100823532|FG001|STARTED|Open Phase (17 Months)||0||
48203556|NCT00814346|100823531|FG000|CNE|Open Phase (17 Months)||21||
48203557|NCT00814346|100823532|FG001|CNE|Open Phase (17 Months)||0||
48203558|NCT00814346|100823531|FG000|MC|Open Phase (17 Months)||20||
48203559|NCT00814346|100823532|FG001|MC|Open Phase (17 Months)||0||
48203560|NCT00814346|100823531|FG000|AD|Open Phase (17 Months)||0||
48203561|NCT00814346|100823532|FG001|AD|Open Phase (17 Months)||0||
48203562|NCT00814346|100823531|FG000|COMPLETED|Open Phase (17 Months)||31||
48203563|NCT00814346|100823532|FG001|COMPLETED|Open Phase (17 Months)||0||
48203564|NCT00814346|100823531|FG000|NOT COMPLETED|Open Phase (17 Months)||10||
48203565|NCT00814346|100823532|FG001|NOT COMPLETED|Open Phase (17 Months)||0||
48041476|NCT04233918|100423792|FG001|STARTED|Part C (Extension Period)||0||
48041477|NCT04233918|100423793|FG002|STARTED|Part C (Extension Period)||6||
48041478|NCT04233918|100423794|FG003|STARTED|Part C (Extension Period)||14||
48041479|NCT04233918|100423791|FG000|COMPLETED|Part C (Extension Period)||0||
48041480|NCT04233918|100423792|FG001|COMPLETED|Part C (Extension Period)||0||
48041481|NCT04233918|100423793|FG002|COMPLETED|Part C (Extension Period)||6||
48041482|NCT04233918|100423794|FG003|COMPLETED|Part C (Extension Period)||14||
48041483|NCT04233918|100423791|FG000|NOT COMPLETED|Part C (Extension Period)||0||
48041484|NCT04233918|100423792|FG001|NOT COMPLETED|Part C (Extension Period)||0||
48041485|NCT04233918|100423793|FG002|NOT COMPLETED|Part C (Extension Period)||0||
48041486|NCT04233918|100423794|FG003|NOT COMPLETED|Part C (Extension Period)||0||
48041487|NCT00220779|100423795|FG000|STARTED|Overall Study||45||
48041488|NCT00220779|100423796|FG001|STARTED|Overall Study||42||
48041489|NCT00220779|100423797|FG002|STARTED|Overall Study||41||
48041490|NCT00220779|100423795|FG000|COMPLETED|Overall Study||38||
48041491|NCT00220779|100423796|FG001|COMPLETED|Overall Study||38||
48041492|NCT00220779|100423797|FG002|COMPLETED|Overall Study||37||
48041493|NCT00220779|100423795|FG000|NOT COMPLETED|Overall Study||7||
48041494|NCT00220779|100423796|FG001|NOT COMPLETED|Overall Study||4||
48203566|NCT03895034|100823533|FG000|STARTED|Overall Study||66||111
48203567|NCT03895034|100823533|FG000|COMPLETED|Overall Study||64||109
48203568|NCT03895034|100823533|FG000|NOT COMPLETED|Overall Study||2||2
48203569|NCT00878722|100823534|FG000|STARTED|Overall Study||3||
48203570|NCT00878722|100823535|FG001|STARTED|Overall Study||3||
48203571|NCT00878722|100823536|FG002|STARTED|Overall Study||3||
48203572|NCT00878722|100823537|FG003|STARTED|Overall Study||9||
48203573|NCT00878722|100823538|FG004|STARTED|Overall Study||7||
48041495|NCT00220779|100423797|FG002|NOT COMPLETED|Overall Study||4||
48041496|NCT01203852|100423798|FG000|STARTED|Metoprolol 8 Weeks||839||
48041497|NCT01203852|100423798|FG000|COMPLETED|Metoprolol 8 Weeks||369||
48041498|NCT01203852|100423798|FG000|NOT COMPLETED|Metoprolol 8 Weeks||470||
48041499|NCT01203852|100423798|FG000|STARTED|Washout 2 Weeks||328||
48041500|NCT01203852|100423798|FG000|COMPLETED|Washout 2 Weeks||282||
48203574|NCT00878722|100823539|FG005|STARTED|Overall Study||3||
48203575|NCT00878722|100823540|FG006|STARTED|Overall Study||6||
48203576|NCT00878722|100823541|FG007|STARTED|Overall Study||7||
48203577|NCT00878722|100823534|FG000|COMPLETED|Overall Study||0||
48203578|NCT00878722|100823535|FG001|COMPLETED|Overall Study||0||
48203579|NCT00878722|100823536|FG002|COMPLETED|Overall Study||0||
48203580|NCT00878722|100823537|FG003|COMPLETED|Overall Study||0||
48203581|NCT00878722|100823538|FG004|COMPLETED|Overall Study||0||
48203582|NCT00878722|100823539|FG005|COMPLETED|Overall Study||1||
48041501|NCT01203852|100423798|FG000|NOT COMPLETED|Washout 2 Weeks||46||
48041502|NCT01203852|100423798|FG000|STARTED|Chlorthalidone 8 Weeks||328||
48041503|NCT01203852|100423798|FG000|Continued From Metoprolol|Chlorthalidone 8 Weeks||282||
48203583|NCT00878722|100823540|FG006|COMPLETED|Overall Study||0||
48203584|NCT00878722|100823541|FG007|COMPLETED|Overall Study||0||
48041504|NCT01203852|100423798|FG000|COMPLETED|Chlorthalidone 8 Weeks||328||
48041505|NCT01203852|100423798|FG000|NOT COMPLETED|Chlorthalidone 8 Weeks||0||
48041506|NCT00275821|100423799|FG000|STARTED|Overall Study||120||
48041507|NCT00275821|100423800|FG001|STARTED|Overall Study||118||
48041508|NCT00275821|100423801|FG002|STARTED|Overall Study||115||
48041509|NCT00275821|100423799|FG000|COMPLETED|Overall Study||106||
48041510|NCT00275821|100423800|FG001|COMPLETED|Overall Study||95||
48041511|NCT00275821|100423801|FG002|COMPLETED|Overall Study||103||
48041512|NCT00275821|100423799|FG000|NOT COMPLETED|Overall Study||14||
48041513|NCT00275821|100423800|FG001|NOT COMPLETED|Overall Study||23||
48041514|NCT00275821|100423801|FG002|NOT COMPLETED|Overall Study||12||
48041515|NCT04604132|100423802|FG000|STARTED|Overall Study||13||
48041516|NCT04604132|100423803|FG001|STARTED|Overall Study||8||
48041517|NCT04604132|100423804|FG002|STARTED|Overall Study||13||
48041518|NCT04604132|100423805|FG003|STARTED|Overall Study||6||
48041519|NCT04604132|100423806|FG004|STARTED|Overall Study||7||
48041520|NCT04604132|100423802|FG000|COMPLETED|Overall Study||0|One patient still received derazantinib while the study was early terminated and was transferred to a post-trial access program.|
48041521|NCT04604132|100423803|FG001|COMPLETED|Overall Study||0|One patient still received derazantinib while the study was early terminated and was transferred to a post-trial access program.|
48041522|NCT04604132|100423804|FG002|COMPLETED|Overall Study||0|One patient still received derazantinib while the study was early terminated and was transferred to a post-trial access program.|
48041523|NCT04604132|100423805|FG003|COMPLETED|Overall Study||0|One patient still received derazantinib while the study was early terminated and was transferred to a post-trial access program.|
48041524|NCT04604132|100423806|FG004|COMPLETED|Overall Study||1|One patient still received derazantinib while the study was early terminated and was transferred to a post-trial access program.|
48041525|NCT04604132|100423802|FG000|NOT COMPLETED|Overall Study||13||
48041526|NCT04604132|100423803|FG001|NOT COMPLETED|Overall Study||8||
48041527|NCT04604132|100423804|FG002|NOT COMPLETED|Overall Study||13||
48041528|NCT04604132|100423805|FG003|NOT COMPLETED|Overall Study||6||
48041529|NCT04604132|100423806|FG004|NOT COMPLETED|Overall Study||6||
48041530|NCT01252667|100423807|FG000|STARTED|Overall Study||3||
48041531|NCT01252667|100423808|FG001|STARTED|Overall Study||3||
48041532|NCT01252667|100423809|FG002|STARTED|Overall Study||3||
48041533|NCT01252667|100423810|FG003|STARTED|Overall Study||0||
48041534|NCT01252667|100423811|FG004|STARTED|Overall Study||0||
48041535|NCT01252667|100423812|FG005|STARTED|Overall Study||35||
48041536|NCT01252667|100423807|FG000|COMPLETED|Overall Study||3||
48041537|NCT01252667|100423808|FG001|COMPLETED|Overall Study||3||
48041538|NCT01252667|100423809|FG002|COMPLETED|Overall Study||3||
48041539|NCT01252667|100423810|FG003|COMPLETED|Overall Study||0||
48041540|NCT01252667|100423811|FG004|COMPLETED|Overall Study||0||
48041541|NCT01252667|100423812|FG005|COMPLETED|Overall Study||34||
48041542|NCT01252667|100423807|FG000|NOT COMPLETED|Overall Study||0||
48041543|NCT01252667|100423808|FG001|NOT COMPLETED|Overall Study||0||
48041544|NCT01252667|100423809|FG002|NOT COMPLETED|Overall Study||0||
48041545|NCT01252667|100423810|FG003|NOT COMPLETED|Overall Study||0||
48041546|NCT01252667|100423811|FG004|NOT COMPLETED|Overall Study||0||
48041547|NCT01252667|100423812|FG005|NOT COMPLETED|Overall Study||1||
48041548|NCT00395343|100423813|FG000|STARTED|Overall Study||322||
48041549|NCT00395343|100423814|FG001|STARTED|Overall Study||319||
48041550|NCT00395343|100423813|FG000|COMPLETED|Overall Study||281||
48041551|NCT00395343|100423814|FG001|COMPLETED|Overall Study||283||
48041552|NCT00395343|100423813|FG000|NOT COMPLETED|Overall Study||41||
48041553|NCT00395343|100423814|FG001|NOT COMPLETED|Overall Study||36||
48041554|NCT03387111|100423815|FG000|STARTED|Overall Study||4||
48041555|NCT03387111|100423815|FG000|COMPLETED|Overall Study||0||
48041556|NCT03387111|100423815|FG000|NOT COMPLETED|Overall Study||4||
48041557|NCT03339297|100423816|FG000|STARTED|Overall Study||79||
48041558|NCT03339297|100423817|FG001|STARTED|Overall Study||73||
48041559|NCT03339297|100423816|FG000|COMPLETED|Overall Study||56||
48041560|NCT03339297|100423817|FG001|COMPLETED|Overall Study||59||
48041561|NCT03339297|100423816|FG000|NOT COMPLETED|Overall Study||23||
48041562|NCT03339297|100423817|FG001|NOT COMPLETED|Overall Study||14||
48041563|NCT00819793|100423818|FG000|STARTED|Overall Study||32||
48041564|NCT00819793|100423818|FG000|COMPLETED|Overall Study||32||
48041565|NCT00819793|100423818|FG000|NOT COMPLETED|Overall Study||0||
48041566|NCT03565367|100423819|FG000|STARTED|Overall Study||7||
48041567|NCT03565367|100423820|FG001|STARTED|Overall Study||2||
48041568|NCT03565367|100423819|FG000|Received Interventions|Overall Study||3||
48041569|NCT03565367|100423820|FG001|Received Interventions|Overall Study||2||
48041570|NCT03565367|100423819|FG000|COMPLETED|Overall Study||3||
48041571|NCT03565367|100423820|FG001|COMPLETED|Overall Study||2||
48041572|NCT03565367|100423819|FG000|NOT COMPLETED|Overall Study||4||
48203585|NCT00878722|100823534|FG000|NOT COMPLETED|Overall Study||3||
48041573|NCT03565367|100423820|FG001|NOT COMPLETED|Overall Study||0||
48041574|NCT02396160|100423821|FG000|STARTED|Overall Study||75||
48041575|NCT02396160|100423822|FG001|STARTED|Overall Study||75||
48041576|NCT02396160|100423821|FG000|COMPLETED|Overall Study||69||
48041577|NCT02396160|100423822|FG001|COMPLETED|Overall Study||73||
48041578|NCT02396160|100423821|FG000|NOT COMPLETED|Overall Study||6||
48203586|NCT00878722|100823535|FG001|NOT COMPLETED|Overall Study||3||
48203587|NCT00878722|100823536|FG002|NOT COMPLETED|Overall Study||3||
48203588|NCT00878722|100823537|FG003|NOT COMPLETED|Overall Study||9||
48041579|NCT02396160|100423822|FG001|NOT COMPLETED|Overall Study||2||
48041580|NCT02694757|100423823|FG000|STARTED|Overall Study||3||
48041581|NCT02694757|100423823|FG000|COMPLETED|Overall Study||0||
48041582|NCT02694757|100423823|FG000|NOT COMPLETED|Overall Study||3||
48041583|NCT00265148|100423824|FG000|STARTED|Overall Study||40||
48041584|NCT00265148|100423825|FG001|STARTED|Overall Study||40||
48041585|NCT00265148|100423824|FG000|COMPLETED|Overall Study||31||
48041586|NCT00265148|100423825|FG001|COMPLETED|Overall Study||31||
48041587|NCT00265148|100423824|FG000|NOT COMPLETED|Overall Study||9||
48041588|NCT00265148|100423825|FG001|NOT COMPLETED|Overall Study||9||
48041589|NCT04966910|100423826|FG000|STARTED|Baseline||22||2
48041590|NCT04966910|100423827|FG001|STARTED|Baseline||18||2
48041591|NCT04966910|100423828|FG002|STARTED|Baseline||2||2
48041592|NCT04966910|100423829|FG003|STARTED|Baseline||2||2
48041593|NCT04966910|100423826|FG000|COMPLETED|Baseline||22||2
48041594|NCT04966910|100423827|FG001|COMPLETED|Baseline||18||2
48041595|NCT04966910|100423828|FG002|COMPLETED|Baseline||1||1
48041596|NCT04966910|100423829|FG003|COMPLETED|Baseline||2||2
48041597|NCT04966910|100423826|FG000|NOT COMPLETED|Baseline||0||0
48041598|NCT04966910|100423827|FG001|NOT COMPLETED|Baseline||0||0
48041599|NCT04966910|100423828|FG002|NOT COMPLETED|Baseline||1||1
48041600|NCT04966910|100423829|FG003|NOT COMPLETED|Baseline||0||0
48041601|NCT04966910|100423826|FG000|STARTED|4-Week Follow-Up||22|All enrolled participants at baseline were considered to start the 4-week follow-up time period.|2
48041602|NCT04966910|100423827|FG001|STARTED|4-Week Follow-Up||18|All enrolled participants at baseline were considered to start the 4-week follow-up time period.|2
48041603|NCT04966910|100423828|FG002|STARTED|4-Week Follow-Up||0|All enrolled participants at baseline were considered to start the 4-week follow-up time period.|0
48041604|NCT04966910|100423829|FG003|STARTED|4-Week Follow-Up||0|All enrolled participants at baseline were considered to start the 4-week follow-up time period.|0
48041605|NCT04966910|100423826|FG000|COMPLETED|4-Week Follow-Up||17||2
48041606|NCT04966910|100423827|FG001|COMPLETED|4-Week Follow-Up||14||2
48041607|NCT04966910|100423828|FG002|COMPLETED|4-Week Follow-Up||0||0
48041608|NCT04966910|100423829|FG003|COMPLETED|4-Week Follow-Up||0||0
48041609|NCT04966910|100423826|FG000|NOT COMPLETED|4-Week Follow-Up||5||0
48041610|NCT04966910|100423827|FG001|NOT COMPLETED|4-Week Follow-Up||4||0
48041611|NCT04966910|100423828|FG002|NOT COMPLETED|4-Week Follow-Up||0||0
48041612|NCT04966910|100423829|FG003|NOT COMPLETED|4-Week Follow-Up||0||0
48041613|NCT04966910|100423826|FG000|STARTED|9-Week Follow-Up||22|All enrolled participants at baseline were considered to start the 9-week follow-up time period. Participants were not required to complete the 4-week follow-up to start and be considered for the 9-week follow-up.|2
48041614|NCT04966910|100423827|FG001|STARTED|9-Week Follow-Up||18|All enrolled participants at baseline were considered to start the 9-week follow-up time period. Participants were not required to complete the 4-week follow-up to start and be considered for the 9-week follow-up.|2
48041615|NCT04966910|100423828|FG002|STARTED|9-Week Follow-Up||2|All enrolled participants at baseline were considered to start the 9-week follow-up time period. Participants were not required to complete the 4-week follow-up to start and be considered for the 9-week follow-up.|2
48041616|NCT04966910|100423829|FG003|STARTED|9-Week Follow-Up||2|All enrolled participants at baseline were considered to start the 9-week follow-up time period. Participants were not required to complete the 4-week follow-up to start and be considered for the 9-week follow-up.|2
48041617|NCT04966910|100423826|FG000|COMPLETED|9-Week Follow-Up||19||2
48041618|NCT04966910|100423827|FG001|COMPLETED|9-Week Follow-Up||17||2
48041619|NCT04966910|100423828|FG002|COMPLETED|9-Week Follow-Up||2||2
48041620|NCT04966910|100423829|FG003|COMPLETED|9-Week Follow-Up||0||0
48041621|NCT04966910|100423826|FG000|NOT COMPLETED|9-Week Follow-Up||3||0
48041622|NCT04966910|100423827|FG001|NOT COMPLETED|9-Week Follow-Up||1||0
48041623|NCT04966910|100423828|FG002|NOT COMPLETED|9-Week Follow-Up||0||0
48041624|NCT04966910|100423829|FG003|NOT COMPLETED|9-Week Follow-Up||2||2
48041625|NCT03473548|100423830|FG000|STARTED|Overall Study||11||
48041626|NCT03473548|100423831|FG001|STARTED|Overall Study||0||
48041627|NCT03473548|100423830|FG000|COMPLETED|Overall Study||8||
48041628|NCT03473548|100423831|FG001|COMPLETED|Overall Study||0||
48041629|NCT03473548|100423830|FG000|NOT COMPLETED|Overall Study||3||
48041630|NCT03473548|100423831|FG001|NOT COMPLETED|Overall Study||0||
48041631|NCT00436501|100423832|FG000|STARTED|Complete Study Participation||9||
48041632|NCT00436501|100423833|FG001|STARTED|Complete Study Participation||49||
48041633|NCT00436501|100423832|FG000|COMPLETED|Complete Study Participation||9||
48041634|NCT00436501|100423833|FG001|COMPLETED|Complete Study Participation||49||
48041635|NCT00436501|100423832|FG000|NOT COMPLETED|Complete Study Participation||0||
48041636|NCT00436501|100423833|FG001|NOT COMPLETED|Complete Study Participation||0||
48041637|NCT00436501|100423832|FG000|STARTED|Phase 1: VEGF Trap Escalating Dose||9||
48041638|NCT00436501|100423833|FG001|STARTED|Phase 1: VEGF Trap Escalating Dose||0||
48041639|NCT00436501|100423832|FG000|COMPLETED|Phase 1: VEGF Trap Escalating Dose||9||
48041640|NCT00436501|100423833|FG001|COMPLETED|Phase 1: VEGF Trap Escalating Dose||0||
48041641|NCT00436501|100423832|FG000|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0||
48041642|NCT00436501|100423833|FG001|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0||
48041643|NCT00436501|100423832|FG000|STARTED|Phase 2: MTD VEGF Trap + Docetaxel||0||
48041644|NCT00436501|100423833|FG001|STARTED|Phase 2: MTD VEGF Trap + Docetaxel||49||
48041645|NCT00436501|100423832|FG000|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0||
48041646|NCT00436501|100423833|FG001|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||46||
48041647|NCT00436501|100423832|FG000|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0||
48041648|NCT00436501|100423833|FG001|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||3||
48041649|NCT00300430|100423834|FG000|STARTED|Overall Study||1186||
48041650|NCT00300430|100423835|FG001|STARTED|Overall Study||514||
48041651|NCT00300430|100423836|FG002|STARTED|Overall Study||501||
48041652|NCT00300430|100423834|FG000|COMPLETED|Overall Study||819||
48041653|NCT00300430|100423835|FG001|COMPLETED|Overall Study||345||
48041654|NCT00300430|100423836|FG002|COMPLETED|Overall Study||350||
48041655|NCT00300430|100423834|FG000|NOT COMPLETED|Overall Study||367||
48041656|NCT00300430|100423835|FG001|NOT COMPLETED|Overall Study||169||
48203589|NCT00878722|100823538|FG004|NOT COMPLETED|Overall Study||7||
48203590|NCT00878722|100823539|FG005|NOT COMPLETED|Overall Study||2||
48203591|NCT00878722|100823540|FG006|NOT COMPLETED|Overall Study||6||
48041657|NCT00300430|100423836|FG002|NOT COMPLETED|Overall Study||151||
48041658|NCT03472547|100423837|FG000|STARTED|Overall Study||234||702
48203592|NCT00878722|100823541|FG007|NOT COMPLETED|Overall Study||7||
48203593|NCT01669148|100823542|FG000|STARTED|Overall Study||496||
48203594|NCT01669148|100823542|FG000|COMPLETED|Overall Study||426||
48203595|NCT01669148|100823542|FG000|NOT COMPLETED|Overall Study||70||
48203596|NCT01215695|100823543|FG000|STARTED|Overall Study||70||
48203597|NCT01215695|100823544|FG001|STARTED|Overall Study||70||
48203598|NCT01215695|100823543|FG000|COMPLETED|Overall Study||70||
48041659|NCT03472547|100423837|FG000|COMPLETED|Overall Study||204||612
48041660|NCT03472547|100423837|FG000|NOT COMPLETED|Overall Study||30||90
48041661|NCT01324518|100423838|FG000|STARTED|Overall Study||33||
48041662|NCT01324518|100423839|FG001|STARTED|Overall Study||33||
48041663|NCT01324518|100423840|FG002|STARTED|Overall Study||34||
48041664|NCT01324518|100423838|FG000|COMPLETED|Overall Study||28||
48203599|NCT01215695|100823544|FG001|COMPLETED|Overall Study||70||
48203600|NCT01215695|100823543|FG000|NOT COMPLETED|Overall Study||0||
48203601|NCT01215695|100823544|FG001|NOT COMPLETED|Overall Study||0||
48041665|NCT01324518|100423839|FG001|COMPLETED|Overall Study||30||
48041666|NCT01324518|100423840|FG002|COMPLETED|Overall Study||33||
48041667|NCT01324518|100423838|FG000|NOT COMPLETED|Overall Study||5||
48041668|NCT01324518|100423839|FG001|NOT COMPLETED|Overall Study||3||
48041669|NCT01324518|100423840|FG002|NOT COMPLETED|Overall Study||1||
48041670|NCT01214057|100423841|FG000|STARTED|Overall Study||12||
48041671|NCT01214057|100423842|FG001|STARTED|Overall Study||11||
48041672|NCT01214057|100423841|FG000|COMPLETED|Overall Study||12||
48041673|NCT01214057|100423842|FG001|COMPLETED|Overall Study||11||
48041674|NCT01214057|100423841|FG000|NOT COMPLETED|Overall Study||0||
48041675|NCT01214057|100423842|FG001|NOT COMPLETED|Overall Study||0||
48041676|NCT00402233|100423843|FG000|STARTED|Overall Study||77||
48041677|NCT00402233|100423844|FG001|STARTED|Overall Study||80||
48041678|NCT00402233|100423845|FG002|STARTED|Overall Study||81||
48041679|NCT00402233|100423846|FG003|STARTED|Overall Study||73||
48041680|NCT00402233|100423843|FG000|COMPLETED|Overall Study||72||
48041681|NCT00402233|100423844|FG001|COMPLETED|Overall Study||70||
48041682|NCT00402233|100423845|FG002|COMPLETED|Overall Study||70||
48041683|NCT00402233|100423846|FG003|COMPLETED|Overall Study||62||
48041684|NCT00402233|100423843|FG000|NOT COMPLETED|Overall Study||5||
48041685|NCT00402233|100423844|FG001|NOT COMPLETED|Overall Study||10||
48041686|NCT00402233|100423845|FG002|NOT COMPLETED|Overall Study||11||
48041687|NCT00402233|100423846|FG003|NOT COMPLETED|Overall Study||11||
48041688|NCT01431209|100423847|FG000|STARTED|Overall Study||47||
48203602|NCT00854906|100823545|FG000|STARTED|Overall Study||26||
48203603|NCT00854906|100823545|FG000|COMPLETED|Overall Study||25||
48203604|NCT00854906|100823545|FG000|NOT COMPLETED|Overall Study||1||
48203605|NCT01114945|100823546|FG000|STARTED|Overall Study||30||
48203606|NCT01114945|100823547|FG001|STARTED|Overall Study||30||
48203607|NCT01114945|100823548|FG002|STARTED|Overall Study||30||
48203608|NCT01114945|100823549|FG003|STARTED|Overall Study||31||
48203609|NCT01114945|100823546|FG000|COMPLETED|Overall Study||30||
48203610|NCT01114945|100823547|FG001|COMPLETED|Overall Study||30||
48203611|NCT01114945|100823548|FG002|COMPLETED|Overall Study||30||
48203612|NCT01114945|100823549|FG003|COMPLETED|Overall Study||31||
48203613|NCT01114945|100823546|FG000|NOT COMPLETED|Overall Study||0||
48203614|NCT01114945|100823547|FG001|NOT COMPLETED|Overall Study||0||
48203615|NCT01114945|100823548|FG002|NOT COMPLETED|Overall Study||0||
48203616|NCT01114945|100823549|FG003|NOT COMPLETED|Overall Study||0||
48203617|NCT01930045|100823550|FG000|STARTED|Part 1 - Period 1||3||
48203618|NCT01930045|100823551|FG001|STARTED|Part 1 - Period 1||3||
48203619|NCT01930045|100823552|FG002|STARTED|Part 1 - Period 1||3||
48203620|NCT01930045|100823553|FG003|STARTED|Part 1 - Period 1||3||
48203621|NCT01930045|100823554|FG004|STARTED|Part 1 - Period 1||3||
48041689|NCT01431209|100423848|FG001|STARTED|Overall Study||13||
48041690|NCT01431209|100423847|FG000|COMPLETED|Overall Study||43||
48041691|NCT01431209|100423848|FG001|COMPLETED|Overall Study||12||
48203622|NCT01930045|100823555|FG005|STARTED|Part 1 - Period 1||3||
48041692|NCT01431209|100423847|FG000|NOT COMPLETED|Overall Study||4||
48041693|NCT01431209|100423848|FG001|NOT COMPLETED|Overall Study||1||
48041694|NCT01892384|100423849|FG000|STARTED|Overall Study||10||
48041695|NCT01892384|100423850|FG001|STARTED|Overall Study||10||
48041696|NCT01892384|100423851|FG002|STARTED|Overall Study||10||
48041697|NCT01892384|100423852|FG003|STARTED|Overall Study||10||
48203623|NCT01930045|100823550|FG000|COMPLETED|Part 1 - Period 1||3||
48203624|NCT01930045|100823551|FG001|COMPLETED|Part 1 - Period 1||3||
48203625|NCT01930045|100823552|FG002|COMPLETED|Part 1 - Period 1||3||
48203626|NCT01930045|100823553|FG003|COMPLETED|Part 1 - Period 1||3||
48203627|NCT01930045|100823554|FG004|COMPLETED|Part 1 - Period 1||3||
48203628|NCT01930045|100823555|FG005|COMPLETED|Part 1 - Period 1||3||
48203629|NCT01930045|100823550|FG000|NOT COMPLETED|Part 1 - Period 1||0||
48495349|NCT03499353|101547828|FG000|COMPLETED|Long-Term Follow-up||0||
48495350|NCT03499353|101547828|FG000|NOT COMPLETED|Long-Term Follow-up||58||
48495351|NCT04583423|101547829|FG000|STARTED|Overall Study||45||
48495352|NCT04583423|101547830|FG001|STARTED|Overall Study||48||
48495353|NCT04583423|101547831|FG002|STARTED|Overall Study||46||
48041698|NCT01892384|100423849|FG000|COMPLETED|Overall Study||9||
48041699|NCT01892384|100423850|FG001|COMPLETED|Overall Study||9||
48041700|NCT01892384|100423851|FG002|COMPLETED|Overall Study||10||
48041701|NCT01892384|100423852|FG003|COMPLETED|Overall Study||10||
48041702|NCT01892384|100423849|FG000|NOT COMPLETED|Overall Study||1||
48041703|NCT01892384|100423850|FG001|NOT COMPLETED|Overall Study||1||
48041704|NCT01892384|100423851|FG002|NOT COMPLETED|Overall Study||0||
48041705|NCT01892384|100423852|FG003|NOT COMPLETED|Overall Study||0||
48041706|NCT00947791|100423853|FG000|STARTED|Overall Study||0||
48041707|NCT00947791|100423854|FG001|STARTED|Overall Study||1||
48041708|NCT00947791|100423853|FG000|COMPLETED|Overall Study||0||
48041709|NCT00947791|100423854|FG001|COMPLETED|Overall Study||1||
48041710|NCT00947791|100423853|FG000|NOT COMPLETED|Overall Study||0||
48041711|NCT00947791|100423854|FG001|NOT COMPLETED|Overall Study||0||
48041712|NCT01122264|100423855|FG000|STARTED|Overall Study||252||
48041713|NCT01122264|100423856|FG001|STARTED|Overall Study||257||
48041714|NCT01122264|100423857|FG002|STARTED|Overall Study||261||
48041715|NCT01122264|100423855|FG000|Received at Least 1 Dose of Study Drug|Overall Study||250||
48041716|NCT01122264|100423856|FG001|Received at Least 1 Dose of Study Drug|Overall Study||257||
48041717|NCT01122264|100423857|FG002|Received at Least 1 Dose of Study Drug|Overall Study||260||
48041718|NCT01122264|100423855|FG000|COMPLETED|Overall Study||220||
48041719|NCT01122264|100423856|FG001|COMPLETED|Overall Study||228||
48041720|NCT01122264|100423857|FG002|COMPLETED|Overall Study||214||
48041721|NCT01122264|100423855|FG000|NOT COMPLETED|Overall Study||32||
48041722|NCT01122264|100423856|FG001|NOT COMPLETED|Overall Study||29||
48041723|NCT01122264|100423857|FG002|NOT COMPLETED|Overall Study||47||
48041724|NCT00835731|100423858|FG000|STARTED|Overall Study||64||
48041725|NCT00835731|100423859|FG001|STARTED|Overall Study||61||
48041726|NCT00835731|100423858|FG000|COMPLETED|Overall Study||62||
48041727|NCT00835731|100423859|FG001|COMPLETED|Overall Study||60||
48041728|NCT00835731|100423858|FG000|NOT COMPLETED|Overall Study||2||
48041729|NCT00835731|100423859|FG001|NOT COMPLETED|Overall Study||1||
48041730|NCT00875589|100423860|FG000|STARTED|Overall Study||15||
48041731|NCT00875589|100423861|FG001|STARTED|Overall Study||11||
48041732|NCT00875589|100423860|FG000|COMPLETED|Overall Study||15||
48041733|NCT00875589|100423861|FG001|COMPLETED|Overall Study||11||
48041734|NCT00875589|100423860|FG000|NOT COMPLETED|Overall Study||0||
48041735|NCT00875589|100423861|FG001|NOT COMPLETED|Overall Study||0||
48041736|NCT00435045|100423862|FG000|STARTED|Weeks 1-8 / 10 mg Dose Level||123||
48203630|NCT01930045|100823551|FG001|NOT COMPLETED|Part 1 - Period 1||0||
48203631|NCT01930045|100823552|FG002|NOT COMPLETED|Part 1 - Period 1||0||
48203632|NCT01930045|100823553|FG003|NOT COMPLETED|Part 1 - Period 1||0||
48203633|NCT01930045|100823554|FG004|NOT COMPLETED|Part 1 - Period 1||0||
48203634|NCT01930045|100823555|FG005|NOT COMPLETED|Part 1 - Period 1||0||
48203635|NCT01930045|100823550|FG000|STARTED|Part 1 - Period 2||3||
48203636|NCT01930045|100823551|FG001|STARTED|Part 1 - Period 2||3||
48203637|NCT01930045|100823552|FG002|STARTED|Part 1 - Period 2||3||
48203638|NCT01930045|100823553|FG003|STARTED|Part 1 - Period 2||3||
48203639|NCT01930045|100823554|FG004|STARTED|Part 1 - Period 2||3||
48203640|NCT01930045|100823555|FG005|STARTED|Part 1 - Period 2||3||
48203641|NCT01930045|100823550|FG000|COMPLETED|Part 1 - Period 2||3||
48203642|NCT01930045|100823551|FG001|COMPLETED|Part 1 - Period 2||3||
48203643|NCT01930045|100823552|FG002|COMPLETED|Part 1 - Period 2||3||
48203644|NCT01930045|100823553|FG003|COMPLETED|Part 1 - Period 2||3||
48203645|NCT01930045|100823554|FG004|COMPLETED|Part 1 - Period 2||3||
48203646|NCT01930045|100823555|FG005|COMPLETED|Part 1 - Period 2||3||
48203647|NCT01930045|100823550|FG000|NOT COMPLETED|Part 1 - Period 2||0||
48203648|NCT01930045|100823551|FG001|NOT COMPLETED|Part 1 - Period 2||0||
48203649|NCT01930045|100823552|FG002|NOT COMPLETED|Part 1 - Period 2||0||
48203650|NCT01930045|100823553|FG003|NOT COMPLETED|Part 1 - Period 2||0||
48203651|NCT01930045|100823554|FG004|NOT COMPLETED|Part 1 - Period 2||0||
48203652|NCT01930045|100823555|FG005|NOT COMPLETED|Part 1 - Period 2||0||
48203653|NCT01930045|100823550|FG000|STARTED|Part 1 - Period 3||3||
48203654|NCT01930045|100823551|FG001|STARTED|Part 1 - Period 3||3||
48203655|NCT01930045|100823552|FG002|STARTED|Part 1 - Period 3||2||
48203656|NCT01930045|100823553|FG003|STARTED|Part 1 - Period 3||3||
48203657|NCT01930045|100823554|FG004|STARTED|Part 1 - Period 3||3||
48203658|NCT01930045|100823555|FG005|STARTED|Part 1 - Period 3||3||
48495354|NCT04583423|101547832|FG003|STARTED|Overall Study||44||
48041737|NCT00435045|100423863|FG001|STARTED|Weeks 1-8 / 10 mg Dose Level||122||
48041738|NCT00435045|100423862|FG000|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118||
48041739|NCT00435045|100423863|FG001|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118||
48041740|NCT00435045|100423862|FG000|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||5||
48041741|NCT00435045|100423863|FG001|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||4||
48041742|NCT00435045|100423862|FG000|STARTED|Weeks 9-12 / 20mg Dose Level||118||
48041743|NCT00435045|100423863|FG001|STARTED|Weeks 9-12 / 20mg Dose Level||118||
48041744|NCT00435045|100423862|FG000|COMPLETED|Weeks 9-12 / 20mg Dose Level||113||
48041745|NCT00435045|100423863|FG001|COMPLETED|Weeks 9-12 / 20mg Dose Level||113||
48041746|NCT00435045|100423862|FG000|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5||
48041747|NCT00435045|100423863|FG001|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5||
48041748|NCT00435045|100423862|FG000|STARTED|Weeks 13-16 / 40mg Dose Level||113||
48041749|NCT00435045|100423863|FG001|STARTED|Weeks 13-16 / 40mg Dose Level||113||
48041750|NCT00435045|100423862|FG000|COMPLETED|Weeks 13-16 / 40mg Dose Level||108||
48041751|NCT00435045|100423863|FG001|COMPLETED|Weeks 13-16 / 40mg Dose Level||111||
48041752|NCT00435045|100423862|FG000|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||5||
48041753|NCT00435045|100423863|FG001|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||2||
48041754|NCT03445156|100423864|FG000|STARTED|Pilot Study||20||
48041755|NCT03445156|100423865|FG001|STARTED|Pilot Study||20||
48041756|NCT03445156|100423866|FG002|STARTED|Pilot Study||0||
48041757|NCT03445156|100423864|FG000|COMPLETED|Pilot Study||20||
48041758|NCT03445156|100423865|FG001|COMPLETED|Pilot Study||20||
48041759|NCT03445156|100423866|FG002|COMPLETED|Pilot Study||0||
48041760|NCT03445156|100423864|FG000|NOT COMPLETED|Pilot Study||0||
48041761|NCT03445156|100423865|FG001|NOT COMPLETED|Pilot Study||0||
48041762|NCT03445156|100423866|FG002|NOT COMPLETED|Pilot Study||0||
48041763|NCT03445156|100423864|FG000|STARTED|Experiment Proper||113||
48041764|NCT03445156|100423865|FG001|STARTED|Experiment Proper||115||
48041765|NCT03445156|100423866|FG002|STARTED|Experiment Proper||59||
48041766|NCT03445156|100423864|FG000|COMPLETED|Experiment Proper||113||
48041767|NCT03445156|100423865|FG001|COMPLETED|Experiment Proper||115||
48041768|NCT03445156|100423866|FG002|COMPLETED|Experiment Proper||59||
48041769|NCT03445156|100423864|FG000|NOT COMPLETED|Experiment Proper||0||
48041770|NCT03445156|100423865|FG001|NOT COMPLETED|Experiment Proper||0||
48041771|NCT03445156|100423866|FG002|NOT COMPLETED|Experiment Proper||0||
48041772|NCT02000908|100423867|FG000|STARTED|Overall Study||30||
48041773|NCT02000908|100423868|FG001|STARTED|Overall Study||40||
48041774|NCT02000908|100423867|FG000|COMPLETED|Overall Study||28||
48041775|NCT02000908|100423868|FG001|COMPLETED|Overall Study||36||
48041776|NCT02000908|100423867|FG000|NOT COMPLETED|Overall Study||2||
48041777|NCT02000908|100423868|FG001|NOT COMPLETED|Overall Study||4||
48041778|NCT01779219|100423869|FG000|STARTED|Overall Study||21||
48041779|NCT01779219|100423870|FG001|STARTED|Overall Study||21||
48041780|NCT01779219|100423869|FG000|COMPLETED|Overall Study||21||
48041781|NCT01779219|100423870|FG001|COMPLETED|Overall Study||21||
48041782|NCT01779219|100423869|FG000|NOT COMPLETED|Overall Study||0||
48041783|NCT01779219|100423870|FG001|NOT COMPLETED|Overall Study||0||
48041784|NCT01917656|100423871|FG000|STARTED|Overall Study||172||
48041785|NCT01917656|100423872|FG001|STARTED|Overall Study||171||
48041786|NCT01917656|100423871|FG000|Exposed|Overall Study||171||
48041787|NCT01917656|100423872|FG001|Exposed|Overall Study||170||
48041788|NCT01917656|100423871|FG000|Exposed During Ramadan (Fasting)|Overall Study||152||
48041789|NCT01917656|100423872|FG001|Exposed During Ramadan (Fasting)|Overall Study||163||
48041790|NCT01917656|100423871|FG000|COMPLETED|Overall Study||146||
48041791|NCT01917656|100423872|FG001|COMPLETED|Overall Study||147||
48041792|NCT01917656|100423871|FG000|NOT COMPLETED|Overall Study||26||
48041793|NCT01917656|100423872|FG001|NOT COMPLETED|Overall Study||24||
48041794|NCT01883856|100423873|FG000|STARTED|Overall Study||26||
48041795|NCT01883856|100423874|FG001|STARTED|Overall Study||26||
48041796|NCT01883856|100423873|FG000|COMPLETED|Overall Study||26||
48041797|NCT01883856|100423874|FG001|COMPLETED|Overall Study||26||
48041798|NCT01883856|100423873|FG000|NOT COMPLETED|Overall Study||0||
48041799|NCT01883856|100423874|FG001|NOT COMPLETED|Overall Study||0||
48041800|NCT01029405|100423875|FG000|STARTED|Overall Study||36||
48041801|NCT01029405|100423876|FG001|STARTED|Overall Study||37||
48041802|NCT01029405|100423877|FG002|STARTED|Overall Study||35||
48041803|NCT01029405|100423878|FG003|STARTED|Overall Study||37||
48041804|NCT01029405|100423875|FG000|COMPLETED|Overall Study||34||
48041805|NCT01029405|100423876|FG001|COMPLETED|Overall Study||34||
48041806|NCT01029405|100423877|FG002|COMPLETED|Overall Study||31||
48041807|NCT01029405|100423878|FG003|COMPLETED|Overall Study||32||
48041808|NCT01029405|100423875|FG000|NOT COMPLETED|Overall Study||2||
48041809|NCT01029405|100423876|FG001|NOT COMPLETED|Overall Study||3||
48041810|NCT01029405|100423877|FG002|NOT COMPLETED|Overall Study||4||
48041811|NCT01029405|100423878|FG003|NOT COMPLETED|Overall Study||5||
48041812|NCT02930980|100423879|FG000|STARTED|Overall Study||43||
48041813|NCT02930980|100423879|FG000|COMPLETED|Overall Study||43||
48041814|NCT02930980|100423879|FG000|NOT COMPLETED|Overall Study||0||
48041815|NCT04518995|100423880|FG000|STARTED|Overall Study||140||
48041816|NCT04518995|100423881|FG001|STARTED|Overall Study||351||
48041817|NCT04518995|100423882|FG002|STARTED|Overall Study||215||
48041818|NCT04518995|100423880|FG000|Efficacy Population|Overall Study||140|Efficacy population included all participants who were randomized in the study and dispensed study drug during the treatment period.|
48041819|NCT04518995|100423881|FG001|Efficacy Population|Overall Study||351|Efficacy population included all participants who were randomized in the study and dispensed study drug during the treatment period.|
48203659|NCT01930045|100823550|FG000|COMPLETED|Part 1 - Period 3||3||
48203660|NCT01930045|100823551|FG001|COMPLETED|Part 1 - Period 3||3||
48203661|NCT01930045|100823552|FG002|COMPLETED|Part 1 - Period 3||2||
48203662|NCT01930045|100823553|FG003|COMPLETED|Part 1 - Period 3||3||
48203663|NCT01930045|100823554|FG004|COMPLETED|Part 1 - Period 3||3||
48203664|NCT01930045|100823555|FG005|COMPLETED|Part 1 - Period 3||3||
48203665|NCT01930045|100823550|FG000|NOT COMPLETED|Part 1 - Period 3||0||
48203666|NCT01930045|100823551|FG001|NOT COMPLETED|Part 1 - Period 3||0||
48203667|NCT01930045|100823552|FG002|NOT COMPLETED|Part 1 - Period 3||0||
48203668|NCT01930045|100823553|FG003|NOT COMPLETED|Part 1 - Period 3||0||
48203669|NCT01930045|100823554|FG004|NOT COMPLETED|Part 1 - Period 3||0||
48203670|NCT01930045|100823555|FG005|NOT COMPLETED|Part 1 - Period 3||0||
48203671|NCT01930045|100823550|FG000|STARTED|Pause (up to 37 Days)||3||
48203672|NCT01930045|100823551|FG001|STARTED|Pause (up to 37 Days)||3||
48203673|NCT01930045|100823552|FG002|STARTED|Pause (up to 37 Days)||3||
48203674|NCT01930045|100823553|FG003|STARTED|Pause (up to 37 Days)||3||
48203675|NCT01930045|100823554|FG004|STARTED|Pause (up to 37 Days)||3||
48203676|NCT01930045|100823555|FG005|STARTED|Pause (up to 37 Days)||3||
48203677|NCT01930045|100823550|FG000|COMPLETED|Pause (up to 37 Days)||3||
48041820|NCT04518995|100423882|FG002|Efficacy Population|Overall Study||215|Efficacy population included all participants who were randomized in the study and dispensed study drug during the treatment period.|
48041821|NCT04518995|100423880|FG000|Safety Population|Overall Study||140|Safety population included all participants who received study drug during the treatment period.|
48041822|NCT04518995|100423881|FG001|Safety Population|Overall Study||350|Safety population included all participants who received study drug during the treatment period.|
48041823|NCT04518995|100423882|FG002|Safety Population|Overall Study||215|Safety population included all participants who received study drug during the treatment period.|
48041824|NCT04518995|100423880|FG000|COMPLETED|Overall Study||129||
48041825|NCT04518995|100423881|FG001|COMPLETED|Overall Study||318||
48041826|NCT04518995|100423882|FG002|COMPLETED|Overall Study||199||
48041827|NCT04518995|100423880|FG000|NOT COMPLETED|Overall Study||11||
48041828|NCT04518995|100423881|FG001|NOT COMPLETED|Overall Study||33||
48041829|NCT04518995|100423882|FG002|NOT COMPLETED|Overall Study||16||
48203678|NCT01930045|100823551|FG001|COMPLETED|Pause (up to 37 Days)||3||
48203679|NCT01930045|100823552|FG002|COMPLETED|Pause (up to 37 Days)||3||
48203680|NCT01930045|100823553|FG003|COMPLETED|Pause (up to 37 Days)||3||
48203681|NCT01930045|100823554|FG004|COMPLETED|Pause (up to 37 Days)||3||
48203682|NCT01930045|100823555|FG005|COMPLETED|Pause (up to 37 Days)||1||
48203683|NCT01930045|100823550|FG000|NOT COMPLETED|Pause (up to 37 Days)||0||
48203684|NCT01930045|100823551|FG001|NOT COMPLETED|Pause (up to 37 Days)||0||
48203685|NCT01930045|100823552|FG002|NOT COMPLETED|Pause (up to 37 Days)||0||
48203686|NCT01930045|100823553|FG003|NOT COMPLETED|Pause (up to 37 Days)||0||
48203687|NCT01930045|100823554|FG004|NOT COMPLETED|Pause (up to 37 Days)||0||
48203688|NCT01930045|100823555|FG005|NOT COMPLETED|Pause (up to 37 Days)||2||
48203689|NCT01930045|100823550|FG000|STARTED|Part 2 - Period 4||3||
48203690|NCT01930045|100823551|FG001|STARTED|Part 2 - Period 4||3||
48203691|NCT01930045|100823552|FG002|STARTED|Part 2 - Period 4||3||
48203692|NCT01930045|100823553|FG003|STARTED|Part 2 - Period 4||3||
48203693|NCT01930045|100823554|FG004|STARTED|Part 2 - Period 4||3||
48203694|NCT01930045|100823555|FG005|STARTED|Part 2 - Period 4||1||
48203695|NCT01930045|100823550|FG000|COMPLETED|Part 2 - Period 4||3||
48203696|NCT01930045|100823551|FG001|COMPLETED|Part 2 - Period 4||3||
48203697|NCT01930045|100823552|FG002|COMPLETED|Part 2 - Period 4||3||
48203698|NCT01930045|100823553|FG003|COMPLETED|Part 2 - Period 4||3||
48203699|NCT01930045|100823554|FG004|COMPLETED|Part 2 - Period 4||3||
48203700|NCT01930045|100823555|FG005|COMPLETED|Part 2 - Period 4||1||
48203701|NCT01930045|100823550|FG000|NOT COMPLETED|Part 2 - Period 4||0||
48203702|NCT01930045|100823551|FG001|NOT COMPLETED|Part 2 - Period 4||0||
48203703|NCT01930045|100823552|FG002|NOT COMPLETED|Part 2 - Period 4||0||
48203704|NCT01930045|100823553|FG003|NOT COMPLETED|Part 2 - Period 4||0||
48203705|NCT01930045|100823554|FG004|NOT COMPLETED|Part 2 - Period 4||0||
48203706|NCT01930045|100823555|FG005|NOT COMPLETED|Part 2 - Period 4||0||
48203707|NCT01930045|100823550|FG000|STARTED|Part 2 - Period 5||3||
48203708|NCT01930045|100823551|FG001|STARTED|Part 2 - Period 5||3||
48203709|NCT01930045|100823552|FG002|STARTED|Part 2 - Period 5||3||
48203710|NCT01930045|100823553|FG003|STARTED|Part 2 - Period 5||3||
48203711|NCT01930045|100823554|FG004|STARTED|Part 2 - Period 5||3||
48203712|NCT01930045|100823555|FG005|STARTED|Part 2 - Period 5||1||
48203713|NCT01930045|100823550|FG000|COMPLETED|Part 2 - Period 5||3||
48203714|NCT01930045|100823551|FG001|COMPLETED|Part 2 - Period 5||3||
48203715|NCT01930045|100823552|FG002|COMPLETED|Part 2 - Period 5||3||
48203716|NCT01930045|100823553|FG003|COMPLETED|Part 2 - Period 5||3||
48203717|NCT01930045|100823554|FG004|COMPLETED|Part 2 - Period 5||3||
48203718|NCT01930045|100823555|FG005|COMPLETED|Part 2 - Period 5||1||
48203719|NCT01930045|100823550|FG000|NOT COMPLETED|Part 2 - Period 5||0||
48203720|NCT01930045|100823551|FG001|NOT COMPLETED|Part 2 - Period 5||0||
48203721|NCT01930045|100823552|FG002|NOT COMPLETED|Part 2 - Period 5||0||
48203722|NCT01930045|100823553|FG003|NOT COMPLETED|Part 2 - Period 5||0||
48203723|NCT01930045|100823554|FG004|NOT COMPLETED|Part 2 - Period 5||0||
48203724|NCT01930045|100823555|FG005|NOT COMPLETED|Part 2 - Period 5||0||
48495355|NCT04583423|101547829|FG000|Received 1st Dose|Overall Study||45||
48203725|NCT02263508|100823556|FG000|STARTED|Overall Study||21||
48203726|NCT02263508|100823557|FG001|STARTED|Overall Study||346||
48203727|NCT02263508|100823558|FG002|STARTED|Overall Study||346||
48203728|NCT02263508|100823556|FG000|Received Talimogene Laherparepvec/Placebo|Overall Study||21||
48203729|NCT02263508|100823557|FG001|Received Talimogene Laherparepvec/Placebo|Overall Study||345||
48203730|NCT02263508|100823558|FG002|Received Talimogene Laherparepvec/Placebo|Overall Study||343||
48203731|NCT02263508|100823556|FG000|Received Pembrolizumab|Overall Study||21||
48203732|NCT02263508|100823557|FG001|Received Pembrolizumab|Overall Study||345||
48203733|NCT02263508|100823558|FG002|Received Pembrolizumab|Overall Study||343||
48203734|NCT02263508|100823556|FG000|COMPLETED|Overall Study||0||
48203735|NCT02263508|100823557|FG001|COMPLETED|Overall Study||0||
48203736|NCT02263508|100823558|FG002|COMPLETED|Overall Study||0||
48203737|NCT02263508|100823556|FG000|NOT COMPLETED|Overall Study||21||
48041830|NCT02878057|100423883|FG000|STARTED|Overall Study||30||
48041831|NCT02878057|100423883|FG000|COMPLETED|Overall Study||26||
48041832|NCT02878057|100423883|FG000|NOT COMPLETED|Overall Study||4||
48041833|NCT01244490|100423884|FG000|STARTED|Overall Study||111||
48041834|NCT01244490|100423885|FG001|STARTED|Overall Study||115||
48041835|NCT01244490|100423886|FG002|STARTED|Overall Study||112||
48041836|NCT01244490|100423884|FG000|COMPLETED|Overall Study||92||
48041837|NCT01244490|100423885|FG001|COMPLETED|Overall Study||91||
48041838|NCT01244490|100423886|FG002|COMPLETED|Overall Study||89||
48041839|NCT01244490|100423884|FG000|NOT COMPLETED|Overall Study||19||
48041840|NCT01244490|100423885|FG001|NOT COMPLETED|Overall Study||24||
48041841|NCT01244490|100423886|FG002|NOT COMPLETED|Overall Study||23||
48041842|NCT03720392|100423887|FG000|STARTED|Overall Study||3||
48041843|NCT03720392|100423888|FG001|STARTED|Overall Study||3||
48041844|NCT03720392|100423887|FG000|COMPLETED|Overall Study||3||
48041845|NCT03720392|100423888|FG001|COMPLETED|Overall Study||3||
48041846|NCT03720392|100423887|FG000|NOT COMPLETED|Overall Study||0||
48041847|NCT03720392|100423888|FG001|NOT COMPLETED|Overall Study||0||
48041848|NCT04022733|100423889|FG000|STARTED|Overall Study||67||
48041849|NCT04022733|100423890|FG001|STARTED|Overall Study||67||
48041850|NCT04022733|100423889|FG000|COMPLETED|Overall Study||64||
48041851|NCT04022733|100423890|FG001|COMPLETED|Overall Study||64||
48041852|NCT04022733|100423889|FG000|NOT COMPLETED|Overall Study||3||
48041853|NCT04022733|100423890|FG001|NOT COMPLETED|Overall Study||3||
48041854|NCT00797966|100423891|FG000|STARTED|Phase A||0||
48041855|NCT00797966|100423892|FG001|STARTED|Phase A||0||
48041856|NCT00797966|100423893|FG002|STARTED|Phase A||0||
48041857|NCT00797966|100423894|FG003|STARTED|Phase A||0||
48041858|NCT00797966|100423895|FG004|STARTED|Phase A||849||
48041859|NCT00797966|100423896|FG005|STARTED|Phase A||0||
48041860|NCT00797966|100423891|FG000|COMPLETED|Phase A||0||
48041861|NCT00797966|100423892|FG001|COMPLETED|Phase A||0||
48041862|NCT00797966|100423893|FG002|COMPLETED|Phase A||0||
48041863|NCT00797966|100423894|FG003|COMPLETED|Phase A||0||
48041864|NCT00797966|100423895|FG004|COMPLETED|Phase A||664||
48041865|NCT00797966|100423896|FG005|COMPLETED|Phase A||0||
48041866|NCT00797966|100423891|FG000|NOT COMPLETED|Phase A||0||
48041867|NCT00797966|100423892|FG001|NOT COMPLETED|Phase A||0||
48041868|NCT00797966|100423893|FG002|NOT COMPLETED|Phase A||0||
48041869|NCT00797966|100423894|FG003|NOT COMPLETED|Phase A||0||
48041870|NCT00797966|100423895|FG004|NOT COMPLETED|Phase A||185||
48041871|NCT00797966|100423896|FG005|NOT COMPLETED|Phase A||0||
48041872|NCT00797966|100423891|FG000|STARTED|Phase B||62||
48041873|NCT00797966|100423892|FG001|STARTED|Phase B||120||
48041874|NCT00797966|100423893|FG002|STARTED|Phase B||121||
48041875|NCT00797966|100423894|FG003|STARTED|Phase B||126||
48041876|NCT00797966|100423895|FG004|STARTED|Phase B||0||
48203738|NCT02263508|100823557|FG001|NOT COMPLETED|Overall Study||346||
48203739|NCT02263508|100823558|FG002|NOT COMPLETED|Overall Study||346||
48203740|NCT00868192|100823559|FG000|STARTED|Overall Study||38||
48203741|NCT00868192|100823559|FG000|COMPLETED|Overall Study||34||
48203742|NCT00868192|100823559|FG000|NOT COMPLETED|Overall Study||4||
48203743|NCT03698708|100823560|FG000|STARTED|Overall Study||17||
48203744|NCT03698708|100823561|FG001|STARTED|Overall Study||20||
48203745|NCT03698708|100823560|FG000|COMPLETED|Overall Study||13||
48203746|NCT03698708|100823561|FG001|COMPLETED|Overall Study||16||
48203747|NCT03698708|100823560|FG000|NOT COMPLETED|Overall Study||4||
48203748|NCT03698708|100823561|FG001|NOT COMPLETED|Overall Study||4||
48203749|NCT00726999|100823562|FG000|STARTED|Overall Study||32||
48203750|NCT00726999|100823563|FG001|STARTED|Overall Study||31||
48203751|NCT00726999|100823562|FG000|COMPLETED|Overall Study||29||
48203752|NCT00726999|100823563|FG001|COMPLETED|Overall Study||30||
48203753|NCT00726999|100823562|FG000|NOT COMPLETED|Overall Study||3||
48203754|NCT00726999|100823563|FG001|NOT COMPLETED|Overall Study||1||
48203755|NCT00843193|100823564|FG000|STARTED|Overall Study||99||
48203756|NCT00843193|100823565|FG001|STARTED|Overall Study||99||
48203757|NCT00843193|100823564|FG000|COMPLETED|Overall Study||91||
48041877|NCT00797966|100423896|FG005|STARTED|Phase B||0||
48041878|NCT00797966|100423891|FG000|COMPLETED|Phase B||51||
48041879|NCT00797966|100423892|FG001|COMPLETED|Phase B||102||
48041880|NCT00797966|100423893|FG002|COMPLETED|Phase B||100||
48041881|NCT00797966|100423894|FG003|COMPLETED|Phase B||110||
48041882|NCT00797966|100423895|FG004|COMPLETED|Phase B||0||
48041883|NCT00797966|100423896|FG005|COMPLETED|Phase B||0||
48203758|NCT00843193|100823565|FG001|COMPLETED|Overall Study||88||
48203759|NCT00843193|100823564|FG000|NOT COMPLETED|Overall Study||8||
48203760|NCT00843193|100823565|FG001|NOT COMPLETED|Overall Study||11||
48041884|NCT00797966|100423891|FG000|NOT COMPLETED|Phase B||11||
48041885|NCT00797966|100423892|FG001|NOT COMPLETED|Phase B||18||
48041886|NCT00797966|100423893|FG002|NOT COMPLETED|Phase B||21||
48041887|NCT00797966|100423894|FG003|NOT COMPLETED|Phase B||16||
48041888|NCT00797966|100423895|FG004|NOT COMPLETED|Phase B||0||
48041889|NCT00797966|100423896|FG005|NOT COMPLETED|Phase B||0||
48041890|NCT00797966|100423891|FG000|STARTED|Phase A+||0||
48041891|NCT00797966|100423892|FG001|STARTED|Phase A+||0||
48041892|NCT00797966|100423893|FG002|STARTED|Phase A+||0||
48041893|NCT00797966|100423894|FG003|STARTED|Phase A+||0||
48041894|NCT00797966|100423895|FG004|STARTED|Phase A+||0||
48041895|NCT00797966|100423896|FG005|STARTED|Phase A+||235||
48041896|NCT00797966|100423891|FG000|COMPLETED|Phase A+||0||
48041897|NCT00797966|100423892|FG001|COMPLETED|Phase A+||0||
48041898|NCT00797966|100423893|FG002|COMPLETED|Phase A+||0||
48041899|NCT00797966|100423894|FG003|COMPLETED|Phase A+||0||
48041900|NCT00797966|100423895|FG004|COMPLETED|Phase A+||0||
48041901|NCT00797966|100423896|FG005|COMPLETED|Phase A+||207||
48041902|NCT00797966|100423891|FG000|NOT COMPLETED|Phase A+||0||
48041903|NCT00797966|100423892|FG001|NOT COMPLETED|Phase A+||0||
48041904|NCT00797966|100423893|FG002|NOT COMPLETED|Phase A+||0||
48041905|NCT00797966|100423894|FG003|NOT COMPLETED|Phase A+||0||
48041906|NCT00797966|100423895|FG004|NOT COMPLETED|Phase A+||0||
48041907|NCT00797966|100423896|FG005|NOT COMPLETED|Phase A+||28||
48041908|NCT02527200|100423897|FG000|STARTED|Overall Study||20||
48041909|NCT02527200|100423898|FG001|STARTED|Overall Study||12||
48041910|NCT02527200|100423899|FG002|STARTED|Overall Study||17||
48041911|NCT02527200|100423900|FG003|STARTED|Overall Study||7||
48041912|NCT02527200|100423897|FG000|Safety Analysis Set (SAS)|Overall Study||20||
48041913|NCT02527200|100423898|FG001|Safety Analysis Set (SAS)|Overall Study||12||
48041914|NCT02527200|100423899|FG002|Safety Analysis Set (SAS)|Overall Study||17||
48041915|NCT02527200|100423900|FG003|Safety Analysis Set (SAS)|Overall Study||7||
48041916|NCT02527200|100423897|FG000|Full Analysis Set (FAS)|Overall Study||19||
48041917|NCT02527200|100423898|FG001|Full Analysis Set (FAS)|Overall Study||12||
48041918|NCT02527200|100423899|FG002|Full Analysis Set (FAS)|Overall Study||17||
48041919|NCT02527200|100423900|FG003|Full Analysis Set (FAS)|Overall Study||7||
48041920|NCT02527200|100423897|FG000|COMPLETED|Overall Study||17||
48041921|NCT02527200|100423898|FG001|COMPLETED|Overall Study||9||
48041922|NCT02527200|100423899|FG002|COMPLETED|Overall Study||15||
48041923|NCT02527200|100423900|FG003|COMPLETED|Overall Study||7||
48041924|NCT02527200|100423897|FG000|NOT COMPLETED|Overall Study||3||
48041925|NCT02527200|100423898|FG001|NOT COMPLETED|Overall Study||3||
48041926|NCT02527200|100423899|FG002|NOT COMPLETED|Overall Study||2||
48041927|NCT02527200|100423900|FG003|NOT COMPLETED|Overall Study||0||
48041928|NCT01584544|100423901|FG000|STARTED|Overall Study||3||
48041929|NCT01584544|100423902|FG001|STARTED|Overall Study||6||
48041930|NCT01584544|100423903|FG002|STARTED|Overall Study||6||
48041931|NCT01584544|100423904|FG003|STARTED|Overall Study||3||
48041932|NCT01584544|100423905|FG004|STARTED|Overall Study||6||
48041933|NCT01584544|100423901|FG000|COMPLETED|Overall Study||3||
48041934|NCT01584544|100423902|FG001|COMPLETED|Overall Study||6||
48041935|NCT01584544|100423903|FG002|COMPLETED|Overall Study||6||
48041936|NCT01584544|100423904|FG003|COMPLETED|Overall Study||3||
48041937|NCT01584544|100423905|FG004|COMPLETED|Overall Study||6||
48041938|NCT01584544|100423901|FG000|NOT COMPLETED|Overall Study||0||
48041939|NCT01584544|100423902|FG001|NOT COMPLETED|Overall Study||0||
48041940|NCT01584544|100423903|FG002|NOT COMPLETED|Overall Study||0||
48041941|NCT01584544|100423904|FG003|NOT COMPLETED|Overall Study||0||
48041942|NCT01584544|100423905|FG004|NOT COMPLETED|Overall Study||0||
48041943|NCT03678870|100423906|FG000|STARTED|Overall Study||97||
48041944|NCT03678870|100423907|FG001|STARTED|Overall Study||99||
48041945|NCT03678870|100423906|FG000|COMPLETED|Overall Study||84||
48041946|NCT03678870|100423907|FG001|COMPLETED|Overall Study||91||
48041947|NCT03678870|100423906|FG000|NOT COMPLETED|Overall Study||13||
48041948|NCT03678870|100423907|FG001|NOT COMPLETED|Overall Study||8||
48041949|NCT03859973|100423908|FG000|STARTED|Overall Study||99||
48203761|NCT03284411|100823566|FG000|STARTED|Overall Study||30||
48203762|NCT03284411|100823566|FG000|COMPLETED|Overall Study||30||
48203763|NCT03284411|100823566|FG000|NOT COMPLETED|Overall Study||0||
48041950|NCT03859973|100423909|FG001|STARTED|Overall Study||101||
48041951|NCT03859973|100423908|FG000|COMPLETED|Overall Study||79|Completed trial medication|
48041952|NCT03859973|100423909|FG001|COMPLETED|Overall Study||75|Completed trial medication|
48041953|NCT03859973|100423908|FG000|NOT COMPLETED|Overall Study||20||
48041954|NCT03859973|100423909|FG001|NOT COMPLETED|Overall Study||26||
48041955|NCT02151773|100423910|FG000|STARTED|Overall Study||3493||
48041956|NCT02151773|100423910|FG000|COMPLETED|Overall Study||3429||
48041957|NCT02151773|100423910|FG000|NOT COMPLETED|Overall Study||64||
48041958|NCT00430183|100423911|FG000|STARTED|Overall Study||391||
48041959|NCT00430183|100423912|FG001|STARTED|Overall Study||397||
48041960|NCT00430183|100423911|FG000|COMPLETED|Overall Study||391||
48203764|NCT01989910|100823567|FG000|STARTED|Overall Study||53||
48041961|NCT00430183|100423912|FG001|COMPLETED|Overall Study||397||
48203765|NCT01989910|100823568|FG001|STARTED|Overall Study||54||
48203766|NCT01989910|100823567|FG000|COMPLETED|Overall Study||51||
48203767|NCT01989910|100823568|FG001|COMPLETED|Overall Study||54||
48203768|NCT01989910|100823567|FG000|NOT COMPLETED|Overall Study||2||
48203769|NCT01989910|100823568|FG001|NOT COMPLETED|Overall Study||0||
48041962|NCT00430183|100423911|FG000|NOT COMPLETED|Overall Study||0||
48041963|NCT00430183|100423912|FG001|NOT COMPLETED|Overall Study||0||
48203770|NCT00299741|100823569|FG000|STARTED|Overall Study||36||
48203771|NCT00299741|100823569|FG000|COMPLETED|Overall Study||36||
48203772|NCT00299741|100823569|FG000|NOT COMPLETED|Overall Study||0||
48203773|NCT00748410|100823570|FG000|STARTED|Overall Study||1||
48203774|NCT00748410|100823571|FG001|STARTED|Overall Study||2||
48203775|NCT00748410|100823570|FG000|COMPLETED|Overall Study||1||
48203776|NCT00748410|100823571|FG001|COMPLETED|Overall Study||2||
48203777|NCT00748410|100823570|FG000|NOT COMPLETED|Overall Study||0||
48203778|NCT00748410|100823571|FG001|NOT COMPLETED|Overall Study||0||
48203779|NCT05149313|100823572|FG000|STARTED|Overall Study||220||
48203780|NCT05149313|100823573|FG001|STARTED|Overall Study||111||
48203781|NCT05149313|100823572|FG000|COMPLETED|Overall Study||212||
48203782|NCT05149313|100823573|FG001|COMPLETED|Overall Study||100||
48203783|NCT05149313|100823572|FG000|NOT COMPLETED|Overall Study||8||
48203784|NCT05149313|100823573|FG001|NOT COMPLETED|Overall Study||11||
48203785|NCT02082158|100823574|FG000|STARTED|Overall Study||66||
48203786|NCT02082158|100823575|FG001|STARTED|Overall Study||61||
48203787|NCT02082158|100823576|FG002|STARTED|Overall Study||52||
48203788|NCT02082158|100823577|FG003|STARTED|Overall Study||72||
48041964|NCT01733212|100423913|FG000|STARTED|Overall Study||116||
48041965|NCT01733212|100423914|FG001|STARTED|Overall Study||123||
48041966|NCT01733212|100423913|FG000|COMPLETED|Overall Study||116||
48041967|NCT01733212|100423914|FG001|COMPLETED|Overall Study||123||
48041968|NCT01733212|100423913|FG000|NOT COMPLETED|Overall Study||0||
48041969|NCT01733212|100423914|FG001|NOT COMPLETED|Overall Study||0||
48041970|NCT01235598|100423915|FG000|STARTED|Overall Study||13||
48041971|NCT01235598|100423916|FG001|STARTED|Overall Study||28||
48041972|NCT01235598|100423915|FG000|COMPLETED|Overall Study||12||
48041973|NCT01235598|100423916|FG001|COMPLETED|Overall Study||24||
48041974|NCT01235598|100423915|FG000|NOT COMPLETED|Overall Study||1||
48041975|NCT01235598|100423916|FG001|NOT COMPLETED|Overall Study||4||
48203789|NCT02082158|100823578|FG004|STARTED|Overall Study||68||
48203790|NCT02082158|100823579|FG005|STARTED|Overall Study||63||
48203791|NCT02082158|100823574|FG000|COMPLETED|Overall Study||58||
48203792|NCT02082158|100823575|FG001|COMPLETED|Overall Study||53||
48203793|NCT02082158|100823576|FG002|COMPLETED|Overall Study||38||
48203794|NCT02082158|100823577|FG003|COMPLETED|Overall Study||68||
48203795|NCT02082158|100823578|FG004|COMPLETED|Overall Study||64||
48203796|NCT02082158|100823579|FG005|COMPLETED|Overall Study||56||
48203797|NCT02082158|100823574|FG000|NOT COMPLETED|Overall Study||8||
48203798|NCT02082158|100823575|FG001|NOT COMPLETED|Overall Study||8||
48203799|NCT02082158|100823576|FG002|NOT COMPLETED|Overall Study||14||
48203800|NCT02082158|100823577|FG003|NOT COMPLETED|Overall Study||4||
48203801|NCT02082158|100823578|FG004|NOT COMPLETED|Overall Study||4||
48203802|NCT02082158|100823579|FG005|NOT COMPLETED|Overall Study||7||
48203803|NCT00130780|100823580|FG000|STARTED|Overall Study||51||
48203804|NCT00130780|100823581|FG001|STARTED|Overall Study||20||
48203805|NCT00130780|100823580|FG000|COMPLETED|Overall Study||51||
48203806|NCT00130780|100823581|FG001|COMPLETED|Overall Study||20||
48203807|NCT00130780|100823580|FG000|NOT COMPLETED|Overall Study||0||
48203808|NCT00130780|100823581|FG001|NOT COMPLETED|Overall Study||0||
48203809|NCT04002973|100823582|FG000|STARTED|Overall Study||11||
48203810|NCT04002973|100823582|FG000|COMPLETED|Overall Study||11||
48203811|NCT04002973|100823582|FG000|NOT COMPLETED|Overall Study||0||
48203812|NCT03808883|100823583|FG000|STARTED|Overall Study||20||
48203813|NCT03808883|100823584|FG001|STARTED|Overall Study||29||
48203814|NCT03808883|100823583|FG000|COMPLETED|Overall Study||14||
48203815|NCT03808883|100823584|FG001|COMPLETED|Overall Study||26||
48203816|NCT03808883|100823583|FG000|NOT COMPLETED|Overall Study||6||
48203817|NCT03808883|100823584|FG001|NOT COMPLETED|Overall Study||3||
48203818|NCT00918957|100823585|FG000|STARTED|Overall Study||32||
48203819|NCT00918957|100823586|FG001|STARTED|Overall Study||30||
48203820|NCT00918957|100823585|FG000|COMPLETED|Overall Study||29||
48203821|NCT00918957|100823586|FG001|COMPLETED|Overall Study||30||
48203822|NCT00918957|100823585|FG000|NOT COMPLETED|Overall Study||3||
48203823|NCT00918957|100823586|FG001|NOT COMPLETED|Overall Study||0||
48203824|NCT02806869|100823587|FG000|STARTED|First Intervention (1 Day)||24||
48203825|NCT02806869|100823588|FG001|STARTED|First Intervention (1 Day)||24||
48203826|NCT02806869|100823587|FG000|COMPLETED|First Intervention (1 Day)||13||
48203827|NCT02806869|100823588|FG001|COMPLETED|First Intervention (1 Day)||12||
48203828|NCT02806869|100823587|FG000|NOT COMPLETED|First Intervention (1 Day)||11||
48203829|NCT02806869|100823588|FG001|NOT COMPLETED|First Intervention (1 Day)||12||
48203830|NCT02806869|100823587|FG000|STARTED|Washout (7 Days)||7||
48041976|NCT01236547|100423917|FG000|STARTED|Overall Study||11||
48041977|NCT01236547|100423918|FG001|STARTED|Overall Study||11||
48041978|NCT01236547|100423919|FG002|STARTED|Overall Study||12||
48041979|NCT01236547|100423920|FG003|STARTED|Overall Study||42||
48041980|NCT01236547|100423921|FG004|STARTED|Overall Study||47||
48041981|NCT01236547|100423917|FG000|Eligible|Overall Study||11||
48041982|NCT01236547|100423918|FG001|Eligible|Overall Study||10||
48041983|NCT01236547|100423919|FG002|Eligible|Overall Study||11||
48041984|NCT01236547|100423920|FG003|Eligible|Overall Study||36||
48041985|NCT01236547|100423921|FG004|Eligible|Overall Study||35||
48041986|NCT01236547|100423917|FG000|Eligible and Started Study Treatment|Overall Study||11||
48041987|NCT01236547|100423918|FG001|Eligible and Started Study Treatment|Overall Study||10||
48041988|NCT01236547|100423919|FG002|Eligible and Started Study Treatment|Overall Study||11||
48041989|NCT01236547|100423920|FG003|Eligible and Started Study Treatment|Overall Study||36||
48041990|NCT01236547|100423921|FG004|Eligible and Started Study Treatment|Overall Study||34||
48041991|NCT01236547|100423917|FG000|Eligible and Response Assessed|Overall Study||0||
48041992|NCT01236547|100423918|FG001|Eligible and Response Assessed|Overall Study||0||
48041993|NCT01236547|100423919|FG002|Eligible and Response Assessed|Overall Study||0||
48041994|NCT01236547|100423920|FG003|Eligible and Response Assessed|Overall Study||23||
48041995|NCT01236547|100423921|FG004|Eligible and Response Assessed|Overall Study||27||
48041996|NCT01236547|100423917|FG000|COMPLETED|Overall Study||11|Participants contributing data to results are considered to have completed the study|
48041997|NCT01236547|100423918|FG001|COMPLETED|Overall Study||10|Participants contributing data to results are considered to have completed the study|
48041998|NCT01236547|100423919|FG002|COMPLETED|Overall Study||11|Participants contributing data to results are considered to have completed the study|
48041999|NCT01236547|100423920|FG003|COMPLETED|Overall Study||36|Participants contributing data to results are considered to have completed the study|
48042000|NCT01236547|100423921|FG004|COMPLETED|Overall Study||35|Participants contributing data to results are considered to have completed the study|
48042001|NCT01236547|100423917|FG000|NOT COMPLETED|Overall Study||0||
48042002|NCT01236547|100423918|FG001|NOT COMPLETED|Overall Study||1||
48042003|NCT01236547|100423919|FG002|NOT COMPLETED|Overall Study||1||
48042004|NCT01236547|100423920|FG003|NOT COMPLETED|Overall Study||6||
48042005|NCT01236547|100423921|FG004|NOT COMPLETED|Overall Study||12||
48042006|NCT00816023|100423922|FG000|STARTED|Overall Study||71||
48042007|NCT00816023|100423923|FG001|STARTED|Overall Study||62||
48042008|NCT00816023|100423924|FG002|STARTED|Overall Study||69||
48042009|NCT00816023|100423925|FG003|STARTED|Overall Study||74||
48042010|NCT00816023|100423922|FG000|Completed Therapy|Overall Study||65||
48042011|NCT00816023|100423923|FG001|Completed Therapy|Overall Study||59||
48042012|NCT00816023|100423924|FG002|Completed Therapy|Overall Study||61||
48042013|NCT00816023|100423925|FG003|Completed Therapy|Overall Study||63||
48042014|NCT00816023|100423922|FG000|COMPLETED|Overall Study||62||
48042015|NCT00816023|100423923|FG001|COMPLETED|Overall Study||56||
48042016|NCT00816023|100423924|FG002|COMPLETED|Overall Study||60||
48042017|NCT00816023|100423925|FG003|COMPLETED|Overall Study||62||
48042018|NCT00816023|100423922|FG000|NOT COMPLETED|Overall Study||9||
48042019|NCT00816023|100423923|FG001|NOT COMPLETED|Overall Study||6||
48042020|NCT00816023|100423924|FG002|NOT COMPLETED|Overall Study||9||
48042021|NCT00816023|100423925|FG003|NOT COMPLETED|Overall Study||12||
48042022|NCT02213133|100423926|FG000|STARTED|Overall Study||37|Enrolled|
48042023|NCT02213133|100423927|FG001|STARTED|Overall Study||5|Enrolled|
48042024|NCT02213133|100423928|FG002|STARTED|Overall Study||3|Enrolled|
48042025|NCT02213133|100423926|FG000|Treated|Overall Study||33||
48042026|NCT02213133|100423927|FG001|Treated|Overall Study||4||
48042027|NCT02213133|100423928|FG002|Treated|Overall Study||1||
48042028|NCT02213133|100423926|FG000|COMPLETED|Overall Study||0||
48042029|NCT02213133|100423927|FG001|COMPLETED|Overall Study||0||
48042030|NCT02213133|100423928|FG002|COMPLETED|Overall Study||0||
48042031|NCT02213133|100423926|FG000|NOT COMPLETED|Overall Study||37||
48042032|NCT02213133|100423927|FG001|NOT COMPLETED|Overall Study||5||
48042033|NCT02213133|100423928|FG002|NOT COMPLETED|Overall Study||3||
48042034|NCT00711516|100423929|FG000|STARTED|Overall Study||21||
48042035|NCT00711516|100423930|FG001|STARTED|Overall Study||19||
48042036|NCT00711516|100423929|FG000|COMPLETED|Overall Study||20||
48042037|NCT00711516|100423930|FG001|COMPLETED|Overall Study||16||
48042038|NCT00711516|100423929|FG000|NOT COMPLETED|Overall Study||1||
48042039|NCT00711516|100423930|FG001|NOT COMPLETED|Overall Study||3||
48042040|NCT00281658|100423931|FG000|STARTED|Randomized Phase||222|All randomized subjects were included in the Intent-to-Treat (ITT) Population|
48042041|NCT00281658|100423932|FG001|STARTED|Randomized Phase||222|All randomized subjects were included in the Intent-to-Treat (ITT) Population|
48042042|NCT00281658|100423933|FG002|STARTED|Randomized Phase||0|All randomized subjects were included in the Intent-to-Treat (ITT) Population|
48042043|NCT00281658|100423934|FG003|STARTED|Randomized Phase||0|All randomized subjects were included in the Intent-to-Treat (ITT) Population|
48042044|NCT00281658|100423931|FG000|Safety Population|Randomized Phase||222|All randomized subjects who received at least one dose of study medication|
48042045|NCT00281658|100423932|FG001|Safety Population|Randomized Phase||221|All randomized subjects who received at least one dose of study medication|
48042046|NCT00281658|100423933|FG002|Safety Population|Randomized Phase||0|All randomized subjects who received at least one dose of study medication|
48042047|NCT00281658|100423934|FG003|Safety Population|Randomized Phase||0|All randomized subjects who received at least one dose of study medication|
48042048|NCT00281658|100423931|FG000|COMPLETED|Randomized Phase||133||
48042049|NCT00281658|100423932|FG001|COMPLETED|Randomized Phase||149||
48203831|NCT02806869|100823588|FG001|STARTED|Washout (7 Days)||7||
48203832|NCT02806869|100823587|FG000|COMPLETED|Washout (7 Days)||7||
48042050|NCT00281658|100423933|FG002|COMPLETED|Randomized Phase||0||
48042051|NCT00281658|100423934|FG003|COMPLETED|Randomized Phase||0||
48042052|NCT00281658|100423931|FG000|NOT COMPLETED|Randomized Phase||89||
48042053|NCT00281658|100423932|FG001|NOT COMPLETED|Randomized Phase||73||
48042054|NCT00281658|100423933|FG002|NOT COMPLETED|Randomized Phase||0||
48203833|NCT02806869|100823588|FG001|COMPLETED|Washout (7 Days)||7||
48203834|NCT02806869|100823587|FG000|NOT COMPLETED|Washout (7 Days)||0||
48203835|NCT02806869|100823588|FG001|NOT COMPLETED|Washout (7 Days)||0||
48203836|NCT02806869|100823587|FG000|STARTED|Second Intervention (1 Day)||7||
48203837|NCT02806869|100823588|FG001|STARTED|Second Intervention (1 Day)||7||
48203838|NCT02806869|100823587|FG000|COMPLETED|Second Intervention (1 Day)||7||
48203839|NCT02806869|100823588|FG001|COMPLETED|Second Intervention (1 Day)||5||
48203840|NCT02806869|100823587|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48203841|NCT02806869|100823588|FG001|NOT COMPLETED|Second Intervention (1 Day)||2||
48203842|NCT01943799|100823589|FG000|STARTED|Overall Study||27||
48203843|NCT01943799|100823590|FG001|STARTED|Overall Study||50||
48203844|NCT01943799|100823591|FG002|STARTED|Overall Study||51||
48203845|NCT01943799|100823592|FG003|STARTED|Overall Study||50||
48203846|NCT01943799|100823589|FG000|COMPLETED|Overall Study||22||
48203847|NCT01943799|100823590|FG001|COMPLETED|Overall Study||47||
48203848|NCT01943799|100823591|FG002|COMPLETED|Overall Study||49||
48203849|NCT01943799|100823592|FG003|COMPLETED|Overall Study||50||
48203850|NCT01943799|100823589|FG000|NOT COMPLETED|Overall Study||5||
48203851|NCT01943799|100823590|FG001|NOT COMPLETED|Overall Study||3||
48203852|NCT01943799|100823591|FG002|NOT COMPLETED|Overall Study||2||
48203853|NCT01943799|100823592|FG003|NOT COMPLETED|Overall Study||0||
48203854|NCT00442117|100823593|FG000|STARTED|Overall Study||85||
48203855|NCT00442117|100823594|FG001|STARTED|Overall Study||87||
48203856|NCT00442117|100823593|FG000|COMPLETED|Overall Study||47||
48203857|NCT00442117|100823594|FG001|COMPLETED|Overall Study||49||
48203858|NCT00442117|100823593|FG000|NOT COMPLETED|Overall Study||38||
48203859|NCT00442117|100823594|FG001|NOT COMPLETED|Overall Study||38||
48203860|NCT01794936|100823595|FG000|STARTED|Overall Study||9||
48042055|NCT00281658|100423934|FG003|NOT COMPLETED|Randomized Phase||0||
48042056|NCT00281658|100423931|FG000|STARTED|Open Label Phase||0||
48042057|NCT00281658|100423932|FG001|STARTED|Open Label Phase||0||
48042058|NCT00281658|100423933|FG002|STARTED|Open Label Phase||149||
48042059|NCT00281658|100423934|FG003|STARTED|Open Label Phase||4||
48042060|NCT00281658|100423931|FG000|COMPLETED|Open Label Phase||0||
48042061|NCT00281658|100423932|FG001|COMPLETED|Open Label Phase||0||
48203861|NCT01794936|100823595|FG000|COMPLETED|Overall Study||9||
48203862|NCT01794936|100823595|FG000|NOT COMPLETED|Overall Study||0||
48203863|NCT00332644|100823596|FG000|STARTED|Overall Study||262||
48203864|NCT00332644|100823597|FG001|STARTED|Overall Study||260||
48203865|NCT00332644|100823598|FG002|STARTED|Overall Study||267||
48203866|NCT00332644|100823599|FG003|STARTED|Overall Study||264||
48203867|NCT00332644|100823600|FG004|STARTED|Overall Study||262||
48203868|NCT00332644|100823601|FG005|STARTED|Overall Study||189||
48203869|NCT00332644|100823596|FG000|COMPLETED|Overall Study||250||
48203870|NCT00332644|100823597|FG001|COMPLETED|Overall Study||238||
48203871|NCT00332644|100823598|FG002|COMPLETED|Overall Study||258||
48203872|NCT00332644|100823599|FG003|COMPLETED|Overall Study||244||
48203873|NCT00332644|100823600|FG004|COMPLETED|Overall Study||250||
48203874|NCT00332644|100823601|FG005|COMPLETED|Overall Study||174||
48203875|NCT00332644|100823596|FG000|NOT COMPLETED|Overall Study||12||
48042062|NCT00281658|100423933|FG002|COMPLETED|Open Label Phase||104||
48042063|NCT00281658|100423934|FG003|COMPLETED|Open Label Phase||0||
48042064|NCT00281658|100423931|FG000|NOT COMPLETED|Open Label Phase||0||
48042065|NCT00281658|100423932|FG001|NOT COMPLETED|Open Label Phase||0||
48042066|NCT00281658|100423933|FG002|NOT COMPLETED|Open Label Phase||45||
48042067|NCT00281658|100423934|FG003|NOT COMPLETED|Open Label Phase||4||
48042068|NCT02995369|100423935|FG000|STARTED|Overall Study||8||
48042069|NCT02995369|100423936|FG001|STARTED|Overall Study||8||
48042070|NCT02995369|100423937|FG002|STARTED|Overall Study||8||
48042071|NCT02995369|100423938|FG003|STARTED|Overall Study||8||
48042072|NCT02995369|100423935|FG000|COMPLETED|Overall Study||8||
48042073|NCT02995369|100423936|FG001|COMPLETED|Overall Study||8||
48042074|NCT02995369|100423937|FG002|COMPLETED|Overall Study||8||
48042075|NCT02995369|100423938|FG003|COMPLETED|Overall Study||8||
48042076|NCT02995369|100423935|FG000|NOT COMPLETED|Overall Study||0||
48042077|NCT02995369|100423936|FG001|NOT COMPLETED|Overall Study||0||
48042078|NCT02995369|100423937|FG002|NOT COMPLETED|Overall Study||0||
48203876|NCT00332644|100823597|FG001|NOT COMPLETED|Overall Study||22||
48203877|NCT00332644|100823598|FG002|NOT COMPLETED|Overall Study||9||
48203878|NCT00332644|100823599|FG003|NOT COMPLETED|Overall Study||20||
48203879|NCT00332644|100823600|FG004|NOT COMPLETED|Overall Study||12||
48203880|NCT00332644|100823601|FG005|NOT COMPLETED|Overall Study||15||
48203881|NCT01831791|100823602|FG000|STARTED|Overall Study||120||
48203882|NCT01831791|100823602|FG000|COMPLETED|Overall Study||110||
48203883|NCT01831791|100823602|FG000|NOT COMPLETED|Overall Study||10||
48042079|NCT02995369|100423938|FG003|NOT COMPLETED|Overall Study||0||
48042080|NCT00528970|100423939|FG000|STARTED|Overall Study||124||
48203884|NCT03939819|100823603|FG000|STARTED|Overall Study||50||
48203885|NCT03939819|100823604|FG001|STARTED|Overall Study||56||
48042081|NCT00528970|100423940|FG001|STARTED|Overall Study||125||
48042082|NCT00528970|100423941|FG002|STARTED|Overall Study||125||
48042083|NCT00528970|100423939|FG000|Received at Least 1 Dose of Study Drug|Overall Study||124|Modified intent-to-treat (mITT)/Safety population|
48042084|NCT00528970|100423940|FG001|Received at Least 1 Dose of Study Drug|Overall Study||125|Modified intent-to-treat (mITT)/Safety population|
48042085|NCT00528970|100423941|FG002|Received at Least 1 Dose of Study Drug|Overall Study||124|Modified intent-to-treat (mITT)/Safety population|
48042086|NCT00528970|100423939|FG000|COMPLETED|Overall Study||110||
48042087|NCT00528970|100423940|FG001|COMPLETED|Overall Study||110||
48042088|NCT00528970|100423941|FG002|COMPLETED|Overall Study||105||
48042089|NCT00528970|100423939|FG000|NOT COMPLETED|Overall Study||14||
48042090|NCT00528970|100423940|FG001|NOT COMPLETED|Overall Study||15||
48042091|NCT00528970|100423941|FG002|NOT COMPLETED|Overall Study||20||
48042092|NCT04136444|100423942|FG000|STARTED|Overall Study||3||
48042093|NCT04136444|100423943|FG001|STARTED|Overall Study||9||
48042094|NCT04136444|100423942|FG000|COMPLETED|Overall Study||3||
48042095|NCT04136444|100423943|FG001|COMPLETED|Overall Study||8||
48042096|NCT04136444|100423942|FG000|NOT COMPLETED|Overall Study||0||
48042097|NCT04136444|100423943|FG001|NOT COMPLETED|Overall Study||1||
48042098|NCT01625260|100423944|FG000|STARTED|Overall Study||9||
48042099|NCT01625260|100423945|FG001|STARTED|Overall Study||3||
48042100|NCT01625260|100423944|FG000|COMPLETED|Overall Study||2||
48042101|NCT01625260|100423945|FG001|COMPLETED|Overall Study||2||
48203886|NCT03939819|100823603|FG000|COMPLETED|Overall Study||48||
48203887|NCT03939819|100823604|FG001|COMPLETED|Overall Study||56||
48203888|NCT03939819|100823603|FG000|NOT COMPLETED|Overall Study||2||
48203889|NCT03939819|100823604|FG001|NOT COMPLETED|Overall Study||0||
48203890|NCT02101190|100823605|FG000|STARTED|Overall Study||8||
48495356|NCT04583423|101547830|FG001|Received 1st Dose|Overall Study||47||
48042102|NCT01625260|100423944|FG000|NOT COMPLETED|Overall Study||7||
48042103|NCT01625260|100423945|FG001|NOT COMPLETED|Overall Study||1||
48042104|NCT01872325|100423946|FG000|STARTED|Overall Study||689||
48042105|NCT01872325|100423947|FG001|STARTED|Overall Study||387||
48042106|NCT01872325|100423946|FG000|COMPLETED|Overall Study||689||
48042107|NCT01872325|100423947|FG001|COMPLETED|Overall Study||387||
48042108|NCT01872325|100423946|FG000|NOT COMPLETED|Overall Study||0||
48042109|NCT01872325|100423947|FG001|NOT COMPLETED|Overall Study||0||
48042110|NCT00353470|100423948|FG000|STARTED|Overall Study||81||
48042111|NCT00353470|100423949|FG001|STARTED|Overall Study||81||
48042112|NCT00353470|100423950|FG002|STARTED|Overall Study||39||
48042113|NCT00353470|100423948|FG000|COMPLETED|Overall Study||61||
48042114|NCT00353470|100423949|FG001|COMPLETED|Overall Study||61||
48042115|NCT00353470|100423950|FG002|COMPLETED|Overall Study||23||
48042116|NCT00353470|100423948|FG000|NOT COMPLETED|Overall Study||20||
48042117|NCT00353470|100423949|FG001|NOT COMPLETED|Overall Study||20||
48042118|NCT00353470|100423950|FG002|NOT COMPLETED|Overall Study||16||
48042119|NCT02386189|100423951|FG000|STARTED|Overall Study||30||
48042120|NCT02386189|100423952|FG001|STARTED|Overall Study||33||
48042121|NCT02386189|100423951|FG000|COMPLETED|Overall Study||26||
48042122|NCT02386189|100423952|FG001|COMPLETED|Overall Study||30||
48042123|NCT02386189|100423951|FG000|NOT COMPLETED|Overall Study||4||
48042124|NCT02386189|100423952|FG001|NOT COMPLETED|Overall Study||3||
48042125|NCT03616223|100423953|FG000|STARTED|Overall Study||4||
48042126|NCT03616223|100423954|FG001|STARTED|Overall Study||4||
48042127|NCT03616223|100423955|FG002|STARTED|Overall Study||7||
48042128|NCT03616223|100423956|FG003|STARTED|Overall Study||8||
48042129|NCT03616223|100423953|FG000|COMPLETED|Overall Study||4||
48042130|NCT03616223|100423954|FG001|COMPLETED|Overall Study||4||
48042131|NCT03616223|100423955|FG002|COMPLETED|Overall Study||7||
48042132|NCT03616223|100423956|FG003|COMPLETED|Overall Study||8||
48042133|NCT03616223|100423953|FG000|NOT COMPLETED|Overall Study||0||
48042134|NCT03616223|100423954|FG001|NOT COMPLETED|Overall Study||0||
48042135|NCT03616223|100423955|FG002|NOT COMPLETED|Overall Study||0||
48042136|NCT03616223|100423956|FG003|NOT COMPLETED|Overall Study||0||
48042137|NCT01038869|100423957|FG000|STARTED|Overall Study||20||
48042138|NCT01038869|100423957|FG000|COMPLETED|Overall Study||13||
48042139|NCT01038869|100423957|FG000|NOT COMPLETED|Overall Study||7||
48042140|NCT03127098|100423958|FG000|STARTED|Overall Study||3||
48042141|NCT03127098|100423958|FG000|COMPLETED|Overall Study||3||
48203891|NCT02101190|100823606|FG001|STARTED|Overall Study||8||
48203892|NCT02101190|100823605|FG000|COMPLETED|Overall Study||8||
48203893|NCT02101190|100823606|FG001|COMPLETED|Overall Study||8||
48203894|NCT02101190|100823605|FG000|NOT COMPLETED|Overall Study||0||
48203895|NCT02101190|100823606|FG001|NOT COMPLETED|Overall Study||0||
48495357|NCT04583423|101547831|FG002|Received 1st Dose|Overall Study||46||
48495358|NCT04583423|101547832|FG003|Received 1st Dose|Overall Study||44||
48495359|NCT04583423|101547829|FG000|COMPLETED|Overall Study||10||
48495360|NCT04583423|101547830|FG001|COMPLETED|Overall Study||11||
48495361|NCT04583423|101547831|FG002|COMPLETED|Overall Study||8||
48495362|NCT04583423|101547832|FG003|COMPLETED|Overall Study||8||
48042142|NCT03127098|100423958|FG000|NOT COMPLETED|Overall Study||0||
48042143|NCT00045942|100423959|FG000|STARTED|PKC412A2104 (Core)||20||
48042144|NCT00045942|100423960|FG001|STARTED|PKC412A2104 (Core)||0||
48042145|NCT00045942|100423961|FG002|STARTED|PKC412A2104 (Core)||0||
48042146|NCT00045942|100423962|FG003|STARTED|PKC412A2104 (Core)||0||
48042147|NCT00045942|100423963|FG004|STARTED|PKC412A2104 (Core)||0||
48042148|NCT00045942|100423964|FG005|STARTED|PKC412A2104 (Core)||0||
48042149|NCT00045942|100423965|FG006|STARTED|PKC412A2104 (Core)||0||
48042150|NCT00045942|100423966|FG007|STARTED|PKC412A2104 (Core)||0||
48042151|NCT00045942|100423967|FG008|STARTED|PKC412A2104 (Core)||0||
48042152|NCT00045942|100423959|FG000|Core Primary Efficacy|PKC412A2104 (Core)||20||
48042153|NCT00045942|100423960|FG001|Core Primary Efficacy|PKC412A2104 (Core)||0||
48042154|NCT00045942|100423961|FG002|Core Primary Efficacy|PKC412A2104 (Core)||0||
48042155|NCT00045942|100423962|FG003|Core Primary Efficacy|PKC412A2104 (Core)||0||
48042156|NCT00045942|100423963|FG004|Core Primary Efficacy|PKC412A2104 (Core)||0||
48042157|NCT00045942|100423964|FG005|Core Primary Efficacy|PKC412A2104 (Core)||0||
48042158|NCT00045942|100423965|FG006|Core Primary Efficacy|PKC412A2104 (Core)||0||
48042159|NCT00045942|100423966|FG007|Core Primary Efficacy|PKC412A2104 (Core)||0||
48042160|NCT00045942|100423967|FG008|Core Primary Efficacy|PKC412A2104 (Core)||0||
48042161|NCT00045942|100423959|FG000|COMPLETED|PKC412A2104 (Core)||0||
48042162|NCT00045942|100423960|FG001|COMPLETED|PKC412A2104 (Core)||0||
48042163|NCT00045942|100423961|FG002|COMPLETED|PKC412A2104 (Core)||0||
48042164|NCT00045942|100423962|FG003|COMPLETED|PKC412A2104 (Core)||0||
48042165|NCT00045942|100423963|FG004|COMPLETED|PKC412A2104 (Core)||0||
48042166|NCT00045942|100423964|FG005|COMPLETED|PKC412A2104 (Core)||0||
48042167|NCT00045942|100423965|FG006|COMPLETED|PKC412A2104 (Core)||0||
48042168|NCT00045942|100423966|FG007|COMPLETED|PKC412A2104 (Core)||0||
48042169|NCT00045942|100423967|FG008|COMPLETED|PKC412A2104 (Core)||0||
48042170|NCT00045942|100423959|FG000|NOT COMPLETED|PKC412A2104 (Core)||20||
48203896|NCT00545077|100823607|FG000|STARTED|Overall Study||189||
48203897|NCT00545077|100823608|FG001|STARTED|Overall Study||191||
48203898|NCT00545077|100823607|FG000|COMPLETED|Overall Study||41||
48203899|NCT00545077|100823608|FG001|COMPLETED|Overall Study||36||
48042171|NCT00045942|100423960|FG001|NOT COMPLETED|PKC412A2104 (Core)||0||
48042172|NCT00045942|100423961|FG002|NOT COMPLETED|PKC412A2104 (Core)||0||
48042173|NCT00045942|100423962|FG003|NOT COMPLETED|PKC412A2104 (Core)||0||
48042174|NCT00045942|100423963|FG004|NOT COMPLETED|PKC412A2104 (Core)||0||
48042175|NCT00045942|100423964|FG005|NOT COMPLETED|PKC412A2104 (Core)||0||
48042176|NCT00045942|100423965|FG006|NOT COMPLETED|PKC412A2104 (Core)||0||
48042177|NCT00045942|100423966|FG007|NOT COMPLETED|PKC412A2104 (Core)||0||
48042178|NCT00045942|100423967|FG008|NOT COMPLETED|PKC412A2104 (Core)||0||
48042179|NCT00045942|100423959|FG000|STARTED|PKC412A2104E1||0||
48042180|NCT00045942|100423960|FG001|STARTED|PKC412A2104E1||18||
48042181|NCT00045942|100423961|FG002|STARTED|PKC412A2104E1||17||
48042182|NCT00045942|100423962|FG003|STARTED|PKC412A2104E1||33||
48042183|NCT00045942|100423963|FG004|STARTED|PKC412A2104E1||27||
48042184|NCT00045942|100423964|FG005|STARTED|PKC412A2104E1||0||
48042185|NCT00045942|100423965|FG006|STARTED|PKC412A2104E1||0||
48042186|NCT00045942|100423966|FG007|STARTED|PKC412A2104E1||0||
48042187|NCT00045942|100423967|FG008|STARTED|PKC412A2104E1||0||
48042188|NCT00045942|100423959|FG000|Primary Efficacy|PKC412A2104E1||0||
48042189|NCT00045942|100423960|FG001|Primary Efficacy|PKC412A2104E1||18||
48042190|NCT00045942|100423961|FG002|Primary Efficacy|PKC412A2104E1||17||
48042191|NCT00045942|100423962|FG003|Primary Efficacy|PKC412A2104E1||32||
48042192|NCT00045942|100423963|FG004|Primary Efficacy|PKC412A2104E1||25||
48042193|NCT00045942|100423964|FG005|Primary Efficacy|PKC412A2104E1||0||
48042194|NCT00045942|100423965|FG006|Primary Efficacy|PKC412A2104E1||0||
48042195|NCT00045942|100423966|FG007|Primary Efficacy|PKC412A2104E1||0||
48042196|NCT00045942|100423967|FG008|Primary Efficacy|PKC412A2104E1||0||
48042197|NCT00045942|100423959|FG000|COMPLETED|PKC412A2104E1||0||
48042198|NCT00045942|100423960|FG001|COMPLETED|PKC412A2104E1||0||
48042199|NCT00045942|100423961|FG002|COMPLETED|PKC412A2104E1||0||
48042200|NCT00045942|100423962|FG003|COMPLETED|PKC412A2104E1||0||
48042201|NCT00045942|100423963|FG004|COMPLETED|PKC412A2104E1||0||
48042202|NCT00045942|100423964|FG005|COMPLETED|PKC412A2104E1||0||
48042203|NCT00045942|100423965|FG006|COMPLETED|PKC412A2104E1||0||
48042204|NCT00045942|100423966|FG007|COMPLETED|PKC412A2104E1||0||
48042205|NCT00045942|100423967|FG008|COMPLETED|PKC412A2104E1||0||
48042206|NCT00045942|100423959|FG000|NOT COMPLETED|PKC412A2104E1||0||
48042207|NCT00045942|100423960|FG001|NOT COMPLETED|PKC412A2104E1||18||
48042208|NCT00045942|100423961|FG002|NOT COMPLETED|PKC412A2104E1||17||
48042209|NCT00045942|100423962|FG003|NOT COMPLETED|PKC412A2104E1||33||
48042210|NCT00045942|100423963|FG004|NOT COMPLETED|PKC412A2104E1||27||
48042211|NCT00045942|100423964|FG005|NOT COMPLETED|PKC412A2104E1||0||
48042212|NCT00045942|100423965|FG006|NOT COMPLETED|PKC412A2104E1||0||
48042213|NCT00045942|100423966|FG007|NOT COMPLETED|PKC412A2104E1||0||
48042214|NCT00045942|100423967|FG008|NOT COMPLETED|PKC412A2104E1||0||
48042215|NCT00045942|100423959|FG000|STARTED|PKC412A2104E2||0||
48042216|NCT00045942|100423960|FG001|STARTED|PKC412A2104E2||0||
48042217|NCT00045942|100423961|FG002|STARTED|PKC412A2104E2||0||
48042218|NCT00045942|100423962|FG003|STARTED|PKC412A2104E2||0||
48042219|NCT00045942|100423963|FG004|STARTED|PKC412A2104E2||0||
48042220|NCT00045942|100423964|FG005|STARTED|PKC412A2104E2||9||
48042221|NCT00045942|100423965|FG006|STARTED|PKC412A2104E2||7||
48203900|NCT00545077|100823607|FG000|NOT COMPLETED|Overall Study||148||
48042222|NCT00045942|100423966|FG007|STARTED|PKC412A2104E2||7||
48042223|NCT00045942|100423967|FG008|STARTED|PKC412A2104E2||6||
48203901|NCT00545077|100823608|FG001|NOT COMPLETED|Overall Study||155||
48042224|NCT00045942|100423959|FG000|Primary Efficacy|PKC412A2104E2||0||
48042225|NCT00045942|100423960|FG001|Primary Efficacy|PKC412A2104E2||0||
48042226|NCT00045942|100423961|FG002|Primary Efficacy|PKC412A2104E2||0||
48042227|NCT00045942|100423962|FG003|Primary Efficacy|PKC412A2104E2||0||
48042228|NCT00045942|100423963|FG004|Primary Efficacy|PKC412A2104E2||0||
48042229|NCT00045942|100423964|FG005|Primary Efficacy|PKC412A2104E2||9||
48042230|NCT00045942|100423965|FG006|Primary Efficacy|PKC412A2104E2||7||
48042231|NCT00045942|100423966|FG007|Primary Efficacy|PKC412A2104E2||7||
48042232|NCT00045942|100423967|FG008|Primary Efficacy|PKC412A2104E2||6||
48042233|NCT00045942|100423959|FG000|COMPLETED|PKC412A2104E2||0||
48042234|NCT00045942|100423960|FG001|COMPLETED|PKC412A2104E2||0||
48042235|NCT00045942|100423961|FG002|COMPLETED|PKC412A2104E2||0||
48042236|NCT00045942|100423962|FG003|COMPLETED|PKC412A2104E2||0||
48042237|NCT00045942|100423963|FG004|COMPLETED|PKC412A2104E2||0||
48042238|NCT00045942|100423964|FG005|COMPLETED|PKC412A2104E2||0||
48042239|NCT00045942|100423965|FG006|COMPLETED|PKC412A2104E2||0||
48042240|NCT00045942|100423966|FG007|COMPLETED|PKC412A2104E2||0||
48042241|NCT00045942|100423967|FG008|COMPLETED|PKC412A2104E2||0||
48042242|NCT00045942|100423959|FG000|NOT COMPLETED|PKC412A2104E2||0||
48042243|NCT00045942|100423960|FG001|NOT COMPLETED|PKC412A2104E2||0||
48042244|NCT00045942|100423961|FG002|NOT COMPLETED|PKC412A2104E2||0||
48042245|NCT00045942|100423962|FG003|NOT COMPLETED|PKC412A2104E2||0||
48042246|NCT00045942|100423963|FG004|NOT COMPLETED|PKC412A2104E2||0||
48042247|NCT00045942|100423964|FG005|NOT COMPLETED|PKC412A2104E2||9||
48042248|NCT00045942|100423965|FG006|NOT COMPLETED|PKC412A2104E2||7||
48042249|NCT00045942|100423966|FG007|NOT COMPLETED|PKC412A2104E2||7||
48042250|NCT00045942|100423967|FG008|NOT COMPLETED|PKC412A2104E2||6||
48042251|NCT02168387|100423968|FG000|STARTED|Overall Study||20||
48042252|NCT02168387|100423969|FG001|STARTED|Overall Study||19||
48042253|NCT02168387|100423968|FG000|COMPLETED|Overall Study||13||
48042254|NCT02168387|100423969|FG001|COMPLETED|Overall Study||16||
48042255|NCT02168387|100423968|FG000|NOT COMPLETED|Overall Study||7||
48042256|NCT02168387|100423969|FG001|NOT COMPLETED|Overall Study||3||
48042257|NCT00329901|100423970|FG000|STARTED|Overall Study||361||
48042258|NCT00329901|100423971|FG001|STARTED|Overall Study||354||
48042259|NCT00329901|100423972|FG002|STARTED|Overall Study||357||
48042260|NCT00329901|100423970|FG000|COMPLETED|Overall Study||352||
48042261|NCT00329901|100423971|FG001|COMPLETED|Overall Study||349||
48042262|NCT00329901|100423972|FG002|COMPLETED|Overall Study||353||
48042263|NCT00329901|100423970|FG000|NOT COMPLETED|Overall Study||9||
48042264|NCT00329901|100423971|FG001|NOT COMPLETED|Overall Study||5||
48042265|NCT00329901|100423972|FG002|NOT COMPLETED|Overall Study||4||
48042266|NCT00732901|100423973|FG000|STARTED|Overall Study||11||
48042267|NCT00732901|100423974|FG001|STARTED|Overall Study||12||
48042268|NCT00732901|100423973|FG000|COMPLETED|Overall Study||11||
48042269|NCT00732901|100423974|FG001|COMPLETED|Overall Study||12||
48042270|NCT00732901|100423973|FG000|NOT COMPLETED|Overall Study||0||
48042271|NCT00732901|100423974|FG001|NOT COMPLETED|Overall Study||0||
48042272|NCT02650921|100423975|FG000|STARTED|Overall Study||92||184
48042273|NCT02650921|100423975|FG000|COMPLETED|Overall Study||84||168
48042274|NCT02650921|100423975|FG000|NOT COMPLETED|Overall Study||8||16
48042275|NCT04620798|100423976|FG000|STARTED|Overall Study||536|Includes all eligible participants who consented to enrollment and were randomized to received either immediate or delayed results.|
48042276|NCT04620798|100423977|FG001|STARTED|Overall Study||540|Includes all eligible participants who consented to enrollment and were randomized to received either immediate or delayed results.|
48042277|NCT04620798|100423976|FG000|Completed Behavioral Survey|Overall Study||477|Includes all participants who completed the behavioral survey two weeks following baseline antibody testing.|
48042278|NCT04620798|100423977|FG001|Completed Behavioral Survey|Overall Study||508|Includes all participants who completed the behavioral survey two weeks following baseline antibody testing.|
48042279|NCT04620798|100423976|FG000|COMPLETED|Overall Study||410|Includes all participants who completed endline antibody testing eight weeks following baseline antibody testing.|
48042280|NCT04620798|100423977|FG001|COMPLETED|Overall Study||402|Includes all participants who completed endline antibody testing eight weeks following baseline antibody testing.|
48042281|NCT04620798|100423976|FG000|NOT COMPLETED|Overall Study||126||
48042282|NCT04620798|100423977|FG001|NOT COMPLETED|Overall Study||138||
48042283|NCT00322621|100423978|FG000|STARTED|Period II - Acute Therapy Phase||216||
48042284|NCT00322621|100423979|FG001|STARTED|Period II - Acute Therapy Phase||0||
48042285|NCT00322621|100423980|FG002|STARTED|Period II - Acute Therapy Phase||0||
48042286|NCT00322621|100423978|FG000|COMPLETED|Period II - Acute Therapy Phase||184||
48042287|NCT00322621|100423979|FG001|COMPLETED|Period II - Acute Therapy Phase||0||
48042288|NCT00322621|100423980|FG002|COMPLETED|Period II - Acute Therapy Phase||0||
48042289|NCT00322621|100423978|FG000|NOT COMPLETED|Period II - Acute Therapy Phase||32||
48042290|NCT00322621|100423979|FG001|NOT COMPLETED|Period II - Acute Therapy Phase||0||
48042291|NCT00322621|100423980|FG002|NOT COMPLETED|Period II - Acute Therapy Phase||0||
48042292|NCT00322621|100423978|FG000|STARTED|Period III - Maintenance / Rescue Phase||0||
48042293|NCT00322621|100423979|FG001|STARTED|Period III - Maintenance / Rescue Phase||115||
48042294|NCT00322621|100423980|FG002|STARTED|Period III - Maintenance / Rescue Phase||69||
48042295|NCT00322621|100423978|FG000|COMPLETED|Period III - Maintenance / Rescue Phase||0||
48042296|NCT00322621|100423979|FG001|COMPLETED|Period III - Maintenance / Rescue Phase||86||
48042297|NCT00322621|100423980|FG002|COMPLETED|Period III - Maintenance / Rescue Phase||33||
48042298|NCT00322621|100423978|FG000|NOT COMPLETED|Period III - Maintenance / Rescue Phase||0||
48042299|NCT00322621|100423979|FG001|NOT COMPLETED|Period III - Maintenance / Rescue Phase||29||
48042300|NCT00322621|100423980|FG002|NOT COMPLETED|Period III - Maintenance / Rescue Phase||36||
48042301|NCT03593473|100423981|FG000|STARTED|Overall Study||53||
48042302|NCT03593473|100423982|FG001|STARTED|Overall Study||56||
48042303|NCT03593473|100423981|FG000|Randomized|Overall Study||53||
48042304|NCT03593473|100423982|FG001|Randomized|Overall Study||56||
48042305|NCT03593473|100423981|FG000|Received Intervention|Overall Study||51||
48042306|NCT03593473|100423982|FG001|Received Intervention|Overall Study||54||
48042307|NCT03593473|100423981|FG000|COMPLETED|Overall Study||51||
48042308|NCT03593473|100423982|FG001|COMPLETED|Overall Study||54||
48042309|NCT03593473|100423981|FG000|NOT COMPLETED|Overall Study||2||
48042310|NCT03593473|100423982|FG001|NOT COMPLETED|Overall Study||2||
48042311|NCT03848871|100423983|FG000|STARTED|Overall Study||20||
48042312|NCT03848871|100423983|FG000|COMPLETED|Overall Study||20||
48042313|NCT03848871|100423983|FG000|NOT COMPLETED|Overall Study||0||
48042314|NCT00770146|100423984|FG000|STARTED|Treatment Period||53||
48042315|NCT00770146|100423985|FG001|STARTED|Treatment Period||105||
48042316|NCT00770146|100423984|FG000|Treated|Treatment Period||52||
48042317|NCT00770146|100423985|FG001|Treated|Treatment Period||105||
48042318|NCT00770146|100423984|FG000|Full Analysis Set|Treatment Period||50||
48042319|NCT00770146|100423985|FG001|Full Analysis Set|Treatment Period||101||
48042320|NCT00770146|100423984|FG000|COMPLETED|Treatment Period||44||
48042321|NCT00770146|100423985|FG001|COMPLETED|Treatment Period||60||
48042322|NCT00770146|100423984|FG000|NOT COMPLETED|Treatment Period||9||
48042323|NCT00770146|100423985|FG001|NOT COMPLETED|Treatment Period||45||
48042324|NCT00770146|100423984|FG000|STARTED|Follow-up Period||53||
48042325|NCT00770146|100423985|FG001|STARTED|Follow-up Period||105||
48042326|NCT00770146|100423984|FG000|COMPLETED|Follow-up Period||42||
48042327|NCT00770146|100423985|FG001|COMPLETED|Follow-up Period||85||
48042328|NCT00770146|100423984|FG000|NOT COMPLETED|Follow-up Period||11||
48042329|NCT00770146|100423985|FG001|NOT COMPLETED|Follow-up Period||20||
48042330|NCT00588159|100423986|FG000|STARTED|Overall Study||72||
48042331|NCT00588159|100423987|FG001|STARTED|Overall Study||74||
48042332|NCT00588159|100423986|FG000|COMPLETED|Overall Study||57||
48042333|NCT00588159|100423987|FG001|COMPLETED|Overall Study||63||
48042334|NCT00588159|100423986|FG000|NOT COMPLETED|Overall Study||15||
48042335|NCT00588159|100423987|FG001|NOT COMPLETED|Overall Study||11||
48203902|NCT00981630|100823609|FG000|STARTED|Overall Study||32||
48203903|NCT00981630|100823610|FG001|STARTED|Overall Study||32||
48203904|NCT00981630|100823611|FG002|STARTED|Overall Study||32||
48042336|NCT03493932|100423988|FG000|STARTED|Overall Study||21||
48042337|NCT03493932|100423988|FG000|COMPLETED|Overall Study||13||
48042338|NCT03493932|100423988|FG000|NOT COMPLETED|Overall Study||8||
48042339|NCT02815280|100423989|FG000|STARTED|Double-Blind Phase||333||
48042340|NCT02815280|100423990|FG001|STARTED|Double-Blind Phase||162||
48042341|NCT02815280|100423989|FG000|COMPLETED|Double-Blind Phase||297||
48042342|NCT02815280|100423990|FG001|COMPLETED|Double-Blind Phase||137||
48042343|NCT02815280|100423989|FG000|NOT COMPLETED|Double-Blind Phase||36||
48042344|NCT02815280|100423990|FG001|NOT COMPLETED|Double-Blind Phase||25||
48042345|NCT02815280|100423989|FG000|STARTED|Open-Label Phase||256||
48042346|NCT02815280|100423990|FG001|STARTED|Open-Label Phase||117||
48042347|NCT02815280|100423989|FG000|COMPLETED|Open-Label Phase||169||
48042348|NCT02815280|100423990|FG001|COMPLETED|Open-Label Phase||73||
48042349|NCT02815280|100423989|FG000|NOT COMPLETED|Open-Label Phase||87||
48042350|NCT02815280|100423990|FG001|NOT COMPLETED|Open-Label Phase||44||
48042351|NCT01954927|100423991|FG000|STARTED|Overall Study||45||
48042352|NCT01954927|100423992|FG001|STARTED|Overall Study||45||
48042353|NCT01954927|100423991|FG000|COMPLETED|Overall Study||42||
48042354|NCT01954927|100423992|FG001|COMPLETED|Overall Study||44||
48042355|NCT01954927|100423991|FG000|NOT COMPLETED|Overall Study||3||
48042356|NCT01954927|100423992|FG001|NOT COMPLETED|Overall Study||1||
48042357|NCT02984943|100423993|FG000|STARTED|Overall Study||14||
48042358|NCT02984943|100423993|FG000|COMPLETED|Overall Study||10||
48042359|NCT02984943|100423993|FG000|NOT COMPLETED|Overall Study||4||
48042360|NCT00538785|100423994|FG000|STARTED|Overall Study||623||
48042361|NCT00538785|100423995|FG001|STARTED|Overall Study||612||
48203905|NCT00981630|100823612|FG003|STARTED|Overall Study||32||
48203906|NCT00981630|100823609|FG000|COMPLETED|Overall Study||32||
48203907|NCT00981630|100823610|FG001|COMPLETED|Overall Study||32||
48203908|NCT00981630|100823611|FG002|COMPLETED|Overall Study||32||
48203909|NCT00981630|100823612|FG003|COMPLETED|Overall Study||32||
48042362|NCT00538785|100423994|FG000|COMPLETED|Overall Study||604||
48042363|NCT00538785|100423995|FG001|COMPLETED|Overall Study||595||
48042364|NCT00538785|100423994|FG000|NOT COMPLETED|Overall Study||19||
48042365|NCT00538785|100423995|FG001|NOT COMPLETED|Overall Study||17||
48042366|NCT02434471|100423996|FG000|STARTED|Overall Study||34||
48203910|NCT00981630|100823609|FG000|NOT COMPLETED|Overall Study||0||
48203911|NCT00981630|100823610|FG001|NOT COMPLETED|Overall Study||0||
48203912|NCT00981630|100823611|FG002|NOT COMPLETED|Overall Study||0||
48042367|NCT02434471|100423996|FG000|COMPLETED|Overall Study||25||
48042368|NCT02434471|100423996|FG000|NOT COMPLETED|Overall Study||9||
48203913|NCT00981630|100823612|FG003|NOT COMPLETED|Overall Study||0||
48203914|NCT02723929|100823613|FG000|STARTED|Overall Study||30||
48203915|NCT02723929|100823614|FG001|STARTED|Overall Study||34||
48203916|NCT02723929|100823613|FG000|COMPLETED|Overall Study||24||
48203917|NCT02723929|100823614|FG001|COMPLETED|Overall Study||24||
48203918|NCT02723929|100823613|FG000|NOT COMPLETED|Overall Study||6||
48203919|NCT02723929|100823614|FG001|NOT COMPLETED|Overall Study||10||
48203920|NCT03110458|100823615|FG000|STARTED|Overall Study||37||
48203921|NCT03110458|100823616|FG001|STARTED|Overall Study||36||
48203922|NCT03110458|100823617|FG002|STARTED|Overall Study||34||
48203923|NCT03110458|100823615|FG000|COMPLETED|Overall Study||31||
48203924|NCT03110458|100823616|FG001|COMPLETED|Overall Study||32||
48203925|NCT03110458|100823617|FG002|COMPLETED|Overall Study||31||
48203926|NCT03110458|100823615|FG000|NOT COMPLETED|Overall Study||6||
48203927|NCT03110458|100823616|FG001|NOT COMPLETED|Overall Study||4||
48203928|NCT03110458|100823617|FG002|NOT COMPLETED|Overall Study||3||
48042369|NCT02819908|100423997|FG000|STARTED|Overall Study||12|25 patients total of 50 eyes|
48042370|NCT02819908|100423998|FG001|STARTED|Overall Study||13|25 patients total of 50 eyes|
48042371|NCT02819908|100423997|FG000|COMPLETED|Overall Study||12||
48042372|NCT02819908|100423998|FG001|COMPLETED|Overall Study||13||
48042373|NCT02819908|100423997|FG000|NOT COMPLETED|Overall Study||0||
48042374|NCT02819908|100423998|FG001|NOT COMPLETED|Overall Study||0||
48042375|NCT02122783|100423999|FG000|STARTED|Overall Study||2||
48042376|NCT02122783|100424000|FG001|STARTED|Overall Study||3||
48042377|NCT02122783|100423999|FG000|COMPLETED|Overall Study||2||
48042378|NCT02122783|100424000|FG001|COMPLETED|Overall Study||2||
48042379|NCT02122783|100423999|FG000|NOT COMPLETED|Overall Study||0||
48042380|NCT02122783|100424000|FG001|NOT COMPLETED|Overall Study||1||
48042381|NCT02232880|100424001|FG000|STARTED|Overall Study||1||
48042382|NCT02232880|100424001|FG000|COMPLETED|Overall Study||0||
48042383|NCT02232880|100424001|FG000|NOT COMPLETED|Overall Study||1||
48042384|NCT00282347|100424002|FG000|STARTED|Treatment Period||72||
48042385|NCT00282347|100424003|FG001|STARTED|Treatment Period||72||
48042386|NCT00282347|100424002|FG000|COMPLETED|Treatment Period||67||
48042387|NCT00282347|100424003|FG001|COMPLETED|Treatment Period||63||
48042388|NCT00282347|100424002|FG000|NOT COMPLETED|Treatment Period||5||
48042389|NCT00282347|100424003|FG001|NOT COMPLETED|Treatment Period||9||
48042390|NCT00282347|100424002|FG000|STARTED|Safety Follow-up Period||67||
48042391|NCT00282347|100424003|FG001|STARTED|Safety Follow-up Period||63||
48042392|NCT00282347|100424002|FG000|COMPLETED|Safety Follow-up Period||64||
48042393|NCT00282347|100424003|FG001|COMPLETED|Safety Follow-up Period||57||
48042394|NCT00282347|100424002|FG000|NOT COMPLETED|Safety Follow-up Period||3||
48042395|NCT00282347|100424003|FG001|NOT COMPLETED|Safety Follow-up Period||6||
48042396|NCT00282347|100424002|FG000|STARTED|B Cell Follow-up Period||20||
48042397|NCT00282347|100424003|FG001|STARTED|B Cell Follow-up Period||4||
48203929|NCT04340362|100823618|FG000|STARTED|Overall Study||16||
48203930|NCT04340362|100823618|FG000|Cohort 1|Overall Study||3|The milestone represents the number of participants in Cohort 1.|
48203931|NCT04340362|100823618|FG000|Cohort 2|Overall Study||13|The milestone represents the number of participants in Cohort 2.|
48203932|NCT04340362|100823618|FG000|COMPLETED|Overall Study||15||
48203933|NCT04340362|100823618|FG000|NOT COMPLETED|Overall Study||1||
48203934|NCT01771666|100823619|FG000|STARTED|Overall Study||23||
48203935|NCT01771666|100823619|FG000|COMPLETED|Overall Study||23||
48203936|NCT01771666|100823619|FG000|NOT COMPLETED|Overall Study||0||
48203937|NCT04347954|100823620|FG000|STARTED|Overall Study||15||
48203938|NCT04347954|100823621|FG001|STARTED|Overall Study||15||
48203939|NCT04347954|100823622|FG002|STARTED|Overall Study||17||
48203940|NCT04347954|100823620|FG000|Received Allocated Intervention|Overall Study||12||
48203941|NCT04347954|100823621|FG001|Received Allocated Intervention|Overall Study||15||
48203942|NCT04347954|100823622|FG002|Received Allocated Intervention|Overall Study||14||
48203943|NCT04347954|100823620|FG000|Negative PCR Swab at Baseline|Overall Study||1||
48203944|NCT04347954|100823621|FG001|Negative PCR Swab at Baseline|Overall Study||3||
48203945|NCT04347954|100823622|FG002|Negative PCR Swab at Baseline|Overall Study||1||
48203946|NCT04347954|100823620|FG000|COMPLETED|Overall Study||12||
48203947|NCT04347954|100823621|FG001|COMPLETED|Overall Study||14||
48203948|NCT04347954|100823622|FG002|COMPLETED|Overall Study||14||
48203949|NCT04347954|100823620|FG000|NOT COMPLETED|Overall Study||3||
48203950|NCT04347954|100823621|FG001|NOT COMPLETED|Overall Study||1||
48203951|NCT04347954|100823622|FG002|NOT COMPLETED|Overall Study||3||
48203952|NCT00158054|100823623|FG000|STARTED|Overall Study||80||
48203953|NCT00158054|100823624|FG001|STARTED|Overall Study||77||
48203954|NCT00158054|100823623|FG000|COMPLETED|Overall Study||70||
48203955|NCT00158054|100823624|FG001|COMPLETED|Overall Study||74||
48203956|NCT00158054|100823623|FG000|NOT COMPLETED|Overall Study||10||
48203957|NCT00158054|100823624|FG001|NOT COMPLETED|Overall Study||3||
48203958|NCT03646123|100823625|FG000|STARTED|Overall Study||41||
48203959|NCT03646123|100823626|FG001|STARTED|Overall Study||58||
48203960|NCT03646123|100823627|FG002|STARTED|Overall Study||156||
48203961|NCT03646123|100823625|FG000|COMPLETED|Overall Study||31||
48203962|NCT03646123|100823626|FG001|COMPLETED|Overall Study||0||
48042398|NCT00282347|100424002|FG000|COMPLETED|B Cell Follow-up Period||15||
48042399|NCT00282347|100424003|FG001|COMPLETED|B Cell Follow-up Period||4||
48042400|NCT00282347|100424002|FG000|NOT COMPLETED|B Cell Follow-up Period||5||
48042401|NCT00282347|100424003|FG001|NOT COMPLETED|B Cell Follow-up Period||0||
48203963|NCT03646123|100823627|FG002|COMPLETED|Overall Study||0||
48203964|NCT03646123|100823625|FG000|NOT COMPLETED|Overall Study||10||
48203965|NCT03646123|100823626|FG001|NOT COMPLETED|Overall Study||58||
48203966|NCT03646123|100823627|FG002|NOT COMPLETED|Overall Study||156||
48203967|NCT03684265|100823628|FG000|STARTED|Treatment Period 1||13||
48203968|NCT03684265|100823629|FG001|STARTED|Treatment Period 1||13||
48203969|NCT03684265|100823628|FG000|COMPLETED|Treatment Period 1||13||
48203970|NCT03684265|100823629|FG001|COMPLETED|Treatment Period 1||13||
48203971|NCT03684265|100823628|FG000|NOT COMPLETED|Treatment Period 1||0||
48203972|NCT03684265|100823629|FG001|NOT COMPLETED|Treatment Period 1||0||
48203973|NCT03684265|100823628|FG000|STARTED|Washout Period of 1 Week||13||
48203974|NCT03684265|100823629|FG001|STARTED|Washout Period of 1 Week||13||
48203975|NCT03684265|100823628|FG000|COMPLETED|Washout Period of 1 Week||13||
48203976|NCT03684265|100823629|FG001|COMPLETED|Washout Period of 1 Week||13||
48203977|NCT03684265|100823628|FG000|NOT COMPLETED|Washout Period of 1 Week||0||
48203978|NCT03684265|100823629|FG001|NOT COMPLETED|Washout Period of 1 Week||0||
48203979|NCT03684265|100823628|FG000|STARTED|Treatment Period 2||13||
48203980|NCT03684265|100823629|FG001|STARTED|Treatment Period 2||13||
48203981|NCT03684265|100823628|FG000|COMPLETED|Treatment Period 2||13||
48203982|NCT03684265|100823629|FG001|COMPLETED|Treatment Period 2||13||
48203983|NCT03684265|100823628|FG000|NOT COMPLETED|Treatment Period 2||0||
48203984|NCT03684265|100823629|FG001|NOT COMPLETED|Treatment Period 2||0||
48203985|NCT01196429|100823630|FG000|STARTED|Overall Study||45||
48203986|NCT01196429|100823631|FG001|STARTED|Overall Study||45||
48203987|NCT01196429|100823630|FG000|COMPLETED|Overall Study||42||
48203988|NCT01196429|100823631|FG001|COMPLETED|Overall Study||45||
48203989|NCT01196429|100823630|FG000|NOT COMPLETED|Overall Study||3||
48203990|NCT01196429|100823631|FG001|NOT COMPLETED|Overall Study||0||
48203991|NCT00845832|100823632|FG000|STARTED|Treatment Period||4||
48203992|NCT00845832|100823633|FG001|STARTED|Treatment Period||10||
48203993|NCT00845832|100823634|FG002|STARTED|Treatment Period||10||
48203994|NCT00845832|100823632|FG000|COMPLETED|Treatment Period||3||
48203995|NCT00845832|100823633|FG001|COMPLETED|Treatment Period||7||
48203996|NCT00845832|100823634|FG002|COMPLETED|Treatment Period||10||
48203997|NCT00845832|100823632|FG000|NOT COMPLETED|Treatment Period||1||
48203998|NCT00845832|100823633|FG001|NOT COMPLETED|Treatment Period||3||
48203999|NCT00845832|100823634|FG002|NOT COMPLETED|Treatment Period||0||
48204000|NCT00845832|100823632|FG000|STARTED|Safety Follow-Up||3||
48204001|NCT00845832|100823633|FG001|STARTED|Safety Follow-Up||9||
48204002|NCT00845832|100823634|FG002|STARTED|Safety Follow-Up||12||
48204003|NCT00845832|100823632|FG000|COMPLETED|Safety Follow-Up||2||
48204004|NCT00845832|100823633|FG001|COMPLETED|Safety Follow-Up||9||
48204005|NCT00845832|100823634|FG002|COMPLETED|Safety Follow-Up||12||
48204006|NCT00845832|100823632|FG000|NOT COMPLETED|Safety Follow-Up||1||
48204007|NCT00845832|100823633|FG001|NOT COMPLETED|Safety Follow-Up||0||
48204008|NCT00845832|100823634|FG002|NOT COMPLETED|Safety Follow-Up||0||
48204009|NCT00845832|100823632|FG000|STARTED|Extended Safety Follow-Up||2||
48204010|NCT00845832|100823633|FG001|STARTED|Extended Safety Follow-Up||5||
48204011|NCT00845832|100823634|FG002|STARTED|Extended Safety Follow-Up||7||
48204012|NCT00845832|100823632|FG000|COMPLETED|Extended Safety Follow-Up||2||
48204013|NCT00845832|100823633|FG001|COMPLETED|Extended Safety Follow-Up||5||
48204014|NCT00845832|100823634|FG002|COMPLETED|Extended Safety Follow-Up||0||
48204015|NCT00845832|100823632|FG000|NOT COMPLETED|Extended Safety Follow-Up||0||
48204016|NCT00845832|100823633|FG001|NOT COMPLETED|Extended Safety Follow-Up||0||
48204017|NCT00845832|100823634|FG002|NOT COMPLETED|Extended Safety Follow-Up||7||
48204018|NCT02888080|100823635|FG000|STARTED|Overall Study||20||
48204019|NCT02888080|100823636|FG001|STARTED|Overall Study||20||
48204020|NCT02888080|100823635|FG000|COMPLETED|Overall Study||18||
48204021|NCT02888080|100823636|FG001|COMPLETED|Overall Study||15||
48204022|NCT02888080|100823635|FG000|NOT COMPLETED|Overall Study||2||
48204023|NCT02888080|100823636|FG001|NOT COMPLETED|Overall Study||5||
48204024|NCT00457691|100823637|FG000|STARTED|Overall Study||386||
48204025|NCT00457691|100823638|FG001|STARTED|Overall Study||382||
48204026|NCT00457691|100823637|FG000|COMPLETED|Overall Study||0||
48204027|NCT00457691|100823638|FG001|COMPLETED|Overall Study||0||
48204028|NCT00457691|100823637|FG000|NOT COMPLETED|Overall Study||386||
48204029|NCT00457691|100823638|FG001|NOT COMPLETED|Overall Study||382||
48204030|NCT00708032|100823639|FG000|STARTED|Overall Study||36||
48204031|NCT00708032|100823640|FG001|STARTED|Overall Study||38||
48204032|NCT00708032|100823639|FG000|COMPLETED|Overall Study||26||
48204033|NCT00708032|100823640|FG001|COMPLETED|Overall Study||22||
48204034|NCT00708032|100823639|FG000|NOT COMPLETED|Overall Study||10||
48204035|NCT00708032|100823640|FG001|NOT COMPLETED|Overall Study||16||
48204036|NCT02001623|100823641|FG000|STARTED|Overall Study||3||
48204037|NCT02001623|100823642|FG001|STARTED|Overall Study||3||
48204038|NCT02001623|100823643|FG002|STARTED|Overall Study||3||
48204039|NCT02001623|100823644|FG003|STARTED|Overall Study||3||
48204040|NCT02001623|100823645|FG004|STARTED|Overall Study||3||
48204041|NCT02001623|100823646|FG005|STARTED|Overall Study||3||
48204042|NCT02001623|100823647|FG006|STARTED|Overall Study||3||
48204043|NCT02001623|100823648|FG007|STARTED|Overall Study||6||
48204044|NCT02001623|100823649|FG008|STARTED|Overall Study||15||
48204045|NCT02001623|100823650|FG009|STARTED|Overall Study||55||
48204046|NCT02001623|100823651|FG010|STARTED|Overall Study||14||
48204047|NCT02001623|100823652|FG011|STARTED|Overall Study||15||
48204048|NCT02001623|100823653|FG012|STARTED|Overall Study||15||
48204049|NCT02001623|100823654|FG013|STARTED|Overall Study||36||
48204050|NCT02001623|100823655|FG014|STARTED|Overall Study||18||
48204051|NCT02001623|100823641|FG000|Completed 4 Cycles of Treatment|Overall Study||0||
48204052|NCT02001623|100823642|FG001|Completed 4 Cycles of Treatment|Overall Study||1||
48204053|NCT02001623|100823643|FG002|Completed 4 Cycles of Treatment|Overall Study||1||
48204054|NCT02001623|100823644|FG003|Completed 4 Cycles of Treatment|Overall Study||2||
48204055|NCT02001623|100823645|FG004|Completed 4 Cycles of Treatment|Overall Study||0||
48204056|NCT02001623|100823646|FG005|Completed 4 Cycles of Treatment|Overall Study||2||
48204057|NCT02001623|100823647|FG006|Completed 4 Cycles of Treatment|Overall Study||2||
48204058|NCT02001623|100823648|FG007|Completed 4 Cycles of Treatment|Overall Study||1||
48204059|NCT02001623|100823649|FG008|Completed 4 Cycles of Treatment|Overall Study||5||
48042402|NCT00002975|100424004|FG000|STARTED|Overall Study||180||
48042403|NCT00002975|100424004|FG000|Treated With Study Therapy|Overall Study||175||
48042404|NCT00002975|100424004|FG000|COMPLETED|Overall Study||175||
48042405|NCT00002975|100424004|FG000|NOT COMPLETED|Overall Study||5||
48042406|NCT02181517|100424005|FG000|STARTED|Overall Study||10||
48042407|NCT02181517|100424006|FG001|STARTED|Overall Study||10||
48042408|NCT02181517|100424007|FG002|STARTED|Overall Study||5||
48042409|NCT02181517|100424005|FG000|COMPLETED|Overall Study||10||
48042410|NCT02181517|100424006|FG001|COMPLETED|Overall Study||10||
48042411|NCT02181517|100424007|FG002|COMPLETED|Overall Study||5||
48042412|NCT02181517|100424005|FG000|NOT COMPLETED|Overall Study||0||
48042413|NCT02181517|100424006|FG001|NOT COMPLETED|Overall Study||0||
48042414|NCT02181517|100424007|FG002|NOT COMPLETED|Overall Study||0||
48042415|NCT02248688|100424008|FG000|STARTED|Overall Study||5||
48204060|NCT02001623|100823650|FG009|Completed 4 Cycles of Treatment|Overall Study||31||
48204061|NCT02001623|100823651|FG010|Completed 4 Cycles of Treatment|Overall Study||6||
48204062|NCT02001623|100823652|FG011|Completed 4 Cycles of Treatment|Overall Study||4||
48204063|NCT02001623|100823653|FG012|Completed 4 Cycles of Treatment|Overall Study||6||
48204064|NCT02001623|100823654|FG013|Completed 4 Cycles of Treatment|Overall Study||22||
48204065|NCT02001623|100823655|FG014|Completed 4 Cycles of Treatment|Overall Study||7||
48204066|NCT02001623|100823641|FG000|Completed 12 Cycles of Treatment|Overall Study||0||
48042416|NCT02248688|100424008|FG000|COMPLETED|Overall Study||5||
48042417|NCT02248688|100424008|FG000|NOT COMPLETED|Overall Study||0||
48042418|NCT02390791|100424009|FG000|STARTED|Overall Study||40||
48042419|NCT02390791|100424010|FG001|STARTED|Overall Study||45||
48042420|NCT02390791|100424009|FG000|COMPLETED|Overall Study||40||
48042421|NCT02390791|100424010|FG001|COMPLETED|Overall Study||45||
48042422|NCT02390791|100424009|FG000|NOT COMPLETED|Overall Study||0||
48042423|NCT02390791|100424010|FG001|NOT COMPLETED|Overall Study||0||
48042424|NCT00729469|100424011|FG000|STARTED|Overall Study||456||
48042425|NCT00729469|100424012|FG001|STARTED|Overall Study||463||
48042426|NCT00729469|100424011|FG000|COMPLETED|Overall Study||403||
48042427|NCT00729469|100424012|FG001|COMPLETED|Overall Study||416||
48042428|NCT00729469|100424011|FG000|NOT COMPLETED|Overall Study||53||
48042429|NCT00729469|100424012|FG001|NOT COMPLETED|Overall Study||47||
48042430|NCT00407381|100424013|FG000|STARTED|Overall Study||42||
48042431|NCT00407381|100424014|FG001|STARTED|Overall Study||42||
48042432|NCT00407381|100424015|FG002|STARTED|Overall Study||42||
48042433|NCT00407381|100424013|FG000|COMPLETED|Overall Study||39||
48042434|NCT00407381|100424014|FG001|COMPLETED|Overall Study||38||
48042435|NCT00407381|100424015|FG002|COMPLETED|Overall Study||40||
48042436|NCT00407381|100424013|FG000|NOT COMPLETED|Overall Study||3||
48042437|NCT00407381|100424014|FG001|NOT COMPLETED|Overall Study||4||
48042438|NCT00407381|100424015|FG002|NOT COMPLETED|Overall Study||2||
48042439|NCT01634256|100424016|FG000|STARTED|Overall Study||30||
48204067|NCT02001623|100823642|FG001|Completed 12 Cycles of Treatment|Overall Study||1||
48204068|NCT02001623|100823643|FG002|Completed 12 Cycles of Treatment|Overall Study||0||
48204069|NCT02001623|100823644|FG003|Completed 12 Cycles of Treatment|Overall Study||1||
48204070|NCT02001623|100823645|FG004|Completed 12 Cycles of Treatment|Overall Study||0||
48204071|NCT02001623|100823646|FG005|Completed 12 Cycles of Treatment|Overall Study||0||
48204072|NCT02001623|100823647|FG006|Completed 12 Cycles of Treatment|Overall Study||0||
48204073|NCT02001623|100823648|FG007|Completed 12 Cycles of Treatment|Overall Study||0||
48204074|NCT02001623|100823649|FG008|Completed 12 Cycles of Treatment|Overall Study||0||
48204075|NCT02001623|100823650|FG009|Completed 12 Cycles of Treatment|Overall Study||3||
48204076|NCT02001623|100823651|FG010|Completed 12 Cycles of Treatment|Overall Study||0||
48042440|NCT01634256|100424017|FG001|STARTED|Overall Study||30||
48042441|NCT01634256|100424016|FG000|COMPLETED|Overall Study||26||
48042442|NCT01634256|100424017|FG001|COMPLETED|Overall Study||22||
48042443|NCT01634256|100424016|FG000|NOT COMPLETED|Overall Study||4||
48042444|NCT01634256|100424017|FG001|NOT COMPLETED|Overall Study||8||
48042445|NCT00617669|100424018|FG000|STARTED|Overall Study||524||
48042446|NCT00617669|100424019|FG001|STARTED|Overall Study||528||
48042447|NCT00617669|100424018|FG000|Patients Who Received IP|Overall Study||522||
48042448|NCT00617669|100424019|FG001|Patients Who Received IP|Overall Study||525||
48042449|NCT00617669|100424018|FG000|COMPLETED|Overall Study||94||
48204077|NCT02001623|100823652|FG011|Completed 12 Cycles of Treatment|Overall Study||0||
48204078|NCT02001623|100823653|FG012|Completed 12 Cycles of Treatment|Overall Study||1||
48204079|NCT02001623|100823654|FG013|Completed 12 Cycles of Treatment|Overall Study||1||
48204080|NCT02001623|100823655|FG014|Completed 12 Cycles of Treatment|Overall Study||0||
48204081|NCT02001623|100823641|FG000|COMPLETED|Overall Study||0||
48204082|NCT02001623|100823642|FG001|COMPLETED|Overall Study||0||
48204083|NCT02001623|100823643|FG002|COMPLETED|Overall Study||0||
48204084|NCT02001623|100823644|FG003|COMPLETED|Overall Study||1||
48204085|NCT02001623|100823645|FG004|COMPLETED|Overall Study||0||
48204086|NCT02001623|100823646|FG005|COMPLETED|Overall Study||0||
48204087|NCT02001623|100823647|FG006|COMPLETED|Overall Study||0||
48204088|NCT02001623|100823648|FG007|COMPLETED|Overall Study||0||
48204089|NCT02001623|100823649|FG008|COMPLETED|Overall Study||0||
48204090|NCT02001623|100823650|FG009|COMPLETED|Overall Study||2||
48204091|NCT02001623|100823651|FG010|COMPLETED|Overall Study||0||
48204092|NCT02001623|100823652|FG011|COMPLETED|Overall Study||0||
48204093|NCT02001623|100823653|FG012|COMPLETED|Overall Study||1||
48204094|NCT02001623|100823654|FG013|COMPLETED|Overall Study||1||
48204095|NCT02001623|100823655|FG014|COMPLETED|Overall Study||0||
48204096|NCT02001623|100823641|FG000|NOT COMPLETED|Overall Study||3||
48042450|NCT00617669|100424019|FG001|COMPLETED|Overall Study||77||
48042451|NCT00617669|100424018|FG000|NOT COMPLETED|Overall Study||430||
48042452|NCT00617669|100424019|FG001|NOT COMPLETED|Overall Study||451||
48042453|NCT00923364|100424020|FG000|STARTED|Overall Study||14||
48042454|NCT00923364|100424021|FG001|STARTED|Overall Study||5||
48042455|NCT00923364|100424020|FG000|COMPLETED|Overall Study||10||
48042456|NCT00923364|100424021|FG001|COMPLETED|Overall Study||5||
48042457|NCT00923364|100424020|FG000|NOT COMPLETED|Overall Study||4||
48042458|NCT00923364|100424021|FG001|NOT COMPLETED|Overall Study||0||
48042459|NCT02491359|100424022|FG000|STARTED|Overall Study||20||
48042460|NCT02491359|100424022|FG000|COMPLETED|Overall Study||4||
48042461|NCT02491359|100424022|FG000|NOT COMPLETED|Overall Study||16||
48042462|NCT02216812|100424023|FG000|STARTED|Overall Study||67||
48042463|NCT02216812|100424024|FG001|STARTED|Overall Study||67||
48042464|NCT02216812|100424023|FG000|COMPLETED|Overall Study||57||
48042465|NCT02216812|100424024|FG001|COMPLETED|Overall Study||62||
48042466|NCT02216812|100424023|FG000|NOT COMPLETED|Overall Study||10||
48042467|NCT02216812|100424024|FG001|NOT COMPLETED|Overall Study||5||
48042468|NCT00910624|100424025|FG000|STARTED|Treatment Phase||52||
48042469|NCT00910624|100424026|FG001|STARTED|Treatment Phase||85||
48042470|NCT00910624|100424027|FG002|STARTED|Treatment Phase||29||
48042471|NCT00910624|100424028|FG003|STARTED|Treatment Phase||2||
48042472|NCT00910624|100424025|FG000|COMPLETED|Treatment Phase||22||
48042473|NCT00910624|100424026|FG001|COMPLETED|Treatment Phase||64||
48042474|NCT00910624|100424027|FG002|COMPLETED|Treatment Phase||20||
48204097|NCT02001623|100823642|FG001|NOT COMPLETED|Overall Study||3||
48204098|NCT02001623|100823643|FG002|NOT COMPLETED|Overall Study||3||
48204099|NCT02001623|100823644|FG003|NOT COMPLETED|Overall Study||2||
48204100|NCT02001623|100823645|FG004|NOT COMPLETED|Overall Study||3||
48204101|NCT02001623|100823646|FG005|NOT COMPLETED|Overall Study||3||
48204102|NCT02001623|100823647|FG006|NOT COMPLETED|Overall Study||3||
48204103|NCT02001623|100823648|FG007|NOT COMPLETED|Overall Study||6||
48204104|NCT02001623|100823649|FG008|NOT COMPLETED|Overall Study||15||
48204105|NCT02001623|100823650|FG009|NOT COMPLETED|Overall Study||53||
48204106|NCT02001623|100823651|FG010|NOT COMPLETED|Overall Study||14||
48204107|NCT02001623|100823652|FG011|NOT COMPLETED|Overall Study||15||
48204108|NCT02001623|100823653|FG012|NOT COMPLETED|Overall Study||14||
48204109|NCT02001623|100823654|FG013|NOT COMPLETED|Overall Study||35||
48204110|NCT02001623|100823655|FG014|NOT COMPLETED|Overall Study||18||
48204111|NCT01466881|100823656|FG000|STARTED|Overall Study||42||
48204112|NCT01466881|100823656|FG000|Eligible and Treated|Overall Study||37||
48204113|NCT01466881|100823656|FG000|COMPLETED|Overall Study||2||
48204114|NCT01466881|100823656|FG000|NOT COMPLETED|Overall Study||40||
48204115|NCT01909778|100823657|FG000|STARTED|Overall Study||2||
48204116|NCT01909778|100823657|FG000|COMPLETED|Overall Study||1||
48204117|NCT01909778|100823657|FG000|NOT COMPLETED|Overall Study||1||
48204118|NCT01597258|100823658|FG000|STARTED|Overall Study||2029||
48204119|NCT01597258|100823658|FG000|COMPLETED|Overall Study||2028||
48204120|NCT01597258|100823658|FG000|NOT COMPLETED|Overall Study||1||
48204121|NCT03959241|100823659|FG000|STARTED|Overall Study||214||
48204122|NCT03959241|100823660|FG001|STARTED|Overall Study||217||
48204123|NCT03959241|100823659|FG000|COMPLETED|Overall Study||203||
48204124|NCT03959241|100823660|FG001|COMPLETED|Overall Study||208||
48204125|NCT03959241|100823659|FG000|NOT COMPLETED|Overall Study||11||
48204126|NCT03959241|100823660|FG001|NOT COMPLETED|Overall Study||9||
48204127|NCT02049866|100823661|FG000|STARTED|Overall Study||33||
48042475|NCT00910624|100424028|FG003|COMPLETED|Treatment Phase||2||
48204128|NCT02049866|100823661|FG000|COMPLETED|Overall Study||32||
48204129|NCT02049866|100823661|FG000|NOT COMPLETED|Overall Study||1||
48042476|NCT00910624|100424025|FG000|NOT COMPLETED|Treatment Phase||30||
48042477|NCT00910624|100424026|FG001|NOT COMPLETED|Treatment Phase||21||
48042478|NCT00910624|100424027|FG002|NOT COMPLETED|Treatment Phase||9||
48042479|NCT00910624|100424028|FG003|NOT COMPLETED|Treatment Phase||0||
48204130|NCT04628572|100823662|FG000|STARTED|Overall Study||189||
48042480|NCT00910624|100424025|FG000|STARTED|Follow-Up Phase||48||
48042481|NCT00910624|100424026|FG001|STARTED|Follow-Up Phase||80||
48042482|NCT00910624|100424027|FG002|STARTED|Follow-Up Phase||29||
48042483|NCT00910624|100424028|FG003|STARTED|Follow-Up Phase||2||
48042484|NCT00910624|100424025|FG000|COMPLETED|Follow-Up Phase||42||
48042485|NCT00910624|100424026|FG001|COMPLETED|Follow-Up Phase||76||
48042486|NCT00910624|100424027|FG002|COMPLETED|Follow-Up Phase||25||
48042487|NCT00910624|100424028|FG003|COMPLETED|Follow-Up Phase||2||
48042488|NCT00910624|100424025|FG000|NOT COMPLETED|Follow-Up Phase||6||
48042489|NCT00910624|100424026|FG001|NOT COMPLETED|Follow-Up Phase||4||
48204131|NCT04628572|100823662|FG000|COMPLETED|Overall Study||189||
48042490|NCT00910624|100424027|FG002|NOT COMPLETED|Follow-Up Phase||4||
48204132|NCT04628572|100823662|FG000|NOT COMPLETED|Overall Study||0||
48204133|NCT02534350|100823663|FG000|STARTED|Overall Study||41||
48204134|NCT02534350|100823664|FG001|STARTED|Overall Study||20||
48204135|NCT02534350|100823663|FG000|COMPLETED|Overall Study||37||
48204136|NCT02534350|100823664|FG001|COMPLETED|Overall Study||20||
48042491|NCT00910624|100424028|FG003|NOT COMPLETED|Follow-Up Phase||0||
48042492|NCT02848729|100424029|FG000|STARTED|Overall Study||27||
48042493|NCT02848729|100424030|FG001|STARTED|Overall Study||23||
48042494|NCT02848729|100424029|FG000|Per Protocol Population|Overall Study||11||
48042495|NCT02848729|100424030|FG001|Per Protocol Population|Overall Study||11||
48042496|NCT02848729|100424029|FG000|Safety Population|Overall Study||27||
48042497|NCT02848729|100424030|FG001|Safety Population|Overall Study||23||
48042498|NCT02848729|100424029|FG000|COMPLETED|Overall Study||11||
48042499|NCT02848729|100424030|FG001|COMPLETED|Overall Study||12||
48042500|NCT02848729|100424029|FG000|NOT COMPLETED|Overall Study||16||
48042501|NCT02848729|100424030|FG001|NOT COMPLETED|Overall Study||11||
48042502|NCT04583709|100424031|FG000|STARTED|Overall Study||20|Initial enrollment|
48042503|NCT04583709|100424031|FG000|COMPLETED|Overall Study||20|Completion of study participation of last enrollment (patient 20)|
48042504|NCT04583709|100424031|FG000|NOT COMPLETED|Overall Study||0||
48042505|NCT02296138|100424032|FG000|STARTED|Overall Study||3952||
48042506|NCT02296138|100424033|FG001|STARTED|Overall Study||3951||
48042507|NCT02296138|100424032|FG000|Treated|Overall Study||3941||
48042508|NCT02296138|100424033|FG001|Treated|Overall Study||3939||
48042509|NCT02296138|100424032|FG000|COMPLETED|Overall Study||3291||
48042510|NCT02296138|100424033|FG001|COMPLETED|Overall Study||3451||
48042511|NCT02296138|100424032|FG000|NOT COMPLETED|Overall Study||661||
48042512|NCT02296138|100424033|FG001|NOT COMPLETED|Overall Study||500||
48042513|NCT00766753|100424034|FG000|STARTED|Overall Study||11||
48042514|NCT00766753|100424035|FG001|STARTED|Overall Study||11||
48042515|NCT00766753|100424034|FG000|Received at Least One Vaccine|Overall Study||11||
48042516|NCT00766753|100424035|FG001|Received at Least One Vaccine|Overall Study||11||
48042517|NCT00766753|100424034|FG000|Completed at Least Four Vaccines|Overall Study||10||
48042518|NCT00766753|100424035|FG001|Completed at Least Four Vaccines|Overall Study||9||
48042519|NCT00766753|100424034|FG000|COMPLETED|Overall Study||11||
48042520|NCT00766753|100424035|FG001|COMPLETED|Overall Study||11||
48042521|NCT00766753|100424034|FG000|NOT COMPLETED|Overall Study||0||
48042522|NCT00766753|100424035|FG001|NOT COMPLETED|Overall Study||0||
48042523|NCT02248558|100424036|FG000|STARTED|Overall Study||369||
48042524|NCT02248558|100424037|FG001|STARTED|Overall Study||352||
48042525|NCT02248558|100424036|FG000|COMPLETED|Overall Study||317||
48042526|NCT02248558|100424037|FG001|COMPLETED|Overall Study||307||
48042527|NCT02248558|100424036|FG000|NOT COMPLETED|Overall Study||52||
48042528|NCT02248558|100424037|FG001|NOT COMPLETED|Overall Study||45||
48042529|NCT01328444|100424038|FG000|STARTED|Treatment Period 1 (12 Weeks)||94||
48042530|NCT01328444|100424039|FG001|STARTED|Treatment Period 1 (12 Weeks)||26||
48042531|NCT01328444|100424040|FG002|STARTED|Treatment Period 1 (12 Weeks)||28||
48042532|NCT01328444|100424041|FG003|STARTED|Treatment Period 1 (12 Weeks)||41||
48042533|NCT01328444|100424042|FG004|STARTED|Treatment Period 1 (12 Weeks)||81||
48204137|NCT02534350|100823663|FG000|NOT COMPLETED|Overall Study||4||
48204138|NCT02534350|100823664|FG001|NOT COMPLETED|Overall Study||0||
48204139|NCT03185819|100823665|FG000|STARTED|Double-Blind Phase: Day 1 to Day 25||63||
48204140|NCT03185819|100823666|FG001|STARTED|Double-Blind Phase: Day 1 to Day 25||29||
48204141|NCT03185819|100823667|FG002|STARTED|Double-Blind Phase: Day 1 to Day 25||31||
48042534|NCT01328444|100424043|FG005|STARTED|Treatment Period 1 (12 Weeks)||78||
48042535|NCT01328444|100424038|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||83||
48042536|NCT01328444|100424039|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||21||
48042537|NCT01328444|100424040|FG002|COMPLETED|Treatment Period 1 (12 Weeks)||25||
48042538|NCT01328444|100424041|FG003|COMPLETED|Treatment Period 1 (12 Weeks)||33||
48042539|NCT01328444|100424042|FG004|COMPLETED|Treatment Period 1 (12 Weeks)||67||
48042540|NCT01328444|100424043|FG005|COMPLETED|Treatment Period 1 (12 Weeks)||72||
48042541|NCT01328444|100424038|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11||
48042542|NCT01328444|100424039|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5||
48042543|NCT01328444|100424040|FG002|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3||
48042544|NCT01328444|100424041|FG003|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8||
48204142|NCT03185819|100823668|FG003|STARTED|Double-Blind Phase: Day 1 to Day 25||24||
48204143|NCT03185819|100823665|FG000|Safety Analysis Set|Double-Blind Phase: Day 1 to Day 25||63|Safety analysis set included all randomized participants who received at least 1 dose of study medication in the double-blind phase.|
48204144|NCT03185819|100823666|FG001|Safety Analysis Set|Double-Blind Phase: Day 1 to Day 25||29|Safety analysis set included all randomized participants who received at least 1 dose of study medication in the double-blind phase.|
48204145|NCT03185819|100823667|FG002|Safety Analysis Set|Double-Blind Phase: Day 1 to Day 25||31|Safety analysis set included all randomized participants who received at least 1 dose of study medication in the double-blind phase.|
48204146|NCT03185819|100823668|FG003|Safety Analysis Set|Double-Blind Phase: Day 1 to Day 25||23|Safety analysis set included all randomized participants who received at least 1 dose of study medication in the double-blind phase.|
48204147|NCT03185819|100823665|FG000|Full Efficacy Analysis Set|Double-Blind Phase: Day 1 to Day 25||63|The full efficacy analysis set included all randomized participants who received at least 1 dose of double-blind study intervention during the double-blind treatment phase and had both baseline and post-baseline evaluation for the CDRS-R total score.|
48204148|NCT03185819|100823666|FG001|Full Efficacy Analysis Set|Double-Blind Phase: Day 1 to Day 25||28|The full efficacy analysis set included all randomized participants who received at least 1 dose of double-blind study intervention during the double-blind treatment phase and had both baseline and post-baseline evaluation for the CDRS-R total score.|
48204149|NCT03185819|100823667|FG002|Full Efficacy Analysis Set|Double-Blind Phase: Day 1 to Day 25||31|The full efficacy analysis set included all randomized participants who received at least 1 dose of double-blind study intervention during the double-blind treatment phase and had both baseline and post-baseline evaluation for the CDRS-R total score.|
48204150|NCT03185819|100823668|FG003|Full Efficacy Analysis Set|Double-Blind Phase: Day 1 to Day 25||23|The full efficacy analysis set included all randomized participants who received at least 1 dose of double-blind study intervention during the double-blind treatment phase and had both baseline and post-baseline evaluation for the CDRS-R total score.|
48204151|NCT03185819|100823665|FG000|Follow-up Analysis Set|Double-Blind Phase: Day 1 to Day 25||59|The follow-up analysis set included all participants who completed the double-blind phase and either entered the follow-up phase or have provided adverse event data after the double-blind phase.|
48204152|NCT03185819|100823666|FG001|Follow-up Analysis Set|Double-Blind Phase: Day 1 to Day 25||29|The follow-up analysis set included all participants who completed the double-blind phase and either entered the follow-up phase or have provided adverse event data after the double-blind phase.|
48204153|NCT03185819|100823667|FG002|Follow-up Analysis Set|Double-Blind Phase: Day 1 to Day 25||29|The follow-up analysis set included all participants who completed the double-blind phase and either entered the follow-up phase or have provided adverse event data after the double-blind phase.|
48204154|NCT03185819|100823668|FG003|Follow-up Analysis Set|Double-Blind Phase: Day 1 to Day 25||21|The follow-up analysis set included all participants who completed the double-blind phase and either entered the follow-up phase or have provided adverse event data after the double-blind phase.|
48204155|NCT03185819|100823665|FG000|COMPLETED|Double-Blind Phase: Day 1 to Day 25||59||
48204156|NCT03185819|100823666|FG001|COMPLETED|Double-Blind Phase: Day 1 to Day 25||29||
48204157|NCT03185819|100823667|FG002|COMPLETED|Double-Blind Phase: Day 1 to Day 25||29||
48204158|NCT03185819|100823668|FG003|COMPLETED|Double-Blind Phase: Day 1 to Day 25||22||
48204159|NCT03185819|100823665|FG000|NOT COMPLETED|Double-Blind Phase: Day 1 to Day 25||4||
48204160|NCT03185819|100823666|FG001|NOT COMPLETED|Double-Blind Phase: Day 1 to Day 25||0||
48204161|NCT03185819|100823667|FG002|NOT COMPLETED|Double-Blind Phase: Day 1 to Day 25||2||
48204162|NCT03185819|100823668|FG003|NOT COMPLETED|Double-Blind Phase: Day 1 to Day 25||2||
48204163|NCT03185819|100823665|FG000|STARTED|Post-treatment Follow-up: Days 26 to 200||59||
48204164|NCT03185819|100823666|FG001|STARTED|Post-treatment Follow-up: Days 26 to 200||29||
48204165|NCT03185819|100823667|FG002|STARTED|Post-treatment Follow-up: Days 26 to 200||29||
48204166|NCT03185819|100823668|FG003|STARTED|Post-treatment Follow-up: Days 26 to 200||21||
48204167|NCT03185819|100823665|FG000|COMPLETED|Post-treatment Follow-up: Days 26 to 200||48||
48204168|NCT03185819|100823666|FG001|COMPLETED|Post-treatment Follow-up: Days 26 to 200||24||
48204169|NCT03185819|100823667|FG002|COMPLETED|Post-treatment Follow-up: Days 26 to 200||21||
48204170|NCT03185819|100823668|FG003|COMPLETED|Post-treatment Follow-up: Days 26 to 200||18||
48204171|NCT03185819|100823665|FG000|NOT COMPLETED|Post-treatment Follow-up: Days 26 to 200||11||
48204172|NCT03185819|100823666|FG001|NOT COMPLETED|Post-treatment Follow-up: Days 26 to 200||5||
48204173|NCT03185819|100823667|FG002|NOT COMPLETED|Post-treatment Follow-up: Days 26 to 200||8||
48204174|NCT03185819|100823668|FG003|NOT COMPLETED|Post-treatment Follow-up: Days 26 to 200||3||
48204175|NCT01370694|100823669|FG000|STARTED|Overall Study||7||
48204176|NCT01370694|100823669|FG000|COMPLETED|Overall Study||1||
48204177|NCT01370694|100823669|FG000|NOT COMPLETED|Overall Study||6||
48204178|NCT03336450|100823670|FG000|STARTED|Overall Study||3||
48204179|NCT03336450|100823670|FG000|COMPLETED|Overall Study||3||
48204180|NCT03336450|100823670|FG000|NOT COMPLETED|Overall Study||0||
48204181|NCT00754936|100823671|FG000|STARTED|Overall Study||71||
48204182|NCT00754936|100823671|FG000|COMPLETED|Overall Study||59||
48204183|NCT00754936|100823671|FG000|NOT COMPLETED|Overall Study||12||
48204184|NCT01069341|100823672|FG000|STARTED|Overall Study||4||
48204185|NCT01069341|100823672|FG000|COMPLETED|Overall Study||3||
48204186|NCT01069341|100823672|FG000|NOT COMPLETED|Overall Study||1||
48204187|NCT00354640|100823673|FG000|STARTED|Overall Study||11||
48204188|NCT00354640|100823673|FG000|COMPLETED|Overall Study||11||
48204189|NCT00354640|100823673|FG000|NOT COMPLETED|Overall Study||0||
48204190|NCT04033432|100823674|FG000|STARTED|Overall Study||14||
48204191|NCT04033432|100823674|FG000|Registered for Study|Overall Study||14||
48204192|NCT04033432|100823674|FG000|Started Cycle 1|Overall Study||14||
48204193|NCT04033432|100823674|FG000|Started Cycle 2|Overall Study||13||
48204194|NCT04033432|100823674|FG000|Started Cycle 3|Overall Study||10||
48204195|NCT04033432|100823674|FG000|Started Cycle 4|Overall Study||7||
48204196|NCT04033432|100823674|FG000|Started Cycle 5|Overall Study||1||
48204197|NCT04033432|100823674|FG000|Started Cycle 6|Overall Study||1||
48204198|NCT04033432|100823674|FG000|Started Cycle 7+|Overall Study||1|Beginning at Cycle 7, cycle length will be 21 days and patients will return for treatment on Day 1 of each cycle.|
48204199|NCT04033432|100823674|FG000|COMPLETED|Overall Study||1||
48204200|NCT04033432|100823674|FG000|NOT COMPLETED|Overall Study||13||
48204201|NCT03320096|100823675|FG000|STARTED|Overall Study||20||
48204202|NCT03320096|100823675|FG000|COMPLETED|Overall Study||20||
48204203|NCT03320096|100823675|FG000|NOT COMPLETED|Overall Study||0||
48204204|NCT03920215|100823676|FG000|STARTED|Overall Study||26||
48204205|NCT03920215|100823677|FG001|STARTED|Overall Study||29||
48204206|NCT03920215|100823678|FG002|STARTED|Overall Study||23||
48204207|NCT03920215|100823679|FG003|STARTED|Overall Study||23||
48204208|NCT03920215|100823676|FG000|COMPLETED|Overall Study||25||
48204209|NCT03920215|100823677|FG001|COMPLETED|Overall Study||27||
48204210|NCT03920215|100823678|FG002|COMPLETED|Overall Study||23||
48204211|NCT03920215|100823679|FG003|COMPLETED|Overall Study||22||
48204212|NCT03920215|100823676|FG000|NOT COMPLETED|Overall Study||1||
48204213|NCT03920215|100823677|FG001|NOT COMPLETED|Overall Study||2||
48204214|NCT03920215|100823678|FG002|NOT COMPLETED|Overall Study||0||
48204215|NCT03920215|100823679|FG003|NOT COMPLETED|Overall Study||1||
48204216|NCT03897348|100823680|FG000|STARTED|ADP Session 1||1||
48204217|NCT03897348|100823681|FG001|STARTED|ADP Session 1||1||
48204218|NCT03897348|100823682|FG002|STARTED|ADP Session 1||1||
48204219|NCT03897348|100823683|FG003|STARTED|ADP Session 1||1||
48204220|NCT03897348|100823680|FG000|COMPLETED|ADP Session 1||1||
48204221|NCT03897348|100823681|FG001|COMPLETED|ADP Session 1||1||
48204222|NCT03897348|100823682|FG002|COMPLETED|ADP Session 1||1||
48204223|NCT03897348|100823683|FG003|COMPLETED|ADP Session 1||1||
48204224|NCT03897348|100823680|FG000|NOT COMPLETED|ADP Session 1||0||
48204225|NCT03897348|100823681|FG001|NOT COMPLETED|ADP Session 1||0||
48204226|NCT03897348|100823682|FG002|NOT COMPLETED|ADP Session 1||0||
48204227|NCT03897348|100823683|FG003|NOT COMPLETED|ADP Session 1||0||
48204228|NCT03897348|100823680|FG000|STARTED|ADP Session 2||1||
48204229|NCT03897348|100823681|FG001|STARTED|ADP Session 2||1||
48204230|NCT03897348|100823682|FG002|STARTED|ADP Session 2||1||
48204231|NCT03897348|100823683|FG003|STARTED|ADP Session 2||1||
48204232|NCT03897348|100823680|FG000|COMPLETED|ADP Session 2||1||
48204233|NCT03897348|100823681|FG001|COMPLETED|ADP Session 2||1||
48204234|NCT03897348|100823682|FG002|COMPLETED|ADP Session 2||1||
48204235|NCT03897348|100823683|FG003|COMPLETED|ADP Session 2||1||
48204236|NCT03897348|100823680|FG000|NOT COMPLETED|ADP Session 2||0||
48204237|NCT03897348|100823681|FG001|NOT COMPLETED|ADP Session 2||0||
48204238|NCT03897348|100823682|FG002|NOT COMPLETED|ADP Session 2||0||
48204239|NCT03897348|100823683|FG003|NOT COMPLETED|ADP Session 2||0||
48204240|NCT03897348|100823680|FG000|STARTED|ADP Session 3||1||
48204241|NCT03897348|100823681|FG001|STARTED|ADP Session 3||1||
48204242|NCT03897348|100823682|FG002|STARTED|ADP Session 3||0||
48204243|NCT03897348|100823683|FG003|STARTED|ADP Session 3||1||
48204244|NCT03897348|100823680|FG000|COMPLETED|ADP Session 3||1||
48204245|NCT03897348|100823681|FG001|COMPLETED|ADP Session 3||1||
48204246|NCT03897348|100823682|FG002|COMPLETED|ADP Session 3||0||
48204247|NCT03897348|100823683|FG003|COMPLETED|ADP Session 3||1||
48204248|NCT03897348|100823680|FG000|NOT COMPLETED|ADP Session 3||0||
48204249|NCT03897348|100823681|FG001|NOT COMPLETED|ADP Session 3||0||
48204250|NCT03897348|100823682|FG002|NOT COMPLETED|ADP Session 3||0||
48204251|NCT03897348|100823683|FG003|NOT COMPLETED|ADP Session 3||0||
48204252|NCT02994654|100823684|FG000|STARTED|Overall Study||12||
48204253|NCT02994654|100823684|FG000|COMPLETED|Overall Study||11||
48204254|NCT02994654|100823684|FG000|NOT COMPLETED|Overall Study||1||
48204255|NCT03224299|100823685|FG000|STARTED|Overall Study||131|Enrolled|
48204256|NCT03224299|100823686|FG001|STARTED|Overall Study||424|Enrolled|
48204257|NCT03224299|100823685|FG000|Treated With IP#1|Overall Study||65||
48204258|NCT03224299|100823686|FG001|Treated With IP#1|Overall Study||101||
48204259|NCT03224299|100823685|FG000|Treated With IP#2|Overall Study||66||
48204260|NCT03224299|100823686|FG001|Treated With IP#2|Overall Study||107||
48204261|NCT03224299|100823685|FG000|Treated With AC|Overall Study||66||
48204262|NCT03224299|100823686|FG001|Treated With AC|Overall Study||110||
48204263|NCT03224299|100823685|FG000|Treated With NC|Overall Study||65||
48204264|NCT03224299|100823686|FG001|Treated With NC|Overall Study||106||
48204265|NCT03224299|100823685|FG000|COMPLETED|Overall Study||131||
48204266|NCT03224299|100823686|FG001|COMPLETED|Overall Study||424||
48204267|NCT03224299|100823685|FG000|NOT COMPLETED|Overall Study||0||
48204268|NCT03224299|100823686|FG001|NOT COMPLETED|Overall Study||0||
48204269|NCT01071993|100823687|FG000|STARTED|Overall Study||0||
48204270|NCT01071993|100823688|FG001|STARTED|Overall Study||0||
48204271|NCT01071993|100823687|FG000|COMPLETED|Overall Study||0||
48204272|NCT01071993|100823688|FG001|COMPLETED|Overall Study||0||
48204273|NCT01071993|100823687|FG000|NOT COMPLETED|Overall Study||0||
48204274|NCT01071993|100823688|FG001|NOT COMPLETED|Overall Study||0||
48204275|NCT01321606|100823689|FG000|STARTED|Overall Study||18||
48204276|NCT01321606|100823690|FG001|STARTED|Overall Study||32||
48204277|NCT01321606|100823691|FG002|STARTED|Overall Study||34||
48204278|NCT01321606|100823692|FG003|STARTED|Overall Study||29||
48204279|NCT01321606|100823689|FG000|COMPLETED|Overall Study||18||
48204280|NCT01321606|100823690|FG001|COMPLETED|Overall Study||32||
48204281|NCT01321606|100823691|FG002|COMPLETED|Overall Study||34||
48204282|NCT01321606|100823692|FG003|COMPLETED|Overall Study||28||
48204283|NCT01321606|100823689|FG000|NOT COMPLETED|Overall Study||0||
48204284|NCT01321606|100823690|FG001|NOT COMPLETED|Overall Study||0||
48204285|NCT01321606|100823691|FG002|NOT COMPLETED|Overall Study||0||
48204286|NCT01321606|100823692|FG003|NOT COMPLETED|Overall Study||1||
48204287|NCT01269736|100823693|FG000|STARTED|Nurses' Knowledge Assessments||1585||9
48204288|NCT01269736|100823694|FG001|STARTED|Nurses' Knowledge Assessments||1428||8
48204289|NCT01269736|100823693|FG000|Baseline Assessment|Nurses' Knowledge Assessments||873||9
48204290|NCT01269736|100823694|FG001|Baseline Assessment|Nurses' Knowledge Assessments||866||8
48204291|NCT01269736|100823693|FG000|15 Months Assessment|Nurses' Knowledge Assessments||1108||9
48204292|NCT01269736|100823694|FG001|15 Months Assessment|Nurses' Knowledge Assessments||782||8
48204293|NCT01269736|100823693|FG000|30 Months Assessment|Nurses' Knowledge Assessments||741||8
48204294|NCT01269736|100823694|FG001|30 Months Assessment|Nurses' Knowledge Assessments||926||8
48204295|NCT01269736|100823693|FG000|COMPLETED|Nurses' Knowledge Assessments||1585||8
48204296|NCT01269736|100823694|FG001|COMPLETED|Nurses' Knowledge Assessments||1428||8
48204297|NCT01269736|100823693|FG000|NOT COMPLETED|Nurses' Knowledge Assessments||0||1
48204298|NCT01269736|100823694|FG001|NOT COMPLETED|Nurses' Knowledge Assessments||0||0
48204299|NCT01269736|100823693|FG000|STARTED|Patient Quality of Care Assessments||2299||9
48204300|NCT01269736|100823694|FG001|STARTED|Patient Quality of Care Assessments||2288||8
48204301|NCT01269736|100823693|FG000|Baseline Assessment|Patient Quality of Care Assessments||915||9
48204302|NCT01269736|100823694|FG001|Baseline Assessment|Patient Quality of Care Assessments||889||8
48204303|NCT01269736|100823693|FG000|15 Months Assessment|Patient Quality of Care Assessments||687||8
48204304|NCT01269736|100823694|FG001|15 Months Assessment|Patient Quality of Care Assessments||773||8
48204305|NCT01269736|100823693|FG000|30 Months Assessment|Patient Quality of Care Assessments||697||8
48204306|NCT01269736|100823694|FG001|30 Months Assessment|Patient Quality of Care Assessments||626||7
48204307|NCT01269736|100823693|FG000|COMPLETED|Patient Quality of Care Assessments||2299||8
48204308|NCT01269736|100823694|FG001|COMPLETED|Patient Quality of Care Assessments||2288||7
48204309|NCT01269736|100823693|FG000|NOT COMPLETED|Patient Quality of Care Assessments||0||1
48204310|NCT01269736|100823694|FG001|NOT COMPLETED|Patient Quality of Care Assessments||0||1
48204311|NCT01269736|100823693|FG000|STARTED|Patient Outcomes (Hospital Admissions)||52085||7
48042545|NCT01328444|100424042|FG004|NOT COMPLETED|Treatment Period 1 (12 Weeks)||14||
48042546|NCT01328444|100424043|FG005|NOT COMPLETED|Treatment Period 1 (12 Weeks)||6||
48042547|NCT01328444|100424038|FG000|STARTED|Washout Period (14 Days)||83||
48042548|NCT01328444|100424039|FG001|STARTED|Washout Period (14 Days)||21||
48042549|NCT01328444|100424040|FG002|STARTED|Washout Period (14 Days)||25||
48042550|NCT01328444|100424041|FG003|STARTED|Washout Period (14 Days)||33||
48042551|NCT01328444|100424042|FG004|STARTED|Washout Period (14 Days)||67||
48042552|NCT01328444|100424043|FG005|STARTED|Washout Period (14 Days)||72||
48042553|NCT01328444|100424038|FG000|COMPLETED|Washout Period (14 Days)||82||
48042554|NCT01328444|100424039|FG001|COMPLETED|Washout Period (14 Days)||20||
48042555|NCT01328444|100424040|FG002|COMPLETED|Washout Period (14 Days)||25||
48042556|NCT01328444|100424041|FG003|COMPLETED|Washout Period (14 Days)||32||
48042557|NCT01328444|100424042|FG004|COMPLETED|Washout Period (14 Days)||66||
48042558|NCT01328444|100424043|FG005|COMPLETED|Washout Period (14 Days)||68||
48042559|NCT01328444|100424038|FG000|NOT COMPLETED|Washout Period (14 Days)||1||
48042560|NCT01328444|100424039|FG001|NOT COMPLETED|Washout Period (14 Days)||1||
48042561|NCT01328444|100424040|FG002|NOT COMPLETED|Washout Period (14 Days)||0||
48042562|NCT01328444|100424041|FG003|NOT COMPLETED|Washout Period (14 Days)||1||
48042563|NCT01328444|100424042|FG004|NOT COMPLETED|Washout Period (14 Days)||1||
48042564|NCT01328444|100424043|FG005|NOT COMPLETED|Washout Period (14 Days)||4||
48042565|NCT01328444|100424038|FG000|STARTED|Treatment Period 2 (12 Weeks)||76||
48042566|NCT01328444|100424039|FG001|STARTED|Treatment Period 2 (12 Weeks)||23||
48042567|NCT01328444|100424040|FG002|STARTED|Treatment Period 2 (12 Weeks)||22||
48204312|NCT01269736|100823694|FG001|STARTED|Patient Outcomes (Hospital Admissions)||43799||6
48204313|NCT01269736|100823693|FG000|Baseline Assessment|Patient Outcomes (Hospital Admissions)||17352||7
48204314|NCT01269736|100823694|FG001|Baseline Assessment|Patient Outcomes (Hospital Admissions)||16549||6
48204315|NCT01269736|100823693|FG000|15 Months Assessment|Patient Outcomes (Hospital Admissions)||18031||7
48204316|NCT01269736|100823694|FG001|15 Months Assessment|Patient Outcomes (Hospital Admissions)||14075||6
48204317|NCT01269736|100823693|FG000|30 Months Assessment|Patient Outcomes (Hospital Admissions)||16702||7
48204318|NCT01269736|100823694|FG001|30 Months Assessment|Patient Outcomes (Hospital Admissions)||13265||6
48204319|NCT01269736|100823693|FG000|COMPLETED|Patient Outcomes (Hospital Admissions)||52085||7
48204320|NCT01269736|100823694|FG001|COMPLETED|Patient Outcomes (Hospital Admissions)||43799||6
48204321|NCT01269736|100823693|FG000|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0||0
48204322|NCT01269736|100823694|FG001|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0||0
48204323|NCT03993392|100823695|FG000|STARTED|Overall Study||26||
48204324|NCT03993392|100823695|FG000|Treated With SUBLOCADE|Overall Study||24|Safety and Full Analysis Sets|
48204325|NCT03993392|100823695|FG000|COMPLETED|Overall Study||20||
48204326|NCT03993392|100823695|FG000|NOT COMPLETED|Overall Study||6||
48204327|NCT01290224|100823696|FG000|STARTED|Overall Study||10||
48204328|NCT01290224|100823696|FG000|COMPLETED|Overall Study||5||
48042568|NCT01328444|100424041|FG003|STARTED|Treatment Period 2 (12 Weeks)||35||
48042569|NCT01328444|100424042|FG004|STARTED|Treatment Period 2 (12 Weeks)||71||
48204329|NCT01290224|100823696|FG000|NOT COMPLETED|Overall Study||5||
48204330|NCT02796092|100823697|FG000|STARTED|Overall Study||50||
48204331|NCT02796092|100823698|FG001|STARTED|Overall Study||50||
48204332|NCT02796092|100823697|FG000|COMPLETED|Overall Study||50||
48204333|NCT02796092|100823698|FG001|COMPLETED|Overall Study||50||
48204334|NCT02796092|100823697|FG000|NOT COMPLETED|Overall Study||0||
48204335|NCT02796092|100823698|FG001|NOT COMPLETED|Overall Study||0||
48204336|NCT00886145|100823699|FG000|STARTED|Overall Study||1||
48204337|NCT00886145|100823699|FG000|COMPLETED|Overall Study||1||
48204338|NCT00886145|100823699|FG000|NOT COMPLETED|Overall Study||0||
48204339|NCT02013830|100823700|FG000|STARTED|Overall Study||45||
48204340|NCT02013830|100823700|FG000|COMPLETED|Overall Study||15||
48204341|NCT02013830|100823700|FG000|NOT COMPLETED|Overall Study||30||
48204342|NCT02050308|100823701|FG000|STARTED|Overall Study||127||
48204343|NCT02050308|100823702|FG001|STARTED|Overall Study||124||
48204344|NCT02050308|100823701|FG000|COMPLETED|Overall Study||28||
48204345|NCT02050308|100823702|FG001|COMPLETED|Overall Study||22||
48204346|NCT02050308|100823701|FG000|NOT COMPLETED|Overall Study||99||
48204347|NCT02050308|100823702|FG001|NOT COMPLETED|Overall Study||102||
48204348|NCT00688519|100823703|FG000|STARTED|Overall Study||223||
48204349|NCT00688519|100823704|FG001|STARTED|Overall Study||113||
48204350|NCT00688519|100823703|FG000|COMPLETED|Overall Study||204||
48204351|NCT00688519|100823704|FG001|COMPLETED|Overall Study||98||
48204352|NCT00688519|100823703|FG000|NOT COMPLETED|Overall Study||19||
48204353|NCT00688519|100823704|FG001|NOT COMPLETED|Overall Study||15||
48204354|NCT04365400|100823705|FG000|STARTED|Overall Study||79||
48204355|NCT04365400|100823706|FG001|STARTED|Overall Study||77||
48204356|NCT04365400|100823707|FG002|STARTED|Overall Study||77||
48204357|NCT04365400|100823705|FG000|COMPLETED|Overall Study||49||
48204358|NCT04365400|100823706|FG001|COMPLETED|Overall Study||50||
48204359|NCT04365400|100823707|FG002|COMPLETED|Overall Study||50||
48204360|NCT04365400|100823705|FG000|NOT COMPLETED|Overall Study||30||
48204361|NCT04365400|100823706|FG001|NOT COMPLETED|Overall Study||27||
48204362|NCT04365400|100823707|FG002|NOT COMPLETED|Overall Study||27||
48204363|NCT01391130|100823708|FG000|STARTED|Overall Study||73||
48204364|NCT01391130|100823709|FG001|STARTED|Overall Study||37||
48204365|NCT01391130|100823708|FG000|Received At Least One Dose of Study Drug|Overall Study||72||
48204366|NCT01391130|100823709|FG001|Received At Least One Dose of Study Drug|Overall Study||36||
48204367|NCT01391130|100823708|FG000|COMPLETED|Overall Study||67||
48204368|NCT01391130|100823709|FG001|COMPLETED|Overall Study||31||
48204369|NCT01391130|100823708|FG000|NOT COMPLETED|Overall Study||6||
48204370|NCT01391130|100823709|FG001|NOT COMPLETED|Overall Study||6||
48204371|NCT05859971|100823710|FG000|STARTED|Overall Study||10||
48204372|NCT05859971|100823710|FG000|COMPLETED|Overall Study||10||
48204373|NCT05859971|100823710|FG000|NOT COMPLETED|Overall Study||0||
48204374|NCT01335542|100823711|FG000|STARTED|Overall Study||45||
48204375|NCT01335542|100823712|FG001|STARTED|Overall Study||45||
48204376|NCT01335542|100823711|FG000|COMPLETED|Overall Study||45||
48204377|NCT01335542|100823712|FG001|COMPLETED|Overall Study||45||
48204378|NCT01335542|100823711|FG000|NOT COMPLETED|Overall Study||0||
48204379|NCT01335542|100823712|FG001|NOT COMPLETED|Overall Study||0||
48204380|NCT03253913|100823713|FG000|STARTED|First 8 Weeks (250mg Daily Resveratrol)||25||
48204381|NCT03253913|100823713|FG000|COMPLETED|First 8 Weeks (250mg Daily Resveratrol)||25||
48204382|NCT03253913|100823713|FG000|NOT COMPLETED|First 8 Weeks (250mg Daily Resveratrol)||0||
48204383|NCT03253913|100823713|FG000|STARTED|Weeks 8 - 16 (Resveratrol 500mg Daily)||25||
48495363|NCT04583423|101547829|FG000|NOT COMPLETED|Overall Study||35||
48495364|NCT04583423|101547830|FG001|NOT COMPLETED|Overall Study||37||
48042570|NCT01328444|100424043|FG005|STARTED|Treatment Period 2 (12 Weeks)||66||
48042571|NCT01328444|100424038|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||65||
48042572|NCT01328444|100424039|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||22||
48042573|NCT01328444|100424040|FG002|COMPLETED|Treatment Period 2 (12 Weeks)||19||
48042574|NCT01328444|100424041|FG003|COMPLETED|Treatment Period 2 (12 Weeks)||30||
48042575|NCT01328444|100424042|FG004|COMPLETED|Treatment Period 2 (12 Weeks)||63||
48042576|NCT01328444|100424043|FG005|COMPLETED|Treatment Period 2 (12 Weeks)||59||
48042577|NCT01328444|100424038|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||11||
48042578|NCT01328444|100424039|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1||
48042579|NCT01328444|100424040|FG002|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3||
48042580|NCT01328444|100424041|FG003|NOT COMPLETED|Treatment Period 2 (12 Weeks)||5||
48042581|NCT01328444|100424042|FG004|NOT COMPLETED|Treatment Period 2 (12 Weeks)||8||
48204384|NCT03253913|100823713|FG000|COMPLETED|Weeks 8 - 16 (Resveratrol 500mg Daily)||25||
48204385|NCT03253913|100823713|FG000|NOT COMPLETED|Weeks 8 - 16 (Resveratrol 500mg Daily)||0||
48204386|NCT03253913|100823713|FG000|STARTED|Weeks 16-24 (Resveratrol 1,000mg Daily)||25||
48204387|NCT03253913|100823713|FG000|COMPLETED|Weeks 16-24 (Resveratrol 1,000mg Daily)||25||
48204388|NCT03253913|100823713|FG000|NOT COMPLETED|Weeks 16-24 (Resveratrol 1,000mg Daily)||0||
48204389|NCT00761930|100823714|FG000|STARTED|Overall Study||34||
48204390|NCT00761930|100823715|FG001|STARTED|Overall Study||34||
48204391|NCT00761930|100823716|FG002|STARTED|Overall Study||35||
48204392|NCT00761930|100823714|FG000|COMPLETED|Overall Study||34||
48204393|NCT00761930|100823715|FG001|COMPLETED|Overall Study||34||
48204394|NCT00761930|100823716|FG002|COMPLETED|Overall Study||35||
48204395|NCT00761930|100823714|FG000|NOT COMPLETED|Overall Study||0||
48204396|NCT00761930|100823715|FG001|NOT COMPLETED|Overall Study||0||
48204397|NCT00761930|100823716|FG002|NOT COMPLETED|Overall Study||0||
48204398|NCT04246762|100823717|FG000|STARTED|Period 1: Cocktail Alone||17||
48204399|NCT04246762|100823717|FG000|COMPLETED|Period 1: Cocktail Alone||16||
48204400|NCT04246762|100823717|FG000|NOT COMPLETED|Period 1: Cocktail Alone||1||
48042582|NCT01328444|100424043|FG005|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7||
48042583|NCT03562767|100424044|FG000|STARTED|Overall Study||10||
48042584|NCT03562767|100424045|FG001|STARTED|Overall Study||10||
48042585|NCT03562767|100424046|FG002|STARTED|Overall Study||0||
48042586|NCT03562767|100424044|FG000|COMPLETED|Overall Study||7||
48042587|NCT03562767|100424045|FG001|COMPLETED|Overall Study||7||
48042588|NCT03562767|100424046|FG002|COMPLETED|Overall Study||0||
48042589|NCT03562767|100424044|FG000|NOT COMPLETED|Overall Study||3||
48204401|NCT04246762|100823717|FG000|STARTED|Period 2: Olokizumab Administration||16||
48204402|NCT04246762|100823717|FG000|COMPLETED|Period 2: Olokizumab Administration||16||
48204403|NCT04246762|100823717|FG000|NOT COMPLETED|Period 2: Olokizumab Administration||0||
48204404|NCT04246762|100823717|FG000|STARTED|Period 3: Olokizumab + Cocktail||16||
48204405|NCT04246762|100823717|FG000|COMPLETED|Period 3: Olokizumab + Cocktail||16||
48204406|NCT04246762|100823717|FG000|NOT COMPLETED|Period 3: Olokizumab + Cocktail||0||
48204407|NCT04246762|100823717|FG000|STARTED|Safety Follow-up||16||
48204408|NCT04246762|100823717|FG000|COMPLETED|Safety Follow-up||16||
48204409|NCT04246762|100823717|FG000|NOT COMPLETED|Safety Follow-up||0||
48204410|NCT03727854|100823718|FG000|STARTED|Overall Study||20||
48204411|NCT03727854|100823719|FG001|STARTED|Overall Study||20||
48042590|NCT03562767|100424045|FG001|NOT COMPLETED|Overall Study||3||
48042591|NCT03562767|100424046|FG002|NOT COMPLETED|Overall Study||0||
48042592|NCT00927940|100424047|FG000|STARTED|Overall Study||100||
48042593|NCT00927940|100424047|FG000|COMPLETED|Overall Study||99||
48042594|NCT00927940|100424047|FG000|NOT COMPLETED|Overall Study||1||
48042595|NCT00713310|100424048|FG000|STARTED|Overall Study||41||
48042596|NCT00713310|100424049|FG001|STARTED|Overall Study||42||
48042597|NCT00713310|100424048|FG000|mITT Population|Overall Study||41||
48042598|NCT00713310|100424049|FG001|mITT Population|Overall Study||41||
48042599|NCT00713310|100424048|FG000|COMPLETED|Overall Study||36||
48042600|NCT00713310|100424049|FG001|COMPLETED|Overall Study||36||
48042601|NCT00713310|100424048|FG000|NOT COMPLETED|Overall Study||5||
48042602|NCT00713310|100424049|FG001|NOT COMPLETED|Overall Study||6||
48042603|NCT01439815|100424050|FG000|STARTED|Overall Study||11||
48042604|NCT01439815|100424051|FG001|STARTED|Overall Study||11||
48042605|NCT01439815|100424050|FG000|All Randomized Participant Population|Overall Study||11||
48042606|NCT01439815|100424051|FG001|All Randomized Participant Population|Overall Study||11||
48042607|NCT01439815|100424050|FG000|COMPLETED|Overall Study||11||
48042608|NCT01439815|100424051|FG001|COMPLETED|Overall Study||9||
48042609|NCT01439815|100424050|FG000|NOT COMPLETED|Overall Study||0||
48042610|NCT01439815|100424051|FG001|NOT COMPLETED|Overall Study||2||
48042611|NCT00266864|100424052|FG000|STARTED|Overall Study||18||
48042612|NCT00266864|100424053|FG001|STARTED|Overall Study||13||
48042613|NCT00266864|100424052|FG000|COMPLETED|Overall Study||13||
48042614|NCT00266864|100424053|FG001|COMPLETED|Overall Study||11||
48042615|NCT00266864|100424052|FG000|NOT COMPLETED|Overall Study||5||
48042616|NCT00266864|100424053|FG001|NOT COMPLETED|Overall Study||2||
48204412|NCT03727854|100823718|FG000|COMPLETED|Overall Study||20||
48042617|NCT00535288|100424054|FG000|STARTED|Overall Study||314||
48042618|NCT00535288|100424055|FG001|STARTED|Overall Study||162||
48042619|NCT00535288|100424056|FG002|STARTED|Overall Study||160||
48042620|NCT00535288|100424057|FG003|STARTED|Overall Study||151||
48042621|NCT00535288|100424058|FG004|STARTED|Overall Study||158||
48042622|NCT00535288|100424054|FG000|COMPLETED|Overall Study||260||
48042623|NCT00535288|100424055|FG001|COMPLETED|Overall Study||130||
48042624|NCT00535288|100424056|FG002|COMPLETED|Overall Study||127||
48042625|NCT00535288|100424057|FG003|COMPLETED|Overall Study||122||
48042626|NCT00535288|100424058|FG004|COMPLETED|Overall Study||116||
48042627|NCT00535288|100424054|FG000|NOT COMPLETED|Overall Study||54||
48042628|NCT00535288|100424055|FG001|NOT COMPLETED|Overall Study||32||
48042629|NCT00535288|100424056|FG002|NOT COMPLETED|Overall Study||33||
48042630|NCT00535288|100424057|FG003|NOT COMPLETED|Overall Study||29||
48042631|NCT00535288|100424058|FG004|NOT COMPLETED|Overall Study||42||
48042632|NCT04224688|100424059|FG000|STARTED|Overall Study||10||
48042633|NCT04224688|100424060|FG001|STARTED|Overall Study||20||
48204413|NCT03727854|100823719|FG001|COMPLETED|Overall Study||20||
48204414|NCT03727854|100823718|FG000|NOT COMPLETED|Overall Study||0||
48204415|NCT03727854|100823719|FG001|NOT COMPLETED|Overall Study||0||
48204416|NCT00538213|100823720|FG000|STARTED|Overall Study||55||
48204417|NCT00538213|100823721|FG001|STARTED|Overall Study||40||
48204418|NCT00538213|100823722|FG002|STARTED|Overall Study||38||
48204419|NCT00538213|100823720|FG000|COMPLETED|Overall Study||55||
48204420|NCT00538213|100823721|FG001|COMPLETED|Overall Study||40||
48204421|NCT00538213|100823722|FG002|COMPLETED|Overall Study||38||
48204422|NCT00538213|100823720|FG000|NOT COMPLETED|Overall Study||0||
48204423|NCT00538213|100823721|FG001|NOT COMPLETED|Overall Study||0||
48042634|NCT04224688|100424059|FG000|COMPLETED|Overall Study||8||
48042635|NCT04224688|100424060|FG001|COMPLETED|Overall Study||13||
48042636|NCT04224688|100424059|FG000|NOT COMPLETED|Overall Study||2||
48042637|NCT04224688|100424060|FG001|NOT COMPLETED|Overall Study||7||
48042638|NCT02535572|100424061|FG000|STARTED|Overall Study||21||
48042639|NCT02535572|100424062|FG001|STARTED|Overall Study||20||
48042640|NCT02535572|100424061|FG000|COMPLETED|Overall Study||17||
48042641|NCT02535572|100424062|FG001|COMPLETED|Overall Study||17||
48042642|NCT02535572|100424061|FG000|NOT COMPLETED|Overall Study||4||
48042643|NCT02535572|100424062|FG001|NOT COMPLETED|Overall Study||3||
48204424|NCT00538213|100823722|FG002|NOT COMPLETED|Overall Study||0||
48204425|NCT00157014|100823723|FG000|STARTED|Overall Study||52||
48204426|NCT00157014|100823724|FG001|STARTED|Overall Study||46||
48204427|NCT00157014|100823725|FG002|STARTED|Overall Study||5||
48495365|NCT04583423|101547831|FG002|NOT COMPLETED|Overall Study||38||
48042644|NCT02946931|100427835|FG000|STARTED|Overall Study||1402|Treated with Prizbind®|
48042645|NCT02946931|100427835|FG000|Case Report Forms (CRFs) Collected|Overall Study||814||
48042646|NCT02946931|100427835|FG000|CRFs Valid|Overall Study||813||
48042647|NCT02946931|100427835|FG000|COMPLETED|Overall Study||571||
48042648|NCT02946931|100427835|FG000|NOT COMPLETED|Overall Study||831||
48042649|NCT00721253|100427836|FG000|STARTED|Overall Study||20||
48042650|NCT00721253|100427837|FG001|STARTED|Overall Study||22||
48042651|NCT00721253|100427838|FG002|STARTED|Overall Study||0||
48042652|NCT00721253|100427836|FG000|COMPLETED|Overall Study||20||
48042653|NCT00721253|100427837|FG001|COMPLETED|Overall Study||22||
48042654|NCT00721253|100427838|FG002|COMPLETED|Overall Study||0||
48042655|NCT00721253|100427836|FG000|NOT COMPLETED|Overall Study||0||
48042656|NCT00721253|100427837|FG001|NOT COMPLETED|Overall Study||0||
48042657|NCT00721253|100427838|FG002|NOT COMPLETED|Overall Study||0||
48042658|NCT01106092|100427839|FG000|STARTED|Overall Study||78||
48042659|NCT01106092|100427840|FG001|STARTED|Overall Study||78||
48042660|NCT01106092|100427841|FG002|STARTED|Overall Study||78||
48042661|NCT01106092|100427842|FG003|STARTED|Overall Study||78||
48042662|NCT01106092|100427839|FG000|COMPLETED|Overall Study||78||
48042663|NCT01106092|100427840|FG001|COMPLETED|Overall Study||78||
48042664|NCT01106092|100427841|FG002|COMPLETED|Overall Study||78||
48042665|NCT01106092|100427842|FG003|COMPLETED|Overall Study||77||
48042666|NCT01106092|100427839|FG000|NOT COMPLETED|Overall Study||0||
48042667|NCT01106092|100427840|FG001|NOT COMPLETED|Overall Study||0||
48042668|NCT01106092|100427841|FG002|NOT COMPLETED|Overall Study||0||
48042669|NCT01106092|100427842|FG003|NOT COMPLETED|Overall Study||1||
48042670|NCT00606047|100427843|FG000|STARTED|Overall Study||200||
48042671|NCT00606047|100427843|FG000|COMPLETED|Overall Study||200||
48042672|NCT00606047|100427843|FG000|NOT COMPLETED|Overall Study||0||
48042673|NCT02307253|100427844|FG000|STARTED|Overall Study||246||
48042674|NCT02307253|100427844|FG000|COMPLETED|Overall Study||246||
48042675|NCT02307253|100427844|FG000|NOT COMPLETED|Overall Study||0||
48042676|NCT01743001|100427845|FG000|STARTED|Overall Study||114||
48042677|NCT01743001|100427846|FG001|STARTED|Overall Study||112||
48042678|NCT01743001|100427845|FG000|COMPLETED|Overall Study||111||
48042679|NCT01743001|100427846|FG001|COMPLETED|Overall Study||112||
48042680|NCT01743001|100427845|FG000|NOT COMPLETED|Overall Study||3||
48042681|NCT01743001|100427846|FG001|NOT COMPLETED|Overall Study||0||
48042682|NCT00362180|100427847|FG000|STARTED|Treated Period||4||
48042683|NCT00362180|100427848|FG001|STARTED|Treated Period||2||
48042684|NCT00362180|100427849|FG002|STARTED|Treated Period||1||
48042685|NCT00362180|100427850|FG003|STARTED|Treated Period||0||
48042686|NCT00362180|100427851|FG004|STARTED|Treated Period||11||
48042687|NCT00362180|100427852|FG005|STARTED|Treated Period||10||
48042688|NCT00362180|100427853|FG006|STARTED|Treated Period||6||
48042689|NCT00362180|100427854|FG007|STARTED|Treated Period||3||
48042690|NCT00362180|100427855|FG008|STARTED|Treated Period||1||
48204428|NCT00157014|100823726|FG003|STARTED|Overall Study||6||
48204429|NCT00157014|100823723|FG000|COMPLETED|Overall Study||45||
48204430|NCT00157014|100823724|FG001|COMPLETED|Overall Study||41||
48042691|NCT00362180|100427847|FG000|COMPLETED|Treated Period||3||
48042692|NCT00362180|100427848|FG001|COMPLETED|Treated Period||2||
48042693|NCT00362180|100427849|FG002|COMPLETED|Treated Period||1||
48042694|NCT00362180|100427850|FG003|COMPLETED|Treated Period||0||
48042695|NCT00362180|100427851|FG004|COMPLETED|Treated Period||11||
48042696|NCT00362180|100427852|FG005|COMPLETED|Treated Period||9||
48042697|NCT00362180|100427853|FG006|COMPLETED|Treated Period||6||
48042698|NCT00362180|100427854|FG007|COMPLETED|Treated Period||2||
48042699|NCT00362180|100427855|FG008|COMPLETED|Treated Period||1||
48042700|NCT00362180|100427847|FG000|NOT COMPLETED|Treated Period||1||
48042701|NCT00362180|100427848|FG001|NOT COMPLETED|Treated Period||0||
48042702|NCT00362180|100427849|FG002|NOT COMPLETED|Treated Period||0||
48042703|NCT00362180|100427850|FG003|NOT COMPLETED|Treated Period||0||
48042704|NCT00362180|100427851|FG004|NOT COMPLETED|Treated Period||0||
48042705|NCT00362180|100427852|FG005|NOT COMPLETED|Treated Period||1||
48042706|NCT00362180|100427853|FG006|NOT COMPLETED|Treated Period||0||
48204431|NCT00157014|100823725|FG002|COMPLETED|Overall Study||4||
48204432|NCT00157014|100823726|FG003|COMPLETED|Overall Study||5||
48042707|NCT00362180|100427854|FG007|NOT COMPLETED|Treated Period||1||
48042708|NCT00362180|100427855|FG008|NOT COMPLETED|Treated Period||0||
48204433|NCT00157014|100823723|FG000|NOT COMPLETED|Overall Study||7||
48204434|NCT00157014|100823724|FG001|NOT COMPLETED|Overall Study||5||
48204435|NCT00157014|100823725|FG002|NOT COMPLETED|Overall Study||1||
48204436|NCT00157014|100823726|FG003|NOT COMPLETED|Overall Study||1||
48204437|NCT02551055|100823727|FG000|STARTED|Overall Study||4||
48042709|NCT00362180|100427847|FG000|STARTED|20 Week Safety Follow-up||3||
48042710|NCT00362180|100427848|FG001|STARTED|20 Week Safety Follow-up||2||
48042711|NCT00362180|100427849|FG002|STARTED|20 Week Safety Follow-up||1||
48042712|NCT00362180|100427850|FG003|STARTED|20 Week Safety Follow-up||0||
48042713|NCT00362180|100427851|FG004|STARTED|20 Week Safety Follow-up||11||
48042714|NCT00362180|100427852|FG005|STARTED|20 Week Safety Follow-up||9||
48204438|NCT02551055|100823728|FG001|STARTED|Overall Study||6||
48204439|NCT02551055|100823729|FG002|STARTED|Overall Study||3||
48495366|NCT04583423|101547832|FG003|NOT COMPLETED|Overall Study||36||
48042715|NCT00362180|100427853|FG006|STARTED|20 Week Safety Follow-up||0||
48042716|NCT00362180|100427854|FG007|STARTED|20 Week Safety Follow-up||3||
48042717|NCT00362180|100427855|FG008|STARTED|20 Week Safety Follow-up||1||
48042718|NCT00362180|100427847|FG000|COMPLETED|20 Week Safety Follow-up||3||
48042719|NCT00362180|100427848|FG001|COMPLETED|20 Week Safety Follow-up||2||
48042720|NCT00362180|100427849|FG002|COMPLETED|20 Week Safety Follow-up||1||
48042721|NCT00362180|100427850|FG003|COMPLETED|20 Week Safety Follow-up||0||
48042722|NCT00362180|100427851|FG004|COMPLETED|20 Week Safety Follow-up||11||
48042723|NCT00362180|100427852|FG005|COMPLETED|20 Week Safety Follow-up||9||
48042724|NCT00362180|100427853|FG006|COMPLETED|20 Week Safety Follow-up||0||
48042725|NCT00362180|100427854|FG007|COMPLETED|20 Week Safety Follow-up||3||
48042726|NCT00362180|100427855|FG008|COMPLETED|20 Week Safety Follow-up||1||
48042727|NCT00362180|100427847|FG000|NOT COMPLETED|20 Week Safety Follow-up||0||
48042728|NCT00362180|100427848|FG001|NOT COMPLETED|20 Week Safety Follow-up||0||
48042729|NCT00362180|100427849|FG002|NOT COMPLETED|20 Week Safety Follow-up||0||
48042730|NCT00362180|100427850|FG003|NOT COMPLETED|20 Week Safety Follow-up||0||
48042731|NCT00362180|100427851|FG004|NOT COMPLETED|20 Week Safety Follow-up||0||
48042732|NCT00362180|100427852|FG005|NOT COMPLETED|20 Week Safety Follow-up||0||
48042733|NCT00362180|100427853|FG006|NOT COMPLETED|20 Week Safety Follow-up||0||
48042734|NCT00362180|100427854|FG007|NOT COMPLETED|20 Week Safety Follow-up||0||
48042735|NCT00362180|100427855|FG008|NOT COMPLETED|20 Week Safety Follow-up||0||
48042736|NCT00745849|100427856|FG000|STARTED|First Intervention||21||
48042737|NCT00745849|100427857|FG001|STARTED|First Intervention||22||
48042738|NCT00745849|100427856|FG000|COMPLETED|First Intervention||20||
48042739|NCT00745849|100427857|FG001|COMPLETED|First Intervention||20||
48042740|NCT00745849|100427856|FG000|NOT COMPLETED|First Intervention||1||
48042741|NCT00745849|100427857|FG001|NOT COMPLETED|First Intervention||2||
48042742|NCT00745849|100427856|FG000|STARTED|Washout Period||20||
48042743|NCT00745849|100427857|FG001|STARTED|Washout Period||20||
48042744|NCT00745849|100427856|FG000|COMPLETED|Washout Period||20||
48042745|NCT00745849|100427857|FG001|COMPLETED|Washout Period||20||
48042746|NCT00745849|100427856|FG000|NOT COMPLETED|Washout Period||0||
48042747|NCT00745849|100427857|FG001|NOT COMPLETED|Washout Period||0||
48042748|NCT00745849|100427856|FG000|STARTED|Second Intervention||20||
48042749|NCT00745849|100427857|FG001|STARTED|Second Intervention||20||
48042750|NCT00745849|100427856|FG000|COMPLETED|Second Intervention||18||
48042751|NCT00745849|100427857|FG001|COMPLETED|Second Intervention||19||
48042752|NCT00745849|100427856|FG000|NOT COMPLETED|Second Intervention||2||
48042753|NCT00745849|100427857|FG001|NOT COMPLETED|Second Intervention||1||
48042754|NCT03104816|100427858|FG000|STARTED|Overall Study||11||
48042755|NCT03104816|100427859|FG001|STARTED|Overall Study||11||
48042756|NCT03104816|100427860|FG002|STARTED|Overall Study||6||
48042757|NCT03104816|100427858|FG000|COMPLETED|Overall Study||9||
48042758|NCT03104816|100427859|FG001|COMPLETED|Overall Study||9||
48042759|NCT03104816|100427860|FG002|COMPLETED|Overall Study||4||
48042760|NCT03104816|100427858|FG000|NOT COMPLETED|Overall Study||2||
48042761|NCT03104816|100427859|FG001|NOT COMPLETED|Overall Study||2||
48042762|NCT03104816|100427860|FG002|NOT COMPLETED|Overall Study||2||
48042763|NCT00321646|100427861|FG000|STARTED|Neoadjuvant Chemotherapy||42||
48042764|NCT00321646|100427861|FG000|COMPLETED|Neoadjuvant Chemotherapy||38||
48042765|NCT00321646|100427861|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||4||
48042766|NCT00321646|100427861|FG000|STARTED|Prostatectomy||37||
48042767|NCT00321646|100427861|FG000|COMPLETED|Prostatectomy||37||
48042768|NCT00321646|100427861|FG000|NOT COMPLETED|Prostatectomy||0||
48042769|NCT03985878|100427862|FG000|STARTED|Overall Study||15||
48042770|NCT03985878|100427862|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||15|Safety Set|
48042771|NCT03985878|100427862|FG000|COMPLETED|Overall Study||0||
48042772|NCT03985878|100427862|FG000|NOT COMPLETED|Overall Study||15||
48042773|NCT03207438|100427863|FG000|STARTED|Overall Study||167||
48204440|NCT02551055|100823730|FG003|STARTED|Overall Study||6||
48204441|NCT02551055|100823731|FG004|STARTED|Overall Study||7||
48204442|NCT02551055|100823732|FG005|STARTED|Overall Study||2||
48204443|NCT02551055|100823733|FG006|STARTED|Overall Study||4||
48204444|NCT02551055|100823734|FG007|STARTED|Overall Study||0||
48042774|NCT03207438|100427864|FG001|STARTED|Overall Study||166||
48042775|NCT03207438|100427865|FG002|STARTED|Overall Study||875||
48042776|NCT03207438|100427866|FG003|STARTED|Overall Study||582||
48042777|NCT03207438|100427863|FG000|COMPLETED|Overall Study||148||
48042778|NCT03207438|100427864|FG001|COMPLETED|Overall Study||145||
48204445|NCT02551055|100823727|FG000|COMPLETED|Overall Study||0||
48204446|NCT02551055|100823728|FG001|COMPLETED|Overall Study||0||
48204447|NCT02551055|100823729|FG002|COMPLETED|Overall Study||1||
48204448|NCT02551055|100823730|FG003|COMPLETED|Overall Study||1||
48204449|NCT02551055|100823731|FG004|COMPLETED|Overall Study||0||
48204450|NCT02551055|100823732|FG005|COMPLETED|Overall Study||1||
48204451|NCT02551055|100823733|FG006|COMPLETED|Overall Study||1||
48204452|NCT02551055|100823734|FG007|COMPLETED|Overall Study||0||
48204453|NCT02551055|100823727|FG000|NOT COMPLETED|Overall Study||4||
48204454|NCT02551055|100823728|FG001|NOT COMPLETED|Overall Study||6||
48204455|NCT02551055|100823729|FG002|NOT COMPLETED|Overall Study||2||
48204456|NCT02551055|100823730|FG003|NOT COMPLETED|Overall Study||5||
48204457|NCT02551055|100823731|FG004|NOT COMPLETED|Overall Study||7||
48204458|NCT02551055|100823732|FG005|NOT COMPLETED|Overall Study||1||
48204459|NCT02551055|100823733|FG006|NOT COMPLETED|Overall Study||3||
48204460|NCT02551055|100823734|FG007|NOT COMPLETED|Overall Study||0||
48204461|NCT00410124|100823735|FG000|STARTED|Core Phase Double Blind (15 Months)||277||
48204462|NCT00410124|100823736|FG001|STARTED|Core Phase Double Blind (15 Months)||139||
48204463|NCT00410124|100823735|FG000|Ongoing|Core Phase Double Blind (15 Months)||13||
48204464|NCT00410124|100823736|FG001|Ongoing|Core Phase Double Blind (15 Months)||4||
48204465|NCT00410124|100823735|FG000|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||62||
48204466|NCT00410124|100823736|FG001|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||2||
48495367|NCT03808376|101547833|FG000|STARTED|Overall Study||181||
48495368|NCT03808376|101547833|FG000|Received SBA Sensor|Overall Study||43||
48495369|NCT03808376|101547833|FG000|COMPLETED|Overall Study||171||
48495370|NCT03808376|101547833|FG000|NOT COMPLETED|Overall Study||10||
48495371|NCT00221299|101547834|FG000|STARTED|Overall Study||11||
48042779|NCT03207438|100427865|FG002|COMPLETED|Overall Study||643||
48042780|NCT03207438|100427866|FG003|COMPLETED|Overall Study||470||
48042781|NCT03207438|100427863|FG000|NOT COMPLETED|Overall Study||19||
48042782|NCT03207438|100427864|FG001|NOT COMPLETED|Overall Study||21||
48042783|NCT03207438|100427865|FG002|NOT COMPLETED|Overall Study||232||
48042784|NCT03207438|100427866|FG003|NOT COMPLETED|Overall Study||112||
48042785|NCT00475423|100427867|FG000|STARTED|Overall Study||122||
48042786|NCT00475423|100427867|FG000|COMPLETED|Overall Study||90||
48042787|NCT00475423|100427867|FG000|NOT COMPLETED|Overall Study||32||
48042788|NCT01589770|100427868|FG000|STARTED|Overall Study||67||
48042789|NCT01589770|100427869|FG001|STARTED|Overall Study||61||
48042790|NCT01589770|100427868|FG000|COMPLETED|Overall Study||59||
48042791|NCT01589770|100427869|FG001|COMPLETED|Overall Study||56||
48042792|NCT01589770|100427868|FG000|NOT COMPLETED|Overall Study||8||
48042793|NCT01589770|100427869|FG001|NOT COMPLETED|Overall Study||5||
48042794|NCT02656680|100427870|FG000|STARTED|Overall Study||40||
48042795|NCT02656680|100427871|FG001|STARTED|Overall Study||40||
48042796|NCT02656680|100427872|FG002|STARTED|Overall Study||54||
48042797|NCT02656680|100427870|FG000|COMPLETED|Overall Study||40||
48042798|NCT02656680|100427871|FG001|COMPLETED|Overall Study||39||
48042799|NCT02656680|100427872|FG002|COMPLETED|Overall Study||47||
48042800|NCT02656680|100427870|FG000|NOT COMPLETED|Overall Study||0||
48042801|NCT02656680|100427871|FG001|NOT COMPLETED|Overall Study||1||
48042802|NCT02656680|100427872|FG002|NOT COMPLETED|Overall Study||7||
48042803|NCT03400956|100427873|FG000|STARTED|Treatment Period 1||35|Allocated|
48042804|NCT03400956|100427874|FG001|STARTED|Treatment Period 1||34|Allocated|
48042805|NCT03400956|100427875|FG002|STARTED|Treatment Period 1||34|Allocated|
48204467|NCT00410124|100823735|FG000|COMPLETED|Core Phase Double Blind (15 Months)||75||
48204468|NCT00410124|100823736|FG001|COMPLETED|Core Phase Double Blind (15 Months)||6||
48204469|NCT00410124|100823735|FG000|NOT COMPLETED|Core Phase Double Blind (15 Months)||202||
48204470|NCT00410124|100823736|FG001|NOT COMPLETED|Core Phase Double Blind (15 Months)||133||
48204471|NCT00410124|100823735|FG000|STARTED|Extension Phase - Open Label (45 Months)||67||
48204472|NCT00410124|100823736|FG001|STARTED|Extension Phase - Open Label (45 Months)||111||
48204473|NCT00410124|100823735|FG000|COMPLETED|Extension Phase - Open Label (45 Months)||0||
48204474|NCT00410124|100823736|FG001|COMPLETED|Extension Phase - Open Label (45 Months)||0||
48204475|NCT00410124|100823735|FG000|NOT COMPLETED|Extension Phase - Open Label (45 Months)||67||
48204476|NCT00410124|100823736|FG001|NOT COMPLETED|Extension Phase - Open Label (45 Months)||111||
48204477|NCT01883492|100823737|FG000|STARTED|Overall Study||75||
48204478|NCT01883492|100823738|FG001|STARTED|Overall Study||78||
48204479|NCT01883492|100823737|FG000|COMPLETED|Overall Study||62||
48204480|NCT01883492|100823738|FG001|COMPLETED|Overall Study||67||
48204481|NCT01883492|100823737|FG000|NOT COMPLETED|Overall Study||13||
48204482|NCT01883492|100823738|FG001|NOT COMPLETED|Overall Study||11||
48204483|NCT05340244|100823739|FG000|STARTED|Overall Study||8||
48204484|NCT05340244|100823739|FG000|COMPLETED|Overall Study||8||
48204485|NCT05340244|100823739|FG000|NOT COMPLETED|Overall Study||0||
48042806|NCT03400956|100427873|FG000|Treated|Treatment Period 1||31||
48042807|NCT03400956|100427874|FG001|Treated|Treatment Period 1||30||
48042808|NCT03400956|100427875|FG002|Treated|Treatment Period 1||30||
48042809|NCT03400956|100427873|FG000|FAS|Treatment Period 1||32|Full analysis set|
48204486|NCT00189202|100823740|FG000|STARTED|Overall Study||49||
48204487|NCT00189202|100823740|FG000|COMPLETED|Overall Study||44||
48204488|NCT00189202|100823740|FG000|NOT COMPLETED|Overall Study||5||
48204489|NCT00940537|100823741|FG000|STARTED|Overall Study||5||
48204490|NCT00940537|100823742|FG001|STARTED|Overall Study||9||
48204491|NCT00940537|100823741|FG000|COMPLETED|Overall Study||5||
48204492|NCT00940537|100823742|FG001|COMPLETED|Overall Study||9||
48204493|NCT00940537|100823741|FG000|NOT COMPLETED|Overall Study||0||
48204494|NCT00940537|100823742|FG001|NOT COMPLETED|Overall Study||0||
48204495|NCT03441360|100823743|FG000|STARTED|Overall Study||8||
48204496|NCT03441360|100823744|FG001|STARTED|Overall Study||8||
48204497|NCT03441360|100823745|FG002|STARTED|Overall Study||5||
48204498|NCT03441360|100823743|FG000|COMPLETED|Overall Study||0||
48204499|NCT03441360|100823744|FG001|COMPLETED|Overall Study||0||
48204500|NCT03441360|100823745|FG002|COMPLETED|Overall Study||0||
48204501|NCT03441360|100823743|FG000|NOT COMPLETED|Overall Study||8||
48204502|NCT03441360|100823744|FG001|NOT COMPLETED|Overall Study||8||
48204503|NCT03441360|100823745|FG002|NOT COMPLETED|Overall Study||5||
48204504|NCT03710564|100823746|FG000|STARTED|Overall Study||356|All randomized Participants|
48204505|NCT03710564|100823747|FG001|STARTED|Overall Study||179|All randomized Participants|
48204506|NCT03710564|100823746|FG000|COMPLETED|Overall Study||172||
48204507|NCT03710564|100823747|FG001|COMPLETED|Overall Study||86||
48204508|NCT03710564|100823746|FG000|NOT COMPLETED|Overall Study||184||
48204509|NCT03710564|100823747|FG001|NOT COMPLETED|Overall Study||93||
48204510|NCT02414204|100823748|FG000|STARTED|Overall Study||2||
48204511|NCT02414204|100823749|FG001|STARTED|Overall Study||2||
48204512|NCT02414204|100823748|FG000|COMPLETED|Overall Study||2||
48204513|NCT02414204|100823749|FG001|COMPLETED|Overall Study||2||
48204514|NCT02414204|100823748|FG000|NOT COMPLETED|Overall Study||0||
48204515|NCT02414204|100823749|FG001|NOT COMPLETED|Overall Study||0||
48204516|NCT01534910|100823750|FG000|STARTED|Overall Study||33||
48204517|NCT01534910|100823751|FG001|STARTED|Overall Study||32||
48204518|NCT01534910|100823750|FG000|COMPLETED|Overall Study||29||
48204519|NCT01534910|100823751|FG001|COMPLETED|Overall Study||28||
48204520|NCT01534910|100823750|FG000|NOT COMPLETED|Overall Study||4||
48204521|NCT01534910|100823751|FG001|NOT COMPLETED|Overall Study||4||
48204522|NCT00346151|100823752|FG000|STARTED|Overall Study||5||
48204523|NCT00346151|100823752|FG000|COMPLETED|Overall Study||2||
48204524|NCT00346151|100823752|FG000|NOT COMPLETED|Overall Study||3||
48204525|NCT01456936|100823753|FG000|STARTED|Overall Study||2037||
48204526|NCT01456936|100823754|FG001|STARTED|Overall Study||2034||
48204527|NCT01456936|100823755|FG002|STARTED|Overall Study||2038||
48204528|NCT01456936|100823756|FG003|STARTED|Overall Study||2035||
48204529|NCT01456936|100823753|FG000|Randomized and Treated|Overall Study||2016||
48204530|NCT01456936|100823754|FG001|Randomized and Treated|Overall Study||2006||
48204531|NCT01456936|100823755|FG002|Randomized and Treated|Overall Study||2022||
48204532|NCT01456936|100823756|FG003|Randomized and Treated|Overall Study||2014||
48204533|NCT01456936|100823753|FG000|COMPLETED|Overall Study||1598||
48204534|NCT01456936|100823754|FG001|COMPLETED|Overall Study||1586||
48204535|NCT01456936|100823755|FG002|COMPLETED|Overall Study||1557||
48204536|NCT01456936|100823756|FG003|COMPLETED|Overall Study||1552||
48204537|NCT01456936|100823753|FG000|NOT COMPLETED|Overall Study||439||
48204538|NCT01456936|100823754|FG001|NOT COMPLETED|Overall Study||448||
48204539|NCT01456936|100823755|FG002|NOT COMPLETED|Overall Study||481||
48042810|NCT03400956|100427874|FG001|FAS|Treatment Period 1||33|Full analysis set|
48042811|NCT03400956|100427875|FG002|FAS|Treatment Period 1||31|Full analysis set|
48042812|NCT03400956|100427873|FG000|COMPLETED|Treatment Period 1||31||
48042813|NCT03400956|100427874|FG001|COMPLETED|Treatment Period 1||26||
48042814|NCT03400956|100427875|FG002|COMPLETED|Treatment Period 1||25||
48042815|NCT03400956|100427873|FG000|NOT COMPLETED|Treatment Period 1||4||
48042816|NCT03400956|100427874|FG001|NOT COMPLETED|Treatment Period 1||8||
48042817|NCT03400956|100427875|FG002|NOT COMPLETED|Treatment Period 1||9||
48042818|NCT03400956|100427873|FG000|STARTED|Post-treatment Period 1||31||
48042819|NCT03400956|100427874|FG001|STARTED|Post-treatment Period 1||26||
48042820|NCT03400956|100427875|FG002|STARTED|Post-treatment Period 1||25||
48042821|NCT03400956|100427873|FG000|COMPLETED|Post-treatment Period 1||9||
48042822|NCT03400956|100427874|FG001|COMPLETED|Post-treatment Period 1||10||
48042823|NCT03400956|100427875|FG002|COMPLETED|Post-treatment Period 1||9||
48204540|NCT01456936|100823756|FG003|NOT COMPLETED|Overall Study||483||
48204541|NCT03720990|100823757|FG000|STARTED|Overall Study||12||
48204542|NCT03720990|100823757|FG000|COMPLETED|Overall Study||12||
48204543|NCT03720990|100823757|FG000|NOT COMPLETED|Overall Study||0||
48204544|NCT00414648|100823758|FG000|STARTED|Overall Study||46||
48204545|NCT00414648|100823759|FG001|STARTED|Overall Study||43||
48042824|NCT03400956|100427873|FG000|NOT COMPLETED|Post-treatment Period 1||22||
48204546|NCT00414648|100823758|FG000|COMPLETED|Overall Study||41||
48204547|NCT00414648|100823759|FG001|COMPLETED|Overall Study||34||
48204548|NCT00414648|100823758|FG000|NOT COMPLETED|Overall Study||5||
48204549|NCT00414648|100823759|FG001|NOT COMPLETED|Overall Study||9||
48204550|NCT00042224|100823760|FG000|STARTED|Overall Study||20||
48204551|NCT00042224|100823761|FG001|STARTED|Overall Study||19||
48204552|NCT00042224|100823760|FG000|COMPLETED|Overall Study||17||
48204553|NCT00042224|100823761|FG001|COMPLETED|Overall Study||16||
48204554|NCT00042224|100823760|FG000|NOT COMPLETED|Overall Study||3||
48204555|NCT00042224|100823761|FG001|NOT COMPLETED|Overall Study||3||
48204556|NCT02104765|100823762|FG000|STARTED|Overall Study||8||
48204557|NCT02104765|100823763|FG001|STARTED|Overall Study||6||
48204558|NCT02104765|100823764|FG002|STARTED|Overall Study||6||
48204559|NCT02104765|100823765|FG003|STARTED|Overall Study||7||
48204560|NCT02104765|100823766|FG004|STARTED|Overall Study||8||
48204561|NCT02104765|100823767|FG005|STARTED|Overall Study||2||
48204562|NCT02104765|100823768|FG006|STARTED|Overall Study||8||
48204563|NCT02104765|100823762|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8||
48204564|NCT02104765|100823763|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
48204565|NCT02104765|100823764|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
48204566|NCT02104765|100823765|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7||
48204567|NCT02104765|100823766|FG004|Received at Least 1 Dose of Study Drug|Overall Study||8||
48204568|NCT02104765|100823767|FG005|Received at Least 1 Dose of Study Drug|Overall Study||2||
48204569|NCT02104765|100823768|FG006|Received at Least 1 Dose of Study Drug|Overall Study||8||
48204570|NCT02104765|100823762|FG000|COMPLETED|Overall Study||8||
48204571|NCT02104765|100823763|FG001|COMPLETED|Overall Study||6||
48204572|NCT02104765|100823764|FG002|COMPLETED|Overall Study||5||
48204573|NCT02104765|100823765|FG003|COMPLETED|Overall Study||6||
48204574|NCT02104765|100823766|FG004|COMPLETED|Overall Study||7||
48204575|NCT02104765|100823767|FG005|COMPLETED|Overall Study||2||
48204576|NCT02104765|100823768|FG006|COMPLETED|Overall Study||7||
48204577|NCT02104765|100823762|FG000|NOT COMPLETED|Overall Study||0||
48204578|NCT02104765|100823763|FG001|NOT COMPLETED|Overall Study||0||
48204579|NCT02104765|100823764|FG002|NOT COMPLETED|Overall Study||1||
48204580|NCT02104765|100823765|FG003|NOT COMPLETED|Overall Study||1||
48204581|NCT02104765|100823766|FG004|NOT COMPLETED|Overall Study||1||
48204582|NCT02104765|100823767|FG005|NOT COMPLETED|Overall Study||0||
48204583|NCT02104765|100823768|FG006|NOT COMPLETED|Overall Study||1||
48204584|NCT01050569|100823769|FG000|STARTED|Overall Study||79||
48204585|NCT01050569|100823770|FG001|STARTED|Overall Study||76||
48204586|NCT01050569|100823771|FG002|STARTED|Overall Study||80||
48204587|NCT01050569|100823769|FG000|COMPLETED|Overall Study||41||
48204588|NCT01050569|100823770|FG001|COMPLETED|Overall Study||52||
48204589|NCT01050569|100823771|FG002|COMPLETED|Overall Study||47||
48204590|NCT01050569|100823769|FG000|NOT COMPLETED|Overall Study||38||
48204591|NCT01050569|100823770|FG001|NOT COMPLETED|Overall Study||24||
48204592|NCT01050569|100823771|FG002|NOT COMPLETED|Overall Study||33||
48204593|NCT01140048|100823772|FG000|STARTED|Overall Study||343||
48204594|NCT01140048|100823772|FG000|COMPLETED|Overall Study||298||
48204595|NCT01140048|100823772|FG000|NOT COMPLETED|Overall Study||45||
48204596|NCT02698891|100823773|FG000|STARTED|Overall Study||127||
48204597|NCT02698891|100823773|FG000|Treated|Overall Study||125||
48204598|NCT02698891|100823773|FG000|COMPLETED|Overall Study||115||
48204599|NCT02698891|100823773|FG000|NOT COMPLETED|Overall Study||12||
48204600|NCT00842257|100827303|FG000|STARTED|Overall Study||20||
48204601|NCT00842257|100827303|FG000|COMPLETED|Overall Study||19||
48204602|NCT00842257|100827303|FG000|NOT COMPLETED|Overall Study||1||
48204603|NCT01025843|100827304|FG000|STARTED|Period 1||2||
48204604|NCT01025843|100827305|FG001|STARTED|Period 1||2||
48204605|NCT01025843|100827306|FG002|STARTED|Period 1||2||
48204606|NCT01025843|100827307|FG003|STARTED|Period 1||2||
48204607|NCT01025843|100827308|FG004|STARTED|Period 1||2||
48204608|NCT01025843|100827309|FG005|STARTED|Period 1||2||
48204609|NCT01025843|100827310|FG006|STARTED|Period 1||2||
48204610|NCT01025843|100827311|FG007|STARTED|Period 1||2||
48204611|NCT01025843|100827312|FG008|STARTED|Period 1||2||
48204612|NCT01025843|100827313|FG009|STARTED|Period 1||2||
48204613|NCT01025843|100827304|FG000|COMPLETED|Period 1||2||
48204614|NCT01025843|100827305|FG001|COMPLETED|Period 1||2||
48204615|NCT01025843|100827306|FG002|COMPLETED|Period 1||2||
48204616|NCT01025843|100827307|FG003|COMPLETED|Period 1||2||
48204617|NCT01025843|100827308|FG004|COMPLETED|Period 1||2||
48204618|NCT01025843|100827309|FG005|COMPLETED|Period 1||2||
48204619|NCT01025843|100827310|FG006|COMPLETED|Period 1||2||
48204620|NCT01025843|100827311|FG007|COMPLETED|Period 1||2||
48204621|NCT01025843|100827312|FG008|COMPLETED|Period 1||2||
48204622|NCT01025843|100827313|FG009|COMPLETED|Period 1||2||
48495372|NCT00221299|101547835|FG001|STARTED|Overall Study||13||
48495373|NCT00221299|101547836|FG002|STARTED|Overall Study||14||
48204623|NCT01025843|100827304|FG000|NOT COMPLETED|Period 1||0||
48204624|NCT01025843|100827305|FG001|NOT COMPLETED|Period 1||0||
48204625|NCT01025843|100827306|FG002|NOT COMPLETED|Period 1||0||
48204626|NCT01025843|100827307|FG003|NOT COMPLETED|Period 1||0||
48204627|NCT01025843|100827308|FG004|NOT COMPLETED|Period 1||0||
48204628|NCT01025843|100827309|FG005|NOT COMPLETED|Period 1||0||
48204629|NCT01025843|100827310|FG006|NOT COMPLETED|Period 1||0||
48204630|NCT01025843|100827311|FG007|NOT COMPLETED|Period 1||0||
48204631|NCT01025843|100827312|FG008|NOT COMPLETED|Period 1||0||
48204632|NCT01025843|100827313|FG009|NOT COMPLETED|Period 1||0||
48204633|NCT01025843|100827304|FG000|STARTED|Washout 1||2||
48204634|NCT01025843|100827305|FG001|STARTED|Washout 1||2||
48204635|NCT01025843|100827306|FG002|STARTED|Washout 1||2||
48204636|NCT01025843|100827307|FG003|STARTED|Washout 1||2||
48204637|NCT01025843|100827308|FG004|STARTED|Washout 1||2||
48204638|NCT01025843|100827309|FG005|STARTED|Washout 1||2||
48204639|NCT01025843|100827310|FG006|STARTED|Washout 1||2||
48204640|NCT01025843|100827311|FG007|STARTED|Washout 1||2||
48204641|NCT01025843|100827312|FG008|STARTED|Washout 1||2||
48204642|NCT01025843|100827313|FG009|STARTED|Washout 1||2||
48204643|NCT01025843|100827304|FG000|COMPLETED|Washout 1||2||
48204644|NCT01025843|100827305|FG001|COMPLETED|Washout 1||2||
48204645|NCT01025843|100827306|FG002|COMPLETED|Washout 1||2||
48204646|NCT01025843|100827307|FG003|COMPLETED|Washout 1||2||
48204647|NCT01025843|100827308|FG004|COMPLETED|Washout 1||2||
48204648|NCT01025843|100827309|FG005|COMPLETED|Washout 1||2||
48204649|NCT01025843|100827310|FG006|COMPLETED|Washout 1||2||
48204650|NCT01025843|100827311|FG007|COMPLETED|Washout 1||2||
48204651|NCT01025843|100827312|FG008|COMPLETED|Washout 1||2||
48204652|NCT01025843|100827313|FG009|COMPLETED|Washout 1||2||
48204653|NCT01025843|100827304|FG000|NOT COMPLETED|Washout 1||0||
48204654|NCT01025843|100827305|FG001|NOT COMPLETED|Washout 1||0||
48204655|NCT01025843|100827306|FG002|NOT COMPLETED|Washout 1||0||
48204656|NCT01025843|100827307|FG003|NOT COMPLETED|Washout 1||0||
48204657|NCT01025843|100827308|FG004|NOT COMPLETED|Washout 1||0||
48204658|NCT01025843|100827309|FG005|NOT COMPLETED|Washout 1||0||
48204659|NCT01025843|100827310|FG006|NOT COMPLETED|Washout 1||0||
48204660|NCT01025843|100827311|FG007|NOT COMPLETED|Washout 1||0||
48204661|NCT01025843|100827312|FG008|NOT COMPLETED|Washout 1||0||
48204662|NCT01025843|100827313|FG009|NOT COMPLETED|Washout 1||0||
48204663|NCT01025843|100827304|FG000|STARTED|Period 2||2||
48204664|NCT01025843|100827305|FG001|STARTED|Period 2||2||
48204665|NCT01025843|100827306|FG002|STARTED|Period 2||2||
48204666|NCT01025843|100827307|FG003|STARTED|Period 2||2||
48204667|NCT01025843|100827308|FG004|STARTED|Period 2||2||
48204668|NCT01025843|100827309|FG005|STARTED|Period 2||2||
48204669|NCT01025843|100827310|FG006|STARTED|Period 2||2||
48204670|NCT01025843|100827311|FG007|STARTED|Period 2||2||
48204671|NCT01025843|100827312|FG008|STARTED|Period 2||2||
48204672|NCT01025843|100827313|FG009|STARTED|Period 2||2||
48204673|NCT01025843|100827304|FG000|COMPLETED|Period 2||2||
48204674|NCT01025843|100827305|FG001|COMPLETED|Period 2||2||
48204675|NCT01025843|100827306|FG002|COMPLETED|Period 2||2||
48204676|NCT01025843|100827307|FG003|COMPLETED|Period 2||2||
48204677|NCT01025843|100827308|FG004|COMPLETED|Period 2||2||
48204678|NCT01025843|100827309|FG005|COMPLETED|Period 2||2||
48204679|NCT01025843|100827310|FG006|COMPLETED|Period 2||2||
48204680|NCT01025843|100827311|FG007|COMPLETED|Period 2||2||
48204681|NCT01025843|100827312|FG008|COMPLETED|Period 2||2||
48204682|NCT01025843|100827313|FG009|COMPLETED|Period 2||2||
48204683|NCT01025843|100827304|FG000|NOT COMPLETED|Period 2||0||
48204684|NCT01025843|100827305|FG001|NOT COMPLETED|Period 2||0||
48204685|NCT01025843|100827306|FG002|NOT COMPLETED|Period 2||0||
48204686|NCT01025843|100827307|FG003|NOT COMPLETED|Period 2||0||
48204687|NCT01025843|100827308|FG004|NOT COMPLETED|Period 2||0||
48204688|NCT01025843|100827309|FG005|NOT COMPLETED|Period 2||0||
48204689|NCT01025843|100827310|FG006|NOT COMPLETED|Period 2||0||
48204690|NCT01025843|100827311|FG007|NOT COMPLETED|Period 2||0||
48204691|NCT01025843|100827312|FG008|NOT COMPLETED|Period 2||0||
48204692|NCT01025843|100827313|FG009|NOT COMPLETED|Period 2||0||
48204693|NCT01025843|100827304|FG000|STARTED|Washout 2||2||
48204694|NCT01025843|100827305|FG001|STARTED|Washout 2||2||
48204695|NCT01025843|100827306|FG002|STARTED|Washout 2||2||
48204696|NCT01025843|100827307|FG003|STARTED|Washout 2||2||
48204697|NCT01025843|100827308|FG004|STARTED|Washout 2||2||
48204698|NCT01025843|100827309|FG005|STARTED|Washout 2||2||
48204699|NCT01025843|100827310|FG006|STARTED|Washout 2||2||
48204700|NCT01025843|100827311|FG007|STARTED|Washout 2||2||
48204701|NCT01025843|100827312|FG008|STARTED|Washout 2||2||
48204702|NCT01025843|100827313|FG009|STARTED|Washout 2||2||
48204703|NCT01025843|100827304|FG000|COMPLETED|Washout 2||2||
48204704|NCT01025843|100827305|FG001|COMPLETED|Washout 2||2||
48204705|NCT01025843|100827306|FG002|COMPLETED|Washout 2||2||
48204706|NCT01025843|100827307|FG003|COMPLETED|Washout 2||2||
48204707|NCT01025843|100827308|FG004|COMPLETED|Washout 2||2||
48204708|NCT01025843|100827309|FG005|COMPLETED|Washout 2||2||
48204709|NCT01025843|100827310|FG006|COMPLETED|Washout 2||2||
48204710|NCT01025843|100827311|FG007|COMPLETED|Washout 2||2||
48204711|NCT01025843|100827312|FG008|COMPLETED|Washout 2||2||
48204712|NCT01025843|100827313|FG009|COMPLETED|Washout 2||2||
48204713|NCT01025843|100827304|FG000|NOT COMPLETED|Washout 2||0||
48204714|NCT01025843|100827305|FG001|NOT COMPLETED|Washout 2||0||
48204715|NCT01025843|100827306|FG002|NOT COMPLETED|Washout 2||0||
48204716|NCT01025843|100827307|FG003|NOT COMPLETED|Washout 2||0||
48204717|NCT01025843|100827308|FG004|NOT COMPLETED|Washout 2||0||
48204718|NCT01025843|100827309|FG005|NOT COMPLETED|Washout 2||0||
48204719|NCT01025843|100827310|FG006|NOT COMPLETED|Washout 2||0||
48204720|NCT01025843|100827311|FG007|NOT COMPLETED|Washout 2||0||
48204721|NCT01025843|100827312|FG008|NOT COMPLETED|Washout 2||0||
48204722|NCT01025843|100827313|FG009|NOT COMPLETED|Washout 2||0||
48204723|NCT01025843|100827304|FG000|STARTED|Period 3||2||
48204724|NCT01025843|100827305|FG001|STARTED|Period 3||2||
48204725|NCT01025843|100827306|FG002|STARTED|Period 3||2||
48204726|NCT01025843|100827307|FG003|STARTED|Period 3||2||
48204727|NCT01025843|100827308|FG004|STARTED|Period 3||2||
48204728|NCT01025843|100827309|FG005|STARTED|Period 3||2||
48204729|NCT01025843|100827310|FG006|STARTED|Period 3||2||
48042825|NCT03400956|100427874|FG001|NOT COMPLETED|Post-treatment Period 1||16||
48042826|NCT03400956|100427875|FG002|NOT COMPLETED|Post-treatment Period 1||16||
48042827|NCT03400956|100427873|FG000|STARTED|Treatment Period 2||9|Treatment started|
48042828|NCT03400956|100427874|FG001|STARTED|Treatment Period 2||10|Treatment started|
48042829|NCT03400956|100427875|FG002|STARTED|Treatment Period 2||9|Treatment started|
48042830|NCT03400956|100427873|FG000|COMPLETED|Treatment Period 2||5||
48042831|NCT03400956|100427874|FG001|COMPLETED|Treatment Period 2||7||
48042832|NCT03400956|100427875|FG002|COMPLETED|Treatment Period 2||5||
48042833|NCT03400956|100427873|FG000|NOT COMPLETED|Treatment Period 2||4||
48042834|NCT03400956|100427874|FG001|NOT COMPLETED|Treatment Period 2||3||
48042835|NCT03400956|100427875|FG002|NOT COMPLETED|Treatment Period 2||4||
48042836|NCT03400956|100427873|FG000|STARTED|Follow-up Period||6||
48042837|NCT03400956|100427874|FG001|STARTED|Follow-up Period||9||
48042838|NCT03400956|100427875|FG002|STARTED|Follow-up Period||7||
48042839|NCT03400956|100427873|FG000|COMPLETED|Follow-up Period||6||
48042840|NCT03400956|100427874|FG001|COMPLETED|Follow-up Period||9||
48042841|NCT03400956|100427875|FG002|COMPLETED|Follow-up Period||5||
48042842|NCT03400956|100427873|FG000|NOT COMPLETED|Follow-up Period||0||
48042843|NCT03400956|100427874|FG001|NOT COMPLETED|Follow-up Period||0||
48042844|NCT03400956|100427875|FG002|NOT COMPLETED|Follow-up Period||2||
48042845|NCT03911843|100427876|FG000|STARTED|Overall Study||26||
48042846|NCT03911843|100427877|FG001|STARTED|Overall Study||38||
48042847|NCT03911843|100427876|FG000|COMPLETED|Overall Study||22||
48042848|NCT03911843|100427877|FG001|COMPLETED|Overall Study||37||
48042849|NCT03911843|100427876|FG000|NOT COMPLETED|Overall Study||4||
48042850|NCT03911843|100427877|FG001|NOT COMPLETED|Overall Study||1||
48042851|NCT02241889|100427878|FG000|STARTED|Overall Study||4||
48042852|NCT02241889|100427879|FG001|STARTED|Overall Study||4||
48042853|NCT02241889|100427880|FG002|STARTED|Overall Study||3||
48042854|NCT02241889|100427881|FG003|STARTED|Overall Study||3||
48042855|NCT02241889|100427882|FG004|STARTED|Overall Study||5||
48042856|NCT02241889|100427883|FG005|STARTED|Overall Study||4||
48042857|NCT02241889|100427878|FG000|COMPLETED|Overall Study||4||
48042858|NCT02241889|100427879|FG001|COMPLETED|Overall Study||4||
48042859|NCT02241889|100427880|FG002|COMPLETED|Overall Study||2||
48042860|NCT02241889|100427881|FG003|COMPLETED|Overall Study||3||
48042861|NCT02241889|100427882|FG004|COMPLETED|Overall Study||5||
48042862|NCT02241889|100427883|FG005|COMPLETED|Overall Study||3||
48042863|NCT02241889|100427878|FG000|NOT COMPLETED|Overall Study||0||
48042864|NCT02241889|100427879|FG001|NOT COMPLETED|Overall Study||0||
48042865|NCT02241889|100427880|FG002|NOT COMPLETED|Overall Study||1||
48042866|NCT02241889|100427881|FG003|NOT COMPLETED|Overall Study||0||
48042867|NCT02241889|100427882|FG004|NOT COMPLETED|Overall Study||0||
48042868|NCT02241889|100427883|FG005|NOT COMPLETED|Overall Study||1||
48042869|NCT03709576|100427884|FG000|STARTED|Overall Study||3||
48042870|NCT03709576|100427884|FG000|COMPLETED|Overall Study||2||
48042871|NCT03709576|100427884|FG000|NOT COMPLETED|Overall Study||1||
48042872|NCT02545543|100427885|FG000|STARTED|Overall Study||1709||
48042873|NCT02545543|100427886|FG001|STARTED|Overall Study||569||
48042874|NCT02545543|100427885|FG000|COMPLETED|Overall Study||1628||
48042875|NCT02545543|100427886|FG001|COMPLETED|Overall Study||535||
48042876|NCT02545543|100427885|FG000|NOT COMPLETED|Overall Study||81||
48042877|NCT02545543|100427886|FG001|NOT COMPLETED|Overall Study||34||
48042878|NCT01715129|100427887|FG000|STARTED|Overall Study||126||
48042879|NCT01715129|100427887|FG000|COMPLETED|Overall Study||117||
48042880|NCT01715129|100427887|FG000|NOT COMPLETED|Overall Study||9||
48042881|NCT00567255|100427888|FG000|STARTED|Overall Study||1001||
48042882|NCT00567255|100427889|FG001|STARTED|Overall Study||495||
48042883|NCT00567255|100427888|FG000|COMPLETED|Overall Study||538||
48042884|NCT00567255|100427889|FG001|COMPLETED|Overall Study||267||
48042885|NCT00567255|100427888|FG000|NOT COMPLETED|Overall Study||463||
48042886|NCT00567255|100427889|FG001|NOT COMPLETED|Overall Study||228||
48042887|NCT01233518|100427890|FG000|STARTED|Overall Study||285||
48042888|NCT01233518|100427890|FG000|COMPLETED|Overall Study||252||
48042889|NCT01233518|100427890|FG000|NOT COMPLETED|Overall Study||33||
48042890|NCT05347147|100427891|FG000|STARTED|Overall Study||8||
48042891|NCT05347147|100427892|FG001|STARTED|Overall Study||6||
48204730|NCT01025843|100827311|FG007|STARTED|Period 3||2||
48495374|NCT00221299|101547837|FG003|STARTED|Overall Study||11||
48204731|NCT01025843|100827312|FG008|STARTED|Period 3||2||
48042892|NCT05347147|100427891|FG000|COMPLETED|Overall Study||3||
48204732|NCT01025843|100827313|FG009|STARTED|Period 3||2||
48042893|NCT05347147|100427892|FG001|COMPLETED|Overall Study||1||
48042894|NCT05347147|100427891|FG000|NOT COMPLETED|Overall Study||5||
48042895|NCT05347147|100427892|FG001|NOT COMPLETED|Overall Study||5||
48042896|NCT01658813|100427893|FG000|STARTED|Overall Study||18||
48042897|NCT01658813|100427893|FG000|Eligible|Overall Study||18||
48042898|NCT01658813|100427893|FG000|Treated|Overall Study||18||
48042899|NCT01658813|100427893|FG000|COMPLETED|Overall Study||15||
48042900|NCT01658813|100427893|FG000|NOT COMPLETED|Overall Study||3||
48042901|NCT03769376|100427894|FG000|STARTED|Overall Study||20||
48042902|NCT03769376|100427895|FG001|STARTED|Overall Study||18||
48042903|NCT03769376|100427894|FG000|COMPLETED|Overall Study||13||
48042904|NCT03769376|100427895|FG001|COMPLETED|Overall Study||11||
48204733|NCT01025843|100827304|FG000|COMPLETED|Period 3||2||
48042905|NCT03769376|100427894|FG000|NOT COMPLETED|Overall Study||7||
48042906|NCT03769376|100427895|FG001|NOT COMPLETED|Overall Study||7||
48042907|NCT01943474|100427896|FG000|STARTED|Overall Study||123||
48042908|NCT01943474|100427897|FG001|STARTED|Overall Study||125||
48042909|NCT01943474|100427896|FG000|COMPLETED|Overall Study||123||
48042910|NCT01943474|100427897|FG001|COMPLETED|Overall Study||125||
48042911|NCT01943474|100427896|FG000|NOT COMPLETED|Overall Study||0||
48042912|NCT01943474|100427897|FG001|NOT COMPLETED|Overall Study||0||
48042913|NCT00654147|100427898|FG000|STARTED|Overall Study||21||
48042914|NCT00654147|100427899|FG001|STARTED|Overall Study||23||
48042915|NCT00654147|100427898|FG000|COMPLETED|Overall Study||19||
48042916|NCT00654147|100427899|FG001|COMPLETED|Overall Study||19||
48042917|NCT00654147|100427898|FG000|NOT COMPLETED|Overall Study||2||
48042918|NCT00654147|100427899|FG001|NOT COMPLETED|Overall Study||4||
48042919|NCT01073462|100427900|FG000|STARTED|Overall Study||67||
48042920|NCT01073462|100427900|FG000|COMPLETED|Overall Study||26||
48042921|NCT01073462|100427900|FG000|NOT COMPLETED|Overall Study||41||
48042922|NCT02882152|100427901|FG000|STARTED|Overall Study||20||
48042923|NCT02882152|100427902|FG001|STARTED|Overall Study||20||
48042924|NCT02882152|100427901|FG000|COMPLETED|Overall Study||19||
48042925|NCT02882152|100427902|FG001|COMPLETED|Overall Study||20||
48042926|NCT02882152|100427901|FG000|NOT COMPLETED|Overall Study||1||
48042927|NCT02882152|100427902|FG001|NOT COMPLETED|Overall Study||0||
48042928|NCT00729846|100427903|FG000|STARTED|Overall Study||11||
48042929|NCT00729846|100427904|FG001|STARTED|Overall Study||11||
48042930|NCT00729846|100427903|FG000|COMPLETED|Overall Study||11||
48042931|NCT00729846|100427904|FG001|COMPLETED|Overall Study||11||
48042932|NCT00729846|100427903|FG000|NOT COMPLETED|Overall Study||0||
48042933|NCT00729846|100427904|FG001|NOT COMPLETED|Overall Study||0||
48042934|NCT00178503|100427905|FG000|STARTED|MPH Trial: Placebo||24||
48042935|NCT00178503|100427905|FG000|COMPLETED|MPH Trial: Placebo||24||
48042936|NCT00178503|100427905|FG000|NOT COMPLETED|MPH Trial: Placebo||0||
48042937|NCT00178503|100427905|FG000|STARTED|MPH Trial: Low Dose||24||
48042938|NCT00178503|100427905|FG000|COMPLETED|MPH Trial: Low Dose||24||
48042939|NCT00178503|100427905|FG000|NOT COMPLETED|MPH Trial: Low Dose||0||
48042940|NCT00178503|100427905|FG000|STARTED|MPH Trial: Med Dose||24||
48042941|NCT00178503|100427905|FG000|COMPLETED|MPH Trial: Med Dose||24||
48042942|NCT00178503|100427905|FG000|NOT COMPLETED|MPH Trial: Med Dose||0||
48042943|NCT00178503|100427905|FG000|STARTED|MPH Trial: High Dose||24||
48042944|NCT00178503|100427905|FG000|COMPLETED|MPH Trial: High Dose||24||
48042945|NCT00178503|100427905|FG000|NOT COMPLETED|MPH Trial: High Dose||0||
48042946|NCT02373371|100427906|FG000|STARTED|Overall Study||13||
48042947|NCT02373371|100427907|FG001|STARTED|Overall Study||13||
48042948|NCT02373371|100427906|FG000|COMPLETED|Overall Study||13||
48042949|NCT02373371|100427907|FG001|COMPLETED|Overall Study||13||
48042950|NCT02373371|100427906|FG000|NOT COMPLETED|Overall Study||0||
48042951|NCT02373371|100427907|FG001|NOT COMPLETED|Overall Study||0||
48042952|NCT03739242|100427908|FG000|STARTED|Overall Study||44||
48042953|NCT03739242|100427909|FG001|STARTED|Overall Study||44||
48042954|NCT03739242|100427908|FG000|COMPLETED|Overall Study||43||
48042955|NCT03739242|100427909|FG001|COMPLETED|Overall Study||42||
48042956|NCT03739242|100427908|FG000|NOT COMPLETED|Overall Study||1||
48042957|NCT03739242|100427909|FG001|NOT COMPLETED|Overall Study||2||
48042958|NCT00130247|100427910|FG000|STARTED|Overall Study||196||
48042959|NCT00130247|100427911|FG001|STARTED|Overall Study||198||
48042960|NCT00130247|100427910|FG000|COMPLETED|Overall Study||194||
48042961|NCT00130247|100427911|FG001|COMPLETED|Overall Study||194||
48042962|NCT00130247|100427910|FG000|NOT COMPLETED|Overall Study||2||
48042963|NCT00130247|100427911|FG001|NOT COMPLETED|Overall Study||4||
48042964|NCT03029884|100427912|FG000|STARTED|Inactive DBS Run in Period (6 Months)||4||
48042965|NCT03029884|100427912|FG000|COMPLETED|Inactive DBS Run in Period (6 Months)||4||
48042966|NCT03029884|100427912|FG000|NOT COMPLETED|Inactive DBS Run in Period (6 Months)||0||
48042967|NCT03029884|100427912|FG000|STARTED|Open-Loop DBS (6 Weeks)||4||
48042968|NCT03029884|100427912|FG000|COMPLETED|Open-Loop DBS (6 Weeks)||4||
48495375|NCT00221299|101547834|FG000|COMPLETED|Overall Study||10||
48042969|NCT03029884|100427912|FG000|NOT COMPLETED|Open-Loop DBS (6 Weeks)||0||
48042970|NCT03029884|100427912|FG000|STARTED|Closed-Loop DBS (6 Weeks)||4||
48042971|NCT03029884|100427912|FG000|COMPLETED|Closed-Loop DBS (6 Weeks)||4||
48042972|NCT03029884|100427912|FG000|NOT COMPLETED|Closed-Loop DBS (6 Weeks)||0||
48042973|NCT03029884|100427912|FG000|STARTED|Sham DBS (3 Weeks)||4||
48042974|NCT03029884|100427912|FG000|COMPLETED|Sham DBS (3 Weeks)||4||
48042975|NCT03029884|100427912|FG000|NOT COMPLETED|Sham DBS (3 Weeks)||0||
48042976|NCT02700334|100427913|FG000|STARTED|Overall Study||12||
48042977|NCT02700334|100427914|FG001|STARTED|Overall Study||12||
48042978|NCT02700334|100427913|FG000|COMPLETED|Overall Study||12||
48042979|NCT02700334|100427914|FG001|COMPLETED|Overall Study||12||
48042980|NCT02700334|100427913|FG000|NOT COMPLETED|Overall Study||0||
48042981|NCT02700334|100427914|FG001|NOT COMPLETED|Overall Study||0||
48042982|NCT02635646|100427915|FG000|STARTED|Overall Study||57||
48042983|NCT02635646|100427916|FG001|STARTED|Overall Study||65||
48042984|NCT02635646|100427915|FG000|COMPLETED|Overall Study||32||
48042985|NCT02635646|100427916|FG001|COMPLETED|Overall Study||39||
48042986|NCT02635646|100427915|FG000|NOT COMPLETED|Overall Study||25||
48042987|NCT02635646|100427916|FG001|NOT COMPLETED|Overall Study||26||
48042988|NCT04473235|100427917|FG000|STARTED|Overall Study||58||
48042989|NCT04473235|100427918|FG001|STARTED|Overall Study||50||
48042990|NCT04473235|100427917|FG000|COMPLETED|Overall Study||39||
48042991|NCT04473235|100427918|FG001|COMPLETED|Overall Study||38||
48042992|NCT04473235|100427917|FG000|NOT COMPLETED|Overall Study||19||
48042993|NCT04473235|100427918|FG001|NOT COMPLETED|Overall Study||12||
48042994|NCT02279407|100427919|FG000|STARTED|Overall Study||22||
48042995|NCT02279407|100427920|FG001|STARTED|Overall Study||21||
48042996|NCT02279407|100427921|FG002|STARTED|Overall Study||20||
48042997|NCT02279407|100427922|FG003|STARTED|Overall Study||21||
48042998|NCT02279407|100427919|FG000|COMPLETED|Overall Study||20||
48042999|NCT02279407|100427920|FG001|COMPLETED|Overall Study||20||
48043000|NCT02279407|100427921|FG002|COMPLETED|Overall Study||15||
48043001|NCT02279407|100427922|FG003|COMPLETED|Overall Study||20||
48043002|NCT02279407|100427919|FG000|NOT COMPLETED|Overall Study||2||
48043003|NCT02279407|100427920|FG001|NOT COMPLETED|Overall Study||1||
48043004|NCT02279407|100427921|FG002|NOT COMPLETED|Overall Study||5||
48043005|NCT02279407|100427922|FG003|NOT COMPLETED|Overall Study||1||
48043006|NCT00594945|100427923|FG000|STARTED|Cohort 1 / Treatment Period 1||4||
48043007|NCT00594945|100427924|FG001|STARTED|Cohort 1 / Treatment Period 1||0||
48043008|NCT00594945|100427925|FG002|STARTED|Cohort 1 / Treatment Period 1||2||
48043009|NCT00594945|100427923|FG000|COMPLETED|Cohort 1 / Treatment Period 1||4||
48043010|NCT00594945|100427924|FG001|COMPLETED|Cohort 1 / Treatment Period 1||0||
48043011|NCT00594945|100427925|FG002|COMPLETED|Cohort 1 / Treatment Period 1||2||
48043012|NCT00594945|100427923|FG000|NOT COMPLETED|Cohort 1 / Treatment Period 1||0||
48043013|NCT00594945|100427924|FG001|NOT COMPLETED|Cohort 1 / Treatment Period 1||0||
48043014|NCT00594945|100427925|FG002|NOT COMPLETED|Cohort 1 / Treatment Period 1||0||
48043015|NCT00594945|100427923|FG000|STARTED|Cohort 2 / Treatment Period 2||0||
48043016|NCT00594945|100427924|FG001|STARTED|Cohort 2 / Treatment Period 2||3||
48043017|NCT00594945|100427925|FG002|STARTED|Cohort 2 / Treatment Period 2||2||
48043018|NCT00594945|100427923|FG000|COMPLETED|Cohort 2 / Treatment Period 2||0||
48043019|NCT00594945|100427924|FG001|COMPLETED|Cohort 2 / Treatment Period 2||3||
48043020|NCT00594945|100427925|FG002|COMPLETED|Cohort 2 / Treatment Period 2||2||
48043021|NCT00594945|100427923|FG000|NOT COMPLETED|Cohort 2 / Treatment Period 2||0||
48043022|NCT00594945|100427924|FG001|NOT COMPLETED|Cohort 2 / Treatment Period 2||0||
48043023|NCT00594945|100427925|FG002|NOT COMPLETED|Cohort 2 / Treatment Period 2||0||
48043024|NCT02047344|100427926|FG000|STARTED|Overall Study||16||
48043025|NCT02047344|100427927|FG001|STARTED|Overall Study||15||
48043026|NCT02047344|100427926|FG000|COMPLETED|Overall Study||16||
48043027|NCT02047344|100427927|FG001|COMPLETED|Overall Study||15||
48043028|NCT02047344|100427926|FG000|NOT COMPLETED|Overall Study||0||
48043029|NCT02047344|100427927|FG001|NOT COMPLETED|Overall Study||0||
48043030|NCT01343901|100427928|FG000|STARTED|Overall Study||210||
48043031|NCT01343901|100427928|FG000|Efficacy Population|Overall Study||205||
48043032|NCT01343901|100427928|FG000|COMPLETED|Overall Study||97||
48043033|NCT01343901|100427928|FG000|NOT COMPLETED|Overall Study||113||
48043034|NCT02186301|100427929|FG000|STARTED|Overall Study||20||
48043035|NCT02186301|100427930|FG001|STARTED|Overall Study||30||
48043036|NCT02186301|100427931|FG002|STARTED|Overall Study||50||
48043037|NCT02186301|100427929|FG000|COMPLETED|Overall Study||0||
48043038|NCT02186301|100427930|FG001|COMPLETED|Overall Study||0||
48043039|NCT02186301|100427931|FG002|COMPLETED|Overall Study||0||
48043040|NCT02186301|100427929|FG000|NOT COMPLETED|Overall Study||20||
48043041|NCT02186301|100427930|FG001|NOT COMPLETED|Overall Study||30||
48043042|NCT02186301|100427931|FG002|NOT COMPLETED|Overall Study||50||
48043043|NCT02446171|100427932|FG000|STARTED|Overall Study||11||
48043044|NCT02446171|100427933|FG001|STARTED|Overall Study||11||
48204734|NCT01025843|100827305|FG001|COMPLETED|Period 3||2||
48043045|NCT02446171|100427934|FG002|STARTED|Overall Study||11||
48043046|NCT02446171|100427935|FG003|STARTED|Overall Study||11||
48043047|NCT02446171|100427932|FG000|COMPLETED|Overall Study||11||
48043048|NCT02446171|100427933|FG001|COMPLETED|Overall Study||11||
48043049|NCT02446171|100427934|FG002|COMPLETED|Overall Study||9||
48043050|NCT02446171|100427935|FG003|COMPLETED|Overall Study||11||
48043051|NCT02446171|100427932|FG000|NOT COMPLETED|Overall Study||0||
48043052|NCT02446171|100427933|FG001|NOT COMPLETED|Overall Study||0||
48043053|NCT02446171|100427934|FG002|NOT COMPLETED|Overall Study||2||
48043054|NCT02446171|100427935|FG003|NOT COMPLETED|Overall Study||0||
48043055|NCT00331552|100427936|FG000|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||3||
48043056|NCT00331552|100427937|FG001|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||0||
48043057|NCT00331552|100427936|FG000|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||3||
48043058|NCT00331552|100427937|FG001|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0||
48043059|NCT00331552|100427936|FG000|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0||
48043060|NCT00331552|100427937|FG001|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0||
48043061|NCT00331552|100427936|FG000|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||0||
48043062|NCT00331552|100427937|FG001|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||3||
48043063|NCT00331552|100427936|FG000|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0||
48043064|NCT00331552|100427937|FG001|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||3||
48043065|NCT00331552|100427936|FG000|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0||
48043066|NCT00331552|100427937|FG001|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0||
48043067|NCT00331552|100427936|FG000|STARTED|Period 3: Phase II||24||
48043068|NCT00331552|100427937|FG001|STARTED|Period 3: Phase II||0||
48043069|NCT00331552|100427936|FG000|COMPLETED|Period 3: Phase II||22||
48043070|NCT00331552|100427937|FG001|COMPLETED|Period 3: Phase II||0||
48043071|NCT00331552|100427936|FG000|NOT COMPLETED|Period 3: Phase II||2||
48043072|NCT00331552|100427937|FG001|NOT COMPLETED|Period 3: Phase II||0||
48043073|NCT03452527|100427938|FG000|STARTED|Overall Study||7||
48043074|NCT03452527|100427939|FG001|STARTED|Overall Study||8||
48043075|NCT03452527|100427938|FG000|COMPLETED|Overall Study||4||
48043076|NCT03452527|100427939|FG001|COMPLETED|Overall Study||4||
48043077|NCT03452527|100427938|FG000|NOT COMPLETED|Overall Study||3||
48043078|NCT03452527|100427939|FG001|NOT COMPLETED|Overall Study||4||
48043079|NCT01579812|100427940|FG000|STARTED|Overall Study||90||
48043080|NCT01579812|100427940|FG000|COMPLETED|Overall Study||38||
48043081|NCT01579812|100427940|FG000|NOT COMPLETED|Overall Study||52||
48043082|NCT01924429|100427941|FG000|STARTED|Period 1 - First Intervention (4 Weeks)||17||
48043083|NCT01924429|100427942|FG001|STARTED|Period 1 - First Intervention (4 Weeks)||13||
48043084|NCT01924429|100427941|FG000|COMPLETED|Period 1 - First Intervention (4 Weeks)||17||
48043085|NCT01924429|100427942|FG001|COMPLETED|Period 1 - First Intervention (4 Weeks)||13||
48043086|NCT01924429|100427941|FG000|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0||
48043087|NCT01924429|100427942|FG001|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0||
48043088|NCT01924429|100427941|FG000|STARTED|Washout Period (2 Weeks)||17||
48043089|NCT01924429|100427942|FG001|STARTED|Washout Period (2 Weeks)||13||
48043090|NCT01924429|100427941|FG000|COMPLETED|Washout Period (2 Weeks)||14||
48043091|NCT01924429|100427942|FG001|COMPLETED|Washout Period (2 Weeks)||11||
48043092|NCT01924429|100427941|FG000|NOT COMPLETED|Washout Period (2 Weeks)||3||
48043093|NCT01924429|100427942|FG001|NOT COMPLETED|Washout Period (2 Weeks)||2||
48043094|NCT01924429|100427941|FG000|STARTED|Period 2 - Second Intervention (4 Weeks)||14||
48043095|NCT01924429|100427942|FG001|STARTED|Period 2 - Second Intervention (4 Weeks)||11||
48043096|NCT01924429|100427941|FG000|COMPLETED|Period 2 - Second Intervention (4 Weeks)||14||
48043097|NCT01924429|100427942|FG001|COMPLETED|Period 2 - Second Intervention (4 Weeks)||11||
48043098|NCT01924429|100427941|FG000|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0||
48043099|NCT01924429|100427942|FG001|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0||
48043100|NCT03102190|100427943|FG000|STARTED|Overall Study||6||
48043101|NCT03102190|100427943|FG000|COMPLETED|Overall Study||6||
48043102|NCT03102190|100427943|FG000|NOT COMPLETED|Overall Study||0||
48043103|NCT02661178|100427944|FG000|STARTED|Part 1||1||
48043104|NCT02661178|100427945|FG001|STARTED|Part 1||5||
48043105|NCT02661178|100427946|FG002|STARTED|Part 1||6||
48043106|NCT02661178|100427947|FG003|STARTED|Part 1||6||
48043107|NCT02661178|100427948|FG004|STARTED|Part 1||5||
48043108|NCT02661178|100427949|FG005|STARTED|Part 1||6||
48043109|NCT02661178|100427950|FG006|STARTED|Part 1||6||
48043110|NCT02661178|100427951|FG007|STARTED|Part 1||6||
48043111|NCT02661178|100427952|FG008|STARTED|Part 1||6||
48043112|NCT02661178|100427953|FG009|STARTED|Part 1||12||
48043113|NCT02661178|100427954|FG010|STARTED|Part 1||4||
48043114|NCT02661178|100427955|FG011|STARTED|Part 1||0||
48043115|NCT02661178|100427956|FG012|STARTED|Part 1||0||
48043116|NCT02661178|100427957|FG013|STARTED|Part 1||0||
48043117|NCT02661178|100427958|FG014|STARTED|Part 1||0||
48043118|NCT02661178|100427944|FG000|COMPLETED|Part 1||0||
48043119|NCT02661178|100427945|FG001|COMPLETED|Part 1||5||
48043120|NCT02661178|100427946|FG002|COMPLETED|Part 1||6||
48043121|NCT02661178|100427947|FG003|COMPLETED|Part 1||6||
48043122|NCT02661178|100427948|FG004|COMPLETED|Part 1||5||
48043123|NCT02661178|100427949|FG005|COMPLETED|Part 1||6||
48043124|NCT02661178|100427950|FG006|COMPLETED|Part 1||6||
48043125|NCT02661178|100427951|FG007|COMPLETED|Part 1||6||
48043126|NCT02661178|100427952|FG008|COMPLETED|Part 1||6||
48043127|NCT02661178|100427953|FG009|COMPLETED|Part 1||12||
48043128|NCT02661178|100427954|FG010|COMPLETED|Part 1||4||
48043129|NCT02661178|100427955|FG011|COMPLETED|Part 1||0||
48043130|NCT02661178|100427956|FG012|COMPLETED|Part 1||0||
48043131|NCT02661178|100427957|FG013|COMPLETED|Part 1||0||
48043132|NCT02661178|100427958|FG014|COMPLETED|Part 1||0||
48204735|NCT01025843|100827306|FG002|COMPLETED|Period 3||2||
48204736|NCT01025843|100827307|FG003|COMPLETED|Period 3||2||
48204737|NCT01025843|100827308|FG004|COMPLETED|Period 3||2||
48043133|NCT02661178|100427944|FG000|NOT COMPLETED|Part 1||1||
48043134|NCT02661178|100427945|FG001|NOT COMPLETED|Part 1||0||
48043135|NCT02661178|100427946|FG002|NOT COMPLETED|Part 1||0||
48043136|NCT02661178|100427947|FG003|NOT COMPLETED|Part 1||0||
48043137|NCT02661178|100427948|FG004|NOT COMPLETED|Part 1||0||
48043138|NCT02661178|100427949|FG005|NOT COMPLETED|Part 1||0||
48043139|NCT02661178|100427950|FG006|NOT COMPLETED|Part 1||0||
48043140|NCT02661178|100427951|FG007|NOT COMPLETED|Part 1||0||
48043141|NCT02661178|100427952|FG008|NOT COMPLETED|Part 1||0||
48043142|NCT02661178|100427953|FG009|NOT COMPLETED|Part 1||0||
48043143|NCT02661178|100427954|FG010|NOT COMPLETED|Part 1||0||
48043144|NCT02661178|100427955|FG011|NOT COMPLETED|Part 1||0||
48043145|NCT02661178|100427956|FG012|NOT COMPLETED|Part 1||0||
48043146|NCT02661178|100427957|FG013|NOT COMPLETED|Part 1||0||
48043147|NCT02661178|100427958|FG014|NOT COMPLETED|Part 1||0||
48043148|NCT02661178|100427944|FG000|STARTED|Part 2||0||
48043149|NCT02661178|100427945|FG001|STARTED|Part 2||0||
48043150|NCT02661178|100427946|FG002|STARTED|Part 2||0||
48043151|NCT02661178|100427947|FG003|STARTED|Part 2||0||
48043152|NCT02661178|100427948|FG004|STARTED|Part 2||0||
48043153|NCT02661178|100427949|FG005|STARTED|Part 2||0||
48043154|NCT02661178|100427950|FG006|STARTED|Part 2||0||
48043155|NCT02661178|100427951|FG007|STARTED|Part 2||0||
48043156|NCT02661178|100427952|FG008|STARTED|Part 2||0||
48043157|NCT02661178|100427953|FG009|STARTED|Part 2||0||
48043158|NCT02661178|100427954|FG010|STARTED|Part 2||0||
48043159|NCT02661178|100427955|FG011|STARTED|Part 2||6||
48043160|NCT02661178|100427956|FG012|STARTED|Part 2||6||
48043161|NCT02661178|100427957|FG013|STARTED|Part 2||2||
48043162|NCT02661178|100427958|FG014|STARTED|Part 2||2||
48043163|NCT02661178|100427944|FG000|COMPLETED|Part 2||0||
48043164|NCT02661178|100427945|FG001|COMPLETED|Part 2||0||
48043165|NCT02661178|100427946|FG002|COMPLETED|Part 2||0||
48043166|NCT02661178|100427947|FG003|COMPLETED|Part 2||0||
48043167|NCT02661178|100427948|FG004|COMPLETED|Part 2||0||
48043168|NCT02661178|100427949|FG005|COMPLETED|Part 2||0||
48043169|NCT02661178|100427950|FG006|COMPLETED|Part 2||0||
48043170|NCT02661178|100427951|FG007|COMPLETED|Part 2||0||
48043171|NCT02661178|100427952|FG008|COMPLETED|Part 2||0||
48043172|NCT02661178|100427953|FG009|COMPLETED|Part 2||0||
48043173|NCT02661178|100427954|FG010|COMPLETED|Part 2||0||
48043174|NCT02661178|100427955|FG011|COMPLETED|Part 2||6||
48043175|NCT02661178|100427956|FG012|COMPLETED|Part 2||6||
48043176|NCT02661178|100427957|FG013|COMPLETED|Part 2||2||
48043177|NCT02661178|100427958|FG014|COMPLETED|Part 2||2||
48043178|NCT02661178|100427944|FG000|NOT COMPLETED|Part 2||0||
48043179|NCT02661178|100427945|FG001|NOT COMPLETED|Part 2||0||
48043180|NCT02661178|100427946|FG002|NOT COMPLETED|Part 2||0||
48043181|NCT02661178|100427947|FG003|NOT COMPLETED|Part 2||0||
48043182|NCT02661178|100427948|FG004|NOT COMPLETED|Part 2||0||
48043183|NCT02661178|100427949|FG005|NOT COMPLETED|Part 2||0||
48043184|NCT02661178|100427950|FG006|NOT COMPLETED|Part 2||0||
48043185|NCT02661178|100427951|FG007|NOT COMPLETED|Part 2||0||
48043186|NCT02661178|100427952|FG008|NOT COMPLETED|Part 2||0||
48043187|NCT02661178|100427953|FG009|NOT COMPLETED|Part 2||0||
48043188|NCT02661178|100427954|FG010|NOT COMPLETED|Part 2||0||
48043189|NCT02661178|100427955|FG011|NOT COMPLETED|Part 2||0||
48043190|NCT02661178|100427956|FG012|NOT COMPLETED|Part 2||0||
48043191|NCT02661178|100427957|FG013|NOT COMPLETED|Part 2||0||
48043192|NCT02661178|100427958|FG014|NOT COMPLETED|Part 2||0||
48043193|NCT04179409|100427959|FG000|STARTED|Overall Study||2||
48043194|NCT04179409|100427960|FG001|STARTED|Overall Study||0||
48043195|NCT04179409|100427961|FG002|STARTED|Overall Study||1||
48043196|NCT04179409|100427959|FG000|COMPLETED|Overall Study||2||
48043197|NCT04179409|100427960|FG001|COMPLETED|Overall Study||0||
48043198|NCT04179409|100427961|FG002|COMPLETED|Overall Study||1||
48043199|NCT04179409|100427959|FG000|NOT COMPLETED|Overall Study||0||
48043200|NCT04179409|100427960|FG001|NOT COMPLETED|Overall Study||0||
48043201|NCT04179409|100427961|FG002|NOT COMPLETED|Overall Study||0||
48043202|NCT02830438|100427962|FG000|STARTED|Overall Study||8||
48043203|NCT02830438|100427962|FG000|COMPLETED|Overall Study||8||
48043204|NCT02830438|100427962|FG000|NOT COMPLETED|Overall Study||0||
48043205|NCT00722371|100427963|FG000|STARTED|Overall Study||231||
48043206|NCT00722371|100427964|FG001|STARTED|Overall Study||230||
48043207|NCT00722371|100427965|FG002|STARTED|Overall Study||233||
48043208|NCT00722371|100427966|FG003|STARTED|Overall Study||230||
48043209|NCT00722371|100427967|FG004|STARTED|Overall Study||230||
48043210|NCT00722371|100427968|FG005|STARTED|Overall Study||231||
48043211|NCT00722371|100427969|FG006|STARTED|Overall Study||230||
48043212|NCT00722371|100427963|FG000|COMPLETED|Overall Study||175||
48043213|NCT00722371|100427964|FG001|COMPLETED|Overall Study||158||
48043214|NCT00722371|100427965|FG002|COMPLETED|Overall Study||168||
48043215|NCT00722371|100427966|FG003|COMPLETED|Overall Study||167||
48043216|NCT00722371|100427967|FG004|COMPLETED|Overall Study||182||
48043217|NCT00722371|100427968|FG005|COMPLETED|Overall Study||178||
48043218|NCT00722371|100427969|FG006|COMPLETED|Overall Study||179||
48043219|NCT00722371|100427963|FG000|NOT COMPLETED|Overall Study||56||
48043220|NCT00722371|100427964|FG001|NOT COMPLETED|Overall Study||72||
48043221|NCT00722371|100427965|FG002|NOT COMPLETED|Overall Study||65||
48043222|NCT00722371|100427966|FG003|NOT COMPLETED|Overall Study||63||
48043223|NCT00722371|100427967|FG004|NOT COMPLETED|Overall Study||48||
48043224|NCT00722371|100427968|FG005|NOT COMPLETED|Overall Study||53||
48043225|NCT00722371|100427969|FG006|NOT COMPLETED|Overall Study||51||
48043226|NCT01642732|100427970|FG000|STARTED|Overall Study||1||
48043227|NCT01642732|100427970|FG000|COMPLETED|Overall Study||0||
48043228|NCT01642732|100427970|FG000|NOT COMPLETED|Overall Study||1||
48043229|NCT01958827|100427971|FG000|STARTED|Overall Study||28||
48043230|NCT01958827|100427971|FG000|COMPLETED|Overall Study||18||
48043231|NCT01958827|100427971|FG000|NOT COMPLETED|Overall Study||10||
48043232|NCT02395302|100427972|FG000|STARTED|Overall Study||28||
48043233|NCT02395302|100427972|FG000|COMPLETED|Overall Study||14||
48043234|NCT02395302|100427972|FG000|NOT COMPLETED|Overall Study||14||
48043235|NCT02052414|100427973|FG000|STARTED|Overall Study||34||
48043236|NCT02052414|100427973|FG000|COMPLETED|Overall Study||17||
48043237|NCT02052414|100427973|FG000|NOT COMPLETED|Overall Study||17||
48043238|NCT00246571|100427974|FG000|STARTED|Overall Study||113||
48043239|NCT00246571|100427975|FG001|STARTED|Overall Study||104||
48043240|NCT00246571|100427974|FG000|Randomized But Not Treated|Overall Study||3||
48043241|NCT00246571|100427975|FG001|Randomized But Not Treated|Overall Study||1||
48043242|NCT00246571|100427974|FG000|COMPLETED|Overall Study||0||
48043243|NCT00246571|100427975|FG001|COMPLETED|Overall Study||0||
48043244|NCT00246571|100427974|FG000|NOT COMPLETED|Overall Study||113||
48043245|NCT00246571|100427975|FG001|NOT COMPLETED|Overall Study||104||
48043246|NCT04176601|100427976|FG000|STARTED|Overall Study||30||
48043247|NCT04176601|100427976|FG000|COMPLETED|Overall Study||25||
48043248|NCT04176601|100427976|FG000|NOT COMPLETED|Overall Study||5||
48043249|NCT02933671|100427977|FG000|STARTED|Overall Study||5||
48043250|NCT02933671|100427978|FG001|STARTED|Overall Study||5||
48043251|NCT02933671|100427977|FG000|COMPLETED|Overall Study||5||
48043252|NCT02933671|100427978|FG001|COMPLETED|Overall Study||5||
48043253|NCT02933671|100427977|FG000|NOT COMPLETED|Overall Study||0||
48043254|NCT02933671|100427978|FG001|NOT COMPLETED|Overall Study||0||
48043255|NCT02775240|100427979|FG000|STARTED|Overall Study||18||
48043256|NCT02775240|100427979|FG000|Started Treatment A|Overall Study||18||
48043257|NCT02775240|100427979|FG000|Started Treatment B|Overall Study||17||
48043258|NCT02775240|100427979|FG000|COMPLETED|Overall Study||17||
48043259|NCT02775240|100427979|FG000|NOT COMPLETED|Overall Study||1||
48043260|NCT03708562|100427980|FG000|STARTED|Overall Study||24||
48043261|NCT03708562|100427980|FG000|COMPLETED|Overall Study||12||
48043262|NCT03708562|100427980|FG000|NOT COMPLETED|Overall Study||12||
48043263|NCT00223236|100427981|FG000|STARTED|Overall Study||16||
48043264|NCT00223236|100427982|FG001|STARTED|Overall Study||18||
48204738|NCT01025843|100827309|FG005|COMPLETED|Period 3||2||
48204739|NCT01025843|100827310|FG006|COMPLETED|Period 3||2||
48204740|NCT01025843|100827311|FG007|COMPLETED|Period 3||2||
48204741|NCT01025843|100827312|FG008|COMPLETED|Period 3||2||
48204742|NCT01025843|100827313|FG009|COMPLETED|Period 3||2||
48204743|NCT01025843|100827304|FG000|NOT COMPLETED|Period 3||0||
48204744|NCT01025843|100827305|FG001|NOT COMPLETED|Period 3||0||
48204745|NCT01025843|100827306|FG002|NOT COMPLETED|Period 3||0||
48204746|NCT01025843|100827307|FG003|NOT COMPLETED|Period 3||0||
48204747|NCT01025843|100827308|FG004|NOT COMPLETED|Period 3||0||
48204748|NCT01025843|100827309|FG005|NOT COMPLETED|Period 3||0||
48204749|NCT01025843|100827310|FG006|NOT COMPLETED|Period 3||0||
48204750|NCT01025843|100827311|FG007|NOT COMPLETED|Period 3||0||
48204751|NCT01025843|100827312|FG008|NOT COMPLETED|Period 3||0||
48204752|NCT01025843|100827313|FG009|NOT COMPLETED|Period 3||0||
48204753|NCT01025843|100827304|FG000|STARTED|Washout 3||2||
48204754|NCT01025843|100827305|FG001|STARTED|Washout 3||2||
48204755|NCT01025843|100827306|FG002|STARTED|Washout 3||2||
48204756|NCT01025843|100827307|FG003|STARTED|Washout 3||2||
48204757|NCT01025843|100827308|FG004|STARTED|Washout 3||2||
48204758|NCT01025843|100827309|FG005|STARTED|Washout 3||2||
48204759|NCT01025843|100827310|FG006|STARTED|Washout 3||2||
48204760|NCT01025843|100827311|FG007|STARTED|Washout 3||2||
48204761|NCT01025843|100827312|FG008|STARTED|Washout 3||2||
48204762|NCT01025843|100827313|FG009|STARTED|Washout 3||2||
48204763|NCT01025843|100827304|FG000|COMPLETED|Washout 3||2||
48204764|NCT01025843|100827305|FG001|COMPLETED|Washout 3||2||
48204765|NCT01025843|100827306|FG002|COMPLETED|Washout 3||2||
48204766|NCT01025843|100827307|FG003|COMPLETED|Washout 3||2||
48204767|NCT01025843|100827308|FG004|COMPLETED|Washout 3||2||
48204768|NCT01025843|100827309|FG005|COMPLETED|Washout 3||2||
48204769|NCT01025843|100827310|FG006|COMPLETED|Washout 3||2||
48204770|NCT01025843|100827311|FG007|COMPLETED|Washout 3||2||
48204771|NCT01025843|100827312|FG008|COMPLETED|Washout 3||2||
48204772|NCT01025843|100827313|FG009|COMPLETED|Washout 3||2||
48204773|NCT01025843|100827304|FG000|NOT COMPLETED|Washout 3||0||
48204774|NCT01025843|100827305|FG001|NOT COMPLETED|Washout 3||0||
48204775|NCT01025843|100827306|FG002|NOT COMPLETED|Washout 3||0||
48204776|NCT01025843|100827307|FG003|NOT COMPLETED|Washout 3||0||
48204777|NCT01025843|100827308|FG004|NOT COMPLETED|Washout 3||0||
48204778|NCT01025843|100827309|FG005|NOT COMPLETED|Washout 3||0||
48204779|NCT01025843|100827310|FG006|NOT COMPLETED|Washout 3||0||
48043265|NCT00223236|100427981|FG000|COMPLETED|Overall Study||9||
48043266|NCT00223236|100427982|FG001|COMPLETED|Overall Study||4||
48043267|NCT00223236|100427981|FG000|NOT COMPLETED|Overall Study||7||
48043268|NCT00223236|100427982|FG001|NOT COMPLETED|Overall Study||14||
48204780|NCT01025843|100827311|FG007|NOT COMPLETED|Washout 3||0||
48204781|NCT01025843|100827312|FG008|NOT COMPLETED|Washout 3||0||
48204782|NCT01025843|100827313|FG009|NOT COMPLETED|Washout 3||0||
48043269|NCT00282464|100427983|FG000|STARTED|Overall Study||185||
48043270|NCT00282464|100427984|FG001|STARTED|Overall Study||196||
48043271|NCT00282464|100427983|FG000|COMPLETED|Overall Study||112||
48043272|NCT00282464|100427984|FG001|COMPLETED|Overall Study||134||
48043273|NCT00282464|100427983|FG000|NOT COMPLETED|Overall Study||73||
48204783|NCT01025843|100827304|FG000|STARTED|Period 4||2||
48204784|NCT01025843|100827305|FG001|STARTED|Period 4||2||
48204785|NCT01025843|100827306|FG002|STARTED|Period 4||2||
48204786|NCT01025843|100827307|FG003|STARTED|Period 4||2||
48204787|NCT01025843|100827308|FG004|STARTED|Period 4||2||
48204788|NCT01025843|100827309|FG005|STARTED|Period 4||2||
48204789|NCT01025843|100827310|FG006|STARTED|Period 4||2||
48043274|NCT00282464|100427984|FG001|NOT COMPLETED|Overall Study||62||
48043275|NCT00395057|100427985|FG000|STARTED|Overall Study||34||
48043276|NCT00395057|100427986|FG001|STARTED|Overall Study||35||
48043277|NCT00395057|100427987|FG002|STARTED|Overall Study||35||
48043278|NCT00395057|100427988|FG003|STARTED|Overall Study||34||
48043279|NCT00395057|100427985|FG000|COMPLETED|Overall Study||2||
48043280|NCT00395057|100427986|FG001|COMPLETED|Overall Study||1||
48043281|NCT00395057|100427987|FG002|COMPLETED|Overall Study||2||
48043282|NCT00395057|100427988|FG003|COMPLETED|Overall Study||1||
48043283|NCT00395057|100427985|FG000|NOT COMPLETED|Overall Study||32||
48043284|NCT00395057|100427986|FG001|NOT COMPLETED|Overall Study||34||
48043285|NCT00395057|100427987|FG002|NOT COMPLETED|Overall Study||33||
48043286|NCT00395057|100427988|FG003|NOT COMPLETED|Overall Study||33||
48043287|NCT02793856|100427989|FG000|STARTED|Overall Study||2||
48043288|NCT02793856|100427990|FG001|STARTED|Overall Study||4||
48043289|NCT02793856|100427991|FG002|STARTED|Overall Study||3||
48043290|NCT02793856|100427992|FG003|STARTED|Overall Study||3||
48043291|NCT02793856|100427989|FG000|COMPLETED|Overall Study||2||
48043292|NCT02793856|100427990|FG001|COMPLETED|Overall Study||4||
48043293|NCT02793856|100427991|FG002|COMPLETED|Overall Study||3||
48043294|NCT02793856|100427992|FG003|COMPLETED|Overall Study||3||
48043295|NCT02793856|100427989|FG000|NOT COMPLETED|Overall Study||0||
48043296|NCT02793856|100427990|FG001|NOT COMPLETED|Overall Study||0||
48043297|NCT02793856|100427991|FG002|NOT COMPLETED|Overall Study||0||
48043298|NCT02793856|100427992|FG003|NOT COMPLETED|Overall Study||0||
48043299|NCT01009840|100427993|FG000|STARTED|Overall Study||30||
48043300|NCT01009840|100427993|FG000|COMPLETED|Overall Study||16||
48043301|NCT01009840|100427993|FG000|NOT COMPLETED|Overall Study||14||
48043302|NCT02160002|100427994|FG000|STARTED|Overall Study||187||
48043303|NCT02160002|100427995|FG001|STARTED|Overall Study||179||
48043304|NCT02160002|100427994|FG000|Primary Outcome|Overall Study||185||
48043305|NCT02160002|100427995|FG001|Primary Outcome|Overall Study||178||
48043306|NCT02160002|100427994|FG000|COMPLETED|Overall Study||185||
48043307|NCT02160002|100427995|FG001|COMPLETED|Overall Study||178||
48043308|NCT02160002|100427994|FG000|NOT COMPLETED|Overall Study||2||
48043309|NCT02160002|100427995|FG001|NOT COMPLETED|Overall Study||1||
48043310|NCT04672954|100427996|FG000|STARTED|Overall Study||4||
48043311|NCT04672954|100427997|FG001|STARTED|Overall Study||4||
48043312|NCT04672954|100427998|FG002|STARTED|Overall Study||4||
48043313|NCT04672954|100427999|FG003|STARTED|Overall Study||6||
48043314|NCT04672954|100428000|FG004|STARTED|Overall Study||6||
48043315|NCT04672954|100427996|FG000|COMPLETED|Overall Study||4||
48043316|NCT04672954|100427997|FG001|COMPLETED|Overall Study||4||
48043317|NCT04672954|100427998|FG002|COMPLETED|Overall Study||4||
48043318|NCT04672954|100427999|FG003|COMPLETED|Overall Study||6||
48043319|NCT04672954|100428000|FG004|COMPLETED|Overall Study||6||
48043320|NCT04672954|100427996|FG000|NOT COMPLETED|Overall Study||0||
48043321|NCT04672954|100427997|FG001|NOT COMPLETED|Overall Study||0||
48043322|NCT04672954|100427998|FG002|NOT COMPLETED|Overall Study||0||
48043323|NCT04672954|100427999|FG003|NOT COMPLETED|Overall Study||0||
48043324|NCT04672954|100428000|FG004|NOT COMPLETED|Overall Study||0||
48043325|NCT01247298|100428001|FG000|STARTED|Overall Study||17||
48043326|NCT01247298|100428001|FG000|COMPLETED|Overall Study||17||
48043327|NCT01247298|100428001|FG000|NOT COMPLETED|Overall Study||0||
48043328|NCT00594425|100428002|FG000|STARTED|Overall Study||50||
48043329|NCT00594425|100428003|FG001|STARTED|Overall Study||48||
48043330|NCT00594425|100428004|FG002|STARTED|Overall Study||52||
48043331|NCT00594425|100428002|FG000|COMPLETED|Overall Study||43||
48043332|NCT00594425|100428003|FG001|COMPLETED|Overall Study||34||
48043333|NCT00594425|100428004|FG002|COMPLETED|Overall Study||42||
48043334|NCT00594425|100428002|FG000|NOT COMPLETED|Overall Study||7||
48043335|NCT00594425|100428003|FG001|NOT COMPLETED|Overall Study||14||
48043336|NCT00594425|100428004|FG002|NOT COMPLETED|Overall Study||10||
48043337|NCT01698710|100428005|FG000|STARTED|Overall Study||5||
48043338|NCT01698710|100428005|FG000|COMPLETED|Overall Study||5||
48043339|NCT01698710|100428005|FG000|NOT COMPLETED|Overall Study||0||
48043340|NCT04740905|100428006|FG000|STARTED|Part 1 (Baseline up to Week 24)||276|Intent-to-Treat (ITT) Population|
48043341|NCT04740905|100428007|FG001|STARTED|Part 1 (Baseline up to Week 24)||277|Intent-to-Treat (ITT) Population|
48043342|NCT04740905|100428006|FG000|Received at Least One Dose of Study Drug|Part 1 (Baseline up to Week 24)||276|Safety-Evaluable Population|
48043343|NCT04740905|100428007|FG001|Received at Least One Dose of Study Drug|Part 1 (Baseline up to Week 24)||274|Safety-Evaluable Population|
48043344|NCT04740905|100428006|FG000|COMPLETED|Part 1 (Baseline up to Week 24)||271|Completed Part 1|
48043345|NCT04740905|100428007|FG001|COMPLETED|Part 1 (Baseline up to Week 24)||274|Completed Part 1|
48043346|NCT04740905|100428006|FG000|NOT COMPLETED|Part 1 (Baseline up to Week 24)||5||
48043347|NCT04740905|100428007|FG001|NOT COMPLETED|Part 1 (Baseline up to Week 24)||3||
48043348|NCT04740905|100428006|FG000|STARTED|Part 2 (Week 24 to Week 72)||271||
48043349|NCT04740905|100428007|FG001|STARTED|Part 2 (Week 24 to Week 72)||274||
48043350|NCT04740905|100428006|FG000|COMPLETED|Part 2 (Week 24 to Week 72)||245||
48043351|NCT04740905|100428007|FG001|COMPLETED|Part 2 (Week 24 to Week 72)||244||
48043352|NCT04740905|100428006|FG000|NOT COMPLETED|Part 2 (Week 24 to Week 72)||26||
48043353|NCT04740905|100428007|FG001|NOT COMPLETED|Part 2 (Week 24 to Week 72)||30||
48495376|NCT00221299|101547835|FG001|COMPLETED|Overall Study||11||
48204790|NCT01025843|100827311|FG007|STARTED|Period 4||2||
48204791|NCT01025843|100827312|FG008|STARTED|Period 4||2||
48204792|NCT01025843|100827313|FG009|STARTED|Period 4||2||
48204793|NCT01025843|100827304|FG000|COMPLETED|Period 4||2||
48204794|NCT01025843|100827305|FG001|COMPLETED|Period 4||2||
48204795|NCT01025843|100827306|FG002|COMPLETED|Period 4||2||
48204796|NCT01025843|100827307|FG003|COMPLETED|Period 4||2||
48204797|NCT01025843|100827308|FG004|COMPLETED|Period 4||2||
48204798|NCT01025843|100827309|FG005|COMPLETED|Period 4||2||
48204799|NCT01025843|100827310|FG006|COMPLETED|Period 4||2||
48204800|NCT01025843|100827311|FG007|COMPLETED|Period 4||2||
48204801|NCT01025843|100827312|FG008|COMPLETED|Period 4||2||
48204802|NCT01025843|100827313|FG009|COMPLETED|Period 4||2||
48204803|NCT01025843|100827304|FG000|NOT COMPLETED|Period 4||0||
48204804|NCT01025843|100827305|FG001|NOT COMPLETED|Period 4||0||
48204805|NCT01025843|100827306|FG002|NOT COMPLETED|Period 4||0||
48204806|NCT01025843|100827307|FG003|NOT COMPLETED|Period 4||0||
48204807|NCT01025843|100827308|FG004|NOT COMPLETED|Period 4||0||
48204808|NCT01025843|100827309|FG005|NOT COMPLETED|Period 4||0||
48204809|NCT01025843|100827310|FG006|NOT COMPLETED|Period 4||0||
48204810|NCT01025843|100827311|FG007|NOT COMPLETED|Period 4||0||
48204811|NCT01025843|100827312|FG008|NOT COMPLETED|Period 4||0||
48204812|NCT01025843|100827313|FG009|NOT COMPLETED|Period 4||0||
48204813|NCT01025843|100827304|FG000|STARTED|Washout 4||2||
48204814|NCT01025843|100827305|FG001|STARTED|Washout 4||2||
48204815|NCT01025843|100827306|FG002|STARTED|Washout 4||2||
48204816|NCT01025843|100827307|FG003|STARTED|Washout 4||2||
48204817|NCT01025843|100827308|FG004|STARTED|Washout 4||2||
48204818|NCT01025843|100827309|FG005|STARTED|Washout 4||2||
48204819|NCT01025843|100827310|FG006|STARTED|Washout 4||2||
48043354|NCT00274924|100428008|FG000|STARTED|Step 1 (R-CHOP X 3 Cycles)||17||
48043355|NCT00274924|100428009|FG001|STARTED|Step 1 (R-CHOP X 3 Cycles)||77||
48043356|NCT00274924|100428010|FG002|STARTED|Step 1 (R-CHOP X 3 Cycles)||6||
48043357|NCT00274924|100428008|FG000|Treated|Step 1 (R-CHOP X 3 Cycles)||17||
48043358|NCT00274924|100428009|FG001|Treated|Step 1 (R-CHOP X 3 Cycles)||77||
48043359|NCT00274924|100428010|FG002|Treated|Step 1 (R-CHOP X 3 Cycles)||5||
48043360|NCT00274924|100428008|FG000|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||13||
48043361|NCT00274924|100428009|FG001|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||63||
48043362|NCT00274924|100428010|FG002|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||4||
48043363|NCT00274924|100428008|FG000|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||13||
48043364|NCT00274924|100428009|FG001|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||63||
48043365|NCT00274924|100428010|FG002|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||0||
48043366|NCT00274924|100428008|FG000|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||4||
48043367|NCT00274924|100428009|FG001|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||14||
48043368|NCT00274924|100428010|FG002|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||6||
48043369|NCT00274924|100428008|FG000|STARTED|Step 2 (Tx Based on Mid-treatment PET)||17||
48043370|NCT00274924|100428009|FG001|STARTED|Step 2 (Tx Based on Mid-treatment PET)||76||
48043371|NCT00274924|100428010|FG002|STARTED|Step 2 (Tx Based on Mid-treatment PET)||0||
48043372|NCT00274924|100428008|FG000|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||13||
48043373|NCT00274924|100428009|FG001|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||61||
48043374|NCT00274924|100428010|FG002|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||0||
48043375|NCT00274924|100428008|FG000|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||10||
48043376|NCT00274924|100428009|FG001|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||58||
48043377|NCT00274924|100428010|FG002|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0||
48043378|NCT00274924|100428008|FG000|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||7||
48043379|NCT00274924|100428009|FG001|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||18||
48043380|NCT00274924|100428010|FG002|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0||
48043381|NCT01268579|100428011|FG000|STARTED|Overall Study||9||
48043382|NCT01268579|100428011|FG000|COMPLETED|Overall Study||6||
48043383|NCT01268579|100428011|FG000|NOT COMPLETED|Overall Study||3||
48043384|NCT01568528|100428012|FG000|STARTED|Overall Study||19||
48043385|NCT01568528|100428013|FG001|STARTED|Overall Study||11||
48043386|NCT01568528|100428014|FG002|STARTED|Overall Study||9||
48043387|NCT01568528|100428012|FG000|COMPLETED|Overall Study||19||
48043388|NCT01568528|100428013|FG001|COMPLETED|Overall Study||11||
48043389|NCT01568528|100428014|FG002|COMPLETED|Overall Study||9||
48043390|NCT01568528|100428012|FG000|NOT COMPLETED|Overall Study||0||
48204820|NCT01025843|100827311|FG007|STARTED|Washout 4||2||
48204821|NCT01025843|100827312|FG008|STARTED|Washout 4||2||
48204822|NCT01025843|100827313|FG009|STARTED|Washout 4||2||
48204823|NCT01025843|100827304|FG000|COMPLETED|Washout 4||2||
48204824|NCT01025843|100827305|FG001|COMPLETED|Washout 4||2||
48204825|NCT01025843|100827306|FG002|COMPLETED|Washout 4||1||
48204826|NCT01025843|100827307|FG003|COMPLETED|Washout 4||1||
48204827|NCT01025843|100827308|FG004|COMPLETED|Washout 4||2||
48204828|NCT01025843|100827309|FG005|COMPLETED|Washout 4||2||
48204829|NCT01025843|100827310|FG006|COMPLETED|Washout 4||2||
48204830|NCT01025843|100827311|FG007|COMPLETED|Washout 4||2||
48204831|NCT01025843|100827312|FG008|COMPLETED|Washout 4||2||
48204832|NCT01025843|100827313|FG009|COMPLETED|Washout 4||2||
48204833|NCT01025843|100827304|FG000|NOT COMPLETED|Washout 4||0||
48204834|NCT01025843|100827305|FG001|NOT COMPLETED|Washout 4||0||
48043391|NCT01568528|100428013|FG001|NOT COMPLETED|Overall Study||0||
48043392|NCT01568528|100428014|FG002|NOT COMPLETED|Overall Study||0||
48043393|NCT01848782|100428015|FG000|STARTED|Overall Study||150||
48204835|NCT01025843|100827306|FG002|NOT COMPLETED|Washout 4||1||
48043394|NCT01848782|100428016|FG001|STARTED|Overall Study||150||
48043395|NCT01848782|100428015|FG000|COMPLETED|Overall Study||150||
48043396|NCT01848782|100428016|FG001|COMPLETED|Overall Study||150||
48043397|NCT01848782|100428015|FG000|NOT COMPLETED|Overall Study||0||
48043398|NCT01848782|100428016|FG001|NOT COMPLETED|Overall Study||0||
48043399|NCT01514162|100428017|FG000|STARTED|Overall Study||245||
48043400|NCT01514162|100428017|FG000|COMPLETED|Overall Study||160||
48043401|NCT01514162|100428017|FG000|NOT COMPLETED|Overall Study||85||
48043402|NCT01054183|100428018|FG000|STARTED|Overall Study||10||
48043403|NCT01054183|100428019|FG001|STARTED|Overall Study||12||
48043404|NCT01054183|100428018|FG000|COMPLETED|Overall Study||10||
48043405|NCT01054183|100428019|FG001|COMPLETED|Overall Study||12||
48043406|NCT01054183|100428018|FG000|NOT COMPLETED|Overall Study||0||
48204836|NCT01025843|100827307|FG003|NOT COMPLETED|Washout 4||1||
48204837|NCT01025843|100827308|FG004|NOT COMPLETED|Washout 4||0||
48204838|NCT01025843|100827309|FG005|NOT COMPLETED|Washout 4||0||
48204839|NCT01025843|100827310|FG006|NOT COMPLETED|Washout 4||0||
48204840|NCT01025843|100827311|FG007|NOT COMPLETED|Washout 4||0||
48204841|NCT01025843|100827312|FG008|NOT COMPLETED|Washout 4||0||
48204842|NCT01025843|100827313|FG009|NOT COMPLETED|Washout 4||0||
48204843|NCT01025843|100827304|FG000|STARTED|Period 5||2||
48204844|NCT01025843|100827305|FG001|STARTED|Period 5||2||
48204845|NCT01025843|100827306|FG002|STARTED|Period 5||1||
48204846|NCT01025843|100827307|FG003|STARTED|Period 5||1||
48204847|NCT01025843|100827308|FG004|STARTED|Period 5||2||
48204848|NCT01025843|100827309|FG005|STARTED|Period 5||2||
48204849|NCT01025843|100827310|FG006|STARTED|Period 5||2||
48204850|NCT01025843|100827311|FG007|STARTED|Period 5||2||
48204851|NCT01025843|100827312|FG008|STARTED|Period 5||2||
48204852|NCT01025843|100827313|FG009|STARTED|Period 5||2||
48204853|NCT01025843|100827304|FG000|COMPLETED|Period 5||2||
48204854|NCT01025843|100827305|FG001|COMPLETED|Period 5||2||
48204855|NCT01025843|100827306|FG002|COMPLETED|Period 5||1||
48204856|NCT01025843|100827307|FG003|COMPLETED|Period 5||1||
48204857|NCT01025843|100827308|FG004|COMPLETED|Period 5||2||
48204858|NCT01025843|100827309|FG005|COMPLETED|Period 5||2||
48204859|NCT01025843|100827310|FG006|COMPLETED|Period 5||2||
48204860|NCT01025843|100827311|FG007|COMPLETED|Period 5||2||
48204861|NCT01025843|100827312|FG008|COMPLETED|Period 5||2||
48204862|NCT01025843|100827313|FG009|COMPLETED|Period 5||2||
48204863|NCT01025843|100827304|FG000|NOT COMPLETED|Period 5||0||
48204864|NCT01025843|100827305|FG001|NOT COMPLETED|Period 5||0||
48204865|NCT01025843|100827306|FG002|NOT COMPLETED|Period 5||0||
48204866|NCT01025843|100827307|FG003|NOT COMPLETED|Period 5||0||
48204867|NCT01025843|100827308|FG004|NOT COMPLETED|Period 5||0||
48204868|NCT01025843|100827309|FG005|NOT COMPLETED|Period 5||0||
48204869|NCT01025843|100827310|FG006|NOT COMPLETED|Period 5||0||
48204870|NCT01025843|100827311|FG007|NOT COMPLETED|Period 5||0||
48204871|NCT01025843|100827312|FG008|NOT COMPLETED|Period 5||0||
48204872|NCT01025843|100827313|FG009|NOT COMPLETED|Period 5||0||
48204873|NCT00732381|100827314|FG000|STARTED|Overall Study||176||
48204874|NCT00732381|100827315|FG001|STARTED|Overall Study||175||
48204875|NCT00732381|100827314|FG000|COMPLETED|Overall Study||174||
48043407|NCT01054183|100428019|FG001|NOT COMPLETED|Overall Study||0||
48043408|NCT02810444|100428020|FG000|STARTED|Overall Study||81||
48043409|NCT02810444|100428020|FG000|Treatment Started|Overall Study||67||
48043410|NCT02810444|100428020|FG000|COMPLETED|Overall Study||60||
48043411|NCT02810444|100428020|FG000|NOT COMPLETED|Overall Study||21||
48043412|NCT01107379|100428021|FG000|STARTED|Overall Study||203||
48043413|NCT01107379|100428021|FG000|COMPLETED|Overall Study||182||
48043414|NCT01107379|100428021|FG000|NOT COMPLETED|Overall Study||21||
48043415|NCT03149848|100428022|FG000|STARTED|Period 1 (Day 1 to Day 14)||15||
48043416|NCT03149848|100428022|FG000|COMPLETED|Period 1 (Day 1 to Day 14)||14||
48043417|NCT03149848|100428022|FG000|NOT COMPLETED|Period 1 (Day 1 to Day 14)||1||
48043418|NCT03149848|100428022|FG000|STARTED|Period 2 (Day 15 to Day 28)||14||
48043419|NCT03149848|100428022|FG000|COMPLETED|Period 2 (Day 15 to Day 28)||12||
48043420|NCT03149848|100428022|FG000|NOT COMPLETED|Period 2 (Day 15 to Day 28)||2||
48043421|NCT00409331|100428023|FG000|STARTED|Overall Study||1||
48043422|NCT00409331|100428023|FG000|COMPLETED|Overall Study||0||
48043423|NCT00409331|100428023|FG000|NOT COMPLETED|Overall Study||1||
48043424|NCT00918125|100428024|FG000|STARTED|Overall Study||20||
48043425|NCT00918125|100428025|FG001|STARTED|Overall Study||39||
48204876|NCT00732381|100827315|FG001|COMPLETED|Overall Study||174||
48204877|NCT00732381|100827314|FG000|NOT COMPLETED|Overall Study||2||
48204878|NCT00732381|100827315|FG001|NOT COMPLETED|Overall Study||1||
48204879|NCT02734056|100827316|FG000|STARTED|Overall Study||50||
48204880|NCT02734056|100827317|FG001|STARTED|Overall Study||50||
48204881|NCT02734056|100827316|FG000|COMPLETED|Overall Study||50||
48204882|NCT02734056|100827317|FG001|COMPLETED|Overall Study||49||
48204883|NCT02734056|100827316|FG000|NOT COMPLETED|Overall Study||0||
48204884|NCT02734056|100827317|FG001|NOT COMPLETED|Overall Study||1||
48204885|NCT04153435|100827318|FG000|STARTED|Overall Study||197||
48204886|NCT04153435|100827319|FG001|STARTED|Overall Study||200||
48204887|NCT04153435|100827318|FG000|COMPLETED|Overall Study||197||
48204888|NCT04153435|100827319|FG001|COMPLETED|Overall Study||200||
48204889|NCT04153435|100827318|FG000|NOT COMPLETED|Overall Study||0||
48204890|NCT04153435|100827319|FG001|NOT COMPLETED|Overall Study||0||
48204891|NCT01353963|100827320|FG000|STARTED|Overall Study||13||
48204892|NCT01353963|100827320|FG000|COMPLETED|Overall Study||11||
48204893|NCT01353963|100827320|FG000|NOT COMPLETED|Overall Study||2||
48204894|NCT02000817|100827321|FG000|STARTED|Overall Study||6||
48204895|NCT02000817|100827322|FG001|STARTED|Overall Study||9||
48204896|NCT02000817|100827323|FG002|STARTED|Overall Study||8||
48204897|NCT02000817|100827324|FG003|STARTED|Overall Study||7||
48204898|NCT02000817|100827321|FG000|COMPLETED|Overall Study||4||
48204899|NCT02000817|100827322|FG001|COMPLETED|Overall Study||8||
48204900|NCT02000817|100827323|FG002|COMPLETED|Overall Study||7||
48204901|NCT02000817|100827324|FG003|COMPLETED|Overall Study||7||
48204902|NCT02000817|100827321|FG000|NOT COMPLETED|Overall Study||2||
48204903|NCT02000817|100827322|FG001|NOT COMPLETED|Overall Study||1||
48204904|NCT02000817|100827323|FG002|NOT COMPLETED|Overall Study||1||
48204905|NCT02000817|100827324|FG003|NOT COMPLETED|Overall Study||0||
48204906|NCT01801449|100827325|FG000|STARTED|Overall Study||6||
48204907|NCT01801449|100827325|FG000|COMPLETED|Overall Study||6||
48204908|NCT01801449|100827325|FG000|NOT COMPLETED|Overall Study||0||
48204909|NCT03257813|100827326|FG000|STARTED|Overall Study||30||
48204910|NCT03257813|100827327|FG001|STARTED|Overall Study||30||
48204911|NCT03257813|100827326|FG000|COMPLETED|Overall Study||24||
48204912|NCT03257813|100827327|FG001|COMPLETED|Overall Study||27||
48204913|NCT03257813|100827326|FG000|NOT COMPLETED|Overall Study||6||
48204914|NCT03257813|100827327|FG001|NOT COMPLETED|Overall Study||3||
48043426|NCT00918125|100428024|FG000|COMPLETED|Overall Study||20||
48043427|NCT00918125|100428025|FG001|COMPLETED|Overall Study||39||
48204915|NCT02393716|100827328|FG000|STARTED|Overall Study||139||
48204916|NCT02393716|100827328|FG000|COMPLETED|Overall Study||78||
48204917|NCT02393716|100827328|FG000|NOT COMPLETED|Overall Study||61||
48204918|NCT02670525|100827329|FG000|STARTED|Overall Study||236||
48204919|NCT02670525|100827330|FG001|STARTED|Overall Study||102||
48204920|NCT02670525|100827329|FG000|Matched Targeted Therapy (MTT) Data Available|Overall Study||157||
48204921|NCT02670525|100827330|FG001|Matched Targeted Therapy (MTT) Data Available|Overall Study||74||
48204922|NCT02670525|100827329|FG000|Evaluable for Primary Endpoint|Overall Study||101||
48204923|NCT02670525|100827330|FG001|Evaluable for Primary Endpoint|Overall Study||0||
48204924|NCT02670525|100827329|FG000|COMPLETED|Overall Study||14|A patient is completed if they completed the required follow-up and came off study.|
48204925|NCT02670525|100827330|FG001|COMPLETED|Overall Study||9|A patient is completed if they completed the required follow-up and came off study.|
48204926|NCT02670525|100827329|FG000|NOT COMPLETED|Overall Study||222||
48204927|NCT02670525|100827330|FG001|NOT COMPLETED|Overall Study||93||
48204928|NCT00801983|100827331|FG000|STARTED|Period 1||44||
48204929|NCT00801983|100827332|FG001|STARTED|Period 1||41||
48204930|NCT00801983|100827331|FG000|COMPLETED|Period 1||40||
48204931|NCT00801983|100827332|FG001|COMPLETED|Period 1||33||
48204932|NCT00801983|100827331|FG000|NOT COMPLETED|Period 1||4||
48204933|NCT00801983|100827332|FG001|NOT COMPLETED|Period 1||8||
48204934|NCT00801983|100827331|FG000|STARTED|Period 2||40||
48204935|NCT00801983|100827332|FG001|STARTED|Period 2||33||
48204936|NCT00801983|100827331|FG000|COMPLETED|Period 2||38||
48204937|NCT00801983|100827332|FG001|COMPLETED|Period 2||32||
48204938|NCT00801983|100827331|FG000|NOT COMPLETED|Period 2||2||
48204939|NCT00801983|100827332|FG001|NOT COMPLETED|Period 2||1||
48043428|NCT00918125|100428024|FG000|NOT COMPLETED|Overall Study||0||
48043429|NCT00918125|100428025|FG001|NOT COMPLETED|Overall Study||0||
48043430|NCT00599131|100428026|FG000|STARTED|Overall Study||4||
48043431|NCT00599131|100428026|FG000|COMPLETED|Overall Study||4||
48043432|NCT00599131|100428026|FG000|NOT COMPLETED|Overall Study||0||
48043433|NCT02338336|100428027|FG000|STARTED|Overall Study||26||
48043434|NCT02338336|100428028|FG001|STARTED|Overall Study||17||
48043435|NCT02338336|100428029|FG002|STARTED|Overall Study||7||
48043436|NCT02338336|100428030|FG003|STARTED|Overall Study||4||
48043437|NCT02338336|100428027|FG000|COMPLETED|Overall Study||24||
48043438|NCT02338336|100428028|FG001|COMPLETED|Overall Study||17||
48043439|NCT02338336|100428029|FG002|COMPLETED|Overall Study||7||
48204940|NCT01596751|100827333|FG000|STARTED|Overall Study||5||
48204941|NCT01596751|100827334|FG001|STARTED|Overall Study||4||
48043440|NCT02338336|100428030|FG003|COMPLETED|Overall Study||4||
48043441|NCT02338336|100428027|FG000|NOT COMPLETED|Overall Study||2||
48043442|NCT02338336|100428028|FG001|NOT COMPLETED|Overall Study||0||
48043443|NCT02338336|100428029|FG002|NOT COMPLETED|Overall Study||0||
48204942|NCT01596751|100827335|FG002|STARTED|Overall Study||3||
48204943|NCT01596751|100827336|FG003|STARTED|Overall Study||6||
48204944|NCT01596751|100827337|FG004|STARTED|Overall Study||4||
48204945|NCT01596751|100827338|FG005|STARTED|Overall Study||6||
48204946|NCT01596751|100827339|FG006|STARTED|Overall Study||17||
48204947|NCT01596751|100827340|FG007|STARTED|Overall Study||22||
48204948|NCT01596751|100827333|FG000|COMPLETED|Overall Study||5||
48204949|NCT01596751|100827334|FG001|COMPLETED|Overall Study||4||
48204950|NCT01596751|100827335|FG002|COMPLETED|Overall Study||3||
48204951|NCT01596751|100827336|FG003|COMPLETED|Overall Study||6||
48204952|NCT01596751|100827337|FG004|COMPLETED|Overall Study||4||
48043444|NCT02338336|100428030|FG003|NOT COMPLETED|Overall Study||0||
48043445|NCT00492063|100428031|FG000|STARTED|Overall Study||652||
48043446|NCT00492063|100428032|FG001|STARTED|Overall Study||648||
48043447|NCT00492063|100428033|FG002|STARTED|Overall Study||678||
48043448|NCT00492063|100428034|FG003|STARTED|Overall Study||676||
48043449|NCT00492063|100428031|FG000|COMPLETED|Overall Study||642||
48043450|NCT00492063|100428032|FG001|COMPLETED|Overall Study||634||
48043451|NCT00492063|100428033|FG002|COMPLETED|Overall Study||667||
48043452|NCT00492063|100428034|FG003|COMPLETED|Overall Study||666||
48043453|NCT00492063|100428031|FG000|NOT COMPLETED|Overall Study||10||
48043454|NCT00492063|100428032|FG001|NOT COMPLETED|Overall Study||14||
48043455|NCT00492063|100428033|FG002|NOT COMPLETED|Overall Study||11||
48043456|NCT00492063|100428034|FG003|NOT COMPLETED|Overall Study||10||
48043457|NCT03996369|100428035|FG000|STARTED|Overall Study||238||
48043458|NCT03996369|100428036|FG001|STARTED|Overall Study||116||
48043459|NCT03996369|100428035|FG000|COMPLETED|Overall Study||213||
48043460|NCT03996369|100428036|FG001|COMPLETED|Overall Study||103||
48043461|NCT03996369|100428035|FG000|NOT COMPLETED|Overall Study||25||
48043462|NCT03996369|100428036|FG001|NOT COMPLETED|Overall Study||13||
48043463|NCT01909791|100428037|FG000|STARTED|Overall Study||226||
48043464|NCT01909791|100428038|FG001|STARTED|Overall Study||240||
48043465|NCT01909791|100428039|FG002|STARTED|Overall Study||236||
48043466|NCT01909791|100428037|FG000|COMPLETED|Overall Study||205||
48043467|NCT01909791|100428038|FG001|COMPLETED|Overall Study||212||
48043468|NCT01909791|100428039|FG002|COMPLETED|Overall Study||208||
48043469|NCT01909791|100428037|FG000|NOT COMPLETED|Overall Study||21||
48043470|NCT01909791|100428038|FG001|NOT COMPLETED|Overall Study||28||
48043471|NCT01909791|100428039|FG002|NOT COMPLETED|Overall Study||28||
48043472|NCT01479426|100428040|FG000|STARTED|Overall Study||40||
48043473|NCT01479426|100428041|FG001|STARTED|Overall Study||40||
48043474|NCT01479426|100428040|FG000|COMPLETED|Overall Study||36||
48043475|NCT01479426|100428041|FG001|COMPLETED|Overall Study||37||
48043476|NCT01479426|100428040|FG000|NOT COMPLETED|Overall Study||4||
48043477|NCT01479426|100428041|FG001|NOT COMPLETED|Overall Study||3||
48043478|NCT02969408|100428042|FG000|STARTED|Overall Study||397||
48043479|NCT02969408|100428042|FG000|Used ABS eMDPI at Least Once|Overall Study||370||
48043480|NCT02969408|100428042|FG000|COMPLETED|Overall Study||381||
48043481|NCT02969408|100428042|FG000|NOT COMPLETED|Overall Study||16||
48043482|NCT00412373|100428043|FG000|STARTED|Overall Study||93||
48043483|NCT00412373|100428044|FG001|STARTED|Overall Study||211||
48043484|NCT00412373|100428043|FG000|COMPLETED|Overall Study||52||
48043485|NCT00412373|100428044|FG001|COMPLETED|Overall Study||134||
48043486|NCT00412373|100428043|FG000|NOT COMPLETED|Overall Study||41||
48043487|NCT00412373|100428044|FG001|NOT COMPLETED|Overall Study||77||
48043488|NCT01947907|100428045|FG000|STARTED|Overall Study||12||
48043489|NCT01947907|100428046|FG001|STARTED|Overall Study||14||
48043490|NCT01947907|100428047|FG002|STARTED|Overall Study||14||
48043491|NCT01947907|100428048|FG003|STARTED|Overall Study||13||
48043492|NCT01947907|100428045|FG000|COMPLETED|Overall Study||12||
48043493|NCT01947907|100428046|FG001|COMPLETED|Overall Study||14||
48043494|NCT01947907|100428047|FG002|COMPLETED|Overall Study||14||
48043495|NCT01947907|100428048|FG003|COMPLETED|Overall Study||13||
48043496|NCT01947907|100428045|FG000|NOT COMPLETED|Overall Study||0||
48043497|NCT01947907|100428046|FG001|NOT COMPLETED|Overall Study||0||
48043498|NCT01947907|100428047|FG002|NOT COMPLETED|Overall Study||0||
48043499|NCT01947907|100428048|FG003|NOT COMPLETED|Overall Study||0||
48043500|NCT00669409|100428049|FG000|STARTED|Part 1||6||
48043501|NCT00669409|100428050|FG001|STARTED|Part 1||6||
48043502|NCT00669409|100428051|FG002|STARTED|Part 1||6||
48043503|NCT00669409|100428052|FG003|STARTED|Part 1||6||
48043504|NCT00669409|100428053|FG004|STARTED|Part 1||6||
48043505|NCT00669409|100428054|FG005|STARTED|Part 1||12||
48043506|NCT00669409|100428055|FG006|STARTED|Part 1||0||
48043507|NCT00669409|100428056|FG007|STARTED|Part 1||0||
48043508|NCT00669409|100428057|FG008|STARTED|Part 1||0||
48043509|NCT00669409|100428058|FG009|STARTED|Part 1||0||
48204953|NCT01596751|100827338|FG005|COMPLETED|Overall Study||6||
48204954|NCT01596751|100827339|FG006|COMPLETED|Overall Study||17||
48204955|NCT01596751|100827340|FG007|COMPLETED|Overall Study||22||
48043510|NCT00669409|100428059|FG010|STARTED|Part 1||0||
48043511|NCT00669409|100428049|FG000|COMPLETED|Part 1||6||
48043512|NCT00669409|100428050|FG001|COMPLETED|Part 1||6||
48043513|NCT00669409|100428051|FG002|COMPLETED|Part 1||6||
48043514|NCT00669409|100428052|FG003|COMPLETED|Part 1||6||
48043515|NCT00669409|100428053|FG004|COMPLETED|Part 1||6||
48043516|NCT00669409|100428054|FG005|COMPLETED|Part 1||12||
48043517|NCT00669409|100428055|FG006|COMPLETED|Part 1||0||
48043518|NCT00669409|100428056|FG007|COMPLETED|Part 1||0||
48043519|NCT00669409|100428057|FG008|COMPLETED|Part 1||0||
48043520|NCT00669409|100428058|FG009|COMPLETED|Part 1||0||
48204956|NCT01596751|100827333|FG000|NOT COMPLETED|Overall Study||0||
48204957|NCT01596751|100827334|FG001|NOT COMPLETED|Overall Study||0||
48204958|NCT01596751|100827335|FG002|NOT COMPLETED|Overall Study||0||
48043521|NCT00669409|100428059|FG010|COMPLETED|Part 1||0||
48043522|NCT00669409|100428049|FG000|NOT COMPLETED|Part 1||0||
48043523|NCT00669409|100428050|FG001|NOT COMPLETED|Part 1||0||
48043524|NCT00669409|100428051|FG002|NOT COMPLETED|Part 1||0||
48043525|NCT00669409|100428052|FG003|NOT COMPLETED|Part 1||0||
48043526|NCT00669409|100428053|FG004|NOT COMPLETED|Part 1||0||
48043527|NCT00669409|100428054|FG005|NOT COMPLETED|Part 1||0||
48043528|NCT00669409|100428055|FG006|NOT COMPLETED|Part 1||0||
48043529|NCT00669409|100428056|FG007|NOT COMPLETED|Part 1||0||
48043530|NCT00669409|100428057|FG008|NOT COMPLETED|Part 1||0||
48043531|NCT00669409|100428058|FG009|NOT COMPLETED|Part 1||0||
48043532|NCT00669409|100428059|FG010|NOT COMPLETED|Part 1||0||
48043533|NCT00669409|100428049|FG000|STARTED|Part 2||0||
48043534|NCT00669409|100428050|FG001|STARTED|Part 2||0||
48043535|NCT00669409|100428051|FG002|STARTED|Part 2||0||
48043536|NCT00669409|100428052|FG003|STARTED|Part 2||0||
48043537|NCT00669409|100428053|FG004|STARTED|Part 2||0||
48043538|NCT00669409|100428054|FG005|STARTED|Part 2||0||
48043539|NCT00669409|100428055|FG006|STARTED|Part 2||9||
48043540|NCT00669409|100428056|FG007|STARTED|Part 2||9||
48043541|NCT00669409|100428057|FG008|STARTED|Part 2||9||
48043542|NCT00669409|100428058|FG009|STARTED|Part 2||10||
48043543|NCT00669409|100428059|FG010|STARTED|Part 2||4||
48043544|NCT00669409|100428049|FG000|COMPLETED|Part 2||0||
48043545|NCT00669409|100428050|FG001|COMPLETED|Part 2||0||
48043546|NCT00669409|100428051|FG002|COMPLETED|Part 2||0||
48043547|NCT00669409|100428052|FG003|COMPLETED|Part 2||0||
48043548|NCT00669409|100428053|FG004|COMPLETED|Part 2||0||
48043549|NCT00669409|100428054|FG005|COMPLETED|Part 2||0||
48043550|NCT00669409|100428055|FG006|COMPLETED|Part 2||9||
48043551|NCT00669409|100428056|FG007|COMPLETED|Part 2||9||
48043552|NCT00669409|100428057|FG008|COMPLETED|Part 2||9||
48043553|NCT00669409|100428058|FG009|COMPLETED|Part 2||9||
48043554|NCT00669409|100428059|FG010|COMPLETED|Part 2||4||
48043555|NCT00669409|100428049|FG000|NOT COMPLETED|Part 2||0||
48043556|NCT00669409|100428050|FG001|NOT COMPLETED|Part 2||0||
48043557|NCT00669409|100428051|FG002|NOT COMPLETED|Part 2||0||
48043558|NCT00669409|100428052|FG003|NOT COMPLETED|Part 2||0||
48043559|NCT00669409|100428053|FG004|NOT COMPLETED|Part 2||0||
48043560|NCT00669409|100428054|FG005|NOT COMPLETED|Part 2||0||
48043561|NCT00669409|100428055|FG006|NOT COMPLETED|Part 2||0||
48043562|NCT00669409|100428056|FG007|NOT COMPLETED|Part 2||0||
48043563|NCT00669409|100428057|FG008|NOT COMPLETED|Part 2||0||
48043564|NCT00669409|100428058|FG009|NOT COMPLETED|Part 2||1||
48043565|NCT00669409|100428059|FG010|NOT COMPLETED|Part 2||0||
48043566|NCT01238588|100428060|FG000|STARTED|Overall Study||12||
48043567|NCT01238588|100428060|FG000|COMPLETED|Overall Study||9||
48043568|NCT01238588|100428060|FG000|NOT COMPLETED|Overall Study||3||
48043569|NCT00509262|100428061|FG000|STARTED|Overall Study||211||
48043570|NCT00509262|100428062|FG001|STARTED|Overall Study||212||
48043571|NCT00509262|100428061|FG000|COMPLETED|Overall Study||164||
48043572|NCT00509262|100428062|FG001|COMPLETED|Overall Study||170||
48043573|NCT00509262|100428061|FG000|NOT COMPLETED|Overall Study||47||
48043574|NCT00509262|100428062|FG001|NOT COMPLETED|Overall Study||42||
48043575|NCT02009384|100428063|FG000|STARTED|Overall Study||2||
48043576|NCT02009384|100428063|FG000|COMPLETED|Overall Study||0||
48043577|NCT02009384|100428063|FG000|NOT COMPLETED|Overall Study||2||
48043578|NCT00253708|100428064|FG000|STARTED|Overall Study||20||
48043579|NCT00253708|100428065|FG001|STARTED|Overall Study||10||
48043580|NCT00253708|100428066|FG002|STARTED|Overall Study||9||
48043581|NCT00253708|100428064|FG000|COMPLETED|Overall Study||20||
48043582|NCT00253708|100428065|FG001|COMPLETED|Overall Study||10||
48043583|NCT00253708|100428066|FG002|COMPLETED|Overall Study||8||
48043584|NCT00253708|100428064|FG000|NOT COMPLETED|Overall Study||0||
48043585|NCT00253708|100428065|FG001|NOT COMPLETED|Overall Study||0||
48043586|NCT00253708|100428066|FG002|NOT COMPLETED|Overall Study||1||
48043587|NCT00791973|100428067|FG000|STARTED|First Intervention (1 Week)||8||
48043588|NCT00791973|100428068|FG001|STARTED|First Intervention (1 Week)||7||
48043589|NCT00791973|100428067|FG000|COMPLETED|First Intervention (1 Week)||8||
48043590|NCT00791973|100428068|FG001|COMPLETED|First Intervention (1 Week)||7||
48043591|NCT00791973|100428067|FG000|NOT COMPLETED|First Intervention (1 Week)||0||
48043592|NCT00791973|100428068|FG001|NOT COMPLETED|First Intervention (1 Week)||0||
48043593|NCT00791973|100428067|FG000|STARTED|Washout (1 Week)||8||
48043594|NCT00791973|100428068|FG001|STARTED|Washout (1 Week)||7||
48043595|NCT00791973|100428067|FG000|COMPLETED|Washout (1 Week)||8||
48043596|NCT00791973|100428068|FG001|COMPLETED|Washout (1 Week)||7||
48043597|NCT00791973|100428067|FG000|NOT COMPLETED|Washout (1 Week)||0||
48043598|NCT00791973|100428068|FG001|NOT COMPLETED|Washout (1 Week)||0||
48043599|NCT00791973|100428067|FG000|STARTED|Second Intervention (1 Week)||8||
48043600|NCT00791973|100428068|FG001|STARTED|Second Intervention (1 Week)||7||
48043601|NCT00791973|100428067|FG000|COMPLETED|Second Intervention (1 Week)||8||
48043602|NCT00791973|100428068|FG001|COMPLETED|Second Intervention (1 Week)||7||
48043603|NCT00791973|100428067|FG000|NOT COMPLETED|Second Intervention (1 Week)||0||
48043604|NCT00791973|100428068|FG001|NOT COMPLETED|Second Intervention (1 Week)||0||
48043605|NCT00991952|100428069|FG000|STARTED|Overall Study||13||
48043606|NCT00991952|100428070|FG001|STARTED|Overall Study||6||
48043607|NCT00991952|100428069|FG000|COMPLETED|Overall Study||13||
48043608|NCT00991952|100428070|FG001|COMPLETED|Overall Study||5||
48043609|NCT00991952|100428069|FG000|NOT COMPLETED|Overall Study||0||
48043610|NCT00991952|100428070|FG001|NOT COMPLETED|Overall Study||1||
48043611|NCT03011892|100428071|FG000|STARTED|Double Blind (DB) Period||52||
48043612|NCT03011892|100428072|FG001|STARTED|Double Blind (DB) Period||51||
48043613|NCT03011892|100428073|FG002|STARTED|Double Blind (DB) Period||51||
48043614|NCT03011892|100428074|FG003|STARTED|Double Blind (DB) Period||51||
48043615|NCT03011892|100428075|FG004|STARTED|Double Blind (DB) Period||52||
48043616|NCT03011892|100428076|FG005|STARTED|Double Blind (DB) Period||50||
48043617|NCT03011892|100428077|FG006|STARTED|Double Blind (DB) Period||0||
48043618|NCT03011892|100428078|FG007|STARTED|Double Blind (DB) Period||0||
48043619|NCT03011892|100428079|FG008|STARTED|Double Blind (DB) Period||0||
48043620|NCT03011892|100428080|FG009|STARTED|Double Blind (DB) Period||0||
48043621|NCT03011892|100428081|FG010|STARTED|Double Blind (DB) Period||0||
48043622|NCT03011892|100428082|FG011|STARTED|Double Blind (DB) Period||0||
48043623|NCT03011892|100428071|FG000|Treated in DB Period|Double Blind (DB) Period||52|One participant was randomized but did not receive study drug.|
48043624|NCT03011892|100428072|FG001|Treated in DB Period|Double Blind (DB) Period||51|One participant was randomized but did not receive study drug.|
48043625|NCT03011892|100428073|FG002|Treated in DB Period|Double Blind (DB) Period||51|One participant was randomized but did not receive study drug.|
48043626|NCT03011892|100428074|FG003|Treated in DB Period|Double Blind (DB) Period||51|One participant was randomized but did not receive study drug.|
48043627|NCT03011892|100428075|FG004|Treated in DB Period|Double Blind (DB) Period||51|One participant was randomized but did not receive study drug.|
48043628|NCT03011892|100428076|FG005|Treated in DB Period|Double Blind (DB) Period||50|One participant was randomized but did not receive study drug.|
48043629|NCT03011892|100428077|FG006|Treated in DB Period|Double Blind (DB) Period||0|One participant was randomized but did not receive study drug.|
48043630|NCT03011892|100428078|FG007|Treated in DB Period|Double Blind (DB) Period||0|One participant was randomized but did not receive study drug.|
48043631|NCT03011892|100428079|FG008|Treated in DB Period|Double Blind (DB) Period||0|One participant was randomized but did not receive study drug.|
48043632|NCT03011892|100428080|FG009|Treated in DB Period|Double Blind (DB) Period||0|One participant was randomized but did not receive study drug.|
48043633|NCT03011892|100428081|FG010|Treated in DB Period|Double Blind (DB) Period||0|One participant was randomized but did not receive study drug.|
48043634|NCT03011892|100428082|FG011|Treated in DB Period|Double Blind (DB) Period||0|One participant was randomized but did not receive study drug.|
48043635|NCT03011892|100428071|FG000|Completed Treatment Through Week 4|Double Blind (DB) Period||44||
48043636|NCT03011892|100428072|FG001|Completed Treatment Through Week 4|Double Blind (DB) Period||46||
48043637|NCT03011892|100428073|FG002|Completed Treatment Through Week 4|Double Blind (DB) Period||48||
48043638|NCT03011892|100428074|FG003|Completed Treatment Through Week 4|Double Blind (DB) Period||47||
48043639|NCT03011892|100428075|FG004|Completed Treatment Through Week 4|Double Blind (DB) Period||49||
48043640|NCT03011892|100428076|FG005|Completed Treatment Through Week 4|Double Blind (DB) Period||49||
48043641|NCT03011892|100428077|FG006|Completed Treatment Through Week 4|Double Blind (DB) Period||0||
48043642|NCT03011892|100428078|FG007|Completed Treatment Through Week 4|Double Blind (DB) Period||0||
48043643|NCT03011892|100428079|FG008|Completed Treatment Through Week 4|Double Blind (DB) Period||0||
48043644|NCT03011892|100428080|FG009|Completed Treatment Through Week 4|Double Blind (DB) Period||0||
48043645|NCT03011892|100428081|FG010|Completed Treatment Through Week 4|Double Blind (DB) Period||0||
48043646|NCT03011892|100428082|FG011|Completed Treatment Through Week 4|Double Blind (DB) Period||0||
48043647|NCT03011892|100428071|FG000|COMPLETED|Double Blind (DB) Period||41|Completed= Number of participants who completed treatment through Week 8 in DB period.|
48043648|NCT03011892|100428072|FG001|COMPLETED|Double Blind (DB) Period||41|Completed= Number of participants who completed treatment through Week 8 in DB period.|
48043649|NCT03011892|100428073|FG002|COMPLETED|Double Blind (DB) Period||45|Completed= Number of participants who completed treatment through Week 8 in DB period.|
48043650|NCT03011892|100428074|FG003|COMPLETED|Double Blind (DB) Period||44|Completed= Number of participants who completed treatment through Week 8 in DB period.|
48043651|NCT03011892|100428075|FG004|COMPLETED|Double Blind (DB) Period||45|Completed= Number of participants who completed treatment through Week 8 in DB period.|
48043652|NCT03011892|100428076|FG005|COMPLETED|Double Blind (DB) Period||45|Completed= Number of participants who completed treatment through Week 8 in DB period.|
48043653|NCT03011892|100428077|FG006|COMPLETED|Double Blind (DB) Period||0|Completed= Number of participants who completed treatment through Week 8 in DB period.|
48043654|NCT03011892|100428078|FG007|COMPLETED|Double Blind (DB) Period||0|Completed= Number of participants who completed treatment through Week 8 in DB period.|
48043655|NCT03011892|100428079|FG008|COMPLETED|Double Blind (DB) Period||0|Completed= Number of participants who completed treatment through Week 8 in DB period.|
48043656|NCT03011892|100428080|FG009|COMPLETED|Double Blind (DB) Period||0|Completed= Number of participants who completed treatment through Week 8 in DB period.|
48043657|NCT03011892|100428081|FG010|COMPLETED|Double Blind (DB) Period||0|Completed= Number of participants who completed treatment through Week 8 in DB period.|
48043658|NCT03011892|100428082|FG011|COMPLETED|Double Blind (DB) Period||0|Completed= Number of participants who completed treatment through Week 8 in DB period.|
48043659|NCT03011892|100428071|FG000|NOT COMPLETED|Double Blind (DB) Period||11||
48043660|NCT03011892|100428072|FG001|NOT COMPLETED|Double Blind (DB) Period||10||
48043661|NCT03011892|100428073|FG002|NOT COMPLETED|Double Blind (DB) Period||6||
48043662|NCT03011892|100428074|FG003|NOT COMPLETED|Double Blind (DB) Period||7||
48043663|NCT03011892|100428075|FG004|NOT COMPLETED|Double Blind (DB) Period||7||
48043664|NCT03011892|100428076|FG005|NOT COMPLETED|Double Blind (DB) Period||5||
48043665|NCT03011892|100428077|FG006|NOT COMPLETED|Double Blind (DB) Period||0||
48043666|NCT03011892|100428078|FG007|NOT COMPLETED|Double Blind (DB) Period||0||
48043667|NCT03011892|100428079|FG008|NOT COMPLETED|Double Blind (DB) Period||0||
48204959|NCT01596751|100827336|FG003|NOT COMPLETED|Overall Study||0||
48043668|NCT03011892|100428080|FG009|NOT COMPLETED|Double Blind (DB) Period||0||
48043669|NCT03011892|100428081|FG010|NOT COMPLETED|Double Blind (DB) Period||0||
48043670|NCT03011892|100428082|FG011|NOT COMPLETED|Double Blind (DB) Period||0||
48043671|NCT03011892|100428071|FG000|STARTED|Open Label (OL) Period||0||
48043672|NCT03011892|100428072|FG001|STARTED|Open Label (OL) Period||0||
48043673|NCT03011892|100428073|FG002|STARTED|Open Label (OL) Period||0||
48043674|NCT03011892|100428074|FG003|STARTED|Open Label (OL) Period||0||
48043675|NCT03011892|100428075|FG004|STARTED|Open Label (OL) Period||0||
48043676|NCT03011892|100428076|FG005|STARTED|Open Label (OL) Period||0||
48043677|NCT03011892|100428077|FG006|STARTED|Open Label (OL) Period||41||
48043678|NCT03011892|100428078|FG007|STARTED|Open Label (OL) Period||40||
48043679|NCT03011892|100428079|FG008|STARTED|Open Label (OL) Period||45||
48204960|NCT01596751|100827337|FG004|NOT COMPLETED|Overall Study||0||
48204961|NCT01596751|100827338|FG005|NOT COMPLETED|Overall Study||0||
48204962|NCT01596751|100827339|FG006|NOT COMPLETED|Overall Study||0||
48204963|NCT01596751|100827340|FG007|NOT COMPLETED|Overall Study||0||
48204964|NCT02715258|100827341|FG000|STARTED|Overall Study||140||
48204965|NCT02715258|100827342|FG001|STARTED|Overall Study||70||
48204966|NCT02715258|100827341|FG000|Intent to Treat/Safety Analysis|Overall Study||138|Three randomized subject numbers were excluded in the ITT and the safety populations due to GCP violation.|
48204967|NCT02715258|100827342|FG001|Intent to Treat/Safety Analysis|Overall Study||69|Three randomized subject numbers were excluded in the ITT and the safety populations due to GCP violation.|
48204968|NCT02715258|100827341|FG000|COMPLETED|Overall Study||124||
48204969|NCT02715258|100827342|FG001|COMPLETED|Overall Study||64||
48204970|NCT02715258|100827341|FG000|NOT COMPLETED|Overall Study||16||
48204971|NCT02715258|100827342|FG001|NOT COMPLETED|Overall Study||6||
48204972|NCT00478335|100827343|FG000|STARTED|Period 1 (4 Days)||2||
48204973|NCT00478335|100827344|FG001|STARTED|Period 1 (4 Days)||2||
48204974|NCT00478335|100827343|FG000|COMPLETED|Period 1 (4 Days)||2||
48204975|NCT00478335|100827344|FG001|COMPLETED|Period 1 (4 Days)||2||
48204976|NCT00478335|100827343|FG000|NOT COMPLETED|Period 1 (4 Days)||0||
48204977|NCT00478335|100827344|FG001|NOT COMPLETED|Period 1 (4 Days)||0||
48204978|NCT00478335|100827343|FG000|STARTED|Period 2 (4 Days)||2||
48204979|NCT00478335|100827344|FG001|STARTED|Period 2 (4 Days)||2||
48204980|NCT00478335|100827343|FG000|COMPLETED|Period 2 (4 Days)||2||
48204981|NCT00478335|100827344|FG001|COMPLETED|Period 2 (4 Days)||2||
48204982|NCT00478335|100827343|FG000|NOT COMPLETED|Period 2 (4 Days)||0||
48204983|NCT00478335|100827344|FG001|NOT COMPLETED|Period 2 (4 Days)||0||
48204984|NCT00922207|100827345|FG000|STARTED|Overall Study||91||
48204985|NCT00922207|100827346|FG001|STARTED|Overall Study||95||
48204986|NCT00922207|100827347|FG002|STARTED|Overall Study||94||
48204987|NCT00922207|100827345|FG000|COMPLETED|Overall Study||85||
48204988|NCT00922207|100827346|FG001|COMPLETED|Overall Study||88||
48204989|NCT00922207|100827347|FG002|COMPLETED|Overall Study||90||
48204990|NCT00922207|100827345|FG000|NOT COMPLETED|Overall Study||6||
48204991|NCT00922207|100827346|FG001|NOT COMPLETED|Overall Study||7||
48204992|NCT00922207|100827347|FG002|NOT COMPLETED|Overall Study||4||
48043680|NCT03011892|100428080|FG009|STARTED|Open Label (OL) Period||41||
48043681|NCT03011892|100428081|FG010|STARTED|Open Label (OL) Period||42||
48043682|NCT03011892|100428082|FG011|STARTED|Open Label (OL) Period||43||
48043683|NCT03011892|100428071|FG000|COMPLETED|Open Label (OL) Period||0||
48043684|NCT03011892|100428072|FG001|COMPLETED|Open Label (OL) Period||0||
48043685|NCT03011892|100428073|FG002|COMPLETED|Open Label (OL) Period||0||
48043686|NCT03011892|100428074|FG003|COMPLETED|Open Label (OL) Period||0||
48043687|NCT03011892|100428075|FG004|COMPLETED|Open Label (OL) Period||0||
48204993|NCT02281318|100827348|FG000|STARTED|Overall Study||277||
48204994|NCT02281318|100827349|FG001|STARTED|Overall Study||274||
48204995|NCT02281318|100827348|FG000|COMPLETED|Overall Study||263||
48043688|NCT03011892|100428076|FG005|COMPLETED|Open Label (OL) Period||0||
48043689|NCT03011892|100428077|FG006|COMPLETED|Open Label (OL) Period||34||
48043690|NCT03011892|100428078|FG007|COMPLETED|Open Label (OL) Period||37||
48043691|NCT03011892|100428079|FG008|COMPLETED|Open Label (OL) Period||43||
48043692|NCT03011892|100428080|FG009|COMPLETED|Open Label (OL) Period||41||
48043693|NCT03011892|100428081|FG010|COMPLETED|Open Label (OL) Period||40||
48043694|NCT03011892|100428082|FG011|COMPLETED|Open Label (OL) Period||40||
48043695|NCT03011892|100428071|FG000|NOT COMPLETED|Open Label (OL) Period||0||
48043696|NCT03011892|100428072|FG001|NOT COMPLETED|Open Label (OL) Period||0||
48043697|NCT03011892|100428073|FG002|NOT COMPLETED|Open Label (OL) Period||0||
48043698|NCT03011892|100428074|FG003|NOT COMPLETED|Open Label (OL) Period||0||
48043699|NCT03011892|100428075|FG004|NOT COMPLETED|Open Label (OL) Period||0||
48043700|NCT03011892|100428076|FG005|NOT COMPLETED|Open Label (OL) Period||0||
48043701|NCT03011892|100428077|FG006|NOT COMPLETED|Open Label (OL) Period||7||
48043702|NCT03011892|100428078|FG007|NOT COMPLETED|Open Label (OL) Period||3||
48043703|NCT03011892|100428079|FG008|NOT COMPLETED|Open Label (OL) Period||2||
48043704|NCT03011892|100428080|FG009|NOT COMPLETED|Open Label (OL) Period||0||
48204996|NCT02281318|100827349|FG001|COMPLETED|Overall Study||269||
48204997|NCT02281318|100827348|FG000|NOT COMPLETED|Overall Study||14||
48204998|NCT02281318|100827349|FG001|NOT COMPLETED|Overall Study||5||
48204999|NCT01585558|100827350|FG000|STARTED|Overall Study||62||
48205000|NCT01585558|100827351|FG001|STARTED|Overall Study||69||
48205001|NCT01585558|100827352|FG002|STARTED|Overall Study||49||
48205002|NCT01585558|100827350|FG000|COMPLETED|Overall Study||49||
48043705|NCT03011892|100428081|FG010|NOT COMPLETED|Open Label (OL) Period||2||
48043706|NCT03011892|100428082|FG011|NOT COMPLETED|Open Label (OL) Period||3||
48043707|NCT04313647|100428083|FG000|STARTED|Overall Study||3||
48043708|NCT04313647|100428084|FG001|STARTED|Overall Study||3||
48043709|NCT04313647|100428085|FG002|STARTED|Overall Study||6||
48043710|NCT04313647|100428086|FG003|STARTED|Overall Study||6||
48205003|NCT01585558|100827351|FG001|COMPLETED|Overall Study||57||
48205004|NCT01585558|100827352|FG002|COMPLETED|Overall Study||34||
48205005|NCT01585558|100827350|FG000|NOT COMPLETED|Overall Study||13||
48205006|NCT01585558|100827351|FG001|NOT COMPLETED|Overall Study||12||
48205007|NCT01585558|100827352|FG002|NOT COMPLETED|Overall Study||15||
48205008|NCT00468910|100827353|FG000|STARTED|Overall Study||40||
48205009|NCT00468910|100827354|FG001|STARTED|Overall Study||39||
48205010|NCT00468910|100827353|FG000|Randomization|Overall Study||40||
48205011|NCT00468910|100827354|FG001|Randomization|Overall Study||39||
48205012|NCT00468910|100827353|FG000|Treatment|Overall Study||36||
48205013|NCT00468910|100827354|FG001|Treatment|Overall Study||36||
48205014|NCT00468910|100827353|FG000|Post-Treatment Biopsy|Overall Study||36||
48205015|NCT00468910|100827354|FG001|Post-Treatment Biopsy|Overall Study||36||
48205016|NCT00468910|100827353|FG000|Follow-up|Overall Study||36||
48205017|NCT00468910|100827354|FG001|Follow-up|Overall Study||36||
48205018|NCT00468910|100827353|FG000|COMPLETED|Overall Study||36||
48205019|NCT00468910|100827354|FG001|COMPLETED|Overall Study||36||
48205020|NCT00468910|100827353|FG000|NOT COMPLETED|Overall Study||4||
48205021|NCT00468910|100827354|FG001|NOT COMPLETED|Overall Study||3||
48205022|NCT01070888|100827355|FG000|STARTED|First Intervention (14 Days)||2||
48205023|NCT01070888|100827356|FG001|STARTED|First Intervention (14 Days)||4||
48205024|NCT01070888|100827355|FG000|COMPLETED|First Intervention (14 Days)||2||
48205025|NCT01070888|100827356|FG001|COMPLETED|First Intervention (14 Days)||2||
48205026|NCT01070888|100827355|FG000|NOT COMPLETED|First Intervention (14 Days)||0||
48205027|NCT01070888|100827356|FG001|NOT COMPLETED|First Intervention (14 Days)||2||
48205028|NCT01070888|100827355|FG000|STARTED|Washout (14 Days)||2||
48043711|NCT04313647|100428087|FG004|STARTED|Overall Study||6||
48043712|NCT04313647|100428083|FG000|COMPLETED|Overall Study||3||
48043713|NCT04313647|100428084|FG001|COMPLETED|Overall Study||3||
48043714|NCT04313647|100428085|FG002|COMPLETED|Overall Study||6||
48043715|NCT04313647|100428086|FG003|COMPLETED|Overall Study||6||
48043716|NCT04313647|100428087|FG004|COMPLETED|Overall Study||6||
48043717|NCT04313647|100428083|FG000|NOT COMPLETED|Overall Study||0||
48043718|NCT04313647|100428084|FG001|NOT COMPLETED|Overall Study||0||
48043719|NCT04313647|100428085|FG002|NOT COMPLETED|Overall Study||0||
48043720|NCT04313647|100428086|FG003|NOT COMPLETED|Overall Study||0||
48043721|NCT04313647|100428087|FG004|NOT COMPLETED|Overall Study||0||
48043722|NCT01227629|100428088|FG000|STARTED|Overall Study||58||
48043723|NCT01227629|100428089|FG001|STARTED|Overall Study||20||
48043724|NCT01227629|100428090|FG002|STARTED|Overall Study||27||
48043725|NCT01227629|100428091|FG003|STARTED|Overall Study||99||
48043726|NCT01227629|100428092|FG004|STARTED|Overall Study||34||
48043727|NCT01227629|100428093|FG005|STARTED|Overall Study||33||
48043728|NCT01227629|100428094|FG006|STARTED|Overall Study||98||
48043729|NCT01227629|100428095|FG007|STARTED|Overall Study||33||
48043730|NCT01227629|100428096|FG008|STARTED|Overall Study||30||
48043731|NCT01227629|100428097|FG009|STARTED|Overall Study||70||
48043732|NCT01227629|100428088|FG000|COMPLETED|Overall Study||56||
48043733|NCT01227629|100428089|FG001|COMPLETED|Overall Study||18||
48043734|NCT01227629|100428090|FG002|COMPLETED|Overall Study||26||
48043735|NCT01227629|100428091|FG003|COMPLETED|Overall Study||91||
48043736|NCT01227629|100428092|FG004|COMPLETED|Overall Study||32||
48043737|NCT01227629|100428093|FG005|COMPLETED|Overall Study||32||
48043738|NCT01227629|100428094|FG006|COMPLETED|Overall Study||90||
48043739|NCT01227629|100428095|FG007|COMPLETED|Overall Study||27||
48043740|NCT01227629|100428096|FG008|COMPLETED|Overall Study||24||
48043741|NCT01227629|100428097|FG009|COMPLETED|Overall Study||68||
48043742|NCT01227629|100428088|FG000|NOT COMPLETED|Overall Study||2||
48043743|NCT01227629|100428089|FG001|NOT COMPLETED|Overall Study||2||
48043744|NCT01227629|100428090|FG002|NOT COMPLETED|Overall Study||1||
48043745|NCT01227629|100428091|FG003|NOT COMPLETED|Overall Study||8||
48043746|NCT01227629|100428092|FG004|NOT COMPLETED|Overall Study||2||
48043747|NCT01227629|100428093|FG005|NOT COMPLETED|Overall Study||1||
48043748|NCT01227629|100428094|FG006|NOT COMPLETED|Overall Study||8||
48043749|NCT01227629|100428095|FG007|NOT COMPLETED|Overall Study||6||
48043750|NCT01227629|100428096|FG008|NOT COMPLETED|Overall Study||6||
48205029|NCT01070888|100827356|FG001|STARTED|Washout (14 Days)||2||
48205030|NCT01070888|100827355|FG000|COMPLETED|Washout (14 Days)||1||
48205031|NCT01070888|100827356|FG001|COMPLETED|Washout (14 Days)||2||
48205032|NCT01070888|100827355|FG000|NOT COMPLETED|Washout (14 Days)||1||
48205033|NCT01070888|100827356|FG001|NOT COMPLETED|Washout (14 Days)||0||
48205034|NCT01070888|100827355|FG000|STARTED|Second Intervention (14 Days)||1||
48043751|NCT01227629|100428097|FG009|NOT COMPLETED|Overall Study||2||
48043752|NCT01445548|100428098|FG000|STARTED|Overall Study||6||
48043753|NCT01445548|100428098|FG000|COMPLETED|Overall Study||5||
48043754|NCT01445548|100428098|FG000|NOT COMPLETED|Overall Study||1||
48043755|NCT00997113|100428099|FG000|STARTED|Overall Study||10||
48043756|NCT00997113|100428100|FG001|STARTED|Overall Study||10||
48043757|NCT00997113|100428099|FG000|COMPLETED|Overall Study||10||
48043758|NCT00997113|100428100|FG001|COMPLETED|Overall Study||10||
48043759|NCT00997113|100428099|FG000|NOT COMPLETED|Overall Study||0||
48043760|NCT00997113|100428100|FG001|NOT COMPLETED|Overall Study||0||
48043761|NCT00869778|100428101|FG000|STARTED|Overall Study||120||
48205035|NCT01070888|100827356|FG001|STARTED|Second Intervention (14 Days)||2||
48205036|NCT01070888|100827355|FG000|COMPLETED|Second Intervention (14 Days)||1||
48205037|NCT01070888|100827356|FG001|COMPLETED|Second Intervention (14 Days)||2||
48205038|NCT01070888|100827355|FG000|NOT COMPLETED|Second Intervention (14 Days)||0||
48205039|NCT01070888|100827356|FG001|NOT COMPLETED|Second Intervention (14 Days)||0||
48205040|NCT02621424|100827357|FG000|STARTED|Overall Study||14||
48205041|NCT02621424|100827358|FG001|STARTED|Overall Study||18||
48205042|NCT02621424|100827357|FG000|COMPLETED|Overall Study||13||
48205043|NCT02621424|100827358|FG001|COMPLETED|Overall Study||16||
48205044|NCT02621424|100827357|FG000|NOT COMPLETED|Overall Study||1||
48205045|NCT02621424|100827358|FG001|NOT COMPLETED|Overall Study||2||
48205046|NCT00746330|100827359|FG000|STARTED|Period 1||7||
48205047|NCT00746330|100827360|FG001|STARTED|Period 1||9||
48205048|NCT00746330|100827361|FG002|STARTED|Period 1||9||
48205049|NCT00746330|100827362|FG003|STARTED|Period 1||7||
48205050|NCT00746330|100827359|FG000|COMPLETED|Period 1||7||
48205051|NCT00746330|100827360|FG001|COMPLETED|Period 1||9||
48205052|NCT00746330|100827361|FG002|COMPLETED|Period 1||8||
48205053|NCT00746330|100827362|FG003|COMPLETED|Period 1||7||
48205054|NCT00746330|100827359|FG000|NOT COMPLETED|Period 1||0||
48043762|NCT00869778|100428102|FG001|STARTED|Overall Study||120||
48043763|NCT00869778|100428103|FG002|STARTED|Overall Study||120||
48043764|NCT00869778|100428101|FG000|COMPLETED|Overall Study||108||
48043765|NCT00869778|100428102|FG001|COMPLETED|Overall Study||113||
48043766|NCT00869778|100428103|FG002|COMPLETED|Overall Study||110||
48043767|NCT00869778|100428101|FG000|NOT COMPLETED|Overall Study||12||
48043768|NCT00869778|100428102|FG001|NOT COMPLETED|Overall Study||7||
48043769|NCT00869778|100428103|FG002|NOT COMPLETED|Overall Study||10||
48043770|NCT01129583|100428104|FG000|STARTED|Overall Study||9||
48043771|NCT01129583|100428105|FG001|STARTED|Overall Study||9||
48043772|NCT01129583|100428104|FG000|COMPLETED|Overall Study||6||
48043773|NCT01129583|100428105|FG001|COMPLETED|Overall Study||7||
48043774|NCT01129583|100428104|FG000|NOT COMPLETED|Overall Study||3||
48043775|NCT01129583|100428105|FG001|NOT COMPLETED|Overall Study||2||
48043776|NCT01981057|100428106|FG000|STARTED|Overall Study||50||
48043777|NCT01981057|100428107|FG001|STARTED|Overall Study||50||
48043778|NCT01981057|100428106|FG000|COMPLETED|Overall Study||50||
48043779|NCT01981057|100428107|FG001|COMPLETED|Overall Study||50||
48043780|NCT01981057|100428106|FG000|NOT COMPLETED|Overall Study||0||
48043781|NCT01981057|100428107|FG001|NOT COMPLETED|Overall Study||0||
48043782|NCT03726996|100428108|FG000|STARTED|Overall Study||4||
48043783|NCT03726996|100428108|FG000|COMPLETED|Overall Study||0||
48043784|NCT03726996|100428108|FG000|NOT COMPLETED|Overall Study||4||
48043785|NCT00740376|100428109|FG000|STARTED|Overall Study||22||26
48043786|NCT00740376|100428110|FG001|STARTED|Overall Study||15||21
48043787|NCT00740376|100428109|FG000|COMPLETED|Overall Study||19||22
48043788|NCT00740376|100428110|FG001|COMPLETED|Overall Study||12||18
48043789|NCT00740376|100428109|FG000|NOT COMPLETED|Overall Study||3||4
48043790|NCT00740376|100428110|FG001|NOT COMPLETED|Overall Study||3||3
48043791|NCT00621621|100428111|FG000|STARTED|Overall Study||105||
48043792|NCT00621621|100428112|FG001|STARTED|Overall Study||705||
48043793|NCT00621621|100428111|FG000|COMPLETED|Overall Study||75||
48043794|NCT00621621|100428112|FG001|COMPLETED|Overall Study||705||
48043795|NCT00621621|100428111|FG000|NOT COMPLETED|Overall Study||30||
48043796|NCT00621621|100428112|FG001|NOT COMPLETED|Overall Study||0||
48043797|NCT01894568|100428113|FG000|STARTED|Overall Study||192||
48043798|NCT01894568|100428114|FG001|STARTED|Overall Study||196||
48043799|NCT01894568|100428113|FG000|Received at Least 1 Dose of Study Drug|Overall Study||192||
48043800|NCT01894568|100428114|FG001|Received at Least 1 Dose of Study Drug|Overall Study||196||
48043801|NCT01894568|100428113|FG000|COMPLETED|Overall Study||182||
48043802|NCT01894568|100428114|FG001|COMPLETED|Overall Study||186||
48043803|NCT01894568|100428113|FG000|NOT COMPLETED|Overall Study||10||
48043804|NCT01894568|100428114|FG001|NOT COMPLETED|Overall Study||10||
48043805|NCT03381729|100428115|FG000|STARTED|Overall Study||3||
48043806|NCT03381729|100428116|FG001|STARTED|Overall Study||13||
48043807|NCT03381729|100428117|FG002|STARTED|Overall Study||12||
48043808|NCT03381729|100428118|FG003|STARTED|Overall Study||4||
48205055|NCT00746330|100827360|FG001|NOT COMPLETED|Period 1||0||
48205056|NCT00746330|100827361|FG002|NOT COMPLETED|Period 1||1||
48205057|NCT00746330|100827362|FG003|NOT COMPLETED|Period 1||0||
48205058|NCT00746330|100827359|FG000|STARTED|Period 2||7||
48205059|NCT00746330|100827360|FG001|STARTED|Period 2||9||
48205060|NCT00746330|100827361|FG002|STARTED|Period 2||8||
48043809|NCT03381729|100428119|FG004|STARTED|Overall Study||0||
48043810|NCT03381729|100428115|FG000|Received AVXS-101|Overall Study||3||
48043811|NCT03381729|100428116|FG001|Received AVXS-101|Overall Study||13||
48043812|NCT03381729|100428117|FG002|Received AVXS-101|Overall Study||12||
48205061|NCT00746330|100827362|FG003|STARTED|Period 2||7||
48205062|NCT00746330|100827359|FG000|COMPLETED|Period 2||7||
48205063|NCT00746330|100827360|FG001|COMPLETED|Period 2||9||
48043813|NCT03381729|100428118|FG003|Received AVXS-101|Overall Study||4||
48043814|NCT03381729|100428119|FG004|Received AVXS-101|Overall Study||0||
48043815|NCT03381729|100428115|FG000|COMPLETED|Overall Study||3||
48043816|NCT03381729|100428116|FG001|COMPLETED|Overall Study||13||
48043817|NCT03381729|100428117|FG002|COMPLETED|Overall Study||12||
48043818|NCT03381729|100428118|FG003|COMPLETED|Overall Study||4||
48043819|NCT03381729|100428119|FG004|COMPLETED|Overall Study||0||
48043820|NCT03381729|100428115|FG000|NOT COMPLETED|Overall Study||0||
48043821|NCT03381729|100428116|FG001|NOT COMPLETED|Overall Study||0||
48043822|NCT03381729|100428117|FG002|NOT COMPLETED|Overall Study||0||
48043823|NCT03381729|100428118|FG003|NOT COMPLETED|Overall Study||0||
48205064|NCT00746330|100827361|FG002|COMPLETED|Period 2||8||
48205065|NCT00746330|100827362|FG003|COMPLETED|Period 2||7||
48205066|NCT00746330|100827359|FG000|NOT COMPLETED|Period 2||0||
48205067|NCT00746330|100827360|FG001|NOT COMPLETED|Period 2||0||
48205068|NCT00746330|100827361|FG002|NOT COMPLETED|Period 2||0||
48205069|NCT00746330|100827362|FG003|NOT COMPLETED|Period 2||0||
48205070|NCT00746330|100827359|FG000|STARTED|Period 3||7||
48666739|NCT03391882|101970468|FG003|Safety Population Part A|Part A - Titration Phase||18||
48043824|NCT03381729|100428119|FG004|NOT COMPLETED|Overall Study||0||
48043825|NCT00534313|100428120|FG000|STARTED|Short-term Period||43||
48043826|NCT00534313|100428121|FG001|STARTED|Short-term Period||40||
48043827|NCT00534313|100428122|FG002|STARTED|Short-term Period||45||
48043828|NCT00534313|100428123|FG003|STARTED|Short-term Period||42||
48043829|NCT00534313|100428120|FG000|COMPLETED|Short-term Period||37||
48043830|NCT00534313|100428121|FG001|COMPLETED|Short-term Period||34||
48043831|NCT00534313|100428122|FG002|COMPLETED|Short-term Period||43||
48043832|NCT00534313|100428123|FG003|COMPLETED|Short-term Period||33||
48043833|NCT00534313|100428120|FG000|NOT COMPLETED|Short-term Period||6||
48043834|NCT00534313|100428121|FG001|NOT COMPLETED|Short-term Period||6||
48043835|NCT00534313|100428122|FG002|NOT COMPLETED|Short-term Period||2||
48043836|NCT00534313|100428123|FG003|NOT COMPLETED|Short-term Period||9||
48043837|NCT00534313|100428120|FG000|STARTED|Long-term Period||37||
48043838|NCT00534313|100428121|FG001|STARTED|Long-term Period||34||
48043839|NCT00534313|100428122|FG002|STARTED|Long-term Period||43||
48043840|NCT00534313|100428123|FG003|STARTED|Long-term Period||33||
48043841|NCT00534313|100428120|FG000|COMPLETED|Long-term Period||0||
48043842|NCT00534313|100428121|FG001|COMPLETED|Long-term Period||0||
48043843|NCT00534313|100428122|FG002|COMPLETED|Long-term Period||0||
48043844|NCT00534313|100428123|FG003|COMPLETED|Long-term Period||0||
48043845|NCT00534313|100428120|FG000|NOT COMPLETED|Long-term Period||37||
48043846|NCT00534313|100428121|FG001|NOT COMPLETED|Long-term Period||34||
48043847|NCT00534313|100428122|FG002|NOT COMPLETED|Long-term Period||43||
48043848|NCT00534313|100428123|FG003|NOT COMPLETED|Long-term Period||33||
48043849|NCT01215916|100428124|FG000|STARTED|Overall Study||1||
48043850|NCT01215916|100428125|FG001|STARTED|Overall Study||5||
48043851|NCT01215916|100428126|FG002|STARTED|Overall Study||3||
48043852|NCT01215916|100428127|FG003|STARTED|Overall Study||6||
48043853|NCT01215916|100428128|FG004|STARTED|Overall Study||6||
48043854|NCT01215916|100428129|FG005|STARTED|Overall Study||4||
48043855|NCT01215916|100428130|FG006|STARTED|Overall Study||9||
48043856|NCT01215916|100428131|FG007|STARTED|Overall Study||3||
48043857|NCT01215916|100428132|FG008|STARTED|Overall Study||2||
48043858|NCT01215916|100428124|FG000|Received at Least 1 Dose of Either Drug|Overall Study||1||
48043859|NCT01215916|100428125|FG001|Received at Least 1 Dose of Either Drug|Overall Study||5||
48043860|NCT01215916|100428126|FG002|Received at Least 1 Dose of Either Drug|Overall Study||3||
48043861|NCT01215916|100428127|FG003|Received at Least 1 Dose of Either Drug|Overall Study||6||
48043862|NCT01215916|100428128|FG004|Received at Least 1 Dose of Either Drug|Overall Study||6||
48043863|NCT01215916|100428129|FG005|Received at Least 1 Dose of Either Drug|Overall Study||4||
48043864|NCT01215916|100428130|FG006|Received at Least 1 Dose of Either Drug|Overall Study||9||
48043865|NCT01215916|100428131|FG007|Received at Least 1 Dose of Either Drug|Overall Study||3||
48043866|NCT01215916|100428132|FG008|Received at Least 1 Dose of Either Drug|Overall Study||2||
48043867|NCT01215916|100428124|FG000|COMPLETED|Overall Study||0||
48043868|NCT01215916|100428125|FG001|COMPLETED|Overall Study||0||
48043869|NCT01215916|100428126|FG002|COMPLETED|Overall Study||0||
48043870|NCT01215916|100428127|FG003|COMPLETED|Overall Study||0||
48043871|NCT01215916|100428128|FG004|COMPLETED|Overall Study||0||
48043872|NCT01215916|100428129|FG005|COMPLETED|Overall Study||0||
48043873|NCT01215916|100428130|FG006|COMPLETED|Overall Study||0||
48043874|NCT01215916|100428131|FG007|COMPLETED|Overall Study||0||
48043875|NCT01215916|100428132|FG008|COMPLETED|Overall Study||0||
48043876|NCT01215916|100428124|FG000|NOT COMPLETED|Overall Study||1||
48043877|NCT01215916|100428125|FG001|NOT COMPLETED|Overall Study||5||
48043878|NCT01215916|100428126|FG002|NOT COMPLETED|Overall Study||3||
48043879|NCT01215916|100428127|FG003|NOT COMPLETED|Overall Study||6||
48043880|NCT01215916|100428128|FG004|NOT COMPLETED|Overall Study||6||
48205071|NCT00746330|100827360|FG001|STARTED|Period 3||9||
48205072|NCT00746330|100827361|FG002|STARTED|Period 3||8||
48205073|NCT00746330|100827362|FG003|STARTED|Period 3||7||
48205074|NCT00746330|100827359|FG000|COMPLETED|Period 3||7||
48205075|NCT00746330|100827360|FG001|COMPLETED|Period 3||9||
48205076|NCT00746330|100827361|FG002|COMPLETED|Period 3||8||
48205077|NCT00746330|100827362|FG003|COMPLETED|Period 3||7||
48043881|NCT01215916|100428129|FG005|NOT COMPLETED|Overall Study||4||
48043882|NCT01215916|100428130|FG006|NOT COMPLETED|Overall Study||9||
48043883|NCT01215916|100428131|FG007|NOT COMPLETED|Overall Study||3||
48043884|NCT01215916|100428132|FG008|NOT COMPLETED|Overall Study||2||
48043885|NCT04987944|100428133|FG000|STARTED|Overall Study||7||
48043886|NCT04987944|100428134|FG001|STARTED|Overall Study||8||
48043887|NCT04987944|100428133|FG000|COMPLETED|Overall Study||7||
48043888|NCT04987944|100428134|FG001|COMPLETED|Overall Study||6||
48043889|NCT04987944|100428133|FG000|NOT COMPLETED|Overall Study||0||
48043890|NCT04987944|100428134|FG001|NOT COMPLETED|Overall Study||2||
48043891|NCT05070546|100428135|FG000|STARTED|Overall Study||320||
48043892|NCT05070546|100428136|FG001|STARTED|Overall Study||68||
48043893|NCT05070546|100428137|FG002|STARTED|Overall Study||320||
48043894|NCT05070546|100428138|FG003|STARTED|Overall Study||70||
48043895|NCT05070546|100428139|FG004|STARTED|Overall Study||316||
48043896|NCT05070546|100428140|FG005|STARTED|Overall Study||30||
48043897|NCT05070546|100428135|FG000|Vaccinated|Overall Study||319||
48043898|NCT05070546|100428136|FG001|Vaccinated|Overall Study||68||
48043899|NCT05070546|100428137|FG002|Vaccinated|Overall Study||319||
48043900|NCT05070546|100428138|FG003|Vaccinated|Overall Study||69||
48043901|NCT05070546|100428139|FG004|Vaccinated|Overall Study||313||
48043902|NCT05070546|100428140|FG005|Vaccinated|Overall Study||30||
48043903|NCT05070546|100428135|FG000|COMPLETED|Overall Study||310||
48043904|NCT05070546|100428136|FG001|COMPLETED|Overall Study||65||
48043905|NCT05070546|100428137|FG002|COMPLETED|Overall Study||309||
48043906|NCT05070546|100428138|FG003|COMPLETED|Overall Study||68||
48043907|NCT05070546|100428139|FG004|COMPLETED|Overall Study||308||
48205078|NCT00746330|100827359|FG000|NOT COMPLETED|Period 3||0||
48205079|NCT00746330|100827360|FG001|NOT COMPLETED|Period 3||0||
48205080|NCT00746330|100827361|FG002|NOT COMPLETED|Period 3||0||
48205081|NCT00746330|100827362|FG003|NOT COMPLETED|Period 3||0||
48205082|NCT00746330|100827359|FG000|STARTED|Period 4||7||
48205083|NCT00746330|100827360|FG001|STARTED|Period 4||9||
48205084|NCT00746330|100827361|FG002|STARTED|Period 4||8||
48205085|NCT00746330|100827362|FG003|STARTED|Period 4||7||
48205086|NCT00746330|100827359|FG000|COMPLETED|Period 4||7||
48205087|NCT00746330|100827360|FG001|COMPLETED|Period 4||9||
48205088|NCT00746330|100827361|FG002|COMPLETED|Period 4||8||
48205089|NCT00746330|100827362|FG003|COMPLETED|Period 4||7||
48205090|NCT00746330|100827359|FG000|NOT COMPLETED|Period 4||0||
48043908|NCT05070546|100428140|FG005|COMPLETED|Overall Study||29||
48043909|NCT05070546|100428135|FG000|NOT COMPLETED|Overall Study||10||
48043910|NCT05070546|100428136|FG001|NOT COMPLETED|Overall Study||3||
48043911|NCT05070546|100428137|FG002|NOT COMPLETED|Overall Study||11||
48043912|NCT05070546|100428138|FG003|NOT COMPLETED|Overall Study||2||
48043913|NCT05070546|100428139|FG004|NOT COMPLETED|Overall Study||8||
48043914|NCT05070546|100428140|FG005|NOT COMPLETED|Overall Study||1||
48043915|NCT03874429|100428141|FG000|STARTED|Overall Study||50||
48043916|NCT03874429|100428142|FG001|STARTED|Overall Study||51||
48043917|NCT03874429|100428141|FG000|COMPLETED|Overall Study||44||
48043918|NCT03874429|100428142|FG001|COMPLETED|Overall Study||46||
48043919|NCT03874429|100428141|FG000|NOT COMPLETED|Overall Study||6||
48043920|NCT03874429|100428142|FG001|NOT COMPLETED|Overall Study||5||
48043921|NCT00684047|100428143|FG000|STARTED|Overall Study||72||
48043922|NCT00684047|100428144|FG001|STARTED|Overall Study||110||
48043923|NCT00684047|100428145|FG002|STARTED|Overall Study||57||
48043924|NCT00684047|100428143|FG000|COMPLETED|Overall Study||59||
48043925|NCT00684047|100428144|FG001|COMPLETED|Overall Study||94||
48043926|NCT00684047|100428145|FG002|COMPLETED|Overall Study||52||
48043927|NCT00684047|100428143|FG000|NOT COMPLETED|Overall Study||13||
48043928|NCT00684047|100428144|FG001|NOT COMPLETED|Overall Study||16||
48043929|NCT00684047|100428145|FG002|NOT COMPLETED|Overall Study||5||
48043930|NCT04821362|100428146|FG000|STARTED|Overall Study||90||
48043931|NCT04821362|100428147|FG001|STARTED|Overall Study||90||
48043932|NCT04821362|100428148|FG002|STARTED|Overall Study||90||
48043933|NCT04821362|100428146|FG000|COMPLETED|Overall Study||90||
48043934|NCT04821362|100428147|FG001|COMPLETED|Overall Study||90||
48043935|NCT04821362|100428148|FG002|COMPLETED|Overall Study||90||
48043936|NCT04821362|100428146|FG000|NOT COMPLETED|Overall Study||0||
48043937|NCT04821362|100428147|FG001|NOT COMPLETED|Overall Study||0||
48043938|NCT04821362|100428148|FG002|NOT COMPLETED|Overall Study||0||
48043939|NCT02673541|100428149|FG000|STARTED|Overall Study||3||
48043940|NCT02673541|100428150|FG001|STARTED|Overall Study||2||
48043941|NCT02673541|100428149|FG000|COMPLETED|Overall Study||3||
48043942|NCT02673541|100428150|FG001|COMPLETED|Overall Study||2||
48043943|NCT02673541|100428149|FG000|NOT COMPLETED|Overall Study||0||
48043944|NCT02673541|100428150|FG001|NOT COMPLETED|Overall Study||0||
48043945|NCT01782469|100428151|FG000|STARTED|Overall Study||16||
48043946|NCT01782469|100428151|FG000|COMPLETED|Overall Study||15||
48043947|NCT01782469|100428151|FG000|NOT COMPLETED|Overall Study||1||
48043948|NCT00873873|100428152|FG000|STARTED|Overall Study||20||
48043949|NCT00873873|100428153|FG001|STARTED|Overall Study||8||
48043950|NCT00873873|100428154|FG002|STARTED|Overall Study||9||
48043951|NCT00873873|100428155|FG003|STARTED|Overall Study||18||
48043952|NCT00873873|100428152|FG000|COMPLETED|Overall Study||20||
48043953|NCT00873873|100428153|FG001|COMPLETED|Overall Study||8||
48205091|NCT00746330|100827360|FG001|NOT COMPLETED|Period 4||0||
48043954|NCT00873873|100428154|FG002|COMPLETED|Overall Study||9||
48043955|NCT00873873|100428155|FG003|COMPLETED|Overall Study||18||
48043956|NCT00873873|100428152|FG000|NOT COMPLETED|Overall Study||0||
48043957|NCT00873873|100428153|FG001|NOT COMPLETED|Overall Study||0||
48043958|NCT00873873|100428154|FG002|NOT COMPLETED|Overall Study||0||
48043959|NCT00873873|100428155|FG003|NOT COMPLETED|Overall Study||0||
48043960|NCT02937584|100428156|FG000|STARTED|Period 1||11||
48043961|NCT02937584|100428157|FG001|STARTED|Period 1||12||
48043962|NCT02937584|100428156|FG000|COMPLETED|Period 1||10||
48043963|NCT02937584|100428157|FG001|COMPLETED|Period 1||10||
48043964|NCT02937584|100428156|FG000|NOT COMPLETED|Period 1||1||
48043965|NCT02937584|100428157|FG001|NOT COMPLETED|Period 1||2||
48043966|NCT02937584|100428156|FG000|STARTED|Washout||10||
48043967|NCT02937584|100428157|FG001|STARTED|Washout||10||
48043968|NCT02937584|100428156|FG000|COMPLETED|Washout||10||
48043969|NCT02937584|100428157|FG001|COMPLETED|Washout||9||
48043970|NCT02937584|100428156|FG000|NOT COMPLETED|Washout||0||
48043971|NCT02937584|100428157|FG001|NOT COMPLETED|Washout||1||
48043972|NCT02937584|100428156|FG000|STARTED|Period 2||10||
48043973|NCT02937584|100428157|FG001|STARTED|Period 2||9||
48043974|NCT02937584|100428156|FG000|COMPLETED|Period 2||10||
48043975|NCT02937584|100428157|FG001|COMPLETED|Period 2||9||
48043976|NCT02937584|100428156|FG000|NOT COMPLETED|Period 2||0||
48043977|NCT02937584|100428157|FG001|NOT COMPLETED|Period 2||0||
48043978|NCT02921061|100428158|FG000|STARTED|Overall Study||28||
48043979|NCT02921061|100428158|FG000|COMPLETED|Overall Study||28||
48043980|NCT02921061|100428158|FG000|NOT COMPLETED|Overall Study||0||
48043981|NCT01229462|100428159|FG000|STARTED|Overall Study||120||
48043982|NCT01229462|100428160|FG001|STARTED|Overall Study||118||
48043983|NCT01229462|100428159|FG000|COMPLETED|Overall Study||115||
48043984|NCT01229462|100428160|FG001|COMPLETED|Overall Study||109||
48043985|NCT01229462|100428159|FG000|NOT COMPLETED|Overall Study||5||
48043986|NCT01229462|100428160|FG001|NOT COMPLETED|Overall Study||9||
48043987|NCT00592774|100428161|FG000|STARTED|Overall Study||26||
48043988|NCT00592774|100428162|FG001|STARTED|Overall Study||53||
48043989|NCT00592774|100428163|FG002|STARTED|Overall Study||22||
48043990|NCT00592774|100428164|FG003|STARTED|Overall Study||22||
48043991|NCT00592774|100428165|FG004|STARTED|Overall Study||23||
48043992|NCT00592774|100428161|FG000|COMPLETED|Overall Study||15||
48043993|NCT00592774|100428162|FG001|COMPLETED|Overall Study||21||
48043994|NCT00592774|100428163|FG002|COMPLETED|Overall Study||18||
48043995|NCT00592774|100428164|FG003|COMPLETED|Overall Study||8||
48043996|NCT00592774|100428165|FG004|COMPLETED|Overall Study||9||
48043997|NCT00592774|100428161|FG000|NOT COMPLETED|Overall Study||11||
48043998|NCT00592774|100428162|FG001|NOT COMPLETED|Overall Study||32||
48043999|NCT00592774|100428163|FG002|NOT COMPLETED|Overall Study||4||
48044000|NCT00592774|100428164|FG003|NOT COMPLETED|Overall Study||14||
48044001|NCT00592774|100428165|FG004|NOT COMPLETED|Overall Study||14||
48044002|NCT03048383|100428166|FG000|STARTED|Overall Study||28||
48044003|NCT03048383|100428167|FG001|STARTED|Overall Study||21||
48044004|NCT03048383|100428168|FG002|STARTED|Overall Study||22||
48044005|NCT03048383|100428166|FG000|COMPLETED|Overall Study||15||
48044006|NCT03048383|100428167|FG001|COMPLETED|Overall Study||13||
48044007|NCT03048383|100428168|FG002|COMPLETED|Overall Study||10||
48044008|NCT03048383|100428166|FG000|NOT COMPLETED|Overall Study||13||
48044009|NCT03048383|100428167|FG001|NOT COMPLETED|Overall Study||8||
48044010|NCT03048383|100428168|FG002|NOT COMPLETED|Overall Study||12||
48044011|NCT00852371|100428169|FG000|STARTED|Overall Study||198||
48044012|NCT00852371|100428170|FG001|STARTED|Overall Study||200||
48044013|NCT00852371|100428171|FG002|STARTED|Overall Study||196||
48205092|NCT00746330|100827361|FG002|NOT COMPLETED|Period 4||0||
48205093|NCT00746330|100827362|FG003|NOT COMPLETED|Period 4||0||
48205094|NCT00246012|100827363|FG000|STARTED|Overall Study||3||
48044014|NCT00852371|100428172|FG003|STARTED|Overall Study||186||
48044015|NCT00852371|100428169|FG000|COMPLETED|Overall Study||196||
48044016|NCT00852371|100428170|FG001|COMPLETED|Overall Study||197||
48205095|NCT00246012|100827364|FG001|STARTED|Overall Study||3||
48205096|NCT00246012|100827365|FG002|STARTED|Overall Study||3||
48205097|NCT00246012|100827366|FG003|STARTED|Overall Study||3||
48205098|NCT00246012|100827367|FG004|STARTED|Overall Study||3||
48044017|NCT00852371|100428171|FG002|COMPLETED|Overall Study||192||
48044018|NCT00852371|100428172|FG003|COMPLETED|Overall Study||184||
48044019|NCT00852371|100428169|FG000|NOT COMPLETED|Overall Study||2||
48044020|NCT00852371|100428170|FG001|NOT COMPLETED|Overall Study||3||
48044021|NCT00852371|100428171|FG002|NOT COMPLETED|Overall Study||4||
48044022|NCT00852371|100428172|FG003|NOT COMPLETED|Overall Study||2||
48044023|NCT01390064|100428173|FG000|STARTED|Overall Study||3||
48044024|NCT01390064|100428174|FG001|STARTED|Overall Study||3||
48044025|NCT01390064|100428173|FG000|COMPLETED|Overall Study||3||
48044026|NCT01390064|100428174|FG001|COMPLETED|Overall Study||3||
48044027|NCT01390064|100428173|FG000|NOT COMPLETED|Overall Study||0||
48044028|NCT01390064|100428174|FG001|NOT COMPLETED|Overall Study||0||
48044029|NCT01006603|100428175|FG000|STARTED|Overall Study||360||
48044030|NCT01006603|100428176|FG001|STARTED|Overall Study||360||
48044031|NCT01006603|100428175|FG000|COMPLETED|Overall Study||289||
48044032|NCT01006603|100428176|FG001|COMPLETED|Overall Study||285||
48044033|NCT01006603|100428175|FG000|NOT COMPLETED|Overall Study||71||
48044034|NCT01006603|100428176|FG001|NOT COMPLETED|Overall Study||75||
48044035|NCT04738318|100428177|FG000|STARTED|Overall Study||2||
48044036|NCT04738318|100428178|FG001|STARTED|Overall Study||0||
48044037|NCT04738318|100428177|FG000|COMPLETED|Overall Study||1||
48044038|NCT04738318|100428178|FG001|COMPLETED|Overall Study||0||
48044039|NCT04738318|100428177|FG000|NOT COMPLETED|Overall Study||1||
48044040|NCT04738318|100428178|FG001|NOT COMPLETED|Overall Study||0||
48044041|NCT04839562|100428179|FG000|STARTED|Overall Study||29||
48044042|NCT04839562|100428180|FG001|STARTED|Overall Study||31||
48044043|NCT04839562|100428179|FG000|COMPLETED|Overall Study||29||
48044044|NCT04839562|100428180|FG001|COMPLETED|Overall Study||29||
48044045|NCT04839562|100428179|FG000|NOT COMPLETED|Overall Study||0||
48044046|NCT04839562|100428180|FG001|NOT COMPLETED|Overall Study||2||
48044047|NCT00053898|100428181|FG000|STARTED|Overall Study||1552||
48044048|NCT00053898|100428182|FG001|STARTED|Overall Study||1552||
48044049|NCT00053898|100428181|FG000|COMPLETED|Overall Study||1538||
48044050|NCT00053898|100428182|FG001|COMPLETED|Overall Study||1539||
48044051|NCT00053898|100428181|FG000|NOT COMPLETED|Overall Study||14||
48044052|NCT00053898|100428182|FG001|NOT COMPLETED|Overall Study||13||
48044053|NCT00714571|100428183|FG000|STARTED|Stage 1||12||
48044054|NCT00714571|100428184|FG001|STARTED|Stage 1||15||
48044055|NCT00714571|100428185|FG002|STARTED|Stage 1||11||
48044056|NCT00714571|100428186|FG003|STARTED|Stage 1||14||
48044057|NCT00714571|100428187|FG004|STARTED|Stage 1||0||
48044058|NCT00714571|100428188|FG005|STARTED|Stage 1||0||
48044059|NCT00714571|100428183|FG000|COMPLETED|Stage 1||12||
48044060|NCT00714571|100428184|FG001|COMPLETED|Stage 1||15||
48044061|NCT00714571|100428185|FG002|COMPLETED|Stage 1||10||
48044062|NCT00714571|100428186|FG003|COMPLETED|Stage 1||14||
48044063|NCT00714571|100428187|FG004|COMPLETED|Stage 1||0||
48044064|NCT00714571|100428188|FG005|COMPLETED|Stage 1||0||
48044065|NCT00714571|100428183|FG000|NOT COMPLETED|Stage 1||0||
48044066|NCT00714571|100428184|FG001|NOT COMPLETED|Stage 1||0||
48044067|NCT00714571|100428185|FG002|NOT COMPLETED|Stage 1||1||
48044068|NCT00714571|100428186|FG003|NOT COMPLETED|Stage 1||0||
48044069|NCT00714571|100428187|FG004|NOT COMPLETED|Stage 1||0||
48044070|NCT00714571|100428188|FG005|NOT COMPLETED|Stage 1||0||
48044071|NCT00714571|100428183|FG000|STARTED|Stage 2||0||
48044072|NCT00714571|100428184|FG001|STARTED|Stage 2||0||
48044073|NCT00714571|100428185|FG002|STARTED|Stage 2||0||
48044074|NCT00714571|100428186|FG003|STARTED|Stage 2||0||
48044075|NCT00714571|100428187|FG004|STARTED|Stage 2||15||
48044076|NCT00714571|100428188|FG005|STARTED|Stage 2||15||
48044077|NCT00714571|100428183|FG000|COMPLETED|Stage 2||0||
48044078|NCT00714571|100428184|FG001|COMPLETED|Stage 2||0||
48044079|NCT00714571|100428185|FG002|COMPLETED|Stage 2||0||
48044080|NCT00714571|100428186|FG003|COMPLETED|Stage 2||0||
48044081|NCT00714571|100428187|FG004|COMPLETED|Stage 2||15||
48044082|NCT00714571|100428188|FG005|COMPLETED|Stage 2||15||
48044083|NCT00714571|100428183|FG000|NOT COMPLETED|Stage 2||0||
48044084|NCT00714571|100428184|FG001|NOT COMPLETED|Stage 2||0||
48044085|NCT00714571|100428185|FG002|NOT COMPLETED|Stage 2||0||
48044086|NCT00714571|100428186|FG003|NOT COMPLETED|Stage 2||0||
48044087|NCT00714571|100428187|FG004|NOT COMPLETED|Stage 2||0||
48044088|NCT00714571|100428188|FG005|NOT COMPLETED|Stage 2||0||
48044089|NCT00432601|100431455|FG000|STARTED|Time 1 to Time 2||510||
48044090|NCT00432601|100431456|FG001|STARTED|Time 1 to Time 2||512||
48205099|NCT00246012|100827368|FG005|STARTED|Overall Study||32||
48205100|NCT00246012|100827369|FG006|STARTED|Overall Study||32||
48044091|NCT00432601|100431455|FG000|COMPLETED|Time 1 to Time 2||141||
48044092|NCT00432601|100431456|FG001|COMPLETED|Time 1 to Time 2||144||
48044093|NCT00432601|100431455|FG000|NOT COMPLETED|Time 1 to Time 2||369||
48044094|NCT00432601|100431456|FG001|NOT COMPLETED|Time 1 to Time 2||368||
48044095|NCT00432601|100431455|FG000|STARTED|Time 2 to Time 3||141||
48044096|NCT00432601|100431456|FG001|STARTED|Time 2 to Time 3||144||
48044097|NCT00432601|100431455|FG000|COMPLETED|Time 2 to Time 3||122||
48044098|NCT00432601|100431456|FG001|COMPLETED|Time 2 to Time 3||122||
48044099|NCT00432601|100431455|FG000|NOT COMPLETED|Time 2 to Time 3||19||
48044100|NCT00432601|100431456|FG001|NOT COMPLETED|Time 2 to Time 3||22||
48044101|NCT00052442|100431457|FG000|STARTED|Overall Study||16||
48044102|NCT00052442|100431458|FG001|STARTED|Overall Study||3||
48205101|NCT00246012|100827370|FG007|STARTED|Overall Study||33||
48205102|NCT00246012|100827371|FG008|STARTED|Overall Study||32||
48205103|NCT00246012|100827363|FG000|Treated|Overall Study||3||
48044103|NCT00052442|100431459|FG002|STARTED|Overall Study||27||
48044104|NCT00052442|100431460|FG003|STARTED|Overall Study||11||
48205104|NCT00246012|100827364|FG001|Treated|Overall Study||3||
48205105|NCT00246012|100827365|FG002|Treated|Overall Study||3||
48044105|NCT00052442|100431461|FG004|STARTED|Overall Study||15||
48044106|NCT00052442|100431457|FG000|COMPLETED|Overall Study||16||
48044107|NCT00052442|100431458|FG001|COMPLETED|Overall Study||3||
48044108|NCT00052442|100431459|FG002|COMPLETED|Overall Study||27||
48044109|NCT00052442|100431460|FG003|COMPLETED|Overall Study||11||
48044110|NCT00052442|100431461|FG004|COMPLETED|Overall Study||15||
48044111|NCT00052442|100431457|FG000|NOT COMPLETED|Overall Study||0||
48044112|NCT00052442|100431458|FG001|NOT COMPLETED|Overall Study||0||
48044113|NCT00052442|100431459|FG002|NOT COMPLETED|Overall Study||0||
48044114|NCT00052442|100431460|FG003|NOT COMPLETED|Overall Study||0||
48205106|NCT00246012|100827366|FG003|Treated|Overall Study||3||
48044115|NCT00052442|100431461|FG004|NOT COMPLETED|Overall Study||0||
48044116|NCT00890045|100431462|FG000|STARTED|Overall Study||20||
48044117|NCT00890045|100431463|FG001|STARTED|Overall Study||52||
48044118|NCT00890045|100431462|FG000|COMPLETED|Overall Study||15||
48044119|NCT00890045|100431463|FG001|COMPLETED|Overall Study||42||
48044120|NCT00890045|100431462|FG000|NOT COMPLETED|Overall Study||5||
48044121|NCT00890045|100431463|FG001|NOT COMPLETED|Overall Study||10||
48044122|NCT02048241|100431464|FG000|STARTED|Overall Study||5||
48044123|NCT02048241|100431465|FG001|STARTED|Overall Study||6||
48044124|NCT02048241|100431464|FG000|COMPLETED|Overall Study||5||
48044125|NCT02048241|100431465|FG001|COMPLETED|Overall Study||5||
48044126|NCT02048241|100431464|FG000|NOT COMPLETED|Overall Study||0||
48044127|NCT02048241|100431465|FG001|NOT COMPLETED|Overall Study||1||
48044128|NCT01120067|100431466|FG000|STARTED|Overall Study||12||
48044129|NCT01120067|100431467|FG001|STARTED|Overall Study||11||
48044130|NCT01120067|100431466|FG000|COMPLETED|Overall Study||7||
48044131|NCT01120067|100431467|FG001|COMPLETED|Overall Study||10||
48044132|NCT01120067|100431466|FG000|NOT COMPLETED|Overall Study||5||
48044133|NCT01120067|100431467|FG001|NOT COMPLETED|Overall Study||1||
48044134|NCT00727532|100431468|FG000|STARTED|Overall Study||9||
48044135|NCT00727532|100431468|FG000|COMPLETED|Overall Study||7||
48044136|NCT00727532|100431468|FG000|NOT COMPLETED|Overall Study||2||
48044137|NCT01001299|100431469|FG000|STARTED|Overall Study||25||
48044138|NCT01001299|100431469|FG000|COMPLETED|Overall Study||0||
48044139|NCT01001299|100431469|FG000|NOT COMPLETED|Overall Study||25||
48044140|NCT01993836|100431470|FG000|STARTED|Overall Study||72||
48044141|NCT01993836|100431471|FG001|STARTED|Overall Study||68||
48044142|NCT01993836|100431472|FG002|STARTED|Overall Study||51||
48044143|NCT01993836|100431470|FG000|COMPLETED|Overall Study||55||
48044144|NCT01993836|100431471|FG001|COMPLETED|Overall Study||55||
48044145|NCT01993836|100431472|FG002|COMPLETED|Overall Study||46||
48044146|NCT01993836|100431470|FG000|NOT COMPLETED|Overall Study||17||
48044147|NCT01993836|100431471|FG001|NOT COMPLETED|Overall Study||13||
48044148|NCT01993836|100431472|FG002|NOT COMPLETED|Overall Study||5||
48044149|NCT03774823|100431473|FG000|STARTED|Overall Study||5||
48044150|NCT03774823|100431474|FG001|STARTED|Overall Study||5||
48044151|NCT03774823|100431473|FG000|COMPLETED|Overall Study||4||
48044152|NCT03774823|100431474|FG001|COMPLETED|Overall Study||4||
48044153|NCT03774823|100431473|FG000|NOT COMPLETED|Overall Study||1||
48044154|NCT03774823|100431474|FG001|NOT COMPLETED|Overall Study||1||
48044155|NCT00159822|100431475|FG000|STARTED|Voriconazole Treatment Period||48||
48044156|NCT00159822|100431475|FG000|COMPLETED|Voriconazole Treatment Period||26||
48044157|NCT00159822|100431475|FG000|NOT COMPLETED|Voriconazole Treatment Period||22||
48044158|NCT00159822|100431475|FG000|STARTED|Post-treatment Follow-up Period||26||
48044159|NCT00159822|100431475|FG000|COMPLETED|Post-treatment Follow-up Period||23||
48044160|NCT00159822|100431475|FG000|NOT COMPLETED|Post-treatment Follow-up Period||3||
48044161|NCT00686634|100431476|FG000|STARTED|Overall Study||108||
48044162|NCT00686634|100431476|FG000|COMPLETED|Overall Study||102||
48044163|NCT00686634|100431476|FG000|NOT COMPLETED|Overall Study||6||
48044164|NCT02108262|100431477|FG000|STARTED|Overall Study||9||
48044165|NCT02108262|100431478|FG001|STARTED|Overall Study||419||
48044166|NCT02108262|100431479|FG002|STARTED|Overall Study||421||
48044167|NCT02108262|100431480|FG003|STARTED|Overall Study||418||
48044168|NCT02108262|100431477|FG000|COMPLETED|Overall Study||9||
48044169|NCT02108262|100431478|FG001|COMPLETED|Overall Study||375||
48044170|NCT02108262|100431479|FG002|COMPLETED|Overall Study||379||
48044171|NCT02108262|100431480|FG003|COMPLETED|Overall Study||376||
48044172|NCT02108262|100431477|FG000|NOT COMPLETED|Overall Study||0||
48044173|NCT02108262|100431478|FG001|NOT COMPLETED|Overall Study||44||
48044174|NCT02108262|100431479|FG002|NOT COMPLETED|Overall Study||42||
48044175|NCT02108262|100431480|FG003|NOT COMPLETED|Overall Study||42||
48044176|NCT01604278|100431481|FG000|STARTED|Overall Study||226||
48044177|NCT01604278|100431482|FG001|STARTED|Overall Study||223||
48044178|NCT01604278|100431481|FG000|Safety Set|Overall Study||226||
48044179|NCT01604278|100431482|FG001|Safety Set|Overall Study||221||
48044180|NCT01604278|100431481|FG000|Full Analysis Set|Overall Study||226||
48044181|NCT01604278|100431482|FG001|Full Analysis Set|Overall Study||220||
48044182|NCT01604278|100431481|FG000|COMPLETED|Overall Study||212||
48044183|NCT01604278|100431482|FG001|COMPLETED|Overall Study||210||
48205107|NCT00246012|100827367|FG004|Treated|Overall Study||3||
48205108|NCT00246012|100827368|FG005|Treated|Overall Study||31||
48044184|NCT01604278|100431481|FG000|NOT COMPLETED|Overall Study||14||
48044185|NCT01604278|100431482|FG001|NOT COMPLETED|Overall Study||13||
48044186|NCT02158364|100431483|FG000|STARTED|Overall Study||3331||
48044187|NCT02158364|100431483|FG000|COMPLETED|Overall Study||3271||
48044188|NCT02158364|100431483|FG000|NOT COMPLETED|Overall Study||60||
48044189|NCT00830791|100431484|FG000|STARTED|Overall Study||8||
48044190|NCT00830791|100431485|FG001|STARTED|Overall Study||8||
48044191|NCT00830791|100431486|FG002|STARTED|Overall Study||8||
48044192|NCT00830791|100431487|FG003|STARTED|Overall Study||8||
48044193|NCT00830791|100431488|FG004|STARTED|Overall Study||0||
48044194|NCT00830791|100431489|FG005|STARTED|Overall Study||0||
48044195|NCT00830791|100431484|FG000|COMPLETED|Overall Study||8||
48044196|NCT00830791|100431485|FG001|COMPLETED|Overall Study||8||
48044197|NCT00830791|100431486|FG002|COMPLETED|Overall Study||8||
48044198|NCT00830791|100431487|FG003|COMPLETED|Overall Study||8||
48044199|NCT00830791|100431488|FG004|COMPLETED|Overall Study||0||
48044200|NCT00830791|100431489|FG005|COMPLETED|Overall Study||0||
48044201|NCT00830791|100431484|FG000|NOT COMPLETED|Overall Study||0||
48044202|NCT00830791|100431485|FG001|NOT COMPLETED|Overall Study||0||
48044203|NCT00830791|100431486|FG002|NOT COMPLETED|Overall Study||0||
48044204|NCT00830791|100431487|FG003|NOT COMPLETED|Overall Study||0||
48044205|NCT00830791|100431488|FG004|NOT COMPLETED|Overall Study||0||
48044206|NCT00830791|100431489|FG005|NOT COMPLETED|Overall Study||0||
48044207|NCT04054947|100431490|FG000|STARTED|Overall Study||31||
48044208|NCT04054947|100431491|FG001|STARTED|Overall Study||28||
48044209|NCT04054947|100431490|FG000|COMPLETED|Overall Study||28||
48044210|NCT04054947|100431491|FG001|COMPLETED|Overall Study||23||
48044211|NCT04054947|100431490|FG000|NOT COMPLETED|Overall Study||3||
48044212|NCT04054947|100431491|FG001|NOT COMPLETED|Overall Study||5||
48044213|NCT02409914|100431492|FG000|STARTED|Overall Study||7||
48044214|NCT02409914|100431492|FG000|COMPLETED|Overall Study||7||
48044215|NCT02409914|100431492|FG000|NOT COMPLETED|Overall Study||0||
48044216|NCT00133978|100431493|FG000|STARTED|Overall Study||303||
48044217|NCT00133978|100431494|FG001|STARTED|Overall Study||308||
48044218|NCT00133978|100431495|FG002|STARTED|Overall Study||310||
48044219|NCT00133978|100431496|FG003|STARTED|Overall Study||302||
48044220|NCT00133978|100431493|FG000|COMPLETED|Overall Study||301||
48044221|NCT00133978|100431494|FG001|COMPLETED|Overall Study||307||
48044222|NCT00133978|100431495|FG002|COMPLETED|Overall Study||310||
48044223|NCT00133978|100431496|FG003|COMPLETED|Overall Study||300||
48044224|NCT00133978|100431493|FG000|NOT COMPLETED|Overall Study||2||
48044225|NCT00133978|100431494|FG001|NOT COMPLETED|Overall Study||1||
48044226|NCT00133978|100431495|FG002|NOT COMPLETED|Overall Study||0||
48044227|NCT00133978|100431496|FG003|NOT COMPLETED|Overall Study||2||
48044228|NCT03492840|100431497|FG000|STARTED|Overall Study||6||
48044229|NCT03492840|100431498|FG001|STARTED|Overall Study||3||
48044230|NCT03492840|100431499|FG002|STARTED|Overall Study||3||
48044231|NCT03492840|100431497|FG000|COMPLETED|Overall Study||6||
48044232|NCT03492840|100431498|FG001|COMPLETED|Overall Study||3||
48044233|NCT03492840|100431499|FG002|COMPLETED|Overall Study||3||
48044234|NCT03492840|100431497|FG000|NOT COMPLETED|Overall Study||0||
48044235|NCT03492840|100431498|FG001|NOT COMPLETED|Overall Study||0||
48044236|NCT03492840|100431499|FG002|NOT COMPLETED|Overall Study||0||
48044237|NCT00807573|100431500|FG000|STARTED|Overall Study||44||
48044238|NCT00807573|100431500|FG000|COMPLETED|Overall Study||42||
48044239|NCT00807573|100431500|FG000|NOT COMPLETED|Overall Study||2||
48044240|NCT02217527|100431501|FG000|STARTED|Drug Condition 1: First Study Phase||18||
48044241|NCT02217527|100431502|FG001|STARTED|Drug Condition 1: First Study Phase||18||
48044242|NCT02217527|100431501|FG000|COMPLETED|Drug Condition 1: First Study Phase||17||
48044243|NCT02217527|100431502|FG001|COMPLETED|Drug Condition 1: First Study Phase||15||
48044244|NCT02217527|100431501|FG000|NOT COMPLETED|Drug Condition 1: First Study Phase||1||
48044245|NCT02217527|100431502|FG001|NOT COMPLETED|Drug Condition 1: First Study Phase||3||
48044246|NCT02217527|100431501|FG000|STARTED|Drug Condition 2: Second Study Phase||17||
48044247|NCT02217527|100431502|FG001|STARTED|Drug Condition 2: Second Study Phase||15||
48044248|NCT02217527|100431501|FG000|COMPLETED|Drug Condition 2: Second Study Phase||17||
48044249|NCT02217527|100431502|FG001|COMPLETED|Drug Condition 2: Second Study Phase||14||
48044250|NCT02217527|100431501|FG000|NOT COMPLETED|Drug Condition 2: Second Study Phase||0||
48044251|NCT02217527|100431502|FG001|NOT COMPLETED|Drug Condition 2: Second Study Phase||1||
48044252|NCT03615508|100431503|FG000|STARTED|Overall Study||1||
48044253|NCT03615508|100431503|FG000|COMPLETED|Overall Study||1||
48044254|NCT03615508|100431503|FG000|NOT COMPLETED|Overall Study||0||
48044255|NCT02674854|100431504|FG000|STARTED|Overall Study||245||
48044256|NCT02674854|100431505|FG001|STARTED|Overall Study||255||
48044257|NCT02674854|100431506|FG002|STARTED|Overall Study||250||
48044258|NCT02674854|100431504|FG000|COMPLETED|Overall Study||221||
48044259|NCT02674854|100431505|FG001|COMPLETED|Overall Study||228||
48044260|NCT02674854|100431506|FG002|COMPLETED|Overall Study||236||
48205109|NCT00246012|100827369|FG006|Treated|Overall Study||31||
48205110|NCT00246012|100827370|FG007|Treated|Overall Study||33||
48044261|NCT02674854|100431504|FG000|NOT COMPLETED|Overall Study||24||
48205111|NCT00246012|100827371|FG008|Treated|Overall Study||32||
48495377|NCT00221299|101547836|FG002|COMPLETED|Overall Study||14||
48044262|NCT02674854|100431505|FG001|NOT COMPLETED|Overall Study||27||
48044263|NCT02674854|100431506|FG002|NOT COMPLETED|Overall Study||14||
48044264|NCT01059929|100431507|FG000|STARTED|Overall Study||20||
48044265|NCT01059929|100431508|FG001|STARTED|Overall Study||21||
48044266|NCT01059929|100431507|FG000|COMPLETED|Overall Study||20||
48044267|NCT01059929|100431508|FG001|COMPLETED|Overall Study||21||
48044268|NCT01059929|100431507|FG000|NOT COMPLETED|Overall Study||0||
48044269|NCT01059929|100431508|FG001|NOT COMPLETED|Overall Study||0||
48044270|NCT02507960|100431509|FG000|STARTED|Overall Study||17||
48044271|NCT02507960|100431509|FG000|COMPLETED|Overall Study||17||
48044272|NCT02507960|100431509|FG000|NOT COMPLETED|Overall Study||0||
48044273|NCT01092832|100431510|FG000|STARTED|Overall Study||14||
48044274|NCT01092832|100431511|FG001|STARTED|Overall Study||8||
48044275|NCT01092832|100431510|FG000|COMPLETED|Overall Study||13||
48044276|NCT01092832|100431511|FG001|COMPLETED|Overall Study||8||
48044277|NCT01092832|100431510|FG000|NOT COMPLETED|Overall Study||1||
48044278|NCT01092832|100431511|FG001|NOT COMPLETED|Overall Study||0||
48044279|NCT02276027|100431512|FG000|STARTED|Overall Study||2||
48044280|NCT02276027|100431513|FG001|STARTED|Overall Study||16||
48044281|NCT02276027|100431514|FG002|STARTED|Overall Study||26||
48044282|NCT02276027|100431515|FG003|STARTED|Overall Study||22||
48044283|NCT02276027|100431512|FG000|COMPLETED|Overall Study||0||
48044284|NCT02276027|100431513|FG001|COMPLETED|Overall Study||0||
48044285|NCT02276027|100431514|FG002|COMPLETED|Overall Study||6||
48044286|NCT02276027|100431515|FG003|COMPLETED|Overall Study||0||
48044287|NCT02276027|100431512|FG000|NOT COMPLETED|Overall Study||2||
48044288|NCT02276027|100431513|FG001|NOT COMPLETED|Overall Study||16||
48044289|NCT02276027|100431514|FG002|NOT COMPLETED|Overall Study||20||
48044290|NCT02276027|100431515|FG003|NOT COMPLETED|Overall Study||22||
48044291|NCT01323920|100431516|FG000|STARTED|Overall Study||35||
48044292|NCT01323920|100431516|FG000|COMPLETED|Overall Study||29||
48044293|NCT01323920|100431516|FG000|NOT COMPLETED|Overall Study||6||
48044294|NCT04585009|100431517|FG000|STARTED|PartA, Cohort1, Treatment Period1(Day1)||3||
48044295|NCT04585009|100431518|FG001|STARTED|PartA, Cohort1, Treatment Period1(Day1)||3||
48044296|NCT04585009|100431519|FG002|STARTED|PartA, Cohort1, Treatment Period1(Day1)||3||
48044297|NCT04585009|100431520|FG003|STARTED|PartA, Cohort1, Treatment Period1(Day1)||3||
48044298|NCT04585009|100431521|FG004|STARTED|PartA, Cohort1, Treatment Period1(Day1)||0||
48044299|NCT04585009|100431522|FG005|STARTED|PartA, Cohort1, Treatment Period1(Day1)||0||
48044300|NCT04585009|100431523|FG006|STARTED|PartA, Cohort1, Treatment Period1(Day1)||0||
48044301|NCT04585009|100431524|FG007|STARTED|PartA, Cohort1, Treatment Period1(Day1)||0||
48044302|NCT04585009|100431525|FG008|STARTED|PartA, Cohort1, Treatment Period1(Day1)||0||
48044303|NCT04585009|100431526|FG009|STARTED|PartA, Cohort1, Treatment Period1(Day1)||0||
48044304|NCT04585009|100431527|FG010|STARTED|PartA, Cohort1, Treatment Period1(Day1)||0||
48044305|NCT04585009|100431528|FG011|STARTED|PartA, Cohort1, Treatment Period1(Day1)||0||
48044306|NCT04585009|100431517|FG000|COMPLETED|PartA, Cohort1, Treatment Period1(Day1)||2||
48044307|NCT04585009|100431518|FG001|COMPLETED|PartA, Cohort1, Treatment Period1(Day1)||3||
48044308|NCT04585009|100431519|FG002|COMPLETED|PartA, Cohort1, Treatment Period1(Day1)||3||
48044309|NCT04585009|100431520|FG003|COMPLETED|PartA, Cohort1, Treatment Period1(Day1)||3||
48044310|NCT04585009|100431521|FG004|COMPLETED|PartA, Cohort1, Treatment Period1(Day1)||0||
48044311|NCT04585009|100431522|FG005|COMPLETED|PartA, Cohort1, Treatment Period1(Day1)||0||
48044312|NCT04585009|100431523|FG006|COMPLETED|PartA, Cohort1, Treatment Period1(Day1)||0||
48044313|NCT04585009|100431524|FG007|COMPLETED|PartA, Cohort1, Treatment Period1(Day1)||0||
48044314|NCT04585009|100431525|FG008|COMPLETED|PartA, Cohort1, Treatment Period1(Day1)||0||
48044315|NCT04585009|100431526|FG009|COMPLETED|PartA, Cohort1, Treatment Period1(Day1)||0||
48044316|NCT04585009|100431527|FG010|COMPLETED|PartA, Cohort1, Treatment Period1(Day1)||0||
48044317|NCT04585009|100431528|FG011|COMPLETED|PartA, Cohort1, Treatment Period1(Day1)||0||
48044318|NCT04585009|100431517|FG000|NOT COMPLETED|PartA, Cohort1, Treatment Period1(Day1)||1||
48044319|NCT04585009|100431518|FG001|NOT COMPLETED|PartA, Cohort1, Treatment Period1(Day1)||0||
48044320|NCT04585009|100431519|FG002|NOT COMPLETED|PartA, Cohort1, Treatment Period1(Day1)||0||
48044321|NCT04585009|100431520|FG003|NOT COMPLETED|PartA, Cohort1, Treatment Period1(Day1)||0||
48044322|NCT04585009|100431521|FG004|NOT COMPLETED|PartA, Cohort1, Treatment Period1(Day1)||0||
48044323|NCT04585009|100431522|FG005|NOT COMPLETED|PartA, Cohort1, Treatment Period1(Day1)||0||
48044324|NCT04585009|100431523|FG006|NOT COMPLETED|PartA, Cohort1, Treatment Period1(Day1)||0||
48044325|NCT04585009|100431524|FG007|NOT COMPLETED|PartA, Cohort1, Treatment Period1(Day1)||0||
48044326|NCT04585009|100431525|FG008|NOT COMPLETED|PartA, Cohort1, Treatment Period1(Day1)||0||
48044327|NCT04585009|100431526|FG009|NOT COMPLETED|PartA, Cohort1, Treatment Period1(Day1)||0||
48044328|NCT04585009|100431527|FG010|NOT COMPLETED|PartA, Cohort1, Treatment Period1(Day1)||0||
48044329|NCT04585009|100431528|FG011|NOT COMPLETED|PartA, Cohort1, Treatment Period1(Day1)||0||
48044330|NCT04585009|100431517|FG000|STARTED|Cohort1: Washout Period1 (10Days)||2||
48044331|NCT04585009|100431518|FG001|STARTED|Cohort1: Washout Period1 (10Days)||3||
48044332|NCT04585009|100431519|FG002|STARTED|Cohort1: Washout Period1 (10Days)||3||
48044333|NCT04585009|100431520|FG003|STARTED|Cohort1: Washout Period1 (10Days)||3||
48044334|NCT04585009|100431521|FG004|STARTED|Cohort1: Washout Period1 (10Days)||0||
48044335|NCT04585009|100431522|FG005|STARTED|Cohort1: Washout Period1 (10Days)||0||
48044336|NCT04585009|100431523|FG006|STARTED|Cohort1: Washout Period1 (10Days)||0||
48044337|NCT04585009|100431524|FG007|STARTED|Cohort1: Washout Period1 (10Days)||0||
48044338|NCT04585009|100431525|FG008|STARTED|Cohort1: Washout Period1 (10Days)||0||
48044339|NCT04585009|100431526|FG009|STARTED|Cohort1: Washout Period1 (10Days)||0||
48044340|NCT04585009|100431527|FG010|STARTED|Cohort1: Washout Period1 (10Days)||0||
48044341|NCT04585009|100431528|FG011|STARTED|Cohort1: Washout Period1 (10Days)||0||
48044342|NCT04585009|100431517|FG000|COMPLETED|Cohort1: Washout Period1 (10Days)||2||
48044343|NCT04585009|100431518|FG001|COMPLETED|Cohort1: Washout Period1 (10Days)||3||
48044344|NCT04585009|100431519|FG002|COMPLETED|Cohort1: Washout Period1 (10Days)||3||
48044345|NCT04585009|100431520|FG003|COMPLETED|Cohort1: Washout Period1 (10Days)||3||
48044346|NCT04585009|100431521|FG004|COMPLETED|Cohort1: Washout Period1 (10Days)||0||
48044347|NCT04585009|100431522|FG005|COMPLETED|Cohort1: Washout Period1 (10Days)||0||
48205112|NCT00246012|100827363|FG000|COMPLETED|Overall Study||0||
48205113|NCT00246012|100827364|FG001|COMPLETED|Overall Study||2||
48205114|NCT00246012|100827365|FG002|COMPLETED|Overall Study||1||
48044348|NCT04585009|100431523|FG006|COMPLETED|Cohort1: Washout Period1 (10Days)||0||
48044349|NCT04585009|100431524|FG007|COMPLETED|Cohort1: Washout Period1 (10Days)||0||
48044350|NCT04585009|100431525|FG008|COMPLETED|Cohort1: Washout Period1 (10Days)||0||
48044351|NCT04585009|100431526|FG009|COMPLETED|Cohort1: Washout Period1 (10Days)||0||
48044352|NCT04585009|100431527|FG010|COMPLETED|Cohort1: Washout Period1 (10Days)||0||
48044353|NCT04585009|100431528|FG011|COMPLETED|Cohort1: Washout Period1 (10Days)||0||
48044354|NCT04585009|100431517|FG000|NOT COMPLETED|Cohort1: Washout Period1 (10Days)||0||
48044355|NCT04585009|100431518|FG001|NOT COMPLETED|Cohort1: Washout Period1 (10Days)||0||
48044356|NCT04585009|100431519|FG002|NOT COMPLETED|Cohort1: Washout Period1 (10Days)||0||
48044357|NCT04585009|100431520|FG003|NOT COMPLETED|Cohort1: Washout Period1 (10Days)||0||
48044358|NCT04585009|100431521|FG004|NOT COMPLETED|Cohort1: Washout Period1 (10Days)||0||
48044359|NCT04585009|100431522|FG005|NOT COMPLETED|Cohort1: Washout Period1 (10Days)||0||
48044360|NCT04585009|100431523|FG006|NOT COMPLETED|Cohort1: Washout Period1 (10Days)||0||
48044361|NCT04585009|100431524|FG007|NOT COMPLETED|Cohort1: Washout Period1 (10Days)||0||
48044362|NCT04585009|100431525|FG008|NOT COMPLETED|Cohort1: Washout Period1 (10Days)||0||
48044363|NCT04585009|100431526|FG009|NOT COMPLETED|Cohort1: Washout Period1 (10Days)||0||
48044364|NCT04585009|100431527|FG010|NOT COMPLETED|Cohort1: Washout Period1 (10Days)||0||
48044365|NCT04585009|100431528|FG011|NOT COMPLETED|Cohort1: Washout Period1 (10Days)||0||
48044366|NCT04585009|100431517|FG000|STARTED|PartA, Cohort1,Treatment Period2(Day1)||3||
48044367|NCT04585009|100431518|FG001|STARTED|PartA, Cohort1,Treatment Period2(Day1)||3||
48044368|NCT04585009|100431519|FG002|STARTED|PartA, Cohort1,Treatment Period2(Day1)||3||
48044369|NCT04585009|100431520|FG003|STARTED|PartA, Cohort1,Treatment Period2(Day1)||3||
48044370|NCT04585009|100431521|FG004|STARTED|PartA, Cohort1,Treatment Period2(Day1)||0||
48044371|NCT04585009|100431522|FG005|STARTED|PartA, Cohort1,Treatment Period2(Day1)||0||
48044372|NCT04585009|100431523|FG006|STARTED|PartA, Cohort1,Treatment Period2(Day1)||0||
48044373|NCT04585009|100431524|FG007|STARTED|PartA, Cohort1,Treatment Period2(Day1)||0||
48044374|NCT04585009|100431525|FG008|STARTED|PartA, Cohort1,Treatment Period2(Day1)||0||
48044375|NCT04585009|100431526|FG009|STARTED|PartA, Cohort1,Treatment Period2(Day1)||0||
48044376|NCT04585009|100431527|FG010|STARTED|PartA, Cohort1,Treatment Period2(Day1)||0||
48044377|NCT04585009|100431528|FG011|STARTED|PartA, Cohort1,Treatment Period2(Day1)||0||
48044378|NCT04585009|100431517|FG000|COMPLETED|PartA, Cohort1,Treatment Period2(Day1)||2||
48044379|NCT04585009|100431518|FG001|COMPLETED|PartA, Cohort1,Treatment Period2(Day1)||3||
48044380|NCT04585009|100431519|FG002|COMPLETED|PartA, Cohort1,Treatment Period2(Day1)||3||
48044381|NCT04585009|100431520|FG003|COMPLETED|PartA, Cohort1,Treatment Period2(Day1)||3||
48044382|NCT04585009|100431521|FG004|COMPLETED|PartA, Cohort1,Treatment Period2(Day1)||0||
48044383|NCT04585009|100431522|FG005|COMPLETED|PartA, Cohort1,Treatment Period2(Day1)||0||
48044384|NCT04585009|100431523|FG006|COMPLETED|PartA, Cohort1,Treatment Period2(Day1)||0||
48044385|NCT04585009|100431524|FG007|COMPLETED|PartA, Cohort1,Treatment Period2(Day1)||0||
48044386|NCT04585009|100431525|FG008|COMPLETED|PartA, Cohort1,Treatment Period2(Day1)||0||
48044387|NCT04585009|100431526|FG009|COMPLETED|PartA, Cohort1,Treatment Period2(Day1)||0||
48044388|NCT04585009|100431527|FG010|COMPLETED|PartA, Cohort1,Treatment Period2(Day1)||0||
48044389|NCT04585009|100431528|FG011|COMPLETED|PartA, Cohort1,Treatment Period2(Day1)||0||
48044390|NCT04585009|100431517|FG000|NOT COMPLETED|PartA, Cohort1,Treatment Period2(Day1)||1||
48205115|NCT00246012|100827366|FG003|COMPLETED|Overall Study||0||
48205116|NCT00246012|100827367|FG004|COMPLETED|Overall Study||0||
48205117|NCT00246012|100827368|FG005|COMPLETED|Overall Study||4||
48205118|NCT00246012|100827369|FG006|COMPLETED|Overall Study||1||
48205119|NCT00246012|100827370|FG007|COMPLETED|Overall Study||5||
48205120|NCT00246012|100827371|FG008|COMPLETED|Overall Study||4||
48205121|NCT00246012|100827363|FG000|NOT COMPLETED|Overall Study||3||
48205122|NCT00246012|100827364|FG001|NOT COMPLETED|Overall Study||1||
48205123|NCT00246012|100827365|FG002|NOT COMPLETED|Overall Study||2||
48205124|NCT00246012|100827366|FG003|NOT COMPLETED|Overall Study||3||
48205125|NCT00246012|100827367|FG004|NOT COMPLETED|Overall Study||3||
48205126|NCT00246012|100827368|FG005|NOT COMPLETED|Overall Study||28||
48205127|NCT00246012|100827369|FG006|NOT COMPLETED|Overall Study||31||
48205128|NCT00246012|100827370|FG007|NOT COMPLETED|Overall Study||28||
48205129|NCT00246012|100827371|FG008|NOT COMPLETED|Overall Study||28||
48205130|NCT01649180|100827372|FG000|STARTED|Overall Study||3||
48044391|NCT04585009|100431518|FG001|NOT COMPLETED|PartA, Cohort1,Treatment Period2(Day1)||0||
48044392|NCT04585009|100431519|FG002|NOT COMPLETED|PartA, Cohort1,Treatment Period2(Day1)||0||
48044393|NCT04585009|100431520|FG003|NOT COMPLETED|PartA, Cohort1,Treatment Period2(Day1)||0||
48044394|NCT04585009|100431521|FG004|NOT COMPLETED|PartA, Cohort1,Treatment Period2(Day1)||0||
48044395|NCT04585009|100431522|FG005|NOT COMPLETED|PartA, Cohort1,Treatment Period2(Day1)||0||
48205131|NCT01649180|100827372|FG000|COMPLETED|Overall Study||3||
48205132|NCT01649180|100827372|FG000|NOT COMPLETED|Overall Study||0||
48205133|NCT01212991|100827373|FG000|STARTED|Double-blind||872||
48205134|NCT01212991|100827374|FG001|STARTED|Double-blind||845||
48205135|NCT01212991|100827375|FG002|STARTED|Double-blind||0||
48205136|NCT01212991|100827373|FG000|Safety Population|Double-blind||871||
48205137|NCT01212991|100827374|FG001|Safety Population|Double-blind||844||
48205138|NCT01212991|100827375|FG002|Safety Population|Double-blind||0||
48205139|NCT01212991|100827373|FG000|COMPLETED|Double-blind||0||
48205140|NCT01212991|100827374|FG001|COMPLETED|Double-blind||234||
48044396|NCT04585009|100431523|FG006|NOT COMPLETED|PartA, Cohort1,Treatment Period2(Day1)||0||
48044397|NCT04585009|100431524|FG007|NOT COMPLETED|PartA, Cohort1,Treatment Period2(Day1)||0||
48044398|NCT04585009|100431525|FG008|NOT COMPLETED|PartA, Cohort1,Treatment Period2(Day1)||0||
48044399|NCT04585009|100431526|FG009|NOT COMPLETED|PartA, Cohort1,Treatment Period2(Day1)||0||
48044400|NCT04585009|100431527|FG010|NOT COMPLETED|PartA, Cohort1,Treatment Period2(Day1)||0||
48044401|NCT04585009|100431528|FG011|NOT COMPLETED|PartA, Cohort1,Treatment Period2(Day1)||0||
48044402|NCT04585009|100431517|FG000|STARTED|Cohort1: Washout Period2(10 Days)||2||
48044403|NCT04585009|100431518|FG001|STARTED|Cohort1: Washout Period2(10 Days)||3||
48044404|NCT04585009|100431519|FG002|STARTED|Cohort1: Washout Period2(10 Days)||3||
48044405|NCT04585009|100431520|FG003|STARTED|Cohort1: Washout Period2(10 Days)||3||
48044406|NCT04585009|100431521|FG004|STARTED|Cohort1: Washout Period2(10 Days)||0||
48044407|NCT04585009|100431522|FG005|STARTED|Cohort1: Washout Period2(10 Days)||0||
48044408|NCT04585009|100431523|FG006|STARTED|Cohort1: Washout Period2(10 Days)||0||
48044409|NCT04585009|100431524|FG007|STARTED|Cohort1: Washout Period2(10 Days)||0||
48044410|NCT04585009|100431525|FG008|STARTED|Cohort1: Washout Period2(10 Days)||0||
48044411|NCT04585009|100431526|FG009|STARTED|Cohort1: Washout Period2(10 Days)||0||
48044412|NCT04585009|100431527|FG010|STARTED|Cohort1: Washout Period2(10 Days)||0||
48044413|NCT04585009|100431528|FG011|STARTED|Cohort1: Washout Period2(10 Days)||0||
48044414|NCT04585009|100431517|FG000|COMPLETED|Cohort1: Washout Period2(10 Days)||2||
48044415|NCT04585009|100431518|FG001|COMPLETED|Cohort1: Washout Period2(10 Days)||3||
48044416|NCT04585009|100431519|FG002|COMPLETED|Cohort1: Washout Period2(10 Days)||3||
48044417|NCT04585009|100431520|FG003|COMPLETED|Cohort1: Washout Period2(10 Days)||3||
48044418|NCT04585009|100431521|FG004|COMPLETED|Cohort1: Washout Period2(10 Days)||0||
48044419|NCT04585009|100431522|FG005|COMPLETED|Cohort1: Washout Period2(10 Days)||0||
48044420|NCT04585009|100431523|FG006|COMPLETED|Cohort1: Washout Period2(10 Days)||0||
48044421|NCT04585009|100431524|FG007|COMPLETED|Cohort1: Washout Period2(10 Days)||0||
48044422|NCT04585009|100431525|FG008|COMPLETED|Cohort1: Washout Period2(10 Days)||0||
48044423|NCT04585009|100431526|FG009|COMPLETED|Cohort1: Washout Period2(10 Days)||0||
48044424|NCT04585009|100431527|FG010|COMPLETED|Cohort1: Washout Period2(10 Days)||0||
48044425|NCT04585009|100431528|FG011|COMPLETED|Cohort1: Washout Period2(10 Days)||0||
48044426|NCT04585009|100431517|FG000|NOT COMPLETED|Cohort1: Washout Period2(10 Days)||0||
48044427|NCT04585009|100431518|FG001|NOT COMPLETED|Cohort1: Washout Period2(10 Days)||0||
48044428|NCT04585009|100431519|FG002|NOT COMPLETED|Cohort1: Washout Period2(10 Days)||0||
48044429|NCT04585009|100431520|FG003|NOT COMPLETED|Cohort1: Washout Period2(10 Days)||0||
48044430|NCT04585009|100431521|FG004|NOT COMPLETED|Cohort1: Washout Period2(10 Days)||0||
48044431|NCT04585009|100431522|FG005|NOT COMPLETED|Cohort1: Washout Period2(10 Days)||0||
48044432|NCT04585009|100431523|FG006|NOT COMPLETED|Cohort1: Washout Period2(10 Days)||0||
48044433|NCT04585009|100431524|FG007|NOT COMPLETED|Cohort1: Washout Period2(10 Days)||0||
48044434|NCT04585009|100431525|FG008|NOT COMPLETED|Cohort1: Washout Period2(10 Days)||0||
48044435|NCT04585009|100431526|FG009|NOT COMPLETED|Cohort1: Washout Period2(10 Days)||0||
48044436|NCT04585009|100431527|FG010|NOT COMPLETED|Cohort1: Washout Period2(10 Days)||0||
48044437|NCT04585009|100431528|FG011|NOT COMPLETED|Cohort1: Washout Period2(10 Days)||0||
48044438|NCT04585009|100431517|FG000|STARTED|PartA, Cohort1, Treatment Period3(Day1)||3||
48044439|NCT04585009|100431518|FG001|STARTED|PartA, Cohort1, Treatment Period3(Day1)||3||
48044440|NCT04585009|100431519|FG002|STARTED|PartA, Cohort1, Treatment Period3(Day1)||3||
48044441|NCT04585009|100431520|FG003|STARTED|PartA, Cohort1, Treatment Period3(Day1)||3||
48044442|NCT04585009|100431521|FG004|STARTED|PartA, Cohort1, Treatment Period3(Day1)||0||
48044443|NCT04585009|100431522|FG005|STARTED|PartA, Cohort1, Treatment Period3(Day1)||0||
48044444|NCT04585009|100431523|FG006|STARTED|PartA, Cohort1, Treatment Period3(Day1)||0||
48044445|NCT04585009|100431524|FG007|STARTED|PartA, Cohort1, Treatment Period3(Day1)||0||
48044446|NCT04585009|100431525|FG008|STARTED|PartA, Cohort1, Treatment Period3(Day1)||0||
48044447|NCT04585009|100431526|FG009|STARTED|PartA, Cohort1, Treatment Period3(Day1)||0||
48044448|NCT04585009|100431527|FG010|STARTED|PartA, Cohort1, Treatment Period3(Day1)||0||
48044449|NCT04585009|100431528|FG011|STARTED|PartA, Cohort1, Treatment Period3(Day1)||0||
48044450|NCT04585009|100431517|FG000|COMPLETED|PartA, Cohort1, Treatment Period3(Day1)||3||
48044451|NCT04585009|100431518|FG001|COMPLETED|PartA, Cohort1, Treatment Period3(Day1)||3||
48044452|NCT04585009|100431519|FG002|COMPLETED|PartA, Cohort1, Treatment Period3(Day1)||3||
48044453|NCT04585009|100431520|FG003|COMPLETED|PartA, Cohort1, Treatment Period3(Day1)||3||
48044454|NCT04585009|100431521|FG004|COMPLETED|PartA, Cohort1, Treatment Period3(Day1)||0||
48044455|NCT04585009|100431522|FG005|COMPLETED|PartA, Cohort1, Treatment Period3(Day1)||0||
48044456|NCT04585009|100431523|FG006|COMPLETED|PartA, Cohort1, Treatment Period3(Day1)||0||
48044457|NCT04585009|100431524|FG007|COMPLETED|PartA, Cohort1, Treatment Period3(Day1)||0||
48044458|NCT04585009|100431525|FG008|COMPLETED|PartA, Cohort1, Treatment Period3(Day1)||0||
48044459|NCT04585009|100431526|FG009|COMPLETED|PartA, Cohort1, Treatment Period3(Day1)||0||
48044460|NCT04585009|100431527|FG010|COMPLETED|PartA, Cohort1, Treatment Period3(Day1)||0||
48044461|NCT04585009|100431528|FG011|COMPLETED|PartA, Cohort1, Treatment Period3(Day1)||0||
48044462|NCT04585009|100431517|FG000|NOT COMPLETED|PartA, Cohort1, Treatment Period3(Day1)||0||
48044463|NCT04585009|100431518|FG001|NOT COMPLETED|PartA, Cohort1, Treatment Period3(Day1)||0||
48044464|NCT04585009|100431519|FG002|NOT COMPLETED|PartA, Cohort1, Treatment Period3(Day1)||0||
48044465|NCT04585009|100431520|FG003|NOT COMPLETED|PartA, Cohort1, Treatment Period3(Day1)||0||
48044466|NCT04585009|100431521|FG004|NOT COMPLETED|PartA, Cohort1, Treatment Period3(Day1)||0||
48044467|NCT04585009|100431522|FG005|NOT COMPLETED|PartA, Cohort1, Treatment Period3(Day1)||0||
48044468|NCT04585009|100431523|FG006|NOT COMPLETED|PartA, Cohort1, Treatment Period3(Day1)||0||
48044469|NCT04585009|100431524|FG007|NOT COMPLETED|PartA, Cohort1, Treatment Period3(Day1)||0||
48044470|NCT04585009|100431525|FG008|NOT COMPLETED|PartA, Cohort1, Treatment Period3(Day1)||0||
48044471|NCT04585009|100431526|FG009|NOT COMPLETED|PartA, Cohort1, Treatment Period3(Day1)||0||
48044472|NCT04585009|100431527|FG010|NOT COMPLETED|PartA, Cohort1, Treatment Period3(Day1)||0||
48044473|NCT04585009|100431528|FG011|NOT COMPLETED|PartA, Cohort1, Treatment Period3(Day1)||0||
48044474|NCT04585009|100431517|FG000|STARTED|PartA, Cohort2: Treatment Period4(Day1)||0||
48044475|NCT04585009|100431518|FG001|STARTED|PartA, Cohort2: Treatment Period4(Day1)||0||
48044476|NCT04585009|100431519|FG002|STARTED|PartA, Cohort2: Treatment Period4(Day1)||0||
48044477|NCT04585009|100431520|FG003|STARTED|PartA, Cohort2: Treatment Period4(Day1)||0||
48044478|NCT04585009|100431521|FG004|STARTED|PartA, Cohort2: Treatment Period4(Day1)||3||
48044479|NCT04585009|100431522|FG005|STARTED|PartA, Cohort2: Treatment Period4(Day1)||3||
48044480|NCT04585009|100431523|FG006|STARTED|PartA, Cohort2: Treatment Period4(Day1)||3||
48044481|NCT04585009|100431524|FG007|STARTED|PartA, Cohort2: Treatment Period4(Day1)||3||
48044482|NCT04585009|100431525|FG008|STARTED|PartA, Cohort2: Treatment Period4(Day1)||0||
48044483|NCT04585009|100431526|FG009|STARTED|PartA, Cohort2: Treatment Period4(Day1)||0||
48044484|NCT04585009|100431527|FG010|STARTED|PartA, Cohort2: Treatment Period4(Day1)||0||
48044485|NCT04585009|100431528|FG011|STARTED|PartA, Cohort2: Treatment Period4(Day1)||0||
48044486|NCT04585009|100431517|FG000|COMPLETED|PartA, Cohort2: Treatment Period4(Day1)||0||
48044487|NCT04585009|100431518|FG001|COMPLETED|PartA, Cohort2: Treatment Period4(Day1)||0||
48044488|NCT04585009|100431519|FG002|COMPLETED|PartA, Cohort2: Treatment Period4(Day1)||0||
48044489|NCT04585009|100431520|FG003|COMPLETED|PartA, Cohort2: Treatment Period4(Day1)||0||
48044490|NCT04585009|100431521|FG004|COMPLETED|PartA, Cohort2: Treatment Period4(Day1)||3||
48044491|NCT04585009|100431522|FG005|COMPLETED|PartA, Cohort2: Treatment Period4(Day1)||3||
48044492|NCT04585009|100431523|FG006|COMPLETED|PartA, Cohort2: Treatment Period4(Day1)||3||
48044493|NCT04585009|100431524|FG007|COMPLETED|PartA, Cohort2: Treatment Period4(Day1)||2||
48044494|NCT04585009|100431525|FG008|COMPLETED|PartA, Cohort2: Treatment Period4(Day1)||0||
48044495|NCT04585009|100431526|FG009|COMPLETED|PartA, Cohort2: Treatment Period4(Day1)||0||
48044496|NCT04585009|100431527|FG010|COMPLETED|PartA, Cohort2: Treatment Period4(Day1)||0||
48044497|NCT04585009|100431528|FG011|COMPLETED|PartA, Cohort2: Treatment Period4(Day1)||0||
48044498|NCT04585009|100431517|FG000|NOT COMPLETED|PartA, Cohort2: Treatment Period4(Day1)||0||
48044499|NCT04585009|100431518|FG001|NOT COMPLETED|PartA, Cohort2: Treatment Period4(Day1)||0||
48044500|NCT04585009|100431519|FG002|NOT COMPLETED|PartA, Cohort2: Treatment Period4(Day1)||0||
48044501|NCT04585009|100431520|FG003|NOT COMPLETED|PartA, Cohort2: Treatment Period4(Day1)||0||
48044502|NCT04585009|100431521|FG004|NOT COMPLETED|PartA, Cohort2: Treatment Period4(Day1)||0||
48044503|NCT04585009|100431522|FG005|NOT COMPLETED|PartA, Cohort2: Treatment Period4(Day1)||0||
48044504|NCT04585009|100431523|FG006|NOT COMPLETED|PartA, Cohort2: Treatment Period4(Day1)||0||
48044505|NCT04585009|100431524|FG007|NOT COMPLETED|PartA, Cohort2: Treatment Period4(Day1)||1||
48044506|NCT04585009|100431525|FG008|NOT COMPLETED|PartA, Cohort2: Treatment Period4(Day1)||0||
48044507|NCT04585009|100431526|FG009|NOT COMPLETED|PartA, Cohort2: Treatment Period4(Day1)||0||
48044508|NCT04585009|100431527|FG010|NOT COMPLETED|PartA, Cohort2: Treatment Period4(Day1)||0||
48044509|NCT04585009|100431528|FG011|NOT COMPLETED|PartA, Cohort2: Treatment Period4(Day1)||0||
48044510|NCT04585009|100431517|FG000|STARTED|Cohort2: Washout Period1 (10 Days)||0||
48044511|NCT04585009|100431518|FG001|STARTED|Cohort2: Washout Period1 (10 Days)||0||
48044512|NCT04585009|100431519|FG002|STARTED|Cohort2: Washout Period1 (10 Days)||0||
48044513|NCT04585009|100431520|FG003|STARTED|Cohort2: Washout Period1 (10 Days)||0||
48044514|NCT04585009|100431521|FG004|STARTED|Cohort2: Washout Period1 (10 Days)||3||
48044515|NCT04585009|100431522|FG005|STARTED|Cohort2: Washout Period1 (10 Days)||3||
48044516|NCT04585009|100431523|FG006|STARTED|Cohort2: Washout Period1 (10 Days)||3||
48044517|NCT04585009|100431524|FG007|STARTED|Cohort2: Washout Period1 (10 Days)||2||
48044518|NCT04585009|100431525|FG008|STARTED|Cohort2: Washout Period1 (10 Days)||0||
48044519|NCT04585009|100431526|FG009|STARTED|Cohort2: Washout Period1 (10 Days)||0||
48044520|NCT04585009|100431527|FG010|STARTED|Cohort2: Washout Period1 (10 Days)||0||
48044521|NCT04585009|100431528|FG011|STARTED|Cohort2: Washout Period1 (10 Days)||0||
48044522|NCT04585009|100431517|FG000|COMPLETED|Cohort2: Washout Period1 (10 Days)||0||
48044523|NCT04585009|100431518|FG001|COMPLETED|Cohort2: Washout Period1 (10 Days)||0||
48044524|NCT04585009|100431519|FG002|COMPLETED|Cohort2: Washout Period1 (10 Days)||0||
48044525|NCT04585009|100431520|FG003|COMPLETED|Cohort2: Washout Period1 (10 Days)||0||
48044526|NCT04585009|100431521|FG004|COMPLETED|Cohort2: Washout Period1 (10 Days)||3||
48044527|NCT04585009|100431522|FG005|COMPLETED|Cohort2: Washout Period1 (10 Days)||3||
48044528|NCT04585009|100431523|FG006|COMPLETED|Cohort2: Washout Period1 (10 Days)||3||
48044529|NCT04585009|100431524|FG007|COMPLETED|Cohort2: Washout Period1 (10 Days)||2||
48044530|NCT04585009|100431525|FG008|COMPLETED|Cohort2: Washout Period1 (10 Days)||0||
48044531|NCT04585009|100431526|FG009|COMPLETED|Cohort2: Washout Period1 (10 Days)||0||
48044532|NCT04585009|100431527|FG010|COMPLETED|Cohort2: Washout Period1 (10 Days)||0||
48044533|NCT04585009|100431528|FG011|COMPLETED|Cohort2: Washout Period1 (10 Days)||0||
48044534|NCT04585009|100431517|FG000|NOT COMPLETED|Cohort2: Washout Period1 (10 Days)||0||
48044535|NCT04585009|100431518|FG001|NOT COMPLETED|Cohort2: Washout Period1 (10 Days)||0||
48044536|NCT04585009|100431519|FG002|NOT COMPLETED|Cohort2: Washout Period1 (10 Days)||0||
48044537|NCT04585009|100431520|FG003|NOT COMPLETED|Cohort2: Washout Period1 (10 Days)||0||
48044538|NCT04585009|100431521|FG004|NOT COMPLETED|Cohort2: Washout Period1 (10 Days)||0||
48495378|NCT00221299|101547837|FG003|COMPLETED|Overall Study||10||
48495379|NCT00221299|101547834|FG000|NOT COMPLETED|Overall Study||1||
48495380|NCT00221299|101547835|FG001|NOT COMPLETED|Overall Study||2||
48495381|NCT00221299|101547836|FG002|NOT COMPLETED|Overall Study||0||
48495382|NCT00221299|101547837|FG003|NOT COMPLETED|Overall Study||1||
48495383|NCT04723693|101547838|FG000|STARTED|Overall Study||30||
48044539|NCT04585009|100431522|FG005|NOT COMPLETED|Cohort2: Washout Period1 (10 Days)||0||
48044540|NCT04585009|100431523|FG006|NOT COMPLETED|Cohort2: Washout Period1 (10 Days)||0||
48044541|NCT04585009|100431524|FG007|NOT COMPLETED|Cohort2: Washout Period1 (10 Days)||0||
48044542|NCT04585009|100431525|FG008|NOT COMPLETED|Cohort2: Washout Period1 (10 Days)||0||
48044543|NCT04585009|100431526|FG009|NOT COMPLETED|Cohort2: Washout Period1 (10 Days)||0||
48044544|NCT04585009|100431527|FG010|NOT COMPLETED|Cohort2: Washout Period1 (10 Days)||0||
48044545|NCT04585009|100431528|FG011|NOT COMPLETED|Cohort2: Washout Period1 (10 Days)||0||
48044546|NCT04585009|100431517|FG000|STARTED|PartA, Cohort2: Treatment Period5(Day1)||0||
48044547|NCT04585009|100431518|FG001|STARTED|PartA, Cohort2: Treatment Period5(Day1)||0||
48044548|NCT04585009|100431519|FG002|STARTED|PartA, Cohort2: Treatment Period5(Day1)||0||
48044549|NCT04585009|100431520|FG003|STARTED|PartA, Cohort2: Treatment Period5(Day1)||0||
48044550|NCT04585009|100431521|FG004|STARTED|PartA, Cohort2: Treatment Period5(Day1)||3||
48044551|NCT04585009|100431522|FG005|STARTED|PartA, Cohort2: Treatment Period5(Day1)||3||
48044552|NCT04585009|100431523|FG006|STARTED|PartA, Cohort2: Treatment Period5(Day1)||3||
48044553|NCT04585009|100431524|FG007|STARTED|PartA, Cohort2: Treatment Period5(Day1)||3||
48044554|NCT04585009|100431525|FG008|STARTED|PartA, Cohort2: Treatment Period5(Day1)||0||
48044555|NCT04585009|100431526|FG009|STARTED|PartA, Cohort2: Treatment Period5(Day1)||0||
48044556|NCT04585009|100431527|FG010|STARTED|PartA, Cohort2: Treatment Period5(Day1)||0||
48044557|NCT04585009|100431528|FG011|STARTED|PartA, Cohort2: Treatment Period5(Day1)||0||
48044558|NCT04585009|100431517|FG000|COMPLETED|PartA, Cohort2: Treatment Period5(Day1)||0||
48044559|NCT04585009|100431518|FG001|COMPLETED|PartA, Cohort2: Treatment Period5(Day1)||0||
48044560|NCT04585009|100431519|FG002|COMPLETED|PartA, Cohort2: Treatment Period5(Day1)||0||
48044561|NCT04585009|100431520|FG003|COMPLETED|PartA, Cohort2: Treatment Period5(Day1)||0||
48044562|NCT04585009|100431521|FG004|COMPLETED|PartA, Cohort2: Treatment Period5(Day1)||2||
48044563|NCT04585009|100431522|FG005|COMPLETED|PartA, Cohort2: Treatment Period5(Day1)||3||
48044564|NCT04585009|100431523|FG006|COMPLETED|PartA, Cohort2: Treatment Period5(Day1)||3||
48044565|NCT04585009|100431524|FG007|COMPLETED|PartA, Cohort2: Treatment Period5(Day1)||3||
48044566|NCT04585009|100431525|FG008|COMPLETED|PartA, Cohort2: Treatment Period5(Day1)||0||
48044567|NCT04585009|100431526|FG009|COMPLETED|PartA, Cohort2: Treatment Period5(Day1)||0||
48044568|NCT04585009|100431527|FG010|COMPLETED|PartA, Cohort2: Treatment Period5(Day1)||0||
48044569|NCT04585009|100431528|FG011|COMPLETED|PartA, Cohort2: Treatment Period5(Day1)||0||
48044570|NCT04585009|100431517|FG000|NOT COMPLETED|PartA, Cohort2: Treatment Period5(Day1)||0||
48044571|NCT04585009|100431518|FG001|NOT COMPLETED|PartA, Cohort2: Treatment Period5(Day1)||0||
48044572|NCT04585009|100431519|FG002|NOT COMPLETED|PartA, Cohort2: Treatment Period5(Day1)||0||
48044573|NCT04585009|100431520|FG003|NOT COMPLETED|PartA, Cohort2: Treatment Period5(Day1)||0||
48044574|NCT04585009|100431521|FG004|NOT COMPLETED|PartA, Cohort2: Treatment Period5(Day1)||1||
48044575|NCT04585009|100431522|FG005|NOT COMPLETED|PartA, Cohort2: Treatment Period5(Day1)||0||
48044576|NCT04585009|100431523|FG006|NOT COMPLETED|PartA, Cohort2: Treatment Period5(Day1)||0||
48044577|NCT04585009|100431524|FG007|NOT COMPLETED|PartA, Cohort2: Treatment Period5(Day1)||0||
48044578|NCT04585009|100431525|FG008|NOT COMPLETED|PartA, Cohort2: Treatment Period5(Day1)||0||
48044579|NCT04585009|100431526|FG009|NOT COMPLETED|PartA, Cohort2: Treatment Period5(Day1)||0||
48044580|NCT04585009|100431527|FG010|NOT COMPLETED|PartA, Cohort2: Treatment Period5(Day1)||0||
48044581|NCT04585009|100431528|FG011|NOT COMPLETED|PartA, Cohort2: Treatment Period5(Day1)||0||
48044582|NCT04585009|100431517|FG000|STARTED|Cohort2: Washout Period2 (10 Days)||0||
48044583|NCT04585009|100431518|FG001|STARTED|Cohort2: Washout Period2 (10 Days)||0||
48044584|NCT04585009|100431519|FG002|STARTED|Cohort2: Washout Period2 (10 Days)||0||
48044585|NCT04585009|100431520|FG003|STARTED|Cohort2: Washout Period2 (10 Days)||0||
48044586|NCT04585009|100431521|FG004|STARTED|Cohort2: Washout Period2 (10 Days)||2||
48044587|NCT04585009|100431522|FG005|STARTED|Cohort2: Washout Period2 (10 Days)||3||
48044588|NCT04585009|100431523|FG006|STARTED|Cohort2: Washout Period2 (10 Days)||3||
48044589|NCT04585009|100431524|FG007|STARTED|Cohort2: Washout Period2 (10 Days)||3||
48044590|NCT04585009|100431525|FG008|STARTED|Cohort2: Washout Period2 (10 Days)||0||
48044591|NCT04585009|100431526|FG009|STARTED|Cohort2: Washout Period2 (10 Days)||0||
48044592|NCT04585009|100431527|FG010|STARTED|Cohort2: Washout Period2 (10 Days)||0||
48044593|NCT04585009|100431528|FG011|STARTED|Cohort2: Washout Period2 (10 Days)||0||
48044594|NCT04585009|100431517|FG000|COMPLETED|Cohort2: Washout Period2 (10 Days)||0||
48044595|NCT04585009|100431518|FG001|COMPLETED|Cohort2: Washout Period2 (10 Days)||0||
48044596|NCT04585009|100431519|FG002|COMPLETED|Cohort2: Washout Period2 (10 Days)||0||
48495384|NCT04723693|101547838|FG000|COMPLETED|Overall Study||28||
48495385|NCT04723693|101547838|FG000|NOT COMPLETED|Overall Study||2||
48495386|NCT00064038|101547839|FG000|STARTED|Initial Randomization||100||
48044597|NCT04585009|100431520|FG003|COMPLETED|Cohort2: Washout Period2 (10 Days)||0||
48044598|NCT04585009|100431521|FG004|COMPLETED|Cohort2: Washout Period2 (10 Days)||2||
48044599|NCT04585009|100431522|FG005|COMPLETED|Cohort2: Washout Period2 (10 Days)||3||
48044600|NCT04585009|100431523|FG006|COMPLETED|Cohort2: Washout Period2 (10 Days)||3||
48044601|NCT04585009|100431524|FG007|COMPLETED|Cohort2: Washout Period2 (10 Days)||3||
48044602|NCT04585009|100431525|FG008|COMPLETED|Cohort2: Washout Period2 (10 Days)||0||
48044603|NCT04585009|100431526|FG009|COMPLETED|Cohort2: Washout Period2 (10 Days)||0||
48044604|NCT04585009|100431527|FG010|COMPLETED|Cohort2: Washout Period2 (10 Days)||0||
48044605|NCT04585009|100431528|FG011|COMPLETED|Cohort2: Washout Period2 (10 Days)||0||
48044606|NCT04585009|100431517|FG000|NOT COMPLETED|Cohort2: Washout Period2 (10 Days)||0||
48044607|NCT04585009|100431518|FG001|NOT COMPLETED|Cohort2: Washout Period2 (10 Days)||0||
48044608|NCT04585009|100431519|FG002|NOT COMPLETED|Cohort2: Washout Period2 (10 Days)||0||
48044609|NCT04585009|100431520|FG003|NOT COMPLETED|Cohort2: Washout Period2 (10 Days)||0||
48044610|NCT04585009|100431521|FG004|NOT COMPLETED|Cohort2: Washout Period2 (10 Days)||0||
48044611|NCT04585009|100431522|FG005|NOT COMPLETED|Cohort2: Washout Period2 (10 Days)||0||
48044612|NCT04585009|100431523|FG006|NOT COMPLETED|Cohort2: Washout Period2 (10 Days)||0||
48044613|NCT04585009|100431524|FG007|NOT COMPLETED|Cohort2: Washout Period2 (10 Days)||0||
48044614|NCT04585009|100431525|FG008|NOT COMPLETED|Cohort2: Washout Period2 (10 Days)||0||
48044615|NCT04585009|100431526|FG009|NOT COMPLETED|Cohort2: Washout Period2 (10 Days)||0||
48044616|NCT04585009|100431527|FG010|NOT COMPLETED|Cohort2: Washout Period2 (10 Days)||0||
48044617|NCT04585009|100431528|FG011|NOT COMPLETED|Cohort2: Washout Period2 (10 Days)||0||
48044618|NCT04585009|100431517|FG000|STARTED|PartA, Cohort2: Treatment Period6(Day1)||0||
48044619|NCT04585009|100431518|FG001|STARTED|PartA, Cohort2: Treatment Period6(Day1)||0||
48044620|NCT04585009|100431519|FG002|STARTED|PartA, Cohort2: Treatment Period6(Day1)||0||
48044621|NCT04585009|100431520|FG003|STARTED|PartA, Cohort2: Treatment Period6(Day1)||0||
48044622|NCT04585009|100431521|FG004|STARTED|PartA, Cohort2: Treatment Period6(Day1)||3||
48044623|NCT04585009|100431522|FG005|STARTED|PartA, Cohort2: Treatment Period6(Day1)||3||
48044624|NCT04585009|100431523|FG006|STARTED|PartA, Cohort2: Treatment Period6(Day1)||3||
48044625|NCT04585009|100431524|FG007|STARTED|PartA, Cohort2: Treatment Period6(Day1)||3||
48044626|NCT04585009|100431525|FG008|STARTED|PartA, Cohort2: Treatment Period6(Day1)||0||
48044627|NCT04585009|100431526|FG009|STARTED|PartA, Cohort2: Treatment Period6(Day1)||0||
48044628|NCT04585009|100431527|FG010|STARTED|PartA, Cohort2: Treatment Period6(Day1)||0||
48044629|NCT04585009|100431528|FG011|STARTED|PartA, Cohort2: Treatment Period6(Day1)||0||
48044630|NCT04585009|100431517|FG000|COMPLETED|PartA, Cohort2: Treatment Period6(Day1)||0||
48044631|NCT04585009|100431518|FG001|COMPLETED|PartA, Cohort2: Treatment Period6(Day1)||0||
48044632|NCT04585009|100431519|FG002|COMPLETED|PartA, Cohort2: Treatment Period6(Day1)||0||
48044633|NCT04585009|100431520|FG003|COMPLETED|PartA, Cohort2: Treatment Period6(Day1)||0||
48044634|NCT04585009|100431521|FG004|COMPLETED|PartA, Cohort2: Treatment Period6(Day1)||3||
48044635|NCT04585009|100431522|FG005|COMPLETED|PartA, Cohort2: Treatment Period6(Day1)||3||
48044636|NCT04585009|100431523|FG006|COMPLETED|PartA, Cohort2: Treatment Period6(Day1)||3||
48044637|NCT04585009|100431524|FG007|COMPLETED|PartA, Cohort2: Treatment Period6(Day1)||3||
48044638|NCT04585009|100431525|FG008|COMPLETED|PartA, Cohort2: Treatment Period6(Day1)||0||
48044639|NCT04585009|100431526|FG009|COMPLETED|PartA, Cohort2: Treatment Period6(Day1)||0||
48044640|NCT04585009|100431527|FG010|COMPLETED|PartA, Cohort2: Treatment Period6(Day1)||0||
48044641|NCT04585009|100431528|FG011|COMPLETED|PartA, Cohort2: Treatment Period6(Day1)||0||
48044642|NCT04585009|100431517|FG000|NOT COMPLETED|PartA, Cohort2: Treatment Period6(Day1)||0||
48044643|NCT04585009|100431518|FG001|NOT COMPLETED|PartA, Cohort2: Treatment Period6(Day1)||0||
48044644|NCT04585009|100431519|FG002|NOT COMPLETED|PartA, Cohort2: Treatment Period6(Day1)||0||
48044645|NCT04585009|100431520|FG003|NOT COMPLETED|PartA, Cohort2: Treatment Period6(Day1)||0||
48044646|NCT04585009|100431521|FG004|NOT COMPLETED|PartA, Cohort2: Treatment Period6(Day1)||0||
48044647|NCT04585009|100431522|FG005|NOT COMPLETED|PartA, Cohort2: Treatment Period6(Day1)||0||
48044648|NCT04585009|100431523|FG006|NOT COMPLETED|PartA, Cohort2: Treatment Period6(Day1)||0||
48044649|NCT04585009|100431524|FG007|NOT COMPLETED|PartA, Cohort2: Treatment Period6(Day1)||0||
48044650|NCT04585009|100431525|FG008|NOT COMPLETED|PartA, Cohort2: Treatment Period6(Day1)||0||
48044651|NCT04585009|100431526|FG009|NOT COMPLETED|PartA, Cohort2: Treatment Period6(Day1)||0||
48044652|NCT04585009|100431527|FG010|NOT COMPLETED|PartA, Cohort2: Treatment Period6(Day1)||0||
48044653|NCT04585009|100431528|FG011|NOT COMPLETED|PartA, Cohort2: Treatment Period6(Day1)||0||
48044654|NCT04585009|100431517|FG000|STARTED|Part B, Cohorts 3 & 4 (Days 1 to 14)||0||
48044655|NCT04585009|100431518|FG001|STARTED|Part B, Cohorts 3 & 4 (Days 1 to 14)||0||
48044656|NCT04585009|100431519|FG002|STARTED|Part B, Cohorts 3 & 4 (Days 1 to 14)||0||
48044657|NCT04585009|100431520|FG003|STARTED|Part B, Cohorts 3 & 4 (Days 1 to 14)||0||
48044658|NCT04585009|100431521|FG004|STARTED|Part B, Cohorts 3 & 4 (Days 1 to 14)||0||
48044659|NCT04585009|100431522|FG005|STARTED|Part B, Cohorts 3 & 4 (Days 1 to 14)||0||
48044660|NCT04585009|100431523|FG006|STARTED|Part B, Cohorts 3 & 4 (Days 1 to 14)||0||
48044661|NCT04585009|100431524|FG007|STARTED|Part B, Cohorts 3 & 4 (Days 1 to 14)||0||
48044662|NCT04585009|100431525|FG008|STARTED|Part B, Cohorts 3 & 4 (Days 1 to 14)||4||
48044663|NCT04585009|100431526|FG009|STARTED|Part B, Cohorts 3 & 4 (Days 1 to 14)||13||
48044664|NCT04585009|100431527|FG010|STARTED|Part B, Cohorts 3 & 4 (Days 1 to 14)||0||
48044665|NCT04585009|100431528|FG011|STARTED|Part B, Cohorts 3 & 4 (Days 1 to 14)||0||
48044666|NCT04585009|100431517|FG000|COMPLETED|Part B, Cohorts 3 & 4 (Days 1 to 14)||0||
48044667|NCT04585009|100431518|FG001|COMPLETED|Part B, Cohorts 3 & 4 (Days 1 to 14)||0||
48044668|NCT04585009|100431519|FG002|COMPLETED|Part B, Cohorts 3 & 4 (Days 1 to 14)||0||
48044669|NCT04585009|100431520|FG003|COMPLETED|Part B, Cohorts 3 & 4 (Days 1 to 14)||0||
48044670|NCT04585009|100431521|FG004|COMPLETED|Part B, Cohorts 3 & 4 (Days 1 to 14)||0||
48044671|NCT04585009|100431522|FG005|COMPLETED|Part B, Cohorts 3 & 4 (Days 1 to 14)||0||
48044672|NCT04585009|100431523|FG006|COMPLETED|Part B, Cohorts 3 & 4 (Days 1 to 14)||0||
48044673|NCT04585009|100431524|FG007|COMPLETED|Part B, Cohorts 3 & 4 (Days 1 to 14)||0||
48044674|NCT04585009|100431525|FG008|COMPLETED|Part B, Cohorts 3 & 4 (Days 1 to 14)||4||
48044675|NCT04585009|100431526|FG009|COMPLETED|Part B, Cohorts 3 & 4 (Days 1 to 14)||12||
48044676|NCT04585009|100431527|FG010|COMPLETED|Part B, Cohorts 3 & 4 (Days 1 to 14)||0||
48044677|NCT04585009|100431528|FG011|COMPLETED|Part B, Cohorts 3 & 4 (Days 1 to 14)||0||
48044678|NCT04585009|100431517|FG000|NOT COMPLETED|Part B, Cohorts 3 & 4 (Days 1 to 14)||0||
48044679|NCT04585009|100431518|FG001|NOT COMPLETED|Part B, Cohorts 3 & 4 (Days 1 to 14)||0||
48495387|NCT00064038|101547840|FG001|STARTED|Initial Randomization||98||
48495388|NCT00064038|101547841|FG002|STARTED|Initial Randomization||0||
48495389|NCT00064038|101547839|FG000|Eligible and Analyzable|Initial Randomization||97||
48495390|NCT00064038|101547840|FG001|Eligible and Analyzable|Initial Randomization||95||
48044680|NCT04585009|100431519|FG002|NOT COMPLETED|Part B, Cohorts 3 & 4 (Days 1 to 14)||0||
48044681|NCT04585009|100431520|FG003|NOT COMPLETED|Part B, Cohorts 3 & 4 (Days 1 to 14)||0||
48044682|NCT04585009|100431521|FG004|NOT COMPLETED|Part B, Cohorts 3 & 4 (Days 1 to 14)||0||
48044683|NCT04585009|100431522|FG005|NOT COMPLETED|Part B, Cohorts 3 & 4 (Days 1 to 14)||0||
48044684|NCT04585009|100431523|FG006|NOT COMPLETED|Part B, Cohorts 3 & 4 (Days 1 to 14)||0||
48044685|NCT04585009|100431524|FG007|NOT COMPLETED|Part B, Cohorts 3 & 4 (Days 1 to 14)||0||
48044686|NCT04585009|100431525|FG008|NOT COMPLETED|Part B, Cohorts 3 & 4 (Days 1 to 14)||0||
48044687|NCT04585009|100431526|FG009|NOT COMPLETED|Part B, Cohorts 3 & 4 (Days 1 to 14)||1||
48044688|NCT04585009|100431527|FG010|NOT COMPLETED|Part B, Cohorts 3 & 4 (Days 1 to 14)||0||
48044689|NCT04585009|100431528|FG011|NOT COMPLETED|Part B, Cohorts 3 & 4 (Days 1 to 14)||0||
48044690|NCT04585009|100431517|FG000|STARTED|Part C, Cohort 5 (Days 1 to 7)||0||
48044691|NCT04585009|100431518|FG001|STARTED|Part C, Cohort 5 (Days 1 to 7)||0||
48044692|NCT04585009|100431519|FG002|STARTED|Part C, Cohort 5 (Days 1 to 7)||0||
48044693|NCT04585009|100431520|FG003|STARTED|Part C, Cohort 5 (Days 1 to 7)||0||
48044694|NCT04585009|100431521|FG004|STARTED|Part C, Cohort 5 (Days 1 to 7)||0||
48044695|NCT04585009|100431522|FG005|STARTED|Part C, Cohort 5 (Days 1 to 7)||0||
48044696|NCT04585009|100431523|FG006|STARTED|Part C, Cohort 5 (Days 1 to 7)||0||
48044697|NCT04585009|100431524|FG007|STARTED|Part C, Cohort 5 (Days 1 to 7)||0||
48044698|NCT04585009|100431525|FG008|STARTED|Part C, Cohort 5 (Days 1 to 7)||0||
48044699|NCT04585009|100431526|FG009|STARTED|Part C, Cohort 5 (Days 1 to 7)||0||
48044700|NCT04585009|100431527|FG010|STARTED|Part C, Cohort 5 (Days 1 to 7)||3||
48044701|NCT04585009|100431528|FG011|STARTED|Part C, Cohort 5 (Days 1 to 7)||8||
48044702|NCT04585009|100431517|FG000|COMPLETED|Part C, Cohort 5 (Days 1 to 7)||0||
48044703|NCT04585009|100431518|FG001|COMPLETED|Part C, Cohort 5 (Days 1 to 7)||0||
48044704|NCT04585009|100431519|FG002|COMPLETED|Part C, Cohort 5 (Days 1 to 7)||0||
48044705|NCT04585009|100431520|FG003|COMPLETED|Part C, Cohort 5 (Days 1 to 7)||0||
48044706|NCT04585009|100431521|FG004|COMPLETED|Part C, Cohort 5 (Days 1 to 7)||0||
48044707|NCT04585009|100431522|FG005|COMPLETED|Part C, Cohort 5 (Days 1 to 7)||0||
48044708|NCT04585009|100431523|FG006|COMPLETED|Part C, Cohort 5 (Days 1 to 7)||0||
48044709|NCT04585009|100431524|FG007|COMPLETED|Part C, Cohort 5 (Days 1 to 7)||0||
48044710|NCT04585009|100431525|FG008|COMPLETED|Part C, Cohort 5 (Days 1 to 7)||0||
48044711|NCT04585009|100431526|FG009|COMPLETED|Part C, Cohort 5 (Days 1 to 7)||0||
48044712|NCT04585009|100431527|FG010|COMPLETED|Part C, Cohort 5 (Days 1 to 7)||3||
48044713|NCT04585009|100431528|FG011|COMPLETED|Part C, Cohort 5 (Days 1 to 7)||7||
48044714|NCT04585009|100431517|FG000|NOT COMPLETED|Part C, Cohort 5 (Days 1 to 7)||0||
48044715|NCT04585009|100431518|FG001|NOT COMPLETED|Part C, Cohort 5 (Days 1 to 7)||0||
48044716|NCT04585009|100431519|FG002|NOT COMPLETED|Part C, Cohort 5 (Days 1 to 7)||0||
48044717|NCT04585009|100431520|FG003|NOT COMPLETED|Part C, Cohort 5 (Days 1 to 7)||0||
48044718|NCT04585009|100431521|FG004|NOT COMPLETED|Part C, Cohort 5 (Days 1 to 7)||0||
48044719|NCT04585009|100431522|FG005|NOT COMPLETED|Part C, Cohort 5 (Days 1 to 7)||0||
48044720|NCT04585009|100431523|FG006|NOT COMPLETED|Part C, Cohort 5 (Days 1 to 7)||0||
48044721|NCT04585009|100431524|FG007|NOT COMPLETED|Part C, Cohort 5 (Days 1 to 7)||0||
48044722|NCT04585009|100431525|FG008|NOT COMPLETED|Part C, Cohort 5 (Days 1 to 7)||0||
48044723|NCT04585009|100431526|FG009|NOT COMPLETED|Part C, Cohort 5 (Days 1 to 7)||0||
48044724|NCT04585009|100431527|FG010|NOT COMPLETED|Part C, Cohort 5 (Days 1 to 7)||0||
48044725|NCT04585009|100431528|FG011|NOT COMPLETED|Part C, Cohort 5 (Days 1 to 7)||1||
48044726|NCT00573287|100431529|FG000|STARTED|Overall Study||7||
48044727|NCT00573287|100431530|FG001|STARTED|Overall Study||7||
48044728|NCT00573287|100431529|FG000|COMPLETED|Overall Study||3||
48044729|NCT00573287|100431530|FG001|COMPLETED|Overall Study||4||
48044730|NCT00573287|100431529|FG000|NOT COMPLETED|Overall Study||4||
48044731|NCT00573287|100431530|FG001|NOT COMPLETED|Overall Study||3||
48044732|NCT00859638|100431531|FG000|STARTED|Overall Study||65||
48044733|NCT00859638|100431532|FG001|STARTED|Overall Study||59||
48495391|NCT00064038|101547841|FG002|Eligible and Analyzable|Initial Randomization||0||
48044734|NCT00859638|100431531|FG000|COMPLETED|Overall Study||55||
48044735|NCT00859638|100431532|FG001|COMPLETED|Overall Study||55||
48044736|NCT00859638|100431531|FG000|NOT COMPLETED|Overall Study||10||
48044737|NCT00859638|100431532|FG001|NOT COMPLETED|Overall Study||4||
48044738|NCT02280122|100431533|FG000|STARTED|Overall Study||15||
48044739|NCT02280122|100431534|FG001|STARTED|Overall Study||15||
48044740|NCT02280122|100431535|FG002|STARTED|Overall Study||30||
48044741|NCT02280122|100431533|FG000|COMPLETED|Overall Study||15||
48044742|NCT02280122|100431534|FG001|COMPLETED|Overall Study||15||
48044743|NCT02280122|100431535|FG002|COMPLETED|Overall Study||30||
48044744|NCT02280122|100431533|FG000|NOT COMPLETED|Overall Study||0||
48044745|NCT02280122|100431534|FG001|NOT COMPLETED|Overall Study||0||
48044746|NCT02280122|100431535|FG002|NOT COMPLETED|Overall Study||0||
48205141|NCT01212991|100827375|FG002|COMPLETED|Double-blind||0||
48205142|NCT01212991|100827373|FG000|NOT COMPLETED|Double-blind||872||
48205143|NCT01212991|100827374|FG001|NOT COMPLETED|Double-blind||611||
48205144|NCT01212991|100827375|FG002|NOT COMPLETED|Double-blind||0||
48205145|NCT01212991|100827373|FG000|STARTED|Open-label||0||
48205146|NCT01212991|100827374|FG001|STARTED|Open-label||0||
48205147|NCT01212991|100827375|FG002|STARTED|Open-label||234||
48205148|NCT01212991|100827373|FG000|COMPLETED|Open-label||0||
48205149|NCT01212991|100827374|FG001|COMPLETED|Open-label||0||
48205150|NCT01212991|100827375|FG002|COMPLETED|Open-label||0||
48205151|NCT01212991|100827373|FG000|NOT COMPLETED|Open-label||0||
48044747|NCT01470989|100431536|FG000|STARTED|Overall Study||227||
48044748|NCT01470989|100431537|FG001|STARTED|Overall Study||229||
48044749|NCT01470989|100431536|FG000|Completed Core Study|Overall Study||208||
48044750|NCT01470989|100431537|FG001|Completed Core Study|Overall Study||208||
48044751|NCT01470989|100431536|FG000|Entered Extension 1 Study|Overall Study||174||
48044752|NCT01470989|100431537|FG001|Entered Extension 1 Study|Overall Study||161||
48044753|NCT01470989|100431536|FG000|Completed Extension 1 Study|Overall Study||165||
48044754|NCT01470989|100431537|FG001|Completed Extension 1 Study|Overall Study||152||
48044755|NCT01470989|100431536|FG000|Entered Extension 2 Study|Overall Study||141||
48044756|NCT01470989|100431537|FG001|Entered Extension 2 Study|Overall Study||131||
48044757|NCT01470989|100431536|FG000|Completed Extension 2 Study|Overall Study||132||
48044758|NCT01470989|100431537|FG001|Completed Extension 2 Study|Overall Study||117||
48044759|NCT01470989|100431536|FG000|Entered Extension 3|Overall Study||87||
48044760|NCT01470989|100431537|FG001|Entered Extension 3|Overall Study||49||
48044761|NCT01470989|100431536|FG000|COMPLETED|Overall Study||79||
48044762|NCT01470989|100431537|FG001|COMPLETED|Overall Study||43||
48044763|NCT01470989|100431536|FG000|NOT COMPLETED|Overall Study||148||
48044764|NCT01470989|100431537|FG001|NOT COMPLETED|Overall Study||186||
48044765|NCT02899078|100431538|FG000|STARTED|Overall Study||31||
48044766|NCT02899078|100431538|FG000|COMPLETED|Overall Study||28||
48044767|NCT02899078|100431538|FG000|NOT COMPLETED|Overall Study||3||
48044768|NCT01966432|100431539|FG000|STARTED|Overall Study||10||
48044769|NCT01966432|100431540|FG001|STARTED|Overall Study||34||
48044770|NCT01966432|100431541|FG002|STARTED|Overall Study||54||
48044771|NCT01966432|100431539|FG000|COMPLETED|Overall Study||5||
48205152|NCT01212991|100827374|FG001|NOT COMPLETED|Open-label||0||
48205153|NCT01212991|100827375|FG002|NOT COMPLETED|Open-label||234||
48205154|NCT05355116|100827376|FG000|STARTED|Overall Study||32|The number of participants enrolled to receive each treatment condition (in a randomised order)|
48044772|NCT01966432|100431540|FG001|COMPLETED|Overall Study||21||
48044773|NCT01966432|100431541|FG002|COMPLETED|Overall Study||28||
48044774|NCT01966432|100431539|FG000|NOT COMPLETED|Overall Study||5||
48044775|NCT01966432|100431540|FG001|NOT COMPLETED|Overall Study||13||
48044776|NCT01966432|100431541|FG002|NOT COMPLETED|Overall Study||26||
48044777|NCT01486043|100431542|FG000|STARTED|Overall Study||4||
48044778|NCT01486043|100431542|FG000|COMPLETED|Overall Study||2||
48044779|NCT01486043|100431542|FG000|NOT COMPLETED|Overall Study||2||
48044780|NCT04850781|100431543|FG000|STARTED|Overall Study||128||
48044781|NCT04850781|100431544|FG001|STARTED|Overall Study||115||
48044782|NCT04850781|100431543|FG000|COMPLETED|Overall Study||128||
48044783|NCT04850781|100431544|FG001|COMPLETED|Overall Study||115||
48044784|NCT04850781|100431543|FG000|NOT COMPLETED|Overall Study||0||
48044785|NCT04850781|100431544|FG001|NOT COMPLETED|Overall Study||0||
48044786|NCT01436162|100431545|FG000|STARTED|Single-blind Lead-in Phase||1105||
48044787|NCT01436162|100431546|FG001|STARTED|Single-blind Lead-in Phase||0||
48044788|NCT01436162|100431547|FG002|STARTED|Single-blind Lead-in Phase||0||
48044789|NCT01436162|100431545|FG000|COMPLETED|Single-blind Lead-in Phase||823||
48044790|NCT01436162|100431546|FG001|COMPLETED|Single-blind Lead-in Phase||0||
48044791|NCT01436162|100431547|FG002|COMPLETED|Single-blind Lead-in Phase||0||
48044792|NCT01436162|100431545|FG000|NOT COMPLETED|Single-blind Lead-in Phase||282||
48044793|NCT01436162|100431546|FG001|NOT COMPLETED|Single-blind Lead-in Phase||0||
48044794|NCT01436162|100431547|FG002|NOT COMPLETED|Single-blind Lead-in Phase||0||
48044795|NCT01436162|100431545|FG000|STARTED|Randomized Phase||397||
48205155|NCT05355116|100827376|FG000|Physiolab S1|Overall Study||32|The number of participants who received a treatment with the Physiolab S1 device.|
48205156|NCT05355116|100827376|FG000|Breg VPulse|Overall Study||31|The number of participants who received a treatment with the Breg VPulse device|
48495392|NCT00064038|101547839|FG000|Safety Population|Initial Randomization||96||
48044796|NCT01436162|100431546|FG001|STARTED|Randomized Phase||212||
48044797|NCT01436162|100431547|FG002|STARTED|Randomized Phase||214||
48044798|NCT01436162|100431545|FG000|COMPLETED|Randomized Phase||353||
48044799|NCT01436162|100431546|FG001|COMPLETED|Randomized Phase||181||
48205157|NCT05355116|100827376|FG000|Cryo/Cuff|Overall Study||31|The number of participants who received a treatment with the Cryo/Cuff device.|
48205158|NCT05355116|100827376|FG000|GameReady|Overall Study||30|The number of participants who received a treatment with the GameReady device.|
48205159|NCT05355116|100827376|FG000|Gel Wrap|Overall Study||31|The number of participants who received a treatment with the Gel Wrap.|
48205160|NCT05355116|100827376|FG000|COMPLETED|Overall Study||30|The number of participants who completed their participation in the study by receiving a treatment with each of the 5 devices under investigation.|
48205161|NCT05355116|100827376|FG000|NOT COMPLETED|Overall Study||2||
48205162|NCT05001945|100827377|FG000|STARTED|Overall Study||30||
48205163|NCT05001945|100827378|FG001|STARTED|Overall Study||22||
48205164|NCT05001945|100827379|FG002|STARTED|Overall Study||30||
48205165|NCT05001945|100827380|FG003|STARTED|Overall Study||23||
48205166|NCT05001945|100827381|FG004|STARTED|Overall Study||28||
48205167|NCT05001945|100827382|FG005|STARTED|Overall Study||30||
48205168|NCT05001945|100827383|FG006|STARTED|Overall Study||6||
48205169|NCT05001945|100827384|FG007|STARTED|Overall Study||31||
48205170|NCT05001945|100827377|FG000|COMPLETED|Overall Study||29||
48205171|NCT05001945|100827378|FG001|COMPLETED|Overall Study||18||
48205172|NCT05001945|100827379|FG002|COMPLETED|Overall Study||28||
48205173|NCT05001945|100827380|FG003|COMPLETED|Overall Study||18||
48205174|NCT05001945|100827381|FG004|COMPLETED|Overall Study||26||
48205175|NCT05001945|100827382|FG005|COMPLETED|Overall Study||27||
48205176|NCT05001945|100827383|FG006|COMPLETED|Overall Study||6||
48205177|NCT05001945|100827384|FG007|COMPLETED|Overall Study||30||
48205178|NCT05001945|100827377|FG000|NOT COMPLETED|Overall Study||1||
48044800|NCT01436162|100431547|FG002|COMPLETED|Randomized Phase||189||
48044801|NCT01436162|100431545|FG000|NOT COMPLETED|Randomized Phase||44||
48044802|NCT01436162|100431546|FG001|NOT COMPLETED|Randomized Phase||31||
48044803|NCT01436162|100431547|FG002|NOT COMPLETED|Randomized Phase||25||
48044804|NCT00775203|100431548|FG000|STARTED|Overall Study||206||
48044805|NCT00775203|100431549|FG001|STARTED|Overall Study||206||
48044806|NCT00775203|100431548|FG000|Received Study Medication|Overall Study||202||
48044807|NCT00775203|100431549|FG001|Received Study Medication|Overall Study||204||
48044808|NCT00775203|100431548|FG000|COMPLETED|Overall Study||144||
48044809|NCT00775203|100431549|FG001|COMPLETED|Overall Study||163||
48044810|NCT00775203|100431548|FG000|NOT COMPLETED|Overall Study||62||
48044811|NCT00775203|100431549|FG001|NOT COMPLETED|Overall Study||43||
48044812|NCT03702244|100431550|FG000|STARTED|Overall Study||1057||
48044813|NCT03702244|100431551|FG001|STARTED|Overall Study||1046||
48044814|NCT03702244|100431550|FG000|COMPLETED|Overall Study||1057||
48044815|NCT03702244|100431551|FG001|COMPLETED|Overall Study||1046||
48044816|NCT03702244|100431550|FG000|NOT COMPLETED|Overall Study||0||
48044817|NCT03702244|100431551|FG001|NOT COMPLETED|Overall Study||0||
48044818|NCT02506985|100431552|FG000|STARTED|Overall Study||4||
48044819|NCT02506985|100431553|FG001|STARTED|Overall Study||6||
48044820|NCT02506985|100431552|FG000|COMPLETED|Overall Study||4||
48044821|NCT02506985|100431553|FG001|COMPLETED|Overall Study||6||
48044822|NCT02506985|100431552|FG000|NOT COMPLETED|Overall Study||0||
48044823|NCT02506985|100431553|FG001|NOT COMPLETED|Overall Study||0||
48044824|NCT00266877|100431554|FG000|STARTED|Overall Study||91||
48044825|NCT00266877|100431555|FG001|STARTED|Overall Study||48||
48044826|NCT00266877|100431556|FG002|STARTED|Overall Study||28||
48044827|NCT00266877|100431554|FG000|COMPLETED|Overall Study||0||
48044828|NCT00266877|100431555|FG001|COMPLETED|Overall Study||0||
48044829|NCT00266877|100431556|FG002|COMPLETED|Overall Study||0||
48044830|NCT00266877|100431554|FG000|NOT COMPLETED|Overall Study||91||
48044831|NCT00266877|100431555|FG001|NOT COMPLETED|Overall Study||48||
48044832|NCT00266877|100431556|FG002|NOT COMPLETED|Overall Study||28||
48044833|NCT02204761|100431557|FG000|STARTED|Overall Study||6||
48044834|NCT02204761|100431557|FG000|COMPLETED|Overall Study||6||
48205179|NCT05001945|100827378|FG001|NOT COMPLETED|Overall Study||4||
48205180|NCT05001945|100827379|FG002|NOT COMPLETED|Overall Study||2||
48044835|NCT02204761|100431557|FG000|NOT COMPLETED|Overall Study||0||
48044836|NCT01904773|100431558|FG000|STARTED|Screen||28||
48044837|NCT01904773|100431559|FG001|STARTED|Screen||0||
48044838|NCT01904773|100431560|FG002|STARTED|Screen||0||
48044839|NCT01904773|100431561|FG003|STARTED|Screen||0||
48044840|NCT01904773|100431562|FG004|STARTED|Screen||0||
48044841|NCT01904773|100431563|FG005|STARTED|Screen||0||
48044842|NCT01904773|100431564|FG006|STARTED|Screen||0||
48044843|NCT01904773|100431565|FG007|STARTED|Screen||0||
48044844|NCT01904773|100431566|FG008|STARTED|Screen||0||
48044845|NCT01904773|100431558|FG000|COMPLETED|Screen||24||
48044846|NCT01904773|100431559|FG001|COMPLETED|Screen||0||
48044847|NCT01904773|100431560|FG002|COMPLETED|Screen||0||
48044848|NCT01904773|100431561|FG003|COMPLETED|Screen||0||
48044849|NCT01904773|100431562|FG004|COMPLETED|Screen||0||
48044850|NCT01904773|100431563|FG005|COMPLETED|Screen||0||
48044851|NCT01904773|100431564|FG006|COMPLETED|Screen||0||
48044852|NCT01904773|100431565|FG007|COMPLETED|Screen||0||
48044853|NCT01904773|100431566|FG008|COMPLETED|Screen||0||
48044854|NCT01904773|100431558|FG000|NOT COMPLETED|Screen||4||
48044855|NCT01904773|100431559|FG001|NOT COMPLETED|Screen||0||
48205181|NCT05001945|100827380|FG003|NOT COMPLETED|Overall Study||5||
48044856|NCT01904773|100431560|FG002|NOT COMPLETED|Screen||0||
48044857|NCT01904773|100431561|FG003|NOT COMPLETED|Screen||0||
48044858|NCT01904773|100431562|FG004|NOT COMPLETED|Screen||0||
48044859|NCT01904773|100431563|FG005|NOT COMPLETED|Screen||0||
48044860|NCT01904773|100431564|FG006|NOT COMPLETED|Screen||0||
48044861|NCT01904773|100431565|FG007|NOT COMPLETED|Screen||0||
48044862|NCT01904773|100431566|FG008|NOT COMPLETED|Screen||0||
48044863|NCT01904773|100431558|FG000|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||24||
48044864|NCT01904773|100431559|FG001|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
48044865|NCT01904773|100431560|FG002|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
48044866|NCT01904773|100431561|FG003|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
48044867|NCT01904773|100431562|FG004|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
48044868|NCT01904773|100431563|FG005|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
48044869|NCT01904773|100431564|FG006|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
48044870|NCT01904773|100431565|FG007|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
48044871|NCT01904773|100431566|FG008|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
48044872|NCT01904773|100431558|FG000|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||24||
48044873|NCT01904773|100431559|FG001|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
48044874|NCT01904773|100431560|FG002|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
48044875|NCT01904773|100431561|FG003|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
48044876|NCT01904773|100431562|FG004|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
48044877|NCT01904773|100431563|FG005|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
48044878|NCT01904773|100431564|FG006|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
48044879|NCT01904773|100431565|FG007|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
48044880|NCT01904773|100431566|FG008|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
48044881|NCT01904773|100431558|FG000|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
48044882|NCT01904773|100431559|FG001|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
48044883|NCT01904773|100431560|FG002|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
48044884|NCT01904773|100431561|FG003|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
48044885|NCT01904773|100431562|FG004|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
48044886|NCT01904773|100431563|FG005|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
48044887|NCT01904773|100431564|FG006|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
48044888|NCT01904773|100431565|FG007|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
48044889|NCT01904773|100431566|FG008|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
48044890|NCT01904773|100431558|FG000|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||24||
48044891|NCT01904773|100431559|FG001|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044892|NCT01904773|100431560|FG002|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044893|NCT01904773|100431561|FG003|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044894|NCT01904773|100431562|FG004|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044895|NCT01904773|100431563|FG005|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044896|NCT01904773|100431564|FG006|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044897|NCT01904773|100431565|FG007|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044898|NCT01904773|100431566|FG008|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044899|NCT01904773|100431558|FG000|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||20||
48044900|NCT01904773|100431559|FG001|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044901|NCT01904773|100431560|FG002|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044902|NCT01904773|100431561|FG003|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044903|NCT01904773|100431562|FG004|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044904|NCT01904773|100431563|FG005|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044905|NCT01904773|100431564|FG006|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044906|NCT01904773|100431565|FG007|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044907|NCT01904773|100431566|FG008|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044908|NCT01904773|100431558|FG000|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||4||
48044909|NCT01904773|100431559|FG001|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044910|NCT01904773|100431560|FG002|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044911|NCT01904773|100431561|FG003|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044912|NCT01904773|100431562|FG004|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044913|NCT01904773|100431563|FG005|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044914|NCT01904773|100431564|FG006|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044915|NCT01904773|100431565|FG007|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044916|NCT01904773|100431566|FG008|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044917|NCT01904773|100431558|FG000|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||23||
48044918|NCT01904773|100431559|FG001|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044919|NCT01904773|100431560|FG002|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044920|NCT01904773|100431561|FG003|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044921|NCT01904773|100431562|FG004|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044922|NCT01904773|100431563|FG005|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48205182|NCT05001945|100827381|FG004|NOT COMPLETED|Overall Study||2||
48205183|NCT05001945|100827382|FG005|NOT COMPLETED|Overall Study||3||
48205184|NCT05001945|100827383|FG006|NOT COMPLETED|Overall Study||0||
48205185|NCT05001945|100827384|FG007|NOT COMPLETED|Overall Study||1||
48205186|NCT00855465|100827385|FG000|STARTED|Treatment Period||174||
48205187|NCT00855465|100827386|FG001|STARTED|Treatment Period||88||
48205188|NCT00855465|100827385|FG000|Participants Received Treatment|Treatment Period||173||
48205189|NCT00855465|100827386|FG001|Participants Received Treatment|Treatment Period||88||
48205190|NCT00855465|100827385|FG000|COMPLETED|Treatment Period||160||
48205191|NCT00855465|100827386|FG001|COMPLETED|Treatment Period||83||
48205192|NCT00855465|100827385|FG000|NOT COMPLETED|Treatment Period||14||
48205193|NCT00855465|100827386|FG001|NOT COMPLETED|Treatment Period||5||
48205194|NCT00855465|100827385|FG000|STARTED|Follow-up Period (FUP)||17||
48205195|NCT00855465|100827386|FG001|STARTED|Follow-up Period (FUP)||4||
48205196|NCT00855465|100827385|FG000|COMPLETED|Follow-up Period (FUP)||9||
48205197|NCT00855465|100827386|FG001|COMPLETED|Follow-up Period (FUP)||2||
48205198|NCT00855465|100827385|FG000|NOT COMPLETED|Follow-up Period (FUP)||8||
48205199|NCT00855465|100827386|FG001|NOT COMPLETED|Follow-up Period (FUP)||2||
48205200|NCT02950558|100827387|FG000|STARTED|Overall Study||8||
48205201|NCT02950558|100827388|FG001|STARTED|Overall Study||6||
48205202|NCT02950558|100827387|FG000|12 Month Pain Questionnaire|Overall Study||6||
48205203|NCT02950558|100827388|FG001|12 Month Pain Questionnaire|Overall Study||6||
48495393|NCT00064038|101547840|FG001|Safety Population|Initial Randomization||94||
48495394|NCT00064038|101547841|FG002|Safety Population|Initial Randomization||0||
48495395|NCT00064038|101547839|FG000|COMPLETED|Initial Randomization||0||
48495396|NCT00064038|101547840|FG001|COMPLETED|Initial Randomization||0||
48495397|NCT00064038|101547841|FG002|COMPLETED|Initial Randomization||0||
48044923|NCT01904773|100431564|FG006|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044924|NCT01904773|100431565|FG007|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044925|NCT01904773|100431566|FG008|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044926|NCT01904773|100431558|FG000|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||1||
48044927|NCT01904773|100431559|FG001|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044928|NCT01904773|100431560|FG002|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044929|NCT01904773|100431561|FG003|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044930|NCT01904773|100431562|FG004|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044931|NCT01904773|100431563|FG005|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044932|NCT01904773|100431564|FG006|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044933|NCT01904773|100431565|FG007|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044934|NCT01904773|100431566|FG008|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
48044935|NCT01904773|100431558|FG000|STARTED|First Intervention||0||
48044936|NCT01904773|100431559|FG001|STARTED|First Intervention||2||
48044937|NCT01904773|100431560|FG002|STARTED|First Intervention||1||
48044938|NCT01904773|100431561|FG003|STARTED|First Intervention||2||
48044939|NCT01904773|100431562|FG004|STARTED|First Intervention||3||
48044940|NCT01904773|100431563|FG005|STARTED|First Intervention||4||
48044941|NCT01904773|100431564|FG006|STARTED|First Intervention||4||
48044942|NCT01904773|100431565|FG007|STARTED|First Intervention||3||
48044943|NCT01904773|100431566|FG008|STARTED|First Intervention||4||
48044944|NCT01904773|100431558|FG000|COMPLETED|First Intervention||0||
48044945|NCT01904773|100431559|FG001|COMPLETED|First Intervention||2||
48044946|NCT01904773|100431560|FG002|COMPLETED|First Intervention||1||
48044947|NCT01904773|100431561|FG003|COMPLETED|First Intervention||2||
48044948|NCT01904773|100431562|FG004|COMPLETED|First Intervention||3||
48044949|NCT01904773|100431563|FG005|COMPLETED|First Intervention||4||
48044950|NCT01904773|100431564|FG006|COMPLETED|First Intervention||3||
48044951|NCT01904773|100431565|FG007|COMPLETED|First Intervention||3||
48044952|NCT01904773|100431566|FG008|COMPLETED|First Intervention||4||
48044953|NCT01904773|100431558|FG000|NOT COMPLETED|First Intervention||0||
48044954|NCT01904773|100431559|FG001|NOT COMPLETED|First Intervention||0||
48044955|NCT01904773|100431560|FG002|NOT COMPLETED|First Intervention||0||
48044956|NCT01904773|100431561|FG003|NOT COMPLETED|First Intervention||0||
48044957|NCT01904773|100431562|FG004|NOT COMPLETED|First Intervention||0||
48044958|NCT01904773|100431563|FG005|NOT COMPLETED|First Intervention||0||
48044959|NCT01904773|100431564|FG006|NOT COMPLETED|First Intervention||1||
48044960|NCT01904773|100431565|FG007|NOT COMPLETED|First Intervention||0||
48044961|NCT01904773|100431566|FG008|NOT COMPLETED|First Intervention||0||
48044962|NCT01904773|100431558|FG000|STARTED|Placebo Washout First Intervention||0||
48044963|NCT01904773|100431559|FG001|STARTED|Placebo Washout First Intervention||2||
48044964|NCT01904773|100431560|FG002|STARTED|Placebo Washout First Intervention||1||
48044965|NCT01904773|100431561|FG003|STARTED|Placebo Washout First Intervention||2||
48044966|NCT01904773|100431562|FG004|STARTED|Placebo Washout First Intervention||3||
48044967|NCT01904773|100431563|FG005|STARTED|Placebo Washout First Intervention||4||
48044968|NCT01904773|100431564|FG006|STARTED|Placebo Washout First Intervention||3||
48205204|NCT02950558|100827387|FG000|COMPLETED|Overall Study||6||
48205205|NCT02950558|100827388|FG001|COMPLETED|Overall Study||6||
48205206|NCT02950558|100827387|FG000|NOT COMPLETED|Overall Study||2||
48205207|NCT02950558|100827388|FG001|NOT COMPLETED|Overall Study||0||
48205208|NCT02507336|100827389|FG000|STARTED|Overall Study||2||
48205209|NCT02507336|100827389|FG000|COMPLETED|Overall Study||2||
48205210|NCT02507336|100827389|FG000|NOT COMPLETED|Overall Study||0||
48205211|NCT00420316|100827390|FG000|STARTED|Overall Study||1082||
48205212|NCT00420316|100827391|FG001|STARTED|Overall Study||531||
48205213|NCT00420316|100827390|FG000|COMPLETED|Overall Study||1070||
48205214|NCT00420316|100827391|FG001|COMPLETED|Overall Study||522||
48205215|NCT00420316|100827390|FG000|NOT COMPLETED|Overall Study||12||
48205216|NCT00420316|100827391|FG001|NOT COMPLETED|Overall Study||9||
48205217|NCT03299816|100827392|FG000|STARTED|Phase 1: 4-month Intervention Period||70||
48044969|NCT01904773|100431565|FG007|STARTED|Placebo Washout First Intervention||3||
48044970|NCT01904773|100431566|FG008|STARTED|Placebo Washout First Intervention||4||
48044971|NCT01904773|100431558|FG000|COMPLETED|Placebo Washout First Intervention||0||
48044972|NCT01904773|100431559|FG001|COMPLETED|Placebo Washout First Intervention||1||
48044973|NCT01904773|100431560|FG002|COMPLETED|Placebo Washout First Intervention||1||
48044974|NCT01904773|100431561|FG003|COMPLETED|Placebo Washout First Intervention||2||
48044975|NCT01904773|100431562|FG004|COMPLETED|Placebo Washout First Intervention||3||
48044976|NCT01904773|100431563|FG005|COMPLETED|Placebo Washout First Intervention||4||
48044977|NCT01904773|100431564|FG006|COMPLETED|Placebo Washout First Intervention||3||
48044978|NCT01904773|100431565|FG007|COMPLETED|Placebo Washout First Intervention||3||
48044979|NCT01904773|100431566|FG008|COMPLETED|Placebo Washout First Intervention||4||
48044980|NCT01904773|100431558|FG000|NOT COMPLETED|Placebo Washout First Intervention||0||
48044981|NCT01904773|100431559|FG001|NOT COMPLETED|Placebo Washout First Intervention||1||
48044982|NCT01904773|100431560|FG002|NOT COMPLETED|Placebo Washout First Intervention||0||
48044983|NCT01904773|100431561|FG003|NOT COMPLETED|Placebo Washout First Intervention||0||
48044984|NCT01904773|100431562|FG004|NOT COMPLETED|Placebo Washout First Intervention||0||
48044985|NCT01904773|100431563|FG005|NOT COMPLETED|Placebo Washout First Intervention||0||
48044986|NCT01904773|100431564|FG006|NOT COMPLETED|Placebo Washout First Intervention||0||
48044987|NCT01904773|100431565|FG007|NOT COMPLETED|Placebo Washout First Intervention||0||
48044988|NCT01904773|100431566|FG008|NOT COMPLETED|Placebo Washout First Intervention||0||
48044989|NCT01904773|100431558|FG000|STARTED|Second Intervention||0||
48044990|NCT01904773|100431559|FG001|STARTED|Second Intervention||1||
48044991|NCT01904773|100431560|FG002|STARTED|Second Intervention||1||
48044992|NCT01904773|100431561|FG003|STARTED|Second Intervention||2||
48044993|NCT01904773|100431562|FG004|STARTED|Second Intervention||3||
48044994|NCT01904773|100431563|FG005|STARTED|Second Intervention||4||
48044995|NCT01904773|100431564|FG006|STARTED|Second Intervention||3||
48044996|NCT01904773|100431565|FG007|STARTED|Second Intervention||3||
48044997|NCT01904773|100431566|FG008|STARTED|Second Intervention||4||
48044998|NCT01904773|100431558|FG000|COMPLETED|Second Intervention||0||
48044999|NCT01904773|100431559|FG001|COMPLETED|Second Intervention||1||
48045000|NCT01904773|100431560|FG002|COMPLETED|Second Intervention||1||
48045001|NCT01904773|100431561|FG003|COMPLETED|Second Intervention||2||
48045002|NCT01904773|100431562|FG004|COMPLETED|Second Intervention||3||
48045003|NCT01904773|100431563|FG005|COMPLETED|Second Intervention||4||
48045004|NCT01904773|100431564|FG006|COMPLETED|Second Intervention||3||
48045005|NCT01904773|100431565|FG007|COMPLETED|Second Intervention||3||
48495398|NCT00064038|101547839|FG000|NOT COMPLETED|Initial Randomization||100||
48495399|NCT00064038|101547840|FG001|NOT COMPLETED|Initial Randomization||98||
48495400|NCT00064038|101547841|FG002|NOT COMPLETED|Initial Randomization||0||
48495401|NCT00064038|101547839|FG000|STARTED|Crossover to Lenalidomide+Dexamethasone||0||
48045006|NCT01904773|100431566|FG008|COMPLETED|Second Intervention||4||
48045007|NCT01904773|100431558|FG000|NOT COMPLETED|Second Intervention||0||
48045008|NCT01904773|100431559|FG001|NOT COMPLETED|Second Intervention||0||
48045009|NCT01904773|100431560|FG002|NOT COMPLETED|Second Intervention||0||
48045010|NCT01904773|100431561|FG003|NOT COMPLETED|Second Intervention||0||
48045011|NCT01904773|100431562|FG004|NOT COMPLETED|Second Intervention||0||
48045012|NCT01904773|100431563|FG005|NOT COMPLETED|Second Intervention||0||
48045013|NCT01904773|100431564|FG006|NOT COMPLETED|Second Intervention||0||
48045014|NCT01904773|100431565|FG007|NOT COMPLETED|Second Intervention||0||
48045015|NCT01904773|100431566|FG008|NOT COMPLETED|Second Intervention||0||
48045016|NCT01904773|100431558|FG000|STARTED|Placebo Washout Second Intervention||0||
48045017|NCT01904773|100431559|FG001|STARTED|Placebo Washout Second Intervention||1||
48045018|NCT01904773|100431560|FG002|STARTED|Placebo Washout Second Intervention||1||
48045019|NCT01904773|100431561|FG003|STARTED|Placebo Washout Second Intervention||2||
48045020|NCT01904773|100431562|FG004|STARTED|Placebo Washout Second Intervention||3||
48205218|NCT03299816|100827393|FG001|STARTED|Phase 1: 4-month Intervention Period||72||
48205219|NCT03299816|100827392|FG000|COMPLETED|Phase 1: 4-month Intervention Period||69||
48205220|NCT03299816|100827393|FG001|COMPLETED|Phase 1: 4-month Intervention Period||72||
48205221|NCT03299816|100827392|FG000|NOT COMPLETED|Phase 1: 4-month Intervention Period||1||
48495402|NCT00064038|101547840|FG001|STARTED|Crossover to Lenalidomide+Dexamethasone||0||
48666740|NCT03391882|101970469|FG004|Safety Population Part A|Part A - Titration Phase||18||
48205222|NCT03299816|100827393|FG001|NOT COMPLETED|Phase 1: 4-month Intervention Period||0||
48205223|NCT03299816|100827392|FG000|STARTED|Phase 2: 12-month Follow-up Period||52||
48205224|NCT03299816|100827393|FG001|STARTED|Phase 2: 12-month Follow-up Period||56||
48045021|NCT01904773|100431563|FG005|STARTED|Placebo Washout Second Intervention||4||
48045022|NCT01904773|100431564|FG006|STARTED|Placebo Washout Second Intervention||3||
48045023|NCT01904773|100431565|FG007|STARTED|Placebo Washout Second Intervention||3||
48045024|NCT01904773|100431566|FG008|STARTED|Placebo Washout Second Intervention||4||
48045025|NCT01904773|100431558|FG000|COMPLETED|Placebo Washout Second Intervention||0||
48045026|NCT01904773|100431559|FG001|COMPLETED|Placebo Washout Second Intervention||1||
48045027|NCT01904773|100431560|FG002|COMPLETED|Placebo Washout Second Intervention||1||
48045028|NCT01904773|100431561|FG003|COMPLETED|Placebo Washout Second Intervention||2||
48045029|NCT01904773|100431562|FG004|COMPLETED|Placebo Washout Second Intervention||3||
48045030|NCT01904773|100431563|FG005|COMPLETED|Placebo Washout Second Intervention||4||
48045031|NCT01904773|100431564|FG006|COMPLETED|Placebo Washout Second Intervention||3||
48045032|NCT01904773|100431565|FG007|COMPLETED|Placebo Washout Second Intervention||3||
48045033|NCT01904773|100431566|FG008|COMPLETED|Placebo Washout Second Intervention||4||
48045034|NCT01904773|100431558|FG000|NOT COMPLETED|Placebo Washout Second Intervention||0||
48205225|NCT03299816|100827392|FG000|COMPLETED|Phase 2: 12-month Follow-up Period||49||
48205226|NCT03299816|100827393|FG001|COMPLETED|Phase 2: 12-month Follow-up Period||53||
48205227|NCT03299816|100827392|FG000|NOT COMPLETED|Phase 2: 12-month Follow-up Period||3||
48205228|NCT03299816|100827393|FG001|NOT COMPLETED|Phase 2: 12-month Follow-up Period||3||
48205229|NCT05686421|100827394|FG000|STARTED|Overall Study||42||
48205230|NCT05686421|100827395|FG001|STARTED|Overall Study||0||
48205231|NCT05686421|100827396|FG002|STARTED|Overall Study||0||
48205232|NCT05686421|100827397|FG003|STARTED|Overall Study||0||
48045035|NCT01904773|100431559|FG001|NOT COMPLETED|Placebo Washout Second Intervention||0||
48045036|NCT01904773|100431560|FG002|NOT COMPLETED|Placebo Washout Second Intervention||0||
48045037|NCT01904773|100431561|FG003|NOT COMPLETED|Placebo Washout Second Intervention||0||
48045038|NCT01904773|100431562|FG004|NOT COMPLETED|Placebo Washout Second Intervention||0||
48045039|NCT01904773|100431563|FG005|NOT COMPLETED|Placebo Washout Second Intervention||0||
48045040|NCT01904773|100431564|FG006|NOT COMPLETED|Placebo Washout Second Intervention||0||
48045041|NCT01904773|100431565|FG007|NOT COMPLETED|Placebo Washout Second Intervention||0||
48045042|NCT01904773|100431566|FG008|NOT COMPLETED|Placebo Washout Second Intervention||0||
48045043|NCT01904773|100431558|FG000|STARTED|Third Intervention||0||
48045044|NCT01904773|100431559|FG001|STARTED|Third Intervention||1||
48045045|NCT01904773|100431560|FG002|STARTED|Third Intervention||1||
48045046|NCT01904773|100431561|FG003|STARTED|Third Intervention||2||
48045047|NCT01904773|100431562|FG004|STARTED|Third Intervention||3||
48045048|NCT01904773|100431563|FG005|STARTED|Third Intervention||4||
48045049|NCT01904773|100431564|FG006|STARTED|Third Intervention||3||
48045050|NCT01904773|100431565|FG007|STARTED|Third Intervention||3||
48045051|NCT01904773|100431566|FG008|STARTED|Third Intervention||4||
48045052|NCT01904773|100431558|FG000|COMPLETED|Third Intervention||0||
48045053|NCT01904773|100431559|FG001|COMPLETED|Third Intervention||1||
48045054|NCT01904773|100431560|FG002|COMPLETED|Third Intervention||1||
48045055|NCT01904773|100431561|FG003|COMPLETED|Third Intervention||2||
48045056|NCT01904773|100431562|FG004|COMPLETED|Third Intervention||3||
48045057|NCT01904773|100431563|FG005|COMPLETED|Third Intervention||4||
48045058|NCT01904773|100431564|FG006|COMPLETED|Third Intervention||3||
48045059|NCT01904773|100431565|FG007|COMPLETED|Third Intervention||3||
48205233|NCT05686421|100827394|FG000|COMPLETED|Overall Study||20||
48205234|NCT05686421|100827395|FG001|COMPLETED|Overall Study||0||
48205235|NCT05686421|100827396|FG002|COMPLETED|Overall Study||0||
48205236|NCT05686421|100827397|FG003|COMPLETED|Overall Study||0||
48205237|NCT05686421|100827394|FG000|NOT COMPLETED|Overall Study||22||
48205238|NCT05686421|100827395|FG001|NOT COMPLETED|Overall Study||0||
48205239|NCT05686421|100827396|FG002|NOT COMPLETED|Overall Study||0||
48205240|NCT05686421|100827397|FG003|NOT COMPLETED|Overall Study||0||
48205241|NCT00509769|100827398|FG000|STARTED|Overall Study||112||
48205242|NCT00509769|100827398|FG000|COMPLETED|Overall Study||21||
48205243|NCT00509769|100827398|FG000|NOT COMPLETED|Overall Study||91||
48205244|NCT01134562|100827399|FG000|STARTED|Overall Study||4||
48205245|NCT01134562|100827400|FG001|STARTED|Overall Study||4||
48205246|NCT01134562|100827401|FG002|STARTED|Overall Study||4||
48205247|NCT01134562|100827402|FG003|STARTED|Overall Study||8||
48205248|NCT01134562|100827403|FG004|STARTED|Overall Study||8||
48205249|NCT01134562|100827399|FG000|COMPLETED|Overall Study||4||
48205250|NCT01134562|100827400|FG001|COMPLETED|Overall Study||3||
48205251|NCT01134562|100827401|FG002|COMPLETED|Overall Study||4||
48205252|NCT01134562|100827402|FG003|COMPLETED|Overall Study||8||
48045060|NCT01904773|100431566|FG008|COMPLETED|Third Intervention||4||
48045061|NCT01904773|100431558|FG000|NOT COMPLETED|Third Intervention||0||
48045062|NCT01904773|100431559|FG001|NOT COMPLETED|Third Intervention||0||
48045063|NCT01904773|100431560|FG002|NOT COMPLETED|Third Intervention||0||
48045064|NCT01904773|100431561|FG003|NOT COMPLETED|Third Intervention||0||
48045065|NCT01904773|100431562|FG004|NOT COMPLETED|Third Intervention||0||
48045066|NCT01904773|100431563|FG005|NOT COMPLETED|Third Intervention||0||
48205253|NCT01134562|100827403|FG004|COMPLETED|Overall Study||8||
48205254|NCT01134562|100827399|FG000|NOT COMPLETED|Overall Study||0||
48205255|NCT01134562|100827400|FG001|NOT COMPLETED|Overall Study||1||
48205256|NCT01134562|100827401|FG002|NOT COMPLETED|Overall Study||0||
48045067|NCT01904773|100431564|FG006|NOT COMPLETED|Third Intervention||0||
48045068|NCT01904773|100431565|FG007|NOT COMPLETED|Third Intervention||0||
48045069|NCT01904773|100431566|FG008|NOT COMPLETED|Third Intervention||0||
48045070|NCT01904773|100431558|FG000|STARTED|Placebo Washout Third Intervention||0||
48045071|NCT01904773|100431559|FG001|STARTED|Placebo Washout Third Intervention||1||
48045072|NCT01904773|100431560|FG002|STARTED|Placebo Washout Third Intervention||1||
48045073|NCT01904773|100431561|FG003|STARTED|Placebo Washout Third Intervention||2||
48045074|NCT01904773|100431562|FG004|STARTED|Placebo Washout Third Intervention||3||
48045075|NCT01904773|100431563|FG005|STARTED|Placebo Washout Third Intervention||4||
48045076|NCT01904773|100431564|FG006|STARTED|Placebo Washout Third Intervention||3||
48045077|NCT01904773|100431565|FG007|STARTED|Placebo Washout Third Intervention||3||
48045078|NCT01904773|100431566|FG008|STARTED|Placebo Washout Third Intervention||4||
48045079|NCT01904773|100431558|FG000|COMPLETED|Placebo Washout Third Intervention||0||
48045080|NCT01904773|100431559|FG001|COMPLETED|Placebo Washout Third Intervention||1||
48045081|NCT01904773|100431560|FG002|COMPLETED|Placebo Washout Third Intervention||1||
48045082|NCT01904773|100431561|FG003|COMPLETED|Placebo Washout Third Intervention||2||
48045083|NCT01904773|100431562|FG004|COMPLETED|Placebo Washout Third Intervention||3||
48045084|NCT01904773|100431563|FG005|COMPLETED|Placebo Washout Third Intervention||4||
48045085|NCT01904773|100431564|FG006|COMPLETED|Placebo Washout Third Intervention||3||
48045086|NCT01904773|100431565|FG007|COMPLETED|Placebo Washout Third Intervention||3||
48045087|NCT01904773|100431566|FG008|COMPLETED|Placebo Washout Third Intervention||4||
48045088|NCT01904773|100431558|FG000|NOT COMPLETED|Placebo Washout Third Intervention||0||
48045089|NCT01904773|100431559|FG001|NOT COMPLETED|Placebo Washout Third Intervention||0||
48045090|NCT01904773|100431560|FG002|NOT COMPLETED|Placebo Washout Third Intervention||0||
48045091|NCT01904773|100431561|FG003|NOT COMPLETED|Placebo Washout Third Intervention||0||
48045092|NCT01904773|100431562|FG004|NOT COMPLETED|Placebo Washout Third Intervention||0||
48045093|NCT01904773|100431563|FG005|NOT COMPLETED|Placebo Washout Third Intervention||0||
48045094|NCT01904773|100431564|FG006|NOT COMPLETED|Placebo Washout Third Intervention||0||
48045095|NCT01904773|100431565|FG007|NOT COMPLETED|Placebo Washout Third Intervention||0||
48045096|NCT01904773|100431566|FG008|NOT COMPLETED|Placebo Washout Third Intervention||0||
48045097|NCT01904773|100431558|FG000|STARTED|Fourth Intervention||0||
48045098|NCT01904773|100431559|FG001|STARTED|Fourth Intervention||1||
48045099|NCT01904773|100431560|FG002|STARTED|Fourth Intervention||1||
48045100|NCT01904773|100431561|FG003|STARTED|Fourth Intervention||2||
48045101|NCT01904773|100431562|FG004|STARTED|Fourth Intervention||3||
48045102|NCT01904773|100431563|FG005|STARTED|Fourth Intervention||4||
48045103|NCT01904773|100431564|FG006|STARTED|Fourth Intervention||3||
48045104|NCT01904773|100431565|FG007|STARTED|Fourth Intervention||3||
48045105|NCT01904773|100431566|FG008|STARTED|Fourth Intervention||4||
48045106|NCT01904773|100431558|FG000|COMPLETED|Fourth Intervention||0||
48045107|NCT01904773|100431559|FG001|COMPLETED|Fourth Intervention||1||
48045108|NCT01904773|100431560|FG002|COMPLETED|Fourth Intervention||1||
48045109|NCT01904773|100431561|FG003|COMPLETED|Fourth Intervention||2||
48045110|NCT01904773|100431562|FG004|COMPLETED|Fourth Intervention||3||
48045111|NCT01904773|100431563|FG005|COMPLETED|Fourth Intervention||4||
48045112|NCT01904773|100431564|FG006|COMPLETED|Fourth Intervention||3||
48045113|NCT01904773|100431565|FG007|COMPLETED|Fourth Intervention||3||
48045114|NCT01904773|100431566|FG008|COMPLETED|Fourth Intervention||4||
48045115|NCT01904773|100431558|FG000|NOT COMPLETED|Fourth Intervention||0||
48045116|NCT01904773|100431559|FG001|NOT COMPLETED|Fourth Intervention||0||
48045117|NCT01904773|100431560|FG002|NOT COMPLETED|Fourth Intervention||0||
48045118|NCT01904773|100431561|FG003|NOT COMPLETED|Fourth Intervention||0||
48045119|NCT01904773|100431562|FG004|NOT COMPLETED|Fourth Intervention||0||
48045120|NCT01904773|100431563|FG005|NOT COMPLETED|Fourth Intervention||0||
48045121|NCT01904773|100431564|FG006|NOT COMPLETED|Fourth Intervention||0||
48045122|NCT01904773|100431565|FG007|NOT COMPLETED|Fourth Intervention||0||
48045123|NCT01904773|100431566|FG008|NOT COMPLETED|Fourth Intervention||0||
48045124|NCT01904773|100431558|FG000|STARTED|Placebo Washout Fourth Intervention||0||
48045125|NCT01904773|100431559|FG001|STARTED|Placebo Washout Fourth Intervention||1||
48045126|NCT01904773|100431560|FG002|STARTED|Placebo Washout Fourth Intervention||1||
48045127|NCT01904773|100431561|FG003|STARTED|Placebo Washout Fourth Intervention||2||
48045128|NCT01904773|100431562|FG004|STARTED|Placebo Washout Fourth Intervention||3||
48045129|NCT01904773|100431563|FG005|STARTED|Placebo Washout Fourth Intervention||4||
48045130|NCT01904773|100431564|FG006|STARTED|Placebo Washout Fourth Intervention||3||
48045131|NCT01904773|100431565|FG007|STARTED|Placebo Washout Fourth Intervention||3||
48045132|NCT01904773|100431566|FG008|STARTED|Placebo Washout Fourth Intervention||4||
48045133|NCT01904773|100431558|FG000|COMPLETED|Placebo Washout Fourth Intervention||0||
48045134|NCT01904773|100431559|FG001|COMPLETED|Placebo Washout Fourth Intervention||1||
48045135|NCT01904773|100431560|FG002|COMPLETED|Placebo Washout Fourth Intervention||1||
48045136|NCT01904773|100431561|FG003|COMPLETED|Placebo Washout Fourth Intervention||2||
48045137|NCT01904773|100431562|FG004|COMPLETED|Placebo Washout Fourth Intervention||3||
48045138|NCT01904773|100431563|FG005|COMPLETED|Placebo Washout Fourth Intervention||4||
48045139|NCT01904773|100431564|FG006|COMPLETED|Placebo Washout Fourth Intervention||3||
48045140|NCT01904773|100431565|FG007|COMPLETED|Placebo Washout Fourth Intervention||3||
48205257|NCT01134562|100827402|FG003|NOT COMPLETED|Overall Study||0||
48205258|NCT01134562|100827403|FG004|NOT COMPLETED|Overall Study||0||
48205259|NCT00597519|100827404|FG000|STARTED|Overall Study||28||
48205260|NCT00597519|100827404|FG000|COMPLETED|Overall Study||27||
48205261|NCT00597519|100827404|FG000|NOT COMPLETED|Overall Study||1||
48205262|NCT00588666|100827405|FG000|STARTED|Overall Study||51||
48205263|NCT00588666|100827405|FG000|COMPLETED|Overall Study||47||
48205264|NCT00588666|100827405|FG000|NOT COMPLETED|Overall Study||4||
48205265|NCT00835380|100827406|FG000|STARTED|Overall Study||80||
48205266|NCT00835380|100827406|FG000|COMPLETED|Overall Study||78||
48205267|NCT00835380|100827406|FG000|NOT COMPLETED|Overall Study||2||
48205268|NCT02631148|100827407|FG000|STARTED|Overall Study||12||
48205269|NCT02631148|100827408|FG001|STARTED|Overall Study||0||
48205270|NCT02631148|100827407|FG000|COMPLETED|Overall Study||2|2 completed visits, however blood samples did not undergo analysis and other measurements were not analyzed.|
48045141|NCT01904773|100431566|FG008|COMPLETED|Placebo Washout Fourth Intervention||4||
48045142|NCT01904773|100431558|FG000|NOT COMPLETED|Placebo Washout Fourth Intervention||0||
48045143|NCT01904773|100431559|FG001|NOT COMPLETED|Placebo Washout Fourth Intervention||0||
48045144|NCT01904773|100431560|FG002|NOT COMPLETED|Placebo Washout Fourth Intervention||0||
48045145|NCT01904773|100431561|FG003|NOT COMPLETED|Placebo Washout Fourth Intervention||0||
48045146|NCT01904773|100431562|FG004|NOT COMPLETED|Placebo Washout Fourth Intervention||0||
48045147|NCT01904773|100431563|FG005|NOT COMPLETED|Placebo Washout Fourth Intervention||0||
48045148|NCT01904773|100431564|FG006|NOT COMPLETED|Placebo Washout Fourth Intervention||0||
48045149|NCT01904773|100431565|FG007|NOT COMPLETED|Placebo Washout Fourth Intervention||0||
48045150|NCT01904773|100431566|FG008|NOT COMPLETED|Placebo Washout Fourth Intervention||0||
48045151|NCT01904773|100431558|FG000|STARTED|Fifth Intervention||0||
48045152|NCT01904773|100431559|FG001|STARTED|Fifth Intervention||1||
48045153|NCT01904773|100431560|FG002|STARTED|Fifth Intervention||1||
48045154|NCT01904773|100431561|FG003|STARTED|Fifth Intervention||2||
48045155|NCT01904773|100431562|FG004|STARTED|Fifth Intervention||3||
48045156|NCT01904773|100431563|FG005|STARTED|Fifth Intervention||4||
48045157|NCT01904773|100431564|FG006|STARTED|Fifth Intervention||3||
48045158|NCT01904773|100431565|FG007|STARTED|Fifth Intervention||3||
48045159|NCT01904773|100431566|FG008|STARTED|Fifth Intervention||4||
48045160|NCT01904773|100431558|FG000|COMPLETED|Fifth Intervention||0||
48045161|NCT01904773|100431559|FG001|COMPLETED|Fifth Intervention||1||
48045162|NCT01904773|100431560|FG002|COMPLETED|Fifth Intervention||1||
48045163|NCT01904773|100431561|FG003|COMPLETED|Fifth Intervention||2||
48045164|NCT01904773|100431562|FG004|COMPLETED|Fifth Intervention||3||
48045165|NCT01904773|100431563|FG005|COMPLETED|Fifth Intervention||4||
48045166|NCT01904773|100431564|FG006|COMPLETED|Fifth Intervention||3||
48045167|NCT01904773|100431565|FG007|COMPLETED|Fifth Intervention||2||
48045168|NCT01904773|100431566|FG008|COMPLETED|Fifth Intervention||4||
48045169|NCT01904773|100431558|FG000|NOT COMPLETED|Fifth Intervention||0||
48045170|NCT01904773|100431559|FG001|NOT COMPLETED|Fifth Intervention||0||
48045171|NCT01904773|100431560|FG002|NOT COMPLETED|Fifth Intervention||0||
48045172|NCT01904773|100431561|FG003|NOT COMPLETED|Fifth Intervention||0||
48045173|NCT01904773|100431562|FG004|NOT COMPLETED|Fifth Intervention||0||
48045174|NCT01904773|100431563|FG005|NOT COMPLETED|Fifth Intervention||0||
48045175|NCT01904773|100431564|FG006|NOT COMPLETED|Fifth Intervention||0||
48045176|NCT01904773|100431565|FG007|NOT COMPLETED|Fifth Intervention||1||
48045177|NCT01904773|100431566|FG008|NOT COMPLETED|Fifth Intervention||0||
48045178|NCT01904773|100431558|FG000|STARTED|Placebo Washout Fifth Intervention||0||
48045179|NCT01904773|100431559|FG001|STARTED|Placebo Washout Fifth Intervention||1||
48045180|NCT01904773|100431560|FG002|STARTED|Placebo Washout Fifth Intervention||1||
48045181|NCT01904773|100431561|FG003|STARTED|Placebo Washout Fifth Intervention||2||
48045182|NCT01904773|100431562|FG004|STARTED|Placebo Washout Fifth Intervention||3||
48045183|NCT01904773|100431563|FG005|STARTED|Placebo Washout Fifth Intervention||4||
48045184|NCT01904773|100431564|FG006|STARTED|Placebo Washout Fifth Intervention||3||
48045185|NCT01904773|100431565|FG007|STARTED|Placebo Washout Fifth Intervention||2||
48045186|NCT01904773|100431566|FG008|STARTED|Placebo Washout Fifth Intervention||4||
48045187|NCT01904773|100431558|FG000|COMPLETED|Placebo Washout Fifth Intervention||0||
48045188|NCT01904773|100431559|FG001|COMPLETED|Placebo Washout Fifth Intervention||0||
48045189|NCT01904773|100431560|FG002|COMPLETED|Placebo Washout Fifth Intervention||1||
48045190|NCT01904773|100431561|FG003|COMPLETED|Placebo Washout Fifth Intervention||2||
48045191|NCT01904773|100431562|FG004|COMPLETED|Placebo Washout Fifth Intervention||3||
48045192|NCT01904773|100431563|FG005|COMPLETED|Placebo Washout Fifth Intervention||4||
48045193|NCT01904773|100431564|FG006|COMPLETED|Placebo Washout Fifth Intervention||3||
48045194|NCT01904773|100431565|FG007|COMPLETED|Placebo Washout Fifth Intervention||2||
48045195|NCT01904773|100431566|FG008|COMPLETED|Placebo Washout Fifth Intervention||4||
48045196|NCT01904773|100431558|FG000|NOT COMPLETED|Placebo Washout Fifth Intervention||0||
48045197|NCT01904773|100431559|FG001|NOT COMPLETED|Placebo Washout Fifth Intervention||1||
48045198|NCT01904773|100431560|FG002|NOT COMPLETED|Placebo Washout Fifth Intervention||0||
48205271|NCT02631148|100827408|FG001|COMPLETED|Overall Study||0|2 completed visits, however blood samples did not undergo analysis and other measurements were not analyzed.|
48205272|NCT02631148|100827407|FG000|NOT COMPLETED|Overall Study||10||
48205273|NCT02631148|100827408|FG001|NOT COMPLETED|Overall Study||0||
48045199|NCT01904773|100431561|FG003|NOT COMPLETED|Placebo Washout Fifth Intervention||0||
48045200|NCT01904773|100431562|FG004|NOT COMPLETED|Placebo Washout Fifth Intervention||0||
48045201|NCT01904773|100431563|FG005|NOT COMPLETED|Placebo Washout Fifth Intervention||0||
48045202|NCT01904773|100431564|FG006|NOT COMPLETED|Placebo Washout Fifth Intervention||0||
48045203|NCT01904773|100431565|FG007|NOT COMPLETED|Placebo Washout Fifth Intervention||0||
48045204|NCT01904773|100431566|FG008|NOT COMPLETED|Placebo Washout Fifth Intervention||0||
48045205|NCT01904773|100431558|FG000|STARTED|Sixth Intervention||0||
48045206|NCT01904773|100431559|FG001|STARTED|Sixth Intervention||0||
48045207|NCT01904773|100431560|FG002|STARTED|Sixth Intervention||1||
48045208|NCT01904773|100431561|FG003|STARTED|Sixth Intervention||2||
48045209|NCT01904773|100431562|FG004|STARTED|Sixth Intervention||3||
48045210|NCT01904773|100431563|FG005|STARTED|Sixth Intervention||4||
48045211|NCT01904773|100431564|FG006|STARTED|Sixth Intervention||3||
48045212|NCT01904773|100431565|FG007|STARTED|Sixth Intervention||2||
48045213|NCT01904773|100431566|FG008|STARTED|Sixth Intervention||4||
48045214|NCT01904773|100431558|FG000|COMPLETED|Sixth Intervention||0||
48045215|NCT01904773|100431559|FG001|COMPLETED|Sixth Intervention||0||
48045216|NCT01904773|100431560|FG002|COMPLETED|Sixth Intervention||1||
48045217|NCT01904773|100431561|FG003|COMPLETED|Sixth Intervention||2||
48045218|NCT01904773|100431562|FG004|COMPLETED|Sixth Intervention||3||
48045219|NCT01904773|100431563|FG005|COMPLETED|Sixth Intervention||4||
48045220|NCT01904773|100431564|FG006|COMPLETED|Sixth Intervention||3||
48045221|NCT01904773|100431565|FG007|COMPLETED|Sixth Intervention||2||
48045222|NCT01904773|100431566|FG008|COMPLETED|Sixth Intervention||4||
48045223|NCT01904773|100431558|FG000|NOT COMPLETED|Sixth Intervention||0||
48045224|NCT01904773|100431559|FG001|NOT COMPLETED|Sixth Intervention||0||
48045225|NCT01904773|100431560|FG002|NOT COMPLETED|Sixth Intervention||0||
48045226|NCT01904773|100431561|FG003|NOT COMPLETED|Sixth Intervention||0||
48045227|NCT01904773|100431562|FG004|NOT COMPLETED|Sixth Intervention||0||
48045228|NCT01904773|100431563|FG005|NOT COMPLETED|Sixth Intervention||0||
48045229|NCT01904773|100431564|FG006|NOT COMPLETED|Sixth Intervention||0||
48045230|NCT01904773|100431565|FG007|NOT COMPLETED|Sixth Intervention||0||
48045231|NCT01904773|100431566|FG008|NOT COMPLETED|Sixth Intervention||0||
48045232|NCT01440543|100431567|FG000|STARTED|Overall Study||106||
48045233|NCT01440543|100431568|FG001|STARTED|Overall Study||105||
48045234|NCT01440543|100431569|FG002|STARTED|Overall Study||102||
48045235|NCT01440543|100431570|FG003|STARTED|Overall Study||107||
48045236|NCT01440543|100431567|FG000|COMPLETED|Overall Study||102||
48045237|NCT01440543|100431568|FG001|COMPLETED|Overall Study||101||
48045238|NCT01440543|100431569|FG002|COMPLETED|Overall Study||100||
48045239|NCT01440543|100431570|FG003|COMPLETED|Overall Study||101||
48045240|NCT01440543|100431567|FG000|NOT COMPLETED|Overall Study||4||
48045241|NCT01440543|100431568|FG001|NOT COMPLETED|Overall Study||4||
48045242|NCT01440543|100431569|FG002|NOT COMPLETED|Overall Study||2||
48045243|NCT01440543|100431570|FG003|NOT COMPLETED|Overall Study||6||
48045244|NCT03505710|100431571|FG000|STARTED|Overall Study||49||
48045245|NCT03505710|100431572|FG001|STARTED|Overall Study||41||
48045246|NCT03505710|100431573|FG002|STARTED|Overall Study||91||
48045247|NCT03505710|100431571|FG000|COMPLETED|Overall Study||2|Completed = Participants ongoing treatment as of 03 May 2021, Not Completed = Participants who discontinued treatment|
48045248|NCT03505710|100431572|FG001|COMPLETED|Overall Study||14|Completed = Participants ongoing treatment as of 03 May 2021, Not Completed = Participants who discontinued treatment|
48045249|NCT03505710|100431573|FG002|COMPLETED|Overall Study||15|Completed = Participants ongoing treatment as of 03 May 2021, Not Completed = Participants who discontinued treatment|
48045250|NCT03505710|100431571|FG000|NOT COMPLETED|Overall Study||47||
48045251|NCT03505710|100431572|FG001|NOT COMPLETED|Overall Study||27||
48045252|NCT03505710|100431573|FG002|NOT COMPLETED|Overall Study||76||
48045253|NCT02233478|100431574|FG000|STARTED|First Intervention (1 Day)||3||
48045254|NCT02233478|100431575|FG001|STARTED|First Intervention (1 Day)||3||
48045255|NCT02233478|100431576|FG002|STARTED|First Intervention (1 Day)||3||
48045256|NCT02233478|100431577|FG003|STARTED|First Intervention (1 Day)||3||
48045257|NCT02233478|100431578|FG004|STARTED|First Intervention (1 Day)||3||
48045258|NCT02233478|100431579|FG005|STARTED|First Intervention (1 Day)||3||
48045259|NCT02233478|100431574|FG000|COMPLETED|First Intervention (1 Day)||3||
48045260|NCT02233478|100431575|FG001|COMPLETED|First Intervention (1 Day)||3||
48045261|NCT02233478|100431576|FG002|COMPLETED|First Intervention (1 Day)||3||
48045262|NCT02233478|100431577|FG003|COMPLETED|First Intervention (1 Day)||3||
48045263|NCT02233478|100431578|FG004|COMPLETED|First Intervention (1 Day)||3||
48045264|NCT02233478|100431579|FG005|COMPLETED|First Intervention (1 Day)||3||
48045265|NCT02233478|100431574|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48045266|NCT02233478|100431575|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48045267|NCT02233478|100431576|FG002|NOT COMPLETED|First Intervention (1 Day)||0||
48045268|NCT02233478|100431577|FG003|NOT COMPLETED|First Intervention (1 Day)||0||
48045269|NCT02233478|100431578|FG004|NOT COMPLETED|First Intervention (1 Day)||0||
48045270|NCT02233478|100431579|FG005|NOT COMPLETED|First Intervention (1 Day)||0||
48045271|NCT02233478|100431574|FG000|STARTED|Washout (7 Days)||3||
48045272|NCT02233478|100431575|FG001|STARTED|Washout (7 Days)||3||
48045273|NCT02233478|100431576|FG002|STARTED|Washout (7 Days)||3||
48045274|NCT02233478|100431577|FG003|STARTED|Washout (7 Days)||3||
48045275|NCT02233478|100431578|FG004|STARTED|Washout (7 Days)||3||
48045276|NCT02233478|100431579|FG005|STARTED|Washout (7 Days)||3||
48045277|NCT02233478|100431574|FG000|COMPLETED|Washout (7 Days)||3||
48045278|NCT02233478|100431575|FG001|COMPLETED|Washout (7 Days)||3||
48045279|NCT02233478|100431576|FG002|COMPLETED|Washout (7 Days)||3||
48045280|NCT02233478|100431577|FG003|COMPLETED|Washout (7 Days)||3||
48045281|NCT02233478|100431578|FG004|COMPLETED|Washout (7 Days)||3||
48205274|NCT00558363|100827409|FG000|STARTED|Overall Study||147||
48205275|NCT00558363|100827410|FG001|STARTED|Overall Study||147||
48205276|NCT00558363|100827409|FG000|COMPLETED|Overall Study||76||
48205277|NCT00558363|100827410|FG001|COMPLETED|Overall Study||111||
48205278|NCT00558363|100827409|FG000|NOT COMPLETED|Overall Study||71||
48205279|NCT00558363|100827410|FG001|NOT COMPLETED|Overall Study||36||
48205280|NCT01911169|100827411|FG000|STARTED|Overall Study||6||
48205281|NCT01911169|100827412|FG001|STARTED|Overall Study||3||
48205282|NCT01911169|100827411|FG000|COMPLETED|Overall Study||6||
48205283|NCT01911169|100827412|FG001|COMPLETED|Overall Study||3||
48205284|NCT01911169|100827411|FG000|NOT COMPLETED|Overall Study||0||
48205285|NCT01911169|100827412|FG001|NOT COMPLETED|Overall Study||0||
48205286|NCT01692730|100827413|FG000|STARTED|Overall Study||723||
48205287|NCT01692730|100827414|FG001|STARTED|Overall Study||729||
48205288|NCT01692730|100827413|FG000|COMPLETED|Overall Study||498||
48205289|NCT01692730|100827414|FG001|COMPLETED|Overall Study||502||
48045282|NCT02233478|100431579|FG005|COMPLETED|Washout (7 Days)||3||
48045283|NCT02233478|100431574|FG000|NOT COMPLETED|Washout (7 Days)||0||
48045284|NCT02233478|100431575|FG001|NOT COMPLETED|Washout (7 Days)||0||
48045285|NCT02233478|100431576|FG002|NOT COMPLETED|Washout (7 Days)||0||
48045286|NCT02233478|100431577|FG003|NOT COMPLETED|Washout (7 Days)||0||
48045287|NCT02233478|100431578|FG004|NOT COMPLETED|Washout (7 Days)||0||
48045288|NCT02233478|100431579|FG005|NOT COMPLETED|Washout (7 Days)||0||
48045289|NCT02233478|100431574|FG000|STARTED|Second Intervention (1 Day)||3||
48045290|NCT02233478|100431575|FG001|STARTED|Second Intervention (1 Day)||3||
48045291|NCT02233478|100431576|FG002|STARTED|Second Intervention (1 Day)||3||
48045292|NCT02233478|100431577|FG003|STARTED|Second Intervention (1 Day)||3||
48045293|NCT02233478|100431578|FG004|STARTED|Second Intervention (1 Day)||3||
48045294|NCT02233478|100431579|FG005|STARTED|Second Intervention (1 Day)||3||
48045295|NCT02233478|100431574|FG000|COMPLETED|Second Intervention (1 Day)||3||
48045296|NCT02233478|100431575|FG001|COMPLETED|Second Intervention (1 Day)||3||
48045297|NCT02233478|100431576|FG002|COMPLETED|Second Intervention (1 Day)||3||
48045298|NCT02233478|100431577|FG003|COMPLETED|Second Intervention (1 Day)||3||
48045299|NCT02233478|100431578|FG004|COMPLETED|Second Intervention (1 Day)||3||
48045300|NCT02233478|100431579|FG005|COMPLETED|Second Intervention (1 Day)||3||
48045301|NCT02233478|100431574|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48045302|NCT02233478|100431575|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48045303|NCT02233478|100431576|FG002|NOT COMPLETED|Second Intervention (1 Day)||0||
48045304|NCT02233478|100431577|FG003|NOT COMPLETED|Second Intervention (1 Day)||0||
48045305|NCT02233478|100431578|FG004|NOT COMPLETED|Second Intervention (1 Day)||0||
48045306|NCT02233478|100431579|FG005|NOT COMPLETED|Second Intervention (1 Day)||0||
48045307|NCT02233478|100431574|FG000|STARTED|Washout (7 Days)||3||
48045308|NCT02233478|100431575|FG001|STARTED|Washout (7 Days)||3||
48045309|NCT02233478|100431576|FG002|STARTED|Washout (7 Days)||3||
48045310|NCT02233478|100431577|FG003|STARTED|Washout (7 Days)||3||
48045311|NCT02233478|100431578|FG004|STARTED|Washout (7 Days)||3||
48045312|NCT02233478|100431579|FG005|STARTED|Washout (7 Days)||3||
48045313|NCT02233478|100431574|FG000|COMPLETED|Washout (7 Days)||3||
48045314|NCT02233478|100431575|FG001|COMPLETED|Washout (7 Days)||3||
48045315|NCT02233478|100431576|FG002|COMPLETED|Washout (7 Days)||3||
48045316|NCT02233478|100431577|FG003|COMPLETED|Washout (7 Days)||3||
48045317|NCT02233478|100431578|FG004|COMPLETED|Washout (7 Days)||3||
48045318|NCT02233478|100431579|FG005|COMPLETED|Washout (7 Days)||3||
48045319|NCT02233478|100431574|FG000|NOT COMPLETED|Washout (7 Days)||0||
48045320|NCT02233478|100431575|FG001|NOT COMPLETED|Washout (7 Days)||0||
48045321|NCT02233478|100431576|FG002|NOT COMPLETED|Washout (7 Days)||0||
48045322|NCT02233478|100431577|FG003|NOT COMPLETED|Washout (7 Days)||0||
48045323|NCT02233478|100431578|FG004|NOT COMPLETED|Washout (7 Days)||0||
48045324|NCT02233478|100431579|FG005|NOT COMPLETED|Washout (7 Days)||0||
48045325|NCT02233478|100431574|FG000|STARTED|Third Intervention (1 Day)||3||
48045326|NCT02233478|100431575|FG001|STARTED|Third Intervention (1 Day)||3||
48045327|NCT02233478|100431576|FG002|STARTED|Third Intervention (1 Day)||3||
48045328|NCT02233478|100431577|FG003|STARTED|Third Intervention (1 Day)||3||
48045329|NCT02233478|100431578|FG004|STARTED|Third Intervention (1 Day)||3||
48045330|NCT02233478|100431579|FG005|STARTED|Third Intervention (1 Day)||3||
48045331|NCT02233478|100431574|FG000|COMPLETED|Third Intervention (1 Day)||3||
48045332|NCT02233478|100431575|FG001|COMPLETED|Third Intervention (1 Day)||3||
48045333|NCT02233478|100431576|FG002|COMPLETED|Third Intervention (1 Day)||3||
48045334|NCT02233478|100431577|FG003|COMPLETED|Third Intervention (1 Day)||3||
48045335|NCT02233478|100431578|FG004|COMPLETED|Third Intervention (1 Day)||3||
48045336|NCT02233478|100431579|FG005|COMPLETED|Third Intervention (1 Day)||3||
48205290|NCT01692730|100827413|FG000|NOT COMPLETED|Overall Study||225||
48205291|NCT01692730|100827414|FG001|NOT COMPLETED|Overall Study||227||
48205292|NCT02695290|100827415|FG000|STARTED|Overall Study||1||
48045337|NCT02233478|100431574|FG000|NOT COMPLETED|Third Intervention (1 Day)||0||
48045338|NCT02233478|100431575|FG001|NOT COMPLETED|Third Intervention (1 Day)||0||
48045339|NCT02233478|100431576|FG002|NOT COMPLETED|Third Intervention (1 Day)||0||
48045340|NCT02233478|100431577|FG003|NOT COMPLETED|Third Intervention (1 Day)||0||
48045341|NCT02233478|100431578|FG004|NOT COMPLETED|Third Intervention (1 Day)||0||
48045342|NCT02233478|100431579|FG005|NOT COMPLETED|Third Intervention (1 Day)||0||
48045343|NCT04355728|100431580|FG000|STARTED|Overall Study||12||
48045344|NCT04355728|100431581|FG001|STARTED|Overall Study||12||
48045345|NCT04355728|100431580|FG000|COMPLETED|Overall Study||12||
48045346|NCT04355728|100431581|FG001|COMPLETED|Overall Study||12||
48045347|NCT04355728|100431580|FG000|NOT COMPLETED|Overall Study||0||
48045348|NCT04355728|100431581|FG001|NOT COMPLETED|Overall Study||0||
48045349|NCT00369629|100431582|FG000|STARTED|Treated 2 Cycles/Reached First Response||6||
48045350|NCT00369629|100431583|FG001|STARTED|Treated 2 Cycles/Reached First Response||3||
48045351|NCT00369629|100431584|FG002|STARTED|Treated 2 Cycles/Reached First Response||5||
48045352|NCT00369629|100431585|FG003|STARTED|Treated 2 Cycles/Reached First Response||0||
48045353|NCT00369629|100431582|FG000|COMPLETED|Treated 2 Cycles/Reached First Response||4||
48045354|NCT00369629|100431583|FG001|COMPLETED|Treated 2 Cycles/Reached First Response||2||
48045355|NCT00369629|100431584|FG002|COMPLETED|Treated 2 Cycles/Reached First Response||3||
48045356|NCT00369629|100431585|FG003|COMPLETED|Treated 2 Cycles/Reached First Response||0||
48045357|NCT00369629|100431582|FG000|NOT COMPLETED|Treated 2 Cycles/Reached First Response||2||
48045358|NCT00369629|100431583|FG001|NOT COMPLETED|Treated 2 Cycles/Reached First Response||1||
48045359|NCT00369629|100431584|FG002|NOT COMPLETED|Treated 2 Cycles/Reached First Response||2||
48045360|NCT00369629|100431585|FG003|NOT COMPLETED|Treated 2 Cycles/Reached First Response||0||
48045361|NCT00369629|100431582|FG000|STARTED|Moved on to 4 More Cycles||4||
48045362|NCT00369629|100431583|FG001|STARTED|Moved on to 4 More Cycles||2||
48045363|NCT00369629|100431584|FG002|STARTED|Moved on to 4 More Cycles||3||
48045364|NCT00369629|100431585|FG003|STARTED|Moved on to 4 More Cycles||0||
48045365|NCT00369629|100431582|FG000|COMPLETED|Moved on to 4 More Cycles||4||
48045366|NCT00369629|100431583|FG001|COMPLETED|Moved on to 4 More Cycles||2||
48045367|NCT00369629|100431584|FG002|COMPLETED|Moved on to 4 More Cycles||2||
48045368|NCT00369629|100431585|FG003|COMPLETED|Moved on to 4 More Cycles||0||
48045369|NCT00369629|100431582|FG000|NOT COMPLETED|Moved on to 4 More Cycles||0||
48045370|NCT00369629|100431583|FG001|NOT COMPLETED|Moved on to 4 More Cycles||0||
48045371|NCT00369629|100431584|FG002|NOT COMPLETED|Moved on to 4 More Cycles||1||
48045372|NCT00369629|100431585|FG003|NOT COMPLETED|Moved on to 4 More Cycles||0||
48045373|NCT00369629|100431582|FG000|STARTED|Completed 4 More Cycles||4||
48045374|NCT00369629|100431583|FG001|STARTED|Completed 4 More Cycles||2||
48045375|NCT00369629|100431584|FG002|STARTED|Completed 4 More Cycles||2||
48045376|NCT00369629|100431585|FG003|STARTED|Completed 4 More Cycles||0||
48045377|NCT00369629|100431582|FG000|COMPLETED|Completed 4 More Cycles||0||
48045378|NCT00369629|100431583|FG001|COMPLETED|Completed 4 More Cycles||0||
48045379|NCT00369629|100431584|FG002|COMPLETED|Completed 4 More Cycles||0||
48045380|NCT00369629|100431585|FG003|COMPLETED|Completed 4 More Cycles||0||
48045381|NCT00369629|100431582|FG000|NOT COMPLETED|Completed 4 More Cycles||4||
48045382|NCT00369629|100431583|FG001|NOT COMPLETED|Completed 4 More Cycles||2||
48045383|NCT00369629|100431584|FG002|NOT COMPLETED|Completed 4 More Cycles||2||
48045384|NCT00369629|100431585|FG003|NOT COMPLETED|Completed 4 More Cycles||0||
48045385|NCT00369629|100431582|FG000|STARTED|Follow up for 1 Year||6||
48045386|NCT00369629|100431583|FG001|STARTED|Follow up for 1 Year||3||
48045387|NCT00369629|100431584|FG002|STARTED|Follow up for 1 Year||5||
48045388|NCT00369629|100431585|FG003|STARTED|Follow up for 1 Year||0||
48045389|NCT00369629|100431582|FG000|COMPLETED|Follow up for 1 Year||4||
48045390|NCT00369629|100431583|FG001|COMPLETED|Follow up for 1 Year||1||
48045391|NCT00369629|100431584|FG002|COMPLETED|Follow up for 1 Year||2||
48045392|NCT00369629|100431585|FG003|COMPLETED|Follow up for 1 Year||0||
48045393|NCT00369629|100431582|FG000|NOT COMPLETED|Follow up for 1 Year||2||
48045394|NCT00369629|100431583|FG001|NOT COMPLETED|Follow up for 1 Year||2||
48045395|NCT00369629|100431584|FG002|NOT COMPLETED|Follow up for 1 Year||3||
48045396|NCT00369629|100431585|FG003|NOT COMPLETED|Follow up for 1 Year||0||
48045397|NCT01556347|100431586|FG000|STARTED|Induction Immunotherapy||2||
48045398|NCT01556347|100431586|FG000|COMPLETED|Induction Immunotherapy||2||
48045399|NCT01556347|100431586|FG000|NOT COMPLETED|Induction Immunotherapy||0||
48045400|NCT01556347|100431586|FG000|STARTED|Bortezomib Treatment Phase||2||
48045401|NCT01556347|100431586|FG000|COMPLETED|Bortezomib Treatment Phase||2||
48045402|NCT01556347|100431586|FG000|NOT COMPLETED|Bortezomib Treatment Phase||0||
48045403|NCT01556347|100431586|FG000|STARTED|Recovery Phase||2||
48045404|NCT01556347|100431586|FG000|COMPLETED|Recovery Phase||2||
48045405|NCT01556347|100431586|FG000|NOT COMPLETED|Recovery Phase||0||
48045406|NCT00245219|100431587|FG000|STARTED|Overall Study||91||
48045407|NCT00245219|100431588|FG001|STARTED|Overall Study||94||
48045408|NCT00245219|100431589|FG002|STARTED|Overall Study||60||
48045409|NCT00245219|100431587|FG000|COMPLETED|Overall Study||85||
48045410|NCT00245219|100431588|FG001|COMPLETED|Overall Study||88||
48045411|NCT00245219|100431589|FG002|COMPLETED|Overall Study||58||
48045412|NCT00245219|100431587|FG000|NOT COMPLETED|Overall Study||6||
48045413|NCT00245219|100431588|FG001|NOT COMPLETED|Overall Study||6||
48045414|NCT00245219|100431589|FG002|NOT COMPLETED|Overall Study||2||
48045415|NCT01845103|100431590|FG000|STARTED|Overall Study||1||
48045416|NCT01845103|100431590|FG000|COMPLETED|Overall Study||1||
48045417|NCT01845103|100431590|FG000|NOT COMPLETED|Overall Study||0||
48045418|NCT00528541|100431591|FG000|STARTED|Overall Study||75||
48045419|NCT00528541|100431592|FG001|STARTED|Overall Study||70||
48045420|NCT00528541|100431591|FG000|COMPLETED|Overall Study||73||
48045421|NCT00528541|100431592|FG001|COMPLETED|Overall Study||69||
48045422|NCT00528541|100431591|FG000|NOT COMPLETED|Overall Study||2||
48045423|NCT00528541|100431592|FG001|NOT COMPLETED|Overall Study||1||
48045424|NCT02496676|100431593|FG000|STARTED|Phase 1 - Period 1||2||
48045425|NCT02496676|100431594|FG001|STARTED|Phase 1 - Period 1||3||
48045426|NCT02496676|100431593|FG000|COMPLETED|Phase 1 - Period 1||2||
48045427|NCT02496676|100431594|FG001|COMPLETED|Phase 1 - Period 1||2||
48045428|NCT02496676|100431593|FG000|NOT COMPLETED|Phase 1 - Period 1||0||
48045429|NCT02496676|100431594|FG001|NOT COMPLETED|Phase 1 - Period 1||1||
48045430|NCT02496676|100431593|FG000|STARTED|Phase 1 - Period 2||2||
48045431|NCT02496676|100431594|FG001|STARTED|Phase 1 - Period 2||2||
48045432|NCT02496676|100431593|FG000|COMPLETED|Phase 1 - Period 2||2||
48045433|NCT02496676|100431594|FG001|COMPLETED|Phase 1 - Period 2||2||
48045434|NCT02496676|100431593|FG000|NOT COMPLETED|Phase 1 - Period 2||0||
48045435|NCT02496676|100431594|FG001|NOT COMPLETED|Phase 1 - Period 2||0||
48045436|NCT02496676|100431593|FG000|STARTED|Washout Period||2||
48045437|NCT02496676|100431594|FG001|STARTED|Washout Period||2||
48045438|NCT02496676|100431593|FG000|COMPLETED|Washout Period||2||
48045439|NCT02496676|100431594|FG001|COMPLETED|Washout Period||2||
48045440|NCT02496676|100431593|FG000|NOT COMPLETED|Washout Period||0||
48045441|NCT02496676|100431594|FG001|NOT COMPLETED|Washout Period||0||
48045442|NCT02496676|100431593|FG000|STARTED|Phase 2 - IV MgSO4||2||
48045443|NCT02496676|100431594|FG001|STARTED|Phase 2 - IV MgSO4||2||
48045444|NCT02496676|100431593|FG000|COMPLETED|Phase 2 - IV MgSO4||2||
48045445|NCT02496676|100431594|FG001|COMPLETED|Phase 2 - IV MgSO4||1||
48045446|NCT02496676|100431593|FG000|NOT COMPLETED|Phase 2 - IV MgSO4||0||
48045447|NCT02496676|100431594|FG001|NOT COMPLETED|Phase 2 - IV MgSO4||1||
48045448|NCT02496676|100431593|FG000|STARTED|Phase 2 - Oral Magnesium||2||
48045449|NCT02496676|100431594|FG001|STARTED|Phase 2 - Oral Magnesium||1||
48045450|NCT02496676|100431593|FG000|COMPLETED|Phase 2 - Oral Magnesium||2||
48045451|NCT02496676|100431594|FG001|COMPLETED|Phase 2 - Oral Magnesium||1||
48045452|NCT02496676|100431593|FG000|NOT COMPLETED|Phase 2 - Oral Magnesium||0||
48045453|NCT02496676|100431594|FG001|NOT COMPLETED|Phase 2 - Oral Magnesium||0||
48045454|NCT02195414|100431595|FG000|STARTED|Overall Study||31||
48045455|NCT02195414|100431595|FG000|Primary Endpoint|Overall Study||31||
48045456|NCT02195414|100431595|FG000|COMPLETED|Overall Study||31||
48045457|NCT02195414|100431595|FG000|NOT COMPLETED|Overall Study||0||
48045458|NCT00604214|100431596|FG000|STARTED|Baseline to Day 28||851||
48045459|NCT00604214|100431597|FG001|STARTED|Baseline to Day 28||845||
48045460|NCT00604214|100431596|FG000|Received Study Drug|Baseline to Day 28||833||
48045461|NCT00604214|100431597|FG001|Received Study Drug|Baseline to Day 28||833||
48045462|NCT00604214|100431596|FG000|COMPLETED|Baseline to Day 28||623||
48045463|NCT00604214|100431597|FG001|COMPLETED|Baseline to Day 28||632||
48045464|NCT00604214|100431596|FG000|NOT COMPLETED|Baseline to Day 28||228||
48045465|NCT00604214|100431597|FG001|NOT COMPLETED|Baseline to Day 28||213||
48045466|NCT00604214|100431596|FG000|STARTED|Day 29 to Day 90||623||
48045467|NCT00604214|100431597|FG001|STARTED|Day 29 to Day 90||632||
48045468|NCT00604214|100431596|FG000|COMPLETED|Day 29 to Day 90||555||
48045469|NCT00604214|100431597|FG001|COMPLETED|Day 29 to Day 90||553||
48045470|NCT00604214|100431596|FG000|NOT COMPLETED|Day 29 to Day 90||68||
48045471|NCT00604214|100431597|FG001|NOT COMPLETED|Day 29 to Day 90||79||
48045472|NCT00604214|100431596|FG000|STARTED|Day 91 to Day 180||555||
48045473|NCT00604214|100431597|FG001|STARTED|Day 91 to Day 180||553||
48045474|NCT00604214|100431596|FG000|COMPLETED|Day 91 to Day 180||529||
48045475|NCT00604214|100431597|FG001|COMPLETED|Day 91 to Day 180||521||
48045476|NCT00604214|100431596|FG000|NOT COMPLETED|Day 91 to Day 180||26||
48045477|NCT00604214|100431597|FG001|NOT COMPLETED|Day 91 to Day 180||32||
48045478|NCT03338959|100431598|FG000|STARTED|Overall Study||27||
48045479|NCT03338959|100431598|FG000|COMPLETED|Overall Study||9||
48045480|NCT03338959|100431598|FG000|NOT COMPLETED|Overall Study||18||
48045481|NCT01143389|100431599|FG000|STARTED|Overall Study||253||
48045482|NCT01143389|100431600|FG001|STARTED|Overall Study||257||
48045483|NCT01143389|100431599|FG000|COMPLETED|Overall Study||227||
48045484|NCT01143389|100431600|FG001|COMPLETED|Overall Study||232||
48045485|NCT01143389|100431599|FG000|NOT COMPLETED|Overall Study||26||
48045486|NCT01143389|100431600|FG001|NOT COMPLETED|Overall Study||25||
48045487|NCT03007888|100431601|FG000|STARTED|First Intervention (14 Days)||15||
48045488|NCT03007888|100431602|FG001|STARTED|First Intervention (14 Days)||13||
48045489|NCT03007888|100431601|FG000|COMPLETED|First Intervention (14 Days)||14||
48045490|NCT03007888|100431602|FG001|COMPLETED|First Intervention (14 Days)||13||
48045491|NCT03007888|100431601|FG000|NOT COMPLETED|First Intervention (14 Days)||1||
48045492|NCT03007888|100431602|FG001|NOT COMPLETED|First Intervention (14 Days)||0||
48045493|NCT03007888|100431601|FG000|STARTED|Washout (7 Days)||14||
48045494|NCT03007888|100431602|FG001|STARTED|Washout (7 Days)||13||
48045495|NCT03007888|100431601|FG000|COMPLETED|Washout (7 Days)||14||
48045496|NCT03007888|100431602|FG001|COMPLETED|Washout (7 Days)||13||
48045497|NCT03007888|100431601|FG000|NOT COMPLETED|Washout (7 Days)||0||
48045498|NCT03007888|100431602|FG001|NOT COMPLETED|Washout (7 Days)||0||
48045499|NCT03007888|100431601|FG000|STARTED|Second Interventions (14 Days)||14||
48045500|NCT03007888|100431602|FG001|STARTED|Second Interventions (14 Days)||13||
48045501|NCT03007888|100431601|FG000|COMPLETED|Second Interventions (14 Days)||14||
48045502|NCT03007888|100431602|FG001|COMPLETED|Second Interventions (14 Days)||13||
48045503|NCT03007888|100431601|FG000|NOT COMPLETED|Second Interventions (14 Days)||0||
48045504|NCT03007888|100431602|FG001|NOT COMPLETED|Second Interventions (14 Days)||0||
48045505|NCT04381988|100431603|FG000|STARTED|Overall Study||4||
48045506|NCT04381988|100431604|FG001|STARTED|Overall Study||0||
48045507|NCT04381988|100431603|FG000|COMPLETED|Overall Study||0||
48045508|NCT04381988|100431604|FG001|COMPLETED|Overall Study||0||
48045509|NCT04381988|100431603|FG000|NOT COMPLETED|Overall Study||4||
48045510|NCT04381988|100431604|FG001|NOT COMPLETED|Overall Study||0||
48045511|NCT01607203|100431605|FG000|STARTED|Overall Study||59||
48045512|NCT01607203|100431606|FG001|STARTED|Overall Study||61||
48045513|NCT01607203|100431605|FG000|COMPLETED|Overall Study||59||
48045514|NCT01607203|100431606|FG001|COMPLETED|Overall Study||61||
48045515|NCT01607203|100431605|FG000|NOT COMPLETED|Overall Study||0||
48045516|NCT01607203|100431606|FG001|NOT COMPLETED|Overall Study||0||
48045517|NCT05463198|100431607|FG000|STARTED|Overall Study||351||
48045518|NCT05463198|100431607|FG000|COMPLETED|Overall Study||314||
48045519|NCT05463198|100431607|FG000|NOT COMPLETED|Overall Study||37||
48045520|NCT03483922|100431608|FG000|STARTED|Overall Study||49||
48045521|NCT03483922|100431609|FG001|STARTED|Overall Study||51||
48045522|NCT03483922|100431610|FG002|STARTED|Overall Study||2||
48045523|NCT03483922|100431611|FG003|STARTED|Overall Study||32||
48045524|NCT03483922|100431612|FG004|STARTED|Overall Study||86||
48045525|NCT03483922|100431613|FG005|STARTED|Overall Study||106||
48045526|NCT03483922|100431614|FG006|STARTED|Overall Study||76||
48045527|NCT03483922|100431608|FG000|COMPLETED|Overall Study||49||
48045528|NCT03483922|100431609|FG001|COMPLETED|Overall Study||51||
48045529|NCT03483922|100431610|FG002|COMPLETED|Overall Study||2||
48045530|NCT03483922|100431611|FG003|COMPLETED|Overall Study||32||
48045531|NCT03483922|100431612|FG004|COMPLETED|Overall Study||86||
48045532|NCT03483922|100431613|FG005|COMPLETED|Overall Study||106||
48045533|NCT03483922|100431614|FG006|COMPLETED|Overall Study||76||
48045534|NCT03483922|100431608|FG000|NOT COMPLETED|Overall Study||0||
48045535|NCT03483922|100431609|FG001|NOT COMPLETED|Overall Study||0||
48045536|NCT03483922|100431610|FG002|NOT COMPLETED|Overall Study||0||
48045537|NCT03483922|100431611|FG003|NOT COMPLETED|Overall Study||0||
48045538|NCT03483922|100431612|FG004|NOT COMPLETED|Overall Study||0||
48045539|NCT03483922|100431613|FG005|NOT COMPLETED|Overall Study||0||
48045540|NCT03483922|100431614|FG006|NOT COMPLETED|Overall Study||0||
48045541|NCT00040846|100431615|FG000|STARTED|Overall Study||60||
48045542|NCT00040846|100431616|FG001|STARTED|Overall Study||0||
48045543|NCT00040846|100431617|FG002|STARTED|Overall Study||0||
48045544|NCT00040846|100431618|FG003|STARTED|Overall Study||0||
48045545|NCT00040846|100431619|FG004|STARTED|Overall Study||0||
48045546|NCT00040846|100431620|FG005|STARTED|Overall Study||0||
48045547|NCT00040846|100431615|FG000|COMPLETED|Overall Study||60||
48045548|NCT00040846|100431616|FG001|COMPLETED|Overall Study||0||
48045549|NCT00040846|100431617|FG002|COMPLETED|Overall Study||0||
48045550|NCT00040846|100431618|FG003|COMPLETED|Overall Study||0||
48045551|NCT00040846|100431619|FG004|COMPLETED|Overall Study||0||
48045552|NCT00040846|100431620|FG005|COMPLETED|Overall Study||0||
48045553|NCT00040846|100431615|FG000|NOT COMPLETED|Overall Study||0||
48045554|NCT00040846|100431616|FG001|NOT COMPLETED|Overall Study||0||
48205293|NCT02695290|100827415|FG000|COMPLETED|Overall Study||1||
48205294|NCT02695290|100827415|FG000|NOT COMPLETED|Overall Study||0||
48205295|NCT00753012|100827416|FG000|STARTED|Overall Study||15||
48495403|NCT00064038|101547841|FG002|STARTED|Crossover to Lenalidomide+Dexamethasone||42||
48666741|NCT03391882|101970470|FG005|Safety Population Part A|Part A - Titration Phase||19||
48045555|NCT00040846|100431617|FG002|NOT COMPLETED|Overall Study||0||
48045556|NCT00040846|100431618|FG003|NOT COMPLETED|Overall Study||0||
48045557|NCT00040846|100431619|FG004|NOT COMPLETED|Overall Study||0||
48045558|NCT00040846|100431620|FG005|NOT COMPLETED|Overall Study||0||
48045559|NCT01104376|100431621|FG000|STARTED|Overall Study||89||
48045560|NCT01104376|100431621|FG000|COMPLETED|Overall Study||61||
48045561|NCT01104376|100431621|FG000|NOT COMPLETED|Overall Study||28||
48045562|NCT01185301|100431622|FG000|STARTED|Overall Study||98||
48045563|NCT01185301|100431623|FG001|STARTED|Overall Study||100||
48045564|NCT01185301|100431624|FG002|STARTED|Overall Study||99||
48045565|NCT01185301|100431625|FG003|STARTED|Overall Study||98||
48045566|NCT01185301|100431622|FG000|COMPLETED|Overall Study||83||
48045567|NCT01185301|100431623|FG001|COMPLETED|Overall Study||93||
48045568|NCT01185301|100431624|FG002|COMPLETED|Overall Study||93||
48045569|NCT01185301|100431625|FG003|COMPLETED|Overall Study||89||
48045570|NCT01185301|100431622|FG000|NOT COMPLETED|Overall Study||15||
48045571|NCT01185301|100431623|FG001|NOT COMPLETED|Overall Study||7||
48045572|NCT01185301|100431624|FG002|NOT COMPLETED|Overall Study||6||
48045573|NCT01185301|100431625|FG003|NOT COMPLETED|Overall Study||9||
48045574|NCT01343823|100431626|FG000|STARTED|Overall Study||20||
48045575|NCT01343823|100431627|FG001|STARTED|Overall Study||20||
48045576|NCT01343823|100431628|FG002|STARTED|Overall Study||19||
48045577|NCT01343823|100431629|FG003|STARTED|Overall Study||20||
48045578|NCT01343823|100431626|FG000|COMPLETED|Overall Study||18||
48045579|NCT01343823|100431627|FG001|COMPLETED|Overall Study||20||
48045580|NCT01343823|100431628|FG002|COMPLETED|Overall Study||19||
48045581|NCT01343823|100431629|FG003|COMPLETED|Overall Study||19||
48045582|NCT01343823|100431626|FG000|NOT COMPLETED|Overall Study||2||
48045583|NCT01343823|100431627|FG001|NOT COMPLETED|Overall Study||0||
48045584|NCT01343823|100431628|FG002|NOT COMPLETED|Overall Study||0||
48045585|NCT01343823|100431629|FG003|NOT COMPLETED|Overall Study||1||
48045586|NCT00392379|100431630|FG000|STARTED|Overall Study||136||
48045587|NCT00392379|100431631|FG001|STARTED|Overall Study||134||
48045588|NCT00392379|100431630|FG000|COMPLETED|Overall Study||114||
48045589|NCT00392379|100431631|FG001|COMPLETED|Overall Study||96||
48045590|NCT00392379|100431630|FG000|NOT COMPLETED|Overall Study||22||
48045591|NCT00392379|100431631|FG001|NOT COMPLETED|Overall Study||38||
48045592|NCT03367247|100431632|FG000|STARTED|Overall Study||6||
48045593|NCT03367247|100431633|FG001|STARTED|Overall Study||6||
48045594|NCT03367247|100431634|FG002|STARTED|Overall Study||5||
48045595|NCT03367247|100431635|FG003|STARTED|Overall Study||4||
48045596|NCT03367247|100431636|FG004|STARTED|Overall Study||29||
48045597|NCT03367247|100431637|FG005|STARTED|Overall Study||17||
48045598|NCT03367247|100431638|FG006|STARTED|Overall Study||32||
48045599|NCT03367247|100431639|FG007|STARTED|Overall Study||22||
48045600|NCT03367247|100431632|FG000|COMPLETED|Overall Study||3||
48045601|NCT03367247|100431633|FG001|COMPLETED|Overall Study||3||
48045602|NCT03367247|100431634|FG002|COMPLETED|Overall Study||5||
48045603|NCT03367247|100431635|FG003|COMPLETED|Overall Study||4||
48045604|NCT03367247|100431636|FG004|COMPLETED|Overall Study||21||
48045605|NCT03367247|100431637|FG005|COMPLETED|Overall Study||11||
48045606|NCT03367247|100431638|FG006|COMPLETED|Overall Study||20||
48045607|NCT03367247|100431639|FG007|COMPLETED|Overall Study||15||
48045608|NCT03367247|100431632|FG000|NOT COMPLETED|Overall Study||3||
48045609|NCT03367247|100431633|FG001|NOT COMPLETED|Overall Study||3||
48045610|NCT03367247|100431634|FG002|NOT COMPLETED|Overall Study||0||
48045611|NCT03367247|100431635|FG003|NOT COMPLETED|Overall Study||0||
48045612|NCT03367247|100431636|FG004|NOT COMPLETED|Overall Study||8||
48045613|NCT03367247|100431637|FG005|NOT COMPLETED|Overall Study||6||
48045614|NCT03367247|100431638|FG006|NOT COMPLETED|Overall Study||12||
48045615|NCT03367247|100431639|FG007|NOT COMPLETED|Overall Study||7||
48045616|NCT02558829|100431640|FG000|STARTED|Overall Study||21|Safety population (SAF): all randomized subjects who took at least one dose of trial medication.|
48045617|NCT02558829|100431641|FG001|STARTED|Overall Study||21|Safety population (SAF): all randomized subjects who took at least one dose of trial medication.|
48045618|NCT02558829|100431642|FG002|STARTED|Overall Study||24|Safety population (SAF): all randomized subjects who took at least one dose of trial medication.|
48045619|NCT02558829|100431643|FG003|STARTED|Overall Study||18|Safety population (SAF): all randomized subjects who took at least one dose of trial medication.|
48045620|NCT02558829|100431644|FG004|STARTED|Overall Study||18|Safety population (SAF): all randomized subjects who took at least one dose of trial medication.|
48045621|NCT02558829|100431645|FG005|STARTED|Overall Study||26|Safety population (SAF): all randomized subjects who took at least one dose of trial medication.|
48045622|NCT02558829|100431646|FG006|STARTED|Overall Study||18|Safety population (SAF): all randomized subjects who took at least one dose of trial medication.|
48045623|NCT02558829|100431647|FG007|STARTED|Overall Study||11|Safety population (SAF): all randomized subjects who took at least one dose of trial medication.|
48045624|NCT02558829|100431640|FG000|COMPLETED|Overall Study||20|Modified Intention-to-Treat (mITT): randomized subjects with both GHSTs of the cross-over evaluable.|
48045625|NCT02558829|100431641|FG001|COMPLETED|Overall Study||18|Modified Intention-to-Treat (mITT): randomized subjects with both GHSTs of the cross-over evaluable.|
48045626|NCT02558829|100431642|FG002|COMPLETED|Overall Study||21|Modified Intention-to-Treat (mITT): randomized subjects with both GHSTs of the cross-over evaluable.|
48045627|NCT02558829|100431643|FG003|COMPLETED|Overall Study||16|Modified Intention-to-Treat (mITT): randomized subjects with both GHSTs of the cross-over evaluable.|
48045628|NCT02558829|100431644|FG004|COMPLETED|Overall Study||16|Modified Intention-to-Treat (mITT): randomized subjects with both GHSTs of the cross-over evaluable.|
48045629|NCT02558829|100431645|FG005|COMPLETED|Overall Study||24|Modified Intention-to-Treat (mITT): randomized subjects with both GHSTs of the cross-over evaluable.|
48045630|NCT02558829|100431646|FG006|COMPLETED|Overall Study||17|Modified Intention-to-Treat (mITT): randomized subjects with both GHSTs of the cross-over evaluable.|
48045631|NCT02558829|100431647|FG007|COMPLETED|Overall Study||8|Modified Intention-to-Treat (mITT): randomized subjects with both GHSTs of the cross-over evaluable.|
48045632|NCT02558829|100431640|FG000|NOT COMPLETED|Overall Study||1||
48045633|NCT02558829|100431641|FG001|NOT COMPLETED|Overall Study||3||
48495404|NCT00064038|101547839|FG000|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||0||
48495405|NCT00064038|101547840|FG001|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||0||
48045634|NCT02558829|100431642|FG002|NOT COMPLETED|Overall Study||3||
48045635|NCT02558829|100431643|FG003|NOT COMPLETED|Overall Study||2||
48045636|NCT02558829|100431644|FG004|NOT COMPLETED|Overall Study||2||
48495406|NCT00064038|101547841|FG002|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||40||
48495407|NCT00064038|101547839|FG000|Safety Population|Crossover to Lenalidomide+Dexamethasone||0||
48495408|NCT00064038|101547840|FG001|Safety Population|Crossover to Lenalidomide+Dexamethasone||0||
48045637|NCT02558829|100431645|FG005|NOT COMPLETED|Overall Study||2||
48045638|NCT02558829|100431646|FG006|NOT COMPLETED|Overall Study||1||
48045639|NCT02558829|100431647|FG007|NOT COMPLETED|Overall Study||3||
48045640|NCT00634270|100431648|FG000|STARTED|Overall Study||49||
48045641|NCT00634270|100431649|FG001|STARTED|Overall Study||13||
48045642|NCT00634270|100431648|FG000|COMPLETED|Overall Study||46||
48045643|NCT00634270|100431649|FG001|COMPLETED|Overall Study||12||
48045644|NCT00634270|100431648|FG000|NOT COMPLETED|Overall Study||3||
48045645|NCT00634270|100431649|FG001|NOT COMPLETED|Overall Study||1||
48045646|NCT00424255|100431650|FG000|STARTED|Overall Study||342||
48045647|NCT00424255|100431651|FG001|STARTED|Overall Study||346||
48045648|NCT00424255|100431650|FG000|COMPLETED|Overall Study||0||
48045649|NCT00424255|100431651|FG001|COMPLETED|Overall Study||0||
48045650|NCT00424255|100431650|FG000|NOT COMPLETED|Overall Study||342||
48045651|NCT00424255|100431651|FG001|NOT COMPLETED|Overall Study||346||
48045652|NCT03330002|100431652|FG000|STARTED|Overall Study||500||
48045653|NCT03330002|100431652|FG000|COMPLETED|Overall Study||478||
48045654|NCT03330002|100431652|FG000|NOT COMPLETED|Overall Study||22||
48045655|NCT00481507|100431653|FG000|STARTED|Overall Study||64||
48045656|NCT00481507|100431654|FG001|STARTED|Overall Study||61||
48045657|NCT00481507|100431653|FG000|COMPLETED|Overall Study||64||
48045658|NCT00481507|100431654|FG001|COMPLETED|Overall Study||61||
48045659|NCT00481507|100431653|FG000|NOT COMPLETED|Overall Study||0||
48045660|NCT00481507|100431654|FG001|NOT COMPLETED|Overall Study||0||
48045661|NCT02528721|100431655|FG000|STARTED|Overall Study||203||
48045662|NCT02528721|100431656|FG001|STARTED|Overall Study||79||
48045663|NCT02528721|100431655|FG000|COMPLETED|Overall Study||196||
48045664|NCT02528721|100431656|FG001|COMPLETED|Overall Study||76||
48045665|NCT02528721|100431655|FG000|NOT COMPLETED|Overall Study||7||
48045666|NCT02528721|100431656|FG001|NOT COMPLETED|Overall Study||3||
48045667|NCT00576680|100431657|FG000|STARTED|Overall Study||43||
48045668|NCT00576680|100431657|FG000|COMPLETED|Overall Study||43||
48045669|NCT00576680|100431657|FG000|NOT COMPLETED|Overall Study||0||
48045670|NCT00177047|100431658|FG000|STARTED|Overall Study||363||
48045671|NCT00177047|100431658|FG000|COMPLETED|Overall Study||363||
48045672|NCT00177047|100431658|FG000|NOT COMPLETED|Overall Study||0||
48045673|NCT00075270|100431659|FG000|STARTED|Overall Study||291||
48045674|NCT00075270|100431660|FG001|STARTED|Overall Study||288||
48045675|NCT00075270|100431659|FG000|Missing|Overall Study||26||
48045676|NCT00075270|100431660|FG001|Missing|Overall Study||13||
48045677|NCT00075270|100431659|FG000|COMPLETED|Overall Study||5||
48045678|NCT00075270|100431660|FG001|COMPLETED|Overall Study||4||
48045679|NCT00075270|100431659|FG000|NOT COMPLETED|Overall Study||286||
48045680|NCT00075270|100431660|FG001|NOT COMPLETED|Overall Study||284||
48045681|NCT00081861|100431661|FG000|STARTED|Overall Study||13||
48045682|NCT00081861|100431661|FG000|COMPLETED|Overall Study||13||
48045683|NCT00081861|100431661|FG000|NOT COMPLETED|Overall Study||0||
48045684|NCT02125604|100431662|FG000|STARTED|Overall Study||211||
48045685|NCT02125604|100431662|FG000|COMPLETED|Overall Study||180||
48045686|NCT02125604|100431662|FG000|NOT COMPLETED|Overall Study||31||
48045687|NCT00169442|100431663|FG000|STARTED|Overall Study||119||
48045688|NCT00169442|100431664|FG001|STARTED|Overall Study||124||
48045689|NCT00169442|100431665|FG002|STARTED|Overall Study||167||
48045690|NCT00169442|100431666|FG003|STARTED|Overall Study||250||
48045691|NCT00169442|100431667|FG004|STARTED|Overall Study||42||
48045692|NCT00169442|100431668|FG005|STARTED|Overall Study||43||
48045693|NCT00169442|100431663|FG000|COMPLETED|Overall Study||119||
48045694|NCT00169442|100431664|FG001|COMPLETED|Overall Study||123||
48045695|NCT00169442|100431665|FG002|COMPLETED|Overall Study||166||
48045696|NCT00169442|100431666|FG003|COMPLETED|Overall Study||250||
48045697|NCT00169442|100431667|FG004|COMPLETED|Overall Study||41||
48045698|NCT00169442|100431668|FG005|COMPLETED|Overall Study||41||
48045699|NCT00169442|100431663|FG000|NOT COMPLETED|Overall Study||0||
48045700|NCT00169442|100431664|FG001|NOT COMPLETED|Overall Study||1||
48045701|NCT00169442|100431665|FG002|NOT COMPLETED|Overall Study||1||
48045702|NCT00169442|100431666|FG003|NOT COMPLETED|Overall Study||0||
48045703|NCT00169442|100431667|FG004|NOT COMPLETED|Overall Study||1||
48045704|NCT00169442|100431668|FG005|NOT COMPLETED|Overall Study||2||
48045705|NCT00586664|100431669|FG000|STARTED|Overall Study||43||
48045706|NCT00586664|100431670|FG001|STARTED|Overall Study||43||
48045707|NCT00586664|100431671|FG002|STARTED|Overall Study||44||
48045708|NCT00586664|100431669|FG000|COMPLETED|Overall Study||38||
48045709|NCT00586664|100431670|FG001|COMPLETED|Overall Study||36||
48045710|NCT00586664|100431671|FG002|COMPLETED|Overall Study||43||
48045711|NCT00586664|100431669|FG000|NOT COMPLETED|Overall Study||5||
48045712|NCT00586664|100431670|FG001|NOT COMPLETED|Overall Study||7||
48045713|NCT00586664|100431671|FG002|NOT COMPLETED|Overall Study||1||
48045714|NCT03235180|100431672|FG000|STARTED|Overall Study||9||
48045715|NCT03235180|100431672|FG000|COMPLETED|Overall Study||9||
48045716|NCT03235180|100431672|FG000|NOT COMPLETED|Overall Study||0||
48045717|NCT03680742|100431673|FG000|STARTED|Overall Study||34||
48045718|NCT03680742|100431673|FG000|COMPLETED|Overall Study||32||
48045719|NCT03680742|100431673|FG000|NOT COMPLETED|Overall Study||2||
48045720|NCT01534182|100431674|FG000|STARTED|Overall Study||230||
48045721|NCT01534182|100431675|FG001|STARTED|Overall Study||68||
48045722|NCT01534182|100431674|FG000|Safety Set|Overall Study||230||
48045723|NCT01534182|100431675|FG001|Safety Set|Overall Study||64||
48045724|NCT01534182|100431674|FG000|Full Analysis Set|Overall Study||229||
48045725|NCT01534182|100431675|FG001|Full Analysis Set|Overall Study||62||
48045726|NCT01534182|100431674|FG000|COMPLETED|Overall Study||218||
48045727|NCT01534182|100431675|FG001|COMPLETED|Overall Study||58||
48045728|NCT01534182|100431674|FG000|NOT COMPLETED|Overall Study||12||
48045729|NCT01534182|100431675|FG001|NOT COMPLETED|Overall Study||10||
48045730|NCT00821509|100431676|FG000|STARTED|Overall Study||257||
48045731|NCT00821509|100431677|FG001|STARTED|Overall Study||202||
48045732|NCT00821509|100431678|FG002|STARTED|Overall Study||224||
48045733|NCT00821509|100431676|FG000|COMPLETED|Overall Study||245||
48045734|NCT00821509|100431677|FG001|COMPLETED|Overall Study||191||
48495409|NCT00064038|101547841|FG002|Safety Population|Crossover to Lenalidomide+Dexamethasone||40||
48495410|NCT00064038|101547839|FG000|COMPLETED|Crossover to Lenalidomide+Dexamethasone||0||
48495411|NCT00064038|101547840|FG001|COMPLETED|Crossover to Lenalidomide+Dexamethasone||0||
48045735|NCT00821509|100431678|FG002|COMPLETED|Overall Study||190||
48045736|NCT00821509|100431676|FG000|NOT COMPLETED|Overall Study||12||
48045737|NCT00821509|100431677|FG001|NOT COMPLETED|Overall Study||11||
48045738|NCT00821509|100431678|FG002|NOT COMPLETED|Overall Study||34||
48045739|NCT00830076|100431679|FG000|STARTED|Sitagliptin + Placebo Metformin||18||
48045740|NCT00830076|100431679|FG000|COMPLETED|Sitagliptin + Placebo Metformin||18||
48045741|NCT00830076|100431679|FG000|NOT COMPLETED|Sitagliptin + Placebo Metformin||0||
48045742|NCT00830076|100431679|FG000|STARTED|7-day Washout||18||
48045743|NCT00830076|100431679|FG000|COMPLETED|7-day Washout||18||
48045744|NCT00830076|100431679|FG000|NOT COMPLETED|7-day Washout||0||
48045745|NCT00830076|100431679|FG000|STARTED|Metformin + Placebo Sitagliptin||18||
48045746|NCT00830076|100431679|FG000|COMPLETED|Metformin + Placebo Sitagliptin||18||
48045747|NCT00830076|100431679|FG000|NOT COMPLETED|Metformin + Placebo Sitagliptin||0||
48045748|NCT00830076|100431679|FG000|STARTED|7-day Washout||18||
48045749|NCT00830076|100431679|FG000|COMPLETED|7-day Washout||18||
48045750|NCT00830076|100431679|FG000|NOT COMPLETED|7-day Washout||0||
48045751|NCT00830076|100431679|FG000|STARTED|Sitagliptin + Metformin||18||
48045752|NCT00830076|100431679|FG000|COMPLETED|Sitagliptin + Metformin||18||
48045753|NCT00830076|100431679|FG000|NOT COMPLETED|Sitagliptin + Metformin||0||
48045754|NCT00830076|100431679|FG000|STARTED|7-day Washout||18||
48045755|NCT00830076|100431679|FG000|COMPLETED|7-day Washout||18||
48045756|NCT00830076|100431679|FG000|NOT COMPLETED|7-day Washout||0||
48045757|NCT00830076|100431679|FG000|STARTED|Placebo Sitagliptin + Placebo Metformin||18||
48045758|NCT00830076|100431679|FG000|COMPLETED|Placebo Sitagliptin + Placebo Metformin||18||
48045759|NCT00830076|100431679|FG000|NOT COMPLETED|Placebo Sitagliptin + Placebo Metformin||0||
48045760|NCT04964193|100431680|FG000|STARTED|1st Intervention||12||
48045761|NCT04964193|100431681|FG001|STARTED|1st Intervention||12||
48045762|NCT04964193|100431680|FG000|COMPLETED|1st Intervention||12||
48045763|NCT04964193|100431681|FG001|COMPLETED|1st Intervention||12||
48045764|NCT04964193|100431680|FG000|NOT COMPLETED|1st Intervention||0||
48045765|NCT04964193|100431681|FG001|NOT COMPLETED|1st Intervention||0||
48045766|NCT04964193|100431680|FG000|STARTED|Washout = Three Weeks||12||
48045767|NCT04964193|100431681|FG001|STARTED|Washout = Three Weeks||12||
48045768|NCT04964193|100431680|FG000|COMPLETED|Washout = Three Weeks||12||
48045769|NCT04964193|100431681|FG001|COMPLETED|Washout = Three Weeks||12||
48045770|NCT04964193|100431680|FG000|NOT COMPLETED|Washout = Three Weeks||0||
48045771|NCT04964193|100431681|FG001|NOT COMPLETED|Washout = Three Weeks||0||
48045772|NCT04964193|100431680|FG000|STARTED|2nd Intervention||12||
48045773|NCT04964193|100431681|FG001|STARTED|2nd Intervention||12||
48045774|NCT04964193|100431680|FG000|COMPLETED|2nd Intervention||12||
48045775|NCT04964193|100431681|FG001|COMPLETED|2nd Intervention||12||
48045776|NCT04964193|100431680|FG000|NOT COMPLETED|2nd Intervention||0||
48045777|NCT04964193|100431681|FG001|NOT COMPLETED|2nd Intervention||0||
48495412|NCT00064038|101547841|FG002|COMPLETED|Crossover to Lenalidomide+Dexamethasone||40||
48045778|NCT02095132|100431682|FG000|STARTED|Overall Study||4||
48045779|NCT02095132|100431683|FG001|STARTED|Overall Study||5||
48045780|NCT02095132|100431684|FG002|STARTED|Overall Study||4||
48045781|NCT02095132|100431685|FG003|STARTED|Overall Study||10||
48045782|NCT02095132|100431686|FG004|STARTED|Overall Study||8||
48045783|NCT02095132|100431687|FG005|STARTED|Overall Study||6||
48045784|NCT02095132|100431688|FG006|STARTED|Overall Study||19||
48045785|NCT02095132|100431689|FG007|STARTED|Overall Study||10||
48495413|NCT00064038|101547839|FG000|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0||
48045786|NCT02095132|100431690|FG008|STARTED|Overall Study||10||
48045787|NCT02095132|100431682|FG000|COMPLETED|Overall Study||0||
48045788|NCT02095132|100431683|FG001|COMPLETED|Overall Study||0||
48045789|NCT02095132|100431684|FG002|COMPLETED|Overall Study||0||
48045790|NCT02095132|100431685|FG003|COMPLETED|Overall Study||0||
48045791|NCT02095132|100431686|FG004|COMPLETED|Overall Study||1||
48045792|NCT02095132|100431687|FG005|COMPLETED|Overall Study||0||
48045793|NCT02095132|100431688|FG006|COMPLETED|Overall Study||1||
48045794|NCT02095132|100431689|FG007|COMPLETED|Overall Study||1||
48045795|NCT02095132|100431690|FG008|COMPLETED|Overall Study||0||
48045796|NCT02095132|100431682|FG000|NOT COMPLETED|Overall Study||4||
48045797|NCT02095132|100431683|FG001|NOT COMPLETED|Overall Study||5||
48045798|NCT02095132|100431684|FG002|NOT COMPLETED|Overall Study||4||
48045799|NCT02095132|100431685|FG003|NOT COMPLETED|Overall Study||10||
48045800|NCT02095132|100431686|FG004|NOT COMPLETED|Overall Study||7||
48205296|NCT00753012|100827417|FG001|STARTED|Overall Study||9||
48205297|NCT00753012|100827416|FG000|COMPLETED|Overall Study||7||
48205298|NCT00753012|100827417|FG001|COMPLETED|Overall Study||8||
48205299|NCT00753012|100827416|FG000|NOT COMPLETED|Overall Study||8||
48205300|NCT00753012|100827417|FG001|NOT COMPLETED|Overall Study||1||
48205301|NCT00117663|100827418|FG000|STARTED|Overall Study||567||
48205302|NCT00117663|100827419|FG001|STARTED|Overall Study||570||
48205303|NCT00117663|100827420|FG002|STARTED|Overall Study||567||
48205304|NCT00117663|100827418|FG000|COMPLETED|Overall Study||542||
48205305|NCT00117663|100827419|FG001|COMPLETED|Overall Study||478||
48205306|NCT00117663|100827420|FG002|COMPLETED|Overall Study||451||
48045801|NCT02095132|100431687|FG005|NOT COMPLETED|Overall Study||6||
48045802|NCT02095132|100431688|FG006|NOT COMPLETED|Overall Study||18||
48045803|NCT02095132|100431689|FG007|NOT COMPLETED|Overall Study||9||
48045804|NCT02095132|100431690|FG008|NOT COMPLETED|Overall Study||10||
48045805|NCT01829243|100431691|FG000|STARTED|First Intervention||11||
48045806|NCT01829243|100431692|FG001|STARTED|First Intervention||15||
48045807|NCT01829243|100431691|FG000|COMPLETED|First Intervention||7||
48045808|NCT01829243|100431692|FG001|COMPLETED|First Intervention||13||
48045809|NCT01829243|100431691|FG000|NOT COMPLETED|First Intervention||4||
48045810|NCT01829243|100431692|FG001|NOT COMPLETED|First Intervention||2||
48045811|NCT01829243|100431691|FG000|STARTED|Washout Period of 1 Week||7||
48045812|NCT01829243|100431692|FG001|STARTED|Washout Period of 1 Week||13||
48045813|NCT01829243|100431691|FG000|COMPLETED|Washout Period of 1 Week||7||
48045814|NCT01829243|100431692|FG001|COMPLETED|Washout Period of 1 Week||13||
48045815|NCT01829243|100431691|FG000|NOT COMPLETED|Washout Period of 1 Week||0||
48045816|NCT01829243|100431692|FG001|NOT COMPLETED|Washout Period of 1 Week||0||
48045817|NCT01829243|100431691|FG000|STARTED|Second Intervention||7||
48045818|NCT01829243|100431692|FG001|STARTED|Second Intervention||13||
48045819|NCT01829243|100431691|FG000|COMPLETED|Second Intervention||7||
48045820|NCT01829243|100431692|FG001|COMPLETED|Second Intervention||13||
48045821|NCT01829243|100431691|FG000|NOT COMPLETED|Second Intervention||0||
48045822|NCT01829243|100431692|FG001|NOT COMPLETED|Second Intervention||0||
48045823|NCT01444092|100431693|FG000|STARTED|Overall Study||108||
48045824|NCT01444092|100431693|FG000|INFORMED CONSENT OBTAINED|Overall Study||108||
48045825|NCT01444092|100431693|FG000|COMPLETED|Overall Study||91||
48045826|NCT01444092|100431693|FG000|NOT COMPLETED|Overall Study||17||
48045827|NCT02915874|100431694|FG000|STARTED|Overall Study||44||
48045828|NCT02915874|100431695|FG001|STARTED|Overall Study||28||
48045829|NCT02915874|100431694|FG000|Week 6 Follow Up|Overall Study||41||
48045830|NCT02915874|100431695|FG001|Week 6 Follow Up|Overall Study||26||
48045831|NCT02915874|100431694|FG000|COMPLETED|Overall Study||38||
48045832|NCT02915874|100431695|FG001|COMPLETED|Overall Study||22||
48045833|NCT02915874|100431694|FG000|NOT COMPLETED|Overall Study||6||
48205307|NCT00117663|100827418|FG000|NOT COMPLETED|Overall Study||25||
48205308|NCT00117663|100827419|FG001|NOT COMPLETED|Overall Study||92||
48205309|NCT00117663|100827420|FG002|NOT COMPLETED|Overall Study||116||
48205310|NCT04222959|100827421|FG000|STARTED|Overall Study||138||9
48205311|NCT04222959|100827422|FG001|STARTED|Overall Study||102||9
48205312|NCT04222959|100827421|FG000|COMPLETED|Overall Study||62||9
48205313|NCT04222959|100827422|FG001|COMPLETED|Overall Study||74||9
48205314|NCT04222959|100827421|FG000|NOT COMPLETED|Overall Study||76||0
48205315|NCT04222959|100827422|FG001|NOT COMPLETED|Overall Study||28||0
48205316|NCT02613871|100827423|FG000|STARTED|Overall Study||111||
48205317|NCT02613871|100827423|FG000|COMPLETED|Overall Study||108||
48205318|NCT02613871|100827423|FG000|NOT COMPLETED|Overall Study||3||
48205319|NCT02666742|100827424|FG000|STARTED|Overall Study||123||
48205320|NCT02666742|100827425|FG001|STARTED|Overall Study||123||
48205321|NCT02666742|100827424|FG000|COMPLETED|Overall Study||123||
48205322|NCT02666742|100827425|FG001|COMPLETED|Overall Study||123||
48205323|NCT02666742|100827424|FG000|NOT COMPLETED|Overall Study||0||
48205324|NCT02666742|100827425|FG001|NOT COMPLETED|Overall Study||0||
48205325|NCT00846066|100827426|FG000|STARTED|Overall Study||27||
48205326|NCT00846066|100827427|FG001|STARTED|Overall Study||29||
48205327|NCT00846066|100827426|FG000|COMPLETED|Overall Study||27||
48205328|NCT00846066|100827427|FG001|COMPLETED|Overall Study||29||
48205329|NCT00846066|100827426|FG000|NOT COMPLETED|Overall Study||0||
48205330|NCT00846066|100827427|FG001|NOT COMPLETED|Overall Study||0||
48205331|NCT01035658|100827428|FG000|STARTED|Overall Study||5||
48205332|NCT01035658|100827429|FG001|STARTED|Overall Study||8||
48205333|NCT01035658|100827430|FG002|STARTED|Overall Study||3||
48205334|NCT01035658|100827431|FG003|STARTED|Overall Study||6||
48205335|NCT01035658|100827428|FG000|COMPLETED|Overall Study||5||
48205336|NCT01035658|100827429|FG001|COMPLETED|Overall Study||8||
48205337|NCT01035658|100827430|FG002|COMPLETED|Overall Study||3||
48045834|NCT02915874|100431695|FG001|NOT COMPLETED|Overall Study||6||
48045835|NCT01976988|100431696|FG000|STARTED|Overall Study||208||
48045836|NCT01976988|100431697|FG001|STARTED|Overall Study||202||
48045837|NCT01976988|100431696|FG000|COMPLETED|Overall Study||192||
48045838|NCT01976988|100431697|FG001|COMPLETED|Overall Study||184||
48045839|NCT01976988|100431696|FG000|NOT COMPLETED|Overall Study||16||
48045840|NCT01976988|100431697|FG001|NOT COMPLETED|Overall Study||18||
48205338|NCT01035658|100827431|FG003|COMPLETED|Overall Study||6||
48205339|NCT01035658|100827428|FG000|NOT COMPLETED|Overall Study||0||
48205340|NCT01035658|100827429|FG001|NOT COMPLETED|Overall Study||0||
48205341|NCT01035658|100827430|FG002|NOT COMPLETED|Overall Study||0||
48205342|NCT01035658|100827431|FG003|NOT COMPLETED|Overall Study||0||
48205343|NCT02630719|100827432|FG000|STARTED|Overall Study||4||
48205344|NCT02630719|100827433|FG001|STARTED|Overall Study||6||
48205345|NCT02630719|100827432|FG000|COMPLETED|Overall Study||4||
48205346|NCT02630719|100827433|FG001|COMPLETED|Overall Study||6||
48205347|NCT02630719|100827432|FG000|NOT COMPLETED|Overall Study||0||
48205348|NCT02630719|100827433|FG001|NOT COMPLETED|Overall Study||0||
48205349|NCT00361283|100827434|FG000|STARTED|Overall Study||108||
48205350|NCT00361283|100827434|FG000|COMPLETED|Overall Study||81||
48205351|NCT00361283|100827434|FG000|NOT COMPLETED|Overall Study||27||
48205352|NCT01188499|100827435|FG000|STARTED|Overall Study||24||
48205353|NCT01188499|100827436|FG001|STARTED|Overall Study||83||
48205354|NCT01188499|100827437|FG002|STARTED|Overall Study||33||
48205355|NCT01188499|100827438|FG003|STARTED|Overall Study||18||
48045841|NCT03821844|100431698|FG000|STARTED|Overall Study||532||27
48045842|NCT03821844|100431699|FG001|STARTED|Overall Study||541||27
48045843|NCT03821844|100431698|FG000|COMPLETED|Overall Study||483||27
48045844|NCT03821844|100431699|FG001|COMPLETED|Overall Study||493||27
48045845|NCT03821844|100431698|FG000|NOT COMPLETED|Overall Study||49||0
48045846|NCT03821844|100431699|FG001|NOT COMPLETED|Overall Study||48||0
48045847|NCT04575597|100431700|FG000|STARTED|Overall Study||75||
48045848|NCT04575597|100431701|FG001|STARTED|Overall Study||77||
48045849|NCT04575597|100431702|FG002|STARTED|Overall Study||76||
48045850|NCT04575597|100431703|FG003|STARTED|Overall Study||74||
48045851|NCT04575597|100431704|FG004|STARTED|Overall Study||716||
48045852|NCT04575597|100431705|FG005|STARTED|Overall Study||717||
48045853|NCT04575597|100431700|FG000|Treated|Overall Study||74||
48045854|NCT04575597|100431701|FG001|Treated|Overall Study||77||
48205356|NCT01188499|100827439|FG004|STARTED|Overall Study||18||
48205357|NCT01188499|100827435|FG000|COMPLETED|Overall Study||24||
48205358|NCT01188499|100827436|FG001|COMPLETED|Overall Study||83||
48205359|NCT01188499|100827437|FG002|COMPLETED|Overall Study||33||
48205360|NCT01188499|100827438|FG003|COMPLETED|Overall Study||18||
48205361|NCT01188499|100827439|FG004|COMPLETED|Overall Study||18||
48205362|NCT01188499|100827435|FG000|NOT COMPLETED|Overall Study||0||
48205363|NCT01188499|100827436|FG001|NOT COMPLETED|Overall Study||0||
48205364|NCT01188499|100827437|FG002|NOT COMPLETED|Overall Study||0||
48205365|NCT01188499|100827438|FG003|NOT COMPLETED|Overall Study||0||
48205366|NCT01188499|100827439|FG004|NOT COMPLETED|Overall Study||0||
48205367|NCT02547922|100827440|FG000|STARTED|Overall Study||46||
48205368|NCT02547922|100827441|FG001|STARTED|Overall Study||52||
48205369|NCT02547922|100827442|FG002|STARTED|Overall Study||49||
48205370|NCT02547922|100827440|FG000|FAS (Full Analysis Set)|Overall Study||45|Patients did not receive IP|
48205371|NCT02547922|100827441|FG001|FAS (Full Analysis Set)|Overall Study||51|Patients did not receive IP|
48205372|NCT02547922|100827442|FG002|FAS (Full Analysis Set)|Overall Study||49|Patients did not receive IP|
48205373|NCT02547922|100827440|FG000|COMPLETED|Overall Study||18||
48205374|NCT02547922|100827441|FG001|COMPLETED|Overall Study||28||
48205375|NCT02547922|100827442|FG002|COMPLETED|Overall Study||20||
48205376|NCT02547922|100827440|FG000|NOT COMPLETED|Overall Study||28||
48205377|NCT02547922|100827441|FG001|NOT COMPLETED|Overall Study||24||
48205378|NCT02547922|100827442|FG002|NOT COMPLETED|Overall Study||29||
48205379|NCT00790790|100827443|FG000|STARTED|Study Period 2: Therapy Phase||49||
48205380|NCT00790790|100827444|FG001|STARTED|Study Period 2: Therapy Phase||50||
48205381|NCT00790790|100827445|FG002|STARTED|Study Period 2: Therapy Phase||48||
48495414|NCT00064038|101547840|FG001|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0||
48495415|NCT00064038|101547841|FG002|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||2||
48045855|NCT04575597|100431702|FG002|Treated|Overall Study||74||
48045856|NCT04575597|100431703|FG003|Treated|Overall Study||74||
48045857|NCT04575597|100431704|FG004|Treated|Overall Study||710||
48495416|NCT03502811|101547842|FG000|STARTED|Overall Study||1041||
48045858|NCT04575597|100431705|FG005|Treated|Overall Study||701||
48045859|NCT04575597|100431700|FG000|COMPLETED|Overall Study||71||
48045860|NCT04575597|100431701|FG001|COMPLETED|Overall Study||74||
48205382|NCT00790790|100827443|FG000|COMPLETED|Study Period 2: Therapy Phase||37||
48205383|NCT00790790|100827444|FG001|COMPLETED|Study Period 2: Therapy Phase||32||
48205384|NCT00790790|100827445|FG002|COMPLETED|Study Period 2: Therapy Phase||27||
48205385|NCT00790790|100827443|FG000|NOT COMPLETED|Study Period 2: Therapy Phase||12||
48205386|NCT00790790|100827444|FG001|NOT COMPLETED|Study Period 2: Therapy Phase||18||
48205387|NCT00790790|100827445|FG002|NOT COMPLETED|Study Period 2: Therapy Phase||21||
48205388|NCT00790790|100827443|FG000|STARTED|Study Period 3: 1-Week Washout Phase||37||
48205389|NCT00790790|100827444|FG001|STARTED|Study Period 3: 1-Week Washout Phase||32||
48205390|NCT00790790|100827445|FG002|STARTED|Study Period 3: 1-Week Washout Phase||27||
48205391|NCT00790790|100827443|FG000|COMPLETED|Study Period 3: 1-Week Washout Phase||37||
48205392|NCT00790790|100827444|FG001|COMPLETED|Study Period 3: 1-Week Washout Phase||31||
48205393|NCT00790790|100827445|FG002|COMPLETED|Study Period 3: 1-Week Washout Phase||26||
48205394|NCT00790790|100827443|FG000|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0||
48205395|NCT00790790|100827444|FG001|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1||
48045861|NCT04575597|100431702|FG002|COMPLETED|Overall Study||71||
48205396|NCT00790790|100827445|FG002|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1||
48205397|NCT01199705|100827446|FG000|STARTED|IVIG Treatment||25||
48205398|NCT01199705|100827446|FG000|COMPLETED|IVIG Treatment||25||
48205399|NCT01199705|100827446|FG000|NOT COMPLETED|IVIG Treatment||0||
48205400|NCT01199705|100827446|FG000|STARTED|SCIG Treatment (Wash-in/Wash-out)||25||
48205401|NCT01199705|100827446|FG000|COMPLETED|SCIG Treatment (Wash-in/Wash-out)||24||
48205402|NCT01199705|100827446|FG000|NOT COMPLETED|SCIG Treatment (Wash-in/Wash-out)||1||
48205403|NCT01199705|100827446|FG000|STARTED|SCIG Treatment (Efficacy)||24||
48205404|NCT01199705|100827446|FG000|COMPLETED|SCIG Treatment (Efficacy)||24||
48205405|NCT01199705|100827446|FG000|NOT COMPLETED|SCIG Treatment (Efficacy)||0||
48205406|NCT00475319|100827447|FG000|STARTED|Overall Study||103||
48205407|NCT00475319|100827448|FG001|STARTED|Overall Study||102||
48205408|NCT00475319|100827449|FG002|STARTED|Overall Study||103||
48205409|NCT00475319|100827447|FG000|COMPLETED|Overall Study||101||
48205410|NCT00475319|100827448|FG001|COMPLETED|Overall Study||101||
48205411|NCT00475319|100827449|FG002|COMPLETED|Overall Study||99||
48205412|NCT00475319|100827447|FG000|NOT COMPLETED|Overall Study||2||
48205413|NCT00475319|100827448|FG001|NOT COMPLETED|Overall Study||1||
48205414|NCT00475319|100827449|FG002|NOT COMPLETED|Overall Study||4||
48205415|NCT04661150|100827450|FG000|STARTED|Overall Study||21||
48205416|NCT04661150|100827451|FG001|STARTED|Overall Study||21||
48205417|NCT04661150|100827450|FG000|COMPLETED|Overall Study||0||
48205418|NCT04661150|100827451|FG001|COMPLETED|Overall Study||0||
48205419|NCT04661150|100827450|FG000|NOT COMPLETED|Overall Study||21||
48205420|NCT04661150|100827451|FG001|NOT COMPLETED|Overall Study||21||
48205421|NCT00419094|100827452|FG000|STARTED|Overall Study||57||
48205422|NCT00419094|100827453|FG001|STARTED|Overall Study||171||
48205423|NCT00419094|100827452|FG000|COMPLETED|Overall Study||50||
48205424|NCT00419094|100827453|FG001|COMPLETED|Overall Study||141||
48205425|NCT00419094|100827452|FG000|NOT COMPLETED|Overall Study||7||
48205426|NCT00419094|100827453|FG001|NOT COMPLETED|Overall Study||30||
48205427|NCT03280836|100827454|FG000|STARTED|Overall Study||10||
48205428|NCT03280836|100827455|FG001|STARTED|Overall Study||9||
48205429|NCT03280836|100827454|FG000|COMPLETED|Overall Study||9||
48205430|NCT03280836|100827455|FG001|COMPLETED|Overall Study||8||
48205431|NCT03280836|100827454|FG000|NOT COMPLETED|Overall Study||1||
48205432|NCT03280836|100827455|FG001|NOT COMPLETED|Overall Study||1||
48205433|NCT00367991|100827456|FG000|STARTED|Overall Study||29||
48205434|NCT00367991|100827457|FG001|STARTED|Overall Study||15||
48205435|NCT00367991|100827456|FG000|COMPLETED|Overall Study||27||
48205436|NCT00367991|100827457|FG001|COMPLETED|Overall Study||13||
48205437|NCT00367991|100827456|FG000|NOT COMPLETED|Overall Study||2||
48205438|NCT00367991|100827457|FG001|NOT COMPLETED|Overall Study||2||
48205439|NCT03512756|100827458|FG000|STARTED|Part 1||25||
48205440|NCT03512756|100827459|FG001|STARTED|Part 1||24||
48205441|NCT03512756|100827460|FG002|STARTED|Part 1||0||
48205442|NCT03512756|100827461|FG003|STARTED|Part 1||0||
48205443|NCT03512756|100827458|FG000|Received At Least 1 Dose of Study Drug|Part 1||25|Per protocol, only participants in this row have been included in the Safety Analysis Population, and have been used to report Baseline Measures and Adverse Events.|
48205444|NCT03512756|100827459|FG001|Received At Least 1 Dose of Study Drug|Part 1||23|Per protocol, only participants in this row have been included in the Safety Analysis Population, and have been used to report Baseline Measures and Adverse Events.|
48205445|NCT03512756|100827460|FG002|Received At Least 1 Dose of Study Drug|Part 1||0|Per protocol, only participants in this row have been included in the Safety Analysis Population, and have been used to report Baseline Measures and Adverse Events.|
48205446|NCT03512756|100827461|FG003|Received At Least 1 Dose of Study Drug|Part 1||0|Per protocol, only participants in this row have been included in the Safety Analysis Population, and have been used to report Baseline Measures and Adverse Events.|
48205447|NCT03512756|100827458|FG000|COMPLETED|Part 1||0||
48205448|NCT03512756|100827459|FG001|COMPLETED|Part 1||0||
48205449|NCT03512756|100827460|FG002|COMPLETED|Part 1||0||
48495417|NCT03502811|101547842|FG000|COMPLETED|Overall Study||722||
48045862|NCT04575597|100431703|FG003|COMPLETED|Overall Study||69||
48045863|NCT04575597|100431704|FG004|COMPLETED|Overall Study||675||
48045864|NCT04575597|100431705|FG005|COMPLETED|Overall Study||663||
48045865|NCT04575597|100431700|FG000|NOT COMPLETED|Overall Study||4||
48045866|NCT04575597|100431701|FG001|NOT COMPLETED|Overall Study||3||
48045867|NCT04575597|100431702|FG002|NOT COMPLETED|Overall Study||5||
48045868|NCT04575597|100431703|FG003|NOT COMPLETED|Overall Study||5||
48045869|NCT04575597|100431704|FG004|NOT COMPLETED|Overall Study||41||
48045870|NCT04575597|100431705|FG005|NOT COMPLETED|Overall Study||54||
48205450|NCT03512756|100827461|FG003|COMPLETED|Part 1||0||
48205451|NCT03512756|100827458|FG000|NOT COMPLETED|Part 1||25||
48205452|NCT03512756|100827459|FG001|NOT COMPLETED|Part 1||24||
48205453|NCT03512756|100827460|FG002|NOT COMPLETED|Part 1||0||
48205454|NCT03512756|100827461|FG003|NOT COMPLETED|Part 1||0||
48205455|NCT03512756|100827458|FG000|STARTED|Part 2||0||
48205456|NCT03512756|100827459|FG001|STARTED|Part 2||0||
48045871|NCT01325792|100431706|FG000|STARTED|Overall Study||104||
48045872|NCT01325792|100431706|FG000|COMPLETED|Overall Study||87||
48045873|NCT01325792|100431706|FG000|NOT COMPLETED|Overall Study||17||
48205457|NCT03512756|100827460|FG002|STARTED|Part 2||41||
48205458|NCT03512756|100827461|FG003|STARTED|Part 2||40||
48045874|NCT00880464|100431707|FG000|STARTED|Overall Study||7||
48045875|NCT00880464|100431707|FG000|COMPLETED|Overall Study||7||
48045876|NCT00880464|100431707|FG000|NOT COMPLETED|Overall Study||0||
48045877|NCT01109056|100431708|FG000|STARTED|Overall Study||57||
48045878|NCT01109056|100431709|FG001|STARTED|Overall Study||58||
48045879|NCT01109056|100431708|FG000|COMPLETED|Overall Study||50||
48045880|NCT01109056|100431709|FG001|COMPLETED|Overall Study||53||
48045881|NCT01109056|100431708|FG000|NOT COMPLETED|Overall Study||7||
48045882|NCT01109056|100431709|FG001|NOT COMPLETED|Overall Study||5||
48045883|NCT04905498|100431710|FG000|STARTED|Overall Study||19||
48045884|NCT04905498|100431711|FG001|STARTED|Overall Study||30||
48045885|NCT04905498|100431710|FG000|COMPLETED|Overall Study||18||
48205459|NCT03512756|100827458|FG000|Received At Least 1 Dose of Study Drug|Part 2||0|Per protocol, only participants in this row have been included in the Safety Analysis Population, and have been used to report Baseline Measures and Adverse Events.|
48205460|NCT03512756|100827459|FG001|Received At Least 1 Dose of Study Drug|Part 2||0|Per protocol, only participants in this row have been included in the Safety Analysis Population, and have been used to report Baseline Measures and Adverse Events.|
48205461|NCT03512756|100827460|FG002|Received At Least 1 Dose of Study Drug|Part 2||40|Per protocol, only participants in this row have been included in the Safety Analysis Population, and have been used to report Baseline Measures and Adverse Events.|
48205462|NCT03512756|100827461|FG003|Received At Least 1 Dose of Study Drug|Part 2||30|Per protocol, only participants in this row have been included in the Safety Analysis Population, and have been used to report Baseline Measures and Adverse Events.|
48205463|NCT03512756|100827458|FG000|COMPLETED|Part 2||0||
48205464|NCT03512756|100827459|FG001|COMPLETED|Part 2||0||
48205465|NCT03512756|100827460|FG002|COMPLETED|Part 2||0||
48205466|NCT03512756|100827461|FG003|COMPLETED|Part 2||0||
48205467|NCT03512756|100827458|FG000|NOT COMPLETED|Part 2||0||
48205468|NCT03512756|100827459|FG001|NOT COMPLETED|Part 2||0||
48205469|NCT03512756|100827460|FG002|NOT COMPLETED|Part 2||41||
48205470|NCT03512756|100827461|FG003|NOT COMPLETED|Part 2||40||
48205471|NCT03192046|100827462|FG000|STARTED|Overall Study||5||
48205472|NCT03192046|100827463|FG001|STARTED|Overall Study||4||
48205473|NCT03192046|100827462|FG000|COMPLETED|Overall Study||4||
48205474|NCT03192046|100827463|FG001|COMPLETED|Overall Study||3||
48205475|NCT03192046|100827462|FG000|NOT COMPLETED|Overall Study||1||
48205476|NCT03192046|100827463|FG001|NOT COMPLETED|Overall Study||1||
48205477|NCT04353037|100827464|FG000|STARTED|Overall Study||6||
48205478|NCT04353037|100827465|FG001|STARTED|Overall Study||3||
48205479|NCT04353037|100827466|FG002|STARTED|Overall Study||13||
48205480|NCT04353037|100827467|FG003|STARTED|Overall Study||17||
48205481|NCT04353037|100827464|FG000|COMPLETED|Overall Study||6||
48205482|NCT04353037|100827465|FG001|COMPLETED|Overall Study||0||
48205483|NCT04353037|100827466|FG002|COMPLETED|Overall Study||6||
48205484|NCT04353037|100827467|FG003|COMPLETED|Overall Study||7||
48205485|NCT04353037|100827464|FG000|NOT COMPLETED|Overall Study||0||
48205486|NCT04353037|100827465|FG001|NOT COMPLETED|Overall Study||3||
48205487|NCT04353037|100827466|FG002|NOT COMPLETED|Overall Study||7||
48205488|NCT04353037|100827467|FG003|NOT COMPLETED|Overall Study||10||
48205489|NCT04493242|100827468|FG000|STARTED|Overall Study||34||
48205490|NCT04493242|100827469|FG001|STARTED|Overall Study||34||
48205491|NCT04493242|100827470|FG002|STARTED|Overall Study||34||
48205492|NCT04493242|100827468|FG000|Received 1 Dose Only|Overall Study||7||
48205493|NCT04493242|100827469|FG001|Received 1 Dose Only|Overall Study||5||
48205494|NCT04493242|100827470|FG002|Received 1 Dose Only|Overall Study||7||
48205495|NCT04493242|100827468|FG000|Received 2 Doses|Overall Study||27||
48205496|NCT04493242|100827469|FG001|Received 2 Doses|Overall Study||29||
48205497|NCT04493242|100827470|FG002|Received 2 Doses|Overall Study||27||
48205498|NCT04493242|100827468|FG000|Subjects Who Did Not Receive a Full Dose at Any Dose (Dose 1 or 2)|Overall Study||1||
48205499|NCT04493242|100827469|FG001|Subjects Who Did Not Receive a Full Dose at Any Dose (Dose 1 or 2)|Overall Study||0||
48205500|NCT04493242|100827470|FG002|Subjects Who Did Not Receive a Full Dose at Any Dose (Dose 1 or 2)|Overall Study||0||
48205501|NCT04493242|100827468|FG000|COMPLETED|Overall Study||20||
48205502|NCT04493242|100827469|FG001|COMPLETED|Overall Study||16||
48205503|NCT04493242|100827470|FG002|COMPLETED|Overall Study||17||
48205504|NCT04493242|100827468|FG000|NOT COMPLETED|Overall Study||14||
48205505|NCT04493242|100827469|FG001|NOT COMPLETED|Overall Study||18||
48205506|NCT04493242|100827470|FG002|NOT COMPLETED|Overall Study||17||
48205507|NCT03131206|100827471|FG000|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||5||
48205508|NCT03131206|100827472|FG001|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0||
48205509|NCT03131206|100827473|FG002|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0||
48205510|NCT03131206|100827474|FG003|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0||
48205511|NCT03131206|100827471|FG000|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||5||
48205512|NCT03131206|100827472|FG001|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0||
48205513|NCT03131206|100827473|FG002|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0||
48205514|NCT03131206|100827474|FG003|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0||
48205515|NCT03131206|100827471|FG000|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0||
48495418|NCT03502811|101547842|FG000|NOT COMPLETED|Overall Study||319||
48205516|NCT03131206|100827472|FG001|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0||
48205517|NCT03131206|100827473|FG002|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0||
48495419|NCT01665508|101547843|FG000|STARTED|Overall Study||12||
48045886|NCT04905498|100431711|FG001|COMPLETED|Overall Study||28||
48045887|NCT04905498|100431710|FG000|NOT COMPLETED|Overall Study||1||
48205518|NCT03131206|100827474|FG003|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0||
48205519|NCT03131206|100827471|FG000|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0||
48205520|NCT03131206|100827472|FG001|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0||
48205521|NCT03131206|100827473|FG002|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0||
48205522|NCT03131206|100827474|FG003|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0||
48205523|NCT03131206|100827471|FG000|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0||
48205524|NCT03131206|100827472|FG001|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0||
48205525|NCT03131206|100827473|FG002|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0||
48205526|NCT03131206|100827474|FG003|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0||
48205527|NCT03131206|100827471|FG000|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0||
48205528|NCT03131206|100827472|FG001|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0||
48205529|NCT03131206|100827473|FG002|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0||
48205530|NCT03131206|100827474|FG003|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0||
48205531|NCT02314117|100827475|FG000|STARTED|Overall Study||326||
48205532|NCT02314117|100827476|FG001|STARTED|Overall Study||319||
48205533|NCT02314117|100827475|FG000|Received at Least One Dose of Study Drug|Overall Study||323||
48205534|NCT02314117|100827476|FG001|Received at Least One Dose of Study Drug|Overall Study||315||
48205535|NCT02314117|100827475|FG000|COMPLETED|Overall Study||314||
48205536|NCT02314117|100827476|FG001|COMPLETED|Overall Study||303||
48205537|NCT02314117|100827475|FG000|NOT COMPLETED|Overall Study||12||
48205538|NCT02314117|100827476|FG001|NOT COMPLETED|Overall Study||16||
48205539|NCT02507752|100827477|FG000|STARTED|Overall Study||72||
48205540|NCT02507752|100827477|FG000|COMPLETED|Overall Study||55||
48205541|NCT02507752|100827477|FG000|NOT COMPLETED|Overall Study||17||
48205542|NCT00597038|100827478|FG000|STARTED|Overall Study||16||
48205543|NCT00597038|100827479|FG001|STARTED|Overall Study||34||
48205544|NCT00597038|100827478|FG000|COMPLETED|Overall Study||14||
48205545|NCT00597038|100827479|FG001|COMPLETED|Overall Study||30||
48205546|NCT00597038|100827478|FG000|NOT COMPLETED|Overall Study||2||
48205547|NCT00597038|100827479|FG001|NOT COMPLETED|Overall Study||4||
48205548|NCT03196167|100827480|FG000|STARTED|Overall Study||45||
48205549|NCT03196167|100827481|FG001|STARTED|Overall Study||45||
48205550|NCT03196167|100827480|FG000|COMPLETED|Overall Study||40||
48205551|NCT03196167|100827481|FG001|COMPLETED|Overall Study||43||
48205552|NCT03196167|100827480|FG000|NOT COMPLETED|Overall Study||5||
48205553|NCT03196167|100827481|FG001|NOT COMPLETED|Overall Study||2||
48205554|NCT04567888|100827482|FG000|STARTED|Overall Study||178||
48205555|NCT04567888|100827483|FG001|STARTED|Overall Study||175||
48205556|NCT04567888|100827482|FG000|COMPLETED|Overall Study||132||
48205557|NCT04567888|100827483|FG001|COMPLETED|Overall Study||171||
48205558|NCT04567888|100827482|FG000|NOT COMPLETED|Overall Study||46||
48205559|NCT04567888|100827483|FG001|NOT COMPLETED|Overall Study||4||
48045888|NCT04905498|100431711|FG001|NOT COMPLETED|Overall Study||2||
48045889|NCT02312687|100431712|FG000|STARTED|Overall Study||20||
48045890|NCT02312687|100431712|FG000|COMPLETED|Overall Study||19||
48045891|NCT02312687|100431712|FG000|NOT COMPLETED|Overall Study||1||
48045892|NCT01031420|100431713|FG000|STARTED|Overall Study||54||
48045893|NCT01031420|100431713|FG000|COMPLETED|Overall Study||44||
48045894|NCT01031420|100431713|FG000|NOT COMPLETED|Overall Study||10||
48045895|NCT01262352|100431714|FG000|STARTED|Period 1||11||
48045896|NCT01262352|100431715|FG001|STARTED|Period 1||10||
48045897|NCT01262352|100431714|FG000|Dosed|Period 1||10||
48045898|NCT01262352|100431715|FG001|Dosed|Period 1||10||
48045899|NCT01262352|100431714|FG000|COMPLETED|Period 1||10||
48205560|NCT03823911|100827484|FG000|STARTED|Overall Study||43||
48205561|NCT03823911|100827485|FG001|STARTED|Overall Study||37||
48205562|NCT03823911|100827486|FG002|STARTED|Overall Study||7||
48205563|NCT03823911|100827484|FG000|COMPLETED|Overall Study||29||
48205564|NCT03823911|100827485|FG001|COMPLETED|Overall Study||24||
48205565|NCT03823911|100827486|FG002|COMPLETED|Overall Study||1||
48205566|NCT03823911|100827484|FG000|NOT COMPLETED|Overall Study||14||
48045900|NCT01262352|100431715|FG001|COMPLETED|Period 1||10||
48045901|NCT01262352|100431714|FG000|NOT COMPLETED|Period 1||1||
48205567|NCT03823911|100827485|FG001|NOT COMPLETED|Overall Study||13||
48205568|NCT03823911|100827486|FG002|NOT COMPLETED|Overall Study||6||
48205569|NCT03762213|100827487|FG000|STARTED|Overall Study||16||
48205570|NCT03762213|100827488|FG001|STARTED|Overall Study||14||
48205571|NCT03762213|100827487|FG000|COMPLETED|Overall Study||16||
48205572|NCT03762213|100827488|FG001|COMPLETED|Overall Study||14||
48205573|NCT03762213|100827487|FG000|NOT COMPLETED|Overall Study||0||
48205574|NCT03762213|100827488|FG001|NOT COMPLETED|Overall Study||0||
48205575|NCT00244855|100827489|FG000|STARTED|Overall Study||7||
48205576|NCT00244855|100827490|FG001|STARTED|Overall Study||25||
48045902|NCT01262352|100431715|FG001|NOT COMPLETED|Period 1||0||
48045903|NCT01262352|100431714|FG000|STARTED|Washout||10||
48045904|NCT01262352|100431715|FG001|STARTED|Washout||10||
48045905|NCT01262352|100431714|FG000|COMPLETED|Washout||9||
48045906|NCT01262352|100431715|FG001|COMPLETED|Washout||8||
48045907|NCT01262352|100431714|FG000|NOT COMPLETED|Washout||1||
48205577|NCT00244855|100827489|FG000|COMPLETED|Overall Study||7||
48205578|NCT00244855|100827490|FG001|COMPLETED|Overall Study||24||
48205579|NCT00244855|100827489|FG000|NOT COMPLETED|Overall Study||0||
48045908|NCT01262352|100431715|FG001|NOT COMPLETED|Washout||2||
48045909|NCT01262352|100431714|FG000|STARTED|Period 2||9||
48045910|NCT01262352|100431715|FG001|STARTED|Period 2||8||
48045911|NCT01262352|100431714|FG000|Dosed|Period 2||9||
48045912|NCT01262352|100431715|FG001|Dosed|Period 2||8||
48045913|NCT01262352|100431714|FG000|COMPLETED|Period 2||9||
48045914|NCT01262352|100431715|FG001|COMPLETED|Period 2||8||
48045915|NCT01262352|100431714|FG000|NOT COMPLETED|Period 2||0||
48045916|NCT01262352|100431715|FG001|NOT COMPLETED|Period 2||0||
48045917|NCT00913692|100431716|FG000|STARTED|Screening (4 Months)||11||
48045918|NCT00913692|100431716|FG000|COMPLETED|Screening (4 Months)||2||
48045919|NCT00913692|100431716|FG000|NOT COMPLETED|Screening (4 Months)||9||
48045920|NCT00913692|100431716|FG000|STARTED|Treatment Phase 1 (5 Months)||2||
48045921|NCT00913692|100431716|FG000|COMPLETED|Treatment Phase 1 (5 Months)||1||
48045922|NCT00913692|100431716|FG000|NOT COMPLETED|Treatment Phase 1 (5 Months)||1||
48045923|NCT00913692|100431716|FG000|STARTED|Washout (2 Weeks)||1||
48045924|NCT00913692|100431716|FG000|COMPLETED|Washout (2 Weeks)||1||
48045925|NCT00913692|100431716|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
48205580|NCT00244855|100827490|FG001|NOT COMPLETED|Overall Study||1||
48205581|NCT05609032|100827491|FG000|STARTED|Overall Study||30||
48205582|NCT05609032|100827492|FG001|STARTED|Overall Study||30||
48205583|NCT05609032|100827491|FG000|COMPLETED|Overall Study||26||
48205584|NCT05609032|100827492|FG001|COMPLETED|Overall Study||29||
48205585|NCT05609032|100827491|FG000|NOT COMPLETED|Overall Study||4||
48205586|NCT05609032|100827492|FG001|NOT COMPLETED|Overall Study||1||
48205587|NCT01645098|100827493|FG000|STARTED|Overall Study||24||
48205588|NCT01645098|100827494|FG001|STARTED|Overall Study||29||
48205589|NCT01645098|100827493|FG000|COMPLETED|Overall Study||24||
48205590|NCT01645098|100827494|FG001|COMPLETED|Overall Study||29||
48205591|NCT01645098|100827493|FG000|NOT COMPLETED|Overall Study||0||
48495420|NCT01665508|101547843|FG000|COMPLETED|Overall Study||7||
48495421|NCT01665508|101547843|FG000|NOT COMPLETED|Overall Study||5||
48495422|NCT01822119|101547844|FG000|STARTED|Overall Study||27||
48495423|NCT01822119|101547844|FG000|COMPLETED|Overall Study||27||
48045926|NCT00913692|100431716|FG000|STARTED|Treatment Phase 2 (5 Months)||1||
48045927|NCT00913692|100431716|FG000|COMPLETED|Treatment Phase 2 (5 Months)||1||
48045928|NCT00913692|100431716|FG000|NOT COMPLETED|Treatment Phase 2 (5 Months)||0||
48045929|NCT04559529|100431717|FG000|STARTED|First Intervention (1 Day)||15||
48045930|NCT04559529|100431718|FG001|STARTED|First Intervention (1 Day)||15||
48045931|NCT04559529|100431719|FG002|STARTED|First Intervention (1 Day)||15||
48045932|NCT04559529|100431720|FG003|STARTED|First Intervention (1 Day)||17||
48045933|NCT04559529|100431717|FG000|COMPLETED|First Intervention (1 Day)||15||
48045934|NCT04559529|100431718|FG001|COMPLETED|First Intervention (1 Day)||15||
48045935|NCT04559529|100431719|FG002|COMPLETED|First Intervention (1 Day)||14||
48045936|NCT04559529|100431720|FG003|COMPLETED|First Intervention (1 Day)||16||
48045937|NCT04559529|100431717|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48045938|NCT04559529|100431718|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48045939|NCT04559529|100431719|FG002|NOT COMPLETED|First Intervention (1 Day)||1||
48045940|NCT04559529|100431720|FG003|NOT COMPLETED|First Intervention (1 Day)||1||
48045941|NCT04559529|100431717|FG000|STARTED|Washout (At Least 7 Days)||15||
48045942|NCT04559529|100431718|FG001|STARTED|Washout (At Least 7 Days)||15||
48045943|NCT04559529|100431719|FG002|STARTED|Washout (At Least 7 Days)||14||
48045944|NCT04559529|100431720|FG003|STARTED|Washout (At Least 7 Days)||16||
48045945|NCT04559529|100431717|FG000|COMPLETED|Washout (At Least 7 Days)||15||
48045946|NCT04559529|100431718|FG001|COMPLETED|Washout (At Least 7 Days)||15||
48205592|NCT01645098|100827494|FG001|NOT COMPLETED|Overall Study||0||
48205593|NCT05790408|100827495|FG000|STARTED|Overall Study||10||10
48205594|NCT05790408|100827495|FG000|COMPLETED|Overall Study||7||7
48205595|NCT05790408|100827495|FG000|NOT COMPLETED|Overall Study||3||3
48205596|NCT04058990|100827496|FG000|STARTED|Overall Study||101||
48205597|NCT04058990|100827497|FG001|STARTED|Overall Study||49||
48205598|NCT04058990|100827498|FG002|STARTED|Overall Study||30||
48205599|NCT04058990|100827496|FG000|COMPLETED|Overall Study||100||
48205600|NCT04058990|100827497|FG001|COMPLETED|Overall Study||49||
48205601|NCT04058990|100827498|FG002|COMPLETED|Overall Study||30||
48205602|NCT04058990|100827496|FG000|NOT COMPLETED|Overall Study||1||
48205603|NCT04058990|100827497|FG001|NOT COMPLETED|Overall Study||0||
48205604|NCT04058990|100827498|FG002|NOT COMPLETED|Overall Study||0||
48205605|NCT00590369|100827499|FG000|STARTED|Overall Study||6||
48205606|NCT00590369|100827500|FG001|STARTED|Overall Study||5||
48205607|NCT00590369|100827499|FG000|COMPLETED|Overall Study||6||
48205608|NCT00590369|100827500|FG001|COMPLETED|Overall Study||5||
48205609|NCT00590369|100827499|FG000|NOT COMPLETED|Overall Study||0||
48205610|NCT00590369|100827500|FG001|NOT COMPLETED|Overall Study||0||
48205611|NCT01131494|100827501|FG000|STARTED|Overall Study||17||
48205612|NCT01131494|100827501|FG000|COMPLETED|Overall Study||15||
48205613|NCT01131494|100827501|FG000|NOT COMPLETED|Overall Study||2||
48205614|NCT00326924|100827502|FG000|STARTED|Overall Study||188||
48205615|NCT00326924|100827503|FG001|STARTED|Overall Study||189||
48205616|NCT00326924|100827502|FG000|COMPLETED|Overall Study||187||
48205617|NCT00326924|100827503|FG001|COMPLETED|Overall Study||188||
48045947|NCT04559529|100431719|FG002|COMPLETED|Washout (At Least 7 Days)||14||
48495424|NCT01822119|101547844|FG000|NOT COMPLETED|Overall Study||0||
48045948|NCT04559529|100431720|FG003|COMPLETED|Washout (At Least 7 Days)||16||
48045949|NCT04559529|100431717|FG000|NOT COMPLETED|Washout (At Least 7 Days)||0||
48045950|NCT04559529|100431718|FG001|NOT COMPLETED|Washout (At Least 7 Days)||0||
48045951|NCT04559529|100431719|FG002|NOT COMPLETED|Washout (At Least 7 Days)||0||
48045952|NCT04559529|100431720|FG003|NOT COMPLETED|Washout (At Least 7 Days)||0||
48045953|NCT04559529|100431717|FG000|STARTED|Second Intervention (1 Day)||15||
48045954|NCT04559529|100431718|FG001|STARTED|Second Intervention (1 Day)||15||
48045955|NCT04559529|100431719|FG002|STARTED|Second Intervention (1 Day)||14||
48045956|NCT04559529|100431720|FG003|STARTED|Second Intervention (1 Day)||16||
48045957|NCT04559529|100431717|FG000|COMPLETED|Second Intervention (1 Day)||15||
48045958|NCT04559529|100431718|FG001|COMPLETED|Second Intervention (1 Day)||15||
48045959|NCT04559529|100431719|FG002|COMPLETED|Second Intervention (1 Day)||13||
48045960|NCT04559529|100431720|FG003|COMPLETED|Second Intervention (1 Day)||16||
48045961|NCT04559529|100431717|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
48045962|NCT04559529|100431718|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
48045963|NCT04559529|100431719|FG002|NOT COMPLETED|Second Intervention (1 Day)||1||
48045964|NCT04559529|100431720|FG003|NOT COMPLETED|Second Intervention (1 Day)||0||
48045965|NCT01254942|100431721|FG000|STARTED|Overall Study||27||
48045966|NCT01254942|100431722|FG001|STARTED|Overall Study||26||
48045967|NCT01254942|100431721|FG000|COMPLETED|Overall Study||25||
48045968|NCT01254942|100431722|FG001|COMPLETED|Overall Study||24||
48045969|NCT01254942|100431721|FG000|NOT COMPLETED|Overall Study||2||
48045970|NCT01254942|100431722|FG001|NOT COMPLETED|Overall Study||2||
48045971|NCT00527488|100431723|FG000|STARTED|Overall Study||13||
48045972|NCT00527488|100431724|FG001|STARTED|Overall Study||13||
48045973|NCT00527488|100431725|FG002|STARTED|Overall Study||13||
48045974|NCT00527488|100431726|FG003|STARTED|Overall Study||13||
48045975|NCT00527488|100431723|FG000|COMPLETED|Overall Study||13||
48045976|NCT00527488|100431724|FG001|COMPLETED|Overall Study||12||
48045977|NCT00527488|100431725|FG002|COMPLETED|Overall Study||12||
48045978|NCT00527488|100431726|FG003|COMPLETED|Overall Study||13||
48045979|NCT00527488|100431723|FG000|NOT COMPLETED|Overall Study||0||
48045980|NCT00527488|100431724|FG001|NOT COMPLETED|Overall Study||1||
48045981|NCT00527488|100431725|FG002|NOT COMPLETED|Overall Study||1||
48045982|NCT00527488|100431726|FG003|NOT COMPLETED|Overall Study||0||
48045983|NCT01945710|100431727|FG000|STARTED|Overall Study||7||
48045984|NCT01945710|100431728|FG001|STARTED|Overall Study||6||
48045985|NCT01945710|100431729|FG002|STARTED|Overall Study||7||
48045986|NCT01945710|100431730|FG003|STARTED|Overall Study||3||
48045987|NCT01945710|100431731|FG004|STARTED|Overall Study||9||
48045988|NCT01945710|100431732|FG005|STARTED|Overall Study||3||
48045989|NCT01945710|100431733|FG006|STARTED|Overall Study||23||
48045990|NCT01945710|100431727|FG000|COMPLETED|Overall Study||0||
48045991|NCT01945710|100431728|FG001|COMPLETED|Overall Study||0||
48045992|NCT01945710|100431729|FG002|COMPLETED|Overall Study||0||
48045993|NCT01945710|100431730|FG003|COMPLETED|Overall Study||0||
48045994|NCT01945710|100431731|FG004|COMPLETED|Overall Study||0||
48045995|NCT01945710|100431732|FG005|COMPLETED|Overall Study||0||
48045996|NCT01945710|100431733|FG006|COMPLETED|Overall Study||0||
48045997|NCT01945710|100431727|FG000|NOT COMPLETED|Overall Study||7||
48045998|NCT01945710|100431728|FG001|NOT COMPLETED|Overall Study||6||
48045999|NCT01945710|100431729|FG002|NOT COMPLETED|Overall Study||7||
48046000|NCT01945710|100431730|FG003|NOT COMPLETED|Overall Study||3||
48495425|NCT01808651|101547845|FG000|STARTED|Study Period 1||99||
48046001|NCT01945710|100431731|FG004|NOT COMPLETED|Overall Study||9||
48046002|NCT01945710|100431732|FG005|NOT COMPLETED|Overall Study||3||
48046003|NCT01945710|100431733|FG006|NOT COMPLETED|Overall Study||23||
48046004|NCT00674154|100431734|FG000|STARTED|Overall Study||23||
48046005|NCT00674154|100431735|FG001|STARTED|Overall Study||23||
48046006|NCT00674154|100431734|FG000|COMPLETED|Overall Study||20||
48046007|NCT00674154|100431735|FG001|COMPLETED|Overall Study||20||
48046008|NCT00674154|100431734|FG000|NOT COMPLETED|Overall Study||3||
48046009|NCT00674154|100431735|FG001|NOT COMPLETED|Overall Study||3||
48046010|NCT00278915|100431736|FG000|STARTED|Overall Study||30||
48046011|NCT00278915|100431736|FG000|COMPLETED|Overall Study||29||
48495426|NCT01808651|101547846|FG001|STARTED|Study Period 1||65||
48495427|NCT01808651|101547847|FG002|STARTED|Study Period 1||36||
48495428|NCT01808651|101547845|FG000|Received at Least One Dose of Study Drug|Study Period 1||98||
48495429|NCT01808651|101547846|FG001|Received at Least One Dose of Study Drug|Study Period 1||65||
48495430|NCT01808651|101547847|FG002|Received at Least One Dose of Study Drug|Study Period 1||36||
48495431|NCT01808651|101547845|FG000|COMPLETED|Study Period 1||73||
48495432|NCT01808651|101547846|FG001|COMPLETED|Study Period 1||48||
48046012|NCT00278915|100431736|FG000|NOT COMPLETED|Overall Study||1||
48046013|NCT01373671|100431737|FG000|STARTED|Overall Study||764||
48046014|NCT01373671|100431737|FG000|COMPLETED|Overall Study||672||
48046015|NCT01373671|100431737|FG000|NOT COMPLETED|Overall Study||92||
48046016|NCT01535664|100431738|FG000|STARTED|Overall Study||20||
48046017|NCT01535664|100431738|FG000|COMPLETED|Overall Study||20||
48046018|NCT01535664|100431738|FG000|NOT COMPLETED|Overall Study||0||
48046019|NCT05615935|100431739|FG000|STARTED|Overall Study||37||
48046020|NCT05615935|100431740|FG001|STARTED|Overall Study||37||
48046021|NCT05615935|100431739|FG000|COMPLETED|Overall Study||36||
48046022|NCT05615935|100431740|FG001|COMPLETED|Overall Study||36||
48046023|NCT05615935|100431739|FG000|NOT COMPLETED|Overall Study||1||
48046024|NCT05615935|100431740|FG001|NOT COMPLETED|Overall Study||1||
48046025|NCT02093351|100431741|FG000|STARTED|Part A||30||
48046026|NCT02093351|100431742|FG001|STARTED|Part A||23||
48046027|NCT02093351|100431743|FG002|STARTED|Part A||26||
48046028|NCT02093351|100431744|FG003|STARTED|Part A||0||
48046029|NCT02093351|100431741|FG000|Completing Treatment Period 1|Part A||29||
48046030|NCT02093351|100431742|FG001|Completing Treatment Period 1|Part A||22||
48046031|NCT02093351|100431743|FG002|Completing Treatment Period 1|Part A||23||
48046032|NCT02093351|100431744|FG003|Completing Treatment Period 1|Part A||0||
48046033|NCT02093351|100431741|FG000|Completing Treatment Period 2|Part A||29||
48046034|NCT02093351|100431742|FG001|Completing Treatment Period 2|Part A||21||
48046035|NCT02093351|100431743|FG002|Completing Treatment Period 2|Part A||23||
48046036|NCT02093351|100431744|FG003|Completing Treatment Period 2|Part A||0||
48046037|NCT02093351|100431741|FG000|Completing Treatment Period 3|Part A||28||
48046038|NCT02093351|100431742|FG001|Completing Treatment Period 3|Part A||21||
48046039|NCT02093351|100431743|FG002|Completing Treatment Period 3|Part A||23||
48046040|NCT02093351|100431744|FG003|Completing Treatment Period 3|Part A||0||
48046041|NCT02093351|100431741|FG000|COMPLETED|Part A||28||
48046042|NCT02093351|100431742|FG001|COMPLETED|Part A||21||
48046043|NCT02093351|100431743|FG002|COMPLETED|Part A||23||
48046044|NCT02093351|100431744|FG003|COMPLETED|Part A||0||
48046045|NCT02093351|100431741|FG000|NOT COMPLETED|Part A||2||
48046046|NCT02093351|100431742|FG001|NOT COMPLETED|Part A||2||
48046047|NCT02093351|100431743|FG002|NOT COMPLETED|Part A||3||
48046048|NCT02093351|100431744|FG003|NOT COMPLETED|Part A||0||
48046049|NCT02093351|100431741|FG000|STARTED|Part B||0||
48046050|NCT02093351|100431742|FG001|STARTED|Part B||0||
48046051|NCT02093351|100431743|FG002|STARTED|Part B||0||
48046052|NCT02093351|100431744|FG003|STARTED|Part B||69||
48046053|NCT02093351|100431741|FG000|COMPLETED|Part B||0||
48046054|NCT02093351|100431742|FG001|COMPLETED|Part B||0||
48046055|NCT02093351|100431743|FG002|COMPLETED|Part B||0||
48046056|NCT02093351|100431744|FG003|COMPLETED|Part B||6||
48046057|NCT02093351|100431741|FG000|NOT COMPLETED|Part B||0||
48046058|NCT02093351|100431742|FG001|NOT COMPLETED|Part B||0||
48046059|NCT02093351|100431743|FG002|NOT COMPLETED|Part B||0||
48046060|NCT02093351|100431744|FG003|NOT COMPLETED|Part B||63||
48046061|NCT01481129|100431745|FG000|STARTED|Overall Study||22||
48046062|NCT01481129|100431745|FG000|COMPLETED|Overall Study||22||
48046063|NCT01481129|100431745|FG000|NOT COMPLETED|Overall Study||0||
48046064|NCT00641316|100431746|FG000|STARTED|Overall Study||9||9
48046065|NCT00641316|100431747|FG001|STARTED|Overall Study||11||11
48046066|NCT00641316|100431748|FG002|STARTED|Overall Study||12||12
48046067|NCT00641316|100431749|FG003|STARTED|Overall Study||9||9
48046068|NCT00641316|100431746|FG000|COMPLETED|Overall Study||9||9
48046069|NCT00641316|100431747|FG001|COMPLETED|Overall Study||11||11
48046070|NCT00641316|100431748|FG002|COMPLETED|Overall Study||12||12
48046071|NCT00641316|100431749|FG003|COMPLETED|Overall Study||9||9
48046072|NCT00641316|100431746|FG000|NOT COMPLETED|Overall Study||0||0
48046073|NCT00641316|100431747|FG001|NOT COMPLETED|Overall Study||0||0
48046074|NCT00641316|100431748|FG002|NOT COMPLETED|Overall Study||0||0
48046075|NCT00641316|100431749|FG003|NOT COMPLETED|Overall Study||0||0
48046076|NCT01303003|100431750|FG000|STARTED|Overall Study||0||
48046077|NCT01303003|100431751|FG001|STARTED|Overall Study||0||
48046078|NCT01303003|100431750|FG000|COMPLETED|Overall Study||0||
48046079|NCT01303003|100431751|FG001|COMPLETED|Overall Study||0||
48046080|NCT01303003|100431750|FG000|NOT COMPLETED|Overall Study||0||
48046081|NCT01303003|100431751|FG001|NOT COMPLETED|Overall Study||0||
48046082|NCT02616601|100431752|FG000|STARTED|Overall Study||140||
48046083|NCT02616601|100431753|FG001|STARTED|Overall Study||140||
48046084|NCT02616601|100431754|FG002|STARTED|Overall Study||142||
48046085|NCT02616601|100431752|FG000|Safety Population|Overall Study||140|Randomized participants who received the study drug.|
48046086|NCT02616601|100431753|FG001|Safety Population|Overall Study||140|Randomized participants who received the study drug.|
48046087|NCT02616601|100431754|FG002|Safety Population|Overall Study||142|Randomized participants who received the study drug.|
48046088|NCT02616601|100431752|FG000|mITT Population|Overall Study||137|Randomized participants, applied ≥1 dose study drug, returned for ≥1 post-baseline evaluation visit|
48046089|NCT02616601|100431753|FG001|mITT Population|Overall Study||136|Randomized participants, applied ≥1 dose study drug, returned for ≥1 post-baseline evaluation visit|
48046090|NCT02616601|100431754|FG002|mITT Population|Overall Study||138|Randomized participants, applied ≥1 dose study drug, returned for ≥1 post-baseline evaluation visit|
48046091|NCT02616601|100431752|FG000|PP Population|Overall Study||112|mITT, \>75-125% doses and \>6 consecutive doses or discontinued for lack of treatment- completed ≥8wks|
48046092|NCT02616601|100431753|FG001|PP Population|Overall Study||121|mITT, \>75-125% doses and \>6 consecutive doses or discontinued for lack of treatment- completed ≥8wks|
48046093|NCT02616601|100431754|FG002|PP Population|Overall Study||123|mITT, \>75-125% doses and \>6 consecutive doses or discontinued for lack of treatment- completed ≥8wks|
48046094|NCT02616601|100431752|FG000|COMPLETED|Overall Study||131||
48046095|NCT02616601|100431753|FG001|COMPLETED|Overall Study||136||
48046096|NCT02616601|100431754|FG002|COMPLETED|Overall Study||135||
48046097|NCT02616601|100431752|FG000|NOT COMPLETED|Overall Study||9||
48046098|NCT02616601|100431753|FG001|NOT COMPLETED|Overall Study||4||
48046099|NCT02616601|100431754|FG002|NOT COMPLETED|Overall Study||7||
48046100|NCT00591578|100431755|FG000|STARTED|Double-Blind Treatment Phase||327||
48046101|NCT00591578|100431756|FG001|STARTED|Double-Blind Treatment Phase||329||
48046102|NCT00591578|100431757|FG002|STARTED|Double-Blind Treatment Phase||328||
48046103|NCT00591578|100431755|FG000|COMPLETED|Double-Blind Treatment Phase||249||
48046104|NCT00591578|100431756|FG001|COMPLETED|Double-Blind Treatment Phase||249||
48046105|NCT00591578|100431757|FG002|COMPLETED|Double-Blind Treatment Phase||244||
48046106|NCT00591578|100431755|FG000|NOT COMPLETED|Double-Blind Treatment Phase||78||
48046107|NCT00591578|100431756|FG001|NOT COMPLETED|Double-Blind Treatment Phase||80||
48046108|NCT00591578|100431757|FG002|NOT COMPLETED|Double-Blind Treatment Phase||84||
48046109|NCT00591578|100431755|FG000|STARTED|Open-Label Extension Phase||55||
48046110|NCT00591578|100431756|FG001|STARTED|Open-Label Extension Phase||115||
48046111|NCT00591578|100431757|FG002|STARTED|Open-Label Extension Phase||0||
48046112|NCT00591578|100431755|FG000|COMPLETED|Open-Label Extension Phase||49||
48046113|NCT00591578|100431756|FG001|COMPLETED|Open-Label Extension Phase||105||
48046114|NCT00591578|100431757|FG002|COMPLETED|Open-Label Extension Phase||0||
48046115|NCT00591578|100431755|FG000|NOT COMPLETED|Open-Label Extension Phase||6||
48046116|NCT00591578|100431756|FG001|NOT COMPLETED|Open-Label Extension Phase||10||
48046117|NCT00591578|100431757|FG002|NOT COMPLETED|Open-Label Extension Phase||0||
48046118|NCT03222492|100431758|FG000|STARTED|Overall Study||6||
48046119|NCT03222492|100431759|FG001|STARTED|Overall Study||2||
48046120|NCT03222492|100431760|FG002|STARTED|Overall Study||7||
48046121|NCT03222492|100431761|FG003|STARTED|Overall Study||2||
48046122|NCT03222492|100431758|FG000|COMPLETED|Overall Study||6||
48046123|NCT03222492|100431759|FG001|COMPLETED|Overall Study||2||
48046124|NCT03222492|100431760|FG002|COMPLETED|Overall Study||5||
48046125|NCT03222492|100431761|FG003|COMPLETED|Overall Study||2||
48046126|NCT03222492|100431758|FG000|NOT COMPLETED|Overall Study||0||
48046127|NCT03222492|100431759|FG001|NOT COMPLETED|Overall Study||0||
48046128|NCT03222492|100431760|FG002|NOT COMPLETED|Overall Study||2||
48046129|NCT03222492|100431761|FG003|NOT COMPLETED|Overall Study||0||
48046130|NCT00938886|100431762|FG000|STARTED|Overall Study||75||
48046131|NCT00938886|100431763|FG001|STARTED|Overall Study||75||
48046132|NCT00938886|100431762|FG000|Attended 1 Counseling Session|Overall Study||70||
48205618|NCT00326924|100827502|FG000|NOT COMPLETED|Overall Study||1||
48205619|NCT00326924|100827503|FG001|NOT COMPLETED|Overall Study||1||
48205620|NCT04439799|100827504|FG000|STARTED|Overall Study||41||
48205621|NCT04439799|100827505|FG001|STARTED|Overall Study||40||
48205622|NCT04439799|100827504|FG000|COMPLETED|Overall Study||31||
48205623|NCT04439799|100827505|FG001|COMPLETED|Overall Study||23||
48205624|NCT04439799|100827504|FG000|NOT COMPLETED|Overall Study||10||
48205625|NCT04439799|100827505|FG001|NOT COMPLETED|Overall Study||17||
48205626|NCT02808585|100827506|FG000|STARTED|Overall Study||3||
48046133|NCT00938886|100431763|FG001|Attended 1 Counseling Session|Overall Study||70||
48046134|NCT00938886|100431762|FG000|COMPLETED|Overall Study||68||
48046135|NCT00938886|100431763|FG001|COMPLETED|Overall Study||65||
48046136|NCT00938886|100431762|FG000|NOT COMPLETED|Overall Study||7||
48046137|NCT00938886|100431763|FG001|NOT COMPLETED|Overall Study||10||
48046138|NCT02589600|100431764|FG000|STARTED|Overall Study||154||
48046139|NCT02589600|100431765|FG001|STARTED|Overall Study||156||
48046140|NCT02589600|100431764|FG000|COMPLETED|Overall Study||101||
48046141|NCT02589600|100431765|FG001|COMPLETED|Overall Study||102||
48046142|NCT02589600|100431764|FG000|NOT COMPLETED|Overall Study||53||
48046143|NCT02589600|100431765|FG001|NOT COMPLETED|Overall Study||54||
48046144|NCT02165839|100431766|FG000|STARTED|Overall Study||66||
48046145|NCT02165839|100431767|FG001|STARTED|Overall Study||73||
48046146|NCT02165839|100431766|FG000|COMPLETED|Overall Study||66||
48046147|NCT02165839|100431767|FG001|COMPLETED|Overall Study||73||
48046148|NCT02165839|100431766|FG000|NOT COMPLETED|Overall Study||0||
48046149|NCT02165839|100431767|FG001|NOT COMPLETED|Overall Study||0||
48046150|NCT01903252|100431768|FG000|STARTED|Double-Blind Induction||409||
48046151|NCT01903252|100431769|FG001|STARTED|Double-Blind Induction||408||
48046152|NCT01903252|100431770|FG002|STARTED|Double-Blind Induction||0||
48046153|NCT01903252|100431771|FG003|STARTED|Double-Blind Induction||0||
48046154|NCT01903252|100431772|FG004|STARTED|Double-Blind Induction||0||
48046155|NCT01903252|100431773|FG005|STARTED|Double-Blind Induction||0||
48046156|NCT01903252|100431768|FG000|COMPLETED|Double-Blind Induction||370||
48046157|NCT01903252|100431769|FG001|COMPLETED|Double-Blind Induction||367||
48046158|NCT01903252|100431770|FG002|COMPLETED|Double-Blind Induction||0||
48046159|NCT01903252|100431771|FG003|COMPLETED|Double-Blind Induction||0||
48046160|NCT01903252|100431772|FG004|COMPLETED|Double-Blind Induction||0||
48046161|NCT01903252|100431773|FG005|COMPLETED|Double-Blind Induction||0||
48046162|NCT01903252|100431768|FG000|NOT COMPLETED|Double-Blind Induction||39||
48046163|NCT01903252|100431769|FG001|NOT COMPLETED|Double-Blind Induction||41||
48046164|NCT01903252|100431770|FG002|NOT COMPLETED|Double-Blind Induction||0||
48046165|NCT01903252|100431771|FG003|NOT COMPLETED|Double-Blind Induction||0||
48205627|NCT02808585|100827507|FG001|STARTED|Overall Study||6||
48205628|NCT02808585|100827508|FG002|STARTED|Overall Study||7||
48205629|NCT02808585|100827509|FG003|STARTED|Overall Study||6||
48205630|NCT02808585|100827510|FG004|STARTED|Overall Study||7||
48205631|NCT02808585|100827506|FG000|COMPLETED|Overall Study||3||
48205632|NCT02808585|100827507|FG001|COMPLETED|Overall Study||6||
48046166|NCT01903252|100431772|FG004|NOT COMPLETED|Double-Blind Induction||0||
48046167|NCT01903252|100431773|FG005|NOT COMPLETED|Double-Blind Induction||0||
48046168|NCT01903252|100431768|FG000|STARTED|Extended Induction, Open-Label||0|This treatment arm was only used in Period 1, double-blind induction phase.|
48046169|NCT01903252|100431769|FG001|STARTED|Extended Induction, Open-Label||0|This treatment arm was only used in Period 1, double-blind induction phase.|
48046170|NCT01903252|100431770|FG002|STARTED|Extended Induction, Open-Label||243|This treatment arm was only used in Period 1, double-blind induction phase.|
48046171|NCT01903252|100431771|FG003|STARTED|Extended Induction, Open-Label||0|This treatment arm was only used in Period 1, double-blind induction phase.|
48046172|NCT01903252|100431772|FG004|STARTED|Extended Induction, Open-Label||0|This treatment arm was only used in Period 1, double-blind induction phase.|
48046173|NCT01903252|100431773|FG005|STARTED|Extended Induction, Open-Label||0|This treatment arm was only used in Period 1, double-blind induction phase.|
48046174|NCT01903252|100431768|FG000|COMPLETED|Extended Induction, Open-Label||0||
48046175|NCT01903252|100431769|FG001|COMPLETED|Extended Induction, Open-Label||0||
48046176|NCT01903252|100431770|FG002|COMPLETED|Extended Induction, Open-Label||220||
48046177|NCT01903252|100431771|FG003|COMPLETED|Extended Induction, Open-Label||0||
48046178|NCT01903252|100431772|FG004|COMPLETED|Extended Induction, Open-Label||0||
48046179|NCT01903252|100431773|FG005|COMPLETED|Extended Induction, Open-Label||0||
48046180|NCT01903252|100431768|FG000|NOT COMPLETED|Extended Induction, Open-Label||0||
48046181|NCT01903252|100431769|FG001|NOT COMPLETED|Extended Induction, Open-Label||0||
48046182|NCT01903252|100431770|FG002|NOT COMPLETED|Extended Induction, Open-Label||23||
48046183|NCT01903252|100431771|FG003|NOT COMPLETED|Extended Induction, Open-Label||0||
48046184|NCT01903252|100431772|FG004|NOT COMPLETED|Extended Induction, Open-Label||0||
48046185|NCT01903252|100431773|FG005|NOT COMPLETED|Extended Induction, Open-Label||0||
48046186|NCT01903252|100431768|FG000|STARTED|Maintenance, Open-Label||0|"All patients received TP05, three diffrent daily doses:~1.6g, 3.2g, 4.8g"|
48046187|NCT01903252|100431769|FG001|STARTED|Maintenance, Open-Label||0|"All patients received TP05, three diffrent daily doses:~1.6g, 3.2g, 4.8g"|
48046188|NCT01903252|100431770|FG002|STARTED|Maintenance, Open-Label||0|"All patients received TP05, three diffrent daily doses:~1.6g, 3.2g, 4.8g"|
48046189|NCT01903252|100431771|FG003|STARTED|Maintenance, Open-Label||202|"All patients received TP05, three diffrent daily doses:~1.6g, 3.2g, 4.8g"|
48046190|NCT01903252|100431772|FG004|STARTED|Maintenance, Open-Label||274|"All patients received TP05, three diffrent daily doses:~1.6g, 3.2g, 4.8g"|
48046191|NCT01903252|100431773|FG005|STARTED|Maintenance, Open-Label||199|"All patients received TP05, three diffrent daily doses:~1.6g, 3.2g, 4.8g"|
48046192|NCT01903252|100431768|FG000|COMPLETED|Maintenance, Open-Label||0||
48046193|NCT01903252|100431769|FG001|COMPLETED|Maintenance, Open-Label||0||
48046194|NCT01903252|100431770|FG002|COMPLETED|Maintenance, Open-Label||0||
48046195|NCT01903252|100431771|FG003|COMPLETED|Maintenance, Open-Label||196||
48046196|NCT01903252|100431772|FG004|COMPLETED|Maintenance, Open-Label||253||
48046197|NCT01903252|100431773|FG005|COMPLETED|Maintenance, Open-Label||181||
48046198|NCT01903252|100431768|FG000|NOT COMPLETED|Maintenance, Open-Label||0||
48046199|NCT01903252|100431769|FG001|NOT COMPLETED|Maintenance, Open-Label||0||
48046200|NCT01903252|100431770|FG002|NOT COMPLETED|Maintenance, Open-Label||0||
48046201|NCT01903252|100431771|FG003|NOT COMPLETED|Maintenance, Open-Label||6||
48046202|NCT01903252|100431772|FG004|NOT COMPLETED|Maintenance, Open-Label||21||
48046203|NCT01903252|100431773|FG005|NOT COMPLETED|Maintenance, Open-Label||18||
48046204|NCT04250077|100431774|FG000|STARTED|Overall Study||15||
48046205|NCT04250077|100431775|FG001|STARTED|Overall Study||15||
48046206|NCT04250077|100431776|FG002|STARTED|Overall Study||15||
48046207|NCT04250077|100431774|FG000|COMPLETED|Overall Study||13||
48046208|NCT04250077|100431775|FG001|COMPLETED|Overall Study||11||
48046209|NCT04250077|100431776|FG002|COMPLETED|Overall Study||15||
48046210|NCT04250077|100431774|FG000|NOT COMPLETED|Overall Study||2||
48046211|NCT04250077|100431775|FG001|NOT COMPLETED|Overall Study||4||
48046212|NCT04250077|100431776|FG002|NOT COMPLETED|Overall Study||0||
48046213|NCT01371032|100431777|FG000|STARTED|Overall Study||14||
48046214|NCT01371032|100431778|FG001|STARTED|Overall Study||14||
48046215|NCT01371032|100431777|FG000|COMPLETED|Overall Study||14||
48046216|NCT01371032|100431778|FG001|COMPLETED|Overall Study||14||
48046217|NCT01371032|100431777|FG000|NOT COMPLETED|Overall Study||0||
48046218|NCT01371032|100431778|FG001|NOT COMPLETED|Overall Study||0||
48046219|NCT00783302|100431779|FG000|STARTED|Overall Study||885||
48046220|NCT00783302|100431779|FG000|COMPLETED|Overall Study||850||
48046221|NCT00783302|100431779|FG000|NOT COMPLETED|Overall Study||35||
48046222|NCT05672667|100431780|FG000|STARTED|Overall Study||25||
48046223|NCT05672667|100431780|FG000|COMPLETED|Overall Study||24||
48046224|NCT05672667|100431780|FG000|NOT COMPLETED|Overall Study||1||
48046225|NCT02195011|100431781|FG000|STARTED|Overall Study||25||
48046226|NCT02195011|100431782|FG001|STARTED|Overall Study||1||
48046227|NCT02195011|100431781|FG000|COMPLETED|Overall Study||0||
48046228|NCT02195011|100431782|FG001|COMPLETED|Overall Study||0||
48205633|NCT02808585|100827508|FG002|COMPLETED|Overall Study||6||
48046229|NCT02195011|100431781|FG000|NOT COMPLETED|Overall Study||25||
48205634|NCT02808585|100827509|FG003|COMPLETED|Overall Study||4||
48205635|NCT02808585|100827510|FG004|COMPLETED|Overall Study||7||
48205636|NCT02808585|100827506|FG000|NOT COMPLETED|Overall Study||0||
48205637|NCT02808585|100827507|FG001|NOT COMPLETED|Overall Study||0||
48205638|NCT02808585|100827508|FG002|NOT COMPLETED|Overall Study||1||
48205639|NCT02808585|100827509|FG003|NOT COMPLETED|Overall Study||2||
48046230|NCT02195011|100431782|FG001|NOT COMPLETED|Overall Study||1||
48046231|NCT00217464|100431783|FG000|STARTED|Overall Study||17||
48046232|NCT00217464|100431783|FG000|COMPLETED|Overall Study||0||
48046233|NCT00217464|100431783|FG000|NOT COMPLETED|Overall Study||17||
48046234|NCT02412488|100431784|FG000|STARTED|Overall Study||192||
48046235|NCT02412488|100431784|FG000|Reveal LINQ Implanted|Overall Study||191||
48046236|NCT02412488|100431784|FG000|COMPLETED|Overall Study||174||
48046237|NCT02412488|100431784|FG000|NOT COMPLETED|Overall Study||18||
48046238|NCT01998984|100431785|FG000|STARTED|Overall Study||55||
48046239|NCT01998984|100431786|FG001|STARTED|Overall Study||59||
48046240|NCT01998984|100431787|FG002|STARTED|Overall Study||49||
48046241|NCT01998984|100431788|FG003|STARTED|Overall Study||61||
48046242|NCT01998984|100431785|FG000|COMPLETED|Overall Study||55||
48046243|NCT01998984|100431786|FG001|COMPLETED|Overall Study||58||
48046244|NCT01998984|100431787|FG002|COMPLETED|Overall Study||48||
48046245|NCT01998984|100431788|FG003|COMPLETED|Overall Study||58||
48046246|NCT01998984|100431785|FG000|NOT COMPLETED|Overall Study||0||
48046247|NCT01998984|100431786|FG001|NOT COMPLETED|Overall Study||1||
48046248|NCT01998984|100431787|FG002|NOT COMPLETED|Overall Study||1||
48046249|NCT01998984|100431788|FG003|NOT COMPLETED|Overall Study||3||
48046250|NCT01145638|100434664|FG000|STARTED|Overall Study||231||
48046251|NCT01145638|100434665|FG001|STARTED|Overall Study||119||
48046252|NCT01145638|100434664|FG000|COMPLETED|Overall Study||141||
48046253|NCT01145638|100434665|FG001|COMPLETED|Overall Study||62||
48046254|NCT01145638|100434664|FG000|NOT COMPLETED|Overall Study||90||
48046255|NCT01145638|100434665|FG001|NOT COMPLETED|Overall Study||57||
48046256|NCT04507373|100434666|FG000|STARTED|Overall Study||0||
48046257|NCT04507373|100434667|FG001|STARTED|Overall Study||0||
48046258|NCT04507373|100434666|FG000|COMPLETED|Overall Study||0||
48046259|NCT04507373|100434667|FG001|COMPLETED|Overall Study||0||
48046260|NCT04507373|100434666|FG000|NOT COMPLETED|Overall Study||0||
48046261|NCT04507373|100434667|FG001|NOT COMPLETED|Overall Study||0||
48046262|NCT01227824|100434668|FG000|STARTED|Double-blind Phase: 96 Weeks Duration||411||
48046263|NCT01227824|100434669|FG001|STARTED|Double-blind Phase: 96 Weeks Duration||411||
48046264|NCT01227824|100434670|FG002|STARTED|Double-blind Phase: 96 Weeks Duration||0||
48046265|NCT01227824|100434668|FG000|COMPLETED|Double-blind Phase: 96 Weeks Duration||304||
48046266|NCT01227824|100434669|FG001|COMPLETED|Double-blind Phase: 96 Weeks Duration||332||
48046267|NCT01227824|100434670|FG002|COMPLETED|Double-blind Phase: 96 Weeks Duration||0||
48046268|NCT01227824|100434668|FG000|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||107||
48046269|NCT01227824|100434669|FG001|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||79||
48046270|NCT01227824|100434670|FG002|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||0||
48046271|NCT01227824|100434668|FG000|STARTED|Open-label Phase: Median of 1267 Days||0||
48046272|NCT01227824|100434669|FG001|STARTED|Open-label Phase: Median of 1267 Days||0||
48046273|NCT01227824|100434670|FG002|STARTED|Open-label Phase: Median of 1267 Days||338||
48046274|NCT01227824|100434668|FG000|COMPLETED|Open-label Phase: Median of 1267 Days||0||
48046275|NCT01227824|100434669|FG001|COMPLETED|Open-label Phase: Median of 1267 Days||0||
48046276|NCT01227824|100434670|FG002|COMPLETED|Open-label Phase: Median of 1267 Days||294||
48046277|NCT01227824|100434668|FG000|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0||
48046278|NCT01227824|100434669|FG001|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0||
48046279|NCT01227824|100434670|FG002|NOT COMPLETED|Open-label Phase: Median of 1267 Days||44||
48046280|NCT02747433|100434671|FG000|STARTED|Overall Study||5||
48046281|NCT02747433|100434672|FG001|STARTED|Overall Study||5||
48046282|NCT02747433|100434671|FG000|COMPLETED|Overall Study||5||
48205640|NCT02808585|100827510|FG004|NOT COMPLETED|Overall Study||0||
48205641|NCT02261467|100827511|FG000|STARTED|Overall Study||101||
48205642|NCT02261467|100827512|FG001|STARTED|Overall Study||290||
48205643|NCT02261467|100827511|FG000|COMPLETED|Overall Study||80||
48205644|NCT02261467|100827512|FG001|COMPLETED|Overall Study||253||
48205645|NCT02261467|100827511|FG000|NOT COMPLETED|Overall Study||21||
48205646|NCT02261467|100827512|FG001|NOT COMPLETED|Overall Study||37||
48205647|NCT00102063|100827513|FG000|STARTED|Overall Study||100||
48205648|NCT00102063|100827514|FG001|STARTED|Overall Study||102||
48046283|NCT02747433|100434672|FG001|COMPLETED|Overall Study||5||
48205649|NCT00102063|100827515|FG002|STARTED|Overall Study||100||
48205650|NCT00102063|100827513|FG000|COMPLETED|Overall Study||84||
48205651|NCT00102063|100827514|FG001|COMPLETED|Overall Study||84||
48046284|NCT02747433|100434671|FG000|NOT COMPLETED|Overall Study||0||
48046285|NCT02747433|100434672|FG001|NOT COMPLETED|Overall Study||0||
48046286|NCT01476202|100434673|FG000|STARTED|Overall Study||40||
48046287|NCT01476202|100434674|FG001|STARTED|Overall Study||40||
48205652|NCT00102063|100827515|FG002|COMPLETED|Overall Study||90||
48205653|NCT00102063|100827513|FG000|NOT COMPLETED|Overall Study||16||
48046288|NCT01476202|100434675|FG002|STARTED|Overall Study||40||
48046289|NCT01476202|100434673|FG000|COMPLETED|Overall Study||40||
48046290|NCT01476202|100434674|FG001|COMPLETED|Overall Study||40||
48046291|NCT01476202|100434675|FG002|COMPLETED|Overall Study||40||
48046292|NCT01476202|100434673|FG000|NOT COMPLETED|Overall Study||0||
48046293|NCT01476202|100434674|FG001|NOT COMPLETED|Overall Study||0||
48046294|NCT01476202|100434675|FG002|NOT COMPLETED|Overall Study||0||
48205654|NCT00102063|100827514|FG001|NOT COMPLETED|Overall Study||18||
48205655|NCT00102063|100827515|FG002|NOT COMPLETED|Overall Study||10||
48046295|NCT01027273|100434676|FG000|STARTED|Overall Study||301||
48046296|NCT01027273|100434677|FG001|STARTED|Overall Study||299||
48046297|NCT01027273|100434676|FG000|COMPLETED|Overall Study||242||
48046298|NCT01027273|100434677|FG001|COMPLETED|Overall Study||266||
48046299|NCT01027273|100434676|FG000|NOT COMPLETED|Overall Study||59||
48046300|NCT01027273|100434677|FG001|NOT COMPLETED|Overall Study||33||
48046301|NCT03189381|100434678|FG000|STARTED|Overall Study||20||
48046302|NCT03189381|100434679|FG001|STARTED|Overall Study||0||
48046303|NCT03189381|100434678|FG000|COMPLETED|Overall Study||19||
48046304|NCT03189381|100434679|FG001|COMPLETED|Overall Study||0||
48046305|NCT03189381|100434678|FG000|NOT COMPLETED|Overall Study||1||
48046306|NCT03189381|100434679|FG001|NOT COMPLETED|Overall Study||0||
48046307|NCT00348933|100434680|FG000|STARTED|Overall Study||90||
48046308|NCT00348933|100434680|FG000|COMPLETED|Overall Study||65||
48046309|NCT00348933|100434680|FG000|NOT COMPLETED|Overall Study||25||
48046310|NCT01514786|100434681|FG000|STARTED|Overall Study||286||
48046311|NCT01514786|100434682|FG001|STARTED|Overall Study||284||
48046312|NCT01514786|100434681|FG000|COMPLETED|Overall Study||286||
48046313|NCT01514786|100434682|FG001|COMPLETED|Overall Study||284||
48046314|NCT01514786|100434681|FG000|NOT COMPLETED|Overall Study||0||
48046315|NCT01514786|100434682|FG001|NOT COMPLETED|Overall Study||0||
48046316|NCT02106923|100434683|FG000|STARTED|Overall Study||12||
48046317|NCT02106923|100434684|FG001|STARTED|Overall Study||12||
48046318|NCT02106923|100434685|FG002|STARTED|Overall Study||12||
48046319|NCT02106923|100434686|FG003|STARTED|Overall Study||12||
48046320|NCT02106923|100434687|FG004|STARTED|Overall Study||12||
48046321|NCT02106923|100434688|FG005|STARTED|Overall Study||12||
48046322|NCT02106923|100434683|FG000|COMPLETED|Overall Study||12||
48046323|NCT02106923|100434684|FG001|COMPLETED|Overall Study||12||
48046324|NCT02106923|100434685|FG002|COMPLETED|Overall Study||12||
48046325|NCT02106923|100434686|FG003|COMPLETED|Overall Study||12||
48046326|NCT02106923|100434687|FG004|COMPLETED|Overall Study||12||
48046327|NCT02106923|100434688|FG005|COMPLETED|Overall Study||11||
48046328|NCT02106923|100434683|FG000|NOT COMPLETED|Overall Study||0||
48046329|NCT02106923|100434684|FG001|NOT COMPLETED|Overall Study||0||
48046330|NCT02106923|100434685|FG002|NOT COMPLETED|Overall Study||0||
48046331|NCT02106923|100434686|FG003|NOT COMPLETED|Overall Study||0||
48046332|NCT02106923|100434687|FG004|NOT COMPLETED|Overall Study||0||
48046333|NCT02106923|100434688|FG005|NOT COMPLETED|Overall Study||1||
48046334|NCT01640327|100434689|FG000|STARTED|Overall Study||63||
48046335|NCT01640327|100434690|FG001|STARTED|Overall Study||63||
48046336|NCT01640327|100434689|FG000|COMPLETED|Overall Study||63||
48046337|NCT01640327|100434690|FG001|COMPLETED|Overall Study||63||
48046338|NCT01640327|100434689|FG000|NOT COMPLETED|Overall Study||0||
48046339|NCT01640327|100434690|FG001|NOT COMPLETED|Overall Study||0||
48046340|NCT01565343|100434691|FG000|STARTED|Overall Study||11||
48046341|NCT01565343|100434692|FG001|STARTED|Overall Study||4||
48046342|NCT01565343|100434693|FG002|STARTED|Overall Study||10||
48046343|NCT01565343|100434691|FG000|COMPLETED|Overall Study||10||
48046344|NCT01565343|100434692|FG001|COMPLETED|Overall Study||4||
48046345|NCT01565343|100434693|FG002|COMPLETED|Overall Study||10||
48046346|NCT01565343|100434691|FG000|NOT COMPLETED|Overall Study||1||
48046347|NCT01565343|100434692|FG001|NOT COMPLETED|Overall Study||0||
48046348|NCT01565343|100434693|FG002|NOT COMPLETED|Overall Study||0||
48046349|NCT01820260|100434694|FG000|STARTED|Phase 1 (Part 1)||3||
48046350|NCT01820260|100434695|FG001|STARTED|Phase 1 (Part 1)||12||
48046351|NCT01820260|100434696|FG002|STARTED|Phase 1 (Part 1)||10||
48046352|NCT01820260|100434697|FG003|STARTED|Phase 1 (Part 1)||12||
48046353|NCT01820260|100434698|FG004|STARTED|Phase 1 (Part 1)||12||
48046354|NCT01820260|100434699|FG005|STARTED|Phase 1 (Part 1)||10||
48046355|NCT01820260|100434700|FG006|STARTED|Phase 1 (Part 1)||12||
48046356|NCT01820260|100434701|FG007|STARTED|Phase 1 (Part 1)||11||
48046357|NCT01820260|100434702|FG008|STARTED|Phase 1 (Part 1)||0||
48046358|NCT01820260|100434703|FG009|STARTED|Phase 1 (Part 1)||0||
48046359|NCT01820260|100434704|FG010|STARTED|Phase 1 (Part 1)||0||
48046360|NCT01820260|100434705|FG011|STARTED|Phase 1 (Part 1)||0||
48046361|NCT01820260|100434706|FG012|STARTED|Phase 1 (Part 1)||0||
48046362|NCT01820260|100434707|FG013|STARTED|Phase 1 (Part 1)||0||
48046363|NCT01820260|100434694|FG000|COMPLETED|Phase 1 (Part 1)||3||
48046364|NCT01820260|100434695|FG001|COMPLETED|Phase 1 (Part 1)||12||
48046365|NCT01820260|100434696|FG002|COMPLETED|Phase 1 (Part 1)||10||
48046366|NCT01820260|100434697|FG003|COMPLETED|Phase 1 (Part 1)||12||
48046367|NCT01820260|100434698|FG004|COMPLETED|Phase 1 (Part 1)||12||
48046368|NCT01820260|100434699|FG005|COMPLETED|Phase 1 (Part 1)||10||
48046369|NCT01820260|100434700|FG006|COMPLETED|Phase 1 (Part 1)||11||
48046370|NCT01820260|100434701|FG007|COMPLETED|Phase 1 (Part 1)||11||
48046371|NCT01820260|100434702|FG008|COMPLETED|Phase 1 (Part 1)||0||
48046372|NCT01820260|100434703|FG009|COMPLETED|Phase 1 (Part 1)||0||
48046373|NCT01820260|100434704|FG010|COMPLETED|Phase 1 (Part 1)||0||
48046374|NCT01820260|100434705|FG011|COMPLETED|Phase 1 (Part 1)||0||
48046375|NCT01820260|100434706|FG012|COMPLETED|Phase 1 (Part 1)||0||
48046376|NCT01820260|100434707|FG013|COMPLETED|Phase 1 (Part 1)||0||
48046377|NCT01820260|100434694|FG000|NOT COMPLETED|Phase 1 (Part 1)||0||
48046378|NCT01820260|100434695|FG001|NOT COMPLETED|Phase 1 (Part 1)||0||
48046379|NCT01820260|100434696|FG002|NOT COMPLETED|Phase 1 (Part 1)||0||
48046380|NCT01820260|100434697|FG003|NOT COMPLETED|Phase 1 (Part 1)||0||
48046381|NCT01820260|100434698|FG004|NOT COMPLETED|Phase 1 (Part 1)||0||
48046382|NCT01820260|100434699|FG005|NOT COMPLETED|Phase 1 (Part 1)||0||
48046383|NCT01820260|100434700|FG006|NOT COMPLETED|Phase 1 (Part 1)||1||
48046384|NCT01820260|100434701|FG007|NOT COMPLETED|Phase 1 (Part 1)||0||
48046385|NCT01820260|100434702|FG008|NOT COMPLETED|Phase 1 (Part 1)||0||
48046386|NCT01820260|100434703|FG009|NOT COMPLETED|Phase 1 (Part 1)||0||
48046387|NCT01820260|100434704|FG010|NOT COMPLETED|Phase 1 (Part 1)||0||
48046388|NCT01820260|100434705|FG011|NOT COMPLETED|Phase 1 (Part 1)||0||
48046389|NCT01820260|100434706|FG012|NOT COMPLETED|Phase 1 (Part 1)||0||
48046390|NCT01820260|100434707|FG013|NOT COMPLETED|Phase 1 (Part 1)||0||
48046391|NCT01820260|100434694|FG000|STARTED|Phase 2 (Part 2)||0||
48046392|NCT01820260|100434695|FG001|STARTED|Phase 2 (Part 2)||0||
48046393|NCT01820260|100434696|FG002|STARTED|Phase 2 (Part 2)||0||
48046394|NCT01820260|100434697|FG003|STARTED|Phase 2 (Part 2)||0||
48046395|NCT01820260|100434698|FG004|STARTED|Phase 2 (Part 2)||0||
48046396|NCT01820260|100434699|FG005|STARTED|Phase 2 (Part 2)||0||
48046397|NCT01820260|100434700|FG006|STARTED|Phase 2 (Part 2)||0||
48046398|NCT01820260|100434701|FG007|STARTED|Phase 2 (Part 2)||0||
48046399|NCT01820260|100434702|FG008|STARTED|Phase 2 (Part 2)||64||
48046400|NCT01820260|100434703|FG009|STARTED|Phase 2 (Part 2)||62||
48205656|NCT01063036|100827516|FG000|STARTED|Participants Treated With Study Drug||92||
48205657|NCT01063036|100827516|FG000|COMPLETED|Participants Treated With Study Drug||86||
48205658|NCT01063036|100827516|FG000|NOT COMPLETED|Participants Treated With Study Drug||6||
48046401|NCT01820260|100434704|FG010|STARTED|Phase 2 (Part 2)||61||
48046402|NCT01820260|100434705|FG011|STARTED|Phase 2 (Part 2)||64||
48046403|NCT01820260|100434706|FG012|STARTED|Phase 2 (Part 2)||31||
48046404|NCT01820260|100434707|FG013|STARTED|Phase 2 (Part 2)||31||
48046405|NCT01820260|100434694|FG000|COMPLETED|Phase 2 (Part 2)||0||
48046406|NCT01820260|100434695|FG001|COMPLETED|Phase 2 (Part 2)||0||
48046407|NCT01820260|100434696|FG002|COMPLETED|Phase 2 (Part 2)||0||
48046408|NCT01820260|100434697|FG003|COMPLETED|Phase 2 (Part 2)||0||
48046409|NCT01820260|100434698|FG004|COMPLETED|Phase 2 (Part 2)||0||
48046410|NCT01820260|100434699|FG005|COMPLETED|Phase 2 (Part 2)||0||
48046411|NCT01820260|100434700|FG006|COMPLETED|Phase 2 (Part 2)||0||
48046412|NCT01820260|100434701|FG007|COMPLETED|Phase 2 (Part 2)||0||
48046413|NCT01820260|100434702|FG008|COMPLETED|Phase 2 (Part 2)||64||
48046414|NCT01820260|100434703|FG009|COMPLETED|Phase 2 (Part 2)||61||
48046415|NCT01820260|100434704|FG010|COMPLETED|Phase 2 (Part 2)||61||
48046416|NCT01820260|100434705|FG011|COMPLETED|Phase 2 (Part 2)||64||
48046417|NCT01820260|100434706|FG012|COMPLETED|Phase 2 (Part 2)||31||
48046418|NCT01820260|100434707|FG013|COMPLETED|Phase 2 (Part 2)||31||
48046419|NCT01820260|100434694|FG000|NOT COMPLETED|Phase 2 (Part 2)||0||
48046420|NCT01820260|100434695|FG001|NOT COMPLETED|Phase 2 (Part 2)||0||
48046421|NCT01820260|100434696|FG002|NOT COMPLETED|Phase 2 (Part 2)||0||
48046422|NCT01820260|100434697|FG003|NOT COMPLETED|Phase 2 (Part 2)||0||
48046423|NCT01820260|100434698|FG004|NOT COMPLETED|Phase 2 (Part 2)||0||
48046424|NCT01820260|100434699|FG005|NOT COMPLETED|Phase 2 (Part 2)||0||
48046425|NCT01820260|100434700|FG006|NOT COMPLETED|Phase 2 (Part 2)||0||
48046426|NCT01820260|100434701|FG007|NOT COMPLETED|Phase 2 (Part 2)||0||
48046427|NCT01820260|100434702|FG008|NOT COMPLETED|Phase 2 (Part 2)||0||
48046428|NCT01820260|100434703|FG009|NOT COMPLETED|Phase 2 (Part 2)||1||
48205659|NCT01063036|100827516|FG000|STARTED|Post Dosing Follow-up Through 24 Weeks||85||
48495433|NCT01808651|101547847|FG002|COMPLETED|Study Period 1||31||
48046429|NCT01820260|100434704|FG010|NOT COMPLETED|Phase 2 (Part 2)||0||
48046430|NCT01820260|100434705|FG011|NOT COMPLETED|Phase 2 (Part 2)||0||
48046431|NCT01820260|100434706|FG012|NOT COMPLETED|Phase 2 (Part 2)||0||
48046432|NCT01820260|100434707|FG013|NOT COMPLETED|Phase 2 (Part 2)||0||
48046433|NCT00130442|100434708|FG000|STARTED|Overall Study||66||
48046434|NCT00130442|100434709|FG001|STARTED|Overall Study||68||
48046435|NCT00130442|100434708|FG000|COMPLETED|Overall Study||65||
48046436|NCT00130442|100434709|FG001|COMPLETED|Overall Study||66||
48046437|NCT00130442|100434708|FG000|NOT COMPLETED|Overall Study||1||
48046438|NCT00130442|100434709|FG001|NOT COMPLETED|Overall Study||2||
48046439|NCT03271983|100434710|FG000|STARTED|Overall Study||7||
48046440|NCT03271983|100434710|FG000|COMPLETED|Overall Study||7||
48205660|NCT01063036|100827516|FG000|COMPLETED|Post Dosing Follow-up Through 24 Weeks||46||
48205661|NCT01063036|100827516|FG000|NOT COMPLETED|Post Dosing Follow-up Through 24 Weeks||39||
48205662|NCT02205307|100827517|FG000|STARTED|Overall Study||178||
48046441|NCT03271983|100434710|FG000|NOT COMPLETED|Overall Study||0||
48046442|NCT01146860|100434711|FG000|STARTED|Overall Study||194||
48046443|NCT01146860|100434712|FG001|STARTED|Overall Study||192||
48046444|NCT01146860|100434711|FG000|COMPLETED|Overall Study||194||
48046445|NCT01146860|100434712|FG001|COMPLETED|Overall Study||191||
48046446|NCT01146860|100434711|FG000|NOT COMPLETED|Overall Study||0||
48046447|NCT01146860|100434712|FG001|NOT COMPLETED|Overall Study||1||
48046448|NCT00555425|100434713|FG000|STARTED|Overall Study||57||
48046449|NCT00555425|100434714|FG001|STARTED|Overall Study||56||
48046450|NCT00555425|100434713|FG000|COMPLETED|Overall Study||6||
48046451|NCT00555425|100434714|FG001|COMPLETED|Overall Study||37||
48046452|NCT00555425|100434713|FG000|NOT COMPLETED|Overall Study||51||
48046453|NCT00555425|100434714|FG001|NOT COMPLETED|Overall Study||19||
48046454|NCT02057042|100434715|FG000|STARTED|Overall Study||163||
48046455|NCT02057042|100434716|FG001|STARTED|Overall Study||167||
48046456|NCT02057042|100434715|FG000|COMPLETED|Overall Study||118||
48046457|NCT02057042|100434716|FG001|COMPLETED|Overall Study||101||
48046458|NCT02057042|100434715|FG000|NOT COMPLETED|Overall Study||45||
48046459|NCT02057042|100434716|FG001|NOT COMPLETED|Overall Study||66||
48046460|NCT02068768|100434717|FG000|STARTED|Overall Study||13||
48046461|NCT02068768|100434717|FG000|COMPLETED|Overall Study||6||
48046462|NCT02068768|100434717|FG000|NOT COMPLETED|Overall Study||7||
48046463|NCT00829985|100434718|FG000|STARTED|Overall Study||28||
48046464|NCT00829985|100434719|FG001|STARTED|Overall Study||26||
48046465|NCT00829985|100434718|FG000|COMPLETED|Overall Study||19||
48046466|NCT00829985|100434719|FG001|COMPLETED|Overall Study||22||
48046467|NCT00829985|100434718|FG000|NOT COMPLETED|Overall Study||9||
48046468|NCT00829985|100434719|FG001|NOT COMPLETED|Overall Study||4||
48046469|NCT01155479|100434720|FG000|STARTED|Part I||204||
48046470|NCT01155479|100434721|FG001|STARTED|Part I||204||
48046471|NCT01155479|100434722|FG002|STARTED|Part I||206||
48046472|NCT01155479|100434723|FG003|STARTED|Part I||204||
48046473|NCT01155479|100434724|FG004|STARTED|Part I||204||
48046474|NCT01155479|100434720|FG000|Treated|Part I||200||
48046475|NCT01155479|100434721|FG001|Treated|Part I||202||
48046476|NCT01155479|100434722|FG002|Treated|Part I||204||
48046477|NCT01155479|100434723|FG003|Treated|Part I||198||
48046478|NCT01155479|100434724|FG004|Treated|Part I||203||
48046479|NCT01155479|100434720|FG000|COMPLETED|Part I||166||
48046480|NCT01155479|100434721|FG001|COMPLETED|Part I||177||
48046481|NCT01155479|100434722|FG002|COMPLETED|Part I||167||
48046482|NCT01155479|100434723|FG003|COMPLETED|Part I||177||
48046483|NCT01155479|100434724|FG004|COMPLETED|Part I||181||
48046484|NCT01155479|100434720|FG000|NOT COMPLETED|Part I||38||
48046485|NCT01155479|100434721|FG001|NOT COMPLETED|Part I||27||
48046486|NCT01155479|100434722|FG002|NOT COMPLETED|Part I||39||
48046487|NCT01155479|100434723|FG003|NOT COMPLETED|Part I||27||
48046488|NCT01155479|100434724|FG004|NOT COMPLETED|Part I||23||
48046489|NCT01155479|100434720|FG000|STARTED|Part II||166||
48046490|NCT01155479|100434721|FG001|STARTED|Part II||177||
48046491|NCT01155479|100434722|FG002|STARTED|Part II||167||
48046492|NCT01155479|100434723|FG003|STARTED|Part II||177||
48046493|NCT01155479|100434724|FG004|STARTED|Part II||181||
48046494|NCT01155479|100434720|FG000|COMPLETED|Part II||107||
48046495|NCT01155479|100434721|FG001|COMPLETED|Part II||116||
48046496|NCT01155479|100434722|FG002|COMPLETED|Part II||109||
48046497|NCT01155479|100434723|FG003|COMPLETED|Part II||127||
48046498|NCT01155479|100434724|FG004|COMPLETED|Part II||126||
48046499|NCT01155479|100434720|FG000|NOT COMPLETED|Part II||59||
48046500|NCT01155479|100434721|FG001|NOT COMPLETED|Part II||61||
48046501|NCT01155479|100434722|FG002|NOT COMPLETED|Part II||58||
48046502|NCT01155479|100434723|FG003|NOT COMPLETED|Part II||50||
48046503|NCT01155479|100434724|FG004|NOT COMPLETED|Part II||55||
48046504|NCT01544088|100434725|FG000|STARTED|Overall Study||98||
48046505|NCT01544088|100434726|FG001|STARTED|Overall Study||100||
48046506|NCT01544088|100434725|FG000|COMPLETED|Overall Study||61||
48046507|NCT01544088|100434726|FG001|COMPLETED|Overall Study||79||
48046508|NCT01544088|100434725|FG000|NOT COMPLETED|Overall Study||37||
48046509|NCT01544088|100434726|FG001|NOT COMPLETED|Overall Study||21||
48046510|NCT01119937|100434727|FG000|STARTED|Overall Study||123||
48046511|NCT01119937|100434728|FG001|STARTED|Overall Study||40||
48046512|NCT01119937|100434727|FG000|COMPLETED|Overall Study||104||
48046513|NCT01119937|100434728|FG001|COMPLETED|Overall Study||33||
48046514|NCT01119937|100434727|FG000|NOT COMPLETED|Overall Study||19||
48046515|NCT01119937|100434728|FG001|NOT COMPLETED|Overall Study||7||
48046516|NCT00409175|100434729|FG000|STARTED|Overall Study||65||
48046517|NCT00409175|100434730|FG001|STARTED|Overall Study||63||
48046518|NCT00409175|100434729|FG000|COMPLETED|Overall Study||47||
48046519|NCT00409175|100434730|FG001|COMPLETED|Overall Study||44||
48046520|NCT00409175|100434729|FG000|NOT COMPLETED|Overall Study||18||
48046521|NCT00409175|100434730|FG001|NOT COMPLETED|Overall Study||19||
48046522|NCT00924170|100434731|FG000|STARTED|Overall Study||10||
48046523|NCT00924170|100434732|FG001|STARTED|Overall Study||8||
48046524|NCT00924170|100434731|FG000|COMPLETED|Overall Study||3||
48046525|NCT00924170|100434732|FG001|COMPLETED|Overall Study||0||
48046526|NCT00924170|100434731|FG000|NOT COMPLETED|Overall Study||7||
48046527|NCT00924170|100434732|FG001|NOT COMPLETED|Overall Study||8||
48046528|NCT01879579|100434733|FG000|STARTED|Overall Study||33||
48046529|NCT01879579|100434734|FG001|STARTED|Overall Study||28||
48046530|NCT01879579|100434733|FG000|COMPLETED|Overall Study||28||
48046531|NCT01879579|100434734|FG001|COMPLETED|Overall Study||26||
48046532|NCT01879579|100434733|FG000|NOT COMPLETED|Overall Study||5||
48046533|NCT01879579|100434734|FG001|NOT COMPLETED|Overall Study||2||
48046534|NCT00718237|100434735|FG000|STARTED|Overall Study||381||
48046535|NCT00718237|100434736|FG001|STARTED|Overall Study||381||
48046536|NCT00718237|100434735|FG000|Vaccinated at Visit 1|Overall Study||380||
48046537|NCT00718237|100434736|FG001|Vaccinated at Visit 1|Overall Study||381||
48046538|NCT00718237|100434735|FG000|Vaccinated at Visit 2|Overall Study||373||
48046539|NCT00718237|100434736|FG001|Vaccinated at Visit 2|Overall Study||374||
48046540|NCT00718237|100434735|FG000|Vaccinated at Visit 3|Overall Study||371||
48046541|NCT00718237|100434736|FG001|Vaccinated at Visit 3|Overall Study||369||
48046542|NCT00718237|100434735|FG000|COMPLETED|Overall Study||368||
48046543|NCT00718237|100434736|FG001|COMPLETED|Overall Study||366||
48046544|NCT00718237|100434735|FG000|NOT COMPLETED|Overall Study||13||
48046545|NCT00718237|100434736|FG001|NOT COMPLETED|Overall Study||15||
48046546|NCT00635024|100434737|FG000|STARTED|Overall Study||1||
48046547|NCT00635024|100434737|FG000|COMPLETED|Overall Study||0||
48046548|NCT00635024|100434737|FG000|NOT COMPLETED|Overall Study||1||
48046549|NCT00459056|100434738|FG000|STARTED|First Intervention (First Three Months)||10||
48046550|NCT00459056|100434739|FG001|STARTED|First Intervention (First Three Months)||15||
48046551|NCT00459056|100434738|FG000|COMPLETED|First Intervention (First Three Months)||9||
48046552|NCT00459056|100434739|FG001|COMPLETED|First Intervention (First Three Months)||14||
48046553|NCT00459056|100434738|FG000|NOT COMPLETED|First Intervention (First Three Months)||1||
48046554|NCT00459056|100434739|FG001|NOT COMPLETED|First Intervention (First Three Months)||1||
48046555|NCT00459056|100434738|FG000|STARTED|Washout (1 Month)||9||
48205663|NCT02205307|100827518|FG001|STARTED|Overall Study||169||
48205664|NCT02205307|100827517|FG000|COMPLETED|Overall Study||161||
48205665|NCT02205307|100827518|FG001|COMPLETED|Overall Study||163||
48205666|NCT02205307|100827517|FG000|NOT COMPLETED|Overall Study||17||
48205667|NCT02205307|100827518|FG001|NOT COMPLETED|Overall Study||6||
48205668|NCT03615924|100827519|FG000|STARTED|Overall Study||101|Randomized to treatment.|
48205669|NCT03615924|100827520|FG001|STARTED|Overall Study||92|Randomized to treatment.|
48205670|NCT03615924|100827519|FG000|Received Treatment|Overall Study||101||
48205671|NCT03615924|100827520|FG001|Received Treatment|Overall Study||92||
48205672|NCT03615924|100827519|FG000|COMPLETED|Overall Study||0|Completed the study.|
48205673|NCT03615924|100827520|FG001|COMPLETED|Overall Study||0|Completed the study.|
48205674|NCT03615924|100827519|FG000|NOT COMPLETED|Overall Study||101||
48205675|NCT03615924|100827520|FG001|NOT COMPLETED|Overall Study||92||
48205676|NCT02712099|100827521|FG000|STARTED|Overall Study||30||
48205677|NCT02712099|100827522|FG001|STARTED|Overall Study||20||
48205678|NCT02712099|100827521|FG000|COMPLETED|Overall Study||30||
48205679|NCT02712099|100827522|FG001|COMPLETED|Overall Study||20||
48205680|NCT02712099|100827521|FG000|NOT COMPLETED|Overall Study||0||
48205681|NCT02712099|100827522|FG001|NOT COMPLETED|Overall Study||0||
48495434|NCT01808651|101547845|FG000|NOT COMPLETED|Study Period 1||26||
48046556|NCT00459056|100434739|FG001|STARTED|Washout (1 Month)||14||
48046557|NCT00459056|100434738|FG000|COMPLETED|Washout (1 Month)||9||
48046558|NCT00459056|100434739|FG001|COMPLETED|Washout (1 Month)||14||
48046559|NCT00459056|100434738|FG000|NOT COMPLETED|Washout (1 Month)||0||
48046560|NCT00459056|100434739|FG001|NOT COMPLETED|Washout (1 Month)||0||
48046561|NCT00459056|100434738|FG000|STARTED|Second Intervention (Final Three Months)||9||
48046562|NCT00459056|100434739|FG001|STARTED|Second Intervention (Final Three Months)||14||
48046563|NCT00459056|100434738|FG000|COMPLETED|Second Intervention (Final Three Months)||9||
48046564|NCT00459056|100434739|FG001|COMPLETED|Second Intervention (Final Three Months)||14||
48046565|NCT00459056|100434738|FG000|NOT COMPLETED|Second Intervention (Final Three Months)||0||
48046566|NCT00459056|100434739|FG001|NOT COMPLETED|Second Intervention (Final Three Months)||0||
48046567|NCT00534469|100434740|FG000|STARTED|Overall Study||52||
48046568|NCT00534469|100434740|FG000|COMPLETED|Overall Study||52||
48046569|NCT00534469|100434740|FG000|NOT COMPLETED|Overall Study||0||
48046570|NCT00969280|100434741|FG000|STARTED|Overall Study||21||
48046571|NCT00969280|100434742|FG001|STARTED|Overall Study||21||
48046572|NCT00969280|100434741|FG000|COMPLETED|Overall Study||19||
48046573|NCT00969280|100434742|FG001|COMPLETED|Overall Study||18||
48046574|NCT00969280|100434741|FG000|NOT COMPLETED|Overall Study||2||
48046575|NCT00969280|100434742|FG001|NOT COMPLETED|Overall Study||3||
48046576|NCT00584740|100434743|FG000|STARTED|Overall Study||39||
48046577|NCT00584740|100434744|FG001|STARTED|Overall Study||20||
48046578|NCT00584740|100434743|FG000|COMPLETED|Overall Study||27||
48046579|NCT00584740|100434744|FG001|COMPLETED|Overall Study||14||
48205682|NCT02957539|100827523|FG000|STARTED|Baseline to Week 16||73||
48205683|NCT02957539|100827524|FG001|STARTED|Baseline to Week 16||91||
48205684|NCT02957539|100827525|FG002|STARTED|Baseline to Week 16||87||
48205685|NCT02957539|100827523|FG000|COMPLETED|Baseline to Week 16||51||
48205686|NCT02957539|100827524|FG001|COMPLETED|Baseline to Week 16||77||
48205687|NCT02957539|100827525|FG002|COMPLETED|Baseline to Week 16||66||
48205688|NCT02957539|100827523|FG000|NOT COMPLETED|Baseline to Week 16||22||
48046580|NCT00584740|100434743|FG000|NOT COMPLETED|Overall Study||12||
48046581|NCT00584740|100434744|FG001|NOT COMPLETED|Overall Study||6||
48046582|NCT00870233|100434745|FG000|STARTED|Overall Study||120||
48046583|NCT00870233|100434745|FG000|COMPLETED|Overall Study||96||
48046584|NCT00870233|100434745|FG000|NOT COMPLETED|Overall Study||24||
48205689|NCT02957539|100827524|FG001|NOT COMPLETED|Baseline to Week 16||14||
48205690|NCT02957539|100827525|FG002|NOT COMPLETED|Baseline to Week 16||21||
48495435|NCT01808651|101547846|FG001|NOT COMPLETED|Study Period 1||17||
48046585|NCT00256282|100434746|FG000|STARTED|Overall Study||52||
48046586|NCT00256282|100434746|FG000|COMPLETED|Overall Study||36||
48046587|NCT00256282|100434746|FG000|NOT COMPLETED|Overall Study||16||
48046588|NCT01246466|100434747|FG000|STARTED|Overall Study||24||
48046589|NCT01246466|100434747|FG000|COMPLETED|Overall Study||22||
48046590|NCT01246466|100434747|FG000|NOT COMPLETED|Overall Study||2||
48046591|NCT00645710|100434748|FG000|STARTED|Overall Study||3||
48046592|NCT00645710|100434749|FG001|STARTED|Overall Study||3||
48046593|NCT00645710|100434750|FG002|STARTED|Overall Study||10||
48046594|NCT00645710|100434748|FG000|COMPLETED|Overall Study||3||
48046595|NCT00645710|100434749|FG001|COMPLETED|Overall Study||3||
48046596|NCT00645710|100434750|FG002|COMPLETED|Overall Study||10||
48046597|NCT00645710|100434748|FG000|NOT COMPLETED|Overall Study||0||
48046598|NCT00645710|100434749|FG001|NOT COMPLETED|Overall Study||0||
48046599|NCT00645710|100434750|FG002|NOT COMPLETED|Overall Study||0||
48046600|NCT01847131|100434751|FG000|STARTED|Overall Study||25||
48046601|NCT01847131|100434752|FG001|STARTED|Overall Study||25||
48046602|NCT01847131|100434751|FG000|COMPLETED|Overall Study||25||
48046603|NCT01847131|100434752|FG001|COMPLETED|Overall Study||25||
48046604|NCT01847131|100434751|FG000|NOT COMPLETED|Overall Study||0||
48046605|NCT01847131|100434752|FG001|NOT COMPLETED|Overall Study||0||
48046606|NCT04601454|100434753|FG000|STARTED|Overall Study||57||
48046607|NCT04601454|100434753|FG000|Completed Per Protocol at the 12 Month Visit|Overall Study||27||
48046608|NCT04601454|100434753|FG000|COMPLETED|Overall Study||32||
48046609|NCT04601454|100434753|FG000|NOT COMPLETED|Overall Study||25||
48046610|NCT04140227|100434754|FG000|STARTED|Overall Study||256||
48046611|NCT04140227|100434754|FG000|COMPLETED|Overall Study||208||
48046612|NCT04140227|100434754|FG000|NOT COMPLETED|Overall Study||48||
48046613|NCT02871882|100434755|FG000|STARTED|Overall Study||11||
48046614|NCT02871882|100434756|FG001|STARTED|Overall Study||12||
48046615|NCT02871882|100434755|FG000|COMPLETED|Overall Study||11||
48046616|NCT02871882|100434756|FG001|COMPLETED|Overall Study||12||
48046617|NCT02871882|100434755|FG000|NOT COMPLETED|Overall Study||0||
48046618|NCT02871882|100434756|FG001|NOT COMPLETED|Overall Study||0||
48046619|NCT02324543|100434757|FG000|STARTED|Overall Study||6||
48046620|NCT02324543|100434758|FG001|STARTED|Overall Study||6||
48046621|NCT02324543|100434759|FG002|STARTED|Overall Study||3||
48046622|NCT02324543|100434760|FG003|STARTED|Overall Study||4||
48046623|NCT02324543|100434761|FG004|STARTED|Overall Study||4||
48046624|NCT02324543|100434762|FG005|STARTED|Overall Study||24||
48046625|NCT02324543|100434757|FG000|COMPLETED|Overall Study||6||
48046626|NCT02324543|100434758|FG001|COMPLETED|Overall Study||6||
48046627|NCT02324543|100434759|FG002|COMPLETED|Overall Study||3||
48046628|NCT02324543|100434760|FG003|COMPLETED|Overall Study||4||
48046629|NCT02324543|100434761|FG004|COMPLETED|Overall Study||4||
48046630|NCT02324543|100434762|FG005|COMPLETED|Overall Study||24||
48046631|NCT02324543|100434757|FG000|NOT COMPLETED|Overall Study||0||
48046632|NCT02324543|100434758|FG001|NOT COMPLETED|Overall Study||0||
48205691|NCT02957539|100827523|FG000|STARTED|Week 16 to 32||51||
48205692|NCT02957539|100827524|FG001|STARTED|Week 16 to 32||77||
48205693|NCT02957539|100827525|FG002|STARTED|Week 16 to 32||66||
48046633|NCT02324543|100434759|FG002|NOT COMPLETED|Overall Study||0||
48046634|NCT02324543|100434760|FG003|NOT COMPLETED|Overall Study||0||
48046635|NCT02324543|100434761|FG004|NOT COMPLETED|Overall Study||0||
48046636|NCT02324543|100434762|FG005|NOT COMPLETED|Overall Study||0||
48046637|NCT01659554|100434763|FG000|STARTED|Overall Study||4||
48046638|NCT01659554|100434763|FG000|COMPLETED|Overall Study||0||
48046639|NCT01659554|100434763|FG000|NOT COMPLETED|Overall Study||4||
48046640|NCT02320903|100434764|FG000|STARTED|Overall Study||24||
48046641|NCT02320903|100434765|FG001|STARTED|Overall Study||32||
48046642|NCT02320903|100434766|FG002|STARTED|Overall Study||32||
48046643|NCT02320903|100434764|FG000|COMPLETED|Overall Study||16||
48046644|NCT02320903|100434765|FG001|COMPLETED|Overall Study||16||
48046645|NCT02320903|100434766|FG002|COMPLETED|Overall Study||16||
48046646|NCT02320903|100434764|FG000|NOT COMPLETED|Overall Study||8||
48046647|NCT02320903|100434765|FG001|NOT COMPLETED|Overall Study||16||
48046648|NCT02320903|100434766|FG002|NOT COMPLETED|Overall Study||16||
48046649|NCT00570232|100434767|FG000|STARTED|Overall Study||31||
48046650|NCT00570232|100434767|FG000|COMPLETED|Overall Study||8||
48046651|NCT00570232|100434767|FG000|NOT COMPLETED|Overall Study||23||
48046652|NCT02230527|100434768|FG000|STARTED|Overall Study||23||
48046653|NCT02230527|100434769|FG001|STARTED|Overall Study||23||
48046654|NCT02230527|100434768|FG000|COMPLETED|Overall Study||18||
48046655|NCT02230527|100434769|FG001|COMPLETED|Overall Study||21||
48205694|NCT02957539|100827523|FG000|COMPLETED|Week 16 to 32||40||
48046656|NCT02230527|100434768|FG000|NOT COMPLETED|Overall Study||5||
48046657|NCT02230527|100434769|FG001|NOT COMPLETED|Overall Study||2||
48046658|NCT04240678|100434770|FG000|STARTED|Overall Study||4141||
48046659|NCT04240678|100434771|FG001|STARTED|Overall Study||4158||
48046660|NCT04240678|100434770|FG000|COMPLETED|Overall Study||4141||
48046661|NCT04240678|100434771|FG001|COMPLETED|Overall Study||4158||
48046662|NCT04240678|100434770|FG000|NOT COMPLETED|Overall Study||0||
48046663|NCT04240678|100434771|FG001|NOT COMPLETED|Overall Study||0||
48046664|NCT03390101|100434772|FG000|STARTED|Weeks 0-12||85||
48046665|NCT03390101|100434773|FG001|STARTED|Weeks 0-12||84||
48046666|NCT03390101|100434774|FG002|STARTED|Weeks 0-12||44||
48046667|NCT03390101|100434772|FG000|COMPLETED|Weeks 0-12||85||
48046668|NCT03390101|100434773|FG001|COMPLETED|Weeks 0-12||82||
48046669|NCT03390101|100434774|FG002|COMPLETED|Weeks 0-12||43||
48046670|NCT03390101|100434772|FG000|NOT COMPLETED|Weeks 0-12||0||
48046671|NCT03390101|100434773|FG001|NOT COMPLETED|Weeks 0-12||2||
48046672|NCT03390101|100434774|FG002|NOT COMPLETED|Weeks 0-12||1||
48046673|NCT03390101|100434772|FG000|STARTED|Weeks 12-54||85||
48046674|NCT03390101|100434773|FG001|STARTED|Weeks 12-54||82||
48046675|NCT03390101|100434774|FG002|STARTED|Weeks 12-54||43||
48046676|NCT03390101|100434772|FG000|COMPLETED|Weeks 12-54||82||
48046677|NCT03390101|100434773|FG001|COMPLETED|Weeks 12-54||78||
48046678|NCT03390101|100434774|FG002|COMPLETED|Weeks 12-54||41||
48046679|NCT03390101|100434772|FG000|NOT COMPLETED|Weeks 12-54||3||
48046680|NCT03390101|100434773|FG001|NOT COMPLETED|Weeks 12-54||4||
48046681|NCT03390101|100434774|FG002|NOT COMPLETED|Weeks 12-54||2||
48046682|NCT01653132|100434775|FG000|STARTED|First Intervention||5||
48046683|NCT01653132|100434776|FG001|STARTED|First Intervention||5||
48046684|NCT01653132|100434775|FG000|COMPLETED|First Intervention||4||
48046685|NCT01653132|100434776|FG001|COMPLETED|First Intervention||5||
48046686|NCT01653132|100434775|FG000|NOT COMPLETED|First Intervention||1||
48046687|NCT01653132|100434776|FG001|NOT COMPLETED|First Intervention||0||
48046688|NCT01653132|100434775|FG000|STARTED|Washout 1-2 Months||4||
48046689|NCT01653132|100434776|FG001|STARTED|Washout 1-2 Months||5||
48046690|NCT01653132|100434775|FG000|COMPLETED|Washout 1-2 Months||4||
48046691|NCT01653132|100434776|FG001|COMPLETED|Washout 1-2 Months||5||
48046692|NCT01653132|100434775|FG000|NOT COMPLETED|Washout 1-2 Months||0||
48046693|NCT01653132|100434776|FG001|NOT COMPLETED|Washout 1-2 Months||0||
48046694|NCT01653132|100434775|FG000|STARTED|Second Intervention||4||
48046695|NCT01653132|100434776|FG001|STARTED|Second Intervention||5||
48046696|NCT01653132|100434775|FG000|COMPLETED|Second Intervention||4||
48046697|NCT01653132|100434776|FG001|COMPLETED|Second Intervention||5||
48046698|NCT01653132|100434775|FG000|NOT COMPLETED|Second Intervention||0||
48046699|NCT01653132|100434776|FG001|NOT COMPLETED|Second Intervention||0||
48046700|NCT00484185|100434777|FG000|STARTED|Overall Study||183||
48046701|NCT00484185|100434777|FG000|Treated|Overall Study||178||
48046702|NCT00484185|100434777|FG000|COMPLETED|Overall Study||112||
48046703|NCT00484185|100434777|FG000|NOT COMPLETED|Overall Study||71||
48046704|NCT03442868|100434778|FG000|STARTED|Overall Study||15||
48046705|NCT03442868|100434778|FG000|COMPLETED|Overall Study||15||
48046706|NCT03442868|100434778|FG000|NOT COMPLETED|Overall Study||0||
48046707|NCT02273739|100434779|FG000|STARTED|Overall Study||3||
48046708|NCT02273739|100434780|FG001|STARTED|Overall Study||4||
48046709|NCT02273739|100434781|FG002|STARTED|Overall Study||7||
48046710|NCT02273739|100434782|FG003|STARTED|Overall Study||7||
48046711|NCT02273739|100434779|FG000|COMPLETED|Overall Study||0|Participants ongoing treatment|
48046712|NCT02273739|100434780|FG001|COMPLETED|Overall Study||0|Participants ongoing treatment|
48046713|NCT02273739|100434781|FG002|COMPLETED|Overall Study||0|Participants ongoing treatment|
48046714|NCT02273739|100434782|FG003|COMPLETED|Overall Study||0|Participants ongoing treatment|
48046715|NCT02273739|100434779|FG000|NOT COMPLETED|Overall Study||3||
48046716|NCT02273739|100434780|FG001|NOT COMPLETED|Overall Study||4||
48046717|NCT02273739|100434781|FG002|NOT COMPLETED|Overall Study||7||
48046718|NCT02273739|100434782|FG003|NOT COMPLETED|Overall Study||7||
48046719|NCT00817479|100434783|FG000|STARTED|Overall Study||6||
48046720|NCT00817479|100434784|FG001|STARTED|Overall Study||14||
48046721|NCT00817479|100434783|FG000|COMPLETED|Overall Study||5||
48046722|NCT00817479|100434784|FG001|COMPLETED|Overall Study||13||
48046723|NCT00817479|100434783|FG000|NOT COMPLETED|Overall Study||1||
48046724|NCT00817479|100434784|FG001|NOT COMPLETED|Overall Study||1||
48046725|NCT04739865|100434785|FG000|STARTED|Overall Study||19||
48046726|NCT04739865|100434785|FG000|COMPLETED|Overall Study||19||
48046727|NCT04739865|100434785|FG000|NOT COMPLETED|Overall Study||0||
48046728|NCT00134784|100434786|FG000|STARTED|Overall Study||29||
48046729|NCT00134784|100434787|FG001|STARTED|Overall Study||38||
48046730|NCT00134784|100434788|FG002|STARTED|Overall Study||37||
48046731|NCT00134784|100434789|FG003|STARTED|Overall Study||38||
48046732|NCT00134784|100434786|FG000|COMPLETED|Overall Study||27||
48046733|NCT00134784|100434787|FG001|COMPLETED|Overall Study||36||
48046734|NCT00134784|100434788|FG002|COMPLETED|Overall Study||35||
48046735|NCT00134784|100434789|FG003|COMPLETED|Overall Study||37||
48046736|NCT00134784|100434786|FG000|NOT COMPLETED|Overall Study||2||
48046737|NCT00134784|100434787|FG001|NOT COMPLETED|Overall Study||2||
48046738|NCT00134784|100434788|FG002|NOT COMPLETED|Overall Study||2||
48046739|NCT00134784|100434789|FG003|NOT COMPLETED|Overall Study||1||
48046740|NCT03513848|100434790|FG000|STARTED|Overall Study||9||
48046741|NCT03513848|100434791|FG001|STARTED|Overall Study||6||
48205695|NCT02957539|100827524|FG001|COMPLETED|Week 16 to 32||67||
48205696|NCT02957539|100827525|FG002|COMPLETED|Week 16 to 32||60||
48046742|NCT03513848|100434790|FG000|COMPLETED|Overall Study||9||
48046743|NCT03513848|100434791|FG001|COMPLETED|Overall Study||6||
48046744|NCT03513848|100434790|FG000|NOT COMPLETED|Overall Study||0||
48046745|NCT03513848|100434791|FG001|NOT COMPLETED|Overall Study||0||
48046746|NCT03835728|100434792|FG000|STARTED|Overall Study||2||
48046747|NCT03835728|100434793|FG001|STARTED|Overall Study||1||
48046748|NCT03835728|100434792|FG000|COMPLETED|Overall Study||2|Completed is defined as completing study procedures according to protocol even if the participant met primary endpoint and discontinued prior to 12 months.|
48046749|NCT03835728|100434793|FG001|COMPLETED|Overall Study||1|Completed is defined as completing study procedures according to protocol even if the participant met primary endpoint and discontinued prior to 12 months.|
48046750|NCT03835728|100434792|FG000|NOT COMPLETED|Overall Study||0||
48046751|NCT03835728|100434793|FG001|NOT COMPLETED|Overall Study||0||
48205697|NCT02957539|100827523|FG000|NOT COMPLETED|Week 16 to 32||11||
48205698|NCT02957539|100827524|FG001|NOT COMPLETED|Week 16 to 32||10||
48046752|NCT01367080|100434794|FG000|STARTED|1st Administration||6||
48046753|NCT01367080|100434795|FG001|STARTED|1st Administration||6||
48046754|NCT01367080|100434794|FG000|COMPLETED|1st Administration||6||
48205699|NCT02957539|100827525|FG002|NOT COMPLETED|Week 16 to 32||6||
48205700|NCT02957539|100827523|FG000|STARTED|Week 32 to Week 52||40||
48205701|NCT02957539|100827524|FG001|STARTED|Week 32 to Week 52||67||
48205702|NCT02957539|100827525|FG002|STARTED|Week 32 to Week 52||60||
48205703|NCT02957539|100827523|FG000|COMPLETED|Week 32 to Week 52||29||
48205704|NCT02957539|100827524|FG001|COMPLETED|Week 32 to Week 52||50||
48046755|NCT01367080|100434795|FG001|COMPLETED|1st Administration||6||
48046756|NCT01367080|100434794|FG000|NOT COMPLETED|1st Administration||0||
48046757|NCT01367080|100434795|FG001|NOT COMPLETED|1st Administration||0||
48046758|NCT01367080|100434794|FG000|STARTED|2nd Administration||6||
48046759|NCT01367080|100434795|FG001|STARTED|2nd Administration||6||
48046760|NCT01367080|100434794|FG000|COMPLETED|2nd Administration||6||
48205705|NCT02957539|100827525|FG002|COMPLETED|Week 32 to Week 52||33||
48205706|NCT02957539|100827523|FG000|NOT COMPLETED|Week 32 to Week 52||11||
48205707|NCT02957539|100827524|FG001|NOT COMPLETED|Week 32 to Week 52||17||
48205708|NCT02957539|100827525|FG002|NOT COMPLETED|Week 32 to Week 52||27||
48205709|NCT03691428|100827526|FG000|STARTED|Overall Study||48||
48205710|NCT03691428|100827527|FG001|STARTED|Overall Study||42||
48205711|NCT03691428|100827526|FG000|COMPLETED|Overall Study||42||
48205712|NCT03691428|100827527|FG001|COMPLETED|Overall Study||34||
48205713|NCT03691428|100827526|FG000|NOT COMPLETED|Overall Study||6||
48205714|NCT03691428|100827527|FG001|NOT COMPLETED|Overall Study||8||
48205715|NCT01883908|100827528|FG000|STARTED|Overall Study||3||
48205716|NCT01883908|100827529|FG001|STARTED|Overall Study||1||
48205717|NCT01883908|100827528|FG000|COMPLETED|Overall Study||3||
48205718|NCT01883908|100827529|FG001|COMPLETED|Overall Study||1||
48205719|NCT01883908|100827528|FG000|NOT COMPLETED|Overall Study||0||
48205720|NCT01883908|100827529|FG001|NOT COMPLETED|Overall Study||0||
48205721|NCT03941912|100827530|FG000|STARTED|Overall Study||44||
48205722|NCT03941912|100827530|FG000|COMPLETED|Overall Study||44||
48205723|NCT03941912|100827530|FG000|NOT COMPLETED|Overall Study||0||
48205724|NCT03597100|100827531|FG000|STARTED|Overall Study||263||
48205725|NCT03597100|100827531|FG000|COMPLETED|Overall Study||205||
48205726|NCT03597100|100827531|FG000|NOT COMPLETED|Overall Study||58||
48046761|NCT01367080|100434795|FG001|COMPLETED|2nd Administration||6||
48046762|NCT01367080|100434794|FG000|NOT COMPLETED|2nd Administration||0||
48046763|NCT01367080|100434795|FG001|NOT COMPLETED|2nd Administration||0||
48046764|NCT01126671|100434796|FG000|STARTED|Overall Study||26||
48046765|NCT01126671|100434797|FG001|STARTED|Overall Study||30||
48046766|NCT01126671|100434796|FG000|COMPLETED|Overall Study||24||
48046767|NCT01126671|100434797|FG001|COMPLETED|Overall Study||29||
48046768|NCT01126671|100434796|FG000|NOT COMPLETED|Overall Study||2||
48046769|NCT01126671|100434797|FG001|NOT COMPLETED|Overall Study||1||
48046770|NCT02483533|100434798|FG000|STARTED|Overall Study||50|Lack of efficacy - not completed|
48046771|NCT02483533|100434799|FG001|STARTED|Overall Study||50|Lack of efficacy - not completed|
48046772|NCT02483533|100434798|FG000|COMPLETED|Overall Study||0|Lack of efficacy - not completed|
48046773|NCT02483533|100434799|FG001|COMPLETED|Overall Study||0|Lack of efficacy - not completed|
48046774|NCT02483533|100434798|FG000|NOT COMPLETED|Overall Study||50||
48046775|NCT02483533|100434799|FG001|NOT COMPLETED|Overall Study||50||
48046776|NCT00706849|100434800|FG000|STARTED|Treatment Period||41||
48046777|NCT00706849|100434801|FG001|STARTED|Treatment Period||83||
48046778|NCT00706849|100434800|FG000|Full Analysis Set|Treatment Period||41||
48046779|NCT00706849|100434801|FG001|Full Analysis Set|Treatment Period||82||
48046780|NCT00706849|100434800|FG000|COMPLETED|Treatment Period||41||
48046781|NCT00706849|100434801|FG001|COMPLETED|Treatment Period||73||
48046782|NCT00706849|100434800|FG000|NOT COMPLETED|Treatment Period||0||
48046783|NCT00706849|100434801|FG001|NOT COMPLETED|Treatment Period||10||
48046784|NCT00706849|100434800|FG000|STARTED|Follow-up Period||3||
48046785|NCT00706849|100434801|FG001|STARTED|Follow-up Period||28||
48046786|NCT00706849|100434800|FG000|COMPLETED|Follow-up Period||3||
48046787|NCT00706849|100434801|FG001|COMPLETED|Follow-up Period||25||
48046788|NCT00706849|100434800|FG000|NOT COMPLETED|Follow-up Period||0||
48046789|NCT00706849|100434801|FG001|NOT COMPLETED|Follow-up Period||3||
48046790|NCT00740051|100434802|FG000|STARTED|Overall Study||76||
48046791|NCT00740051|100434803|FG001|STARTED|Overall Study||151||
48046792|NCT00740051|100434802|FG000|COMPLETED|Overall Study||58||
48046793|NCT00740051|100434803|FG001|COMPLETED|Overall Study||119||
48046794|NCT00740051|100434802|FG000|NOT COMPLETED|Overall Study||18||
48046795|NCT00740051|100434803|FG001|NOT COMPLETED|Overall Study||32||
48046796|NCT03705273|100434804|FG000|STARTED|Overall Study||20||
48046797|NCT03705273|100434805|FG001|STARTED|Overall Study||20||
48046798|NCT03705273|100434804|FG000|COMPLETED|Overall Study||20||
48046799|NCT03705273|100434805|FG001|COMPLETED|Overall Study||20||
48046800|NCT03705273|100434804|FG000|NOT COMPLETED|Overall Study||0||
48046801|NCT03705273|100434805|FG001|NOT COMPLETED|Overall Study||0||
48046802|NCT02274038|100434806|FG000|STARTED|Overall Study||3||
48046803|NCT02274038|100434806|FG000|COMPLETED|Overall Study||2||
48046804|NCT02274038|100434806|FG000|NOT COMPLETED|Overall Study||1||
48046805|NCT02484859|100434807|FG000|STARTED|Overall Study||44||
48046806|NCT02484859|100434808|FG001|STARTED|Overall Study||44||
48046807|NCT02484859|100434807|FG000|COMPLETED|Overall Study||44||
48046808|NCT02484859|100434808|FG001|COMPLETED|Overall Study||44||
48046809|NCT02484859|100434807|FG000|NOT COMPLETED|Overall Study||0||
48046810|NCT02484859|100434808|FG001|NOT COMPLETED|Overall Study||0||
48046811|NCT01224782|100434809|FG000|STARTED|Overall Study||994||
48046812|NCT01224782|100434809|FG000|COMPLETED|Overall Study||730||
48046813|NCT01224782|100434809|FG000|NOT COMPLETED|Overall Study||264||
48046814|NCT01505647|100434810|FG000|STARTED|Day 1 Through Day 42 Follow-up||332||
48046815|NCT01505647|100434811|FG001|STARTED|Day 1 Through Day 42 Follow-up||166||
48046816|NCT01505647|100434810|FG000|Vaccinated|Day 1 Through Day 42 Follow-up||331||
48205727|NCT04707313|100827532|FG000|STARTED|Cohorts 1 and 2(Week 1 - Week 26)||71||
48205728|NCT04707313|100827533|FG001|STARTED|Cohorts 1 and 2(Week 1 - Week 26)||62||
48205729|NCT04707313|100827534|FG002|STARTED|Cohorts 1 and 2(Week 1 - Week 26)||64||
48205730|NCT04707313|100827535|FG003|STARTED|Cohorts 1 and 2(Week 1 - Week 26)||64||
48205731|NCT04707313|100827536|FG004|STARTED|Cohorts 1 and 2(Week 1 - Week 26)||38||
48046817|NCT01505647|100434811|FG001|Vaccinated|Day 1 Through Day 42 Follow-up||166||
48046818|NCT01505647|100434810|FG000|COMPLETED|Day 1 Through Day 42 Follow-up||329||
48046819|NCT01505647|100434811|FG001|COMPLETED|Day 1 Through Day 42 Follow-up||166||
48046820|NCT01505647|100434810|FG000|NOT COMPLETED|Day 1 Through Day 42 Follow-up||3||
48046821|NCT01505647|100434811|FG001|NOT COMPLETED|Day 1 Through Day 42 Follow-up||0||
48046822|NCT01505647|100434810|FG000|STARTED|Day 43 Through Day 182 Follow-up||329||
48046823|NCT01505647|100434811|FG001|STARTED|Day 43 Through Day 182 Follow-up||166||
48046824|NCT01505647|100434810|FG000|COMPLETED|Day 43 Through Day 182 Follow-up||328||
48046825|NCT01505647|100434811|FG001|COMPLETED|Day 43 Through Day 182 Follow-up||163||
48046826|NCT01505647|100434810|FG000|NOT COMPLETED|Day 43 Through Day 182 Follow-up||1||
48046827|NCT01505647|100434811|FG001|NOT COMPLETED|Day 43 Through Day 182 Follow-up||3||
48046828|NCT01781169|100434812|FG000|STARTED|Overall Study||22||
48046829|NCT01781169|100434813|FG001|STARTED|Overall Study||21||
48046830|NCT01781169|100434812|FG000|COMPLETED|Overall Study||21||
48046831|NCT01781169|100434813|FG001|COMPLETED|Overall Study||21||
48046832|NCT01781169|100434812|FG000|NOT COMPLETED|Overall Study||1||
48046833|NCT01781169|100434813|FG001|NOT COMPLETED|Overall Study||0||
48046834|NCT01910311|100434814|FG000|STARTED|Period 1 (Days 1-2)||18||
48046835|NCT01910311|100434814|FG000|Received Baricitinib|Period 1 (Days 1-2)||18||
48046836|NCT01910311|100434814|FG000|COMPLETED|Period 1 (Days 1-2)||18||
48046837|NCT01910311|100434814|FG000|NOT COMPLETED|Period 1 (Days 1-2)||0||
48046838|NCT01910311|100434814|FG000|STARTED|Period 2 (Days 3-32)||18||
48046839|NCT01910311|100434814|FG000|Received Baricitinib|Period 2 (Days 3-32)||18||
48046840|NCT01910311|100434814|FG000|Received At Least 1 Dose of Rifampicin|Period 2 (Days 3-32)||18||
48046841|NCT01910311|100434814|FG000|COMPLETED|Period 2 (Days 3-32)||18||
48046842|NCT01910311|100434814|FG000|NOT COMPLETED|Period 2 (Days 3-32)||0||
48046843|NCT03794882|100434815|FG000|STARTED|Overall Study||8||
48046844|NCT03794882|100434816|FG001|STARTED|Overall Study||6||
48046845|NCT03794882|100434815|FG000|COMPLETED|Overall Study||8||
48046846|NCT03794882|100434816|FG001|COMPLETED|Overall Study||6||
48046847|NCT03794882|100434815|FG000|NOT COMPLETED|Overall Study||0||
48046848|NCT03794882|100434816|FG001|NOT COMPLETED|Overall Study||0||
48046849|NCT03044574|100434817|FG000|STARTED|Overall Study||204||
48046850|NCT03044574|100434818|FG001|STARTED|Overall Study||203||
48046851|NCT03044574|100434817|FG000|Inpatient Period|Overall Study||204||
48046852|NCT03044574|100434818|FG001|Inpatient Period|Overall Study||203||
48046853|NCT03044574|100434817|FG000|30 Days After Surgery|Overall Study||193||
48046854|NCT03044574|100434818|FG001|30 Days After Surgery|Overall Study||194||
48046855|NCT03044574|100434817|FG000|180 Days After Surgery|Overall Study||167||
48046856|NCT03044574|100434818|FG001|180 Days After Surgery|Overall Study||158||
48046857|NCT03044574|100434817|FG000|COMPLETED|Overall Study||167||
48046858|NCT03044574|100434818|FG001|COMPLETED|Overall Study||158||
48046859|NCT03044574|100434817|FG000|NOT COMPLETED|Overall Study||37||
48046860|NCT03044574|100434818|FG001|NOT COMPLETED|Overall Study||45||
48046861|NCT02128100|100434819|FG000|STARTED|Overall Study||5||
48046862|NCT02128100|100434819|FG000|COMPLETED|Overall Study||5||
48046863|NCT02128100|100434819|FG000|NOT COMPLETED|Overall Study||0||
48046864|NCT00480987|100434820|FG000|STARTED|Overall Study||27||
48046865|NCT00480987|100434820|FG000|COMPLETED|Overall Study||27||
48046866|NCT00480987|100434820|FG000|NOT COMPLETED|Overall Study||0||
48046867|NCT04461600|100434821|FG000|STARTED|Overall Study||12||
48046868|NCT04461600|100434822|FG001|STARTED|Overall Study||6||
48046869|NCT04461600|100434821|FG000|COMPLETED|Overall Study||6||
48046870|NCT04461600|100434822|FG001|COMPLETED|Overall Study||0||
48046871|NCT04461600|100434821|FG000|NOT COMPLETED|Overall Study||6||
48046872|NCT04461600|100434822|FG001|NOT COMPLETED|Overall Study||6||
48046873|NCT02777749|100434823|FG000|STARTED|Overall Study||53||
48046874|NCT02777749|100434824|FG001|STARTED|Overall Study||51||
48046875|NCT02777749|100434825|FG002|STARTED|Overall Study||51||
48046876|NCT02777749|100434823|FG000|COMPLETED|Overall Study||53||
48046877|NCT02777749|100434824|FG001|COMPLETED|Overall Study||51||
48046878|NCT02777749|100434825|FG002|COMPLETED|Overall Study||51||
48046879|NCT02777749|100434823|FG000|NOT COMPLETED|Overall Study||0||
48205732|NCT04707313|100827537|FG005|STARTED|Cohorts 1 and 2(Week 1 - Week 26)||63||
48205733|NCT04707313|100827538|FG006|STARTED|Cohorts 1 and 2(Week 1 - Week 26)||37||
48205734|NCT04707313|100827539|FG007|STARTED|Cohorts 1 and 2(Week 1 - Week 26)||64||
48205735|NCT04707313|100827540|FG008|STARTED|Cohorts 1 and 2(Week 1 - Week 26)||36||
48205736|NCT04707313|100827541|FG009|STARTED|Cohorts 1 and 2(Week 1 - Week 26)||0||
48205737|NCT04707313|100827542|FG010|STARTED|Cohorts 1 and 2(Week 1 - Week 26)||0||
48205738|NCT04707313|100827543|FG011|STARTED|Cohorts 1 and 2(Week 1 - Week 26)||0||
48205739|NCT04707313|100827544|FG012|STARTED|Cohorts 1 and 2(Week 1 - Week 26)||0||
48205740|NCT04707313|100827532|FG000|Received Treatment|Cohorts 1 and 2(Week 1 - Week 26)||71||
48205741|NCT04707313|100827533|FG001|Received Treatment|Cohorts 1 and 2(Week 1 - Week 26)||62||
48205742|NCT04707313|100827534|FG002|Received Treatment|Cohorts 1 and 2(Week 1 - Week 26)||63||
48205743|NCT04707313|100827535|FG003|Received Treatment|Cohorts 1 and 2(Week 1 - Week 26)||64||
48205744|NCT04707313|100827536|FG004|Received Treatment|Cohorts 1 and 2(Week 1 - Week 26)||38||
48205745|NCT04707313|100827537|FG005|Received Treatment|Cohorts 1 and 2(Week 1 - Week 26)||63||
48046880|NCT02777749|100434824|FG001|NOT COMPLETED|Overall Study||0||
48046881|NCT02777749|100434825|FG002|NOT COMPLETED|Overall Study||0||
48046882|NCT03054129|100434826|FG000|STARTED|Overall Study||21||
48046883|NCT03054129|100434827|FG001|STARTED|Overall Study||21||
48046884|NCT03054129|100434826|FG000|COMPLETED|Overall Study||19||
48046885|NCT03054129|100434827|FG001|COMPLETED|Overall Study||20||
48046886|NCT03054129|100434826|FG000|NOT COMPLETED|Overall Study||2||
48046887|NCT03054129|100434827|FG001|NOT COMPLETED|Overall Study||1||
48046888|NCT00466687|100434828|FG000|STARTED|Overall Study||34||
48046889|NCT00466687|100434828|FG000|COMPLETED|Overall Study||0||
48046890|NCT00466687|100434828|FG000|NOT COMPLETED|Overall Study||34||
48046891|NCT02554279|100434829|FG000|STARTED|Overall Study||311||
48046892|NCT02554279|100434830|FG001|STARTED|Overall Study||309||
48205746|NCT04707313|100827538|FG006|Received Treatment|Cohorts 1 and 2(Week 1 - Week 26)||37||
48205747|NCT04707313|100827539|FG007|Received Treatment|Cohorts 1 and 2(Week 1 - Week 26)||63||
48205748|NCT04707313|100827540|FG008|Received Treatment|Cohorts 1 and 2(Week 1 - Week 26)||36||
48205749|NCT04707313|100827541|FG009|Received Treatment|Cohorts 1 and 2(Week 1 - Week 26)||0||
48205750|NCT04707313|100827542|FG010|Received Treatment|Cohorts 1 and 2(Week 1 - Week 26)||0||
48205751|NCT04707313|100827543|FG011|Received Treatment|Cohorts 1 and 2(Week 1 - Week 26)||0||
48205752|NCT04707313|100827544|FG012|Received Treatment|Cohorts 1 and 2(Week 1 - Week 26)||0||
48046893|NCT02554279|100434829|FG000|Treated|Overall Study||310||
48046894|NCT02554279|100434830|FG001|Treated|Overall Study||309||
48046895|NCT02554279|100434829|FG000|Completed Day 6 of Stimulation|Overall Study||308||
48046896|NCT02554279|100434830|FG001|Completed Day 6 of Stimulation|Overall Study||309||
48205753|NCT04707313|100827532|FG000|COMPLETED|Cohorts 1 and 2(Week 1 - Week 26)||44||
48205754|NCT04707313|100827533|FG001|COMPLETED|Cohorts 1 and 2(Week 1 - Week 26)||27||
48205755|NCT04707313|100827534|FG002|COMPLETED|Cohorts 1 and 2(Week 1 - Week 26)||30||
48205756|NCT04707313|100827535|FG003|COMPLETED|Cohorts 1 and 2(Week 1 - Week 26)||26||
48205757|NCT04707313|100827536|FG004|COMPLETED|Cohorts 1 and 2(Week 1 - Week 26)||13||
48205758|NCT04707313|100827537|FG005|COMPLETED|Cohorts 1 and 2(Week 1 - Week 26)||18||
48046897|NCT02554279|100434829|FG000|Received Trigger|Overall Study||293||
48046898|NCT02554279|100434830|FG001|Received Trigger|Overall Study||307||
48205759|NCT04707313|100827538|FG006|COMPLETED|Cohorts 1 and 2(Week 1 - Week 26)||11||
48205760|NCT04707313|100827539|FG007|COMPLETED|Cohorts 1 and 2(Week 1 - Week 26)||14||
48205761|NCT04707313|100827540|FG008|COMPLETED|Cohorts 1 and 2(Week 1 - Week 26)||13||
48205762|NCT04707313|100827541|FG009|COMPLETED|Cohorts 1 and 2(Week 1 - Week 26)||0||
48205763|NCT04707313|100827542|FG010|COMPLETED|Cohorts 1 and 2(Week 1 - Week 26)||0||
48205764|NCT04707313|100827543|FG011|COMPLETED|Cohorts 1 and 2(Week 1 - Week 26)||0||
48205765|NCT04707313|100827544|FG012|COMPLETED|Cohorts 1 and 2(Week 1 - Week 26)||0||
48205766|NCT04707313|100827532|FG000|NOT COMPLETED|Cohorts 1 and 2(Week 1 - Week 26)||27||
48205767|NCT04707313|100827533|FG001|NOT COMPLETED|Cohorts 1 and 2(Week 1 - Week 26)||35||
48205768|NCT04707313|100827534|FG002|NOT COMPLETED|Cohorts 1 and 2(Week 1 - Week 26)||34||
48205769|NCT04707313|100827535|FG003|NOT COMPLETED|Cohorts 1 and 2(Week 1 - Week 26)||38||
48205770|NCT04707313|100827536|FG004|NOT COMPLETED|Cohorts 1 and 2(Week 1 - Week 26)||25||
48205771|NCT04707313|100827537|FG005|NOT COMPLETED|Cohorts 1 and 2(Week 1 - Week 26)||45||
48205772|NCT04707313|100827538|FG006|NOT COMPLETED|Cohorts 1 and 2(Week 1 - Week 26)||26||
48205773|NCT04707313|100827539|FG007|NOT COMPLETED|Cohorts 1 and 2(Week 1 - Week 26)||50||
48205774|NCT04707313|100827540|FG008|NOT COMPLETED|Cohorts 1 and 2(Week 1 - Week 26)||23||
48205775|NCT04707313|100827541|FG009|NOT COMPLETED|Cohorts 1 and 2(Week 1 - Week 26)||0||
48205776|NCT04707313|100827542|FG010|NOT COMPLETED|Cohorts 1 and 2(Week 1 - Week 26)||0||
48205777|NCT04707313|100827543|FG011|NOT COMPLETED|Cohorts 1 and 2(Week 1 - Week 26)||0||
48205778|NCT04707313|100827544|FG012|NOT COMPLETED|Cohorts 1 and 2(Week 1 - Week 26)||0||
48205779|NCT04707313|100827532|FG000|STARTED|Cohort 3 (Week 0 to Week 32)||0||
48046899|NCT02554279|100434829|FG000|Completed Oocyte Retrieval|Overall Study||292||
48046900|NCT02554279|100434830|FG001|Completed Oocyte Retrieval|Overall Study||306||
48046901|NCT02554279|100434829|FG000|Completed Fresh Blastocyst Transfer|Overall Study||201||
48046902|NCT02554279|100434830|FG001|Completed Fresh Blastocyst Transfer|Overall Study||191||
48046903|NCT02554279|100434829|FG000|COMPLETED|Overall Study||279||
48046904|NCT02554279|100434830|FG001|COMPLETED|Overall Study||291||
48205780|NCT04707313|100827533|FG001|STARTED|Cohort 3 (Week 0 to Week 32)||0||
48205781|NCT04707313|100827534|FG002|STARTED|Cohort 3 (Week 0 to Week 32)||0||
48205782|NCT04707313|100827535|FG003|STARTED|Cohort 3 (Week 0 to Week 32)||0||
48046905|NCT02554279|100434829|FG000|NOT COMPLETED|Overall Study||32||
48046906|NCT02554279|100434830|FG001|NOT COMPLETED|Overall Study||18||
48046907|NCT03055377|100434831|FG000|STARTED|Treatment Phase||98||
48205783|NCT04707313|100827536|FG004|STARTED|Cohort 3 (Week 0 to Week 32)||0||
48495436|NCT01808651|101547847|FG002|NOT COMPLETED|Study Period 1||5||
48495437|NCT01808651|101547845|FG000|STARTED|Study Period 2||77||
48495438|NCT01808651|101547846|FG001|STARTED|Study Period 2||52||
48495439|NCT01808651|101547847|FG002|STARTED|Study Period 2||33||
48495440|NCT01808651|101547845|FG000|COMPLETED|Study Period 2||77||
48495441|NCT01808651|101547846|FG001|COMPLETED|Study Period 2||52||
48495442|NCT01808651|101547847|FG002|COMPLETED|Study Period 2||33||
48495443|NCT01808651|101547845|FG000|NOT COMPLETED|Study Period 2||0||
48495444|NCT01808651|101547846|FG001|NOT COMPLETED|Study Period 2||0||
48495445|NCT01808651|101547847|FG002|NOT COMPLETED|Study Period 2||0||
48495446|NCT02658487|101547848|FG000|STARTED|Overall Study||42||
48495447|NCT02658487|101547848|FG000|COMPLETED|Overall Study||26||
48495448|NCT02658487|101547848|FG000|NOT COMPLETED|Overall Study||16||
48495449|NCT04183335|101547849|FG000|STARTED|Overall Study||76||
48046908|NCT03055377|100434832|FG001|STARTED|Treatment Phase||94||
48046909|NCT03055377|100434831|FG000|COMPLETED|Treatment Phase||70||
48046910|NCT03055377|100434832|FG001|COMPLETED|Treatment Phase||70||
48046911|NCT03055377|100434831|FG000|NOT COMPLETED|Treatment Phase||28||
48046912|NCT03055377|100434832|FG001|NOT COMPLETED|Treatment Phase||24||
48046913|NCT03055377|100434831|FG000|STARTED|Post-Treatment Follow-Up||70||
48495450|NCT04183335|101547850|FG001|STARTED|Overall Study||75||
48495451|NCT04183335|101547849|FG000|Treated|Overall Study||75||
48495452|NCT04183335|101547850|FG001|Treated|Overall Study||75||
48495453|NCT04183335|101547849|FG000|COMPLETED|Overall Study||63||
48495454|NCT04183335|101547850|FG001|COMPLETED|Overall Study||72||
48495455|NCT04183335|101547849|FG000|NOT COMPLETED|Overall Study||13||
48046914|NCT03055377|100434832|FG001|STARTED|Post-Treatment Follow-Up||70||
48046915|NCT03055377|100434831|FG000|COMPLETED|Post-Treatment Follow-Up||44||
48046916|NCT03055377|100434832|FG001|COMPLETED|Post-Treatment Follow-Up||49||
48495456|NCT04183335|101547850|FG001|NOT COMPLETED|Overall Study||3||
48495457|NCT04428307|101547851|FG000|STARTED|Overall Study||1692||13
48495458|NCT04428307|101547852|FG001|STARTED|Overall Study||1789||13
48495459|NCT04428307|101547853|FG002|STARTED|Overall Study||2215||13
48495460|NCT04428307|101547851|FG000|COMPLETED|Overall Study||1692||13
48495461|NCT04428307|101547852|FG001|COMPLETED|Overall Study||1789||13
48495462|NCT04428307|101547853|FG002|COMPLETED|Overall Study||2214||13
48495463|NCT04428307|101547851|FG000|NOT COMPLETED|Overall Study||0||0
48495464|NCT04428307|101547852|FG001|NOT COMPLETED|Overall Study||0||0
48495465|NCT04428307|101547853|FG002|NOT COMPLETED|Overall Study||1||0
48495466|NCT01515891|101547854|FG000|STARTED|Overall Study||4||
48495467|NCT01515891|101547854|FG000|COMPLETED|Overall Study||4||
48495468|NCT01515891|101547854|FG000|NOT COMPLETED|Overall Study||0||
48495469|NCT04089553|101547855|FG000|STARTED|Overall Study||29||
48495470|NCT04089553|101547856|FG001|STARTED|Overall Study||30||
48495471|NCT04089553|101547855|FG000|COMPLETED|Overall Study||3|Patients ongoing study treatment at data cut-off date|
48495472|NCT04089553|101547856|FG001|COMPLETED|Overall Study||2|Patients ongoing study treatment at data cut-off date|
48495473|NCT04089553|101547855|FG000|NOT COMPLETED|Overall Study||26||
48495474|NCT04089553|101547856|FG001|NOT COMPLETED|Overall Study||28||
48495475|NCT03703258|101547857|FG000|STARTED|Overall Study||20||
48495476|NCT03703258|101547858|FG001|STARTED|Overall Study||21||
48495477|NCT03703258|101547857|FG000|COMPLETED|Overall Study||20||
48495478|NCT03703258|101547858|FG001|COMPLETED|Overall Study||21||
48495479|NCT03703258|101547857|FG000|NOT COMPLETED|Overall Study||0||
48495480|NCT03703258|101547858|FG001|NOT COMPLETED|Overall Study||0||
48495481|NCT05034874|101547859|FG000|STARTED|Overall Study||41||
48495482|NCT05034874|101547860|FG001|STARTED|Overall Study||20||
48495483|NCT05034874|101547859|FG000|COMPLETED|Overall Study||15||
48495484|NCT05034874|101547860|FG001|COMPLETED|Overall Study||4||
48495485|NCT05034874|101547859|FG000|NOT COMPLETED|Overall Study||26||
48046917|NCT03055377|100434831|FG000|NOT COMPLETED|Post-Treatment Follow-Up||26||
48046918|NCT03055377|100434832|FG001|NOT COMPLETED|Post-Treatment Follow-Up||21||
48046919|NCT04545944|100434833|FG000|STARTED|Overall Study||20||
48046920|NCT04545944|100434833|FG000|COMPLETED|Overall Study||20||
48046921|NCT04545944|100434833|FG000|NOT COMPLETED|Overall Study||0||
48046922|NCT02126748|100434834|FG000|STARTED|Overall Study||33||
48046923|NCT02126748|100434835|FG001|STARTED|Overall Study||34||
48046924|NCT02126748|100434836|FG002|STARTED|Overall Study||36||
48205784|NCT04707313|100827537|FG005|STARTED|Cohort 3 (Week 0 to Week 32)||0||
48205785|NCT04707313|100827538|FG006|STARTED|Cohort 3 (Week 0 to Week 32)||0||
48205786|NCT04707313|100827539|FG007|STARTED|Cohort 3 (Week 0 to Week 32)||0||
48205787|NCT04707313|100827540|FG008|STARTED|Cohort 3 (Week 0 to Week 32)||0||
48205788|NCT04707313|100827541|FG009|STARTED|Cohort 3 (Week 0 to Week 32)||19||
48205789|NCT04707313|100827542|FG010|STARTED|Cohort 3 (Week 0 to Week 32)||37||
48205790|NCT04707313|100827543|FG011|STARTED|Cohort 3 (Week 0 to Week 32)||37||
48205791|NCT04707313|100827544|FG012|STARTED|Cohort 3 (Week 0 to Week 32)||36||
48205792|NCT04707313|100827532|FG000|Received Treatment|Cohort 3 (Week 0 to Week 32)||0||
48205793|NCT04707313|100827533|FG001|Received Treatment|Cohort 3 (Week 0 to Week 32)||0||
48205794|NCT04707313|100827534|FG002|Received Treatment|Cohort 3 (Week 0 to Week 32)||0||
48205795|NCT04707313|100827535|FG003|Received Treatment|Cohort 3 (Week 0 to Week 32)||0||
48205796|NCT04707313|100827536|FG004|Received Treatment|Cohort 3 (Week 0 to Week 32)||0||
48205797|NCT04707313|100827537|FG005|Received Treatment|Cohort 3 (Week 0 to Week 32)||0||
48205798|NCT04707313|100827538|FG006|Received Treatment|Cohort 3 (Week 0 to Week 32)||0||
48205799|NCT04707313|100827539|FG007|Received Treatment|Cohort 3 (Week 0 to Week 32)||0||
48205800|NCT04707313|100827540|FG008|Received Treatment|Cohort 3 (Week 0 to Week 32)||0||
48205801|NCT04707313|100827541|FG009|Received Treatment|Cohort 3 (Week 0 to Week 32)||19||
48205802|NCT04707313|100827542|FG010|Received Treatment|Cohort 3 (Week 0 to Week 32)||37||
48205803|NCT04707313|100827543|FG011|Received Treatment|Cohort 3 (Week 0 to Week 32)||37||
48205804|NCT04707313|100827544|FG012|Received Treatment|Cohort 3 (Week 0 to Week 32)||36||
48205805|NCT04707313|100827532|FG000|COMPLETED|Cohort 3 (Week 0 to Week 32)||0||
48205806|NCT04707313|100827533|FG001|COMPLETED|Cohort 3 (Week 0 to Week 32)||0||
48205807|NCT04707313|100827534|FG002|COMPLETED|Cohort 3 (Week 0 to Week 32)||0||
48205808|NCT04707313|100827535|FG003|COMPLETED|Cohort 3 (Week 0 to Week 32)||0||
48205809|NCT04707313|100827536|FG004|COMPLETED|Cohort 3 (Week 0 to Week 32)||0||
48205810|NCT04707313|100827537|FG005|COMPLETED|Cohort 3 (Week 0 to Week 32)||0||
48205811|NCT04707313|100827538|FG006|COMPLETED|Cohort 3 (Week 0 to Week 32)||0||
48205812|NCT04707313|100827539|FG007|COMPLETED|Cohort 3 (Week 0 to Week 32)||0||
48495486|NCT05034874|101547860|FG001|NOT COMPLETED|Overall Study||16||
48495487|NCT02105272|101547861|FG000|STARTED|Overall Study||118||
48495488|NCT02105272|101547862|FG001|STARTED|Overall Study||119||
48495489|NCT02105272|101547861|FG000|COMPLETED|Overall Study||113||
48495490|NCT02105272|101547862|FG001|COMPLETED|Overall Study||116||
48495491|NCT02105272|101547861|FG000|NOT COMPLETED|Overall Study||5||
48495492|NCT02105272|101547862|FG001|NOT COMPLETED|Overall Study||3||
48495493|NCT03676634|101547863|FG000|STARTED|Overall Study||32||
48495494|NCT03676634|101547863|FG000|Screening|Overall Study||32||
48495495|NCT03676634|101547863|FG000|Participants Received rBV A/B Injection|Overall Study||32||
48495496|NCT03676634|101547863|FG000|Participants Included in the Plasma-donating Population|Overall Study||32||
48495497|NCT03676634|101547863|FG000|Participants Completed Follow up|Overall Study||32||
48495498|NCT03676634|101547863|FG000|COMPLETED|Overall Study||29||
48495499|NCT03676634|101547863|FG000|NOT COMPLETED|Overall Study||3||
48495500|NCT03867760|101547864|FG000|STARTED|Overall Study||55||
48495501|NCT03867760|101547865|FG001|STARTED|Overall Study||54||
48495502|NCT03867760|101547864|FG000|COMPLETED|Overall Study||49||
48495503|NCT03867760|101547865|FG001|COMPLETED|Overall Study||46||
48046925|NCT02126748|100434834|FG000|COMPLETED|Overall Study||31||
48046926|NCT02126748|100434835|FG001|COMPLETED|Overall Study||31||
48046927|NCT02126748|100434836|FG002|COMPLETED|Overall Study||31||
48046928|NCT02126748|100434834|FG000|NOT COMPLETED|Overall Study||2||
48046929|NCT02126748|100434835|FG001|NOT COMPLETED|Overall Study||3||
48046930|NCT02126748|100434836|FG002|NOT COMPLETED|Overall Study||5||
48046931|NCT01077375|100434837|FG000|STARTED|Overall Study||21||
48046932|NCT01077375|100434838|FG001|STARTED|Overall Study||86||
48205813|NCT04707313|100827540|FG008|COMPLETED|Cohort 3 (Week 0 to Week 32)||0||
48205814|NCT04707313|100827541|FG009|COMPLETED|Cohort 3 (Week 0 to Week 32)||11||
48205815|NCT04707313|100827542|FG010|COMPLETED|Cohort 3 (Week 0 to Week 32)||13||
48205816|NCT04707313|100827543|FG011|COMPLETED|Cohort 3 (Week 0 to Week 32)||15||
48495504|NCT03867760|101547864|FG000|NOT COMPLETED|Overall Study||6||
48495505|NCT03867760|101547865|FG001|NOT COMPLETED|Overall Study||8||
48495506|NCT03684928|101547866|FG000|STARTED|First Intervention||23||
48495507|NCT03684928|101547867|FG001|STARTED|First Intervention||22||
48046933|NCT01077375|100434837|FG000|COMPLETED|Overall Study||11||
48046934|NCT01077375|100434838|FG001|COMPLETED|Overall Study||51||
48046935|NCT01077375|100434837|FG000|NOT COMPLETED|Overall Study||10||
48046936|NCT01077375|100434838|FG001|NOT COMPLETED|Overall Study||35||
48046937|NCT02661711|100434839|FG000|STARTED|Overall Study||30||
48046938|NCT02661711|100434839|FG000|COMPLETED|Overall Study||29||
48046939|NCT02661711|100434839|FG000|NOT COMPLETED|Overall Study||1||
48046940|NCT02239120|100434840|FG000|STARTED|Overall Study||2695|Randomised|
48046941|NCT02239120|100434841|FG001|STARTED|Overall Study||2695|Randomised|
48046942|NCT02239120|100434840|FG000|COMPLETED|Overall Study||2620||
48046943|NCT02239120|100434841|FG001|COMPLETED|Overall Study||2623||
48046944|NCT02239120|100434840|FG000|NOT COMPLETED|Overall Study||75||
48046945|NCT02239120|100434841|FG001|NOT COMPLETED|Overall Study||72||
48046946|NCT03467152|100434842|FG000|STARTED|Overall Study||100||
48205817|NCT04707313|100827544|FG012|COMPLETED|Cohort 3 (Week 0 to Week 32)||11||
48205818|NCT04707313|100827532|FG000|NOT COMPLETED|Cohort 3 (Week 0 to Week 32)||0||
48205819|NCT04707313|100827533|FG001|NOT COMPLETED|Cohort 3 (Week 0 to Week 32)||0||
48205820|NCT04707313|100827534|FG002|NOT COMPLETED|Cohort 3 (Week 0 to Week 32)||0||
48205821|NCT04707313|100827535|FG003|NOT COMPLETED|Cohort 3 (Week 0 to Week 32)||0||
48205822|NCT04707313|100827536|FG004|NOT COMPLETED|Cohort 3 (Week 0 to Week 32)||0||
48495508|NCT03684928|101547866|FG000|COMPLETED|First Intervention||23||
48495509|NCT03684928|101547867|FG001|COMPLETED|First Intervention||19||
48495510|NCT03684928|101547866|FG000|NOT COMPLETED|First Intervention||0||
48046947|NCT03467152|100434843|FG001|STARTED|Overall Study||100||
48046948|NCT03467152|100434844|FG002|STARTED|Overall Study||6||
48046949|NCT03467152|100434842|FG000|Treated|Overall Study||97||
48046950|NCT03467152|100434843|FG001|Treated|Overall Study||99||
48046951|NCT03467152|100434844|FG002|Treated|Overall Study||0||
48046952|NCT03467152|100434842|FG000|COMPLETED|Overall Study||84||
48046953|NCT03467152|100434843|FG001|COMPLETED|Overall Study||89||
48046954|NCT03467152|100434844|FG002|COMPLETED|Overall Study||0||
48046955|NCT03467152|100434842|FG000|NOT COMPLETED|Overall Study||16||
48046956|NCT03467152|100434843|FG001|NOT COMPLETED|Overall Study||11||
48046957|NCT03467152|100434844|FG002|NOT COMPLETED|Overall Study||6||
48046958|NCT01995045|100434845|FG000|STARTED|Overall Study||29||
48046959|NCT01995045|100434846|FG001|STARTED|Overall Study||28||
48046960|NCT01995045|100434845|FG000|COMPLETED|Overall Study||29||
48046961|NCT01995045|100434846|FG001|COMPLETED|Overall Study||28||
48046962|NCT01995045|100434845|FG000|NOT COMPLETED|Overall Study||0||
48046963|NCT01995045|100434846|FG001|NOT COMPLETED|Overall Study||0||
48046964|NCT03761797|100434847|FG000|STARTED|Overall Study||1164||
48046965|NCT03761797|100434847|FG000|Safety Set|Overall Study||1146||
48046966|NCT03761797|100434847|FG000|COMPLETED|Overall Study||1025||
48046967|NCT03761797|100434847|FG000|NOT COMPLETED|Overall Study||139||
48046968|NCT01185834|100434848|FG000|STARTED|Overall Study||118||
48046969|NCT01185834|100434848|FG000|COMPLETED|Overall Study||104||
48046970|NCT01185834|100434848|FG000|NOT COMPLETED|Overall Study||14||
48046971|NCT02692651|100434849|FG000|STARTED|Study Treatment||70||
48046972|NCT02692651|100434850|FG001|STARTED|Study Treatment||74||
48046973|NCT02692651|100434849|FG000|COMPLETED|Study Treatment||54||
48046974|NCT02692651|100434850|FG001|COMPLETED|Study Treatment||64||
48046975|NCT02692651|100434849|FG000|NOT COMPLETED|Study Treatment||16||
48046976|NCT02692651|100434850|FG001|NOT COMPLETED|Study Treatment||10||
48046977|NCT02692651|100434849|FG000|STARTED|Post Study Treatment Follow-up||54||
48046978|NCT02692651|100434850|FG001|STARTED|Post Study Treatment Follow-up||64||
48046979|NCT02692651|100434849|FG000|COMPLETED|Post Study Treatment Follow-up||50||
48046980|NCT02692651|100434850|FG001|COMPLETED|Post Study Treatment Follow-up||60||
48046981|NCT02692651|100434849|FG000|NOT COMPLETED|Post Study Treatment Follow-up||4||
48046982|NCT02692651|100434850|FG001|NOT COMPLETED|Post Study Treatment Follow-up||4||
48046983|NCT00400153|100434851|FG000|STARTED|Overall Study||486||
48046984|NCT00400153|100434852|FG001|STARTED|Overall Study||491||
48046985|NCT00400153|100434853|FG002|STARTED|Overall Study||483||
48046986|NCT00400153|100434851|FG000|COMPLETED|Overall Study||438||
48046987|NCT00400153|100434852|FG001|COMPLETED|Overall Study||436||
48046988|NCT00400153|100434853|FG002|COMPLETED|Overall Study||422||
48046989|NCT00400153|100434851|FG000|NOT COMPLETED|Overall Study||48||
48046990|NCT00400153|100434852|FG001|NOT COMPLETED|Overall Study||55||
48046991|NCT00400153|100434853|FG002|NOT COMPLETED|Overall Study||61||
48046992|NCT00830869|100434854|FG000|STARTED|Period 1: Part 1||1||
48046993|NCT00830869|100434855|FG001|STARTED|Period 1: Part 1||1||
48046994|NCT00830869|100434856|FG002|STARTED|Period 1: Part 1||1||
48046995|NCT00830869|100434857|FG003|STARTED|Period 1: Part 1||7||
48046996|NCT00830869|100434858|FG004|STARTED|Period 1: Part 1||4||
48046997|NCT00830869|100434859|FG005|STARTED|Period 1: Part 1||6||
48046998|NCT00830869|100434860|FG006|STARTED|Period 1: Part 1||3||
48046999|NCT00830869|100434861|FG007|STARTED|Period 1: Part 1||0||
48047000|NCT00830869|100434862|FG008|STARTED|Period 1: Part 1||0||
48047001|NCT00830869|100434863|FG009|STARTED|Period 1: Part 1||0||
48047002|NCT00830869|100434864|FG010|STARTED|Period 1: Part 1||0||
48047003|NCT00830869|100434865|FG011|STARTED|Period 1: Part 1||0||
48047004|NCT00830869|100434854|FG000|COMPLETED|Period 1: Part 1||0||
48205823|NCT04707313|100827537|FG005|NOT COMPLETED|Cohort 3 (Week 0 to Week 32)||0||
48205824|NCT04707313|100827538|FG006|NOT COMPLETED|Cohort 3 (Week 0 to Week 32)||0||
48205825|NCT04707313|100827539|FG007|NOT COMPLETED|Cohort 3 (Week 0 to Week 32)||0||
48205826|NCT04707313|100827540|FG008|NOT COMPLETED|Cohort 3 (Week 0 to Week 32)||0||
48205827|NCT04707313|100827541|FG009|NOT COMPLETED|Cohort 3 (Week 0 to Week 32)||8||
48205828|NCT04707313|100827542|FG010|NOT COMPLETED|Cohort 3 (Week 0 to Week 32)||24||
48205829|NCT04707313|100827543|FG011|NOT COMPLETED|Cohort 3 (Week 0 to Week 32)||22||
48205830|NCT04707313|100827544|FG012|NOT COMPLETED|Cohort 3 (Week 0 to Week 32)||25||
48205831|NCT01685606|100827545|FG000|STARTED|Overall Study||6||
48047005|NCT00830869|100434855|FG001|COMPLETED|Period 1: Part 1||0||
48047006|NCT00830869|100434856|FG002|COMPLETED|Period 1: Part 1||0||
48047007|NCT00830869|100434857|FG003|COMPLETED|Period 1: Part 1||0||
48047008|NCT00830869|100434858|FG004|COMPLETED|Period 1: Part 1||0||
48047009|NCT00830869|100434859|FG005|COMPLETED|Period 1: Part 1||0||
48047010|NCT00830869|100434860|FG006|COMPLETED|Period 1: Part 1||0||
48205832|NCT01685606|100827545|FG000|COMPLETED|Overall Study||5||
48205833|NCT01685606|100827545|FG000|NOT COMPLETED|Overall Study||1||
48205834|NCT02348658|100827546|FG000|STARTED|Period 1 (7 Days)||6||
48047011|NCT00830869|100434861|FG007|COMPLETED|Period 1: Part 1||0||
48047012|NCT00830869|100434862|FG008|COMPLETED|Period 1: Part 1||0||
48047013|NCT00830869|100434863|FG009|COMPLETED|Period 1: Part 1||0||
48047014|NCT00830869|100434864|FG010|COMPLETED|Period 1: Part 1||0||
48047015|NCT00830869|100434865|FG011|COMPLETED|Period 1: Part 1||0||
48047016|NCT00830869|100434854|FG000|NOT COMPLETED|Period 1: Part 1||1||
48047017|NCT00830869|100434855|FG001|NOT COMPLETED|Period 1: Part 1||1||
48047018|NCT00830869|100434856|FG002|NOT COMPLETED|Period 1: Part 1||1||
48047019|NCT00830869|100434857|FG003|NOT COMPLETED|Period 1: Part 1||7||
48047020|NCT00830869|100434858|FG004|NOT COMPLETED|Period 1: Part 1||4||
48047021|NCT00830869|100434859|FG005|NOT COMPLETED|Period 1: Part 1||6||
48047022|NCT00830869|100434860|FG006|NOT COMPLETED|Period 1: Part 1||3||
48047023|NCT00830869|100434861|FG007|NOT COMPLETED|Period 1: Part 1||0||
48047024|NCT00830869|100434862|FG008|NOT COMPLETED|Period 1: Part 1||0||
48047025|NCT00830869|100434863|FG009|NOT COMPLETED|Period 1: Part 1||0||
48047026|NCT00830869|100434864|FG010|NOT COMPLETED|Period 1: Part 1||0||
48047027|NCT00830869|100434865|FG011|NOT COMPLETED|Period 1: Part 1||0||
48047028|NCT00830869|100434854|FG000|STARTED|Period 2: Part 2||0||
48047029|NCT00830869|100434855|FG001|STARTED|Period 2: Part 2||0||
48047030|NCT00830869|100434856|FG002|STARTED|Period 2: Part 2||0||
48047031|NCT00830869|100434857|FG003|STARTED|Period 2: Part 2||0||
48047032|NCT00830869|100434858|FG004|STARTED|Period 2: Part 2||0||
48047033|NCT00830869|100434859|FG005|STARTED|Period 2: Part 2||0||
48047034|NCT00830869|100434860|FG006|STARTED|Period 2: Part 2||0||
48047035|NCT00830869|100434861|FG007|STARTED|Period 2: Part 2||20||
48047036|NCT00830869|100434862|FG008|STARTED|Period 2: Part 2||22||
48047037|NCT00830869|100434863|FG009|STARTED|Period 2: Part 2||20||
48205835|NCT02348658|100827547|FG001|STARTED|Period 1 (7 Days)||6||
48205836|NCT02348658|100827546|FG000|COMPLETED|Period 1 (7 Days)||6||
48205837|NCT02348658|100827547|FG001|COMPLETED|Period 1 (7 Days)||6||
48205838|NCT02348658|100827546|FG000|NOT COMPLETED|Period 1 (7 Days)||0||
48205839|NCT02348658|100827547|FG001|NOT COMPLETED|Period 1 (7 Days)||0||
48205840|NCT02348658|100827546|FG000|STARTED|Washout Period (22 Days)||6||
48047038|NCT00830869|100434864|FG010|STARTED|Period 2: Part 2||11||
48047039|NCT00830869|100434865|FG011|STARTED|Period 2: Part 2||20||
48047040|NCT00830869|100434854|FG000|COMPLETED|Period 2: Part 2||0||
48047041|NCT00830869|100434855|FG001|COMPLETED|Period 2: Part 2||0||
48047042|NCT00830869|100434856|FG002|COMPLETED|Period 2: Part 2||0||
48047043|NCT00830869|100434857|FG003|COMPLETED|Period 2: Part 2||0||
48205841|NCT02348658|100827547|FG001|STARTED|Washout Period (22 Days)||6||
48205842|NCT02348658|100827546|FG000|COMPLETED|Washout Period (22 Days)||6||
48205843|NCT02348658|100827547|FG001|COMPLETED|Washout Period (22 Days)||6||
48495511|NCT03684928|101547867|FG001|NOT COMPLETED|First Intervention||3||
48495512|NCT03684928|101547866|FG000|STARTED|Second Intervention||21||
48495513|NCT03684928|101547867|FG001|STARTED|Second Intervention||19||
48495514|NCT03684928|101547866|FG000|COMPLETED|Second Intervention||20||
48495515|NCT03684928|101547867|FG001|COMPLETED|Second Intervention||19||
48495516|NCT03684928|101547866|FG000|NOT COMPLETED|Second Intervention||1||
48495517|NCT03684928|101547867|FG001|NOT COMPLETED|Second Intervention||0||
48495518|NCT00537095|101547868|FG000|STARTED|Randomized Treatment Period (433 Days)||72||
48495519|NCT00537095|101547869|FG001|STARTED|Randomized Treatment Period (433 Days)||73||
48495520|NCT00537095|101547868|FG000|Safety Population|Randomized Treatment Period (433 Days)||73||
48495521|NCT00537095|101547869|FG001|Safety Population|Randomized Treatment Period (433 Days)||72||
48495522|NCT00537095|101547868|FG000|COMPLETED|Randomized Treatment Period (433 Days)||0||
48495523|NCT00537095|101547869|FG001|COMPLETED|Randomized Treatment Period (433 Days)||0||
48495524|NCT00537095|101547868|FG000|NOT COMPLETED|Randomized Treatment Period (433 Days)||72||
48047044|NCT00830869|100434858|FG004|COMPLETED|Period 2: Part 2||0||
48047045|NCT00830869|100434859|FG005|COMPLETED|Period 2: Part 2||0||
48047046|NCT00830869|100434860|FG006|COMPLETED|Period 2: Part 2||0||
48047047|NCT00830869|100434861|FG007|COMPLETED|Period 2: Part 2||0||
48205844|NCT02348658|100827546|FG000|NOT COMPLETED|Washout Period (22 Days)||0||
48205845|NCT02348658|100827547|FG001|NOT COMPLETED|Washout Period (22 Days)||0||
48205846|NCT02348658|100827546|FG000|STARTED|Period 2 (7 Days)||6||
48495525|NCT00537095|101547869|FG001|NOT COMPLETED|Randomized Treatment Period (433 Days)||73||
48495526|NCT00537095|101547868|FG000|STARTED|Open-label Period (590 Days)||28|Post completion of randomized treatment period, the participants were given the option to enter the open label period. In the open-label period, all participants received vandetanib (ZD6474).|
48495527|NCT00537095|101547869|FG001|STARTED|Open-label Period (590 Days)||59|Post completion of randomized treatment period, the participants were given the option to enter the open label period. In the open-label period, all participants received vandetanib (ZD6474).|
48495528|NCT00537095|101547868|FG000|Safety Population|Open-label Period (590 Days)||29||
48495529|NCT00537095|101547869|FG001|Safety Population|Open-label Period (590 Days)||58||
48495530|NCT00537095|101547868|FG000|COMPLETED|Open-label Period (590 Days)||16||
48495531|NCT00537095|101547869|FG001|COMPLETED|Open-label Period (590 Days)||20||
48495532|NCT00537095|101547868|FG000|NOT COMPLETED|Open-label Period (590 Days)||12||
48495533|NCT00537095|101547869|FG001|NOT COMPLETED|Open-label Period (590 Days)||39||
48495534|NCT05590039|101547870|FG000|STARTED|Overall Study||10||
48495535|NCT05590039|101547870|FG000|COMPLETED|Overall Study||10||
48047048|NCT00830869|100434862|FG008|COMPLETED|Period 2: Part 2||0||
48047049|NCT00830869|100434863|FG009|COMPLETED|Period 2: Part 2||0||
48047050|NCT00830869|100434864|FG010|COMPLETED|Period 2: Part 2||0||
48205847|NCT02348658|100827547|FG001|STARTED|Period 2 (7 Days)||6||
48205848|NCT02348658|100827546|FG000|COMPLETED|Period 2 (7 Days)||6||
48047051|NCT00830869|100434865|FG011|COMPLETED|Period 2: Part 2||0||
48047052|NCT00830869|100434854|FG000|NOT COMPLETED|Period 2: Part 2||0||
48047053|NCT00830869|100434855|FG001|NOT COMPLETED|Period 2: Part 2||0||
48047054|NCT00830869|100434856|FG002|NOT COMPLETED|Period 2: Part 2||0||
48047055|NCT00830869|100434857|FG003|NOT COMPLETED|Period 2: Part 2||0||
48047056|NCT00830869|100434858|FG004|NOT COMPLETED|Period 2: Part 2||0||
48047057|NCT00830869|100434859|FG005|NOT COMPLETED|Period 2: Part 2||0||
48047058|NCT00830869|100434860|FG006|NOT COMPLETED|Period 2: Part 2||0||
48047059|NCT00830869|100434861|FG007|NOT COMPLETED|Period 2: Part 2||20||
48047060|NCT00830869|100434862|FG008|NOT COMPLETED|Period 2: Part 2||22||
48047061|NCT00830869|100434863|FG009|NOT COMPLETED|Period 2: Part 2||20||
48047062|NCT00830869|100434864|FG010|NOT COMPLETED|Period 2: Part 2||11||
48047063|NCT00830869|100434865|FG011|NOT COMPLETED|Period 2: Part 2||20||
48047064|NCT01060345|100434866|FG000|STARTED|Overall Study||20||
48047065|NCT01060345|100434866|FG000|COMPLETED|Overall Study||20||
48047066|NCT01060345|100434866|FG000|NOT COMPLETED|Overall Study||0||
48047067|NCT03381742|100434867|FG000|STARTED|Overall Study||525||
48047068|NCT03381742|100434868|FG001|STARTED|Overall Study||501||
48047069|NCT03381742|100434869|FG002|STARTED|Overall Study||1511||
48047070|NCT03381742|100434870|FG003|STARTED|Overall Study||506||
48047071|NCT03381742|100434867|FG000|COMPLETED|Overall Study||525||
48047072|NCT03381742|100434868|FG001|COMPLETED|Overall Study||501||
48047073|NCT03381742|100434869|FG002|COMPLETED|Overall Study||1511||
48047074|NCT03381742|100434870|FG003|COMPLETED|Overall Study||506||
48047075|NCT03381742|100434867|FG000|NOT COMPLETED|Overall Study||0||
48047076|NCT03381742|100434868|FG001|NOT COMPLETED|Overall Study||0||
48047077|NCT03381742|100434869|FG002|NOT COMPLETED|Overall Study||0||
48047078|NCT03381742|100434870|FG003|NOT COMPLETED|Overall Study||0||
48047079|NCT03780400|100434871|FG000|STARTED|Overall Study||60||
48205849|NCT02348658|100827547|FG001|COMPLETED|Period 2 (7 Days)||6||
48205850|NCT02348658|100827546|FG000|NOT COMPLETED|Period 2 (7 Days)||0||
48205851|NCT02348658|100827547|FG001|NOT COMPLETED|Period 2 (7 Days)||0||
48205852|NCT01901276|100827548|FG000|STARTED|No PPI: Week 0 to Week 4||0||
48205853|NCT01901276|100827549|FG001|STARTED|No PPI: Week 0 to Week 4||14||
48205854|NCT01901276|100827548|FG000|COMPLETED|No PPI: Week 0 to Week 4||0||
48047080|NCT03780400|100434871|FG000|COMPLETED|Overall Study||53||
48047081|NCT03780400|100434871|FG000|NOT COMPLETED|Overall Study||7||
48047082|NCT03699475|100434872|FG000|STARTED|Overall Study||1||
48047083|NCT03699475|100434872|FG000|COMPLETED|Overall Study||0||
48047084|NCT03699475|100434872|FG000|NOT COMPLETED|Overall Study||1||
48047085|NCT00791076|100434873|FG000|STARTED|Overall Study||8||
48205855|NCT01901276|100827549|FG001|COMPLETED|No PPI: Week 0 to Week 4||12||
48205856|NCT01901276|100827548|FG000|NOT COMPLETED|No PPI: Week 0 to Week 4||0||
48205857|NCT01901276|100827549|FG001|NOT COMPLETED|No PPI: Week 0 to Week 4||2||
48205858|NCT01901276|100827548|FG000|STARTED|On PPI: Week 4 to Week 8||12||
48205859|NCT01901276|100827549|FG001|STARTED|On PPI: Week 4 to Week 8||0||
48205860|NCT01901276|100827548|FG000|COMPLETED|On PPI: Week 4 to Week 8||12||
48205861|NCT01901276|100827549|FG001|COMPLETED|On PPI: Week 4 to Week 8||0||
48205862|NCT01901276|100827548|FG000|NOT COMPLETED|On PPI: Week 4 to Week 8||0||
48205863|NCT01901276|100827549|FG001|NOT COMPLETED|On PPI: Week 4 to Week 8||0||
48205864|NCT01901276|100827548|FG000|STARTED|Randomization: Week 8 to Week 12||6||
48205865|NCT01901276|100827549|FG001|STARTED|Randomization: Week 8 to Week 12||6||
48047086|NCT00791076|100434873|FG000|COMPLETED|Overall Study||0||
48047087|NCT00791076|100434873|FG000|NOT COMPLETED|Overall Study||8||
48047088|NCT04148872|100434874|FG000|STARTED|Overall Study||7||
48047089|NCT04148872|100434875|FG001|STARTED|Overall Study||8||
48047090|NCT04148872|100434874|FG000|COMPLETED|Overall Study||5||
48047091|NCT04148872|100434875|FG001|COMPLETED|Overall Study||7||
48047092|NCT04148872|100434874|FG000|NOT COMPLETED|Overall Study||2||
48047093|NCT04148872|100434875|FG001|NOT COMPLETED|Overall Study||1||
48047094|NCT00829933|100434876|FG000|STARTED|Overall Study||135||
48047095|NCT00829933|100434877|FG001|STARTED|Overall Study||135||
48047096|NCT00829933|100434878|FG002|STARTED|Overall Study||132||
48047097|NCT00829933|100434879|FG003|STARTED|Overall Study||134||
48047098|NCT00829933|100434876|FG000|Baseline Analysis Population|Overall Study||131||
48047099|NCT00829933|100434877|FG001|Baseline Analysis Population|Overall Study||134||
48047100|NCT00829933|100434878|FG002|Baseline Analysis Population|Overall Study||131||
48047101|NCT00829933|100434879|FG003|Baseline Analysis Population|Overall Study||129||
48047102|NCT00829933|100434876|FG000|COMPLETED|Overall Study||121||
48047103|NCT00829933|100434877|FG001|COMPLETED|Overall Study||122||
48047104|NCT00829933|100434878|FG002|COMPLETED|Overall Study||119||
48047105|NCT00829933|100434879|FG003|COMPLETED|Overall Study||120||
48047106|NCT00829933|100434876|FG000|NOT COMPLETED|Overall Study||14||
48047107|NCT00829933|100434877|FG001|NOT COMPLETED|Overall Study||13||
48047108|NCT00829933|100434878|FG002|NOT COMPLETED|Overall Study||13||
48047109|NCT00829933|100434879|FG003|NOT COMPLETED|Overall Study||14||
48047110|NCT00064298|100434880|FG000|STARTED|Overall Study||72||
48205866|NCT01901276|100827548|FG000|COMPLETED|Randomization: Week 8 to Week 12||6||
48205867|NCT01901276|100827549|FG001|COMPLETED|Randomization: Week 8 to Week 12||6||
48205868|NCT01901276|100827548|FG000|NOT COMPLETED|Randomization: Week 8 to Week 12||0||
48205869|NCT01901276|100827549|FG001|NOT COMPLETED|Randomization: Week 8 to Week 12||0||
48205870|NCT00172185|100827550|FG000|STARTED|Overall Study||6||
48205871|NCT00172185|100827551|FG001|STARTED|Overall Study||7||
48205872|NCT00172185|100827552|FG002|STARTED|Overall Study||25||
48205873|NCT00172185|100827553|FG003|STARTED|Overall Study||27||
48205874|NCT00172185|100827550|FG000|COMPLETED|Overall Study||6||
48047111|NCT00064298|100434881|FG001|STARTED|Overall Study||62||
48047112|NCT00064298|100434880|FG000|COMPLETED|Overall Study||66||
48205875|NCT00172185|100827551|FG001|COMPLETED|Overall Study||5||
48205876|NCT00172185|100827552|FG002|COMPLETED|Overall Study||20||
48205877|NCT00172185|100827553|FG003|COMPLETED|Overall Study||23||
48205878|NCT00172185|100827550|FG000|NOT COMPLETED|Overall Study||0||
48205879|NCT00172185|100827551|FG001|NOT COMPLETED|Overall Study||2||
48047113|NCT00064298|100434881|FG001|COMPLETED|Overall Study||57||
48047114|NCT00064298|100434880|FG000|NOT COMPLETED|Overall Study||6||
48047115|NCT00064298|100434881|FG001|NOT COMPLETED|Overall Study||5||
48047116|NCT01511055|100434882|FG000|STARTED|Overall Study||27||
48047117|NCT01511055|100434882|FG000|COMPLETED|Overall Study||21||
48047118|NCT01511055|100434882|FG000|NOT COMPLETED|Overall Study||6||
48047119|NCT01905423|100434883|FG000|STARTED|Overall Study||4456||
48047120|NCT01905423|100434884|FG001|STARTED|Overall Study||3297||
48047121|NCT01905423|100434885|FG002|STARTED|Overall Study||4111||
48047122|NCT01905423|100434886|FG003|STARTED|Overall Study||2757||
48047123|NCT01905423|100434887|FG004|STARTED|Overall Study||2487||
48047124|NCT01905423|100434883|FG000|Baseline|Overall Study||1443||
48047125|NCT01905423|100434884|FG001|Baseline|Overall Study||722||
48047126|NCT01905423|100434885|FG002|Baseline|Overall Study||1033||
48047127|NCT01905423|100434886|FG003|Baseline|Overall Study||1482||
48047128|NCT01905423|100434887|FG004|Baseline|Overall Study||1326||
48047129|NCT01905423|100434883|FG000|Year 1 Follow-up|Overall Study||994||
48047130|NCT01905423|100434884|FG001|Year 1 Follow-up|Overall Study||846||
48047131|NCT01905423|100434885|FG002|Year 1 Follow-up|Overall Study||1007||
48047132|NCT01905423|100434886|FG003|Year 1 Follow-up|Overall Study||1275||
48047133|NCT01905423|100434887|FG004|Year 1 Follow-up|Overall Study||1161||
48047134|NCT01905423|100434883|FG000|Year 2 Follow-up|Overall Study||1114||
48047135|NCT01905423|100434884|FG001|Year 2 Follow-up|Overall Study||858||
48047136|NCT01905423|100434885|FG002|Year 2 Follow-up|Overall Study||1043||
48047137|NCT01905423|100434886|FG003|Year 2 Follow-up|Overall Study||0||
48047138|NCT01905423|100434887|FG004|Year 2 Follow-up|Overall Study||0||
48047139|NCT01905423|100434883|FG000|Year 3 Follow-up|Overall Study||905||
48047140|NCT01905423|100434884|FG001|Year 3 Follow-up|Overall Study||871||
48047141|NCT01905423|100434885|FG002|Year 3 Follow-up|Overall Study||1028||
48047142|NCT01905423|100434886|FG003|Year 3 Follow-up|Overall Study||0||
48047143|NCT01905423|100434887|FG004|Year 3 Follow-up|Overall Study||0||
48047144|NCT01905423|100434883|FG000|COMPLETED|Overall Study||4456||
48047145|NCT01905423|100434884|FG001|COMPLETED|Overall Study||3297||
48047146|NCT01905423|100434885|FG002|COMPLETED|Overall Study||4111||
48047147|NCT01905423|100434886|FG003|COMPLETED|Overall Study||2757||
48047148|NCT01905423|100434887|FG004|COMPLETED|Overall Study||2487||
48047149|NCT01905423|100434883|FG000|NOT COMPLETED|Overall Study||0||
48047150|NCT01905423|100434884|FG001|NOT COMPLETED|Overall Study||0||
48047151|NCT01905423|100434885|FG002|NOT COMPLETED|Overall Study||0||
48047152|NCT01905423|100434886|FG003|NOT COMPLETED|Overall Study||0||
48047153|NCT01905423|100434887|FG004|NOT COMPLETED|Overall Study||0||
48047154|NCT02694718|100434888|FG000|STARTED|Overall Study||60||
48047155|NCT02694718|100434888|FG000|COMPLETED|Overall Study||58||
48047156|NCT02694718|100434888|FG000|NOT COMPLETED|Overall Study||2||
48047157|NCT00877773|100434889|FG000|STARTED|Overall Study||44||
48047158|NCT00877773|100434889|FG000|COMPLETED|Overall Study||0||
48047159|NCT00877773|100434889|FG000|NOT COMPLETED|Overall Study||44||
48047160|NCT01673347|100434890|FG000|STARTED|Overall Study||24||
48047161|NCT01673347|100434890|FG000|COMPLETED|Overall Study||17||
48047162|NCT01673347|100434890|FG000|NOT COMPLETED|Overall Study||7||
48047163|NCT03025789|100434891|FG000|STARTED|Overall Study||136||
48047164|NCT03025789|100434892|FG001|STARTED|Overall Study||38||
48047165|NCT03025789|100434891|FG000|COMPLETED|Overall Study||129||
48047166|NCT03025789|100434892|FG001|COMPLETED|Overall Study||35||
48047167|NCT03025789|100434891|FG000|NOT COMPLETED|Overall Study||7||
48047168|NCT03025789|100434892|FG001|NOT COMPLETED|Overall Study||3||
48047169|NCT00813176|100434893|FG000|STARTED|Overall Study||25||
48047170|NCT00813176|100434894|FG001|STARTED|Overall Study||25||
48047171|NCT00813176|100434893|FG000|COMPLETED|Overall Study||25||
48047172|NCT00813176|100434894|FG001|COMPLETED|Overall Study||25||
48047173|NCT00813176|100434893|FG000|NOT COMPLETED|Overall Study||0||
48047174|NCT00813176|100434894|FG001|NOT COMPLETED|Overall Study||0||
48047175|NCT01309893|100434895|FG000|STARTED|Week 1 - First Intervention||33||
48047176|NCT01309893|100434896|FG001|STARTED|Week 1 - First Intervention||33||
48047177|NCT01309893|100434895|FG000|COMPLETED|Week 1 - First Intervention||33||
48047178|NCT01309893|100434896|FG001|COMPLETED|Week 1 - First Intervention||33||
48047179|NCT01309893|100434895|FG000|NOT COMPLETED|Week 1 - First Intervention||0||
48047180|NCT01309893|100434896|FG001|NOT COMPLETED|Week 1 - First Intervention||0||
48047181|NCT01309893|100434895|FG000|STARTED|Week 2 - Crossover Intervention||33||
48047182|NCT01309893|100434896|FG001|STARTED|Week 2 - Crossover Intervention||33||
48047183|NCT01309893|100434895|FG000|COMPLETED|Week 2 - Crossover Intervention||32||
48205880|NCT00172185|100827552|FG002|NOT COMPLETED|Overall Study||5||
48205881|NCT00172185|100827553|FG003|NOT COMPLETED|Overall Study||4||
48205882|NCT00943735|100827554|FG000|STARTED|Overall Study||774||
48205883|NCT00943735|100827554|FG000|Per Protocol Population|Overall Study||500||
48205884|NCT00943735|100827554|FG000|COMPLETED|Overall Study||742||
48205885|NCT00943735|100827554|FG000|NOT COMPLETED|Overall Study||32||
48047184|NCT01309893|100434896|FG001|COMPLETED|Week 2 - Crossover Intervention||32||
48047185|NCT01309893|100434895|FG000|NOT COMPLETED|Week 2 - Crossover Intervention||1||
48047186|NCT01309893|100434896|FG001|NOT COMPLETED|Week 2 - Crossover Intervention||1||
48047187|NCT01723696|100434897|FG000|STARTED|Overall Study||126||
48047188|NCT01723696|100434898|FG001|STARTED|Overall Study||126||
48047189|NCT01723696|100434897|FG000|COMPLETED|Overall Study||109|Number of participants who completed the primary outcome.|
48047190|NCT01723696|100434898|FG001|COMPLETED|Overall Study||113|Number of participants who completed the primary outcome.|
48047191|NCT01723696|100434897|FG000|NOT COMPLETED|Overall Study||17||
48047192|NCT01723696|100434898|FG001|NOT COMPLETED|Overall Study||13||
48047193|NCT04719832|100434899|FG000|STARTED|Overall Study||136||
48047194|NCT04719832|100434900|FG001|STARTED|Overall Study||259||
48047195|NCT04719832|100434899|FG000|Full Analysis Population|Overall Study||132||
48047196|NCT04719832|100434900|FG001|Full Analysis Population|Overall Study||250||
48047197|NCT04719832|100434899|FG000|COMPLETED|Overall Study||122||
48047198|NCT04719832|100434900|FG001|COMPLETED|Overall Study||237||
48047199|NCT04719832|100434899|FG000|NOT COMPLETED|Overall Study||14||
48047200|NCT04719832|100434900|FG001|NOT COMPLETED|Overall Study||22||
48047201|NCT02502006|100434901|FG000|STARTED|Celecoxib||16||
48047202|NCT02502006|100434901|FG000|COMPLETED|Celecoxib||16||
48047203|NCT02502006|100434901|FG000|NOT COMPLETED|Celecoxib||0||
48047204|NCT02502006|100434901|FG000|STARTED|Naproxen||16||
48047205|NCT02502006|100434901|FG000|COMPLETED|Naproxen||16||
48047206|NCT02502006|100434901|FG000|NOT COMPLETED|Naproxen||0||
48047207|NCT02502006|100434901|FG000|STARTED|Placebo||16||
48047208|NCT02502006|100434901|FG000|COMPLETED|Placebo||16||
48047209|NCT02502006|100434901|FG000|NOT COMPLETED|Placebo||0||
48047210|NCT00976508|100434902|FG000|STARTED|Overall Study||17||
48047211|NCT00976508|100434903|FG001|STARTED|Overall Study||6||
48047212|NCT00976508|100434902|FG000|COMPLETED|Overall Study||3||
48047213|NCT00976508|100434903|FG001|COMPLETED|Overall Study||0||
48047214|NCT00976508|100434902|FG000|NOT COMPLETED|Overall Study||14||
48047215|NCT00976508|100434903|FG001|NOT COMPLETED|Overall Study||6||
48047216|NCT05780268|100434904|FG000|STARTED|Overall Study||163||
48047217|NCT05780268|100434905|FG001|STARTED|Overall Study||151||
48047218|NCT05780268|100434904|FG000|COMPLETED|Overall Study||163||
48047219|NCT05780268|100434905|FG001|COMPLETED|Overall Study||151||
48047220|NCT05780268|100434904|FG000|NOT COMPLETED|Overall Study||0||
48047221|NCT05780268|100434905|FG001|NOT COMPLETED|Overall Study||0||
48047222|NCT01758289|100434906|FG000|STARTED|Overall Study||105||
48047223|NCT01758289|100434906|FG000|COMPLETED|Overall Study||52||
48047224|NCT01758289|100434906|FG000|NOT COMPLETED|Overall Study||53||
48047225|NCT01129024|100434907|FG000|STARTED|Overall Study||19||
48047226|NCT01129024|100434907|FG000|COMPLETED|Overall Study||0||
48047227|NCT01129024|100434907|FG000|NOT COMPLETED|Overall Study||19||
48047228|NCT01752036|100434908|FG000|STARTED|Overall Study||33||
48047229|NCT01752036|100434908|FG000|COMPLETED|Overall Study||31||
48047230|NCT01752036|100434908|FG000|NOT COMPLETED|Overall Study||2||
48047231|NCT02290431|100434909|FG000|STARTED|Overall Study||31||
48047232|NCT02290431|100434909|FG000|Subjects. Discont. Prematurely|Overall Study||27||
48047233|NCT02290431|100434909|FG000|Subjects Completed Study Per Protocol|Overall Study||8||
48047234|NCT02290431|100434909|FG000|Subjs. Ntered Post-treatment Eval. Phase|Overall Study||31||
48047235|NCT02290431|100434909|FG000|Subjects Entered Survival f/u Phase|Overall Study||24||
48047236|NCT02290431|100434909|FG000|Entered Treatment Phase 2|Overall Study||17||
48047237|NCT02290431|100434909|FG000|COMPLETED|Overall Study||4||
48047238|NCT02290431|100434909|FG000|NOT COMPLETED|Overall Study||27||
48047239|NCT00827931|100434910|FG000|STARTED|Overall Study||49||
48047240|NCT00827931|100434911|FG001|STARTED|Overall Study||45||
48047241|NCT00827931|100434910|FG000|COMPLETED|Overall Study||43||
48047242|NCT00827931|100434911|FG001|COMPLETED|Overall Study||39||
48047243|NCT00827931|100434910|FG000|NOT COMPLETED|Overall Study||6||
48047244|NCT00827931|100434911|FG001|NOT COMPLETED|Overall Study||6||
48047245|NCT03170232|100434912|FG000|STARTED|Overall Study||27||
48047246|NCT03170232|100434913|FG001|STARTED|Overall Study||27||
48047247|NCT03170232|100434912|FG000|COMPLETED|Overall Study||0||
48047248|NCT03170232|100434913|FG001|COMPLETED|Overall Study||0||
48047249|NCT03170232|100434912|FG000|NOT COMPLETED|Overall Study||27||
48047250|NCT03170232|100434913|FG001|NOT COMPLETED|Overall Study||27||
48047251|NCT00219544|100434914|FG000|STARTED|Single Blind Treatment Period||256||
48047252|NCT00219544|100434915|FG001|STARTED|Single Blind Treatment Period||0||
48047253|NCT00219544|100434914|FG000|COMPLETED|Single Blind Treatment Period||234||
48047254|NCT00219544|100434915|FG001|COMPLETED|Single Blind Treatment Period||0||
48495536|NCT05590039|101547870|FG000|NOT COMPLETED|Overall Study||0||
48047255|NCT00219544|100434914|FG000|NOT COMPLETED|Single Blind Treatment Period||22||
48047256|NCT00219544|100434915|FG001|NOT COMPLETED|Single Blind Treatment Period||0||
48047257|NCT00219544|100434914|FG000|STARTED|Double Blind Treatment Period||80||
48047258|NCT00219544|100434915|FG001|STARTED|Double Blind Treatment Period||77||
48047259|NCT00219544|100434914|FG000|COMPLETED|Double Blind Treatment Period||80||
48047260|NCT00219544|100434915|FG001|COMPLETED|Double Blind Treatment Period||77||
48047261|NCT00219544|100434914|FG000|NOT COMPLETED|Double Blind Treatment Period||0||
48047262|NCT00219544|100434915|FG001|NOT COMPLETED|Double Blind Treatment Period||0||
48047263|NCT03239665|100434916|FG000|STARTED|Overall Study||175||
48047264|NCT03239665|100434917|FG001|STARTED|Overall Study||160||
48047265|NCT03239665|100434916|FG000|Met Inclusion Criteria|Overall Study||150||
48047266|NCT03239665|100434917|FG001|Met Inclusion Criteria|Overall Study||144||
48047267|NCT03239665|100434916|FG000|Submitted Survey Data|Overall Study||147||
48047268|NCT03239665|100434917|FG001|Submitted Survey Data|Overall Study||140||
48047269|NCT03239665|100434916|FG000|COMPLETED|Overall Study||147||
48047270|NCT03239665|100434917|FG001|COMPLETED|Overall Study||140||
48047271|NCT03239665|100434916|FG000|NOT COMPLETED|Overall Study||28||
48047272|NCT03239665|100434917|FG001|NOT COMPLETED|Overall Study||20||
48047273|NCT01925989|100434918|FG000|STARTED|Period 1||7||
48047274|NCT01925989|100434919|FG001|STARTED|Period 1||8||
48047275|NCT01925989|100434920|FG002|STARTED|Period 1||12||
48047276|NCT01925989|100434918|FG000|Received at Least 1 Dose of Study Drug|Period 1||7||
48047277|NCT01925989|100434919|FG001|Received at Least 1 Dose of Study Drug|Period 1||8||
48047278|NCT01925989|100434920|FG002|Received at Least 1 Dose of Study Drug|Period 1||0||
48047279|NCT01925989|100434918|FG000|COMPLETED|Period 1||6||
48047280|NCT01925989|100434919|FG001|COMPLETED|Period 1||6||
48047281|NCT01925989|100434920|FG002|COMPLETED|Period 1||12||
48047282|NCT01925989|100434918|FG000|NOT COMPLETED|Period 1||1||
48047283|NCT01925989|100434919|FG001|NOT COMPLETED|Period 1||2||
48047284|NCT01925989|100434920|FG002|NOT COMPLETED|Period 1||0||
48047285|NCT01925989|100434918|FG000|STARTED|Period 2||6||
48047286|NCT01925989|100434919|FG001|STARTED|Period 2||6||
48047287|NCT01925989|100434920|FG002|STARTED|Period 2||12||
48047288|NCT01925989|100434918|FG000|COMPLETED|Period 2||6||
48047289|NCT01925989|100434919|FG001|COMPLETED|Period 2||6||
48047290|NCT01925989|100434920|FG002|COMPLETED|Period 2||12||
48047291|NCT01925989|100434918|FG000|NOT COMPLETED|Period 2||0||
48047292|NCT01925989|100434919|FG001|NOT COMPLETED|Period 2||0||
48047293|NCT01925989|100434920|FG002|NOT COMPLETED|Period 2||0||
48047294|NCT01445626|100434921|FG000|STARTED|Overall Study||87||
48047295|NCT01445626|100434921|FG000|COMPLETED|Overall Study||87||
48047296|NCT01445626|100434921|FG000|NOT COMPLETED|Overall Study||0||
48047297|NCT04456153|100434922|FG000|STARTED|Overall Study||19||
48047298|NCT04456153|100434923|FG001|STARTED|Overall Study||41||
48047299|NCT04456153|100434922|FG000|COMPLETED|Overall Study||19||
48047300|NCT04456153|100434923|FG001|COMPLETED|Overall Study||41||
48047301|NCT04456153|100434922|FG000|NOT COMPLETED|Overall Study||0||
48047302|NCT04456153|100434923|FG001|NOT COMPLETED|Overall Study||0||
48047303|NCT01606878|100434924|FG000|STARTED|Overall Study||6||
48047304|NCT01606878|100434925|FG001|STARTED|Overall Study||4||
48047305|NCT01606878|100434926|FG002|STARTED|Overall Study||5||
48047306|NCT01606878|100434927|FG003|STARTED|Overall Study||3||
48205886|NCT02031471|100827555|FG000|STARTED|24 Week Treatment Period||57||
48047307|NCT01606878|100434928|FG004|STARTED|Overall Study||3||
48205887|NCT02031471|100827555|FG000|COMPLETED|24 Week Treatment Period||46||
48205888|NCT02031471|100827555|FG000|NOT COMPLETED|24 Week Treatment Period||11||
48205889|NCT02031471|100827555|FG000|STARTED|Long Term Extension (LTE) Period||39||
48205890|NCT02031471|100827555|FG000|COMPLETED|Long Term Extension (LTE) Period||37||
48205891|NCT02031471|100827555|FG000|NOT COMPLETED|Long Term Extension (LTE) Period||2||
48205892|NCT00970307|100827556|FG000|STARTED|Overall Study||141||
48205893|NCT00970307|100827557|FG001|STARTED|Overall Study||139||
48205894|NCT00970307|100827558|FG002|STARTED|Overall Study||141||
48205895|NCT00970307|100827556|FG000|COMPLETED|Overall Study||138||
48205896|NCT00970307|100827557|FG001|COMPLETED|Overall Study||136||
48205897|NCT00970307|100827558|FG002|COMPLETED|Overall Study||139||
48205898|NCT00970307|100827556|FG000|NOT COMPLETED|Overall Study||3||
48205899|NCT00970307|100827557|FG001|NOT COMPLETED|Overall Study||3||
48205900|NCT00970307|100827558|FG002|NOT COMPLETED|Overall Study||2||
48205901|NCT00282971|100827559|FG000|STARTED|Overall Study||180||
48205902|NCT00282971|100827560|FG001|STARTED|Overall Study||171||
48205903|NCT00282971|100827559|FG000|COMPLETED|Overall Study||146||
48495537|NCT01447511|101547871|FG000|STARTED|Control Period||8||
48047308|NCT01606878|100434929|FG005|STARTED|Overall Study||4||
48047309|NCT01606878|100434930|FG006|STARTED|Overall Study||6||
48047310|NCT01606878|100434931|FG007|STARTED|Overall Study||3||
48205904|NCT00282971|100827560|FG001|COMPLETED|Overall Study||149||
48205905|NCT00282971|100827559|FG000|NOT COMPLETED|Overall Study||34||
48205906|NCT00282971|100827560|FG001|NOT COMPLETED|Overall Study||22||
48205907|NCT05274217|100827561|FG000|STARTED|Overall Study||33||
48495538|NCT01447511|101547872|FG001|STARTED|Control Period||5||
48047311|NCT01606878|100434932|FG008|STARTED|Overall Study||6||
48047312|NCT01606878|100434933|FG009|STARTED|Overall Study||3||
48047313|NCT01606878|100434934|FG010|STARTED|Overall Study||3||
48047314|NCT01606878|100434924|FG000|COMPLETED|Overall Study||0||
48047315|NCT01606878|100434925|FG001|COMPLETED|Overall Study||0||
48047316|NCT01606878|100434926|FG002|COMPLETED|Overall Study||0||
48047317|NCT01606878|100434927|FG003|COMPLETED|Overall Study||0||
48205908|NCT05274217|100827562|FG001|STARTED|Overall Study||0||
48205909|NCT05274217|100827561|FG000|COMPLETED|Overall Study||22||
48205910|NCT05274217|100827562|FG001|COMPLETED|Overall Study||0||
48205911|NCT05274217|100827561|FG000|NOT COMPLETED|Overall Study||11||
48205912|NCT05274217|100827562|FG001|NOT COMPLETED|Overall Study||0||
48205913|NCT01942707|100827563|FG000|STARTED|Overall Study||23||
48205914|NCT01942707|100827564|FG001|STARTED|Overall Study||23||
48047318|NCT01606878|100434928|FG004|COMPLETED|Overall Study||0||
48047319|NCT01606878|100434929|FG005|COMPLETED|Overall Study||0||
48047320|NCT01606878|100434930|FG006|COMPLETED|Overall Study||0||
48047321|NCT01606878|100434931|FG007|COMPLETED|Overall Study||0||
48047322|NCT01606878|100434932|FG008|COMPLETED|Overall Study||0||
48047323|NCT01606878|100434933|FG009|COMPLETED|Overall Study||0||
48047324|NCT01606878|100434934|FG010|COMPLETED|Overall Study||0||
48047325|NCT01606878|100434924|FG000|NOT COMPLETED|Overall Study||6||
48047326|NCT01606878|100434925|FG001|NOT COMPLETED|Overall Study||4||
48047327|NCT01606878|100434926|FG002|NOT COMPLETED|Overall Study||5||
48205915|NCT01942707|100827563|FG000|COMPLETED|Overall Study||23||
48205916|NCT01942707|100827564|FG001|COMPLETED|Overall Study||23||
48205917|NCT01942707|100827563|FG000|NOT COMPLETED|Overall Study||0||
48205918|NCT01942707|100827564|FG001|NOT COMPLETED|Overall Study||0||
48205919|NCT04480827|100827565|FG000|STARTED|Overall Study||8||
48047328|NCT01606878|100434927|FG003|NOT COMPLETED|Overall Study||3||
48205920|NCT04480827|100827566|FG001|STARTED|Overall Study||8||
48047329|NCT01606878|100434928|FG004|NOT COMPLETED|Overall Study||3||
48047330|NCT01606878|100434929|FG005|NOT COMPLETED|Overall Study||4||
48205921|NCT04480827|100827567|FG002|STARTED|Overall Study||8||
48205922|NCT04480827|100827568|FG003|STARTED|Overall Study||15||
48205923|NCT04480827|100827569|FG004|STARTED|Overall Study||4||
48205924|NCT04480827|100827570|FG005|STARTED|Overall Study||7||
48205925|NCT04480827|100827571|FG006|STARTED|Overall Study||7||
48205926|NCT04480827|100827565|FG000|COMPLETED|Overall Study||8||
48205927|NCT04480827|100827566|FG001|COMPLETED|Overall Study||8||
48205928|NCT04480827|100827567|FG002|COMPLETED|Overall Study||8||
48205929|NCT04480827|100827568|FG003|COMPLETED|Overall Study||15||
48205930|NCT04480827|100827569|FG004|COMPLETED|Overall Study||4||
48205931|NCT04480827|100827570|FG005|COMPLETED|Overall Study||6||
48205932|NCT04480827|100827571|FG006|COMPLETED|Overall Study||7||
48205933|NCT04480827|100827565|FG000|NOT COMPLETED|Overall Study||0||
48205934|NCT04480827|100827566|FG001|NOT COMPLETED|Overall Study||0||
48205935|NCT04480827|100827567|FG002|NOT COMPLETED|Overall Study||0||
48205936|NCT04480827|100827568|FG003|NOT COMPLETED|Overall Study||0||
48205937|NCT04480827|100827569|FG004|NOT COMPLETED|Overall Study||0||
48205938|NCT04480827|100827570|FG005|NOT COMPLETED|Overall Study||1||
48205939|NCT04480827|100827571|FG006|NOT COMPLETED|Overall Study||0||
48205940|NCT01944319|100827572|FG000|STARTED|Overall Study||40||
48205941|NCT01944319|100827573|FG001|STARTED|Overall Study||39||
48205942|NCT01944319|100827572|FG000|COMPLETED|Overall Study||40||
48205943|NCT01944319|100827573|FG001|COMPLETED|Overall Study||39||
48205944|NCT01944319|100827572|FG000|NOT COMPLETED|Overall Study||0||
48205945|NCT01944319|100827573|FG001|NOT COMPLETED|Overall Study||0||
48205946|NCT01097343|100827574|FG000|STARTED|First Intervention- 30 Days||25||
48205947|NCT01097343|100827575|FG001|STARTED|First Intervention- 30 Days||25||
48205948|NCT01097343|100827574|FG000|COMPLETED|First Intervention- 30 Days||25||
48205949|NCT01097343|100827575|FG001|COMPLETED|First Intervention- 30 Days||25||
48205950|NCT01097343|100827574|FG000|NOT COMPLETED|First Intervention- 30 Days||0||
48205951|NCT01097343|100827575|FG001|NOT COMPLETED|First Intervention- 30 Days||0||
48205952|NCT01097343|100827574|FG000|STARTED|Second Intervention- 30 Days||25||
48205953|NCT01097343|100827575|FG001|STARTED|Second Intervention- 30 Days||25||
48205954|NCT01097343|100827574|FG000|COMPLETED|Second Intervention- 30 Days||25||
48205955|NCT01097343|100827575|FG001|COMPLETED|Second Intervention- 30 Days||25||
48205956|NCT01097343|100827574|FG000|NOT COMPLETED|Second Intervention- 30 Days||0||
48205957|NCT01097343|100827575|FG001|NOT COMPLETED|Second Intervention- 30 Days||0||
48205958|NCT02441036|100827576|FG000|STARTED|Overall Study||3||
48205959|NCT02441036|100827577|FG001|STARTED|Overall Study||5||
48205960|NCT02441036|100827578|FG002|STARTED|Overall Study||3||
48205961|NCT02441036|100827579|FG003|STARTED|Overall Study||4||
48205962|NCT02441036|100827580|FG004|STARTED|Overall Study||1||
48205963|NCT02441036|100827576|FG000|Treated|Overall Study||3||
48205964|NCT02441036|100827577|FG001|Treated|Overall Study||5||
48205965|NCT02441036|100827578|FG002|Treated|Overall Study||3||
48205966|NCT02441036|100827579|FG003|Treated|Overall Study||4||
48205967|NCT02441036|100827580|FG004|Treated|Overall Study||1||
48205968|NCT02441036|100827576|FG000|Tissue Resected|Overall Study||3||
48205969|NCT02441036|100827577|FG001|Tissue Resected|Overall Study||4||
48205970|NCT02441036|100827578|FG002|Tissue Resected|Overall Study||3||
48047331|NCT01606878|100434930|FG006|NOT COMPLETED|Overall Study||6||
48205971|NCT02441036|100827579|FG003|Tissue Resected|Overall Study||3||
48047332|NCT01606878|100434931|FG007|NOT COMPLETED|Overall Study||3||
48047333|NCT01606878|100434932|FG008|NOT COMPLETED|Overall Study||6||
48047334|NCT01606878|100434933|FG009|NOT COMPLETED|Overall Study||3||
48205972|NCT02441036|100827580|FG004|Tissue Resected|Overall Study||1||
48205973|NCT02441036|100827576|FG000|COMPLETED|Overall Study||3||
48205974|NCT02441036|100827577|FG001|COMPLETED|Overall Study||4||
48205975|NCT02441036|100827578|FG002|COMPLETED|Overall Study||3||
48205976|NCT02441036|100827579|FG003|COMPLETED|Overall Study||3||
48205977|NCT02441036|100827580|FG004|COMPLETED|Overall Study||1||
48205978|NCT02441036|100827576|FG000|NOT COMPLETED|Overall Study||0||
48205979|NCT02441036|100827577|FG001|NOT COMPLETED|Overall Study||1||
48205980|NCT02441036|100827578|FG002|NOT COMPLETED|Overall Study||0||
48205981|NCT02441036|100827579|FG003|NOT COMPLETED|Overall Study||1||
48205982|NCT02441036|100827580|FG004|NOT COMPLETED|Overall Study||0||
48205983|NCT02950896|100827581|FG000|STARTED|Overall Study||4||
48205984|NCT02950896|100827581|FG000|COMPLETED|Overall Study||4||
48205985|NCT02950896|100827581|FG000|NOT COMPLETED|Overall Study||0||
48205986|NCT01183780|100827582|FG000|STARTED|Overall Study||536||
48205987|NCT01183780|100827583|FG001|STARTED|Overall Study||536||
48205988|NCT01183780|100827582|FG000|Received at Least 1 Dose of Study Drug|Overall Study||528||
48047335|NCT01606878|100434934|FG010|NOT COMPLETED|Overall Study||3||
48047336|NCT04291001|100434935|FG000|STARTED|Overall Study||20||
48047337|NCT04291001|100434936|FG001|STARTED|Overall Study||20||
48047338|NCT04291001|100434935|FG000|COMPLETED|Overall Study||20||
48047339|NCT04291001|100434936|FG001|COMPLETED|Overall Study||19||
48047340|NCT04291001|100434935|FG000|NOT COMPLETED|Overall Study||0||
48047341|NCT04291001|100434936|FG001|NOT COMPLETED|Overall Study||1||
48047342|NCT02519855|100434937|FG000|STARTED|Overall Study||441||
48047343|NCT02519855|100434938|FG001|STARTED|Overall Study||441||
48047344|NCT02519855|100434937|FG000|Vaccinated on Day 1|Overall Study||440||
48047345|NCT02519855|100434938|FG001|Vaccinated on Day 1|Overall Study||441||
48047346|NCT02519855|100434937|FG000|Vaccinated at Week 4|Overall Study||432||
48047347|NCT02519855|100434938|FG001|Vaccinated at Week 4|Overall Study||424||
48047348|NCT02519855|100434937|FG000|COMPLETED|Overall Study||438||
48047349|NCT02519855|100434938|FG001|COMPLETED|Overall Study||437||
48047350|NCT02519855|100434937|FG000|NOT COMPLETED|Overall Study||3||
48047351|NCT02519855|100434938|FG001|NOT COMPLETED|Overall Study||4||
48047352|NCT01226121|100434939|FG000|STARTED|Overall Study||13||
48047353|NCT01226121|100434940|FG001|STARTED|Overall Study||11||
48047354|NCT01226121|100434941|FG002|STARTED|Overall Study||13||
48047355|NCT01226121|100434939|FG000|30 Day Evaluation|Overall Study||12||
48047356|NCT01226121|100434940|FG001|30 Day Evaluation|Overall Study||11||
48047357|NCT01226121|100434941|FG002|30 Day Evaluation|Overall Study||13||
48047358|NCT01226121|100434939|FG000|COMPLETED|Overall Study||11||
48047359|NCT01226121|100434940|FG001|COMPLETED|Overall Study||11||
48047360|NCT01226121|100434941|FG002|COMPLETED|Overall Study||12||
48047361|NCT01226121|100434939|FG000|NOT COMPLETED|Overall Study||2||
48047362|NCT01226121|100434940|FG001|NOT COMPLETED|Overall Study||0||
48047363|NCT01226121|100434941|FG002|NOT COMPLETED|Overall Study||1||
48047364|NCT02599051|100434942|FG000|STARTED|Overall Study||49||
48047365|NCT02599051|100434943|FG001|STARTED|Overall Study||49||
48047366|NCT02599051|100434942|FG000|COMPLETED|Overall Study||42||
48047367|NCT02599051|100434943|FG001|COMPLETED|Overall Study||41||
48047368|NCT02599051|100434942|FG000|NOT COMPLETED|Overall Study||7||
48047369|NCT02599051|100434943|FG001|NOT COMPLETED|Overall Study||8||
48047370|NCT00541190|100434944|FG000|STARTED|Overall Study||10||
48047371|NCT00541190|100434945|FG001|STARTED|Overall Study||11||
48047372|NCT00541190|100434944|FG000|COMPLETED|Overall Study||10||
48047373|NCT00541190|100434945|FG001|COMPLETED|Overall Study||11||
48047374|NCT00541190|100434944|FG000|NOT COMPLETED|Overall Study||0||
48047375|NCT00541190|100434945|FG001|NOT COMPLETED|Overall Study||0||
48047376|NCT01923168|100434946|FG000|STARTED|Overall Study||131||
48047377|NCT01923168|100434947|FG001|STARTED|Overall Study||83||
48047378|NCT01923168|100434948|FG002|STARTED|Overall Study||126||
48047379|NCT01923168|100434946|FG000|COMPLETED|Overall Study||94||
48047380|NCT01923168|100434947|FG001|COMPLETED|Overall Study||44||
48047381|NCT01923168|100434948|FG002|COMPLETED|Overall Study||109||
48047382|NCT01923168|100434946|FG000|NOT COMPLETED|Overall Study||37||
48047383|NCT01923168|100434947|FG001|NOT COMPLETED|Overall Study||39||
48047384|NCT01923168|100434948|FG002|NOT COMPLETED|Overall Study||17||
48047385|NCT03398278|100434949|FG000|STARTED|Period 1||19||
48047386|NCT03398278|100434950|FG001|STARTED|Period 1||19||
48047387|NCT03398278|100434949|FG000|COMPLETED|Period 1||18||
48047388|NCT03398278|100434950|FG001|COMPLETED|Period 1||19||
48047389|NCT03398278|100434949|FG000|NOT COMPLETED|Period 1||1||
48047390|NCT03398278|100434950|FG001|NOT COMPLETED|Period 1||0||
48047391|NCT03398278|100434949|FG000|STARTED|Period 2||18||
48047392|NCT03398278|100434950|FG001|STARTED|Period 2||19||
48047393|NCT03398278|100434949|FG000|COMPLETED|Period 2||16||
48047394|NCT03398278|100434950|FG001|COMPLETED|Period 2||17||
48047395|NCT03398278|100434949|FG000|NOT COMPLETED|Period 2||2||
48047396|NCT03398278|100434950|FG001|NOT COMPLETED|Period 2||2||
48205989|NCT01183780|100827583|FG001|Received at Least 1 Dose of Study Drug|Overall Study||529||
48205990|NCT01183780|100827582|FG000|COMPLETED|Overall Study||505||
48205991|NCT01183780|100827583|FG001|COMPLETED|Overall Study||511||
48205992|NCT01183780|100827582|FG000|NOT COMPLETED|Overall Study||31||
48205993|NCT01183780|100827583|FG001|NOT COMPLETED|Overall Study||25||
48205994|NCT01039688|100827584|FG000|STARTED|Overall Study||373||
48047397|NCT01673282|100434951|FG000|STARTED|Overall Study||153||
48047398|NCT01673282|100434952|FG001|STARTED|Overall Study||158||
48047399|NCT01673282|100434951|FG000|COMPLETED|Overall Study||120||
48047400|NCT01673282|100434952|FG001|COMPLETED|Overall Study||132||
48047401|NCT01673282|100434951|FG000|NOT COMPLETED|Overall Study||33||
48047402|NCT01673282|100434952|FG001|NOT COMPLETED|Overall Study||26||
48047403|NCT01489111|100434953|FG000|STARTED|Overall Study||36||53
48047404|NCT01489111|100434953|FG000|COMPLETED|Overall Study||35||49
48047405|NCT01489111|100434953|FG000|NOT COMPLETED|Overall Study||1||4
48205995|NCT01039688|100827585|FG001|STARTED|Overall Study||397||
48205996|NCT01039688|100827586|FG002|STARTED|Overall Study||186||
48205997|NCT01039688|100827584|FG000|COMPLETED|Overall Study||266||
48205998|NCT01039688|100827585|FG001|COMPLETED|Overall Study||286||
48205999|NCT01039688|100827586|FG002|COMPLETED|Overall Study||106||
48206000|NCT01039688|100827584|FG000|NOT COMPLETED|Overall Study||107||
48206001|NCT01039688|100827585|FG001|NOT COMPLETED|Overall Study||111||
48206002|NCT01039688|100827586|FG002|NOT COMPLETED|Overall Study||80||
48206003|NCT00880048|100827587|FG000|STARTED|Overall Study||116||
48206004|NCT00880048|100827588|FG001|STARTED|Overall Study||115||
48206005|NCT00880048|100827589|FG002|STARTED|Overall Study||112||
48206006|NCT00880048|100827587|FG000|COMPLETED|Overall Study||88||
48206007|NCT00880048|100827588|FG001|COMPLETED|Overall Study||82||
48206008|NCT00880048|100827589|FG002|COMPLETED|Overall Study||77||
48206009|NCT00880048|100827587|FG000|NOT COMPLETED|Overall Study||28||
48495539|NCT01447511|101547873|FG002|STARTED|Control Period||9||
48495540|NCT01447511|101547874|FG003|STARTED|Control Period||3||
48495541|NCT01447511|101547875|FG004|STARTED|Control Period||4||
48047406|NCT02353143|100434954|FG000|STARTED|Overall Study||4|number of patients treated|
48047407|NCT02353143|100434955|FG001|STARTED|Overall Study||7|number of patients treated|
48047408|NCT02353143|100434956|FG002|STARTED|Overall Study||6|number of patients treated|
48047409|NCT02353143|100434957|FG003|STARTED|Overall Study||8|number of patients treated|
48047410|NCT02353143|100434958|FG004|STARTED|Overall Study||26|number of patients treated|
48047411|NCT02353143|100434959|FG005|STARTED|Overall Study||5|number of patients treated|
48047412|NCT02353143|100434960|FG006|STARTED|Overall Study||3|number of patients treated|
48047413|NCT02353143|100434961|FG007|STARTED|Overall Study||8|number of patients treated|
48047414|NCT02353143|100434962|FG008|STARTED|Overall Study||4|number of patients treated|
48047415|NCT02353143|100434954|FG000|COMPLETED|Overall Study||0||
48047416|NCT02353143|100434955|FG001|COMPLETED|Overall Study||0||
48047417|NCT02353143|100434956|FG002|COMPLETED|Overall Study||0||
48047418|NCT02353143|100434957|FG003|COMPLETED|Overall Study||0||
48047419|NCT02353143|100434958|FG004|COMPLETED|Overall Study||0||
48047420|NCT02353143|100434959|FG005|COMPLETED|Overall Study||0||
48047421|NCT02353143|100434960|FG006|COMPLETED|Overall Study||0||
48047422|NCT02353143|100434961|FG007|COMPLETED|Overall Study||0||
48047423|NCT02353143|100434962|FG008|COMPLETED|Overall Study||0||
48047424|NCT02353143|100434954|FG000|NOT COMPLETED|Overall Study||4||
48047425|NCT02353143|100434955|FG001|NOT COMPLETED|Overall Study||7||
48047426|NCT02353143|100434956|FG002|NOT COMPLETED|Overall Study||6||
48047427|NCT02353143|100434957|FG003|NOT COMPLETED|Overall Study||8||
48047428|NCT02353143|100434958|FG004|NOT COMPLETED|Overall Study||26||
48047429|NCT02353143|100434959|FG005|NOT COMPLETED|Overall Study||5||
48047430|NCT02353143|100434960|FG006|NOT COMPLETED|Overall Study||3||
48047431|NCT02353143|100434961|FG007|NOT COMPLETED|Overall Study||8||
48047432|NCT02353143|100434962|FG008|NOT COMPLETED|Overall Study||4||
48047433|NCT02380690|100434963|FG000|STARTED|Overall Study||119||
48047434|NCT02380690|100434964|FG001|STARTED|Overall Study||94||
48047435|NCT02380690|100434963|FG000|COMPLETED|Overall Study||85||
48047436|NCT02380690|100434964|FG001|COMPLETED|Overall Study||82||
48047437|NCT02380690|100434963|FG000|NOT COMPLETED|Overall Study||34||
48047438|NCT02380690|100434964|FG001|NOT COMPLETED|Overall Study||12||
48047439|NCT01426789|100434965|FG000|STARTED|Part 1||68||
48047440|NCT01426789|100434966|FG001|STARTED|Part 1||32||
48047441|NCT01426789|100434967|FG002|STARTED|Part 1||0||
48206010|NCT00880048|100827588|FG001|NOT COMPLETED|Overall Study||33||
48206011|NCT00880048|100827589|FG002|NOT COMPLETED|Overall Study||35||
48206012|NCT01692938|100827590|FG000|STARTED|Overall Study||16||
48206013|NCT01692938|100827591|FG001|STARTED|Overall Study||16||
48206014|NCT01692938|100827590|FG000|COMPLETED|Overall Study||12||
48206015|NCT01692938|100827591|FG001|COMPLETED|Overall Study||12||
48206016|NCT01692938|100827590|FG000|NOT COMPLETED|Overall Study||4||
48206017|NCT01692938|100827591|FG001|NOT COMPLETED|Overall Study||4||
48206018|NCT00317226|100827592|FG000|STARTED|Overall Study||127||
48206019|NCT00317226|100827592|FG000|COMPLETED|Overall Study||104||
48206020|NCT00317226|100827592|FG000|NOT COMPLETED|Overall Study||23||
48206021|NCT03861767|100827593|FG000|STARTED|Overall Study||39||
48206022|NCT03861767|100827594|FG001|STARTED|Overall Study||20||
48206023|NCT03861767|100827595|FG002|STARTED|Overall Study||5||
48206024|NCT03861767|100827596|FG003|STARTED|Overall Study||39||
48206025|NCT03861767|100827597|FG004|STARTED|Overall Study||19||
48206026|NCT03861767|100827598|FG005|STARTED|Overall Study||8||
48206027|NCT03861767|100827599|FG006|STARTED|Overall Study||40||
48206028|NCT03861767|100827600|FG007|STARTED|Overall Study||26||
48206029|NCT03861767|100827601|FG008|STARTED|Overall Study||0||
48206030|NCT03861767|100827602|FG009|STARTED|Overall Study||106||
48206031|NCT03861767|100827593|FG000|Underwent Surgery|Overall Study||36||
48206032|NCT03861767|100827594|FG001|Underwent Surgery|Overall Study||20||
48206033|NCT03861767|100827595|FG002|Underwent Surgery|Overall Study||5||
48206034|NCT03861767|100827596|FG003|Underwent Surgery|Overall Study||35||
48206035|NCT03861767|100827597|FG004|Underwent Surgery|Overall Study||19||
48206036|NCT03861767|100827598|FG005|Underwent Surgery|Overall Study||8||
48206037|NCT03861767|100827599|FG006|Underwent Surgery|Overall Study||38||
48206038|NCT03861767|100827600|FG007|Underwent Surgery|Overall Study||23||
48495542|NCT01447511|101547871|FG000|COMPLETED|Control Period||8||
48206039|NCT03861767|100827601|FG008|Underwent Surgery|Overall Study||0||
48206040|NCT03861767|100827602|FG009|Underwent Surgery|Overall Study||98||
48206041|NCT03861767|100827593|FG000|Drug Compliance|Overall Study||34||
48206042|NCT03861767|100827594|FG001|Drug Compliance|Overall Study||19||
48206043|NCT03861767|100827595|FG002|Drug Compliance|Overall Study||4||
48206044|NCT03861767|100827596|FG003|Drug Compliance|Overall Study||37||
48206045|NCT03861767|100827597|FG004|Drug Compliance|Overall Study||15||
48206046|NCT03861767|100827598|FG005|Drug Compliance|Overall Study||8||
48206047|NCT03861767|100827599|FG006|Drug Compliance|Overall Study||35||
48206048|NCT03861767|100827600|FG007|Drug Compliance|Overall Study||21||
48206049|NCT03861767|100827601|FG008|Drug Compliance|Overall Study||0||
48206050|NCT03861767|100827602|FG009|Drug Compliance|Overall Study||95||
48206051|NCT03861767|100827593|FG000|COMPLETED|Overall Study||37|This total number is for intention-to-treat group. Per-Protocol group is the compliant group - (the group that did not undergo surgery + group that withdrew)|
48206052|NCT03861767|100827594|FG001|COMPLETED|Overall Study||19|This total number is for intention-to-treat group. Per-Protocol group is the compliant group - (the group that did not undergo surgery + group that withdrew)|
48206053|NCT03861767|100827595|FG002|COMPLETED|Overall Study||5|This total number is for intention-to-treat group. Per-Protocol group is the compliant group - (the group that did not undergo surgery + group that withdrew)|
48206054|NCT03861767|100827596|FG003|COMPLETED|Overall Study||34|This total number is for intention-to-treat group. Per-Protocol group is the compliant group - (the group that did not undergo surgery + group that withdrew)|
48047442|NCT01426789|100434968|FG003|STARTED|Part 1||0||
48047443|NCT01426789|100434969|FG004|STARTED|Part 1||0||
48047444|NCT01426789|100434970|FG005|STARTED|Part 1||0||
48206055|NCT03861767|100827597|FG004|COMPLETED|Overall Study||17|This total number is for intention-to-treat group. Per-Protocol group is the compliant group - (the group that did not undergo surgery + group that withdrew)|
48206056|NCT03861767|100827598|FG005|COMPLETED|Overall Study||7|This total number is for intention-to-treat group. Per-Protocol group is the compliant group - (the group that did not undergo surgery + group that withdrew)|
48206057|NCT03861767|100827599|FG006|COMPLETED|Overall Study||37|This total number is for intention-to-treat group. Per-Protocol group is the compliant group - (the group that did not undergo surgery + group that withdrew)|
48206058|NCT03861767|100827600|FG007|COMPLETED|Overall Study||25|This total number is for intention-to-treat group. Per-Protocol group is the compliant group - (the group that did not undergo surgery + group that withdrew)|
48206059|NCT03861767|100827601|FG008|COMPLETED|Overall Study||0|This total number is for intention-to-treat group. Per-Protocol group is the compliant group - (the group that did not undergo surgery + group that withdrew)|
48206060|NCT03861767|100827602|FG009|COMPLETED|Overall Study||101|This total number is for intention-to-treat group. Per-Protocol group is the compliant group - (the group that did not undergo surgery + group that withdrew)|
48206061|NCT03861767|100827593|FG000|NOT COMPLETED|Overall Study||2||
48206062|NCT03861767|100827594|FG001|NOT COMPLETED|Overall Study||1||
48206063|NCT03861767|100827595|FG002|NOT COMPLETED|Overall Study||0||
48206064|NCT03861767|100827596|FG003|NOT COMPLETED|Overall Study||5||
48206065|NCT03861767|100827597|FG004|NOT COMPLETED|Overall Study||2||
48206066|NCT03861767|100827598|FG005|NOT COMPLETED|Overall Study||1||
48206067|NCT03861767|100827599|FG006|NOT COMPLETED|Overall Study||3||
48206068|NCT03861767|100827600|FG007|NOT COMPLETED|Overall Study||1||
48206069|NCT03861767|100827601|FG008|NOT COMPLETED|Overall Study||0||
48206070|NCT03861767|100827602|FG009|NOT COMPLETED|Overall Study||5||
48206071|NCT03760419|100827603|FG000|STARTED|Overall Study||535||
48206072|NCT03760419|100827604|FG001|STARTED|Overall Study||492||
48206073|NCT03760419|100827603|FG000|Received Intervention|Overall Study||214||
48206074|NCT03760419|100827604|FG001|Received Intervention|Overall Study||335||
48206075|NCT03760419|100827603|FG000|Received Contol|Overall Study||321||
48206076|NCT03760419|100827604|FG001|Received Contol|Overall Study||157||
48206077|NCT03760419|100827603|FG000|COMPLETED|Overall Study||535||
48206078|NCT03760419|100827604|FG001|COMPLETED|Overall Study||492||
48206079|NCT03760419|100827603|FG000|NOT COMPLETED|Overall Study||0||
48047445|NCT01426789|100434965|FG000|COMPLETED|Part 1||62||
48047446|NCT01426789|100434966|FG001|COMPLETED|Part 1||28||
48047447|NCT01426789|100434967|FG002|COMPLETED|Part 1||0||
48047448|NCT01426789|100434968|FG003|COMPLETED|Part 1||0||
48047449|NCT01426789|100434969|FG004|COMPLETED|Part 1||0||
48047450|NCT01426789|100434970|FG005|COMPLETED|Part 1||0||
48047451|NCT01426789|100434965|FG000|NOT COMPLETED|Part 1||6||
48047452|NCT01426789|100434966|FG001|NOT COMPLETED|Part 1||4||
48047453|NCT01426789|100434967|FG002|NOT COMPLETED|Part 1||0||
48047454|NCT01426789|100434968|FG003|NOT COMPLETED|Part 1||0||
48047455|NCT01426789|100434969|FG004|NOT COMPLETED|Part 1||0||
48047456|NCT01426789|100434970|FG005|NOT COMPLETED|Part 1||0||
48047457|NCT01426789|100434965|FG000|STARTED|Part 2||0||
48206080|NCT03760419|100827604|FG001|NOT COMPLETED|Overall Study||0||
48206081|NCT00717626|100827605|FG000|STARTED|Overall Study||14||
48206082|NCT00717626|100827605|FG000|COMPLETED|Overall Study||14||
48206083|NCT00717626|100827605|FG000|NOT COMPLETED|Overall Study||0||
48206084|NCT00891176|100827606|FG000|STARTED|At 3 Years of Age||144||
48206085|NCT00891176|100827607|FG001|STARTED|At 3 Years of Age||147||
48206086|NCT00891176|100827608|FG002|STARTED|At 3 Years of Age||149||
48206087|NCT00891176|100827609|FG003|STARTED|At 3 Years of Age||141||
48206088|NCT00891176|100827606|FG000|COMPLETED|At 3 Years of Age||144||
48206089|NCT00891176|100827607|FG001|COMPLETED|At 3 Years of Age||147||
48206090|NCT00891176|100827608|FG002|COMPLETED|At 3 Years of Age||149||
48206091|NCT00891176|100827609|FG003|COMPLETED|At 3 Years of Age||141||
48206092|NCT00891176|100827606|FG000|NOT COMPLETED|At 3 Years of Age||0||
48206093|NCT00891176|100827607|FG001|NOT COMPLETED|At 3 Years of Age||0||
48206094|NCT00891176|100827608|FG002|NOT COMPLETED|At 3 Years of Age||0||
48206095|NCT00891176|100827609|FG003|NOT COMPLETED|At 3 Years of Age||0||
48206096|NCT00891176|100827606|FG000|STARTED|At 4 Years of Age||140||
48206097|NCT00891176|100827607|FG001|STARTED|At 4 Years of Age||142||
48206098|NCT00891176|100827608|FG002|STARTED|At 4 Years of Age||142||
48206099|NCT00891176|100827609|FG003|STARTED|At 4 Years of Age||137||
48047458|NCT01426789|100434966|FG001|STARTED|Part 2||0||
48047459|NCT01426789|100434967|FG002|STARTED|Part 2||49||
48047460|NCT01426789|100434968|FG003|STARTED|Part 2||13||
48047461|NCT01426789|100434969|FG004|STARTED|Part 2||27||
48047462|NCT01426789|100434970|FG005|STARTED|Part 2||1||
48047463|NCT01426789|100434965|FG000|COMPLETED|Part 2||0||
48047464|NCT01426789|100434966|FG001|COMPLETED|Part 2||0||
48047465|NCT01426789|100434967|FG002|COMPLETED|Part 2||34||
48047466|NCT01426789|100434968|FG003|COMPLETED|Part 2||12||
48047467|NCT01426789|100434969|FG004|COMPLETED|Part 2||19||
48047468|NCT01426789|100434970|FG005|COMPLETED|Part 2||1||
48047469|NCT01426789|100434965|FG000|NOT COMPLETED|Part 2||0||
48047470|NCT01426789|100434966|FG001|NOT COMPLETED|Part 2||0||
48206100|NCT00891176|100827606|FG000|COMPLETED|At 4 Years of Age||140||
48206101|NCT00891176|100827607|FG001|COMPLETED|At 4 Years of Age||142||
48206102|NCT00891176|100827608|FG002|COMPLETED|At 4 Years of Age||142||
48206103|NCT00891176|100827609|FG003|COMPLETED|At 4 Years of Age||137||
48206104|NCT00891176|100827606|FG000|NOT COMPLETED|At 4 Years of Age||0||
48206105|NCT00891176|100827607|FG001|NOT COMPLETED|At 4 Years of Age||0||
48206106|NCT00891176|100827608|FG002|NOT COMPLETED|At 4 Years of Age||0||
48206107|NCT00891176|100827609|FG003|NOT COMPLETED|At 4 Years of Age||0||
48206108|NCT00891176|100827606|FG000|STARTED|At 6 Years of Age||131||
48206109|NCT00891176|100827607|FG001|STARTED|At 6 Years of Age||138||
48206110|NCT00891176|100827608|FG002|STARTED|At 6 Years of Age||135||
48206111|NCT00891176|100827609|FG003|STARTED|At 6 Years of Age||135||
48206112|NCT00891176|100827606|FG000|COMPLETED|At 6 Years of Age||131||
48206113|NCT00891176|100827607|FG001|COMPLETED|At 6 Years of Age||138||
48206114|NCT00891176|100827608|FG002|COMPLETED|At 6 Years of Age||135||
48206115|NCT00891176|100827609|FG003|COMPLETED|At 6 Years of Age||135||
48206116|NCT00891176|100827606|FG000|NOT COMPLETED|At 6 Years of Age||0||
48206117|NCT00891176|100827607|FG001|NOT COMPLETED|At 6 Years of Age||0||
48206118|NCT00891176|100827608|FG002|NOT COMPLETED|At 6 Years of Age||0||
48206119|NCT00891176|100827609|FG003|NOT COMPLETED|At 6 Years of Age||0||
48206120|NCT00711958|100827610|FG000|STARTED|Overall Study||74||
48206121|NCT00711958|100827611|FG001|STARTED|Overall Study||40||
48206122|NCT00711958|100827610|FG000|COMPLETED|Overall Study||41||
48206123|NCT00711958|100827611|FG001|COMPLETED|Overall Study||17||
48206124|NCT00711958|100827610|FG000|NOT COMPLETED|Overall Study||33||
48206125|NCT00711958|100827611|FG001|NOT COMPLETED|Overall Study||23||
48206126|NCT03837028|100827612|FG000|STARTED|Overall Study||35||
48206127|NCT03837028|100827613|FG001|STARTED|Overall Study||34||
48206128|NCT03837028|100827614|FG002|STARTED|Overall Study||33||
48206129|NCT03837028|100827615|FG003|STARTED|Overall Study||25||
48206130|NCT03837028|100827612|FG000|COMPLETED|Overall Study||19||
48206131|NCT03837028|100827613|FG001|COMPLETED|Overall Study||23||
48206132|NCT03837028|100827614|FG002|COMPLETED|Overall Study||20||
48206133|NCT03837028|100827615|FG003|COMPLETED|Overall Study||18||
48206134|NCT03837028|100827612|FG000|NOT COMPLETED|Overall Study||16||
48206135|NCT03837028|100827613|FG001|NOT COMPLETED|Overall Study||11||
48206136|NCT03837028|100827614|FG002|NOT COMPLETED|Overall Study||13||
48047471|NCT01426789|100434967|FG002|NOT COMPLETED|Part 2||15||
48206137|NCT03837028|100827615|FG003|NOT COMPLETED|Overall Study||7||
48206138|NCT00057837|100827616|FG000|STARTED|Overall Study||70||
48206139|NCT00057837|100827617|FG001|STARTED|Overall Study||70||
48206140|NCT00057837|100827616|FG000|Treated|Overall Study||69||
48495543|NCT01447511|101547872|FG001|COMPLETED|Control Period||5||
48206141|NCT00057837|100827617|FG001|Treated|Overall Study||68||
48206142|NCT00057837|100827616|FG000|Eligible and Treated|Overall Study||66||
48206143|NCT00057837|100827617|FG001|Eligible and Treated|Overall Study||66||
48206144|NCT00057837|100827616|FG000|Patients With Response|Overall Study||46||
48206145|NCT00057837|100827617|FG001|Patients With Response|Overall Study||38||
48206146|NCT00057837|100827616|FG000|COMPLETED|Overall Study||39||
48206147|NCT00057837|100827617|FG001|COMPLETED|Overall Study||31||
48206148|NCT00057837|100827616|FG000|NOT COMPLETED|Overall Study||31||
48206149|NCT00057837|100827617|FG001|NOT COMPLETED|Overall Study||39||
48495544|NCT01447511|101547873|FG002|COMPLETED|Control Period||9||
48047472|NCT01426789|100434968|FG003|NOT COMPLETED|Part 2||1||
48047473|NCT01426789|100434969|FG004|NOT COMPLETED|Part 2||8||
48206150|NCT01595854|100827618|FG000|STARTED|Overall Study||8||
48047474|NCT01426789|100434970|FG005|NOT COMPLETED|Part 2||0||
48047475|NCT02000154|100438251|FG000|STARTED|Overall Study||1||
48047476|NCT02000154|100438251|FG000|COMPLETED|Overall Study||1||
48206151|NCT01595854|100827619|FG001|STARTED|Overall Study||4||
48206152|NCT01595854|100827620|FG002|STARTED|Overall Study||8||
48206153|NCT01595854|100827621|FG003|STARTED|Overall Study||4||
48047477|NCT02000154|100438251|FG000|NOT COMPLETED|Overall Study||0||
48495545|NCT01447511|101547874|FG003|COMPLETED|Control Period||3||
48206154|NCT01595854|100827622|FG004|STARTED|Overall Study||12||
48206155|NCT01595854|100827618|FG000|COMPLETED|Overall Study||8||
48206156|NCT01595854|100827619|FG001|COMPLETED|Overall Study||4||
48206157|NCT01595854|100827620|FG002|COMPLETED|Overall Study||8||
48206158|NCT01595854|100827621|FG003|COMPLETED|Overall Study||4||
48206159|NCT01595854|100827622|FG004|COMPLETED|Overall Study||12||
48206160|NCT01595854|100827618|FG000|NOT COMPLETED|Overall Study||0||
48495546|NCT01447511|101547875|FG004|COMPLETED|Control Period||4||
48495547|NCT01447511|101547871|FG000|NOT COMPLETED|Control Period||0||
48495548|NCT01447511|101547872|FG001|NOT COMPLETED|Control Period||0||
48495549|NCT01447511|101547873|FG002|NOT COMPLETED|Control Period||0||
48495550|NCT01447511|101547874|FG003|NOT COMPLETED|Control Period||0||
48495551|NCT01447511|101547875|FG004|NOT COMPLETED|Control Period||0||
48495552|NCT01447511|101547871|FG000|STARTED|Fluconazole Period||8||
48495553|NCT01447511|101547872|FG001|STARTED|Fluconazole Period||0||
48495554|NCT01447511|101547873|FG002|STARTED|Fluconazole Period||9||
48495555|NCT01447511|101547874|FG003|STARTED|Fluconazole Period||3||
48495556|NCT01447511|101547875|FG004|STARTED|Fluconazole Period||4||
48495557|NCT01447511|101547871|FG000|COMPLETED|Fluconazole Period||8||
48495558|NCT01447511|101547872|FG001|COMPLETED|Fluconazole Period||0||
48495559|NCT01447511|101547873|FG002|COMPLETED|Fluconazole Period||8||
48495560|NCT01447511|101547874|FG003|COMPLETED|Fluconazole Period||3||
48495561|NCT01447511|101547875|FG004|COMPLETED|Fluconazole Period||4||
48495562|NCT01447511|101547871|FG000|NOT COMPLETED|Fluconazole Period||0||
48495563|NCT01447511|101547872|FG001|NOT COMPLETED|Fluconazole Period||0||
48495564|NCT01447511|101547873|FG002|NOT COMPLETED|Fluconazole Period||1||
48495565|NCT01447511|101547874|FG003|NOT COMPLETED|Fluconazole Period||0||
48495566|NCT01447511|101547875|FG004|NOT COMPLETED|Fluconazole Period||0||
48495567|NCT01447511|101547871|FG000|STARTED|Rifampin Period||8||
48495568|NCT01447511|101547872|FG001|STARTED|Rifampin Period||5||
48495569|NCT01447511|101547873|FG002|STARTED|Rifampin Period||8||
48495570|NCT01447511|101547874|FG003|STARTED|Rifampin Period||3||
48495571|NCT01447511|101547875|FG004|STARTED|Rifampin Period||4||
48495572|NCT01447511|101547871|FG000|COMPLETED|Rifampin Period||8||
48495573|NCT01447511|101547872|FG001|COMPLETED|Rifampin Period||5||
48495574|NCT01447511|101547873|FG002|COMPLETED|Rifampin Period||8||
48495575|NCT01447511|101547874|FG003|COMPLETED|Rifampin Period||2||
48495576|NCT01447511|101547875|FG004|COMPLETED|Rifampin Period||4||
48495577|NCT01447511|101547871|FG000|NOT COMPLETED|Rifampin Period||0||
48495578|NCT01447511|101547872|FG001|NOT COMPLETED|Rifampin Period||0||
48495579|NCT01447511|101547873|FG002|NOT COMPLETED|Rifampin Period||0||
48495580|NCT01447511|101547874|FG003|NOT COMPLETED|Rifampin Period||1||
48495581|NCT01447511|101547875|FG004|NOT COMPLETED|Rifampin Period||0||
48495582|NCT03599362|101547876|FG000|STARTED|Overall Study||7||
48495583|NCT03599362|101547876|FG000|COMPLETED|Overall Study||4||
48495584|NCT03599362|101547876|FG000|NOT COMPLETED|Overall Study||3||
48495585|NCT04029545|101547877|FG000|STARTED|Overall Study||2||
48495586|NCT04029545|101547878|FG001|STARTED|Overall Study||1||
48495587|NCT04029545|101547879|FG002|STARTED|Overall Study||2||
48495588|NCT04029545|101547877|FG000|COMPLETED|Overall Study||2||
48495589|NCT04029545|101547878|FG001|COMPLETED|Overall Study||1||
48495590|NCT04029545|101547879|FG002|COMPLETED|Overall Study||2||
48495591|NCT04029545|101547877|FG000|NOT COMPLETED|Overall Study||0||
48495592|NCT04029545|101547878|FG001|NOT COMPLETED|Overall Study||0||
48495593|NCT04029545|101547879|FG002|NOT COMPLETED|Overall Study||0||
48495594|NCT01051349|101547880|FG000|STARTED|Overall Study||410||
48495595|NCT01051349|101547880|FG000|COMPLETED|Overall Study||237||
48495596|NCT01051349|101547880|FG000|NOT COMPLETED|Overall Study||173||
48495597|NCT01958294|101547881|FG000|STARTED|Overall Study||12||
48495598|NCT01958294|101547881|FG000|COMPLETED|Overall Study||10||
48495599|NCT01958294|101547881|FG000|NOT COMPLETED|Overall Study||2||
48495600|NCT04383587|101547882|FG000|STARTED|Overall Study||300||
48495601|NCT04383587|101547882|FG000|COMPLETED|Overall Study||292||
48495602|NCT04383587|101547882|FG000|NOT COMPLETED|Overall Study||8||
48495603|NCT01660243|101547883|FG000|STARTED|Overall Study||10||
48206161|NCT01595854|100827619|FG001|NOT COMPLETED|Overall Study||0||
48206162|NCT01595854|100827620|FG002|NOT COMPLETED|Overall Study||0||
48206163|NCT01595854|100827621|FG003|NOT COMPLETED|Overall Study||0||
48206164|NCT01595854|100827622|FG004|NOT COMPLETED|Overall Study||0||
48206165|NCT01490086|100827623|FG000|STARTED|Overall Study||58||
48206166|NCT01490086|100827624|FG001|STARTED|Overall Study||59||
48206167|NCT01490086|100827625|FG002|STARTED|Overall Study||58||
48206168|NCT01490086|100827626|FG003|STARTED|Overall Study||20||
48495604|NCT01660243|101547884|FG001|STARTED|Overall Study||13||
48495605|NCT01660243|101547885|FG002|STARTED|Overall Study||11||
48495606|NCT01660243|101547886|FG003|STARTED|Overall Study||11||
48495607|NCT01660243|101547883|FG000|COMPLETED|Overall Study||8||
48495608|NCT01660243|101547884|FG001|COMPLETED|Overall Study||13||
48495609|NCT01660243|101547885|FG002|COMPLETED|Overall Study||9||
48495610|NCT01660243|101547886|FG003|COMPLETED|Overall Study||10||
48495611|NCT01660243|101547883|FG000|NOT COMPLETED|Overall Study||2||
48495612|NCT01660243|101547884|FG001|NOT COMPLETED|Overall Study||0||
48495613|NCT01660243|101547885|FG002|NOT COMPLETED|Overall Study||2||
48495614|NCT01660243|101547886|FG003|NOT COMPLETED|Overall Study||1||
48495615|NCT00819169|101547887|FG000|STARTED|Overall Study||3||
48206169|NCT01490086|100827627|FG004|STARTED|Overall Study||39||
48206170|NCT01490086|100827623|FG000|COMPLETED|Overall Study||50||
48206171|NCT01490086|100827624|FG001|COMPLETED|Overall Study||44||
48206172|NCT01490086|100827625|FG002|COMPLETED|Overall Study||51||
48206173|NCT01490086|100827626|FG003|COMPLETED|Overall Study||13||
48206174|NCT01490086|100827627|FG004|COMPLETED|Overall Study||28||
48206175|NCT01490086|100827623|FG000|NOT COMPLETED|Overall Study||8||
48206176|NCT01490086|100827624|FG001|NOT COMPLETED|Overall Study||15||
48206177|NCT01490086|100827625|FG002|NOT COMPLETED|Overall Study||7||
48206178|NCT01490086|100827626|FG003|NOT COMPLETED|Overall Study||7||
48206179|NCT01490086|100827627|FG004|NOT COMPLETED|Overall Study||11||
48206180|NCT00988637|100827628|FG000|STARTED|Overall Study||70||
48206181|NCT00988637|100827629|FG001|STARTED|Overall Study||68||
48206182|NCT00988637|100827628|FG000|COMPLETED|Overall Study||67||
48206183|NCT00988637|100827629|FG001|COMPLETED|Overall Study||65||
48206184|NCT00988637|100827628|FG000|NOT COMPLETED|Overall Study||3||
48206185|NCT00988637|100827629|FG001|NOT COMPLETED|Overall Study||3||
48206186|NCT00475501|100827630|FG000|STARTED|Overall Study||14||
48206187|NCT00475501|100827631|FG001|STARTED|Overall Study||13||
48206188|NCT00475501|100827632|FG002|STARTED|Overall Study||17||
48206189|NCT00475501|100827633|FG003|STARTED|Overall Study||16||
48206190|NCT00475501|100827630|FG000|COMPLETED|Overall Study||7||
48206191|NCT00475501|100827631|FG001|COMPLETED|Overall Study||8||
48206192|NCT00475501|100827632|FG002|COMPLETED|Overall Study||13||
48206193|NCT00475501|100827633|FG003|COMPLETED|Overall Study||12||
48206194|NCT00475501|100827630|FG000|NOT COMPLETED|Overall Study||7||
48206195|NCT00475501|100827631|FG001|NOT COMPLETED|Overall Study||5||
48206196|NCT00475501|100827632|FG002|NOT COMPLETED|Overall Study||4||
48206197|NCT00475501|100827633|FG003|NOT COMPLETED|Overall Study||4||
48206198|NCT01063517|100827634|FG000|STARTED|Overall Study||62||
48206199|NCT01063517|100827635|FG001|STARTED|Overall Study||62||
48206200|NCT01063517|100827634|FG000|Received Randomised Treatment|Overall Study||61||
48206201|NCT01063517|100827635|FG001|Received Randomised Treatment|Overall Study||62||
48206202|NCT01063517|100827634|FG000|COMPLETED|Overall Study||4||
48206203|NCT01063517|100827635|FG001|COMPLETED|Overall Study||2||
48206204|NCT01063517|100827634|FG000|NOT COMPLETED|Overall Study||58||
48206205|NCT01063517|100827635|FG001|NOT COMPLETED|Overall Study||60||
48206206|NCT03624413|100827636|FG000|STARTED|Overall Study||40||
48206207|NCT03624413|100827637|FG001|STARTED|Overall Study||40||
48206208|NCT03624413|100827636|FG000|COMPLETED|Overall Study||40||
48206209|NCT03624413|100827637|FG001|COMPLETED|Overall Study||40||
48206210|NCT03624413|100827636|FG000|NOT COMPLETED|Overall Study||0||
48206211|NCT03624413|100827637|FG001|NOT COMPLETED|Overall Study||0||
48206212|NCT01241435|100830224|FG000|STARTED|Overall Study||12||
48206213|NCT01241435|100830225|FG001|STARTED|Overall Study||8||
48206214|NCT01241435|100830226|FG002|STARTED|Overall Study||8||
48206215|NCT01241435|100830227|FG003|STARTED|Overall Study||8||
48206216|NCT01241435|100830224|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12||
48206217|NCT01241435|100830225|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8||
48206218|NCT01241435|100830226|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8||
48206219|NCT01241435|100830227|FG003|Received at Least 1 Dose of Study Drug|Overall Study||8||
48206220|NCT01241435|100830224|FG000|COMPLETED|Overall Study||12||
48206221|NCT01241435|100830225|FG001|COMPLETED|Overall Study||8||
48206222|NCT01241435|100830226|FG002|COMPLETED|Overall Study||8||
48206223|NCT01241435|100830227|FG003|COMPLETED|Overall Study||8||
48206224|NCT01241435|100830224|FG000|NOT COMPLETED|Overall Study||0||
48047478|NCT03696927|100438252|FG000|STARTED|Overall Study||4||
48047479|NCT03696927|100438252|FG000|COMPLETED|Overall Study||4||
48047480|NCT03696927|100438252|FG000|NOT COMPLETED|Overall Study||0||
48047481|NCT00824070|100438253|FG000|STARTED|Overall Study||34||
48047482|NCT00824070|100438254|FG001|STARTED|Overall Study||35||
48047483|NCT00824070|100438255|FG002|STARTED|Overall Study||36||
48206225|NCT01241435|100830225|FG001|NOT COMPLETED|Overall Study||0||
48206226|NCT01241435|100830226|FG002|NOT COMPLETED|Overall Study||0||
48206227|NCT01241435|100830227|FG003|NOT COMPLETED|Overall Study||0||
48206228|NCT01787240|100830228|FG000|STARTED|Overall Study||15||
48206229|NCT01787240|100830229|FG001|STARTED|Overall Study||5||
48206230|NCT01787240|100830228|FG000|COMPLETED|Overall Study||10||
48206231|NCT01787240|100830229|FG001|COMPLETED|Overall Study||4||
48206232|NCT01787240|100830228|FG000|NOT COMPLETED|Overall Study||5||
48047484|NCT00824070|100438253|FG000|COMPLETED|Overall Study||34||
48047485|NCT00824070|100438254|FG001|COMPLETED|Overall Study||35||
48047486|NCT00824070|100438255|FG002|COMPLETED|Overall Study||36||
48047487|NCT00824070|100438253|FG000|NOT COMPLETED|Overall Study||0||
48047488|NCT00824070|100438254|FG001|NOT COMPLETED|Overall Study||0||
48047489|NCT00824070|100438255|FG002|NOT COMPLETED|Overall Study||0||
48047490|NCT00089674|100438256|FG000|STARTED|Overall Study||734||
48047491|NCT00089674|100438257|FG001|STARTED|Overall Study||734||
48206233|NCT01787240|100830229|FG001|NOT COMPLETED|Overall Study||1||
48206234|NCT04333758|100830230|FG000|STARTED|Overall Study||35||
48206235|NCT04333758|100830230|FG000|COMPLETED|Overall Study||32||
48206236|NCT04333758|100830230|FG000|NOT COMPLETED|Overall Study||3||
48206237|NCT00630786|100830231|FG000|STARTED|Overall Study||19||
48206238|NCT00630786|100830232|FG001|STARTED|Overall Study||25||
48206239|NCT00630786|100830233|FG002|STARTED|Overall Study||9||
48206240|NCT00630786|100830231|FG000|Received Study Medication|Overall Study||19||
48206241|NCT00630786|100830232|FG001|Received Study Medication|Overall Study||25||
48206242|NCT00630786|100830233|FG002|Received Study Medication|Overall Study||8||
48206243|NCT00630786|100830231|FG000|COMPLETED|Overall Study||18||
48047492|NCT00089674|100438256|FG000|Received Study Drug|Overall Study||730||
48047493|NCT00089674|100438257|FG001|Received Study Drug|Overall Study||726||
48047494|NCT00089674|100438256|FG000|COMPLETED|Overall Study||445||
48047495|NCT00089674|100438257|FG001|COMPLETED|Overall Study||467||
48047496|NCT00089674|100438256|FG000|NOT COMPLETED|Overall Study||289||
48047497|NCT00089674|100438257|FG001|NOT COMPLETED|Overall Study||267||
48206244|NCT00630786|100830232|FG001|COMPLETED|Overall Study||23||
48206245|NCT00630786|100830233|FG002|COMPLETED|Overall Study||7||
48206246|NCT00630786|100830231|FG000|NOT COMPLETED|Overall Study||1||
48206247|NCT00630786|100830232|FG001|NOT COMPLETED|Overall Study||2||
48047498|NCT01011478|100438258|FG000|STARTED|Overall Study||204||
48047499|NCT01011478|100438259|FG001|STARTED|Overall Study||202||
48047500|NCT01011478|100438258|FG000|COMPLETED|Overall Study||192||
48047501|NCT01011478|100438259|FG001|COMPLETED|Overall Study||195||
48047502|NCT01011478|100438258|FG000|NOT COMPLETED|Overall Study||12||
48047503|NCT01011478|100438259|FG001|NOT COMPLETED|Overall Study||7||
48047504|NCT03123185|100438260|FG000|STARTED|Overall Study||12||
48047505|NCT03123185|100438261|FG001|STARTED|Overall Study||8||
48047506|NCT03123185|100438262|FG002|STARTED|Overall Study||6||
48047507|NCT03123185|100438263|FG003|STARTED|Overall Study||5||
48047508|NCT03123185|100438264|FG004|STARTED|Overall Study||6||
48047509|NCT03123185|100438265|FG005|STARTED|Overall Study||6||
48047510|NCT03123185|100438266|FG006|STARTED|Overall Study||6||
48047511|NCT03123185|100438267|FG007|STARTED|Overall Study||6||
48047512|NCT03123185|100438268|FG008|STARTED|Overall Study||6||
48047513|NCT03123185|100438269|FG009|STARTED|Overall Study||6||
48047514|NCT03123185|100438270|FG010|STARTED|Overall Study||6||
48047515|NCT03123185|100438271|FG011|STARTED|Overall Study||6||
48047516|NCT03123185|100438272|FG012|STARTED|Overall Study||6||
48047517|NCT03123185|100438273|FG013|STARTED|Overall Study||6||
48047518|NCT03123185|100438260|FG000|COMPLETED|Overall Study||12||
48047519|NCT03123185|100438261|FG001|COMPLETED|Overall Study||8||
48047520|NCT03123185|100438262|FG002|COMPLETED|Overall Study||6||
48047521|NCT03123185|100438263|FG003|COMPLETED|Overall Study||5||
48047522|NCT03123185|100438264|FG004|COMPLETED|Overall Study||6||
48047523|NCT03123185|100438265|FG005|COMPLETED|Overall Study||6||
48047524|NCT03123185|100438266|FG006|COMPLETED|Overall Study||6||
48047525|NCT03123185|100438267|FG007|COMPLETED|Overall Study||6||
48047526|NCT03123185|100438268|FG008|COMPLETED|Overall Study||6||
48047527|NCT03123185|100438269|FG009|COMPLETED|Overall Study||6||
48047528|NCT03123185|100438270|FG010|COMPLETED|Overall Study||6||
48047529|NCT03123185|100438271|FG011|COMPLETED|Overall Study||6||
48047530|NCT03123185|100438272|FG012|COMPLETED|Overall Study||5||
48047531|NCT03123185|100438273|FG013|COMPLETED|Overall Study||6||
48047532|NCT03123185|100438260|FG000|NOT COMPLETED|Overall Study||0||
48047533|NCT03123185|100438261|FG001|NOT COMPLETED|Overall Study||0||
48047534|NCT03123185|100438262|FG002|NOT COMPLETED|Overall Study||0||
48047535|NCT03123185|100438263|FG003|NOT COMPLETED|Overall Study||0||
48206248|NCT00630786|100830233|FG002|NOT COMPLETED|Overall Study||2||
48206249|NCT02027558|100830234|FG000|STARTED|Overall Study||62||
48206250|NCT02027558|100830235|FG001|STARTED|Overall Study||63||
48206251|NCT02027558|100830234|FG000|Post-treatment|Overall Study||49||
48206252|NCT02027558|100830235|FG001|Post-treatment|Overall Study||60||
48206253|NCT02027558|100830234|FG000|3-month Follow-up|Overall Study||53||
48206254|NCT02027558|100830235|FG001|3-month Follow-up|Overall Study||58||
48206255|NCT02027558|100830234|FG000|6-month Follow-up|Overall Study||53||
48206256|NCT02027558|100830235|FG001|6-month Follow-up|Overall Study||61||
48206257|NCT02027558|100830234|FG000|COMPLETED|Overall Study||53||
48047536|NCT03123185|100438264|FG004|NOT COMPLETED|Overall Study||0||
48047537|NCT03123185|100438265|FG005|NOT COMPLETED|Overall Study||0||
48047538|NCT03123185|100438266|FG006|NOT COMPLETED|Overall Study||0||
48047539|NCT03123185|100438267|FG007|NOT COMPLETED|Overall Study||0||
48047540|NCT03123185|100438268|FG008|NOT COMPLETED|Overall Study||0||
48047541|NCT03123185|100438269|FG009|NOT COMPLETED|Overall Study||0||
48047542|NCT03123185|100438270|FG010|NOT COMPLETED|Overall Study||0||
48047543|NCT03123185|100438271|FG011|NOT COMPLETED|Overall Study||0||
48047544|NCT03123185|100438272|FG012|NOT COMPLETED|Overall Study||1||
48047545|NCT03123185|100438273|FG013|NOT COMPLETED|Overall Study||0||
48206258|NCT02027558|100830235|FG001|COMPLETED|Overall Study||61||
48206259|NCT02027558|100830234|FG000|NOT COMPLETED|Overall Study||9||
48206260|NCT02027558|100830235|FG001|NOT COMPLETED|Overall Study||2||
48206261|NCT03804918|100830236|FG000|STARTED|Overall Study||17||
48047546|NCT00667446|100438274|FG000|STARTED|Treatment Period (36 Months)||34||
48047547|NCT00667446|100438275|FG001|STARTED|Treatment Period (36 Months)||38||
48047548|NCT00667446|100438274|FG000|COMPLETED|Treatment Period (36 Months)||11||
48047549|NCT00667446|100438275|FG001|COMPLETED|Treatment Period (36 Months)||13||
48047550|NCT00667446|100438274|FG000|NOT COMPLETED|Treatment Period (36 Months)||23||
48047551|NCT00667446|100438275|FG001|NOT COMPLETED|Treatment Period (36 Months)||25||
48047552|NCT00667446|100438274|FG000|STARTED|Safety Follow-up Period (12 Weeks)||28||
48047553|NCT00667446|100438275|FG001|STARTED|Safety Follow-up Period (12 Weeks)||26||
48047554|NCT00667446|100438274|FG000|COMPLETED|Safety Follow-up Period (12 Weeks)||28||
48047555|NCT00667446|100438275|FG001|COMPLETED|Safety Follow-up Period (12 Weeks)||25||
48206262|NCT03804918|100830236|FG000|COMPLETED|Overall Study||16||
48206263|NCT03804918|100830236|FG000|NOT COMPLETED|Overall Study||1||
48206264|NCT01787760|100830237|FG000|STARTED|Overall Study||51||
48206265|NCT01787760|100830238|FG001|STARTED|Overall Study||50||
48206266|NCT01787760|100830239|FG002|STARTED|Overall Study||51||
48206267|NCT01787760|100830237|FG000|COMPLETED|Overall Study||25||
48206268|NCT01787760|100830238|FG001|COMPLETED|Overall Study||34||
48206269|NCT01787760|100830239|FG002|COMPLETED|Overall Study||46||
48206270|NCT01787760|100830237|FG000|NOT COMPLETED|Overall Study||26||
48206271|NCT01787760|100830238|FG001|NOT COMPLETED|Overall Study||16||
48206272|NCT01787760|100830239|FG002|NOT COMPLETED|Overall Study||5||
48206273|NCT03380390|100830240|FG000|STARTED|Overall Study||46||
48206274|NCT03380390|100830240|FG000|COMPLETED|Overall Study||43||
48206275|NCT03380390|100830240|FG000|NOT COMPLETED|Overall Study||3||
48206276|NCT02878330|100830241|FG000|STARTED|Overall Study||484||
48206277|NCT02878330|100830242|FG001|STARTED|Overall Study||969||
48206278|NCT02878330|100830241|FG000|COMPLETED|Overall Study||455||
48206279|NCT02878330|100830242|FG001|COMPLETED|Overall Study||913||
48206280|NCT02878330|100830241|FG000|NOT COMPLETED|Overall Study||29||
48206281|NCT02878330|100830242|FG001|NOT COMPLETED|Overall Study||56||
48206282|NCT02122445|100830243|FG000|STARTED|Overall Study||20||
48206283|NCT02122445|100830243|FG000|COMPLETED|Overall Study||20||
48206284|NCT02122445|100830243|FG000|NOT COMPLETED|Overall Study||0||
48206285|NCT04009577|100830244|FG000|STARTED|Core Study||7||
48206286|NCT04009577|100830245|FG001|STARTED|Core Study||3||
48206287|NCT04009577|100830246|FG002|STARTED|Core Study||21||
48206288|NCT04009577|100830247|FG003|STARTED|Core Study||22||
48206289|NCT04009577|100830244|FG000|LEM5|Core Study||7||
48206290|NCT04009577|100830245|FG001|LEM5|Core Study||3||
48206291|NCT04009577|100830246|FG002|LEM5|Core Study||21||
48206292|NCT04009577|100830247|FG003|LEM5|Core Study||5||
48206293|NCT04009577|100830244|FG000|LEM10|Core Study||3||
48047556|NCT00667446|100438274|FG000|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||0||
48047557|NCT00667446|100438275|FG001|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||1||
48047558|NCT02101112|100438276|FG000|STARTED|Overall Study||6||
48047559|NCT02101112|100438277|FG001|STARTED|Overall Study||5||
48047560|NCT02101112|100438278|FG002|STARTED|Overall Study||6||
48047561|NCT02101112|100438279|FG003|STARTED|Overall Study||5||
48047562|NCT02101112|100438280|FG004|STARTED|Overall Study||6||
48047563|NCT02101112|100438281|FG005|STARTED|Overall Study||5||
48047564|NCT02101112|100438276|FG000|COMPLETED|Overall Study||6||
48047565|NCT02101112|100438277|FG001|COMPLETED|Overall Study||5||
48047566|NCT02101112|100438278|FG002|COMPLETED|Overall Study||5||
48047567|NCT02101112|100438279|FG003|COMPLETED|Overall Study||5||
48047568|NCT02101112|100438280|FG004|COMPLETED|Overall Study||5||
48047569|NCT02101112|100438281|FG005|COMPLETED|Overall Study||5||
48047570|NCT02101112|100438276|FG000|NOT COMPLETED|Overall Study||0||
48047571|NCT02101112|100438277|FG001|NOT COMPLETED|Overall Study||0||
48047572|NCT02101112|100438278|FG002|NOT COMPLETED|Overall Study||1||
48047573|NCT02101112|100438279|FG003|NOT COMPLETED|Overall Study||0||
48206294|NCT04009577|100830245|FG001|LEM10|Core Study||2||
48206295|NCT04009577|100830246|FG002|LEM10|Core Study||10||
48206296|NCT04009577|100830247|FG003|LEM10|Core Study||22||
48206297|NCT04009577|100830244|FG000|COMPLETED|Core Study||6||
48206298|NCT04009577|100830245|FG001|COMPLETED|Core Study||3||
48206299|NCT04009577|100830246|FG002|COMPLETED|Core Study||17||
48206300|NCT04009577|100830247|FG003|COMPLETED|Core Study||17||
48206301|NCT04009577|100830244|FG000|NOT COMPLETED|Core Study||1||
48206302|NCT04009577|100830245|FG001|NOT COMPLETED|Core Study||0||
48206303|NCT04009577|100830246|FG002|NOT COMPLETED|Core Study||4||
48206304|NCT04009577|100830247|FG003|NOT COMPLETED|Core Study||5||
48206305|NCT04009577|100830244|FG000|STARTED|Extension Phase||6|Participants who completed the Core Study had the option to participate in the Extension Phase|
48206306|NCT04009577|100830245|FG001|STARTED|Extension Phase||3|Participants who completed the Core Study had the option to participate in the Extension Phase|
48206307|NCT04009577|100830246|FG002|STARTED|Extension Phase||17|Participants who completed the Core Study had the option to participate in the Extension Phase|
48206308|NCT04009577|100830247|FG003|STARTED|Extension Phase||17|Participants who completed the Core Study had the option to participate in the Extension Phase|
48206309|NCT04009577|100830244|FG000|Treated|Extension Phase||6||
48206310|NCT04009577|100830245|FG001|Treated|Extension Phase||3||
48206311|NCT04009577|100830246|FG002|Treated|Extension Phase||15||
48047574|NCT02101112|100438280|FG004|NOT COMPLETED|Overall Study||1||
48047575|NCT02101112|100438281|FG005|NOT COMPLETED|Overall Study||0||
48047576|NCT01350544|100438282|FG000|STARTED|Overall Study||108||
48206312|NCT04009577|100830247|FG003|Treated|Extension Phase||17||
48206313|NCT04009577|100830244|FG000|LEM5|Extension Phase||6||
48206314|NCT04009577|100830245|FG001|LEM5|Extension Phase||3||
48206315|NCT04009577|100830246|FG002|LEM5|Extension Phase||15||
48206316|NCT04009577|100830247|FG003|LEM5|Extension Phase||8||
48206317|NCT04009577|100830244|FG000|LEM10|Extension Phase||5||
48206318|NCT04009577|100830245|FG001|LEM10|Extension Phase||3||
48206319|NCT04009577|100830246|FG002|LEM10|Extension Phase||12||
48206320|NCT04009577|100830247|FG003|LEM10|Extension Phase||17||
48206321|NCT04009577|100830244|FG000|COMPLETED|Extension Phase||6||
48206322|NCT04009577|100830245|FG001|COMPLETED|Extension Phase||3||
48206323|NCT04009577|100830246|FG002|COMPLETED|Extension Phase||13||
48206324|NCT04009577|100830247|FG003|COMPLETED|Extension Phase||16||
48206325|NCT04009577|100830244|FG000|NOT COMPLETED|Extension Phase||0||
48206326|NCT04009577|100830245|FG001|NOT COMPLETED|Extension Phase||0||
48206327|NCT04009577|100830246|FG002|NOT COMPLETED|Extension Phase||4||
48206328|NCT04009577|100830247|FG003|NOT COMPLETED|Extension Phase||1||
48206329|NCT03102710|100830248|FG000|STARTED|Overall Study||28||
48206330|NCT03102710|100830249|FG001|STARTED|Overall Study||30||
48206331|NCT03102710|100830250|FG002|STARTED|Overall Study||27||
48206332|NCT03102710|100830248|FG000|COMPLETED|Overall Study||27||
48206333|NCT03102710|100830249|FG001|COMPLETED|Overall Study||27||
48206334|NCT03102710|100830250|FG002|COMPLETED|Overall Study||27||
48206335|NCT03102710|100830248|FG000|NOT COMPLETED|Overall Study||1||
48206336|NCT03102710|100830249|FG001|NOT COMPLETED|Overall Study||3||
48206337|NCT03102710|100830250|FG002|NOT COMPLETED|Overall Study||0||
48206338|NCT01243619|100830251|FG000|STARTED|Overall Study||5||
48206339|NCT01243619|100830251|FG000|COMPLETED|Overall Study||5||
48206340|NCT01243619|100830251|FG000|NOT COMPLETED|Overall Study||0||
48206341|NCT03161327|100830252|FG000|STARTED|Overall Study||238||
48206342|NCT03161327|100830252|FG000|COMPLETED|Overall Study||238||
48206343|NCT03161327|100830252|FG000|NOT COMPLETED|Overall Study||0||
48206344|NCT03460756|100830253|FG000|STARTED|Overall Study||2||
48206345|NCT03460756|100830254|FG001|STARTED|Overall Study||14||
48206346|NCT03460756|100830255|FG002|STARTED|Overall Study||25||
48206347|NCT03460756|100830256|FG003|STARTED|Overall Study||43||
48206348|NCT03460756|100830253|FG000|COMPLETED|Overall Study||2|2-week TID group was discontinued after 2 subjects were enrolled due to daytime TEAE of sedation and dizziness|
48047577|NCT01350544|100438283|FG001|STARTED|Overall Study||108||
48047578|NCT01350544|100438282|FG000|COMPLETED|Overall Study||85||
48047579|NCT01350544|100438283|FG001|COMPLETED|Overall Study||86||
48047580|NCT01350544|100438282|FG000|NOT COMPLETED|Overall Study||23||
48047581|NCT01350544|100438283|FG001|NOT COMPLETED|Overall Study||22||
48047582|NCT01115582|100438284|FG000|STARTED|Overall Study||16||
48206349|NCT03460756|100830254|FG001|COMPLETED|Overall Study||9|2-week TID group was discontinued after 2 subjects were enrolled due to daytime TEAE of sedation and dizziness|
48206350|NCT03460756|100830255|FG002|COMPLETED|Overall Study||16|2-week TID group was discontinued after 2 subjects were enrolled due to daytime TEAE of sedation and dizziness|
48206351|NCT03460756|100830256|FG003|COMPLETED|Overall Study||34|2-week TID group was discontinued after 2 subjects were enrolled due to daytime TEAE of sedation and dizziness|
48206352|NCT03460756|100830253|FG000|NOT COMPLETED|Overall Study||0||
48206353|NCT03460756|100830254|FG001|NOT COMPLETED|Overall Study||5||
48206354|NCT03460756|100830255|FG002|NOT COMPLETED|Overall Study||9||
48206355|NCT03460756|100830256|FG003|NOT COMPLETED|Overall Study||9||
48206356|NCT02798835|100830257|FG000|STARTED|Overall Study||60||
48206357|NCT02798835|100830258|FG001|STARTED|Overall Study||60||
48206358|NCT02798835|100830259|FG002|STARTED|Overall Study||60||
48206359|NCT02798835|100830257|FG000|COMPLETED|Overall Study||60||
48206360|NCT02798835|100830258|FG001|COMPLETED|Overall Study||60||
48206361|NCT02798835|100830259|FG002|COMPLETED|Overall Study||57||
48206362|NCT02798835|100830257|FG000|NOT COMPLETED|Overall Study||0||
48206363|NCT02798835|100830258|FG001|NOT COMPLETED|Overall Study||0||
48206364|NCT02798835|100830259|FG002|NOT COMPLETED|Overall Study||3||
48206365|NCT01924767|100830260|FG000|STARTED|Overall Study||12||
48206366|NCT01924767|100830261|FG001|STARTED|Overall Study||9||
48206367|NCT01924767|100830262|FG002|STARTED|Overall Study||9||
48206368|NCT01924767|100830263|FG003|STARTED|Overall Study||9||
48206369|NCT01924767|100830264|FG004|STARTED|Overall Study||9||
48206370|NCT01924767|100830260|FG000|COMPLETED|Overall Study||11||
48206371|NCT01924767|100830261|FG001|COMPLETED|Overall Study||9||
48206372|NCT01924767|100830262|FG002|COMPLETED|Overall Study||8||
48206373|NCT01924767|100830263|FG003|COMPLETED|Overall Study||9||
48206374|NCT01924767|100830264|FG004|COMPLETED|Overall Study||9||
48206375|NCT01924767|100830260|FG000|NOT COMPLETED|Overall Study||1||
48206376|NCT01924767|100830261|FG001|NOT COMPLETED|Overall Study||0||
48206377|NCT01924767|100830262|FG002|NOT COMPLETED|Overall Study||1||
48206378|NCT01924767|100830263|FG003|NOT COMPLETED|Overall Study||0||
48206379|NCT01924767|100830264|FG004|NOT COMPLETED|Overall Study||0||
48206380|NCT04870645|100830265|FG000|STARTED|Overall Study||15||
48206381|NCT04870645|100830265|FG000|COMPLETED|Overall Study||15||
48206382|NCT04870645|100830265|FG000|NOT COMPLETED|Overall Study||0||
48206383|NCT02326649|100830266|FG000|STARTED|Overall Study||33||
48206384|NCT02326649|100830266|FG000|COMPLETED|Overall Study||21||
48206385|NCT02326649|100830266|FG000|NOT COMPLETED|Overall Study||12||
48047583|NCT01115582|100438284|FG000|COMPLETED|Overall Study||16||
48047584|NCT01115582|100438284|FG000|NOT COMPLETED|Overall Study||0||
48047585|NCT00672204|100438285|FG000|STARTED|Overall Study||23||
48047586|NCT00672204|100438285|FG000|COMPLETED|Overall Study||3||
48047587|NCT00672204|100438285|FG000|NOT COMPLETED|Overall Study||20||
48206386|NCT00588809|100830267|FG000|STARTED|Overall Study||47||
48206387|NCT00588809|100830267|FG000|COMPLETED|Overall Study||47||
48047588|NCT01461057|100438286|FG000|STARTED|Overall Study||15||
48047589|NCT01461057|100438287|FG001|STARTED|Overall Study||15||
48206388|NCT00588809|100830267|FG000|NOT COMPLETED|Overall Study||0||
48206389|NCT01576523|100830268|FG000|STARTED|Dosing Period 1||3||
48206390|NCT01576523|100830269|FG001|STARTED|Dosing Period 1||3||
48206391|NCT01576523|100830270|FG002|STARTED|Dosing Period 1||3||
48206392|NCT01576523|100830271|FG003|STARTED|Dosing Period 1||3||
48206393|NCT01576523|100830272|FG004|STARTED|Dosing Period 1||3||
48047590|NCT01461057|100438286|FG000|COMPLETED|Overall Study||0||
48047591|NCT01461057|100438287|FG001|COMPLETED|Overall Study||0||
48206394|NCT01576523|100830273|FG005|STARTED|Dosing Period 1||3||
48206395|NCT01576523|100830268|FG000|COMPLETED|Dosing Period 1||3||
48206396|NCT01576523|100830269|FG001|COMPLETED|Dosing Period 1||3||
48206397|NCT01576523|100830270|FG002|COMPLETED|Dosing Period 1||3||
48206398|NCT01576523|100830271|FG003|COMPLETED|Dosing Period 1||3||
48206399|NCT01576523|100830272|FG004|COMPLETED|Dosing Period 1||3||
48206400|NCT01576523|100830273|FG005|COMPLETED|Dosing Period 1||3||
48206401|NCT01576523|100830268|FG000|NOT COMPLETED|Dosing Period 1||0||
48206402|NCT01576523|100830269|FG001|NOT COMPLETED|Dosing Period 1||0||
48206403|NCT01576523|100830270|FG002|NOT COMPLETED|Dosing Period 1||0||
48206404|NCT01576523|100830271|FG003|NOT COMPLETED|Dosing Period 1||0||
48206405|NCT01576523|100830272|FG004|NOT COMPLETED|Dosing Period 1||0||
48206406|NCT01576523|100830273|FG005|NOT COMPLETED|Dosing Period 1||0||
48206407|NCT01576523|100830268|FG000|STARTED|Dosing Period 2||3||
48206408|NCT01576523|100830269|FG001|STARTED|Dosing Period 2||3||
48206409|NCT01576523|100830270|FG002|STARTED|Dosing Period 2||3||
48206410|NCT01576523|100830271|FG003|STARTED|Dosing Period 2||3||
48206411|NCT01576523|100830272|FG004|STARTED|Dosing Period 2||3||
48206412|NCT01576523|100830273|FG005|STARTED|Dosing Period 2||3||
48206413|NCT01576523|100830268|FG000|COMPLETED|Dosing Period 2||3||
48206414|NCT01576523|100830269|FG001|COMPLETED|Dosing Period 2||3||
48206415|NCT01576523|100830270|FG002|COMPLETED|Dosing Period 2||3||
48206416|NCT01576523|100830271|FG003|COMPLETED|Dosing Period 2||3||
48206417|NCT01576523|100830272|FG004|COMPLETED|Dosing Period 2||3||
48206418|NCT01576523|100830273|FG005|COMPLETED|Dosing Period 2||3||
48206419|NCT01576523|100830268|FG000|NOT COMPLETED|Dosing Period 2||0||
48206420|NCT01576523|100830269|FG001|NOT COMPLETED|Dosing Period 2||0||
48206421|NCT01576523|100830270|FG002|NOT COMPLETED|Dosing Period 2||0||
48206422|NCT01576523|100830271|FG003|NOT COMPLETED|Dosing Period 2||0||
48206423|NCT01576523|100830272|FG004|NOT COMPLETED|Dosing Period 2||0||
48206424|NCT01576523|100830273|FG005|NOT COMPLETED|Dosing Period 2||0||
48047592|NCT01461057|100438286|FG000|NOT COMPLETED|Overall Study||15||
48047593|NCT01461057|100438287|FG001|NOT COMPLETED|Overall Study||15||
48047594|NCT00397943|100438288|FG000|STARTED|Overall Study||40||
48047595|NCT00397943|100438289|FG001|STARTED|Overall Study||40||
48047596|NCT00397943|100438290|FG002|STARTED|Overall Study||10||
48047597|NCT00397943|100438291|FG003|STARTED|Overall Study||10||
48047598|NCT00397943|100438292|FG004|STARTED|Overall Study||10||
48047599|NCT00397943|100438288|FG000|COMPLETED|Overall Study||28||
48047600|NCT00397943|100438289|FG001|COMPLETED|Overall Study||31||
48047601|NCT00397943|100438290|FG002|COMPLETED|Overall Study||10||
48047602|NCT00397943|100438291|FG003|COMPLETED|Overall Study||10||
48047603|NCT00397943|100438292|FG004|COMPLETED|Overall Study||10||
48047604|NCT00397943|100438288|FG000|NOT COMPLETED|Overall Study||12||
48047605|NCT00397943|100438289|FG001|NOT COMPLETED|Overall Study||9||
48047606|NCT00397943|100438290|FG002|NOT COMPLETED|Overall Study||0||
48047607|NCT00397943|100438291|FG003|NOT COMPLETED|Overall Study||0||
48047608|NCT00397943|100438292|FG004|NOT COMPLETED|Overall Study||0||
48047609|NCT03188042|100438293|FG000|STARTED|Overall Study||8||16
48047610|NCT03188042|100438294|FG001|STARTED|Overall Study||10||20
48047611|NCT03188042|100438293|FG000|COMPLETED|Overall Study||7||14
48047612|NCT03188042|100438294|FG001|COMPLETED|Overall Study||9||18
48206425|NCT03951649|100830274|FG000|STARTED|Overall Study||31||
48206426|NCT03951649|100830275|FG001|STARTED|Overall Study||31||
48206427|NCT03951649|100830274|FG000|COMPLETED|Overall Study||31||
48206428|NCT03951649|100830275|FG001|COMPLETED|Overall Study||31||
48206429|NCT03951649|100830274|FG000|NOT COMPLETED|Overall Study||0||
48206430|NCT03951649|100830275|FG001|NOT COMPLETED|Overall Study||0||
48206431|NCT04594759|100830276|FG000|STARTED|Overall Study||22||
48206432|NCT04594759|100830276|FG000|COMPLETED|Overall Study||19||
48206433|NCT04594759|100830276|FG000|NOT COMPLETED|Overall Study||3||
48206434|NCT01849055|100830277|FG000|STARTED|Overall Study||8||
48206435|NCT01849055|100830278|FG001|STARTED|Overall Study||8||
48206436|NCT01849055|100830279|FG002|STARTED|Overall Study||8||
48206437|NCT01849055|100830280|FG003|STARTED|Overall Study||8||
48206438|NCT01849055|100830281|FG004|STARTED|Overall Study||8||
48206439|NCT01849055|100830282|FG005|STARTED|Overall Study||8||
48047613|NCT03188042|100438293|FG000|NOT COMPLETED|Overall Study||1||2
48047614|NCT03188042|100438294|FG001|NOT COMPLETED|Overall Study||1||2
48047615|NCT04473482|100438295|FG000|STARTED|Overall Study||30||
48047616|NCT04473482|100438296|FG001|STARTED|Overall Study||30||
48047617|NCT04473482|100438295|FG000|3-month Post Intervention Phone Call|Overall Study||22||
48206440|NCT01849055|100830277|FG000|COMPLETED|Overall Study||8||
48206441|NCT01849055|100830278|FG001|COMPLETED|Overall Study||8||
48206442|NCT01849055|100830279|FG002|COMPLETED|Overall Study||7||
48206443|NCT01849055|100830280|FG003|COMPLETED|Overall Study||8||
48206444|NCT01849055|100830281|FG004|COMPLETED|Overall Study||8||
48206445|NCT01849055|100830282|FG005|COMPLETED|Overall Study||8||
48206446|NCT01849055|100830277|FG000|NOT COMPLETED|Overall Study||0||
48206447|NCT01849055|100830278|FG001|NOT COMPLETED|Overall Study||0||
48206448|NCT01849055|100830279|FG002|NOT COMPLETED|Overall Study||1||
48206449|NCT01849055|100830280|FG003|NOT COMPLETED|Overall Study||0||
48206450|NCT01849055|100830281|FG004|NOT COMPLETED|Overall Study||0||
48206451|NCT01849055|100830282|FG005|NOT COMPLETED|Overall Study||0||
48206452|NCT00959946|100830283|FG000|STARTED|Overall Study||2||
48206453|NCT00959946|100830284|FG001|STARTED|Overall Study||4||
48206454|NCT00959946|100830285|FG002|STARTED|Overall Study||4||
48206455|NCT00959946|100830286|FG003|STARTED|Overall Study||5||
48206456|NCT00959946|100830287|FG004|STARTED|Overall Study||4||
48206457|NCT00959946|100830288|FG005|STARTED|Overall Study||9||
48206458|NCT00959946|100830289|FG006|STARTED|Overall Study||2||
48206459|NCT00959946|100830290|FG007|STARTED|Overall Study||2||
48206460|NCT00959946|100830283|FG000|COMPLETED|Overall Study||0||
48206461|NCT00959946|100830284|FG001|COMPLETED|Overall Study||0||
48206462|NCT00959946|100830285|FG002|COMPLETED|Overall Study||0||
48206463|NCT00959946|100830286|FG003|COMPLETED|Overall Study||0||
48047618|NCT04473482|100438296|FG001|3-month Post Intervention Phone Call|Overall Study||27||
48047619|NCT04473482|100438295|FG000|6-month Post Intervention Phone Call|Overall Study||19||
48047620|NCT04473482|100438296|FG001|6-month Post Intervention Phone Call|Overall Study||19||
48047621|NCT04473482|100438295|FG000|COMPLETED|Overall Study||19||
48047622|NCT04473482|100438296|FG001|COMPLETED|Overall Study||19||
48047623|NCT04473482|100438295|FG000|NOT COMPLETED|Overall Study||11||
48047624|NCT04473482|100438296|FG001|NOT COMPLETED|Overall Study||11||
48047625|NCT04590248|100438297|FG000|STARTED|Overall Study||109||
48047626|NCT04590248|100438297|FG000|COMPLETED|Overall Study||90||
48047627|NCT04590248|100438297|FG000|NOT COMPLETED|Overall Study||19||
48047628|NCT02764190|100438298|FG000|STARTED|Overall Study||167||
48047629|NCT02764190|100438299|FG001|STARTED|Overall Study||135||
48047630|NCT02764190|100438298|FG000|1 Day Follow-up|Overall Study||161||
48206464|NCT00959946|100830287|FG004|COMPLETED|Overall Study||0||
48206465|NCT00959946|100830288|FG005|COMPLETED|Overall Study||0||
48206466|NCT00959946|100830289|FG006|COMPLETED|Overall Study||0||
48206467|NCT00959946|100830290|FG007|COMPLETED|Overall Study||0||
48206468|NCT00959946|100830283|FG000|NOT COMPLETED|Overall Study||2||
48206469|NCT00959946|100830284|FG001|NOT COMPLETED|Overall Study||4||
48206470|NCT00959946|100830285|FG002|NOT COMPLETED|Overall Study||4||
48206471|NCT00959946|100830286|FG003|NOT COMPLETED|Overall Study||5||
48206472|NCT00959946|100830287|FG004|NOT COMPLETED|Overall Study||4||
48206473|NCT00959946|100830288|FG005|NOT COMPLETED|Overall Study||9||
48206474|NCT00959946|100830289|FG006|NOT COMPLETED|Overall Study||2||
48206475|NCT00959946|100830290|FG007|NOT COMPLETED|Overall Study||2||
48206476|NCT03781336|100830291|FG000|STARTED|Overall Study||45||
48206477|NCT03781336|100830292|FG001|STARTED|Overall Study||37||
48206478|NCT03781336|100830291|FG000|COMPLETED|Overall Study||43||
48206479|NCT03781336|100830292|FG001|COMPLETED|Overall Study||35||
48206480|NCT03781336|100830291|FG000|NOT COMPLETED|Overall Study||2||
48206481|NCT03781336|100830292|FG001|NOT COMPLETED|Overall Study||2||
48206482|NCT01538719|100830293|FG000|STARTED|Overall Study||7||
48206483|NCT01538719|100830294|FG001|STARTED|Overall Study||12||
48206484|NCT01538719|100830293|FG000|COMPLETED|Overall Study||5||
48206485|NCT01538719|100830294|FG001|COMPLETED|Overall Study||12||
48206486|NCT01538719|100830293|FG000|NOT COMPLETED|Overall Study||2||
48206487|NCT01538719|100830294|FG001|NOT COMPLETED|Overall Study||0||
48206488|NCT01147380|100830295|FG000|STARTED|Overall Study||6||
48047631|NCT02764190|100438299|FG001|1 Day Follow-up|Overall Study||131||
48047632|NCT02764190|100438298|FG000|3 Month Follow-up|Overall Study||156||
48047633|NCT02764190|100438299|FG001|3 Month Follow-up|Overall Study||128||
48047634|NCT02764190|100438298|FG000|6 Month Follow-up|Overall Study||155||
48047635|NCT02764190|100438299|FG001|6 Month Follow-up|Overall Study||128||
48047636|NCT02764190|100438298|FG000|12 Month Follow-up|Overall Study||150||
48047637|NCT02764190|100438299|FG001|12 Month Follow-up|Overall Study||122||
48047638|NCT02764190|100438298|FG000|COMPLETED|Overall Study||150||
48047639|NCT02764190|100438299|FG001|COMPLETED|Overall Study||122||
48047640|NCT02764190|100438298|FG000|NOT COMPLETED|Overall Study||17||
48047641|NCT02764190|100438299|FG001|NOT COMPLETED|Overall Study||13||
48206489|NCT01147380|100830296|FG001|STARTED|Overall Study||12||
48206490|NCT01147380|100830295|FG000|COMPLETED|Overall Study||6||
48206491|NCT01147380|100830296|FG001|COMPLETED|Overall Study||12||
48206492|NCT01147380|100830295|FG000|NOT COMPLETED|Overall Study||0||
48206493|NCT01147380|100830296|FG001|NOT COMPLETED|Overall Study||0||
48206494|NCT01179334|100830297|FG000|STARTED|Treatment Period||12||
48206495|NCT01179334|100830298|FG001|STARTED|Treatment Period||6||
48206496|NCT01179334|100830297|FG000|Participants Received Treatment|Treatment Period||12||
48206497|NCT01179334|100830298|FG001|Participants Received Treatment|Treatment Period||6||
48206498|NCT01179334|100830297|FG000|COMPLETED|Treatment Period||11||
48206499|NCT01179334|100830298|FG001|COMPLETED|Treatment Period||6||
48206500|NCT01179334|100830297|FG000|NOT COMPLETED|Treatment Period||1||
48206501|NCT01179334|100830298|FG001|NOT COMPLETED|Treatment Period||0||
48206502|NCT01179334|100830297|FG000|STARTED|Long-term Extension (LTE) Period||11||
48206503|NCT01179334|100830298|FG001|STARTED|Long-term Extension (LTE) Period||6||
48206504|NCT01179334|100830297|FG000|COMPLETED|Long-term Extension (LTE) Period||0||
48206505|NCT01179334|100830298|FG001|COMPLETED|Long-term Extension (LTE) Period||0||
48206506|NCT01179334|100830297|FG000|NOT COMPLETED|Long-term Extension (LTE) Period||11||
48206507|NCT01179334|100830298|FG001|NOT COMPLETED|Long-term Extension (LTE) Period||6||
48206508|NCT00628862|100830299|FG000|STARTED|Overall Study||206||
48206509|NCT00628862|100830300|FG001|STARTED|Overall Study||199||
48206510|NCT00628862|100830301|FG002|STARTED|Overall Study||208||
48206511|NCT00628862|100830299|FG000|COMPLETED|Overall Study||195||
48206512|NCT00628862|100830300|FG001|COMPLETED|Overall Study||182||
48206513|NCT00628862|100830301|FG002|COMPLETED|Overall Study||186||
48206514|NCT00628862|100830299|FG000|NOT COMPLETED|Overall Study||11||
48206515|NCT00628862|100830300|FG001|NOT COMPLETED|Overall Study||17||
48206516|NCT00628862|100830301|FG002|NOT COMPLETED|Overall Study||22||
48206517|NCT02808338|100830302|FG000|STARTED|Screening||25||
48206518|NCT02808338|100830302|FG000|COMPLETED|Screening||15||
48206519|NCT02808338|100830302|FG000|NOT COMPLETED|Screening||10||
48047642|NCT01931709|100438300|FG000|STARTED|Overall Study||35||
48047643|NCT01931709|100438300|FG000|COMPLETED|Overall Study||35||
48047644|NCT01931709|100438300|FG000|NOT COMPLETED|Overall Study||0||
48047645|NCT03619811|100438301|FG000|STARTED|Overall Study||43||
48047646|NCT03619811|100438301|FG000|COMPLETED|Overall Study||31||
48047647|NCT03619811|100438301|FG000|NOT COMPLETED|Overall Study||12||
48047648|NCT00450385|100438302|FG000|STARTED|Overall Study||57||
48047649|NCT00450385|100438302|FG000|COMPLETED|Overall Study||44||
48047650|NCT00450385|100438302|FG000|NOT COMPLETED|Overall Study||13||
48047651|NCT01089361|100438303|FG000|STARTED|Overall Study||9||
48047652|NCT01089361|100438304|FG001|STARTED|Overall Study||10||
48047653|NCT01089361|100438303|FG000|COMPLETED|Overall Study||8||
48047654|NCT01089361|100438304|FG001|COMPLETED|Overall Study||10||
48047655|NCT01089361|100438303|FG000|NOT COMPLETED|Overall Study||1||
48047656|NCT01089361|100438304|FG001|NOT COMPLETED|Overall Study||0||
48047657|NCT01307020|100438305|FG000|STARTED|Overall Study||61||
48047658|NCT01307020|100438306|FG001|STARTED|Overall Study||63||
48047659|NCT01307020|100438307|FG002|STARTED|Overall Study||63||
48047660|NCT01307020|100438308|FG003|STARTED|Overall Study||61||
48047661|NCT01307020|100438309|FG004|STARTED|Overall Study||60||
48047662|NCT01307020|100438310|FG005|STARTED|Overall Study||61||
48047663|NCT01307020|100438311|FG006|STARTED|Overall Study||59||
48047664|NCT01307020|100438312|FG007|STARTED|Overall Study||60||
48047665|NCT01307020|100438313|FG008|STARTED|Overall Study||61||
48206520|NCT02808338|100830302|FG000|STARTED|Overnight In-lab Polysomonography||15||
48206521|NCT02808338|100830302|FG000|Modified Philips BiPAP ASV|Overnight In-lab Polysomonography||13||
48206522|NCT02808338|100830302|FG000|ResMed S7 VPAP Adapt|Overnight In-lab Polysomonography||13||
48206523|NCT02808338|100830302|FG000|Philips BiPAP AutoSV Advanced System One|Overnight In-lab Polysomonography||12||
48206524|NCT02808338|100830302|FG000|ResMed S9 VPAP Adapt|Overnight In-lab Polysomonography||12||
48206525|NCT02808338|100830302|FG000|COMPLETED|Overnight In-lab Polysomonography||13||
48206526|NCT02808338|100830302|FG000|NOT COMPLETED|Overnight In-lab Polysomonography||2||
48206527|NCT02808338|100830302|FG000|STARTED|Take Home Period||13||
48206528|NCT02808338|100830302|FG000|COMPLETED|Take Home Period||13||
48206529|NCT02808338|100830302|FG000|NOT COMPLETED|Take Home Period||0||
48206530|NCT00888979|100830303|FG000|STARTED|Overall Study||10||
48206531|NCT00888979|100830303|FG000|Received the Inhaler/Counseling|Overall Study||8||
48206532|NCT00888979|100830303|FG000|COMPLETED|Overall Study||6||
48047666|NCT01307020|100438314|FG009|STARTED|Overall Study||62||
48047667|NCT01307020|100438305|FG000|Safety Population|Overall Study||61||
48047668|NCT01307020|100438306|FG001|Safety Population|Overall Study||63||
48047669|NCT01307020|100438307|FG002|Safety Population|Overall Study||63||
48047670|NCT01307020|100438308|FG003|Safety Population|Overall Study||61||
48047671|NCT01307020|100438309|FG004|Safety Population|Overall Study||60||
48047672|NCT01307020|100438310|FG005|Safety Population|Overall Study||61||
48047673|NCT01307020|100438311|FG006|Safety Population|Overall Study||59||
48047674|NCT01307020|100438312|FG007|Safety Population|Overall Study||60||
48047675|NCT01307020|100438313|FG008|Safety Population|Overall Study||61||
48047676|NCT01307020|100438314|FG009|Safety Population|Overall Study||62||
48047677|NCT01307020|100438305|FG000|ITT (>= 1 Assessment Post Randomization)|Overall Study||60||
48047678|NCT01307020|100438306|FG001|ITT (>= 1 Assessment Post Randomization)|Overall Study||62||
48206533|NCT00888979|100830303|FG000|NOT COMPLETED|Overall Study||4||
48206534|NCT04979988|100830304|FG000|STARTED|Overall Study||29||
48206535|NCT04979988|100830305|FG001|STARTED|Overall Study||22||
48206536|NCT04979988|100830304|FG000|COMPLETED|Overall Study||29||
48206537|NCT04979988|100830305|FG001|COMPLETED|Overall Study||22||
48206538|NCT04979988|100830304|FG000|NOT COMPLETED|Overall Study||0||
48206539|NCT04979988|100830305|FG001|NOT COMPLETED|Overall Study||0||
48047679|NCT01307020|100438307|FG002|ITT (>= 1 Assessment Post Randomization)|Overall Study||63||
48047680|NCT01307020|100438308|FG003|ITT (>= 1 Assessment Post Randomization)|Overall Study||61||
48047681|NCT01307020|100438309|FG004|ITT (>= 1 Assessment Post Randomization)|Overall Study||60||
48206540|NCT01185782|100830306|FG000|STARTED|Overall Study||129||
48206541|NCT01185782|100830307|FG001|STARTED|Overall Study||136||
48206542|NCT01185782|100830306|FG000|Treated|Overall Study||129||
48206543|NCT01185782|100830307|FG001|Treated|Overall Study||132||
48206544|NCT01185782|100830306|FG000|COMPLETED|Overall Study||123||
48206545|NCT01185782|100830307|FG001|COMPLETED|Overall Study||125||
48206546|NCT01185782|100830306|FG000|NOT COMPLETED|Overall Study||6||
48206547|NCT01185782|100830307|FG001|NOT COMPLETED|Overall Study||11||
48206548|NCT03608839|100830308|FG000|STARTED|Overall Study||9||
48206549|NCT03608839|100830309|FG001|STARTED|Overall Study||9||
48206550|NCT03608839|100830310|FG002|STARTED|Overall Study||9||
48206551|NCT03608839|100830308|FG000|COMPLETED|Overall Study||9||
48206552|NCT03608839|100830309|FG001|COMPLETED|Overall Study||9||
48206553|NCT03608839|100830310|FG002|COMPLETED|Overall Study||9||
48206554|NCT03608839|100830308|FG000|NOT COMPLETED|Overall Study||0||
48206555|NCT03608839|100830309|FG001|NOT COMPLETED|Overall Study||0||
48206556|NCT03608839|100830310|FG002|NOT COMPLETED|Overall Study||0||
48206557|NCT04464421|100830311|FG000|STARTED|Overall Study||24||
48206558|NCT04464421|100830312|FG001|STARTED|Overall Study||24||
48206559|NCT04464421|100830311|FG000|COMPLETED|Overall Study||22||
48206560|NCT04464421|100830312|FG001|COMPLETED|Overall Study||22||
48206561|NCT04464421|100830311|FG000|NOT COMPLETED|Overall Study||2||
48206562|NCT04464421|100830312|FG001|NOT COMPLETED|Overall Study||2||
48206563|NCT01169311|100830313|FG000|STARTED|Overall Study||27||
48206564|NCT01169311|100830313|FG000|COMPLETED|Overall Study||27||
48206565|NCT01169311|100830313|FG000|NOT COMPLETED|Overall Study||0||
48206566|NCT02158091|100830314|FG000|STARTED|Overall Study||6||
48206567|NCT02158091|100830315|FG001|STARTED|Overall Study||6||
48206568|NCT02158091|100830316|FG002|STARTED|Overall Study||20||
48206569|NCT02158091|100830314|FG000|COMPLETED|Overall Study||4||
48206570|NCT02158091|100830315|FG001|COMPLETED|Overall Study||5||
48206571|NCT02158091|100830316|FG002|COMPLETED|Overall Study||20||
48206572|NCT02158091|100830314|FG000|NOT COMPLETED|Overall Study||2||
48206573|NCT02158091|100830315|FG001|NOT COMPLETED|Overall Study||1||
48206574|NCT02158091|100830316|FG002|NOT COMPLETED|Overall Study||0||
48206575|NCT01461655|100830317|FG000|STARTED|Overall Study||40||
48206576|NCT01461655|100830317|FG000|COMPLETED|Overall Study||40||
48206577|NCT01461655|100830317|FG000|NOT COMPLETED|Overall Study||0||
48206578|NCT01124188|100830318|FG000|STARTED|Overall Study||68||
48206579|NCT01124188|100830319|FG001|STARTED|Overall Study||71||
48206580|NCT01124188|100830318|FG000|COMPLETED|Overall Study||60||
48206581|NCT01124188|100830319|FG001|COMPLETED|Overall Study||65||
48206582|NCT01124188|100830318|FG000|NOT COMPLETED|Overall Study||8||
48206583|NCT01124188|100830319|FG001|NOT COMPLETED|Overall Study||6||
48206584|NCT00001304|100830320|FG000|STARTED|Overall Study||13||
48206585|NCT00001304|100830321|FG001|STARTED|Overall Study||14||
48206586|NCT00001304|100830320|FG000|COMPLETED|Overall Study||13||
48206587|NCT00001304|100830321|FG001|COMPLETED|Overall Study||14||
48206588|NCT00001304|100830320|FG000|NOT COMPLETED|Overall Study||0||
48206589|NCT00001304|100830321|FG001|NOT COMPLETED|Overall Study||0||
48206590|NCT01772420|100830322|FG000|STARTED|Overall Study||16||
48206591|NCT01772420|100830323|FG001|STARTED|Overall Study||15||
48206592|NCT01772420|100830324|FG002|STARTED|Overall Study||21||
48206593|NCT01772420|100830322|FG000|COMPLETED|Overall Study||16||
48206594|NCT01772420|100830323|FG001|COMPLETED|Overall Study||15||
48206595|NCT01772420|100830324|FG002|COMPLETED|Overall Study||21||
48206596|NCT01772420|100830322|FG000|NOT COMPLETED|Overall Study||0||
48206597|NCT01772420|100830323|FG001|NOT COMPLETED|Overall Study||0||
48206598|NCT01772420|100830324|FG002|NOT COMPLETED|Overall Study||0||
48206599|NCT02753413|100830325|FG000|STARTED|Overall Study||49||
48206600|NCT02753413|100830326|FG001|STARTED|Overall Study||51||
48206601|NCT02753413|100830325|FG000|COMPLETED|Overall Study||49||
48206602|NCT02753413|100830326|FG001|COMPLETED|Overall Study||51||
48206603|NCT02753413|100830325|FG000|NOT COMPLETED|Overall Study||0||
48206604|NCT02753413|100830326|FG001|NOT COMPLETED|Overall Study||0||
48206605|NCT01111526|100830327|FG000|STARTED|Overall Study||4||
48206606|NCT01111526|100830328|FG001|STARTED|Overall Study||8||
48206607|NCT01111526|100830329|FG002|STARTED|Overall Study||10||
48206608|NCT01111526|100830327|FG000|COMPLETED|Overall Study||4||
48206609|NCT01111526|100830328|FG001|COMPLETED|Overall Study||7||
48206610|NCT01111526|100830329|FG002|COMPLETED|Overall Study||8||
48206611|NCT01111526|100830327|FG000|NOT COMPLETED|Overall Study||0||
48206612|NCT01111526|100830328|FG001|NOT COMPLETED|Overall Study||1||
48206613|NCT01111526|100830329|FG002|NOT COMPLETED|Overall Study||2||
48206614|NCT00396084|100830330|FG000|STARTED|Overall Study||10||
48206615|NCT00396084|100830331|FG001|STARTED|Overall Study||10||
48206616|NCT00396084|100830332|FG002|STARTED|Overall Study||10||
48206617|NCT00396084|100830333|FG003|STARTED|Overall Study||10||
48206618|NCT00396084|100830334|FG004|STARTED|Overall Study||10||
48206619|NCT00396084|100830335|FG005|STARTED|Overall Study||20||
48206620|NCT00396084|100830330|FG000|COMPLETED|Overall Study||10||
48206621|NCT00396084|100830331|FG001|COMPLETED|Overall Study||10||
48206622|NCT00396084|100830332|FG002|COMPLETED|Overall Study||10||
48206623|NCT00396084|100830333|FG003|COMPLETED|Overall Study||9||
48206624|NCT00396084|100830334|FG004|COMPLETED|Overall Study||9||
48206625|NCT00396084|100830335|FG005|COMPLETED|Overall Study||18||
48206626|NCT00396084|100830330|FG000|NOT COMPLETED|Overall Study||0||
48206627|NCT00396084|100830331|FG001|NOT COMPLETED|Overall Study||0||
48206628|NCT00396084|100830332|FG002|NOT COMPLETED|Overall Study||0||
48206629|NCT00396084|100830333|FG003|NOT COMPLETED|Overall Study||1||
48206630|NCT00396084|100830334|FG004|NOT COMPLETED|Overall Study||1||
48206631|NCT00396084|100830335|FG005|NOT COMPLETED|Overall Study||2||
48206632|NCT02694978|100830336|FG000|STARTED|Overall Study||1006||
48206633|NCT02694978|100830337|FG001|STARTED|Overall Study||1008||
48206634|NCT02694978|100830336|FG000|Received at Least 1 Dose of Study Drug|Overall Study||997||
48206635|NCT02694978|100830337|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1000||
48206636|NCT02694978|100830336|FG000|COMPLETED|Overall Study||935|Completed=received at least 1 dose of study drug and returned for final study visit (Week 5).|
48206637|NCT02694978|100830337|FG001|COMPLETED|Overall Study||948|Completed=received at least 1 dose of study drug and returned for final study visit (Week 5).|
48206638|NCT02694978|100830336|FG000|NOT COMPLETED|Overall Study||71||
48206639|NCT02694978|100830337|FG001|NOT COMPLETED|Overall Study||60||
48206640|NCT01576484|100830338|FG000|STARTED|Overall Study||12||
48206641|NCT01576484|100830339|FG001|STARTED|Overall Study||46||
48206642|NCT01576484|100830338|FG000|COMPLETED|Overall Study||7||
48206643|NCT01576484|100830339|FG001|COMPLETED|Overall Study||27||
48206644|NCT01576484|100830338|FG000|NOT COMPLETED|Overall Study||5||
48206645|NCT01576484|100830339|FG001|NOT COMPLETED|Overall Study||19||
48206646|NCT03854253|100830340|FG000|STARTED|Overall Study||50||
48206647|NCT03854253|100830341|FG001|STARTED|Overall Study||50||
48206648|NCT03854253|100830340|FG000|COMPLETED|Overall Study||49||
48206649|NCT03854253|100830341|FG001|COMPLETED|Overall Study||50||
48206650|NCT03854253|100830340|FG000|NOT COMPLETED|Overall Study||1||
48206651|NCT03854253|100830341|FG001|NOT COMPLETED|Overall Study||0||
48206652|NCT02749968|100830342|FG000|STARTED|Overall Study||50||
48206653|NCT02749968|100830343|FG001|STARTED|Overall Study||50||
48206654|NCT02749968|100830342|FG000|Interim Analysis|Overall Study||25|Interim safety and efficacy analysis was performed after 25 patients were recruited to each arm.|
48206655|NCT02749968|100830343|FG001|Interim Analysis|Overall Study||25|Interim safety and efficacy analysis was performed after 25 patients were recruited to each arm.|
48206656|NCT02749968|100830342|FG000|COMPLETED|Overall Study||50||
48206657|NCT02749968|100830343|FG001|COMPLETED|Overall Study||50||
48206658|NCT02749968|100830342|FG000|NOT COMPLETED|Overall Study||0||
48206659|NCT02749968|100830343|FG001|NOT COMPLETED|Overall Study||0||
48206660|NCT01733238|100830344|FG000|STARTED|Overall Study||13||
48206661|NCT01733238|100830344|FG000|COMPLETED|Overall Study||8|8 subjects completed the Induction Phase and 7 subjects started Maintenance Phase|
48206662|NCT01733238|100830344|FG000|NOT COMPLETED|Overall Study||5||
48206663|NCT00223795|100830345|FG000|STARTED|First Intervention - Eight Weeks||26||
48206664|NCT00223795|100830346|FG001|STARTED|First Intervention - Eight Weeks||27||
48206665|NCT00223795|100830345|FG000|COMPLETED|First Intervention - Eight Weeks||19||
48206666|NCT00223795|100830346|FG001|COMPLETED|First Intervention - Eight Weeks||18||
48206667|NCT00223795|100830345|FG000|NOT COMPLETED|First Intervention - Eight Weeks||7||
48206668|NCT00223795|100830346|FG001|NOT COMPLETED|First Intervention - Eight Weeks||9||
48206669|NCT00223795|100830345|FG000|STARTED|Second Intervention - All Use Canes 4 mo||19||
48206670|NCT00223795|100830346|FG001|STARTED|Second Intervention - All Use Canes 4 mo||18||
48206671|NCT00223795|100830345|FG000|COMPLETED|Second Intervention - All Use Canes 4 mo||18||
48206672|NCT00223795|100830346|FG001|COMPLETED|Second Intervention - All Use Canes 4 mo||17||
48206673|NCT00223795|100830345|FG000|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1||
48206674|NCT00223795|100830346|FG001|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1||
48206675|NCT00834834|100830347|FG000|STARTED|Overall Study||42||
48206676|NCT00834834|100830348|FG001|STARTED|Overall Study||42||
48206677|NCT00834834|100830347|FG000|COMPLETED|Overall Study||38||
48206678|NCT00834834|100830348|FG001|COMPLETED|Overall Study||39||
48206679|NCT00834834|100830347|FG000|NOT COMPLETED|Overall Study||4||
48206680|NCT00834834|100830348|FG001|NOT COMPLETED|Overall Study||3||
48206681|NCT00258895|100830349|FG000|STARTED|Overall Study||487||
48206682|NCT00258895|100830350|FG001|STARTED|Overall Study||162||
48206683|NCT00258895|100830349|FG000|COMPLETED|Overall Study||477||
48206684|NCT00258895|100830350|FG001|COMPLETED|Overall Study||159||
48206685|NCT00258895|100830349|FG000|NOT COMPLETED|Overall Study||10||
48206686|NCT00258895|100830350|FG001|NOT COMPLETED|Overall Study||3||
48206687|NCT01281813|100830351|FG000|STARTED|Overall Study||4||
48206688|NCT01281813|100830352|FG001|STARTED|Overall Study||4||
48206689|NCT01281813|100830353|FG002|STARTED|Overall Study||137||
48206690|NCT01281813|100830351|FG000|COMPLETED|Overall Study||0||
48206691|NCT01281813|100830352|FG001|COMPLETED|Overall Study||0||
48206692|NCT01281813|100830353|FG002|COMPLETED|Overall Study||0||
48206693|NCT01281813|100830351|FG000|NOT COMPLETED|Overall Study||4||
48206694|NCT01281813|100830352|FG001|NOT COMPLETED|Overall Study||4||
48206695|NCT01281813|100830353|FG002|NOT COMPLETED|Overall Study||137||
48206696|NCT00664430|100830354|FG000|STARTED|Overall Study||13||
48206697|NCT00664430|100830354|FG000|COMPLETED|Overall Study||0||
48206698|NCT00664430|100830354|FG000|NOT COMPLETED|Overall Study||13||
48206699|NCT01059877|100830355|FG000|STARTED|Overall Study||6||
48206700|NCT01059877|100830356|FG001|STARTED|Overall Study||5||
48206701|NCT01059877|100830355|FG000|COMPLETED|Overall Study||6||
48206702|NCT01059877|100830356|FG001|COMPLETED|Overall Study||3||
48206703|NCT01059877|100830355|FG000|NOT COMPLETED|Overall Study||0||
48206704|NCT01059877|100830356|FG001|NOT COMPLETED|Overall Study||2||
48206705|NCT00658996|100830357|FG000|STARTED|First Intervention||109||
48206706|NCT00658996|100830358|FG001|STARTED|First Intervention||107||
48206707|NCT00658996|100830357|FG000|COMPLETED|First Intervention||108||
48206708|NCT00658996|100830358|FG001|COMPLETED|First Intervention||106||
48206709|NCT00658996|100830357|FG000|NOT COMPLETED|First Intervention||1||
48206710|NCT00658996|100830358|FG001|NOT COMPLETED|First Intervention||1||
48206711|NCT00658996|100830357|FG000|STARTED|Crossover Period||108||
48047682|NCT01307020|100438310|FG005|ITT (>= 1 Assessment Post Randomization)|Overall Study||60||
48047683|NCT01307020|100438311|FG006|ITT (>= 1 Assessment Post Randomization)|Overall Study||59||
48047684|NCT01307020|100438312|FG007|ITT (>= 1 Assessment Post Randomization)|Overall Study||59||
48047685|NCT01307020|100438313|FG008|ITT (>= 1 Assessment Post Randomization)|Overall Study||60||
48047686|NCT01307020|100438314|FG009|ITT (>= 1 Assessment Post Randomization)|Overall Study||62||
48047687|NCT01307020|100438305|FG000|COMPLETED|Overall Study||61||
48047688|NCT01307020|100438306|FG001|COMPLETED|Overall Study||62||
48047689|NCT01307020|100438307|FG002|COMPLETED|Overall Study||62||
48047690|NCT01307020|100438308|FG003|COMPLETED|Overall Study||60||
48047691|NCT01307020|100438309|FG004|COMPLETED|Overall Study||60||
48047692|NCT01307020|100438310|FG005|COMPLETED|Overall Study||61||
48047693|NCT01307020|100438311|FG006|COMPLETED|Overall Study||58||
48047694|NCT01307020|100438312|FG007|COMPLETED|Overall Study||60||
48047695|NCT01307020|100438313|FG008|COMPLETED|Overall Study||61||
48047696|NCT01307020|100438314|FG009|COMPLETED|Overall Study||62||
48047697|NCT01307020|100438305|FG000|NOT COMPLETED|Overall Study||0||
48047698|NCT01307020|100438306|FG001|NOT COMPLETED|Overall Study||1||
48047699|NCT01307020|100438307|FG002|NOT COMPLETED|Overall Study||1||
48047700|NCT01307020|100438308|FG003|NOT COMPLETED|Overall Study||1||
48047701|NCT01307020|100438309|FG004|NOT COMPLETED|Overall Study||0||
48047702|NCT01307020|100438310|FG005|NOT COMPLETED|Overall Study||0||
48047703|NCT01307020|100438311|FG006|NOT COMPLETED|Overall Study||1||
48047704|NCT01307020|100438312|FG007|NOT COMPLETED|Overall Study||0||
48047705|NCT01307020|100438313|FG008|NOT COMPLETED|Overall Study||0||
48047706|NCT01307020|100438314|FG009|NOT COMPLETED|Overall Study||0||
48047707|NCT01280201|100438315|FG000|STARTED|Overall Study||44||
48047708|NCT01280201|100438315|FG000|COMPLETED|Overall Study||44||
48047709|NCT01280201|100438315|FG000|NOT COMPLETED|Overall Study||0||
48047710|NCT00923949|100438316|FG000|STARTED|Overall Study||1||
48047711|NCT00923949|100438316|FG000|COMPLETED|Overall Study||1||
48047712|NCT00923949|100438316|FG000|NOT COMPLETED|Overall Study||0||
48047713|NCT05011279|100438317|FG000|STARTED|Overall Study||10||
48047714|NCT05011279|100438317|FG000|COMPLETED|Overall Study||10||
48047715|NCT05011279|100438317|FG000|NOT COMPLETED|Overall Study||0||
48047716|NCT00548405|100438318|FG000|STARTED|Overall Study||231||
48047717|NCT00548405|100438319|FG001|STARTED|Overall Study||436||
48047718|NCT00548405|100438320|FG002|STARTED|Overall Study||173||
48047719|NCT00548405|100438318|FG000|Treated|Overall Study||202||
48047720|NCT00548405|100438319|FG001|Treated|Overall Study||426||
48047721|NCT00548405|100438320|FG002|Treated|Overall Study||170||
48047722|NCT00548405|100438318|FG000|COMPLETED|Overall Study||175||
48047723|NCT00548405|100438319|FG001|COMPLETED|Overall Study||416||
48047724|NCT00548405|100438320|FG002|COMPLETED|Overall Study||164||
48047725|NCT00548405|100438318|FG000|NOT COMPLETED|Overall Study||56||
48206712|NCT00658996|100830358|FG001|STARTED|Crossover Period||106||
48206713|NCT00658996|100830357|FG000|COMPLETED|Crossover Period||106||
48206714|NCT00658996|100830358|FG001|COMPLETED|Crossover Period||105||
48495616|NCT00819169|101547888|FG001|STARTED|Overall Study||3||
48495617|NCT00819169|101547889|FG002|STARTED|Overall Study||3||
48047726|NCT00548405|100438319|FG001|NOT COMPLETED|Overall Study||20||
48047727|NCT00548405|100438320|FG002|NOT COMPLETED|Overall Study||9||
48047728|NCT02292784|100438321|FG000|STARTED|Overall Study||5||
48047729|NCT02292784|100438322|FG001|STARTED|Overall Study||44||
48047730|NCT02292784|100438323|FG002|STARTED|Overall Study||49||
48047731|NCT02292784|100438321|FG000|COMPLETED|Overall Study||4||
48047732|NCT02292784|100438322|FG001|COMPLETED|Overall Study||24||
48047733|NCT02292784|100438323|FG002|COMPLETED|Overall Study||28||
48047734|NCT02292784|100438321|FG000|NOT COMPLETED|Overall Study||1||
48047735|NCT02292784|100438322|FG001|NOT COMPLETED|Overall Study||20||
48047736|NCT02292784|100438323|FG002|NOT COMPLETED|Overall Study||21||
48047737|NCT02614469|100438324|FG000|STARTED|Period 1||9||
48047738|NCT02614469|100438325|FG001|STARTED|Period 1||9||
48047739|NCT02614469|100438324|FG000|COMPLETED|Period 1||9||
48047740|NCT02614469|100438325|FG001|COMPLETED|Period 1||9||
48047741|NCT02614469|100438324|FG000|NOT COMPLETED|Period 1||0||
48047742|NCT02614469|100438325|FG001|NOT COMPLETED|Period 1||0||
48047743|NCT02614469|100438324|FG000|STARTED|Period 2||9||
48047744|NCT02614469|100438325|FG001|STARTED|Period 2||9||
48047745|NCT02614469|100438324|FG000|COMPLETED|Period 2||9||
48047746|NCT02614469|100438325|FG001|COMPLETED|Period 2||9||
48047747|NCT02614469|100438324|FG000|NOT COMPLETED|Period 2||0||
48047748|NCT02614469|100438325|FG001|NOT COMPLETED|Period 2||0||
48047749|NCT03324581|100438326|FG000|STARTED|Overall Study||77||
48047750|NCT03324581|100438327|FG001|STARTED|Overall Study||80||
48047751|NCT03324581|100438328|FG002|STARTED|Overall Study||82||
48047752|NCT03324581|100438326|FG000|COMPLETED|Overall Study||38||
48047753|NCT03324581|100438327|FG001|COMPLETED|Overall Study||44||
48047754|NCT03324581|100438328|FG002|COMPLETED|Overall Study||57||
48047755|NCT03324581|100438326|FG000|NOT COMPLETED|Overall Study||39||
48206715|NCT00658996|100830357|FG000|NOT COMPLETED|Crossover Period||2||
48206716|NCT00658996|100830358|FG001|NOT COMPLETED|Crossover Period||1||
48495618|NCT00819169|101547890|FG003|STARTED|Overall Study||15||
48206717|NCT00658996|100830357|FG000|STARTED|Second Intervention||106||
48206718|NCT00658996|100830358|FG001|STARTED|Second Intervention||105||
48206719|NCT00658996|100830357|FG000|COMPLETED|Second Intervention||105||
48206720|NCT00658996|100830358|FG001|COMPLETED|Second Intervention||104||
48206721|NCT00658996|100830357|FG000|NOT COMPLETED|Second Intervention||1||
48206722|NCT00658996|100830358|FG001|NOT COMPLETED|Second Intervention||1||
48206723|NCT00486759|100830359|FG000|STARTED|Treatment||390||
48206724|NCT00486759|100830360|FG001|STARTED|Treatment||397||
48206725|NCT00486759|100830359|FG000|COMPLETED|Treatment||203||
48206726|NCT00486759|100830360|FG001|COMPLETED|Treatment||260||
48206727|NCT00486759|100830359|FG000|NOT COMPLETED|Treatment||187||
48206728|NCT00486759|100830360|FG001|NOT COMPLETED|Treatment||137||
48206729|NCT00486759|100830359|FG000|STARTED|Safety Follow-up||203||
48206730|NCT00486759|100830360|FG001|STARTED|Safety Follow-up||260||
48206731|NCT00486759|100830359|FG000|COMPLETED|Safety Follow-up||64||
48206732|NCT00486759|100830360|FG001|COMPLETED|Safety Follow-up||142||
48206733|NCT00486759|100830359|FG000|NOT COMPLETED|Safety Follow-up||139||
48206734|NCT00486759|100830360|FG001|NOT COMPLETED|Safety Follow-up||118||
48206735|NCT00617201|100830361|FG000|STARTED|Overall Study||25||
48206736|NCT00617201|100830362|FG001|STARTED|Overall Study||25||
48206737|NCT00617201|100830361|FG000|COMPLETED|Overall Study||16||
48206738|NCT00617201|100830362|FG001|COMPLETED|Overall Study||12||
48206739|NCT00617201|100830361|FG000|NOT COMPLETED|Overall Study||9||
48206740|NCT00617201|100830362|FG001|NOT COMPLETED|Overall Study||13||
48206741|NCT04424641|100830363|FG000|STARTED|Overall Study||1||
48206742|NCT04424641|100830364|FG001|STARTED|Overall Study||4||
48206743|NCT04424641|100830365|FG002|STARTED|Overall Study||7||
48206744|NCT04424641|100830366|FG003|STARTED|Overall Study||7||
48206745|NCT04424641|100830367|FG004|STARTED|Overall Study||6||
48206746|NCT04424641|100830368|FG005|STARTED|Overall Study||2||
48206747|NCT04424641|100830369|FG006|STARTED|Overall Study||4||
48206748|NCT04424641|100830370|FG007|STARTED|Overall Study||6||
48206749|NCT04424641|100830363|FG000|COMPLETED|Overall Study||0||
48206750|NCT04424641|100830364|FG001|COMPLETED|Overall Study||0||
48206751|NCT04424641|100830365|FG002|COMPLETED|Overall Study||0||
48206752|NCT04424641|100830366|FG003|COMPLETED|Overall Study||0||
48206753|NCT04424641|100830367|FG004|COMPLETED|Overall Study||0||
48206754|NCT04424641|100830368|FG005|COMPLETED|Overall Study||0||
48206755|NCT04424641|100830369|FG006|COMPLETED|Overall Study||0||
48206756|NCT04424641|100830370|FG007|COMPLETED|Overall Study||0||
48206757|NCT04424641|100830363|FG000|NOT COMPLETED|Overall Study||1||
48206758|NCT04424641|100830364|FG001|NOT COMPLETED|Overall Study||4||
48206759|NCT04424641|100830365|FG002|NOT COMPLETED|Overall Study||7||
48206760|NCT04424641|100830366|FG003|NOT COMPLETED|Overall Study||7||
48206761|NCT04424641|100830367|FG004|NOT COMPLETED|Overall Study||6||
48206762|NCT04424641|100830368|FG005|NOT COMPLETED|Overall Study||2||
48206763|NCT04424641|100830369|FG006|NOT COMPLETED|Overall Study||4||
48206764|NCT04424641|100830370|FG007|NOT COMPLETED|Overall Study||6||
48206765|NCT02165761|100830371|FG000|STARTED|Overall Study||23||
48206766|NCT02165761|100830372|FG001|STARTED|Overall Study||19||
48206767|NCT02165761|100830371|FG000|COMPLETED|Overall Study||4||
48206768|NCT02165761|100830372|FG001|COMPLETED|Overall Study||5||
48206769|NCT02165761|100830371|FG000|NOT COMPLETED|Overall Study||19||
48206770|NCT02165761|100830372|FG001|NOT COMPLETED|Overall Study||14||
48206771|NCT00716144|100830373|FG000|STARTED|Overall Study||41||
48206772|NCT00716144|100830374|FG001|STARTED|Overall Study||45||
48206773|NCT00716144|100830375|FG002|STARTED|Overall Study||45||
48206774|NCT00716144|100830376|FG003|STARTED|Overall Study||45||
48206775|NCT00716144|100830373|FG000|COMPLETED|Overall Study||32||
48206776|NCT00716144|100830374|FG001|COMPLETED|Overall Study||38||
48206777|NCT00716144|100830375|FG002|COMPLETED|Overall Study||33||
48206778|NCT00716144|100830376|FG003|COMPLETED|Overall Study||33||
48206779|NCT00716144|100830373|FG000|NOT COMPLETED|Overall Study||9||
48206780|NCT00716144|100830374|FG001|NOT COMPLETED|Overall Study||7||
48206781|NCT00716144|100830375|FG002|NOT COMPLETED|Overall Study||12||
48206782|NCT00716144|100830376|FG003|NOT COMPLETED|Overall Study||12||
48206783|NCT00311363|100830377|FG000|STARTED|24-Week Single-Blind Treatment Period||327||
48206784|NCT00311363|100830378|FG001|STARTED|24-Week Single-Blind Treatment Period||0||
48206785|NCT00311363|100830379|FG002|STARTED|24-Week Single-Blind Treatment Period||0||
48206786|NCT00311363|100830377|FG000|COMPLETED|24-Week Single-Blind Treatment Period||221||
48206787|NCT00311363|100830378|FG001|COMPLETED|24-Week Single-Blind Treatment Period||0||
48206788|NCT00311363|100830379|FG002|COMPLETED|24-Week Single-Blind Treatment Period||0||
48206789|NCT00311363|100830377|FG000|NOT COMPLETED|24-Week Single-Blind Treatment Period||106||
48206790|NCT00311363|100830378|FG001|NOT COMPLETED|24-Week Single-Blind Treatment Period||0||
48206791|NCT00311363|100830379|FG002|NOT COMPLETED|24-Week Single-Blind Treatment Period||0||
48206792|NCT00311363|100830377|FG000|STARTED|12-Week Double-Blind Treatment Period||0||
48206793|NCT00311363|100830378|FG001|STARTED|12-Week Double-Blind Treatment Period||98||
48206794|NCT00311363|100830379|FG002|STARTED|12-Week Double-Blind Treatment Period||96||
48206795|NCT00311363|100830377|FG000|COMPLETED|12-Week Double-Blind Treatment Period||0||
48206796|NCT00311363|100830378|FG001|COMPLETED|12-Week Double-Blind Treatment Period||84||
48206797|NCT00311363|100830379|FG002|COMPLETED|12-Week Double-Blind Treatment Period||84||
48206798|NCT00311363|100830377|FG000|NOT COMPLETED|12-Week Double-Blind Treatment Period||0||
48206799|NCT00311363|100830378|FG001|NOT COMPLETED|12-Week Double-Blind Treatment Period||14||
48206800|NCT00311363|100830379|FG002|NOT COMPLETED|12-Week Double-Blind Treatment Period||12||
48206801|NCT03399370|100830380|FG000|STARTED|Overall Study||781||
48206802|NCT03399370|100830381|FG001|STARTED|Overall Study||780||
48206803|NCT03399370|100830380|FG000|COMPLETED|Overall Study||721||
48206804|NCT03399370|100830381|FG001|COMPLETED|Overall Study||694||
48206805|NCT03399370|100830380|FG000|NOT COMPLETED|Overall Study||60||
48206806|NCT03399370|100830381|FG001|NOT COMPLETED|Overall Study||86||
48206807|NCT01175317|100830382|FG000|STARTED|Overall Study||27||
48206808|NCT01175317|100830383|FG001|STARTED|Overall Study||31||
48206809|NCT01175317|100830382|FG000|COMPLETED|Overall Study||27||
48206810|NCT01175317|100830383|FG001|COMPLETED|Overall Study||31||
48206811|NCT01175317|100830382|FG000|NOT COMPLETED|Overall Study||0||
48206812|NCT01175317|100830383|FG001|NOT COMPLETED|Overall Study||0||
48206813|NCT00949975|100830384|FG000|STARTED|Overall Study||212||
48206814|NCT00949975|100830385|FG001|STARTED|Overall Study||206||
48206815|NCT00949975|100830386|FG002|STARTED|Overall Study||202||
48206816|NCT00949975|100830387|FG003|STARTED|Overall Study||218||
48206817|NCT00949975|100830384|FG000|COMPLETED|Overall Study||185||
48206818|NCT00949975|100830385|FG001|COMPLETED|Overall Study||177||
48206819|NCT00949975|100830386|FG002|COMPLETED|Overall Study||183||
48206820|NCT00949975|100830387|FG003|COMPLETED|Overall Study||190||
48206821|NCT00949975|100830384|FG000|NOT COMPLETED|Overall Study||27||
48206822|NCT00949975|100830385|FG001|NOT COMPLETED|Overall Study||29||
48206823|NCT00949975|100830386|FG002|NOT COMPLETED|Overall Study||19||
48206824|NCT00949975|100830387|FG003|NOT COMPLETED|Overall Study||28||
48206825|NCT02754479|100830388|FG000|STARTED|Overall Study||4||
48206826|NCT02754479|100830388|FG000|COMPLETED|Overall Study||3||
48206827|NCT02754479|100830388|FG000|NOT COMPLETED|Overall Study||1||
48206828|NCT01430611|100830389|FG000|STARTED|Overall Study||332||
48206829|NCT01430611|100830390|FG001|STARTED|Overall Study||333||
48206830|NCT01430611|100830389|FG000|COMPLETED|Overall Study||315||
48206831|NCT01430611|100830390|FG001|COMPLETED|Overall Study||318||
48206832|NCT01430611|100830389|FG000|NOT COMPLETED|Overall Study||17||
48206833|NCT01430611|100830390|FG001|NOT COMPLETED|Overall Study||15||
48206834|NCT03506880|100830391|FG000|STARTED|Overall Study||393|The start of study enrollment included 1,176 parent-teen dyads. This means there were 1,176 enrolled in the study with 1,176 teens who completed the baseline survey.|
48206835|NCT03506880|100830392|FG001|STARTED|Overall Study||393|The start of study enrollment included 1,176 parent-teen dyads. This means there were 1,176 enrolled in the study with 1,176 teens who completed the baseline survey.|
48206836|NCT03506880|100830393|FG002|STARTED|Overall Study||390|The start of study enrollment included 1,176 parent-teen dyads. This means there were 1,176 enrolled in the study with 1,176 teens who completed the baseline survey.|
48206837|NCT03506880|100830391|FG000|T2 (30 -Days Post-baseline)|Overall Study||331|Only teen participants received the T2 baseline survey. 1,001 teen participants completed this survey.|
48206838|NCT03506880|100830392|FG001|T2 (30 -Days Post-baseline)|Overall Study||328|Only teen participants received the T2 baseline survey. 1,001 teen participants completed this survey.|
48206839|NCT03506880|100830393|FG002|T2 (30 -Days Post-baseline)|Overall Study||342|Only teen participants received the T2 baseline survey. 1,001 teen participants completed this survey.|
48206840|NCT03506880|100830391|FG000|T3 (6-months Post-baseline)|Overall Study||315|Parents and teens received the T3 survey. This means there were 952 parents and 952 teens who completed this survey.|
48206841|NCT03506880|100830392|FG001|T3 (6-months Post-baseline)|Overall Study||318|Parents and teens received the T3 survey. This means there were 952 parents and 952 teens who completed this survey.|
48206842|NCT03506880|100830393|FG002|T3 (6-months Post-baseline)|Overall Study||319|Parents and teens received the T3 survey. This means there were 952 parents and 952 teens who completed this survey.|
48206843|NCT03506880|100830391|FG000|T4 (12-months Post-baseline)|Overall Study||296|Parents and teens received the T4 survey. This means there were 906 parents and 906 teens who completed this survey.|
48206844|NCT03506880|100830392|FG001|T4 (12-months Post-baseline)|Overall Study||305|Parents and teens received the T4 survey. This means there were 906 parents and 906 teens who completed this survey.|
48206845|NCT03506880|100830393|FG002|T4 (12-months Post-baseline)|Overall Study||305|Parents and teens received the T4 survey. This means there were 906 parents and 906 teens who completed this survey.|
48206846|NCT03506880|100830391|FG000|COMPLETED|Overall Study||296|The completed number reflects the number of parent-teen dyads who completed the study. There were 906 parents and 906 teens who completed this study.|
48206847|NCT03506880|100830392|FG001|COMPLETED|Overall Study||305|The completed number reflects the number of parent-teen dyads who completed the study. There were 906 parents and 906 teens who completed this study.|
48206848|NCT03506880|100830393|FG002|COMPLETED|Overall Study||305|The completed number reflects the number of parent-teen dyads who completed the study. There were 906 parents and 906 teens who completed this study.|
48206849|NCT03506880|100830391|FG000|NOT COMPLETED|Overall Study||97||
48206850|NCT03506880|100830392|FG001|NOT COMPLETED|Overall Study||88||
48206851|NCT03506880|100830393|FG002|NOT COMPLETED|Overall Study||85||
48206852|NCT00079183|100830394|FG000|STARTED|Overall Study||44||
48206853|NCT00079183|100830394|FG000|Drop Outs|Overall Study||7||
48206854|NCT00079183|100830394|FG000|COMPLETED|Overall Study||37||
48206855|NCT00079183|100830394|FG000|NOT COMPLETED|Overall Study||7||
48206856|NCT00028769|100830395|FG000|STARTED|Overall Study||41||
48206857|NCT00028769|100830395|FG000|Eligible|Overall Study||36||
48206858|NCT00028769|100830395|FG000|Eligible and Began Protocol Therapy|Overall Study||35||
48495619|NCT00819169|101547891|FG004|STARTED|Overall Study||8||
48495620|NCT00819169|101547892|FG005|STARTED|Overall Study||16||
48206859|NCT00028769|100830395|FG000|COMPLETED|Overall Study||0||
48206860|NCT00028769|100830395|FG000|NOT COMPLETED|Overall Study||41||
48206861|NCT04001517|100830396|FG000|STARTED|Overall Study||20||
48206862|NCT04001517|100830397|FG001|STARTED|Overall Study||26||
48206863|NCT04001517|100830398|FG002|STARTED|Overall Study||27||
48206864|NCT04001517|100830399|FG003|STARTED|Overall Study||18||
48206865|NCT04001517|100830396|FG000|COMPLETED|Overall Study||20||
48206866|NCT04001517|100830397|FG001|COMPLETED|Overall Study||20||
48206867|NCT04001517|100830398|FG002|COMPLETED|Overall Study||26||
48206868|NCT04001517|100830399|FG003|COMPLETED|Overall Study||15||
48206869|NCT04001517|100830396|FG000|NOT COMPLETED|Overall Study||0||
48206870|NCT04001517|100830397|FG001|NOT COMPLETED|Overall Study||6||
48206871|NCT04001517|100830398|FG002|NOT COMPLETED|Overall Study||1||
48206872|NCT04001517|100830399|FG003|NOT COMPLETED|Overall Study||3||
48206873|NCT02126878|100830400|FG000|STARTED|Overall Study||0||
48206874|NCT02126878|100830401|FG001|STARTED|Overall Study||0||
48206875|NCT02126878|100830402|FG002|STARTED|Overall Study||0||
48206876|NCT02126878|100830400|FG000|COMPLETED|Overall Study||0||
48206877|NCT02126878|100830401|FG001|COMPLETED|Overall Study||0||
48206878|NCT02126878|100830402|FG002|COMPLETED|Overall Study||0||
48206879|NCT02126878|100830400|FG000|NOT COMPLETED|Overall Study||0||
48206880|NCT02126878|100830401|FG001|NOT COMPLETED|Overall Study||0||
48206881|NCT02126878|100830402|FG002|NOT COMPLETED|Overall Study||0||
48206882|NCT04305405|100830403|FG000|STARTED|Overall Study||15||
48206883|NCT04305405|100830404|FG001|STARTED|Overall Study||15||
48206884|NCT04305405|100830403|FG000|COMPLETED|Overall Study||15||
48206885|NCT04305405|100830404|FG001|COMPLETED|Overall Study||14||
48206886|NCT04305405|100830403|FG000|NOT COMPLETED|Overall Study||0||
48206887|NCT04305405|100830404|FG001|NOT COMPLETED|Overall Study||1||
48206888|NCT00723450|100830405|FG000|STARTED|Open-Label Phase||298||
48206889|NCT00723450|100830406|FG001|STARTED|Open-Label Phase||0||
48206890|NCT00723450|100830407|FG002|STARTED|Open-Label Phase||0||
48206891|NCT00723450|100830405|FG000|COMPLETED|Open-Label Phase||173||
48206892|NCT00723450|100830406|FG001|COMPLETED|Open-Label Phase||0||
48206893|NCT00723450|100830407|FG002|COMPLETED|Open-Label Phase||0||
48206894|NCT00723450|100830405|FG000|NOT COMPLETED|Open-Label Phase||125||
48206895|NCT00723450|100830406|FG001|NOT COMPLETED|Open-Label Phase||0||
48206896|NCT00723450|100830407|FG002|NOT COMPLETED|Open-Label Phase||0||
48206897|NCT00723450|100830405|FG000|STARTED|Randomized Phase||0||
48206898|NCT00723450|100830406|FG001|STARTED|Randomized Phase||86||
48206899|NCT00723450|100830407|FG002|STARTED|Randomized Phase||87||
48047756|NCT03324581|100438327|FG001|NOT COMPLETED|Overall Study||36||
48047757|NCT03324581|100438328|FG002|NOT COMPLETED|Overall Study||25||
48047758|NCT00895011|100438329|FG000|STARTED|Overall Study||100||
48047759|NCT00895011|100438330|FG001|STARTED|Overall Study||99||
48047760|NCT00895011|100438331|FG002|STARTED|Overall Study||99||
48206900|NCT00723450|100830405|FG000|COMPLETED|Randomized Phase||0||
48206901|NCT00723450|100830406|FG001|COMPLETED|Randomized Phase||21||
48206902|NCT00723450|100830407|FG002|COMPLETED|Randomized Phase||20||
48206903|NCT00723450|100830405|FG000|NOT COMPLETED|Randomized Phase||0||
48206904|NCT00723450|100830406|FG001|NOT COMPLETED|Randomized Phase||65||
48206905|NCT00723450|100830407|FG002|NOT COMPLETED|Randomized Phase||67||
48206906|NCT02425111|100830408|FG000|STARTED|Part A: Treatment Period||101||
48206907|NCT02425111|100830408|FG000|COMPLETED|Part A: Treatment Period||78|Completed=Completed Study Drug|
48206908|NCT02425111|100830408|FG000|NOT COMPLETED|Part A: Treatment Period||23||
48047761|NCT00895011|100438329|FG000|COMPLETED|Overall Study||76||
48047762|NCT00895011|100438330|FG001|COMPLETED|Overall Study||85||
48047763|NCT00895011|100438331|FG002|COMPLETED|Overall Study||91||
48047764|NCT00895011|100438329|FG000|NOT COMPLETED|Overall Study||24||
48047765|NCT00895011|100438330|FG001|NOT COMPLETED|Overall Study||14||
48047766|NCT00895011|100438331|FG002|NOT COMPLETED|Overall Study||8||
48206909|NCT02425111|100830408|FG000|STARTED|Part B: Treatment Extension Period||56||
48206910|NCT02425111|100830408|FG000|COMPLETED|Part B: Treatment Extension Period||46||
48495621|NCT00819169|101547893|FG006|STARTED|Overall Study||16||
48206911|NCT02425111|100830408|FG000|NOT COMPLETED|Part B: Treatment Extension Period||10||
48206912|NCT03863834|100830409|FG000|STARTED|Overall Study||12||
48206913|NCT03863834|100830409|FG000|COMPLETED|Overall Study||9||
48206914|NCT03863834|100830409|FG000|NOT COMPLETED|Overall Study||3||
48206915|NCT04349150|100830410|FG000|STARTED|Overall Study||31||
48206916|NCT04349150|100830410|FG000|COMPLETED|Overall Study||27||
48206917|NCT04349150|100830410|FG000|NOT COMPLETED|Overall Study||4||
48206918|NCT03720210|100830411|FG000|STARTED|Overall Study||1||
48206919|NCT03720210|100830411|FG000|COMPLETED|Overall Study||0||
48206920|NCT03720210|100830411|FG000|NOT COMPLETED|Overall Study||1||
48206921|NCT04669249|100830412|FG000|STARTED|Overall Study||8||
48206922|NCT04669249|100830413|FG001|STARTED|Overall Study||5||
48206923|NCT04669249|100830412|FG000|COMPLETED|Overall Study||7||
48206924|NCT04669249|100830413|FG001|COMPLETED|Overall Study||4||
48206925|NCT04669249|100830412|FG000|NOT COMPLETED|Overall Study||1||
48206926|NCT04669249|100830413|FG001|NOT COMPLETED|Overall Study||1||
48206927|NCT02512965|100830414|FG000|STARTED|Overall Study||115||
48206928|NCT02512965|100830415|FG001|STARTED|Overall Study||114||
48206929|NCT02512965|100830414|FG000|COMPLETED|Overall Study||115||
48206930|NCT02512965|100830415|FG001|COMPLETED|Overall Study||110||
48206931|NCT02512965|100830414|FG000|NOT COMPLETED|Overall Study||0||
48206932|NCT02512965|100830415|FG001|NOT COMPLETED|Overall Study||4||
48206933|NCT05263037|100830416|FG000|STARTED|Overall Study||275||
48206934|NCT05263037|100830417|FG001|STARTED|Overall Study||272||
48206935|NCT05263037|100830418|FG002|STARTED|Overall Study||273||
48206936|NCT05263037|100830419|FG003|STARTED|Overall Study||273||
48206937|NCT05263037|100830416|FG000|COMPLETED|Overall Study||269||
48206938|NCT05263037|100830417|FG001|COMPLETED|Overall Study||267||
48206939|NCT05263037|100830418|FG002|COMPLETED|Overall Study||266||
48206940|NCT05263037|100830419|FG003|COMPLETED|Overall Study||265||
48206941|NCT05263037|100830416|FG000|NOT COMPLETED|Overall Study||6||
48206942|NCT05263037|100830417|FG001|NOT COMPLETED|Overall Study||5||
48206943|NCT05263037|100830418|FG002|NOT COMPLETED|Overall Study||7||
48206944|NCT05263037|100830419|FG003|NOT COMPLETED|Overall Study||8||
48206945|NCT02425449|100830420|FG000|STARTED|Overall Study||0||
48206946|NCT02425449|100830421|FG001|STARTED|Overall Study||4||
48206947|NCT02425449|100830422|FG002|STARTED|Overall Study||5||
48206948|NCT02425449|100830423|FG003|STARTED|Overall Study||5||
48206949|NCT02425449|100830424|FG004|STARTED|Overall Study||5||
48206950|NCT02425449|100830420|FG000|COMPLETED|Overall Study||0||
48206951|NCT02425449|100830421|FG001|COMPLETED|Overall Study||4||
48206952|NCT02425449|100830422|FG002|COMPLETED|Overall Study||5||
48206953|NCT02425449|100830423|FG003|COMPLETED|Overall Study||5||
48206954|NCT02425449|100830424|FG004|COMPLETED|Overall Study||5||
48206955|NCT02425449|100830420|FG000|NOT COMPLETED|Overall Study||0||
48206956|NCT02425449|100830421|FG001|NOT COMPLETED|Overall Study||0||
48206957|NCT02425449|100830422|FG002|NOT COMPLETED|Overall Study||0||
48206958|NCT02425449|100830423|FG003|NOT COMPLETED|Overall Study||0||
48206959|NCT02425449|100830424|FG004|NOT COMPLETED|Overall Study||0||
48047767|NCT01002820|100438332|FG000|STARTED|Overall Study||11||
48047768|NCT01002820|100438332|FG000|COMPLETED|Overall Study||7||
48047769|NCT01002820|100438332|FG000|NOT COMPLETED|Overall Study||4||
48047770|NCT02456103|100438333|FG000|STARTED|Overall Study||246||
48047771|NCT02456103|100438333|FG000|As-Treated Population|Overall Study||245|Participants who received at least 1 dose of ataluren.|
48047772|NCT02456103|100438333|FG000|Intent-to-treat (ITT) Population|Overall Study||244|Participants in the As-Treated Population with at least 1 postbaseline efficacy assessment.|
48047773|NCT02456103|100438333|FG000|COMPLETED|Overall Study||0||
48047774|NCT02456103|100438333|FG000|NOT COMPLETED|Overall Study||246||
48047775|NCT02047318|100438334|FG000|STARTED|Core Study Period||19||
48047776|NCT02047318|100438334|FG000|Received MRX 14 ug/kg/Day|Core Study Period||6|Only participants who received PBO in the previous study, LUM001-302, went through dose escalation.|
48047777|NCT02047318|100438334|FG000|Received MRX 35 ug/kg/Day|Core Study Period||6|Only participants who received PBO in the previous study, LUM001-302, went through dose escalation.|
48047778|NCT02047318|100438334|FG000|Received MRX 70 ug/kg/Day|Core Study Period||6|Only participants who received PBO in the previous study, LUM001-302, went through dose escalation.|
48047779|NCT02047318|100438334|FG000|Received MRX 140 ug/kg/Day|Core Study Period||11|Only participants who received PBO in the previous study, LUM001-302, went through dose escalation. Additionally, participants who were randomized to receive 140 ug/kg/day in LUM001-302 were kept at their previous dose when entering this study.|
48047780|NCT02047318|100438334|FG000|Received MRX 280 ug/kg/Day|Core Study Period||19|All participants reached the 280 ug/kg/day dose, either through dose escalated or by continuing their previous dose from LUM001-302.|
48047781|NCT02047318|100438334|FG000|COMPLETED|Core Study Period||7||
48047782|NCT02047318|100438334|FG000|NOT COMPLETED|Core Study Period||12||
48047783|NCT02047318|100438334|FG000|STARTED|52-week Follow-up Treatment Period||6||
48047784|NCT02047318|100438334|FG000|COMPLETED|52-week Follow-up Treatment Period||6||
48047785|NCT02047318|100438334|FG000|NOT COMPLETED|52-week Follow-up Treatment Period||0||
48047786|NCT02047318|100438334|FG000|STARTED|Long-term Follow-up Treatment Period||7||
48206960|NCT03350542|100830425|FG000|STARTED|Overall Study||100||
48206961|NCT03350542|100830425|FG000|Completed 12-Month Clinical F/U|Overall Study||96||
48206962|NCT03350542|100830425|FG000|Death With no 12-month F/U|Overall Study||4||
48206963|NCT03350542|100830425|FG000|COMPLETED|Overall Study||96||
48206964|NCT03350542|100830425|FG000|NOT COMPLETED|Overall Study||4||
48206965|NCT00813904|100830426|FG000|STARTED|Overall Study||31||
48206966|NCT00813904|100830426|FG000|COMPLETED|Overall Study||30||
48206967|NCT00813904|100830426|FG000|NOT COMPLETED|Overall Study||1||
48206968|NCT03201562|100830427|FG000|STARTED|Overall Study||18||
48206969|NCT03201562|100830428|FG001|STARTED|Overall Study||20||
48206970|NCT03201562|100830429|FG002|STARTED|Overall Study||20||
48206971|NCT03201562|100830427|FG000|COMPLETED|Overall Study||18||
48206972|NCT03201562|100830428|FG001|COMPLETED|Overall Study||19||
48206973|NCT03201562|100830429|FG002|COMPLETED|Overall Study||16||
48206974|NCT03201562|100830427|FG000|NOT COMPLETED|Overall Study||0||
48206975|NCT03201562|100830428|FG001|NOT COMPLETED|Overall Study||1||
48206976|NCT03201562|100830429|FG002|NOT COMPLETED|Overall Study||4||
48206977|NCT01304277|100830430|FG000|STARTED|Screening (Replagal RB, Week 0- Week 2)||17||
48206978|NCT01304277|100830430|FG000|COMPLETED|Screening (Replagal RB, Week 0- Week 2)||17||
48206979|NCT01304277|100830430|FG000|NOT COMPLETED|Screening (Replagal RB, Week 0- Week 2)||0||
48206980|NCT01304277|100830430|FG000|STARTED|Treatment (Replagal AF, Week 2- EOS)||17||
48206981|NCT01304277|100830430|FG000|COMPLETED|Treatment (Replagal AF, Week 2- EOS)||17||
48206982|NCT01304277|100830430|FG000|NOT COMPLETED|Treatment (Replagal AF, Week 2- EOS)||0||
48206983|NCT05297864|100830431|FG000|STARTED|Overall Study||9||
48206984|NCT05297864|100830431|FG000|COMPLETED|Overall Study||9||
48047787|NCT02047318|100438334|FG000|Received MRX 280 ug/kg/Day|Long-term Follow-up Treatment Period||7||
48047788|NCT02047318|100438334|FG000|Received 420 ug/kg/Day|Long-term Follow-up Treatment Period||5|Participants who received 420ug/kg/day, received 280ug/kg dose in the morning and 140ug/kg in the afternoon during the long term extension period.|
48047789|NCT02047318|100438334|FG000|Received 560 ug/kg/Day|Long-term Follow-up Treatment Period||5|Participants who received 560ug/kg/day, received 280ug/kg dose in the morning and 280ug/kg in the afternoon during the long term extension period.|
48047790|NCT02047318|100438334|FG000|COMPLETED|Long-term Follow-up Treatment Period||6||
48047791|NCT02047318|100438334|FG000|NOT COMPLETED|Long-term Follow-up Treatment Period||1||
48047792|NCT01133990|100438335|FG000|STARTED|Phase 1b (Dose Escalation Phase)||5||
48047793|NCT01133990|100438336|FG001|STARTED|Phase 1b (Dose Escalation Phase)||0||
48047794|NCT01133990|100438337|FG002|STARTED|Phase 1b (Dose Escalation Phase)||0||
48047795|NCT01133990|100438338|FG003|STARTED|Phase 1b (Dose Escalation Phase)||0||
48047796|NCT01133990|100438339|FG004|STARTED|Phase 1b (Dose Escalation Phase)||0||
48047797|NCT01133990|100438340|FG005|STARTED|Phase 1b (Dose Escalation Phase)||0||
48047798|NCT01133990|100438335|FG000|COMPLETED|Phase 1b (Dose Escalation Phase)||1||
48047799|NCT01133990|100438336|FG001|COMPLETED|Phase 1b (Dose Escalation Phase)||0||
48047800|NCT01133990|100438337|FG002|COMPLETED|Phase 1b (Dose Escalation Phase)||0||
48047801|NCT01133990|100438338|FG003|COMPLETED|Phase 1b (Dose Escalation Phase)||0||
48047802|NCT01133990|100438339|FG004|COMPLETED|Phase 1b (Dose Escalation Phase)||0||
48047803|NCT01133990|100438340|FG005|COMPLETED|Phase 1b (Dose Escalation Phase)||0||
48047804|NCT01133990|100438335|FG000|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||4||
48206985|NCT05297864|100830431|FG000|NOT COMPLETED|Overall Study||0||
48206986|NCT00833365|100830432|FG000|STARTED|Overall Study||9||
48206987|NCT00833365|100830433|FG001|STARTED|Overall Study||6||
48206988|NCT00833365|100830432|FG000|COMPLETED|Overall Study||9||
48206989|NCT00833365|100830433|FG001|COMPLETED|Overall Study||6||
48206990|NCT00833365|100830432|FG000|NOT COMPLETED|Overall Study||0||
48206991|NCT00833365|100830433|FG001|NOT COMPLETED|Overall Study||0||
48206992|NCT02139046|100830434|FG000|STARTED|Overall Study||358||
48206993|NCT02139046|100830435|FG001|STARTED|Overall Study||359||
48206994|NCT02139046|100830436|FG002|STARTED|Overall Study||357||
48206995|NCT02139046|100830437|FG003|STARTED|Overall Study||358||
48206996|NCT02139046|100830438|FG004|STARTED|Overall Study||358||
48206997|NCT02139046|100830434|FG000|Safety Analysis Set|Overall Study||356||
48206998|NCT02139046|100830435|FG001|Safety Analysis Set|Overall Study||358||
48206999|NCT02139046|100830436|FG002|Safety Analysis Set|Overall Study||355||
48207000|NCT02139046|100830437|FG003|Safety Analysis Set|Overall Study||357||
48207001|NCT02139046|100830438|FG004|Safety Analysis Set|Overall Study||357||
48207002|NCT02139046|100830434|FG000|Full Analysis Set|Overall Study||357||
48207003|NCT02139046|100830435|FG001|Full Analysis Set|Overall Study||357||
48207004|NCT02139046|100830436|FG002|Full Analysis Set|Overall Study||355||
48207005|NCT02139046|100830437|FG003|Full Analysis Set|Overall Study||357||
48207006|NCT02139046|100830438|FG004|Full Analysis Set|Overall Study||357||
48207007|NCT02139046|100830434|FG000|COMPLETED|Overall Study||296||
48207008|NCT02139046|100830435|FG001|COMPLETED|Overall Study||305||
48207009|NCT02139046|100830436|FG002|COMPLETED|Overall Study||298||
48207010|NCT02139046|100830437|FG003|COMPLETED|Overall Study||290||
48207011|NCT02139046|100830438|FG004|COMPLETED|Overall Study||301||
48047805|NCT01133990|100438336|FG001|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||0||
48047806|NCT01133990|100438337|FG002|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||0||
48047807|NCT01133990|100438338|FG003|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||0||
48047808|NCT01133990|100438339|FG004|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||0||
48047809|NCT01133990|100438340|FG005|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||0||
48047810|NCT01133990|100438335|FG000|STARTED|Phase 2 (Dose-confirmation Phase)||0|The study was terminated after phase 1b (E7820 40 mg/day). Hence, no participants were enrolled in Phase 2.|
48047811|NCT01133990|100438336|FG001|STARTED|Phase 2 (Dose-confirmation Phase)||0|The study was terminated after phase 1b (E7820 40 mg/day). Hence, no participants were enrolled in Phase 2.|
48047812|NCT01133990|100438337|FG002|STARTED|Phase 2 (Dose-confirmation Phase)||0|The study was terminated after phase 1b (E7820 40 mg/day). Hence, no participants were enrolled in Phase 2.|
48047813|NCT01133990|100438338|FG003|STARTED|Phase 2 (Dose-confirmation Phase)||0|The study was terminated after phase 1b (E7820 40 mg/day). Hence, no participants were enrolled in Phase 2.|
48047814|NCT01133990|100438339|FG004|STARTED|Phase 2 (Dose-confirmation Phase)||0|The study was terminated after phase 1b (E7820 40 mg/day). Hence, no participants were enrolled in Phase 2.|
48047815|NCT01133990|100438340|FG005|STARTED|Phase 2 (Dose-confirmation Phase)||0|The study was terminated after phase 1b (E7820 40 mg/day). Hence, no participants were enrolled in Phase 2.|
48047816|NCT01133990|100438335|FG000|COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
48047817|NCT01133990|100438336|FG001|COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
48207012|NCT02139046|100830434|FG000|NOT COMPLETED|Overall Study||62||
48207013|NCT02139046|100830435|FG001|NOT COMPLETED|Overall Study||54||
48207014|NCT02139046|100830436|FG002|NOT COMPLETED|Overall Study||59||
48207015|NCT02139046|100830437|FG003|NOT COMPLETED|Overall Study||68||
48207016|NCT02139046|100830438|FG004|NOT COMPLETED|Overall Study||57||
48207017|NCT01292252|100830439|FG000|STARTED|Overall Study||21||
48207018|NCT01292252|100830440|FG001|STARTED|Overall Study||15||
48207019|NCT01292252|100830439|FG000|COMPLETED|Overall Study||21||
48207020|NCT01292252|100830440|FG001|COMPLETED|Overall Study||14||
48047818|NCT01133990|100438337|FG002|COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
48047819|NCT01133990|100438338|FG003|COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
48047820|NCT01133990|100438339|FG004|COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
48047821|NCT01133990|100438340|FG005|COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
48047822|NCT01133990|100438335|FG000|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
48047823|NCT01133990|100438336|FG001|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
48047824|NCT01133990|100438337|FG002|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
48047825|NCT01133990|100438338|FG003|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
48047826|NCT01133990|100438339|FG004|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
48047827|NCT01133990|100438340|FG005|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
48047828|NCT00420641|100438341|FG000|STARTED|Overall Study||160||
48047829|NCT00420641|100438342|FG001|STARTED|Overall Study||172||
48047830|NCT00420641|100438343|FG002|STARTED|Overall Study||172||
48047831|NCT00420641|100438341|FG000|COMPLETED|Overall Study||115||
48047832|NCT00420641|100438342|FG001|COMPLETED|Overall Study||100||
48047833|NCT00420641|100438343|FG002|COMPLETED|Overall Study||128||
48207021|NCT01292252|100830439|FG000|NOT COMPLETED|Overall Study||0||
48207022|NCT01292252|100830440|FG001|NOT COMPLETED|Overall Study||1||
48047834|NCT00420641|100438341|FG000|NOT COMPLETED|Overall Study||45||
48047835|NCT00420641|100438342|FG001|NOT COMPLETED|Overall Study||72||
48047836|NCT00420641|100438343|FG002|NOT COMPLETED|Overall Study||44||
48047837|NCT03533686|100438344|FG000|STARTED|Overall Study||9||
48047838|NCT03533686|100438345|FG001|STARTED|Overall Study||3||
48047839|NCT03533686|100438346|FG002|STARTED|Overall Study||18||
48047840|NCT03533686|100438347|FG003|STARTED|Overall Study||15||
48047841|NCT03533686|100438348|FG004|STARTED|Overall Study||17||
48047842|NCT03533686|100438349|FG005|STARTED|Overall Study||4||
48047843|NCT03533686|100438344|FG000|Received Intervention|Overall Study||8||
48047844|NCT03533686|100438345|FG001|Received Intervention|Overall Study||3||
48047845|NCT03533686|100438346|FG002|Received Intervention|Overall Study||18||
48047846|NCT03533686|100438347|FG003|Received Intervention|Overall Study||12||
48047847|NCT03533686|100438348|FG004|Received Intervention|Overall Study||14||
48047848|NCT03533686|100438349|FG005|Received Intervention|Overall Study||4||
48047849|NCT03533686|100438344|FG000|COMPLETED|Overall Study||8||
48047850|NCT03533686|100438345|FG001|COMPLETED|Overall Study||2||
48047851|NCT03533686|100438346|FG002|COMPLETED|Overall Study||18||
48047852|NCT03533686|100438347|FG003|COMPLETED|Overall Study||10||
48047853|NCT03533686|100438348|FG004|COMPLETED|Overall Study||10||
48047854|NCT03533686|100438349|FG005|COMPLETED|Overall Study||3||
48047855|NCT03533686|100438344|FG000|NOT COMPLETED|Overall Study||1||
48047856|NCT03533686|100438345|FG001|NOT COMPLETED|Overall Study||1||
48047857|NCT03533686|100438346|FG002|NOT COMPLETED|Overall Study||0||
48047858|NCT03533686|100438347|FG003|NOT COMPLETED|Overall Study||5||
48047859|NCT03533686|100438348|FG004|NOT COMPLETED|Overall Study||7||
48047860|NCT03533686|100438349|FG005|NOT COMPLETED|Overall Study||1||
48047861|NCT03020446|100438350|FG000|STARTED|Overall Study||3||
48047862|NCT03020446|100438350|FG000|COMPLETED|Overall Study||0||
48047863|NCT03020446|100438350|FG000|NOT COMPLETED|Overall Study||3||
48047864|NCT03915860|100438351|FG000|STARTED|Overall Study||47||
48047865|NCT03915860|100438351|FG000|Treated|Overall Study||46||
48047866|NCT03915860|100438351|FG000|COMPLETED|Overall Study||33||
48047867|NCT03915860|100438351|FG000|NOT COMPLETED|Overall Study||14||
48047868|NCT00622739|100438352|FG000|STARTED|Overall Study||13||
48047869|NCT00622739|100438353|FG001|STARTED|Overall Study||15||
48047870|NCT00622739|100438352|FG000|COMPLETED|Overall Study||11||
48047871|NCT00622739|100438353|FG001|COMPLETED|Overall Study||9||
48047872|NCT00622739|100438352|FG000|NOT COMPLETED|Overall Study||2||
48047873|NCT00622739|100438353|FG001|NOT COMPLETED|Overall Study||6||
48047874|NCT01233687|100438354|FG000|STARTED|Phase I RP2D AMG 102 + Erlotinib||7||
48047875|NCT01233687|100438354|FG000|COMPLETED|Phase I RP2D AMG 102 + Erlotinib||7||
48047876|NCT01233687|100438354|FG000|NOT COMPLETED|Phase I RP2D AMG 102 + Erlotinib||0||
48047877|NCT01233687|100438354|FG000|STARTED|Phase II AMG 102 + Erlotinib||49||
48207023|NCT04584099|100830441|FG000|STARTED|Overall Study||12||
48207024|NCT04584099|100830441|FG000|COMPLETED|Overall Study||0||
48207025|NCT04584099|100830441|FG000|NOT COMPLETED|Overall Study||12||
48207026|NCT00004124|100830442|FG000|STARTED|Overall Study||481|Eligible Patients Enrolled \& Randomized to Study|
48207027|NCT00004124|100830443|FG001|STARTED|Overall Study||480|Eligible Patients Enrolled \& Randomized to Study|
48207028|NCT00004124|100830442|FG000|COMPLETED|Overall Study||469|Received Any Protocol Treatment -- population assessable for adverse events.|
48207029|NCT00004124|100830443|FG001|COMPLETED|Overall Study||460|Received Any Protocol Treatment -- population assessable for adverse events.|
48207030|NCT00004124|100830442|FG000|NOT COMPLETED|Overall Study||12||
48047878|NCT01233687|100438354|FG000|Response-Evaluable|Phase II AMG 102 + Erlotinib||45||
48047879|NCT01233687|100438354|FG000|COMPLETED|Phase II AMG 102 + Erlotinib||45||
48047880|NCT01233687|100438354|FG000|NOT COMPLETED|Phase II AMG 102 + Erlotinib||4||
48207031|NCT00004124|100830443|FG001|NOT COMPLETED|Overall Study||20||
48047881|NCT00171054|100438355|FG000|STARTED|Overall Study||63||
48047882|NCT00171054|100438356|FG001|STARTED|Overall Study||62||
48047883|NCT00171054|100438355|FG000|COMPLETED|Overall Study||53||
48047884|NCT00171054|100438356|FG001|COMPLETED|Overall Study||50||
48047885|NCT00171054|100438355|FG000|NOT COMPLETED|Overall Study||10||
48207032|NCT05283395|100830444|FG000|STARTED|Overall Study||61||
48207033|NCT05283395|100830445|FG001|STARTED|Overall Study||45||
48207034|NCT05283395|100830446|FG002|STARTED|Overall Study||30||
48207035|NCT05283395|100830444|FG000|COMPLETED|Overall Study||54||
48207036|NCT05283395|100830445|FG001|COMPLETED|Overall Study||37||
48207037|NCT05283395|100830446|FG002|COMPLETED|Overall Study||25||
48047886|NCT00171054|100438356|FG001|NOT COMPLETED|Overall Study||12||
48047887|NCT01975831|100438357|FG000|STARTED|Overall Study||3||
48047888|NCT01975831|100438358|FG001|STARTED|Overall Study||11||
48047889|NCT01975831|100438359|FG002|STARTED|Overall Study||4||
48047890|NCT01975831|100438360|FG003|STARTED|Overall Study||4||
48047891|NCT01975831|100438361|FG004|STARTED|Overall Study||19||
48047892|NCT01975831|100438362|FG005|STARTED|Overall Study||16||
48047893|NCT01975831|100438363|FG006|STARTED|Overall Study||16||
48047894|NCT01975831|100438364|FG007|STARTED|Overall Study||16||
48047895|NCT01975831|100438365|FG008|STARTED|Overall Study||15||
48047896|NCT01975831|100438357|FG000|COMPLETED|Overall Study||0||
48047897|NCT01975831|100438358|FG001|COMPLETED|Overall Study||2||
48047898|NCT01975831|100438359|FG002|COMPLETED|Overall Study||0||
48047899|NCT01975831|100438360|FG003|COMPLETED|Overall Study||0||
48047900|NCT01975831|100438361|FG004|COMPLETED|Overall Study||1||
48047901|NCT01975831|100438362|FG005|COMPLETED|Overall Study||2||
48047902|NCT01975831|100438363|FG006|COMPLETED|Overall Study||0||
48047903|NCT01975831|100438364|FG007|COMPLETED|Overall Study||1||
48047904|NCT01975831|100438365|FG008|COMPLETED|Overall Study||3||
48047905|NCT01975831|100438357|FG000|NOT COMPLETED|Overall Study||3||
48047906|NCT01975831|100438358|FG001|NOT COMPLETED|Overall Study||9||
48047907|NCT01975831|100438359|FG002|NOT COMPLETED|Overall Study||4||
48047908|NCT01975831|100438360|FG003|NOT COMPLETED|Overall Study||4||
48047909|NCT01975831|100438361|FG004|NOT COMPLETED|Overall Study||18||
48047910|NCT01975831|100438362|FG005|NOT COMPLETED|Overall Study||14||
48047911|NCT01975831|100438363|FG006|NOT COMPLETED|Overall Study||16||
48047912|NCT01975831|100438364|FG007|NOT COMPLETED|Overall Study||15||
48047913|NCT01975831|100438365|FG008|NOT COMPLETED|Overall Study||12||
48047914|NCT03963401|100438366|FG000|STARTED|Initial Period (Day 1 - Week 16)||60||
48047915|NCT03963401|100438367|FG001|STARTED|Initial Period (Day 1 - Week 16)||61||
48047916|NCT03963401|100438368|FG002|STARTED|Initial Period (Day 1 - Week 16)||16||
48047917|NCT03963401|100438369|FG003|STARTED|Initial Period (Day 1 - Week 16)||15||
48047918|NCT03963401|100438370|FG004|STARTED|Initial Period (Day 1 - Week 16)||34||
48047919|NCT03963401|100438371|FG005|STARTED|Initial Period (Day 1 - Week 16)||33||
48047920|NCT03963401|100438366|FG000|Treated|Initial Period (Day 1 - Week 16)||60||
48047921|NCT03963401|100438367|FG001|Treated|Initial Period (Day 1 - Week 16)||60||
48047922|NCT03963401|100438368|FG002|Treated|Initial Period (Day 1 - Week 16)||16||
48047923|NCT03963401|100438369|FG003|Treated|Initial Period (Day 1 - Week 16)||15||
48047924|NCT03963401|100438370|FG004|Treated|Initial Period (Day 1 - Week 16)||34||
48047925|NCT03963401|100438371|FG005|Treated|Initial Period (Day 1 - Week 16)||33||
48047926|NCT03963401|100438366|FG000|COMPLETED|Initial Period (Day 1 - Week 16)||57||
48047927|NCT03963401|100438367|FG001|COMPLETED|Initial Period (Day 1 - Week 16)||57||
48047928|NCT03963401|100438368|FG002|COMPLETED|Initial Period (Day 1 - Week 16)||14||
48047929|NCT03963401|100438369|FG003|COMPLETED|Initial Period (Day 1 - Week 16)||13||
48047930|NCT03963401|100438370|FG004|COMPLETED|Initial Period (Day 1 - Week 16)||31||
48207038|NCT05283395|100830444|FG000|NOT COMPLETED|Overall Study||7||
48207039|NCT05283395|100830445|FG001|NOT COMPLETED|Overall Study||8||
48207040|NCT05283395|100830446|FG002|NOT COMPLETED|Overall Study||5||
48207041|NCT02738840|100830447|FG000|STARTED|Overall Study||56||
48207042|NCT02738840|100830447|FG000|COMPLETED|Overall Study||48||
48207043|NCT02738840|100830447|FG000|NOT COMPLETED|Overall Study||8||
48207044|NCT00516386|100830448|FG000|STARTED|Overall Study||16||
48207045|NCT00516386|100830448|FG000|COMPLETED|Overall Study||10||
48207046|NCT00516386|100830448|FG000|NOT COMPLETED|Overall Study||6||
48207047|NCT00114244|100830449|FG000|STARTED|Overall Study||15||
48207048|NCT00114244|100830450|FG001|STARTED|Overall Study||37||
48207049|NCT00114244|100830449|FG000|COMPLETED|Overall Study||13||
48207050|NCT00114244|100830450|FG001|COMPLETED|Overall Study||30||
48047931|NCT03963401|100438371|FG005|COMPLETED|Initial Period (Day 1 - Week 16)||31||
48047932|NCT03963401|100438366|FG000|NOT COMPLETED|Initial Period (Day 1 - Week 16)||3||
48047933|NCT03963401|100438367|FG001|NOT COMPLETED|Initial Period (Day 1 - Week 16)||4||
48047934|NCT03963401|100438368|FG002|NOT COMPLETED|Initial Period (Day 1 - Week 16)||2||
48047935|NCT03963401|100438369|FG003|NOT COMPLETED|Initial Period (Day 1 - Week 16)||2||
48047936|NCT03963401|100438370|FG004|NOT COMPLETED|Initial Period (Day 1 - Week 16)||3||
48047937|NCT03963401|100438371|FG005|NOT COMPLETED|Initial Period (Day 1 - Week 16)||2||
48207051|NCT00114244|100830449|FG000|NOT COMPLETED|Overall Study||2||
48207052|NCT00114244|100830450|FG001|NOT COMPLETED|Overall Study||7||
48207053|NCT02971488|100830451|FG000|STARTED|Overall Study||529||
48207054|NCT02971488|100830451|FG000|COMPLETED|Overall Study||529||
48207055|NCT02971488|100830451|FG000|NOT COMPLETED|Overall Study||0||
48207056|NCT01239316|100830452|FG000|STARTED|Overall Study||12||
48207057|NCT01239316|100830452|FG000|COMPLETED|Overall Study||0||
48207058|NCT01239316|100830452|FG000|NOT COMPLETED|Overall Study||12||
48207059|NCT03072953|100830453|FG000|STARTED|Overall Study||2||
48207060|NCT03072953|100830453|FG000|COMPLETED|Overall Study||2||
48207061|NCT03072953|100830453|FG000|NOT COMPLETED|Overall Study||0||
48207062|NCT01104415|100830454|FG000|STARTED|Core Phase||15||
48207063|NCT01104415|100830455|FG001|STARTED|Core Phase||0||
48207064|NCT01104415|100830454|FG000|COMPLETED|Core Phase||14||
48207065|NCT01104415|100830455|FG001|COMPLETED|Core Phase||0||
48207066|NCT01104415|100830454|FG000|NOT COMPLETED|Core Phase||1||
48207067|NCT01104415|100830455|FG001|NOT COMPLETED|Core Phase||0||
48207068|NCT01104415|100830454|FG000|STARTED|Extension Period||0||
48207069|NCT01104415|100830455|FG001|STARTED|Extension Period||11||
48207070|NCT01104415|100830454|FG000|COMPLETED|Extension Period||0||
48207071|NCT01104415|100830455|FG001|COMPLETED|Extension Period||0||
48207072|NCT01104415|100830454|FG000|NOT COMPLETED|Extension Period||0||
48207073|NCT01104415|100830455|FG001|NOT COMPLETED|Extension Period||11||
48207074|NCT03923491|100830456|FG000|STARTED|Overall Study||33||
48207075|NCT03923491|100830457|FG001|STARTED|Overall Study||30||
48207076|NCT03923491|100830456|FG000|COMPLETED|Overall Study||24||
48207077|NCT03923491|100830457|FG001|COMPLETED|Overall Study||16||
48207078|NCT03923491|100830456|FG000|NOT COMPLETED|Overall Study||9||
48207079|NCT03923491|100830457|FG001|NOT COMPLETED|Overall Study||14||
48207080|NCT00094575|100830458|FG000|STARTED|Overall Study||444||
48207081|NCT00094575|100830459|FG001|STARTED|Overall Study||437||
48207082|NCT00094575|100830458|FG000|COMPLETED|Overall Study||298||
48207083|NCT00094575|100830459|FG001|COMPLETED|Overall Study||291||
48207084|NCT00094575|100830458|FG000|NOT COMPLETED|Overall Study||146||
48207085|NCT00094575|100830459|FG001|NOT COMPLETED|Overall Study||146||
48207086|NCT04020718|100830460|FG000|STARTED|Pre-assessment and Adaptation||16||
48207087|NCT04020718|100830461|FG001|STARTED|Pre-assessment and Adaptation||19||
48207088|NCT04020718|100830462|FG002|STARTED|Pre-assessment and Adaptation||0||
48207089|NCT04020718|100830463|FG003|STARTED|Pre-assessment and Adaptation||0||
48207090|NCT04020718|100830464|FG004|STARTED|Pre-assessment and Adaptation||0||
48207091|NCT04020718|100830465|FG005|STARTED|Pre-assessment and Adaptation||0||
48207092|NCT04020718|100830466|FG006|STARTED|Pre-assessment and Adaptation||0||
48207093|NCT04020718|100830467|FG007|STARTED|Pre-assessment and Adaptation||0||
48207094|NCT04020718|100830460|FG000|COMPLETED|Pre-assessment and Adaptation||16||
48207095|NCT04020718|100830461|FG001|COMPLETED|Pre-assessment and Adaptation||15||
48207096|NCT04020718|100830462|FG002|COMPLETED|Pre-assessment and Adaptation||0||
48207097|NCT04020718|100830463|FG003|COMPLETED|Pre-assessment and Adaptation||0||
48207098|NCT04020718|100830464|FG004|COMPLETED|Pre-assessment and Adaptation||0||
48207099|NCT04020718|100830465|FG005|COMPLETED|Pre-assessment and Adaptation||0||
48207100|NCT04020718|100830466|FG006|COMPLETED|Pre-assessment and Adaptation||0||
48207101|NCT04020718|100830467|FG007|COMPLETED|Pre-assessment and Adaptation||0||
48495622|NCT00819169|101547894|FG007|STARTED|Overall Study||9||
48495623|NCT00819169|101547895|FG008|STARTED|Overall Study||16||
48495624|NCT00819169|101547887|FG000|COMPLETED|Overall Study||0||
48207102|NCT04020718|100830460|FG000|NOT COMPLETED|Pre-assessment and Adaptation||0||
48207103|NCT04020718|100830461|FG001|NOT COMPLETED|Pre-assessment and Adaptation||4||
48207104|NCT04020718|100830462|FG002|NOT COMPLETED|Pre-assessment and Adaptation||0||
48207105|NCT04020718|100830463|FG003|NOT COMPLETED|Pre-assessment and Adaptation||0||
48207106|NCT04020718|100830464|FG004|NOT COMPLETED|Pre-assessment and Adaptation||0||
48207107|NCT04020718|100830465|FG005|NOT COMPLETED|Pre-assessment and Adaptation||0||
48207108|NCT04020718|100830466|FG006|NOT COMPLETED|Pre-assessment and Adaptation||0||
48207109|NCT04020718|100830467|FG007|NOT COMPLETED|Pre-assessment and Adaptation||0||
48207110|NCT04020718|100830460|FG000|STARTED|Post-assessment and Adaptation||0||
48207111|NCT04020718|100830461|FG001|STARTED|Post-assessment and Adaptation||0||
48207112|NCT04020718|100830462|FG002|STARTED|Post-assessment and Adaptation||8||
48207113|NCT04020718|100830463|FG003|STARTED|Post-assessment and Adaptation||6||
48207114|NCT04020718|100830464|FG004|STARTED|Post-assessment and Adaptation||8||
48207115|NCT04020718|100830465|FG005|STARTED|Post-assessment and Adaptation||7||
48207116|NCT04020718|100830466|FG006|STARTED|Post-assessment and Adaptation||2||
48207117|NCT04020718|100830467|FG007|STARTED|Post-assessment and Adaptation||0||
48207118|NCT04020718|100830460|FG000|COMPLETED|Post-assessment and Adaptation||0||
48207119|NCT04020718|100830461|FG001|COMPLETED|Post-assessment and Adaptation||0||
48207120|NCT04020718|100830462|FG002|COMPLETED|Post-assessment and Adaptation||8||
48207121|NCT04020718|100830463|FG003|COMPLETED|Post-assessment and Adaptation||5||
48207122|NCT04020718|100830464|FG004|COMPLETED|Post-assessment and Adaptation||8||
48207123|NCT04020718|100830465|FG005|COMPLETED|Post-assessment and Adaptation||7||
48207124|NCT04020718|100830466|FG006|COMPLETED|Post-assessment and Adaptation||2||
48207125|NCT04020718|100830467|FG007|COMPLETED|Post-assessment and Adaptation||0||
48207126|NCT04020718|100830460|FG000|NOT COMPLETED|Post-assessment and Adaptation||0||
48207127|NCT04020718|100830461|FG001|NOT COMPLETED|Post-assessment and Adaptation||0||
48207128|NCT04020718|100830462|FG002|NOT COMPLETED|Post-assessment and Adaptation||0||
48207129|NCT04020718|100830463|FG003|NOT COMPLETED|Post-assessment and Adaptation||1||
48207130|NCT04020718|100830464|FG004|NOT COMPLETED|Post-assessment and Adaptation||0||
48207131|NCT04020718|100830465|FG005|NOT COMPLETED|Post-assessment and Adaptation||0||
48207132|NCT04020718|100830466|FG006|NOT COMPLETED|Post-assessment and Adaptation||0||
48207133|NCT04020718|100830467|FG007|NOT COMPLETED|Post-assessment and Adaptation||0||
48207134|NCT00565110|100830468|FG000|STARTED|Overall Study||230||
48207135|NCT00565110|100830469|FG001|STARTED|Overall Study||242||
48207136|NCT00565110|100830468|FG000|12-Month|Overall Study||114||
48207137|NCT00565110|100830469|FG001|12-Month|Overall Study||144||
48207138|NCT00565110|100830468|FG000|COMPLETED|Overall Study||99||
48047938|NCT03963401|100438366|FG000|STARTED|Extension Period (Week 17 - Week 52)||57||
48047939|NCT03963401|100438367|FG001|STARTED|Extension Period (Week 17 - Week 52)||57||
48047940|NCT03963401|100438368|FG002|STARTED|Extension Period (Week 17 - Week 52)||14||
48047941|NCT03963401|100438369|FG003|STARTED|Extension Period (Week 17 - Week 52)||13||
48047942|NCT03963401|100438370|FG004|STARTED|Extension Period (Week 17 - Week 52)||31||
48047943|NCT03963401|100438371|FG005|STARTED|Extension Period (Week 17 - Week 52)||31||
48047944|NCT03963401|100438366|FG000|COMPLETED|Extension Period (Week 17 - Week 52)||43||
48047945|NCT03963401|100438367|FG001|COMPLETED|Extension Period (Week 17 - Week 52)||52||
48047946|NCT03963401|100438368|FG002|COMPLETED|Extension Period (Week 17 - Week 52)||10||
48047947|NCT03963401|100438369|FG003|COMPLETED|Extension Period (Week 17 - Week 52)||12||
48047948|NCT03963401|100438370|FG004|COMPLETED|Extension Period (Week 17 - Week 52)||25||
48047949|NCT03963401|100438371|FG005|COMPLETED|Extension Period (Week 17 - Week 52)||26||
48047950|NCT03963401|100438366|FG000|NOT COMPLETED|Extension Period (Week 17 - Week 52)||14||
48047951|NCT03963401|100438367|FG001|NOT COMPLETED|Extension Period (Week 17 - Week 52)||5||
48047952|NCT03963401|100438368|FG002|NOT COMPLETED|Extension Period (Week 17 - Week 52)||4||
48047953|NCT03963401|100438369|FG003|NOT COMPLETED|Extension Period (Week 17 - Week 52)||1||
48047954|NCT03963401|100438370|FG004|NOT COMPLETED|Extension Period (Week 17 - Week 52)||6||
48047955|NCT03963401|100438371|FG005|NOT COMPLETED|Extension Period (Week 17 - Week 52)||5||
48047956|NCT01949337|100438372|FG000|STARTED|Overall Study||657||
48047957|NCT01949337|100438373|FG001|STARTED|Overall Study||654||
48047958|NCT01949337|100438372|FG000|COMPLETED|Overall Study||657||
48047959|NCT01949337|100438373|FG001|COMPLETED|Overall Study||654||
48047960|NCT01949337|100438372|FG000|NOT COMPLETED|Overall Study||0||
48047961|NCT01949337|100438373|FG001|NOT COMPLETED|Overall Study||0||
48047962|NCT01330017|100438374|FG000|STARTED|Overall Study||109||
48047963|NCT01330017|100438375|FG001|STARTED|Overall Study||108||
48047964|NCT01330017|100438376|FG002|STARTED|Overall Study||107||
48047965|NCT01330017|100438377|FG003|STARTED|Overall Study||112||
48047966|NCT01330017|100438378|FG004|STARTED|Overall Study||103||
48047967|NCT01330017|100438374|FG000|COMPLETED|Overall Study||104||
48047968|NCT01330017|100438375|FG001|COMPLETED|Overall Study||104||
48047969|NCT01330017|100438376|FG002|COMPLETED|Overall Study||99||
48047970|NCT01330017|100438377|FG003|COMPLETED|Overall Study||100||
48047971|NCT01330017|100438378|FG004|COMPLETED|Overall Study||100||
48047972|NCT01330017|100438374|FG000|NOT COMPLETED|Overall Study||5||
48047973|NCT01330017|100438375|FG001|NOT COMPLETED|Overall Study||4||
48047974|NCT01330017|100438376|FG002|NOT COMPLETED|Overall Study||8||
48047975|NCT01330017|100438377|FG003|NOT COMPLETED|Overall Study||12||
48047976|NCT01330017|100438378|FG004|NOT COMPLETED|Overall Study||3||
48047977|NCT03945175|100438379|FG000|STARTED|Overall Study||52|Participants Assessed for Eligibility|
48047978|NCT03945175|100438379|FG000|Participants Who Met Inclusion Criteria|Overall Study||21||
48047979|NCT03945175|100438379|FG000|Participants Allocated to Single-Blind Placebo Treatment|Overall Study||21||
48047980|NCT03945175|100438379|FG000|Participants Who Completed Single-Blind Placebo Treatment|Overall Study||20||
48047981|NCT03945175|100438379|FG000|Participants Allocated to Mydayis Treatment|Overall Study||18||
48047982|NCT03945175|100438379|FG000|Participants Included in Analysis of Outcome Measures|Overall Study||18||
48047983|NCT03945175|100438379|FG000|COMPLETED|Overall Study||17||
48047984|NCT03945175|100438379|FG000|NOT COMPLETED|Overall Study||35||
48047985|NCT01085500|100438380|FG000|STARTED|Overall Study||26||
48047986|NCT01085500|100438381|FG001|STARTED|Overall Study||24||
48047987|NCT01085500|100438380|FG000|COMPLETED|Overall Study||26||
48047988|NCT01085500|100438381|FG001|COMPLETED|Overall Study||24||
48047989|NCT01085500|100438380|FG000|NOT COMPLETED|Overall Study||0||
48047990|NCT01085500|100438381|FG001|NOT COMPLETED|Overall Study||0||
48047991|NCT00645788|100438382|FG000|STARTED|Overall Study||94||
48207139|NCT00565110|100830469|FG001|COMPLETED|Overall Study||111||
48207140|NCT00565110|100830468|FG000|NOT COMPLETED|Overall Study||131||
48207141|NCT00565110|100830469|FG001|NOT COMPLETED|Overall Study||131||
48207142|NCT00082810|100830470|FG000|STARTED|Overall Study||33||
48207143|NCT00082810|100830470|FG000|COMPLETED|Overall Study||2||
48207144|NCT00082810|100830470|FG000|NOT COMPLETED|Overall Study||31||
48207145|NCT02814643|100830471|FG000|STARTED|Overall Study||51||
48207146|NCT02814643|100830472|FG001|STARTED|Overall Study||52||
48207147|NCT02814643|100830471|FG000|COMPLETED|Overall Study||50||
48207148|NCT02814643|100830472|FG001|COMPLETED|Overall Study||49||
48207149|NCT02814643|100830471|FG000|NOT COMPLETED|Overall Study||1||
48207150|NCT02814643|100830472|FG001|NOT COMPLETED|Overall Study||3||
48207151|NCT02471755|100830473|FG000|STARTED|Overall Study||45||
48047992|NCT00645788|100438383|FG001|STARTED|Overall Study||94||
48047993|NCT00645788|100438384|FG002|STARTED|Overall Study||65||
48047994|NCT00645788|100438385|FG003|STARTED|Overall Study||35||
48047995|NCT00645788|100438382|FG000|Participants Receive Treatment|Overall Study||93||
48207152|NCT02471755|100830474|FG001|STARTED|Overall Study||45||
48207153|NCT02471755|100830473|FG000|COMPLETED|Overall Study||44||
48207154|NCT02471755|100830474|FG001|COMPLETED|Overall Study||44||
48207155|NCT02471755|100830473|FG000|NOT COMPLETED|Overall Study||1||
48207156|NCT02471755|100830474|FG001|NOT COMPLETED|Overall Study||1||
48207157|NCT00149838|100830475|FG000|STARTED|Phase I||92||
48207158|NCT00149838|100830476|FG001|STARTED|Phase I||98||
48207159|NCT00149838|100830477|FG002|STARTED|Phase I||0||
48207160|NCT00149838|100830478|FG003|STARTED|Phase I||0||
48047996|NCT00645788|100438383|FG001|Participants Receive Treatment|Overall Study||93||
48047997|NCT00645788|100438384|FG002|Participants Receive Treatment|Overall Study||65||
48047998|NCT00645788|100438385|FG003|Participants Receive Treatment|Overall Study||35||
48207161|NCT00149838|100830475|FG000|COMPLETED|Phase I||72||
48207162|NCT00149838|100830476|FG001|COMPLETED|Phase I||82||
48207163|NCT00149838|100830477|FG002|COMPLETED|Phase I||0||
48207164|NCT00149838|100830478|FG003|COMPLETED|Phase I||0||
48207165|NCT00149838|100830475|FG000|NOT COMPLETED|Phase I||20||
48207166|NCT00149838|100830476|FG001|NOT COMPLETED|Phase I||16||
48207167|NCT00149838|100830477|FG002|NOT COMPLETED|Phase I||0||
48207168|NCT00149838|100830478|FG003|NOT COMPLETED|Phase I||0||
48207169|NCT00149838|100830475|FG000|STARTED|Phase II||0||
48207170|NCT00149838|100830476|FG001|STARTED|Phase II||0||
48207171|NCT00149838|100830477|FG002|STARTED|Phase II||144||
48047999|NCT00645788|100438382|FG000|COMPLETED|Overall Study||74||
48048000|NCT00645788|100438383|FG001|COMPLETED|Overall Study||67||
48048001|NCT00645788|100438384|FG002|COMPLETED|Overall Study||47||
48048002|NCT00645788|100438385|FG003|COMPLETED|Overall Study||21||
48048003|NCT00645788|100438382|FG000|NOT COMPLETED|Overall Study||20||
48048004|NCT00645788|100438383|FG001|NOT COMPLETED|Overall Study||27||
48207172|NCT00149838|100830478|FG003|STARTED|Phase II||0||
48207173|NCT00149838|100830475|FG000|COMPLETED|Phase II||0||
48207174|NCT00149838|100830476|FG001|COMPLETED|Phase II||0||
48207175|NCT00149838|100830477|FG002|COMPLETED|Phase II||144||
48207176|NCT00149838|100830478|FG003|COMPLETED|Phase II||0||
48207177|NCT00149838|100830475|FG000|NOT COMPLETED|Phase II||0||
48207178|NCT00149838|100830476|FG001|NOT COMPLETED|Phase II||0||
48207179|NCT00149838|100830477|FG002|NOT COMPLETED|Phase II||0||
48207180|NCT00149838|100830478|FG003|NOT COMPLETED|Phase II||0||
48207181|NCT00149838|100830475|FG000|STARTED|Phase III||0||
48207182|NCT00149838|100830476|FG001|STARTED|Phase III||0||
48207183|NCT00149838|100830477|FG002|STARTED|Phase III||0||
48207184|NCT00149838|100830478|FG003|STARTED|Phase III||61||
48207185|NCT00149838|100830475|FG000|COMPLETED|Phase III||0||
48207186|NCT00149838|100830476|FG001|COMPLETED|Phase III||0||
48207187|NCT00149838|100830477|FG002|COMPLETED|Phase III||0||
48207188|NCT00149838|100830478|FG003|COMPLETED|Phase III||37||
48207189|NCT00149838|100830475|FG000|NOT COMPLETED|Phase III||0||
48207190|NCT00149838|100830476|FG001|NOT COMPLETED|Phase III||0||
48207191|NCT00149838|100830477|FG002|NOT COMPLETED|Phase III||0||
48207192|NCT00149838|100830478|FG003|NOT COMPLETED|Phase III||24||
48207193|NCT03830866|100830479|FG000|STARTED|Overall Study||385||
48207194|NCT03830866|100830480|FG001|STARTED|Overall Study||385||
48207195|NCT03830866|100830479|FG000|COMPLETED|Overall Study||268||
48207196|NCT03830866|100830480|FG001|COMPLETED|Overall Study||249||
48207197|NCT03830866|100830479|FG000|NOT COMPLETED|Overall Study||117||
48207198|NCT03830866|100830480|FG001|NOT COMPLETED|Overall Study||136||
48207199|NCT03148496|100830481|FG000|STARTED|Overall Study||27||
48207200|NCT03148496|100830482|FG001|STARTED|Overall Study||28||
48207201|NCT03148496|100830483|FG002|STARTED|Overall Study||25||
48207202|NCT03148496|100830484|FG003|STARTED|Overall Study||27||
48207203|NCT03148496|100830481|FG000|COMPLETED|Overall Study||20||
48207204|NCT03148496|100830482|FG001|COMPLETED|Overall Study||19||
48207205|NCT03148496|100830483|FG002|COMPLETED|Overall Study||19||
48207206|NCT03148496|100830484|FG003|COMPLETED|Overall Study||26||
48207207|NCT03148496|100830481|FG000|NOT COMPLETED|Overall Study||7||
48207208|NCT03148496|100830482|FG001|NOT COMPLETED|Overall Study||9||
48207209|NCT03148496|100830483|FG002|NOT COMPLETED|Overall Study||6||
48207210|NCT03148496|100830484|FG003|NOT COMPLETED|Overall Study||1||
48207211|NCT01591733|100830485|FG000|STARTED|Overall Study||48||
48207212|NCT01591733|100830485|FG000|COMPLETED|Overall Study||48||
48207213|NCT01591733|100830485|FG000|NOT COMPLETED|Overall Study||0||
48207214|NCT02045836|100830486|FG000|STARTED|Overall Study||432||
48048005|NCT00645788|100438384|FG002|NOT COMPLETED|Overall Study||18||
48048006|NCT00645788|100438385|FG003|NOT COMPLETED|Overall Study||14||
48048007|NCT04706416|100438386|FG000|STARTED|Overall Study||50||
48048008|NCT04706416|100438387|FG001|STARTED|Overall Study||100||
48207215|NCT02045836|100830487|FG001|STARTED|Overall Study||433||
48207216|NCT02045836|100830486|FG000|COMPLETED|Overall Study||423||
48207217|NCT02045836|100830487|FG001|COMPLETED|Overall Study||419||
48207218|NCT02045836|100830486|FG000|NOT COMPLETED|Overall Study||9||
48207219|NCT02045836|100830487|FG001|NOT COMPLETED|Overall Study||14||
48207220|NCT01064817|100830488|FG000|STARTED|All Study Treatment Days 1-9||62||
48207221|NCT01064817|100830489|FG001|STARTED|All Study Treatment Days 1-9||62||
48207222|NCT01064817|100830488|FG000|COMPLETED|All Study Treatment Days 1-9||62||
48207223|NCT01064817|100830489|FG001|COMPLETED|All Study Treatment Days 1-9||62||
48207224|NCT01064817|100830488|FG000|NOT COMPLETED|All Study Treatment Days 1-9||0||
48207225|NCT01064817|100830489|FG001|NOT COMPLETED|All Study Treatment Days 1-9||0||
48207226|NCT01064817|100830488|FG000|STARTED|Study Completion||62||
48207227|NCT01064817|100830489|FG001|STARTED|Study Completion||62||
48207228|NCT01064817|100830488|FG000|COMPLETED|Study Completion||60||
48207229|NCT01064817|100830489|FG001|COMPLETED|Study Completion||62||
48207230|NCT01064817|100830488|FG000|NOT COMPLETED|Study Completion||2||
48207231|NCT01064817|100830489|FG001|NOT COMPLETED|Study Completion||0||
48495625|NCT00819169|101547888|FG001|COMPLETED|Overall Study||0||
48495626|NCT00819169|101547889|FG002|COMPLETED|Overall Study||0||
48495627|NCT00819169|101547890|FG003|COMPLETED|Overall Study||3||
48495628|NCT00819169|101547891|FG004|COMPLETED|Overall Study||0||
48495629|NCT00819169|101547892|FG005|COMPLETED|Overall Study||0||
48048009|NCT04706416|100438386|FG000|COMPLETED|Overall Study||48||
48048010|NCT04706416|100438387|FG001|COMPLETED|Overall Study||100||
48048011|NCT04706416|100438386|FG000|NOT COMPLETED|Overall Study||2||
48048012|NCT04706416|100438387|FG001|NOT COMPLETED|Overall Study||0||
48048013|NCT02119676|100438388|FG000|STARTED|Overall Study||87||
48048014|NCT02119676|100438389|FG001|STARTED|Overall Study||88||
48048015|NCT02119676|100438390|FG002|STARTED|Overall Study||110||
48048016|NCT02119676|100438391|FG003|STARTED|Overall Study||111||
48048017|NCT02119676|100438388|FG000|Treated Patients|Overall Study||85||
48048018|NCT02119676|100438389|FG001|Treated Patients|Overall Study||86||
48048019|NCT02119676|100438390|FG002|Treated Patients|Overall Study||106||
48048020|NCT02119676|100438391|FG003|Treated Patients|Overall Study||106||
48048021|NCT02119676|100438388|FG000|COMPLETED|Overall Study||4|Ongoing treatment at time of termination. Termination=Substudy 1: 27Jan2016; Substudy 2: 11Feb2016.|
48048022|NCT02119676|100438389|FG001|COMPLETED|Overall Study||2|Ongoing treatment at time of termination. Termination=Substudy 1: 27Jan2016; Substudy 2: 11Feb2016.|
48048023|NCT02119676|100438390|FG002|COMPLETED|Overall Study||13|Ongoing treatment at time of termination. Termination=Substudy 1: 27Jan2016; Substudy 2: 11Feb2016.|
48048024|NCT02119676|100438391|FG003|COMPLETED|Overall Study||10|Ongoing treatment at time of termination. Termination=Substudy 1: 27Jan2016; Substudy 2: 11Feb2016.|
48048025|NCT02119676|100438388|FG000|NOT COMPLETED|Overall Study||83||
48048026|NCT02119676|100438389|FG001|NOT COMPLETED|Overall Study||86||
48048027|NCT02119676|100438390|FG002|NOT COMPLETED|Overall Study||97||
48048028|NCT02119676|100438391|FG003|NOT COMPLETED|Overall Study||101||
48048029|NCT01535976|100438392|FG000|STARTED|Overall Study||27||
48048030|NCT01535976|100438393|FG001|STARTED|Overall Study||27||
48048031|NCT01535976|100438392|FG000|COMPLETED|Overall Study||26||
48048032|NCT01535976|100438393|FG001|COMPLETED|Overall Study||26||
48048033|NCT01535976|100438392|FG000|NOT COMPLETED|Overall Study||1||
48048034|NCT01535976|100438393|FG001|NOT COMPLETED|Overall Study||1||
48048035|NCT04941443|100438394|FG000|STARTED|Overall Study||4||
48048036|NCT04941443|100438394|FG000|COMPLETED|Overall Study||0||
48048037|NCT04941443|100438394|FG000|NOT COMPLETED|Overall Study||4||
48048038|NCT00625703|100438395|FG000|STARTED|Overall Study||0||
48048039|NCT00625703|100438395|FG000|COMPLETED|Overall Study||0||
48048040|NCT00625703|100438395|FG000|NOT COMPLETED|Overall Study||0||
48048041|NCT02538783|100438396|FG000|STARTED|Overall Study||130||
48048042|NCT02538783|100438397|FG001|STARTED|Overall Study||129||
48048043|NCT02538783|100438396|FG000|COMPLETED|Overall Study||130||
48048044|NCT02538783|100438397|FG001|COMPLETED|Overall Study||128||
48048045|NCT02538783|100438396|FG000|NOT COMPLETED|Overall Study||0||
48048046|NCT02538783|100438397|FG001|NOT COMPLETED|Overall Study||1||
48048047|NCT02677324|100438398|FG000|STARTED|Overall Study||33||
48048048|NCT02677324|100438398|FG000|COMPLETED|Overall Study||21||
48048049|NCT02677324|100438398|FG000|NOT COMPLETED|Overall Study||12||
48048050|NCT03234881|100438399|FG000|STARTED|Overall Study||56||
48048051|NCT03234881|100438400|FG001|STARTED|Overall Study||53||
48048052|NCT03234881|100438399|FG000|COMPLETED|Overall Study||47||
48048053|NCT03234881|100438400|FG001|COMPLETED|Overall Study||50||
48048054|NCT03234881|100438399|FG000|NOT COMPLETED|Overall Study||9||
48048055|NCT03234881|100438400|FG001|NOT COMPLETED|Overall Study||3||
48048056|NCT01401959|100438401|FG000|STARTED|Enrolled||54||
48048057|NCT01401959|100438402|FG001|STARTED|Enrolled||42||
48048058|NCT01401959|100438403|FG002|STARTED|Enrolled||31||
48048059|NCT01401959|100438401|FG000|COMPLETED|Enrolled||53||
48048060|NCT01401959|100438402|FG001|COMPLETED|Enrolled||42||
48048061|NCT01401959|100438403|FG002|COMPLETED|Enrolled||31||
48048062|NCT01401959|100438401|FG000|NOT COMPLETED|Enrolled||1||
48048063|NCT01401959|100438402|FG001|NOT COMPLETED|Enrolled||0||
48048064|NCT01401959|100438403|FG002|NOT COMPLETED|Enrolled||0||
48048065|NCT01401959|100438401|FG000|STARTED|Treated||53||
48048066|NCT01401959|100438402|FG001|STARTED|Treated||42||
48048067|NCT01401959|100438403|FG002|STARTED|Treated||31||
48048068|NCT01401959|100438401|FG000|COMPLETED|Treated||46||
48048069|NCT01401959|100438402|FG001|COMPLETED|Treated||34||
48048070|NCT01401959|100438403|FG002|COMPLETED|Treated||26||
48048071|NCT01401959|100438401|FG000|NOT COMPLETED|Treated||7||
48048072|NCT01401959|100438402|FG001|NOT COMPLETED|Treated||8||
48048073|NCT01401959|100438403|FG002|NOT COMPLETED|Treated||5||
48048074|NCT00799773|100438404|FG000|STARTED|Overall Study||2||
48048075|NCT00799773|100438405|FG001|STARTED|Overall Study||1||
48048076|NCT00799773|100438404|FG000|COMPLETED|Overall Study||2||
48048077|NCT00799773|100438405|FG001|COMPLETED|Overall Study||1||
48048078|NCT00799773|100438404|FG000|NOT COMPLETED|Overall Study||0||
48048079|NCT00799773|100438405|FG001|NOT COMPLETED|Overall Study||0||
48048080|NCT01585584|100438406|FG000|STARTED|Overall Study||10||
48495630|NCT00819169|101547893|FG006|COMPLETED|Overall Study||0||
48495631|NCT00819169|101547894|FG007|COMPLETED|Overall Study||0||
48495632|NCT00819169|101547895|FG008|COMPLETED|Overall Study||3||
48048081|NCT01585584|100438406|FG000|COMPLETED|Overall Study||6||
48048082|NCT01585584|100438406|FG000|NOT COMPLETED|Overall Study||4||
48048083|NCT01547780|100438407|FG000|STARTED|Baseline PET Scan||12||
48048084|NCT01547780|100438408|FG001|STARTED|Baseline PET Scan||0||
48048085|NCT01547780|100438409|FG002|STARTED|Baseline PET Scan||19||
48048086|NCT01547780|100438410|FG003|STARTED|Baseline PET Scan||19||
48048087|NCT01547780|100438407|FG000|COMPLETED|Baseline PET Scan||9||
48048088|NCT01547780|100438408|FG001|COMPLETED|Baseline PET Scan||0||
48048089|NCT01547780|100438409|FG002|COMPLETED|Baseline PET Scan||17||
48048090|NCT01547780|100438410|FG003|COMPLETED|Baseline PET Scan||19||
48048091|NCT01547780|100438407|FG000|NOT COMPLETED|Baseline PET Scan||3||
48048092|NCT01547780|100438408|FG001|NOT COMPLETED|Baseline PET Scan||0||
48048093|NCT01547780|100438409|FG002|NOT COMPLETED|Baseline PET Scan||2||
48048094|NCT01547780|100438410|FG003|NOT COMPLETED|Baseline PET Scan||0||
48048095|NCT01547780|100438407|FG000|STARTED|Repeat PET Scan||0|Period 2 only applicable to repeat PET Scan|
48048096|NCT01547780|100438408|FG001|STARTED|Repeat PET Scan||4|Period 2 only applicable to repeat PET Scan|
48048097|NCT01547780|100438409|FG002|STARTED|Repeat PET Scan||0|Period 2 only applicable to repeat PET Scan|
48048098|NCT01547780|100438410|FG003|STARTED|Repeat PET Scan||0|Period 2 only applicable to repeat PET Scan|
48048099|NCT01547780|100438407|FG000|COMPLETED|Repeat PET Scan||0||
48048100|NCT01547780|100438408|FG001|COMPLETED|Repeat PET Scan||4||
48048101|NCT01547780|100438409|FG002|COMPLETED|Repeat PET Scan||0||
48048102|NCT01547780|100438410|FG003|COMPLETED|Repeat PET Scan||0||
48048103|NCT01547780|100438407|FG000|NOT COMPLETED|Repeat PET Scan||0||
48048104|NCT01547780|100438408|FG001|NOT COMPLETED|Repeat PET Scan||0||
48048105|NCT01547780|100438409|FG002|NOT COMPLETED|Repeat PET Scan||0||
48048106|NCT01547780|100438410|FG003|NOT COMPLETED|Repeat PET Scan||0||
48048107|NCT02522871|100438411|FG000|STARTED|Overall Study||153|Enrolled and received liver allograft|
48048108|NCT02522871|100438412|FG001|STARTED|Overall Study||147|Enrolled and received liver allograft|
48048109|NCT02522871|100438411|FG000|As-Treated and Safety Population|Overall Study||153||
48048110|NCT02522871|100438412|FG001|As-Treated and Safety Population|Overall Study||146||
48048111|NCT02522871|100438411|FG000|Modified Intent to Treat Population|Overall Study||152||
48207232|NCT00523237|100830490|FG000|STARTED|Overall Study||14||
48207233|NCT00523237|100830490|FG000|COMPLETED|Overall Study||14||
48207234|NCT00523237|100830490|FG000|NOT COMPLETED|Overall Study||0||
48207235|NCT00639002|100830491|FG000|STARTED|Overall Study||13||
48207236|NCT00639002|100830491|FG000|Received Ruxolitinib|Overall Study||13||
48207237|NCT00639002|100830491|FG000|Received Ruxolitinib + Dexamethasone|Overall Study||7||
48207238|NCT00639002|100830491|FG000|COMPLETED|Overall Study||0||
48207239|NCT00639002|100830491|FG000|NOT COMPLETED|Overall Study||13||
48207240|NCT00356265|100830492|FG000|STARTED|Overall Study||7||
48207241|NCT00356265|100830493|FG001|STARTED|Overall Study||2||
48207242|NCT00356265|100830494|FG002|STARTED|Overall Study||6||
48207243|NCT00356265|100830492|FG000|COMPLETED|Overall Study||7||
48207244|NCT00356265|100830493|FG001|COMPLETED|Overall Study||2||
48207245|NCT00356265|100830494|FG002|COMPLETED|Overall Study||5||
48207246|NCT00356265|100830492|FG000|NOT COMPLETED|Overall Study||0||
48207247|NCT00356265|100830493|FG001|NOT COMPLETED|Overall Study||0||
48207248|NCT00356265|100830494|FG002|NOT COMPLETED|Overall Study||1||
48207249|NCT01001078|100830495|FG000|STARTED|Overall Study||50||
48207250|NCT01001078|100830496|FG001|STARTED|Overall Study||50||
48207251|NCT01001078|100830495|FG000|Received Allocated Intervention|Overall Study||46||
48207252|NCT01001078|100830496|FG001|Received Allocated Intervention|Overall Study||46||
48207253|NCT01001078|100830495|FG000|Received Crossover|Overall Study||2||
48207254|NCT01001078|100830496|FG001|Received Crossover|Overall Study||3||
48207255|NCT01001078|100830495|FG000|Intubated|Overall Study||2||
48207256|NCT01001078|100830496|FG001|Intubated|Overall Study||1||
48207257|NCT01001078|100830495|FG000|Lost to Followup Interview|Overall Study||5||
48207258|NCT01001078|100830496|FG001|Lost to Followup Interview|Overall Study||2||
48207259|NCT01001078|100830495|FG000|COMPLETED|Overall Study||50||
48207260|NCT01001078|100830496|FG001|COMPLETED|Overall Study||50||
48207261|NCT01001078|100830495|FG000|NOT COMPLETED|Overall Study||0||
48048112|NCT02522871|100438412|FG001|Modified Intent to Treat Population|Overall Study||146||
48048113|NCT02522871|100438411|FG000|Per Protocol Population|Overall Study||151||
48048114|NCT02522871|100438412|FG001|Per Protocol Population|Overall Study||142||
48207262|NCT01001078|100830496|FG001|NOT COMPLETED|Overall Study||0||
48207263|NCT01505881|100830497|FG000|STARTED|Overall Study||99||
48207264|NCT01505881|100830498|FG001|STARTED|Overall Study||59||
48207265|NCT01505881|100830497|FG000|COMPLETED|Overall Study||95||
48207266|NCT01505881|100830498|FG001|COMPLETED|Overall Study||58||
48207267|NCT01505881|100830497|FG000|NOT COMPLETED|Overall Study||4||
48207268|NCT01505881|100830498|FG001|NOT COMPLETED|Overall Study||1||
48207269|NCT02553460|100830499|FG000|STARTED|Overall Study||50||
48207270|NCT02553460|100830499|FG000|COMPLETED|Overall Study||21||
48207271|NCT02553460|100830499|FG000|NOT COMPLETED|Overall Study||29||
48207272|NCT03247543|100830500|FG000|STARTED|Overall Study||102|The number of subjects reported here is based on the Safety Population (assigned treatment arm); includes subjects who were randomized and took at least one dose of study medication.|
48207273|NCT03247543|100830501|FG001|STARTED|Overall Study||107|The number of subjects reported here is based on the Safety Population (assigned treatment arm); includes subjects who were randomized and took at least one dose of study medication.|
48207274|NCT03247543|100830502|FG002|STARTED|Overall Study||101|The number of subjects reported here is based on the Safety Population (assigned treatment arm); includes subjects who were randomized and took at least one dose of study medication.|
48207275|NCT03247543|100830500|FG000|COMPLETED|Overall Study||85||
48207276|NCT03247543|100830501|FG001|COMPLETED|Overall Study||88||
48207277|NCT03247543|100830502|FG002|COMPLETED|Overall Study||78||
48207278|NCT03247543|100830500|FG000|NOT COMPLETED|Overall Study||17||
48207279|NCT03247543|100830501|FG001|NOT COMPLETED|Overall Study||19||
48207280|NCT03247543|100830502|FG002|NOT COMPLETED|Overall Study||23||
48207281|NCT02195713|100830503|FG000|STARTED|Overall Study||10||
48207282|NCT02195713|100830504|FG001|STARTED|Overall Study||10||
48207283|NCT02195713|100830503|FG000|COMPLETED|Overall Study||10||
48207284|NCT02195713|100830504|FG001|COMPLETED|Overall Study||10||
48207285|NCT02195713|100830503|FG000|NOT COMPLETED|Overall Study||0||
48207286|NCT02195713|100830504|FG001|NOT COMPLETED|Overall Study||0||
48207287|NCT01259102|100830505|FG000|STARTED|Overall Study||13||
48207288|NCT01259102|100830506|FG001|STARTED|Overall Study||14||
48207289|NCT01259102|100830507|FG002|STARTED|Overall Study||15||
48207290|NCT01259102|100830508|FG003|STARTED|Overall Study||14||
48207291|NCT01259102|100830509|FG004|STARTED|Overall Study||14||
48207292|NCT01259102|100830505|FG000|COMPLETED|Overall Study||12||
48207293|NCT01259102|100830506|FG001|COMPLETED|Overall Study||14||
48207294|NCT01259102|100830507|FG002|COMPLETED|Overall Study||13||
48207295|NCT01259102|100830508|FG003|COMPLETED|Overall Study||12||
48207296|NCT01259102|100830509|FG004|COMPLETED|Overall Study||13||
48207297|NCT01259102|100830505|FG000|NOT COMPLETED|Overall Study||1||
48207298|NCT01259102|100830506|FG001|NOT COMPLETED|Overall Study||0||
48207299|NCT01259102|100830507|FG002|NOT COMPLETED|Overall Study||2||
48207300|NCT01259102|100830508|FG003|NOT COMPLETED|Overall Study||2||
48207301|NCT01259102|100830509|FG004|NOT COMPLETED|Overall Study||1||
48207302|NCT02470949|100830510|FG000|STARTED|First Intervention||4||
48207303|NCT02470949|100830511|FG001|STARTED|First Intervention||5||
48207304|NCT02470949|100830510|FG000|COMPLETED|First Intervention||4||
48207305|NCT02470949|100830511|FG001|COMPLETED|First Intervention||5||
48207306|NCT02470949|100830510|FG000|NOT COMPLETED|First Intervention||0||
48207307|NCT02470949|100830511|FG001|NOT COMPLETED|First Intervention||0||
48207308|NCT02470949|100830510|FG000|STARTED|Washout Period for a Minimum of 4 Weeks||4||
48207309|NCT02470949|100830511|FG001|STARTED|Washout Period for a Minimum of 4 Weeks||5||
48207310|NCT02470949|100830510|FG000|COMPLETED|Washout Period for a Minimum of 4 Weeks||4||
48207311|NCT02470949|100830511|FG001|COMPLETED|Washout Period for a Minimum of 4 Weeks||5||
48207312|NCT02470949|100830510|FG000|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0||
48207313|NCT02470949|100830511|FG001|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0||
48207314|NCT02470949|100830510|FG000|STARTED|Second Intervention||4||
48207315|NCT02470949|100830511|FG001|STARTED|Second Intervention||2||
48207316|NCT02470949|100830510|FG000|COMPLETED|Second Intervention||4||
48207317|NCT02470949|100830511|FG001|COMPLETED|Second Intervention||2||
48207318|NCT02470949|100830510|FG000|NOT COMPLETED|Second Intervention||0||
48207319|NCT02470949|100830511|FG001|NOT COMPLETED|Second Intervention||0||
48207320|NCT00756730|100830512|FG000|STARTED|Overall Study||25||
48207321|NCT00756730|100830513|FG001|STARTED|Overall Study||24||
48207322|NCT00756730|100830512|FG000|COMPLETED|Overall Study||25||
48207323|NCT00756730|100830513|FG001|COMPLETED|Overall Study||22||
48207324|NCT00756730|100830512|FG000|NOT COMPLETED|Overall Study||0||
48207325|NCT00756730|100830513|FG001|NOT COMPLETED|Overall Study||2||
48207326|NCT03368937|100830514|FG000|STARTED|Overall Study||5||
48207327|NCT03368937|100830514|FG000|COMPLETED|Overall Study||5||
48207328|NCT03368937|100830514|FG000|NOT COMPLETED|Overall Study||0||
48207329|NCT02999477|100830515|FG000|STARTED|Overall Study||16||
48207330|NCT02999477|100830516|FG001|STARTED|Overall Study||16||
48207331|NCT02999477|100830515|FG000|COMPLETED|Overall Study||15||
48207332|NCT02999477|100830516|FG001|COMPLETED|Overall Study||14||
48207333|NCT02999477|100830515|FG000|NOT COMPLETED|Overall Study||1||
48207334|NCT02999477|100830516|FG001|NOT COMPLETED|Overall Study||2||
48207335|NCT02384070|100832964|FG000|STARTED|Overall Study||100||
48207336|NCT02384070|100832965|FG001|STARTED|Overall Study||100||
48207337|NCT02384070|100832966|FG002|STARTED|Overall Study||100||
48207338|NCT02384070|100832964|FG000|COMPLETED|Overall Study||100||
48207339|NCT02384070|100832965|FG001|COMPLETED|Overall Study||100||
48207340|NCT02384070|100832966|FG002|COMPLETED|Overall Study||100||
48207341|NCT02384070|100832964|FG000|NOT COMPLETED|Overall Study||0||
48207342|NCT02384070|100832965|FG001|NOT COMPLETED|Overall Study||0||
48207343|NCT02384070|100832966|FG002|NOT COMPLETED|Overall Study||0||
48207344|NCT02320123|100832967|FG000|STARTED|Overall Study||10||
48207345|NCT02320123|100832968|FG001|STARTED|Overall Study||12||
48207346|NCT02320123|100832967|FG000|COMPLETED|Overall Study||0||
48207347|NCT02320123|100832968|FG001|COMPLETED|Overall Study||1||
48207348|NCT02320123|100832967|FG000|NOT COMPLETED|Overall Study||10||
48207349|NCT02320123|100832968|FG001|NOT COMPLETED|Overall Study||11||
48207350|NCT03546907|100832969|FG000|STARTED|Overall Study||171||
48207351|NCT03546907|100832970|FG001|STARTED|Overall Study||172||
48207352|NCT03546907|100832969|FG000|COMPLETED|Overall Study||154||
48207353|NCT03546907|100832970|FG001|COMPLETED|Overall Study||151||
48207354|NCT03546907|100832969|FG000|NOT COMPLETED|Overall Study||17||
48207355|NCT03546907|100832970|FG001|NOT COMPLETED|Overall Study||21||
48207356|NCT00604019|100832971|FG000|STARTED|Overall Study||134||
48207357|NCT00604019|100832972|FG001|STARTED|Overall Study||118||
48207358|NCT00604019|100832971|FG000|COMPLETED|Overall Study||134||
48207359|NCT00604019|100832972|FG001|COMPLETED|Overall Study||118||
48207360|NCT00604019|100832971|FG000|NOT COMPLETED|Overall Study||0||
48207361|NCT00604019|100832972|FG001|NOT COMPLETED|Overall Study||0||
48207362|NCT02703714|100832973|FG000|STARTED|Overall Study||42||
48207363|NCT02703714|100832973|FG000|COMPLETED|Overall Study||42||
48207364|NCT02703714|100832973|FG000|NOT COMPLETED|Overall Study||0||
48207365|NCT00869323|100832974|FG000|STARTED|Induction Therapy||3||
48207366|NCT00869323|100832974|FG000|COMPLETED|Induction Therapy||3||
48207367|NCT00869323|100832974|FG000|NOT COMPLETED|Induction Therapy||0||
48207368|NCT00869323|100832974|FG000|STARTED|Maintenance Therapy||2||
48207369|NCT00869323|100832974|FG000|COMPLETED|Maintenance Therapy||1||
48207370|NCT00869323|100832974|FG000|NOT COMPLETED|Maintenance Therapy||1||
48207371|NCT00839241|100832975|FG000|STARTED|Overall Study||20||
48207372|NCT00839241|100832976|FG001|STARTED|Overall Study||25||
48207373|NCT00839241|100832975|FG000|COMPLETED|Overall Study||15||
48207374|NCT00839241|100832976|FG001|COMPLETED|Overall Study||8||
48207375|NCT00839241|100832975|FG000|NOT COMPLETED|Overall Study||5||
48207376|NCT00839241|100832976|FG001|NOT COMPLETED|Overall Study||17||
48207377|NCT00976937|100832977|FG000|STARTED|Overall Study||158||
48207378|NCT00976937|100832978|FG001|STARTED|Overall Study||161||
48207379|NCT00976937|100832977|FG000|Treated/Safety Population|Overall Study||158||
48207380|NCT00976937|100832978|FG001|Treated/Safety Population|Overall Study||161||
48207381|NCT00976937|100832977|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study||158||
48207382|NCT00976937|100832978|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||161||
48207383|NCT00976937|100832977|FG000|COMPLETED|Overall Study||142||
48207384|NCT00976937|100832978|FG001|COMPLETED|Overall Study||150||
48207385|NCT00976937|100832977|FG000|NOT COMPLETED|Overall Study||16||
48207386|NCT00976937|100832978|FG001|NOT COMPLETED|Overall Study||11||
48207387|NCT03183518|100832979|FG000|STARTED|Overall Study||36||
48207388|NCT03183518|100832979|FG000|Test Product|Overall Study||36|All participants received both the study treatments in single semi-occlusive patch|
48207389|NCT03183518|100832979|FG000|Negative Control|Overall Study||36|All participants received both the study treatments in single semi-occlusive patch|
48207390|NCT03183518|100832979|FG000|COMPLETED|Overall Study||33||
48207391|NCT03183518|100832979|FG000|NOT COMPLETED|Overall Study||3||
48207392|NCT04740164|100832980|FG000|STARTED|Overall Study||33||
48207393|NCT04740164|100832981|FG001|STARTED|Overall Study||33||
48207394|NCT04740164|100832980|FG000|COMPLETED|Overall Study||26||
48207395|NCT04740164|100832981|FG001|COMPLETED|Overall Study||30||
48207396|NCT04740164|100832980|FG000|NOT COMPLETED|Overall Study||7||
48207397|NCT04740164|100832981|FG001|NOT COMPLETED|Overall Study||3||
48207398|NCT01147341|100832982|FG000|STARTED|Double Blind Period||27||
48207399|NCT01147341|100832983|FG001|STARTED|Double Blind Period||10||
48207400|NCT01147341|100832982|FG000|COMPLETED|Double Blind Period||26||
48207401|NCT01147341|100832983|FG001|COMPLETED|Double Blind Period||8||
48207402|NCT01147341|100832982|FG000|NOT COMPLETED|Double Blind Period||1||
48207403|NCT01147341|100832983|FG001|NOT COMPLETED|Double Blind Period||2||
48207404|NCT01147341|100832982|FG000|STARTED|Open Label Period||26||
48207405|NCT01147341|100832983|FG001|STARTED|Open Label Period||8||
48207406|NCT01147341|100832982|FG000|COMPLETED|Open Label Period||22||
48207407|NCT01147341|100832983|FG001|COMPLETED|Open Label Period||8||
48207408|NCT01147341|100832982|FG000|NOT COMPLETED|Open Label Period||4||
48207409|NCT01147341|100832983|FG001|NOT COMPLETED|Open Label Period||0||
48207410|NCT01199575|100832984|FG000|STARTED|Overall Study||30||
48207411|NCT01199575|100832984|FG000|COMPLETED|Overall Study||25||
48207412|NCT01199575|100832984|FG000|NOT COMPLETED|Overall Study||5||
48207413|NCT00971789|100832985|FG000|STARTED|Overall Study||18||
48207414|NCT00971789|100832985|FG000|COMPLETED|Overall Study||18||
48048115|NCT02522871|100438411|FG000|COMPLETED|Overall Study||142|Completing the 12 month visit.|
48048116|NCT02522871|100438412|FG001|COMPLETED|Overall Study||133|Completing the 12 month visit.|
48048117|NCT02522871|100438411|FG000|NOT COMPLETED|Overall Study||11||
48048118|NCT02522871|100438412|FG001|NOT COMPLETED|Overall Study||14||
48048119|NCT00968032|100438413|FG000|STARTED|Overall Study||63||
48048120|NCT00968032|100438413|FG000|COMPLETED|Overall Study||61||
48048121|NCT00968032|100438413|FG000|NOT COMPLETED|Overall Study||2||
48048122|NCT00636987|100438414|FG000|STARTED|Overall Study||297||
48048123|NCT00636987|100438414|FG000|COMPLETED|Overall Study||108||
48048124|NCT00636987|100438414|FG000|NOT COMPLETED|Overall Study||189||
48048125|NCT01546402|100438415|FG000|STARTED|Overall Study||10||
48048126|NCT01546402|100438416|FG001|STARTED|Overall Study||10||
48048127|NCT01546402|100438415|FG000|COMPLETED|Overall Study||10||
48048128|NCT01546402|100438416|FG001|COMPLETED|Overall Study||10||
48048129|NCT01546402|100438415|FG000|NOT COMPLETED|Overall Study||0||
48207415|NCT00971789|100832985|FG000|NOT COMPLETED|Overall Study||0||
48207416|NCT00390299|100832986|FG000|STARTED|Overall Study||4||
48207417|NCT00390299|100832987|FG001|STARTED|Overall Study||3||
48207418|NCT00390299|100832988|FG002|STARTED|Overall Study||3||
48207419|NCT00390299|100832989|FG003|STARTED|Overall Study||3||
48207420|NCT00390299|100832990|FG004|STARTED|Overall Study||10||
48207421|NCT00390299|100832986|FG000|COMPLETED|Overall Study||3||
48048130|NCT01546402|100438416|FG001|NOT COMPLETED|Overall Study||0||
48207422|NCT00390299|100832987|FG001|COMPLETED|Overall Study||3||
48048131|NCT00393042|100438417|FG000|STARTED|First Intervention||31||
48048132|NCT00393042|100438418|FG001|STARTED|First Intervention||33||
48048133|NCT00393042|100438417|FG000|Completed the Placebo Dosage|First Intervention||27||
48048134|NCT00393042|100438418|FG001|Completed the Placebo Dosage|First Intervention||29||
48048135|NCT00393042|100438417|FG000|Completed 10mg Dosage|First Intervention||29||
48048136|NCT00393042|100438418|FG001|Completed 10mg Dosage|First Intervention||29||
48048137|NCT00393042|100438417|FG000|Completed 20 mg Dosage|First Intervention||26||
48048138|NCT00393042|100438418|FG001|Completed 20 mg Dosage|First Intervention||28||
48048139|NCT00393042|100438417|FG000|Completed 25/30mg Dosage|First Intervention||27||
48048140|NCT00393042|100438418|FG001|Completed 25/30mg Dosage|First Intervention||27||
48048141|NCT00393042|100438417|FG000|COMPLETED|First Intervention||26||
48048142|NCT00393042|100438418|FG001|COMPLETED|First Intervention||27||
48207423|NCT00390299|100832988|FG002|COMPLETED|Overall Study||3||
48207424|NCT00390299|100832989|FG003|COMPLETED|Overall Study||3||
48207425|NCT00390299|100832990|FG004|COMPLETED|Overall Study||10||
48207426|NCT00390299|100832986|FG000|NOT COMPLETED|Overall Study||1||
48207427|NCT00390299|100832987|FG001|NOT COMPLETED|Overall Study||0||
48207428|NCT00390299|100832988|FG002|NOT COMPLETED|Overall Study||0||
48207429|NCT00390299|100832989|FG003|NOT COMPLETED|Overall Study||0||
48207430|NCT00390299|100832990|FG004|NOT COMPLETED|Overall Study||0||
48207431|NCT01323777|100832991|FG000|STARTED|Overall Study||65||
48207432|NCT01323777|100832991|FG000|COMPLETED|Overall Study||65||
48207433|NCT01323777|100832991|FG000|NOT COMPLETED|Overall Study||0||
48207434|NCT01066923|100832992|FG000|STARTED|Overall Study||28||
48207435|NCT01066923|100832993|FG001|STARTED|Overall Study||32||
48207436|NCT01066923|100832994|FG002|STARTED|Overall Study||33||
48207437|NCT01066923|100832995|FG003|STARTED|Overall Study||31||
48207438|NCT01066923|100832992|FG000|Platelet Closure Time|Overall Study||25||
48207439|NCT01066923|100832993|FG001|Platelet Closure Time|Overall Study||29||
48207440|NCT01066923|100832994|FG002|Platelet Closure Time|Overall Study||25||
48207441|NCT01066923|100832995|FG003|Platelet Closure Time|Overall Study||23||
48207442|NCT01066923|100832992|FG000|Vascular Function|Overall Study||13||
48207443|NCT01066923|100832993|FG001|Vascular Function|Overall Study||14||
48207444|NCT01066923|100832994|FG002|Vascular Function|Overall Study||12||
48207445|NCT01066923|100832995|FG003|Vascular Function|Overall Study||13||
48207446|NCT01066923|100832992|FG000|Activation of Coagulation|Overall Study||0||
48207447|NCT01066923|100832993|FG001|Activation of Coagulation|Overall Study||0||
48207448|NCT01066923|100832994|FG002|Activation of Coagulation|Overall Study||0||
48207449|NCT01066923|100832995|FG003|Activation of Coagulation|Overall Study||0||
48207450|NCT01066923|100832992|FG000|Retinal Imaging|Overall Study||0||
48207451|NCT01066923|100832993|FG001|Retinal Imaging|Overall Study||0||
48207452|NCT01066923|100832994|FG002|Retinal Imaging|Overall Study||0||
48207453|NCT01066923|100832995|FG003|Retinal Imaging|Overall Study||0||
48207454|NCT01066923|100832992|FG000|COMPLETED|Overall Study||25||
48207455|NCT01066923|100832993|FG001|COMPLETED|Overall Study||29||
48207456|NCT01066923|100832994|FG002|COMPLETED|Overall Study||25||
48207457|NCT01066923|100832995|FG003|COMPLETED|Overall Study||23||
48207458|NCT01066923|100832992|FG000|NOT COMPLETED|Overall Study||3||
48207459|NCT01066923|100832993|FG001|NOT COMPLETED|Overall Study||3||
48207460|NCT01066923|100832994|FG002|NOT COMPLETED|Overall Study||8||
48207461|NCT01066923|100832995|FG003|NOT COMPLETED|Overall Study||8||
48207462|NCT00446550|100832996|FG000|STARTED|Overall Study||11||
48207463|NCT00446550|100832997|FG001|STARTED|Overall Study||8||
48207464|NCT00446550|100832996|FG000|Safety Population|Overall Study||11|All participants who received at least 1 dose of study drug.|
48207465|NCT00446550|100832997|FG001|Safety Population|Overall Study||8|All participants who received at least 1 dose of study drug.|
48207466|NCT00446550|100832996|FG000|PD Population|Overall Study||11|Participants in the Safety Population with a baseline and at least 1 post-baseline PD measurement.|
48207467|NCT00446550|100832997|FG001|PD Population|Overall Study||8|Participants in the Safety Population with a baseline and at least 1 post-baseline PD measurement.|
48207468|NCT00446550|100832996|FG000|COMPLETED|Overall Study||10||
48207469|NCT00446550|100832997|FG001|COMPLETED|Overall Study||8||
48207470|NCT00446550|100832996|FG000|NOT COMPLETED|Overall Study||1||
48207471|NCT00446550|100832997|FG001|NOT COMPLETED|Overall Study||0||
48207472|NCT00534937|100832998|FG000|STARTED|Overall Study||42||
48207473|NCT00534937|100832999|FG001|STARTED|Overall Study||47||
48207474|NCT00534937|100832998|FG000|COMPLETED|Overall Study||34||
48207475|NCT00534937|100832999|FG001|COMPLETED|Overall Study||35||
48207476|NCT00534937|100832998|FG000|NOT COMPLETED|Overall Study||8||
48207477|NCT00534937|100832999|FG001|NOT COMPLETED|Overall Study||12||
48207478|NCT00917865|100833000|FG000|STARTED|Overall Study||11||
48207479|NCT00917865|100833000|FG000|COMPLETED|Overall Study||11||
48207480|NCT00917865|100833000|FG000|NOT COMPLETED|Overall Study||0||
48207481|NCT01091454|100833001|FG000|STARTED|Overall Study||48||
48207482|NCT01091454|100833001|FG000|COMPLETED|Overall Study||47||
48207483|NCT01091454|100833001|FG000|NOT COMPLETED|Overall Study||1||
48207484|NCT01924975|100833002|FG000|STARTED|Overall Study||51||
48207485|NCT01924975|100833003|FG001|STARTED|Overall Study||51||
48207486|NCT01924975|100833002|FG000|COMPLETED|Overall Study||51||
48207487|NCT01924975|100833003|FG001|COMPLETED|Overall Study||51||
48207488|NCT01924975|100833002|FG000|NOT COMPLETED|Overall Study||0||
48207489|NCT01924975|100833003|FG001|NOT COMPLETED|Overall Study||0||
48207490|NCT01576952|100833004|FG000|STARTED|Overall Study||180||
48207491|NCT01576952|100833005|FG001|STARTED|Overall Study||88||
48207492|NCT01576952|100833004|FG000|Safety Population|Overall Study||169||
48207493|NCT01576952|100833005|FG001|Safety Population|Overall Study||85||
48207494|NCT01576952|100833004|FG000|mITT Population|Overall Study||168||
48207495|NCT01576952|100833005|FG001|mITT Population|Overall Study||85||
48207496|NCT01576952|100833004|FG000|COMPLETED|Overall Study||139||
48207497|NCT01576952|100833005|FG001|COMPLETED|Overall Study||33||
48207498|NCT01576952|100833004|FG000|NOT COMPLETED|Overall Study||41||
48207499|NCT01576952|100833005|FG001|NOT COMPLETED|Overall Study||55||
48207500|NCT02899000|100833006|FG000|STARTED|Overall Study||186||
48207501|NCT02899000|100833006|FG000|COMPLETED|Overall Study||157||
48207502|NCT02899000|100833006|FG000|NOT COMPLETED|Overall Study||29||
48207503|NCT00346333|100833007|FG000|STARTED|Overall Study||121||
48207504|NCT00346333|100833008|FG001|STARTED|Overall Study||119||
48207505|NCT00346333|100833007|FG000|COMPLETED|Overall Study||116||
48207506|NCT00346333|100833008|FG001|COMPLETED|Overall Study||111||
48207507|NCT00346333|100833007|FG000|NOT COMPLETED|Overall Study||5||
48207508|NCT00346333|100833008|FG001|NOT COMPLETED|Overall Study||8||
48207509|NCT02620761|100833009|FG000|STARTED|Overall Study||1||
48207510|NCT02620761|100833010|FG001|STARTED|Overall Study||0||
48207511|NCT02620761|100833009|FG000|COMPLETED|Overall Study||1||
48207512|NCT02620761|100833010|FG001|COMPLETED|Overall Study||0||
48207513|NCT02620761|100833009|FG000|NOT COMPLETED|Overall Study||0||
48207514|NCT02620761|100833010|FG001|NOT COMPLETED|Overall Study||0||
48207515|NCT02138006|100833011|FG000|STARTED|Overall Study||48||
48207516|NCT02138006|100833012|FG001|STARTED|Overall Study||54||
48207517|NCT02138006|100833011|FG000|COMPLETED|Overall Study||48||
48207518|NCT02138006|100833012|FG001|COMPLETED|Overall Study||54||
48207519|NCT02138006|100833011|FG000|NOT COMPLETED|Overall Study||0||
48207520|NCT02138006|100833012|FG001|NOT COMPLETED|Overall Study||0||
48207521|NCT01560416|100833013|FG000|STARTED|Randomized Phase||15||
48207522|NCT01560416|100833014|FG001|STARTED|Randomized Phase||35||
48207523|NCT01560416|100833013|FG000|COMPLETED|Randomized Phase||8||
48207524|NCT01560416|100833014|FG001|COMPLETED|Randomized Phase||35||
48207525|NCT01560416|100833013|FG000|NOT COMPLETED|Randomized Phase||7||
48207526|NCT01560416|100833014|FG001|NOT COMPLETED|Randomized Phase||0||
48207527|NCT01560416|100833013|FG000|STARTED|Crossover Phase||7|Only participants randomized to Arm A potentially received crossover treatment.|
48207528|NCT01560416|100833014|FG001|STARTED|Crossover Phase||0|Only participants randomized to Arm A potentially received crossover treatment.|
48207529|NCT01560416|100833013|FG000|COMPLETED|Crossover Phase||7||
48207530|NCT01560416|100833014|FG001|COMPLETED|Crossover Phase||0||
48207531|NCT01560416|100833013|FG000|NOT COMPLETED|Crossover Phase||0||
48207532|NCT01560416|100833014|FG001|NOT COMPLETED|Crossover Phase||0||
48207533|NCT04086966|100833015|FG000|STARTED|Overall Study||10||
48207534|NCT04086966|100833015|FG000|COMPLETED|Overall Study||10||
48207535|NCT04086966|100833015|FG000|NOT COMPLETED|Overall Study||0||
48207536|NCT02020616|100833016|FG000|STARTED|Overall Study||10||
48207537|NCT02020616|100833017|FG001|STARTED|Overall Study||8||
48207538|NCT02020616|100833018|FG002|STARTED|Overall Study||8||
48207539|NCT02020616|100833019|FG003|STARTED|Overall Study||8||
48207540|NCT02020616|100833020|FG004|STARTED|Overall Study||8||
48207541|NCT02020616|100833021|FG005|STARTED|Overall Study||8||
48207542|NCT02020616|100833022|FG006|STARTED|Overall Study||10||
48207543|NCT02020616|100833016|FG000|Received at Least One Dose of Study Drug|Overall Study||10||
48207544|NCT02020616|100833017|FG001|Received at Least One Dose of Study Drug|Overall Study||8||
48207545|NCT02020616|100833018|FG002|Received at Least One Dose of Study Drug|Overall Study||8||
48207546|NCT02020616|100833019|FG003|Received at Least One Dose of Study Drug|Overall Study||7||
48207547|NCT02020616|100833020|FG004|Received at Least One Dose of Study Drug|Overall Study||8||
48207548|NCT02020616|100833021|FG005|Received at Least One Dose of Study Drug|Overall Study||8||
48207549|NCT02020616|100833022|FG006|Received at Least One Dose of Study Drug|Overall Study||10||
48207550|NCT02020616|100833016|FG000|COMPLETED|Overall Study||10||
48207551|NCT02020616|100833017|FG001|COMPLETED|Overall Study||7||
48207552|NCT02020616|100833018|FG002|COMPLETED|Overall Study||6||
48207553|NCT02020616|100833019|FG003|COMPLETED|Overall Study||6||
48207554|NCT02020616|100833020|FG004|COMPLETED|Overall Study||6||
48207555|NCT02020616|100833021|FG005|COMPLETED|Overall Study||3||
48207556|NCT02020616|100833022|FG006|COMPLETED|Overall Study||6||
48207557|NCT02020616|100833016|FG000|NOT COMPLETED|Overall Study||0||
48207558|NCT02020616|100833017|FG001|NOT COMPLETED|Overall Study||1||
48207559|NCT02020616|100833018|FG002|NOT COMPLETED|Overall Study||2||
48207560|NCT02020616|100833019|FG003|NOT COMPLETED|Overall Study||2||
48207561|NCT02020616|100833020|FG004|NOT COMPLETED|Overall Study||2||
48207562|NCT02020616|100833021|FG005|NOT COMPLETED|Overall Study||5||
48207563|NCT02020616|100833022|FG006|NOT COMPLETED|Overall Study||4||
48207564|NCT02957136|100833023|FG000|STARTED|Overall Study||95||
48207565|NCT02957136|100833024|FG001|STARTED|Overall Study||99||
48207566|NCT02957136|100833023|FG000|COMPLETED|Overall Study||93||
48207567|NCT02957136|100833024|FG001|COMPLETED|Overall Study||98||
48207568|NCT02957136|100833023|FG000|NOT COMPLETED|Overall Study||2||
48207569|NCT02957136|100833024|FG001|NOT COMPLETED|Overall Study||1||
48207570|NCT03024606|100833025|FG000|STARTED|Overall Study||23||
48207571|NCT03024606|100833026|FG001|STARTED|Overall Study||26||
48048143|NCT00393042|100438417|FG000|NOT COMPLETED|First Intervention||5||
48048144|NCT00393042|100438418|FG001|NOT COMPLETED|First Intervention||6||
48048145|NCT00393042|100438417|FG000|STARTED|Second Intervetion||26||
48048146|NCT00393042|100438418|FG001|STARTED|Second Intervetion||27||
48048147|NCT00393042|100438417|FG000|Completed Placebo Dosage|Second Intervetion||25||
48048148|NCT00393042|100438418|FG001|Completed Placebo Dosage|Second Intervetion||21||
48048149|NCT00393042|100438417|FG000|Completed 10 mg Dosage|Second Intervetion||26||
48048150|NCT00393042|100438418|FG001|Completed 10 mg Dosage|Second Intervetion||24||
48048151|NCT00393042|100438417|FG000|Completed the 20mg Dosage|Second Intervetion||24||
48048152|NCT00393042|100438418|FG001|Completed the 20mg Dosage|Second Intervetion||21||
48048153|NCT00393042|100438417|FG000|Completed 25/30 mg Dosage|Second Intervetion||24||
48048154|NCT00393042|100438418|FG001|Completed 25/30 mg Dosage|Second Intervetion||20||
48048155|NCT00393042|100438417|FG000|COMPLETED|Second Intervetion||24||
48048156|NCT00393042|100438418|FG001|COMPLETED|Second Intervetion||19||
48048157|NCT00393042|100438417|FG000|NOT COMPLETED|Second Intervetion||2||
48048158|NCT00393042|100438418|FG001|NOT COMPLETED|Second Intervetion||8||
48048159|NCT00971620|100438419|FG000|STARTED|Overall Study||9||
48048160|NCT00971620|100438420|FG001|STARTED|Overall Study||9||
48048161|NCT00971620|100438419|FG000|COMPLETED|Overall Study||9||
48048162|NCT00971620|100438420|FG001|COMPLETED|Overall Study||9||
48048163|NCT00971620|100438419|FG000|NOT COMPLETED|Overall Study||0||
48048164|NCT00971620|100438420|FG001|NOT COMPLETED|Overall Study||0||
48048165|NCT00704522|100438421|FG000|STARTED|Overall Study||481||
48048166|NCT00704522|100438422|FG001|STARTED|Overall Study||120||
48048167|NCT00704522|100438421|FG000|COMPLETED|Overall Study||298||
48048168|NCT00704522|100438422|FG001|COMPLETED|Overall Study||75||
48048169|NCT00704522|100438421|FG000|NOT COMPLETED|Overall Study||183||
48048170|NCT00704522|100438422|FG001|NOT COMPLETED|Overall Study||45||
48048171|NCT04535167|100438423|FG000|STARTED|Treatment||2||
48048172|NCT04535167|100438424|FG001|STARTED|Treatment||2||
48048173|NCT04535167|100438425|FG002|STARTED|Treatment||2||
48048174|NCT04535167|100438426|FG003|STARTED|Treatment||2||
48048175|NCT04535167|100438427|FG004|STARTED|Treatment||6||
48048176|NCT04535167|100438428|FG005|STARTED|Treatment||7||
48048177|NCT04535167|100438429|FG006|STARTED|Treatment||4||
48048178|NCT04535167|100438423|FG000|COMPLETED|Treatment||2||
48048179|NCT04535167|100438424|FG001|COMPLETED|Treatment||2||
48048180|NCT04535167|100438425|FG002|COMPLETED|Treatment||2||
48048181|NCT04535167|100438426|FG003|COMPLETED|Treatment||2||
48048182|NCT04535167|100438427|FG004|COMPLETED|Treatment||6||
48048183|NCT04535167|100438428|FG005|COMPLETED|Treatment||7||
48048184|NCT04535167|100438429|FG006|COMPLETED|Treatment||3||
48048185|NCT04535167|100438423|FG000|NOT COMPLETED|Treatment||0||
48048186|NCT04535167|100438424|FG001|NOT COMPLETED|Treatment||0||
48048187|NCT04535167|100438425|FG002|NOT COMPLETED|Treatment||0||
48048188|NCT04535167|100438426|FG003|NOT COMPLETED|Treatment||0||
48048189|NCT04535167|100438427|FG004|NOT COMPLETED|Treatment||0||
48048190|NCT04535167|100438428|FG005|NOT COMPLETED|Treatment||0||
48048191|NCT04535167|100438429|FG006|NOT COMPLETED|Treatment||1||
48048192|NCT04535167|100438423|FG000|STARTED|Follow-Up||2||
48048193|NCT04535167|100438424|FG001|STARTED|Follow-Up||2||
48048194|NCT04535167|100438425|FG002|STARTED|Follow-Up||2||
48048195|NCT04535167|100438426|FG003|STARTED|Follow-Up||2||
48048196|NCT04535167|100438427|FG004|STARTED|Follow-Up||6||
48048197|NCT04535167|100438428|FG005|STARTED|Follow-Up||7||
48048198|NCT04535167|100438429|FG006|STARTED|Follow-Up||4||
48048199|NCT04535167|100438423|FG000|COMPLETED|Follow-Up||2||
48048200|NCT04535167|100438424|FG001|COMPLETED|Follow-Up||2||
48048201|NCT04535167|100438425|FG002|COMPLETED|Follow-Up||2||
48048202|NCT04535167|100438426|FG003|COMPLETED|Follow-Up||1||
48048203|NCT04535167|100438427|FG004|COMPLETED|Follow-Up||6||
48048204|NCT04535167|100438428|FG005|COMPLETED|Follow-Up||7||
48048205|NCT04535167|100438429|FG006|COMPLETED|Follow-Up||3||
48048206|NCT04535167|100438423|FG000|NOT COMPLETED|Follow-Up||0||
48048207|NCT04535167|100438424|FG001|NOT COMPLETED|Follow-Up||0||
48048208|NCT04535167|100438425|FG002|NOT COMPLETED|Follow-Up||0||
48207572|NCT03024606|100833025|FG000|COMPLETED|Overall Study||14||
48495633|NCT00819169|101547887|FG000|NOT COMPLETED|Overall Study||3||
48048209|NCT04535167|100438426|FG003|NOT COMPLETED|Follow-Up||1||
48495634|NCT00819169|101547888|FG001|NOT COMPLETED|Overall Study||3||
48048210|NCT04535167|100438427|FG004|NOT COMPLETED|Follow-Up||0||
48048211|NCT04535167|100438428|FG005|NOT COMPLETED|Follow-Up||0||
48048212|NCT04535167|100438429|FG006|NOT COMPLETED|Follow-Up||1||
48048213|NCT01879540|100438430|FG000|STARTED|Overall Study||63||
48048214|NCT01879540|100438430|FG000|COMPLETED|Overall Study||63||
48207573|NCT03024606|100833026|FG001|COMPLETED|Overall Study||16||
48048215|NCT01879540|100438430|FG000|NOT COMPLETED|Overall Study||0||
48048216|NCT00476047|100438431|FG000|STARTED|Overall Study||16||
48048217|NCT00476047|100438431|FG000|Completed Treatment|Overall Study||16||
48048218|NCT00476047|100438431|FG000|COMPLETED|Overall Study||15||
48048219|NCT00476047|100438431|FG000|NOT COMPLETED|Overall Study||1||
48048220|NCT05093790|100438432|FG000|STARTED|Overall Study||16||
48048221|NCT05093790|100438433|FG001|STARTED|Overall Study||15||
48048222|NCT05093790|100438434|FG002|STARTED|Overall Study||16||
48048223|NCT05093790|100438435|FG003|STARTED|Overall Study||11||
48207574|NCT03024606|100833025|FG000|NOT COMPLETED|Overall Study||9||
48207575|NCT03024606|100833026|FG001|NOT COMPLETED|Overall Study||10||
48207576|NCT03070483|100833027|FG000|STARTED|Overall Study||5|First person was screened March 25, 2018|
48207577|NCT03070483|100833027|FG000|COMPLETED|Overall Study||3|Completed the trial|
48207578|NCT03070483|100833027|FG000|NOT COMPLETED|Overall Study||2||
48207579|NCT01331824|100833028|FG000|STARTED|Overall Study||22||
48207580|NCT01331824|100833028|FG000|COMPLETED|Overall Study||9||
48207581|NCT01331824|100833028|FG000|NOT COMPLETED|Overall Study||13||
48207582|NCT01832480|100833029|FG000|STARTED|Overall Study||311||
48207583|NCT01832480|100833030|FG001|STARTED|Overall Study||312||
48207584|NCT01832480|100833029|FG000|COMPLETED|Overall Study||270||
48207585|NCT01832480|100833030|FG001|COMPLETED|Overall Study||270||
48207586|NCT01832480|100833029|FG000|NOT COMPLETED|Overall Study||41||
48207587|NCT01832480|100833030|FG001|NOT COMPLETED|Overall Study||42||
48207588|NCT04567407|100833031|FG000|STARTED|Overall Study||45||
48207589|NCT04567407|100833031|FG000|COMPLETED|Overall Study||40||
48207590|NCT04567407|100833031|FG000|NOT COMPLETED|Overall Study||5||
48207591|NCT02202499|100833032|FG000|STARTED|Overall Study||21||
48207592|NCT02202499|100833033|FG001|STARTED|Overall Study||20||
48207593|NCT02202499|100833034|FG002|STARTED|Overall Study||21||
48207594|NCT02202499|100833032|FG000|COMPLETED|Overall Study||19||
48207595|NCT02202499|100833033|FG001|COMPLETED|Overall Study||20||
48207596|NCT02202499|100833034|FG002|COMPLETED|Overall Study||19||
48207597|NCT02202499|100833032|FG000|NOT COMPLETED|Overall Study||2||
48207598|NCT02202499|100833033|FG001|NOT COMPLETED|Overall Study||0||
48207599|NCT02202499|100833034|FG002|NOT COMPLETED|Overall Study||2||
48207600|NCT03290248|100833035|FG000|STARTED|Study Part 1||8||
48207601|NCT03290248|100833036|FG001|STARTED|Study Part 1||8||
48207602|NCT03290248|100833037|FG002|STARTED|Study Part 1||8||
48207603|NCT03290248|100833035|FG000|COMPLETED|Study Part 1||8||
48207604|NCT03290248|100833036|FG001|COMPLETED|Study Part 1||8||
48207605|NCT03290248|100833037|FG002|COMPLETED|Study Part 1||8||
48207606|NCT03290248|100833035|FG000|NOT COMPLETED|Study Part 1||0||
48207607|NCT03290248|100833036|FG001|NOT COMPLETED|Study Part 1||0||
48207608|NCT03290248|100833037|FG002|NOT COMPLETED|Study Part 1||0||
48207609|NCT03290248|100833035|FG000|STARTED|Study Part 2||15||
48207610|NCT03290248|100833036|FG001|STARTED|Study Part 2||16||
48207611|NCT03290248|100833037|FG002|STARTED|Study Part 2||16||
48207612|NCT03290248|100833035|FG000|COMPLETED|Study Part 2||15||
48207613|NCT03290248|100833036|FG001|COMPLETED|Study Part 2||16||
48207614|NCT03290248|100833037|FG002|COMPLETED|Study Part 2||16||
48207615|NCT03290248|100833035|FG000|NOT COMPLETED|Study Part 2||0||
48207616|NCT03290248|100833036|FG001|NOT COMPLETED|Study Part 2||0||
48207617|NCT03290248|100833037|FG002|NOT COMPLETED|Study Part 2||0||
48207618|NCT03387319|100833038|FG000|STARTED|Overall Study||25||
48207619|NCT03387319|100833039|FG001|STARTED|Overall Study||25||
48207620|NCT03387319|100833038|FG000|COMPLETED|Overall Study||25||
48207621|NCT03387319|100833039|FG001|COMPLETED|Overall Study||25||
48207622|NCT03387319|100833038|FG000|NOT COMPLETED|Overall Study||0||
48207623|NCT03387319|100833039|FG001|NOT COMPLETED|Overall Study||0||
48207624|NCT03227757|100833040|FG000|STARTED|Overall Study||98||
48207625|NCT03227757|100833040|FG000|COMPLETED|Overall Study||60||
48207626|NCT03227757|100833040|FG000|NOT COMPLETED|Overall Study||38||
48207627|NCT01081145|100833041|FG000|STARTED|Open-Label Phase||528||
48207628|NCT01081145|100833042|FG001|STARTED|Open-Label Phase||0||
48207629|NCT01081145|100833041|FG000|COMPLETED|Open-Label Phase||316||
48207630|NCT01081145|100833042|FG001|COMPLETED|Open-Label Phase||0||
48207631|NCT01081145|100833041|FG000|NOT COMPLETED|Open-Label Phase||212||
48207632|NCT01081145|100833042|FG001|NOT COMPLETED|Open-Label Phase||0||
48207633|NCT01081145|100833041|FG000|STARTED|Double-Blind Randomized-Withdrawal Phase||157||
48207634|NCT01081145|100833042|FG001|STARTED|Double-Blind Randomized-Withdrawal Phase||159||
48207635|NCT01081145|100833041|FG000|COMPLETED|Double-Blind Randomized-Withdrawal Phase||76||
48207636|NCT01081145|100833042|FG001|COMPLETED|Double-Blind Randomized-Withdrawal Phase||53||
48207637|NCT01081145|100833041|FG000|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||81||
48207638|NCT01081145|100833042|FG001|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||106||
48207639|NCT00736853|100833043|FG000|STARTED|Open-Label Period||319||
48207640|NCT00736853|100833044|FG001|STARTED|Open-Label Period||0||
48207641|NCT00736853|100833045|FG002|STARTED|Open-Label Period||0||
48207642|NCT00736853|100833043|FG000|Treated|Open-Label Period||277||
48207643|NCT00736853|100833044|FG001|Treated|Open-Label Period||0||
48207644|NCT00736853|100833045|FG002|Treated|Open-Label Period||0||
48207645|NCT00736853|100833043|FG000|COMPLETED|Open-Label Period||187||
48207646|NCT00736853|100833044|FG001|COMPLETED|Open-Label Period||0||
48207647|NCT00736853|100833045|FG002|COMPLETED|Open-Label Period||0||
48207648|NCT00736853|100833043|FG000|NOT COMPLETED|Open-Label Period||132||
48207649|NCT00736853|100833044|FG001|NOT COMPLETED|Open-Label Period||0||
48207650|NCT00736853|100833045|FG002|NOT COMPLETED|Open-Label Period||0||
48207651|NCT00736853|100833043|FG000|STARTED|Double-Blind Period||0||
48207652|NCT00736853|100833044|FG001|STARTED|Double-Blind Period||94||
48207653|NCT00736853|100833045|FG002|STARTED|Double-Blind Period||93||
48207654|NCT00736853|100833043|FG000|COMPLETED|Double-Blind Period||0||
48207655|NCT00736853|100833044|FG001|COMPLETED|Double-Blind Period||70||
48207656|NCT00736853|100833045|FG002|COMPLETED|Double-Blind Period||45||
48207657|NCT00736853|100833043|FG000|NOT COMPLETED|Double-Blind Period||0||
48207658|NCT00736853|100833044|FG001|NOT COMPLETED|Double-Blind Period||24||
48207659|NCT00736853|100833045|FG002|NOT COMPLETED|Double-Blind Period||48||
48207660|NCT05641311|100833046|FG000|STARTED|Dosing Period 1||12||
48207661|NCT05641311|100833047|FG001|STARTED|Dosing Period 1||12||
48207662|NCT05641311|100833046|FG000|Received At Least 1 Dose Of Study Drug|Dosing Period 1||12||
48207663|NCT05641311|100833047|FG001|Received At Least 1 Dose Of Study Drug|Dosing Period 1||12||
48207664|NCT05641311|100833046|FG000|COMPLETED|Dosing Period 1||11||
48207665|NCT05641311|100833047|FG001|COMPLETED|Dosing Period 1||12||
48207666|NCT05641311|100833046|FG000|NOT COMPLETED|Dosing Period 1||1||
48207667|NCT05641311|100833047|FG001|NOT COMPLETED|Dosing Period 1||0||
48207668|NCT05641311|100833046|FG000|STARTED|Dosing Period 2||11||
48207669|NCT05641311|100833047|FG001|STARTED|Dosing Period 2||12||
48207670|NCT05641311|100833046|FG000|Received At Least 1 Dose Of Study Drug|Dosing Period 2||11||
48207671|NCT05641311|100833047|FG001|Received At Least 1 Dose Of Study Drug|Dosing Period 2||12||
48207672|NCT05641311|100833046|FG000|COMPLETED|Dosing Period 2||11||
48048224|NCT05093790|100438432|FG000|COMPLETED|Overall Study||15||
48048225|NCT05093790|100438433|FG001|COMPLETED|Overall Study||15||
48048226|NCT05093790|100438434|FG002|COMPLETED|Overall Study||15||
48048227|NCT05093790|100438435|FG003|COMPLETED|Overall Study||11||
48048228|NCT05093790|100438432|FG000|NOT COMPLETED|Overall Study||1||
48048229|NCT05093790|100438433|FG001|NOT COMPLETED|Overall Study||0||
48048230|NCT05093790|100438434|FG002|NOT COMPLETED|Overall Study||1||
48207673|NCT05641311|100833047|FG001|COMPLETED|Dosing Period 2||12||
48207674|NCT05641311|100833046|FG000|NOT COMPLETED|Dosing Period 2||0||
48207675|NCT05641311|100833047|FG001|NOT COMPLETED|Dosing Period 2||0||
48207676|NCT01117480|100833048|FG000|STARTED|Overall Study||1013||
48207677|NCT01117480|100833048|FG000|COMPLETED|Overall Study||985||
48207678|NCT01117480|100833048|FG000|NOT COMPLETED|Overall Study||28||
48207679|NCT02139943|100833049|FG000|STARTED|Overall Study||117||
48207680|NCT02139943|100833050|FG001|STARTED|Overall Study||117||
48207681|NCT02139943|100833051|FG002|STARTED|Overall Study||117||
48207682|NCT02139943|100833049|FG000|COMPLETED|Overall Study||107||
48207683|NCT02139943|100833050|FG001|COMPLETED|Overall Study||111||
48207684|NCT02139943|100833051|FG002|COMPLETED|Overall Study||110||
48207685|NCT02139943|100833049|FG000|NOT COMPLETED|Overall Study||10||
48207686|NCT02139943|100833050|FG001|NOT COMPLETED|Overall Study||6||
48207687|NCT02139943|100833051|FG002|NOT COMPLETED|Overall Study||7||
48207688|NCT01271452|100833052|FG000|STARTED|Overall Study||112||
48207689|NCT01271452|100833053|FG001|STARTED|Overall Study||112||
48207690|NCT01271452|100833052|FG000|COMPLETED|Overall Study||105||
48207691|NCT01271452|100833053|FG001|COMPLETED|Overall Study||104||
48207692|NCT01271452|100833052|FG000|NOT COMPLETED|Overall Study||7||
48207693|NCT01271452|100833053|FG001|NOT COMPLETED|Overall Study||8||
48207694|NCT02452918|100833054|FG000|STARTED|Overall Study||15||
48207695|NCT02452918|100833055|FG001|STARTED|Overall Study||2||
48207696|NCT02452918|100833054|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15||
48207697|NCT02452918|100833055|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2||
48207698|NCT02452918|100833054|FG000|COMPLETED|Overall Study||15||
48207699|NCT02452918|100833055|FG001|COMPLETED|Overall Study||2||
48207700|NCT02452918|100833054|FG000|NOT COMPLETED|Overall Study||0||
48048231|NCT05093790|100438435|FG003|NOT COMPLETED|Overall Study||0||
48048232|NCT00251004|100438436|FG000|STARTED|Overall Study||277||
48048233|NCT00251004|100438437|FG001|STARTED|Overall Study||279||
48048234|NCT00251004|100438438|FG002|STARTED|Overall Study||277||
48048235|NCT00251004|100438436|FG000|12 Month Analysis|Overall Study||241||
48048236|NCT00251004|100438437|FG001|12 Month Analysis|Overall Study||249||
48048237|NCT00251004|100438438|FG002|12 Month Analysis|Overall Study||253||
48048238|NCT00251004|100438436|FG000|24 Month Analysis|Overall Study||232||
48207701|NCT02452918|100833055|FG001|NOT COMPLETED|Overall Study||0||
48207702|NCT01075217|100833056|FG000|STARTED|Overall Study||84||
48207703|NCT01075217|100833057|FG001|STARTED|Overall Study||85||
48207704|NCT01075217|100833056|FG000|COMPLETED|Overall Study||82||
48207705|NCT01075217|100833057|FG001|COMPLETED|Overall Study||84||
48207706|NCT01075217|100833056|FG000|NOT COMPLETED|Overall Study||2||
48207707|NCT01075217|100833057|FG001|NOT COMPLETED|Overall Study||1||
48207708|NCT05325853|100833058|FG000|STARTED|Overall Study||30||
48207709|NCT05325853|100833059|FG001|STARTED|Overall Study||30||
48207710|NCT05325853|100833058|FG000|COMPLETED|Overall Study||30||
48207711|NCT05325853|100833059|FG001|COMPLETED|Overall Study||30||
48048239|NCT00251004|100438437|FG001|24 Month Analysis|Overall Study||238||
48207712|NCT05325853|100833058|FG000|NOT COMPLETED|Overall Study||0||
48207713|NCT05325853|100833059|FG001|NOT COMPLETED|Overall Study||0||
48207714|NCT02488980|100833060|FG000|STARTED|Overall Study||104||
48207715|NCT02488980|100833061|FG001|STARTED|Overall Study||101||
48207716|NCT02488980|100833062|FG002|STARTED|Overall Study||101||
48048240|NCT00251004|100438438|FG002|24 Month Analysis|Overall Study||246||
48207717|NCT02488980|100833060|FG000|COMPLETED|Overall Study||102||
48207718|NCT02488980|100833061|FG001|COMPLETED|Overall Study||99||
48207719|NCT02488980|100833062|FG002|COMPLETED|Overall Study||99||
48207720|NCT02488980|100833060|FG000|NOT COMPLETED|Overall Study||2||
48207721|NCT02488980|100833061|FG001|NOT COMPLETED|Overall Study||2||
48207722|NCT02488980|100833062|FG002|NOT COMPLETED|Overall Study||2||
48048241|NCT00251004|100438436|FG000|COMPLETED|Overall Study||232||
48048242|NCT00251004|100438437|FG001|COMPLETED|Overall Study||238||
48048243|NCT00251004|100438438|FG002|COMPLETED|Overall Study||246||
48048244|NCT00251004|100438436|FG000|NOT COMPLETED|Overall Study||45||
48048245|NCT00251004|100438437|FG001|NOT COMPLETED|Overall Study||41||
48048246|NCT00251004|100438438|FG002|NOT COMPLETED|Overall Study||31||
48048247|NCT01288976|100438439|FG000|STARTED|Overall Study||567||
48048248|NCT01288976|100438440|FG001|STARTED|Overall Study||49||
48048249|NCT01288976|100438441|FG002|STARTED|Overall Study||105||
48207723|NCT04762875|100833063|FG000|STARTED|Overall Study||4||
48207724|NCT04762875|100833064|FG001|STARTED|Overall Study||3||
48207725|NCT04762875|100833063|FG000|COMPLETED|Overall Study||3||
48048250|NCT01288976|100438439|FG000|COMPLETED|Overall Study||389||
48048251|NCT01288976|100438440|FG001|COMPLETED|Overall Study||22||
48048252|NCT01288976|100438441|FG002|COMPLETED|Overall Study||85||
48048253|NCT01288976|100438439|FG000|NOT COMPLETED|Overall Study||178||
48048254|NCT01288976|100438440|FG001|NOT COMPLETED|Overall Study||27||
48207726|NCT04762875|100833064|FG001|COMPLETED|Overall Study||0||
48207727|NCT04762875|100833063|FG000|NOT COMPLETED|Overall Study||1||
48207728|NCT04762875|100833064|FG001|NOT COMPLETED|Overall Study||3||
48207729|NCT00807144|100833065|FG000|STARTED|Overall Study||52||
48207730|NCT00807144|100833066|FG001|STARTED|Overall Study||50||
48207731|NCT00807144|100833065|FG000|COMPLETED|Overall Study||52||
48207732|NCT00807144|100833066|FG001|COMPLETED|Overall Study||49||
48207733|NCT00807144|100833065|FG000|NOT COMPLETED|Overall Study||0||
48048255|NCT01288976|100438441|FG002|NOT COMPLETED|Overall Study||20||
48048256|NCT02742246|100438442|FG000|STARTED|Overall Study||34|Number randomized to treatment assignment|
48048257|NCT02742246|100438443|FG001|STARTED|Overall Study||32|Number randomized to treatment assignment|
48048258|NCT02742246|100438444|FG002|STARTED|Overall Study||33|Number randomized to treatment assignment|
48207734|NCT00807144|100833066|FG001|NOT COMPLETED|Overall Study||1||
48207735|NCT00831272|100833067|FG000|STARTED|Overall Study||38||
48207736|NCT00831272|100833068|FG001|STARTED|Overall Study||44||
48207737|NCT00831272|100833069|FG002|STARTED|Overall Study||73||
48207738|NCT00831272|100833070|FG003|STARTED|Overall Study||66||
48207739|NCT00831272|100833067|FG000|COMPLETED|Overall Study||30||
48207740|NCT00831272|100833068|FG001|COMPLETED|Overall Study||37||
48207741|NCT00831272|100833069|FG002|COMPLETED|Overall Study||63||
48207742|NCT00831272|100833070|FG003|COMPLETED|Overall Study||56||
48207743|NCT00831272|100833067|FG000|NOT COMPLETED|Overall Study||8||
48207744|NCT00831272|100833068|FG001|NOT COMPLETED|Overall Study||7||
48207745|NCT00831272|100833069|FG002|NOT COMPLETED|Overall Study||10||
48207746|NCT00831272|100833070|FG003|NOT COMPLETED|Overall Study||10||
48207747|NCT02960659|100833071|FG000|STARTED|Overall Study||13||
48207748|NCT02960659|100833072|FG001|STARTED|Overall Study||11||
48207749|NCT02960659|100833071|FG000|COMPLETED|Overall Study||12||
48207750|NCT02960659|100833072|FG001|COMPLETED|Overall Study||10||
48207751|NCT02960659|100833071|FG000|NOT COMPLETED|Overall Study||1||
48207752|NCT02960659|100833072|FG001|NOT COMPLETED|Overall Study||1||
48207753|NCT02705586|100833073|FG000|STARTED|Overall Study||13||
48207754|NCT02705586|100833073|FG000|COMPLETED|Overall Study||5||
48207755|NCT02705586|100833073|FG000|NOT COMPLETED|Overall Study||8||
48207756|NCT00237770|100833074|FG000|STARTED|Overall Study||9||
48207757|NCT00237770|100833075|FG001|STARTED|Overall Study||7||
48207758|NCT00237770|100833074|FG000|COMPLETED|Overall Study||9||
48207759|NCT00237770|100833075|FG001|COMPLETED|Overall Study||7||
48207760|NCT00237770|100833074|FG000|NOT COMPLETED|Overall Study||0||
48207761|NCT00237770|100833075|FG001|NOT COMPLETED|Overall Study||0||
48207762|NCT02412748|100833076|FG000|STARTED|Overall Study||145||
48048259|NCT02742246|100438442|FG000|COMPLETED|Overall Study||21||
48048260|NCT02742246|100438443|FG001|COMPLETED|Overall Study||16||
48048261|NCT02742246|100438444|FG002|COMPLETED|Overall Study||22||
48048262|NCT02742246|100438442|FG000|NOT COMPLETED|Overall Study||13||
48048263|NCT02742246|100438443|FG001|NOT COMPLETED|Overall Study||16||
48048264|NCT02742246|100438444|FG002|NOT COMPLETED|Overall Study||11||
48048265|NCT03745820|100438445|FG000|STARTED|Overall Study||64||
48048266|NCT03745820|100438446|FG001|STARTED|Overall Study||66||
48048267|NCT03745820|100438447|FG002|STARTED|Overall Study||65||
48048268|NCT03745820|100438445|FG000|Safety Analysis Set|Overall Study||63|The safety population included all randomized participants who received at least 1 dose of study treatment(BIIB104 or placebo). One participant randomized to placebo, inadvertently received one or more doses of active treatment.|
48207763|NCT02412748|100833077|FG001|STARTED|Overall Study||163||
48207764|NCT02412748|100833076|FG000|COMPLETED|Overall Study||107||
48207765|NCT02412748|100833077|FG001|COMPLETED|Overall Study||124||
48207766|NCT02412748|100833076|FG000|NOT COMPLETED|Overall Study||38||
48207767|NCT02412748|100833077|FG001|NOT COMPLETED|Overall Study||39||
48207768|NCT04128319|100833078|FG000|STARTED|Overall Study||3||
48207769|NCT04128319|100833078|FG000|Initiated T-Guard Treatment|Overall Study||3||
48207770|NCT04128319|100833078|FG000|COMPLETED|Overall Study||0||
48207771|NCT04128319|100833078|FG000|NOT COMPLETED|Overall Study||3||
48207772|NCT00494780|100833079|FG000|STARTED|Overall Study||29||
48207773|NCT00494780|100833080|FG001|STARTED|Overall Study||30||
48495635|NCT00819169|101547889|FG002|NOT COMPLETED|Overall Study||3||
48207774|NCT00494780|100833079|FG000|COMPLETED|Overall Study||18||
48207775|NCT00494780|100833080|FG001|COMPLETED|Overall Study||17||
48048269|NCT03745820|100438446|FG001|Safety Analysis Set|Overall Study||66|The safety population included all randomized participants who received at least 1 dose of study treatment(BIIB104 or placebo). One participant randomized to placebo, inadvertently received one or more doses of active treatment.|
48048270|NCT03745820|100438447|FG002|Safety Analysis Set|Overall Study||66|The safety population included all randomized participants who received at least 1 dose of study treatment(BIIB104 or placebo). One participant randomized to placebo, inadvertently received one or more doses of active treatment.|
48048271|NCT03745820|100438445|FG000|COMPLETED|Overall Study||52||
48048272|NCT03745820|100438446|FG001|COMPLETED|Overall Study||52||
48048273|NCT03745820|100438447|FG002|COMPLETED|Overall Study||51||
48048274|NCT03745820|100438445|FG000|NOT COMPLETED|Overall Study||12||
48048275|NCT03745820|100438446|FG001|NOT COMPLETED|Overall Study||14||
48207776|NCT00494780|100833079|FG000|NOT COMPLETED|Overall Study||11||
48207777|NCT00494780|100833080|FG001|NOT COMPLETED|Overall Study||13||
48207778|NCT00739765|100833081|FG000|STARTED|Overall Study||40||
48207779|NCT00739765|100833082|FG001|STARTED|Overall Study||38||
48207780|NCT00739765|100833083|FG002|STARTED|Overall Study||32||
48207781|NCT00739765|100833081|FG000|COMPLETED|Overall Study||34||
48207782|NCT00739765|100833082|FG001|COMPLETED|Overall Study||27||
48207783|NCT00739765|100833083|FG002|COMPLETED|Overall Study||21||
48207784|NCT00739765|100833081|FG000|NOT COMPLETED|Overall Study||6||
48207785|NCT00739765|100833082|FG001|NOT COMPLETED|Overall Study||11||
48207786|NCT00739765|100833083|FG002|NOT COMPLETED|Overall Study||11||
48048276|NCT03745820|100438447|FG002|NOT COMPLETED|Overall Study||14||
48048277|NCT03737851|100438448|FG000|STARTED|Overall Study||70||
48048278|NCT03737851|100438449|FG001|STARTED|Overall Study||69||
48207787|NCT01755949|100833084|FG000|STARTED|Overall Study||5||
48207788|NCT01755949|100833085|FG001|STARTED|Overall Study||5||
48207789|NCT01755949|100833086|FG002|STARTED|Overall Study||4||
48048279|NCT03737851|100438450|FG002|STARTED|Overall Study||69||
48048280|NCT03737851|100438448|FG000|COMPLETED|Overall Study||62||
48048281|NCT03737851|100438449|FG001|COMPLETED|Overall Study||63||
48048282|NCT03737851|100438450|FG002|COMPLETED|Overall Study||57||
48048283|NCT03737851|100438448|FG000|NOT COMPLETED|Overall Study||8||
48048284|NCT03737851|100438449|FG001|NOT COMPLETED|Overall Study||6||
48048285|NCT03737851|100438450|FG002|NOT COMPLETED|Overall Study||12||
48048286|NCT02397564|100438451|FG000|STARTED|Overall Study||20||
48048287|NCT02397564|100438451|FG000|COMPLETED|Overall Study||16||
48048288|NCT02397564|100438451|FG000|NOT COMPLETED|Overall Study||4||
48207790|NCT01755949|100833087|FG003|STARTED|Overall Study||5||
48207791|NCT01755949|100833088|FG004|STARTED|Overall Study||4||
48207792|NCT01755949|100833089|FG005|STARTED|Overall Study||3||
48207793|NCT01755949|100833084|FG000|COMPLETED|Overall Study||5||
48207794|NCT01755949|100833085|FG001|COMPLETED|Overall Study||5||
48207795|NCT01755949|100833086|FG002|COMPLETED|Overall Study||4||
48207796|NCT01755949|100833087|FG003|COMPLETED|Overall Study||5||
48207797|NCT01755949|100833088|FG004|COMPLETED|Overall Study||4||
48207798|NCT01755949|100833089|FG005|COMPLETED|Overall Study||3||
48207799|NCT01755949|100833084|FG000|NOT COMPLETED|Overall Study||0||
48207800|NCT01755949|100833085|FG001|NOT COMPLETED|Overall Study||0||
48207801|NCT01755949|100833086|FG002|NOT COMPLETED|Overall Study||0||
48207802|NCT01755949|100833087|FG003|NOT COMPLETED|Overall Study||0||
48207803|NCT01755949|100833088|FG004|NOT COMPLETED|Overall Study||0||
48207804|NCT01755949|100833089|FG005|NOT COMPLETED|Overall Study||0||
48207805|NCT02685488|100833090|FG000|STARTED|Overall Study||12||
48207806|NCT02685488|100833091|FG001|STARTED|Overall Study||14||
48495636|NCT00819169|101547890|FG003|NOT COMPLETED|Overall Study||12||
48495637|NCT00819169|101547891|FG004|NOT COMPLETED|Overall Study||8||
48048289|NCT01525173|100438452|FG000|STARTED|Overall Study||70||
48207807|NCT02685488|100833090|FG000|COMPLETED|Overall Study||12||
48207808|NCT02685488|100833091|FG001|COMPLETED|Overall Study||13||
48207809|NCT02685488|100833090|FG000|NOT COMPLETED|Overall Study||0||
48207810|NCT02685488|100833091|FG001|NOT COMPLETED|Overall Study||1||
48207811|NCT02969863|100833092|FG000|STARTED|Overall Study||4||
48207812|NCT02969863|100833093|FG001|STARTED|Overall Study||4||
48207813|NCT02969863|100833094|FG002|STARTED|Overall Study||4||
48207814|NCT02969863|100833095|FG003|STARTED|Overall Study||4||
48207815|NCT02969863|100833096|FG004|STARTED|Overall Study||4||
48207816|NCT02969863|100833097|FG005|STARTED|Overall Study||4||
48207817|NCT02969863|100833092|FG000|COMPLETED|Overall Study||3||
48207818|NCT02969863|100833093|FG001|COMPLETED|Overall Study||4||
48207819|NCT02969863|100833094|FG002|COMPLETED|Overall Study||4||
48207820|NCT02969863|100833095|FG003|COMPLETED|Overall Study||4||
48207821|NCT02969863|100833096|FG004|COMPLETED|Overall Study||4||
48207822|NCT02969863|100833097|FG005|COMPLETED|Overall Study||4||
48207823|NCT02969863|100833092|FG000|NOT COMPLETED|Overall Study||1||
48207824|NCT02969863|100833093|FG001|NOT COMPLETED|Overall Study||0||
48207825|NCT02969863|100833094|FG002|NOT COMPLETED|Overall Study||0||
48207826|NCT02969863|100833095|FG003|NOT COMPLETED|Overall Study||0||
48207827|NCT02969863|100833096|FG004|NOT COMPLETED|Overall Study||0||
48207828|NCT02969863|100833097|FG005|NOT COMPLETED|Overall Study||0||
48207829|NCT02729701|100833098|FG000|STARTED|Overall Study||28||
48207830|NCT02729701|100833098|FG000|COMPLETED|Overall Study||28||
48207831|NCT02729701|100833098|FG000|NOT COMPLETED|Overall Study||0||
48207832|NCT02570711|100833099|FG000|STARTED|Overall Study||1||
48207833|NCT02570711|100833100|FG001|STARTED|Overall Study||2||
48207834|NCT02570711|100833099|FG000|COMPLETED|Overall Study||0||
48207835|NCT02570711|100833100|FG001|COMPLETED|Overall Study||0||
48207836|NCT02570711|100833099|FG000|NOT COMPLETED|Overall Study||1||
48207837|NCT02570711|100833100|FG001|NOT COMPLETED|Overall Study||2||
48207838|NCT03239899|100833101|FG000|STARTED|Overall Study||13||
48207839|NCT03239899|100833101|FG000|COMPLETED|Overall Study||6||
48207840|NCT03239899|100833101|FG000|NOT COMPLETED|Overall Study||7||
48207841|NCT02448446|100833102|FG000|STARTED|Overall Study||13||
48207842|NCT02448446|100833103|FG001|STARTED|Overall Study||12||
48207843|NCT02448446|100833102|FG000|COMPLETED|Overall Study||12||
48207844|NCT02448446|100833103|FG001|COMPLETED|Overall Study||12||
48207845|NCT02448446|100833102|FG000|NOT COMPLETED|Overall Study||1||
48048290|NCT01525173|100438453|FG001|STARTED|Overall Study||67||
48048291|NCT01525173|100438452|FG000|COMPLETED|Overall Study||63||
48048292|NCT01525173|100438453|FG001|COMPLETED|Overall Study||62||
48048293|NCT01525173|100438452|FG000|NOT COMPLETED|Overall Study||7||
48048294|NCT01525173|100438453|FG001|NOT COMPLETED|Overall Study||5||
48048295|NCT01209832|100438454|FG000|STARTED|Period 1||11||
48048296|NCT01209832|100438454|FG000|Received At Least 1 Dose of Study Drug|Period 1||10||
48048297|NCT01209832|100438454|FG000|COMPLETED|Period 1||10||
48048298|NCT01209832|100438454|FG000|NOT COMPLETED|Period 1||1||
48048299|NCT01209832|100438454|FG000|STARTED|Period 2||10||
48048300|NCT01209832|100438454|FG000|COMPLETED|Period 2||9||
48048301|NCT01209832|100438454|FG000|NOT COMPLETED|Period 2||1||
48048302|NCT01209832|100438454|FG000|STARTED|Maintenance Period 1 (M1)||4||
48048303|NCT01209832|100438454|FG000|COMPLETED|Maintenance Period 1 (M1)||4||
48048304|NCT01209832|100438454|FG000|NOT COMPLETED|Maintenance Period 1 (M1)||0||
48048305|NCT01209832|100438454|FG000|STARTED|Maintenance Period 2 (M1)||3||
48048306|NCT01209832|100438454|FG000|COMPLETED|Maintenance Period 2 (M1)||3||
48048307|NCT01209832|100438454|FG000|NOT COMPLETED|Maintenance Period 2 (M1)||0||
48048308|NCT02438358|100438455|FG000|STARTED|Overall Study||5||
48048309|NCT02438358|100438456|FG001|STARTED|Overall Study||5||
48048310|NCT02438358|100438457|FG002|STARTED|Overall Study||5||
48048311|NCT02438358|100438458|FG003|STARTED|Overall Study||45||
48048312|NCT02438358|100438455|FG000|COMPLETED|Overall Study||5||
48048313|NCT02438358|100438456|FG001|COMPLETED|Overall Study||5||
48048314|NCT02438358|100438457|FG002|COMPLETED|Overall Study||5||
48048315|NCT02438358|100438458|FG003|COMPLETED|Overall Study||44||
48048316|NCT02438358|100438455|FG000|NOT COMPLETED|Overall Study||0||
48048317|NCT02438358|100438456|FG001|NOT COMPLETED|Overall Study||0||
48048318|NCT02438358|100438457|FG002|NOT COMPLETED|Overall Study||0||
48048319|NCT02438358|100438458|FG003|NOT COMPLETED|Overall Study||1||
48048320|NCT02153710|100438459|FG000|STARTED|Overall Study||28||
48048321|NCT02153710|100438460|FG001|STARTED|Overall Study||30||
48048322|NCT02153710|100438459|FG000|COMPLETED|Overall Study||28||
48048323|NCT02153710|100438460|FG001|COMPLETED|Overall Study||30||
48048324|NCT02153710|100438459|FG000|NOT COMPLETED|Overall Study||0||
48048325|NCT02153710|100438460|FG001|NOT COMPLETED|Overall Study||0||
48207846|NCT02448446|100833103|FG001|NOT COMPLETED|Overall Study||0||
48207847|NCT02059980|100833104|FG000|STARTED|Overall Study||18||
48207848|NCT02059980|100833105|FG001|STARTED|Overall Study||15||
48207849|NCT02059980|100833104|FG000|COMPLETED|Overall Study||16||
48207850|NCT02059980|100833105|FG001|COMPLETED|Overall Study||14||
48207851|NCT02059980|100833104|FG000|NOT COMPLETED|Overall Study||2||
48207852|NCT02059980|100833105|FG001|NOT COMPLETED|Overall Study||1||
48207853|NCT01269749|100833106|FG000|STARTED|Overall Study||16||
48207854|NCT01269749|100833107|FG001|STARTED|Overall Study||3||
48207855|NCT01269749|100833106|FG000|COMPLETED|Overall Study||16||
48207856|NCT01269749|100833107|FG001|COMPLETED|Overall Study||3||
48207857|NCT01269749|100833106|FG000|NOT COMPLETED|Overall Study||0||
48207858|NCT01269749|100833107|FG001|NOT COMPLETED|Overall Study||0||
48207859|NCT05190419|100833108|FG000|STARTED|Overall Study||51||
48207860|NCT05190419|100833109|FG001|STARTED|Overall Study||48||
48207861|NCT05190419|100833110|FG002|STARTED|Overall Study||50||
48207862|NCT05190419|100833111|FG003|STARTED|Overall Study||53||
48207863|NCT05190419|100833108|FG000|COMPLETED|Overall Study||32||
48207864|NCT05190419|100833109|FG001|COMPLETED|Overall Study||34||
48048326|NCT00762424|100438461|FG000|STARTED|Overall Study||28||
48048327|NCT00762424|100438462|FG001|STARTED|Overall Study||25||
48048328|NCT00762424|100438461|FG000|COMPLETED|Overall Study||28||
48048329|NCT00762424|100438462|FG001|COMPLETED|Overall Study||25||
48048330|NCT00762424|100438461|FG000|NOT COMPLETED|Overall Study||0||
48048331|NCT00762424|100438462|FG001|NOT COMPLETED|Overall Study||0||
48207865|NCT05190419|100833110|FG002|COMPLETED|Overall Study||33||
48207866|NCT05190419|100833111|FG003|COMPLETED|Overall Study||26||
48207867|NCT05190419|100833108|FG000|NOT COMPLETED|Overall Study||19||
48207868|NCT05190419|100833109|FG001|NOT COMPLETED|Overall Study||14||
48048332|NCT02045303|100438463|FG000|STARTED|Overall Study||6||6
48048333|NCT02045303|100438464|FG001|STARTED|Overall Study||3||10
48207869|NCT05190419|100833110|FG002|NOT COMPLETED|Overall Study||17||
48207870|NCT05190419|100833111|FG003|NOT COMPLETED|Overall Study||27||
48207871|NCT04283552|100833112|FG000|STARTED|Overall Study||80||
48207872|NCT04283552|100833112|FG000|COMPLETED|Overall Study||80||
48207873|NCT04283552|100833112|FG000|NOT COMPLETED|Overall Study||0||
48207874|NCT03557008|100833113|FG000|STARTED|Overall Study||19||
48207875|NCT03557008|100833114|FG001|STARTED|Overall Study||18||
48207876|NCT03557008|100833113|FG000|COMPLETED|Overall Study||14|Completed the Day 28 assessment|
48207877|NCT03557008|100833114|FG001|COMPLETED|Overall Study||15|Completed the Day 28 assessment|
48207878|NCT03557008|100833113|FG000|NOT COMPLETED|Overall Study||5||
48207879|NCT03557008|100833114|FG001|NOT COMPLETED|Overall Study||3||
48207880|NCT01266265|100833115|FG000|STARTED|Overall Study||666||
48207881|NCT01266265|100833116|FG001|STARTED|Overall Study||667||
48207882|NCT01266265|100833115|FG000|COMPLETED|Overall Study||461||
48048334|NCT02045303|100438465|FG002|STARTED|Overall Study||2||8
48048335|NCT02045303|100438463|FG000|COMPLETED|Overall Study||4||4
48048336|NCT02045303|100438464|FG001|COMPLETED|Overall Study||0||0
48048337|NCT02045303|100438465|FG002|COMPLETED|Overall Study||2||8
48048338|NCT02045303|100438463|FG000|NOT COMPLETED|Overall Study||2||2
48048339|NCT02045303|100438464|FG001|NOT COMPLETED|Overall Study||3||10
48048340|NCT02045303|100438465|FG002|NOT COMPLETED|Overall Study||0||0
48048341|NCT03614975|100438466|FG000|STARTED|Overall Study||85||
48048342|NCT03614975|100438467|FG001|STARTED|Overall Study||81||
48048343|NCT03614975|100438466|FG000|COMPLETED|Overall Study||75||
48048344|NCT03614975|100438467|FG001|COMPLETED|Overall Study||73||
48048345|NCT03614975|100438466|FG000|NOT COMPLETED|Overall Study||10||
48048346|NCT03614975|100438467|FG001|NOT COMPLETED|Overall Study||8||
48048347|NCT03036800|100438468|FG000|STARTED|Overall Study||260||
48048348|NCT03036800|100438469|FG001|STARTED|Overall Study||132||
48048349|NCT03036800|100438468|FG000|Week 16|Overall Study||252||
48048350|NCT03036800|100438469|FG001|Week 16|Overall Study||117||
48048351|NCT03036800|100438468|FG000|Week 32|Overall Study||243||
48207883|NCT01266265|100833116|FG001|COMPLETED|Overall Study||477||
48207884|NCT01266265|100833115|FG000|NOT COMPLETED|Overall Study||205||
48207885|NCT01266265|100833116|FG001|NOT COMPLETED|Overall Study||190||
48207886|NCT02794480|100833117|FG000|STARTED|Period 1: Treatment Period 1 (28 Days)||80||
48207887|NCT02794480|100833118|FG001|STARTED|Period 1: Treatment Period 1 (28 Days)||82||
48207888|NCT02794480|100833119|FG002|STARTED|Period 1: Treatment Period 1 (28 Days)||81||
48207889|NCT02794480|100833120|FG003|STARTED|Period 1: Treatment Period 1 (28 Days)||81||
48207890|NCT02794480|100833117|FG000|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80||
48207891|NCT02794480|100833118|FG001|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80||
48207892|NCT02794480|100833119|FG002|COMPLETED|Period 1: Treatment Period 1 (28 Days)||79||
48207893|NCT02794480|100833120|FG003|COMPLETED|Period 1: Treatment Period 1 (28 Days)||78||
48207894|NCT02794480|100833117|FG000|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||0||
48207895|NCT02794480|100833118|FG001|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2||
48207896|NCT02794480|100833119|FG002|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2||
48048352|NCT03036800|100438469|FG001|Week 32|Overall Study||113||
48048353|NCT03036800|100438468|FG000|Week 52|Overall Study||237||
48048354|NCT03036800|100438469|FG001|Week 52|Overall Study||110||
48048355|NCT03036800|100438468|FG000|Week 104|Overall Study||215||
48207897|NCT02794480|100833120|FG003|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||3||
48207898|NCT02794480|100833117|FG000|STARTED|Period 2: Treatment Period 2 (28 Days)||80||
48207899|NCT02794480|100833118|FG001|STARTED|Period 2: Treatment Period 2 (28 Days)||80||
48207900|NCT02794480|100833119|FG002|STARTED|Period 2: Treatment Period 2 (28 Days)||79||
48207901|NCT02794480|100833120|FG003|STARTED|Period 2: Treatment Period 2 (28 Days)||78||
48207902|NCT02794480|100833117|FG000|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79||
48207903|NCT02794480|100833118|FG001|COMPLETED|Period 2: Treatment Period 2 (28 Days)||80||
48207904|NCT02794480|100833119|FG002|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79||
48207905|NCT02794480|100833120|FG003|COMPLETED|Period 2: Treatment Period 2 (28 Days)||77||
48207906|NCT02794480|100833117|FG000|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1||
48207907|NCT02794480|100833118|FG001|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0||
48207908|NCT02794480|100833119|FG002|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0||
48207909|NCT02794480|100833120|FG003|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1||
48207910|NCT02477670|100833121|FG000|STARTED|Stage 1||47||
48207911|NCT02477670|100833122|FG001|STARTED|Stage 1||80||
48207912|NCT02477670|100833123|FG002|STARTED|Stage 1||0||
48207913|NCT02477670|100833124|FG003|STARTED|Stage 1||0||
48207914|NCT02477670|100833125|FG004|STARTED|Stage 1||0||
48207915|NCT02477670|100833126|FG005|STARTED|Stage 1||0||
48207916|NCT02477670|100833127|FG006|STARTED|Stage 1||0||
48207917|NCT02477670|100833121|FG000|COMPLETED|Stage 1||43||
48207918|NCT02477670|100833122|FG001|COMPLETED|Stage 1||67||
48207919|NCT02477670|100833123|FG002|COMPLETED|Stage 1||0||
48207920|NCT02477670|100833124|FG003|COMPLETED|Stage 1||0||
48207921|NCT02477670|100833125|FG004|COMPLETED|Stage 1||0||
48207922|NCT02477670|100833126|FG005|COMPLETED|Stage 1||0||
48495638|NCT00819169|101547892|FG005|NOT COMPLETED|Overall Study||16||
48207923|NCT02477670|100833127|FG006|COMPLETED|Stage 1||0||
48207924|NCT02477670|100833121|FG000|NOT COMPLETED|Stage 1||4||
48048356|NCT03036800|100438469|FG001|Week 104|Overall Study||104||
48048357|NCT03036800|100438468|FG000|COMPLETED|Overall Study||201||
48048358|NCT03036800|100438469|FG001|COMPLETED|Overall Study||93||
48048359|NCT03036800|100438468|FG000|NOT COMPLETED|Overall Study||59||
48048360|NCT03036800|100438469|FG001|NOT COMPLETED|Overall Study||39||
48048361|NCT02829944|100438470|FG000|STARTED|Overall Study||44||
48048362|NCT02829944|100438471|FG001|STARTED|Overall Study||40||
48207925|NCT02477670|100833122|FG001|NOT COMPLETED|Stage 1||13||
48207926|NCT02477670|100833123|FG002|NOT COMPLETED|Stage 1||0||
48207927|NCT02477670|100833124|FG003|NOT COMPLETED|Stage 1||0||
48207928|NCT02477670|100833125|FG004|NOT COMPLETED|Stage 1||0||
48207929|NCT02477670|100833126|FG005|NOT COMPLETED|Stage 1||0||
48207930|NCT02477670|100833127|FG006|NOT COMPLETED|Stage 1||0||
48207931|NCT02477670|100833121|FG000|STARTED|Stage 2||0||
48207932|NCT02477670|100833122|FG001|STARTED|Stage 2||0||
48207933|NCT02477670|100833123|FG002|STARTED|Stage 2||30||
48207934|NCT02477670|100833124|FG003|STARTED|Stage 2||33||
48207935|NCT02477670|100833125|FG004|STARTED|Stage 2||2||
48048363|NCT02829944|100438470|FG000|COMPLETED|Overall Study||38||
48048364|NCT02829944|100438471|FG001|COMPLETED|Overall Study||33||
48048365|NCT02829944|100438470|FG000|NOT COMPLETED|Overall Study||6||
48048366|NCT02829944|100438471|FG001|NOT COMPLETED|Overall Study||7||
48048367|NCT01376557|100438472|FG000|STARTED|Overall Study||59||
48048368|NCT01376557|100438473|FG001|STARTED|Overall Study||60||
48048369|NCT01376557|100438474|FG002|STARTED|Overall Study||60||
48048370|NCT01376557|100438475|FG003|STARTED|Overall Study||60||
48048371|NCT01376557|100438476|FG004|STARTED|Overall Study||60||
48048372|NCT01376557|100438472|FG000|COMPLETED|Overall Study||51||
48048373|NCT01376557|100438473|FG001|COMPLETED|Overall Study||54||
48207936|NCT02477670|100833126|FG005|STARTED|Stage 2||1||
48207937|NCT02477670|100833127|FG006|STARTED|Stage 2||42||
48207938|NCT02477670|100833121|FG000|COMPLETED|Stage 2||0||
48207939|NCT02477670|100833122|FG001|COMPLETED|Stage 2||0||
48207940|NCT02477670|100833123|FG002|COMPLETED|Stage 2||28||
48207941|NCT02477670|100833124|FG003|COMPLETED|Stage 2||32||
48207942|NCT02477670|100833125|FG004|COMPLETED|Stage 2||2||
48207943|NCT02477670|100833126|FG005|COMPLETED|Stage 2||1||
48207944|NCT02477670|100833127|FG006|COMPLETED|Stage 2||42||
48207945|NCT02477670|100833121|FG000|NOT COMPLETED|Stage 2||0||
48207946|NCT02477670|100833122|FG001|NOT COMPLETED|Stage 2||0||
48207947|NCT02477670|100833123|FG002|NOT COMPLETED|Stage 2||2||
48207948|NCT02477670|100833124|FG003|NOT COMPLETED|Stage 2||1||
48207949|NCT02477670|100833125|FG004|NOT COMPLETED|Stage 2||0||
48207950|NCT02477670|100833126|FG005|NOT COMPLETED|Stage 2||0||
48207951|NCT02477670|100833127|FG006|NOT COMPLETED|Stage 2||0||
48207952|NCT00065260|100833128|FG000|STARTED|Overall Study||27||
48207953|NCT00065260|100833129|FG001|STARTED|Overall Study||27||
48207954|NCT00065260|100833128|FG000|COMPLETED|Overall Study||27||
48207955|NCT00065260|100833129|FG001|COMPLETED|Overall Study||26||
48207956|NCT00065260|100833128|FG000|NOT COMPLETED|Overall Study||0||
48207957|NCT00065260|100833129|FG001|NOT COMPLETED|Overall Study||1||
48207958|NCT03233633|100833130|FG000|STARTED|Overall Study||66||
48207959|NCT03233633|100833130|FG000|COMPLETED|Overall Study||58||
48207960|NCT03233633|100833130|FG000|NOT COMPLETED|Overall Study||8||
48207961|NCT00463788|100833131|FG000|STARTED|Overall Study||115||
48207962|NCT00463788|100833132|FG001|STARTED|Overall Study||58||
48207963|NCT00463788|100833131|FG000|Treated|Overall Study||114||
48207964|NCT00463788|100833132|FG001|Treated|Overall Study||57||
48207965|NCT00463788|100833131|FG000|COMPLETED|Overall Study||6||
48207966|NCT00463788|100833132|FG001|COMPLETED|Overall Study||4||
48207967|NCT00463788|100833131|FG000|NOT COMPLETED|Overall Study||109||
48207968|NCT00463788|100833132|FG001|NOT COMPLETED|Overall Study||54||
48207969|NCT02937831|100833133|FG000|STARTED|Overall Study||6||
48207970|NCT02937831|100833133|FG000|COMPLETED|Overall Study||2||
48207971|NCT02937831|100833133|FG000|NOT COMPLETED|Overall Study||4||
48207972|NCT01926977|100833134|FG000|STARTED|Overall Study||47||
48207973|NCT01926977|100833135|FG001|STARTED|Overall Study||53||
48207974|NCT01926977|100833134|FG000|COMPLETED|Overall Study||47||
48207975|NCT01926977|100833135|FG001|COMPLETED|Overall Study||53||
48207976|NCT01926977|100833134|FG000|NOT COMPLETED|Overall Study||0||
48207977|NCT01926977|100833135|FG001|NOT COMPLETED|Overall Study||0||
48207978|NCT01400776|100833136|FG000|STARTED|Overall Study||238||
48207979|NCT01400776|100833137|FG001|STARTED|Overall Study||124||
48207980|NCT01400776|100833138|FG002|STARTED|Overall Study||237||
48207981|NCT01400776|100833139|FG003|STARTED|Overall Study||123||
48207982|NCT01400776|100833136|FG000|COMPLETED|Overall Study||217||
48207983|NCT01400776|100833137|FG001|COMPLETED|Overall Study||119||
48207984|NCT01400776|100833138|FG002|COMPLETED|Overall Study||209||
48207985|NCT01400776|100833139|FG003|COMPLETED|Overall Study||114||
48207986|NCT01400776|100833136|FG000|NOT COMPLETED|Overall Study||21||
48207987|NCT01400776|100833137|FG001|NOT COMPLETED|Overall Study||5||
48207988|NCT01400776|100833138|FG002|NOT COMPLETED|Overall Study||28||
48207989|NCT01400776|100833139|FG003|NOT COMPLETED|Overall Study||9||
48207990|NCT01568918|100833140|FG000|STARTED|Overall Study||39||
48207991|NCT01568918|100833141|FG001|STARTED|Overall Study||51||
48207992|NCT01568918|100833140|FG000|COMPLETED|Overall Study||39||
48207993|NCT01568918|100833141|FG001|COMPLETED|Overall Study||51||
48207994|NCT01568918|100833140|FG000|NOT COMPLETED|Overall Study||0||
48207995|NCT01568918|100833141|FG001|NOT COMPLETED|Overall Study||0||
48207996|NCT02550197|100833142|FG000|STARTED|Overall Study||200||
48207997|NCT02550197|100833143|FG001|STARTED|Overall Study||100||
48207998|NCT02550197|100833142|FG000|COMPLETED|Overall Study||200||
48207999|NCT02550197|100833143|FG001|COMPLETED|Overall Study||100||
48048374|NCT01376557|100438474|FG002|COMPLETED|Overall Study||55||
48048375|NCT01376557|100438475|FG003|COMPLETED|Overall Study||54||
48208000|NCT02550197|100833142|FG000|NOT COMPLETED|Overall Study||0||
48208001|NCT02550197|100833143|FG001|NOT COMPLETED|Overall Study||0||
48208002|NCT00101010|100833144|FG000|STARTED|Overall Study||80||
48208003|NCT00101010|100833144|FG000|COMPLETED|Overall Study||79||
48208004|NCT00101010|100833144|FG000|NOT COMPLETED|Overall Study||1||
48208005|NCT01568073|100833145|FG000|STARTED|Overall Study||121||
48208006|NCT01568073|100833146|FG001|STARTED|Overall Study||122||
48208007|NCT01568073|100833147|FG002|STARTED|Overall Study||122||
48208008|NCT01568073|100833148|FG003|STARTED|Overall Study||119||
48208009|NCT01568073|100833149|FG004|STARTED|Overall Study||116||
48208010|NCT01568073|100833145|FG000|COMPLETED|Overall Study||110||
48208011|NCT01568073|100833146|FG001|COMPLETED|Overall Study||107||
48208012|NCT01568073|100833147|FG002|COMPLETED|Overall Study||110||
48048376|NCT01376557|100438476|FG004|COMPLETED|Overall Study||53||
48048377|NCT01376557|100438472|FG000|NOT COMPLETED|Overall Study||8||
48048378|NCT01376557|100438473|FG001|NOT COMPLETED|Overall Study||6||
48048379|NCT01376557|100438474|FG002|NOT COMPLETED|Overall Study||5||
48048380|NCT01376557|100438475|FG003|NOT COMPLETED|Overall Study||6||
48208013|NCT01568073|100833148|FG003|COMPLETED|Overall Study||108||
48208014|NCT01568073|100833149|FG004|COMPLETED|Overall Study||107||
48208015|NCT01568073|100833145|FG000|NOT COMPLETED|Overall Study||11||
48208016|NCT01568073|100833146|FG001|NOT COMPLETED|Overall Study||15||
48208017|NCT01568073|100833147|FG002|NOT COMPLETED|Overall Study||12||
48208018|NCT01568073|100833148|FG003|NOT COMPLETED|Overall Study||11||
48208019|NCT01568073|100833149|FG004|NOT COMPLETED|Overall Study||9||
48208020|NCT05510245|100833150|FG000|STARTED|Overall Study||5||
48208021|NCT05510245|100833151|FG001|STARTED|Overall Study||5||
48208022|NCT05510245|100833152|FG002|STARTED|Overall Study||8||
48208023|NCT05510245|100833150|FG000|COMPLETED|Overall Study||4||
48208024|NCT05510245|100833151|FG001|COMPLETED|Overall Study||5||
48208025|NCT05510245|100833152|FG002|COMPLETED|Overall Study||8||
48208026|NCT05510245|100833150|FG000|NOT COMPLETED|Overall Study||1||
48208027|NCT05510245|100833151|FG001|NOT COMPLETED|Overall Study||0||
48208028|NCT05510245|100833152|FG002|NOT COMPLETED|Overall Study||0||
48208029|NCT00507689|100833153|FG000|STARTED|Pre-Randomization Period||40||
48208030|NCT00507689|100833154|FG001|STARTED|Pre-Randomization Period||0||
48208031|NCT00507689|100833153|FG000|COMPLETED|Pre-Randomization Period||37||
48208032|NCT00507689|100833154|FG001|COMPLETED|Pre-Randomization Period||0||
48048381|NCT01376557|100438476|FG004|NOT COMPLETED|Overall Study||7||
48048382|NCT03221764|100438477|FG000|STARTED|Overall Study||20||
48048383|NCT03221764|100438477|FG000|COMPLETED|Overall Study||20||
48048384|NCT03221764|100438477|FG000|NOT COMPLETED|Overall Study||0||
48048385|NCT03328182|100438478|FG000|STARTED|Overall Study||34||
48048386|NCT03328182|100438478|FG000|COMPLETED|Overall Study||30||
48048387|NCT03328182|100438478|FG000|NOT COMPLETED|Overall Study||4||
48048388|NCT02288377|100438479|FG000|STARTED|Overall Study||26||
48048389|NCT02288377|100438480|FG001|STARTED|Overall Study||27||
48048390|NCT02288377|100438479|FG000|COMPLETED|Overall Study||25||
48048391|NCT02288377|100438480|FG001|COMPLETED|Overall Study||27||
48048392|NCT02288377|100438479|FG000|NOT COMPLETED|Overall Study||1||
48048393|NCT02288377|100438480|FG001|NOT COMPLETED|Overall Study||0||
48048394|NCT01112683|100438481|FG000|STARTED|Overall Study||19||
48048395|NCT01112683|100438482|FG001|STARTED|Overall Study||20||
48048396|NCT01112683|100438481|FG000|COMPLETED|Overall Study||18||
48048397|NCT01112683|100438482|FG001|COMPLETED|Overall Study||19||
48048398|NCT01112683|100438481|FG000|NOT COMPLETED|Overall Study||1||
48048399|NCT01112683|100438482|FG001|NOT COMPLETED|Overall Study||1||
48048400|NCT01551420|100438483|FG000|STARTED|In-laboratory (Part A)||39||
48048401|NCT01551420|100438484|FG001|STARTED|In-laboratory (Part A)||13||
48048402|NCT01551420|100438483|FG000|COMPLETED|In-laboratory (Part A)||33||
48048403|NCT01551420|100438484|FG001|COMPLETED|In-laboratory (Part A)||11||
48048404|NCT01551420|100438483|FG000|NOT COMPLETED|In-laboratory (Part A)||6||
48048405|NCT01551420|100438484|FG001|NOT COMPLETED|In-laboratory (Part A)||2||
48048406|NCT01551420|100438483|FG000|STARTED|Screened for Part B Eligibility||33||
48048407|NCT01551420|100438484|FG001|STARTED|Screened for Part B Eligibility||11||
48048408|NCT01551420|100438483|FG000|COMPLETED|Screened for Part B Eligibility||24||
48048409|NCT01551420|100438484|FG001|COMPLETED|Screened for Part B Eligibility||8||
48048410|NCT01551420|100438483|FG000|NOT COMPLETED|Screened for Part B Eligibility||9||
48208033|NCT00507689|100833153|FG000|NOT COMPLETED|Pre-Randomization Period||3||
48208034|NCT00507689|100833154|FG001|NOT COMPLETED|Pre-Randomization Period||0||
48208035|NCT00507689|100833153|FG000|STARTED|Randomized Period||19||
48208036|NCT00507689|100833154|FG001|STARTED|Randomized Period||18||
48208037|NCT00507689|100833153|FG000|COMPLETED|Randomized Period||18||
48048411|NCT01551420|100438484|FG001|NOT COMPLETED|Screened for Part B Eligibility||3||
48048412|NCT01551420|100438483|FG000|STARTED|Home Use (Part B)||24||
48048413|NCT01551420|100438484|FG001|STARTED|Home Use (Part B)||8||
48048414|NCT01551420|100438483|FG000|COMPLETED|Home Use (Part B)||18||
48048415|NCT01551420|100438484|FG001|COMPLETED|Home Use (Part B)||7||
48048416|NCT01551420|100438483|FG000|NOT COMPLETED|Home Use (Part B)||6||
48048417|NCT01551420|100438484|FG001|NOT COMPLETED|Home Use (Part B)||1||
48208038|NCT00507689|100833154|FG001|COMPLETED|Randomized Period||16||
48208039|NCT00507689|100833153|FG000|NOT COMPLETED|Randomized Period||1||
48208040|NCT00507689|100833154|FG001|NOT COMPLETED|Randomized Period||2||
48208041|NCT00841035|100833155|FG000|STARTED|Phase 1 Overall Study||19||
48208042|NCT00841035|100833155|FG000|COMPLETED|Phase 1 Overall Study||6||
48208043|NCT00841035|100833155|FG000|NOT COMPLETED|Phase 1 Overall Study||13||
48208044|NCT00841035|100833155|FG000|STARTED|Phase 2 of Overall Study||6||
48208045|NCT00841035|100833155|FG000|COMPLETED|Phase 2 of Overall Study||6||
48208046|NCT00841035|100833155|FG000|NOT COMPLETED|Phase 2 of Overall Study||0||
48208047|NCT03130439|100833156|FG000|STARTED|Overall Study||27||
48208048|NCT03130439|100833156|FG000|COMPLETED|Overall Study||27||
48208049|NCT03130439|100833156|FG000|NOT COMPLETED|Overall Study||0||
48208050|NCT02341625|100833157|FG000|STARTED|Overall Study||2||
48208051|NCT02341625|100833158|FG001|STARTED|Overall Study||2||
48208052|NCT02341625|100833159|FG002|STARTED|Overall Study||3||
48208053|NCT02341625|100833160|FG003|STARTED|Overall Study||8||
48208054|NCT02341625|100833161|FG004|STARTED|Overall Study||8||
48208055|NCT02341625|100833162|FG005|STARTED|Overall Study||10||
48208056|NCT02341625|100833163|FG006|STARTED|Overall Study||51||
48208057|NCT02341625|100833164|FG007|STARTED|Overall Study||8||
48208058|NCT02341625|100833165|FG008|STARTED|Overall Study||4||
48208059|NCT02341625|100833166|FG009|STARTED|Overall Study||30||
48208060|NCT02341625|100833157|FG000|COMPLETED|Overall Study||0||
48208061|NCT02341625|100833158|FG001|COMPLETED|Overall Study||0||
48208062|NCT02341625|100833159|FG002|COMPLETED|Overall Study||0||
48208063|NCT02341625|100833160|FG003|COMPLETED|Overall Study||0||
48208064|NCT02341625|100833161|FG004|COMPLETED|Overall Study||0||
48208065|NCT02341625|100833162|FG005|COMPLETED|Overall Study||0||
48208066|NCT02341625|100833163|FG006|COMPLETED|Overall Study||0||
48208067|NCT02341625|100833164|FG007|COMPLETED|Overall Study||0||
48208068|NCT02341625|100833165|FG008|COMPLETED|Overall Study||0||
48208069|NCT02341625|100833166|FG009|COMPLETED|Overall Study||0||
48208070|NCT02341625|100833157|FG000|NOT COMPLETED|Overall Study||2||
48208071|NCT02341625|100833158|FG001|NOT COMPLETED|Overall Study||2||
48208072|NCT02341625|100833159|FG002|NOT COMPLETED|Overall Study||3||
48208073|NCT02341625|100833160|FG003|NOT COMPLETED|Overall Study||8||
48208074|NCT02341625|100833161|FG004|NOT COMPLETED|Overall Study||8||
48208075|NCT02341625|100833162|FG005|NOT COMPLETED|Overall Study||10||
48208076|NCT02341625|100833163|FG006|NOT COMPLETED|Overall Study||51||
48208077|NCT02341625|100833164|FG007|NOT COMPLETED|Overall Study||8||
48208078|NCT02341625|100833165|FG008|NOT COMPLETED|Overall Study||4||
48208079|NCT02341625|100833166|FG009|NOT COMPLETED|Overall Study||30||
48208080|NCT03145480|100833167|FG000|STARTED|Overall Study||3||
48208081|NCT03145480|100833168|FG001|STARTED|Overall Study||0||
48208082|NCT03145480|100833167|FG000|COMPLETED|Overall Study||0||
48208083|NCT03145480|100833168|FG001|COMPLETED|Overall Study||0||
48208084|NCT03145480|100833167|FG000|NOT COMPLETED|Overall Study||3||
48208085|NCT03145480|100833168|FG001|NOT COMPLETED|Overall Study||0||
48208086|NCT02115139|100833169|FG000|STARTED|Overall Study||58||
48208087|NCT02115139|100833169|FG000|COMPLETED|Overall Study||51||
48208088|NCT02115139|100833169|FG000|NOT COMPLETED|Overall Study||7||
48208089|NCT03127358|100833170|FG000|STARTED|Overall Study||3||
48208090|NCT03127358|100833171|FG001|STARTED|Overall Study||3||
48208091|NCT03127358|100833172|FG002|STARTED|Overall Study||5||
48208092|NCT03127358|100833170|FG000|COMPLETED|Overall Study||3||
48208093|NCT03127358|100833171|FG001|COMPLETED|Overall Study||3||
48208094|NCT03127358|100833172|FG002|COMPLETED|Overall Study||5||
48208095|NCT03127358|100833170|FG000|NOT COMPLETED|Overall Study||0||
48208096|NCT03127358|100833171|FG001|NOT COMPLETED|Overall Study||0||
48208097|NCT03127358|100833172|FG002|NOT COMPLETED|Overall Study||0||
48208098|NCT00568854|100833173|FG000|STARTED|Overall Study||6||
48208099|NCT00568854|100833174|FG001|STARTED|Overall Study||4||
48208100|NCT00568854|100833173|FG000|COMPLETED|Overall Study||6||
48208101|NCT00568854|100833174|FG001|COMPLETED|Overall Study||4||
48208102|NCT00568854|100833173|FG000|NOT COMPLETED|Overall Study||0||
48208103|NCT00568854|100833174|FG001|NOT COMPLETED|Overall Study||0||
48208104|NCT00908830|100833175|FG000|STARTED|Overall Study||5||
48208105|NCT00908830|100833176|FG001|STARTED|Overall Study||5||
48208106|NCT00908830|100833175|FG000|COMPLETED|Overall Study||5||
48208107|NCT00908830|100833176|FG001|COMPLETED|Overall Study||5||
48208108|NCT00908830|100833175|FG000|NOT COMPLETED|Overall Study||0||
48208109|NCT00908830|100833176|FG001|NOT COMPLETED|Overall Study||0||
48208110|NCT01819883|100833177|FG000|STARTED|Overall Study||20||
48208111|NCT01819883|100833178|FG001|STARTED|Overall Study||20||
48208112|NCT01819883|100833177|FG000|COMPLETED|Overall Study||16||
48208113|NCT01819883|100833178|FG001|COMPLETED|Overall Study||20||
48208114|NCT01819883|100833177|FG000|NOT COMPLETED|Overall Study||4||
48208115|NCT01819883|100833178|FG001|NOT COMPLETED|Overall Study||0||
48208116|NCT01184508|100833179|FG000|STARTED|Overall Study||45||
48208117|NCT01184508|100833180|FG001|STARTED|Overall Study||42||
48208118|NCT01184508|100833179|FG000|Received at Least 1 Dose of Study Drug|Overall Study||45||
48208119|NCT01184508|100833180|FG001|Received at Least 1 Dose of Study Drug|Overall Study||41||
48208120|NCT01184508|100833179|FG000|COMPLETED|Overall Study||29||
48208121|NCT01184508|100833180|FG001|COMPLETED|Overall Study||27||
48208122|NCT01184508|100833179|FG000|NOT COMPLETED|Overall Study||16||
48208123|NCT01184508|100833180|FG001|NOT COMPLETED|Overall Study||15||
48208124|NCT00980330|100833181|FG000|STARTED|Overall Study||66||
48208125|NCT00980330|100833182|FG001|STARTED|Overall Study||65||
48208126|NCT00980330|100833183|FG002|STARTED|Overall Study||66||
48208127|NCT00980330|100833184|FG003|STARTED|Overall Study||66||
48208128|NCT00980330|100833185|FG004|STARTED|Overall Study||68||
48208129|NCT00980330|100833186|FG005|STARTED|Overall Study||65||
48208130|NCT00980330|100833187|FG006|STARTED|Overall Study||66||
48208131|NCT00980330|100833181|FG000|COMPLETED|Overall Study||61||
48208132|NCT00980330|100833182|FG001|COMPLETED|Overall Study||60||
48208133|NCT00980330|100833183|FG002|COMPLETED|Overall Study||58||
48208134|NCT00980330|100833184|FG003|COMPLETED|Overall Study||61||
48208135|NCT00980330|100833185|FG004|COMPLETED|Overall Study||63||
48208136|NCT00980330|100833186|FG005|COMPLETED|Overall Study||61||
48208137|NCT00980330|100833187|FG006|COMPLETED|Overall Study||59||
48208138|NCT00980330|100833181|FG000|NOT COMPLETED|Overall Study||5||
48208139|NCT00980330|100833182|FG001|NOT COMPLETED|Overall Study||5||
48208140|NCT00980330|100833183|FG002|NOT COMPLETED|Overall Study||8||
48208141|NCT00980330|100833184|FG003|NOT COMPLETED|Overall Study||5||
48208142|NCT00980330|100833185|FG004|NOT COMPLETED|Overall Study||5||
48208143|NCT00980330|100833186|FG005|NOT COMPLETED|Overall Study||4||
48208144|NCT00980330|100833187|FG006|NOT COMPLETED|Overall Study||7||
48208145|NCT04504916|100833188|FG000|STARTED|Overall Study||70||
48208146|NCT04504916|100833189|FG001|STARTED|Overall Study||32||
48208147|NCT04504916|100833188|FG000|COMPLETED|Overall Study||0||
48208148|NCT04504916|100833189|FG001|COMPLETED|Overall Study||0||
48208149|NCT04504916|100833188|FG000|NOT COMPLETED|Overall Study||70||
48208150|NCT04504916|100833189|FG001|NOT COMPLETED|Overall Study||32||
48208151|NCT01161498|100833190|FG000|STARTED|Overall Study||3||
48208152|NCT01161498|100833191|FG001|STARTED|Overall Study||2||
48208153|NCT01161498|100833190|FG000|COMPLETED|Overall Study||3||
48208154|NCT01161498|100833191|FG001|COMPLETED|Overall Study||1||
48208155|NCT01161498|100833190|FG000|NOT COMPLETED|Overall Study||0||
48208156|NCT01161498|100833191|FG001|NOT COMPLETED|Overall Study||1||
48208157|NCT00831675|100833192|FG000|STARTED|Overall Study||12||
48208158|NCT00831675|100833193|FG001|STARTED|Overall Study||18||
48208159|NCT00831675|100833192|FG000|COMPLETED|Overall Study||12||
48208160|NCT00831675|100833193|FG001|COMPLETED|Overall Study||18||
48208161|NCT00831675|100833192|FG000|NOT COMPLETED|Overall Study||0||
48208162|NCT00831675|100833193|FG001|NOT COMPLETED|Overall Study||0||
48208163|NCT00703911|100833194|FG000|STARTED|Overall Study||102||
48208164|NCT00703911|100833194|FG000|COMPLETED|Overall Study||92||
48208165|NCT00703911|100833194|FG000|NOT COMPLETED|Overall Study||10||
48208166|NCT04199728|100833195|FG000|STARTED|Overall Study||12||
48208167|NCT04199728|100833196|FG001|STARTED|Overall Study||13||
48208168|NCT04199728|100833195|FG000|COMPLETED|Overall Study||1||
48208169|NCT04199728|100833196|FG001|COMPLETED|Overall Study||8||
48208170|NCT04199728|100833195|FG000|NOT COMPLETED|Overall Study||11||
48208171|NCT04199728|100833196|FG001|NOT COMPLETED|Overall Study||5||
48208172|NCT00704184|100837001|FG000|STARTED|Double-Blind Treatment||20||
48208173|NCT00704184|100837002|FG001|STARTED|Double-Blind Treatment||18||
48208174|NCT00704184|100837003|FG002|STARTED|Double-Blind Treatment||20||
48208175|NCT00704184|100837004|FG003|STARTED|Double-Blind Treatment||18||
48208176|NCT00704184|100837005|FG004|STARTED|Double-Blind Treatment||19||
48208177|NCT00704184|100837001|FG000|Treated|Double-Blind Treatment||19||
48208178|NCT00704184|100837002|FG001|Treated|Double-Blind Treatment||18||
48208179|NCT00704184|100837003|FG002|Treated|Double-Blind Treatment||20||
48208180|NCT00704184|100837004|FG003|Treated|Double-Blind Treatment||18||
48208181|NCT00704184|100837005|FG004|Treated|Double-Blind Treatment||19||
48208182|NCT00704184|100837001|FG000|COMPLETED|Double-Blind Treatment||19||
48208183|NCT00704184|100837002|FG001|COMPLETED|Double-Blind Treatment||18||
48208184|NCT00704184|100837003|FG002|COMPLETED|Double-Blind Treatment||20||
48208185|NCT00704184|100837004|FG003|COMPLETED|Double-Blind Treatment||18||
48208186|NCT00704184|100837005|FG004|COMPLETED|Double-Blind Treatment||19||
48208187|NCT00704184|100837001|FG000|NOT COMPLETED|Double-Blind Treatment||1||
48208188|NCT00704184|100837002|FG001|NOT COMPLETED|Double-Blind Treatment||0||
48208189|NCT00704184|100837003|FG002|NOT COMPLETED|Double-Blind Treatment||0||
48208190|NCT00704184|100837004|FG003|NOT COMPLETED|Double-Blind Treatment||0||
48208191|NCT00704184|100837005|FG004|NOT COMPLETED|Double-Blind Treatment||0||
48208192|NCT00704184|100837001|FG000|STARTED|Open-Label Treatment||19||
48208193|NCT00704184|100837002|FG001|STARTED|Open-Label Treatment||18||
48208194|NCT00704184|100837003|FG002|STARTED|Open-Label Treatment||20||
48208195|NCT00704184|100837004|FG003|STARTED|Open-Label Treatment||18||
48208196|NCT00704184|100837005|FG004|STARTED|Open-Label Treatment||19||
48208197|NCT00704184|100837001|FG000|COMPLETED|Open-Label Treatment||18||
48208198|NCT00704184|100837002|FG001|COMPLETED|Open-Label Treatment||16||
48208199|NCT00704184|100837003|FG002|COMPLETED|Open-Label Treatment||16||
48208200|NCT00704184|100837004|FG003|COMPLETED|Open-Label Treatment||13||
48208201|NCT00704184|100837005|FG004|COMPLETED|Open-Label Treatment||16||
48208202|NCT00704184|100837001|FG000|NOT COMPLETED|Open-Label Treatment||1||
48208203|NCT00704184|100837002|FG001|NOT COMPLETED|Open-Label Treatment||2||
48208204|NCT00704184|100837003|FG002|NOT COMPLETED|Open-Label Treatment||4||
48208205|NCT00704184|100837004|FG003|NOT COMPLETED|Open-Label Treatment||5||
48208206|NCT00704184|100837005|FG004|NOT COMPLETED|Open-Label Treatment||3||
48208207|NCT03712930|100837006|FG000|STARTED|Overall Study||13||
48208208|NCT03712930|100837006|FG000|COMPLETED|Overall Study||0||
48208209|NCT03712930|100837006|FG000|NOT COMPLETED|Overall Study||13||
48208210|NCT00457743|100837007|FG000|STARTED|Overall Study||3||
48208211|NCT00457743|100837008|FG001|STARTED|Overall Study||30||
48208212|NCT00457743|100837009|FG002|STARTED|Overall Study||3||
48208213|NCT00457743|100837007|FG000|Enrolled in Phase 1|Overall Study||3||
48208214|NCT00457743|100837008|FG001|Enrolled in Phase 1|Overall Study||6||
48208215|NCT00457743|100837009|FG002|Enrolled in Phase 1|Overall Study||3||
48208216|NCT00457743|100837007|FG000|Completed Phase 1|Overall Study||3||
48208217|NCT00457743|100837008|FG001|Completed Phase 1|Overall Study||6||
48208218|NCT00457743|100837009|FG002|Completed Phase 1|Overall Study||3||
48208219|NCT00457743|100837007|FG000|Enrolled in Phase 2|Overall Study||3||
48208220|NCT00457743|100837008|FG001|Enrolled in Phase 2|Overall Study||30||
48208221|NCT00457743|100837009|FG002|Enrolled in Phase 2|Overall Study||3||
48208222|NCT00457743|100837007|FG000|COMPLETED|Overall Study||0||
48208223|NCT00457743|100837008|FG001|COMPLETED|Overall Study||3||
48208224|NCT00457743|100837009|FG002|COMPLETED|Overall Study||0||
48208225|NCT00457743|100837007|FG000|NOT COMPLETED|Overall Study||3||
48208226|NCT00457743|100837008|FG001|NOT COMPLETED|Overall Study||27||
48208227|NCT00457743|100837009|FG002|NOT COMPLETED|Overall Study||3||
48208228|NCT01350804|100837010|FG000|STARTED|Core Study||138||
48208229|NCT01350804|100837011|FG001|STARTED|Core Study||137||
48208230|NCT01350804|100837012|FG002|STARTED|Core Study||138||
48208231|NCT01350804|100837013|FG003|STARTED|Core Study||138||
48208232|NCT01350804|100837010|FG000|Safety Set|Core Study||137||
48208233|NCT01350804|100837011|FG001|Safety Set|Core Study||136||
48208234|NCT01350804|100837012|FG002|Safety Set|Core Study||139||
48048418|NCT00245583|100438485|FG000|STARTED|Overall Study||20||
48048419|NCT00245583|100438486|FG001|STARTED|Overall Study||22||
48048420|NCT00245583|100438485|FG000|COMPLETED|Overall Study||14||
48048421|NCT00245583|100438486|FG001|COMPLETED|Overall Study||13||
48048422|NCT00245583|100438485|FG000|NOT COMPLETED|Overall Study||6||
48048423|NCT00245583|100438486|FG001|NOT COMPLETED|Overall Study||9||
48048424|NCT02220998|100438487|FG000|STARTED|Overall Study||135||
48048425|NCT02220998|100438488|FG001|STARTED|Overall Study||134||
48048426|NCT02220998|100438487|FG000|COMPLETED|Overall Study||128||
48048427|NCT02220998|100438488|FG001|COMPLETED|Overall Study||123||
48048428|NCT02220998|100438487|FG000|NOT COMPLETED|Overall Study||7||
48048429|NCT02220998|100438488|FG001|NOT COMPLETED|Overall Study||11||
48048430|NCT03682809|100438489|FG000|STARTED|Overall Study||22||
48048431|NCT03682809|100438490|FG001|STARTED|Overall Study||24||
48048432|NCT03682809|100438489|FG000|COMPLETED|Overall Study||22||
48048433|NCT03682809|100438490|FG001|COMPLETED|Overall Study||24||
48048434|NCT03682809|100438489|FG000|NOT COMPLETED|Overall Study||0||
48048435|NCT03682809|100438490|FG001|NOT COMPLETED|Overall Study||0||
48048436|NCT01142089|100438491|FG000|STARTED|Overall Study||65||
48048437|NCT01142089|100438492|FG001|STARTED|Overall Study||199||
48048438|NCT01142089|100438491|FG000|COMPLETED|Overall Study||53||
48048439|NCT01142089|100438492|FG001|COMPLETED|Overall Study||178||
48048440|NCT01142089|100438491|FG000|NOT COMPLETED|Overall Study||12||
48048441|NCT01142089|100438492|FG001|NOT COMPLETED|Overall Study||21||
48048442|NCT01778179|100438493|FG000|STARTED|Overall Study||25||
48048443|NCT01778179|100438494|FG001|STARTED|Overall Study||25||
48048444|NCT01778179|100438493|FG000|COMPLETED|Overall Study||23||
48048445|NCT01778179|100438494|FG001|COMPLETED|Overall Study||22||
48048446|NCT01778179|100438493|FG000|NOT COMPLETED|Overall Study||2||
48048447|NCT01778179|100438494|FG001|NOT COMPLETED|Overall Study||3||
48048448|NCT00812487|100438495|FG000|STARTED|Overall Study||32||
48048449|NCT00812487|100438496|FG001|STARTED|Overall Study||42||
48048450|NCT00812487|100438495|FG000|COMPLETED|Overall Study||26||
48048451|NCT00812487|100438496|FG001|COMPLETED|Overall Study||39||
48048452|NCT00812487|100438495|FG000|NOT COMPLETED|Overall Study||6||
48048453|NCT00812487|100438496|FG001|NOT COMPLETED|Overall Study||3||
48048454|NCT00056498|100438497|FG000|STARTED|Overall Study||30||
48048455|NCT00056498|100438498|FG001|STARTED|Overall Study||35||
48048456|NCT00056498|100438497|FG000|COMPLETED|Overall Study||25||
48208235|NCT01350804|100837013|FG003|Safety Set|Core Study||137||
48208236|NCT01350804|100837010|FG000|Tratment Switch to AIN457 at Week 16|Core Study||0||
48208237|NCT01350804|100837011|FG001|Tratment Switch to AIN457 at Week 16|Core Study||0||
48208238|NCT01350804|100837012|FG002|Tratment Switch to AIN457 at Week 16|Core Study||78||
48208239|NCT01350804|100837013|FG003|Tratment Switch to AIN457 at Week 16|Core Study||0||
48208240|NCT01350804|100837010|FG000|Treatment Switch to AIN457 at Week 24|Core Study||0||
48208241|NCT01350804|100837011|FG001|Treatment Switch to AIN457 at Week 24|Core Study||0||
48208242|NCT01350804|100837012|FG002|Treatment Switch to AIN457 at Week 24|Core Study||45||
48208243|NCT01350804|100837013|FG003|Treatment Switch to AIN457 at Week 24|Core Study||37||
48208244|NCT01350804|100837010|FG000|Full Analysis Set|Core Study||138||
48208245|NCT01350804|100837011|FG001|Full Analysis Set|Core Study||137||
48048457|NCT00056498|100438498|FG001|COMPLETED|Overall Study||28||
48048458|NCT00056498|100438497|FG000|NOT COMPLETED|Overall Study||5||
48048459|NCT00056498|100438498|FG001|NOT COMPLETED|Overall Study||7||
48048460|NCT00206076|100438499|FG000|STARTED|Overall Study||9||
48048461|NCT00206076|100438500|FG001|STARTED|Overall Study||10||
48048462|NCT00206076|100438499|FG000|COMPLETED|Overall Study||6||
48048463|NCT00206076|100438500|FG001|COMPLETED|Overall Study||9||
48048464|NCT00206076|100438499|FG000|NOT COMPLETED|Overall Study||3||
48048465|NCT00206076|100438500|FG001|NOT COMPLETED|Overall Study||1||
48048466|NCT00789074|100438501|FG000|STARTED|Overall Study||53||
48048467|NCT00789074|100438502|FG001|STARTED|Overall Study||48||
48048468|NCT00789074|100438501|FG000|COMPLETED|Overall Study||42||
48048469|NCT00789074|100438502|FG001|COMPLETED|Overall Study||35||
48048470|NCT00789074|100438501|FG000|NOT COMPLETED|Overall Study||11||
48048471|NCT00789074|100438502|FG001|NOT COMPLETED|Overall Study||13||
48048472|NCT03616171|100438503|FG000|STARTED|Overall Study||4||
48048473|NCT03616171|100438504|FG001|STARTED|Overall Study||2||
48048474|NCT03616171|100438503|FG000|COMPLETED|Overall Study||4||
48048475|NCT03616171|100438504|FG001|COMPLETED|Overall Study||2||
48048476|NCT03616171|100438503|FG000|NOT COMPLETED|Overall Study||0||
48048477|NCT03616171|100438504|FG001|NOT COMPLETED|Overall Study||0||
48048478|NCT03560739|100438505|FG000|STARTED|Overall Study||128||
48048479|NCT03560739|100438506|FG001|STARTED|Overall Study||130||
48048480|NCT03560739|100438507|FG002|STARTED|Overall Study||13||
48048481|NCT03560739|100438508|FG003|STARTED|Overall Study||13||
48048482|NCT03560739|100438505|FG000|COMPLETED|Overall Study||128||
48048483|NCT03560739|100438506|FG001|COMPLETED|Overall Study||129||
48048484|NCT03560739|100438507|FG002|COMPLETED|Overall Study||13||
48048485|NCT03560739|100438508|FG003|COMPLETED|Overall Study||13||
48048486|NCT03560739|100438505|FG000|NOT COMPLETED|Overall Study||0||
48048487|NCT03560739|100438506|FG001|NOT COMPLETED|Overall Study||1||
48048488|NCT03560739|100438507|FG002|NOT COMPLETED|Overall Study||0||
48048489|NCT03560739|100438508|FG003|NOT COMPLETED|Overall Study||0||
48048490|NCT02486627|100438509|FG000|STARTED|Overall Study||306||
48048491|NCT02486627|100438510|FG001|STARTED|Overall Study||303||
48048492|NCT02486627|100438509|FG000|COMPLETED|Overall Study||299||
48048493|NCT02486627|100438510|FG001|COMPLETED|Overall Study||294||
48048494|NCT02486627|100438509|FG000|NOT COMPLETED|Overall Study||7||
48048495|NCT02486627|100438510|FG001|NOT COMPLETED|Overall Study||9||
48048496|NCT02873585|100438511|FG000|STARTED|Overall Study||32||217
48048497|NCT02873585|100438511|FG000|COMPLETED|Overall Study||32||217
48048498|NCT02873585|100438511|FG000|NOT COMPLETED|Overall Study||0||0
48048499|NCT01974765|100438512|FG000|STARTED|Overall Study||59||
48048500|NCT01974765|100438512|FG000|COMPLETED|Overall Study||55||
48048501|NCT01974765|100438512|FG000|NOT COMPLETED|Overall Study||4||
48048502|NCT01609478|100438513|FG000|STARTED|Overall Study||111||
48048503|NCT01609478|100438514|FG001|STARTED|Overall Study||108||
48048504|NCT01609478|100438515|FG002|STARTED|Overall Study||116||
48048505|NCT01609478|100438513|FG000|Full Analysis Set (FAS)|Overall Study||110||
48048506|NCT01609478|100438514|FG001|Full Analysis Set (FAS)|Overall Study||108||
48048507|NCT01609478|100438515|FG002|Full Analysis Set (FAS)|Overall Study||115||
48048508|NCT01609478|100438513|FG000|COMPLETED|Overall Study||104||
48048509|NCT01609478|100438514|FG001|COMPLETED|Overall Study||106||
48208246|NCT01350804|100837012|FG002|Full Analysis Set|Core Study||138||
48208247|NCT01350804|100837013|FG003|Full Analysis Set|Core Study||138||
48495639|NCT00819169|101547893|FG006|NOT COMPLETED|Overall Study||16||
48048510|NCT01609478|100438515|FG002|COMPLETED|Overall Study||107||
48048511|NCT01609478|100438513|FG000|NOT COMPLETED|Overall Study||7||
48048512|NCT01609478|100438514|FG001|NOT COMPLETED|Overall Study||2||
48048513|NCT01609478|100438515|FG002|NOT COMPLETED|Overall Study||9||
48048514|NCT01629771|100438516|FG000|STARTED|Overall Study||36||
48048515|NCT01629771|100438517|FG001|STARTED|Overall Study||36||
48048516|NCT01629771|100438516|FG000|COMPLETED|Overall Study||36||
48048517|NCT01629771|100438517|FG001|COMPLETED|Overall Study||36||
48048518|NCT01629771|100438516|FG000|NOT COMPLETED|Overall Study||0||
48048519|NCT01629771|100438517|FG001|NOT COMPLETED|Overall Study||0||
48048520|NCT03490981|100438518|FG000|STARTED|Overall Study||15||
48048521|NCT03490981|100438519|FG001|STARTED|Overall Study||15||
48048522|NCT03490981|100438518|FG000|COMPLETED|Overall Study||14||
48048523|NCT03490981|100438519|FG001|COMPLETED|Overall Study||13||
48048524|NCT03490981|100438518|FG000|NOT COMPLETED|Overall Study||1||
48048525|NCT03490981|100438519|FG001|NOT COMPLETED|Overall Study||2||
48048526|NCT01074047|100438520|FG000|STARTED|Treatment Phase||241||
48048527|NCT01074047|100438521|FG001|STARTED|Treatment Phase||247||
48048528|NCT01074047|100438520|FG000|Treated Population|Treatment Phase||236||
48048529|NCT01074047|100438521|FG001|Treated Population|Treatment Phase||240||
48048530|NCT01074047|100438520|FG000|Safety Population|Treatment Phase||236||
48048531|NCT01074047|100438521|FG001|Safety Population|Treatment Phase||235||
48048532|NCT01074047|100438520|FG000|Evaluable Population|Treatment Phase||179||
48048533|NCT01074047|100438521|FG001|Evaluable Population|Treatment Phase||191||
48048534|NCT01074047|100438520|FG000|COMPLETED|Treatment Phase||24||
48048535|NCT01074047|100438521|FG001|COMPLETED|Treatment Phase||13||
48048536|NCT01074047|100438520|FG000|NOT COMPLETED|Treatment Phase||217||
48208248|NCT01350804|100837010|FG000|COMPLETED|Core Study||97||
48208249|NCT01350804|100837011|FG001|COMPLETED|Core Study||90||
48048537|NCT01074047|100438521|FG001|NOT COMPLETED|Treatment Phase||234||
48048538|NCT01074047|100438520|FG000|STARTED|Survival Follow-Up Phase||140||
48048539|NCT01074047|100438521|FG001|STARTED|Survival Follow-Up Phase||163||
48048540|NCT01074047|100438520|FG000|COMPLETED|Survival Follow-Up Phase||16||
48048541|NCT01074047|100438521|FG001|COMPLETED|Survival Follow-Up Phase||27||
48048542|NCT01074047|100438520|FG000|NOT COMPLETED|Survival Follow-Up Phase||124||
48048543|NCT01074047|100438521|FG001|NOT COMPLETED|Survival Follow-Up Phase||136||
48048544|NCT01074047|100438520|FG000|STARTED|Extension Phase||22||
48048545|NCT01074047|100438521|FG001|STARTED|Extension Phase||0||
48048546|NCT01074047|100438520|FG000|Safety Population|Extension Phase||22||
48048547|NCT01074047|100438521|FG001|Safety Population|Extension Phase||0||
48048548|NCT01074047|100438520|FG000|COMPLETED|Extension Phase||0||
48048549|NCT01074047|100438521|FG001|COMPLETED|Extension Phase||0||
48048550|NCT01074047|100438520|FG000|NOT COMPLETED|Extension Phase||22||
48048551|NCT01074047|100438521|FG001|NOT COMPLETED|Extension Phase||0||
48048552|NCT03112590|100438522|FG000|STARTED|Overall Study||3||
48048553|NCT03112590|100438523|FG001|STARTED|Overall Study||6||
48048554|NCT03112590|100438524|FG002|STARTED|Overall Study||42||
48048555|NCT03112590|100438522|FG000|COMPLETED|Overall Study||3||
48048556|NCT03112590|100438523|FG001|COMPLETED|Overall Study||5||
48048557|NCT03112590|100438524|FG002|COMPLETED|Overall Study||42||
48048558|NCT03112590|100438522|FG000|NOT COMPLETED|Overall Study||0||
48048559|NCT03112590|100438523|FG001|NOT COMPLETED|Overall Study||1||
48048560|NCT03112590|100438524|FG002|NOT COMPLETED|Overall Study||0||
48048561|NCT00290407|100438525|FG000|STARTED|Overall Study||2||
48048562|NCT00290407|100438525|FG000|COMPLETED|Overall Study||0||
48048563|NCT00290407|100438525|FG000|NOT COMPLETED|Overall Study||2||
48048564|NCT04175509|100438526|FG000|STARTED|Overall Study||19||
48048565|NCT04175509|100438527|FG001|STARTED|Overall Study||21||
48048566|NCT04175509|100438526|FG000|COMPLETED|Overall Study||17||
48048567|NCT04175509|100438527|FG001|COMPLETED|Overall Study||19||
48048568|NCT04175509|100438526|FG000|NOT COMPLETED|Overall Study||2||
48048569|NCT04175509|100438527|FG001|NOT COMPLETED|Overall Study||2||
48048570|NCT03584373|100438528|FG000|STARTED|Overall Study||51||
48048571|NCT03584373|100438529|FG001|STARTED|Overall Study||54||
48048572|NCT03584373|100438528|FG000|COMPLETED|Overall Study||44||
48048573|NCT03584373|100438529|FG001|COMPLETED|Overall Study||46||
48048574|NCT03584373|100438528|FG000|NOT COMPLETED|Overall Study||7||
48048575|NCT03584373|100438529|FG001|NOT COMPLETED|Overall Study||8||
48048576|NCT01007253|100438530|FG000|STARTED|First Intervention||6||
48048577|NCT01007253|100438531|FG001|STARTED|First Intervention||5||
48048578|NCT01007253|100438532|FG002|STARTED|First Intervention||5||
48048579|NCT01007253|100438533|FG003|STARTED|First Intervention||5||
48048580|NCT01007253|100438530|FG000|COMPLETED|First Intervention||6||
48048581|NCT01007253|100438531|FG001|COMPLETED|First Intervention||5||
48048582|NCT01007253|100438532|FG002|COMPLETED|First Intervention||5||
48048583|NCT01007253|100438533|FG003|COMPLETED|First Intervention||5||
48048584|NCT01007253|100438530|FG000|NOT COMPLETED|First Intervention||0||
48048585|NCT01007253|100438531|FG001|NOT COMPLETED|First Intervention||0||
48048586|NCT01007253|100438532|FG002|NOT COMPLETED|First Intervention||0||
48048587|NCT01007253|100438533|FG003|NOT COMPLETED|First Intervention||0||
48048588|NCT01007253|100438530|FG000|STARTED|Washout Period (2 Weeks) # 1||6||
48048589|NCT01007253|100438531|FG001|STARTED|Washout Period (2 Weeks) # 1||5||
48048590|NCT01007253|100438532|FG002|STARTED|Washout Period (2 Weeks) # 1||5||
48048591|NCT01007253|100438533|FG003|STARTED|Washout Period (2 Weeks) # 1||5||
48048592|NCT01007253|100438530|FG000|COMPLETED|Washout Period (2 Weeks) # 1||6||
48048593|NCT01007253|100438531|FG001|COMPLETED|Washout Period (2 Weeks) # 1||5||
48048594|NCT01007253|100438532|FG002|COMPLETED|Washout Period (2 Weeks) # 1||5||
48048595|NCT01007253|100438533|FG003|COMPLETED|Washout Period (2 Weeks) # 1||5||
48048596|NCT01007253|100438530|FG000|NOT COMPLETED|Washout Period (2 Weeks) # 1||0||
48048597|NCT01007253|100438531|FG001|NOT COMPLETED|Washout Period (2 Weeks) # 1||0||
48048598|NCT01007253|100438532|FG002|NOT COMPLETED|Washout Period (2 Weeks) # 1||0||
48048599|NCT01007253|100438533|FG003|NOT COMPLETED|Washout Period (2 Weeks) # 1||0||
48048600|NCT01007253|100438530|FG000|STARTED|Second Intervention||6||
48048601|NCT01007253|100438531|FG001|STARTED|Second Intervention||5||
48048602|NCT01007253|100438532|FG002|STARTED|Second Intervention||5||
48048603|NCT01007253|100438533|FG003|STARTED|Second Intervention||5||
48048604|NCT01007253|100438530|FG000|COMPLETED|Second Intervention||6||
48048605|NCT01007253|100438531|FG001|COMPLETED|Second Intervention||5||
48048606|NCT01007253|100438532|FG002|COMPLETED|Second Intervention||5||
48048607|NCT01007253|100438533|FG003|COMPLETED|Second Intervention||5||
48048608|NCT01007253|100438530|FG000|NOT COMPLETED|Second Intervention||0||
48048609|NCT01007253|100438531|FG001|NOT COMPLETED|Second Intervention||0||
48048610|NCT01007253|100438532|FG002|NOT COMPLETED|Second Intervention||0||
48048611|NCT01007253|100438533|FG003|NOT COMPLETED|Second Intervention||0||
48048612|NCT01007253|100438530|FG000|STARTED|Washout Period (2 Weeks) # 2||6||
48048613|NCT01007253|100438531|FG001|STARTED|Washout Period (2 Weeks) # 2||5||
48048614|NCT01007253|100438532|FG002|STARTED|Washout Period (2 Weeks) # 2||5||
48048615|NCT01007253|100438533|FG003|STARTED|Washout Period (2 Weeks) # 2||5||
48048616|NCT01007253|100438530|FG000|COMPLETED|Washout Period (2 Weeks) # 2||6||
48048617|NCT01007253|100438531|FG001|COMPLETED|Washout Period (2 Weeks) # 2||5||
48048618|NCT01007253|100438532|FG002|COMPLETED|Washout Period (2 Weeks) # 2||5||
48048619|NCT01007253|100438533|FG003|COMPLETED|Washout Period (2 Weeks) # 2||5||
48048620|NCT01007253|100438530|FG000|NOT COMPLETED|Washout Period (2 Weeks) # 2||0||
48048621|NCT01007253|100438531|FG001|NOT COMPLETED|Washout Period (2 Weeks) # 2||0||
48048622|NCT01007253|100438532|FG002|NOT COMPLETED|Washout Period (2 Weeks) # 2||0||
48048623|NCT01007253|100438533|FG003|NOT COMPLETED|Washout Period (2 Weeks) # 2||0||
48048624|NCT01007253|100438530|FG000|STARTED|Third Intervention||6||
48048625|NCT01007253|100438531|FG001|STARTED|Third Intervention||5||
48048626|NCT01007253|100438532|FG002|STARTED|Third Intervention||5||
48048627|NCT01007253|100438533|FG003|STARTED|Third Intervention||5||
48048628|NCT01007253|100438530|FG000|COMPLETED|Third Intervention||6||
48048629|NCT01007253|100438531|FG001|COMPLETED|Third Intervention||5||
48048630|NCT01007253|100438532|FG002|COMPLETED|Third Intervention||5||
48048631|NCT01007253|100438533|FG003|COMPLETED|Third Intervention||5||
48048632|NCT01007253|100438530|FG000|NOT COMPLETED|Third Intervention||0||
48048633|NCT01007253|100438531|FG001|NOT COMPLETED|Third Intervention||0||
48048634|NCT01007253|100438532|FG002|NOT COMPLETED|Third Intervention||0||
48048635|NCT01007253|100438533|FG003|NOT COMPLETED|Third Intervention||0||
48048636|NCT01007253|100438530|FG000|STARTED|Washout Period (2 Weeks) # 3||6||
48048637|NCT01007253|100438531|FG001|STARTED|Washout Period (2 Weeks) # 3||5||
48048638|NCT01007253|100438532|FG002|STARTED|Washout Period (2 Weeks) # 3||5||
48048639|NCT01007253|100438533|FG003|STARTED|Washout Period (2 Weeks) # 3||5||
48048640|NCT01007253|100438530|FG000|COMPLETED|Washout Period (2 Weeks) # 3||5||
48048641|NCT01007253|100438531|FG001|COMPLETED|Washout Period (2 Weeks) # 3||5||
48048642|NCT01007253|100438532|FG002|COMPLETED|Washout Period (2 Weeks) # 3||5||
48048643|NCT01007253|100438533|FG003|COMPLETED|Washout Period (2 Weeks) # 3||5||
48048644|NCT01007253|100438530|FG000|NOT COMPLETED|Washout Period (2 Weeks) # 3||1||
48048645|NCT01007253|100438531|FG001|NOT COMPLETED|Washout Period (2 Weeks) # 3||0||
48048646|NCT01007253|100438532|FG002|NOT COMPLETED|Washout Period (2 Weeks) # 3||0||
48048647|NCT01007253|100438533|FG003|NOT COMPLETED|Washout Period (2 Weeks) # 3||0||
48048648|NCT01007253|100438530|FG000|STARTED|Fourth Intervention||5||
48048649|NCT01007253|100438531|FG001|STARTED|Fourth Intervention||5||
48048650|NCT01007253|100438532|FG002|STARTED|Fourth Intervention||5||
48048651|NCT01007253|100438533|FG003|STARTED|Fourth Intervention||5||
48048652|NCT01007253|100438530|FG000|COMPLETED|Fourth Intervention||5||
48048653|NCT01007253|100438531|FG001|COMPLETED|Fourth Intervention||5||
48048654|NCT01007253|100438532|FG002|COMPLETED|Fourth Intervention||5||
48048655|NCT01007253|100438533|FG003|COMPLETED|Fourth Intervention||5||
48048656|NCT01007253|100438530|FG000|NOT COMPLETED|Fourth Intervention||0||
48048657|NCT01007253|100438531|FG001|NOT COMPLETED|Fourth Intervention||0||
48048658|NCT01007253|100438532|FG002|NOT COMPLETED|Fourth Intervention||0||
48048659|NCT01007253|100438533|FG003|NOT COMPLETED|Fourth Intervention||0||
48048660|NCT03935399|100438534|FG000|STARTED|First Study Day||5||
48048661|NCT03935399|100438535|FG001|STARTED|First Study Day||5||
48048662|NCT03935399|100438534|FG000|COMPLETED|First Study Day||5||
48048663|NCT03935399|100438535|FG001|COMPLETED|First Study Day||5||
48048664|NCT03935399|100438534|FG000|NOT COMPLETED|First Study Day||0||
48048665|NCT03935399|100438535|FG001|NOT COMPLETED|First Study Day||0||
48048666|NCT03935399|100438534|FG000|STARTED|Second Study Day||5||
48048667|NCT03935399|100438535|FG001|STARTED|Second Study Day||5||
48048668|NCT03935399|100438534|FG000|COMPLETED|Second Study Day||5||
48048669|NCT03935399|100438535|FG001|COMPLETED|Second Study Day||5||
48048670|NCT03935399|100438534|FG000|NOT COMPLETED|Second Study Day||0||
48048671|NCT03935399|100438535|FG001|NOT COMPLETED|Second Study Day||0||
48048672|NCT02632838|100438536|FG000|STARTED|Overall Study||15||
48048673|NCT02632838|100438537|FG001|STARTED|Overall Study||15||
48048674|NCT02632838|100438536|FG000|COMPLETED|Overall Study||12||
48048675|NCT02632838|100438537|FG001|COMPLETED|Overall Study||13||
48048676|NCT02632838|100438536|FG000|NOT COMPLETED|Overall Study||3||
48048677|NCT02632838|100438537|FG001|NOT COMPLETED|Overall Study||2||
48048678|NCT00495079|100438538|FG000|STARTED|Overall Study||65||
48048679|NCT00495079|100438538|FG000|COMPLETED|Overall Study||65||
48048680|NCT00495079|100438538|FG000|NOT COMPLETED|Overall Study||0||
48048681|NCT04859114|100438539|FG000|STARTED|Overall Study||176||
48048682|NCT04859114|100438540|FG001|STARTED|Overall Study||177||
48208250|NCT01350804|100837012|FG002|COMPLETED|Core Study||91||
48208251|NCT01350804|100837013|FG003|COMPLETED|Core Study||112||
48208252|NCT01350804|100837010|FG000|NOT COMPLETED|Core Study||41||
48208253|NCT01350804|100837011|FG001|NOT COMPLETED|Core Study||47||
48048683|NCT04859114|100438541|FG002|STARTED|Overall Study||179||
48048684|NCT04859114|100438542|FG003|STARTED|Overall Study||177||
48048685|NCT04859114|100438543|FG004|STARTED|Overall Study||176||
48048686|NCT04859114|100438544|FG005|STARTED|Overall Study||167||
48048687|NCT04859114|100438539|FG000|COMPLETED|Overall Study||176||
48048688|NCT04859114|100438540|FG001|COMPLETED|Overall Study||177||
48048689|NCT04859114|100438541|FG002|COMPLETED|Overall Study||179||
48048690|NCT04859114|100438542|FG003|COMPLETED|Overall Study||177||
48048691|NCT04859114|100438543|FG004|COMPLETED|Overall Study||176||
48048692|NCT04859114|100438544|FG005|COMPLETED|Overall Study||167||
48048693|NCT04859114|100438539|FG000|NOT COMPLETED|Overall Study||0||
48208254|NCT01350804|100837012|FG002|NOT COMPLETED|Core Study||47||
48208255|NCT01350804|100837013|FG003|NOT COMPLETED|Core Study||26||
48048694|NCT04859114|100438540|FG001|NOT COMPLETED|Overall Study||0||
48048695|NCT04859114|100438541|FG002|NOT COMPLETED|Overall Study||0||
48048696|NCT04859114|100438542|FG003|NOT COMPLETED|Overall Study||0||
48048697|NCT04859114|100438543|FG004|NOT COMPLETED|Overall Study||0||
48048698|NCT04859114|100438544|FG005|NOT COMPLETED|Overall Study||0||
48048699|NCT00993044|100438545|FG000|STARTED|Irinotecan 30 mg||6||
48048700|NCT00993044|100438545|FG000|COMPLETED|Irinotecan 30 mg||6||
48048701|NCT00993044|100438545|FG000|NOT COMPLETED|Irinotecan 30 mg||0||
48048702|NCT00993044|100438545|FG000|STARTED|Irinotecan 50 mg||7||
48048703|NCT00993044|100438545|FG000|COMPLETED|Irinotecan 50 mg||6||
48048704|NCT00993044|100438545|FG000|NOT COMPLETED|Irinotecan 50 mg||1||
48048705|NCT04449029|100438546|FG000|STARTED|Overall Study||68||
48048706|NCT04449029|100438547|FG001|STARTED|Overall Study||68||
48048707|NCT04449029|100438548|FG002|STARTED|Overall Study||68||
48048708|NCT04449029|100438549|FG003|STARTED|Overall Study||23||
48048709|NCT04449029|100438550|FG004|STARTED|Overall Study||70||
48048710|NCT04449029|100438551|FG005|STARTED|Overall Study||68||
48048711|NCT04449029|100438552|FG006|STARTED|Overall Study||68||
48048712|NCT04449029|100438553|FG007|STARTED|Overall Study||24||
48048713|NCT04449029|100438546|FG000|COMPLETED|Overall Study||65||
48048714|NCT04449029|100438547|FG001|COMPLETED|Overall Study||65||
48048715|NCT04449029|100438548|FG002|COMPLETED|Overall Study||66||
48048716|NCT04449029|100438549|FG003|COMPLETED|Overall Study||22||
48048717|NCT04449029|100438550|FG004|COMPLETED|Overall Study||64||
48048718|NCT04449029|100438551|FG005|COMPLETED|Overall Study||66||
48048719|NCT04449029|100438552|FG006|COMPLETED|Overall Study||63||
48048720|NCT04449029|100438553|FG007|COMPLETED|Overall Study||24||
48048721|NCT04449029|100438546|FG000|NOT COMPLETED|Overall Study||3||
48048722|NCT04449029|100438547|FG001|NOT COMPLETED|Overall Study||3||
48048723|NCT04449029|100438548|FG002|NOT COMPLETED|Overall Study||2||
48048724|NCT04449029|100438549|FG003|NOT COMPLETED|Overall Study||1||
48048725|NCT04449029|100438550|FG004|NOT COMPLETED|Overall Study||6||
48048726|NCT04449029|100438551|FG005|NOT COMPLETED|Overall Study||2||
48048727|NCT04449029|100438552|FG006|NOT COMPLETED|Overall Study||5||
48048728|NCT04449029|100438553|FG007|NOT COMPLETED|Overall Study||0||
48048729|NCT00924781|100438554|FG000|STARTED|Overall Study||20||
48048730|NCT00924781|100438555|FG001|STARTED|Overall Study||19||
48048731|NCT00924781|100438554|FG000|COMPLETED|Overall Study||8||
48048732|NCT00924781|100438555|FG001|COMPLETED|Overall Study||9||
48048733|NCT00924781|100438554|FG000|NOT COMPLETED|Overall Study||12||
48048734|NCT00924781|100438555|FG001|NOT COMPLETED|Overall Study||10||
48048735|NCT00868517|100438556|FG000|STARTED|Overall Study||12||
48048736|NCT00868517|100438557|FG001|STARTED|Overall Study||12||
48048737|NCT00868517|100438558|FG002|STARTED|Overall Study||11||
48048738|NCT00868517|100438556|FG000|COMPLETED|Overall Study||8||
48048739|NCT00868517|100438557|FG001|COMPLETED|Overall Study||8||
48048740|NCT00868517|100438558|FG002|COMPLETED|Overall Study||9||
48048741|NCT00868517|100438556|FG000|NOT COMPLETED|Overall Study||4||
48048742|NCT00868517|100438557|FG001|NOT COMPLETED|Overall Study||4||
48048743|NCT00868517|100438558|FG002|NOT COMPLETED|Overall Study||2||
48048744|NCT02282345|100438559|FG000|STARTED|Overall Study||13||
48048745|NCT02282345|100438560|FG001|STARTED|Overall Study||20||
48048746|NCT02282345|100438559|FG000|COMPLETED|Overall Study||13||
48048747|NCT02282345|100438560|FG001|COMPLETED|Overall Study||19||
48048748|NCT02282345|100438559|FG000|NOT COMPLETED|Overall Study||0||
48048749|NCT02282345|100438560|FG001|NOT COMPLETED|Overall Study||1||
48048750|NCT02478398|100438561|FG000|STARTED|Overall Study||513||
48048751|NCT02478398|100438562|FG001|STARTED|Overall Study||512||
48048752|NCT02478398|100438561|FG000|Treated|Overall Study||512||
48048753|NCT02478398|100438562|FG001|Treated|Overall Study||510||
48048754|NCT02478398|100438561|FG000|COMPLETED|Overall Study||461||
48048755|NCT02478398|100438562|FG001|COMPLETED|Overall Study||491||
48048756|NCT02478398|100438561|FG000|NOT COMPLETED|Overall Study||52||
48048757|NCT02478398|100438562|FG001|NOT COMPLETED|Overall Study||21||
48048758|NCT02195687|100438563|FG000|STARTED|Overall Study||316||
48048759|NCT02195687|100438564|FG001|STARTED|Overall Study||101||
48048760|NCT02195687|100438563|FG000|COMPLETED|Overall Study||311||
48048761|NCT02195687|100438564|FG001|COMPLETED|Overall Study||99||
48208256|NCT01350804|100837010|FG000|STARTED|Extension Study, Weeks 52 - 260||80||
48208257|NCT01350804|100837011|FG001|STARTED|Extension Study, Weeks 52 - 260||79||
48048762|NCT02195687|100438563|FG000|NOT COMPLETED|Overall Study||5||
48048763|NCT02195687|100438564|FG001|NOT COMPLETED|Overall Study||2||
48048764|NCT01095094|100438565|FG000|STARTED|Overall Study||19||
48048765|NCT01095094|100438565|FG000|COMPLETED|Overall Study||16||
48048766|NCT01095094|100438565|FG000|NOT COMPLETED|Overall Study||3||
48048767|NCT00768469|100441537|FG000|STARTED|Overall Study||3||
48048768|NCT00768469|100441538|FG001|STARTED|Overall Study||7||
48048769|NCT00768469|100441537|FG000|COMPLETED|Overall Study||0||
48048770|NCT00768469|100441538|FG001|COMPLETED|Overall Study||0||
48208258|NCT01350804|100837012|FG002|STARTED|Extension Study, Weeks 52 - 260||72||
48048771|NCT00768469|100441537|FG000|NOT COMPLETED|Overall Study||3||
48048772|NCT00768469|100441538|FG001|NOT COMPLETED|Overall Study||7||
48048773|NCT02718300|100441539|FG000|STARTED|Overall Study||21|Due to early termination of the study, per the Statistical Analysis Plan, participants were combined into arms based on the dosage received regardless of what phase of the study they participated in.|
48048774|NCT02718300|100441540|FG001|STARTED|Overall Study||21|Due to early termination of the study, per the Statistical Analysis Plan, participants were combined into arms based on the dosage received regardless of what phase of the study they participated in.|
48048775|NCT02718300|100441541|FG002|STARTED|Overall Study||32|Due to early termination of the study, per the Statistical Analysis Plan, participants were combined into arms based on the dosage received regardless of what phase of the study they participated in.|
48048776|NCT02718300|100441539|FG000|COMPLETED|Overall Study||0||
48048777|NCT02718300|100441540|FG001|COMPLETED|Overall Study||0||
48048778|NCT02718300|100441541|FG002|COMPLETED|Overall Study||0||
48048779|NCT02718300|100441539|FG000|NOT COMPLETED|Overall Study||21||
48048780|NCT02718300|100441540|FG001|NOT COMPLETED|Overall Study||21||
48048781|NCT02718300|100441541|FG002|NOT COMPLETED|Overall Study||32||
48048782|NCT00769483|100441542|FG000|STARTED|Overall Study||9||
48048783|NCT00769483|100441543|FG001|STARTED|Overall Study||13||
48048784|NCT00769483|100441544|FG002|STARTED|Overall Study||15||
48048785|NCT00769483|100441545|FG003|STARTED|Overall Study||15||
48048786|NCT00769483|100441546|FG004|STARTED|Overall Study||16||
48048787|NCT00769483|100441547|FG005|STARTED|Overall Study||9||
48048788|NCT00769483|100441542|FG000|COMPLETED|Overall Study||9||
48048789|NCT00769483|100441543|FG001|COMPLETED|Overall Study||12||
48048790|NCT00769483|100441544|FG002|COMPLETED|Overall Study||15||
48048791|NCT00769483|100441545|FG003|COMPLETED|Overall Study||15||
48048792|NCT00769483|100441546|FG004|COMPLETED|Overall Study||15||
48048793|NCT00769483|100441547|FG005|COMPLETED|Overall Study||9||
48048794|NCT00769483|100441542|FG000|NOT COMPLETED|Overall Study||0||
48048795|NCT00769483|100441543|FG001|NOT COMPLETED|Overall Study||1||
48048796|NCT00769483|100441544|FG002|NOT COMPLETED|Overall Study||0||
48048797|NCT00769483|100441545|FG003|NOT COMPLETED|Overall Study||0||
48048798|NCT00769483|100441546|FG004|NOT COMPLETED|Overall Study||1||
48048799|NCT00769483|100441547|FG005|NOT COMPLETED|Overall Study||0||
48048800|NCT03603509|100441548|FG000|STARTED|Overall Study||120||
48048801|NCT03603509|100441549|FG001|STARTED|Overall Study||121||
48048802|NCT03603509|100441548|FG000|COMPLETED|Overall Study||117||
48048803|NCT03603509|100441549|FG001|COMPLETED|Overall Study||117||
48048804|NCT03603509|100441548|FG000|NOT COMPLETED|Overall Study||3||
48048805|NCT03603509|100441549|FG001|NOT COMPLETED|Overall Study||4||
48048806|NCT01499862|100441550|FG000|STARTED|Overall Study||3||
48048807|NCT01499862|100441550|FG000|COMPLETED|Overall Study||3||
48048808|NCT01499862|100441550|FG000|NOT COMPLETED|Overall Study||0||
48048809|NCT02153476|100441551|FG000|STARTED|Overall Study||23||
48048810|NCT02153476|100441552|FG001|STARTED|Overall Study||22||
48048811|NCT02153476|100441551|FG000|COMPLETED|Overall Study||22||
48048812|NCT02153476|100441552|FG001|COMPLETED|Overall Study||22||
48048813|NCT02153476|100441551|FG000|NOT COMPLETED|Overall Study||1||
48048814|NCT02153476|100441552|FG001|NOT COMPLETED|Overall Study||0||
48048815|NCT02162576|100441553|FG000|STARTED|Overall Study||95||
48048816|NCT02162576|100441553|FG000|COMPLETED|Overall Study||95||
48048817|NCT02162576|100441553|FG000|NOT COMPLETED|Overall Study||0||
48048818|NCT04010539|100441554|FG000|STARTED|Overall Study||314|Intent-to-Treat (ITT) Population: All participants randomly assigned to study treatment.|
48048819|NCT04010539|100441555|FG001|STARTED|Overall Study||314|Intent-to-Treat (ITT) Population: All participants randomly assigned to study treatment.|
48048820|NCT04010539|100441554|FG000|Safety Population|Overall Study||309|All participants who received at least 1 dose of study treatment.|
48048821|NCT04010539|100441555|FG001|Safety Population|Overall Study||313|All participants who received at least 1 dose of study treatment.|
48048822|NCT04010539|100441554|FG000|Microbiological ITT (Micro-ITT) Population|Overall Study||202|All participants randomly assigned to study treatment who received at least 1 dose of study treatment and have confirmed NG isolated that is ceftriaxone-susceptible (based on Clinical \& Laboratory Standards Institute (CLSI) breakpoints) from baseline culture of their urogenital specimen.|
48048823|NCT04010539|100441555|FG001|Microbiological ITT (Micro-ITT) Population|Overall Study||204|All participants randomly assigned to study treatment who received at least 1 dose of study treatment and have confirmed NG isolated that is ceftriaxone-susceptible (based on Clinical \& Laboratory Standards Institute (CLSI) breakpoints) from baseline culture of their urogenital specimen.|
48048824|NCT04010539|100441554|FG000|Micro-ITT Rectal Population|Overall Study||26|All participants who met the definition of the Micro-ITT Population and have confirmed NG isolated that is ceftriaxone-susceptible (based on CLSI breakpoints) from baseline culture of their rectal specimen.|
48048825|NCT04010539|100441555|FG001|Micro-ITT Rectal Population|Overall Study||15|All participants who met the definition of the Micro-ITT Population and have confirmed NG isolated that is ceftriaxone-susceptible (based on CLSI breakpoints) from baseline culture of their rectal specimen.|
48048826|NCT04010539|100441554|FG000|Micro-ITT Pharyngeal Population|Overall Study||18|All participants who met the definition of the Micro-ITT Population and have confirmed NG isolated that is ceftriaxone-susceptible (based on CLSI breakpoints) from baseline culture of their pharyngeal specimen.|
48048827|NCT04010539|100441555|FG001|Micro-ITT Pharyngeal Population|Overall Study||17|All participants who met the definition of the Micro-ITT Population and have confirmed NG isolated that is ceftriaxone-susceptible (based on CLSI breakpoints) from baseline culture of their pharyngeal specimen.|
48048828|NCT04010539|100441554|FG000|COMPLETED|Overall Study||294||
48048829|NCT04010539|100441555|FG001|COMPLETED|Overall Study||295||
48495640|NCT00819169|101547894|FG007|NOT COMPLETED|Overall Study||9||
48495641|NCT00819169|101547895|FG008|NOT COMPLETED|Overall Study||13||
48495642|NCT00948792|101547896|FG000|STARTED|Overall Study||21||
48495643|NCT00948792|101547896|FG000|COMPLETED|Overall Study||21||
48495644|NCT00948792|101547896|FG000|NOT COMPLETED|Overall Study||0||
48048830|NCT04010539|100441554|FG000|NOT COMPLETED|Overall Study||20||
48048831|NCT04010539|100441555|FG001|NOT COMPLETED|Overall Study||19||
48048832|NCT00137839|100441556|FG000|STARTED|Overall Study||84||
48048833|NCT00137839|100441556|FG000|Treated|Overall Study||83||
48048834|NCT00137839|100441556|FG000|COMPLETED|Overall Study||0||
48048835|NCT00137839|100441556|FG000|NOT COMPLETED|Overall Study||84||
48048836|NCT01423604|100441557|FG000|STARTED|Safety Run-In||9||
48048837|NCT01423604|100441558|FG001|STARTED|Safety Run-In||0||
48048838|NCT01423604|100441557|FG000|COMPLETED|Safety Run-In||0||
48048839|NCT01423604|100441558|FG001|COMPLETED|Safety Run-In||0||
48048840|NCT01423604|100441557|FG000|NOT COMPLETED|Safety Run-In||9||
48048841|NCT01423604|100441558|FG001|NOT COMPLETED|Safety Run-In||0||
48048842|NCT01423604|100441557|FG000|STARTED|Randomized||64||
48048843|NCT01423604|100441558|FG001|STARTED|Randomized||63||
48048844|NCT01423604|100441557|FG000|COMPLETED|Randomized||1||
48048845|NCT01423604|100441558|FG001|COMPLETED|Randomized||0||
48048846|NCT01423604|100441557|FG000|NOT COMPLETED|Randomized||63||
48048847|NCT01423604|100441558|FG001|NOT COMPLETED|Randomized||63||
48048848|NCT01634178|100441559|FG000|STARTED|Treatment Period 1||23||
48048849|NCT01634178|100441560|FG001|STARTED|Treatment Period 1||23||
48048850|NCT01634178|100441559|FG000|COMPLETED|Treatment Period 1||23||
48048851|NCT01634178|100441560|FG001|COMPLETED|Treatment Period 1||22||
48048852|NCT01634178|100441559|FG000|NOT COMPLETED|Treatment Period 1||0||
48048853|NCT01634178|100441560|FG001|NOT COMPLETED|Treatment Period 1||1||
48048854|NCT01634178|100441559|FG000|STARTED|Treatment Period 2||23||
48048855|NCT01634178|100441560|FG001|STARTED|Treatment Period 2||22||
48048856|NCT01634178|100441559|FG000|COMPLETED|Treatment Period 2||22||
48048857|NCT01634178|100441560|FG001|COMPLETED|Treatment Period 2||22||
48048858|NCT01634178|100441559|FG000|NOT COMPLETED|Treatment Period 2||1||
48048859|NCT01634178|100441560|FG001|NOT COMPLETED|Treatment Period 2||0||
48048860|NCT01099709|100441561|FG000|STARTED|Period 1||42||
48048861|NCT01099709|100441562|FG001|STARTED|Period 1||43||
48048862|NCT01099709|100441561|FG000|COMPLETED|Period 1||41||
48048863|NCT01099709|100441562|FG001|COMPLETED|Period 1||41||
48048864|NCT01099709|100441561|FG000|NOT COMPLETED|Period 1||1||
48048865|NCT01099709|100441562|FG001|NOT COMPLETED|Period 1||2||
48048866|NCT01099709|100441561|FG000|STARTED|Period 2||41||
48048867|NCT01099709|100441562|FG001|STARTED|Period 2||41||
48048868|NCT01099709|100441561|FG000|COMPLETED|Period 2||41||
48048869|NCT01099709|100441562|FG001|COMPLETED|Period 2||41||
48048870|NCT01099709|100441561|FG000|NOT COMPLETED|Period 2||0||
48048871|NCT01099709|100441562|FG001|NOT COMPLETED|Period 2||0||
48048872|NCT00542451|100441563|FG000|STARTED|Overall Study||406||
48048873|NCT00542451|100441563|FG000|COMPLETED|Overall Study||327||
48048874|NCT00542451|100441563|FG000|NOT COMPLETED|Overall Study||79||
48048875|NCT00945854|100441564|FG000|STARTED|Overall Study||30||
48048876|NCT00945854|100441565|FG001|STARTED|Overall Study||30||
48048877|NCT00945854|100441564|FG000|COMPLETED|Overall Study||28||
48048878|NCT00945854|100441565|FG001|COMPLETED|Overall Study||26||
48048879|NCT00945854|100441564|FG000|NOT COMPLETED|Overall Study||2||
48048880|NCT00945854|100441565|FG001|NOT COMPLETED|Overall Study||4||
48048881|NCT01362595|100441566|FG000|STARTED|Overall Study||55||
48048882|NCT01362595|100441566|FG000|COMPLETED|Overall Study||43||
48048883|NCT01362595|100441566|FG000|NOT COMPLETED|Overall Study||12||
48048884|NCT02750215|100441567|FG000|STARTED|Overall Study||20||
48048885|NCT02750215|100441567|FG000|COMPLETED|Overall Study||20||
48048886|NCT02750215|100441567|FG000|NOT COMPLETED|Overall Study||0||
48208259|NCT01350804|100837013|FG003|STARTED|Extension Study, Weeks 52 - 260||23||
48208260|NCT01350804|100837010|FG000|COMPLETED|Extension Study, Weeks 52 - 260||0||
48048887|NCT03361176|100441568|FG000|STARTED|Overall Study||10||
48048888|NCT03361176|100441569|FG001|STARTED|Overall Study||20||
48048889|NCT03361176|100441568|FG000|COMPLETED|Overall Study||9||
48048890|NCT03361176|100441569|FG001|COMPLETED|Overall Study||15||
48048891|NCT03361176|100441568|FG000|NOT COMPLETED|Overall Study||1||
48048892|NCT03361176|100441569|FG001|NOT COMPLETED|Overall Study||5||
48048893|NCT04369924|100441570|FG000|STARTED|Overall Study||637||
48048894|NCT04369924|100441571|FG001|STARTED|Overall Study||624||
48048895|NCT04369924|100441570|FG000|Completed at Least One Measurement-based Care Measure|Overall Study||411||
48048896|NCT04369924|100441571|FG001|Completed at Least One Measurement-based Care Measure|Overall Study||370||
48048897|NCT04369924|100441570|FG000|Consented to Complete Additional Research Measures|Overall Study||67||
48048898|NCT04369924|100441571|FG001|Consented to Complete Additional Research Measures|Overall Study||54||
48048899|NCT04369924|100441570|FG000|COMPLETED|Overall Study||335|This was defined as completing at least two measurement-based care measures.|
48048900|NCT04369924|100441571|FG001|COMPLETED|Overall Study||285|This was defined as completing at least two measurement-based care measures.|
48208261|NCT01350804|100837011|FG001|COMPLETED|Extension Study, Weeks 52 - 260||0||
48208262|NCT01350804|100837012|FG002|COMPLETED|Extension Study, Weeks 52 - 260||0||
48208263|NCT01350804|100837013|FG003|COMPLETED|Extension Study, Weeks 52 - 260||0||
48208264|NCT01350804|100837010|FG000|NOT COMPLETED|Extension Study, Weeks 52 - 260||80||
48208265|NCT01350804|100837011|FG001|NOT COMPLETED|Extension Study, Weeks 52 - 260||79||
48048901|NCT04369924|100441570|FG000|NOT COMPLETED|Overall Study||302||
48048902|NCT04369924|100441571|FG001|NOT COMPLETED|Overall Study||339||
48048903|NCT00755911|100441572|FG000|STARTED|Overall Study||12||
48048904|NCT00755911|100441573|FG001|STARTED|Overall Study||12||
48048905|NCT00755911|100441572|FG000|COMPLETED|Overall Study||12||
48048906|NCT00755911|100441573|FG001|COMPLETED|Overall Study||12||
48048907|NCT00755911|100441572|FG000|NOT COMPLETED|Overall Study||0||
48048908|NCT00755911|100441573|FG001|NOT COMPLETED|Overall Study||0||
48048909|NCT03956355|100441574|FG000|STARTED|Overall Study||340||
48048910|NCT03956355|100441575|FG001|STARTED|Overall Study||170||
48048911|NCT03956355|100441574|FG000|COMPLETED|Overall Study||269||
48048912|NCT03956355|100441575|FG001|COMPLETED|Overall Study||130||
48048913|NCT03956355|100441574|FG000|NOT COMPLETED|Overall Study||71||
48048914|NCT03956355|100441575|FG001|NOT COMPLETED|Overall Study||40||
48048915|NCT02925793|100441576|FG000|STARTED|Overall Study||106||
48048916|NCT02925793|100441577|FG001|STARTED|Overall Study||110||
48048917|NCT02925793|100441578|FG002|STARTED|Overall Study||111||
48048918|NCT02925793|100441576|FG000|COMPLETED|Overall Study||81||
48048919|NCT02925793|100441577|FG001|COMPLETED|Overall Study||81||
48048920|NCT02925793|100441578|FG002|COMPLETED|Overall Study||83||
48048921|NCT02925793|100441576|FG000|NOT COMPLETED|Overall Study||25||
48048922|NCT02925793|100441577|FG001|NOT COMPLETED|Overall Study||29||
48048923|NCT02925793|100441578|FG002|NOT COMPLETED|Overall Study||28||
48048924|NCT01486810|100441579|FG000|STARTED|Overall Study||17||
48048925|NCT01486810|100441579|FG000|COMPLETED|Overall Study||9||
48048926|NCT01486810|100441579|FG000|NOT COMPLETED|Overall Study||8||
48048927|NCT02628769|100441580|FG000|STARTED|First Intervention||3||
48048928|NCT02628769|100441581|FG001|STARTED|First Intervention||3||
48048929|NCT02628769|100441580|FG000|COMPLETED|First Intervention||2||
48048930|NCT02628769|100441581|FG001|COMPLETED|First Intervention||2||
48048931|NCT02628769|100441580|FG000|NOT COMPLETED|First Intervention||1||
48048932|NCT02628769|100441581|FG001|NOT COMPLETED|First Intervention||1||
48048933|NCT02628769|100441580|FG000|STARTED|Wash Out (28 Days)||2||
48048934|NCT02628769|100441581|FG001|STARTED|Wash Out (28 Days)||2||
48048935|NCT02628769|100441580|FG000|COMPLETED|Wash Out (28 Days)||2||
48048936|NCT02628769|100441581|FG001|COMPLETED|Wash Out (28 Days)||2||
48048937|NCT02628769|100441580|FG000|NOT COMPLETED|Wash Out (28 Days)||0||
48048938|NCT02628769|100441581|FG001|NOT COMPLETED|Wash Out (28 Days)||0||
48048939|NCT02628769|100441580|FG000|STARTED|Second Intervention||2||
48048940|NCT02628769|100441581|FG001|STARTED|Second Intervention||2||
48048941|NCT02628769|100441580|FG000|COMPLETED|Second Intervention||0||
48048942|NCT02628769|100441581|FG001|COMPLETED|Second Intervention||1||
48048943|NCT02628769|100441580|FG000|NOT COMPLETED|Second Intervention||2||
48048944|NCT02628769|100441581|FG001|NOT COMPLETED|Second Intervention||1||
48048945|NCT00874614|100441582|FG000|STARTED|Overall Study||74||
48048946|NCT00874614|100441582|FG000|Received at Least One Therapeutic Dose|Overall Study||68||
48048947|NCT00874614|100441582|FG000|Received Two Therapeutic Doses|Overall Study||50||
48048948|NCT00874614|100441582|FG000|COMPLETED|Overall Study||16|Completed or continuing in long-term follow-up phase|
48048949|NCT00874614|100441582|FG000|NOT COMPLETED|Overall Study||58||
48048950|NCT00136604|100441583|FG000|STARTED|Overall Study||249||
48048951|NCT00136604|100441584|FG001|STARTED|Overall Study||123||
48048952|NCT00136604|100441585|FG002|STARTED|Overall Study||79||
48048953|NCT00136604|100441586|FG003|STARTED|Overall Study||41||
48048954|NCT00136604|100441587|FG004|STARTED|Overall Study||125||
48048955|NCT00136604|100441583|FG000|COMPLETED|Overall Study||248||
48048956|NCT00136604|100441584|FG001|COMPLETED|Overall Study||122||
48048957|NCT00136604|100441585|FG002|COMPLETED|Overall Study||79||
48048958|NCT00136604|100441586|FG003|COMPLETED|Overall Study||41||
48048959|NCT00136604|100441587|FG004|COMPLETED|Overall Study||124||
48048960|NCT00136604|100441583|FG000|NOT COMPLETED|Overall Study||1||
48048961|NCT00136604|100441584|FG001|NOT COMPLETED|Overall Study||1||
48048962|NCT00136604|100441585|FG002|NOT COMPLETED|Overall Study||0||
48048963|NCT00136604|100441586|FG003|NOT COMPLETED|Overall Study||0||
48048964|NCT00136604|100441587|FG004|NOT COMPLETED|Overall Study||1||
48048965|NCT03042702|100441588|FG000|STARTED|Overall Study||2||
48208266|NCT01350804|100837012|FG002|NOT COMPLETED|Extension Study, Weeks 52 - 260||72||
48048966|NCT03042702|100441588|FG000|COMPLETED|Overall Study||2||
48048967|NCT03042702|100441588|FG000|NOT COMPLETED|Overall Study||0||
48048968|NCT02155946|100441589|FG000|STARTED|Overall Study||29||
48048969|NCT02155946|100441590|FG001|STARTED|Overall Study||25||
48048970|NCT02155946|100441591|FG002|STARTED|Overall Study||29||
48048971|NCT02155946|100441592|FG003|STARTED|Overall Study||24||
48048972|NCT02155946|100441589|FG000|COMPLETED|Overall Study||29||
48048973|NCT02155946|100441590|FG001|COMPLETED|Overall Study||23||
48048974|NCT02155946|100441591|FG002|COMPLETED|Overall Study||29||
48048975|NCT02155946|100441592|FG003|COMPLETED|Overall Study||24||
48048976|NCT02155946|100441589|FG000|NOT COMPLETED|Overall Study||0||
48048977|NCT02155946|100441590|FG001|NOT COMPLETED|Overall Study||2||
48048978|NCT02155946|100441591|FG002|NOT COMPLETED|Overall Study||0||
48048979|NCT02155946|100441592|FG003|NOT COMPLETED|Overall Study||0||
48048980|NCT00327470|100441593|FG000|STARTED|Overall Study||107||
48048981|NCT00327470|100441594|FG001|STARTED|Overall Study||181||
48048982|NCT00327470|100441593|FG000|Treated|Overall Study||107||
48048983|NCT00327470|100441594|FG001|Treated|Overall Study||179||
48048984|NCT00327470|100441593|FG000|COMPLETED|Overall Study||78||
48048985|NCT00327470|100441594|FG001|COMPLETED|Overall Study||118||
48048986|NCT00327470|100441593|FG000|NOT COMPLETED|Overall Study||29||
48048987|NCT00327470|100441594|FG001|NOT COMPLETED|Overall Study||63||
48048988|NCT01895361|100441595|FG000|STARTED|Overall Study||67||
48048989|NCT01895361|100441596|FG001|STARTED|Overall Study||66||
48048990|NCT01895361|100441597|FG002|STARTED|Overall Study||65||
48048991|NCT01895361|100441595|FG000|COMPLETED|Overall Study||43||
48048992|NCT01895361|100441596|FG001|COMPLETED|Overall Study||45||
48048993|NCT01895361|100441597|FG002|COMPLETED|Overall Study||41||
48048994|NCT01895361|100441595|FG000|NOT COMPLETED|Overall Study||24||
48048995|NCT01895361|100441596|FG001|NOT COMPLETED|Overall Study||21||
48048996|NCT01895361|100441597|FG002|NOT COMPLETED|Overall Study||24||
48048997|NCT00887744|100441598|FG000|STARTED|Overall Study||162||
48048998|NCT00887744|100441598|FG000|COMPLETED|Overall Study||128||
48048999|NCT00887744|100441598|FG000|NOT COMPLETED|Overall Study||34||
48049000|NCT01275339|100441599|FG000|STARTED|Overall Study||2||
48049001|NCT01275339|100441600|FG001|STARTED|Overall Study||0||
48049002|NCT01275339|100441601|FG002|STARTED|Overall Study||4||
48049003|NCT01275339|100441602|FG003|STARTED|Overall Study||4||
48049004|NCT01275339|100441599|FG000|COMPLETED|Overall Study||1||
48049005|NCT01275339|100441600|FG001|COMPLETED|Overall Study||0||
48049006|NCT01275339|100441601|FG002|COMPLETED|Overall Study||3||
48049007|NCT01275339|100441602|FG003|COMPLETED|Overall Study||4||
48049008|NCT01275339|100441599|FG000|NOT COMPLETED|Overall Study||1||
48049009|NCT01275339|100441600|FG001|NOT COMPLETED|Overall Study||0||
48049010|NCT01275339|100441601|FG002|NOT COMPLETED|Overall Study||1||
48049011|NCT01275339|100441602|FG003|NOT COMPLETED|Overall Study||0||
48049012|NCT02314143|100441603|FG000|STARTED|Overall Study||16||
48049013|NCT02314143|100441604|FG001|STARTED|Overall Study||16||
48049014|NCT02314143|100441605|FG002|STARTED|Overall Study||16||
48049015|NCT02314143|100441603|FG000|COMPLETED|Overall Study||8||
48049016|NCT02314143|100441604|FG001|COMPLETED|Overall Study||6||
48049017|NCT02314143|100441605|FG002|COMPLETED|Overall Study||7||
48049018|NCT02314143|100441603|FG000|NOT COMPLETED|Overall Study||8||
48049019|NCT02314143|100441604|FG001|NOT COMPLETED|Overall Study||10||
48049020|NCT02314143|100441605|FG002|NOT COMPLETED|Overall Study||9||
48049021|NCT00321893|100441606|FG000|STARTED|Overall Study||101||
48049022|NCT00321893|100441607|FG001|STARTED|Overall Study||101||
48049023|NCT00321893|100441606|FG000|COMPLETED|Overall Study||77||
48049024|NCT00321893|100441607|FG001|COMPLETED|Overall Study||87||
48049025|NCT00321893|100441606|FG000|NOT COMPLETED|Overall Study||24||
48049026|NCT00321893|100441607|FG001|NOT COMPLETED|Overall Study||14||
48049027|NCT05498701|100441608|FG000|STARTED|Period 1||11||
48049028|NCT05498701|100441609|FG001|STARTED|Period 1||11||
48049029|NCT05498701|100441608|FG000|COMPLETED|Period 1||11||
48049030|NCT05498701|100441609|FG001|COMPLETED|Period 1||11||
48049031|NCT05498701|100441608|FG000|NOT COMPLETED|Period 1||0||
48049032|NCT05498701|100441609|FG001|NOT COMPLETED|Period 1||0||
48049033|NCT05498701|100441608|FG000|STARTED|Period 2||11||
48049034|NCT05498701|100441609|FG001|STARTED|Period 2||11||
48049035|NCT05498701|100441608|FG000|COMPLETED|Period 2||11||
48049036|NCT05498701|100441609|FG001|COMPLETED|Period 2||11||
48049037|NCT05498701|100441608|FG000|NOT COMPLETED|Period 2||0||
48049038|NCT05498701|100441609|FG001|NOT COMPLETED|Period 2||0||
48049039|NCT05498701|100441608|FG000|STARTED|Period 3||11||
48049040|NCT05498701|100441609|FG001|STARTED|Period 3||11||
48049041|NCT05498701|100441608|FG000|COMPLETED|Period 3||10||
48049042|NCT05498701|100441609|FG001|COMPLETED|Period 3||11||
48049043|NCT05498701|100441608|FG000|NOT COMPLETED|Period 3||1||
48049044|NCT05498701|100441609|FG001|NOT COMPLETED|Period 3||0||
48049045|NCT00829283|100441610|FG000|STARTED|Overall Study||39||
48049046|NCT00829283|100441611|FG001|STARTED|Overall Study||152||
48049047|NCT00829283|100441610|FG000|COMPLETED|Overall Study||32||
48049048|NCT00829283|100441611|FG001|COMPLETED|Overall Study||127||
48049049|NCT00829283|100441610|FG000|NOT COMPLETED|Overall Study||7||
48049050|NCT00829283|100441611|FG001|NOT COMPLETED|Overall Study||25||
48049051|NCT00998764|100441612|FG000|STARTED|Overall Study||216||
48049052|NCT00998764|100441613|FG001|STARTED|Overall Study||276||
48049053|NCT00998764|100441612|FG000|Treated|Overall Study||215||
48049054|NCT00998764|100441613|FG001|Treated|Overall Study||275||
48049055|NCT00998764|100441612|FG000|COMPLETED|Overall Study||0||
48049056|NCT00998764|100441613|FG001|COMPLETED|Overall Study||2||
48049057|NCT00998764|100441612|FG000|NOT COMPLETED|Overall Study||216||
48049058|NCT00998764|100441613|FG001|NOT COMPLETED|Overall Study||274||
48049059|NCT03269552|100441614|FG000|STARTED|Overall Study||4||
48049060|NCT03269552|100441614|FG000|COMPLETED|Overall Study||2||
48049061|NCT03269552|100441614|FG000|NOT COMPLETED|Overall Study||2||
48049062|NCT01736657|100441615|FG000|STARTED|Overall Study||73||
48049063|NCT01736657|100441615|FG000|COMPLETED|Overall Study||72||
48049064|NCT01736657|100441615|FG000|NOT COMPLETED|Overall Study||1||
48049065|NCT01966692|100441616|FG000|STARTED|Period 1||6||
48049066|NCT01966692|100441617|FG001|STARTED|Period 1||6||
48049067|NCT01966692|100441618|FG002|STARTED|Period 1||6||
48049068|NCT01966692|100441619|FG003|STARTED|Period 1||6||
48049069|NCT01966692|100441616|FG000|COMPLETED|Period 1||6||
48049070|NCT01966692|100441617|FG001|COMPLETED|Period 1||6||
48049071|NCT01966692|100441618|FG002|COMPLETED|Period 1||6||
48049072|NCT01966692|100441619|FG003|COMPLETED|Period 1||6||
48049073|NCT01966692|100441616|FG000|NOT COMPLETED|Period 1||0||
48049074|NCT01966692|100441617|FG001|NOT COMPLETED|Period 1||0||
48049075|NCT01966692|100441618|FG002|NOT COMPLETED|Period 1||0||
48049076|NCT01966692|100441619|FG003|NOT COMPLETED|Period 1||0||
48049077|NCT01966692|100441616|FG000|STARTED|Period 2||6||
48049078|NCT01966692|100441617|FG001|STARTED|Period 2||6||
48049079|NCT01966692|100441618|FG002|STARTED|Period 2||6||
48049080|NCT01966692|100441619|FG003|STARTED|Period 2||6||
48049081|NCT01966692|100441616|FG000|COMPLETED|Period 2||6||
48049082|NCT01966692|100441617|FG001|COMPLETED|Period 2||6||
48049083|NCT01966692|100441618|FG002|COMPLETED|Period 2||6||
48049084|NCT01966692|100441619|FG003|COMPLETED|Period 2||6||
48049085|NCT01966692|100441616|FG000|NOT COMPLETED|Period 2||0||
48049086|NCT01966692|100441617|FG001|NOT COMPLETED|Period 2||0||
48049087|NCT01966692|100441618|FG002|NOT COMPLETED|Period 2||0||
48049088|NCT01966692|100441619|FG003|NOT COMPLETED|Period 2||0||
48049089|NCT01966692|100441616|FG000|STARTED|Period 3||6||
48049090|NCT01966692|100441617|FG001|STARTED|Period 3||6||
48049091|NCT01966692|100441618|FG002|STARTED|Period 3||6||
48049092|NCT01966692|100441619|FG003|STARTED|Period 3||6||
48049093|NCT01966692|100441616|FG000|COMPLETED|Period 3||6||
48049094|NCT01966692|100441617|FG001|COMPLETED|Period 3||6||
48049095|NCT01966692|100441618|FG002|COMPLETED|Period 3||6||
48049096|NCT01966692|100441619|FG003|COMPLETED|Period 3||6||
48049097|NCT01966692|100441616|FG000|NOT COMPLETED|Period 3||0||
48049098|NCT01966692|100441617|FG001|NOT COMPLETED|Period 3||0||
48049099|NCT01966692|100441618|FG002|NOT COMPLETED|Period 3||0||
48049100|NCT01966692|100441619|FG003|NOT COMPLETED|Period 3||0||
48049101|NCT01966692|100441616|FG000|STARTED|Period 4||6||
48049102|NCT01966692|100441617|FG001|STARTED|Period 4||6||
48049103|NCT01966692|100441618|FG002|STARTED|Period 4||6||
48049104|NCT01966692|100441619|FG003|STARTED|Period 4||6||
48049105|NCT01966692|100441616|FG000|COMPLETED|Period 4||6||
48049106|NCT01966692|100441617|FG001|COMPLETED|Period 4||6||
48049107|NCT01966692|100441618|FG002|COMPLETED|Period 4||6||
48049108|NCT01966692|100441619|FG003|COMPLETED|Period 4||6||
48049109|NCT01966692|100441616|FG000|NOT COMPLETED|Period 4||0||
48049110|NCT01966692|100441617|FG001|NOT COMPLETED|Period 4||0||
48049111|NCT01966692|100441618|FG002|NOT COMPLETED|Period 4||0||
48049112|NCT01966692|100441619|FG003|NOT COMPLETED|Period 4||0||
48049113|NCT03729362|100441620|FG000|STARTED|Overall Study||85||
48049114|NCT03729362|100441621|FG001|STARTED|Overall Study||40||
48049115|NCT03729362|100441620|FG000|Received at Least 1 Dose of Study Drug|Overall Study||85||
48049116|NCT03729362|100441621|FG001|Received at Least 1 Dose of Study Drug|Overall Study||38||
48049117|NCT03729362|100441620|FG000|COMPLETED|Overall Study||80||
48049118|NCT03729362|100441621|FG001|COMPLETED|Overall Study||37||
48049119|NCT03729362|100441620|FG000|NOT COMPLETED|Overall Study||5||
48049120|NCT03729362|100441621|FG001|NOT COMPLETED|Overall Study||3||
48049121|NCT03355664|100441622|FG000|STARTED|Overall Study||154||
48049122|NCT03355664|100441623|FG001|STARTED|Overall Study||156||
48049123|NCT03355664|100441622|FG000|COMPLETED|Overall Study||139||
48049124|NCT03355664|100441623|FG001|COMPLETED|Overall Study||144||
48049125|NCT03355664|100441622|FG000|NOT COMPLETED|Overall Study||15||
48049126|NCT03355664|100441623|FG001|NOT COMPLETED|Overall Study||12||
48049127|NCT00249288|100441624|FG000|STARTED|Overall Study||19||
48049128|NCT00249288|100441625|FG001|STARTED|Overall Study||19||
48049129|NCT00249288|100441624|FG000|Initiated Treatment|Overall Study||17||
48049130|NCT00249288|100441625|FG001|Initiated Treatment|Overall Study||15||
48049131|NCT00249288|100441624|FG000|COMPLETED|Overall Study||14||
48049132|NCT00249288|100441625|FG001|COMPLETED|Overall Study||14||
48049133|NCT00249288|100441624|FG000|NOT COMPLETED|Overall Study||5||
48049134|NCT00249288|100441625|FG001|NOT COMPLETED|Overall Study||5||
48049135|NCT03442400|100441626|FG000|STARTED|Overall Study||5||
48049136|NCT03442400|100441626|FG000|COMPLETED|Overall Study||5||
48049137|NCT03442400|100441626|FG000|NOT COMPLETED|Overall Study||0||
48049138|NCT01987401|100441627|FG000|STARTED|Overall Study||591||
48049139|NCT01987401|100441628|FG001|STARTED|Overall Study||591||
48049140|NCT01987401|100441629|FG002|STARTED|Overall Study||60||
48049141|NCT01987401|100441627|FG000|COMPLETED|Overall Study||137||
48049142|NCT01987401|100441628|FG001|COMPLETED|Overall Study||121||
48049143|NCT01987401|100441629|FG002|COMPLETED|Overall Study||16||
48049144|NCT01987401|100441627|FG000|NOT COMPLETED|Overall Study||454||
48049145|NCT01987401|100441628|FG001|NOT COMPLETED|Overall Study||470||
48049146|NCT01987401|100441629|FG002|NOT COMPLETED|Overall Study||44||
48049147|NCT02882074|100441630|FG000|STARTED|Overall Study||43||
48049148|NCT02882074|100441631|FG001|STARTED|Overall Study||42||
48049149|NCT02882074|100441630|FG000|COMPLETED|Overall Study||43||
48049150|NCT02882074|100441631|FG001|COMPLETED|Overall Study||42||
48049151|NCT02882074|100441630|FG000|NOT COMPLETED|Overall Study||0||
48049152|NCT02882074|100441631|FG001|NOT COMPLETED|Overall Study||0||
48049153|NCT02325791|100441632|FG000|STARTED|Overall Study||23||
48049154|NCT02325791|100441633|FG001|STARTED|Overall Study||383||
48049155|NCT02325791|100441634|FG002|STARTED|Overall Study||385||
48049156|NCT02325791|100441635|FG003|STARTED|Overall Study||381||
48049157|NCT02325791|100441632|FG000|COMPLETED|Overall Study||23||
48049158|NCT02325791|100441633|FG001|COMPLETED|Overall Study||358||
48049159|NCT02325791|100441634|FG002|COMPLETED|Overall Study||360||
48049160|NCT02325791|100441635|FG003|COMPLETED|Overall Study||355||
48049161|NCT02325791|100441632|FG000|NOT COMPLETED|Overall Study||0||
48049162|NCT02325791|100441633|FG001|NOT COMPLETED|Overall Study||25||
48049163|NCT02325791|100441634|FG002|NOT COMPLETED|Overall Study||25||
48049164|NCT02325791|100441635|FG003|NOT COMPLETED|Overall Study||26||
48049165|NCT01604109|100441636|FG000|STARTED|Overall Study||150||
48049166|NCT01604109|100441637|FG001|STARTED|Overall Study||146||
48049167|NCT01604109|100441636|FG000|COMPLETED|Overall Study||117||
48049168|NCT01604109|100441637|FG001|COMPLETED|Overall Study||112||
48049169|NCT01604109|100441636|FG000|NOT COMPLETED|Overall Study||33||
48049170|NCT01604109|100441637|FG001|NOT COMPLETED|Overall Study||34||
48049171|NCT02096575|100441638|FG000|STARTED|Overall Study||68||
48049172|NCT02096575|100441639|FG001|STARTED|Overall Study||67||
48049173|NCT02096575|100441640|FG002|STARTED|Overall Study||5||
48049174|NCT02096575|100441638|FG000|COMPLETED|Overall Study||68||
48049175|NCT02096575|100441639|FG001|COMPLETED|Overall Study||67||
48049176|NCT02096575|100441640|FG002|COMPLETED|Overall Study||0||
48049177|NCT02096575|100441638|FG000|NOT COMPLETED|Overall Study||0||
48049178|NCT02096575|100441639|FG001|NOT COMPLETED|Overall Study||0||
48049179|NCT02096575|100441640|FG002|NOT COMPLETED|Overall Study||5||
48049180|NCT01117792|100441641|FG000|STARTED|Overall Study||55||
48049181|NCT01117792|100441641|FG000|COMPLETED|Overall Study||51||
48049182|NCT01117792|100441641|FG000|NOT COMPLETED|Overall Study||4||
48049183|NCT00814879|100441642|FG000|STARTED|By Week 24||28||
48049184|NCT00814879|100441643|FG001|STARTED|By Week 24||30||
48049185|NCT00814879|100441642|FG000|COMPLETED|By Week 24||27||
48049186|NCT00814879|100441643|FG001|COMPLETED|By Week 24||29||
48049187|NCT00814879|100441642|FG000|NOT COMPLETED|By Week 24||1||
48049188|NCT00814879|100441643|FG001|NOT COMPLETED|By Week 24||1||
48049189|NCT00814879|100441642|FG000|STARTED|By Week 48||27||
48049190|NCT00814879|100441643|FG001|STARTED|By Week 48||29||
48049191|NCT00814879|100441642|FG000|COMPLETED|By Week 48||25||
48049192|NCT00814879|100441643|FG001|COMPLETED|By Week 48||26||
48049193|NCT00814879|100441642|FG000|NOT COMPLETED|By Week 48||2||
48049194|NCT00814879|100441643|FG001|NOT COMPLETED|By Week 48||3||
48049195|NCT00910247|100441644|FG000|STARTED|Overall Study||274||
48049196|NCT00910247|100441644|FG000|COMPLETED|Overall Study||205||
48049197|NCT00910247|100441644|FG000|NOT COMPLETED|Overall Study||69||
48049198|NCT03742440|100441645|FG000|STARTED|Overall Study||40||
48049199|NCT03742440|100441645|FG000|COMPLETED|Overall Study||40||
48049200|NCT03742440|100441645|FG000|NOT COMPLETED|Overall Study||0||
48049201|NCT04322539|100441646|FG000|STARTED|Overall Study||461||
48049202|NCT04322539|100441647|FG001|STARTED|Overall Study||230||
48049203|NCT04322539|100441646|FG000|Safety Population (SP)|Overall Study||456|The Safety population (SP) included all randomized participants who received at least 1 dose of study drug.|
48049204|NCT04322539|100441647|FG001|Safety Population (SP)|Overall Study||230|The Safety population (SP) included all randomized participants who received at least 1 dose of study drug.|
48049205|NCT04322539|100441646|FG000|Pharmacokinetic (PK) Population|Overall Study||329|The Pharmacokinetic (PK) population included all participants who received at least 1 dose of study drug and had at least 1 post dose PK sample collected and analyzed.|
48049206|NCT04322539|100441647|FG001|Pharmacokinetic (PK) Population|Overall Study||2|The Pharmacokinetic (PK) population included all participants who received at least 1 dose of study drug and had at least 1 post dose PK sample collected and analyzed.|
48049207|NCT04322539|100441646|FG000|COMPLETED|Overall Study||0||
48049208|NCT04322539|100441647|FG001|COMPLETED|Overall Study||0||
48049209|NCT04322539|100441646|FG000|NOT COMPLETED|Overall Study||461||
48208267|NCT01350804|100837013|FG003|NOT COMPLETED|Extension Study, Weeks 52 - 260||23||
48495645|NCT01906372|101547897|FG000|STARTED|Overall Study||12||
48495646|NCT01906372|101547897|FG000|Visit 7: Treatment Phase Completed|Overall Study||10||
48049210|NCT04322539|100441647|FG001|NOT COMPLETED|Overall Study||230||
48049211|NCT05680740|100441648|FG000|STARTED|Overall Study||34||
48049212|NCT05680740|100441648|FG000|COMPLETED|Overall Study||28||
48049213|NCT05680740|100441648|FG000|NOT COMPLETED|Overall Study||6||
48049214|NCT03860935|100441649|FG000|STARTED|Overall Study||421||
48049215|NCT03860935|100441650|FG001|STARTED|Overall Study||211||
48049216|NCT03860935|100441649|FG000|COMPLETED|Overall Study||331||
48049217|NCT03860935|100441650|FG001|COMPLETED|Overall Study||154||
48049218|NCT03860935|100441649|FG000|NOT COMPLETED|Overall Study||90||
48049219|NCT03860935|100441650|FG001|NOT COMPLETED|Overall Study||57||
48049220|NCT02012582|100441651|FG000|STARTED|Overall Study||8||
48049221|NCT02012582|100441652|FG001|STARTED|Overall Study||8||
48049222|NCT02012582|100441653|FG002|STARTED|Overall Study||8||
48049223|NCT02012582|100441654|FG003|STARTED|Overall Study||8||
48049224|NCT02012582|100441651|FG000|COMPLETED|Overall Study||8||
48049225|NCT02012582|100441652|FG001|COMPLETED|Overall Study||8||
48049226|NCT02012582|100441653|FG002|COMPLETED|Overall Study||8||
48049227|NCT02012582|100441654|FG003|COMPLETED|Overall Study||7||
48049228|NCT02012582|100441651|FG000|NOT COMPLETED|Overall Study||0||
48049229|NCT02012582|100441652|FG001|NOT COMPLETED|Overall Study||0||
48049230|NCT02012582|100441653|FG002|NOT COMPLETED|Overall Study||0||
48049231|NCT02012582|100441654|FG003|NOT COMPLETED|Overall Study||1||
48208268|NCT02162446|100837014|FG000|STARTED|Overall Study||12||
48208269|NCT02162446|100837014|FG000|COMPLETED|Overall Study||12||
48495647|NCT01906372|101547897|FG000|Visit 10: Follow up Phase Completed|Overall Study||8||
48049232|NCT02054481|100441655|FG000|STARTED|Overall Study||43||
48049233|NCT02054481|100441656|FG001|STARTED|Overall Study||41||
48049234|NCT02054481|100441657|FG002|STARTED|Overall Study||42||
48049235|NCT02054481|100441658|FG003|STARTED|Overall Study||40||
48049236|NCT02054481|100441655|FG000|COMPLETED|Overall Study||39||
48049237|NCT02054481|100441656|FG001|COMPLETED|Overall Study||39||
48049238|NCT02054481|100441657|FG002|COMPLETED|Overall Study||40||
48049239|NCT02054481|100441658|FG003|COMPLETED|Overall Study||39||
48049240|NCT02054481|100441655|FG000|NOT COMPLETED|Overall Study||4||
48049241|NCT02054481|100441656|FG001|NOT COMPLETED|Overall Study||2||
48049242|NCT02054481|100441657|FG002|NOT COMPLETED|Overall Study||2||
48049243|NCT02054481|100441658|FG003|NOT COMPLETED|Overall Study||1||
48049244|NCT01347580|100441659|FG000|STARTED|Overall Study||909||
48049245|NCT01347580|100441660|FG001|STARTED|Overall Study||953||
48049246|NCT01347580|100441659|FG000|Modified Intent to Treat Population|Overall Study||906||
48049247|NCT01347580|100441660|FG001|Modified Intent to Treat Population|Overall Study||952||
48049248|NCT01347580|100441659|FG000|Safety Population|Overall Study||908||
48049249|NCT01347580|100441660|FG001|Safety Population|Overall Study||950||
48049250|NCT01347580|100441659|FG000|COMPLETED|Overall Study||844||
48049251|NCT01347580|100441660|FG001|COMPLETED|Overall Study||897||
48208270|NCT02162446|100837014|FG000|NOT COMPLETED|Overall Study||0||
48208271|NCT00590707|100837015|FG000|STARTED|Overall Study||100||
48495648|NCT01906372|101547897|FG000|COMPLETED|Overall Study||10||
48049252|NCT01347580|100441659|FG000|NOT COMPLETED|Overall Study||65||
48049253|NCT01347580|100441660|FG001|NOT COMPLETED|Overall Study||56||
48049254|NCT02093026|100441661|FG000|STARTED|Overall Study||465||
48049255|NCT02093026|100441661|FG000|COMPLETED|Overall Study||272||
48049256|NCT02093026|100441661|FG000|NOT COMPLETED|Overall Study||193||
48049257|NCT00366340|100441662|FG000|STARTED|Infant Series||301||
48049258|NCT00366340|100441663|FG001|STARTED|Infant Series||303||
48049259|NCT00366340|100441662|FG000|Vaccinated Dose 1|Infant Series||300||
48049260|NCT00366340|100441663|FG001|Vaccinated Dose 1|Infant Series||303||
48049261|NCT00366340|100441662|FG000|Vaccinated Dose 2|Infant Series||296||
48049262|NCT00366340|100441663|FG001|Vaccinated Dose 2|Infant Series||297||
48049263|NCT00366340|100441662|FG000|Vaccinated Dose 3|Infant Series||294||
48049264|NCT00366340|100441663|FG001|Vaccinated Dose 3|Infant Series||293||
48049265|NCT00366340|100441662|FG000|COMPLETED|Infant Series||293||
48049266|NCT00366340|100441663|FG001|COMPLETED|Infant Series||293||
48049267|NCT00366340|100441662|FG000|NOT COMPLETED|Infant Series||8||
48049268|NCT00366340|100441663|FG001|NOT COMPLETED|Infant Series||10||
48049269|NCT00366340|100441662|FG000|STARTED|After the Infant Series||293||
48049270|NCT00366340|100441663|FG001|STARTED|After the Infant Series||293||
48049271|NCT00366340|100441662|FG000|COMPLETED|After the Infant Series||290||
48049272|NCT00366340|100441663|FG001|COMPLETED|After the Infant Series||287||
48049273|NCT00366340|100441662|FG000|NOT COMPLETED|After the Infant Series||3||
48049274|NCT00366340|100441663|FG001|NOT COMPLETED|After the Infant Series||6||
48049275|NCT00366340|100441662|FG000|STARTED|Toddler Dose||290||
48049276|NCT00366340|100441663|FG001|STARTED|Toddler Dose||287||
48049277|NCT00366340|100441662|FG000|COMPLETED|Toddler Dose||289||
48049278|NCT00366340|100441663|FG001|COMPLETED|Toddler Dose||286||
48049279|NCT00366340|100441662|FG000|NOT COMPLETED|Toddler Dose||1||
48049280|NCT00366340|100441663|FG001|NOT COMPLETED|Toddler Dose||1||
48049281|NCT00873860|100441664|FG000|STARTED|Overall Study||48||
48049282|NCT00873860|100441665|FG001|STARTED|Overall Study||47||
48049283|NCT00873860|100441666|FG002|STARTED|Overall Study||51||
48049284|NCT00873860|100441667|FG003|STARTED|Overall Study||48||
48049285|NCT00873860|100441664|FG000|Treated|Overall Study||47||
48049286|NCT00873860|100441665|FG001|Treated|Overall Study||47||
48049287|NCT00873860|100441666|FG002|Treated|Overall Study||51||
48049288|NCT00873860|100441667|FG003|Treated|Overall Study||48||
48049289|NCT00873860|100441664|FG000|COMPLETED|Overall Study||44||
48049290|NCT00873860|100441665|FG001|COMPLETED|Overall Study||47||
48049291|NCT00873860|100441666|FG002|COMPLETED|Overall Study||48||
48049292|NCT00873860|100441667|FG003|COMPLETED|Overall Study||47||
48049293|NCT00873860|100441664|FG000|NOT COMPLETED|Overall Study||4||
48049294|NCT00873860|100441665|FG001|NOT COMPLETED|Overall Study||0||
48049295|NCT00873860|100441666|FG002|NOT COMPLETED|Overall Study||3||
48049296|NCT00873860|100441667|FG003|NOT COMPLETED|Overall Study||1||
48049297|NCT01850602|100441668|FG000|STARTED|Overall Study||108||
48049298|NCT01850602|100441669|FG001|STARTED|Overall Study||105||
48049299|NCT01850602|100441668|FG000|COMPLETED|Overall Study||94||
48049300|NCT01850602|100441669|FG001|COMPLETED|Overall Study||87||
48049301|NCT01850602|100441668|FG000|NOT COMPLETED|Overall Study||14||
48049302|NCT01850602|100441669|FG001|NOT COMPLETED|Overall Study||18||
48049303|NCT01490723|100441670|FG000|STARTED|Overall Study||20||
48049304|NCT01490723|100441670|FG000|COMPLETED|Overall Study||20||
48049305|NCT01490723|100441670|FG000|NOT COMPLETED|Overall Study||0||
48049306|NCT00378079|100441671|FG000|STARTED|Overall Study||70||
48049307|NCT00378079|100441672|FG001|STARTED|Overall Study||70||
48049308|NCT00378079|100441673|FG002|STARTED|Overall Study||71||
48049309|NCT00378079|100441671|FG000|COMPLETED|Overall Study||64||
48049310|NCT00378079|100441672|FG001|COMPLETED|Overall Study||69||
48049311|NCT00378079|100441673|FG002|COMPLETED|Overall Study||71||
48208272|NCT00590707|100837016|FG001|STARTED|Overall Study||100||
48049312|NCT00378079|100441671|FG000|NOT COMPLETED|Overall Study||6||
48208273|NCT00590707|100837015|FG000|COMPLETED|Overall Study||100||
48049313|NCT00378079|100441672|FG001|NOT COMPLETED|Overall Study||1||
48049314|NCT00378079|100441673|FG002|NOT COMPLETED|Overall Study||0||
48049315|NCT00718081|100441674|FG000|STARTED|Overall Study||29||
48049316|NCT00718081|100441675|FG001|STARTED|Overall Study||29||
48049317|NCT00718081|100441676|FG002|STARTED|Overall Study||30||
48049318|NCT00718081|100441674|FG000|COMPLETED|Overall Study||22||
48049319|NCT00718081|100441675|FG001|COMPLETED|Overall Study||25||
48049320|NCT00718081|100441676|FG002|COMPLETED|Overall Study||9||
48049321|NCT00718081|100441674|FG000|NOT COMPLETED|Overall Study||7||
48049322|NCT00718081|100441675|FG001|NOT COMPLETED|Overall Study||4||
48049323|NCT00718081|100441676|FG002|NOT COMPLETED|Overall Study||21||
48049324|NCT01056380|100441677|FG000|STARTED|Overall Study||37||
48049325|NCT01056380|100441678|FG001|STARTED|Overall Study||42||
48049326|NCT01056380|100441677|FG000|COMPLETED|Overall Study||35||
48049327|NCT01056380|100441678|FG001|COMPLETED|Overall Study||39||
48049328|NCT01056380|100441677|FG000|NOT COMPLETED|Overall Study||2||
48049329|NCT01056380|100441678|FG001|NOT COMPLETED|Overall Study||3||
48049330|NCT00362128|100441679|FG000|STARTED|Overall Study||2072||
48049331|NCT00362128|100441679|FG000|COMPLETED|Overall Study||2072||
48049332|NCT00362128|100441679|FG000|NOT COMPLETED|Overall Study||0||
48049333|NCT04352127|100441680|FG000|STARTED|Overall Study||29||
48049334|NCT04352127|100441681|FG001|STARTED|Overall Study||26||
48049335|NCT04352127|100441680|FG000|COMPLETED|Overall Study||25||
48049336|NCT04352127|100441681|FG001|COMPLETED|Overall Study||25||
48049337|NCT04352127|100441680|FG000|NOT COMPLETED|Overall Study||4||
48049338|NCT04352127|100441681|FG001|NOT COMPLETED|Overall Study||1||
48049339|NCT01017575|100441682|FG000|STARTED|Overall Study||8||
48049340|NCT01017575|100441683|FG001|STARTED|Overall Study||9||
48049341|NCT01017575|100441684|FG002|STARTED|Overall Study||8||
48049342|NCT01017575|100441685|FG003|STARTED|Overall Study||8||
48049343|NCT01017575|100441686|FG004|STARTED|Overall Study||9||
48049344|NCT01017575|100441682|FG000|COMPLETED|Overall Study||7||
48049345|NCT01017575|100441683|FG001|COMPLETED|Overall Study||7||
48049346|NCT01017575|100441684|FG002|COMPLETED|Overall Study||8||
48049347|NCT01017575|100441685|FG003|COMPLETED|Overall Study||7||
48049348|NCT01017575|100441686|FG004|COMPLETED|Overall Study||6||
48049349|NCT01017575|100441682|FG000|NOT COMPLETED|Overall Study||1||
48049350|NCT01017575|100441683|FG001|NOT COMPLETED|Overall Study||2||
48049351|NCT01017575|100441684|FG002|NOT COMPLETED|Overall Study||0||
48049352|NCT01017575|100441685|FG003|NOT COMPLETED|Overall Study||1||
48049353|NCT01017575|100441686|FG004|NOT COMPLETED|Overall Study||3||
48049354|NCT03891667|100441687|FG000|STARTED|Overall Study||6|Started means that participants signed consent and were randomized to study medication.|
48049355|NCT03891667|100441688|FG001|STARTED|Overall Study||5|Started means that participants signed consent and were randomized to study medication.|
48049356|NCT03891667|100441687|FG000|Start of the Medication|Overall Study||5||
48049357|NCT03891667|100441688|FG001|Start of the Medication|Overall Study||5||
48049358|NCT03891667|100441687|FG000|Completed All 8 Weeks of Drug Treatment|Overall Study||1||
48049359|NCT03891667|100441688|FG001|Completed All 8 Weeks of Drug Treatment|Overall Study||2||
48049360|NCT03891667|100441687|FG000|Completed All 10 Weeks of Assessments|Overall Study||4||
48049361|NCT03891667|100441688|FG001|Completed All 10 Weeks of Assessments|Overall Study||2||
48049362|NCT03891667|100441687|FG000|COMPLETED|Overall Study||4||
48049363|NCT03891667|100441688|FG001|COMPLETED|Overall Study||2||
48049364|NCT03891667|100441687|FG000|NOT COMPLETED|Overall Study||2||
48049365|NCT03891667|100441688|FG001|NOT COMPLETED|Overall Study||3||
48049366|NCT00636701|100441689|FG000|STARTED|Overall Study||2||
48049367|NCT00636701|100441690|FG001|STARTED|Overall Study||2||
48049368|NCT00636701|100441689|FG000|COMPLETED|Overall Study||2||
48049369|NCT00636701|100441690|FG001|COMPLETED|Overall Study||2||
48049370|NCT00636701|100441689|FG000|NOT COMPLETED|Overall Study||0||
48049371|NCT00636701|100441690|FG001|NOT COMPLETED|Overall Study||0||
48049372|NCT01856764|100441691|FG000|STARTED|Overall Study||20||
48049373|NCT01856764|100441692|FG001|STARTED|Overall Study||20||
48049374|NCT01856764|100441691|FG000|COMPLETED|Overall Study||20||
48049375|NCT01856764|100441692|FG001|COMPLETED|Overall Study||20||
48049376|NCT01856764|100441691|FG000|NOT COMPLETED|Overall Study||0||
48049377|NCT01856764|100441692|FG001|NOT COMPLETED|Overall Study||0||
48049378|NCT01967784|100441693|FG000|STARTED|Overall Study||100||
48049379|NCT01967784|100441693|FG000|COMPLETED|Overall Study||100||
48049380|NCT01967784|100441693|FG000|NOT COMPLETED|Overall Study||0||
48049381|NCT01467427|100441694|FG000|STARTED|Overall Study||12||
48049382|NCT01467427|100441695|FG001|STARTED|Overall Study||13||
48049383|NCT01467427|100441694|FG000|Completed Main Phase|Overall Study||11||
48049384|NCT01467427|100441695|FG001|Completed Main Phase|Overall Study||13||
48049385|NCT01467427|100441694|FG000|COMPLETED|Overall Study||0||
48049386|NCT01467427|100441695|FG001|COMPLETED|Overall Study||0||
48049387|NCT01467427|100441694|FG000|NOT COMPLETED|Overall Study||12||
48049388|NCT01467427|100441695|FG001|NOT COMPLETED|Overall Study||13||
48049389|NCT02189954|100441696|FG000|STARTED|Overall Study||45||
48049390|NCT02189954|100441697|FG001|STARTED|Overall Study||45||
48049391|NCT02189954|100441696|FG000|COMPLETED|Overall Study||45||
48049392|NCT02189954|100441697|FG001|COMPLETED|Overall Study||45||
48049393|NCT02189954|100441696|FG000|NOT COMPLETED|Overall Study||0||
48049394|NCT02189954|100441697|FG001|NOT COMPLETED|Overall Study||0||
48049395|NCT02051816|100441698|FG000|STARTED|Overall Study||37||
48049396|NCT02051816|100441699|FG001|STARTED|Overall Study||40||
48049397|NCT02051816|100441700|FG002|STARTED|Overall Study||37||
48049398|NCT02051816|100441701|FG003|STARTED|Overall Study||36||
48049399|NCT02051816|100441698|FG000|COMPLETED|Overall Study||37||
48049400|NCT02051816|100441699|FG001|COMPLETED|Overall Study||40||
48049401|NCT02051816|100441700|FG002|COMPLETED|Overall Study||37||
48049402|NCT02051816|100441701|FG003|COMPLETED|Overall Study||36||
48049403|NCT02051816|100441698|FG000|NOT COMPLETED|Overall Study||0||
48049404|NCT02051816|100441699|FG001|NOT COMPLETED|Overall Study||0||
48049405|NCT02051816|100441700|FG002|NOT COMPLETED|Overall Study||0||
48049406|NCT02051816|100441701|FG003|NOT COMPLETED|Overall Study||0||
48049407|NCT02446743|100441702|FG000|STARTED|Overall Study||276||
48049408|NCT02446743|100441703|FG001|STARTED|Overall Study||255||
48495649|NCT01906372|101547897|FG000|NOT COMPLETED|Overall Study||2||
48495650|NCT03049748|101547898|FG000|STARTED|Overall Study||20||
48495651|NCT03049748|101547899|FG001|STARTED|Overall Study||20||
48495652|NCT03049748|101547898|FG000|COMPLETED|Overall Study||16||
48049409|NCT02446743|100441702|FG000|COMPLETED|Overall Study||271||
48049410|NCT02446743|100441703|FG001|COMPLETED|Overall Study||250||
48049411|NCT02446743|100441702|FG000|NOT COMPLETED|Overall Study||5||
48049412|NCT02446743|100441703|FG001|NOT COMPLETED|Overall Study||5||
48049413|NCT01695668|100441704|FG000|STARTED|Overall Study||38||
48049414|NCT01695668|100441705|FG001|STARTED|Overall Study||37||
48049415|NCT01695668|100441704|FG000|COMPLETED|Overall Study||23||
48049416|NCT01695668|100441705|FG001|COMPLETED|Overall Study||20||
48049417|NCT01695668|100441704|FG000|NOT COMPLETED|Overall Study||15||
48049418|NCT01695668|100441705|FG001|NOT COMPLETED|Overall Study||17||
48049419|NCT05342532|100441706|FG000|STARTED|Overall Study||58||
48049420|NCT05342532|100441707|FG001|STARTED|Overall Study||54||
48049421|NCT05342532|100441706|FG000|COMPLETED|Overall Study||43||
48049422|NCT05342532|100441707|FG001|COMPLETED|Overall Study||19||
48049423|NCT05342532|100441706|FG000|NOT COMPLETED|Overall Study||15||
48049424|NCT05342532|100441707|FG001|NOT COMPLETED|Overall Study||35||
48049425|NCT01276197|100441708|FG000|STARTED|Overall Study||308||
48049426|NCT01276197|100441709|FG001|STARTED|Overall Study||310||
48049427|NCT01276197|100441708|FG000|COMPLETED|Overall Study||200||
48049428|NCT01276197|100441709|FG001|COMPLETED|Overall Study||200||
48049429|NCT01276197|100441708|FG000|NOT COMPLETED|Overall Study||108||
48049430|NCT01276197|100441709|FG001|NOT COMPLETED|Overall Study||110||
48049431|NCT01476644|100441710|FG000|STARTED|Overall Study||161||
48049432|NCT01476644|100441710|FG000|COMPLETED|Overall Study||122||
48049433|NCT01476644|100441710|FG000|NOT COMPLETED|Overall Study||39||
48049434|NCT03500679|100441711|FG000|STARTED|Overall Study||75||
48049435|NCT03500679|100441712|FG001|STARTED|Overall Study||25||
48049436|NCT03500679|100441711|FG000|COMPLETED|Overall Study||66||
48049437|NCT03500679|100441712|FG001|COMPLETED|Overall Study||22||
48049438|NCT03500679|100441711|FG000|NOT COMPLETED|Overall Study||9||
48049439|NCT03500679|100441712|FG001|NOT COMPLETED|Overall Study||3||
48049440|NCT06309407|100441713|FG000|STARTED|Overall Study||5||
48049441|NCT06309407|100441714|FG001|STARTED|Overall Study||5||
48049442|NCT06309407|100441713|FG000|COMPLETED|Overall Study||5||
48049443|NCT06309407|100441714|FG001|COMPLETED|Overall Study||5||
48049444|NCT06309407|100441713|FG000|NOT COMPLETED|Overall Study||0||
48049445|NCT06309407|100441714|FG001|NOT COMPLETED|Overall Study||0||
48049446|NCT01277081|100441715|FG000|STARTED|Overall Study||100||
48049447|NCT01277081|100441716|FG001|STARTED|Overall Study||100||
48049448|NCT01277081|100441715|FG000|COMPLETED|Overall Study||100||
48049449|NCT01277081|100441716|FG001|COMPLETED|Overall Study||100||
48049450|NCT01277081|100441715|FG000|NOT COMPLETED|Overall Study||0||
48049451|NCT01277081|100441716|FG001|NOT COMPLETED|Overall Study||0||
48049452|NCT01206387|100441717|FG000|STARTED|Overall Study||60||
48049453|NCT01206387|100441718|FG001|STARTED|Overall Study||60||
48049454|NCT01206387|100441717|FG000|COMPLETED|Overall Study||59||
48049455|NCT01206387|100441718|FG001|COMPLETED|Overall Study||60||
48049456|NCT01206387|100441717|FG000|NOT COMPLETED|Overall Study||1||
48049457|NCT01206387|100441718|FG001|NOT COMPLETED|Overall Study||0||
48049458|NCT01514370|100441719|FG000|STARTED|Overall Study||40||
48049459|NCT01514370|100441720|FG001|STARTED|Overall Study||40||
48049460|NCT01514370|100441719|FG000|Safety Population|Overall Study||38||
48049461|NCT01514370|100441720|FG001|Safety Population|Overall Study||40||
48049462|NCT01514370|100441719|FG000|COMPLETED|Overall Study||29||
48049463|NCT01514370|100441720|FG001|COMPLETED|Overall Study||24||
48049464|NCT01514370|100441719|FG000|NOT COMPLETED|Overall Study||11||
48049465|NCT01514370|100441720|FG001|NOT COMPLETED|Overall Study||16||
48049466|NCT00761150|100441721|FG000|STARTED|Open-label Period||308||
48049467|NCT00761150|100441722|FG001|STARTED|Open-label Period||0||
48049468|NCT00761150|100441723|FG002|STARTED|Open-label Period||0||
48049469|NCT00761150|100441721|FG000|COMPLETED|Open-label Period||238||
48049470|NCT00761150|100441722|FG001|COMPLETED|Open-label Period||0||
48049471|NCT00761150|100441723|FG002|COMPLETED|Open-label Period||0||
48049472|NCT00761150|100441721|FG000|NOT COMPLETED|Open-label Period||70||
48049473|NCT00761150|100441722|FG001|NOT COMPLETED|Open-label Period||0||
48049474|NCT00761150|100441723|FG002|NOT COMPLETED|Open-label Period||0||
48049475|NCT00761150|100441721|FG000|STARTED|Double-blind Period||0||
48049476|NCT00761150|100441722|FG001|STARTED|Double-blind Period||120||
48049477|NCT00761150|100441723|FG002|STARTED|Double-blind Period||118||
48049478|NCT00761150|100441721|FG000|COMPLETED|Double-blind Period||0||
48049479|NCT00761150|100441722|FG001|COMPLETED|Double-blind Period||106||
48049480|NCT00761150|100441723|FG002|COMPLETED|Double-blind Period||89||
48049481|NCT00761150|100441721|FG000|NOT COMPLETED|Double-blind Period||0||
48049482|NCT00761150|100441722|FG001|NOT COMPLETED|Double-blind Period||14||
48049483|NCT00761150|100441723|FG002|NOT COMPLETED|Double-blind Period||29||
48049484|NCT00879879|100441724|FG000|STARTED|Overall Study||20||
48049485|NCT00879879|100441724|FG000|COMPLETED|Overall Study||17||
48049486|NCT00879879|100441724|FG000|NOT COMPLETED|Overall Study||3||
48049487|NCT00384111|100441725|FG000|STARTED|Overall Study||26||
48049488|NCT00384111|100441725|FG000|COMPLETED|Overall Study||0||
48049489|NCT00384111|100441725|FG000|NOT COMPLETED|Overall Study||26||
48049490|NCT01844479|100441726|FG000|STARTED|First Intervention up to 30 Minutes||14||
48049491|NCT01844479|100441727|FG001|STARTED|First Intervention up to 30 Minutes||13||
48049492|NCT01844479|100441726|FG000|COMPLETED|First Intervention up to 30 Minutes||14||
48049493|NCT01844479|100441727|FG001|COMPLETED|First Intervention up to 30 Minutes||13||
48049494|NCT01844479|100441726|FG000|NOT COMPLETED|First Intervention up to 30 Minutes||0||
48049495|NCT01844479|100441727|FG001|NOT COMPLETED|First Intervention up to 30 Minutes||0||
48049496|NCT01844479|100441726|FG000|STARTED|Second Intervention up to 30 Minutes||14||
48049497|NCT01844479|100441727|FG001|STARTED|Second Intervention up to 30 Minutes||13||
48049498|NCT01844479|100441726|FG000|COMPLETED|Second Intervention up to 30 Minutes||14||
48049499|NCT01844479|100441727|FG001|COMPLETED|Second Intervention up to 30 Minutes||13||
48049500|NCT01844479|100441726|FG000|NOT COMPLETED|Second Intervention up to 30 Minutes||0||
48049501|NCT01844479|100441727|FG001|NOT COMPLETED|Second Intervention up to 30 Minutes||0||
48049502|NCT01289782|100441728|FG000|STARTED|Overall Study||264||
48049503|NCT01289782|100441729|FG001|STARTED|Overall Study||130||
48049504|NCT01289782|100441728|FG000|COMPLETED|Overall Study||239||
48049505|NCT01289782|100441729|FG001|COMPLETED|Overall Study||118||
48049506|NCT01289782|100441728|FG000|NOT COMPLETED|Overall Study||25||
48049507|NCT01289782|100441729|FG001|NOT COMPLETED|Overall Study||12||
48495653|NCT03049748|101547899|FG001|COMPLETED|Overall Study||14||
48495654|NCT03049748|101547898|FG000|NOT COMPLETED|Overall Study||4||
48495655|NCT03049748|101547899|FG001|NOT COMPLETED|Overall Study||6||
48495656|NCT00319696|101547900|FG000|STARTED|Overall Study||116||
48495657|NCT00319696|101547900|FG000|COMPLETED|Overall Study||56||
48049508|NCT01445886|100441730|FG000|STARTED|Overall Study||33||
48049509|NCT01445886|100441730|FG000|COMPLETED|Overall Study||28||
48049510|NCT01445886|100441730|FG000|NOT COMPLETED|Overall Study||5||
48049511|NCT01827358|100441731|FG000|STARTED|Overall Study||80||
48049512|NCT01827358|100441732|FG001|STARTED|Overall Study||75||
48049513|NCT01827358|100441731|FG000|COMPLETED|Overall Study||45||
48049514|NCT01827358|100441732|FG001|COMPLETED|Overall Study||44||
48049515|NCT01827358|100441731|FG000|NOT COMPLETED|Overall Study||35||
48049516|NCT01827358|100441732|FG001|NOT COMPLETED|Overall Study||31||
48049517|NCT05765227|100441733|FG000|STARTED|First Wear Period (Approx. 2 Days)||8||
48049518|NCT05765227|100441734|FG001|STARTED|First Wear Period (Approx. 2 Days)||9||
48049519|NCT05765227|100441733|FG000|COMPLETED|First Wear Period (Approx. 2 Days)||8||
48049520|NCT05765227|100441734|FG001|COMPLETED|First Wear Period (Approx. 2 Days)||9||
48049521|NCT05765227|100441733|FG000|NOT COMPLETED|First Wear Period (Approx. 2 Days)||0||
48049522|NCT05765227|100441734|FG001|NOT COMPLETED|First Wear Period (Approx. 2 Days)||0||
48049523|NCT05765227|100441733|FG000|STARTED|Second Wear Period (Approx. 2 Days)||8||
48049524|NCT05765227|100441734|FG001|STARTED|Second Wear Period (Approx. 2 Days)||9||
48049525|NCT05765227|100441733|FG000|COMPLETED|Second Wear Period (Approx. 2 Days)||8||
48049526|NCT05765227|100441734|FG001|COMPLETED|Second Wear Period (Approx. 2 Days)||9||
48049527|NCT05765227|100441733|FG000|NOT COMPLETED|Second Wear Period (Approx. 2 Days)||0||
48049528|NCT05765227|100441734|FG001|NOT COMPLETED|Second Wear Period (Approx. 2 Days)||0||
48049529|NCT00236951|100441735|FG000|STARTED|Overall Study||59||
48049530|NCT00236951|100441736|FG001|STARTED|Overall Study||77||
48049531|NCT00236951|100441737|FG002|STARTED|Overall Study||40||
48049532|NCT00236951|100441738|FG003|STARTED|Overall Study||48||
48049533|NCT00236951|100441735|FG000|COMPLETED|Overall Study||33||
48049534|NCT00236951|100441736|FG001|COMPLETED|Overall Study||46||
48049535|NCT00236951|100441737|FG002|COMPLETED|Overall Study||21||
48049536|NCT00236951|100441738|FG003|COMPLETED|Overall Study||17||
48049537|NCT00236951|100441735|FG000|NOT COMPLETED|Overall Study||26||
48049538|NCT00236951|100441736|FG001|NOT COMPLETED|Overall Study||31||
48049539|NCT00236951|100441737|FG002|NOT COMPLETED|Overall Study||19||
48049540|NCT00236951|100441738|FG003|NOT COMPLETED|Overall Study||31||
48049541|NCT02652767|100441739|FG000|STARTED|Overall Study||39||
48049542|NCT02652767|100441739|FG000|Completed Week 48|Overall Study||38||
48049543|NCT02652767|100441739|FG000|COMPLETED|Overall Study||35||
48049544|NCT02652767|100441739|FG000|NOT COMPLETED|Overall Study||4||
48049545|NCT04647890|100441740|FG000|STARTED|Overall Study||10||
48495658|NCT00319696|101547900|FG000|NOT COMPLETED|Overall Study||60||
48495659|NCT03220958|101547901|FG000|STARTED|Overall Study||81||
48049546|NCT04647890|100441741|FG001|STARTED|Overall Study||10||
48049547|NCT04647890|100441742|FG002|STARTED|Overall Study||10||
48049548|NCT04647890|100441740|FG000|COMPLETED|Overall Study||9||
48049549|NCT04647890|100441741|FG001|COMPLETED|Overall Study||9||
48049550|NCT04647890|100441742|FG002|COMPLETED|Overall Study||10||
48049551|NCT04647890|100441740|FG000|NOT COMPLETED|Overall Study||1||
48049552|NCT04647890|100441741|FG001|NOT COMPLETED|Overall Study||1||
48049553|NCT04647890|100441742|FG002|NOT COMPLETED|Overall Study||0||
48049554|NCT00194675|100441743|FG000|STARTED|Overall Study||27||
48049555|NCT00194675|100441744|FG001|STARTED|Overall Study||26||
48049556|NCT00194675|100441743|FG000|COMPLETED|Overall Study||22||
48049557|NCT00194675|100441744|FG001|COMPLETED|Overall Study||24||
48049558|NCT00194675|100441743|FG000|NOT COMPLETED|Overall Study||5||
48049559|NCT00194675|100441744|FG001|NOT COMPLETED|Overall Study||2||
48049560|NCT01150474|100441745|FG000|STARTED|Overall Study||51||
48049561|NCT01150474|100441746|FG001|STARTED|Overall Study||52||
48049562|NCT01150474|100441745|FG000|COMPLETED|Overall Study||41||
48049563|NCT01150474|100441746|FG001|COMPLETED|Overall Study||49||
48049564|NCT01150474|100441745|FG000|NOT COMPLETED|Overall Study||10||
48049565|NCT01150474|100441746|FG001|NOT COMPLETED|Overall Study||3||
48049566|NCT01285947|100441747|FG000|STARTED|Overall Study||10||
48049567|NCT01285947|100441748|FG001|STARTED|Overall Study||10||
48049568|NCT01285947|100441747|FG000|COMPLETED|Overall Study||10||
48049569|NCT01285947|100441748|FG001|COMPLETED|Overall Study||10||
48049570|NCT01285947|100441747|FG000|NOT COMPLETED|Overall Study||0||
48049571|NCT01285947|100441748|FG001|NOT COMPLETED|Overall Study||0||
48049572|NCT00973349|100441749|FG000|STARTED|Overall Study||170||
48049573|NCT00973349|100441750|FG001|STARTED|Overall Study||168||
48049574|NCT00973349|100441751|FG002|STARTED|Overall Study||171||
48049575|NCT00973349|100441752|FG003|STARTED|Overall Study||168||
48049576|NCT00973349|100441753|FG004|STARTED|Overall Study||170||
48049577|NCT00973349|100441754|FG005|STARTED|Overall Study||169||
48049578|NCT00973349|100441755|FG006|STARTED|Overall Study||174||
48049579|NCT00973349|100441756|FG007|STARTED|Overall Study||169||
48049580|NCT00973349|100441757|FG008|STARTED|Overall Study||171||
48049581|NCT00973349|100441758|FG009|STARTED|Overall Study||169||
48049582|NCT00973349|100441759|FG010|STARTED|Overall Study||174||
48049583|NCT00973349|100441760|FG011|STARTED|Overall Study||169||
48049584|NCT00973349|100441761|FG012|STARTED|Overall Study||169||
48049585|NCT00973349|100441762|FG013|STARTED|Overall Study||171||
48049586|NCT00973349|100441763|FG014|STARTED|Overall Study||170||
48049587|NCT00973349|100441764|FG015|STARTED|Overall Study||167||
48049588|NCT00973349|100441749|FG000|COMPLETED|Overall Study||166||
48049589|NCT00973349|100441750|FG001|COMPLETED|Overall Study||165||
48049590|NCT00973349|100441751|FG002|COMPLETED|Overall Study||166||
48049591|NCT00973349|100441752|FG003|COMPLETED|Overall Study||163||
48049592|NCT00973349|100441753|FG004|COMPLETED|Overall Study||165||
48049593|NCT00973349|100441754|FG005|COMPLETED|Overall Study||165||
48208274|NCT00590707|100837016|FG001|COMPLETED|Overall Study||100||
48208275|NCT00590707|100837015|FG000|NOT COMPLETED|Overall Study||0||
48208276|NCT00590707|100837016|FG001|NOT COMPLETED|Overall Study||0||
48208277|NCT00891930|100837017|FG000|STARTED|Part 1 Panitumumab + Irinotecan||74||
48049594|NCT00973349|100441755|FG006|COMPLETED|Overall Study||172||
48049595|NCT00973349|100441756|FG007|COMPLETED|Overall Study||166||
48049596|NCT00973349|100441757|FG008|COMPLETED|Overall Study||167||
48049597|NCT00973349|100441758|FG009|COMPLETED|Overall Study||163||
48049598|NCT00973349|100441759|FG010|COMPLETED|Overall Study||174||
48049599|NCT00973349|100441760|FG011|COMPLETED|Overall Study||167||
48049600|NCT00973349|100441761|FG012|COMPLETED|Overall Study||168||
48049601|NCT00973349|100441762|FG013|COMPLETED|Overall Study||171||
48049602|NCT00973349|100441763|FG014|COMPLETED|Overall Study||168||
48049603|NCT00973349|100441764|FG015|COMPLETED|Overall Study||165||
48049604|NCT00973349|100441749|FG000|NOT COMPLETED|Overall Study||4||
48049605|NCT00973349|100441750|FG001|NOT COMPLETED|Overall Study||3||
48049606|NCT00973349|100441751|FG002|NOT COMPLETED|Overall Study||5||
48049607|NCT00973349|100441752|FG003|NOT COMPLETED|Overall Study||5||
48049608|NCT00973349|100441753|FG004|NOT COMPLETED|Overall Study||5||
48049609|NCT00973349|100441754|FG005|NOT COMPLETED|Overall Study||4||
48049610|NCT00973349|100441755|FG006|NOT COMPLETED|Overall Study||2||
48049611|NCT00973349|100441756|FG007|NOT COMPLETED|Overall Study||3||
48049612|NCT00973349|100441757|FG008|NOT COMPLETED|Overall Study||4||
48049613|NCT00973349|100441758|FG009|NOT COMPLETED|Overall Study||6||
48049614|NCT00973349|100441759|FG010|NOT COMPLETED|Overall Study||0||
48049615|NCT00973349|100441760|FG011|NOT COMPLETED|Overall Study||2||
48049616|NCT00973349|100441761|FG012|NOT COMPLETED|Overall Study||1||
48049617|NCT00973349|100441762|FG013|NOT COMPLETED|Overall Study||0||
48049618|NCT00973349|100441763|FG014|NOT COMPLETED|Overall Study||2||
48049619|NCT00973349|100441764|FG015|NOT COMPLETED|Overall Study||2||
48049620|NCT03631355|100441765|FG000|STARTED|Overall Study||55||
48049621|NCT03631355|100441766|FG001|STARTED|Overall Study||55||
48049622|NCT03631355|100441765|FG000|COMPLETED|Overall Study||54||
48049623|NCT03631355|100441766|FG001|COMPLETED|Overall Study||53||
48049624|NCT03631355|100441765|FG000|NOT COMPLETED|Overall Study||1||
48208278|NCT00891930|100837017|FG000|COMPLETED|Part 1 Panitumumab + Irinotecan||5||
48208279|NCT00891930|100837017|FG000|NOT COMPLETED|Part 1 Panitumumab + Irinotecan||69||
48049625|NCT03631355|100441766|FG001|NOT COMPLETED|Overall Study||2||
48049626|NCT02404532|100441767|FG000|STARTED|Overall Study||29||
48208280|NCT00891930|100837017|FG000|STARTED|Part 2 Panitumumab + AMG479||36||
48049627|NCT02404532|100441767|FG000|COMPLETED|Overall Study||29||
48049628|NCT02404532|100441767|FG000|NOT COMPLETED|Overall Study||0||
48049629|NCT00323869|100441768|FG000|STARTED|Overall Study||48||
48049630|NCT00323869|100441768|FG000|Treatment Initiation|Overall Study||47||
48049631|NCT00323869|100441768|FG000|COMPLETED|Overall Study||47||
48049632|NCT00323869|100441768|FG000|NOT COMPLETED|Overall Study||1||
48049633|NCT00453388|100441769|FG000|STARTED|Overall Study||0||
48049634|NCT00453388|100441770|FG001|STARTED|Overall Study||5||
48049635|NCT00453388|100441771|FG002|STARTED|Overall Study||1||
48049636|NCT00453388|100441772|FG003|STARTED|Overall Study||0||
48049637|NCT00453388|100441769|FG000|COMPLETED|Overall Study||0||
48049638|NCT00453388|100441770|FG001|COMPLETED|Overall Study||5||
48049639|NCT00453388|100441771|FG002|COMPLETED|Overall Study||1||
48049640|NCT00453388|100441772|FG003|COMPLETED|Overall Study||0||
48049641|NCT00453388|100441769|FG000|NOT COMPLETED|Overall Study||0||
48049642|NCT00453388|100441770|FG001|NOT COMPLETED|Overall Study||0||
48049643|NCT00453388|100441771|FG002|NOT COMPLETED|Overall Study||0||
48049644|NCT00453388|100441772|FG003|NOT COMPLETED|Overall Study||0||
48049645|NCT01101191|100441773|FG000|STARTED|Period 1||42||
48049646|NCT01101191|100441774|FG001|STARTED|Period 1||42||
48049647|NCT01101191|100441773|FG000|COMPLETED|Period 1||40||
48049648|NCT01101191|100441774|FG001|COMPLETED|Period 1||40||
48049649|NCT01101191|100441773|FG000|NOT COMPLETED|Period 1||2||
48049650|NCT01101191|100441774|FG001|NOT COMPLETED|Period 1||2||
48049651|NCT01101191|100441773|FG000|STARTED|Period 2||40||
48049652|NCT01101191|100441774|FG001|STARTED|Period 2||40||
48049653|NCT01101191|100441773|FG000|COMPLETED|Period 2||40||
48049654|NCT01101191|100441774|FG001|COMPLETED|Period 2||40||
48049655|NCT01101191|100441773|FG000|NOT COMPLETED|Period 2||0||
48049656|NCT01101191|100441774|FG001|NOT COMPLETED|Period 2||0||
48049657|NCT04571515|100441775|FG000|STARTED|Overall Study||22||
48049658|NCT04571515|100441776|FG001|STARTED|Overall Study||24||
48049659|NCT04571515|100441777|FG002|STARTED|Overall Study||23||
48049660|NCT04571515|100441778|FG003|STARTED|Overall Study||23||
48049661|NCT04571515|100441779|FG004|STARTED|Overall Study||22||
48049662|NCT04571515|100441775|FG000|COMPLETED|Overall Study||21||
48049663|NCT04571515|100441776|FG001|COMPLETED|Overall Study||24||
48049664|NCT04571515|100441777|FG002|COMPLETED|Overall Study||23||
48049665|NCT04571515|100441778|FG003|COMPLETED|Overall Study||23||
48049666|NCT04571515|100441779|FG004|COMPLETED|Overall Study||19||
48049667|NCT04571515|100441775|FG000|NOT COMPLETED|Overall Study||1||
48049668|NCT04571515|100441776|FG001|NOT COMPLETED|Overall Study||0||
48049669|NCT04571515|100441777|FG002|NOT COMPLETED|Overall Study||0||
48049670|NCT04571515|100441778|FG003|NOT COMPLETED|Overall Study||0||
48049671|NCT04571515|100441779|FG004|NOT COMPLETED|Overall Study||3||
48049672|NCT00821327|100441780|FG000|STARTED|Overall Study||36||
48049673|NCT00821327|100441780|FG000|COMPLETED|Overall Study||1||
48049674|NCT00821327|100441780|FG000|NOT COMPLETED|Overall Study||35||
48049675|NCT02604017|100441781|FG000|STARTED|Overall Study||352|Intent-to-treat population: all participants who received at least 1 dose of study drug.|
48049676|NCT02604017|100441782|FG001|STARTED|Overall Study||351|Intent-to-treat population: all participants who received at least 1 dose of study drug.|
48049677|NCT02604017|100441781|FG000|COMPLETED|Overall Study||346||
48049678|NCT02604017|100441782|FG001|COMPLETED|Overall Study||343||
48049679|NCT02604017|100441781|FG000|NOT COMPLETED|Overall Study||6||
48049680|NCT02604017|100441782|FG001|NOT COMPLETED|Overall Study||8||
48049681|NCT02398227|100441783|FG000|STARTED|Overall Study||83||
48049682|NCT02398227|100441784|FG001|STARTED|Overall Study||89||
48049683|NCT02398227|100441783|FG000|COMPLETED|Overall Study||56||
48049684|NCT02398227|100441784|FG001|COMPLETED|Overall Study||71||
48049685|NCT02398227|100441783|FG000|NOT COMPLETED|Overall Study||27||
48495660|NCT03220958|101547902|FG001|STARTED|Overall Study||79||
48049686|NCT02398227|100441784|FG001|NOT COMPLETED|Overall Study||18||
48049687|NCT02793128|100441785|FG000|STARTED|Overall Study||71||
48049688|NCT02793128|100441785|FG000|COMPLETED|Overall Study||62||
48049689|NCT02793128|100441785|FG000|NOT COMPLETED|Overall Study||9||
48049690|NCT00686998|100441786|FG000|STARTED|Overall Study||43||
48049691|NCT00686998|100441787|FG001|STARTED|Overall Study||41||
48049692|NCT00686998|100441788|FG002|STARTED|Overall Study||22||
48049693|NCT00686998|100441786|FG000|Randomized|Overall Study||43||
48049694|NCT00686998|100441787|FG001|Randomized|Overall Study||41||
48049695|NCT00686998|100441788|FG002|Randomized|Overall Study||22||
48049696|NCT00686998|100441786|FG000|Received Treatment|Overall Study||43||
48049697|NCT00686998|100441787|FG001|Received Treatment|Overall Study||41||
48049698|NCT00686998|100441788|FG002|Received Treatment|Overall Study||22||
48049699|NCT00686998|100441786|FG000|Eligible for Efficacy Analysis|Overall Study||42||
48049700|NCT00686998|100441787|FG001|Eligible for Efficacy Analysis|Overall Study||39||
48049701|NCT00686998|100441788|FG002|Eligible for Efficacy Analysis|Overall Study||21||
48049702|NCT00686998|100441786|FG000|Completed Scheduled Treatment|Overall Study||30||
48049703|NCT00686998|100441787|FG001|Completed Scheduled Treatment|Overall Study||33||
48049704|NCT00686998|100441788|FG002|Completed Scheduled Treatment|Overall Study||18||
48049705|NCT00686998|100441786|FG000|COMPLETED|Overall Study||30||
48049706|NCT00686998|100441787|FG001|COMPLETED|Overall Study||33||
48049707|NCT00686998|100441788|FG002|COMPLETED|Overall Study||18||
48495661|NCT03220958|101547901|FG000|COMPLETED|Overall Study||81||
48049708|NCT00686998|100441786|FG000|NOT COMPLETED|Overall Study||13||
48049709|NCT00686998|100441787|FG001|NOT COMPLETED|Overall Study||8||
48049710|NCT00686998|100441788|FG002|NOT COMPLETED|Overall Study||4||
48049711|NCT01230125|100441789|FG000|STARTED|Overall Study||207||
48049712|NCT01230125|100441790|FG001|STARTED|Overall Study||104||
48049713|NCT01230125|100441789|FG000|COMPLETED|Overall Study||134||
48049714|NCT01230125|100441790|FG001|COMPLETED|Overall Study||54||
48049715|NCT01230125|100441789|FG000|NOT COMPLETED|Overall Study||73||
48049716|NCT01230125|100441790|FG001|NOT COMPLETED|Overall Study||50||
48049717|NCT00999921|100441791|FG000|STARTED|Overall Study||127||
48049718|NCT00999921|100441792|FG001|STARTED|Overall Study||129||
48049719|NCT00999921|100441791|FG000|COMPLETED|Overall Study||117||
48049720|NCT00999921|100441792|FG001|COMPLETED|Overall Study||110||
48049721|NCT00999921|100441791|FG000|NOT COMPLETED|Overall Study||10||
48049722|NCT00999921|100441792|FG001|NOT COMPLETED|Overall Study||19||
48049723|NCT02582255|100441793|FG000|STARTED|Overall Study||50||
48049724|NCT02582255|100441794|FG001|STARTED|Overall Study||50||
48049725|NCT02582255|100441793|FG000|COMPLETED|Overall Study||50||
48049726|NCT02582255|100441794|FG001|COMPLETED|Overall Study||47||
48049727|NCT02582255|100441793|FG000|NOT COMPLETED|Overall Study||0||
48049728|NCT02582255|100441794|FG001|NOT COMPLETED|Overall Study||3||
48049729|NCT03783702|100441795|FG000|STARTED|Overall Study||56||
48049730|NCT03783702|100441796|FG001|STARTED|Overall Study||62||
48049731|NCT03783702|100441795|FG000|COMPLETED|Overall Study||49||
48049732|NCT03783702|100441796|FG001|COMPLETED|Overall Study||51||
48049733|NCT03783702|100441795|FG000|NOT COMPLETED|Overall Study||7||
48049734|NCT03783702|100441796|FG001|NOT COMPLETED|Overall Study||11||
48049735|NCT00911443|100441797|FG000|STARTED|Overall Study||97||
48049736|NCT00911443|100441798|FG001|STARTED|Overall Study||97||
48049737|NCT00911443|100441799|FG002|STARTED|Overall Study||98||
48049738|NCT00911443|100441800|FG003|STARTED|Overall Study||99||
48049739|NCT00911443|100441801|FG004|STARTED|Overall Study||97||
48049740|NCT00911443|100441797|FG000|COMPLETED|Overall Study||97||
48049741|NCT00911443|100441798|FG001|COMPLETED|Overall Study||97||
48049742|NCT00911443|100441799|FG002|COMPLETED|Overall Study||98||
48049743|NCT00911443|100441800|FG003|COMPLETED|Overall Study||99||
48049744|NCT00911443|100441801|FG004|COMPLETED|Overall Study||97||
48049745|NCT00911443|100441797|FG000|NOT COMPLETED|Overall Study||0||
48049746|NCT00911443|100441798|FG001|NOT COMPLETED|Overall Study||0||
48049747|NCT00911443|100441799|FG002|NOT COMPLETED|Overall Study||0||
48049748|NCT00911443|100441800|FG003|NOT COMPLETED|Overall Study||0||
48049749|NCT00911443|100441801|FG004|NOT COMPLETED|Overall Study||0||
48049750|NCT00708071|100441802|FG000|STARTED|Overall Study||45||
48049751|NCT00708071|100441802|FG000|COMPLETED|Overall Study||45||
48049752|NCT00708071|100441802|FG000|NOT COMPLETED|Overall Study||0||
48049753|NCT00730028|100441803|FG000|STARTED|Overall Study||264||
48049754|NCT00730028|100441804|FG001|STARTED|Overall Study||260||
48049755|NCT00730028|100441805|FG002|STARTED|Overall Study||266||
48049756|NCT00730028|100441806|FG003|STARTED|Overall Study||263||
48049757|NCT00730028|100441807|FG004|STARTED|Overall Study||257||
48049758|NCT00730028|100441803|FG000|COMPLETED|Overall Study||204||
48049759|NCT00730028|100441804|FG001|COMPLETED|Overall Study||194||
48049760|NCT00730028|100441805|FG002|COMPLETED|Overall Study||221||
48049761|NCT00730028|100441806|FG003|COMPLETED|Overall Study||207||
48049762|NCT00730028|100441807|FG004|COMPLETED|Overall Study||175||
48049763|NCT00730028|100441803|FG000|NOT COMPLETED|Overall Study||60||
48049764|NCT00730028|100441804|FG001|NOT COMPLETED|Overall Study||66||
48049765|NCT00730028|100441805|FG002|NOT COMPLETED|Overall Study||45||
48049766|NCT00730028|100441806|FG003|NOT COMPLETED|Overall Study||56||
48049767|NCT00730028|100441807|FG004|NOT COMPLETED|Overall Study||82||
48049768|NCT01854944|100441808|FG000|STARTED|Overall Study||4||
48049769|NCT01854944|100441809|FG001|STARTED|Overall Study||4||
48049770|NCT01854944|100441810|FG002|STARTED|Overall Study||4||
48049771|NCT01854944|100441808|FG000|COMPLETED|Overall Study||4||
48049772|NCT01854944|100441809|FG001|COMPLETED|Overall Study||4||
48049773|NCT01854944|100441810|FG002|COMPLETED|Overall Study||3||
48049774|NCT01854944|100441808|FG000|NOT COMPLETED|Overall Study||0||
48049775|NCT01854944|100441809|FG001|NOT COMPLETED|Overall Study||0||
48049776|NCT01854944|100441810|FG002|NOT COMPLETED|Overall Study||1||
48049777|NCT00395538|100441811|FG000|STARTED|Overall Study||8|Previously enrolled in original protocol or (for Cohort 3) newly enrolled in current protocol|
48049778|NCT00395538|100441812|FG001|STARTED|Overall Study||15|Previously enrolled in original protocol or (for Cohort 3) newly enrolled in current protocol|
48049779|NCT00395538|100441813|FG002|STARTED|Overall Study||23|Previously enrolled in original protocol or (for Cohort 3) newly enrolled in current protocol|
48049780|NCT00395538|100441811|FG000|Signed Consent to the New Protocol|Overall Study||7||
48049781|NCT00395538|100441812|FG001|Signed Consent to the New Protocol|Overall Study||5||
48049782|NCT00395538|100441813|FG002|Signed Consent to the New Protocol|Overall Study||23||
48049783|NCT00395538|100441811|FG000|Received HPTH on New Protocol|Overall Study||7|This category identifies the subset of subjects in the Safety Population.|
48049784|NCT00395538|100441812|FG001|Received HPTH on New Protocol|Overall Study||5|This category identifies the subset of subjects in the Safety Population.|
48049785|NCT00395538|100441813|FG002|Received HPTH on New Protocol|Overall Study||19|This category identifies the subset of subjects in the Safety Population.|
48049786|NCT00395538|100441811|FG000|Randomized to Bone Biopsy Year 1|Overall Study||0||
48049787|NCT00395538|100441812|FG001|Randomized to Bone Biopsy Year 1|Overall Study||1||
48049788|NCT00395538|100441813|FG002|Randomized to Bone Biopsy Year 1|Overall Study||5||
48049789|NCT00395538|100441811|FG000|Randomized to Bone Biopsy Year 2|Overall Study||0||
48049790|NCT00395538|100441812|FG001|Randomized to Bone Biopsy Year 2|Overall Study||2||
48049791|NCT00395538|100441813|FG002|Randomized to Bone Biopsy Year 2|Overall Study||6||
48049792|NCT00395538|100441811|FG000|Randomized to Bone Biospy Year 4|Overall Study||0||
48049793|NCT00395538|100441812|FG001|Randomized to Bone Biospy Year 4|Overall Study||2||
48049794|NCT00395538|100441813|FG002|Randomized to Bone Biospy Year 4|Overall Study||8||
48049795|NCT00395538|100441811|FG000|Completed Bone Biopsy Year 1|Overall Study||0||
48049796|NCT00395538|100441812|FG001|Completed Bone Biopsy Year 1|Overall Study||1||
48049797|NCT00395538|100441813|FG002|Completed Bone Biopsy Year 1|Overall Study||4||
48049798|NCT00395538|100441811|FG000|Completed Bone Biopsy Year 2|Overall Study||0||
48049799|NCT00395538|100441812|FG001|Completed Bone Biopsy Year 2|Overall Study||2||
48049800|NCT00395538|100441813|FG002|Completed Bone Biopsy Year 2|Overall Study||3||
48049801|NCT00395538|100441811|FG000|Completed Bone Biopsy Year 4|Overall Study||0||
48049802|NCT00395538|100441812|FG001|Completed Bone Biopsy Year 4|Overall Study||1||
48049803|NCT00395538|100441813|FG002|Completed Bone Biopsy Year 4|Overall Study||1||
48049804|NCT00395538|100441811|FG000|COMPLETED|Overall Study||5|Completed 5 years of HPTH therapy and 6 month safety follow-up visit.|
48049805|NCT00395538|100441812|FG001|COMPLETED|Overall Study||2|Completed 5 years of HPTH therapy and 6 month safety follow-up visit.|
48049806|NCT00395538|100441813|FG002|COMPLETED|Overall Study||0|Completed 5 years of HPTH therapy and 6 month safety follow-up visit.|
48049807|NCT00395538|100441811|FG000|NOT COMPLETED|Overall Study||3||
48049808|NCT00395538|100441812|FG001|NOT COMPLETED|Overall Study||13||
48049809|NCT00395538|100441813|FG002|NOT COMPLETED|Overall Study||23||
48049810|NCT03021564|100441814|FG000|STARTED|Overall Study||120||
48049811|NCT03021564|100441815|FG001|STARTED|Overall Study||557||
48049812|NCT03021564|100441814|FG000|COMPLETED|Overall Study||36||
48049813|NCT03021564|100441815|FG001|COMPLETED|Overall Study||89||
48049814|NCT03021564|100441814|FG000|NOT COMPLETED|Overall Study||84||
48049815|NCT03021564|100441815|FG001|NOT COMPLETED|Overall Study||468||
48049816|NCT03455764|100441816|FG000|STARTED|Overall Study||6||
48049817|NCT03455764|100441817|FG001|STARTED|Overall Study||0||
48049818|NCT03455764|100441818|FG002|STARTED|Overall Study||0||
48049819|NCT03455764|100441819|FG003|STARTED|Overall Study||0||
48049820|NCT03455764|100441820|FG004|STARTED|Overall Study||0||
48049821|NCT03455764|100441816|FG000|COMPLETED|Overall Study||0||
48049822|NCT03455764|100441817|FG001|COMPLETED|Overall Study||0||
48049823|NCT03455764|100441818|FG002|COMPLETED|Overall Study||0||
48049824|NCT03455764|100441819|FG003|COMPLETED|Overall Study||0||
48049825|NCT03455764|100441820|FG004|COMPLETED|Overall Study||0||
48049826|NCT03455764|100441816|FG000|NOT COMPLETED|Overall Study||6||
48049827|NCT03455764|100441817|FG001|NOT COMPLETED|Overall Study||0||
48049828|NCT03455764|100441818|FG002|NOT COMPLETED|Overall Study||0||
48049829|NCT03455764|100441819|FG003|NOT COMPLETED|Overall Study||0||
48049830|NCT03455764|100441820|FG004|NOT COMPLETED|Overall Study||0||
48049831|NCT02536833|100444983|FG000|STARTED|Overall Study||112||
48049832|NCT02536833|100444984|FG001|STARTED|Overall Study||117||
48049833|NCT02536833|100444985|FG002|STARTED|Overall Study||110||
48049834|NCT02536833|100444986|FG003|STARTED|Overall Study||116||
48049835|NCT02536833|100444983|FG000|COMPLETED|Overall Study||103||
48049836|NCT02536833|100444984|FG001|COMPLETED|Overall Study||107||
48049837|NCT02536833|100444985|FG002|COMPLETED|Overall Study||95||
48049838|NCT02536833|100444986|FG003|COMPLETED|Overall Study||97||
48049839|NCT02536833|100444983|FG000|NOT COMPLETED|Overall Study||9||
48049840|NCT02536833|100444984|FG001|NOT COMPLETED|Overall Study||10||
48049841|NCT02536833|100444985|FG002|NOT COMPLETED|Overall Study||15||
48049842|NCT02536833|100444986|FG003|NOT COMPLETED|Overall Study||19||
48049843|NCT05466448|100444987|FG000|STARTED|Overall Study||6||
48049844|NCT05466448|100444988|FG001|STARTED|Overall Study||9||
48049845|NCT05466448|100444987|FG000|COMPLETED|Overall Study||5||
48049846|NCT05466448|100444988|FG001|COMPLETED|Overall Study||9||
48049847|NCT05466448|100444987|FG000|NOT COMPLETED|Overall Study||1||
48049848|NCT05466448|100444988|FG001|NOT COMPLETED|Overall Study||0||
48049849|NCT00633867|100444989|FG000|STARTED|Overall Study||60||
48208281|NCT00891930|100837017|FG000|COMPLETED|Part 2 Panitumumab + AMG479||5||
48495662|NCT03220958|101547902|FG001|COMPLETED|Overall Study||79||
48049850|NCT00633867|100444990|FG001|STARTED|Overall Study||60||
48049851|NCT00633867|100444989|FG000|COMPLETED|Overall Study||60||
48049852|NCT00633867|100444990|FG001|COMPLETED|Overall Study||60||
48049853|NCT00633867|100444989|FG000|NOT COMPLETED|Overall Study||0||
48049854|NCT00633867|100444990|FG001|NOT COMPLETED|Overall Study||0||
48049855|NCT00588952|100444991|FG000|STARTED|Overall Study||29||
48049856|NCT00588952|100444992|FG001|STARTED|Overall Study||70||
48049857|NCT00588952|100444991|FG000|COMPLETED|Overall Study||26||
48049858|NCT00588952|100444992|FG001|COMPLETED|Overall Study||63||
48049859|NCT00588952|100444991|FG000|NOT COMPLETED|Overall Study||3||
48049860|NCT00588952|100444992|FG001|NOT COMPLETED|Overall Study||7||
48049861|NCT01484938|100444993|FG000|STARTED|Overall Study||175||
48049862|NCT01484938|100444993|FG000|COMPLETED|Overall Study||171||
48049863|NCT01484938|100444993|FG000|NOT COMPLETED|Overall Study||4||
48049864|NCT04831788|100444994|FG000|STARTED|Overall Study||521||1042
48049865|NCT04831788|100444994|FG000|COMPLETED|Overall Study||521||1042
48049866|NCT04831788|100444994|FG000|NOT COMPLETED|Overall Study||0||0
48049867|NCT03535571|100444995|FG000|STARTED|Overall Study||20||
48049868|NCT03535571|100444995|FG000|COMPLETED|Overall Study||19||
48049869|NCT03535571|100444995|FG000|NOT COMPLETED|Overall Study||1||
48049870|NCT01475071|100444996|FG000|STARTED|Overall Study||100||
48049871|NCT01475071|100444996|FG000|COMPLETED|Overall Study||92||
48049872|NCT01475071|100444996|FG000|NOT COMPLETED|Overall Study||8||
48049873|NCT02021656|100444997|FG000|STARTED|Overall Study||384||
48049874|NCT02021656|100444997|FG000|COMPLETED|Overall Study||378||
48049875|NCT02021656|100444997|FG000|NOT COMPLETED|Overall Study||6||
48049876|NCT03475875|100444998|FG000|STARTED|Period 1||46||
48049877|NCT03475875|100444999|FG001|STARTED|Period 1||45||
48049878|NCT03475875|100444998|FG000|COMPLETED|Period 1||43||
48049879|NCT03475875|100444999|FG001|COMPLETED|Period 1||44||
48049880|NCT03475875|100444998|FG000|NOT COMPLETED|Period 1||3||
48049881|NCT03475875|100444999|FG001|NOT COMPLETED|Period 1||1||
48049882|NCT03475875|100444998|FG000|STARTED|Period 2||43||
48049883|NCT03475875|100444999|FG001|STARTED|Period 2||44||
48049884|NCT03475875|100444998|FG000|COMPLETED|Period 2||40||
48049885|NCT03475875|100444999|FG001|COMPLETED|Period 2||43||
48049886|NCT03475875|100444998|FG000|NOT COMPLETED|Period 2||3||
48049887|NCT03475875|100444999|FG001|NOT COMPLETED|Period 2||1||
48049888|NCT03475875|100444998|FG000|STARTED|Period 3||40||
48049889|NCT03475875|100444999|FG001|STARTED|Period 3||43||
48049890|NCT03475875|100444998|FG000|COMPLETED|Period 3||40||
48049891|NCT03475875|100444999|FG001|COMPLETED|Period 3||43||
48049892|NCT03475875|100444998|FG000|NOT COMPLETED|Period 3||0||
48049893|NCT03475875|100444999|FG001|NOT COMPLETED|Period 3||0||
48049894|NCT01369485|100445000|FG000|STARTED|Randomized Phase (Day 0 to Week 12)||80||
48049895|NCT01369485|100445001|FG001|STARTED|Randomized Phase (Day 0 to Week 12)||83||
48049896|NCT01369485|100445000|FG000|COMPLETED|Randomized Phase (Day 0 to Week 12)||57||
48049897|NCT01369485|100445001|FG001|COMPLETED|Randomized Phase (Day 0 to Week 12)||66||
48049898|NCT01369485|100445000|FG000|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||23||
48049899|NCT01369485|100445001|FG001|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||17||
48049900|NCT01369485|100445000|FG000|STARTED|Open Label Phase (Week 12 to Month 12)||57||
48049901|NCT01369485|100445001|FG001|STARTED|Open Label Phase (Week 12 to Month 12)||66||
48049902|NCT01369485|100445000|FG000|COMPLETED|Open Label Phase (Week 12 to Month 12)||24||
48049903|NCT01369485|100445001|FG001|COMPLETED|Open Label Phase (Week 12 to Month 12)||26||
48049904|NCT01369485|100445000|FG000|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||33||
48049905|NCT01369485|100445001|FG001|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||40||
48049906|NCT00214500|100445002|FG000|STARTED|Treatment Period||9|6 additional participants were dosed screen failures and are not included|
48049907|NCT00214500|100445002|FG000|Safety Population|Treatment Period||9|All eligible-enrolled participants who received at least 1 dose of study drug|
48049908|NCT00214500|100445002|FG000|Pharmacokinetic (PK) Population|Treatment Period||9|Received study drug and had at least 1 postbaseline PK parameter recorded|
48049909|NCT00214500|100445002|FG000|Pharmacodynamic (PD) Population|Treatment Period||9|Received study drug on Day 1 and had a non-missing baseline and postbaseline PD parameter recorded|
48049910|NCT00214500|100445002|FG000|COMPLETED|Treatment Period||8||
48049911|NCT00214500|100445002|FG000|NOT COMPLETED|Treatment Period||1||
48049912|NCT00214500|100445002|FG000|STARTED|Extension Period||8||
48049913|NCT00214500|100445002|FG000|COMPLETED|Extension Period||6||
48049914|NCT00214500|100445002|FG000|NOT COMPLETED|Extension Period||2||
48049915|NCT01527357|100445003|FG000|STARTED|Overall Study||482||
48049916|NCT01527357|100445004|FG001|STARTED|Overall Study||239||
48049917|NCT01527357|100445003|FG000|Efficacy Population|Overall Study||480||
48049918|NCT01527357|100445004|FG001|Efficacy Population|Overall Study||239||
48049919|NCT01527357|100445003|FG000|COMPLETED|Overall Study||465||
48049920|NCT01527357|100445004|FG001|COMPLETED|Overall Study||230||
48049921|NCT01527357|100445003|FG000|NOT COMPLETED|Overall Study||17||
48049922|NCT01527357|100445004|FG001|NOT COMPLETED|Overall Study||9||
48049923|NCT02017171|100445005|FG000|STARTED|Overall Study||267||
48049924|NCT02017171|100445006|FG001|STARTED|Overall Study||263||
48049925|NCT02017171|100445005|FG000|COMPLETED|Overall Study||205||
48049926|NCT02017171|100445006|FG001|COMPLETED|Overall Study||217||
48049927|NCT02017171|100445005|FG000|NOT COMPLETED|Overall Study||62||
48049928|NCT02017171|100445006|FG001|NOT COMPLETED|Overall Study||46||
48049929|NCT01860573|100445007|FG000|STARTED|Overall Study||83||
48049930|NCT01860573|100445008|FG001|STARTED|Overall Study||85||
48049931|NCT01860573|100445007|FG000|COMPLETED|Overall Study||83||
48049932|NCT01860573|100445008|FG001|COMPLETED|Overall Study||85||
48049933|NCT01860573|100445007|FG000|NOT COMPLETED|Overall Study||0||
48049934|NCT01860573|100445008|FG001|NOT COMPLETED|Overall Study||0||
48049935|NCT01611454|100445009|FG000|STARTED|Overall Study||58||
48049936|NCT01611454|100445010|FG001|STARTED|Overall Study||48||
48049937|NCT01611454|100445009|FG000|COMPLETED|Overall Study||40||
48049938|NCT01611454|100445010|FG001|COMPLETED|Overall Study||38||
48049939|NCT01611454|100445009|FG000|NOT COMPLETED|Overall Study||18||
48049940|NCT01611454|100445010|FG001|NOT COMPLETED|Overall Study||10||
48049941|NCT02117414|100445011|FG000|STARTED|Overall Study||175||
48049942|NCT02117414|100445012|FG001|STARTED|Overall Study||88||
48049943|NCT02117414|100445011|FG000|COMPLETED|Overall Study||160||
48049944|NCT02117414|100445012|FG001|COMPLETED|Overall Study||82||
48049945|NCT02117414|100445011|FG000|NOT COMPLETED|Overall Study||15||
48049946|NCT02117414|100445012|FG001|NOT COMPLETED|Overall Study||6||
48049947|NCT02477423|100445013|FG000|STARTED|Overall Study||12||
48049948|NCT02477423|100445014|FG001|STARTED|Overall Study||15||
48049949|NCT02477423|100445013|FG000|COMPLETED|Overall Study||11||
48049950|NCT02477423|100445014|FG001|COMPLETED|Overall Study||11||
48049951|NCT02477423|100445013|FG000|NOT COMPLETED|Overall Study||1||
48049952|NCT02477423|100445014|FG001|NOT COMPLETED|Overall Study||4||
48049953|NCT01931670|100445015|FG000|STARTED|Treatment Period||360||
48049954|NCT01931670|100445016|FG001|STARTED|Treatment Period||226||
48049955|NCT01931670|100445017|FG002|STARTED|Treatment Period||229||
48049956|NCT01931670|100445015|FG000|COMPLETED|Treatment Period||270||
48049957|NCT01931670|100445016|FG001|COMPLETED|Treatment Period||178||
48049958|NCT01931670|100445017|FG002|COMPLETED|Treatment Period||184||
48049959|NCT01931670|100445015|FG000|NOT COMPLETED|Treatment Period||90||
48049960|NCT01931670|100445016|FG001|NOT COMPLETED|Treatment Period||48||
48049961|NCT01931670|100445017|FG002|NOT COMPLETED|Treatment Period||45||
48049962|NCT01931670|100445015|FG000|STARTED|Post-Treatment Follow-Up (PTFU) Period||61|Participants who elected to enter the PTFU Period in this study for up to an additional 12 months.|
48049963|NCT01931670|100445016|FG001|STARTED|Post-Treatment Follow-Up (PTFU) Period||40|Participants who elected to enter the PTFU Period in this study for up to an additional 12 months.|
48049964|NCT01931670|100445017|FG002|STARTED|Post-Treatment Follow-Up (PTFU) Period||54|Participants who elected to enter the PTFU Period in this study for up to an additional 12 months.|
48049965|NCT01931670|100445015|FG000|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||42||
48049966|NCT01931670|100445016|FG001|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||24||
48049967|NCT01931670|100445017|FG002|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||18||
48049968|NCT01931670|100445015|FG000|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||0||
48049969|NCT01931670|100445016|FG001|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||4||
48049970|NCT01931670|100445017|FG002|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||15||
48049971|NCT01931670|100445015|FG000|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||42||
48049972|NCT01931670|100445016|FG001|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||28||
48049973|NCT01931670|100445017|FG002|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||33||
48049974|NCT01931670|100445015|FG000|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||19||
48049975|NCT01931670|100445016|FG001|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||12||
48049976|NCT01931670|100445017|FG002|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||21||
48049977|NCT02355977|100445018|FG000|STARTED|Overall Study||21||
48049978|NCT02355977|100445019|FG001|STARTED|Overall Study||26||
48049979|NCT02355977|100445020|FG002|STARTED|Overall Study||23||
48049980|NCT02355977|100445018|FG000|COMPLETED|Overall Study||21||
48049981|NCT02355977|100445019|FG001|COMPLETED|Overall Study||26||
48049982|NCT02355977|100445020|FG002|COMPLETED|Overall Study||23||
48049983|NCT02355977|100445018|FG000|NOT COMPLETED|Overall Study||0||
48049984|NCT02355977|100445019|FG001|NOT COMPLETED|Overall Study||0||
48049985|NCT02355977|100445020|FG002|NOT COMPLETED|Overall Study||0||
48049986|NCT01465191|100445021|FG000|STARTED|Overall Study||56||
48049987|NCT01465191|100445022|FG001|STARTED|Overall Study||63||
48049988|NCT01465191|100445023|FG002|STARTED|Overall Study||50||
48049989|NCT01465191|100445021|FG000|COMPLETED|Overall Study||47||
48049990|NCT01465191|100445022|FG001|COMPLETED|Overall Study||54||
48049991|NCT01465191|100445023|FG002|COMPLETED|Overall Study||43||
48049992|NCT01465191|100445021|FG000|NOT COMPLETED|Overall Study||9||
48049993|NCT01465191|100445022|FG001|NOT COMPLETED|Overall Study||9||
48049994|NCT01465191|100445023|FG002|NOT COMPLETED|Overall Study||7||
48049995|NCT05072470|100445024|FG000|STARTED|Overall Study||10||
48049996|NCT05072470|100445024|FG000|COMPLETED|Overall Study||10||
48049997|NCT05072470|100445024|FG000|NOT COMPLETED|Overall Study||0||
48049998|NCT03055858|100445025|FG000|STARTED|Overall Study||200||
48049999|NCT03055858|100445025|FG000|IDE|Overall Study||136||
48050000|NCT03055858|100445025|FG000|CAP|Overall Study||46||
48050001|NCT03055858|100445025|FG000|COMPLETED|Overall Study||156||
48050002|NCT03055858|100445025|FG000|NOT COMPLETED|Overall Study||44||
48050003|NCT00719264|100445026|FG000|STARTED|Overall Study||182||
48050004|NCT00719264|100445027|FG001|STARTED|Overall Study||183||
48050005|NCT00719264|100445026|FG000|Full Analysis Set|Overall Study||182||
48050006|NCT00719264|100445027|FG001|Full Analysis Set|Overall Study||183||
48050007|NCT00719264|100445026|FG000|Safety Set|Overall Study||180||
48050008|NCT00719264|100445027|FG001|Safety Set|Overall Study||181||
48050009|NCT00719264|100445026|FG000|COMPLETED|Overall Study||0||
48050010|NCT00719264|100445027|FG001|COMPLETED|Overall Study||0||
48050011|NCT00719264|100445026|FG000|NOT COMPLETED|Overall Study||182||
48050012|NCT00719264|100445027|FG001|NOT COMPLETED|Overall Study||183||
48050013|NCT01172275|100445028|FG000|STARTED|Overall Study||5||
48050014|NCT01172275|100445029|FG001|STARTED|Overall Study||6||
48050015|NCT01172275|100445028|FG000|COMPLETED|Overall Study||3||
48050016|NCT01172275|100445029|FG001|COMPLETED|Overall Study||6||
48050017|NCT01172275|100445028|FG000|NOT COMPLETED|Overall Study||2||
48050018|NCT01172275|100445029|FG001|NOT COMPLETED|Overall Study||0||
48050019|NCT03004248|100445030|FG000|STARTED|Overall Study||2691||
48050020|NCT03004248|100445030|FG000|Received a Single Treatment|Overall Study||1809||
48050021|NCT03004248|100445030|FG000|Received Two Treatments|Overall Study||314||
48050022|NCT03004248|100445030|FG000|Received Three Treatments|Overall Study||568||
48050023|NCT03004248|100445030|FG000|COMPLETED|Overall Study||2314||
48050024|NCT03004248|100445030|FG000|NOT COMPLETED|Overall Study||377||
48050025|NCT00413478|100445031|FG000|STARTED|Overall Study||9||
48050026|NCT00413478|100445031|FG000|COMPLETED|Overall Study||9||
48050027|NCT00413478|100445031|FG000|NOT COMPLETED|Overall Study||0||
48050028|NCT02300727|100445032|FG000|STARTED|Overall Study||0||
48050029|NCT02300727|100445033|FG001|STARTED|Overall Study||0||
48050030|NCT02300727|100445034|FG002|STARTED|Overall Study||3||
48050031|NCT02300727|100445035|FG003|STARTED|Overall Study||3||
48050032|NCT02300727|100445036|FG004|STARTED|Overall Study||0||
48050033|NCT02300727|100445037|FG005|STARTED|Overall Study||0||
48050034|NCT02300727|100445032|FG000|COMPLETED|Overall Study||0||
48050035|NCT02300727|100445033|FG001|COMPLETED|Overall Study||0||
48050036|NCT02300727|100445034|FG002|COMPLETED|Overall Study||3||
48208282|NCT00891930|100837017|FG000|NOT COMPLETED|Part 2 Panitumumab + AMG479||31||
48495663|NCT03220958|101547901|FG000|NOT COMPLETED|Overall Study||0||
48495664|NCT03220958|101547902|FG001|NOT COMPLETED|Overall Study||0||
48495665|NCT02312154|101547903|FG000|STARTED|Overall Study||25||
48495666|NCT02312154|101547903|FG000|COMPLETED|Overall Study||24||
48050037|NCT02300727|100445035|FG003|COMPLETED|Overall Study||2||
48050038|NCT02300727|100445036|FG004|COMPLETED|Overall Study||0||
48050039|NCT02300727|100445037|FG005|COMPLETED|Overall Study||0||
48050040|NCT02300727|100445032|FG000|NOT COMPLETED|Overall Study||0||
48050041|NCT02300727|100445033|FG001|NOT COMPLETED|Overall Study||0||
48050042|NCT02300727|100445034|FG002|NOT COMPLETED|Overall Study||0||
48050043|NCT02300727|100445035|FG003|NOT COMPLETED|Overall Study||1||
48050044|NCT02300727|100445036|FG004|NOT COMPLETED|Overall Study||0||
48050045|NCT02300727|100445037|FG005|NOT COMPLETED|Overall Study||0||
48050046|NCT00459979|100445038|FG000|STARTED|Overall Study||30||
48050047|NCT00459979|100445038|FG000|COMPLETED|Overall Study||28||
48050048|NCT00459979|100445038|FG000|NOT COMPLETED|Overall Study||2||
48050049|NCT01251146|100445039|FG000|STARTED|Overall Study||86||
48050050|NCT01251146|100445040|FG001|STARTED|Overall Study||91||
48050051|NCT01251146|100445039|FG000|COMPLETED|Overall Study||83||
48050052|NCT01251146|100445040|FG001|COMPLETED|Overall Study||81||
48050053|NCT01251146|100445039|FG000|NOT COMPLETED|Overall Study||3||
48050054|NCT01251146|100445040|FG001|NOT COMPLETED|Overall Study||10||
48050055|NCT04761627|100445041|FG000|STARTED|Run-in Period||494||
48050056|NCT04761627|100445042|FG001|STARTED|Run-in Period||0||
48050057|NCT04761627|100445043|FG002|STARTED|Run-in Period||0||
48050058|NCT04761627|100445041|FG000|COMPLETED|Run-in Period||453||
48050059|NCT04761627|100445042|FG001|COMPLETED|Run-in Period||0||
48050060|NCT04761627|100445043|FG002|COMPLETED|Run-in Period||0||
48050061|NCT04761627|100445041|FG000|NOT COMPLETED|Run-in Period||41||
48050062|NCT04761627|100445042|FG001|NOT COMPLETED|Run-in Period||0||
48050063|NCT04761627|100445043|FG002|NOT COMPLETED|Run-in Period||0||
48050064|NCT04761627|100445041|FG000|STARTED|Post-randomization Period||0||
48050065|NCT04761627|100445042|FG001|STARTED|Post-randomization Period||228||
48050066|NCT04761627|100445043|FG002|STARTED|Post-randomization Period||225||
48050067|NCT04761627|100445041|FG000|Full Analysis Set|Post-randomization Period||0||
48050068|NCT04761627|100445042|FG001|Full Analysis Set|Post-randomization Period||228||
48050069|NCT04761627|100445043|FG002|Full Analysis Set|Post-randomization Period||225||
48050070|NCT04761627|100445041|FG000|Safety Analysis Set|Post-randomization Period||0||
48050071|NCT04761627|100445042|FG001|Safety Analysis Set|Post-randomization Period||228||
48050072|NCT04761627|100445043|FG002|Safety Analysis Set|Post-randomization Period||224||
48050073|NCT04761627|100445041|FG000|COMPLETED|Post-randomization Period||0||
48050074|NCT04761627|100445042|FG001|COMPLETED|Post-randomization Period||209||
48050075|NCT04761627|100445043|FG002|COMPLETED|Post-randomization Period||209||
48050076|NCT04761627|100445041|FG000|NOT COMPLETED|Post-randomization Period||0||
48050077|NCT04761627|100445042|FG001|NOT COMPLETED|Post-randomization Period||19||
48050078|NCT04761627|100445043|FG002|NOT COMPLETED|Post-randomization Period||16||
48050079|NCT00847171|100445044|FG000|STARTED|Overall Study||20||
48050080|NCT00847171|100445044|FG000|COMPLETED|Overall Study||20||
48050081|NCT00847171|100445044|FG000|NOT COMPLETED|Overall Study||0||
48050082|NCT03828370|100445045|FG000|STARTED|Baseline||130||
48050083|NCT03828370|100445046|FG001|STARTED|Baseline||116||
48050084|NCT03828370|100445045|FG000|COMPLETED|Baseline||130||
48050085|NCT03828370|100445046|FG001|COMPLETED|Baseline||116||
48050086|NCT03828370|100445045|FG000|NOT COMPLETED|Baseline||0||
48050087|NCT03828370|100445046|FG001|NOT COMPLETED|Baseline||0||
48208283|NCT05636332|100837018|FG000|STARTED|Overall Study||20||
48495667|NCT02312154|101547903|FG000|NOT COMPLETED|Overall Study||1||
48050088|NCT03828370|100445045|FG000|STARTED|3 Month Follow-up||130||
48050089|NCT03828370|100445046|FG001|STARTED|3 Month Follow-up||116||
48050090|NCT03828370|100445045|FG000|COMPLETED|3 Month Follow-up||126||
48050091|NCT03828370|100445046|FG001|COMPLETED|3 Month Follow-up||104||
48050092|NCT03828370|100445045|FG000|NOT COMPLETED|3 Month Follow-up||4||
48050093|NCT03828370|100445046|FG001|NOT COMPLETED|3 Month Follow-up||12||
48050094|NCT03828370|100445045|FG000|STARTED|9 Month Follow up||126||
48050095|NCT03828370|100445046|FG001|STARTED|9 Month Follow up||104||
48050096|NCT03828370|100445045|FG000|COMPLETED|9 Month Follow up||114||
48050097|NCT03828370|100445046|FG001|COMPLETED|9 Month Follow up||84||
48050098|NCT03828370|100445045|FG000|NOT COMPLETED|9 Month Follow up||12||
48050099|NCT03828370|100445046|FG001|NOT COMPLETED|9 Month Follow up||20||
48050100|NCT04179890|100445047|FG000|STARTED|Overall Study||255|Reporting Enrolled Patients|
48050101|NCT04179890|100445048|FG001|STARTED|Overall Study||207|Reporting Enrolled Patients|
48050102|NCT04179890|100445047|FG000|Eligible Patients|Overall Study||246||
48050103|NCT04179890|100445048|FG001|Eligible Patients|Overall Study||191||
48050104|NCT04179890|100445047|FG000|COMPLETED|Overall Study||246||
48050105|NCT04179890|100445048|FG001|COMPLETED|Overall Study||191||
48050106|NCT04179890|100445047|FG000|NOT COMPLETED|Overall Study||9||
48050107|NCT04179890|100445048|FG001|NOT COMPLETED|Overall Study||16||
48050108|NCT02663687|100445049|FG000|STARTED|Overall Study||12||
48050109|NCT02663687|100445050|FG001|STARTED|Overall Study||9||
48050110|NCT02663687|100445051|FG002|STARTED|Overall Study||9||
48050111|NCT02663687|100445052|FG003|STARTED|Overall Study||9||
48050112|NCT02663687|100445053|FG004|STARTED|Overall Study||9||
48050113|NCT02663687|100445049|FG000|Treatment Period 1 (IV)|Overall Study||12||
48050114|NCT02663687|100445050|FG001|Treatment Period 1 (IV)|Overall Study||9||
48050115|NCT02663687|100445051|FG002|Treatment Period 1 (IV)|Overall Study||9||
48050116|NCT02663687|100445052|FG003|Treatment Period 1 (IV)|Overall Study||9||
48050117|NCT02663687|100445053|FG004|Treatment Period 1 (IV)|Overall Study||9||
48050118|NCT02663687|100445049|FG000|Treatment Period 2 (SC)|Overall Study||10||
48050119|NCT02663687|100445050|FG001|Treatment Period 2 (SC)|Overall Study||9||
48050120|NCT02663687|100445051|FG002|Treatment Period 2 (SC)|Overall Study||8||
48050121|NCT02663687|100445052|FG003|Treatment Period 2 (SC)|Overall Study||9||
48050122|NCT02663687|100445053|FG004|Treatment Period 2 (SC)|Overall Study||9||
48050123|NCT02663687|100445049|FG000|COMPLETED|Overall Study||10||
48050124|NCT02663687|100445050|FG001|COMPLETED|Overall Study||9||
48050125|NCT02663687|100445051|FG002|COMPLETED|Overall Study||8||
48050126|NCT02663687|100445052|FG003|COMPLETED|Overall Study||9||
48050127|NCT02663687|100445053|FG004|COMPLETED|Overall Study||9||
48050128|NCT02663687|100445049|FG000|NOT COMPLETED|Overall Study||2||
48050129|NCT02663687|100445050|FG001|NOT COMPLETED|Overall Study||0||
48050130|NCT02663687|100445051|FG002|NOT COMPLETED|Overall Study||1||
48050131|NCT02663687|100445052|FG003|NOT COMPLETED|Overall Study||0||
48050132|NCT02663687|100445053|FG004|NOT COMPLETED|Overall Study||0||
48050133|NCT00337350|100445054|FG000|STARTED|Overall Study||9||
48050134|NCT00337350|100445055|FG001|STARTED|Overall Study||11||
48050135|NCT00337350|100445054|FG000|COMPLETED|Overall Study||8||
48050136|NCT00337350|100445055|FG001|COMPLETED|Overall Study||10||
48050137|NCT00337350|100445054|FG000|NOT COMPLETED|Overall Study||1||
48050138|NCT00337350|100445055|FG001|NOT COMPLETED|Overall Study||1||
48050139|NCT02987660|100445056|FG000|STARTED|Overall Study||10|All randomized subjects|
48050140|NCT02987660|100445057|FG001|STARTED|Overall Study||10|All randomized subjects|
48050141|NCT02987660|100445056|FG000|COMPLETED|Overall Study||0||
48050142|NCT02987660|100445057|FG001|COMPLETED|Overall Study||0||
48050143|NCT02987660|100445056|FG000|NOT COMPLETED|Overall Study||10||
48050144|NCT02987660|100445057|FG001|NOT COMPLETED|Overall Study||10||
48050145|NCT00058539|100445058|FG000|STARTED|Overall Study||42||
48050146|NCT00058539|100445058|FG000|COMPLETED|Overall Study||0||
48050147|NCT00058539|100445058|FG000|NOT COMPLETED|Overall Study||42||
48050148|NCT01574079|100445059|FG000|STARTED|Overall Study||18||
48050149|NCT01574079|100445060|FG001|STARTED|Overall Study||15||
48050150|NCT01574079|100445059|FG000|COMPLETED|Overall Study||17||
48050151|NCT01574079|100445060|FG001|COMPLETED|Overall Study||13||
48050152|NCT01574079|100445059|FG000|NOT COMPLETED|Overall Study||1||
48050153|NCT01574079|100445060|FG001|NOT COMPLETED|Overall Study||2||
48050154|NCT02865343|100445061|FG000|STARTED|Overall Study||6||
48050155|NCT02865343|100445062|FG001|STARTED|Overall Study||5||
48050156|NCT02865343|100445061|FG000|COMPLETED|Overall Study||6||
48050157|NCT02865343|100445062|FG001|COMPLETED|Overall Study||3||
48050158|NCT02865343|100445061|FG000|NOT COMPLETED|Overall Study||0||
48050159|NCT02865343|100445062|FG001|NOT COMPLETED|Overall Study||2||
48050160|NCT01687036|100445063|FG000|STARTED|Overall Study||10||
48050161|NCT01687036|100445063|FG000|COMPLETED|Overall Study||10||
48050162|NCT01687036|100445063|FG000|NOT COMPLETED|Overall Study||0||
48050163|NCT00814801|100445064|FG000|STARTED|Overall Study||194||
48050164|NCT00814801|100445065|FG001|STARTED|Overall Study||192||
48050165|NCT00814801|100445066|FG002|STARTED|Overall Study||194||
48050166|NCT00814801|100445064|FG000|COMPLETED|Overall Study||160||
48050167|NCT00814801|100445065|FG001|COMPLETED|Overall Study||154||
48050168|NCT00814801|100445066|FG002|COMPLETED|Overall Study||151||
48050169|NCT00814801|100445064|FG000|NOT COMPLETED|Overall Study||34||
48050170|NCT00814801|100445065|FG001|NOT COMPLETED|Overall Study||38||
48050171|NCT00814801|100445066|FG002|NOT COMPLETED|Overall Study||43||
48495668|NCT00493805|101547904|FG000|STARTED|Overall Study||17||
48050172|NCT01631656|100445067|FG000|STARTED|Overall Study||5||
48050173|NCT01631656|100445068|FG001|STARTED|Overall Study||5||
48050174|NCT01631656|100445067|FG000|COMPLETED|Overall Study||5||
48050175|NCT01631656|100445068|FG001|COMPLETED|Overall Study||5||
48050176|NCT01631656|100445067|FG000|NOT COMPLETED|Overall Study||0||
48050177|NCT01631656|100445068|FG001|NOT COMPLETED|Overall Study||0||
48050178|NCT00609362|100445069|FG000|STARTED|Overall Study||29||
48050179|NCT00609362|100445070|FG001|STARTED|Overall Study||28||
48050180|NCT00609362|100445069|FG000|COMPLETED|Overall Study||26||
48050181|NCT00609362|100445070|FG001|COMPLETED|Overall Study||27||
48050182|NCT00609362|100445069|FG000|NOT COMPLETED|Overall Study||3||
48050183|NCT00609362|100445070|FG001|NOT COMPLETED|Overall Study||1||
48050184|NCT03312751|100445071|FG000|STARTED|Overall Study||16||
48050185|NCT03312751|100445072|FG001|STARTED|Overall Study||19||
48050186|NCT03312751|100445071|FG000|COMPLETED|Overall Study||9||
48050187|NCT03312751|100445072|FG001|COMPLETED|Overall Study||9||
48050188|NCT03312751|100445071|FG000|NOT COMPLETED|Overall Study||7||
48050189|NCT03312751|100445072|FG001|NOT COMPLETED|Overall Study||10||
48050190|NCT02414139|100445073|FG000|STARTED|Treatment Period||69||
48050191|NCT02414139|100445074|FG001|STARTED|Treatment Period||42||
48050192|NCT02414139|100445075|FG002|STARTED|Treatment Period||54||
48050193|NCT02414139|100445076|FG003|STARTED|Treatment Period||30||
48050194|NCT02414139|100445077|FG004|STARTED|Treatment Period||69||
48050195|NCT02414139|100445078|FG005|STARTED|Treatment Period||15||
48050196|NCT02414139|100445079|FG006|STARTED|Treatment Period||28||
48050197|NCT02414139|100445080|FG007|STARTED|Treatment Period||3||
48050198|NCT02414139|100445081|FG008|STARTED|Treatment Period||31||
48050199|NCT02414139|100445082|FG009|STARTED|Treatment Period||32||
48050200|NCT02414139|100445073|FG000|COMPLETED|Treatment Period||0||
48050201|NCT02414139|100445074|FG001|COMPLETED|Treatment Period||0||
48050202|NCT02414139|100445075|FG002|COMPLETED|Treatment Period||0||
48050203|NCT02414139|100445076|FG003|COMPLETED|Treatment Period||0||
48050204|NCT02414139|100445077|FG004|COMPLETED|Treatment Period||0||
48050205|NCT02414139|100445078|FG005|COMPLETED|Treatment Period||0||
48050206|NCT02414139|100445079|FG006|COMPLETED|Treatment Period||0||
48050207|NCT02414139|100445080|FG007|COMPLETED|Treatment Period||0||
48050208|NCT02414139|100445081|FG008|COMPLETED|Treatment Period||0||
48050209|NCT02414139|100445082|FG009|COMPLETED|Treatment Period||0||
48050210|NCT02414139|100445073|FG000|NOT COMPLETED|Treatment Period||69||
48050211|NCT02414139|100445074|FG001|NOT COMPLETED|Treatment Period||42||
48050212|NCT02414139|100445075|FG002|NOT COMPLETED|Treatment Period||54||
48050213|NCT02414139|100445076|FG003|NOT COMPLETED|Treatment Period||30||
48050214|NCT02414139|100445077|FG004|NOT COMPLETED|Treatment Period||69||
48050215|NCT02414139|100445078|FG005|NOT COMPLETED|Treatment Period||15||
48050216|NCT02414139|100445079|FG006|NOT COMPLETED|Treatment Period||28||
48050217|NCT02414139|100445080|FG007|NOT COMPLETED|Treatment Period||3||
48050218|NCT02414139|100445081|FG008|NOT COMPLETED|Treatment Period||31||
48050219|NCT02414139|100445082|FG009|NOT COMPLETED|Treatment Period||32||
48050220|NCT02414139|100445073|FG000|STARTED|Post-treatment Efficacy Follow-up||16||
48050221|NCT02414139|100445074|FG001|STARTED|Post-treatment Efficacy Follow-up||11||
48050222|NCT02414139|100445075|FG002|STARTED|Post-treatment Efficacy Follow-up||16||
48050223|NCT02414139|100445076|FG003|STARTED|Post-treatment Efficacy Follow-up||8||
48050224|NCT02414139|100445077|FG004|STARTED|Post-treatment Efficacy Follow-up||23||
48050225|NCT02414139|100445078|FG005|STARTED|Post-treatment Efficacy Follow-up||5||
48050226|NCT02414139|100445079|FG006|STARTED|Post-treatment Efficacy Follow-up||6||
48050227|NCT02414139|100445080|FG007|STARTED|Post-treatment Efficacy Follow-up||1||
48050228|NCT02414139|100445081|FG008|STARTED|Post-treatment Efficacy Follow-up||3||
48050229|NCT02414139|100445082|FG009|STARTED|Post-treatment Efficacy Follow-up||8||
48050230|NCT02414139|100445073|FG000|COMPLETED|Post-treatment Efficacy Follow-up||0||
48050231|NCT02414139|100445074|FG001|COMPLETED|Post-treatment Efficacy Follow-up||0||
48050232|NCT02414139|100445075|FG002|COMPLETED|Post-treatment Efficacy Follow-up||0||
48050233|NCT02414139|100445076|FG003|COMPLETED|Post-treatment Efficacy Follow-up||0||
48050234|NCT02414139|100445077|FG004|COMPLETED|Post-treatment Efficacy Follow-up||0||
48050235|NCT02414139|100445078|FG005|COMPLETED|Post-treatment Efficacy Follow-up||0||
48050236|NCT02414139|100445079|FG006|COMPLETED|Post-treatment Efficacy Follow-up||0||
48050237|NCT02414139|100445080|FG007|COMPLETED|Post-treatment Efficacy Follow-up||0||
48050238|NCT02414139|100445081|FG008|COMPLETED|Post-treatment Efficacy Follow-up||0||
48050239|NCT02414139|100445082|FG009|COMPLETED|Post-treatment Efficacy Follow-up||0||
48050240|NCT02414139|100445073|FG000|NOT COMPLETED|Post-treatment Efficacy Follow-up||16||
48050241|NCT02414139|100445074|FG001|NOT COMPLETED|Post-treatment Efficacy Follow-up||11||
48050242|NCT02414139|100445075|FG002|NOT COMPLETED|Post-treatment Efficacy Follow-up||16||
48050243|NCT02414139|100445076|FG003|NOT COMPLETED|Post-treatment Efficacy Follow-up||8||
48050244|NCT02414139|100445077|FG004|NOT COMPLETED|Post-treatment Efficacy Follow-up||23||
48050245|NCT02414139|100445078|FG005|NOT COMPLETED|Post-treatment Efficacy Follow-up||5||
48050246|NCT02414139|100445079|FG006|NOT COMPLETED|Post-treatment Efficacy Follow-up||6||
48050247|NCT02414139|100445080|FG007|NOT COMPLETED|Post-treatment Efficacy Follow-up||1||
48050248|NCT02414139|100445081|FG008|NOT COMPLETED|Post-treatment Efficacy Follow-up||3||
48050249|NCT02414139|100445082|FG009|NOT COMPLETED|Post-treatment Efficacy Follow-up||8||
48050250|NCT01992159|100445083|FG000|STARTED|Overall Study||63||
48495669|NCT00493805|101547905|FG001|STARTED|Overall Study||42||
48050251|NCT01992159|100445084|FG001|STARTED|Overall Study||63||
48050252|NCT01992159|100445085|FG002|STARTED|Overall Study||63||
48050253|NCT01992159|100445086|FG003|STARTED|Overall Study||63||
48050254|NCT01992159|100445083|FG000|Received Treatment|Overall Study||63||
48050255|NCT01992159|100445084|FG001|Received Treatment|Overall Study||63||
48050256|NCT01992159|100445085|FG002|Received Treatment|Overall Study||63||
48050257|NCT01992159|100445086|FG003|Received Treatment|Overall Study||63||
48050258|NCT01992159|100445083|FG000|Completed First 12 Months of Study|Overall Study||59||
48050259|NCT01992159|100445084|FG001|Completed First 12 Months of Study|Overall Study||56||
48050260|NCT01992159|100445085|FG002|Completed First 12 Months of Study|Overall Study||63||
48050261|NCT01992159|100445086|FG003|Completed First 12 Months of Study|Overall Study||59||
48050262|NCT01992159|100445083|FG000|COMPLETED|Overall Study||59||
48050263|NCT01992159|100445084|FG001|COMPLETED|Overall Study||55||
48208284|NCT05636332|100837019|FG001|STARTED|Overall Study||20||
48495670|NCT00493805|101547904|FG000|COMPLETED|Overall Study||17||
48050264|NCT01992159|100445085|FG002|COMPLETED|Overall Study||62||
48050265|NCT01992159|100445086|FG003|COMPLETED|Overall Study||59||
48050266|NCT01992159|100445083|FG000|NOT COMPLETED|Overall Study||4||
48050267|NCT01992159|100445084|FG001|NOT COMPLETED|Overall Study||8||
48050268|NCT01992159|100445085|FG002|NOT COMPLETED|Overall Study||1||
48050269|NCT01992159|100445086|FG003|NOT COMPLETED|Overall Study||4||
48050270|NCT02378025|100445087|FG000|STARTED|Overall Study||39||
48050271|NCT02378025|100445088|FG001|STARTED|Overall Study||36||
48050272|NCT02378025|100445087|FG000|COMPLETED|Overall Study||26||
48050273|NCT02378025|100445088|FG001|COMPLETED|Overall Study||15||
48050274|NCT02378025|100445087|FG000|NOT COMPLETED|Overall Study||13||
48050275|NCT02378025|100445088|FG001|NOT COMPLETED|Overall Study||21||
48050276|NCT01823510|100445089|FG000|STARTED|Days 1-7||10||
48050277|NCT01823510|100445090|FG001|STARTED|Days 1-7||10||
48050278|NCT01823510|100445089|FG000|COMPLETED|Days 1-7||10||
48050279|NCT01823510|100445090|FG001|COMPLETED|Days 1-7||10||
48050280|NCT01823510|100445089|FG000|NOT COMPLETED|Days 1-7||0||
48050281|NCT01823510|100445090|FG001|NOT COMPLETED|Days 1-7||0||
48050282|NCT01823510|100445089|FG000|STARTED|Days 8-21||10||
48050283|NCT01823510|100445090|FG001|STARTED|Days 8-21||10||
48050284|NCT01823510|100445089|FG000|COMPLETED|Days 8-21||10||
48050285|NCT01823510|100445090|FG001|COMPLETED|Days 8-21||10||
48050286|NCT01823510|100445089|FG000|NOT COMPLETED|Days 8-21||0||
48050287|NCT01823510|100445090|FG001|NOT COMPLETED|Days 8-21||0||
48050288|NCT01823510|100445089|FG000|STARTED|Days 22-28||10||
48050289|NCT01823510|100445090|FG001|STARTED|Days 22-28||10||
48050290|NCT01823510|100445089|FG000|COMPLETED|Days 22-28||10||
48050291|NCT01823510|100445090|FG001|COMPLETED|Days 22-28||10||
48050292|NCT01823510|100445089|FG000|NOT COMPLETED|Days 22-28||0||
48050293|NCT01823510|100445090|FG001|NOT COMPLETED|Days 22-28||0||
48050294|NCT01721577|100445091|FG000|STARTED|Overall Study||2||
48050295|NCT01721577|100445092|FG001|STARTED|Overall Study||7||
48050296|NCT01721577|100445091|FG000|COMPLETED|Overall Study||0||
48050297|NCT01721577|100445092|FG001|COMPLETED|Overall Study||4||
48050298|NCT01721577|100445091|FG000|NOT COMPLETED|Overall Study||2||
48050299|NCT01721577|100445092|FG001|NOT COMPLETED|Overall Study||3||
48050300|NCT03523000|100445093|FG000|STARTED|Overall Study||20||
48050301|NCT03523000|100445094|FG001|STARTED|Overall Study||16||
48050302|NCT03523000|100445093|FG000|COMPLETED|Overall Study||15||
48050303|NCT03523000|100445094|FG001|COMPLETED|Overall Study||16||
48050304|NCT03523000|100445093|FG000|NOT COMPLETED|Overall Study||5||
48050305|NCT03523000|100445094|FG001|NOT COMPLETED|Overall Study||0||
48050306|NCT00266851|100445095|FG000|STARTED|Overall Study||37||
48050307|NCT00266851|100445096|FG001|STARTED|Overall Study||38||
48050308|NCT00266851|100445097|FG002|STARTED|Overall Study||22||
48050309|NCT00266851|100445095|FG000|Completed 3 Month Follow up|Overall Study||26||
48050310|NCT00266851|100445096|FG001|Completed 3 Month Follow up|Overall Study||22||
48050311|NCT00266851|100445097|FG002|Completed 3 Month Follow up|Overall Study||15||
48050312|NCT00266851|100445095|FG000|Completed 6 Month Follow up|Overall Study||27||
48050313|NCT00266851|100445096|FG001|Completed 6 Month Follow up|Overall Study||22||
48050314|NCT00266851|100445097|FG002|Completed 6 Month Follow up|Overall Study||17||
48050315|NCT00266851|100445095|FG000|Completed 9 Month Follow up|Overall Study||22||
48050316|NCT00266851|100445096|FG001|Completed 9 Month Follow up|Overall Study||23||
48050317|NCT00266851|100445097|FG002|Completed 9 Month Follow up|Overall Study||15||
48050318|NCT00266851|100445095|FG000|Completed 12 Month Follow up|Overall Study||25||
48050319|NCT00266851|100445096|FG001|Completed 12 Month Follow up|Overall Study||19||
48050320|NCT00266851|100445097|FG002|Completed 12 Month Follow up|Overall Study||13||
48050321|NCT00266851|100445095|FG000|COMPLETED|Overall Study||37|All participants received the intervention or participated in the open-label arm completed study.|
48050322|NCT00266851|100445096|FG001|COMPLETED|Overall Study||38|All participants received the intervention or participated in the open-label arm completed study.|
48050323|NCT00266851|100445097|FG002|COMPLETED|Overall Study||22|All participants received the intervention or participated in the open-label arm completed study.|
48050324|NCT00266851|100445095|FG000|NOT COMPLETED|Overall Study||0||
48050325|NCT00266851|100445096|FG001|NOT COMPLETED|Overall Study||0||
48050326|NCT00266851|100445097|FG002|NOT COMPLETED|Overall Study||0||
48050327|NCT01214174|100445098|FG000|STARTED|Overall Study||13||
48050328|NCT01214174|100445099|FG001|STARTED|Overall Study||16||
48050329|NCT01214174|100445100|FG002|STARTED|Overall Study||14||
48050330|NCT01214174|100445098|FG000|COMPLETED|Overall Study||13||
48050331|NCT01214174|100445099|FG001|COMPLETED|Overall Study||16||
48050332|NCT01214174|100445100|FG002|COMPLETED|Overall Study||13||
48050333|NCT01214174|100445098|FG000|NOT COMPLETED|Overall Study||0||
48208285|NCT05636332|100837020|FG002|STARTED|Overall Study||20||
48495671|NCT00493805|101547905|FG001|COMPLETED|Overall Study||42||
48050334|NCT01214174|100445099|FG001|NOT COMPLETED|Overall Study||0||
48050335|NCT01214174|100445100|FG002|NOT COMPLETED|Overall Study||1||
48050336|NCT02415855|100445101|FG000|STARTED|Overall Study||37||
48050337|NCT02415855|100445102|FG001|STARTED|Overall Study||64||
48050338|NCT02415855|100445101|FG000|COMPLETED|Overall Study||34||
48050339|NCT02415855|100445102|FG001|COMPLETED|Overall Study||62||
48050340|NCT02415855|100445101|FG000|NOT COMPLETED|Overall Study||3||
48050341|NCT02415855|100445102|FG001|NOT COMPLETED|Overall Study||2||
48050342|NCT00470184|100445103|FG000|STARTED|Overall Study||41||
48050343|NCT00470184|100445103|FG000|Treated With Study Therapy|Overall Study||36||
48208286|NCT05636332|100837018|FG000|COMPLETED|Overall Study||20||
48208287|NCT05636332|100837019|FG001|COMPLETED|Overall Study||20||
48208288|NCT05636332|100837020|FG002|COMPLETED|Overall Study||20||
48208289|NCT05636332|100837018|FG000|NOT COMPLETED|Overall Study||0||
48208290|NCT05636332|100837019|FG001|NOT COMPLETED|Overall Study||0||
48050344|NCT00470184|100445103|FG000|COMPLETED|Overall Study||19||
48050345|NCT00470184|100445103|FG000|NOT COMPLETED|Overall Study||22||
48050346|NCT03345342|100445104|FG000|STARTED|Open-Label Phase||838||
48050347|NCT03345342|100445105|FG001|STARTED|Open-Label Phase||0||
48050348|NCT03345342|100445106|FG002|STARTED|Open-Label Phase||0||
48050349|NCT03345342|100445107|FG003|STARTED|Open-Label Phase||0||
48050350|NCT03345342|100445108|FG004|STARTED|Open-Label Phase||0||
48050351|NCT03345342|100445104|FG000|COMPLETED|Open-Label Phase||702||
48050352|NCT03345342|100445105|FG001|COMPLETED|Open-Label Phase||0||
48050353|NCT03345342|100445106|FG002|COMPLETED|Open-Label Phase||0||
48050354|NCT03345342|100445107|FG003|COMPLETED|Open-Label Phase||0||
48050355|NCT03345342|100445108|FG004|COMPLETED|Open-Label Phase||0||
48050356|NCT03345342|100445104|FG000|NOT COMPLETED|Open-Label Phase||136||
48050357|NCT03345342|100445105|FG001|NOT COMPLETED|Open-Label Phase||0||
48050358|NCT03345342|100445106|FG002|NOT COMPLETED|Open-Label Phase||0||
48050359|NCT03345342|100445107|FG003|NOT COMPLETED|Open-Label Phase||0||
48050360|NCT03345342|100445108|FG004|NOT COMPLETED|Open-Label Phase||0||
48050361|NCT03345342|100445104|FG000|STARTED|Double-Blind Phase||0||
48050362|NCT03345342|100445105|FG001|STARTED|Double-Blind Phase||224||
48050363|NCT03345342|100445106|FG002|STARTED|Double-Blind Phase||478||
48050364|NCT03345342|100445107|FG003|STARTED|Double-Blind Phase||0||
48050365|NCT03345342|100445108|FG004|STARTED|Double-Blind Phase||0||
48050366|NCT03345342|100445104|FG000|COMPLETED|Double-Blind Phase||0||
48050367|NCT03345342|100445105|FG001|COMPLETED|Double-Blind Phase||202||
48050368|NCT03345342|100445106|FG002|COMPLETED|Double-Blind Phase||416||
48050369|NCT03345342|100445107|FG003|COMPLETED|Double-Blind Phase||0||
48050370|NCT03345342|100445108|FG004|COMPLETED|Double-Blind Phase||0||
48050371|NCT03345342|100445104|FG000|NOT COMPLETED|Double-Blind Phase||0||
48050372|NCT03345342|100445105|FG001|NOT COMPLETED|Double-Blind Phase||22||
48050373|NCT03345342|100445106|FG002|NOT COMPLETED|Double-Blind Phase||62||
48050374|NCT03345342|100445107|FG003|NOT COMPLETED|Double-Blind Phase||0||
48050375|NCT03345342|100445108|FG004|NOT COMPLETED|Double-Blind Phase||0||
48050376|NCT03345342|100445104|FG000|STARTED|Follow-Up Phase||0||
48050377|NCT03345342|100445105|FG001|STARTED|Follow-Up Phase||0||
48050378|NCT03345342|100445106|FG002|STARTED|Follow-Up Phase||0||
48050379|NCT03345342|100445107|FG003|STARTED|Follow-Up Phase||42||
48050380|NCT03345342|100445108|FG004|STARTED|Follow-Up Phase||109||
48050381|NCT03345342|100445104|FG000|COMPLETED|Follow-Up Phase||0||
48050382|NCT03345342|100445105|FG001|COMPLETED|Follow-Up Phase||0||
48050383|NCT03345342|100445106|FG002|COMPLETED|Follow-Up Phase||0||
48050384|NCT03345342|100445107|FG003|COMPLETED|Follow-Up Phase||34||
48050385|NCT03345342|100445108|FG004|COMPLETED|Follow-Up Phase||78||
48050386|NCT03345342|100445104|FG000|NOT COMPLETED|Follow-Up Phase||0||
48050387|NCT03345342|100445105|FG001|NOT COMPLETED|Follow-Up Phase||0||
48050388|NCT03345342|100445106|FG002|NOT COMPLETED|Follow-Up Phase||0||
48050389|NCT03345342|100445107|FG003|NOT COMPLETED|Follow-Up Phase||8||
48050390|NCT03345342|100445108|FG004|NOT COMPLETED|Follow-Up Phase||31||
48050391|NCT04198818|100445109|FG000|STARTED|25mg BID||3||
48050392|NCT04198818|100445110|FG001|STARTED|25mg BID||0||
48050393|NCT04198818|100445111|FG002|STARTED|25mg BID||0||
48050394|NCT04198818|100445112|FG003|STARTED|25mg BID||0||
48050395|NCT04198818|100445113|FG004|STARTED|25mg BID||0||
48050396|NCT04198818|100445114|FG005|STARTED|25mg BID||0||
48050397|NCT04198818|100445115|FG006|STARTED|25mg BID||0||
48050398|NCT04198818|100445116|FG007|STARTED|25mg BID||0||
48050399|NCT04198818|100445109|FG000|COMPLETED|25mg BID||0||
48050400|NCT04198818|100445110|FG001|COMPLETED|25mg BID||0||
48050401|NCT04198818|100445111|FG002|COMPLETED|25mg BID||0||
48050402|NCT04198818|100445112|FG003|COMPLETED|25mg BID||0||
48208291|NCT05636332|100837020|FG002|NOT COMPLETED|Overall Study||0||
48050403|NCT04198818|100445113|FG004|COMPLETED|25mg BID||0||
48050404|NCT04198818|100445114|FG005|COMPLETED|25mg BID||0||
48050405|NCT04198818|100445115|FG006|COMPLETED|25mg BID||0||
48050406|NCT04198818|100445116|FG007|COMPLETED|25mg BID||0||
48050407|NCT04198818|100445109|FG000|NOT COMPLETED|25mg BID||3||
48050408|NCT04198818|100445110|FG001|NOT COMPLETED|25mg BID||0||
48050409|NCT04198818|100445111|FG002|NOT COMPLETED|25mg BID||0||
48050410|NCT04198818|100445112|FG003|NOT COMPLETED|25mg BID||0||
48050411|NCT04198818|100445113|FG004|NOT COMPLETED|25mg BID||0||
48050412|NCT04198818|100445114|FG005|NOT COMPLETED|25mg BID||0||
48208292|NCT03520413|100837021|FG000|STARTED|Overall Study||101||
48050413|NCT04198818|100445115|FG006|NOT COMPLETED|25mg BID||0||
48050414|NCT04198818|100445116|FG007|NOT COMPLETED|25mg BID||0||
48050415|NCT04198818|100445109|FG000|STARTED|50mg BID||0||
48050416|NCT04198818|100445110|FG001|STARTED|50mg BID||3||
48050417|NCT04198818|100445111|FG002|STARTED|50mg BID||0||
48050418|NCT04198818|100445112|FG003|STARTED|50mg BID||0||
48050419|NCT04198818|100445113|FG004|STARTED|50mg BID||0||
48050420|NCT04198818|100445114|FG005|STARTED|50mg BID||0||
48050421|NCT04198818|100445115|FG006|STARTED|50mg BID||0||
48050422|NCT04198818|100445116|FG007|STARTED|50mg BID||0||
48050423|NCT04198818|100445109|FG000|COMPLETED|50mg BID||0||
48050424|NCT04198818|100445110|FG001|COMPLETED|50mg BID||0||
48050425|NCT04198818|100445111|FG002|COMPLETED|50mg BID||0||
48050426|NCT04198818|100445112|FG003|COMPLETED|50mg BID||0||
48050427|NCT04198818|100445113|FG004|COMPLETED|50mg BID||0||
48050428|NCT04198818|100445114|FG005|COMPLETED|50mg BID||0||
48050429|NCT04198818|100445115|FG006|COMPLETED|50mg BID||0||
48050430|NCT04198818|100445116|FG007|COMPLETED|50mg BID||0||
48050431|NCT04198818|100445109|FG000|NOT COMPLETED|50mg BID||0||
48050432|NCT04198818|100445110|FG001|NOT COMPLETED|50mg BID||3||
48050433|NCT04198818|100445111|FG002|NOT COMPLETED|50mg BID||0||
48050434|NCT04198818|100445112|FG003|NOT COMPLETED|50mg BID||0||
48050435|NCT04198818|100445113|FG004|NOT COMPLETED|50mg BID||0||
48050436|NCT04198818|100445114|FG005|NOT COMPLETED|50mg BID||0||
48050437|NCT04198818|100445115|FG006|NOT COMPLETED|50mg BID||0||
48050438|NCT04198818|100445116|FG007|NOT COMPLETED|50mg BID||0||
48050439|NCT04198818|100445109|FG000|STARTED|100mg BID||0||
48050440|NCT04198818|100445110|FG001|STARTED|100mg BID||0||
48050441|NCT04198818|100445111|FG002|STARTED|100mg BID||4||
48050442|NCT04198818|100445112|FG003|STARTED|100mg BID||0||
48050443|NCT04198818|100445113|FG004|STARTED|100mg BID||0||
48050444|NCT04198818|100445114|FG005|STARTED|100mg BID||0||
48050445|NCT04198818|100445115|FG006|STARTED|100mg BID||0||
48050446|NCT04198818|100445116|FG007|STARTED|100mg BID||0||
48050447|NCT04198818|100445109|FG000|COMPLETED|100mg BID||0||
48050448|NCT04198818|100445110|FG001|COMPLETED|100mg BID||0||
48050449|NCT04198818|100445111|FG002|COMPLETED|100mg BID||0||
48050450|NCT04198818|100445112|FG003|COMPLETED|100mg BID||0||
48050451|NCT04198818|100445113|FG004|COMPLETED|100mg BID||0||
48050452|NCT04198818|100445114|FG005|COMPLETED|100mg BID||0||
48050453|NCT04198818|100445115|FG006|COMPLETED|100mg BID||0||
48050454|NCT04198818|100445116|FG007|COMPLETED|100mg BID||0||
48050455|NCT04198818|100445109|FG000|NOT COMPLETED|100mg BID||0||
48050456|NCT04198818|100445110|FG001|NOT COMPLETED|100mg BID||0||
48050457|NCT04198818|100445111|FG002|NOT COMPLETED|100mg BID||4||
48050458|NCT04198818|100445112|FG003|NOT COMPLETED|100mg BID||0||
48050459|NCT04198818|100445113|FG004|NOT COMPLETED|100mg BID||0||
48050460|NCT04198818|100445114|FG005|NOT COMPLETED|100mg BID||0||
48050461|NCT04198818|100445115|FG006|NOT COMPLETED|100mg BID||0||
48050462|NCT04198818|100445116|FG007|NOT COMPLETED|100mg BID||0||
48050463|NCT04198818|100445109|FG000|STARTED|300mg QD||0||
48050464|NCT04198818|100445110|FG001|STARTED|300mg QD||0||
48050465|NCT04198818|100445111|FG002|STARTED|300mg QD||0||
48050466|NCT04198818|100445112|FG003|STARTED|300mg QD||4||
48050467|NCT04198818|100445113|FG004|STARTED|300mg QD||0||
48050468|NCT04198818|100445114|FG005|STARTED|300mg QD||0||
48050469|NCT04198818|100445115|FG006|STARTED|300mg QD||0||
48050470|NCT04198818|100445116|FG007|STARTED|300mg QD||0||
48050471|NCT04198818|100445109|FG000|COMPLETED|300mg QD||0||
48050472|NCT04198818|100445110|FG001|COMPLETED|300mg QD||0||
48050473|NCT04198818|100445111|FG002|COMPLETED|300mg QD||0||
48050474|NCT04198818|100445112|FG003|COMPLETED|300mg QD||0||
48050475|NCT04198818|100445113|FG004|COMPLETED|300mg QD||0||
48050476|NCT04198818|100445114|FG005|COMPLETED|300mg QD||0||
48050477|NCT04198818|100445115|FG006|COMPLETED|300mg QD||0||
48050478|NCT04198818|100445116|FG007|COMPLETED|300mg QD||0||
48050479|NCT04198818|100445109|FG000|NOT COMPLETED|300mg QD||0||
48050480|NCT04198818|100445110|FG001|NOT COMPLETED|300mg QD||0||
48050481|NCT04198818|100445111|FG002|NOT COMPLETED|300mg QD||0||
48050482|NCT04198818|100445112|FG003|NOT COMPLETED|300mg QD||4||
48050483|NCT04198818|100445113|FG004|NOT COMPLETED|300mg QD||0||
48050484|NCT04198818|100445114|FG005|NOT COMPLETED|300mg QD||0||
48050485|NCT04198818|100445115|FG006|NOT COMPLETED|300mg QD||0||
48050486|NCT04198818|100445116|FG007|NOT COMPLETED|300mg QD||0||
48050487|NCT04198818|100445109|FG000|STARTED|400mg QD||0||
48050488|NCT04198818|100445110|FG001|STARTED|400mg QD||0||
48050489|NCT04198818|100445111|FG002|STARTED|400mg QD||0||
48050490|NCT04198818|100445112|FG003|STARTED|400mg QD||0||
48050491|NCT04198818|100445113|FG004|STARTED|400mg QD||4||
48050492|NCT04198818|100445114|FG005|STARTED|400mg QD||0||
48050493|NCT04198818|100445115|FG006|STARTED|400mg QD||0||
48050494|NCT04198818|100445116|FG007|STARTED|400mg QD||0||
48050495|NCT04198818|100445109|FG000|COMPLETED|400mg QD||0||
48050496|NCT04198818|100445110|FG001|COMPLETED|400mg QD||0||
48050497|NCT04198818|100445111|FG002|COMPLETED|400mg QD||0||
48050498|NCT04198818|100445112|FG003|COMPLETED|400mg QD||0||
48050499|NCT04198818|100445113|FG004|COMPLETED|400mg QD||0||
48050500|NCT04198818|100445114|FG005|COMPLETED|400mg QD||0||
48050501|NCT04198818|100445115|FG006|COMPLETED|400mg QD||0||
48050502|NCT04198818|100445116|FG007|COMPLETED|400mg QD||0||
48050503|NCT04198818|100445109|FG000|NOT COMPLETED|400mg QD||0||
48050504|NCT04198818|100445110|FG001|NOT COMPLETED|400mg QD||0||
48050505|NCT04198818|100445111|FG002|NOT COMPLETED|400mg QD||0||
48050506|NCT04198818|100445112|FG003|NOT COMPLETED|400mg QD||0||
48050507|NCT04198818|100445113|FG004|NOT COMPLETED|400mg QD||4||
48050508|NCT04198818|100445114|FG005|NOT COMPLETED|400mg QD||0||
48050509|NCT04198818|100445115|FG006|NOT COMPLETED|400mg QD||0||
48050510|NCT04198818|100445116|FG007|NOT COMPLETED|400mg QD||0||
48050511|NCT04198818|100445109|FG000|STARTED|600mg QD||0||
48050512|NCT04198818|100445110|FG001|STARTED|600mg QD||0||
48050513|NCT04198818|100445111|FG002|STARTED|600mg QD||0||
48050514|NCT04198818|100445112|FG003|STARTED|600mg QD||0||
48050515|NCT04198818|100445113|FG004|STARTED|600mg QD||0||
48050516|NCT04198818|100445114|FG005|STARTED|600mg QD||8||
48050517|NCT04198818|100445115|FG006|STARTED|600mg QD||0||
48050518|NCT04198818|100445116|FG007|STARTED|600mg QD||0||
48050519|NCT04198818|100445109|FG000|COMPLETED|600mg QD||0||
48050520|NCT04198818|100445110|FG001|COMPLETED|600mg QD||0||
48050521|NCT04198818|100445111|FG002|COMPLETED|600mg QD||0||
48050522|NCT04198818|100445112|FG003|COMPLETED|600mg QD||0||
48050523|NCT04198818|100445113|FG004|COMPLETED|600mg QD||0||
48050524|NCT04198818|100445114|FG005|COMPLETED|600mg QD||0||
48050525|NCT04198818|100445115|FG006|COMPLETED|600mg QD||0||
48050526|NCT04198818|100445116|FG007|COMPLETED|600mg QD||0||
48050527|NCT04198818|100445109|FG000|NOT COMPLETED|600mg QD||0||
48050528|NCT04198818|100445110|FG001|NOT COMPLETED|600mg QD||0||
48050529|NCT04198818|100445111|FG002|NOT COMPLETED|600mg QD||0||
48050530|NCT04198818|100445112|FG003|NOT COMPLETED|600mg QD||0||
48050531|NCT04198818|100445113|FG004|NOT COMPLETED|600mg QD||0||
48050532|NCT04198818|100445114|FG005|NOT COMPLETED|600mg QD||8||
48050533|NCT04198818|100445115|FG006|NOT COMPLETED|600mg QD||0||
48050534|NCT04198818|100445116|FG007|NOT COMPLETED|600mg QD||0||
48050535|NCT04198818|100445109|FG000|STARTED|800mg QD||0||
48050536|NCT04198818|100445110|FG001|STARTED|800mg QD||0||
48050537|NCT04198818|100445111|FG002|STARTED|800mg QD||0||
48050538|NCT04198818|100445112|FG003|STARTED|800mg QD||0||
48050539|NCT04198818|100445113|FG004|STARTED|800mg QD||0||
48050540|NCT04198818|100445114|FG005|STARTED|800mg QD||0||
48050541|NCT04198818|100445115|FG006|STARTED|800mg QD||4||
48050542|NCT04198818|100445116|FG007|STARTED|800mg QD||0||
48050543|NCT04198818|100445109|FG000|COMPLETED|800mg QD||0||
48050544|NCT04198818|100445110|FG001|COMPLETED|800mg QD||0||
48050545|NCT04198818|100445111|FG002|COMPLETED|800mg QD||0||
48050546|NCT04198818|100445112|FG003|COMPLETED|800mg QD||0||
48050547|NCT04198818|100445113|FG004|COMPLETED|800mg QD||0||
48208293|NCT03520413|100837022|FG001|STARTED|Overall Study||99||
48208294|NCT03520413|100837021|FG000|COMPLETED|Overall Study||77||
48050548|NCT04198818|100445114|FG005|COMPLETED|800mg QD||0||
48050549|NCT04198818|100445115|FG006|COMPLETED|800mg QD||0||
48050550|NCT04198818|100445116|FG007|COMPLETED|800mg QD||0||
48050551|NCT04198818|100445109|FG000|NOT COMPLETED|800mg QD||0||
48050552|NCT04198818|100445110|FG001|NOT COMPLETED|800mg QD||0||
48050553|NCT04198818|100445111|FG002|NOT COMPLETED|800mg QD||0||
48050554|NCT04198818|100445112|FG003|NOT COMPLETED|800mg QD||0||
48050555|NCT04198818|100445113|FG004|NOT COMPLETED|800mg QD||0||
48050556|NCT04198818|100445114|FG005|NOT COMPLETED|800mg QD||0||
48050557|NCT04198818|100445115|FG006|NOT COMPLETED|800mg QD||4||
48050558|NCT04198818|100445116|FG007|NOT COMPLETED|800mg QD||0||
48050559|NCT04198818|100445109|FG000|STARTED|200mg BID||0||
48050560|NCT04198818|100445110|FG001|STARTED|200mg BID||0||
48050561|NCT04198818|100445111|FG002|STARTED|200mg BID||0||
48050562|NCT04198818|100445112|FG003|STARTED|200mg BID||0||
48050563|NCT04198818|100445113|FG004|STARTED|200mg BID||0||
48050564|NCT04198818|100445114|FG005|STARTED|200mg BID||0||
48050565|NCT04198818|100445115|FG006|STARTED|200mg BID||0||
48050566|NCT04198818|100445116|FG007|STARTED|200mg BID||7||
48050567|NCT04198818|100445109|FG000|COMPLETED|200mg BID||0||
48050568|NCT04198818|100445110|FG001|COMPLETED|200mg BID||0||
48050569|NCT04198818|100445111|FG002|COMPLETED|200mg BID||0||
48208295|NCT03520413|100837022|FG001|COMPLETED|Overall Study||73||
48050570|NCT04198818|100445112|FG003|COMPLETED|200mg BID||0||
48050571|NCT04198818|100445113|FG004|COMPLETED|200mg BID||0||
48050572|NCT04198818|100445114|FG005|COMPLETED|200mg BID||0||
48050573|NCT04198818|100445115|FG006|COMPLETED|200mg BID||0||
48050574|NCT04198818|100445116|FG007|COMPLETED|200mg BID||0||
48050575|NCT04198818|100445109|FG000|NOT COMPLETED|200mg BID||0||
48050576|NCT04198818|100445110|FG001|NOT COMPLETED|200mg BID||0||
48050577|NCT04198818|100445111|FG002|NOT COMPLETED|200mg BID||0||
48050578|NCT04198818|100445112|FG003|NOT COMPLETED|200mg BID||0||
48050579|NCT04198818|100445113|FG004|NOT COMPLETED|200mg BID||0||
48050580|NCT04198818|100445114|FG005|NOT COMPLETED|200mg BID||0||
48050581|NCT04198818|100445115|FG006|NOT COMPLETED|200mg BID||0||
48050582|NCT04198818|100445116|FG007|NOT COMPLETED|200mg BID||7||
48050583|NCT01487577|100445117|FG000|STARTED|Overall Study||19||
48050584|NCT01487577|100445117|FG000|COMPLETED|Overall Study||18||
48050585|NCT01487577|100445117|FG000|NOT COMPLETED|Overall Study||1||
48050586|NCT01439347|100445118|FG000|STARTED|Overall Study||13||
48050587|NCT01439347|100445119|FG001|STARTED|Overall Study||13||
48050588|NCT01439347|100445118|FG000|COMPLETED|Overall Study||0||
48208296|NCT03520413|100837021|FG000|NOT COMPLETED|Overall Study||24||
48208297|NCT03520413|100837022|FG001|NOT COMPLETED|Overall Study||26||
48050589|NCT01439347|100445119|FG001|COMPLETED|Overall Study||0||
48050590|NCT01439347|100445118|FG000|NOT COMPLETED|Overall Study||13||
48050591|NCT01439347|100445119|FG001|NOT COMPLETED|Overall Study||13||
48050592|NCT00371761|100445120|FG000|STARTED|Overall Study||13||
48050593|NCT00371761|100445121|FG001|STARTED|Overall Study||12||
48050594|NCT00371761|100445120|FG000|COMPLETED|Overall Study||5||
48050595|NCT00371761|100445121|FG001|COMPLETED|Overall Study||2||
48050596|NCT00371761|100445120|FG000|NOT COMPLETED|Overall Study||8||
48050597|NCT00371761|100445121|FG001|NOT COMPLETED|Overall Study||10||
48050598|NCT01249118|100445122|FG000|STARTED|First Intervention Period||2||
48050599|NCT01249118|100445123|FG001|STARTED|First Intervention Period||6||
48050600|NCT01249118|100445124|FG002|STARTED|First Intervention Period||5||
48050601|NCT01249118|100445122|FG000|COMPLETED|First Intervention Period||2||
48050602|NCT01249118|100445123|FG001|COMPLETED|First Intervention Period||6||
48050603|NCT01249118|100445124|FG002|COMPLETED|First Intervention Period||5||
48050604|NCT01249118|100445122|FG000|NOT COMPLETED|First Intervention Period||0||
48050605|NCT01249118|100445123|FG001|NOT COMPLETED|First Intervention Period||0||
48050606|NCT01249118|100445124|FG002|NOT COMPLETED|First Intervention Period||0||
48050607|NCT01249118|100445122|FG000|STARTED|First Washout Period||2||
48050608|NCT01249118|100445123|FG001|STARTED|First Washout Period||6||
48050609|NCT01249118|100445124|FG002|STARTED|First Washout Period||5||
48050610|NCT01249118|100445122|FG000|COMPLETED|First Washout Period||2||
48050611|NCT01249118|100445123|FG001|COMPLETED|First Washout Period||5||
48050612|NCT01249118|100445124|FG002|COMPLETED|First Washout Period||5||
48050613|NCT01249118|100445122|FG000|NOT COMPLETED|First Washout Period||0||
48050614|NCT01249118|100445123|FG001|NOT COMPLETED|First Washout Period||1||
48050615|NCT01249118|100445124|FG002|NOT COMPLETED|First Washout Period||0||
48050616|NCT01249118|100445122|FG000|STARTED|Second Intervention Period||2||
48050617|NCT01249118|100445123|FG001|STARTED|Second Intervention Period||5||
48050618|NCT01249118|100445124|FG002|STARTED|Second Intervention Period||5||
48050619|NCT01249118|100445122|FG000|COMPLETED|Second Intervention Period||2||
48050620|NCT01249118|100445123|FG001|COMPLETED|Second Intervention Period||5||
48050621|NCT01249118|100445124|FG002|COMPLETED|Second Intervention Period||5||
48050622|NCT01249118|100445122|FG000|NOT COMPLETED|Second Intervention Period||0||
48050623|NCT01249118|100445123|FG001|NOT COMPLETED|Second Intervention Period||0||
48050624|NCT01249118|100445124|FG002|NOT COMPLETED|Second Intervention Period||0||
48050625|NCT01249118|100445122|FG000|STARTED|Second Washout Period||2||
48050626|NCT01249118|100445123|FG001|STARTED|Second Washout Period||5||
48050627|NCT01249118|100445124|FG002|STARTED|Second Washout Period||5||
48050628|NCT01249118|100445122|FG000|COMPLETED|Second Washout Period||2||
48050629|NCT01249118|100445123|FG001|COMPLETED|Second Washout Period||5||
48050630|NCT01249118|100445124|FG002|COMPLETED|Second Washout Period||5||
48050631|NCT01249118|100445122|FG000|NOT COMPLETED|Second Washout Period||0||
48050632|NCT01249118|100445123|FG001|NOT COMPLETED|Second Washout Period||0||
48050633|NCT01249118|100445124|FG002|NOT COMPLETED|Second Washout Period||0||
48050634|NCT03194490|100445125|FG000|STARTED|Overall Study||20||
48050635|NCT03194490|100445126|FG001|STARTED|Overall Study||23||
48050636|NCT03194490|100445125|FG000|COMPLETED|Overall Study||18||
48050637|NCT03194490|100445126|FG001|COMPLETED|Overall Study||20||
48050638|NCT03194490|100445125|FG000|NOT COMPLETED|Overall Study||2||
48050639|NCT03194490|100445126|FG001|NOT COMPLETED|Overall Study||3||
48050640|NCT04644783|100445127|FG000|STARTED|Overall Study||10||
48050641|NCT04644783|100445127|FG000|COMPLETED|Overall Study||10||
48050642|NCT04644783|100445127|FG000|NOT COMPLETED|Overall Study||0||
48050643|NCT02596750|100445128|FG000|STARTED|Baseline||21|21 participants total started|21
48050644|NCT02596750|100445129|FG001|STARTED|Baseline||21|21 participants total started|21
48050645|NCT02596750|100445128|FG000|COMPLETED|Baseline||21|21 participants total completed|21
48050646|NCT02596750|100445129|FG001|COMPLETED|Baseline||21|21 participants total completed|21
48050647|NCT02596750|100445128|FG000|NOT COMPLETED|Baseline||0||0
48050648|NCT02596750|100445129|FG001|NOT COMPLETED|Baseline||0||0
48050649|NCT02596750|100445128|FG000|STARTED|2 Minutes||21||21
48050650|NCT02596750|100445129|FG001|STARTED|2 Minutes||21||21
48050651|NCT02596750|100445128|FG000|COMPLETED|2 Minutes||21||21
48050652|NCT02596750|100445129|FG001|COMPLETED|2 Minutes||21||21
48050653|NCT02596750|100445128|FG000|NOT COMPLETED|2 Minutes||0||0
48050654|NCT02596750|100445129|FG001|NOT COMPLETED|2 Minutes||0||0
48050655|NCT02596750|100445128|FG000|STARTED|5 Minutes||21||21
48050656|NCT02596750|100445129|FG001|STARTED|5 Minutes||21||21
48050657|NCT02596750|100445128|FG000|COMPLETED|5 Minutes||21||21
48208298|NCT00661778|100837023|FG000|STARTED|Overall Study||50||
48050658|NCT02596750|100445129|FG001|COMPLETED|5 Minutes||21||21
48050659|NCT02596750|100445128|FG000|NOT COMPLETED|5 Minutes||0||0
48050660|NCT02596750|100445129|FG001|NOT COMPLETED|5 Minutes||0||0
48050661|NCT02596750|100445128|FG000|STARTED|10 Minutes||21||21
48050662|NCT02596750|100445129|FG001|STARTED|10 Minutes||21||21
48050663|NCT02596750|100445128|FG000|COMPLETED|10 Minutes||21||21
48050664|NCT02596750|100445129|FG001|COMPLETED|10 Minutes||21||21
48050665|NCT02596750|100445128|FG000|NOT COMPLETED|10 Minutes||0||0
48050666|NCT02596750|100445129|FG001|NOT COMPLETED|10 Minutes||0||0
48050667|NCT02596750|100445128|FG000|STARTED|30 Minutes||21||21
48050668|NCT02596750|100445129|FG001|STARTED|30 Minutes||21||21
48050669|NCT02596750|100445128|FG000|COMPLETED|30 Minutes||21||21
48050670|NCT02596750|100445129|FG001|COMPLETED|30 Minutes||21||21
48050671|NCT02596750|100445128|FG000|NOT COMPLETED|30 Minutes||0||0
48050672|NCT02596750|100445129|FG001|NOT COMPLETED|30 Minutes||0||0
48050673|NCT02117427|100445130|FG000|STARTED|Overall Study||6||
48050674|NCT02117427|100445131|FG001|STARTED|Overall Study||5||
48050675|NCT02117427|100445132|FG002|STARTED|Overall Study||0||
48050676|NCT02117427|100445130|FG000|Run in Phase & Harvest|Overall Study||6||
48050677|NCT02117427|100445131|FG001|Run in Phase & Harvest|Overall Study||4||
48050678|NCT02117427|100445132|FG002|Run in Phase & Harvest|Overall Study||0||
48050679|NCT02117427|100445130|FG000|Implantation & Efficacy|Overall Study||6||
48050680|NCT02117427|100445131|FG001|Implantation & Efficacy|Overall Study||4||
48050681|NCT02117427|100445132|FG002|Implantation & Efficacy|Overall Study||0||
48050682|NCT02117427|100445130|FG000|Safety Follow-up|Overall Study||1||
48050683|NCT02117427|100445131|FG001|Safety Follow-up|Overall Study||0||
48050684|NCT02117427|100445132|FG002|Safety Follow-up|Overall Study||0||
48050685|NCT02117427|100445130|FG000|Long Term Safety Follow-up|Overall Study||1||
48050686|NCT02117427|100445131|FG001|Long Term Safety Follow-up|Overall Study||0||
48050687|NCT02117427|100445132|FG002|Long Term Safety Follow-up|Overall Study||0||
48050688|NCT02117427|100445130|FG000|COMPLETED|Overall Study||1||
48050689|NCT02117427|100445131|FG001|COMPLETED|Overall Study||0||
48050690|NCT02117427|100445132|FG002|COMPLETED|Overall Study||0||
48050691|NCT02117427|100445130|FG000|NOT COMPLETED|Overall Study||5||
48050692|NCT02117427|100445131|FG001|NOT COMPLETED|Overall Study||5||
48050693|NCT02117427|100445132|FG002|NOT COMPLETED|Overall Study||0||
48050694|NCT02376283|100445133|FG000|STARTED|Overall Study||27||
48050695|NCT02376283|100445134|FG001|STARTED|Overall Study||30||
48050696|NCT02376283|100445135|FG002|STARTED|Overall Study||30||
48050697|NCT02376283|100445133|FG000|COMPLETED|Overall Study||27||
48050698|NCT02376283|100445134|FG001|COMPLETED|Overall Study||30||
48050699|NCT02376283|100445135|FG002|COMPLETED|Overall Study||30||
48050700|NCT02376283|100445133|FG000|NOT COMPLETED|Overall Study||0||
48050701|NCT02376283|100445134|FG001|NOT COMPLETED|Overall Study||0||
48050702|NCT02376283|100445135|FG002|NOT COMPLETED|Overall Study||0||
48050703|NCT01856023|100445136|FG000|STARTED|Overall Study||13|I pt withdrew consent prior to receiving study drug- should have been listed as screen failure|
48050704|NCT01856023|100445137|FG001|STARTED|Overall Study||16|I pt withdrew consent prior to receiving study drug- should have been listed as screen failure|
48050705|NCT01856023|100445136|FG000|Intent to Treat: Received One Dose of Study Drug|Overall Study||12||
48050706|NCT01856023|100445137|FG001|Intent to Treat: Received One Dose of Study Drug|Overall Study||16||
48050707|NCT01856023|100445136|FG000|Evaluable: Received 50% of Each Study Drug|Overall Study||8||
48050708|NCT01856023|100445137|FG001|Evaluable: Received 50% of Each Study Drug|Overall Study||10||
48050709|NCT01856023|100445136|FG000|COMPLETED|Overall Study||3|completed all study requirements|
48050710|NCT01856023|100445137|FG001|COMPLETED|Overall Study||4|completed all study requirements|
48050711|NCT01856023|100445136|FG000|NOT COMPLETED|Overall Study||10||
48050712|NCT01856023|100445137|FG001|NOT COMPLETED|Overall Study||12||
48050713|NCT01888003|100445138|FG000|STARTED|Overall Study||5||
48050714|NCT01888003|100445139|FG001|STARTED|Overall Study||6||
48050715|NCT01888003|100445140|FG002|STARTED|Overall Study||40||
48050716|NCT01888003|100445138|FG000|COMPLETED|Overall Study||0||
48050717|NCT01888003|100445139|FG001|COMPLETED|Overall Study||0||
48050718|NCT01888003|100445140|FG002|COMPLETED|Overall Study||0||
48050719|NCT01888003|100445138|FG000|NOT COMPLETED|Overall Study||5||
48050720|NCT01888003|100445139|FG001|NOT COMPLETED|Overall Study||6||
48050721|NCT01888003|100445140|FG002|NOT COMPLETED|Overall Study||40||
48050722|NCT00473746|100445141|FG000|STARTED|Period 1 (Phase 1)||6||
48050723|NCT00473746|100445142|FG001|STARTED|Period 1 (Phase 1)||9||
48050724|NCT00473746|100445143|FG002|STARTED|Period 1 (Phase 1)||6||
48050725|NCT00473746|100445144|FG003|STARTED|Period 1 (Phase 1)||12||
48050726|NCT00473746|100445145|FG004|STARTED|Period 1 (Phase 1)||0||
48050727|NCT00473746|100445141|FG000|COMPLETED|Period 1 (Phase 1)||0||
48050728|NCT00473746|100445142|FG001|COMPLETED|Period 1 (Phase 1)||0||
48050729|NCT00473746|100445143|FG002|COMPLETED|Period 1 (Phase 1)||0||
48050730|NCT00473746|100445144|FG003|COMPLETED|Period 1 (Phase 1)||2||
48050731|NCT00473746|100445145|FG004|COMPLETED|Period 1 (Phase 1)||0||
48050732|NCT00473746|100445141|FG000|NOT COMPLETED|Period 1 (Phase 1)||6||
48050733|NCT00473746|100445142|FG001|NOT COMPLETED|Period 1 (Phase 1)||9||
48050734|NCT00473746|100445143|FG002|NOT COMPLETED|Period 1 (Phase 1)||6||
48050735|NCT00473746|100445144|FG003|NOT COMPLETED|Period 1 (Phase 1)||10||
48050736|NCT00473746|100445145|FG004|NOT COMPLETED|Period 1 (Phase 1)||0||
48050737|NCT00473746|100445141|FG000|STARTED|Period 2 (Phase 2)||0||
48050738|NCT00473746|100445142|FG001|STARTED|Period 2 (Phase 2)||0||
48050739|NCT00473746|100445143|FG002|STARTED|Period 2 (Phase 2)||0||
48050740|NCT00473746|100445144|FG003|STARTED|Period 2 (Phase 2)||0||
48050741|NCT00473746|100445145|FG004|STARTED|Period 2 (Phase 2)||33||
48050742|NCT00473746|100445141|FG000|COMPLETED|Period 2 (Phase 2)||0||
48050743|NCT00473746|100445142|FG001|COMPLETED|Period 2 (Phase 2)||0||
48050744|NCT00473746|100445143|FG002|COMPLETED|Period 2 (Phase 2)||0||
48050745|NCT00473746|100445144|FG003|COMPLETED|Period 2 (Phase 2)||0||
48050746|NCT00473746|100445145|FG004|COMPLETED|Period 2 (Phase 2)||6||
48050747|NCT00473746|100445141|FG000|NOT COMPLETED|Period 2 (Phase 2)||0||
48050748|NCT00473746|100445142|FG001|NOT COMPLETED|Period 2 (Phase 2)||0||
48050749|NCT00473746|100445143|FG002|NOT COMPLETED|Period 2 (Phase 2)||0||
48050750|NCT00473746|100445144|FG003|NOT COMPLETED|Period 2 (Phase 2)||0||
48050751|NCT00473746|100445145|FG004|NOT COMPLETED|Period 2 (Phase 2)||27||
48050752|NCT01958112|100445146|FG000|STARTED|Overall Study||14||
48050753|NCT01958112|100445146|FG000|COMPLETED|Overall Study||14||
48050754|NCT01958112|100445146|FG000|NOT COMPLETED|Overall Study||0||
48050755|NCT04697381|100445147|FG000|STARTED|Overall Study||6||
48050756|NCT04697381|100445148|FG001|STARTED|Overall Study||7||
48050757|NCT04697381|100445149|FG002|STARTED|Overall Study||20||
48050758|NCT04697381|100445147|FG000|COMPLETED|Overall Study||6||
48050759|NCT04697381|100445148|FG001|COMPLETED|Overall Study||7||
48050760|NCT04697381|100445149|FG002|COMPLETED|Overall Study||20||
48050761|NCT04697381|100445147|FG000|NOT COMPLETED|Overall Study||0||
48050762|NCT04697381|100445148|FG001|NOT COMPLETED|Overall Study||0||
48050763|NCT04697381|100445149|FG002|NOT COMPLETED|Overall Study||0||
48050764|NCT01752712|100445150|FG000|STARTED|Overall Study||31||
48050765|NCT01752712|100445151|FG001|STARTED|Overall Study||31||
48050766|NCT01752712|100445150|FG000|COMPLETED|Overall Study||22||
48050767|NCT01752712|100445151|FG001|COMPLETED|Overall Study||21||
48050768|NCT01752712|100445150|FG000|NOT COMPLETED|Overall Study||9||
48050769|NCT01752712|100445151|FG001|NOT COMPLETED|Overall Study||10||
48050770|NCT01466595|100445152|FG000|STARTED|Overall Study||49||
48050771|NCT01466595|100445153|FG001|STARTED|Overall Study||24||
48050772|NCT01466595|100445152|FG000|COMPLETED|Overall Study||49||
48050773|NCT01466595|100445153|FG001|COMPLETED|Overall Study||23||
48050774|NCT01466595|100445152|FG000|NOT COMPLETED|Overall Study||0||
48050775|NCT01466595|100445153|FG001|NOT COMPLETED|Overall Study||1||
48050776|NCT04218123|100445154|FG000|STARTED|Overall Study||20||
48050777|NCT04218123|100445155|FG001|STARTED|Overall Study||20||
48050778|NCT04218123|100445154|FG000|COMPLETED|Overall Study||18||
48050779|NCT04218123|100445155|FG001|COMPLETED|Overall Study||20||
48050780|NCT04218123|100445154|FG000|NOT COMPLETED|Overall Study||2||
48050781|NCT04218123|100445155|FG001|NOT COMPLETED|Overall Study||0||
48050782|NCT01151098|100445156|FG000|STARTED|Overall Study||189||
48050783|NCT01151098|100445156|FG000|COMPLETED|Overall Study||72||
48050784|NCT01151098|100445156|FG000|NOT COMPLETED|Overall Study||117||
48050785|NCT02233946|100445157|FG000|STARTED|Baseline||628||
48208299|NCT00661778|100837023|FG000|COMPLETED|Overall Study||0||
48208300|NCT00661778|100837023|FG000|NOT COMPLETED|Overall Study||50||
48208301|NCT00178399|100837024|FG000|STARTED|Overall Study||128||
48495672|NCT00493805|101547904|FG000|NOT COMPLETED|Overall Study||0||
48495673|NCT00493805|101547905|FG001|NOT COMPLETED|Overall Study||0||
48050786|NCT02233946|100445158|FG001|STARTED|Baseline||243||
48050787|NCT02233946|100445157|FG000|COMPLETED|Baseline||626||
48050788|NCT02233946|100445158|FG001|COMPLETED|Baseline||243||
48050789|NCT02233946|100445157|FG000|NOT COMPLETED|Baseline||2||
48050790|NCT02233946|100445158|FG001|NOT COMPLETED|Baseline||0||
48050791|NCT02233946|100445157|FG000|STARTED|Immediate Post-visit Questionnaire||626||
48050792|NCT02233946|100445158|FG001|STARTED|Immediate Post-visit Questionnaire||243||
48050793|NCT02233946|100445157|FG000|COMPLETED|Immediate Post-visit Questionnaire||624||
48050794|NCT02233946|100445158|FG001|COMPLETED|Immediate Post-visit Questionnaire||243||
48050795|NCT02233946|100445157|FG000|NOT COMPLETED|Immediate Post-visit Questionnaire||2||
48050796|NCT02233946|100445158|FG001|NOT COMPLETED|Immediate Post-visit Questionnaire||0||
48050797|NCT02233946|100445157|FG000|STARTED|3-months Follow-up||624||
48050798|NCT02233946|100445158|FG001|STARTED|3-months Follow-up||243||
48050799|NCT02233946|100445157|FG000|COMPLETED|3-months Follow-up||571||
48050800|NCT02233946|100445158|FG001|COMPLETED|3-months Follow-up||214||
48050801|NCT02233946|100445157|FG000|NOT COMPLETED|3-months Follow-up||53||
48050802|NCT02233946|100445158|FG001|NOT COMPLETED|3-months Follow-up||29||
48050803|NCT02233946|100445157|FG000|STARTED|6-months Follow-up||571||
48050804|NCT02233946|100445158|FG001|STARTED|6-months Follow-up||214||
48050805|NCT02233946|100445157|FG000|COMPLETED|6-months Follow-up||550||
48050806|NCT02233946|100445158|FG001|COMPLETED|6-months Follow-up||212||
48050807|NCT02233946|100445157|FG000|NOT COMPLETED|6-months Follow-up||21||
48050808|NCT02233946|100445158|FG001|NOT COMPLETED|6-months Follow-up||2||
48050809|NCT02233946|100445157|FG000|STARTED|9-month Follow-up||550||
48050810|NCT02233946|100445158|FG001|STARTED|9-month Follow-up||212||
48050811|NCT02233946|100445157|FG000|COMPLETED|9-month Follow-up||530||
48050812|NCT02233946|100445158|FG001|COMPLETED|9-month Follow-up||201||
48050813|NCT02233946|100445157|FG000|NOT COMPLETED|9-month Follow-up||20||
48050814|NCT02233946|100445158|FG001|NOT COMPLETED|9-month Follow-up||11||
48050815|NCT02233946|100445157|FG000|STARTED|12-month Follow-up||530||
48495674|NCT02718963|101547906|FG000|STARTED|Overall Study||10||
48050816|NCT02233946|100445158|FG001|STARTED|12-month Follow-up||201||
48050817|NCT02233946|100445157|FG000|COMPLETED|12-month Follow-up||502||
48050818|NCT02233946|100445158|FG001|COMPLETED|12-month Follow-up||190||
48050819|NCT02233946|100445157|FG000|NOT COMPLETED|12-month Follow-up||28||
48050820|NCT02233946|100445158|FG001|NOT COMPLETED|12-month Follow-up||11||
48050821|NCT00739596|100445159|FG000|STARTED|Overall Study||166||
48050822|NCT00739596|100445160|FG001|STARTED|Overall Study||166||
48050823|NCT00739596|100445159|FG000|COMPLETED|Overall Study||141||
48050824|NCT00739596|100445160|FG001|COMPLETED|Overall Study||149||
48050825|NCT00739596|100445159|FG000|NOT COMPLETED|Overall Study||25||
48050826|NCT00739596|100445160|FG001|NOT COMPLETED|Overall Study||17||
48050827|NCT02361580|100445161|FG000|STARTED|Overall Study||6||
48050828|NCT02361580|100445162|FG001|STARTED|Overall Study||3||
48050829|NCT02361580|100445161|FG000|COMPLETED|Overall Study||0||
48050830|NCT02361580|100445162|FG001|COMPLETED|Overall Study||0||
48050831|NCT02361580|100445161|FG000|NOT COMPLETED|Overall Study||6||
48050832|NCT02361580|100445162|FG001|NOT COMPLETED|Overall Study||3||
48050833|NCT01306877|100445163|FG000|STARTED|Overall Study||78||
48050834|NCT01306877|100445164|FG001|STARTED|Overall Study||71||
48050835|NCT01306877|100445163|FG000|COMPLETED|Overall Study||75||
48050836|NCT01306877|100445164|FG001|COMPLETED|Overall Study||67||
48050837|NCT01306877|100445163|FG000|NOT COMPLETED|Overall Study||3||
48050838|NCT01306877|100445164|FG001|NOT COMPLETED|Overall Study||4||
48050839|NCT00922701|100445165|FG000|STARTED|Overall Study||4||
48050840|NCT00922701|100445165|FG000|COMPLETED|Overall Study||4||
48050841|NCT00922701|100445165|FG000|NOT COMPLETED|Overall Study||0||
48050842|NCT01057901|100445166|FG000|STARTED|Overall Study||376||
48050843|NCT01057901|100445167|FG001|STARTED|Overall Study||372||
48050844|NCT01057901|100445166|FG000|COMPLETED|Overall Study||116||
48050845|NCT01057901|100445167|FG001|COMPLETED|Overall Study||126||
48050846|NCT01057901|100445166|FG000|NOT COMPLETED|Overall Study||260||
48050847|NCT01057901|100445167|FG001|NOT COMPLETED|Overall Study||246||
48050848|NCT00244842|100445168|FG000|STARTED|Overall Study||115||
48050849|NCT00244842|100445169|FG001|STARTED|Overall Study||107||
48050850|NCT00244842|100445170|FG002|STARTED|Overall Study||113||
48050851|NCT00244842|100445171|FG003|STARTED|Overall Study||116||
48050852|NCT00244842|100445168|FG000|COMPLETED|Overall Study||92||
48050853|NCT00244842|100445169|FG001|COMPLETED|Overall Study||76||
48050854|NCT00244842|100445170|FG002|COMPLETED|Overall Study||91||
48050855|NCT00244842|100445171|FG003|COMPLETED|Overall Study||83||
48050856|NCT00244842|100445168|FG000|NOT COMPLETED|Overall Study||23||
48050857|NCT00244842|100445169|FG001|NOT COMPLETED|Overall Study||31||
48050858|NCT00244842|100445170|FG002|NOT COMPLETED|Overall Study||22||
48050859|NCT00244842|100445171|FG003|NOT COMPLETED|Overall Study||33||
48050860|NCT02497976|100445172|FG000|STARTED|Overall Study||28||
48050861|NCT02497976|100445173|FG001|STARTED|Overall Study||14||
48050862|NCT02497976|100445172|FG000|COMPLETED|Overall Study||26||
48050863|NCT02497976|100445173|FG001|COMPLETED|Overall Study||13||
48050864|NCT02497976|100445172|FG000|NOT COMPLETED|Overall Study||2||
48050865|NCT02497976|100445173|FG001|NOT COMPLETED|Overall Study||1||
48050866|NCT02960997|100445174|FG000|STARTED|First Intervention, 12 Weeks||4||
48050867|NCT02960997|100445175|FG001|STARTED|First Intervention, 12 Weeks||4||
48050868|NCT02960997|100445174|FG000|COMPLETED|First Intervention, 12 Weeks||4||
48050869|NCT02960997|100445175|FG001|COMPLETED|First Intervention, 12 Weeks||4||
48050870|NCT02960997|100445174|FG000|NOT COMPLETED|First Intervention, 12 Weeks||0||
48050871|NCT02960997|100445175|FG001|NOT COMPLETED|First Intervention, 12 Weeks||0||
48050872|NCT02960997|100445174|FG000|STARTED|Washout Period, 4 Weeks||4||
48050873|NCT02960997|100445175|FG001|STARTED|Washout Period, 4 Weeks||4||
48050874|NCT02960997|100445174|FG000|COMPLETED|Washout Period, 4 Weeks||4||
48050875|NCT02960997|100445175|FG001|COMPLETED|Washout Period, 4 Weeks||4||
48050876|NCT02960997|100445174|FG000|NOT COMPLETED|Washout Period, 4 Weeks||0||
48050877|NCT02960997|100445175|FG001|NOT COMPLETED|Washout Period, 4 Weeks||0||
48050878|NCT02960997|100445174|FG000|STARTED|Second Treatment, 12 Weeks||4||
48050879|NCT02960997|100445175|FG001|STARTED|Second Treatment, 12 Weeks||4||
48050880|NCT02960997|100445174|FG000|COMPLETED|Second Treatment, 12 Weeks||4||
48050881|NCT02960997|100445175|FG001|COMPLETED|Second Treatment, 12 Weeks||4||
48050882|NCT02960997|100445174|FG000|NOT COMPLETED|Second Treatment, 12 Weeks||0||
48050883|NCT02960997|100445175|FG001|NOT COMPLETED|Second Treatment, 12 Weeks||0||
48050884|NCT02960997|100445174|FG000|STARTED|Follow-up Period, 4 Weeks||4||
48050885|NCT02960997|100445175|FG001|STARTED|Follow-up Period, 4 Weeks||4||
48050886|NCT02960997|100445174|FG000|COMPLETED|Follow-up Period, 4 Weeks||4||
48050887|NCT02960997|100445175|FG001|COMPLETED|Follow-up Period, 4 Weeks||4||
48050888|NCT02960997|100445174|FG000|NOT COMPLETED|Follow-up Period, 4 Weeks||0||
48050889|NCT02960997|100445175|FG001|NOT COMPLETED|Follow-up Period, 4 Weeks||0||
48050890|NCT03340428|100445176|FG000|STARTED|Overall Study||117||
48050891|NCT03340428|100445177|FG001|STARTED|Overall Study||59||
48050892|NCT03340428|100445176|FG000|COMPLETED|Overall Study||116||
48050893|NCT03340428|100445177|FG001|COMPLETED|Overall Study||59||
48050894|NCT03340428|100445176|FG000|NOT COMPLETED|Overall Study||1||
48050895|NCT03340428|100445177|FG001|NOT COMPLETED|Overall Study||0||
48050896|NCT00456807|100445178|FG000|STARTED|Overall Study||53||
48050897|NCT00456807|100445179|FG001|STARTED|Overall Study||47||
48050898|NCT00456807|100445178|FG000|COMPLETED|Overall Study||52||
48050899|NCT00456807|100445179|FG001|COMPLETED|Overall Study||47||
48050900|NCT00456807|100445178|FG000|NOT COMPLETED|Overall Study||1||
48050901|NCT00456807|100445179|FG001|NOT COMPLETED|Overall Study||0||
48050902|NCT02283177|100445180|FG000|STARTED|Overall Study||29||
48050903|NCT02283177|100445181|FG001|STARTED|Overall Study||15||
48050904|NCT02283177|100445180|FG000|COMPLETED|Overall Study||28||
48050905|NCT02283177|100445181|FG001|COMPLETED|Overall Study||14||
48050906|NCT02283177|100445180|FG000|NOT COMPLETED|Overall Study||1||
48050907|NCT02283177|100445181|FG001|NOT COMPLETED|Overall Study||1||
48050908|NCT00938964|100445182|FG000|STARTED|Overall Study||241||
48050909|NCT00938964|100445183|FG001|STARTED|Overall Study||237||
48050910|NCT00938964|100445182|FG000|COMPLETED|Overall Study||211||
48050911|NCT00938964|100445183|FG001|COMPLETED|Overall Study||209||
48050912|NCT00938964|100445182|FG000|NOT COMPLETED|Overall Study||30||
48050913|NCT00938964|100445183|FG001|NOT COMPLETED|Overall Study||28||
48050914|NCT00760084|100445184|FG000|STARTED|Overall Study||10||
48050915|NCT00760084|100445184|FG000|COMPLETED|Overall Study||0||
48050916|NCT00760084|100445184|FG000|NOT COMPLETED|Overall Study||10||
48050917|NCT01933789|100445185|FG000|STARTED|Overall Study||65||
48050918|NCT01933789|100445186|FG001|STARTED|Overall Study||67||
48050919|NCT01933789|100445187|FG002|STARTED|Overall Study||2||
48050920|NCT01933789|100445188|FG003|STARTED|Overall Study||2||
48050921|NCT01933789|100445189|FG004|STARTED|Overall Study||249||
48050922|NCT01933789|100445190|FG005|STARTED|Overall Study||288||
48050923|NCT01933789|100445191|FG006|STARTED|Overall Study||58||
48050924|NCT01933789|100445192|FG007|STARTED|Overall Study||61||
48050925|NCT01933789|100445193|FG008|STARTED|Overall Study||25||
48050926|NCT01933789|100445185|FG000|Had Target Visit|Overall Study||61||
48050927|NCT01933789|100445186|FG001|Had Target Visit|Overall Study||65||
48050928|NCT01933789|100445187|FG002|Had Target Visit|Overall Study||2||
48050929|NCT01933789|100445188|FG003|Had Target Visit|Overall Study||2||
48050930|NCT01933789|100445189|FG004|Had Target Visit|Overall Study||228||
48050931|NCT01933789|100445190|FG005|Had Target Visit|Overall Study||266||
48050932|NCT01933789|100445191|FG006|Had Target Visit|Overall Study||0||
48050933|NCT01933789|100445192|FG007|Had Target Visit|Overall Study||0||
48050934|NCT01933789|100445193|FG008|Had Target Visit|Overall Study||0||
48050935|NCT01933789|100445185|FG000|Completed After-visit Survey|Overall Study||57||
48050936|NCT01933789|100445186|FG001|Completed After-visit Survey|Overall Study||64||
48050937|NCT01933789|100445187|FG002|Completed After-visit Survey|Overall Study||2||
48050938|NCT01933789|100445188|FG003|Completed After-visit Survey|Overall Study||1||
48050939|NCT01933789|100445189|FG004|Completed After-visit Survey|Overall Study||0||
48050940|NCT01933789|100445190|FG005|Completed After-visit Survey|Overall Study||0||
48050941|NCT01933789|100445191|FG006|Completed After-visit Survey|Overall Study||0||
48050942|NCT01933789|100445192|FG007|Completed After-visit Survey|Overall Study||0||
48050943|NCT01933789|100445193|FG008|Completed After-visit Survey|Overall Study||0||
48050944|NCT01933789|100445185|FG000|Completed 2-Week Survey|Overall Study||0||
48050945|NCT01933789|100445186|FG001|Completed 2-Week Survey|Overall Study||0||
48050946|NCT01933789|100445187|FG002|Completed 2-Week Survey|Overall Study||0||
48050947|NCT01933789|100445188|FG003|Completed 2-Week Survey|Overall Study||0||
48050948|NCT01933789|100445189|FG004|Completed 2-Week Survey|Overall Study||184||
48050949|NCT01933789|100445190|FG005|Completed 2-Week Survey|Overall Study||215||
48050950|NCT01933789|100445191|FG006|Completed 2-Week Survey|Overall Study||0||
48050951|NCT01933789|100445192|FG007|Completed 2-Week Survey|Overall Study||0||
48208302|NCT00178399|100837024|FG000|COMPLETED|Overall Study||115||
48208303|NCT00178399|100837024|FG000|NOT COMPLETED|Overall Study||13||
48050952|NCT01933789|100445193|FG008|Completed 2-Week Survey|Overall Study||0||
48050953|NCT01933789|100445185|FG000|Completed 3-Month Survey|Overall Study||0||
48050954|NCT01933789|100445186|FG001|Completed 3-Month Survey|Overall Study||0||
48050955|NCT01933789|100445187|FG002|Completed 3-Month Survey|Overall Study||0||
48050956|NCT01933789|100445188|FG003|Completed 3-Month Survey|Overall Study||0||
48050957|NCT01933789|100445189|FG004|Completed 3-Month Survey|Overall Study||176||
48050958|NCT01933789|100445190|FG005|Completed 3-Month Survey|Overall Study||211||
48050959|NCT01933789|100445191|FG006|Completed 3-Month Survey|Overall Study||37||
48050960|NCT01933789|100445192|FG007|Completed 3-Month Survey|Overall Study||43||
48050961|NCT01933789|100445193|FG008|Completed 3-Month Survey|Overall Study||0||
48050962|NCT01933789|100445185|FG000|Completed 6-Month Survey|Overall Study||0||
48050963|NCT01933789|100445186|FG001|Completed 6-Month Survey|Overall Study||0||
48050964|NCT01933789|100445187|FG002|Completed 6-Month Survey|Overall Study||0||
48050965|NCT01933789|100445188|FG003|Completed 6-Month Survey|Overall Study||0||
48050966|NCT01933789|100445189|FG004|Completed 6-Month Survey|Overall Study||160||
48050967|NCT01933789|100445190|FG005|Completed 6-Month Survey|Overall Study||188||
48050968|NCT01933789|100445191|FG006|Completed 6-Month Survey|Overall Study||35||
48050969|NCT01933789|100445192|FG007|Completed 6-Month Survey|Overall Study||40||
48050970|NCT01933789|100445193|FG008|Completed 6-Month Survey|Overall Study||0||
48050971|NCT01933789|100445185|FG000|Qualitative Interviews|Overall Study||0||
48050972|NCT01933789|100445186|FG001|Qualitative Interviews|Overall Study||0||
48050973|NCT01933789|100445187|FG002|Qualitative Interviews|Overall Study||0||
48050974|NCT01933789|100445188|FG003|Qualitative Interviews|Overall Study||0||
48050975|NCT01933789|100445189|FG004|Qualitative Interviews|Overall Study||0||
48050976|NCT01933789|100445190|FG005|Qualitative Interviews|Overall Study||0||
48050977|NCT01933789|100445191|FG006|Qualitative Interviews|Overall Study||0||
48050978|NCT01933789|100445192|FG007|Qualitative Interviews|Overall Study||0||
48050979|NCT01933789|100445193|FG008|Qualitative Interviews|Overall Study||25||
48208304|NCT00364013|100837025|FG000|STARTED|Overall Study||593||
48208305|NCT00364013|100837026|FG001|STARTED|Overall Study||590||
48208306|NCT00364013|100837025|FG000|Received Study Drug|Overall Study||586||
48208307|NCT00364013|100837026|FG001|Received Study Drug|Overall Study||583||
48050980|NCT01933789|100445185|FG000|COMPLETED|Overall Study||59||
48050981|NCT01933789|100445186|FG001|COMPLETED|Overall Study||66||
48050982|NCT01933789|100445187|FG002|COMPLETED|Overall Study||2||
48050983|NCT01933789|100445188|FG003|COMPLETED|Overall Study||1||
48050984|NCT01933789|100445189|FG004|COMPLETED|Overall Study||190||
48050985|NCT01933789|100445190|FG005|COMPLETED|Overall Study||221||
48050986|NCT01933789|100445191|FG006|COMPLETED|Overall Study||43||
48050987|NCT01933789|100445192|FG007|COMPLETED|Overall Study||47||
48050988|NCT01933789|100445193|FG008|COMPLETED|Overall Study||25||
48050989|NCT01933789|100445185|FG000|NOT COMPLETED|Overall Study||6||
48050990|NCT01933789|100445186|FG001|NOT COMPLETED|Overall Study||1||
48050991|NCT01933789|100445187|FG002|NOT COMPLETED|Overall Study||0||
48050992|NCT01933789|100445188|FG003|NOT COMPLETED|Overall Study||1||
48050993|NCT01933789|100445189|FG004|NOT COMPLETED|Overall Study||59||
48050994|NCT01933789|100445190|FG005|NOT COMPLETED|Overall Study||67||
48050995|NCT01933789|100445191|FG006|NOT COMPLETED|Overall Study||15||
48050996|NCT01933789|100445192|FG007|NOT COMPLETED|Overall Study||14||
48050997|NCT01933789|100445193|FG008|NOT COMPLETED|Overall Study||0||
48050998|NCT02325856|100445194|FG000|STARTED|Overall Study||148||
48050999|NCT02325856|100445195|FG001|STARTED|Overall Study||150||
48051000|NCT02325856|100445194|FG000|COMPLETED|Overall Study||128||
48051001|NCT02325856|100445195|FG001|COMPLETED|Overall Study||123||
48051002|NCT02325856|100445194|FG000|NOT COMPLETED|Overall Study||20||
48051003|NCT02325856|100445195|FG001|NOT COMPLETED|Overall Study||27||
48051004|NCT01525901|100445196|FG000|STARTED|Period 1: 12 Weeks||5||
48051005|NCT01525901|100445197|FG001|STARTED|Period 1: 12 Weeks||4||
48051006|NCT01525901|100445198|FG002|STARTED|Period 1: 12 Weeks||5||
48051007|NCT01525901|100445199|FG003|STARTED|Period 1: 12 Weeks||5||
48051008|NCT01525901|100445196|FG000|COMPLETED|Period 1: 12 Weeks||5||
48051009|NCT01525901|100445197|FG001|COMPLETED|Period 1: 12 Weeks||4||
48051010|NCT01525901|100445198|FG002|COMPLETED|Period 1: 12 Weeks||5||
48051011|NCT01525901|100445199|FG003|COMPLETED|Period 1: 12 Weeks||5||
48051012|NCT01525901|100445196|FG000|NOT COMPLETED|Period 1: 12 Weeks||0||
48051013|NCT01525901|100445197|FG001|NOT COMPLETED|Period 1: 12 Weeks||0||
48051014|NCT01525901|100445198|FG002|NOT COMPLETED|Period 1: 12 Weeks||0||
48051015|NCT01525901|100445199|FG003|NOT COMPLETED|Period 1: 12 Weeks||0||
48051016|NCT01525901|100445196|FG000|STARTED|Washout 4 Weeks||5||
48051017|NCT01525901|100445197|FG001|STARTED|Washout 4 Weeks||4||
48051018|NCT01525901|100445198|FG002|STARTED|Washout 4 Weeks||5||
48051019|NCT01525901|100445199|FG003|STARTED|Washout 4 Weeks||5||
48051020|NCT01525901|100445196|FG000|COMPLETED|Washout 4 Weeks||5||
48051021|NCT01525901|100445197|FG001|COMPLETED|Washout 4 Weeks||4||
48051022|NCT01525901|100445198|FG002|COMPLETED|Washout 4 Weeks||5||
48051023|NCT01525901|100445199|FG003|COMPLETED|Washout 4 Weeks||5||
48051024|NCT01525901|100445196|FG000|NOT COMPLETED|Washout 4 Weeks||0||
48051025|NCT01525901|100445197|FG001|NOT COMPLETED|Washout 4 Weeks||0||
48051026|NCT01525901|100445198|FG002|NOT COMPLETED|Washout 4 Weeks||0||
48051027|NCT01525901|100445199|FG003|NOT COMPLETED|Washout 4 Weeks||0||
48051028|NCT01525901|100445196|FG000|STARTED|Period 2: 12 Weeks||5||
48051029|NCT01525901|100445197|FG001|STARTED|Period 2: 12 Weeks||4||
48051030|NCT01525901|100445198|FG002|STARTED|Period 2: 12 Weeks||5||
48051031|NCT01525901|100445199|FG003|STARTED|Period 2: 12 Weeks||5||
48051032|NCT01525901|100445196|FG000|COMPLETED|Period 2: 12 Weeks||5||
48051033|NCT01525901|100445197|FG001|COMPLETED|Period 2: 12 Weeks||3||
48051034|NCT01525901|100445198|FG002|COMPLETED|Period 2: 12 Weeks||5||
48051035|NCT01525901|100445199|FG003|COMPLETED|Period 2: 12 Weeks||5||
48051036|NCT01525901|100445196|FG000|NOT COMPLETED|Period 2: 12 Weeks||0||
48051037|NCT01525901|100445197|FG001|NOT COMPLETED|Period 2: 12 Weeks||1||
48051038|NCT01525901|100445198|FG002|NOT COMPLETED|Period 2: 12 Weeks||0||
48051039|NCT01525901|100445199|FG003|NOT COMPLETED|Period 2: 12 Weeks||0||
48051040|NCT02043379|100445200|FG000|STARTED|Overall Study||30||
48051041|NCT02043379|100445201|FG001|STARTED|Overall Study||20||
48051042|NCT02043379|100445200|FG000|COMPLETED|Overall Study||30||
48051043|NCT02043379|100445201|FG001|COMPLETED|Overall Study||20||
48051044|NCT02043379|100445200|FG000|NOT COMPLETED|Overall Study||0||
48051045|NCT02043379|100445201|FG001|NOT COMPLETED|Overall Study||0||
48051046|NCT01593722|100445202|FG000|STARTED|Overall Study||6||
48051047|NCT01593722|100445203|FG001|STARTED|Overall Study||6||
48051048|NCT01593722|100445202|FG000|COMPLETED|Overall Study||6||
48051049|NCT01593722|100445203|FG001|COMPLETED|Overall Study||6||
48051050|NCT01593722|100445202|FG000|NOT COMPLETED|Overall Study||0||
48051051|NCT01593722|100445203|FG001|NOT COMPLETED|Overall Study||0||
48051052|NCT04271280|100445204|FG000|STARTED|Overall Study||9559||
48051053|NCT04271280|100445204|FG000|Baseline Analysis Set|Overall Study||9543|The Baseline Analysis Set (BAS) consisted of all eligible patients of the All-Documented Patient Set (APS) for whom adequate baseline information was available.|
48051054|NCT04271280|100445204|FG000|Full Analysis Set|Overall Study||9136|The Full Analysis Set (FAS) consisted of all patients from the BAS with any available 1-year follow-up data (including study termination data where the reason for termination was death).|
48051055|NCT04271280|100445204|FG000|COMPLETED|Overall Study||8954||
48051056|NCT04271280|100445204|FG000|NOT COMPLETED|Overall Study||605||
48051057|NCT02757950|100445205|FG000|STARTED|Overall Study||1203||
48051058|NCT02757950|100445206|FG001|STARTED|Overall Study||1259||
48051059|NCT02757950|100445205|FG000|COMPLETED|Overall Study||1199||
48051060|NCT02757950|100445206|FG001|COMPLETED|Overall Study||1248||
48051061|NCT02757950|100445205|FG000|NOT COMPLETED|Overall Study||4||
48051062|NCT02757950|100445206|FG001|NOT COMPLETED|Overall Study||11||
48051063|NCT01860846|100445207|FG000|STARTED|Overall Study||106||
48051064|NCT01860846|100445207|FG000|Month 1|Overall Study||97||
48051065|NCT01860846|100445207|FG000|Month 2|Overall Study||83||
48051066|NCT01860846|100445207|FG000|Month 4|Overall Study||82||
48051067|NCT01860846|100445207|FG000|Month 6|Overall Study||85||
48051068|NCT01860846|100445207|FG000|Month 12|Overall Study||73||
48051069|NCT01860846|100445207|FG000|COMPLETED|Overall Study||73||
48051070|NCT01860846|100445207|FG000|NOT COMPLETED|Overall Study||33||
48051071|NCT00911742|100445208|FG000|STARTED|Treatment Phase I||13||
48051072|NCT00911742|100445209|FG001|STARTED|Treatment Phase I||13||
48051073|NCT00911742|100445208|FG000|COMPLETED|Treatment Phase I||13||
48051074|NCT00911742|100445209|FG001|COMPLETED|Treatment Phase I||13||
48051075|NCT00911742|100445208|FG000|NOT COMPLETED|Treatment Phase I||0||
48051076|NCT00911742|100445209|FG001|NOT COMPLETED|Treatment Phase I||0||
48051077|NCT00911742|100445208|FG000|STARTED|Treatment Phase II||13||
48051078|NCT00911742|100445209|FG001|STARTED|Treatment Phase II||13||
48051079|NCT00911742|100445208|FG000|COMPLETED|Treatment Phase II||13||
48051080|NCT00911742|100445209|FG001|COMPLETED|Treatment Phase II||13||
48051081|NCT00911742|100445208|FG000|NOT COMPLETED|Treatment Phase II||0||
48051082|NCT00911742|100445209|FG001|NOT COMPLETED|Treatment Phase II||0||
48051083|NCT01285960|100445210|FG000|STARTED|Overall Study||108||
48051084|NCT01285960|100445210|FG000|COMPLETED|Overall Study||102||
48051085|NCT01285960|100445210|FG000|NOT COMPLETED|Overall Study||6||
48051086|NCT00461331|100445211|FG000|STARTED|Intervention 1||10||
48051087|NCT00461331|100445212|FG001|STARTED|Intervention 1||10||
48051088|NCT00461331|100445211|FG000|COMPLETED|Intervention 1||10||
48051089|NCT00461331|100445212|FG001|COMPLETED|Intervention 1||10||
48051090|NCT00461331|100445211|FG000|NOT COMPLETED|Intervention 1||0||
48051091|NCT00461331|100445212|FG001|NOT COMPLETED|Intervention 1||0||
48051092|NCT00461331|100445211|FG000|STARTED|Washout||10||
48051093|NCT00461331|100445212|FG001|STARTED|Washout||10||
48051094|NCT00461331|100445211|FG000|COMPLETED|Washout||10||
48051095|NCT00461331|100445212|FG001|COMPLETED|Washout||10||
48051096|NCT00461331|100445211|FG000|NOT COMPLETED|Washout||0||
48051097|NCT00461331|100445212|FG001|NOT COMPLETED|Washout||0||
48051098|NCT00461331|100445211|FG000|STARTED|Intervention 2||10||
48051099|NCT00461331|100445212|FG001|STARTED|Intervention 2||10||
48051100|NCT00461331|100445211|FG000|COMPLETED|Intervention 2||10||
48051101|NCT00461331|100445212|FG001|COMPLETED|Intervention 2||10||
48051102|NCT00461331|100445211|FG000|NOT COMPLETED|Intervention 2||0||
48051103|NCT00461331|100445212|FG001|NOT COMPLETED|Intervention 2||0||
48051104|NCT03309046|100445213|FG000|STARTED|Overall Study||82||
48051105|NCT03309046|100445214|FG001|STARTED|Overall Study||81||
48051106|NCT03309046|100445213|FG000|COMPLETED|Overall Study||78||
48051107|NCT03309046|100445214|FG001|COMPLETED|Overall Study||64||
48051108|NCT03309046|100445213|FG000|NOT COMPLETED|Overall Study||4||
48051109|NCT03309046|100445214|FG001|NOT COMPLETED|Overall Study||17||
48051110|NCT00880165|100445215|FG000|STARTED|Overall Study||148||
48051111|NCT00880165|100445216|FG001|STARTED|Overall Study||148||
48051112|NCT00880165|100445215|FG000|COMPLETED|Overall Study||86||
48051113|NCT00880165|100445216|FG001|COMPLETED|Overall Study||98||
48051114|NCT00880165|100445215|FG000|NOT COMPLETED|Overall Study||62||
48051115|NCT00880165|100445216|FG001|NOT COMPLETED|Overall Study||50||
48051116|NCT00908011|100445217|FG000|STARTED|Overall Study||23||
48051117|NCT00908011|100445218|FG001|STARTED|Overall Study||20||
48051118|NCT00908011|100445217|FG000|COMPLETED|Overall Study||21||
48051119|NCT00908011|100445218|FG001|COMPLETED|Overall Study||18||
48051120|NCT00908011|100445217|FG000|NOT COMPLETED|Overall Study||2||
48051121|NCT00908011|100445218|FG001|NOT COMPLETED|Overall Study||2||
48051122|NCT03723603|100445219|FG000|STARTED|Overall Study||8||
48051123|NCT03723603|100445219|FG000|COMPLETED|Overall Study||5||
48051124|NCT03723603|100445219|FG000|NOT COMPLETED|Overall Study||3||
48051125|NCT01948310|100445220|FG000|STARTED|Overall Study||19||
48051126|NCT01948310|100445221|FG001|STARTED|Overall Study||18||
48051127|NCT01948310|100445220|FG000|COMPLETED|Overall Study||16||
48051128|NCT01948310|100445221|FG001|COMPLETED|Overall Study||13||
48051129|NCT01948310|100445220|FG000|NOT COMPLETED|Overall Study||3||
48208308|NCT00364013|100837025|FG000|COMPLETED|Overall Study||492||
48208309|NCT00364013|100837026|FG001|COMPLETED|Overall Study||495||
48051130|NCT01948310|100445221|FG001|NOT COMPLETED|Overall Study||5||
48051131|NCT01887743|100445222|FG000|STARTED|Overall Study||20||
48051132|NCT01887743|100445223|FG001|STARTED|Overall Study||19||
48051133|NCT01887743|100445224|FG002|STARTED|Overall Study||32||
48051134|NCT01887743|100445222|FG000|COMPLETED|Overall Study||19||
48051135|NCT01887743|100445223|FG001|COMPLETED|Overall Study||17||
48051136|NCT01887743|100445224|FG002|COMPLETED|Overall Study||29||
48051137|NCT01887743|100445222|FG000|NOT COMPLETED|Overall Study||1||
48051138|NCT01887743|100445223|FG001|NOT COMPLETED|Overall Study||2||
48051139|NCT01887743|100445224|FG002|NOT COMPLETED|Overall Study||3||
48051140|NCT00392821|100445225|FG000|STARTED|Overall Study||3||
48051141|NCT00392821|100445226|FG001|STARTED|Overall Study||6||
48051142|NCT00392821|100445227|FG002|STARTED|Overall Study||69||
48051143|NCT00392821|100445225|FG000|COMPLETED|Overall Study||0||
48051144|NCT00392821|100445226|FG001|COMPLETED|Overall Study||0||
48051145|NCT00392821|100445227|FG002|COMPLETED|Overall Study||0||
48051146|NCT00392821|100445225|FG000|NOT COMPLETED|Overall Study||3||
48051147|NCT00392821|100445226|FG001|NOT COMPLETED|Overall Study||6||
48051148|NCT00392821|100445227|FG002|NOT COMPLETED|Overall Study||69||
48051149|NCT01562873|100445228|FG000|STARTED|Overall Study||21||
48051150|NCT01562873|100445229|FG001|STARTED|Overall Study||0||
48051151|NCT01562873|100445228|FG000|COMPLETED|Overall Study||0||
48051152|NCT01562873|100445229|FG001|COMPLETED|Overall Study||0||
48051153|NCT01562873|100445228|FG000|NOT COMPLETED|Overall Study||21||
48051154|NCT01562873|100445229|FG001|NOT COMPLETED|Overall Study||0||
48051155|NCT00357032|100445230|FG000|STARTED|Overall Study||12||
48051156|NCT00357032|100445230|FG000|COMPLETED|Overall Study||12||
48051157|NCT00357032|100445230|FG000|NOT COMPLETED|Overall Study||0||
48051158|NCT01205581|100445231|FG000|STARTED|Overall Study||14||
48051159|NCT01205581|100445232|FG001|STARTED|Overall Study||13||
48051160|NCT01205581|100445233|FG002|STARTED|Overall Study||8||
48051161|NCT01205581|100445234|FG003|STARTED|Overall Study||9||
48051162|NCT01205581|100445235|FG004|STARTED|Overall Study||20||
48051163|NCT01205581|100445236|FG005|STARTED|Overall Study||20||
48051164|NCT01205581|100445231|FG000|COMPLETED|Overall Study||13||
48051165|NCT01205581|100445232|FG001|COMPLETED|Overall Study||13||
48051166|NCT01205581|100445233|FG002|COMPLETED|Overall Study||8||
48051167|NCT01205581|100445234|FG003|COMPLETED|Overall Study||9||
48051168|NCT01205581|100445235|FG004|COMPLETED|Overall Study||20||
48051169|NCT01205581|100445236|FG005|COMPLETED|Overall Study||20||
48051170|NCT01205581|100445231|FG000|NOT COMPLETED|Overall Study||1||
48051171|NCT01205581|100445232|FG001|NOT COMPLETED|Overall Study||0||
48051172|NCT01205581|100445233|FG002|NOT COMPLETED|Overall Study||0||
48051173|NCT01205581|100445234|FG003|NOT COMPLETED|Overall Study||0||
48051174|NCT01205581|100445235|FG004|NOT COMPLETED|Overall Study||0||
48051175|NCT01205581|100445236|FG005|NOT COMPLETED|Overall Study||0||
48051176|NCT02898116|100445237|FG000|STARTED|Overall Study||2||
48051177|NCT02898116|100445237|FG000|COMPLETED|Overall Study||0||
48051178|NCT02898116|100445237|FG000|NOT COMPLETED|Overall Study||2||
48051179|NCT02263131|100445238|FG000|STARTED|Overall Study||347||
48051180|NCT02263131|100445239|FG001|STARTED|Overall Study||69||
48051181|NCT02263131|100445238|FG000|COMPLETED|Overall Study||337||
48051182|NCT02263131|100445239|FG001|COMPLETED|Overall Study||68||
48051183|NCT02263131|100445238|FG000|NOT COMPLETED|Overall Study||10||
48051184|NCT02263131|100445239|FG001|NOT COMPLETED|Overall Study||1||
48051185|NCT00322153|100445240|FG000|STARTED|Overall Study||335||
48051186|NCT00322153|100445241|FG001|STARTED|Overall Study||342||
48051187|NCT00322153|100445240|FG000|SAFETY POPULATION|Overall Study||335||
48051188|NCT00322153|100445241|FG001|SAFETY POPULATION|Overall Study||341||
48051189|NCT00322153|100445240|FG000|COMPLETED|Overall Study||272||
48051190|NCT00322153|100445241|FG001|COMPLETED|Overall Study||273||
48051191|NCT00322153|100445240|FG000|NOT COMPLETED|Overall Study||63||
48051192|NCT00322153|100445241|FG001|NOT COMPLETED|Overall Study||69||
48051193|NCT01076296|100445242|FG000|STARTED|Overall Study||54||
48051194|NCT01076296|100445243|FG001|STARTED|Overall Study||196||
48051195|NCT01076296|100445244|FG002|STARTED|Overall Study||51||
48051196|NCT01076296|100445245|FG003|STARTED|Overall Study||199||
48051197|NCT01076296|100445246|FG004|STARTED|Overall Study||59||
48051198|NCT01076296|100445247|FG005|STARTED|Overall Study||191||
48051199|NCT01076296|100445248|FG006|STARTED|Overall Study||51||
48051200|NCT01076296|100445249|FG007|STARTED|Overall Study||199||
48051201|NCT01076296|100445242|FG000|COMPLETED|Overall Study||54||
48051202|NCT01076296|100445243|FG001|COMPLETED|Overall Study||196||
48051203|NCT01076296|100445244|FG002|COMPLETED|Overall Study||51||
48051204|NCT01076296|100445245|FG003|COMPLETED|Overall Study||199||
48051205|NCT01076296|100445246|FG004|COMPLETED|Overall Study||59||
48051206|NCT01076296|100445247|FG005|COMPLETED|Overall Study||191||
48051207|NCT01076296|100445248|FG006|COMPLETED|Overall Study||51||
48051208|NCT01076296|100445249|FG007|COMPLETED|Overall Study||199||
48051209|NCT01076296|100445242|FG000|NOT COMPLETED|Overall Study||0||
48051210|NCT01076296|100445243|FG001|NOT COMPLETED|Overall Study||0||
48051211|NCT01076296|100445244|FG002|NOT COMPLETED|Overall Study||0||
48051212|NCT01076296|100445245|FG003|NOT COMPLETED|Overall Study||0||
48051213|NCT01076296|100445246|FG004|NOT COMPLETED|Overall Study||0||
48051214|NCT01076296|100445247|FG005|NOT COMPLETED|Overall Study||0||
48051215|NCT01076296|100445248|FG006|NOT COMPLETED|Overall Study||0||
48051216|NCT01076296|100445249|FG007|NOT COMPLETED|Overall Study||0||
48051217|NCT02797054|100445250|FG000|STARTED|Post-test||387||
48051218|NCT02797054|100445251|FG001|STARTED|Post-test||383||
48051219|NCT02797054|100445252|FG002|STARTED|Post-test||435||
48051220|NCT02797054|100445250|FG000|COMPLETED|Post-test||380||
48051221|NCT02797054|100445251|FG001|COMPLETED|Post-test||372||
48051222|NCT02797054|100445252|FG002|COMPLETED|Post-test||87||
48495675|NCT02718963|101547907|FG001|STARTED|Overall Study||10||
48051223|NCT02797054|100445250|FG000|NOT COMPLETED|Post-test||7||
48051224|NCT02797054|100445251|FG001|NOT COMPLETED|Post-test||11||
48051225|NCT02797054|100445252|FG002|NOT COMPLETED|Post-test||348||
48051226|NCT02797054|100445250|FG000|STARTED|Follow-up||387|All participants who volunteered at consent were contacted for follow-up.|
48051227|NCT02797054|100445251|FG001|STARTED|Follow-up||383|All participants who volunteered at consent were contacted for follow-up.|
48051228|NCT02797054|100445252|FG002|STARTED|Follow-up||435|All participants who volunteered at consent were contacted for follow-up.|
48051229|NCT02797054|100445250|FG000|COMPLETED|Follow-up||178||
48051230|NCT02797054|100445251|FG001|COMPLETED|Follow-up||155||
48051231|NCT02797054|100445252|FG002|COMPLETED|Follow-up||150||
48051232|NCT02797054|100445250|FG000|NOT COMPLETED|Follow-up||209||
48051233|NCT02797054|100445251|FG001|NOT COMPLETED|Follow-up||228||
48051234|NCT02797054|100445252|FG002|NOT COMPLETED|Follow-up||285||
48051235|NCT01280955|100445253|FG000|STARTED|Overall Study||30||
48051236|NCT01280955|100445253|FG000|COMPLETED|Overall Study||27||
48051237|NCT01280955|100445253|FG000|NOT COMPLETED|Overall Study||3||
48051238|NCT01727700|100445254|FG000|STARTED|Overall Study||44||
48051239|NCT01727700|100445255|FG001|STARTED|Overall Study||45||
48051240|NCT01727700|100445256|FG002|STARTED|Overall Study||44||
48051241|NCT01727700|100445254|FG000|COMPLETED|Overall Study||42||
48051242|NCT01727700|100445255|FG001|COMPLETED|Overall Study||35||
48051243|NCT01727700|100445256|FG002|COMPLETED|Overall Study||42||
48051244|NCT01727700|100445254|FG000|NOT COMPLETED|Overall Study||2||
48051245|NCT01727700|100445255|FG001|NOT COMPLETED|Overall Study||10||
48051246|NCT01727700|100445256|FG002|NOT COMPLETED|Overall Study||2||
48051247|NCT01009281|100445257|FG000|STARTED|Overall Study||7||
48051248|NCT01009281|100445257|FG000|COMPLETED|Overall Study||0||
48051249|NCT01009281|100445257|FG000|NOT COMPLETED|Overall Study||7||
48051250|NCT02431247|100445258|FG000|STARTED|BL to EOE-Test and BL to Switch- Control||362||
48051251|NCT02431247|100445259|FG001|STARTED|BL to EOE-Test and BL to Switch- Control||363||
48051252|NCT02431247|100445260|FG002|STARTED|BL to EOE-Test and BL to Switch- Control||0||
48051253|NCT02431247|100445258|FG000|COMPLETED|BL to EOE-Test and BL to Switch- Control||296||
48051254|NCT02431247|100445259|FG001|COMPLETED|BL to EOE-Test and BL to Switch- Control||322||
48051255|NCT02431247|100445260|FG002|COMPLETED|BL to EOE-Test and BL to Switch- Control||0||
48051256|NCT02431247|100445258|FG000|NOT COMPLETED|BL to EOE-Test and BL to Switch- Control||66||
48051257|NCT02431247|100445259|FG001|NOT COMPLETED|BL to EOE-Test and BL to Switch- Control||41||
48051258|NCT02431247|100445260|FG002|NOT COMPLETED|BL to EOE-Test and BL to Switch- Control||0||
48051259|NCT02431247|100445258|FG000|STARTED|Switch to D/C/F/TAF (Until EOE)||0||
48051260|NCT02431247|100445259|FG001|STARTED|Switch to D/C/F/TAF (Until EOE)||0||
48051261|NCT02431247|100445260|FG002|STARTED|Switch to D/C/F/TAF (Until EOE)||322||
48051262|NCT02431247|100445258|FG000|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0||
48051263|NCT02431247|100445259|FG001|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0||
48051264|NCT02431247|100445260|FG002|COMPLETED|Switch to D/C/F/TAF (Until EOE)||289||
48051265|NCT02431247|100445258|FG000|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0||
48051266|NCT02431247|100445259|FG001|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0||
48051267|NCT02431247|100445260|FG002|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||33||
48051268|NCT01680549|100445261|FG000|STARTED|Overall Study||25||
48051269|NCT01680549|100445262|FG001|STARTED|Overall Study||25||
48051270|NCT01680549|100445261|FG000|COMPLETED|Overall Study||20||
48051271|NCT01680549|100445262|FG001|COMPLETED|Overall Study||17||
48051272|NCT01680549|100445261|FG000|NOT COMPLETED|Overall Study||5||
48051273|NCT01680549|100445262|FG001|NOT COMPLETED|Overall Study||8||
48051274|NCT00939952|100445263|FG000|STARTED|Overall Study||7||
48051275|NCT00939952|100445263|FG000|COMPLETED|Overall Study||7||
48051276|NCT00939952|100445263|FG000|NOT COMPLETED|Overall Study||0||
48051277|NCT01569464|100445264|FG000|STARTED|Overall Study||101||
48051278|NCT01569464|100445265|FG001|STARTED|Overall Study||49||
48051279|NCT01569464|100445264|FG000|COMPLETED|Overall Study||91||
48051280|NCT01569464|100445265|FG001|COMPLETED|Overall Study||44||
48051281|NCT01569464|100445264|FG000|NOT COMPLETED|Overall Study||10||
48051282|NCT01569464|100445265|FG001|NOT COMPLETED|Overall Study||5||
48051283|NCT01255787|100445266|FG000|STARTED|Overall Study||152||
48051284|NCT01255787|100445267|FG001|STARTED|Overall Study||144||
48051285|NCT01255787|100445268|FG002|STARTED|Overall Study||150||
48051286|NCT01255787|100445269|FG003|STARTED|Overall Study||154||
48051287|NCT01255787|100445266|FG000|Treated|Overall Study||152||
48051288|NCT01255787|100445267|FG001|Treated|Overall Study||144||
48051289|NCT01255787|100445268|FG002|Treated|Overall Study||148||
48051290|NCT01255787|100445269|FG003|Treated|Overall Study||150||
48051291|NCT01255787|100445266|FG000|COMPLETED|Overall Study||136||
48051292|NCT01255787|100445267|FG001|COMPLETED|Overall Study||127||
48051293|NCT01255787|100445268|FG002|COMPLETED|Overall Study||132||
48051294|NCT01255787|100445269|FG003|COMPLETED|Overall Study||132||
48051295|NCT01255787|100445266|FG000|NOT COMPLETED|Overall Study||16||
48051296|NCT01255787|100445267|FG001|NOT COMPLETED|Overall Study||17||
48051297|NCT01255787|100445268|FG002|NOT COMPLETED|Overall Study||18||
48051298|NCT01255787|100445269|FG003|NOT COMPLETED|Overall Study||22||
48051299|NCT05038904|100445270|FG000|STARTED|Overall Study||10||
48051300|NCT05038904|100445270|FG000|COMPLETED|Overall Study||10||
48051301|NCT05038904|100445270|FG000|NOT COMPLETED|Overall Study||0||
48051302|NCT00745615|100445271|FG000|STARTED|Double-Blind Extension (36 Weeks)||80||
48051303|NCT00745615|100445272|FG001|STARTED|Double-Blind Extension (36 Weeks)||94||
48051304|NCT00745615|100445273|FG002|STARTED|Double-Blind Extension (36 Weeks)||39||
48051305|NCT00745615|100445274|FG003|STARTED|Double-Blind Extension (36 Weeks)||44||
48051306|NCT00745615|100445275|FG004|STARTED|Double-Blind Extension (36 Weeks)||0||
48051307|NCT00745615|100445276|FG005|STARTED|Double-Blind Extension (36 Weeks)||0||
48051308|NCT00745615|100445271|FG000|COMPLETED|Double-Blind Extension (36 Weeks)||75||
48051309|NCT00745615|100445272|FG001|COMPLETED|Double-Blind Extension (36 Weeks)||87||
48051310|NCT00745615|100445273|FG002|COMPLETED|Double-Blind Extension (36 Weeks)||38||
48051311|NCT00745615|100445274|FG003|COMPLETED|Double-Blind Extension (36 Weeks)||39||
48051312|NCT00745615|100445275|FG004|COMPLETED|Double-Blind Extension (36 Weeks)||0||
48051313|NCT00745615|100445276|FG005|COMPLETED|Double-Blind Extension (36 Weeks)||0||
48051314|NCT00745615|100445271|FG000|NOT COMPLETED|Double-Blind Extension (36 Weeks)||5||
48051315|NCT00745615|100445272|FG001|NOT COMPLETED|Double-Blind Extension (36 Weeks)||7||
48051316|NCT00745615|100445273|FG002|NOT COMPLETED|Double-Blind Extension (36 Weeks)||1||
48051317|NCT00745615|100445274|FG003|NOT COMPLETED|Double-Blind Extension (36 Weeks)||5||
48051318|NCT00745615|100445275|FG004|NOT COMPLETED|Double-Blind Extension (36 Weeks)||0||
48051319|NCT00745615|100445276|FG005|NOT COMPLETED|Double-Blind Extension (36 Weeks)||0||
48051320|NCT00745615|100445271|FG000|STARTED|Open-Label (up to Approx 10.5 Years)||0||
48051321|NCT00745615|100445272|FG001|STARTED|Open-Label (up to Approx 10.5 Years)||0||
48051322|NCT00745615|100445273|FG002|STARTED|Open-Label (up to Approx 10.5 Years)||0||
48051323|NCT00745615|100445274|FG003|STARTED|Open-Label (up to Approx 10.5 Years)||0||
48051324|NCT00745615|100445275|FG004|STARTED|Open-Label (up to Approx 10.5 Years)||96||
48051325|NCT00745615|100445276|FG005|STARTED|Open-Label (up to Approx 10.5 Years)||113||
48051326|NCT00745615|100445271|FG000|COMPLETED|Open-Label (up to Approx 10.5 Years)||0||
48051327|NCT00745615|100445272|FG001|COMPLETED|Open-Label (up to Approx 10.5 Years)||0||
48051328|NCT00745615|100445273|FG002|COMPLETED|Open-Label (up to Approx 10.5 Years)||0||
48051329|NCT00745615|100445274|FG003|COMPLETED|Open-Label (up to Approx 10.5 Years)||0||
48051330|NCT00745615|100445275|FG004|COMPLETED|Open-Label (up to Approx 10.5 Years)||5||
48051331|NCT00745615|100445276|FG005|COMPLETED|Open-Label (up to Approx 10.5 Years)||5||
48051332|NCT00745615|100445271|FG000|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0||
48051333|NCT00745615|100445272|FG001|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0||
48051334|NCT00745615|100445273|FG002|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0||
48051335|NCT00745615|100445274|FG003|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0||
48051336|NCT00745615|100445275|FG004|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||91||
48051337|NCT00745615|100445276|FG005|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||108||
48051338|NCT00636220|100445277|FG000|STARTED|Overall Study||101||
48051339|NCT00636220|100445277|FG000|COMPLETED|Overall Study||101||
48051340|NCT00636220|100445277|FG000|NOT COMPLETED|Overall Study||0||
48051341|NCT02025556|100445278|FG000|STARTED|Overall Study||104|All randomized participants|
48051342|NCT02025556|100445279|FG001|STARTED|Overall Study||96|All randomized participants|
48051343|NCT02025556|100445280|FG002|STARTED|Overall Study||97|All randomized participants|
48051344|NCT02025556|100445278|FG000|Safety Analysis Set|Overall Study||104|All randomized participants who received at least one dose of study drug|
48051345|NCT02025556|100445279|FG001|Safety Analysis Set|Overall Study||96|All randomized participants who received at least one dose of study drug|
48051346|NCT02025556|100445280|FG002|Safety Analysis Set|Overall Study||96|All randomized participants who received at least one dose of study drug|
48051347|NCT02025556|100445278|FG000|Intent-to-treat (ITT) Set|Overall Study||104|Received at least one dose of study drug and obtained at least one efficacy measurement|
48051348|NCT02025556|100445279|FG001|Intent-to-treat (ITT) Set|Overall Study||95|Received at least one dose of study drug and obtained at least one efficacy measurement|
48051349|NCT02025556|100445280|FG002|Intent-to-treat (ITT) Set|Overall Study||96|Received at least one dose of study drug and obtained at least one efficacy measurement|
48051350|NCT02025556|100445278|FG000|COMPLETED|Overall Study||98||
48051351|NCT02025556|100445279|FG001|COMPLETED|Overall Study||83||
48051352|NCT02025556|100445280|FG002|COMPLETED|Overall Study||88||
48051353|NCT02025556|100445278|FG000|NOT COMPLETED|Overall Study||6||
48051354|NCT02025556|100445279|FG001|NOT COMPLETED|Overall Study||13||
48051355|NCT02025556|100445280|FG002|NOT COMPLETED|Overall Study||9||
48051356|NCT03425019|100445281|FG000|STARTED|Overall Study||20||
48051357|NCT03425019|100445281|FG000|COMPLETED|Overall Study||20||
48051358|NCT03425019|100445281|FG000|NOT COMPLETED|Overall Study||0||
48051359|NCT00510952|100445282|FG000|STARTED|Overall Study||235||
48051360|NCT00510952|100445283|FG001|STARTED|Overall Study||236||
48051361|NCT00510952|100445282|FG000|Full Analysis Set (Intent to Treat)|Overall Study||229||
48051362|NCT00510952|100445283|FG001|Full Analysis Set (Intent to Treat)|Overall Study||229||
48051363|NCT00510952|100445282|FG000|COMPLETED|Overall Study||209||
48051364|NCT00510952|100445283|FG001|COMPLETED|Overall Study||220||
48051365|NCT00510952|100445282|FG000|NOT COMPLETED|Overall Study||26||
48051366|NCT00510952|100445283|FG001|NOT COMPLETED|Overall Study||16||
48051367|NCT01277042|100445284|FG000|STARTED|Overall Study||606||
48051368|NCT01277042|100445285|FG001|STARTED|Overall Study||606||
48051369|NCT01277042|100445284|FG000|COMPLETED|Overall Study||598||
48051370|NCT01277042|100445285|FG001|COMPLETED|Overall Study||601||
48051371|NCT01277042|100445284|FG000|NOT COMPLETED|Overall Study||8||
48051372|NCT01277042|100445285|FG001|NOT COMPLETED|Overall Study||5||
48051373|NCT02313454|100445286|FG000|STARTED|Treatment 1||9||
48051374|NCT02313454|100445287|FG001|STARTED|Treatment 1||11||
48051375|NCT02313454|100445286|FG000|COMPLETED|Treatment 1||9||
48051376|NCT02313454|100445287|FG001|COMPLETED|Treatment 1||11||
48051377|NCT02313454|100445286|FG000|NOT COMPLETED|Treatment 1||0||
48051378|NCT02313454|100445287|FG001|NOT COMPLETED|Treatment 1||0||
48051379|NCT02313454|100445286|FG000|STARTED|Treatment 2||8||
48051380|NCT02313454|100445287|FG001|STARTED|Treatment 2||10||
48051381|NCT02313454|100445286|FG000|COMPLETED|Treatment 2||8||
48051382|NCT02313454|100445287|FG001|COMPLETED|Treatment 2||10||
48051383|NCT02313454|100445286|FG000|NOT COMPLETED|Treatment 2||0||
48051384|NCT02313454|100445287|FG001|NOT COMPLETED|Treatment 2||0||
48051385|NCT00596362|100445288|FG000|STARTED|Overall Study||1||
48051386|NCT00596362|100445288|FG000|COMPLETED|Overall Study||0||
48051387|NCT00596362|100445288|FG000|NOT COMPLETED|Overall Study||1||
48051388|NCT04285580|100445289|FG000|STARTED|Overall Study||31||
48051389|NCT04285580|100445290|FG001|STARTED|Overall Study||6||
48051390|NCT04285580|100445289|FG000|COMPLETED|Overall Study||31||
48051391|NCT04285580|100445290|FG001|COMPLETED|Overall Study||5||
48051392|NCT04285580|100445289|FG000|NOT COMPLETED|Overall Study||0||
48051393|NCT04285580|100445290|FG001|NOT COMPLETED|Overall Study||1||
48051394|NCT03114059|100445291|FG000|STARTED|Overall Study||230||
48051395|NCT03114059|100445291|FG000|COMPLETED|Overall Study||230||
48051396|NCT03114059|100445291|FG000|NOT COMPLETED|Overall Study||0||
48051397|NCT01055496|100448226|FG000|STARTED|Overall Study||48||
48051398|NCT01055496|100448227|FG001|STARTED|Overall Study||55||
48051399|NCT01055496|100448226|FG000|COMPLETED|Overall Study||33||
48051400|NCT01055496|100448227|FG001|COMPLETED|Overall Study||25||
48051401|NCT01055496|100448226|FG000|NOT COMPLETED|Overall Study||15||
48051402|NCT01055496|100448227|FG001|NOT COMPLETED|Overall Study||30||
48051403|NCT01555957|100448228|FG000|STARTED|Overall Study||20||
48051404|NCT01555957|100448229|FG001|STARTED|Overall Study||20||
48051405|NCT01555957|100448228|FG000|COMPLETED|Overall Study||20||
48051406|NCT01555957|100448229|FG001|COMPLETED|Overall Study||20||
48051407|NCT01555957|100448228|FG000|NOT COMPLETED|Overall Study||0||
48051408|NCT01555957|100448229|FG001|NOT COMPLETED|Overall Study||0||
48051409|NCT01337687|100448230|FG000|STARTED|Overall Study||10||
48051410|NCT01337687|100448231|FG001|STARTED|Overall Study||9||
48051411|NCT01337687|100448230|FG000|COMPLETED|Overall Study||10||
48051412|NCT01337687|100448231|FG001|COMPLETED|Overall Study||9||
48051413|NCT01337687|100448230|FG000|NOT COMPLETED|Overall Study||0||
48051414|NCT01337687|100448231|FG001|NOT COMPLETED|Overall Study||0||
48051415|NCT01163032|100448232|FG000|STARTED|Randomization Phase||42||
48051416|NCT01163032|100448233|FG001|STARTED|Randomization Phase||42||
48051417|NCT01163032|100448234|FG002|STARTED|Randomization Phase||0||
48051418|NCT01163032|100448232|FG000|COMPLETED|Randomization Phase||32||
48051419|NCT01163032|100448233|FG001|COMPLETED|Randomization Phase||30||
48051420|NCT01163032|100448234|FG002|COMPLETED|Randomization Phase||0||
48051421|NCT01163032|100448232|FG000|NOT COMPLETED|Randomization Phase||10||
48051422|NCT01163032|100448233|FG001|NOT COMPLETED|Randomization Phase||12||
48051423|NCT01163032|100448234|FG002|NOT COMPLETED|Randomization Phase||0||
48051424|NCT01163032|100448232|FG000|STARTED|Open Label Extension Phase||0||
48051425|NCT01163032|100448233|FG001|STARTED|Open Label Extension Phase||0||
48051426|NCT01163032|100448234|FG002|STARTED|Open Label Extension Phase||55||
48051427|NCT01163032|100448232|FG000|COMPLETED|Open Label Extension Phase||0||
48051428|NCT01163032|100448233|FG001|COMPLETED|Open Label Extension Phase||0||
48051429|NCT01163032|100448234|FG002|COMPLETED|Open Label Extension Phase||39||
48051430|NCT01163032|100448232|FG000|NOT COMPLETED|Open Label Extension Phase||0||
48051431|NCT01163032|100448233|FG001|NOT COMPLETED|Open Label Extension Phase||0||
48051432|NCT01163032|100448234|FG002|NOT COMPLETED|Open Label Extension Phase||16||
48051433|NCT03103061|100448235|FG000|STARTED|Overall Study||24||
48051434|NCT03103061|100448235|FG000|COMPLETED|Overall Study||24||
48051435|NCT03103061|100448235|FG000|NOT COMPLETED|Overall Study||0||
48051436|NCT03158714|100448236|FG000|STARTED|Overall Study||626||
48051437|NCT03158714|100448237|FG001|STARTED|Overall Study||626||
48051438|NCT03158714|100448238|FG002|STARTED|Overall Study||606||
48051439|NCT03158714|100448236|FG000|COMPLETED|Overall Study||445||
48051440|NCT03158714|100448237|FG001|COMPLETED|Overall Study||398||
48051441|NCT03158714|100448238|FG002|COMPLETED|Overall Study||606||
48051442|NCT03158714|100448236|FG000|NOT COMPLETED|Overall Study||181||
48051443|NCT03158714|100448237|FG001|NOT COMPLETED|Overall Study||228||
48051444|NCT03158714|100448238|FG002|NOT COMPLETED|Overall Study||0||
48051445|NCT03442764|100448239|FG000|STARTED|Overall Study||19||
48051446|NCT03442764|100448240|FG001|STARTED|Overall Study||21||
48051447|NCT03442764|100448241|FG002|STARTED|Overall Study||19||
48051448|NCT03442764|100448239|FG000|COMPLETED|Overall Study||18||
48051449|NCT03442764|100448240|FG001|COMPLETED|Overall Study||21||
48051450|NCT03442764|100448241|FG002|COMPLETED|Overall Study||19||
48051451|NCT03442764|100448239|FG000|NOT COMPLETED|Overall Study||1||
48051452|NCT03442764|100448240|FG001|NOT COMPLETED|Overall Study||0||
48051453|NCT03442764|100448241|FG002|NOT COMPLETED|Overall Study||0||
48051454|NCT03119701|100448242|FG000|STARTED|6-day Dosing||29||
48051455|NCT03119701|100448243|FG001|STARTED|6-day Dosing||11||
48051456|NCT03119701|100448242|FG000|COMPLETED|6-day Dosing||22||
48051457|NCT03119701|100448243|FG001|COMPLETED|6-day Dosing||8||
48051458|NCT03119701|100448242|FG000|NOT COMPLETED|6-day Dosing||7||
48051459|NCT03119701|100448243|FG001|NOT COMPLETED|6-day Dosing||3||
48051460|NCT03119701|100448242|FG000|STARTED|Mid-term (Final) Follow-up at D90||25||
48051461|NCT03119701|100448243|FG001|STARTED|Mid-term (Final) Follow-up at D90||10||
48051462|NCT03119701|100448242|FG000|COMPLETED|Mid-term (Final) Follow-up at D90||22||
48208310|NCT00364013|100837025|FG000|NOT COMPLETED|Overall Study||101||
48051463|NCT03119701|100448243|FG001|COMPLETED|Mid-term (Final) Follow-up at D90||9||
48051464|NCT03119701|100448242|FG000|NOT COMPLETED|Mid-term (Final) Follow-up at D90||3||
48051465|NCT03119701|100448243|FG001|NOT COMPLETED|Mid-term (Final) Follow-up at D90||1||
48051466|NCT01314911|100448244|FG000|STARTED|Overall Study||278||
48051467|NCT01314911|100448245|FG001|STARTED|Overall Study||280||
48051468|NCT01314911|100448244|FG000|COMPLETED|Overall Study||273|Data were locked on July 12, 2018 and were retrieved on August 14, 2018.|
48051469|NCT01314911|100448245|FG001|COMPLETED|Overall Study||274|Data were locked on July 12, 2018 and were retrieved on August 14, 2018.|
48051470|NCT01314911|100448244|FG000|NOT COMPLETED|Overall Study||5||
48051471|NCT01314911|100448245|FG001|NOT COMPLETED|Overall Study||6||
48051472|NCT02280473|100448246|FG000|STARTED|Overall Study||94||
48051473|NCT02280473|100448247|FG001|STARTED|Overall Study||94||
48051474|NCT02280473|100448246|FG000|COMPLETED|Overall Study||93||
48051475|NCT02280473|100448247|FG001|COMPLETED|Overall Study||91||
48051476|NCT02280473|100448246|FG000|NOT COMPLETED|Overall Study||1||
48051477|NCT02280473|100448247|FG001|NOT COMPLETED|Overall Study||3||
48051478|NCT01315236|100448248|FG000|STARTED|Double-blind Phase||44||
48051479|NCT01315236|100448249|FG001|STARTED|Double-blind Phase||45||
48051480|NCT01315236|100448248|FG000|COMPLETED|Double-blind Phase||40||
48051481|NCT01315236|100448249|FG001|COMPLETED|Double-blind Phase||45||
48051482|NCT01315236|100448248|FG000|NOT COMPLETED|Double-blind Phase||4||
48051483|NCT01315236|100448249|FG001|NOT COMPLETED|Double-blind Phase||0||
48051484|NCT01315236|100448248|FG000|STARTED|Open-label Phase||35||
48051485|NCT01315236|100448249|FG001|STARTED|Open-label Phase||43||
48051486|NCT01315236|100448248|FG000|COMPLETED|Open-label Phase||34||
48051487|NCT01315236|100448249|FG001|COMPLETED|Open-label Phase||41||
48051488|NCT01315236|100448248|FG000|NOT COMPLETED|Open-label Phase||1||
48051489|NCT01315236|100448249|FG001|NOT COMPLETED|Open-label Phase||2||
48051490|NCT01315236|100448248|FG000|STARTED|12-Month Follow-up Period||27||
48051491|NCT01315236|100448249|FG001|STARTED|12-Month Follow-up Period||32||
48051492|NCT01315236|100448248|FG000|COMPLETED|12-Month Follow-up Period||26||
48051493|NCT01315236|100448249|FG001|COMPLETED|12-Month Follow-up Period||31||
48051494|NCT01315236|100448248|FG000|NOT COMPLETED|12-Month Follow-up Period||1||
48051495|NCT01315236|100448249|FG001|NOT COMPLETED|12-Month Follow-up Period||1||
48208311|NCT00364013|100837026|FG001|NOT COMPLETED|Overall Study||95||
48208312|NCT04767698|100837027|FG000|STARTED|Overall Study||1||
48051496|NCT02011893|100448250|FG000|STARTED|Enrollment to Randomization||173||
48051497|NCT02011893|100448251|FG001|STARTED|Enrollment to Randomization||0||
48051498|NCT02011893|100448252|FG002|STARTED|Enrollment to Randomization||0||
48051499|NCT02011893|100448250|FG000|Baseline|Enrollment to Randomization||141||
48051500|NCT02011893|100448251|FG001|Baseline|Enrollment to Randomization||0||
48051501|NCT02011893|100448252|FG002|Baseline|Enrollment to Randomization||0||
48051502|NCT02011893|100448250|FG000|Trial Stimulation Implant|Enrollment to Randomization||121||
48051503|NCT02011893|100448251|FG001|Trial Stimulation Implant|Enrollment to Randomization||0||
48051504|NCT02011893|100448252|FG002|Trial Stimulation Implant|Enrollment to Randomization||0||
48051505|NCT02011893|100448250|FG000|Permanent Stimulation Implant|Enrollment to Randomization||101||
48051506|NCT02011893|100448251|FG001|Permanent Stimulation Implant|Enrollment to Randomization||0||
48051507|NCT02011893|100448252|FG002|Permanent Stimulation Implant|Enrollment to Randomization||0||
48051508|NCT02011893|100448250|FG000|Randomization|Enrollment to Randomization||100||
48051509|NCT02011893|100448251|FG001|Randomization|Enrollment to Randomization||0||
48051510|NCT02011893|100448252|FG002|Randomization|Enrollment to Randomization||0||
48051511|NCT02011893|100448250|FG000|COMPLETED|Enrollment to Randomization||100||
48051512|NCT02011893|100448251|FG001|COMPLETED|Enrollment to Randomization||0||
48051513|NCT02011893|100448252|FG002|COMPLETED|Enrollment to Randomization||0||
48051514|NCT02011893|100448250|FG000|NOT COMPLETED|Enrollment to Randomization||73||
48051515|NCT02011893|100448251|FG001|NOT COMPLETED|Enrollment to Randomization||0||
48051516|NCT02011893|100448252|FG002|NOT COMPLETED|Enrollment to Randomization||0||
48051517|NCT02011893|100448250|FG000|STARTED|Period 1 (Randomization to 12 Weeks)||0||
48051518|NCT02011893|100448251|FG001|STARTED|Period 1 (Randomization to 12 Weeks)||45||
48051519|NCT02011893|100448252|FG002|STARTED|Period 1 (Randomization to 12 Weeks)||55||
48051520|NCT02011893|100448250|FG000|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0||
48051521|NCT02011893|100448251|FG001|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45||
48051522|NCT02011893|100448252|FG002|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52||
48051523|NCT02011893|100448250|FG000|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0||
48051524|NCT02011893|100448251|FG001|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45||
48051525|NCT02011893|100448252|FG002|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52||
48051526|NCT02011893|100448250|FG000|COMPLETED|Period 1 (Randomization to 12 Weeks)||0||
48051527|NCT02011893|100448251|FG001|COMPLETED|Period 1 (Randomization to 12 Weeks)||45||
48051528|NCT02011893|100448252|FG002|COMPLETED|Period 1 (Randomization to 12 Weeks)||52||
48051529|NCT02011893|100448250|FG000|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0||
48051530|NCT02011893|100448251|FG001|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0||
48051531|NCT02011893|100448252|FG002|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||3||
48051532|NCT02011893|100448250|FG000|STARTED|Period 2 (12 Weeks to 24 Weeks)||0||
48051533|NCT02011893|100448251|FG001|STARTED|Period 2 (12 Weeks to 24 Weeks)||45||
48208313|NCT04767698|100837028|FG001|STARTED|Overall Study||2||
48051534|NCT02011893|100448252|FG002|STARTED|Period 2 (12 Weeks to 24 Weeks)||52||
48051535|NCT02011893|100448250|FG000|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0||
48051536|NCT02011893|100448251|FG001|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||44||
48051537|NCT02011893|100448252|FG002|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51||
48051538|NCT02011893|100448250|FG000|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0||
48051539|NCT02011893|100448251|FG001|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||45||
48051540|NCT02011893|100448252|FG002|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51||
48051541|NCT02011893|100448250|FG000|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0||
48051542|NCT02011893|100448251|FG001|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||45||
48051543|NCT02011893|100448252|FG002|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||51||
48051544|NCT02011893|100448250|FG000|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0||
48051545|NCT02011893|100448251|FG001|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0||
48051546|NCT02011893|100448252|FG002|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||1||
48051547|NCT03762915|100448253|FG000|STARTED|Overall Study||35||
48051548|NCT03762915|100448254|FG001|STARTED|Overall Study||35||
48051549|NCT03762915|100448253|FG000|COMPLETED|Overall Study||34||
48051550|NCT03762915|100448254|FG001|COMPLETED|Overall Study||30||
48051551|NCT03762915|100448253|FG000|NOT COMPLETED|Overall Study||1||
48051552|NCT03762915|100448254|FG001|NOT COMPLETED|Overall Study||5||
48051553|NCT01142128|100448255|FG000|STARTED|Overall Study||8||
48051554|NCT01142128|100448255|FG000|Nexium Alone|Overall Study||3||
48051555|NCT01142128|100448255|FG000|Placebo to Nexium, Alone|Overall Study||3||
48051556|NCT01142128|100448255|FG000|Viokase 16 Plus Nexium|Overall Study||2||
48051557|NCT01142128|100448255|FG000|Viokase 16 Plus Placebo to Nexium|Overall Study||0||
48051558|NCT01142128|100448255|FG000|COMPLETED|Overall Study||4||
48051559|NCT01142128|100448255|FG000|NOT COMPLETED|Overall Study||4||
48051560|NCT04867434|100448256|FG000|STARTED|Overall Study||50||
48051561|NCT04867434|100448257|FG001|STARTED|Overall Study||53||
48051562|NCT04867434|100448258|FG002|STARTED|Overall Study||48||
48051563|NCT04867434|100448256|FG000|COMPLETED|Overall Study||50||
48051564|NCT04867434|100448257|FG001|COMPLETED|Overall Study||49||
48051565|NCT04867434|100448258|FG002|COMPLETED|Overall Study||47||
48051566|NCT04867434|100448256|FG000|NOT COMPLETED|Overall Study||0||
48051567|NCT04867434|100448257|FG001|NOT COMPLETED|Overall Study||4||
48051568|NCT04867434|100448258|FG002|NOT COMPLETED|Overall Study||1||
48051569|NCT01962922|100448259|FG000|STARTED|PK Portion Day 7||27||
48051570|NCT01962922|100448260|FG001|STARTED|PK Portion Day 7||23||
48051571|NCT01962922|100448259|FG000|COMPLETED|PK Portion Day 7||23||
48051572|NCT01962922|100448260|FG001|COMPLETED|PK Portion Day 7||23||
48051573|NCT01962922|100448259|FG000|NOT COMPLETED|PK Portion Day 7||4||
48051574|NCT01962922|100448260|FG001|NOT COMPLETED|PK Portion Day 7||0||
48051575|NCT01962922|100448259|FG000|STARTED|PK Portion Day 14||23||
48051576|NCT01962922|100448260|FG001|STARTED|PK Portion Day 14||23||
48051577|NCT01962922|100448259|FG000|COMPLETED|PK Portion Day 14||23||
48051578|NCT01962922|100448260|FG001|COMPLETED|PK Portion Day 14||23||
48051579|NCT01962922|100448259|FG000|NOT COMPLETED|PK Portion Day 14||0||
48051580|NCT01962922|100448260|FG001|NOT COMPLETED|PK Portion Day 14||0||
48051581|NCT01962922|100448259|FG000|STARTED|PK Portion Day 21||23||
48051582|NCT01962922|100448260|FG001|STARTED|PK Portion Day 21||23||
48051583|NCT01962922|100448259|FG000|COMPLETED|PK Portion Day 21||23||
48051584|NCT01962922|100448260|FG001|COMPLETED|PK Portion Day 21||23||
48051585|NCT01962922|100448259|FG000|NOT COMPLETED|PK Portion Day 21||0||
48051586|NCT01962922|100448260|FG001|NOT COMPLETED|PK Portion Day 21||0||
48051587|NCT01962922|100448259|FG000|STARTED|Extendion Portion (up to Month 6)||23||
48051588|NCT01962922|100448260|FG001|STARTED|Extendion Portion (up to Month 6)||23||
48051589|NCT01962922|100448259|FG000|COMPLETED|Extendion Portion (up to Month 6)||18||
48051590|NCT01962922|100448260|FG001|COMPLETED|Extendion Portion (up to Month 6)||20||
48051591|NCT01962922|100448259|FG000|NOT COMPLETED|Extendion Portion (up to Month 6)||5||
48051592|NCT01962922|100448260|FG001|NOT COMPLETED|Extendion Portion (up to Month 6)||3||
48051593|NCT00618839|100448261|FG000|STARTED|Overall Study||15||
48051594|NCT00618839|100448261|FG000|COMPLETED|Overall Study||15||
48051595|NCT00618839|100448261|FG000|NOT COMPLETED|Overall Study||0||
48051596|NCT01082640|100448262|FG000|STARTED|Overall Study||32||
48051597|NCT01082640|100448263|FG001|STARTED|Overall Study||32||
48051598|NCT01082640|100448264|FG002|STARTED|Overall Study||32||
48051599|NCT01082640|100448262|FG000|COMPLETED|Overall Study||15||
48051600|NCT01082640|100448263|FG001|COMPLETED|Overall Study||17||
48051601|NCT01082640|100448264|FG002|COMPLETED|Overall Study||24||
48051602|NCT01082640|100448262|FG000|NOT COMPLETED|Overall Study||17||
48051603|NCT01082640|100448263|FG001|NOT COMPLETED|Overall Study||15||
48051604|NCT01082640|100448264|FG002|NOT COMPLETED|Overall Study||8||
48051605|NCT01115803|100448265|FG000|STARTED|Overall Study||4||
48051606|NCT01115803|100448266|FG001|STARTED|Overall Study||5||
48051607|NCT01115803|100448267|FG002|STARTED|Overall Study||3||
48051608|NCT01115803|100448268|FG003|STARTED|Overall Study||5||
48051609|NCT01115803|100448269|FG004|STARTED|Overall Study||3||
48051610|NCT01115803|100448270|FG005|STARTED|Overall Study||3||
48051611|NCT01115803|100448271|FG006|STARTED|Overall Study||6||
48051612|NCT01115803|100448265|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4||
48051613|NCT01115803|100448266|FG001|Received at Least 1 Dose of Study Drug|Overall Study||5||
48051614|NCT01115803|100448267|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
48051615|NCT01115803|100448268|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5||
48051616|NCT01115803|100448269|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3||
48051617|NCT01115803|100448270|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3||
48051618|NCT01115803|100448271|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6||
48051619|NCT01115803|100448265|FG000|COMPLETED|Overall Study||4||
48051620|NCT01115803|100448266|FG001|COMPLETED|Overall Study||5||
48051621|NCT01115803|100448267|FG002|COMPLETED|Overall Study||2||
48051622|NCT01115803|100448268|FG003|COMPLETED|Overall Study||5||
48051623|NCT01115803|100448269|FG004|COMPLETED|Overall Study||3||
48051624|NCT01115803|100448270|FG005|COMPLETED|Overall Study||3||
48051625|NCT01115803|100448271|FG006|COMPLETED|Overall Study||4||
48051626|NCT01115803|100448265|FG000|NOT COMPLETED|Overall Study||0||
48051627|NCT01115803|100448266|FG001|NOT COMPLETED|Overall Study||0||
48051628|NCT01115803|100448267|FG002|NOT COMPLETED|Overall Study||1||
48051629|NCT01115803|100448268|FG003|NOT COMPLETED|Overall Study||0||
48051630|NCT01115803|100448269|FG004|NOT COMPLETED|Overall Study||0||
48051631|NCT01115803|100448270|FG005|NOT COMPLETED|Overall Study||0||
48051632|NCT01115803|100448271|FG006|NOT COMPLETED|Overall Study||2||
48051633|NCT04163822|100448272|FG000|STARTED|Overall Study||78||
48051634|NCT04163822|100448273|FG001|STARTED|Overall Study||178||
48051635|NCT04163822|100448272|FG000|COMPLETED|Overall Study||78||
48051636|NCT04163822|100448273|FG001|COMPLETED|Overall Study||178||
48051637|NCT04163822|100448272|FG000|NOT COMPLETED|Overall Study||0||
48051638|NCT04163822|100448273|FG001|NOT COMPLETED|Overall Study||0||
48051639|NCT02197455|100448274|FG000|STARTED|Overall Study||30||
48051640|NCT02197455|100448274|FG000|COMPLETED|Overall Study||30||
48051641|NCT02197455|100448274|FG000|NOT COMPLETED|Overall Study||0||
48051642|NCT02514473|100448275|FG000|STARTED|Overall Study||101||
48051643|NCT02514473|100448276|FG001|STARTED|Overall Study||103||
48051644|NCT02514473|100448275|FG000|COMPLETED|Overall Study||98||
48051645|NCT02514473|100448276|FG001|COMPLETED|Overall Study||98||
48051646|NCT02514473|100448275|FG000|NOT COMPLETED|Overall Study||3||
48051647|NCT02514473|100448276|FG001|NOT COMPLETED|Overall Study||5||
48051648|NCT02605837|100448277|FG000|STARTED|Overall Study||105||
48051649|NCT02605837|100448278|FG001|STARTED|Overall Study||213||
48051650|NCT02605837|100448277|FG000|COMPLETED|Overall Study||94||
48051651|NCT02605837|100448278|FG001|COMPLETED|Overall Study||202||
48051652|NCT02605837|100448277|FG000|NOT COMPLETED|Overall Study||11||
48051653|NCT02605837|100448278|FG001|NOT COMPLETED|Overall Study||11||
48051654|NCT01082380|100448279|FG000|STARTED|Overall Study||6||
48051655|NCT01082380|100448279|FG000|COMPLETED|Overall Study||6||
48051656|NCT01082380|100448279|FG000|NOT COMPLETED|Overall Study||0||
48051657|NCT01412918|100448280|FG000|STARTED|Overall Study||20||
48051658|NCT01412918|100448281|FG001|STARTED|Overall Study||1||
48051659|NCT01412918|100448280|FG000|COMPLETED|Overall Study||20||
48051660|NCT01412918|100448281|FG001|COMPLETED|Overall Study||1||
48051661|NCT01412918|100448280|FG000|NOT COMPLETED|Overall Study||0||
48051662|NCT01412918|100448281|FG001|NOT COMPLETED|Overall Study||0||
48051663|NCT00708201|100448282|FG000|STARTED|Overall Study||137||
48051664|NCT00708201|100448283|FG001|STARTED|Overall Study||143||
48051665|NCT00708201|100448282|FG000|Received at Least 1 Dose of Study Drug|Overall Study||130||
48051666|NCT00708201|100448283|FG001|Received at Least 1 Dose of Study Drug|Overall Study||137||
48051667|NCT00708201|100448282|FG000|COMPLETED|Overall Study||130||
48051668|NCT00708201|100448283|FG001|COMPLETED|Overall Study||137||
48051669|NCT00708201|100448282|FG000|NOT COMPLETED|Overall Study||7||
48051670|NCT00708201|100448283|FG001|NOT COMPLETED|Overall Study||6||
48051671|NCT01178827|100448284|FG000|STARTED|Overall Study||6||
48208314|NCT04767698|100837027|FG000|COMPLETED|Overall Study||0|Study was terminated|
48495676|NCT02718963|101547906|FG000|COMPLETED|Overall Study||9||
48051672|NCT01178827|100448285|FG001|STARTED|Overall Study||10||
48051673|NCT01178827|100448286|FG002|STARTED|Overall Study||4||
48051674|NCT01178827|100448284|FG000|COMPLETED|Overall Study||6||
48051675|NCT01178827|100448285|FG001|COMPLETED|Overall Study||10||
48051676|NCT01178827|100448286|FG002|COMPLETED|Overall Study||4||
48051677|NCT01178827|100448284|FG000|NOT COMPLETED|Overall Study||0||
48051678|NCT01178827|100448285|FG001|NOT COMPLETED|Overall Study||0||
48051679|NCT01178827|100448286|FG002|NOT COMPLETED|Overall Study||0||
48051680|NCT00439465|100448287|FG000|STARTED|Overall Study||23||
48051681|NCT00439465|100448287|FG000|COMPLETED|Overall Study||19||
48051682|NCT00439465|100448287|FG000|NOT COMPLETED|Overall Study||4||
48051683|NCT02942576|100448288|FG000|STARTED|Overall Study||405||
48051684|NCT02942576|100448289|FG001|STARTED|Overall Study||197||
48051685|NCT02942576|100448288|FG000|COMPLETED|Overall Study||359||
48051686|NCT02942576|100448289|FG001|COMPLETED|Overall Study||174||
48051687|NCT02942576|100448288|FG000|NOT COMPLETED|Overall Study||46||
48051688|NCT02942576|100448289|FG001|NOT COMPLETED|Overall Study||23||
48051689|NCT01565499|100448290|FG000|STARTED|Overall Study||83||
48051690|NCT01565499|100448290|FG000|COMPLETED|Overall Study||75||
48051691|NCT01565499|100448290|FG000|NOT COMPLETED|Overall Study||8||
48051692|NCT01653782|100448291|FG000|STARTED|Overall Study||52||
48051693|NCT01653782|100448292|FG001|STARTED|Overall Study||55||
48051694|NCT01653782|100448293|FG002|STARTED|Overall Study||52||
48051695|NCT01653782|100448291|FG000|COMPLETED|Overall Study||36||
48051696|NCT01653782|100448292|FG001|COMPLETED|Overall Study||37||
48051697|NCT01653782|100448293|FG002|COMPLETED|Overall Study||46||
48051698|NCT01653782|100448291|FG000|NOT COMPLETED|Overall Study||16||
48051699|NCT01653782|100448292|FG001|NOT COMPLETED|Overall Study||18||
48051700|NCT01653782|100448293|FG002|NOT COMPLETED|Overall Study||6||
48051701|NCT00510874|100448294|FG000|STARTED|Overall Study||78||
48051702|NCT00510874|100448295|FG001|STARTED|Overall Study||152||
48051703|NCT00510874|100448296|FG002|STARTED|Overall Study||151||
48051704|NCT00510874|100448297|FG003|STARTED|Overall Study||151||
48051705|NCT00510874|100448298|FG004|STARTED|Overall Study||148||
48051706|NCT00510874|100448299|FG005|STARTED|Overall Study||50||
48051707|NCT00510874|100448300|FG006|STARTED|Overall Study||50||
48051708|NCT00510874|100448294|FG000|COMPLETED|Overall Study||75||
48051709|NCT00510874|100448295|FG001|COMPLETED|Overall Study||148||
48051710|NCT00510874|100448296|FG002|COMPLETED|Overall Study||150||
48051711|NCT00510874|100448297|FG003|COMPLETED|Overall Study||148||
48051712|NCT00510874|100448298|FG004|COMPLETED|Overall Study||141||
48051713|NCT00510874|100448299|FG005|COMPLETED|Overall Study||50||
48051714|NCT00510874|100448300|FG006|COMPLETED|Overall Study||49||
48051715|NCT00510874|100448294|FG000|NOT COMPLETED|Overall Study||3||
48051716|NCT00510874|100448295|FG001|NOT COMPLETED|Overall Study||4||
48051717|NCT00510874|100448296|FG002|NOT COMPLETED|Overall Study||1||
48051718|NCT00510874|100448297|FG003|NOT COMPLETED|Overall Study||3||
48051719|NCT00510874|100448298|FG004|NOT COMPLETED|Overall Study||7||
48051720|NCT00510874|100448299|FG005|NOT COMPLETED|Overall Study||0||
48051721|NCT00510874|100448300|FG006|NOT COMPLETED|Overall Study||1||
48051722|NCT03242824|100448301|FG000|STARTED|Overall Study||20||
48051723|NCT03242824|100448301|FG000|COMPLETED|Overall Study||20||
48051724|NCT03242824|100448301|FG000|NOT COMPLETED|Overall Study||0||
48051725|NCT04389970|100448302|FG000|STARTED|Overall Study||12||
48051726|NCT04389970|100448302|FG000|COMPLETED|Overall Study||11||
48051727|NCT04389970|100448302|FG000|NOT COMPLETED|Overall Study||1||
48051728|NCT02734433|100448303|FG000|STARTED|Overall Study||3||
48051729|NCT02734433|100448304|FG001|STARTED|Overall Study||8||
48051730|NCT02734433|100448303|FG000|COMPLETED|Overall Study||1||
48051731|NCT02734433|100448304|FG001|COMPLETED|Overall Study||0||
48051732|NCT02734433|100448303|FG000|NOT COMPLETED|Overall Study||2||
48051733|NCT02734433|100448304|FG001|NOT COMPLETED|Overall Study||8||
48051734|NCT01028378|100448305|FG000|STARTED|Overall Study||212||
48051735|NCT01028378|100448305|FG000|COMPLETED|Overall Study||195||
48051736|NCT01028378|100448305|FG000|NOT COMPLETED|Overall Study||17||
48051737|NCT00976573|100448306|FG000|STARTED|Overall Study||75||
48051738|NCT00976573|100448307|FG001|STARTED|Overall Study||74||
48051739|NCT00976573|100448306|FG000|COMPLETED|Overall Study||71||
48051740|NCT00976573|100448307|FG001|COMPLETED|Overall Study||71||
48051741|NCT00976573|100448306|FG000|NOT COMPLETED|Overall Study||4||
48051742|NCT00976573|100448307|FG001|NOT COMPLETED|Overall Study||3||
48051743|NCT02992132|100448308|FG000|STARTED|Overall Study||40||
48051744|NCT02992132|100448309|FG001|STARTED|Overall Study||35||
48051745|NCT02992132|100448310|FG002|STARTED|Overall Study||36||
48051746|NCT02992132|100448308|FG000|COMPLETED|Overall Study||27||
48051747|NCT02992132|100448309|FG001|COMPLETED|Overall Study||27||
48051748|NCT02992132|100448310|FG002|COMPLETED|Overall Study||29||
48051749|NCT02992132|100448308|FG000|NOT COMPLETED|Overall Study||13||
48051750|NCT02992132|100448309|FG001|NOT COMPLETED|Overall Study||8||
48051751|NCT02992132|100448310|FG002|NOT COMPLETED|Overall Study||7||
48051752|NCT03091777|100448311|FG000|STARTED|Overall Study||289||
48051753|NCT03091777|100448312|FG001|STARTED|Overall Study||288||
48051754|NCT03091777|100448313|FG002|STARTED|Overall Study||294||
48051755|NCT03091777|100448311|FG000|COMPLETED|Overall Study||257||
48051756|NCT03091777|100448312|FG001|COMPLETED|Overall Study||255||
48051757|NCT03091777|100448313|FG002|COMPLETED|Overall Study||257||
48051758|NCT03091777|100448311|FG000|NOT COMPLETED|Overall Study||32||
48051759|NCT03091777|100448312|FG001|NOT COMPLETED|Overall Study||33||
48051760|NCT03091777|100448313|FG002|NOT COMPLETED|Overall Study||37||
48051761|NCT02658097|100448314|FG000|STARTED|Overall Study||13||
48051762|NCT02658097|100448314|FG000|COMPLETED|Overall Study||13||
48051763|NCT02658097|100448314|FG000|NOT COMPLETED|Overall Study||0||
48051764|NCT02862600|100448315|FG000|STARTED|Period 1--Perhexiline-low Target Range||35|Target range 100-300 ng/mL|
48051765|NCT02862600|100448315|FG000|COMPLETED|Period 1--Perhexiline-low Target Range||22|Period and study terminated|
48051766|NCT02862600|100448315|FG000|NOT COMPLETED|Period 1--Perhexiline-low Target Range||13||
48051767|NCT02862600|100448315|FG000|STARTED|Period 2--Perhexiline-high Target Range||22|Target range 300-500 ng/mL|
48051768|NCT02862600|100448315|FG000|COMPLETED|Period 2--Perhexiline-high Target Range||15|Period and study termination|
48051769|NCT02862600|100448315|FG000|NOT COMPLETED|Period 2--Perhexiline-high Target Range||7||
48051770|NCT00930982|100448316|FG000|STARTED|Overall Study||60||
48051771|NCT00930982|100448317|FG001|STARTED|Overall Study||64||
48051772|NCT00930982|100448316|FG000|COMPLETED|Overall Study||39||
48051773|NCT00930982|100448317|FG001|COMPLETED|Overall Study||35||
48051774|NCT00930982|100448316|FG000|NOT COMPLETED|Overall Study||21||
48051775|NCT00930982|100448317|FG001|NOT COMPLETED|Overall Study||29||
48051776|NCT01751802|100448318|FG000|STARTED|Overall Study||5||
48051777|NCT01751802|100448319|FG001|STARTED|Overall Study||4||
48051778|NCT01751802|100448318|FG000|Completed Period 1|Overall Study||2||
48051779|NCT01751802|100448319|FG001|Completed Period 1|Overall Study||4||
48051780|NCT01751802|100448318|FG000|Completed Period 2|Overall Study||2||
48051781|NCT01751802|100448319|FG001|Completed Period 2|Overall Study||1||
48051782|NCT01751802|100448318|FG000|Completed Period 3|Overall Study||2||
48051783|NCT01751802|100448319|FG001|Completed Period 3|Overall Study||1||
48051784|NCT01751802|100448318|FG000|COMPLETED|Overall Study||1||
48051785|NCT01751802|100448319|FG001|COMPLETED|Overall Study||2||
48051786|NCT01751802|100448318|FG000|NOT COMPLETED|Overall Study||4||
48051787|NCT01751802|100448319|FG001|NOT COMPLETED|Overall Study||2||
48051788|NCT01729247|100448320|FG000|STARTED|Overall Study||50||
48051789|NCT01729247|100448320|FG000|COMPLETED|Overall Study||50||
48051790|NCT01729247|100448320|FG000|NOT COMPLETED|Overall Study||0||
48051791|NCT00579436|100448321|FG000|STARTED|Overall Study||19||
48051792|NCT00579436|100448322|FG001|STARTED|Overall Study||14||
48051793|NCT00579436|100448321|FG000|COMPLETED|Overall Study||19||
48051794|NCT00579436|100448322|FG001|COMPLETED|Overall Study||14||
48051795|NCT00579436|100448321|FG000|NOT COMPLETED|Overall Study||0||
48051796|NCT00579436|100448322|FG001|NOT COMPLETED|Overall Study||0||
48051797|NCT01408329|100448323|FG000|STARTED|Overall Study||13||
48051798|NCT01408329|100448324|FG001|STARTED|Overall Study||15||
48051799|NCT01408329|100448323|FG000|COMPLETED|Overall Study||10||
48051800|NCT01408329|100448324|FG001|COMPLETED|Overall Study||11||
48051801|NCT01408329|100448323|FG000|NOT COMPLETED|Overall Study||3||
48051802|NCT01408329|100448324|FG001|NOT COMPLETED|Overall Study||4||
48051803|NCT01739400|100448325|FG000|STARTED|Overall Study||109|Enrolled from DB parent study MAESTRO (AC-0553-305, NCT01743001)|
48051804|NCT01739400|100448326|FG001|STARTED|Overall Study||108|Enrolled from DB parent study MAESTRO (AC-0553-305, NCT01743001)|
48051805|NCT01739400|100448325|FG000|Treated With 10 mg Macitentan|Overall Study||109||
48051806|NCT01739400|100448326|FG001|Treated With 10 mg Macitentan|Overall Study||108||
48051807|NCT01739400|100448325|FG000|COMPLETED|Overall Study||92|Completed OL study|
48051808|NCT01739400|100448326|FG001|COMPLETED|Overall Study||99|Completed OL study|
48051809|NCT01739400|100448325|FG000|NOT COMPLETED|Overall Study||17||
48051810|NCT01739400|100448326|FG001|NOT COMPLETED|Overall Study||9||
48051811|NCT01624870|100448327|FG000|STARTED|Overall Study||200||
48051812|NCT01624870|100448327|FG000|COMPLETED|Overall Study||173||
48051813|NCT01624870|100448327|FG000|NOT COMPLETED|Overall Study||27||
48051814|NCT03612856|100448328|FG000|STARTED|Pre-dose Period||8||
48051815|NCT03612856|100448329|FG001|STARTED|Pre-dose Period||10||
48051816|NCT03612856|100448330|FG002|STARTED|Pre-dose Period||9||
48051817|NCT03612856|100448328|FG000|COMPLETED|Pre-dose Period||8||
48051818|NCT03612856|100448329|FG001|COMPLETED|Pre-dose Period||8||
48051819|NCT03612856|100448330|FG002|COMPLETED|Pre-dose Period||8||
48051820|NCT03612856|100448328|FG000|NOT COMPLETED|Pre-dose Period||0||
48051821|NCT03612856|100448329|FG001|NOT COMPLETED|Pre-dose Period||2||
48051822|NCT03612856|100448330|FG002|NOT COMPLETED|Pre-dose Period||1||
48051823|NCT03612856|100448328|FG000|STARTED|Post-dose Period||8||
48051824|NCT03612856|100448329|FG001|STARTED|Post-dose Period||8||
48051825|NCT03612856|100448330|FG002|STARTED|Post-dose Period||8||
48051826|NCT03612856|100448328|FG000|COMPLETED|Post-dose Period||8||
48051827|NCT03612856|100448329|FG001|COMPLETED|Post-dose Period||8||
48051828|NCT03612856|100448330|FG002|COMPLETED|Post-dose Period||8||
48051829|NCT03612856|100448328|FG000|NOT COMPLETED|Post-dose Period||0||
48051830|NCT03612856|100448329|FG001|NOT COMPLETED|Post-dose Period||0||
48051831|NCT03612856|100448330|FG002|NOT COMPLETED|Post-dose Period||0||
48051832|NCT00586326|100448331|FG000|STARTED|Enrollment to Device Placement-Enrolled||133||
48051833|NCT00586326|100448331|FG000|COMPLETED|Enrollment to Device Placement-Enrolled||118||
48051834|NCT00586326|100448331|FG000|NOT COMPLETED|Enrollment to Device Placement-Enrolled||15||
48051835|NCT00586326|100448331|FG000|STARTED|Device Placed toTreatment-ITT||118||
48051836|NCT00586326|100448331|FG000|COMPLETED|Device Placed toTreatment-ITT||100||
48051837|NCT00586326|100448331|FG000|NOT COMPLETED|Device Placed toTreatment-ITT||18||
48051838|NCT00586326|100448331|FG000|STARTED|Treated Through 5-yr Follow Up-Treated||100||
48051839|NCT00586326|100448331|FG000|COMPLETED|Treated Through 5-yr Follow Up-Treated||74||
48208315|NCT04767698|100837028|FG001|COMPLETED|Overall Study||0|Study was terminated|
48051840|NCT00586326|100448331|FG000|NOT COMPLETED|Treated Through 5-yr Follow Up-Treated||26||
48051841|NCT00390234|100448332|FG000|STARTED|Overall Study||63||
48051842|NCT00390234|100448332|FG000|COMPLETED|Overall Study||63||
48051843|NCT00390234|100448332|FG000|NOT COMPLETED|Overall Study||0||
48051844|NCT00521001|100448333|FG000|STARTED|Overall Study||49||
48051845|NCT00521001|100448333|FG000|COMPLETED|Overall Study||48||
48051846|NCT00521001|100448333|FG000|NOT COMPLETED|Overall Study||1||
48051847|NCT02301988|100448334|FG000|STARTED|Overall Study||76||
48051848|NCT02301988|100448335|FG001|STARTED|Overall Study||75||
48051849|NCT02301988|100448334|FG000|COMPLETED|Overall Study||66||
48051850|NCT02301988|100448335|FG001|COMPLETED|Overall Study||66||
48051851|NCT02301988|100448334|FG000|NOT COMPLETED|Overall Study||10||
48051852|NCT02301988|100448335|FG001|NOT COMPLETED|Overall Study||9||
48051853|NCT01076075|100448336|FG000|STARTED|Overall Study||213||
48051854|NCT01076075|100448337|FG001|STARTED|Overall Study||214||
48051855|NCT01076075|100448336|FG000|Completed Phase A|Overall Study||199||
48051856|NCT01076075|100448337|FG001|Completed Phase A|Overall Study||189||
48051857|NCT01076075|100448336|FG000|COMPLETED|Overall Study||172||
48051858|NCT01076075|100448337|FG001|COMPLETED|Overall Study||167||
48051859|NCT01076075|100448336|FG000|NOT COMPLETED|Overall Study||41||
48051860|NCT01076075|100448337|FG001|NOT COMPLETED|Overall Study||47||
48051861|NCT00442468|100448338|FG000|STARTED|Overall Study||1283||
48051862|NCT00442468|100448338|FG000|COMPLETED|Overall Study||1100||
48051863|NCT00442468|100448338|FG000|NOT COMPLETED|Overall Study||183||
48051864|NCT02312882|100448339|FG000|STARTED|Overall Study||40||
48051865|NCT02312882|100448339|FG000|COMPLETED|Overall Study||36||
48051866|NCT02312882|100448339|FG000|NOT COMPLETED|Overall Study||4||
48051867|NCT02448680|100448340|FG000|STARTED|Overall Study||12||
48051868|NCT02448680|100448341|FG001|STARTED|Overall Study||13||
48051869|NCT02448680|100448340|FG000|COMPLETED|Overall Study||11||
48051870|NCT02448680|100448341|FG001|COMPLETED|Overall Study||10||
48051871|NCT02448680|100448340|FG000|NOT COMPLETED|Overall Study||1||
48051872|NCT02448680|100448341|FG001|NOT COMPLETED|Overall Study||3||
48051873|NCT00761748|100448342|FG000|STARTED|First Intervention (21 +/- 3 Days)||20||
48051874|NCT00761748|100448343|FG001|STARTED|First Intervention (21 +/- 3 Days)||10||
48051875|NCT00761748|100448342|FG000|COMPLETED|First Intervention (21 +/- 3 Days)||17||
48051876|NCT00761748|100448343|FG001|COMPLETED|First Intervention (21 +/- 3 Days)||7||
48051877|NCT00761748|100448342|FG000|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3||
48051878|NCT00761748|100448343|FG001|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3||
48051879|NCT00761748|100448342|FG000|STARTED|Second Intervention (21 +/- 3 Days)||17||
48051880|NCT00761748|100448343|FG001|STARTED|Second Intervention (21 +/- 3 Days)||7||
48051881|NCT00761748|100448342|FG000|COMPLETED|Second Intervention (21 +/- 3 Days)||17||
48051882|NCT00761748|100448343|FG001|COMPLETED|Second Intervention (21 +/- 3 Days)||7||
48051883|NCT00761748|100448342|FG000|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0||
48051884|NCT00761748|100448343|FG001|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0||
48051885|NCT05108922|100448344|FG000|STARTED|Overall Study||74||
48051886|NCT05108922|100448345|FG001|STARTED|Overall Study||74||
48051887|NCT05108922|100448344|FG000|Received at Least One Dose of Study Drug|Overall Study||69||
48051888|NCT05108922|100448345|FG001|Received at Least One Dose of Study Drug|Overall Study||71||
48051889|NCT05108922|100448344|FG000|Intermediate Tau Analysis Set|Overall Study||28||
48051890|NCT05108922|100448345|FG001|Intermediate Tau Analysis Set|Overall Study||27||
48051891|NCT05108922|100448344|FG000|COMPLETED|Overall Study||55||
48051892|NCT05108922|100448345|FG001|COMPLETED|Overall Study||58||
48051893|NCT05108922|100448344|FG000|NOT COMPLETED|Overall Study||19||
48051894|NCT05108922|100448345|FG001|NOT COMPLETED|Overall Study||16||
48051895|NCT05867342|100448346|FG000|STARTED|Overall Study||40||40
48051896|NCT05867342|100448347|FG001|STARTED|Overall Study||40||40
48051897|NCT05867342|100448346|FG000|COMPLETED|Overall Study||37||37
48051898|NCT05867342|100448347|FG001|COMPLETED|Overall Study||37||37
48051899|NCT05867342|100448346|FG000|NOT COMPLETED|Overall Study||3||3
48051900|NCT05867342|100448347|FG001|NOT COMPLETED|Overall Study||3||3
48051901|NCT02360605|100448348|FG000|STARTED|Overall Study||311||
48051902|NCT02360605|100448349|FG001|STARTED|Overall Study||309||
48051903|NCT02360605|100448348|FG000|COMPLETED|Overall Study||300||
48051904|NCT02360605|100448349|FG001|COMPLETED|Overall Study||291||
48051905|NCT02360605|100448348|FG000|NOT COMPLETED|Overall Study||11||
48051906|NCT02360605|100448349|FG001|NOT COMPLETED|Overall Study||18||
48051907|NCT00076024|100448350|FG000|STARTED|Phase 1, Lead-in||6||
48051908|NCT00076024|100448351|FG001|STARTED|Phase 1, Lead-in||0||
48051909|NCT00076024|100448352|FG002|STARTED|Phase 1, Lead-in||0||
48051910|NCT00076024|100448353|FG003|STARTED|Phase 1, Lead-in||0||
48051911|NCT00076024|100448350|FG000|COMPLETED|Phase 1, Lead-in||0||
48051912|NCT00076024|100448351|FG001|COMPLETED|Phase 1, Lead-in||0||
48051913|NCT00076024|100448352|FG002|COMPLETED|Phase 1, Lead-in||0||
48051914|NCT00076024|100448353|FG003|COMPLETED|Phase 1, Lead-in||0||
48051915|NCT00076024|100448350|FG000|NOT COMPLETED|Phase 1, Lead-in||6||
48051916|NCT00076024|100448351|FG001|NOT COMPLETED|Phase 1, Lead-in||0||
48051917|NCT00076024|100448352|FG002|NOT COMPLETED|Phase 1, Lead-in||0||
48051918|NCT00076024|100448353|FG003|NOT COMPLETED|Phase 1, Lead-in||0||
48051919|NCT00076024|100448350|FG000|STARTED|Phase 2, Double-blind||0||
48051920|NCT00076024|100448351|FG001|STARTED|Phase 2, Double-blind||112||
48051921|NCT00076024|100448352|FG002|STARTED|Phase 2, Double-blind||56||
48051922|NCT00076024|100448353|FG003|STARTED|Phase 2, Double-blind||0||
48051923|NCT00076024|100448350|FG000|Treated|Phase 2, Double-blind||0||
48051924|NCT00076024|100448351|FG001|Treated|Phase 2, Double-blind||111||
48051925|NCT00076024|100448352|FG002|Treated|Phase 2, Double-blind||56||
48051926|NCT00076024|100448353|FG003|Treated|Phase 2, Double-blind||0||
48051927|NCT00076024|100448350|FG000|COMPLETED|Phase 2, Double-blind||0||
48051928|NCT00076024|100448351|FG001|COMPLETED|Phase 2, Double-blind||0||
48051929|NCT00076024|100448352|FG002|COMPLETED|Phase 2, Double-blind||0||
48051930|NCT00076024|100448353|FG003|COMPLETED|Phase 2, Double-blind||0||
48051931|NCT00076024|100448350|FG000|NOT COMPLETED|Phase 2, Double-blind||0||
48051932|NCT00076024|100448351|FG001|NOT COMPLETED|Phase 2, Double-blind||112||
48051933|NCT00076024|100448352|FG002|NOT COMPLETED|Phase 2, Double-blind||56||
48051934|NCT00076024|100448353|FG003|NOT COMPLETED|Phase 2, Double-blind||0||
48051935|NCT00076024|100448350|FG000|STARTED|Phase 2, Open-label||0||
48051936|NCT00076024|100448351|FG001|STARTED|Phase 2, Open-label||0||
48051937|NCT00076024|100448352|FG002|STARTED|Phase 2, Open-label||0||
48051938|NCT00076024|100448353|FG003|STARTED|Phase 2, Open-label||16||
48051939|NCT00076024|100448350|FG000|COMPLETED|Phase 2, Open-label||0||
48051940|NCT00076024|100448351|FG001|COMPLETED|Phase 2, Open-label||0||
48051941|NCT00076024|100448352|FG002|COMPLETED|Phase 2, Open-label||0||
48051942|NCT00076024|100448353|FG003|COMPLETED|Phase 2, Open-label||0||
48051943|NCT00076024|100448350|FG000|NOT COMPLETED|Phase 2, Open-label||0||
48051944|NCT00076024|100448351|FG001|NOT COMPLETED|Phase 2, Open-label||0||
48051945|NCT00076024|100448352|FG002|NOT COMPLETED|Phase 2, Open-label||0||
48051946|NCT00076024|100448353|FG003|NOT COMPLETED|Phase 2, Open-label||16||
48051947|NCT00640835|100448354|FG000|STARTED|Overall Study||194||
48051948|NCT00640835|100448355|FG001|STARTED|Overall Study||188||
48051949|NCT00640835|100448354|FG000|COMPLETED|Overall Study||118||
48051950|NCT00640835|100448355|FG001|COMPLETED|Overall Study||131||
48051951|NCT00640835|100448354|FG000|NOT COMPLETED|Overall Study||76||
48051952|NCT00640835|100448355|FG001|NOT COMPLETED|Overall Study||57||
48051953|NCT01757691|100448356|FG000|STARTED|Overall Study||2||
48051954|NCT01757691|100448357|FG001|STARTED|Overall Study||0||
48051955|NCT01757691|100448356|FG000|COMPLETED|Overall Study||0||
48051956|NCT01757691|100448357|FG001|COMPLETED|Overall Study||0||
48051957|NCT01757691|100448356|FG000|NOT COMPLETED|Overall Study||2||
48051958|NCT01757691|100448357|FG001|NOT COMPLETED|Overall Study||0||
48051959|NCT05074173|100448358|FG000|STARTED|Overall Study||36||
48051960|NCT05074173|100448358|FG000|COMPLETED|Overall Study||36||
48051961|NCT05074173|100448358|FG000|NOT COMPLETED|Overall Study||0||
48051962|NCT02564432|100448359|FG000|STARTED|Overall Study||10||
48051963|NCT02564432|100448359|FG000|COMPLETED|Overall Study||8||
48051964|NCT02564432|100448359|FG000|NOT COMPLETED|Overall Study||2||
48051965|NCT00902161|100448360|FG000|STARTED|Pre-study Washout/Propanolol Run-in||0||
48051966|NCT00902161|100448361|FG001|STARTED|Pre-study Washout/Propanolol Run-in||0||
48051967|NCT00902161|100448362|FG002|STARTED|Pre-study Washout/Propanolol Run-in||22||
48051968|NCT00902161|100448360|FG000|COMPLETED|Pre-study Washout/Propanolol Run-in||0||
48051969|NCT00902161|100448361|FG001|COMPLETED|Pre-study Washout/Propanolol Run-in||0||
48051970|NCT00902161|100448362|FG002|COMPLETED|Pre-study Washout/Propanolol Run-in||22||
48051971|NCT00902161|100448360|FG000|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0||
48051972|NCT00902161|100448361|FG001|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0||
48051973|NCT00902161|100448362|FG002|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0||
48051974|NCT00902161|100448360|FG000|STARTED|Period 1||12||
48051975|NCT00902161|100448361|FG001|STARTED|Period 1||10||
48051976|NCT00902161|100448362|FG002|STARTED|Period 1||0||
48051977|NCT00902161|100448360|FG000|COMPLETED|Period 1||12||
48051978|NCT00902161|100448361|FG001|COMPLETED|Period 1||10||
48051979|NCT00902161|100448362|FG002|COMPLETED|Period 1||0||
48051980|NCT00902161|100448360|FG000|NOT COMPLETED|Period 1||0||
48051981|NCT00902161|100448361|FG001|NOT COMPLETED|Period 1||0||
48051982|NCT00902161|100448362|FG002|NOT COMPLETED|Period 1||0||
48051983|NCT00902161|100448360|FG000|STARTED|Post-clamp Washout||0||
48051984|NCT00902161|100448361|FG001|STARTED|Post-clamp Washout||0||
48051985|NCT00902161|100448362|FG002|STARTED|Post-clamp Washout||22||
48051986|NCT00902161|100448360|FG000|COMPLETED|Post-clamp Washout||0||
48051987|NCT00902161|100448361|FG001|COMPLETED|Post-clamp Washout||0||
48051988|NCT00902161|100448362|FG002|COMPLETED|Post-clamp Washout||22||
48051989|NCT00902161|100448360|FG000|NOT COMPLETED|Post-clamp Washout||0||
48051990|NCT00902161|100448361|FG001|NOT COMPLETED|Post-clamp Washout||0||
48051991|NCT00902161|100448362|FG002|NOT COMPLETED|Post-clamp Washout||0||
48051992|NCT00902161|100448360|FG000|STARTED|Period 2||8||
48051993|NCT00902161|100448361|FG001|STARTED|Period 2||9||
48051994|NCT00902161|100448362|FG002|STARTED|Period 2||0||
48051995|NCT00902161|100448360|FG000|COMPLETED|Period 2||8||
48051996|NCT00902161|100448361|FG001|COMPLETED|Period 2||9||
48208316|NCT04767698|100837027|FG000|NOT COMPLETED|Overall Study||1||
48208317|NCT04767698|100837028|FG001|NOT COMPLETED|Overall Study||2||
48208318|NCT02709655|100837029|FG000|STARTED|Single-Blind Phase (4 Weeks)||683||
48208319|NCT02709655|100837030|FG001|STARTED|Single-Blind Phase (4 Weeks)||0||
48208320|NCT02709655|100837031|FG002|STARTED|Single-Blind Phase (4 Weeks)||0||
48208321|NCT02709655|100837032|FG003|STARTED|Single-Blind Phase (4 Weeks)||0||
48208322|NCT02709655|100837033|FG004|STARTED|Single-Blind Phase (4 Weeks)||0||
48051997|NCT00902161|100448362|FG002|COMPLETED|Period 2||0||
48051998|NCT00902161|100448360|FG000|NOT COMPLETED|Period 2||0||
48051999|NCT00902161|100448361|FG001|NOT COMPLETED|Period 2||0||
48052000|NCT00902161|100448362|FG002|NOT COMPLETED|Period 2||0||
48052001|NCT02284178|100448363|FG000|STARTED|Overall Study||255||
48052002|NCT02284178|100448364|FG001|STARTED|Overall Study||258||
48052003|NCT02284178|100448363|FG000|COMPLETED|Overall Study||206||
48052004|NCT02284178|100448364|FG001|COMPLETED|Overall Study||204||
48052005|NCT02284178|100448363|FG000|NOT COMPLETED|Overall Study||49||
48052006|NCT02284178|100448364|FG001|NOT COMPLETED|Overall Study||54||
48052007|NCT00920829|100448365|FG000|STARTED|Allocation||38||
48052008|NCT00920829|100448366|FG001|STARTED|Allocation||39||
48052009|NCT00920829|100448367|FG002|STARTED|Allocation||38||
48052010|NCT00920829|100448368|FG003|STARTED|Allocation||37||
48052011|NCT00920829|100448365|FG000|COMPLETED|Allocation||35||
48052012|NCT00920829|100448366|FG001|COMPLETED|Allocation||38||
48052013|NCT00920829|100448367|FG002|COMPLETED|Allocation||38||
48052014|NCT00920829|100448368|FG003|COMPLETED|Allocation||35||
48052015|NCT00920829|100448365|FG000|NOT COMPLETED|Allocation||3||
48052016|NCT00920829|100448366|FG001|NOT COMPLETED|Allocation||1||
48052017|NCT00920829|100448367|FG002|NOT COMPLETED|Allocation||0||
48052018|NCT00920829|100448368|FG003|NOT COMPLETED|Allocation||2||
48052019|NCT00920829|100448365|FG000|STARTED|Available for Analysis||35||
48052020|NCT00920829|100448366|FG001|STARTED|Available for Analysis||38||
48052021|NCT00920829|100448367|FG002|STARTED|Available for Analysis||38||
48052022|NCT00920829|100448368|FG003|STARTED|Available for Analysis||35||
48052023|NCT00920829|100448365|FG000|COMPLETED|Available for Analysis||27||
48052024|NCT00920829|100448366|FG001|COMPLETED|Available for Analysis||27||
48052025|NCT00920829|100448367|FG002|COMPLETED|Available for Analysis||28||
48052026|NCT00920829|100448368|FG003|COMPLETED|Available for Analysis||24||
48052027|NCT00920829|100448365|FG000|NOT COMPLETED|Available for Analysis||8||
48052028|NCT00920829|100448366|FG001|NOT COMPLETED|Available for Analysis||11||
48052029|NCT00920829|100448367|FG002|NOT COMPLETED|Available for Analysis||10||
48052030|NCT00920829|100448368|FG003|NOT COMPLETED|Available for Analysis||11||
48052031|NCT01227564|100448369|FG000|STARTED|Overall Study||22||
48052032|NCT01227564|100448370|FG001|STARTED|Overall Study||20||
48052033|NCT01227564|100448371|FG002|STARTED|Overall Study||21||
48052034|NCT01227564|100448369|FG000|Treated|Overall Study||22||
48052035|NCT01227564|100448370|FG001|Treated|Overall Study||20||
48052036|NCT01227564|100448371|FG002|Treated|Overall Study||21||
48052037|NCT01227564|100448369|FG000|Completed Treatment|Overall Study||21||
48052038|NCT01227564|100448370|FG001|Completed Treatment|Overall Study||18||
48052039|NCT01227564|100448371|FG002|Completed Treatment|Overall Study||17||
48052040|NCT01227564|100448369|FG000|COMPLETED|Overall Study||18||
48052041|NCT01227564|100448370|FG001|COMPLETED|Overall Study||18||
48052042|NCT01227564|100448371|FG002|COMPLETED|Overall Study||15||
48052043|NCT01227564|100448369|FG000|NOT COMPLETED|Overall Study||4||
48052044|NCT01227564|100448370|FG001|NOT COMPLETED|Overall Study||2||
48052045|NCT01227564|100448371|FG002|NOT COMPLETED|Overall Study||6||
48052046|NCT03862040|100448372|FG000|STARTED|Overall Study||7||
48052047|NCT03862040|100448372|FG000|COMPLETED|Overall Study||7||
48052048|NCT03862040|100448372|FG000|NOT COMPLETED|Overall Study||0||
48052049|NCT03901456|100448373|FG000|STARTED|Overall Study||20||
48052050|NCT03901456|100448374|FG001|STARTED|Overall Study||22||
48052051|NCT03901456|100448375|FG002|STARTED|Overall Study||21||
48052052|NCT03901456|100448373|FG000|COMPLETED|Overall Study||20||
48052053|NCT03901456|100448374|FG001|COMPLETED|Overall Study||21||
48052054|NCT03901456|100448375|FG002|COMPLETED|Overall Study||20||
48052055|NCT03901456|100448373|FG000|NOT COMPLETED|Overall Study||0||
48052056|NCT03901456|100448374|FG001|NOT COMPLETED|Overall Study||1||
48052057|NCT03901456|100448375|FG002|NOT COMPLETED|Overall Study||1||
48052058|NCT02927067|100448376|FG000|STARTED|Overall Study||277||
48052059|NCT02927067|100448377|FG001|STARTED|Overall Study||276||
48052060|NCT02927067|100448376|FG000|Treated Participants|Overall Study||274|Treated participants (full analysis set) included the participants from the randomized set who took at least one dose of assigned study drug and were analyzed for efficacy and safety evaluations.|
48052061|NCT02927067|100448377|FG001|Treated Participants|Overall Study||273|Treated participants (full analysis set) included the participants from the randomized set who took at least one dose of assigned study drug and were analyzed for efficacy and safety evaluations.|
48052062|NCT02927067|100448376|FG000|Participants Received 8 Weeks Treatment|Overall Study||140|Participants who received 8 weeks of treatment include the participants who completed study drug treatment.|
48052063|NCT02927067|100448377|FG001|Participants Received 8 Weeks Treatment|Overall Study||179|Participants who received 8 weeks of treatment include the participants who completed study drug treatment.|
48052064|NCT02927067|100448376|FG000|COMPLETED|Overall Study||217||
48052065|NCT02927067|100448377|FG001|COMPLETED|Overall Study||215||
48052066|NCT02927067|100448376|FG000|NOT COMPLETED|Overall Study||60||
48052067|NCT02927067|100448377|FG001|NOT COMPLETED|Overall Study||61||
48052068|NCT01765803|100448378|FG000|STARTED|Overall Study||6||
48052069|NCT01765803|100448378|FG000|COMPLETED|Overall Study||6||
48052070|NCT01765803|100448378|FG000|NOT COMPLETED|Overall Study||0||
48052071|NCT02935543|100448379|FG000|STARTED|Overall Study||1||
48052072|NCT02935543|100448379|FG000|COMPLETED|Overall Study||1||
48052073|NCT02935543|100448379|FG000|NOT COMPLETED|Overall Study||0||
48052074|NCT01629706|100448380|FG000|STARTED|Phase 1 PureVision||44||
48052075|NCT01629706|100448380|FG000|COMPLETED|Phase 1 PureVision||35||
48052076|NCT01629706|100448380|FG000|NOT COMPLETED|Phase 1 PureVision||9||
48052077|NCT01629706|100448380|FG000|STARTED|Phase 2 Habitual||58||
48052078|NCT01629706|100448380|FG000|COMPLETED|Phase 2 Habitual||48||
48052079|NCT01629706|100448380|FG000|NOT COMPLETED|Phase 2 Habitual||10||
48052080|NCT02034422|100448381|FG000|STARTED|Overall Study||49||
48052081|NCT02034422|100448382|FG001|STARTED|Overall Study||26||
48052082|NCT02034422|100448381|FG000|COMPLETED|Overall Study||49||
48052083|NCT02034422|100448382|FG001|COMPLETED|Overall Study||26||
48052084|NCT02034422|100448381|FG000|NOT COMPLETED|Overall Study||0||
48052085|NCT02034422|100448382|FG001|NOT COMPLETED|Overall Study||0||
48052086|NCT01858636|100448383|FG000|STARTED|Overall Study||235||
48052087|NCT01858636|100448383|FG000|Device Deployment|Overall Study||211||
48052088|NCT01858636|100448383|FG000|COMPLETED|Overall Study||207||
48052089|NCT01858636|100448383|FG000|NOT COMPLETED|Overall Study||28||
48052090|NCT04534465|100448384|FG000|STARTED|Overall Study||10||
48052091|NCT04534465|100448385|FG001|STARTED|Overall Study||10||
48052092|NCT04534465|100448386|FG002|STARTED|Overall Study||10||
48052093|NCT04534465|100448387|FG003|STARTED|Overall Study||10||
48052094|NCT04534465|100448388|FG004|STARTED|Overall Study||10||
48052095|NCT04534465|100448384|FG000|COMPLETED|Overall Study||10||
48052096|NCT04534465|100448385|FG001|COMPLETED|Overall Study||10||
48052097|NCT04534465|100448386|FG002|COMPLETED|Overall Study||10||
48052098|NCT04534465|100448387|FG003|COMPLETED|Overall Study||10||
48052099|NCT04534465|100448388|FG004|COMPLETED|Overall Study||10||
48052100|NCT04534465|100448384|FG000|NOT COMPLETED|Overall Study||0||
48052101|NCT04534465|100448385|FG001|NOT COMPLETED|Overall Study||0||
48052102|NCT04534465|100448386|FG002|NOT COMPLETED|Overall Study||0||
48052103|NCT04534465|100448387|FG003|NOT COMPLETED|Overall Study||0||
48052104|NCT04534465|100448388|FG004|NOT COMPLETED|Overall Study||0||
48052105|NCT00970736|100448389|FG000|STARTED|Overall Study||20||
48052106|NCT00970736|100448389|FG000|COMPLETED|Overall Study||18||
48052107|NCT00970736|100448389|FG000|NOT COMPLETED|Overall Study||2||
48052108|NCT02775903|100448390|FG000|STARTED|Overall Study||42||
48052109|NCT02775903|100448391|FG001|STARTED|Overall Study||42||
48052110|NCT02775903|100448392|FG002|STARTED|Overall Study||64||
48052111|NCT02775903|100448393|FG003|STARTED|Overall Study||65||
48052112|NCT02775903|100448390|FG000|COMPLETED|Overall Study||4||
48052113|NCT02775903|100448391|FG001|COMPLETED|Overall Study||1||
48052114|NCT02775903|100448392|FG002|COMPLETED|Overall Study||1||
48052115|NCT02775903|100448393|FG003|COMPLETED|Overall Study||5||
48052116|NCT02775903|100448390|FG000|NOT COMPLETED|Overall Study||38||
48052117|NCT02775903|100448391|FG001|NOT COMPLETED|Overall Study||41||
48052118|NCT02775903|100448392|FG002|NOT COMPLETED|Overall Study||63||
48052119|NCT02775903|100448393|FG003|NOT COMPLETED|Overall Study||60||
48052120|NCT02352922|100448394|FG000|STARTED|Overall Study||32||
48052121|NCT02352922|100448395|FG001|STARTED|Overall Study||32||
48052122|NCT02352922|100448394|FG000|COMPLETED|Overall Study||28||
48052123|NCT02352922|100448395|FG001|COMPLETED|Overall Study||28||
48052124|NCT02352922|100448394|FG000|NOT COMPLETED|Overall Study||4||
48052125|NCT02352922|100448395|FG001|NOT COMPLETED|Overall Study||4||
48052126|NCT02945787|100448396|FG000|STARTED|Overall Study||714||
48052127|NCT02945787|100448397|FG001|STARTED|Overall Study||703||
48052128|NCT02945787|100448396|FG000|COMPLETED|Overall Study||714||
48052129|NCT02945787|100448397|FG001|COMPLETED|Overall Study||703||
48052130|NCT02945787|100448396|FG000|NOT COMPLETED|Overall Study||0||
48052131|NCT02945787|100448397|FG001|NOT COMPLETED|Overall Study||0||
48052132|NCT02716896|100448398|FG000|STARTED|Overall Study||1||
48052133|NCT02716896|100448399|FG001|STARTED|Overall Study||1||
48052134|NCT02716896|100448398|FG000|COMPLETED|Overall Study||1||
48052135|NCT02716896|100448399|FG001|COMPLETED|Overall Study||0||
48052136|NCT02716896|100448398|FG000|NOT COMPLETED|Overall Study||0||
48052137|NCT02716896|100448399|FG001|NOT COMPLETED|Overall Study||1||
48052138|NCT03173534|100448400|FG000|STARTED|Overall Study||172|Enrollment started December 2017. Last subject enrolled November 2020. Subjects were followed for 24 months from enrollment date. Follow up period ended December 2022.|
48052139|NCT03173534|100448401|FG001|STARTED|Overall Study||177|Enrollment started December 2017. Last subject enrolled November 2020. Subjects were followed for 24 months from enrollment date. Follow up period ended December 2022.|
48052140|NCT03173534|100448400|FG000|COMPLETED|Overall Study||172||
48052141|NCT03173534|100448401|FG001|COMPLETED|Overall Study||177||
48052142|NCT03173534|100448400|FG000|NOT COMPLETED|Overall Study||0||
48052143|NCT03173534|100448401|FG001|NOT COMPLETED|Overall Study||0||
48052144|NCT00667420|100448402|FG000|STARTED|Overall Study||17||
48052145|NCT00667420|100448402|FG000|Completion of Pre-operative EOX-P|Overall Study||15||
48052146|NCT00667420|100448402|FG000|Completion of Surgery/Re-staging|Overall Study||11||
48052147|NCT00667420|100448402|FG000|COMPLETED|Overall Study||7||
48052148|NCT00667420|100448402|FG000|NOT COMPLETED|Overall Study||10||
48052149|NCT00558571|100448403|FG000|STARTED|Overall Study||16||
48052150|NCT00558571|100448404|FG001|STARTED|Overall Study||16||
48208323|NCT02709655|100837029|FG000|Received at Least 1 Dose of Study Drug|Single-Blind Phase (4 Weeks)||677||
48208324|NCT02709655|100837030|FG001|Received at Least 1 Dose of Study Drug|Single-Blind Phase (4 Weeks)||0||
48208325|NCT02709655|100837031|FG002|Received at Least 1 Dose of Study Drug|Single-Blind Phase (4 Weeks)||0||
48495677|NCT02718963|101547907|FG001|COMPLETED|Overall Study||9||
48495678|NCT02718963|101547906|FG000|NOT COMPLETED|Overall Study||1||
48052151|NCT00558571|100448405|FG002|STARTED|Overall Study||16||
48052152|NCT00558571|100448406|FG003|STARTED|Overall Study||30||
48052153|NCT00558571|100448403|FG000|COMPLETED|Overall Study||16||
48052154|NCT00558571|100448404|FG001|COMPLETED|Overall Study||16||
48052155|NCT00558571|100448405|FG002|COMPLETED|Overall Study||16||
48052156|NCT00558571|100448406|FG003|COMPLETED|Overall Study||30||
48052157|NCT00558571|100448403|FG000|NOT COMPLETED|Overall Study||0||
48052158|NCT00558571|100448404|FG001|NOT COMPLETED|Overall Study||0||
48052159|NCT00558571|100448405|FG002|NOT COMPLETED|Overall Study||0||
48052160|NCT00558571|100448406|FG003|NOT COMPLETED|Overall Study||0||
48052161|NCT01616082|100448407|FG000|STARTED|Overall Study||19||
48052162|NCT01616082|100448408|FG001|STARTED|Overall Study||20||
48052163|NCT01616082|100448407|FG000|COMPLETED|Overall Study||19||
48052164|NCT01616082|100448408|FG001|COMPLETED|Overall Study||18||
48052165|NCT01616082|100448407|FG000|NOT COMPLETED|Overall Study||0||
48052166|NCT01616082|100448408|FG001|NOT COMPLETED|Overall Study||2||
48052167|NCT02691962|100448409|FG000|STARTED|Overall Study||75||
48052168|NCT02691962|100448409|FG000|COMPLETED|Overall Study||59||
48052169|NCT02691962|100448409|FG000|NOT COMPLETED|Overall Study||16||
48052170|NCT02145507|100448410|FG000|STARTED|First Donation||82||
48052171|NCT02145507|100448411|FG001|STARTED|First Donation||88||
48052172|NCT02145507|100448410|FG000|Randomized to Have Blood Processed With SOLX (IP)|First Donation||52||
48052173|NCT02145507|100448411|FG001|Randomized to Have Blood Processed With SOLX (IP)|First Donation||51||
48052174|NCT02145507|100448410|FG000|Randomized to Have Blood Processed With AS-3 (CP)|First Donation||30||
48052175|NCT02145507|100448411|FG001|Randomized to Have Blood Processed With AS-3 (CP)|First Donation||37||
48052176|NCT02145507|100448410|FG000|COMPLETED|First Donation||70||
48052177|NCT02145507|100448411|FG001|COMPLETED|First Donation||67||
48052178|NCT02145507|100448410|FG000|NOT COMPLETED|First Donation||12||
48052179|NCT02145507|100448411|FG001|NOT COMPLETED|First Donation||21||
48052180|NCT02145507|100448410|FG000|STARTED|Second Donation||65||
48052181|NCT02145507|100448411|FG001|STARTED|Second Donation||65||
48052182|NCT02145507|100448410|FG000|Blood Processed With AS-3 (CP)|Second Donation||39||
48052183|NCT02145507|100448411|FG001|Blood Processed With AS-3 (CP)|Second Donation||35||
48052184|NCT02145507|100448410|FG000|Blood Processed With SOLX (IP)|Second Donation||26||
48052185|NCT02145507|100448411|FG001|Blood Processed With SOLX (IP)|Second Donation||27||
48052186|NCT02145507|100448410|FG000|COMPLETED|Second Donation||63||
48052187|NCT02145507|100448411|FG001|COMPLETED|Second Donation||60||
48052188|NCT02145507|100448410|FG000|NOT COMPLETED|Second Donation||2||
48052189|NCT02145507|100448411|FG001|NOT COMPLETED|Second Donation||5||
48052190|NCT00988325|100448412|FG000|STARTED|Overall Study||40||
48052191|NCT00988325|100448413|FG001|STARTED|Overall Study||20||
48052192|NCT00988325|100448414|FG002|STARTED|Overall Study||5||
48052193|NCT00988325|100448412|FG000|COMPLETED|Overall Study||40||
48052194|NCT00988325|100448413|FG001|COMPLETED|Overall Study||20||
48052195|NCT00988325|100448414|FG002|COMPLETED|Overall Study||5||
48052196|NCT00988325|100448412|FG000|NOT COMPLETED|Overall Study||0||
48052197|NCT00988325|100448413|FG001|NOT COMPLETED|Overall Study||0||
48052198|NCT00988325|100448414|FG002|NOT COMPLETED|Overall Study||0||
48052199|NCT00989573|100448415|FG000|STARTED|Overall Study||65||
48052200|NCT00989573|100448416|FG001|STARTED|Overall Study||63||
48052201|NCT00989573|100448417|FG002|STARTED|Overall Study||63||
48052202|NCT00989573|100448415|FG000|COMPLETED|Overall Study||52||
48052203|NCT00989573|100448416|FG001|COMPLETED|Overall Study||41||
48052204|NCT00989573|100448417|FG002|COMPLETED|Overall Study||55||
48052205|NCT00989573|100448415|FG000|NOT COMPLETED|Overall Study||13||
48052206|NCT00989573|100448416|FG001|NOT COMPLETED|Overall Study||22||
48052207|NCT00989573|100448417|FG002|NOT COMPLETED|Overall Study||8||
48052208|NCT04626310|100448418|FG000|STARTED|Overall Study||27||
48052209|NCT04626310|100448419|FG001|STARTED|Overall Study||28||
48052210|NCT04626310|100448420|FG002|STARTED|Overall Study||29||
48052211|NCT04626310|100448418|FG000|COMPLETED|Overall Study||20||
48052212|NCT04626310|100448419|FG001|COMPLETED|Overall Study||23||
48052213|NCT04626310|100448420|FG002|COMPLETED|Overall Study||21||
48052214|NCT04626310|100448418|FG000|NOT COMPLETED|Overall Study||7||
48052215|NCT04626310|100448419|FG001|NOT COMPLETED|Overall Study||5||
48052216|NCT04626310|100448420|FG002|NOT COMPLETED|Overall Study||8||
48052217|NCT01117051|100448421|FG000|STARTED|Overall Study||86||
48052218|NCT01117051|100448422|FG001|STARTED|Overall Study||88||
48052219|NCT01117051|100448421|FG000|COMPLETED|Overall Study||73||
48052220|NCT01117051|100448422|FG001|COMPLETED|Overall Study||77||
48052221|NCT01117051|100448421|FG000|NOT COMPLETED|Overall Study||13||
48052222|NCT01117051|100448422|FG001|NOT COMPLETED|Overall Study||11||
48052223|NCT03115580|100448423|FG000|STARTED|Overall Study||35||
48052224|NCT03115580|100448424|FG001|STARTED|Overall Study||36||
48052225|NCT03115580|100448423|FG000|COMPLETED|Overall Study||35||
48052226|NCT03115580|100448424|FG001|COMPLETED|Overall Study||36||
48052227|NCT03115580|100448423|FG000|NOT COMPLETED|Overall Study||0||
48052228|NCT03115580|100448424|FG001|NOT COMPLETED|Overall Study||0||
48052229|NCT02581839|100448425|FG000|STARTED|Overall Study||9||
48052230|NCT02581839|100448425|FG000|COMPLETED|Overall Study||9||
48052231|NCT02581839|100448425|FG000|NOT COMPLETED|Overall Study||0||
48052232|NCT05014412|100448426|FG000|STARTED|Overall Study||33||
48052233|NCT05014412|100448427|FG001|STARTED|Overall Study||12||
48052234|NCT05014412|100448428|FG002|STARTED|Overall Study||11||
48052235|NCT05014412|100448429|FG003|STARTED|Overall Study||29||
48052236|NCT05014412|100448426|FG000|COMPLETED|Overall Study||0||
48052237|NCT05014412|100448427|FG001|COMPLETED|Overall Study||0||
48052238|NCT05014412|100448428|FG002|COMPLETED|Overall Study||0||
48052239|NCT05014412|100448429|FG003|COMPLETED|Overall Study||0||
48052240|NCT05014412|100448426|FG000|NOT COMPLETED|Overall Study||33||
48052241|NCT05014412|100448427|FG001|NOT COMPLETED|Overall Study||12||
48052242|NCT05014412|100448428|FG002|NOT COMPLETED|Overall Study||11||
48052243|NCT05014412|100448429|FG003|NOT COMPLETED|Overall Study||29||
48052244|NCT00589784|100448430|FG000|STARTED|Overall Study||36||
48052245|NCT00589784|100448431|FG001|STARTED|Overall Study||14||
48052246|NCT00589784|100448430|FG000|COMPLETED|Overall Study||35||
48052247|NCT00589784|100448431|FG001|COMPLETED|Overall Study||4||
48052248|NCT00589784|100448430|FG000|NOT COMPLETED|Overall Study||1||
48052249|NCT00589784|100448431|FG001|NOT COMPLETED|Overall Study||10||
48052250|NCT00417482|100448432|FG000|STARTED|Phase B 1st 16 Weeks||32||
48052251|NCT00417482|100448433|FG001|STARTED|Phase B 1st 16 Weeks||38||
48052252|NCT00417482|100448434|FG002|STARTED|Phase B 1st 16 Weeks||40||
48052253|NCT00417482|100448432|FG000|COMPLETED|Phase B 1st 16 Weeks||13||
48052254|NCT00417482|100448433|FG001|COMPLETED|Phase B 1st 16 Weeks||27||
48052255|NCT00417482|100448434|FG002|COMPLETED|Phase B 1st 16 Weeks||13||
48052256|NCT00417482|100448432|FG000|NOT COMPLETED|Phase B 1st 16 Weeks||19||
48052257|NCT00417482|100448433|FG001|NOT COMPLETED|Phase B 1st 16 Weeks||11||
48052258|NCT00417482|100448434|FG002|NOT COMPLETED|Phase B 1st 16 Weeks||27||
48052259|NCT00417482|100448432|FG000|STARTED|Phase B 2nd 16 Weeks||13||
48052260|NCT00417482|100448433|FG001|STARTED|Phase B 2nd 16 Weeks||27||
48052261|NCT00417482|100448434|FG002|STARTED|Phase B 2nd 16 Weeks||13||
48052262|NCT00417482|100448432|FG000|COMPLETED|Phase B 2nd 16 Weeks||10||
48052263|NCT00417482|100448433|FG001|COMPLETED|Phase B 2nd 16 Weeks||14||
48052264|NCT00417482|100448434|FG002|COMPLETED|Phase B 2nd 16 Weeks||10||
48052265|NCT00417482|100448432|FG000|NOT COMPLETED|Phase B 2nd 16 Weeks||3||
48052266|NCT00417482|100448433|FG001|NOT COMPLETED|Phase B 2nd 16 Weeks||13||
48052267|NCT00417482|100448434|FG002|NOT COMPLETED|Phase B 2nd 16 Weeks||3||
48052268|NCT00543855|100448435|FG000|STARTED|Overall Study||35||
48052269|NCT00543855|100448436|FG001|STARTED|Overall Study||33||
48052270|NCT00543855|100448437|FG002|STARTED|Overall Study||37||
48052271|NCT00543855|100448438|FG003|STARTED|Overall Study||34||
48052272|NCT00543855|100448435|FG000|COMPLETED|Overall Study||31||
48052273|NCT00543855|100448436|FG001|COMPLETED|Overall Study||31||
48052274|NCT00543855|100448437|FG002|COMPLETED|Overall Study||31||
48052275|NCT00543855|100448438|FG003|COMPLETED|Overall Study||30||
48052276|NCT00543855|100448435|FG000|NOT COMPLETED|Overall Study||4||
48052277|NCT00543855|100448436|FG001|NOT COMPLETED|Overall Study||2||
48052278|NCT00543855|100448437|FG002|NOT COMPLETED|Overall Study||6||
48052279|NCT00543855|100448438|FG003|NOT COMPLETED|Overall Study||4||
48052280|NCT03416374|100448439|FG000|STARTED|Treatment Period I||6||
48052281|NCT03416374|100448440|FG001|STARTED|Treatment Period I||39||
48052282|NCT03416374|100448439|FG000|COMPLETED|Treatment Period I||0||
48052283|NCT03416374|100448440|FG001|COMPLETED|Treatment Period I||0||
48052284|NCT03416374|100448439|FG000|NOT COMPLETED|Treatment Period I||6||
48052285|NCT03416374|100448440|FG001|NOT COMPLETED|Treatment Period I||39||
48052286|NCT03416374|100448439|FG000|STARTED|Between Treatment Period I and II||6||
48052287|NCT03416374|100448440|FG001|STARTED|Between Treatment Period I and II||39||
48052288|NCT03416374|100448439|FG000|COMPLETED|Between Treatment Period I and II||6||
48052289|NCT03416374|100448440|FG001|COMPLETED|Between Treatment Period I and II||30||
48052290|NCT03416374|100448439|FG000|NOT COMPLETED|Between Treatment Period I and II||0||
48052291|NCT03416374|100448440|FG001|NOT COMPLETED|Between Treatment Period I and II||9||
48052292|NCT03416374|100448439|FG000|STARTED|Treatment Period II||6||
48052293|NCT03416374|100448440|FG001|STARTED|Treatment Period II||30||
48052294|NCT03416374|100448439|FG000|COMPLETED|Treatment Period II||2||
48052295|NCT03416374|100448440|FG001|COMPLETED|Treatment Period II||12||
48052296|NCT03416374|100448439|FG000|NOT COMPLETED|Treatment Period II||4||
48052297|NCT03416374|100448440|FG001|NOT COMPLETED|Treatment Period II||18||
48052298|NCT02139800|100448441|FG000|STARTED|Overall Study||224||
48052299|NCT02139800|100448442|FG001|STARTED|Overall Study||236||
48052300|NCT02139800|100448441|FG000|COMPLETED|Overall Study||211|These infants have completed their 36 week PMA primary outcome|
48052301|NCT02139800|100448442|FG001|COMPLETED|Overall Study||215|These infants have completed their 36 week PMA primary outcome|
48052302|NCT02139800|100448441|FG000|NOT COMPLETED|Overall Study||13||
48052303|NCT02139800|100448442|FG001|NOT COMPLETED|Overall Study||21||
48052304|NCT02889562|100448443|FG000|STARTED|Overall Study||28||
48052305|NCT02889562|100448444|FG001|STARTED|Overall Study||28||
48052306|NCT02889562|100448443|FG000|COMPLETED|Overall Study||28||
48052307|NCT02889562|100448444|FG001|COMPLETED|Overall Study||26||
48052308|NCT02889562|100448443|FG000|NOT COMPLETED|Overall Study||0||
48052309|NCT02889562|100448444|FG001|NOT COMPLETED|Overall Study||2||
48052310|NCT02721979|100448445|FG000|STARTED|Overall Study||23||
48052311|NCT02721979|100448445|FG000|COMPLETED|Overall Study||22||
48052312|NCT02721979|100448445|FG000|NOT COMPLETED|Overall Study||1||
48052313|NCT00773383|100448446|FG000|STARTED|Overall Study||35||
48052314|NCT00773383|100448446|FG000|Received Study Drug|Overall Study||34||
48052315|NCT00773383|100448446|FG000|COMPLETED|Overall Study||4||
48208326|NCT02709655|100837032|FG003|Received at Least 1 Dose of Study Drug|Single-Blind Phase (4 Weeks)||0||
48495679|NCT02718963|101547907|FG001|NOT COMPLETED|Overall Study||1||
48052316|NCT00773383|100448446|FG000|NOT COMPLETED|Overall Study||31||
48052317|NCT03739840|100448447|FG000|STARTED|Treatment Period: Wk0-16||56||
48052318|NCT03739840|100448448|FG001|STARTED|Treatment Period: Wk0-16||60||
48052319|NCT03739840|100448449|FG002|STARTED|Treatment Period: Wk0-16||57||
48052320|NCT03739840|100448450|FG003|STARTED|Treatment Period: Wk0-16||59||
48052321|NCT03739840|100448447|FG000|Completed Titration and Stabilization|Treatment Period: Wk0-16||54||
48052322|NCT03739840|100448448|FG001|Completed Titration and Stabilization|Treatment Period: Wk0-16||58||
48052323|NCT03739840|100448449|FG002|Completed Titration and Stabilization|Treatment Period: Wk0-16||51||
48052324|NCT03739840|100448450|FG003|Completed Titration and Stabilization|Treatment Period: Wk0-16||54||
48052325|NCT03739840|100448447|FG000|Completed Maintenance Period|Treatment Period: Wk0-16||46||
48052326|NCT03739840|100448448|FG001|Completed Maintenance Period|Treatment Period: Wk0-16||44||
48052327|NCT03739840|100448449|FG002|Completed Maintenance Period|Treatment Period: Wk0-16||44||
48052328|NCT03739840|100448450|FG003|Completed Maintenance Period|Treatment Period: Wk0-16||36||
48052329|NCT03739840|100448447|FG000|COMPLETED|Treatment Period: Wk0-16||46||
48052330|NCT03739840|100448448|FG001|COMPLETED|Treatment Period: Wk0-16||44||
48052331|NCT03739840|100448449|FG002|COMPLETED|Treatment Period: Wk0-16||44||
48052332|NCT03739840|100448450|FG003|COMPLETED|Treatment Period: Wk0-16||36||
48052333|NCT03739840|100448447|FG000|NOT COMPLETED|Treatment Period: Wk0-16||10||
48052334|NCT03739840|100448448|FG001|NOT COMPLETED|Treatment Period: Wk0-16||16||
48052335|NCT03739840|100448449|FG002|NOT COMPLETED|Treatment Period: Wk0-16||13||
48052336|NCT03739840|100448450|FG003|NOT COMPLETED|Treatment Period: Wk0-16||23||
48052337|NCT03739840|100448447|FG000|STARTED|Post-Treatment Period: Wk16-23||46||
48052338|NCT03739840|100448448|FG001|STARTED|Post-Treatment Period: Wk16-23||44||
48052339|NCT03739840|100448449|FG002|STARTED|Post-Treatment Period: Wk16-23||44||
48052340|NCT03739840|100448450|FG003|STARTED|Post-Treatment Period: Wk16-23||36||
48052341|NCT03739840|100448447|FG000|Started Conversion Period|Post-Treatment Period: Wk16-23||33||
48052342|NCT03739840|100448448|FG001|Started Conversion Period|Post-Treatment Period: Wk16-23||31||
48052343|NCT03739840|100448449|FG002|Started Conversion Period|Post-Treatment Period: Wk16-23||29||
48052344|NCT03739840|100448450|FG003|Started Conversion Period|Post-Treatment Period: Wk16-23||28||
48052345|NCT03739840|100448447|FG000|Completed Conversion Period|Post-Treatment Period: Wk16-23||33||
48052346|NCT03739840|100448448|FG001|Completed Conversion Period|Post-Treatment Period: Wk16-23||31||
48052347|NCT03739840|100448449|FG002|Completed Conversion Period|Post-Treatment Period: Wk16-23||29||
48052348|NCT03739840|100448450|FG003|Completed Conversion Period|Post-Treatment Period: Wk16-23||28||
48052349|NCT03739840|100448447|FG000|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||19||
48052350|NCT03739840|100448448|FG001|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||18||
48052351|NCT03739840|100448449|FG002|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||21||
48052352|NCT03739840|100448450|FG003|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||13||
48052353|NCT03739840|100448447|FG000|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||15||
48052354|NCT03739840|100448448|FG001|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||16||
48052355|NCT03739840|100448449|FG002|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||18||
48052356|NCT03739840|100448450|FG003|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||12||
48052357|NCT03739840|100448447|FG000|Enrolled in EP0093|Post-Treatment Period: Wk16-23||27||
48052358|NCT03739840|100448448|FG001|Enrolled in EP0093|Post-Treatment Period: Wk16-23||26||
48052359|NCT03739840|100448449|FG002|Enrolled in EP0093|Post-Treatment Period: Wk16-23||23||
48052360|NCT03739840|100448450|FG003|Enrolled in EP0093|Post-Treatment Period: Wk16-23||23||
48052361|NCT03739840|100448447|FG000|COMPLETED|Post-Treatment Period: Wk16-23||42||
48052362|NCT03739840|100448448|FG001|COMPLETED|Post-Treatment Period: Wk16-23||42||
48052363|NCT03739840|100448449|FG002|COMPLETED|Post-Treatment Period: Wk16-23||41||
48052364|NCT03739840|100448450|FG003|COMPLETED|Post-Treatment Period: Wk16-23||35||
48052365|NCT03739840|100448447|FG000|NOT COMPLETED|Post-Treatment Period: Wk16-23||4||
48052366|NCT03739840|100448448|FG001|NOT COMPLETED|Post-Treatment Period: Wk16-23||2||
48052367|NCT03739840|100448449|FG002|NOT COMPLETED|Post-Treatment Period: Wk16-23||3||
48052368|NCT03739840|100448450|FG003|NOT COMPLETED|Post-Treatment Period: Wk16-23||1||
48052369|NCT04251156|100448451|FG000|STARTED|Overall Study||249||
48052370|NCT04251156|100448452|FG001|STARTED|Overall Study||126||
48052371|NCT04251156|100448451|FG000|Full Analysis Set (FAS)|Overall Study||249||
48052372|NCT04251156|100448452|FG001|Full Analysis Set (FAS)|Overall Study||126||
48052373|NCT04251156|100448451|FG000|Safety Analysis Set (SAS)|Overall Study||249||
48052374|NCT04251156|100448452|FG001|Safety Analysis Set (SAS)|Overall Study||126||
48052375|NCT04251156|100448451|FG000|Treated|Overall Study||249||
48052376|NCT04251156|100448452|FG001|Treated|Overall Study||126||
48052377|NCT04251156|100448451|FG000|COMPLETED|Overall Study||244||
48052378|NCT04251156|100448452|FG001|COMPLETED|Overall Study||121||
48052379|NCT04251156|100448451|FG000|NOT COMPLETED|Overall Study||5||
48052380|NCT04251156|100448452|FG001|NOT COMPLETED|Overall Study||5||
48052381|NCT03481660|100448453|FG000|STARTED|Overall Study||179|All randomized treated patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF)|
48052382|NCT03481660|100448454|FG001|STARTED|Overall Study||181|All randomized treated patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF)|
48052383|NCT03481660|100448453|FG000|COMPLETED|Overall Study||143||
48052384|NCT03481660|100448454|FG001|COMPLETED|Overall Study||156||
48052385|NCT03481660|100448453|FG000|NOT COMPLETED|Overall Study||36||
48052386|NCT03481660|100448454|FG001|NOT COMPLETED|Overall Study||25||
48052387|NCT01367119|100448455|FG000|STARTED|Overall Study||21||
48052388|NCT01367119|100448456|FG001|STARTED|Overall Study||17||
48052389|NCT01367119|100448455|FG000|COMPLETED|Overall Study||19||
48052390|NCT01367119|100448456|FG001|COMPLETED|Overall Study||16||
48052391|NCT01367119|100448455|FG000|NOT COMPLETED|Overall Study||2||
48052392|NCT01367119|100448456|FG001|NOT COMPLETED|Overall Study||1||
48052393|NCT03718299|100448457|FG000|STARTED|Overall Study||55||
48052394|NCT03718299|100448457|FG000|COMPLETED|Overall Study||45||
48052395|NCT03718299|100448457|FG000|NOT COMPLETED|Overall Study||10||
48052396|NCT00772070|100448458|FG000|STARTED|Overall Study||102||
48052397|NCT00772070|100448459|FG001|STARTED|Overall Study||71||
48052398|NCT00772070|100448458|FG000|COMPLETED|Overall Study||100||
48052399|NCT00772070|100448459|FG001|COMPLETED|Overall Study||61||
48052400|NCT00772070|100448458|FG000|NOT COMPLETED|Overall Study||2||
48052401|NCT00772070|100448459|FG001|NOT COMPLETED|Overall Study||10||
48052402|NCT02469038|100448460|FG000|STARTED|Overall Study||26||
48052403|NCT02469038|100448461|FG001|STARTED|Overall Study||24||
48052404|NCT02469038|100448460|FG000|COMPLETED|Overall Study||22||
48052405|NCT02469038|100448461|FG001|COMPLETED|Overall Study||19||
48052406|NCT02469038|100448460|FG000|NOT COMPLETED|Overall Study||4||
48052407|NCT02469038|100448461|FG001|NOT COMPLETED|Overall Study||5||
48052408|NCT00179127|100448462|FG000|STARTED|Overall Study||0||
48052409|NCT00179127|100448463|FG001|STARTED|Overall Study||0||
48052410|NCT00179127|100448462|FG000|COMPLETED|Overall Study||0||
48052411|NCT00179127|100448463|FG001|COMPLETED|Overall Study||0||
48052412|NCT00179127|100448462|FG000|NOT COMPLETED|Overall Study||0||
48052413|NCT00179127|100448463|FG001|NOT COMPLETED|Overall Study||0||
48052414|NCT00336583|100448464|FG000|STARTED|Overall Study||27||
48052415|NCT00336583|100448464|FG000|COMPLETED|Overall Study||25||
48052416|NCT00336583|100448464|FG000|NOT COMPLETED|Overall Study||2||
48052417|NCT03116347|100448465|FG000|STARTED|Overall Study||23||
48052418|NCT03116347|100448466|FG001|STARTED|Overall Study||19||
48052419|NCT03116347|100448465|FG000|Started Epoch 1|Overall Study||23||
48052420|NCT03116347|100448466|FG001|Started Epoch 1|Overall Study||0||
48052421|NCT03116347|100448465|FG000|Completed Epoch 1|Overall Study||22||
48052422|NCT03116347|100448466|FG001|Completed Epoch 1|Overall Study||0||
48052423|NCT03116347|100448465|FG000|Started Epoch 2|Overall Study||22||
48052424|NCT03116347|100448466|FG001|Started Epoch 2|Overall Study||19||
48052425|NCT03116347|100448465|FG000|Completed Epoch 2|Overall Study||22||
48052426|NCT03116347|100448466|FG001|Completed Epoch 2|Overall Study||17||
48052427|NCT03116347|100448465|FG000|Moved From Epoch 2 to Epoch 3|Overall Study||1||
48052428|NCT03116347|100448466|FG001|Moved From Epoch 2 to Epoch 3|Overall Study||0||
48052429|NCT03116347|100448465|FG000|Completed Epoch 3|Overall Study||1||
48052430|NCT03116347|100448466|FG001|Completed Epoch 3|Overall Study||0||
48052431|NCT03116347|100448465|FG000|COMPLETED|Overall Study||22||
48052432|NCT03116347|100448466|FG001|COMPLETED|Overall Study||17||
48052433|NCT03116347|100448465|FG000|NOT COMPLETED|Overall Study||1||
48052434|NCT03116347|100448466|FG001|NOT COMPLETED|Overall Study||2||
48052435|NCT03059446|100448467|FG000|STARTED|Overall Study||167||
48052436|NCT03059446|100448467|FG000|COMPLETED|Overall Study||0||
48052437|NCT03059446|100448467|FG000|NOT COMPLETED|Overall Study||167||
48052438|NCT01689909|100448468|FG000|STARTED|Overall Study||51||
48052439|NCT01689909|100448469|FG001|STARTED|Overall Study||52||
48052440|NCT01689909|100448468|FG000|COMPLETED|Overall Study||51||
48052441|NCT01689909|100448469|FG001|COMPLETED|Overall Study||52||
48052442|NCT01689909|100448468|FG000|NOT COMPLETED|Overall Study||0||
48052443|NCT01689909|100448469|FG001|NOT COMPLETED|Overall Study||0||
48052444|NCT01753739|100448470|FG000|STARTED|Overall Study||124||
48052445|NCT01753739|100448471|FG001|STARTED|Overall Study||123||
48052446|NCT01753739|100448472|FG002|STARTED|Overall Study||123||
48052447|NCT01753739|100448473|FG003|STARTED|Overall Study||124||
48052448|NCT01753739|100448474|FG004|STARTED|Overall Study||123||
48052449|NCT01753739|100448470|FG000|COMPLETED|Overall Study||120||
48052450|NCT01753739|100448471|FG001|COMPLETED|Overall Study||118||
48052451|NCT01753739|100448472|FG002|COMPLETED|Overall Study||118||
48052452|NCT01753739|100448473|FG003|COMPLETED|Overall Study||117||
48052453|NCT01753739|100448474|FG004|COMPLETED|Overall Study||120||
48052454|NCT01753739|100448470|FG000|NOT COMPLETED|Overall Study||4||
48052455|NCT01753739|100448471|FG001|NOT COMPLETED|Overall Study||5||
48052456|NCT01753739|100448472|FG002|NOT COMPLETED|Overall Study||5||
48052457|NCT01753739|100448473|FG003|NOT COMPLETED|Overall Study||7||
48052458|NCT01753739|100448474|FG004|NOT COMPLETED|Overall Study||3||
48052459|NCT00285467|100451551|FG000|STARTED|Overall Study||25||
48052460|NCT00285467|100451552|FG001|STARTED|Overall Study||22||
48052461|NCT00285467|100451551|FG000|COMPLETED|Overall Study||25||
48052462|NCT00285467|100451552|FG001|COMPLETED|Overall Study||22||
48052463|NCT00285467|100451551|FG000|NOT COMPLETED|Overall Study||0||
48052464|NCT00285467|100451552|FG001|NOT COMPLETED|Overall Study||0||
48052465|NCT03131453|100451553|FG000|STARTED|Overall Study||456||
48052466|NCT03131453|100451554|FG001|STARTED|Overall Study||233||
48052467|NCT03131453|100451555|FG002|STARTED|Overall Study||456||
48052468|NCT03131453|100451553|FG000|Patient Misrandomized|Overall Study||1||
48052469|NCT03131453|100451554|FG001|Patient Misrandomized|Overall Study||0||
48052470|NCT03131453|100451555|FG002|Patient Misrandomized|Overall Study||0||
48052471|NCT03131453|100451553|FG000|COMPLETED|Overall Study||0||
48052472|NCT03131453|100451554|FG001|COMPLETED|Overall Study||0||
48052473|NCT03131453|100451555|FG002|COMPLETED|Overall Study||0||
48052474|NCT03131453|100451553|FG000|NOT COMPLETED|Overall Study||456||
48052475|NCT03131453|100451554|FG001|NOT COMPLETED|Overall Study||233||
48052476|NCT03131453|100451555|FG002|NOT COMPLETED|Overall Study||456||
48052477|NCT01231230|100451556|FG000|STARTED|Overall Study||14||
48052478|NCT01231230|100451556|FG000|Fluticasone|Overall Study||14||
48052479|NCT01231230|100451556|FG000|Salmeterol|Overall Study||14||
48052480|NCT01231230|100451556|FG000|Fluticasone/Salmeterol|Overall Study||14||
48052481|NCT01231230|100451556|FG000|Placebo|Overall Study||14||
48052482|NCT01231230|100451556|FG000|COMPLETED|Overall Study||14||
48052483|NCT01231230|100451556|FG000|NOT COMPLETED|Overall Study||0||
48052484|NCT01594385|100451557|FG000|STARTED|Overall Study||17||
48052485|NCT01594385|100451558|FG001|STARTED|Overall Study||13||
48052486|NCT01594385|100451557|FG000|COMPLETED|Overall Study||17||
48052487|NCT01594385|100451558|FG001|COMPLETED|Overall Study||13||
48052488|NCT01594385|100451557|FG000|NOT COMPLETED|Overall Study||0||
48052489|NCT01594385|100451558|FG001|NOT COMPLETED|Overall Study||0||
48052490|NCT03435640|100451559|FG000|STARTED|Overall Study||3||
48052491|NCT03435640|100451560|FG001|STARTED|Overall Study||3||
48052492|NCT03435640|100451561|FG002|STARTED|Overall Study||4||
48052493|NCT03435640|100451562|FG003|STARTED|Overall Study||3||
48052494|NCT03435640|100451563|FG004|STARTED|Overall Study||4||
48052495|NCT03435640|100451564|FG005|STARTED|Overall Study||4||
48052496|NCT03435640|100451565|FG006|STARTED|Overall Study||4||
48052497|NCT03435640|100451566|FG007|STARTED|Overall Study||3||
48052498|NCT03435640|100451567|FG008|STARTED|Overall Study||8||
48052499|NCT03435640|100451568|FG009|STARTED|Overall Study||14||
48052500|NCT03435640|100451569|FG010|STARTED|Overall Study||14||
48052501|NCT03435640|100451559|FG000|COMPLETED|Overall Study||3||
48052502|NCT03435640|100451560|FG001|COMPLETED|Overall Study||2||
48052503|NCT03435640|100451561|FG002|COMPLETED|Overall Study||3||
48052504|NCT03435640|100451562|FG003|COMPLETED|Overall Study||1||
48052505|NCT03435640|100451563|FG004|COMPLETED|Overall Study||4||
48052506|NCT03435640|100451564|FG005|COMPLETED|Overall Study||4||
48052507|NCT03435640|100451565|FG006|COMPLETED|Overall Study||1||
48052508|NCT03435640|100451566|FG007|COMPLETED|Overall Study||3||
48052509|NCT03435640|100451567|FG008|COMPLETED|Overall Study||8||
48052510|NCT03435640|100451568|FG009|COMPLETED|Overall Study||12||
48052511|NCT03435640|100451569|FG010|COMPLETED|Overall Study||11||
48052512|NCT03435640|100451559|FG000|NOT COMPLETED|Overall Study||0||
48052513|NCT03435640|100451560|FG001|NOT COMPLETED|Overall Study||1||
48052514|NCT03435640|100451561|FG002|NOT COMPLETED|Overall Study||1||
48052515|NCT03435640|100451562|FG003|NOT COMPLETED|Overall Study||2||
48052516|NCT03435640|100451563|FG004|NOT COMPLETED|Overall Study||0||
48052517|NCT03435640|100451564|FG005|NOT COMPLETED|Overall Study||0||
48052518|NCT03435640|100451565|FG006|NOT COMPLETED|Overall Study||3||
48052519|NCT03435640|100451566|FG007|NOT COMPLETED|Overall Study||0||
48052520|NCT03435640|100451567|FG008|NOT COMPLETED|Overall Study||0||
48052521|NCT03435640|100451568|FG009|NOT COMPLETED|Overall Study||2||
48052522|NCT03435640|100451569|FG010|NOT COMPLETED|Overall Study||3||
48052523|NCT00367770|100451570|FG000|STARTED|Overall Study||37||
48052524|NCT00367770|100451570|FG000|COMPLETED|Overall Study||35||
48052525|NCT00367770|100451570|FG000|NOT COMPLETED|Overall Study||2||
48052526|NCT00381381|100451571|FG000|STARTED|Overall Study||199||
48052527|NCT00381381|100451571|FG000|COMPLETED|Overall Study||135||
48052528|NCT00381381|100451571|FG000|NOT COMPLETED|Overall Study||64||
48052529|NCT03463031|100451572|FG000|STARTED|Overall Study||225||
48052530|NCT03463031|100451573|FG001|STARTED|Overall Study||221||
48052531|NCT03463031|100451572|FG000|COMPLETED|Overall Study||215||
48052532|NCT03463031|100451573|FG001|COMPLETED|Overall Study||216||
48052533|NCT03463031|100451572|FG000|NOT COMPLETED|Overall Study||10||
48052534|NCT03463031|100451573|FG001|NOT COMPLETED|Overall Study||5||
48052535|NCT01390220|100451574|FG000|STARTED|Test Dose Phase||292||
48052536|NCT01390220|100451575|FG001|STARTED|Test Dose Phase||0||
48052537|NCT01390220|100451576|FG002|STARTED|Test Dose Phase||0||
48052538|NCT01390220|100451574|FG000|COMPLETED|Test Dose Phase||201||
48052539|NCT01390220|100451575|FG001|COMPLETED|Test Dose Phase||0||
48052540|NCT01390220|100451576|FG002|COMPLETED|Test Dose Phase||0||
48052541|NCT01390220|100451574|FG000|NOT COMPLETED|Test Dose Phase||91||
48052542|NCT01390220|100451575|FG001|NOT COMPLETED|Test Dose Phase||0||
48052543|NCT01390220|100451576|FG002|NOT COMPLETED|Test Dose Phase||0||
48052544|NCT01390220|100451574|FG000|STARTED|Comparative Phase||0|Patients completing TDP, were randomized, and received double-blind dose in CP|
48052545|NCT01390220|100451575|FG001|STARTED|Comparative Phase||134|Patients completing TDP, were randomized, and received double-blind dose in CP|
48052546|NCT01390220|100451576|FG002|STARTED|Comparative Phase||67|Patients completing TDP, were randomized, and received double-blind dose in CP|
48052547|NCT01390220|100451574|FG000|COMPLETED|Comparative Phase||0||
48052548|NCT01390220|100451575|FG001|COMPLETED|Comparative Phase||133||
48052549|NCT01390220|100451576|FG002|COMPLETED|Comparative Phase||67||
48052550|NCT01390220|100451574|FG000|NOT COMPLETED|Comparative Phase||0||
48052551|NCT01390220|100451575|FG001|NOT COMPLETED|Comparative Phase||1||
48052552|NCT01390220|100451576|FG002|NOT COMPLETED|Comparative Phase||0||
48052553|NCT02140775|100451577|FG000|STARTED|Overall Study||87||
48052554|NCT02140775|100451578|FG001|STARTED|Overall Study||29||
48052555|NCT02140775|100451577|FG000|COMPLETED|Overall Study||57||
48052556|NCT02140775|100451578|FG001|COMPLETED|Overall Study||22||
48052557|NCT02140775|100451577|FG000|NOT COMPLETED|Overall Study||30||
48052558|NCT02140775|100451578|FG001|NOT COMPLETED|Overall Study||7||
48052559|NCT04231318|100451579|FG000|STARTED|Overall Study||99||
48052560|NCT04231318|100451580|FG001|STARTED|Overall Study||99||
48052561|NCT04231318|100451581|FG002|STARTED|Overall Study||33||
48052562|NCT04231318|100451579|FG000|COMPLETED|Overall Study||99||
48052563|NCT04231318|100451580|FG001|COMPLETED|Overall Study||99||
48052564|NCT04231318|100451581|FG002|COMPLETED|Overall Study||33||
48052565|NCT04231318|100451579|FG000|NOT COMPLETED|Overall Study||0||
48052566|NCT04231318|100451580|FG001|NOT COMPLETED|Overall Study||0||
48052567|NCT04231318|100451581|FG002|NOT COMPLETED|Overall Study||0||
48052568|NCT03023046|100451582|FG000|STARTED|Overall Study||54||
48052569|NCT03023046|100451582|FG000|COMPLETED|Overall Study||53||
48052570|NCT03023046|100451582|FG000|NOT COMPLETED|Overall Study||1||
48052571|NCT00937391|100451583|FG000|STARTED|Stage 1||20||
48052572|NCT00937391|100451583|FG000|Treated|Stage 1||20||
48052573|NCT00937391|100451583|FG000|COMPLETED|Stage 1||20||
48052574|NCT00937391|100451583|FG000|NOT COMPLETED|Stage 1||0||
48052575|NCT00937391|100451583|FG000|STARTED|Stage 2||34||
48052576|NCT00937391|100451583|FG000|Treated|Stage 2||34||
48052577|NCT00937391|100451583|FG000|COMPLETED|Stage 2||33||
48052578|NCT00937391|100451583|FG000|NOT COMPLETED|Stage 2||1||
48052579|NCT02480712|100451584|FG000|STARTED|Overall Study||107||
48052580|NCT02480712|100451584|FG000|COMPLETED|Overall Study||96||
48052581|NCT02480712|100451584|FG000|NOT COMPLETED|Overall Study||11||
48052582|NCT04499599|100451585|FG000|STARTED|Overall Study||35||
48052583|NCT04499599|100451586|FG001|STARTED|Overall Study||35||
48052584|NCT04499599|100451587|FG002|STARTED|Overall Study||35||
48052585|NCT04499599|100451585|FG000|COMPLETED|Overall Study||35||
48052586|NCT04499599|100451586|FG001|COMPLETED|Overall Study||35||
48052587|NCT04499599|100451587|FG002|COMPLETED|Overall Study||35||
48052588|NCT04499599|100451585|FG000|NOT COMPLETED|Overall Study||0||
48052589|NCT04499599|100451586|FG001|NOT COMPLETED|Overall Study||0||
48052590|NCT04499599|100451587|FG002|NOT COMPLETED|Overall Study||0||
48052591|NCT04618770|100451588|FG000|STARTED|Overall Study||37||
48052592|NCT04618770|100451588|FG000|COMPLETED|Overall Study||0||
48052593|NCT04618770|100451588|FG000|NOT COMPLETED|Overall Study||37||
48052594|NCT00586196|100451589|FG000|STARTED|Overall Study||7||
48052595|NCT00586196|100451590|FG001|STARTED|Overall Study||9||
48052596|NCT00586196|100451589|FG000|COMPLETED|Overall Study||7||
48052597|NCT00586196|100451590|FG001|COMPLETED|Overall Study||9||
48052598|NCT00586196|100451589|FG000|NOT COMPLETED|Overall Study||0||
48052599|NCT00586196|100451590|FG001|NOT COMPLETED|Overall Study||0||
48052600|NCT02581943|100451591|FG000|STARTED|Overall Study||22||
48052601|NCT02581943|100451592|FG001|STARTED|Overall Study||21||
48052602|NCT02581943|100451591|FG000|COMPLETED|Overall Study||4||
48052603|NCT02581943|100451592|FG001|COMPLETED|Overall Study||2||
48052604|NCT02581943|100451591|FG000|NOT COMPLETED|Overall Study||18||
48052605|NCT02581943|100451592|FG001|NOT COMPLETED|Overall Study||19||
48052606|NCT01684020|100451593|FG000|STARTED|Overall Study||5||
48052607|NCT01684020|100451594|FG001|STARTED|Overall Study||5||
48052608|NCT01684020|100451593|FG000|COMPLETED|Overall Study||4||
48052609|NCT01684020|100451594|FG001|COMPLETED|Overall Study||5||
48052610|NCT01684020|100451593|FG000|NOT COMPLETED|Overall Study||1||
48052611|NCT01684020|100451594|FG001|NOT COMPLETED|Overall Study||0||
48052612|NCT01785095|100451595|FG000|STARTED|Overall Study||27||
48052613|NCT01785095|100451595|FG000|COMPLETED|Overall Study||24||
48052614|NCT01785095|100451595|FG000|NOT COMPLETED|Overall Study||3||
48052615|NCT00559936|100451596|FG000|STARTED|Overall Study||24||
48052616|NCT00559936|100451596|FG000|COMPLETED|Overall Study||20||
48052617|NCT00559936|100451596|FG000|NOT COMPLETED|Overall Study||4||
48052618|NCT03468543|100451597|FG000|STARTED|Overall Study||3||
48052619|NCT03468543|100451597|FG000|COMPLETED|Overall Study||0||
48052620|NCT03468543|100451597|FG000|NOT COMPLETED|Overall Study||3||
48052621|NCT02038829|100451598|FG000|STARTED|Treatment Period 1||8||
48052622|NCT02038829|100451599|FG001|STARTED|Treatment Period 1||8||
48052623|NCT02038829|100451600|FG002|STARTED|Treatment Period 1||8||
48052624|NCT02038829|100451601|FG003|STARTED|Treatment Period 1||8||
48052625|NCT02038829|100451602|FG004|STARTED|Treatment Period 1||8||
48052626|NCT02038829|100451603|FG005|STARTED|Treatment Period 1||8||
48052627|NCT02038829|100451604|FG006|STARTED|Treatment Period 1||8||
48052628|NCT02038829|100451605|FG007|STARTED|Treatment Period 1||8||
48052629|NCT02038829|100451606|FG008|STARTED|Treatment Period 1||8||
48052630|NCT02038829|100451607|FG009|STARTED|Treatment Period 1||8||
48052631|NCT02038829|100451608|FG010|STARTED|Treatment Period 1||8||
48052632|NCT02038829|100451609|FG011|STARTED|Treatment Period 1||8||
48052633|NCT02038829|100451598|FG000|COMPLETED|Treatment Period 1||8||
48052634|NCT02038829|100451599|FG001|COMPLETED|Treatment Period 1||8||
48052635|NCT02038829|100451600|FG002|COMPLETED|Treatment Period 1||8||
48052636|NCT02038829|100451601|FG003|COMPLETED|Treatment Period 1||8||
48052637|NCT02038829|100451602|FG004|COMPLETED|Treatment Period 1||8||
48052638|NCT02038829|100451603|FG005|COMPLETED|Treatment Period 1||8||
48052639|NCT02038829|100451604|FG006|COMPLETED|Treatment Period 1||8||
48052640|NCT02038829|100451605|FG007|COMPLETED|Treatment Period 1||8||
48052641|NCT02038829|100451606|FG008|COMPLETED|Treatment Period 1||8||
48052642|NCT02038829|100451607|FG009|COMPLETED|Treatment Period 1||8||
48052643|NCT02038829|100451608|FG010|COMPLETED|Treatment Period 1||8||
48052644|NCT02038829|100451609|FG011|COMPLETED|Treatment Period 1||8||
48052645|NCT02038829|100451598|FG000|NOT COMPLETED|Treatment Period 1||0||
48052646|NCT02038829|100451599|FG001|NOT COMPLETED|Treatment Period 1||0||
48052647|NCT02038829|100451600|FG002|NOT COMPLETED|Treatment Period 1||0||
48052648|NCT02038829|100451601|FG003|NOT COMPLETED|Treatment Period 1||0||
48052649|NCT02038829|100451602|FG004|NOT COMPLETED|Treatment Period 1||0||
48052650|NCT02038829|100451603|FG005|NOT COMPLETED|Treatment Period 1||0||
48052651|NCT02038829|100451604|FG006|NOT COMPLETED|Treatment Period 1||0||
48052652|NCT02038829|100451605|FG007|NOT COMPLETED|Treatment Period 1||0||
48052653|NCT02038829|100451606|FG008|NOT COMPLETED|Treatment Period 1||0||
48052654|NCT02038829|100451607|FG009|NOT COMPLETED|Treatment Period 1||0||
48052655|NCT02038829|100451608|FG010|NOT COMPLETED|Treatment Period 1||0||
48052656|NCT02038829|100451609|FG011|NOT COMPLETED|Treatment Period 1||0||
48052657|NCT02038829|100451598|FG000|STARTED|Washout Period 1||8||
48052658|NCT02038829|100451599|FG001|STARTED|Washout Period 1||8||
48052659|NCT02038829|100451600|FG002|STARTED|Washout Period 1||8||
48052660|NCT02038829|100451601|FG003|STARTED|Washout Period 1||8||
48052661|NCT02038829|100451602|FG004|STARTED|Washout Period 1||8||
48052662|NCT02038829|100451603|FG005|STARTED|Washout Period 1||8||
48052663|NCT02038829|100451604|FG006|STARTED|Washout Period 1||8||
48052664|NCT02038829|100451605|FG007|STARTED|Washout Period 1||8||
48052665|NCT02038829|100451606|FG008|STARTED|Washout Period 1||8||
48052666|NCT02038829|100451607|FG009|STARTED|Washout Period 1||8||
48052667|NCT02038829|100451608|FG010|STARTED|Washout Period 1||8||
48052668|NCT02038829|100451609|FG011|STARTED|Washout Period 1||8||
48052669|NCT02038829|100451598|FG000|COMPLETED|Washout Period 1||8||
48052670|NCT02038829|100451599|FG001|COMPLETED|Washout Period 1||8||
48052671|NCT02038829|100451600|FG002|COMPLETED|Washout Period 1||8||
48052672|NCT02038829|100451601|FG003|COMPLETED|Washout Period 1||8||
48052673|NCT02038829|100451602|FG004|COMPLETED|Washout Period 1||7||
48052674|NCT02038829|100451603|FG005|COMPLETED|Washout Period 1||8||
48052675|NCT02038829|100451604|FG006|COMPLETED|Washout Period 1||8||
48052676|NCT02038829|100451605|FG007|COMPLETED|Washout Period 1||8||
48052677|NCT02038829|100451606|FG008|COMPLETED|Washout Period 1||8||
48052678|NCT02038829|100451607|FG009|COMPLETED|Washout Period 1||8||
48052679|NCT02038829|100451608|FG010|COMPLETED|Washout Period 1||8||
48052680|NCT02038829|100451609|FG011|COMPLETED|Washout Period 1||8||
48052681|NCT02038829|100451598|FG000|NOT COMPLETED|Washout Period 1||0||
48052682|NCT02038829|100451599|FG001|NOT COMPLETED|Washout Period 1||0||
48052683|NCT02038829|100451600|FG002|NOT COMPLETED|Washout Period 1||0||
48052684|NCT02038829|100451601|FG003|NOT COMPLETED|Washout Period 1||0||
48052685|NCT02038829|100451602|FG004|NOT COMPLETED|Washout Period 1||1||
48052686|NCT02038829|100451603|FG005|NOT COMPLETED|Washout Period 1||0||
48052687|NCT02038829|100451604|FG006|NOT COMPLETED|Washout Period 1||0||
48052688|NCT02038829|100451605|FG007|NOT COMPLETED|Washout Period 1||0||
48052689|NCT02038829|100451606|FG008|NOT COMPLETED|Washout Period 1||0||
48052690|NCT02038829|100451607|FG009|NOT COMPLETED|Washout Period 1||0||
48052691|NCT02038829|100451608|FG010|NOT COMPLETED|Washout Period 1||0||
48052692|NCT02038829|100451609|FG011|NOT COMPLETED|Washout Period 1||0||
48052693|NCT02038829|100451598|FG000|STARTED|Treatment Period 2||8||
48052694|NCT02038829|100451599|FG001|STARTED|Treatment Period 2||8||
48052695|NCT02038829|100451600|FG002|STARTED|Treatment Period 2||8||
48052696|NCT02038829|100451601|FG003|STARTED|Treatment Period 2||8||
48052697|NCT02038829|100451602|FG004|STARTED|Treatment Period 2||7||
48052698|NCT02038829|100451603|FG005|STARTED|Treatment Period 2||8||
48052699|NCT02038829|100451604|FG006|STARTED|Treatment Period 2||8||
48052700|NCT02038829|100451605|FG007|STARTED|Treatment Period 2||8||
48052701|NCT02038829|100451606|FG008|STARTED|Treatment Period 2||8||
48052702|NCT02038829|100451607|FG009|STARTED|Treatment Period 2||8||
48052703|NCT02038829|100451608|FG010|STARTED|Treatment Period 2||8||
48052704|NCT02038829|100451609|FG011|STARTED|Treatment Period 2||8||
48052705|NCT02038829|100451598|FG000|COMPLETED|Treatment Period 2||7||
48052706|NCT02038829|100451599|FG001|COMPLETED|Treatment Period 2||8||
48052707|NCT02038829|100451600|FG002|COMPLETED|Treatment Period 2||8||
48052708|NCT02038829|100451601|FG003|COMPLETED|Treatment Period 2||8||
48052709|NCT02038829|100451602|FG004|COMPLETED|Treatment Period 2||7||
48052710|NCT02038829|100451603|FG005|COMPLETED|Treatment Period 2||8||
48052711|NCT02038829|100451604|FG006|COMPLETED|Treatment Period 2||8||
48052712|NCT02038829|100451605|FG007|COMPLETED|Treatment Period 2||8||
48052713|NCT02038829|100451606|FG008|COMPLETED|Treatment Period 2||8||
48052714|NCT02038829|100451607|FG009|COMPLETED|Treatment Period 2||8||
48052715|NCT02038829|100451608|FG010|COMPLETED|Treatment Period 2||7||
48052716|NCT02038829|100451609|FG011|COMPLETED|Treatment Period 2||8||
48052717|NCT02038829|100451598|FG000|NOT COMPLETED|Treatment Period 2||1||
48052718|NCT02038829|100451599|FG001|NOT COMPLETED|Treatment Period 2||0||
48052719|NCT02038829|100451600|FG002|NOT COMPLETED|Treatment Period 2||0||
48052720|NCT02038829|100451601|FG003|NOT COMPLETED|Treatment Period 2||0||
48052721|NCT02038829|100451602|FG004|NOT COMPLETED|Treatment Period 2||0||
48052722|NCT02038829|100451603|FG005|NOT COMPLETED|Treatment Period 2||0||
48052723|NCT02038829|100451604|FG006|NOT COMPLETED|Treatment Period 2||0||
48052724|NCT02038829|100451605|FG007|NOT COMPLETED|Treatment Period 2||0||
48052725|NCT02038829|100451606|FG008|NOT COMPLETED|Treatment Period 2||0||
48052726|NCT02038829|100451607|FG009|NOT COMPLETED|Treatment Period 2||0||
48052727|NCT02038829|100451608|FG010|NOT COMPLETED|Treatment Period 2||1||
48052728|NCT02038829|100451609|FG011|NOT COMPLETED|Treatment Period 2||0||
48052729|NCT02038829|100451598|FG000|STARTED|Washout Period 2||7||
48052730|NCT02038829|100451599|FG001|STARTED|Washout Period 2||8||
48052731|NCT02038829|100451600|FG002|STARTED|Washout Period 2||8||
48052732|NCT02038829|100451601|FG003|STARTED|Washout Period 2||8||
48052733|NCT02038829|100451602|FG004|STARTED|Washout Period 2||7||
48052734|NCT02038829|100451603|FG005|STARTED|Washout Period 2||8||
48052735|NCT02038829|100451604|FG006|STARTED|Washout Period 2||8||
48052736|NCT02038829|100451605|FG007|STARTED|Washout Period 2||8||
48052737|NCT02038829|100451606|FG008|STARTED|Washout Period 2||8||
48052738|NCT02038829|100451607|FG009|STARTED|Washout Period 2||8||
48052739|NCT02038829|100451608|FG010|STARTED|Washout Period 2||7||
48052740|NCT02038829|100451609|FG011|STARTED|Washout Period 2||8||
48052741|NCT02038829|100451598|FG000|COMPLETED|Washout Period 2||7||
48052742|NCT02038829|100451599|FG001|COMPLETED|Washout Period 2||8||
48052743|NCT02038829|100451600|FG002|COMPLETED|Washout Period 2||8||
48052744|NCT02038829|100451601|FG003|COMPLETED|Washout Period 2||8||
48052745|NCT02038829|100451602|FG004|COMPLETED|Washout Period 2||7||
48052746|NCT02038829|100451603|FG005|COMPLETED|Washout Period 2||7||
48052747|NCT02038829|100451604|FG006|COMPLETED|Washout Period 2||8||
48052748|NCT02038829|100451605|FG007|COMPLETED|Washout Period 2||8||
48052749|NCT02038829|100451606|FG008|COMPLETED|Washout Period 2||7||
48052750|NCT02038829|100451607|FG009|COMPLETED|Washout Period 2||8||
48052751|NCT02038829|100451608|FG010|COMPLETED|Washout Period 2||7||
48052752|NCT02038829|100451609|FG011|COMPLETED|Washout Period 2||8||
48052753|NCT02038829|100451598|FG000|NOT COMPLETED|Washout Period 2||0||
48052754|NCT02038829|100451599|FG001|NOT COMPLETED|Washout Period 2||0||
48052755|NCT02038829|100451600|FG002|NOT COMPLETED|Washout Period 2||0||
48052756|NCT02038829|100451601|FG003|NOT COMPLETED|Washout Period 2||0||
48052757|NCT02038829|100451602|FG004|NOT COMPLETED|Washout Period 2||0||
48052758|NCT02038829|100451603|FG005|NOT COMPLETED|Washout Period 2||1||
48052759|NCT02038829|100451604|FG006|NOT COMPLETED|Washout Period 2||0||
48052760|NCT02038829|100451605|FG007|NOT COMPLETED|Washout Period 2||0||
48052761|NCT02038829|100451606|FG008|NOT COMPLETED|Washout Period 2||1||
48052762|NCT02038829|100451607|FG009|NOT COMPLETED|Washout Period 2||0||
48052763|NCT02038829|100451608|FG010|NOT COMPLETED|Washout Period 2||0||
48052764|NCT02038829|100451609|FG011|NOT COMPLETED|Washout Period 2||0||
48052765|NCT02038829|100451598|FG000|STARTED|Treatment Period 3||7||
48052766|NCT02038829|100451599|FG001|STARTED|Treatment Period 3||8||
48052767|NCT02038829|100451600|FG002|STARTED|Treatment Period 3||8||
48052768|NCT02038829|100451601|FG003|STARTED|Treatment Period 3||8||
48052769|NCT02038829|100451602|FG004|STARTED|Treatment Period 3||7||
48052770|NCT02038829|100451603|FG005|STARTED|Treatment Period 3||7||
48052771|NCT02038829|100451604|FG006|STARTED|Treatment Period 3||8||
48052772|NCT02038829|100451605|FG007|STARTED|Treatment Period 3||8||
48052773|NCT02038829|100451606|FG008|STARTED|Treatment Period 3||7||
48052774|NCT02038829|100451607|FG009|STARTED|Treatment Period 3||8||
48052775|NCT02038829|100451608|FG010|STARTED|Treatment Period 3||7||
48052776|NCT02038829|100451609|FG011|STARTED|Treatment Period 3||8||
48052777|NCT02038829|100451598|FG000|COMPLETED|Treatment Period 3||7||
48052778|NCT02038829|100451599|FG001|COMPLETED|Treatment Period 3||8||
48052779|NCT02038829|100451600|FG002|COMPLETED|Treatment Period 3||8||
48052780|NCT02038829|100451601|FG003|COMPLETED|Treatment Period 3||8||
48052781|NCT02038829|100451602|FG004|COMPLETED|Treatment Period 3||7||
48052782|NCT02038829|100451603|FG005|COMPLETED|Treatment Period 3||7||
48052783|NCT02038829|100451604|FG006|COMPLETED|Treatment Period 3||8||
48052784|NCT02038829|100451605|FG007|COMPLETED|Treatment Period 3||8||
48052785|NCT02038829|100451606|FG008|COMPLETED|Treatment Period 3||7||
48052786|NCT02038829|100451607|FG009|COMPLETED|Treatment Period 3||8||
48052787|NCT02038829|100451608|FG010|COMPLETED|Treatment Period 3||7||
48052788|NCT02038829|100451609|FG011|COMPLETED|Treatment Period 3||8||
48052789|NCT02038829|100451598|FG000|NOT COMPLETED|Treatment Period 3||0||
48052790|NCT02038829|100451599|FG001|NOT COMPLETED|Treatment Period 3||0||
48052791|NCT02038829|100451600|FG002|NOT COMPLETED|Treatment Period 3||0||
48052792|NCT02038829|100451601|FG003|NOT COMPLETED|Treatment Period 3||0||
48052793|NCT02038829|100451602|FG004|NOT COMPLETED|Treatment Period 3||0||
48052794|NCT02038829|100451603|FG005|NOT COMPLETED|Treatment Period 3||0||
48052795|NCT02038829|100451604|FG006|NOT COMPLETED|Treatment Period 3||0||
48052796|NCT02038829|100451605|FG007|NOT COMPLETED|Treatment Period 3||0||
48052797|NCT02038829|100451606|FG008|NOT COMPLETED|Treatment Period 3||0||
48052798|NCT02038829|100451607|FG009|NOT COMPLETED|Treatment Period 3||0||
48052799|NCT02038829|100451608|FG010|NOT COMPLETED|Treatment Period 3||0||
48052800|NCT02038829|100451609|FG011|NOT COMPLETED|Treatment Period 3||0||
48052801|NCT02038829|100451598|FG000|STARTED|Washout Period 3||7||
48052802|NCT02038829|100451599|FG001|STARTED|Washout Period 3||8||
48052803|NCT02038829|100451600|FG002|STARTED|Washout Period 3||8||
48495680|NCT03922490|101547908|FG000|STARTED|Overall Study||2||
48052804|NCT02038829|100451601|FG003|STARTED|Washout Period 3||8||
48052805|NCT02038829|100451602|FG004|STARTED|Washout Period 3||7||
48052806|NCT02038829|100451603|FG005|STARTED|Washout Period 3||7||
48052807|NCT02038829|100451604|FG006|STARTED|Washout Period 3||8||
48052808|NCT02038829|100451605|FG007|STARTED|Washout Period 3||8||
48052809|NCT02038829|100451606|FG008|STARTED|Washout Period 3||7||
48052810|NCT02038829|100451607|FG009|STARTED|Washout Period 3||8||
48052811|NCT02038829|100451608|FG010|STARTED|Washout Period 3||7||
48052812|NCT02038829|100451609|FG011|STARTED|Washout Period 3||8||
48052813|NCT02038829|100451598|FG000|COMPLETED|Washout Period 3||7||
48052814|NCT02038829|100451599|FG001|COMPLETED|Washout Period 3||8||
48052815|NCT02038829|100451600|FG002|COMPLETED|Washout Period 3||8||
48052816|NCT02038829|100451601|FG003|COMPLETED|Washout Period 3||8||
48052817|NCT02038829|100451602|FG004|COMPLETED|Washout Period 3||7||
48052818|NCT02038829|100451603|FG005|COMPLETED|Washout Period 3||7||
48052819|NCT02038829|100451604|FG006|COMPLETED|Washout Period 3||8||
48052820|NCT02038829|100451605|FG007|COMPLETED|Washout Period 3||8||
48052821|NCT02038829|100451606|FG008|COMPLETED|Washout Period 3||7||
48052822|NCT02038829|100451607|FG009|COMPLETED|Washout Period 3||8||
48052823|NCT02038829|100451608|FG010|COMPLETED|Washout Period 3||7||
48052824|NCT02038829|100451609|FG011|COMPLETED|Washout Period 3||8||
48052825|NCT02038829|100451598|FG000|NOT COMPLETED|Washout Period 3||0||
48052826|NCT02038829|100451599|FG001|NOT COMPLETED|Washout Period 3||0||
48495681|NCT03922490|101547909|FG001|STARTED|Overall Study||0||
48052827|NCT02038829|100451600|FG002|NOT COMPLETED|Washout Period 3||0||
48052828|NCT02038829|100451601|FG003|NOT COMPLETED|Washout Period 3||0||
48052829|NCT02038829|100451602|FG004|NOT COMPLETED|Washout Period 3||0||
48052830|NCT02038829|100451603|FG005|NOT COMPLETED|Washout Period 3||0||
48052831|NCT02038829|100451604|FG006|NOT COMPLETED|Washout Period 3||0||
48052832|NCT02038829|100451605|FG007|NOT COMPLETED|Washout Period 3||0||
48052833|NCT02038829|100451606|FG008|NOT COMPLETED|Washout Period 3||0||
48052834|NCT02038829|100451607|FG009|NOT COMPLETED|Washout Period 3||0||
48052835|NCT02038829|100451608|FG010|NOT COMPLETED|Washout Period 3||0||
48052836|NCT02038829|100451609|FG011|NOT COMPLETED|Washout Period 3||0||
48052837|NCT02038829|100451598|FG000|STARTED|Treatment Period 4||7||
48052838|NCT02038829|100451599|FG001|STARTED|Treatment Period 4||8||
48052839|NCT02038829|100451600|FG002|STARTED|Treatment Period 4||8||
48052840|NCT02038829|100451601|FG003|STARTED|Treatment Period 4||8||
48052841|NCT02038829|100451602|FG004|STARTED|Treatment Period 4||7||
48052842|NCT02038829|100451603|FG005|STARTED|Treatment Period 4||7||
48052843|NCT02038829|100451604|FG006|STARTED|Treatment Period 4||8||
48052844|NCT02038829|100451605|FG007|STARTED|Treatment Period 4||8||
48052845|NCT02038829|100451606|FG008|STARTED|Treatment Period 4||7||
48052846|NCT02038829|100451607|FG009|STARTED|Treatment Period 4||8||
48052847|NCT02038829|100451608|FG010|STARTED|Treatment Period 4||7||
48052848|NCT02038829|100451609|FG011|STARTED|Treatment Period 4||8||
48052849|NCT02038829|100451598|FG000|COMPLETED|Treatment Period 4||7||
48052850|NCT02038829|100451599|FG001|COMPLETED|Treatment Period 4||7||
48052851|NCT02038829|100451600|FG002|COMPLETED|Treatment Period 4||8||
48052852|NCT02038829|100451601|FG003|COMPLETED|Treatment Period 4||8||
48052853|NCT02038829|100451602|FG004|COMPLETED|Treatment Period 4||7||
48052854|NCT02038829|100451603|FG005|COMPLETED|Treatment Period 4||7||
48052855|NCT02038829|100451604|FG006|COMPLETED|Treatment Period 4||8||
48052856|NCT02038829|100451605|FG007|COMPLETED|Treatment Period 4||8||
48052857|NCT02038829|100451606|FG008|COMPLETED|Treatment Period 4||7||
48052858|NCT02038829|100451607|FG009|COMPLETED|Treatment Period 4||8||
48052859|NCT02038829|100451608|FG010|COMPLETED|Treatment Period 4||7||
48052860|NCT02038829|100451609|FG011|COMPLETED|Treatment Period 4||8||
48052861|NCT02038829|100451598|FG000|NOT COMPLETED|Treatment Period 4||0||
48052862|NCT02038829|100451599|FG001|NOT COMPLETED|Treatment Period 4||1||
48052863|NCT02038829|100451600|FG002|NOT COMPLETED|Treatment Period 4||0||
48052864|NCT02038829|100451601|FG003|NOT COMPLETED|Treatment Period 4||0||
48052865|NCT02038829|100451602|FG004|NOT COMPLETED|Treatment Period 4||0||
48052866|NCT02038829|100451603|FG005|NOT COMPLETED|Treatment Period 4||0||
48052867|NCT02038829|100451604|FG006|NOT COMPLETED|Treatment Period 4||0||
48052868|NCT02038829|100451605|FG007|NOT COMPLETED|Treatment Period 4||0||
48052869|NCT02038829|100451606|FG008|NOT COMPLETED|Treatment Period 4||0||
48052870|NCT02038829|100451607|FG009|NOT COMPLETED|Treatment Period 4||0||
48052871|NCT02038829|100451608|FG010|NOT COMPLETED|Treatment Period 4||0||
48052872|NCT02038829|100451609|FG011|NOT COMPLETED|Treatment Period 4||0||
48052873|NCT02038829|100451598|FG000|STARTED|Washout Period 4||7||
48052874|NCT02038829|100451599|FG001|STARTED|Washout Period 4||7||
48052875|NCT02038829|100451600|FG002|STARTED|Washout Period 4||8||
48052876|NCT02038829|100451601|FG003|STARTED|Washout Period 4||8||
48052877|NCT02038829|100451602|FG004|STARTED|Washout Period 4||7||
48052878|NCT02038829|100451603|FG005|STARTED|Washout Period 4||7||
48052879|NCT02038829|100451604|FG006|STARTED|Washout Period 4||8||
48052880|NCT02038829|100451605|FG007|STARTED|Washout Period 4||8||
48052881|NCT02038829|100451606|FG008|STARTED|Washout Period 4||7||
48052882|NCT02038829|100451607|FG009|STARTED|Washout Period 4||8||
48052883|NCT02038829|100451608|FG010|STARTED|Washout Period 4||7||
48052884|NCT02038829|100451609|FG011|STARTED|Washout Period 4||8||
48052885|NCT02038829|100451598|FG000|COMPLETED|Washout Period 4||7||
48052886|NCT02038829|100451599|FG001|COMPLETED|Washout Period 4||7||
48052887|NCT02038829|100451600|FG002|COMPLETED|Washout Period 4||8||
48052888|NCT02038829|100451601|FG003|COMPLETED|Washout Period 4||8||
48052889|NCT02038829|100451602|FG004|COMPLETED|Washout Period 4||7||
48052890|NCT02038829|100451603|FG005|COMPLETED|Washout Period 4||7||
48052891|NCT02038829|100451604|FG006|COMPLETED|Washout Period 4||7||
48052892|NCT02038829|100451605|FG007|COMPLETED|Washout Period 4||8||
48052893|NCT02038829|100451606|FG008|COMPLETED|Washout Period 4||7||
48052894|NCT02038829|100451607|FG009|COMPLETED|Washout Period 4||8||
48052895|NCT02038829|100451608|FG010|COMPLETED|Washout Period 4||7||
48052896|NCT02038829|100451609|FG011|COMPLETED|Washout Period 4||8||
48052897|NCT02038829|100451598|FG000|NOT COMPLETED|Washout Period 4||0||
48052898|NCT02038829|100451599|FG001|NOT COMPLETED|Washout Period 4||0||
48052899|NCT02038829|100451600|FG002|NOT COMPLETED|Washout Period 4||0||
48052900|NCT02038829|100451601|FG003|NOT COMPLETED|Washout Period 4||0||
48052901|NCT02038829|100451602|FG004|NOT COMPLETED|Washout Period 4||0||
48052902|NCT02038829|100451603|FG005|NOT COMPLETED|Washout Period 4||0||
48052903|NCT02038829|100451604|FG006|NOT COMPLETED|Washout Period 4||1||
48052904|NCT02038829|100451605|FG007|NOT COMPLETED|Washout Period 4||0||
48208327|NCT02709655|100837033|FG004|Received at Least 1 Dose of Study Drug|Single-Blind Phase (4 Weeks)||0||
48208328|NCT02709655|100837029|FG000|COMPLETED|Single-Blind Phase (4 Weeks)||540||
48208329|NCT02709655|100837030|FG001|COMPLETED|Single-Blind Phase (4 Weeks)||0||
48208330|NCT02709655|100837031|FG002|COMPLETED|Single-Blind Phase (4 Weeks)||0||
48208331|NCT02709655|100837032|FG003|COMPLETED|Single-Blind Phase (4 Weeks)||0||
48208332|NCT02709655|100837033|FG004|COMPLETED|Single-Blind Phase (4 Weeks)||0||
48208333|NCT02709655|100837029|FG000|NOT COMPLETED|Single-Blind Phase (4 Weeks)||143||
48208334|NCT02709655|100837030|FG001|NOT COMPLETED|Single-Blind Phase (4 Weeks)||0||
48208335|NCT02709655|100837031|FG002|NOT COMPLETED|Single-Blind Phase (4 Weeks)||0||
48208336|NCT02709655|100837032|FG003|NOT COMPLETED|Single-Blind Phase (4 Weeks)||0||
48208337|NCT02709655|100837033|FG004|NOT COMPLETED|Single-Blind Phase (4 Weeks)||0||
48208338|NCT02709655|100837029|FG000|STARTED|Double-Blind Phase (8 Weeks)||0||
48208339|NCT02709655|100837030|FG001|STARTED|Double-Blind Phase (8 Weeks)||153||
48208340|NCT02709655|100837031|FG002|STARTED|Double-Blind Phase (8 Weeks)||151||
48208341|NCT02709655|100837032|FG003|STARTED|Double-Blind Phase (8 Weeks)||153||
48495682|NCT03922490|101547908|FG000|COMPLETED|Overall Study||0||
48495683|NCT03922490|101547909|FG001|COMPLETED|Overall Study||0||
48495684|NCT03922490|101547908|FG000|NOT COMPLETED|Overall Study||2||
48052905|NCT02038829|100451606|FG008|NOT COMPLETED|Washout Period 4||0||
48052906|NCT02038829|100451607|FG009|NOT COMPLETED|Washout Period 4||0||
48052907|NCT02038829|100451608|FG010|NOT COMPLETED|Washout Period 4||0||
48052908|NCT02038829|100451609|FG011|NOT COMPLETED|Washout Period 4||0||
48052909|NCT02038829|100451598|FG000|STARTED|Treatment Period 5||7||
48052910|NCT02038829|100451599|FG001|STARTED|Treatment Period 5||7||
48052911|NCT02038829|100451600|FG002|STARTED|Treatment Period 5||8||
48052912|NCT02038829|100451601|FG003|STARTED|Treatment Period 5||8||
48052913|NCT02038829|100451602|FG004|STARTED|Treatment Period 5||7||
48052914|NCT02038829|100451603|FG005|STARTED|Treatment Period 5||7||
48052915|NCT02038829|100451604|FG006|STARTED|Treatment Period 5||7||
48052916|NCT02038829|100451605|FG007|STARTED|Treatment Period 5||8||
48052917|NCT02038829|100451606|FG008|STARTED|Treatment Period 5||7||
48052918|NCT02038829|100451607|FG009|STARTED|Treatment Period 5||8||
48052919|NCT02038829|100451608|FG010|STARTED|Treatment Period 5||7||
48052920|NCT02038829|100451609|FG011|STARTED|Treatment Period 5||8||
48052921|NCT02038829|100451598|FG000|COMPLETED|Treatment Period 5||7||
48052922|NCT02038829|100451599|FG001|COMPLETED|Treatment Period 5||7||
48052923|NCT02038829|100451600|FG002|COMPLETED|Treatment Period 5||8||
48052924|NCT02038829|100451601|FG003|COMPLETED|Treatment Period 5||8||
48052925|NCT02038829|100451602|FG004|COMPLETED|Treatment Period 5||7||
48052926|NCT02038829|100451603|FG005|COMPLETED|Treatment Period 5||7||
48052927|NCT02038829|100451604|FG006|COMPLETED|Treatment Period 5||7||
48052928|NCT02038829|100451605|FG007|COMPLETED|Treatment Period 5||8||
48052929|NCT02038829|100451606|FG008|COMPLETED|Treatment Period 5||7||
48052930|NCT02038829|100451607|FG009|COMPLETED|Treatment Period 5||8||
48052931|NCT02038829|100451608|FG010|COMPLETED|Treatment Period 5||7||
48052932|NCT02038829|100451609|FG011|COMPLETED|Treatment Period 5||8||
48052933|NCT02038829|100451598|FG000|NOT COMPLETED|Treatment Period 5||0||
48052934|NCT02038829|100451599|FG001|NOT COMPLETED|Treatment Period 5||0||
48052935|NCT02038829|100451600|FG002|NOT COMPLETED|Treatment Period 5||0||
48208342|NCT02709655|100837033|FG004|STARTED|Double-Blind Phase (8 Weeks)||83||
48208343|NCT02709655|100837029|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Phase (8 Weeks)||0||
48495685|NCT03922490|101547909|FG001|NOT COMPLETED|Overall Study||0||
48052936|NCT02038829|100451601|FG003|NOT COMPLETED|Treatment Period 5||0||
48052937|NCT02038829|100451602|FG004|NOT COMPLETED|Treatment Period 5||0||
48052938|NCT02038829|100451603|FG005|NOT COMPLETED|Treatment Period 5||0||
48052939|NCT02038829|100451604|FG006|NOT COMPLETED|Treatment Period 5||0||
48052940|NCT02038829|100451605|FG007|NOT COMPLETED|Treatment Period 5||0||
48052941|NCT02038829|100451606|FG008|NOT COMPLETED|Treatment Period 5||0||
48052942|NCT02038829|100451607|FG009|NOT COMPLETED|Treatment Period 5||0||
48052943|NCT02038829|100451608|FG010|NOT COMPLETED|Treatment Period 5||0||
48052944|NCT02038829|100451609|FG011|NOT COMPLETED|Treatment Period 5||0||
48052945|NCT02038829|100451598|FG000|STARTED|Washout Period 5||7||
48052946|NCT02038829|100451599|FG001|STARTED|Washout Period 5||7||
48052947|NCT02038829|100451600|FG002|STARTED|Washout Period 5||8||
48052948|NCT02038829|100451601|FG003|STARTED|Washout Period 5||8||
48052949|NCT02038829|100451602|FG004|STARTED|Washout Period 5||7||
48052950|NCT02038829|100451603|FG005|STARTED|Washout Period 5||7||
48208344|NCT02709655|100837030|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Phase (8 Weeks)||153||
48052951|NCT02038829|100451604|FG006|STARTED|Washout Period 5||7||
48052952|NCT02038829|100451605|FG007|STARTED|Washout Period 5||8||
48052953|NCT02038829|100451606|FG008|STARTED|Washout Period 5||7||
48052954|NCT02038829|100451607|FG009|STARTED|Washout Period 5||8||
48052955|NCT02038829|100451608|FG010|STARTED|Washout Period 5||7||
48052956|NCT02038829|100451609|FG011|STARTED|Washout Period 5||8||
48052957|NCT02038829|100451598|FG000|COMPLETED|Washout Period 5||7||
48052958|NCT02038829|100451599|FG001|COMPLETED|Washout Period 5||7||
48052959|NCT02038829|100451600|FG002|COMPLETED|Washout Period 5||8||
48052960|NCT02038829|100451601|FG003|COMPLETED|Washout Period 5||8||
48052961|NCT02038829|100451602|FG004|COMPLETED|Washout Period 5||7||
48052962|NCT02038829|100451603|FG005|COMPLETED|Washout Period 5||7||
48052963|NCT02038829|100451604|FG006|COMPLETED|Washout Period 5||7||
48052964|NCT02038829|100451605|FG007|COMPLETED|Washout Period 5||8||
48052965|NCT02038829|100451606|FG008|COMPLETED|Washout Period 5||7||
48052966|NCT02038829|100451607|FG009|COMPLETED|Washout Period 5||8||
48052967|NCT02038829|100451608|FG010|COMPLETED|Washout Period 5||7||
48052968|NCT02038829|100451609|FG011|COMPLETED|Washout Period 5||8||
48052969|NCT02038829|100451598|FG000|NOT COMPLETED|Washout Period 5||0||
48052970|NCT02038829|100451599|FG001|NOT COMPLETED|Washout Period 5||0||
48052971|NCT02038829|100451600|FG002|NOT COMPLETED|Washout Period 5||0||
48052972|NCT02038829|100451601|FG003|NOT COMPLETED|Washout Period 5||0||
48052973|NCT02038829|100451602|FG004|NOT COMPLETED|Washout Period 5||0||
48052974|NCT02038829|100451603|FG005|NOT COMPLETED|Washout Period 5||0||
48052975|NCT02038829|100451604|FG006|NOT COMPLETED|Washout Period 5||0||
48052976|NCT02038829|100451605|FG007|NOT COMPLETED|Washout Period 5||0||
48052977|NCT02038829|100451606|FG008|NOT COMPLETED|Washout Period 5||0||
48052978|NCT02038829|100451607|FG009|NOT COMPLETED|Washout Period 5||0||
48052979|NCT02038829|100451608|FG010|NOT COMPLETED|Washout Period 5||0||
48052980|NCT02038829|100451609|FG011|NOT COMPLETED|Washout Period 5||0||
48052981|NCT02038829|100451598|FG000|STARTED|Treatment Period 6||7||
48052982|NCT02038829|100451599|FG001|STARTED|Treatment Period 6||7||
48208345|NCT02709655|100837031|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Phase (8 Weeks)||151||
48052983|NCT02038829|100451600|FG002|STARTED|Treatment Period 6||8||
48052984|NCT02038829|100451601|FG003|STARTED|Treatment Period 6||8||
48052985|NCT02038829|100451602|FG004|STARTED|Treatment Period 6||7||
48052986|NCT02038829|100451603|FG005|STARTED|Treatment Period 6||7||
48052987|NCT02038829|100451604|FG006|STARTED|Treatment Period 6||7||
48052988|NCT02038829|100451605|FG007|STARTED|Treatment Period 6||8||
48052989|NCT02038829|100451606|FG008|STARTED|Treatment Period 6||7||
48052990|NCT02038829|100451607|FG009|STARTED|Treatment Period 6||8||
48052991|NCT02038829|100451608|FG010|STARTED|Treatment Period 6||7||
48052992|NCT02038829|100451609|FG011|STARTED|Treatment Period 6||8||
48052993|NCT02038829|100451598|FG000|COMPLETED|Treatment Period 6||7||
48052994|NCT02038829|100451599|FG001|COMPLETED|Treatment Period 6||7||
48052995|NCT02038829|100451600|FG002|COMPLETED|Treatment Period 6||7||
48052996|NCT02038829|100451601|FG003|COMPLETED|Treatment Period 6||8||
48052997|NCT02038829|100451602|FG004|COMPLETED|Treatment Period 6||7||
48052998|NCT02038829|100451603|FG005|COMPLETED|Treatment Period 6||7||
48052999|NCT02038829|100451604|FG006|COMPLETED|Treatment Period 6||7||
48053000|NCT02038829|100451605|FG007|COMPLETED|Treatment Period 6||8||
48053001|NCT02038829|100451606|FG008|COMPLETED|Treatment Period 6||7||
48053002|NCT02038829|100451607|FG009|COMPLETED|Treatment Period 6||8||
48053003|NCT02038829|100451608|FG010|COMPLETED|Treatment Period 6||7||
48053004|NCT02038829|100451609|FG011|COMPLETED|Treatment Period 6||8||
48053005|NCT02038829|100451598|FG000|NOT COMPLETED|Treatment Period 6||0||
48053006|NCT02038829|100451599|FG001|NOT COMPLETED|Treatment Period 6||0||
48053007|NCT02038829|100451600|FG002|NOT COMPLETED|Treatment Period 6||1||
48053008|NCT02038829|100451601|FG003|NOT COMPLETED|Treatment Period 6||0||
48053009|NCT02038829|100451602|FG004|NOT COMPLETED|Treatment Period 6||0||
48053010|NCT02038829|100451603|FG005|NOT COMPLETED|Treatment Period 6||0||
48053011|NCT02038829|100451604|FG006|NOT COMPLETED|Treatment Period 6||0||
48053012|NCT02038829|100451605|FG007|NOT COMPLETED|Treatment Period 6||0||
48053013|NCT02038829|100451606|FG008|NOT COMPLETED|Treatment Period 6||0||
48053014|NCT02038829|100451607|FG009|NOT COMPLETED|Treatment Period 6||0||
48053015|NCT02038829|100451608|FG010|NOT COMPLETED|Treatment Period 6||0||
48053016|NCT02038829|100451609|FG011|NOT COMPLETED|Treatment Period 6||0||
48053017|NCT04243421|100451610|FG000|STARTED|Overall Study||30||
48053018|NCT04243421|100451610|FG000|COMPLETED|Overall Study||30||
48053019|NCT04243421|100451610|FG000|NOT COMPLETED|Overall Study||0||
48053020|NCT01931202|100451611|FG000|STARTED|Overall Study||8||
48053021|NCT01931202|100451612|FG001|STARTED|Overall Study||51||
48053022|NCT01931202|100451613|FG002|STARTED|Overall Study||49||
48053023|NCT01931202|100451611|FG000|COMPLETED|Overall Study||8||
48053024|NCT01931202|100451612|FG001|COMPLETED|Overall Study||46||
48053025|NCT01931202|100451613|FG002|COMPLETED|Overall Study||45||
48053026|NCT01931202|100451611|FG000|NOT COMPLETED|Overall Study||0||
48053027|NCT01931202|100451612|FG001|NOT COMPLETED|Overall Study||5||
48053028|NCT01931202|100451613|FG002|NOT COMPLETED|Overall Study||4||
48053029|NCT03687970|100451614|FG000|STARTED|Overall Study||22||
48053030|NCT03687970|100451615|FG001|STARTED|Overall Study||20||
48053031|NCT03687970|100451614|FG000|COMPLETED|Overall Study||20||
48053032|NCT03687970|100451615|FG001|COMPLETED|Overall Study||20||
48053033|NCT03687970|100451614|FG000|NOT COMPLETED|Overall Study||2||
48053034|NCT03687970|100451615|FG001|NOT COMPLETED|Overall Study||0||
48053035|NCT00590460|100451616|FG000|STARTED|Overall Study||5||
48053036|NCT00590460|100451616|FG000|COMPLETED|Overall Study||5||
48053037|NCT00590460|100451616|FG000|NOT COMPLETED|Overall Study||0||
48053038|NCT03237871|100451617|FG000|STARTED|Overall Study||17||
48053039|NCT03237871|100451617|FG000|COMPLETED|Overall Study||11||
48053040|NCT03237871|100451617|FG000|NOT COMPLETED|Overall Study||6||
48053041|NCT00057681|100451618|FG000|STARTED|Overall Study||137||
48053042|NCT00057681|100451619|FG001|STARTED|Overall Study||139||
48053043|NCT00057681|100451620|FG002|STARTED|Overall Study||103||
48053044|NCT00057681|100451618|FG000|COMPLETED|Overall Study||72||
48053045|NCT00057681|100451619|FG001|COMPLETED|Overall Study||67||
48053046|NCT00057681|100451620|FG002|COMPLETED|Overall Study||69||
48053047|NCT00057681|100451618|FG000|NOT COMPLETED|Overall Study||65||
48053048|NCT00057681|100451619|FG001|NOT COMPLETED|Overall Study||72||
48053049|NCT00057681|100451620|FG002|NOT COMPLETED|Overall Study||34||
48053050|NCT05402020|100451621|FG000|STARTED|Overall Study||3815||
48053051|NCT05402020|100451622|FG001|STARTED|Overall Study||13203||
48053052|NCT05402020|100451621|FG000|Propensity Score-matched Cohorts|Overall Study||3752||
48053053|NCT05402020|100451622|FG001|Propensity Score-matched Cohorts|Overall Study||3752||
48053054|NCT05402020|100451621|FG000|COMPLETED|Overall Study||3815||
48053055|NCT05402020|100451622|FG001|COMPLETED|Overall Study||13203||
48053056|NCT05402020|100451621|FG000|NOT COMPLETED|Overall Study||0||
48053057|NCT05402020|100451622|FG001|NOT COMPLETED|Overall Study||0||
48053058|NCT00252629|100451623|FG000|STARTED|Overall Study||9||
48053059|NCT00252629|100451624|FG001|STARTED|Overall Study||9||
48053060|NCT00252629|100451625|FG002|STARTED|Overall Study||11||
48053061|NCT00252629|100451623|FG000|COMPLETED|Overall Study||8||
48053062|NCT00252629|100451624|FG001|COMPLETED|Overall Study||9||
48053063|NCT00252629|100451625|FG002|COMPLETED|Overall Study||11||
48053064|NCT00252629|100451623|FG000|NOT COMPLETED|Overall Study||1||
48053065|NCT00252629|100451624|FG001|NOT COMPLETED|Overall Study||0||
48053066|NCT00252629|100451625|FG002|NOT COMPLETED|Overall Study||0||
48053067|NCT04041700|100451626|FG000|STARTED|Overall Study||29||
48053068|NCT04041700|100451626|FG000|COMPLETED|Overall Study||27||
48053069|NCT04041700|100451626|FG000|NOT COMPLETED|Overall Study||2||
48053070|NCT01654796|100451627|FG000|STARTED|Overall Study||26||
48053071|NCT01654796|100451628|FG001|STARTED|Overall Study||29||
48053072|NCT01654796|100451629|FG002|STARTED|Overall Study||29||
48053073|NCT01654796|100451627|FG000|COMPLETED|Overall Study||25||
48053074|NCT01654796|100451628|FG001|COMPLETED|Overall Study||26||
48053075|NCT01654796|100451629|FG002|COMPLETED|Overall Study||28||
48053076|NCT01654796|100451627|FG000|NOT COMPLETED|Overall Study||1||
48053077|NCT01654796|100451628|FG001|NOT COMPLETED|Overall Study||3||
48053078|NCT01654796|100451629|FG002|NOT COMPLETED|Overall Study||1||
48053079|NCT01952470|100451630|FG000|STARTED|Overall Study||16||
48053080|NCT01952470|100451631|FG001|STARTED|Overall Study||16||
48053081|NCT01952470|100451630|FG000|ITT Analysis|Overall Study||16||
48053082|NCT01952470|100451631|FG001|ITT Analysis|Overall Study||16||
48053083|NCT01952470|100451630|FG000|Discontinued Intervention|Overall Study||2||
48053084|NCT01952470|100451631|FG001|Discontinued Intervention|Overall Study||1||
48053085|NCT01952470|100451630|FG000|Death|Overall Study||1||
48053086|NCT01952470|100451631|FG001|Death|Overall Study||1||
48053087|NCT01952470|100451630|FG000|Missing Baseline LCI 2% Data.|Overall Study||0||
48053088|NCT01952470|100451631|FG001|Missing Baseline LCI 2% Data.|Overall Study||2||
48053089|NCT01952470|100451630|FG000|Missing 1+3 Month LCI 2% Data.|Overall Study||2||
48053090|NCT01952470|100451631|FG001|Missing 1+3 Month LCI 2% Data.|Overall Study||1||
48053091|NCT01952470|100451630|FG000|Missing 3 Month LCI 2% Data.|Overall Study||1||
48053092|NCT01952470|100451631|FG001|Missing 3 Month LCI 2% Data.|Overall Study||0||
48053093|NCT01952470|100451630|FG000|COMPLETED|Overall Study||13|Complete data for primary outcome.|
48053094|NCT01952470|100451631|FG001|COMPLETED|Overall Study||13|Complete data for primary outcome.|
48053095|NCT01952470|100451630|FG000|NOT COMPLETED|Overall Study||3||
48053096|NCT01952470|100451631|FG001|NOT COMPLETED|Overall Study||3||
48053097|NCT02359851|100451632|FG000|STARTED|Overall Study||5||
48053098|NCT02359851|100451632|FG000|COMPLETED|Overall Study||3||
48053099|NCT02359851|100451632|FG000|NOT COMPLETED|Overall Study||2||
48053100|NCT04085367|100451633|FG000|STARTED|Overall Study||364||
48053101|NCT04085367|100451634|FG001|STARTED|Overall Study||193||
48053102|NCT04085367|100451633|FG000|COMPLETED|Overall Study||344||
48053103|NCT04085367|100451634|FG001|COMPLETED|Overall Study||185||
48053104|NCT04085367|100451633|FG000|NOT COMPLETED|Overall Study||20||
48053105|NCT04085367|100451634|FG001|NOT COMPLETED|Overall Study||8||
48053106|NCT02730208|100451635|FG000|STARTED|Overall Study||20||
48053107|NCT02730208|100451636|FG001|STARTED|Overall Study||21||
48053108|NCT02730208|100451635|FG000|COMPLETED|Overall Study||20||
48053109|NCT02730208|100451636|FG001|COMPLETED|Overall Study||20||
48053110|NCT02730208|100451635|FG000|NOT COMPLETED|Overall Study||0||
48053111|NCT02730208|100451636|FG001|NOT COMPLETED|Overall Study||1||
48053112|NCT02524977|100451637|FG000|STARTED|Overall Study||738||
48053113|NCT02524977|100451638|FG001|STARTED|Overall Study||846||
48053114|NCT02524977|100451637|FG000|COMPLETED|Overall Study||692||
48053115|NCT02524977|100451638|FG001|COMPLETED|Overall Study||801||
48053116|NCT02524977|100451637|FG000|NOT COMPLETED|Overall Study||46||
48053117|NCT02524977|100451638|FG001|NOT COMPLETED|Overall Study||45||
48053118|NCT02398409|100451639|FG000|STARTED|Overall Study||69||
48053119|NCT02398409|100451640|FG001|STARTED|Overall Study||68||
48053120|NCT02398409|100451639|FG000|COMPLETED|Overall Study||67||
48053121|NCT02398409|100451640|FG001|COMPLETED|Overall Study||63||
48053122|NCT02398409|100451639|FG000|NOT COMPLETED|Overall Study||2||
48053123|NCT02398409|100451640|FG001|NOT COMPLETED|Overall Study||5||
48053124|NCT00920907|100451641|FG000|STARTED|Induction Period||37||
48053125|NCT00920907|100451642|FG001|STARTED|Induction Period||38||
48053126|NCT00920907|100451641|FG000|COMPLETED|Induction Period||15||
48053127|NCT00920907|100451642|FG001|COMPLETED|Induction Period||16||
48053128|NCT00920907|100451641|FG000|NOT COMPLETED|Induction Period||22||
48053129|NCT00920907|100451642|FG001|NOT COMPLETED|Induction Period||22||
48053130|NCT00920907|100451641|FG000|STARTED|Maintenance Period||15||
48053131|NCT00920907|100451642|FG001|STARTED|Maintenance Period||15||
48053132|NCT00920907|100451641|FG000|COMPLETED|Maintenance Period||3||
48053133|NCT00920907|100451642|FG001|COMPLETED|Maintenance Period||2||
48053134|NCT00920907|100451641|FG000|NOT COMPLETED|Maintenance Period||12||
48053135|NCT00920907|100451642|FG001|NOT COMPLETED|Maintenance Period||13||
48053136|NCT01653028|100451643|FG000|STARTED|Overall Study||12||
48053137|NCT01653028|100451644|FG001|STARTED|Overall Study||10||
48053138|NCT01653028|100451645|FG002|STARTED|Overall Study||11||
48053139|NCT01653028|100451646|FG003|STARTED|Overall Study||10||
48053140|NCT01653028|100451647|FG004|STARTED|Overall Study||29||
48053141|NCT01653028|100451643|FG000|COMPLETED|Overall Study||12||
48053142|NCT01653028|100451644|FG001|COMPLETED|Overall Study||10||
48053143|NCT01653028|100451645|FG002|COMPLETED|Overall Study||11||
48053144|NCT01653028|100451646|FG003|COMPLETED|Overall Study||10||
48053145|NCT01653028|100451647|FG004|COMPLETED|Overall Study||29||
48053146|NCT01653028|100451643|FG000|NOT COMPLETED|Overall Study||0||
48053147|NCT01653028|100451644|FG001|NOT COMPLETED|Overall Study||0||
48053148|NCT01653028|100451645|FG002|NOT COMPLETED|Overall Study||0||
48053149|NCT01653028|100451646|FG003|NOT COMPLETED|Overall Study||0||
48053150|NCT01653028|100451647|FG004|NOT COMPLETED|Overall Study||0||
48053151|NCT01336569|100451648|FG000|STARTED|Overall Study||49||
48053152|NCT01336569|100451648|FG000|COMPLETED|Overall Study||45||
48053153|NCT01336569|100451648|FG000|NOT COMPLETED|Overall Study||4||
48053154|NCT02028871|100451649|FG000|STARTED|Overall Study||14||
48053155|NCT02028871|100451650|FG001|STARTED|Overall Study||12||
48053156|NCT02028871|100451649|FG000|COMPLETED|Overall Study||10||
48053157|NCT02028871|100451650|FG001|COMPLETED|Overall Study||9||
48053158|NCT02028871|100451649|FG000|NOT COMPLETED|Overall Study||4||
48053159|NCT02028871|100451650|FG001|NOT COMPLETED|Overall Study||3||
48053160|NCT03350984|100451651|FG000|STARTED|Overall Study||39||
48053161|NCT03350984|100451652|FG001|STARTED|Overall Study||36||
48053162|NCT03350984|100451651|FG000|COMPLETED|Overall Study||31||
48053163|NCT03350984|100451652|FG001|COMPLETED|Overall Study||28||
48053164|NCT03350984|100451651|FG000|NOT COMPLETED|Overall Study||8||
48053165|NCT03350984|100451652|FG001|NOT COMPLETED|Overall Study||8||
48053166|NCT02537574|100451653|FG000|STARTED|Overall Study||126||
48053167|NCT02537574|100451654|FG001|STARTED|Overall Study||126||
48053168|NCT02537574|100451655|FG002|STARTED|Overall Study||126||
48053169|NCT02537574|100451653|FG000|COMPLETED|Overall Study||27||
48053170|NCT02537574|100451654|FG001|COMPLETED|Overall Study||23||
48053171|NCT02537574|100451655|FG002|COMPLETED|Overall Study||18||
48053172|NCT02537574|100451653|FG000|NOT COMPLETED|Overall Study||99||
48053173|NCT02537574|100451654|FG001|NOT COMPLETED|Overall Study||103||
48053174|NCT02537574|100451655|FG002|NOT COMPLETED|Overall Study||108||
48053175|NCT02711345|100451656|FG000|STARTED|Overall Study||2||
48053176|NCT02711345|100451657|FG001|STARTED|Overall Study||3||
48053177|NCT02711345|100451658|FG002|STARTED|Overall Study||6||
48053178|NCT02711345|100451659|FG003|STARTED|Overall Study||4||
48053179|NCT02711345|100451660|FG004|STARTED|Overall Study||8||
48053180|NCT02711345|100451661|FG005|STARTED|Overall Study||6||
48053181|NCT02711345|100451662|FG006|STARTED|Overall Study||12||
48053182|NCT02711345|100451663|FG007|STARTED|Overall Study||6||
48053183|NCT02711345|100451664|FG008|STARTED|Overall Study||6||
48053184|NCT02711345|100451665|FG009|STARTED|Overall Study||12||
48053185|NCT02711345|100451656|FG000|COMPLETED|Overall Study||0||
48053186|NCT02711345|100451657|FG001|COMPLETED|Overall Study||0||
48053187|NCT02711345|100451658|FG002|COMPLETED|Overall Study||0||
48053188|NCT02711345|100451659|FG003|COMPLETED|Overall Study||0||
48053189|NCT02711345|100451660|FG004|COMPLETED|Overall Study||0||
48053190|NCT02711345|100451661|FG005|COMPLETED|Overall Study||0||
48053191|NCT02711345|100451662|FG006|COMPLETED|Overall Study||0||
48053192|NCT02711345|100451663|FG007|COMPLETED|Overall Study||0||
48053193|NCT02711345|100451664|FG008|COMPLETED|Overall Study||0||
48053194|NCT02711345|100451665|FG009|COMPLETED|Overall Study||0||
48053195|NCT02711345|100451656|FG000|NOT COMPLETED|Overall Study||2||
48053196|NCT02711345|100451657|FG001|NOT COMPLETED|Overall Study||3||
48053197|NCT02711345|100451658|FG002|NOT COMPLETED|Overall Study||6||
48053198|NCT02711345|100451659|FG003|NOT COMPLETED|Overall Study||4||
48053199|NCT02711345|100451660|FG004|NOT COMPLETED|Overall Study||8||
48053200|NCT02711345|100451661|FG005|NOT COMPLETED|Overall Study||6||
48053201|NCT02711345|100451662|FG006|NOT COMPLETED|Overall Study||12||
48053202|NCT02711345|100451663|FG007|NOT COMPLETED|Overall Study||6||
48053203|NCT02711345|100451664|FG008|NOT COMPLETED|Overall Study||6||
48053204|NCT02711345|100451665|FG009|NOT COMPLETED|Overall Study||12||
48053205|NCT01222403|100451666|FG000|STARTED|Overall Study||386||
48053206|NCT01222403|100451667|FG001|STARTED|Overall Study||381||
48053207|NCT01222403|100451666|FG000|COMPLETED|Overall Study||386||
48053208|NCT01222403|100451667|FG001|COMPLETED|Overall Study||379||
48053209|NCT01222403|100451666|FG000|NOT COMPLETED|Overall Study||0||
48053210|NCT01222403|100451667|FG001|NOT COMPLETED|Overall Study||2||
48053211|NCT01709578|100451668|FG000|STARTED|Overall Study||181||
48053212|NCT01709578|100451669|FG001|STARTED|Overall Study||181||
48053213|NCT01709578|100451670|FG002|STARTED|Overall Study||184||
48053214|NCT01709578|100451668|FG000|COMPLETED|Overall Study||101||
48053215|NCT01709578|100451669|FG001|COMPLETED|Overall Study||125||
48053216|NCT01709578|100451670|FG002|COMPLETED|Overall Study||133||
48053217|NCT01709578|100451668|FG000|NOT COMPLETED|Overall Study||80||
48053218|NCT01709578|100451669|FG001|NOT COMPLETED|Overall Study||56||
48053219|NCT01709578|100451670|FG002|NOT COMPLETED|Overall Study||51||
48053220|NCT02821910|100451671|FG000|STARTED|Overall Study||7||
48053221|NCT02821910|100451672|FG001|STARTED|Overall Study||8||
48053222|NCT02821910|100451673|FG002|STARTED|Overall Study||10||
48053223|NCT02821910|100451674|FG003|STARTED|Overall Study||10||
48053224|NCT02821910|100451675|FG004|STARTED|Overall Study||7||
48053225|NCT02821910|100451676|FG005|STARTED|Overall Study||8||
48053226|NCT02821910|100451671|FG000|COMPLETED|Overall Study||6||
48053227|NCT02821910|100451672|FG001|COMPLETED|Overall Study||8||
48053228|NCT02821910|100451673|FG002|COMPLETED|Overall Study||8||
48053229|NCT02821910|100451674|FG003|COMPLETED|Overall Study||10||
48053230|NCT02821910|100451675|FG004|COMPLETED|Overall Study||7||
48053231|NCT02821910|100451676|FG005|COMPLETED|Overall Study||7||
48053232|NCT02821910|100451671|FG000|NOT COMPLETED|Overall Study||1||
48053233|NCT02821910|100451672|FG001|NOT COMPLETED|Overall Study||0||
48053234|NCT02821910|100451673|FG002|NOT COMPLETED|Overall Study||2||
48208346|NCT02709655|100837032|FG003|Received at Least 1 Dose of Study Drug|Double-Blind Phase (8 Weeks)||153||
48208347|NCT02709655|100837033|FG004|Received at Least 1 Dose of Study Drug|Double-Blind Phase (8 Weeks)||83||
48495686|NCT00374231|101547910|FG000|STARTED|Overall Study||40||
48053235|NCT02821910|100451674|FG003|NOT COMPLETED|Overall Study||0||
48053236|NCT02821910|100451675|FG004|NOT COMPLETED|Overall Study||0||
48053237|NCT02821910|100451676|FG005|NOT COMPLETED|Overall Study||1||
48053238|NCT01298193|100451677|FG000|STARTED|Observational Phase (First Cycle)||212||
48053239|NCT01298193|100451677|FG000|COMPLETED|Observational Phase (First Cycle)||185||
48053240|NCT01298193|100451677|FG000|NOT COMPLETED|Observational Phase (First Cycle)||27||
48053241|NCT01298193|100451677|FG000|STARTED|Efficacy Phase (Second Cycle)||24||
48053242|NCT01298193|100451677|FG000|COMPLETED|Efficacy Phase (Second Cycle)||23||
48053243|NCT01298193|100451677|FG000|NOT COMPLETED|Efficacy Phase (Second Cycle)||1||
48053244|NCT00566501|100451678|FG000|STARTED|Overall Study||570||
48053245|NCT00566501|100451679|FG001|STARTED|Overall Study||332||
48053246|NCT00566501|100451678|FG000|COMPLETED|Overall Study||423||
48053247|NCT00566501|100451679|FG001|COMPLETED|Overall Study||210||
48053248|NCT00566501|100451678|FG000|NOT COMPLETED|Overall Study||147||
48053249|NCT00566501|100451679|FG001|NOT COMPLETED|Overall Study||122||
48053250|NCT02278471|100451680|FG000|STARTED|Overall Study||155||
48053251|NCT02278471|100451681|FG001|STARTED|Overall Study||148||
48053252|NCT02278471|100451680|FG000|COMPLETED|Overall Study||147||
48053253|NCT02278471|100451681|FG001|COMPLETED|Overall Study||128||
48053254|NCT02278471|100451680|FG000|NOT COMPLETED|Overall Study||8||
48053255|NCT02278471|100451681|FG001|NOT COMPLETED|Overall Study||20||
48053256|NCT03960554|100451682|FG000|STARTED|Overall Study||4||
48053257|NCT03960554|100451683|FG001|STARTED|Overall Study||4||
48053258|NCT03960554|100451682|FG000|COMPLETED|Overall Study||0||
48053259|NCT03960554|100451683|FG001|COMPLETED|Overall Study||0||
48053260|NCT03960554|100451682|FG000|NOT COMPLETED|Overall Study||4||
48053261|NCT03960554|100451683|FG001|NOT COMPLETED|Overall Study||4||
48053262|NCT00470158|100451684|FG000|STARTED|Overall Study||201||
48053263|NCT00470158|100451685|FG001|STARTED|Overall Study||199||
48495687|NCT00374231|101547910|FG000|COMPLETED|Overall Study||40||
48495688|NCT00374231|101547910|FG000|NOT COMPLETED|Overall Study||0||
48053264|NCT00470158|100451686|FG002|STARTED|Overall Study||201||
48053265|NCT00470158|100451687|FG003|STARTED|Overall Study||198||
48053266|NCT00470158|100451688|FG004|STARTED|Overall Study||201||
48053267|NCT00470158|100451684|FG000|COMPLETED|Overall Study||193||
48053268|NCT00470158|100451685|FG001|COMPLETED|Overall Study||191||
48053269|NCT00470158|100451686|FG002|COMPLETED|Overall Study||193||
48053270|NCT00470158|100451687|FG003|COMPLETED|Overall Study||193||
48053271|NCT00470158|100451688|FG004|COMPLETED|Overall Study||195||
48053272|NCT00470158|100451684|FG000|NOT COMPLETED|Overall Study||8||
48053273|NCT00470158|100451685|FG001|NOT COMPLETED|Overall Study||8||
48053274|NCT00470158|100451686|FG002|NOT COMPLETED|Overall Study||8||
48053275|NCT00470158|100451687|FG003|NOT COMPLETED|Overall Study||5||
48053276|NCT00470158|100451688|FG004|NOT COMPLETED|Overall Study||6||
48053277|NCT00920231|100451689|FG000|STARTED|Overall Study||8||
48495689|NCT05169710|101547911|FG000|STARTED|Overall Study||27||
48053278|NCT00920231|100451690|FG001|STARTED|Overall Study||8||
48053279|NCT00920231|100451689|FG000|COMPLETED|Overall Study||8||
48053280|NCT00920231|100451690|FG001|COMPLETED|Overall Study||8||
48053281|NCT00920231|100451689|FG000|NOT COMPLETED|Overall Study||0||
48053282|NCT00920231|100451690|FG001|NOT COMPLETED|Overall Study||0||
48053283|NCT01178073|100451691|FG000|STARTED|Overall Study||302||
48053284|NCT01178073|100451692|FG001|STARTED|Overall Study||152||
48053285|NCT01178073|100451693|FG002|STARTED|Overall Study||151||
48053286|NCT01178073|100451691|FG000|COMPLETED|Overall Study||240||
48053287|NCT01178073|100451692|FG001|COMPLETED|Overall Study||108||
48053288|NCT01178073|100451693|FG002|COMPLETED|Overall Study||105||
48053289|NCT01178073|100451691|FG000|NOT COMPLETED|Overall Study||62||
48053290|NCT01178073|100451692|FG001|NOT COMPLETED|Overall Study||44||
48053291|NCT01178073|100451693|FG002|NOT COMPLETED|Overall Study||46||
48053292|NCT03505671|100451694|FG000|STARTED|Overall Study||11||
48053293|NCT03505671|100451695|FG001|STARTED|Overall Study||12||
48053294|NCT03505671|100451694|FG000|COMPLETED|Overall Study||8||
48053295|NCT03505671|100451695|FG001|COMPLETED|Overall Study||11||
48053296|NCT03505671|100451694|FG000|NOT COMPLETED|Overall Study||3||
48053297|NCT03505671|100451695|FG001|NOT COMPLETED|Overall Study||1||
48053298|NCT03206073|100451696|FG000|STARTED|Overall Study||4||
48053299|NCT03206073|100451697|FG001|STARTED|Overall Study||12||
48053300|NCT03206073|100451698|FG002|STARTED|Overall Study||4||
48053301|NCT03206073|100451699|FG003|STARTED|Overall Study||14||
48053302|NCT03206073|100451696|FG000|COMPLETED|Overall Study||3||
48053303|NCT03206073|100451697|FG001|COMPLETED|Overall Study||11||
48053304|NCT03206073|100451698|FG002|COMPLETED|Overall Study||0||
48053305|NCT03206073|100451699|FG003|COMPLETED|Overall Study||14||
48053306|NCT03206073|100451696|FG000|NOT COMPLETED|Overall Study||1||
48053307|NCT03206073|100451697|FG001|NOT COMPLETED|Overall Study||1||
48053308|NCT03206073|100451698|FG002|NOT COMPLETED|Overall Study||4||
48053309|NCT03206073|100451699|FG003|NOT COMPLETED|Overall Study||0||
48053310|NCT00046891|100451700|FG000|STARTED|Overall Study||113||
48053311|NCT00046891|100451701|FG001|STARTED|Overall Study||113||
48053312|NCT00046891|100451700|FG000|COMPLETED|Overall Study||84||
48053313|NCT00046891|100451701|FG001|COMPLETED|Overall Study||83||
48053314|NCT00046891|100451700|FG000|NOT COMPLETED|Overall Study||29||
48053315|NCT00046891|100451701|FG001|NOT COMPLETED|Overall Study||30||
48053316|NCT01903525|100451702|FG000|STARTED|Overall Study||20||
48053317|NCT01903525|100451703|FG001|STARTED|Overall Study||20||
48053318|NCT01903525|100451702|FG000|COMPLETED|Overall Study||15||
48053319|NCT01903525|100451703|FG001|COMPLETED|Overall Study||10||
48053320|NCT01903525|100451702|FG000|NOT COMPLETED|Overall Study||5||
48053321|NCT01903525|100451703|FG001|NOT COMPLETED|Overall Study||10||
48053322|NCT00450112|100451704|FG000|STARTED|Overall Study||125||
48053323|NCT00450112|100451705|FG001|STARTED|Overall Study||77||
48053324|NCT00450112|100451704|FG000|Received Injection|Overall Study||125||
48053325|NCT00450112|100451705|FG001|Received Injection|Overall Study||74||
48053326|NCT00450112|100451704|FG000|Analyzed Participants|Overall Study||122||
48053327|NCT00450112|100451705|FG001|Analyzed Participants|Overall Study||74||
48053328|NCT00450112|100451704|FG000|COMPLETED|Overall Study||112||
48053329|NCT00450112|100451705|FG001|COMPLETED|Overall Study||71||
48053330|NCT00450112|100451704|FG000|NOT COMPLETED|Overall Study||13||
48053331|NCT00450112|100451705|FG001|NOT COMPLETED|Overall Study||6||
48053332|NCT01515540|100451706|FG000|STARTED|Overall Study||20||
48053333|NCT01515540|100451707|FG001|STARTED|Overall Study||18||
48053334|NCT01515540|100451706|FG000|COMPLETED|Overall Study||15||
48053335|NCT01515540|100451707|FG001|COMPLETED|Overall Study||15||
48053336|NCT01515540|100451706|FG000|NOT COMPLETED|Overall Study||5||
48053337|NCT01515540|100451707|FG001|NOT COMPLETED|Overall Study||3||
48053338|NCT03224546|100451708|FG000|STARTED|Overall Study||42||
48053339|NCT03224546|100451709|FG001|STARTED|Overall Study||41||
48053340|NCT03224546|100451710|FG002|STARTED|Overall Study||44||
48053341|NCT03224546|100451708|FG000|COMPLETED|Overall Study||26||
48495690|NCT05169710|101547912|FG001|STARTED|Overall Study||27||
48495691|NCT05169710|101547913|FG002|STARTED|Overall Study||28||
48053342|NCT03224546|100451709|FG001|COMPLETED|Overall Study||19||
48053343|NCT03224546|100451710|FG002|COMPLETED|Overall Study||29||
48053344|NCT03224546|100451708|FG000|NOT COMPLETED|Overall Study||16||
48053345|NCT03224546|100451709|FG001|NOT COMPLETED|Overall Study||22||
48053346|NCT03224546|100451710|FG002|NOT COMPLETED|Overall Study||15||
48053347|NCT03577171|100451711|FG000|STARTED|Overall Study||13||
48053348|NCT03577171|100451712|FG001|STARTED|Overall Study||12||
48053349|NCT03577171|100451711|FG000|COMPLETED|Overall Study||13||
48053350|NCT03577171|100451712|FG001|COMPLETED|Overall Study||12||
48053351|NCT03577171|100451711|FG000|NOT COMPLETED|Overall Study||0||
48053352|NCT03577171|100451712|FG001|NOT COMPLETED|Overall Study||0||
48053353|NCT01617148|100451713|FG000|STARTED|Overall Study||26||
48053354|NCT01617148|100451713|FG000|COMPLETED|Overall Study||26||
48053355|NCT01617148|100451713|FG000|NOT COMPLETED|Overall Study||0||
48053356|NCT00926588|100451714|FG000|STARTED|Overall Study||124||
48053357|NCT00926588|100451715|FG001|STARTED|Overall Study||126||
48053358|NCT00926588|100451714|FG000|COMPLETED|Overall Study||116||
48053359|NCT00926588|100451715|FG001|COMPLETED|Overall Study||122||
48053360|NCT00926588|100451714|FG000|NOT COMPLETED|Overall Study||8||
48495692|NCT05169710|101547911|FG000|COMPLETED|Overall Study||24||
48053361|NCT00926588|100451715|FG001|NOT COMPLETED|Overall Study||4||
48053362|NCT03727373|100451716|FG000|STARTED|Overall Study||8||
48053363|NCT03727373|100451716|FG000|COMPLETED|Overall Study||8||
48053364|NCT03727373|100451716|FG000|NOT COMPLETED|Overall Study||0||
48053365|NCT02285283|100451717|FG000|STARTED|Overall Study||29||
48053366|NCT02285283|100451718|FG001|STARTED|Overall Study||29||
48053367|NCT02285283|100451717|FG000|COMPLETED|Overall Study||25||
48053368|NCT02285283|100451718|FG001|COMPLETED|Overall Study||20||
48053369|NCT02285283|100451717|FG000|NOT COMPLETED|Overall Study||4||
48053370|NCT02285283|100451718|FG001|NOT COMPLETED|Overall Study||9||
48053371|NCT01490788|100451719|FG000|STARTED|Overall Study||5||
48053372|NCT01490788|100451720|FG001|STARTED|Overall Study||5||
48053373|NCT01490788|100451721|FG002|STARTED|Overall Study||5||
48053374|NCT01490788|100451722|FG003|STARTED|Overall Study||5||
48053375|NCT01490788|100451723|FG004|STARTED|Overall Study||5||
48053376|NCT01490788|100451724|FG005|STARTED|Overall Study||5||
48053377|NCT01490788|100451719|FG000|COMPLETED|Overall Study||4||
48053378|NCT01490788|100451720|FG001|COMPLETED|Overall Study||5||
48053379|NCT01490788|100451721|FG002|COMPLETED|Overall Study||5||
48053380|NCT01490788|100451722|FG003|COMPLETED|Overall Study||5||
48053381|NCT01490788|100451723|FG004|COMPLETED|Overall Study||5||
48053382|NCT01490788|100451724|FG005|COMPLETED|Overall Study||5||
48053383|NCT01490788|100451719|FG000|NOT COMPLETED|Overall Study||1||
48053384|NCT01490788|100451720|FG001|NOT COMPLETED|Overall Study||0||
48053385|NCT01490788|100451721|FG002|NOT COMPLETED|Overall Study||0||
48053386|NCT01490788|100451722|FG003|NOT COMPLETED|Overall Study||0||
48053387|NCT01490788|100451723|FG004|NOT COMPLETED|Overall Study||0||
48053388|NCT01490788|100451724|FG005|NOT COMPLETED|Overall Study||0||
48053389|NCT02310321|100451725|FG000|STARTED|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)||3||
48053390|NCT02310321|100451726|FG001|STARTED|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)||0||
48053391|NCT02310321|100451727|FG002|STARTED|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)||0||
48053392|NCT02310321|100451725|FG000|COMPLETED|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)||2||
48053393|NCT02310321|100451726|FG001|COMPLETED|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)||0||
48053394|NCT02310321|100451727|FG002|COMPLETED|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)||0||
48053395|NCT02310321|100451725|FG000|NOT COMPLETED|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)||1||
48053396|NCT02310321|100451726|FG001|NOT COMPLETED|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)||0||
48053397|NCT02310321|100451727|FG002|NOT COMPLETED|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)||0||
48053398|NCT02310321|100451725|FG000|STARTED|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)||2||
48053399|NCT02310321|100451726|FG001|STARTED|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)||0||
48053400|NCT02310321|100451727|FG002|STARTED|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)||0||
48053401|NCT02310321|100451725|FG000|COMPLETED|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)||1||
48053402|NCT02310321|100451726|FG001|COMPLETED|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)||0||
48053403|NCT02310321|100451727|FG002|COMPLETED|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)||0||
48053404|NCT02310321|100451725|FG000|NOT COMPLETED|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)||1||
48053405|NCT02310321|100451726|FG001|NOT COMPLETED|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)||0||
48053406|NCT02310321|100451727|FG002|NOT COMPLETED|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)||0||
48053407|NCT02310321|100451725|FG000|STARTED|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)||1||
48053408|NCT02310321|100451726|FG001|STARTED|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)||0||
48053409|NCT02310321|100451727|FG002|STARTED|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)||0||
48053410|NCT02310321|100451725|FG000|COMPLETED|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)||0||
48053411|NCT02310321|100451726|FG001|COMPLETED|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)||0||
48053412|NCT02310321|100451727|FG002|COMPLETED|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)||0||
48053413|NCT02310321|100451725|FG000|NOT COMPLETED|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)||1||
48053414|NCT02310321|100451726|FG001|NOT COMPLETED|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)||0||
48053415|NCT02310321|100451727|FG002|NOT COMPLETED|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)||0||
48053416|NCT02310321|100451725|FG000|STARTED|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)||0||
48053417|NCT02310321|100451726|FG001|STARTED|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)||10||
48053418|NCT02310321|100451727|FG002|STARTED|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)||0||
48053419|NCT02310321|100451725|FG000|COMPLETED|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)||0||
48053420|NCT02310321|100451726|FG001|COMPLETED|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)||3||
48053421|NCT02310321|100451727|FG002|COMPLETED|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)||0||
48053422|NCT02310321|100451725|FG000|NOT COMPLETED|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)||0||
48053423|NCT02310321|100451726|FG001|NOT COMPLETED|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)||7||
48053424|NCT02310321|100451727|FG002|NOT COMPLETED|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)||0||
48053425|NCT02310321|100451725|FG000|STARTED|Phase 1(DEx):CP (3 Cycles;28 Days/Cycle)||0||
48053426|NCT02310321|100451726|FG001|STARTED|Phase 1(DEx):CP (3 Cycles;28 Days/Cycle)||3||
48053427|NCT02310321|100451727|FG002|STARTED|Phase 1(DEx):CP (3 Cycles;28 Days/Cycle)||0||
48053428|NCT02310321|100451725|FG000|COMPLETED|Phase 1(DEx):CP (3 Cycles;28 Days/Cycle)||0||
48053429|NCT02310321|100451726|FG001|COMPLETED|Phase 1(DEx):CP (3 Cycles;28 Days/Cycle)||3||
48053430|NCT02310321|100451727|FG002|COMPLETED|Phase 1(DEx):CP (3 Cycles;28 Days/Cycle)||0||
48053431|NCT02310321|100451725|FG000|NOT COMPLETED|Phase 1(DEx):CP (3 Cycles;28 Days/Cycle)||0||
48053432|NCT02310321|100451726|FG001|NOT COMPLETED|Phase 1(DEx):CP (3 Cycles;28 Days/Cycle)||0||
48053433|NCT02310321|100451727|FG002|NOT COMPLETED|Phase 1(DEx):CP (3 Cycles;28 Days/Cycle)||0||
48053434|NCT02310321|100451725|FG000|STARTED|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)||0||
48053435|NCT02310321|100451726|FG001|STARTED|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)||3||
48053436|NCT02310321|100451727|FG002|STARTED|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)||0||
48053437|NCT02310321|100451725|FG000|COMPLETED|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)||0||
48053438|NCT02310321|100451726|FG001|COMPLETED|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)||0||
48053439|NCT02310321|100451727|FG002|COMPLETED|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)||0||
48053440|NCT02310321|100451725|FG000|NOT COMPLETED|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)||0||
48053441|NCT02310321|100451726|FG001|NOT COMPLETED|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)||3||
48053442|NCT02310321|100451727|FG002|NOT COMPLETED|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)||0||
48053443|NCT02310321|100451725|FG000|STARTED|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)||0||
48053444|NCT02310321|100451726|FG001|STARTED|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)||0||
48053445|NCT02310321|100451727|FG002|STARTED|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)||84||
48053446|NCT02310321|100451725|FG000|COMPLETED|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)||0||
48053447|NCT02310321|100451726|FG001|COMPLETED|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)||0||
48053448|NCT02310321|100451727|FG002|COMPLETED|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)||62||
48053449|NCT02310321|100451725|FG000|NOT COMPLETED|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)||0||
48053450|NCT02310321|100451726|FG001|NOT COMPLETED|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)||0||
48053451|NCT02310321|100451727|FG002|NOT COMPLETED|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)||22||
48053452|NCT02310321|100451725|FG000|STARTED|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)||0||
48053453|NCT02310321|100451726|FG001|STARTED|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)||0||
48053454|NCT02310321|100451727|FG002|STARTED|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)||57||
48053455|NCT02310321|100451725|FG000|COMPLETED|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)||0||
48053456|NCT02310321|100451726|FG001|COMPLETED|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)||0||
48053457|NCT02310321|100451727|FG002|COMPLETED|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)||32||
48053458|NCT02310321|100451725|FG000|NOT COMPLETED|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)||0||
48053459|NCT02310321|100451726|FG001|NOT COMPLETED|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)||0||
48053460|NCT02310321|100451727|FG002|NOT COMPLETED|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)||25||
48053461|NCT02310321|100451725|FG000|STARTED|Phase 2:MP(26 Cycles; 28 Days/Cycle)||0||
48053462|NCT02310321|100451726|FG001|STARTED|Phase 2:MP(26 Cycles; 28 Days/Cycle)||0||
48053463|NCT02310321|100451727|FG002|STARTED|Phase 2:MP(26 Cycles; 28 Days/Cycle)||28||
48053464|NCT02310321|100451725|FG000|COMPLETED|Phase 2:MP(26 Cycles; 28 Days/Cycle)||0||
48053465|NCT02310321|100451726|FG001|COMPLETED|Phase 2:MP(26 Cycles; 28 Days/Cycle)||0||
48053466|NCT02310321|100451727|FG002|COMPLETED|Phase 2:MP(26 Cycles; 28 Days/Cycle)||0||
48053467|NCT02310321|100451725|FG000|NOT COMPLETED|Phase 2:MP(26 Cycles; 28 Days/Cycle)||0||
48053468|NCT02310321|100451726|FG001|NOT COMPLETED|Phase 2:MP(26 Cycles; 28 Days/Cycle)||0||
48053469|NCT02310321|100451727|FG002|NOT COMPLETED|Phase 2:MP(26 Cycles; 28 Days/Cycle)||28||
48053470|NCT03418571|100451728|FG000|STARTED|Overall Study||12||
48053471|NCT03418571|100451729|FG001|STARTED|Overall Study||3||
48053472|NCT03418571|100451728|FG000|COMPLETED|Overall Study||11||
48053473|NCT03418571|100451729|FG001|COMPLETED|Overall Study||3||
48053474|NCT03418571|100451728|FG000|NOT COMPLETED|Overall Study||1||
48053475|NCT03418571|100451729|FG001|NOT COMPLETED|Overall Study||0||
48053476|NCT02452697|100451730|FG000|STARTED|Overall Study||14||
48053477|NCT02452697|100451731|FG001|STARTED|Overall Study||11||
48053478|NCT02452697|100451732|FG002|STARTED|Overall Study||4||
48053479|NCT02452697|100451733|FG003|STARTED|Overall Study||7||
48053480|NCT02452697|100451730|FG000|COMPLETED|Overall Study||7||
48053481|NCT02452697|100451731|FG001|COMPLETED|Overall Study||5||
48053482|NCT02452697|100451732|FG002|COMPLETED|Overall Study||0||
48053483|NCT02452697|100451733|FG003|COMPLETED|Overall Study||2||
48053484|NCT02452697|100451730|FG000|NOT COMPLETED|Overall Study||7||
48053485|NCT02452697|100451731|FG001|NOT COMPLETED|Overall Study||6||
48053486|NCT02452697|100451732|FG002|NOT COMPLETED|Overall Study||4||
48053487|NCT02452697|100451733|FG003|NOT COMPLETED|Overall Study||5||
48053488|NCT02651714|100451734|FG000|STARTED|Overall Study||84||
48053489|NCT02651714|100451735|FG001|STARTED|Overall Study||84||
48053490|NCT02651714|100451734|FG000|COMPLETED|Overall Study||59||
48053491|NCT02651714|100451735|FG001|COMPLETED|Overall Study||56||
48053492|NCT02651714|100451734|FG000|NOT COMPLETED|Overall Study||25||
48053493|NCT02651714|100451735|FG001|NOT COMPLETED|Overall Study||28||
48053494|NCT00427960|100451736|FG000|STARTED|Overall Study||30||
48053495|NCT00427960|100451737|FG001|STARTED|Overall Study||25||
48495693|NCT05169710|101547912|FG001|COMPLETED|Overall Study||22||
48053496|NCT00427960|100451736|FG000|COMPLETED|Overall Study||28||
48495694|NCT05169710|101547913|FG002|COMPLETED|Overall Study||25||
48495695|NCT05169710|101547911|FG000|NOT COMPLETED|Overall Study||3||
48495696|NCT05169710|101547912|FG001|NOT COMPLETED|Overall Study||5||
48495697|NCT05169710|101547913|FG002|NOT COMPLETED|Overall Study||3||
48495698|NCT03272685|101547914|FG000|STARTED|Overall Study||220||
48053497|NCT00427960|100451737|FG001|COMPLETED|Overall Study||21||
48053498|NCT00427960|100451736|FG000|NOT COMPLETED|Overall Study||2||
48053499|NCT00427960|100451737|FG001|NOT COMPLETED|Overall Study||4||
48053500|NCT01711879|100451738|FG000|STARTED|Overall Study||3||
48053501|NCT01711879|100451739|FG001|STARTED|Overall Study||4||
48053502|NCT01711879|100451738|FG000|COMPLETED|Overall Study||2||
48053503|NCT01711879|100451739|FG001|COMPLETED|Overall Study||4||
48053504|NCT01711879|100451738|FG000|NOT COMPLETED|Overall Study||1||
48053505|NCT01711879|100451739|FG001|NOT COMPLETED|Overall Study||0||
48053506|NCT00306202|100451740|FG000|STARTED|Overall Study||17||
48053507|NCT00306202|100451741|FG001|STARTED|Overall Study||17||
48053508|NCT00306202|100451742|FG002|STARTED|Overall Study||24||
48053509|NCT00306202|100451740|FG000|COMPLETED|Overall Study||17||
48053510|NCT00306202|100451741|FG001|COMPLETED|Overall Study||17||
48053511|NCT00306202|100451742|FG002|COMPLETED|Overall Study||24||
48053512|NCT00306202|100451740|FG000|NOT COMPLETED|Overall Study||0||
48053513|NCT00306202|100451741|FG001|NOT COMPLETED|Overall Study||0||
48053514|NCT00306202|100451742|FG002|NOT COMPLETED|Overall Study||0||
48053515|NCT05442775|100451743|FG000|STARTED|Overall Study||71||
48053516|NCT05442775|100451743|FG000|COMPLETED|Overall Study||0||
48053517|NCT05442775|100451743|FG000|NOT COMPLETED|Overall Study||71||
48053518|NCT00679055|100451744|FG000|STARTED|Overall Study||8||
48053519|NCT00679055|100451745|FG001|STARTED|Overall Study||6||
48053520|NCT00679055|100451744|FG000|COMPLETED|Overall Study||6||
48053521|NCT00679055|100451745|FG001|COMPLETED|Overall Study||1||
48053522|NCT00679055|100451744|FG000|NOT COMPLETED|Overall Study||2||
48053523|NCT00679055|100451745|FG001|NOT COMPLETED|Overall Study||5||
48053524|NCT02445391|100451746|FG000|STARTED|Overall Study||3|All patients who were randomized to one of the three arms in the trial throughout the accrual period between April 2015 and March 2021.|
48053525|NCT02445391|100451747|FG001|STARTED|Overall Study||199|All patients who were randomized to one of the three arms in the trial throughout the accrual period between April 2015 and March 2021.|
48053526|NCT02445391|100451748|FG002|STARTED|Overall Study||213|All patients who were randomized to one of the three arms in the trial throughout the accrual period between April 2015 and March 2021.|
48053527|NCT02445391|100451746|FG000|Concurrently Randomized to Arms B and C|Overall Study||0||
48053528|NCT02445391|100451747|FG001|Concurrently Randomized to Arms B and C|Overall Study||197||
48053529|NCT02445391|100451748|FG002|Concurrently Randomized to Arms B and C|Overall Study||213||
48053530|NCT02445391|100451746|FG000|Concurrently Randomized to Arms A and B|Overall Study||3||
48053531|NCT02445391|100451747|FG001|Concurrently Randomized to Arms A and B|Overall Study||2||
48053532|NCT02445391|100451748|FG002|Concurrently Randomized to Arms A and B|Overall Study||0||
48053533|NCT02445391|100451746|FG000|Started Protocol Therapy|Overall Study||0||
48053534|NCT02445391|100451747|FG001|Started Protocol Therapy|Overall Study||187||
48053535|NCT02445391|100451748|FG002|Started Protocol Therapy|Overall Study||204||
48053536|NCT02445391|100451746|FG000|Reported Treatment Data|Overall Study||0||
48053537|NCT02445391|100451747|FG001|Reported Treatment Data|Overall Study||185||
48053538|NCT02445391|100451748|FG002|Reported Treatment Data|Overall Study||199||
48053539|NCT02445391|100451746|FG000|Reported Adverse Event Data|Overall Study||0|This is the analysis population for adverse event outcomes|
48053540|NCT02445391|100451747|FG001|Reported Adverse Event Data|Overall Study||186|This is the analysis population for adverse event outcomes|
48053541|NCT02445391|100451748|FG002|Reported Adverse Event Data|Overall Study||201|This is the analysis population for adverse event outcomes|
48053542|NCT02445391|100451746|FG000|Reported Mortality Data|Overall Study||3||
48053543|NCT02445391|100451747|FG001|Reported Mortality Data|Overall Study||199||
48053544|NCT02445391|100451748|FG002|Reported Mortality Data|Overall Study||213||
48053545|NCT02445391|100451746|FG000|Basal-subtype Disease|Overall Study||3||
48053546|NCT02445391|100451747|FG001|Basal-subtype Disease|Overall Study||150||
48053547|NCT02445391|100451748|FG002|Basal-subtype Disease|Overall Study||160||
48053548|NCT02445391|100451746|FG000|Basal-subtype Disease Randomized After 6/22/2016|Overall Study||0|This is the primary analysis population for IDFS (primary endpoint) and OS and RFS (secondary endpoints).|
48053549|NCT02445391|100451747|FG001|Basal-subtype Disease Randomized After 6/22/2016|Overall Study||148|This is the primary analysis population for IDFS (primary endpoint) and OS and RFS (secondary endpoints).|
48053550|NCT02445391|100451748|FG002|Basal-subtype Disease Randomized After 6/22/2016|Overall Study||160|This is the primary analysis population for IDFS (primary endpoint) and OS and RFS (secondary endpoints).|
48053551|NCT02445391|100451746|FG000|Non Basal-subtype Disease|Overall Study||0|Intrinsic subtype was added as a stratification factor in amendment #3 (activated on 6/22/2016), all eligible patients regardless of intrinsic subtype were randomized to arms B and C|
48053552|NCT02445391|100451747|FG001|Non Basal-subtype Disease|Overall Study||42|Intrinsic subtype was added as a stratification factor in amendment #3 (activated on 6/22/2016), all eligible patients regardless of intrinsic subtype were randomized to arms B and C|
48053553|NCT02445391|100451748|FG002|Non Basal-subtype Disease|Overall Study||46|Intrinsic subtype was added as a stratification factor in amendment #3 (activated on 6/22/2016), all eligible patients regardless of intrinsic subtype were randomized to arms B and C|
48053554|NCT02445391|100451746|FG000|Intrinsic Subtype Unknown|Overall Study||0|In amendment #7 (activated in Nov 2020), intrinsic subtype was removed as a stratification factor, all patients were randomized to arms B and C as long as they submitted tumor specimen for PAM50 test. Intrinsic subtype was not known at randomization. At the time of the final analysis, intrinsic subtype was still pending for these patients.|
48053555|NCT02445391|100451747|FG001|Intrinsic Subtype Unknown|Overall Study||7|In amendment #7 (activated in Nov 2020), intrinsic subtype was removed as a stratification factor, all patients were randomized to arms B and C as long as they submitted tumor specimen for PAM50 test. Intrinsic subtype was not known at randomization. At the time of the final analysis, intrinsic subtype was still pending for these patients.|
48053556|NCT02445391|100451748|FG002|Intrinsic Subtype Unknown|Overall Study||7|In amendment #7 (activated in Nov 2020), intrinsic subtype was removed as a stratification factor, all patients were randomized to arms B and C as long as they submitted tumor specimen for PAM50 test. Intrinsic subtype was not known at randomization. At the time of the final analysis, intrinsic subtype was still pending for these patients.|
48053557|NCT02445391|100451746|FG000|Reported Health-related Quality of Life Data at 6 Months Assessment|Overall Study||0||
48053558|NCT02445391|100451747|FG001|Reported Health-related Quality of Life Data at 6 Months Assessment|Overall Study||69||
48053559|NCT02445391|100451748|FG002|Reported Health-related Quality of Life Data at 6 Months Assessment|Overall Study||84||
48053560|NCT02445391|100451746|FG000|Reported Health-related Quality of Life Data at 15 Months Assessment|Overall Study||0||
48053561|NCT02445391|100451747|FG001|Reported Health-related Quality of Life Data at 15 Months Assessment|Overall Study||37||
48053562|NCT02445391|100451748|FG002|Reported Health-related Quality of Life Data at 15 Months Assessment|Overall Study||54||
48053563|NCT02445391|100451746|FG000|COMPLETED|Overall Study||0||
48053564|NCT02445391|100451747|FG001|COMPLETED|Overall Study||146||
48053565|NCT02445391|100451748|FG002|COMPLETED|Overall Study||141||
48053566|NCT02445391|100451746|FG000|NOT COMPLETED|Overall Study||3||
48053567|NCT02445391|100451747|FG001|NOT COMPLETED|Overall Study||53||
48053568|NCT02445391|100451748|FG002|NOT COMPLETED|Overall Study||72||
48053569|NCT01545843|100451749|FG000|STARTED|Overall Study||19||
48053570|NCT01545843|100451750|FG001|STARTED|Overall Study||24||
48053571|NCT01545843|100451751|FG002|STARTED|Overall Study||25||
48053572|NCT01545843|100451749|FG000|COMPLETED|Overall Study||16||
48053573|NCT01545843|100451750|FG001|COMPLETED|Overall Study||17||
48053574|NCT01545843|100451751|FG002|COMPLETED|Overall Study||21||
48053575|NCT01545843|100451749|FG000|NOT COMPLETED|Overall Study||3||
48053576|NCT01545843|100451750|FG001|NOT COMPLETED|Overall Study||7||
48053577|NCT01545843|100451751|FG002|NOT COMPLETED|Overall Study||4||
48053578|NCT00901927|100451752|FG000|STARTED|Overall Study||14||
48053579|NCT00901927|100451752|FG000|COMPLETED|Overall Study||8||
48053580|NCT00901927|100451752|FG000|NOT COMPLETED|Overall Study||6||
48053581|NCT02519387|100451753|FG000|STARTED|Overall Study||78||
48053582|NCT02519387|100451753|FG000|COMPLETED|Overall Study||56||
48053583|NCT02519387|100451753|FG000|NOT COMPLETED|Overall Study||22||
48053584|NCT00568685|100451754|FG000|STARTED|Overall Study||51||
48053585|NCT00568685|100451755|FG001|STARTED|Overall Study||51||
48053586|NCT00568685|100451756|FG002|STARTED|Overall Study||51||
48053587|NCT00568685|100451754|FG000|COMPLETED|Overall Study||41||
48053588|NCT00568685|100451755|FG001|COMPLETED|Overall Study||46||
48053589|NCT00568685|100451756|FG002|COMPLETED|Overall Study||46||
48053590|NCT00568685|100451754|FG000|NOT COMPLETED|Overall Study||10||
48053591|NCT00568685|100451755|FG001|NOT COMPLETED|Overall Study||5||
48053592|NCT00568685|100451756|FG002|NOT COMPLETED|Overall Study||5||
48053593|NCT00413166|100451757|FG000|STARTED|Overall Study||57||
48053594|NCT00413166|100451758|FG001|STARTED|Overall Study||5||
48053595|NCT00413166|100451759|FG002|STARTED|Overall Study||16||
48053596|NCT00413166|100451757|FG000|COMPLETED|Overall Study||57||
48053597|NCT00413166|100451758|FG001|COMPLETED|Overall Study||5||
48053598|NCT00413166|100451759|FG002|COMPLETED|Overall Study||16||
48053599|NCT00413166|100451757|FG000|NOT COMPLETED|Overall Study||0||
48053600|NCT00413166|100451758|FG001|NOT COMPLETED|Overall Study||0||
48053601|NCT00413166|100451759|FG002|NOT COMPLETED|Overall Study||0||
48053602|NCT02037607|100451760|FG000|STARTED|Overall Study||100||
48053603|NCT02037607|100451760|FG000|COMPLETED|Overall Study||91||
48053604|NCT02037607|100451760|FG000|NOT COMPLETED|Overall Study||9||
48053605|NCT00301821|100451761|FG000|STARTED|Overall Study||107||
48053606|NCT00301821|100451761|FG000|COMPLETED|Overall Study||81||
48053607|NCT00301821|100451761|FG000|NOT COMPLETED|Overall Study||26||
48053608|NCT02354482|100451762|FG000|STARTED|Patient Communication and Care||2158||
48053609|NCT02354482|100451762|FG000|COMPLETED|Patient Communication and Care||2158||
48053610|NCT02354482|100451762|FG000|NOT COMPLETED|Patient Communication and Care||0||
48053611|NCT02354482|100451762|FG000|STARTED|Home-Based Trust and Plain Language||1979||
48053612|NCT02354482|100451762|FG000|COMPLETED|Home-Based Trust and Plain Language||1979||
48053613|NCT02354482|100451762|FG000|NOT COMPLETED|Home-Based Trust and Plain Language||0||
48053614|NCT02354482|100451762|FG000|STARTED|Hospital-Based Trust and Plain Language||2090||
48053615|NCT02354482|100451762|FG000|COMPLETED|Hospital-Based Trust and Plain Language||2090||
48053616|NCT02354482|100451762|FG000|NOT COMPLETED|Hospital-Based Trust and Plain Language||0||
48053617|NCT02354482|100451762|FG000|STARTED|Patient/Family Caregiver Assessment||3093||
48053618|NCT02354482|100451762|FG000|COMPLETED|Patient/Family Caregiver Assessment||3093||
48053619|NCT02354482|100451762|FG000|NOT COMPLETED|Patient/Family Caregiver Assessment||0||
48053620|NCT02354482|100451762|FG000|STARTED|Assessment and Teach Back||508||
48053621|NCT02354482|100451762|FG000|COMPLETED|Assessment and Teach Back||508||
48053622|NCT02354482|100451762|FG000|NOT COMPLETED|Assessment and Teach Back||0||
48053623|NCT02354482|100451762|FG000|STARTED|Reference||2042||
48053624|NCT02354482|100451762|FG000|COMPLETED|Reference||2042||
48053625|NCT02354482|100451762|FG000|NOT COMPLETED|Reference||0||
48053626|NCT00597701|100451763|FG000|STARTED|Overall Study||25||
48053627|NCT00597701|100451764|FG001|STARTED|Overall Study||21||
48053628|NCT00597701|100451763|FG000|COMPLETED|Overall Study||18||
48053629|NCT00597701|100451764|FG001|COMPLETED|Overall Study||13||
48053630|NCT00597701|100451763|FG000|NOT COMPLETED|Overall Study||7||
48053631|NCT00597701|100451764|FG001|NOT COMPLETED|Overall Study||8||
48053632|NCT00144027|100451765|FG000|STARTED|Overall Study||39||
48053633|NCT00144027|100451766|FG001|STARTED|Overall Study||36||
48053634|NCT00144027|100451765|FG000|Completed Baseline Assessment|Overall Study||39||
48053635|NCT00144027|100451766|FG001|Completed Baseline Assessment|Overall Study||29||
48053636|NCT00144027|100451765|FG000|Completed 6 Month Assessment|Overall Study||37||
48053637|NCT00144027|100451766|FG001|Completed 6 Month Assessment|Overall Study||24||
48053638|NCT00144027|100451765|FG000|COMPLETED|Overall Study||36||
48053639|NCT00144027|100451766|FG001|COMPLETED|Overall Study||25||
48053640|NCT00144027|100451765|FG000|NOT COMPLETED|Overall Study||3||
48053641|NCT00144027|100451766|FG001|NOT COMPLETED|Overall Study||11||
48053642|NCT01464723|100451767|FG000|STARTED|Overall Study||0||
48053643|NCT01464723|100451767|FG000|COMPLETED|Overall Study||0||
48053644|NCT01464723|100451767|FG000|NOT COMPLETED|Overall Study||0||
48053645|NCT03101267|100451768|FG000|STARTED|Primary Study Period||50||
48053646|NCT03101267|100451769|FG001|STARTED|Primary Study Period||50||
48053647|NCT03101267|100451770|FG002|STARTED|Primary Study Period||50||
48053648|NCT03101267|100451768|FG000|COMPLETED|Primary Study Period||47||
48053649|NCT03101267|100451769|FG001|COMPLETED|Primary Study Period||48||
48053650|NCT03101267|100451770|FG002|COMPLETED|Primary Study Period||47||
48053651|NCT03101267|100451768|FG000|NOT COMPLETED|Primary Study Period||3||
48053652|NCT03101267|100451769|FG001|NOT COMPLETED|Primary Study Period||2||
48053653|NCT03101267|100451770|FG002|NOT COMPLETED|Primary Study Period||3||
48053654|NCT03101267|100451768|FG000|STARTED|Pollinosis Symptoms Survey Period||47||
48053655|NCT03101267|100451769|FG001|STARTED|Pollinosis Symptoms Survey Period||48||
48053656|NCT03101267|100451770|FG002|STARTED|Pollinosis Symptoms Survey Period||47||
48053657|NCT03101267|100451768|FG000|COMPLETED|Pollinosis Symptoms Survey Period||47||
48053658|NCT03101267|100451769|FG001|COMPLETED|Pollinosis Symptoms Survey Period||48||
48053659|NCT03101267|100451770|FG002|COMPLETED|Pollinosis Symptoms Survey Period||47||
48053660|NCT03101267|100451768|FG000|NOT COMPLETED|Pollinosis Symptoms Survey Period||0||
48053661|NCT03101267|100451769|FG001|NOT COMPLETED|Pollinosis Symptoms Survey Period||0||
48053662|NCT03101267|100451770|FG002|NOT COMPLETED|Pollinosis Symptoms Survey Period||0||
48053663|NCT01361854|100451771|FG000|STARTED|Day 1||51||
48053664|NCT01361854|100451772|FG001|STARTED|Day 1||51||
48053665|NCT01361854|100451771|FG000|COMPLETED|Day 1||47||
48053666|NCT01361854|100451772|FG001|COMPLETED|Day 1||48||
48053667|NCT01361854|100451771|FG000|NOT COMPLETED|Day 1||4||
48053668|NCT01361854|100451772|FG001|NOT COMPLETED|Day 1||3||
48053669|NCT01361854|100451771|FG000|STARTED|Wash-out, Maximum 2 Weeks||47||
48053670|NCT01361854|100451772|FG001|STARTED|Wash-out, Maximum 2 Weeks||48||
48053671|NCT01361854|100451771|FG000|COMPLETED|Wash-out, Maximum 2 Weeks||47||
48053672|NCT01361854|100451772|FG001|COMPLETED|Wash-out, Maximum 2 Weeks||48||
48053673|NCT01361854|100451771|FG000|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0||
48053674|NCT01361854|100451772|FG001|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0||
48053675|NCT01361854|100451771|FG000|STARTED|Second Intervention||47||
48053676|NCT01361854|100451772|FG001|STARTED|Second Intervention||48||
48053677|NCT01361854|100451771|FG000|COMPLETED|Second Intervention||47||
48053678|NCT01361854|100451772|FG001|COMPLETED|Second Intervention||48||
48053679|NCT01361854|100451771|FG000|NOT COMPLETED|Second Intervention||0||
48053680|NCT01361854|100451772|FG001|NOT COMPLETED|Second Intervention||0||
48053681|NCT04812080|100451773|FG000|STARTED|Overall Study||20||
48053682|NCT04812080|100451773|FG000|COMPLETED|Overall Study||20||
48053683|NCT04812080|100451773|FG000|NOT COMPLETED|Overall Study||0||
48053684|NCT01120834|100451774|FG000|STARTED|Overall Study||18||
48053685|NCT01120834|100451774|FG000|COMPLETED|Overall Study||18||
48053686|NCT01120834|100451774|FG000|NOT COMPLETED|Overall Study||0||
48053687|NCT00997438|100451775|FG000|STARTED|Overall Study||21||
48053688|NCT00997438|100451776|FG001|STARTED|Overall Study||24||
48053689|NCT00997438|100451777|FG002|STARTED|Overall Study||24||
48053690|NCT00997438|100451775|FG000|COMPLETED|Overall Study||16||
48053691|NCT00997438|100451776|FG001|COMPLETED|Overall Study||21||
48053692|NCT00997438|100451777|FG002|COMPLETED|Overall Study||20||
48053693|NCT00997438|100451775|FG000|NOT COMPLETED|Overall Study||5||
48053694|NCT00997438|100451776|FG001|NOT COMPLETED|Overall Study||3||
48053695|NCT00997438|100451777|FG002|NOT COMPLETED|Overall Study||4||
48053696|NCT00560885|100451778|FG000|STARTED|Overall Study||55||
48053697|NCT00560885|100451778|FG000|30 Day Follow-up|Overall Study||53||
48495699|NCT03272685|101547915|FG001|STARTED|Overall Study||218||
48495700|NCT03272685|101547914|FG000|COMPLETED|Overall Study||166||
48053698|NCT00560885|100451778|FG000|3 Month Follow-up|Overall Study||51||
48053699|NCT00560885|100451778|FG000|6 Month Follow-up|Overall Study||50||
48053700|NCT00560885|100451778|FG000|12 Month Follow-up|Overall Study||48||
48053701|NCT00560885|100451778|FG000|2 Year Follow-up|Overall Study||47||
48053702|NCT00560885|100451778|FG000|COMPLETED|Overall Study||47||
48053703|NCT00560885|100451778|FG000|NOT COMPLETED|Overall Study||8||
48053704|NCT02567552|100451779|FG000|STARTED|Overall Study||12||
48053705|NCT02567552|100451780|FG001|STARTED|Overall Study||12||
48053706|NCT02567552|100451779|FG000|COMPLETED|Overall Study||12||
48053707|NCT02567552|100451780|FG001|COMPLETED|Overall Study||11||
48053708|NCT02567552|100451779|FG000|NOT COMPLETED|Overall Study||0||
48053709|NCT02567552|100451780|FG001|NOT COMPLETED|Overall Study||1||
48053710|NCT01857310|100451781|FG000|STARTED|Primary Analysis: Live Birth||1185||
48053711|NCT01857310|100451782|FG001|STARTED|Primary Analysis: Live Birth||1185||
48053712|NCT01857310|100451781|FG000|COMPLETED|Primary Analysis: Live Birth||1185||
48053713|NCT01857310|100451782|FG001|COMPLETED|Primary Analysis: Live Birth||1185||
48053714|NCT01857310|100451781|FG000|NOT COMPLETED|Primary Analysis: Live Birth||0||
48053715|NCT01857310|100451782|FG001|NOT COMPLETED|Primary Analysis: Live Birth||0||
48053716|NCT01857310|100451781|FG000|STARTED|Secondary Analysis: Semen Quality at 6m||1185||
48053717|NCT01857310|100451782|FG001|STARTED|Secondary Analysis: Semen Quality at 6m||1185||
48053718|NCT01857310|100451781|FG000|COMPLETED|Secondary Analysis: Semen Quality at 6m||870||
48053719|NCT01857310|100451782|FG001|COMPLETED|Secondary Analysis: Semen Quality at 6m||903||
48053720|NCT01857310|100451781|FG000|NOT COMPLETED|Secondary Analysis: Semen Quality at 6m||315||
48053721|NCT01857310|100451782|FG001|NOT COMPLETED|Secondary Analysis: Semen Quality at 6m||282||
48053722|NCT02670343|100451783|FG000|STARTED|Overall Study||8||
48053723|NCT02670343|100451783|FG000|COMPLETED|Overall Study||8||
48053724|NCT02670343|100451783|FG000|NOT COMPLETED|Overall Study||0||
48053725|NCT00744471|100451784|FG000|STARTED|Overall Study||156||
48053726|NCT00744471|100451785|FG001|STARTED|Overall Study||156||
48053727|NCT00744471|100451786|FG002|STARTED|Overall Study||158||
48053728|NCT00744471|100451787|FG003|STARTED|Overall Study||157||
48053729|NCT00744471|100451784|FG000|Treated|Overall Study||155||
48053730|NCT00744471|100451785|FG001|Treated|Overall Study||155||
48053731|NCT00744471|100451786|FG002|Treated|Overall Study||154||
48053732|NCT00744471|100451787|FG003|Treated|Overall Study||157||
48053733|NCT00744471|100451784|FG000|COMPLETED|Overall Study||13||
48053734|NCT00744471|100451785|FG001|COMPLETED|Overall Study||11||
48053735|NCT00744471|100451786|FG002|COMPLETED|Overall Study||6||
48053736|NCT00744471|100451787|FG003|COMPLETED|Overall Study||9||
48053737|NCT00744471|100451784|FG000|NOT COMPLETED|Overall Study||143||
48053738|NCT00744471|100451785|FG001|NOT COMPLETED|Overall Study||145||
48053739|NCT00744471|100451786|FG002|NOT COMPLETED|Overall Study||152||
48053740|NCT00744471|100451787|FG003|NOT COMPLETED|Overall Study||148||
48053741|NCT00542971|100451788|FG000|STARTED|Overall Study||75||
48053742|NCT00542971|100451788|FG000|COMPLETED|Overall Study||75||
48053743|NCT00542971|100451788|FG000|NOT COMPLETED|Overall Study||0||
48053744|NCT03707184|100451789|FG000|STARTED|Overall Study||17||
48053745|NCT03707184|100451789|FG000|COMPLETED|Overall Study||15||
48053746|NCT03707184|100451789|FG000|NOT COMPLETED|Overall Study||2||
48053747|NCT02097537|100451790|FG000|STARTED|Overall Study||10|Informed consent|
48053748|NCT02097537|100451790|FG000|Enrollment|Overall Study||10||
48053749|NCT02097537|100451790|FG000|Follow-Up|Overall Study||10||
48053750|NCT02097537|100451790|FG000|COMPLETED|Overall Study||10||
48053751|NCT02097537|100451790|FG000|NOT COMPLETED|Overall Study||0||
48053752|NCT02376829|100451791|FG000|STARTED|Overall Study||81||
48053753|NCT02376829|100451792|FG001|STARTED|Overall Study||83||
48053754|NCT02376829|100451791|FG000|COMPLETED|Overall Study||54||
48053755|NCT02376829|100451792|FG001|COMPLETED|Overall Study||39||
48053756|NCT02376829|100451791|FG000|NOT COMPLETED|Overall Study||27||
48053757|NCT02376829|100451792|FG001|NOT COMPLETED|Overall Study||44||
48053758|NCT03052764|100451793|FG000|STARTED|Double-Blind Treatment Period||80||
48053759|NCT03052764|100451794|FG001|STARTED|Double-Blind Treatment Period||40||
48053760|NCT03052764|100451793|FG000|mITT|Double-Blind Treatment Period||78||
48053761|NCT03052764|100451794|FG001|mITT|Double-Blind Treatment Period||39||
48053762|NCT03052764|100451793|FG000|COMPLETED|Double-Blind Treatment Period||70||
48053763|NCT03052764|100451794|FG001|COMPLETED|Double-Blind Treatment Period||37||
48053764|NCT03052764|100451793|FG000|NOT COMPLETED|Double-Blind Treatment Period||10||
48053765|NCT03052764|100451794|FG001|NOT COMPLETED|Double-Blind Treatment Period||3||
48053766|NCT03052764|100451793|FG000|STARTED|Open-Label Re-Treatment Period||58||
48053767|NCT03052764|100451794|FG001|STARTED|Open-Label Re-Treatment Period||33||
48053768|NCT03052764|100451793|FG000|COMPLETED|Open-Label Re-Treatment Period||58||
48053769|NCT03052764|100451794|FG001|COMPLETED|Open-Label Re-Treatment Period||33||
48053770|NCT03052764|100451793|FG000|NOT COMPLETED|Open-Label Re-Treatment Period||0||
48053771|NCT03052764|100451794|FG001|NOT COMPLETED|Open-Label Re-Treatment Period||0||
48053772|NCT05223335|100451795|FG000|STARTED|Overall Study||29||
48053773|NCT05223335|100451796|FG001|STARTED|Overall Study||69||
48053774|NCT05223335|100451795|FG000|COMPLETED|Overall Study||29||
48053775|NCT05223335|100451796|FG001|COMPLETED|Overall Study||69||
48053776|NCT05223335|100451795|FG000|NOT COMPLETED|Overall Study||0||
48053777|NCT05223335|100451796|FG001|NOT COMPLETED|Overall Study||0||
48053778|NCT02129660|100451797|FG000|STARTED|Overall Study||21||
48495701|NCT03272685|101547915|FG001|COMPLETED|Overall Study||173||
48053779|NCT02129660|100451798|FG001|STARTED|Overall Study||20||
48053780|NCT02129660|100451799|FG002|STARTED|Overall Study||22||
48053781|NCT02129660|100451800|FG003|STARTED|Overall Study||20||
48053782|NCT02129660|100451801|FG004|STARTED|Overall Study||22||
48053783|NCT02129660|100451797|FG000|COMPLETED|Overall Study||19||
48053784|NCT02129660|100451798|FG001|COMPLETED|Overall Study||20||
48053785|NCT02129660|100451799|FG002|COMPLETED|Overall Study||21||
48053786|NCT02129660|100451800|FG003|COMPLETED|Overall Study||20||
48053787|NCT02129660|100451801|FG004|COMPLETED|Overall Study||20||
48053788|NCT02129660|100451797|FG000|NOT COMPLETED|Overall Study||2||
48053789|NCT02129660|100451798|FG001|NOT COMPLETED|Overall Study||0||
48053790|NCT02129660|100451799|FG002|NOT COMPLETED|Overall Study||1||
48053791|NCT02129660|100451800|FG003|NOT COMPLETED|Overall Study||0||
48053792|NCT02129660|100451801|FG004|NOT COMPLETED|Overall Study||2||
48495702|NCT03272685|101547914|FG000|NOT COMPLETED|Overall Study||54||
48495703|NCT03272685|101547915|FG001|NOT COMPLETED|Overall Study||45||
48495704|NCT02584608|101547916|FG000|STARTED|Overall Study||12||
48053793|NCT00495131|100451802|FG000|STARTED|Overall Study||154||
48053794|NCT00495131|100451803|FG001|STARTED|Overall Study||154||
48053795|NCT00495131|100451802|FG000|COMPLETED|Overall Study||147||
48053796|NCT00495131|100451803|FG001|COMPLETED|Overall Study||148||
48053797|NCT00495131|100451802|FG000|NOT COMPLETED|Overall Study||7||
48208348|NCT02709655|100837029|FG000|Full Analysis Set (FAS)|Double-Blind Phase (8 Weeks)||0|All participants randomized to the double-blind, 8-week treatment period (Phase B) who took at least 1 dose of double-blind study drug and who had a valid baseline (Week 4 of Phase A) assessment and at least 1 valid post-baseline assessment of the Children Depression Rating Scale - Revised (CDRS-R) total score|
48208349|NCT02709655|100837030|FG001|Full Analysis Set (FAS)|Double-Blind Phase (8 Weeks)||153|All participants randomized to the double-blind, 8-week treatment period (Phase B) who took at least 1 dose of double-blind study drug and who had a valid baseline (Week 4 of Phase A) assessment and at least 1 valid post-baseline assessment of the Children Depression Rating Scale - Revised (CDRS-R) total score|
48208350|NCT02709655|100837031|FG002|Full Analysis Set (FAS)|Double-Blind Phase (8 Weeks)||148|All participants randomized to the double-blind, 8-week treatment period (Phase B) who took at least 1 dose of double-blind study drug and who had a valid baseline (Week 4 of Phase A) assessment and at least 1 valid post-baseline assessment of the Children Depression Rating Scale - Revised (CDRS-R) total score|
48208351|NCT02709655|100837032|FG003|Full Analysis Set (FAS)|Double-Blind Phase (8 Weeks)||148|All participants randomized to the double-blind, 8-week treatment period (Phase B) who took at least 1 dose of double-blind study drug and who had a valid baseline (Week 4 of Phase A) assessment and at least 1 valid post-baseline assessment of the Children Depression Rating Scale - Revised (CDRS-R) total score|
48208352|NCT02709655|100837033|FG004|Full Analysis Set (FAS)|Double-Blind Phase (8 Weeks)||81|All participants randomized to the double-blind, 8-week treatment period (Phase B) who took at least 1 dose of double-blind study drug and who had a valid baseline (Week 4 of Phase A) assessment and at least 1 valid post-baseline assessment of the Children Depression Rating Scale - Revised (CDRS-R) total score|
48208353|NCT02709655|100837029|FG000|COMPLETED|Double-Blind Phase (8 Weeks)||0||
48208354|NCT02709655|100837030|FG001|COMPLETED|Double-Blind Phase (8 Weeks)||138||
48208355|NCT02709655|100837031|FG002|COMPLETED|Double-Blind Phase (8 Weeks)||135||
48208356|NCT02709655|100837032|FG003|COMPLETED|Double-Blind Phase (8 Weeks)||133||
48208357|NCT02709655|100837033|FG004|COMPLETED|Double-Blind Phase (8 Weeks)||78||
48208358|NCT02709655|100837029|FG000|NOT COMPLETED|Double-Blind Phase (8 Weeks)||0||
48208359|NCT02709655|100837030|FG001|NOT COMPLETED|Double-Blind Phase (8 Weeks)||15||
48208360|NCT02709655|100837031|FG002|NOT COMPLETED|Double-Blind Phase (8 Weeks)||16||
48208361|NCT02709655|100837032|FG003|NOT COMPLETED|Double-Blind Phase (8 Weeks)||20||
48208362|NCT02709655|100837033|FG004|NOT COMPLETED|Double-Blind Phase (8 Weeks)||5||
48208363|NCT00979992|100837034|FG000|STARTED|Overall Study||35||
48208364|NCT00979992|100837034|FG000|COMPLETED|Overall Study||30||
48208365|NCT00979992|100837034|FG000|NOT COMPLETED|Overall Study||5||
48208366|NCT01759771|100837035|FG000|STARTED|Overall Study||58||
48208367|NCT01759771|100837036|FG001|STARTED|Overall Study||56||
48208368|NCT01759771|100837035|FG000|COMPLETED|Overall Study||57||
48208369|NCT01759771|100837036|FG001|COMPLETED|Overall Study||55||
48208370|NCT01759771|100837035|FG000|NOT COMPLETED|Overall Study||1||
48208371|NCT01759771|100837036|FG001|NOT COMPLETED|Overall Study||1||
48208372|NCT00019747|100837037|FG000|STARTED|Overall Study||23||
48208373|NCT00019747|100837038|FG001|STARTED|Overall Study||16||
48208374|NCT00019747|100837037|FG000|COMPLETED|Overall Study||23||
48208375|NCT00019747|100837038|FG001|COMPLETED|Overall Study||16||
48208376|NCT00019747|100837037|FG000|NOT COMPLETED|Overall Study||0||
48208377|NCT00019747|100837038|FG001|NOT COMPLETED|Overall Study||0||
48208378|NCT03401190|100837039|FG000|STARTED|Overall Study||8||
48208379|NCT03401190|100837040|FG001|STARTED|Overall Study||6||
48208380|NCT03401190|100837041|FG002|STARTED|Overall Study||7||
48208381|NCT03401190|100837039|FG000|COMPLETED|Overall Study||8||
48208382|NCT03401190|100837040|FG001|COMPLETED|Overall Study||4||
48208383|NCT03401190|100837041|FG002|COMPLETED|Overall Study||7||
48208384|NCT03401190|100837039|FG000|NOT COMPLETED|Overall Study||0||
48208385|NCT03401190|100837040|FG001|NOT COMPLETED|Overall Study||2||
48208386|NCT03401190|100837041|FG002|NOT COMPLETED|Overall Study||0||
48208387|NCT01697969|100837042|FG000|STARTED|Overall Study||13||
48208388|NCT01697969|100837042|FG000|COMPLETED|Overall Study||10||
48208389|NCT01697969|100837042|FG000|NOT COMPLETED|Overall Study||3||
48053798|NCT00495131|100451803|FG001|NOT COMPLETED|Overall Study||6||
48053799|NCT03026088|100451804|FG000|STARTED|Overall Study||20||
48053800|NCT03026088|100451804|FG000|COMPLETED|Overall Study||0||
48053801|NCT03026088|100451804|FG000|NOT COMPLETED|Overall Study||20||
48053802|NCT00084838|100451805|FG000|STARTED|Overall Study||25||
48053803|NCT00084838|100451805|FG000|Eligible and Treated|Overall Study||20||
48053804|NCT00084838|100451805|FG000|COMPLETED|Overall Study||12||
48053805|NCT00084838|100451805|FG000|NOT COMPLETED|Overall Study||13||
48053806|NCT00586729|100451806|FG000|STARTED|Overall Study||14||
48053807|NCT00586729|100451807|FG001|STARTED|Overall Study||9||
48053808|NCT00586729|100451806|FG000|COMPLETED|Overall Study||11||
48053809|NCT00586729|100451807|FG001|COMPLETED|Overall Study||8||
48053810|NCT00586729|100451806|FG000|NOT COMPLETED|Overall Study||3||
48053811|NCT00586729|100451807|FG001|NOT COMPLETED|Overall Study||1||
48053812|NCT00815516|100451808|FG000|STARTED|Overall Study||20||
48053813|NCT00815516|100451809|FG001|STARTED|Overall Study||10||
48053814|NCT00815516|100451808|FG000|COMPLETED|Overall Study||16||
48053815|NCT00815516|100451809|FG001|COMPLETED|Overall Study||9||
48053816|NCT00815516|100451808|FG000|NOT COMPLETED|Overall Study||4||
48053817|NCT00815516|100451809|FG001|NOT COMPLETED|Overall Study||1||
48053818|NCT04050371|100451810|FG000|STARTED|Overall Study||24||
48053819|NCT04050371|100451811|FG001|STARTED|Overall Study||24||
48053820|NCT04050371|100451810|FG000|COMPLETED|Overall Study||23||
48053821|NCT04050371|100451811|FG001|COMPLETED|Overall Study||24||
48053822|NCT04050371|100451810|FG000|NOT COMPLETED|Overall Study||1||
48053823|NCT04050371|100451811|FG001|NOT COMPLETED|Overall Study||0||
48053824|NCT03509467|100451812|FG000|STARTED|Overall Study||227||
48053825|NCT03509467|100451813|FG001|STARTED|Overall Study||226||
48053826|NCT03509467|100451814|FG002|STARTED|Overall Study||339||
48053827|NCT03509467|100451815|FG003|STARTED|Overall Study||342||
48053828|NCT03509467|100451816|FG004|STARTED|Overall Study||195||
48053829|NCT03509467|100451817|FG005|STARTED|Overall Study||195||
48053830|NCT03509467|100451818|FG006|STARTED|Overall Study||262||
48053831|NCT03509467|100451819|FG007|STARTED|Overall Study||268||
48053832|NCT03509467|100451812|FG000|COMPLETED|Overall Study||222||
48053833|NCT03509467|100451813|FG001|COMPLETED|Overall Study||225||
48053834|NCT03509467|100451814|FG002|COMPLETED|Overall Study||331||
48053835|NCT03509467|100451815|FG003|COMPLETED|Overall Study||333||
48053836|NCT03509467|100451816|FG004|COMPLETED|Overall Study||184||
48053837|NCT03509467|100451817|FG005|COMPLETED|Overall Study||185||
48053838|NCT03509467|100451818|FG006|COMPLETED|Overall Study||251||
48053839|NCT03509467|100451819|FG007|COMPLETED|Overall Study||257||
48053840|NCT03509467|100451812|FG000|NOT COMPLETED|Overall Study||5||
48053841|NCT03509467|100451813|FG001|NOT COMPLETED|Overall Study||1||
48053842|NCT03509467|100451814|FG002|NOT COMPLETED|Overall Study||8||
48053843|NCT03509467|100451815|FG003|NOT COMPLETED|Overall Study||9||
48053844|NCT03509467|100451816|FG004|NOT COMPLETED|Overall Study||11||
48053845|NCT03509467|100451817|FG005|NOT COMPLETED|Overall Study||10||
48053846|NCT03509467|100451818|FG006|NOT COMPLETED|Overall Study||11||
48053847|NCT03509467|100451819|FG007|NOT COMPLETED|Overall Study||11||
48053848|NCT00723203|100451820|FG000|STARTED|Overall Study||16||
48053849|NCT00723203|100451820|FG000|COMPLETED|Overall Study||13||
48053850|NCT00723203|100451820|FG000|NOT COMPLETED|Overall Study||3||
48053851|NCT02876640|100451821|FG000|STARTED|Overall Study||27||
48053852|NCT02876640|100451821|FG000|COMPLETED|Overall Study||27||
48053853|NCT02876640|100451821|FG000|NOT COMPLETED|Overall Study||0||
48053854|NCT01557894|100451822|FG000|STARTED|Overall Study||38||
48053855|NCT01557894|100451823|FG001|STARTED|Overall Study||38||
48053856|NCT01557894|100451822|FG000|COMPLETED|Overall Study||35||
48053857|NCT01557894|100451823|FG001|COMPLETED|Overall Study||33||
48053858|NCT01557894|100451822|FG000|NOT COMPLETED|Overall Study||3||
48053859|NCT01557894|100451823|FG001|NOT COMPLETED|Overall Study||5||
48053860|NCT03977454|100451824|FG000|STARTED|Overall Study||97||
48053861|NCT03977454|100451825|FG001|STARTED|Overall Study||95||
48053862|NCT03977454|100451824|FG000|COMPLETED|Overall Study||95||
48053863|NCT03977454|100451825|FG001|COMPLETED|Overall Study||93||
48053864|NCT03977454|100451824|FG000|NOT COMPLETED|Overall Study||2||
48053865|NCT03977454|100451825|FG001|NOT COMPLETED|Overall Study||2||
48053866|NCT04163718|100451826|FG000|STARTED|Overall Study||12||
48053867|NCT04163718|100451826|FG000|COMPLETED|Overall Study||0||
48053868|NCT04163718|100451826|FG000|NOT COMPLETED|Overall Study||12||
48053869|NCT01828515|100451827|FG000|STARTED|First Intervention (19 Days)||13||
48053870|NCT01828515|100451828|FG001|STARTED|First Intervention (19 Days)||11||
48053871|NCT01828515|100451827|FG000|COMPLETED|First Intervention (19 Days)||11||
48053872|NCT01828515|100451828|FG001|COMPLETED|First Intervention (19 Days)||9||
48053873|NCT01828515|100451827|FG000|NOT COMPLETED|First Intervention (19 Days)||2||
48053874|NCT01828515|100451828|FG001|NOT COMPLETED|First Intervention (19 Days)||2||
48053875|NCT01828515|100451827|FG000|STARTED|Washout (23 Days)||11||
48053876|NCT01828515|100451828|FG001|STARTED|Washout (23 Days)||9||
48053877|NCT01828515|100451827|FG000|COMPLETED|Washout (23 Days)||6||
48053878|NCT01828515|100451828|FG001|COMPLETED|Washout (23 Days)||8||
48208390|NCT04598321|100837043|FG000|STARTED|Overall Study||1||
48208391|NCT04598321|100837043|FG000|COMPLETED|Overall Study||1||
48053879|NCT01828515|100451827|FG000|NOT COMPLETED|Washout (23 Days)||5||
48053880|NCT01828515|100451828|FG001|NOT COMPLETED|Washout (23 Days)||1||
48053881|NCT01828515|100451827|FG000|STARTED|Second Intervention (19 Days)||6||
48053882|NCT01828515|100451828|FG001|STARTED|Second Intervention (19 Days)||8||
48053883|NCT01828515|100451827|FG000|COMPLETED|Second Intervention (19 Days)||6||
48053884|NCT01828515|100451828|FG001|COMPLETED|Second Intervention (19 Days)||5||
48053885|NCT01828515|100451827|FG000|NOT COMPLETED|Second Intervention (19 Days)||0||
48053886|NCT01828515|100451828|FG001|NOT COMPLETED|Second Intervention (19 Days)||3||
48053887|NCT01960387|100454223|FG000|STARTED|Overall Study||2||
48053888|NCT01960387|100454223|FG000|COMPLETED|Overall Study||2||
48053889|NCT01960387|100454223|FG000|NOT COMPLETED|Overall Study||0||
48053890|NCT04099251|100454224|FG000|STARTED|Pre-Treatment||526|Started=randomized|
48053891|NCT04099251|100454225|FG001|STARTED|Pre-Treatment||264|Started=randomized|
48053892|NCT04099251|100454224|FG000|COMPLETED|Pre-Treatment||524|Completed=treated|
48053893|NCT04099251|100454225|FG001|COMPLETED|Pre-Treatment||264|Completed=treated|
48053894|NCT04099251|100454224|FG000|NOT COMPLETED|Pre-Treatment||2||
48053895|NCT04099251|100454225|FG001|NOT COMPLETED|Pre-Treatment||0||
48053896|NCT04099251|100454224|FG000|STARTED|Blinded Treatment Phase||524||
48053897|NCT04099251|100454225|FG001|STARTED|Blinded Treatment Phase||264||
48053898|NCT04099251|100454224|FG000|COMPLETED|Blinded Treatment Phase||257||
48053899|NCT04099251|100454225|FG001|COMPLETED|Blinded Treatment Phase||158||
48208392|NCT04598321|100837043|FG000|NOT COMPLETED|Overall Study||0||
48208393|NCT03473340|100837044|FG000|STARTED|Overall Study||13||
48208394|NCT03473340|100837045|FG001|STARTED|Overall Study||11||
48208395|NCT03473340|100837044|FG000|COMPLETED|Overall Study||8||
48208396|NCT03473340|100837045|FG001|COMPLETED|Overall Study||9||
48208397|NCT03473340|100837044|FG000|NOT COMPLETED|Overall Study||5||
48208398|NCT03473340|100837045|FG001|NOT COMPLETED|Overall Study||2||
48208399|NCT02496702|100837046|FG000|STARTED|Overall Study||30||
48208400|NCT02496702|100837047|FG001|STARTED|Overall Study||30||
48208401|NCT02496702|100837046|FG000|Received Allocated Intervention|Overall Study||21||
48208402|NCT02496702|100837047|FG001|Received Allocated Intervention|Overall Study||0||
48208403|NCT02496702|100837046|FG000|Did Not Receive Allocated Intervention|Overall Study||9||
48208404|NCT02496702|100837047|FG001|Did Not Receive Allocated Intervention|Overall Study||0||
48208405|NCT02496702|100837046|FG000|COMPLETED|Overall Study||22||
48208406|NCT02496702|100837047|FG001|COMPLETED|Overall Study||22||
48208407|NCT02496702|100837046|FG000|NOT COMPLETED|Overall Study||8||
48208408|NCT02496702|100837047|FG001|NOT COMPLETED|Overall Study||8||
48208409|NCT04970342|100837048|FG000|STARTED|Treatment Visit 1 (1 Day)||2||
48208410|NCT04970342|100837049|FG001|STARTED|Treatment Visit 1 (1 Day)||2||
48208411|NCT04970342|100837050|FG002|STARTED|Treatment Visit 1 (1 Day)||1||
48208412|NCT04970342|100837051|FG003|STARTED|Treatment Visit 1 (1 Day)||1||
48208413|NCT04970342|100837052|FG004|STARTED|Treatment Visit 1 (1 Day)||1||
48208414|NCT04970342|100837053|FG005|STARTED|Treatment Visit 1 (1 Day)||1||
48208415|NCT04970342|100837048|FG000|COMPLETED|Treatment Visit 1 (1 Day)||2||
48208416|NCT04970342|100837049|FG001|COMPLETED|Treatment Visit 1 (1 Day)||2||
48208417|NCT04970342|100837050|FG002|COMPLETED|Treatment Visit 1 (1 Day)||1||
48208418|NCT04970342|100837051|FG003|COMPLETED|Treatment Visit 1 (1 Day)||1||
48208419|NCT04970342|100837052|FG004|COMPLETED|Treatment Visit 1 (1 Day)||1||
48208420|NCT04970342|100837053|FG005|COMPLETED|Treatment Visit 1 (1 Day)||1||
48208421|NCT04970342|100837048|FG000|NOT COMPLETED|Treatment Visit 1 (1 Day)||0||
48208422|NCT04970342|100837049|FG001|NOT COMPLETED|Treatment Visit 1 (1 Day)||0||
48208423|NCT04970342|100837050|FG002|NOT COMPLETED|Treatment Visit 1 (1 Day)||0||
48208424|NCT04970342|100837051|FG003|NOT COMPLETED|Treatment Visit 1 (1 Day)||0||
48208425|NCT04970342|100837052|FG004|NOT COMPLETED|Treatment Visit 1 (1 Day)||0||
48208426|NCT04970342|100837053|FG005|NOT COMPLETED|Treatment Visit 1 (1 Day)||0||
48208427|NCT04970342|100837048|FG000|STARTED|Washout (7 Days)||2||
48208428|NCT04970342|100837049|FG001|STARTED|Washout (7 Days)||2||
48208429|NCT04970342|100837050|FG002|STARTED|Washout (7 Days)||1||
48208430|NCT04970342|100837051|FG003|STARTED|Washout (7 Days)||1||
48208431|NCT04970342|100837052|FG004|STARTED|Washout (7 Days)||1||
48208432|NCT04970342|100837053|FG005|STARTED|Washout (7 Days)||1||
48053900|NCT04099251|100454224|FG000|NOT COMPLETED|Blinded Treatment Phase||267||
48053901|NCT04099251|100454225|FG001|NOT COMPLETED|Blinded Treatment Phase||106||
48053902|NCT04099251|100454224|FG000|STARTED|Optional Open-Label Phase Pre-Treatment||2|"Started=Number of participants enrolled in the open-label phase~Eligible participants received open-label Nivolumab treatment during a follow-up phase."|
48053903|NCT04099251|100454225|FG001|STARTED|Optional Open-Label Phase Pre-Treatment||30|"Started=Number of participants enrolled in the open-label phase~Eligible participants received open-label Nivolumab treatment during a follow-up phase."|
48053904|NCT04099251|100454224|FG000|COMPLETED|Optional Open-Label Phase Pre-Treatment||2|Completed=received treatment|
48208433|NCT04970342|100837048|FG000|COMPLETED|Washout (7 Days)||2||
48053905|NCT04099251|100454225|FG001|COMPLETED|Optional Open-Label Phase Pre-Treatment||28|Completed=received treatment|
48053906|NCT04099251|100454224|FG000|NOT COMPLETED|Optional Open-Label Phase Pre-Treatment||0||
48053907|NCT04099251|100454225|FG001|NOT COMPLETED|Optional Open-Label Phase Pre-Treatment||2||
48053908|NCT04099251|100454224|FG000|STARTED|Optional Open-Label Phase Treatment||2|Started=received optional open-label treatment|
48053909|NCT04099251|100454225|FG001|STARTED|Optional Open-Label Phase Treatment||28|Started=received optional open-label treatment|
48053910|NCT04099251|100454224|FG000|COMPLETED|Optional Open-Label Phase Treatment||0||
48053911|NCT04099251|100454225|FG001|COMPLETED|Optional Open-Label Phase Treatment||3||
48053912|NCT04099251|100454224|FG000|NOT COMPLETED|Optional Open-Label Phase Treatment||2||
48053913|NCT04099251|100454225|FG001|NOT COMPLETED|Optional Open-Label Phase Treatment||25||
48053914|NCT01058265|100454226|FG000|STARTED|Overall Study||22||
48053915|NCT01058265|100454227|FG001|STARTED|Overall Study||25||
48053916|NCT01058265|100454226|FG000|COMPLETED|Overall Study||11||
48053917|NCT01058265|100454227|FG001|COMPLETED|Overall Study||13||
48053918|NCT01058265|100454226|FG000|NOT COMPLETED|Overall Study||11||
48053919|NCT01058265|100454227|FG001|NOT COMPLETED|Overall Study||12||
48053920|NCT04633460|100454228|FG000|STARTED|First Intervention||10||
48053921|NCT04633460|100454229|FG001|STARTED|First Intervention||10||
48053922|NCT04633460|100454228|FG000|COMPLETED|First Intervention||10||
48053923|NCT04633460|100454229|FG001|COMPLETED|First Intervention||10||
48053924|NCT04633460|100454228|FG000|NOT COMPLETED|First Intervention||0||
48053925|NCT04633460|100454229|FG001|NOT COMPLETED|First Intervention||0||
48053926|NCT04633460|100454228|FG000|STARTED|Washout||10||
48053927|NCT04633460|100454229|FG001|STARTED|Washout||10||
48053928|NCT04633460|100454228|FG000|COMPLETED|Washout||10||
48053929|NCT04633460|100454229|FG001|COMPLETED|Washout||10||
48053930|NCT04633460|100454228|FG000|NOT COMPLETED|Washout||0||
48053931|NCT04633460|100454229|FG001|NOT COMPLETED|Washout||0||
48053932|NCT04633460|100454228|FG000|STARTED|Second Intervention||10||
48053933|NCT04633460|100454229|FG001|STARTED|Second Intervention||10||
48053934|NCT04633460|100454228|FG000|COMPLETED|Second Intervention||10||
48053935|NCT04633460|100454229|FG001|COMPLETED|Second Intervention||10||
48053936|NCT04633460|100454228|FG000|NOT COMPLETED|Second Intervention||0||
48053937|NCT04633460|100454229|FG001|NOT COMPLETED|Second Intervention||0||
48053938|NCT04022343|100454230|FG000|STARTED|Overall Study||22||
48053939|NCT04022343|100454230|FG000|COMPLETED|Overall Study||17||
48053940|NCT04022343|100454230|FG000|NOT COMPLETED|Overall Study||5||
48053941|NCT02641483|100454231|FG000|STARTED|Overall Study||2||
48053942|NCT02641483|100454231|FG000|COMPLETED|Overall Study||2||
48053943|NCT02641483|100454231|FG000|NOT COMPLETED|Overall Study||0||
48053944|NCT02435069|100454232|FG000|STARTED|Preoperative Baseline Phase||5||
48053945|NCT02435069|100454233|FG001|STARTED|Preoperative Baseline Phase||0||
48053946|NCT02435069|100454234|FG002|STARTED|Preoperative Baseline Phase||0||
48053947|NCT02435069|100454235|FG003|STARTED|Preoperative Baseline Phase||0||
48053948|NCT02435069|100454236|FG004|STARTED|Preoperative Baseline Phase||0||
48053949|NCT02435069|100454232|FG000|COMPLETED|Preoperative Baseline Phase||5||
48053950|NCT02435069|100454233|FG001|COMPLETED|Preoperative Baseline Phase||0||
48053951|NCT02435069|100454234|FG002|COMPLETED|Preoperative Baseline Phase||0||
48053952|NCT02435069|100454235|FG003|COMPLETED|Preoperative Baseline Phase||0||
48053953|NCT02435069|100454236|FG004|COMPLETED|Preoperative Baseline Phase||0||
48053954|NCT02435069|100454232|FG000|NOT COMPLETED|Preoperative Baseline Phase||0||
48053955|NCT02435069|100454233|FG001|NOT COMPLETED|Preoperative Baseline Phase||0||
48053956|NCT02435069|100454234|FG002|NOT COMPLETED|Preoperative Baseline Phase||0||
48053957|NCT02435069|100454235|FG003|NOT COMPLETED|Preoperative Baseline Phase||0||
48053958|NCT02435069|100454236|FG004|NOT COMPLETED|Preoperative Baseline Phase||0||
48053959|NCT02435069|100454232|FG000|STARTED|Dose Response - First Intervention||0||
48053960|NCT02435069|100454233|FG001|STARTED|Dose Response - First Intervention||3||
48053961|NCT02435069|100454234|FG002|STARTED|Dose Response - First Intervention||2||
48053962|NCT02435069|100454235|FG003|STARTED|Dose Response - First Intervention||0||
48053963|NCT02435069|100454236|FG004|STARTED|Dose Response - First Intervention||0||
48053964|NCT02435069|100454232|FG000|COMPLETED|Dose Response - First Intervention||0||
48053965|NCT02435069|100454233|FG001|COMPLETED|Dose Response - First Intervention||2||
48053966|NCT02435069|100454234|FG002|COMPLETED|Dose Response - First Intervention||1||
48053967|NCT02435069|100454235|FG003|COMPLETED|Dose Response - First Intervention||0||
48053968|NCT02435069|100454236|FG004|COMPLETED|Dose Response - First Intervention||0||
48208434|NCT04970342|100837049|FG001|COMPLETED|Washout (7 Days)||2||
48208435|NCT04970342|100837050|FG002|COMPLETED|Washout (7 Days)||1||
48208436|NCT04970342|100837051|FG003|COMPLETED|Washout (7 Days)||1||
48208437|NCT04970342|100837052|FG004|COMPLETED|Washout (7 Days)||1||
48208438|NCT04970342|100837053|FG005|COMPLETED|Washout (7 Days)||1||
48208439|NCT04970342|100837048|FG000|NOT COMPLETED|Washout (7 Days)||0||
48053969|NCT02435069|100454232|FG000|NOT COMPLETED|Dose Response - First Intervention||0||
48053970|NCT02435069|100454233|FG001|NOT COMPLETED|Dose Response - First Intervention||1||
48053971|NCT02435069|100454234|FG002|NOT COMPLETED|Dose Response - First Intervention||1||
48053972|NCT02435069|100454235|FG003|NOT COMPLETED|Dose Response - First Intervention||0||
48053973|NCT02435069|100454236|FG004|NOT COMPLETED|Dose Response - First Intervention||0||
48053974|NCT02435069|100454232|FG000|STARTED|Effectiveness - Second Intervention||0||
48053975|NCT02435069|100454233|FG001|STARTED|Effectiveness - Second Intervention||0||
48053976|NCT02435069|100454234|FG002|STARTED|Effectiveness - Second Intervention||0||
48053977|NCT02435069|100454235|FG003|STARTED|Effectiveness - Second Intervention||1||
48053978|NCT02435069|100454236|FG004|STARTED|Effectiveness - Second Intervention||1||
48053979|NCT02435069|100454232|FG000|COMPLETED|Effectiveness - Second Intervention||0||
48053980|NCT02435069|100454233|FG001|COMPLETED|Effectiveness - Second Intervention||0||
48053981|NCT02435069|100454234|FG002|COMPLETED|Effectiveness - Second Intervention||0||
48053982|NCT02435069|100454235|FG003|COMPLETED|Effectiveness - Second Intervention||1||
48053983|NCT02435069|100454236|FG004|COMPLETED|Effectiveness - Second Intervention||0||
48053984|NCT02435069|100454232|FG000|NOT COMPLETED|Effectiveness - Second Intervention||0||
48053985|NCT02435069|100454233|FG001|NOT COMPLETED|Effectiveness - Second Intervention||0||
48053986|NCT02435069|100454234|FG002|NOT COMPLETED|Effectiveness - Second Intervention||0||
48053987|NCT02435069|100454235|FG003|NOT COMPLETED|Effectiveness - Second Intervention||0||
48053988|NCT02435069|100454236|FG004|NOT COMPLETED|Effectiveness - Second Intervention||1||
48053989|NCT01916967|100454237|FG000|STARTED|Overall Study||80||
48053990|NCT01916967|100454238|FG001|STARTED|Overall Study||79||
48053991|NCT01916967|100454239|FG002|STARTED|Overall Study||80||
48053992|NCT01916967|100454237|FG000|COMPLETED|Overall Study||80||
48053993|NCT01916967|100454238|FG001|COMPLETED|Overall Study||78||
48053994|NCT01916967|100454239|FG002|COMPLETED|Overall Study||71||
48053995|NCT01916967|100454237|FG000|NOT COMPLETED|Overall Study||0||
48053996|NCT01916967|100454238|FG001|NOT COMPLETED|Overall Study||1||
48053997|NCT01916967|100454239|FG002|NOT COMPLETED|Overall Study||9||
48053998|NCT01606254|100454240|FG000|STARTED|Overall Study||14||
48053999|NCT01606254|100454241|FG001|STARTED|Overall Study||14||
48054000|NCT01606254|100454242|FG002|STARTED|Overall Study||14||
48054001|NCT01606254|100454243|FG003|STARTED|Overall Study||14||
48054002|NCT01606254|100454240|FG000|COMPLETED|Overall Study||12||
48054003|NCT01606254|100454241|FG001|COMPLETED|Overall Study||10||
48054004|NCT01606254|100454242|FG002|COMPLETED|Overall Study||14||
48054005|NCT01606254|100454243|FG003|COMPLETED|Overall Study||11||
48054006|NCT01606254|100454240|FG000|NOT COMPLETED|Overall Study||2||
48054007|NCT01606254|100454241|FG001|NOT COMPLETED|Overall Study||4||
48054008|NCT01606254|100454242|FG002|NOT COMPLETED|Overall Study||0||
48054009|NCT01606254|100454243|FG003|NOT COMPLETED|Overall Study||3||
48054010|NCT01912963|100454244|FG000|STARTED|Overall Study||6||
48054011|NCT01912963|100454245|FG001|STARTED|Overall Study||19||
48054012|NCT01912963|100454246|FG002|STARTED|Overall Study||7||
48054013|NCT01912963|100454244|FG000|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all participants were considered 'Not Completed'.|
48054014|NCT01912963|100454245|FG001|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all participants were considered 'Not Completed'.|
48054015|NCT01912963|100454246|FG002|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all participants were considered 'Not Completed'.|
48054016|NCT01912963|100454244|FG000|NOT COMPLETED|Overall Study||6||
48054017|NCT01912963|100454245|FG001|NOT COMPLETED|Overall Study||19||
48054018|NCT01912963|100454246|FG002|NOT COMPLETED|Overall Study||7||
48054019|NCT01278303|100454247|FG000|STARTED|Overall Study||82||
48054020|NCT01278303|100454247|FG000|COMPLETED|Overall Study||82||
48054021|NCT01278303|100454247|FG000|NOT COMPLETED|Overall Study||0||
48054022|NCT01479985|100454248|FG000|STARTED|Overall Study||167||
48054023|NCT01479985|100454249|FG001|STARTED|Overall Study||86||
48054024|NCT01479985|100454248|FG000|Baseline Survey|Overall Study||166||
48054025|NCT01479985|100454249|FG001|Baseline Survey|Overall Study||85||
48054026|NCT01479985|100454248|FG000|COMPLETED|Overall Study||161||
48054027|NCT01479985|100454249|FG001|COMPLETED|Overall Study||80||
48054028|NCT01479985|100454248|FG000|NOT COMPLETED|Overall Study||6||
48054029|NCT01479985|100454249|FG001|NOT COMPLETED|Overall Study||6||
48054030|NCT00072176|100454250|FG000|STARTED|Overall Study||34||
48054031|NCT00072176|100454251|FG001|STARTED|Overall Study||28||
48054032|NCT00072176|100454250|FG000|COMPLETED|Overall Study||33||
48054033|NCT00072176|100454251|FG001|COMPLETED|Overall Study||27||
48054034|NCT00072176|100454250|FG000|NOT COMPLETED|Overall Study||1||
48054035|NCT00072176|100454251|FG001|NOT COMPLETED|Overall Study||1||
48054036|NCT01272284|100454252|FG000|STARTED|3-month Follow-up Visit||113||
48054037|NCT01272284|100454252|FG000|COMPLETED|3-month Follow-up Visit||112||
48054038|NCT01272284|100454252|FG000|NOT COMPLETED|3-month Follow-up Visit||1||
48054039|NCT01272284|100454252|FG000|STARTED|6-month Follow-up Visit||112||
48054040|NCT01272284|100454252|FG000|COMPLETED|6-month Follow-up Visit||109||
48054041|NCT01272284|100454252|FG000|NOT COMPLETED|6-month Follow-up Visit||3||
48054042|NCT01272284|100454252|FG000|STARTED|12-month Follow-up Visit||109||
48054043|NCT01272284|100454252|FG000|COMPLETED|12-month Follow-up Visit||105||
48054044|NCT01272284|100454252|FG000|NOT COMPLETED|12-month Follow-up Visit||4||
48054045|NCT02829983|100454253|FG000|STARTED|Overall Study||20||
48054046|NCT02829983|100454254|FG001|STARTED|Overall Study||20||
48054047|NCT02829983|100454253|FG000|COMPLETED|Overall Study||20||
48054048|NCT02829983|100454254|FG001|COMPLETED|Overall Study||20||
48054049|NCT02829983|100454253|FG000|NOT COMPLETED|Overall Study||0||
48054050|NCT02829983|100454254|FG001|NOT COMPLETED|Overall Study||0||
48054051|NCT00289718|100454255|FG000|STARTED|Overall Study||51||
48208440|NCT04970342|100837049|FG001|NOT COMPLETED|Washout (7 Days)||0||
48208441|NCT04970342|100837050|FG002|NOT COMPLETED|Washout (7 Days)||0||
48054052|NCT00289718|100454255|FG000|COMPLETED|Overall Study||51||
48054053|NCT00289718|100454255|FG000|NOT COMPLETED|Overall Study||0||
48054054|NCT00963677|100454256|FG000|STARTED|Overall Study||35||
48054055|NCT00963677|100454257|FG001|STARTED|Overall Study||20||
48054056|NCT00963677|100454256|FG000|COMPLETED|Overall Study||35||
48054057|NCT00963677|100454257|FG001|COMPLETED|Overall Study||18||
48054058|NCT00963677|100454256|FG000|NOT COMPLETED|Overall Study||0||
48054059|NCT00963677|100454257|FG001|NOT COMPLETED|Overall Study||2||
48054060|NCT04263454|100454258|FG000|STARTED|Overall Study||16||
48054061|NCT04263454|100454259|FG001|STARTED|Overall Study||20||
48054062|NCT04263454|100454258|FG000|COMPLETED|Overall Study||13||
48054063|NCT04263454|100454259|FG001|COMPLETED|Overall Study||12||
48054064|NCT04263454|100454258|FG000|NOT COMPLETED|Overall Study||3||
48054065|NCT04263454|100454259|FG001|NOT COMPLETED|Overall Study||8||
48054066|NCT01898494|100454260|FG000|STARTED|Step 1 (Arm S - Transoral Surgery)||49||
48054067|NCT01898494|100454261|FG001|STARTED|Step 1 (Arm S - Transoral Surgery)||126||
48054068|NCT01898494|100454262|FG002|STARTED|Step 1 (Arm S - Transoral Surgery)||132||
48054069|NCT01898494|100454263|FG003|STARTED|Step 1 (Arm S - Transoral Surgery)||138||
48054070|NCT01898494|100454264|FG004|STARTED|Step 1 (Arm S - Transoral Surgery)||74||
48054071|NCT01898494|100454260|FG000|COMPLETED|Step 1 (Arm S - Transoral Surgery)||49||
48054072|NCT01898494|100454261|FG001|COMPLETED|Step 1 (Arm S - Transoral Surgery)||126||
48054073|NCT01898494|100454262|FG002|COMPLETED|Step 1 (Arm S - Transoral Surgery)||132||
48054074|NCT01898494|100454263|FG003|COMPLETED|Step 1 (Arm S - Transoral Surgery)||138||
48054075|NCT01898494|100454264|FG004|COMPLETED|Step 1 (Arm S - Transoral Surgery)||50||
48054076|NCT01898494|100454260|FG000|NOT COMPLETED|Step 1 (Arm S - Transoral Surgery)||0||
48054077|NCT01898494|100454261|FG001|NOT COMPLETED|Step 1 (Arm S - Transoral Surgery)||0||
48054078|NCT01898494|100454262|FG002|NOT COMPLETED|Step 1 (Arm S - Transoral Surgery)||0||
48054079|NCT01898494|100454263|FG003|NOT COMPLETED|Step 1 (Arm S - Transoral Surgery)||0||
48054080|NCT01898494|100454264|FG004|NOT COMPLETED|Step 1 (Arm S - Transoral Surgery)||24||
48054081|NCT01898494|100454260|FG000|STARTED|Step 2 (Adjuvant Treatment)||49||
48054082|NCT01898494|100454261|FG001|STARTED|Step 2 (Adjuvant Treatment)||126||
48054083|NCT01898494|100454262|FG002|STARTED|Step 2 (Adjuvant Treatment)||132||
48054084|NCT01898494|100454263|FG003|STARTED|Step 2 (Adjuvant Treatment)||138||
48054085|NCT01898494|100454264|FG004|STARTED|Step 2 (Adjuvant Treatment)||0||
48054086|NCT01898494|100454260|FG000|Treated|Step 2 (Adjuvant Treatment)||49||
48054087|NCT01898494|100454261|FG001|Treated|Step 2 (Adjuvant Treatment)||120||
48054088|NCT01898494|100454262|FG002|Treated|Step 2 (Adjuvant Treatment)||127||
48054089|NCT01898494|100454263|FG003|Treated|Step 2 (Adjuvant Treatment)||134||
48054090|NCT01898494|100454264|FG004|Treated|Step 2 (Adjuvant Treatment)||0||
48054091|NCT01898494|100454260|FG000|Eligible and Treated|Step 2 (Adjuvant Treatment)||38||
48054092|NCT01898494|100454261|FG001|Eligible and Treated|Step 2 (Adjuvant Treatment)||100||
48054093|NCT01898494|100454262|FG002|Eligible and Treated|Step 2 (Adjuvant Treatment)||108||
48054094|NCT01898494|100454263|FG003|Eligible and Treated|Step 2 (Adjuvant Treatment)||113||
48054095|NCT01898494|100454264|FG004|Eligible and Treated|Step 2 (Adjuvant Treatment)||0||
48054096|NCT01898494|100454260|FG000|Eligible and Treated Patients With Baseline MDADI Assessed|Step 2 (Adjuvant Treatment)||35||
48054097|NCT01898494|100454261|FG001|Eligible and Treated Patients With Baseline MDADI Assessed|Step 2 (Adjuvant Treatment)||91||
48054098|NCT01898494|100454262|FG002|Eligible and Treated Patients With Baseline MDADI Assessed|Step 2 (Adjuvant Treatment)||99||
48054099|NCT01898494|100454263|FG003|Eligible and Treated Patients With Baseline MDADI Assessed|Step 2 (Adjuvant Treatment)||102||
48054100|NCT01898494|100454264|FG004|Eligible and Treated Patients With Baseline MDADI Assessed|Step 2 (Adjuvant Treatment)||0||
48054101|NCT01898494|100454260|FG000|Eligible and Treated Patients With Post-surgery MDADI Assessed|Step 2 (Adjuvant Treatment)||31||
48054102|NCT01898494|100454261|FG001|Eligible and Treated Patients With Post-surgery MDADI Assessed|Step 2 (Adjuvant Treatment)||83||
48054103|NCT01898494|100454262|FG002|Eligible and Treated Patients With Post-surgery MDADI Assessed|Step 2 (Adjuvant Treatment)||88||
48054104|NCT01898494|100454263|FG003|Eligible and Treated Patients With Post-surgery MDADI Assessed|Step 2 (Adjuvant Treatment)||94||
48054105|NCT01898494|100454264|FG004|Eligible and Treated Patients With Post-surgery MDADI Assessed|Step 2 (Adjuvant Treatment)||0||
48054106|NCT01898494|100454260|FG000|Eligible and Treated Patients With FACT-H&N Assessed at 6 Months|Step 2 (Adjuvant Treatment)||21||
48054107|NCT01898494|100454261|FG001|Eligible and Treated Patients With FACT-H&N Assessed at 6 Months|Step 2 (Adjuvant Treatment)||75||
48054108|NCT01898494|100454262|FG002|Eligible and Treated Patients With FACT-H&N Assessed at 6 Months|Step 2 (Adjuvant Treatment)||80||
48054109|NCT01898494|100454263|FG003|Eligible and Treated Patients With FACT-H&N Assessed at 6 Months|Step 2 (Adjuvant Treatment)||77||
48054110|NCT01898494|100454264|FG004|Eligible and Treated Patients With FACT-H&N Assessed at 6 Months|Step 2 (Adjuvant Treatment)||0||
48054111|NCT01898494|100454260|FG000|COMPLETED|Step 2 (Adjuvant Treatment)||49||
48054112|NCT01898494|100454261|FG001|COMPLETED|Step 2 (Adjuvant Treatment)||119||
48054113|NCT01898494|100454262|FG002|COMPLETED|Step 2 (Adjuvant Treatment)||118||
48054114|NCT01898494|100454263|FG003|COMPLETED|Step 2 (Adjuvant Treatment)||127||
48054115|NCT01898494|100454264|FG004|COMPLETED|Step 2 (Adjuvant Treatment)||0||
48054116|NCT01898494|100454260|FG000|NOT COMPLETED|Step 2 (Adjuvant Treatment)||0||
48054117|NCT01898494|100454261|FG001|NOT COMPLETED|Step 2 (Adjuvant Treatment)||7||
48054118|NCT01898494|100454262|FG002|NOT COMPLETED|Step 2 (Adjuvant Treatment)||14||
48054119|NCT01898494|100454263|FG003|NOT COMPLETED|Step 2 (Adjuvant Treatment)||11||
48054120|NCT01898494|100454264|FG004|NOT COMPLETED|Step 2 (Adjuvant Treatment)||0||
48054121|NCT01920555|100454265|FG000|STARTED|Overall Study||18||
48054122|NCT01920555|100454266|FG001|STARTED|Overall Study||20||
48054123|NCT01920555|100454267|FG002|STARTED|Overall Study||22||
48054124|NCT01920555|100454268|FG003|STARTED|Overall Study||20||
48054125|NCT01920555|100454269|FG004|STARTED|Overall Study||19||
48054126|NCT01920555|100454265|FG000|COMPLETED|Overall Study||14||
48054127|NCT01920555|100454266|FG001|COMPLETED|Overall Study||16||
48054128|NCT01920555|100454267|FG002|COMPLETED|Overall Study||21||
48054129|NCT01920555|100454268|FG003|COMPLETED|Overall Study||17||
48054130|NCT01920555|100454269|FG004|COMPLETED|Overall Study||18||
48054131|NCT01920555|100454265|FG000|NOT COMPLETED|Overall Study||4||
48208442|NCT04970342|100837051|FG003|NOT COMPLETED|Washout (7 Days)||0||
48054132|NCT01920555|100454266|FG001|NOT COMPLETED|Overall Study||4||
48054133|NCT01920555|100454267|FG002|NOT COMPLETED|Overall Study||1||
48054134|NCT01920555|100454268|FG003|NOT COMPLETED|Overall Study||3||
48054135|NCT01920555|100454269|FG004|NOT COMPLETED|Overall Study||1||
48054136|NCT00107952|100454270|FG000|STARTED|Overall Study||381||
48054137|NCT00107952|100454271|FG001|STARTED|Overall Study||380||
48208443|NCT04970342|100837052|FG004|NOT COMPLETED|Washout (7 Days)||0||
48054138|NCT00107952|100454270|FG000|COMPLETED|Overall Study||286||
48054139|NCT00107952|100454271|FG001|COMPLETED|Overall Study||299||
48208444|NCT04970342|100837053|FG005|NOT COMPLETED|Washout (7 Days)||0||
48208445|NCT04970342|100837048|FG000|STARTED|Treatment Visit 2 (1 Day)||2||
48208446|NCT04970342|100837049|FG001|STARTED|Treatment Visit 2 (1 Day)||2||
48208447|NCT04970342|100837050|FG002|STARTED|Treatment Visit 2 (1 Day)||1||
48208448|NCT04970342|100837051|FG003|STARTED|Treatment Visit 2 (1 Day)||1||
48208449|NCT04970342|100837052|FG004|STARTED|Treatment Visit 2 (1 Day)||1||
48208450|NCT04970342|100837053|FG005|STARTED|Treatment Visit 2 (1 Day)||1||
48054140|NCT00107952|100454270|FG000|NOT COMPLETED|Overall Study||95||
48054141|NCT00107952|100454271|FG001|NOT COMPLETED|Overall Study||81||
48054142|NCT02923427|100454272|FG000|STARTED|Overall Study||55||
48054143|NCT02923427|100454273|FG001|STARTED|Overall Study||57||
48054144|NCT02923427|100454272|FG000|COMPLETED|Overall Study||51||
48054145|NCT02923427|100454273|FG001|COMPLETED|Overall Study||55||
48054146|NCT02923427|100454272|FG000|NOT COMPLETED|Overall Study||4||
48054147|NCT02923427|100454273|FG001|NOT COMPLETED|Overall Study||2||
48054148|NCT03722173|100454274|FG000|STARTED|Period 1 (2 Days)||14|Started are treated|
48054149|NCT03722173|100454274|FG000|COMPLETED|Period 1 (2 Days)||14||
48054150|NCT03722173|100454274|FG000|NOT COMPLETED|Period 1 (2 Days)||0||
48054151|NCT03722173|100454274|FG000|STARTED|Washout Period||14||
48054152|NCT03722173|100454274|FG000|COMPLETED|Washout Period||14||
48054153|NCT03722173|100454274|FG000|NOT COMPLETED|Washout Period||0||
48054154|NCT03722173|100454274|FG000|STARTED|Period 2 (4 Days)||14||
48054155|NCT03722173|100454274|FG000|COMPLETED|Period 2 (4 Days)||14||
48054156|NCT03722173|100454274|FG000|NOT COMPLETED|Period 2 (4 Days)||0||
48054157|NCT04656275|100454275|FG000|STARTED|Overall Study||2||
48054158|NCT04656275|100454276|FG001|STARTED|Overall Study||5||
48054159|NCT04656275|100454275|FG000|COMPLETED|Overall Study||0|Completed treatment|
48054160|NCT04656275|100454276|FG001|COMPLETED|Overall Study||1|Completed treatment|
48054161|NCT04656275|100454275|FG000|NOT COMPLETED|Overall Study||2||
48054162|NCT04656275|100454276|FG001|NOT COMPLETED|Overall Study||4||
48054163|NCT03649867|100454277|FG000|STARTED|Overall Study||13||
48054164|NCT03649867|100454277|FG000|COMPLETED|Overall Study||13||
48054165|NCT03649867|100454277|FG000|NOT COMPLETED|Overall Study||0||
48054166|NCT02780609|100454278|FG000|STARTED|Overall Study||3||
48054167|NCT02780609|100454279|FG001|STARTED|Overall Study||3||
48054168|NCT02780609|100454280|FG002|STARTED|Overall Study||6||
48054169|NCT02780609|100454281|FG003|STARTED|Overall Study||10||
48208451|NCT04970342|100837048|FG000|COMPLETED|Treatment Visit 2 (1 Day)||2||
48208452|NCT04970342|100837049|FG001|COMPLETED|Treatment Visit 2 (1 Day)||2||
48208453|NCT04970342|100837050|FG002|COMPLETED|Treatment Visit 2 (1 Day)||1||
48054170|NCT02780609|100454278|FG000|COMPLETED|Overall Study||3||
48054171|NCT02780609|100454279|FG001|COMPLETED|Overall Study||3||
48054172|NCT02780609|100454280|FG002|COMPLETED|Overall Study||6||
48054173|NCT02780609|100454281|FG003|COMPLETED|Overall Study||10||
48054174|NCT02780609|100454278|FG000|NOT COMPLETED|Overall Study||0||
48054175|NCT02780609|100454279|FG001|NOT COMPLETED|Overall Study||0||
48054176|NCT02780609|100454280|FG002|NOT COMPLETED|Overall Study||0||
48054177|NCT02780609|100454281|FG003|NOT COMPLETED|Overall Study||0||
48054178|NCT01754909|100454282|FG000|STARTED|Overall Study||20||
48054179|NCT01754909|100454283|FG001|STARTED|Overall Study||23||
48054180|NCT01754909|100454282|FG000|COMPLETED|Overall Study||20||
48054181|NCT01754909|100454283|FG001|COMPLETED|Overall Study||23||
48054182|NCT01754909|100454282|FG000|NOT COMPLETED|Overall Study||0||
48054183|NCT01754909|100454283|FG001|NOT COMPLETED|Overall Study||0||
48054184|NCT02495103|100454284|FG000|STARTED|Overall Study||3||
48054185|NCT02495103|100454285|FG001|STARTED|Overall Study||4||
48054186|NCT02495103|100454284|FG000|COMPLETED|Overall Study||3||
48054187|NCT02495103|100454285|FG001|COMPLETED|Overall Study||4||
48054188|NCT02495103|100454284|FG000|NOT COMPLETED|Overall Study||0||
48054189|NCT02495103|100454285|FG001|NOT COMPLETED|Overall Study||0||
48054190|NCT02579928|100454286|FG000|STARTED|Overall Study||6||
48054191|NCT02579928|100454287|FG001|STARTED|Overall Study||11||
48054192|NCT02579928|100454286|FG000|COMPLETED|Overall Study||5||
48054193|NCT02579928|100454287|FG001|COMPLETED|Overall Study||11||
48054194|NCT02579928|100454286|FG000|NOT COMPLETED|Overall Study||1||
48054195|NCT02579928|100454287|FG001|NOT COMPLETED|Overall Study||0||
48054196|NCT01063712|100454288|FG000|STARTED|Overall Study||29||
48054197|NCT01063712|100454288|FG000|COMPLETED|Overall Study||29||
48054198|NCT01063712|100454288|FG000|NOT COMPLETED|Overall Study||0||
48054199|NCT02547714|100454289|FG000|STARTED|Overall Study||34||
48054200|NCT02547714|100454289|FG000|COMPLETED|Overall Study||34||
48054201|NCT02547714|100454289|FG000|NOT COMPLETED|Overall Study||0||
48054202|NCT03051646|100454290|FG000|STARTED|Overall Study||6||
48054203|NCT03051646|100454291|FG001|STARTED|Overall Study||6||
48054204|NCT03051646|100454290|FG000|COMPLETED|Overall Study||6||
48054205|NCT03051646|100454291|FG001|COMPLETED|Overall Study||6||
48054206|NCT03051646|100454290|FG000|NOT COMPLETED|Overall Study||0||
48054207|NCT03051646|100454291|FG001|NOT COMPLETED|Overall Study||0||
48054208|NCT03823378|100454292|FG000|STARTED|Overall Study||28||
48054209|NCT03823378|100454293|FG001|STARTED|Overall Study||16||
48054210|NCT03823378|100454294|FG002|STARTED|Overall Study||12||
48054211|NCT03823378|100454295|FG003|STARTED|Overall Study||12||
48054212|NCT03823378|100454296|FG004|STARTED|Overall Study||20||
48054213|NCT03823378|100454297|FG005|STARTED|Overall Study||9||
48054214|NCT03823378|100454292|FG000|COMPLETED|Overall Study||7||
48054215|NCT03823378|100454293|FG001|COMPLETED|Overall Study||0||
48054216|NCT03823378|100454294|FG002|COMPLETED|Overall Study||2||
48054217|NCT03823378|100454295|FG003|COMPLETED|Overall Study||2||
48054218|NCT03823378|100454296|FG004|COMPLETED|Overall Study||2||
48054219|NCT03823378|100454297|FG005|COMPLETED|Overall Study||1||
48054220|NCT03823378|100454292|FG000|NOT COMPLETED|Overall Study||21||
48208454|NCT04970342|100837051|FG003|COMPLETED|Treatment Visit 2 (1 Day)||1||
48208455|NCT04970342|100837052|FG004|COMPLETED|Treatment Visit 2 (1 Day)||1||
48208456|NCT04970342|100837053|FG005|COMPLETED|Treatment Visit 2 (1 Day)||1||
48208457|NCT04970342|100837048|FG000|NOT COMPLETED|Treatment Visit 2 (1 Day)||0||
48208458|NCT04970342|100837049|FG001|NOT COMPLETED|Treatment Visit 2 (1 Day)||0||
48208459|NCT04970342|100837050|FG002|NOT COMPLETED|Treatment Visit 2 (1 Day)||0||
48054221|NCT03823378|100454293|FG001|NOT COMPLETED|Overall Study||16||
48054222|NCT03823378|100454294|FG002|NOT COMPLETED|Overall Study||10||
48054223|NCT03823378|100454295|FG003|NOT COMPLETED|Overall Study||10||
48054224|NCT03823378|100454296|FG004|NOT COMPLETED|Overall Study||18||
48054225|NCT03823378|100454297|FG005|NOT COMPLETED|Overall Study||8||
48054226|NCT00894127|100454298|FG000|STARTED|Overall Study||128||
48054227|NCT00894127|100454298|FG000|COMPLETED|Overall Study||128||
48054228|NCT00894127|100454298|FG000|NOT COMPLETED|Overall Study||0||
48054229|NCT00006389|100454299|FG000|STARTED|Overall Study||12||
48054230|NCT00006389|100454299|FG000|COMPLETED|Overall Study||11||
48054231|NCT00006389|100454299|FG000|NOT COMPLETED|Overall Study||1||
48054232|NCT01880047|100454300|FG000|STARTED|Weeks 0-2||17||
48054233|NCT01880047|100454301|FG001|STARTED|Weeks 0-2||9||
48054234|NCT01880047|100454302|FG002|STARTED|Weeks 0-2||5||
48054235|NCT01880047|100454303|FG003|STARTED|Weeks 0-2||3||
48054236|NCT01880047|100454300|FG000|COMPLETED|Weeks 0-2||17||
48054237|NCT01880047|100454301|FG001|COMPLETED|Weeks 0-2||8||
48054238|NCT01880047|100454302|FG002|COMPLETED|Weeks 0-2||4||
48054239|NCT01880047|100454303|FG003|COMPLETED|Weeks 0-2||2||
48054240|NCT01880047|100454300|FG000|NOT COMPLETED|Weeks 0-2||0||
48054241|NCT01880047|100454301|FG001|NOT COMPLETED|Weeks 0-2||1||
48054242|NCT01880047|100454302|FG002|NOT COMPLETED|Weeks 0-2||1||
48054243|NCT01880047|100454303|FG003|NOT COMPLETED|Weeks 0-2||1||
48054244|NCT01880047|100454300|FG000|STARTED|Weeks 3-4||17||
48054245|NCT01880047|100454301|FG001|STARTED|Weeks 3-4||8||
48054246|NCT01880047|100454302|FG002|STARTED|Weeks 3-4||4||
48054247|NCT01880047|100454303|FG003|STARTED|Weeks 3-4||2||
48054248|NCT01880047|100454300|FG000|COMPLETED|Weeks 3-4||17||
48054249|NCT01880047|100454301|FG001|COMPLETED|Weeks 3-4||7||
48054250|NCT01880047|100454302|FG002|COMPLETED|Weeks 3-4||4||
48054251|NCT01880047|100454303|FG003|COMPLETED|Weeks 3-4||2||
48054252|NCT01880047|100454300|FG000|NOT COMPLETED|Weeks 3-4||0||
48054253|NCT01880047|100454301|FG001|NOT COMPLETED|Weeks 3-4||1||
48054254|NCT01880047|100454302|FG002|NOT COMPLETED|Weeks 3-4||0||
48054255|NCT01880047|100454303|FG003|NOT COMPLETED|Weeks 3-4||0||
48054256|NCT01880047|100454300|FG000|STARTED|Weeks 5-8||17||
48054257|NCT01880047|100454301|FG001|STARTED|Weeks 5-8||7||
48054258|NCT01880047|100454302|FG002|STARTED|Weeks 5-8||4||
48054259|NCT01880047|100454303|FG003|STARTED|Weeks 5-8||2||
48054260|NCT01880047|100454300|FG000|COMPLETED|Weeks 5-8||15||
48054261|NCT01880047|100454301|FG001|COMPLETED|Weeks 5-8||6||
48054262|NCT01880047|100454302|FG002|COMPLETED|Weeks 5-8||4||
48054263|NCT01880047|100454303|FG003|COMPLETED|Weeks 5-8||2||
48054264|NCT01880047|100454300|FG000|NOT COMPLETED|Weeks 5-8||2||
48054265|NCT01880047|100454301|FG001|NOT COMPLETED|Weeks 5-8||1||
48054266|NCT01880047|100454302|FG002|NOT COMPLETED|Weeks 5-8||0||
48054267|NCT01880047|100454303|FG003|NOT COMPLETED|Weeks 5-8||0||
48054268|NCT01880047|100454300|FG000|STARTED|Extension Phase - 18 Months||15||
48054269|NCT01880047|100454301|FG001|STARTED|Extension Phase - 18 Months||6||
48054270|NCT01880047|100454302|FG002|STARTED|Extension Phase - 18 Months||4||
48054271|NCT01880047|100454303|FG003|STARTED|Extension Phase - 18 Months||2||
48054272|NCT01880047|100454300|FG000|COMPLETED|Extension Phase - 18 Months||6||
48054273|NCT01880047|100454301|FG001|COMPLETED|Extension Phase - 18 Months||3||
48054274|NCT01880047|100454302|FG002|COMPLETED|Extension Phase - 18 Months||3||
48054275|NCT01880047|100454303|FG003|COMPLETED|Extension Phase - 18 Months||0||
48054276|NCT01880047|100454300|FG000|NOT COMPLETED|Extension Phase - 18 Months||9||
48054277|NCT01880047|100454301|FG001|NOT COMPLETED|Extension Phase - 18 Months||3||
48054278|NCT01880047|100454302|FG002|NOT COMPLETED|Extension Phase - 18 Months||1||
48054279|NCT01880047|100454303|FG003|NOT COMPLETED|Extension Phase - 18 Months||2||
48054280|NCT02059005|100454304|FG000|STARTED|Overall Study||49||
48054281|NCT02059005|100454305|FG001|STARTED|Overall Study||48||
48054282|NCT02059005|100454304|FG000|3 Month Assessment|Overall Study||37||
48054283|NCT02059005|100454305|FG001|3 Month Assessment|Overall Study||33||
48054284|NCT02059005|100454304|FG000|6 Month Assessment|Overall Study||29||
48054285|NCT02059005|100454305|FG001|6 Month Assessment|Overall Study||24||
48054286|NCT02059005|100454304|FG000|COMPLETED|Overall Study||29||
48054287|NCT02059005|100454305|FG001|COMPLETED|Overall Study||24||
48054288|NCT02059005|100454304|FG000|NOT COMPLETED|Overall Study||20||
48054289|NCT02059005|100454305|FG001|NOT COMPLETED|Overall Study||24||
48054290|NCT01016561|100454306|FG000|STARTED|Overall Study||0||
48054291|NCT01016561|100454306|FG000|COMPLETED|Overall Study||0||
48054292|NCT01016561|100454306|FG000|NOT COMPLETED|Overall Study||0||
48054293|NCT01410552|100454307|FG000|STARTED|Overall Study||1013||
48054294|NCT01410552|100454307|FG000|COMPLETED|Overall Study||877||
48054295|NCT01410552|100454307|FG000|NOT COMPLETED|Overall Study||136||
48054296|NCT01278160|100454308|FG000|STARTED|Overall Study||89||
48054297|NCT01278160|100454309|FG001|STARTED|Overall Study||90||
48054298|NCT01278160|100454308|FG000|COMPLETED|Overall Study||84||
48054299|NCT01278160|100454309|FG001|COMPLETED|Overall Study||84||
48054300|NCT01278160|100454308|FG000|NOT COMPLETED|Overall Study||5||
48054301|NCT01278160|100454309|FG001|NOT COMPLETED|Overall Study||6||
48054302|NCT00433654|100454310|FG000|STARTED|Overall Study||258||
48054303|NCT00433654|100454311|FG001|STARTED|Overall Study||206||
48054304|NCT00433654|100454310|FG000|COMPLETED|Overall Study||243||
48054305|NCT00433654|100454311|FG001|COMPLETED|Overall Study||201||
48054306|NCT00433654|100454310|FG000|NOT COMPLETED|Overall Study||15||
48054307|NCT00433654|100454311|FG001|NOT COMPLETED|Overall Study||5||
48054308|NCT04714359|100454312|FG000|STARTED|Overall Study||87||
48054309|NCT04714359|100454312|FG000|COMPLETED|Overall Study||78||
48054310|NCT04714359|100454312|FG000|NOT COMPLETED|Overall Study||9||
48054311|NCT00364130|100454313|FG000|STARTED|Intervention Period||69||
48054312|NCT00364130|100454314|FG001|STARTED|Intervention Period||69||
48054313|NCT00364130|100454313|FG000|COMPLETED|Intervention Period||60||
48054314|NCT00364130|100454314|FG001|COMPLETED|Intervention Period||61||
48054315|NCT00364130|100454313|FG000|NOT COMPLETED|Intervention Period||9||
48054316|NCT00364130|100454314|FG001|NOT COMPLETED|Intervention Period||8||
48054317|NCT00364130|100454313|FG000|STARTED|Post Intervention Follow-up Period||60||
48054318|NCT00364130|100454314|FG001|STARTED|Post Intervention Follow-up Period||61||
48054319|NCT00364130|100454313|FG000|COMPLETED|Post Intervention Follow-up Period||55||
48054320|NCT00364130|100454314|FG001|COMPLETED|Post Intervention Follow-up Period||50||
48054321|NCT00364130|100454313|FG000|NOT COMPLETED|Post Intervention Follow-up Period||5||
48054322|NCT00364130|100454314|FG001|NOT COMPLETED|Post Intervention Follow-up Period||11||
48054323|NCT01232205|100454315|FG000|STARTED|Overall Study||52||
48054324|NCT01232205|100454316|FG001|STARTED|Overall Study||58||
48054325|NCT01232205|100454315|FG000|COMPLETED|Overall Study||49||
48054326|NCT01232205|100454316|FG001|COMPLETED|Overall Study||55||
48054327|NCT01232205|100454315|FG000|NOT COMPLETED|Overall Study||3||
48054328|NCT01232205|100454316|FG001|NOT COMPLETED|Overall Study||3||
48054329|NCT04856865|100454317|FG000|STARTED|Overall Study||25||
48054330|NCT04856865|100454318|FG001|STARTED|Overall Study||24||
48054331|NCT04856865|100454319|FG002|STARTED|Overall Study||24||
48495705|NCT02584608|101547916|FG000|COMPLETED|Overall Study||12||
48054332|NCT04856865|100454317|FG000|COMPLETED|Overall Study||19||
48054333|NCT04856865|100454318|FG001|COMPLETED|Overall Study||16||
48054334|NCT04856865|100454319|FG002|COMPLETED|Overall Study||21||
48054335|NCT04856865|100454317|FG000|NOT COMPLETED|Overall Study||6||
48054336|NCT04856865|100454318|FG001|NOT COMPLETED|Overall Study||8||
48054337|NCT04856865|100454319|FG002|NOT COMPLETED|Overall Study||3||
48054338|NCT02417844|100454320|FG000|STARTED|Overall Study||17||
48054339|NCT02417844|100454321|FG001|STARTED|Overall Study||17||
48054340|NCT02417844|100454320|FG000|COMPLETED|Overall Study||17||
48054341|NCT02417844|100454321|FG001|COMPLETED|Overall Study||17||
48054342|NCT02417844|100454320|FG000|NOT COMPLETED|Overall Study||0||
48054343|NCT02417844|100454321|FG001|NOT COMPLETED|Overall Study||0||
48054344|NCT03194503|100454322|FG000|STARTED|Overall Study||458||
48054345|NCT03194503|100454323|FG001|STARTED|Overall Study||1054||
48054346|NCT03194503|100454322|FG000|COMPLETED|Overall Study||458||
48054347|NCT03194503|100454323|FG001|COMPLETED|Overall Study||1054||
48054348|NCT03194503|100454322|FG000|NOT COMPLETED|Overall Study||0||
48054349|NCT03194503|100454323|FG001|NOT COMPLETED|Overall Study||0||
48054350|NCT04468321|100454324|FG000|STARTED|Overall Study||70||
48054351|NCT04468321|100454325|FG001|STARTED|Overall Study||35||
48054352|NCT04468321|100454324|FG000|COMPLETED|Overall Study||60||
48054353|NCT04468321|100454325|FG001|COMPLETED|Overall Study||25||
48054354|NCT04468321|100454324|FG000|NOT COMPLETED|Overall Study||10||
48054355|NCT04468321|100454325|FG001|NOT COMPLETED|Overall Study||10||
48054356|NCT02301611|100454326|FG000|STARTED|Overall Study||47||
48054357|NCT02301611|100454327|FG001|STARTED|Overall Study||41||
48054358|NCT02301611|100454328|FG002|STARTED|Overall Study||43||
48054359|NCT02301611|100454329|FG003|STARTED|Overall Study||56||
48054360|NCT02301611|100454326|FG000|COMPLETED|Overall Study||19||
48054361|NCT02301611|100454327|FG001|COMPLETED|Overall Study||8||
48054362|NCT02301611|100454328|FG002|COMPLETED|Overall Study||1||
48054363|NCT02301611|100454329|FG003|COMPLETED|Overall Study||8||
48054364|NCT02301611|100454326|FG000|NOT COMPLETED|Overall Study||28||
48054365|NCT02301611|100454327|FG001|NOT COMPLETED|Overall Study||33||
48054366|NCT02301611|100454328|FG002|NOT COMPLETED|Overall Study||42||
48054367|NCT02301611|100454329|FG003|NOT COMPLETED|Overall Study||48||
48054368|NCT04059185|100454330|FG000|STARTED|Longitudinal Assessment-Adults Only||289||
48054369|NCT04059185|100454331|FG001|STARTED|Longitudinal Assessment-Adults Only||294||
48054370|NCT04059185|100454332|FG002|STARTED|Longitudinal Assessment-Adults Only||297||
48054371|NCT04059185|100454330|FG000|Completed Baseline Survey and Study Condition|Longitudinal Assessment-Adults Only||272||
48054372|NCT04059185|100454331|FG001|Completed Baseline Survey and Study Condition|Longitudinal Assessment-Adults Only||271||
48054373|NCT04059185|100454332|FG002|Completed Baseline Survey and Study Condition|Longitudinal Assessment-Adults Only||280||
48054374|NCT04059185|100454330|FG000|Completed 3 Month Post-intervention Survey|Longitudinal Assessment-Adults Only||243||
48054375|NCT04059185|100454331|FG001|Completed 3 Month Post-intervention Survey|Longitudinal Assessment-Adults Only||239||
48054376|NCT04059185|100454332|FG002|Completed 3 Month Post-intervention Survey|Longitudinal Assessment-Adults Only||258||
48054377|NCT04059185|100454330|FG000|Completed 4 Year Post-intervention Survey|Longitudinal Assessment-Adults Only||142||
48054378|NCT04059185|100454331|FG001|Completed 4 Year Post-intervention Survey|Longitudinal Assessment-Adults Only||133||
48054379|NCT04059185|100454332|FG002|Completed 4 Year Post-intervention Survey|Longitudinal Assessment-Adults Only||165||
48054380|NCT04059185|100454330|FG000|COMPLETED|Longitudinal Assessment-Adults Only||81|This is the number of adults who completed all longitudinal assessments (4 year post-intervention clinic visit, 4 year post-intervention survey, 3 month post-intervention survey, and baseline); only 2 persons in this group did not complete the 3 month post-intervention survey|
48054381|NCT04059185|100454331|FG001|COMPLETED|Longitudinal Assessment-Adults Only||72|This is the number of adults who completed all longitudinal assessments (4 year post-intervention clinic visit, 4 year post-intervention survey, 3 month post-intervention survey, and baseline); only 2 persons in this group did not complete the 3 month post-intervention survey|
48054382|NCT04059185|100454332|FG002|COMPLETED|Longitudinal Assessment-Adults Only||100|This is the number of adults who completed all longitudinal assessments (4 year post-intervention clinic visit, 4 year post-intervention survey, 3 month post-intervention survey, and baseline); only 2 persons in this group did not complete the 3 month post-intervention survey|
48054383|NCT04059185|100454330|FG000|NOT COMPLETED|Longitudinal Assessment-Adults Only||208||
48054384|NCT04059185|100454331|FG001|NOT COMPLETED|Longitudinal Assessment-Adults Only||222||
48054385|NCT04059185|100454332|FG002|NOT COMPLETED|Longitudinal Assessment-Adults Only||197||
48054386|NCT04059185|100454330|FG000|STARTED|4 Year Post-Intervention Clinic-Children||81|These numbers reflect the index children who were eligible to participate in the 4 year post-intervention clinic visit with their adult caregiver. Only those children whose adult caregiver agreed to partcipate in the 4 year post-intervention clinic visit were eligible.|
48054387|NCT04059185|100454331|FG001|STARTED|4 Year Post-Intervention Clinic-Children||72|These numbers reflect the index children who were eligible to participate in the 4 year post-intervention clinic visit with their adult caregiver. Only those children whose adult caregiver agreed to partcipate in the 4 year post-intervention clinic visit were eligible.|
48054388|NCT04059185|100454332|FG002|STARTED|4 Year Post-Intervention Clinic-Children||100|These numbers reflect the index children who were eligible to participate in the 4 year post-intervention clinic visit with their adult caregiver. Only those children whose adult caregiver agreed to partcipate in the 4 year post-intervention clinic visit were eligible.|
48054389|NCT04059185|100454330|FG000|COMPLETED|4 Year Post-Intervention Clinic-Children||81||
48054390|NCT04059185|100454331|FG001|COMPLETED|4 Year Post-Intervention Clinic-Children||72||
48054391|NCT04059185|100454332|FG002|COMPLETED|4 Year Post-Intervention Clinic-Children||100||
48054392|NCT04059185|100454330|FG000|NOT COMPLETED|4 Year Post-Intervention Clinic-Children||0||
48054393|NCT04059185|100454331|FG001|NOT COMPLETED|4 Year Post-Intervention Clinic-Children||0||
48054394|NCT04059185|100454332|FG002|NOT COMPLETED|4 Year Post-Intervention Clinic-Children||0||
48054395|NCT00400946|100454333|FG000|STARTED|Overall Study||231||
48054396|NCT00400946|100454334|FG001|STARTED|Overall Study||232||
48054397|NCT00400946|100454335|FG002|STARTED|Overall Study||42||
48054398|NCT00400946|100454336|FG003|STARTED|Overall Study||51||
48495706|NCT02584608|101547916|FG000|NOT COMPLETED|Overall Study||0||
48495707|NCT05327777|101547917|FG000|STARTED|Overall Study||58||
48495708|NCT05327777|101547918|FG001|STARTED|Overall Study||42||
48054399|NCT00400946|100454337|FG004|STARTED|Overall Study||244||
48054400|NCT00400946|100454333|FG000|Evaluable for CNS Directed-Treatment|Overall Study||231|Patients who achieved an induction complete remission with an evaluable sample at diagnosis.|
48054401|NCT00400946|100454334|FG001|Evaluable for CNS Directed-Treatment|Overall Study||232|Patients who achieved an induction complete remission with an evaluable sample at diagnosis.|
48054402|NCT00400946|100454335|FG002|Evaluable for CNS Directed-Treatment|Overall Study||42|Patients who achieved an induction complete remission with an evaluable sample at diagnosis.|
48495709|NCT05327777|101547919|FG002|STARTED|Overall Study||29||
48666742|NCT03391882|101970465|FG000|Modified Intent-to-Treat Population Part A|Part A - Titration Phase||20||
48054403|NCT00400946|100454336|FG003|Evaluable for CNS Directed-Treatment|Overall Study||21|Patients who achieved an induction complete remission with an evaluable sample at diagnosis.|
48054404|NCT00400946|100454337|FG004|Evaluable for CNS Directed-Treatment|Overall Study||227|Patients who achieved an induction complete remission with an evaluable sample at diagnosis.|
48054405|NCT00400946|100454333|FG000|Evaluable for Day 18 Marrow Morphology|Overall Study||158|Patients who achieved an induction complete remission with an optional evaluable sample at day 18.|
48054406|NCT00400946|100454334|FG001|Evaluable for Day 18 Marrow Morphology|Overall Study||161|Patients who achieved an induction complete remission with an optional evaluable sample at day 18.|
48054407|NCT00400946|100454335|FG002|Evaluable for Day 18 Marrow Morphology|Overall Study||19|Patients who achieved an induction complete remission with an optional evaluable sample at day 18.|
48054408|NCT00400946|100454336|FG003|Evaluable for Day 18 Marrow Morphology|Overall Study||13|Patients who achieved an induction complete remission with an optional evaluable sample at day 18.|
48054409|NCT00400946|100454337|FG004|Evaluable for Day 18 Marrow Morphology|Overall Study||152|Patients who achieved an induction complete remission with an optional evaluable sample at day 18.|
48054410|NCT00400946|100454333|FG000|Evaluable for Day 32 MRD|Overall Study||166|B cell patients who achieved an induction complete remission with an evaluable sample at day 32.|
48054411|NCT00400946|100454334|FG001|Evaluable for Day 32 MRD|Overall Study||167|B cell patients who achieved an induction complete remission with an evaluable sample at day 32.|
48054412|NCT00400946|100454335|FG002|Evaluable for Day 32 MRD|Overall Study||33|B cell patients who achieved an induction complete remission with an evaluable sample at day 32.|
48054413|NCT00400946|100454336|FG003|Evaluable for Day 32 MRD|Overall Study||12|B cell patients who achieved an induction complete remission with an evaluable sample at day 32.|
48054414|NCT00400946|100454337|FG004|Evaluable for Day 32 MRD|Overall Study||168|B cell patients who achieved an induction complete remission with an evaluable sample at day 32.|
48054415|NCT00400946|100454333|FG000|Eligible and Treated|Overall Study||231|Ineligible: Burkitt's leuk diag (n=2), pr therapy (n=1), hyperbilirubinemia (n=1), w/d consent (n=2)|
48054416|NCT00400946|100454334|FG001|Eligible and Treated|Overall Study||232|Ineligible: Burkitt's leuk diag (n=2), pr therapy (n=1), hyperbilirubinemia (n=1), w/d consent (n=2)|
48054417|NCT00400946|100454335|FG002|Eligible and Treated|Overall Study||42|Ineligible: Burkitt's leuk diag (n=2), pr therapy (n=1), hyperbilirubinemia (n=1), w/d consent (n=2)|
48054418|NCT00400946|100454336|FG003|Eligible and Treated|Overall Study||46|Ineligible: Burkitt's leuk diag (n=2), pr therapy (n=1), hyperbilirubinemia (n=1), w/d consent (n=2)|
48054419|NCT00400946|100454337|FG004|Eligible and Treated|Overall Study||243|Ineligible: Burkitt's leuk diag (n=2), pr therapy (n=1), hyperbilirubinemia (n=1), w/d consent (n=2)|
48054420|NCT00400946|100454333|FG000|COMPLETED|Overall Study||217||
48054421|NCT00400946|100454334|FG001|COMPLETED|Overall Study||221||
48054422|NCT00400946|100454335|FG002|COMPLETED|Overall Study||40||
48054423|NCT00400946|100454336|FG003|COMPLETED|Overall Study||4||
48054424|NCT00400946|100454337|FG004|COMPLETED|Overall Study||206||
48054425|NCT00400946|100454333|FG000|NOT COMPLETED|Overall Study||14||
48054426|NCT00400946|100454334|FG001|NOT COMPLETED|Overall Study||11||
48054427|NCT00400946|100454335|FG002|NOT COMPLETED|Overall Study||2||
48054428|NCT00400946|100454336|FG003|NOT COMPLETED|Overall Study||47||
48054429|NCT00400946|100454337|FG004|NOT COMPLETED|Overall Study||38||
48054430|NCT05868382|100454338|FG000|STARTED|Overall Study||60||
48054431|NCT05868382|100454339|FG001|STARTED|Overall Study||30||
48054432|NCT05868382|100454340|FG002|STARTED|Overall Study||60||
48054433|NCT05868382|100454341|FG003|STARTED|Overall Study||30||
48054434|NCT05868382|100454342|FG004|STARTED|Overall Study||30||
48054435|NCT05868382|100454343|FG005|STARTED|Overall Study||60||
48054436|NCT05868382|100454338|FG000|Received Injection|Overall Study||60||
48054437|NCT05868382|100454339|FG001|Received Injection|Overall Study||30||
48054438|NCT05868382|100454340|FG002|Received Injection|Overall Study||60||
48054439|NCT05868382|100454341|FG003|Received Injection|Overall Study||30||
48054440|NCT05868382|100454342|FG004|Received Injection|Overall Study||30||
48054441|NCT05868382|100454343|FG005|Received Injection|Overall Study||60||
48054442|NCT05868382|100454338|FG000|Safety Set|Overall Study||60|All participants who received 1 dose of study intervention. Participants were included in the study arm corresponding to the study intervention that they received.|
48054443|NCT05868382|100454339|FG001|Safety Set|Overall Study||30|All participants who received 1 dose of study intervention. Participants were included in the study arm corresponding to the study intervention that they received.|
48054444|NCT05868382|100454340|FG002|Safety Set|Overall Study||60|All participants who received 1 dose of study intervention. Participants were included in the study arm corresponding to the study intervention that they received.|
48054445|NCT05868382|100454341|FG003|Safety Set|Overall Study||30|All participants who received 1 dose of study intervention. Participants were included in the study arm corresponding to the study intervention that they received.|
48054446|NCT05868382|100454342|FG004|Safety Set|Overall Study||31|All participants who received 1 dose of study intervention. Participants were included in the study arm corresponding to the study intervention that they received.|
48054447|NCT05868382|100454343|FG005|Safety Set|Overall Study||59|All participants who received 1 dose of study intervention. Participants were included in the study arm corresponding to the study intervention that they received.|
48054448|NCT05868382|100454338|FG000|Solicited Safety Set|Overall Study||60|All participants who received 1 dose of study intervention and contributed any solicited AR data (that is, had at least 1 post baseline solicited safety \[eDiary\] assessment). Participants were included in the study arm corresponding to the study intervention that they received.|
48208460|NCT04970342|100837051|FG003|NOT COMPLETED|Treatment Visit 2 (1 Day)||0||
48208461|NCT04970342|100837052|FG004|NOT COMPLETED|Treatment Visit 2 (1 Day)||0||
48208462|NCT04970342|100837053|FG005|NOT COMPLETED|Treatment Visit 2 (1 Day)||0||
48208463|NCT04970342|100837048|FG000|STARTED|Washout (7 Days)||2||
48054449|NCT05868382|100454339|FG001|Solicited Safety Set|Overall Study||30|All participants who received 1 dose of study intervention and contributed any solicited AR data (that is, had at least 1 post baseline solicited safety \[eDiary\] assessment). Participants were included in the study arm corresponding to the study intervention that they received.|
48054450|NCT05868382|100454340|FG002|Solicited Safety Set|Overall Study||60|All participants who received 1 dose of study intervention and contributed any solicited AR data (that is, had at least 1 post baseline solicited safety \[eDiary\] assessment). Participants were included in the study arm corresponding to the study intervention that they received.|
48054451|NCT05868382|100454341|FG003|Solicited Safety Set|Overall Study||30|All participants who received 1 dose of study intervention and contributed any solicited AR data (that is, had at least 1 post baseline solicited safety \[eDiary\] assessment). Participants were included in the study arm corresponding to the study intervention that they received.|
48054452|NCT05868382|100454342|FG004|Solicited Safety Set|Overall Study||31|All participants who received 1 dose of study intervention and contributed any solicited AR data (that is, had at least 1 post baseline solicited safety \[eDiary\] assessment). Participants were included in the study arm corresponding to the study intervention that they received.|
48054453|NCT05868382|100454343|FG005|Solicited Safety Set|Overall Study||59|All participants who received 1 dose of study intervention and contributed any solicited AR data (that is, had at least 1 post baseline solicited safety \[eDiary\] assessment). Participants were included in the study arm corresponding to the study intervention that they received.|
48054454|NCT05868382|100454338|FG000|Per-Protocol Set|Overall Study||55|All randomized participants who received the study intervention, complied with the injection schedule, timing of immunogenicity blood sampling to have a baseline (Day 1), had at least 1 post injection assessment, had a Day 29 assessment that was within 22 days to 43 days after injection, had no important protocol deviations which impacted the immune response, and did not use prohibited medication or nonstudy vaccines against influenza.|
48054455|NCT05868382|100454339|FG001|Per-Protocol Set|Overall Study||28|All randomized participants who received the study intervention, complied with the injection schedule, timing of immunogenicity blood sampling to have a baseline (Day 1), had at least 1 post injection assessment, had a Day 29 assessment that was within 22 days to 43 days after injection, had no important protocol deviations which impacted the immune response, and did not use prohibited medication or nonstudy vaccines against influenza.|
48054456|NCT05868382|100454340|FG002|Per-Protocol Set|Overall Study||56|All randomized participants who received the study intervention, complied with the injection schedule, timing of immunogenicity blood sampling to have a baseline (Day 1), had at least 1 post injection assessment, had a Day 29 assessment that was within 22 days to 43 days after injection, had no important protocol deviations which impacted the immune response, and did not use prohibited medication or nonstudy vaccines against influenza.|
48054457|NCT05868382|100454341|FG003|Per-Protocol Set|Overall Study||29|All randomized participants who received the study intervention, complied with the injection schedule, timing of immunogenicity blood sampling to have a baseline (Day 1), had at least 1 post injection assessment, had a Day 29 assessment that was within 22 days to 43 days after injection, had no important protocol deviations which impacted the immune response, and did not use prohibited medication or nonstudy vaccines against influenza.|
48054458|NCT05868382|100454342|FG004|Per-Protocol Set|Overall Study||28|All randomized participants who received the study intervention, complied with the injection schedule, timing of immunogenicity blood sampling to have a baseline (Day 1), had at least 1 post injection assessment, had a Day 29 assessment that was within 22 days to 43 days after injection, had no important protocol deviations which impacted the immune response, and did not use prohibited medication or nonstudy vaccines against influenza.|
48054459|NCT05868382|100454343|FG005|Per-Protocol Set|Overall Study||52|All randomized participants who received the study intervention, complied with the injection schedule, timing of immunogenicity blood sampling to have a baseline (Day 1), had at least 1 post injection assessment, had a Day 29 assessment that was within 22 days to 43 days after injection, had no important protocol deviations which impacted the immune response, and did not use prohibited medication or nonstudy vaccines against influenza.|
48054460|NCT05868382|100454338|FG000|COMPLETED|Overall Study||54||
48054461|NCT05868382|100454339|FG001|COMPLETED|Overall Study||30||
48054462|NCT05868382|100454340|FG002|COMPLETED|Overall Study||54||
48054463|NCT05868382|100454341|FG003|COMPLETED|Overall Study||26||
48054464|NCT05868382|100454342|FG004|COMPLETED|Overall Study||27||
48054465|NCT05868382|100454343|FG005|COMPLETED|Overall Study||54||
48054466|NCT05868382|100454338|FG000|NOT COMPLETED|Overall Study||6||
48054467|NCT05868382|100454339|FG001|NOT COMPLETED|Overall Study||0||
48054468|NCT05868382|100454340|FG002|NOT COMPLETED|Overall Study||6||
48054469|NCT05868382|100454341|FG003|NOT COMPLETED|Overall Study||4||
48054470|NCT05868382|100454342|FG004|NOT COMPLETED|Overall Study||3||
48054471|NCT05868382|100454343|FG005|NOT COMPLETED|Overall Study||6||
48054472|NCT02829918|100454344|FG000|STARTED|Overall Study||54||
48054473|NCT02829918|100454344|FG000|COMPLETED|Overall Study||46||
48054474|NCT02829918|100454344|FG000|NOT COMPLETED|Overall Study||8||
48054475|NCT01257802|100454345|FG000|STARTED|Overall Study||6||
48054476|NCT01257802|100454346|FG001|STARTED|Overall Study||8||
48054477|NCT01257802|100454345|FG000|6 Month / 24 Week Visit|Overall Study||5||
48054478|NCT01257802|100454346|FG001|6 Month / 24 Week Visit|Overall Study||2||
48054479|NCT01257802|100454345|FG000|COMPLETED|Overall Study||5||
48054480|NCT01257802|100454346|FG001|COMPLETED|Overall Study||2||
48208464|NCT04970342|100837049|FG001|STARTED|Washout (7 Days)||2||
48208465|NCT04970342|100837050|FG002|STARTED|Washout (7 Days)||1||
48495710|NCT05327777|101547917|FG000|COMPLETED|Overall Study||58||
48495711|NCT05327777|101547918|FG001|COMPLETED|Overall Study||42||
48495712|NCT05327777|101547919|FG002|COMPLETED|Overall Study||29||
48495713|NCT05327777|101547917|FG000|NOT COMPLETED|Overall Study||0||
48495714|NCT05327777|101547918|FG001|NOT COMPLETED|Overall Study||0||
48495715|NCT05327777|101547919|FG002|NOT COMPLETED|Overall Study||0||
48495716|NCT00834132|101547920|FG000|STARTED|First Intervention||12||
48054481|NCT01257802|100454345|FG000|NOT COMPLETED|Overall Study||1||
48054482|NCT01257802|100454346|FG001|NOT COMPLETED|Overall Study||6||
48054483|NCT01674634|100454347|FG000|STARTED|Overall Study||715||
48054484|NCT01674634|100454347|FG000|COMPLETED|Overall Study||709||
48054485|NCT01674634|100454347|FG000|NOT COMPLETED|Overall Study||6||
48054486|NCT01236118|100454348|FG000|STARTED|Overall Study||6||
48054487|NCT01236118|100454349|FG001|STARTED|Overall Study||5||
48054488|NCT01236118|100454350|FG002|STARTED|Overall Study||17||
48054489|NCT01236118|100454348|FG000|COMPLETED|Overall Study||4||
48054490|NCT01236118|100454349|FG001|COMPLETED|Overall Study||4||
48054491|NCT01236118|100454350|FG002|COMPLETED|Overall Study||14||
48054492|NCT01236118|100454348|FG000|NOT COMPLETED|Overall Study||2||
48054493|NCT01236118|100454349|FG001|NOT COMPLETED|Overall Study||1||
48054494|NCT01236118|100454350|FG002|NOT COMPLETED|Overall Study||3||
48054495|NCT01002482|100454351|FG000|STARTED|Overall Study||1351||
48054496|NCT01002482|100454352|FG001|STARTED|Overall Study||1333||
48054497|NCT01002482|100454351|FG000|COMPLETED|Overall Study||1336||
48054498|NCT01002482|100454352|FG001|COMPLETED|Overall Study||1312||
48054499|NCT01002482|100454351|FG000|NOT COMPLETED|Overall Study||15||
48054500|NCT01002482|100454352|FG001|NOT COMPLETED|Overall Study||21||
48054501|NCT01467583|100454353|FG000|STARTED|Overall Study||16||
48054502|NCT01467583|100454354|FG001|STARTED|Overall Study||4||
48054503|NCT01467583|100454355|FG002|STARTED|Overall Study||12||
48054504|NCT01467583|100454353|FG000|COMPLETED|Overall Study||14||
48054505|NCT01467583|100454354|FG001|COMPLETED|Overall Study||3||
48054506|NCT01467583|100454355|FG002|COMPLETED|Overall Study||10||
48054507|NCT01467583|100454353|FG000|NOT COMPLETED|Overall Study||2||
48054508|NCT01467583|100454354|FG001|NOT COMPLETED|Overall Study||1||
48054509|NCT01467583|100454355|FG002|NOT COMPLETED|Overall Study||2||
48054510|NCT04457973|100454356|FG000|STARTED|Overall Study||20||
48054511|NCT04457973|100454357|FG001|STARTED|Overall Study||20||
48054512|NCT04457973|100454356|FG000|COMPLETED|Overall Study||20||
48054513|NCT04457973|100454357|FG001|COMPLETED|Overall Study||20||
48054514|NCT04457973|100454356|FG000|NOT COMPLETED|Overall Study||0||
48054515|NCT04457973|100454357|FG001|NOT COMPLETED|Overall Study||0||
48054516|NCT04707326|100454358|FG000|STARTED|Overall Study||390||
48054517|NCT04707326|100454359|FG001|STARTED|Overall Study||780||
48054518|NCT04707326|100454360|FG002|STARTED|Overall Study||290||
48054519|NCT04707326|100454361|FG003|STARTED|Overall Study||580||
48054520|NCT04707326|100454358|FG000|COMPLETED|Overall Study||390||
48054521|NCT04707326|100454359|FG001|COMPLETED|Overall Study||780||
48054522|NCT04707326|100454360|FG002|COMPLETED|Overall Study||290||
48054523|NCT04707326|100454361|FG003|COMPLETED|Overall Study||580||
48054524|NCT04707326|100454358|FG000|NOT COMPLETED|Overall Study||0||
48054525|NCT04707326|100454359|FG001|NOT COMPLETED|Overall Study||0||
48054526|NCT04707326|100454360|FG002|NOT COMPLETED|Overall Study||0||
48054527|NCT04707326|100454361|FG003|NOT COMPLETED|Overall Study||0||
48054528|NCT00055471|100454362|FG000|STARTED|Period 1: Dose Escalation Period||3||
48054529|NCT00055471|100454363|FG001|STARTED|Period 1: Dose Escalation Period||10||
48054530|NCT00055471|100454364|FG002|STARTED|Period 1: Dose Escalation Period||3||
48054531|NCT00055471|100454362|FG000|COMPLETED|Period 1: Dose Escalation Period||3||
48054532|NCT00055471|100454363|FG001|COMPLETED|Period 1: Dose Escalation Period||8||
48054533|NCT00055471|100454364|FG002|COMPLETED|Period 1: Dose Escalation Period||0||
48054534|NCT00055471|100454362|FG000|NOT COMPLETED|Period 1: Dose Escalation Period||0||
48054535|NCT00055471|100454363|FG001|NOT COMPLETED|Period 1: Dose Escalation Period||2||
48054536|NCT00055471|100454364|FG002|NOT COMPLETED|Period 1: Dose Escalation Period||3||
48054537|NCT00055471|100454362|FG000|STARTED|Period 2: Extension Period||3||
48054538|NCT00055471|100454363|FG001|STARTED|Period 2: Extension Period||6||
48054539|NCT00055471|100454364|FG002|STARTED|Period 2: Extension Period||0||
48054540|NCT00055471|100454362|FG000|COMPLETED|Period 2: Extension Period||3||
48054541|NCT00055471|100454363|FG001|COMPLETED|Period 2: Extension Period||6||
48054542|NCT00055471|100454364|FG002|COMPLETED|Period 2: Extension Period||0||
48054543|NCT00055471|100454362|FG000|NOT COMPLETED|Period 2: Extension Period||0||
48054544|NCT00055471|100454363|FG001|NOT COMPLETED|Period 2: Extension Period||0||
48054545|NCT00055471|100454364|FG002|NOT COMPLETED|Period 2: Extension Period||0||
48054546|NCT03370289|100454365|FG000|STARTED|Overall Study||55||
48054547|NCT03370289|100454365|FG000|COMPLETED|Overall Study||50||
48054548|NCT03370289|100454365|FG000|NOT COMPLETED|Overall Study||5||
48054549|NCT05128773|100454366|FG000|STARTED|Overall Study||3||
48054550|NCT05128773|100454366|FG000|COMPLETED|Overall Study||0||
48054551|NCT05128773|100454366|FG000|NOT COMPLETED|Overall Study||3||
48054552|NCT01756300|100454367|FG000|STARTED|Overall Study||35||
48054553|NCT01756300|100454367|FG000|COMPLETED|Overall Study||33||
48054554|NCT01756300|100454367|FG000|NOT COMPLETED|Overall Study||2||
48054555|NCT03868124|100454368|FG000|STARTED|Overall Study||185||
48054556|NCT03868124|100454369|FG001|STARTED|Overall Study||183||
48054557|NCT03868124|100454370|FG002|STARTED|Overall Study||192||
48054558|NCT03868124|100454368|FG000|Month 3|Overall Study||182||
48054559|NCT03868124|100454369|FG001|Month 3|Overall Study||182||
48054560|NCT03868124|100454370|FG002|Month 3|Overall Study||190||
48054561|NCT03868124|100454368|FG000|Month 12|Overall Study||176||
48054562|NCT03868124|100454369|FG001|Month 12|Overall Study||180||
48054563|NCT03868124|100454370|FG002|Month 12|Overall Study||183||
48054564|NCT03868124|100454368|FG000|COMPLETED|Overall Study||0||
48054565|NCT03868124|100454369|FG001|COMPLETED|Overall Study||0||
48054566|NCT03868124|100454370|FG002|COMPLETED|Overall Study||0||
48054567|NCT03868124|100454368|FG000|NOT COMPLETED|Overall Study||185||
48054568|NCT03868124|100454369|FG001|NOT COMPLETED|Overall Study||183||
48054569|NCT03868124|100454370|FG002|NOT COMPLETED|Overall Study||192||
48054570|NCT03822468|100454371|FG000|STARTED|Treatment Period||188||
48054571|NCT03822468|100454372|FG001|STARTED|Treatment Period||188||
48054572|NCT03822468|100454371|FG000|COMPLETED|Treatment Period||0||
48054573|NCT03822468|100454372|FG001|COMPLETED|Treatment Period||0||
48054574|NCT03822468|100454371|FG000|NOT COMPLETED|Treatment Period||188||
48054575|NCT03822468|100454372|FG001|NOT COMPLETED|Treatment Period||188||
48054576|NCT03822468|100454371|FG000|STARTED|Post-treatment Efficacy Follow-up||19||
48054577|NCT03822468|100454372|FG001|STARTED|Post-treatment Efficacy Follow-up||21||
48054578|NCT03822468|100454371|FG000|COMPLETED|Post-treatment Efficacy Follow-up||0||
48054579|NCT03822468|100454372|FG001|COMPLETED|Post-treatment Efficacy Follow-up||0||
48054580|NCT03822468|100454371|FG000|NOT COMPLETED|Post-treatment Efficacy Follow-up||19||
48054581|NCT03822468|100454372|FG001|NOT COMPLETED|Post-treatment Efficacy Follow-up||21||
48054582|NCT05386823|100454373|FG000|STARTED|Overall Study||6||
48054583|NCT05386823|100454374|FG001|STARTED|Overall Study||6||
48054584|NCT05386823|100454375|FG002|STARTED|Overall Study||4||
48054585|NCT05386823|100454373|FG000|COMPLETED|Overall Study||6||
48054586|NCT05386823|100454374|FG001|COMPLETED|Overall Study||6||
48054587|NCT05386823|100454375|FG002|COMPLETED|Overall Study||4||
48054588|NCT05386823|100454373|FG000|NOT COMPLETED|Overall Study||0||
48054589|NCT05386823|100454374|FG001|NOT COMPLETED|Overall Study||0||
48054590|NCT05386823|100454375|FG002|NOT COMPLETED|Overall Study||0||
48054591|NCT01721473|100454376|FG000|STARTED|Overall Study||47||
48054592|NCT01721473|100454377|FG001|STARTED|Overall Study||22||
48054593|NCT01721473|100454378|FG002|STARTED|Overall Study||41||
48054594|NCT01721473|100454379|FG003|STARTED|Overall Study||34||
48054595|NCT01721473|100454380|FG004|STARTED|Overall Study||22||
48054596|NCT01721473|100454381|FG005|STARTED|Overall Study||18||
48054597|NCT01721473|100454376|FG000|COMPLETED|Overall Study||47||
48054598|NCT01721473|100454377|FG001|COMPLETED|Overall Study||22||
48054599|NCT01721473|100454378|FG002|COMPLETED|Overall Study||41||
48054600|NCT01721473|100454379|FG003|COMPLETED|Overall Study||34||
48054601|NCT01721473|100454380|FG004|COMPLETED|Overall Study||22||
48054602|NCT01721473|100454381|FG005|COMPLETED|Overall Study||18||
48054603|NCT01721473|100454376|FG000|NOT COMPLETED|Overall Study||0||
48054604|NCT01721473|100454377|FG001|NOT COMPLETED|Overall Study||0||
48054605|NCT01721473|100454378|FG002|NOT COMPLETED|Overall Study||0||
48054606|NCT01721473|100454379|FG003|NOT COMPLETED|Overall Study||0||
48054607|NCT01721473|100454380|FG004|NOT COMPLETED|Overall Study||0||
48054608|NCT01721473|100454381|FG005|NOT COMPLETED|Overall Study||0||
48054609|NCT01041495|100454382|FG000|STARTED|Overall Study||16||
48054610|NCT01041495|100454383|FG001|STARTED|Overall Study||12||
48054611|NCT01041495|100454382|FG000|COMPLETED|Overall Study||12||
48054612|NCT01041495|100454383|FG001|COMPLETED|Overall Study||5||
48054613|NCT01041495|100454382|FG000|NOT COMPLETED|Overall Study||4||
48054614|NCT01041495|100454383|FG001|NOT COMPLETED|Overall Study||7||
48054615|NCT06120777|100454384|FG000|STARTED|Overall Study||89||
48054616|NCT06120777|100454384|FG000|COMPLETED|Overall Study||36||
48054617|NCT06120777|100454384|FG000|NOT COMPLETED|Overall Study||53||
48054618|NCT02278341|100454385|FG000|STARTED|Overall Study||415||
48054619|NCT02278341|100454386|FG001|STARTED|Overall Study||421||
48054620|NCT02278341|100454385|FG000|Received Treatment|Overall Study||414||
48054621|NCT02278341|100454386|FG001|Received Treatment|Overall Study||420||
48054622|NCT02278341|100454385|FG000|COMPLETED|Overall Study||297||
48054623|NCT02278341|100454386|FG001|COMPLETED|Overall Study||329||
48054624|NCT02278341|100454385|FG000|NOT COMPLETED|Overall Study||118||
48054625|NCT02278341|100454386|FG001|NOT COMPLETED|Overall Study||92||
48054626|NCT04982588|100454387|FG000|STARTED|Overall Study||52||
48054627|NCT04982588|100454387|FG000|COMPLETED|Overall Study||50||
48054628|NCT04982588|100454387|FG000|NOT COMPLETED|Overall Study||2||
48054629|NCT01599832|100454388|FG000|STARTED|Overall Study||20||
48054630|NCT01599832|100454388|FG000|COMPLETED|Overall Study||20||
48054631|NCT01599832|100454388|FG000|NOT COMPLETED|Overall Study||0||
48054632|NCT03028350|100454389|FG000|STARTED|Overall Study||25||
48208466|NCT04970342|100837051|FG003|STARTED|Washout (7 Days)||1||
48054633|NCT03028350|100454390|FG001|STARTED|Overall Study||29||
48054634|NCT03028350|100454389|FG000|COMPLETED|Overall Study||21||
48054635|NCT03028350|100454390|FG001|COMPLETED|Overall Study||28||
48054636|NCT03028350|100454389|FG000|NOT COMPLETED|Overall Study||4||
48208467|NCT04970342|100837052|FG004|STARTED|Washout (7 Days)||1||
48054637|NCT03028350|100454390|FG001|NOT COMPLETED|Overall Study||1||
48054638|NCT03882008|100454391|FG000|STARTED|Overall Study||25||
48054639|NCT03882008|100454391|FG000|COMPLETED|Overall Study||23||
48054640|NCT03882008|100454391|FG000|NOT COMPLETED|Overall Study||2||
48054641|NCT03187756|100454392|FG000|STARTED|Overall Study||6||
48054642|NCT03187756|100454392|FG000|COMPLETED|Overall Study||2||
48054643|NCT03187756|100454392|FG000|NOT COMPLETED|Overall Study||4||
48208468|NCT04970342|100837053|FG005|STARTED|Washout (7 Days)||1||
48208469|NCT04970342|100837048|FG000|COMPLETED|Washout (7 Days)||2||
48054644|NCT04509739|100454393|FG000|STARTED|Overall Study||16|We enrolled 17 participants and conducted pre-test on them. One participant failed the pre-test (couldn't get through the procedure to produce data) and was therefore not started on the intervention.|
48054645|NCT04509739|100454393|FG000|COMPLETED|Overall Study||15|One infants could not complete all 12 intervention sessions within the 5-week period due to repeated colds.|
48054646|NCT04509739|100454393|FG000|NOT COMPLETED|Overall Study||1||
48054647|NCT00995865|100454394|FG000|STARTED|Overall Study||24||
48054648|NCT00995865|100454395|FG001|STARTED|Overall Study||24||
48054649|NCT00995865|100454396|FG002|STARTED|Overall Study||12||
48054650|NCT00995865|100454394|FG000|COMPLETED|Overall Study||22||
48054651|NCT00995865|100454395|FG001|COMPLETED|Overall Study||24||
48054652|NCT00995865|100454396|FG002|COMPLETED|Overall Study||11||
48054653|NCT00995865|100454394|FG000|NOT COMPLETED|Overall Study||2||
48054654|NCT00995865|100454395|FG001|NOT COMPLETED|Overall Study||0||
48054655|NCT00995865|100454396|FG002|NOT COMPLETED|Overall Study||1||
48054656|NCT00255801|100454397|FG000|STARTED|Overall Study||37||
48054657|NCT00255801|100454397|FG000|COMPLETED|Overall Study||37||
48054658|NCT00255801|100454397|FG000|NOT COMPLETED|Overall Study||0||
48054659|NCT01158703|100454398|FG000|STARTED|Overall Study||12||
48054660|NCT01158703|100454399|FG001|STARTED|Overall Study||8||
48054661|NCT01158703|100454398|FG000|COMPLETED|Overall Study||12||
48054662|NCT01158703|100454399|FG001|COMPLETED|Overall Study||8||
48054663|NCT01158703|100454398|FG000|NOT COMPLETED|Overall Study||0||
48054664|NCT01158703|100454399|FG001|NOT COMPLETED|Overall Study||0||
48054665|NCT00977808|100454400|FG000|STARTED|Overall Study||12||
48054666|NCT00977808|100454400|FG000|Completion of Open-Loop Admission|Overall Study||12||
48054667|NCT00977808|100454400|FG000|Completion of Closed-Loop Admission|Overall Study||11||
48054668|NCT00977808|100454400|FG000|COMPLETED|Overall Study||11||
48054669|NCT00977808|100454400|FG000|NOT COMPLETED|Overall Study||1||
48054670|NCT00880685|100454401|FG000|STARTED|Memantine 10mg||12||
48054671|NCT00880685|100454401|FG000|COMPLETED|Memantine 10mg||10||
48054672|NCT00880685|100454401|FG000|NOT COMPLETED|Memantine 10mg||2||
48054673|NCT00880685|100454401|FG000|STARTED|Memantine 20mg||10||
48054674|NCT00880685|100454401|FG000|COMPLETED|Memantine 20mg||9||
48054675|NCT00880685|100454401|FG000|NOT COMPLETED|Memantine 20mg||1||
48054676|NCT00880685|100454401|FG000|STARTED|Memantine 30mg||9||
48054677|NCT00880685|100454401|FG000|COMPLETED|Memantine 30mg||9||
48054678|NCT00880685|100454401|FG000|NOT COMPLETED|Memantine 30mg||0||
48054679|NCT04647253|100454402|FG000|STARTED|Overall Study||406||
48054680|NCT04647253|100454403|FG001|STARTED|Overall Study||194||
48054681|NCT04647253|100454402|FG000|COMPLETED|Overall Study||373|12-Month clinical follow-up performed, with visit window of 365 +/- 30 days|
48054682|NCT04647253|100454403|FG001|COMPLETED|Overall Study||176|12-Month clinical follow-up performed, with visit window of 365 +/- 30 days|
48054683|NCT04647253|100454402|FG000|NOT COMPLETED|Overall Study||33||
48054684|NCT04647253|100454403|FG001|NOT COMPLETED|Overall Study||18||
48054685|NCT04185246|100454404|FG000|STARTED|Overall Study||12||
48054686|NCT04185246|100454405|FG001|STARTED|Overall Study||12||
48054687|NCT04185246|100454406|FG002|STARTED|Overall Study||12||
48054688|NCT04185246|100454404|FG000|COMPLETED|Overall Study||12||
48054689|NCT04185246|100454405|FG001|COMPLETED|Overall Study||12||
48054690|NCT04185246|100454406|FG002|COMPLETED|Overall Study||12||
48054691|NCT04185246|100454404|FG000|NOT COMPLETED|Overall Study||0||
48054692|NCT04185246|100454405|FG001|NOT COMPLETED|Overall Study||0||
48054693|NCT04185246|100454406|FG002|NOT COMPLETED|Overall Study||0||
48054694|NCT04972630|100454407|FG000|STARTED|Overall Study||45||
48054695|NCT04972630|100454408|FG001|STARTED|Overall Study||45||
48054696|NCT04972630|100454409|FG002|STARTED|Overall Study||22||
48054697|NCT04972630|100454407|FG000|COMPLETED|Overall Study||8||
48054698|NCT04972630|100454408|FG001|COMPLETED|Overall Study||8||
48054699|NCT04972630|100454409|FG002|COMPLETED|Overall Study||22||
48054700|NCT04972630|100454407|FG000|NOT COMPLETED|Overall Study||37||
48054701|NCT04972630|100454408|FG001|NOT COMPLETED|Overall Study||37||
48054702|NCT04972630|100454409|FG002|NOT COMPLETED|Overall Study||0||
48054703|NCT03127956|100454410|FG000|STARTED|Overall Study||748||
48054704|NCT03127956|100454410|FG000|COMPLETED|Overall Study||431||
48054705|NCT03127956|100454410|FG000|NOT COMPLETED|Overall Study||317||
48054706|NCT05291689|100454411|FG000|STARTED|Overall Study||35||
48054707|NCT05291689|100454411|FG000|COMPLETED|Overall Study||18||
48054708|NCT05291689|100454411|FG000|NOT COMPLETED|Overall Study||17||
48054709|NCT00689091|100454412|FG000|STARTED|Overall Study||10831||
48054710|NCT00689091|100454413|FG001|STARTED|Overall Study||10770||
48054711|NCT00689091|100454412|FG000|COMPLETED|Overall Study||9460||
48054712|NCT00689091|100454413|FG001|COMPLETED|Overall Study||9376||
48054713|NCT00689091|100454412|FG000|NOT COMPLETED|Overall Study||1371||
48054714|NCT00689091|100454413|FG001|NOT COMPLETED|Overall Study||1394||
48054715|NCT03381274|100454414|FG000|STARTED|Overall Study||5||
48208470|NCT04970342|100837049|FG001|COMPLETED|Washout (7 Days)||2||
48054716|NCT03381274|100454415|FG001|STARTED|Overall Study||21||
48054717|NCT03381274|100454416|FG002|STARTED|Overall Study||6||
48054718|NCT03381274|100454417|FG003|STARTED|Overall Study||6||
48054719|NCT03381274|100454418|FG004|STARTED|Overall Study||5||
48054720|NCT03381274|100454414|FG000|COMPLETED|Overall Study||0||
48054721|NCT03381274|100454415|FG001|COMPLETED|Overall Study||0||
48054722|NCT03381274|100454416|FG002|COMPLETED|Overall Study||0||
48054723|NCT03381274|100454417|FG003|COMPLETED|Overall Study||0||
48054724|NCT03381274|100454418|FG004|COMPLETED|Overall Study||0||
48054725|NCT03381274|100454414|FG000|NOT COMPLETED|Overall Study||5||
48054726|NCT03381274|100454415|FG001|NOT COMPLETED|Overall Study||21||
48054727|NCT03381274|100454416|FG002|NOT COMPLETED|Overall Study||6||
48054728|NCT03381274|100454417|FG003|NOT COMPLETED|Overall Study||6||
48054729|NCT03381274|100454418|FG004|NOT COMPLETED|Overall Study||5||
48054730|NCT04597918|100454419|FG000|STARTED|Overall Study||99||
48054731|NCT04597918|100454419|FG000|COMPLETED|Overall Study||89||
48054732|NCT04597918|100454419|FG000|NOT COMPLETED|Overall Study||10||
48054733|NCT00775944|100454420|FG000|STARTED|Overall Study||648||
48054734|NCT00775944|100454421|FG001|STARTED|Overall Study||647||
48054735|NCT00775944|100454422|FG002|STARTED|Overall Study||648||
48054736|NCT00775944|100454423|FG003|STARTED|Overall Study||648||
48054737|NCT00775944|100454420|FG000|COMPLETED|Overall Study||633||
48054738|NCT00775944|100454421|FG001|COMPLETED|Overall Study||638||
48054739|NCT00775944|100454422|FG002|COMPLETED|Overall Study||632||
48054740|NCT00775944|100454423|FG003|COMPLETED|Overall Study||632||
48054741|NCT00775944|100454420|FG000|NOT COMPLETED|Overall Study||15||
48054742|NCT00775944|100454421|FG001|NOT COMPLETED|Overall Study||9||
48054743|NCT00775944|100454422|FG002|NOT COMPLETED|Overall Study||16||
48054744|NCT00775944|100454423|FG003|NOT COMPLETED|Overall Study||16||
48054745|NCT01272661|100454424|FG000|STARTED|Overall Study||413||
48054746|NCT01272661|100454425|FG001|STARTED|Overall Study||497||
48054747|NCT01272661|100454426|FG002|STARTED|Overall Study||386||
48054748|NCT01272661|100454424|FG000|COMPLETED|Overall Study||287||
48054749|NCT01272661|100454425|FG001|COMPLETED|Overall Study||288||
48054750|NCT01272661|100454426|FG002|COMPLETED|Overall Study||314||
48054751|NCT01272661|100454424|FG000|NOT COMPLETED|Overall Study||126||
48054752|NCT01272661|100454425|FG001|NOT COMPLETED|Overall Study||209||
48054753|NCT01272661|100454426|FG002|NOT COMPLETED|Overall Study||72||
48054754|NCT05014490|100454427|FG000|STARTED|First Intervention||14||
48054755|NCT05014490|100454428|FG001|STARTED|First Intervention||14||
48054756|NCT05014490|100454427|FG000|COMPLETED|First Intervention||14||
48054757|NCT05014490|100454428|FG001|COMPLETED|First Intervention||14||
48054758|NCT05014490|100454427|FG000|NOT COMPLETED|First Intervention||0||
48054759|NCT05014490|100454428|FG001|NOT COMPLETED|First Intervention||0||
48054760|NCT05014490|100454427|FG000|STARTED|Second Intervention||14||
48054761|NCT05014490|100454428|FG001|STARTED|Second Intervention||14||
48054762|NCT05014490|100454427|FG000|COMPLETED|Second Intervention||14||
48054763|NCT05014490|100454428|FG001|COMPLETED|Second Intervention||14||
48054764|NCT05014490|100454427|FG000|NOT COMPLETED|Second Intervention||0||
48054765|NCT05014490|100454428|FG001|NOT COMPLETED|Second Intervention||0||
48054766|NCT02128828|100454429|FG000|STARTED|Overall Study||20||
48054767|NCT02128828|100454429|FG000|COMPLETED|Overall Study||17||
48054768|NCT02128828|100454429|FG000|NOT COMPLETED|Overall Study||3||
48054769|NCT01955980|100454430|FG000|STARTED|Overall Study||10||
48054770|NCT01955980|100454431|FG001|STARTED|Overall Study||9||
48054771|NCT01955980|100454430|FG000|COMPLETED|Overall Study||10||
48054772|NCT01955980|100454431|FG001|COMPLETED|Overall Study||9||
48054773|NCT01955980|100454430|FG000|NOT COMPLETED|Overall Study||0||
48054774|NCT01955980|100454431|FG001|NOT COMPLETED|Overall Study||0||
48054775|NCT03410823|100454432|FG000|STARTED|Overall Study||14||
48054776|NCT03410823|100454432|FG000|COMPLETED|Overall Study||9||
48054777|NCT03410823|100454432|FG000|NOT COMPLETED|Overall Study||5||
48054778|NCT01982331|100454433|FG000|STARTED|Received Vaccination 1||28||
48054779|NCT01982331|100454434|FG001|STARTED|Received Vaccination 1||10||
48054780|NCT01982331|100454433|FG000|COMPLETED|Received Vaccination 1||28||
48054781|NCT01982331|100454434|FG001|COMPLETED|Received Vaccination 1||10||
48054782|NCT01982331|100454433|FG000|NOT COMPLETED|Received Vaccination 1||0||
48054783|NCT01982331|100454434|FG001|NOT COMPLETED|Received Vaccination 1||0||
48054784|NCT01982331|100454433|FG000|STARTED|Received Vaccination 2||28||
48054785|NCT01982331|100454434|FG001|STARTED|Received Vaccination 2||10||
48054786|NCT01982331|100454433|FG000|COMPLETED|Received Vaccination 2||27||
48054787|NCT01982331|100454434|FG001|COMPLETED|Received Vaccination 2||7||
48054788|NCT01982331|100454433|FG000|NOT COMPLETED|Received Vaccination 2||1||
48054789|NCT01982331|100454434|FG001|NOT COMPLETED|Received Vaccination 2||3||
48054790|NCT01982331|100454433|FG000|STARTED|Completed Study (Day 112)||27||
48054791|NCT01982331|100454434|FG001|STARTED|Completed Study (Day 112)||7||
48054792|NCT01982331|100454433|FG000|COMPLETED|Completed Study (Day 112)||25||
48054793|NCT01982331|100454434|FG001|COMPLETED|Completed Study (Day 112)||7||
48054794|NCT01982331|100454433|FG000|NOT COMPLETED|Completed Study (Day 112)||2||
48054795|NCT01982331|100454434|FG001|NOT COMPLETED|Completed Study (Day 112)||0||
48054796|NCT02779855|100454435|FG000|STARTED|Overall Study||4||
48054797|NCT02779855|100454436|FG001|STARTED|Overall Study||6||
48054798|NCT02779855|100454437|FG002|STARTED|Overall Study||40||
48054799|NCT02779855|100454435|FG000|COMPLETED|Overall Study||3||
48054800|NCT02779855|100454436|FG001|COMPLETED|Overall Study||6||
48054801|NCT02779855|100454437|FG002|COMPLETED|Overall Study||40||
48054802|NCT02779855|100454435|FG000|NOT COMPLETED|Overall Study||1||
48054803|NCT02779855|100454436|FG001|NOT COMPLETED|Overall Study||0||
48054804|NCT02779855|100454437|FG002|NOT COMPLETED|Overall Study||0||
48054805|NCT01483690|100454438|FG000|STARTED|Overall Study||5||
48054806|NCT01483690|100454439|FG001|STARTED|Overall Study||18||
48054807|NCT01483690|100454438|FG000|COMPLETED|Overall Study||3||
48054808|NCT01483690|100454439|FG001|COMPLETED|Overall Study||13||
48054809|NCT01483690|100454438|FG000|NOT COMPLETED|Overall Study||2||
48054810|NCT01483690|100454439|FG001|NOT COMPLETED|Overall Study||5||
48054811|NCT00749580|100454440|FG000|STARTED|Overall Study||21||
48054812|NCT00749580|100454441|FG001|STARTED|Overall Study||25||
48054813|NCT00749580|100454440|FG000|COMPLETED|Overall Study||17||
48054814|NCT00749580|100454441|FG001|COMPLETED|Overall Study||16||
48054815|NCT00749580|100454440|FG000|NOT COMPLETED|Overall Study||4||
48054816|NCT00749580|100454441|FG001|NOT COMPLETED|Overall Study||9||
48054817|NCT03150810|100454442|FG000|STARTED|Overall Study||4||
48054818|NCT03150810|100454443|FG001|STARTED|Overall Study||13||
48054819|NCT03150810|100454444|FG002|STARTED|Overall Study||9||
48054820|NCT03150810|100454445|FG003|STARTED|Overall Study||3||
48054821|NCT03150810|100454446|FG004|STARTED|Overall Study||3||
48054822|NCT03150810|100454447|FG005|STARTED|Overall Study||14||
48054823|NCT03150810|100454448|FG006|STARTED|Overall Study||14||
48054824|NCT03150810|100454449|FG007|STARTED|Overall Study||6||
48054825|NCT03150810|100454450|FG008|STARTED|Overall Study||21||
48054826|NCT03150810|100454451|FG009|STARTED|Overall Study||4||
48054827|NCT03150810|100454452|FG010|STARTED|Overall Study||22||
48054828|NCT03150810|100454453|FG011|STARTED|Overall Study||1||
48054829|NCT03150810|100454454|FG012|STARTED|Overall Study||25||
48054830|NCT03150810|100454442|FG000|COMPLETED|Overall Study||0||
48054831|NCT03150810|100454443|FG001|COMPLETED|Overall Study||0||
48054832|NCT03150810|100454444|FG002|COMPLETED|Overall Study||0||
48054833|NCT03150810|100454445|FG003|COMPLETED|Overall Study||0||
48054834|NCT03150810|100454446|FG004|COMPLETED|Overall Study||0||
48054835|NCT03150810|100454447|FG005|COMPLETED|Overall Study||0||
48054836|NCT03150810|100454448|FG006|COMPLETED|Overall Study||0||
48054837|NCT03150810|100454449|FG007|COMPLETED|Overall Study||0||
48054838|NCT03150810|100454450|FG008|COMPLETED|Overall Study||0||
48054839|NCT03150810|100454451|FG009|COMPLETED|Overall Study||0||
48054840|NCT03150810|100454452|FG010|COMPLETED|Overall Study||0||
48054841|NCT03150810|100454453|FG011|COMPLETED|Overall Study||0||
48054842|NCT03150810|100454454|FG012|COMPLETED|Overall Study||0||
48054843|NCT03150810|100454442|FG000|NOT COMPLETED|Overall Study||4||
48054844|NCT03150810|100454443|FG001|NOT COMPLETED|Overall Study||13||
48054845|NCT03150810|100454444|FG002|NOT COMPLETED|Overall Study||9||
48054846|NCT03150810|100454445|FG003|NOT COMPLETED|Overall Study||3||
48054847|NCT03150810|100454446|FG004|NOT COMPLETED|Overall Study||3||
48054848|NCT03150810|100454447|FG005|NOT COMPLETED|Overall Study||14||
48054849|NCT03150810|100454448|FG006|NOT COMPLETED|Overall Study||14||
48054850|NCT03150810|100454449|FG007|NOT COMPLETED|Overall Study||6||
48054851|NCT03150810|100454450|FG008|NOT COMPLETED|Overall Study||21||
48054852|NCT03150810|100454451|FG009|NOT COMPLETED|Overall Study||4||
48054853|NCT03150810|100454452|FG010|NOT COMPLETED|Overall Study||22||
48054854|NCT03150810|100454453|FG011|NOT COMPLETED|Overall Study||1||
48054855|NCT03150810|100454454|FG012|NOT COMPLETED|Overall Study||25||
48054856|NCT03845296|100454455|FG000|STARTED|Overall Study||25||
48208471|NCT04970342|100837050|FG002|COMPLETED|Washout (7 Days)||1||
48208472|NCT04970342|100837051|FG003|COMPLETED|Washout (7 Days)||1||
48208473|NCT04970342|100837052|FG004|COMPLETED|Washout (7 Days)||1||
48208474|NCT04970342|100837053|FG005|COMPLETED|Washout (7 Days)||1||
48054857|NCT03845296|100454456|FG001|STARTED|Overall Study||34||
48054858|NCT03845296|100454455|FG000|COMPLETED|Overall Study||0||
48054859|NCT03845296|100454456|FG001|COMPLETED|Overall Study||0||
48054860|NCT03845296|100454455|FG000|NOT COMPLETED|Overall Study||25||
48054861|NCT03845296|100454456|FG001|NOT COMPLETED|Overall Study||34||
48054862|NCT03645681|100454457|FG000|STARTED|Overall Study||26||
48054863|NCT03645681|100454457|FG000|Primary Endpoint Analyzed|Overall Study||12||
48054864|NCT03645681|100454457|FG000|Completed 24 Month|Overall Study||3||
48054865|NCT03645681|100454457|FG000|Not Completed|Overall Study||23||
48054866|NCT03645681|100454457|FG000|Entered Long Term Follow Up|Overall Study||3||
48054867|NCT03645681|100454457|FG000|COMPLETED|Overall Study||1|Completed long term follow up to date (Feb 2023)|
48054868|NCT03645681|100454457|FG000|NOT COMPLETED|Overall Study||25||
48054869|NCT01152450|100454458|FG000|STARTED|Period 1 (4 Weeks)||15||
48208475|NCT04970342|100837048|FG000|NOT COMPLETED|Washout (7 Days)||0||
48054870|NCT01152450|100454459|FG001|STARTED|Period 1 (4 Weeks)||16||
48054871|NCT01152450|100454460|FG002|STARTED|Period 1 (4 Weeks)||17||
48054872|NCT01152450|100454461|FG003|STARTED|Period 1 (4 Weeks)||15||
48054873|NCT01152450|100454462|FG004|STARTED|Period 1 (4 Weeks)||18||
48054874|NCT01152450|100454463|FG005|STARTED|Period 1 (4 Weeks)||13||
48054875|NCT01152450|100454458|FG000|COMPLETED|Period 1 (4 Weeks)||15||
48054876|NCT01152450|100454459|FG001|COMPLETED|Period 1 (4 Weeks)||15||
48054877|NCT01152450|100454460|FG002|COMPLETED|Period 1 (4 Weeks)||16||
48054878|NCT01152450|100454461|FG003|COMPLETED|Period 1 (4 Weeks)||15||
48054879|NCT01152450|100454462|FG004|COMPLETED|Period 1 (4 Weeks)||16||
48054880|NCT01152450|100454463|FG005|COMPLETED|Period 1 (4 Weeks)||12||
48054881|NCT01152450|100454458|FG000|NOT COMPLETED|Period 1 (4 Weeks)||0||
48054882|NCT01152450|100454459|FG001|NOT COMPLETED|Period 1 (4 Weeks)||1||
48054883|NCT01152450|100454460|FG002|NOT COMPLETED|Period 1 (4 Weeks)||1||
48054884|NCT01152450|100454461|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0||
48054885|NCT01152450|100454462|FG004|NOT COMPLETED|Period 1 (4 Weeks)||2||
48054886|NCT01152450|100454463|FG005|NOT COMPLETED|Period 1 (4 Weeks)||1||
48054887|NCT01152450|100454458|FG000|STARTED|Period 2 (4 Weeks)||15||
48054888|NCT01152450|100454459|FG001|STARTED|Period 2 (4 Weeks)||15||
48054889|NCT01152450|100454460|FG002|STARTED|Period 2 (4 Weeks)||16||
48054890|NCT01152450|100454461|FG003|STARTED|Period 2 (4 Weeks)||15||
48054891|NCT01152450|100454462|FG004|STARTED|Period 2 (4 Weeks)||16||
48054892|NCT01152450|100454463|FG005|STARTED|Period 2 (4 Weeks)||12||
48054893|NCT01152450|100454458|FG000|COMPLETED|Period 2 (4 Weeks)||15||
48054894|NCT01152450|100454459|FG001|COMPLETED|Period 2 (4 Weeks)||15||
48054895|NCT01152450|100454460|FG002|COMPLETED|Period 2 (4 Weeks)||16||
48054896|NCT01152450|100454461|FG003|COMPLETED|Period 2 (4 Weeks)||15||
48054897|NCT01152450|100454462|FG004|COMPLETED|Period 2 (4 Weeks)||16||
48054898|NCT01152450|100454463|FG005|COMPLETED|Period 2 (4 Weeks)||12||
48054899|NCT01152450|100454458|FG000|NOT COMPLETED|Period 2 (4 Weeks)||0||
48054900|NCT01152450|100454459|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0||
48054901|NCT01152450|100454460|FG002|NOT COMPLETED|Period 2 (4 Weeks)||0||
48054902|NCT01152450|100454461|FG003|NOT COMPLETED|Period 2 (4 Weeks)||0||
48054903|NCT01152450|100454462|FG004|NOT COMPLETED|Period 2 (4 Weeks)||0||
48054904|NCT01152450|100454463|FG005|NOT COMPLETED|Period 2 (4 Weeks)||0||
48054905|NCT01152450|100454458|FG000|STARTED|Period 3 (4 Weeks)||15||
48054906|NCT01152450|100454459|FG001|STARTED|Period 3 (4 Weeks)||15||
48054907|NCT01152450|100454460|FG002|STARTED|Period 3 (4 Weeks)||16||
48054908|NCT01152450|100454461|FG003|STARTED|Period 3 (4 Weeks)||15||
48054909|NCT01152450|100454462|FG004|STARTED|Period 3 (4 Weeks)||16||
48054910|NCT01152450|100454463|FG005|STARTED|Period 3 (4 Weeks)||12||
48054911|NCT01152450|100454458|FG000|COMPLETED|Period 3 (4 Weeks)||15||
48054912|NCT01152450|100454459|FG001|COMPLETED|Period 3 (4 Weeks)||15||
48054913|NCT01152450|100454460|FG002|COMPLETED|Period 3 (4 Weeks)||16||
48054914|NCT01152450|100454461|FG003|COMPLETED|Period 3 (4 Weeks)||15||
48054915|NCT01152450|100454462|FG004|COMPLETED|Period 3 (4 Weeks)||16||
48054916|NCT01152450|100454463|FG005|COMPLETED|Period 3 (4 Weeks)||12||
48054917|NCT01152450|100454458|FG000|NOT COMPLETED|Period 3 (4 Weeks)||0||
48054918|NCT01152450|100454459|FG001|NOT COMPLETED|Period 3 (4 Weeks)||0||
48054919|NCT01152450|100454460|FG002|NOT COMPLETED|Period 3 (4 Weeks)||0||
48054920|NCT01152450|100454461|FG003|NOT COMPLETED|Period 3 (4 Weeks)||0||
48054921|NCT01152450|100454462|FG004|NOT COMPLETED|Period 3 (4 Weeks)||0||
48054922|NCT01152450|100454463|FG005|NOT COMPLETED|Period 3 (4 Weeks)||0||
48054923|NCT04418232|100454464|FG000|STARTED|Overall Study||243|"This number includes 100 caregivers of 84 care recipients who underwent the Alianza Latina care support intervention; 26 caregivers were part of 10 clusters of 2 (n=5), 3 (n=4), and 4 (n=1) caregivers of the same person with dementia.~This number also includes results from 59 primary care providers who underwent a dementia training delivered as standard training by the KU Alzheimer's Disease Research Center."|
48208476|NCT04970342|100837049|FG001|NOT COMPLETED|Washout (7 Days)||0||
48054924|NCT04418232|100454464|FG000|COMPLETED|Overall Study||172|"This number includes 88 caregivers of 73 care recipients who completed the Alianza Latina study.~This number also includes results from 11 primary care providers who completed the 6-month survey after the dementia training delivered as standard training by the KU Alzheimer's Disease Research Center."|
48054925|NCT04418232|100454464|FG000|NOT COMPLETED|Overall Study||71||
48054926|NCT05441579|100454465|FG000|STARTED|Overall Study||64||
48054927|NCT05441579|100454466|FG001|STARTED|Overall Study||64||
48054928|NCT05441579|100454467|FG002|STARTED|Overall Study||0||
48054929|NCT05441579|100454468|FG003|STARTED|Overall Study||0||
48054930|NCT05441579|100454465|FG000|COMPLETED|Overall Study||64||
48054931|NCT05441579|100454466|FG001|COMPLETED|Overall Study||64||
48054932|NCT05441579|100454467|FG002|COMPLETED|Overall Study||0||
48054933|NCT05441579|100454468|FG003|COMPLETED|Overall Study||0||
48054934|NCT05441579|100454465|FG000|NOT COMPLETED|Overall Study||0||
48054935|NCT05441579|100454466|FG001|NOT COMPLETED|Overall Study||0||
48054936|NCT05441579|100454467|FG002|NOT COMPLETED|Overall Study||0||
48054937|NCT05441579|100454468|FG003|NOT COMPLETED|Overall Study||0||
48054938|NCT03953183|100454469|FG000|STARTED|Overall Study||30||
48054939|NCT03953183|100454470|FG001|STARTED|Overall Study||30||
48054940|NCT03953183|100454469|FG000|COMPLETED|Overall Study||30||
48054941|NCT03953183|100454470|FG001|COMPLETED|Overall Study||28||
48054942|NCT03953183|100454469|FG000|NOT COMPLETED|Overall Study||0||
48054943|NCT03953183|100454470|FG001|NOT COMPLETED|Overall Study||2||
48054944|NCT03643744|100454471|FG000|STARTED|Overall Study||3||
48054945|NCT03643744|100454472|FG001|STARTED|Overall Study||3||
48054946|NCT03643744|100454473|FG002|STARTED|Overall Study||3||
48054947|NCT03643744|100454474|FG003|STARTED|Overall Study||3||
48054948|NCT03643744|100454471|FG000|COMPLETED|Overall Study||3||
48054949|NCT03643744|100454472|FG001|COMPLETED|Overall Study||3||
48054950|NCT03643744|100454473|FG002|COMPLETED|Overall Study||3||
48054951|NCT03643744|100454474|FG003|COMPLETED|Overall Study||3||
48054952|NCT03643744|100454471|FG000|NOT COMPLETED|Overall Study||0||
48054953|NCT03643744|100454472|FG001|NOT COMPLETED|Overall Study||0||
48054954|NCT03643744|100454473|FG002|NOT COMPLETED|Overall Study||0||
48054955|NCT03643744|100454474|FG003|NOT COMPLETED|Overall Study||0||
48054956|NCT00737464|100454475|FG000|STARTED|Overall Study||132||
48054957|NCT00737464|100454475|FG000|COMPLETED|Overall Study||114||
48054958|NCT00737464|100454475|FG000|NOT COMPLETED|Overall Study||18||
48054959|NCT04622735|100454476|FG000|STARTED|Overall Study||107||
48054960|NCT04622735|100454477|FG001|STARTED|Overall Study||108||
48054961|NCT04622735|100454478|FG002|STARTED|Overall Study||106||
48054962|NCT04622735|100454476|FG000|COMPLETED|Overall Study||105||
48054963|NCT04622735|100454477|FG001|COMPLETED|Overall Study||106||
48054964|NCT04622735|100454478|FG002|COMPLETED|Overall Study||104||
48208477|NCT04970342|100837050|FG002|NOT COMPLETED|Washout (7 Days)||0||
48208478|NCT04970342|100837051|FG003|NOT COMPLETED|Washout (7 Days)||0||
48208479|NCT04970342|100837052|FG004|NOT COMPLETED|Washout (7 Days)||0||
48208480|NCT04970342|100837053|FG005|NOT COMPLETED|Washout (7 Days)||0||
48208481|NCT04970342|100837048|FG000|STARTED|Treatment Visit 3 (1 Day)||2||
48208482|NCT04970342|100837049|FG001|STARTED|Treatment Visit 3 (1 Day)||2||
48208483|NCT04970342|100837050|FG002|STARTED|Treatment Visit 3 (1 Day)||1||
48208484|NCT04970342|100837051|FG003|STARTED|Treatment Visit 3 (1 Day)||1||
48208485|NCT04970342|100837052|FG004|STARTED|Treatment Visit 3 (1 Day)||1||
48208486|NCT04970342|100837053|FG005|STARTED|Treatment Visit 3 (1 Day)||1||
48208487|NCT04970342|100837048|FG000|COMPLETED|Treatment Visit 3 (1 Day)||2||
48208488|NCT04970342|100837049|FG001|COMPLETED|Treatment Visit 3 (1 Day)||2||
48208489|NCT04970342|100837050|FG002|COMPLETED|Treatment Visit 3 (1 Day)||1||
48208490|NCT04970342|100837051|FG003|COMPLETED|Treatment Visit 3 (1 Day)||1||
48208491|NCT04970342|100837052|FG004|COMPLETED|Treatment Visit 3 (1 Day)||1||
48208492|NCT04970342|100837053|FG005|COMPLETED|Treatment Visit 3 (1 Day)||1||
48208493|NCT04970342|100837048|FG000|NOT COMPLETED|Treatment Visit 3 (1 Day)||0||
48208494|NCT04970342|100837049|FG001|NOT COMPLETED|Treatment Visit 3 (1 Day)||0||
48208495|NCT04970342|100837050|FG002|NOT COMPLETED|Treatment Visit 3 (1 Day)||0||
48208496|NCT04970342|100837051|FG003|NOT COMPLETED|Treatment Visit 3 (1 Day)||0||
48208497|NCT04970342|100837052|FG004|NOT COMPLETED|Treatment Visit 3 (1 Day)||0||
48208498|NCT04970342|100837053|FG005|NOT COMPLETED|Treatment Visit 3 (1 Day)||0||
48208499|NCT01135511|100837054|FG000|STARTED|Overall Study||41||
48208500|NCT01135511|100837055|FG001|STARTED|Overall Study||42||
48208501|NCT01135511|100837056|FG002|STARTED|Overall Study||41||
48208502|NCT01135511|100837057|FG003|STARTED|Overall Study||40||
48208503|NCT01135511|100837058|FG004|STARTED|Overall Study||39||
48208504|NCT01135511|100837059|FG005|STARTED|Overall Study||21||
48208505|NCT01135511|100837060|FG006|STARTED|Overall Study||19||
48208506|NCT01135511|100837061|FG007|STARTED|Overall Study||21||
48208507|NCT01135511|100837062|FG008|STARTED|Overall Study||21||
48208508|NCT01135511|100837054|FG000|COMPLETED|Overall Study||41||
48208509|NCT01135511|100837055|FG001|COMPLETED|Overall Study||39||
48208510|NCT01135511|100837056|FG002|COMPLETED|Overall Study||33||
48208511|NCT01135511|100837057|FG003|COMPLETED|Overall Study||37||
48208512|NCT01135511|100837058|FG004|COMPLETED|Overall Study||38||
48208513|NCT01135511|100837059|FG005|COMPLETED|Overall Study||20||
48208514|NCT01135511|100837060|FG006|COMPLETED|Overall Study||18||
48208515|NCT01135511|100837061|FG007|COMPLETED|Overall Study||20||
48208516|NCT01135511|100837062|FG008|COMPLETED|Overall Study||20||
48208517|NCT01135511|100837054|FG000|NOT COMPLETED|Overall Study||0||
48495717|NCT00834132|101547921|FG001|STARTED|First Intervention||12||
48208518|NCT01135511|100837055|FG001|NOT COMPLETED|Overall Study||3||
48208519|NCT01135511|100837056|FG002|NOT COMPLETED|Overall Study||8||
48208520|NCT01135511|100837057|FG003|NOT COMPLETED|Overall Study||3||
48208521|NCT01135511|100837058|FG004|NOT COMPLETED|Overall Study||1||
48208522|NCT01135511|100837059|FG005|NOT COMPLETED|Overall Study||1||
48208523|NCT01135511|100837060|FG006|NOT COMPLETED|Overall Study||1||
48208524|NCT01135511|100837061|FG007|NOT COMPLETED|Overall Study||1||
48208525|NCT01135511|100837062|FG008|NOT COMPLETED|Overall Study||1||
48208526|NCT03426228|100837063|FG000|STARTED|Overall Study||158||
48208527|NCT03426228|100837064|FG001|STARTED|Overall Study||191||
48208528|NCT03426228|100837063|FG000|COMPLETED|Overall Study||117||
48208529|NCT03426228|100837064|FG001|COMPLETED|Overall Study||158||
48208530|NCT03426228|100837063|FG000|NOT COMPLETED|Overall Study||41||
48208531|NCT03426228|100837064|FG001|NOT COMPLETED|Overall Study||33||
48208532|NCT05216510|100837065|FG000|STARTED|Overall Study||1||
48208533|NCT05216510|100837066|FG001|STARTED|Overall Study||1||
48208534|NCT05216510|100837067|FG002|STARTED|Overall Study||7||
48208535|NCT05216510|100837065|FG000|COMPLETED|Overall Study||0||
48208536|NCT05216510|100837066|FG001|COMPLETED|Overall Study||1||
48208537|NCT05216510|100837067|FG002|COMPLETED|Overall Study||7||
48208538|NCT05216510|100837065|FG000|NOT COMPLETED|Overall Study||1||
48495718|NCT00834132|101547920|FG000|COMPLETED|First Intervention||12||
48054965|NCT04622735|100454476|FG000|NOT COMPLETED|Overall Study||2||
48054966|NCT04622735|100454477|FG001|NOT COMPLETED|Overall Study||2||
48054967|NCT04622735|100454478|FG002|NOT COMPLETED|Overall Study||2||
48054968|NCT04811573|100454479|FG000|STARTED|Overall Study||2||
48054969|NCT04811573|100454480|FG001|STARTED|Overall Study||2||
48054970|NCT04811573|100454481|FG002|STARTED|Overall Study||2||
48054971|NCT04811573|100454482|FG003|STARTED|Overall Study||2||
48054972|NCT04811573|100454483|FG004|STARTED|Overall Study||2||
48054973|NCT04811573|100454484|FG005|STARTED|Overall Study||2||
48054974|NCT04811573|100454485|FG006|STARTED|Overall Study||2||
48054975|NCT04811573|100454486|FG007|STARTED|Overall Study||2||
48054976|NCT04811573|100454487|FG008|STARTED|Overall Study||2||
48054977|NCT04811573|100454488|FG009|STARTED|Overall Study||2||
48054978|NCT04811573|100454479|FG000|COMPLETED|Overall Study||2||
48054979|NCT04811573|100454480|FG001|COMPLETED|Overall Study||2||
48054980|NCT04811573|100454481|FG002|COMPLETED|Overall Study||2||
48054981|NCT04811573|100454482|FG003|COMPLETED|Overall Study||2||
48054982|NCT04811573|100454483|FG004|COMPLETED|Overall Study||2||
48054983|NCT04811573|100454484|FG005|COMPLETED|Overall Study||2||
48054984|NCT04811573|100454485|FG006|COMPLETED|Overall Study||2||
48054985|NCT04811573|100454486|FG007|COMPLETED|Overall Study||2||
48054986|NCT04811573|100454487|FG008|COMPLETED|Overall Study||2||
48054987|NCT04811573|100454488|FG009|COMPLETED|Overall Study||2||
48054988|NCT04811573|100454479|FG000|NOT COMPLETED|Overall Study||0||
48054989|NCT04811573|100454480|FG001|NOT COMPLETED|Overall Study||0||
48054990|NCT04811573|100454481|FG002|NOT COMPLETED|Overall Study||0||
48054991|NCT04811573|100454482|FG003|NOT COMPLETED|Overall Study||0||
48054992|NCT04811573|100454483|FG004|NOT COMPLETED|Overall Study||0||
48054993|NCT04811573|100454484|FG005|NOT COMPLETED|Overall Study||0||
48054994|NCT04811573|100454485|FG006|NOT COMPLETED|Overall Study||0||
48054995|NCT04811573|100454486|FG007|NOT COMPLETED|Overall Study||0||
48054996|NCT04811573|100454487|FG008|NOT COMPLETED|Overall Study||0||
48054997|NCT04811573|100454488|FG009|NOT COMPLETED|Overall Study||0||
48054998|NCT02861131|100454489|FG000|STARTED|Overall Study||100||
48054999|NCT02861131|100454490|FG001|STARTED|Overall Study||100||
48055000|NCT02861131|100454489|FG000|COMPLETED|Overall Study||100||
48055001|NCT02861131|100454490|FG001|COMPLETED|Overall Study||100||
48055002|NCT02861131|100454489|FG000|NOT COMPLETED|Overall Study||0||
48055003|NCT02861131|100454490|FG001|NOT COMPLETED|Overall Study||0||
48055004|NCT04690582|100454491|FG000|STARTED|Overall Study||81||
48055005|NCT04690582|100454492|FG001|STARTED|Overall Study||76||
48055006|NCT04690582|100454491|FG000|COMPLETED|Overall Study||75||
48055007|NCT04690582|100454492|FG001|COMPLETED|Overall Study||72||
48055008|NCT04690582|100454491|FG000|NOT COMPLETED|Overall Study||6||
48055009|NCT04690582|100454492|FG001|NOT COMPLETED|Overall Study||4||
48055010|NCT00457366|100454493|FG000|STARTED|Overall Study||40||
48055011|NCT00457366|100454494|FG001|STARTED|Overall Study||32||
48055012|NCT00457366|100454493|FG000|COMPLETED|Overall Study||40||
48055013|NCT00457366|100454494|FG001|COMPLETED|Overall Study||32||
48208539|NCT05216510|100837066|FG001|NOT COMPLETED|Overall Study||0||
48208540|NCT05216510|100837067|FG002|NOT COMPLETED|Overall Study||0||
48055014|NCT00457366|100454493|FG000|NOT COMPLETED|Overall Study||0||
48055015|NCT00457366|100454494|FG001|NOT COMPLETED|Overall Study||0||
48055016|NCT00403403|100456085|FG000|STARTED|Overall Study||50||
48055017|NCT00403403|100456086|FG001|STARTED|Overall Study||52||
48055018|NCT00403403|100456085|FG000|Safety-Evaluable Patients|Overall Study||47||
48055019|NCT00403403|100456086|FG001|Safety-Evaluable Patients|Overall Study||51||
48055020|NCT00403403|100456085|FG000|COMPLETED|Overall Study||50||
48055021|NCT00403403|100456086|FG001|COMPLETED|Overall Study||52||
48055022|NCT00403403|100456085|FG000|NOT COMPLETED|Overall Study||0||
48055023|NCT00403403|100456086|FG001|NOT COMPLETED|Overall Study||0||
48055024|NCT00843726|100456087|FG000|STARTED|Overall Study||49||
48055025|NCT00843726|100456088|FG001|STARTED|Overall Study||49||
48055026|NCT00843726|100456087|FG000|COMPLETED|Overall Study||48||
48055027|NCT00843726|100456088|FG001|COMPLETED|Overall Study||48||
48055028|NCT00843726|100456087|FG000|NOT COMPLETED|Overall Study||1||
48055029|NCT00843726|100456088|FG001|NOT COMPLETED|Overall Study||1||
48055030|NCT02425644|100456089|FG000|STARTED|Overall Study||567||
48055031|NCT02425644|100456090|FG001|STARTED|Overall Study||566||
48055032|NCT02425644|100456089|FG000|Treated|Overall Study||565||
48055033|NCT02425644|100456090|FG001|Treated|Overall Study||566||
48055034|NCT02425644|100456089|FG000|COMPLETED|Overall Study||490||
48055035|NCT02425644|100456090|FG001|COMPLETED|Overall Study||495||
48055036|NCT02425644|100456089|FG000|NOT COMPLETED|Overall Study||77||
48055037|NCT02425644|100456090|FG001|NOT COMPLETED|Overall Study||71||
48055038|NCT04638673|100456091|FG000|STARTED|Overall Study||6||
48055039|NCT04638673|100456092|FG001|STARTED|Overall Study||6||
48055040|NCT04638673|100456091|FG000|COMPLETED|Overall Study||6||
48055041|NCT04638673|100456092|FG001|COMPLETED|Overall Study||6||
48055042|NCT04638673|100456091|FG000|NOT COMPLETED|Overall Study||0||
48055043|NCT04638673|100456092|FG001|NOT COMPLETED|Overall Study||0||
48055044|NCT04616027|100456093|FG000|STARTED|Overall Study||8||
48208541|NCT00166166|100837068|FG000|STARTED|Overall Study||103||
48055045|NCT04616027|100456094|FG001|STARTED|Overall Study||7||
48055046|NCT04616027|100456095|FG002|STARTED|Overall Study||8||
48055047|NCT04616027|100456096|FG003|STARTED|Overall Study||8||
48208542|NCT00166166|100837069|FG001|STARTED|Overall Study||71||
48055048|NCT04616027|100456097|FG004|STARTED|Overall Study||8||
48055049|NCT04616027|100456093|FG000|COMPLETED|Overall Study||8||
48055050|NCT04616027|100456094|FG001|COMPLETED|Overall Study||7||
48055051|NCT04616027|100456095|FG002|COMPLETED|Overall Study||8||
48055052|NCT04616027|100456096|FG003|COMPLETED|Overall Study||8||
48055053|NCT04616027|100456097|FG004|COMPLETED|Overall Study||8||
48055054|NCT04616027|100456093|FG000|NOT COMPLETED|Overall Study||0||
48055055|NCT04616027|100456094|FG001|NOT COMPLETED|Overall Study||0||
48055056|NCT04616027|100456095|FG002|NOT COMPLETED|Overall Study||0||
48055057|NCT04616027|100456096|FG003|NOT COMPLETED|Overall Study||0||
48055058|NCT04616027|100456097|FG004|NOT COMPLETED|Overall Study||0||
48055059|NCT04612790|100456098|FG000|STARTED|DB Period (Up to 36 Weeks)||34||
48055060|NCT04612790|100456099|FG001|STARTED|DB Period (Up to 36 Weeks)||33||
48055061|NCT04612790|100456100|FG002|STARTED|DB Period (Up to 36 Weeks)||0||
48055062|NCT04612790|100456101|FG003|STARTED|DB Period (Up to 36 Weeks)||0||
48055063|NCT04612790|100456098|FG000|COMPLETED|DB Period (Up to 36 Weeks)||16||
48055064|NCT04612790|100456099|FG001|COMPLETED|DB Period (Up to 36 Weeks)||19||
48055065|NCT04612790|100456100|FG002|COMPLETED|DB Period (Up to 36 Weeks)||0||
48055066|NCT04612790|100456101|FG003|COMPLETED|DB Period (Up to 36 Weeks)||0||
48055067|NCT04612790|100456098|FG000|NOT COMPLETED|DB Period (Up to 36 Weeks)||18||
48055068|NCT04612790|100456099|FG001|NOT COMPLETED|DB Period (Up to 36 Weeks)||14||
48055069|NCT04612790|100456100|FG002|NOT COMPLETED|DB Period (Up to 36 Weeks)||0||
48055070|NCT04612790|100456101|FG003|NOT COMPLETED|DB Period (Up to 36 Weeks)||0||
48055071|NCT04612790|100456098|FG000|STARTED|OLE Period (Up to 1 Year)||0||
48055072|NCT04612790|100456099|FG001|STARTED|OLE Period (Up to 1 Year)||0||
48055073|NCT04612790|100456100|FG002|STARTED|OLE Period (Up to 1 Year)||16||
48055074|NCT04612790|100456101|FG003|STARTED|OLE Period (Up to 1 Year)||18||
48055075|NCT04612790|100456098|FG000|Randomized But Did Not Receive Treatment in OLE Period|OLE Period (Up to 1 Year)||0||
48055076|NCT04612790|100456099|FG001|Randomized But Did Not Receive Treatment in OLE Period|OLE Period (Up to 1 Year)||0||
48055077|NCT04612790|100456100|FG002|Randomized But Did Not Receive Treatment in OLE Period|OLE Period (Up to 1 Year)||0||
48055078|NCT04612790|100456101|FG003|Randomized But Did Not Receive Treatment in OLE Period|OLE Period (Up to 1 Year)||1||
48055079|NCT04612790|100456098|FG000|COMPLETED|OLE Period (Up to 1 Year)||0||
48055080|NCT04612790|100456099|FG001|COMPLETED|OLE Period (Up to 1 Year)||0||
48055081|NCT04612790|100456100|FG002|COMPLETED|OLE Period (Up to 1 Year)||0||
48055082|NCT04612790|100456101|FG003|COMPLETED|OLE Period (Up to 1 Year)||0||
48055083|NCT04612790|100456098|FG000|NOT COMPLETED|OLE Period (Up to 1 Year)||0||
48055084|NCT04612790|100456099|FG001|NOT COMPLETED|OLE Period (Up to 1 Year)||0||
48055085|NCT04612790|100456100|FG002|NOT COMPLETED|OLE Period (Up to 1 Year)||16||
48055086|NCT04612790|100456101|FG003|NOT COMPLETED|OLE Period (Up to 1 Year)||18||
48055087|NCT03981822|100456102|FG000|STARTED|Overall Study||5||
48055088|NCT03981822|100456103|FG001|STARTED|Overall Study||5||
48055089|NCT03981822|100456104|FG002|STARTED|Overall Study||5||
48055090|NCT03981822|100456105|FG003|STARTED|Overall Study||3||
48055091|NCT03981822|100456106|FG004|STARTED|Overall Study||25||
48055092|NCT03981822|100456107|FG005|STARTED|Overall Study||23||
48055093|NCT03981822|100456108|FG006|STARTED|Overall Study||22||
48055094|NCT03981822|100456109|FG007|STARTED|Overall Study||17||
48055095|NCT03981822|100456102|FG000|COMPLETED|Overall Study||5||
48055096|NCT03981822|100456103|FG001|COMPLETED|Overall Study||3||
48055097|NCT03981822|100456104|FG002|COMPLETED|Overall Study||4||
48055098|NCT03981822|100456105|FG003|COMPLETED|Overall Study||3||
48055099|NCT03981822|100456106|FG004|COMPLETED|Overall Study||17||
48055100|NCT03981822|100456107|FG005|COMPLETED|Overall Study||17||
48055101|NCT03981822|100456108|FG006|COMPLETED|Overall Study||16||
48055102|NCT03981822|100456109|FG007|COMPLETED|Overall Study||12||
48055103|NCT03981822|100456102|FG000|NOT COMPLETED|Overall Study||0||
48055104|NCT03981822|100456103|FG001|NOT COMPLETED|Overall Study||2||
48055105|NCT03981822|100456104|FG002|NOT COMPLETED|Overall Study||1||
48055106|NCT03981822|100456105|FG003|NOT COMPLETED|Overall Study||0||
48055107|NCT03981822|100456106|FG004|NOT COMPLETED|Overall Study||8||
48055108|NCT03981822|100456107|FG005|NOT COMPLETED|Overall Study||6||
48055109|NCT03981822|100456108|FG006|NOT COMPLETED|Overall Study||6||
48055110|NCT03981822|100456109|FG007|NOT COMPLETED|Overall Study||5||
48055111|NCT00117286|100456110|FG000|STARTED|Overall Study||30||
48055112|NCT00117286|100456111|FG001|STARTED|Overall Study||27||
48055113|NCT00117286|100456110|FG000|Switched to Higher Dose|Overall Study||17||
48055114|NCT00117286|100456111|FG001|Switched to Higher Dose|Overall Study||17||
48055115|NCT00117286|100456110|FG000|COMPLETED|Overall Study||2||
48055116|NCT00117286|100456111|FG001|COMPLETED|Overall Study||6||
48055117|NCT00117286|100456110|FG000|NOT COMPLETED|Overall Study||28||
48055118|NCT00117286|100456111|FG001|NOT COMPLETED|Overall Study||21||
48055119|NCT01155219|100456112|FG000|STARTED|Overall Study||77||
48055120|NCT01155219|100456113|FG001|STARTED|Overall Study||73||
48055121|NCT01155219|100456112|FG000|COMPLETED|Overall Study||73||
48055122|NCT01155219|100456113|FG001|COMPLETED|Overall Study||70||
48055123|NCT01155219|100456112|FG000|NOT COMPLETED|Overall Study||4||
48055124|NCT01155219|100456113|FG001|NOT COMPLETED|Overall Study||3||
48055125|NCT02495233|100456114|FG000|STARTED|Overall Study||3||
48055126|NCT02495233|100456115|FG001|STARTED|Overall Study||7||
48055127|NCT02495233|100456114|FG000|COMPLETED|Overall Study||3||
48055128|NCT02495233|100456115|FG001|COMPLETED|Overall Study||6||
48055129|NCT02495233|100456114|FG000|NOT COMPLETED|Overall Study||0||
48055130|NCT02495233|100456115|FG001|NOT COMPLETED|Overall Study||1||
48055131|NCT04423939|100456116|FG000|STARTED|Overall Study||14||
48055132|NCT04423939|100456117|FG001|STARTED|Overall Study||14||
48055133|NCT04423939|100456116|FG000|COMPLETED|Overall Study||0||
48055134|NCT04423939|100456117|FG001|COMPLETED|Overall Study||0||
48055135|NCT04423939|100456116|FG000|NOT COMPLETED|Overall Study||14||
48055136|NCT04423939|100456117|FG001|NOT COMPLETED|Overall Study||14||
48055137|NCT06010836|100456118|FG000|STARTED|Overall Study||132||
48055138|NCT06010836|100456119|FG001|STARTED|Overall Study||125||
48055139|NCT06010836|100456118|FG000|COMPLETED|Overall Study||121||
48055140|NCT06010836|100456119|FG001|COMPLETED|Overall Study||113||
48055141|NCT06010836|100456118|FG000|NOT COMPLETED|Overall Study||11||
48055142|NCT06010836|100456119|FG001|NOT COMPLETED|Overall Study||12||
48055143|NCT01638819|100456120|FG000|STARTED|Overall Study||15||
48055144|NCT01638819|100456121|FG001|STARTED|Overall Study||15||
48055145|NCT01638819|100456120|FG000|First Intervention (8 Weeks)|Overall Study||15||
48055146|NCT01638819|100456121|FG001|First Intervention (8 Weeks)|Overall Study||15||
48055147|NCT01638819|100456120|FG000|Second Intervention (24 Weeks)|Overall Study||14||
48055148|NCT01638819|100456121|FG001|Second Intervention (24 Weeks)|Overall Study||15||
48055149|NCT01638819|100456120|FG000|COMPLETED|Overall Study||14||
48055150|NCT01638819|100456121|FG001|COMPLETED|Overall Study||15||
48055151|NCT01638819|100456120|FG000|NOT COMPLETED|Overall Study||1||
48055152|NCT01638819|100456121|FG001|NOT COMPLETED|Overall Study||0||
48055153|NCT00095628|100456122|FG000|STARTED|Overall Study||21||
48055154|NCT00095628|100456122|FG000|COMPLETED|Overall Study||20||
48055155|NCT00095628|100456122|FG000|NOT COMPLETED|Overall Study||1||
48055156|NCT01056328|100456123|FG000|STARTED|Overall Study||164||
48055157|NCT01056328|100456124|FG001|STARTED|Overall Study||160||
48055158|NCT01056328|100456123|FG000|COMPLETED|Overall Study||147||
48055159|NCT01056328|100456124|FG001|COMPLETED|Overall Study||144||
48055160|NCT01056328|100456123|FG000|NOT COMPLETED|Overall Study||17||
48055161|NCT01056328|100456124|FG001|NOT COMPLETED|Overall Study||16||
48055162|NCT02962765|100456125|FG000|STARTED|Overall Study||78||
48055163|NCT02962765|100456125|FG000|FAS Population|Overall Study||78||
48055164|NCT02962765|100456125|FG000|SAF Population|Overall Study||78||
48055165|NCT02962765|100456125|FG000|Prophylactic Treatment Group|Overall Study||77||
48055166|NCT02962765|100456125|FG000|On Demand Treatment Group|Overall Study||2||
48055167|NCT02962765|100456125|FG000|SURG Population|Overall Study||4||
48055168|NCT02962765|100456125|FG000|COMPLETED|Overall Study||61||
48055169|NCT02962765|100456125|FG000|NOT COMPLETED|Overall Study||17||
48055170|NCT01482351|100456126|FG000|STARTED|Overall Study||68||
48055171|NCT01482351|100456126|FG000|6 Months|Overall Study||54||
48055172|NCT01482351|100456126|FG000|12 Months|Overall Study||54||
48055173|NCT01482351|100456126|FG000|COMPLETED|Overall Study||54||
48055174|NCT01482351|100456126|FG000|NOT COMPLETED|Overall Study||14||
48055175|NCT02105766|100456127|FG000|STARTED|Overall Study||11||
48055176|NCT02105766|100456128|FG001|STARTED|Overall Study||18||
48055177|NCT02105766|100456129|FG002|STARTED|Overall Study||27||
48055178|NCT02105766|100456127|FG000|COMPLETED|Overall Study||7||
48055179|NCT02105766|100456128|FG001|COMPLETED|Overall Study||16||
48055180|NCT02105766|100456129|FG002|COMPLETED|Overall Study||27||
48055181|NCT02105766|100456127|FG000|NOT COMPLETED|Overall Study||4||
48055182|NCT02105766|100456128|FG001|NOT COMPLETED|Overall Study||2||
48055183|NCT02105766|100456129|FG002|NOT COMPLETED|Overall Study||0||
48055184|NCT04186481|100456130|FG000|STARTED|Overall Study||32||
48208543|NCT00166166|100837068|FG000|COMPLETED|Overall Study||103||
48055185|NCT04186481|100456130|FG000|Completed 6 Month Visit|Overall Study||31||
48055186|NCT04186481|100456130|FG000|Completed 12 Month Visit|Overall Study||4||
48055187|NCT04186481|100456130|FG000|COMPLETED|Overall Study||32||
48055188|NCT04186481|100456130|FG000|NOT COMPLETED|Overall Study||0||
48055189|NCT04123665|100456131|FG000|STARTED|Overall Study||50||
48055190|NCT04123665|100456132|FG001|STARTED|Overall Study||48||
48055191|NCT04123665|100456131|FG000|COMPLETED|Overall Study||42||
48055192|NCT04123665|100456132|FG001|COMPLETED|Overall Study||48||
48055193|NCT04123665|100456131|FG000|NOT COMPLETED|Overall Study||8||
48055194|NCT04123665|100456132|FG001|NOT COMPLETED|Overall Study||0||
48055195|NCT05153473|100456133|FG000|STARTED|Overall Study||120||124
48055196|NCT05153473|100456133|FG000|COMPLETED|Overall Study||71||73
48055197|NCT05153473|100456133|FG000|NOT COMPLETED|Overall Study||49||51
48055198|NCT02944071|100456134|FG000|STARTED|Overall Study||123||
48055199|NCT02944071|100456134|FG000|COMPLETED|Overall Study||113||
48055200|NCT02944071|100456134|FG000|NOT COMPLETED|Overall Study||10||
48055201|NCT04490109|100456135|FG000|STARTED|Overall Study||180||
48055202|NCT04490109|100456136|FG001|STARTED|Overall Study||180||
48055203|NCT04490109|100456137|FG002|STARTED|Overall Study||187||
48055204|NCT04490109|100456135|FG000|Treated|Overall Study||180||
48055205|NCT04490109|100456136|FG001|Treated|Overall Study||180||
48208544|NCT00166166|100837069|FG001|COMPLETED|Overall Study||71||
48055206|NCT04490109|100456137|FG002|Treated|Overall Study||186||
48055207|NCT04490109|100456135|FG000|COMPLETED|Overall Study||161||
48055208|NCT04490109|100456136|FG001|COMPLETED|Overall Study||155||
48055209|NCT04490109|100456137|FG002|COMPLETED|Overall Study||166||
48055210|NCT04490109|100456135|FG000|NOT COMPLETED|Overall Study||19||
48055211|NCT04490109|100456136|FG001|NOT COMPLETED|Overall Study||25||
48055212|NCT04490109|100456137|FG002|NOT COMPLETED|Overall Study||21||
48055213|NCT02961218|100456138|FG000|STARTED|Overall Study||25||
48055214|NCT02961218|100456139|FG001|STARTED|Overall Study||24||
48055215|NCT02961218|100456138|FG000|Safety Analysis Set|Overall Study||25|included all subjects that received any study drug|
48055216|NCT02961218|100456139|FG001|Safety Analysis Set|Overall Study||24|included all subjects that received any study drug|
48055217|NCT02961218|100456138|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||25|included all subjects with at least one available valid PK concentration measurement|
48055218|NCT02961218|100456139|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||0|included all subjects with at least one available valid PK concentration measurement|
48055219|NCT02961218|100456138|FG000|Primary PD Analysis Set|Overall Study||25|included all subjects with available PD data, who received any study drug.|
48055220|NCT02961218|100456139|FG001|Primary PD Analysis Set|Overall Study||24|included all subjects with available PD data, who received any study drug.|
48055221|NCT02961218|100456138|FG000|COMPLETED|Overall Study||22||
48055222|NCT02961218|100456139|FG001|COMPLETED|Overall Study||19||
48055223|NCT02961218|100456138|FG000|NOT COMPLETED|Overall Study||3||
48055224|NCT02961218|100456139|FG001|NOT COMPLETED|Overall Study||5||
48055225|NCT00625742|100456140|FG000|STARTED|Overall Study||15||
48055226|NCT00625742|100456140|FG000|COMPLETED|Overall Study||3||
48055227|NCT00625742|100456140|FG000|NOT COMPLETED|Overall Study||12||
48055228|NCT02464917|100456141|FG000|STARTED|Overall Study||35||
48055229|NCT02464917|100456142|FG001|STARTED|Overall Study||35||
48055230|NCT02464917|100456141|FG000|COMPLETED|Overall Study||35||
48055231|NCT02464917|100456142|FG001|COMPLETED|Overall Study||35||
48055232|NCT02464917|100456141|FG000|NOT COMPLETED|Overall Study||0||
48055233|NCT02464917|100456142|FG001|NOT COMPLETED|Overall Study||0||
48055234|NCT02112526|100456143|FG000|STARTED|Overall Study||11||
48055235|NCT02112526|100456144|FG001|STARTED|Overall Study||10||
48055236|NCT02112526|100456143|FG000|Enrolled|Overall Study||11||
48055237|NCT02112526|100456144|FG001|Enrolled|Overall Study||10||
48055238|NCT02112526|100456143|FG000|Received Study Medication|Overall Study||11||
48055239|NCT02112526|100456144|FG001|Received Study Medication|Overall Study||10||
48055240|NCT02112526|100456143|FG000|Discontinued Study|Overall Study||11||
48055241|NCT02112526|100456144|FG001|Discontinued Study|Overall Study||9||
48055242|NCT02112526|100456143|FG000|Subjects Continuing Study Medication|Overall Study||0||
48055243|NCT02112526|100456144|FG001|Subjects Continuing Study Medication|Overall Study||1||
48055244|NCT02112526|100456143|FG000|COMPLETED|Overall Study||0||
48055245|NCT02112526|100456144|FG001|COMPLETED|Overall Study||1||
48055246|NCT02112526|100456143|FG000|NOT COMPLETED|Overall Study||11||
48055247|NCT02112526|100456144|FG001|NOT COMPLETED|Overall Study||9||
48055248|NCT02675231|100456145|FG000|STARTED|Overall Study||79||
48208545|NCT00166166|100837068|FG000|NOT COMPLETED|Overall Study||0||
48208546|NCT00166166|100837069|FG001|NOT COMPLETED|Overall Study||0||
48055249|NCT02675231|100456146|FG001|STARTED|Overall Study||79||
48055250|NCT02675231|100456147|FG002|STARTED|Overall Study||79||
48055251|NCT02675231|100456145|FG000|Received at Least One Dose of Drug|Overall Study||78||
48055252|NCT02675231|100456146|FG001|Received at Least One Dose of Drug|Overall Study||77||
48055253|NCT02675231|100456147|FG002|Received at Least One Dose of Drug|Overall Study||72||
48055254|NCT02675231|100456145|FG000|COMPLETED|Overall Study||74||
48055255|NCT02675231|100456146|FG001|COMPLETED|Overall Study||71||
48055256|NCT02675231|100456147|FG002|COMPLETED|Overall Study||74||
48055257|NCT02675231|100456145|FG000|NOT COMPLETED|Overall Study||5||
48055258|NCT02675231|100456146|FG001|NOT COMPLETED|Overall Study||8||
48055259|NCT02675231|100456147|FG002|NOT COMPLETED|Overall Study||5||
48055260|NCT00842764|100456148|FG000|STARTED|Overall Study||7||
48055261|NCT00842764|100456148|FG000|COMPLETED|Overall Study||5||
48055262|NCT00842764|100456148|FG000|NOT COMPLETED|Overall Study||2||
48055263|NCT05350501|100456149|FG000|STARTED|Overall Study||1||
48055264|NCT05350501|100456149|FG000|COMPLETED|Overall Study||1||
48055265|NCT05350501|100456149|FG000|NOT COMPLETED|Overall Study||0||
48055266|NCT00174291|100456150|FG000|STARTED|Overall Study||11||
48055267|NCT00174291|100456151|FG001|STARTED|Overall Study||10||
48055268|NCT00174291|100456150|FG000|COMPLETED|Overall Study||6||
48055269|NCT00174291|100456151|FG001|COMPLETED|Overall Study||4||
48055270|NCT00174291|100456150|FG000|NOT COMPLETED|Overall Study||5||
48055271|NCT00174291|100456151|FG001|NOT COMPLETED|Overall Study||6||
48055272|NCT03122301|100456152|FG000|STARTED|Overall Study||1||
48055273|NCT03122301|100456153|FG001|STARTED|Overall Study||1||
48055274|NCT03122301|100456152|FG000|COMPLETED|Overall Study||1||
48208547|NCT02694835|100837070|FG000|STARTED|Overall Study||41|Randomized and Treated|
48055275|NCT03122301|100456153|FG001|COMPLETED|Overall Study||1||
48055276|NCT03122301|100456152|FG000|NOT COMPLETED|Overall Study||0||
48055277|NCT03122301|100456153|FG001|NOT COMPLETED|Overall Study||0||
48055278|NCT01520454|100456154|FG000|STARTED|Overall Study||9||
48055279|NCT01520454|100456155|FG001|STARTED|Overall Study||6||
48055280|NCT01520454|100456156|FG002|STARTED|Overall Study||5||
48055281|NCT01520454|100456157|FG003|STARTED|Overall Study||6||
48055282|NCT01520454|100456154|FG000|COMPLETED|Overall Study||9||
48208548|NCT02694835|100837071|FG001|STARTED|Overall Study||39|Randomized and Treated|
48208549|NCT02694835|100837070|FG000|COMPLETED|Overall Study||41||
48055283|NCT01520454|100456155|FG001|COMPLETED|Overall Study||6||
48055284|NCT01520454|100456156|FG002|COMPLETED|Overall Study||5||
48055285|NCT01520454|100456157|FG003|COMPLETED|Overall Study||6||
48055286|NCT01520454|100456154|FG000|NOT COMPLETED|Overall Study||0||
48055287|NCT01520454|100456155|FG001|NOT COMPLETED|Overall Study||0||
48055288|NCT01520454|100456156|FG002|NOT COMPLETED|Overall Study||0||
48055289|NCT01520454|100456157|FG003|NOT COMPLETED|Overall Study||0||
48055290|NCT00048061|100456158|FG000|STARTED|Overall Study||400||
48055291|NCT00048061|100456159|FG001|STARTED|Overall Study||401||
48055292|NCT00048061|100456160|FG002|STARTED|Overall Study||400||
48055293|NCT00048061|100456161|FG003|STARTED|Overall Study||401||
48055294|NCT00048061|100456158|FG000|COMPLETED|Overall Study||325||
48055295|NCT00048061|100456159|FG001|COMPLETED|Overall Study||328||
48055296|NCT00048061|100456160|FG002|COMPLETED|Overall Study||316||
48055297|NCT00048061|100456161|FG003|COMPLETED|Overall Study||322||
48055298|NCT00048061|100456158|FG000|NOT COMPLETED|Overall Study||75||
48055299|NCT00048061|100456159|FG001|NOT COMPLETED|Overall Study||73||
48055300|NCT00048061|100456160|FG002|NOT COMPLETED|Overall Study||84||
48055301|NCT00048061|100456161|FG003|NOT COMPLETED|Overall Study||79||
48055302|NCT04854642|100456162|FG000|STARTED|Overall Study||18||
48055303|NCT04854642|100456163|FG001|STARTED|Overall Study||18||
48055304|NCT04854642|100456162|FG000|Safety Set|Overall Study||18||
48055305|NCT04854642|100456163|FG001|Safety Set|Overall Study||18||
48055306|NCT04854642|100456162|FG000|PK Set 1|Overall Study||18||
48055307|NCT04854642|100456163|FG001|PK Set 1|Overall Study||18||
48055308|NCT04854642|100456162|FG000|PK Set 2|Overall Study||18||
48055309|NCT04854642|100456163|FG001|PK Set 2|Overall Study||18||
48055310|NCT04854642|100456162|FG000|COMPLETED|Overall Study||17||
48055311|NCT04854642|100456163|FG001|COMPLETED|Overall Study||15||
48055312|NCT04854642|100456162|FG000|NOT COMPLETED|Overall Study||1||
48055313|NCT04854642|100456163|FG001|NOT COMPLETED|Overall Study||3||
48055314|NCT05008055|100456164|FG000|STARTED|Overall Study||16||
48055315|NCT05008055|100456165|FG001|STARTED|Overall Study||4||
48055316|NCT05008055|100456166|FG002|STARTED|Overall Study||10||
48055317|NCT05008055|100456164|FG000|COMPLETED|Overall Study||13||
48055318|NCT05008055|100456165|FG001|COMPLETED|Overall Study||3||
48055319|NCT05008055|100456166|FG002|COMPLETED|Overall Study||9||
48055320|NCT05008055|100456164|FG000|NOT COMPLETED|Overall Study||3||
48055321|NCT05008055|100456165|FG001|NOT COMPLETED|Overall Study||1||
48055322|NCT05008055|100456166|FG002|NOT COMPLETED|Overall Study||1||
48055323|NCT03901534|100456167|FG000|STARTED|Aim 1||1852||
48055324|NCT03901534|100456168|FG001|STARTED|Aim 1||0||
48055325|NCT03901534|100456169|FG002|STARTED|Aim 1||0||
48055326|NCT03901534|100456170|FG003|STARTED|Aim 1||0||
48055327|NCT03901534|100456167|FG000|COMPLETED|Aim 1||1852||
48055328|NCT03901534|100456168|FG001|COMPLETED|Aim 1||0||
48055329|NCT03901534|100456169|FG002|COMPLETED|Aim 1||0||
48055330|NCT03901534|100456170|FG003|COMPLETED|Aim 1||0||
48055331|NCT03901534|100456167|FG000|NOT COMPLETED|Aim 1||0||
48208550|NCT02694835|100837071|FG001|COMPLETED|Overall Study||39||
48208551|NCT02694835|100837070|FG000|NOT COMPLETED|Overall Study||0||
48208552|NCT02694835|100837071|FG001|NOT COMPLETED|Overall Study||0||
48208553|NCT01968226|100837072|FG000|STARTED|Overall Study||3||
48208554|NCT01968226|100837072|FG000|COMPLETED|Overall Study||1||
48208555|NCT01968226|100837072|FG000|NOT COMPLETED|Overall Study||2||
48208556|NCT01616459|100837073|FG000|STARTED|Overall Study||240||
48208557|NCT01616459|100837074|FG001|STARTED|Overall Study||240||
48208558|NCT01616459|100837075|FG002|STARTED|Overall Study||230||
48208559|NCT01616459|100837076|FG003|STARTED|Overall Study||241||
48208560|NCT01616459|100837073|FG000|COMPLETED|Overall Study||236||
48208561|NCT01616459|100837074|FG001|COMPLETED|Overall Study||223||
48208562|NCT01616459|100837075|FG002|COMPLETED|Overall Study||220||
48208563|NCT01616459|100837076|FG003|COMPLETED|Overall Study||233||
48208564|NCT01616459|100837073|FG000|NOT COMPLETED|Overall Study||4||
48208565|NCT01616459|100837074|FG001|NOT COMPLETED|Overall Study||17||
48208566|NCT01616459|100837075|FG002|NOT COMPLETED|Overall Study||10||
48208567|NCT01616459|100837076|FG003|NOT COMPLETED|Overall Study||8||
48208568|NCT02528188|100837077|FG000|STARTED|Overall Study||1008||
48208569|NCT02528188|100837078|FG001|STARTED|Overall Study||1005||
48208570|NCT02528188|100837079|FG002|STARTED|Overall Study||1008||
48055332|NCT03901534|100456168|FG001|NOT COMPLETED|Aim 1||0||
48055333|NCT03901534|100456169|FG002|NOT COMPLETED|Aim 1||0||
48055334|NCT03901534|100456170|FG003|NOT COMPLETED|Aim 1||0||
48055335|NCT03901534|100456167|FG000|STARTED|Aim 2||0||
48055336|NCT03901534|100456168|FG001|STARTED|Aim 2||82||
48208571|NCT02528188|100837077|FG000|Treated|Overall Study||1002||
48208572|NCT02528188|100837078|FG001|Treated|Overall Study||998||
48208573|NCT02528188|100837079|FG002|Treated|Overall Study||996||
48208574|NCT02528188|100837077|FG000|COMPLETED|Overall Study||741||
48208575|NCT02528188|100837078|FG001|COMPLETED|Overall Study||729||
48208576|NCT02528188|100837079|FG002|COMPLETED|Overall Study||757||
48055337|NCT03901534|100456169|FG002|STARTED|Aim 2||0||
48055338|NCT03901534|100456170|FG003|STARTED|Aim 2||0||
48055339|NCT03901534|100456167|FG000|COMPLETED|Aim 2||0||
48055340|NCT03901534|100456168|FG001|COMPLETED|Aim 2||82||
48055341|NCT03901534|100456169|FG002|COMPLETED|Aim 2||0||
48055342|NCT03901534|100456170|FG003|COMPLETED|Aim 2||0||
48208577|NCT02528188|100837077|FG000|NOT COMPLETED|Overall Study||267||
48055343|NCT03901534|100456167|FG000|NOT COMPLETED|Aim 2||0||
48055344|NCT03901534|100456168|FG001|NOT COMPLETED|Aim 2||0||
48055345|NCT03901534|100456169|FG002|NOT COMPLETED|Aim 2||0||
48055346|NCT03901534|100456170|FG003|NOT COMPLETED|Aim 2||0||
48055347|NCT03901534|100456167|FG000|STARTED|Aim 3a||0||
48055348|NCT03901534|100456168|FG001|STARTED|Aim 3a||0||
48055349|NCT03901534|100456169|FG002|STARTED|Aim 3a||87||
48055350|NCT03901534|100456170|FG003|STARTED|Aim 3a||0||
48055351|NCT03901534|100456167|FG000|COMPLETED|Aim 3a||0||
48055352|NCT03901534|100456168|FG001|COMPLETED|Aim 3a||0||
48055353|NCT03901534|100456169|FG002|COMPLETED|Aim 3a||87||
48055354|NCT03901534|100456170|FG003|COMPLETED|Aim 3a||0||
48055355|NCT03901534|100456167|FG000|NOT COMPLETED|Aim 3a||0||
48055356|NCT03901534|100456168|FG001|NOT COMPLETED|Aim 3a||0||
48055357|NCT03901534|100456169|FG002|NOT COMPLETED|Aim 3a||0||
48055358|NCT03901534|100456170|FG003|NOT COMPLETED|Aim 3a||0||
48055359|NCT03901534|100456167|FG000|STARTED|Aim 3b||0||
48055360|NCT03901534|100456168|FG001|STARTED|Aim 3b||0||
48055361|NCT03901534|100456169|FG002|STARTED|Aim 3b||0||
48055362|NCT03901534|100456170|FG003|STARTED|Aim 3b||0||
48055363|NCT03901534|100456167|FG000|COMPLETED|Aim 3b||0||
48055364|NCT03901534|100456168|FG001|COMPLETED|Aim 3b||0||
48055365|NCT03901534|100456169|FG002|COMPLETED|Aim 3b||0||
48055366|NCT03901534|100456170|FG003|COMPLETED|Aim 3b||0||
48055367|NCT03901534|100456167|FG000|NOT COMPLETED|Aim 3b||0||
48055368|NCT03901534|100456168|FG001|NOT COMPLETED|Aim 3b||0||
48055369|NCT03901534|100456169|FG002|NOT COMPLETED|Aim 3b||0||
48055370|NCT03901534|100456170|FG003|NOT COMPLETED|Aim 3b||0||
48055371|NCT00504582|100456171|FG000|STARTED|Overall Study||47||
48055372|NCT00504582|100456172|FG001|STARTED|Overall Study||45||
48055373|NCT00504582|100456173|FG002|STARTED|Overall Study||20||
48055374|NCT00504582|100456171|FG000|COMPLETED|Overall Study||46||
48055375|NCT00504582|100456172|FG001|COMPLETED|Overall Study||45||
48055376|NCT00504582|100456173|FG002|COMPLETED|Overall Study||20||
48055377|NCT00504582|100456171|FG000|NOT COMPLETED|Overall Study||1||
48055378|NCT00504582|100456172|FG001|NOT COMPLETED|Overall Study||0||
48055379|NCT00504582|100456173|FG002|NOT COMPLETED|Overall Study||0||
48055380|NCT05409183|100456174|FG000|STARTED|Period 1||40||
48055381|NCT05409183|100456175|FG001|STARTED|Period 1||20||
48055382|NCT05409183|100456174|FG000|COMPLETED|Period 1||40||
48055383|NCT05409183|100456175|FG001|COMPLETED|Period 1||20||
48055384|NCT05409183|100456174|FG000|NOT COMPLETED|Period 1||0||
48055385|NCT05409183|100456175|FG001|NOT COMPLETED|Period 1||0||
48055386|NCT05409183|100456174|FG000|STARTED|Period 2||40||
48055387|NCT05409183|100456175|FG001|STARTED|Period 2||20||
48055388|NCT05409183|100456174|FG000|COMPLETED|Period 2||38||
48055389|NCT05409183|100456175|FG001|COMPLETED|Period 2||19||
48055390|NCT05409183|100456174|FG000|NOT COMPLETED|Period 2||2||
48055391|NCT05409183|100456175|FG001|NOT COMPLETED|Period 2||1||
48055392|NCT05409183|100456174|FG000|STARTED|Period 3||38||
48055393|NCT05409183|100456175|FG001|STARTED|Period 3||19||
48055394|NCT05409183|100456174|FG000|COMPLETED|Period 3||36||
48055395|NCT05409183|100456175|FG001|COMPLETED|Period 3||19||
48055396|NCT05409183|100456174|FG000|NOT COMPLETED|Period 3||2||
48055397|NCT05409183|100456175|FG001|NOT COMPLETED|Period 3||0||
48055398|NCT05409183|100456174|FG000|STARTED|Complete Study||40||
48055399|NCT05409183|100456175|FG001|STARTED|Complete Study||20||
48055400|NCT05409183|100456174|FG000|COMPLETED|Complete Study||36||
48055401|NCT05409183|100456175|FG001|COMPLETED|Complete Study||18||
48055402|NCT05409183|100456174|FG000|NOT COMPLETED|Complete Study||4||
48055403|NCT05409183|100456175|FG001|NOT COMPLETED|Complete Study||2||
48055404|NCT06106022|100456176|FG000|STARTED|Overall Study||11||
48055405|NCT06106022|100456177|FG001|STARTED|Overall Study||11||
48055406|NCT06106022|100456176|FG000|COMPLETED|Overall Study||10||
48055407|NCT06106022|100456177|FG001|COMPLETED|Overall Study||9||
48055408|NCT06106022|100456176|FG000|NOT COMPLETED|Overall Study||1||
48208578|NCT02528188|100837078|FG001|NOT COMPLETED|Overall Study||276||
48208579|NCT02528188|100837079|FG002|NOT COMPLETED|Overall Study||251||
48055409|NCT06106022|100456177|FG001|NOT COMPLETED|Overall Study||2||
48055410|NCT03043599|100456178|FG000|STARTED|Overall Study||21||
48055411|NCT03043599|100456178|FG000|COMPLETED|Overall Study||21||
48055412|NCT03043599|100456178|FG000|NOT COMPLETED|Overall Study||0||
48055413|NCT05273749|100456179|FG000|STARTED|Overall Study||231||
48055414|NCT05273749|100456180|FG001|STARTED|Overall Study||226||
48055415|NCT05273749|100456179|FG000|COMPLETED|Overall Study||187||
48055416|NCT05273749|100456180|FG001|COMPLETED|Overall Study||179||
48055417|NCT05273749|100456179|FG000|NOT COMPLETED|Overall Study||44||
48055418|NCT05273749|100456180|FG001|NOT COMPLETED|Overall Study||47||
48055419|NCT02257736|100456181|FG000|STARTED|Overall Study||490||
48055420|NCT02257736|100456182|FG001|STARTED|Overall Study||492||
48055421|NCT02257736|100456181|FG000|COMPLETED|Overall Study||39||
48055422|NCT02257736|100456182|FG001|COMPLETED|Overall Study||45||
48055423|NCT02257736|100456181|FG000|NOT COMPLETED|Overall Study||451||
48055424|NCT02257736|100456182|FG001|NOT COMPLETED|Overall Study||447||
48055425|NCT05423730|100456183|FG000|STARTED|Overall Study||9||
48055426|NCT05423730|100456184|FG001|STARTED|Overall Study||11||
48055427|NCT05423730|100456183|FG000|COMPLETED|Overall Study||9||
48055428|NCT05423730|100456184|FG001|COMPLETED|Overall Study||11||
48055429|NCT05423730|100456183|FG000|NOT COMPLETED|Overall Study||0||
48055430|NCT05423730|100456184|FG001|NOT COMPLETED|Overall Study||0||
48055431|NCT04541706|100456185|FG000|STARTED|Overall Study||100||
48055432|NCT04541706|100456185|FG000|COMPLETED|Overall Study||55||
48055433|NCT04541706|100456185|FG000|NOT COMPLETED|Overall Study||45||
48055434|NCT03524092|100456186|FG000|STARTED|Blinded Maintenance Period (Wk 0-40)||192||
48055435|NCT03524092|100456187|FG001|STARTED|Blinded Maintenance Period (Wk 0-40)||389||
48055436|NCT03524092|100456188|FG002|STARTED|Blinded Maintenance Period (Wk 0-40)||135||
48055437|NCT03524092|100456189|FG003|STARTED|Blinded Maintenance Period (Wk 0-40)||0||
48055438|NCT03524092|100456190|FG004|STARTED|Blinded Maintenance Period (Wk 0-40)||0||
48055439|NCT03524092|100456191|FG005|STARTED|Blinded Maintenance Period (Wk 0-40)||0||
48055440|NCT03524092|100456186|FG000|Received at Least One Dose of Study Drug|Blinded Maintenance Period (Wk 0-40)||192||
48055441|NCT03524092|100456187|FG001|Received at Least One Dose of Study Drug|Blinded Maintenance Period (Wk 0-40)||389||
48055442|NCT03524092|100456188|FG002|Received at Least One Dose of Study Drug|Blinded Maintenance Period (Wk 0-40)||135||
48055443|NCT03524092|100456189|FG003|Received at Least One Dose of Study Drug|Blinded Maintenance Period (Wk 0-40)||0||
48055444|NCT03524092|100456190|FG004|Received at Least One Dose of Study Drug|Blinded Maintenance Period (Wk 0-40)||0||
48055445|NCT03524092|100456191|FG005|Received at Least One Dose of Study Drug|Blinded Maintenance Period (Wk 0-40)||0||
48055446|NCT03524092|100456186|FG000|COMPLETED|Blinded Maintenance Period (Wk 0-40)||119||
48055447|NCT03524092|100456187|FG001|COMPLETED|Blinded Maintenance Period (Wk 0-40)||347||
48055448|NCT03524092|100456188|FG002|COMPLETED|Blinded Maintenance Period (Wk 0-40)||90||
48055449|NCT03524092|100456189|FG003|COMPLETED|Blinded Maintenance Period (Wk 0-40)||0||
48055450|NCT03524092|100456190|FG004|COMPLETED|Blinded Maintenance Period (Wk 0-40)||0||
48055451|NCT03524092|100456191|FG005|COMPLETED|Blinded Maintenance Period (Wk 0-40)||0||
48055452|NCT03524092|100456186|FG000|NOT COMPLETED|Blinded Maintenance Period (Wk 0-40)||73||
48208580|NCT04054635|100837080|FG000|STARTED|First Visit (Baseline)||28||
48208581|NCT04054635|100837081|FG001|STARTED|First Visit (Baseline)||28||
48055453|NCT03524092|100456187|FG001|NOT COMPLETED|Blinded Maintenance Period (Wk 0-40)||42||
48055454|NCT03524092|100456188|FG002|NOT COMPLETED|Blinded Maintenance Period (Wk 0-40)||45||
48055455|NCT03524092|100456189|FG003|NOT COMPLETED|Blinded Maintenance Period (Wk 0-40)||0||
48055456|NCT03524092|100456190|FG004|NOT COMPLETED|Blinded Maintenance Period (Wk 0-40)||0||
48055457|NCT03524092|100456191|FG005|NOT COMPLETED|Blinded Maintenance Period (Wk 0-40)||0||
48055458|NCT03524092|100456186|FG000|STARTED|Loss of Response Rescue Period||0||
48055459|NCT03524092|100456187|FG001|STARTED|Loss of Response Rescue Period||0||
48055460|NCT03524092|100456188|FG002|STARTED|Loss of Response Rescue Period||0||
48055461|NCT03524092|100456189|FG003|STARTED|Loss of Response Rescue Period||90||
48055462|NCT03524092|100456190|FG004|STARTED|Loss of Response Rescue Period||0||
48055463|NCT03524092|100456191|FG005|STARTED|Loss of Response Rescue Period||0||
48055464|NCT03524092|100456186|FG000|COMPLETED|Loss of Response Rescue Period||0||
48055465|NCT03524092|100456187|FG001|COMPLETED|Loss of Response Rescue Period||0||
48055466|NCT03524092|100456188|FG002|COMPLETED|Loss of Response Rescue Period||0||
48055467|NCT03524092|100456189|FG003|COMPLETED|Loss of Response Rescue Period||81||
48055468|NCT03524092|100456190|FG004|COMPLETED|Loss of Response Rescue Period||0||
48055469|NCT03524092|100456191|FG005|COMPLETED|Loss of Response Rescue Period||0||
48055470|NCT03524092|100456186|FG000|NOT COMPLETED|Loss of Response Rescue Period||0||
48055471|NCT03524092|100456187|FG001|NOT COMPLETED|Loss of Response Rescue Period||0||
48055472|NCT03524092|100456188|FG002|NOT COMPLETED|Loss of Response Rescue Period||0||
48055473|NCT03524092|100456189|FG003|NOT COMPLETED|Loss of Response Rescue Period||9||
48055474|NCT03524092|100456190|FG004|NOT COMPLETED|Loss of Response Rescue Period||0||
48055475|NCT03524092|100456191|FG005|NOT COMPLETED|Loss of Response Rescue Period||0||
48055476|NCT03524092|100456186|FG000|STARTED|Open Label Extended Induction (Wk 0-12)||0||
48055477|NCT03524092|100456187|FG001|STARTED|Open Label Extended Induction (Wk 0-12)||0||
48055478|NCT03524092|100456188|FG002|STARTED|Open Label Extended Induction (Wk 0-12)||0||
48055479|NCT03524092|100456189|FG003|STARTED|Open Label Extended Induction (Wk 0-12)||0||
48055480|NCT03524092|100456190|FG004|STARTED|Open Label Extended Induction (Wk 0-12)||461||
48055481|NCT03524092|100456191|FG005|STARTED|Open Label Extended Induction (Wk 0-12)||0||
48055482|NCT03524092|100456186|FG000|COMPLETED|Open Label Extended Induction (Wk 0-12)||0||
48055483|NCT03524092|100456187|FG001|COMPLETED|Open Label Extended Induction (Wk 0-12)||0||
48055484|NCT03524092|100456188|FG002|COMPLETED|Open Label Extended Induction (Wk 0-12)||0||
48055485|NCT03524092|100456189|FG003|COMPLETED|Open Label Extended Induction (Wk 0-12)||0||
48055486|NCT03524092|100456190|FG004|COMPLETED|Open Label Extended Induction (Wk 0-12)||271||
48055487|NCT03524092|100456191|FG005|COMPLETED|Open Label Extended Induction (Wk 0-12)||0||
48055488|NCT03524092|100456186|FG000|NOT COMPLETED|Open Label Extended Induction (Wk 0-12)||0||
48055489|NCT03524092|100456187|FG001|NOT COMPLETED|Open Label Extended Induction (Wk 0-12)||0||
48055490|NCT03524092|100456188|FG002|NOT COMPLETED|Open Label Extended Induction (Wk 0-12)||0||
48055491|NCT03524092|100456189|FG003|NOT COMPLETED|Open Label Extended Induction (Wk 0-12)||0||
48055492|NCT03524092|100456190|FG004|NOT COMPLETED|Open Label Extended Induction (Wk 0-12)||190||
48495719|NCT00834132|101547921|FG001|COMPLETED|First Intervention||12||
48055493|NCT03524092|100456191|FG005|NOT COMPLETED|Open Label Extended Induction (Wk 0-12)||0||
48208582|NCT04054635|100837082|FG002|STARTED|First Visit (Baseline)||28||
48208583|NCT04054635|100837080|FG000|COMPLETED|First Visit (Baseline)||28||
48208584|NCT04054635|100837081|FG001|COMPLETED|First Visit (Baseline)||28||
48055494|NCT03524092|100456186|FG000|STARTED|Open Label Maintenance Period (Wk 12-40)||0||
48055495|NCT03524092|100456187|FG001|STARTED|Open Label Maintenance Period (Wk 12-40)||0||
48055496|NCT03524092|100456188|FG002|STARTED|Open Label Maintenance Period (Wk 12-40)||0||
48055497|NCT03524092|100456189|FG003|STARTED|Open Label Maintenance Period (Wk 12-40)||0||
48055498|NCT03524092|100456190|FG004|STARTED|Open Label Maintenance Period (Wk 12-40)||0||
48055499|NCT03524092|100456191|FG005|STARTED|Open Label Maintenance Period (Wk 12-40)||271||
48055500|NCT03524092|100456186|FG000|COMPLETED|Open Label Maintenance Period (Wk 12-40)||0||
48055501|NCT03524092|100456187|FG001|COMPLETED|Open Label Maintenance Period (Wk 12-40)||0||
48055502|NCT03524092|100456188|FG002|COMPLETED|Open Label Maintenance Period (Wk 12-40)||0||
48055503|NCT03524092|100456189|FG003|COMPLETED|Open Label Maintenance Period (Wk 12-40)||0||
48055504|NCT03524092|100456190|FG004|COMPLETED|Open Label Maintenance Period (Wk 12-40)||0||
48055505|NCT03524092|100456191|FG005|COMPLETED|Open Label Maintenance Period (Wk 12-40)||256||
48055506|NCT03524092|100456186|FG000|NOT COMPLETED|Open Label Maintenance Period (Wk 12-40)||0||
48055507|NCT03524092|100456187|FG001|NOT COMPLETED|Open Label Maintenance Period (Wk 12-40)||0||
48055508|NCT03524092|100456188|FG002|NOT COMPLETED|Open Label Maintenance Period (Wk 12-40)||0||
48055509|NCT03524092|100456189|FG003|NOT COMPLETED|Open Label Maintenance Period (Wk 12-40)||0||
48055510|NCT03524092|100456190|FG004|NOT COMPLETED|Open Label Maintenance Period (Wk 12-40)||0||
48055511|NCT03524092|100456191|FG005|NOT COMPLETED|Open Label Maintenance Period (Wk 12-40)||15||
48055512|NCT05691309|100456192|FG000|STARTED|Overall Study||22||
48055513|NCT05691309|100456192|FG000|COMPLETED|Overall Study||18||
48055514|NCT05691309|100456192|FG000|NOT COMPLETED|Overall Study||4||
48055515|NCT05710107|100456193|FG000|STARTED|Overall Study||53||
48055516|NCT05710107|100456194|FG001|STARTED|Overall Study||53||
48055517|NCT05710107|100456193|FG000|COMPLETED|Overall Study||42|53 subjects began the study. in the PENG + LFC group 3 subjects were removed and their data was not included (1 subject withdrew, and 2 were unable to have the assigned block performed) bringing the total to 50. 53 subjects began in the QL block group and 2 were removed (1 voluntarily withdrew and 1 was withdrawn by the study team) bringing the total to 51 included in this group. Lost to follow up were included in analysis but had missing data.|
48055518|NCT05710107|100456194|FG001|COMPLETED|Overall Study||42|53 subjects began the study. in the PENG + LFC group 3 subjects were removed and their data was not included (1 subject withdrew, and 2 were unable to have the assigned block performed) bringing the total to 50. 53 subjects began in the QL block group and 2 were removed (1 voluntarily withdrew and 1 was withdrawn by the study team) bringing the total to 51 included in this group. Lost to follow up were included in analysis but had missing data.|
48055519|NCT05710107|100456193|FG000|NOT COMPLETED|Overall Study||11||
48055520|NCT05710107|100456194|FG001|NOT COMPLETED|Overall Study||11||
48055521|NCT00764504|100456195|FG000|STARTED|Overall Study||141||
48055522|NCT00764504|100456196|FG001|STARTED|Overall Study||141||
48055523|NCT00764504|100456197|FG002|STARTED|Overall Study||234||
48055524|NCT00764504|100456195|FG000|COMPLETED|Overall Study||75||
48055525|NCT00764504|100456196|FG001|COMPLETED|Overall Study||71||
48055526|NCT00764504|100456197|FG002|COMPLETED|Overall Study||131||
48055527|NCT00764504|100456195|FG000|NOT COMPLETED|Overall Study||66||
48055528|NCT00764504|100456196|FG001|NOT COMPLETED|Overall Study||70||
48055529|NCT00764504|100456197|FG002|NOT COMPLETED|Overall Study||103||
48055530|NCT04902326|100456198|FG000|STARTED|Overall Study||95||
48055531|NCT04902326|100456199|FG001|STARTED|Overall Study||95||
48055532|NCT04902326|100456200|FG002|STARTED|Overall Study||95||
48055533|NCT04902326|100456201|FG003|STARTED|Overall Study||95||
48055534|NCT04902326|100456198|FG000|6-month Assessment|Overall Study||85|Participants who completed at least one of the following three assessments at 6 months: HbA1c, weight, and survey to assess potential mediators and moderators.|
48055535|NCT04902326|100456199|FG001|6-month Assessment|Overall Study||88|Participants who completed at least one of the following three assessments at 6 months: HbA1c, weight, and survey to assess potential mediators and moderators.|
48055536|NCT04902326|100456200|FG002|6-month Assessment|Overall Study||90|Participants who completed at least one of the following three assessments at 6 months: HbA1c, weight, and survey to assess potential mediators and moderators.|
48055537|NCT04902326|100456201|FG003|6-month Assessment|Overall Study||88|Participants who completed at least one of the following three assessments at 6 months: HbA1c, weight, and survey to assess potential mediators and moderators.|
48055538|NCT04902326|100456198|FG000|COMPLETED|Overall Study||80|Participants who completed at least one of the following three assessments at 12 months: HbA1c, weight, and survey to assess potential mediators and moderators.|
48055539|NCT04902326|100456199|FG001|COMPLETED|Overall Study||78|Participants who completed at least one of the following three assessments at 12 months: HbA1c, weight, and survey to assess potential mediators and moderators.|
48055540|NCT04902326|100456200|FG002|COMPLETED|Overall Study||81|Participants who completed at least one of the following three assessments at 12 months: HbA1c, weight, and survey to assess potential mediators and moderators.|
48055541|NCT04902326|100456201|FG003|COMPLETED|Overall Study||88|Participants who completed at least one of the following three assessments at 12 months: HbA1c, weight, and survey to assess potential mediators and moderators.|
48055542|NCT04902326|100456198|FG000|NOT COMPLETED|Overall Study||15||
48055543|NCT04902326|100456199|FG001|NOT COMPLETED|Overall Study||17||
48055544|NCT04902326|100456200|FG002|NOT COMPLETED|Overall Study||14||
48055545|NCT04902326|100456201|FG003|NOT COMPLETED|Overall Study||7||
48055546|NCT01352468|100456202|FG000|STARTED|Overall Study||22||
48055547|NCT01352468|100456203|FG001|STARTED|Overall Study||22||
48055548|NCT01352468|100456202|FG000|COMPLETED|Overall Study||17||
48495720|NCT00834132|101547920|FG000|NOT COMPLETED|First Intervention||0||
48495721|NCT00834132|101547921|FG001|NOT COMPLETED|First Intervention||0||
48055549|NCT01352468|100456203|FG001|COMPLETED|Overall Study||18||
48055550|NCT01352468|100456202|FG000|NOT COMPLETED|Overall Study||5||
48055551|NCT01352468|100456203|FG001|NOT COMPLETED|Overall Study||4||
48055552|NCT03544775|100456204|FG000|STARTED|Overall Study||28571||
48055553|NCT03544775|100456205|FG001|STARTED|Overall Study||31073||
48055554|NCT03544775|100456204|FG000|COMPLETED|Overall Study||28571||
48055555|NCT03544775|100456205|FG001|COMPLETED|Overall Study||31073||
48055556|NCT03544775|100456204|FG000|NOT COMPLETED|Overall Study||0||
48055557|NCT03544775|100456205|FG001|NOT COMPLETED|Overall Study||0||
48055558|NCT00267189|100456206|FG000|STARTED|Overall Study||72||
48055559|NCT00267189|100456207|FG001|STARTED|Overall Study||73||
48055560|NCT00267189|100456206|FG000|Completed Study Medication|Overall Study||54||
48055561|NCT00267189|100456207|FG001|Completed Study Medication|Overall Study||72||
48055562|NCT00267189|100456206|FG000|COMPLETED|Overall Study||67||
48055563|NCT00267189|100456207|FG001|COMPLETED|Overall Study||72||
48055564|NCT00267189|100456206|FG000|NOT COMPLETED|Overall Study||5||
48055565|NCT00267189|100456207|FG001|NOT COMPLETED|Overall Study||1||
48055566|NCT01809691|100456208|FG000|STARTED|Overall Study||638||
48055567|NCT01809691|100456209|FG001|STARTED|Overall Study||641||
48055568|NCT01809691|100456208|FG000|COMPLETED|Overall Study||0||
48055569|NCT01809691|100456209|FG001|COMPLETED|Overall Study||0||
48055570|NCT01809691|100456208|FG000|NOT COMPLETED|Overall Study||638||
48055571|NCT01809691|100456209|FG001|NOT COMPLETED|Overall Study||641||
48055572|NCT02421939|100456210|FG000|STARTED|Overall Study||247||
48055573|NCT02421939|100456211|FG001|STARTED|Overall Study||124||
48055574|NCT02421939|100456210|FG000|Treated|Overall Study||246||
48055575|NCT02421939|100456211|FG001|Treated|Overall Study||109||
48055576|NCT02421939|100456210|FG000|COMPLETED|Overall Study||38|Participants still on treatment. Last assessment of remission status at the end of treatment visit.|
48055577|NCT02421939|100456211|FG001|COMPLETED|Overall Study||0|Participants still on treatment. Last assessment of remission status at the end of treatment visit.|
48055578|NCT02421939|100456210|FG000|NOT COMPLETED|Overall Study||209||
48055579|NCT02421939|100456211|FG001|NOT COMPLETED|Overall Study||124||
48055580|NCT00484718|100456212|FG000|STARTED|Treatment Period 1 (2 Weeks)||1||
48055581|NCT00484718|100456213|FG001|STARTED|Treatment Period 1 (2 Weeks)||1||
48055582|NCT00484718|100456214|FG002|STARTED|Treatment Period 1 (2 Weeks)||1||
48055583|NCT00484718|100456215|FG003|STARTED|Treatment Period 1 (2 Weeks)||1||
48055584|NCT00484718|100456216|FG004|STARTED|Treatment Period 1 (2 Weeks)||1||
48055585|NCT00484718|100456217|FG005|STARTED|Treatment Period 1 (2 Weeks)||1||
48055586|NCT00484718|100456212|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||1||
48055587|NCT00484718|100456213|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||1||
48055588|NCT00484718|100456214|FG002|COMPLETED|Treatment Period 1 (2 Weeks)||1||
48055589|NCT00484718|100456215|FG003|COMPLETED|Treatment Period 1 (2 Weeks)||1||
48055590|NCT00484718|100456216|FG004|COMPLETED|Treatment Period 1 (2 Weeks)||1||
48055591|NCT00484718|100456217|FG005|COMPLETED|Treatment Period 1 (2 Weeks)||1||
48055592|NCT00484718|100456212|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0||
48055593|NCT00484718|100456213|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0||
48055594|NCT00484718|100456214|FG002|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0||
48055595|NCT00484718|100456215|FG003|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0||
48055596|NCT00484718|100456216|FG004|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0||
48055597|NCT00484718|100456217|FG005|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0||
48055598|NCT00484718|100456212|FG000|STARTED|Washout Period (2 Weeks)||1||
48055599|NCT00484718|100456213|FG001|STARTED|Washout Period (2 Weeks)||1||
48055600|NCT00484718|100456214|FG002|STARTED|Washout Period (2 Weeks)||1||
48055601|NCT00484718|100456215|FG003|STARTED|Washout Period (2 Weeks)||1||
48055602|NCT00484718|100456216|FG004|STARTED|Washout Period (2 Weeks)||1||
48055603|NCT00484718|100456217|FG005|STARTED|Washout Period (2 Weeks)||1||
48055604|NCT00484718|100456212|FG000|COMPLETED|Washout Period (2 Weeks)||1||
48055605|NCT00484718|100456213|FG001|COMPLETED|Washout Period (2 Weeks)||1||
48055606|NCT00484718|100456214|FG002|COMPLETED|Washout Period (2 Weeks)||1||
48055607|NCT00484718|100456215|FG003|COMPLETED|Washout Period (2 Weeks)||1||
48055608|NCT00484718|100456216|FG004|COMPLETED|Washout Period (2 Weeks)||1||
48055609|NCT00484718|100456217|FG005|COMPLETED|Washout Period (2 Weeks)||1||
48055610|NCT00484718|100456212|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0||
48055611|NCT00484718|100456213|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0||
48055612|NCT00484718|100456214|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0||
48055613|NCT00484718|100456215|FG003|NOT COMPLETED|Washout Period (2 Weeks)||0||
48055614|NCT00484718|100456216|FG004|NOT COMPLETED|Washout Period (2 Weeks)||0||
48055615|NCT00484718|100456217|FG005|NOT COMPLETED|Washout Period (2 Weeks)||0||
48055616|NCT00484718|100456212|FG000|STARTED|Treatment Period 2 (2 Weeks)||1||
48055617|NCT00484718|100456213|FG001|STARTED|Treatment Period 2 (2 Weeks)||1||
48055618|NCT00484718|100456214|FG002|STARTED|Treatment Period 2 (2 Weeks)||1||
48055619|NCT00484718|100456215|FG003|STARTED|Treatment Period 2 (2 Weeks)||1||
48055620|NCT00484718|100456216|FG004|STARTED|Treatment Period 2 (2 Weeks)||1||
48055621|NCT00484718|100456217|FG005|STARTED|Treatment Period 2 (2 Weeks)||1||
48055622|NCT00484718|100456212|FG000|COMPLETED|Treatment Period 2 (2 Weeks)||1||
48055623|NCT00484718|100456213|FG001|COMPLETED|Treatment Period 2 (2 Weeks)||1||
48055624|NCT00484718|100456214|FG002|COMPLETED|Treatment Period 2 (2 Weeks)||1||
48055625|NCT00484718|100456215|FG003|COMPLETED|Treatment Period 2 (2 Weeks)||1||
48055626|NCT00484718|100456216|FG004|COMPLETED|Treatment Period 2 (2 Weeks)||1||
48055627|NCT00484718|100456217|FG005|COMPLETED|Treatment Period 2 (2 Weeks)||1||
48055628|NCT00484718|100456212|FG000|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0||
48055629|NCT00484718|100456213|FG001|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0||
48055630|NCT00484718|100456214|FG002|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0||
48055631|NCT00484718|100456215|FG003|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0||
48055632|NCT00484718|100456216|FG004|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0||
48055633|NCT00484718|100456217|FG005|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0||
48055634|NCT00484718|100456212|FG000|STARTED|Washout Period (2 Weeks)||1||
48055635|NCT00484718|100456213|FG001|STARTED|Washout Period (2 Weeks)||1||
48055636|NCT00484718|100456214|FG002|STARTED|Washout Period (2 Weeks)||1||
48055637|NCT00484718|100456215|FG003|STARTED|Washout Period (2 Weeks)||1||
48055638|NCT00484718|100456216|FG004|STARTED|Washout Period (2 Weeks)||1||
48055639|NCT00484718|100456217|FG005|STARTED|Washout Period (2 Weeks)||1||
48055640|NCT00484718|100456212|FG000|COMPLETED|Washout Period (2 Weeks)||1||
48055641|NCT00484718|100456213|FG001|COMPLETED|Washout Period (2 Weeks)||1||
48055642|NCT00484718|100456214|FG002|COMPLETED|Washout Period (2 Weeks)||1||
48055643|NCT00484718|100456215|FG003|COMPLETED|Washout Period (2 Weeks)||1||
48055644|NCT00484718|100456216|FG004|COMPLETED|Washout Period (2 Weeks)||1||
48055645|NCT00484718|100456217|FG005|COMPLETED|Washout Period (2 Weeks)||1||
48055646|NCT00484718|100456212|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0||
48055647|NCT00484718|100456213|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0||
48055648|NCT00484718|100456214|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0||
48055649|NCT00484718|100456215|FG003|NOT COMPLETED|Washout Period (2 Weeks)||0||
48055650|NCT00484718|100456216|FG004|NOT COMPLETED|Washout Period (2 Weeks)||0||
48055651|NCT00484718|100456217|FG005|NOT COMPLETED|Washout Period (2 Weeks)||0||
48055652|NCT00484718|100456212|FG000|STARTED|Treatment Period 3 (2 Weeks)||1||
48055653|NCT00484718|100456213|FG001|STARTED|Treatment Period 3 (2 Weeks)||1||
48055654|NCT00484718|100456214|FG002|STARTED|Treatment Period 3 (2 Weeks)||1||
48055655|NCT00484718|100456215|FG003|STARTED|Treatment Period 3 (2 Weeks)||1||
48055656|NCT00484718|100456216|FG004|STARTED|Treatment Period 3 (2 Weeks)||1||
48055657|NCT00484718|100456217|FG005|STARTED|Treatment Period 3 (2 Weeks)||1||
48055658|NCT00484718|100456212|FG000|COMPLETED|Treatment Period 3 (2 Weeks)||1||
48055659|NCT00484718|100456213|FG001|COMPLETED|Treatment Period 3 (2 Weeks)||1||
48055660|NCT00484718|100456214|FG002|COMPLETED|Treatment Period 3 (2 Weeks)||1||
48055661|NCT00484718|100456215|FG003|COMPLETED|Treatment Period 3 (2 Weeks)||1||
48055662|NCT00484718|100456216|FG004|COMPLETED|Treatment Period 3 (2 Weeks)||1||
48055663|NCT00484718|100456217|FG005|COMPLETED|Treatment Period 3 (2 Weeks)||1||
48055664|NCT00484718|100456212|FG000|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0||
48055665|NCT00484718|100456213|FG001|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0||
48055666|NCT00484718|100456214|FG002|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0||
48055667|NCT00484718|100456215|FG003|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0||
48055668|NCT00484718|100456216|FG004|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0||
48055669|NCT00484718|100456217|FG005|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0||
48055670|NCT05407714|100456218|FG000|STARTED|Overall Study||15||
48055671|NCT05407714|100456218|FG000|Cases of Valid Data|Overall Study||14||
48055672|NCT05407714|100456218|FG000|COMPLETED|Overall Study||15||
48055673|NCT05407714|100456218|FG000|NOT COMPLETED|Overall Study||0||
48055674|NCT03315754|100456219|FG000|STARTED|Overall Study||50||
48055675|NCT03315754|100456219|FG000|COMPLETED|Overall Study||48||
48055676|NCT03315754|100456219|FG000|NOT COMPLETED|Overall Study||2||
48055677|NCT04029688|100456220|FG000|STARTED|Overall Study||8||
48055678|NCT04029688|100456221|FG001|STARTED|Overall Study||3||
48055679|NCT04029688|100456222|FG002|STARTED|Overall Study||6||
48055680|NCT04029688|100456223|FG003|STARTED|Overall Study||3||
48055681|NCT04029688|100456224|FG004|STARTED|Overall Study||6||
48055682|NCT04029688|100456225|FG005|STARTED|Overall Study||3||
48055683|NCT04029688|100456226|FG006|STARTED|Overall Study||3||
48055684|NCT04029688|100456227|FG007|STARTED|Overall Study||6||
48055685|NCT04029688|100456220|FG000|COMPLETED|Overall Study||0||
48208585|NCT04054635|100837082|FG002|COMPLETED|First Visit (Baseline)||28||
48208586|NCT04054635|100837080|FG000|NOT COMPLETED|First Visit (Baseline)||0||
48055686|NCT04029688|100456221|FG001|COMPLETED|Overall Study||0||
48055687|NCT04029688|100456222|FG002|COMPLETED|Overall Study||0||
48055688|NCT04029688|100456223|FG003|COMPLETED|Overall Study||0||
48055689|NCT04029688|100456224|FG004|COMPLETED|Overall Study||0||
48055690|NCT04029688|100456225|FG005|COMPLETED|Overall Study||0||
48055691|NCT04029688|100456226|FG006|COMPLETED|Overall Study||0||
48055692|NCT04029688|100456227|FG007|COMPLETED|Overall Study||0||
48055693|NCT04029688|100456220|FG000|NOT COMPLETED|Overall Study||8||
48055694|NCT04029688|100456221|FG001|NOT COMPLETED|Overall Study||3||
48055695|NCT04029688|100456222|FG002|NOT COMPLETED|Overall Study||6||
48055696|NCT04029688|100456223|FG003|NOT COMPLETED|Overall Study||3||
48055697|NCT04029688|100456224|FG004|NOT COMPLETED|Overall Study||6||
48055698|NCT04029688|100456225|FG005|NOT COMPLETED|Overall Study||3||
48055699|NCT04029688|100456226|FG006|NOT COMPLETED|Overall Study||3||
48055700|NCT04029688|100456227|FG007|NOT COMPLETED|Overall Study||6||
48055701|NCT04528173|100456228|FG000|STARTED|Overall Study||18||
48055702|NCT04528173|100456229|FG001|STARTED|Overall Study||17||
48055703|NCT04528173|100456228|FG000|COMPLETED|Overall Study||18||
48055704|NCT04528173|100456229|FG001|COMPLETED|Overall Study||17||
48055705|NCT04528173|100456228|FG000|NOT COMPLETED|Overall Study||0||
48055706|NCT04528173|100456229|FG001|NOT COMPLETED|Overall Study||0||
48055707|NCT01946204|100456230|FG000|STARTED|Overall Study||401||
48055708|NCT01946204|100456231|FG001|STARTED|Overall Study||806||
48055709|NCT01946204|100456230|FG000|Treated|Overall Study||398||
48055710|NCT01946204|100456231|FG001|Treated|Overall Study||803||
48055711|NCT01946204|100456230|FG000|COMPLETED|Overall Study||0||
48055712|NCT01946204|100456231|FG001|COMPLETED|Overall Study||0||
48055713|NCT01946204|100456230|FG000|NOT COMPLETED|Overall Study||401||
48055714|NCT01946204|100456231|FG001|NOT COMPLETED|Overall Study||806||
48055715|NCT05126862|100456232|FG000|STARTED|Overall Study||22||
48055716|NCT05126862|100456233|FG001|STARTED|Overall Study||21||
48055717|NCT05126862|100456232|FG000|COMPLETED|Overall Study||14||
48055718|NCT05126862|100456233|FG001|COMPLETED|Overall Study||12||
48055719|NCT05126862|100456232|FG000|NOT COMPLETED|Overall Study||8||
48055720|NCT05126862|100456233|FG001|NOT COMPLETED|Overall Study||9||
48055721|NCT02252172|100456234|FG000|STARTED|Overall Study||369||
48055722|NCT02252172|100456235|FG001|STARTED|Overall Study||368||
48055723|NCT02252172|100456234|FG000|Treated|Overall Study||365||
48055724|NCT02252172|100456235|FG001|Treated|Overall Study||364||
48055725|NCT02252172|100456234|FG000|COMPLETED|Overall Study||90|Participants who died or withdrew consent were considered as completed.|
48055726|NCT02252172|100456235|FG001|COMPLETED|Overall Study||69|Participants who died or withdrew consent were considered as completed.|
48055727|NCT02252172|100456234|FG000|NOT COMPLETED|Overall Study||279||
48055728|NCT02252172|100456235|FG001|NOT COMPLETED|Overall Study||299||
48055729|NCT03538678|100456236|FG000|STARTED|Overall Study||20||
48055730|NCT03538678|100456237|FG001|STARTED|Overall Study||20||
48055731|NCT03538678|100456236|FG000|COMPLETED|Overall Study||5||
48055732|NCT03538678|100456237|FG001|COMPLETED|Overall Study||9||
48055733|NCT03538678|100456236|FG000|NOT COMPLETED|Overall Study||15||
48055734|NCT03538678|100456237|FG001|NOT COMPLETED|Overall Study||11||
48055735|NCT04551066|100456238|FG000|STARTED|Overall Study||125||
48055736|NCT04551066|100456239|FG001|STARTED|Overall Study||127||
48055737|NCT04551066|100456238|FG000|COMPLETED|Overall Study||0||
48055738|NCT04551066|100456239|FG001|COMPLETED|Overall Study||0||
48055739|NCT04551066|100456238|FG000|NOT COMPLETED|Overall Study||125||
48055740|NCT04551066|100456239|FG001|NOT COMPLETED|Overall Study||127||
48055741|NCT05081583|100456240|FG000|STARTED|Overall Study||22||
48055742|NCT05081583|100456240|FG000|COMPLETED|Overall Study||22||
48055743|NCT05081583|100456240|FG000|NOT COMPLETED|Overall Study||0||
48055744|NCT04364048|100456241|FG000|STARTED|Overall Study||10||
48055745|NCT04364048|100456241|FG000|COMPLETED|Overall Study||10||
48055746|NCT04364048|100456241|FG000|NOT COMPLETED|Overall Study||0||
48055747|NCT05683392|100458133|FG000|STARTED|Overall Study||36||
48055748|NCT05683392|100458134|FG001|STARTED|Overall Study||36||
48055749|NCT05683392|100458133|FG000|COMPLETED|Overall Study||36||
48055750|NCT05683392|100458134|FG001|COMPLETED|Overall Study||36||
48055751|NCT05683392|100458133|FG000|NOT COMPLETED|Overall Study||0||
48055752|NCT05683392|100458134|FG001|NOT COMPLETED|Overall Study||0||
48055753|NCT03898960|100458135|FG000|STARTED|Overall Study||54||
48055754|NCT03898960|100458135|FG000|COMPLETED|Overall Study||44||
48055755|NCT03898960|100458135|FG000|NOT COMPLETED|Overall Study||10||
48055756|NCT02933970|100458136|FG000|STARTED|Step 1: Months 0-9||52||4
48055757|NCT02933970|100458137|FG001|STARTED|Step 1: Months 0-9||52||4
48055758|NCT02933970|100458138|FG002|STARTED|Step 1: Months 0-9||52||4
48055759|NCT02933970|100458136|FG000|COMPLETED|Step 1: Months 0-9||52||4
48055760|NCT02933970|100458137|FG001|COMPLETED|Step 1: Months 0-9||52||4
48055761|NCT02933970|100458138|FG002|COMPLETED|Step 1: Months 0-9||52||4
48055762|NCT02933970|100458136|FG000|NOT COMPLETED|Step 1: Months 0-9||0||0
48055763|NCT02933970|100458137|FG001|NOT COMPLETED|Step 1: Months 0-9||0||0
48055764|NCT02933970|100458138|FG002|NOT COMPLETED|Step 1: Months 0-9||0||0
48055765|NCT02933970|100458136|FG000|STARTED|Step 2: Months 10-18||52||4
48055766|NCT02933970|100458137|FG001|STARTED|Step 2: Months 10-18||52||4
48055767|NCT02933970|100458138|FG002|STARTED|Step 2: Months 10-18||52||4
48055768|NCT02933970|100458136|FG000|COMPLETED|Step 2: Months 10-18||52||4
48055769|NCT02933970|100458137|FG001|COMPLETED|Step 2: Months 10-18||52||4
48055770|NCT02933970|100458138|FG002|COMPLETED|Step 2: Months 10-18||52||4
48055771|NCT02933970|100458136|FG000|NOT COMPLETED|Step 2: Months 10-18||0||0
48055772|NCT02933970|100458137|FG001|NOT COMPLETED|Step 2: Months 10-18||0||0
48055773|NCT02933970|100458138|FG002|NOT COMPLETED|Step 2: Months 10-18||0||0
48055774|NCT02933970|100458136|FG000|STARTED|Step 3: Months 19-27||52||4
48055775|NCT02933970|100458137|FG001|STARTED|Step 3: Months 19-27||48||4
48055776|NCT02933970|100458138|FG002|STARTED|Step 3: Months 19-27||52||4
48055777|NCT02933970|100458136|FG000|COMPLETED|Step 3: Months 19-27||52||4
48055778|NCT02933970|100458137|FG001|COMPLETED|Step 3: Months 19-27||48||4
48055779|NCT02933970|100458138|FG002|COMPLETED|Step 3: Months 19-27||52||4
48055780|NCT02933970|100458136|FG000|NOT COMPLETED|Step 3: Months 19-27||0||0
48055781|NCT02933970|100458137|FG001|NOT COMPLETED|Step 3: Months 19-27||0||0
48055782|NCT02933970|100458138|FG002|NOT COMPLETED|Step 3: Months 19-27||0||0
48055783|NCT02933970|100458136|FG000|STARTED|Period 4: Mos 28-36||51||4
48055784|NCT02933970|100458137|FG001|STARTED|Period 4: Mos 28-36||35||4
48055785|NCT02933970|100458138|FG002|STARTED|Period 4: Mos 28-36||52||4
48055786|NCT02933970|100458136|FG000|COMPLETED|Period 4: Mos 28-36||51||4
48055787|NCT02933970|100458137|FG001|COMPLETED|Period 4: Mos 28-36||25||4
48055788|NCT02933970|100458138|FG002|COMPLETED|Period 4: Mos 28-36||51||4
48055789|NCT02933970|100458136|FG000|NOT COMPLETED|Period 4: Mos 28-36||0||0
48055790|NCT02933970|100458137|FG001|NOT COMPLETED|Period 4: Mos 28-36||10||0
48055791|NCT02933970|100458138|FG002|NOT COMPLETED|Period 4: Mos 28-36||1||0
48055792|NCT02969707|100458139|FG000|STARTED|Overall Study||49||
48055793|NCT02969707|100458140|FG001|STARTED|Overall Study||52||
48055794|NCT02969707|100458139|FG000|Received Intervention|Overall Study||40||
48055795|NCT02969707|100458140|FG001|Received Intervention|Overall Study||40||
48055796|NCT02969707|100458139|FG000|Completed Pain Evaluation Study Day|Overall Study||41||
48055797|NCT02969707|100458140|FG001|Completed Pain Evaluation Study Day|Overall Study||44||
48055798|NCT02969707|100458139|FG000|Completed Mechanistic Evaluation Study Day|Overall Study||40||
48055799|NCT02969707|100458140|FG001|Completed Mechanistic Evaluation Study Day|Overall Study||40||
48055800|NCT02969707|100458139|FG000|COMPLETED|Overall Study||40||
48055801|NCT02969707|100458140|FG001|COMPLETED|Overall Study||40||
48055802|NCT02969707|100458139|FG000|NOT COMPLETED|Overall Study||9||
48055803|NCT02969707|100458140|FG001|NOT COMPLETED|Overall Study||12||
48055804|NCT02910583|100458141|FG000|STARTED|Overall Study||159||
48055805|NCT02910583|100458142|FG001|STARTED|Overall Study||164||
48055806|NCT02910583|100458141|FG000|MRD Cohort/ Not Randomized|Overall Study||0||
48055807|NCT02910583|100458142|FG001|MRD Cohort/ Not Randomized|Overall Study||15||
48055808|NCT02910583|100458141|FG000|MRD Cohort/ Confirmed uMRD: Randomized to Ibrutinib (Blinded)|Overall Study||0||
48055809|NCT02910583|100458142|FG001|MRD Cohort/ Confirmed uMRD: Randomized to Ibrutinib (Blinded)|Overall Study||43||
48055810|NCT02910583|100458141|FG000|MRD Cohort/ Confirmed uMRD: Randomized Placebo (Blinded)|Overall Study||0||
48055811|NCT02910583|100458142|FG001|MRD Cohort/ Confirmed uMRD: Randomized Placebo (Blinded)|Overall Study||43||
48055812|NCT02910583|100458141|FG000|MRD Cohort/uMRD Not Confirmed: Randomized to Ibrutinib (Open-Label)|Overall Study||0||
48055813|NCT02910583|100458142|FG001|MRD Cohort/uMRD Not Confirmed: Randomized to Ibrutinib (Open-Label)|Overall Study||31||
48055814|NCT02910583|100458141|FG000|MRD Cohort/uMRD Not Confirmed: Randomized Ibrutinib + Venetoclax (Open-Label)|Overall Study||0||
48055815|NCT02910583|100458142|FG001|MRD Cohort/uMRD Not Confirmed: Randomized Ibrutinib + Venetoclax (Open-Label)|Overall Study||32||
48055816|NCT02910583|100458141|FG000|COMPLETED|Overall Study||133|Participants who were on study when the sponsor closed the treatment arm or terminated the study and provided option to rollover to long term follow-up study.|
48055817|NCT02910583|100458142|FG001|COMPLETED|Overall Study||150|Participants who were on study when the sponsor closed the treatment arm or terminated the study and provided option to rollover to long term follow-up study.|
48055818|NCT02910583|100458141|FG000|NOT COMPLETED|Overall Study||26||
48055819|NCT02910583|100458142|FG001|NOT COMPLETED|Overall Study||14||
48055820|NCT04544956|100458143|FG000|STARTED|Overall Study||12||
48055821|NCT04544956|100458143|FG000|COMPLETED|Overall Study||11||
48055822|NCT04544956|100458143|FG000|NOT COMPLETED|Overall Study||1||
48055823|NCT05070728|100458144|FG000|STARTED|Overall Study||6||12
48055824|NCT05070728|100458145|FG001|STARTED|Overall Study||6||12
48055825|NCT05070728|100458144|FG000|COMPLETED|Overall Study||6||12
48055826|NCT05070728|100458145|FG001|COMPLETED|Overall Study||0||0
48055827|NCT05070728|100458144|FG000|NOT COMPLETED|Overall Study||0||0
48055828|NCT05070728|100458145|FG001|NOT COMPLETED|Overall Study||6||12
48055829|NCT03213457|100458146|FG000|STARTED|Screening Period||194|Includes all randomized participants.|
48055830|NCT03213457|100458147|FG001|STARTED|Screening Period||98|Includes all randomized participants.|
48055831|NCT03213457|100458148|FG002|STARTED|Screening Period||389|Includes all randomized participants.|
48055832|NCT03213457|100458146|FG000|COMPLETED|Screening Period||193||
48055833|NCT03213457|100458147|FG001|COMPLETED|Screening Period||97||
48055834|NCT03213457|100458148|FG002|COMPLETED|Screening Period||389||
48055835|NCT03213457|100458146|FG000|NOT COMPLETED|Screening Period||1||
48055836|NCT03213457|100458147|FG001|NOT COMPLETED|Screening Period||1||
48055837|NCT03213457|100458148|FG002|NOT COMPLETED|Screening Period||0||
48055838|NCT03213457|100458146|FG000|STARTED|Double-Blind Period||193|Includes all treated participants who received at least one dose of study drug.|
48055839|NCT03213457|100458147|FG001|STARTED|Double-Blind Period||97|Includes all treated participants who received at least one dose of study drug.|
48055840|NCT03213457|100458148|FG002|STARTED|Double-Blind Period||389|Includes all treated participants who received at least one dose of study drug.|
48055841|NCT03213457|100458146|FG000|COMPLETED|Double-Blind Period||157||
48055842|NCT03213457|100458147|FG001|COMPLETED|Double-Blind Period||85||
48055843|NCT03213457|100458148|FG002|COMPLETED|Double-Blind Period||337||
48055844|NCT03213457|100458146|FG000|NOT COMPLETED|Double-Blind Period||36||
48055845|NCT03213457|100458147|FG001|NOT COMPLETED|Double-Blind Period||12||
48495722|NCT00834132|101547920|FG000|STARTED|Washout: 21 Days||12||
48055846|NCT03213457|100458148|FG002|NOT COMPLETED|Double-Blind Period||52||
48495723|NCT00834132|101547921|FG001|STARTED|Washout: 21 Days||12||
48055847|NCT03213457|100458146|FG000|STARTED|Open-Label Period||106|Includes participants who completed the Placebo-Controlled Treatment Period and entered the Open-Label Treatment Period.|
48055848|NCT03213457|100458147|FG001|STARTED|Open-Label Period||59|Includes participants who completed the Placebo-Controlled Treatment Period and entered the Open-Label Treatment Period.|
48055849|NCT03213457|100458148|FG002|STARTED|Open-Label Period||215|Includes participants who completed the Placebo-Controlled Treatment Period and entered the Open-Label Treatment Period.|
48055850|NCT03213457|100458146|FG000|COMPLETED|Open-Label Period||90||
48055851|NCT03213457|100458147|FG001|COMPLETED|Open-Label Period||48||
48055852|NCT03213457|100458148|FG002|COMPLETED|Open-Label Period||170||
48055853|NCT03213457|100458146|FG000|NOT COMPLETED|Open-Label Period||16||
48055854|NCT03213457|100458147|FG001|NOT COMPLETED|Open-Label Period||11||
48055855|NCT03213457|100458148|FG002|NOT COMPLETED|Open-Label Period||45||
48055856|NCT03213457|100458146|FG000|STARTED|Follow-Up Period||194|Includes all randomized participants. Participants were expected to enter the Follow-Up Period after Treatment Month 48, or if a participant prematurely discontinued from the Treatment Period at the time of or after Treatment Month 6.|
48055857|NCT03213457|100458147|FG001|STARTED|Follow-Up Period||98|Includes all randomized participants. Participants were expected to enter the Follow-Up Period after Treatment Month 48, or if a participant prematurely discontinued from the Treatment Period at the time of or after Treatment Month 6.|
48055858|NCT03213457|100458148|FG002|STARTED|Follow-Up Period||389|Includes all randomized participants. Participants were expected to enter the Follow-Up Period after Treatment Month 48, or if a participant prematurely discontinued from the Treatment Period at the time of or after Treatment Month 6.|
48055859|NCT03213457|100458146|FG000|COMPLETED|Follow-Up Period||102||
48055860|NCT03213457|100458147|FG001|COMPLETED|Follow-Up Period||51||
48055861|NCT03213457|100458148|FG002|COMPLETED|Follow-Up Period||185||
48055862|NCT03213457|100458146|FG000|NOT COMPLETED|Follow-Up Period||92||
48055863|NCT03213457|100458147|FG001|NOT COMPLETED|Follow-Up Period||47||
48055864|NCT03213457|100458148|FG002|NOT COMPLETED|Follow-Up Period||204||
48055865|NCT03834493|100458149|FG000|STARTED|Overall Study||621||
48055866|NCT03834493|100458150|FG001|STARTED|Overall Study||623||
48055867|NCT03834493|100458149|FG000|Treated|Overall Study||615||
48055868|NCT03834493|100458150|FG001|Treated|Overall Study||620||
48055869|NCT03834493|100458149|FG000|COMPLETED|Overall Study||0||
48055870|NCT03834493|100458150|FG001|COMPLETED|Overall Study||0||
48055871|NCT03834493|100458149|FG000|NOT COMPLETED|Overall Study||621||
48055872|NCT03834493|100458150|FG001|NOT COMPLETED|Overall Study||623||
48055873|NCT05717907|100458151|FG000|STARTED|Overall Study||26||
48055874|NCT05717907|100458152|FG001|STARTED|Overall Study||26||
48055875|NCT05717907|100458151|FG000|COMPLETED|Overall Study||26||
48055876|NCT05717907|100458152|FG001|COMPLETED|Overall Study||26||
48055877|NCT05717907|100458151|FG000|NOT COMPLETED|Overall Study||0||
48055878|NCT05717907|100458152|FG001|NOT COMPLETED|Overall Study||0||
48055879|NCT04302493|100458153|FG000|STARTED|Overall Study||16||
48055880|NCT04302493|100458154|FG001|STARTED|Overall Study||14||
48055881|NCT04302493|100458153|FG000|COMPLETED|Overall Study||14||
48055882|NCT04302493|100458154|FG001|COMPLETED|Overall Study||14||
48055883|NCT04302493|100458153|FG000|NOT COMPLETED|Overall Study||2||
48055884|NCT04302493|100458154|FG001|NOT COMPLETED|Overall Study||0||
48055885|NCT04567615|100458155|FG000|STARTED|Randomization||128||
48055886|NCT04567615|100458156|FG001|STARTED|Randomization||114||
48055887|NCT04567615|100458157|FG002|STARTED|Randomization||24||
48055888|NCT04567615|100458155|FG000|COMPLETED|Randomization||127|Completed = received atleast 1 dose of study treatment|
48055889|NCT04567615|100458156|FG001|COMPLETED|Randomization||113|Completed = received atleast 1 dose of study treatment|
48055890|NCT04567615|100458157|FG002|COMPLETED|Randomization||24|Completed = received atleast 1 dose of study treatment|
48055891|NCT04567615|100458155|FG000|NOT COMPLETED|Randomization||1||
48055892|NCT04567615|100458156|FG001|NOT COMPLETED|Randomization||1||
48055893|NCT04567615|100458157|FG002|NOT COMPLETED|Randomization||0||
48055894|NCT04567615|100458155|FG000|STARTED|Treatment Period||127||
48055895|NCT04567615|100458156|FG001|STARTED|Treatment Period||113||
48055896|NCT04567615|100458157|FG002|STARTED|Treatment Period||24||
48055897|NCT04567615|100458155|FG000|COMPLETED|Treatment Period||3||
48055898|NCT04567615|100458156|FG001|COMPLETED|Treatment Period||1||
48055899|NCT04567615|100458157|FG002|COMPLETED|Treatment Period||0||
48055900|NCT04567615|100458155|FG000|NOT COMPLETED|Treatment Period||124||
48055901|NCT04567615|100458156|FG001|NOT COMPLETED|Treatment Period||112||
48055902|NCT04567615|100458157|FG002|NOT COMPLETED|Treatment Period||24||
48055903|NCT05902793|100458158|FG000|STARTED|Overall Study||84||
48055904|NCT05902793|100458159|FG001|STARTED|Overall Study||86||
48055905|NCT05902793|100458158|FG000|COMPLETED|Overall Study||77||
48055906|NCT05902793|100458159|FG001|COMPLETED|Overall Study||85||
48055907|NCT05902793|100458158|FG000|NOT COMPLETED|Overall Study||7||
48055908|NCT05902793|100458159|FG001|NOT COMPLETED|Overall Study||1||
48055909|NCT04024462|100458160|FG000|STARTED|Overall Study||101|Intent-to-Treat (ITT) Population|
48055910|NCT04024462|100458161|FG001|STARTED|Overall Study||99|Intent-to-Treat (ITT) Population|
48495724|NCT00834132|101547920|FG000|COMPLETED|Washout: 21 Days||12||
48055911|NCT04024462|100458160|FG000|Completed Neoadjuvant Treatment (24 Weeks)|Overall Study||96||
48055912|NCT04024462|100458161|FG001|Completed Neoadjuvant Treatment (24 Weeks)|Overall Study||95||
48055913|NCT04024462|100458160|FG000|Completed Surgery (<9 Weeks)|Overall Study||94||
48055914|NCT04024462|100458161|FG001|Completed Surgery (<9 Weeks)|Overall Study||93||
48055915|NCT04024462|100458160|FG000|Started Adjuvant Treatment|Overall Study||89||
48055916|NCT04024462|100458161|FG001|Started Adjuvant Treatment|Overall Study||89||
48055917|NCT04024462|100458160|FG000|Completed Adjuvant Treatment (42 Weeks)|Overall Study||12||
48055918|NCT04024462|100458161|FG001|Completed Adjuvant Treatment (42 Weeks)|Overall Study||14||
48055919|NCT04024462|100458160|FG000|Started Follow-Up (≥3 Years)|Overall Study||23|Participants who completed treatment or prematurely withdrew from treatment entered the follow-up phase.|
48055920|NCT04024462|100458161|FG001|Started Follow-Up (≥3 Years)|Overall Study||20|Participants who completed treatment or prematurely withdrew from treatment entered the follow-up phase.|
48055921|NCT04024462|100458160|FG000|COMPLETED|Overall Study||0||
48055922|NCT04024462|100458161|FG001|COMPLETED|Overall Study||0||
48055923|NCT04024462|100458160|FG000|NOT COMPLETED|Overall Study||101||
48055924|NCT04024462|100458161|FG001|NOT COMPLETED|Overall Study||99||
48055925|NCT05093478|100458162|FG000|STARTED|Overall Study||28||
48055926|NCT05093478|100458162|FG000|COMPLETED|Overall Study||24||
48055927|NCT05093478|100458162|FG000|NOT COMPLETED|Overall Study||4||
48055928|NCT00978432|100458163|FG000|STARTED|Overall Study||10||
48055929|NCT00978432|100458164|FG001|STARTED|Overall Study||5||
48055930|NCT00978432|100458165|FG002|STARTED|Overall Study||18||
48055931|NCT00978432|100458163|FG000|COMPLETED|Overall Study||7||
48055932|NCT00978432|100458164|FG001|COMPLETED|Overall Study||4||
48055933|NCT00978432|100458165|FG002|COMPLETED|Overall Study||13||
48055934|NCT00978432|100458163|FG000|NOT COMPLETED|Overall Study||3||
48055935|NCT00978432|100458164|FG001|NOT COMPLETED|Overall Study||1||
48055936|NCT00978432|100458165|FG002|NOT COMPLETED|Overall Study||5||
48055937|NCT00586846|100458166|FG000|STARTED|Overall Study||40||
48055938|NCT00586846|100458166|FG000|COMPLETED|Overall Study||34||
48055939|NCT00586846|100458166|FG000|NOT COMPLETED|Overall Study||6||
48055940|NCT03711266|100458167|FG000|STARTED|Overall Study||30||
48055941|NCT03711266|100458167|FG000|COMPLETED|Overall Study||20||
48055942|NCT03711266|100458167|FG000|NOT COMPLETED|Overall Study||10||
48055943|NCT00145600|100458168|FG000|STARTED|Overall Study||91||
48055944|NCT00145600|100458169|FG001|STARTED|Overall Study||46||
48055945|NCT00145600|100458170|FG002|STARTED|Overall Study||13||
48055946|NCT00145600|100458171|FG003|STARTED|Overall Study||146||
48055947|NCT00145600|100458168|FG000|COMPLETED|Overall Study||83||
48055948|NCT00145600|100458169|FG001|COMPLETED|Overall Study||36||
48055949|NCT00145600|100458170|FG002|COMPLETED|Overall Study||8||
48055950|NCT00145600|100458171|FG003|COMPLETED|Overall Study||130||
48055951|NCT00145600|100458168|FG000|NOT COMPLETED|Overall Study||8||
48055952|NCT00145600|100458169|FG001|NOT COMPLETED|Overall Study||10||
48055953|NCT00145600|100458170|FG002|NOT COMPLETED|Overall Study||5||
48055954|NCT00145600|100458171|FG003|NOT COMPLETED|Overall Study||16||
48055955|NCT01388920|100458172|FG000|STARTED|Overall Study||1||
48055956|NCT01388920|100458173|FG001|STARTED|Overall Study||1||
48055957|NCT01388920|100458174|FG002|STARTED|Overall Study||0||
48055958|NCT01388920|100458172|FG000|COMPLETED|Overall Study||1||
48055959|NCT01388920|100458173|FG001|COMPLETED|Overall Study||1||
48055960|NCT01388920|100458174|FG002|COMPLETED|Overall Study||0||
48055961|NCT01388920|100458172|FG000|NOT COMPLETED|Overall Study||0||
48055962|NCT01388920|100458173|FG001|NOT COMPLETED|Overall Study||0||
48055963|NCT01388920|100458174|FG002|NOT COMPLETED|Overall Study||0||
48055964|NCT05128929|100458175|FG000|STARTED|Overall Study||10||
48055965|NCT05128929|100458176|FG001|STARTED|Overall Study||6||
48055966|NCT05128929|100458175|FG000|Primary Analysis (Week 24)|Overall Study||10||
48055967|NCT05128929|100458176|FG001|Primary Analysis (Week 24)|Overall Study||6||
48055968|NCT05128929|100458175|FG000|COMPLETED|Overall Study||10||
48055969|NCT05128929|100458176|FG001|COMPLETED|Overall Study||5||
48055970|NCT05128929|100458175|FG000|NOT COMPLETED|Overall Study||0||
48055971|NCT05128929|100458176|FG001|NOT COMPLETED|Overall Study||1||
48055972|NCT02038452|100458177|FG000|STARTED|Overall Study||116||
48055973|NCT02038452|100458178|FG001|STARTED|Overall Study||118||
48055974|NCT02038452|100458177|FG000|Baseline|Overall Study||113||
48055975|NCT02038452|100458178|FG001|Baseline|Overall Study||117||
48055976|NCT02038452|100458177|FG000|6 Weeks Follow-up|Overall Study||108||
48055977|NCT02038452|100458178|FG001|6 Weeks Follow-up|Overall Study||109||
48055978|NCT02038452|100458177|FG000|6 Months Follow-up|Overall Study||96||
48055979|NCT02038452|100458178|FG001|6 Months Follow-up|Overall Study||97||
48055980|NCT02038452|100458177|FG000|12 Months Follow-up|Overall Study||87||
48055981|NCT02038452|100458178|FG001|12 Months Follow-up|Overall Study||88||
48055982|NCT02038452|100458177|FG000|24 Months Follow-up|Overall Study||78||
48055983|NCT02038452|100458178|FG001|24 Months Follow-up|Overall Study||81||
48055984|NCT02038452|100458177|FG000|COMPLETED|Overall Study||78||
48055985|NCT02038452|100458178|FG001|COMPLETED|Overall Study||81||
48055986|NCT02038452|100458177|FG000|NOT COMPLETED|Overall Study||38||
48055987|NCT02038452|100458178|FG001|NOT COMPLETED|Overall Study||37||
48055988|NCT01539317|100458179|FG000|STARTED|Overall Study||25||
48055989|NCT01539317|100458180|FG001|STARTED|Overall Study||25||
48055990|NCT01539317|100458179|FG000|COMPLETED|Overall Study||24||
48055991|NCT01539317|100458180|FG001|COMPLETED|Overall Study||25||
48055992|NCT01539317|100458179|FG000|NOT COMPLETED|Overall Study||1||
48055993|NCT01539317|100458180|FG001|NOT COMPLETED|Overall Study||0||
48055994|NCT04735536|100458181|FG000|STARTED|Period 1||8||
48055995|NCT04735536|100458182|FG001|STARTED|Period 1||8||
48055996|NCT04735536|100458181|FG000|COMPLETED|Period 1||8||
48055997|NCT04735536|100458182|FG001|COMPLETED|Period 1||8||
48055998|NCT04735536|100458181|FG000|NOT COMPLETED|Period 1||0||
48055999|NCT04735536|100458182|FG001|NOT COMPLETED|Period 1||0||
48056000|NCT04735536|100458181|FG000|STARTED|Period 2||8||
48056001|NCT04735536|100458182|FG001|STARTED|Period 2||7||
48056002|NCT04735536|100458181|FG000|COMPLETED|Period 2||8||
48056003|NCT04735536|100458182|FG001|COMPLETED|Period 2||7||
48056004|NCT04735536|100458181|FG000|NOT COMPLETED|Period 2||0||
48056005|NCT04735536|100458182|FG001|NOT COMPLETED|Period 2||0||
48056006|NCT00846742|100458183|FG000|STARTED|Overall Study||85||
48056007|NCT00846742|100458183|FG000|With Radiation Therapy (RT)|Overall Study||17|Seventeen (17) participants out of the 85 analyzed received radiation therapy (RT)|
48056008|NCT00846742|100458183|FG000|Without Radiation Therapy (RT)|Overall Study||68|Sixty-eight (68) participants out of the 85 analyzed did not receive RT|
48056009|NCT00846742|100458183|FG000|COMPLETED|Overall Study||84||
48056010|NCT00846742|100458183|FG000|NOT COMPLETED|Overall Study||1||
48056011|NCT02557295|100458184|FG000|STARTED|Overall Study||111||
48056012|NCT02557295|100458185|FG001|STARTED|Overall Study||8||
48056013|NCT02557295|100458186|FG002|STARTED|Overall Study||15||
48056014|NCT02557295|100458187|FG003|STARTED|Overall Study||3||
48056015|NCT02557295|100458188|FG004|STARTED|Overall Study||0||
48056016|NCT02557295|100458189|FG005|STARTED|Overall Study||0||
48056017|NCT02557295|100458190|FG006|STARTED|Overall Study||81||
48056018|NCT02557295|100458191|FG007|STARTED|Overall Study||7||
48056019|NCT02557295|100458192|FG008|STARTED|Overall Study||23||
48056020|NCT02557295|100458184|FG000|COMPLETED|Overall Study||0||
48056021|NCT02557295|100458185|FG001|COMPLETED|Overall Study||0||
48056022|NCT02557295|100458186|FG002|COMPLETED|Overall Study||0||
48056023|NCT02557295|100458187|FG003|COMPLETED|Overall Study||0||
48056024|NCT02557295|100458188|FG004|COMPLETED|Overall Study||0||
48056025|NCT02557295|100458189|FG005|COMPLETED|Overall Study||0||
48056026|NCT02557295|100458190|FG006|COMPLETED|Overall Study||0||
48056027|NCT02557295|100458191|FG007|COMPLETED|Overall Study||0||
48056028|NCT02557295|100458192|FG008|COMPLETED|Overall Study||0||
48056029|NCT02557295|100458184|FG000|NOT COMPLETED|Overall Study||111||
48056030|NCT02557295|100458185|FG001|NOT COMPLETED|Overall Study||8||
48056031|NCT02557295|100458186|FG002|NOT COMPLETED|Overall Study||15||
48056032|NCT02557295|100458187|FG003|NOT COMPLETED|Overall Study||3||
48056033|NCT02557295|100458188|FG004|NOT COMPLETED|Overall Study||0||
48056034|NCT02557295|100458189|FG005|NOT COMPLETED|Overall Study||0||
48056035|NCT02557295|100458190|FG006|NOT COMPLETED|Overall Study||81||
48056036|NCT02557295|100458191|FG007|NOT COMPLETED|Overall Study||7||
48056037|NCT02557295|100458192|FG008|NOT COMPLETED|Overall Study||23||
48056038|NCT06624449|100458193|FG000|STARTED|Overall Study||22||
48056039|NCT06624449|100458194|FG001|STARTED|Overall Study||22||
48056040|NCT06624449|100458193|FG000|COMPLETED|Overall Study||22||
48056041|NCT06624449|100458194|FG001|COMPLETED|Overall Study||22||
48056042|NCT06624449|100458193|FG000|NOT COMPLETED|Overall Study||0||
48056043|NCT06624449|100458194|FG001|NOT COMPLETED|Overall Study||0||
48056044|NCT00378105|100458195|FG000|STARTED|Overall Study||31||
48056045|NCT00378105|100458196|FG001|STARTED|Overall Study||35||
48056046|NCT00378105|100458195|FG000|COMPLETED|Overall Study||11||
48056047|NCT00378105|100458196|FG001|COMPLETED|Overall Study||5||
48056048|NCT00378105|100458195|FG000|NOT COMPLETED|Overall Study||20||
48056049|NCT00378105|100458196|FG001|NOT COMPLETED|Overall Study||30||
48056050|NCT01385176|100458197|FG000|STARTED|Randomization Phase||63||
48056051|NCT01385176|100458198|FG001|STARTED|Randomization Phase||32||
48056052|NCT01385176|100458197|FG000|COMPLETED|Randomization Phase||62||
48056053|NCT01385176|100458198|FG001|COMPLETED|Randomization Phase||30||
48056054|NCT01385176|100458197|FG000|NOT COMPLETED|Randomization Phase||1||
48056055|NCT01385176|100458198|FG001|NOT COMPLETED|Randomization Phase||2||
48056056|NCT01385176|100458197|FG000|STARTED|6-18 Month All VNS Active||62||
48056057|NCT01385176|100458198|FG001|STARTED|6-18 Month All VNS Active||30||
48056058|NCT01385176|100458197|FG000|COMPLETED|6-18 Month All VNS Active||58||
48056059|NCT01385176|100458198|FG001|COMPLETED|6-18 Month All VNS Active||27||
48056060|NCT01385176|100458197|FG000|NOT COMPLETED|6-18 Month All VNS Active||4||
48056061|NCT01385176|100458198|FG001|NOT COMPLETED|6-18 Month All VNS Active||3||
48056062|NCT00704808|100458199|FG000|STARTED|Overall Study||180||
48056063|NCT00704808|100458199|FG000|COMPLETED|Overall Study||49||
48056064|NCT00704808|100458199|FG000|NOT COMPLETED|Overall Study||131||
48056065|NCT01741012|100458200|FG000|STARTED|Overall Study||37||
48056066|NCT01741012|100458200|FG000|COMPLETED|Overall Study||34||
48056067|NCT01741012|100458200|FG000|NOT COMPLETED|Overall Study||3||
48056068|NCT00832390|100458201|FG000|STARTED|Overall Study||12||
48056069|NCT00832390|100458202|FG001|STARTED|Overall Study||16||
48056070|NCT00832390|100458203|FG002|STARTED|Overall Study||1||
48056071|NCT00832390|100458201|FG000|COMPLETED|Overall Study||12||
48056072|NCT00832390|100458202|FG001|COMPLETED|Overall Study||16||
48056073|NCT00832390|100458203|FG002|COMPLETED|Overall Study||1||
48056074|NCT00832390|100458201|FG000|NOT COMPLETED|Overall Study||0||
48056075|NCT00832390|100458202|FG001|NOT COMPLETED|Overall Study||0||
48056076|NCT00832390|100458203|FG002|NOT COMPLETED|Overall Study||0||
48056077|NCT00777205|100458204|FG000|STARTED|Overall Study||243||
48056078|NCT00777205|100458205|FG001|STARTED|Overall Study||200||
48056079|NCT00777205|100458204|FG000|Intervention Interruption|Overall Study||0||
48056080|NCT00777205|100458205|FG001|Intervention Interruption|Overall Study||56||
48056081|NCT00777205|100458204|FG000|COMPLETED|Overall Study||212||
48056082|NCT00777205|100458205|FG001|COMPLETED|Overall Study||129||
48056083|NCT00777205|100458204|FG000|NOT COMPLETED|Overall Study||31||
48056084|NCT00777205|100458205|FG001|NOT COMPLETED|Overall Study||71||
48056085|NCT01309308|100458206|FG000|STARTED|Overall Study||75||
48056086|NCT01309308|100458207|FG001|STARTED|Overall Study||75||
48056087|NCT01309308|100458206|FG000|COMPLETED|Overall Study||69||
48056088|NCT01309308|100458207|FG001|COMPLETED|Overall Study||71||
48056089|NCT01309308|100458206|FG000|NOT COMPLETED|Overall Study||6||
48056090|NCT01309308|100458207|FG001|NOT COMPLETED|Overall Study||4||
48056091|NCT04466228|100458208|FG000|STARTED|Overall Study||20||
48056092|NCT04466228|100458209|FG001|STARTED|Overall Study||20||
48056093|NCT04466228|100458210|FG002|STARTED|Overall Study||20||
48056094|NCT04466228|100458208|FG000|COMPLETED|Overall Study||20||
48056095|NCT04466228|100458209|FG001|COMPLETED|Overall Study||20||
48056096|NCT04466228|100458210|FG002|COMPLETED|Overall Study||20||
48056097|NCT04466228|100458208|FG000|NOT COMPLETED|Overall Study||0||
48056098|NCT04466228|100458209|FG001|NOT COMPLETED|Overall Study||0||
48056099|NCT04466228|100458210|FG002|NOT COMPLETED|Overall Study||0||
48056100|NCT03728985|100458211|FG000|STARTED|Overall Study||102||
48056101|NCT03728985|100458211|FG000|Primary Endpoint Determined|Overall Study||102||
48056102|NCT03728985|100458211|FG000|COMPLETED|Overall Study||102||
48056103|NCT03728985|100458211|FG000|NOT COMPLETED|Overall Study||0||
48056104|NCT00701376|100458212|FG000|STARTED|Overall Study||106||
48056105|NCT00701376|100458212|FG000|COMPLETED|Overall Study||105||
48056106|NCT00701376|100458212|FG000|NOT COMPLETED|Overall Study||1||
48056107|NCT01801072|100458213|FG000|STARTED|Overall Study||40||
48056108|NCT01801072|100458214|FG001|STARTED|Overall Study||42||
48056109|NCT01801072|100458213|FG000|Hospitalization|Overall Study||35||
48056110|NCT01801072|100458214|FG001|Hospitalization|Overall Study||39||
48056111|NCT01801072|100458213|FG000|COMPLETED|Overall Study||11||
48056112|NCT01801072|100458214|FG001|COMPLETED|Overall Study||17||
48056113|NCT01801072|100458213|FG000|NOT COMPLETED|Overall Study||29||
48056114|NCT01801072|100458214|FG001|NOT COMPLETED|Overall Study||25||
48056115|NCT03660488|100458215|FG000|STARTED|Overall Study||31||
48056116|NCT03660488|100458216|FG001|STARTED|Overall Study||27||
48056117|NCT03660488|100458215|FG000|COMPLETED|Overall Study||31||
48056118|NCT03660488|100458216|FG001|COMPLETED|Overall Study||27||
48056119|NCT03660488|100458215|FG000|NOT COMPLETED|Overall Study||0||
48056120|NCT03660488|100458216|FG001|NOT COMPLETED|Overall Study||0||
48056121|NCT02343081|100458217|FG000|STARTED|First Intervention (Day 3)||8||
48056122|NCT02343081|100458218|FG001|STARTED|First Intervention (Day 3)||8||
48056123|NCT02343081|100458217|FG000|Received Intervention|First Intervention (Day 3)||8||
48056124|NCT02343081|100458218|FG001|Received Intervention|First Intervention (Day 3)||8||
48056125|NCT02343081|100458217|FG000|COMPLETED|First Intervention (Day 3)||8||
48056126|NCT02343081|100458218|FG001|COMPLETED|First Intervention (Day 3)||8||
48056127|NCT02343081|100458217|FG000|NOT COMPLETED|First Intervention (Day 3)||0||
48056128|NCT02343081|100458218|FG001|NOT COMPLETED|First Intervention (Day 3)||0||
48056129|NCT02343081|100458217|FG000|STARTED|Washout (10 Hours)||8||
48056130|NCT02343081|100458218|FG001|STARTED|Washout (10 Hours)||8||
48056131|NCT02343081|100458217|FG000|COMPLETED|Washout (10 Hours)||8||
48056132|NCT02343081|100458218|FG001|COMPLETED|Washout (10 Hours)||8||
48056133|NCT02343081|100458217|FG000|NOT COMPLETED|Washout (10 Hours)||0||
48056134|NCT02343081|100458218|FG001|NOT COMPLETED|Washout (10 Hours)||0||
48056135|NCT02343081|100458217|FG000|STARTED|Second Intervention (Day 4)||8||
48056136|NCT02343081|100458218|FG001|STARTED|Second Intervention (Day 4)||8||
48056137|NCT02343081|100458217|FG000|Received Intervention|Second Intervention (Day 4)||8||
48056138|NCT02343081|100458218|FG001|Received Intervention|Second Intervention (Day 4)||8||
48056139|NCT02343081|100458217|FG000|COMPLETED|Second Intervention (Day 4)||8||
48056140|NCT02343081|100458218|FG001|COMPLETED|Second Intervention (Day 4)||8||
48056141|NCT02343081|100458217|FG000|NOT COMPLETED|Second Intervention (Day 4)||0||
48056142|NCT02343081|100458218|FG001|NOT COMPLETED|Second Intervention (Day 4)||0||
48056143|NCT03332771|100458219|FG000|STARTED|Overall Study||159||
48056144|NCT03332771|100458220|FG001|STARTED|Overall Study||317||
48056145|NCT03332771|100458221|FG002|STARTED|Overall Study||160||
48056146|NCT03332771|100458222|FG003|STARTED|Overall Study||318||
48056147|NCT03332771|100458219|FG000|COMPLETED|Overall Study||125||
48056148|NCT03332771|100458220|FG001|COMPLETED|Overall Study||266||
48056149|NCT03332771|100458221|FG002|COMPLETED|Overall Study||128||
48056150|NCT03332771|100458222|FG003|COMPLETED|Overall Study||270||
48056151|NCT03332771|100458219|FG000|NOT COMPLETED|Overall Study||34||
48056152|NCT03332771|100458220|FG001|NOT COMPLETED|Overall Study||51||
48056153|NCT03332771|100458221|FG002|NOT COMPLETED|Overall Study||32||
48056154|NCT03332771|100458222|FG003|NOT COMPLETED|Overall Study||48||
48056155|NCT03150485|100458223|FG000|STARTED|Overall Study||2||
48056156|NCT03150485|100458224|FG001|STARTED|Overall Study||9||
48056157|NCT03150485|100458225|FG002|STARTED|Overall Study||4||
48056158|NCT03150485|100458226|FG003|STARTED|Overall Study||5||
48056159|NCT03150485|100458227|FG004|STARTED|Overall Study||2||
48056160|NCT03150485|100458228|FG005|STARTED|Overall Study||1||
48056161|NCT03150485|100458223|FG000|COMPLETED|Overall Study||2||
48056162|NCT03150485|100458224|FG001|COMPLETED|Overall Study||8||
48056163|NCT03150485|100458225|FG002|COMPLETED|Overall Study||4||
48056164|NCT03150485|100458226|FG003|COMPLETED|Overall Study||5||
48056165|NCT03150485|100458227|FG004|COMPLETED|Overall Study||2||
48056166|NCT03150485|100458228|FG005|COMPLETED|Overall Study||1||
48056167|NCT03150485|100458223|FG000|NOT COMPLETED|Overall Study||0||
48056168|NCT03150485|100458224|FG001|NOT COMPLETED|Overall Study||1||
48056169|NCT03150485|100458225|FG002|NOT COMPLETED|Overall Study||0||
48056170|NCT03150485|100458226|FG003|NOT COMPLETED|Overall Study||0||
48056171|NCT03150485|100458227|FG004|NOT COMPLETED|Overall Study||0||
48056172|NCT03150485|100458228|FG005|NOT COMPLETED|Overall Study||0||
48056173|NCT03448653|100458229|FG000|STARTED|Overall Study||314||
48056174|NCT03448653|100458229|FG000|COMPLETED|Overall Study||314||
48056175|NCT03448653|100458229|FG000|NOT COMPLETED|Overall Study||0||
48056176|NCT04711135|100458230|FG000|STARTED|Overall Study||4||
48056177|NCT04711135|100458231|FG001|STARTED|Overall Study||7||
48056178|NCT04711135|100458230|FG000|Ongoing Treatment|Overall Study||0||
48056179|NCT04711135|100458231|FG001|Ongoing Treatment|Overall Study||1||
48056180|NCT04711135|100458230|FG000|Entered Short Term Follow-up|Overall Study||4||
48056181|NCT04711135|100458231|FG001|Entered Short Term Follow-up|Overall Study||5||
48056182|NCT04711135|100458230|FG000|Entered Long Term Follow-up|Overall Study||1||
48056183|NCT04711135|100458231|FG001|Entered Long Term Follow-up|Overall Study||3||
48056184|NCT04711135|100458230|FG000|COMPLETED|Overall Study||4|Completed = Completed treatment plan|
48056185|NCT04711135|100458231|FG001|COMPLETED|Overall Study||5|Completed = Completed treatment plan|
48056186|NCT04711135|100458230|FG000|NOT COMPLETED|Overall Study||0||
48056187|NCT04711135|100458231|FG001|NOT COMPLETED|Overall Study||2||
48056188|NCT02131532|100458232|FG000|STARTED|Overall Study||12||
48056189|NCT02131532|100458232|FG000|COMPLETED|Overall Study||8||
48056190|NCT02131532|100458232|FG000|NOT COMPLETED|Overall Study||4||
48056191|NCT00923936|100458233|FG000|STARTED|Overall Study||10||
48056192|NCT00923936|100458234|FG001|STARTED|Overall Study||6||
48056193|NCT00923936|100458233|FG000|COMPLETED|Overall Study||2||
48056194|NCT00923936|100458234|FG001|COMPLETED|Overall Study||3||
48056195|NCT00923936|100458233|FG000|NOT COMPLETED|Overall Study||8||
48056196|NCT00923936|100458234|FG001|NOT COMPLETED|Overall Study||3||
48056197|NCT00846287|100458235|FG000|STARTED|Overall Study||16||
48056198|NCT00846287|100458236|FG001|STARTED|Overall Study||15||
48056199|NCT00846287|100458235|FG000|COMPLETED|Overall Study||6||
48056200|NCT00846287|100458236|FG001|COMPLETED|Overall Study||10||
48056201|NCT00846287|100458235|FG000|NOT COMPLETED|Overall Study||10||
48056202|NCT00846287|100458236|FG001|NOT COMPLETED|Overall Study||5||
48056203|NCT03035409|100458237|FG000|STARTED|Overall Study||45||
48056204|NCT03035409|100458237|FG000|Day 15|Overall Study||28||
48056205|NCT03035409|100458237|FG000|Day 29|Overall Study||28||
48056206|NCT03035409|100458237|FG000|Day 43|Overall Study||28||
48056207|NCT03035409|100458237|FG000|COMPLETED|Overall Study||28||
48056208|NCT03035409|100458237|FG000|NOT COMPLETED|Overall Study||17||
48056209|NCT03811535|100458238|FG000|STARTED|Overall Study||68||
48056210|NCT03811535|100458239|FG001|STARTED|Overall Study||132||
48056211|NCT03811535|100458238|FG000|COMPLETED|Overall Study||68||
48056212|NCT03811535|100458239|FG001|COMPLETED|Overall Study||132||
48056213|NCT03811535|100458238|FG000|NOT COMPLETED|Overall Study||0||
48056214|NCT03811535|100458239|FG001|NOT COMPLETED|Overall Study||0||
48056215|NCT04386057|100458240|FG000|STARTED|Overall Study||7||
48056216|NCT04386057|100458241|FG001|STARTED|Overall Study||6||
48056217|NCT04386057|100458242|FG002|STARTED|Overall Study||20||
48056218|NCT04386057|100458243|FG003|STARTED|Overall Study||16||
48056219|NCT04386057|100458244|FG004|STARTED|Overall Study||3||
48056220|NCT04386057|100458240|FG000|COMPLETED|Overall Study||7||
48056221|NCT04386057|100458241|FG001|COMPLETED|Overall Study||6||
48056222|NCT04386057|100458242|FG002|COMPLETED|Overall Study||20||
48056223|NCT04386057|100458243|FG003|COMPLETED|Overall Study||16||
48056224|NCT04386057|100458244|FG004|COMPLETED|Overall Study||3||
48056225|NCT04386057|100458240|FG000|NOT COMPLETED|Overall Study||0||
48056226|NCT04386057|100458241|FG001|NOT COMPLETED|Overall Study||0||
48056227|NCT04386057|100458242|FG002|NOT COMPLETED|Overall Study||0||
48056228|NCT04386057|100458243|FG003|NOT COMPLETED|Overall Study||0||
48056229|NCT04386057|100458244|FG004|NOT COMPLETED|Overall Study||0||
48056230|NCT01782833|100458245|FG000|STARTED|Overall Study||3635||
48056231|NCT01782833|100458245|FG000|COMPLETED|Overall Study||3365||
48056232|NCT01782833|100458245|FG000|NOT COMPLETED|Overall Study||270||
48056233|NCT02393690|100458246|FG000|STARTED|Overall Study||28||
48056234|NCT02393690|100458247|FG001|STARTED|Overall Study||30||
48056235|NCT02393690|100458246|FG000|COMPLETED|Overall Study||28||
48056236|NCT02393690|100458247|FG001|COMPLETED|Overall Study||29||
48056237|NCT02393690|100458246|FG000|NOT COMPLETED|Overall Study||0||
48056238|NCT02393690|100458247|FG001|NOT COMPLETED|Overall Study||1||
48056239|NCT01437878|100458248|FG000|STARTED|Overall Study||1||
48056240|NCT01437878|100458249|FG001|STARTED|Overall Study||1||
48056241|NCT01437878|100458248|FG000|COMPLETED|Overall Study||0||
48056242|NCT01437878|100458249|FG001|COMPLETED|Overall Study||1||
48056243|NCT01437878|100458248|FG000|NOT COMPLETED|Overall Study||1||
48056244|NCT01437878|100458249|FG001|NOT COMPLETED|Overall Study||0||
48056245|NCT03309150|100458250|FG000|STARTED|Overall Study||1||
48056246|NCT03309150|100458250|FG000|COMPLETED|Overall Study||1||
48056247|NCT03309150|100458250|FG000|NOT COMPLETED|Overall Study||0||
48056248|NCT01610271|100458251|FG000|STARTED|Overall Study||150||
48056249|NCT01610271|100458252|FG001|STARTED|Overall Study||150||
48056250|NCT01610271|100458251|FG000|COMPLETED|Overall Study||148||
48056251|NCT01610271|100458252|FG001|COMPLETED|Overall Study||146||
48056252|NCT01610271|100458251|FG000|NOT COMPLETED|Overall Study||2||
48056253|NCT01610271|100458252|FG001|NOT COMPLETED|Overall Study||4||
48056254|NCT05896748|100458253|FG000|STARTED|Screening Phase (Week -4 up to Day 1)||94||
48056255|NCT05896748|100458253|FG000|COMPLETED|Screening Phase (Week -4 up to Day 1)||93||
48056256|NCT05896748|100458253|FG000|NOT COMPLETED|Screening Phase (Week -4 up to Day 1)||1||
48056257|NCT05896748|100458253|FG000|STARTED|SC Injection Phase (Day 1 up to Week 12)||93||
48056258|NCT05896748|100458253|FG000|COMPLETED|SC Injection Phase (Day 1 up to Week 12)||87||
48056259|NCT05896748|100458253|FG000|NOT COMPLETED|SC Injection Phase (Day 1 up to Week 12)||6||
48056260|NCT05896748|100458253|FG000|STARTED|Return to IM Glu Inj Phase(Week12-Week20||87||
48056261|NCT05896748|100458253|FG000|COMPLETED|Return to IM Glu Inj Phase(Week12-Week20||86||
48056262|NCT05896748|100458253|FG000|NOT COMPLETED|Return to IM Glu Inj Phase(Week12-Week20||1||
48056263|NCT00695578|100458254|FG000|STARTED|Overall Study||10||
48056264|NCT00695578|100458255|FG001|STARTED|Overall Study||10||
48056265|NCT00695578|100458254|FG000|COMPLETED|Overall Study||10||
48056266|NCT00695578|100458255|FG001|COMPLETED|Overall Study||10||
48056267|NCT00695578|100458254|FG000|NOT COMPLETED|Overall Study||0||
48056268|NCT00695578|100458255|FG001|NOT COMPLETED|Overall Study||0||
48056269|NCT02305888|100458256|FG000|STARTED|Overall Study||63||
48056270|NCT02305888|100458257|FG001|STARTED|Overall Study||63||
48056271|NCT02305888|100458258|FG002|STARTED|Overall Study||63||
48056272|NCT02305888|100458256|FG000|COMPLETED|Overall Study||63||
48056273|NCT02305888|100458257|FG001|COMPLETED|Overall Study||62||
48056274|NCT02305888|100458258|FG002|COMPLETED|Overall Study||62||
48056275|NCT02305888|100458256|FG000|NOT COMPLETED|Overall Study||0||
48056276|NCT02305888|100458257|FG001|NOT COMPLETED|Overall Study||1||
48056277|NCT02305888|100458258|FG002|NOT COMPLETED|Overall Study||1||
48056278|NCT00478881|100458259|FG000|STARTED|Overall Study||199||
48056279|NCT00478881|100458260|FG001|STARTED|Overall Study||198||
48056280|NCT00478881|100458259|FG000|Received Medication|Overall Study||198||
48056281|NCT00478881|100458260|FG001|Received Medication|Overall Study||198||
48056282|NCT00478881|100458259|FG000|COMPLETED|Overall Study||160||
48056283|NCT00478881|100458260|FG001|COMPLETED|Overall Study||176||
48056284|NCT00478881|100458259|FG000|NOT COMPLETED|Overall Study||39||
48056285|NCT00478881|100458260|FG001|NOT COMPLETED|Overall Study||22||
48056286|NCT04654468|100458261|FG000|STARTED|Overall Study||51||
48056287|NCT04654468|100458261|FG000|COMPLETED|Overall Study||0||
48056288|NCT04654468|100458261|FG000|NOT COMPLETED|Overall Study||51||
48056289|NCT04882501|100458262|FG000|STARTED|Overall Study||55||
48056290|NCT04882501|100458263|FG001|STARTED|Overall Study||58||
48056291|NCT04882501|100458262|FG000|COMPLETED|Overall Study||55||
48056292|NCT04882501|100458263|FG001|COMPLETED|Overall Study||58||
48056293|NCT04882501|100458262|FG000|NOT COMPLETED|Overall Study||0||
48056294|NCT04882501|100458263|FG001|NOT COMPLETED|Overall Study||0||
48056295|NCT03487549|100458264|FG000|STARTED|Overall Study||21||
48056296|NCT03487549|100458265|FG001|STARTED|Overall Study||35||
48056297|NCT03487549|100458264|FG000|COMPLETED|Overall Study||17||
48056298|NCT03487549|100458265|FG001|COMPLETED|Overall Study||33||
48056299|NCT03487549|100458264|FG000|NOT COMPLETED|Overall Study||4||
48056300|NCT03487549|100458265|FG001|NOT COMPLETED|Overall Study||2||
48056301|NCT03153410|100458266|FG000|STARTED|Overall Study||9|Started = enrolled and received at least one dose of study drug|
48056302|NCT03153410|100458266|FG000|COMPLETED|Overall Study||2|Completed = Received 18 cycles of treatment|
48056303|NCT03153410|100458266|FG000|NOT COMPLETED|Overall Study||7||
48056304|NCT02759354|100458267|FG000|STARTED|Overall Study||192||
48056305|NCT02759354|100458268|FG001|STARTED|Overall Study||190||
48056306|NCT02759354|100458269|FG002|STARTED|Overall Study||181||
48495725|NCT00834132|101547921|FG001|COMPLETED|Washout: 21 Days||12||
48495726|NCT00834132|101547920|FG000|NOT COMPLETED|Washout: 21 Days||0||
48495727|NCT00834132|101547921|FG001|NOT COMPLETED|Washout: 21 Days||0||
48495728|NCT00834132|101547920|FG000|STARTED|Second Intervention||12||
48495729|NCT00834132|101547921|FG001|STARTED|Second Intervention||12||
48056307|NCT02759354|100458270|FG003|STARTED|Overall Study||191||
48056308|NCT02759354|100458267|FG000|COMPLETED|Overall Study||192||
48056309|NCT02759354|100458268|FG001|COMPLETED|Overall Study||190||
48056310|NCT02759354|100458269|FG002|COMPLETED|Overall Study||181||
48056311|NCT02759354|100458270|FG003|COMPLETED|Overall Study||191||
48495730|NCT00834132|101547920|FG000|COMPLETED|Second Intervention||12||
48056312|NCT02759354|100458267|FG000|NOT COMPLETED|Overall Study||0||
48495731|NCT00834132|101547921|FG001|COMPLETED|Second Intervention||12||
48056313|NCT02759354|100458268|FG001|NOT COMPLETED|Overall Study||0||
48056314|NCT02759354|100458269|FG002|NOT COMPLETED|Overall Study||0||
48056315|NCT02759354|100458270|FG003|NOT COMPLETED|Overall Study||0||
48056316|NCT03489551|100458271|FG000|STARTED|Overall Study||17||
48056317|NCT03489551|100458271|FG000|COMPLETED|Overall Study||15||
48056318|NCT03489551|100458271|FG000|NOT COMPLETED|Overall Study||2||
48056319|NCT05419908|100458272|FG000|STARTED|Overall Study||44||
48056320|NCT05419908|100458273|FG001|STARTED|Overall Study||43||
48056321|NCT05419908|100458272|FG000|COMPLETED|Overall Study||40||
48056322|NCT05419908|100458273|FG001|COMPLETED|Overall Study||40||
48056323|NCT05419908|100458272|FG000|NOT COMPLETED|Overall Study||4||
48056324|NCT05419908|100458273|FG001|NOT COMPLETED|Overall Study||3||
48056325|NCT04966741|100458274|FG000|STARTED|Overall Study||7||
48056326|NCT04966741|100458275|FG001|STARTED|Overall Study||5||
48056327|NCT04966741|100458274|FG000|COMPLETED|Overall Study||6||
48056328|NCT04966741|100458275|FG001|COMPLETED|Overall Study||5||
48056329|NCT04966741|100458274|FG000|NOT COMPLETED|Overall Study||1||
48056330|NCT04966741|100458275|FG001|NOT COMPLETED|Overall Study||0||
48056331|NCT01224665|100458276|FG000|STARTED|Overall Study||300||
48056332|NCT01224665|100458277|FG001|STARTED|Overall Study||292||
48056333|NCT01224665|100458276|FG000|COMPLETED|Overall Study||300||
48056334|NCT01224665|100458277|FG001|COMPLETED|Overall Study||292||
48056335|NCT01224665|100458276|FG000|NOT COMPLETED|Overall Study||0||
48056336|NCT01224665|100458277|FG001|NOT COMPLETED|Overall Study||0||
48056337|NCT04250714|100458278|FG000|STARTED|Overall Study||400||
48056338|NCT04250714|100458278|FG000|COMPLETED|Overall Study||359||
48056339|NCT04250714|100458278|FG000|NOT COMPLETED|Overall Study||41||
48056340|NCT04115644|100458279|FG000|STARTED|Overall Study||26||
48056341|NCT04115644|100458280|FG001|STARTED|Overall Study||30||
48056342|NCT04115644|100458281|FG002|STARTED|Overall Study||26||
48056343|NCT04115644|100458279|FG000|COMPLETED|Overall Study||26||
48056344|NCT04115644|100458280|FG001|COMPLETED|Overall Study||30||
48056345|NCT04115644|100458281|FG002|COMPLETED|Overall Study||25||
48056346|NCT04115644|100458279|FG000|NOT COMPLETED|Overall Study||0||
48056347|NCT04115644|100458280|FG001|NOT COMPLETED|Overall Study||0||
48056348|NCT04115644|100458281|FG002|NOT COMPLETED|Overall Study||1||
48056349|NCT01762046|100458282|FG000|STARTED|Overall Study||1033||
48056350|NCT01762046|100458282|FG000|COMPLETED|Overall Study||1033||
48056351|NCT01762046|100458282|FG000|NOT COMPLETED|Overall Study||0||
48056352|NCT03611010|100458283|FG000|STARTED|Period 1: Lead-In||14||
48056353|NCT03611010|100458284|FG001|STARTED|Period 1: Lead-In||14||
48056354|NCT03611010|100458285|FG002|STARTED|Period 1: Lead-In||2||
48056355|NCT03611010|100458286|FG003|STARTED|Period 1: Lead-In||10||
48056356|NCT03611010|100458283|FG000|COMPLETED|Period 1: Lead-In||14||
48056357|NCT03611010|100458284|FG001|COMPLETED|Period 1: Lead-In||14||
48056358|NCT03611010|100458285|FG002|COMPLETED|Period 1: Lead-In||2||
48056359|NCT03611010|100458286|FG003|COMPLETED|Period 1: Lead-In||10||
48056360|NCT03611010|100458283|FG000|NOT COMPLETED|Period 1: Lead-In||0||
48056361|NCT03611010|100458284|FG001|NOT COMPLETED|Period 1: Lead-In||0||
48056362|NCT03611010|100458285|FG002|NOT COMPLETED|Period 1: Lead-In||0||
48056363|NCT03611010|100458286|FG003|NOT COMPLETED|Period 1: Lead-In||0||
48056364|NCT03611010|100458283|FG000|STARTED|Period 2: 15 Day Treatment||14||
48056365|NCT03611010|100458284|FG001|STARTED|Period 2: 15 Day Treatment||14||
48056366|NCT03611010|100458285|FG002|STARTED|Period 2: 15 Day Treatment||2||
48056367|NCT03611010|100458286|FG003|STARTED|Period 2: 15 Day Treatment||10||
48056368|NCT03611010|100458283|FG000|COMPLETED|Period 2: 15 Day Treatment||13||
48056369|NCT03611010|100458284|FG001|COMPLETED|Period 2: 15 Day Treatment||14||
48056370|NCT03611010|100458285|FG002|COMPLETED|Period 2: 15 Day Treatment||2||
48056371|NCT03611010|100458286|FG003|COMPLETED|Period 2: 15 Day Treatment||10||
48056372|NCT03611010|100458283|FG000|NOT COMPLETED|Period 2: 15 Day Treatment||1||
48056373|NCT03611010|100458284|FG001|NOT COMPLETED|Period 2: 15 Day Treatment||0||
48056374|NCT03611010|100458285|FG002|NOT COMPLETED|Period 2: 15 Day Treatment||0||
48056375|NCT03611010|100458286|FG003|NOT COMPLETED|Period 2: 15 Day Treatment||0||
48056376|NCT03686488|100458287|FG000|STARTED|Overall Study||23||
48056377|NCT03686488|100458287|FG000|COMPLETED|Overall Study||23||
48056378|NCT03686488|100458287|FG000|NOT COMPLETED|Overall Study||0||
48056379|NCT02819518|100458288|FG000|STARTED|Overall Study||11||
48056380|NCT02819518|100458289|FG001|STARTED|Overall Study||14||
48056381|NCT02819518|100458290|FG002|STARTED|Overall Study||10||
48056382|NCT02819518|100458291|FG003|STARTED|Overall Study||566||
48056383|NCT02819518|100458292|FG004|STARTED|Overall Study||281||
48056384|NCT02819518|100458288|FG000|Treated|Overall Study||13||
48056385|NCT02819518|100458289|FG001|Treated|Overall Study||10||
48056386|NCT02819518|100458290|FG002|Treated|Overall Study||11||
48056387|NCT02819518|100458291|FG003|Treated|Overall Study||562||
48056388|NCT02819518|100458292|FG004|Treated|Overall Study||281||
48056389|NCT02819518|100458288|FG000|COMPLETED|Overall Study||0||
48056390|NCT02819518|100458289|FG001|COMPLETED|Overall Study||0||
48056391|NCT02819518|100458290|FG002|COMPLETED|Overall Study||0||
48056392|NCT02819518|100458291|FG003|COMPLETED|Overall Study||0||
48056393|NCT02819518|100458292|FG004|COMPLETED|Overall Study||0||
48056394|NCT02819518|100458288|FG000|NOT COMPLETED|Overall Study||11||
48056395|NCT02819518|100458289|FG001|NOT COMPLETED|Overall Study||14||
48056396|NCT02819518|100458290|FG002|NOT COMPLETED|Overall Study||10||
48056397|NCT02819518|100458291|FG003|NOT COMPLETED|Overall Study||566||
48056398|NCT02819518|100458292|FG004|NOT COMPLETED|Overall Study||281||
48208587|NCT04054635|100837081|FG001|NOT COMPLETED|First Visit (Baseline)||0||
48208588|NCT04054635|100837082|FG002|NOT COMPLETED|First Visit (Baseline)||0||
48056399|NCT03422627|100458293|FG000|STARTED|Overall Study||7||
48056400|NCT03422627|100458294|FG001|STARTED|Overall Study||7||
48056401|NCT03422627|100458295|FG002|STARTED|Overall Study||7||
48056402|NCT03422627|100458296|FG003|STARTED|Overall Study||6||
48056403|NCT03422627|100458297|FG004|STARTED|Overall Study||5||
48056404|NCT03422627|100458293|FG000|Completed up to Week 52 and Opted for Extended Dosing|Overall Study||2||
48056405|NCT03422627|100458294|FG001|Completed up to Week 52 and Opted for Extended Dosing|Overall Study||1||
48056406|NCT03422627|100458295|FG002|Completed up to Week 52 and Opted for Extended Dosing|Overall Study||2||
48056407|NCT03422627|100458296|FG003|Completed up to Week 52 and Opted for Extended Dosing|Overall Study||3||
48056408|NCT03422627|100458297|FG004|Completed up to Week 52 and Opted for Extended Dosing|Overall Study||0||
48056409|NCT03422627|100458293|FG000|Completed up to Week 52 and Did Not Opt for Extended Dosing|Overall Study||0||
48056410|NCT03422627|100458294|FG001|Completed up to Week 52 and Did Not Opt for Extended Dosing|Overall Study||1||
48056411|NCT03422627|100458295|FG002|Completed up to Week 52 and Did Not Opt for Extended Dosing|Overall Study||1||
48056412|NCT03422627|100458296|FG003|Completed up to Week 52 and Did Not Opt for Extended Dosing|Overall Study||0||
48056413|NCT03422627|100458297|FG004|Completed up to Week 52 and Did Not Opt for Extended Dosing|Overall Study||1||
48056414|NCT03422627|100458293|FG000|COMPLETED|Overall Study||2||
48056415|NCT03422627|100458294|FG001|COMPLETED|Overall Study||2||
48056416|NCT03422627|100458295|FG002|COMPLETED|Overall Study||3||
48056417|NCT03422627|100458296|FG003|COMPLETED|Overall Study||3||
48056418|NCT03422627|100458297|FG004|COMPLETED|Overall Study||1||
48056419|NCT03422627|100458293|FG000|NOT COMPLETED|Overall Study||5||
48056420|NCT03422627|100458294|FG001|NOT COMPLETED|Overall Study||5||
48056421|NCT03422627|100458295|FG002|NOT COMPLETED|Overall Study||4||
48056422|NCT03422627|100458296|FG003|NOT COMPLETED|Overall Study||3||
48056423|NCT03422627|100458297|FG004|NOT COMPLETED|Overall Study||4||
48056424|NCT04091750|100458298|FG000|STARTED|Overall Study||14||
48056425|NCT04091750|100458298|FG000|COMPLETED|Overall Study||9||
48056426|NCT04091750|100458298|FG000|NOT COMPLETED|Overall Study||5||
48056427|NCT02745210|100458299|FG000|STARTED|Overall Study||0||
48056428|NCT02745210|100458300|FG001|STARTED|Overall Study||9||
48056429|NCT02745210|100458299|FG000|COMPLETED|Overall Study||0||
48056430|NCT02745210|100458300|FG001|COMPLETED|Overall Study||9||
48056431|NCT02745210|100458299|FG000|NOT COMPLETED|Overall Study||0||
48056432|NCT02745210|100458300|FG001|NOT COMPLETED|Overall Study||0||
48056433|NCT02750943|100458301|FG000|STARTED|Overall Study||125||
48056434|NCT02750943|100458302|FG001|STARTED|Overall Study||128||
48056435|NCT02750943|100458301|FG000|COMPLETED|Overall Study||119||
48056436|NCT02750943|100458302|FG001|COMPLETED|Overall Study||119||
48056437|NCT02750943|100458301|FG000|NOT COMPLETED|Overall Study||6||
48056438|NCT02750943|100458302|FG001|NOT COMPLETED|Overall Study||9||
48056439|NCT02788474|100458303|FG000|STARTED|Double Blind Treatment Period||231|Randomised|
48056440|NCT02788474|100458304|FG001|STARTED|Double Blind Treatment Period||116|Randomised|
48056441|NCT02788474|100458303|FG000|Treated|Double Blind Treatment Period||230||
48056442|NCT02788474|100458304|FG001|Treated|Double Blind Treatment Period||116||
48056443|NCT02788474|100458303|FG000|COMPLETED|Double Blind Treatment Period||221||
48056444|NCT02788474|100458304|FG001|COMPLETED|Double Blind Treatment Period||112||
48056445|NCT02788474|100458303|FG000|NOT COMPLETED|Double Blind Treatment Period||10||
48056446|NCT02788474|100458304|FG001|NOT COMPLETED|Double Blind Treatment Period||4||
48056447|NCT02788474|100458303|FG000|STARTED|Open Label Treatment Period||221||
48056448|NCT02788474|100458304|FG001|STARTED|Open Label Treatment Period||112||
48056449|NCT02788474|100458303|FG000|COMPLETED|Open Label Treatment Period||189||
48056450|NCT02788474|100458304|FG001|COMPLETED|Open Label Treatment Period||100||
48056451|NCT02788474|100458303|FG000|NOT COMPLETED|Open Label Treatment Period||32||
48056452|NCT02788474|100458304|FG001|NOT COMPLETED|Open Label Treatment Period||12||
48056453|NCT03519386|100458305|FG000|STARTED|Overall Study||200||
48056454|NCT03519386|100458306|FG001|STARTED|Overall Study||197||
48056455|NCT03519386|100458307|FG002|STARTED|Overall Study||193||
48056456|NCT03519386|100458305|FG000|Month 3|Overall Study||196||
48056457|NCT03519386|100458306|FG001|Month 3|Overall Study||195||
48056458|NCT03519386|100458307|FG002|Month 3|Overall Study||189||
48208589|NCT04054635|100837080|FG000|STARTED|Second Visit (First Follow-up)||28||
48208590|NCT04054635|100837081|FG001|STARTED|Second Visit (First Follow-up)||28||
48056459|NCT03519386|100458305|FG000|Month 12|Overall Study||190||
48056460|NCT03519386|100458306|FG001|Month 12|Overall Study||192||
48056461|NCT03519386|100458307|FG002|Month 12|Overall Study||183||
48056462|NCT03519386|100458305|FG000|COMPLETED|Overall Study||0||
48056463|NCT03519386|100458306|FG001|COMPLETED|Overall Study||0||
48056464|NCT03519386|100458307|FG002|COMPLETED|Overall Study||0||
48056465|NCT03519386|100458305|FG000|NOT COMPLETED|Overall Study||200||
48056466|NCT03519386|100458306|FG001|NOT COMPLETED|Overall Study||197||
48056467|NCT03519386|100458307|FG002|NOT COMPLETED|Overall Study||193||
48056468|NCT00925990|100458308|FG000|STARTED|Overall Study||35||
48056469|NCT00925990|100458309|FG001|STARTED|Overall Study||35||
48056470|NCT00925990|100458308|FG000|COMPLETED|Overall Study||30||
48056471|NCT00925990|100458309|FG001|COMPLETED|Overall Study||24||
48056472|NCT00925990|100458308|FG000|NOT COMPLETED|Overall Study||5||
48056473|NCT00925990|100458309|FG001|NOT COMPLETED|Overall Study||11||
48056474|NCT05080660|100458310|FG000|STARTED|Overall Study||107||
48056475|NCT05080660|100458311|FG001|STARTED|Overall Study||53||
48056476|NCT05080660|100458310|FG000|Received at Least One Dose of Study Drug (Safety Population Week 1-4)|Overall Study||107||
48056477|NCT05080660|100458311|FG001|Received at Least One Dose of Study Drug (Safety Population Week 1-4)|Overall Study||53||
48056478|NCT05080660|100458310|FG000|Safety Population Week 5-8|Overall Study||99|All participants who took at least 1 dose of study drug and who did not discontinue at or prior to week 4.|
48056479|NCT05080660|100458311|FG001|Safety Population Week 5-8|Overall Study||51|All participants who took at least 1 dose of study drug and who did not discontinue at or prior to week 4.|
48056480|NCT05080660|100458310|FG000|COMPLETED|Overall Study||94||
48056481|NCT05080660|100458311|FG001|COMPLETED|Overall Study||51||
48056482|NCT05080660|100458310|FG000|NOT COMPLETED|Overall Study||13||
48056483|NCT05080660|100458311|FG001|NOT COMPLETED|Overall Study||2||
48056484|NCT02204007|100458312|FG000|STARTED|Overall Study||18||
48056485|NCT02204007|100458313|FG001|STARTED|Overall Study||18||
48056486|NCT02204007|100458312|FG000|COMPLETED|Overall Study||17||
48056487|NCT02204007|100458313|FG001|COMPLETED|Overall Study||17||
48056488|NCT02204007|100458312|FG000|NOT COMPLETED|Overall Study||1||
48056489|NCT02204007|100458313|FG001|NOT COMPLETED|Overall Study||1||
48056490|NCT00750880|100458314|FG000|STARTED|Overall Study||1681||
48056491|NCT00750880|100458314|FG000|COMPLETED|Overall Study||1466||
48056492|NCT00750880|100458314|FG000|NOT COMPLETED|Overall Study||215||
48056493|NCT02676466|100460607|FG000|STARTED|Overall Study||109||
48056494|NCT02676466|100460608|FG001|STARTED|Overall Study||71||
48056495|NCT02676466|100460609|FG002|STARTED|Overall Study||26||
48056496|NCT02676466|100460610|FG003|STARTED|Overall Study||17||
48056497|NCT02676466|100460611|FG004|STARTED|Overall Study||26||
48056498|NCT02676466|100460612|FG005|STARTED|Overall Study||13||
48056499|NCT02676466|100460613|FG006|STARTED|Overall Study||13||
48056500|NCT02676466|100460614|FG007|STARTED|Overall Study||14||
48056501|NCT02676466|100460607|FG000|COMPLETED|Overall Study||105|Recruitment was completed June 22, 2017 and follow-up completed June 22, 2018 in all cells.|
48056502|NCT02676466|100460608|FG001|COMPLETED|Overall Study||66|Recruitment was completed June 22, 2017 and follow-up completed June 22, 2018 in all cells.|
48056503|NCT02676466|100460609|FG002|COMPLETED|Overall Study||24|Recruitment was completed June 22, 2017 and follow-up completed June 22, 2018 in all cells.|
48056504|NCT02676466|100460610|FG003|COMPLETED|Overall Study||17|Recruitment was completed June 22, 2017 and follow-up completed June 22, 2018 in all cells.|
48056505|NCT02676466|100460611|FG004|COMPLETED|Overall Study||23|Recruitment was completed June 22, 2017 and follow-up completed June 22, 2018 in all cells.|
48056506|NCT02676466|100460612|FG005|COMPLETED|Overall Study||12|Recruitment was completed June 22, 2017 and follow-up completed June 22, 2018 in all cells.|
48056507|NCT02676466|100460613|FG006|COMPLETED|Overall Study||12|Recruitment was completed June 22, 2017 and follow-up completed June 22, 2018 in all cells.|
48056508|NCT02676466|100460614|FG007|COMPLETED|Overall Study||13|Recruitment was completed June 22, 2017 and follow-up completed June 22, 2018 in all cells.|
48056509|NCT02676466|100460607|FG000|NOT COMPLETED|Overall Study||4||
48056510|NCT02676466|100460608|FG001|NOT COMPLETED|Overall Study||5||
48056511|NCT02676466|100460609|FG002|NOT COMPLETED|Overall Study||2||
48056512|NCT02676466|100460610|FG003|NOT COMPLETED|Overall Study||0||
48056513|NCT02676466|100460611|FG004|NOT COMPLETED|Overall Study||3||
48056514|NCT02676466|100460612|FG005|NOT COMPLETED|Overall Study||1||
48056515|NCT02676466|100460613|FG006|NOT COMPLETED|Overall Study||1||
48056516|NCT02676466|100460614|FG007|NOT COMPLETED|Overall Study||1||
48056517|NCT03290079|100460615|FG000|STARTED|Overall Study||20||
48056518|NCT03290079|100460615|FG000|COMPLETED|Overall Study||18||
48056519|NCT03290079|100460615|FG000|NOT COMPLETED|Overall Study||2||
48056520|NCT03583164|100460616|FG000|STARTED|Overall Study||203||
48056521|NCT03583164|100460616|FG000|COMPLETED|Overall Study||126||
48056522|NCT03583164|100460616|FG000|NOT COMPLETED|Overall Study||77||
48056523|NCT04981392|100460617|FG000|STARTED|Overall Study||10996||7
48056524|NCT04981392|100460618|FG001|STARTED|Overall Study||10848||7
48056525|NCT04981392|100460617|FG000|COMPLETED|Overall Study||10996||7
48056526|NCT04981392|100460618|FG001|COMPLETED|Overall Study||10848||7
48056527|NCT04981392|100460617|FG000|NOT COMPLETED|Overall Study||0||0
48056528|NCT04981392|100460618|FG001|NOT COMPLETED|Overall Study||0||0
48056529|NCT01325623|100460619|FG000|STARTED|Overall Study||31||
48056530|NCT01325623|100460619|FG000|COMPLETED|Overall Study||28||
48056531|NCT01325623|100460619|FG000|NOT COMPLETED|Overall Study||3||
48056532|NCT02360215|100460620|FG000|STARTED|Overall Study||257||
48495732|NCT00834132|101547920|FG000|NOT COMPLETED|Second Intervention||0||
48056533|NCT02360215|100460621|FG001|STARTED|Overall Study||261||
48056534|NCT02360215|100460620|FG000|All Randomized Participants|Overall Study||257||
48056535|NCT02360215|100460621|FG001|All Randomized Participants|Overall Study||261||
48056536|NCT02360215|100460620|FG000|Started Protocol Treatment|Overall Study||232||
48056537|NCT02360215|100460621|FG001|Started Protocol Treatment|Overall Study||223||
48056538|NCT02360215|100460620|FG000|MDASI-BT Symptom Score|Overall Study||249|M.D. Anderson Symptom Inventory-Brain Module (MDASI-BT) baseline symptom severity subscale completed|
48056539|NCT02360215|100460621|FG001|MDASI-BT Symptom Score|Overall Study||251|M.D. Anderson Symptom Inventory-Brain Module (MDASI-BT) baseline symptom severity subscale completed|
48056540|NCT02360215|100460620|FG000|MDASI-BT Intererence Score|Overall Study||248|MDSAI-BT symptom interference subscale completed at baseline|
48056541|NCT02360215|100460621|FG001|MDASI-BT Intererence Score|Overall Study||251|MDSAI-BT symptom interference subscale completed at baseline|
48056542|NCT02360215|100460620|FG000|MDASI-BT Cognitive Factor Score|Overall Study||249|MDSAI-BT cognifitive factor subscale completed at baseline|
48056543|NCT02360215|100460621|FG001|MDASI-BT Cognitive Factor Score|Overall Study||251|MDSAI-BT cognifitive factor subscale completed at baseline|
48056544|NCT02360215|100460620|FG000|MDASI-BT Neurologic Factor Score|Overall Study||249|MDSAI-BT neurologic factor subscale completed at baseline|
48056545|NCT02360215|100460621|FG001|MDASI-BT Neurologic Factor Score|Overall Study||251|MDSAI-BT neurologic factor subscale completed at baseline|
48056546|NCT02360215|100460620|FG000|HVLT-R Total Recall|Overall Study||256|Has standardized baseline Hopkins Verbal Learning Test - Revised (HVLT-R) Total Recall score|
48056547|NCT02360215|100460621|FG001|HVLT-R Total Recall|Overall Study||259|Has standardized baseline Hopkins Verbal Learning Test - Revised (HVLT-R) Total Recall score|
48056548|NCT02360215|100460620|FG000|HVLT-R Delayed Recall|Overall Study||256|Has standardized baseline HVLT-R Delayed Recall score|
48056549|NCT02360215|100460621|FG001|HVLT-R Delayed Recall|Overall Study||259|Has standardized baseline HVLT-R Delayed Recall score|
48056550|NCT02360215|100460620|FG000|HVLT-R Recognition|Overall Study||255|Has standardized baseline HVLT-R Recognition score|
48056551|NCT02360215|100460621|FG001|HVLT-R Recognition|Overall Study||259|Has standardized baseline HVLT-R Recognition score|
48056552|NCT02360215|100460620|FG000|Trail Making Test (TMT) Part A|Overall Study||256|Has standardized baseline TMT Part A score|
48056553|NCT02360215|100460621|FG001|Trail Making Test (TMT) Part A|Overall Study||260|Has standardized baseline TMT Part A score|
48056554|NCT02360215|100460620|FG000|TMT Part B|Overall Study||250|Has standardized baseline TMT Part B score|
48056555|NCT02360215|100460621|FG001|TMT Part B|Overall Study||257|Has standardized baseline TMT Part B score|
48056556|NCT02360215|100460620|FG000|Controlled Oral Word Association (COWA)|Overall Study||257|Has standardized baseline COWA score|
48056557|NCT02360215|100460621|FG001|Controlled Oral Word Association (COWA)|Overall Study||261|Has standardized baseline COWA score|
48056558|NCT02360215|100460620|FG000|Clinical Trial Battery Composite Score|Overall Study||255|Has standarized baseline Clinical Trial Battery Composite (CTB COMP) score|
48056559|NCT02360215|100460621|FG001|Clinical Trial Battery Composite Score|Overall Study||259|Has standarized baseline Clinical Trial Battery Composite (CTB COMP) score|
48056560|NCT02360215|100460620|FG000|EQ-5D-5L Index at 2 Months|Overall Study||142|EQ-5D-5L index score completed at baseline and 2 months from treatment start|
48056561|NCT02360215|100460621|FG001|EQ-5D-5L Index at 2 Months|Overall Study||125|EQ-5D-5L index score completed at baseline and 2 months from treatment start|
48056562|NCT02360215|100460620|FG000|EQ-5D-5L Index at 4 Months|Overall Study||110|EQ-5D-5L index score completed at baseline and 4 months from treatment start|
48056563|NCT02360215|100460621|FG001|EQ-5D-5L Index at 4 Months|Overall Study||96|EQ-5D-5L index score completed at baseline and 4 months from treatment start|
48056564|NCT02360215|100460620|FG000|EQ-5D-5L Index at 6 Months|Overall Study||79|EQ-5D-5L index score completed at baseline and 6 months from treatment start|
48056565|NCT02360215|100460621|FG001|EQ-5D-5L Index at 6 Months|Overall Study||70|EQ-5D-5L index score completed at baseline and 6 months from treatment start|
48056566|NCT02360215|100460620|FG000|EQ-5D-5L Index at 12 Months|Overall Study||56|EQ-5D-5L index score completed at baseline and 12 months from treatment start|
48056567|NCT02360215|100460621|FG001|EQ-5D-5L Index at 12 Months|Overall Study||45|EQ-5D-5L index score completed at baseline and 12 months from treatment start|
48056568|NCT02360215|100460620|FG000|EQ-5D-5L VAS at 2 Months|Overall Study||139|EQ-5D-5L visual analogue scale (VAS) completed at baseline and 2 months from treatment start|
48056569|NCT02360215|100460621|FG001|EQ-5D-5L VAS at 2 Months|Overall Study||123|EQ-5D-5L visual analogue scale (VAS) completed at baseline and 2 months from treatment start|
48056570|NCT02360215|100460620|FG000|EQ-5D-5L VAS at 4 Months|Overall Study||104|EQ-5D-5L visual analogue scale (VAS) completed at baseline and 4 months from treatment start|
48056571|NCT02360215|100460621|FG001|EQ-5D-5L VAS at 4 Months|Overall Study||193|EQ-5D-5L visual analogue scale (VAS) completed at baseline and 4 months from treatment start|
48056572|NCT02360215|100460620|FG000|EQ-5D-5L VAS at 6 Months|Overall Study||76|EQ-5D-5L visual analogue scale (VAS) completed at baseline and 6 months from treatment start|
48056573|NCT02360215|100460621|FG001|EQ-5D-5L VAS at 6 Months|Overall Study||69|EQ-5D-5L visual analogue scale (VAS) completed at baseline and 6 months from treatment start|
48056574|NCT02360215|100460620|FG000|EQ-5D-5L VAS at 12 Months|Overall Study||57|EQ-5D-5L visual analogue scale (VAS) completed at baseline and 12 months from treatment start|
48056575|NCT02360215|100460621|FG001|EQ-5D-5L VAS at 12 Months|Overall Study||48|EQ-5D-5L visual analogue scale (VAS) completed at baseline and 12 months from treatment start|
48056576|NCT02360215|100460620|FG000|COMPLETED|Overall Study||257|Subjects contributing data to results are considered to have completed the study.|
48056577|NCT02360215|100460621|FG001|COMPLETED|Overall Study||261|Subjects contributing data to results are considered to have completed the study.|
48056578|NCT02360215|100460620|FG000|NOT COMPLETED|Overall Study||0||
48056579|NCT02360215|100460621|FG001|NOT COMPLETED|Overall Study||0||
48056580|NCT01394718|100460622|FG000|STARTED|Overall Study||30||
48056581|NCT01394718|100460623|FG001|STARTED|Overall Study||30||
48056582|NCT01394718|100460622|FG000|COMPLETED|Overall Study||28||
48056583|NCT01394718|100460623|FG001|COMPLETED|Overall Study||29||
48056584|NCT01394718|100460622|FG000|NOT COMPLETED|Overall Study||2||
48056585|NCT01394718|100460623|FG001|NOT COMPLETED|Overall Study||1||
48056586|NCT03604692|100460624|FG000|STARTED|Overall Study||1||
48495733|NCT00834132|101547921|FG001|NOT COMPLETED|Second Intervention||0||
48495734|NCT04692155|101547922|FG000|STARTED|Overall Study||1||
48056587|NCT03604692|100460625|FG001|STARTED|Overall Study||1||
48056588|NCT03604692|100460626|FG002|STARTED|Overall Study||3||
48056589|NCT03604692|100460627|FG003|STARTED|Overall Study||6||
48056590|NCT03604692|100460628|FG004|STARTED|Overall Study||7||
48056591|NCT03604692|100460629|FG005|STARTED|Overall Study||23||
48056592|NCT03604692|100460624|FG000|Received at Least 1 Dose of Study Treatment|Overall Study||1||
48056593|NCT03604692|100460625|FG001|Received at Least 1 Dose of Study Treatment|Overall Study||1||
48056594|NCT03604692|100460626|FG002|Received at Least 1 Dose of Study Treatment|Overall Study||3||
48056595|NCT03604692|100460627|FG003|Received at Least 1 Dose of Study Treatment|Overall Study||6||
48056596|NCT03604692|100460628|FG004|Received at Least 1 Dose of Study Treatment|Overall Study||6||
48056597|NCT03604692|100460629|FG005|Received at Least 1 Dose of Study Treatment|Overall Study||23||
48056598|NCT03604692|100460624|FG000|Dose-limiting Toxicity (DLT) Evaluable|Overall Study||1|Participants who received at least one dose of SNDX-6352 were evaluated for DLTs over 2 cycles (Cycle 1 and Cycle 2).|
48056599|NCT03604692|100460625|FG001|Dose-limiting Toxicity (DLT) Evaluable|Overall Study||1|Participants who received at least one dose of SNDX-6352 were evaluated for DLTs over 2 cycles (Cycle 1 and Cycle 2).|
48056600|NCT03604692|100460626|FG002|Dose-limiting Toxicity (DLT) Evaluable|Overall Study||3|Participants who received at least one dose of SNDX-6352 were evaluated for DLTs over 2 cycles (Cycle 1 and Cycle 2).|
48056601|NCT03604692|100460627|FG003|Dose-limiting Toxicity (DLT) Evaluable|Overall Study||6|Participants who received at least one dose of SNDX-6352 were evaluated for DLTs over 2 cycles (Cycle 1 and Cycle 2).|
48056602|NCT03604692|100460628|FG004|Dose-limiting Toxicity (DLT) Evaluable|Overall Study||6|Participants who received at least one dose of SNDX-6352 were evaluated for DLTs over 2 cycles (Cycle 1 and Cycle 2).|
48056603|NCT03604692|100460629|FG005|Dose-limiting Toxicity (DLT) Evaluable|Overall Study||0|Participants who received at least one dose of SNDX-6352 were evaluated for DLTs over 2 cycles (Cycle 1 and Cycle 2).|
48056604|NCT03604692|100460624|FG000|COMPLETED|Overall Study||0||
48056605|NCT03604692|100460625|FG001|COMPLETED|Overall Study||1||
48056606|NCT03604692|100460626|FG002|COMPLETED|Overall Study||0||
48056607|NCT03604692|100460627|FG003|COMPLETED|Overall Study||2||
48056608|NCT03604692|100460628|FG004|COMPLETED|Overall Study||3||
48056609|NCT03604692|100460629|FG005|COMPLETED|Overall Study||9||
48056610|NCT03604692|100460624|FG000|NOT COMPLETED|Overall Study||1||
48056611|NCT03604692|100460625|FG001|NOT COMPLETED|Overall Study||0||
48056612|NCT03604692|100460626|FG002|NOT COMPLETED|Overall Study||3||
48056613|NCT03604692|100460627|FG003|NOT COMPLETED|Overall Study||4||
48056614|NCT03604692|100460628|FG004|NOT COMPLETED|Overall Study||4||
48056615|NCT03604692|100460629|FG005|NOT COMPLETED|Overall Study||14||
48056616|NCT01302379|100460630|FG000|STARTED|Overall Study||83||
48056617|NCT01302379|100460631|FG001|STARTED|Overall Study||83||
48056618|NCT01302379|100460632|FG002|STARTED|Overall Study||84||
48056619|NCT01302379|100460633|FG003|STARTED|Overall Study||83||
48056620|NCT01302379|100460630|FG000|COMPLETED|Overall Study||76||
48056621|NCT01302379|100460631|FG001|COMPLETED|Overall Study||78||
48056622|NCT01302379|100460632|FG002|COMPLETED|Overall Study||80||
48056623|NCT01302379|100460633|FG003|COMPLETED|Overall Study||79||
48056624|NCT01302379|100460630|FG000|NOT COMPLETED|Overall Study||7||
48056625|NCT01302379|100460631|FG001|NOT COMPLETED|Overall Study||5||
48056626|NCT01302379|100460632|FG002|NOT COMPLETED|Overall Study||4||
48056627|NCT01302379|100460633|FG003|NOT COMPLETED|Overall Study||4||
48056628|NCT04025710|100460634|FG000|STARTED|Overall Study||167||
48056629|NCT04025710|100460634|FG000|COMPLETED|Overall Study||116||
48056630|NCT04025710|100460634|FG000|NOT COMPLETED|Overall Study||51||
48056631|NCT01917929|100460635|FG000|STARTED|Overall Study||326||
48056632|NCT01917929|100460635|FG000|COMPLETED|Overall Study||146|Completed counts are based on participant status at the 5-year primary endpoint interval|
48056633|NCT01917929|100460635|FG000|NOT COMPLETED|Overall Study||180||
48056634|NCT01994590|100460636|FG000|STARTED|Overall Study||4||
48056635|NCT01994590|100460636|FG000|COMPLETED|Overall Study||2||
48056636|NCT01994590|100460636|FG000|NOT COMPLETED|Overall Study||2||
48056637|NCT04233034|100460637|FG000|STARTED|Overall Study||20||
48056638|NCT04233034|100460638|FG001|STARTED|Overall Study||22||
48056639|NCT04233034|100460639|FG002|STARTED|Overall Study||25||
48056640|NCT04233034|100460640|FG003|STARTED|Overall Study||21||
48056641|NCT04233034|100460641|FG004|STARTED|Overall Study||19||
48056642|NCT04233034|100460642|FG005|STARTED|Overall Study||6||
48056643|NCT04233034|100460637|FG000|COMPLETED|Overall Study||20||
48056644|NCT04233034|100460638|FG001|COMPLETED|Overall Study||21||
48056645|NCT04233034|100460639|FG002|COMPLETED|Overall Study||23||
48056646|NCT04233034|100460640|FG003|COMPLETED|Overall Study||19||
48056647|NCT04233034|100460641|FG004|COMPLETED|Overall Study||19||
48056648|NCT04233034|100460642|FG005|COMPLETED|Overall Study||6||
48056649|NCT04233034|100460637|FG000|NOT COMPLETED|Overall Study||0||
48495735|NCT04692155|101547922|FG000|COMPLETED|Overall Study||0||
48056650|NCT04233034|100460638|FG001|NOT COMPLETED|Overall Study||1||
48056651|NCT04233034|100460639|FG002|NOT COMPLETED|Overall Study||2||
48056652|NCT04233034|100460640|FG003|NOT COMPLETED|Overall Study||2||
48056653|NCT04233034|100460641|FG004|NOT COMPLETED|Overall Study||0||
48056654|NCT04233034|100460642|FG005|NOT COMPLETED|Overall Study||0||
48056655|NCT01483807|100460643|FG000|STARTED|First Treatment Phase (7 Weeks)||10||
48056656|NCT01483807|100460644|FG001|STARTED|First Treatment Phase (7 Weeks)||10||
48056657|NCT01483807|100460643|FG000|COMPLETED|First Treatment Phase (7 Weeks)||10||
48056658|NCT01483807|100460644|FG001|COMPLETED|First Treatment Phase (7 Weeks)||10||
48056659|NCT01483807|100460643|FG000|NOT COMPLETED|First Treatment Phase (7 Weeks)||0||
48056660|NCT01483807|100460644|FG001|NOT COMPLETED|First Treatment Phase (7 Weeks)||0||
48056661|NCT01483807|100460643|FG000|STARTED|Washout (2 Weeks)||10||
48056662|NCT01483807|100460644|FG001|STARTED|Washout (2 Weeks)||10||
48056663|NCT01483807|100460643|FG000|COMPLETED|Washout (2 Weeks)||10||
48056664|NCT01483807|100460644|FG001|COMPLETED|Washout (2 Weeks)||10||
48056665|NCT01483807|100460643|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
48056666|NCT01483807|100460644|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
48056667|NCT01483807|100460643|FG000|STARTED|Second Treatment Phase (7 Weeks)||10||
48056668|NCT01483807|100460644|FG001|STARTED|Second Treatment Phase (7 Weeks)||10||
48056669|NCT01483807|100460643|FG000|COMPLETED|Second Treatment Phase (7 Weeks)||10||
48056670|NCT01483807|100460644|FG001|COMPLETED|Second Treatment Phase (7 Weeks)||10||
48056671|NCT01483807|100460643|FG000|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0||
48056672|NCT01483807|100460644|FG001|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0||
48056673|NCT00504985|100460645|FG000|STARTED|Overall Study||14||
48056674|NCT00504985|100460645|FG000|COMPLETED|Overall Study||14||
48056675|NCT00504985|100460645|FG000|NOT COMPLETED|Overall Study||0||
48056676|NCT02316548|100460646|FG000|STARTED|Overall Study||6||
48056677|NCT02316548|100460647|FG001|STARTED|Overall Study||7||
48056678|NCT02316548|100460646|FG000|Eligible Population|Overall Study||6||
48056679|NCT02316548|100460647|FG001|Eligible Population|Overall Study||6||
48056680|NCT02316548|100460646|FG000|Eligible With Disease Assessment|Overall Study||4||
48056681|NCT02316548|100460647|FG001|Eligible With Disease Assessment|Overall Study||1||
48056682|NCT02316548|100460646|FG000|Eligible With Adverse Event Data|Overall Study||4||
48056683|NCT02316548|100460647|FG001|Eligible With Adverse Event Data|Overall Study||2||
48056684|NCT02316548|100460646|FG000|COMPLETED|Overall Study||6||
48056685|NCT02316548|100460647|FG001|COMPLETED|Overall Study||6||
48056686|NCT02316548|100460646|FG000|NOT COMPLETED|Overall Study||0||
48056687|NCT02316548|100460647|FG001|NOT COMPLETED|Overall Study||1||
48056688|NCT03954041|100460648|FG000|STARTED|Overall Study||48||
48056689|NCT03954041|100460649|FG001|STARTED|Overall Study||23||
48056690|NCT03954041|100460650|FG002|STARTED|Overall Study||21||
48056691|NCT03954041|100460648|FG000|COMPLETED|Overall Study||30||
48056692|NCT03954041|100460649|FG001|COMPLETED|Overall Study||14||
48056693|NCT03954041|100460650|FG002|COMPLETED|Overall Study||11||
48056694|NCT03954041|100460648|FG000|NOT COMPLETED|Overall Study||18||
48056695|NCT03954041|100460649|FG001|NOT COMPLETED|Overall Study||9||
48056696|NCT03954041|100460650|FG002|NOT COMPLETED|Overall Study||10||
48056697|NCT01194427|100460651|FG000|STARTED|Overall Study||2||
48056698|NCT01194427|100460651|FG000|COMPLETED|Overall Study||2||
48056699|NCT01194427|100460651|FG000|NOT COMPLETED|Overall Study||0||
48056700|NCT03436563|100460652|FG000|STARTED|Overall Study||4||
48056701|NCT03436563|100460652|FG000|COMPLETED|Overall Study||4||
48056702|NCT03436563|100460652|FG000|NOT COMPLETED|Overall Study||0||
48056703|NCT04543409|100460653|FG000|STARTED|Double-Blind Treatment Period||103||
48056704|NCT04543409|100460654|FG001|STARTED|Double-Blind Treatment Period||107||
48056705|NCT04543409|100460653|FG000|COMPLETED|Double-Blind Treatment Period||101||
48056706|NCT04543409|100460654|FG001|COMPLETED|Double-Blind Treatment Period||106||
48056707|NCT04543409|100460653|FG000|NOT COMPLETED|Double-Blind Treatment Period||2||
48056708|NCT04543409|100460654|FG001|NOT COMPLETED|Double-Blind Treatment Period||1||
48056709|NCT04543409|100460653|FG000|STARTED|Open-Label Treatment Period||100||
48056710|NCT04543409|100460654|FG001|STARTED|Open-Label Treatment Period||105||
48056711|NCT04543409|100460653|FG000|COMPLETED|Open-Label Treatment Period||79||
48056712|NCT04543409|100460654|FG001|COMPLETED|Open-Label Treatment Period||82||
48056713|NCT04543409|100460653|FG000|NOT COMPLETED|Open-Label Treatment Period||21||
48056714|NCT04543409|100460654|FG001|NOT COMPLETED|Open-Label Treatment Period||23||
48208591|NCT04054635|100837082|FG002|STARTED|Second Visit (First Follow-up)||28||
48208592|NCT04054635|100837080|FG000|COMPLETED|Second Visit (First Follow-up)||28||
48208593|NCT04054635|100837081|FG001|COMPLETED|Second Visit (First Follow-up)||27||
48208594|NCT04054635|100837082|FG002|COMPLETED|Second Visit (First Follow-up)||28||
48208595|NCT04054635|100837080|FG000|NOT COMPLETED|Second Visit (First Follow-up)||0||
48208596|NCT04054635|100837081|FG001|NOT COMPLETED|Second Visit (First Follow-up)||1||
48208597|NCT04054635|100837082|FG002|NOT COMPLETED|Second Visit (First Follow-up)||0||
48208598|NCT04054635|100837080|FG000|STARTED|Third Visit (Second Follow-up)||28||
48208599|NCT04054635|100837081|FG001|STARTED|Third Visit (Second Follow-up)||27||
48208600|NCT04054635|100837082|FG002|STARTED|Third Visit (Second Follow-up)||28||
48208601|NCT04054635|100837080|FG000|COMPLETED|Third Visit (Second Follow-up)||27||
48208602|NCT04054635|100837081|FG001|COMPLETED|Third Visit (Second Follow-up)||27||
48056715|NCT04543409|100460653|FG000|STARTED|Open-Label Extension Treatment Period||45||
48208603|NCT04054635|100837082|FG002|COMPLETED|Third Visit (Second Follow-up)||28||
48208604|NCT04054635|100837080|FG000|NOT COMPLETED|Third Visit (Second Follow-up)||1||
48208605|NCT04054635|100837081|FG001|NOT COMPLETED|Third Visit (Second Follow-up)||0||
48056716|NCT04543409|100460654|FG001|STARTED|Open-Label Extension Treatment Period||48||
48056717|NCT04543409|100460653|FG000|COMPLETED|Open-Label Extension Treatment Period||0||
48056718|NCT04543409|100460654|FG001|COMPLETED|Open-Label Extension Treatment Period||0||
48056719|NCT04543409|100460653|FG000|NOT COMPLETED|Open-Label Extension Treatment Period||45||
48056720|NCT04543409|100460654|FG001|NOT COMPLETED|Open-Label Extension Treatment Period||48||
48056721|NCT00667602|100460655|FG000|STARTED|Overall Study||219||
48056722|NCT00667602|100460656|FG001|STARTED|Overall Study||228||
48056723|NCT00667602|100460657|FG002|STARTED|Overall Study||215||
48056724|NCT00667602|100460655|FG000|COMPLETED|Overall Study||211||
48056725|NCT00667602|100460656|FG001|COMPLETED|Overall Study||213||
48056726|NCT00667602|100460657|FG002|COMPLETED|Overall Study||197||
48056727|NCT00667602|100460655|FG000|NOT COMPLETED|Overall Study||8||
48056728|NCT00667602|100460656|FG001|NOT COMPLETED|Overall Study||15||
48056729|NCT00667602|100460657|FG002|NOT COMPLETED|Overall Study||18||
48056730|NCT00814788|100460658|FG000|STARTED|Overall Study||24||
48056731|NCT00814788|100460658|FG000|COMPLETED|Overall Study||24||
48056732|NCT00814788|100460658|FG000|NOT COMPLETED|Overall Study||0||
48056733|NCT01234207|100460659|FG000|STARTED|First Intervention||47||
48056734|NCT01234207|100460660|FG001|STARTED|First Intervention||48||
48056735|NCT01234207|100460659|FG000|COMPLETED|First Intervention||47||
48056736|NCT01234207|100460660|FG001|COMPLETED|First Intervention||48||
48056737|NCT01234207|100460659|FG000|NOT COMPLETED|First Intervention||0||
48056738|NCT01234207|100460660|FG001|NOT COMPLETED|First Intervention||0||
48056739|NCT01234207|100460659|FG000|STARTED|1-Week Washout Period||47||
48056740|NCT01234207|100460660|FG001|STARTED|1-Week Washout Period||48||
48056741|NCT01234207|100460659|FG000|COMPLETED|1-Week Washout Period||47||
48056742|NCT01234207|100460660|FG001|COMPLETED|1-Week Washout Period||48||
48056743|NCT01234207|100460659|FG000|NOT COMPLETED|1-Week Washout Period||0||
48056744|NCT01234207|100460660|FG001|NOT COMPLETED|1-Week Washout Period||0||
48056745|NCT01234207|100460659|FG000|STARTED|Second Intervention||47||
48056746|NCT01234207|100460660|FG001|STARTED|Second Intervention||48||
48056747|NCT01234207|100460659|FG000|COMPLETED|Second Intervention||47||
48056748|NCT01234207|100460660|FG001|COMPLETED|Second Intervention||48||
48056749|NCT01234207|100460659|FG000|NOT COMPLETED|Second Intervention||0||
48056750|NCT01234207|100460660|FG001|NOT COMPLETED|Second Intervention||0||
48056751|NCT00608543|100460661|FG000|STARTED|Overall Study||17||
48056752|NCT00608543|100460661|FG000|COMPLETED|Overall Study||13||
48056753|NCT00608543|100460661|FG000|NOT COMPLETED|Overall Study||4||
48056754|NCT01496976|100460662|FG000|STARTED|Overall Study||45||
48056755|NCT01496976|100460662|FG000|COMPLETED|Overall Study||44||
48056756|NCT01496976|100460662|FG000|NOT COMPLETED|Overall Study||1||
48056757|NCT00089284|100460663|FG000|STARTED|Overall Study||7||
48056758|NCT00089284|100460664|FG001|STARTED|Overall Study||3||
48056759|NCT00089284|100460665|FG002|STARTED|Overall Study||6||
48056760|NCT00089284|100460666|FG003|STARTED|Overall Study||6||
48056761|NCT00089284|100460667|FG004|STARTED|Overall Study||0||
48056762|NCT00089284|100460668|FG005|STARTED|Overall Study||0||
48056763|NCT00089284|100460669|FG006|STARTED|Overall Study||8||
48056764|NCT00089284|100460663|FG000|COMPLETED|Overall Study||7||
48056765|NCT00089284|100460664|FG001|COMPLETED|Overall Study||3||
48056766|NCT00089284|100460665|FG002|COMPLETED|Overall Study||6||
48056767|NCT00089284|100460666|FG003|COMPLETED|Overall Study||6||
48056768|NCT00089284|100460667|FG004|COMPLETED|Overall Study||0||
48056769|NCT00089284|100460668|FG005|COMPLETED|Overall Study||0||
48056770|NCT00089284|100460669|FG006|COMPLETED|Overall Study||7||
48056771|NCT00089284|100460663|FG000|NOT COMPLETED|Overall Study||0||
48056772|NCT00089284|100460664|FG001|NOT COMPLETED|Overall Study||0||
48056773|NCT00089284|100460665|FG002|NOT COMPLETED|Overall Study||0||
48056774|NCT00089284|100460666|FG003|NOT COMPLETED|Overall Study||0||
48056775|NCT00089284|100460667|FG004|NOT COMPLETED|Overall Study||0||
48056776|NCT00089284|100460668|FG005|NOT COMPLETED|Overall Study||0||
48056777|NCT00089284|100460669|FG006|NOT COMPLETED|Overall Study||1||
48056778|NCT00053365|100460670|FG000|STARTED|Overall Study||61||
48056779|NCT00053365|100460670|FG000|COMPLETED|Overall Study||55||
48056780|NCT00053365|100460670|FG000|NOT COMPLETED|Overall Study||6||
48056781|NCT04815031|100460671|FG000|STARTED|Overall Study||14570||
48056782|NCT04815031|100460671|FG000|Received a Booster Vaccination in Completed Paticipants.|Overall Study||13695||
48056783|NCT04815031|100460671|FG000|COMPLETED|Overall Study||14537||
48056784|NCT04815031|100460671|FG000|NOT COMPLETED|Overall Study||33||
48495736|NCT04692155|101547922|FG000|NOT COMPLETED|Overall Study||1||
48056785|NCT02319837|100460672|FG000|STARTED|Study Treatment Phase||355||
48056786|NCT02319837|100460673|FG001|STARTED|Study Treatment Phase||358||
48056787|NCT02319837|100460674|FG002|STARTED|Study Treatment Phase||355||
48056788|NCT02319837|100460672|FG000|Received Treatment|Study Treatment Phase||353||
48056789|NCT02319837|100460673|FG001|Received Treatment|Study Treatment Phase||354||
48056790|NCT02319837|100460674|FG002|Received Treatment|Study Treatment Phase||354||
48056791|NCT02319837|100460672|FG000|COMPLETED|Study Treatment Phase||0||
48056792|NCT02319837|100460673|FG001|COMPLETED|Study Treatment Phase||0||
48056793|NCT02319837|100460674|FG002|COMPLETED|Study Treatment Phase||0||
48056794|NCT02319837|100460672|FG000|NOT COMPLETED|Study Treatment Phase||355||
48056795|NCT02319837|100460673|FG001|NOT COMPLETED|Study Treatment Phase||358||
48056796|NCT02319837|100460674|FG002|NOT COMPLETED|Study Treatment Phase||355||
48056797|NCT02319837|100460672|FG000|STARTED|Long-Term Follow-Up Phase||148||
48056798|NCT02319837|100460673|FG001|STARTED|Long-Term Follow-Up Phase||205||
48056799|NCT02319837|100460674|FG002|STARTED|Long-Term Follow-Up Phase||158||
48056800|NCT02319837|100460672|FG000|COMPLETED|Long-Term Follow-Up Phase||0||
48056801|NCT02319837|100460673|FG001|COMPLETED|Long-Term Follow-Up Phase||0||
48056802|NCT02319837|100460674|FG002|COMPLETED|Long-Term Follow-Up Phase||0||
48056803|NCT02319837|100460672|FG000|NOT COMPLETED|Long-Term Follow-Up Phase||148||
48056804|NCT02319837|100460673|FG001|NOT COMPLETED|Long-Term Follow-Up Phase||205||
48056805|NCT02319837|100460674|FG002|NOT COMPLETED|Long-Term Follow-Up Phase||158||
48056806|NCT02254278|100460675|FG000|STARTED|Overall Study||158||
48056807|NCT02254278|100460676|FG001|STARTED|Overall Study||150||
48056808|NCT02254278|100460675|FG000|Eligible|Overall Study||157||
48056809|NCT02254278|100460676|FG001|Eligible|Overall Study||149||
48056810|NCT02254278|100460675|FG000|Started Study Treatment|Overall Study||152|Randomized and eligible participants who started study treatment|
48056811|NCT02254278|100460676|FG001|Started Study Treatment|Overall Study||147|Randomized and eligible participants who started study treatment|
48056812|NCT02254278|100460675|FG000|Negative Post-treatment PET|Overall Study||58|Randomized and eligible with negative post-treatment positron emission tomography (PET) scan|
48056813|NCT02254278|100460676|FG001|Negative Post-treatment PET|Overall Study||57|Randomized and eligible with negative post-treatment positron emission tomography (PET) scan|
48056814|NCT02254278|100460675|FG000|COMPLETED|Overall Study||157|Participants contributing data to results are considered to have completed the study|
48056815|NCT02254278|100460676|FG001|COMPLETED|Overall Study||149|Participants contributing data to results are considered to have completed the study|
48056816|NCT02254278|100460675|FG000|NOT COMPLETED|Overall Study||1||
48056817|NCT02254278|100460676|FG001|NOT COMPLETED|Overall Study||1||
48056818|NCT01583543|100460677|FG000|STARTED|Overall Study||12||
48056819|NCT01583543|100460677|FG000|COMPLETED|Overall Study||12||
48056820|NCT01583543|100460677|FG000|NOT COMPLETED|Overall Study||0||
48056821|NCT04176705|100460678|FG000|STARTED|Overall Study||9||9
48056822|NCT04176705|100460679|FG001|STARTED|Overall Study||9||9
48056823|NCT04176705|100460678|FG000|COMPLETED|Overall Study||1||1
48056824|NCT04176705|100460679|FG001|COMPLETED|Overall Study||1||1
48056825|NCT04176705|100460678|FG000|NOT COMPLETED|Overall Study||8||8
48056826|NCT04176705|100460679|FG001|NOT COMPLETED|Overall Study||8||8
48056827|NCT04429243|100460680|FG000|STARTED|Overall Study||124||
48056828|NCT04429243|100460680|FG000|COMPLETED|Overall Study||105||
48056829|NCT04429243|100460680|FG000|NOT COMPLETED|Overall Study||19||
48056830|NCT00602667|100460681|FG000|STARTED|Overall Study||57||
48056831|NCT00602667|100460682|FG001|STARTED|Overall Study||156||
48056832|NCT00602667|100460683|FG002|STARTED|Overall Study||77||
48056833|NCT00602667|100460681|FG000|COMPLETED|Overall Study||38||
48056834|NCT00602667|100460682|FG001|COMPLETED|Overall Study||75||
48056835|NCT00602667|100460683|FG002|COMPLETED|Overall Study||14||
48056836|NCT00602667|100460681|FG000|NOT COMPLETED|Overall Study||19||
48056837|NCT00602667|100460682|FG001|NOT COMPLETED|Overall Study||81||
48056838|NCT00602667|100460683|FG002|NOT COMPLETED|Overall Study||63||
48056839|NCT00057876|100460684|FG000|STARTED|Overall Study||38||
48056840|NCT00057876|100460685|FG001|STARTED|Overall Study||36||
48056841|NCT00057876|100460684|FG000|Eligible|Overall Study||37||
48056842|NCT00057876|100460685|FG001|Eligible|Overall Study||34||
48056843|NCT00057876|100460684|FG000|Began Protocol Therapy|Overall Study||35||
48056844|NCT00057876|100460685|FG001|Began Protocol Therapy|Overall Study||34||
48056845|NCT00057876|100460684|FG000|Eligible and Treated|Overall Study||34||
48056846|NCT00057876|100460685|FG001|Eligible and Treated|Overall Study||34||
48056847|NCT00057876|100460684|FG000|COMPLETED|Overall Study||9||
48056848|NCT00057876|100460685|FG001|COMPLETED|Overall Study||9||
48056849|NCT00057876|100460684|FG000|NOT COMPLETED|Overall Study||29||
48056850|NCT00057876|100460685|FG001|NOT COMPLETED|Overall Study||27||
48056851|NCT02694523|100460686|FG000|STARTED|Part A||304||
48056852|NCT02694523|100460687|FG001|STARTED|Part A||301||
48056853|NCT02694523|100460688|FG002|STARTED|Part A||0||
48056854|NCT02694523|100460689|FG003|STARTED|Part A||0||
48056855|NCT02694523|100460690|FG004|STARTED|Part A||0||
48056856|NCT02694523|100460691|FG005|STARTED|Part A||0||
48056857|NCT02694523|100460692|FG006|STARTED|Part A||0||
48056858|NCT02694523|100460686|FG000|COMPLETED|Part A||291||
48056859|NCT02694523|100460687|FG001|COMPLETED|Part A||294||
48056860|NCT02694523|100460688|FG002|COMPLETED|Part A||0||
48056861|NCT02694523|100460689|FG003|COMPLETED|Part A||0||
48056862|NCT02694523|100460690|FG004|COMPLETED|Part A||0||
48056863|NCT02694523|100460691|FG005|COMPLETED|Part A||0||
48056864|NCT02694523|100460692|FG006|COMPLETED|Part A||0||
48056865|NCT02694523|100460686|FG000|NOT COMPLETED|Part A||13||
48056866|NCT02694523|100460687|FG001|NOT COMPLETED|Part A||7||
48056867|NCT02694523|100460688|FG002|NOT COMPLETED|Part A||0||
48056868|NCT02694523|100460689|FG003|NOT COMPLETED|Part A||0||
48056869|NCT02694523|100460690|FG004|NOT COMPLETED|Part A||0||
48056870|NCT02694523|100460691|FG005|NOT COMPLETED|Part A||0||
48056871|NCT02694523|100460692|FG006|NOT COMPLETED|Part A||0||
48056872|NCT02694523|100460686|FG000|STARTED|Part B||0||
48056873|NCT02694523|100460687|FG001|STARTED|Part B||0||
48056874|NCT02694523|100460688|FG002|STARTED|Part B||294||
48056875|NCT02694523|100460689|FG003|STARTED|Part B||144||
48056876|NCT02694523|100460690|FG004|STARTED|Part B||38||
48056877|NCT02694523|100460691|FG005|STARTED|Part B||56||
48056878|NCT02694523|100460692|FG006|STARTED|Part B||53||
48056879|NCT02694523|100460686|FG000|COMPLETED|Part B||0||
48056880|NCT02694523|100460687|FG001|COMPLETED|Part B||0||
48056881|NCT02694523|100460688|FG002|COMPLETED|Part B||274||
48056882|NCT02694523|100460689|FG003|COMPLETED|Part B||140||
48056883|NCT02694523|100460690|FG004|COMPLETED|Part B||34||
48056884|NCT02694523|100460691|FG005|COMPLETED|Part B||51||
48056885|NCT02694523|100460692|FG006|COMPLETED|Part B||51||
48056886|NCT02694523|100460686|FG000|NOT COMPLETED|Part B||0||
48056887|NCT02694523|100460687|FG001|NOT COMPLETED|Part B||0||
48056888|NCT02694523|100460688|FG002|NOT COMPLETED|Part B||20||
48056889|NCT02694523|100460689|FG003|NOT COMPLETED|Part B||4||
48056890|NCT02694523|100460690|FG004|NOT COMPLETED|Part B||4||
48056891|NCT02694523|100460691|FG005|NOT COMPLETED|Part B||5||
48056892|NCT02694523|100460692|FG006|NOT COMPLETED|Part B||2||
48056893|NCT02970318|100460693|FG000|STARTED|Overall for Arm A & Main for Arm B||155||
48056894|NCT02970318|100460694|FG001|STARTED|Overall for Arm A & Main for Arm B||155||
48056895|NCT02970318|100460695|FG002|STARTED|Overall for Arm A & Main for Arm B||0||
48056896|NCT02970318|100460696|FG003|STARTED|Overall for Arm A & Main for Arm B||0||
48056897|NCT02970318|100460693|FG000|Arm B Treatment= Idelalisib Plus Rituximab|Overall for Arm A & Main for Arm B||0||
48056898|NCT02970318|100460694|FG001|Arm B Treatment= Idelalisib Plus Rituximab|Overall for Arm A & Main for Arm B||119||
48056899|NCT02970318|100460695|FG002|Arm B Treatment= Idelalisib Plus Rituximab|Overall for Arm A & Main for Arm B||0||
48056900|NCT02970318|100460696|FG003|Arm B Treatment= Idelalisib Plus Rituximab|Overall for Arm A & Main for Arm B||0||
48056901|NCT02970318|100460693|FG000|Arm B Treatment = Bendamustine Plus Rituximab|Overall for Arm A & Main for Arm B||0||
48056902|NCT02970318|100460694|FG001|Arm B Treatment = Bendamustine Plus Rituximab|Overall for Arm A & Main for Arm B||36||
48056903|NCT02970318|100460695|FG002|Arm B Treatment = Bendamustine Plus Rituximab|Overall for Arm A & Main for Arm B||0||
48056904|NCT02970318|100460696|FG003|Arm B Treatment = Bendamustine Plus Rituximab|Overall for Arm A & Main for Arm B||0||
48056905|NCT02970318|100460693|FG000|Completed|Overall for Arm A & Main for Arm B||0|Completed study treatment at final DCO (03Sep2021)|
48208606|NCT04054635|100837082|FG002|NOT COMPLETED|Third Visit (Second Follow-up)||0||
48056906|NCT02970318|100460694|FG001|Completed|Overall for Arm A & Main for Arm B||1|Completed study treatment at final DCO (03Sep2021)|
48056907|NCT02970318|100460695|FG002|Completed|Overall for Arm A & Main for Arm B||0|Completed study treatment at final DCO (03Sep2021)|
48056908|NCT02970318|100460696|FG003|Completed|Overall for Arm A & Main for Arm B||0|Completed study treatment at final DCO (03Sep2021)|
48056909|NCT02970318|100460693|FG000|Completed|Overall for Arm A & Main for Arm B||99|Patients ongoing treatment at final DCO (03Sep2021)|
48056910|NCT02970318|100460694|FG001|Completed|Overall for Arm A & Main for Arm B||26|Patients ongoing treatment at final DCO (03Sep2021)|
48056911|NCT02970318|100460695|FG002|Completed|Overall for Arm A & Main for Arm B||0|Patients ongoing treatment at final DCO (03Sep2021)|
48056912|NCT02970318|100460696|FG003|Completed|Overall for Arm A & Main for Arm B||0|Patients ongoing treatment at final DCO (03Sep2021)|
48056913|NCT02970318|100460693|FG000|COMPLETED|Overall for Arm A & Main for Arm B||99|Patients Ongoing Treatment + Patients Completed Study Treatment at Final DCO (03Sep2021)|
48056914|NCT02970318|100460694|FG001|COMPLETED|Overall for Arm A & Main for Arm B||27|Patients Ongoing Treatment + Patients Completed Study Treatment at Final DCO (03Sep2021)|
48056915|NCT02970318|100460695|FG002|COMPLETED|Overall for Arm A & Main for Arm B||0|Patients Ongoing Treatment + Patients Completed Study Treatment at Final DCO (03Sep2021)|
48056916|NCT02970318|100460696|FG003|COMPLETED|Overall for Arm A & Main for Arm B||0|Patients Ongoing Treatment + Patients Completed Study Treatment at Final DCO (03Sep2021)|
48056917|NCT02970318|100460693|FG000|NOT COMPLETED|Overall for Arm A & Main for Arm B||56||
48056918|NCT02970318|100460694|FG001|NOT COMPLETED|Overall for Arm A & Main for Arm B||128||
48056919|NCT02970318|100460695|FG002|NOT COMPLETED|Overall for Arm A & Main for Arm B||0||
48056920|NCT02970318|100460696|FG003|NOT COMPLETED|Overall for Arm A & Main for Arm B||0||
48056921|NCT02970318|100460693|FG000|STARTED|ArmB: Inv.Choice Crossed Over to Acala||0||
48056922|NCT02970318|100460694|FG001|STARTED|ArmB: Inv.Choice Crossed Over to Acala||0||
48056923|NCT02970318|100460695|FG002|STARTED|ArmB: Inv.Choice Crossed Over to Acala||63||
48056924|NCT02970318|100460696|FG003|STARTED|ArmB: Inv.Choice Crossed Over to Acala||17||
48056925|NCT02970318|100460693|FG000|COMPLETED|ArmB: Inv.Choice Crossed Over to Acala||0|Ongoing Treatment at Final DCO (03Sep2021)|
48056926|NCT02970318|100460694|FG001|COMPLETED|ArmB: Inv.Choice Crossed Over to Acala||0|Ongoing Treatment at Final DCO (03Sep2021)|
48056927|NCT02970318|100460695|FG002|COMPLETED|ArmB: Inv.Choice Crossed Over to Acala||42|Ongoing Treatment at Final DCO (03Sep2021)|
48056928|NCT02970318|100460696|FG003|COMPLETED|ArmB: Inv.Choice Crossed Over to Acala||14|Ongoing Treatment at Final DCO (03Sep2021)|
48056929|NCT02970318|100460693|FG000|NOT COMPLETED|ArmB: Inv.Choice Crossed Over to Acala||0||
48056930|NCT02970318|100460694|FG001|NOT COMPLETED|ArmB: Inv.Choice Crossed Over to Acala||0||
48056931|NCT02970318|100460695|FG002|NOT COMPLETED|ArmB: Inv.Choice Crossed Over to Acala||21||
48056932|NCT02970318|100460696|FG003|NOT COMPLETED|ArmB: Inv.Choice Crossed Over to Acala||3||
48056933|NCT03053271|100460697|FG000|STARTED|Overall Study||4||
48056934|NCT03053271|100460697|FG000|COMPLETED|Overall Study||0||
48056935|NCT03053271|100460697|FG000|NOT COMPLETED|Overall Study||4||
48208607|NCT03098966|100837083|FG000|STARTED|Overall Study||368||
48208608|NCT03098966|100837083|FG000|COMPLETED|Overall Study||368||
48208609|NCT03098966|100837083|FG000|NOT COMPLETED|Overall Study||0||
48208610|NCT01087762|100837084|FG000|STARTED|Double Blind Period (Weeks 0-24)||107||
48208611|NCT01087762|100837085|FG001|STARTED|Double Blind Period (Weeks 0-24)||111||
48208612|NCT01087762|100837086|FG002|STARTED|Double Blind Period (Weeks 0-24)||107||
48056936|NCT03350620|100460698|FG000|STARTED|Stage 1||164||
48056937|NCT03350620|100460699|FG001|STARTED|Stage 1||247||
48056938|NCT03350620|100460700|FG002|STARTED|Stage 1||165||
48056939|NCT03350620|100460698|FG000|COMPLETED|Stage 1||127||
48056940|NCT03350620|100460699|FG001|COMPLETED|Stage 1||207||
48056941|NCT03350620|100460700|FG002|COMPLETED|Stage 1||143||
48056942|NCT03350620|100460698|FG000|NOT COMPLETED|Stage 1||37||
48056943|NCT03350620|100460699|FG001|NOT COMPLETED|Stage 1||40||
48056944|NCT03350620|100460700|FG002|NOT COMPLETED|Stage 1||22||
48056945|NCT03350620|100460698|FG000|STARTED|Stage 2||159|Per Statistical Analysis Plan, Stage 2 outcomes are all exploratory and tertiary outcomes.|
48056946|NCT03350620|100460699|FG001|STARTED|Stage 2||162|Per Statistical Analysis Plan, Stage 2 outcomes are all exploratory and tertiary outcomes.|
48056947|NCT03350620|100460700|FG002|STARTED|Stage 2||99|Per Statistical Analysis Plan, Stage 2 outcomes are all exploratory and tertiary outcomes.|
48056948|NCT03350620|100460698|FG000|COMPLETED|Stage 2||156||
48056949|NCT03350620|100460699|FG001|COMPLETED|Stage 2||153||
48056950|NCT03350620|100460700|FG002|COMPLETED|Stage 2||96||
48056951|NCT03350620|100460698|FG000|NOT COMPLETED|Stage 2||3||
48056952|NCT03350620|100460699|FG001|NOT COMPLETED|Stage 2||9||
48056953|NCT03350620|100460700|FG002|NOT COMPLETED|Stage 2||3||
48056954|NCT01954342|100460701|FG000|STARTED|Overall Study||36||
48056955|NCT01954342|100460702|FG001|STARTED|Overall Study||8||
48056956|NCT01954342|100460703|FG002|STARTED|Overall Study||10||
48056957|NCT01954342|100460704|FG003|STARTED|Overall Study||18||
48056958|NCT01954342|100460701|FG000|COMPLETED|Overall Study||36||
48056959|NCT01954342|100460702|FG001|COMPLETED|Overall Study||8||
48056960|NCT01954342|100460703|FG002|COMPLETED|Overall Study||10||
48056961|NCT01954342|100460704|FG003|COMPLETED|Overall Study||0||
48056962|NCT01954342|100460701|FG000|NOT COMPLETED|Overall Study||0||
48056963|NCT01954342|100460702|FG001|NOT COMPLETED|Overall Study||0||
48056964|NCT01954342|100460703|FG002|NOT COMPLETED|Overall Study||0||
48056965|NCT01954342|100460704|FG003|NOT COMPLETED|Overall Study||18||
48056966|NCT04365257|100460705|FG000|STARTED|Overall Study||3||
48056967|NCT04365257|100460706|FG001|STARTED|Overall Study||2||
48056968|NCT04365257|100460705|FG000|COMPLETED|Overall Study||1||
48056969|NCT04365257|100460706|FG001|COMPLETED|Overall Study||1||
48056970|NCT04365257|100460705|FG000|NOT COMPLETED|Overall Study||2||
48056971|NCT04365257|100460706|FG001|NOT COMPLETED|Overall Study||1||
48056972|NCT01264016|100460707|FG000|STARTED|Overall Study||96||
48056973|NCT01264016|100460707|FG000|COMPLETED|Overall Study||94||
48056974|NCT01264016|100460707|FG000|NOT COMPLETED|Overall Study||2||
48056975|NCT03034200|100460708|FG000|STARTED|Overall Study||10||
48056976|NCT03034200|100460709|FG001|STARTED|Overall Study||12||
48056977|NCT03034200|100460710|FG002|STARTED|Overall Study||8||
48056978|NCT03034200|100460708|FG000|COMPLETED|Overall Study||0||
48056979|NCT03034200|100460709|FG001|COMPLETED|Overall Study||1||
48056980|NCT03034200|100460710|FG002|COMPLETED|Overall Study||0||
48056981|NCT03034200|100460708|FG000|NOT COMPLETED|Overall Study||10||
48056982|NCT03034200|100460709|FG001|NOT COMPLETED|Overall Study||11||
48056983|NCT03034200|100460710|FG002|NOT COMPLETED|Overall Study||8||
48056984|NCT02035475|100460711|FG000|STARTED|Overall Study||120||
48056985|NCT02035475|100460711|FG000|COMPLETED|Overall Study||114||
48056986|NCT02035475|100460711|FG000|NOT COMPLETED|Overall Study||6||
48056987|NCT04718103|100460712|FG000|STARTED|Overall Study||263|Randomized|
48056988|NCT04718103|100460713|FG001|STARTED|Overall Study||134|Randomized|
48208613|NCT01087762|100837087|FG003|STARTED|Double Blind Period (Weeks 0-24)||0||
48208614|NCT01087762|100837088|FG004|STARTED|Double Blind Period (Weeks 0-24)||0||
48056989|NCT04718103|100460712|FG000|Full Analysis Population|Overall Study||252||
48056990|NCT04718103|100460713|FG001|Full Analysis Population|Overall Study||128||
48056991|NCT04718103|100460712|FG000|COMPLETED|Overall Study||233||
48056992|NCT04718103|100460713|FG001|COMPLETED|Overall Study||117||
48056993|NCT04718103|100460712|FG000|NOT COMPLETED|Overall Study||30||
48056994|NCT04718103|100460713|FG001|NOT COMPLETED|Overall Study||17||
48056995|NCT00365144|100460714|FG000|STARTED|Overall Study||36||
48056996|NCT00365144|100460714|FG000|COMPLETED|Overall Study||36||
48056997|NCT00365144|100460714|FG000|NOT COMPLETED|Overall Study||0||
48056998|NCT02617784|100460715|FG000|STARTED|Overall Study||12||
48056999|NCT02617784|100460716|FG001|STARTED|Overall Study||12||
48057000|NCT02617784|100460715|FG000|First Dose Assessment Period|Overall Study||12||
48057001|NCT02617784|100460716|FG001|First Dose Assessment Period|Overall Study||12||
48057002|NCT02617784|100460715|FG000|Second Dose Assessment Period|Overall Study||11||
48208615|NCT01087762|100837084|FG000|COMPLETED|Double Blind Period (Weeks 0-24)||95||
48208616|NCT01087762|100837085|FG001|COMPLETED|Double Blind Period (Weeks 0-24)||105||
48057003|NCT02617784|100460716|FG001|Second Dose Assessment Period|Overall Study||12||
48057004|NCT02617784|100460715|FG000|COMPLETED|Overall Study||12||
48057005|NCT02617784|100460716|FG001|COMPLETED|Overall Study||12||
48057006|NCT02617784|100460715|FG000|NOT COMPLETED|Overall Study||0||
48057007|NCT02617784|100460716|FG001|NOT COMPLETED|Overall Study||0||
48057008|NCT05156073|100460717|FG000|STARTED|Overall Study||22||
48057009|NCT05156073|100460717|FG000|COMPLETED|Overall Study||21||
48057010|NCT05156073|100460717|FG000|NOT COMPLETED|Overall Study||1||
48057011|NCT00562627|100460718|FG000|STARTED|Overall Study||34||
48057012|NCT00562627|100460719|FG001|STARTED|Overall Study||34||
48057013|NCT00562627|100460720|FG002|STARTED|Overall Study||34||
48057014|NCT00562627|100460718|FG000|COMPLETED|Overall Study||33||
48057015|NCT00562627|100460719|FG001|COMPLETED|Overall Study||33||
48057016|NCT00562627|100460720|FG002|COMPLETED|Overall Study||33||
48057017|NCT00562627|100460718|FG000|NOT COMPLETED|Overall Study||1||
48057018|NCT00562627|100460719|FG001|NOT COMPLETED|Overall Study||1||
48057019|NCT00562627|100460720|FG002|NOT COMPLETED|Overall Study||1||
48057020|NCT02653092|100460721|FG000|STARTED|Overall Study||26||
48057021|NCT02653092|100460722|FG001|STARTED|Overall Study||58||
48057022|NCT02653092|100460721|FG000|COMPLETED|Overall Study||13||
48057023|NCT02653092|100460722|FG001|COMPLETED|Overall Study||18||
48057024|NCT02653092|100460721|FG000|NOT COMPLETED|Overall Study||13||
48057025|NCT02653092|100460722|FG001|NOT COMPLETED|Overall Study||40||
48057026|NCT03402659|100460723|FG000|STARTED|Overall Study||83||
48057027|NCT03402659|100460724|FG001|STARTED|Overall Study||78||
48057028|NCT03402659|100460723|FG000|COMPLETED|Overall Study||78||
48057029|NCT03402659|100460724|FG001|COMPLETED|Overall Study||73||
48057030|NCT03402659|100460723|FG000|NOT COMPLETED|Overall Study||5||
48057031|NCT03402659|100460724|FG001|NOT COMPLETED|Overall Study||5||
48057032|NCT03693170|100460725|FG000|STARTED|Overall Study||95||
48057033|NCT03693170|100460725|FG000|COMPLETED|Overall Study||20||
48057034|NCT03693170|100460725|FG000|NOT COMPLETED|Overall Study||75||
48057035|NCT04478123|100460726|FG000|STARTED|Overall Study||62||
48057036|NCT04478123|100460726|FG000|COMPLETED|Overall Study||59||
48057037|NCT04478123|100460726|FG000|NOT COMPLETED|Overall Study||3||
48057038|NCT01369615|100460727|FG000|STARTED|Overall Study||9||
48057039|NCT01369615|100460728|FG001|STARTED|Overall Study||14||
48057040|NCT01369615|100460727|FG000|COMPLETED|Overall Study||9||
48057041|NCT01369615|100460728|FG001|COMPLETED|Overall Study||12||
48057042|NCT01369615|100460727|FG000|NOT COMPLETED|Overall Study||0||
48057043|NCT01369615|100460728|FG001|NOT COMPLETED|Overall Study||2||
48057044|NCT01226043|100460729|FG000|STARTED|4-week Crossover Phase - Period 1||202||
48057045|NCT01226043|100460730|FG001|STARTED|4-week Crossover Phase - Period 1||203||
48057046|NCT01226043|100460731|FG002|STARTED|4-week Crossover Phase - Period 1||0||
48057047|NCT01226043|100460732|FG003|STARTED|4-week Crossover Phase - Period 1||0||
48057048|NCT01226043|100460729|FG000|TREATED|4-week Crossover Phase - Period 1||202||
48057049|NCT01226043|100460730|FG001|TREATED|4-week Crossover Phase - Period 1||200||
48057050|NCT01226043|100460731|FG002|TREATED|4-week Crossover Phase - Period 1||0||
48057051|NCT01226043|100460732|FG003|TREATED|4-week Crossover Phase - Period 1||0||
48057052|NCT01226043|100460729|FG000|COMPLETED|4-week Crossover Phase - Period 1||199||
48057053|NCT01226043|100460730|FG001|COMPLETED|4-week Crossover Phase - Period 1||194||
48057054|NCT01226043|100460731|FG002|COMPLETED|4-week Crossover Phase - Period 1||0||
48057055|NCT01226043|100460732|FG003|COMPLETED|4-week Crossover Phase - Period 1||0||
48057056|NCT01226043|100460729|FG000|NOT COMPLETED|4-week Crossover Phase - Period 1||3||
48057057|NCT01226043|100460730|FG001|NOT COMPLETED|4-week Crossover Phase - Period 1||9||
48057058|NCT01226043|100460731|FG002|NOT COMPLETED|4-week Crossover Phase - Period 1||0||
48208617|NCT01087762|100837086|FG002|COMPLETED|Double Blind Period (Weeks 0-24)||98||
48208618|NCT01087762|100837087|FG003|COMPLETED|Double Blind Period (Weeks 0-24)||0||
48057059|NCT01226043|100460732|FG003|NOT COMPLETED|4-week Crossover Phase - Period 1||0||
48057060|NCT01226043|100460729|FG000|STARTED|4-week Crossover Phase - Period 2||199||
48057061|NCT01226043|100460730|FG001|STARTED|4-week Crossover Phase - Period 2||194||
48057062|NCT01226043|100460731|FG002|STARTED|4-week Crossover Phase - Period 2||0||
48057063|NCT01226043|100460732|FG003|STARTED|4-week Crossover Phase - Period 2||0||
48057064|NCT01226043|100460729|FG000|TREATED|4-week Crossover Phase - Period 2||199||
48057065|NCT01226043|100460730|FG001|TREATED|4-week Crossover Phase - Period 2||194||
48057066|NCT01226043|100460731|FG002|TREATED|4-week Crossover Phase - Period 2||0||
48057067|NCT01226043|100460732|FG003|TREATED|4-week Crossover Phase - Period 2||0||
48057068|NCT01226043|100460729|FG000|COMPLETED|4-week Crossover Phase - Period 2||195||
48057069|NCT01226043|100460730|FG001|COMPLETED|4-week Crossover Phase - Period 2||188||
48057070|NCT01226043|100460731|FG002|COMPLETED|4-week Crossover Phase - Period 2||0||
48057071|NCT01226043|100460732|FG003|COMPLETED|4-week Crossover Phase - Period 2||0||
48057072|NCT01226043|100460729|FG000|NOT COMPLETED|4-week Crossover Phase - Period 2||4||
48057073|NCT01226043|100460730|FG001|NOT COMPLETED|4-week Crossover Phase - Period 2||6||
48057074|NCT01226043|100460731|FG002|NOT COMPLETED|4-week Crossover Phase - Period 2||0||
48057075|NCT01226043|100460732|FG003|NOT COMPLETED|4-week Crossover Phase - Period 2||0||
48057076|NCT01226043|100460729|FG000|STARTED|6-week Re-randomization Phase||0||
48057077|NCT01226043|100460730|FG001|STARTED|6-week Re-randomization Phase||0||
48057078|NCT01226043|100460731|FG002|STARTED|6-week Re-randomization Phase||166||
48057079|NCT01226043|100460732|FG003|STARTED|6-week Re-randomization Phase||167||
48057080|NCT01226043|100460729|FG000|TREATED|6-week Re-randomization Phase||0||
48057081|NCT01226043|100460730|FG001|TREATED|6-week Re-randomization Phase||0||
48057082|NCT01226043|100460731|FG002|TREATED|6-week Re-randomization Phase||165||
48057083|NCT01226043|100460732|FG003|TREATED|6-week Re-randomization Phase||165||
48057084|NCT01226043|100460729|FG000|COMPLETED|6-week Re-randomization Phase||0||
48057085|NCT01226043|100460730|FG001|COMPLETED|6-week Re-randomization Phase||0||
48057086|NCT01226043|100460731|FG002|COMPLETED|6-week Re-randomization Phase||159||
48057087|NCT01226043|100460732|FG003|COMPLETED|6-week Re-randomization Phase||156||
48057088|NCT01226043|100460729|FG000|NOT COMPLETED|6-week Re-randomization Phase||0||
48057089|NCT01226043|100460730|FG001|NOT COMPLETED|6-week Re-randomization Phase||0||
48057090|NCT01226043|100460731|FG002|NOT COMPLETED|6-week Re-randomization Phase||7||
48057091|NCT01226043|100460732|FG003|NOT COMPLETED|6-week Re-randomization Phase||11||
48057092|NCT01226043|100460729|FG000|STARTED|30-week Observational Phase||0||
48057093|NCT01226043|100460730|FG001|STARTED|30-week Observational Phase||0||
48057094|NCT01226043|100460731|FG002|STARTED|30-week Observational Phase||159||
48057095|NCT01226043|100460732|FG003|STARTED|30-week Observational Phase||153||
48057096|NCT01226043|100460729|FG000|TREATED|30-week Observational Phase||0||
48057097|NCT01226043|100460730|FG001|TREATED|30-week Observational Phase||0||
48057098|NCT01226043|100460731|FG002|TREATED|30-week Observational Phase||159||
48057099|NCT01226043|100460732|FG003|TREATED|30-week Observational Phase||153||
48057100|NCT01226043|100460729|FG000|COMPLETED|30-week Observational Phase||0||
48057101|NCT01226043|100460730|FG001|COMPLETED|30-week Observational Phase||0||
48057102|NCT01226043|100460731|FG002|COMPLETED|30-week Observational Phase||153||
48057103|NCT01226043|100460732|FG003|COMPLETED|30-week Observational Phase||140||
48057104|NCT01226043|100460729|FG000|NOT COMPLETED|30-week Observational Phase||0||
48057105|NCT01226043|100460730|FG001|NOT COMPLETED|30-week Observational Phase||0||
48057106|NCT01226043|100460731|FG002|NOT COMPLETED|30-week Observational Phase||6||
48057107|NCT01226043|100460732|FG003|NOT COMPLETED|30-week Observational Phase||13||
48057108|NCT03387150|100460733|FG000|STARTED|Overall Study||19||
48057109|NCT03387150|100460734|FG001|STARTED|Overall Study||19||
48057110|NCT03387150|100460735|FG002|STARTED|Overall Study||21||
48057111|NCT03387150|100460736|FG003|STARTED|Overall Study||21||
48057112|NCT03387150|100460737|FG004|STARTED|Overall Study||20||
48057113|NCT03387150|100460738|FG005|STARTED|Overall Study||21||
48057114|NCT03387150|100460739|FG006|STARTED|Overall Study||3||
48057115|NCT03387150|100460733|FG000|Safety Population|Overall Study||19||
48057116|NCT03387150|100460734|FG001|Safety Population|Overall Study||19||
48057117|NCT03387150|100460735|FG002|Safety Population|Overall Study||21||
48057118|NCT03387150|100460736|FG003|Safety Population|Overall Study||21||
48057119|NCT03387150|100460737|FG004|Safety Population|Overall Study||20||
48057120|NCT03387150|100460738|FG005|Safety Population|Overall Study||21||
48057121|NCT03387150|100460739|FG006|Safety Population|Overall Study||3||
48057122|NCT03387150|100460733|FG000|COMPLETED|Overall Study||13||
48057123|NCT03387150|100460734|FG001|COMPLETED|Overall Study||16||
48057124|NCT03387150|100460735|FG002|COMPLETED|Overall Study||16||
48057125|NCT03387150|100460736|FG003|COMPLETED|Overall Study||14||
48057126|NCT03387150|100460737|FG004|COMPLETED|Overall Study||14||
48057127|NCT03387150|100460738|FG005|COMPLETED|Overall Study||14||
48057128|NCT03387150|100460739|FG006|COMPLETED|Overall Study||3||
48208619|NCT01087762|100837088|FG004|COMPLETED|Double Blind Period (Weeks 0-24)||0||
48208620|NCT01087762|100837084|FG000|NOT COMPLETED|Double Blind Period (Weeks 0-24)||12||
48057129|NCT03387150|100460733|FG000|NOT COMPLETED|Overall Study||6||
48057130|NCT03387150|100460734|FG001|NOT COMPLETED|Overall Study||3||
48057131|NCT03387150|100460735|FG002|NOT COMPLETED|Overall Study||5||
48057132|NCT03387150|100460736|FG003|NOT COMPLETED|Overall Study||7||
48057133|NCT03387150|100460737|FG004|NOT COMPLETED|Overall Study||6||
48057134|NCT03387150|100460738|FG005|NOT COMPLETED|Overall Study||7||
48057135|NCT03387150|100460739|FG006|NOT COMPLETED|Overall Study||0||
48057136|NCT00116168|100460740|FG000|STARTED|Overall Study||6||
48057137|NCT00116168|100460741|FG001|STARTED|Overall Study||11||
48057138|NCT00116168|100460742|FG002|STARTED|Overall Study||6||
48057139|NCT00116168|100460743|FG003|STARTED|Overall Study||6||
48057140|NCT00116168|100460740|FG000|COMPLETED|Overall Study||0||
48057141|NCT00116168|100460741|FG001|COMPLETED|Overall Study||6||
48208621|NCT01087762|100837085|FG001|NOT COMPLETED|Double Blind Period (Weeks 0-24)||6||
48057142|NCT00116168|100460742|FG002|COMPLETED|Overall Study||6||
48057143|NCT00116168|100460743|FG003|COMPLETED|Overall Study||6||
48057144|NCT00116168|100460740|FG000|NOT COMPLETED|Overall Study||6||
48057145|NCT00116168|100460741|FG001|NOT COMPLETED|Overall Study||5||
48057146|NCT00116168|100460742|FG002|NOT COMPLETED|Overall Study||0||
48057147|NCT00116168|100460743|FG003|NOT COMPLETED|Overall Study||0||
48057148|NCT03803683|100460744|FG000|STARTED|Overall Study||211||
48057149|NCT03803683|100460745|FG001|STARTED|Overall Study||208||
48057150|NCT03803683|100460746|FG002|STARTED|Overall Study||104||
48057151|NCT03803683|100460744|FG000|COMPLETED|Overall Study||161||
48057152|NCT03803683|100460745|FG001|COMPLETED|Overall Study||189||
48057153|NCT03803683|100460746|FG002|COMPLETED|Overall Study||88||
48057154|NCT03803683|100460744|FG000|NOT COMPLETED|Overall Study||50||
48057155|NCT03803683|100460745|FG001|NOT COMPLETED|Overall Study||19||
48057156|NCT03803683|100460746|FG002|NOT COMPLETED|Overall Study||16||
48057157|NCT03514017|100460747|FG000|STARTED|Overall Study||5||
48057158|NCT03514017|100460747|FG000|COMPLETED|Overall Study||3||
48057159|NCT03514017|100460747|FG000|NOT COMPLETED|Overall Study||2||
48057160|NCT04508140|100460748|FG000|STARTED|Overall Study||11||
48057161|NCT04508140|100460749|FG001|STARTED|Overall Study||7||
48057162|NCT04508140|100460748|FG000|COMPLETED|Overall Study||0||
48057163|NCT04508140|100460749|FG001|COMPLETED|Overall Study||0||
48057164|NCT04508140|100460748|FG000|NOT COMPLETED|Overall Study||11||
48057165|NCT04508140|100460749|FG001|NOT COMPLETED|Overall Study||7||
48057166|NCT03646643|100460750|FG000|STARTED|Overall Study||17||
48057167|NCT03646643|100460751|FG001|STARTED|Overall Study||18||
48057168|NCT03646643|100460750|FG000|COMPLETED|Overall Study||15||
48057169|NCT03646643|100460751|FG001|COMPLETED|Overall Study||15||
48057170|NCT03646643|100460750|FG000|NOT COMPLETED|Overall Study||2||
48057171|NCT03646643|100460751|FG001|NOT COMPLETED|Overall Study||3||
48057172|NCT00191646|100460752|FG000|STARTED|Overall Study||417||
48057173|NCT00191646|100460753|FG001|STARTED|Overall Study||414||
48057174|NCT00191646|100460752|FG000|Received Induction Therapy|Overall Study||411||
48057175|NCT00191646|100460753|FG001|Received Induction Therapy|Overall Study||409||
48057176|NCT00191646|100460752|FG000|Received Consolidation Therapy|Overall Study||169||
48057177|NCT00191646|100460753|FG001|Received Consolidation Therapy|Overall Study||183||
48057178|NCT00191646|100460752|FG000|Received Crossover Therapy|Overall Study||77||
48057179|NCT00191646|100460753|FG001|Received Crossover Therapy|Overall Study||78||
48057180|NCT00191646|100460752|FG000|COMPLETED|Overall Study||246||
48057181|NCT00191646|100460753|FG001|COMPLETED|Overall Study||261||
48057182|NCT00191646|100460752|FG000|NOT COMPLETED|Overall Study||171||
48057183|NCT00191646|100460753|FG001|NOT COMPLETED|Overall Study||153||
48057184|NCT00704912|100460754|FG000|STARTED|Overall Study||50||
48057185|NCT00704912|100460755|FG001|STARTED|Overall Study||49||
48057186|NCT00704912|100460756|FG002|STARTED|Overall Study||50||
48057187|NCT00704912|100460754|FG000|COMPLETED|Overall Study||44||
48057188|NCT00704912|100460755|FG001|COMPLETED|Overall Study||45||
48057189|NCT00704912|100460756|FG002|COMPLETED|Overall Study||43||
48057190|NCT00704912|100460754|FG000|NOT COMPLETED|Overall Study||6||
48057191|NCT00704912|100460755|FG001|NOT COMPLETED|Overall Study||4||
48057192|NCT00704912|100460756|FG002|NOT COMPLETED|Overall Study||7||
48057193|NCT02927262|100460757|FG000|STARTED|Treatment Period (Up to 744 Days)||63||
48057194|NCT02927262|100460758|FG001|STARTED|Treatment Period (Up to 744 Days)||35||
48057195|NCT02927262|100460757|FG000|COMPLETED|Treatment Period (Up to 744 Days)||24||
48057196|NCT02927262|100460758|FG001|COMPLETED|Treatment Period (Up to 744 Days)||12||
48057197|NCT02927262|100460757|FG000|NOT COMPLETED|Treatment Period (Up to 744 Days)||39||
48057198|NCT02927262|100460758|FG001|NOT COMPLETED|Treatment Period (Up to 744 Days)||23||
48057199|NCT02927262|100460757|FG000|STARTED|Long Term Follow-up (Up to 1201 Days)||60||
48057200|NCT02927262|100460758|FG001|STARTED|Long Term Follow-up (Up to 1201 Days)||35||
48057201|NCT02927262|100460757|FG000|Did Not Enter Long Term Follow up Period|Long Term Follow-up (Up to 1201 Days)||3||
48057202|NCT02927262|100460758|FG001|Did Not Enter Long Term Follow up Period|Long Term Follow-up (Up to 1201 Days)||0||
48057203|NCT02927262|100460757|FG000|COMPLETED|Long Term Follow-up (Up to 1201 Days)||35||
48057204|NCT02927262|100460758|FG001|COMPLETED|Long Term Follow-up (Up to 1201 Days)||21||
48057205|NCT02927262|100460757|FG000|NOT COMPLETED|Long Term Follow-up (Up to 1201 Days)||25||
48057206|NCT02927262|100460758|FG001|NOT COMPLETED|Long Term Follow-up (Up to 1201 Days)||14||
48057207|NCT03384693|100460759|FG000|STARTED|Overall Study||25||
48057208|NCT03384693|100460759|FG000|COMPLETED|Overall Study||22||
48057209|NCT03384693|100460759|FG000|NOT COMPLETED|Overall Study||3||
48057210|NCT02675114|100460760|FG000|STARTED|Overall Study||497||
48057211|NCT02675114|100460761|FG001|STARTED|Overall Study||503||
48057212|NCT02675114|100460760|FG000|As Treated|Overall Study||454||
48208622|NCT01087762|100837086|FG002|NOT COMPLETED|Double Blind Period (Weeks 0-24)||9||
48057213|NCT02675114|100460761|FG001|As Treated|Overall Study||496||
48057214|NCT02675114|100460760|FG000|Valve Implant|Overall Study||453||
48057215|NCT02675114|100460761|FG001|Valve Implant|Overall Study||495||
48057216|NCT02675114|100460760|FG000|COMPLETED|Overall Study||424||
48057217|NCT02675114|100460761|FG001|COMPLETED|Overall Study||490||
48057218|NCT02675114|100460760|FG000|NOT COMPLETED|Overall Study||73||
48057219|NCT02675114|100460761|FG001|NOT COMPLETED|Overall Study||13||
48057220|NCT00990938|100460762|FG000|STARTED|Overall Study||3||
48057221|NCT00990938|100460763|FG001|STARTED|Overall Study||12||
48057222|NCT00990938|100460764|FG002|STARTED|Overall Study||12||
48057223|NCT00990938|100460765|FG003|STARTED|Overall Study||12||
48057224|NCT00990938|100460766|FG004|STARTED|Overall Study||12||
48057225|NCT00990938|100460767|FG005|STARTED|Overall Study||12||
48057226|NCT00990938|100460762|FG000|COMPLETED|Overall Study||3||
48057227|NCT00990938|100460763|FG001|COMPLETED|Overall Study||12||
48057228|NCT00990938|100460764|FG002|COMPLETED|Overall Study||12||
48057229|NCT00990938|100460765|FG003|COMPLETED|Overall Study||12||
48057230|NCT00990938|100460766|FG004|COMPLETED|Overall Study||12||
48057231|NCT00990938|100460767|FG005|COMPLETED|Overall Study||12||
48057232|NCT00990938|100460762|FG000|NOT COMPLETED|Overall Study||0||
48057233|NCT00990938|100460763|FG001|NOT COMPLETED|Overall Study||0||
48057234|NCT00990938|100460764|FG002|NOT COMPLETED|Overall Study||0||
48057235|NCT00990938|100460765|FG003|NOT COMPLETED|Overall Study||0||
48057236|NCT00990938|100460766|FG004|NOT COMPLETED|Overall Study||0||
48057237|NCT00990938|100460767|FG005|NOT COMPLETED|Overall Study||0||
48057238|NCT01289457|100460768|FG000|STARTED|Overall Study||12||
48057239|NCT01289457|100460769|FG001|STARTED|Overall Study||157||
48057240|NCT01289457|100460770|FG002|STARTED|Overall Study||113||
48057241|NCT01289457|100460768|FG000|COMPLETED|Overall Study||12||
48057242|NCT01289457|100460769|FG001|COMPLETED|Overall Study||157||
48057243|NCT01289457|100460770|FG002|COMPLETED|Overall Study||113||
48057244|NCT01289457|100460768|FG000|NOT COMPLETED|Overall Study||0||
48057245|NCT01289457|100460769|FG001|NOT COMPLETED|Overall Study||0||
48057246|NCT01289457|100460770|FG002|NOT COMPLETED|Overall Study||0||
48057247|NCT03553836|100460771|FG000|STARTED|Overall Study||487||
48057248|NCT03553836|100460772|FG001|STARTED|Overall Study||489||
48057249|NCT03553836|100460771|FG000|Treated|Overall Study||483||
48057250|NCT03553836|100460772|FG001|Treated|Overall Study||486||
48057251|NCT03553836|100460771|FG000|Re-challenged or Switched-over to Pembrolizumab|Overall Study||1||
48057252|NCT03553836|100460772|FG001|Re-challenged or Switched-over to Pembrolizumab|Overall Study||45||
48057253|NCT03553836|100460771|FG000|COMPLETED|Overall Study||0||
48057254|NCT03553836|100460772|FG001|COMPLETED|Overall Study||0||
48057255|NCT03553836|100460771|FG000|NOT COMPLETED|Overall Study||487||
48057256|NCT03553836|100460772|FG001|NOT COMPLETED|Overall Study||489||
48057257|NCT03583073|100460773|FG000|STARTED|Overall Study||45||
48057258|NCT03583073|100460774|FG001|STARTED|Overall Study||32||
48057259|NCT03583073|100460773|FG000|COMPLETED|Overall Study||37||
48057260|NCT03583073|100460774|FG001|COMPLETED|Overall Study||20||
48057261|NCT03583073|100460773|FG000|NOT COMPLETED|Overall Study||8||
48057262|NCT03583073|100460774|FG001|NOT COMPLETED|Overall Study||12||
48057263|NCT00729924|100460775|FG000|STARTED|Overall Study||40||
48057264|NCT00729924|100460775|FG000|COMPLETED|Overall Study||40||
48057265|NCT00729924|100460775|FG000|NOT COMPLETED|Overall Study||0||
48057266|NCT05136690|100460776|FG000|STARTED|Period 1||13||
48057267|NCT05136690|100460777|FG001|STARTED|Period 1||25||
48057268|NCT05136690|100460776|FG000|COMPLETED|Period 1||13||
48057269|NCT05136690|100460777|FG001|COMPLETED|Period 1||24||
48057270|NCT05136690|100460776|FG000|NOT COMPLETED|Period 1||0||
48057271|NCT05136690|100460777|FG001|NOT COMPLETED|Period 1||1||
48057272|NCT05136690|100460776|FG000|STARTED|Period 2||13||
48057273|NCT05136690|100460777|FG001|STARTED|Period 2||24||
48057274|NCT05136690|100460776|FG000|COMPLETED|Period 2||13||
48057275|NCT05136690|100460777|FG001|COMPLETED|Period 2||20||
48057276|NCT05136690|100460776|FG000|NOT COMPLETED|Period 2||0||
48057277|NCT05136690|100460777|FG001|NOT COMPLETED|Period 2||4||
48057278|NCT01986907|100460778|FG000|STARTED|Overall Study||936|All treated participants (one eye or both eyes) (Safety Analysis Set)|
48057279|NCT01986907|100460778|FG000|COMPLETED|Overall Study||774||
48057280|NCT01986907|100460778|FG000|NOT COMPLETED|Overall Study||162||
48057281|NCT01554397|100460779|FG000|STARTED|Overall Study||63||
48057282|NCT01554397|100460780|FG001|STARTED|Overall Study||46||
48057283|NCT01554397|100460779|FG000|COMPLETED|Overall Study||55||
48057284|NCT01554397|100460780|FG001|COMPLETED|Overall Study||46||
48057285|NCT01554397|100460779|FG000|NOT COMPLETED|Overall Study||8||
48057286|NCT01554397|100460780|FG001|NOT COMPLETED|Overall Study||0||
48057287|NCT04764162|100460781|FG000|STARTED|Overall Study||3||
48057288|NCT04764162|100460782|FG001|STARTED|Overall Study||7||
48057289|NCT04764162|100460781|FG000|COMPLETED|Overall Study||3||
48057290|NCT04764162|100460782|FG001|COMPLETED|Overall Study||6||
48057291|NCT04764162|100460781|FG000|NOT COMPLETED|Overall Study||0||
48057292|NCT04764162|100460782|FG001|NOT COMPLETED|Overall Study||1||
48057293|NCT04847622|100460783|FG000|STARTED|Overall Study||448||
48057294|NCT04847622|100460783|FG000|COMPLETED|Overall Study||448||
48057295|NCT04847622|100460783|FG000|NOT COMPLETED|Overall Study||0||
48057296|NCT01669096|100460784|FG000|STARTED|Overall Study||20||
48057297|NCT01669096|100460784|FG000|COMPLETED|Overall Study||20||
48057298|NCT01669096|100460784|FG000|NOT COMPLETED|Overall Study||0||
48057299|NCT02497300|100460785|FG000|STARTED|First Intervention (6 Weeks)||13||
48057300|NCT02497300|100460786|FG001|STARTED|First Intervention (6 Weeks)||6||
48057301|NCT02497300|100460785|FG000|COMPLETED|First Intervention (6 Weeks)||12||
48057302|NCT02497300|100460786|FG001|COMPLETED|First Intervention (6 Weeks)||6||
48057303|NCT02497300|100460785|FG000|NOT COMPLETED|First Intervention (6 Weeks)||1||
48057304|NCT02497300|100460786|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0||
48057305|NCT02497300|100460785|FG000|STARTED|Washout (1 Month)||12||
48057306|NCT02497300|100460786|FG001|STARTED|Washout (1 Month)||6||
48057307|NCT02497300|100460785|FG000|COMPLETED|Washout (1 Month)||12||
48057308|NCT02497300|100460786|FG001|COMPLETED|Washout (1 Month)||6||
48057309|NCT02497300|100460785|FG000|NOT COMPLETED|Washout (1 Month)||0||
48057310|NCT02497300|100460786|FG001|NOT COMPLETED|Washout (1 Month)||0||
48495737|NCT05780463|101547923|FG000|STARTED|Overall Study||247||
48057311|NCT02497300|100460785|FG000|STARTED|Second Intervention (6 Weeks)||12||
48057312|NCT02497300|100460786|FG001|STARTED|Second Intervention (6 Weeks)||6||
48057313|NCT02497300|100460785|FG000|COMPLETED|Second Intervention (6 Weeks)||10||
48057314|NCT02497300|100460786|FG001|COMPLETED|Second Intervention (6 Weeks)||5||
48057315|NCT02497300|100460785|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||2||
48057316|NCT02497300|100460786|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||1||
48057317|NCT01822678|100460787|FG000|STARTED|Overall Study||57||
48057318|NCT01822678|100460788|FG001|STARTED|Overall Study||64||
48057319|NCT01822678|100460789|FG002|STARTED|Overall Study||40||
48057320|NCT01822678|100460787|FG000|Treated|Overall Study||57||
48057321|NCT01822678|100460788|FG001|Treated|Overall Study||64||
48057322|NCT01822678|100460789|FG002|Treated|Overall Study||40||
48057323|NCT01822678|100460787|FG000|Safety Population|Overall Study||57||
48057324|NCT01822678|100460788|FG001|Safety Population|Overall Study||64||
48057325|NCT01822678|100460789|FG002|Safety Population|Overall Study||40||
48057326|NCT01822678|100460787|FG000|Intention-to-Treat Population (ITT)|Overall Study||57||
48057327|NCT01822678|100460788|FG001|Intention-to-Treat Population (ITT)|Overall Study||63||
48057328|NCT01822678|100460789|FG002|Intention-to-Treat Population (ITT)|Overall Study||40||
48057329|NCT01822678|100460787|FG000|Per Protocol Population|Overall Study||45||
48057330|NCT01822678|100460788|FG001|Per Protocol Population|Overall Study||52||
48057331|NCT01822678|100460789|FG002|Per Protocol Population|Overall Study||34||
48057332|NCT01822678|100460787|FG000|COMPLETED|Overall Study||45||
48057333|NCT01822678|100460788|FG001|COMPLETED|Overall Study||49||
48057334|NCT01822678|100460789|FG002|COMPLETED|Overall Study||29||
48057335|NCT01822678|100460787|FG000|NOT COMPLETED|Overall Study||12||
48057336|NCT01822678|100460788|FG001|NOT COMPLETED|Overall Study||15||
48057337|NCT01822678|100460789|FG002|NOT COMPLETED|Overall Study||11||
48057338|NCT03183778|100460790|FG000|STARTED|Overall Study||3||
48057339|NCT03183778|100460790|FG000|COMPLETED|Overall Study||2||
48057340|NCT03183778|100460790|FG000|NOT COMPLETED|Overall Study||1||
48057341|NCT01229397|100460791|FG000|STARTED|Overall Study||103||
48057342|NCT01229397|100460792|FG001|STARTED|Overall Study||102||
48057343|NCT01229397|100460791|FG000|COMPLETED|Overall Study||92||
48057344|NCT01229397|100460792|FG001|COMPLETED|Overall Study||93||
48057345|NCT01229397|100460791|FG000|NOT COMPLETED|Overall Study||11||
48057346|NCT01229397|100460792|FG001|NOT COMPLETED|Overall Study||9||
48057347|NCT01070043|100460793|FG000|STARTED|Run-In Phase||60||
48057348|NCT01070043|100460794|FG001|STARTED|Run-In Phase||0||
48057349|NCT01070043|100460795|FG002|STARTED|Run-In Phase||0||
48057350|NCT01070043|100460793|FG000|COMPLETED|Run-In Phase||42||
48057351|NCT01070043|100460794|FG001|COMPLETED|Run-In Phase||0||
48057352|NCT01070043|100460795|FG002|COMPLETED|Run-In Phase||0||
48057353|NCT01070043|100460793|FG000|NOT COMPLETED|Run-In Phase||18||
48057354|NCT01070043|100460794|FG001|NOT COMPLETED|Run-In Phase||0||
48057355|NCT01070043|100460795|FG002|NOT COMPLETED|Run-In Phase||0||
48057356|NCT01070043|100460793|FG000|STARTED|Double-Blind Treatment||0||
48057357|NCT01070043|100460794|FG001|STARTED|Double-Blind Treatment||21||
48057358|NCT01070043|100460795|FG002|STARTED|Double-Blind Treatment||21||
48057359|NCT01070043|100460793|FG000|COMPLETED|Double-Blind Treatment||0||
48057360|NCT01070043|100460794|FG001|COMPLETED|Double-Blind Treatment||21||
48057361|NCT01070043|100460795|FG002|COMPLETED|Double-Blind Treatment||19||
48057362|NCT01070043|100460793|FG000|NOT COMPLETED|Double-Blind Treatment||0||
48057363|NCT01070043|100460794|FG001|NOT COMPLETED|Double-Blind Treatment||0||
48057364|NCT01070043|100460795|FG002|NOT COMPLETED|Double-Blind Treatment||2||
48057365|NCT04266769|100460796|FG000|STARTED|Overall Study||14||
48057366|NCT04266769|100460796|FG000|COMPLETED|Overall Study||14||
48057367|NCT04266769|100460796|FG000|NOT COMPLETED|Overall Study||0||
48057368|NCT06350474|100460797|FG000|STARTED|Overall Study||240||
48057369|NCT06350474|100460798|FG001|STARTED|Overall Study||237||
48057370|NCT06350474|100460797|FG000|COMPLETED|Overall Study||238||
48057371|NCT06350474|100460798|FG001|COMPLETED|Overall Study||236||
48057372|NCT06350474|100460797|FG000|NOT COMPLETED|Overall Study||2||
48057373|NCT06350474|100460798|FG001|NOT COMPLETED|Overall Study||1||
48057374|NCT05007717|100460799|FG000|STARTED|Overall Study||895||12
48208623|NCT01087762|100837087|FG003|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0||
48208624|NCT01087762|100837088|FG004|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0||
48057375|NCT05007717|100460800|FG001|STARTED|Overall Study||1016||12
48057376|NCT05007717|100460799|FG000|COMPLETED|Overall Study||892||12
48057377|NCT05007717|100460800|FG001|COMPLETED|Overall Study||1014||12
48057378|NCT05007717|100460799|FG000|NOT COMPLETED|Overall Study||3||0
48057379|NCT05007717|100460800|FG001|NOT COMPLETED|Overall Study||2||0
48057380|NCT02353754|100460801|FG000|STARTED|Overall Study||12||
48057381|NCT02353754|100460802|FG001|STARTED|Overall Study||0||
48057382|NCT02353754|100460801|FG000|COMPLETED|Overall Study||10||
48057383|NCT02353754|100460802|FG001|COMPLETED|Overall Study||0||
48057384|NCT02353754|100460801|FG000|NOT COMPLETED|Overall Study||2||
48057385|NCT02353754|100460802|FG001|NOT COMPLETED|Overall Study||0||
48057386|NCT03805646|100460803|FG000|STARTED|Overall Study||1491||
48057387|NCT03805646|100460804|FG001|STARTED|Overall Study||2499||
48057388|NCT03805646|100460803|FG000|COMPLETED|Overall Study||837||
48057389|NCT03805646|100460804|FG001|COMPLETED|Overall Study||1514||
48057390|NCT03805646|100460803|FG000|NOT COMPLETED|Overall Study||654||
48057391|NCT03805646|100460804|FG001|NOT COMPLETED|Overall Study||985||
48057392|NCT01721070|100460805|FG000|STARTED|SUF NT 15 mcg||19||
48057393|NCT01721070|100460805|FG000|COMPLETED|SUF NT 15 mcg||19||
48057394|NCT01721070|100460805|FG000|NOT COMPLETED|SUF NT 15 mcg||0||
48057395|NCT01721070|100460805|FG000|STARTED|Ketoconazole 400 mg and SUF NT 15 mcg||19||
48057396|NCT01721070|100460805|FG000|COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||18||
48057397|NCT01721070|100460805|FG000|NOT COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||1||
48057398|NCT03861611|100460806|FG000|STARTED|Overall Study||66||
48057399|NCT03861611|100460807|FG001|STARTED|Overall Study||66||
48057400|NCT03861611|100460808|FG002|STARTED|Overall Study||66||
48057401|NCT03861611|100460806|FG000|COMPLETED|Overall Study||59||
48057402|NCT03861611|100460807|FG001|COMPLETED|Overall Study||61||
48057403|NCT03861611|100460808|FG002|COMPLETED|Overall Study||62||
48057404|NCT03861611|100460806|FG000|NOT COMPLETED|Overall Study||7||
48057405|NCT03861611|100460807|FG001|NOT COMPLETED|Overall Study||5||
48057406|NCT03861611|100460808|FG002|NOT COMPLETED|Overall Study||4||
48057407|NCT01602380|100460809|FG000|STARTED|Overall Study||230||
48057408|NCT01602380|100460810|FG001|STARTED|Overall Study||232||
48057409|NCT01602380|100460809|FG000|COMPLETED|Overall Study||25||
48057410|NCT01602380|100460810|FG001|COMPLETED|Overall Study||31||
48057411|NCT01602380|100460809|FG000|NOT COMPLETED|Overall Study||205||
48057412|NCT01602380|100460810|FG001|NOT COMPLETED|Overall Study||201||
48057413|NCT03772678|100460811|FG000|STARTED|Overall Study||1||
48057414|NCT03772678|100460812|FG001|STARTED|Overall Study||1||
48057415|NCT03772678|100460813|FG002|STARTED|Overall Study||1||
48057416|NCT03772678|100460814|FG003|STARTED|Overall Study||1||
48057417|NCT03772678|100460815|FG004|STARTED|Overall Study||6||
48057418|NCT03772678|100460816|FG005|STARTED|Overall Study||6||
48057419|NCT03772678|100460817|FG006|STARTED|Overall Study||6||
48057420|NCT03772678|100460818|FG007|STARTED|Overall Study||6||
48057421|NCT03772678|100460819|FG008|STARTED|Overall Study||6||
48057422|NCT03772678|100460820|FG009|STARTED|Overall Study||6||
48057423|NCT03772678|100460821|FG010|STARTED|Overall Study||6||
48057424|NCT03772678|100460822|FG011|STARTED|Overall Study||6||
48057425|NCT03772678|100460811|FG000|COMPLETED|Overall Study||1||
48057426|NCT03772678|100460812|FG001|COMPLETED|Overall Study||1||
48057427|NCT03772678|100460813|FG002|COMPLETED|Overall Study||1||
48057428|NCT03772678|100460814|FG003|COMPLETED|Overall Study||1||
48057429|NCT03772678|100460815|FG004|COMPLETED|Overall Study||5||
48057430|NCT03772678|100460816|FG005|COMPLETED|Overall Study||5||
48057431|NCT03772678|100460817|FG006|COMPLETED|Overall Study||6||
48057432|NCT03772678|100460818|FG007|COMPLETED|Overall Study||5||
48057433|NCT03772678|100460819|FG008|COMPLETED|Overall Study||6||
48057434|NCT03772678|100460820|FG009|COMPLETED|Overall Study||6||
48057435|NCT03772678|100460821|FG010|COMPLETED|Overall Study||6||
48057436|NCT03772678|100460822|FG011|COMPLETED|Overall Study||6||
48057437|NCT03772678|100460811|FG000|NOT COMPLETED|Overall Study||0||
48057438|NCT03772678|100460812|FG001|NOT COMPLETED|Overall Study||0||
48057439|NCT03772678|100460813|FG002|NOT COMPLETED|Overall Study||0||
48057440|NCT03772678|100460814|FG003|NOT COMPLETED|Overall Study||0||
48057441|NCT03772678|100460815|FG004|NOT COMPLETED|Overall Study||1||
48057442|NCT03772678|100460816|FG005|NOT COMPLETED|Overall Study||1||
48057443|NCT03772678|100460817|FG006|NOT COMPLETED|Overall Study||0||
48057444|NCT03772678|100460818|FG007|NOT COMPLETED|Overall Study||1||
48057445|NCT03772678|100460819|FG008|NOT COMPLETED|Overall Study||0||
48057446|NCT03772678|100460820|FG009|NOT COMPLETED|Overall Study||0||
48057447|NCT03772678|100460821|FG010|NOT COMPLETED|Overall Study||0||
48057448|NCT03772678|100460822|FG011|NOT COMPLETED|Overall Study||0||
48057449|NCT03104374|100460823|FG000|STARTED|Overall Study||106||
48057450|NCT03104374|100460824|FG001|STARTED|Overall Study||106||
48057451|NCT03104374|100460825|FG002|STARTED|Overall Study||211||
48057452|NCT03104374|100460826|FG003|STARTED|Overall Study||219||
48057453|NCT03104374|100460823|FG000|Received Study Drug|Overall Study||106||
48057454|NCT03104374|100460824|FG001|Received Study Drug|Overall Study||106||
48057455|NCT03104374|100460825|FG002|Received Study Drug|Overall Study||211||
48057456|NCT03104374|100460826|FG003|Received Study Drug|Overall Study||218||
48057457|NCT03104374|100460823|FG000|Completed Week 24|Overall Study||81||
48057458|NCT03104374|100460824|FG001|Completed Week 24|Overall Study||92||
48057459|NCT03104374|100460825|FG002|Completed Week 24|Overall Study||192||
48057460|NCT03104374|100460826|FG003|Completed Week 24|Overall Study||195||
48057461|NCT03104374|100460823|FG000|COMPLETED|Overall Study||69|Completed Week 56 (Period 1)|
48057462|NCT03104374|100460824|FG001|COMPLETED|Overall Study||77|Completed Week 56 (Period 1)|
48057463|NCT03104374|100460825|FG002|COMPLETED|Overall Study||167|Completed Week 56 (Period 1)|
48057464|NCT03104374|100460826|FG003|COMPLETED|Overall Study||166|Completed Week 56 (Period 1)|
48057465|NCT03104374|100460823|FG000|NOT COMPLETED|Overall Study||37||
48057466|NCT03104374|100460824|FG001|NOT COMPLETED|Overall Study||29||
48057467|NCT03104374|100460825|FG002|NOT COMPLETED|Overall Study||44||
48057468|NCT03104374|100460826|FG003|NOT COMPLETED|Overall Study||53||
48057469|NCT05055453|100460827|FG000|STARTED|Overall Study||16||
48057470|NCT05055453|100460827|FG000|COMPLETED|Overall Study||15||
48057471|NCT05055453|100460827|FG000|NOT COMPLETED|Overall Study||1||
48057472|NCT02063880|100460828|FG000|STARTED|Overall Study||90||
48057473|NCT02063880|100460829|FG001|STARTED|Overall Study||93||
48057474|NCT02063880|100460828|FG000|COMPLETED|Overall Study||62||
48057475|NCT02063880|100460829|FG001|COMPLETED|Overall Study||66||
48057476|NCT02063880|100460828|FG000|NOT COMPLETED|Overall Study||28||
48057477|NCT02063880|100460829|FG001|NOT COMPLETED|Overall Study||27||
48057478|NCT03875118|100460830|FG000|STARTED|Overall Study||34||
48057479|NCT03875118|100460831|FG001|STARTED|Overall Study||34||
48057480|NCT03875118|100460830|FG000|COMPLETED|Overall Study||30||
48057481|NCT03875118|100460831|FG001|COMPLETED|Overall Study||30||
48057482|NCT03875118|100460830|FG000|NOT COMPLETED|Overall Study||4||
48057483|NCT03875118|100460831|FG001|NOT COMPLETED|Overall Study||4||
48057484|NCT01532973|100460832|FG000|STARTED|Part 1||6||
48057485|NCT01532973|100460833|FG001|STARTED|Part 1||6||
48057486|NCT01532973|100460834|FG002|STARTED|Part 1||6||
48057487|NCT01532973|100460835|FG003|STARTED|Part 1||0||
48057488|NCT01532973|100460836|FG004|STARTED|Part 1||0||
48057489|NCT01532973|100460837|FG005|STARTED|Part 1||0||
48057490|NCT01532973|100460838|FG006|STARTED|Part 1||0||
48057491|NCT01532973|100460839|FG007|STARTED|Part 1||0||
48057492|NCT01532973|100460840|FG008|STARTED|Part 1||0||
48057493|NCT01532973|100460841|FG009|STARTED|Part 1||0||
48057494|NCT01532973|100460832|FG000|COMPLETED|Part 1||6||
48057495|NCT01532973|100460833|FG001|COMPLETED|Part 1||6||
48057496|NCT01532973|100460834|FG002|COMPLETED|Part 1||6||
48057497|NCT01532973|100460835|FG003|COMPLETED|Part 1||0||
48057498|NCT01532973|100460836|FG004|COMPLETED|Part 1||0||
48057499|NCT01532973|100460837|FG005|COMPLETED|Part 1||0||
48057500|NCT01532973|100460838|FG006|COMPLETED|Part 1||0||
48057501|NCT01532973|100460839|FG007|COMPLETED|Part 1||0||
48057502|NCT01532973|100460840|FG008|COMPLETED|Part 1||0||
48057503|NCT01532973|100460841|FG009|COMPLETED|Part 1||0||
48057504|NCT01532973|100460832|FG000|NOT COMPLETED|Part 1||0||
48057505|NCT01532973|100460833|FG001|NOT COMPLETED|Part 1||0||
48057506|NCT01532973|100460834|FG002|NOT COMPLETED|Part 1||0||
48057507|NCT01532973|100460835|FG003|NOT COMPLETED|Part 1||0||
48057508|NCT01532973|100460836|FG004|NOT COMPLETED|Part 1||0||
48057509|NCT01532973|100460837|FG005|NOT COMPLETED|Part 1||0||
48057510|NCT01532973|100460838|FG006|NOT COMPLETED|Part 1||0||
48057511|NCT01532973|100460839|FG007|NOT COMPLETED|Part 1||0||
48057512|NCT01532973|100460840|FG008|NOT COMPLETED|Part 1||0||
48057513|NCT01532973|100460841|FG009|NOT COMPLETED|Part 1||0||
48057514|NCT01532973|100460832|FG000|STARTED|Part 2||0||
48057515|NCT01532973|100460833|FG001|STARTED|Part 2||0||
48057516|NCT01532973|100460834|FG002|STARTED|Part 2||0||
48057517|NCT01532973|100460835|FG003|STARTED|Part 2||0||
48057518|NCT01532973|100460836|FG004|STARTED|Part 2||6||
48057519|NCT01532973|100460837|FG005|STARTED|Part 2||6||
48057520|NCT01532973|100460838|FG006|STARTED|Part 2||6||
48057521|NCT01532973|100460839|FG007|STARTED|Part 2||0||
48057522|NCT01532973|100460840|FG008|STARTED|Part 2||0||
48057523|NCT01532973|100460841|FG009|STARTED|Part 2||0||
48057524|NCT01532973|100460832|FG000|COMPLETED|Part 2||0||
48057525|NCT01532973|100460833|FG001|COMPLETED|Part 2||0||
48057526|NCT01532973|100460834|FG002|COMPLETED|Part 2||0||
48057527|NCT01532973|100460835|FG003|COMPLETED|Part 2||0||
48208625|NCT01087762|100837084|FG000|STARTED|Open-Label Period (Weeks 48-204)||0||
48057528|NCT01532973|100460836|FG004|COMPLETED|Part 2||6||
48057529|NCT01532973|100460837|FG005|COMPLETED|Part 2||6||
48057530|NCT01532973|100460838|FG006|COMPLETED|Part 2||6||
48057531|NCT01532973|100460839|FG007|COMPLETED|Part 2||0||
48057532|NCT01532973|100460840|FG008|COMPLETED|Part 2||0||
48057533|NCT01532973|100460841|FG009|COMPLETED|Part 2||0||
48057534|NCT01532973|100460832|FG000|NOT COMPLETED|Part 2||0||
48057535|NCT01532973|100460833|FG001|NOT COMPLETED|Part 2||0||
48057536|NCT01532973|100460834|FG002|NOT COMPLETED|Part 2||0||
48057537|NCT01532973|100460835|FG003|NOT COMPLETED|Part 2||0||
48057538|NCT01532973|100460836|FG004|NOT COMPLETED|Part 2||0||
48057539|NCT01532973|100460837|FG005|NOT COMPLETED|Part 2||0||
48057540|NCT01532973|100460838|FG006|NOT COMPLETED|Part 2||0||
48208626|NCT01087762|100837085|FG001|STARTED|Open-Label Period (Weeks 48-204)||0||
48208627|NCT01087762|100837086|FG002|STARTED|Open-Label Period (Weeks 48-204)||0||
48208628|NCT01087762|100837087|FG003|STARTED|Open-Label Period (Weeks 48-204)||158||
48057541|NCT01532973|100460839|FG007|NOT COMPLETED|Part 2||0||
48057542|NCT01532973|100460840|FG008|NOT COMPLETED|Part 2||0||
48057543|NCT01532973|100460841|FG009|NOT COMPLETED|Part 2||0||
48057544|NCT01532973|100460832|FG000|STARTED|Part 3||0||
48057545|NCT01532973|100460833|FG001|STARTED|Part 3||0||
48208629|NCT01087762|100837088|FG004|STARTED|Open-Label Period (Weeks 48-204)||157||
48057546|NCT01532973|100460834|FG002|STARTED|Part 3||0||
48057547|NCT01532973|100460835|FG003|STARTED|Part 3||0||
48208630|NCT01087762|100837084|FG000|COMPLETED|Open-Label Period (Weeks 48-204)||0||
48057548|NCT01532973|100460836|FG004|STARTED|Part 3||0||
48057549|NCT01532973|100460837|FG005|STARTED|Part 3||0||
48057550|NCT01532973|100460838|FG006|STARTED|Part 3||0||
48057551|NCT01532973|100460839|FG007|STARTED|Part 3||0||
48057552|NCT01532973|100460840|FG008|STARTED|Part 3||6||
48057553|NCT01532973|100460841|FG009|STARTED|Part 3||6||
48057554|NCT01532973|100460832|FG000|COMPLETED|Part 3||0||
48057555|NCT01532973|100460833|FG001|COMPLETED|Part 3||0||
48057556|NCT01532973|100460834|FG002|COMPLETED|Part 3||0||
48057557|NCT01532973|100460835|FG003|COMPLETED|Part 3||0||
48057558|NCT01532973|100460836|FG004|COMPLETED|Part 3||0||
48057559|NCT01532973|100460837|FG005|COMPLETED|Part 3||0||
48057560|NCT01532973|100460838|FG006|COMPLETED|Part 3||0||
48057561|NCT01532973|100460839|FG007|COMPLETED|Part 3||0||
48057562|NCT01532973|100460840|FG008|COMPLETED|Part 3||6||
48057563|NCT01532973|100460841|FG009|COMPLETED|Part 3||6||
48057564|NCT01532973|100460832|FG000|NOT COMPLETED|Part 3||0||
48057565|NCT01532973|100460833|FG001|NOT COMPLETED|Part 3||0||
48057566|NCT01532973|100460834|FG002|NOT COMPLETED|Part 3||0||
48057567|NCT01532973|100460835|FG003|NOT COMPLETED|Part 3||0||
48057568|NCT01532973|100460836|FG004|NOT COMPLETED|Part 3||0||
48057569|NCT01532973|100460837|FG005|NOT COMPLETED|Part 3||0||
48057570|NCT01532973|100460838|FG006|NOT COMPLETED|Part 3||0||
48057571|NCT01532973|100460839|FG007|NOT COMPLETED|Part 3||0||
48057572|NCT01532973|100460840|FG008|NOT COMPLETED|Part 3||0||
48057573|NCT01532973|100460841|FG009|NOT COMPLETED|Part 3||0||
48057574|NCT01163266|100460842|FG000|STARTED|Overall Study||157||
48057575|NCT01163266|100460843|FG001|STARTED|Overall Study||155||
48057576|NCT01163266|100460844|FG002|STARTED|Overall Study||150||
48057577|NCT01163266|100460842|FG000|Treated|Overall Study||157||
48057578|NCT01163266|100460843|FG001|Treated|Overall Study||155||
48057579|NCT01163266|100460844|FG002|Treated|Overall Study||150||
48057580|NCT01163266|100460842|FG000|COMPLETED|Overall Study||139||
48495738|NCT05780463|101547924|FG001|STARTED|Overall Study||238||
48495739|NCT05780463|101547923|FG000|COMPLETED|Overall Study||247||
48495740|NCT05780463|101547924|FG001|COMPLETED|Overall Study||238||
48495741|NCT05780463|101547923|FG000|NOT COMPLETED|Overall Study||0||
48495742|NCT05780463|101547924|FG001|NOT COMPLETED|Overall Study||0||
48495743|NCT00700739|101547925|FG000|STARTED|Overall Study||22||
48495744|NCT00700739|101547926|FG001|STARTED|Overall Study||16||
48495745|NCT00700739|101547925|FG000|COMPLETED|Overall Study||18||
48057581|NCT01163266|100460843|FG001|COMPLETED|Overall Study||124||
48057582|NCT01163266|100460844|FG002|COMPLETED|Overall Study||122||
48057583|NCT01163266|100460842|FG000|NOT COMPLETED|Overall Study||18||
48057584|NCT01163266|100460843|FG001|NOT COMPLETED|Overall Study||31||
48057585|NCT01163266|100460844|FG002|NOT COMPLETED|Overall Study||28||
48057586|NCT05182125|100463440|FG000|STARTED|Overall Study||5|\[1\]Enrolled|
48057587|NCT05182125|100463441|FG001|STARTED|Overall Study||5|\[1\]Enrolled|
48057588|NCT05182125|100463442|FG002|STARTED|Overall Study||2|\[1\]Enrolled|
48495746|NCT00700739|101547926|FG001|COMPLETED|Overall Study||12||
48495747|NCT00700739|101547925|FG000|NOT COMPLETED|Overall Study||4||
48495748|NCT00700739|101547926|FG001|NOT COMPLETED|Overall Study||4||
48495749|NCT03505151|101547927|FG000|STARTED|Overall Study||9||
48495750|NCT03505151|101547927|FG000|COMPLETED|Overall Study||9||
48495751|NCT03505151|101547927|FG000|NOT COMPLETED|Overall Study||0||
48495752|NCT02282722|101547928|FG000|STARTED|Overall Study||94||
48495753|NCT02282722|101547929|FG001|STARTED|Overall Study||92||
48495754|NCT02282722|101547928|FG000|2-week Assessment|Overall Study||79||
48495755|NCT02282722|101547929|FG001|2-week Assessment|Overall Study||75||
48495756|NCT02282722|101547928|FG000|3-month Assessment|Overall Study||71||
48495757|NCT02282722|101547929|FG001|3-month Assessment|Overall Study||73||
48495758|NCT02282722|101547928|FG000|COMPLETED|Overall Study||71||
48495759|NCT02282722|101547929|FG001|COMPLETED|Overall Study||73||
48495760|NCT02282722|101547928|FG000|NOT COMPLETED|Overall Study||23||
48495761|NCT02282722|101547929|FG001|NOT COMPLETED|Overall Study||19||
48495762|NCT01075516|101547930|FG000|STARTED|Overall Study||107||
48495763|NCT01075516|101547931|FG001|STARTED|Overall Study||102||
48495764|NCT01075516|101547930|FG000|COMPLETED|Overall Study||89||
48495765|NCT01075516|101547931|FG001|COMPLETED|Overall Study||86||
48495766|NCT01075516|101547930|FG000|NOT COMPLETED|Overall Study||18||
48495767|NCT01075516|101547931|FG001|NOT COMPLETED|Overall Study||16||
48495768|NCT05533411|101547932|FG000|STARTED|Overall Study||6||
48495769|NCT05533411|101547933|FG001|STARTED|Overall Study||10||
48495770|NCT05533411|101547934|FG002|STARTED|Overall Study||10||
48495771|NCT05533411|101547935|FG003|STARTED|Overall Study||10||
48495772|NCT05533411|101547932|FG000|Received At Least 1 Dose of Study Drug|Overall Study||6||
48495773|NCT05533411|101547933|FG001|Received At Least 1 Dose of Study Drug|Overall Study||10||
48495774|NCT05533411|101547934|FG002|Received At Least 1 Dose of Study Drug|Overall Study||10||
48495775|NCT05533411|101547935|FG003|Received At Least 1 Dose of Study Drug|Overall Study||10||
48495776|NCT05533411|101547932|FG000|COMPLETED|Overall Study||6||
48495777|NCT05533411|101547933|FG001|COMPLETED|Overall Study||10||
48057589|NCT05182125|100463443|FG003|STARTED|Overall Study||10|\[1\]Enrolled|
48057590|NCT05182125|100463444|FG004|STARTED|Overall Study||10|\[1\]Enrolled|
48057591|NCT05182125|100463445|FG005|STARTED|Overall Study||2|\[1\]Enrolled|
48057592|NCT05182125|100463440|FG000|COMPLETED|Overall Study||0|Term form with reason = scheduled exit visit|
48057593|NCT05182125|100463441|FG001|COMPLETED|Overall Study||0|Term form with reason = scheduled exit visit|
48057594|NCT05182125|100463442|FG002|COMPLETED|Overall Study||0|Term form with reason = scheduled exit visit|
48057595|NCT05182125|100463443|FG003|COMPLETED|Overall Study||0|Term form with reason = scheduled exit visit|
48495778|NCT05533411|101547934|FG002|COMPLETED|Overall Study||10||
48495779|NCT05533411|101547935|FG003|COMPLETED|Overall Study||10||
48057596|NCT05182125|100463444|FG004|COMPLETED|Overall Study||0|Term form with reason = scheduled exit visit|
48057597|NCT05182125|100463445|FG005|COMPLETED|Overall Study||0|Term form with reason = scheduled exit visit|
48495780|NCT05533411|101547932|FG000|NOT COMPLETED|Overall Study||0||
48495781|NCT05533411|101547933|FG001|NOT COMPLETED|Overall Study||0||
48495782|NCT05533411|101547934|FG002|NOT COMPLETED|Overall Study||0||
48495783|NCT05533411|101547935|FG003|NOT COMPLETED|Overall Study||0||
48495784|NCT00391365|101547936|FG000|STARTED|Overall Study||103||
48495785|NCT00391365|101547937|FG001|STARTED|Overall Study||170||
48495786|NCT00391365|101547936|FG000|COMPLETED|Overall Study||78||
48495787|NCT00391365|101547937|FG001|COMPLETED|Overall Study||151||
48495788|NCT00391365|101547936|FG000|NOT COMPLETED|Overall Study||25||
48495789|NCT00391365|101547937|FG001|NOT COMPLETED|Overall Study||19||
48495790|NCT03073798|101547938|FG000|STARTED|Overall Study||12||
48495791|NCT03073798|101547938|FG000|COMPLETED|Overall Study||10||
48495792|NCT03073798|101547938|FG000|NOT COMPLETED|Overall Study||2||
48495793|NCT02028221|101547939|FG000|STARTED|Overall Study||75||
48495794|NCT02028221|101547940|FG001|STARTED|Overall Study||76||
48495795|NCT02028221|101547939|FG000|COMPLETED|Overall Study||62||
48208631|NCT01087762|100837085|FG001|COMPLETED|Open-Label Period (Weeks 48-204)||0||
48208632|NCT01087762|100837086|FG002|COMPLETED|Open-Label Period (Weeks 48-204)||0||
48208633|NCT01087762|100837087|FG003|COMPLETED|Open-Label Period (Weeks 48-204)||99||
48208634|NCT01087762|100837088|FG004|COMPLETED|Open-Label Period (Weeks 48-204)||100||
48208635|NCT01087762|100837084|FG000|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0||
48495796|NCT02028221|101547940|FG001|COMPLETED|Overall Study||56||
48495797|NCT02028221|101547939|FG000|NOT COMPLETED|Overall Study||13||
48495798|NCT02028221|101547940|FG001|NOT COMPLETED|Overall Study||20||
48495799|NCT02640235|101547941|FG000|STARTED|Overall Study||131|Number of Subjects randomized or treated (Intent-to-Treat population).|
48495800|NCT02640235|101547942|FG001|STARTED|Overall Study||129|Number of Subjects randomized or treated (Intent-to-Treat population).|
48495801|NCT02640235|101547941|FG000|COMPLETED|Overall Study||117||
48495802|NCT02640235|101547942|FG001|COMPLETED|Overall Study||115||
48495803|NCT02640235|101547941|FG000|NOT COMPLETED|Overall Study||14||
48495804|NCT02640235|101547942|FG001|NOT COMPLETED|Overall Study||14||
48495805|NCT02313558|101547943|FG000|STARTED|Overall Study||50||
48495806|NCT02313558|101547944|FG001|STARTED|Overall Study||50||
48495807|NCT02313558|101547943|FG000|COMPLETED|Overall Study||44||
48495808|NCT02313558|101547944|FG001|COMPLETED|Overall Study||46||
48495809|NCT02313558|101547943|FG000|NOT COMPLETED|Overall Study||6||
48495810|NCT02313558|101547944|FG001|NOT COMPLETED|Overall Study||4||
48495811|NCT00796562|101547945|FG000|STARTED|Overall Study||96||
48495812|NCT00796562|101547945|FG000|COMPLETED|Overall Study||47||
48495813|NCT00796562|101547945|FG000|NOT COMPLETED|Overall Study||49||
48495814|NCT01165047|101547946|FG000|STARTED|Overall Study||10||
48495815|NCT01165047|101547946|FG000|COMPLETED|Overall Study||10||
48495816|NCT01165047|101547946|FG000|NOT COMPLETED|Overall Study||0||
48495817|NCT00363077|101547947|FG000|STARTED|Overall Study||75||
48495818|NCT00363077|101547948|FG001|STARTED|Overall Study||75||
48495819|NCT00363077|101547947|FG000|COMPLETED|Overall Study||75||
48495820|NCT00363077|101547948|FG001|COMPLETED|Overall Study||75||
48495821|NCT00363077|101547947|FG000|NOT COMPLETED|Overall Study||0||
48495822|NCT00363077|101547948|FG001|NOT COMPLETED|Overall Study||0||
48495823|NCT03196284|101547949|FG000|STARTED|Main Part||17||
48495824|NCT03196284|101547950|FG001|STARTED|Main Part||9||
48495825|NCT03196284|101547951|FG002|STARTED|Main Part||0||
48495826|NCT03196284|101547949|FG000|Concizumab 0.15 mg/kg|Main Part||15|The last dose level the participants received in main part of the trial.|
48495827|NCT03196284|101547950|FG001|Concizumab 0.15 mg/kg|Main Part||0|The last dose level the participants received in main part of the trial.|
48495828|NCT03196284|101547951|FG002|Concizumab 0.15 mg/kg|Main Part||0|The last dose level the participants received in main part of the trial.|
48495829|NCT03196284|101547949|FG000|Concizumab 0.20 mg/kg|Main Part||2|The last dose level the participants received in main part of the trial.|
48495830|NCT03196284|101547950|FG001|Concizumab 0.20 mg/kg|Main Part||0|The last dose level the participants received in main part of the trial.|
48495831|NCT03196284|101547951|FG002|Concizumab 0.20 mg/kg|Main Part||0|The last dose level the participants received in main part of the trial.|
48495832|NCT03196284|101547949|FG000|Concizumab 0.25 mg/kg|Main Part||0|The last dose level the participants received in main part of the trial.|
48495833|NCT03196284|101547950|FG001|Concizumab 0.25 mg/kg|Main Part||0|The last dose level the participants received in main part of the trial.|
48495834|NCT03196284|101547951|FG002|Concizumab 0.25 mg/kg|Main Part||0|The last dose level the participants received in main part of the trial.|
48495835|NCT03196284|101547949|FG000|COMPLETED|Main Part||17||
48495836|NCT03196284|101547950|FG001|COMPLETED|Main Part||8||
48495837|NCT03196284|101547951|FG002|COMPLETED|Main Part||0||
48495838|NCT03196284|101547949|FG000|NOT COMPLETED|Main Part||0||
48495839|NCT03196284|101547950|FG001|NOT COMPLETED|Main Part||1||
48495840|NCT03196284|101547951|FG002|NOT COMPLETED|Main Part||0||
48495841|NCT03196284|101547949|FG000|STARTED|Extension Part||0||
48495842|NCT03196284|101547950|FG001|STARTED|Extension Part||0||
48495843|NCT03196284|101547951|FG002|STARTED|Extension Part||25||
48495844|NCT03196284|101547949|FG000|Concizumab 0.15 mg/kg|Extension Part||0|The last dose level the participants received in extension part of the trial.|
48495845|NCT03196284|101547950|FG001|Concizumab 0.15 mg/kg|Extension Part||0|The last dose level the participants received in extension part of the trial.|
48495846|NCT03196284|101547951|FG002|Concizumab 0.15 mg/kg|Extension Part||12|The last dose level the participants received in extension part of the trial.|
48495847|NCT03196284|101547949|FG000|Concizumab 0.20 mg/kg|Extension Part||0|The last dose level the participants received in extension part of the trial.|
48495848|NCT03196284|101547950|FG001|Concizumab 0.20 mg/kg|Extension Part||0|The last dose level the participants received in extension part of the trial.|
48495849|NCT03196284|101547951|FG002|Concizumab 0.20 mg/kg|Extension Part||9|The last dose level the participants received in extension part of the trial.|
48057598|NCT05182125|100463440|FG000|NOT COMPLETED|Overall Study||5||
48057599|NCT05182125|100463441|FG001|NOT COMPLETED|Overall Study||5||
48057600|NCT05182125|100463442|FG002|NOT COMPLETED|Overall Study||2||
48057601|NCT05182125|100463443|FG003|NOT COMPLETED|Overall Study||10||
48057602|NCT05182125|100463444|FG004|NOT COMPLETED|Overall Study||10||
48057603|NCT05182125|100463445|FG005|NOT COMPLETED|Overall Study||2||
48057604|NCT05298306|100463446|FG000|STARTED|Overall Study||2||
48057605|NCT05298306|100463447|FG001|STARTED|Overall Study||2||
48057606|NCT05298306|100463448|FG002|STARTED|Overall Study||2||
48057607|NCT05298306|100463449|FG003|STARTED|Overall Study||3||
48057608|NCT05298306|100463450|FG004|STARTED|Overall Study||8||
48057609|NCT05298306|100463451|FG005|STARTED|Overall Study||9||
48057610|NCT05298306|100463446|FG000|COMPLETED|Overall Study||2||
48057611|NCT05298306|100463447|FG001|COMPLETED|Overall Study||2||
48057612|NCT05298306|100463448|FG002|COMPLETED|Overall Study||2||
48057613|NCT05298306|100463449|FG003|COMPLETED|Overall Study||2||
48057614|NCT05298306|100463450|FG004|COMPLETED|Overall Study||8||
48057615|NCT05298306|100463451|FG005|COMPLETED|Overall Study||9||
48057616|NCT05298306|100463446|FG000|NOT COMPLETED|Overall Study||0||
48057617|NCT05298306|100463447|FG001|NOT COMPLETED|Overall Study||0||
48057618|NCT05298306|100463448|FG002|NOT COMPLETED|Overall Study||0||
48057619|NCT05298306|100463449|FG003|NOT COMPLETED|Overall Study||1||
48057620|NCT05298306|100463450|FG004|NOT COMPLETED|Overall Study||0||
48057621|NCT05298306|100463451|FG005|NOT COMPLETED|Overall Study||0||
48057622|NCT05959200|100463452|FG000|STARTED|First Wear Period (Approx. 14 Days)||48||96
48057623|NCT05959200|100463453|FG001|STARTED|First Wear Period (Approx. 14 Days)||44||88
48057624|NCT05959200|100463452|FG000|COMPLETED|First Wear Period (Approx. 14 Days)||48||96
48057625|NCT05959200|100463453|FG001|COMPLETED|First Wear Period (Approx. 14 Days)||44||88
48057626|NCT05959200|100463452|FG000|NOT COMPLETED|First Wear Period (Approx. 14 Days)||0||0
48057627|NCT05959200|100463453|FG001|NOT COMPLETED|First Wear Period (Approx. 14 Days)||0||0
48057628|NCT05959200|100463452|FG000|STARTED|Second Wear Period (Approx. 14 Days)||48||96
48057629|NCT05959200|100463453|FG001|STARTED|Second Wear Period (Approx. 14 Days)||44||88
48057630|NCT05959200|100463452|FG000|COMPLETED|Second Wear Period (Approx. 14 Days)||48||96
48057631|NCT05959200|100463453|FG001|COMPLETED|Second Wear Period (Approx. 14 Days)||44||88
48057632|NCT05959200|100463452|FG000|NOT COMPLETED|Second Wear Period (Approx. 14 Days)||0||0
48057633|NCT05959200|100463453|FG001|NOT COMPLETED|Second Wear Period (Approx. 14 Days)||0||0
48057634|NCT05147428|100463454|FG000|STARTED|Overall Study||4814|N.B., Providers were NOT enrolled and were NOT study subjects.|
48057635|NCT05147428|100463455|FG001|STARTED|Overall Study||4814|N.B., Providers were NOT enrolled and were NOT study subjects.|
48057636|NCT05147428|100463456|FG002|STARTED|Overall Study||4814|N.B., Providers were NOT enrolled and were NOT study subjects.|
48495850|NCT03196284|101547949|FG000|Concizumab 0.25 mg/kg|Extension Part||0|The last dose level the participants received in extension part of the trial.|
48495851|NCT03196284|101547950|FG001|Concizumab 0.25 mg/kg|Extension Part||0|The last dose level the participants received in extension part of the trial.|
48495852|NCT03196284|101547951|FG002|Concizumab 0.25 mg/kg|Extension Part||4|The last dose level the participants received in extension part of the trial.|
48495853|NCT03196284|101547949|FG000|COMPLETED|Extension Part||0||
48495854|NCT03196284|101547950|FG001|COMPLETED|Extension Part||0||
48057637|NCT05147428|100463454|FG000|COMPLETED|Overall Study||4286|N.B., Providers were NOT enrolled and were NOT study subjects.|
48057638|NCT05147428|100463455|FG001|COMPLETED|Overall Study||4230|N.B., Providers were NOT enrolled and were NOT study subjects.|
48057639|NCT05147428|100463456|FG002|COMPLETED|Overall Study||4271|N.B., Providers were NOT enrolled and were NOT study subjects.|
48057640|NCT05147428|100463454|FG000|NOT COMPLETED|Overall Study||528||
48057641|NCT05147428|100463455|FG001|NOT COMPLETED|Overall Study||584||
48057642|NCT05147428|100463456|FG002|NOT COMPLETED|Overall Study||543||
48057643|NCT03730012|100463457|FG000|STARTED|Overall Study||3||
48057644|NCT03730012|100463458|FG001|STARTED|Overall Study||8||
48057645|NCT03730012|100463457|FG000|COMPLETED|Overall Study||0||
48057646|NCT03730012|100463458|FG001|COMPLETED|Overall Study||0||
48057647|NCT03730012|100463457|FG000|NOT COMPLETED|Overall Study||3||
48057648|NCT03730012|100463458|FG001|NOT COMPLETED|Overall Study||8||
48057649|NCT02484690|100463459|FG000|STARTED|Overall Study||68||
48057650|NCT02484690|100463460|FG001|STARTED|Overall Study||46||
48057651|NCT02484690|100463461|FG002|STARTED|Overall Study||39||
48057652|NCT02484690|100463462|FG003|STARTED|Overall Study||46||
48057653|NCT02484690|100463463|FG004|STARTED|Overall Study||64||
48057654|NCT02484690|100463459|FG000|Received at Least One Dose of Study Drug|Overall Study||67|Safety Population|
48057655|NCT02484690|100463460|FG001|Received at Least One Dose of Study Drug|Overall Study||46|Safety Population|
48057656|NCT02484690|100463461|FG002|Received at Least One Dose of Study Drug|Overall Study||39|Safety Population|
48057657|NCT02484690|100463462|FG003|Received at Least One Dose of Study Drug|Overall Study||46|Safety Population|
48057658|NCT02484690|100463463|FG004|Received at Least One Dose of Study Drug|Overall Study||64|Safety Population|
48057659|NCT02484690|100463459|FG000|COMPLETED|Overall Study||64||
48057660|NCT02484690|100463460|FG001|COMPLETED|Overall Study||40||
48057661|NCT02484690|100463461|FG002|COMPLETED|Overall Study||36||
48057662|NCT02484690|100463462|FG003|COMPLETED|Overall Study||44||
48057663|NCT02484690|100463463|FG004|COMPLETED|Overall Study||58||
48057664|NCT02484690|100463459|FG000|NOT COMPLETED|Overall Study||4||
48057665|NCT02484690|100463460|FG001|NOT COMPLETED|Overall Study||6||
48057666|NCT02484690|100463461|FG002|NOT COMPLETED|Overall Study||3||
48057667|NCT02484690|100463462|FG003|NOT COMPLETED|Overall Study||2||
48057668|NCT02484690|100463463|FG004|NOT COMPLETED|Overall Study||6||
48057669|NCT03274687|100463464|FG000|STARTED|Overall Study||152||
48057670|NCT03274687|100463465|FG001|STARTED|Overall Study||144||
48057671|NCT03274687|100463464|FG000|Eligible|Overall Study||151||
48057672|NCT03274687|100463465|FG001|Eligible|Overall Study||143||
48057673|NCT03274687|100463464|FG000|Eligible With Adverse Event Data|Overall Study||148||
48057674|NCT03274687|100463465|FG001|Eligible With Adverse Event Data|Overall Study||141||
48057675|NCT03274687|100463464|FG000|COMPLETED|Overall Study||151|Participants contributing data to results are considered to have completed the study.|
48057676|NCT03274687|100463465|FG001|COMPLETED|Overall Study||143|Participants contributing data to results are considered to have completed the study.|
48057677|NCT03274687|100463464|FG000|NOT COMPLETED|Overall Study||1||
48057678|NCT03274687|100463465|FG001|NOT COMPLETED|Overall Study||1||
48057679|NCT02891161|100463466|FG000|STARTED|Study Treatment||6||
48057680|NCT02891161|100463467|FG001|STARTED|Study Treatment||20||
48057681|NCT02891161|100463466|FG000|COMPLETED|Study Treatment||2||
48057682|NCT02891161|100463467|FG001|COMPLETED|Study Treatment||7||
48057683|NCT02891161|100463466|FG000|NOT COMPLETED|Study Treatment||4||
48057684|NCT02891161|100463467|FG001|NOT COMPLETED|Study Treatment||13||
48057685|NCT02891161|100463466|FG000|STARTED|Follow up||6|Treatment and Follow up both are at different time period. Therefore, the number of subjects to start follow up is not equal to the number of subjects who have completed treatment.|
48057686|NCT02891161|100463467|FG001|STARTED|Follow up||20|Treatment and Follow up both are at different time period. Therefore, the number of subjects to start follow up is not equal to the number of subjects who have completed treatment.|
48057687|NCT02891161|100463466|FG000|COMPLETED|Follow up||2||
48057688|NCT02891161|100463467|FG001|COMPLETED|Follow up||3||
48057689|NCT02891161|100463466|FG000|NOT COMPLETED|Follow up||4||
48057690|NCT02891161|100463467|FG001|NOT COMPLETED|Follow up||17||
48057691|NCT04078178|100463468|FG000|STARTED|Lead-In Period (4-Weeks)||23||
48057692|NCT04078178|100463469|FG001|STARTED|Lead-In Period (4-Weeks)||23||
48057693|NCT04078178|100463468|FG000|COMPLETED|Lead-In Period (4-Weeks)||22||
48057694|NCT04078178|100463469|FG001|COMPLETED|Lead-In Period (4-Weeks)||20||
48057695|NCT04078178|100463468|FG000|NOT COMPLETED|Lead-In Period (4-Weeks)||1||
48057696|NCT04078178|100463469|FG001|NOT COMPLETED|Lead-In Period (4-Weeks)||3||
48057697|NCT04078178|100463468|FG000|STARTED|Baseline/Initial Treatment (8 Weeks)||22||
48057698|NCT04078178|100463469|FG001|STARTED|Baseline/Initial Treatment (8 Weeks)||20||
48057699|NCT04078178|100463468|FG000|COMPLETED|Baseline/Initial Treatment (8 Weeks)||20||
48057700|NCT04078178|100463469|FG001|COMPLETED|Baseline/Initial Treatment (8 Weeks)||18||
48057701|NCT04078178|100463468|FG000|NOT COMPLETED|Baseline/Initial Treatment (8 Weeks)||2||
48057702|NCT04078178|100463469|FG001|NOT COMPLETED|Baseline/Initial Treatment (8 Weeks)||2||
48057703|NCT04078178|100463468|FG000|STARTED|Crossover Treatment (8 Weeks)||20||
48057704|NCT04078178|100463469|FG001|STARTED|Crossover Treatment (8 Weeks)||18||
48057705|NCT04078178|100463468|FG000|COMPLETED|Crossover Treatment (8 Weeks)||20||
48057706|NCT04078178|100463469|FG001|COMPLETED|Crossover Treatment (8 Weeks)||17||
48057707|NCT04078178|100463468|FG000|NOT COMPLETED|Crossover Treatment (8 Weeks)||0||
48057708|NCT04078178|100463469|FG001|NOT COMPLETED|Crossover Treatment (8 Weeks)||1||
48057709|NCT03282565|100463470|FG000|STARTED|Overall Study||10||
48057710|NCT03282565|100463471|FG001|STARTED|Overall Study||10||
48057711|NCT03282565|100463472|FG002|STARTED|Overall Study||10||
48057712|NCT03282565|100463470|FG000|COMPLETED|Overall Study||10||
48057713|NCT03282565|100463471|FG001|COMPLETED|Overall Study||8||
48057714|NCT03282565|100463472|FG002|COMPLETED|Overall Study||8||
48057715|NCT03282565|100463470|FG000|NOT COMPLETED|Overall Study||0||
48057716|NCT03282565|100463471|FG001|NOT COMPLETED|Overall Study||2||
48057717|NCT03282565|100463472|FG002|NOT COMPLETED|Overall Study||2||
48057718|NCT02213926|100463473|FG000|STARTED|Overall Study||124||
48057719|NCT02213926|100463473|FG000|COMPLETED|Overall Study||0||
48057720|NCT02213926|100463473|FG000|NOT COMPLETED|Overall Study||124||
48057721|NCT03594435|100463474|FG000|STARTED|Overall Study||53||
48057722|NCT03594435|100463475|FG001|STARTED|Overall Study||49||
48057723|NCT03594435|100463474|FG000|COMPLETED|Overall Study||48||
48057724|NCT03594435|100463475|FG001|COMPLETED|Overall Study||41||
48057725|NCT03594435|100463474|FG000|NOT COMPLETED|Overall Study||5||
48208636|NCT01087762|100837085|FG001|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0||
48208637|NCT01087762|100837086|FG002|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0||
48495855|NCT03196284|101547951|FG002|COMPLETED|Extension Part||22||
48495856|NCT03196284|101547949|FG000|NOT COMPLETED|Extension Part||0||
48057726|NCT03594435|100463475|FG001|NOT COMPLETED|Overall Study||8||
48057727|NCT03471065|100463476|FG000|STARTED|Overall Study||100||
48057728|NCT03471065|100463476|FG000|COMPLETED|Overall Study||100||
48057729|NCT03471065|100463476|FG000|NOT COMPLETED|Overall Study||0||
48057730|NCT00606944|100463477|FG000|STARTED|Overall Study||98||
48057731|NCT00606944|100463478|FG001|STARTED|Overall Study||100||
48057732|NCT00606944|100463477|FG000|COMPLETED|Overall Study||98||
48057733|NCT00606944|100463478|FG001|COMPLETED|Overall Study||100||
48057734|NCT00606944|100463477|FG000|NOT COMPLETED|Overall Study||0||
48057735|NCT00606944|100463478|FG001|NOT COMPLETED|Overall Study||0||
48057736|NCT03436810|100463479|FG000|STARTED|Overall Study||20||
48057737|NCT03436810|100463480|FG001|STARTED|Overall Study||20||
48057738|NCT03436810|100463479|FG000|COMPLETED|Overall Study||20||
48057739|NCT03436810|100463480|FG001|COMPLETED|Overall Study||20||
48057740|NCT03436810|100463479|FG000|NOT COMPLETED|Overall Study||0||
48057741|NCT03436810|100463480|FG001|NOT COMPLETED|Overall Study||0||
48057742|NCT03956056|100463481|FG000|STARTED|Overall Study||12||
48057743|NCT03956056|100463481|FG000|COMPLETED|Overall Study||9||
48057744|NCT03956056|100463481|FG000|NOT COMPLETED|Overall Study||3||
48057745|NCT02545075|100463482|FG000|STARTED|Randomization||122|Partipants who were randomized|
48057746|NCT02545075|100463483|FG001|STARTED|Randomization||60|Partipants who were randomized|
48057747|NCT02545075|100463482|FG000|COMPLETED|Randomization||122|participants who were treated|
48057748|NCT02545075|100463483|FG001|COMPLETED|Randomization||53|participants who were treated|
48057749|NCT02545075|100463482|FG000|NOT COMPLETED|Randomization||0||
48057750|NCT02545075|100463483|FG001|NOT COMPLETED|Randomization||7||
48057751|NCT02545075|100463482|FG000|STARTED|Treatment||122|Participants who were treated|
48057752|NCT02545075|100463483|FG001|STARTED|Treatment||53|Participants who were treated|
48057753|NCT02545075|100463482|FG000|COMPLETED|Treatment||0|Participants who were continuing treatment period|
48057754|NCT02545075|100463483|FG001|COMPLETED|Treatment||0|Participants who were continuing treatment period|
48057755|NCT02545075|100463482|FG000|NOT COMPLETED|Treatment||122||
48057756|NCT02545075|100463483|FG001|NOT COMPLETED|Treatment||53||
48057757|NCT00573248|100463484|FG000|STARTED|Overall Study||40||
48057758|NCT00573248|100463485|FG001|STARTED|Overall Study||38||
48057759|NCT00573248|100463484|FG000|Nicotine Patches and Placebo Patches|Overall Study||25||
48057760|NCT00573248|100463485|FG001|Nicotine Patches and Placebo Patches|Overall Study||27||
48057761|NCT00573248|100463484|FG000|COMPLETED|Overall Study||25||
48057762|NCT00573248|100463485|FG001|COMPLETED|Overall Study||27||
48057763|NCT00573248|100463484|FG000|NOT COMPLETED|Overall Study||15||
48057764|NCT00573248|100463485|FG001|NOT COMPLETED|Overall Study||11||
48057765|NCT02808871|100463486|FG000|STARTED|Overall Study||63||
48057766|NCT02808871|100463487|FG001|STARTED|Overall Study||60||
48057767|NCT02808871|100463486|FG000|COMPLETED|Overall Study||52||
48057768|NCT02808871|100463487|FG001|COMPLETED|Overall Study||51||
48057769|NCT02808871|100463486|FG000|NOT COMPLETED|Overall Study||11||
48057770|NCT02808871|100463487|FG001|NOT COMPLETED|Overall Study||9||
48057771|NCT01697358|100463488|FG000|STARTED|Period I: Randomization to 6 Months||110||
48057772|NCT01697358|100463489|FG001|STARTED|Period I: Randomization to 6 Months||108||
48057773|NCT01697358|100463488|FG000|COMPLETED|Period I: Randomization to 6 Months||97||
48495857|NCT03196284|101547950|FG001|NOT COMPLETED|Extension Part||0||
48057774|NCT01697358|100463489|FG001|COMPLETED|Period I: Randomization to 6 Months||107||
48057775|NCT01697358|100463488|FG000|NOT COMPLETED|Period I: Randomization to 6 Months||13||
48057776|NCT01697358|100463489|FG001|NOT COMPLETED|Period I: Randomization to 6 Months||1||
48057777|NCT01697358|100463488|FG000|STARTED|Period II: 6-24M Long-term Follow-up||97||
48057778|NCT01697358|100463489|FG001|STARTED|Period II: 6-24M Long-term Follow-up||107||
48057779|NCT01697358|100463488|FG000|COMPLETED|Period II: 6-24M Long-term Follow-up||48||
48057780|NCT01697358|100463489|FG001|COMPLETED|Period II: 6-24M Long-term Follow-up||52||
48057781|NCT01697358|100463488|FG000|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||49||
48057782|NCT01697358|100463489|FG001|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||55||
48057783|NCT04157621|100463490|FG000|STARTED|Overall Study||17||
48057784|NCT04157621|100463491|FG001|STARTED|Overall Study||16||
48057785|NCT04157621|100463490|FG000|COMPLETED|Overall Study||17||
48057786|NCT04157621|100463491|FG001|COMPLETED|Overall Study||16||
48057787|NCT04157621|100463490|FG000|NOT COMPLETED|Overall Study||0||
48057788|NCT04157621|100463491|FG001|NOT COMPLETED|Overall Study||0||
48057789|NCT01601431|100463492|FG000|STARTED|Overall Study||223||
48057790|NCT01601431|100463493|FG001|STARTED|Overall Study||217||
48057791|NCT01601431|100463492|FG000|COMPLETED|Overall Study||211||
48057792|NCT01601431|100463493|FG001|COMPLETED|Overall Study||214||
48057793|NCT01601431|100463492|FG000|NOT COMPLETED|Overall Study||12||
48057794|NCT01601431|100463493|FG001|NOT COMPLETED|Overall Study||3||
48057795|NCT01865084|100463494|FG000|STARTED|Double Blind Period (DB)||116||
48057796|NCT01865084|100463495|FG001|STARTED|Double Blind Period (DB)||102||
48057797|NCT01865084|100463496|FG002|STARTED|Double Blind Period (DB)||113||
48057798|NCT01865084|100463494|FG000|Received at Least One Dose of Study Drug|Double Blind Period (DB)||116||
48057799|NCT01865084|100463495|FG001|Received at Least One Dose of Study Drug|Double Blind Period (DB)||102||
48057800|NCT01865084|100463496|FG002|Received at Least One Dose of Study Drug|Double Blind Period (DB)||112||
48057801|NCT01865084|100463494|FG000|COMPLETED|Double Blind Period (DB)||111||
48057802|NCT01865084|100463495|FG001|COMPLETED|Double Blind Period (DB)||98||
48057803|NCT01865084|100463496|FG002|COMPLETED|Double Blind Period (DB)||107||
48057804|NCT01865084|100463494|FG000|NOT COMPLETED|Double Blind Period (DB)||5||
48057805|NCT01865084|100463495|FG001|NOT COMPLETED|Double Blind Period (DB)||4||
48057806|NCT01865084|100463496|FG002|NOT COMPLETED|Double Blind Period (DB)||6||
48057807|NCT01865084|100463494|FG000|STARTED|Open Label Extension (OLE) Period||0||
48057808|NCT01865084|100463495|FG001|STARTED|Open Label Extension (OLE) Period||150||
48057809|NCT01865084|100463496|FG002|STARTED|Open Label Extension (OLE) Period||165||
48057810|NCT01865084|100463494|FG000|COMPLETED|Open Label Extension (OLE) Period||0||
48057811|NCT01865084|100463495|FG001|COMPLETED|Open Label Extension (OLE) Period||139||
48057812|NCT01865084|100463496|FG002|COMPLETED|Open Label Extension (OLE) Period||158||
48057813|NCT01865084|100463494|FG000|NOT COMPLETED|Open Label Extension (OLE) Period||0||
48057814|NCT01865084|100463495|FG001|NOT COMPLETED|Open Label Extension (OLE) Period||11||
48057815|NCT01865084|100463496|FG002|NOT COMPLETED|Open Label Extension (OLE) Period||7||
48057816|NCT00697073|100463497|FG000|STARTED|Overall Study||68||
48057817|NCT00697073|100463497|FG000|COMPLETED|Overall Study||59||
48057818|NCT00697073|100463497|FG000|NOT COMPLETED|Overall Study||9||
48057819|NCT00642473|100463498|FG000|STARTED|Overall Study||18||
48057820|NCT00642473|100463499|FG001|STARTED|Overall Study||16||
48057821|NCT00642473|100463498|FG000|COMPLETED|Overall Study||14||
48057822|NCT00642473|100463499|FG001|COMPLETED|Overall Study||5||
48057823|NCT00642473|100463498|FG000|NOT COMPLETED|Overall Study||4||
48057824|NCT00642473|100463499|FG001|NOT COMPLETED|Overall Study||11||
48057825|NCT01981759|100463500|FG000|STARTED|Overall Study||28|Screened|
48057826|NCT01981759|100463501|FG001|STARTED|Overall Study||30|Screened|
48057827|NCT01981759|100463500|FG000|Baseline (Week 1)|Overall Study||28||
48057828|NCT01981759|100463501|FG001|Baseline (Week 1)|Overall Study||30||
48057829|NCT01981759|100463500|FG000|Randomization (Week 3)|Overall Study||28||
48057830|NCT01981759|100463501|FG001|Randomization (Week 3)|Overall Study||30||
48057831|NCT01981759|100463500|FG000|Completed Week 12|Overall Study||22||
48057832|NCT01981759|100463501|FG001|Completed Week 12|Overall Study||22||
48057833|NCT01981759|100463500|FG000|COMPLETED|Overall Study||21|Week 36/All Follow-Up|
48057834|NCT01981759|100463501|FG001|COMPLETED|Overall Study||19|Week 36/All Follow-Up|
48057835|NCT01981759|100463500|FG000|NOT COMPLETED|Overall Study||7||
48057836|NCT01981759|100463501|FG001|NOT COMPLETED|Overall Study||11||
48057837|NCT05654441|100463502|FG000|STARTED|Overall Study||52||
48057838|NCT05654441|100463503|FG001|STARTED|Overall Study||52||
48057839|NCT05654441|100463502|FG000|COMPLETED|Overall Study||52||
48057840|NCT05654441|100463503|FG001|COMPLETED|Overall Study||52||
48057841|NCT05654441|100463502|FG000|NOT COMPLETED|Overall Study||0||
48057842|NCT05654441|100463503|FG001|NOT COMPLETED|Overall Study||0||
48057843|NCT04493333|100463504|FG000|STARTED|Overall Study||5||
48057844|NCT04493333|100463505|FG001|STARTED|Overall Study||3||
48057845|NCT04493333|100463504|FG000|COMPLETED|Overall Study||2||
48057846|NCT04493333|100463505|FG001|COMPLETED|Overall Study||0||
48057847|NCT04493333|100463504|FG000|NOT COMPLETED|Overall Study||3||
48057848|NCT04493333|100463505|FG001|NOT COMPLETED|Overall Study||3||
48057849|NCT00054717|100463506|FG000|STARTED|Overall Study||313||
48057850|NCT00054717|100463507|FG001|STARTED|Overall Study||317||
48057851|NCT00054717|100463506|FG000|COMPLETED|Overall Study||51||
48057852|NCT00054717|100463507|FG001|COMPLETED|Overall Study||18||
48057853|NCT00054717|100463506|FG000|NOT COMPLETED|Overall Study||262||
48057854|NCT00054717|100463507|FG001|NOT COMPLETED|Overall Study||299||
48057855|NCT03029702|100463508|FG000|STARTED|Overall Study||27||
48057856|NCT03029702|100463509|FG001|STARTED|Overall Study||27||
48057857|NCT03029702|100463508|FG000|COMPLETED|Overall Study||27||
48057858|NCT03029702|100463509|FG001|COMPLETED|Overall Study||27||
48057859|NCT03029702|100463508|FG000|NOT COMPLETED|Overall Study||0||
48057860|NCT03029702|100463509|FG001|NOT COMPLETED|Overall Study||0||
48057861|NCT00764491|100463510|FG000|STARTED|Overall Study||123||
48057862|NCT00764491|100463511|FG001|STARTED|Overall Study||33||
48057863|NCT00764491|100463510|FG000|COMPLETED|Overall Study||88||
48057864|NCT00764491|100463511|FG001|COMPLETED|Overall Study||16||
48057865|NCT00764491|100463510|FG000|NOT COMPLETED|Overall Study||35||
48057866|NCT00764491|100463511|FG001|NOT COMPLETED|Overall Study||17||
48057867|NCT02057393|100463512|FG000|STARTED|Overall Study||89||
48057868|NCT02057393|100463512|FG000|COMPLETED|Overall Study||87||
48057869|NCT02057393|100463512|FG000|NOT COMPLETED|Overall Study||2||
48057870|NCT03063203|100463513|FG000|STARTED|Overall Study||17||
48057871|NCT03063203|100463513|FG000|COMPLETED|Overall Study||3||
48057872|NCT03063203|100463513|FG000|NOT COMPLETED|Overall Study||14||
48057873|NCT03538431|100463514|FG000|STARTED|Overall Study||13||
48057874|NCT03538431|100463515|FG001|STARTED|Overall Study||13||
48057875|NCT03538431|100463514|FG000|COMPLETED|Overall Study||12||
48057876|NCT03538431|100463515|FG001|COMPLETED|Overall Study||12||
48057877|NCT03538431|100463514|FG000|NOT COMPLETED|Overall Study||1||
48057878|NCT03538431|100463515|FG001|NOT COMPLETED|Overall Study||1||
48057879|NCT00884377|100463516|FG000|STARTED|Overall Study||28||
48057880|NCT00884377|100463517|FG001|STARTED|Overall Study||28||
48057881|NCT00884377|100463516|FG000|COMPLETED|Overall Study||26||
48057882|NCT00884377|100463517|FG001|COMPLETED|Overall Study||27||
48057883|NCT00884377|100463516|FG000|NOT COMPLETED|Overall Study||2||
48057884|NCT00884377|100463517|FG001|NOT COMPLETED|Overall Study||1||
48057885|NCT01550471|100463518|FG000|STARTED|Run-In Period (3 Weeks)||3||
48057886|NCT01550471|100463519|FG001|STARTED|Run-In Period (3 Weeks)||4||
48057887|NCT01550471|100463520|FG002|STARTED|Run-In Period (3 Weeks)||3||
48057888|NCT01550471|100463521|FG003|STARTED|Run-In Period (3 Weeks)||4||
48057889|NCT01550471|100463522|FG004|STARTED|Run-In Period (3 Weeks)||4||
48057890|NCT01550471|100463523|FG005|STARTED|Run-In Period (3 Weeks)||4||
48057891|NCT01550471|100463518|FG000|COMPLETED|Run-In Period (3 Weeks)||3||
48057892|NCT01550471|100463519|FG001|COMPLETED|Run-In Period (3 Weeks)||4||
48057893|NCT01550471|100463520|FG002|COMPLETED|Run-In Period (3 Weeks)||3||
48057894|NCT01550471|100463521|FG003|COMPLETED|Run-In Period (3 Weeks)||4||
48057895|NCT01550471|100463522|FG004|COMPLETED|Run-In Period (3 Weeks)||4||
48057896|NCT01550471|100463523|FG005|COMPLETED|Run-In Period (3 Weeks)||4||
48057897|NCT01550471|100463518|FG000|NOT COMPLETED|Run-In Period (3 Weeks)||0||
48057898|NCT01550471|100463519|FG001|NOT COMPLETED|Run-In Period (3 Weeks)||0||
48057899|NCT01550471|100463520|FG002|NOT COMPLETED|Run-In Period (3 Weeks)||0||
48057900|NCT01550471|100463521|FG003|NOT COMPLETED|Run-In Period (3 Weeks)||0||
48057901|NCT01550471|100463522|FG004|NOT COMPLETED|Run-In Period (3 Weeks)||0||
48057902|NCT01550471|100463523|FG005|NOT COMPLETED|Run-In Period (3 Weeks)||0||
48057903|NCT01550471|100463518|FG000|STARTED|First Treatment Period (3 Weeks)||3||
48057904|NCT01550471|100463519|FG001|STARTED|First Treatment Period (3 Weeks)||4||
48057905|NCT01550471|100463520|FG002|STARTED|First Treatment Period (3 Weeks)||3||
48057906|NCT01550471|100463521|FG003|STARTED|First Treatment Period (3 Weeks)||4||
48057907|NCT01550471|100463522|FG004|STARTED|First Treatment Period (3 Weeks)||4||
48057908|NCT01550471|100463523|FG005|STARTED|First Treatment Period (3 Weeks)||4||
48057909|NCT01550471|100463518|FG000|COMPLETED|First Treatment Period (3 Weeks)||3||
48057910|NCT01550471|100463519|FG001|COMPLETED|First Treatment Period (3 Weeks)||4||
48057911|NCT01550471|100463520|FG002|COMPLETED|First Treatment Period (3 Weeks)||3||
48057912|NCT01550471|100463521|FG003|COMPLETED|First Treatment Period (3 Weeks)||4||
48057913|NCT01550471|100463522|FG004|COMPLETED|First Treatment Period (3 Weeks)||4||
48057914|NCT01550471|100463523|FG005|COMPLETED|First Treatment Period (3 Weeks)||4||
48057915|NCT01550471|100463518|FG000|NOT COMPLETED|First Treatment Period (3 Weeks)||0||
48057916|NCT01550471|100463519|FG001|NOT COMPLETED|First Treatment Period (3 Weeks)||0||
48057917|NCT01550471|100463520|FG002|NOT COMPLETED|First Treatment Period (3 Weeks)||0||
48057918|NCT01550471|100463521|FG003|NOT COMPLETED|First Treatment Period (3 Weeks)||0||
48057919|NCT01550471|100463522|FG004|NOT COMPLETED|First Treatment Period (3 Weeks)||0||
48057920|NCT01550471|100463523|FG005|NOT COMPLETED|First Treatment Period (3 Weeks)||0||
48057921|NCT01550471|100463518|FG000|STARTED|First Wash Out Period (3 Weeks)||3||
48057922|NCT01550471|100463519|FG001|STARTED|First Wash Out Period (3 Weeks)||4||
48057923|NCT01550471|100463520|FG002|STARTED|First Wash Out Period (3 Weeks)||3||
48057924|NCT01550471|100463521|FG003|STARTED|First Wash Out Period (3 Weeks)||4||
48057925|NCT01550471|100463522|FG004|STARTED|First Wash Out Period (3 Weeks)||4||
48057926|NCT01550471|100463523|FG005|STARTED|First Wash Out Period (3 Weeks)||4||
48057927|NCT01550471|100463518|FG000|COMPLETED|First Wash Out Period (3 Weeks)||3||
48057928|NCT01550471|100463519|FG001|COMPLETED|First Wash Out Period (3 Weeks)||4||
48057929|NCT01550471|100463520|FG002|COMPLETED|First Wash Out Period (3 Weeks)||3||
48057930|NCT01550471|100463521|FG003|COMPLETED|First Wash Out Period (3 Weeks)||4||
48057931|NCT01550471|100463522|FG004|COMPLETED|First Wash Out Period (3 Weeks)||4||
48057932|NCT01550471|100463523|FG005|COMPLETED|First Wash Out Period (3 Weeks)||4||
48057933|NCT01550471|100463518|FG000|NOT COMPLETED|First Wash Out Period (3 Weeks)||0||
48057934|NCT01550471|100463519|FG001|NOT COMPLETED|First Wash Out Period (3 Weeks)||0||
48057935|NCT01550471|100463520|FG002|NOT COMPLETED|First Wash Out Period (3 Weeks)||0||
48057936|NCT01550471|100463521|FG003|NOT COMPLETED|First Wash Out Period (3 Weeks)||0||
48057937|NCT01550471|100463522|FG004|NOT COMPLETED|First Wash Out Period (3 Weeks)||0||
48057938|NCT01550471|100463523|FG005|NOT COMPLETED|First Wash Out Period (3 Weeks)||0||
48057939|NCT01550471|100463518|FG000|STARTED|Second Treatment Period (3 Weeks)||3||
48057940|NCT01550471|100463519|FG001|STARTED|Second Treatment Period (3 Weeks)||4||
48057941|NCT01550471|100463520|FG002|STARTED|Second Treatment Period (3 Weeks)||3||
48057942|NCT01550471|100463521|FG003|STARTED|Second Treatment Period (3 Weeks)||4||
48057943|NCT01550471|100463522|FG004|STARTED|Second Treatment Period (3 Weeks)||4||
48057944|NCT01550471|100463523|FG005|STARTED|Second Treatment Period (3 Weeks)||4||
48057945|NCT01550471|100463518|FG000|COMPLETED|Second Treatment Period (3 Weeks)||3||
48057946|NCT01550471|100463519|FG001|COMPLETED|Second Treatment Period (3 Weeks)||4||
48057947|NCT01550471|100463520|FG002|COMPLETED|Second Treatment Period (3 Weeks)||3||
48057948|NCT01550471|100463521|FG003|COMPLETED|Second Treatment Period (3 Weeks)||4||
48057949|NCT01550471|100463522|FG004|COMPLETED|Second Treatment Period (3 Weeks)||4||
48057950|NCT01550471|100463523|FG005|COMPLETED|Second Treatment Period (3 Weeks)||4||
48057951|NCT01550471|100463518|FG000|NOT COMPLETED|Second Treatment Period (3 Weeks)||0||
48057952|NCT01550471|100463519|FG001|NOT COMPLETED|Second Treatment Period (3 Weeks)||0||
48057953|NCT01550471|100463520|FG002|NOT COMPLETED|Second Treatment Period (3 Weeks)||0||
48057954|NCT01550471|100463521|FG003|NOT COMPLETED|Second Treatment Period (3 Weeks)||0||
48057955|NCT01550471|100463522|FG004|NOT COMPLETED|Second Treatment Period (3 Weeks)||0||
48208638|NCT01087762|100837087|FG003|NOT COMPLETED|Open-Label Period (Weeks 48-204)||59||
48208639|NCT01087762|100837088|FG004|NOT COMPLETED|Open-Label Period (Weeks 48-204)||57||
48208640|NCT00529659|100837089|FG000|STARTED|Overall Study||81||
48057956|NCT01550471|100463523|FG005|NOT COMPLETED|Second Treatment Period (3 Weeks)||0||
48057957|NCT01550471|100463518|FG000|STARTED|Second Wash Out Period (3 Weeks)||3||
48057958|NCT01550471|100463519|FG001|STARTED|Second Wash Out Period (3 Weeks)||4||
48057959|NCT01550471|100463520|FG002|STARTED|Second Wash Out Period (3 Weeks)||3||
48057960|NCT01550471|100463521|FG003|STARTED|Second Wash Out Period (3 Weeks)||4||
48057961|NCT01550471|100463522|FG004|STARTED|Second Wash Out Period (3 Weeks)||4||
48208641|NCT00529659|100837090|FG001|STARTED|Overall Study||89||
48208642|NCT00529659|100837089|FG000|COMPLETED|Overall Study||70||
48057962|NCT01550471|100463523|FG005|STARTED|Second Wash Out Period (3 Weeks)||4||
48057963|NCT01550471|100463518|FG000|COMPLETED|Second Wash Out Period (3 Weeks)||3||
48057964|NCT01550471|100463519|FG001|COMPLETED|Second Wash Out Period (3 Weeks)||4||
48057965|NCT01550471|100463520|FG002|COMPLETED|Second Wash Out Period (3 Weeks)||3||
48057966|NCT01550471|100463521|FG003|COMPLETED|Second Wash Out Period (3 Weeks)||4||
48057967|NCT01550471|100463522|FG004|COMPLETED|Second Wash Out Period (3 Weeks)||4||
48057968|NCT01550471|100463523|FG005|COMPLETED|Second Wash Out Period (3 Weeks)||3||
48057969|NCT01550471|100463518|FG000|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0||
48057970|NCT01550471|100463519|FG001|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0||
48057971|NCT01550471|100463520|FG002|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0||
48057972|NCT01550471|100463521|FG003|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0||
48057973|NCT01550471|100463522|FG004|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0||
48057974|NCT01550471|100463523|FG005|NOT COMPLETED|Second Wash Out Period (3 Weeks)||1||
48057975|NCT01550471|100463518|FG000|STARTED|Third Treatment Period (3 Weeks)||3||
48057976|NCT01550471|100463519|FG001|STARTED|Third Treatment Period (3 Weeks)||4||
48057977|NCT01550471|100463520|FG002|STARTED|Third Treatment Period (3 Weeks)||3||
48057978|NCT01550471|100463521|FG003|STARTED|Third Treatment Period (3 Weeks)||4||
48057979|NCT01550471|100463522|FG004|STARTED|Third Treatment Period (3 Weeks)||4||
48057980|NCT01550471|100463523|FG005|STARTED|Third Treatment Period (3 Weeks)||3||
48057981|NCT01550471|100463518|FG000|COMPLETED|Third Treatment Period (3 Weeks)||3||
48057982|NCT01550471|100463519|FG001|COMPLETED|Third Treatment Period (3 Weeks)||4||
48057983|NCT01550471|100463520|FG002|COMPLETED|Third Treatment Period (3 Weeks)||3||
48057984|NCT01550471|100463521|FG003|COMPLETED|Third Treatment Period (3 Weeks)||4||
48057985|NCT01550471|100463522|FG004|COMPLETED|Third Treatment Period (3 Weeks)||4||
48057986|NCT01550471|100463523|FG005|COMPLETED|Third Treatment Period (3 Weeks)||3||
48057987|NCT01550471|100463518|FG000|NOT COMPLETED|Third Treatment Period (3 Weeks)||0||
48057988|NCT01550471|100463519|FG001|NOT COMPLETED|Third Treatment Period (3 Weeks)||0||
48057989|NCT01550471|100463520|FG002|NOT COMPLETED|Third Treatment Period (3 Weeks)||0||
48057990|NCT01550471|100463521|FG003|NOT COMPLETED|Third Treatment Period (3 Weeks)||0||
48057991|NCT01550471|100463522|FG004|NOT COMPLETED|Third Treatment Period (3 Weeks)||0||
48057992|NCT01550471|100463523|FG005|NOT COMPLETED|Third Treatment Period (3 Weeks)||0||
48057993|NCT01550471|100463518|FG000|STARTED|Third Wash Out Period (3 Weeks)||3||
48057994|NCT01550471|100463519|FG001|STARTED|Third Wash Out Period (3 Weeks)||4||
48057995|NCT01550471|100463520|FG002|STARTED|Third Wash Out Period (3 Weeks)||3||
48057996|NCT01550471|100463521|FG003|STARTED|Third Wash Out Period (3 Weeks)||4||
48057997|NCT01550471|100463522|FG004|STARTED|Third Wash Out Period (3 Weeks)||4||
48057998|NCT01550471|100463523|FG005|STARTED|Third Wash Out Period (3 Weeks)||3||
48057999|NCT01550471|100463518|FG000|COMPLETED|Third Wash Out Period (3 Weeks)||3||
48058000|NCT01550471|100463519|FG001|COMPLETED|Third Wash Out Period (3 Weeks)||4||
48058001|NCT01550471|100463520|FG002|COMPLETED|Third Wash Out Period (3 Weeks)||3||
48058002|NCT01550471|100463521|FG003|COMPLETED|Third Wash Out Period (3 Weeks)||4||
48058003|NCT01550471|100463522|FG004|COMPLETED|Third Wash Out Period (3 Weeks)||4||
48058004|NCT01550471|100463523|FG005|COMPLETED|Third Wash Out Period (3 Weeks)||3||
48058005|NCT01550471|100463518|FG000|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0||
48058006|NCT01550471|100463519|FG001|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0||
48058007|NCT01550471|100463520|FG002|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0||
48058008|NCT01550471|100463521|FG003|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0||
48058009|NCT01550471|100463522|FG004|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0||
48058010|NCT01550471|100463523|FG005|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0||
48058011|NCT00273910|100463524|FG000|STARTED|Overall Study||19||
48058012|NCT00273910|100463525|FG001|STARTED|Overall Study||19||
48058013|NCT00273910|100463526|FG002|STARTED|Overall Study||18||
48058014|NCT00273910|100463527|FG003|STARTED|Overall Study||19||
48058015|NCT00273910|100463528|FG004|STARTED|Overall Study||15||
48058016|NCT00273910|100463529|FG005|STARTED|Overall Study||14||
48058017|NCT00273910|100463524|FG000|COMPLETED|Overall Study||19||
48208643|NCT00529659|100837090|FG001|COMPLETED|Overall Study||66||
48208644|NCT00529659|100837089|FG000|NOT COMPLETED|Overall Study||11||
48058018|NCT00273910|100463525|FG001|COMPLETED|Overall Study||19||
48058019|NCT00273910|100463526|FG002|COMPLETED|Overall Study||18||
48058020|NCT00273910|100463527|FG003|COMPLETED|Overall Study||19||
48058021|NCT00273910|100463528|FG004|COMPLETED|Overall Study||15||
48058022|NCT00273910|100463529|FG005|COMPLETED|Overall Study||14||
48058023|NCT00273910|100463524|FG000|NOT COMPLETED|Overall Study||0||
48058024|NCT00273910|100463525|FG001|NOT COMPLETED|Overall Study||0||
48058025|NCT00273910|100463526|FG002|NOT COMPLETED|Overall Study||0||
48058026|NCT00273910|100463527|FG003|NOT COMPLETED|Overall Study||0||
48058027|NCT00273910|100463528|FG004|NOT COMPLETED|Overall Study||0||
48058028|NCT00273910|100463529|FG005|NOT COMPLETED|Overall Study||0||
48058029|NCT04533880|100463530|FG000|STARTED|Overall Study||52||
48058030|NCT04533880|100463531|FG001|STARTED|Overall Study||50||
48058031|NCT04533880|100463532|FG002|STARTED|Overall Study||48||
48058032|NCT04533880|100463530|FG000|COMPLETED|Overall Study||52||
48208645|NCT00529659|100837090|FG001|NOT COMPLETED|Overall Study||23||
48208646|NCT01195883|100837091|FG000|STARTED|Overall Study||553||
48058033|NCT04533880|100463531|FG001|COMPLETED|Overall Study||49||
48058034|NCT04533880|100463532|FG002|COMPLETED|Overall Study||47||
48058035|NCT04533880|100463530|FG000|NOT COMPLETED|Overall Study||0||
48058036|NCT04533880|100463531|FG001|NOT COMPLETED|Overall Study||1||
48058037|NCT04533880|100463532|FG002|NOT COMPLETED|Overall Study||1||
48058038|NCT03923738|100463533|FG000|STARTED|Period 1||24||
48058039|NCT03923738|100463533|FG000|COMPLETED|Period 1||22||
48058040|NCT03923738|100463533|FG000|NOT COMPLETED|Period 1||2||
48058041|NCT03923738|100463533|FG000|STARTED|Period 2||22||
48058042|NCT03923738|100463533|FG000|COMPLETED|Period 2||22||
48058043|NCT03923738|100463533|FG000|NOT COMPLETED|Period 2||0||
48058044|NCT01143207|100463534|FG000|STARTED|Overall Study||26||
48058045|NCT01143207|100463534|FG000|COMPLETED|Overall Study||24||
48058046|NCT01143207|100463534|FG000|NOT COMPLETED|Overall Study||2||
48058047|NCT06238362|100463535|FG000|STARTED|Overall Study||28||
48058048|NCT06238362|100463536|FG001|STARTED|Overall Study||22||
48058049|NCT06238362|100463535|FG000|COMPLETED|Overall Study||26||
48058050|NCT06238362|100463536|FG001|COMPLETED|Overall Study||22||
48058051|NCT06238362|100463535|FG000|NOT COMPLETED|Overall Study||2||
48058052|NCT06238362|100463536|FG001|NOT COMPLETED|Overall Study||0||
48058053|NCT00853073|100463537|FG000|STARTED|Overall Study||32||
48058054|NCT00853073|100463538|FG001|STARTED|Overall Study||31||
48058055|NCT00853073|100463537|FG000|COMPLETED|Overall Study||29||
48058056|NCT00853073|100463538|FG001|COMPLETED|Overall Study||29||
48058057|NCT00853073|100463537|FG000|NOT COMPLETED|Overall Study||3||
48058058|NCT00853073|100463538|FG001|NOT COMPLETED|Overall Study||2||
48058059|NCT04340193|100463539|FG000|STARTED|Overall Study||9||
48058060|NCT04340193|100463540|FG001|STARTED|Overall Study||9||
48058061|NCT04340193|100463541|FG002|STARTED|Overall Study||8||
48058062|NCT04340193|100463539|FG000|COMPLETED|Overall Study||6||
48058063|NCT04340193|100463540|FG001|COMPLETED|Overall Study||4||
48058064|NCT04340193|100463541|FG002|COMPLETED|Overall Study||4||
48058065|NCT04340193|100463539|FG000|NOT COMPLETED|Overall Study||3||
48058066|NCT04340193|100463540|FG001|NOT COMPLETED|Overall Study||5||
48058067|NCT04340193|100463541|FG002|NOT COMPLETED|Overall Study||4||
48058068|NCT00781508|100463542|FG000|STARTED|Overall Study||5||
48058069|NCT00781508|100463543|FG001|STARTED|Overall Study||5||
48058070|NCT00781508|100463542|FG000|COMPLETED|Overall Study||5||
48058071|NCT00781508|100463543|FG001|COMPLETED|Overall Study||5||
48058072|NCT00781508|100463542|FG000|NOT COMPLETED|Overall Study||0||
48058073|NCT00781508|100463543|FG001|NOT COMPLETED|Overall Study||0||
48058074|NCT00181623|100463544|FG000|STARTED|Overall Study||6||
48058075|NCT00181623|100463544|FG000|COMPLETED|Overall Study||5||
48058076|NCT00181623|100463544|FG000|NOT COMPLETED|Overall Study||1||
48058077|NCT00096954|100463545|FG000|STARTED|Overall Study||159||
48058078|NCT00096954|100463546|FG001|STARTED|Overall Study||174||
48058079|NCT00096954|100463545|FG000|Received Study Drug|Overall Study||157||
48058080|NCT00096954|100463546|FG001|Received Study Drug|Overall Study||171||
48058081|NCT00096954|100463545|FG000|COMPLETED|Overall Study||135||
48208647|NCT01195883|100837092|FG001|STARTED|Overall Study||549||
48208648|NCT01195883|100837091|FG000|COMPLETED|Overall Study||534||
48495858|NCT03196284|101547951|FG002|NOT COMPLETED|Extension Part||3||
48495859|NCT02462837|101547952|FG000|STARTED|Overall Study||4||
48495860|NCT02462837|101547953|FG001|STARTED|Overall Study||3||
48058082|NCT00096954|100463546|FG001|COMPLETED|Overall Study||154||
48058083|NCT00096954|100463545|FG000|NOT COMPLETED|Overall Study||24||
48058084|NCT00096954|100463546|FG001|NOT COMPLETED|Overall Study||20||
48058085|NCT04396496|100463547|FG000|STARTED|Overall Study||2||
48058086|NCT04396496|100463547|FG000|COMPLETED|Overall Study||2||
48058087|NCT04396496|100463547|FG000|NOT COMPLETED|Overall Study||0||
48058088|NCT04081233|100463548|FG000|STARTED|Overall Study||42||
48058089|NCT04081233|100463549|FG001|STARTED|Overall Study||42||
48058090|NCT04081233|100463548|FG000|COMPLETED|Overall Study||36||
48058091|NCT04081233|100463549|FG001|COMPLETED|Overall Study||32||
48058092|NCT04081233|100463548|FG000|NOT COMPLETED|Overall Study||6||
48058093|NCT04081233|100463549|FG001|NOT COMPLETED|Overall Study||10||
48058094|NCT06053463|100463550|FG000|STARTED|Overall Study||35||
48058095|NCT06053463|100463550|FG000|COMPLETED|Overall Study||25||
48058096|NCT06053463|100463550|FG000|NOT COMPLETED|Overall Study||10||
48058097|NCT01296360|100463551|FG000|STARTED|Overall Study||150||
48058098|NCT01296360|100463552|FG001|STARTED|Overall Study||150||
48058099|NCT01296360|100463551|FG000|Visit 2 (Month 12)|Overall Study||148||
48058100|NCT01296360|100463552|FG001|Visit 2 (Month 12)|Overall Study||149||
48058101|NCT01296360|100463551|FG000|Visit 2a (Month 13)|Overall Study||148||
48058102|NCT01296360|100463552|FG001|Visit 2a (Month 13)|Overall Study||0||
48058103|NCT01296360|100463551|FG000|COMPLETED|Overall Study||144||
48058104|NCT01296360|100463552|FG001|COMPLETED|Overall Study||142||
48058105|NCT01296360|100463551|FG000|NOT COMPLETED|Overall Study||6||
48058106|NCT01296360|100463552|FG001|NOT COMPLETED|Overall Study||8||
48058107|NCT00438451|100463553|FG000|STARTED|Overall Study||122||
48058108|NCT00438451|100463554|FG001|STARTED|Overall Study||121||
48058109|NCT00438451|100463555|FG002|STARTED|Overall Study||118||
48058110|NCT00438451|100463553|FG000|Safety Population|Overall Study||122||
48058111|NCT00438451|100463554|FG001|Safety Population|Overall Study||121||
48058112|NCT00438451|100463555|FG002|Safety Population|Overall Study||117||
48058113|NCT00438451|100463553|FG000|ITT Population|Overall Study||122||
48058114|NCT00438451|100463554|FG001|ITT Population|Overall Study||120||
48058115|NCT00438451|100463555|FG002|ITT Population|Overall Study||117||
48058116|NCT00438451|100463553|FG000|Maintenance Phase (Week 7-58)|Overall Study||93||
48058117|NCT00438451|100463554|FG001|Maintenance Phase (Week 7-58)|Overall Study||89||
48058118|NCT00438451|100463555|FG002|Maintenance Phase (Week 7-58)|Overall Study||93||
48058119|NCT00438451|100463553|FG000|COMPLETED|Overall Study||75||
48058120|NCT00438451|100463554|FG001|COMPLETED|Overall Study||55||
48058121|NCT00438451|100463555|FG002|COMPLETED|Overall Study||65||
48058122|NCT00438451|100463553|FG000|NOT COMPLETED|Overall Study||47||
48058123|NCT00438451|100463554|FG001|NOT COMPLETED|Overall Study||66||
48058124|NCT00438451|100463555|FG002|NOT COMPLETED|Overall Study||53||
48058125|NCT02806973|100463556|FG000|STARTED|Period 1||8||
48058126|NCT02806973|100463557|FG001|STARTED|Period 1||8||
48058127|NCT02806973|100463558|FG002|STARTED|Period 1||8||
48058128|NCT02806973|100463559|FG003|STARTED|Period 1||8||
48058129|NCT02806973|100463556|FG000|COMPLETED|Period 1||8||
48058130|NCT02806973|100463557|FG001|COMPLETED|Period 1||6||
48058131|NCT02806973|100463558|FG002|COMPLETED|Period 1||7||
48058132|NCT02806973|100463559|FG003|COMPLETED|Period 1||6||
48058133|NCT02806973|100463556|FG000|NOT COMPLETED|Period 1||0||
48058134|NCT02806973|100463557|FG001|NOT COMPLETED|Period 1||2||
48058135|NCT02806973|100463558|FG002|NOT COMPLETED|Period 1||1||
48058136|NCT02806973|100463559|FG003|NOT COMPLETED|Period 1||2||
48058137|NCT02806973|100463556|FG000|STARTED|Period 2||8||
48058138|NCT02806973|100463557|FG001|STARTED|Period 2||6||
48058139|NCT02806973|100463558|FG002|STARTED|Period 2||7||
48058140|NCT02806973|100463559|FG003|STARTED|Period 2||6||
48058141|NCT02806973|100463556|FG000|COMPLETED|Period 2||8||
48058142|NCT02806973|100463557|FG001|COMPLETED|Period 2||6||
48058143|NCT02806973|100463558|FG002|COMPLETED|Period 2||7||
48058144|NCT02806973|100463559|FG003|COMPLETED|Period 2||6||
48058145|NCT02806973|100463556|FG000|NOT COMPLETED|Period 2||0||
48058146|NCT02806973|100463557|FG001|NOT COMPLETED|Period 2||0||
48058147|NCT02806973|100463558|FG002|NOT COMPLETED|Period 2||0||
48058148|NCT02806973|100463559|FG003|NOT COMPLETED|Period 2||0||
48058149|NCT02806973|100463556|FG000|STARTED|Period 3||8||
48058150|NCT02806973|100463557|FG001|STARTED|Period 3||6||
48058151|NCT02806973|100463558|FG002|STARTED|Period 3||7||
48058152|NCT02806973|100463559|FG003|STARTED|Period 3||6||
48058153|NCT02806973|100463556|FG000|COMPLETED|Period 3||8||
48058154|NCT02806973|100463557|FG001|COMPLETED|Period 3||6||
48058155|NCT02806973|100463558|FG002|COMPLETED|Period 3||6||
48208649|NCT01195883|100837092|FG001|COMPLETED|Overall Study||523||
48208650|NCT01195883|100837091|FG000|NOT COMPLETED|Overall Study||19||
48058156|NCT02806973|100463559|FG003|COMPLETED|Period 3||3||
48058157|NCT02806973|100463556|FG000|NOT COMPLETED|Period 3||0||
48058158|NCT02806973|100463557|FG001|NOT COMPLETED|Period 3||0||
48058159|NCT02806973|100463558|FG002|NOT COMPLETED|Period 3||1||
48058160|NCT02806973|100463559|FG003|NOT COMPLETED|Period 3||3||
48058161|NCT02806973|100463556|FG000|STARTED|Period 4||8||
48058162|NCT02806973|100463557|FG001|STARTED|Period 4||6||
48058163|NCT02806973|100463558|FG002|STARTED|Period 4||6||
48058164|NCT02806973|100463559|FG003|STARTED|Period 4||3||
48058165|NCT02806973|100463556|FG000|COMPLETED|Period 4||8||
48058166|NCT02806973|100463557|FG001|COMPLETED|Period 4||6||
48058167|NCT02806973|100463558|FG002|COMPLETED|Period 4||6||
48058168|NCT02806973|100463559|FG003|COMPLETED|Period 4||3||
48058169|NCT02806973|100463556|FG000|NOT COMPLETED|Period 4||0||
48058170|NCT02806973|100463557|FG001|NOT COMPLETED|Period 4||0||
48058171|NCT02806973|100463558|FG002|NOT COMPLETED|Period 4||0||
48058172|NCT02806973|100463559|FG003|NOT COMPLETED|Period 4||0||
48058173|NCT00292318|100463560|FG000|STARTED|Overall Study||4||
48058174|NCT00292318|100463561|FG001|STARTED|Overall Study||3||
48058175|NCT00292318|100463560|FG000|COMPLETED|Overall Study||2||
48058176|NCT00292318|100463561|FG001|COMPLETED|Overall Study||2||
48058177|NCT00292318|100463560|FG000|NOT COMPLETED|Overall Study||2||
48058178|NCT00292318|100463561|FG001|NOT COMPLETED|Overall Study||1||
48058179|NCT00620464|100463562|FG000|STARTED|Overall Study||52||
48058180|NCT00620464|100463563|FG001|STARTED|Overall Study||56||
48058181|NCT00620464|100463562|FG000|COMPLETED|Overall Study||32||
48058182|NCT00620464|100463563|FG001|COMPLETED|Overall Study||32||
48058183|NCT00620464|100463562|FG000|NOT COMPLETED|Overall Study||20||
48058184|NCT00620464|100463563|FG001|NOT COMPLETED|Overall Study||24||
48058185|NCT01420653|100463564|FG000|STARTED|Overall Study||110||
48058186|NCT01420653|100463565|FG001|STARTED|Overall Study||111||
48058187|NCT01420653|100463566|FG002|STARTED|Overall Study||112||
48058188|NCT01420653|100463567|FG003|STARTED|Overall Study||75||
48058189|NCT01420653|100463564|FG000|COMPLETED|Overall Study||107||
48058190|NCT01420653|100463565|FG001|COMPLETED|Overall Study||108||
48058191|NCT01420653|100463566|FG002|COMPLETED|Overall Study||108||
48058192|NCT01420653|100463567|FG003|COMPLETED|Overall Study||68||
48058193|NCT01420653|100463564|FG000|NOT COMPLETED|Overall Study||3||
48058194|NCT01420653|100463565|FG001|NOT COMPLETED|Overall Study||3||
48058195|NCT01420653|100463566|FG002|NOT COMPLETED|Overall Study||4||
48058196|NCT01420653|100463567|FG003|NOT COMPLETED|Overall Study||7||
48058197|NCT03766685|100463568|FG000|STARTED|Overall Study||66||
48058198|NCT03766685|100463569|FG001|STARTED|Overall Study||68||
48058199|NCT03766685|100463570|FG002|STARTED|Overall Study||19||
48058200|NCT03766685|100463571|FG003|STARTED|Overall Study||19||
48058201|NCT03766685|100463568|FG000|COMPLETED|Overall Study||65||
48058202|NCT03766685|100463569|FG001|COMPLETED|Overall Study||61||
48058203|NCT03766685|100463570|FG002|COMPLETED|Overall Study||19||
48058204|NCT03766685|100463571|FG003|COMPLETED|Overall Study||18||
48058205|NCT03766685|100463568|FG000|NOT COMPLETED|Overall Study||1||
48058206|NCT03766685|100463569|FG001|NOT COMPLETED|Overall Study||7||
48058207|NCT03766685|100463570|FG002|NOT COMPLETED|Overall Study||0||
48058208|NCT03766685|100463571|FG003|NOT COMPLETED|Overall Study||1||
48058209|NCT00410202|100463572|FG000|STARTED|On-Treatment||138||
48058210|NCT00410202|100463573|FG001|STARTED|On-Treatment||140||
48058211|NCT00410202|100463574|FG002|STARTED|On-Treatment||137||
48058212|NCT00410202|100463572|FG000|Discontinued Prior to Week 48 Visit|On-Treatment||4||
48058213|NCT00410202|100463573|FG001|Discontinued Prior to Week 48 Visit|On-Treatment||2||
48058214|NCT00410202|100463574|FG002|Discontinued Prior to Week 48 Visit|On-Treatment||2||
48058215|NCT00410202|100463572|FG000|Discontinued at or After Week 48 Visit|On-Treatment||2||
48058216|NCT00410202|100463573|FG001|Discontinued at or After Week 48 Visit|On-Treatment||6||
48058217|NCT00410202|100463574|FG002|Discontinued at or After Week 48 Visit|On-Treatment||3||
48058218|NCT00410202|100463572|FG000|COMPLETED|On-Treatment||63||
48058219|NCT00410202|100463573|FG001|COMPLETED|On-Treatment||61||
48058220|NCT00410202|100463574|FG002|COMPLETED|On-Treatment||66||
48058221|NCT00410202|100463572|FG000|NOT COMPLETED|On-Treatment||75||
48058222|NCT00410202|100463573|FG001|NOT COMPLETED|On-Treatment||79||
48058223|NCT00410202|100463574|FG002|NOT COMPLETED|On-Treatment||71||
48058224|NCT00410202|100463572|FG000|STARTED|Off-treatment Follow up||15||
48058225|NCT00410202|100463573|FG001|STARTED|Off-treatment Follow up||8||
48058226|NCT00410202|100463574|FG002|STARTED|Off-treatment Follow up||14||
48058227|NCT00410202|100463572|FG000|COMPLETED|Off-treatment Follow up||1||
48058228|NCT00410202|100463573|FG001|COMPLETED|Off-treatment Follow up||0||
48058229|NCT00410202|100463574|FG002|COMPLETED|Off-treatment Follow up||2||
48058230|NCT00410202|100463572|FG000|NOT COMPLETED|Off-treatment Follow up||14||
48058231|NCT00410202|100463573|FG001|NOT COMPLETED|Off-treatment Follow up||8||
48058232|NCT00410202|100463574|FG002|NOT COMPLETED|Off-treatment Follow up||12||
48058233|NCT01539642|100463575|FG000|STARTED|Overall Study||114||
48058234|NCT01539642|100463576|FG001|STARTED|Overall Study||58||
48058235|NCT01539642|100463575|FG000|COMPLETED|Overall Study||78||
48058236|NCT01539642|100463576|FG001|COMPLETED|Overall Study||27||
48058237|NCT01539642|100463575|FG000|NOT COMPLETED|Overall Study||36||
48058238|NCT01539642|100463576|FG001|NOT COMPLETED|Overall Study||31||
48058239|NCT05283928|100463577|FG000|STARTED|Overall Study||15||20
48058240|NCT05283928|100463578|FG001|STARTED|Overall Study||15||20
48058241|NCT05283928|100463577|FG000|COMPLETED|Overall Study||15||20
48058242|NCT05283928|100463578|FG001|COMPLETED|Overall Study||15||20
48058243|NCT05283928|100463577|FG000|NOT COMPLETED|Overall Study||0||0
48058244|NCT05283928|100463578|FG001|NOT COMPLETED|Overall Study||0||0
48058245|NCT03304418|100463579|FG000|STARTED|Overall Study||20||
48058246|NCT03304418|100463579|FG000|COMPLETED|Overall Study||20||
48058247|NCT03304418|100463579|FG000|NOT COMPLETED|Overall Study||0||
48058248|NCT04865640|100463580|FG000|STARTED|Overall Study||20||
48058249|NCT04865640|100463581|FG001|STARTED|Overall Study||20||
48058250|NCT04865640|100463580|FG000|COMPLETED|Overall Study||20||
48058251|NCT04865640|100463581|FG001|COMPLETED|Overall Study||20||
48058252|NCT04865640|100463580|FG000|NOT COMPLETED|Overall Study||0||
48058253|NCT04865640|100463581|FG001|NOT COMPLETED|Overall Study||0||
48058254|NCT03090412|100463582|FG000|STARTED|Overall Study||1||
48058255|NCT03090412|100463583|FG001|STARTED|Overall Study||1||
48058256|NCT03090412|100463582|FG000|COMPLETED|Overall Study||1||
48058257|NCT03090412|100463583|FG001|COMPLETED|Overall Study||1||
48058258|NCT03090412|100463582|FG000|NOT COMPLETED|Overall Study||0||
48058259|NCT03090412|100463583|FG001|NOT COMPLETED|Overall Study||0||
48058260|NCT01462227|100463584|FG000|STARTED|First Assignment||4||
48058261|NCT01462227|100463585|FG001|STARTED|First Assignment||2||
48058262|NCT01462227|100463586|FG002|STARTED|First Assignment||6||
48058263|NCT01462227|100463587|FG003|STARTED|First Assignment||5||
48058264|NCT01462227|100463584|FG000|COMPLETED|First Assignment||4||
48058265|NCT01462227|100463585|FG001|COMPLETED|First Assignment||2||
48058266|NCT01462227|100463586|FG002|COMPLETED|First Assignment||6||
48058267|NCT01462227|100463587|FG003|COMPLETED|First Assignment||5||
48058268|NCT01462227|100463584|FG000|NOT COMPLETED|First Assignment||0||
48058269|NCT01462227|100463585|FG001|NOT COMPLETED|First Assignment||0||
48058270|NCT01462227|100463586|FG002|NOT COMPLETED|First Assignment||0||
48058271|NCT01462227|100463587|FG003|NOT COMPLETED|First Assignment||0||
48058272|NCT01462227|100463584|FG000|STARTED|Second Assignment||4||
48058273|NCT01462227|100463585|FG001|STARTED|Second Assignment||2||
48058274|NCT01462227|100463586|FG002|STARTED|Second Assignment||6||
48058275|NCT01462227|100463587|FG003|STARTED|Second Assignment||5||
48058276|NCT01462227|100463584|FG000|COMPLETED|Second Assignment||3||
48058277|NCT01462227|100463585|FG001|COMPLETED|Second Assignment||1||
48058278|NCT01462227|100463586|FG002|COMPLETED|Second Assignment||5||
48058279|NCT01462227|100463587|FG003|COMPLETED|Second Assignment||5||
48058280|NCT01462227|100463584|FG000|NOT COMPLETED|Second Assignment||1||
48058281|NCT01462227|100463585|FG001|NOT COMPLETED|Second Assignment||1||
48058282|NCT01462227|100463586|FG002|NOT COMPLETED|Second Assignment||1||
48058283|NCT01462227|100463587|FG003|NOT COMPLETED|Second Assignment||0||
48058284|NCT01833546|100463588|FG000|STARTED|Overall Study||3||
48058285|NCT01833546|100463589|FG001|STARTED|Overall Study||3||
48058286|NCT01833546|100463590|FG002|STARTED|Overall Study||8||
48058287|NCT01833546|100463591|FG003|STARTED|Overall Study||6||
48058288|NCT01833546|100463588|FG000|COMPLETED|Overall Study||3||
48058289|NCT01833546|100463589|FG001|COMPLETED|Overall Study||3||
48058290|NCT01833546|100463590|FG002|COMPLETED|Overall Study||8||
48058291|NCT01833546|100463591|FG003|COMPLETED|Overall Study||6||
48058292|NCT01833546|100463588|FG000|NOT COMPLETED|Overall Study||0||
48058293|NCT01833546|100463589|FG001|NOT COMPLETED|Overall Study||0||
48058294|NCT01833546|100463590|FG002|NOT COMPLETED|Overall Study||0||
48058295|NCT01833546|100463591|FG003|NOT COMPLETED|Overall Study||0||
48058296|NCT01083173|100463592|FG000|STARTED|Main Surveillance: Safety Group||595||
48058297|NCT01083173|100463593|FG001|STARTED|Main Surveillance: Safety Group||0||
48058298|NCT01083173|100463592|FG000|COMPLETED|Main Surveillance: Safety Group||580||
48058299|NCT01083173|100463593|FG001|COMPLETED|Main Surveillance: Safety Group||0||
48058300|NCT01083173|100463592|FG000|NOT COMPLETED|Main Surveillance: Safety Group||15||
48058301|NCT01083173|100463593|FG001|NOT COMPLETED|Main Surveillance: Safety Group||0||
48058302|NCT01083173|100463592|FG000|STARTED|Main Surveillance: Effectiveness Group||580||
48058303|NCT01083173|100463593|FG001|STARTED|Main Surveillance: Effectiveness Group||0||
48058304|NCT01083173|100463592|FG000|COMPLETED|Main Surveillance: Effectiveness Group||198||
48208651|NCT01195883|100837092|FG001|NOT COMPLETED|Overall Study||26||
48058305|NCT01083173|100463593|FG001|COMPLETED|Main Surveillance: Effectiveness Group||0||
48058306|NCT01083173|100463592|FG000|NOT COMPLETED|Main Surveillance: Effectiveness Group||382||
48058307|NCT01083173|100463593|FG001|NOT COMPLETED|Main Surveillance: Effectiveness Group||0||
48058308|NCT01083173|100463592|FG000|STARTED|Long-term Surveillance: Safety Group||0||
48058309|NCT01083173|100463593|FG001|STARTED|Long-term Surveillance: Safety Group||595||
48058310|NCT01083173|100463592|FG000|COMPLETED|Long-term Surveillance: Safety Group||0||
48058311|NCT01083173|100463593|FG001|COMPLETED|Long-term Surveillance: Safety Group||479||
48058312|NCT01083173|100463592|FG000|NOT COMPLETED|Long-term Surveillance: Safety Group||0||
48058313|NCT01083173|100463593|FG001|NOT COMPLETED|Long-term Surveillance: Safety Group||116||
48058314|NCT01083173|100463592|FG000|STARTED|Long-term Surveillance: Effectiveness Gr||0||
48058315|NCT01083173|100463593|FG001|STARTED|Long-term Surveillance: Effectiveness Gr||479||
48058316|NCT01083173|100463592|FG000|COMPLETED|Long-term Surveillance: Effectiveness Gr||0||
48058317|NCT01083173|100463593|FG001|COMPLETED|Long-term Surveillance: Effectiveness Gr||102||
48058318|NCT01083173|100463592|FG000|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||0||
48058319|NCT01083173|100463593|FG001|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||377||
48058320|NCT00736879|100463594|FG000|STARTED|Double Blind Treatment Period||68||
48058321|NCT00736879|100463595|FG001|STARTED|Double Blind Treatment Period||72||
48058322|NCT00736879|100463596|FG002|STARTED|Double Blind Treatment Period||74||
48058323|NCT00736879|100463597|FG003|STARTED|Double Blind Treatment Period||68||
48058324|NCT00736879|100463594|FG000|COMPLETED|Double Blind Treatment Period||65||
48058325|NCT00736879|100463595|FG001|COMPLETED|Double Blind Treatment Period||68||
48058326|NCT00736879|100463596|FG002|COMPLETED|Double Blind Treatment Period||67||
48058327|NCT00736879|100463597|FG003|COMPLETED|Double Blind Treatment Period||63||
48058328|NCT00736879|100463594|FG000|NOT COMPLETED|Double Blind Treatment Period||3||
48058329|NCT00736879|100463595|FG001|NOT COMPLETED|Double Blind Treatment Period||4||
48058330|NCT00736879|100463596|FG002|NOT COMPLETED|Double Blind Treatment Period||7||
48058331|NCT00736879|100463597|FG003|NOT COMPLETED|Double Blind Treatment Period||5||
48058332|NCT00736879|100463594|FG000|STARTED|Follow up Period - No Drug Treatment||66||
48058333|NCT00736879|100463595|FG001|STARTED|Follow up Period - No Drug Treatment||70||
48058334|NCT00736879|100463596|FG002|STARTED|Follow up Period - No Drug Treatment||66||
48058335|NCT00736879|100463597|FG003|STARTED|Follow up Period - No Drug Treatment||62||
48058336|NCT00736879|100463594|FG000|COMPLETED|Follow up Period - No Drug Treatment||65||
48058337|NCT00736879|100463595|FG001|COMPLETED|Follow up Period - No Drug Treatment||67||
48058338|NCT00736879|100463596|FG002|COMPLETED|Follow up Period - No Drug Treatment||66||
48058339|NCT00736879|100463597|FG003|COMPLETED|Follow up Period - No Drug Treatment||62||
48058340|NCT00736879|100463594|FG000|NOT COMPLETED|Follow up Period - No Drug Treatment||1||
48058341|NCT00736879|100463595|FG001|NOT COMPLETED|Follow up Period - No Drug Treatment||3||
48058342|NCT00736879|100463596|FG002|NOT COMPLETED|Follow up Period - No Drug Treatment||0||
48058343|NCT00736879|100463597|FG003|NOT COMPLETED|Follow up Period - No Drug Treatment||0||
48058344|NCT03374631|100463598|FG000|STARTED|First Intervention (20 Minutes)||20||
48058345|NCT03374631|100463599|FG001|STARTED|First Intervention (20 Minutes)||20||
48058346|NCT03374631|100463598|FG000|COMPLETED|First Intervention (20 Minutes)||20||
48058347|NCT03374631|100463599|FG001|COMPLETED|First Intervention (20 Minutes)||20||
48058348|NCT03374631|100463598|FG000|NOT COMPLETED|First Intervention (20 Minutes)||0||
48058349|NCT03374631|100463599|FG001|NOT COMPLETED|First Intervention (20 Minutes)||0||
48058350|NCT03374631|100463598|FG000|STARTED|Washout (1 Week)||20||
48058351|NCT03374631|100463599|FG001|STARTED|Washout (1 Week)||20||
48058352|NCT03374631|100463598|FG000|COMPLETED|Washout (1 Week)||20||
48058353|NCT03374631|100463599|FG001|COMPLETED|Washout (1 Week)||20||
48058354|NCT03374631|100463598|FG000|NOT COMPLETED|Washout (1 Week)||0||
48058355|NCT03374631|100463599|FG001|NOT COMPLETED|Washout (1 Week)||0||
48058356|NCT03374631|100463598|FG000|STARTED|Second Intervention (20 Minutes)||20||
48058357|NCT03374631|100463599|FG001|STARTED|Second Intervention (20 Minutes)||20||
48058358|NCT03374631|100463598|FG000|COMPLETED|Second Intervention (20 Minutes)||20||
48058359|NCT03374631|100463599|FG001|COMPLETED|Second Intervention (20 Minutes)||20||
48058360|NCT03374631|100463598|FG000|NOT COMPLETED|Second Intervention (20 Minutes)||0||
48058361|NCT03374631|100463599|FG001|NOT COMPLETED|Second Intervention (20 Minutes)||0||
48058362|NCT00739050|100463600|FG000|STARTED|Overall Study||4||
48058363|NCT00739050|100463601|FG001|STARTED|Overall Study||0||
48058364|NCT00739050|100463600|FG000|COMPLETED|Overall Study||3||
48058365|NCT00739050|100463601|FG001|COMPLETED|Overall Study||0||
48058366|NCT00739050|100463600|FG000|NOT COMPLETED|Overall Study||1||
48058367|NCT00739050|100463601|FG001|NOT COMPLETED|Overall Study||0||
48058368|NCT03148275|100463602|FG000|STARTED|Overall Study||44||
48058369|NCT03148275|100463602|FG000|COMPLETED|Overall Study||25||
48058370|NCT03148275|100463602|FG000|NOT COMPLETED|Overall Study||19||
48058371|NCT02637622|100463603|FG000|STARTED|Overall Study||551||
48058372|NCT02637622|100463604|FG001|STARTED|Overall Study||552||
48058373|NCT02637622|100463603|FG000|COMPLETED|Overall Study||551||
48058374|NCT02637622|100463604|FG001|COMPLETED|Overall Study||552||
48058375|NCT02637622|100463603|FG000|NOT COMPLETED|Overall Study||0||
48058376|NCT02637622|100463604|FG001|NOT COMPLETED|Overall Study||0||
48058377|NCT00572897|100463605|FG000|STARTED|Overall Study||32||
48058378|NCT00572897|100463606|FG001|STARTED|Overall Study||34||
48058379|NCT00572897|100463605|FG000|COMPLETED|Overall Study||32||
48058380|NCT00572897|100463606|FG001|COMPLETED|Overall Study||34||
48058381|NCT00572897|100463605|FG000|NOT COMPLETED|Overall Study||0||
48058382|NCT00572897|100463606|FG001|NOT COMPLETED|Overall Study||0||
48058383|NCT00674973|100463607|FG000|STARTED|Overall Study||103||
48058384|NCT00674973|100463608|FG001|STARTED|Overall Study||104||
48058385|NCT00674973|100463607|FG000|Switch to Open-Label Erlotinib|Overall Study||57||
48058386|NCT00674973|100463608|FG001|Switch to Open-Label Erlotinib|Overall Study||0||
48058387|NCT00674973|100463607|FG000|COMPLETED|Overall Study||3||
48058388|NCT00674973|100463608|FG001|COMPLETED|Overall Study||2||
48058389|NCT00674973|100463607|FG000|NOT COMPLETED|Overall Study||100||
48058390|NCT00674973|100463608|FG001|NOT COMPLETED|Overall Study||102||
48058391|NCT00287079|100463609|FG000|STARTED|Overall Study||32||
48058392|NCT00287079|100463610|FG001|STARTED|Overall Study||3||
48495861|NCT02462837|101547952|FG000|COMPLETED|Overall Study||2||
48495862|NCT02462837|101547953|FG001|COMPLETED|Overall Study||3||
48058393|NCT00287079|100463609|FG000|COMPLETED|Overall Study||10||
48058394|NCT00287079|100463610|FG001|COMPLETED|Overall Study||2||
48058395|NCT00287079|100463609|FG000|NOT COMPLETED|Overall Study||22||
48058396|NCT00287079|100463610|FG001|NOT COMPLETED|Overall Study||1||
48058397|NCT00121173|100463611|FG000|STARTED|Overall Study||4||
48058398|NCT00121173|100463612|FG001|STARTED|Overall Study||3||
48058399|NCT00121173|100463613|FG002|STARTED|Overall Study||9||
48058400|NCT00121173|100463611|FG000|COMPLETED|Overall Study||3||
48058401|NCT00121173|100463612|FG001|COMPLETED|Overall Study||3||
48058402|NCT00121173|100463613|FG002|COMPLETED|Overall Study||9||
48058403|NCT00121173|100463611|FG000|NOT COMPLETED|Overall Study||1||
48058404|NCT00121173|100463612|FG001|NOT COMPLETED|Overall Study||0||
48058405|NCT00121173|100463613|FG002|NOT COMPLETED|Overall Study||0||
48058406|NCT02808650|100463614|FG000|STARTED|Overall Study||6||
48058407|NCT02808650|100463615|FG001|STARTED|Overall Study||6||
48058408|NCT02808650|100463616|FG002|STARTED|Overall Study||6||
48058409|NCT02808650|100463617|FG003|STARTED|Overall Study||6||
48058410|NCT02808650|100463618|FG004|STARTED|Overall Study||6||
48058411|NCT02808650|100463614|FG000|COMPLETED|Overall Study||0||
48058412|NCT02808650|100463615|FG001|COMPLETED|Overall Study||0||
48058413|NCT02808650|100463616|FG002|COMPLETED|Overall Study||0||
48058414|NCT02808650|100463617|FG003|COMPLETED|Overall Study||0||
48058415|NCT02808650|100463618|FG004|COMPLETED|Overall Study||0||
48058416|NCT02808650|100463614|FG000|NOT COMPLETED|Overall Study||6||
48058417|NCT02808650|100463615|FG001|NOT COMPLETED|Overall Study||6||
48058418|NCT02808650|100463616|FG002|NOT COMPLETED|Overall Study||6||
48058419|NCT02808650|100463617|FG003|NOT COMPLETED|Overall Study||6||
48058420|NCT02808650|100463618|FG004|NOT COMPLETED|Overall Study||6||
48058421|NCT02544074|100463619|FG000|STARTED|Overall Study||1||
48058422|NCT02544074|100463620|FG001|STARTED|Overall Study||1||
48058423|NCT02544074|100463621|FG002|STARTED|Overall Study||1||
48058424|NCT02544074|100463622|FG003|STARTED|Overall Study||1||
48058425|NCT02544074|100463623|FG004|STARTED|Overall Study||4||
48058426|NCT02544074|100463624|FG005|STARTED|Overall Study||1||
48058427|NCT02544074|100463625|FG006|STARTED|Overall Study||2||
48058428|NCT02544074|100463626|FG007|STARTED|Overall Study||4||
48058429|NCT02544074|100463627|FG008|STARTED|Overall Study||6||
48058430|NCT02544074|100463628|FG009|STARTED|Overall Study||2||
48058431|NCT02544074|100463629|FG010|STARTED|Overall Study||2||
48058432|NCT02544074|100463630|FG011|STARTED|Overall Study||3||
48058433|NCT02544074|100463631|FG012|STARTED|Overall Study||4||
48058434|NCT02544074|100463632|FG013|STARTED|Overall Study||5||
48058435|NCT02544074|100463633|FG014|STARTED|Overall Study||5||
48058436|NCT02544074|100463634|FG015|STARTED|Overall Study||8||
48058437|NCT02544074|100463635|FG016|STARTED|Overall Study||6||
48058438|NCT02544074|100463636|FG017|STARTED|Overall Study||3||
48058439|NCT02544074|100463637|FG018|STARTED|Overall Study||4||
48058440|NCT02544074|100463638|FG019|STARTED|Overall Study||3||
48058441|NCT02544074|100463639|FG020|STARTED|Overall Study||3||
48058442|NCT02544074|100463619|FG000|COMPLETED|Overall Study||1||
48058443|NCT02544074|100463620|FG001|COMPLETED|Overall Study||0||
48058444|NCT02544074|100463621|FG002|COMPLETED|Overall Study||1||
48058445|NCT02544074|100463622|FG003|COMPLETED|Overall Study||1||
48058446|NCT02544074|100463623|FG004|COMPLETED|Overall Study||4||
48058447|NCT02544074|100463624|FG005|COMPLETED|Overall Study||0||
48058448|NCT02544074|100463625|FG006|COMPLETED|Overall Study||2||
48058449|NCT02544074|100463626|FG007|COMPLETED|Overall Study||4||
48058450|NCT02544074|100463627|FG008|COMPLETED|Overall Study||6||
48058451|NCT02544074|100463628|FG009|COMPLETED|Overall Study||1||
48058452|NCT02544074|100463629|FG010|COMPLETED|Overall Study||2||
48058453|NCT02544074|100463630|FG011|COMPLETED|Overall Study||3||
48058454|NCT02544074|100463631|FG012|COMPLETED|Overall Study||4||
48058455|NCT02544074|100463632|FG013|COMPLETED|Overall Study||5||
48058456|NCT02544074|100463633|FG014|COMPLETED|Overall Study||5||
48058457|NCT02544074|100463634|FG015|COMPLETED|Overall Study||8||
48058458|NCT02544074|100463635|FG016|COMPLETED|Overall Study||6||
48058459|NCT02544074|100463636|FG017|COMPLETED|Overall Study||3||
48058460|NCT02544074|100463637|FG018|COMPLETED|Overall Study||4||
48058461|NCT02544074|100463638|FG019|COMPLETED|Overall Study||3||
48058462|NCT02544074|100463639|FG020|COMPLETED|Overall Study||3||
48058463|NCT02544074|100463619|FG000|NOT COMPLETED|Overall Study||0||
48058464|NCT02544074|100463620|FG001|NOT COMPLETED|Overall Study||1||
48058465|NCT02544074|100463621|FG002|NOT COMPLETED|Overall Study||0||
48058466|NCT02544074|100463622|FG003|NOT COMPLETED|Overall Study||0||
48058467|NCT02544074|100463623|FG004|NOT COMPLETED|Overall Study||0||
48058468|NCT02544074|100463624|FG005|NOT COMPLETED|Overall Study||1||
48058469|NCT02544074|100463625|FG006|NOT COMPLETED|Overall Study||0||
48058470|NCT02544074|100463626|FG007|NOT COMPLETED|Overall Study||0||
48058471|NCT02544074|100463627|FG008|NOT COMPLETED|Overall Study||0||
48058472|NCT02544074|100463628|FG009|NOT COMPLETED|Overall Study||1||
48058473|NCT02544074|100463629|FG010|NOT COMPLETED|Overall Study||0||
48058474|NCT02544074|100463630|FG011|NOT COMPLETED|Overall Study||0||
48058475|NCT02544074|100463631|FG012|NOT COMPLETED|Overall Study||0||
48058476|NCT02544074|100463632|FG013|NOT COMPLETED|Overall Study||0||
48058477|NCT02544074|100463633|FG014|NOT COMPLETED|Overall Study||0||
48058478|NCT02544074|100463634|FG015|NOT COMPLETED|Overall Study||0||
48058479|NCT02544074|100463635|FG016|NOT COMPLETED|Overall Study||0||
48058480|NCT02544074|100463636|FG017|NOT COMPLETED|Overall Study||0||
48058481|NCT02544074|100463637|FG018|NOT COMPLETED|Overall Study||0||
48058482|NCT02544074|100463638|FG019|NOT COMPLETED|Overall Study||0||
48058483|NCT02544074|100463639|FG020|NOT COMPLETED|Overall Study||0||
48058484|NCT02294773|100463640|FG000|STARTED|Overall Study||7||
48058485|NCT02294773|100463641|FG001|STARTED|Overall Study||6||
48058486|NCT02294773|100463640|FG000|COMPLETED|Overall Study||7||
48058487|NCT02294773|100463641|FG001|COMPLETED|Overall Study||4||
48058488|NCT02294773|100463640|FG000|NOT COMPLETED|Overall Study||0||
48058489|NCT02294773|100463641|FG001|NOT COMPLETED|Overall Study||2||
48058490|NCT01439568|100463642|FG000|STARTED|Overall Study||47||
48058491|NCT01439568|100463643|FG001|STARTED|Overall Study||43||
48058492|NCT01439568|100463642|FG000|Received at Least One Dose of Study Drug|Overall Study||47||
48058493|NCT01439568|100463643|FG001|Received at Least One Dose of Study Drug|Overall Study||43||
48058494|NCT01439568|100463642|FG000|COMPLETED|Overall Study||44||
48058495|NCT01439568|100463643|FG001|COMPLETED|Overall Study||41||
48058496|NCT01439568|100463642|FG000|NOT COMPLETED|Overall Study||3||
48058497|NCT01439568|100463643|FG001|NOT COMPLETED|Overall Study||2||
48058498|NCT04072575|100463644|FG000|STARTED|Overall Study||178||
48058499|NCT04072575|100463644|FG000|COMPLETED|Overall Study||154||
48058500|NCT04072575|100463644|FG000|NOT COMPLETED|Overall Study||24||
48058501|NCT04856891|100463645|FG000|STARTED|Overall Study||46||
48058502|NCT04856891|100463646|FG001|STARTED|Overall Study||47||
48058503|NCT04856891|100463645|FG000|COMPLETED|Overall Study||38||
48058504|NCT04856891|100463646|FG001|COMPLETED|Overall Study||44||
48058505|NCT04856891|100463645|FG000|NOT COMPLETED|Overall Study||8||
48058506|NCT04856891|100463646|FG001|NOT COMPLETED|Overall Study||3||
48058507|NCT04850313|100463647|FG000|STARTED|Overall Study||1||
48058508|NCT04850313|100463648|FG001|STARTED|Overall Study||2||
48058509|NCT04850313|100463647|FG000|COMPLETED|Overall Study||1||
48058510|NCT04850313|100463648|FG001|COMPLETED|Overall Study||1||
48058511|NCT04850313|100463647|FG000|NOT COMPLETED|Overall Study||0||
48058512|NCT04850313|100463648|FG001|NOT COMPLETED|Overall Study||1||
48058513|NCT01419639|100463649|FG000|STARTED|Overall Study||10||
48058514|NCT01419639|100463649|FG000|COMPLETED|Overall Study||9||
48058515|NCT01419639|100463649|FG000|NOT COMPLETED|Overall Study||1||
48058516|NCT02260531|100463650|FG000|STARTED|Overall Study||21||
48058517|NCT02260531|100463651|FG001|STARTED|Overall Study||7||
48058518|NCT02260531|100463652|FG002|STARTED|Overall Study||8||
48058519|NCT02260531|100463650|FG000|COMPLETED|Overall Study||21||
48058520|NCT02260531|100463651|FG001|COMPLETED|Overall Study||7||
48058521|NCT02260531|100463652|FG002|COMPLETED|Overall Study||8||
48058522|NCT02260531|100463650|FG000|NOT COMPLETED|Overall Study||0||
48058523|NCT02260531|100463651|FG001|NOT COMPLETED|Overall Study||0||
48058524|NCT02260531|100463652|FG002|NOT COMPLETED|Overall Study||0||
48058525|NCT04088656|100463653|FG000|STARTED|Baseline Period||12307||8
48058526|NCT04088656|100463654|FG001|STARTED|Baseline Period||10042||8
48058527|NCT04088656|100463653|FG000|Patients|Baseline Period||12307||8
48058528|NCT04088656|100463654|FG001|Patients|Baseline Period||10042||8
48058529|NCT04088656|100463653|FG000|COMPLETED|Baseline Period||12307||8
48058530|NCT04088656|100463654|FG001|COMPLETED|Baseline Period||10042||8
48058531|NCT04088656|100463653|FG000|NOT COMPLETED|Baseline Period||0||0
48058532|NCT04088656|100463654|FG001|NOT COMPLETED|Baseline Period||0||0
48058533|NCT04088656|100463653|FG000|STARTED|Intensive Implementation Period||20788||8
48058534|NCT04088656|100463654|FG001|STARTED|Intensive Implementation Period||17909||8
48058535|NCT04088656|100463653|FG000|Healthcare Workers|Intensive Implementation Period||171||8
48058536|NCT04088656|100463654|FG001|Healthcare Workers|Intensive Implementation Period||0||0
48058537|NCT04088656|100463653|FG000|Patients|Intensive Implementation Period||20617|Patients were counted in the phase in which they first came to the facility to receive HIV care. If they were captured in the previous period, they were not counted in this period or the subsequent period.|8
48058538|NCT04088656|100463654|FG001|Patients|Intensive Implementation Period||17909|Patients were counted in the phase in which they first came to the facility to receive HIV care. If they were captured in the previous period, they were not counted in this period or the subsequent period.|8
48058539|NCT04088656|100463653|FG000|COMPLETED|Intensive Implementation Period||20788||8
48058540|NCT04088656|100463654|FG001|COMPLETED|Intensive Implementation Period||17909||8
48058541|NCT04088656|100463653|FG000|NOT COMPLETED|Intensive Implementation Period||0||0
48058542|NCT04088656|100463654|FG001|NOT COMPLETED|Intensive Implementation Period||0||0
48058543|NCT04088656|100463653|FG000|STARTED|Sustainment Implementation Period||2317||8
48058544|NCT04088656|100463654|FG001|STARTED|Sustainment Implementation Period||2567||8
48058545|NCT04088656|100463653|FG000|Healthcare Workers|Sustainment Implementation Period||134||8
48058546|NCT04088656|100463654|FG001|Healthcare Workers|Sustainment Implementation Period||0||0
48058547|NCT04088656|100463653|FG000|Patients|Sustainment Implementation Period||2183|Patients were counted in the phase in which they first came to the facility to receive HIV care. If they were captured in the previous period, they were not counted in this period.|8
48058548|NCT04088656|100463654|FG001|Patients|Sustainment Implementation Period||2567|Patients were counted in the phase in which they first came to the facility to receive HIV care. If they were captured in the previous period, they were not counted in this period.|8
48058549|NCT04088656|100463653|FG000|COMPLETED|Sustainment Implementation Period||2317||8
48058550|NCT04088656|100463654|FG001|COMPLETED|Sustainment Implementation Period||2567||8
48058551|NCT04088656|100463653|FG000|NOT COMPLETED|Sustainment Implementation Period||0||0
48058552|NCT04088656|100463654|FG001|NOT COMPLETED|Sustainment Implementation Period||0||0
48058553|NCT03488927|100463655|FG000|STARTED|Overall Study||305||
48058554|NCT03488927|100463656|FG001|STARTED|Overall Study||432||
48058555|NCT03488927|100463657|FG002|STARTED|Overall Study||531||
48058556|NCT03488927|100463655|FG000|COMPLETED|Overall Study||261||
48058557|NCT03488927|100463656|FG001|COMPLETED|Overall Study||314||
48058558|NCT03488927|100463657|FG002|COMPLETED|Overall Study||314||
48208652|NCT04763044|100837093|FG000|STARTED|Period 1||3||
48208653|NCT04763044|100837094|FG001|STARTED|Period 1||4||
48208654|NCT04763044|100837095|FG002|STARTED|Period 1||4||
48208655|NCT04763044|100837096|FG003|STARTED|Period 1||4||
48058559|NCT03488927|100463655|FG000|NOT COMPLETED|Overall Study||44||
48058560|NCT03488927|100463656|FG001|NOT COMPLETED|Overall Study||118||
48058561|NCT03488927|100463657|FG002|NOT COMPLETED|Overall Study||217||
48058562|NCT01347307|100463658|FG000|STARTED|Overall Study||3||
48058563|NCT01347307|100463659|FG001|STARTED|Overall Study||33||
48058564|NCT01347307|100463658|FG000|COMPLETED|Overall Study||3||
48058565|NCT01347307|100463659|FG001|COMPLETED|Overall Study||28||
48058566|NCT01347307|100463658|FG000|NOT COMPLETED|Overall Study||0||
48058567|NCT01347307|100463659|FG001|NOT COMPLETED|Overall Study||5||
48058568|NCT04545554|100463660|FG000|STARTED|Overall Study||4||
48058569|NCT04545554|100463661|FG001|STARTED|Overall Study||4||
48058570|NCT04545554|100463662|FG002|STARTED|Overall Study||4||
48058571|NCT04545554|100463663|FG003|STARTED|Overall Study||5||
48058572|NCT04545554|100463664|FG004|STARTED|Overall Study||4||
48058573|NCT04545554|100463665|FG005|STARTED|Overall Study||4||
48058574|NCT04545554|100463660|FG000|Received at Least 1 Dose Romosozumab|Overall Study||4||
48058575|NCT04545554|100463661|FG001|Received at Least 1 Dose Romosozumab|Overall Study||4||
48058576|NCT04545554|100463662|FG002|Received at Least 1 Dose Romosozumab|Overall Study||4||
48058577|NCT04545554|100463663|FG003|Received at Least 1 Dose Romosozumab|Overall Study||5||
48058578|NCT04545554|100463664|FG004|Received at Least 1 Dose Romosozumab|Overall Study||4||
48058579|NCT04545554|100463665|FG005|Received at Least 1 Dose Romosozumab|Overall Study||4||
48058580|NCT04545554|100463660|FG000|Received All Doses of Romosozumab|Overall Study||4||
48058581|NCT04545554|100463661|FG001|Received All Doses of Romosozumab|Overall Study||4||
48058582|NCT04545554|100463662|FG002|Received All Doses of Romosozumab|Overall Study||4||
48058583|NCT04545554|100463663|FG003|Received All Doses of Romosozumab|Overall Study||4||
48058584|NCT04545554|100463664|FG004|Received All Doses of Romosozumab|Overall Study||4||
48058585|NCT04545554|100463665|FG005|Received All Doses of Romosozumab|Overall Study||4||
48058586|NCT04545554|100463660|FG000|COMPLETED|Overall Study||4||
48058587|NCT04545554|100463661|FG001|COMPLETED|Overall Study||4||
48058588|NCT04545554|100463662|FG002|COMPLETED|Overall Study||4||
48058589|NCT04545554|100463663|FG003|COMPLETED|Overall Study||4||
48058590|NCT04545554|100463664|FG004|COMPLETED|Overall Study||4||
48058591|NCT04545554|100463665|FG005|COMPLETED|Overall Study||4||
48058592|NCT04545554|100463660|FG000|NOT COMPLETED|Overall Study||0||
48058593|NCT04545554|100463661|FG001|NOT COMPLETED|Overall Study||0||
48058594|NCT04545554|100463662|FG002|NOT COMPLETED|Overall Study||0||
48058595|NCT04545554|100463663|FG003|NOT COMPLETED|Overall Study||1||
48058596|NCT04545554|100463664|FG004|NOT COMPLETED|Overall Study||0||
48058597|NCT04545554|100463665|FG005|NOT COMPLETED|Overall Study||0||
48058598|NCT01241240|100463666|FG000|STARTED|Overall Study||94||
48058599|NCT01241240|100463667|FG001|STARTED|Overall Study||98||
48058600|NCT01241240|100463666|FG000|COMPLETED|Overall Study||86||
48058601|NCT01241240|100463667|FG001|COMPLETED|Overall Study||89||
48058602|NCT01241240|100463666|FG000|NOT COMPLETED|Overall Study||8||
48058603|NCT01241240|100463667|FG001|NOT COMPLETED|Overall Study||9||
48058604|NCT01646073|100463668|FG000|STARTED|Period A (12 Weeks)||87||
48058605|NCT01646073|100463669|FG001|STARTED|Period A (12 Weeks)||338||
48058606|NCT01646073|100463668|FG000|COMPLETED|Period A (12 Weeks)||85||
48058607|NCT01646073|100463669|FG001|COMPLETED|Period A (12 Weeks)||333||
48058608|NCT01646073|100463668|FG000|NOT COMPLETED|Period A (12 Weeks)||2||
48058609|NCT01646073|100463669|FG001|NOT COMPLETED|Period A (12 Weeks)||5||
48058610|NCT01646073|100463668|FG000|STARTED|Period B (12 Weeks)||85||
48058611|NCT01646073|100463669|FG001|STARTED|Period B (12 Weeks)||333||
48058612|NCT01646073|100463668|FG000|COMPLETED|Period B (12 Weeks)||84||
48058613|NCT01646073|100463669|FG001|COMPLETED|Period B (12 Weeks)||320||
48058614|NCT01646073|100463668|FG000|NOT COMPLETED|Period B (12 Weeks)||1||
48058615|NCT01646073|100463669|FG001|NOT COMPLETED|Period B (12 Weeks)||13||
48058616|NCT00426231|100463670|FG000|STARTED|Overall Study||36||
48058617|NCT00426231|100463671|FG001|STARTED|Overall Study||37||
48058618|NCT00426231|100463670|FG000|COMPLETED|Overall Study||27||
48058619|NCT00426231|100463671|FG001|COMPLETED|Overall Study||25||
48058620|NCT00426231|100463670|FG000|NOT COMPLETED|Overall Study||9||
48058621|NCT00426231|100463671|FG001|NOT COMPLETED|Overall Study||12||
48058622|NCT01068652|100463672|FG000|STARTED|Overall Study||200||
48058623|NCT01068652|100463673|FG001|STARTED|Overall Study||203||
48058624|NCT01068652|100463672|FG000|COMPLETED|Overall Study||182||
48058625|NCT01068652|100463673|FG001|COMPLETED|Overall Study||188||
48058626|NCT01068652|100463672|FG000|NOT COMPLETED|Overall Study||18||
48058627|NCT01068652|100463673|FG001|NOT COMPLETED|Overall Study||15||
48058628|NCT00857415|100463674|FG000|STARTED|Overall Study||152||
48058629|NCT00857415|100463675|FG001|STARTED|Overall Study||74||
48058630|NCT00857415|100463674|FG000|Deceased Within One Year of AV-45 Scan|Overall Study||37||
48058631|NCT00857415|100463675|FG001|Deceased Within One Year of AV-45 Scan|Overall Study||0||
48058632|NCT00857415|100463674|FG000|COMPLETED|Overall Study||35||
48058633|NCT00857415|100463675|FG001|COMPLETED|Overall Study||74||
48058634|NCT00857415|100463674|FG000|NOT COMPLETED|Overall Study||117||
48058635|NCT00857415|100463675|FG001|NOT COMPLETED|Overall Study||0||
48058636|NCT03718871|100463676|FG000|STARTED|Overall Study||250||8
48058637|NCT03718871|100463677|FG001|STARTED|Overall Study||250||9
48058638|NCT03718871|100463676|FG000|COMPLETED|Overall Study||250||8
48058639|NCT03718871|100463677|FG001|COMPLETED|Overall Study||250||9
48058640|NCT03718871|100463676|FG000|NOT COMPLETED|Overall Study||0||0
48058641|NCT03718871|100463677|FG001|NOT COMPLETED|Overall Study||0||0
48058642|NCT01267656|100463678|FG000|STARTED|Overall Study||83||
48058643|NCT01267656|100463679|FG001|STARTED|Overall Study||83||
48058644|NCT01267656|100463678|FG000|COMPLETED|Overall Study||82||
48058645|NCT01267656|100463679|FG001|COMPLETED|Overall Study||82||
48058646|NCT01267656|100463678|FG000|NOT COMPLETED|Overall Study||1||
48058647|NCT01267656|100463679|FG001|NOT COMPLETED|Overall Study||1||
48058648|NCT00518973|100463680|FG000|STARTED|Overall Study||9||
48058649|NCT00518973|100463681|FG001|STARTED|Overall Study||6||
48058650|NCT00518973|100463680|FG000|COMPLETED|Overall Study||6||
48058651|NCT00518973|100463681|FG001|COMPLETED|Overall Study||4||
48058652|NCT00518973|100463680|FG000|NOT COMPLETED|Overall Study||3||
48058653|NCT00518973|100463681|FG001|NOT COMPLETED|Overall Study||2||
48058654|NCT00386607|100463682|FG000|STARTED|Core||601||
48058655|NCT00386607|100463683|FG001|STARTED|Core||0||
48058656|NCT00386607|100463682|FG000|COMPLETED|Core||486||
48058657|NCT00386607|100463683|FG001|COMPLETED|Core||0||
48058658|NCT00386607|100463682|FG000|NOT COMPLETED|Core||115||
48058659|NCT00386607|100463683|FG001|NOT COMPLETED|Core||0||
48058660|NCT00386607|100463682|FG000|STARTED|Extension||0||
48058661|NCT00386607|100463683|FG001|STARTED|Extension||162||
48058662|NCT00386607|100463682|FG000|COMPLETED|Extension||0||
48058663|NCT00386607|100463683|FG001|COMPLETED|Extension||145||
48058664|NCT00386607|100463682|FG000|NOT COMPLETED|Extension||0||
48058665|NCT00386607|100463683|FG001|NOT COMPLETED|Extension||17||
48058666|NCT04432272|100463684|FG000|STARTED|Overall Study||43||
48058667|NCT04432272|100463685|FG001|STARTED|Overall Study||28||
48058668|NCT04432272|100463684|FG000|COMPLETED|Overall Study||43||
48058669|NCT04432272|100463685|FG001|COMPLETED|Overall Study||28||
48058670|NCT04432272|100463684|FG000|NOT COMPLETED|Overall Study||0||
48058671|NCT04432272|100463685|FG001|NOT COMPLETED|Overall Study||0||
48058672|NCT01676727|100463686|FG000|STARTED|Overall Study||100||
48058673|NCT01676727|100463686|FG000|Implanted|Overall Study||92||
48058674|NCT01676727|100463686|FG000|COMPLETED|Overall Study||68||
48058675|NCT01676727|100463686|FG000|NOT COMPLETED|Overall Study||32||
48058676|NCT03139279|100463687|FG000|STARTED|Overall Study||58||
48058677|NCT03139279|100463688|FG001|STARTED|Overall Study||56||
48058678|NCT03139279|100463687|FG000|COMPLETED|Overall Study||51||
48058679|NCT03139279|100463688|FG001|COMPLETED|Overall Study||50||
48058680|NCT03139279|100463687|FG000|NOT COMPLETED|Overall Study||7||
48058681|NCT03139279|100463688|FG001|NOT COMPLETED|Overall Study||6||
48058682|NCT04490239|100463689|FG000|STARTED|1000 U Acute (One Dose, Day 1)||6||
48058683|NCT04490239|100463689|FG000|COMPLETED|1000 U Acute (One Dose, Day 1)||6||
48058684|NCT04490239|100463689|FG000|NOT COMPLETED|1000 U Acute (One Dose, Day 1)||0||
48058685|NCT04490239|100463689|FG000|STARTED|2000 U Acute (One Dose, Day 3)||6||
48058686|NCT04490239|100463689|FG000|COMPLETED|2000 U Acute (One Dose, Day 3)||6||
48058687|NCT04490239|100463689|FG000|NOT COMPLETED|2000 U Acute (One Dose, Day 3)||0||
48058688|NCT04490239|100463689|FG000|STARTED|2000 U Chronic (Daily, 14 Days)||6||
48058689|NCT04490239|100463689|FG000|COMPLETED|2000 U Chronic (Daily, 14 Days)||6||
48058690|NCT04490239|100463689|FG000|NOT COMPLETED|2000 U Chronic (Daily, 14 Days)||0||
48058691|NCT00723931|100463690|FG000|STARTED|Overall Study||1267||
48058692|NCT00723931|100463690|FG000|COMPLETED|Overall Study||1267||
48495863|NCT02462837|101547952|FG000|NOT COMPLETED|Overall Study||2||
48495864|NCT02462837|101547953|FG001|NOT COMPLETED|Overall Study||0||
48058693|NCT00723931|100463690|FG000|NOT COMPLETED|Overall Study||0||
48058694|NCT01986140|100463691|FG000|STARTED|Overall Study||157|subjects who were randomized|
48058695|NCT01986140|100463692|FG001|STARTED|Overall Study||79|subjects who were randomized|
48058696|NCT01986140|100463691|FG000|COMPLETED|Overall Study||122|subjects who underwent scalp cooling or non-cooling for a 4 cycles of chemotherapy|
48058697|NCT01986140|100463692|FG001|COMPLETED|Overall Study||51|subjects who underwent scalp cooling or non-cooling for a 4 cycles of chemotherapy|
48058698|NCT01986140|100463691|FG000|NOT COMPLETED|Overall Study||35||
48058699|NCT01986140|100463692|FG001|NOT COMPLETED|Overall Study||28||
48058700|NCT00910988|100463693|FG000|STARTED|Overall Study||16||
48058701|NCT00910988|100463694|FG001|STARTED|Overall Study||16||
48495865|NCT00538031|101547954|FG000|STARTED|Overall Study||26||
48058702|NCT00910988|100463695|FG002|STARTED|Overall Study||8||
48058703|NCT00910988|100463696|FG003|STARTED|Overall Study||6||
48058704|NCT00910988|100463693|FG000|COMPLETED|Overall Study||14||
48208656|NCT04763044|100837093|FG000|COMPLETED|Period 1||3||
48495866|NCT00538031|101547955|FG001|STARTED|Overall Study||26||
48495867|NCT00538031|101547954|FG000|COMPLETED|Overall Study||26||
48495868|NCT00538031|101547955|FG001|COMPLETED|Overall Study||26||
48058705|NCT00910988|100463694|FG001|COMPLETED|Overall Study||12||
48058706|NCT00910988|100463695|FG002|COMPLETED|Overall Study||5||
48058707|NCT00910988|100463696|FG003|COMPLETED|Overall Study||6||
48058708|NCT00910988|100463693|FG000|NOT COMPLETED|Overall Study||2||
48058709|NCT00910988|100463694|FG001|NOT COMPLETED|Overall Study||4||
48058710|NCT00910988|100463695|FG002|NOT COMPLETED|Overall Study||3||
48058711|NCT00910988|100463696|FG003|NOT COMPLETED|Overall Study||0||
48058712|NCT02713204|100463697|FG000|STARTED|Baseline (Day 1) up to Week 12||60||
48495869|NCT00538031|101547954|FG000|NOT COMPLETED|Overall Study||0||
48208657|NCT04763044|100837094|FG001|COMPLETED|Period 1||4||
48058713|NCT02713204|100463698|FG001|STARTED|Baseline (Day 1) up to Week 12||122||
48058714|NCT02713204|100463699|FG002|STARTED|Baseline (Day 1) up to Week 12||183||
48058715|NCT02713204|100463700|FG003|STARTED|Baseline (Day 1) up to Week 12||0||
48058716|NCT02713204|100463701|FG004|STARTED|Baseline (Day 1) up to Week 12||0||
48058717|NCT02713204|100463702|FG005|STARTED|Baseline (Day 1) up to Week 12||0||
48058718|NCT02713204|100463703|FG006|STARTED|Baseline (Day 1) up to Week 12||0||
48058719|NCT02713204|100463704|FG007|STARTED|Baseline (Day 1) up to Week 12||0||
48058720|NCT02713204|100463697|FG000|COMPLETED|Baseline (Day 1) up to Week 12||59||
48058721|NCT02713204|100463698|FG001|COMPLETED|Baseline (Day 1) up to Week 12||121||
48058722|NCT02713204|100463699|FG002|COMPLETED|Baseline (Day 1) up to Week 12||181||
48058723|NCT02713204|100463700|FG003|COMPLETED|Baseline (Day 1) up to Week 12||0||
48058724|NCT02713204|100463701|FG004|COMPLETED|Baseline (Day 1) up to Week 12||0||
48058725|NCT02713204|100463702|FG005|COMPLETED|Baseline (Day 1) up to Week 12||0||
48058726|NCT02713204|100463703|FG006|COMPLETED|Baseline (Day 1) up to Week 12||0||
48058727|NCT02713204|100463704|FG007|COMPLETED|Baseline (Day 1) up to Week 12||0||
48058728|NCT02713204|100463697|FG000|NOT COMPLETED|Baseline (Day 1) up to Week 12||1||
48058729|NCT02713204|100463698|FG001|NOT COMPLETED|Baseline (Day 1) up to Week 12||1||
48058730|NCT02713204|100463699|FG002|NOT COMPLETED|Baseline (Day 1) up to Week 12||2||
48058731|NCT02713204|100463700|FG003|NOT COMPLETED|Baseline (Day 1) up to Week 12||0||
48058732|NCT02713204|100463701|FG004|NOT COMPLETED|Baseline (Day 1) up to Week 12||0||
48058733|NCT02713204|100463702|FG005|NOT COMPLETED|Baseline (Day 1) up to Week 12||0||
48058734|NCT02713204|100463703|FG006|NOT COMPLETED|Baseline (Day 1) up to Week 12||0||
48058735|NCT02713204|100463704|FG007|NOT COMPLETED|Baseline (Day 1) up to Week 12||0||
48058736|NCT02713204|100463697|FG000|STARTED|From Week 12 up to Week 36||58||
48058737|NCT02713204|100463698|FG001|STARTED|From Week 12 up to Week 36||0||
48058738|NCT02713204|100463699|FG002|STARTED|From Week 12 up to Week 36||0||
48058739|NCT02713204|100463700|FG003|STARTED|From Week 12 up to Week 36||57||
48058740|NCT02713204|100463701|FG004|STARTED|From Week 12 up to Week 36||62||
48058741|NCT02713204|100463702|FG005|STARTED|From Week 12 up to Week 36||60||
48058742|NCT02713204|100463703|FG006|STARTED|From Week 12 up to Week 36||62||
48058743|NCT02713204|100463704|FG007|STARTED|From Week 12 up to Week 36||58||
48058744|NCT02713204|100463697|FG000|COMPLETED|From Week 12 up to Week 36||57||
48058745|NCT02713204|100463698|FG001|COMPLETED|From Week 12 up to Week 36||0||
48058746|NCT02713204|100463699|FG002|COMPLETED|From Week 12 up to Week 36||0||
48058747|NCT02713204|100463700|FG003|COMPLETED|From Week 12 up to Week 36||53||
48058748|NCT02713204|100463701|FG004|COMPLETED|From Week 12 up to Week 36||60||
48058749|NCT02713204|100463702|FG005|COMPLETED|From Week 12 up to Week 36||59||
48058750|NCT02713204|100463703|FG006|COMPLETED|From Week 12 up to Week 36||60||
48058751|NCT02713204|100463704|FG007|COMPLETED|From Week 12 up to Week 36||54||
48058752|NCT02713204|100463697|FG000|NOT COMPLETED|From Week 12 up to Week 36||1||
48058753|NCT02713204|100463698|FG001|NOT COMPLETED|From Week 12 up to Week 36||0||
48058754|NCT02713204|100463699|FG002|NOT COMPLETED|From Week 12 up to Week 36||0||
48058755|NCT02713204|100463700|FG003|NOT COMPLETED|From Week 12 up to Week 36||4||
48208658|NCT04763044|100837095|FG002|COMPLETED|Period 1||4||
48208659|NCT04763044|100837096|FG003|COMPLETED|Period 1||3||
48208660|NCT04763044|100837093|FG000|NOT COMPLETED|Period 1||0||
48208661|NCT04763044|100837094|FG001|NOT COMPLETED|Period 1||0||
48208662|NCT04763044|100837095|FG002|NOT COMPLETED|Period 1||0||
48208663|NCT04763044|100837096|FG003|NOT COMPLETED|Period 1||1||
48208664|NCT04763044|100837093|FG000|STARTED|Period 2||3||
48208665|NCT04763044|100837094|FG001|STARTED|Period 2||4||
48058756|NCT02713204|100463701|FG004|NOT COMPLETED|From Week 12 up to Week 36||2||
48058757|NCT02713204|100463702|FG005|NOT COMPLETED|From Week 12 up to Week 36||1||
48058758|NCT02713204|100463703|FG006|NOT COMPLETED|From Week 12 up to Week 36||2||
48058759|NCT02713204|100463704|FG007|NOT COMPLETED|From Week 12 up to Week 36||4||
48058760|NCT01927341|100463705|FG000|STARTED|Phase 1b||10||
48058761|NCT01927341|100463706|FG001|STARTED|Phase 1b||0||
48058762|NCT01927341|100463707|FG002|STARTED|Phase 1b||0||
48058763|NCT01927341|100463708|FG003|STARTED|Phase 1b||0||
48058764|NCT01927341|100463709|FG004|STARTED|Phase 1b||0||
48058765|NCT01927341|100463705|FG000|COMPLETED|Phase 1b||0||
48058766|NCT01927341|100463706|FG001|COMPLETED|Phase 1b||0||
48058767|NCT01927341|100463707|FG002|COMPLETED|Phase 1b||0||
48058768|NCT01927341|100463708|FG003|COMPLETED|Phase 1b||0||
48058769|NCT01927341|100463709|FG004|COMPLETED|Phase 1b||0||
48058770|NCT01927341|100463705|FG000|NOT COMPLETED|Phase 1b||10||
48058771|NCT01927341|100463706|FG001|NOT COMPLETED|Phase 1b||0||
48058772|NCT01927341|100463707|FG002|NOT COMPLETED|Phase 1b||0||
48058773|NCT01927341|100463708|FG003|NOT COMPLETED|Phase 1b||0||
48058774|NCT01927341|100463709|FG004|NOT COMPLETED|Phase 1b||0||
48058775|NCT01927341|100463705|FG000|STARTED|Phase 2||0||
48058776|NCT01927341|100463706|FG001|STARTED|Phase 2||15||
48058777|NCT01927341|100463707|FG002|STARTED|Phase 2||5||
48058778|NCT01927341|100463708|FG003|STARTED|Phase 2||15||
48058779|NCT01927341|100463709|FG004|STARTED|Phase 2||8||
48058780|NCT01927341|100463705|FG000|COMPLETED|Phase 2||0||
48058781|NCT01927341|100463706|FG001|COMPLETED|Phase 2||0||
48058782|NCT01927341|100463707|FG002|COMPLETED|Phase 2||0||
48058783|NCT01927341|100463708|FG003|COMPLETED|Phase 2||0||
48058784|NCT01927341|100463709|FG004|COMPLETED|Phase 2||0||
48208666|NCT04763044|100837095|FG002|STARTED|Period 2||4||
48058785|NCT01927341|100463705|FG000|NOT COMPLETED|Phase 2||0||
48058786|NCT01927341|100463706|FG001|NOT COMPLETED|Phase 2||15||
48058787|NCT01927341|100463707|FG002|NOT COMPLETED|Phase 2||5||
48058788|NCT01927341|100463708|FG003|NOT COMPLETED|Phase 2||15||
48058789|NCT01927341|100463709|FG004|NOT COMPLETED|Phase 2||8||
48058790|NCT02127723|100463710|FG000|STARTED|Overall Study||20||
48058791|NCT02127723|100463710|FG000|COMPLETED|Overall Study||19||
48058792|NCT02127723|100463710|FG000|NOT COMPLETED|Overall Study||1||
48058793|NCT02237911|100463711|FG000|STARTED|Overall Study||96||
48058794|NCT02237911|100463712|FG001|STARTED|Overall Study||96||
48058795|NCT02237911|100463713|FG002|STARTED|Overall Study||48||
48058796|NCT02237911|100463711|FG000|3 Months|Overall Study||90||
48058797|NCT02237911|100463712|FG001|3 Months|Overall Study||87||
48058798|NCT02237911|100463713|FG002|3 Months|Overall Study||44||
48058799|NCT02237911|100463711|FG000|6 Months|Overall Study||89||
48058800|NCT02237911|100463712|FG001|6 Months|Overall Study||88||
48058801|NCT02237911|100463713|FG002|6 Months|Overall Study||45||
48058802|NCT02237911|100463711|FG000|COMPLETED|Overall Study||89||
48058803|NCT02237911|100463712|FG001|COMPLETED|Overall Study||88||
48058804|NCT02237911|100463713|FG002|COMPLETED|Overall Study||45||
48058805|NCT02237911|100463711|FG000|NOT COMPLETED|Overall Study||7||
48058806|NCT02237911|100463712|FG001|NOT COMPLETED|Overall Study||8||
48058807|NCT02237911|100463713|FG002|NOT COMPLETED|Overall Study||3||
48058808|NCT03190369|100463714|FG000|STARTED|Overall Study||220||
48058809|NCT03190369|100463715|FG001|STARTED|Overall Study||220||
48058810|NCT03190369|100463714|FG000|Treated|Overall Study||220||
48058811|NCT03190369|100463715|FG001|Treated|Overall Study||218||
48058812|NCT03190369|100463714|FG000|COMPLETED|Overall Study||219||
48058813|NCT03190369|100463715|FG001|COMPLETED|Overall Study||212||
48058814|NCT03190369|100463714|FG000|NOT COMPLETED|Overall Study||1||
48058815|NCT03190369|100463715|FG001|NOT COMPLETED|Overall Study||8||
48058816|NCT01672736|100463716|FG000|STARTED|Overall Study||19||
48058817|NCT01672736|100463716|FG000|COMPLETED|Overall Study||16|Phase II part of the study not done due to termination of further study drug development.|
48058818|NCT01672736|100463716|FG000|NOT COMPLETED|Overall Study||3||
48058819|NCT00841971|100463717|FG000|STARTED|Overall Study||100||
48058820|NCT00841971|100463718|FG001|STARTED|Overall Study||100||
48058821|NCT00841971|100463717|FG000|COMPLETED|Overall Study||98||
48058822|NCT00841971|100463718|FG001|COMPLETED|Overall Study||99||
48058823|NCT00841971|100463717|FG000|NOT COMPLETED|Overall Study||2||
48058824|NCT00841971|100463718|FG001|NOT COMPLETED|Overall Study||1||
48058825|NCT05736224|100463719|FG000|STARTED|Overall Study||30||
48058826|NCT05736224|100463719|FG000|Formulation 1|Overall Study||8||
48058827|NCT05736224|100463719|FG000|Formulation 2|Overall Study||14||
48058828|NCT05736224|100463719|FG000|Formulation 3|Overall Study||8||
48058829|NCT05736224|100463719|FG000|COMPLETED|Overall Study||29||
48058830|NCT05736224|100463719|FG000|NOT COMPLETED|Overall Study||1||
48058831|NCT00073073|100463720|FG000|STARTED|Overall Study||46||
48058832|NCT00073073|100463720|FG000|COMPLETED|Overall Study||42||
48058833|NCT00073073|100463720|FG000|NOT COMPLETED|Overall Study||4||
48058834|NCT01886716|100463721|FG000|STARTED|Week 1||24||
48058835|NCT01886716|100463722|FG001|STARTED|Week 1||20||
48058836|NCT01886716|100463723|FG002|STARTED|Week 1||22||
48058837|NCT01886716|100463724|FG003|STARTED|Week 1||20||
48058838|NCT01886716|100463721|FG000|COMPLETED|Week 1||24||
48058839|NCT01886716|100463722|FG001|COMPLETED|Week 1||20||
48058840|NCT01886716|100463723|FG002|COMPLETED|Week 1||20||
48058841|NCT01886716|100463724|FG003|COMPLETED|Week 1||18||
48058842|NCT01886716|100463721|FG000|NOT COMPLETED|Week 1||0||
48058843|NCT01886716|100463722|FG001|NOT COMPLETED|Week 1||0||
48058844|NCT01886716|100463723|FG002|NOT COMPLETED|Week 1||2||
48058845|NCT01886716|100463724|FG003|NOT COMPLETED|Week 1||2||
48058846|NCT01886716|100463721|FG000|STARTED|Week 2||24||
48058847|NCT01886716|100463722|FG001|STARTED|Week 2||20||
48058848|NCT01886716|100463723|FG002|STARTED|Week 2||20||
48058849|NCT01886716|100463724|FG003|STARTED|Week 2||18||
48058850|NCT01886716|100463721|FG000|COMPLETED|Week 2||21||
48058851|NCT01886716|100463722|FG001|COMPLETED|Week 2||18||
48058852|NCT01886716|100463723|FG002|COMPLETED|Week 2||19||
48058853|NCT01886716|100463724|FG003|COMPLETED|Week 2||15||
48058854|NCT01886716|100463721|FG000|NOT COMPLETED|Week 2||3||
48058855|NCT01886716|100463722|FG001|NOT COMPLETED|Week 2||2||
48058856|NCT01886716|100463723|FG002|NOT COMPLETED|Week 2||1||
48058857|NCT01886716|100463724|FG003|NOT COMPLETED|Week 2||3||
48058858|NCT01886716|100463721|FG000|STARTED|Week 3||21||
48058859|NCT01886716|100463722|FG001|STARTED|Week 3||18||
48058860|NCT01886716|100463723|FG002|STARTED|Week 3||19||
48058861|NCT01886716|100463724|FG003|STARTED|Week 3||15||
48058862|NCT01886716|100463721|FG000|COMPLETED|Week 3||20||
48058863|NCT01886716|100463722|FG001|COMPLETED|Week 3||17||
48058864|NCT01886716|100463723|FG002|COMPLETED|Week 3||19||
48058865|NCT01886716|100463724|FG003|COMPLETED|Week 3||14||
48058866|NCT01886716|100463721|FG000|NOT COMPLETED|Week 3||1||
48058867|NCT01886716|100463722|FG001|NOT COMPLETED|Week 3||1||
48058868|NCT01886716|100463723|FG002|NOT COMPLETED|Week 3||0||
48058869|NCT01886716|100463724|FG003|NOT COMPLETED|Week 3||1||
48058870|NCT01886716|100463721|FG000|STARTED|Week 4||20||
48058871|NCT01886716|100463722|FG001|STARTED|Week 4||17||
48058872|NCT01886716|100463723|FG002|STARTED|Week 4||19||
48058873|NCT01886716|100463724|FG003|STARTED|Week 4||14||
48058874|NCT01886716|100463721|FG000|COMPLETED|Week 4||20||
48058875|NCT01886716|100463722|FG001|COMPLETED|Week 4||17||
48058876|NCT01886716|100463723|FG002|COMPLETED|Week 4||19||
48058877|NCT01886716|100463724|FG003|COMPLETED|Week 4||14||
48058878|NCT01886716|100463721|FG000|NOT COMPLETED|Week 4||0||
48058879|NCT01886716|100463722|FG001|NOT COMPLETED|Week 4||0||
48058880|NCT01886716|100463723|FG002|NOT COMPLETED|Week 4||0||
48058881|NCT01886716|100463724|FG003|NOT COMPLETED|Week 4||0||
48058882|NCT01886716|100463721|FG000|STARTED|1-Week Post Follow-Up||20||
48058883|NCT01886716|100463722|FG001|STARTED|1-Week Post Follow-Up||17||
48058884|NCT01886716|100463723|FG002|STARTED|1-Week Post Follow-Up||19||
48058885|NCT01886716|100463724|FG003|STARTED|1-Week Post Follow-Up||14||
48058886|NCT01886716|100463721|FG000|COMPLETED|1-Week Post Follow-Up||20||
48058887|NCT01886716|100463722|FG001|COMPLETED|1-Week Post Follow-Up||17||
48058888|NCT01886716|100463723|FG002|COMPLETED|1-Week Post Follow-Up||19||
48058889|NCT01886716|100463724|FG003|COMPLETED|1-Week Post Follow-Up||14||
48058890|NCT01886716|100463721|FG000|NOT COMPLETED|1-Week Post Follow-Up||0||
48058891|NCT01886716|100463722|FG001|NOT COMPLETED|1-Week Post Follow-Up||0||
48058892|NCT01886716|100463723|FG002|NOT COMPLETED|1-Week Post Follow-Up||0||
48058893|NCT01886716|100463724|FG003|NOT COMPLETED|1-Week Post Follow-Up||0||
48058894|NCT01886716|100463721|FG000|STARTED|1-Month Post Follow-Up||20||
48058895|NCT01886716|100463722|FG001|STARTED|1-Month Post Follow-Up||17||
48058896|NCT01886716|100463723|FG002|STARTED|1-Month Post Follow-Up||19||
48058897|NCT01886716|100463724|FG003|STARTED|1-Month Post Follow-Up||14||
48058898|NCT01886716|100463721|FG000|COMPLETED|1-Month Post Follow-Up||20||
48058899|NCT01886716|100463722|FG001|COMPLETED|1-Month Post Follow-Up||17||
48058900|NCT01886716|100463723|FG002|COMPLETED|1-Month Post Follow-Up||19||
48058901|NCT01886716|100463724|FG003|COMPLETED|1-Month Post Follow-Up||14||
48058902|NCT01886716|100463721|FG000|NOT COMPLETED|1-Month Post Follow-Up||0||
48058903|NCT01886716|100463722|FG001|NOT COMPLETED|1-Month Post Follow-Up||0||
48058904|NCT01886716|100463723|FG002|NOT COMPLETED|1-Month Post Follow-Up||0||
48058905|NCT01886716|100463724|FG003|NOT COMPLETED|1-Month Post Follow-Up||0||
48058906|NCT01952600|100463725|FG000|STARTED|Overall Study||80||
48058907|NCT01952600|100463726|FG001|STARTED|Overall Study||90||
48058908|NCT01952600|100463727|FG002|STARTED|Overall Study||45||
48058909|NCT01952600|100463725|FG000|COMPLETED|Overall Study||65||
48058910|NCT01952600|100463726|FG001|COMPLETED|Overall Study||77||
48058911|NCT01952600|100463727|FG002|COMPLETED|Overall Study||38||
48208667|NCT04763044|100837096|FG003|STARTED|Period 2||3||
48208668|NCT04763044|100837093|FG000|COMPLETED|Period 2||3||
48058912|NCT01952600|100463725|FG000|NOT COMPLETED|Overall Study||15||
48058913|NCT01952600|100463726|FG001|NOT COMPLETED|Overall Study||13||
48058914|NCT01952600|100463727|FG002|NOT COMPLETED|Overall Study||7||
48058915|NCT00945555|100463728|FG000|STARTED|Overall Study||264||
48058916|NCT00945555|100463728|FG000|COMPLETED|Overall Study||236||
48058917|NCT00945555|100463728|FG000|NOT COMPLETED|Overall Study||28||
48058918|NCT04251273|100463729|FG000|STARTED|Overall Study||1304||
48058919|NCT04251273|100463730|FG001|STARTED|Overall Study||1284||
48058920|NCT04251273|100463729|FG000|COMPLETED|Overall Study||973||
48058921|NCT04251273|100463730|FG001|COMPLETED|Overall Study||994||
48058922|NCT04251273|100463729|FG000|NOT COMPLETED|Overall Study||331||
48058923|NCT04251273|100463730|FG001|NOT COMPLETED|Overall Study||290||
48058924|NCT03139318|100463731|FG000|STARTED|Overall Study||1||
48058925|NCT03139318|100463731|FG000|COMPLETED|Overall Study||1||
48058926|NCT03139318|100463731|FG000|NOT COMPLETED|Overall Study||0||
48058927|NCT01484054|100466797|FG000|STARTED|Period 1||50||
48058928|NCT01484054|100466798|FG001|STARTED|Period 1||50||
48058929|NCT01484054|100466797|FG000|COMPLETED|Period 1||50||
48058930|NCT01484054|100466798|FG001|COMPLETED|Period 1||49||
48495870|NCT00538031|101547955|FG001|NOT COMPLETED|Overall Study||0||
48495871|NCT02385708|101547956|FG000|STARTED|Overall Study||81||
48058931|NCT01484054|100466797|FG000|NOT COMPLETED|Period 1||0||
48058932|NCT01484054|100466798|FG001|NOT COMPLETED|Period 1||1||
48058933|NCT01484054|100466797|FG000|STARTED|Period 2||50||
48058934|NCT01484054|100466798|FG001|STARTED|Period 2||49||
48058935|NCT01484054|100466797|FG000|COMPLETED|Period 2||50||
48058936|NCT01484054|100466798|FG001|COMPLETED|Period 2||49||
48058937|NCT01484054|100466797|FG000|NOT COMPLETED|Period 2||0||
48058938|NCT01484054|100466798|FG001|NOT COMPLETED|Period 2||0||
48058939|NCT00598702|100466799|FG000|STARTED|Overall Study||1||
48058940|NCT00598702|100466800|FG001|STARTED|Overall Study||3||
48058941|NCT00598702|100466801|FG002|STARTED|Overall Study||7||
48058942|NCT00598702|100466802|FG003|STARTED|Overall Study||33||
48058943|NCT00598702|100466803|FG004|STARTED|Overall Study||9||
48058944|NCT00598702|100466804|FG005|STARTED|Overall Study||42||
48058945|NCT00598702|100466805|FG006|STARTED|Overall Study||1||
48058946|NCT00598702|100466806|FG007|STARTED|Overall Study||4||
48058947|NCT00598702|100466799|FG000|COMPLETED|Overall Study||1||
48058948|NCT00598702|100466800|FG001|COMPLETED|Overall Study||1||
48058949|NCT00598702|100466801|FG002|COMPLETED|Overall Study||5||
48058950|NCT00598702|100466802|FG003|COMPLETED|Overall Study||25||
48058951|NCT00598702|100466803|FG004|COMPLETED|Overall Study||6||
48058952|NCT00598702|100466804|FG005|COMPLETED|Overall Study||30||
48058953|NCT00598702|100466805|FG006|COMPLETED|Overall Study||0||
48208669|NCT04763044|100837094|FG001|COMPLETED|Period 2||4||
48058954|NCT00598702|100466806|FG007|COMPLETED|Overall Study||4||
48058955|NCT00598702|100466799|FG000|NOT COMPLETED|Overall Study||0||
48058956|NCT00598702|100466800|FG001|NOT COMPLETED|Overall Study||2||
48058957|NCT00598702|100466801|FG002|NOT COMPLETED|Overall Study||2||
48058958|NCT00598702|100466802|FG003|NOT COMPLETED|Overall Study||8||
48058959|NCT00598702|100466803|FG004|NOT COMPLETED|Overall Study||3||
48058960|NCT00598702|100466804|FG005|NOT COMPLETED|Overall Study||12||
48058961|NCT00598702|100466805|FG006|NOT COMPLETED|Overall Study||1||
48058962|NCT00598702|100466806|FG007|NOT COMPLETED|Overall Study||0||
48058963|NCT04916769|100466807|FG000|STARTED|Period 1||3||
48058964|NCT04916769|100466808|FG001|STARTED|Period 1||3||
48058965|NCT04916769|100466809|FG002|STARTED|Period 1||3||
48058966|NCT04916769|100466810|FG003|STARTED|Period 1||3||
48058967|NCT04916769|100466811|FG004|STARTED|Period 1||3||
48058968|NCT04916769|100466812|FG005|STARTED|Period 1||3||
48058969|NCT04916769|100466807|FG000|COMPLETED|Period 1||3||
48058970|NCT04916769|100466808|FG001|COMPLETED|Period 1||3||
48058971|NCT04916769|100466809|FG002|COMPLETED|Period 1||3||
48058972|NCT04916769|100466810|FG003|COMPLETED|Period 1||3||
48058973|NCT04916769|100466811|FG004|COMPLETED|Period 1||3||
48058974|NCT04916769|100466812|FG005|COMPLETED|Period 1||2||
48058975|NCT04916769|100466807|FG000|NOT COMPLETED|Period 1||0||
48058976|NCT04916769|100466808|FG001|NOT COMPLETED|Period 1||0||
48058977|NCT04916769|100466809|FG002|NOT COMPLETED|Period 1||0||
48058978|NCT04916769|100466810|FG003|NOT COMPLETED|Period 1||0||
48058979|NCT04916769|100466811|FG004|NOT COMPLETED|Period 1||0||
48058980|NCT04916769|100466812|FG005|NOT COMPLETED|Period 1||1||
48058981|NCT04916769|100466807|FG000|STARTED|Period 2||3||
48058982|NCT04916769|100466808|FG001|STARTED|Period 2||3||
48058983|NCT04916769|100466809|FG002|STARTED|Period 2||3||
48058984|NCT04916769|100466810|FG003|STARTED|Period 2||3||
48058985|NCT04916769|100466811|FG004|STARTED|Period 2||3||
48058986|NCT04916769|100466812|FG005|STARTED|Period 2||2||
48058987|NCT04916769|100466807|FG000|COMPLETED|Period 2||3||
48058988|NCT04916769|100466808|FG001|COMPLETED|Period 2||2||
48058989|NCT04916769|100466809|FG002|COMPLETED|Period 2||3||
48058990|NCT04916769|100466810|FG003|COMPLETED|Period 2||3||
48058991|NCT04916769|100466811|FG004|COMPLETED|Period 2||3||
48058992|NCT04916769|100466812|FG005|COMPLETED|Period 2||2||
48058993|NCT04916769|100466807|FG000|NOT COMPLETED|Period 2||0||
48058994|NCT04916769|100466808|FG001|NOT COMPLETED|Period 2||1||
48058995|NCT04916769|100466809|FG002|NOT COMPLETED|Period 2||0||
48058996|NCT04916769|100466810|FG003|NOT COMPLETED|Period 2||0||
48058997|NCT04916769|100466811|FG004|NOT COMPLETED|Period 2||0||
48058998|NCT04916769|100466812|FG005|NOT COMPLETED|Period 2||0||
48058999|NCT04916769|100466807|FG000|STARTED|Period 3||3||
48059000|NCT04916769|100466808|FG001|STARTED|Period 3||2||
48059001|NCT04916769|100466809|FG002|STARTED|Period 3||3||
48059002|NCT04916769|100466810|FG003|STARTED|Period 3||3||
48059003|NCT04916769|100466811|FG004|STARTED|Period 3||3||
48059004|NCT04916769|100466812|FG005|STARTED|Period 3||2||
48059005|NCT04916769|100466807|FG000|COMPLETED|Period 3||3||
48059006|NCT04916769|100466808|FG001|COMPLETED|Period 3||2||
48059007|NCT04916769|100466809|FG002|COMPLETED|Period 3||3||
48059008|NCT04916769|100466810|FG003|COMPLETED|Period 3||3||
48059009|NCT04916769|100466811|FG004|COMPLETED|Period 3||3||
48059010|NCT04916769|100466812|FG005|COMPLETED|Period 3||2||
48059011|NCT04916769|100466807|FG000|NOT COMPLETED|Period 3||0||
48059012|NCT04916769|100466808|FG001|NOT COMPLETED|Period 3||0||
48059013|NCT04916769|100466809|FG002|NOT COMPLETED|Period 3||0||
48059014|NCT04916769|100466810|FG003|NOT COMPLETED|Period 3||0||
48059015|NCT04916769|100466811|FG004|NOT COMPLETED|Period 3||0||
48059016|NCT04916769|100466812|FG005|NOT COMPLETED|Period 3||0||
48059017|NCT00423670|100466813|FG000|STARTED|Treatment Period||104||
48059018|NCT00423670|100466814|FG001|STARTED|Treatment Period||107||
48059019|NCT00423670|100466815|FG002|STARTED|Treatment Period||103||
48059020|NCT00423670|100466816|FG003|STARTED|Treatment Period||103||
48059021|NCT00423670|100466817|FG004|STARTED|Treatment Period||103||
48059022|NCT00423670|100466818|FG005|STARTED|Treatment Period||16||
48059023|NCT00423670|100466819|FG006|STARTED|Treatment Period||59||
48059024|NCT00423670|100466820|FG007|STARTED|Treatment Period||36||
48059025|NCT00423670|100466813|FG000|COMPLETED|Treatment Period||52||
48059026|NCT00423670|100466814|FG001|COMPLETED|Treatment Period||77||
48059027|NCT00423670|100466815|FG002|COMPLETED|Treatment Period||76||
48059028|NCT00423670|100466816|FG003|COMPLETED|Treatment Period||63||
48059029|NCT00423670|100466817|FG004|COMPLETED|Treatment Period||76||
48059030|NCT00423670|100466818|FG005|COMPLETED|Treatment Period||8||
48059031|NCT00423670|100466819|FG006|COMPLETED|Treatment Period||28||
48059032|NCT00423670|100466820|FG007|COMPLETED|Treatment Period||15||
48059033|NCT00423670|100466813|FG000|NOT COMPLETED|Treatment Period||52||
48059034|NCT00423670|100466814|FG001|NOT COMPLETED|Treatment Period||30||
48059035|NCT00423670|100466815|FG002|NOT COMPLETED|Treatment Period||27||
48059036|NCT00423670|100466816|FG003|NOT COMPLETED|Treatment Period||40||
48059037|NCT00423670|100466817|FG004|NOT COMPLETED|Treatment Period||27||
48059038|NCT00423670|100466818|FG005|NOT COMPLETED|Treatment Period||8||
48059039|NCT00423670|100466819|FG006|NOT COMPLETED|Treatment Period||31||
48059040|NCT00423670|100466820|FG007|NOT COMPLETED|Treatment Period||21||
48059041|NCT00423670|100466813|FG000|STARTED|Follow-up Period||97||
48059042|NCT00423670|100466814|FG001|STARTED|Follow-up Period||100||
48059043|NCT00423670|100466815|FG002|STARTED|Follow-up Period||96||
48059044|NCT00423670|100466816|FG003|STARTED|Follow-up Period||96||
48059045|NCT00423670|100466817|FG004|STARTED|Follow-up Period||91||
48059046|NCT00423670|100466818|FG005|STARTED|Follow-up Period||14||
48059047|NCT00423670|100466819|FG006|STARTED|Follow-up Period||50||
48059048|NCT00423670|100466820|FG007|STARTED|Follow-up Period||35||
48059049|NCT00423670|100466813|FG000|COMPLETED|Follow-up Period||94||
48059050|NCT00423670|100466814|FG001|COMPLETED|Follow-up Period||84||
48059051|NCT00423670|100466815|FG002|COMPLETED|Follow-up Period||85||
48059052|NCT00423670|100466816|FG003|COMPLETED|Follow-up Period||91||
48059053|NCT00423670|100466817|FG004|COMPLETED|Follow-up Period||89||
48059054|NCT00423670|100466818|FG005|COMPLETED|Follow-up Period||14||
48059055|NCT00423670|100466819|FG006|COMPLETED|Follow-up Period||41||
48059056|NCT00423670|100466820|FG007|COMPLETED|Follow-up Period||32||
48059057|NCT00423670|100466813|FG000|NOT COMPLETED|Follow-up Period||3||
48059058|NCT00423670|100466814|FG001|NOT COMPLETED|Follow-up Period||16||
48059059|NCT00423670|100466815|FG002|NOT COMPLETED|Follow-up Period||11||
48059060|NCT00423670|100466816|FG003|NOT COMPLETED|Follow-up Period||5||
48059061|NCT00423670|100466817|FG004|NOT COMPLETED|Follow-up Period||2||
48059062|NCT00423670|100466818|FG005|NOT COMPLETED|Follow-up Period||0||
48059063|NCT00423670|100466819|FG006|NOT COMPLETED|Follow-up Period||9||
48059064|NCT00423670|100466820|FG007|NOT COMPLETED|Follow-up Period||3||
48059065|NCT03114488|100466821|FG000|STARTED|Time Period 1||19||
48059066|NCT03114488|100466822|FG001|STARTED|Time Period 1||22||
48059067|NCT03114488|100466821|FG000|COMPLETED|Time Period 1||19||
48059068|NCT03114488|100466822|FG001|COMPLETED|Time Period 1||22||
48059069|NCT03114488|100466821|FG000|NOT COMPLETED|Time Period 1||0||
48059070|NCT03114488|100466822|FG001|NOT COMPLETED|Time Period 1||0||
48059071|NCT03114488|100466821|FG000|STARTED|Time Period 2||19||
48059072|NCT03114488|100466822|FG001|STARTED|Time Period 2||22||
48059073|NCT03114488|100466821|FG000|COMPLETED|Time Period 2||18||
48059074|NCT03114488|100466822|FG001|COMPLETED|Time Period 2||19||
48059075|NCT03114488|100466821|FG000|NOT COMPLETED|Time Period 2||1||
48059076|NCT03114488|100466822|FG001|NOT COMPLETED|Time Period 2||3||
48059077|NCT04963231|100466823|FG000|STARTED|Stage 1 (Open-Label, Duration: 16 Weeks)||164||
48059078|NCT04963231|100466824|FG001|STARTED|Stage 1 (Open-Label, Duration: 16 Weeks)||0||
48059079|NCT04963231|100466825|FG002|STARTED|Stage 1 (Open-Label, Duration: 16 Weeks)||0||
48059080|NCT04963231|100466823|FG000|COMPLETED|Stage 1 (Open-Label, Duration: 16 Weeks)||100||
48059081|NCT04963231|100466824|FG001|COMPLETED|Stage 1 (Open-Label, Duration: 16 Weeks)||0||
48059082|NCT04963231|100466825|FG002|COMPLETED|Stage 1 (Open-Label, Duration: 16 Weeks)||0||
48059083|NCT04963231|100466823|FG000|NOT COMPLETED|Stage 1 (Open-Label, Duration: 16 Weeks)||64||
48059084|NCT04963231|100466824|FG001|NOT COMPLETED|Stage 1 (Open-Label, Duration: 16 Weeks)||0||
48059085|NCT04963231|100466825|FG002|NOT COMPLETED|Stage 1 (Open-Label, Duration: 16 Weeks)||0||
48059086|NCT04963231|100466823|FG000|STARTED|Stage 2 (Double-Blind, Duration:24 Week)||0|Participants who completed Stage 1 were assessed for eligibility in Stage 2. At the Stage 2 Entry Visit, all eligible participants were randomized 2:1 to either continue daily setmelanotide or receive matching placebo.|
48059087|NCT04963231|100466824|FG001|STARTED|Stage 2 (Double-Blind, Duration:24 Week)||32|Participants who completed Stage 1 were assessed for eligibility in Stage 2. At the Stage 2 Entry Visit, all eligible participants were randomized 2:1 to either continue daily setmelanotide or receive matching placebo.|
48059088|NCT04963231|100466825|FG002|STARTED|Stage 2 (Double-Blind, Duration:24 Week)||17|Participants who completed Stage 1 were assessed for eligibility in Stage 2. At the Stage 2 Entry Visit, all eligible participants were randomized 2:1 to either continue daily setmelanotide or receive matching placebo.|
48059089|NCT04963231|100466823|FG000|Safety Analysis Set Enrolled in Stage 2|Stage 2 (Double-Blind, Duration:24 Week)||0|All participants who were enrolled in Stage 2 and received at least one dose of trial medication in Stage 2. Three participants in the placebo group were rescued with setmelanotide open-label during Stage 2. They were classified to setmelanotide group.|
48059090|NCT04963231|100466824|FG001|Safety Analysis Set Enrolled in Stage 2|Stage 2 (Double-Blind, Duration:24 Week)||35|All participants who were enrolled in Stage 2 and received at least one dose of trial medication in Stage 2. Three participants in the placebo group were rescued with setmelanotide open-label during Stage 2. They were classified to setmelanotide group.|
48059091|NCT04963231|100466825|FG002|Safety Analysis Set Enrolled in Stage 2|Stage 2 (Double-Blind, Duration:24 Week)||14|All participants who were enrolled in Stage 2 and received at least one dose of trial medication in Stage 2. Three participants in the placebo group were rescued with setmelanotide open-label during Stage 2. They were classified to setmelanotide group.|
48059092|NCT04963231|100466823|FG000|COMPLETED|Stage 2 (Double-Blind, Duration:24 Week)||0||
48059093|NCT04963231|100466824|FG001|COMPLETED|Stage 2 (Double-Blind, Duration:24 Week)||29||
48059094|NCT04963231|100466825|FG002|COMPLETED|Stage 2 (Double-Blind, Duration:24 Week)||10||
48059095|NCT04963231|100466823|FG000|NOT COMPLETED|Stage 2 (Double-Blind, Duration:24 Week)||0||
48059096|NCT04963231|100466824|FG001|NOT COMPLETED|Stage 2 (Double-Blind, Duration:24 Week)||3||
48059097|NCT04963231|100466825|FG002|NOT COMPLETED|Stage 2 (Double-Blind, Duration:24 Week)||7||
48059098|NCT01107418|100466826|FG000|STARTED|Overall Study||52||
48059099|NCT01107418|100466826|FG000|COMPLETED|Overall Study||0||
48059100|NCT01107418|100466826|FG000|NOT COMPLETED|Overall Study||52||
48059101|NCT02943460|100466827|FG000|STARTED|Blinded Study Phase||22||
48059102|NCT02943460|100466828|FG001|STARTED|Blinded Study Phase||20||
48059103|NCT02943460|100466829|FG002|STARTED|Blinded Study Phase||10||
48059104|NCT02943460|100466827|FG000|COMPLETED|Blinded Study Phase||19||
48059105|NCT02943460|100466828|FG001|COMPLETED|Blinded Study Phase||19||
48059106|NCT02943460|100466829|FG002|COMPLETED|Blinded Study Phase||10||
48059107|NCT02943460|100466827|FG000|NOT COMPLETED|Blinded Study Phase||3||
48059108|NCT02943460|100466828|FG001|NOT COMPLETED|Blinded Study Phase||1||
48059109|NCT02943460|100466829|FG002|NOT COMPLETED|Blinded Study Phase||0||
48059110|NCT02943460|100466827|FG000|STARTED|Open Label Extension (OLE) Phase||19||
48059111|NCT02943460|100466828|FG001|STARTED|Open Label Extension (OLE) Phase||18||
48059112|NCT02943460|100466829|FG002|STARTED|Open Label Extension (OLE) Phase||10||
48059113|NCT02943460|100466827|FG000|COMPLETED|Open Label Extension (OLE) Phase||14||
48059114|NCT02943460|100466828|FG001|COMPLETED|Open Label Extension (OLE) Phase||11||
48059115|NCT02943460|100466829|FG002|COMPLETED|Open Label Extension (OLE) Phase||8||
48059116|NCT02943460|100466827|FG000|NOT COMPLETED|Open Label Extension (OLE) Phase||5||
48059117|NCT02943460|100466828|FG001|NOT COMPLETED|Open Label Extension (OLE) Phase||7||
48059118|NCT02943460|100466829|FG002|NOT COMPLETED|Open Label Extension (OLE) Phase||2||
48059119|NCT02719327|100466830|FG000|STARTED|Overall Study||63||
48059120|NCT02719327|100466831|FG001|STARTED|Overall Study||68||
48059121|NCT02719327|100466830|FG000|COMPLETED|Overall Study||52||
48059122|NCT02719327|100466831|FG001|COMPLETED|Overall Study||60||
48059123|NCT02719327|100466830|FG000|NOT COMPLETED|Overall Study||11||
48059124|NCT02719327|100466831|FG001|NOT COMPLETED|Overall Study||8||
48059125|NCT04073368|100466832|FG000|STARTED|Overall Study||32||
48059126|NCT04073368|100466833|FG001|STARTED|Overall Study||26||
48059127|NCT04073368|100466834|FG002|STARTED|Overall Study||29||
48059128|NCT04073368|100466835|FG003|STARTED|Overall Study||15||
48059129|NCT04073368|100466832|FG000|COMPLETED|Overall Study||20||
48059130|NCT04073368|100466833|FG001|COMPLETED|Overall Study||18||
48059131|NCT04073368|100466834|FG002|COMPLETED|Overall Study||26||
48059132|NCT04073368|100466835|FG003|COMPLETED|Overall Study||13||
48059133|NCT04073368|100466832|FG000|NOT COMPLETED|Overall Study||12||
48059134|NCT04073368|100466833|FG001|NOT COMPLETED|Overall Study||8||
48059135|NCT04073368|100466834|FG002|NOT COMPLETED|Overall Study||3||
48059136|NCT04073368|100466835|FG003|NOT COMPLETED|Overall Study||2||
48059137|NCT02595970|100466836|FG000|STARTED|Overall Study||120||
48059138|NCT02595970|100466836|FG000|COMPLETED|Overall Study||100||
48059139|NCT02595970|100466836|FG000|NOT COMPLETED|Overall Study||20||
48059140|NCT04075279|100466837|FG000|STARTED|Overall Study||19||
48059141|NCT04075279|100466837|FG000|COMPLETED|Overall Study||19||
48059142|NCT04075279|100466837|FG000|NOT COMPLETED|Overall Study||0||
48059143|NCT00589290|100466838|FG000|STARTED|Overall Study||41||
48059144|NCT00589290|100466838|FG000|COMPLETED|Overall Study||40||
48059145|NCT00589290|100466838|FG000|NOT COMPLETED|Overall Study||1||
48059146|NCT02394548|100466839|FG000|STARTED|Overall Study||26||
48059147|NCT02394548|100466839|FG000|COMPLETED|Overall Study||25||
48059148|NCT02394548|100466839|FG000|NOT COMPLETED|Overall Study||1||
48059149|NCT04465162|100466840|FG000|STARTED|Overall Study||73||
48059150|NCT04465162|100466840|FG000|COMPLETED|Overall Study||73||
48059151|NCT04465162|100466840|FG000|NOT COMPLETED|Overall Study||0||
48059152|NCT00751621|100466841|FG000|STARTED|Overall Study||40||
48059153|NCT00751621|100466841|FG000|COMPLETED|Overall Study||36||
48059154|NCT00751621|100466841|FG000|NOT COMPLETED|Overall Study||4||
48059155|NCT00608972|100466842|FG000|STARTED|Overall Study||31||
48059156|NCT00608972|100466842|FG000|COMPLETED|Overall Study||2||
48059157|NCT00608972|100466842|FG000|NOT COMPLETED|Overall Study||29||
48059158|NCT04508335|100466843|FG000|STARTED|Overall Study||78||
48059159|NCT04508335|100466843|FG000|Treated With Reia Pessary|Overall Study||62||
48059160|NCT04508335|100466843|FG000|COMPLETED|Overall Study||48||
48059161|NCT04508335|100466843|FG000|NOT COMPLETED|Overall Study||30||
48059162|NCT03170856|100466844|FG000|STARTED|Overall Study||20||
48059163|NCT03170856|100466845|FG001|STARTED|Overall Study||21||
48059164|NCT03170856|100466844|FG000|COMPLETED|Overall Study||17||
48059165|NCT03170856|100466845|FG001|COMPLETED|Overall Study||20||
48208670|NCT04763044|100837095|FG002|COMPLETED|Period 2||4||
48059166|NCT03170856|100466844|FG000|NOT COMPLETED|Overall Study||3||
48059167|NCT03170856|100466845|FG001|NOT COMPLETED|Overall Study||1||
48059168|NCT02266914|100466846|FG000|STARTED|Overall Study||9||
48059169|NCT02266914|100466846|FG000|COMPLETED|Overall Study||0||
48059170|NCT02266914|100466846|FG000|NOT COMPLETED|Overall Study||9||
48059171|NCT00771316|100466847|FG000|STARTED|Overall Study||4||
48059172|NCT00771316|100466848|FG001|STARTED|Overall Study||2||
48059173|NCT00771316|100466847|FG000|COMPLETED|Overall Study||2||
48059174|NCT00771316|100466848|FG001|COMPLETED|Overall Study||1||
48059175|NCT00771316|100466847|FG000|NOT COMPLETED|Overall Study||2||
48059176|NCT00771316|100466848|FG001|NOT COMPLETED|Overall Study||1||
48059177|NCT00992927|100466849|FG000|STARTED|Overall Study||32||
48059178|NCT00992927|100466850|FG001|STARTED|Overall Study||22||
48059179|NCT00992927|100466849|FG000|COMPLETED|Overall Study||32||
48059180|NCT00992927|100466850|FG001|COMPLETED|Overall Study||22||
48059181|NCT00992927|100466849|FG000|NOT COMPLETED|Overall Study||0||
48059182|NCT00992927|100466850|FG001|NOT COMPLETED|Overall Study||0||
48059183|NCT01649609|100466851|FG000|STARTED|Overall Study||20||
48059184|NCT01649609|100466852|FG001|STARTED|Overall Study||20||
48059185|NCT01649609|100466851|FG000|COMPLETED|Overall Study||20||
48059186|NCT01649609|100466852|FG001|COMPLETED|Overall Study||20||
48059187|NCT01649609|100466851|FG000|NOT COMPLETED|Overall Study||0||
48059188|NCT01649609|100466852|FG001|NOT COMPLETED|Overall Study||0||
48059189|NCT01484132|100466853|FG000|STARTED|Overall Study||113||
48059190|NCT01484132|100466853|FG000|Pre-treatment Urine Sample|Overall Study||101||
48059191|NCT01484132|100466853|FG000|COMPLETED|Overall Study||91||
48059192|NCT01484132|100466853|FG000|NOT COMPLETED|Overall Study||22||
48059193|NCT00351000|100466854|FG000|STARTED|Overall Study||24||
48059194|NCT00351000|100466854|FG000|COMPLETED|Overall Study||21||
48059195|NCT00351000|100466854|FG000|NOT COMPLETED|Overall Study||3||
48059196|NCT05274165|100466855|FG000|STARTED|Overall Study||12||
48059197|NCT05274165|100466856|FG001|STARTED|Overall Study||13||
48059198|NCT05274165|100466855|FG000|COMPLETED|Overall Study||9||
48059199|NCT05274165|100466856|FG001|COMPLETED|Overall Study||10||
48059200|NCT05274165|100466855|FG000|NOT COMPLETED|Overall Study||3||
48059201|NCT05274165|100466856|FG001|NOT COMPLETED|Overall Study||3||
48059202|NCT03171051|100466857|FG000|STARTED|Overall Study||10||
48059203|NCT03171051|100466857|FG000|COMPLETED|Overall Study||10||
48059204|NCT03171051|100466857|FG000|NOT COMPLETED|Overall Study||0||
48059205|NCT01011738|100466858|FG000|STARTED|Overall Study||877||
48059206|NCT01011738|100466859|FG001|STARTED|Overall Study||912||
48059207|NCT01011738|100466860|FG002|STARTED|Overall Study||53||
48059208|NCT01011738|100466858|FG000|COMPLETED|Overall Study||553||
48059209|NCT01011738|100466859|FG001|COMPLETED|Overall Study||618||
48059210|NCT01011738|100466860|FG002|COMPLETED|Overall Study||36||
48059211|NCT01011738|100466858|FG000|NOT COMPLETED|Overall Study||324||
48059212|NCT01011738|100466859|FG001|NOT COMPLETED|Overall Study||294||
48059213|NCT01011738|100466860|FG002|NOT COMPLETED|Overall Study||17||
48059214|NCT00445978|100466861|FG000|STARTED|Week 0 - Week 4 (2.5 mg/kg/Day)||32||
48059215|NCT00445978|100466861|FG000|COMPLETED|Week 0 - Week 4 (2.5 mg/kg/Day)||29||
48059216|NCT00445978|100466861|FG000|NOT COMPLETED|Week 0 - Week 4 (2.5 mg/kg/Day)||3||
48059217|NCT00445978|100466861|FG000|STARTED|Week 4 - Week 8 (5 mg/kg/Day)||29||
48059218|NCT00445978|100466861|FG000|Received Escalated Dose|Week 4 - Week 8 (5 mg/kg/Day)||29||
48059219|NCT00445978|100466861|FG000|COMPLETED|Week 4 - Week 8 (5 mg/kg/Day)||25||
48059220|NCT00445978|100466861|FG000|NOT COMPLETED|Week 4 - Week 8 (5 mg/kg/Day)||4||
48059221|NCT00445978|100466861|FG000|STARTED|Week 8 - Week 12 (10 mg/kg/Day)||25||
48059222|NCT00445978|100466861|FG000|Received Escalated Dose|Week 8 - Week 12 (10 mg/kg/Day)||25||
48059223|NCT00445978|100466861|FG000|COMPLETED|Week 8 - Week 12 (10 mg/kg/Day)||24||
48059224|NCT00445978|100466861|FG000|NOT COMPLETED|Week 8 - Week 12 (10 mg/kg/Day)||1||
48059225|NCT00445978|100466861|FG000|STARTED|Week 12 - Week 16 (20 mg/kg/Day)||24||
48059226|NCT00445978|100466861|FG000|Received Escalated Dose|Week 12 - Week 16 (20 mg/kg/Day)||21||
48059227|NCT00445978|100466861|FG000|COMPLETED|Week 12 - Week 16 (20 mg/kg/Day)||23||
48059228|NCT00445978|100466861|FG000|NOT COMPLETED|Week 12 - Week 16 (20 mg/kg/Day)||1||
48059229|NCT01555983|100466862|FG000|STARTED|Overall Study||9||
48059230|NCT01555983|100466863|FG001|STARTED|Overall Study||7||
48059231|NCT01555983|100466864|FG002|STARTED|Overall Study||7||
48059232|NCT01555983|100466865|FG003|STARTED|Overall Study||7||
48059233|NCT01555983|100466866|FG004|STARTED|Overall Study||5||
48059234|NCT01555983|100466867|FG005|STARTED|Overall Study||7||
48059235|NCT01555983|100466862|FG000|COMPLETED|Overall Study||8||
48059236|NCT01555983|100466863|FG001|COMPLETED|Overall Study||7||
48059237|NCT01555983|100466864|FG002|COMPLETED|Overall Study||7||
48059238|NCT01555983|100466865|FG003|COMPLETED|Overall Study||7||
48059239|NCT01555983|100466866|FG004|COMPLETED|Overall Study||4||
48059240|NCT01555983|100466867|FG005|COMPLETED|Overall Study||6||
48059241|NCT01555983|100466862|FG000|NOT COMPLETED|Overall Study||1||
48059242|NCT01555983|100466863|FG001|NOT COMPLETED|Overall Study||0||
48059243|NCT01555983|100466864|FG002|NOT COMPLETED|Overall Study||0||
48059244|NCT01555983|100466865|FG003|NOT COMPLETED|Overall Study||0||
48059245|NCT01555983|100466866|FG004|NOT COMPLETED|Overall Study||1||
48059246|NCT01555983|100466867|FG005|NOT COMPLETED|Overall Study||1||
48059247|NCT01282203|100466868|FG000|STARTED|Overall Study||1122||
48059248|NCT01282203|100466868|FG000|COMPLETED|Overall Study||1121||
48059249|NCT01282203|100466868|FG000|NOT COMPLETED|Overall Study||1||
48059250|NCT04041375|100466869|FG000|STARTED|Intervention Phase||110||
48059251|NCT04041375|100466870|FG001|STARTED|Intervention Phase||108||
48059252|NCT04041375|100466869|FG000|COMPLETED|Intervention Phase||108||
48059253|NCT04041375|100466870|FG001|COMPLETED|Intervention Phase||106||
48059254|NCT04041375|100466869|FG000|NOT COMPLETED|Intervention Phase||2||
48059255|NCT04041375|100466870|FG001|NOT COMPLETED|Intervention Phase||2||
48059256|NCT04041375|100466869|FG000|STARTED|Follow-up Phase||108||
48059257|NCT04041375|100466870|FG001|STARTED|Follow-up Phase||106||
48059258|NCT04041375|100466869|FG000|COMPLETED|Follow-up Phase||101||
48059259|NCT04041375|100466870|FG001|COMPLETED|Follow-up Phase||105||
48059260|NCT04041375|100466869|FG000|NOT COMPLETED|Follow-up Phase||7||
48059261|NCT04041375|100466870|FG001|NOT COMPLETED|Follow-up Phase||1||
48059262|NCT00683085|100466871|FG000|STARTED|Overall Study||2||
48059263|NCT00683085|100466871|FG000|COMPLETED|Overall Study||2||
48059264|NCT00683085|100466871|FG000|NOT COMPLETED|Overall Study||0||
48059265|NCT03894046|100466872|FG000|STARTED|Overall Study||92||
48059266|NCT03894046|100466873|FG001|STARTED|Overall Study||89||
48059267|NCT03894046|100466874|FG002|STARTED|Overall Study||26||
48495872|NCT02385708|101547957|FG001|STARTED|Overall Study||82||
48495873|NCT02385708|101547956|FG000|Intervention Started|Overall Study||81||
48059268|NCT03894046|100466872|FG000|COMPLETED|Overall Study||69||
48059269|NCT03894046|100466873|FG001|COMPLETED|Overall Study||61||
48059270|NCT03894046|100466874|FG002|COMPLETED|Overall Study||20||
48059271|NCT03894046|100466872|FG000|NOT COMPLETED|Overall Study||23||
48059272|NCT03894046|100466873|FG001|NOT COMPLETED|Overall Study||28||
48059273|NCT03894046|100466874|FG002|NOT COMPLETED|Overall Study||6||
48059274|NCT00975637|100466875|FG000|STARTED|Overall Study||40||
48059275|NCT00975637|100466876|FG001|STARTED|Overall Study||39||
48059276|NCT00975637|100466877|FG002|STARTED|Overall Study||42||
48059277|NCT00975637|100466878|FG003|STARTED|Overall Study||38||
48059278|NCT00975637|100466879|FG004|STARTED|Overall Study||39||
48059279|NCT00975637|100466875|FG000|COMPLETED|Overall Study||37||
48059280|NCT00975637|100466876|FG001|COMPLETED|Overall Study||38||
48059281|NCT00975637|100466877|FG002|COMPLETED|Overall Study||40||
48059282|NCT00975637|100466878|FG003|COMPLETED|Overall Study||32||
48059283|NCT00975637|100466879|FG004|COMPLETED|Overall Study||37||
48059284|NCT00975637|100466875|FG000|NOT COMPLETED|Overall Study||3||
48059285|NCT00975637|100466876|FG001|NOT COMPLETED|Overall Study||1||
48059286|NCT00975637|100466877|FG002|NOT COMPLETED|Overall Study||2||
48059287|NCT00975637|100466878|FG003|NOT COMPLETED|Overall Study||6||
48059288|NCT00975637|100466879|FG004|NOT COMPLETED|Overall Study||2||
48059289|NCT02556203|100466880|FG000|STARTED|Overall Study||826||
48208671|NCT04763044|100837096|FG003|COMPLETED|Period 2||3||
48208672|NCT04763044|100837093|FG000|NOT COMPLETED|Period 2||0||
48208673|NCT04763044|100837094|FG001|NOT COMPLETED|Period 2||0||
48208674|NCT04763044|100837095|FG002|NOT COMPLETED|Period 2||0||
48208675|NCT04763044|100837096|FG003|NOT COMPLETED|Period 2||0||
48208676|NCT04763044|100837093|FG000|STARTED|Period 3||3||
48208677|NCT04763044|100837094|FG001|STARTED|Period 3||4||
48059290|NCT02556203|100466881|FG001|STARTED|Overall Study||818||
48059291|NCT02556203|100466880|FG000|Received Treatment|Overall Study||801||
48059292|NCT02556203|100466881|FG001|Received Treatment|Overall Study||807||
48059293|NCT02556203|100466880|FG000|COMPLETED|Overall Study||799|Completed study procedures|
48059294|NCT02556203|100466881|FG001|COMPLETED|Overall Study||792|Completed study procedures|
48059295|NCT02556203|100466880|FG000|NOT COMPLETED|Overall Study||27||
48059296|NCT02556203|100466881|FG001|NOT COMPLETED|Overall Study||26||
48059297|NCT01869725|100466882|FG000|STARTED|Overall Study||68||
48059298|NCT01869725|100466882|FG000|COMPLETED|Overall Study||64||
48059299|NCT01869725|100466882|FG000|NOT COMPLETED|Overall Study||4||
48059300|NCT01012167|100466883|FG000|STARTED|Overall Study||17||
48059301|NCT01012167|100466884|FG001|STARTED|Overall Study||20||
48059302|NCT01012167|100466885|FG002|STARTED|Overall Study||21||
48059303|NCT01012167|100466883|FG000|Withdrawn Prior to Study Drug Exposure|Overall Study||1||
48059304|NCT01012167|100466884|FG001|Withdrawn Prior to Study Drug Exposure|Overall Study||0||
48059305|NCT01012167|100466885|FG002|Withdrawn Prior to Study Drug Exposure|Overall Study||1||
48059306|NCT01012167|100466883|FG000|Exposed to Study Drug|Overall Study||16||
48059307|NCT01012167|100466884|FG001|Exposed to Study Drug|Overall Study||20||
48059308|NCT01012167|100466885|FG002|Exposed to Study Drug|Overall Study||20||
48059309|NCT01012167|100466883|FG000|COMPLETED|Overall Study||15||
48059310|NCT01012167|100466884|FG001|COMPLETED|Overall Study||18||
48059311|NCT01012167|100466885|FG002|COMPLETED|Overall Study||17||
48059312|NCT01012167|100466883|FG000|NOT COMPLETED|Overall Study||2||
48059313|NCT01012167|100466884|FG001|NOT COMPLETED|Overall Study||2||
48059314|NCT01012167|100466885|FG002|NOT COMPLETED|Overall Study||4||
48059315|NCT01675427|100466886|FG000|STARTED|Overall Study||4766||
48059316|NCT01675427|100466886|FG000|COMPLETED|Overall Study||4732||
48059317|NCT01675427|100466886|FG000|NOT COMPLETED|Overall Study||34||
48059318|NCT01222884|100466887|FG000|STARTED|Overall Study||234||
48059319|NCT01222884|100466888|FG001|STARTED|Overall Study||117||
48059320|NCT01222884|100466887|FG000|COMPLETED|Overall Study||210||
48059321|NCT01222884|100466888|FG001|COMPLETED|Overall Study||113||
48059322|NCT01222884|100466887|FG000|NOT COMPLETED|Overall Study||24||
48059323|NCT01222884|100466888|FG001|NOT COMPLETED|Overall Study||4||
48059324|NCT00509392|100466889|FG000|STARTED|Overall Study||32||42
48059325|NCT00509392|100466890|FG001|STARTED|Overall Study||33||37
48208678|NCT04763044|100837095|FG002|STARTED|Period 3||4||
48208679|NCT04763044|100837096|FG003|STARTED|Period 3||3||
48059326|NCT00509392|100466891|FG002|STARTED|Overall Study||4||8
48059327|NCT00509392|100466889|FG000|COMPLETED|Overall Study||32||42
48059328|NCT00509392|100466890|FG001|COMPLETED|Overall Study||33||37
48059329|NCT00509392|100466891|FG002|COMPLETED|Overall Study||4||8
48059330|NCT00509392|100466889|FG000|NOT COMPLETED|Overall Study||0||0
48059331|NCT00509392|100466890|FG001|NOT COMPLETED|Overall Study||0||0
48059332|NCT00509392|100466891|FG002|NOT COMPLETED|Overall Study||0||0
48059333|NCT04950166|100466892|FG000|STARTED|Overall Study||51|51 patients consented; however, 1 patient withdrew consent prior to dosing.|
48059334|NCT04950166|100466892|FG000|COMPLETED|Overall Study||50|All patients completed as intent-to-treat|
48059335|NCT04950166|100466892|FG000|NOT COMPLETED|Overall Study||1||
48059336|NCT02869438|100466893|FG000|STARTED|Overall Study||118||
48059337|NCT02869438|100466894|FG001|STARTED|Overall Study||115||
48208680|NCT04763044|100837093|FG000|COMPLETED|Period 3||3||
48208681|NCT04763044|100837094|FG001|COMPLETED|Period 3||4||
48208682|NCT04763044|100837095|FG002|COMPLETED|Period 3||4||
48208683|NCT04763044|100837096|FG003|COMPLETED|Period 3||3||
48059338|NCT02869438|100466893|FG000|COMPLETED|Overall Study||115||
48059339|NCT02869438|100466894|FG001|COMPLETED|Overall Study||113||
48059340|NCT02869438|100466893|FG000|NOT COMPLETED|Overall Study||3||
48059341|NCT02869438|100466894|FG001|NOT COMPLETED|Overall Study||2||
48059342|NCT02751788|100466895|FG000|STARTED|Overall Study||112||
48059343|NCT02751788|100466895|FG000|COMPLETED|Overall Study||49||
48059344|NCT02751788|100466895|FG000|NOT COMPLETED|Overall Study||63||
48059345|NCT02484287|100466896|FG000|STARTED|Overall Study||15||
48059346|NCT02484287|100466897|FG001|STARTED|Overall Study||26||
48059347|NCT02484287|100466898|FG002|STARTED|Overall Study||19||
48059348|NCT02484287|100466896|FG000|COMPLETED|Overall Study||0||
48059349|NCT02484287|100466897|FG001|COMPLETED|Overall Study||0||
48059350|NCT02484287|100466898|FG002|COMPLETED|Overall Study||0||
48059351|NCT02484287|100466896|FG000|NOT COMPLETED|Overall Study||15||
48059352|NCT02484287|100466897|FG001|NOT COMPLETED|Overall Study||26||
48059353|NCT02484287|100466898|FG002|NOT COMPLETED|Overall Study||19||
48059354|NCT04102956|100466899|FG000|STARTED|Overall Study||42||
48059355|NCT04102956|100466900|FG001|STARTED|Overall Study||38||
48059356|NCT04102956|100466899|FG000|COMPLETED|Overall Study||42||
48059357|NCT04102956|100466900|FG001|COMPLETED|Overall Study||38||
48059358|NCT04102956|100466899|FG000|NOT COMPLETED|Overall Study||0||
48059359|NCT04102956|100466900|FG001|NOT COMPLETED|Overall Study||0||
48059360|NCT01067976|100466901|FG000|STARTED|Overall Study||446||
48059361|NCT01067976|100466901|FG000|Received Treatment|Overall Study||426||
48059362|NCT01067976|100466901|FG000|Fulfilled Requirements of FAS Population|Overall Study||390||
48059363|NCT01067976|100466901|FG000|COMPLETED|Overall Study||424||
48059364|NCT01067976|100466901|FG000|NOT COMPLETED|Overall Study||22||
48059365|NCT02103218|100466902|FG000|STARTED|Overall Study||51||
48059366|NCT02103218|100466903|FG001|STARTED|Overall Study||59||
48059367|NCT02103218|100466904|FG002|STARTED|Overall Study||48||
48059368|NCT02103218|100466905|FG003|STARTED|Overall Study||54||
48059369|NCT02103218|100466902|FG000|COMPLETED|Overall Study||46||
48059370|NCT02103218|100466903|FG001|COMPLETED|Overall Study||51||
48059371|NCT02103218|100466904|FG002|COMPLETED|Overall Study||44||
48059372|NCT02103218|100466905|FG003|COMPLETED|Overall Study||47||
48059373|NCT02103218|100466902|FG000|NOT COMPLETED|Overall Study||5||
48059374|NCT02103218|100466903|FG001|NOT COMPLETED|Overall Study||8||
48059375|NCT02103218|100466904|FG002|NOT COMPLETED|Overall Study||4||
48059376|NCT02103218|100466905|FG003|NOT COMPLETED|Overall Study||7||
48059377|NCT00122278|100466906|FG000|STARTED|Overall Study||106||
48059378|NCT00122278|100466907|FG001|STARTED|Overall Study||99||
48059379|NCT00122278|100466906|FG000|COMPLETED|Overall Study||104||
48059380|NCT00122278|100466907|FG001|COMPLETED|Overall Study||99||
48059381|NCT00122278|100466906|FG000|NOT COMPLETED|Overall Study||2||
48059382|NCT00122278|100466907|FG001|NOT COMPLETED|Overall Study||0||
48059383|NCT05036369|100466908|FG000|STARTED|Overall Study||44||
48059384|NCT05036369|100466909|FG001|STARTED|Overall Study||56||
48059385|NCT05036369|100466908|FG000|COMPLETED|Overall Study||43||
48059386|NCT05036369|100466909|FG001|COMPLETED|Overall Study||53||
48059387|NCT05036369|100466908|FG000|NOT COMPLETED|Overall Study||1||
48059388|NCT05036369|100466909|FG001|NOT COMPLETED|Overall Study||3||
48059389|NCT00093782|100466910|FG000|STARTED|Overall Study||36||
48059390|NCT00093782|100466910|FG000|COMPLETED|Overall Study||36||
48059391|NCT00093782|100466910|FG000|NOT COMPLETED|Overall Study||0||
48059392|NCT00986479|100466911|FG000|STARTED|Period 1||12||
48059393|NCT00986479|100466912|FG001|STARTED|Period 1||10||
48059394|NCT00986479|100466911|FG000|COMPLETED|Period 1||10||
48059395|NCT00986479|100466912|FG001|COMPLETED|Period 1||10||
48059396|NCT00986479|100466911|FG000|NOT COMPLETED|Period 1||2||
48059397|NCT00986479|100466912|FG001|NOT COMPLETED|Period 1||0||
48059398|NCT00986479|100466911|FG000|STARTED|Period 2||10||
48059399|NCT00986479|100466912|FG001|STARTED|Period 2||10||
48059400|NCT00986479|100466911|FG000|COMPLETED|Period 2||10||
48059401|NCT00986479|100466912|FG001|COMPLETED|Period 2||10||
48059402|NCT00986479|100466911|FG000|NOT COMPLETED|Period 2||0||
48059403|NCT00986479|100466912|FG001|NOT COMPLETED|Period 2||0||
48059404|NCT01199731|100466913|FG000|STARTED|Overall Study||9||
48059405|NCT01199731|100466914|FG001|STARTED|Overall Study||11||
48059406|NCT01199731|100466915|FG002|STARTED|Overall Study||10||
48059407|NCT01199731|100466913|FG000|COMPLETED|Overall Study||0||
48059408|NCT01199731|100466914|FG001|COMPLETED|Overall Study||0||
48059409|NCT01199731|100466915|FG002|COMPLETED|Overall Study||0||
48059410|NCT01199731|100466913|FG000|NOT COMPLETED|Overall Study||9||
48059411|NCT01199731|100466914|FG001|NOT COMPLETED|Overall Study||11||
48059412|NCT01199731|100466915|FG002|NOT COMPLETED|Overall Study||10||
48059413|NCT02611037|100466916|FG000|STARTED|Overall Study||7||
48059414|NCT02611037|100466917|FG001|STARTED|Overall Study||27||
48059415|NCT02611037|100466916|FG000|COMPLETED|Overall Study||5||
48059416|NCT02611037|100466917|FG001|COMPLETED|Overall Study||27||
48495874|NCT02385708|101547957|FG001|Intervention Started|Overall Study||82||
48059417|NCT02611037|100466916|FG000|NOT COMPLETED|Overall Study||2||
48059418|NCT02611037|100466917|FG001|NOT COMPLETED|Overall Study||0||
48059419|NCT04521777|100466918|FG000|STARTED|Overall Study||24||
48059420|NCT04521777|100466918|FG000|COMPLETED|Overall Study||20||
48059421|NCT04521777|100466918|FG000|NOT COMPLETED|Overall Study||4||
48059422|NCT03950791|100466919|FG000|STARTED|Overall Study||108||
48059423|NCT03950791|100466920|FG001|STARTED|Overall Study||105||
48059424|NCT03950791|100466919|FG000|COMPLETED|Overall Study||81||
48059425|NCT03950791|100466920|FG001|COMPLETED|Overall Study||88||
48059426|NCT03950791|100466919|FG000|NOT COMPLETED|Overall Study||27||
48059427|NCT03950791|100466920|FG001|NOT COMPLETED|Overall Study||17||
48059428|NCT01570868|100466921|FG000|STARTED|Overall Study||43||
48059429|NCT01570868|100466922|FG001|STARTED|Overall Study||8||
48059430|NCT01570868|100466921|FG000|COMPLETED|Overall Study||0||
48059431|NCT01570868|100466922|FG001|COMPLETED|Overall Study||0||
48059432|NCT01570868|100466921|FG000|NOT COMPLETED|Overall Study||43||
48059433|NCT01570868|100466922|FG001|NOT COMPLETED|Overall Study||8||
48059434|NCT00200161|100466923|FG000|STARTED|Overall Study||43||
48059435|NCT00200161|100466924|FG001|STARTED|Overall Study||42||
48059436|NCT00200161|100466923|FG000|COMPLETED|Overall Study||43||
48059437|NCT00200161|100466924|FG001|COMPLETED|Overall Study||42||
48059438|NCT00200161|100466923|FG000|NOT COMPLETED|Overall Study||0||
48059439|NCT00200161|100466924|FG001|NOT COMPLETED|Overall Study||0||
48059440|NCT00950911|100466925|FG000|STARTED|Overall Study||17||
48059441|NCT00950911|100466926|FG001|STARTED|Overall Study||18||
48059442|NCT00950911|100466925|FG000|COMPLETED|Overall Study||5||
48059443|NCT00950911|100466926|FG001|COMPLETED|Overall Study||3||
48059444|NCT00950911|100466925|FG000|NOT COMPLETED|Overall Study||12||
48059445|NCT00950911|100466926|FG001|NOT COMPLETED|Overall Study||15||
48059446|NCT03555435|100466927|FG000|STARTED|Overall Study||28||
48059447|NCT03555435|100466928|FG001|STARTED|Overall Study||27||
48059448|NCT03555435|100466929|FG002|STARTED|Overall Study||26||
48059449|NCT03555435|100466927|FG000|COMPLETED|Overall Study||11||
48059450|NCT03555435|100466928|FG001|COMPLETED|Overall Study||8||
48059451|NCT03555435|100466929|FG002|COMPLETED|Overall Study||18||
48059452|NCT03555435|100466927|FG000|NOT COMPLETED|Overall Study||17||
48059453|NCT03555435|100466928|FG001|NOT COMPLETED|Overall Study||19||
48059454|NCT03555435|100466929|FG002|NOT COMPLETED|Overall Study||8||
48059455|NCT02764697|100466930|FG000|STARTED|Overall Study||5||
48059456|NCT02764697|100466930|FG000|COMPLETED|Overall Study||2||
48059457|NCT02764697|100466930|FG000|NOT COMPLETED|Overall Study||3||
48059458|NCT00749515|100466931|FG000|STARTED|Overall Study||10||
48059459|NCT00749515|100466932|FG001|STARTED|Overall Study||5||
48059460|NCT00749515|100466931|FG000|COMPLETED|Overall Study||10||
48059461|NCT00749515|100466932|FG001|COMPLETED|Overall Study||5||
48059462|NCT00749515|100466931|FG000|NOT COMPLETED|Overall Study||0||
48059463|NCT00749515|100466932|FG001|NOT COMPLETED|Overall Study||0||
48059464|NCT03839082|100466933|FG000|STARTED|Initial Randomization||33||
48059465|NCT03839082|100466934|FG001|STARTED|Initial Randomization||37||
48059466|NCT03839082|100466933|FG000|COMPLETED|Initial Randomization||7|completing visit 2|
48059467|NCT03839082|100466934|FG001|COMPLETED|Initial Randomization||12|completing visit 2|
48059468|NCT03839082|100466933|FG000|NOT COMPLETED|Initial Randomization||26||
48059469|NCT03839082|100466934|FG001|NOT COMPLETED|Initial Randomization||25||
48059470|NCT03839082|100466933|FG000|STARTED|Crossover to Other Arm||7||
48059471|NCT03839082|100466934|FG001|STARTED|Crossover to Other Arm||12||
48059472|NCT03839082|100466933|FG000|COMPLETED|Crossover to Other Arm||0||
48059473|NCT03839082|100466934|FG001|COMPLETED|Crossover to Other Arm||0||
48059474|NCT03839082|100466933|FG000|NOT COMPLETED|Crossover to Other Arm||7||
48059475|NCT03839082|100466934|FG001|NOT COMPLETED|Crossover to Other Arm||12||
48059476|NCT04761822|100466935|FG000|STARTED|Overall Study||227||
48059477|NCT04761822|100466936|FG001|STARTED|Overall Study||219||
48059478|NCT04761822|100466937|FG002|STARTED|Overall Study||117||
48059479|NCT04761822|100466938|FG003|STARTED|Overall Study||123||
48059480|NCT04761822|100466935|FG000|COMPLETED|Overall Study||219||
48059481|NCT04761822|100466936|FG001|COMPLETED|Overall Study||209||
48059482|NCT04761822|100466937|FG002|COMPLETED|Overall Study||113||
48059483|NCT04761822|100466938|FG003|COMPLETED|Overall Study||105||
48059484|NCT04761822|100466935|FG000|NOT COMPLETED|Overall Study||8||
48059485|NCT04761822|100466936|FG001|NOT COMPLETED|Overall Study||10||
48059486|NCT04761822|100466937|FG002|NOT COMPLETED|Overall Study||4||
48059487|NCT04761822|100466938|FG003|NOT COMPLETED|Overall Study||18||
48059488|NCT01654861|100466939|FG000|STARTED|Overall Study||3||
48059489|NCT01654861|100466939|FG000|COMPLETED|Overall Study||3||
48059490|NCT01654861|100466939|FG000|NOT COMPLETED|Overall Study||0||
48059491|NCT02423772|100466940|FG000|STARTED|Overall Study||17||
48059492|NCT02423772|100466941|FG001|STARTED|Overall Study||18||
48059493|NCT02423772|100466940|FG000|Received Allocated Intervention|Overall Study||15||
48059494|NCT02423772|100466941|FG001|Received Allocated Intervention|Overall Study||13||
48059495|NCT02423772|100466940|FG000|COMPLETED|Overall Study||12|"Completed defined as provided 6 month follow-up data."|
48059496|NCT02423772|100466941|FG001|COMPLETED|Overall Study||10|"Completed defined as provided 6 month follow-up data."|
48059497|NCT02423772|100466940|FG000|NOT COMPLETED|Overall Study||5||
48059498|NCT02423772|100466941|FG001|NOT COMPLETED|Overall Study||8||
48059499|NCT01008150|100466942|FG000|STARTED|Overall Study||43||
48059500|NCT01008150|100466943|FG001|STARTED|Overall Study||43||
48059501|NCT01008150|100466944|FG002|STARTED|Overall Study||43||
48059502|NCT01008150|100466945|FG003|STARTED|Overall Study||12||
48059503|NCT01008150|100466942|FG000|COMPLETED|Overall Study||42||
48059504|NCT01008150|100466943|FG001|COMPLETED|Overall Study||42||
48059505|NCT01008150|100466944|FG002|COMPLETED|Overall Study||42||
48059506|NCT01008150|100466945|FG003|COMPLETED|Overall Study||12||
48059507|NCT01008150|100466942|FG000|NOT COMPLETED|Overall Study||1||
48059508|NCT01008150|100466943|FG001|NOT COMPLETED|Overall Study||1||
48059509|NCT01008150|100466944|FG002|NOT COMPLETED|Overall Study||1||
48059510|NCT01008150|100466945|FG003|NOT COMPLETED|Overall Study||0||
48059511|NCT00567593|100466946|FG000|STARTED|Overall Study||12||
48059512|NCT00567593|100466946|FG000|COMPLETED|Overall Study||10||
48059513|NCT00567593|100466946|FG000|NOT COMPLETED|Overall Study||2||
48059514|NCT01907100|100466947|FG000|STARTED|Overall Study||43||
48059515|NCT01907100|100466948|FG001|STARTED|Overall Study||44||
48059516|NCT01907100|100466949|FG002|STARTED|Overall Study||229||
48059517|NCT01907100|100466950|FG003|STARTED|Overall Study||229||
48059518|NCT01907100|100466947|FG000|Treated Patients|Overall Study||41||
48059519|NCT01907100|100466948|FG001|Treated Patients|Overall Study||44||
48059520|NCT01907100|100466949|FG002|Treated Patients|Overall Study||228||
48059521|NCT01907100|100466950|FG003|Treated Patients|Overall Study||227||
48059522|NCT01907100|100466947|FG000|COMPLETED|Overall Study||1|On treatment or completed according to protocol at the time of analysis|
48059523|NCT01907100|100466948|FG001|COMPLETED|Overall Study||4|On treatment or completed according to protocol at the time of analysis|
48059524|NCT01907100|100466949|FG002|COMPLETED|Overall Study||82|On treatment or completed according to protocol at the time of analysis|
48059525|NCT01907100|100466950|FG003|COMPLETED|Overall Study||83|On treatment or completed according to protocol at the time of analysis|
48059526|NCT01907100|100466947|FG000|NOT COMPLETED|Overall Study||42||
48059527|NCT01907100|100466948|FG001|NOT COMPLETED|Overall Study||40||
48059528|NCT01907100|100466949|FG002|NOT COMPLETED|Overall Study||147||
48059529|NCT01907100|100466950|FG003|NOT COMPLETED|Overall Study||146||
48059530|NCT00792077|100466951|FG000|STARTED|Overall Study||6||
48059531|NCT00792077|100466951|FG000|Day 15+/- 3 Days|Overall Study||6||
48059532|NCT00792077|100466951|FG000|Day 29+/-3 Days|Overall Study||6||
48059533|NCT00792077|100466951|FG000|Day 43+/-3 Days|Overall Study||6||
48059534|NCT00792077|100466951|FG000|Day 57+/-3 Days|Overall Study||6||
48208684|NCT04763044|100837093|FG000|NOT COMPLETED|Period 3||0||
48208685|NCT04763044|100837094|FG001|NOT COMPLETED|Period 3||0||
48208686|NCT04763044|100837095|FG002|NOT COMPLETED|Period 3||0||
48208687|NCT04763044|100837096|FG003|NOT COMPLETED|Period 3||0||
48208688|NCT04763044|100837093|FG000|STARTED|Period 4||3||
48208689|NCT04763044|100837094|FG001|STARTED|Period 4||3||
48208690|NCT04763044|100837095|FG002|STARTED|Period 4||4||
48208691|NCT04763044|100837096|FG003|STARTED|Period 4||3||
48208692|NCT04763044|100837093|FG000|COMPLETED|Period 4||3||
48208693|NCT04763044|100837094|FG001|COMPLETED|Period 4||3||
48208694|NCT04763044|100837095|FG002|COMPLETED|Period 4||4||
48208695|NCT04763044|100837096|FG003|COMPLETED|Period 4||3||
48059535|NCT00792077|100466951|FG000|COMPLETED|Overall Study||6||
48059536|NCT00792077|100466951|FG000|NOT COMPLETED|Overall Study||0||
48059537|NCT04449861|100466952|FG000|STARTED|Overall Study||166|07 December 2020|
48059538|NCT04449861|100466952|FG000|COMPLETED|Overall Study||45|30 March 2023|
48059539|NCT04449861|100466952|FG000|NOT COMPLETED|Overall Study||121||
48059540|NCT01442038|100466953|FG000|STARTED|Overall Study||1332||
48059541|NCT01442038|100466954|FG001|STARTED|Overall Study||1319||
48059542|NCT01442038|100466953|FG000|COMPLETED|Overall Study||1029||
48059543|NCT01442038|100466954|FG001|COMPLETED|Overall Study||1040||
48059544|NCT01442038|100466953|FG000|NOT COMPLETED|Overall Study||303||
48059545|NCT01442038|100466954|FG001|NOT COMPLETED|Overall Study||279||
48059546|NCT04996797|100466955|FG000|STARTED|Overall Study||68||
48059547|NCT04996797|100466956|FG001|STARTED|Overall Study||67||
48059548|NCT04996797|100466957|FG002|STARTED|Overall Study||22||
48059549|NCT04996797|100466958|FG003|STARTED|Overall Study||21||
48059550|NCT04996797|100466955|FG000|Treated|Overall Study||68||
48059551|NCT04996797|100466956|FG001|Treated|Overall Study||67||
48059552|NCT04996797|100466957|FG002|Treated|Overall Study||22||
48059553|NCT04996797|100466958|FG003|Treated|Overall Study||21||
48059554|NCT04996797|100466955|FG000|COMPLETED|Overall Study||0||
48059555|NCT04996797|100466956|FG001|COMPLETED|Overall Study||0||
48059556|NCT04996797|100466957|FG002|COMPLETED|Overall Study||0||
48059557|NCT04996797|100466958|FG003|COMPLETED|Overall Study||0||
48059558|NCT04996797|100466955|FG000|NOT COMPLETED|Overall Study||68||
48059559|NCT04996797|100466956|FG001|NOT COMPLETED|Overall Study||67||
48059560|NCT04996797|100466957|FG002|NOT COMPLETED|Overall Study||22||
48208696|NCT04763044|100837093|FG000|NOT COMPLETED|Period 4||0||
48208697|NCT04763044|100837094|FG001|NOT COMPLETED|Period 4||0||
48208698|NCT04763044|100837095|FG002|NOT COMPLETED|Period 4||0||
48208699|NCT04763044|100837096|FG003|NOT COMPLETED|Period 4||0||
48208700|NCT04763044|100837093|FG000|STARTED|Period 5||3||
48208701|NCT04763044|100837094|FG001|STARTED|Period 5||3||
48208702|NCT04763044|100837095|FG002|STARTED|Period 5||4||
48208703|NCT04763044|100837096|FG003|STARTED|Period 5||3||
48059561|NCT04996797|100466958|FG003|NOT COMPLETED|Overall Study||21||
48059562|NCT01052844|100466959|FG000|STARTED|Overall Study||40||
48059563|NCT01052844|100466960|FG001|STARTED|Overall Study||40||
48208704|NCT04763044|100837093|FG000|COMPLETED|Period 5||2||
48208705|NCT04763044|100837094|FG001|COMPLETED|Period 5||3||
48208706|NCT04763044|100837095|FG002|COMPLETED|Period 5||4||
48208707|NCT04763044|100837096|FG003|COMPLETED|Period 5||3||
48208708|NCT04763044|100837093|FG000|NOT COMPLETED|Period 5||1||
48208709|NCT04763044|100837094|FG001|NOT COMPLETED|Period 5||0||
48208710|NCT04763044|100837095|FG002|NOT COMPLETED|Period 5||0||
48208711|NCT04763044|100837096|FG003|NOT COMPLETED|Period 5||0||
48208712|NCT01662336|100837097|FG000|STARTED|Overall Study||173||
48208713|NCT01662336|100837097|FG000|Completed Month 6 Visit|Overall Study||142||
48208714|NCT01662336|100837097|FG000|Completed Month 12 Visit|Overall Study||109||
48208715|NCT01662336|100837097|FG000|COMPLETED|Overall Study||107||
48208716|NCT01662336|100837097|FG000|NOT COMPLETED|Overall Study||66||
48208717|NCT00566527|100837098|FG000|STARTED|Overall Study||541||
48208718|NCT00566527|100837099|FG001|STARTED|Overall Study||540||
48208719|NCT00566527|100837100|FG002|STARTED|Overall Study||539||
48208720|NCT00566527|100837098|FG000|Received ProQuad® Dose 1|Overall Study||529||
48208721|NCT00566527|100837099|FG001|Received ProQuad® Dose 1|Overall Study||484||
48208722|NCT00566527|100837100|FG002|Received ProQuad® Dose 1|Overall Study||470||
48208723|NCT00566527|100837098|FG000|Received ProQuad® Dose 2|Overall Study||525||
48208724|NCT00566527|100837099|FG001|Received ProQuad® Dose 2|Overall Study||478||
48208725|NCT00566527|100837100|FG002|Received ProQuad® Dose 2|Overall Study||462||
48208726|NCT00566527|100837098|FG000|COMPLETED|Overall Study||524||
48208727|NCT00566527|100837099|FG001|COMPLETED|Overall Study||474||
48208728|NCT00566527|100837100|FG002|COMPLETED|Overall Study||461||
48208729|NCT00566527|100837098|FG000|NOT COMPLETED|Overall Study||17||
48208730|NCT00566527|100837099|FG001|NOT COMPLETED|Overall Study||66||
48208731|NCT00566527|100837100|FG002|NOT COMPLETED|Overall Study||78||
48208732|NCT01867216|100837101|FG000|STARTED|Overall Study||16||
48208733|NCT01867216|100837102|FG001|STARTED|Overall Study||8||
48208734|NCT01867216|100837103|FG002|STARTED|Overall Study||8||
48208735|NCT01867216|100837104|FG003|STARTED|Overall Study||8||
48208736|NCT01867216|100837105|FG004|STARTED|Overall Study||9||
48208737|NCT01867216|100837106|FG005|STARTED|Overall Study||8||
48208738|NCT01867216|100837107|FG006|STARTED|Overall Study||9||
48208739|NCT01867216|100837101|FG000|Received Study Drug|Overall Study||14||
48208740|NCT01867216|100837102|FG001|Received Study Drug|Overall Study||8||
48208741|NCT01867216|100837103|FG002|Received Study Drug|Overall Study||8||
48208742|NCT01867216|100837104|FG003|Received Study Drug|Overall Study||8||
48208743|NCT01867216|100837105|FG004|Received Study Drug|Overall Study||9||
48208744|NCT01867216|100837106|FG005|Received Study Drug|Overall Study||8||
48208745|NCT01867216|100837107|FG006|Received Study Drug|Overall Study||9||
48208746|NCT01867216|100837101|FG000|COMPLETED|Overall Study||12||
48208747|NCT01867216|100837102|FG001|COMPLETED|Overall Study||8||
48208748|NCT01867216|100837103|FG002|COMPLETED|Overall Study||8||
48208749|NCT01867216|100837104|FG003|COMPLETED|Overall Study||8||
48208750|NCT01867216|100837105|FG004|COMPLETED|Overall Study||8||
48208751|NCT01867216|100837106|FG005|COMPLETED|Overall Study||8||
48208752|NCT01867216|100837107|FG006|COMPLETED|Overall Study||8||
48208753|NCT01867216|100837101|FG000|NOT COMPLETED|Overall Study||4||
48208754|NCT01867216|100837102|FG001|NOT COMPLETED|Overall Study||0||
48495875|NCT02385708|101547956|FG000|COMPLETED|Overall Study||73||
48495876|NCT02385708|101547957|FG001|COMPLETED|Overall Study||67||
48495877|NCT02385708|101547956|FG000|NOT COMPLETED|Overall Study||8||
48495878|NCT02385708|101547957|FG001|NOT COMPLETED|Overall Study||15||
48495879|NCT05058430|101547958|FG000|STARTED|Selection of the SaliPen Device||8||
48495880|NCT05058430|101547959|FG001|STARTED|Selection of the SaliPen Device||8||
48495881|NCT05058430|101547958|FG000|COMPLETED|Selection of the SaliPen Device||8||
48495882|NCT05058430|101547959|FG001|COMPLETED|Selection of the SaliPen Device||8||
48495883|NCT05058430|101547958|FG000|NOT COMPLETED|Selection of the SaliPen Device||0||
48495884|NCT05058430|101547959|FG001|NOT COMPLETED|Selection of the SaliPen Device||0||
48495885|NCT05058430|101547958|FG000|STARTED|Use of the SaliPen Device||16|"Participants of Arm I were the 8 subjects with xerostomia of Phase 1 and other 8 additional subjects with xerostomia.~Arm II was not part of Phase II. Thus, none of the subjects without xerostomia of Phase I participated in Phase II"|
48495886|NCT05058430|101547959|FG001|STARTED|Use of the SaliPen Device||0|"Participants of Arm I were the 8 subjects with xerostomia of Phase 1 and other 8 additional subjects with xerostomia.~Arm II was not part of Phase II. Thus, none of the subjects without xerostomia of Phase I participated in Phase II"|
48495887|NCT05058430|101547958|FG000|COMPLETED|Use of the SaliPen Device||16||
48495888|NCT05058430|101547959|FG001|COMPLETED|Use of the SaliPen Device||0||
48495889|NCT05058430|101547958|FG000|NOT COMPLETED|Use of the SaliPen Device||0||
48495890|NCT05058430|101547959|FG001|NOT COMPLETED|Use of the SaliPen Device||0||
48495891|NCT03018925|101547960|FG000|STARTED|Overall Study||15||
48495892|NCT03018925|101547960|FG000|COMPLETED|Overall Study||15||
48495893|NCT03018925|101547960|FG000|NOT COMPLETED|Overall Study||0||
48495894|NCT02611687|101547961|FG000|STARTED|Double-blind Period (0 to 8 Weeks)||72||
48495895|NCT02611687|101547962|FG001|STARTED|Double-blind Period (0 to 8 Weeks)||38||
48495896|NCT02611687|101547961|FG000|COMPLETED|Double-blind Period (0 to 8 Weeks)||70||
48495897|NCT02611687|101547962|FG001|COMPLETED|Double-blind Period (0 to 8 Weeks)||37||
48495898|NCT02611687|101547961|FG000|NOT COMPLETED|Double-blind Period (0 to 8 Weeks)||2||
48495899|NCT02611687|101547962|FG001|NOT COMPLETED|Double-blind Period (0 to 8 Weeks)||1||
48495900|NCT02611687|101547961|FG000|STARTED|Open-label Period (0 to >11 Months)||70||
48208755|NCT01867216|100837103|FG002|NOT COMPLETED|Overall Study||0||
48208756|NCT01867216|100837104|FG003|NOT COMPLETED|Overall Study||0||
48208757|NCT01867216|100837105|FG004|NOT COMPLETED|Overall Study||1||
48208758|NCT01867216|100837106|FG005|NOT COMPLETED|Overall Study||0||
48208759|NCT01867216|100837107|FG006|NOT COMPLETED|Overall Study||1||
48208760|NCT02509585|100837108|FG000|STARTED|Overall Study||18||
48208761|NCT02509585|100837108|FG000|COMPLETED|Overall Study||18||
48208762|NCT02509585|100837108|FG000|NOT COMPLETED|Overall Study||0||
48208763|NCT01458210|100837109|FG000|STARTED|Lead-in (1st Course of Ortho-Cyclen)||22||
48208764|NCT01458210|100837109|FG000|Received at Least One Dose of Study Drug|Lead-in (1st Course of Ortho-Cyclen)||22||
48208765|NCT01458210|100837109|FG000|COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||22||
48208766|NCT01458210|100837109|FG000|NOT COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||0||
48208767|NCT01458210|100837109|FG000|STARTED|Ortho-Cyclen Alone (Period 1)||22||
48208768|NCT01458210|100837109|FG000|COMPLETED|Ortho-Cyclen Alone (Period 1)||18||
48208769|NCT01458210|100837109|FG000|NOT COMPLETED|Ortho-Cyclen Alone (Period 1)||4||
48208770|NCT01458210|100837109|FG000|STARTED|Ortho-Cyclen + Dulaglutide (Period 2)||18||
48208771|NCT01458210|100837109|FG000|COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||15||
48208772|NCT01458210|100837109|FG000|NOT COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||3||
48208773|NCT02506257|100837110|FG000|STARTED|Overall Study||26||
48208774|NCT02506257|100837111|FG001|STARTED|Overall Study||28||
48208775|NCT02506257|100837112|FG002|STARTED|Overall Study||27||
48208776|NCT02506257|100837113|FG003|STARTED|Overall Study||9||
48208777|NCT02506257|100837110|FG000|COMPLETED|Overall Study||26||
48208778|NCT02506257|100837111|FG001|COMPLETED|Overall Study||26||
48208779|NCT02506257|100837112|FG002|COMPLETED|Overall Study||23||
48208780|NCT02506257|100837113|FG003|COMPLETED|Overall Study||9||
48208781|NCT02506257|100837110|FG000|NOT COMPLETED|Overall Study||0||
48208782|NCT02506257|100837111|FG001|NOT COMPLETED|Overall Study||2||
48208783|NCT02506257|100837112|FG002|NOT COMPLETED|Overall Study||4||
48208784|NCT02506257|100837113|FG003|NOT COMPLETED|Overall Study||0||
48208785|NCT01202955|100837114|FG000|STARTED|Period 1: 10 Days||9||
48208786|NCT01202955|100837115|FG001|STARTED|Period 1: 10 Days||10||
48208787|NCT01202955|100837114|FG000|COMPLETED|Period 1: 10 Days||9||
48208788|NCT01202955|100837115|FG001|COMPLETED|Period 1: 10 Days||8||
48208789|NCT01202955|100837114|FG000|NOT COMPLETED|Period 1: 10 Days||0||
48208790|NCT01202955|100837115|FG001|NOT COMPLETED|Period 1: 10 Days||2||
48208791|NCT01202955|100837114|FG000|STARTED|Period 2: 7 Days (Wash-Out)||9||
48208792|NCT01202955|100837115|FG001|STARTED|Period 2: 7 Days (Wash-Out)||8||
48208793|NCT01202955|100837114|FG000|COMPLETED|Period 2: 7 Days (Wash-Out)||9||
48208794|NCT01202955|100837115|FG001|COMPLETED|Period 2: 7 Days (Wash-Out)||8||
48208795|NCT01202955|100837114|FG000|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0||
48059564|NCT01052844|100466959|FG000|COMPLETED|Overall Study||40||
48059565|NCT01052844|100466960|FG001|COMPLETED|Overall Study||39||
48059566|NCT01052844|100466959|FG000|NOT COMPLETED|Overall Study||0||
48059567|NCT01052844|100466960|FG001|NOT COMPLETED|Overall Study||1||
48059568|NCT00760214|100466961|FG000|STARTED|Overall Study||295||
48059569|NCT00760214|100466962|FG001|STARTED|Overall Study||294||
48059570|NCT00760214|100466963|FG002|STARTED|Overall Study||296||
48059571|NCT00760214|100466961|FG000|COMPLETED|Overall Study||265||
48059572|NCT00760214|100466962|FG001|COMPLETED|Overall Study||264||
48059573|NCT00760214|100466963|FG002|COMPLETED|Overall Study||255||
48059574|NCT00760214|100466961|FG000|NOT COMPLETED|Overall Study||30||
48059575|NCT00760214|100466962|FG001|NOT COMPLETED|Overall Study||30||
48059576|NCT00760214|100466963|FG002|NOT COMPLETED|Overall Study||41||
48059577|NCT00116428|100466964|FG000|STARTED|Overall Study||106||
48059578|NCT00116428|100466965|FG001|STARTED|Overall Study||61||
48059579|NCT00116428|100466964|FG000|Underwent Study Ablation Procedure|Overall Study||103||
48059580|NCT00116428|100466965|FG001|Underwent Study Ablation Procedure|Overall Study||36||
48059581|NCT00116428|100466964|FG000|COMPLETED|Overall Study||103||
48059582|NCT00116428|100466965|FG001|COMPLETED|Overall Study||56||
48059583|NCT00116428|100466964|FG000|NOT COMPLETED|Overall Study||3||
48059584|NCT00116428|100466965|FG001|NOT COMPLETED|Overall Study||5||
48059585|NCT02939079|100466966|FG000|STARTED|Overall Study||25||
48059586|NCT02939079|100466967|FG001|STARTED|Overall Study||25||
48059587|NCT02939079|100466966|FG000|COMPLETED|Overall Study||21||
48059588|NCT02939079|100466967|FG001|COMPLETED|Overall Study||20||
48059589|NCT02939079|100466966|FG000|NOT COMPLETED|Overall Study||4||
48059590|NCT02939079|100466967|FG001|NOT COMPLETED|Overall Study||5||
48059591|NCT02476422|100466968|FG000|STARTED|Overall Study||166||
48059592|NCT02476422|100466969|FG001|STARTED|Overall Study||162||
48059593|NCT02476422|100466968|FG000|COMPLETED|Overall Study||166||
48059594|NCT02476422|100466969|FG001|COMPLETED|Overall Study||161||
48059595|NCT02476422|100466968|FG000|NOT COMPLETED|Overall Study||0||
48059596|NCT02476422|100466969|FG001|NOT COMPLETED|Overall Study||1||
48059597|NCT00090051|100466970|FG000|STARTED|Overall Study||276||
48208796|NCT01202955|100837115|FG001|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0||
48208797|NCT01202955|100837114|FG000|STARTED|Period 3: 10 Days||9||
48208798|NCT01202955|100837115|FG001|STARTED|Period 3: 10 Days||8||
48208799|NCT01202955|100837114|FG000|COMPLETED|Period 3: 10 Days||9||
48208800|NCT01202955|100837115|FG001|COMPLETED|Period 3: 10 Days||8||
48059598|NCT00090051|100466971|FG001|STARTED|Overall Study||276||
48059599|NCT00090051|100466970|FG000|Safety Population; Received Study Drug|Overall Study||272||
48059600|NCT00090051|100466971|FG001|Safety Population; Received Study Drug|Overall Study||274||
48208801|NCT01202955|100837114|FG000|NOT COMPLETED|Period 3: 10 Days||0||
48208802|NCT01202955|100837115|FG001|NOT COMPLETED|Period 3: 10 Days||0||
48208803|NCT04057196|100837116|FG000|STARTED|Overall Study||30||
48208804|NCT04057196|100837116|FG000|COMPLETED|Overall Study||24||
48208805|NCT04057196|100837116|FG000|NOT COMPLETED|Overall Study||6||
48208806|NCT04925765|100837117|FG000|STARTED|Overall Study||6||
48208807|NCT04925765|100837117|FG000|COMPLETED|Overall Study||6||
48208808|NCT04925765|100837117|FG000|NOT COMPLETED|Overall Study||0||
48208809|NCT01563354|100837118|FG000|STARTED|Core Phase||41||
48208810|NCT01563354|100837119|FG001|STARTED|Core Phase||42||
48208811|NCT01563354|100837120|FG002|STARTED|Core Phase||41||
48208812|NCT01563354|100837118|FG000|Entered Extension Phase|Core Phase||12||
48208813|NCT01563354|100837119|FG001|Entered Extension Phase|Core Phase||14||
48208814|NCT01563354|100837120|FG002|Entered Extension Phase|Core Phase||15||
48208815|NCT01563354|100837118|FG000|COMPLETED|Core Phase||12||
48208816|NCT01563354|100837119|FG001|COMPLETED|Core Phase||14||
48208817|NCT01563354|100837120|FG002|COMPLETED|Core Phase||15||
48208818|NCT01563354|100837118|FG000|NOT COMPLETED|Core Phase||29||
48208819|NCT01563354|100837119|FG001|NOT COMPLETED|Core Phase||28||
48208820|NCT01563354|100837120|FG002|NOT COMPLETED|Core Phase||26||
48208821|NCT01563354|100837118|FG000|STARTED|Extension Phase||12||
48208822|NCT01563354|100837119|FG001|STARTED|Extension Phase||14||
48208823|NCT01563354|100837120|FG002|STARTED|Extension Phase||15||
48208824|NCT01563354|100837118|FG000|COMPLETED|Extension Phase||0||
48208825|NCT01563354|100837119|FG001|COMPLETED|Extension Phase||0||
48208826|NCT01563354|100837120|FG002|COMPLETED|Extension Phase||0||
48208827|NCT01563354|100837118|FG000|NOT COMPLETED|Extension Phase||12||
48208828|NCT01563354|100837119|FG001|NOT COMPLETED|Extension Phase||14||
48208829|NCT01563354|100837120|FG002|NOT COMPLETED|Extension Phase||15||
48208830|NCT02200770|100837121|FG000|STARTED|Randomized-controlled Period (RCP)||56||
48208831|NCT02200770|100837122|FG001|STARTED|Randomized-controlled Period (RCP)||175||
48208832|NCT02200770|100837121|FG000|Treated|Randomized-controlled Period (RCP)||56||
48208833|NCT02200770|100837122|FG001|Treated|Randomized-controlled Period (RCP)||174||
48208834|NCT02200770|100837121|FG000|COMPLETED|Randomized-controlled Period (RCP)||54||
48208835|NCT02200770|100837122|FG001|COMPLETED|Randomized-controlled Period (RCP)||169||
48208836|NCT02200770|100837121|FG000|NOT COMPLETED|Randomized-controlled Period (RCP)||2||
48208837|NCT02200770|100837122|FG001|NOT COMPLETED|Randomized-controlled Period (RCP)||6||
48208838|NCT02200770|100837121|FG000|STARTED|Open-label Period (OLP)||51||
48208839|NCT02200770|100837122|FG001|STARTED|Open-label Period (OLP)||165||
48208840|NCT02200770|100837121|FG000|COMPLETED|Open-label Period (OLP)||43||
48208841|NCT02200770|100837122|FG001|COMPLETED|Open-label Period (OLP)||131||
48208842|NCT02200770|100837121|FG000|NOT COMPLETED|Open-label Period (OLP)||8||
48208843|NCT02200770|100837122|FG001|NOT COMPLETED|Open-label Period (OLP)||34||
48208844|NCT04833855|100837123|FG000|STARTED|Overall Study||48||
48208845|NCT04833855|100837124|FG001|STARTED|Overall Study||31||
48208846|NCT04833855|100837125|FG002|STARTED|Overall Study||52||
48208847|NCT04833855|100837126|FG003|STARTED|Overall Study||52||
48208848|NCT04833855|100837123|FG000|COMPLETED|Overall Study||43||
48208849|NCT04833855|100837124|FG001|COMPLETED|Overall Study||29||
48208850|NCT04833855|100837125|FG002|COMPLETED|Overall Study||45||
48208851|NCT04833855|100837126|FG003|COMPLETED|Overall Study||48||
48208852|NCT04833855|100837123|FG000|NOT COMPLETED|Overall Study||5||
48208853|NCT04833855|100837124|FG001|NOT COMPLETED|Overall Study||2||
48208854|NCT04833855|100837125|FG002|NOT COMPLETED|Overall Study||7||
48208855|NCT04833855|100837126|FG003|NOT COMPLETED|Overall Study||4||
48208856|NCT02568683|100837127|FG000|STARTED|Overall Study||6||
48208857|NCT02568683|100837128|FG001|STARTED|Overall Study||4||
48208858|NCT02568683|100837127|FG000|COMPLETED|Overall Study||0||
48208859|NCT02568683|100837128|FG001|COMPLETED|Overall Study||0||
48208860|NCT02568683|100837127|FG000|NOT COMPLETED|Overall Study||6||
48208861|NCT02568683|100837128|FG001|NOT COMPLETED|Overall Study||4||
48208862|NCT02299375|100837129|FG000|STARTED|Overall Study||94||
48208863|NCT02299375|100837130|FG001|STARTED|Overall Study||90||
48208864|NCT02299375|100837129|FG000|COMPLETED|Overall Study||14||
48495901|NCT02611687|101547962|FG001|STARTED|Open-label Period (0 to >11 Months)||36||
48495902|NCT02611687|101547961|FG000|COMPLETED|Open-label Period (0 to >11 Months)||39||
48495903|NCT02611687|101547962|FG001|COMPLETED|Open-label Period (0 to >11 Months)||21||
48495904|NCT02611687|101547961|FG000|NOT COMPLETED|Open-label Period (0 to >11 Months)||31||
48208865|NCT02299375|100837130|FG001|COMPLETED|Overall Study||10||
48208866|NCT02299375|100837129|FG000|NOT COMPLETED|Overall Study||80||
48208867|NCT02299375|100837130|FG001|NOT COMPLETED|Overall Study||80||
48208868|NCT04048135|100837131|FG000|STARTED|Overall Study||6||
48208869|NCT04048135|100837132|FG001|STARTED|Overall Study||12||
48208870|NCT04048135|100837133|FG002|STARTED|Overall Study||11||
48208871|NCT04048135|100837134|FG003|STARTED|Overall Study||10||
48208872|NCT04048135|100837135|FG004|STARTED|Overall Study||14||
48208873|NCT04048135|100837136|FG005|STARTED|Overall Study||9||
48208874|NCT04048135|100837137|FG006|STARTED|Overall Study||19||
48208875|NCT04048135|100837138|FG007|STARTED|Overall Study||20||
48208876|NCT04048135|100837131|FG000|Received 1 Dose of Study Drug|Overall Study||6|Randomized Analysis Set. Arm groups were based upon planned treatment.|
48495905|NCT02611687|101547962|FG001|NOT COMPLETED|Open-label Period (0 to >11 Months)||15||
48208877|NCT04048135|100837132|FG001|Received 1 Dose of Study Drug|Overall Study||12|Randomized Analysis Set. Arm groups were based upon planned treatment.|
48208878|NCT04048135|100837133|FG002|Received 1 Dose of Study Drug|Overall Study||11|Randomized Analysis Set. Arm groups were based upon planned treatment.|
48208879|NCT04048135|100837134|FG003|Received 1 Dose of Study Drug|Overall Study||10|Randomized Analysis Set. Arm groups were based upon planned treatment.|
48208880|NCT04048135|100837135|FG004|Received 1 Dose of Study Drug|Overall Study||14|Randomized Analysis Set. Arm groups were based upon planned treatment.|
48208881|NCT04048135|100837136|FG005|Received 1 Dose of Study Drug|Overall Study||9|Randomized Analysis Set. Arm groups were based upon planned treatment.|
48208882|NCT04048135|100837137|FG006|Received 1 Dose of Study Drug|Overall Study||19|Randomized Analysis Set. Arm groups were based upon planned treatment.|
48208883|NCT04048135|100837138|FG007|Received 1 Dose of Study Drug|Overall Study||20|Randomized Analysis Set. Arm groups were based upon planned treatment.|
48208884|NCT04048135|100837131|FG000|Safety Analysis Set|Overall Study||7|Arm groups were based upon the actual treatment received for the purpose of safety analysis.|
48208885|NCT04048135|100837132|FG001|Safety Analysis Set|Overall Study||12|Arm groups were based upon the actual treatment received for the purpose of safety analysis.|
48208886|NCT04048135|100837133|FG002|Safety Analysis Set|Overall Study||11|Arm groups were based upon the actual treatment received for the purpose of safety analysis.|
48208887|NCT04048135|100837134|FG003|Safety Analysis Set|Overall Study||10|Arm groups were based upon the actual treatment received for the purpose of safety analysis.|
48208888|NCT04048135|100837135|FG004|Safety Analysis Set|Overall Study||14|Arm groups were based upon the actual treatment received for the purpose of safety analysis.|
48208889|NCT04048135|100837136|FG005|Safety Analysis Set|Overall Study||9|Arm groups were based upon the actual treatment received for the purpose of safety analysis.|
48208890|NCT04048135|100837137|FG006|Safety Analysis Set|Overall Study||18|Arm groups were based upon the actual treatment received for the purpose of safety analysis.|
48208891|NCT04048135|100837138|FG007|Safety Analysis Set|Overall Study||20|Arm groups were based upon the actual treatment received for the purpose of safety analysis.|
48208892|NCT04048135|100837131|FG000|COMPLETED|Overall Study||5||
48208893|NCT04048135|100837132|FG001|COMPLETED|Overall Study||11||
48208894|NCT04048135|100837133|FG002|COMPLETED|Overall Study||10||
48208895|NCT04048135|100837134|FG003|COMPLETED|Overall Study||7||
48208896|NCT04048135|100837135|FG004|COMPLETED|Overall Study||13||
48208897|NCT04048135|100837136|FG005|COMPLETED|Overall Study||8||
48208898|NCT04048135|100837137|FG006|COMPLETED|Overall Study||18||
48208899|NCT04048135|100837138|FG007|COMPLETED|Overall Study||19||
48208900|NCT04048135|100837131|FG000|NOT COMPLETED|Overall Study||1||
48208901|NCT04048135|100837132|FG001|NOT COMPLETED|Overall Study||1||
48208902|NCT04048135|100837133|FG002|NOT COMPLETED|Overall Study||1||
48208903|NCT04048135|100837134|FG003|NOT COMPLETED|Overall Study||3||
48208904|NCT04048135|100837135|FG004|NOT COMPLETED|Overall Study||1||
48208905|NCT04048135|100837136|FG005|NOT COMPLETED|Overall Study||1||
48208906|NCT04048135|100837137|FG006|NOT COMPLETED|Overall Study||1||
48208907|NCT04048135|100837138|FG007|NOT COMPLETED|Overall Study||1||
48208908|NCT03737240|100837139|FG000|STARTED|Overall Study||72||
48208909|NCT03737240|100837140|FG001|STARTED|Overall Study||73||
48208910|NCT03737240|100837139|FG000|COMPLETED|Overall Study||56||
48208911|NCT03737240|100837140|FG001|COMPLETED|Overall Study||58||
48208912|NCT03737240|100837139|FG000|NOT COMPLETED|Overall Study||16||
48208913|NCT03737240|100837140|FG001|NOT COMPLETED|Overall Study||15||
48208914|NCT02296424|100837141|FG000|STARTED|Part 1||84||
48495906|NCT02913924|101547963|FG000|STARTED|Overall Study||34||
48495907|NCT02913924|101547964|FG001|STARTED|Overall Study||34||
48495908|NCT02913924|101547963|FG000|COMPLETED|Overall Study||21||
48495909|NCT02913924|101547964|FG001|COMPLETED|Overall Study||21||
48495910|NCT02913924|101547963|FG000|NOT COMPLETED|Overall Study||13||
48208915|NCT02296424|100837142|FG001|STARTED|Part 1||98||
48208916|NCT02296424|100837143|FG002|STARTED|Part 1||0||
48208917|NCT02296424|100837144|FG003|STARTED|Part 1||0||
48208918|NCT02296424|100837141|FG000|COMPLETED|Part 1||61||
48208919|NCT02296424|100837142|FG001|COMPLETED|Part 1||65||
48208920|NCT02296424|100837143|FG002|COMPLETED|Part 1||0||
48208921|NCT02296424|100837144|FG003|COMPLETED|Part 1||0||
48208922|NCT02296424|100837141|FG000|NOT COMPLETED|Part 1||23||
48208923|NCT02296424|100837142|FG001|NOT COMPLETED|Part 1||33||
48208924|NCT02296424|100837143|FG002|NOT COMPLETED|Part 1||0||
48208925|NCT02296424|100837144|FG003|NOT COMPLETED|Part 1||0||
48208926|NCT02296424|100837141|FG000|STARTED|Part 2||0||
48208927|NCT02296424|100837142|FG001|STARTED|Part 2||0||
48208928|NCT02296424|100837143|FG002|STARTED|Part 2||38||
48208929|NCT02296424|100837144|FG003|STARTED|Part 2||37||
48208930|NCT02296424|100837141|FG000|COMPLETED|Part 2||0||
48208931|NCT02296424|100837142|FG001|COMPLETED|Part 2||0||
48208932|NCT02296424|100837143|FG002|COMPLETED|Part 2||35||
48208933|NCT02296424|100837144|FG003|COMPLETED|Part 2||37||
48208934|NCT02296424|100837141|FG000|NOT COMPLETED|Part 2||0||
48208935|NCT02296424|100837142|FG001|NOT COMPLETED|Part 2||0||
48208936|NCT02296424|100837143|FG002|NOT COMPLETED|Part 2||3||
48208937|NCT02296424|100837144|FG003|NOT COMPLETED|Part 2||0||
48208938|NCT01396837|100837145|FG000|STARTED|Overall Study||20||
48208939|NCT01396837|100837145|FG000|COMPLETED|Overall Study||16||
48208940|NCT01396837|100837145|FG000|NOT COMPLETED|Overall Study||4||
48208941|NCT01161563|100837146|FG000|STARTED|Overall Study||63||
48208942|NCT01161563|100837147|FG001|STARTED|Overall Study||55||
48208943|NCT01161563|100837146|FG000|COMPLETED|Overall Study||58||
48208944|NCT01161563|100837147|FG001|COMPLETED|Overall Study||49||
48208945|NCT01161563|100837146|FG000|NOT COMPLETED|Overall Study||5||
48208946|NCT01161563|100837147|FG001|NOT COMPLETED|Overall Study||6||
48208947|NCT00177216|100837148|FG000|STARTED|Overall Study||26||
48208948|NCT00177216|100837149|FG001|STARTED|Overall Study||23||
48208949|NCT00177216|100837150|FG002|STARTED|Overall Study||20||
48208950|NCT00177216|100837148|FG000|COMPLETED|Overall Study||20||
48208951|NCT00177216|100837149|FG001|COMPLETED|Overall Study||20||
48208952|NCT00177216|100837150|FG002|COMPLETED|Overall Study||19||
48208953|NCT00177216|100837148|FG000|NOT COMPLETED|Overall Study||6||
48208954|NCT00177216|100837149|FG001|NOT COMPLETED|Overall Study||3||
48208955|NCT00177216|100837150|FG002|NOT COMPLETED|Overall Study||1||
48208956|NCT03414658|100837151|FG000|STARTED|Overall Study||20||
48208957|NCT03414658|100837152|FG001|STARTED|Overall Study||46||
48208958|NCT03414658|100837153|FG002|STARTED|Overall Study||34||
48208959|NCT03414658|100837151|FG000|COMPLETED|Overall Study||18||
48208960|NCT03414658|100837152|FG001|COMPLETED|Overall Study||45||
48208961|NCT03414658|100837153|FG002|COMPLETED|Overall Study||34||
48208962|NCT03414658|100837151|FG000|NOT COMPLETED|Overall Study||2||
48208963|NCT03414658|100837152|FG001|NOT COMPLETED|Overall Study||1||
48208964|NCT03414658|100837153|FG002|NOT COMPLETED|Overall Study||0||
48208965|NCT02711839|100837154|FG000|STARTED|Overall Study||20||
48208966|NCT02711839|100837155|FG001|STARTED|Overall Study||34||
48208967|NCT02711839|100837154|FG000|COMPLETED|Overall Study||16||
48208968|NCT02711839|100837155|FG001|COMPLETED|Overall Study||24||
48208969|NCT02711839|100837154|FG000|NOT COMPLETED|Overall Study||4||
48208970|NCT02711839|100837155|FG001|NOT COMPLETED|Overall Study||10||
48208971|NCT02192606|100837156|FG000|STARTED|Overall Study||29||
48208972|NCT02192606|100837157|FG001|STARTED|Overall Study||28||
48208973|NCT02192606|100837156|FG000|COMPLETED|Overall Study||27||
48208974|NCT02192606|100837157|FG001|COMPLETED|Overall Study||24||
48208975|NCT02192606|100837156|FG000|NOT COMPLETED|Overall Study||2||
48208976|NCT02192606|100837157|FG001|NOT COMPLETED|Overall Study||4||
48208977|NCT01012388|100837158|FG000|STARTED|Overall Study||100||
48208978|NCT01012388|100837158|FG000|COMPLETED|Overall Study||100||
48208979|NCT01012388|100837158|FG000|NOT COMPLETED|Overall Study||0||
48208980|NCT00997386|100837159|FG000|STARTED|Overall Study||16||
48208981|NCT00997386|100837159|FG000|COMPLETED|Overall Study||9||
48208982|NCT00997386|100837159|FG000|NOT COMPLETED|Overall Study||7||
48208983|NCT01118377|100837160|FG000|STARTED|Overall Study||45||
48208984|NCT01118377|100837160|FG000|COMPLETED|Overall Study||3||
48208985|NCT01118377|100837160|FG000|NOT COMPLETED|Overall Study||42||
48208986|NCT00818805|100837161|FG000|STARTED|First Intervention||25||
48208987|NCT00818805|100837162|FG001|STARTED|First Intervention||25||
48208988|NCT00818805|100837161|FG000|COMPLETED|First Intervention||25||
48208989|NCT00818805|100837162|FG001|COMPLETED|First Intervention||25||
48208990|NCT00818805|100837161|FG000|NOT COMPLETED|First Intervention||0||
48208991|NCT00818805|100837162|FG001|NOT COMPLETED|First Intervention||0||
48208992|NCT00818805|100837161|FG000|STARTED|Second Intervention||25||
48208993|NCT00818805|100837162|FG001|STARTED|Second Intervention||25||
48208994|NCT00818805|100837161|FG000|COMPLETED|Second Intervention||25||
48208995|NCT00818805|100837162|FG001|COMPLETED|Second Intervention||25||
48208996|NCT00818805|100837161|FG000|NOT COMPLETED|Second Intervention||0||
48208997|NCT00818805|100837162|FG001|NOT COMPLETED|Second Intervention||0||
48208998|NCT01551056|100837163|FG000|STARTED|Overall Study||46||
48208999|NCT01551056|100837164|FG001|STARTED|Overall Study||45||
48209000|NCT01551056|100837163|FG000|COMPLETED|Overall Study||44||
48209001|NCT01551056|100837164|FG001|COMPLETED|Overall Study||45||
48209002|NCT01551056|100837163|FG000|NOT COMPLETED|Overall Study||2||
48209003|NCT01551056|100837164|FG001|NOT COMPLETED|Overall Study||0||
48209004|NCT02988817|100837165|FG000|STARTED|Overall Study||1||
48209005|NCT02988817|100837166|FG001|STARTED|Overall Study||1||
48209006|NCT02988817|100837167|FG002|STARTED|Overall Study||3||
48209007|NCT02988817|100837168|FG003|STARTED|Overall Study||3||
48209008|NCT02988817|100837169|FG004|STARTED|Overall Study||10||
48209009|NCT02988817|100837170|FG005|STARTED|Overall Study||11||
48209010|NCT02988817|100837171|FG006|STARTED|Overall Study||3||
48209011|NCT02988817|100837172|FG007|STARTED|Overall Study||3||
48209012|NCT02988817|100837173|FG008|STARTED|Overall Study||3||
48209013|NCT02988817|100837174|FG009|STARTED|Overall Study||6||
48209014|NCT02988817|100837175|FG010|STARTED|Overall Study||3||
48495911|NCT02913924|101547964|FG001|NOT COMPLETED|Overall Study||13||
48209015|NCT02988817|100837176|FG011|STARTED|Overall Study||22||
48209016|NCT02988817|100837177|FG012|STARTED|Overall Study||16||
48209017|NCT02988817|100837178|FG013|STARTED|Overall Study||25||
48209018|NCT02988817|100837179|FG014|STARTED|Overall Study||25||
48209019|NCT02988817|100837180|FG015|STARTED|Overall Study||44||
48209020|NCT02988817|100837181|FG016|STARTED|Overall Study||25||
48209021|NCT02988817|100837182|FG017|STARTED|Overall Study||55||
48209022|NCT02988817|100837183|FG018|STARTED|Overall Study||21||
48209023|NCT02988817|100837184|FG019|STARTED|Overall Study||26||
48209024|NCT02988817|100837165|FG000|COMPLETED|Overall Study||0||
48209025|NCT02988817|100837166|FG001|COMPLETED|Overall Study||0||
48209026|NCT02988817|100837167|FG002|COMPLETED|Overall Study||0||
48209027|NCT02988817|100837168|FG003|COMPLETED|Overall Study||0||
48209028|NCT02988817|100837169|FG004|COMPLETED|Overall Study||0||
48209029|NCT02988817|100837170|FG005|COMPLETED|Overall Study||0||
48209030|NCT02988817|100837171|FG006|COMPLETED|Overall Study||0||
48209031|NCT02988817|100837172|FG007|COMPLETED|Overall Study||0||
48209032|NCT02988817|100837173|FG008|COMPLETED|Overall Study||0||
48209033|NCT02988817|100837174|FG009|COMPLETED|Overall Study||0||
48209034|NCT02988817|100837175|FG010|COMPLETED|Overall Study||0||
48209035|NCT02988817|100837176|FG011|COMPLETED|Overall Study||0||
48209036|NCT02988817|100837177|FG012|COMPLETED|Overall Study||0||
48209037|NCT02988817|100837178|FG013|COMPLETED|Overall Study||0||
48209038|NCT02988817|100837179|FG014|COMPLETED|Overall Study||0||
48209039|NCT02988817|100837180|FG015|COMPLETED|Overall Study||0||
48209040|NCT02988817|100837181|FG016|COMPLETED|Overall Study||0||
48209041|NCT02988817|100837182|FG017|COMPLETED|Overall Study||0||
48209042|NCT02988817|100837183|FG018|COMPLETED|Overall Study||0||
48209043|NCT02988817|100837184|FG019|COMPLETED|Overall Study||0||
48209044|NCT02988817|100837165|FG000|NOT COMPLETED|Overall Study||1||
48209045|NCT02988817|100837166|FG001|NOT COMPLETED|Overall Study||1||
48209046|NCT02988817|100837167|FG002|NOT COMPLETED|Overall Study||3||
48209047|NCT02988817|100837168|FG003|NOT COMPLETED|Overall Study||3||
48209048|NCT02988817|100837169|FG004|NOT COMPLETED|Overall Study||10||
48209049|NCT02988817|100837170|FG005|NOT COMPLETED|Overall Study||11||
48209050|NCT02988817|100837171|FG006|NOT COMPLETED|Overall Study||3||
48209051|NCT02988817|100837172|FG007|NOT COMPLETED|Overall Study||3||
48209052|NCT02988817|100837173|FG008|NOT COMPLETED|Overall Study||3||
48209053|NCT02988817|100837174|FG009|NOT COMPLETED|Overall Study||6||
48209054|NCT02988817|100837175|FG010|NOT COMPLETED|Overall Study||3||
48209055|NCT02988817|100837176|FG011|NOT COMPLETED|Overall Study||22||
48209056|NCT02988817|100837177|FG012|NOT COMPLETED|Overall Study||16||
48209057|NCT02988817|100837178|FG013|NOT COMPLETED|Overall Study||25||
48209058|NCT02988817|100837179|FG014|NOT COMPLETED|Overall Study||25||
48209059|NCT02988817|100837180|FG015|NOT COMPLETED|Overall Study||44||
48209060|NCT02988817|100837181|FG016|NOT COMPLETED|Overall Study||25||
48209061|NCT02988817|100837182|FG017|NOT COMPLETED|Overall Study||55||
48209062|NCT02988817|100837183|FG018|NOT COMPLETED|Overall Study||21||
48209063|NCT02988817|100837184|FG019|NOT COMPLETED|Overall Study||26||
48209064|NCT00393848|100837185|FG000|STARTED|Overall Study||16||
48209065|NCT00393848|100837186|FG001|STARTED|Overall Study||9||
48209066|NCT00393848|100837187|FG002|STARTED|Overall Study||6||
48209067|NCT00393848|100837188|FG003|STARTED|Overall Study||9||
48209068|NCT00393848|100837185|FG000|COMPLETED|Overall Study||16||
48209069|NCT00393848|100837186|FG001|COMPLETED|Overall Study||9||
48209070|NCT00393848|100837187|FG002|COMPLETED|Overall Study||4||
48209071|NCT00393848|100837188|FG003|COMPLETED|Overall Study||8||
48209072|NCT00393848|100837185|FG000|NOT COMPLETED|Overall Study||0||
48209073|NCT00393848|100837186|FG001|NOT COMPLETED|Overall Study||0||
48209074|NCT00393848|100837187|FG002|NOT COMPLETED|Overall Study||2||
48209075|NCT00393848|100837188|FG003|NOT COMPLETED|Overall Study||1||
48209076|NCT02549170|100837189|FG000|STARTED|Epoch 1: Day 1 to Approximately 32 Weeks||70||
48209077|NCT02549170|100837190|FG001|STARTED|Epoch 1: Day 1 to Approximately 32 Weeks||62||
48209078|NCT02549170|100837191|FG002|STARTED|Epoch 1: Day 1 to Approximately 32 Weeks||0||
48209079|NCT02549170|100837192|FG003|STARTED|Epoch 1: Day 1 to Approximately 32 Weeks||0||
48209080|NCT02549170|100837193|FG004|STARTED|Epoch 1: Day 1 to Approximately 32 Weeks||0||
48059601|NCT00090051|100466970|FG000|COMPLETED|Overall Study||167||
48059602|NCT00090051|100466971|FG001|COMPLETED|Overall Study||181||
48059603|NCT00090051|100466970|FG000|NOT COMPLETED|Overall Study||109||
48059604|NCT00090051|100466971|FG001|NOT COMPLETED|Overall Study||95||
48059605|NCT01104701|100466972|FG000|STARTED|Overall Study||30||
48059606|NCT01104701|100466973|FG001|STARTED|Overall Study||30||
48059607|NCT01104701|100466974|FG002|STARTED|Overall Study||31||
48059608|NCT01104701|100466975|FG003|STARTED|Overall Study||30||
48059609|NCT01104701|100466972|FG000|COMPLETED|Overall Study||30||
48059610|NCT01104701|100466973|FG001|COMPLETED|Overall Study||27||
48059611|NCT01104701|100466974|FG002|COMPLETED|Overall Study||29||
48059612|NCT01104701|100466975|FG003|COMPLETED|Overall Study||28||
48059613|NCT01104701|100466972|FG000|NOT COMPLETED|Overall Study||0||
48059614|NCT01104701|100466973|FG001|NOT COMPLETED|Overall Study||3||
48059615|NCT01104701|100466974|FG002|NOT COMPLETED|Overall Study||2||
48059616|NCT01104701|100466975|FG003|NOT COMPLETED|Overall Study||2||
48059617|NCT04223232|100466976|FG000|STARTED|Overall Study||6||
48059618|NCT04223232|100466976|FG000|COMPLETED|Overall Study||5||
48209081|NCT02549170|100837189|FG000|COMPLETED|Epoch 1: Day 1 to Approximately 32 Weeks||46||
48209082|NCT02549170|100837190|FG001|COMPLETED|Epoch 1: Day 1 to Approximately 32 Weeks||48||
48209083|NCT02549170|100837191|FG002|COMPLETED|Epoch 1: Day 1 to Approximately 32 Weeks||0||
48209084|NCT02549170|100837192|FG003|COMPLETED|Epoch 1: Day 1 to Approximately 32 Weeks||0||
48209085|NCT02549170|100837193|FG004|COMPLETED|Epoch 1: Day 1 to Approximately 32 Weeks||0||
48209086|NCT02549170|100837189|FG000|NOT COMPLETED|Epoch 1: Day 1 to Approximately 32 Weeks||24||
48209087|NCT02549170|100837190|FG001|NOT COMPLETED|Epoch 1: Day 1 to Approximately 32 Weeks||14||
48495912|NCT03025087|101547965|FG000|STARTED|Overall Study||12||
48059619|NCT04223232|100466976|FG000|NOT COMPLETED|Overall Study||1||
48059620|NCT00972088|100466977|FG000|STARTED|Overall Study||26||
48059621|NCT00972088|100466977|FG000|COMPLETED|Overall Study||26||
48059622|NCT00972088|100466977|FG000|NOT COMPLETED|Overall Study||0||
48209088|NCT02549170|100837191|FG002|NOT COMPLETED|Epoch 1: Day 1 to Approximately 32 Weeks||0||
48209089|NCT02549170|100837192|FG003|NOT COMPLETED|Epoch 1: Day 1 to Approximately 32 Weeks||0||
48209090|NCT02549170|100837193|FG004|NOT COMPLETED|Epoch 1: Day 1 to Approximately 32 Weeks||0||
48209091|NCT02549170|100837189|FG000|STARTED|Epoch 2: Up to Approximately Week 61||0||
48209092|NCT02549170|100837190|FG001|STARTED|Epoch 2: Up to Approximately Week 61||0||
48209093|NCT02549170|100837191|FG002|STARTED|Epoch 2: Up to Approximately Week 61||16||
48209094|NCT02549170|100837192|FG003|STARTED|Epoch 2: Up to Approximately Week 61||4||
48209095|NCT02549170|100837193|FG004|STARTED|Epoch 2: Up to Approximately Week 61||1||
48209096|NCT02549170|100837189|FG000|COMPLETED|Epoch 2: Up to Approximately Week 61||0||
48209097|NCT02549170|100837190|FG001|COMPLETED|Epoch 2: Up to Approximately Week 61||0||
48209098|NCT02549170|100837191|FG002|COMPLETED|Epoch 2: Up to Approximately Week 61||16||
48209099|NCT02549170|100837192|FG003|COMPLETED|Epoch 2: Up to Approximately Week 61||4||
48209100|NCT02549170|100837193|FG004|COMPLETED|Epoch 2: Up to Approximately Week 61||1||
48209101|NCT02549170|100837189|FG000|NOT COMPLETED|Epoch 2: Up to Approximately Week 61||0||
48209102|NCT02549170|100837190|FG001|NOT COMPLETED|Epoch 2: Up to Approximately Week 61||0||
48209103|NCT02549170|100837191|FG002|NOT COMPLETED|Epoch 2: Up to Approximately Week 61||0||
48209104|NCT02549170|100837192|FG003|NOT COMPLETED|Epoch 2: Up to Approximately Week 61||0||
48209105|NCT02549170|100837193|FG004|NOT COMPLETED|Epoch 2: Up to Approximately Week 61||0||
48209106|NCT03799783|100837194|FG000|STARTED|Overall Study||19||
48209107|NCT03799783|100837194|FG000|COMPLETED|Overall Study||19||
48209108|NCT03799783|100837194|FG000|NOT COMPLETED|Overall Study||0||
48209109|NCT03276871|100837195|FG000|STARTED|Overall Study||21||
48209110|NCT03276871|100837196|FG001|STARTED|Overall Study||19||
48209111|NCT03276871|100837195|FG000|COMPLETED|Overall Study||21||
48209112|NCT03276871|100837196|FG001|COMPLETED|Overall Study||19||
48209113|NCT03276871|100837195|FG000|NOT COMPLETED|Overall Study||0||
48209114|NCT03276871|100837196|FG001|NOT COMPLETED|Overall Study||0||
48209115|NCT01996917|100837197|FG000|STARTED|Overall Study||21||42
48209116|NCT01996917|100837197|FG000|COMPLETED|Overall Study||21||42
48209117|NCT01996917|100837197|FG000|NOT COMPLETED|Overall Study||0||0
48209118|NCT02220478|100837198|FG000|STARTED|Overall Study||14||
48209119|NCT02220478|100837199|FG001|STARTED|Overall Study||10||
48209120|NCT02220478|100837198|FG000|COMPLETED|Overall Study||11||
48209121|NCT02220478|100837199|FG001|COMPLETED|Overall Study||9||
48209122|NCT02220478|100837198|FG000|NOT COMPLETED|Overall Study||3||
48209123|NCT02220478|100837199|FG001|NOT COMPLETED|Overall Study||1||
48209124|NCT03293498|100837200|FG000|STARTED|Overall Study||109||
48209125|NCT03293498|100837201|FG001|STARTED|Overall Study||111||
48209126|NCT03293498|100837202|FG002|STARTED|Overall Study||110||
48209127|NCT03293498|100837200|FG000|COMPLETED|Overall Study||109||
48209128|NCT03293498|100837201|FG001|COMPLETED|Overall Study||111||
48209129|NCT03293498|100837202|FG002|COMPLETED|Overall Study||110||
48209130|NCT03293498|100837200|FG000|NOT COMPLETED|Overall Study||0||
48209131|NCT03293498|100837201|FG001|NOT COMPLETED|Overall Study||0||
48209132|NCT03293498|100837202|FG002|NOT COMPLETED|Overall Study||0||
48209133|NCT03997916|100837203|FG000|STARTED|Overall Study||113||
48209134|NCT03997916|100837203|FG000|COMPLETED|Overall Study||78||
48209135|NCT03997916|100837203|FG000|NOT COMPLETED|Overall Study||35||
48209136|NCT01803555|100837204|FG000|STARTED|Overall Study||303||
48209137|NCT01803555|100837205|FG001|STARTED|Overall Study||302||
48209138|NCT01803555|100837204|FG000|Received at Least 1 Dose of Study Drug|Overall Study||303||
48209139|NCT01803555|100837205|FG001|Received at Least 1 Dose of Study Drug|Overall Study||299||
48209140|NCT01803555|100837204|FG000|COMPLETED|Overall Study||290||
48209141|NCT01803555|100837205|FG001|COMPLETED|Overall Study||284||
48209142|NCT01803555|100837204|FG000|NOT COMPLETED|Overall Study||13||
48209143|NCT01803555|100837205|FG001|NOT COMPLETED|Overall Study||18||
48209144|NCT01029587|100837206|FG000|STARTED|Overall Study||1||
48209145|NCT01029587|100837206|FG000|COMPLETED|Overall Study||1||
48209146|NCT01029587|100837206|FG000|NOT COMPLETED|Overall Study||0||
48209147|NCT01240330|100837207|FG000|STARTED|Overall Study||33||
48209148|NCT01240330|100837207|FG000|COMPLETED|Overall Study||33||
48209149|NCT01240330|100837207|FG000|NOT COMPLETED|Overall Study||0||
48209150|NCT00186186|100837208|FG000|STARTED|Overall Study||28||
48209151|NCT00186186|100837208|FG000|COMPLETED|Overall Study||20||
48209152|NCT00186186|100837208|FG000|NOT COMPLETED|Overall Study||8||
48209153|NCT00666276|100837209|FG000|STARTED|Overall Study||1004||
48209154|NCT00666276|100837209|FG000|COMPLETED|Overall Study||970||
48209155|NCT00666276|100837209|FG000|NOT COMPLETED|Overall Study||34||
48209156|NCT01867632|100837210|FG000|STARTED|Overall Study||65||
48209157|NCT01867632|100837211|FG001|STARTED|Overall Study||66||
48209158|NCT01867632|100837210|FG000|COMPLETED|Overall Study||65||
48209159|NCT01867632|100837211|FG001|COMPLETED|Overall Study||66||
48209160|NCT01867632|100837210|FG000|NOT COMPLETED|Overall Study||0||
48209161|NCT01867632|100837211|FG001|NOT COMPLETED|Overall Study||0||
48209162|NCT00206375|100837212|FG000|STARTED|Overall Study||6||
48209163|NCT00206375|100837213|FG001|STARTED|Overall Study||3||
48209164|NCT00206375|100837214|FG002|STARTED|Overall Study||7||
48209165|NCT00206375|100837212|FG000|COMPLETED|Overall Study||3||
48209166|NCT00206375|100837213|FG001|COMPLETED|Overall Study||1||
48209167|NCT00206375|100837214|FG002|COMPLETED|Overall Study||3||
48209168|NCT00206375|100837212|FG000|NOT COMPLETED|Overall Study||3||
48209169|NCT00206375|100837213|FG001|NOT COMPLETED|Overall Study||2||
48209170|NCT00206375|100837214|FG002|NOT COMPLETED|Overall Study||4||
48209171|NCT01199783|100837215|FG000|STARTED|Overall Study||1||
48209172|NCT01199783|100837216|FG001|STARTED|Overall Study||0||
48209173|NCT01199783|100837215|FG000|COMPLETED|Overall Study||1||
48209174|NCT01199783|100837216|FG001|COMPLETED|Overall Study||0||
48209175|NCT01199783|100837215|FG000|NOT COMPLETED|Overall Study||0||
48209176|NCT01199783|100837216|FG001|NOT COMPLETED|Overall Study||0||
48209177|NCT04303156|100837217|FG000|STARTED|Overall Study||6||
48209178|NCT04303156|100837218|FG001|STARTED|Overall Study||6||
48209179|NCT04303156|100837217|FG000|COMPLETED|Overall Study||6||
48209180|NCT04303156|100837218|FG001|COMPLETED|Overall Study||6||
48209181|NCT04303156|100837217|FG000|NOT COMPLETED|Overall Study||0||
48209182|NCT04303156|100837218|FG001|NOT COMPLETED|Overall Study||0||
48209183|NCT01764464|100837219|FG000|STARTED|First Intervention||16||
48209184|NCT01764464|100837220|FG001|STARTED|First Intervention||16||
48209185|NCT01764464|100837219|FG000|COMPLETED|First Intervention||14||
48209186|NCT01764464|100837220|FG001|COMPLETED|First Intervention||13||
48209187|NCT01764464|100837219|FG000|NOT COMPLETED|First Intervention||2||
48209188|NCT01764464|100837220|FG001|NOT COMPLETED|First Intervention||3||
48209189|NCT01764464|100837219|FG000|STARTED|Second Intervention (Cross-over)||14||
48209190|NCT01764464|100837220|FG001|STARTED|Second Intervention (Cross-over)||13||
48209191|NCT01764464|100837219|FG000|COMPLETED|Second Intervention (Cross-over)||12||
48209192|NCT01764464|100837220|FG001|COMPLETED|Second Intervention (Cross-over)||13||
48209193|NCT01764464|100837219|FG000|NOT COMPLETED|Second Intervention (Cross-over)||2||
48209194|NCT01764464|100837220|FG001|NOT COMPLETED|Second Intervention (Cross-over)||0||
48209195|NCT03020745|100837221|FG000|STARTED|Part 1 (Up to 60 Days)||3||
48209196|NCT03020745|100837222|FG001|STARTED|Part 1 (Up to 60 Days)||3||
48209197|NCT03020745|100837223|FG002|STARTED|Part 1 (Up to 60 Days)||0||
48209198|NCT03020745|100837224|FG003|STARTED|Part 1 (Up to 60 Days)||6||
48209199|NCT03020745|100837225|FG004|STARTED|Part 1 (Up to 60 Days)||0||
48209200|NCT03020745|100837226|FG005|STARTED|Part 1 (Up to 60 Days)||0||
48209201|NCT03020745|100837227|FG006|STARTED|Part 1 (Up to 60 Days)||0||
48209202|NCT03020745|100837228|FG007|STARTED|Part 1 (Up to 60 Days)||0||
48209203|NCT03020745|100837229|FG008|STARTED|Part 1 (Up to 60 Days)||0||
48209204|NCT03020745|100837230|FG009|STARTED|Part 1 (Up to 60 Days)||0||
48209205|NCT03020745|100837221|FG000|COMPLETED|Part 1 (Up to 60 Days)||3||
48209206|NCT03020745|100837222|FG001|COMPLETED|Part 1 (Up to 60 Days)||3||
48209207|NCT03020745|100837223|FG002|COMPLETED|Part 1 (Up to 60 Days)||0||
48209208|NCT03020745|100837224|FG003|COMPLETED|Part 1 (Up to 60 Days)||6||
48209209|NCT03020745|100837225|FG004|COMPLETED|Part 1 (Up to 60 Days)||0||
48209210|NCT03020745|100837226|FG005|COMPLETED|Part 1 (Up to 60 Days)||0||
48209211|NCT03020745|100837227|FG006|COMPLETED|Part 1 (Up to 60 Days)||0||
48209212|NCT03020745|100837228|FG007|COMPLETED|Part 1 (Up to 60 Days)||0||
48209213|NCT03020745|100837229|FG008|COMPLETED|Part 1 (Up to 60 Days)||0||
48209214|NCT03020745|100837230|FG009|COMPLETED|Part 1 (Up to 60 Days)||0||
48209215|NCT03020745|100837221|FG000|NOT COMPLETED|Part 1 (Up to 60 Days)||0||
48209216|NCT03020745|100837222|FG001|NOT COMPLETED|Part 1 (Up to 60 Days)||0||
48209217|NCT03020745|100837223|FG002|NOT COMPLETED|Part 1 (Up to 60 Days)||0||
48209218|NCT03020745|100837224|FG003|NOT COMPLETED|Part 1 (Up to 60 Days)||0||
48209219|NCT03020745|100837225|FG004|NOT COMPLETED|Part 1 (Up to 60 Days)||0||
48209220|NCT03020745|100837226|FG005|NOT COMPLETED|Part 1 (Up to 60 Days)||0||
48209221|NCT03020745|100837227|FG006|NOT COMPLETED|Part 1 (Up to 60 Days)||0||
48209222|NCT03020745|100837228|FG007|NOT COMPLETED|Part 1 (Up to 60 Days)||0||
48209223|NCT03020745|100837229|FG008|NOT COMPLETED|Part 1 (Up to 60 Days)||0||
48209224|NCT03020745|100837230|FG009|NOT COMPLETED|Part 1 (Up to 60 Days)||0||
48209225|NCT03020745|100837221|FG000|STARTED|Part 2 (Up to 169 Days)||0||
48209226|NCT03020745|100837222|FG001|STARTED|Part 2 (Up to 169 Days)||0||
48209227|NCT03020745|100837223|FG002|STARTED|Part 2 (Up to 169 Days)||0||
48209228|NCT03020745|100837224|FG003|STARTED|Part 2 (Up to 169 Days)||0||
48209229|NCT03020745|100837225|FG004|STARTED|Part 2 (Up to 169 Days)||0||
48209230|NCT03020745|100837226|FG005|STARTED|Part 2 (Up to 169 Days)||10||
48209231|NCT03020745|100837227|FG006|STARTED|Part 2 (Up to 169 Days)||6||
48209232|NCT03020745|100837228|FG007|STARTED|Part 2 (Up to 169 Days)||20||
48209233|NCT03020745|100837229|FG008|STARTED|Part 2 (Up to 169 Days)||15||
48209234|NCT03020745|100837230|FG009|STARTED|Part 2 (Up to 169 Days)||15||
48209235|NCT03020745|100837221|FG000|COMPLETED|Part 2 (Up to 169 Days)||0||
48209236|NCT03020745|100837222|FG001|COMPLETED|Part 2 (Up to 169 Days)||0||
48209237|NCT03020745|100837223|FG002|COMPLETED|Part 2 (Up to 169 Days)||0||
48209238|NCT03020745|100837224|FG003|COMPLETED|Part 2 (Up to 169 Days)||0||
48209239|NCT03020745|100837225|FG004|COMPLETED|Part 2 (Up to 169 Days)||0||
48209240|NCT03020745|100837226|FG005|COMPLETED|Part 2 (Up to 169 Days)||10||
48209241|NCT03020745|100837227|FG006|COMPLETED|Part 2 (Up to 169 Days)||6||
48209242|NCT03020745|100837228|FG007|COMPLETED|Part 2 (Up to 169 Days)||19||
48209243|NCT03020745|100837229|FG008|COMPLETED|Part 2 (Up to 169 Days)||14||
48209244|NCT03020745|100837230|FG009|COMPLETED|Part 2 (Up to 169 Days)||15||
48209245|NCT03020745|100837221|FG000|NOT COMPLETED|Part 2 (Up to 169 Days)||0||
48209246|NCT03020745|100837222|FG001|NOT COMPLETED|Part 2 (Up to 169 Days)||0||
48209247|NCT03020745|100837223|FG002|NOT COMPLETED|Part 2 (Up to 169 Days)||0||
48209248|NCT03020745|100837224|FG003|NOT COMPLETED|Part 2 (Up to 169 Days)||0||
48209249|NCT03020745|100837225|FG004|NOT COMPLETED|Part 2 (Up to 169 Days)||0||
48209250|NCT03020745|100837226|FG005|NOT COMPLETED|Part 2 (Up to 169 Days)||0||
48209251|NCT03020745|100837227|FG006|NOT COMPLETED|Part 2 (Up to 169 Days)||0||
48209252|NCT03020745|100837228|FG007|NOT COMPLETED|Part 2 (Up to 169 Days)||1||
48209253|NCT03020745|100837229|FG008|NOT COMPLETED|Part 2 (Up to 169 Days)||1||
48209254|NCT03020745|100837230|FG009|NOT COMPLETED|Part 2 (Up to 169 Days)||0||
48209255|NCT03020745|100837221|FG000|STARTED|Part 2:Optional FU (Up to 450 Days)||0||
48209256|NCT03020745|100837222|FG001|STARTED|Part 2:Optional FU (Up to 450 Days)||0||
48209257|NCT03020745|100837223|FG002|STARTED|Part 2:Optional FU (Up to 450 Days)||0||
48209258|NCT03020745|100837224|FG003|STARTED|Part 2:Optional FU (Up to 450 Days)||0||
48209259|NCT03020745|100837225|FG004|STARTED|Part 2:Optional FU (Up to 450 Days)||0||
48209260|NCT03020745|100837226|FG005|STARTED|Part 2:Optional FU (Up to 450 Days)||10||
48209261|NCT03020745|100837227|FG006|STARTED|Part 2:Optional FU (Up to 450 Days)||5||
48209262|NCT03020745|100837228|FG007|STARTED|Part 2:Optional FU (Up to 450 Days)||17||
48209263|NCT03020745|100837229|FG008|STARTED|Part 2:Optional FU (Up to 450 Days)||13||
48209264|NCT03020745|100837230|FG009|STARTED|Part 2:Optional FU (Up to 450 Days)||15||
48209265|NCT03020745|100837221|FG000|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0||
48209266|NCT03020745|100837222|FG001|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0||
48209267|NCT03020745|100837223|FG002|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0||
48209268|NCT03020745|100837224|FG003|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0||
48209269|NCT03020745|100837225|FG004|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0||
48209270|NCT03020745|100837226|FG005|COMPLETED|Part 2:Optional FU (Up to 450 Days)||9||
48209271|NCT03020745|100837227|FG006|COMPLETED|Part 2:Optional FU (Up to 450 Days)||5||
48209272|NCT03020745|100837228|FG007|COMPLETED|Part 2:Optional FU (Up to 450 Days)||17||
48209273|NCT03020745|100837229|FG008|COMPLETED|Part 2:Optional FU (Up to 450 Days)||10||
48209274|NCT03020745|100837230|FG009|COMPLETED|Part 2:Optional FU (Up to 450 Days)||15||
48209275|NCT03020745|100837221|FG000|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0||
48209276|NCT03020745|100837222|FG001|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0||
48209277|NCT03020745|100837223|FG002|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0||
48209278|NCT03020745|100837224|FG003|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0||
48209279|NCT03020745|100837225|FG004|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0||
48209280|NCT03020745|100837226|FG005|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||1||
48209281|NCT03020745|100837227|FG006|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0||
48209282|NCT03020745|100837228|FG007|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0||
48209283|NCT03020745|100837229|FG008|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||3||
48209284|NCT03020745|100837230|FG009|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0||
48209285|NCT01691326|100837231|FG000|STARTED|Overall Study||30||
48209286|NCT01691326|100837232|FG001|STARTED|Overall Study||30||
48209287|NCT01691326|100837231|FG000|COMPLETED|Overall Study||30||
48209288|NCT01691326|100837232|FG001|COMPLETED|Overall Study||30||
48209289|NCT01691326|100837231|FG000|NOT COMPLETED|Overall Study||0||
48209290|NCT01691326|100837232|FG001|NOT COMPLETED|Overall Study||0||
48209291|NCT00510887|100837233|FG000|STARTED|Overall Study||12||
48209292|NCT00510887|100837233|FG000|COMPLETED|Overall Study||11||
48209293|NCT00510887|100837233|FG000|NOT COMPLETED|Overall Study||1||
48209294|NCT00712335|100837234|FG000|STARTED|Overall Study||8||
48209295|NCT00712335|100837235|FG001|STARTED|Overall Study||32||
48209296|NCT00712335|100837236|FG002|STARTED|Overall Study||11||
48209297|NCT00712335|100837237|FG003|STARTED|Overall Study||24||
48209298|NCT00712335|100837238|FG004|STARTED|Overall Study||30||
48209299|NCT00712335|100837234|FG000|COMPLETED|Overall Study||5||
48209300|NCT00712335|100837235|FG001|COMPLETED|Overall Study||15||
48209301|NCT00712335|100837236|FG002|COMPLETED|Overall Study||6||
48209302|NCT00712335|100837237|FG003|COMPLETED|Overall Study||19||
48209303|NCT00712335|100837238|FG004|COMPLETED|Overall Study||30||
48209304|NCT00712335|100837234|FG000|NOT COMPLETED|Overall Study||3||
48209305|NCT00712335|100837235|FG001|NOT COMPLETED|Overall Study||17||
48209306|NCT00712335|100837236|FG002|NOT COMPLETED|Overall Study||5||
48209307|NCT00712335|100837237|FG003|NOT COMPLETED|Overall Study||5||
48209308|NCT00712335|100837238|FG004|NOT COMPLETED|Overall Study||0||
48209309|NCT00970359|100837239|FG000|STARTED|Overall Study||24||
48209310|NCT00970359|100837239|FG000|COMPLETED|Overall Study||20||
48209311|NCT00970359|100837239|FG000|NOT COMPLETED|Overall Study||4||
48209312|NCT02807493|100837240|FG000|STARTED|Overall Study||174||
48209313|NCT02807493|100837241|FG001|STARTED|Overall Study||173||
48209314|NCT02807493|100837240|FG000|COMPLETED|Overall Study||87||
48209315|NCT02807493|100837241|FG001|COMPLETED|Overall Study||121||
48209316|NCT02807493|100837240|FG000|NOT COMPLETED|Overall Study||87||
48209317|NCT02807493|100837241|FG001|NOT COMPLETED|Overall Study||52||
48209318|NCT02731755|100837242|FG000|STARTED|First Intervention||8||
48209319|NCT02731755|100837243|FG001|STARTED|First Intervention||10||
48209320|NCT02731755|100837242|FG000|COMPLETED|First Intervention||8||
48209321|NCT02731755|100837243|FG001|COMPLETED|First Intervention||8||
48209322|NCT02731755|100837242|FG000|NOT COMPLETED|First Intervention||0||
48209323|NCT02731755|100837243|FG001|NOT COMPLETED|First Intervention||2||
48209324|NCT02731755|100837242|FG000|STARTED|Second Intervention||8||
48209325|NCT02731755|100837243|FG001|STARTED|Second Intervention||8||
48209326|NCT02731755|100837242|FG000|COMPLETED|Second Intervention||8||
48209327|NCT02731755|100837243|FG001|COMPLETED|Second Intervention||8||
48209328|NCT02731755|100837242|FG000|NOT COMPLETED|Second Intervention||0||
48209329|NCT02731755|100837243|FG001|NOT COMPLETED|Second Intervention||0||
48209330|NCT00393484|100837244|FG000|STARTED|Double-blind Period (Day 1 to Week 96)||56||
48209331|NCT00393484|100837245|FG001|STARTED|Double-blind Period (Day 1 to Week 96)||64||
48209332|NCT00393484|100837244|FG000|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1||
48209333|NCT00393484|100837245|FG001|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1||
48209334|NCT00393484|100837244|FG000|COMPLETED|Double-blind Period (Day 1 to Week 96)||54||
48209335|NCT00393484|100837245|FG001|COMPLETED|Double-blind Period (Day 1 to Week 96)||52||
48209336|NCT00393484|100837244|FG000|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||2||
48209337|NCT00393484|100837245|FG001|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||12||
48209338|NCT00393484|100837244|FG000|STARTED|Open-label Period (Weeks 96 to 240)||48||
48209339|NCT00393484|100837245|FG001|STARTED|Open-label Period (Weeks 96 to 240)||44||
48209340|NCT00393484|100837244|FG000|Withdrew Consent|Open-label Period (Weeks 96 to 240)||6||
48209341|NCT00393484|100837245|FG001|Withdrew Consent|Open-label Period (Weeks 96 to 240)||6||
48209342|NCT00393484|100837244|FG000|Lack of Efficacy|Open-label Period (Weeks 96 to 240)||0||
48209343|NCT00393484|100837245|FG001|Lack of Efficacy|Open-label Period (Weeks 96 to 240)||2||
48209344|NCT00393484|100837244|FG000|COMPLETED|Open-label Period (Weeks 96 to 240)||40||
48209345|NCT00393484|100837245|FG001|COMPLETED|Open-label Period (Weeks 96 to 240)||21||
48209346|NCT00393484|100837244|FG000|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||8||
48209347|NCT00393484|100837245|FG001|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||23||
48209348|NCT01395758|100837246|FG000|STARTED|Open-label Treatment Period||51||
48209349|NCT01395758|100837247|FG001|STARTED|Open-label Treatment Period||45||
48209350|NCT01395758|100837248|FG002|STARTED|Open-label Treatment Period||0||
48209351|NCT01395758|100837246|FG000|COMPLETED|Open-label Treatment Period||47||
48209352|NCT01395758|100837247|FG001|COMPLETED|Open-label Treatment Period||45||
48209353|NCT01395758|100837248|FG002|COMPLETED|Open-label Treatment Period||0||
48209354|NCT01395758|100837246|FG000|NOT COMPLETED|Open-label Treatment Period||4||
48209355|NCT01395758|100837247|FG001|NOT COMPLETED|Open-label Treatment Period||0||
48209356|NCT01395758|100837248|FG002|NOT COMPLETED|Open-label Treatment Period||0||
48209357|NCT01395758|100837246|FG000|STARTED|Crossover Period||0||
48209358|NCT01395758|100837247|FG001|STARTED|Crossover Period||0||
48209359|NCT01395758|100837248|FG002|STARTED|Crossover Period||26||
48209360|NCT01395758|100837246|FG000|COMPLETED|Crossover Period||0||
48209361|NCT01395758|100837247|FG001|COMPLETED|Crossover Period||0||
48209362|NCT01395758|100837248|FG002|COMPLETED|Crossover Period||26||
48209363|NCT01395758|100837246|FG000|NOT COMPLETED|Crossover Period||0||
48209364|NCT01395758|100837247|FG001|NOT COMPLETED|Crossover Period||0||
48209365|NCT01395758|100837248|FG002|NOT COMPLETED|Crossover Period||0||
48209366|NCT00444600|100837249|FG000|STARTED|Overall Study||293||
48209367|NCT00444600|100837250|FG001|STARTED|Overall Study||187||
48209368|NCT00444600|100837251|FG002|STARTED|Overall Study||188||
48209369|NCT00444600|100837252|FG003|STARTED|Overall Study||186||
48209370|NCT00444600|100837249|FG000|COMPLETED|Overall Study||274||
48209371|NCT00444600|100837250|FG001|COMPLETED|Overall Study||171||
48209372|NCT00444600|100837251|FG002|COMPLETED|Overall Study||178||
48209373|NCT00444600|100837252|FG003|COMPLETED|Overall Study||176||
48209374|NCT00444600|100837249|FG000|NOT COMPLETED|Overall Study||19||
48209375|NCT00444600|100837250|FG001|NOT COMPLETED|Overall Study||16||
48209376|NCT00444600|100837251|FG002|NOT COMPLETED|Overall Study||10||
48209377|NCT00444600|100837252|FG003|NOT COMPLETED|Overall Study||10||
48209378|NCT01580293|100837253|FG000|STARTED|Part A_Main Trial||20|Received Treatment|
48209379|NCT01580293|100837254|FG001|STARTED|Part A_Main Trial||114|Received Treatment|
48209380|NCT01580293|100837255|FG002|STARTED|Part A_Main Trial||0|Received Treatment|
48209381|NCT01580293|100837253|FG000|COMPLETED|Part A_Main Trial||18||
48209382|NCT01580293|100837254|FG001|COMPLETED|Part A_Main Trial||108||
48209383|NCT01580293|100837255|FG002|COMPLETED|Part A_Main Trial||0||
48209384|NCT01580293|100837253|FG000|NOT COMPLETED|Part A_Main Trial||2||
48209385|NCT01580293|100837254|FG001|NOT COMPLETED|Part A_Main Trial||6||
48209386|NCT01580293|100837255|FG002|NOT COMPLETED|Part A_Main Trial||0||
48209387|NCT01580293|100837253|FG000|STARTED|Part A_Extension||14||
48209388|NCT01580293|100837254|FG001|STARTED|Part A_Extension||107||
48209389|NCT01580293|100837255|FG002|STARTED|Part A_Extension||0||
48209390|NCT01580293|100837253|FG000|COMPLETED|Part A_Extension||14||
48209391|NCT01580293|100837254|FG001|COMPLETED|Part A_Extension||95||
48209392|NCT01580293|100837255|FG002|COMPLETED|Part A_Extension||0||
48209393|NCT01580293|100837253|FG000|NOT COMPLETED|Part A_Extension||0||
48209394|NCT01580293|100837254|FG001|NOT COMPLETED|Part A_Extension||12||
48209395|NCT01580293|100837255|FG002|NOT COMPLETED|Part A_Extension||0||
48209396|NCT01580293|100837253|FG000|STARTED|Part B||0|Treated in Part B|
48209397|NCT01580293|100837254|FG001|STARTED|Part B||0|Treated in Part B|
48209398|NCT01580293|100837255|FG002|STARTED|Part B||19|Treated in Part B|
48209399|NCT01580293|100837253|FG000|COMPLETED|Part B||0||
48209400|NCT01580293|100837254|FG001|COMPLETED|Part B||0||
48209401|NCT01580293|100837255|FG002|COMPLETED|Part B||17||
48209402|NCT01580293|100837253|FG000|NOT COMPLETED|Part B||0||
48209403|NCT01580293|100837254|FG001|NOT COMPLETED|Part B||0||
48209404|NCT01580293|100837255|FG002|NOT COMPLETED|Part B||2||
48209405|NCT01827787|100837256|FG000|STARTED|Overall Study||45||
48209406|NCT01827787|100837257|FG001|STARTED|Overall Study||38||
48209407|NCT01827787|100837256|FG000|COMPLETED|Overall Study||45||
48209408|NCT01827787|100837257|FG001|COMPLETED|Overall Study||38||
48209409|NCT01827787|100837256|FG000|NOT COMPLETED|Overall Study||0||
48209410|NCT01827787|100837257|FG001|NOT COMPLETED|Overall Study||0||
48209411|NCT03383146|100837258|FG000|STARTED|Overall Study||148||
48209412|NCT03383146|100837259|FG001|STARTED|Overall Study||302||
48209413|NCT03383146|100837258|FG000|Safety Population|Overall Study||145|Safety Population included all participants who received ≥1 administration of study treatment.|
48209414|NCT03383146|100837259|FG001|Safety Population|Overall Study||299|Safety Population included all participants who received ≥1 administration of study treatment.|
48209415|NCT03383146|100837258|FG000|Run-in Period|Overall Study||91|Run-in Period included rollover participants from previous relamorelin study RLM-MD-01 or RLM-MD-02 who met all the inclusion and exclusion criteria.|
48209416|NCT03383146|100837259|FG001|Run-in Period|Overall Study||207|Run-in Period included rollover participants from previous relamorelin study RLM-MD-01 or RLM-MD-02 who met all the inclusion and exclusion criteria.|
48209417|NCT03383146|100837258|FG000|COMPLETED|Overall Study||63||
48209418|NCT03383146|100837259|FG001|COMPLETED|Overall Study||118||
48209419|NCT03383146|100837258|FG000|NOT COMPLETED|Overall Study||85||
48209420|NCT03383146|100837259|FG001|NOT COMPLETED|Overall Study||184||
48209421|NCT03621696|100837260|FG000|STARTED|Overall Study||21||
48209422|NCT03621696|100837261|FG001|STARTED|Overall Study||31||
48209423|NCT03621696|100837262|FG002|STARTED|Overall Study||6||
48209424|NCT03621696|100837263|FG003|STARTED|Overall Study||5||
48209425|NCT03621696|100837260|FG000|COMPLETED|Overall Study||20||
48209426|NCT03621696|100837261|FG001|COMPLETED|Overall Study||30||
48209427|NCT03621696|100837262|FG002|COMPLETED|Overall Study||4||
48209428|NCT03621696|100837263|FG003|COMPLETED|Overall Study||0||
48209429|NCT03621696|100837260|FG000|NOT COMPLETED|Overall Study||1||
48209430|NCT03621696|100837261|FG001|NOT COMPLETED|Overall Study||1||
48209431|NCT03621696|100837262|FG002|NOT COMPLETED|Overall Study||2||
48209432|NCT03621696|100837263|FG003|NOT COMPLETED|Overall Study||5||
48209433|NCT00989937|100837264|FG000|STARTED|Overall Study||0||
48209434|NCT00989937|100837264|FG000|COMPLETED|Overall Study||0||
48209435|NCT00989937|100837264|FG000|NOT COMPLETED|Overall Study||0||
48209436|NCT04661410|100837265|FG000|STARTED|Overall Study||29||
48209437|NCT04661410|100837266|FG001|STARTED|Overall Study||30||
48209438|NCT04661410|100837265|FG000|COMPLETED|Overall Study||24||
48209439|NCT04661410|100837266|FG001|COMPLETED|Overall Study||22||
48209440|NCT04661410|100837265|FG000|NOT COMPLETED|Overall Study||5||
48209441|NCT04661410|100837266|FG001|NOT COMPLETED|Overall Study||8||
48209442|NCT00835770|100837267|FG000|STARTED|Overall Study||868||
48209443|NCT00835770|100837268|FG001|STARTED|Overall Study||868||
48209444|NCT00835770|100837267|FG000|COMPLETED|Overall Study||384||
48209445|NCT00835770|100837268|FG001|COMPLETED|Overall Study||375||
48209446|NCT00835770|100837267|FG000|NOT COMPLETED|Overall Study||484||
48209447|NCT00835770|100837268|FG001|NOT COMPLETED|Overall Study||493||
48209448|NCT01606124|100837269|FG000|STARTED|Overall Study||19||
48209449|NCT01606124|100837270|FG001|STARTED|Overall Study||20||
48209450|NCT01606124|100837269|FG000|COMPLETED|Overall Study||19||
48209451|NCT01606124|100837270|FG001|COMPLETED|Overall Study||20||
48209452|NCT01606124|100837269|FG000|NOT COMPLETED|Overall Study||0||
48209453|NCT01606124|100837270|FG001|NOT COMPLETED|Overall Study||0||
48209454|NCT02880241|100837271|FG000|STARTED|Overall Study||8||
48209455|NCT02880241|100837272|FG001|STARTED|Overall Study||0||
48209456|NCT02880241|100837273|FG002|STARTED|Overall Study||0||
48209457|NCT02880241|100837274|FG003|STARTED|Overall Study||0||
48209458|NCT02880241|100837275|FG004|STARTED|Overall Study||0||
48209459|NCT02880241|100837276|FG005|STARTED|Overall Study||0||
48209460|NCT02880241|100837271|FG000|COMPLETED|Overall Study||7||
48209461|NCT02880241|100837272|FG001|COMPLETED|Overall Study||0||
48209462|NCT02880241|100837273|FG002|COMPLETED|Overall Study||0||
48209463|NCT02880241|100837274|FG003|COMPLETED|Overall Study||0||
48209464|NCT02880241|100837275|FG004|COMPLETED|Overall Study||0||
48209465|NCT02880241|100837276|FG005|COMPLETED|Overall Study||0||
48209466|NCT02880241|100837271|FG000|NOT COMPLETED|Overall Study||1||
48209467|NCT02880241|100837272|FG001|NOT COMPLETED|Overall Study||0||
48209468|NCT02880241|100837273|FG002|NOT COMPLETED|Overall Study||0||
48209469|NCT02880241|100837274|FG003|NOT COMPLETED|Overall Study||0||
48209470|NCT02880241|100837275|FG004|NOT COMPLETED|Overall Study||0||
48495913|NCT03025087|101547966|FG001|STARTED|Overall Study||12||
48495914|NCT03025087|101547967|FG002|STARTED|Overall Study||0||
48209471|NCT02880241|100837276|FG005|NOT COMPLETED|Overall Study||0||
48209472|NCT04358549|100837277|FG000|STARTED|Overall Study||25||
48209473|NCT04358549|100837278|FG001|STARTED|Overall Study||25||
48495915|NCT03025087|101547968|FG003|STARTED|Overall Study||0||
48209474|NCT04358549|100837277|FG000|ITT Population (Randomized Subjects)|Overall Study||25||
48495916|NCT03025087|101547969|FG004|STARTED|Overall Study||0||
48209475|NCT04358549|100837278|FG001|ITT Population (Randomized Subjects)|Overall Study||25||
48209476|NCT04358549|100837277|FG000|Safety Population (Patients Who Received Either Favipiravir + SOC or SOC Alone)|Overall Study||24|One patient randomized in favipiravir + SOC arm withdrew before the first dose of favipiravir.|
48495917|NCT03025087|101547965|FG000|COMPLETED|Overall Study||6||
48209477|NCT04358549|100837278|FG001|Safety Population (Patients Who Received Either Favipiravir + SOC or SOC Alone)|Overall Study||25|One patient randomized in favipiravir + SOC arm withdrew before the first dose of favipiravir.|
48209478|NCT04358549|100837277|FG000|COMPLETED|Overall Study||15||
48209479|NCT04358549|100837278|FG001|COMPLETED|Overall Study||17||
48209480|NCT04358549|100837277|FG000|NOT COMPLETED|Overall Study||10||
48209481|NCT04358549|100837278|FG001|NOT COMPLETED|Overall Study||8||
48209482|NCT00293293|100839907|FG000|STARTED|Overall Study||20||
48209483|NCT00293293|100839908|FG001|STARTED|Overall Study||23||
48209484|NCT00293293|100839907|FG000|COMPLETED|Overall Study||18||
48209485|NCT00293293|100839908|FG001|COMPLETED|Overall Study||21||
48209486|NCT00293293|100839907|FG000|NOT COMPLETED|Overall Study||2||
48209487|NCT00293293|100839908|FG001|NOT COMPLETED|Overall Study||2||
48209488|NCT04200365|100839909|FG000|STARTED|Overall Study||15||
48209489|NCT04200365|100839909|FG000|COMPLETED|Overall Study||4||
48209490|NCT04200365|100839909|FG000|NOT COMPLETED|Overall Study||11||
48209491|NCT05158153|100839910|FG000|STARTED|Overall Study||1||
48209492|NCT05158153|100839910|FG000|COMPLETED|Overall Study||1||
48209493|NCT05158153|100839910|FG000|NOT COMPLETED|Overall Study||0||
48209494|NCT02983617|100839911|FG000|STARTED|Overall Study||6||
48209495|NCT02983617|100839912|FG001|STARTED|Overall Study||30||
48209496|NCT02983617|100839911|FG000|COMPLETED|Overall Study||6||
48209497|NCT02983617|100839912|FG001|COMPLETED|Overall Study||21||
48209498|NCT02983617|100839911|FG000|NOT COMPLETED|Overall Study||0||
48209499|NCT02983617|100839912|FG001|NOT COMPLETED|Overall Study||9||
48209500|NCT04722003|100839913|FG000|STARTED|Overall Study||41||
48209501|NCT04722003|100839914|FG001|STARTED|Overall Study||11||
48209502|NCT04722003|100839913|FG000|COMPLETED|Overall Study||38||
48209503|NCT04722003|100839914|FG001|COMPLETED|Overall Study||11||
48209504|NCT04722003|100839913|FG000|NOT COMPLETED|Overall Study||3||
48209505|NCT04722003|100839914|FG001|NOT COMPLETED|Overall Study||0||
48209506|NCT03074331|100839915|FG000|STARTED|Overall Study||130||
48209507|NCT03074331|100839915|FG000|COMPLETED|Overall Study||123||
48209508|NCT03074331|100839915|FG000|NOT COMPLETED|Overall Study||7||
48209509|NCT03669354|100839916|FG000|STARTED|Overall Study||73||
48209510|NCT03669354|100839917|FG001|STARTED|Overall Study||22||
48209511|NCT03669354|100839918|FG002|STARTED|Overall Study||47||
48209512|NCT03669354|100839919|FG003|STARTED|Overall Study||53||
48209513|NCT03669354|100839916|FG000|COMPLETED|Overall Study||73||
48209514|NCT03669354|100839917|FG001|COMPLETED|Overall Study||22||
48209515|NCT03669354|100839918|FG002|COMPLETED|Overall Study||47||
48209516|NCT03669354|100839919|FG003|COMPLETED|Overall Study||53||
48209517|NCT03669354|100839916|FG000|NOT COMPLETED|Overall Study||0||
48209518|NCT03669354|100839917|FG001|NOT COMPLETED|Overall Study||0||
48209519|NCT03669354|100839918|FG002|NOT COMPLETED|Overall Study||0||
48209520|NCT03669354|100839919|FG003|NOT COMPLETED|Overall Study||0||
48209521|NCT01214824|100839920|FG000|STARTED|Overall Study||32||
48209522|NCT01214824|100839920|FG000|COMPLETED|Overall Study||29||
48209523|NCT01214824|100839920|FG000|NOT COMPLETED|Overall Study||3||
48209524|NCT02092116|100839921|FG000|STARTED|Overall Study||6||
48209525|NCT02092116|100839922|FG001|STARTED|Overall Study||20||
48209526|NCT02092116|100839921|FG000|COMPLETED|Overall Study||6||
48209527|NCT02092116|100839922|FG001|COMPLETED|Overall Study||16||
48209528|NCT02092116|100839921|FG000|NOT COMPLETED|Overall Study||0||
48209529|NCT02092116|100839922|FG001|NOT COMPLETED|Overall Study||4||
48209530|NCT00513526|100839923|FG000|STARTED|Overall Study||109||
48209531|NCT00513526|100839923|FG000|COMPLETED|Overall Study||92||
48209532|NCT00513526|100839923|FG000|NOT COMPLETED|Overall Study||17||
48209533|NCT04426500|100839924|FG000|STARTED|Overall Study||28||
48209534|NCT04426500|100839925|FG001|STARTED|Overall Study||64||
48209535|NCT04426500|100839926|FG002|STARTED|Overall Study||56||
48209536|NCT04426500|100839924|FG000|COMPLETED|Overall Study||28||
48209537|NCT04426500|100839925|FG001|COMPLETED|Overall Study||64||
48209538|NCT04426500|100839926|FG002|COMPLETED|Overall Study||56||
48209539|NCT04426500|100839924|FG000|NOT COMPLETED|Overall Study||0||
48209540|NCT04426500|100839925|FG001|NOT COMPLETED|Overall Study||0||
48209541|NCT04426500|100839926|FG002|NOT COMPLETED|Overall Study||0||
48209542|NCT00433199|100839927|FG000|STARTED|Double-Blind Period||40||
48209543|NCT00433199|100839928|FG001|STARTED|Double-Blind Period||234||
48209544|NCT00433199|100839927|FG000|COMPLETED|Double-Blind Period||28||
48209545|NCT00433199|100839928|FG001|COMPLETED|Double-Blind Period||168||
48209546|NCT00433199|100839927|FG000|NOT COMPLETED|Double-Blind Period||12||
48209547|NCT00433199|100839928|FG001|NOT COMPLETED|Double-Blind Period||66||
48209548|NCT00433199|100839927|FG000|STARTED|Open-Label Period||0||
48209549|NCT00433199|100839928|FG001|STARTED|Open-Label Period||219||
48209550|NCT00433199|100839927|FG000|COMPLETED|Open-Label Period||0||
48209551|NCT00433199|100839928|FG001|COMPLETED|Open-Label Period||185||
48209552|NCT00433199|100839927|FG000|NOT COMPLETED|Open-Label Period||0||
48209553|NCT00433199|100839928|FG001|NOT COMPLETED|Open-Label Period||34||
48209554|NCT00585533|100839929|FG000|STARTED|Overall Study||40||
48209555|NCT00585533|100839929|FG000|COMPLETED|Overall Study||31||
48209556|NCT00585533|100839929|FG000|NOT COMPLETED|Overall Study||9||
48209557|NCT00951379|100839930|FG000|STARTED|Overall Study||27||
48209558|NCT00951379|100839931|FG001|STARTED|Overall Study||25||
48209559|NCT00951379|100839930|FG000|COMPLETED|Overall Study||21||
48209560|NCT00951379|100839931|FG001|COMPLETED|Overall Study||23||
48209561|NCT00951379|100839930|FG000|NOT COMPLETED|Overall Study||6||
48209562|NCT00951379|100839931|FG001|NOT COMPLETED|Overall Study||2||
48209563|NCT00629850|100839932|FG000|STARTED|Overall Study||1||
48209564|NCT00629850|100839933|FG001|STARTED|Overall Study||0||
48209565|NCT00629850|100839932|FG000|COMPLETED|Overall Study||1||
48209566|NCT00629850|100839933|FG001|COMPLETED|Overall Study||0||
48209567|NCT00629850|100839932|FG000|NOT COMPLETED|Overall Study||0||
48209568|NCT00629850|100839933|FG001|NOT COMPLETED|Overall Study||0||
48209569|NCT02556138|100839934|FG000|STARTED|Overall Study||8||
48209570|NCT02556138|100839934|FG000|COMPLETED|Overall Study||7||
48209571|NCT02556138|100839934|FG000|NOT COMPLETED|Overall Study||1||
48209572|NCT00857545|100839935|FG000|STARTED|Overall Study||86||
48209573|NCT00857545|100839936|FG001|STARTED|Overall Study||85||
48209574|NCT00857545|100839935|FG000|COMPLETED|Overall Study||86||
48209575|NCT00857545|100839936|FG001|COMPLETED|Overall Study||85||
48209576|NCT00857545|100839935|FG000|NOT COMPLETED|Overall Study||0||
48209577|NCT00857545|100839936|FG001|NOT COMPLETED|Overall Study||0||
48209578|NCT04035668|100839937|FG000|STARTED|Overall Study||24||
48209579|NCT04035668|100839938|FG001|STARTED|Overall Study||25||
48209580|NCT04035668|100839939|FG002|STARTED|Overall Study||24||
48209581|NCT04035668|100839937|FG000|COMPLETED|Overall Study||17||
48209582|NCT04035668|100839938|FG001|COMPLETED|Overall Study||17||
48209583|NCT04035668|100839939|FG002|COMPLETED|Overall Study||21||
48209584|NCT04035668|100839937|FG000|NOT COMPLETED|Overall Study||7||
48209585|NCT04035668|100839938|FG001|NOT COMPLETED|Overall Study||8||
48209586|NCT04035668|100839939|FG002|NOT COMPLETED|Overall Study||3||
48209587|NCT01904071|100839940|FG000|STARTED|Overall Study||24||
48209588|NCT01904071|100839941|FG001|STARTED|Overall Study||20||
48209589|NCT01904071|100839942|FG002|STARTED|Overall Study||20||
48209590|NCT01904071|100839940|FG000|COMPLETED|Overall Study||24||
48209591|NCT01904071|100839941|FG001|COMPLETED|Overall Study||20||
48209592|NCT01904071|100839942|FG002|COMPLETED|Overall Study||20||
48209593|NCT01904071|100839940|FG000|NOT COMPLETED|Overall Study||0||
48209594|NCT01904071|100839941|FG001|NOT COMPLETED|Overall Study||0||
48209595|NCT01904071|100839942|FG002|NOT COMPLETED|Overall Study||0||
48209596|NCT00194714|100839943|FG000|STARTED|Overall Study||22||
48209597|NCT00194714|100839943|FG000|COMPLETED|Overall Study||21||
48209598|NCT00194714|100839943|FG000|NOT COMPLETED|Overall Study||1||
48209599|NCT01426269|100839944|FG000|STARTED|Period 1: 12 Weeks||235||
48209600|NCT01426269|100839945|FG001|STARTED|Period 1: 12 Weeks||0||
48209601|NCT01426269|100839946|FG002|STARTED|Period 1: 12 Weeks||0||
48209602|NCT01426269|100839944|FG000|COMPLETED|Period 1: 12 Weeks||180||
48209603|NCT01426269|100839945|FG001|COMPLETED|Period 1: 12 Weeks||0||
48209604|NCT01426269|100839946|FG002|COMPLETED|Period 1: 12 Weeks||0||
48209605|NCT01426269|100839944|FG000|NOT COMPLETED|Period 1: 12 Weeks||55||
48209606|NCT01426269|100839945|FG001|NOT COMPLETED|Period 1: 12 Weeks||0||
48209607|NCT01426269|100839946|FG002|NOT COMPLETED|Period 1: 12 Weeks||0||
48209608|NCT01426269|100839944|FG000|STARTED|Eligibility for Period 2, Randomization||180||
48209609|NCT01426269|100839945|FG001|STARTED|Eligibility for Period 2, Randomization||0||
48209610|NCT01426269|100839946|FG002|STARTED|Eligibility for Period 2, Randomization||0||
48209611|NCT01426269|100839944|FG000|COMPLETED|Eligibility for Period 2, Randomization||130||
48209612|NCT01426269|100839945|FG001|COMPLETED|Eligibility for Period 2, Randomization||0||
48209613|NCT01426269|100839946|FG002|COMPLETED|Eligibility for Period 2, Randomization||0||
48209614|NCT01426269|100839944|FG000|NOT COMPLETED|Eligibility for Period 2, Randomization||50||
48209615|NCT01426269|100839945|FG001|NOT COMPLETED|Eligibility for Period 2, Randomization||0||
48209616|NCT01426269|100839946|FG002|NOT COMPLETED|Eligibility for Period 2, Randomization||0||
48209617|NCT01426269|100839944|FG000|STARTED|Period 2: 40 Weeks||0||
48209618|NCT01426269|100839945|FG001|STARTED|Period 2: 40 Weeks||65||
48209619|NCT01426269|100839946|FG002|STARTED|Period 2: 40 Weeks||65||
48209620|NCT01426269|100839944|FG000|COMPLETED|Period 2: 40 Weeks||0||
48209621|NCT01426269|100839945|FG001|COMPLETED|Period 2: 40 Weeks||27||
48209622|NCT01426269|100839946|FG002|COMPLETED|Period 2: 40 Weeks||18||
48209623|NCT01426269|100839944|FG000|NOT COMPLETED|Period 2: 40 Weeks||0||
48209624|NCT01426269|100839945|FG001|NOT COMPLETED|Period 2: 40 Weeks||38||
48209625|NCT01426269|100839946|FG002|NOT COMPLETED|Period 2: 40 Weeks||47||
48209626|NCT01190007|100839947|FG000|STARTED|Overall Study||159||
48209627|NCT01190007|100839947|FG000|COMPLETED|Overall Study||145||
48209628|NCT01190007|100839947|FG000|NOT COMPLETED|Overall Study||14||
48209629|NCT01747486|100839948|FG000|STARTED|Stage 1||15||
48209630|NCT01747486|100839949|FG001|STARTED|Stage 1||15||
48209631|NCT01747486|100839948|FG000|COMPLETED|Stage 1||3||
48209632|NCT01747486|100839949|FG001|COMPLETED|Stage 1||2||
48209633|NCT01747486|100839948|FG000|NOT COMPLETED|Stage 1||12||
48209634|NCT01747486|100839949|FG001|NOT COMPLETED|Stage 1||13||
48209635|NCT01747486|100839948|FG000|STARTED|Stage 2||12||
48209636|NCT01747486|100839949|FG001|STARTED|Stage 2||0||
48209637|NCT01747486|100839948|FG000|COMPLETED|Stage 2||3||
48209638|NCT01747486|100839949|FG001|COMPLETED|Stage 2||0||
48209639|NCT01747486|100839948|FG000|NOT COMPLETED|Stage 2||9||
48209640|NCT01747486|100839949|FG001|NOT COMPLETED|Stage 2||0||
48209641|NCT03403413|100839950|FG000|STARTED|Overall Study||5|Case series of 3 subjects with multiple sclerosis.|
48209642|NCT03403413|100839950|FG000|COMPLETED|Overall Study||3||
48209643|NCT03403413|100839950|FG000|NOT COMPLETED|Overall Study||2||
48209644|NCT01278394|100839951|FG000|STARTED|Overall Study||29||
48209645|NCT01278394|100839951|FG000|COMPLETED|Overall Study||28||
48209646|NCT01278394|100839951|FG000|NOT COMPLETED|Overall Study||1||
48209647|NCT03833661|100839952|FG000|STARTED|Overall Study||159||
48209648|NCT03833661|100839952|FG000|COMPLETED|Overall Study||159||
48209649|NCT03833661|100839952|FG000|NOT COMPLETED|Overall Study||0||
48209650|NCT01667796|100839953|FG000|STARTED|Overall Study||27||
48209651|NCT01667796|100839954|FG001|STARTED|Overall Study||30||
48209652|NCT01667796|100839953|FG000|COMPLETED|Overall Study||24||
48209653|NCT01667796|100839954|FG001|COMPLETED|Overall Study||29||
48209654|NCT01667796|100839953|FG000|NOT COMPLETED|Overall Study||3||
48209655|NCT01667796|100839954|FG001|NOT COMPLETED|Overall Study||1||
48209656|NCT01815008|100839955|FG000|STARTED|Overall Study||19||
48209657|NCT01815008|100839955|FG000|COMPLETED|Overall Study||15||
48209658|NCT01815008|100839955|FG000|NOT COMPLETED|Overall Study||4||
48209659|NCT00439569|100839956|FG000|STARTED|Cohort 1 (500 mg/kg/Day)||7||
48209660|NCT00439569|100839956|FG000|COMPLETED|Cohort 1 (500 mg/kg/Day)||3||
48209661|NCT00439569|100839956|FG000|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||4||
48209662|NCT00439569|100839956|FG000|STARTED|Cohort 2 (500 mg/kg/Day)||2||
48209663|NCT00439569|100839956|FG000|COMPLETED|Cohort 2 (500 mg/kg/Day)||1||
48209664|NCT00439569|100839956|FG000|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||1||
48209665|NCT02568644|100839957|FG000|STARTED|Overall Study||30||
48209666|NCT02568644|100839958|FG001|STARTED|Overall Study||30||
48209667|NCT02568644|100839957|FG000|COMPLETED|Overall Study||30||
48209668|NCT02568644|100839958|FG001|COMPLETED|Overall Study||30||
48209669|NCT02568644|100839957|FG000|NOT COMPLETED|Overall Study||0||
48209670|NCT02568644|100839958|FG001|NOT COMPLETED|Overall Study||0||
48209671|NCT00632424|100839959|FG000|STARTED|Overall Study||18||
48209672|NCT00632424|100839959|FG000|COMPLETED|Overall Study||0||
48209673|NCT00632424|100839959|FG000|NOT COMPLETED|Overall Study||18||
48209674|NCT01574807|100839960|FG000|STARTED|First Appointment||50||
48209675|NCT01574807|100839961|FG001|STARTED|First Appointment||50||
48209676|NCT01574807|100839960|FG000|COMPLETED|First Appointment||50||
48209677|NCT01574807|100839961|FG001|COMPLETED|First Appointment||50||
48209678|NCT01574807|100839960|FG000|NOT COMPLETED|First Appointment||0||
48209679|NCT01574807|100839961|FG001|NOT COMPLETED|First Appointment||0||
48209680|NCT01574807|100839960|FG000|STARTED|Wash Out Period 2 Weeks||50||
48209681|NCT01574807|100839961|FG001|STARTED|Wash Out Period 2 Weeks||50||
48209682|NCT01574807|100839960|FG000|COMPLETED|Wash Out Period 2 Weeks||50||
48209683|NCT01574807|100839961|FG001|COMPLETED|Wash Out Period 2 Weeks||50||
48209684|NCT01574807|100839960|FG000|NOT COMPLETED|Wash Out Period 2 Weeks||0||
48209685|NCT01574807|100839961|FG001|NOT COMPLETED|Wash Out Period 2 Weeks||0||
48209686|NCT01574807|100839960|FG000|STARTED|Second Appointment||50||
48209687|NCT01574807|100839961|FG001|STARTED|Second Appointment||50||
48209688|NCT01574807|100839960|FG000|COMPLETED|Second Appointment||50||
48209689|NCT01574807|100839961|FG001|COMPLETED|Second Appointment||50||
48209690|NCT01574807|100839960|FG000|NOT COMPLETED|Second Appointment||0||
48209691|NCT01574807|100839961|FG001|NOT COMPLETED|Second Appointment||0||
48209692|NCT01264679|100839962|FG000|STARTED|Overall Study||8||
48209693|NCT01264679|100839962|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7|Participants included in Safety and Intent-to-Treat (ITT) populations.|
48209694|NCT01264679|100839962|FG000|COMPLETED|Overall Study||3||
48209695|NCT01264679|100839962|FG000|NOT COMPLETED|Overall Study||5||
48209696|NCT02810080|100839963|FG000|STARTED|Overall Study||104||
48209697|NCT02810080|100839964|FG001|STARTED|Overall Study||102||
48209698|NCT02810080|100839963|FG000|COMPLETED|Overall Study||97||
48209699|NCT02810080|100839964|FG001|COMPLETED|Overall Study||98||
48209700|NCT02810080|100839963|FG000|NOT COMPLETED|Overall Study||7||
48209701|NCT02810080|100839964|FG001|NOT COMPLETED|Overall Study||4||
48209702|NCT03194958|100839965|FG000|STARTED|Overall Study||485||
48209703|NCT03194958|100839966|FG001|STARTED|Overall Study||485||
48209704|NCT03194958|100839967|FG002|STARTED|Overall Study||484||
48209705|NCT03194958|100839968|FG003|STARTED|Overall Study||490||
48209706|NCT03194958|100839965|FG000|COMPLETED|Overall Study||293||
48209707|NCT03194958|100839966|FG001|COMPLETED|Overall Study||261||
48209708|NCT03194958|100839967|FG002|COMPLETED|Overall Study||302||
48209709|NCT03194958|100839968|FG003|COMPLETED|Overall Study||281||
48209710|NCT03194958|100839965|FG000|NOT COMPLETED|Overall Study||192||
48209711|NCT03194958|100839966|FG001|NOT COMPLETED|Overall Study||224||
48209712|NCT03194958|100839967|FG002|NOT COMPLETED|Overall Study||182||
48209713|NCT03194958|100839968|FG003|NOT COMPLETED|Overall Study||209||
48209714|NCT01316263|100839969|FG000|STARTED|Overall Study||7||
48209715|NCT01316263|100839970|FG001|STARTED|Overall Study||14||
48209716|NCT01316263|100839969|FG000|Received Any Study Drug|Overall Study||7||
48209717|NCT01316263|100839970|FG001|Received Any Study Drug|Overall Study||14||
48209718|NCT01316263|100839969|FG000|COMPLETED|Overall Study||7||
48209719|NCT01316263|100839970|FG001|COMPLETED|Overall Study||14||
48209720|NCT01316263|100839969|FG000|NOT COMPLETED|Overall Study||0||
48209721|NCT01316263|100839970|FG001|NOT COMPLETED|Overall Study||0||
48209722|NCT01124734|100839971|FG000|STARTED|Overall Study||17||
48209723|NCT01124734|100839971|FG000|Completion of Course 1 Cycle 1|Overall Study||17||
48209724|NCT01124734|100839971|FG000|Initiation of Course 1 Cycle 2|Overall Study||17||
48209725|NCT01124734|100839971|FG000|COMPLETED|Overall Study||0||
48209726|NCT01124734|100839971|FG000|NOT COMPLETED|Overall Study||17||
48209727|NCT03226899|100839972|FG000|STARTED|Overall Study||118||
48209728|NCT03226899|100839973|FG001|STARTED|Overall Study||124||
48209729|NCT03226899|100839972|FG000|COMPLETED|Overall Study||0|completed the study/24 months of treatment|
48209730|NCT03226899|100839973|FG001|COMPLETED|Overall Study||0|completed the study/24 months of treatment|
48209731|NCT03226899|100839972|FG000|NOT COMPLETED|Overall Study||118||
48209732|NCT03226899|100839973|FG001|NOT COMPLETED|Overall Study||124||
48209733|NCT02284555|100839974|FG000|STARTED|Overall Study||12||
48209734|NCT02284555|100839974|FG000|COMPLETED|Overall Study||12||
48209735|NCT02284555|100839974|FG000|NOT COMPLETED|Overall Study||0||
48209736|NCT02529995|100839975|FG000|STARTED|Part A||15||
48209737|NCT02529995|100839976|FG001|STARTED|Part A||16||
48209738|NCT02529995|100839975|FG000|COMPLETED|Part A||0||
48209739|NCT02529995|100839976|FG001|COMPLETED|Part A||0||
48209740|NCT02529995|100839975|FG000|NOT COMPLETED|Part A||15||
48209741|NCT02529995|100839976|FG001|NOT COMPLETED|Part A||16||
48209742|NCT02529995|100839975|FG000|STARTED|Part B||15||
48209743|NCT02529995|100839976|FG001|STARTED|Part B||16||
48209744|NCT02529995|100839975|FG000|COMPLETED|Part B||9||
48209745|NCT02529995|100839976|FG001|COMPLETED|Part B||4||
48209746|NCT02529995|100839975|FG000|NOT COMPLETED|Part B||6||
48209747|NCT02529995|100839976|FG001|NOT COMPLETED|Part B||12||
48209748|NCT00665444|100839977|FG000|STARTED|Overall Study||3||
48209749|NCT00665444|100839977|FG000|COMPLETED|Overall Study||1||
48209750|NCT00665444|100839977|FG000|NOT COMPLETED|Overall Study||2||
48209751|NCT00465816|100839978|FG000|STARTED|Overall Study||367||
48059623|NCT02106910|100466978|FG000|STARTED|Overall Study||49||
48059624|NCT02106910|100466979|FG001|STARTED|Overall Study||89||
48059625|NCT02106910|100466978|FG000|COMPLETED|Overall Study||48||
48209752|NCT00465816|100839979|FG001|STARTED|Overall Study||122||
48209753|NCT00465816|100839980|FG002|STARTED|Overall Study||122||
48209754|NCT00465816|100839978|FG000|COMPLETED|Overall Study||367||
48209755|NCT00465816|100839979|FG001|COMPLETED|Overall Study||122||
48209756|NCT00465816|100839980|FG002|COMPLETED|Overall Study||120||
48209757|NCT00465816|100839978|FG000|NOT COMPLETED|Overall Study||0||
48209758|NCT00465816|100839979|FG001|NOT COMPLETED|Overall Study||0||
48209759|NCT00465816|100839980|FG002|NOT COMPLETED|Overall Study||2||
48209760|NCT03452189|100839981|FG000|STARTED|First Intervention (3 Months)||10||
48209761|NCT03452189|100839982|FG001|STARTED|First Intervention (3 Months)||5||
48209762|NCT03452189|100839981|FG000|COMPLETED|First Intervention (3 Months)||5||
48209763|NCT03452189|100839982|FG001|COMPLETED|First Intervention (3 Months)||5||
48209764|NCT03452189|100839981|FG000|NOT COMPLETED|First Intervention (3 Months)||5||
48209765|NCT03452189|100839982|FG001|NOT COMPLETED|First Intervention (3 Months)||0||
48209766|NCT03452189|100839981|FG000|STARTED|Intervention 2 (3 Months)||5||
48209767|NCT03452189|100839982|FG001|STARTED|Intervention 2 (3 Months)||5||
48209768|NCT03452189|100839981|FG000|COMPLETED|Intervention 2 (3 Months)||5||
48209769|NCT03452189|100839982|FG001|COMPLETED|Intervention 2 (3 Months)||5||
48209770|NCT03452189|100839981|FG000|NOT COMPLETED|Intervention 2 (3 Months)||0||
48209771|NCT03452189|100839982|FG001|NOT COMPLETED|Intervention 2 (3 Months)||0||
48209772|NCT00595790|100839983|FG000|STARTED|Overall Study||125||
48209773|NCT00595790|100839984|FG001|STARTED|Overall Study||124||
48209774|NCT00595790|100839985|FG002|STARTED|Overall Study||125||
48059626|NCT02106910|100466979|FG001|COMPLETED|Overall Study||88||
48059627|NCT02106910|100466978|FG000|NOT COMPLETED|Overall Study||1||
48059628|NCT02106910|100466979|FG001|NOT COMPLETED|Overall Study||1||
48059629|NCT01288027|100466980|FG000|STARTED|Overall Study||16||
48209775|NCT00595790|100839983|FG000|COMPLETED|Overall Study||123||
48209776|NCT00595790|100839984|FG001|COMPLETED|Overall Study||123||
48209777|NCT00595790|100839985|FG002|COMPLETED|Overall Study||122||
48209778|NCT00595790|100839983|FG000|NOT COMPLETED|Overall Study||2||
48209779|NCT00595790|100839984|FG001|NOT COMPLETED|Overall Study||1||
48209780|NCT00595790|100839985|FG002|NOT COMPLETED|Overall Study||3||
48209781|NCT02633267|100839986|FG000|STARTED|Overall Study||120||
48495918|NCT03025087|101547966|FG001|COMPLETED|Overall Study||6||
48059630|NCT01288027|100466980|FG000|Full Analysis Set (FAS)|Overall Study||16||
48059631|NCT01288027|100466980|FG000|COMPLETED|Overall Study||16||
48059632|NCT01288027|100466980|FG000|NOT COMPLETED|Overall Study||0||
48059633|NCT00467610|100466981|FG000|STARTED|Overall Study||6||
48059634|NCT00467610|100466981|FG000|COMPLETED|Overall Study||5||
48059635|NCT00467610|100466981|FG000|NOT COMPLETED|Overall Study||1||
48059636|NCT00369122|100466982|FG000|STARTED|Overall Study||60||
48059637|NCT00369122|100466982|FG000|COMPLETED|Overall Study||49||
48209782|NCT02633267|100839987|FG001|STARTED|Overall Study||130||
48209783|NCT02633267|100839986|FG000|COMPLETED|Overall Study||89||
48209784|NCT02633267|100839987|FG001|COMPLETED|Overall Study||91||
48209785|NCT02633267|100839986|FG000|NOT COMPLETED|Overall Study||31||
48209786|NCT02633267|100839987|FG001|NOT COMPLETED|Overall Study||39||
48209787|NCT01985542|100839988|FG000|STARTED|Overall Study||7||
48209788|NCT01985542|100839989|FG001|STARTED|Overall Study||9||
48209789|NCT01985542|100839988|FG000|COMPLETED|Overall Study||3||
48209790|NCT01985542|100839989|FG001|COMPLETED|Overall Study||3||
48495919|NCT03025087|101547967|FG002|COMPLETED|Overall Study||0||
48059638|NCT00369122|100466982|FG000|NOT COMPLETED|Overall Study||11||
48059639|NCT02443519|100466983|FG000|STARTED|Overall Study||31||
48209791|NCT01985542|100839988|FG000|NOT COMPLETED|Overall Study||4||
48209792|NCT01985542|100839989|FG001|NOT COMPLETED|Overall Study||6||
48209793|NCT01305252|100839990|FG000|STARTED|Overall Study||10||
48209794|NCT01305252|100839991|FG001|STARTED|Overall Study||11||
48209795|NCT01305252|100839990|FG000|COMPLETED|Overall Study||9||
48209796|NCT01305252|100839991|FG001|COMPLETED|Overall Study||11||
48209797|NCT01305252|100839990|FG000|NOT COMPLETED|Overall Study||1||
48209798|NCT01305252|100839991|FG001|NOT COMPLETED|Overall Study||0||
48209799|NCT00539292|100839992|FG000|STARTED|Overall Study||28||
48209800|NCT00539292|100839993|FG001|STARTED|Overall Study||27||
48209801|NCT00539292|100839992|FG000|COMPLETED|Overall Study||27||
48209802|NCT00539292|100839993|FG001|COMPLETED|Overall Study||27||
48209803|NCT00539292|100839992|FG000|NOT COMPLETED|Overall Study||1||
48209804|NCT00539292|100839993|FG001|NOT COMPLETED|Overall Study||0||
48209805|NCT01170962|100839994|FG000|STARTED|Treatment Period||203||
48209806|NCT01170962|100839995|FG001|STARTED|Treatment Period||199||
48209807|NCT01170962|100839996|FG002|STARTED|Treatment Period||17||
48209808|NCT01170962|100839994|FG000|No PDR|Treatment Period||145||
48209809|NCT01170962|100839995|FG001|No PDR|Treatment Period||127||
48209810|NCT01170962|100839996|FG002|No PDR|Treatment Period||17||
48209811|NCT01170962|100839994|FG000|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||30||
48209812|NCT01170962|100839995|FG001|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||36||
48209813|NCT01170962|100839996|FG002|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||0||
48209814|NCT01170962|100839994|FG000|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||28||
48209815|NCT01170962|100839995|FG001|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||36||
48209816|NCT01170962|100839996|FG002|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||0||
48209817|NCT01170962|100839994|FG000|COMPLETED|Treatment Period||76||
48209818|NCT01170962|100839995|FG001|COMPLETED|Treatment Period||88||
48209819|NCT01170962|100839996|FG002|COMPLETED|Treatment Period||5||
48209820|NCT01170962|100839994|FG000|NOT COMPLETED|Treatment Period||127||
48209821|NCT01170962|100839995|FG001|NOT COMPLETED|Treatment Period||111||
48209822|NCT01170962|100839996|FG002|NOT COMPLETED|Treatment Period||12||
48209823|NCT01170962|100839994|FG000|STARTED|Follow up Period||198||
48209824|NCT01170962|100839995|FG001|STARTED|Follow up Period||192||
48209825|NCT01170962|100839996|FG002|STARTED|Follow up Period||15||
48209826|NCT01170962|100839994|FG000|COMPLETED|Follow up Period||159||
48209827|NCT01170962|100839995|FG001|COMPLETED|Follow up Period||165||
48209828|NCT01170962|100839996|FG002|COMPLETED|Follow up Period||9||
48209829|NCT01170962|100839994|FG000|NOT COMPLETED|Follow up Period||39||
48209830|NCT01170962|100839995|FG001|NOT COMPLETED|Follow up Period||27||
48209831|NCT01170962|100839996|FG002|NOT COMPLETED|Follow up Period||6||
48209832|NCT01875250|100839997|FG000|STARTED|Overall Study||19||
48209833|NCT01875250|100839998|FG001|STARTED|Overall Study||19||
48209834|NCT01875250|100839997|FG000|COMPLETED|Overall Study||17||
48209835|NCT01875250|100839998|FG001|COMPLETED|Overall Study||19||
48209836|NCT01875250|100839997|FG000|NOT COMPLETED|Overall Study||2||
48209837|NCT01875250|100839998|FG001|NOT COMPLETED|Overall Study||0||
48209838|NCT03631550|100839999|FG000|STARTED|Overall Study||94|Full Analysis set (FA) include all the subjects randomized, including the subjects treated with the device up to May 31, 2019|
48209839|NCT03631550|100840000|FG001|STARTED|Overall Study||93|Full Analysis set (FA) include all the subjects randomized, including the subjects treated with the device up to May 31, 2019|
48209840|NCT03631550|100839999|FG000|The ITT Analysis Set|Overall Study||67|The Intent to Treat (ITT) analysis set which includes all randomized subjects who were treated with the device after May 31, 2019 (including self-practice). Per ITT principles, all subjects were analyzed as randomized.|
48209841|NCT03631550|100840000|FG001|The ITT Analysis Set|Overall Study||64|The Intent to Treat (ITT) analysis set which includes all randomized subjects who were treated with the device after May 31, 2019 (including self-practice). Per ITT principles, all subjects were analyzed as randomized.|
48209842|NCT03631550|100839999|FG000|The mITT Analysis Set|Overall Study||50|"The mITT analysis set which includes all subjects from the ITT analysis set who treat at least one eligible attack (excluding the self-practice test) analyzed as treated."|
48209843|NCT03631550|100840000|FG001|The mITT Analysis Set|Overall Study||59|"The mITT analysis set which includes all subjects from the ITT analysis set who treat at least one eligible attack (excluding the self-practice test) analyzed as treated."|
48209844|NCT03631550|100839999|FG000|COMPLETED|Overall Study||67|from FA set|
48209845|NCT03631550|100840000|FG001|COMPLETED|Overall Study||64|from FA set|
48209846|NCT03631550|100839999|FG000|NOT COMPLETED|Overall Study||27||
48209847|NCT03631550|100840000|FG001|NOT COMPLETED|Overall Study||29||
48209848|NCT00738699|100840001|FG000|STARTED|Overall Study||275||
48209849|NCT00738699|100840002|FG001|STARTED|Overall Study||140||
48209850|NCT00738699|100840001|FG000|Participants Not Treated|Overall Study||2||
48209851|NCT00738699|100840002|FG001|Participants Not Treated|Overall Study||1||
48209852|NCT00738699|100840001|FG000|Participants Treated|Overall Study||273||
48209853|NCT00738699|100840002|FG001|Participants Treated|Overall Study||139||
48209854|NCT00738699|100840001|FG000|COMPLETED|Overall Study||0||
48495920|NCT03025087|101547968|FG003|COMPLETED|Overall Study||0||
48209855|NCT00738699|100840002|FG001|COMPLETED|Overall Study||0||
48209856|NCT00738699|100840001|FG000|NOT COMPLETED|Overall Study||275||
48209857|NCT00738699|100840002|FG001|NOT COMPLETED|Overall Study||140||
48209858|NCT01713946|100840003|FG000|STARTED|Overall Study||117||
48209859|NCT01713946|100840004|FG001|STARTED|Overall Study||130||
48495921|NCT03025087|101547969|FG004|COMPLETED|Overall Study||0||
48209860|NCT01713946|100840005|FG002|STARTED|Overall Study||119||
48209861|NCT01713946|100840003|FG000|Completed Core Phase|Overall Study||110||
48209862|NCT01713946|100840004|FG001|Completed Core Phase|Overall Study||122||
48209863|NCT01713946|100840005|FG002|Completed Core Phase|Overall Study||114||
48209864|NCT01713946|100840003|FG000|Continued in Ext. Phase|Overall Study||110||
48209865|NCT01713946|100840004|FG001|Continued in Ext. Phase|Overall Study||119||
48209866|NCT01713946|100840005|FG002|Continued in Ext. Phase|Overall Study||114||
48209867|NCT01713946|100840003|FG000|Completed Ext. Phase|Overall Study||79||
48209868|NCT01713946|100840004|FG001|Completed Ext. Phase|Overall Study||92||
48209869|NCT01713946|100840005|FG002|Completed Ext. Phase|Overall Study||81||
48209870|NCT01713946|100840003|FG000|Continued in Post-Ext. Phase|Overall Study||78||
48209871|NCT01713946|100840004|FG001|Continued in Post-Ext. Phase|Overall Study||90||
48209872|NCT01713946|100840005|FG002|Continued in Post-Ext. Phase|Overall Study||81||
48209873|NCT01713946|100840003|FG000|Completed Post-Ext Phase|Overall Study||74||
48209874|NCT01713946|100840004|FG001|Completed Post-Ext Phase|Overall Study||85||
48209875|NCT01713946|100840005|FG002|Completed Post-Ext Phase|Overall Study||75||
48209876|NCT01713946|100840003|FG000|Did Not Continue in Ext Phase|Overall Study||0||
48209877|NCT01713946|100840004|FG001|Did Not Continue in Ext Phase|Overall Study||3||
48209878|NCT01713946|100840005|FG002|Did Not Continue in Ext Phase|Overall Study||0||
48209879|NCT01713946|100840003|FG000|Did Not Cont. in Post-Ext Phase|Overall Study||1||
48209880|NCT01713946|100840004|FG001|Did Not Cont. in Post-Ext Phase|Overall Study||2||
48209881|NCT01713946|100840005|FG002|Did Not Cont. in Post-Ext Phase|Overall Study||0||
48209882|NCT01713946|100840003|FG000|COMPLETED|Overall Study||74||
48209883|NCT01713946|100840004|FG001|COMPLETED|Overall Study||85||
48209884|NCT01713946|100840005|FG002|COMPLETED|Overall Study||75||
48209885|NCT01713946|100840003|FG000|NOT COMPLETED|Overall Study||43||
48209886|NCT01713946|100840004|FG001|NOT COMPLETED|Overall Study||45||
48209887|NCT01713946|100840005|FG002|NOT COMPLETED|Overall Study||44||
48209888|NCT02665988|100840006|FG000|STARTED|Overall Study||2||
48209889|NCT02665988|100840007|FG001|STARTED|Overall Study||2||
48209890|NCT02665988|100840006|FG000|COMPLETED|Overall Study||2||
48209891|NCT02665988|100840007|FG001|COMPLETED|Overall Study||2||
48209892|NCT02665988|100840006|FG000|NOT COMPLETED|Overall Study||0||
48209893|NCT02665988|100840007|FG001|NOT COMPLETED|Overall Study||0||
48209894|NCT01595061|100840008|FG000|STARTED|Overall Study||57||
48209895|NCT01595061|100840008|FG000|COMPLETED|Overall Study||53||
48209896|NCT01595061|100840008|FG000|NOT COMPLETED|Overall Study||4||
48209897|NCT00194896|100840009|FG000|STARTED|Overall Study||15||
48209898|NCT00194896|100840010|FG001|STARTED|Overall Study||15||
48209899|NCT00194896|100840011|FG002|STARTED|Overall Study||13||
48209900|NCT00194896|100840012|FG003|STARTED|Overall Study||21||
48209901|NCT00194896|100840009|FG000|COMPLETED|Overall Study||4||
48209902|NCT00194896|100840010|FG001|COMPLETED|Overall Study||10||
48209903|NCT00194896|100840011|FG002|COMPLETED|Overall Study||7||
48209904|NCT00194896|100840012|FG003|COMPLETED|Overall Study||9||
48209905|NCT00194896|100840009|FG000|NOT COMPLETED|Overall Study||11||
48209906|NCT00194896|100840010|FG001|NOT COMPLETED|Overall Study||5||
48209907|NCT00194896|100840011|FG002|NOT COMPLETED|Overall Study||6||
48209908|NCT00194896|100840012|FG003|NOT COMPLETED|Overall Study||12||
48209909|NCT04425629|100840013|FG000|STARTED|Overall Study||24||
48209910|NCT04425629|100840014|FG001|STARTED|Overall Study||24||
48209911|NCT04425629|100840015|FG002|STARTED|Overall Study||24||
48209912|NCT04425629|100840016|FG003|STARTED|Overall Study||242||
48209913|NCT04425629|100840017|FG004|STARTED|Overall Study||242||
48209914|NCT04425629|100840018|FG005|STARTED|Overall Study||243||
48209915|NCT04425629|100840019|FG006|STARTED|Overall Study||76||
48209916|NCT04425629|100840020|FG007|STARTED|Overall Study||76||
48209917|NCT04425629|100840021|FG008|STARTED|Overall Study||76||
48209918|NCT04425629|100840022|FG009|STARTED|Overall Study||2378||
48209919|NCT04425629|100840023|FG010|STARTED|Overall Study||2156||
48209920|NCT04425629|100840024|FG011|STARTED|Overall Study||3189||
48209921|NCT04425629|100840025|FG012|STARTED|Overall Study||1027||
48209922|NCT04425629|100840026|FG013|STARTED|Overall Study||2||
48209923|NCT04425629|100840027|FG014|STARTED|Overall Study||129||
48209924|NCT04425629|100840028|FG015|STARTED|Overall Study||75||
48209925|NCT04425629|100840029|FG016|STARTED|Overall Study||3||
48209926|NCT04425629|100840030|FG017|STARTED|Overall Study||43||
48495922|NCT03025087|101547965|FG000|NOT COMPLETED|Overall Study||6||
48209927|NCT04425629|100840031|FG018|STARTED|Overall Study||36||
48209928|NCT04425629|100840013|FG000|COMPLETED|Overall Study||23||
48209929|NCT04425629|100840014|FG001|COMPLETED|Overall Study||19||
48209930|NCT04425629|100840015|FG002|COMPLETED|Overall Study||22||
48209931|NCT04425629|100840016|FG003|COMPLETED|Overall Study||230||
48209932|NCT04425629|100840017|FG004|COMPLETED|Overall Study||232||
48495923|NCT03025087|101547966|FG001|NOT COMPLETED|Overall Study||6||
48209933|NCT04425629|100840018|FG005|COMPLETED|Overall Study||233||
48209934|NCT04425629|100840019|FG006|COMPLETED|Overall Study||71||
48209935|NCT04425629|100840020|FG007|COMPLETED|Overall Study||73||
48209936|NCT04425629|100840021|FG008|COMPLETED|Overall Study||74||
48209937|NCT04425629|100840022|FG009|COMPLETED|Overall Study||2217||
48209938|NCT04425629|100840023|FG010|COMPLETED|Overall Study||1974||
48209939|NCT04425629|100840024|FG011|COMPLETED|Overall Study||2947||
48209940|NCT04425629|100840025|FG012|COMPLETED|Overall Study||962||
48209941|NCT04425629|100840026|FG013|COMPLETED|Overall Study||2||
48209942|NCT04425629|100840027|FG014|COMPLETED|Overall Study||123||
48209943|NCT04425629|100840028|FG015|COMPLETED|Overall Study||65||
48209944|NCT04425629|100840029|FG016|COMPLETED|Overall Study||2||
48209945|NCT04425629|100840030|FG017|COMPLETED|Overall Study||40||
48209946|NCT04425629|100840031|FG018|COMPLETED|Overall Study||33||
48209947|NCT04425629|100840013|FG000|NOT COMPLETED|Overall Study||1||
48209948|NCT04425629|100840014|FG001|NOT COMPLETED|Overall Study||5||
48209949|NCT04425629|100840015|FG002|NOT COMPLETED|Overall Study||2||
48209950|NCT04425629|100840016|FG003|NOT COMPLETED|Overall Study||12||
48209951|NCT04425629|100840017|FG004|NOT COMPLETED|Overall Study||10||
48209952|NCT04425629|100840018|FG005|NOT COMPLETED|Overall Study||10||
48209953|NCT04425629|100840019|FG006|NOT COMPLETED|Overall Study||5||
48209954|NCT04425629|100840020|FG007|NOT COMPLETED|Overall Study||3||
48209955|NCT04425629|100840021|FG008|NOT COMPLETED|Overall Study||2||
48209956|NCT04425629|100840022|FG009|NOT COMPLETED|Overall Study||161||
48209957|NCT04425629|100840023|FG010|NOT COMPLETED|Overall Study||182||
48209958|NCT04425629|100840024|FG011|NOT COMPLETED|Overall Study||242||
48209959|NCT04425629|100840025|FG012|NOT COMPLETED|Overall Study||65||
48209960|NCT04425629|100840026|FG013|NOT COMPLETED|Overall Study||0||
48209961|NCT04425629|100840027|FG014|NOT COMPLETED|Overall Study||6||
48209962|NCT04425629|100840028|FG015|NOT COMPLETED|Overall Study||10||
48209963|NCT04425629|100840029|FG016|NOT COMPLETED|Overall Study||1||
48209964|NCT04425629|100840030|FG017|NOT COMPLETED|Overall Study||3||
48209965|NCT04425629|100840031|FG018|NOT COMPLETED|Overall Study||3||
48209966|NCT01561989|100840032|FG000|STARTED|Overall Study||5||
48209967|NCT01561989|100840033|FG001|STARTED|Overall Study||6||
48209968|NCT01561989|100840032|FG000|COMPLETED|Overall Study||0||
48209969|NCT01561989|100840033|FG001|COMPLETED|Overall Study||0||
48209970|NCT01561989|100840032|FG000|NOT COMPLETED|Overall Study||5||
48209971|NCT01561989|100840033|FG001|NOT COMPLETED|Overall Study||6||
48209972|NCT01925469|100840034|FG000|STARTED|Overall Study||15||
48209973|NCT01925469|100840035|FG001|STARTED|Overall Study||15||
48209974|NCT01925469|100840034|FG000|COMPLETED|Overall Study||14||
48209975|NCT01925469|100840035|FG001|COMPLETED|Overall Study||15||
48209976|NCT01925469|100840034|FG000|NOT COMPLETED|Overall Study||1||
48209977|NCT01925469|100840035|FG001|NOT COMPLETED|Overall Study||0||
48209978|NCT01394510|100840036|FG000|STARTED|Overall Study||13||
48209979|NCT01394510|100840036|FG000|COMPLETED|Overall Study||13||
48209980|NCT01394510|100840036|FG000|NOT COMPLETED|Overall Study||0||
48209981|NCT00891436|100840037|FG000|STARTED|Overall Study||10||
48209982|NCT00891436|100840038|FG001|STARTED|Overall Study||10||
48209983|NCT00891436|100840037|FG000|COMPLETED|Overall Study||10||
48209984|NCT00891436|100840038|FG001|COMPLETED|Overall Study||10||
48209985|NCT00891436|100840037|FG000|NOT COMPLETED|Overall Study||0||
48209986|NCT00891436|100840038|FG001|NOT COMPLETED|Overall Study||0||
48209987|NCT03359889|100840039|FG000|STARTED|Overall Study||5||
48209988|NCT03359889|100840039|FG000|COMPLETED|Overall Study||5||
48209989|NCT03359889|100840039|FG000|NOT COMPLETED|Overall Study||0||
48209990|NCT03593213|100840040|FG000|STARTED|Open-label Treatment Period (18 Weeks)||587||
48209991|NCT03593213|100840041|FG001|STARTED|Open-label Treatment Period (18 Weeks)||0||
48209992|NCT03593213|100840042|FG002|STARTED|Open-label Treatment Period (18 Weeks)||0||
48209993|NCT03593213|100840043|FG003|STARTED|Open-label Treatment Period (18 Weeks)||0||
48209994|NCT03593213|100840040|FG000|COMPLETED|Open-label Treatment Period (18 Weeks)||162||
48209995|NCT03593213|100840041|FG001|COMPLETED|Open-label Treatment Period (18 Weeks)||0||
48209996|NCT03593213|100840042|FG002|COMPLETED|Open-label Treatment Period (18 Weeks)||0||
48209997|NCT03593213|100840043|FG003|COMPLETED|Open-label Treatment Period (18 Weeks)||0||
48209998|NCT03593213|100840040|FG000|NOT COMPLETED|Open-label Treatment Period (18 Weeks)||425||
48209999|NCT03593213|100840041|FG001|NOT COMPLETED|Open-label Treatment Period (18 Weeks)||0||
48210000|NCT03593213|100840042|FG002|NOT COMPLETED|Open-label Treatment Period (18 Weeks)||0||
48210001|NCT03593213|100840043|FG003|NOT COMPLETED|Open-label Treatment Period (18 Weeks)||0||
48210002|NCT03593213|100840040|FG000|STARTED|Double-blind Treatment Period (26 Weeks)||0||
48210003|NCT03593213|100840041|FG001|STARTED|Double-blind Treatment Period (26 Weeks)||54||
48210004|NCT03593213|100840042|FG002|STARTED|Double-blind Treatment Period (26 Weeks)||49||
48210005|NCT03593213|100840043|FG003|STARTED|Double-blind Treatment Period (26 Weeks)||56||
48210006|NCT03593213|100840040|FG000|Safety Population|Double-blind Treatment Period (26 Weeks)||0|Double-blind Safety Population included all participants who took at least 1 dose of cariprazine during and double-blind treatment period.|
48210007|NCT03593213|100840041|FG001|Safety Population|Double-blind Treatment Period (26 Weeks)||53|Double-blind Safety Population included all participants who took at least 1 dose of cariprazine during and double-blind treatment period.|
48210008|NCT03593213|100840042|FG002|Safety Population|Double-blind Treatment Period (26 Weeks)||49|Double-blind Safety Population included all participants who took at least 1 dose of cariprazine during and double-blind treatment period.|
48210009|NCT03593213|100840043|FG003|Safety Population|Double-blind Treatment Period (26 Weeks)||54|Double-blind Safety Population included all participants who took at least 1 dose of cariprazine during and double-blind treatment period.|
48210010|NCT03593213|100840040|FG000|COMPLETED|Double-blind Treatment Period (26 Weeks)||0||
48210011|NCT03593213|100840041|FG001|COMPLETED|Double-blind Treatment Period (26 Weeks)||14||
48210012|NCT03593213|100840042|FG002|COMPLETED|Double-blind Treatment Period (26 Weeks)||16||
48210013|NCT03593213|100840043|FG003|COMPLETED|Double-blind Treatment Period (26 Weeks)||21||
48210014|NCT03593213|100840040|FG000|NOT COMPLETED|Double-blind Treatment Period (26 Weeks)||0||
48210015|NCT03593213|100840041|FG001|NOT COMPLETED|Double-blind Treatment Period (26 Weeks)||40||
48210016|NCT03593213|100840042|FG002|NOT COMPLETED|Double-blind Treatment Period (26 Weeks)||33||
48210017|NCT03593213|100840043|FG003|NOT COMPLETED|Double-blind Treatment Period (26 Weeks)||35||
48210018|NCT01296191|100840044|FG000|STARTED|Overall Study||60||
48210019|NCT01296191|100840045|FG001|STARTED|Overall Study||60||
48210020|NCT01296191|100840044|FG000|COMPLETED|Overall Study||57||
48210021|NCT01296191|100840045|FG001|COMPLETED|Overall Study||59||
48210022|NCT01296191|100840044|FG000|NOT COMPLETED|Overall Study||3||
48210023|NCT01296191|100840045|FG001|NOT COMPLETED|Overall Study||1||
48210024|NCT01241916|100840046|FG000|STARTED|Overall Study||35||
48210025|NCT01241916|100840047|FG001|STARTED|Overall Study||31||
48210026|NCT01241916|100840046|FG000|COMPLETED|Overall Study||28||
48210027|NCT01241916|100840047|FG001|COMPLETED|Overall Study||21||
48210028|NCT01241916|100840046|FG000|NOT COMPLETED|Overall Study||7||
48210029|NCT01241916|100840047|FG001|NOT COMPLETED|Overall Study||10||
48210030|NCT02879695|100840048|FG000|STARTED|Overall Study||8||
48210031|NCT02879695|100840049|FG001|STARTED|Overall Study||3||
48210032|NCT02879695|100840050|FG002|STARTED|Overall Study||11||
48210033|NCT02879695|100840051|FG003|STARTED|Overall Study||6||
48210034|NCT02879695|100840048|FG000|COMPLETED|Overall Study||6||
48210035|NCT02879695|100840049|FG001|COMPLETED|Overall Study||3||
48210036|NCT02879695|100840050|FG002|COMPLETED|Overall Study||8||
48210037|NCT02879695|100840051|FG003|COMPLETED|Overall Study||6||
48210038|NCT02879695|100840048|FG000|NOT COMPLETED|Overall Study||2||
48210039|NCT02879695|100840049|FG001|NOT COMPLETED|Overall Study||0||
48210040|NCT02879695|100840050|FG002|NOT COMPLETED|Overall Study||3||
48210041|NCT02879695|100840051|FG003|NOT COMPLETED|Overall Study||0||
48210042|NCT03803605|100840052|FG000|STARTED|Overall Study||15||
48210043|NCT03803605|100840052|FG000|Step 1: Participants With an RCI Measurement > 0.30 Per Million Cells|Overall Study||8||
48210044|NCT03803605|100840052|FG000|Steps 2-4: Participants Receiving Study Intervention|Overall Study||8||
48210045|NCT03803605|100840052|FG000|COMPLETED|Overall Study||8||
48210046|NCT03803605|100840052|FG000|NOT COMPLETED|Overall Study||7||
48210047|NCT01677936|100840053|FG000|STARTED|Overall Study||31||
48210048|NCT01677936|100840054|FG001|STARTED|Overall Study||20||
48210049|NCT01677936|100840053|FG000|COMPLETED|Overall Study||22||
48210050|NCT01677936|100840054|FG001|COMPLETED|Overall Study||15||
48210051|NCT01677936|100840053|FG000|NOT COMPLETED|Overall Study||9||
48210052|NCT01677936|100840054|FG001|NOT COMPLETED|Overall Study||5||
48210053|NCT00700336|100840055|FG000|STARTED|Overall Study||40||
48210054|NCT00700336|100840056|FG001|STARTED|Overall Study||23||
48210055|NCT00700336|100840057|FG002|STARTED|Overall Study||6||
48210056|NCT00700336|100840055|FG000|COMPLETED|Overall Study||40||
48210057|NCT00700336|100840056|FG001|COMPLETED|Overall Study||23||
48210058|NCT00700336|100840057|FG002|COMPLETED|Overall Study||6||
48210059|NCT00700336|100840055|FG000|NOT COMPLETED|Overall Study||0||
48210060|NCT00700336|100840056|FG001|NOT COMPLETED|Overall Study||0||
48210061|NCT00700336|100840057|FG002|NOT COMPLETED|Overall Study||0||
48210062|NCT01041417|100840058|FG000|STARTED|Overall Study||80||
48210063|NCT01041417|100840059|FG001|STARTED|Overall Study||79||
48210064|NCT01041417|100840058|FG000|COMPLETED|Overall Study||73||
48210065|NCT01041417|100840059|FG001|COMPLETED|Overall Study||76||
48210066|NCT01041417|100840058|FG000|NOT COMPLETED|Overall Study||7||
48210067|NCT01041417|100840059|FG001|NOT COMPLETED|Overall Study||3||
48210068|NCT00812877|100840060|FG000|STARTED|Overall Study||195||
48210069|NCT00812877|100840061|FG001|STARTED|Overall Study||181||
48210070|NCT00812877|100840060|FG000|COMPLETED|Overall Study||158||
48210071|NCT00812877|100840061|FG001|COMPLETED|Overall Study||130||
48210072|NCT00812877|100840060|FG000|NOT COMPLETED|Overall Study||37||
48210073|NCT00812877|100840061|FG001|NOT COMPLETED|Overall Study||51||
48210074|NCT01600729|100840062|FG000|STARTED|Overall Study||66||
48210075|NCT01600729|100840062|FG000|COMPLETED|Overall Study||65||
48210076|NCT01600729|100840062|FG000|NOT COMPLETED|Overall Study||1||
48210077|NCT00360698|100840063|FG000|STARTED|Run-In||0||
48210078|NCT00360698|100840064|FG001|STARTED|Run-In||135||
48210079|NCT00360698|100840063|FG000|COMPLETED|Run-In||0||
48210080|NCT00360698|100840064|FG001|COMPLETED|Run-In||125||
48210081|NCT00360698|100840063|FG000|NOT COMPLETED|Run-In||0||
48210082|NCT00360698|100840064|FG001|NOT COMPLETED|Run-In||10||
48210083|NCT00360698|100840063|FG000|STARTED|Treatment Period||49||
48210084|NCT00360698|100840064|FG001|STARTED|Treatment Period||57||
48210085|NCT00360698|100840063|FG000|COMPLETED|Treatment Period||48||
48210086|NCT00360698|100840064|FG001|COMPLETED|Treatment Period||56||
48210087|NCT00360698|100840063|FG000|NOT COMPLETED|Treatment Period||1||
48210088|NCT00360698|100840064|FG001|NOT COMPLETED|Treatment Period||1||
48210089|NCT03049969|100840065|FG000|STARTED|Overall Study||15||
48210090|NCT03049969|100840065|FG000|COMPLETED|Overall Study||15||
48210091|NCT03049969|100840065|FG000|NOT COMPLETED|Overall Study||0||
48210092|NCT03050814|100840066|FG000|STARTED|Overall Study||10||
48210093|NCT03050814|100840067|FG001|STARTED|Overall Study||16||
48210094|NCT03050814|100840068|FG002|STARTED|Overall Study||4||
48210095|NCT03050814|100840066|FG000|COMPLETED|Overall Study||10||
48210096|NCT03050814|100840067|FG001|COMPLETED|Overall Study||16||
48210097|NCT03050814|100840068|FG002|COMPLETED|Overall Study||0||
48210098|NCT03050814|100840066|FG000|NOT COMPLETED|Overall Study||0||
48210099|NCT03050814|100840067|FG001|NOT COMPLETED|Overall Study||0||
48210100|NCT03050814|100840068|FG002|NOT COMPLETED|Overall Study||4||
48210101|NCT01373346|100840069|FG000|STARTED|Overall Study||15||
48210102|NCT01373346|100840069|FG000|COMPLETED|Overall Study||14||
48210103|NCT01373346|100840069|FG000|NOT COMPLETED|Overall Study||1||
48210104|NCT03109795|100840070|FG000|STARTED|Overall Study||0||
48210105|NCT03109795|100840071|FG001|STARTED|Overall Study||0||
48210106|NCT03109795|100840070|FG000|COMPLETED|Overall Study||0||
48210107|NCT03109795|100840071|FG001|COMPLETED|Overall Study||0||
48210108|NCT03109795|100840070|FG000|NOT COMPLETED|Overall Study||0||
48210109|NCT03109795|100840071|FG001|NOT COMPLETED|Overall Study||0||
48210110|NCT01903798|100840072|FG000|STARTED|Overall Study||2||
48210111|NCT01903798|100840073|FG001|STARTED|Overall Study||0||
48210112|NCT01903798|100840074|FG002|STARTED|Overall Study||1||
48210113|NCT01903798|100840075|FG003|STARTED|Overall Study||1||
48210114|NCT01903798|100840072|FG000|COMPLETED|Overall Study||2||
48210115|NCT01903798|100840073|FG001|COMPLETED|Overall Study||0||
48210116|NCT01903798|100840074|FG002|COMPLETED|Overall Study||1||
48210117|NCT01903798|100840075|FG003|COMPLETED|Overall Study||1||
48210118|NCT01903798|100840072|FG000|NOT COMPLETED|Overall Study||0||
48210119|NCT01903798|100840073|FG001|NOT COMPLETED|Overall Study||0||
48210120|NCT01903798|100840074|FG002|NOT COMPLETED|Overall Study||0||
48210121|NCT01903798|100840075|FG003|NOT COMPLETED|Overall Study||0||
48210122|NCT00130117|100840076|FG000|STARTED|Overall Study||11||
48210123|NCT00130117|100840077|FG001|STARTED|Overall Study||9||
48210124|NCT00130117|100840076|FG000|COMPLETED|Overall Study||7||
48210125|NCT00130117|100840077|FG001|COMPLETED|Overall Study||6||
48210126|NCT00130117|100840076|FG000|NOT COMPLETED|Overall Study||4||
48210127|NCT00130117|100840077|FG001|NOT COMPLETED|Overall Study||3||
48210128|NCT02692417|100840078|FG000|STARTED|Overall Study||9||
48210129|NCT02692417|100840079|FG001|STARTED|Overall Study||7||
48210130|NCT02692417|100840078|FG000|COMPLETED|Overall Study||3||
48210131|NCT02692417|100840079|FG001|COMPLETED|Overall Study||6||
48210132|NCT02692417|100840078|FG000|NOT COMPLETED|Overall Study||6||
48210133|NCT02692417|100840079|FG001|NOT COMPLETED|Overall Study||1||
48210134|NCT01136486|100840080|FG000|STARTED|Overall Study||56||
48210135|NCT01136486|100840080|FG000|COMPLETED|Overall Study||56||
48210136|NCT01136486|100840080|FG000|NOT COMPLETED|Overall Study||0||
48210137|NCT03635151|100840081|FG000|STARTED|Overall Study||36||
48210138|NCT03635151|100840082|FG001|STARTED|Overall Study||38||
48210139|NCT03635151|100840081|FG000|COMPLETED|Overall Study||31||
48210140|NCT03635151|100840082|FG001|COMPLETED|Overall Study||34||
48210141|NCT03635151|100840081|FG000|NOT COMPLETED|Overall Study||5||
48210142|NCT03635151|100840082|FG001|NOT COMPLETED|Overall Study||4||
48210143|NCT02525796|100840083|FG000|STARTED|Randomization to Monotherapy for 4 Weeks||14||
48210144|NCT02525796|100840084|FG001|STARTED|Randomization to Monotherapy for 4 Weeks||14||
48210145|NCT02525796|100840085|FG002|STARTED|Randomization to Monotherapy for 4 Weeks||13||
48210146|NCT02525796|100840083|FG000|COMPLETED|Randomization to Monotherapy for 4 Weeks||12||
48210147|NCT02525796|100840084|FG001|COMPLETED|Randomization to Monotherapy for 4 Weeks||12||
48210148|NCT02525796|100840085|FG002|COMPLETED|Randomization to Monotherapy for 4 Weeks||12||
48210149|NCT02525796|100840083|FG000|NOT COMPLETED|Randomization to Monotherapy for 4 Weeks||2||
48210150|NCT02525796|100840084|FG001|NOT COMPLETED|Randomization to Monotherapy for 4 Weeks||2||
48210151|NCT02525796|100840085|FG002|NOT COMPLETED|Randomization to Monotherapy for 4 Weeks||1||
48210152|NCT02525796|100840083|FG000|STARTED|Open-label Addition of Cinacalcet||12||
48210153|NCT02525796|100840084|FG001|STARTED|Open-label Addition of Cinacalcet||12||
48210154|NCT02525796|100840085|FG002|STARTED|Open-label Addition of Cinacalcet||12||
48210155|NCT02525796|100840083|FG000|Open-label Cinacalcet|Open-label Addition of Cinacalcet||12||
48210156|NCT02525796|100840084|FG001|Open-label Cinacalcet|Open-label Addition of Cinacalcet||12||
48210157|NCT02525796|100840085|FG002|Open-label Cinacalcet|Open-label Addition of Cinacalcet||12||
48210158|NCT02525796|100840083|FG000|COMPLETED|Open-label Addition of Cinacalcet||8||
48210159|NCT02525796|100840084|FG001|COMPLETED|Open-label Addition of Cinacalcet||10||
48210160|NCT02525796|100840085|FG002|COMPLETED|Open-label Addition of Cinacalcet||9||
48210161|NCT02525796|100840083|FG000|NOT COMPLETED|Open-label Addition of Cinacalcet||4||
48210162|NCT02525796|100840084|FG001|NOT COMPLETED|Open-label Addition of Cinacalcet||2||
48210163|NCT02525796|100840085|FG002|NOT COMPLETED|Open-label Addition of Cinacalcet||3||
48210164|NCT00542789|100840086|FG000|STARTED|Overall Study||175||
48210165|NCT00542789|100840087|FG001|STARTED|Overall Study||168||
48210166|NCT00542789|100840086|FG000|COMPLETED|Overall Study||134||
48210167|NCT00542789|100840087|FG001|COMPLETED|Overall Study||90||
48210168|NCT00542789|100840086|FG000|NOT COMPLETED|Overall Study||41||
48210169|NCT00542789|100840087|FG001|NOT COMPLETED|Overall Study||78||
48210170|NCT00869258|100840088|FG000|STARTED|Overall Study||32||
48210171|NCT00869258|100840088|FG000|COMPLETED|Overall Study||31||
48210172|NCT00869258|100840088|FG000|NOT COMPLETED|Overall Study||1||
48210173|NCT02860286|100840089|FG000|STARTED|Overall Study||13||
48210174|NCT02860286|100840090|FG001|STARTED|Overall Study||61||
48210175|NCT02860286|100840089|FG000|COMPLETED|Overall Study||13||
48210176|NCT02860286|100840090|FG001|COMPLETED|Overall Study||61||
48210177|NCT02860286|100840089|FG000|NOT COMPLETED|Overall Study||0||
48210178|NCT02860286|100840090|FG001|NOT COMPLETED|Overall Study||0||
48210179|NCT01731041|100840091|FG000|STARTED|Overall Study||30||
48210180|NCT01731041|100840092|FG001|STARTED|Overall Study||30||
48210181|NCT01731041|100840091|FG000|COMPLETED|Overall Study||30||
48210182|NCT01731041|100840092|FG001|COMPLETED|Overall Study||30||
48210183|NCT01731041|100840091|FG000|NOT COMPLETED|Overall Study||0||
48210184|NCT01731041|100840092|FG001|NOT COMPLETED|Overall Study||0||
48210185|NCT00668863|100840093|FG000|STARTED|Overall Study||71||
48210186|NCT00668863|100840093|FG000|COMPLETED|Overall Study||0||
48210187|NCT00668863|100840093|FG000|NOT COMPLETED|Overall Study||71||
48210188|NCT04476472|100840094|FG000|STARTED|Overall Study||80||
48210189|NCT04476472|100840094|FG000|COMPLETED|Overall Study||80||
48210190|NCT04476472|100840094|FG000|NOT COMPLETED|Overall Study||0||
48210191|NCT00262730|100840095|FG000|STARTED|Overall Study||97||
48210192|NCT00262730|100840095|FG000|COMPLETED|Overall Study||97||
48210193|NCT00262730|100840095|FG000|NOT COMPLETED|Overall Study||0||
48210194|NCT03977935|100840096|FG000|STARTED|Overall Study||40||
48210195|NCT03977935|100840097|FG001|STARTED|Overall Study||40||
48210196|NCT03977935|100840096|FG000|COMPLETED|Overall Study||40||
48210197|NCT03977935|100840097|FG001|COMPLETED|Overall Study||40||
48210198|NCT03977935|100840096|FG000|NOT COMPLETED|Overall Study||0||
48210199|NCT03977935|100840097|FG001|NOT COMPLETED|Overall Study||0||
48210200|NCT00638963|100840098|FG000|STARTED|Overall Study||3||
48210201|NCT00638963|100840099|FG001|STARTED|Overall Study||3||
48210202|NCT00638963|100840098|FG000|COMPLETED|Overall Study||2||
48210203|NCT00638963|100840099|FG001|COMPLETED|Overall Study||3||
48210204|NCT00638963|100840098|FG000|NOT COMPLETED|Overall Study||1||
48210205|NCT00638963|100840099|FG001|NOT COMPLETED|Overall Study||0||
48210206|NCT00636207|100840100|FG000|STARTED|Overall Study||1||
48210207|NCT00636207|100840101|FG001|STARTED|Overall Study||8||
48210208|NCT00636207|100840102|FG002|STARTED|Overall Study||18||
48210209|NCT00636207|100840103|FG003|STARTED|Overall Study||6||
48210210|NCT00636207|100840104|FG004|STARTED|Overall Study||9||
48210211|NCT00636207|100840105|FG005|STARTED|Overall Study||1||
48210212|NCT00636207|100840106|FG006|STARTED|Overall Study||3||
48210213|NCT00636207|100840100|FG000|COMPLETED|Overall Study||0||
48210214|NCT00636207|100840101|FG001|COMPLETED|Overall Study||7||
48210215|NCT00636207|100840102|FG002|COMPLETED|Overall Study||18||
48210216|NCT00636207|100840103|FG003|COMPLETED|Overall Study||6||
48210217|NCT00636207|100840104|FG004|COMPLETED|Overall Study||8||
48210218|NCT00636207|100840105|FG005|COMPLETED|Overall Study||1||
48210219|NCT00636207|100840106|FG006|COMPLETED|Overall Study||3||
48210220|NCT00636207|100840100|FG000|NOT COMPLETED|Overall Study||1||
48210221|NCT00636207|100840101|FG001|NOT COMPLETED|Overall Study||1||
48210222|NCT00636207|100840102|FG002|NOT COMPLETED|Overall Study||0||
48210223|NCT00636207|100840103|FG003|NOT COMPLETED|Overall Study||0||
48210224|NCT00636207|100840104|FG004|NOT COMPLETED|Overall Study||1||
48210225|NCT00636207|100840105|FG005|NOT COMPLETED|Overall Study||0||
48210226|NCT00636207|100840106|FG006|NOT COMPLETED|Overall Study||0||
48210227|NCT02743078|100840107|FG000|STARTED|Overall Study||3||
48210228|NCT02743078|100840107|FG000|Eligible Populaton|Overall Study||3||
48210229|NCT02743078|100840107|FG000|Eligible With Six-month Follow-up Data|Overall Study||3||
48210230|NCT02743078|100840107|FG000|COMPLETED|Overall Study||3|Participants contributing data to results are considered to have completed the study|
48210231|NCT02743078|100840107|FG000|NOT COMPLETED|Overall Study||0||
48210232|NCT01763970|100840108|FG000|STARTED|Overall Study||14||
48210233|NCT01763970|100840108|FG000|COMPLETED|Overall Study||14||
48210234|NCT01763970|100840108|FG000|NOT COMPLETED|Overall Study||0||
48210235|NCT00933400|100840109|FG000|STARTED|Overall Study||929||
48210236|NCT00933400|100840110|FG001|STARTED|Overall Study||463||
48210237|NCT00933400|100840109|FG000|Index Visit|Overall Study||908||
48210238|NCT00933400|100840110|FG001|Index Visit|Overall Study||462||
48210239|NCT00933400|100840109|FG000|CCTA Performed|Overall Study||767||
48210240|NCT00933400|100840110|FG001|CCTA Performed|Overall Study||0||
48210241|NCT00933400|100840109|FG000|Vital Status Available 30 Days Post ED Triage|Overall Study||908||
48210242|NCT00933400|100840110|FG001|Vital Status Available 30 Days Post ED Triage|Overall Study||462||
48210243|NCT00933400|100840109|FG000|30 Day Post ED Triage Follow-up Data|Overall Study||898||
48210244|NCT00933400|100840110|FG001|30 Day Post ED Triage Follow-up Data|Overall Study||457||
48210245|NCT00933400|100840109|FG000|1-year Post ED Triage Follow-up Data|Overall Study||907||
48210246|NCT00933400|100840110|FG001|1-year Post ED Triage Follow-up Data|Overall Study||461||
48210247|NCT00933400|100840109|FG000|COMPLETED|Overall Study||908||
48210248|NCT00933400|100840110|FG001|COMPLETED|Overall Study||462||
48210249|NCT00933400|100840109|FG000|NOT COMPLETED|Overall Study||21||
48210250|NCT00933400|100840110|FG001|NOT COMPLETED|Overall Study||1||
48210251|NCT04723394|100840111|FG000|STARTED|Overall Study||456|All Participants Randomized|
48210252|NCT04723394|100840112|FG001|STARTED|Overall Study||454|All Participants Randomized|
48210253|NCT04723394|100840111|FG000|Dosed|Overall Study||452|Full Analysis Set|
48210254|NCT04723394|100840112|FG001|Dosed|Overall Study||451|Full Analysis Set|
48210255|NCT04723394|100840111|FG000|Modified Full Analysis Set|Overall Study||413|Dosed, randomized \<=7 days from symptom onset and not hospitalized for isolation purposes at baseline|
48495924|NCT03025087|101547967|FG002|NOT COMPLETED|Overall Study||0||
48210256|NCT04723394|100840112|FG001|Modified Full Analysis Set|Overall Study||421|Dosed, randomized \<=7 days from symptom onset and not hospitalized for isolation purposes at baseline|
48210257|NCT04723394|100840111|FG000|Primary Analysis Population|Overall Study||410|Participants who are included in the modified full analysis set excluding those who did not have an assessment for the primary endpoint|
48210258|NCT04723394|100840112|FG001|Primary Analysis Population|Overall Study||419|Participants who are included in the modified full analysis set excluding those who did not have an assessment for the primary endpoint|
48210259|NCT04723394|100840111|FG000|Key Secondary Analysis Population|Overall Study||404|Participants who are included in the modified full analysis set excluding those who did not have an assessment for the key secondary endpoint|
48210260|NCT04723394|100840112|FG001|Key Secondary Analysis Population|Overall Study||411|Participants who are included in the modified full analysis set excluding those who did not have an assessment for the key secondary endpoint|
48210261|NCT04723394|100840111|FG000|COMPLETED|Overall Study||407||
48210262|NCT04723394|100840112|FG001|COMPLETED|Overall Study||390||
48210263|NCT04723394|100840111|FG000|NOT COMPLETED|Overall Study||49||
48210264|NCT04723394|100840112|FG001|NOT COMPLETED|Overall Study||64||
48210265|NCT00749749|100840113|FG000|STARTED|Overall Study||14||
48210266|NCT00749749|100840114|FG001|STARTED|Overall Study||13||
48210267|NCT00749749|100840113|FG000|COMPLETED|Overall Study||14||
48210268|NCT00749749|100840114|FG001|COMPLETED|Overall Study||13||
48210269|NCT00749749|100840113|FG000|NOT COMPLETED|Overall Study||0||
48210270|NCT00749749|100840114|FG001|NOT COMPLETED|Overall Study||0||
48210271|NCT00357097|100840115|FG000|STARTED|Overall Study||199||
48210272|NCT00357097|100840116|FG001|STARTED|Overall Study||67||
48210273|NCT00357097|100840115|FG000|COMPLETED|Overall Study||145||
48210274|NCT00357097|100840116|FG001|COMPLETED|Overall Study||38||
48210275|NCT00357097|100840115|FG000|NOT COMPLETED|Overall Study||54||
48210276|NCT00357097|100840116|FG001|NOT COMPLETED|Overall Study||29||
48210277|NCT03036813|100840117|FG000|STARTED|Overall Study||92||
48210278|NCT03036813|100840118|FG001|STARTED|Overall Study||90||
48210279|NCT03036813|100840119|FG002|STARTED|Overall Study||92||
48210280|NCT03036813|100840117|FG000|COMPLETED|Overall Study||70||
48210281|NCT03036813|100840118|FG001|COMPLETED|Overall Study||63||
48210282|NCT03036813|100840119|FG002|COMPLETED|Overall Study||66||
48210283|NCT03036813|100840117|FG000|NOT COMPLETED|Overall Study||22||
48210284|NCT03036813|100840118|FG001|NOT COMPLETED|Overall Study||27||
48210285|NCT03036813|100840119|FG002|NOT COMPLETED|Overall Study||26||
48210286|NCT03062358|100840120|FG000|STARTED|Overall Study||300|All randomized participants|
48210287|NCT03062358|100840121|FG001|STARTED|Overall Study||153|All randomized participants|
48210288|NCT03062358|100840120|FG000|Treated|Overall Study||299|First Course Pembrolizumab|
48210289|NCT03062358|100840121|FG001|Treated|Overall Study||153|First Course Pembrolizumab|
48210290|NCT03062358|100840120|FG000|Second Course|Overall Study||6|Second Course Pembrolizumab|
48210291|NCT03062358|100840121|FG001|Second Course|Overall Study||0|Second Course Pembrolizumab|
48210292|NCT03062358|100840120|FG000|COMPLETED|Overall Study||0||
48210293|NCT03062358|100840121|FG001|COMPLETED|Overall Study||0||
48210294|NCT03062358|100840120|FG000|NOT COMPLETED|Overall Study||300||
48210295|NCT03062358|100840121|FG001|NOT COMPLETED|Overall Study||153||
48210296|NCT00159783|100840122|FG000|STARTED|Overall Study||32||
48210297|NCT00159783|100840123|FG001|STARTED|Overall Study||79||
48210298|NCT00159783|100840124|FG002|STARTED|Overall Study||107||
48210299|NCT00159783|100840122|FG000|COMPLETED|Overall Study||13||
48059640|NCT02443519|100466984|FG001|STARTED|Overall Study||29||
48059641|NCT02443519|100466983|FG000|COMPLETED|Overall Study||29||
48210300|NCT00159783|100840123|FG001|COMPLETED|Overall Study||52||
48210301|NCT00159783|100840124|FG002|COMPLETED|Overall Study||68||
48210302|NCT00159783|100840122|FG000|NOT COMPLETED|Overall Study||19||
48210303|NCT00159783|100840123|FG001|NOT COMPLETED|Overall Study||27||
48059642|NCT02443519|100466984|FG001|COMPLETED|Overall Study||26||
48059643|NCT02443519|100466983|FG000|NOT COMPLETED|Overall Study||2||
48210304|NCT00159783|100840124|FG002|NOT COMPLETED|Overall Study||39||
48210305|NCT03988023|100840125|FG000|STARTED|Overall Study||520||
48210306|NCT03988023|100840126|FG001|STARTED|Overall Study||523||
48210307|NCT03988023|100840125|FG000|COMPLETED|Overall Study||235||
48210308|NCT03988023|100840126|FG001|COMPLETED|Overall Study||235||
48210309|NCT03988023|100840125|FG000|NOT COMPLETED|Overall Study||285||
48210310|NCT03988023|100840126|FG001|NOT COMPLETED|Overall Study||288||
48210311|NCT00857649|100840127|FG000|STARTED|Overall Study||182||
48210312|NCT00857649|100840128|FG001|STARTED|Overall Study||187||
48210313|NCT00857649|100840127|FG000|COMPLETED|Overall Study||151||
48210314|NCT00857649|100840128|FG001|COMPLETED|Overall Study||155||
48210315|NCT00857649|100840127|FG000|NOT COMPLETED|Overall Study||31||
48210316|NCT00857649|100840128|FG001|NOT COMPLETED|Overall Study||32||
48059644|NCT02443519|100466984|FG001|NOT COMPLETED|Overall Study||3||
48059645|NCT04824365|100466985|FG000|STARTED|Overall Study||15||
48210317|NCT03811574|100840129|FG000|STARTED|Overall Study||101||
48210318|NCT03811574|100840130|FG001|STARTED|Overall Study||199||
48210319|NCT03811574|100840131|FG002|STARTED|Overall Study||101||
48210320|NCT03811574|100840129|FG000|Full Analysis Set (FAS)|Overall Study||101||
48059646|NCT04824365|100466986|FG001|STARTED|Overall Study||15||
48210321|NCT03811574|100840130|FG001|Full Analysis Set (FAS)|Overall Study||199||
48210322|NCT03811574|100840131|FG002|Full Analysis Set (FAS)|Overall Study||101||
48210323|NCT03811574|100840129|FG000|Safety Analysis Set (SAS)|Overall Study||100||
48210324|NCT03811574|100840130|FG001|Safety Analysis Set (SAS)|Overall Study||199||
48210325|NCT03811574|100840131|FG002|Safety Analysis Set (SAS)|Overall Study||101||
48210326|NCT03811574|100840129|FG000|Treated|Overall Study||100||
48210327|NCT03811574|100840130|FG001|Treated|Overall Study||199||
48210328|NCT03811574|100840131|FG002|Treated|Overall Study||101||
48210329|NCT03811574|100840129|FG000|COMPLETED|Overall Study||99||
48210330|NCT03811574|100840130|FG001|COMPLETED|Overall Study||195||
48210331|NCT03811574|100840131|FG002|COMPLETED|Overall Study||101||
48210332|NCT03811574|100840129|FG000|NOT COMPLETED|Overall Study||2||
48210333|NCT03811574|100840130|FG001|NOT COMPLETED|Overall Study||4||
48210334|NCT03811574|100840131|FG002|NOT COMPLETED|Overall Study||0||
48210335|NCT01171625|100840132|FG000|STARTED|Overall Study||283||
48210336|NCT01171625|100840132|FG000|Subjects Implanted With Device|Overall Study||258||
48210337|NCT01171625|100840132|FG000|COMPLETED|Overall Study||103||
48210338|NCT01171625|100840132|FG000|NOT COMPLETED|Overall Study||180||
48210339|NCT02539108|100840133|FG000|STARTED|Overall Study||30||
48210340|NCT02539108|100840134|FG001|STARTED|Overall Study||30||
48210341|NCT02539108|100840133|FG000|COMPLETED|Overall Study||30||
48210342|NCT02539108|100840134|FG001|COMPLETED|Overall Study||30||
48210343|NCT02539108|100840133|FG000|NOT COMPLETED|Overall Study||0||
48210344|NCT02539108|100840134|FG001|NOT COMPLETED|Overall Study||0||
48210345|NCT02974634|100840135|FG000|STARTED|Overall Study||106||
48210346|NCT02974634|100840136|FG001|STARTED|Overall Study||110||
48210347|NCT02974634|100840135|FG000|COMPLETED|Overall Study||78||
48210348|NCT02974634|100840136|FG001|COMPLETED|Overall Study||89||
48210349|NCT02974634|100840135|FG000|NOT COMPLETED|Overall Study||28||
48210350|NCT02974634|100840136|FG001|NOT COMPLETED|Overall Study||21||
48210351|NCT02396316|100840137|FG000|STARTED|Overall Study||27||
48210352|NCT02396316|100840138|FG001|STARTED|Overall Study||27||
48210353|NCT02396316|100840137|FG000|Treated|Overall Study||27||
48210354|NCT02396316|100840138|FG001|Treated|Overall Study||27||
48210355|NCT02396316|100840137|FG000|Received Sham Injection at Week 1|Overall Study||10||
48210356|NCT02396316|100840138|FG001|Received Sham Injection at Week 1|Overall Study||0||
48210357|NCT02396316|100840137|FG000|Received AFL Injection at Week 1|Overall Study||0||
48210358|NCT02396316|100840138|FG001|Received AFL Injection at Week 1|Overall Study||22||
48210359|NCT02396316|100840137|FG000|Received Active Injection at Week 5|Overall Study||4||
48210360|NCT02396316|100840138|FG001|Received Active Injection at Week 5|Overall Study||4||
48210361|NCT02396316|100840137|FG000|Received Active Injection at Week 9|Overall Study||2||
48210362|NCT02396316|100840138|FG001|Received Active Injection at Week 9|Overall Study||1||
48210363|NCT02396316|100840137|FG000|COMPLETED|Overall Study||20||
48210364|NCT02396316|100840138|FG001|COMPLETED|Overall Study||22||
48210365|NCT02396316|100840137|FG000|NOT COMPLETED|Overall Study||7||
48210366|NCT02396316|100840138|FG001|NOT COMPLETED|Overall Study||5||
48210367|NCT01318382|100840139|FG000|STARTED|Overall Study||302||
48210368|NCT01318382|100840139|FG000|COMPLETED|Overall Study||289||
48210369|NCT01318382|100840139|FG000|NOT COMPLETED|Overall Study||13||
48210370|NCT01503749|100840140|FG000|STARTED|Overall Study||3||
48210371|NCT01503749|100840141|FG001|STARTED|Overall Study||3||
48210372|NCT01503749|100840142|FG002|STARTED|Overall Study||3||
48210373|NCT01503749|100840140|FG000|COMPLETED|Overall Study||3||
48210374|NCT01503749|100840141|FG001|COMPLETED|Overall Study||3||
48210375|NCT01503749|100840142|FG002|COMPLETED|Overall Study||3||
48210376|NCT01503749|100840140|FG000|NOT COMPLETED|Overall Study||0||
48210377|NCT01503749|100840141|FG001|NOT COMPLETED|Overall Study||0||
48210378|NCT01503749|100840142|FG002|NOT COMPLETED|Overall Study||0||
48210379|NCT04956575|100840143|FG000|STARTED|Overall Study||45||
48210380|NCT04956575|100840144|FG001|STARTED|Overall Study||45||
48210381|NCT04956575|100840145|FG002|STARTED|Overall Study||45||
48210382|NCT04956575|100840146|FG003|STARTED|Overall Study||45||
48210383|NCT04956575|100840147|FG004|STARTED|Overall Study||53||
48210384|NCT04956575|100840148|FG005|STARTED|Overall Study||153||
48210385|NCT04956575|100840149|FG006|STARTED|Overall Study||149||
48210386|NCT04956575|100840150|FG007|STARTED|Overall Study||148||
48210387|NCT04956575|100840151|FG008|STARTED|Overall Study||51||
48210388|NCT04956575|100840152|FG009|STARTED|Overall Study||50||
48210389|NCT04956575|100840153|FG010|STARTED|Overall Study||51||
48210390|NCT04956575|100840154|FG011|STARTED|Overall Study||50||
48210391|NCT04956575|100840143|FG000|Received at Least 1 Dose of Investigational Product|Overall Study||45|Numbers are based on planned vaccination group.|
48210392|NCT04956575|100840144|FG001|Received at Least 1 Dose of Investigational Product|Overall Study||45|Numbers are based on planned vaccination group.|
48210393|NCT04956575|100840145|FG002|Received at Least 1 Dose of Investigational Product|Overall Study||45|Numbers are based on planned vaccination group.|
48210394|NCT04956575|100840146|FG003|Received at Least 1 Dose of Investigational Product|Overall Study||45|Numbers are based on planned vaccination group.|
48210395|NCT04956575|100840147|FG004|Received at Least 1 Dose of Investigational Product|Overall Study||53|Numbers are based on planned vaccination group.|
48210396|NCT04956575|100840148|FG005|Received at Least 1 Dose of Investigational Product|Overall Study||151|Numbers are based on planned vaccination group.|
48210397|NCT04956575|100840149|FG006|Received at Least 1 Dose of Investigational Product|Overall Study||147|Numbers are based on planned vaccination group.|
48210398|NCT04956575|100840150|FG007|Received at Least 1 Dose of Investigational Product|Overall Study||147|Numbers are based on planned vaccination group.|
48495925|NCT03025087|101547968|FG003|NOT COMPLETED|Overall Study||0||
48495926|NCT03025087|101547969|FG004|NOT COMPLETED|Overall Study||0||
48210399|NCT04956575|100840151|FG008|Received at Least 1 Dose of Investigational Product|Overall Study||51|Numbers are based on planned vaccination group.|
48210400|NCT04956575|100840152|FG009|Received at Least 1 Dose of Investigational Product|Overall Study||50|Numbers are based on planned vaccination group.|
48210401|NCT04956575|100840153|FG010|Received at Least 1 Dose of Investigational Product|Overall Study||50|Numbers are based on planned vaccination group.|
48210402|NCT04956575|100840154|FG011|Received at Least 1 Dose of Investigational Product|Overall Study||49|Numbers are based on planned vaccination group.|
48210403|NCT04956575|100840143|FG000|Safety Analysis Set|Overall Study||45|Safety Analysis Set consisted of all randomly assigned participants who received the investigational product. The Safety Set was used for analysis of safety except for the solicited adverse reactions (ARs). Participants were included in the vaccination group corresponding to the study injection they actually received.|
48210404|NCT04956575|100840144|FG001|Safety Analysis Set|Overall Study||45|Safety Analysis Set consisted of all randomly assigned participants who received the investigational product. The Safety Set was used for analysis of safety except for the solicited adverse reactions (ARs). Participants were included in the vaccination group corresponding to the study injection they actually received.|
48210405|NCT04956575|100840145|FG002|Safety Analysis Set|Overall Study||46|Safety Analysis Set consisted of all randomly assigned participants who received the investigational product. The Safety Set was used for analysis of safety except for the solicited adverse reactions (ARs). Participants were included in the vaccination group corresponding to the study injection they actually received.|
48210406|NCT04956575|100840146|FG003|Safety Analysis Set|Overall Study||44|Safety Analysis Set consisted of all randomly assigned participants who received the investigational product. The Safety Set was used for analysis of safety except for the solicited adverse reactions (ARs). Participants were included in the vaccination group corresponding to the study injection they actually received.|
48210407|NCT04956575|100840147|FG004|Safety Analysis Set|Overall Study||54|Safety Analysis Set consisted of all randomly assigned participants who received the investigational product. The Safety Set was used for analysis of safety except for the solicited adverse reactions (ARs). Participants were included in the vaccination group corresponding to the study injection they actually received.|
48210408|NCT04956575|100840148|FG005|Safety Analysis Set|Overall Study||150|Safety Analysis Set consisted of all randomly assigned participants who received the investigational product. The Safety Set was used for analysis of safety except for the solicited adverse reactions (ARs). Participants were included in the vaccination group corresponding to the study injection they actually received.|
48210409|NCT04956575|100840149|FG006|Safety Analysis Set|Overall Study||147|Safety Analysis Set consisted of all randomly assigned participants who received the investigational product. The Safety Set was used for analysis of safety except for the solicited adverse reactions (ARs). Participants were included in the vaccination group corresponding to the study injection they actually received.|
48210410|NCT04956575|100840150|FG007|Safety Analysis Set|Overall Study||147|Safety Analysis Set consisted of all randomly assigned participants who received the investigational product. The Safety Set was used for analysis of safety except for the solicited adverse reactions (ARs). Participants were included in the vaccination group corresponding to the study injection they actually received.|
48210411|NCT04956575|100840151|FG008|Safety Analysis Set|Overall Study||51|Safety Analysis Set consisted of all randomly assigned participants who received the investigational product. The Safety Set was used for analysis of safety except for the solicited adverse reactions (ARs). Participants were included in the vaccination group corresponding to the study injection they actually received.|
48210412|NCT04956575|100840152|FG009|Safety Analysis Set|Overall Study||50|Safety Analysis Set consisted of all randomly assigned participants who received the investigational product. The Safety Set was used for analysis of safety except for the solicited adverse reactions (ARs). Participants were included in the vaccination group corresponding to the study injection they actually received.|
48210413|NCT04956575|100840153|FG010|Safety Analysis Set|Overall Study||50|Safety Analysis Set consisted of all randomly assigned participants who received the investigational product. The Safety Set was used for analysis of safety except for the solicited adverse reactions (ARs). Participants were included in the vaccination group corresponding to the study injection they actually received.|
48210414|NCT04956575|100840154|FG011|Safety Analysis Set|Overall Study||49|Safety Analysis Set consisted of all randomly assigned participants who received the investigational product. The Safety Set was used for analysis of safety except for the solicited adverse reactions (ARs). Participants were included in the vaccination group corresponding to the study injection they actually received.|
48210415|NCT04956575|100840143|FG000|Solicited Safety Set|Overall Study||44|Solicited Safety Set consisted of all participants in the Safety Set who contributed any solicited AR data. Participants were included in the vaccination group corresponding to the study injection they actually received.|
48210416|NCT04956575|100840144|FG001|Solicited Safety Set|Overall Study||45|Solicited Safety Set consisted of all participants in the Safety Set who contributed any solicited AR data. Participants were included in the vaccination group corresponding to the study injection they actually received.|
48210417|NCT04956575|100840145|FG002|Solicited Safety Set|Overall Study||46|Solicited Safety Set consisted of all participants in the Safety Set who contributed any solicited AR data. Participants were included in the vaccination group corresponding to the study injection they actually received.|
48210418|NCT04956575|100840146|FG003|Solicited Safety Set|Overall Study||44|Solicited Safety Set consisted of all participants in the Safety Set who contributed any solicited AR data. Participants were included in the vaccination group corresponding to the study injection they actually received.|
48210419|NCT04956575|100840147|FG004|Solicited Safety Set|Overall Study||53|Solicited Safety Set consisted of all participants in the Safety Set who contributed any solicited AR data. Participants were included in the vaccination group corresponding to the study injection they actually received.|
48210420|NCT04956575|100840148|FG005|Solicited Safety Set|Overall Study||149|Solicited Safety Set consisted of all participants in the Safety Set who contributed any solicited AR data. Participants were included in the vaccination group corresponding to the study injection they actually received.|
48495927|NCT02426918|101547970|FG000|STARTED|Overall Study||110||
48495928|NCT02426918|101547971|FG001|STARTED|Overall Study||109||
48495929|NCT02426918|101547972|FG002|STARTED|Overall Study||111||
48210421|NCT04956575|100840149|FG006|Solicited Safety Set|Overall Study||146|Solicited Safety Set consisted of all participants in the Safety Set who contributed any solicited AR data. Participants were included in the vaccination group corresponding to the study injection they actually received.|
48210422|NCT04956575|100840150|FG007|Solicited Safety Set|Overall Study||145|Solicited Safety Set consisted of all participants in the Safety Set who contributed any solicited AR data. Participants were included in the vaccination group corresponding to the study injection they actually received.|
48210423|NCT04956575|100840151|FG008|Solicited Safety Set|Overall Study||51|Solicited Safety Set consisted of all participants in the Safety Set who contributed any solicited AR data. Participants were included in the vaccination group corresponding to the study injection they actually received.|
48210424|NCT04956575|100840152|FG009|Solicited Safety Set|Overall Study||50|Solicited Safety Set consisted of all participants in the Safety Set who contributed any solicited AR data. Participants were included in the vaccination group corresponding to the study injection they actually received.|
48210425|NCT04956575|100840153|FG010|Solicited Safety Set|Overall Study||50|Solicited Safety Set consisted of all participants in the Safety Set who contributed any solicited AR data. Participants were included in the vaccination group corresponding to the study injection they actually received.|
48210426|NCT04956575|100840154|FG011|Solicited Safety Set|Overall Study||49|Solicited Safety Set consisted of all participants in the Safety Set who contributed any solicited AR data. Participants were included in the vaccination group corresponding to the study injection they actually received.|
48210427|NCT04956575|100840143|FG000|Per-Protocol (PP) Set|Overall Study||41|PP Set consisted of all participants who received the investigational product and who complied with the injection schedule and timing of immunogenicity blood sampling, did not have influenza infection at baseline through Day 29, and had no major protocol deviations that impacted the immune response.|
48210428|NCT04956575|100840144|FG001|Per-Protocol (PP) Set|Overall Study||43|PP Set consisted of all participants who received the investigational product and who complied with the injection schedule and timing of immunogenicity blood sampling, did not have influenza infection at baseline through Day 29, and had no major protocol deviations that impacted the immune response.|
48210429|NCT04956575|100840145|FG002|Per-Protocol (PP) Set|Overall Study||44|PP Set consisted of all participants who received the investigational product and who complied with the injection schedule and timing of immunogenicity blood sampling, did not have influenza infection at baseline through Day 29, and had no major protocol deviations that impacted the immune response.|
48210430|NCT04956575|100840146|FG003|Per-Protocol (PP) Set|Overall Study||41|PP Set consisted of all participants who received the investigational product and who complied with the injection schedule and timing of immunogenicity blood sampling, did not have influenza infection at baseline through Day 29, and had no major protocol deviations that impacted the immune response.|
48210431|NCT04956575|100840147|FG004|Per-Protocol (PP) Set|Overall Study||52|PP Set consisted of all participants who received the investigational product and who complied with the injection schedule and timing of immunogenicity blood sampling, did not have influenza infection at baseline through Day 29, and had no major protocol deviations that impacted the immune response.|
48210432|NCT04956575|100840148|FG005|Per-Protocol (PP) Set|Overall Study||144|PP Set consisted of all participants who received the investigational product and who complied with the injection schedule and timing of immunogenicity blood sampling, did not have influenza infection at baseline through Day 29, and had no major protocol deviations that impacted the immune response.|
48210433|NCT04956575|100840149|FG006|Per-Protocol (PP) Set|Overall Study||138|PP Set consisted of all participants who received the investigational product and who complied with the injection schedule and timing of immunogenicity blood sampling, did not have influenza infection at baseline through Day 29, and had no major protocol deviations that impacted the immune response.|
48210434|NCT04956575|100840150|FG007|Per-Protocol (PP) Set|Overall Study||141|PP Set consisted of all participants who received the investigational product and who complied with the injection schedule and timing of immunogenicity blood sampling, did not have influenza infection at baseline through Day 29, and had no major protocol deviations that impacted the immune response.|
48210435|NCT04956575|100840151|FG008|Per-Protocol (PP) Set|Overall Study||48|PP Set consisted of all participants who received the investigational product and who complied with the injection schedule and timing of immunogenicity blood sampling, did not have influenza infection at baseline through Day 29, and had no major protocol deviations that impacted the immune response.|
48210436|NCT04956575|100840152|FG009|Per-Protocol (PP) Set|Overall Study||49|PP Set consisted of all participants who received the investigational product and who complied with the injection schedule and timing of immunogenicity blood sampling, did not have influenza infection at baseline through Day 29, and had no major protocol deviations that impacted the immune response.|
48210437|NCT04956575|100840153|FG010|Per-Protocol (PP) Set|Overall Study||47|PP Set consisted of all participants who received the investigational product and who complied with the injection schedule and timing of immunogenicity blood sampling, did not have influenza infection at baseline through Day 29, and had no major protocol deviations that impacted the immune response.|
48210438|NCT04956575|100840154|FG011|Per-Protocol (PP) Set|Overall Study||46|PP Set consisted of all participants who received the investigational product and who complied with the injection schedule and timing of immunogenicity blood sampling, did not have influenza infection at baseline through Day 29, and had no major protocol deviations that impacted the immune response.|
48210439|NCT04956575|100840143|FG000|COMPLETED|Overall Study||40|Participants were considered to have completed the study if they completed the final visit on Day 181 (Month 6), 6 months after the investigational product administration on Day 1|
48210440|NCT04956575|100840144|FG001|COMPLETED|Overall Study||39|Participants were considered to have completed the study if they completed the final visit on Day 181 (Month 6), 6 months after the investigational product administration on Day 1|
48210441|NCT04956575|100840145|FG002|COMPLETED|Overall Study||42|Participants were considered to have completed the study if they completed the final visit on Day 181 (Month 6), 6 months after the investigational product administration on Day 1|
48210442|NCT04956575|100840146|FG003|COMPLETED|Overall Study||38|Participants were considered to have completed the study if they completed the final visit on Day 181 (Month 6), 6 months after the investigational product administration on Day 1|
48495930|NCT02426918|101547970|FG000|Safety Population|Overall Study||110||
48210443|NCT04956575|100840147|FG004|COMPLETED|Overall Study||50|Participants were considered to have completed the study if they completed the final visit on Day 181 (Month 6), 6 months after the investigational product administration on Day 1|
48210444|NCT04956575|100840148|FG005|COMPLETED|Overall Study||135|Participants were considered to have completed the study if they completed the final visit on Day 181 (Month 6), 6 months after the investigational product administration on Day 1|
48210445|NCT04956575|100840149|FG006|COMPLETED|Overall Study||133|Participants were considered to have completed the study if they completed the final visit on Day 181 (Month 6), 6 months after the investigational product administration on Day 1|
48210446|NCT04956575|100840150|FG007|COMPLETED|Overall Study||139|Participants were considered to have completed the study if they completed the final visit on Day 181 (Month 6), 6 months after the investigational product administration on Day 1|
48210447|NCT04956575|100840151|FG008|COMPLETED|Overall Study||46|Participants were considered to have completed the study if they completed the final visit on Day 181 (Month 6), 6 months after the investigational product administration on Day 1|
48210448|NCT04956575|100840152|FG009|COMPLETED|Overall Study||47|Participants were considered to have completed the study if they completed the final visit on Day 181 (Month 6), 6 months after the investigational product administration on Day 1|
48210449|NCT04956575|100840153|FG010|COMPLETED|Overall Study||45|Participants were considered to have completed the study if they completed the final visit on Day 181 (Month 6), 6 months after the investigational product administration on Day 1|
48210450|NCT04956575|100840154|FG011|COMPLETED|Overall Study||41|Participants were considered to have completed the study if they completed the final visit on Day 181 (Month 6), 6 months after the investigational product administration on Day 1|
48210451|NCT04956575|100840143|FG000|NOT COMPLETED|Overall Study||5||
48210452|NCT04956575|100840144|FG001|NOT COMPLETED|Overall Study||6||
48210453|NCT04956575|100840145|FG002|NOT COMPLETED|Overall Study||3||
48210454|NCT04956575|100840146|FG003|NOT COMPLETED|Overall Study||7||
48210455|NCT04956575|100840147|FG004|NOT COMPLETED|Overall Study||3||
48210456|NCT04956575|100840148|FG005|NOT COMPLETED|Overall Study||18||
48210457|NCT04956575|100840149|FG006|NOT COMPLETED|Overall Study||16||
48210458|NCT04956575|100840150|FG007|NOT COMPLETED|Overall Study||9||
48210459|NCT04956575|100840151|FG008|NOT COMPLETED|Overall Study||5||
48210460|NCT04956575|100840152|FG009|NOT COMPLETED|Overall Study||3||
48210461|NCT04956575|100840153|FG010|NOT COMPLETED|Overall Study||6||
48210462|NCT04956575|100840154|FG011|NOT COMPLETED|Overall Study||9||
48210463|NCT01000480|100840155|FG000|STARTED|Induction Phase||90||
48210464|NCT01000480|100840155|FG000|Received at Least 1 Dose of Either Drug|Induction Phase||90||
48210465|NCT01000480|100840155|FG000|Death (Any Cause) or Disease Progression|Induction Phase||8||
48210466|NCT01000480|100840155|FG000|COMPLETED|Induction Phase||83||
48210467|NCT01000480|100840155|FG000|NOT COMPLETED|Induction Phase||7||
48210468|NCT01000480|100840155|FG000|STARTED|Concurrent Therapy Phase||75||
48210469|NCT01000480|100840155|FG000|Death (Any Cause) or Disease Progression|Concurrent Therapy Phase||1||
48210470|NCT01000480|100840155|FG000|COMPLETED|Concurrent Therapy Phase||65||
48210471|NCT01000480|100840155|FG000|NOT COMPLETED|Concurrent Therapy Phase||10||
48210472|NCT01000480|100840155|FG000|STARTED|Follow-Up Period||88||
48210473|NCT01000480|100840155|FG000|COMPLETED|Follow-Up Period||88||
48210474|NCT01000480|100840155|FG000|NOT COMPLETED|Follow-Up Period||0||
48210475|NCT00508924|100840156|FG000|STARTED|Overall Study||36||
48210476|NCT00508924|100840157|FG001|STARTED|Overall Study||38||
48210477|NCT00508924|100840158|FG002|STARTED|Overall Study||32||
48210478|NCT00508924|100840159|FG003|STARTED|Overall Study||34||
48210479|NCT00508924|100840156|FG000|COMPLETED|Overall Study||36||
48210480|NCT00508924|100840157|FG001|COMPLETED|Overall Study||38||
48210481|NCT00508924|100840158|FG002|COMPLETED|Overall Study||31||
48210482|NCT00508924|100840159|FG003|COMPLETED|Overall Study||33||
48210483|NCT00508924|100840156|FG000|NOT COMPLETED|Overall Study||0||
48210484|NCT00508924|100840157|FG001|NOT COMPLETED|Overall Study||0||
48210485|NCT00508924|100840158|FG002|NOT COMPLETED|Overall Study||1||
48210486|NCT00508924|100840159|FG003|NOT COMPLETED|Overall Study||1||
48210487|NCT01149369|100840160|FG000|STARTED|Overall Study||63||
48210488|NCT01149369|100840161|FG001|STARTED|Overall Study||63||
48210489|NCT01149369|100840160|FG000|COMPLETED|Overall Study||57||
48210490|NCT01149369|100840161|FG001|COMPLETED|Overall Study||60||
48210491|NCT01149369|100840160|FG000|NOT COMPLETED|Overall Study||6||
48210492|NCT01149369|100840161|FG001|NOT COMPLETED|Overall Study||3||
48210493|NCT01062126|100840162|FG000|STARTED|Overall Study||3389||
48210494|NCT01062126|100840162|FG000|COMPLETED|Overall Study||2856||
48210495|NCT01062126|100840162|FG000|NOT COMPLETED|Overall Study||533||
48210496|NCT04112069|100840163|FG000|STARTED|Overall Study||10||
48210497|NCT04112069|100840164|FG001|STARTED|Overall Study||10||
48210498|NCT04112069|100840163|FG000|COMPLETED|Overall Study||10||
48210499|NCT04112069|100840164|FG001|COMPLETED|Overall Study||10||
48210500|NCT04112069|100840163|FG000|NOT COMPLETED|Overall Study||0||
48210501|NCT04112069|100840164|FG001|NOT COMPLETED|Overall Study||0||
48210502|NCT01415349|100840165|FG000|STARTED|Treatment Period 1||21||
48210503|NCT01415349|100840166|FG001|STARTED|Treatment Period 1||21||
48210504|NCT01415349|100840165|FG000|COMPLETED|Treatment Period 1||21||
48210505|NCT01415349|100840166|FG001|COMPLETED|Treatment Period 1||19||
48210506|NCT01415349|100840165|FG000|NOT COMPLETED|Treatment Period 1||0||
48210507|NCT01415349|100840166|FG001|NOT COMPLETED|Treatment Period 1||2||
48210508|NCT01415349|100840165|FG000|STARTED|Treatment Period 2||21||
48210509|NCT01415349|100840166|FG001|STARTED|Treatment Period 2||19||
48210510|NCT01415349|100840165|FG000|COMPLETED|Treatment Period 2||21||
48210511|NCT01415349|100840166|FG001|COMPLETED|Treatment Period 2||19||
48210512|NCT01415349|100840165|FG000|NOT COMPLETED|Treatment Period 2||0||
48210513|NCT01415349|100840166|FG001|NOT COMPLETED|Treatment Period 2||0||
48210514|NCT00739141|100840167|FG000|STARTED|Overall Study||86||
48210515|NCT00739141|100840167|FG000|COMPLETED|Overall Study||81||
48210516|NCT00739141|100840167|FG000|NOT COMPLETED|Overall Study||5||
48210517|NCT00738023|100840168|FG000|STARTED|Intralipid Infusion||19||
48210518|NCT00738023|100840169|FG001|STARTED|Intralipid Infusion||13||
48210519|NCT00738023|100840168|FG000|COMPLETED|Intralipid Infusion||19||
48210520|NCT00738023|100840169|FG001|COMPLETED|Intralipid Infusion||13||
48210521|NCT00738023|100840168|FG000|NOT COMPLETED|Intralipid Infusion||0||
48210522|NCT00738023|100840169|FG001|NOT COMPLETED|Intralipid Infusion||0||
48210523|NCT00738023|100840168|FG000|STARTED|Saline Infusion||19||
48210524|NCT00738023|100840169|FG001|STARTED|Saline Infusion||0||
48210525|NCT00738023|100840168|FG000|COMPLETED|Saline Infusion||19||
48210526|NCT00738023|100840169|FG001|COMPLETED|Saline Infusion||0||
48210527|NCT00738023|100840168|FG000|NOT COMPLETED|Saline Infusion||0||
48210528|NCT00738023|100840169|FG001|NOT COMPLETED|Saline Infusion||0||
48210529|NCT00738023|100840168|FG000|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||19||
48210530|NCT00738023|100840169|FG001|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||0||
48210531|NCT00738023|100840168|FG000|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||19||
48210532|NCT00738023|100840169|FG001|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0||
48210533|NCT00738023|100840168|FG000|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0||
48210534|NCT00738023|100840169|FG001|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0||
48210535|NCT01215344|100840170|FG000|STARTED|Overall Study||33||
48210536|NCT01215344|100840171|FG001|STARTED|Overall Study||3||
48210537|NCT01215344|100840170|FG000|COMPLETED|Overall Study||23||
48210538|NCT01215344|100840171|FG001|COMPLETED|Overall Study||3||
48210539|NCT01215344|100840170|FG000|NOT COMPLETED|Overall Study||10||
48210540|NCT01215344|100840171|FG001|NOT COMPLETED|Overall Study||0||
48210541|NCT01937507|100840172|FG000|STARTED|Overall Study||2||
48210542|NCT01937507|100840172|FG000|COMPLETED|Overall Study||0||
48210543|NCT01937507|100840172|FG000|NOT COMPLETED|Overall Study||2||
48210544|NCT02541565|100842541|FG000|STARTED|Overall Study||30||
48210545|NCT02541565|100842541|FG000|COMPLETED|Overall Study||27||
48210546|NCT02541565|100842541|FG000|NOT COMPLETED|Overall Study||3||
48210547|NCT03320434|100842542|FG000|STARTED|Overall Study||32||
48210548|NCT03320434|100842543|FG001|STARTED|Overall Study||29||
48210549|NCT03320434|100842544|FG002|STARTED|Overall Study||30||
48210550|NCT03320434|100842545|FG003|STARTED|Overall Study||29||
48210551|NCT03320434|100842542|FG000|COMPLETED|Overall Study||25||
48210552|NCT03320434|100842543|FG001|COMPLETED|Overall Study||23||
48210553|NCT03320434|100842544|FG002|COMPLETED|Overall Study||28||
48210554|NCT03320434|100842545|FG003|COMPLETED|Overall Study||23||
48210555|NCT03320434|100842542|FG000|NOT COMPLETED|Overall Study||7||
48210556|NCT03320434|100842543|FG001|NOT COMPLETED|Overall Study||6||
48210557|NCT03320434|100842544|FG002|NOT COMPLETED|Overall Study||2||
48210558|NCT03320434|100842545|FG003|NOT COMPLETED|Overall Study||6||
48210559|NCT02751580|100842546|FG000|STARTED|Overall Study||37||
48210560|NCT02751580|100842546|FG000|COMPLETED|Overall Study||31||
48210561|NCT02751580|100842546|FG000|NOT COMPLETED|Overall Study||6||
48210562|NCT02155010|100842547|FG000|STARTED|Overall Study||37||
48495931|NCT02426918|101547971|FG001|Safety Population|Overall Study||107||
48495932|NCT02426918|101547972|FG002|Safety Population|Overall Study||107||
48210563|NCT02155010|100842548|FG001|STARTED|Overall Study||37||
48210564|NCT02155010|100842547|FG000|COMPLETED|Overall Study||31||
48210565|NCT02155010|100842548|FG001|COMPLETED|Overall Study||31||
48210566|NCT02155010|100842547|FG000|NOT COMPLETED|Overall Study||6||
48210567|NCT02155010|100842548|FG001|NOT COMPLETED|Overall Study||6||
48210568|NCT02336438|100842549|FG000|STARTED|Overall Study||11||
48210569|NCT02336438|100842549|FG000|COMPLETED|Overall Study||10||
48210570|NCT02336438|100842549|FG000|NOT COMPLETED|Overall Study||1||
48210571|NCT01319617|100842550|FG000|STARTED|Overall Study||41||
48210572|NCT01319617|100842550|FG000|COMPLETED|Overall Study||40||
48210573|NCT01319617|100842550|FG000|NOT COMPLETED|Overall Study||1||
48210574|NCT02217904|100842551|FG000|STARTED|Overall Study||6||
48210575|NCT02217904|100842552|FG001|STARTED|Overall Study||6||
48210576|NCT02217904|100842553|FG002|STARTED|Overall Study||6||
48210577|NCT02217904|100842554|FG003|STARTED|Overall Study||6||
48210578|NCT02217904|100842555|FG004|STARTED|Overall Study||6||
48210579|NCT02217904|100842556|FG005|STARTED|Overall Study||0||
48210580|NCT02217904|100842557|FG006|STARTED|Overall Study||0||
48210581|NCT02217904|100842551|FG000|COMPLETED|Overall Study||6||
48210582|NCT02217904|100842552|FG001|COMPLETED|Overall Study||6||
48210583|NCT02217904|100842553|FG002|COMPLETED|Overall Study||6||
48210584|NCT02217904|100842554|FG003|COMPLETED|Overall Study||6||
48210585|NCT02217904|100842555|FG004|COMPLETED|Overall Study||6||
48210586|NCT02217904|100842556|FG005|COMPLETED|Overall Study||0||
48210587|NCT02217904|100842557|FG006|COMPLETED|Overall Study||0||
48210588|NCT02217904|100842551|FG000|NOT COMPLETED|Overall Study||0||
48210589|NCT02217904|100842552|FG001|NOT COMPLETED|Overall Study||0||
48210590|NCT02217904|100842553|FG002|NOT COMPLETED|Overall Study||0||
48210591|NCT02217904|100842554|FG003|NOT COMPLETED|Overall Study||0||
48210592|NCT02217904|100842555|FG004|NOT COMPLETED|Overall Study||0||
48210593|NCT02217904|100842556|FG005|NOT COMPLETED|Overall Study||0||
48210594|NCT02217904|100842557|FG006|NOT COMPLETED|Overall Study||0||
48210595|NCT00414544|100842558|FG000|STARTED|Overall Study||145||
48210596|NCT00414544|100842558|FG000|COMPLETED|Overall Study||131||
48210597|NCT00414544|100842558|FG000|NOT COMPLETED|Overall Study||14||
48210598|NCT04987021|100842559|FG000|STARTED|Overall Study||15||
48210599|NCT04987021|100842559|FG000|COMPLETED|Overall Study||15||
48210600|NCT04987021|100842559|FG000|NOT COMPLETED|Overall Study||0||
48210601|NCT02918279|100842560|FG000|STARTED|Overall Study||125||
48210602|NCT02918279|100842561|FG001|STARTED|Overall Study||126||
48210603|NCT02918279|100842560|FG000|Full Analysis Set|Overall Study||125||
48210604|NCT02918279|100842561|FG001|Full Analysis Set|Overall Study||126||
48210605|NCT02918279|100842560|FG000|Safety Analysis Set|Overall Study||125||
48210606|NCT02918279|100842561|FG001|Safety Analysis Set|Overall Study||126||
48210607|NCT02918279|100842560|FG000|COMPLETED|Overall Study||112||
48210608|NCT02918279|100842561|FG001|COMPLETED|Overall Study||103||
48210609|NCT02918279|100842560|FG000|NOT COMPLETED|Overall Study||13||
48210610|NCT02918279|100842561|FG001|NOT COMPLETED|Overall Study||23||
48210611|NCT03684044|100842562|FG000|STARTED|Overall Study||239||
48210612|NCT03684044|100842563|FG001|STARTED|Overall Study||124||
48210613|NCT03684044|100842562|FG000|COMPLETED|Overall Study||217||
48210614|NCT03684044|100842563|FG001|COMPLETED|Overall Study||104||
48210615|NCT03684044|100842562|FG000|NOT COMPLETED|Overall Study||22||
48210616|NCT03684044|100842563|FG001|NOT COMPLETED|Overall Study||20||
48210617|NCT01337635|100842564|FG000|STARTED|Overall Study||3||
48210618|NCT01337635|100842565|FG001|STARTED|Overall Study||4||
48210619|NCT01337635|100842564|FG000|COMPLETED|Overall Study||3||
48210620|NCT01337635|100842565|FG001|COMPLETED|Overall Study||3||
48210621|NCT01337635|100842564|FG000|NOT COMPLETED|Overall Study||0||
48210622|NCT01337635|100842565|FG001|NOT COMPLETED|Overall Study||1||
48210623|NCT04788641|100842566|FG000|STARTED|Treatment Period 1 (4 Days)||16||
48210624|NCT04788641|100842567|FG001|STARTED|Treatment Period 1 (4 Days)||15||
48210625|NCT04788641|100842568|FG002|STARTED|Treatment Period 1 (4 Days)||16||
48210626|NCT04788641|100842569|FG003|STARTED|Treatment Period 1 (4 Days)||15||
48210627|NCT04788641|100842566|FG000|COMPLETED|Treatment Period 1 (4 Days)||16||
48210628|NCT04788641|100842567|FG001|COMPLETED|Treatment Period 1 (4 Days)||15||
48210629|NCT04788641|100842568|FG002|COMPLETED|Treatment Period 1 (4 Days)||16||
48210630|NCT04788641|100842569|FG003|COMPLETED|Treatment Period 1 (4 Days)||15||
48210631|NCT04788641|100842566|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
48210632|NCT04788641|100842567|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
48210633|NCT04788641|100842568|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
48210634|NCT04788641|100842569|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
48210635|NCT04788641|100842566|FG000|STARTED|Washout Period (14 Days)||16||
48210636|NCT04788641|100842567|FG001|STARTED|Washout Period (14 Days)||15||
48210637|NCT04788641|100842568|FG002|STARTED|Washout Period (14 Days)||16||
48210638|NCT04788641|100842569|FG003|STARTED|Washout Period (14 Days)||15||
48210639|NCT04788641|100842566|FG000|COMPLETED|Washout Period (14 Days)||16||
48210640|NCT04788641|100842567|FG001|COMPLETED|Washout Period (14 Days)||15||
48210641|NCT04788641|100842568|FG002|COMPLETED|Washout Period (14 Days)||16||
48210642|NCT04788641|100842569|FG003|COMPLETED|Washout Period (14 Days)||15||
48210643|NCT04788641|100842566|FG000|NOT COMPLETED|Washout Period (14 Days)||0||
48210644|NCT04788641|100842567|FG001|NOT COMPLETED|Washout Period (14 Days)||0||
48210645|NCT04788641|100842568|FG002|NOT COMPLETED|Washout Period (14 Days)||0||
48210646|NCT04788641|100842569|FG003|NOT COMPLETED|Washout Period (14 Days)||0||
48210647|NCT04788641|100842566|FG000|STARTED|Treatment Period 2 (4 Days)||16||
48210648|NCT04788641|100842567|FG001|STARTED|Treatment Period 2 (4 Days)||15||
48210649|NCT04788641|100842568|FG002|STARTED|Treatment Period 2 (4 Days)||16||
48210650|NCT04788641|100842569|FG003|STARTED|Treatment Period 2 (4 Days)||15||
48210651|NCT04788641|100842566|FG000|COMPLETED|Treatment Period 2 (4 Days)||15||
48210652|NCT04788641|100842567|FG001|COMPLETED|Treatment Period 2 (4 Days)||15||
48210653|NCT04788641|100842568|FG002|COMPLETED|Treatment Period 2 (4 Days)||14||
48210654|NCT04788641|100842569|FG003|COMPLETED|Treatment Period 2 (4 Days)||15||
48210655|NCT04788641|100842566|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||1||
48210656|NCT04788641|100842567|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
48210657|NCT04788641|100842568|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||2||
48210658|NCT04788641|100842569|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
48210659|NCT00539734|100842570|FG000|STARTED|Overall Study||26||
48210660|NCT00539734|100842570|FG000|COMPLETED|Overall Study||25||
48210661|NCT00539734|100842570|FG000|NOT COMPLETED|Overall Study||1||
48210662|NCT01063972|100842571|FG000|STARTED|Overall Study||310||
48210663|NCT01063972|100842572|FG001|STARTED|Overall Study||296||
48210664|NCT01063972|100842571|FG000|COMPLETED|Overall Study||296||
48210665|NCT01063972|100842572|FG001|COMPLETED|Overall Study||284||
48210666|NCT01063972|100842571|FG000|NOT COMPLETED|Overall Study||14||
48210667|NCT01063972|100842572|FG001|NOT COMPLETED|Overall Study||12||
48210668|NCT00589667|100842573|FG000|STARTED|Overall Study||26||
48210669|NCT00589667|100842573|FG000|COMPLETED|Overall Study||23||
48210670|NCT00589667|100842573|FG000|NOT COMPLETED|Overall Study||3||
48210671|NCT00265200|100842574|FG000|STARTED|Overall Study||28||
48210672|NCT00265200|100842574|FG000|COMPLETED|Overall Study||24||
48210673|NCT00265200|100842574|FG000|NOT COMPLETED|Overall Study||4||
48210674|NCT00955825|100842575|FG000|STARTED|Overall Study||233||
48210675|NCT00955825|100842576|FG001|STARTED|Overall Study||240||
48210676|NCT00955825|100842575|FG000|COMPLETED|Overall Study||207||
48210677|NCT00955825|100842576|FG001|COMPLETED|Overall Study||223||
48210678|NCT00955825|100842575|FG000|NOT COMPLETED|Overall Study||26||
48210679|NCT00955825|100842576|FG001|NOT COMPLETED|Overall Study||17||
48210680|NCT04530747|100842577|FG000|STARTED|Overall Study||8||
48210681|NCT04530747|100842578|FG001|STARTED|Overall Study||8||
48210682|NCT04530747|100842577|FG000|COMPLETED|Overall Study||7||
48210683|NCT04530747|100842578|FG001|COMPLETED|Overall Study||8||
48210684|NCT04530747|100842577|FG000|NOT COMPLETED|Overall Study||1||
48210685|NCT04530747|100842578|FG001|NOT COMPLETED|Overall Study||0||
48210686|NCT02318134|100842579|FG000|STARTED|Overall Study||30||
48210687|NCT02318134|100842580|FG001|STARTED|Overall Study||30||
48210688|NCT02318134|100842579|FG000|COMPLETED|Overall Study||28||
48210689|NCT02318134|100842580|FG001|COMPLETED|Overall Study||29||
48210690|NCT02318134|100842579|FG000|NOT COMPLETED|Overall Study||2||
48210691|NCT02318134|100842580|FG001|NOT COMPLETED|Overall Study||1||
48210692|NCT00941655|100842581|FG000|STARTED|Overall Study||8||
48210693|NCT00941655|100842582|FG001|STARTED|Overall Study||7||
48210694|NCT00941655|100842581|FG000|COMPLETED|Overall Study||3||
48210695|NCT00941655|100842582|FG001|COMPLETED|Overall Study||2||
48210696|NCT00941655|100842581|FG000|NOT COMPLETED|Overall Study||5||
48210697|NCT00941655|100842582|FG001|NOT COMPLETED|Overall Study||5||
48210698|NCT01542229|100842583|FG000|STARTED|Overall Study||68||
48210699|NCT01542229|100842584|FG001|STARTED|Overall Study||66||
48210700|NCT01542229|100842583|FG000|COMPLETED|Overall Study||45||
48210701|NCT01542229|100842584|FG001|COMPLETED|Overall Study||30||
48210702|NCT01542229|100842583|FG000|NOT COMPLETED|Overall Study||23||
48210703|NCT01542229|100842584|FG001|NOT COMPLETED|Overall Study||36||
48210704|NCT00520546|100842585|FG000|STARTED|Overall Study||44||
48210705|NCT00520546|100842585|FG000|COMPLETED|Overall Study||38||
48210706|NCT00520546|100842585|FG000|NOT COMPLETED|Overall Study||6||
48210707|NCT00535145|100842586|FG000|STARTED|Phase I||114||
48210708|NCT00535145|100842586|FG000|COMPLETED|Phase I||85||
48210709|NCT00535145|100842586|FG000|NOT COMPLETED|Phase I||29||
48210710|NCT00535145|100842586|FG000|STARTED|Phase II||84||
48210711|NCT00535145|100842586|FG000|COMPLETED|Phase II||69||
48210712|NCT00535145|100842586|FG000|NOT COMPLETED|Phase II||15||
48210713|NCT00001277|100842587|FG000|STARTED|Overall Study||634||
48210714|NCT00001277|100842588|FG001|STARTED|Overall Study||900||
48210715|NCT00001277|100842589|FG002|STARTED|Overall Study||19||
48210716|NCT00001277|100842587|FG000|COMPLETED|Overall Study||634||
48210717|NCT00001277|100842588|FG001|COMPLETED|Overall Study||900||
48210718|NCT00001277|100842589|FG002|COMPLETED|Overall Study||16||
48210719|NCT00001277|100842587|FG000|NOT COMPLETED|Overall Study||0||
48210720|NCT00001277|100842588|FG001|NOT COMPLETED|Overall Study||0||
48210721|NCT00001277|100842589|FG002|NOT COMPLETED|Overall Study||3||
48210722|NCT05082935|100842590|FG000|STARTED|Overall Study||1463||
48210723|NCT05082935|100842591|FG001|STARTED|Overall Study||1623||
48210724|NCT05082935|100842590|FG000|COMPLETED|Overall Study||887||
48210725|NCT05082935|100842591|FG001|COMPLETED|Overall Study||934||
48210726|NCT05082935|100842590|FG000|NOT COMPLETED|Overall Study||576||
48210727|NCT05082935|100842591|FG001|NOT COMPLETED|Overall Study||689||
48210728|NCT01044303|100842592|FG000|STARTED|Overall Study||32||
48210729|NCT01044303|100842592|FG000|COMPLETED|Overall Study||30||
48210730|NCT01044303|100842592|FG000|NOT COMPLETED|Overall Study||2||
48210731|NCT02544152|100842593|FG000|STARTED|Overall Study||34||
48210732|NCT02544152|100842594|FG001|STARTED|Overall Study||37||
48210733|NCT02544152|100842593|FG000|Modified Intent to Treat (mITT)|Overall Study||34||
48210734|NCT02544152|100842594|FG001|Modified Intent to Treat (mITT)|Overall Study||37||
48210735|NCT02544152|100842593|FG000|Safety Analysis Set (SAS)|Overall Study||34||
48210736|NCT02544152|100842594|FG001|Safety Analysis Set (SAS)|Overall Study||37||
48210737|NCT02544152|100842593|FG000|COMPLETED|Overall Study||33||
48210738|NCT02544152|100842594|FG001|COMPLETED|Overall Study||30||
48210739|NCT02544152|100842593|FG000|NOT COMPLETED|Overall Study||1||
48210740|NCT02544152|100842594|FG001|NOT COMPLETED|Overall Study||7||
48210741|NCT00701896|100842595|FG000|STARTED|Overall Study||143||
48210742|NCT00701896|100842596|FG001|STARTED|Overall Study||151||
48210743|NCT00701896|100842595|FG000|COMPLETED|Overall Study||110||
48210744|NCT00701896|100842596|FG001|COMPLETED|Overall Study||118||
48210745|NCT00701896|100842595|FG000|NOT COMPLETED|Overall Study||33||
48210746|NCT00701896|100842596|FG001|NOT COMPLETED|Overall Study||33||
48210747|NCT02601170|100842597|FG000|STARTED|Overall Study||11||
48210748|NCT02601170|100842598|FG001|STARTED|Overall Study||11||
48210749|NCT02601170|100842597|FG000|COMPLETED|Overall Study||11||
48210750|NCT02601170|100842598|FG001|COMPLETED|Overall Study||11||
48210751|NCT02601170|100842597|FG000|NOT COMPLETED|Overall Study||0||
48210752|NCT02601170|100842598|FG001|NOT COMPLETED|Overall Study||0||
48210753|NCT00376363|100842599|FG000|STARTED|Overall Study||143||
48210754|NCT00376363|100842600|FG001|STARTED|Overall Study||133||
48210755|NCT00376363|100842599|FG000|COMPLETED|Overall Study||87||
48210756|NCT00376363|100842600|FG001|COMPLETED|Overall Study||87||
48210757|NCT00376363|100842599|FG000|NOT COMPLETED|Overall Study||56||
48210758|NCT00376363|100842600|FG001|NOT COMPLETED|Overall Study||46||
48210759|NCT02015546|100842601|FG000|STARTED|Overall Study||23||
48210760|NCT02015546|100842602|FG001|STARTED|Overall Study||21||
48210761|NCT02015546|100842603|FG002|STARTED|Overall Study||26||
48210762|NCT02015546|100842601|FG000|COMPLETED|Overall Study||20||
48210763|NCT02015546|100842602|FG001|COMPLETED|Overall Study||19||
48210764|NCT02015546|100842603|FG002|COMPLETED|Overall Study||22||
48210765|NCT02015546|100842601|FG000|NOT COMPLETED|Overall Study||3||
48210766|NCT02015546|100842602|FG001|NOT COMPLETED|Overall Study||2||
48210767|NCT02015546|100842603|FG002|NOT COMPLETED|Overall Study||4||
48210768|NCT02933944|100842604|FG000|STARTED|Overall Study||6||
48210769|NCT02933944|100842604|FG000|COMPLETED|Overall Study||6||
48210770|NCT02933944|100842604|FG000|NOT COMPLETED|Overall Study||0||
48210771|NCT02178098|100842605|FG000|STARTED|Overall Study||72||
48210772|NCT02178098|100842606|FG001|STARTED|Overall Study||71||
48210773|NCT02178098|100842605|FG000|COMPLETED|Overall Study||67||
48210774|NCT02178098|100842606|FG001|COMPLETED|Overall Study||59||
48210775|NCT02178098|100842605|FG000|NOT COMPLETED|Overall Study||5||
48210776|NCT02178098|100842606|FG001|NOT COMPLETED|Overall Study||12||
48210777|NCT02539225|100842607|FG000|STARTED|Part A||97||
48210778|NCT02539225|100842608|FG001|STARTED|Part A||94||
48210779|NCT02539225|100842607|FG000|Received Any Quantity of Study Drug|Part A||96||
48210780|NCT02539225|100842608|FG001|Received Any Quantity of Study Drug|Part A||93||
48210781|NCT02539225|100842607|FG000|COMPLETED|Part A||77||
48210782|NCT02539225|100842608|FG001|COMPLETED|Part A||78||
48210783|NCT02539225|100842607|FG000|NOT COMPLETED|Part A||20||
48210784|NCT02539225|100842608|FG001|NOT COMPLETED|Part A||16||
48210785|NCT02539225|100842607|FG000|STARTED|Pre Treatment for Part B||63||
48210786|NCT02539225|100842608|FG001|STARTED|Pre Treatment for Part B||66||
48210787|NCT02539225|100842607|FG000|COMPLETED|Pre Treatment for Part B||58||
48210788|NCT02539225|100842608|FG001|COMPLETED|Pre Treatment for Part B||64||
48210789|NCT02539225|100842607|FG000|NOT COMPLETED|Pre Treatment for Part B||5||
48210790|NCT02539225|100842608|FG001|NOT COMPLETED|Pre Treatment for Part B||2||
48210791|NCT02539225|100842607|FG000|STARTED|Part B||58||
48210792|NCT02539225|100842608|FG001|STARTED|Part B||64||
48210793|NCT02539225|100842607|FG000|COMPLETED|Part B||54||
48210794|NCT02539225|100842608|FG001|COMPLETED|Part B||48||
48210795|NCT02539225|100842607|FG000|NOT COMPLETED|Part B||4||
48210796|NCT02539225|100842608|FG001|NOT COMPLETED|Part B||16||
48210797|NCT00785512|100842609|FG000|STARTED|Overall Study||102||
48210798|NCT00785512|100842610|FG001|STARTED|Overall Study||105||
48210799|NCT00785512|100842609|FG000|COMPLETED|Overall Study||99||
48210800|NCT00785512|100842610|FG001|COMPLETED|Overall Study||101||
48210801|NCT00785512|100842609|FG000|NOT COMPLETED|Overall Study||3||
48210802|NCT00785512|100842610|FG001|NOT COMPLETED|Overall Study||4||
48210803|NCT03887650|100842611|FG000|STARTED|Preoperative-48 Hours Postoperative||45||
48210804|NCT03887650|100842612|FG001|STARTED|Preoperative-48 Hours Postoperative||45||
48210805|NCT03887650|100842611|FG000|COMPLETED|Preoperative-48 Hours Postoperative||45||
48210806|NCT03887650|100842612|FG001|COMPLETED|Preoperative-48 Hours Postoperative||44||
48210807|NCT03887650|100842611|FG000|NOT COMPLETED|Preoperative-48 Hours Postoperative||0||
48210808|NCT03887650|100842612|FG001|NOT COMPLETED|Preoperative-48 Hours Postoperative||1||
48210809|NCT03887650|100842611|FG000|STARTED|48-96 Hours Postoperative||45||
48210810|NCT03887650|100842612|FG001|STARTED|48-96 Hours Postoperative||44||
48210811|NCT03887650|100842611|FG000|COMPLETED|48-96 Hours Postoperative||45||
48210812|NCT03887650|100842612|FG001|COMPLETED|48-96 Hours Postoperative||42||
48210813|NCT03887650|100842611|FG000|NOT COMPLETED|48-96 Hours Postoperative||0||
48210814|NCT03887650|100842612|FG001|NOT COMPLETED|48-96 Hours Postoperative||2||
48210815|NCT03887650|100842611|FG000|STARTED|60 Postoperative Days||45||
48210816|NCT03887650|100842612|FG001|STARTED|60 Postoperative Days||42||
48210817|NCT03887650|100842611|FG000|COMPLETED|60 Postoperative Days||44||
48210818|NCT03887650|100842612|FG001|COMPLETED|60 Postoperative Days||42||
48210819|NCT03887650|100842611|FG000|NOT COMPLETED|60 Postoperative Days||1||
48210820|NCT03887650|100842612|FG001|NOT COMPLETED|60 Postoperative Days||0||
48210821|NCT00085436|100842613|FG000|STARTED|Overall Study||18||
48210822|NCT00085436|100842613|FG000|COMPLETED|Overall Study||18||
48210823|NCT00085436|100842613|FG000|NOT COMPLETED|Overall Study||0||
48210824|NCT00150176|100842614|FG000|STARTED|Overall Study||194||
48210825|NCT00150176|100842615|FG001|STARTED|Overall Study||192||
48210826|NCT00150176|100842614|FG000|COMPLETED|Overall Study||135||
48210827|NCT00150176|100842615|FG001|COMPLETED|Overall Study||72||
48210828|NCT00150176|100842614|FG000|NOT COMPLETED|Overall Study||59||
48210829|NCT00150176|100842615|FG001|NOT COMPLETED|Overall Study||120||
48210830|NCT03454529|100842616|FG000|STARTED|Overall Study||24||
48210831|NCT03454529|100842616|FG000|COMPLETED|Overall Study||17||
48210832|NCT03454529|100842616|FG000|NOT COMPLETED|Overall Study||7||
48210833|NCT03687892|100842617|FG000|STARTED|Overall Study||37||
48210834|NCT03687892|100842617|FG000|COMPLETED|Overall Study||0||
48210835|NCT03687892|100842617|FG000|NOT COMPLETED|Overall Study||37||
48210836|NCT01460446|100842618|FG000|STARTED|Overall Study||105||
48210837|NCT01460446|100842619|FG001|STARTED|Overall Study||113||
48210838|NCT01460446|100842618|FG000|COMPLETED|Overall Study||100||
48210839|NCT01460446|100842619|FG001|COMPLETED|Overall Study||93||
48210840|NCT01460446|100842618|FG000|NOT COMPLETED|Overall Study||5||
48210841|NCT01460446|100842619|FG001|NOT COMPLETED|Overall Study||20||
48210842|NCT05330234|100842620|FG000|STARTED|Overall Study||10||
48210843|NCT05330234|100842620|FG000|Phase 1|Overall Study||10||
48210844|NCT05330234|100842620|FG000|Phase 2|Overall Study||9||
48210845|NCT05330234|100842620|FG000|Phase 3|Overall Study||6||
48210846|NCT05330234|100842620|FG000|COMPLETED|Overall Study||6||
48210847|NCT05330234|100842620|FG000|NOT COMPLETED|Overall Study||4||
48210848|NCT03703336|100842621|FG000|STARTED|Overall Study||552||
48210849|NCT03703336|100842622|FG001|STARTED|Overall Study||273||
48210850|NCT03703336|100842621|FG000|Received Dose 1|Overall Study||552||
48210851|NCT03703336|100842622|FG001|Received Dose 1|Overall Study||273||
48210852|NCT03703336|100842621|FG000|Received Dose 2|Overall Study||518||
48210853|NCT03703336|100842622|FG001|Received Dose 2|Overall Study||263||
48210854|NCT03703336|100842621|FG000|Safety Population|Overall Study||551|The safety population was defined as all participants in the enrolled population who received a study vaccination. One participant was randomized to ROTAVIN but instead received ROTAVIN-M1 and was therefore analyzed in ROTAVIN-M1 group for safety population based on the actual treatment received.|
48210855|NCT03703336|100842622|FG001|Safety Population|Overall Study||274|The safety population was defined as all participants in the enrolled population who received a study vaccination. One participant was randomized to ROTAVIN but instead received ROTAVIN-M1 and was therefore analyzed in ROTAVIN-M1 group for safety population based on the actual treatment received.|
48210856|NCT03703336|100842621|FG000|COMPLETED|Overall Study||514||
48210857|NCT03703336|100842622|FG001|COMPLETED|Overall Study||259||
48210858|NCT03703336|100842621|FG000|NOT COMPLETED|Overall Study||38||
48210859|NCT03703336|100842622|FG001|NOT COMPLETED|Overall Study||14||
48210860|NCT04676334|100842623|FG000|STARTED|Overall Study||20||
48210861|NCT04676334|100842624|FG001|STARTED|Overall Study||14||
48210862|NCT04676334|100842623|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20||
48210863|NCT04676334|100842624|FG001|Received at Least 1 Dose of Study Drug|Overall Study||0||
48210864|NCT04676334|100842623|FG000|COMPLETED|Overall Study||20||
48210865|NCT04676334|100842624|FG001|COMPLETED|Overall Study||14||
48210866|NCT04676334|100842623|FG000|NOT COMPLETED|Overall Study||0||
48210867|NCT04676334|100842624|FG001|NOT COMPLETED|Overall Study||0||
48210868|NCT03639558|100842625|FG000|STARTED|Overall Study||52||
48210869|NCT03639558|100842626|FG001|STARTED|Overall Study||48||
48210870|NCT03639558|100842625|FG000|COMPLETED|Overall Study||51||
48210871|NCT03639558|100842626|FG001|COMPLETED|Overall Study||43||
48210872|NCT03639558|100842625|FG000|NOT COMPLETED|Overall Study||1||
48210873|NCT03639558|100842626|FG001|NOT COMPLETED|Overall Study||5||
48210874|NCT00002842|100842627|FG000|STARTED|Overall Study||49||
48210875|NCT00002842|100842627|FG000|COMPLETED|Overall Study||22||
48210876|NCT00002842|100842627|FG000|NOT COMPLETED|Overall Study||27||
48210877|NCT01625013|100842628|FG000|STARTED|Overall Study||51||
48210878|NCT01625013|100842628|FG000|COMPLETED|Overall Study||48||
48210879|NCT01625013|100842628|FG000|NOT COMPLETED|Overall Study||3||
48210880|NCT02014129|100842629|FG000|STARTED|Overall Study||3||
48210881|NCT02014129|100842630|FG001|STARTED|Overall Study||3||
48210882|NCT02014129|100842631|FG002|STARTED|Overall Study||6||
48210883|NCT02014129|100842629|FG000|Received at Least One Dose of Study Drug|Overall Study||3||
48210884|NCT02014129|100842630|FG001|Received at Least One Dose of Study Drug|Overall Study||3||
48210885|NCT02014129|100842631|FG002|Received at Least One Dose of Study Drug|Overall Study||6||
48210886|NCT02014129|100842629|FG000|COMPLETED|Overall Study||3||
48210887|NCT02014129|100842630|FG001|COMPLETED|Overall Study||3||
48210888|NCT02014129|100842631|FG002|COMPLETED|Overall Study||6||
48210889|NCT02014129|100842629|FG000|NOT COMPLETED|Overall Study||0||
48210890|NCT02014129|100842630|FG001|NOT COMPLETED|Overall Study||0||
48210891|NCT02014129|100842631|FG002|NOT COMPLETED|Overall Study||0||
48210892|NCT02383472|100842632|FG000|STARTED|Overall Study||23||
48210893|NCT02383472|100842633|FG001|STARTED|Overall Study||30||
48210894|NCT02383472|100842632|FG000|COMPLETED|Overall Study||22||
48210895|NCT02383472|100842633|FG001|COMPLETED|Overall Study||29||
48210896|NCT02383472|100842632|FG000|NOT COMPLETED|Overall Study||1||
48210897|NCT02383472|100842633|FG001|NOT COMPLETED|Overall Study||1||
48210898|NCT01061671|100842634|FG000|STARTED|Overall Study||433||
48210899|NCT01061671|100842635|FG001|STARTED|Overall Study||452||
48210900|NCT01061671|100842634|FG000|COMPLETED|Overall Study||386||
48210901|NCT01061671|100842635|FG001|COMPLETED|Overall Study||397||
48210902|NCT01061671|100842634|FG000|NOT COMPLETED|Overall Study||47||
48210903|NCT01061671|100842635|FG001|NOT COMPLETED|Overall Study||55||
48210904|NCT01068743|100842636|FG000|STARTED|Period 1||6||
48210905|NCT01068743|100842637|FG001|STARTED|Period 1||6||
48210906|NCT01068743|100842638|FG002|STARTED|Period 1||6||
48210907|NCT01068743|100842639|FG003|STARTED|Period 1||6||
48210908|NCT01068743|100842636|FG000|COMPLETED|Period 1||6||
48210909|NCT01068743|100842637|FG001|COMPLETED|Period 1||6||
48210910|NCT01068743|100842638|FG002|COMPLETED|Period 1||6||
48210911|NCT01068743|100842639|FG003|COMPLETED|Period 1||6||
48210912|NCT01068743|100842636|FG000|NOT COMPLETED|Period 1||0||
48210913|NCT01068743|100842637|FG001|NOT COMPLETED|Period 1||0||
48059647|NCT04824365|100466985|FG000|COMPLETED|Overall Study||15||
48059648|NCT04824365|100466986|FG001|COMPLETED|Overall Study||15||
48059649|NCT04824365|100466985|FG000|NOT COMPLETED|Overall Study||0||
48059650|NCT04824365|100466986|FG001|NOT COMPLETED|Overall Study||0||
48059651|NCT01231347|100466987|FG000|STARTED|Overall Study||322||
48059652|NCT01231347|100466988|FG001|STARTED|Overall Study||318||
48210914|NCT01068743|100842638|FG002|NOT COMPLETED|Period 1||0||
48210915|NCT01068743|100842639|FG003|NOT COMPLETED|Period 1||0||
48210916|NCT01068743|100842636|FG000|STARTED|Period 2||6||
48210917|NCT01068743|100842637|FG001|STARTED|Period 2||6||
48210918|NCT01068743|100842638|FG002|STARTED|Period 2||6||
48210919|NCT01068743|100842639|FG003|STARTED|Period 2||6||
48210920|NCT01068743|100842636|FG000|COMPLETED|Period 2||6||
48210921|NCT01068743|100842637|FG001|COMPLETED|Period 2||6||
48210922|NCT01068743|100842638|FG002|COMPLETED|Period 2||6||
48210923|NCT01068743|100842639|FG003|COMPLETED|Period 2||6||
48210924|NCT01068743|100842636|FG000|NOT COMPLETED|Period 2||0||
48210925|NCT01068743|100842637|FG001|NOT COMPLETED|Period 2||0||
48210926|NCT01068743|100842638|FG002|NOT COMPLETED|Period 2||0||
48210927|NCT01068743|100842639|FG003|NOT COMPLETED|Period 2||0||
48210928|NCT01068743|100842636|FG000|STARTED|Period 3||6||
48210929|NCT01068743|100842637|FG001|STARTED|Period 3||6||
48210930|NCT01068743|100842638|FG002|STARTED|Period 3||6||
48210931|NCT01068743|100842639|FG003|STARTED|Period 3||6||
48210932|NCT01068743|100842636|FG000|COMPLETED|Period 3||6||
48210933|NCT01068743|100842637|FG001|COMPLETED|Period 3||5||
48210934|NCT01068743|100842638|FG002|COMPLETED|Period 3||6||
48210935|NCT01068743|100842639|FG003|COMPLETED|Period 3||6||
48210936|NCT01068743|100842636|FG000|NOT COMPLETED|Period 3||0||
48210937|NCT01068743|100842637|FG001|NOT COMPLETED|Period 3||1||
48210938|NCT01068743|100842638|FG002|NOT COMPLETED|Period 3||0||
48210939|NCT01068743|100842639|FG003|NOT COMPLETED|Period 3||0||
48210940|NCT01068743|100842636|FG000|STARTED|Period 4||6||
48210941|NCT01068743|100842637|FG001|STARTED|Period 4||5||
48210942|NCT01068743|100842638|FG002|STARTED|Period 4||6||
48210943|NCT01068743|100842639|FG003|STARTED|Period 4||6||
48210944|NCT01068743|100842636|FG000|COMPLETED|Period 4||6||
48210945|NCT01068743|100842637|FG001|COMPLETED|Period 4||5||
48210946|NCT01068743|100842638|FG002|COMPLETED|Period 4||6||
48210947|NCT01068743|100842639|FG003|COMPLETED|Period 4||6||
48210948|NCT01068743|100842636|FG000|NOT COMPLETED|Period 4||0||
48210949|NCT01068743|100842637|FG001|NOT COMPLETED|Period 4||0||
48210950|NCT01068743|100842638|FG002|NOT COMPLETED|Period 4||0||
48210951|NCT01068743|100842639|FG003|NOT COMPLETED|Period 4||0||
48210952|NCT01565148|100842640|FG000|STARTED|Overall Study||47||
48210953|NCT01565148|100842641|FG001|STARTED|Overall Study||46||
48210954|NCT01565148|100842642|FG002|STARTED|Overall Study||47||
48210955|NCT01565148|100842643|FG003|STARTED|Overall Study||45||
48210956|NCT01565148|100842640|FG000|COMPLETED|Overall Study||32||
48210957|NCT01565148|100842641|FG001|COMPLETED|Overall Study||31||
48210958|NCT01565148|100842642|FG002|COMPLETED|Overall Study||40||
48210959|NCT01565148|100842643|FG003|COMPLETED|Overall Study||32||
48210960|NCT01565148|100842640|FG000|NOT COMPLETED|Overall Study||15||
48210961|NCT01565148|100842641|FG001|NOT COMPLETED|Overall Study||15||
48210962|NCT01565148|100842642|FG002|NOT COMPLETED|Overall Study||7||
48210963|NCT01565148|100842643|FG003|NOT COMPLETED|Overall Study||13||
48210964|NCT00309907|100842644|FG000|STARTED|Overall Study||39||
48210965|NCT00309907|100842644|FG000|COMPLETED|Overall Study||19||
48210966|NCT00309907|100842644|FG000|NOT COMPLETED|Overall Study||20||
48210967|NCT02107339|100842645|FG000|STARTED|Overall Study||63||
48210968|NCT02107339|100842646|FG001|STARTED|Overall Study||57||
48210969|NCT02107339|100842645|FG000|COMPLETED|Overall Study||62||
48210970|NCT02107339|100842646|FG001|COMPLETED|Overall Study||53||
48210971|NCT02107339|100842645|FG000|NOT COMPLETED|Overall Study||1||
48210972|NCT02107339|100842646|FG001|NOT COMPLETED|Overall Study||4||
48210973|NCT01198275|100842647|FG000|STARTED|Overall Study||100||
48210974|NCT01198275|100842648|FG001|STARTED|Overall Study||99||
48210975|NCT01198275|100842647|FG000|COMPLETED|Overall Study||94||
48210976|NCT01198275|100842648|FG001|COMPLETED|Overall Study||94||
48210977|NCT01198275|100842647|FG000|NOT COMPLETED|Overall Study||6||
48210978|NCT01198275|100842648|FG001|NOT COMPLETED|Overall Study||5||
48210979|NCT00332241|100842649|FG000|STARTED|Overall Study||51||
48210980|NCT00332241|100842650|FG001|STARTED|Overall Study||47||
48210981|NCT00332241|100842649|FG000|COMPLETED|Overall Study||36||
48210982|NCT00332241|100842650|FG001|COMPLETED|Overall Study||39||
48210983|NCT00332241|100842649|FG000|NOT COMPLETED|Overall Study||15||
48210984|NCT00332241|100842650|FG001|NOT COMPLETED|Overall Study||8||
48210985|NCT03051165|100842651|FG000|STARTED|Overall Study||13||
48210986|NCT03051165|100842651|FG000|Completed Some Baseline Assessments|Overall Study||1|Baseline assessments refer to clinical assessments; demographic information was collected for all.|
48210987|NCT03051165|100842651|FG000|Completed Some Day 105 Assessments|Overall Study||1|Day 105 assessments occur just prior to HGNS treatment withdrawal.|
48210988|NCT03051165|100842651|FG000|Began HGNS Treatment Withdrawal|Overall Study||0||
48210989|NCT03051165|100842651|FG000|Completed Some Day 137 Assessments|Overall Study||0|Day 137 assessments occur after 30 days of HGNS treatment withdrawal.|
48210990|NCT03051165|100842651|FG000|COMPLETED|Overall Study||0||
48210991|NCT03051165|100842651|FG000|NOT COMPLETED|Overall Study||13||
48210992|NCT01122901|100842652|FG000|STARTED|Overall Study||40||
48210993|NCT01122901|100842653|FG001|STARTED|Overall Study||7||
48210994|NCT01122901|100842652|FG000|COMPLETED|Overall Study||40||
48210995|NCT01122901|100842653|FG001|COMPLETED|Overall Study||7||
48210996|NCT01122901|100842652|FG000|NOT COMPLETED|Overall Study||0||
48210997|NCT01122901|100842653|FG001|NOT COMPLETED|Overall Study||0||
48210998|NCT00816751|100842654|FG000|STARTED|Overall Study||45||
48210999|NCT00816751|100842655|FG001|STARTED|Overall Study||44||
48211000|NCT00816751|100842654|FG000|COMPLETED|Overall Study||45||
48211001|NCT00816751|100842655|FG001|COMPLETED|Overall Study||44||
48211002|NCT00816751|100842654|FG000|NOT COMPLETED|Overall Study||0||
48211003|NCT00816751|100842655|FG001|NOT COMPLETED|Overall Study||0||
48211004|NCT00743444|100842656|FG000|STARTED|First Intervention||14||
48211005|NCT00743444|100842657|FG001|STARTED|First Intervention||13||
48211006|NCT00743444|100842656|FG000|COMPLETED|First Intervention||14||
48211007|NCT00743444|100842657|FG001|COMPLETED|First Intervention||12||
48211008|NCT00743444|100842656|FG000|NOT COMPLETED|First Intervention||0||
48211009|NCT00743444|100842657|FG001|NOT COMPLETED|First Intervention||1||
48211010|NCT00743444|100842656|FG000|STARTED|Washout Period||14||
48211011|NCT00743444|100842657|FG001|STARTED|Washout Period||12||
48211012|NCT00743444|100842656|FG000|COMPLETED|Washout Period||14||
48211013|NCT00743444|100842657|FG001|COMPLETED|Washout Period||11||
48211014|NCT00743444|100842656|FG000|NOT COMPLETED|Washout Period||0||
48211015|NCT00743444|100842657|FG001|NOT COMPLETED|Washout Period||1||
48211016|NCT00743444|100842656|FG000|STARTED|Second Intervention||14||
48211017|NCT00743444|100842657|FG001|STARTED|Second Intervention||11||
48211018|NCT00743444|100842656|FG000|COMPLETED|Second Intervention||14||
48211019|NCT00743444|100842657|FG001|COMPLETED|Second Intervention||11||
48211020|NCT00743444|100842656|FG000|NOT COMPLETED|Second Intervention||0||
48211021|NCT00743444|100842657|FG001|NOT COMPLETED|Second Intervention||0||
48211022|NCT01084707|100842658|FG000|STARTED|Overall Study||40||
48211023|NCT01084707|100842658|FG000|COMPLETED|Overall Study||34||
48211024|NCT01084707|100842658|FG000|NOT COMPLETED|Overall Study||6||
48211025|NCT03069313|100842659|FG000|STARTED|Overall Study||41||
48211026|NCT03069313|100842659|FG000|COMPLETED|Overall Study||36||
48211027|NCT03069313|100842659|FG000|NOT COMPLETED|Overall Study||5||
48211028|NCT01641198|100842660|FG000|STARTED|After 12 Months of Function||20||100
48211029|NCT01641198|100842661|FG001|STARTED|After 12 Months of Function||19||95
48211030|NCT01641198|100842662|FG002|STARTED|After 12 Months of Function||19||95
48211031|NCT01641198|100842660|FG000|COMPLETED|After 12 Months of Function||16||67
48211032|NCT01641198|100842661|FG001|COMPLETED|After 12 Months of Function||16||77
48211033|NCT01641198|100842662|FG002|COMPLETED|After 12 Months of Function||17||82
48211034|NCT01641198|100842660|FG000|NOT COMPLETED|After 12 Months of Function||4||33
48211035|NCT01641198|100842661|FG001|NOT COMPLETED|After 12 Months of Function||3||18
48211036|NCT01641198|100842662|FG002|NOT COMPLETED|After 12 Months of Function||2||13
48211037|NCT01641198|100842660|FG000|STARTED|After 24 Months of Function||16||67
48211038|NCT01641198|100842661|FG001|STARTED|After 24 Months of Function||16||77
48211039|NCT01641198|100842662|FG002|STARTED|After 24 Months of Function||17||82
48211040|NCT01641198|100842660|FG000|COMPLETED|After 24 Months of Function||12||57
48211041|NCT01641198|100842661|FG001|COMPLETED|After 24 Months of Function||7||35
48211042|NCT01641198|100842662|FG002|COMPLETED|After 24 Months of Function||11||53
48211043|NCT01641198|100842660|FG000|NOT COMPLETED|After 24 Months of Function||4||10
48211044|NCT01641198|100842661|FG001|NOT COMPLETED|After 24 Months of Function||9||42
48211045|NCT01641198|100842662|FG002|NOT COMPLETED|After 24 Months of Function||6||29
48211046|NCT01641198|100842660|FG000|STARTED|At 15-20 Years of Function||12||57
48211047|NCT01641198|100842661|FG001|STARTED|At 15-20 Years of Function||7||35
48211048|NCT01641198|100842662|FG002|STARTED|At 15-20 Years of Function||11||53
48211049|NCT01641198|100842660|FG000|COMPLETED|At 15-20 Years of Function||6||30
48211050|NCT01641198|100842661|FG001|COMPLETED|At 15-20 Years of Function||6||30
48059653|NCT01231347|100466989|FG002|STARTED|Overall Study||160||
48059654|NCT01231347|100466987|FG000|COMPLETED|Overall Study||90||
48059655|NCT01231347|100466988|FG001|COMPLETED|Overall Study||78||
48059656|NCT01231347|100466989|FG002|COMPLETED|Overall Study||43||
48059657|NCT01231347|100466987|FG000|NOT COMPLETED|Overall Study||232||
48059658|NCT01231347|100466988|FG001|NOT COMPLETED|Overall Study||240||
48211051|NCT01641198|100842662|FG002|COMPLETED|At 15-20 Years of Function||9||45
48211052|NCT01641198|100842660|FG000|NOT COMPLETED|At 15-20 Years of Function||6||27
48211053|NCT01641198|100842661|FG001|NOT COMPLETED|At 15-20 Years of Function||1||5
48211054|NCT01641198|100842662|FG002|NOT COMPLETED|At 15-20 Years of Function||2||8
48211055|NCT01499199|100842663|FG000|STARTED|Overall Study||13||
48211056|NCT01499199|100842663|FG000|COMPLETED|Overall Study||11||
48211057|NCT01499199|100842663|FG000|NOT COMPLETED|Overall Study||2||
48211058|NCT01210820|100842664|FG000|STARTED|Overall Study||17||
48211059|NCT01210820|100842665|FG001|STARTED|Overall Study||4||
48211060|NCT01210820|100842664|FG000|COMPLETED|Overall Study||17||
48211061|NCT01210820|100842665|FG001|COMPLETED|Overall Study||4||
48211062|NCT01210820|100842664|FG000|NOT COMPLETED|Overall Study||0||
48211063|NCT01210820|100842665|FG001|NOT COMPLETED|Overall Study||0||
48211064|NCT03175172|100842666|FG000|STARTED|Overall Study||10||
48211065|NCT03175172|100842666|FG000|COMPLETED|Overall Study||0||
48211066|NCT03175172|100842666|FG000|NOT COMPLETED|Overall Study||10||
48211067|NCT02967458|100842667|FG000|STARTED|Overall Study||55||
48211068|NCT02967458|100842667|FG000|COMPLETED|Overall Study||55||
48211069|NCT02967458|100842667|FG000|NOT COMPLETED|Overall Study||0||
48211070|NCT01665092|100842668|FG000|STARTED|Overall Study||75||
48211071|NCT01665092|100842669|FG001|STARTED|Overall Study||35||
48211072|NCT01665092|100842670|FG002|STARTED|Overall Study||34||
48211073|NCT01665092|100842671|FG003|STARTED|Overall Study||106||
48211074|NCT01665092|100842668|FG000|COMPLETED|Overall Study||75||
48211075|NCT01665092|100842669|FG001|COMPLETED|Overall Study||35||
48211076|NCT01665092|100842670|FG002|COMPLETED|Overall Study||32||
48211077|NCT01665092|100842671|FG003|COMPLETED|Overall Study||105||
48211078|NCT01665092|100842668|FG000|NOT COMPLETED|Overall Study||0||
48211079|NCT01665092|100842669|FG001|NOT COMPLETED|Overall Study||0||
48211080|NCT01665092|100842670|FG002|NOT COMPLETED|Overall Study||2||
48211081|NCT01665092|100842671|FG003|NOT COMPLETED|Overall Study||1||
48211082|NCT00761605|100842672|FG000|STARTED|Overall Study||387||
48211083|NCT00761605|100842672|FG000|COMPLETED|Overall Study||246||
48211084|NCT00761605|100842672|FG000|NOT COMPLETED|Overall Study||141||
48211085|NCT00482729|100842673|FG000|STARTED|Overall Study||626||
48211086|NCT00482729|100842674|FG001|STARTED|Overall Study||624||
48211087|NCT00482729|100842673|FG000|Completed Phase A|Overall Study||484||
48211088|NCT00482729|100842674|FG001|Completed Phase A|Overall Study||482||
48211089|NCT00482729|100842673|FG000|Completed Phase B|Overall Study||409||
48211090|NCT00482729|100842674|FG001|Completed Phase B|Overall Study||406||
48211091|NCT00482729|100842673|FG000|COMPLETED|Overall Study||409||
48211092|NCT00482729|100842674|FG001|COMPLETED|Overall Study||406||
48211093|NCT00482729|100842673|FG000|NOT COMPLETED|Overall Study||217||
48211094|NCT00482729|100842674|FG001|NOT COMPLETED|Overall Study||218||
48211095|NCT02272816|100842675|FG000|STARTED|Overall Study||48||
48211096|NCT02272816|100842675|FG000|COMPLETED|Overall Study||47||
48211097|NCT02272816|100842675|FG000|NOT COMPLETED|Overall Study||1||
48211098|NCT02538107|100842676|FG000|STARTED|Overall Study||290||
48211099|NCT02538107|100842676|FG000|COMPLETED|Overall Study||180||
48211100|NCT02538107|100842676|FG000|NOT COMPLETED|Overall Study||110||
48211101|NCT00687167|100842677|FG000|STARTED|First Intervention||17||
48211102|NCT00687167|100842678|FG001|STARTED|First Intervention||17||
48211103|NCT00687167|100842677|FG000|COMPLETED|First Intervention||17||
48211104|NCT00687167|100842678|FG001|COMPLETED|First Intervention||17||
48211105|NCT00687167|100842677|FG000|NOT COMPLETED|First Intervention||0||
48211106|NCT00687167|100842678|FG001|NOT COMPLETED|First Intervention||0||
48211107|NCT00687167|100842677|FG000|STARTED|Washout Period of 28 Days||17||
48211108|NCT00687167|100842678|FG001|STARTED|Washout Period of 28 Days||17||
48211109|NCT00687167|100842677|FG000|COMPLETED|Washout Period of 28 Days||17||
48211110|NCT00687167|100842678|FG001|COMPLETED|Washout Period of 28 Days||17||
48211111|NCT00687167|100842677|FG000|NOT COMPLETED|Washout Period of 28 Days||0||
48211112|NCT00687167|100842678|FG001|NOT COMPLETED|Washout Period of 28 Days||0||
48211113|NCT00687167|100842677|FG000|STARTED|Second Intervention||17||
48211114|NCT00687167|100842678|FG001|STARTED|Second Intervention||17||
48211115|NCT00687167|100842677|FG000|COMPLETED|Second Intervention||17||
48211116|NCT00687167|100842678|FG001|COMPLETED|Second Intervention||17||
48211117|NCT00687167|100842677|FG000|NOT COMPLETED|Second Intervention||0||
48211118|NCT00687167|100842678|FG001|NOT COMPLETED|Second Intervention||0||
48211119|NCT01112670|100842679|FG000|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||8||
48211120|NCT01112670|100842680|FG001|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0||
48211121|NCT01112670|100842681|FG002|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||7||
48211122|NCT01112670|100842682|FG003|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0||
48211123|NCT01112670|100842683|FG004|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||6||
48211124|NCT01112670|100842684|FG005|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0||
48211125|NCT01112670|100842679|FG000|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||7||
48211126|NCT01112670|100842680|FG001|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0||
48211127|NCT01112670|100842681|FG002|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||6||
48211128|NCT01112670|100842682|FG003|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0||
48211129|NCT01112670|100842683|FG004|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||5||
48211130|NCT01112670|100842684|FG005|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0||
48211131|NCT01112670|100842679|FG000|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1||
48211132|NCT01112670|100842680|FG001|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0||
48211133|NCT01112670|100842681|FG002|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1||
48211134|NCT01112670|100842682|FG003|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0||
48211135|NCT01112670|100842683|FG004|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1||
48211136|NCT01112670|100842684|FG005|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0||
48211137|NCT01112670|100842679|FG000|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0||
48211138|NCT01112670|100842680|FG001|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||3||
48495933|NCT02426918|101547970|FG000|COMPLETED|Overall Study||93||
48495934|NCT02426918|101547971|FG001|COMPLETED|Overall Study||90||
48211139|NCT01112670|100842681|FG002|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0||
48211140|NCT01112670|100842682|FG003|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||4||
48211141|NCT01112670|100842683|FG004|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0||
48211142|NCT01112670|100842684|FG005|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||5||
48211143|NCT01112670|100842679|FG000|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0||
48211144|NCT01112670|100842680|FG001|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||3||
48211145|NCT01112670|100842681|FG002|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0||
48211146|NCT01112670|100842682|FG003|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||4||
48211147|NCT01112670|100842683|FG004|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0||
48211148|NCT01112670|100842684|FG005|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||5||
48211149|NCT01112670|100842679|FG000|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0||
48211150|NCT01112670|100842680|FG001|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0||
48211151|NCT01112670|100842681|FG002|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0||
48211152|NCT01112670|100842682|FG003|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0||
48211153|NCT01112670|100842683|FG004|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0||
48211154|NCT01112670|100842684|FG005|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0||
48211155|NCT02047981|100842685|FG000|STARTED|MORDOR Stage I Year 1-2||97047||
48211156|NCT02047981|100842686|FG001|STARTED|MORDOR Stage I Year 1-2||93191||
48211157|NCT02047981|100842685|FG000|COMPLETED|MORDOR Stage I Year 1-2||87650||
48211158|NCT02047981|100842686|FG001|COMPLETED|MORDOR Stage I Year 1-2||84474||
48211159|NCT02047981|100842685|FG000|NOT COMPLETED|MORDOR Stage I Year 1-2||9397||
48211160|NCT02047981|100842686|FG001|NOT COMPLETED|MORDOR Stage I Year 1-2||8717||
48211161|NCT02047981|100842685|FG000|STARTED|MORDOR Stage II Year 3||37497||
48211162|NCT02047981|100842686|FG001|STARTED|MORDOR Stage II Year 3||33294||
48211163|NCT02047981|100842685|FG000|COMPLETED|MORDOR Stage II Year 3||34611||
48211164|NCT02047981|100842686|FG001|COMPLETED|MORDOR Stage II Year 3||30931||
48211165|NCT02047981|100842685|FG000|NOT COMPLETED|MORDOR Stage II Year 3||2886||
48211166|NCT02047981|100842686|FG001|NOT COMPLETED|MORDOR Stage II Year 3||2363||
48211167|NCT02015520|100842687|FG000|STARTED|Overall Study||40||
48211168|NCT02015520|100842688|FG001|STARTED|Overall Study||21||
48211169|NCT02015520|100842689|FG002|STARTED|Overall Study||42||
48211170|NCT02015520|100842690|FG003|STARTED|Overall Study||40||
48211171|NCT02015520|100842687|FG000|COMPLETED|Overall Study||35||
48211172|NCT02015520|100842688|FG001|COMPLETED|Overall Study||17||
48211173|NCT02015520|100842689|FG002|COMPLETED|Overall Study||35||
48211174|NCT02015520|100842690|FG003|COMPLETED|Overall Study||36||
48211175|NCT02015520|100842687|FG000|NOT COMPLETED|Overall Study||5||
48211176|NCT02015520|100842688|FG001|NOT COMPLETED|Overall Study||4||
48211177|NCT02015520|100842689|FG002|NOT COMPLETED|Overall Study||7||
48211178|NCT02015520|100842690|FG003|NOT COMPLETED|Overall Study||4||
48211179|NCT02639910|100842691|FG000|STARTED|Overall Study||11||
48211180|NCT02639910|100842692|FG001|STARTED|Overall Study||13||
48211181|NCT02639910|100842691|FG000|COMPLETED|Overall Study||7||
48211182|NCT02639910|100842692|FG001|COMPLETED|Overall Study||5||
48211183|NCT02639910|100842691|FG000|NOT COMPLETED|Overall Study||4||
48211184|NCT02639910|100842692|FG001|NOT COMPLETED|Overall Study||8||
48211185|NCT01771731|100842693|FG000|STARTED|Overall Study||13||
48211186|NCT01771731|100842694|FG001|STARTED|Overall Study||14||
48211187|NCT01771731|100842693|FG000|COMPLETED|Overall Study||11||
48211188|NCT01771731|100842694|FG001|COMPLETED|Overall Study||12||
48211189|NCT01771731|100842693|FG000|NOT COMPLETED|Overall Study||2||
48211190|NCT01771731|100842694|FG001|NOT COMPLETED|Overall Study||2||
48211191|NCT04867902|100842695|FG000|STARTED|Overall Study||12||
48211192|NCT04867902|100842695|FG000|COMPLETED|Overall Study||8||
48211193|NCT04867902|100842695|FG000|NOT COMPLETED|Overall Study||4||
48211194|NCT01976312|100842696|FG000|STARTED|Overall Study||190||
48211195|NCT01976312|100842697|FG001|STARTED|Overall Study||62||
48211196|NCT01976312|100842696|FG000|Completed 3 Months|Overall Study||186||
48211197|NCT01976312|100842697|FG001|Completed 3 Months|Overall Study||60||
48211198|NCT01976312|100842696|FG000|Discontinued Study Prior to 3 Months|Overall Study||4||
48211199|NCT01976312|100842697|FG001|Discontinued Study Prior to 3 Months|Overall Study||2||
48211200|NCT01976312|100842696|FG000|COMPLETED|Overall Study||173||
48211201|NCT01976312|100842697|FG001|COMPLETED|Overall Study||53||
48211202|NCT01976312|100842696|FG000|NOT COMPLETED|Overall Study||17||
48211203|NCT01976312|100842697|FG001|NOT COMPLETED|Overall Study||9||
48211204|NCT00924807|100842698|FG000|STARTED|Overall Study||4||
48211205|NCT00924807|100842698|FG000|COMPLETED|Overall Study||4||
48211206|NCT00924807|100842698|FG000|NOT COMPLETED|Overall Study||0||
48211207|NCT01186198|100842699|FG000|STARTED|Overall Study||71||
48211208|NCT01186198|100842699|FG000|COMPLETED|Overall Study||71||
48211209|NCT01186198|100842699|FG000|NOT COMPLETED|Overall Study||0||
48211210|NCT04218110|100842700|FG000|STARTED|Overall Study||82||
48211211|NCT04218110|100842701|FG001|STARTED|Overall Study||81||
48211212|NCT04218110|100842702|FG002|STARTED|Overall Study||83||
48211213|NCT04218110|100842703|FG003|STARTED|Overall Study||83||
48211214|NCT04218110|100842700|FG000|Received Treatment|Overall Study||82||
48211215|NCT04218110|100842701|FG001|Received Treatment|Overall Study||81||
48211216|NCT04218110|100842702|FG002|Received Treatment|Overall Study||83||
48211217|NCT04218110|100842703|FG003|Received Treatment|Overall Study||82||
48211218|NCT04218110|100842700|FG000|COMPLETED|Overall Study||82||
48495935|NCT02426918|101547972|FG002|COMPLETED|Overall Study||97||
48211219|NCT04218110|100842701|FG001|COMPLETED|Overall Study||81||
48211220|NCT04218110|100842702|FG002|COMPLETED|Overall Study||83||
48211221|NCT04218110|100842703|FG003|COMPLETED|Overall Study||82||
48211222|NCT04218110|100842700|FG000|NOT COMPLETED|Overall Study||0||
48211223|NCT04218110|100842701|FG001|NOT COMPLETED|Overall Study||0||
48211224|NCT04218110|100842702|FG002|NOT COMPLETED|Overall Study||0||
48211225|NCT04218110|100842703|FG003|NOT COMPLETED|Overall Study||1||
48211226|NCT04732338|100842704|FG000|STARTED|Overall Study||13||
48211227|NCT04732338|100842705|FG001|STARTED|Overall Study||13||
48211228|NCT04732338|100842704|FG000|COMPLETED|Overall Study||10||
48211229|NCT04732338|100842705|FG001|COMPLETED|Overall Study||10||
48211230|NCT04732338|100842704|FG000|NOT COMPLETED|Overall Study||3||
48211231|NCT04732338|100842705|FG001|NOT COMPLETED|Overall Study||3||
48211232|NCT02242487|100842706|FG000|STARTED|Overall Study||161||
48211233|NCT02242487|100842707|FG001|STARTED|Overall Study||164||
48211234|NCT02242487|100842706|FG000|COMPLETED|Overall Study||99||
48211235|NCT02242487|100842707|FG001|COMPLETED|Overall Study||117||
48211236|NCT02242487|100842706|FG000|NOT COMPLETED|Overall Study||62||
48211237|NCT02242487|100842707|FG001|NOT COMPLETED|Overall Study||47||
48211238|NCT00174382|100842708|FG000|STARTED|Overall Study||149||
48211239|NCT00174382|100842708|FG000|COMPLETED|Overall Study||116||
48211240|NCT00174382|100842708|FG000|NOT COMPLETED|Overall Study||33||
48211241|NCT03504423|100842709|FG000|STARTED|Overall Study||266||
48211242|NCT03504423|100842710|FG001|STARTED|Overall Study||262||
48211243|NCT03504423|100842709|FG000|COMPLETED|Overall Study||259||
48211244|NCT03504423|100842710|FG001|COMPLETED|Overall Study||235||
48211245|NCT03504423|100842709|FG000|NOT COMPLETED|Overall Study||7||
48211246|NCT03504423|100842710|FG001|NOT COMPLETED|Overall Study||27||
48211247|NCT02423291|100842711|FG000|STARTED|Overall Study||15||
48211248|NCT02423291|100842711|FG000|COMPLETED|Overall Study||0||
48211249|NCT02423291|100842711|FG000|NOT COMPLETED|Overall Study||15||
48211250|NCT03169244|100842712|FG000|STARTED|Overall Study||22||
48211251|NCT03169244|100842713|FG001|STARTED|Overall Study||20||
48211252|NCT03169244|100842712|FG000|Randomly Assigned|Overall Study||22||
48211253|NCT03169244|100842713|FG001|Randomly Assigned|Overall Study||20||
48211254|NCT03169244|100842712|FG000|Received Intervention|Overall Study||22||
48211255|NCT03169244|100842713|FG001|Received Intervention|Overall Study||18||
48211256|NCT03169244|100842712|FG000|COMPLETED|Overall Study||17||
48211257|NCT03169244|100842713|FG001|COMPLETED|Overall Study||16||
48495936|NCT02426918|101547970|FG000|NOT COMPLETED|Overall Study||17||
48495937|NCT02426918|101547971|FG001|NOT COMPLETED|Overall Study||19||
48495938|NCT02426918|101547972|FG002|NOT COMPLETED|Overall Study||14||
48495939|NCT01741545|101547973|FG000|STARTED|Treatment Period||12||
48211258|NCT03169244|100842712|FG000|NOT COMPLETED|Overall Study||5||
48211259|NCT03169244|100842713|FG001|NOT COMPLETED|Overall Study||4||
48211260|NCT01102231|100842714|FG000|STARTED|Overall Study||106||
48211261|NCT01102231|100842714|FG000|COMPLETED|Overall Study||91||
48211262|NCT01102231|100842714|FG000|NOT COMPLETED|Overall Study||15||
48211263|NCT00536341|100842715|FG000|STARTED|Overall Study||10||
48211264|NCT00536341|100842716|FG001|STARTED|Overall Study||54||
48211265|NCT00536341|100842715|FG000|COMPLETED|Overall Study||5||
48211266|NCT00536341|100842716|FG001|COMPLETED|Overall Study||43||
48211267|NCT00536341|100842715|FG000|NOT COMPLETED|Overall Study||5||
48211268|NCT00536341|100842716|FG001|NOT COMPLETED|Overall Study||11||
48211269|NCT01198028|100842717|FG000|STARTED|Overall Study||39||
48211270|NCT01198028|100842717|FG000|COMPLETED|Overall Study||29||
48211271|NCT01198028|100842717|FG000|NOT COMPLETED|Overall Study||10||
48211272|NCT00296036|100842718|FG000|STARTED|Overall Study||19||
48211273|NCT00296036|100842719|FG001|STARTED|Overall Study||18||
48211274|NCT00296036|100842720|FG002|STARTED|Overall Study||18||
48211275|NCT00296036|100842721|FG003|STARTED|Overall Study||17||
48211276|NCT00296036|100842722|FG004|STARTED|Overall Study||33||
48211277|NCT00296036|100842723|FG005|STARTED|Overall Study||32||
48211278|NCT00296036|100842718|FG000|COMPLETED|Overall Study||18||
48211279|NCT00296036|100842719|FG001|COMPLETED|Overall Study||18||
48211280|NCT00296036|100842720|FG002|COMPLETED|Overall Study||16||
48211281|NCT00296036|100842721|FG003|COMPLETED|Overall Study||16||
48211282|NCT00296036|100842722|FG004|COMPLETED|Overall Study||31||
48211283|NCT00296036|100842723|FG005|COMPLETED|Overall Study||28||
48211284|NCT00296036|100842718|FG000|NOT COMPLETED|Overall Study||1||
48211285|NCT00296036|100842719|FG001|NOT COMPLETED|Overall Study||0||
48211286|NCT00296036|100842720|FG002|NOT COMPLETED|Overall Study||2||
48211287|NCT00296036|100842721|FG003|NOT COMPLETED|Overall Study||1||
48211288|NCT00296036|100842722|FG004|NOT COMPLETED|Overall Study||2||
48211289|NCT00296036|100842723|FG005|NOT COMPLETED|Overall Study||4||
48211290|NCT00726596|100842724|FG000|STARTED|Overall Study||36||
48211291|NCT00726596|100842725|FG001|STARTED|Overall Study||28||
48211292|NCT00726596|100842724|FG000|COMPLETED|Overall Study||31||
48211293|NCT00726596|100842725|FG001|COMPLETED|Overall Study||24||
48211294|NCT00726596|100842724|FG000|NOT COMPLETED|Overall Study||5||
48211295|NCT00726596|100842725|FG001|NOT COMPLETED|Overall Study||4||
48211296|NCT01765543|100842726|FG000|STARTED|Overall Study||27||
48211297|NCT01765543|100842726|FG000|COMPLETED|Overall Study||24||
48211298|NCT01765543|100842726|FG000|NOT COMPLETED|Overall Study||3||
48211299|NCT05132478|100842727|FG000|STARTED|Overall Study||64||
48211300|NCT05132478|100842728|FG001|STARTED|Overall Study||62||
48211301|NCT05132478|100842727|FG000|Completed Survey|Overall Study||63||
48211302|NCT05132478|100842728|FG001|Completed Survey|Overall Study||61||
48211303|NCT05132478|100842727|FG000|Analysis Population|Overall Study||60|Excluded from analysis are those participants who completed the survey greater than 30 days past biopsy.|
48211304|NCT05132478|100842728|FG001|Analysis Population|Overall Study||58|Excluded from analysis are those participants who completed the survey greater than 30 days past biopsy.|
48211305|NCT05132478|100842727|FG000|COMPLETED|Overall Study||60||
48211306|NCT05132478|100842728|FG001|COMPLETED|Overall Study||58||
48211307|NCT05132478|100842727|FG000|NOT COMPLETED|Overall Study||4||
48211308|NCT05132478|100842728|FG001|NOT COMPLETED|Overall Study||4||
48211309|NCT03101930|100842729|FG000|STARTED|Overall Study||46||
48211310|NCT03101930|100842730|FG001|STARTED|Overall Study||23||
48211311|NCT03101930|100842731|FG002|STARTED|Overall Study||24||
48211312|NCT03101930|100842729|FG000|COMPLETED|Overall Study||44||
48211313|NCT03101930|100842730|FG001|COMPLETED|Overall Study||22||
48211314|NCT03101930|100842731|FG002|COMPLETED|Overall Study||22||
48211315|NCT03101930|100842729|FG000|NOT COMPLETED|Overall Study||2||
48211316|NCT03101930|100842730|FG001|NOT COMPLETED|Overall Study||1||
48211317|NCT03101930|100842731|FG002|NOT COMPLETED|Overall Study||2||
48211318|NCT00529516|100842732|FG000|STARTED|Overall Study||475||
48211319|NCT00529516|100842733|FG001|STARTED|Overall Study||488||
48211320|NCT00529516|100842734|FG002|STARTED|Overall Study||289||
48059659|NCT01231347|100466989|FG002|NOT COMPLETED|Overall Study||117||
48059660|NCT01933217|100466990|FG000|STARTED|Randomization (4 Weeks)||12||
48059661|NCT01933217|100466991|FG001|STARTED|Randomization (4 Weeks)||14||
48211321|NCT00529516|100842732|FG000|COMPLETED|Overall Study||472||
48211322|NCT00529516|100842733|FG001|COMPLETED|Overall Study||486||
48211323|NCT00529516|100842734|FG002|COMPLETED|Overall Study||288||
48211324|NCT00529516|100842732|FG000|NOT COMPLETED|Overall Study||3||
48211325|NCT00529516|100842733|FG001|NOT COMPLETED|Overall Study||2||
48211326|NCT00529516|100842734|FG002|NOT COMPLETED|Overall Study||1||
48211327|NCT00068601|100842735|FG000|STARTED|Overall Study||131||
48211328|NCT00068601|100842736|FG001|STARTED|Overall Study||126||
48211329|NCT00068601|100842735|FG000|COMPLETED|Overall Study||69||
48211330|NCT00068601|100842736|FG001|COMPLETED|Overall Study||66||
48211331|NCT00068601|100842735|FG000|NOT COMPLETED|Overall Study||62||
48211332|NCT00068601|100842736|FG001|NOT COMPLETED|Overall Study||60||
48211333|NCT01359592|100842737|FG000|STARTED|Initial Registration||158||
48211334|NCT01359592|100842738|FG001|STARTED|Initial Registration||1||
48495940|NCT01741545|101547974|FG001|STARTED|Treatment Period||39||
48059662|NCT01933217|100466990|FG000|COMPLETED|Randomization (4 Weeks)||10||
48059663|NCT01933217|100466991|FG001|COMPLETED|Randomization (4 Weeks)||10||
48059664|NCT01933217|100466990|FG000|NOT COMPLETED|Randomization (4 Weeks)||2||
48059665|NCT01933217|100466991|FG001|NOT COMPLETED|Randomization (4 Weeks)||4||
48059666|NCT01933217|100466990|FG000|STARTED|Crossover (4 Weeks)||10||
48059667|NCT01933217|100466991|FG001|STARTED|Crossover (4 Weeks)||10||
48059668|NCT01933217|100466990|FG000|COMPLETED|Crossover (4 Weeks)||10||
48059669|NCT01933217|100466991|FG001|COMPLETED|Crossover (4 Weeks)||10||
48059670|NCT01933217|100466990|FG000|NOT COMPLETED|Crossover (4 Weeks)||0||
48059671|NCT01933217|100466991|FG001|NOT COMPLETED|Crossover (4 Weeks)||0||
48059672|NCT01270542|100466992|FG000|STARTED|Overall Study||10||10
48059673|NCT01270542|100466993|FG001|STARTED|Overall Study||9||10
48059674|NCT01270542|100466992|FG000|COMPLETED|Overall Study||9||9
48059675|NCT01270542|100466993|FG001|COMPLETED|Overall Study||8||9
48059676|NCT01270542|100466992|FG000|NOT COMPLETED|Overall Study||1||1
48059677|NCT01270542|100466993|FG001|NOT COMPLETED|Overall Study||1||1
48059678|NCT02612129|100466994|FG000|STARTED|Single Dose Treatment Period||28||
48059679|NCT02612129|100466995|FG001|STARTED|Single Dose Treatment Period||0||
48059680|NCT02612129|100466996|FG002|STARTED|Single Dose Treatment Period||0||
48059681|NCT02612129|100466994|FG000|COMPLETED|Single Dose Treatment Period||27|One participant who was a screening failure received single-dose arimoclomol for PK evaluation.|
48059682|NCT02612129|100466995|FG001|COMPLETED|Single Dose Treatment Period||0|One participant who was a screening failure received single-dose arimoclomol for PK evaluation.|
48059683|NCT02612129|100466996|FG002|COMPLETED|Single Dose Treatment Period||0|One participant who was a screening failure received single-dose arimoclomol for PK evaluation.|
48059684|NCT02612129|100466994|FG000|NOT COMPLETED|Single Dose Treatment Period||1||
48059685|NCT02612129|100466995|FG001|NOT COMPLETED|Single Dose Treatment Period||0||
48059686|NCT02612129|100466996|FG002|NOT COMPLETED|Single Dose Treatment Period||0||
48059687|NCT02612129|100466994|FG000|STARTED|Continuous Treatment Period||0||
48059688|NCT02612129|100466995|FG001|STARTED|Continuous Treatment Period||34||
48059689|NCT02612129|100466996|FG002|STARTED|Continuous Treatment Period||16||
48211335|NCT01359592|100842739|FG002|STARTED|Initial Registration||0||
48211336|NCT01359592|100842740|FG003|STARTED|Initial Registration||0||
48211337|NCT01359592|100842737|FG000|Eligible and Evaluable|Initial Registration||132||
48211338|NCT01359592|100842738|FG001|Eligible and Evaluable|Initial Registration||1||
48211339|NCT01359592|100842739|FG002|Eligible and Evaluable|Initial Registration||0||
48211340|NCT01359592|100842740|FG003|Eligible and Evaluable|Initial Registration||0||
48211341|NCT01359592|100842737|FG000|COMPLETED|Initial Registration||129||
48211342|NCT01359592|100842738|FG001|COMPLETED|Initial Registration||1||
48211343|NCT01359592|100842739|FG002|COMPLETED|Initial Registration||0||
48211344|NCT01359592|100842740|FG003|COMPLETED|Initial Registration||0||
48211345|NCT01359592|100842737|FG000|NOT COMPLETED|Initial Registration||29||
48211346|NCT01359592|100842738|FG001|NOT COMPLETED|Initial Registration||0||
48211347|NCT01359592|100842739|FG002|NOT COMPLETED|Initial Registration||0||
48211348|NCT01359592|100842740|FG003|NOT COMPLETED|Initial Registration||0||
48211349|NCT01359592|100842737|FG000|STARTED|PET-Directed Therapy||0||
48211350|NCT01359592|100842738|FG001|STARTED|PET-Directed Therapy||0||
48211351|NCT01359592|100842739|FG002|STARTED|PET-Directed Therapy||137||
48211352|NCT01359592|100842740|FG003|STARTED|PET-Directed Therapy||12||
48495941|NCT01741545|101547973|FG000|COMPLETED|Treatment Period||11||
48211353|NCT01359592|100842737|FG000|Eligible and Evaluable|PET-Directed Therapy||0||
48211354|NCT01359592|100842738|FG001|Eligible and Evaluable|PET-Directed Therapy||0||
48211355|NCT01359592|100842739|FG002|Eligible and Evaluable|PET-Directed Therapy||113||
48211356|NCT01359592|100842740|FG003|Eligible and Evaluable|PET-Directed Therapy||12||
48211357|NCT01359592|100842737|FG000|COMPLETED|PET-Directed Therapy||0||
48211358|NCT01359592|100842738|FG001|COMPLETED|PET-Directed Therapy||0||
48211359|NCT01359592|100842739|FG002|COMPLETED|PET-Directed Therapy||111||
48211360|NCT01359592|100842740|FG003|COMPLETED|PET-Directed Therapy||12||
48211361|NCT01359592|100842737|FG000|NOT COMPLETED|PET-Directed Therapy||0||
48211362|NCT01359592|100842738|FG001|NOT COMPLETED|PET-Directed Therapy||0||
48211363|NCT01359592|100842739|FG002|NOT COMPLETED|PET-Directed Therapy||26||
48211364|NCT01359592|100842740|FG003|NOT COMPLETED|PET-Directed Therapy||0||
48211365|NCT04247074|100842741|FG000|STARTED|Overall Study||126||
48211366|NCT04247074|100842742|FG001|STARTED|Overall Study||59||
48211367|NCT04247074|100842743|FG002|STARTED|Overall Study||113||
48211368|NCT04247074|100842744|FG003|STARTED|Overall Study||115||
48211369|NCT04247074|100842741|FG000|COMPLETED|Overall Study||121||
48211370|NCT04247074|100842742|FG001|COMPLETED|Overall Study||52||
48211371|NCT04247074|100842743|FG002|COMPLETED|Overall Study||106||
48211372|NCT04247074|100842744|FG003|COMPLETED|Overall Study||107||
48211373|NCT04247074|100842741|FG000|NOT COMPLETED|Overall Study||5||
48211374|NCT04247074|100842742|FG001|NOT COMPLETED|Overall Study||7||
48211375|NCT04247074|100842743|FG002|NOT COMPLETED|Overall Study||7||
48211376|NCT04247074|100842744|FG003|NOT COMPLETED|Overall Study||8||
48211377|NCT02793154|100842745|FG000|STARTED|Part A (Single Group-up to 12 Days)||4||
48211378|NCT02793154|100842746|FG001|STARTED|Part A (Single Group-up to 12 Days)||0||
48211379|NCT02793154|100842747|FG002|STARTED|Part A (Single Group-up to 12 Days)||0||
48211380|NCT02793154|100842745|FG000|COMPLETED|Part A (Single Group-up to 12 Days)||4||
48211381|NCT02793154|100842746|FG001|COMPLETED|Part A (Single Group-up to 12 Days)||0||
48211382|NCT02793154|100842747|FG002|COMPLETED|Part A (Single Group-up to 12 Days)||0||
48211383|NCT02793154|100842745|FG000|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0||
48211384|NCT02793154|100842746|FG001|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0||
48211385|NCT02793154|100842747|FG002|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0||
48211386|NCT02793154|100842745|FG000|STARTED|Part B (Parallel Group-up to 84 Days)||0||
48211387|NCT02793154|100842746|FG001|STARTED|Part B (Parallel Group-up to 84 Days)||0||
48211388|NCT02793154|100842747|FG002|STARTED|Part B (Parallel Group-up to 84 Days)||0||
48211389|NCT02793154|100842745|FG000|COMPLETED|Part B (Parallel Group-up to 84 Days)||0||
48211390|NCT02793154|100842746|FG001|COMPLETED|Part B (Parallel Group-up to 84 Days)||0||
48211391|NCT02793154|100842747|FG002|COMPLETED|Part B (Parallel Group-up to 84 Days)||0||
48211392|NCT02793154|100842745|FG000|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0||
48211393|NCT02793154|100842746|FG001|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0||
48211394|NCT02793154|100842747|FG002|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0||
48211395|NCT04011631|100842748|FG000|STARTED|Overall Study||100||
48211396|NCT04011631|100842748|FG000|COMPLETED|Overall Study||100||
48211397|NCT04011631|100842748|FG000|NOT COMPLETED|Overall Study||0||
48211398|NCT02531113|100842749|FG000|STARTED|Induction Period: Week 0 to 12||69||
48211399|NCT02531113|100842749|FG000|COMPLETED|Induction Period: Week 0 to 12||58|Completed = completed induction period and eligible to enter extension period.|
48211400|NCT02531113|100842749|FG000|NOT COMPLETED|Induction Period: Week 0 to 12||11||
48211401|NCT02531113|100842749|FG000|STARTED|Extension Period: Week 12 up to Week 160||52||
48211402|NCT02531113|100842749|FG000|COMPLETED|Extension Period: Week 12 up to Week 160||14|Completed = Defined as participants who had 160 visit|
48211403|NCT02531113|100842749|FG000|NOT COMPLETED|Extension Period: Week 12 up to Week 160||38||
48211404|NCT01647438|100842750|FG000|STARTED|Overall Study||32||
48211405|NCT01647438|100842751|FG001|STARTED|Overall Study||31||
48211406|NCT01647438|100842750|FG000|COMPLETED|Overall Study||32||
48211407|NCT01647438|100842751|FG001|COMPLETED|Overall Study||31||
48211408|NCT01647438|100842750|FG000|NOT COMPLETED|Overall Study||0||
48211409|NCT01647438|100842751|FG001|NOT COMPLETED|Overall Study||0||
48211410|NCT00176839|100842752|FG000|STARTED|Overall Study||11||
48211411|NCT00176839|100842752|FG000|COMPLETED|Overall Study||11||
48211412|NCT00176839|100842752|FG000|NOT COMPLETED|Overall Study||0||
48211413|NCT02214550|100842753|FG000|STARTED|Overall Study||6||
48211414|NCT02214550|100842754|FG001|STARTED|Overall Study||4||
48211415|NCT02214550|100842755|FG002|STARTED|Overall Study||8||
48211416|NCT02214550|100842756|FG003|STARTED|Overall Study||15||
48211417|NCT02214550|100842757|FG004|STARTED|Overall Study||45||
48211418|NCT02214550|100842758|FG005|STARTED|Overall Study||39||
48211419|NCT02214550|100842759|FG006|STARTED|Overall Study||187||
48211420|NCT02214550|100842760|FG007|STARTED|Overall Study||35||
48211421|NCT02214550|100842761|FG008|STARTED|Overall Study||14||
48211422|NCT02214550|100842753|FG000|Baseline|Overall Study||6||
48211423|NCT02214550|100842754|FG001|Baseline|Overall Study||4||
48211424|NCT02214550|100842755|FG002|Baseline|Overall Study||8||
48211425|NCT02214550|100842756|FG003|Baseline|Overall Study||14||
48211426|NCT02214550|100842757|FG004|Baseline|Overall Study||37||
48211427|NCT02214550|100842758|FG005|Baseline|Overall Study||31||
48211428|NCT02214550|100842759|FG006|Baseline|Overall Study||102||
48211429|NCT02214550|100842760|FG007|Baseline|Overall Study||34||
48211430|NCT02214550|100842761|FG008|Baseline|Overall Study||10||
48211431|NCT02214550|100842753|FG000|Month 6|Overall Study||6||
48211432|NCT02214550|100842754|FG001|Month 6|Overall Study||4||
48211433|NCT02214550|100842755|FG002|Month 6|Overall Study||5||
48211434|NCT02214550|100842756|FG003|Month 6|Overall Study||8||
48211435|NCT02214550|100842757|FG004|Month 6|Overall Study||0||
48211436|NCT02214550|100842758|FG005|Month 6|Overall Study||0||
48211437|NCT02214550|100842759|FG006|Month 6|Overall Study||0||
48211438|NCT02214550|100842760|FG007|Month 6|Overall Study||0||
48211439|NCT02214550|100842761|FG008|Month 6|Overall Study||0||
48211440|NCT02214550|100842753|FG000|COMPLETED|Overall Study||6||
48211441|NCT02214550|100842754|FG001|COMPLETED|Overall Study||4||
48211442|NCT02214550|100842755|FG002|COMPLETED|Overall Study||5||
48211443|NCT02214550|100842756|FG003|COMPLETED|Overall Study||6||
48211444|NCT02214550|100842757|FG004|COMPLETED|Overall Study||37||
48211445|NCT02214550|100842758|FG005|COMPLETED|Overall Study||31||
48211446|NCT02214550|100842759|FG006|COMPLETED|Overall Study||102||
48211447|NCT02214550|100842760|FG007|COMPLETED|Overall Study||34||
48211448|NCT02214550|100842761|FG008|COMPLETED|Overall Study||10||
48211449|NCT02214550|100842753|FG000|NOT COMPLETED|Overall Study||0||
48211450|NCT02214550|100842754|FG001|NOT COMPLETED|Overall Study||0||
48211451|NCT02214550|100842755|FG002|NOT COMPLETED|Overall Study||3||
48211452|NCT02214550|100842756|FG003|NOT COMPLETED|Overall Study||9||
48211453|NCT02214550|100842757|FG004|NOT COMPLETED|Overall Study||8||
48211454|NCT02214550|100842758|FG005|NOT COMPLETED|Overall Study||8||
48211455|NCT02214550|100842759|FG006|NOT COMPLETED|Overall Study||85||
48211456|NCT02214550|100842760|FG007|NOT COMPLETED|Overall Study||1||
48211457|NCT02214550|100842761|FG008|NOT COMPLETED|Overall Study||4||
48211458|NCT04210180|100842762|FG000|STARTED|Overall Study||25||
48211459|NCT04210180|100842762|FG000|COMPLETED|Overall Study||23||
48211460|NCT04210180|100842762|FG000|NOT COMPLETED|Overall Study||2||
48211461|NCT00203216|100842763|FG000|STARTED|Overall Study||31||
48211462|NCT00203216|100842763|FG000|COMPLETED|Overall Study||27||
48211463|NCT00203216|100842763|FG000|NOT COMPLETED|Overall Study||4||
48211464|NCT00773370|100842764|FG000|STARTED|Overall Study||43||
48211465|NCT00773370|100842765|FG001|STARTED|Overall Study||33||
48211466|NCT00773370|100842764|FG000|COMPLETED|Overall Study||25||
48211467|NCT00773370|100842765|FG001|COMPLETED|Overall Study||23||
48211468|NCT00773370|100842764|FG000|NOT COMPLETED|Overall Study||18||
48211469|NCT00773370|100842765|FG001|NOT COMPLETED|Overall Study||10||
48211470|NCT00761189|100842766|FG000|STARTED|Overall Study||491||
48211471|NCT00761189|100842766|FG000|COMPLETED|Overall Study||306||
48211472|NCT00761189|100842766|FG000|NOT COMPLETED|Overall Study||185||
48211473|NCT01061151|100842767|FG000|STARTED|Protocol Version 2.0: 04/2011-09/2012||855||
48211474|NCT01061151|100842768|FG001|STARTED|Protocol Version 2.0: 04/2011-09/2012||861||
48211475|NCT01061151|100842769|FG002|STARTED|Protocol Version 2.0: 04/2011-09/2012||25||
48211476|NCT01061151|100842770|FG003|STARTED|Protocol Version 2.0: 04/2011-09/2012||129||
48211477|NCT01061151|100842767|FG000|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||853||
48211478|NCT01061151|100842768|FG001|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||861||
48211479|NCT01061151|100842769|FG002|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||24||
48211480|NCT01061151|100842770|FG003|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||129||
48211481|NCT01061151|100842767|FG000|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||623||
48211482|NCT01061151|100842768|FG001|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||620||
48211483|NCT01061151|100842769|FG002|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||16||
48211484|NCT01061151|100842770|FG003|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||101||
48211485|NCT01061151|100842767|FG000|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||232||
48211486|NCT01061151|100842768|FG001|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||241||
48211487|NCT01061151|100842769|FG002|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||9||
48211488|NCT01061151|100842770|FG003|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||28||
48211489|NCT01061151|100842767|FG000|STARTED|Protocol Version 3.0: 10/2012-10/2014||694||
48211490|NCT01061151|100842768|FG001|STARTED|Protocol Version 3.0: 10/2012-10/2014||686||
48211491|NCT01061151|100842769|FG002|STARTED|Protocol Version 3.0: 10/2012-10/2014||422||
48211492|NCT01061151|100842770|FG003|STARTED|Protocol Version 3.0: 10/2012-10/2014||75||
48211493|NCT01061151|100842767|FG000|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||694||
48211494|NCT01061151|100842768|FG001|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||684||
48211495|NCT01061151|100842769|FG002|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||421||
48495942|NCT01741545|101547974|FG001|COMPLETED|Treatment Period||35||
48495943|NCT01741545|101547973|FG000|NOT COMPLETED|Treatment Period||1||
48211496|NCT01061151|100842770|FG003|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||75||
48211497|NCT01061151|100842767|FG000|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||542||
48211498|NCT01061151|100842768|FG001|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||548||
48211499|NCT01061151|100842769|FG002|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||345||
48211500|NCT01061151|100842770|FG003|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||55||
48211501|NCT01061151|100842767|FG000|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||152||
48211502|NCT01061151|100842768|FG001|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||138||
48211503|NCT01061151|100842769|FG002|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||77||
48211504|NCT01061151|100842770|FG003|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||20||
48211505|NCT04238429|100842771|FG000|STARTED|Overall Study||43||
48211506|NCT04238429|100842772|FG001|STARTED|Overall Study||43||
48211507|NCT04238429|100842771|FG000|COMPLETED|Overall Study||40||
48211508|NCT04238429|100842772|FG001|COMPLETED|Overall Study||41||
48211509|NCT04238429|100842771|FG000|NOT COMPLETED|Overall Study||3||
48211510|NCT04238429|100842772|FG001|NOT COMPLETED|Overall Study||2||
48211511|NCT00818454|100842773|FG000|STARTED|Treatment Period 1||115||
48211512|NCT00818454|100842774|FG001|STARTED|Treatment Period 1||111||
48211513|NCT00818454|100842775|FG002|STARTED|Treatment Period 1||0||
48211514|NCT00818454|100842776|FG003|STARTED|Treatment Period 1||0||
48211515|NCT00818454|100842773|FG000|COMPLETED|Treatment Period 1||112||
48211516|NCT00818454|100842774|FG001|COMPLETED|Treatment Period 1||110||
48211517|NCT00818454|100842775|FG002|COMPLETED|Treatment Period 1||0||
48211518|NCT00818454|100842776|FG003|COMPLETED|Treatment Period 1||0||
48211519|NCT00818454|100842773|FG000|NOT COMPLETED|Treatment Period 1||3||
48211520|NCT00818454|100842774|FG001|NOT COMPLETED|Treatment Period 1||1||
48211521|NCT00818454|100842775|FG002|NOT COMPLETED|Treatment Period 1||0||
48211522|NCT00818454|100842776|FG003|NOT COMPLETED|Treatment Period 1||0||
48211523|NCT00818454|100842773|FG000|STARTED|Washout Period of 1 Week||112||
48211524|NCT00818454|100842774|FG001|STARTED|Washout Period of 1 Week||110||
48211525|NCT00818454|100842775|FG002|STARTED|Washout Period of 1 Week||0||
48211526|NCT00818454|100842776|FG003|STARTED|Washout Period of 1 Week||0||
48211527|NCT00818454|100842773|FG000|COMPLETED|Washout Period of 1 Week||108||
48211528|NCT00818454|100842774|FG001|COMPLETED|Washout Period of 1 Week||107||
48211529|NCT00818454|100842775|FG002|COMPLETED|Washout Period of 1 Week||0||
48211530|NCT00818454|100842776|FG003|COMPLETED|Washout Period of 1 Week||0||
48211531|NCT00818454|100842773|FG000|NOT COMPLETED|Washout Period of 1 Week||4||
48211532|NCT00818454|100842774|FG001|NOT COMPLETED|Washout Period of 1 Week||3||
48211533|NCT00818454|100842775|FG002|NOT COMPLETED|Washout Period of 1 Week||0||
48211534|NCT00818454|100842776|FG003|NOT COMPLETED|Washout Period of 1 Week||0||
48211535|NCT00818454|100842773|FG000|STARTED|Treatment Period 2||108||
48211536|NCT00818454|100842774|FG001|STARTED|Treatment Period 2||107||
48211537|NCT00818454|100842775|FG002|STARTED|Treatment Period 2||0||
48211538|NCT00818454|100842776|FG003|STARTED|Treatment Period 2||0||
48211539|NCT00818454|100842773|FG000|COMPLETED|Treatment Period 2||106||
48211540|NCT00818454|100842774|FG001|COMPLETED|Treatment Period 2||106||
48211541|NCT00818454|100842775|FG002|COMPLETED|Treatment Period 2||0||
48211542|NCT00818454|100842776|FG003|COMPLETED|Treatment Period 2||0||
48211543|NCT00818454|100842773|FG000|NOT COMPLETED|Treatment Period 2||2||
48211544|NCT00818454|100842774|FG001|NOT COMPLETED|Treatment Period 2||1||
48211545|NCT00818454|100842775|FG002|NOT COMPLETED|Treatment Period 2||0||
48211546|NCT00818454|100842776|FG003|NOT COMPLETED|Treatment Period 2||0||
48211547|NCT00818454|100842773|FG000|STARTED|Treatment Period 3||0||
48211548|NCT00818454|100842774|FG001|STARTED|Treatment Period 3||0||
48211549|NCT00818454|100842775|FG002|STARTED|Treatment Period 3||26||
48211550|NCT00818454|100842776|FG003|STARTED|Treatment Period 3||139||
48211551|NCT00818454|100842773|FG000|COMPLETED|Treatment Period 3||0||
48211552|NCT00818454|100842774|FG001|COMPLETED|Treatment Period 3||0||
48211553|NCT00818454|100842775|FG002|COMPLETED|Treatment Period 3||26||
48211554|NCT00818454|100842776|FG003|COMPLETED|Treatment Period 3||138||
48211555|NCT00818454|100842773|FG000|NOT COMPLETED|Treatment Period 3||0||
48211556|NCT00818454|100842774|FG001|NOT COMPLETED|Treatment Period 3||0||
48211557|NCT00818454|100842775|FG002|NOT COMPLETED|Treatment Period 3||0||
48211558|NCT00818454|100842776|FG003|NOT COMPLETED|Treatment Period 3||1||
48211559|NCT01127373|100842777|FG000|STARTED|Overall Study||116||
48211560|NCT01127373|100842777|FG000|COMPLETED|Overall Study||104||
48211561|NCT01127373|100842777|FG000|NOT COMPLETED|Overall Study||12||
48211562|NCT03294499|100842778|FG000|STARTED|Overall Study||94||
48211563|NCT03294499|100842778|FG000|COMPLETED|Overall Study||94||
48211564|NCT03294499|100842778|FG000|NOT COMPLETED|Overall Study||0||
48211565|NCT02759016|100842779|FG000|STARTED|Overall Study||4|Assigned to combination treatment BI 836826 and ibrutinib|
48211566|NCT02759016|100842780|FG001|STARTED|Overall Study||3|Assigned to combination treatment BI 836826 and ibrutinib|
48211567|NCT02759016|100842779|FG000|Treated With BI 836826 and Ibrutinib|Overall Study||3||
48211568|NCT02759016|100842780|FG001|Treated With BI 836826 and Ibrutinib|Overall Study||3||
48211569|NCT02759016|100842779|FG000|COMPLETED|Overall Study||0||
48211570|NCT02759016|100842780|FG001|COMPLETED|Overall Study||0||
48211571|NCT02759016|100842779|FG000|NOT COMPLETED|Overall Study||4||
48211572|NCT02759016|100842780|FG001|NOT COMPLETED|Overall Study||3||
48211573|NCT01443845|100842781|FG000|STARTED|Overall Study||1176||
48211574|NCT01443845|100842782|FG001|STARTED|Overall Study||1178||
48211575|NCT01443845|100842781|FG000|COMPLETED|Overall Study||922||
48211576|NCT01443845|100842782|FG001|COMPLETED|Overall Study||841||
48211577|NCT01443845|100842781|FG000|NOT COMPLETED|Overall Study||254||
48211578|NCT01443845|100842782|FG001|NOT COMPLETED|Overall Study||337||
48211579|NCT02658240|100842783|FG000|STARTED|Overall Study||30||
48211580|NCT02658240|100842784|FG001|STARTED|Overall Study||30||
48211581|NCT02658240|100842783|FG000|COMPLETED|Overall Study||30||
48211582|NCT02658240|100842784|FG001|COMPLETED|Overall Study||30||
48211583|NCT02658240|100842783|FG000|NOT COMPLETED|Overall Study||0||
48211584|NCT02658240|100842784|FG001|NOT COMPLETED|Overall Study||0||
48211585|NCT01875848|100842785|FG000|STARTED|Overall Study||3||
48211586|NCT01875848|100842786|FG001|STARTED|Overall Study||4||
48211587|NCT01875848|100842785|FG000|COMPLETED|Overall Study||1||
48211588|NCT01875848|100842786|FG001|COMPLETED|Overall Study||4||
48211589|NCT01875848|100842785|FG000|NOT COMPLETED|Overall Study||2||
48211590|NCT01875848|100842786|FG001|NOT COMPLETED|Overall Study||0||
48211591|NCT01852071|100842787|FG000|STARTED|Overall Study||20||
48211592|NCT01852071|100842788|FG001|STARTED|Overall Study||26||
48211593|NCT01852071|100842787|FG000|COMPLETED|Overall Study||20||
48211594|NCT01852071|100842788|FG001|COMPLETED|Overall Study||26||
48211595|NCT01852071|100842787|FG000|NOT COMPLETED|Overall Study||0||
48211596|NCT01852071|100842788|FG001|NOT COMPLETED|Overall Study||0||
48211597|NCT01109524|100842789|FG000|STARTED|Overall Study||60||
48211598|NCT01109524|100842789|FG000|COMPLETED|Overall Study||3||
48211599|NCT01109524|100842789|FG000|NOT COMPLETED|Overall Study||57||
48211600|NCT00716859|100842790|FG000|STARTED|Overall Study||70||
48211601|NCT00716859|100842791|FG001|STARTED|Overall Study||69||
48211602|NCT00716859|100842790|FG000|Received Treatment|Overall Study||69||
48211603|NCT00716859|100842791|FG001|Received Treatment|Overall Study||68||
48211604|NCT00716859|100842790|FG000|COMPLETED|Overall Study||61||
48211605|NCT00716859|100842791|FG001|COMPLETED|Overall Study||64||
48211606|NCT00716859|100842790|FG000|NOT COMPLETED|Overall Study||9||
48211607|NCT00716859|100842791|FG001|NOT COMPLETED|Overall Study||5||
48211608|NCT01493778|100842792|FG000|STARTED|Overall Study||60||
48211609|NCT01493778|100842792|FG000|COMPLETED|Overall Study||52||
48211610|NCT01493778|100842792|FG000|NOT COMPLETED|Overall Study||8||
48211611|NCT04600752|100842793|FG000|STARTED|Overall Study||136||
48211612|NCT04600752|100842794|FG001|STARTED|Overall Study||106||
48211613|NCT04600752|100842795|FG002|STARTED|Overall Study||68||
48211614|NCT04600752|100842793|FG000|COMPLETED|Overall Study||133||
48211615|NCT04600752|100842794|FG001|COMPLETED|Overall Study||104||
48211616|NCT04600752|100842795|FG002|COMPLETED|Overall Study||67||
48211617|NCT04600752|100842793|FG000|NOT COMPLETED|Overall Study||3||
48211618|NCT04600752|100842794|FG001|NOT COMPLETED|Overall Study||2||
48211619|NCT04600752|100842795|FG002|NOT COMPLETED|Overall Study||1||
48211620|NCT01376089|100845740|FG000|STARTED|Overall Study||151||
48211621|NCT01376089|100845741|FG001|STARTED|Overall Study||148||
48211622|NCT01376089|100845740|FG000|COMPLETED|Overall Study||148||
48211623|NCT01376089|100845741|FG001|COMPLETED|Overall Study||144||
48211624|NCT01376089|100845740|FG000|NOT COMPLETED|Overall Study||3||
48211625|NCT01376089|100845741|FG001|NOT COMPLETED|Overall Study||4||
48211626|NCT03573518|100845742|FG000|STARTED|Overall Study||92||
48211627|NCT03573518|100845743|FG001|STARTED|Overall Study||92||
48211628|NCT03573518|100845744|FG002|STARTED|Overall Study||92||
48211629|NCT03573518|100845745|FG003|STARTED|Overall Study||92||
48211630|NCT03573518|100845742|FG000|COMPLETED|Overall Study||69||
48211631|NCT03573518|100845743|FG001|COMPLETED|Overall Study||77||
48211632|NCT03573518|100845744|FG002|COMPLETED|Overall Study||70||
48211633|NCT03573518|100845745|FG003|COMPLETED|Overall Study||81||
48211634|NCT03573518|100845742|FG000|NOT COMPLETED|Overall Study||23||
48211635|NCT03573518|100845743|FG001|NOT COMPLETED|Overall Study||15||
48211636|NCT03573518|100845744|FG002|NOT COMPLETED|Overall Study||22||
48211637|NCT03573518|100845745|FG003|NOT COMPLETED|Overall Study||11||
48211638|NCT05382104|100845746|FG000|STARTED|Period 1 (2 Days)||5||
48211639|NCT05382104|100845747|FG001|STARTED|Period 1 (2 Days)||6||
48211640|NCT05382104|100845748|FG002|STARTED|Period 1 (2 Days)||5||
48211641|NCT05382104|100845749|FG003|STARTED|Period 1 (2 Days)||5||
48211642|NCT05382104|100845750|FG004|STARTED|Period 1 (2 Days)||5||
48211643|NCT05382104|100845751|FG005|STARTED|Period 1 (2 Days)||5||
48211644|NCT05382104|100845746|FG000|COMPLETED|Period 1 (2 Days)||5||
48211645|NCT05382104|100845747|FG001|COMPLETED|Period 1 (2 Days)||6||
48211646|NCT05382104|100845748|FG002|COMPLETED|Period 1 (2 Days)||5||
48211647|NCT05382104|100845749|FG003|COMPLETED|Period 1 (2 Days)||5||
48211648|NCT05382104|100845750|FG004|COMPLETED|Period 1 (2 Days)||5||
48211649|NCT05382104|100845751|FG005|COMPLETED|Period 1 (2 Days)||5||
48211650|NCT05382104|100845746|FG000|NOT COMPLETED|Period 1 (2 Days)||0||
48211651|NCT05382104|100845747|FG001|NOT COMPLETED|Period 1 (2 Days)||0||
48211652|NCT05382104|100845748|FG002|NOT COMPLETED|Period 1 (2 Days)||0||
48211653|NCT05382104|100845749|FG003|NOT COMPLETED|Period 1 (2 Days)||0||
48211654|NCT05382104|100845750|FG004|NOT COMPLETED|Period 1 (2 Days)||0||
48211655|NCT05382104|100845751|FG005|NOT COMPLETED|Period 1 (2 Days)||0||
48211656|NCT05382104|100845746|FG000|STARTED|Washout Period 1 (72 Hours)||5||
48211657|NCT05382104|100845747|FG001|STARTED|Washout Period 1 (72 Hours)||6||
48211658|NCT05382104|100845748|FG002|STARTED|Washout Period 1 (72 Hours)||5||
48211659|NCT05382104|100845749|FG003|STARTED|Washout Period 1 (72 Hours)||5||
48211660|NCT05382104|100845750|FG004|STARTED|Washout Period 1 (72 Hours)||5||
48211661|NCT05382104|100845751|FG005|STARTED|Washout Period 1 (72 Hours)||5||
48211662|NCT05382104|100845746|FG000|COMPLETED|Washout Period 1 (72 Hours)||5||
48211663|NCT05382104|100845747|FG001|COMPLETED|Washout Period 1 (72 Hours)||6||
48211664|NCT05382104|100845748|FG002|COMPLETED|Washout Period 1 (72 Hours)||5||
48211665|NCT05382104|100845749|FG003|COMPLETED|Washout Period 1 (72 Hours)||5||
48211666|NCT05382104|100845750|FG004|COMPLETED|Washout Period 1 (72 Hours)||5||
48211667|NCT05382104|100845751|FG005|COMPLETED|Washout Period 1 (72 Hours)||5||
48211668|NCT05382104|100845746|FG000|NOT COMPLETED|Washout Period 1 (72 Hours)||0||
48211669|NCT05382104|100845747|FG001|NOT COMPLETED|Washout Period 1 (72 Hours)||0||
48211670|NCT05382104|100845748|FG002|NOT COMPLETED|Washout Period 1 (72 Hours)||0||
48211671|NCT05382104|100845749|FG003|NOT COMPLETED|Washout Period 1 (72 Hours)||0||
48211672|NCT05382104|100845750|FG004|NOT COMPLETED|Washout Period 1 (72 Hours)||0||
48211673|NCT05382104|100845751|FG005|NOT COMPLETED|Washout Period 1 (72 Hours)||0||
48211674|NCT05382104|100845746|FG000|STARTED|Period 2 (2 Days)||5||
48211675|NCT05382104|100845747|FG001|STARTED|Period 2 (2 Days)||6||
48211676|NCT05382104|100845748|FG002|STARTED|Period 2 (2 Days)||5||
48211677|NCT05382104|100845749|FG003|STARTED|Period 2 (2 Days)||5||
48211678|NCT05382104|100845750|FG004|STARTED|Period 2 (2 Days)||5||
48211679|NCT05382104|100845751|FG005|STARTED|Period 2 (2 Days)||5||
48211680|NCT05382104|100845746|FG000|COMPLETED|Period 2 (2 Days)||5||
48211681|NCT05382104|100845747|FG001|COMPLETED|Period 2 (2 Days)||5||
48211682|NCT05382104|100845748|FG002|COMPLETED|Period 2 (2 Days)||5||
48211683|NCT05382104|100845749|FG003|COMPLETED|Period 2 (2 Days)||5||
48211684|NCT05382104|100845750|FG004|COMPLETED|Period 2 (2 Days)||5||
48211685|NCT05382104|100845751|FG005|COMPLETED|Period 2 (2 Days)||5||
48211686|NCT05382104|100845746|FG000|NOT COMPLETED|Period 2 (2 Days)||0||
48211687|NCT05382104|100845747|FG001|NOT COMPLETED|Period 2 (2 Days)||1||
48211688|NCT05382104|100845748|FG002|NOT COMPLETED|Period 2 (2 Days)||0||
48211689|NCT05382104|100845749|FG003|NOT COMPLETED|Period 2 (2 Days)||0||
48211690|NCT05382104|100845750|FG004|NOT COMPLETED|Period 2 (2 Days)||0||
48211691|NCT05382104|100845751|FG005|NOT COMPLETED|Period 2 (2 Days)||0||
48211692|NCT05382104|100845746|FG000|STARTED|Washout Period 2 (72 Hours)||5||
48211693|NCT05382104|100845747|FG001|STARTED|Washout Period 2 (72 Hours)||5||
48211694|NCT05382104|100845748|FG002|STARTED|Washout Period 2 (72 Hours)||5||
48211695|NCT05382104|100845749|FG003|STARTED|Washout Period 2 (72 Hours)||5||
48211696|NCT05382104|100845750|FG004|STARTED|Washout Period 2 (72 Hours)||5||
48211697|NCT05382104|100845751|FG005|STARTED|Washout Period 2 (72 Hours)||5||
48211698|NCT05382104|100845746|FG000|COMPLETED|Washout Period 2 (72 Hours)||5||
48211699|NCT05382104|100845747|FG001|COMPLETED|Washout Period 2 (72 Hours)||5||
48211700|NCT05382104|100845748|FG002|COMPLETED|Washout Period 2 (72 Hours)||5||
48211701|NCT05382104|100845749|FG003|COMPLETED|Washout Period 2 (72 Hours)||5||
48211702|NCT05382104|100845750|FG004|COMPLETED|Washout Period 2 (72 Hours)||5||
48211703|NCT05382104|100845751|FG005|COMPLETED|Washout Period 2 (72 Hours)||5||
48211704|NCT05382104|100845746|FG000|NOT COMPLETED|Washout Period 2 (72 Hours)||0||
48211705|NCT05382104|100845747|FG001|NOT COMPLETED|Washout Period 2 (72 Hours)||0||
48211706|NCT05382104|100845748|FG002|NOT COMPLETED|Washout Period 2 (72 Hours)||0||
48211707|NCT05382104|100845749|FG003|NOT COMPLETED|Washout Period 2 (72 Hours)||0||
48211708|NCT05382104|100845750|FG004|NOT COMPLETED|Washout Period 2 (72 Hours)||0||
48211709|NCT05382104|100845751|FG005|NOT COMPLETED|Washout Period 2 (72 Hours)||0||
48211710|NCT05382104|100845746|FG000|STARTED|Period 3 (2 Days)||5||
48211711|NCT05382104|100845747|FG001|STARTED|Period 3 (2 Days)||5||
48211712|NCT05382104|100845748|FG002|STARTED|Period 3 (2 Days)||5||
48211713|NCT05382104|100845749|FG003|STARTED|Period 3 (2 Days)||5||
48211714|NCT05382104|100845750|FG004|STARTED|Period 3 (2 Days)||5||
48211715|NCT05382104|100845751|FG005|STARTED|Period 3 (2 Days)||5||
48211716|NCT05382104|100845746|FG000|COMPLETED|Period 3 (2 Days)||5||
48211717|NCT05382104|100845747|FG001|COMPLETED|Period 3 (2 Days)||5||
48211718|NCT05382104|100845748|FG002|COMPLETED|Period 3 (2 Days)||5||
48211719|NCT05382104|100845749|FG003|COMPLETED|Period 3 (2 Days)||5||
48211720|NCT05382104|100845750|FG004|COMPLETED|Period 3 (2 Days)||5||
48211721|NCT05382104|100845751|FG005|COMPLETED|Period 3 (2 Days)||5||
48211722|NCT05382104|100845746|FG000|NOT COMPLETED|Period 3 (2 Days)||0||
48211723|NCT05382104|100845747|FG001|NOT COMPLETED|Period 3 (2 Days)||0||
48211724|NCT05382104|100845748|FG002|NOT COMPLETED|Period 3 (2 Days)||0||
48211725|NCT05382104|100845749|FG003|NOT COMPLETED|Period 3 (2 Days)||0||
48211726|NCT05382104|100845750|FG004|NOT COMPLETED|Period 3 (2 Days)||0||
48211727|NCT05382104|100845751|FG005|NOT COMPLETED|Period 3 (2 Days)||0||
48211728|NCT00262301|100845752|FG000|STARTED|Double-blind Phase||16||
48211729|NCT00262301|100845753|FG001|STARTED|Double-blind Phase||16||
48211730|NCT00262301|100845754|FG002|STARTED|Double-blind Phase||0||
48211731|NCT00262301|100845752|FG000|COMPLETED|Double-blind Phase||15||
48211732|NCT00262301|100845753|FG001|COMPLETED|Double-blind Phase||15||
48211733|NCT00262301|100845754|FG002|COMPLETED|Double-blind Phase||0||
48211734|NCT00262301|100845752|FG000|NOT COMPLETED|Double-blind Phase||1||
48211735|NCT00262301|100845753|FG001|NOT COMPLETED|Double-blind Phase||1||
48211736|NCT00262301|100845754|FG002|NOT COMPLETED|Double-blind Phase||0||
48211737|NCT00262301|100845752|FG000|STARTED|Open-label Phase||0||
48211738|NCT00262301|100845753|FG001|STARTED|Open-label Phase||0||
48211739|NCT00262301|100845754|FG002|STARTED|Open-label Phase||57||
48211740|NCT00262301|100845752|FG000|COMPLETED|Open-label Phase||0||
48211741|NCT00262301|100845753|FG001|COMPLETED|Open-label Phase||0||
48211742|NCT00262301|100845754|FG002|COMPLETED|Open-label Phase||57||
48211743|NCT00262301|100845752|FG000|NOT COMPLETED|Open-label Phase||0||
48211744|NCT00262301|100845753|FG001|NOT COMPLETED|Open-label Phase||0||
48211745|NCT00262301|100845754|FG002|NOT COMPLETED|Open-label Phase||0||
48211746|NCT01551355|100845755|FG000|STARTED|Overall Study||622||
48211747|NCT01551355|100845756|FG001|STARTED|Overall Study||594||
48211748|NCT01551355|100845757|FG002|STARTED|Overall Study||493||
48211749|NCT01551355|100845758|FG003|STARTED|Overall Study||435||
48211750|NCT01551355|100845759|FG004|STARTED|Overall Study||64||
48211751|NCT01551355|100845760|FG005|STARTED|Overall Study||71||
48211752|NCT01551355|100845755|FG000|COMPLETED|Overall Study||571||
48211753|NCT01551355|100845756|FG001|COMPLETED|Overall Study||545||
48211754|NCT01551355|100845757|FG002|COMPLETED|Overall Study||459||
48211755|NCT01551355|100845758|FG003|COMPLETED|Overall Study||411||
48211756|NCT01551355|100845759|FG004|COMPLETED|Overall Study||55||
48211757|NCT01551355|100845760|FG005|COMPLETED|Overall Study||65||
48211758|NCT01551355|100845755|FG000|NOT COMPLETED|Overall Study||51||
48211759|NCT01551355|100845756|FG001|NOT COMPLETED|Overall Study||49||
48211760|NCT01551355|100845757|FG002|NOT COMPLETED|Overall Study||34||
48211761|NCT01551355|100845758|FG003|NOT COMPLETED|Overall Study||24||
48211762|NCT01551355|100845759|FG004|NOT COMPLETED|Overall Study||9||
48211763|NCT01551355|100845760|FG005|NOT COMPLETED|Overall Study||6||
48211764|NCT02271854|100845761|FG000|STARTED|Overall Study||102||
48211765|NCT02271854|100845761|FG000|COMPLETED|Overall Study||98||
48211766|NCT02271854|100845761|FG000|NOT COMPLETED|Overall Study||4||
48211767|NCT03714815|100845762|FG000|STARTED|Overall Study||91||
48211768|NCT03714815|100845762|FG000|COMPLETED|Overall Study||76||
48211769|NCT03714815|100845762|FG000|NOT COMPLETED|Overall Study||15||
48211770|NCT00609336|100845763|FG000|STARTED|Overall Study||35||
48211771|NCT00609336|100845763|FG000|Surgery|Overall Study||22||
48211772|NCT00609336|100845763|FG000|COMPLETED|Overall Study||22||
48211773|NCT00609336|100845763|FG000|NOT COMPLETED|Overall Study||13||
48211774|NCT01381471|100845764|FG000|STARTED|Overall Study||11060||
48211775|NCT01381471|100845764|FG000|COMPLETED|Overall Study||11060||
48211776|NCT01381471|100845764|FG000|NOT COMPLETED|Overall Study||0||
48211777|NCT01537419|100845765|FG000|STARTED|Overall Study||63||
48211778|NCT01537419|100845766|FG001|STARTED|Overall Study||66||
48211779|NCT01537419|100845765|FG000|COMPLETED|Overall Study||52||
48211780|NCT01537419|100845766|FG001|COMPLETED|Overall Study||54||
48211781|NCT01537419|100845765|FG000|NOT COMPLETED|Overall Study||11||
48211782|NCT01537419|100845766|FG001|NOT COMPLETED|Overall Study||12||
48211783|NCT00825630|100845767|FG000|STARTED|Overall Study||29||
48211784|NCT00825630|100845768|FG001|STARTED|Overall Study||62||
48211785|NCT00825630|100845769|FG002|STARTED|Overall Study||19||
48211786|NCT00825630|100845770|FG003|STARTED|Overall Study||13||
48211787|NCT00825630|100845767|FG000|COMPLETED|Overall Study||29||
48211788|NCT00825630|100845768|FG001|COMPLETED|Overall Study||62||
48211789|NCT00825630|100845769|FG002|COMPLETED|Overall Study||19||
48211790|NCT00825630|100845770|FG003|COMPLETED|Overall Study||13||
48211791|NCT00825630|100845767|FG000|NOT COMPLETED|Overall Study||0||
48211792|NCT00825630|100845768|FG001|NOT COMPLETED|Overall Study||0||
48211793|NCT00825630|100845769|FG002|NOT COMPLETED|Overall Study||0||
48211794|NCT00825630|100845770|FG003|NOT COMPLETED|Overall Study||0||
48211795|NCT02706717|100845771|FG000|STARTED|Overall Study||47||
48211796|NCT02706717|100845772|FG001|STARTED|Overall Study||46||
48211797|NCT02706717|100845771|FG000|COMPLETED|Overall Study||46||
48211798|NCT02706717|100845772|FG001|COMPLETED|Overall Study||35||
48211799|NCT02706717|100845771|FG000|NOT COMPLETED|Overall Study||1||
48211800|NCT02706717|100845772|FG001|NOT COMPLETED|Overall Study||11||
48211801|NCT02466516|100845773|FG000|STARTED|Overall Study||20||
48211802|NCT02466516|100845774|FG001|STARTED|Overall Study||22||
48211803|NCT02466516|100845775|FG002|STARTED|Overall Study||10||
48211804|NCT02466516|100845776|FG003|STARTED|Overall Study||10||
48211805|NCT02466516|100845777|FG004|STARTED|Overall Study||10||
48211806|NCT02466516|100845773|FG000|COMPLETED|Overall Study||16||
48211807|NCT02466516|100845774|FG001|COMPLETED|Overall Study||21||
48211808|NCT02466516|100845775|FG002|COMPLETED|Overall Study||9||
48211809|NCT02466516|100845776|FG003|COMPLETED|Overall Study||10||
48211810|NCT02466516|100845777|FG004|COMPLETED|Overall Study||10||
48211811|NCT02466516|100845773|FG000|NOT COMPLETED|Overall Study||4||
48211812|NCT02466516|100845774|FG001|NOT COMPLETED|Overall Study||1||
48211813|NCT02466516|100845775|FG002|NOT COMPLETED|Overall Study||1||
48211814|NCT02466516|100845776|FG003|NOT COMPLETED|Overall Study||0||
48211815|NCT02466516|100845777|FG004|NOT COMPLETED|Overall Study||0||
48211816|NCT03950622|100845778|FG000|STARTED|Overall Study||604||
48211817|NCT03950622|100845779|FG001|STARTED|Overall Study||601||
48211818|NCT03950622|100845778|FG000|Vaccinated|Overall Study||602||
48211819|NCT03950622|100845779|FG001|Vaccinated|Overall Study||600||
48495944|NCT01741545|101547974|FG001|NOT COMPLETED|Treatment Period||4||
48495945|NCT01741545|101547973|FG000|STARTED|Follow-up Period (24 Weeks)||12||
48211820|NCT03950622|100845778|FG000|COMPLETED|Overall Study||596||
48211821|NCT03950622|100845779|FG001|COMPLETED|Overall Study||594||
48211822|NCT03950622|100845778|FG000|NOT COMPLETED|Overall Study||8||
48211823|NCT03950622|100845779|FG001|NOT COMPLETED|Overall Study||7||
48211824|NCT01691690|100845780|FG000|STARTED|Overall Study||125||
48211825|NCT01691690|100845781|FG001|STARTED|Overall Study||125||
48211826|NCT01691690|100845780|FG000|COMPLETED|Overall Study||118||
48211827|NCT01691690|100845781|FG001|COMPLETED|Overall Study||121||
48211828|NCT01691690|100845780|FG000|NOT COMPLETED|Overall Study||7||
48211829|NCT01691690|100845781|FG001|NOT COMPLETED|Overall Study||4||
48211830|NCT01070069|100845782|FG000|STARTED|Overall Study||50||
48211831|NCT01070069|100845783|FG001|STARTED|Overall Study||50||
48211832|NCT01070069|100845784|FG002|STARTED|Overall Study||51||
48211833|NCT01070069|100845785|FG003|STARTED|Overall Study||19||
48211834|NCT01070069|100845786|FG004|STARTED|Overall Study||22||
48059690|NCT02612129|100466994|FG000|COMPLETED|Continuous Treatment Period||0||
48059691|NCT02612129|100466995|FG001|COMPLETED|Continuous Treatment Period||27||
48059692|NCT02612129|100466996|FG002|COMPLETED|Continuous Treatment Period||15||
48059693|NCT02612129|100466994|FG000|NOT COMPLETED|Continuous Treatment Period||0||
48059694|NCT02612129|100466995|FG001|NOT COMPLETED|Continuous Treatment Period||7||
48059695|NCT02612129|100466996|FG002|NOT COMPLETED|Continuous Treatment Period||1||
48059696|NCT01885871|100466997|FG000|STARTED|Overall Study||20||
48059697|NCT01885871|100466997|FG000|COMPLETED|Overall Study||20||
48059698|NCT01885871|100466997|FG000|NOT COMPLETED|Overall Study||0||
48059699|NCT02080637|100466998|FG000|STARTED|Overall Study||13||
48059700|NCT02080637|100466999|FG001|STARTED|Overall Study||3||
48059701|NCT02080637|100466998|FG000|COMPLETED|Overall Study||13||
48059702|NCT02080637|100466999|FG001|COMPLETED|Overall Study||3||
48059703|NCT02080637|100466998|FG000|NOT COMPLETED|Overall Study||0||
48059704|NCT02080637|100466999|FG001|NOT COMPLETED|Overall Study||0||
48059705|NCT04926077|100467000|FG000|STARTED|Overall Study||11||
48059706|NCT04926077|100467000|FG000|COMPLETED|Overall Study||11||
48059707|NCT04926077|100467000|FG000|NOT COMPLETED|Overall Study||0||
48059708|NCT02810340|100467001|FG000|STARTED|Overall Study||20||
48059709|NCT02810340|100467002|FG001|STARTED|Overall Study||20||
48059710|NCT02810340|100467003|FG002|STARTED|Overall Study||20||
48059711|NCT02810340|100467001|FG000|COMPLETED|Overall Study||19||
48059712|NCT02810340|100467002|FG001|COMPLETED|Overall Study||19||
48059713|NCT02810340|100467003|FG002|COMPLETED|Overall Study||19||
48059714|NCT02810340|100467001|FG000|NOT COMPLETED|Overall Study||1||
48059715|NCT02810340|100467002|FG001|NOT COMPLETED|Overall Study||1||
48059716|NCT02810340|100467003|FG002|NOT COMPLETED|Overall Study||1||
48059717|NCT00739999|100467004|FG000|STARTED|Overall Study||15||
48059718|NCT00739999|100467005|FG001|STARTED|Overall Study||24||
48059719|NCT00739999|100467004|FG000|COMPLETED|Overall Study||15||
48059720|NCT00739999|100467005|FG001|COMPLETED|Overall Study||24||
48059721|NCT00739999|100467004|FG000|NOT COMPLETED|Overall Study||0||
48059722|NCT00739999|100467005|FG001|NOT COMPLETED|Overall Study||0||
48059723|NCT01323946|100467006|FG000|STARTED|Overall Study||46||
48059724|NCT01323946|100467007|FG001|STARTED|Overall Study||34||
48059725|NCT01323946|100467008|FG002|STARTED|Overall Study||33||
48059726|NCT01323946|100467006|FG000|COMPLETED|Overall Study||43||
48059727|NCT01323946|100467007|FG001|COMPLETED|Overall Study||31||
48059728|NCT01323946|100467008|FG002|COMPLETED|Overall Study||33||
48059729|NCT01323946|100467006|FG000|NOT COMPLETED|Overall Study||3||
48059730|NCT01323946|100467007|FG001|NOT COMPLETED|Overall Study||3||
48059731|NCT01323946|100467008|FG002|NOT COMPLETED|Overall Study||0||
48059732|NCT02963831|100467009|FG000|STARTED|Overall Study||4|Started includes all subjects who received at least one dose of study therapy.|
48059733|NCT02963831|100467010|FG001|STARTED|Overall Study||5|Started includes all subjects who received at least one dose of study therapy.|
48059734|NCT02963831|100467011|FG002|STARTED|Overall Study||19|Started includes all subjects who received at least one dose of study therapy.|
48059735|NCT02963831|100467012|FG003|STARTED|Overall Study||36|Started includes all subjects who received at least one dose of study therapy.|
48059736|NCT02963831|100467009|FG000|COMPLETED|Overall Study||0|Completed includes all subjects who completed 12 cycles of treatment.|
48059737|NCT02963831|100467010|FG001|COMPLETED|Overall Study||1|Completed includes all subjects who completed 12 cycles of treatment.|
48059738|NCT02963831|100467011|FG002|COMPLETED|Overall Study||0|Completed includes all subjects who completed 12 cycles of treatment.|
48059739|NCT02963831|100467012|FG003|COMPLETED|Overall Study||1|Completed includes all subjects who completed 12 cycles of treatment.|
48059740|NCT02963831|100467009|FG000|NOT COMPLETED|Overall Study||4||
48059741|NCT02963831|100467010|FG001|NOT COMPLETED|Overall Study||4||
48059742|NCT02963831|100467011|FG002|NOT COMPLETED|Overall Study||19||
48059743|NCT02963831|100467012|FG003|NOT COMPLETED|Overall Study||35||
48059744|NCT04439175|100467013|FG000|STARTED|Overall Study||70||
48059745|NCT04439175|100467013|FG000|Started Protocol Therapy|Overall Study||66||
48059746|NCT04439175|100467013|FG000|Eligible and Started Protocol Therapy|Overall Study||61|Four patients did not initiate protocol therapy and five patients initiated therapy but were subsequently found to be ineligible by central review. This is the primary analysis population.|
48059747|NCT04439175|100467013|FG000|COMPLETED|Overall Study||0|Treatment continued until disease progression or intolerability.|
48059748|NCT04439175|100467013|FG000|NOT COMPLETED|Overall Study||70||
48059749|NCT01822496|100467014|FG000|STARTED|Overall Study||16||
48059750|NCT01822496|100467015|FG001|STARTED|Overall Study||23||
48059751|NCT01822496|100467016|FG002|STARTED|Overall Study||9||
48059752|NCT01822496|100467017|FG003|STARTED|Overall Study||11||
48059753|NCT01822496|100467014|FG000|Eligible|Overall Study||14||
48059754|NCT01822496|100467015|FG001|Eligible|Overall Study||21||
48059755|NCT01822496|100467016|FG002|Eligible|Overall Study||9||
48211835|NCT01070069|100845782|FG000|COMPLETED|Overall Study||44||
48211836|NCT01070069|100845783|FG001|COMPLETED|Overall Study||48||
48211837|NCT01070069|100845784|FG002|COMPLETED|Overall Study||45||
48211838|NCT01070069|100845785|FG003|COMPLETED|Overall Study||19||
48211839|NCT01070069|100845786|FG004|COMPLETED|Overall Study||18||
48211840|NCT01070069|100845782|FG000|NOT COMPLETED|Overall Study||6||
48211841|NCT01070069|100845783|FG001|NOT COMPLETED|Overall Study||2||
48211842|NCT01070069|100845784|FG002|NOT COMPLETED|Overall Study||6||
48211843|NCT01070069|100845785|FG003|NOT COMPLETED|Overall Study||0||
48211844|NCT01070069|100845786|FG004|NOT COMPLETED|Overall Study||4||
48211845|NCT01154985|100845787|FG000|STARTED|Overall Study||75||
48211846|NCT01154985|100845788|FG001|STARTED|Overall Study||82||
48211847|NCT01154985|100845789|FG002|STARTED|Overall Study||86||
48211848|NCT01154985|100845787|FG000|Full Analysis Set|Overall Study||75||
48211849|NCT01154985|100845788|FG001|Full Analysis Set|Overall Study||82||
48211850|NCT01154985|100845789|FG002|Full Analysis Set|Overall Study||86||
48211851|NCT01154985|100845787|FG000|Valid Biopsy -Baseline and Month 12.5|Overall Study||60||
48211852|NCT01154985|100845788|FG001|Valid Biopsy -Baseline and Month 12.5|Overall Study||62||
48211853|NCT01154985|100845789|FG002|Valid Biopsy -Baseline and Month 12.5|Overall Study||68||
48211854|NCT01154985|100845787|FG000|Efficacy Evaluable Analysis Set|Overall Study||55||
48211855|NCT01154985|100845788|FG001|Efficacy Evaluable Analysis Set|Overall Study||55||
48211856|NCT01154985|100845789|FG002|Efficacy Evaluable Analysis Set|Overall Study||64||
48211857|NCT01154985|100845787|FG000|COMPLETED|Overall Study||58||
48211858|NCT01154985|100845788|FG001|COMPLETED|Overall Study||55||
48211859|NCT01154985|100845789|FG002|COMPLETED|Overall Study||68||
48211860|NCT01154985|100845787|FG000|NOT COMPLETED|Overall Study||17||
48211861|NCT01154985|100845788|FG001|NOT COMPLETED|Overall Study||27||
48211862|NCT01154985|100845789|FG002|NOT COMPLETED|Overall Study||18||
48211863|NCT01579916|100845790|FG000|STARTED|Overall Study||242||
48211864|NCT01579916|100845791|FG001|STARTED|Overall Study||61||
48211865|NCT01579916|100845790|FG000|COMPLETED|Overall Study||234||
48211866|NCT01579916|100845791|FG001|COMPLETED|Overall Study||59||
48211867|NCT01579916|100845790|FG000|NOT COMPLETED|Overall Study||8||
48211868|NCT01579916|100845791|FG001|NOT COMPLETED|Overall Study||2||
48211869|NCT00879060|100845792|FG000|STARTED|Overall Study||26||
48211870|NCT00879060|100845793|FG001|STARTED|Overall Study||27||
48211871|NCT00879060|100845792|FG000|COMPLETED|Overall Study||26||
48211872|NCT00879060|100845793|FG001|COMPLETED|Overall Study||27||
48211873|NCT00879060|100845792|FG000|NOT COMPLETED|Overall Study||0||
48211874|NCT00879060|100845793|FG001|NOT COMPLETED|Overall Study||0||
48211875|NCT00411216|100845794|FG000|STARTED|Overall Study||13||
48059756|NCT01822496|100467017|FG003|Eligible|Overall Study||7||
48059757|NCT01822496|100467014|FG000|Eligible With Disease Assessment|Overall Study||10||
48059758|NCT01822496|100467015|FG001|Eligible With Disease Assessment|Overall Study||15||
48059759|NCT01822496|100467016|FG002|Eligible With Disease Assessment|Overall Study||6||
48059760|NCT01822496|100467017|FG003|Eligible With Disease Assessment|Overall Study||4||
48211876|NCT00411216|100845795|FG001|STARTED|Overall Study||10||
48211877|NCT00411216|100845794|FG000|COMPLETED|Overall Study||13||
48211878|NCT00411216|100845795|FG001|COMPLETED|Overall Study||8||
48211879|NCT00411216|100845794|FG000|NOT COMPLETED|Overall Study||0||
48211880|NCT00411216|100845795|FG001|NOT COMPLETED|Overall Study||2||
48211881|NCT03260140|100845796|FG000|STARTED|Overall Study||254||
48211882|NCT03260140|100845797|FG001|STARTED|Overall Study||257||
48211883|NCT03260140|100845796|FG000|COMPLETED|Overall Study||249||
48211884|NCT03260140|100845797|FG001|COMPLETED|Overall Study||252||
48211885|NCT03260140|100845796|FG000|NOT COMPLETED|Overall Study||5||
48211886|NCT03260140|100845797|FG001|NOT COMPLETED|Overall Study||5||
48211887|NCT01546753|100845798|FG000|STARTED|Overall Study||10||
48211888|NCT01546753|100845799|FG001|STARTED|Overall Study||4||
48211889|NCT01546753|100845798|FG000|COMPLETED|Overall Study||8||
48211890|NCT01546753|100845799|FG001|COMPLETED|Overall Study||3||
48211891|NCT01546753|100845798|FG000|NOT COMPLETED|Overall Study||2||
48211892|NCT01546753|100845799|FG001|NOT COMPLETED|Overall Study||1||
48211893|NCT00595413|100845800|FG000|STARTED|Overall Study||76||
48211894|NCT00595413|100845801|FG001|STARTED|Overall Study||78||
48211895|NCT00595413|100845802|FG002|STARTED|Overall Study||78||
48211896|NCT00595413|100845803|FG003|STARTED|Overall Study||79||
48211897|NCT00595413|100845800|FG000|COMPLETED|Overall Study||69||
48211898|NCT00595413|100845801|FG001|COMPLETED|Overall Study||73||
48211899|NCT00595413|100845802|FG002|COMPLETED|Overall Study||70||
48211900|NCT00595413|100845803|FG003|COMPLETED|Overall Study||75||
48211901|NCT00595413|100845800|FG000|NOT COMPLETED|Overall Study||7||
48211902|NCT00595413|100845801|FG001|NOT COMPLETED|Overall Study||5||
48211903|NCT00595413|100845802|FG002|NOT COMPLETED|Overall Study||8||
48211904|NCT00595413|100845803|FG003|NOT COMPLETED|Overall Study||4||
48211905|NCT00779870|100845804|FG000|STARTED|Overall Study||5||
48211906|NCT00779870|100845805|FG001|STARTED|Overall Study||6||
48211907|NCT00779870|100845806|FG002|STARTED|Overall Study||7||
48211908|NCT00779870|100845804|FG000|COMPLETED|Overall Study||5||
48211909|NCT00779870|100845805|FG001|COMPLETED|Overall Study||6||
48211910|NCT00779870|100845806|FG002|COMPLETED|Overall Study||7||
48211911|NCT00779870|100845804|FG000|NOT COMPLETED|Overall Study||0||
48211912|NCT00779870|100845805|FG001|NOT COMPLETED|Overall Study||0||
48211913|NCT00779870|100845806|FG002|NOT COMPLETED|Overall Study||0||
48211914|NCT01411592|100845807|FG000|STARTED|Overall Study||14||
48211915|NCT01411592|100845808|FG001|STARTED|Overall Study||16||
48211916|NCT01411592|100845807|FG000|5-Year Time Frame|Overall Study||14||
48211917|NCT01411592|100845808|FG001|5-Year Time Frame|Overall Study||16||
48211918|NCT01411592|100845807|FG000|COMPLETED|Overall Study||14||
48211919|NCT01411592|100845808|FG001|COMPLETED|Overall Study||16||
48211920|NCT01411592|100845807|FG000|NOT COMPLETED|Overall Study||0||
48211921|NCT01411592|100845808|FG001|NOT COMPLETED|Overall Study||0||
48211922|NCT01877343|100845809|FG000|STARTED|Overall Study||2||
48211923|NCT01877343|100845810|FG001|STARTED|Overall Study||3||
48211924|NCT01877343|100845811|FG002|STARTED|Overall Study||0||
48211925|NCT01877343|100845812|FG003|STARTED|Overall Study||0||
48211926|NCT01877343|100845813|FG004|STARTED|Overall Study||0||
48211927|NCT01877343|100845814|FG005|STARTED|Overall Study||5||
48211928|NCT01877343|100845815|FG006|STARTED|Overall Study||0||
48211929|NCT01877343|100845809|FG000|COMPLETED|Overall Study||2||
48211930|NCT01877343|100845810|FG001|COMPLETED|Overall Study||3||
48211931|NCT01877343|100845811|FG002|COMPLETED|Overall Study||0||
48211932|NCT01877343|100845812|FG003|COMPLETED|Overall Study||0||
48211933|NCT01877343|100845813|FG004|COMPLETED|Overall Study||0||
48211934|NCT01877343|100845814|FG005|COMPLETED|Overall Study||5||
48211935|NCT01877343|100845815|FG006|COMPLETED|Overall Study||0||
48211936|NCT01877343|100845809|FG000|NOT COMPLETED|Overall Study||0||
48211937|NCT01877343|100845810|FG001|NOT COMPLETED|Overall Study||0||
48211938|NCT01877343|100845811|FG002|NOT COMPLETED|Overall Study||0||
48211939|NCT01877343|100845812|FG003|NOT COMPLETED|Overall Study||0||
48211940|NCT01877343|100845813|FG004|NOT COMPLETED|Overall Study||0||
48211941|NCT01877343|100845814|FG005|NOT COMPLETED|Overall Study||0||
48211942|NCT01877343|100845815|FG006|NOT COMPLETED|Overall Study||0||
48211943|NCT02886286|100845816|FG000|STARTED|Overall Study||8||
48211944|NCT02886286|100845817|FG001|STARTED|Overall Study||9||
48211945|NCT02886286|100845816|FG000|COMPLETED|Overall Study||8|one patient had an unrelated motor stall of the pump|
48211946|NCT02886286|100845817|FG001|COMPLETED|Overall Study||8|one patient had an unrelated motor stall of the pump|
48211947|NCT02886286|100845816|FG000|NOT COMPLETED|Overall Study||0||
48211948|NCT02886286|100845817|FG001|NOT COMPLETED|Overall Study||1||
48211949|NCT02079844|100845818|FG000|STARTED|Treatment Period 1||6||
48211950|NCT02079844|100845819|FG001|STARTED|Treatment Period 1||7||
48211951|NCT02079844|100845820|FG002|STARTED|Treatment Period 1||7||
48211952|NCT02079844|100845818|FG000|COMPLETED|Treatment Period 1||6||
48211953|NCT02079844|100845819|FG001|COMPLETED|Treatment Period 1||7||
48211954|NCT02079844|100845820|FG002|COMPLETED|Treatment Period 1||5||
48211955|NCT02079844|100845818|FG000|NOT COMPLETED|Treatment Period 1||0||
48211956|NCT02079844|100845819|FG001|NOT COMPLETED|Treatment Period 1||0||
48211957|NCT02079844|100845820|FG002|NOT COMPLETED|Treatment Period 1||2||
48211958|NCT02079844|100845818|FG000|STARTED|Treatment Period 2||5||
48211959|NCT02079844|100845819|FG001|STARTED|Treatment Period 2||7||
48211960|NCT02079844|100845820|FG002|STARTED|Treatment Period 2||5||
48211961|NCT02079844|100845818|FG000|COMPLETED|Treatment Period 2||5||
48211962|NCT02079844|100845819|FG001|COMPLETED|Treatment Period 2||6||
48211963|NCT02079844|100845820|FG002|COMPLETED|Treatment Period 2||5||
48211964|NCT02079844|100845818|FG000|NOT COMPLETED|Treatment Period 2||0||
48211965|NCT02079844|100845819|FG001|NOT COMPLETED|Treatment Period 2||1||
48211966|NCT02079844|100845820|FG002|NOT COMPLETED|Treatment Period 2||0||
48211967|NCT02079844|100845818|FG000|STARTED|Treatment Period 3||5||
48211968|NCT02079844|100845819|FG001|STARTED|Treatment Period 3||5||
48211969|NCT02079844|100845820|FG002|STARTED|Treatment Period 3||5||
48211970|NCT02079844|100845818|FG000|COMPLETED|Treatment Period 3||5||
48211971|NCT02079844|100845819|FG001|COMPLETED|Treatment Period 3||5||
48211972|NCT02079844|100845820|FG002|COMPLETED|Treatment Period 3||5||
48211973|NCT02079844|100845818|FG000|NOT COMPLETED|Treatment Period 3||0||
48211974|NCT02079844|100845819|FG001|NOT COMPLETED|Treatment Period 3||0||
48211975|NCT02079844|100845820|FG002|NOT COMPLETED|Treatment Period 3||0||
48211976|NCT04071756|100845821|FG000|STARTED|Overall Study||5||
48211977|NCT04071756|100845822|FG001|STARTED|Overall Study||3||
48211978|NCT04071756|100845821|FG000|Patient Reported Outcomes (PRO) Evaluable|Overall Study||2||
48211979|NCT04071756|100845822|FG001|Patient Reported Outcomes (PRO) Evaluable|Overall Study||1||
48211980|NCT04071756|100845821|FG000|COMPLETED|Overall Study||5||
48211981|NCT04071756|100845822|FG001|COMPLETED|Overall Study||3||
48211982|NCT04071756|100845821|FG000|NOT COMPLETED|Overall Study||0||
48211983|NCT04071756|100845822|FG001|NOT COMPLETED|Overall Study||0||
48211984|NCT01224015|100845823|FG000|STARTED|Overall Study||361||
48211985|NCT01224015|100845824|FG001|STARTED|Overall Study||227||
48211986|NCT01224015|100845825|FG002|STARTED|Overall Study||96||
48211987|NCT01224015|100845823|FG000|COMPLETED|Overall Study||347||
48211988|NCT01224015|100845824|FG001|COMPLETED|Overall Study||211||
48211989|NCT01224015|100845825|FG002|COMPLETED|Overall Study||83||
48211990|NCT01224015|100845823|FG000|NOT COMPLETED|Overall Study||14||
48211991|NCT01224015|100845824|FG001|NOT COMPLETED|Overall Study||16||
48211992|NCT01224015|100845825|FG002|NOT COMPLETED|Overall Study||13||
48211993|NCT00687856|100845826|FG000|STARTED|Overall Study||211||
48211994|NCT00687856|100845826|FG000|COMPLETED|Overall Study||211||
48211995|NCT00687856|100845826|FG000|NOT COMPLETED|Overall Study||0||
48211996|NCT02224924|100845827|FG000|STARTED|Overall Study||226||
48211997|NCT02224924|100845828|FG001|STARTED|Overall Study||228||
48211998|NCT02224924|100845827|FG000|COMPLETED|Overall Study||156||
48211999|NCT02224924|100845828|FG001|COMPLETED|Overall Study||162||
48212000|NCT02224924|100845827|FG000|NOT COMPLETED|Overall Study||70||
48212001|NCT02224924|100845828|FG001|NOT COMPLETED|Overall Study||66||
48212002|NCT01837966|100845829|FG000|STARTED|Overall Study||47||
48212003|NCT01837966|100845830|FG001|STARTED|Overall Study||46||
48212004|NCT01837966|100845829|FG000|COMPLETED|Overall Study||45||
48212005|NCT01837966|100845830|FG001|COMPLETED|Overall Study||45||
48212006|NCT01837966|100845829|FG000|NOT COMPLETED|Overall Study||2||
48212007|NCT01837966|100845830|FG001|NOT COMPLETED|Overall Study||1||
48212008|NCT01406223|100845831|FG000|STARTED|Overall Study||18||
48212009|NCT01406223|100845832|FG001|STARTED|Overall Study||19||
48212010|NCT01406223|100845833|FG002|STARTED|Overall Study||20||
48212011|NCT01406223|100845834|FG003|STARTED|Overall Study||19||
48212012|NCT01406223|100845831|FG000|COMPLETED|Overall Study||6||
48212013|NCT01406223|100845832|FG001|COMPLETED|Overall Study||7||
48212014|NCT01406223|100845833|FG002|COMPLETED|Overall Study||2||
48212015|NCT01406223|100845834|FG003|COMPLETED|Overall Study||3||
48212016|NCT01406223|100845831|FG000|NOT COMPLETED|Overall Study||12||
48212017|NCT01406223|100845832|FG001|NOT COMPLETED|Overall Study||12||
48212018|NCT01406223|100845833|FG002|NOT COMPLETED|Overall Study||18||
48212019|NCT01406223|100845834|FG003|NOT COMPLETED|Overall Study||16||
48212020|NCT04204993|100845835|FG000|STARTED|Overall Study||20||
48212021|NCT04204993|100845835|FG000|Group A|Overall Study||4||
48212022|NCT04204993|100845835|FG000|Group B|Overall Study||6||
48212023|NCT04204993|100845835|FG000|Group C|Overall Study||6||
48212024|NCT04204993|100845835|FG000|Group D|Overall Study||4||
48212025|NCT04204993|100845835|FG000|COMPLETED|Overall Study||20||
48212026|NCT04204993|100845835|FG000|NOT COMPLETED|Overall Study||0||
48212027|NCT02020252|100845836|FG000|STARTED|Overall Study||120||
48212028|NCT02020252|100845836|FG000|COMPLETED|Overall Study||120||
48212029|NCT02020252|100845836|FG000|NOT COMPLETED|Overall Study||0||
48212030|NCT00391846|100845837|FG000|STARTED|Overall Study||127||
48212031|NCT00391846|100845838|FG001|STARTED|Overall Study||125||
48212032|NCT00391846|100845837|FG000|COMPLETED|Overall Study||119||
48212033|NCT00391846|100845838|FG001|COMPLETED|Overall Study||118||
48212034|NCT00391846|100845837|FG000|NOT COMPLETED|Overall Study||8||
48212035|NCT00391846|100845838|FG001|NOT COMPLETED|Overall Study||7||
48212036|NCT01248936|100845839|FG000|STARTED|Overall Study||374||
48212037|NCT01248936|100845839|FG000|COMPLETED|Overall Study||0||
48212038|NCT01248936|100845839|FG000|NOT COMPLETED|Overall Study||374||
48212039|NCT00373386|100845840|FG000|STARTED|Overall Study||9||
48212040|NCT00373386|100845840|FG000|COMPLETED|Overall Study||9||
48212041|NCT00373386|100845840|FG000|NOT COMPLETED|Overall Study||0||
48212042|NCT01369498|100845841|FG000|STARTED|Overall Study||12||
48212043|NCT01369498|100845842|FG001|STARTED|Overall Study||12||
48212044|NCT01369498|100845843|FG002|STARTED|Overall Study||15||
48212045|NCT01369498|100845844|FG003|STARTED|Overall Study||15||
48212046|NCT01369498|100845841|FG000|COMPLETED|Overall Study||0||
48212047|NCT01369498|100845842|FG001|COMPLETED|Overall Study||0||
48212048|NCT01369498|100845843|FG002|COMPLETED|Overall Study||0||
48212049|NCT01369498|100845844|FG003|COMPLETED|Overall Study||0||
48212050|NCT01369498|100845841|FG000|NOT COMPLETED|Overall Study||12||
48212051|NCT01369498|100845842|FG001|NOT COMPLETED|Overall Study||12||
48212052|NCT01369498|100845843|FG002|NOT COMPLETED|Overall Study||15||
48212053|NCT01369498|100845844|FG003|NOT COMPLETED|Overall Study||15||
48212054|NCT01066026|100845845|FG000|STARTED|Overall Study||25||
48495946|NCT01741545|101547974|FG001|STARTED|Follow-up Period (24 Weeks)||39||
48495947|NCT01741545|101547973|FG000|COMPLETED|Follow-up Period (24 Weeks)||11||
48212055|NCT01066026|100845845|FG000|COMPLETED|Overall Study||23||
48212056|NCT01066026|100845845|FG000|NOT COMPLETED|Overall Study||2||
48212057|NCT01429350|100845846|FG000|STARTED|Overall Study||53||
48212058|NCT01429350|100845847|FG001|STARTED|Overall Study||55||
48212059|NCT01429350|100845846|FG000|As-Treated|Overall Study||62||
48212060|NCT01429350|100845847|FG001|As-Treated|Overall Study||43||
48212061|NCT01429350|100845846|FG000|Per Protocol|Overall Study||41||
48212062|NCT01429350|100845847|FG001|Per Protocol|Overall Study||37||
48212063|NCT01429350|100845846|FG000|90 Day|Overall Study||46||
48212064|NCT01429350|100845847|FG001|90 Day|Overall Study||50||
48212065|NCT01429350|100845846|FG000|COMPLETED|Overall Study||46||
48212066|NCT01429350|100845847|FG001|COMPLETED|Overall Study||50||
48212067|NCT01429350|100845846|FG000|NOT COMPLETED|Overall Study||7||
48212068|NCT01429350|100845847|FG001|NOT COMPLETED|Overall Study||5||
48212069|NCT02382744|100845848|FG000|STARTED|Overall Study||40||
48212070|NCT02382744|100845849|FG001|STARTED|Overall Study||40||
48212071|NCT02382744|100845848|FG000|Allocated|Overall Study||40||
48212072|NCT02382744|100845849|FG001|Allocated|Overall Study||40||
48212073|NCT02382744|100845848|FG000|Analyzed|Overall Study||40||
48212074|NCT02382744|100845849|FG001|Analyzed|Overall Study||40||
48212075|NCT02382744|100845848|FG000|COMPLETED|Overall Study||40||
48212076|NCT02382744|100845849|FG001|COMPLETED|Overall Study||40||
48212077|NCT02382744|100845848|FG000|NOT COMPLETED|Overall Study||0||
48212078|NCT02382744|100845849|FG001|NOT COMPLETED|Overall Study||0||
48212079|NCT02346526|100845850|FG000|STARTED|Overall Study||22||
48212080|NCT02346526|100845850|FG000|COMPLETED|Overall Study||22||
48212081|NCT02346526|100845850|FG000|NOT COMPLETED|Overall Study||0||
48212082|NCT00957242|100845851|FG000|STARTED|Overall Study||73||
48212083|NCT00957242|100845852|FG001|STARTED|Overall Study||72||
48212084|NCT00957242|100845851|FG000|COMPLETED|Overall Study||73||
48212085|NCT00957242|100845852|FG001|COMPLETED|Overall Study||72||
48212086|NCT00957242|100845851|FG000|NOT COMPLETED|Overall Study||0||
48212087|NCT00957242|100845852|FG001|NOT COMPLETED|Overall Study||0||
48212088|NCT03344536|100845853|FG000|STARTED|Overall Study||10||
48212089|NCT03344536|100845854|FG001|STARTED|Overall Study||0||
48212090|NCT03344536|100845853|FG000|COMPLETED|Overall Study||10||
48212091|NCT03344536|100845854|FG001|COMPLETED|Overall Study||0||
48212092|NCT03344536|100845853|FG000|NOT COMPLETED|Overall Study||0||
48212093|NCT03344536|100845854|FG001|NOT COMPLETED|Overall Study||0||
48212094|NCT01255670|100845855|FG000|STARTED|Overall Study||100||
48212095|NCT01255670|100845856|FG001|STARTED|Overall Study||100||
48212096|NCT01255670|100845855|FG000|COMPLETED|Overall Study||74||
48212097|NCT01255670|100845856|FG001|COMPLETED|Overall Study||80||
48212098|NCT01255670|100845855|FG000|NOT COMPLETED|Overall Study||26||
48212099|NCT01255670|100845856|FG001|NOT COMPLETED|Overall Study||20||
48212100|NCT02214160|100845857|FG000|STARTED|Overall Study||24||
48212101|NCT02214160|100845858|FG001|STARTED|Overall Study||37||
48212102|NCT02214160|100845859|FG002|STARTED|Overall Study||33||
48212103|NCT02214160|100845857|FG000|COMPLETED|Overall Study||20||
48212104|NCT02214160|100845858|FG001|COMPLETED|Overall Study||29||
48212105|NCT02214160|100845859|FG002|COMPLETED|Overall Study||23||
48212106|NCT02214160|100845857|FG000|NOT COMPLETED|Overall Study||4||
48212107|NCT02214160|100845858|FG001|NOT COMPLETED|Overall Study||8||
48212108|NCT02214160|100845859|FG002|NOT COMPLETED|Overall Study||10||
48212109|NCT02270645|100845860|FG000|STARTED|Overall Study||8||11
48212110|NCT02270645|100845861|FG001|STARTED|Overall Study||4||5
48212111|NCT02270645|100845860|FG000|COMPLETED|Overall Study||6||9
48212112|NCT02270645|100845861|FG001|COMPLETED|Overall Study||4||5
48212113|NCT02270645|100845860|FG000|NOT COMPLETED|Overall Study||2||2
48212114|NCT02270645|100845861|FG001|NOT COMPLETED|Overall Study||0||0
48212115|NCT00232180|100845862|FG000|STARTED|Double-blind (DB) Phase||1367||
48212116|NCT00232180|100845863|FG001|STARTED|Double-blind (DB) Phase||1376||
48212117|NCT00232180|100845864|FG002|STARTED|Double-blind (DB) Phase||0||
48212118|NCT00232180|100845862|FG000|Treated|Double-blind (DB) Phase||1364||
48212119|NCT00232180|100845863|FG001|Treated|Double-blind (DB) Phase||1372||
48212120|NCT00232180|100845864|FG002|Treated|Double-blind (DB) Phase||0||
48212121|NCT00232180|100845862|FG000|COMPLETED|Double-blind (DB) Phase||826||
48212122|NCT00232180|100845863|FG001|COMPLETED|Double-blind (DB) Phase||771||
48212123|NCT00232180|100845864|FG002|COMPLETED|Double-blind (DB) Phase||0||
48212124|NCT00232180|100845862|FG000|NOT COMPLETED|Double-blind (DB) Phase||541||
48212125|NCT00232180|100845863|FG001|NOT COMPLETED|Double-blind (DB) Phase||605||
48212126|NCT00232180|100845864|FG002|NOT COMPLETED|Double-blind (DB) Phase||0||
48212127|NCT00232180|100845862|FG000|STARTED|Open Label Phase||0||
48212128|NCT00232180|100845863|FG001|STARTED|Open Label Phase||0||
48212129|NCT00232180|100845864|FG002|STARTED|Open Label Phase||1246||
48212130|NCT00232180|100845862|FG000|Treated|Open Label Phase||0||
48212131|NCT00232180|100845863|FG001|Treated|Open Label Phase||0||
48212132|NCT00232180|100845864|FG002|Treated|Open Label Phase||1245||
48212133|NCT00232180|100845862|FG000|COMPLETED|Open Label Phase||0||
48212134|NCT00232180|100845863|FG001|COMPLETED|Open Label Phase||0||
48212135|NCT00232180|100845864|FG002|COMPLETED|Open Label Phase||1098||
48212136|NCT00232180|100845862|FG000|NOT COMPLETED|Open Label Phase||0||
48212137|NCT00232180|100845863|FG001|NOT COMPLETED|Open Label Phase||0||
48212138|NCT00232180|100845864|FG002|NOT COMPLETED|Open Label Phase||148||
48212139|NCT02771899|100845865|FG000|STARTED|Overall Study||20||
48212140|NCT02771899|100845866|FG001|STARTED|Overall Study||17||
48212141|NCT02771899|100845867|FG002|STARTED|Overall Study||6||
48212142|NCT02771899|100845868|FG003|STARTED|Overall Study||11||
48212143|NCT02771899|100845865|FG000|COMPLETED|Overall Study||0||
48212144|NCT02771899|100845866|FG001|COMPLETED|Overall Study||0||
48212145|NCT02771899|100845867|FG002|COMPLETED|Overall Study||0||
48212146|NCT02771899|100845868|FG003|COMPLETED|Overall Study||0||
48212147|NCT02771899|100845865|FG000|NOT COMPLETED|Overall Study||20||
48212148|NCT02771899|100845866|FG001|NOT COMPLETED|Overall Study||17||
48212149|NCT02771899|100845867|FG002|NOT COMPLETED|Overall Study||6||
48212150|NCT02771899|100845868|FG003|NOT COMPLETED|Overall Study||11||
48212151|NCT04056611|100845869|FG000|STARTED|Overall Study||3||
48212152|NCT04056611|100845869|FG000|COMPLETED|Overall Study||2||
48212153|NCT04056611|100845869|FG000|NOT COMPLETED|Overall Study||1||
48212154|NCT00371787|100845870|FG000|STARTED|Overall Study||26||
48212155|NCT00371787|100845871|FG001|STARTED|Overall Study||12||
48212156|NCT00371787|100845870|FG000|COMPLETED|Overall Study||23||
48212157|NCT00371787|100845871|FG001|COMPLETED|Overall Study||11||
48212158|NCT00371787|100845870|FG000|NOT COMPLETED|Overall Study||3||
48212159|NCT00371787|100845871|FG001|NOT COMPLETED|Overall Study||1||
48212160|NCT00352976|100845872|FG000|STARTED|Overall Study||83||
48212161|NCT00352976|100845872|FG000|COMPLETED|Overall Study||83||
48212162|NCT00352976|100845872|FG000|NOT COMPLETED|Overall Study||0||
48212163|NCT03245580|100845873|FG000|STARTED|Overall Study||75||
48212164|NCT03245580|100845874|FG001|STARTED|Overall Study||78||
48212165|NCT03245580|100845873|FG000|COMPLETED|Overall Study||75||
48212166|NCT03245580|100845874|FG001|COMPLETED|Overall Study||78||
48212167|NCT03245580|100845873|FG000|NOT COMPLETED|Overall Study||0||
48212168|NCT03245580|100845874|FG001|NOT COMPLETED|Overall Study||0||
48212169|NCT01610297|100845875|FG000|STARTED|Overall Study||27||
48212170|NCT01610297|100845875|FG000|COMPLETED|Overall Study||26||
48212171|NCT01610297|100845875|FG000|NOT COMPLETED|Overall Study||1||
48212172|NCT03675581|100845876|FG000|STARTED|Period 1: Microgynon Alone||17||
48212173|NCT03675581|100845876|FG000|COMPLETED|Period 1: Microgynon Alone||17||
48212174|NCT03675581|100845876|FG000|NOT COMPLETED|Period 1: Microgynon Alone||0||
48212175|NCT03675581|100845876|FG000|STARTED|Period 2: Microgynon + Nintedanib||17||
48212176|NCT03675581|100845876|FG000|COMPLETED|Period 2: Microgynon + Nintedanib||17||
48212177|NCT03675581|100845876|FG000|NOT COMPLETED|Period 2: Microgynon + Nintedanib||0||
48212178|NCT01836133|100845877|FG000|STARTED|Overall Study||70||
48212179|NCT01836133|100845877|FG000|COMPLETED|Overall Study||70||
48212180|NCT01836133|100845877|FG000|NOT COMPLETED|Overall Study||0||
48212181|NCT00373529|100845878|FG000|STARTED|Overall Study||116||
48212182|NCT00373529|100845878|FG000|Full Analysis Set|Overall Study||112||
48212183|NCT00373529|100845878|FG000|COMPLETED|Overall Study||8||
48212184|NCT00373529|100845878|FG000|NOT COMPLETED|Overall Study||108||
48212185|NCT01188369|100845879|FG000|STARTED|Overall Study||10||
48212186|NCT01188369|100845880|FG001|STARTED|Overall Study||10||
48212187|NCT01188369|100845879|FG000|COMPLETED|Overall Study||10||
48212188|NCT01188369|100845880|FG001|COMPLETED|Overall Study||10||
48212189|NCT01188369|100845879|FG000|NOT COMPLETED|Overall Study||0||
48212190|NCT01188369|100845880|FG001|NOT COMPLETED|Overall Study||0||
48212191|NCT02965846|100845881|FG000|STARTED|Overall Study||5||
48212192|NCT02965846|100845882|FG001|STARTED|Overall Study||5||
48212193|NCT02965846|100845883|FG002|STARTED|Overall Study||33||
48212194|NCT02965846|100845881|FG000|COMPLETED|Overall Study||0||
48212195|NCT02965846|100845882|FG001|COMPLETED|Overall Study||0||
48212196|NCT02965846|100845883|FG002|COMPLETED|Overall Study||0||
48212197|NCT02965846|100845881|FG000|NOT COMPLETED|Overall Study||5||
48212198|NCT02965846|100845882|FG001|NOT COMPLETED|Overall Study||5||
48212199|NCT02965846|100845883|FG002|NOT COMPLETED|Overall Study||33||
48212200|NCT02150967|100845884|FG000|STARTED|Overall Study||108||
48212201|NCT02150967|100845885|FG001|STARTED|Overall Study||25||
48212202|NCT02150967|100845886|FG002|STARTED|Overall Study||10||
48212203|NCT02150967|100845884|FG000|Treatment Ongoing|Overall Study||0||
48212204|NCT02150967|100845885|FG001|Treatment Ongoing|Overall Study||0||
48212205|NCT02150967|100845886|FG002|Treatment Ongoing|Overall Study||0||
48212206|NCT02150967|100845884|FG000|Treatment Ended|Overall Study||108|Per protocol, patients continue treatment until radiographical documentation of disease progression.|
48212207|NCT02150967|100845885|FG001|Treatment Ended|Overall Study||25|Per protocol, patients continue treatment until radiographical documentation of disease progression.|
48212208|NCT02150967|100845886|FG002|Treatment Ended|Overall Study||10|Per protocol, patients continue treatment until radiographical documentation of disease progression.|
48212209|NCT02150967|100845884|FG000|COMPLETED|Overall Study||108|"Cohort 1: completed is defined as patients who had the opportunity to be followed for at least 10 months after their initial exposure of infigratinib. This cohort supports the primary efficacy analysis of the study~Cohort 2 and 3: completed is defined as patients who may have had the opportunity to be followed for at least 10 months after their initial exposure of infigratinib or up to the time of study termination.~These cohorts support only the exploratory endpoints of the study"|
48212210|NCT02150967|100845885|FG001|COMPLETED|Overall Study||25|"Cohort 1: completed is defined as patients who had the opportunity to be followed for at least 10 months after their initial exposure of infigratinib. This cohort supports the primary efficacy analysis of the study~Cohort 2 and 3: completed is defined as patients who may have had the opportunity to be followed for at least 10 months after their initial exposure of infigratinib or up to the time of study termination.~These cohorts support only the exploratory endpoints of the study"|
48212211|NCT02150967|100845886|FG002|COMPLETED|Overall Study||10|"Cohort 1: completed is defined as patients who had the opportunity to be followed for at least 10 months after their initial exposure of infigratinib. This cohort supports the primary efficacy analysis of the study~Cohort 2 and 3: completed is defined as patients who may have had the opportunity to be followed for at least 10 months after their initial exposure of infigratinib or up to the time of study termination.~These cohorts support only the exploratory endpoints of the study"|
48212212|NCT02150967|100845884|FG000|NOT COMPLETED|Overall Study||0||
48212213|NCT02150967|100845885|FG001|NOT COMPLETED|Overall Study||0||
48212214|NCT02150967|100845886|FG002|NOT COMPLETED|Overall Study||0||
48212215|NCT00440011|100845887|FG000|STARTED|Overall Study||131||
48212216|NCT00440011|100845888|FG001|STARTED|Overall Study||135||
48212217|NCT00440011|100845887|FG000|COMPLETED|Overall Study||127||
48212218|NCT00440011|100845888|FG001|COMPLETED|Overall Study||132||
48212219|NCT00440011|100845887|FG000|NOT COMPLETED|Overall Study||4||
48212220|NCT00440011|100845888|FG001|NOT COMPLETED|Overall Study||3||
48212221|NCT01285635|100845889|FG000|STARTED|First Intervention (2 Weeks)||13||
48212222|NCT01285635|100845890|FG001|STARTED|First Intervention (2 Weeks)||11||
48212223|NCT01285635|100845891|FG002|STARTED|First Intervention (2 Weeks)||11||
48059761|NCT01822496|100467014|FG000|Eligible and Started Study Treatment|Overall Study||14||
48059762|NCT01822496|100467015|FG001|Eligible and Started Study Treatment|Overall Study||20||
48059763|NCT01822496|100467016|FG002|Eligible and Started Study Treatment|Overall Study||9||
48059764|NCT01822496|100467017|FG003|Eligible and Started Study Treatment|Overall Study||7||
48212224|NCT01285635|100845889|FG000|COMPLETED|First Intervention (2 Weeks)||13||
48212225|NCT01285635|100845890|FG001|COMPLETED|First Intervention (2 Weeks)||11||
48212226|NCT01285635|100845891|FG002|COMPLETED|First Intervention (2 Weeks)||11||
48212227|NCT01285635|100845889|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0||
48212228|NCT01285635|100845890|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0||
48212229|NCT01285635|100845891|FG002|NOT COMPLETED|First Intervention (2 Weeks)||0||
48212230|NCT01285635|100845889|FG000|STARTED|Second Intervention (10, 3 Week Cycles)||13||
48212231|NCT01285635|100845890|FG001|STARTED|Second Intervention (10, 3 Week Cycles)||11||
48212232|NCT01285635|100845891|FG002|STARTED|Second Intervention (10, 3 Week Cycles)||11||
48212233|NCT01285635|100845889|FG000|COMPLETED|Second Intervention (10, 3 Week Cycles)||13||
48212234|NCT01285635|100845890|FG001|COMPLETED|Second Intervention (10, 3 Week Cycles)||11||
48212235|NCT01285635|100845891|FG002|COMPLETED|Second Intervention (10, 3 Week Cycles)||11||
48212236|NCT01285635|100845889|FG000|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0||
48212237|NCT01285635|100845890|FG001|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0||
48212238|NCT01285635|100845891|FG002|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0||
48212239|NCT00683696|100845892|FG000|STARTED|Overall Study||404||
48212240|NCT00683696|100845893|FG001|STARTED|Overall Study||405||
48212241|NCT00683696|100845892|FG000|COMPLETED|Overall Study||0||
48212242|NCT00683696|100845893|FG001|COMPLETED|Overall Study||0||
48495948|NCT01741545|101547974|FG001|COMPLETED|Follow-up Period (24 Weeks)||37||
48495949|NCT01741545|101547973|FG000|NOT COMPLETED|Follow-up Period (24 Weeks)||1||
48495950|NCT01741545|101547974|FG001|NOT COMPLETED|Follow-up Period (24 Weeks)||2||
48495951|NCT02286466|101547975|FG000|STARTED|Overall Study||72||
48495952|NCT02286466|101547976|FG001|STARTED|Overall Study||73||
48495953|NCT02286466|101547975|FG000|Baseline Clinician Assessment|Overall Study||72||
48495954|NCT02286466|101547976|FG001|Baseline Clinician Assessment|Overall Study||72||
48495955|NCT02286466|101547975|FG000|Post Self-report|Overall Study||67||
48495956|NCT02286466|101547976|FG001|Post Self-report|Overall Study||68||
48495957|NCT02286466|101547975|FG000|COMPLETED|Overall Study||65|Post clinician assessment is collected after completing post self-report survey.|
48495958|NCT02286466|101547976|FG001|COMPLETED|Overall Study||63|Post clinician assessment is collected after completing post self-report survey.|
48495959|NCT02286466|101547975|FG000|NOT COMPLETED|Overall Study||7||
48495960|NCT02286466|101547976|FG001|NOT COMPLETED|Overall Study||10||
48495961|NCT04773600|101547977|FG000|STARTED|Overall Study||451||
48495962|NCT04773600|101547978|FG001|STARTED|Overall Study||232||
48495963|NCT04773600|101547977|FG000|COMPLETED|Overall Study||410||
48495964|NCT04773600|101547978|FG001|COMPLETED|Overall Study||211||
48495965|NCT04773600|101547977|FG000|NOT COMPLETED|Overall Study||41||
48495966|NCT04773600|101547978|FG001|NOT COMPLETED|Overall Study||21||
48495967|NCT00881569|101547979|FG000|STARTED|Overall Study||1||
48495968|NCT00881569|101547980|FG001|STARTED|Overall Study||1||
48495969|NCT00881569|101547979|FG000|COMPLETED|Overall Study||0||
48495970|NCT00881569|101547980|FG001|COMPLETED|Overall Study||0||
48495971|NCT00881569|101547979|FG000|NOT COMPLETED|Overall Study||1||
48495972|NCT00881569|101547980|FG001|NOT COMPLETED|Overall Study||1||
48495973|NCT00506831|101547981|FG000|STARTED|Overall Study||9||
48495974|NCT00506831|101547981|FG000|COMPLETED|Overall Study||7||
48495975|NCT00506831|101547981|FG000|NOT COMPLETED|Overall Study||2||
48495976|NCT05098743|101547982|FG000|STARTED|Overall Study||32||
48495977|NCT05098743|101547983|FG001|STARTED|Overall Study||33||
48495978|NCT05098743|101547982|FG000|COMPLETED|Overall Study||30||
48495979|NCT05098743|101547983|FG001|COMPLETED|Overall Study||31||
48495980|NCT05098743|101547982|FG000|NOT COMPLETED|Overall Study||2||
48495981|NCT05098743|101547983|FG001|NOT COMPLETED|Overall Study||2||
48495982|NCT00705666|101547984|FG000|STARTED|Overall Study||789||
48495983|NCT00705666|101547984|FG000|COMPLETED|Overall Study||450||
48495984|NCT00705666|101547984|FG000|NOT COMPLETED|Overall Study||339||
48495985|NCT00425308|101547985|FG000|STARTED|Overall Study||15||
48495986|NCT00425308|101547986|FG001|STARTED|Overall Study||15||
48495987|NCT00425308|101547985|FG000|COMPLETED|Overall Study||11||
48495988|NCT00425308|101547986|FG001|COMPLETED|Overall Study||14||
48495989|NCT00425308|101547985|FG000|NOT COMPLETED|Overall Study||4||
48495990|NCT00425308|101547986|FG001|NOT COMPLETED|Overall Study||1||
48495991|NCT00989950|101547987|FG000|STARTED|Open Label Dose Optimization||6||
48495992|NCT00989950|101547988|FG001|STARTED|Open Label Dose Optimization||9||
48495993|NCT00989950|101547989|FG002|STARTED|Open Label Dose Optimization||4||
48495994|NCT00989950|101547990|FG003|STARTED|Open Label Dose Optimization||7||
48495995|NCT00989950|101547987|FG000|COMPLETED|Open Label Dose Optimization||6||
48495996|NCT00989950|101547988|FG001|COMPLETED|Open Label Dose Optimization||9||
48495997|NCT00989950|101547989|FG002|COMPLETED|Open Label Dose Optimization||4||
48495998|NCT00989950|101547990|FG003|COMPLETED|Open Label Dose Optimization||7||
48495999|NCT00989950|101547987|FG000|NOT COMPLETED|Open Label Dose Optimization||0||
48496000|NCT00989950|101547988|FG001|NOT COMPLETED|Open Label Dose Optimization||0||
48212243|NCT00683696|100845892|FG000|NOT COMPLETED|Overall Study||404||
48212244|NCT00683696|100845893|FG001|NOT COMPLETED|Overall Study||405||
48212245|NCT00493649|100845894|FG000|STARTED|Overall Study||493||
48212246|NCT00493649|100845894|FG000|COMPLETED|Overall Study||411||
48212247|NCT00493649|100845894|FG000|NOT COMPLETED|Overall Study||82||
48212248|NCT02423798|100845895|FG000|STARTED|Overall Study||24||
48496001|NCT00989950|101547989|FG002|NOT COMPLETED|Open Label Dose Optimization||0||
48496002|NCT00989950|101547990|FG003|NOT COMPLETED|Open Label Dose Optimization||0||
48496003|NCT00989950|101547987|FG000|STARTED|Randomized Phase||6||
48496004|NCT00989950|101547988|FG001|STARTED|Randomized Phase||9||
48212249|NCT02423798|100845895|FG000|COMPLETED|Overall Study||21||
48212250|NCT02423798|100845895|FG000|NOT COMPLETED|Overall Study||3||
48212251|NCT01996605|100845896|FG000|STARTED|Overall Study||8||
48212252|NCT01996605|100845897|FG001|STARTED|Overall Study||5||
48212253|NCT01996605|100845898|FG002|STARTED|Overall Study||7||
48212254|NCT01996605|100845896|FG000|COMPLETED|Overall Study||8||
48212255|NCT01996605|100845897|FG001|COMPLETED|Overall Study||5||
48212256|NCT01996605|100845898|FG002|COMPLETED|Overall Study||7||
48212257|NCT01996605|100845896|FG000|NOT COMPLETED|Overall Study||0||
48212258|NCT01996605|100845897|FG001|NOT COMPLETED|Overall Study||0||
48212259|NCT01996605|100845898|FG002|NOT COMPLETED|Overall Study||0||
48212260|NCT02909439|100845899|FG000|STARTED|Overall Study||31||
48212261|NCT02909439|100845900|FG001|STARTED|Overall Study||31||
48212262|NCT02909439|100845899|FG000|COMPLETED|Overall Study||31||
48212263|NCT02909439|100845900|FG001|COMPLETED|Overall Study||31||
48212264|NCT02909439|100845899|FG000|NOT COMPLETED|Overall Study||0||
48212265|NCT02909439|100845900|FG001|NOT COMPLETED|Overall Study||0||
48212266|NCT05674136|100845901|FG000|STARTED|Overall Study||62||
48212267|NCT05674136|100845901|FG000|COMPLETED|Overall Study||42||
48212268|NCT05674136|100845901|FG000|NOT COMPLETED|Overall Study||20||
48212269|NCT03482635|100845902|FG000|STARTED|Overall Study||23||
48212270|NCT03482635|100845903|FG001|STARTED|Overall Study||24||
48212271|NCT03482635|100845904|FG002|STARTED|Overall Study||23||
48212272|NCT03482635|100845905|FG003|STARTED|Overall Study||28||
48212273|NCT03482635|100845902|FG000|Treated|Overall Study||23||
48212274|NCT03482635|100845903|FG001|Treated|Overall Study||24||
48212275|NCT03482635|100845904|FG002|Treated|Overall Study||23||
48212276|NCT03482635|100845905|FG003|Treated|Overall Study||27||
48212277|NCT03482635|100845902|FG000|COMPLETED|Overall Study||18|Completed trial medication|
48212278|NCT03482635|100845903|FG001|COMPLETED|Overall Study||21|Completed trial medication|
48212279|NCT03482635|100845904|FG002|COMPLETED|Overall Study||22|Completed trial medication|
48059765|NCT01822496|100467014|FG000|COMPLETED|Overall Study||14|Subjects contributing any data to results are considered to have completed the study|
48212280|NCT03482635|100845905|FG003|COMPLETED|Overall Study||20|Completed trial medication|
48212281|NCT03482635|100845902|FG000|NOT COMPLETED|Overall Study||5||
48212282|NCT03482635|100845903|FG001|NOT COMPLETED|Overall Study||3||
48212283|NCT03482635|100845904|FG002|NOT COMPLETED|Overall Study||1||
48212284|NCT03482635|100845905|FG003|NOT COMPLETED|Overall Study||8||
48212285|NCT03495713|100845906|FG000|STARTED|Overall Study||7||
48212286|NCT03495713|100845906|FG000|COMPLETED|Overall Study||7||
48212287|NCT03495713|100845906|FG000|NOT COMPLETED|Overall Study||0||
48212288|NCT01254188|100845907|FG000|STARTED|Overall Study||421||
48212289|NCT01254188|100845907|FG000|COMPLETED|Overall Study||328||
48212290|NCT01254188|100845907|FG000|NOT COMPLETED|Overall Study||93||
48212291|NCT04058626|100845908|FG000|STARTED|Overall Study||305||
48212292|NCT04058626|100845908|FG000|COMPLETED|Overall Study||305||
48212293|NCT04058626|100845908|FG000|NOT COMPLETED|Overall Study||0||
48212294|NCT01198145|100845909|FG000|STARTED|Overall Study||44||
48496005|NCT00989950|101547989|FG002|STARTED|Randomized Phase||4||
48059766|NCT01822496|100467015|FG001|COMPLETED|Overall Study||21|Subjects contributing any data to results are considered to have completed the study|
48059767|NCT01822496|100467016|FG002|COMPLETED|Overall Study||9|Subjects contributing any data to results are considered to have completed the study|
48059768|NCT01822496|100467017|FG003|COMPLETED|Overall Study||7|Subjects contributing any data to results are considered to have completed the study|
48059769|NCT01822496|100467014|FG000|NOT COMPLETED|Overall Study||2||
48059770|NCT01822496|100467015|FG001|NOT COMPLETED|Overall Study||2||
48212295|NCT01198145|100845910|FG001|STARTED|Overall Study||43||
48212296|NCT01198145|100845909|FG000|COMPLETED|Overall Study||43||
48212297|NCT01198145|100845910|FG001|COMPLETED|Overall Study||42||
48212298|NCT01198145|100845909|FG000|NOT COMPLETED|Overall Study||1||
48212299|NCT01198145|100845910|FG001|NOT COMPLETED|Overall Study||1||
48212300|NCT01105117|100845911|FG000|STARTED|Overall Study||1||
48212301|NCT01105117|100845912|FG001|STARTED|Overall Study||1||
48212302|NCT01105117|100845911|FG000|COMPLETED|Overall Study||1||
48212303|NCT01105117|100845912|FG001|COMPLETED|Overall Study||1||
48212304|NCT01105117|100845911|FG000|NOT COMPLETED|Overall Study||0||
48212305|NCT01105117|100845912|FG001|NOT COMPLETED|Overall Study||0||
48212306|NCT02708108|100845913|FG000|STARTED|Overall Study||40||
48212307|NCT02708108|100845914|FG001|STARTED|Overall Study||83||
48212308|NCT02708108|100845913|FG000|COMPLETED|Overall Study||38||
48212309|NCT02708108|100845914|FG001|COMPLETED|Overall Study||80||
48212310|NCT02708108|100845913|FG000|NOT COMPLETED|Overall Study||2||
48212311|NCT02708108|100845914|FG001|NOT COMPLETED|Overall Study||3||
48212312|NCT01144468|100845915|FG000|STARTED|Overall Study||176||
48212313|NCT01144468|100845916|FG001|STARTED|Overall Study||175||
48212314|NCT01144468|100845915|FG000|COMPLETED|Overall Study||124||
48212315|NCT01144468|100845916|FG001|COMPLETED|Overall Study||118||
48212316|NCT01144468|100845915|FG000|NOT COMPLETED|Overall Study||52||
48212317|NCT01144468|100845916|FG001|NOT COMPLETED|Overall Study||57||
48212318|NCT02376530|100845917|FG000|STARTED|Overall Study||196||
48212319|NCT02376530|100845918|FG001|STARTED|Overall Study||198||
48212320|NCT02376530|100845919|FG002|STARTED|Overall Study||197||
48212321|NCT02376530|100845920|FG003|STARTED|Overall Study||197||
48496006|NCT00989950|101547990|FG003|STARTED|Randomized Phase||7||
48212322|NCT02376530|100845917|FG000|COMPLETED|Overall Study||196||
48212323|NCT02376530|100845918|FG001|COMPLETED|Overall Study||198||
48212324|NCT02376530|100845919|FG002|COMPLETED|Overall Study||197||
48212325|NCT02376530|100845920|FG003|COMPLETED|Overall Study||197||
48212326|NCT02376530|100845917|FG000|NOT COMPLETED|Overall Study||0||
48212327|NCT02376530|100845918|FG001|NOT COMPLETED|Overall Study||0||
48212328|NCT02376530|100845919|FG002|NOT COMPLETED|Overall Study||0||
48212329|NCT02376530|100845920|FG003|NOT COMPLETED|Overall Study||0||
48212330|NCT01149512|100845921|FG000|STARTED|Overall Study||178||
48212331|NCT01149512|100845921|FG000|COMPLETED|Overall Study||178||
48212332|NCT01149512|100845921|FG000|NOT COMPLETED|Overall Study||0||
48212333|NCT00978042|100845922|FG000|STARTED|Initial Treatment Period||235||
48212334|NCT00978042|100845923|FG001|STARTED|Initial Treatment Period||47||
48212335|NCT00978042|100845922|FG000|MITT_treated With VOLUMA XC|Initial Treatment Period||235||
48212336|NCT00978042|100845923|FG001|MITT_treated With VOLUMA XC|Initial Treatment Period||35||
48212337|NCT00978042|100845922|FG000|COMPLETED|Initial Treatment Period||174||
48212338|NCT00978042|100845923|FG001|COMPLETED|Initial Treatment Period||32||
48212339|NCT00978042|100845922|FG000|NOT COMPLETED|Initial Treatment Period||61||
48212340|NCT00978042|100845923|FG001|NOT COMPLETED|Initial Treatment Period||15||
48212341|NCT00978042|100845922|FG000|STARTED|Received Repeat Treatment||141||
48212342|NCT00978042|100845923|FG001|STARTED|Received Repeat Treatment||26||
48212343|NCT00978042|100845922|FG000|COMPLETED|Received Repeat Treatment||98||
48212344|NCT00978042|100845923|FG001|COMPLETED|Received Repeat Treatment||23||
48212345|NCT00978042|100845922|FG000|NOT COMPLETED|Received Repeat Treatment||43||
48212346|NCT00978042|100845923|FG001|NOT COMPLETED|Received Repeat Treatment||3||
48212347|NCT00490802|100845924|FG000|STARTED|Overall Study||10||
48212348|NCT00490802|100845925|FG001|STARTED|Overall Study||9||
48212349|NCT00490802|100845924|FG000|COMPLETED|Overall Study||9||
48212350|NCT00490802|100845925|FG001|COMPLETED|Overall Study||7||
48212351|NCT00490802|100845924|FG000|NOT COMPLETED|Overall Study||1||
48212352|NCT00490802|100845925|FG001|NOT COMPLETED|Overall Study||2||
48212353|NCT01643616|100845926|FG000|STARTED|Overall Study||125||
48212354|NCT01643616|100845927|FG001|STARTED|Overall Study||125||
48212355|NCT01643616|100845926|FG000|COMPLETED|Overall Study||125||
48212356|NCT01643616|100845927|FG001|COMPLETED|Overall Study||125||
48212357|NCT01643616|100845926|FG000|NOT COMPLETED|Overall Study||0||
48212358|NCT01643616|100845927|FG001|NOT COMPLETED|Overall Study||0||
48212359|NCT00011986|100845928|FG000|STARTED|Overall Study||864||
48212360|NCT00011986|100845929|FG001|STARTED|Overall Study||864||
48212361|NCT00011986|100845930|FG002|STARTED|Overall Study||862||
48212362|NCT00011986|100845931|FG003|STARTED|Overall Study||861||
48212363|NCT00011986|100845932|FG004|STARTED|Overall Study||861||
48212364|NCT00011986|100845928|FG000|Initiated Treatment|Overall Study||862||
48212365|NCT00011986|100845929|FG001|Initiated Treatment|Overall Study||860||
48212366|NCT00011986|100845930|FG002|Initiated Treatment|Overall Study||854||
48212367|NCT00011986|100845931|FG003|Initiated Treatment|Overall Study||846||
48212368|NCT00011986|100845932|FG004|Initiated Treatment|Overall Study||851||
48212369|NCT00011986|100845928|FG000|COMPLETED|Overall Study||864||
48212370|NCT00011986|100845929|FG001|COMPLETED|Overall Study||864||
48212371|NCT00011986|100845930|FG002|COMPLETED|Overall Study||862||
48212372|NCT00011986|100845931|FG003|COMPLETED|Overall Study||861||
48212373|NCT00011986|100845932|FG004|COMPLETED|Overall Study||861||
48212374|NCT00011986|100845928|FG000|NOT COMPLETED|Overall Study||0||
48212375|NCT00011986|100845929|FG001|NOT COMPLETED|Overall Study||0||
48212376|NCT00011986|100845930|FG002|NOT COMPLETED|Overall Study||0||
48212377|NCT00011986|100845931|FG003|NOT COMPLETED|Overall Study||0||
48212378|NCT00011986|100845932|FG004|NOT COMPLETED|Overall Study||0||
48212379|NCT02555449|100845933|FG000|STARTED|Overall Study||6||
48212380|NCT02555449|100845933|FG000|COMPLETED|Overall Study||6||
48212381|NCT02555449|100845933|FG000|NOT COMPLETED|Overall Study||0||
48212382|NCT00424645|100845934|FG000|STARTED|Overall Study||3||
48212383|NCT00424645|100845935|FG001|STARTED|Overall Study||0||
48212384|NCT00424645|100845934|FG000|COMPLETED|Overall Study||2||
48212385|NCT00424645|100845935|FG001|COMPLETED|Overall Study||0||
48212386|NCT00424645|100845934|FG000|NOT COMPLETED|Overall Study||1||
48212387|NCT00424645|100845935|FG001|NOT COMPLETED|Overall Study||0||
48212388|NCT05123742|100845936|FG000|STARTED|Overall Study||13||
48212389|NCT05123742|100845937|FG001|STARTED|Overall Study||16||
48212390|NCT05123742|100845938|FG002|STARTED|Overall Study||20||
48212391|NCT05123742|100845939|FG003|STARTED|Overall Study||23||
48212392|NCT05123742|100845936|FG000|COMPLETED|Overall Study||13||
48212393|NCT05123742|100845937|FG001|COMPLETED|Overall Study||15||
48212394|NCT05123742|100845938|FG002|COMPLETED|Overall Study||19||
48212395|NCT05123742|100845939|FG003|COMPLETED|Overall Study||22||
48212396|NCT05123742|100845936|FG000|NOT COMPLETED|Overall Study||0||
48212397|NCT05123742|100845937|FG001|NOT COMPLETED|Overall Study||1||
48212398|NCT05123742|100845938|FG002|NOT COMPLETED|Overall Study||1||
48212399|NCT05123742|100845939|FG003|NOT COMPLETED|Overall Study||1||
48212400|NCT00821184|100845940|FG000|STARTED|Overall Study||6||
48212401|NCT00821184|100845941|FG001|STARTED|Overall Study||6||
48212402|NCT00821184|100845940|FG000|COMPLETED|Overall Study||6||
48212403|NCT00821184|100845941|FG001|COMPLETED|Overall Study||6||
48212404|NCT00821184|100845940|FG000|NOT COMPLETED|Overall Study||0||
48212405|NCT00821184|100845941|FG001|NOT COMPLETED|Overall Study||0||
48212406|NCT00480077|100845942|FG000|STARTED|Overall Study||168||
48212407|NCT00480077|100845943|FG001|STARTED|Overall Study||167||
48212408|NCT00480077|100845942|FG000|COMPLETED|Overall Study||137||
48212409|NCT00480077|100845943|FG001|COMPLETED|Overall Study||141||
48212410|NCT00480077|100845942|FG000|NOT COMPLETED|Overall Study||31||
48212411|NCT00480077|100845943|FG001|NOT COMPLETED|Overall Study||26||
48212412|NCT03113617|100845944|FG000|STARTED|Overall Study||44||
48212413|NCT03113617|100845944|FG000|COMPLETED|Overall Study||44||
48212414|NCT03113617|100845944|FG000|NOT COMPLETED|Overall Study||0||
48212415|NCT01437605|100845945|FG000|STARTED|Overall Study||9||
48212416|NCT01437605|100845946|FG001|STARTED|Overall Study||5||
48212417|NCT01437605|100845945|FG000|COMPLETED|Overall Study||9||
48212418|NCT01437605|100845946|FG001|COMPLETED|Overall Study||5||
48212419|NCT01437605|100845945|FG000|NOT COMPLETED|Overall Study||0||
48212420|NCT01437605|100845946|FG001|NOT COMPLETED|Overall Study||0||
48212421|NCT00774852|100845947|FG000|STARTED|Overall Study||69||
48212422|NCT00774852|100845948|FG001|STARTED|Overall Study||68||
48212423|NCT00774852|100845947|FG000|COMPLETED|Overall Study||24||
48212424|NCT00774852|100845948|FG001|COMPLETED|Overall Study||27||
48212425|NCT00774852|100845947|FG000|NOT COMPLETED|Overall Study||45||
48212426|NCT00774852|100845948|FG001|NOT COMPLETED|Overall Study||41||
48212427|NCT01571596|100845949|FG000|STARTED|Overall Study||21||
48212428|NCT01571596|100845950|FG001|STARTED|Overall Study||1||
48212429|NCT01571596|100845951|FG002|STARTED|Overall Study||1||
48212430|NCT01571596|100845949|FG000|COMPLETED|Overall Study||19||
48212431|NCT01571596|100845950|FG001|COMPLETED|Overall Study||0||
48212432|NCT01571596|100845951|FG002|COMPLETED|Overall Study||0||
48212433|NCT01571596|100845949|FG000|NOT COMPLETED|Overall Study||2||
48212434|NCT01571596|100845950|FG001|NOT COMPLETED|Overall Study||1||
48212435|NCT01571596|100845951|FG002|NOT COMPLETED|Overall Study||1||
48212436|NCT03475316|100845952|FG000|STARTED|6 Month Intervention||13||
48212437|NCT03475316|100845953|FG001|STARTED|6 Month Intervention||12||
48212438|NCT03475316|100845952|FG000|COMPLETED|6 Month Intervention||8||
48212439|NCT03475316|100845953|FG001|COMPLETED|6 Month Intervention||8||
48212440|NCT03475316|100845952|FG000|NOT COMPLETED|6 Month Intervention||5||
48212441|NCT03475316|100845953|FG001|NOT COMPLETED|6 Month Intervention||4||
48212442|NCT03475316|100845952|FG000|STARTED|9 Months||8||
48212443|NCT03475316|100845953|FG001|STARTED|9 Months||8||
48212444|NCT03475316|100845952|FG000|COMPLETED|9 Months||5||
48212445|NCT03475316|100845953|FG001|COMPLETED|9 Months||4||
48212446|NCT03475316|100845952|FG000|NOT COMPLETED|9 Months||3||
48212447|NCT03475316|100845953|FG001|NOT COMPLETED|9 Months||4||
48212448|NCT02253537|100845954|FG000|STARTED|Overall Study||15||
48212449|NCT02253537|100845954|FG000|COMPLETED|Overall Study||15||
48212450|NCT02253537|100845954|FG000|NOT COMPLETED|Overall Study||0||
48212451|NCT02616900|100845955|FG000|STARTED|Overall Study||74||
48212452|NCT02616900|100845955|FG000|Completed 3mo Trial|Overall Study||57||
48212453|NCT02616900|100845955|FG000|COMPLETED|Overall Study||51||
48212454|NCT02616900|100845955|FG000|NOT COMPLETED|Overall Study||23||
48212455|NCT01919450|100845956|FG000|STARTED|Overall Study||20||
48212456|NCT01919450|100845957|FG001|STARTED|Overall Study||20||
48212457|NCT01919450|100845958|FG002|STARTED|Overall Study||20||
48212458|NCT01919450|100845959|FG003|STARTED|Overall Study||20||
48212459|NCT01919450|100845956|FG000|COMPLETED|Overall Study||20||
48212460|NCT01919450|100845957|FG001|COMPLETED|Overall Study||20||
48212461|NCT01919450|100845958|FG002|COMPLETED|Overall Study||20||
48059771|NCT01822496|100467016|FG002|NOT COMPLETED|Overall Study||0||
48059772|NCT01822496|100467017|FG003|NOT COMPLETED|Overall Study||4||
48059773|NCT05268055|100467018|FG000|STARTED|Overall Study||103||
48059774|NCT05268055|100467019|FG001|STARTED|Overall Study||105||
48059775|NCT05268055|100467018|FG000|Reviewed Training Intervention|Overall Study||51||
48059776|NCT05268055|100467019|FG001|Reviewed Training Intervention|Overall Study||56||
48059777|NCT05268055|100467018|FG000|Scheduled Study Simulation Session|Overall Study||35||
48059778|NCT05268055|100467019|FG001|Scheduled Study Simulation Session|Overall Study||38||
48059779|NCT05268055|100467018|FG000|Completed Study Simulation Session|Overall Study||23||
48212462|NCT01919450|100845959|FG003|COMPLETED|Overall Study||19||
48212463|NCT01919450|100845956|FG000|NOT COMPLETED|Overall Study||0||
48212464|NCT01919450|100845957|FG001|NOT COMPLETED|Overall Study||0||
48212465|NCT01919450|100845958|FG002|NOT COMPLETED|Overall Study||0||
48212466|NCT01919450|100845959|FG003|NOT COMPLETED|Overall Study||1||
48212467|NCT03844269|100845960|FG000|STARTED|Overall Study||28||
48212468|NCT03844269|100845960|FG000|COMPLETED|Overall Study||25||
48212469|NCT03844269|100845960|FG000|NOT COMPLETED|Overall Study||3||
48212470|NCT03482011|100845961|FG000|STARTED|Induction Period (16 Weeks)||107||
48212471|NCT03482011|100845962|FG001|STARTED|Induction Period (16 Weeks)||423||
48212472|NCT03482011|100845963|FG002|STARTED|Induction Period (16 Weeks)||0||
48212473|NCT03482011|100845964|FG003|STARTED|Induction Period (16 Weeks)||0||
48212474|NCT03482011|100845965|FG004|STARTED|Induction Period (16 Weeks)||0||
48212475|NCT03482011|100845966|FG005|STARTED|Induction Period (16 Weeks)||0||
48059780|NCT05268055|100467019|FG001|Completed Study Simulation Session|Overall Study||29||
48059781|NCT05268055|100467018|FG000|COMPLETED|Overall Study||23||
48059782|NCT05268055|100467019|FG001|COMPLETED|Overall Study||29||
48212476|NCT03482011|100845967|FG006|STARTED|Induction Period (16 Weeks)||0||
48212477|NCT03482011|100845968|FG007|STARTED|Induction Period (16 Weeks)||0||
48212478|NCT03482011|100845961|FG000|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||107||
48212479|NCT03482011|100845962|FG001|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||422||
48212480|NCT03482011|100845963|FG002|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
48212481|NCT03482011|100845964|FG003|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
48212482|NCT03482011|100845965|FG004|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
48212483|NCT03482011|100845966|FG005|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
48212484|NCT03482011|100845967|FG006|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
48212485|NCT03482011|100845968|FG007|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
48212486|NCT03482011|100845961|FG000|COMPLETED|Induction Period (16 Weeks)||101||
48212487|NCT03482011|100845962|FG001|COMPLETED|Induction Period (16 Weeks)||412||
48212488|NCT03482011|100845963|FG002|COMPLETED|Induction Period (16 Weeks)||0||
48212489|NCT03482011|100845964|FG003|COMPLETED|Induction Period (16 Weeks)||0||
48212490|NCT03482011|100845965|FG004|COMPLETED|Induction Period (16 Weeks)||0||
48212491|NCT03482011|100845966|FG005|COMPLETED|Induction Period (16 Weeks)||0||
48212492|NCT03482011|100845967|FG006|COMPLETED|Induction Period (16 Weeks)||0||
48212493|NCT03482011|100845968|FG007|COMPLETED|Induction Period (16 Weeks)||0||
48212494|NCT03482011|100845961|FG000|NOT COMPLETED|Induction Period (16 Weeks)||6||
48212495|NCT03482011|100845962|FG001|NOT COMPLETED|Induction Period (16 Weeks)||11||
48212496|NCT03482011|100845963|FG002|NOT COMPLETED|Induction Period (16 Weeks)||0||
48212497|NCT03482011|100845964|FG003|NOT COMPLETED|Induction Period (16 Weeks)||0||
48212498|NCT03482011|100845965|FG004|NOT COMPLETED|Induction Period (16 Weeks)||0||
48212499|NCT03482011|100845966|FG005|NOT COMPLETED|Induction Period (16 Weeks)||0||
48212500|NCT03482011|100845967|FG006|NOT COMPLETED|Induction Period (16 Weeks)||0||
48212501|NCT03482011|100845968|FG007|NOT COMPLETED|Induction Period (16 Weeks)||0||
48212502|NCT03482011|100845961|FG000|STARTED|Maintenance Period (36 Weeks)||0||
48212503|NCT03482011|100845962|FG001|STARTED|Maintenance Period (36 Weeks)||0||
48212504|NCT03482011|100845963|FG002|STARTED|Maintenance Period (36 Weeks)||7||
48212505|NCT03482011|100845964|FG003|STARTED|Maintenance Period (36 Weeks)||94||
48212506|NCT03482011|100845965|FG004|STARTED|Maintenance Period (36 Weeks)||91||
48212507|NCT03482011|100845966|FG005|STARTED|Maintenance Period (36 Weeks)||90||
48212508|NCT03482011|100845967|FG006|STARTED|Maintenance Period (36 Weeks)||91||
48212509|NCT03482011|100845968|FG007|STARTED|Maintenance Period (36 Weeks)||140||
48212510|NCT03482011|100845961|FG000|Relapse|Maintenance Period (36 Weeks)||0||
48212511|NCT03482011|100845962|FG001|Relapse|Maintenance Period (36 Weeks)||0||
48212512|NCT03482011|100845963|FG002|Relapse|Maintenance Period (36 Weeks)||1||
48212513|NCT03482011|100845964|FG003|Relapse|Maintenance Period (36 Weeks)||0||
48212514|NCT03482011|100845965|FG004|Relapse|Maintenance Period (36 Weeks)||41||
48212515|NCT03482011|100845966|FG005|Relapse|Maintenance Period (36 Weeks)||3||
48212516|NCT03482011|100845967|FG006|Relapse|Maintenance Period (36 Weeks)||2||
48212517|NCT03482011|100845968|FG007|Relapse|Maintenance Period (36 Weeks)||0||
48212518|NCT03482011|100845961|FG000|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||0||
48212519|NCT03482011|100845962|FG001|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||0||
48212520|NCT03482011|100845963|FG002|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||6||
48212521|NCT03482011|100845964|FG003|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||88||
48212522|NCT03482011|100845965|FG004|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||86||
48212523|NCT03482011|100845966|FG005|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||85||
48212524|NCT03482011|100845967|FG006|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||87||
48212525|NCT03482011|100845968|FG007|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||121||
48212526|NCT03482011|100845961|FG000|COMPLETED|Maintenance Period (36 Weeks)||0||
48212527|NCT03482011|100845962|FG001|COMPLETED|Maintenance Period (36 Weeks)||0||
48212528|NCT03482011|100845963|FG002|COMPLETED|Maintenance Period (36 Weeks)||6||
48212529|NCT03482011|100845964|FG003|COMPLETED|Maintenance Period (36 Weeks)||90||
48212530|NCT03482011|100845965|FG004|COMPLETED|Maintenance Period (36 Weeks)||86||
48212531|NCT03482011|100845966|FG005|COMPLETED|Maintenance Period (36 Weeks)||86||
48212532|NCT03482011|100845967|FG006|COMPLETED|Maintenance Period (36 Weeks)||87||
48212533|NCT03482011|100845968|FG007|COMPLETED|Maintenance Period (36 Weeks)||123||
48212534|NCT03482011|100845961|FG000|NOT COMPLETED|Maintenance Period (36 Weeks)||0||
48212535|NCT03482011|100845962|FG001|NOT COMPLETED|Maintenance Period (36 Weeks)||0||
48212536|NCT03482011|100845963|FG002|NOT COMPLETED|Maintenance Period (36 Weeks)||1||
48212537|NCT03482011|100845964|FG003|NOT COMPLETED|Maintenance Period (36 Weeks)||4||
48212538|NCT03482011|100845965|FG004|NOT COMPLETED|Maintenance Period (36 Weeks)||5||
48212539|NCT03482011|100845966|FG005|NOT COMPLETED|Maintenance Period (36 Weeks)||4||
48212540|NCT03482011|100845967|FG006|NOT COMPLETED|Maintenance Period (36 Weeks)||4||
48212541|NCT03482011|100845968|FG007|NOT COMPLETED|Maintenance Period (36 Weeks)||17||
48212542|NCT03482011|100845961|FG000|STARTED|Follow-up Period (12 Weeks)||0||
48212543|NCT03482011|100845962|FG001|STARTED|Follow-up Period (12 Weeks)||0||
48212544|NCT03482011|100845963|FG002|STARTED|Follow-up Period (12 Weeks)||1||
48496007|NCT00989950|101547987|FG000|COMPLETED|Randomized Phase||5||
48212545|NCT03482011|100845964|FG003|STARTED|Follow-up Period (12 Weeks)||10||
48212546|NCT03482011|100845965|FG004|STARTED|Follow-up Period (12 Weeks)||2||
48212547|NCT03482011|100845966|FG005|STARTED|Follow-up Period (12 Weeks)||4||
48212548|NCT03482011|100845967|FG006|STARTED|Follow-up Period (12 Weeks)||4||
48212549|NCT03482011|100845968|FG007|STARTED|Follow-up Period (12 Weeks)||21||
48212550|NCT03482011|100845961|FG000|COMPLETED|Follow-up Period (12 Weeks)||0||
48212551|NCT03482011|100845962|FG001|COMPLETED|Follow-up Period (12 Weeks)||0||
48212552|NCT03482011|100845963|FG002|COMPLETED|Follow-up Period (12 Weeks)||0||
48212553|NCT03482011|100845964|FG003|COMPLETED|Follow-up Period (12 Weeks)||5||
48212554|NCT03482011|100845965|FG004|COMPLETED|Follow-up Period (12 Weeks)||2||
48212555|NCT03482011|100845966|FG005|COMPLETED|Follow-up Period (12 Weeks)||3||
48212556|NCT03482011|100845967|FG006|COMPLETED|Follow-up Period (12 Weeks)||2||
48212557|NCT03482011|100845968|FG007|COMPLETED|Follow-up Period (12 Weeks)||4||
48212558|NCT03482011|100845961|FG000|NOT COMPLETED|Follow-up Period (12 Weeks)||0||
48212559|NCT03482011|100845962|FG001|NOT COMPLETED|Follow-up Period (12 Weeks)||0||
48212560|NCT03482011|100845963|FG002|NOT COMPLETED|Follow-up Period (12 Weeks)||1||
48212561|NCT03482011|100845964|FG003|NOT COMPLETED|Follow-up Period (12 Weeks)||5||
48212562|NCT03482011|100845965|FG004|NOT COMPLETED|Follow-up Period (12 Weeks)||0||
48212563|NCT03482011|100845966|FG005|NOT COMPLETED|Follow-up Period (12 Weeks)||1||
48212564|NCT03482011|100845967|FG006|NOT COMPLETED|Follow-up Period (12 Weeks)||2||
48212565|NCT03482011|100845968|FG007|NOT COMPLETED|Follow-up Period (12 Weeks)||17||
48212566|NCT01078116|100845969|FG000|STARTED|Overall Study||124||
48212567|NCT01078116|100845969|FG000|COMPLETED|Overall Study||76||
48212568|NCT01078116|100845969|FG000|NOT COMPLETED|Overall Study||48||
48212569|NCT01420549|100845970|FG000|STARTED|Overall Study||66|Treatment (Open- label / 9 weeks)|
48212570|NCT01420549|100845971|FG001|STARTED|Overall Study||63|Treatment (Open- label / 9 weeks)|
48212571|NCT01420549|100845970|FG000|COMPLETED|Overall Study||59||
48212572|NCT01420549|100845971|FG001|COMPLETED|Overall Study||58||
48212573|NCT01420549|100845970|FG000|NOT COMPLETED|Overall Study||7||
48212574|NCT01420549|100845971|FG001|NOT COMPLETED|Overall Study||5||
48212575|NCT03565315|100845972|FG000|STARTED|Overall Study||3||
48212576|NCT03565315|100845973|FG001|STARTED|Overall Study||3||
48212577|NCT03565315|100845974|FG002|STARTED|Overall Study||1||
48212578|NCT03565315|100845975|FG003|STARTED|Overall Study||2||
48212579|NCT03565315|100845972|FG000|Product Administration Completed|Overall Study||3||
48212580|NCT03565315|100845973|FG001|Product Administration Completed|Overall Study||0||
48212581|NCT03565315|100845974|FG002|Product Administration Completed|Overall Study||1||
48212582|NCT03565315|100845975|FG003|Product Administration Completed|Overall Study||0||
48212583|NCT03565315|100845972|FG000|Discontinued Product Administrations|Overall Study||0|All altered or discontinued product administration schedules were due to the IND Sponsor/PI decision to terminate the study.|
48212584|NCT03565315|100845973|FG001|Discontinued Product Administrations|Overall Study||3|All altered or discontinued product administration schedules were due to the IND Sponsor/PI decision to terminate the study.|
48212585|NCT03565315|100845974|FG002|Discontinued Product Administrations|Overall Study||0|All altered or discontinued product administration schedules were due to the IND Sponsor/PI decision to terminate the study.|
48212586|NCT03565315|100845975|FG003|Discontinued Product Administrations|Overall Study||2|All altered or discontinued product administration schedules were due to the IND Sponsor/PI decision to terminate the study.|
48212587|NCT03565315|100845972|FG000|COMPLETED|Overall Study||3||
48212588|NCT03565315|100845973|FG001|COMPLETED|Overall Study||3||
48212589|NCT03565315|100845974|FG002|COMPLETED|Overall Study||1||
48212590|NCT03565315|100845975|FG003|COMPLETED|Overall Study||1||
48212591|NCT03565315|100845972|FG000|NOT COMPLETED|Overall Study||0||
48212592|NCT03565315|100845973|FG001|NOT COMPLETED|Overall Study||0||
48212593|NCT03565315|100845974|FG002|NOT COMPLETED|Overall Study||0||
48212594|NCT03565315|100845975|FG003|NOT COMPLETED|Overall Study||1||
48212595|NCT02064959|100845976|FG000|STARTED|Overall Study||16||
48212596|NCT02064959|100845977|FG001|STARTED|Overall Study||16||
48212597|NCT02064959|100845976|FG000|COMPLETED|Overall Study||16||
48212598|NCT02064959|100845977|FG001|COMPLETED|Overall Study||16||
48212599|NCT02064959|100845976|FG000|NOT COMPLETED|Overall Study||0||
48212600|NCT02064959|100845977|FG001|NOT COMPLETED|Overall Study||0||
48212601|NCT01227278|100845978|FG000|STARTED|Overall Study||50||
48212602|NCT01227278|100845979|FG001|STARTED|Overall Study||51||
48212603|NCT01227278|100845978|FG000|COMPLETED|Overall Study||45||
48212604|NCT01227278|100845979|FG001|COMPLETED|Overall Study||43||
48212605|NCT01227278|100845978|FG000|NOT COMPLETED|Overall Study||5||
48212606|NCT01227278|100845979|FG001|NOT COMPLETED|Overall Study||8||
48212607|NCT02701257|100845980|FG000|STARTED|Overall Study||6||
48212608|NCT02701257|100845981|FG001|STARTED|Overall Study||6||
48212609|NCT02701257|100845982|FG002|STARTED|Overall Study||0||
48212610|NCT02701257|100845983|FG003|STARTED|Overall Study||4||
48212611|NCT02701257|100845984|FG004|STARTED|Overall Study||4||
48212612|NCT02701257|100845980|FG000|COMPLETED|Overall Study||6||
48212613|NCT02701257|100845981|FG001|COMPLETED|Overall Study||3||
48212614|NCT02701257|100845982|FG002|COMPLETED|Overall Study||0||
48212615|NCT02701257|100845983|FG003|COMPLETED|Overall Study||3||
48212616|NCT02701257|100845984|FG004|COMPLETED|Overall Study||1||
48212617|NCT02701257|100845980|FG000|NOT COMPLETED|Overall Study||0||
48212618|NCT02701257|100845981|FG001|NOT COMPLETED|Overall Study||3||
48212619|NCT02701257|100845982|FG002|NOT COMPLETED|Overall Study||0||
48212620|NCT02701257|100845983|FG003|NOT COMPLETED|Overall Study||1||
48212621|NCT02701257|100845984|FG004|NOT COMPLETED|Overall Study||3||
48212622|NCT01613716|100845985|FG000|STARTED|Overall Study||30||
48212623|NCT01613716|100845985|FG000|COMPLETED|Overall Study||23||
48212624|NCT01613716|100845985|FG000|NOT COMPLETED|Overall Study||7||
48212625|NCT00516321|100845986|FG000|STARTED|Open-label (OL) Pre-Antiviral Treatment||715||
48212626|NCT00516321|100845987|FG001|STARTED|Open-label (OL) Pre-Antiviral Treatment||0||
48212627|NCT00516321|100845988|FG002|STARTED|Open-label (OL) Pre-Antiviral Treatment||0||
48212628|NCT00516321|100845986|FG000|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||682||
48212629|NCT00516321|100845987|FG001|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0||
48212630|NCT00516321|100845988|FG002|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0||
48212631|NCT00516321|100845986|FG000|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||33||
48212632|NCT00516321|100845987|FG001|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0||
48212633|NCT00516321|100845988|FG002|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0||
48212634|NCT00516321|100845986|FG000|STARTED|Double-blind (DB) Antiviral Treatment||0||
48212635|NCT00516321|100845987|FG001|STARTED|Double-blind (DB) Antiviral Treatment||232||
48212636|NCT00516321|100845988|FG002|STARTED|Double-blind (DB) Antiviral Treatment||450||
48212637|NCT00516321|100845986|FG000|COMPLETED|Double-blind (DB) Antiviral Treatment||0||
48212638|NCT00516321|100845987|FG001|COMPLETED|Double-blind (DB) Antiviral Treatment||197||
48212639|NCT00516321|100845988|FG002|COMPLETED|Double-blind (DB) Antiviral Treatment||396||
48212640|NCT00516321|100845986|FG000|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||0||
48212641|NCT00516321|100845987|FG001|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||35||
48059783|NCT05268055|100467018|FG000|NOT COMPLETED|Overall Study||80||
48059784|NCT05268055|100467019|FG001|NOT COMPLETED|Overall Study||76||
48059785|NCT01243671|100467020|FG000|STARTED|Overall Study||20||
48059786|NCT01243671|100467020|FG000|Completed 24 Weeks of Treatment|Overall Study||18||
48212642|NCT00516321|100845988|FG002|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||54||
48212643|NCT03527160|100845989|FG000|STARTED|Overall Study||134||
48212644|NCT03527160|100845989|FG000|COMPLETED|Overall Study||113||
48212645|NCT03527160|100845989|FG000|NOT COMPLETED|Overall Study||21||
48212646|NCT03873337|100845990|FG000|STARTED|Overall Study||34||
48212647|NCT03873337|100845990|FG000|COMPLETED|Overall Study||22||
48212648|NCT03873337|100845990|FG000|NOT COMPLETED|Overall Study||12||
48212649|NCT01011946|100845991|FG000|STARTED|Overall Study||36||
48212650|NCT01011946|100845991|FG000|COMPLETED|Overall Study||33||
48212651|NCT01011946|100845991|FG000|NOT COMPLETED|Overall Study||3||
48212652|NCT03029598|100845992|FG000|STARTED|Overall Study||29||
48212653|NCT03029598|100845992|FG000|COMPLETED|Overall Study||29||
48212654|NCT03029598|100845992|FG000|NOT COMPLETED|Overall Study||0||
48212655|NCT01925339|100845993|FG000|STARTED|Overall Study||20||
48212656|NCT01925339|100845994|FG001|STARTED|Overall Study||20||
48212657|NCT01925339|100845993|FG000|COMPLETED|Overall Study||18||
48212658|NCT01925339|100845994|FG001|COMPLETED|Overall Study||20||
48212659|NCT01925339|100845993|FG000|NOT COMPLETED|Overall Study||2||
48212660|NCT01925339|100845994|FG001|NOT COMPLETED|Overall Study||0||
48212661|NCT03149991|100845995|FG000|STARTED|Overall Study||25||
48212662|NCT03149991|100845996|FG001|STARTED|Overall Study||26||
48212663|NCT03149991|100845995|FG000|Completed Primary Endpoint (Day 14)|Overall Study||25||
48212664|NCT03149991|100845996|FG001|Completed Primary Endpoint (Day 14)|Overall Study||24||
48212665|NCT03149991|100845995|FG000|Exited|Overall Study||4||
48212666|NCT03149991|100845996|FG001|Exited|Overall Study||2||
48212667|NCT03149991|100845995|FG000|COMPLETED|Overall Study||21||
48212668|NCT03149991|100845996|FG001|COMPLETED|Overall Study||24||
48212669|NCT03149991|100845995|FG000|NOT COMPLETED|Overall Study||4||
48212670|NCT03149991|100845996|FG001|NOT COMPLETED|Overall Study||2||
48212671|NCT03485950|100845997|FG000|STARTED|Overall Study||50||
48212672|NCT03485950|100845998|FG001|STARTED|Overall Study||50||
48212673|NCT03485950|100845997|FG000|COMPLETED|Overall Study||43||
48212674|NCT03485950|100845998|FG001|COMPLETED|Overall Study||48||
48496008|NCT00989950|101547988|FG001|COMPLETED|Randomized Phase||8||
48212675|NCT03485950|100845997|FG000|NOT COMPLETED|Overall Study||7||
48212676|NCT03485950|100845998|FG001|NOT COMPLETED|Overall Study||2||
48212677|NCT03903822|100845999|FG000|STARTED|Treatment Phase (6 Weeks)||37||
48212678|NCT03903822|100846000|FG001|STARTED|Treatment Phase (6 Weeks)||37||
48212679|NCT03903822|100846001|FG002|STARTED|Treatment Phase (6 Weeks)||36||
48212680|NCT03903822|100846002|FG003|STARTED|Treatment Phase (6 Weeks)||37||
48212681|NCT03903822|100846003|FG004|STARTED|Treatment Phase (6 Weeks)||36||
48212682|NCT03903822|100846004|FG005|STARTED|Treatment Phase (6 Weeks)||36||
48212683|NCT03903822|100846005|FG006|STARTED|Treatment Phase (6 Weeks)||36||
48212684|NCT03903822|100846006|FG007|STARTED|Treatment Phase (6 Weeks)||37||
48212685|NCT03903822|100845999|FG000|COMPLETED|Treatment Phase (6 Weeks)||28||
48212686|NCT03903822|100846000|FG001|COMPLETED|Treatment Phase (6 Weeks)||27||
48059787|NCT01243671|100467020|FG000|Completed 52 Weeks of Treatment|Overall Study||17||
48059788|NCT01243671|100467020|FG000|COMPLETED|Overall Study||15||
48059789|NCT01243671|100467020|FG000|NOT COMPLETED|Overall Study||5||
48059790|NCT01842815|100467021|FG000|STARTED|Overall Study||20||26
48059791|NCT01842815|100467021|FG000|COMPLETED|Overall Study||16||22
48059792|NCT01842815|100467021|FG000|NOT COMPLETED|Overall Study||4||4
48059793|NCT04399837|100467022|FG000|STARTED|Overall Study||31||
48212687|NCT03903822|100846001|FG002|COMPLETED|Treatment Phase (6 Weeks)||33||
48212688|NCT03903822|100846002|FG003|COMPLETED|Treatment Phase (6 Weeks)||32||
48212689|NCT03903822|100846003|FG004|COMPLETED|Treatment Phase (6 Weeks)||31||
48212690|NCT03903822|100846004|FG005|COMPLETED|Treatment Phase (6 Weeks)||25||
48212691|NCT03903822|100846005|FG006|COMPLETED|Treatment Phase (6 Weeks)||31||
48212692|NCT03903822|100846006|FG007|COMPLETED|Treatment Phase (6 Weeks)||33||
48212693|NCT03903822|100845999|FG000|NOT COMPLETED|Treatment Phase (6 Weeks)||9||
48212694|NCT03903822|100846000|FG001|NOT COMPLETED|Treatment Phase (6 Weeks)||10||
48212695|NCT03903822|100846001|FG002|NOT COMPLETED|Treatment Phase (6 Weeks)||3||
48212696|NCT03903822|100846002|FG003|NOT COMPLETED|Treatment Phase (6 Weeks)||5||
48212697|NCT03903822|100846003|FG004|NOT COMPLETED|Treatment Phase (6 Weeks)||5||
48212698|NCT03903822|100846004|FG005|NOT COMPLETED|Treatment Phase (6 Weeks)||11||
48212699|NCT03903822|100846005|FG006|NOT COMPLETED|Treatment Phase (6 Weeks)||5||
48212700|NCT03903822|100846006|FG007|NOT COMPLETED|Treatment Phase (6 Weeks)||4||
48212701|NCT03903822|100845999|FG000|STARTED|Follow up Phase (4 Weeks)||37||
48212702|NCT03903822|100846000|FG001|STARTED|Follow up Phase (4 Weeks)||37||
48212703|NCT03903822|100846001|FG002|STARTED|Follow up Phase (4 Weeks)||36||
48212704|NCT03903822|100846002|FG003|STARTED|Follow up Phase (4 Weeks)||37||
48212705|NCT03903822|100846003|FG004|STARTED|Follow up Phase (4 Weeks)||36||
48212706|NCT03903822|100846004|FG005|STARTED|Follow up Phase (4 Weeks)||36||
48212707|NCT03903822|100846005|FG006|STARTED|Follow up Phase (4 Weeks)||36||
48212708|NCT03903822|100846006|FG007|STARTED|Follow up Phase (4 Weeks)||37||
48212709|NCT03903822|100845999|FG000|COMPLETED|Follow up Phase (4 Weeks)||29||
48212710|NCT03903822|100846000|FG001|COMPLETED|Follow up Phase (4 Weeks)||29||
48212711|NCT03903822|100846001|FG002|COMPLETED|Follow up Phase (4 Weeks)||32||
48212712|NCT03903822|100846002|FG003|COMPLETED|Follow up Phase (4 Weeks)||33||
48212713|NCT03903822|100846003|FG004|COMPLETED|Follow up Phase (4 Weeks)||32||
48212714|NCT03903822|100846004|FG005|COMPLETED|Follow up Phase (4 Weeks)||28||
48212715|NCT03903822|100846005|FG006|COMPLETED|Follow up Phase (4 Weeks)||31||
48212716|NCT03903822|100846006|FG007|COMPLETED|Follow up Phase (4 Weeks)||31||
48212717|NCT03903822|100845999|FG000|NOT COMPLETED|Follow up Phase (4 Weeks)||8||
48212718|NCT03903822|100846000|FG001|NOT COMPLETED|Follow up Phase (4 Weeks)||8||
48212719|NCT03903822|100846001|FG002|NOT COMPLETED|Follow up Phase (4 Weeks)||4||
48212720|NCT03903822|100846002|FG003|NOT COMPLETED|Follow up Phase (4 Weeks)||4||
48212721|NCT03903822|100846003|FG004|NOT COMPLETED|Follow up Phase (4 Weeks)||4||
48212722|NCT03903822|100846004|FG005|NOT COMPLETED|Follow up Phase (4 Weeks)||8||
48212723|NCT03903822|100846005|FG006|NOT COMPLETED|Follow up Phase (4 Weeks)||5||
48212724|NCT03903822|100846006|FG007|NOT COMPLETED|Follow up Phase (4 Weeks)||6||
48212725|NCT03010631|100846007|FG000|STARTED|Cohort 1||18|Participants in Cohort 2 were not included in the first treatment period|
48212726|NCT03010631|100846008|FG001|STARTED|Cohort 1||17|Participants in Cohort 2 were not included in the first treatment period|
48212727|NCT03010631|100846009|FG002|STARTED|Cohort 1||0|Participants in Cohort 2 were not included in the first treatment period|
48212728|NCT03010631|100846010|FG003|STARTED|Cohort 1||0|Participants in Cohort 2 were not included in the first treatment period|
48212729|NCT03010631|100846007|FG000|COMPLETED|Cohort 1||14||
48212730|NCT03010631|100846008|FG001|COMPLETED|Cohort 1||17||
48212731|NCT03010631|100846009|FG002|COMPLETED|Cohort 1||0||
48212732|NCT03010631|100846010|FG003|COMPLETED|Cohort 1||0||
48212733|NCT03010631|100846007|FG000|NOT COMPLETED|Cohort 1||4||
48212734|NCT03010631|100846008|FG001|NOT COMPLETED|Cohort 1||0||
48212735|NCT03010631|100846009|FG002|NOT COMPLETED|Cohort 1||0||
48212736|NCT03010631|100846010|FG003|NOT COMPLETED|Cohort 1||0||
48212737|NCT03010631|100846007|FG000|STARTED|Cohort 2||0|Participants from Cohort 1 were not included in the second treatment period|
48212738|NCT03010631|100846008|FG001|STARTED|Cohort 2||0|Participants from Cohort 1 were not included in the second treatment period|
48212739|NCT03010631|100846009|FG002|STARTED|Cohort 2||7|Participants from Cohort 1 were not included in the second treatment period|
48212740|NCT03010631|100846010|FG003|STARTED|Cohort 2||7|Participants from Cohort 1 were not included in the second treatment period|
48212741|NCT03010631|100846007|FG000|COMPLETED|Cohort 2||0||
48212742|NCT03010631|100846008|FG001|COMPLETED|Cohort 2||0||
48212743|NCT03010631|100846009|FG002|COMPLETED|Cohort 2||7||
48212744|NCT03010631|100846010|FG003|COMPLETED|Cohort 2||7||
48212745|NCT03010631|100846007|FG000|NOT COMPLETED|Cohort 2||0||
48212746|NCT03010631|100846008|FG001|NOT COMPLETED|Cohort 2||0||
48212747|NCT03010631|100846009|FG002|NOT COMPLETED|Cohort 2||0||
48212748|NCT03010631|100846010|FG003|NOT COMPLETED|Cohort 2||0||
48212749|NCT03762668|100846011|FG000|STARTED|Period 1, First Week of Wear||30||
48212750|NCT03762668|100846012|FG001|STARTED|Period 1, First Week of Wear||30||
48212751|NCT03762668|100846011|FG000|COMPLETED|Period 1, First Week of Wear||30||
48212752|NCT03762668|100846012|FG001|COMPLETED|Period 1, First Week of Wear||29||
48212753|NCT03762668|100846011|FG000|NOT COMPLETED|Period 1, First Week of Wear||0||
48212754|NCT03762668|100846012|FG001|NOT COMPLETED|Period 1, First Week of Wear||1||
48212755|NCT03762668|100846011|FG000|STARTED|Period 2, Second Week of Wear||30||
48212756|NCT03762668|100846012|FG001|STARTED|Period 2, Second Week of Wear||29||
48212757|NCT03762668|100846011|FG000|COMPLETED|Period 2, Second Week of Wear||30||
48212758|NCT03762668|100846012|FG001|COMPLETED|Period 2, Second Week of Wear||29||
48212759|NCT03762668|100846011|FG000|NOT COMPLETED|Period 2, Second Week of Wear||0||
48496009|NCT00989950|101547989|FG002|COMPLETED|Randomized Phase||4||
48212760|NCT03762668|100846012|FG001|NOT COMPLETED|Period 2, Second Week of Wear||0||
48212761|NCT04410367|100846013|FG000|STARTED|Overall Study||23||
48212762|NCT04410367|100846013|FG000|Underwent 18F-fluciclovine PET|Overall Study||23||
48212763|NCT04410367|100846013|FG000|COMPLETED|Overall Study||23||
48212764|NCT04410367|100846013|FG000|NOT COMPLETED|Overall Study||0||
48212765|NCT02395978|100846014|FG000|STARTED|Overall Study||6||
48212766|NCT02395978|100846015|FG001|STARTED|Overall Study||6||
48212767|NCT02395978|100846016|FG002|STARTED|Overall Study||21||
48212768|NCT02395978|100846017|FG003|STARTED|Overall Study||19||
48212769|NCT02395978|100846018|FG004|STARTED|Overall Study||20||
48212770|NCT02395978|100846014|FG000|COMPLETED|Overall Study||6||
48212771|NCT02395978|100846015|FG001|COMPLETED|Overall Study||6||
48212772|NCT02395978|100846016|FG002|COMPLETED|Overall Study||19||
48212773|NCT02395978|100846017|FG003|COMPLETED|Overall Study||14||
48212774|NCT02395978|100846018|FG004|COMPLETED|Overall Study||15||
48212775|NCT02395978|100846014|FG000|NOT COMPLETED|Overall Study||0||
48212776|NCT02395978|100846015|FG001|NOT COMPLETED|Overall Study||0||
48212777|NCT02395978|100846016|FG002|NOT COMPLETED|Overall Study||2||
48212778|NCT02395978|100846017|FG003|NOT COMPLETED|Overall Study||5||
48212779|NCT02395978|100846018|FG004|NOT COMPLETED|Overall Study||5||
48212780|NCT00212134|100846019|FG000|STARTED|Phase 1 (to Age 1 Year)||57||
48212781|NCT00212134|100846020|FG001|STARTED|Phase 1 (to Age 1 Year)||57||
48212782|NCT00212134|100846019|FG000|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57||
48212783|NCT00212134|100846020|FG001|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57||
48212784|NCT00212134|100846019|FG000|COMPLETED|Phase 1 (to Age 1 Year)||57||
48212785|NCT00212134|100846020|FG001|COMPLETED|Phase 1 (to Age 1 Year)||57||
48212786|NCT00212134|100846019|FG000|NOT COMPLETED|Phase 1 (to Age 1 Year)||0||
48212787|NCT00212134|100846020|FG001|NOT COMPLETED|Phase 1 (to Age 1 Year)||0||
48212788|NCT00212134|100846019|FG000|STARTED|Phase 2 (Age 1 Year to Age 5 Years)||57||
48212789|NCT00212134|100846020|FG001|STARTED|Phase 2 (Age 1 Year to Age 5 Years)||57||
48212790|NCT00212134|100846019|FG000|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||57||
48212791|NCT00212134|100846020|FG001|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||56||
48212792|NCT00212134|100846019|FG000|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||0||
48212793|NCT00212134|100846020|FG001|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||1||
48212794|NCT00212134|100846019|FG000|STARTED|Phase 3 (Age 10 Years)||57||
48212795|NCT00212134|100846020|FG001|STARTED|Phase 3 (Age 10 Years)||56||
48212796|NCT00212134|100846019|FG000|COMPLETED|Phase 3 (Age 10 Years)||55||
48212797|NCT00212134|100846020|FG001|COMPLETED|Phase 3 (Age 10 Years)||55||
48212798|NCT00212134|100846019|FG000|NOT COMPLETED|Phase 3 (Age 10 Years)||2||
48212799|NCT00212134|100846020|FG001|NOT COMPLETED|Phase 3 (Age 10 Years)||1||
48212800|NCT03648762|100846021|FG000|STARTED|Overall Study||16||
48212801|NCT03648762|100846022|FG001|STARTED|Overall Study||17||
48212802|NCT03648762|100846023|FG002|STARTED|Overall Study||12||
48212803|NCT03648762|100846021|FG000|COMPLETED|Overall Study||10||
48212804|NCT03648762|100846022|FG001|COMPLETED|Overall Study||13||
48212805|NCT03648762|100846023|FG002|COMPLETED|Overall Study||11||
48212806|NCT03648762|100846021|FG000|NOT COMPLETED|Overall Study||6||
48212807|NCT03648762|100846022|FG001|NOT COMPLETED|Overall Study||4||
48212808|NCT03648762|100846023|FG002|NOT COMPLETED|Overall Study||1||
48212809|NCT00203411|100846024|FG000|STARTED|Treatment Period||45||
48212810|NCT00203411|100846024|FG000|COMPLETED|Treatment Period||45||
48212811|NCT00203411|100846024|FG000|NOT COMPLETED|Treatment Period||0||
48212812|NCT00203411|100846024|FG000|STARTED|Follow-up||45||
48212813|NCT00203411|100846024|FG000|COMPLETED|Follow-up||41||
48212814|NCT00203411|100846024|FG000|NOT COMPLETED|Follow-up||4||
48212815|NCT00925899|100846025|FG000|STARTED|Part 1||34||
48496010|NCT00989950|101547990|FG003|COMPLETED|Randomized Phase||7||
48496011|NCT00989950|101547987|FG000|NOT COMPLETED|Randomized Phase||1||
48496012|NCT00989950|101547988|FG001|NOT COMPLETED|Randomized Phase||1||
48212816|NCT00925899|100846026|FG001|STARTED|Part 1||38||
48212817|NCT00925899|100846025|FG000|COMPLETED|Part 1||23||
48212818|NCT00925899|100846026|FG001|COMPLETED|Part 1||27||
48212819|NCT00925899|100846025|FG000|NOT COMPLETED|Part 1||11||
48212820|NCT00925899|100846026|FG001|NOT COMPLETED|Part 1||11||
48212821|NCT00925899|100846025|FG000|STARTED|Part 2||15|Nine patients withdrew before part two because they did not wish to continue in the study|
48212822|NCT00925899|100846026|FG001|STARTED|Part 2||21|Nine patients withdrew before part two because they did not wish to continue in the study|
48212823|NCT00925899|100846025|FG000|COMPLETED|Part 2||9||
48212824|NCT00925899|100846026|FG001|COMPLETED|Part 2||9||
48212825|NCT00925899|100846025|FG000|NOT COMPLETED|Part 2||6||
48212826|NCT00925899|100846026|FG001|NOT COMPLETED|Part 2||12||
48212827|NCT02928224|100846027|FG000|STARTED|Overall Study||37||
48212828|NCT02928224|100846028|FG001|STARTED|Overall Study||224||
48212829|NCT02928224|100846029|FG002|STARTED|Overall Study||220||
48212830|NCT02928224|100846030|FG003|STARTED|Overall Study||221||
48212831|NCT02928224|100846027|FG000|Crossover Participants|Overall Study||0||
48212832|NCT02928224|100846028|FG001|Crossover Participants|Overall Study||0||
48212833|NCT02928224|100846029|FG002|Crossover Participants|Overall Study||0||
48212834|NCT02928224|100846030|FG003|Crossover Participants|Overall Study||3||
48212835|NCT02928224|100846027|FG000|COMPLETED|Overall Study||0||
48212836|NCT02928224|100846028|FG001|COMPLETED|Overall Study||0||
48212837|NCT02928224|100846029|FG002|COMPLETED|Overall Study||0||
48212838|NCT02928224|100846030|FG003|COMPLETED|Overall Study||0||
48212839|NCT02928224|100846027|FG000|NOT COMPLETED|Overall Study||37||
48212840|NCT02928224|100846028|FG001|NOT COMPLETED|Overall Study||224||
48212841|NCT02928224|100846029|FG002|NOT COMPLETED|Overall Study||220||
48212842|NCT02928224|100846030|FG003|NOT COMPLETED|Overall Study||221||
48212843|NCT00585052|100846031|FG000|STARTED|Overall Study||11||
48212844|NCT00585052|100846031|FG000|COMPLETED|Overall Study||10||
48212845|NCT00585052|100846031|FG000|NOT COMPLETED|Overall Study||1||
48212846|NCT00041938|100846032|FG000|STARTED|Overall Study||1163||
48212847|NCT00041938|100846033|FG001|STARTED|Overall Study||1142||
48212848|NCT00041938|100846032|FG000|Completed Follow-up|Overall Study||761||
48212849|NCT00041938|100846033|FG001|Completed Follow-up|Overall Study||745||
48212850|NCT00041938|100846032|FG000|Primary Endpoint|Overall Study||320||
48212851|NCT00041938|100846033|FG001|Primary Endpoint|Overall Study||302||
48212852|NCT00041938|100846032|FG000|Only Vital Status Known|Overall Study||44||
48212853|NCT00041938|100846033|FG001|Only Vital Status Known|Overall Study||46||
48212854|NCT00041938|100846032|FG000|Lost to Follow-up|Overall Study||18||
48212855|NCT00041938|100846033|FG001|Lost to Follow-up|Overall Study||17||
48212856|NCT00041938|100846032|FG000|Withdrew Consent|Overall Study||20||
48212857|NCT00041938|100846033|FG001|Withdrew Consent|Overall Study||14||
48212858|NCT00041938|100846032|FG000|COMPLETED|Overall Study||1125||
48212859|NCT00041938|100846033|FG001|COMPLETED|Overall Study||1111||
48212860|NCT00041938|100846032|FG000|NOT COMPLETED|Overall Study||38||
48212861|NCT00041938|100846033|FG001|NOT COMPLETED|Overall Study||31||
48212862|NCT03638427|100846034|FG000|STARTED|Overall Study||159||
48212863|NCT03638427|100846034|FG000|COMPLETED|Overall Study||110||
48212864|NCT03638427|100846034|FG000|NOT COMPLETED|Overall Study||49||
48212865|NCT02769858|100846035|FG000|STARTED|Overall Study||10||
48212866|NCT02769858|100846035|FG000|COMPLETED|Overall Study||8||
48212867|NCT02769858|100846035|FG000|NOT COMPLETED|Overall Study||2||
48212868|NCT01424670|100846036|FG000|STARTED|6-Month Intensive Period (182 Days)||341||
48212869|NCT01424670|100846037|FG001|STARTED|6-Month Intensive Period (182 Days)||170||
48212870|NCT01424670|100846036|FG000|Received at Least 1 Dose of Study Drug|6-Month Intensive Period (182 Days)||341||
48212871|NCT01424670|100846037|FG001|Received at Least 1 Dose of Study Drug|6-Month Intensive Period (182 Days)||170||
48212872|NCT01424670|100846036|FG000|COMPLETED|6-Month Intensive Period (182 Days)||322|The duration of the 6-month Intensive Period was over 182 days from the date of the first dose.|
48212873|NCT01424670|100846037|FG001|COMPLETED|6-Month Intensive Period (182 Days)||156|The duration of the 6-month Intensive Period was over 182 days from the date of the first dose.|
48212874|NCT01424670|100846036|FG000|NOT COMPLETED|6-Month Intensive Period (182 Days)||19||
48212875|NCT01424670|100846037|FG001|NOT COMPLETED|6-Month Intensive Period (182 Days)||14||
48212876|NCT01424670|100846036|FG000|STARTED|Continuation Period||322||
48212877|NCT01424670|100846037|FG001|STARTED|Continuation Period||156||
48212878|NCT01424670|100846036|FG000|COMPLETED|Continuation Period||288||
48212879|NCT01424670|100846037|FG001|COMPLETED|Continuation Period||142||
48212880|NCT01424670|100846036|FG000|NOT COMPLETED|Continuation Period||34||
48212881|NCT01424670|100846037|FG001|NOT COMPLETED|Continuation Period||14||
48212882|NCT03086369|100846038|FG000|STARTED|Overall Study||3||
48212883|NCT03086369|100846039|FG001|STARTED|Overall Study||7||
48212884|NCT03086369|100846040|FG002|STARTED|Overall Study||12||
48212885|NCT03086369|100846041|FG003|STARTED|Overall Study||82||
48212886|NCT03086369|100846042|FG004|STARTED|Overall Study||80||
48212887|NCT03086369|100846038|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
48212888|NCT03086369|100846039|FG001|Received at Least 1 Dose of Study Drug|Overall Study||7||
48212889|NCT03086369|100846040|FG002|Received at Least 1 Dose of Study Drug|Overall Study||12||
48212890|NCT03086369|100846041|FG003|Received at Least 1 Dose of Study Drug|Overall Study||81||
48212891|NCT03086369|100846042|FG004|Received at Least 1 Dose of Study Drug|Overall Study||78||
48212892|NCT03086369|100846038|FG000|COMPLETED|Overall Study||2||
48212893|NCT03086369|100846039|FG001|COMPLETED|Overall Study||7||
48212894|NCT03086369|100846040|FG002|COMPLETED|Overall Study||12||
48496013|NCT00989950|101547989|FG002|NOT COMPLETED|Randomized Phase||0||
48212895|NCT03086369|100846041|FG003|COMPLETED|Overall Study||73||
48212896|NCT03086369|100846042|FG004|COMPLETED|Overall Study||73||
48212897|NCT03086369|100846038|FG000|NOT COMPLETED|Overall Study||1||
48212898|NCT03086369|100846039|FG001|NOT COMPLETED|Overall Study||0||
48212899|NCT03086369|100846040|FG002|NOT COMPLETED|Overall Study||0||
48212900|NCT03086369|100846041|FG003|NOT COMPLETED|Overall Study||9||
48212901|NCT03086369|100846042|FG004|NOT COMPLETED|Overall Study||7||
48212902|NCT01811706|100846043|FG000|STARTED|First Intervention ( 4 Weeks)||10||
48212903|NCT01811706|100846044|FG001|STARTED|First Intervention ( 4 Weeks)||10||
48212904|NCT01811706|100846043|FG000|COMPLETED|First Intervention ( 4 Weeks)||9||
48212905|NCT01811706|100846044|FG001|COMPLETED|First Intervention ( 4 Weeks)||10||
48212906|NCT01811706|100846043|FG000|NOT COMPLETED|First Intervention ( 4 Weeks)||1||
48212907|NCT01811706|100846044|FG001|NOT COMPLETED|First Intervention ( 4 Weeks)||0||
48212908|NCT01811706|100846043|FG000|STARTED|Washout ( 2 Weeks)||9||
48212909|NCT01811706|100846044|FG001|STARTED|Washout ( 2 Weeks)||10||
48212910|NCT01811706|100846043|FG000|COMPLETED|Washout ( 2 Weeks)||9||
48212911|NCT01811706|100846044|FG001|COMPLETED|Washout ( 2 Weeks)||10||
48212912|NCT01811706|100846043|FG000|NOT COMPLETED|Washout ( 2 Weeks)||0||
48212913|NCT01811706|100846044|FG001|NOT COMPLETED|Washout ( 2 Weeks)||0||
48212914|NCT01811706|100846043|FG000|STARTED|Second Intervention (4 Weeks)||9||
48212915|NCT01811706|100846044|FG001|STARTED|Second Intervention (4 Weeks)||10||
48212916|NCT01811706|100846043|FG000|COMPLETED|Second Intervention (4 Weeks)||9||
48212917|NCT01811706|100846044|FG001|COMPLETED|Second Intervention (4 Weeks)||10||
48212918|NCT01811706|100846043|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0||
48212919|NCT01811706|100846044|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0||
48212920|NCT00799396|100846045|FG000|STARTED|Clopidogrel Treatment||682||
48212921|NCT00799396|100846045|FG000|COMPLETED|Clopidogrel Treatment||669||
48212922|NCT00799396|100846045|FG000|NOT COMPLETED|Clopidogrel Treatment||13||
48212923|NCT00799396|100846045|FG000|STARTED|Clopidogrel Plus Aspirin||669||
48212924|NCT00799396|100846045|FG000|COMPLETED|Clopidogrel Plus Aspirin||663||
48212925|NCT00799396|100846045|FG000|NOT COMPLETED|Clopidogrel Plus Aspirin||6||
48212926|NCT04296227|100846046|FG000|STARTED|Overall Study||85||
48212927|NCT04296227|100846046|FG000|COMPLETED|Overall Study||85||
48212928|NCT04296227|100846046|FG000|NOT COMPLETED|Overall Study||0||
48212929|NCT02467166|100846047|FG000|STARTED|Overall Study||36||
48212930|NCT02467166|100846047|FG000|COMPLETED|Overall Study||36||
48212931|NCT02467166|100846047|FG000|NOT COMPLETED|Overall Study||0||
48212932|NCT03764475|100846048|FG000|STARTED|Overall Study||230||
48212933|NCT03764475|100846049|FG001|STARTED|Overall Study||102||
48212934|NCT03764475|100846048|FG000|COMPLETED|Overall Study||164||
48212935|NCT03764475|100846049|FG001|COMPLETED|Overall Study||80||
48212936|NCT03764475|100846048|FG000|NOT COMPLETED|Overall Study||66||
48212937|NCT03764475|100846049|FG001|NOT COMPLETED|Overall Study||22||
48212938|NCT01424397|100846050|FG000|STARTED|Period-1 (8 Days)||7||
48212939|NCT01424397|100846051|FG001|STARTED|Period-1 (8 Days)||8||
48212940|NCT01424397|100846052|FG002|STARTED|Period-1 (8 Days)||8||
48212941|NCT01424397|100846053|FG003|STARTED|Period-1 (8 Days)||8||
48212942|NCT01424397|100846054|FG004|STARTED|Period-1 (8 Days)||8||
48212943|NCT01424397|100846055|FG005|STARTED|Period-1 (8 Days)||8||
48212944|NCT01424397|100846056|FG006|STARTED|Period-1 (8 Days)||4||
48212945|NCT01424397|100846057|FG007|STARTED|Period-1 (8 Days)||4||
48212946|NCT01424397|100846058|FG008|STARTED|Period-1 (8 Days)||4||
48212947|NCT01424397|100846059|FG009|STARTED|Period-1 (8 Days)||3||
48212948|NCT01424397|100846060|FG010|STARTED|Period-1 (8 Days)||4||
48212949|NCT01424397|100846061|FG011|STARTED|Period-1 (8 Days)||4||
48212950|NCT01424397|100846050|FG000|COMPLETED|Period-1 (8 Days)||7||
48212951|NCT01424397|100846051|FG001|COMPLETED|Period-1 (8 Days)||8||
48212952|NCT01424397|100846052|FG002|COMPLETED|Period-1 (8 Days)||8||
48212953|NCT01424397|100846053|FG003|COMPLETED|Period-1 (8 Days)||8||
48212954|NCT01424397|100846054|FG004|COMPLETED|Period-1 (8 Days)||8||
48212955|NCT01424397|100846055|FG005|COMPLETED|Period-1 (8 Days)||8||
48212956|NCT01424397|100846056|FG006|COMPLETED|Period-1 (8 Days)||4||
48212957|NCT01424397|100846057|FG007|COMPLETED|Period-1 (8 Days)||4||
48212958|NCT01424397|100846058|FG008|COMPLETED|Period-1 (8 Days)||4||
48212959|NCT01424397|100846059|FG009|COMPLETED|Period-1 (8 Days)||3||
48212960|NCT01424397|100846060|FG010|COMPLETED|Period-1 (8 Days)||4||
48212961|NCT01424397|100846061|FG011|COMPLETED|Period-1 (8 Days)||4||
48212962|NCT01424397|100846050|FG000|NOT COMPLETED|Period-1 (8 Days)||0||
48212963|NCT01424397|100846051|FG001|NOT COMPLETED|Period-1 (8 Days)||0||
48212964|NCT01424397|100846052|FG002|NOT COMPLETED|Period-1 (8 Days)||0||
48212965|NCT01424397|100846053|FG003|NOT COMPLETED|Period-1 (8 Days)||0||
48212966|NCT01424397|100846054|FG004|NOT COMPLETED|Period-1 (8 Days)||0||
48212967|NCT01424397|100846055|FG005|NOT COMPLETED|Period-1 (8 Days)||0||
48212968|NCT01424397|100846056|FG006|NOT COMPLETED|Period-1 (8 Days)||0||
48212969|NCT01424397|100846057|FG007|NOT COMPLETED|Period-1 (8 Days)||0||
48212970|NCT01424397|100846058|FG008|NOT COMPLETED|Period-1 (8 Days)||0||
48212971|NCT01424397|100846059|FG009|NOT COMPLETED|Period-1 (8 Days)||0||
48212972|NCT01424397|100846060|FG010|NOT COMPLETED|Period-1 (8 Days)||0||
48212973|NCT01424397|100846061|FG011|NOT COMPLETED|Period-1 (8 Days)||0||
48212974|NCT01424397|100846050|FG000|STARTED|Washout Period-1 (14-20 Days)||7||
48212975|NCT01424397|100846051|FG001|STARTED|Washout Period-1 (14-20 Days)||8||
48212976|NCT01424397|100846052|FG002|STARTED|Washout Period-1 (14-20 Days)||8||
48212977|NCT01424397|100846053|FG003|STARTED|Washout Period-1 (14-20 Days)||8||
48212978|NCT01424397|100846054|FG004|STARTED|Washout Period-1 (14-20 Days)||8||
48212979|NCT01424397|100846055|FG005|STARTED|Washout Period-1 (14-20 Days)||8||
48212980|NCT01424397|100846056|FG006|STARTED|Washout Period-1 (14-20 Days)||4||
48212981|NCT01424397|100846057|FG007|STARTED|Washout Period-1 (14-20 Days)||4||
48212982|NCT01424397|100846058|FG008|STARTED|Washout Period-1 (14-20 Days)||4||
48212983|NCT01424397|100846059|FG009|STARTED|Washout Period-1 (14-20 Days)||3||
48212984|NCT01424397|100846060|FG010|STARTED|Washout Period-1 (14-20 Days)||4||
48212985|NCT01424397|100846061|FG011|STARTED|Washout Period-1 (14-20 Days)||4||
48212986|NCT01424397|100846050|FG000|COMPLETED|Washout Period-1 (14-20 Days)||7||
48212987|NCT01424397|100846051|FG001|COMPLETED|Washout Period-1 (14-20 Days)||8||
48212988|NCT01424397|100846052|FG002|COMPLETED|Washout Period-1 (14-20 Days)||8||
48212989|NCT01424397|100846053|FG003|COMPLETED|Washout Period-1 (14-20 Days)||8||
48212990|NCT01424397|100846054|FG004|COMPLETED|Washout Period-1 (14-20 Days)||8||
48212991|NCT01424397|100846055|FG005|COMPLETED|Washout Period-1 (14-20 Days)||8||
48212992|NCT01424397|100846056|FG006|COMPLETED|Washout Period-1 (14-20 Days)||4||
48212993|NCT01424397|100846057|FG007|COMPLETED|Washout Period-1 (14-20 Days)||4||
48059794|NCT04399837|100467023|FG001|STARTED|Overall Study||31||
48059795|NCT04399837|100467024|FG002|STARTED|Overall Study||31||
48059796|NCT04399837|100467025|FG003|STARTED|Overall Study||30||
48059797|NCT04399837|100467022|FG000|COMPLETED|Overall Study||30|Completed trial|
48059798|NCT04399837|100467023|FG001|COMPLETED|Overall Study||27|Completed trial|
48059799|NCT04399837|100467024|FG002|COMPLETED|Overall Study||28|Completed trial|
48212994|NCT01424397|100846058|FG008|COMPLETED|Washout Period-1 (14-20 Days)||4||
48212995|NCT01424397|100846059|FG009|COMPLETED|Washout Period-1 (14-20 Days)||3||
48212996|NCT01424397|100846060|FG010|COMPLETED|Washout Period-1 (14-20 Days)||4||
48212997|NCT01424397|100846061|FG011|COMPLETED|Washout Period-1 (14-20 Days)||4||
48212998|NCT01424397|100846050|FG000|NOT COMPLETED|Washout Period-1 (14-20 Days)||0||
48212999|NCT01424397|100846051|FG001|NOT COMPLETED|Washout Period-1 (14-20 Days)||0||
48213000|NCT01424397|100846052|FG002|NOT COMPLETED|Washout Period-1 (14-20 Days)||0||
48213001|NCT01424397|100846053|FG003|NOT COMPLETED|Washout Period-1 (14-20 Days)||0||
48213002|NCT01424397|100846054|FG004|NOT COMPLETED|Washout Period-1 (14-20 Days)||0||
48213003|NCT01424397|100846055|FG005|NOT COMPLETED|Washout Period-1 (14-20 Days)||0||
48213004|NCT01424397|100846056|FG006|NOT COMPLETED|Washout Period-1 (14-20 Days)||0||
48213005|NCT01424397|100846057|FG007|NOT COMPLETED|Washout Period-1 (14-20 Days)||0||
48213006|NCT01424397|100846058|FG008|NOT COMPLETED|Washout Period-1 (14-20 Days)||0||
48213007|NCT01424397|100846059|FG009|NOT COMPLETED|Washout Period-1 (14-20 Days)||0||
48213008|NCT01424397|100846060|FG010|NOT COMPLETED|Washout Period-1 (14-20 Days)||0||
48213009|NCT01424397|100846061|FG011|NOT COMPLETED|Washout Period-1 (14-20 Days)||0||
48213010|NCT01424397|100846050|FG000|STARTED|Period-2 (8 Days)||7||
48213011|NCT01424397|100846051|FG001|STARTED|Period-2 (8 Days)||8||
48213012|NCT01424397|100846052|FG002|STARTED|Period-2 (8 Days)||8||
48213013|NCT01424397|100846053|FG003|STARTED|Period-2 (8 Days)||8||
48213014|NCT01424397|100846054|FG004|STARTED|Period-2 (8 Days)||8||
48213015|NCT01424397|100846055|FG005|STARTED|Period-2 (8 Days)||8||
48213016|NCT01424397|100846056|FG006|STARTED|Period-2 (8 Days)||4||
48213017|NCT01424397|100846057|FG007|STARTED|Period-2 (8 Days)||4||
48213018|NCT01424397|100846058|FG008|STARTED|Period-2 (8 Days)||4||
48213019|NCT01424397|100846059|FG009|STARTED|Period-2 (8 Days)||3||
48213020|NCT01424397|100846060|FG010|STARTED|Period-2 (8 Days)||4||
48213021|NCT01424397|100846061|FG011|STARTED|Period-2 (8 Days)||4||
48213022|NCT01424397|100846050|FG000|COMPLETED|Period-2 (8 Days)||7||
48213023|NCT01424397|100846051|FG001|COMPLETED|Period-2 (8 Days)||8||
48213024|NCT01424397|100846052|FG002|COMPLETED|Period-2 (8 Days)||7||
48213025|NCT01424397|100846053|FG003|COMPLETED|Period-2 (8 Days)||8||
48213026|NCT01424397|100846054|FG004|COMPLETED|Period-2 (8 Days)||8||
48213027|NCT01424397|100846055|FG005|COMPLETED|Period-2 (8 Days)||8||
48213028|NCT01424397|100846056|FG006|COMPLETED|Period-2 (8 Days)||4||
48213029|NCT01424397|100846057|FG007|COMPLETED|Period-2 (8 Days)||4||
48213030|NCT01424397|100846058|FG008|COMPLETED|Period-2 (8 Days)||4||
48213031|NCT01424397|100846059|FG009|COMPLETED|Period-2 (8 Days)||3||
48213032|NCT01424397|100846060|FG010|COMPLETED|Period-2 (8 Days)||4||
48496014|NCT00989950|101547990|FG003|NOT COMPLETED|Randomized Phase||0||
48496015|NCT00087529|101547991|FG000|STARTED|Overall Study||147||
48496016|NCT00087529|101547992|FG001|STARTED|Overall Study||292||
48496017|NCT00087529|101547991|FG000|COMPLETED|Overall Study||116||
48059800|NCT04399837|100467025|FG003|COMPLETED|Overall Study||26|Completed trial|
48059801|NCT04399837|100467022|FG000|NOT COMPLETED|Overall Study||1||
48059802|NCT04399837|100467023|FG001|NOT COMPLETED|Overall Study||4||
48059803|NCT04399837|100467024|FG002|NOT COMPLETED|Overall Study||3||
48213033|NCT01424397|100846061|FG011|COMPLETED|Period-2 (8 Days)||4||
48213034|NCT01424397|100846050|FG000|NOT COMPLETED|Period-2 (8 Days)||0||
48213035|NCT01424397|100846051|FG001|NOT COMPLETED|Period-2 (8 Days)||0||
48213036|NCT01424397|100846052|FG002|NOT COMPLETED|Period-2 (8 Days)||1||
48213037|NCT01424397|100846053|FG003|NOT COMPLETED|Period-2 (8 Days)||0||
48213038|NCT01424397|100846054|FG004|NOT COMPLETED|Period-2 (8 Days)||0||
48213039|NCT01424397|100846055|FG005|NOT COMPLETED|Period-2 (8 Days)||0||
48213040|NCT01424397|100846056|FG006|NOT COMPLETED|Period-2 (8 Days)||0||
48213041|NCT01424397|100846057|FG007|NOT COMPLETED|Period-2 (8 Days)||0||
48213042|NCT01424397|100846058|FG008|NOT COMPLETED|Period-2 (8 Days)||0||
48213043|NCT01424397|100846059|FG009|NOT COMPLETED|Period-2 (8 Days)||0||
48213044|NCT01424397|100846060|FG010|NOT COMPLETED|Period-2 (8 Days)||0||
48213045|NCT01424397|100846061|FG011|NOT COMPLETED|Period-2 (8 Days)||0||
48213046|NCT01424397|100846050|FG000|STARTED|Washout Period-2 (14-20 Days)||7||
48213047|NCT01424397|100846051|FG001|STARTED|Washout Period-2 (14-20 Days)||8||
48213048|NCT01424397|100846052|FG002|STARTED|Washout Period-2 (14-20 Days)||7||
48213049|NCT01424397|100846053|FG003|STARTED|Washout Period-2 (14-20 Days)||8||
48213050|NCT01424397|100846054|FG004|STARTED|Washout Period-2 (14-20 Days)||8||
48213051|NCT01424397|100846055|FG005|STARTED|Washout Period-2 (14-20 Days)||8||
48213052|NCT01424397|100846056|FG006|STARTED|Washout Period-2 (14-20 Days)||4||
48213053|NCT01424397|100846057|FG007|STARTED|Washout Period-2 (14-20 Days)||4||
48213054|NCT01424397|100846058|FG008|STARTED|Washout Period-2 (14-20 Days)||4||
48213055|NCT01424397|100846059|FG009|STARTED|Washout Period-2 (14-20 Days)||3||
48213056|NCT01424397|100846060|FG010|STARTED|Washout Period-2 (14-20 Days)||4||
48213057|NCT01424397|100846061|FG011|STARTED|Washout Period-2 (14-20 Days)||4||
48059804|NCT04399837|100467025|FG003|NOT COMPLETED|Overall Study||4||
48496018|NCT00087529|101547992|FG001|COMPLETED|Overall Study||224||
48496019|NCT00087529|101547991|FG000|NOT COMPLETED|Overall Study||31||
48496020|NCT00087529|101547992|FG001|NOT COMPLETED|Overall Study||68||
48496021|NCT03131895|101547993|FG000|STARTED|Intervention Period 1 (2 Days)||28||
48496022|NCT03131895|101547994|FG001|STARTED|Intervention Period 1 (2 Days)||28||
48496023|NCT03131895|101547995|FG002|STARTED|Intervention Period 1 (2 Days)||30||
48496024|NCT03131895|101547996|FG003|STARTED|Intervention Period 1 (2 Days)||30||
48496025|NCT03131895|101547993|FG000|COMPLETED|Intervention Period 1 (2 Days)||28||
48496026|NCT03131895|101547994|FG001|COMPLETED|Intervention Period 1 (2 Days)||28||
48496027|NCT03131895|101547995|FG002|COMPLETED|Intervention Period 1 (2 Days)||30||
48496028|NCT03131895|101547996|FG003|COMPLETED|Intervention Period 1 (2 Days)||30||
48496029|NCT03131895|101547993|FG000|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
48496030|NCT03131895|101547994|FG001|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
48496031|NCT03131895|101547995|FG002|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
48496032|NCT03131895|101547996|FG003|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
48496033|NCT03131895|101547993|FG000|STARTED|Washout Period (at Least 5 Days)||28||
48496034|NCT03131895|101547994|FG001|STARTED|Washout Period (at Least 5 Days)||28||
48496035|NCT03131895|101547995|FG002|STARTED|Washout Period (at Least 5 Days)||30||
48496036|NCT03131895|101547996|FG003|STARTED|Washout Period (at Least 5 Days)||30||
48496037|NCT03131895|101547993|FG000|COMPLETED|Washout Period (at Least 5 Days)||27||
48496038|NCT03131895|101547994|FG001|COMPLETED|Washout Period (at Least 5 Days)||23||
48496039|NCT03131895|101547995|FG002|COMPLETED|Washout Period (at Least 5 Days)||26||
48496040|NCT03131895|101547996|FG003|COMPLETED|Washout Period (at Least 5 Days)||25||
48496041|NCT03131895|101547993|FG000|NOT COMPLETED|Washout Period (at Least 5 Days)||1||
48496042|NCT03131895|101547994|FG001|NOT COMPLETED|Washout Period (at Least 5 Days)||5||
48496043|NCT03131895|101547995|FG002|NOT COMPLETED|Washout Period (at Least 5 Days)||4||
48496044|NCT03131895|101547996|FG003|NOT COMPLETED|Washout Period (at Least 5 Days)||5||
48496045|NCT03131895|101547993|FG000|STARTED|Intervention Period 2 (2 Days)||27||
48496046|NCT03131895|101547994|FG001|STARTED|Intervention Period 2 (2 Days)||23||
48496047|NCT03131895|101547995|FG002|STARTED|Intervention Period 2 (2 Days)||26||
48496048|NCT03131895|101547996|FG003|STARTED|Intervention Period 2 (2 Days)||25||
48496049|NCT03131895|101547993|FG000|COMPLETED|Intervention Period 2 (2 Days)||26||
48496050|NCT03131895|101547994|FG001|COMPLETED|Intervention Period 2 (2 Days)||22||
48496051|NCT03131895|101547995|FG002|COMPLETED|Intervention Period 2 (2 Days)||26||
48496052|NCT03131895|101547996|FG003|COMPLETED|Intervention Period 2 (2 Days)||25||
48496053|NCT03131895|101547993|FG000|NOT COMPLETED|Intervention Period 2 (2 Days)||1||
48496054|NCT03131895|101547994|FG001|NOT COMPLETED|Intervention Period 2 (2 Days)||1||
48496055|NCT03131895|101547995|FG002|NOT COMPLETED|Intervention Period 2 (2 Days)||0||
48496056|NCT03131895|101547996|FG003|NOT COMPLETED|Intervention Period 2 (2 Days)||0||
48496057|NCT02654145|101547997|FG000|STARTED|Overall Study||145||
48496058|NCT02654145|101547997|FG000|COMPLETED|Overall Study||138||
48496059|NCT02654145|101547997|FG000|NOT COMPLETED|Overall Study||7||
48496060|NCT03930732|101547998|FG000|STARTED|Overall Study||471|Randomized|
48496061|NCT03930732|101547999|FG001|STARTED|Overall Study||468|Randomized|
48496062|NCT03930732|101547998|FG000|Safety Population|Overall Study||470|One participant was exposed to different treatment other than planned (was randomized to placebo arm but received dupilumab on Day 40). The actual arm was considered as dupilumab 300 mg q2w. In safety analyses, the actual arms are used.|
48496063|NCT03930732|101547999|FG001|Safety Population|Overall Study||469|One participant was exposed to different treatment other than planned (was randomized to placebo arm but received dupilumab on Day 40). The actual arm was considered as dupilumab 300 mg q2w. In safety analyses, the actual arms are used.|
48496064|NCT03930732|101547998|FG000|COMPLETED|Overall Study||434||
48496065|NCT03930732|101547999|FG001|COMPLETED|Overall Study||440||
48496066|NCT03930732|101547998|FG000|NOT COMPLETED|Overall Study||37||
48496067|NCT03930732|101547999|FG001|NOT COMPLETED|Overall Study||28||
48496068|NCT00828321|101548000|FG000|STARTED|First Intervention||20||
48496069|NCT00828321|101548001|FG001|STARTED|First Intervention||20||
48496070|NCT00828321|101548000|FG000|COMPLETED|First Intervention||20||
48496071|NCT00828321|101548001|FG001|COMPLETED|First Intervention||20||
48496072|NCT00828321|101548000|FG000|NOT COMPLETED|First Intervention||0||
48496073|NCT00828321|101548001|FG001|NOT COMPLETED|First Intervention||0||
48496074|NCT00828321|101548000|FG000|STARTED|Washout of 42 Days||20||
48496075|NCT00828321|101548001|FG001|STARTED|Washout of 42 Days||20||
48496076|NCT00828321|101548000|FG000|COMPLETED|Washout of 42 Days||18||
48496077|NCT00828321|101548001|FG001|COMPLETED|Washout of 42 Days||20||
48496078|NCT00828321|101548000|FG000|NOT COMPLETED|Washout of 42 Days||2||
48496079|NCT00828321|101548001|FG001|NOT COMPLETED|Washout of 42 Days||0||
48496080|NCT00828321|101548000|FG000|STARTED|Second Intervention||18||
48496081|NCT00828321|101548001|FG001|STARTED|Second Intervention||20||
48496082|NCT00828321|101548000|FG000|COMPLETED|Second Intervention||18||
48496083|NCT00828321|101548001|FG001|COMPLETED|Second Intervention||19||
48496084|NCT00828321|101548000|FG000|NOT COMPLETED|Second Intervention||0||
48496085|NCT00828321|101548001|FG001|NOT COMPLETED|Second Intervention||1||
48496086|NCT00834873|101548002|FG000|STARTED|First Intervention||12||
48496087|NCT00834873|101548003|FG001|STARTED|First Intervention||12||
48496088|NCT00834873|101548002|FG000|COMPLETED|First Intervention||12||
48496089|NCT00834873|101548003|FG001|COMPLETED|First Intervention||11||
48496090|NCT00834873|101548002|FG000|NOT COMPLETED|First Intervention||0||
48213058|NCT01424397|100846050|FG000|COMPLETED|Washout Period-2 (14-20 Days)||7||
48213059|NCT01424397|100846051|FG001|COMPLETED|Washout Period-2 (14-20 Days)||8||
48213060|NCT01424397|100846052|FG002|COMPLETED|Washout Period-2 (14-20 Days)||7||
48213061|NCT01424397|100846053|FG003|COMPLETED|Washout Period-2 (14-20 Days)||8||
48213062|NCT01424397|100846054|FG004|COMPLETED|Washout Period-2 (14-20 Days)||8||
48213063|NCT01424397|100846055|FG005|COMPLETED|Washout Period-2 (14-20 Days)||8||
48213064|NCT01424397|100846056|FG006|COMPLETED|Washout Period-2 (14-20 Days)||4||
48213065|NCT01424397|100846057|FG007|COMPLETED|Washout Period-2 (14-20 Days)||4||
48213066|NCT01424397|100846058|FG008|COMPLETED|Washout Period-2 (14-20 Days)||4||
48213067|NCT01424397|100846059|FG009|COMPLETED|Washout Period-2 (14-20 Days)||3||
48213068|NCT01424397|100846060|FG010|COMPLETED|Washout Period-2 (14-20 Days)||4||
48213069|NCT01424397|100846061|FG011|COMPLETED|Washout Period-2 (14-20 Days)||4||
48213070|NCT01424397|100846050|FG000|NOT COMPLETED|Washout Period-2 (14-20 Days)||0||
48213071|NCT01424397|100846051|FG001|NOT COMPLETED|Washout Period-2 (14-20 Days)||0||
48213072|NCT01424397|100846052|FG002|NOT COMPLETED|Washout Period-2 (14-20 Days)||0||
48213073|NCT01424397|100846053|FG003|NOT COMPLETED|Washout Period-2 (14-20 Days)||0||
48213074|NCT01424397|100846054|FG004|NOT COMPLETED|Washout Period-2 (14-20 Days)||0||
48213075|NCT01424397|100846055|FG005|NOT COMPLETED|Washout Period-2 (14-20 Days)||0||
48213076|NCT01424397|100846056|FG006|NOT COMPLETED|Washout Period-2 (14-20 Days)||0||
48213077|NCT01424397|100846057|FG007|NOT COMPLETED|Washout Period-2 (14-20 Days)||0||
48213078|NCT01424397|100846058|FG008|NOT COMPLETED|Washout Period-2 (14-20 Days)||0||
48213079|NCT01424397|100846059|FG009|NOT COMPLETED|Washout Period-2 (14-20 Days)||0||
48213080|NCT01424397|100846060|FG010|NOT COMPLETED|Washout Period-2 (14-20 Days)||0||
48213081|NCT01424397|100846061|FG011|NOT COMPLETED|Washout Period-2 (14-20 Days)||0||
48213082|NCT01424397|100846050|FG000|STARTED|Period-3 (8 Days)||7||
48213083|NCT01424397|100846051|FG001|STARTED|Period-3 (8 Days)||8||
48213084|NCT01424397|100846052|FG002|STARTED|Period-3 (8 Days)||7||
48213085|NCT01424397|100846053|FG003|STARTED|Period-3 (8 Days)||8||
48213086|NCT01424397|100846054|FG004|STARTED|Period-3 (8 Days)||8||
48213087|NCT01424397|100846055|FG005|STARTED|Period-3 (8 Days)||8||
48213088|NCT01424397|100846056|FG006|STARTED|Period-3 (8 Days)||4||
48213089|NCT01424397|100846057|FG007|STARTED|Period-3 (8 Days)||4||
48213090|NCT01424397|100846058|FG008|STARTED|Period-3 (8 Days)||4||
48213091|NCT01424397|100846059|FG009|STARTED|Period-3 (8 Days)||3||
48213092|NCT01424397|100846060|FG010|STARTED|Period-3 (8 Days)||4||
48213093|NCT01424397|100846061|FG011|STARTED|Period-3 (8 Days)||4||
48213094|NCT01424397|100846050|FG000|COMPLETED|Period-3 (8 Days)||7||
48213095|NCT01424397|100846051|FG001|COMPLETED|Period-3 (8 Days)||8||
48213096|NCT01424397|100846052|FG002|COMPLETED|Period-3 (8 Days)||7||
48213097|NCT01424397|100846053|FG003|COMPLETED|Period-3 (8 Days)||8||
48213098|NCT01424397|100846054|FG004|COMPLETED|Period-3 (8 Days)||8||
48213099|NCT01424397|100846055|FG005|COMPLETED|Period-3 (8 Days)||8||
48213100|NCT01424397|100846056|FG006|COMPLETED|Period-3 (8 Days)||4||
48213101|NCT01424397|100846057|FG007|COMPLETED|Period-3 (8 Days)||4||
48213102|NCT01424397|100846058|FG008|COMPLETED|Period-3 (8 Days)||4||
48213103|NCT01424397|100846059|FG009|COMPLETED|Period-3 (8 Days)||3||
48213104|NCT01424397|100846060|FG010|COMPLETED|Period-3 (8 Days)||4||
48213105|NCT01424397|100846061|FG011|COMPLETED|Period-3 (8 Days)||4||
48213106|NCT01424397|100846050|FG000|NOT COMPLETED|Period-3 (8 Days)||0||
48213107|NCT01424397|100846051|FG001|NOT COMPLETED|Period-3 (8 Days)||0||
48059805|NCT04795622|100467026|FG000|STARTED|Overall Study||101||
48059806|NCT04795622|100467027|FG001|STARTED|Overall Study||100||
48059807|NCT04795622|100467026|FG000|Safety Evaluation Set (SES)|Overall Study||97||
48059808|NCT04795622|100467027|FG001|Safety Evaluation Set (SES)|Overall Study||96||
48059809|NCT04795622|100467026|FG000|COMPLETED|Overall Study||88||
48059810|NCT04795622|100467027|FG001|COMPLETED|Overall Study||84||
48059811|NCT04795622|100467026|FG000|NOT COMPLETED|Overall Study||13||
48059812|NCT04795622|100467027|FG001|NOT COMPLETED|Overall Study||16||
48059813|NCT03469570|100467028|FG000|STARTED|Overall Study||330||
48059814|NCT03469570|100467028|FG000|COMPLETED|Overall Study||307||
48059815|NCT03469570|100467028|FG000|NOT COMPLETED|Overall Study||23||
48059816|NCT01147172|100467029|FG000|STARTED|Overall Study||100||
48059817|NCT01147172|100467029|FG000|COMPLETED|Overall Study||96||
48059818|NCT01147172|100467029|FG000|NOT COMPLETED|Overall Study||4||
48059819|NCT01945112|100467030|FG000|STARTED|Overall Study||77||153
48059820|NCT01945112|100467031|FG001|STARTED|Overall Study||51||87
48059821|NCT01945112|100467030|FG000|COMPLETED|Overall Study||77||153
48059822|NCT01945112|100467031|FG001|COMPLETED|Overall Study||51||87
48059823|NCT01945112|100467030|FG000|NOT COMPLETED|Overall Study||0||0
48059824|NCT01945112|100467031|FG001|NOT COMPLETED|Overall Study||0||0
48059825|NCT00943124|100467032|FG000|STARTED|Period 1||110||
48059826|NCT00943124|100467033|FG001|STARTED|Period 1||110||
48059827|NCT00943124|100467032|FG000|COMPLETED|Period 1||108||
48059828|NCT00943124|100467033|FG001|COMPLETED|Period 1||108||
48059829|NCT00943124|100467032|FG000|NOT COMPLETED|Period 1||2||
48213108|NCT01424397|100846052|FG002|NOT COMPLETED|Period-3 (8 Days)||0||
48059830|NCT00943124|100467033|FG001|NOT COMPLETED|Period 1||2||
48059831|NCT00943124|100467032|FG000|STARTED|Period 2||108||
48059832|NCT00943124|100467033|FG001|STARTED|Period 2||108||
48059833|NCT00943124|100467032|FG000|COMPLETED|Period 2||108||
48059834|NCT00943124|100467033|FG001|COMPLETED|Period 2||108||
48213109|NCT01424397|100846053|FG003|NOT COMPLETED|Period-3 (8 Days)||0||
48213110|NCT01424397|100846054|FG004|NOT COMPLETED|Period-3 (8 Days)||0||
48213111|NCT01424397|100846055|FG005|NOT COMPLETED|Period-3 (8 Days)||0||
48213112|NCT01424397|100846056|FG006|NOT COMPLETED|Period-3 (8 Days)||0||
48213113|NCT01424397|100846057|FG007|NOT COMPLETED|Period-3 (8 Days)||0||
48213114|NCT01424397|100846058|FG008|NOT COMPLETED|Period-3 (8 Days)||0||
48213115|NCT01424397|100846059|FG009|NOT COMPLETED|Period-3 (8 Days)||0||
48213116|NCT01424397|100846060|FG010|NOT COMPLETED|Period-3 (8 Days)||0||
48213117|NCT01424397|100846061|FG011|NOT COMPLETED|Period-3 (8 Days)||0||
48213118|NCT04470375|100846062|FG000|STARTED|Overall Study||20||
48213119|NCT04470375|100846062|FG000|COMPLETED|Overall Study||20||
48213120|NCT04470375|100846062|FG000|NOT COMPLETED|Overall Study||0||
48213121|NCT00088413|100846063|FG000|STARTED|Overall Study||10||
48213122|NCT00088413|100846064|FG001|STARTED|Overall Study||15||
48213123|NCT00088413|100846065|FG002|STARTED|Overall Study||12||
48213124|NCT00088413|100846066|FG003|STARTED|Overall Study||14||
48213125|NCT00088413|100846063|FG000|COMPLETED|Overall Study||0||
48213126|NCT00088413|100846064|FG001|COMPLETED|Overall Study||0||
48213127|NCT00088413|100846065|FG002|COMPLETED|Overall Study||0||
48213128|NCT00088413|100846066|FG003|COMPLETED|Overall Study||0||
48213129|NCT00088413|100846063|FG000|NOT COMPLETED|Overall Study||10||
48213130|NCT00088413|100846064|FG001|NOT COMPLETED|Overall Study||15||
48213131|NCT00088413|100846065|FG002|NOT COMPLETED|Overall Study||12||
48213132|NCT00088413|100846066|FG003|NOT COMPLETED|Overall Study||14||
48213133|NCT01381406|100846067|FG000|STARTED|Overall Study||2481||
48213134|NCT01381406|100846068|FG001|STARTED|Overall Study||852||
48213135|NCT01381406|100846067|FG000|COMPLETED|Overall Study||2481||
48213136|NCT01381406|100846068|FG001|COMPLETED|Overall Study||852||
48213137|NCT01381406|100846067|FG000|NOT COMPLETED|Overall Study||0||
48213138|NCT01381406|100846068|FG001|NOT COMPLETED|Overall Study||0||
48213139|NCT03740009|100846069|FG000|STARTED|Overall Study||20||
48213140|NCT03740009|100846069|FG000|Consented|Overall Study||20||
48213141|NCT03740009|100846069|FG000|Received Intervention|Overall Study||10||
48213142|NCT03740009|100846069|FG000|COMPLETED|Overall Study||10||
48213143|NCT03740009|100846069|FG000|NOT COMPLETED|Overall Study||10||
48213144|NCT00807937|100846070|FG000|STARTED|Overall Study||93||
48213145|NCT00807937|100846071|FG001|STARTED|Overall Study||92||
48213146|NCT00807937|100846072|FG002|STARTED|Overall Study||92||
48213147|NCT00807937|100846073|FG003|STARTED|Overall Study||92||
48213148|NCT00807937|100846070|FG000|COMPLETED|Overall Study||66||
48213149|NCT00807937|100846071|FG001|COMPLETED|Overall Study||67||
48213150|NCT00807937|100846072|FG002|COMPLETED|Overall Study||78||
48213151|NCT00807937|100846073|FG003|COMPLETED|Overall Study||77||
48059835|NCT00943124|100467032|FG000|NOT COMPLETED|Period 2||0||
48059836|NCT00943124|100467033|FG001|NOT COMPLETED|Period 2||0||
48059837|NCT01225887|100467034|FG000|STARTED|Overall Study||37||
48059838|NCT01225887|100467034|FG000|COMPLETED|Overall Study||32||
48213152|NCT00807937|100846070|FG000|NOT COMPLETED|Overall Study||27||
48213153|NCT00807937|100846071|FG001|NOT COMPLETED|Overall Study||25||
48213154|NCT00807937|100846072|FG002|NOT COMPLETED|Overall Study||14||
48213155|NCT00807937|100846073|FG003|NOT COMPLETED|Overall Study||15||
48213156|NCT00770757|100846074|FG000|STARTED|Overall Study||13||
48213157|NCT00770757|100846074|FG000|COMPLETED|Overall Study||13||
48213158|NCT00770757|100846074|FG000|NOT COMPLETED|Overall Study||0||
48213159|NCT01444417|100846075|FG000|STARTED|Overall Study||20||
48213160|NCT01444417|100846076|FG001|STARTED|Overall Study||42||
48213161|NCT01444417|100846075|FG000|Received Treatment|Overall Study||19||
48213162|NCT01444417|100846076|FG001|Received Treatment|Overall Study||42||
48213163|NCT01444417|100846075|FG000|COMPLETED|Overall Study||18||
48213164|NCT01444417|100846076|FG001|COMPLETED|Overall Study||41||
48213165|NCT01444417|100846075|FG000|NOT COMPLETED|Overall Study||2||
48213166|NCT01444417|100846076|FG001|NOT COMPLETED|Overall Study||1||
48059839|NCT01225887|100467034|FG000|NOT COMPLETED|Overall Study||5||
48059840|NCT01086423|100467035|FG000|STARTED|Overall Study||330||
48059841|NCT01086423|100467036|FG001|STARTED|Overall Study||324||
48059842|NCT01086423|100467037|FG002|STARTED|Overall Study||330||
48059843|NCT01086423|100467035|FG000|COMPLETED|Overall Study||320||
48059844|NCT01086423|100467036|FG001|COMPLETED|Overall Study||321||
48213167|NCT01736215|100846077|FG000|STARTED|Overall Study||33||
48213168|NCT01736215|100846077|FG000|Treated|Overall Study||25||
48213169|NCT01736215|100846077|FG000|COMPLETED|Overall Study||19||
48213170|NCT01736215|100846077|FG000|NOT COMPLETED|Overall Study||14||
48213171|NCT03379740|100846078|FG000|STARTED|Overall Study||8||
48213172|NCT03379740|100846079|FG001|STARTED|Overall Study||7||
48213173|NCT03379740|100846078|FG000|COMPLETED|Overall Study||8||
48213174|NCT03379740|100846079|FG001|COMPLETED|Overall Study||7||
48213175|NCT03379740|100846078|FG000|NOT COMPLETED|Overall Study||0||
48213176|NCT03379740|100846079|FG001|NOT COMPLETED|Overall Study||0||
48213177|NCT03451721|100846080|FG000|STARTED|Overall Study||20||
48213178|NCT03451721|100846080|FG000|COMPLETED|Overall Study||19||
48213179|NCT03451721|100846080|FG000|NOT COMPLETED|Overall Study||1||
48213180|NCT03848910|100846081|FG000|STARTED|Overall Study||11||
48213181|NCT03848910|100846081|FG000|COMPLETED|Overall Study||11||
48059845|NCT01086423|100467037|FG002|COMPLETED|Overall Study||321||
48059846|NCT01086423|100467035|FG000|NOT COMPLETED|Overall Study||10||
48213182|NCT03848910|100846081|FG000|NOT COMPLETED|Overall Study||0||
48213183|NCT02234128|100846082|FG000|STARTED|Overall Study||35||
48213184|NCT02234128|100846083|FG001|STARTED|Overall Study||31||
48213185|NCT02234128|100846084|FG002|STARTED|Overall Study||52||
48213186|NCT02234128|100846082|FG000|COMPLETED|Overall Study||30||
48213187|NCT02234128|100846083|FG001|COMPLETED|Overall Study||29||
48213188|NCT02234128|100846084|FG002|COMPLETED|Overall Study||48||
48213189|NCT02234128|100846082|FG000|NOT COMPLETED|Overall Study||5||
48213190|NCT02234128|100846083|FG001|NOT COMPLETED|Overall Study||2||
48213191|NCT02234128|100846084|FG002|NOT COMPLETED|Overall Study||4||
48213192|NCT03447249|100846085|FG000|STARTED|Overall Study||190||
48213193|NCT03447249|100846086|FG001|STARTED|Overall Study||192||
48213194|NCT03447249|100846085|FG000|Safety Set|Overall Study||189|Based on actual treatment received.|
48213195|NCT03447249|100846086|FG001|Safety Set|Overall Study||193|Based on actual treatment received.|
48213196|NCT03447249|100846085|FG000|COMPLETED|Overall Study||185||
48213197|NCT03447249|100846086|FG001|COMPLETED|Overall Study||192||
48213198|NCT03447249|100846085|FG000|NOT COMPLETED|Overall Study||5||
48213199|NCT03447249|100846086|FG001|NOT COMPLETED|Overall Study||0||
48213200|NCT01943916|100846087|FG000|STARTED|Overall Study||2105||
48213201|NCT01943916|100846087|FG000|COMPLETED|Overall Study||1739||
48213202|NCT01943916|100846087|FG000|NOT COMPLETED|Overall Study||366||
48213203|NCT00490100|100846088|FG000|STARTED|Overall Study||6||
48213204|NCT00490100|100846088|FG000|COMPLETED|Overall Study||3||
48213205|NCT00490100|100846088|FG000|NOT COMPLETED|Overall Study||3||
48213206|NCT02554786|100849468|FG000|STARTED|Overall Study||445||
48213207|NCT02554786|100849469|FG001|STARTED|Overall Study||439||
48213208|NCT02554786|100849470|FG002|STARTED|Overall Study||442||
48213209|NCT02554786|100849471|FG003|STARTED|Overall Study||444||
48213210|NCT02554786|100849472|FG004|STARTED|Overall Study||446||
48213211|NCT02554786|100849468|FG000|COMPLETED|Overall Study||410||
48213212|NCT02554786|100849469|FG001|COMPLETED|Overall Study||413||
48213213|NCT02554786|100849470|FG002|COMPLETED|Overall Study||412||
48213214|NCT02554786|100849471|FG003|COMPLETED|Overall Study||403||
48059847|NCT01086423|100467036|FG001|NOT COMPLETED|Overall Study||3||
48059848|NCT01086423|100467037|FG002|NOT COMPLETED|Overall Study||9||
48059849|NCT01104155|100467038|FG000|STARTED|Overall Study||63||
48059850|NCT01104155|100467039|FG001|STARTED|Overall Study||60||
48059851|NCT01104155|100467038|FG000|COMPLETED|Overall Study||38||
48059852|NCT01104155|100467039|FG001|COMPLETED|Overall Study||42||
48059853|NCT01104155|100467038|FG000|NOT COMPLETED|Overall Study||25||
48059854|NCT01104155|100467039|FG001|NOT COMPLETED|Overall Study||18||
48059855|NCT00979069|100467040|FG000|STARTED|Overall Study||10||
48213215|NCT02554786|100849472|FG004|COMPLETED|Overall Study||416||
48213216|NCT02554786|100849468|FG000|NOT COMPLETED|Overall Study||35||
48213217|NCT02554786|100849469|FG001|NOT COMPLETED|Overall Study||26||
48213218|NCT02554786|100849470|FG002|NOT COMPLETED|Overall Study||30||
48213219|NCT02554786|100849471|FG003|NOT COMPLETED|Overall Study||41||
48213220|NCT02554786|100849472|FG004|NOT COMPLETED|Overall Study||30||
48213221|NCT01007396|100849473|FG000|STARTED|Overall Study||322||
48213222|NCT01007396|100849473|FG000|COMPLETED|Overall Study||275||
48213223|NCT01007396|100849473|FG000|NOT COMPLETED|Overall Study||47||
48213224|NCT02355275|100849474|FG000|STARTED|Overall Study||22||
48213225|NCT02355275|100849474|FG000|COMPLETED|Overall Study||14||
48213226|NCT02355275|100849474|FG000|NOT COMPLETED|Overall Study||8||
48213227|NCT03405714|100849475|FG000|STARTED|Overall Study||12||
48213228|NCT03405714|100849476|FG001|STARTED|Overall Study||12||
48213229|NCT03405714|100849477|FG002|STARTED|Overall Study||13||
48213230|NCT03405714|100849478|FG003|STARTED|Overall Study||13||
48213231|NCT03405714|100849475|FG000|COMPLETED|Overall Study||12||
48213232|NCT03405714|100849476|FG001|COMPLETED|Overall Study||12||
48213233|NCT03405714|100849477|FG002|COMPLETED|Overall Study||13||
48213234|NCT03405714|100849478|FG003|COMPLETED|Overall Study||13||
48213235|NCT03405714|100849475|FG000|NOT COMPLETED|Overall Study||0||
48213236|NCT03405714|100849476|FG001|NOT COMPLETED|Overall Study||0||
48213237|NCT03405714|100849477|FG002|NOT COMPLETED|Overall Study||0||
48213238|NCT03405714|100849478|FG003|NOT COMPLETED|Overall Study||0||
48213239|NCT00640250|100849479|FG000|STARTED|Overall Study||48||
48213240|NCT00640250|100849479|FG000|COMPLETED|Overall Study||48||
48213241|NCT00640250|100849479|FG000|NOT COMPLETED|Overall Study||0||
48213242|NCT00812461|100849480|FG000|STARTED|All Randomised Patients||360||
48213243|NCT00812461|100849481|FG001|STARTED|All Randomised Patients||358||
48213244|NCT00812461|100849480|FG000|COMPLETED|All Randomised Patients||337||
48213245|NCT00812461|100849481|FG001|COMPLETED|All Randomised Patients||341||
48213246|NCT00812461|100849480|FG000|NOT COMPLETED|All Randomised Patients||23||
48213247|NCT00812461|100849481|FG001|NOT COMPLETED|All Randomised Patients||17||
48213248|NCT00812461|100849480|FG000|STARTED|All Treated Patients||337||
48213249|NCT00812461|100849481|FG001|STARTED|All Treated Patients||341||
48213250|NCT00812461|100849480|FG000|COMPLETED|All Treated Patients||205||
48213251|NCT00812461|100849481|FG001|COMPLETED|All Treated Patients||194||
48213252|NCT00812461|100849480|FG000|NOT COMPLETED|All Treated Patients||132||
48213253|NCT00812461|100849481|FG001|NOT COMPLETED|All Treated Patients||147||
48213254|NCT03292913|100849482|FG000|STARTED|Overall Study||397||
48213255|NCT03292913|100849483|FG001|STARTED|Overall Study||402||
48213256|NCT03292913|100849482|FG000|COMPLETED|Overall Study||315||
48213257|NCT03292913|100849483|FG001|COMPLETED|Overall Study||314||
48213258|NCT03292913|100849482|FG000|NOT COMPLETED|Overall Study||82||
48213259|NCT03292913|100849483|FG001|NOT COMPLETED|Overall Study||88||
48213260|NCT02410018|100849484|FG000|STARTED|Overall Study||2||
48213261|NCT02410018|100849485|FG001|STARTED|Overall Study||1||
48213262|NCT02410018|100849484|FG000|COMPLETED|Overall Study||2||
48213263|NCT02410018|100849485|FG001|COMPLETED|Overall Study||1||
48213264|NCT02410018|100849484|FG000|NOT COMPLETED|Overall Study||0||
48213265|NCT02410018|100849485|FG001|NOT COMPLETED|Overall Study||0||
48213266|NCT03481816|100849486|FG000|STARTED|Starting Dose||6||
48213267|NCT03481816|100849487|FG001|STARTED|Starting Dose||0||
48213268|NCT03481816|100849486|FG000|COMPLETED|Starting Dose||5||
48213269|NCT03481816|100849487|FG001|COMPLETED|Starting Dose||0||
48213270|NCT03481816|100849486|FG000|NOT COMPLETED|Starting Dose||1||
48213271|NCT03481816|100849487|FG001|NOT COMPLETED|Starting Dose||0||
48213272|NCT03481816|100849486|FG000|STARTED|Dose Expansion||0||
48213273|NCT03481816|100849487|FG001|STARTED|Dose Expansion||12||
48213274|NCT03481816|100849486|FG000|COMPLETED|Dose Expansion||0||
48213275|NCT03481816|100849487|FG001|COMPLETED|Dose Expansion||0||
48213276|NCT03481816|100849486|FG000|NOT COMPLETED|Dose Expansion||0||
48213277|NCT03481816|100849487|FG001|NOT COMPLETED|Dose Expansion||12||
48213278|NCT04766034|100849488|FG000|STARTED|Aim 2 - Pre-Randomization Survey||0||
48213279|NCT04766034|100849489|FG001|STARTED|Aim 2 - Pre-Randomization Survey||0||
48213280|NCT04766034|100849490|FG002|STARTED|Aim 2 - Pre-Randomization Survey||0||
48213281|NCT04766034|100849491|FG003|STARTED|Aim 2 - Pre-Randomization Survey||0||
48213282|NCT04766034|100849492|FG004|STARTED|Aim 2 - Pre-Randomization Survey||7710||
48213283|NCT04766034|100849488|FG000|COMPLETED|Aim 2 - Pre-Randomization Survey||0||
48213284|NCT04766034|100849489|FG001|COMPLETED|Aim 2 - Pre-Randomization Survey||0||
48213285|NCT04766034|100849490|FG002|COMPLETED|Aim 2 - Pre-Randomization Survey||0||
48213286|NCT04766034|100849491|FG003|COMPLETED|Aim 2 - Pre-Randomization Survey||0||
48213287|NCT04766034|100849492|FG004|COMPLETED|Aim 2 - Pre-Randomization Survey||3838||
48213288|NCT04766034|100849488|FG000|NOT COMPLETED|Aim 2 - Pre-Randomization Survey||0||
48213289|NCT04766034|100849489|FG001|NOT COMPLETED|Aim 2 - Pre-Randomization Survey||0||
48213290|NCT04766034|100849490|FG002|NOT COMPLETED|Aim 2 - Pre-Randomization Survey||0||
48213291|NCT04766034|100849491|FG003|NOT COMPLETED|Aim 2 - Pre-Randomization Survey||0||
48213292|NCT04766034|100849492|FG004|NOT COMPLETED|Aim 2 - Pre-Randomization Survey||3872||
48213293|NCT04766034|100849488|FG000|STARTED|Aim 3 - Randomization/Online Shopping||922||
48213294|NCT04766034|100849489|FG001|STARTED|Aim 3 - Randomization/Online Shopping||991||
48213295|NCT04766034|100849490|FG002|STARTED|Aim 3 - Randomization/Online Shopping||957||
48213296|NCT04766034|100849491|FG003|STARTED|Aim 3 - Randomization/Online Shopping||968||
48213297|NCT04766034|100849492|FG004|STARTED|Aim 3 - Randomization/Online Shopping||0||
48213298|NCT04766034|100849488|FG000|COMPLETED|Aim 3 - Randomization/Online Shopping||649||
48213299|NCT04766034|100849489|FG001|COMPLETED|Aim 3 - Randomization/Online Shopping||682||
48213300|NCT04766034|100849490|FG002|COMPLETED|Aim 3 - Randomization/Online Shopping||727||
48213301|NCT04766034|100849491|FG003|COMPLETED|Aim 3 - Randomization/Online Shopping||686||
48213302|NCT04766034|100849492|FG004|COMPLETED|Aim 3 - Randomization/Online Shopping||0||
48213303|NCT04766034|100849488|FG000|NOT COMPLETED|Aim 3 - Randomization/Online Shopping||273||
48213304|NCT04766034|100849489|FG001|NOT COMPLETED|Aim 3 - Randomization/Online Shopping||309||
48213305|NCT04766034|100849490|FG002|NOT COMPLETED|Aim 3 - Randomization/Online Shopping||230||
48213306|NCT04766034|100849491|FG003|NOT COMPLETED|Aim 3 - Randomization/Online Shopping||282||
48213307|NCT04766034|100849492|FG004|NOT COMPLETED|Aim 3 - Randomization/Online Shopping||0||
48213308|NCT00714714|100849493|FG000|STARTED|Overall Study||25||
48213309|NCT00714714|100849493|FG000|COMPLETED|Overall Study||24||
48213310|NCT00714714|100849493|FG000|NOT COMPLETED|Overall Study||1||
48213311|NCT02755116|100849494|FG000|STARTED|Overall Study||74||
48213312|NCT02755116|100849495|FG001|STARTED|Overall Study||70||
48213313|NCT02755116|100849494|FG000|COMPLETED|Overall Study||71||
48059856|NCT00979069|100467041|FG001|STARTED|Overall Study||10||
48059857|NCT00979069|100467040|FG000|COMPLETED|Overall Study||10||
48059858|NCT00979069|100467041|FG001|COMPLETED|Overall Study||8||
48059859|NCT00979069|100467040|FG000|NOT COMPLETED|Overall Study||0||
48059860|NCT00979069|100467041|FG001|NOT COMPLETED|Overall Study||2||
48059861|NCT00932737|100467042|FG000|STARTED|Overall Study||87||
48059862|NCT00932737|100467043|FG001|STARTED|Overall Study||88||
48059863|NCT00932737|100467042|FG000|COMPLETED|Overall Study||86||
48059864|NCT00932737|100467043|FG001|COMPLETED|Overall Study||87||
48059865|NCT00932737|100467042|FG000|NOT COMPLETED|Overall Study||1||
48059866|NCT00932737|100467043|FG001|NOT COMPLETED|Overall Study||1||
48059867|NCT03799211|100467044|FG000|STARTED|Overall Study||36||
48059868|NCT03799211|100467045|FG001|STARTED|Overall Study||40||
48059869|NCT03799211|100467044|FG000|COMPLETED|Overall Study||32||
48059870|NCT03799211|100467045|FG001|COMPLETED|Overall Study||27||
48213314|NCT02755116|100849495|FG001|COMPLETED|Overall Study||69||
48213315|NCT02755116|100849494|FG000|NOT COMPLETED|Overall Study||3||
48213316|NCT02755116|100849495|FG001|NOT COMPLETED|Overall Study||1||
48059871|NCT03799211|100467044|FG000|NOT COMPLETED|Overall Study||4||
48059872|NCT03799211|100467045|FG001|NOT COMPLETED|Overall Study||13||
48059873|NCT02640716|100467046|FG000|STARTED|Overall Study||30|Completed baseline assessments and randomized|
48213317|NCT02742519|100849496|FG000|STARTED|Part 1 Treatment Period 1 (8 Weeks)||8||
48213318|NCT02742519|100849497|FG001|STARTED|Part 1 Treatment Period 1 (8 Weeks)||6||
48213319|NCT02742519|100849498|FG002|STARTED|Part 1 Treatment Period 1 (8 Weeks)||0||
48213320|NCT02742519|100849496|FG000|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||8||
48213321|NCT02742519|100849497|FG001|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||6||
48213322|NCT02742519|100849498|FG002|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0||
48213323|NCT02742519|100849496|FG000|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0||
48213324|NCT02742519|100849497|FG001|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0||
48213325|NCT02742519|100849498|FG002|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0||
48213326|NCT02742519|100849496|FG000|STARTED|Part 1 Treatment Period 2 (8 Weeks)||8||
48213327|NCT02742519|100849497|FG001|STARTED|Part 1 Treatment Period 2 (8 Weeks)||6||
48213328|NCT02742519|100849498|FG002|STARTED|Part 1 Treatment Period 2 (8 Weeks)||0||
48213329|NCT02742519|100849496|FG000|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||7||
48213330|NCT02742519|100849497|FG001|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||5||
48213331|NCT02742519|100849498|FG002|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||0||
48213332|NCT02742519|100849496|FG000|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||1||
48213333|NCT02742519|100849497|FG001|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||1||
48213334|NCT02742519|100849498|FG002|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||0||
48213335|NCT02742519|100849496|FG000|STARTED|Part 2 Open Label Period (32 Weeks)||0||
48213336|NCT02742519|100849497|FG001|STARTED|Part 2 Open Label Period (32 Weeks)||0||
48213337|NCT02742519|100849498|FG002|STARTED|Part 2 Open Label Period (32 Weeks)||10||
48213338|NCT02742519|100849496|FG000|COMPLETED|Part 2 Open Label Period (32 Weeks)||0||
48213339|NCT02742519|100849497|FG001|COMPLETED|Part 2 Open Label Period (32 Weeks)||0||
48213340|NCT02742519|100849498|FG002|COMPLETED|Part 2 Open Label Period (32 Weeks)||0||
48213341|NCT02742519|100849496|FG000|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||0||
48213342|NCT02742519|100849497|FG001|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||0||
48213343|NCT02742519|100849498|FG002|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||10||
48213344|NCT00111813|100849499|FG000|STARTED|Overall Study||3||
48213345|NCT00111813|100849500|FG001|STARTED|Overall Study||3||
48213346|NCT00111813|100849501|FG002|STARTED|Overall Study||10||
48213347|NCT00111813|100849502|FG003|STARTED|Overall Study||6||
48213348|NCT00111813|100849503|FG004|STARTED|Overall Study||6||
48213349|NCT00111813|100849504|FG005|STARTED|Overall Study||6||
48213350|NCT00111813|100849499|FG000|COMPLETED|Overall Study||0||
48213351|NCT00111813|100849500|FG001|COMPLETED|Overall Study||0||
48213352|NCT00111813|100849501|FG002|COMPLETED|Overall Study||0||
48213353|NCT00111813|100849502|FG003|COMPLETED|Overall Study||1||
48213354|NCT00111813|100849503|FG004|COMPLETED|Overall Study||0||
48213355|NCT00111813|100849504|FG005|COMPLETED|Overall Study||0||
48213356|NCT00111813|100849499|FG000|NOT COMPLETED|Overall Study||3||
48213357|NCT00111813|100849500|FG001|NOT COMPLETED|Overall Study||3||
48213358|NCT00111813|100849501|FG002|NOT COMPLETED|Overall Study||10||
48213359|NCT00111813|100849502|FG003|NOT COMPLETED|Overall Study||5||
48213360|NCT00111813|100849503|FG004|NOT COMPLETED|Overall Study||6||
48213361|NCT00111813|100849504|FG005|NOT COMPLETED|Overall Study||6||
48213362|NCT00529100|100849505|FG000|STARTED|Overall Study||16||
48213363|NCT00529100|100849506|FG001|STARTED|Overall Study||33||
48213364|NCT00529100|100849505|FG000|Received at Least 1 Dose of Study Drug|Overall Study||16||
48213365|NCT00529100|100849506|FG001|Received at Least 1 Dose of Study Drug|Overall Study||33||
48059874|NCT02640716|100467047|FG001|STARTED|Overall Study||30|Completed baseline assessments and randomized|
48059875|NCT02640716|100467046|FG000|Training Completion|Overall Study||27|Training completion|
48059876|NCT02640716|100467047|FG001|Training Completion|Overall Study||27|Training completion|
48059877|NCT02640716|100467046|FG000|COMPLETED|Overall Study||23|6-month follow-up|
48059878|NCT02640716|100467047|FG001|COMPLETED|Overall Study||21|6-month follow-up|
48059879|NCT02640716|100467046|FG000|NOT COMPLETED|Overall Study||7||
48059880|NCT02640716|100467047|FG001|NOT COMPLETED|Overall Study||9||
48059881|NCT03092024|100467048|FG000|STARTED|Overall Study||24||
48213366|NCT00529100|100849505|FG000|COMPLETED|Overall Study||16||
48213367|NCT00529100|100849506|FG001|COMPLETED|Overall Study||24||
48213368|NCT00529100|100849505|FG000|NOT COMPLETED|Overall Study||0||
48213369|NCT00529100|100849506|FG001|NOT COMPLETED|Overall Study||9||
48213370|NCT03795194|100849507|FG000|STARTED|Overall Study||3||
48213371|NCT03795194|100849508|FG001|STARTED|Overall Study||4||
48213372|NCT03795194|100849507|FG000|COMPLETED|Overall Study||3||
48213373|NCT03795194|100849508|FG001|COMPLETED|Overall Study||4||
48213374|NCT03795194|100849507|FG000|NOT COMPLETED|Overall Study||0||
48213375|NCT03795194|100849508|FG001|NOT COMPLETED|Overall Study||0||
48213376|NCT01622868|100849509|FG000|STARTED|Overall Study||72||
48213377|NCT01622868|100849510|FG001|STARTED|Overall Study||71||
48213378|NCT01622868|100849509|FG000|Eligible|Overall Study||65||
48213379|NCT01622868|100849510|FG001|Eligible|Overall Study||71||
48213380|NCT01622868|100849509|FG000|Eligible, Started Study Treatment, Has Adverse Event Data|Overall Study||63||
48213381|NCT01622868|100849510|FG001|Eligible, Started Study Treatment, Has Adverse Event Data|Overall Study||71||
48213382|NCT01622868|100849509|FG000|COMPLETED|Overall Study||65|Participants contributing data to results are considered to have completed the study|
48496091|NCT00834873|101548003|FG001|NOT COMPLETED|First Intervention||1||
48213383|NCT01622868|100849510|FG001|COMPLETED|Overall Study||71|Participants contributing data to results are considered to have completed the study|
48213384|NCT01622868|100849509|FG000|NOT COMPLETED|Overall Study||7||
48213385|NCT01622868|100849510|FG001|NOT COMPLETED|Overall Study||0||
48213386|NCT00802464|100849511|FG000|STARTED|Month 0 - Month 8||38||
48213387|NCT00802464|100849512|FG001|STARTED|Month 0 - Month 8||73||
48213388|NCT00802464|100849513|FG002|STARTED|Month 0 - Month 8||149||
48213389|NCT00802464|100849514|FG003|STARTED|Month 0 - Month 8||150||
48213390|NCT00802464|100849511|FG000|COMPLETED|Month 0 - Month 8||38||
48213391|NCT00802464|100849512|FG001|COMPLETED|Month 0 - Month 8||70||
48213392|NCT00802464|100849513|FG002|COMPLETED|Month 0 - Month 8||142||
48213393|NCT00802464|100849514|FG003|COMPLETED|Month 0 - Month 8||141||
48213394|NCT00802464|100849511|FG000|NOT COMPLETED|Month 0 - Month 8||0||
48213395|NCT00802464|100849512|FG001|NOT COMPLETED|Month 0 - Month 8||3||
48213396|NCT00802464|100849513|FG002|NOT COMPLETED|Month 0 - Month 8||7||
48059882|NCT03092024|100467049|FG001|STARTED|Overall Study||16||
48059883|NCT03092024|100467048|FG000|COMPLETED|Overall Study||24||
48059884|NCT03092024|100467049|FG001|COMPLETED|Overall Study||16||
48059885|NCT03092024|100467048|FG000|NOT COMPLETED|Overall Study||0||
48059886|NCT03092024|100467049|FG001|NOT COMPLETED|Overall Study||0||
48059887|NCT01742936|100467050|FG000|STARTED|Overall Study||50||
48059888|NCT01742936|100467051|FG001|STARTED|Overall Study||50||
48213397|NCT00802464|100849514|FG003|NOT COMPLETED|Month 0 - Month 8||9||
48213398|NCT00802464|100849511|FG000|STARTED|Month 8 - Month 14||34||
48213399|NCT00802464|100849512|FG001|STARTED|Month 8 - Month 14||65||
48213400|NCT00802464|100849513|FG002|STARTED|Month 8 - Month 14||130||
48213401|NCT00802464|100849514|FG003|STARTED|Month 8 - Month 14||126||
48213402|NCT00802464|100849511|FG000|COMPLETED|Month 8 - Month 14||33||
48213403|NCT00802464|100849512|FG001|COMPLETED|Month 8 - Month 14||63||
48213404|NCT00802464|100849513|FG002|COMPLETED|Month 8 - Month 14||129||
48213405|NCT00802464|100849514|FG003|COMPLETED|Month 8 - Month 14||126||
48213406|NCT00802464|100849511|FG000|NOT COMPLETED|Month 8 - Month 14||1||
48213407|NCT00802464|100849512|FG001|NOT COMPLETED|Month 8 - Month 14||2||
48213408|NCT00802464|100849513|FG002|NOT COMPLETED|Month 8 - Month 14||1||
48213409|NCT00802464|100849514|FG003|NOT COMPLETED|Month 8 - Month 14||0||
48213410|NCT02574455|100849515|FG000|STARTED|Overall Study||267||
48213411|NCT02574455|100849516|FG001|STARTED|Overall Study||262||
48213412|NCT02574455|100849515|FG000|Enrolled and Treated|Overall Study||258||
48213413|NCT02574455|100849516|FG001|Enrolled and Treated|Overall Study||224||
48213414|NCT02574455|100849515|FG000|COMPLETED|Overall Study||0||
48213415|NCT02574455|100849516|FG001|COMPLETED|Overall Study||0||
48213416|NCT02574455|100849515|FG000|NOT COMPLETED|Overall Study||267||
48213417|NCT02574455|100849516|FG001|NOT COMPLETED|Overall Study||262||
48213418|NCT02561702|100849517|FG000|STARTED|First Intervention||2||
48213419|NCT02561702|100849518|FG001|STARTED|First Intervention||2||
48213420|NCT02561702|100849517|FG000|COMPLETED|First Intervention||2||
48213421|NCT02561702|100849518|FG001|COMPLETED|First Intervention||2||
48059889|NCT01742936|100467050|FG000|COMPLETED|Overall Study||50||
48059890|NCT01742936|100467051|FG001|COMPLETED|Overall Study||50||
48213422|NCT02561702|100849517|FG000|NOT COMPLETED|First Intervention||0||
48213423|NCT02561702|100849518|FG001|NOT COMPLETED|First Intervention||0||
48213424|NCT02561702|100849517|FG000|STARTED|Washout||2||
48213425|NCT02561702|100849518|FG001|STARTED|Washout||2||
48213426|NCT02561702|100849517|FG000|COMPLETED|Washout||2||
48213427|NCT02561702|100849518|FG001|COMPLETED|Washout||2||
48213428|NCT02561702|100849517|FG000|NOT COMPLETED|Washout||0||
48213429|NCT02561702|100849518|FG001|NOT COMPLETED|Washout||0||
48213430|NCT02561702|100849517|FG000|STARTED|Second Intervention||2||
48213431|NCT02561702|100849518|FG001|STARTED|Second Intervention||2||
48213432|NCT02561702|100849517|FG000|COMPLETED|Second Intervention||2||
48213433|NCT02561702|100849518|FG001|COMPLETED|Second Intervention||2||
48213434|NCT02561702|100849517|FG000|NOT COMPLETED|Second Intervention||0||
48213435|NCT02561702|100849518|FG001|NOT COMPLETED|Second Intervention||0||
48213436|NCT03169894|100849519|FG000|STARTED|Overall Study||4||
48213437|NCT03169894|100849520|FG001|STARTED|Overall Study||4||
48213438|NCT03169894|100849519|FG000|Safety Analysis Set|Overall Study||4||
48213439|NCT03169894|100849520|FG001|Safety Analysis Set|Overall Study||4||
48213440|NCT03169894|100849519|FG000|Full Analysis Set|Overall Study||4||
48213441|NCT03169894|100849520|FG001|Full Analysis Set|Overall Study||4||
48213442|NCT03169894|100849519|FG000|PK Analysis Set|Overall Study||4||
48213443|NCT03169894|100849520|FG001|PK Analysis Set|Overall Study||3||
48213444|NCT03169894|100849519|FG000|COMPLETED|Overall Study||4||
48213445|NCT03169894|100849520|FG001|COMPLETED|Overall Study||4||
48213446|NCT03169894|100849519|FG000|NOT COMPLETED|Overall Study||0||
48213447|NCT03169894|100849520|FG001|NOT COMPLETED|Overall Study||0||
48213448|NCT01236001|100849521|FG000|STARTED|Overall Study||105||
48213449|NCT01236001|100849522|FG001|STARTED|Overall Study||87||
48213450|NCT01236001|100849521|FG000|COMPLETED|Overall Study||87||
48213451|NCT01236001|100849522|FG001|COMPLETED|Overall Study||65||
48213452|NCT01236001|100849521|FG000|NOT COMPLETED|Overall Study||18||
48059891|NCT01742936|100467050|FG000|NOT COMPLETED|Overall Study||0||
48059892|NCT01742936|100467051|FG001|NOT COMPLETED|Overall Study||0||
48213453|NCT01236001|100849522|FG001|NOT COMPLETED|Overall Study||22||
48213454|NCT02290613|100849523|FG000|STARTED|Overall Study||19||
48213455|NCT02290613|100849524|FG001|STARTED|Overall Study||19||
48213456|NCT02290613|100849523|FG000|COMPLETED|Overall Study||17||
48213457|NCT02290613|100849524|FG001|COMPLETED|Overall Study||15||
48213458|NCT02290613|100849523|FG000|NOT COMPLETED|Overall Study||2||
48213459|NCT02290613|100849524|FG001|NOT COMPLETED|Overall Study||4||
48213460|NCT00084552|100849525|FG000|STARTED|Overall Study||54||
48213461|NCT00084552|100849526|FG001|STARTED|Overall Study||62||
48213462|NCT00084552|100849525|FG000|COMPLETED|Overall Study||54||
48213463|NCT00084552|100849526|FG001|COMPLETED|Overall Study||62||
48213464|NCT00084552|100849525|FG000|NOT COMPLETED|Overall Study||0||
48213465|NCT00084552|100849526|FG001|NOT COMPLETED|Overall Study||0||
48213466|NCT04048382|100849527|FG000|STARTED|3-Month Follow Up||28||
48213467|NCT04048382|100849528|FG001|STARTED|3-Month Follow Up||29||
48213468|NCT04048382|100849527|FG000|COMPLETED|3-Month Follow Up||26||
48213469|NCT04048382|100849528|FG001|COMPLETED|3-Month Follow Up||28||
48213470|NCT04048382|100849527|FG000|NOT COMPLETED|3-Month Follow Up||2||
48213471|NCT04048382|100849528|FG001|NOT COMPLETED|3-Month Follow Up||1||
48213472|NCT04048382|100849527|FG000|STARTED|6-Month Follow up||28||
48213473|NCT04048382|100849528|FG001|STARTED|6-Month Follow up||28||
48213474|NCT04048382|100849527|FG000|COMPLETED|6-Month Follow up||26||
48213475|NCT04048382|100849528|FG001|COMPLETED|6-Month Follow up||28||
48213476|NCT04048382|100849527|FG000|NOT COMPLETED|6-Month Follow up||2||
48213477|NCT04048382|100849528|FG001|NOT COMPLETED|6-Month Follow up||0||
48213478|NCT01522924|100849529|FG000|STARTED|Overall Study||42||
48213479|NCT01522924|100849530|FG001|STARTED|Overall Study||52||
48213480|NCT01522924|100849529|FG000|COMPLETED|Overall Study||42||
48213481|NCT01522924|100849530|FG001|COMPLETED|Overall Study||52||
48213482|NCT01522924|100849529|FG000|NOT COMPLETED|Overall Study||0||
48213483|NCT01522924|100849530|FG001|NOT COMPLETED|Overall Study||0||
48213484|NCT01184326|100849531|FG000|STARTED|Overall Study||3||
48213485|NCT01184326|100849532|FG001|STARTED|Overall Study||6||
48213486|NCT01184326|100849533|FG002|STARTED|Overall Study||14||
48213487|NCT01184326|100849531|FG000|COMPLETED|Overall Study||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed'.|
48213488|NCT01184326|100849532|FG001|COMPLETED|Overall Study||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed'.|
48213489|NCT01184326|100849533|FG002|COMPLETED|Overall Study||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed'.|
48213490|NCT01184326|100849531|FG000|NOT COMPLETED|Overall Study||3||
48213491|NCT01184326|100849532|FG001|NOT COMPLETED|Overall Study||6||
48213492|NCT01184326|100849533|FG002|NOT COMPLETED|Overall Study||14||
48213493|NCT00522951|100849534|FG000|STARTED|Period 1||86||
48213494|NCT00522951|100849535|FG001|STARTED|Period 1||79||
48213495|NCT00522951|100849534|FG000|Received Treatment|Period 1||86||
48213496|NCT00522951|100849535|FG001|Received Treatment|Period 1||78||
48213497|NCT00522951|100849534|FG000|COMPLETED|Period 1||86||
48213498|NCT00522951|100849535|FG001|COMPLETED|Period 1||78||
48213499|NCT00522951|100849534|FG000|NOT COMPLETED|Period 1||0||
48213500|NCT00522951|100849535|FG001|NOT COMPLETED|Period 1||1||
48213501|NCT00522951|100849534|FG000|STARTED|Washout Period||86||
48213502|NCT00522951|100849535|FG001|STARTED|Washout Period||78||
48213503|NCT00522951|100849534|FG000|COMPLETED|Washout Period||86||
48213504|NCT00522951|100849535|FG001|COMPLETED|Washout Period||76||
48213505|NCT00522951|100849534|FG000|NOT COMPLETED|Washout Period||0||
48213506|NCT00522951|100849535|FG001|NOT COMPLETED|Washout Period||2||
48213507|NCT00522951|100849534|FG000|STARTED|Period 2||86||
48213508|NCT00522951|100849535|FG001|STARTED|Period 2||76||
48213509|NCT00522951|100849534|FG000|Subjects Received Treatment|Period 2||84||
48213510|NCT00522951|100849535|FG001|Subjects Received Treatment|Period 2||75||
48213511|NCT00522951|100849534|FG000|COMPLETED|Period 2||84||
48213512|NCT00522951|100849535|FG001|COMPLETED|Period 2||75||
48213513|NCT00522951|100849534|FG000|NOT COMPLETED|Period 2||2||
48213514|NCT00522951|100849535|FG001|NOT COMPLETED|Period 2||1||
48213515|NCT04218266|100849536|FG000|STARTED|Overall Study||251|Randomized|
48213516|NCT04218266|100849537|FG001|STARTED|Overall Study||254|Randomized|
48213517|NCT04218266|100849538|FG002|STARTED|Overall Study||250|Randomized|
48213518|NCT04218266|100849536|FG000|Treated|Overall Study||249||
48213519|NCT04218266|100849537|FG001|Treated|Overall Study||254||
48059893|NCT03004443|100467052|FG000|STARTED|Overall Study||11||
48059894|NCT03004443|100467053|FG001|STARTED|Overall Study||11||
48059895|NCT03004443|100467052|FG000|COMPLETED|Overall Study||11||
48059896|NCT03004443|100467053|FG001|COMPLETED|Overall Study||10||
48059897|NCT03004443|100467052|FG000|NOT COMPLETED|Overall Study||0||
48059898|NCT03004443|100467053|FG001|NOT COMPLETED|Overall Study||1||
48059899|NCT03875235|100467054|FG000|STARTED|Overall Study||341||
48059900|NCT03875235|100467055|FG001|STARTED|Overall Study||344||
48059901|NCT03875235|100467054|FG000|Treated|Overall Study||338||
48213520|NCT04218266|100849538|FG002|Treated|Overall Study||250||
48213521|NCT04218266|100849536|FG000|COMPLETED|Overall Study||226||
48213522|NCT04218266|100849537|FG001|COMPLETED|Overall Study||227||
48213523|NCT04218266|100849538|FG002|COMPLETED|Overall Study||218||
48213524|NCT04218266|100849536|FG000|NOT COMPLETED|Overall Study||25||
48213525|NCT04218266|100849537|FG001|NOT COMPLETED|Overall Study||27||
48213526|NCT04218266|100849538|FG002|NOT COMPLETED|Overall Study||32||
48213527|NCT04820686|100849539|FG000|STARTED|Overall Study||32||
48213528|NCT04820686|100849540|FG001|STARTED|Overall Study||16||
48059902|NCT03875235|100467055|FG001|Treated|Overall Study||342||
48059903|NCT03875235|100467054|FG000|COMPLETED|Overall Study||0||
48059904|NCT03875235|100467055|FG001|COMPLETED|Overall Study||0||
48059905|NCT03875235|100467054|FG000|NOT COMPLETED|Overall Study||341||
48059906|NCT03875235|100467055|FG001|NOT COMPLETED|Overall Study||344||
48059907|NCT01848704|100467056|FG000|STARTED|Overall Study||150||
48059908|NCT01848704|100467057|FG001|STARTED|Overall Study||150||
48059909|NCT01848704|100467056|FG000|COMPLETED|Overall Study||150||
48213529|NCT04820686|100849541|FG002|STARTED|Overall Study||17||
48213530|NCT04820686|100849539|FG000|COMPLETED|Overall Study||2||
48213531|NCT04820686|100849540|FG001|COMPLETED|Overall Study||0||
48213532|NCT04820686|100849541|FG002|COMPLETED|Overall Study||0||
48213533|NCT04820686|100849539|FG000|NOT COMPLETED|Overall Study||30||
48213534|NCT04820686|100849540|FG001|NOT COMPLETED|Overall Study||16||
48213535|NCT04820686|100849541|FG002|NOT COMPLETED|Overall Study||17||
48213536|NCT03101371|100849542|FG000|STARTED|Overall Study||48||
48213537|NCT03101371|100849543|FG001|STARTED|Overall Study||51||
48213538|NCT03101371|100849542|FG000|COMPLETED|Overall Study||45||
48213539|NCT03101371|100849543|FG001|COMPLETED|Overall Study||45||
48213540|NCT03101371|100849542|FG000|NOT COMPLETED|Overall Study||3||
48213541|NCT03101371|100849543|FG001|NOT COMPLETED|Overall Study||6||
48213542|NCT01388777|100849544|FG000|STARTED|Overall Study||1||
48213543|NCT01388777|100849544|FG000|Cryoablation|Overall Study||1||
48213544|NCT01388777|100849544|FG000|COMPLETED|Overall Study||1||
48213545|NCT01388777|100849544|FG000|NOT COMPLETED|Overall Study||0||
48213546|NCT02374307|100849545|FG000|STARTED|3-months Follow-up||77||
48213547|NCT02374307|100849546|FG001|STARTED|3-months Follow-up||78||
48213548|NCT02374307|100849545|FG000|COMPLETED|3-months Follow-up||69||
48213549|NCT02374307|100849546|FG001|COMPLETED|3-months Follow-up||69||
48213550|NCT02374307|100849545|FG000|NOT COMPLETED|3-months Follow-up||8||
48213551|NCT02374307|100849546|FG001|NOT COMPLETED|3-months Follow-up||9||
48213552|NCT02374307|100849545|FG000|STARTED|6-months Follow-up||74||
48213553|NCT02374307|100849546|FG001|STARTED|6-months Follow-up||70||
48213554|NCT02374307|100849545|FG000|COMPLETED|6-months Follow-up||71||
48213555|NCT02374307|100849546|FG001|COMPLETED|6-months Follow-up||64||
48213556|NCT02374307|100849545|FG000|NOT COMPLETED|6-months Follow-up||3||
48213557|NCT02374307|100849546|FG001|NOT COMPLETED|6-months Follow-up||6||
48213558|NCT00686855|100849547|FG000|STARTED|Overall Study||28||
48213559|NCT00686855|100849548|FG001|STARTED|Overall Study||18||
48213560|NCT00686855|100849547|FG000|COMPLETED|Overall Study||27||
48213561|NCT00686855|100849548|FG001|COMPLETED|Overall Study||17||
48213562|NCT00686855|100849547|FG000|NOT COMPLETED|Overall Study||1||
48213563|NCT00686855|100849548|FG001|NOT COMPLETED|Overall Study||1||
48213564|NCT01923480|100849549|FG000|STARTED|Period 1 (Hours 1-7)||1||
48213565|NCT01923480|100849550|FG001|STARTED|Period 1 (Hours 1-7)||2||
48213566|NCT01923480|100849551|FG002|STARTED|Period 1 (Hours 1-7)||2||
48213567|NCT01923480|100849552|FG003|STARTED|Period 1 (Hours 1-7)||2||
48213568|NCT01923480|100849553|FG004|STARTED|Period 1 (Hours 1-7)||2||
48213569|NCT01923480|100849554|FG005|STARTED|Period 1 (Hours 1-7)||2||
48213570|NCT01923480|100849549|FG000|COMPLETED|Period 1 (Hours 1-7)||1||
48213571|NCT01923480|100849550|FG001|COMPLETED|Period 1 (Hours 1-7)||2||
48213572|NCT01923480|100849551|FG002|COMPLETED|Period 1 (Hours 1-7)||2||
48213573|NCT01923480|100849552|FG003|COMPLETED|Period 1 (Hours 1-7)||2||
48213574|NCT01923480|100849553|FG004|COMPLETED|Period 1 (Hours 1-7)||2||
48213575|NCT01923480|100849554|FG005|COMPLETED|Period 1 (Hours 1-7)||2||
48213576|NCT01923480|100849549|FG000|NOT COMPLETED|Period 1 (Hours 1-7)||0||
48213577|NCT01923480|100849550|FG001|NOT COMPLETED|Period 1 (Hours 1-7)||0||
48213578|NCT01923480|100849551|FG002|NOT COMPLETED|Period 1 (Hours 1-7)||0||
48213579|NCT01923480|100849552|FG003|NOT COMPLETED|Period 1 (Hours 1-7)||0||
48213580|NCT01923480|100849553|FG004|NOT COMPLETED|Period 1 (Hours 1-7)||0||
48213581|NCT01923480|100849554|FG005|NOT COMPLETED|Period 1 (Hours 1-7)||0||
48213582|NCT01923480|100849549|FG000|STARTED|Period 2 (Hours 1-7)||1||
48213583|NCT01923480|100849550|FG001|STARTED|Period 2 (Hours 1-7)||1||
48213584|NCT01923480|100849551|FG002|STARTED|Period 2 (Hours 1-7)||2||
48213585|NCT01923480|100849552|FG003|STARTED|Period 2 (Hours 1-7)||2||
48213586|NCT01923480|100849553|FG004|STARTED|Period 2 (Hours 1-7)||2||
48213587|NCT01923480|100849554|FG005|STARTED|Period 2 (Hours 1-7)||2||
48213588|NCT01923480|100849549|FG000|COMPLETED|Period 2 (Hours 1-7)||1||
48213589|NCT01923480|100849550|FG001|COMPLETED|Period 2 (Hours 1-7)||1||
48213590|NCT01923480|100849551|FG002|COMPLETED|Period 2 (Hours 1-7)||2||
48213591|NCT01923480|100849552|FG003|COMPLETED|Period 2 (Hours 1-7)||2||
48213592|NCT01923480|100849553|FG004|COMPLETED|Period 2 (Hours 1-7)||2||
48213593|NCT01923480|100849554|FG005|COMPLETED|Period 2 (Hours 1-7)||2||
48213594|NCT01923480|100849549|FG000|NOT COMPLETED|Period 2 (Hours 1-7)||0||
48213595|NCT01923480|100849550|FG001|NOT COMPLETED|Period 2 (Hours 1-7)||0||
48213596|NCT01923480|100849551|FG002|NOT COMPLETED|Period 2 (Hours 1-7)||0||
48213597|NCT01923480|100849552|FG003|NOT COMPLETED|Period 2 (Hours 1-7)||0||
48213598|NCT01923480|100849553|FG004|NOT COMPLETED|Period 2 (Hours 1-7)||0||
48213599|NCT01923480|100849554|FG005|NOT COMPLETED|Period 2 (Hours 1-7)||0||
48213600|NCT02200523|100849555|FG000|STARTED|Overall Study||20||
48213601|NCT02200523|100849556|FG001|STARTED|Overall Study||20||
48059910|NCT01848704|100467057|FG001|COMPLETED|Overall Study||150||
48213602|NCT02200523|100849555|FG000|COMPLETED|Overall Study||20||
48213603|NCT02200523|100849556|FG001|COMPLETED|Overall Study||20||
48213604|NCT02200523|100849555|FG000|NOT COMPLETED|Overall Study||0||
48213605|NCT02200523|100849556|FG001|NOT COMPLETED|Overall Study||0||
48213606|NCT01625104|100849557|FG000|STARTED|Overall Study||448||
48213607|NCT01625104|100849558|FG001|STARTED|Overall Study||434||
48213608|NCT01625104|100849557|FG000|COMPLETED|Overall Study||448||
48213609|NCT01625104|100849558|FG001|COMPLETED|Overall Study||434||
48213610|NCT01625104|100849557|FG000|NOT COMPLETED|Overall Study||0||
48213611|NCT01625104|100849558|FG001|NOT COMPLETED|Overall Study||0||
48213612|NCT00634621|100849559|FG000|STARTED|Overall Study||283||
48213613|NCT00634621|100849559|FG000|COMPLETED|Overall Study||283||
48213614|NCT00634621|100849559|FG000|NOT COMPLETED|Overall Study||0||
48213615|NCT04110054|100849560|FG000|STARTED|Overall Study||101||
48213616|NCT04110054|100849561|FG001|STARTED|Overall Study||103||
48213617|NCT04110054|100849562|FG002|STARTED|Overall Study||100||
48213618|NCT04110054|100849563|FG003|STARTED|Overall Study||102||
48213619|NCT04110054|100849560|FG000|Received At Least 1 Dose of Study Drug|Overall Study||100||
48213620|NCT04110054|100849561|FG001|Received At Least 1 Dose of Study Drug|Overall Study||103||
48213621|NCT04110054|100849562|FG002|Received At Least 1 Dose of Study Drug|Overall Study||100||
48213622|NCT04110054|100849563|FG003|Received At Least 1 Dose of Study Drug|Overall Study||102||
48213623|NCT04110054|100849560|FG000|COMPLETED|Overall Study||100||
48213624|NCT04110054|100849561|FG001|COMPLETED|Overall Study||99||
48213625|NCT04110054|100849562|FG002|COMPLETED|Overall Study||92||
48213626|NCT04110054|100849563|FG003|COMPLETED|Overall Study||99||
48213627|NCT04110054|100849560|FG000|NOT COMPLETED|Overall Study||1||
48213628|NCT04110054|100849561|FG001|NOT COMPLETED|Overall Study||4||
48213629|NCT04110054|100849562|FG002|NOT COMPLETED|Overall Study||8||
48213630|NCT04110054|100849563|FG003|NOT COMPLETED|Overall Study||3||
48213631|NCT02601820|100849564|FG000|STARTED|Pre-Treatment (T1)||1601||
48213632|NCT02601820|100849564|FG000|COMPLETED|Pre-Treatment (T1)||1601||
48213633|NCT02601820|100849564|FG000|NOT COMPLETED|Pre-Treatment (T1)||0||
48213634|NCT02601820|100849564|FG000|STARTED|Early On-Treatment (T2)||1584||
48213635|NCT02601820|100849564|FG000|COMPLETED|Early On-Treatment (T2)||1533||
48213636|NCT02601820|100849564|FG000|NOT COMPLETED|Early On-Treatment (T2)||51||
48213637|NCT02601820|100849564|FG000|STARTED|Late On-Treatment (T3)||1573||
48213638|NCT02601820|100849564|FG000|COMPLETED|Late On-Treatment (T3)||1524||
48213639|NCT02601820|100849564|FG000|NOT COMPLETED|Late On-Treatment (T3)||49||
48213640|NCT02601820|100849564|FG000|STARTED|12 Weeks Post-Treatment (T4)||1564||
48213641|NCT02601820|100849564|FG000|COMPLETED|12 Weeks Post-Treatment (T4)||1561||
48213642|NCT02601820|100849564|FG000|NOT COMPLETED|12 Weeks Post-Treatment (T4)||3||
48213643|NCT02601820|100849564|FG000|STARTED|1-Yr Post-Treatment (T5)||1528||
48213644|NCT02601820|100849564|FG000|COMPLETED|1-Yr Post-Treatment (T5)||1440||
48213645|NCT02601820|100849564|FG000|NOT COMPLETED|1-Yr Post-Treatment (T5)||88||
48213646|NCT03531840|100849565|FG000|STARTED|Overall Study||5||
48213647|NCT03531840|100849566|FG001|STARTED|Overall Study||6||
48213648|NCT03531840|100849567|FG002|STARTED|Overall Study||8||
48213649|NCT03531840|100849568|FG003|STARTED|Overall Study||4||
48213650|NCT03531840|100849565|FG000|COMPLETED|Overall Study||0||
48213651|NCT03531840|100849566|FG001|COMPLETED|Overall Study||1||
48213652|NCT03531840|100849567|FG002|COMPLETED|Overall Study||3||
48213653|NCT03531840|100849568|FG003|COMPLETED|Overall Study||1||
48213654|NCT03531840|100849565|FG000|NOT COMPLETED|Overall Study||5||
48213655|NCT03531840|100849566|FG001|NOT COMPLETED|Overall Study||5||
48213656|NCT03531840|100849567|FG002|NOT COMPLETED|Overall Study||5||
48213657|NCT03531840|100849568|FG003|NOT COMPLETED|Overall Study||3||
48213658|NCT02252042|100849569|FG000|STARTED|Overall Study||247||
48213659|NCT02252042|100849570|FG001|STARTED|Overall Study||248||
48213660|NCT02252042|100849569|FG000|Received First Course of Pembrolizumab|Overall Study||246||
48213661|NCT02252042|100849570|FG001|Received First Course of Pembrolizumab|Overall Study||234||
48213662|NCT02252042|100849569|FG000|Received Second Course of Pembrolizumab|Overall Study||2||
48213663|NCT02252042|100849570|FG001|Received Second Course of Pembrolizumab|Overall Study||0||
48213664|NCT02252042|100849569|FG000|COMPLETED|Overall Study||0||
48213665|NCT02252042|100849570|FG001|COMPLETED|Overall Study||0||
48213666|NCT02252042|100849569|FG000|NOT COMPLETED|Overall Study||247||
48213667|NCT02252042|100849570|FG001|NOT COMPLETED|Overall Study||248||
48213668|NCT02140645|100849571|FG000|STARTED|Overall Study||5732||
48213669|NCT02140645|100849572|FG001|STARTED|Overall Study||64695||
48213670|NCT02140645|100849573|FG002|STARTED|Overall Study||4441||
48213671|NCT02140645|100849574|FG003|STARTED|Overall Study||14363||
48213672|NCT02140645|100849575|FG004|STARTED|Overall Study||3436||
48213673|NCT02140645|100849576|FG005|STARTED|Overall Study||73946||
48213674|NCT02140645|100849571|FG000|COMPLETED|Overall Study||243||
48213675|NCT02140645|100849572|FG001|COMPLETED|Overall Study||3041||
48213676|NCT02140645|100849573|FG002|COMPLETED|Overall Study||205||
48213677|NCT02140645|100849574|FG003|COMPLETED|Overall Study||530||
48213678|NCT02140645|100849575|FG004|COMPLETED|Overall Study||150||
48213679|NCT02140645|100849576|FG005|COMPLETED|Overall Study||3050||
48213680|NCT02140645|100849571|FG000|NOT COMPLETED|Overall Study||5489||
48213681|NCT02140645|100849572|FG001|NOT COMPLETED|Overall Study||61654||
48213682|NCT02140645|100849573|FG002|NOT COMPLETED|Overall Study||4236||
48213683|NCT02140645|100849574|FG003|NOT COMPLETED|Overall Study||13833||
48213684|NCT02140645|100849575|FG004|NOT COMPLETED|Overall Study||3286||
48213685|NCT02140645|100849576|FG005|NOT COMPLETED|Overall Study||70896||
48213686|NCT03165175|100849577|FG000|STARTED|1-month to 3-month||41||
48213687|NCT03165175|100849578|FG001|STARTED|1-month to 3-month||39||
48213688|NCT03165175|100849577|FG000|COMPLETED|1-month to 3-month||35||
48213689|NCT03165175|100849578|FG001|COMPLETED|1-month to 3-month||39||
48213690|NCT03165175|100849577|FG000|NOT COMPLETED|1-month to 3-month||6||
48213691|NCT03165175|100849578|FG001|NOT COMPLETED|1-month to 3-month||0||
48213692|NCT03165175|100849577|FG000|STARTED|Baseline to 3-month||35||
48213693|NCT03165175|100849578|FG001|STARTED|Baseline to 3-month||39||
48213694|NCT03165175|100849577|FG000|COMPLETED|Baseline to 3-month||31||
48213695|NCT03165175|100849578|FG001|COMPLETED|Baseline to 3-month||39||
48213696|NCT03165175|100849577|FG000|NOT COMPLETED|Baseline to 3-month||4||
48213697|NCT03165175|100849578|FG001|NOT COMPLETED|Baseline to 3-month||0||
48213698|NCT03859869|100849579|FG000|STARTED|Overall Study||0||
48213699|NCT03859869|100849580|FG001|STARTED|Overall Study||1||
48213700|NCT03859869|100849581|FG002|STARTED|Overall Study||0||
48213701|NCT03859869|100849579|FG000|COMPLETED|Overall Study||0||
48213702|NCT03859869|100849580|FG001|COMPLETED|Overall Study||1||
48213703|NCT03859869|100849581|FG002|COMPLETED|Overall Study||0||
48213704|NCT03859869|100849579|FG000|NOT COMPLETED|Overall Study||0||
48213705|NCT03859869|100849580|FG001|NOT COMPLETED|Overall Study||0||
48213706|NCT03859869|100849581|FG002|NOT COMPLETED|Overall Study||0||
48213707|NCT00089544|100849582|FG000|STARTED|Overall Study||16||
48213708|NCT00089544|100849583|FG001|STARTED|Overall Study||7||
48213709|NCT00089544|100849582|FG000|COMPLETED|Overall Study||15||
48213710|NCT00089544|100849583|FG001|COMPLETED|Overall Study||7||
48213711|NCT00089544|100849582|FG000|NOT COMPLETED|Overall Study||1||
48213712|NCT00089544|100849583|FG001|NOT COMPLETED|Overall Study||0||
48213713|NCT02036424|100849584|FG000|STARTED|Overall Study||23||
48213714|NCT02036424|100849585|FG001|STARTED|Overall Study||27||
48213715|NCT02036424|100849584|FG000|COMPLETED|Overall Study||23||
48213716|NCT02036424|100849585|FG001|COMPLETED|Overall Study||27||
48213717|NCT02036424|100849584|FG000|NOT COMPLETED|Overall Study||0||
48213718|NCT02036424|100849585|FG001|NOT COMPLETED|Overall Study||0||
48213719|NCT03892564|100849586|FG000|STARTED|Overall Study||35||
48213720|NCT03892564|100849586|FG000|MC2-01 Cream + Irridiation|Overall Study||35||
48213721|NCT03892564|100849586|FG000|MC2-01 Cream + Non-irridiation|Overall Study||35||
48213722|NCT03892564|100849586|FG000|MC2-01 Vehicle + Irridiation|Overall Study||35||
48213723|NCT03892564|100849586|FG000|MC2-01 Vehicle + Non-irridiation|Overall Study||35||
48213724|NCT03892564|100849586|FG000|Control Site|Overall Study||35||
48213725|NCT03892564|100849586|FG000|COMPLETED|Overall Study||33||
48213726|NCT03892564|100849586|FG000|NOT COMPLETED|Overall Study||2||
48213727|NCT00687713|100849587|FG000|STARTED|Overall Study||100||
48213728|NCT00687713|100849588|FG001|STARTED|Overall Study||104||
48213729|NCT00687713|100849587|FG000|COMPLETED|Overall Study||68||
48213730|NCT00687713|100849588|FG001|COMPLETED|Overall Study||64||
48213731|NCT00687713|100849587|FG000|NOT COMPLETED|Overall Study||32||
48213732|NCT00687713|100849588|FG001|NOT COMPLETED|Overall Study||40||
48213733|NCT01599104|100849589|FG000|STARTED|Overall Study||387||
48213734|NCT01599104|100849590|FG001|STARTED|Overall Study||385||
48213735|NCT01599104|100849591|FG002|STARTED|Overall Study||389||
48213736|NCT01599104|100849589|FG000|COMPLETED|Overall Study||371||
48213737|NCT01599104|100849590|FG001|COMPLETED|Overall Study||371||
48213738|NCT01599104|100849591|FG002|COMPLETED|Overall Study||363||
48213739|NCT01599104|100849589|FG000|NOT COMPLETED|Overall Study||16||
48213740|NCT01599104|100849590|FG001|NOT COMPLETED|Overall Study||14||
48213741|NCT01599104|100849591|FG002|NOT COMPLETED|Overall Study||26||
48213742|NCT03262935|100849592|FG000|STARTED|Overall Study||291||
48213743|NCT03262935|100849593|FG001|STARTED|Overall Study||146||
48213744|NCT03262935|100849592|FG000|COMPLETED|Overall Study||0||
48213745|NCT03262935|100849593|FG001|COMPLETED|Overall Study||0||
48213746|NCT03262935|100849592|FG000|NOT COMPLETED|Overall Study||291||
48213747|NCT03262935|100849593|FG001|NOT COMPLETED|Overall Study||146||
48213748|NCT03733119|100849594|FG000|STARTED|Overall Study||2||
48213749|NCT03733119|100849595|FG001|STARTED|Overall Study||2||
48213750|NCT03733119|100849594|FG000|Treated|Overall Study||2||
48213751|NCT03733119|100849595|FG001|Treated|Overall Study||1||
48059911|NCT01848704|100467056|FG000|NOT COMPLETED|Overall Study||0||
48213752|NCT03733119|100849594|FG000|Stopped Treatment After 1 Dose|Overall Study||1|removed by physician for disease progression 2 days after first dose|
48213753|NCT03733119|100849595|FG001|Stopped Treatment After 1 Dose|Overall Study||0|removed by physician for disease progression 2 days after first dose|
48213754|NCT03733119|100849594|FG000|Stopped Treatment After 3 Cycles|Overall Study||1|removed by physician for disease progression after the first planned time point for disease evaluation|
48213755|NCT03733119|100849595|FG001|Stopped Treatment After 3 Cycles|Overall Study||1|removed by physician for disease progression after the first planned time point for disease evaluation|
48059912|NCT01848704|100467057|FG001|NOT COMPLETED|Overall Study||0||
48213756|NCT03733119|100849594|FG000|COMPLETED|Overall Study||0||
48213757|NCT03733119|100849595|FG001|COMPLETED|Overall Study||0||
48213758|NCT03733119|100849594|FG000|NOT COMPLETED|Overall Study||2||
48059913|NCT01631812|100467058|FG000|STARTED|Overall Study||130||
48059914|NCT01631812|100467058|FG000|COMPLETED|Overall Study||93||
48213759|NCT03733119|100849595|FG001|NOT COMPLETED|Overall Study||2||
48213760|NCT01599793|100849596|FG000|STARTED|Overall Study||19||
48213761|NCT01599793|100849596|FG000|COMPLETED|Overall Study||17||
48213762|NCT01599793|100849596|FG000|NOT COMPLETED|Overall Study||2||
48213763|NCT01414738|100849597|FG000|STARTED|Overall Study||49|1 patient did not initiate treatment|
48213764|NCT01414738|100849597|FG000|Follow-up (3 Months)|Overall Study||18||
48213765|NCT01414738|100849597|FG000|Follow-up (6 Months)|Overall Study||8||
48213766|NCT01414738|100849597|FG000|Follow-up (9 Months)|Overall Study||5||
48213767|NCT01414738|100849597|FG000|COMPLETED|Overall Study||5||
48213768|NCT01414738|100849597|FG000|NOT COMPLETED|Overall Study||44||
48213769|NCT01037985|100849598|FG000|STARTED|Part A: Skin Testing (50 Days)||41||
48213770|NCT01037985|100849599|FG001|STARTED|Part A: Skin Testing (50 Days)||0||
48059915|NCT01631812|100467058|FG000|NOT COMPLETED|Overall Study||37||
48059916|NCT02520661|100467059|FG000|STARTED|Overall Study||992||
48059917|NCT02520661|100467060|FG001|STARTED|Overall Study||987||
48059918|NCT02520661|100467059|FG000|Removed Following Randomization|Overall Study||124|Reasons include, admitted from ED, ED stay greater than 24 hours, other ineligibility|
48059919|NCT02520661|100467060|FG001|Removed Following Randomization|Overall Study||99|Reasons include, admitted from ED, ED stay greater than 24 hours, other ineligibility|
48059920|NCT02520661|100467059|FG000|CTI Home Visit Scheduled|Overall Study||0|CTI = Care Transitions Intervention|
48059921|NCT02520661|100467060|FG001|CTI Home Visit Scheduled|Overall Study||863|CTI = Care Transitions Intervention|
48059922|NCT02520661|100467059|FG000|Participants in Dataset|Overall Study||893||
48059923|NCT02520661|100467060|FG001|Participants in Dataset|Overall Study||863||
48059924|NCT02520661|100467059|FG000|Participants Completing Home Visit|Overall Study||0|Intervention arm|
48213771|NCT01037985|100849598|FG000|COMPLETED|Part A: Skin Testing (50 Days)||37||
48213772|NCT01037985|100849599|FG001|COMPLETED|Part A: Skin Testing (50 Days)||0||
48213773|NCT01037985|100849598|FG000|NOT COMPLETED|Part A: Skin Testing (50 Days)||4||
48213774|NCT01037985|100849599|FG001|NOT COMPLETED|Part A: Skin Testing (50 Days)||0||
48213775|NCT01037985|100849598|FG000|STARTED|Part B:Abdominoplasty Surgery (24 Weeks)||0||
48213776|NCT01037985|100849599|FG001|STARTED|Part B:Abdominoplasty Surgery (24 Weeks)||37||
48213777|NCT01037985|100849598|FG000|Treated|Part B:Abdominoplasty Surgery (24 Weeks)||0||
48213778|NCT01037985|100849599|FG001|Treated|Part B:Abdominoplasty Surgery (24 Weeks)||33||
48213779|NCT01037985|100849598|FG000|COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||0||
48213780|NCT01037985|100849599|FG001|COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||32||
48213781|NCT01037985|100849598|FG000|NOT COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||0||
48213782|NCT01037985|100849599|FG001|NOT COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||5||
48213783|NCT00446459|100849600|FG000|STARTED|8 Months||34||
48213784|NCT00446459|100849600|FG000|COMPLETED|8 Months||22||
48213785|NCT00446459|100849600|FG000|NOT COMPLETED|8 Months||12||
48213786|NCT00446459|100849600|FG000|STARTED|12 Months||22||
48213787|NCT00446459|100849600|FG000|COMPLETED|12 Months||4||
48213788|NCT00446459|100849600|FG000|NOT COMPLETED|12 Months||18||
48213789|NCT00549848|100849601|FG000|STARTED|Overall Study||206||
48213790|NCT00549848|100849602|FG001|STARTED|Overall Study||208||
48213791|NCT00549848|100849603|FG002|STARTED|Overall Study||184||
48213792|NCT00549848|100849601|FG000|COMPLETED|Overall Study||194||
48213793|NCT00549848|100849602|FG001|COMPLETED|Overall Study||188||
48213794|NCT00549848|100849603|FG002|COMPLETED|Overall Study||133||
48213795|NCT00549848|100849601|FG000|NOT COMPLETED|Overall Study||12||
48213796|NCT00549848|100849602|FG001|NOT COMPLETED|Overall Study||20||
48213797|NCT00549848|100849603|FG002|NOT COMPLETED|Overall Study||51||
48213798|NCT00903162|100849604|FG000|STARTED|Overall Study||16||
48213799|NCT00903162|100849604|FG000|COMPLETED|Overall Study||12||
48213800|NCT00903162|100849604|FG000|NOT COMPLETED|Overall Study||4||
48213801|NCT01950780|100849605|FG000|STARTED|Overall Study||12||
48213802|NCT01950780|100849605|FG000|COMPLETED|Overall Study||12||
48213803|NCT01950780|100849605|FG000|NOT COMPLETED|Overall Study||0||
48213804|NCT01494922|100849606|FG000|STARTED|Overall Study||14||
48213805|NCT01494922|100849606|FG000|COMPLETED|Overall Study||13||
48213806|NCT01494922|100849606|FG000|NOT COMPLETED|Overall Study||1||
48213807|NCT05368831|100849607|FG000|STARTED|Probe Drugs Cocktail #1||24||
48213808|NCT05368831|100849607|FG000|COMPLETED|Probe Drugs Cocktail #1||24||
48213809|NCT05368831|100849607|FG000|NOT COMPLETED|Probe Drugs Cocktail #1||0||
48213810|NCT05368831|100849607|FG000|STARTED|200 mg NST-1024 + Probe Drug Cocktail #1||24||
48213811|NCT05368831|100849607|FG000|COMPLETED|200 mg NST-1024 + Probe Drug Cocktail #1||24||
48213812|NCT05368831|100849607|FG000|NOT COMPLETED|200 mg NST-1024 + Probe Drug Cocktail #1||0||
48213813|NCT05368831|100849607|FG000|STARTED|200 mg NST-1024 (QD)||24||
48213814|NCT05368831|100849607|FG000|COMPLETED|200 mg NST-1024 (QD)||21||
48059925|NCT02520661|100467060|FG001|Participants Completing Home Visit|Overall Study||726|Intervention arm|
48213815|NCT05368831|100849607|FG000|NOT COMPLETED|200 mg NST-1024 (QD)||3||
48213816|NCT05368831|100849607|FG000|STARTED|200 mg NST-1024 (QD) + Probe Cocktail #2||21||
48213817|NCT05368831|100849607|FG000|COMPLETED|200 mg NST-1024 (QD) + Probe Cocktail #2||21||
48213818|NCT05368831|100849607|FG000|NOT COMPLETED|200 mg NST-1024 (QD) + Probe Cocktail #2||0||
48213819|NCT02121002|100849608|FG000|STARTED|Overall Study||392||
48213820|NCT02121002|100849609|FG001|STARTED|Overall Study||393||
48213821|NCT02121002|100849610|FG002|STARTED|Overall Study||391||
48213822|NCT02121002|100849608|FG000|COMPLETED|Overall Study||385||
48213823|NCT02121002|100849609|FG001|COMPLETED|Overall Study||389||
48213824|NCT02121002|100849610|FG002|COMPLETED|Overall Study||381||
48213825|NCT02121002|100849608|FG000|NOT COMPLETED|Overall Study||7||
48213826|NCT02121002|100849609|FG001|NOT COMPLETED|Overall Study||4||
48213827|NCT02121002|100849610|FG002|NOT COMPLETED|Overall Study||10||
48213828|NCT01324453|100849611|FG000|STARTED|Overall Study||54||
48213829|NCT01324453|100849612|FG001|STARTED|Overall Study||49||
48213830|NCT01324453|100849611|FG000|COMPLETED|Overall Study||54||
48213831|NCT01324453|100849612|FG001|COMPLETED|Overall Study||49||
48213832|NCT01324453|100849611|FG000|NOT COMPLETED|Overall Study||0||
48213833|NCT01324453|100849612|FG001|NOT COMPLETED|Overall Study||0||
48213834|NCT01072006|100849613|FG000|STARTED|Overall Study||14||
48213835|NCT01072006|100849614|FG001|STARTED|Overall Study||5||
48213836|NCT01072006|100849615|FG002|STARTED|Overall Study||0||
48213837|NCT01072006|100849616|FG003|STARTED|Overall Study||11||
48213838|NCT01072006|100849613|FG000|COMPLETED|Overall Study||14||
48213839|NCT01072006|100849614|FG001|COMPLETED|Overall Study||5||
48213840|NCT01072006|100849615|FG002|COMPLETED|Overall Study||0||
48213841|NCT01072006|100849616|FG003|COMPLETED|Overall Study||11||
48213842|NCT01072006|100849613|FG000|NOT COMPLETED|Overall Study||0||
48213843|NCT01072006|100849614|FG001|NOT COMPLETED|Overall Study||0||
48213844|NCT01072006|100849615|FG002|NOT COMPLETED|Overall Study||0||
48213845|NCT01072006|100849616|FG003|NOT COMPLETED|Overall Study||0||
48213846|NCT02372253|100849617|FG000|STARTED|Overall Study||13||
48213847|NCT02372253|100849618|FG001|STARTED|Overall Study||13||
48213848|NCT02372253|100849617|FG000|COMPLETED|Overall Study||11||
48213849|NCT02372253|100849618|FG001|COMPLETED|Overall Study||13||
48213850|NCT02372253|100849617|FG000|NOT COMPLETED|Overall Study||2||
48213851|NCT02372253|100849618|FG001|NOT COMPLETED|Overall Study||0||
48213852|NCT00566735|100849619|FG000|STARTED|Overall Study||20||
48213853|NCT00566735|100849620|FG001|STARTED|Overall Study||19||
48213854|NCT00566735|100849619|FG000|Withdrew Before Baseline Measures|Overall Study||2||
48213855|NCT00566735|100849620|FG001|Withdrew Before Baseline Measures|Overall Study||7||
48213856|NCT00566735|100849619|FG000|COMPLETED|Overall Study||18||
48213857|NCT00566735|100849620|FG001|COMPLETED|Overall Study||12||
48213858|NCT00566735|100849619|FG000|NOT COMPLETED|Overall Study||2||
48213859|NCT00566735|100849620|FG001|NOT COMPLETED|Overall Study||7||
48213860|NCT01061034|100849621|FG000|STARTED|Aspirin||9||
48213861|NCT01061034|100849621|FG000|COMPLETED|Aspirin||9||
48213862|NCT01061034|100849621|FG000|NOT COMPLETED|Aspirin||0||
48213863|NCT01061034|100849621|FG000|STARTED|Aspirin Plus Omeprazole||9||
48213864|NCT01061034|100849621|FG000|COMPLETED|Aspirin Plus Omeprazole||9||
48213865|NCT01061034|100849621|FG000|NOT COMPLETED|Aspirin Plus Omeprazole||0||
48213866|NCT01636687|100849622|FG000|STARTED|Induction Period||61||
48213867|NCT01636687|100849623|FG001|STARTED|Induction Period||60||
48213868|NCT01636687|100849624|FG002|STARTED|Induction Period||0||
48213869|NCT01636687|100849625|FG003|STARTED|Induction Period||0||
48213870|NCT01636687|100849626|FG004|STARTED|Induction Period||61||
48213871|NCT01636687|100849622|FG000|COMPLETED|Induction Period||58||
48213872|NCT01636687|100849623|FG001|COMPLETED|Induction Period||60||
48213873|NCT01636687|100849624|FG002|COMPLETED|Induction Period||0||
48213874|NCT01636687|100849625|FG003|COMPLETED|Induction Period||0||
48213875|NCT01636687|100849626|FG004|COMPLETED|Induction Period||59||
48213876|NCT01636687|100849622|FG000|NOT COMPLETED|Induction Period||3||
48213877|NCT01636687|100849623|FG001|NOT COMPLETED|Induction Period||0||
48213878|NCT01636687|100849624|FG002|NOT COMPLETED|Induction Period||0||
48213879|NCT01636687|100849625|FG003|NOT COMPLETED|Induction Period||0||
48213880|NCT01636687|100849626|FG004|NOT COMPLETED|Induction Period||2||
48213881|NCT01636687|100849622|FG000|STARTED|Maintenance Period||58||
48213882|NCT01636687|100849623|FG001|STARTED|Maintenance Period||60||
48059926|NCT02520661|100467059|FG000|Participants With Primary Outcome Data (ITT)|Overall Study||886|ITT = Intent to Treat|
48059927|NCT02520661|100467060|FG001|Participants With Primary Outcome Data (ITT)|Overall Study||860|ITT = Intent to Treat|
48059928|NCT02520661|100467059|FG000|Participants With Primary Outcome Data (PP)|Overall Study||886|PP = Per Protocol|
48059929|NCT02520661|100467060|FG001|Participants With Primary Outcome Data (PP)|Overall Study||725|PP = Per Protocol|
48059930|NCT02520661|100467059|FG000|COMPLETED|Overall Study||886||
48059931|NCT02520661|100467060|FG001|COMPLETED|Overall Study||860||
48059932|NCT02520661|100467059|FG000|NOT COMPLETED|Overall Study||106||
48213883|NCT01636687|100849624|FG002|STARTED|Maintenance Period||28||
48213884|NCT01636687|100849625|FG003|STARTED|Maintenance Period||28||
48213885|NCT01636687|100849626|FG004|STARTED|Maintenance Period||3||
48213886|NCT01636687|100849622|FG000|COMPLETED|Maintenance Period||50||
48213887|NCT01636687|100849623|FG001|COMPLETED|Maintenance Period||58||
48213888|NCT01636687|100849624|FG002|COMPLETED|Maintenance Period||26||
48213889|NCT01636687|100849625|FG003|COMPLETED|Maintenance Period||28||
48213890|NCT01636687|100849626|FG004|COMPLETED|Maintenance Period||1||
48213891|NCT01636687|100849622|FG000|NOT COMPLETED|Maintenance Period||8||
48213892|NCT01636687|100849623|FG001|NOT COMPLETED|Maintenance Period||2||
48213893|NCT01636687|100849624|FG002|NOT COMPLETED|Maintenance Period||2||
48213894|NCT01636687|100849625|FG003|NOT COMPLETED|Maintenance Period||0||
48213895|NCT01636687|100849626|FG004|NOT COMPLETED|Maintenance Period||2||
48213896|NCT01636687|100849622|FG000|STARTED|Extension Period||47||
48213897|NCT01636687|100849623|FG001|STARTED|Extension Period||54||
48213898|NCT01636687|100849624|FG002|STARTED|Extension Period||25||
48213899|NCT01636687|100849625|FG003|STARTED|Extension Period||28||
48213900|NCT01636687|100849626|FG004|STARTED|Extension Period||0||
48213901|NCT01636687|100849622|FG000|COMPLETED|Extension Period||0||
48213902|NCT01636687|100849623|FG001|COMPLETED|Extension Period||0||
48213903|NCT01636687|100849624|FG002|COMPLETED|Extension Period||0||
48213904|NCT01636687|100849625|FG003|COMPLETED|Extension Period||0||
48213905|NCT01636687|100849626|FG004|COMPLETED|Extension Period||0||
48213906|NCT01636687|100849622|FG000|NOT COMPLETED|Extension Period||47||
48213907|NCT01636687|100849623|FG001|NOT COMPLETED|Extension Period||54||
48213908|NCT01636687|100849624|FG002|NOT COMPLETED|Extension Period||25||
48213909|NCT01636687|100849625|FG003|NOT COMPLETED|Extension Period||28||
48213910|NCT01636687|100849626|FG004|NOT COMPLETED|Extension Period||0||
48213911|NCT01636687|100849622|FG000|STARTED|Follow-up Period||38||
48213912|NCT01636687|100849623|FG001|STARTED|Follow-up Period||45||
48213913|NCT01636687|100849624|FG002|STARTED|Follow-up Period||21||
48213914|NCT01636687|100849625|FG003|STARTED|Follow-up Period||20||
48213915|NCT01636687|100849626|FG004|STARTED|Follow-up Period||2||
48213916|NCT01636687|100849622|FG000|COMPLETED|Follow-up Period||37||
48213917|NCT01636687|100849623|FG001|COMPLETED|Follow-up Period||45||
48213918|NCT01636687|100849624|FG002|COMPLETED|Follow-up Period||21||
48213919|NCT01636687|100849625|FG003|COMPLETED|Follow-up Period||20||
48213920|NCT01636687|100849626|FG004|COMPLETED|Follow-up Period||1||
48213921|NCT01636687|100849622|FG000|NOT COMPLETED|Follow-up Period||1||
48213922|NCT01636687|100849623|FG001|NOT COMPLETED|Follow-up Period||0||
48213923|NCT01636687|100849624|FG002|NOT COMPLETED|Follow-up Period||0||
48213924|NCT01636687|100849625|FG003|NOT COMPLETED|Follow-up Period||0||
48213925|NCT01636687|100849626|FG004|NOT COMPLETED|Follow-up Period||1||
48213926|NCT00392054|100849627|FG000|STARTED|Overall Study||66||
48213927|NCT00392054|100849628|FG001|STARTED|Overall Study||61||
48213928|NCT00392054|100849627|FG000|Received Allocated Intervention|Overall Study||65||
48213929|NCT00392054|100849628|FG001|Received Allocated Intervention|Overall Study||60||
48213930|NCT00392054|100849627|FG000|COMPLETED|Overall Study||66||
48213931|NCT00392054|100849628|FG001|COMPLETED|Overall Study||61||
48213932|NCT00392054|100849627|FG000|NOT COMPLETED|Overall Study||0||
48213933|NCT00392054|100849628|FG001|NOT COMPLETED|Overall Study||0||
48213934|NCT02869334|100849629|FG000|STARTED|Overall Study||10||
48213935|NCT02869334|100849630|FG001|STARTED|Overall Study||10||
48213936|NCT02869334|100849629|FG000|COMPLETED|Overall Study||2||
48213937|NCT02869334|100849630|FG001|COMPLETED|Overall Study||3||
48213938|NCT02869334|100849629|FG000|NOT COMPLETED|Overall Study||8||
48213939|NCT02869334|100849630|FG001|NOT COMPLETED|Overall Study||7||
48213940|NCT00925587|100849631|FG000|STARTED|Overall Study||178||
48213941|NCT00925587|100849632|FG001|STARTED|Overall Study||180||
48213942|NCT00925587|100849631|FG000|COMPLETED|Overall Study||142||
48213943|NCT00925587|100849632|FG001|COMPLETED|Overall Study||155||
48213944|NCT00925587|100849631|FG000|NOT COMPLETED|Overall Study||36||
48213945|NCT00925587|100849632|FG001|NOT COMPLETED|Overall Study||25||
48213946|NCT01136876|100849633|FG000|STARTED|Overall Study||28||
48213947|NCT01136876|100849634|FG001|STARTED|Overall Study||29||
48213948|NCT01136876|100849633|FG000|COMPLETED|Overall Study||23||
48213949|NCT01136876|100849634|FG001|COMPLETED|Overall Study||18||
48213950|NCT01136876|100849633|FG000|NOT COMPLETED|Overall Study||5||
48213951|NCT01136876|100849634|FG001|NOT COMPLETED|Overall Study||11||
48213952|NCT00840177|100849635|FG000|STARTED|Overall Study||36||
48213953|NCT00840177|100849636|FG001|STARTED|Overall Study||29||
48213954|NCT00840177|100849637|FG002|STARTED|Overall Study||50||
48213955|NCT00840177|100849635|FG000|Treated|Overall Study||36||
48213956|NCT00840177|100849636|FG001|Treated|Overall Study||29||
48213957|NCT00840177|100849637|FG002|Treated|Overall Study||46||
48213958|NCT00840177|100849635|FG000|Assessed for AEs|Overall Study||35||
48213959|NCT00840177|100849636|FG001|Assessed for AEs|Overall Study||29||
48213960|NCT00840177|100849637|FG002|Assessed for AEs|Overall Study||46||
48213961|NCT00840177|100849635|FG000|COMPLETED|Overall Study||18||
48213962|NCT00840177|100849636|FG001|COMPLETED|Overall Study||20||
48213963|NCT00840177|100849637|FG002|COMPLETED|Overall Study||39||
48213964|NCT00840177|100849635|FG000|NOT COMPLETED|Overall Study||18||
48213965|NCT00840177|100849636|FG001|NOT COMPLETED|Overall Study||9||
48213966|NCT00840177|100849637|FG002|NOT COMPLETED|Overall Study||11||
48213967|NCT01049503|100849638|FG000|STARTED|Overall Study||52||
48213968|NCT01049503|100849639|FG001|STARTED|Overall Study||48||
48213969|NCT01049503|100849640|FG002|STARTED|Overall Study||56||
48213970|NCT01049503|100849641|FG003|STARTED|Overall Study||55||
48213971|NCT01049503|100849642|FG004|STARTED|Overall Study||56||
48213972|NCT01049503|100849643|FG005|STARTED|Overall Study||48||
48213973|NCT01049503|100849638|FG000|COMPLETED|Overall Study||41||
48213974|NCT01049503|100849639|FG001|COMPLETED|Overall Study||36||
48213975|NCT01049503|100849640|FG002|COMPLETED|Overall Study||32||
48213976|NCT01049503|100849641|FG003|COMPLETED|Overall Study||29||
48213977|NCT01049503|100849642|FG004|COMPLETED|Overall Study||29||
48213978|NCT01049503|100849643|FG005|COMPLETED|Overall Study||40||
48213979|NCT01049503|100849638|FG000|NOT COMPLETED|Overall Study||11||
48213980|NCT01049503|100849639|FG001|NOT COMPLETED|Overall Study||12||
48213981|NCT01049503|100849640|FG002|NOT COMPLETED|Overall Study||24||
48213982|NCT01049503|100849641|FG003|NOT COMPLETED|Overall Study||26||
48059933|NCT02520661|100467060|FG001|NOT COMPLETED|Overall Study||127||
48059934|NCT03882788|100467061|FG000|STARTED|Overall Study||44||
48059935|NCT03882788|100467062|FG001|STARTED|Overall Study||45||
48059936|NCT03882788|100467061|FG000|COMPLETED|Overall Study||44||
48059937|NCT03882788|100467062|FG001|COMPLETED|Overall Study||45||
48059938|NCT03882788|100467061|FG000|NOT COMPLETED|Overall Study||0||
48059939|NCT03882788|100467062|FG001|NOT COMPLETED|Overall Study||0||
48059940|NCT03727425|100470110|FG000|STARTED|Overall Study||55||
48059941|NCT03727425|100470110|FG000|COMPLETED|Overall Study||55||
48059942|NCT03727425|100470110|FG000|NOT COMPLETED|Overall Study||0||
48059943|NCT02521766|100470111|FG000|STARTED|Overall Study||49||
48059944|NCT02521766|100470112|FG001|STARTED|Overall Study||65||
48059945|NCT02521766|100470111|FG000|Per Protocol|Overall Study||47|Successful HMIOL implantation without a major protocol deviation|
48059946|NCT02521766|100470112|FG001|Per Protocol|Overall Study||65|Successful HMIOL implantation without a major protocol deviation|
48059947|NCT02521766|100470111|FG000|COMPLETED|Overall Study||44||
48059948|NCT02521766|100470112|FG001|COMPLETED|Overall Study||62||
48059949|NCT02521766|100470111|FG000|NOT COMPLETED|Overall Study||5||
48059950|NCT02521766|100470112|FG001|NOT COMPLETED|Overall Study||3||
48059951|NCT00591344|100470113|FG000|STARTED|Overall Study||25||
48059952|NCT00591344|100470114|FG001|STARTED|Overall Study||26||
48059953|NCT00591344|100470113|FG000|Completed the 6 Month Test|Overall Study||24||
48059954|NCT00591344|100470114|FG001|Completed the 6 Month Test|Overall Study||24||
48059955|NCT00591344|100470113|FG000|COMPLETED|Overall Study||20||
48059956|NCT00591344|100470114|FG001|COMPLETED|Overall Study||18||
48059957|NCT00591344|100470113|FG000|NOT COMPLETED|Overall Study||5||
48059958|NCT00591344|100470114|FG001|NOT COMPLETED|Overall Study||8||
48059959|NCT02595996|100470115|FG000|STARTED|Overall Study||1||
48059960|NCT02595996|100470115|FG000|COMPLETED|Overall Study||1||
48059961|NCT02595996|100470115|FG000|NOT COMPLETED|Overall Study||0||
48059962|NCT00900601|100470116|FG000|STARTED|Overall Study||9||
48059963|NCT00900601|100470116|FG000|COMPLETED|Overall Study||8||
48059964|NCT00900601|100470116|FG000|NOT COMPLETED|Overall Study||1||
48059965|NCT00145704|100470117|FG000|STARTED|Overall Study||3||
48059966|NCT00145704|100470118|FG001|STARTED|Overall Study||3||
48059967|NCT00145704|100470117|FG000|COMPLETED|Overall Study||0||
48059968|NCT00145704|100470118|FG001|COMPLETED|Overall Study||0||
48059969|NCT00145704|100470117|FG000|NOT COMPLETED|Overall Study||3||
48059970|NCT00145704|100470118|FG001|NOT COMPLETED|Overall Study||3||
48059971|NCT00537238|100470119|FG000|STARTED|Overall Study||254||
48059972|NCT00537238|100470120|FG001|STARTED|Overall Study||255||
48059973|NCT00537238|100470119|FG000|Completed Titration Phase|Overall Study||226||
48059974|NCT00537238|100470120|FG001|Completed Titration Phase|Overall Study||236||
48059975|NCT00537238|100470119|FG000|Completed Maintenance Phase|Overall Study||208||
48059976|NCT00537238|100470120|FG001|Completed Maintenance Phase|Overall Study||210||
48059977|NCT00537238|100470119|FG000|Entered Opt Blinded Continuation Phase|Overall Study||185||
48059978|NCT00537238|100470120|FG001|Entered Opt Blinded Continuation Phase|Overall Study||195||
48059979|NCT00537238|100470119|FG000|COMPLETED|Overall Study||80||
48059980|NCT00537238|100470120|FG001|COMPLETED|Overall Study||82||
48059981|NCT00537238|100470119|FG000|NOT COMPLETED|Overall Study||174||
48059982|NCT00537238|100470120|FG001|NOT COMPLETED|Overall Study||173||
48059983|NCT04526509|100470121|FG000|STARTED|Screening (Day -35 to Day -8)||327|Participants consented to HLA/NY-ESO-1 target expression screening|
48059984|NCT04526509|100470122|FG001|STARTED|Screening (Day -35 to Day -8)||0|Participants consented to HLA/NY-ESO-1 target expression screening|
48059985|NCT04526509|100470123|FG002|STARTED|Screening (Day -35 to Day -8)||0|Participants consented to HLA/NY-ESO-1 target expression screening|
48059986|NCT04526509|100470124|FG003|STARTED|Screening (Day -35 to Day -8)||0|Participants consented to HLA/NY-ESO-1 target expression screening|
48059987|NCT04526509|100470125|FG004|STARTED|Screening (Day -35 to Day -8)||0|Participants consented to HLA/NY-ESO-1 target expression screening|
48059988|NCT04526509|100470126|FG005|STARTED|Screening (Day -35 to Day -8)||0|Participants consented to HLA/NY-ESO-1 target expression screening|
48059989|NCT04526509|100470127|FG006|STARTED|Screening (Day -35 to Day -8)||0|Participants consented to HLA/NY-ESO-1 target expression screening|
48059990|NCT04526509|100470121|FG000|Participants Were Tested for HLA-type|Screening (Day -35 to Day -8)||277||
48059991|NCT04526509|100470122|FG001|Participants Were Tested for HLA-type|Screening (Day -35 to Day -8)||0||
48059992|NCT04526509|100470123|FG002|Participants Were Tested for HLA-type|Screening (Day -35 to Day -8)||0||
48059993|NCT04526509|100470124|FG003|Participants Were Tested for HLA-type|Screening (Day -35 to Day -8)||0||
48059994|NCT04526509|100470125|FG004|Participants Were Tested for HLA-type|Screening (Day -35 to Day -8)||0||
48059995|NCT04526509|100470126|FG005|Participants Were Tested for HLA-type|Screening (Day -35 to Day -8)||0||
48059996|NCT04526509|100470127|FG006|Participants Were Tested for HLA-type|Screening (Day -35 to Day -8)||0||
48059997|NCT04526509|100470121|FG000|Participants Tested for HLA-type and Were HLA Positive|Screening (Day -35 to Day -8)||146||
48059998|NCT04526509|100470122|FG001|Participants Tested for HLA-type and Were HLA Positive|Screening (Day -35 to Day -8)||0||
48059999|NCT04526509|100470123|FG002|Participants Tested for HLA-type and Were HLA Positive|Screening (Day -35 to Day -8)||0||
48060000|NCT04526509|100470124|FG003|Participants Tested for HLA-type and Were HLA Positive|Screening (Day -35 to Day -8)||0||
48060001|NCT04526509|100470125|FG004|Participants Tested for HLA-type and Were HLA Positive|Screening (Day -35 to Day -8)||0||
48213983|NCT01049503|100849642|FG004|NOT COMPLETED|Overall Study||27||
48213984|NCT01049503|100849643|FG005|NOT COMPLETED|Overall Study||8||
48213985|NCT00529789|100849644|FG000|STARTED|Study Period II/III||72||
48213986|NCT00529789|100849644|FG000|COMPLETED|Study Period II/III||48||
48213987|NCT00529789|100849644|FG000|NOT COMPLETED|Study Period II/III||24||
48213988|NCT00529789|100849644|FG000|STARTED|Study Period IV||48||
48213989|NCT00529789|100849644|FG000|COMPLETED|Study Period IV||42||
48213990|NCT00529789|100849644|FG000|NOT COMPLETED|Study Period IV||6||
48213991|NCT02477605|100849645|FG000|STARTED|Overall Study||68||
48213992|NCT02477605|100849646|FG001|STARTED|Overall Study||68||
48213993|NCT02477605|100849645|FG000|Randomized and Treated|Overall Study||67||
48213994|NCT02477605|100849646|FG001|Randomized and Treated|Overall Study||68||
48213995|NCT02477605|100849645|FG000|COMPLETED|Overall Study||67||
48213996|NCT02477605|100849646|FG001|COMPLETED|Overall Study||64||
48213997|NCT02477605|100849645|FG000|NOT COMPLETED|Overall Study||1||
48213998|NCT02477605|100849646|FG001|NOT COMPLETED|Overall Study||4||
48213999|NCT02134951|100849647|FG000|STARTED|Overall Study||39||
48214000|NCT02134951|100849648|FG001|STARTED|Overall Study||20||
48214001|NCT02134951|100849647|FG000|COMPLETED|Overall Study||39||
48214002|NCT02134951|100849648|FG001|COMPLETED|Overall Study||20||
48214003|NCT02134951|100849647|FG000|NOT COMPLETED|Overall Study||0||
48214004|NCT02134951|100849648|FG001|NOT COMPLETED|Overall Study||0||
48214005|NCT01402531|100849649|FG000|STARTED|Overall Study||0||
48214006|NCT01402531|100849649|FG000|COMPLETED|Overall Study||0||
48214007|NCT01402531|100849649|FG000|NOT COMPLETED|Overall Study||0||
48214008|NCT00431834|100849650|FG000|STARTED|Overall Study||75||
48214009|NCT00431834|100849650|FG000|COMPLETED|Overall Study||62||
48214010|NCT00431834|100849650|FG000|NOT COMPLETED|Overall Study||13||
48214011|NCT01164098|100849651|FG000|STARTED|Overall Study||15||
48214012|NCT01164098|100849652|FG001|STARTED|Overall Study||15||
48214013|NCT01164098|100849651|FG000|COMPLETED|Overall Study||15||
48214014|NCT01164098|100849652|FG001|COMPLETED|Overall Study||15||
48214015|NCT01164098|100849651|FG000|NOT COMPLETED|Overall Study||0||
48496092|NCT00834873|101548002|FG000|STARTED|Washout: 7 Days||12||
48496093|NCT00834873|101548003|FG001|STARTED|Washout: 7 Days||11||
48496094|NCT00834873|101548002|FG000|COMPLETED|Washout: 7 Days||12||
48496095|NCT00834873|101548003|FG001|COMPLETED|Washout: 7 Days||11||
48496096|NCT00834873|101548002|FG000|NOT COMPLETED|Washout: 7 Days||0||
48496097|NCT00834873|101548003|FG001|NOT COMPLETED|Washout: 7 Days||0||
48496098|NCT00834873|101548002|FG000|STARTED|Second Intervention||12||
48666743|NCT03391882|101970466|FG001|Modified Intent-to-Treat Population Part A|Part A - Titration Phase||18||
48214016|NCT01164098|100849652|FG001|NOT COMPLETED|Overall Study||0||
48214017|NCT00106080|100849653|FG000|STARTED|Overall Study||194||
48214018|NCT00106080|100849654|FG001|STARTED|Overall Study||182||
48214019|NCT00106080|100849653|FG000|COMPLETED|Overall Study||151||
48214020|NCT00106080|100849654|FG001|COMPLETED|Overall Study||155||
48214021|NCT00106080|100849653|FG000|NOT COMPLETED|Overall Study||43||
48214022|NCT00106080|100849654|FG001|NOT COMPLETED|Overall Study||27||
48214023|NCT00132964|100849655|FG000|STARTED|Overall Study||54||
48214024|NCT00132964|100849656|FG001|STARTED|Overall Study||57||
48214025|NCT00132964|100849655|FG000|COMPLETED|Overall Study||50||
48214026|NCT00132964|100849656|FG001|COMPLETED|Overall Study||54||
48214027|NCT00132964|100849655|FG000|NOT COMPLETED|Overall Study||4||
48214028|NCT00132964|100849656|FG001|NOT COMPLETED|Overall Study||3||
48214029|NCT01985334|100849657|FG000|STARTED|Overall Study||130||
48214030|NCT01985334|100849658|FG001|STARTED|Overall Study||387||
48214031|NCT01985334|100849659|FG002|STARTED|Overall Study||420||
48496099|NCT00834873|101548003|FG001|STARTED|Second Intervention||11||
48496100|NCT00834873|101548002|FG000|COMPLETED|Second Intervention||12||
48496101|NCT00834873|101548003|FG001|COMPLETED|Second Intervention||11||
48496102|NCT00834873|101548002|FG000|NOT COMPLETED|Second Intervention||0||
48496103|NCT00834873|101548003|FG001|NOT COMPLETED|Second Intervention||0||
48496104|NCT03359863|101548004|FG000|STARTED|Overall Study||10||
48496105|NCT03359863|101548004|FG000|COMPLETED|Overall Study||5||
48496106|NCT03359863|101548004|FG000|NOT COMPLETED|Overall Study||5||
48496107|NCT00835705|101548005|FG000|STARTED|First Intervention||24||
48496108|NCT00835705|101548006|FG001|STARTED|First Intervention||28||
48496109|NCT00835705|101548005|FG000|COMPLETED|First Intervention||23||
48496110|NCT00835705|101548006|FG001|COMPLETED|First Intervention||28||
48496111|NCT00835705|101548005|FG000|NOT COMPLETED|First Intervention||1||
48496112|NCT00835705|101548006|FG001|NOT COMPLETED|First Intervention||0||
48496113|NCT00835705|101548005|FG000|STARTED|Second Intervention||23||
48496114|NCT00835705|101548006|FG001|STARTED|Second Intervention||28||
48496115|NCT00835705|101548005|FG000|COMPLETED|Second Intervention||22||
48496116|NCT00835705|101548006|FG001|COMPLETED|Second Intervention||28||
48496117|NCT00835705|101548005|FG000|NOT COMPLETED|Second Intervention||1||
48496118|NCT00835705|101548006|FG001|NOT COMPLETED|Second Intervention||0||
48496119|NCT00852696|101548007|FG000|STARTED|Overall Study||0||
48496120|NCT00852696|101548008|FG001|STARTED|Overall Study||0||
48496121|NCT00852696|101548007|FG000|COMPLETED|Overall Study||0||
48214032|NCT01985334|100849660|FG003|STARTED|Overall Study||1262||
48496122|NCT00852696|101548008|FG001|COMPLETED|Overall Study||0||
48496123|NCT00852696|101548007|FG000|NOT COMPLETED|Overall Study||0||
48496124|NCT00852696|101548008|FG001|NOT COMPLETED|Overall Study||0||
48214033|NCT01985334|100849661|FG004|STARTED|Overall Study||274||
48214034|NCT01985334|100849662|FG005|STARTED|Overall Study||822||
48214035|NCT01985334|100849663|FG006|STARTED|Overall Study||274||
48214036|NCT01985334|100849664|FG007|STARTED|Overall Study||820||
48214037|NCT01985334|100849657|FG000|The Intention-to-treat (ITT) Population|Overall Study||122||
48214038|NCT01985334|100849658|FG001|The Intention-to-treat (ITT) Population|Overall Study||369||
48214039|NCT01985334|100849659|FG002|The Intention-to-treat (ITT) Population|Overall Study||420||
48214040|NCT01985334|100849660|FG003|The Intention-to-treat (ITT) Population|Overall Study||1254||
48214041|NCT01985334|100849661|FG004|The Intention-to-treat (ITT) Population|Overall Study||269||
48214042|NCT01985334|100849662|FG005|The Intention-to-treat (ITT) Population|Overall Study||811||
48214043|NCT01985334|100849663|FG006|The Intention-to-treat (ITT) Population|Overall Study||268||
48214044|NCT01985334|100849664|FG007|The Intention-to-treat (ITT) Population|Overall Study||811||
48214045|NCT01985334|100849657|FG000|COMPLETED|Overall Study||107||
48214046|NCT01985334|100849658|FG001|COMPLETED|Overall Study||303||
48214047|NCT01985334|100849659|FG002|COMPLETED|Overall Study||367||
48214048|NCT01985334|100849660|FG003|COMPLETED|Overall Study||1033||
48214049|NCT01985334|100849661|FG004|COMPLETED|Overall Study||234||
48214050|NCT01985334|100849662|FG005|COMPLETED|Overall Study||666||
48214051|NCT01985334|100849663|FG006|COMPLETED|Overall Study||237||
48214052|NCT01985334|100849664|FG007|COMPLETED|Overall Study||699||
48214053|NCT01985334|100849657|FG000|NOT COMPLETED|Overall Study||23||
48214054|NCT01985334|100849658|FG001|NOT COMPLETED|Overall Study||84||
48214055|NCT01985334|100849659|FG002|NOT COMPLETED|Overall Study||53||
48214056|NCT01985334|100849660|FG003|NOT COMPLETED|Overall Study||229||
48214057|NCT01985334|100849661|FG004|NOT COMPLETED|Overall Study||40||
48214058|NCT01985334|100849662|FG005|NOT COMPLETED|Overall Study||156||
48214059|NCT01985334|100849663|FG006|NOT COMPLETED|Overall Study||37||
48214060|NCT01985334|100849664|FG007|NOT COMPLETED|Overall Study||121||
48214061|NCT02594735|100849665|FG000|STARTED|Overall Study||10||
48214062|NCT02594735|100849665|FG000|COMPLETED|Overall Study||9||
48214063|NCT02594735|100849665|FG000|NOT COMPLETED|Overall Study||1||
48214064|NCT00972439|100849666|FG000|STARTED|Overall Study||17||
48214065|NCT00972439|100849667|FG001|STARTED|Overall Study||16||
48214066|NCT00972439|100849666|FG000|COMPLETED|Overall Study||17||
48214067|NCT00972439|100849667|FG001|COMPLETED|Overall Study||16||
48496125|NCT00669162|101548009|FG000|STARTED|Overall Study||27||
48496126|NCT00669162|101548009|FG000|COMPLETED|Overall Study||26||
48496127|NCT00669162|101548009|FG000|NOT COMPLETED|Overall Study||1||
48496128|NCT03856320|101548010|FG000|STARTED|Overall Study||20||
48496129|NCT03856320|101548011|FG001|STARTED|Overall Study||22||
48496130|NCT03856320|101548010|FG000|COMPLETED|Overall Study||20||
48496131|NCT03856320|101548011|FG001|COMPLETED|Overall Study||20||
48496132|NCT03856320|101548010|FG000|NOT COMPLETED|Overall Study||0||
48496133|NCT03856320|101548011|FG001|NOT COMPLETED|Overall Study||2||
48496134|NCT00712959|101548012|FG000|STARTED|Overall Study||361||
48496135|NCT00712959|101548013|FG001|STARTED|Overall Study||407||
48496136|NCT00712959|101548012|FG000|COMPLETED|Overall Study||342||
48496137|NCT00712959|101548013|FG001|COMPLETED|Overall Study||404||
48496138|NCT00712959|101548012|FG000|NOT COMPLETED|Overall Study||19||
48496139|NCT00712959|101548013|FG001|NOT COMPLETED|Overall Study||3||
48496140|NCT00847535|101548014|FG000|STARTED|Overall Study||24||
48496141|NCT00847535|101548015|FG001|STARTED|Overall Study||24||
48496142|NCT00847535|101548016|FG002|STARTED|Overall Study||16||
48496143|NCT00847535|101548014|FG000|10 Million AMDC|Overall Study||8||
48496144|NCT00847535|101548015|FG001|10 Million AMDC|Overall Study||8||
48496145|NCT00847535|101548016|FG002|10 Million AMDC|Overall Study||0||
48496146|NCT00847535|101548014|FG000|50 Million AMDC|Overall Study||8||
48496147|NCT00847535|101548015|FG001|50 Million AMDC|Overall Study||8||
48496148|NCT00847535|101548016|FG002|50 Million AMDC|Overall Study||0||
48496149|NCT00847535|101548014|FG000|100 Million AMDC|Overall Study||8||
48496150|NCT00847535|101548015|FG001|100 Million AMDC|Overall Study||8||
48496151|NCT00847535|101548016|FG002|100 Million AMDC|Overall Study||8||
48496152|NCT00847535|101548014|FG000|200 Million AMDC|Overall Study||0||
48496153|NCT00847535|101548015|FG001|200 Million AMDC|Overall Study||0||
48496154|NCT00847535|101548016|FG002|200 Million AMDC|Overall Study||8||
48496155|NCT00847535|101548014|FG000|COMPLETED|Overall Study||22||
48496156|NCT00847535|101548015|FG001|COMPLETED|Overall Study||22||
48214068|NCT00972439|100849666|FG000|NOT COMPLETED|Overall Study||0||
48214069|NCT00972439|100849667|FG001|NOT COMPLETED|Overall Study||0||
48214070|NCT00999167|100849668|FG000|STARTED|Part A: Open Label Safety run-in||15||
48496157|NCT00847535|101548016|FG002|COMPLETED|Overall Study||15||
48496158|NCT00847535|101548014|FG000|NOT COMPLETED|Overall Study||2||
48496159|NCT00847535|101548015|FG001|NOT COMPLETED|Overall Study||2||
48496160|NCT00847535|101548016|FG002|NOT COMPLETED|Overall Study||1||
48214071|NCT00999167|100849669|FG001|STARTED|Part A: Open Label Safety run-in||0||
48214072|NCT00999167|100849670|FG002|STARTED|Part A: Open Label Safety run-in||0||
48214073|NCT00999167|100849668|FG000|Received 9 mL BID|Part A: Open Label Safety run-in||15||
48214074|NCT00999167|100849669|FG001|Received 9 mL BID|Part A: Open Label Safety run-in||0||
48496161|NCT01994980|101548017|FG000|STARTED|Overall Study||7||
48496162|NCT01994980|101548018|FG001|STARTED|Overall Study||14||
48496163|NCT01994980|101548017|FG000|COMPLETED|Overall Study||7||
48496164|NCT01994980|101548018|FG001|COMPLETED|Overall Study||14||
48214075|NCT00999167|100849670|FG002|Received 9 mL BID|Part A: Open Label Safety run-in||0||
48214076|NCT00999167|100849668|FG000|COMPLETED|Part A: Open Label Safety run-in||8||
48214077|NCT00999167|100849669|FG001|COMPLETED|Part A: Open Label Safety run-in||0||
48214078|NCT00999167|100849670|FG002|COMPLETED|Part A: Open Label Safety run-in||0||
48214079|NCT00999167|100849668|FG000|NOT COMPLETED|Part A: Open Label Safety run-in||7||
48214080|NCT00999167|100849669|FG001|NOT COMPLETED|Part A: Open Label Safety run-in||0||
48214081|NCT00999167|100849670|FG002|NOT COMPLETED|Part A: Open Label Safety run-in||0||
48214082|NCT00999167|100849668|FG000|STARTED|Part B: Randomized, Placebo Controlled||0||
48214083|NCT00999167|100849669|FG001|STARTED|Part B: Randomized, Placebo Controlled||90||
48214084|NCT00999167|100849670|FG002|STARTED|Part B: Randomized, Placebo Controlled||88||
48214085|NCT00999167|100849668|FG000|COMPLETED|Part B: Randomized, Placebo Controlled||0||
48214086|NCT00999167|100849669|FG001|COMPLETED|Part B: Randomized, Placebo Controlled||55||
48214087|NCT00999167|100849670|FG002|COMPLETED|Part B: Randomized, Placebo Controlled||67||
48214088|NCT00999167|100849668|FG000|NOT COMPLETED|Part B: Randomized, Placebo Controlled||0||
48214089|NCT00999167|100849669|FG001|NOT COMPLETED|Part B: Randomized, Placebo Controlled||35||
48214090|NCT00999167|100849670|FG002|NOT COMPLETED|Part B: Randomized, Placebo Controlled||21||
48214091|NCT00914589|100849671|FG000|STARTED|Overall Study||128||
48214092|NCT00914589|100849672|FG001|STARTED|Overall Study||143||
48214093|NCT00914589|100849673|FG002|STARTED|Overall Study||138||
48214094|NCT00914589|100849671|FG000|COMPLETED|Overall Study||103||
48214095|NCT00914589|100849672|FG001|COMPLETED|Overall Study||127||
48214096|NCT00914589|100849673|FG002|COMPLETED|Overall Study||126||
48060002|NCT04526509|100470126|FG005|Participants Tested for HLA-type and Were HLA Positive|Screening (Day -35 to Day -8)||0||
48060003|NCT04526509|100470127|FG006|Participants Tested for HLA-type and Were HLA Positive|Screening (Day -35 to Day -8)||0||
48060004|NCT04526509|100470121|FG000|Participants Tested HLA Positive and NY-ESO-1 Expression Positive|Screening (Day -35 to Day -8)||49||
48060005|NCT04526509|100470122|FG001|Participants Tested HLA Positive and NY-ESO-1 Expression Positive|Screening (Day -35 to Day -8)||0||
48060006|NCT04526509|100470123|FG002|Participants Tested HLA Positive and NY-ESO-1 Expression Positive|Screening (Day -35 to Day -8)||0||
48060007|NCT04526509|100470124|FG003|Participants Tested HLA Positive and NY-ESO-1 Expression Positive|Screening (Day -35 to Day -8)||0||
48060008|NCT04526509|100470125|FG004|Participants Tested HLA Positive and NY-ESO-1 Expression Positive|Screening (Day -35 to Day -8)||0||
48060009|NCT04526509|100470126|FG005|Participants Tested HLA Positive and NY-ESO-1 Expression Positive|Screening (Day -35 to Day -8)||0||
48060010|NCT04526509|100470127|FG006|Participants Tested HLA Positive and NY-ESO-1 Expression Positive|Screening (Day -35 to Day -8)||0||
48060011|NCT04526509|100470121|FG000|COMPLETED|Screening (Day -35 to Day -8)||12|Participants deemed eligible and enrolled|
48060012|NCT04526509|100470122|FG001|COMPLETED|Screening (Day -35 to Day -8)||0|Participants deemed eligible and enrolled|
48060013|NCT04526509|100470123|FG002|COMPLETED|Screening (Day -35 to Day -8)||0|Participants deemed eligible and enrolled|
48060014|NCT04526509|100470124|FG003|COMPLETED|Screening (Day -35 to Day -8)||0|Participants deemed eligible and enrolled|
48060015|NCT04526509|100470125|FG004|COMPLETED|Screening (Day -35 to Day -8)||0|Participants deemed eligible and enrolled|
48060016|NCT04526509|100470126|FG005|COMPLETED|Screening (Day -35 to Day -8)||0|Participants deemed eligible and enrolled|
48060017|NCT04526509|100470127|FG006|COMPLETED|Screening (Day -35 to Day -8)||0|Participants deemed eligible and enrolled|
48060018|NCT04526509|100470121|FG000|NOT COMPLETED|Screening (Day -35 to Day -8)||315||
48060019|NCT04526509|100470122|FG001|NOT COMPLETED|Screening (Day -35 to Day -8)||0||
48060020|NCT04526509|100470123|FG002|NOT COMPLETED|Screening (Day -35 to Day -8)||0||
48060021|NCT04526509|100470124|FG003|NOT COMPLETED|Screening (Day -35 to Day -8)||0||
48060022|NCT04526509|100470125|FG004|NOT COMPLETED|Screening (Day -35 to Day -8)||0||
48060023|NCT04526509|100470126|FG005|NOT COMPLETED|Screening (Day -35 to Day -8)||0||
48060024|NCT04526509|100470127|FG006|NOT COMPLETED|Screening (Day -35 to Day -8)||0||
48060025|NCT04526509|100470121|FG000|STARTED|Enrolled||0||
48060026|NCT04526509|100470122|FG001|STARTED|Enrolled||1||
48060027|NCT04526509|100470123|FG002|STARTED|Enrolled||4||
48060028|NCT04526509|100470124|FG003|STARTED|Enrolled||2||
48060029|NCT04526509|100470125|FG004|STARTED|Enrolled||2||
48060030|NCT04526509|100470126|FG005|STARTED|Enrolled||2||
48060031|NCT04526509|100470127|FG006|STARTED|Enrolled||1||
48060032|NCT04526509|100470121|FG000|COMPLETED|Enrolled||0|Participants who received T cell infusion and were followed up in this study until death or until transfer to the separate long term follow-up study are considered to have completed.|
48214097|NCT00914589|100849671|FG000|NOT COMPLETED|Overall Study||25||
48214098|NCT00914589|100849672|FG001|NOT COMPLETED|Overall Study||16||
48214099|NCT00914589|100849673|FG002|NOT COMPLETED|Overall Study||12||
48214100|NCT00858117|100849674|FG000|STARTED|Treatment on Study||30||
48214101|NCT00858117|100849674|FG000|Completed 18 Weeks of Treatment|Treatment on Study||28||
48214102|NCT00858117|100849674|FG000|COMPLETED|Treatment on Study||28||
48214103|NCT00858117|100849674|FG000|NOT COMPLETED|Treatment on Study||2||
48214104|NCT00858117|100849674|FG000|STARTED|Follow up for 5 Years||30||
48214105|NCT00858117|100849674|FG000|COMPLETED|Follow up for 5 Years||17||
48214106|NCT00858117|100849674|FG000|NOT COMPLETED|Follow up for 5 Years||13||
48214107|NCT00895531|100849675|FG000|STARTED|Overall Study||38||
48214108|NCT00895531|100849676|FG001|STARTED|Overall Study||37||
48214109|NCT00895531|100849675|FG000|COMPLETED|Overall Study||38||
48214110|NCT00895531|100849676|FG001|COMPLETED|Overall Study||37||
48214111|NCT00895531|100849675|FG000|NOT COMPLETED|Overall Study||0||
48214112|NCT00895531|100849676|FG001|NOT COMPLETED|Overall Study||0||
48060033|NCT04526509|100470122|FG001|COMPLETED|Enrolled||0|Participants who received T cell infusion and were followed up in this study until death or until transfer to the separate long term follow-up study are considered to have completed.|
48060034|NCT04526509|100470123|FG002|COMPLETED|Enrolled||4|Participants who received T cell infusion and were followed up in this study until death or until transfer to the separate long term follow-up study are considered to have completed.|
48060035|NCT04526509|100470124|FG003|COMPLETED|Enrolled||0|Participants who received T cell infusion and were followed up in this study until death or until transfer to the separate long term follow-up study are considered to have completed.|
48060036|NCT04526509|100470125|FG004|COMPLETED|Enrolled||2|Participants who received T cell infusion and were followed up in this study until death or until transfer to the separate long term follow-up study are considered to have completed.|
48060037|NCT04526509|100470126|FG005|COMPLETED|Enrolled||2|Participants who received T cell infusion and were followed up in this study until death or until transfer to the separate long term follow-up study are considered to have completed.|
48060038|NCT04526509|100470127|FG006|COMPLETED|Enrolled||0|Participants who received T cell infusion and were followed up in this study until death or until transfer to the separate long term follow-up study are considered to have completed.|
48060039|NCT04526509|100470121|FG000|NOT COMPLETED|Enrolled||0||
48060040|NCT04526509|100470122|FG001|NOT COMPLETED|Enrolled||1||
48060041|NCT04526509|100470123|FG002|NOT COMPLETED|Enrolled||0||
48060042|NCT04526509|100470124|FG003|NOT COMPLETED|Enrolled||2||
48060043|NCT04526509|100470125|FG004|NOT COMPLETED|Enrolled||0||
48060044|NCT04526509|100470126|FG005|NOT COMPLETED|Enrolled||0||
48060045|NCT04526509|100470127|FG006|NOT COMPLETED|Enrolled||1||
48060046|NCT03014492|100470128|FG000|STARTED|Overall Study||44||
48060047|NCT03014492|100470129|FG001|STARTED|Overall Study||28||
48060048|NCT03014492|100470128|FG000|COMPLETED|Overall Study||44||
48060049|NCT03014492|100470129|FG001|COMPLETED|Overall Study||28||
48060050|NCT03014492|100470128|FG000|NOT COMPLETED|Overall Study||0||
48060051|NCT03014492|100470129|FG001|NOT COMPLETED|Overall Study||0||
48060052|NCT02963935|100470130|FG000|STARTED|Overall Study||142||
48060053|NCT02963935|100470131|FG001|STARTED|Overall Study||140||
48060054|NCT02963935|100470130|FG000|COMPLETED|Overall Study||114|Completed without discontinuation of trial product|
48060055|NCT02963935|100470131|FG001|COMPLETED|Overall Study||103|Completed without discontinuation of trial product|
48060056|NCT02963935|100470130|FG000|NOT COMPLETED|Overall Study||28||
48060057|NCT02963935|100470131|FG001|NOT COMPLETED|Overall Study||37||
48060058|NCT01813110|100470132|FG000|STARTED|Overall Study||10||
48060059|NCT01813110|100470133|FG001|STARTED|Overall Study||11||
48060060|NCT01813110|100470132|FG000|COMPLETED|Overall Study||10||
48060061|NCT01813110|100470133|FG001|COMPLETED|Overall Study||10||
48060062|NCT01813110|100470132|FG000|NOT COMPLETED|Overall Study||0||
48060063|NCT01813110|100470133|FG001|NOT COMPLETED|Overall Study||1||
48060064|NCT03686514|100470134|FG000|STARTED|Overall Study||20||
48060065|NCT03686514|100470135|FG001|STARTED|Overall Study||19||
48060066|NCT03686514|100470134|FG000|Started 2018-2019 Vaccine Year|Overall Study||10||
48060067|NCT03686514|100470135|FG001|Started 2018-2019 Vaccine Year|Overall Study||10||
48060068|NCT03686514|100470134|FG000|Completed 2018-2019 Vaccine Follow up|Overall Study||10||
48060069|NCT03686514|100470135|FG001|Completed 2018-2019 Vaccine Follow up|Overall Study||10||
48060070|NCT03686514|100470134|FG000|Started 2019-2020 Vaccine Year|Overall Study||10||
48060071|NCT03686514|100470135|FG001|Started 2019-2020 Vaccine Year|Overall Study||10||
48060072|NCT03686514|100470134|FG000|Completed 2019-2020 Vaccine Follow up|Overall Study||10||
48060073|NCT03686514|100470135|FG001|Completed 2019-2020 Vaccine Follow up|Overall Study||10||
48060074|NCT03686514|100470134|FG000|COMPLETED|Overall Study||20||
48060075|NCT03686514|100470135|FG001|COMPLETED|Overall Study||19||
48060076|NCT03686514|100470134|FG000|NOT COMPLETED|Overall Study||0||
48060077|NCT03686514|100470135|FG001|NOT COMPLETED|Overall Study||0||
48060078|NCT02160782|100470136|FG000|STARTED|Open-label Period: Maralixibat||31||
48060079|NCT02160782|100470137|FG001|STARTED|Open-label Period: Maralixibat||0||
48060080|NCT02160782|100470138|FG002|STARTED|Open-label Period: Maralixibat||0||
48060081|NCT02160782|100470139|FG003|STARTED|Open-label Period: Maralixibat||0||
48060082|NCT02160782|100470140|FG004|STARTED|Open-label Period: Maralixibat||0||
48060083|NCT02160782|100470136|FG000|COMPLETED|Open-label Period: Maralixibat||29||
48060084|NCT02160782|100470137|FG001|COMPLETED|Open-label Period: Maralixibat||0||
48060085|NCT02160782|100470138|FG002|COMPLETED|Open-label Period: Maralixibat||0||
48060086|NCT02160782|100470139|FG003|COMPLETED|Open-label Period: Maralixibat||0||
48214113|NCT02515305|100849677|FG000|STARTED|Overall Study||385||
48060087|NCT02160782|100470140|FG004|COMPLETED|Open-label Period: Maralixibat||0||
48060088|NCT02160782|100470136|FG000|NOT COMPLETED|Open-label Period: Maralixibat||2||
48060089|NCT02160782|100470137|FG001|NOT COMPLETED|Open-label Period: Maralixibat||0||
48060090|NCT02160782|100470138|FG002|NOT COMPLETED|Open-label Period: Maralixibat||0||
48060091|NCT02160782|100470139|FG003|NOT COMPLETED|Open-label Period: Maralixibat||0||
48060092|NCT02160782|100470140|FG004|NOT COMPLETED|Open-label Period: Maralixibat||0||
48060093|NCT02160782|100470136|FG000|STARTED|Randomized Withdrawal Period- Pbo vs MRX||0||
48060094|NCT02160782|100470137|FG001|STARTED|Randomized Withdrawal Period- Pbo vs MRX||13||
48060095|NCT02160782|100470138|FG002|STARTED|Randomized Withdrawal Period- Pbo vs MRX||16||
48060096|NCT02160782|100470139|FG003|STARTED|Randomized Withdrawal Period- Pbo vs MRX||0||
48214114|NCT02515305|100849678|FG001|STARTED|Overall Study||378||
48496165|NCT01994980|101548017|FG000|NOT COMPLETED|Overall Study||0||
48060097|NCT02160782|100470140|FG004|STARTED|Randomized Withdrawal Period- Pbo vs MRX||0||
48060098|NCT02160782|100470136|FG000|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0||
48060099|NCT02160782|100470137|FG001|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||13||
48060100|NCT02160782|100470138|FG002|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||16||
48060101|NCT02160782|100470139|FG003|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0||
48060102|NCT02160782|100470140|FG004|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0||
48060103|NCT02160782|100470136|FG000|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0||
48060104|NCT02160782|100470137|FG001|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0||
48060105|NCT02160782|100470138|FG002|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0||
48060106|NCT02160782|100470139|FG003|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0||
48060107|NCT02160782|100470140|FG004|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0||
48214115|NCT02515305|100849679|FG002|STARTED|Overall Study||127||
48214116|NCT02515305|100849677|FG000|COMPLETED|Overall Study||356||
48214117|NCT02515305|100849678|FG001|COMPLETED|Overall Study||343||
48214118|NCT02515305|100849679|FG002|COMPLETED|Overall Study||113||
48214119|NCT02515305|100849677|FG000|NOT COMPLETED|Overall Study||29||
48214120|NCT02515305|100849678|FG001|NOT COMPLETED|Overall Study||35||
48214121|NCT02515305|100849679|FG002|NOT COMPLETED|Overall Study||14||
48214122|NCT01967836|100849680|FG000|STARTED|Overall Study||20||
48214123|NCT01967836|100849680|FG000|COMPLETED|Overall Study||11||
48214124|NCT01967836|100849680|FG000|NOT COMPLETED|Overall Study||9||
48214125|NCT01047241|100849681|FG000|STARTED|Overall Study||50||
48214126|NCT01047241|100849681|FG000|COMPLETED|Overall Study||50||
48214127|NCT01047241|100849681|FG000|NOT COMPLETED|Overall Study||0||
48214128|NCT00581854|100849682|FG000|STARTED|Overall Study||22||
48214129|NCT00581854|100849682|FG000|COMPLETED|Overall Study||22||
48214130|NCT00581854|100849682|FG000|NOT COMPLETED|Overall Study||0||
48214131|NCT01017146|100849683|FG000|STARTED|Overall Study||372||
48214132|NCT01017146|100849684|FG001|STARTED|Overall Study||372||
48214133|NCT01017146|100849683|FG000|COMPLETED|Overall Study||306||
48214134|NCT01017146|100849684|FG001|COMPLETED|Overall Study||333||
48214135|NCT01017146|100849683|FG000|NOT COMPLETED|Overall Study||66||
48214136|NCT01017146|100849684|FG001|NOT COMPLETED|Overall Study||39||
48214137|NCT01668940|100849685|FG000|STARTED|Overall Study||17||
48214138|NCT01668940|100849686|FG001|STARTED|Overall Study||14||
48214139|NCT01668940|100849687|FG002|STARTED|Overall Study||9||
48214140|NCT01668940|100849688|FG003|STARTED|Overall Study||14||
48214141|NCT01668940|100849685|FG000|COMPLETED|Overall Study||17||
48214142|NCT01668940|100849686|FG001|COMPLETED|Overall Study||14||
48214143|NCT01668940|100849687|FG002|COMPLETED|Overall Study||9||
48214144|NCT01668940|100849688|FG003|COMPLETED|Overall Study||14||
48214145|NCT01668940|100849685|FG000|NOT COMPLETED|Overall Study||0||
48214146|NCT01668940|100849686|FG001|NOT COMPLETED|Overall Study||0||
48214147|NCT01668940|100849687|FG002|NOT COMPLETED|Overall Study||0||
48214148|NCT01668940|100849688|FG003|NOT COMPLETED|Overall Study||0||
48214149|NCT02238483|100849689|FG000|STARTED|Overall Study||108||108
48214150|NCT02238483|100849690|FG001|STARTED|Overall Study||105||105
48214151|NCT02238483|100849689|FG000|COMPLETED|Overall Study||93||93
48214152|NCT02238483|100849690|FG001|COMPLETED|Overall Study||91||91
48214153|NCT02238483|100849689|FG000|NOT COMPLETED|Overall Study||15||15
48214154|NCT02238483|100849690|FG001|NOT COMPLETED|Overall Study||14||14
48214155|NCT01510717|100849691|FG000|STARTED|Overall Study||155||
48214156|NCT01510717|100849692|FG001|STARTED|Overall Study||165||
48214157|NCT01510717|100849691|FG000|COMPLETED|Overall Study||153||
48214158|NCT01510717|100849692|FG001|COMPLETED|Overall Study||160||
48214159|NCT01510717|100849691|FG000|NOT COMPLETED|Overall Study||2||
48214160|NCT01510717|100849692|FG001|NOT COMPLETED|Overall Study||5||
48214161|NCT02101281|100849693|FG000|STARTED|Overall Study||20||
48214162|NCT02101281|100849694|FG001|STARTED|Overall Study||20||
48214163|NCT02101281|100849693|FG000|COMPLETED|Overall Study||20||
48214164|NCT02101281|100849694|FG001|COMPLETED|Overall Study||19||
48214165|NCT02101281|100849693|FG000|NOT COMPLETED|Overall Study||0||
48214166|NCT02101281|100849694|FG001|NOT COMPLETED|Overall Study||1||
48214167|NCT00093015|100849695|FG000|STARTED|Overall Study||2026||
48060108|NCT02160782|100470136|FG000|STARTED|After Randomized Withdrawal: Maralixibat||0||
48060109|NCT02160782|100470137|FG001|STARTED|After Randomized Withdrawal: Maralixibat||0||
48060110|NCT02160782|100470138|FG002|STARTED|After Randomized Withdrawal: Maralixibat||0||
48060111|NCT02160782|100470139|FG003|STARTED|After Randomized Withdrawal: Maralixibat||29||
48060112|NCT02160782|100470140|FG004|STARTED|After Randomized Withdrawal: Maralixibat||0||
48060113|NCT02160782|100470136|FG000|COMPLETED|After Randomized Withdrawal: Maralixibat||0||
48214168|NCT00093015|100849696|FG001|STARTED|Overall Study||2012||
48214169|NCT00093015|100849695|FG000|Received Study Medication|Overall Study||2019||
48214170|NCT00093015|100849696|FG001|Received Study Medication|Overall Study||2004||
48214171|NCT00093015|100849695|FG000|COMPLETED|Overall Study||1361||
48214172|NCT00093015|100849696|FG001|COMPLETED|Overall Study||1348||
48214173|NCT00093015|100849695|FG000|NOT COMPLETED|Overall Study||665||
48214174|NCT00093015|100849696|FG001|NOT COMPLETED|Overall Study||664||
48214175|NCT02730871|100849697|FG000|STARTED|Overall Study||67|All randomized subjects|
48214176|NCT02730871|100849698|FG001|STARTED|Overall Study||67|All randomized subjects|
48496166|NCT01994980|101548018|FG001|NOT COMPLETED|Overall Study||0||
48214177|NCT02730871|100849697|FG000|Full Analysis Set (FAS)|Overall Study||67|Randomized subjects with a baseline assessment who completed at least 1 scheduled on-therapy visit|
48214178|NCT02730871|100849698|FG001|Full Analysis Set (FAS)|Overall Study||67|Randomized subjects with a baseline assessment who completed at least 1 scheduled on-therapy visit|
48214179|NCT02730871|100849697|FG000|Safety Analysis Set|Overall Study||67|All subjects who received a dose of masked investigational product|
48214180|NCT02730871|100849698|FG001|Safety Analysis Set|Overall Study||67|All subjects who received a dose of masked investigational product|
48214181|NCT02730871|100849697|FG000|COMPLETED|Overall Study||61|All subjects who completed the treatment phase whether on study treatment or not|
48214182|NCT02730871|100849698|FG001|COMPLETED|Overall Study||67|All subjects who completed the treatment phase whether on study treatment or not|
48214183|NCT02730871|100849697|FG000|NOT COMPLETED|Overall Study||6||
48214184|NCT02730871|100849698|FG001|NOT COMPLETED|Overall Study||0||
48214185|NCT00546754|100849699|FG000|STARTED|Overall Study||425||
48214186|NCT00546754|100849700|FG001|STARTED|Overall Study||383||
48214187|NCT00546754|100849699|FG000|Treated|Overall Study||416||
48214188|NCT00546754|100849700|FG001|Treated|Overall Study||373||
48214189|NCT00546754|100849699|FG000|Week 6|Overall Study||396||
48214190|NCT00546754|100849700|FG001|Week 6|Overall Study||347||
48214191|NCT00546754|100849699|FG000|Week 12|Overall Study||375||
48214192|NCT00546754|100849700|FG001|Week 12|Overall Study||334||
48214193|NCT00546754|100849699|FG000|COMPLETED|Overall Study||375||
48214194|NCT00546754|100849700|FG001|COMPLETED|Overall Study||334||
48214195|NCT00546754|100849699|FG000|NOT COMPLETED|Overall Study||50||
48214196|NCT00546754|100849700|FG001|NOT COMPLETED|Overall Study||49||
48214197|NCT04149002|100849701|FG000|STARTED|Overall Study||14||
48214198|NCT04149002|100849702|FG001|STARTED|Overall Study||16||
48214199|NCT04149002|100849701|FG000|COMPLETED|Overall Study||12||
48214200|NCT04149002|100849702|FG001|COMPLETED|Overall Study||16||
48214201|NCT04149002|100849701|FG000|NOT COMPLETED|Overall Study||2||
48214202|NCT04149002|100849702|FG001|NOT COMPLETED|Overall Study||0||
48214203|NCT01390818|100849703|FG000|STARTED|Overall Study||3||
48214204|NCT01390818|100849704|FG001|STARTED|Overall Study||3||
48214205|NCT01390818|100849705|FG002|STARTED|Overall Study||3||
48214206|NCT01390818|100849706|FG003|STARTED|Overall Study||4||
48214207|NCT01390818|100849707|FG004|STARTED|Overall Study||4||
48214208|NCT01390818|100849708|FG005|STARTED|Overall Study||3||
48214209|NCT01390818|100849709|FG006|STARTED|Overall Study||19||
48214210|NCT01390818|100849710|FG007|STARTED|Overall Study||14||
48214211|NCT01390818|100849711|FG008|STARTED|Overall Study||3||
48214212|NCT01390818|100849712|FG009|STARTED|Overall Study||3||
48214213|NCT01390818|100849713|FG010|STARTED|Overall Study||4||
48214214|NCT01390818|100849714|FG011|STARTED|Overall Study||26||
48214215|NCT01390818|100849715|FG012|STARTED|Overall Study||24||
48214216|NCT01390818|100849716|FG013|STARTED|Overall Study||18||
48214217|NCT01390818|100849717|FG014|STARTED|Overall Study||15||
48214218|NCT01390818|100849703|FG000|COMPLETED|Overall Study||3||
48214219|NCT01390818|100849704|FG001|COMPLETED|Overall Study||3||
48214220|NCT01390818|100849705|FG002|COMPLETED|Overall Study||3||
48214221|NCT01390818|100849706|FG003|COMPLETED|Overall Study||4||
48214222|NCT01390818|100849707|FG004|COMPLETED|Overall Study||4||
48214223|NCT01390818|100849708|FG005|COMPLETED|Overall Study||3||
48214224|NCT01390818|100849709|FG006|COMPLETED|Overall Study||19||
48214225|NCT01390818|100849710|FG007|COMPLETED|Overall Study||14||
48214226|NCT01390818|100849711|FG008|COMPLETED|Overall Study||3||
48214227|NCT01390818|100849712|FG009|COMPLETED|Overall Study||3||
48214228|NCT01390818|100849713|FG010|COMPLETED|Overall Study||4||
48214229|NCT01390818|100849714|FG011|COMPLETED|Overall Study||26||
48214230|NCT01390818|100849715|FG012|COMPLETED|Overall Study||24||
48214231|NCT01390818|100849716|FG013|COMPLETED|Overall Study||18||
48214232|NCT01390818|100849717|FG014|COMPLETED|Overall Study||15||
48214233|NCT01390818|100849703|FG000|NOT COMPLETED|Overall Study||0||
48214234|NCT01390818|100849704|FG001|NOT COMPLETED|Overall Study||0||
48214235|NCT01390818|100849705|FG002|NOT COMPLETED|Overall Study||0||
48214236|NCT01390818|100849706|FG003|NOT COMPLETED|Overall Study||0||
48214237|NCT01390818|100849707|FG004|NOT COMPLETED|Overall Study||0||
48214238|NCT01390818|100849708|FG005|NOT COMPLETED|Overall Study||0||
48214239|NCT01390818|100849709|FG006|NOT COMPLETED|Overall Study||0||
48214240|NCT01390818|100849710|FG007|NOT COMPLETED|Overall Study||0||
48214241|NCT01390818|100849711|FG008|NOT COMPLETED|Overall Study||0||
48214242|NCT01390818|100849712|FG009|NOT COMPLETED|Overall Study||0||
48214243|NCT01390818|100849713|FG010|NOT COMPLETED|Overall Study||0||
48214244|NCT01390818|100849714|FG011|NOT COMPLETED|Overall Study||0||
48214245|NCT01390818|100849715|FG012|NOT COMPLETED|Overall Study||0||
48214246|NCT01390818|100849716|FG013|NOT COMPLETED|Overall Study||0||
48214247|NCT01390818|100849717|FG014|NOT COMPLETED|Overall Study||0||
48214248|NCT01808339|100849718|FG000|STARTED|Treatment Period 1 (14 Days)||4||
48214249|NCT01808339|100849719|FG001|STARTED|Treatment Period 1 (14 Days)||4||
48214250|NCT01808339|100849720|FG002|STARTED|Treatment Period 1 (14 Days)||4||
48214251|NCT01808339|100849721|FG003|STARTED|Treatment Period 1 (14 Days)||4||
48214252|NCT01808339|100849722|FG004|STARTED|Treatment Period 1 (14 Days)||6||
48214253|NCT01808339|100849723|FG005|STARTED|Treatment Period 1 (14 Days)||6||
48214254|NCT01808339|100849718|FG000|COMPLETED|Treatment Period 1 (14 Days)||4||
48214255|NCT01808339|100849719|FG001|COMPLETED|Treatment Period 1 (14 Days)||3||
48214256|NCT01808339|100849720|FG002|COMPLETED|Treatment Period 1 (14 Days)||4||
48214257|NCT01808339|100849721|FG003|COMPLETED|Treatment Period 1 (14 Days)||2||
48214258|NCT01808339|100849722|FG004|COMPLETED|Treatment Period 1 (14 Days)||4||
48214259|NCT01808339|100849723|FG005|COMPLETED|Treatment Period 1 (14 Days)||5||
48214260|NCT01808339|100849718|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||0||
48214261|NCT01808339|100849719|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1||
48214262|NCT01808339|100849720|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||0||
48214263|NCT01808339|100849721|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||2||
48214264|NCT01808339|100849722|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||2||
48214265|NCT01808339|100849723|FG005|NOT COMPLETED|Treatment Period 1 (14 Days)||1||
48214266|NCT01808339|100849718|FG000|STARTED|Washout Period 1 (14-21 Days)||4||
48214267|NCT01808339|100849719|FG001|STARTED|Washout Period 1 (14-21 Days)||3||
48214268|NCT01808339|100849720|FG002|STARTED|Washout Period 1 (14-21 Days)||4||
48214269|NCT01808339|100849721|FG003|STARTED|Washout Period 1 (14-21 Days)||2||
48214270|NCT01808339|100849722|FG004|STARTED|Washout Period 1 (14-21 Days)||4||
48214271|NCT01808339|100849723|FG005|STARTED|Washout Period 1 (14-21 Days)||5||
48214272|NCT01808339|100849718|FG000|COMPLETED|Washout Period 1 (14-21 Days)||4||
48214273|NCT01808339|100849719|FG001|COMPLETED|Washout Period 1 (14-21 Days)||3||
48214274|NCT01808339|100849720|FG002|COMPLETED|Washout Period 1 (14-21 Days)||4||
48214275|NCT01808339|100849721|FG003|COMPLETED|Washout Period 1 (14-21 Days)||2||
48214276|NCT01808339|100849722|FG004|COMPLETED|Washout Period 1 (14-21 Days)||4||
48214277|NCT01808339|100849723|FG005|COMPLETED|Washout Period 1 (14-21 Days)||5||
48214278|NCT01808339|100849718|FG000|NOT COMPLETED|Washout Period 1 (14-21 Days)||0||
48214279|NCT01808339|100849719|FG001|NOT COMPLETED|Washout Period 1 (14-21 Days)||0||
48214280|NCT01808339|100849720|FG002|NOT COMPLETED|Washout Period 1 (14-21 Days)||0||
48214281|NCT01808339|100849721|FG003|NOT COMPLETED|Washout Period 1 (14-21 Days)||0||
48214282|NCT01808339|100849722|FG004|NOT COMPLETED|Washout Period 1 (14-21 Days)||0||
48214283|NCT01808339|100849723|FG005|NOT COMPLETED|Washout Period 1 (14-21 Days)||0||
48214284|NCT01808339|100849718|FG000|STARTED|Treatment Period 2 (14 Days)||4||
48214285|NCT01808339|100849719|FG001|STARTED|Treatment Period 2 (14 Days)||3||
48214286|NCT01808339|100849720|FG002|STARTED|Treatment Period 2 (14 Days)||4||
48214287|NCT01808339|100849721|FG003|STARTED|Treatment Period 2 (14 Days)||2||
48214288|NCT01808339|100849722|FG004|STARTED|Treatment Period 2 (14 Days)||4||
48214289|NCT01808339|100849723|FG005|STARTED|Treatment Period 2 (14 Days)||5||
48214290|NCT01808339|100849718|FG000|COMPLETED|Treatment Period 2 (14 Days)||4||
48214291|NCT01808339|100849719|FG001|COMPLETED|Treatment Period 2 (14 Days)||3||
48214292|NCT01808339|100849720|FG002|COMPLETED|Treatment Period 2 (14 Days)||4||
48214293|NCT01808339|100849721|FG003|COMPLETED|Treatment Period 2 (14 Days)||2||
48214294|NCT01808339|100849722|FG004|COMPLETED|Treatment Period 2 (14 Days)||4||
48214295|NCT01808339|100849723|FG005|COMPLETED|Treatment Period 2 (14 Days)||5||
48214296|NCT01808339|100849718|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
48214297|NCT01808339|100849719|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
48214298|NCT01808339|100849720|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
48214299|NCT01808339|100849721|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
48214300|NCT01808339|100849722|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
48214301|NCT01808339|100849723|FG005|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
48214302|NCT01808339|100849718|FG000|STARTED|Washout Period 2 (14-21 Days)||4||
48214303|NCT01808339|100849719|FG001|STARTED|Washout Period 2 (14-21 Days)||3||
48214304|NCT01808339|100849720|FG002|STARTED|Washout Period 2 (14-21 Days)||4||
48214305|NCT01808339|100849721|FG003|STARTED|Washout Period 2 (14-21 Days)||2||
48214306|NCT01808339|100849722|FG004|STARTED|Washout Period 2 (14-21 Days)||4||
48214307|NCT01808339|100849723|FG005|STARTED|Washout Period 2 (14-21 Days)||5||
48214308|NCT01808339|100849718|FG000|COMPLETED|Washout Period 2 (14-21 Days)||4||
48214309|NCT01808339|100849719|FG001|COMPLETED|Washout Period 2 (14-21 Days)||3||
48214310|NCT01808339|100849720|FG002|COMPLETED|Washout Period 2 (14-21 Days)||4||
48214311|NCT01808339|100849721|FG003|COMPLETED|Washout Period 2 (14-21 Days)||2||
48214312|NCT01808339|100849722|FG004|COMPLETED|Washout Period 2 (14-21 Days)||4||
48214313|NCT01808339|100849723|FG005|COMPLETED|Washout Period 2 (14-21 Days)||5||
48214314|NCT01808339|100849718|FG000|NOT COMPLETED|Washout Period 2 (14-21 Days)||0||
48214315|NCT01808339|100849719|FG001|NOT COMPLETED|Washout Period 2 (14-21 Days)||0||
48214316|NCT01808339|100849720|FG002|NOT COMPLETED|Washout Period 2 (14-21 Days)||0||
48214317|NCT01808339|100849721|FG003|NOT COMPLETED|Washout Period 2 (14-21 Days)||0||
48214318|NCT01808339|100849722|FG004|NOT COMPLETED|Washout Period 2 (14-21 Days)||0||
48214319|NCT01808339|100849723|FG005|NOT COMPLETED|Washout Period 2 (14-21 Days)||0||
48214320|NCT01808339|100849718|FG000|STARTED|Treatment Period 3 (14 Days)||4||
48214321|NCT01808339|100849719|FG001|STARTED|Treatment Period 3 (14 Days)||3||
48214322|NCT01808339|100849720|FG002|STARTED|Treatment Period 3 (14 Days)||4||
48214323|NCT01808339|100849721|FG003|STARTED|Treatment Period 3 (14 Days)||2||
48214324|NCT01808339|100849722|FG004|STARTED|Treatment Period 3 (14 Days)||4||
48214325|NCT01808339|100849723|FG005|STARTED|Treatment Period 3 (14 Days)||5||
48496167|NCT01991548|101548019|FG000|STARTED|Overall Study||40||
48214326|NCT01808339|100849718|FG000|COMPLETED|Treatment Period 3 (14 Days)||4||
48214327|NCT01808339|100849719|FG001|COMPLETED|Treatment Period 3 (14 Days)||3||
48496168|NCT01991548|101548019|FG000|COMPLETED|Overall Study||39||
48214328|NCT01808339|100849720|FG002|COMPLETED|Treatment Period 3 (14 Days)||3||
48214329|NCT01808339|100849721|FG003|COMPLETED|Treatment Period 3 (14 Days)||2||
48214330|NCT01808339|100849722|FG004|COMPLETED|Treatment Period 3 (14 Days)||4||
48214331|NCT01808339|100849723|FG005|COMPLETED|Treatment Period 3 (14 Days)||5||
48214332|NCT01808339|100849718|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0||
48214333|NCT01808339|100849719|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||0||
48214334|NCT01808339|100849720|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||1||
48214335|NCT01808339|100849721|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0||
48214336|NCT01808339|100849722|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||0||
48214337|NCT01808339|100849723|FG005|NOT COMPLETED|Treatment Period 3 (14 Days)||0||
48214338|NCT03538717|100849724|FG000|STARTED|Overall Study||157||
48214339|NCT03538717|100849724|FG000|COMPLETED|Overall Study||157||
48214340|NCT03538717|100849724|FG000|NOT COMPLETED|Overall Study||0||
48214341|NCT00741455|100849725|FG000|STARTED|Overall Study||18||
48214342|NCT00741455|100849725|FG000|COMPLETED|Overall Study||17||
48214343|NCT00741455|100849725|FG000|NOT COMPLETED|Overall Study||1||
48214344|NCT03582722|100849726|FG000|STARTED|Overall Study||49|Individuals who gave consent to participate and were randomized to a study arm.|
48214345|NCT03582722|100849727|FG001|STARTED|Overall Study||51|Individuals who gave consent to participate and were randomized to a study arm.|
48214346|NCT03582722|100849726|FG000|Completed the Enrollment Visit and Initiated Study Medication|Overall Study||49||
48214347|NCT03582722|100849727|FG001|Completed the Enrollment Visit and Initiated Study Medication|Overall Study||50||
48214348|NCT03582722|100849726|FG000|Completed the 3 Month Follow-up Visit|Overall Study||46|Participants who completed at least a 3-month follow-up visit are included in the outcome tables (n=91).|
48214349|NCT03582722|100849727|FG001|Completed the 3 Month Follow-up Visit|Overall Study||45|Participants who completed at least a 3-month follow-up visit are included in the outcome tables (n=91).|
48214350|NCT03582722|100849726|FG000|COMPLETED|Overall Study||45|Completed the 6 month follow-up visit. Two people who completed the 3-month visit but not the 6-month visit are included in the outcome tables.|
48214351|NCT03582722|100849727|FG001|COMPLETED|Overall Study||44|Completed the 6 month follow-up visit. Two people who completed the 3-month visit but not the 6-month visit are included in the outcome tables.|
48214352|NCT03582722|100849726|FG000|NOT COMPLETED|Overall Study||4||
48214353|NCT03582722|100849727|FG001|NOT COMPLETED|Overall Study||7||
48214354|NCT01303445|100849728|FG000|STARTED|First Intervention (7 Days)||30||
48214355|NCT01303445|100849729|FG001|STARTED|First Intervention (7 Days)||30||
48214356|NCT01303445|100849728|FG000|COMPLETED|First Intervention (7 Days)||29||
48214357|NCT01303445|100849729|FG001|COMPLETED|First Intervention (7 Days)||30||
48214358|NCT01303445|100849728|FG000|NOT COMPLETED|First Intervention (7 Days)||1||
48214359|NCT01303445|100849729|FG001|NOT COMPLETED|First Intervention (7 Days)||0||
48214360|NCT01303445|100849728|FG000|STARTED|Second Intervention (7 Days)||29||
48214361|NCT01303445|100849729|FG001|STARTED|Second Intervention (7 Days)||30||
48214362|NCT01303445|100849728|FG000|COMPLETED|Second Intervention (7 Days)||28||
48214363|NCT01303445|100849729|FG001|COMPLETED|Second Intervention (7 Days)||28||
48214364|NCT01303445|100849728|FG000|NOT COMPLETED|Second Intervention (7 Days)||1||
48214365|NCT01303445|100849729|FG001|NOT COMPLETED|Second Intervention (7 Days)||2||
48214366|NCT01303445|100849728|FG000|STARTED|Washout (14 Days)||28||
48214367|NCT01303445|100849729|FG001|STARTED|Washout (14 Days)||28||
48214368|NCT01303445|100849728|FG000|COMPLETED|Washout (14 Days)||27||
48214369|NCT01303445|100849729|FG001|COMPLETED|Washout (14 Days)||26||
48214370|NCT01303445|100849728|FG000|NOT COMPLETED|Washout (14 Days)||1||
48214371|NCT01303445|100849729|FG001|NOT COMPLETED|Washout (14 Days)||2||
48214372|NCT01303445|100849728|FG000|STARTED|Third Intervention (7 Days)||27||
48214373|NCT01303445|100849729|FG001|STARTED|Third Intervention (7 Days)||26||
48214374|NCT01303445|100849728|FG000|COMPLETED|Third Intervention (7 Days)||27||
48214375|NCT01303445|100849729|FG001|COMPLETED|Third Intervention (7 Days)||26||
48214376|NCT01303445|100849728|FG000|NOT COMPLETED|Third Intervention (7 Days)||0||
48214377|NCT01303445|100849729|FG001|NOT COMPLETED|Third Intervention (7 Days)||0||
48214378|NCT01303445|100849728|FG000|STARTED|Fourth Intervention (7 Days)||27||
48214379|NCT01303445|100849729|FG001|STARTED|Fourth Intervention (7 Days)||26||
48214380|NCT01303445|100849728|FG000|COMPLETED|Fourth Intervention (7 Days)||26||
48214381|NCT01303445|100849729|FG001|COMPLETED|Fourth Intervention (7 Days)||26||
48214382|NCT01303445|100849728|FG000|NOT COMPLETED|Fourth Intervention (7 Days)||1||
48214383|NCT01303445|100849729|FG001|NOT COMPLETED|Fourth Intervention (7 Days)||0||
48214384|NCT01303445|100849728|FG000|STARTED|Follow-up Period (14 Days)||26||
48214385|NCT01303445|100849729|FG001|STARTED|Follow-up Period (14 Days)||26||
48214386|NCT01303445|100849728|FG000|COMPLETED|Follow-up Period (14 Days)||26||
48214387|NCT01303445|100849729|FG001|COMPLETED|Follow-up Period (14 Days)||25||
48214388|NCT01303445|100849728|FG000|NOT COMPLETED|Follow-up Period (14 Days)||0||
48214389|NCT01303445|100849729|FG001|NOT COMPLETED|Follow-up Period (14 Days)||1||
48496169|NCT01991548|101548019|FG000|NOT COMPLETED|Overall Study||1||
48496170|NCT01968551|101548020|FG000|STARTED|Open Label Phase (48 Weeks)||22||
48496171|NCT01968551|101548021|FG001|STARTED|Open Label Phase (48 Weeks)||90||
48214390|NCT02570022|100849730|FG000|STARTED|Overall Study||26||
48496172|NCT01968551|101548022|FG002|STARTED|Open Label Phase (48 Weeks)||46||
48496173|NCT01968551|101548020|FG000|COMPLETED|Open Label Phase (48 Weeks)||20||
48496174|NCT01968551|101548021|FG001|COMPLETED|Open Label Phase (48 Weeks)||87||
48214391|NCT02570022|100849731|FG001|STARTED|Overall Study||31||
48214392|NCT02570022|100849730|FG000|COMPLETED|Overall Study||26||
48214393|NCT02570022|100849731|FG001|COMPLETED|Overall Study||31||
48214394|NCT02570022|100849730|FG000|NOT COMPLETED|Overall Study||0||
48214395|NCT02570022|100849731|FG001|NOT COMPLETED|Overall Study||0||
48214396|NCT02724592|100849732|FG000|STARTED|Overall Study||35||
48214397|NCT02724592|100849733|FG001|STARTED|Overall Study||35||
48214398|NCT02724592|100849732|FG000|COMPLETED|Overall Study||31||
48214399|NCT02724592|100849733|FG001|COMPLETED|Overall Study||34||
48214400|NCT02724592|100849732|FG000|NOT COMPLETED|Overall Study||4||
48214401|NCT02724592|100849733|FG001|NOT COMPLETED|Overall Study||1||
48214402|NCT03501264|100849734|FG000|STARTED|Overall Study||120||
48214403|NCT03501264|100849735|FG001|STARTED|Overall Study||120||
48496175|NCT01968551|101548022|FG002|COMPLETED|Open Label Phase (48 Weeks)||41||
48496176|NCT01968551|101548020|FG000|NOT COMPLETED|Open Label Phase (48 Weeks)||2||
48060114|NCT02160782|100470137|FG001|COMPLETED|After Randomized Withdrawal: Maralixibat||0||
48060115|NCT02160782|100470138|FG002|COMPLETED|After Randomized Withdrawal: Maralixibat||0||
48060116|NCT02160782|100470139|FG003|COMPLETED|After Randomized Withdrawal: Maralixibat||23||
48060117|NCT02160782|100470140|FG004|COMPLETED|After Randomized Withdrawal: Maralixibat||0||
48060118|NCT02160782|100470136|FG000|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0||
48060119|NCT02160782|100470137|FG001|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0||
48060120|NCT02160782|100470138|FG002|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0||
48060121|NCT02160782|100470139|FG003|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||6||
48060122|NCT02160782|100470140|FG004|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0||
48060123|NCT02160782|100470136|FG000|STARTED|Long-term Extension Period: Maralixibat||0||
48060124|NCT02160782|100470137|FG001|STARTED|Long-term Extension Period: Maralixibat||0||
48060125|NCT02160782|100470138|FG002|STARTED|Long-term Extension Period: Maralixibat||0||
48060126|NCT02160782|100470139|FG003|STARTED|Long-term Extension Period: Maralixibat||0||
48060127|NCT02160782|100470140|FG004|STARTED|Long-term Extension Period: Maralixibat||23||
48060128|NCT02160782|100470136|FG000|COMPLETED|Long-term Extension Period: Maralixibat||0||
48060129|NCT02160782|100470137|FG001|COMPLETED|Long-term Extension Period: Maralixibat||0||
48060130|NCT02160782|100470138|FG002|COMPLETED|Long-term Extension Period: Maralixibat||0||
48060131|NCT02160782|100470139|FG003|COMPLETED|Long-term Extension Period: Maralixibat||0||
48060132|NCT02160782|100470140|FG004|COMPLETED|Long-term Extension Period: Maralixibat||14||
48060133|NCT02160782|100470136|FG000|NOT COMPLETED|Long-term Extension Period: Maralixibat||0||
48060134|NCT02160782|100470137|FG001|NOT COMPLETED|Long-term Extension Period: Maralixibat||0||
48060135|NCT02160782|100470138|FG002|NOT COMPLETED|Long-term Extension Period: Maralixibat||0||
48060136|NCT02160782|100470139|FG003|NOT COMPLETED|Long-term Extension Period: Maralixibat||0||
48060137|NCT02160782|100470140|FG004|NOT COMPLETED|Long-term Extension Period: Maralixibat||9||
48060138|NCT04192370|100470141|FG000|STARTED|Overall Study||8||
48060139|NCT04192370|100470141|FG000|COMPLETED|Overall Study||5||
48060140|NCT04192370|100470141|FG000|NOT COMPLETED|Overall Study||3||
48060141|NCT01859143|100470142|FG000|STARTED|Overall Study||240||
48060142|NCT01859143|100470143|FG001|STARTED|Overall Study||60||
48060143|NCT01859143|100470142|FG000|COMPLETED|Overall Study||238||
48060144|NCT01859143|100470143|FG001|COMPLETED|Overall Study||60||
48060145|NCT01859143|100470142|FG000|NOT COMPLETED|Overall Study||2||
48060146|NCT01859143|100470143|FG001|NOT COMPLETED|Overall Study||0||
48060147|NCT03225599|100470144|FG000|STARTED|Overall Study||9||
48060148|NCT03225599|100470144|FG000|COMPLETED|Overall Study||7||
48060149|NCT03225599|100470144|FG000|NOT COMPLETED|Overall Study||2||
48060150|NCT03347188|100470145|FG000|STARTED|Double-blind (DB) Period (12 Weeks)||44||
48060151|NCT03347188|100470146|FG001|STARTED|Double-blind (DB) Period (12 Weeks)||43||
48060152|NCT03347188|100470145|FG000|Received at Least 1 Dose of Study Drug|Double-blind (DB) Period (12 Weeks)||43||
48214404|NCT03501264|100849734|FG000|COMPLETED|Overall Study||120||
48214405|NCT03501264|100849735|FG001|COMPLETED|Overall Study||120||
48214406|NCT03501264|100849734|FG000|NOT COMPLETED|Overall Study||0||
48214407|NCT03501264|100849735|FG001|NOT COMPLETED|Overall Study||0||
48214408|NCT04277936|100849736|FG000|STARTED|Overall Study||1||
48214409|NCT04277936|100849736|FG000|COMPLETED|Overall Study||1||
48214410|NCT04277936|100849736|FG000|NOT COMPLETED|Overall Study||0||
48214411|NCT01211405|100849737|FG000|STARTED|Overall Study||7||
48214412|NCT01211405|100849738|FG001|STARTED|Overall Study||7||
48496177|NCT01968551|101548021|FG001|NOT COMPLETED|Open Label Phase (48 Weeks)||3||
48060153|NCT03347188|100470146|FG001|Received at Least 1 Dose of Study Drug|Double-blind (DB) Period (12 Weeks)||43||
48060154|NCT03347188|100470145|FG000|Full Analysis Set (FAS)|Double-blind (DB) Period (12 Weeks)||42|Received at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment on primary endpoint.|
48060155|NCT03347188|100470146|FG001|Full Analysis Set (FAS)|Double-blind (DB) Period (12 Weeks)||43|Received at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment on primary endpoint.|
48060156|NCT03347188|100470145|FG000|COMPLETED|Double-blind (DB) Period (12 Weeks)||29||
48060157|NCT03347188|100470146|FG001|COMPLETED|Double-blind (DB) Period (12 Weeks)||26||
48060158|NCT03347188|100470145|FG000|NOT COMPLETED|Double-blind (DB) Period (12 Weeks)||15||
48060159|NCT03347188|100470146|FG001|NOT COMPLETED|Double-blind (DB) Period (12 Weeks)||17||
48060160|NCT03347188|100470145|FG000|STARTED|Open-label (OL) Period (12 Weeks)||35||
48214413|NCT01211405|100849739|FG002|STARTED|Overall Study||12||
48214414|NCT01211405|100849737|FG000|Completed Primary Endpoint|Overall Study||7||
48214415|NCT01211405|100849738|FG001|Completed Primary Endpoint|Overall Study||7||
48214416|NCT01211405|100849739|FG002|Completed Primary Endpoint|Overall Study||12||
48214417|NCT01211405|100849737|FG000|Completed Stage 1|Overall Study||6||
48214418|NCT01211405|100849738|FG001|Completed Stage 1|Overall Study||6||
48214419|NCT01211405|100849739|FG002|Completed Stage 1|Overall Study||12||
48214420|NCT01211405|100849737|FG000|Completed Stage 2|Overall Study||6||
48214421|NCT01211405|100849738|FG001|Completed Stage 2|Overall Study||6||
48214422|NCT01211405|100849739|FG002|Completed Stage 2|Overall Study||0||
48214423|NCT01211405|100849737|FG000|COMPLETED|Overall Study||6|Completed 12-month follow-up|
48214424|NCT01211405|100849738|FG001|COMPLETED|Overall Study||7|Completed 12-month follow-up|
48214425|NCT01211405|100849739|FG002|COMPLETED|Overall Study||11|Completed 12-month follow-up|
48214426|NCT01211405|100849737|FG000|NOT COMPLETED|Overall Study||1||
48214427|NCT01211405|100849738|FG001|NOT COMPLETED|Overall Study||0||
48214428|NCT01211405|100849739|FG002|NOT COMPLETED|Overall Study||1||
48214429|NCT02960204|100849740|FG000|STARTED|Overall Study||65||
48214430|NCT02960204|100849741|FG001|STARTED|Overall Study||65||
48214431|NCT02960204|100849742|FG002|STARTED|Overall Study||66||
48214432|NCT02960204|100849743|FG003|STARTED|Overall Study||67||
48214433|NCT02960204|100849740|FG000|Randomized|Overall Study||65||
48214434|NCT02960204|100849741|FG001|Randomized|Overall Study||65||
48214435|NCT02960204|100849742|FG002|Randomized|Overall Study||66||
48214436|NCT02960204|100849743|FG003|Randomized|Overall Study||67||
48214437|NCT02960204|100849740|FG000|Completed Week 24 of Study|Overall Study||62||
48214438|NCT02960204|100849741|FG001|Completed Week 24 of Study|Overall Study||62||
48214439|NCT02960204|100849742|FG002|Completed Week 24 of Study|Overall Study||60||
48214440|NCT02960204|100849743|FG003|Completed Week 24 of Study|Overall Study||66||
48214441|NCT02960204|100849740|FG000|Completed Week 48 of Study|Overall Study||55||
48214442|NCT02960204|100849741|FG001|Completed Week 48 of Study|Overall Study||55||
48214443|NCT02960204|100849742|FG002|Completed Week 48 of Study|Overall Study||50||
48214444|NCT02960204|100849743|FG003|Completed Week 48 of Study|Overall Study||59||
48214445|NCT02960204|100849740|FG000|COMPLETED|Overall Study||36|Follow-Up|
48214446|NCT02960204|100849741|FG001|COMPLETED|Overall Study||44|Follow-Up|
48214447|NCT02960204|100849742|FG002|COMPLETED|Overall Study||37|Follow-Up|
48214448|NCT02960204|100849743|FG003|COMPLETED|Overall Study||38|Follow-Up|
48214449|NCT02960204|100849740|FG000|NOT COMPLETED|Overall Study||29||
48214450|NCT02960204|100849741|FG001|NOT COMPLETED|Overall Study||21||
48214451|NCT02960204|100849742|FG002|NOT COMPLETED|Overall Study||29||
48214452|NCT02960204|100849743|FG003|NOT COMPLETED|Overall Study||29||
48214453|NCT02740231|100849744|FG000|STARTED|Overall Study||41||
48214454|NCT02740231|100849745|FG001|STARTED|Overall Study||41||
48214455|NCT02740231|100849746|FG002|STARTED|Overall Study||41||
48214456|NCT02740231|100849747|FG003|STARTED|Overall Study||41||
48214457|NCT02740231|100849744|FG000|COMPLETED|Overall Study||39||
48214458|NCT02740231|100849745|FG001|COMPLETED|Overall Study||35||
48214459|NCT02740231|100849746|FG002|COMPLETED|Overall Study||40||
48214460|NCT02740231|100849747|FG003|COMPLETED|Overall Study||33||
48214461|NCT02740231|100849744|FG000|NOT COMPLETED|Overall Study||2||
48214462|NCT02740231|100849745|FG001|NOT COMPLETED|Overall Study||6||
48214463|NCT02740231|100849746|FG002|NOT COMPLETED|Overall Study||1||
48214464|NCT02740231|100849747|FG003|NOT COMPLETED|Overall Study||8||
48214465|NCT02880137|100849748|FG000|STARTED|Overall Study||36||
48214466|NCT02880137|100849748|FG000|COMPLETED|Overall Study||36||
48214467|NCT02880137|100849748|FG000|NOT COMPLETED|Overall Study||0||
48496178|NCT01968551|101548022|FG002|NOT COMPLETED|Open Label Phase (48 Weeks)||5||
48496179|NCT01968551|101548020|FG000|STARTED|Extension Phase||20||
48214468|NCT04484935|100849749|FG000|STARTED|Overall Study||48||
48214469|NCT04484935|100849750|FG001|STARTED|Overall Study||52||
48214470|NCT04484935|100849749|FG000|COMPLETED|Overall Study||45||
48214471|NCT04484935|100849750|FG001|COMPLETED|Overall Study||49||
48214472|NCT04484935|100849749|FG000|NOT COMPLETED|Overall Study||3||
48214473|NCT04484935|100849750|FG001|NOT COMPLETED|Overall Study||3||
48214474|NCT00423098|100849751|FG000|STARTED|Overall Study||42||
48214475|NCT00423098|100849752|FG001|STARTED|Overall Study||39||
48214476|NCT00423098|100849751|FG000|COMPLETED|Overall Study||39||
48214477|NCT00423098|100849752|FG001|COMPLETED|Overall Study||35||
48214478|NCT00423098|100849751|FG000|NOT COMPLETED|Overall Study||3||
48214479|NCT00423098|100849752|FG001|NOT COMPLETED|Overall Study||4||
48214480|NCT04578496|100849753|FG000|STARTED|Overall Study||16||
48214481|NCT04578496|100849753|FG000|COMPLETED|Overall Study||12||
48214482|NCT04578496|100849753|FG000|NOT COMPLETED|Overall Study||4||
48214483|NCT02207972|100849754|FG000|STARTED|Overall Study||22||
48214484|NCT02207972|100849755|FG001|STARTED|Overall Study||24||
48214485|NCT02207972|100849754|FG000|COMPLETED|Overall Study||22||
48214486|NCT02207972|100849755|FG001|COMPLETED|Overall Study||24||
48214487|NCT02207972|100849754|FG000|NOT COMPLETED|Overall Study||0||
48214488|NCT02207972|100849755|FG001|NOT COMPLETED|Overall Study||0||
48214489|NCT00593866|100849756|FG000|STARTED|Overall Study||50||
48214490|NCT00593866|100849756|FG000|COMPLETED|Overall Study||50||
48214491|NCT00593866|100849756|FG000|NOT COMPLETED|Overall Study||0||
48214492|NCT02584829|100849757|FG000|STARTED|Overall Study||1||
48496180|NCT01968551|101548021|FG001|STARTED|Extension Phase||87||
48214493|NCT02584829|100849758|FG001|STARTED|Overall Study||7||
48214494|NCT02584829|100849757|FG000|COMPLETED|Overall Study||0||
48214495|NCT02584829|100849758|FG001|COMPLETED|Overall Study||3||
48214496|NCT02584829|100849757|FG000|NOT COMPLETED|Overall Study||1||
48214497|NCT02584829|100849758|FG001|NOT COMPLETED|Overall Study||4||
48214498|NCT00548418|100849759|FG000|STARTED|Overall Study||27||
48214499|NCT00548418|100849759|FG000|COMPLETED|Overall Study||27||
48214500|NCT00548418|100849759|FG000|NOT COMPLETED|Overall Study||0||
48214501|NCT02555215|100849760|FG000|STARTED|Overall Study||20||
48214502|NCT02555215|100849760|FG000|COMPLETED|Overall Study||17||
48214503|NCT02555215|100849760|FG000|NOT COMPLETED|Overall Study||3||
48214504|NCT01759264|100849761|FG000|STARTED|Overall Study||101||
48214505|NCT01759264|100849761|FG000|COMPLETED|Overall Study||91||
48214506|NCT01759264|100849761|FG000|NOT COMPLETED|Overall Study||10||
48214507|NCT03640949|100849762|FG000|STARTED|Overall Study||237||
48214508|NCT03640949|100849763|FG001|STARTED|Overall Study||264||
48214509|NCT03640949|100849762|FG000|COMPLETED|Overall Study||237||
48214510|NCT03640949|100849763|FG001|COMPLETED|Overall Study||264||
48214511|NCT03640949|100849762|FG000|NOT COMPLETED|Overall Study||0||
48214512|NCT03640949|100849763|FG001|NOT COMPLETED|Overall Study||0||
48214513|NCT04252586|100849764|FG000|STARTED|Overall Study||21||
48214514|NCT04252586|100849764|FG000|COMPLETED|Overall Study||0||
48214515|NCT04252586|100849764|FG000|NOT COMPLETED|Overall Study||21||
48214516|NCT01828554|100849765|FG000|STARTED|Overall Study||8||
48214517|NCT01828554|100849765|FG000|COMPLETED|Overall Study||8||
48214518|NCT01828554|100849765|FG000|NOT COMPLETED|Overall Study||0||
48214519|NCT03432858|100853289|FG000|STARTED|Overall Study||12||
48214520|NCT03432858|100853290|FG001|STARTED|Overall Study||83||
48214521|NCT03432858|100853291|FG002|STARTED|Overall Study||89||
48214522|NCT03432858|100853289|FG000|COMPLETED|Overall Study||10||
48214523|NCT03432858|100853290|FG001|COMPLETED|Overall Study||72||
48214524|NCT03432858|100853291|FG002|COMPLETED|Overall Study||72||
48214525|NCT03432858|100853289|FG000|NOT COMPLETED|Overall Study||2||
48214526|NCT03432858|100853290|FG001|NOT COMPLETED|Overall Study||11||
48214527|NCT03432858|100853291|FG002|NOT COMPLETED|Overall Study||17||
48214528|NCT03338816|100853292|FG000|STARTED|6-Month Double-blind Period||46||
48214529|NCT03338816|100853293|FG001|STARTED|6-Month Double-blind Period||48||
48214530|NCT03338816|100853294|FG002|STARTED|6-Month Double-blind Period||0||
48214531|NCT03338816|100853295|FG003|STARTED|6-Month Double-blind Period||0||
48214532|NCT03338816|100853292|FG000|COMPLETED|6-Month Double-blind Period||46||
48214533|NCT03338816|100853293|FG001|COMPLETED|6-Month Double-blind Period||48||
48214534|NCT03338816|100853294|FG002|COMPLETED|6-Month Double-blind Period||0||
48214535|NCT03338816|100853295|FG003|COMPLETED|6-Month Double-blind Period||0||
48214536|NCT03338816|100853292|FG000|NOT COMPLETED|6-Month Double-blind Period||0||
48214537|NCT03338816|100853293|FG001|NOT COMPLETED|6-Month Double-blind Period||0||
48214538|NCT03338816|100853294|FG002|NOT COMPLETED|6-Month Double-blind Period||0||
48214539|NCT03338816|100853295|FG003|NOT COMPLETED|6-Month Double-blind Period||0||
48214540|NCT03338816|100853292|FG000|STARTED|6-Month DB + Open-Label Extension Period||0||
48214541|NCT03338816|100853293|FG001|STARTED|6-Month DB + Open-Label Extension Period||0||
48214542|NCT03338816|100853294|FG002|STARTED|6-Month DB + Open-Label Extension Period||46||
48214543|NCT03338816|100853295|FG003|STARTED|6-Month DB + Open-Label Extension Period||47||
48214544|NCT03338816|100853292|FG000|COMPLETED|6-Month DB + Open-Label Extension Period||0||
48214545|NCT03338816|100853293|FG001|COMPLETED|6-Month DB + Open-Label Extension Period||0||
48214546|NCT03338816|100853294|FG002|COMPLETED|6-Month DB + Open-Label Extension Period||38||
48214547|NCT03338816|100853295|FG003|COMPLETED|6-Month DB + Open-Label Extension Period||41||
48214548|NCT03338816|100853292|FG000|NOT COMPLETED|6-Month DB + Open-Label Extension Period||0||
48214549|NCT03338816|100853293|FG001|NOT COMPLETED|6-Month DB + Open-Label Extension Period||0||
48214550|NCT03338816|100853294|FG002|NOT COMPLETED|6-Month DB + Open-Label Extension Period||8||
48214551|NCT03338816|100853295|FG003|NOT COMPLETED|6-Month DB + Open-Label Extension Period||6||
48214552|NCT03990649|100853296|FG000|STARTED|Part A: DB Treatment Period (15 Weeks)||9||
48214553|NCT03990649|100853297|FG001|STARTED|Part A: DB Treatment Period (15 Weeks)||15||
48214554|NCT03990649|100853298|FG002|STARTED|Part A: DB Treatment Period (15 Weeks)||0||
48214555|NCT03990649|100853296|FG000|COMPLETED|Part A: DB Treatment Period (15 Weeks)||6||
48214556|NCT03990649|100853297|FG001|COMPLETED|Part A: DB Treatment Period (15 Weeks)||12||
48214557|NCT03990649|100853298|FG002|COMPLETED|Part A: DB Treatment Period (15 Weeks)||0||
48214558|NCT03990649|100853296|FG000|NOT COMPLETED|Part A: DB Treatment Period (15 Weeks)||3||
48496181|NCT01968551|101548022|FG002|STARTED|Extension Phase||34||
48214559|NCT03990649|100853297|FG001|NOT COMPLETED|Part A: DB Treatment Period (15 Weeks)||3||
48214560|NCT03990649|100853298|FG002|NOT COMPLETED|Part A: DB Treatment Period (15 Weeks)||0||
48496182|NCT01968551|101548020|FG000|COMPLETED|Extension Phase||19||
48496183|NCT01968551|101548021|FG001|COMPLETED|Extension Phase||86||
48496184|NCT01968551|101548022|FG002|COMPLETED|Extension Phase||30||
48496185|NCT01968551|101548020|FG000|NOT COMPLETED|Extension Phase||1||
48214561|NCT03990649|100853296|FG000|STARTED|Part B: OL Extension Period (14 Weeks)||0||
48214562|NCT03990649|100853297|FG001|STARTED|Part B: OL Extension Period (14 Weeks)||0||
48214563|NCT03990649|100853298|FG002|STARTED|Part B: OL Extension Period (14 Weeks)||18||
48214564|NCT03990649|100853296|FG000|COMPLETED|Part B: OL Extension Period (14 Weeks)||0||
48496186|NCT01968551|101548021|FG001|NOT COMPLETED|Extension Phase||1||
48214565|NCT03990649|100853297|FG001|COMPLETED|Part B: OL Extension Period (14 Weeks)||0||
48214566|NCT03990649|100853298|FG002|COMPLETED|Part B: OL Extension Period (14 Weeks)||14||
48214567|NCT03990649|100853296|FG000|NOT COMPLETED|Part B: OL Extension Period (14 Weeks)||0||
48214568|NCT03990649|100853297|FG001|NOT COMPLETED|Part B: OL Extension Period (14 Weeks)||0||
48214569|NCT03990649|100853298|FG002|NOT COMPLETED|Part B: OL Extension Period (14 Weeks)||4||
48214570|NCT01266122|100853299|FG000|STARTED|Overall Study||48||
48214571|NCT01266122|100853300|FG001|STARTED|Overall Study||48||
48214572|NCT01266122|100853299|FG000|COMPLETED|Overall Study||42||
48214573|NCT01266122|100853300|FG001|COMPLETED|Overall Study||42||
48214574|NCT01266122|100853299|FG000|NOT COMPLETED|Overall Study||6||
48214575|NCT01266122|100853300|FG001|NOT COMPLETED|Overall Study||6||
48214576|NCT02267824|100853301|FG000|STARTED|Overall Study||83||
48214577|NCT02267824|100853302|FG001|STARTED|Overall Study||18||
48214578|NCT02267824|100853301|FG000|COMPLETED|Overall Study||73||
48214579|NCT02267824|100853302|FG001|COMPLETED|Overall Study||17||
48214580|NCT02267824|100853301|FG000|NOT COMPLETED|Overall Study||10||
48214581|NCT02267824|100853302|FG001|NOT COMPLETED|Overall Study||1||
48214582|NCT00277355|100853303|FG000|STARTED|Overall Study||87||
48214583|NCT00277355|100853304|FG001|STARTED|Overall Study||27||
48214584|NCT00277355|100853303|FG000|COMPLETED|Overall Study||73||
48214585|NCT00277355|100853304|FG001|COMPLETED|Overall Study||22||
48214586|NCT00277355|100853303|FG000|NOT COMPLETED|Overall Study||14||
48214587|NCT00277355|100853304|FG001|NOT COMPLETED|Overall Study||5||
48214588|NCT02622568|100853305|FG000|STARTED|Overall Study||14||
48214589|NCT02622568|100853306|FG001|STARTED|Overall Study||14||
48214590|NCT02622568|100853305|FG000|COMPLETED|Overall Study||9||
48214591|NCT02622568|100853306|FG001|COMPLETED|Overall Study||9||
48214592|NCT02622568|100853305|FG000|NOT COMPLETED|Overall Study||5||
48214593|NCT02622568|100853306|FG001|NOT COMPLETED|Overall Study||5||
48214594|NCT00856739|100853307|FG000|STARTED|Overall Study||70||
48214595|NCT00856739|100853308|FG001|STARTED|Overall Study||52||
48214596|NCT00856739|100853309|FG002|STARTED|Overall Study||55||
48214597|NCT00856739|100853307|FG000|COMPLETED|Overall Study||70||
48214598|NCT00856739|100853308|FG001|COMPLETED|Overall Study||52||
48214599|NCT00856739|100853309|FG002|COMPLETED|Overall Study||55||
48214600|NCT00856739|100853307|FG000|NOT COMPLETED|Overall Study||0||
48214601|NCT00856739|100853308|FG001|NOT COMPLETED|Overall Study||0||
48214602|NCT00856739|100853309|FG002|NOT COMPLETED|Overall Study||0||
48214603|NCT01872078|100853310|FG000|STARTED|Overall Study||16||
48214604|NCT01872078|100853311|FG001|STARTED|Overall Study||15||
48214605|NCT01872078|100853312|FG002|STARTED|Overall Study||17||
48214606|NCT01872078|100853313|FG003|STARTED|Overall Study||17||
48214607|NCT01872078|100853310|FG000|COMPLETED|Overall Study||16||
48214608|NCT01872078|100853311|FG001|COMPLETED|Overall Study||15||
48214609|NCT01872078|100853312|FG002|COMPLETED|Overall Study||14||
48214610|NCT01872078|100853313|FG003|COMPLETED|Overall Study||15||
48214611|NCT01872078|100853310|FG000|NOT COMPLETED|Overall Study||0||
48214612|NCT01872078|100853311|FG001|NOT COMPLETED|Overall Study||0||
48214613|NCT01872078|100853312|FG002|NOT COMPLETED|Overall Study||3||
48214614|NCT01872078|100853313|FG003|NOT COMPLETED|Overall Study||2||
48214615|NCT00205179|100853314|FG000|STARTED|Overall Study||32||
48214616|NCT00205179|100853315|FG001|STARTED|Overall Study||33||
48214617|NCT00205179|100853314|FG000|COMPLETED|Overall Study||30||
48214618|NCT00205179|100853315|FG001|COMPLETED|Overall Study||29||
48214619|NCT00205179|100853314|FG000|NOT COMPLETED|Overall Study||2||
48214620|NCT00205179|100853315|FG001|NOT COMPLETED|Overall Study||4||
48214621|NCT00632749|100853316|FG000|STARTED|Overall Study||4||
48214622|NCT00632749|100853317|FG001|STARTED|Overall Study||5||
48214623|NCT00632749|100853318|FG002|STARTED|Overall Study||3||
48214624|NCT00632749|100853319|FG003|STARTED|Overall Study||4||
48214625|NCT00632749|100853320|FG004|STARTED|Overall Study||7||
48214626|NCT00632749|100853321|FG005|STARTED|Overall Study||8||
48214627|NCT00632749|100853322|FG006|STARTED|Overall Study||5||
48214628|NCT00632749|100853323|FG007|STARTED|Overall Study||4||
48214629|NCT00632749|100853324|FG008|STARTED|Overall Study||5||
48214630|NCT00632749|100853325|FG009|STARTED|Overall Study||3||
48214631|NCT00632749|100853326|FG010|STARTED|Overall Study||7||
48214632|NCT00632749|100853327|FG011|STARTED|Overall Study||4||
48214633|NCT00632749|100853328|FG012|STARTED|Overall Study||3||
48214634|NCT00632749|100853329|FG013|STARTED|Overall Study||6||
48214635|NCT00632749|100853316|FG000|Treated|Overall Study||4||
48214636|NCT00632749|100853317|FG001|Treated|Overall Study||3||
48214637|NCT00632749|100853318|FG002|Treated|Overall Study||3||
48214638|NCT00632749|100853319|FG003|Treated|Overall Study||4||
48214639|NCT00632749|100853320|FG004|Treated|Overall Study||7||
48214640|NCT00632749|100853321|FG005|Treated|Overall Study||7||
48214641|NCT00632749|100853322|FG006|Treated|Overall Study||4||
48214642|NCT00632749|100853323|FG007|Treated|Overall Study||4||
48214643|NCT00632749|100853324|FG008|Treated|Overall Study||5||
48214644|NCT00632749|100853325|FG009|Treated|Overall Study||3||
48214645|NCT00632749|100853326|FG010|Treated|Overall Study||7||
48214646|NCT00632749|100853327|FG011|Treated|Overall Study||4||
48214647|NCT00632749|100853328|FG012|Treated|Overall Study||3||
48214648|NCT00632749|100853329|FG013|Treated|Overall Study||6||
48214649|NCT00632749|100853316|FG000|Not Treated|Overall Study||0||
48214650|NCT00632749|100853317|FG001|Not Treated|Overall Study||2||
48214651|NCT00632749|100853318|FG002|Not Treated|Overall Study||0||
48214652|NCT00632749|100853319|FG003|Not Treated|Overall Study||0||
48214653|NCT00632749|100853320|FG004|Not Treated|Overall Study||0||
48214654|NCT00632749|100853321|FG005|Not Treated|Overall Study||1||
48214655|NCT00632749|100853322|FG006|Not Treated|Overall Study||1||
48214656|NCT00632749|100853323|FG007|Not Treated|Overall Study||0||
48214657|NCT00632749|100853324|FG008|Not Treated|Overall Study||0||
48214658|NCT00632749|100853325|FG009|Not Treated|Overall Study||0||
48214659|NCT00632749|100853326|FG010|Not Treated|Overall Study||0||
48214660|NCT00632749|100853327|FG011|Not Treated|Overall Study||0||
48214661|NCT00632749|100853328|FG012|Not Treated|Overall Study||0||
48214662|NCT00632749|100853329|FG013|Not Treated|Overall Study||0||
48214663|NCT00632749|100853316|FG000|COMPLETED|Overall Study||0||
48214664|NCT00632749|100853317|FG001|COMPLETED|Overall Study||0||
48214665|NCT00632749|100853318|FG002|COMPLETED|Overall Study||0||
48214666|NCT00632749|100853319|FG003|COMPLETED|Overall Study||0||
48214667|NCT00632749|100853320|FG004|COMPLETED|Overall Study||0||
48214668|NCT00632749|100853321|FG005|COMPLETED|Overall Study||0||
48214669|NCT00632749|100853322|FG006|COMPLETED|Overall Study||0||
48214670|NCT00632749|100853323|FG007|COMPLETED|Overall Study||0||
48214671|NCT00632749|100853324|FG008|COMPLETED|Overall Study||0||
48214672|NCT00632749|100853325|FG009|COMPLETED|Overall Study||0||
48214673|NCT00632749|100853326|FG010|COMPLETED|Overall Study||0||
48214674|NCT00632749|100853327|FG011|COMPLETED|Overall Study||0||
48214675|NCT00632749|100853328|FG012|COMPLETED|Overall Study||0||
48214676|NCT00632749|100853329|FG013|COMPLETED|Overall Study||0||
48214677|NCT00632749|100853316|FG000|NOT COMPLETED|Overall Study||4||
48214678|NCT00632749|100853317|FG001|NOT COMPLETED|Overall Study||5||
48214679|NCT00632749|100853318|FG002|NOT COMPLETED|Overall Study||3||
48214680|NCT00632749|100853319|FG003|NOT COMPLETED|Overall Study||4||
48496187|NCT01968551|101548022|FG002|NOT COMPLETED|Extension Phase||4||
48496188|NCT03789110|101548023|FG000|STARTED|Overall Study||30||
48496189|NCT03789110|101548023|FG000|COMPLETED|Overall Study||0||
48496190|NCT03789110|101548023|FG000|NOT COMPLETED|Overall Study||30||
48496191|NCT01134549|101548024|FG000|STARTED|Overall Study||8||
48496192|NCT01134549|101548025|FG001|STARTED|Overall Study||6||
48496193|NCT01134549|101548026|FG002|STARTED|Overall Study||6||
48496194|NCT01134549|101548027|FG003|STARTED|Overall Study||6||
48496195|NCT01134549|101548028|FG004|STARTED|Overall Study||6||
48496196|NCT01134549|101548024|FG000|COMPLETED|Overall Study||8||
48496197|NCT01134549|101548025|FG001|COMPLETED|Overall Study||6||
48496198|NCT01134549|101548026|FG002|COMPLETED|Overall Study||6||
48496199|NCT01134549|101548027|FG003|COMPLETED|Overall Study||6||
48496200|NCT01134549|101548028|FG004|COMPLETED|Overall Study||6||
48496201|NCT01134549|101548024|FG000|NOT COMPLETED|Overall Study||0||
48496202|NCT01134549|101548025|FG001|NOT COMPLETED|Overall Study||0||
48496203|NCT01134549|101548026|FG002|NOT COMPLETED|Overall Study||0||
48496204|NCT01134549|101548027|FG003|NOT COMPLETED|Overall Study||0||
48496205|NCT01134549|101548028|FG004|NOT COMPLETED|Overall Study||0||
48496206|NCT01874535|101548029|FG000|STARTED|Overall Study||207||
48496207|NCT01874535|101548030|FG001|STARTED|Overall Study||201||
48496208|NCT01874535|101548029|FG000|COMPLETED|Overall Study||152||
48496209|NCT01874535|101548030|FG001|COMPLETED|Overall Study||157||
48496210|NCT01874535|101548029|FG000|NOT COMPLETED|Overall Study||55||
48496211|NCT01874535|101548030|FG001|NOT COMPLETED|Overall Study||44||
48496212|NCT02512900|101548031|FG000|STARTED|Overall Study||11||
48496213|NCT02512900|101548032|FG001|STARTED|Overall Study||10||
48496214|NCT02512900|101548031|FG000|COMPLETED|Overall Study||11||
48496215|NCT02512900|101548032|FG001|COMPLETED|Overall Study||10||
48496216|NCT02512900|101548031|FG000|NOT COMPLETED|Overall Study||0||
48496217|NCT02512900|101548032|FG001|NOT COMPLETED|Overall Study||0||
48496218|NCT01252953|101548033|FG000|STARTED|Overall Study||15225||
48496219|NCT01252953|101548034|FG001|STARTED|Overall Study||15224||
48496220|NCT01252953|101548033|FG000|COMPLETED|Overall Study||15187||
48496221|NCT01252953|101548034|FG001|COMPLETED|Overall Study||15186||
48496222|NCT01252953|101548033|FG000|NOT COMPLETED|Overall Study||38||
48496223|NCT01252953|101548034|FG001|NOT COMPLETED|Overall Study||38||
48496224|NCT01572662|101548035|FG000|STARTED|Overall Study||50||
48496225|NCT01572662|101548036|FG001|STARTED|Overall Study||151||
48496226|NCT01572662|101548035|FG000|COMPLETED|Overall Study||49||
48496227|NCT01572662|101548036|FG001|COMPLETED|Overall Study||150||
48496228|NCT01572662|101548035|FG000|NOT COMPLETED|Overall Study||1||
48496229|NCT01572662|101548036|FG001|NOT COMPLETED|Overall Study||1||
48496230|NCT03599193|101548037|FG000|STARTED|Overall Study||34||
48496231|NCT03599193|101548038|FG001|STARTED|Overall Study||24||
48496232|NCT03599193|101548037|FG000|COMPLETED|Overall Study||32||
48496233|NCT03599193|101548038|FG001|COMPLETED|Overall Study||21||
48496234|NCT03599193|101548037|FG000|NOT COMPLETED|Overall Study||2||
48496235|NCT03599193|101548038|FG001|NOT COMPLETED|Overall Study||3||
48496236|NCT02241551|101548039|FG000|STARTED|Overall Study||1||
48496237|NCT02241551|101548040|FG001|STARTED|Overall Study||0||
48214681|NCT00632749|100853320|FG004|NOT COMPLETED|Overall Study||7||
48214682|NCT00632749|100853321|FG005|NOT COMPLETED|Overall Study||8||
48214683|NCT00632749|100853322|FG006|NOT COMPLETED|Overall Study||5||
48496238|NCT02241551|101548039|FG000|COMPLETED|Overall Study||0||
48214684|NCT00632749|100853323|FG007|NOT COMPLETED|Overall Study||4||
48214685|NCT00632749|100853324|FG008|NOT COMPLETED|Overall Study||5||
48214686|NCT00632749|100853325|FG009|NOT COMPLETED|Overall Study||3||
48214687|NCT00632749|100853326|FG010|NOT COMPLETED|Overall Study||7||
48214688|NCT00632749|100853327|FG011|NOT COMPLETED|Overall Study||4||
48214689|NCT00632749|100853328|FG012|NOT COMPLETED|Overall Study||3||
48214690|NCT00632749|100853329|FG013|NOT COMPLETED|Overall Study||6||
48214691|NCT02318901|100853330|FG000|STARTED|Overall Study||5||
48214692|NCT02318901|100853331|FG001|STARTED|Overall Study||1||
48214693|NCT02318901|100853332|FG002|STARTED|Overall Study||10||
48214694|NCT02318901|100853330|FG000|COMPLETED|Overall Study||0||
48214695|NCT02318901|100853331|FG001|COMPLETED|Overall Study||0||
48214696|NCT02318901|100853332|FG002|COMPLETED|Overall Study||0||
48214697|NCT02318901|100853330|FG000|NOT COMPLETED|Overall Study||5||
48214698|NCT02318901|100853331|FG001|NOT COMPLETED|Overall Study||1||
48214699|NCT02318901|100853332|FG002|NOT COMPLETED|Overall Study||10||
48060161|NCT03347188|100470146|FG001|STARTED|Open-label (OL) Period (12 Weeks)||35||
48060162|NCT03347188|100470145|FG000|Entered in OL Period for Anti-drug Antibody (ADA) Only|Open-label (OL) Period (12 Weeks)||26||
48060163|NCT03347188|100470146|FG001|Entered in OL Period for Anti-drug Antibody (ADA) Only|Open-label (OL) Period (12 Weeks)||28||
48060164|NCT03347188|100470145|FG000|Received at Least 1 Dose of Study Drug|Open-label (OL) Period (12 Weeks)||9||
48060165|NCT03347188|100470146|FG001|Received at Least 1 Dose of Study Drug|Open-label (OL) Period (12 Weeks)||7||
48060166|NCT03347188|100470145|FG000|COMPLETED|Open-label (OL) Period (12 Weeks)||8||
48060167|NCT03347188|100470146|FG001|COMPLETED|Open-label (OL) Period (12 Weeks)||6||
48060168|NCT03347188|100470145|FG000|NOT COMPLETED|Open-label (OL) Period (12 Weeks)||27||
48060169|NCT03347188|100470146|FG001|NOT COMPLETED|Open-label (OL) Period (12 Weeks)||29||
48060170|NCT04209348|100470147|FG000|STARTED|Overall Study||10||
48060171|NCT04209348|100470148|FG001|STARTED|Overall Study||10||
48060172|NCT04209348|100470147|FG000|COMPLETED|Overall Study||9|Completed n shown here for the Physical Activity Questionnaire Data (For the Physical Activity monitor data, there one participant who delivered early and thus did not have device data at follow-up, and another participant with damaged device data at follow-up; both were in the Wellness Intervention)|
48060173|NCT04209348|100470148|FG001|COMPLETED|Overall Study||10|Completed n shown here for the Physical Activity Questionnaire Data (For the Physical Activity monitor data, there one participant who delivered early and thus did not have device data at follow-up, and another participant with damaged device data at follow-up; both were in the Wellness Intervention)|
48060174|NCT04209348|100470147|FG000|NOT COMPLETED|Overall Study||1||
48060175|NCT04209348|100470148|FG001|NOT COMPLETED|Overall Study||0||
48060176|NCT00240227|100470149|FG000|STARTED|Overall Study||8||
48060177|NCT00240227|100470149|FG000|COMPLETED|Overall Study||8||
48060178|NCT00240227|100470149|FG000|NOT COMPLETED|Overall Study||0||
48060179|NCT02787551|100470150|FG000|STARTED|Core Period: 26 Weeks||257||
48214700|NCT00445315|100853333|FG000|STARTED|Overall Study||6||
48214701|NCT00445315|100853334|FG001|STARTED|Overall Study||6||
48214702|NCT00445315|100853335|FG002|STARTED|Overall Study||6||
48214703|NCT00445315|100853336|FG003|STARTED|Overall Study||6||
48214704|NCT00445315|100853337|FG004|STARTED|Overall Study||8||
48214705|NCT00445315|100853333|FG000|COMPLETED|Overall Study||6||
48214706|NCT00445315|100853334|FG001|COMPLETED|Overall Study||6||
48214707|NCT00445315|100853335|FG002|COMPLETED|Overall Study||6||
48214708|NCT00445315|100853336|FG003|COMPLETED|Overall Study||6||
48214709|NCT00445315|100853337|FG004|COMPLETED|Overall Study||8||
48214710|NCT00445315|100853333|FG000|NOT COMPLETED|Overall Study||0||
48214711|NCT00445315|100853334|FG001|NOT COMPLETED|Overall Study||0||
48214712|NCT00445315|100853335|FG002|NOT COMPLETED|Overall Study||0||
48214713|NCT00445315|100853336|FG003|NOT COMPLETED|Overall Study||0||
48214714|NCT00445315|100853337|FG004|NOT COMPLETED|Overall Study||0||
48214715|NCT03928522|100853338|FG000|STARTED|Overall Study||12||
48214716|NCT03928522|100853339|FG001|STARTED|Overall Study||12||
48060180|NCT02787551|100470151|FG001|STARTED|Core Period: 26 Weeks||257||
48060181|NCT02787551|100470150|FG000|Treated|Core Period: 26 Weeks||255||
48060182|NCT02787551|100470151|FG001|Treated|Core Period: 26 Weeks||256||
48060183|NCT02787551|100470150|FG000|COMPLETED|Core Period: 26 Weeks||230||
48060184|NCT02787551|100470151|FG001|COMPLETED|Core Period: 26 Weeks||246||
48060185|NCT02787551|100470150|FG000|NOT COMPLETED|Core Period: 26 Weeks||27||
48060186|NCT02787551|100470151|FG001|NOT COMPLETED|Core Period: 26 Weeks||11||
48060187|NCT02787551|100470150|FG000|STARTED|Extension Period:26 Weeks(Upto 52 Weeks)||206||
48060188|NCT02787551|100470151|FG001|STARTED|Extension Period:26 Weeks(Upto 52 Weeks)||0||
48060189|NCT02787551|100470150|FG000|COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||197||
48060190|NCT02787551|100470151|FG001|COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||0||
48060191|NCT02787551|100470150|FG000|NOT COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||9||
48060192|NCT02787551|100470151|FG001|NOT COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||0||
48060193|NCT00761579|100470152|FG000|STARTED|Overall Study||190||
48060194|NCT00761579|100470152|FG000|COMPLETED|Overall Study||98||
48060195|NCT00761579|100470152|FG000|NOT COMPLETED|Overall Study||92||
48060196|NCT02322021|100470153|FG000|STARTED|Core Phase||17||
48060197|NCT02322021|100470154|FG001|STARTED|Core Phase||17||
48060198|NCT02322021|100470155|FG002|STARTED|Core Phase||19||
48060199|NCT02322021|100470156|FG003|STARTED|Core Phase||17||
48060200|NCT02322021|100470157|FG004|STARTED|Core Phase||0||
48060201|NCT02322021|100470153|FG000|COMPLETED|Core Phase||12||
48060202|NCT02322021|100470154|FG001|COMPLETED|Core Phase||9||
48060203|NCT02322021|100470155|FG002|COMPLETED|Core Phase||10||
48060204|NCT02322021|100470156|FG003|COMPLETED|Core Phase||12||
48060205|NCT02322021|100470157|FG004|COMPLETED|Core Phase||0||
48060206|NCT02322021|100470153|FG000|NOT COMPLETED|Core Phase||5||
48060207|NCT02322021|100470154|FG001|NOT COMPLETED|Core Phase||8||
48060208|NCT02322021|100470155|FG002|NOT COMPLETED|Core Phase||9||
48060209|NCT02322021|100470156|FG003|NOT COMPLETED|Core Phase||5||
48060210|NCT02322021|100470157|FG004|NOT COMPLETED|Core Phase||0||
48060211|NCT02322021|100470153|FG000|STARTED|Extension Phase||0||
48060212|NCT02322021|100470154|FG001|STARTED|Extension Phase||0||
48060213|NCT02322021|100470155|FG002|STARTED|Extension Phase||0||
48060214|NCT02322021|100470156|FG003|STARTED|Extension Phase||0||
48060215|NCT02322021|100470157|FG004|STARTED|Extension Phase||41||
48060216|NCT02322021|100470153|FG000|COMPLETED|Extension Phase||0||
48060217|NCT02322021|100470154|FG001|COMPLETED|Extension Phase||0||
48060218|NCT02322021|100470155|FG002|COMPLETED|Extension Phase||0||
48060219|NCT02322021|100470156|FG003|COMPLETED|Extension Phase||0||
48060220|NCT02322021|100470157|FG004|COMPLETED|Extension Phase||0||
48060221|NCT02322021|100470153|FG000|NOT COMPLETED|Extension Phase||0||
48060222|NCT02322021|100470154|FG001|NOT COMPLETED|Extension Phase||0||
48060223|NCT02322021|100470155|FG002|NOT COMPLETED|Extension Phase||0||
48060224|NCT02322021|100470156|FG003|NOT COMPLETED|Extension Phase||0||
48060225|NCT02322021|100470157|FG004|NOT COMPLETED|Extension Phase||41||
48060226|NCT05314478|100470158|FG000|STARTED|Overall Study||30||
48060227|NCT05314478|100470158|FG000|COMPLETED|Overall Study||29||
48060228|NCT05314478|100470158|FG000|NOT COMPLETED|Overall Study||1||
48060229|NCT01702571|100470159|FG000|STARTED|Overall Study||2003||
48060230|NCT01702571|100470160|FG001|STARTED|Overall Study||182||
48060231|NCT01702571|100470159|FG000|COMPLETED|Overall Study||494||
48060232|NCT01702571|100470160|FG001|COMPLETED|Overall Study||65||
48060233|NCT01702571|100470159|FG000|NOT COMPLETED|Overall Study||1509||
48060234|NCT01702571|100470160|FG001|NOT COMPLETED|Overall Study||117||
48060235|NCT03360747|100470161|FG000|STARTED|Overall Study||3||
48060236|NCT03360747|100470161|FG000|COMPLETED|Overall Study||2||
48060237|NCT03360747|100470161|FG000|NOT COMPLETED|Overall Study||1||
48060238|NCT00976677|100470162|FG000|STARTED|Overall Study||5||
48060239|NCT00976677|100470163|FG001|STARTED|Overall Study||5||
48060240|NCT00976677|100470162|FG000|COMPLETED|Overall Study||0||
48060241|NCT00976677|100470163|FG001|COMPLETED|Overall Study||0||
48060242|NCT00976677|100470162|FG000|NOT COMPLETED|Overall Study||5||
48060243|NCT00976677|100470163|FG001|NOT COMPLETED|Overall Study||5||
48060244|NCT02497612|100470164|FG000|STARTED|Overall Study||93||
48060245|NCT02497612|100470165|FG001|STARTED|Overall Study||94||
48060246|NCT02497612|100470166|FG002|STARTED|Overall Study||97||
48060247|NCT02497612|100470167|FG003|STARTED|Overall Study||93||
48060248|NCT02497612|100470164|FG000|Treated|Overall Study||92||
48060249|NCT02497612|100470165|FG001|Treated|Overall Study||94||
48060250|NCT02497612|100470166|FG002|Treated|Overall Study||96||
48060251|NCT02497612|100470167|FG003|Treated|Overall Study||91||
48060252|NCT02497612|100470164|FG000|Cohort 1: >14 Years to <70 Years|Overall Study||14||
48060253|NCT02497612|100470165|FG001|Cohort 1: >14 Years to <70 Years|Overall Study||15||
48060254|NCT02497612|100470166|FG002|Cohort 1: >14 Years to <70 Years|Overall Study||18||
48060255|NCT02497612|100470167|FG003|Cohort 1: >14 Years to <70 Years|Overall Study||16||
48060256|NCT02497612|100470164|FG000|Cohort 2: >5 Years to <=14 Years|Overall Study||6||
48060257|NCT02497612|100470165|FG001|Cohort 2: >5 Years to <=14 Years|Overall Study||5||
48060258|NCT02497612|100470166|FG002|Cohort 2: >5 Years to <=14 Years|Overall Study||6||
48060259|NCT02497612|100470167|FG003|Cohort 2: >5 Years to <=14 Years|Overall Study||5||
48060260|NCT02497612|100470164|FG000|Cohort 3: >2 Years to <=5 Years|Overall Study||66||
48060261|NCT02497612|100470165|FG001|Cohort 3: >2 Years to <=5 Years|Overall Study||66||
48060262|NCT02497612|100470166|FG002|Cohort 3: >2 Years to <=5 Years|Overall Study||67||
48060263|NCT02497612|100470167|FG003|Cohort 3: >2 Years to <=5 Years|Overall Study||65||
48060264|NCT02497612|100470164|FG000|Cohort 4: >6 Months to <=2 Years|Overall Study||7||
48060265|NCT02497612|100470165|FG001|Cohort 4: >6 Months to <=2 Years|Overall Study||8||
48060266|NCT02497612|100470166|FG002|Cohort 4: >6 Months to <=2 Years|Overall Study||6||
48060267|NCT02497612|100470167|FG003|Cohort 4: >6 Months to <=2 Years|Overall Study||7||
48060268|NCT02497612|100470164|FG000|COMPLETED|Overall Study||27||
48060269|NCT02497612|100470165|FG001|COMPLETED|Overall Study||37||
48060270|NCT02497612|100470166|FG002|COMPLETED|Overall Study||48||
48060271|NCT02497612|100470167|FG003|COMPLETED|Overall Study||46||
48060272|NCT02497612|100470164|FG000|NOT COMPLETED|Overall Study||66||
48060273|NCT02497612|100470165|FG001|NOT COMPLETED|Overall Study||57||
48060274|NCT02497612|100470166|FG002|NOT COMPLETED|Overall Study||49||
48060275|NCT02497612|100470167|FG003|NOT COMPLETED|Overall Study||47||
48060276|NCT01072669|100470168|FG000|STARTED|Overall Study||15||
48060277|NCT01072669|100470169|FG001|STARTED|Overall Study||5||
48060278|NCT01072669|100470168|FG000|COMPLETED|Overall Study||15||
48060279|NCT01072669|100470169|FG001|COMPLETED|Overall Study||5||
48060280|NCT01072669|100470168|FG000|NOT COMPLETED|Overall Study||0||
48060281|NCT01072669|100470169|FG001|NOT COMPLETED|Overall Study||0||
48060282|NCT02024529|100470170|FG000|STARTED|Overall Study||269||
48060283|NCT02024529|100470171|FG001|STARTED|Overall Study||269||
48060284|NCT02024529|100470170|FG000|COMPLETED|Overall Study||256||
48060285|NCT02024529|100470171|FG001|COMPLETED|Overall Study||244||
48214717|NCT03928522|100853340|FG002|STARTED|Overall Study||12||
48214718|NCT03928522|100853341|FG003|STARTED|Overall Study||12||
48214719|NCT03928522|100853342|FG004|STARTED|Overall Study||12||
48214720|NCT03928522|100853338|FG000|COMPLETED|Overall Study||12||
48214721|NCT03928522|100853339|FG001|COMPLETED|Overall Study||12||
48214722|NCT03928522|100853340|FG002|COMPLETED|Overall Study||12||
48214723|NCT03928522|100853341|FG003|COMPLETED|Overall Study||12||
48214724|NCT03928522|100853342|FG004|COMPLETED|Overall Study||12||
48214725|NCT03928522|100853338|FG000|NOT COMPLETED|Overall Study||0||
48214726|NCT03928522|100853339|FG001|NOT COMPLETED|Overall Study||0||
48214727|NCT03928522|100853340|FG002|NOT COMPLETED|Overall Study||0||
48214728|NCT03928522|100853341|FG003|NOT COMPLETED|Overall Study||0||
48214729|NCT03928522|100853342|FG004|NOT COMPLETED|Overall Study||0||
48214730|NCT01913314|100853343|FG000|STARTED|Overall Study||6||
48214731|NCT01913314|100853343|FG000|Received Study Drug|Overall Study||6||
48214732|NCT01913314|100853343|FG000|COMPLETED|Overall Study||6||
48214733|NCT01913314|100853343|FG000|NOT COMPLETED|Overall Study||0||
48214734|NCT02334436|100853344|FG000|STARTED|Overall Study||246||
48496239|NCT02241551|101548040|FG001|COMPLETED|Overall Study||0||
48496240|NCT02241551|101548039|FG000|NOT COMPLETED|Overall Study||1||
48060286|NCT02024529|100470170|FG000|NOT COMPLETED|Overall Study||13||
48060287|NCT02024529|100470171|FG001|NOT COMPLETED|Overall Study||25||
48060288|NCT02758171|100470172|FG000|STARTED|Treatment Period 1||28||
48060289|NCT02758171|100470173|FG001|STARTED|Treatment Period 1||28||
48060290|NCT02758171|100470172|FG000|COMPLETED|Treatment Period 1||28||
48060291|NCT02758171|100470173|FG001|COMPLETED|Treatment Period 1||28||
48060292|NCT02758171|100470172|FG000|NOT COMPLETED|Treatment Period 1||0||
48060293|NCT02758171|100470173|FG001|NOT COMPLETED|Treatment Period 1||0||
48060294|NCT02758171|100470172|FG000|STARTED|Wash-out||28||
48060295|NCT02758171|100470173|FG001|STARTED|Wash-out||28||
48060296|NCT02758171|100470172|FG000|COMPLETED|Wash-out||26||
48060297|NCT02758171|100470173|FG001|COMPLETED|Wash-out||28||
48060298|NCT02758171|100470172|FG000|NOT COMPLETED|Wash-out||2||
48060299|NCT02758171|100470173|FG001|NOT COMPLETED|Wash-out||0||
48060300|NCT02758171|100470172|FG000|STARTED|Treatment Period 2||26||
48060301|NCT02758171|100470173|FG001|STARTED|Treatment Period 2||28||
48060302|NCT02758171|100470172|FG000|COMPLETED|Treatment Period 2||26||
48060303|NCT02758171|100470173|FG001|COMPLETED|Treatment Period 2||28||
48060304|NCT02758171|100470172|FG000|NOT COMPLETED|Treatment Period 2||0||
48060305|NCT02758171|100470173|FG001|NOT COMPLETED|Treatment Period 2||0||
48060306|NCT01130103|100470174|FG000|STARTED|Randomized Treatment||19||
48060307|NCT01130103|100470175|FG001|STARTED|Randomized Treatment||18||
48060308|NCT01130103|100470174|FG000|COMPLETED|Randomized Treatment||13||
48060309|NCT01130103|100470175|FG001|COMPLETED|Randomized Treatment||13||
48060310|NCT01130103|100470174|FG000|NOT COMPLETED|Randomized Treatment||6||
48060311|NCT01130103|100470175|FG001|NOT COMPLETED|Randomized Treatment||5||
48060312|NCT01130103|100470174|FG000|STARTED|Maintenance Treatment||13||
48060313|NCT01130103|100470175|FG001|STARTED|Maintenance Treatment||13||
48060314|NCT01130103|100470174|FG000|COMPLETED|Maintenance Treatment||11||
48060315|NCT01130103|100470175|FG001|COMPLETED|Maintenance Treatment||11||
48060316|NCT01130103|100470174|FG000|NOT COMPLETED|Maintenance Treatment||2||
48060317|NCT01130103|100470175|FG001|NOT COMPLETED|Maintenance Treatment||2||
48060318|NCT02642029|100470176|FG000|STARTED|Study Visit 1 (1 Day)||6||
48060319|NCT02642029|100470177|FG001|STARTED|Study Visit 1 (1 Day)||5||
48214735|NCT02334436|100853345|FG001|STARTED|Overall Study||78||
48214736|NCT02334436|100853344|FG000|COMPLETED|Overall Study||237||
48214737|NCT02334436|100853345|FG001|COMPLETED|Overall Study||77||
48214738|NCT02334436|100853344|FG000|NOT COMPLETED|Overall Study||9||
48214739|NCT02334436|100853345|FG001|NOT COMPLETED|Overall Study||1||
48214740|NCT01401023|100853346|FG000|STARTED|Overall Study||10||
48214741|NCT01401023|100853346|FG000|COMPLETED|Overall Study||10||
48214742|NCT01401023|100853346|FG000|NOT COMPLETED|Overall Study||0||
48214743|NCT01553058|100853347|FG000|STARTED|Overall Study||33||
48214744|NCT01553058|100853348|FG001|STARTED|Overall Study||31||
48214745|NCT01553058|100853349|FG002|STARTED|Overall Study||33||
48214746|NCT01553058|100853347|FG000|COMPLETED|Overall Study||32||
48214747|NCT01553058|100853348|FG001|COMPLETED|Overall Study||30||
48214748|NCT01553058|100853349|FG002|COMPLETED|Overall Study||30||
48214749|NCT01553058|100853347|FG000|NOT COMPLETED|Overall Study||1||
48214750|NCT01553058|100853348|FG001|NOT COMPLETED|Overall Study||1||
48214751|NCT01553058|100853349|FG002|NOT COMPLETED|Overall Study||3||
48214752|NCT01839331|100853350|FG000|STARTED|Overall Study||83||83
48214753|NCT01839331|100853351|FG001|STARTED|Overall Study||83||83
48214754|NCT01839331|100853352|FG002|STARTED|Overall Study||82||82
48060320|NCT02642029|100470178|FG002|STARTED|Study Visit 1 (1 Day)||3||
48060321|NCT02642029|100470179|FG003|STARTED|Study Visit 1 (1 Day)||4||
48060322|NCT02642029|100470180|FG004|STARTED|Study Visit 1 (1 Day)||4||
48060323|NCT02642029|100470181|FG005|STARTED|Study Visit 1 (1 Day)||4||
48214755|NCT01839331|100853353|FG003|STARTED|Overall Study||81||81
48214756|NCT01839331|100853350|FG000|Week 6|Overall Study||83||83
48214757|NCT01839331|100853351|FG001|Week 6|Overall Study||83||83
48496241|NCT02241551|101548040|FG001|NOT COMPLETED|Overall Study||0||
48214758|NCT01839331|100853352|FG002|Week 6|Overall Study||82||82
48214759|NCT01839331|100853353|FG003|Week 6|Overall Study||81||81
48214760|NCT01839331|100853350|FG000|COMPLETED|Overall Study||79||79
48214761|NCT01839331|100853351|FG001|COMPLETED|Overall Study||77||77
48214762|NCT01839331|100853352|FG002|COMPLETED|Overall Study||77||77
48214763|NCT01839331|100853353|FG003|COMPLETED|Overall Study||76||76
48214764|NCT01839331|100853350|FG000|NOT COMPLETED|Overall Study||4||4
48214765|NCT01839331|100853351|FG001|NOT COMPLETED|Overall Study||6||6
48214766|NCT01839331|100853352|FG002|NOT COMPLETED|Overall Study||5||5
48214767|NCT01839331|100853353|FG003|NOT COMPLETED|Overall Study||5||5
48214768|NCT04377308|100853354|FG000|STARTED|Overall Study||4||
48214769|NCT04377308|100853355|FG001|STARTED|Overall Study||12||
48214770|NCT04377308|100853354|FG000|COMPLETED|Overall Study||4||
48214771|NCT04377308|100853355|FG001|COMPLETED|Overall Study||11||
48214772|NCT04377308|100853354|FG000|NOT COMPLETED|Overall Study||0||
48214773|NCT04377308|100853355|FG001|NOT COMPLETED|Overall Study||1||
48214774|NCT04018924|100853356|FG000|STARTED|Overall Study||90||
48214775|NCT04018924|100853356|FG000|Standard Of Care Intervention|Overall Study||90||
48214776|NCT04018924|100853356|FG000|EmoLED Intervention|Overall Study||90||
48214777|NCT04018924|100853356|FG000|COMPLETED|Overall Study||84||
48214778|NCT04018924|100853356|FG000|NOT COMPLETED|Overall Study||6||
48214779|NCT01796236|100853357|FG000|STARTED|Overall Study||51||
48214780|NCT01796236|100853358|FG001|STARTED|Overall Study||52||
48214781|NCT01796236|100853357|FG000|COMPLETED|Overall Study||49||
48214782|NCT01796236|100853358|FG001|COMPLETED|Overall Study||50||
48214783|NCT01796236|100853357|FG000|NOT COMPLETED|Overall Study||2||
48214784|NCT01796236|100853358|FG001|NOT COMPLETED|Overall Study||2||
48214785|NCT04512482|100853359|FG000|STARTED|First Intervention (1 Day)||24||
48214786|NCT04512482|100853360|FG001|STARTED|First Intervention (1 Day)||21||
48214787|NCT04512482|100853359|FG000|Baseline Plaque Assessment|First Intervention (1 Day)||24||
48214788|NCT04512482|100853360|FG001|Baseline Plaque Assessment|First Intervention (1 Day)||21||
48214789|NCT04512482|100853359|FG000|Baseline Photographs|First Intervention (1 Day)||24||
48214790|NCT04512482|100853360|FG001|Baseline Photographs|First Intervention (1 Day)||21||
48214791|NCT04512482|100853359|FG000|Received Rinse Intervention|First Intervention (1 Day)||24||
48214792|NCT04512482|100853360|FG001|Received Rinse Intervention|First Intervention (1 Day)||21||
48214793|NCT04512482|100853359|FG000|Post-rinse Photographs|First Intervention (1 Day)||24||
48214794|NCT04512482|100853360|FG001|Post-rinse Photographs|First Intervention (1 Day)||21||
48214795|NCT04512482|100853359|FG000|Toothbrush Utilization|First Intervention (1 Day)||24||
48214796|NCT04512482|100853360|FG001|Toothbrush Utilization|First Intervention (1 Day)||21||
48214797|NCT04512482|100853359|FG000|Post-toothbrush Photographs|First Intervention (1 Day)||24||
48214798|NCT04512482|100853360|FG001|Post-toothbrush Photographs|First Intervention (1 Day)||21||
48214799|NCT04512482|100853359|FG000|Waterpik Utilization|First Intervention (1 Day)||24||
48214800|NCT04512482|100853360|FG001|Waterpik Utilization|First Intervention (1 Day)||21||
48214801|NCT04512482|100853359|FG000|Post-Waterpik Photographs|First Intervention (1 Day)||24||
48214802|NCT04512482|100853360|FG001|Post-Waterpik Photographs|First Intervention (1 Day)||21||
48214803|NCT04512482|100853359|FG000|COMPLETED|First Intervention (1 Day)||24||
48214804|NCT04512482|100853360|FG001|COMPLETED|First Intervention (1 Day)||21||
48214805|NCT04512482|100853359|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
48214806|NCT04512482|100853360|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
48214807|NCT04512482|100853359|FG000|STARTED|Washout (1 Week)||24||
48214808|NCT04512482|100853360|FG001|STARTED|Washout (1 Week)||21||
48214809|NCT04512482|100853359|FG000|COMPLETED|Washout (1 Week)||24||
48214810|NCT04512482|100853360|FG001|COMPLETED|Washout (1 Week)||21||
48214811|NCT04512482|100853359|FG000|NOT COMPLETED|Washout (1 Week)||0||
48214812|NCT04512482|100853360|FG001|NOT COMPLETED|Washout (1 Week)||0||
48214813|NCT04512482|100853359|FG000|STARTED|Second Intervention (1 Day)||24||
48214814|NCT04512482|100853360|FG001|STARTED|Second Intervention (1 Day)||21||
48214815|NCT04512482|100853359|FG000|Baseline Plaque Assessment|Second Intervention (1 Day)||22||
48214816|NCT04512482|100853360|FG001|Baseline Plaque Assessment|Second Intervention (1 Day)||20||
48214817|NCT04512482|100853359|FG000|Baseline Photographs|Second Intervention (1 Day)||22||
48214818|NCT04512482|100853360|FG001|Baseline Photographs|Second Intervention (1 Day)||20||
48214819|NCT04512482|100853359|FG000|Received Intervention|Second Intervention (1 Day)||22||
48214820|NCT04512482|100853360|FG001|Received Intervention|Second Intervention (1 Day)||20||
48214821|NCT04512482|100853359|FG000|Post-rinse Photographs|Second Intervention (1 Day)||22||
48214822|NCT04512482|100853360|FG001|Post-rinse Photographs|Second Intervention (1 Day)||20||
48214823|NCT04512482|100853359|FG000|Toothbrush Utilization|Second Intervention (1 Day)||22||
48214824|NCT04512482|100853360|FG001|Toothbrush Utilization|Second Intervention (1 Day)||20||
48214825|NCT04512482|100853359|FG000|Post-toothbrush Photographs|Second Intervention (1 Day)||22||
48214826|NCT04512482|100853360|FG001|Post-toothbrush Photographs|Second Intervention (1 Day)||20||
48214827|NCT04512482|100853359|FG000|Waterpik Utilization|Second Intervention (1 Day)||22||
48496242|NCT04310345|101548041|FG000|STARTED|Overall Study||31||
48496243|NCT04310345|101548042|FG001|STARTED|Overall Study||43||
48214828|NCT04512482|100853360|FG001|Waterpik Utilization|Second Intervention (1 Day)||20||
48214829|NCT04512482|100853359|FG000|Post-Waterpik Photographs|Second Intervention (1 Day)||22||
48214830|NCT04512482|100853360|FG001|Post-Waterpik Photographs|Second Intervention (1 Day)||20||
48214831|NCT04512482|100853359|FG000|COMPLETED|Second Intervention (1 Day)||22||
48214832|NCT04512482|100853360|FG001|COMPLETED|Second Intervention (1 Day)||20||
48214833|NCT04512482|100853359|FG000|NOT COMPLETED|Second Intervention (1 Day)||2||
48214834|NCT04512482|100853360|FG001|NOT COMPLETED|Second Intervention (1 Day)||1||
48214835|NCT02814838|100853361|FG000|STARTED|Overall Study||50||
48214836|NCT02814838|100853362|FG001|STARTED|Overall Study||26||
48214837|NCT02814838|100853361|FG000|COMPLETED|Overall Study||48||
48214838|NCT02814838|100853362|FG001|COMPLETED|Overall Study||25||
48214839|NCT02814838|100853361|FG000|NOT COMPLETED|Overall Study||2||
48214840|NCT02814838|100853362|FG001|NOT COMPLETED|Overall Study||1||
48214841|NCT02029235|100853363|FG000|STARTED|Overall Study||34||
48214842|NCT02029235|100853364|FG001|STARTED|Overall Study||31||
48214843|NCT02029235|100853363|FG000|COMPLETED|Overall Study||30||
48214844|NCT02029235|100853364|FG001|COMPLETED|Overall Study||30||
48214845|NCT02029235|100853363|FG000|NOT COMPLETED|Overall Study||4||
48214846|NCT02029235|100853364|FG001|NOT COMPLETED|Overall Study||1||
48214847|NCT04502472|100853365|FG000|STARTED|Overall Study||61||
48214848|NCT04502472|100853366|FG001|STARTED|Overall Study||48||
48214849|NCT04502472|100853365|FG000|COMPLETED|Overall Study||58||
48214850|NCT04502472|100853366|FG001|COMPLETED|Overall Study||45||
48214851|NCT04502472|100853365|FG000|NOT COMPLETED|Overall Study||3||
48214852|NCT04502472|100853366|FG001|NOT COMPLETED|Overall Study||3||
48214853|NCT00150813|100853367|FG000|STARTED|Overall Study||66||
48214854|NCT00150813|100853367|FG000|COMPLETED|Overall Study||48||
48214855|NCT00150813|100853367|FG000|NOT COMPLETED|Overall Study||18||
48214856|NCT03580369|100853368|FG000|STARTED|Overall Study||307||
48214857|NCT03580369|100853369|FG001|STARTED|Overall Study||10||
48214858|NCT03580369|100853370|FG002|STARTED|Overall Study||312||
48214859|NCT03580369|100853371|FG003|STARTED|Overall Study||12||
48214860|NCT03580369|100853372|FG004|STARTED|Overall Study||309||
48214861|NCT03580369|100853373|FG005|STARTED|Overall Study||13||
48214862|NCT03580369|100853374|FG006|STARTED|Overall Study||106||
48214863|NCT03580369|100853375|FG007|STARTED|Overall Study||3||
48214864|NCT03580369|100853368|FG000|COMPLETED|Overall Study||263||
48214865|NCT03580369|100853369|FG001|COMPLETED|Overall Study||10||
48214866|NCT03580369|100853370|FG002|COMPLETED|Overall Study||258||
48214867|NCT03580369|100853371|FG003|COMPLETED|Overall Study||9||
48214868|NCT03580369|100853372|FG004|COMPLETED|Overall Study||267||
48214869|NCT03580369|100853373|FG005|COMPLETED|Overall Study||10||
48214870|NCT03580369|100853374|FG006|COMPLETED|Overall Study||91||
48214871|NCT03580369|100853375|FG007|COMPLETED|Overall Study||3||
48214872|NCT03580369|100853368|FG000|NOT COMPLETED|Overall Study||44||
48214873|NCT03580369|100853369|FG001|NOT COMPLETED|Overall Study||0||
48214874|NCT03580369|100853370|FG002|NOT COMPLETED|Overall Study||54||
48214875|NCT03580369|100853371|FG003|NOT COMPLETED|Overall Study||3||
48214876|NCT03580369|100853372|FG004|NOT COMPLETED|Overall Study||42||
48214877|NCT03580369|100853373|FG005|NOT COMPLETED|Overall Study||3||
48214878|NCT03580369|100853374|FG006|NOT COMPLETED|Overall Study||15||
48214879|NCT03580369|100853375|FG007|NOT COMPLETED|Overall Study||0||
48214880|NCT01376700|100853376|FG000|STARTED|Overall Study||19||
48214881|NCT01376700|100853376|FG000|COMPLETED|Overall Study||3||
48214882|NCT01376700|100853376|FG000|NOT COMPLETED|Overall Study||16||
48214883|NCT02058108|100853377|FG000|STARTED|Overall Study||43|All randomized patients were included in the Full Analysis (FAS) and Safety Set|
48214884|NCT02058108|100853378|FG001|STARTED|Overall Study||10|All randomized patients were included in the Full Analysis (FAS) and Safety Set|
48214885|NCT02058108|100853377|FG000|Switched to Telbivudine After Week 24|Overall Study||0|Placebo randomized patients who switched to LdT after week 24|
48214886|NCT02058108|100853378|FG001|Switched to Telbivudine After Week 24|Overall Study||5|Placebo randomized patients who switched to LdT after week 24|
48214887|NCT02058108|100853377|FG000|COMPLETED|Overall Study||2||
48214888|NCT02058108|100853378|FG001|COMPLETED|Overall Study||0||
48214889|NCT02058108|100853377|FG000|NOT COMPLETED|Overall Study||41||
48214890|NCT02058108|100853378|FG001|NOT COMPLETED|Overall Study||10||
48214891|NCT00610649|100853379|FG000|STARTED|Overall Study||4||
48214892|NCT00610649|100853380|FG001|STARTED|Overall Study||2||
48214893|NCT00610649|100853381|FG002|STARTED|Overall Study||4||
48214894|NCT00610649|100853382|FG003|STARTED|Overall Study||2||
48214895|NCT00610649|100853383|FG004|STARTED|Overall Study||4||
48214896|NCT00610649|100853384|FG005|STARTED|Overall Study||2||
48214897|NCT00610649|100853385|FG006|STARTED|Overall Study||4||
48496244|NCT04310345|101548041|FG000|COMPLETED|Overall Study||28||
48060324|NCT02642029|100470176|FG000|COMPLETED|Study Visit 1 (1 Day)||6||
48060325|NCT02642029|100470177|FG001|COMPLETED|Study Visit 1 (1 Day)||5||
48060326|NCT02642029|100470178|FG002|COMPLETED|Study Visit 1 (1 Day)||3||
48060327|NCT02642029|100470179|FG003|COMPLETED|Study Visit 1 (1 Day)||4||
48214898|NCT00610649|100853386|FG007|STARTED|Overall Study||2||
48214899|NCT00610649|100853387|FG008|STARTED|Overall Study||10||
48214900|NCT00610649|100853388|FG009|STARTED|Overall Study||10||
48214901|NCT00610649|100853389|FG010|STARTED|Overall Study||10||
48214902|NCT00610649|100853379|FG000|COMPLETED|Overall Study||3||
48060328|NCT02642029|100470180|FG004|COMPLETED|Study Visit 1 (1 Day)||4||
48214903|NCT00610649|100853380|FG001|COMPLETED|Overall Study||1||
48214904|NCT00610649|100853381|FG002|COMPLETED|Overall Study||4||
48214905|NCT00610649|100853382|FG003|COMPLETED|Overall Study||2||
48214906|NCT00610649|100853383|FG004|COMPLETED|Overall Study||4||
48214907|NCT00610649|100853384|FG005|COMPLETED|Overall Study||2||
48214908|NCT00610649|100853385|FG006|COMPLETED|Overall Study||4||
48214909|NCT00610649|100853386|FG007|COMPLETED|Overall Study||2||
48214910|NCT00610649|100853387|FG008|COMPLETED|Overall Study||10||
48214911|NCT00610649|100853388|FG009|COMPLETED|Overall Study||9||
48214912|NCT00610649|100853389|FG010|COMPLETED|Overall Study||9||
48214913|NCT00610649|100853379|FG000|NOT COMPLETED|Overall Study||1||
48214914|NCT00610649|100853380|FG001|NOT COMPLETED|Overall Study||1||
48214915|NCT00610649|100853381|FG002|NOT COMPLETED|Overall Study||0||
48214916|NCT00610649|100853382|FG003|NOT COMPLETED|Overall Study||0||
48214917|NCT00610649|100853383|FG004|NOT COMPLETED|Overall Study||0||
48214918|NCT00610649|100853384|FG005|NOT COMPLETED|Overall Study||0||
48214919|NCT00610649|100853385|FG006|NOT COMPLETED|Overall Study||0||
48214920|NCT00610649|100853386|FG007|NOT COMPLETED|Overall Study||0||
48214921|NCT00610649|100853387|FG008|NOT COMPLETED|Overall Study||0||
48214922|NCT00610649|100853388|FG009|NOT COMPLETED|Overall Study||1||
48214923|NCT00610649|100853389|FG010|NOT COMPLETED|Overall Study||1||
48214924|NCT00639860|100853390|FG000|STARTED|Overall Study||10||
48214925|NCT00639860|100853390|FG000|COMPLETED|Overall Study||10||
48214926|NCT00639860|100853390|FG000|NOT COMPLETED|Overall Study||0||
48214927|NCT02168400|100853391|FG000|STARTED|Overall Study||39||
48214928|NCT02168400|100853392|FG001|STARTED|Overall Study||36||
48214929|NCT02168400|100853391|FG000|COMPLETED|Overall Study||31||
48214930|NCT02168400|100853392|FG001|COMPLETED|Overall Study||29||
48214931|NCT02168400|100853391|FG000|NOT COMPLETED|Overall Study||8||
48214932|NCT02168400|100853392|FG001|NOT COMPLETED|Overall Study||7||
48214933|NCT02189915|100853393|FG000|STARTED|Overall Study||14||
48214934|NCT02189915|100853393|FG000|COMPLETED|Overall Study||11||
48214935|NCT02189915|100853393|FG000|NOT COMPLETED|Overall Study||3||
48214936|NCT01227265|100853394|FG000|STARTED|Overall Study||158||
48214937|NCT01227265|100853395|FG001|STARTED|Overall Study||159||
48214938|NCT01227265|100853396|FG002|STARTED|Overall Study||159||
48214939|NCT01227265|100853394|FG000|Treated|Overall Study||157||
48214940|NCT01227265|100853395|FG001|Treated|Overall Study||157||
48214941|NCT01227265|100853396|FG002|Treated|Overall Study||159||
48214942|NCT01227265|100853394|FG000|COMPLETED|Overall Study||139||
48214943|NCT01227265|100853395|FG001|COMPLETED|Overall Study||139||
48214944|NCT01227265|100853396|FG002|COMPLETED|Overall Study||145||
48214945|NCT01227265|100853394|FG000|NOT COMPLETED|Overall Study||19||
48214946|NCT01227265|100853395|FG001|NOT COMPLETED|Overall Study||20||
48214947|NCT01227265|100853396|FG002|NOT COMPLETED|Overall Study||14||
48214948|NCT00557492|100853397|FG000|STARTED|Overall Study||59||
48214949|NCT00557492|100853397|FG000|COMPLETED|Overall Study||58||
48214950|NCT00557492|100853397|FG000|NOT COMPLETED|Overall Study||1||
48214951|NCT01094184|100853398|FG000|STARTED|Overall Study||36||
48214952|NCT01094184|100853399|FG001|STARTED|Overall Study||13||
48214953|NCT01094184|100853398|FG000|COMPLETED|Overall Study||1||
48214954|NCT01094184|100853399|FG001|COMPLETED|Overall Study||2||
48214955|NCT01094184|100853398|FG000|NOT COMPLETED|Overall Study||35||
48214956|NCT01094184|100853399|FG001|NOT COMPLETED|Overall Study||11||
48214957|NCT02379819|100853400|FG000|STARTED|Overall Study||52||
48214958|NCT02379819|100853400|FG000|COMPLETED|Overall Study||38||
48214959|NCT02379819|100853400|FG000|NOT COMPLETED|Overall Study||14||
48214960|NCT00676091|100853401|FG000|STARTED|Infant Series||177||
48214961|NCT00676091|100853402|FG001|STARTED|Infant Series||177||
48214962|NCT00676091|100853401|FG000|Vaccinated Dose 1|Infant Series||163||
48214963|NCT00676091|100853402|FG001|Vaccinated Dose 1|Infant Series||162||
48214964|NCT00676091|100853401|FG000|Vaccinated Dose 2|Infant Series||159||
48214965|NCT00676091|100853402|FG001|Vaccinated Dose 2|Infant Series||162||
48214966|NCT00676091|100853401|FG000|Vaccinated Dose 3|Infant Series||158||
48214967|NCT00676091|100853402|FG001|Vaccinated Dose 3|Infant Series||161||
48214968|NCT00676091|100853401|FG000|COMPLETED|Infant Series||157||
48214969|NCT00676091|100853402|FG001|COMPLETED|Infant Series||159||
48214970|NCT00676091|100853401|FG000|NOT COMPLETED|Infant Series||20||
48214971|NCT00676091|100853402|FG001|NOT COMPLETED|Infant Series||18||
48214972|NCT00676091|100853401|FG000|STARTED|After Infant Series||157||
48214973|NCT00676091|100853402|FG001|STARTED|After Infant Series||159||
48214974|NCT00676091|100853401|FG000|COMPLETED|After Infant Series||156||
48214975|NCT00676091|100853402|FG001|COMPLETED|After Infant Series||156||
48214976|NCT00676091|100853401|FG000|NOT COMPLETED|After Infant Series||1||
48214977|NCT00676091|100853402|FG001|NOT COMPLETED|After Infant Series||3||
48214978|NCT00676091|100853401|FG000|STARTED|Toddler Dose||156||
48214979|NCT00676091|100853402|FG001|STARTED|Toddler Dose||156||
48214980|NCT00676091|100853401|FG000|COMPLETED|Toddler Dose||153||
48214981|NCT00676091|100853402|FG001|COMPLETED|Toddler Dose||156||
48214982|NCT00676091|100853401|FG000|NOT COMPLETED|Toddler Dose||3||
48214983|NCT00676091|100853402|FG001|NOT COMPLETED|Toddler Dose||0||
48214984|NCT02538341|100853403|FG000|STARTED|Overall Study||310||
48214985|NCT02538341|100853404|FG001|STARTED|Overall Study||307||
48214986|NCT02538341|100853403|FG000|Week 6 (Primary Outcome)|Overall Study||303||
48214987|NCT02538341|100853404|FG001|Week 6 (Primary Outcome)|Overall Study||299||
48214988|NCT02538341|100853403|FG000|Month 6 (Safety Outcome)|Overall Study||276|All participants were followed in a blinded manner until Month 6 when clinical sites and participants were unblinded. Participants randomized to placebo completed the study at Month 6.|
48214989|NCT02538341|100853404|FG001|Month 6 (Safety Outcome)|Overall Study||260|All participants were followed in a blinded manner until Month 6 when clinical sites and participants were unblinded. Participants randomized to placebo completed the study at Month 6.|
48214990|NCT02538341|100853403|FG000|1 Year Visit|Overall Study||254|As an exploratory outcome to assess the immunologic persistence of live herpes zoster vaccine among participants randomized to the vaccine, only those participants were invited to provide a Year 1 blood sample for the same lab assessments.|
48214991|NCT02538341|100853404|FG001|1 Year Visit|Overall Study||0|As an exploratory outcome to assess the immunologic persistence of live herpes zoster vaccine among participants randomized to the vaccine, only those participants were invited to provide a Year 1 blood sample for the same lab assessments.|
48214992|NCT02538341|100853403|FG000|COMPLETED|Overall Study||254||
48214993|NCT02538341|100853404|FG001|COMPLETED|Overall Study||260||
48214994|NCT02538341|100853403|FG000|NOT COMPLETED|Overall Study||56||
48214995|NCT02538341|100853404|FG001|NOT COMPLETED|Overall Study||47||
48214996|NCT01307267|100853405|FG000|STARTED|Overall Study||4||
48214997|NCT01307267|100853406|FG001|STARTED|Overall Study||3||
48214998|NCT01307267|100853407|FG002|STARTED|Overall Study||6||
48214999|NCT01307267|100853408|FG003|STARTED|Overall Study||4||
48215000|NCT01307267|100853409|FG004|STARTED|Overall Study||3||
48215001|NCT01307267|100853410|FG005|STARTED|Overall Study||42||
48215002|NCT01307267|100853411|FG006|STARTED|Overall Study||3||
48215003|NCT01307267|100853412|FG007|STARTED|Overall Study||4||
48215004|NCT01307267|100853413|FG008|STARTED|Overall Study||31||
48215005|NCT01307267|100853414|FG009|STARTED|Overall Study||5||
48215006|NCT01307267|100853415|FG010|STARTED|Overall Study||6||
48215007|NCT01307267|100853416|FG011|STARTED|Overall Study||11||
48215008|NCT01307267|100853417|FG012|STARTED|Overall Study||3||
48215009|NCT01307267|100853418|FG013|STARTED|Overall Study||3||
48215010|NCT01307267|100853419|FG014|STARTED|Overall Study||4||
48215011|NCT01307267|100853420|FG015|STARTED|Overall Study||3||
48215012|NCT01307267|100853421|FG016|STARTED|Overall Study||3||
48215013|NCT01307267|100853422|FG017|STARTED|Overall Study||3||
48215014|NCT01307267|100853423|FG018|STARTED|Overall Study||4||
48215015|NCT01307267|100853424|FG019|STARTED|Overall Study||32||
48215016|NCT01307267|100853425|FG020|STARTED|Overall Study||3||
48215017|NCT01307267|100853426|FG021|STARTED|Overall Study||5||
48215018|NCT01307267|100853427|FG022|STARTED|Overall Study||4||
48215019|NCT01307267|100853405|FG000|COMPLETED|Overall Study||0||
48215020|NCT01307267|100853406|FG001|COMPLETED|Overall Study||0||
48215021|NCT01307267|100853407|FG002|COMPLETED|Overall Study||1||
48215022|NCT01307267|100853408|FG003|COMPLETED|Overall Study||1||
48215023|NCT01307267|100853409|FG004|COMPLETED|Overall Study||2||
48215024|NCT01307267|100853410|FG005|COMPLETED|Overall Study||1||
48215025|NCT01307267|100853411|FG006|COMPLETED|Overall Study||1||
48215026|NCT01307267|100853412|FG007|COMPLETED|Overall Study||0||
48215027|NCT01307267|100853413|FG008|COMPLETED|Overall Study||1||
48215028|NCT01307267|100853414|FG009|COMPLETED|Overall Study||0||
48215029|NCT01307267|100853415|FG010|COMPLETED|Overall Study||0||
48215030|NCT01307267|100853416|FG011|COMPLETED|Overall Study||0||
48215031|NCT01307267|100853417|FG012|COMPLETED|Overall Study||2||
48215032|NCT01307267|100853418|FG013|COMPLETED|Overall Study||3||
48215033|NCT01307267|100853419|FG014|COMPLETED|Overall Study||2||
48496245|NCT04310345|101548042|FG001|COMPLETED|Overall Study||39||
48496246|NCT04310345|101548041|FG000|NOT COMPLETED|Overall Study||3||
48215034|NCT01307267|100853420|FG015|COMPLETED|Overall Study||2||
48215035|NCT01307267|100853421|FG016|COMPLETED|Overall Study||2||
48215036|NCT01307267|100853422|FG017|COMPLETED|Overall Study||2||
48215037|NCT01307267|100853423|FG018|COMPLETED|Overall Study||2||
48215038|NCT01307267|100853424|FG019|COMPLETED|Overall Study||0||
48215039|NCT01307267|100853425|FG020|COMPLETED|Overall Study||0||
48215040|NCT01307267|100853426|FG021|COMPLETED|Overall Study||0||
48215041|NCT01307267|100853427|FG022|COMPLETED|Overall Study||0||
48215042|NCT01307267|100853405|FG000|NOT COMPLETED|Overall Study||4||
48215043|NCT01307267|100853406|FG001|NOT COMPLETED|Overall Study||3||
48215044|NCT01307267|100853407|FG002|NOT COMPLETED|Overall Study||5||
48215045|NCT01307267|100853408|FG003|NOT COMPLETED|Overall Study||3||
48215046|NCT01307267|100853409|FG004|NOT COMPLETED|Overall Study||1||
48215047|NCT01307267|100853410|FG005|NOT COMPLETED|Overall Study||41||
48215048|NCT01307267|100853411|FG006|NOT COMPLETED|Overall Study||2||
48215049|NCT01307267|100853412|FG007|NOT COMPLETED|Overall Study||4||
48215050|NCT01307267|100853413|FG008|NOT COMPLETED|Overall Study||30||
48215051|NCT01307267|100853414|FG009|NOT COMPLETED|Overall Study||5||
48215052|NCT01307267|100853415|FG010|NOT COMPLETED|Overall Study||6||
48215053|NCT01307267|100853416|FG011|NOT COMPLETED|Overall Study||11||
48215054|NCT01307267|100853417|FG012|NOT COMPLETED|Overall Study||1||
48215055|NCT01307267|100853418|FG013|NOT COMPLETED|Overall Study||0||
48215056|NCT01307267|100853419|FG014|NOT COMPLETED|Overall Study||2||
48215057|NCT01307267|100853420|FG015|NOT COMPLETED|Overall Study||1||
48215058|NCT01307267|100853421|FG016|NOT COMPLETED|Overall Study||1||
48215059|NCT01307267|100853422|FG017|NOT COMPLETED|Overall Study||1||
48215060|NCT01307267|100853423|FG018|NOT COMPLETED|Overall Study||2||
48215061|NCT01307267|100853424|FG019|NOT COMPLETED|Overall Study||32||
48215062|NCT01307267|100853425|FG020|NOT COMPLETED|Overall Study||3||
48215063|NCT01307267|100853426|FG021|NOT COMPLETED|Overall Study||5||
48215064|NCT01307267|100853427|FG022|NOT COMPLETED|Overall Study||4||
48215065|NCT02204982|100853428|FG000|STARTED|Overall Study||6||
48215066|NCT02204982|100853429|FG001|STARTED|Overall Study||7||
48215067|NCT02204982|100853428|FG000|COMPLETED|Overall Study||2||
48215068|NCT02204982|100853429|FG001|COMPLETED|Overall Study||0||
48215069|NCT02204982|100853428|FG000|NOT COMPLETED|Overall Study||4||
48215070|NCT02204982|100853429|FG001|NOT COMPLETED|Overall Study||7||
48215071|NCT03287622|100853430|FG000|STARTED|Overall Study||356||
48215072|NCT03287622|100853431|FG001|STARTED|Overall Study||356||
48215073|NCT03287622|100853430|FG000|Sub-randomized to Nudge/NoNudge|Overall Study||253||
48215074|NCT03287622|100853431|FG001|Sub-randomized to Nudge/NoNudge|Overall Study||266||
48215075|NCT03287622|100853430|FG000|COMPLETED|Overall Study||298||
48215076|NCT03287622|100853431|FG001|COMPLETED|Overall Study||308||
48215077|NCT03287622|100853430|FG000|NOT COMPLETED|Overall Study||58||
48215078|NCT03287622|100853431|FG001|NOT COMPLETED|Overall Study||48||
48215079|NCT03345901|100853432|FG000|STARTED|Overall Study||18||
48215080|NCT03345901|100853432|FG000|COMPLETED|Overall Study||0||
48215081|NCT03345901|100853432|FG000|NOT COMPLETED|Overall Study||18||
48215082|NCT02057939|100853433|FG000|STARTED|Overall Study||38||
48215083|NCT02057939|100853433|FG000|COMPLETED|Overall Study||37||
48215084|NCT02057939|100853433|FG000|NOT COMPLETED|Overall Study||1||
48215085|NCT01556724|100853434|FG000|STARTED|Overall Study||16||
48215086|NCT01556724|100853435|FG001|STARTED|Overall Study||14||
48215087|NCT01556724|100853434|FG000|COMPLETED|Overall Study||16||
48215088|NCT01556724|100853435|FG001|COMPLETED|Overall Study||14||
48215089|NCT01556724|100853434|FG000|NOT COMPLETED|Overall Study||0||
48215090|NCT01556724|100853435|FG001|NOT COMPLETED|Overall Study||0||
48215091|NCT03544515|100853436|FG000|STARTED|Overall Study||16||
48215092|NCT03544515|100853437|FG001|STARTED|Overall Study||15||
48215093|NCT03544515|100853436|FG000|COMPLETED|Overall Study||10||
48215094|NCT03544515|100853437|FG001|COMPLETED|Overall Study||13||
48215095|NCT03544515|100853436|FG000|NOT COMPLETED|Overall Study||6||
48215096|NCT03544515|100853437|FG001|NOT COMPLETED|Overall Study||2||
48215097|NCT02724956|100853438|FG000|STARTED|Overall Study||27||
48215098|NCT02724956|100853439|FG001|STARTED|Overall Study||26||
48215099|NCT02724956|100853438|FG000|COMPLETED|Overall Study||26||
48215100|NCT02724956|100853439|FG001|COMPLETED|Overall Study||24||
48215101|NCT02724956|100853438|FG000|NOT COMPLETED|Overall Study||1||
48215102|NCT02724956|100853439|FG001|NOT COMPLETED|Overall Study||2||
48215103|NCT03224390|100853440|FG000|STARTED|Overall Study||56||
48215104|NCT03224390|100853441|FG001|STARTED|Overall Study||56||
48215105|NCT03224390|100853440|FG000|COMPLETED|Overall Study||29||
48215106|NCT03224390|100853441|FG001|COMPLETED|Overall Study||21||
48215107|NCT03224390|100853440|FG000|NOT COMPLETED|Overall Study||27||
48215108|NCT03224390|100853441|FG001|NOT COMPLETED|Overall Study||35||
48215109|NCT00031694|100853442|FG000|STARTED|Overall Study||19||
48215110|NCT00031694|100853442|FG000|COMPLETED|Overall Study||0||
48215111|NCT00031694|100853442|FG000|NOT COMPLETED|Overall Study||19||
48215112|NCT04093752|100853443|FG000|STARTED|Overall Study||230||
48215113|NCT04093752|100853444|FG001|STARTED|Overall Study||228||
48215114|NCT04093752|100853445|FG002|STARTED|Overall Study||229||
48215115|NCT04093752|100853446|FG003|STARTED|Overall Study||230||
48215116|NCT04093752|100853443|FG000|Received At Least One Dose of Study Drug|Overall Study||230||
48215117|NCT04093752|100853444|FG001|Received At Least One Dose of Study Drug|Overall Study||228||
48215118|NCT04093752|100853445|FG002|Received At Least One Dose of Study Drug|Overall Study||229||
48215119|NCT04093752|100853446|FG003|Received At Least One Dose of Study Drug|Overall Study||220||
48215120|NCT04093752|100853443|FG000|COMPLETED|Overall Study||213||
48215121|NCT04093752|100853444|FG001|COMPLETED|Overall Study||201||
48215122|NCT04093752|100853445|FG002|COMPLETED|Overall Study||200||
48215123|NCT04093752|100853446|FG003|COMPLETED|Overall Study||201||
48215124|NCT04093752|100853443|FG000|NOT COMPLETED|Overall Study||17||
48215125|NCT04093752|100853444|FG001|NOT COMPLETED|Overall Study||27||
48215126|NCT04093752|100853445|FG002|NOT COMPLETED|Overall Study||29||
48215127|NCT04093752|100853446|FG003|NOT COMPLETED|Overall Study||29||
48215128|NCT03390296|100853447|FG000|STARTED|Overall Study||4||
48215129|NCT03390296|100853448|FG001|STARTED|Overall Study||21||
48215130|NCT03390296|100853449|FG002|STARTED|Overall Study||7||
48215131|NCT03390296|100853450|FG003|STARTED|Overall Study||13||
48215132|NCT03390296|100853451|FG004|STARTED|Overall Study||0||
48215133|NCT03390296|100853452|FG005|STARTED|Overall Study||5||
48215134|NCT03390296|100853447|FG000|COMPLETED|Overall Study||4||
48215135|NCT03390296|100853448|FG001|COMPLETED|Overall Study||21||
48496247|NCT04310345|101548042|FG001|NOT COMPLETED|Overall Study||4||
48496248|NCT05479058|101548043|FG000|STARTED|Overall Study||11||
48215136|NCT03390296|100853449|FG002|COMPLETED|Overall Study||7||
48215137|NCT03390296|100853450|FG003|COMPLETED|Overall Study||13||
48215138|NCT03390296|100853451|FG004|COMPLETED|Overall Study||0||
48215139|NCT03390296|100853452|FG005|COMPLETED|Overall Study||5||
48215140|NCT03390296|100853447|FG000|NOT COMPLETED|Overall Study||0||
48215141|NCT03390296|100853448|FG001|NOT COMPLETED|Overall Study||0||
48215142|NCT03390296|100853449|FG002|NOT COMPLETED|Overall Study||0||
48215143|NCT03390296|100853450|FG003|NOT COMPLETED|Overall Study||0||
48215144|NCT03390296|100853451|FG004|NOT COMPLETED|Overall Study||0||
48215145|NCT03390296|100853452|FG005|NOT COMPLETED|Overall Study||0||
48215146|NCT03655262|100853453|FG000|STARTED|Overall Study||7||
48215147|NCT03655262|100853454|FG001|STARTED|Overall Study||8||
48215148|NCT03655262|100853455|FG002|STARTED|Overall Study||8||
48215149|NCT03655262|100853453|FG000|COMPLETED|Overall Study||7||
48215150|NCT03655262|100853454|FG001|COMPLETED|Overall Study||8||
48215151|NCT03655262|100853455|FG002|COMPLETED|Overall Study||7||
48215152|NCT03655262|100853453|FG000|NOT COMPLETED|Overall Study||0||
48215153|NCT03655262|100853454|FG001|NOT COMPLETED|Overall Study||0||
48215154|NCT03655262|100853455|FG002|NOT COMPLETED|Overall Study||1||
48215155|NCT00780234|100853456|FG000|STARTED|Overall Study||47||
48215156|NCT00780234|100853457|FG001|STARTED|Overall Study||45||
48215157|NCT00780234|100853456|FG000|COMPLETED|Overall Study||39||
48215158|NCT00780234|100853457|FG001|COMPLETED|Overall Study||37||
48215159|NCT00780234|100853456|FG000|NOT COMPLETED|Overall Study||8||
48215160|NCT00780234|100853457|FG001|NOT COMPLETED|Overall Study||8||
48215161|NCT03593876|100853458|FG000|STARTED|Overall Study||16||
48215162|NCT03593876|100853458|FG000|COMPLETED|Overall Study||13||
48215163|NCT03593876|100853458|FG000|NOT COMPLETED|Overall Study||3||
48215164|NCT00998881|100853459|FG000|STARTED|Overall Study||104||
48215165|NCT00998881|100853460|FG001|STARTED|Overall Study||99||
48215166|NCT00998881|100853459|FG000|COMPLETED|Overall Study||96||
48215167|NCT00998881|100853460|FG001|COMPLETED|Overall Study||97||
48215168|NCT00998881|100853459|FG000|NOT COMPLETED|Overall Study||8||
48215169|NCT00998881|100853460|FG001|NOT COMPLETED|Overall Study||2||
48215170|NCT02222493|100853461|FG000|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||324||
48215171|NCT02222493|100853462|FG001|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||326||
48215172|NCT02222493|100853461|FG000|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||323||
48215173|NCT02222493|100853462|FG001|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||326||
48215174|NCT02222493|100853461|FG000|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||280||
48215175|NCT02222493|100853462|FG001|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||286||
48215176|NCT02222493|100853461|FG000|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||44||
48215177|NCT02222493|100853462|FG001|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||40||
48215178|NCT02222493|100853461|FG000|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||423||
48215179|NCT02222493|100853462|FG001|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||143||
48215180|NCT02222493|100853461|FG000|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||380||
48215181|NCT02222493|100853462|FG001|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||126||
48215182|NCT02222493|100853461|FG000|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||43||
48215183|NCT02222493|100853462|FG001|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||17||
48215184|NCT02222493|100853461|FG000|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||505||
48215185|NCT02222493|100853462|FG001|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||0||
48215186|NCT02222493|100853461|FG000|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||474||
48215187|NCT02222493|100853462|FG001|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0||
48215188|NCT02222493|100853461|FG000|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||31||
48215189|NCT02222493|100853462|FG001|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0||
48215190|NCT00709098|100853463|FG000|STARTED|Double-blind Period||25||
48215191|NCT00709098|100853464|FG001|STARTED|Double-blind Period||24||
48215192|NCT00709098|100853465|FG002|STARTED|Double-blind Period||0||
48215193|NCT00709098|100853463|FG000|COMPLETED|Double-blind Period||19||
48215194|NCT00709098|100853464|FG001|COMPLETED|Double-blind Period||16||
48215195|NCT00709098|100853465|FG002|COMPLETED|Double-blind Period||0||
48215196|NCT00709098|100853463|FG000|NOT COMPLETED|Double-blind Period||6||
48215197|NCT00709098|100853464|FG001|NOT COMPLETED|Double-blind Period||8||
48215198|NCT00709098|100853465|FG002|NOT COMPLETED|Double-blind Period||0||
48215199|NCT00709098|100853463|FG000|STARTED|Open-label Period||0||
48215200|NCT00709098|100853464|FG001|STARTED|Open-label Period||0||
48215201|NCT00709098|100853465|FG002|STARTED|Open-label Period||32||
48215202|NCT00709098|100853463|FG000|COMPLETED|Open-label Period||0||
48215203|NCT00709098|100853464|FG001|COMPLETED|Open-label Period||0||
48215204|NCT00709098|100853465|FG002|COMPLETED|Open-label Period||18||
48215205|NCT00709098|100853463|FG000|NOT COMPLETED|Open-label Period||0||
48215206|NCT00709098|100853464|FG001|NOT COMPLETED|Open-label Period||0||
48215207|NCT00709098|100853465|FG002|NOT COMPLETED|Open-label Period||14||
48215208|NCT02590432|100853466|FG000|STARTED|Open-label Treatment Period||508||
48215209|NCT02590432|100853467|FG001|STARTED|Open-label Treatment Period||318||
48215210|NCT02590432|100853468|FG002|STARTED|Open-label Treatment Period||0||
48215211|NCT02590432|100853469|FG003|STARTED|Open-label Treatment Period||0||
48215212|NCT02590432|100853470|FG004|STARTED|Open-label Treatment Period||0||
48215213|NCT02590432|100853471|FG005|STARTED|Open-label Treatment Period||0||
48215214|NCT02590432|100853472|FG006|STARTED|Open-label Treatment Period||0||
48215215|NCT02590432|100853473|FG007|STARTED|Open-label Treatment Period||0||
48215216|NCT02590432|100853474|FG008|STARTED|Open-label Treatment Period||0||
48215217|NCT02590432|100853466|FG000|COMPLETED|Open-label Treatment Period||276|Out of 384 participants who discontinued, 114 continued to Double-blind Treatment Period.|
48215218|NCT02590432|100853467|FG001|COMPLETED|Open-label Treatment Period||166|Out of 384 participants who discontinued, 114 continued to Double-blind Treatment Period.|
48215219|NCT02590432|100853468|FG002|COMPLETED|Open-label Treatment Period||0|Out of 384 participants who discontinued, 114 continued to Double-blind Treatment Period.|
48215220|NCT02590432|100853469|FG003|COMPLETED|Open-label Treatment Period||0|Out of 384 participants who discontinued, 114 continued to Double-blind Treatment Period.|
48215221|NCT02590432|100853470|FG004|COMPLETED|Open-label Treatment Period||0|Out of 384 participants who discontinued, 114 continued to Double-blind Treatment Period.|
48215222|NCT02590432|100853471|FG005|COMPLETED|Open-label Treatment Period||0|Out of 384 participants who discontinued, 114 continued to Double-blind Treatment Period.|
48215223|NCT02590432|100853472|FG006|COMPLETED|Open-label Treatment Period||0|Out of 384 participants who discontinued, 114 continued to Double-blind Treatment Period.|
48215224|NCT02590432|100853473|FG007|COMPLETED|Open-label Treatment Period||0|Out of 384 participants who discontinued, 114 continued to Double-blind Treatment Period.|
48215225|NCT02590432|100853474|FG008|COMPLETED|Open-label Treatment Period||0|Out of 384 participants who discontinued, 114 continued to Double-blind Treatment Period.|
48215226|NCT02590432|100853466|FG000|NOT COMPLETED|Open-label Treatment Period||232||
48215227|NCT02590432|100853467|FG001|NOT COMPLETED|Open-label Treatment Period||152||
48215228|NCT02590432|100853468|FG002|NOT COMPLETED|Open-label Treatment Period||0||
48215229|NCT02590432|100853469|FG003|NOT COMPLETED|Open-label Treatment Period||0||
48215230|NCT02590432|100853470|FG004|NOT COMPLETED|Open-label Treatment Period||0||
48215231|NCT02590432|100853471|FG005|NOT COMPLETED|Open-label Treatment Period||0||
48215232|NCT02590432|100853472|FG006|NOT COMPLETED|Open-label Treatment Period||0||
48215233|NCT02590432|100853473|FG007|NOT COMPLETED|Open-label Treatment Period||0||
48215234|NCT02590432|100853474|FG008|NOT COMPLETED|Open-label Treatment Period||0||
48215235|NCT02590432|100853466|FG000|STARTED|Double-blind Treatment Period||0||
48215236|NCT02590432|100853467|FG001|STARTED|Double-blind Treatment Period||0||
48215237|NCT02590432|100853468|FG002|STARTED|Double-blind Treatment Period||18||
48215238|NCT02590432|100853469|FG003|STARTED|Double-blind Treatment Period||18||
48215239|NCT02590432|100853470|FG004|STARTED|Double-blind Treatment Period||16||
48215240|NCT02590432|100853471|FG005|STARTED|Double-blind Treatment Period||32||
48215241|NCT02590432|100853472|FG006|STARTED|Double-blind Treatment Period||30||
48215242|NCT02590432|100853473|FG007|STARTED|Double-blind Treatment Period||0||
48215243|NCT02590432|100853474|FG008|STARTED|Double-blind Treatment Period||0||
48215244|NCT02590432|100853466|FG000|COMPLETED|Double-blind Treatment Period||0|Out of 88 participants who discontinued, 57 continued to Dose-reduced Open Label Treatment Period.|
48215245|NCT02590432|100853467|FG001|COMPLETED|Double-blind Treatment Period||0|Out of 88 participants who discontinued, 57 continued to Dose-reduced Open Label Treatment Period.|
48215246|NCT02590432|100853468|FG002|COMPLETED|Double-blind Treatment Period||1|Out of 88 participants who discontinued, 57 continued to Dose-reduced Open Label Treatment Period.|
48215247|NCT02590432|100853469|FG003|COMPLETED|Double-blind Treatment Period||3|Out of 88 participants who discontinued, 57 continued to Dose-reduced Open Label Treatment Period.|
48215248|NCT02590432|100853470|FG004|COMPLETED|Double-blind Treatment Period||7|Out of 88 participants who discontinued, 57 continued to Dose-reduced Open Label Treatment Period.|
48215249|NCT02590432|100853471|FG005|COMPLETED|Double-blind Treatment Period||6|Out of 88 participants who discontinued, 57 continued to Dose-reduced Open Label Treatment Period.|
48215250|NCT02590432|100853472|FG006|COMPLETED|Double-blind Treatment Period||9|Out of 88 participants who discontinued, 57 continued to Dose-reduced Open Label Treatment Period.|
48215251|NCT02590432|100853473|FG007|COMPLETED|Double-blind Treatment Period||0|Out of 88 participants who discontinued, 57 continued to Dose-reduced Open Label Treatment Period.|
48215252|NCT02590432|100853474|FG008|COMPLETED|Double-blind Treatment Period||0|Out of 88 participants who discontinued, 57 continued to Dose-reduced Open Label Treatment Period.|
48215253|NCT02590432|100853466|FG000|NOT COMPLETED|Double-blind Treatment Period||0||
48215254|NCT02590432|100853467|FG001|NOT COMPLETED|Double-blind Treatment Period||0||
48215255|NCT02590432|100853468|FG002|NOT COMPLETED|Double-blind Treatment Period||17||
48215256|NCT02590432|100853469|FG003|NOT COMPLETED|Double-blind Treatment Period||15||
48215257|NCT02590432|100853470|FG004|NOT COMPLETED|Double-blind Treatment Period||9||
48215258|NCT02590432|100853471|FG005|NOT COMPLETED|Double-blind Treatment Period||26||
48215259|NCT02590432|100853472|FG006|NOT COMPLETED|Double-blind Treatment Period||21||
48215260|NCT02590432|100853473|FG007|NOT COMPLETED|Double-blind Treatment Period||0||
48215261|NCT02590432|100853474|FG008|NOT COMPLETED|Double-blind Treatment Period||0||
48215262|NCT02590432|100853466|FG000|STARTED|Dose-reduced Open Label Treatment Period||0||
48215263|NCT02590432|100853467|FG001|STARTED|Dose-reduced Open Label Treatment Period||0||
48215264|NCT02590432|100853468|FG002|STARTED|Dose-reduced Open Label Treatment Period||0||
48215265|NCT02590432|100853469|FG003|STARTED|Dose-reduced Open Label Treatment Period||0||
48215266|NCT02590432|100853470|FG004|STARTED|Dose-reduced Open Label Treatment Period||0||
48215267|NCT02590432|100853471|FG005|STARTED|Dose-reduced Open Label Treatment Period||0||
48215268|NCT02590432|100853472|FG006|STARTED|Dose-reduced Open Label Treatment Period||0||
48215269|NCT02590432|100853473|FG007|STARTED|Dose-reduced Open Label Treatment Period||31||
48215270|NCT02590432|100853474|FG008|STARTED|Dose-reduced Open Label Treatment Period||26||
48215271|NCT02590432|100853466|FG000|COMPLETED|Dose-reduced Open Label Treatment Period||0||
48215272|NCT02590432|100853467|FG001|COMPLETED|Dose-reduced Open Label Treatment Period||0||
48215273|NCT02590432|100853468|FG002|COMPLETED|Dose-reduced Open Label Treatment Period||0||
48215274|NCT02590432|100853469|FG003|COMPLETED|Dose-reduced Open Label Treatment Period||0||
48215275|NCT02590432|100853470|FG004|COMPLETED|Dose-reduced Open Label Treatment Period||0||
48215276|NCT02590432|100853471|FG005|COMPLETED|Dose-reduced Open Label Treatment Period||0||
48215277|NCT02590432|100853472|FG006|COMPLETED|Dose-reduced Open Label Treatment Period||0||
48215278|NCT02590432|100853473|FG007|COMPLETED|Dose-reduced Open Label Treatment Period||13||
48215279|NCT02590432|100853474|FG008|COMPLETED|Dose-reduced Open Label Treatment Period||8||
48215280|NCT02590432|100853466|FG000|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0||
48215281|NCT02590432|100853467|FG001|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0||
48215282|NCT02590432|100853468|FG002|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0||
48215283|NCT02590432|100853469|FG003|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0||
48215284|NCT02590432|100853470|FG004|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0||
48215285|NCT02590432|100853471|FG005|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0||
48215286|NCT02590432|100853472|FG006|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0||
48215287|NCT02590432|100853473|FG007|NOT COMPLETED|Dose-reduced Open Label Treatment Period||18||
48215288|NCT02590432|100853474|FG008|NOT COMPLETED|Dose-reduced Open Label Treatment Period||18||
48215289|NCT01256840|100853475|FG000|STARTED|Overall Study||30||
48215290|NCT01256840|100853476|FG001|STARTED|Overall Study||16||
48215291|NCT01256840|100853477|FG002|STARTED|Overall Study||25||
48215292|NCT01256840|100853475|FG000|COMPLETED|Overall Study||30||
48215293|NCT01256840|100853476|FG001|COMPLETED|Overall Study||16||
48215294|NCT01256840|100853477|FG002|COMPLETED|Overall Study||25||
48215295|NCT01256840|100853475|FG000|NOT COMPLETED|Overall Study||0||
48215296|NCT01256840|100853476|FG001|NOT COMPLETED|Overall Study||0||
48215297|NCT01256840|100853477|FG002|NOT COMPLETED|Overall Study||0||
48215298|NCT00722046|100853478|FG000|STARTED|Overall Study||26||
48215299|NCT00722046|100853479|FG001|STARTED|Overall Study||26||
48215300|NCT00722046|100853480|FG002|STARTED|Overall Study||25||
48215301|NCT00722046|100853481|FG003|STARTED|Overall Study||26||
48215302|NCT00722046|100853482|FG004|STARTED|Overall Study||32||
48215303|NCT00722046|100853483|FG005|STARTED|Overall Study||31||
48215304|NCT00722046|100853484|FG006|STARTED|Overall Study||32||
48215305|NCT00722046|100853478|FG000|Treated|Overall Study||25||
48215306|NCT00722046|100853479|FG001|Treated|Overall Study||25||
48215307|NCT00722046|100853480|FG002|Treated|Overall Study||25||
48215308|NCT00722046|100853481|FG003|Treated|Overall Study||24||
48215309|NCT00722046|100853482|FG004|Treated|Overall Study||32||
48215310|NCT00722046|100853483|FG005|Treated|Overall Study||31||
48215311|NCT00722046|100853484|FG006|Treated|Overall Study||32||
48215312|NCT00722046|100853478|FG000|COMPLETED|Overall Study||21||
48215313|NCT00722046|100853479|FG001|COMPLETED|Overall Study||20||
48215314|NCT00722046|100853480|FG002|COMPLETED|Overall Study||18||
48215315|NCT00722046|100853481|FG003|COMPLETED|Overall Study||18||
48215316|NCT00722046|100853482|FG004|COMPLETED|Overall Study||23||
48215317|NCT00722046|100853483|FG005|COMPLETED|Overall Study||20||
48215318|NCT00722046|100853484|FG006|COMPLETED|Overall Study||26||
48215319|NCT00722046|100853478|FG000|NOT COMPLETED|Overall Study||5||
48215320|NCT00722046|100853479|FG001|NOT COMPLETED|Overall Study||6||
48215321|NCT00722046|100853480|FG002|NOT COMPLETED|Overall Study||7||
48215322|NCT00722046|100853481|FG003|NOT COMPLETED|Overall Study||8||
48215323|NCT00722046|100853482|FG004|NOT COMPLETED|Overall Study||9||
48215324|NCT00722046|100853483|FG005|NOT COMPLETED|Overall Study||11||
48215325|NCT00722046|100853484|FG006|NOT COMPLETED|Overall Study||6||
48215326|NCT04056624|100853485|FG000|STARTED|Overall Study||53||
48215327|NCT04056624|100853486|FG001|STARTED|Overall Study||56||
48215328|NCT04056624|100853487|FG002|STARTED|Overall Study||53||
48215329|NCT04056624|100853485|FG000|COMPLETED|Overall Study||52||
48215330|NCT04056624|100853486|FG001|COMPLETED|Overall Study||54||
48215331|NCT04056624|100853487|FG002|COMPLETED|Overall Study||52||
48215332|NCT04056624|100853485|FG000|NOT COMPLETED|Overall Study||1||
48215333|NCT04056624|100853486|FG001|NOT COMPLETED|Overall Study||2||
48215334|NCT04056624|100853487|FG002|NOT COMPLETED|Overall Study||1||
48215335|NCT03752151|100853488|FG000|STARTED|Overall Study||77||
48215336|NCT03752151|100853488|FG000|COMPLETED|Overall Study||75||
48215337|NCT03752151|100853488|FG000|NOT COMPLETED|Overall Study||2||
48215338|NCT01188655|100853489|FG000|STARTED|Overall Study||89||
48215339|NCT01188655|100853489|FG000|COMPLETED|Overall Study||76||
48215340|NCT01188655|100853489|FG000|NOT COMPLETED|Overall Study||13||
48215341|NCT02187887|100853490|FG000|STARTED|Overall Study||393||
48215342|NCT02187887|100853491|FG001|STARTED|Overall Study||400||
48215343|NCT02187887|100853490|FG000|COMPLETED|Overall Study||388||
48215344|NCT02187887|100853491|FG001|COMPLETED|Overall Study||396||
48215345|NCT02187887|100853490|FG000|NOT COMPLETED|Overall Study||5||
48215346|NCT02187887|100853491|FG001|NOT COMPLETED|Overall Study||4||
48215347|NCT02476409|100853492|FG000|STARTED|Overall Study||19||
48215348|NCT02476409|100853493|FG001|STARTED|Overall Study||21||
48215349|NCT02476409|100853492|FG000|COMPLETED|Overall Study||19||
48215350|NCT02476409|100853493|FG001|COMPLETED|Overall Study||21||
48215351|NCT02476409|100853492|FG000|NOT COMPLETED|Overall Study||0||
48215352|NCT02476409|100853493|FG001|NOT COMPLETED|Overall Study||0||
48215353|NCT01609218|100853494|FG000|STARTED|Period 1||13||
48215354|NCT01609218|100853495|FG001|STARTED|Period 1||14||
48215355|NCT01609218|100853494|FG000|Received LY2140023|Period 1||13||
48215356|NCT01609218|100853495|FG001|Received LY2140023|Period 1||14||
48215357|NCT01609218|100853494|FG000|Received Activated Charcoal|Period 1||0||
48215358|NCT01609218|100853495|FG001|Received Activated Charcoal|Period 1||12||
48215359|NCT01609218|100853494|FG000|COMPLETED|Period 1||10||
48215360|NCT01609218|100853495|FG001|COMPLETED|Period 1||8||
48215361|NCT01609218|100853494|FG000|NOT COMPLETED|Period 1||3||
48215362|NCT01609218|100853495|FG001|NOT COMPLETED|Period 1||6||
48215363|NCT01609218|100853494|FG000|STARTED|Period 2||10||
48215364|NCT01609218|100853495|FG001|STARTED|Period 2||9||
48215365|NCT01609218|100853494|FG000|Received LY2140023|Period 2||10||
48215366|NCT01609218|100853495|FG001|Received LY2140023|Period 2||9||
48215367|NCT01609218|100853494|FG000|Received Activated Charcoal|Period 2||9||
48215368|NCT01609218|100853495|FG001|Received Activated Charcoal|Period 2||0||
48215369|NCT01609218|100853494|FG000|COMPLETED|Period 2||9||
48215370|NCT01609218|100853495|FG001|COMPLETED|Period 2||9||
48215371|NCT01609218|100853494|FG000|NOT COMPLETED|Period 2||1||
48215372|NCT01609218|100853495|FG001|NOT COMPLETED|Period 2||0||
48215373|NCT03785405|100853496|FG000|STARTED|Overall Study||130||
48215374|NCT03785405|100853497|FG001|STARTED|Overall Study||86||
48215375|NCT03785405|100853496|FG000|Safety Set (SAF)|Overall Study||130|All screened participants who received at least one dose of open-label study treatment.|
48215376|NCT03785405|100853497|FG001|Safety Set (SAF)|Overall Study||85|All screened participants who received at least one dose of open-label study treatment.|
48215377|NCT03785405|100853496|FG000|COMPLETED|Overall Study||92||
48215378|NCT03785405|100853497|FG001|COMPLETED|Overall Study||74||
48215379|NCT03785405|100853496|FG000|NOT COMPLETED|Overall Study||38||
48215380|NCT03785405|100853497|FG001|NOT COMPLETED|Overall Study||12||
48215381|NCT00650104|100853498|FG000|STARTED|Overall Study||83||
48215382|NCT00650104|100853498|FG000|COMPLETED|Overall Study||42||
48215383|NCT00650104|100853498|FG000|NOT COMPLETED|Overall Study||41||
48215384|NCT03242148|100853499|FG000|STARTED|Overall Study||38||
48215385|NCT03242148|100853499|FG000|COMPLETED|Overall Study||38||
48215386|NCT03242148|100853499|FG000|NOT COMPLETED|Overall Study||0||
48215387|NCT00823472|100853500|FG000|STARTED|Overall Study||80||
48215388|NCT00823472|100853501|FG001|STARTED|Overall Study||67||
48215389|NCT00823472|100853500|FG000|COMPLETED|Overall Study||56||
48215390|NCT00823472|100853501|FG001|COMPLETED|Overall Study||39||
48215391|NCT00823472|100853500|FG000|NOT COMPLETED|Overall Study||24||
48215392|NCT00823472|100853501|FG001|NOT COMPLETED|Overall Study||28||
48215393|NCT01647581|100853502|FG000|STARTED|Overall Study||547||
48215394|NCT01647581|100853503|FG001|STARTED|Overall Study||551||
48215395|NCT01647581|100853502|FG000|COMPLETED|Overall Study||530||
48215396|NCT01647581|100853503|FG001|COMPLETED|Overall Study||520||
48215397|NCT01647581|100853502|FG000|NOT COMPLETED|Overall Study||17||
48215398|NCT01647581|100853503|FG001|NOT COMPLETED|Overall Study||31||
48215399|NCT03771352|100853504|FG000|STARTED|Overall Study||55||110
48215400|NCT03771352|100853504|FG000|COMPLETED|Overall Study||51||101
48215401|NCT03771352|100853504|FG000|NOT COMPLETED|Overall Study||4||9
48215402|NCT01040689|100853505|FG000|STARTED|Overall Study||27||
48215403|NCT01040689|100853506|FG001|STARTED|Overall Study||27||
48215404|NCT01040689|100853507|FG002|STARTED|Overall Study||27||
48215405|NCT01040689|100853508|FG003|STARTED|Overall Study||27||
48215406|NCT01040689|100853505|FG000|COMPLETED|Overall Study||24||
48215407|NCT01040689|100853506|FG001|COMPLETED|Overall Study||25||
48215408|NCT01040689|100853507|FG002|COMPLETED|Overall Study||23||
48215409|NCT01040689|100853508|FG003|COMPLETED|Overall Study||23||
48215410|NCT01040689|100853505|FG000|NOT COMPLETED|Overall Study||3||
48215411|NCT01040689|100853506|FG001|NOT COMPLETED|Overall Study||2||
48215412|NCT01040689|100853507|FG002|NOT COMPLETED|Overall Study||4||
48215413|NCT01040689|100853508|FG003|NOT COMPLETED|Overall Study||4||
48215414|NCT00533910|100853509|FG000|STARTED|Overall Study||21||
48215415|NCT00533910|100853510|FG001|STARTED|Overall Study||21||
48215416|NCT00533910|100853509|FG000|COMPLETED|Overall Study||21||
48215417|NCT00533910|100853510|FG001|COMPLETED|Overall Study||21||
48215418|NCT00533910|100853509|FG000|NOT COMPLETED|Overall Study||0||
48215419|NCT00533910|100853510|FG001|NOT COMPLETED|Overall Study||0||
48215420|NCT01953692|100853511|FG000|STARTED|Overall Study||28||
48215421|NCT01953692|100853512|FG001|STARTED|Overall Study||30||
48215422|NCT01953692|100853513|FG002|STARTED|Overall Study||31||
48215423|NCT01953692|100853514|FG003|STARTED|Overall Study||21||
48215424|NCT01953692|100853515|FG004|STARTED|Overall Study||4||
48215425|NCT01953692|100853516|FG005|STARTED|Overall Study||22||
48215426|NCT01953692|100853517|FG006|STARTED|Overall Study||42||
48215427|NCT01953692|100853518|FG007|STARTED|Overall Study||13||
48215428|NCT01953692|100853519|FG008|STARTED|Overall Study||6||
48215429|NCT01953692|100853511|FG000|COMPLETED|Overall Study||1||
48215430|NCT01953692|100853512|FG001|COMPLETED|Overall Study||5||
48215431|NCT01953692|100853513|FG002|COMPLETED|Overall Study||11||
48215432|NCT01953692|100853514|FG003|COMPLETED|Overall Study||7||
48215433|NCT01953692|100853515|FG004|COMPLETED|Overall Study||1||
48215434|NCT01953692|100853516|FG005|COMPLETED|Overall Study||4||
48215435|NCT01953692|100853517|FG006|COMPLETED|Overall Study||10||
48215436|NCT01953692|100853518|FG007|COMPLETED|Overall Study||3||
48215437|NCT01953692|100853519|FG008|COMPLETED|Overall Study||1||
48215438|NCT01953692|100853511|FG000|NOT COMPLETED|Overall Study||27||
48215439|NCT01953692|100853512|FG001|NOT COMPLETED|Overall Study||25||
48215440|NCT01953692|100853513|FG002|NOT COMPLETED|Overall Study||20||
48215441|NCT01953692|100853514|FG003|NOT COMPLETED|Overall Study||14||
48215442|NCT01953692|100853515|FG004|NOT COMPLETED|Overall Study||3||
48215443|NCT01953692|100853516|FG005|NOT COMPLETED|Overall Study||18||
48215444|NCT01953692|100853517|FG006|NOT COMPLETED|Overall Study||32||
48215445|NCT01953692|100853518|FG007|NOT COMPLETED|Overall Study||10||
48215446|NCT01953692|100853519|FG008|NOT COMPLETED|Overall Study||5||
48215447|NCT03717506|100853520|FG000|STARTED|Overall Study||496||
48215448|NCT03717506|100853521|FG001|STARTED|Overall Study||491||
48215449|NCT03717506|100853522|FG002|STARTED|Overall Study||249||
48215450|NCT03717506|100853520|FG000|COMPLETED|Overall Study||447||
48215451|NCT03717506|100853521|FG001|COMPLETED|Overall Study||441||
48215452|NCT03717506|100853522|FG002|COMPLETED|Overall Study||222||
48215453|NCT03717506|100853520|FG000|NOT COMPLETED|Overall Study||49||
48215454|NCT03717506|100853521|FG001|NOT COMPLETED|Overall Study||50||
48215455|NCT03717506|100853522|FG002|NOT COMPLETED|Overall Study||27||
48215456|NCT00434304|100853523|FG000|STARTED|Overall Study||62||
48215457|NCT00434304|100853523|FG000|COMPLETED|Overall Study||42||
48215458|NCT00434304|100853523|FG000|NOT COMPLETED|Overall Study||20||
48215459|NCT02680457|100853524|FG000|STARTED|Initial Intervention||6||
48215460|NCT02680457|100853525|FG001|STARTED|Initial Intervention||6||
48215461|NCT02680457|100853524|FG000|COMPLETED|Initial Intervention||6||
48215462|NCT02680457|100853525|FG001|COMPLETED|Initial Intervention||6||
48215463|NCT02680457|100853524|FG000|NOT COMPLETED|Initial Intervention||0||
48215464|NCT02680457|100853525|FG001|NOT COMPLETED|Initial Intervention||0||
48215465|NCT02680457|100853524|FG000|STARTED|Washout Period||6||
48215466|NCT02680457|100853525|FG001|STARTED|Washout Period||6||
48215467|NCT02680457|100853524|FG000|COMPLETED|Washout Period||6||
48215468|NCT02680457|100853525|FG001|COMPLETED|Washout Period||6||
48215469|NCT02680457|100853524|FG000|NOT COMPLETED|Washout Period||0||
48215470|NCT02680457|100853525|FG001|NOT COMPLETED|Washout Period||0||
48215471|NCT02680457|100853524|FG000|STARTED|Cross-over Intervention||6||
48215472|NCT02680457|100853525|FG001|STARTED|Cross-over Intervention||6||
48215473|NCT02680457|100853524|FG000|COMPLETED|Cross-over Intervention||6||
48215474|NCT02680457|100853525|FG001|COMPLETED|Cross-over Intervention||6||
48215475|NCT02680457|100853524|FG000|NOT COMPLETED|Cross-over Intervention||0||
48215476|NCT02680457|100853525|FG001|NOT COMPLETED|Cross-over Intervention||0||
48215477|NCT01261052|100853526|FG000|STARTED|FMPD/APD Intervention (33 Hours)||14||
48215478|NCT01261052|100853526|FG000|COMPLETED|FMPD/APD Intervention (33 Hours)||14||
48215479|NCT01261052|100853526|FG000|NOT COMPLETED|FMPD/APD Intervention (33 Hours)||0||
48496249|NCT05479058|101548044|FG001|STARTED|Overall Study||11||
48496250|NCT05479058|101548043|FG000|COMPLETED|Overall Study||0||
48496251|NCT05479058|101548044|FG001|COMPLETED|Overall Study||0||
48496252|NCT05479058|101548043|FG000|NOT COMPLETED|Overall Study||11||
48496253|NCT05479058|101548044|FG001|NOT COMPLETED|Overall Study||11||
48496254|NCT01586039|101548045|FG000|STARTED|Overall Study||8||
48060329|NCT02642029|100470181|FG005|COMPLETED|Study Visit 1 (1 Day)||4||
48060330|NCT02642029|100470176|FG000|NOT COMPLETED|Study Visit 1 (1 Day)||0||
48060331|NCT02642029|100470177|FG001|NOT COMPLETED|Study Visit 1 (1 Day)||0||
48060332|NCT02642029|100470178|FG002|NOT COMPLETED|Study Visit 1 (1 Day)||0||
48060333|NCT02642029|100470179|FG003|NOT COMPLETED|Study Visit 1 (1 Day)||0||
48060334|NCT02642029|100470180|FG004|NOT COMPLETED|Study Visit 1 (1 Day)||0||
48060335|NCT02642029|100470181|FG005|NOT COMPLETED|Study Visit 1 (1 Day)||0||
48060336|NCT02642029|100470176|FG000|STARTED|Washout 1 (≥ 36 Hours)||6||
48060337|NCT02642029|100470177|FG001|STARTED|Washout 1 (≥ 36 Hours)||5||
48060338|NCT02642029|100470178|FG002|STARTED|Washout 1 (≥ 36 Hours)||3||
48060339|NCT02642029|100470179|FG003|STARTED|Washout 1 (≥ 36 Hours)||4||
48060340|NCT02642029|100470180|FG004|STARTED|Washout 1 (≥ 36 Hours)||4||
48060341|NCT02642029|100470181|FG005|STARTED|Washout 1 (≥ 36 Hours)||4||
48060342|NCT02642029|100470176|FG000|COMPLETED|Washout 1 (≥ 36 Hours)||5||
48060343|NCT02642029|100470177|FG001|COMPLETED|Washout 1 (≥ 36 Hours)||4||
48060344|NCT02642029|100470178|FG002|COMPLETED|Washout 1 (≥ 36 Hours)||3||
48060345|NCT02642029|100470179|FG003|COMPLETED|Washout 1 (≥ 36 Hours)||4||
48060346|NCT02642029|100470180|FG004|COMPLETED|Washout 1 (≥ 36 Hours)||3||
48060347|NCT02642029|100470181|FG005|COMPLETED|Washout 1 (≥ 36 Hours)||4||
48060348|NCT02642029|100470176|FG000|NOT COMPLETED|Washout 1 (≥ 36 Hours)||1||
48060349|NCT02642029|100470177|FG001|NOT COMPLETED|Washout 1 (≥ 36 Hours)||1||
48060350|NCT02642029|100470178|FG002|NOT COMPLETED|Washout 1 (≥ 36 Hours)||0||
48060351|NCT02642029|100470179|FG003|NOT COMPLETED|Washout 1 (≥ 36 Hours)||0||
48060352|NCT02642029|100470180|FG004|NOT COMPLETED|Washout 1 (≥ 36 Hours)||1||
48215480|NCT01261052|100853526|FG000|STARTED|APD Only Intervention (33 Hours)||14||
48215481|NCT01261052|100853526|FG000|COMPLETED|APD Only Intervention (33 Hours)||14||
48215482|NCT01261052|100853526|FG000|NOT COMPLETED|APD Only Intervention (33 Hours)||0||
48215483|NCT00419341|100853527|FG000|STARTED|Wash in/Wash Out Period||49||
48215484|NCT00419341|100853527|FG000|COMPLETED|Wash in/Wash Out Period||38||
48215485|NCT00419341|100853527|FG000|NOT COMPLETED|Wash in/Wash Out Period||11||
48215486|NCT00419341|100853527|FG000|STARTED|Efficacy Period||38||
48215487|NCT00419341|100853527|FG000|COMPLETED|Efficacy Period||28||
48215488|NCT00419341|100853527|FG000|NOT COMPLETED|Efficacy Period||10||
48215489|NCT01363492|100853528|FG000|STARTED|Overall Study||14||
48215490|NCT01363492|100853528|FG000|COMPLETED|Overall Study||14||
48215491|NCT01363492|100853528|FG000|NOT COMPLETED|Overall Study||0||
48215492|NCT03067948|100853529|FG000|STARTED|Overall Study||32||
48496255|NCT01586039|101548046|FG001|STARTED|Overall Study||9||
48060353|NCT02642029|100470181|FG005|NOT COMPLETED|Washout 1 (≥ 36 Hours)||0||
48060354|NCT02642029|100470176|FG000|STARTED|Study Visit 2 (1 Day)||5||
48060355|NCT02642029|100470177|FG001|STARTED|Study Visit 2 (1 Day)||4||
48215493|NCT03067948|100853529|FG000|COMPLETED|Overall Study||32||
48215494|NCT03067948|100853529|FG000|NOT COMPLETED|Overall Study||0||
48215495|NCT01388361|100853530|FG000|STARTED|Overall Study||236||
48215496|NCT01388361|100853531|FG001|STARTED|Overall Study||88||
48215497|NCT01388361|100853532|FG002|STARTED|Overall Study||89||
48215498|NCT01388361|100853530|FG000|Exposed|Overall Study||234||
48215499|NCT01388361|100853531|FG001|Exposed|Overall Study||87||
48215500|NCT01388361|100853532|FG002|Exposed|Overall Study||86||
48215501|NCT01388361|100853530|FG000|COMPLETED|Overall Study||224||
48215502|NCT01388361|100853531|FG001|COMPLETED|Overall Study||76||
48215503|NCT01388361|100853532|FG002|COMPLETED|Overall Study||75||
48215504|NCT01388361|100853530|FG000|NOT COMPLETED|Overall Study||12||
48215505|NCT01388361|100853531|FG001|NOT COMPLETED|Overall Study||12||
48215506|NCT01388361|100853532|FG002|NOT COMPLETED|Overall Study||14||
48215507|NCT00901901|100853533|FG000|STARTED|Treatment Period||362||
48215508|NCT00901901|100853534|FG001|STARTED|Treatment Period||358||
48215509|NCT00901901|100853533|FG000|Participants Received Treatment|Treatment Period||362||
48215510|NCT00901901|100853534|FG001|Participants Received Treatment|Treatment Period||355||
48215511|NCT00901901|100853533|FG000|COMPLETED|Treatment Period||193||
48496256|NCT01586039|101548047|FG002|STARTED|Overall Study||8||
48496257|NCT01586039|101548048|FG003|STARTED|Overall Study||8||
48060356|NCT02642029|100470178|FG002|STARTED|Study Visit 2 (1 Day)||3||
48060357|NCT02642029|100470179|FG003|STARTED|Study Visit 2 (1 Day)||4||
48060358|NCT02642029|100470180|FG004|STARTED|Study Visit 2 (1 Day)||3||
48060359|NCT02642029|100470181|FG005|STARTED|Study Visit 2 (1 Day)||4||
48060360|NCT02642029|100470176|FG000|COMPLETED|Study Visit 2 (1 Day)||4||
48060361|NCT02642029|100470177|FG001|COMPLETED|Study Visit 2 (1 Day)||4||
48060362|NCT02642029|100470178|FG002|COMPLETED|Study Visit 2 (1 Day)||3||
48060363|NCT02642029|100470179|FG003|COMPLETED|Study Visit 2 (1 Day)||4||
48060364|NCT02642029|100470180|FG004|COMPLETED|Study Visit 2 (1 Day)||3||
48060365|NCT02642029|100470181|FG005|COMPLETED|Study Visit 2 (1 Day)||4||
48060366|NCT02642029|100470176|FG000|NOT COMPLETED|Study Visit 2 (1 Day)||1||
48060367|NCT02642029|100470177|FG001|NOT COMPLETED|Study Visit 2 (1 Day)||0||
48060368|NCT02642029|100470178|FG002|NOT COMPLETED|Study Visit 2 (1 Day)||0||
48060369|NCT02642029|100470179|FG003|NOT COMPLETED|Study Visit 2 (1 Day)||0||
48060370|NCT02642029|100470180|FG004|NOT COMPLETED|Study Visit 2 (1 Day)||0||
48060371|NCT02642029|100470181|FG005|NOT COMPLETED|Study Visit 2 (1 Day)||0||
48060372|NCT02642029|100470176|FG000|STARTED|Washout 2 (≥ 36 Hours)||4||
48060373|NCT02642029|100470177|FG001|STARTED|Washout 2 (≥ 36 Hours)||4||
48060374|NCT02642029|100470178|FG002|STARTED|Washout 2 (≥ 36 Hours)||3||
48060375|NCT02642029|100470179|FG003|STARTED|Washout 2 (≥ 36 Hours)||4||
48060376|NCT02642029|100470180|FG004|STARTED|Washout 2 (≥ 36 Hours)||3||
48060377|NCT02642029|100470181|FG005|STARTED|Washout 2 (≥ 36 Hours)||4||
48060378|NCT02642029|100470176|FG000|COMPLETED|Washout 2 (≥ 36 Hours)||2||
48060379|NCT02642029|100470177|FG001|COMPLETED|Washout 2 (≥ 36 Hours)||4||
48060380|NCT02642029|100470178|FG002|COMPLETED|Washout 2 (≥ 36 Hours)||3||
48215512|NCT00901901|100853534|FG001|COMPLETED|Treatment Period||181||
48060381|NCT02642029|100470179|FG003|COMPLETED|Washout 2 (≥ 36 Hours)||4||
48060382|NCT02642029|100470180|FG004|COMPLETED|Washout 2 (≥ 36 Hours)||3||
48060383|NCT02642029|100470181|FG005|COMPLETED|Washout 2 (≥ 36 Hours)||4||
48060384|NCT02642029|100470176|FG000|NOT COMPLETED|Washout 2 (≥ 36 Hours)||2||
48060385|NCT02642029|100470177|FG001|NOT COMPLETED|Washout 2 (≥ 36 Hours)||0||
48060386|NCT02642029|100470178|FG002|NOT COMPLETED|Washout 2 (≥ 36 Hours)||0||
48060387|NCT02642029|100470179|FG003|NOT COMPLETED|Washout 2 (≥ 36 Hours)||0||
48060388|NCT02642029|100470180|FG004|NOT COMPLETED|Washout 2 (≥ 36 Hours)||0||
48060389|NCT02642029|100470181|FG005|NOT COMPLETED|Washout 2 (≥ 36 Hours)||0||
48060390|NCT02642029|100470176|FG000|STARTED|Study Visit 3 (1 Day)||2||
48215513|NCT00901901|100853533|FG000|NOT COMPLETED|Treatment Period||169||
48215514|NCT00901901|100853534|FG001|NOT COMPLETED|Treatment Period||177||
48215515|NCT00901901|100853533|FG000|STARTED|Follow-up Period||340||
48215516|NCT00901901|100853534|FG001|STARTED|Follow-up Period||341||
48215517|NCT00901901|100853533|FG000|COMPLETED|Follow-up Period||0||
48060391|NCT02642029|100470177|FG001|STARTED|Study Visit 3 (1 Day)||4||
48060392|NCT02642029|100470178|FG002|STARTED|Study Visit 3 (1 Day)||3||
48060393|NCT02642029|100470179|FG003|STARTED|Study Visit 3 (1 Day)||4||
48060394|NCT02642029|100470180|FG004|STARTED|Study Visit 3 (1 Day)||3||
48060395|NCT02642029|100470181|FG005|STARTED|Study Visit 3 (1 Day)||4||
48060396|NCT02642029|100470176|FG000|COMPLETED|Study Visit 3 (1 Day)||2||
48060397|NCT02642029|100470177|FG001|COMPLETED|Study Visit 3 (1 Day)||4||
48060398|NCT02642029|100470178|FG002|COMPLETED|Study Visit 3 (1 Day)||3||
48060399|NCT02642029|100470179|FG003|COMPLETED|Study Visit 3 (1 Day)||4||
48215518|NCT00901901|100853534|FG001|COMPLETED|Follow-up Period||0||
48215519|NCT00901901|100853533|FG000|NOT COMPLETED|Follow-up Period||340||
48215520|NCT00901901|100853534|FG001|NOT COMPLETED|Follow-up Period||341||
48215521|NCT00194610|100853535|FG000|STARTED|Overall Study||11||
48215522|NCT00194610|100853536|FG001|STARTED|Overall Study||9||
48215523|NCT00194610|100853535|FG000|COMPLETED|Overall Study||11||
48060400|NCT02642029|100470180|FG004|COMPLETED|Study Visit 3 (1 Day)||3||
48060401|NCT02642029|100470181|FG005|COMPLETED|Study Visit 3 (1 Day)||4||
48060402|NCT02642029|100470176|FG000|NOT COMPLETED|Study Visit 3 (1 Day)||0||
48215524|NCT00194610|100853536|FG001|COMPLETED|Overall Study||9||
48215525|NCT00194610|100853535|FG000|NOT COMPLETED|Overall Study||0||
48215526|NCT00194610|100853536|FG001|NOT COMPLETED|Overall Study||0||
48215527|NCT01185561|100853537|FG000|STARTED|Overall Study||36||
48215528|NCT01185561|100853538|FG001|STARTED|Overall Study||38||
48215529|NCT01185561|100853537|FG000|COMPLETED|Overall Study||34||
48215530|NCT01185561|100853538|FG001|COMPLETED|Overall Study||26||
48215531|NCT01185561|100853537|FG000|NOT COMPLETED|Overall Study||2||
48215532|NCT01185561|100853538|FG001|NOT COMPLETED|Overall Study||12||
48215533|NCT00227994|100853539|FG000|STARTED|Overall Study||20||
48215534|NCT00227994|100853540|FG001|STARTED|Overall Study||20||
48215535|NCT00227994|100853539|FG000|COMPLETED|Overall Study||13||
48215536|NCT00227994|100853540|FG001|COMPLETED|Overall Study||13||
48215537|NCT00227994|100853539|FG000|NOT COMPLETED|Overall Study||7||
48215538|NCT00227994|100853540|FG001|NOT COMPLETED|Overall Study||7||
48215539|NCT04530149|100853541|FG000|STARTED|Overall Study||1||
48215540|NCT04530149|100853542|FG001|STARTED|Overall Study||2||
48215541|NCT04530149|100853541|FG000|COMPLETED|Overall Study||1||
48215542|NCT04530149|100853542|FG001|COMPLETED|Overall Study||2||
48215543|NCT04530149|100853541|FG000|NOT COMPLETED|Overall Study||0||
48215544|NCT04530149|100853542|FG001|NOT COMPLETED|Overall Study||0||
48215545|NCT02867059|100853543|FG000|STARTED|Overall Study||7||
48215546|NCT02867059|100853544|FG001|STARTED|Overall Study||10||
48215547|NCT02867059|100853543|FG000|COMPLETED|Overall Study||7||
48215548|NCT02867059|100853544|FG001|COMPLETED|Overall Study||8||
48215549|NCT02867059|100853543|FG000|NOT COMPLETED|Overall Study||0||
48215550|NCT02867059|100853544|FG001|NOT COMPLETED|Overall Study||2||
48215551|NCT01972724|100853545|FG000|STARTED|Double-Blind||19||
48215552|NCT01972724|100853546|FG001|STARTED|Double-Blind||18||
48215553|NCT01972724|100853547|FG002|STARTED|Double-Blind||0||
48215554|NCT01972724|100853545|FG000|Intent-to-treat:Received Study Drug|Double-Blind||17||
48215555|NCT01972724|100853546|FG001|Intent-to-treat:Received Study Drug|Double-Blind||17||
48215556|NCT01972724|100853547|FG002|Intent-to-treat:Received Study Drug|Double-Blind||0||
48215557|NCT01972724|100853545|FG000|COMPLETED|Double-Blind||10||
48215558|NCT01972724|100853546|FG001|COMPLETED|Double-Blind||9||
48215559|NCT01972724|100853547|FG002|COMPLETED|Double-Blind||0||
48215560|NCT01972724|100853545|FG000|NOT COMPLETED|Double-Blind||9||
48215561|NCT01972724|100853546|FG001|NOT COMPLETED|Double-Blind||9||
48215562|NCT01972724|100853547|FG002|NOT COMPLETED|Double-Blind||0||
48215563|NCT01972724|100853545|FG000|STARTED|Open-Label||0||
48215564|NCT01972724|100853546|FG001|STARTED|Open-Label||0||
48215565|NCT01972724|100853547|FG002|STARTED|Open-Label||77||
48215566|NCT01972724|100853545|FG000|COMPLETED|Open-Label||0||
48215567|NCT01972724|100853546|FG001|COMPLETED|Open-Label||0||
48215568|NCT01972724|100853547|FG002|COMPLETED|Open-Label||72||
48215569|NCT01972724|100853545|FG000|NOT COMPLETED|Open-Label||0||
48215570|NCT01972724|100853546|FG001|NOT COMPLETED|Open-Label||0||
48215571|NCT01972724|100853547|FG002|NOT COMPLETED|Open-Label||5||
48215572|NCT01236560|100853548|FG000|STARTED|Overall Study||6||
48215573|NCT01236560|100853549|FG001|STARTED|Overall Study||32||
48215574|NCT01236560|100853550|FG002|STARTED|Overall Study||31||
48215575|NCT01236560|100853551|FG003|STARTED|Overall Study||32||
48215576|NCT01236560|100853552|FG004|STARTED|Overall Study||0||
48215577|NCT01236560|100853553|FG005|STARTED|Overall Study||0||
48215578|NCT01236560|100853548|FG000|COMPLETED|Overall Study||1||
48215579|NCT01236560|100853549|FG001|COMPLETED|Overall Study||8||
48215580|NCT01236560|100853550|FG002|COMPLETED|Overall Study||11||
48215581|NCT01236560|100853551|FG003|COMPLETED|Overall Study||10||
48215582|NCT01236560|100853552|FG004|COMPLETED|Overall Study||0||
48215583|NCT01236560|100853553|FG005|COMPLETED|Overall Study||0||
48215584|NCT01236560|100853548|FG000|NOT COMPLETED|Overall Study||5||
48215585|NCT01236560|100853549|FG001|NOT COMPLETED|Overall Study||24||
48215586|NCT01236560|100853550|FG002|NOT COMPLETED|Overall Study||20||
48215587|NCT01236560|100853551|FG003|NOT COMPLETED|Overall Study||22||
48215588|NCT01236560|100853552|FG004|NOT COMPLETED|Overall Study||0||
48215589|NCT01236560|100853553|FG005|NOT COMPLETED|Overall Study||0||
48215590|NCT03988842|100853554|FG000|STARTED|Overall Study||4||
48215591|NCT03988842|100853554|FG000|COMPLETED|Overall Study||3||
48215592|NCT03988842|100853554|FG000|NOT COMPLETED|Overall Study||1||
48215593|NCT03664960|100853555|FG000|STARTED|Overall Study||21||
48215594|NCT03664960|100853556|FG001|STARTED|Overall Study||37||
48215595|NCT03664960|100853555|FG000|COMPLETED|Overall Study||12||
48215596|NCT03664960|100853556|FG001|COMPLETED|Overall Study||15||
48215597|NCT03664960|100853555|FG000|NOT COMPLETED|Overall Study||9||
48215598|NCT03664960|100853556|FG001|NOT COMPLETED|Overall Study||22||
48215599|NCT00304031|100853557|FG000|STARTED|Concomitant RT+TMZ (Pre-randomization)||1125||
48215600|NCT00304031|100853558|FG001|STARTED|Concomitant RT+TMZ (Pre-randomization)||0||
48215601|NCT00304031|100853559|FG002|STARTED|Concomitant RT+TMZ (Pre-randomization)||0||
48215602|NCT00304031|100853557|FG000|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||1125||
48215603|NCT00304031|100853558|FG001|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||0||
48215604|NCT00304031|100853559|FG002|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||0||
48215605|NCT00304031|100853557|FG000|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||1120|Eligible pre-randomization participants with any follow-up data.|
48496258|NCT01586039|101548045|FG000|COMPLETED|Overall Study||8||
48496259|NCT01586039|101548046|FG001|COMPLETED|Overall Study||8||
48215606|NCT00304031|100853558|FG001|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||0|Eligible pre-randomization participants with any follow-up data.|
48215607|NCT00304031|100853559|FG002|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||0|Eligible pre-randomization participants with any follow-up data.|
48215608|NCT00304031|100853557|FG000|COMPLETED|Concomitant RT+TMZ (Pre-randomization)||833||
48215609|NCT00304031|100853558|FG001|COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0||
48215610|NCT00304031|100853559|FG002|COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0||
48215611|NCT00304031|100853557|FG000|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||292||
48215612|NCT00304031|100853558|FG001|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0||
48215613|NCT00304031|100853559|FG002|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0||
48215614|NCT00304031|100853557|FG000|STARTED|Randomization to Adjuvant TMZ Arm||0|Participants who met requirements after concomitant treatment were randomized to an adjuvant arm.|
48215615|NCT00304031|100853558|FG001|STARTED|Randomization to Adjuvant TMZ Arm||411|Participants who met requirements after concomitant treatment were randomized to an adjuvant arm.|
48215616|NCT00304031|100853559|FG002|STARTED|Randomization to Adjuvant TMZ Arm||422|Participants who met requirements after concomitant treatment were randomized to an adjuvant arm.|
48215617|NCT00304031|100853557|FG000|Eligible Population|Randomization to Adjuvant TMZ Arm||0||
48215618|NCT00304031|100853558|FG001|Eligible Population|Randomization to Adjuvant TMZ Arm||411||
48215619|NCT00304031|100853559|FG002|Eligible Population|Randomization to Adjuvant TMZ Arm||420||
48215620|NCT00304031|100853557|FG000|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||0|Eligible participants determined to have unmethylated MGMT.|
48215621|NCT00304031|100853558|FG001|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||254|Eligible participants determined to have unmethylated MGMT.|
48215622|NCT00304031|100853559|FG002|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||262|Eligible participants determined to have unmethylated MGMT.|
48215623|NCT00304031|100853557|FG000|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||0|Eligible participants determined to have methylated MGMT.|
48215624|NCT00304031|100853558|FG001|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||122|Eligible participants determined to have methylated MGMT.|
48215625|NCT00304031|100853559|FG002|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||122|Eligible participants determined to have methylated MGMT.|
48215626|NCT00304031|100853557|FG000|Quality of Life Population|Randomization to Adjuvant TMZ Arm||0|Eligible participants who consented to the quality of life study component, offered after 07-12-2007|
48215627|NCT00304031|100853558|FG001|Quality of Life Population|Randomization to Adjuvant TMZ Arm||96|Eligible participants who consented to the quality of life study component, offered after 07-12-2007|
48215628|NCT00304031|100853559|FG002|Quality of Life Population|Randomization to Adjuvant TMZ Arm||95|Eligible participants who consented to the quality of life study component, offered after 07-12-2007|
48215629|NCT00304031|100853557|FG000|COMPLETED|Randomization to Adjuvant TMZ Arm||0||
48215630|NCT00304031|100853558|FG001|COMPLETED|Randomization to Adjuvant TMZ Arm||411||
48215631|NCT00304031|100853559|FG002|COMPLETED|Randomization to Adjuvant TMZ Arm||420||
48215632|NCT00304031|100853557|FG000|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0||
48215633|NCT00304031|100853558|FG001|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0||
48215634|NCT00304031|100853559|FG002|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||2||
48215635|NCT02639286|100853560|FG000|STARTED|Overall Study||3||
48215636|NCT02639286|100853561|FG001|STARTED|Overall Study||2||
48215637|NCT02639286|100853560|FG000|COMPLETED|Overall Study||3||
48215638|NCT02639286|100853561|FG001|COMPLETED|Overall Study||2||
48215639|NCT02639286|100853560|FG000|NOT COMPLETED|Overall Study||0||
48215640|NCT02639286|100853561|FG001|NOT COMPLETED|Overall Study||0||
48215641|NCT01637246|100853562|FG000|STARTED|Overall Study||4385||
48215642|NCT01637246|100853562|FG000|COMPLETED|Overall Study||2246||
48215643|NCT01637246|100853562|FG000|NOT COMPLETED|Overall Study||2139||
48215644|NCT02164240|100853563|FG000|STARTED|Overall Study||4||
48215645|NCT02164240|100853564|FG001|STARTED|Overall Study||5||
48215646|NCT02164240|100853565|FG002|STARTED|Overall Study||4||
48215647|NCT02164240|100853563|FG000|COMPLETED|Overall Study||4||
48215648|NCT02164240|100853564|FG001|COMPLETED|Overall Study||5||
48215649|NCT02164240|100853565|FG002|COMPLETED|Overall Study||4||
48215650|NCT02164240|100853563|FG000|NOT COMPLETED|Overall Study||0||
48215651|NCT02164240|100853564|FG001|NOT COMPLETED|Overall Study||0||
48215652|NCT02164240|100853565|FG002|NOT COMPLETED|Overall Study||0||
48215653|NCT02919449|100853566|FG000|STARTED|Overall Study||2||
48215654|NCT02919449|100853566|FG000|COMPLETED|Overall Study||0||
48215655|NCT02919449|100853566|FG000|NOT COMPLETED|Overall Study||2||
48215656|NCT01534494|100853567|FG000|STARTED|Overall Study||10||
48215657|NCT01534494|100853567|FG000|COMPLETED|Overall Study||9||
48215658|NCT01534494|100853567|FG000|NOT COMPLETED|Overall Study||1||
48215659|NCT00632203|100853568|FG000|STARTED|Overall Study||26||
48215660|NCT00632203|100853569|FG001|STARTED|Overall Study||27||
48215661|NCT00632203|100853568|FG000|COMPLETED|Overall Study||25||
48215662|NCT00632203|100853569|FG001|COMPLETED|Overall Study||27||
48215663|NCT00632203|100853568|FG000|NOT COMPLETED|Overall Study||1||
48215664|NCT00632203|100853569|FG001|NOT COMPLETED|Overall Study||0||
48215665|NCT00243503|100853570|FG000|STARTED|Overall Study||60||
48215666|NCT00243503|100853570|FG000|COMPLETED|Overall Study||2||
48215667|NCT00243503|100853570|FG000|NOT COMPLETED|Overall Study||58||
48215668|NCT01582100|100853571|FG000|STARTED|Overall Study||2||
48215669|NCT01582100|100853571|FG000|COMPLETED|Overall Study||0||
48215670|NCT01582100|100853571|FG000|NOT COMPLETED|Overall Study||2||
48215671|NCT00533546|100853572|FG000|STARTED|Overall Study||12||
48215672|NCT00533546|100853572|FG000|COMPLETED|Overall Study||12||
48215673|NCT00533546|100853572|FG000|NOT COMPLETED|Overall Study||0||
48215674|NCT01714492|100853573|FG000|STARTED|Overall Study||8||
48215675|NCT01714492|100853573|FG000|COMPLETED|Overall Study||8||
48215676|NCT01714492|100853573|FG000|NOT COMPLETED|Overall Study||0||
48215677|NCT02283749|100853574|FG000|STARTED|Overall Study||5||
48215678|NCT02283749|100853574|FG000|COMPLETED|Overall Study||5||
48215679|NCT02283749|100853574|FG000|NOT COMPLETED|Overall Study||0||
48215680|NCT00350792|100853575|FG000|STARTED|Overall Study||62||
48215681|NCT00350792|100853575|FG000|COMPLETED|Overall Study||29||
48215682|NCT00350792|100853575|FG000|NOT COMPLETED|Overall Study||33||
48215683|NCT00087139|100853576|FG000|STARTED|Overall Study||39||
48215684|NCT00087139|100853577|FG001|STARTED|Overall Study||49||
48215685|NCT00087139|100853578|FG002|STARTED|Overall Study||36||
48215686|NCT00087139|100853576|FG000|Treated|Overall Study||39||
48215687|NCT00087139|100853577|FG001|Treated|Overall Study||48||
48215688|NCT00087139|100853578|FG002|Treated|Overall Study||36||
48215689|NCT00087139|100853576|FG000|Eligible and Treated|Overall Study||35||
48215690|NCT00087139|100853577|FG001|Eligible and Treated|Overall Study||42||
48215691|NCT00087139|100853578|FG002|Eligible and Treated|Overall Study||32||
48215692|NCT00087139|100853576|FG000|Patients for the Analysis of PSA Respons|Overall Study||30||
48215693|NCT00087139|100853577|FG001|Patients for the Analysis of PSA Respons|Overall Study||34||
48215694|NCT00087139|100853578|FG002|Patients for the Analysis of PSA Respons|Overall Study||22||
48215695|NCT00087139|100853576|FG000|Patients With Measurable Disease|Overall Study||22||
48215696|NCT00087139|100853577|FG001|Patients With Measurable Disease|Overall Study||25||
48215697|NCT00087139|100853578|FG002|Patients With Measurable Disease|Overall Study||24||
48215698|NCT00087139|100853576|FG000|Patients With PSA Response|Overall Study||10||
48215699|NCT00087139|100853577|FG001|Patients With PSA Response|Overall Study||8||
48215700|NCT00087139|100853578|FG002|Patients With PSA Response|Overall Study||4||
48215701|NCT00087139|100853576|FG000|Patients w/ Measurable Disease Response|Overall Study||5||
48215702|NCT00087139|100853577|FG001|Patients w/ Measurable Disease Response|Overall Study||2||
48215703|NCT00087139|100853578|FG002|Patients w/ Measurable Disease Response|Overall Study||0||
48215704|NCT00087139|100853576|FG000|COMPLETED|Overall Study||0||
48215705|NCT00087139|100853577|FG001|COMPLETED|Overall Study||0||
48215706|NCT00087139|100853578|FG002|COMPLETED|Overall Study||0||
48215707|NCT00087139|100853576|FG000|NOT COMPLETED|Overall Study||39||
48215708|NCT00087139|100853577|FG001|NOT COMPLETED|Overall Study||49||
48215709|NCT00087139|100853578|FG002|NOT COMPLETED|Overall Study||36||
48215710|NCT01704196|100853579|FG000|STARTED|Overall Study||90||
48215711|NCT01704196|100853580|FG001|STARTED|Overall Study||89||
48215712|NCT01704196|100853579|FG000|COMPLETED|Overall Study||71||
48215713|NCT01704196|100853580|FG001|COMPLETED|Overall Study||65||
48215714|NCT01704196|100853579|FG000|NOT COMPLETED|Overall Study||19||
48215715|NCT01704196|100853580|FG001|NOT COMPLETED|Overall Study||24||
48215716|NCT02407249|100853581|FG000|STARTED|Overall Study||73||
48215717|NCT02407249|100853581|FG000|Treated|Overall Study||60||
48215718|NCT02407249|100853581|FG000|COMPLETED|Overall Study||47||
48215719|NCT02407249|100853581|FG000|NOT COMPLETED|Overall Study||26||
48215720|NCT02411084|100853582|FG000|STARTED|Overall Study||18||
48215721|NCT02411084|100853583|FG001|STARTED|Overall Study||18||
48215722|NCT02411084|100853582|FG000|COMPLETED|Overall Study||5||
48215723|NCT02411084|100853583|FG001|COMPLETED|Overall Study||5||
48215724|NCT02411084|100853582|FG000|NOT COMPLETED|Overall Study||13||
48215725|NCT02411084|100853583|FG001|NOT COMPLETED|Overall Study||13||
48215726|NCT00550394|100856307|FG000|STARTED|Overall Study||21||
48215727|NCT00550394|100856308|FG001|STARTED|Overall Study||18||
48215728|NCT00550394|100856307|FG000|COMPLETED|Overall Study||9||
48215729|NCT00550394|100856308|FG001|COMPLETED|Overall Study||5||
48215730|NCT00550394|100856307|FG000|NOT COMPLETED|Overall Study||12||
48215731|NCT00550394|100856308|FG001|NOT COMPLETED|Overall Study||13||
48215732|NCT04048681|100856309|FG000|STARTED|Overall Study||1||
48215733|NCT04048681|100856310|FG001|STARTED|Overall Study||1||
48215734|NCT04048681|100856311|FG002|STARTED|Overall Study||1||
48215735|NCT04048681|100856312|FG003|STARTED|Overall Study||1||
48215736|NCT04048681|100856313|FG004|STARTED|Overall Study||1||
48215737|NCT04048681|100856309|FG000|COMPLETED|Overall Study||1||
48215738|NCT04048681|100856310|FG001|COMPLETED|Overall Study||1||
48215739|NCT04048681|100856311|FG002|COMPLETED|Overall Study||1||
48215740|NCT04048681|100856312|FG003|COMPLETED|Overall Study||0||
48215741|NCT04048681|100856313|FG004|COMPLETED|Overall Study||1||
48215742|NCT04048681|100856309|FG000|NOT COMPLETED|Overall Study||0||
48215743|NCT04048681|100856310|FG001|NOT COMPLETED|Overall Study||0||
48215744|NCT04048681|100856311|FG002|NOT COMPLETED|Overall Study||0||
48215745|NCT04048681|100856312|FG003|NOT COMPLETED|Overall Study||1||
48215746|NCT04048681|100856313|FG004|NOT COMPLETED|Overall Study||0||
48215747|NCT02178241|100856314|FG000|STARTED|Overall Study||24|Two enrolled patients did not receive any study treatment and were excluded from analysis.|
48215748|NCT02178241|100856314|FG000|COMPLETED|Overall Study||24||
48215749|NCT02178241|100856314|FG000|NOT COMPLETED|Overall Study||0||
48215750|NCT03189589|100856315|FG000|STARTED|Overall Study||6||
48215751|NCT03189589|100856316|FG001|STARTED|Overall Study||6||
48496260|NCT01586039|101548047|FG002|COMPLETED|Overall Study||8||
48215752|NCT03189589|100856315|FG000|COMPLETED|Overall Study||6||
48215753|NCT03189589|100856316|FG001|COMPLETED|Overall Study||6||
48215754|NCT03189589|100856315|FG000|NOT COMPLETED|Overall Study||0||
48215755|NCT03189589|100856316|FG001|NOT COMPLETED|Overall Study||0||
48215756|NCT03176654|100856317|FG000|STARTED|Overall Study||13||
48215757|NCT03176654|100856318|FG001|STARTED|Overall Study||15||
48215758|NCT03176654|100856317|FG000|COMPLETED|Overall Study||13||
48215759|NCT03176654|100856318|FG001|COMPLETED|Overall Study||15||
48215760|NCT03176654|100856317|FG000|NOT COMPLETED|Overall Study||0||
48215761|NCT03176654|100856318|FG001|NOT COMPLETED|Overall Study||0||
48215762|NCT00253890|100856319|FG000|STARTED|Overall Study||69||
48215763|NCT00253890|100856320|FG001|STARTED|Overall Study||68||
48060403|NCT02642029|100470177|FG001|NOT COMPLETED|Study Visit 3 (1 Day)||0||
48060404|NCT02642029|100470178|FG002|NOT COMPLETED|Study Visit 3 (1 Day)||0||
48060405|NCT02642029|100470179|FG003|NOT COMPLETED|Study Visit 3 (1 Day)||0||
48060406|NCT02642029|100470180|FG004|NOT COMPLETED|Study Visit 3 (1 Day)||0||
48060407|NCT02642029|100470181|FG005|NOT COMPLETED|Study Visit 3 (1 Day)||0||
48060408|NCT02611960|100470182|FG000|STARTED|Overall Study||117||
48060409|NCT02611960|100470183|FG001|STARTED|Overall Study||116||
48060410|NCT02611960|100470182|FG000|Discontinued|Overall Study||117||
48060411|NCT02611960|100470183|FG001|Discontinued|Overall Study||116||
48060412|NCT02611960|100470182|FG000|COMPLETED|Overall Study||0||
48060413|NCT02611960|100470183|FG001|COMPLETED|Overall Study||0||
48060414|NCT02611960|100470182|FG000|NOT COMPLETED|Overall Study||117||
48060415|NCT02611960|100470183|FG001|NOT COMPLETED|Overall Study||116||
48060416|NCT00706810|100470184|FG000|STARTED|Overall Study||8||
48060417|NCT00706810|100470184|FG000|COMPLETED|Overall Study||7||
48060418|NCT00706810|100470184|FG000|NOT COMPLETED|Overall Study||1||
48060419|NCT03452228|100470185|FG000|STARTED|Double-Blind Treatment Period (12 Weeks)||17|Randomized|
48060420|NCT03452228|100470186|FG001|STARTED|Double-Blind Treatment Period (12 Weeks)||35|Randomized|
48060421|NCT03452228|100470187|FG002|STARTED|Double-Blind Treatment Period (12 Weeks)||0|Randomized|
48060422|NCT03452228|100470185|FG000|Treated|Double-Blind Treatment Period (12 Weeks)||16|Randomized and Treated|
48060423|NCT03452228|100470186|FG001|Treated|Double-Blind Treatment Period (12 Weeks)||35|Randomized and Treated|
48060424|NCT03452228|100470187|FG002|Treated|Double-Blind Treatment Period (12 Weeks)||0|Randomized and Treated|
48060425|NCT03452228|100470185|FG000|Actual Cohort 1|Double-Blind Treatment Period (12 Weeks)||5|Actual Cohort 1 included participants with homozygous or compound heterozygous loss-of-function (LOF) mutations in genes in the lipoprotein lipase (LPL) pathway as was determined based on genotype data.|
48060426|NCT03452228|100470186|FG001|Actual Cohort 1|Double-Blind Treatment Period (12 Weeks)||12|Actual Cohort 1 included participants with homozygous or compound heterozygous loss-of-function (LOF) mutations in genes in the lipoprotein lipase (LPL) pathway as was determined based on genotype data.|
48060427|NCT03452228|100470187|FG002|Actual Cohort 1|Double-Blind Treatment Period (12 Weeks)||0|Actual Cohort 1 included participants with homozygous or compound heterozygous loss-of-function (LOF) mutations in genes in the lipoprotein lipase (LPL) pathway as was determined based on genotype data.|
48060428|NCT03452228|100470185|FG000|Actual Cohort 2|Double-Blind Treatment Period (12 Weeks)||6|Actual Cohort 2 included participants with heterozygous LOF mutations in genes in the LPL pathway as was determined based on genotype data.|
48215764|NCT00253890|100856319|FG000|COMPLETED|Overall Study||62||
48215765|NCT00253890|100856320|FG001|COMPLETED|Overall Study||61||
48215766|NCT00253890|100856319|FG000|NOT COMPLETED|Overall Study||7||
48215767|NCT00253890|100856320|FG001|NOT COMPLETED|Overall Study||7||
48215768|NCT02034916|100856321|FG000|STARTED|Overall Study||49||
48215769|NCT02034916|100856322|FG001|STARTED|Overall Study||35||
48215770|NCT02034916|100856321|FG000|Treated|Overall Study||48||
48215771|NCT02034916|100856322|FG001|Treated|Overall Study||35||
48215772|NCT02034916|100856321|FG000|COMPLETED|Overall Study||0||
48215773|NCT02034916|100856322|FG001|COMPLETED|Overall Study||0||
48215774|NCT02034916|100856321|FG000|NOT COMPLETED|Overall Study||49||
48215775|NCT02034916|100856322|FG001|NOT COMPLETED|Overall Study||35||
48215776|NCT03567252|100856323|FG000|STARTED|Overall Study||48||
48215777|NCT03567252|100856324|FG001|STARTED|Overall Study||19||
48215778|NCT03567252|100856323|FG000|COMPLETED|Overall Study||48||
48215779|NCT03567252|100856324|FG001|COMPLETED|Overall Study||19||
48215780|NCT03567252|100856323|FG000|NOT COMPLETED|Overall Study||0||
48215781|NCT03567252|100856324|FG001|NOT COMPLETED|Overall Study||0||
48215782|NCT00331136|100856325|FG000|STARTED|Overall Study||15||
48215783|NCT00331136|100856326|FG001|STARTED|Overall Study||15||
48215784|NCT00331136|100856327|FG002|STARTED|Overall Study||15||
48215785|NCT00331136|100856328|FG003|STARTED|Overall Study||15||
48215786|NCT00331136|100856325|FG000|COMPLETED|Overall Study||10||
48215787|NCT00331136|100856326|FG001|COMPLETED|Overall Study||8||
48215788|NCT00331136|100856327|FG002|COMPLETED|Overall Study||15||
48215789|NCT00331136|100856328|FG003|COMPLETED|Overall Study||14||
48215790|NCT00331136|100856325|FG000|NOT COMPLETED|Overall Study||5||
48215791|NCT00331136|100856326|FG001|NOT COMPLETED|Overall Study||7||
48215792|NCT00331136|100856327|FG002|NOT COMPLETED|Overall Study||0||
48215793|NCT00331136|100856328|FG003|NOT COMPLETED|Overall Study||1||
48215794|NCT03926039|100856329|FG000|STARTED|Overall Study||35||
48215795|NCT03926039|100856330|FG001|STARTED|Overall Study||35||
48215796|NCT03926039|100856329|FG000|COMPLETED|Overall Study||35||
48215797|NCT03926039|100856330|FG001|COMPLETED|Overall Study||34||
48215798|NCT03926039|100856329|FG000|NOT COMPLETED|Overall Study||0||
48215799|NCT03926039|100856330|FG001|NOT COMPLETED|Overall Study||1||
48215800|NCT03693937|100856331|FG000|STARTED|Overall Study||776||
48215801|NCT03693937|100856331|FG000|COMPLETED|Overall Study||776||
48215802|NCT03693937|100856331|FG000|NOT COMPLETED|Overall Study||0||
48215803|NCT01639131|100856332|FG000|STARTED|Overall Study||6||
48215804|NCT01639131|100856332|FG000|COMPLETED|Overall Study||0||
48215805|NCT01639131|100856332|FG000|NOT COMPLETED|Overall Study||6||
48215806|NCT01172418|100856333|FG000|STARTED|Overall Study||100||
48215807|NCT01172418|100856334|FG001|STARTED|Overall Study||100||
48215808|NCT01172418|100856333|FG000|COMPLETED|Overall Study||100||
48215809|NCT01172418|100856334|FG001|COMPLETED|Overall Study||100||
48215810|NCT01172418|100856333|FG000|NOT COMPLETED|Overall Study||0||
48215811|NCT01172418|100856334|FG001|NOT COMPLETED|Overall Study||0||
48215812|NCT02075554|100856335|FG000|STARTED|Overall Study||58||
48215813|NCT02075554|100856335|FG000|COMPLETED|Overall Study||43||
48215814|NCT02075554|100856335|FG000|NOT COMPLETED|Overall Study||15||
48215815|NCT00704769|100856336|FG000|STARTED|Overall Study||591||
48215816|NCT00704769|100856336|FG000|COMPLETED|Overall Study||591||
48215817|NCT00704769|100856336|FG000|NOT COMPLETED|Overall Study||0||
48215818|NCT02647905|100856337|FG000|STARTED|Overall Study||90||
48215819|NCT02647905|100856337|FG000|COMPLETED|Overall Study||87||
48215820|NCT02647905|100856337|FG000|NOT COMPLETED|Overall Study||3||
48215821|NCT02422615|100856338|FG000|STARTED|Treatment Period||484||
48215822|NCT02422615|100856339|FG001|STARTED|Treatment Period||242||
48215823|NCT02422615|100856338|FG000|Untreated|Treatment Period||1||
48215824|NCT02422615|100856339|FG001|Untreated|Treatment Period||1||
48215825|NCT02422615|100856338|FG000|Crossover Cohort|Treatment Period||0|Participants in the placebo+fulvestrant arm who crossed over to the ribociclib+fulvestrant arm and received at least one dose of the study treatment.|
48215826|NCT02422615|100856339|FG001|Crossover Cohort|Treatment Period||3|Participants in the placebo+fulvestrant arm who crossed over to the ribociclib+fulvestrant arm and received at least one dose of the study treatment.|
48215827|NCT02422615|100856338|FG000|COMPLETED|Treatment Period||0|Treatment ongoing at the time of the cut-off 11-Jan-2023|
48215828|NCT02422615|100856339|FG001|COMPLETED|Treatment Period||0|Treatment ongoing at the time of the cut-off 11-Jan-2023|
48215829|NCT02422615|100856338|FG000|NOT COMPLETED|Treatment Period||484||
48215830|NCT02422615|100856339|FG001|NOT COMPLETED|Treatment Period||242||
48215831|NCT02422615|100856338|FG000|STARTED|Post-treatment Efficacy Follow-up||34||
48215832|NCT02422615|100856339|FG001|STARTED|Post-treatment Efficacy Follow-up||9||
48215833|NCT02422615|100856338|FG000|COMPLETED|Post-treatment Efficacy Follow-up||0||
48215834|NCT02422615|100856339|FG001|COMPLETED|Post-treatment Efficacy Follow-up||0||
48215835|NCT02422615|100856338|FG000|NOT COMPLETED|Post-treatment Efficacy Follow-up||34||
48215836|NCT02422615|100856339|FG001|NOT COMPLETED|Post-treatment Efficacy Follow-up||9||
48215837|NCT04287985|100856340|FG000|STARTED|Overall Study||38||
48215838|NCT04287985|100856341|FG001|STARTED|Overall Study||41||
48215839|NCT04287985|100856342|FG002|STARTED|Overall Study||38||
48215840|NCT04287985|100856343|FG003|STARTED|Overall Study||38||
48215841|NCT04287985|100856340|FG000|COMPLETED|Overall Study||35||
48215842|NCT04287985|100856341|FG001|COMPLETED|Overall Study||39||
48215843|NCT04287985|100856342|FG002|COMPLETED|Overall Study||37||
48215844|NCT04287985|100856343|FG003|COMPLETED|Overall Study||35||
48215845|NCT04287985|100856340|FG000|NOT COMPLETED|Overall Study||3||
48215846|NCT04287985|100856341|FG001|NOT COMPLETED|Overall Study||2||
48215847|NCT04287985|100856342|FG002|NOT COMPLETED|Overall Study||1||
48215848|NCT04287985|100856343|FG003|NOT COMPLETED|Overall Study||3||
48215849|NCT02567656|100856344|FG000|STARTED|Overall Study||4||
48215850|NCT02567656|100856345|FG001|STARTED|Overall Study||4||
48215851|NCT02567656|100856346|FG002|STARTED|Overall Study||5||
48215852|NCT02567656|100856347|FG003|STARTED|Overall Study||6||
48215853|NCT02567656|100856348|FG004|STARTED|Overall Study||19||
48215854|NCT02567656|100856349|FG005|STARTED|Overall Study||20||
48215855|NCT02567656|100856344|FG000|COMPLETED|Overall Study||3||
48215856|NCT02567656|100856345|FG001|COMPLETED|Overall Study||3||
48215857|NCT02567656|100856346|FG002|COMPLETED|Overall Study||3||
48215858|NCT02567656|100856347|FG003|COMPLETED|Overall Study||6||
48215859|NCT02567656|100856348|FG004|COMPLETED|Overall Study||19||
48215860|NCT02567656|100856349|FG005|COMPLETED|Overall Study||20||
48215861|NCT02567656|100856344|FG000|NOT COMPLETED|Overall Study||1||
48215862|NCT02567656|100856345|FG001|NOT COMPLETED|Overall Study||1||
48215863|NCT02567656|100856346|FG002|NOT COMPLETED|Overall Study||2||
48215864|NCT02567656|100856347|FG003|NOT COMPLETED|Overall Study||0||
48215865|NCT02567656|100856348|FG004|NOT COMPLETED|Overall Study||0||
48215866|NCT02567656|100856349|FG005|NOT COMPLETED|Overall Study||0||
48215867|NCT00603954|100856350|FG000|STARTED|Overall Study||50||
48215868|NCT00603954|100856351|FG001|STARTED|Overall Study||47||
48215869|NCT00603954|100856350|FG000|COMPLETED|Overall Study||49||
48215870|NCT00603954|100856351|FG001|COMPLETED|Overall Study||45||
48215871|NCT00603954|100856350|FG000|NOT COMPLETED|Overall Study||1||
48215872|NCT00603954|100856351|FG001|NOT COMPLETED|Overall Study||2||
48215873|NCT03144518|100856352|FG000|STARTED|Primary Outcome (Mood)||52||
48215874|NCT03144518|100856353|FG001|STARTED|Primary Outcome (Mood)||51||
48215875|NCT03144518|100856352|FG000|COMPLETED|Primary Outcome (Mood)||52||
48215876|NCT03144518|100856353|FG001|COMPLETED|Primary Outcome (Mood)||51||
48215877|NCT03144518|100856352|FG000|NOT COMPLETED|Primary Outcome (Mood)||0||
48215878|NCT03144518|100856353|FG001|NOT COMPLETED|Primary Outcome (Mood)||0||
48215879|NCT03144518|100856352|FG000|STARTED|4 Weeks Post-Vaccination||52||
48215880|NCT03144518|100856353|FG001|STARTED|4 Weeks Post-Vaccination||51||
48215881|NCT03144518|100856352|FG000|COMPLETED|4 Weeks Post-Vaccination||51||
48215882|NCT03144518|100856353|FG001|COMPLETED|4 Weeks Post-Vaccination||51||
48215883|NCT03144518|100856352|FG000|NOT COMPLETED|4 Weeks Post-Vaccination||1||
48215884|NCT03144518|100856353|FG001|NOT COMPLETED|4 Weeks Post-Vaccination||0||
48215885|NCT03144518|100856352|FG000|STARTED|16 Week Post-Vaccination||52||
48215886|NCT03144518|100856353|FG001|STARTED|16 Week Post-Vaccination||51||
48215887|NCT03144518|100856352|FG000|COMPLETED|16 Week Post-Vaccination||49||
48215888|NCT03144518|100856353|FG001|COMPLETED|16 Week Post-Vaccination||49||
48215889|NCT03144518|100856352|FG000|NOT COMPLETED|16 Week Post-Vaccination||3||
48215890|NCT03144518|100856353|FG001|NOT COMPLETED|16 Week Post-Vaccination||2||
48215891|NCT00731614|100856354|FG000|STARTED|Overall Study||23||
48215892|NCT00731614|100856355|FG001|STARTED|Overall Study||31||
48215893|NCT00731614|100856354|FG000|End of Treatment|Overall Study||16||
48215894|NCT00731614|100856355|FG001|End of Treatment|Overall Study||24||
48215895|NCT00731614|100856354|FG000|12 Weeks Posttreatment|Overall Study||18||
48215896|NCT00731614|100856355|FG001|12 Weeks Posttreatment|Overall Study||23||
48215897|NCT00731614|100856354|FG000|COMPLETED|Overall Study||16||
48215898|NCT00731614|100856355|FG001|COMPLETED|Overall Study||18||
48215899|NCT00731614|100856354|FG000|NOT COMPLETED|Overall Study||7||
48215900|NCT00731614|100856355|FG001|NOT COMPLETED|Overall Study||13||
48215901|NCT04327843|100856356|FG000|STARTED|Baseline Assessment||19||
48215902|NCT04327843|100856356|FG000|COMPLETED|Baseline Assessment||19||
48215903|NCT04327843|100856356|FG000|NOT COMPLETED|Baseline Assessment||0||
48215904|NCT04327843|100856356|FG000|STARTED|Week 13 Assessment||19||
48215905|NCT04327843|100856356|FG000|COMPLETED|Week 13 Assessment||19||
48215906|NCT04327843|100856356|FG000|NOT COMPLETED|Week 13 Assessment||0||
48215907|NCT04327843|100856356|FG000|STARTED|Week 25 Assessment||19||
48215908|NCT04327843|100856356|FG000|COMPLETED|Week 25 Assessment||18||
48215909|NCT04327843|100856356|FG000|NOT COMPLETED|Week 25 Assessment||1||
48215910|NCT00611559|100856357|FG000|STARTED|Overall Study||111||
48215911|NCT00611559|100856358|FG001|STARTED|Overall Study||115||
48215912|NCT00611559|100856359|FG002|STARTED|Overall Study||57||
48215913|NCT00611559|100856357|FG000|COMPLETED|Overall Study||110||
48215914|NCT00611559|100856358|FG001|COMPLETED|Overall Study||114||
48215915|NCT00611559|100856359|FG002|COMPLETED|Overall Study||56||
48215916|NCT00611559|100856357|FG000|NOT COMPLETED|Overall Study||1||
48215917|NCT00611559|100856358|FG001|NOT COMPLETED|Overall Study||1||
48215918|NCT00611559|100856359|FG002|NOT COMPLETED|Overall Study||1||
48215919|NCT03498196|100856360|FG000|STARTED|Overall Study||1||
48215920|NCT03498196|100856360|FG000|COMPLETED|Overall Study||1||
48215921|NCT03498196|100856360|FG000|NOT COMPLETED|Overall Study||0||
48215922|NCT02885636|100856361|FG000|STARTED|Overall Study||15||
48215923|NCT02885636|100856362|FG001|STARTED|Overall Study||15||
48215924|NCT02885636|100856361|FG000|COMPLETED|Overall Study||15||
48215925|NCT02885636|100856362|FG001|COMPLETED|Overall Study||15||
48215926|NCT02885636|100856361|FG000|NOT COMPLETED|Overall Study||0||
48215927|NCT02885636|100856362|FG001|NOT COMPLETED|Overall Study||0||
48215928|NCT00894543|100856363|FG000|STARTED|Baseline||104||
48215929|NCT00894543|100856364|FG001|STARTED|Baseline||101||
48215930|NCT00894543|100856363|FG000|COMPLETED|Baseline||104||
48215931|NCT00894543|100856364|FG001|COMPLETED|Baseline||101||
48215932|NCT00894543|100856363|FG000|NOT COMPLETED|Baseline||0||
48215933|NCT00894543|100856364|FG001|NOT COMPLETED|Baseline||0||
48215934|NCT00894543|100856363|FG000|STARTED|Baseline to Week 4||104||
48215935|NCT00894543|100856364|FG001|STARTED|Baseline to Week 4||101||
48215936|NCT00894543|100856363|FG000|COMPLETED|Baseline to Week 4||101||
48215937|NCT00894543|100856364|FG001|COMPLETED|Baseline to Week 4||99||
48215938|NCT00894543|100856363|FG000|NOT COMPLETED|Baseline to Week 4||3||
48215939|NCT00894543|100856364|FG001|NOT COMPLETED|Baseline to Week 4||2||
48215940|NCT00894543|100856363|FG000|STARTED|Week 4 to Week 8||101||
48215941|NCT00894543|100856364|FG001|STARTED|Week 4 to Week 8||99||
48215942|NCT00894543|100856363|FG000|COMPLETED|Week 4 to Week 8||97||
48215943|NCT00894543|100856364|FG001|COMPLETED|Week 4 to Week 8||97||
48215944|NCT00894543|100856363|FG000|NOT COMPLETED|Week 4 to Week 8||4||
48215945|NCT00894543|100856364|FG001|NOT COMPLETED|Week 4 to Week 8||2||
48215946|NCT00995904|100856365|FG000|STARTED|Visit 2 (Randomization)||4||
48215947|NCT00995904|100856366|FG001|STARTED|Visit 2 (Randomization)||3||
48215948|NCT00995904|100856367|FG002|STARTED|Visit 2 (Randomization)||4||
48215949|NCT00995904|100856368|FG003|STARTED|Visit 2 (Randomization)||5||
48215950|NCT00995904|100856369|FG004|STARTED|Visit 2 (Randomization)||5||
48215951|NCT00995904|100856370|FG005|STARTED|Visit 2 (Randomization)||4||
48215952|NCT00995904|100856365|FG000|COMPLETED|Visit 2 (Randomization)||4||
48215953|NCT00995904|100856366|FG001|COMPLETED|Visit 2 (Randomization)||3||
48215954|NCT00995904|100856367|FG002|COMPLETED|Visit 2 (Randomization)||4||
48215955|NCT00995904|100856368|FG003|COMPLETED|Visit 2 (Randomization)||5||
48215956|NCT00995904|100856369|FG004|COMPLETED|Visit 2 (Randomization)||5||
48215957|NCT00995904|100856370|FG005|COMPLETED|Visit 2 (Randomization)||4||
48215958|NCT00995904|100856365|FG000|NOT COMPLETED|Visit 2 (Randomization)||0||
48215959|NCT00995904|100856366|FG001|NOT COMPLETED|Visit 2 (Randomization)||0||
48215960|NCT00995904|100856367|FG002|NOT COMPLETED|Visit 2 (Randomization)||0||
48215961|NCT00995904|100856368|FG003|NOT COMPLETED|Visit 2 (Randomization)||0||
48215962|NCT00995904|100856369|FG004|NOT COMPLETED|Visit 2 (Randomization)||0||
48215963|NCT00995904|100856370|FG005|NOT COMPLETED|Visit 2 (Randomization)||0||
48215964|NCT00995904|100856365|FG000|STARTED|Visit 3||4||
48215965|NCT00995904|100856366|FG001|STARTED|Visit 3||3||
48215966|NCT00995904|100856367|FG002|STARTED|Visit 3||4||
48215967|NCT00995904|100856368|FG003|STARTED|Visit 3||5||
48215968|NCT00995904|100856369|FG004|STARTED|Visit 3||5||
48215969|NCT00995904|100856370|FG005|STARTED|Visit 3||3||
48215970|NCT00995904|100856365|FG000|COMPLETED|Visit 3||4||
48215971|NCT00995904|100856366|FG001|COMPLETED|Visit 3||3||
48215972|NCT00995904|100856367|FG002|COMPLETED|Visit 3||4||
48215973|NCT00995904|100856368|FG003|COMPLETED|Visit 3||5||
48215974|NCT00995904|100856369|FG004|COMPLETED|Visit 3||5||
48215975|NCT00995904|100856370|FG005|COMPLETED|Visit 3||3||
48215976|NCT00995904|100856365|FG000|NOT COMPLETED|Visit 3||0||
48215977|NCT00995904|100856366|FG001|NOT COMPLETED|Visit 3||0||
48215978|NCT00995904|100856367|FG002|NOT COMPLETED|Visit 3||0||
48215979|NCT00995904|100856368|FG003|NOT COMPLETED|Visit 3||0||
48215980|NCT00995904|100856369|FG004|NOT COMPLETED|Visit 3||0||
48215981|NCT00995904|100856370|FG005|NOT COMPLETED|Visit 3||0||
48215982|NCT00995904|100856365|FG000|STARTED|Visit 4||4||
48215983|NCT00995904|100856366|FG001|STARTED|Visit 4||3||
48215984|NCT00995904|100856367|FG002|STARTED|Visit 4||4||
48215985|NCT00995904|100856368|FG003|STARTED|Visit 4||5||
48215986|NCT00995904|100856369|FG004|STARTED|Visit 4||5||
48215987|NCT00995904|100856370|FG005|STARTED|Visit 4||3||
48215988|NCT00995904|100856365|FG000|COMPLETED|Visit 4||4||
48215989|NCT00995904|100856366|FG001|COMPLETED|Visit 4||3||
48215990|NCT00995904|100856367|FG002|COMPLETED|Visit 4||4||
48215991|NCT00995904|100856368|FG003|COMPLETED|Visit 4||5||
48215992|NCT00995904|100856369|FG004|COMPLETED|Visit 4||5||
48215993|NCT00995904|100856370|FG005|COMPLETED|Visit 4||3||
48215994|NCT00995904|100856365|FG000|NOT COMPLETED|Visit 4||0||
48215995|NCT00995904|100856366|FG001|NOT COMPLETED|Visit 4||0||
48215996|NCT00995904|100856367|FG002|NOT COMPLETED|Visit 4||0||
48215997|NCT00995904|100856368|FG003|NOT COMPLETED|Visit 4||0||
48215998|NCT00995904|100856369|FG004|NOT COMPLETED|Visit 4||0||
48215999|NCT00995904|100856370|FG005|NOT COMPLETED|Visit 4||0||
48216000|NCT00995904|100856365|FG000|STARTED|Follow-up Visit (Final Visit)||4||
48216001|NCT00995904|100856366|FG001|STARTED|Follow-up Visit (Final Visit)||3||
48216002|NCT00995904|100856367|FG002|STARTED|Follow-up Visit (Final Visit)||4||
48216003|NCT00995904|100856368|FG003|STARTED|Follow-up Visit (Final Visit)||5||
48216004|NCT00995904|100856369|FG004|STARTED|Follow-up Visit (Final Visit)||5||
48216005|NCT00995904|100856370|FG005|STARTED|Follow-up Visit (Final Visit)||3||
48216006|NCT00995904|100856365|FG000|COMPLETED|Follow-up Visit (Final Visit)||4||
48216007|NCT00995904|100856366|FG001|COMPLETED|Follow-up Visit (Final Visit)||3||
48216008|NCT00995904|100856367|FG002|COMPLETED|Follow-up Visit (Final Visit)||4||
48216009|NCT00995904|100856368|FG003|COMPLETED|Follow-up Visit (Final Visit)||5||
48216010|NCT00995904|100856369|FG004|COMPLETED|Follow-up Visit (Final Visit)||5||
48216011|NCT00995904|100856370|FG005|COMPLETED|Follow-up Visit (Final Visit)||3||
48216012|NCT00995904|100856365|FG000|NOT COMPLETED|Follow-up Visit (Final Visit)||0||
48216013|NCT00995904|100856366|FG001|NOT COMPLETED|Follow-up Visit (Final Visit)||0||
48216014|NCT00995904|100856367|FG002|NOT COMPLETED|Follow-up Visit (Final Visit)||0||
48216015|NCT00995904|100856368|FG003|NOT COMPLETED|Follow-up Visit (Final Visit)||0||
48216016|NCT00995904|100856369|FG004|NOT COMPLETED|Follow-up Visit (Final Visit)||0||
48216017|NCT00995904|100856370|FG005|NOT COMPLETED|Follow-up Visit (Final Visit)||0||
48216018|NCT03394885|100856371|FG000|STARTED|Overall Study||18||
48216019|NCT03394885|100856371|FG000|COMPLETED|Overall Study||3||
48216020|NCT03394885|100856371|FG000|NOT COMPLETED|Overall Study||15||
48216021|NCT03014453|100856372|FG000|STARTED|Overall Study||187||
48216022|NCT03014453|100856372|FG000|COMPLETED|Overall Study||116||
48216023|NCT03014453|100856372|FG000|NOT COMPLETED|Overall Study||71||
48216024|NCT02006758|100856373|FG000|STARTED|Overall Study||68||
48216025|NCT02006758|100856373|FG000|Underwent Renal Denervation|Overall Study||67||
48216026|NCT02006758|100856373|FG000|1-month Follow up|Overall Study||66||
48216027|NCT02006758|100856373|FG000|6-month Follow up|Overall Study||60||
48496261|NCT01586039|101548048|FG003|COMPLETED|Overall Study||8||
48496262|NCT01586039|101548045|FG000|NOT COMPLETED|Overall Study||0||
48216028|NCT02006758|100856373|FG000|12-month Follow up|Overall Study||55||
48216029|NCT02006758|100856373|FG000|COMPLETED|Overall Study||55||
48216030|NCT02006758|100856373|FG000|NOT COMPLETED|Overall Study||13||
48216031|NCT02139436|100856374|FG000|STARTED|Overall Study||41||
48216032|NCT02139436|100856375|FG001|STARTED|Overall Study||14||
48216033|NCT02139436|100856376|FG002|STARTED|Overall Study||13||
48216034|NCT02139436|100856374|FG000|COMPLETED|Overall Study||41||
48216035|NCT02139436|100856375|FG001|COMPLETED|Overall Study||14||
48216036|NCT02139436|100856376|FG002|COMPLETED|Overall Study||13||
48216037|NCT02139436|100856374|FG000|NOT COMPLETED|Overall Study||0||
48216038|NCT02139436|100856375|FG001|NOT COMPLETED|Overall Study||0||
48216039|NCT02139436|100856376|FG002|NOT COMPLETED|Overall Study||0||
48216040|NCT04221828|100856377|FG000|STARTED|Overall Study||1||
48216041|NCT04221828|100856377|FG000|COMPLETED|Overall Study||1||
48216042|NCT04221828|100856377|FG000|NOT COMPLETED|Overall Study||0||
48216043|NCT02564744|100856378|FG000|STARTED|Overall Study||17||
48216044|NCT02564744|100856379|FG001|STARTED|Overall Study||8||
48216045|NCT02564744|100856380|FG002|STARTED|Overall Study||12||
48216046|NCT02564744|100856381|FG003|STARTED|Overall Study||33||
48216047|NCT02564744|100856382|FG004|STARTED|Overall Study||30||
48216048|NCT02564744|100856378|FG000|Efficacy Evaluable (EE) Population|Overall Study||15|EE population included all participants who received at least one dose of Debio 1562 and rituximab and had both baseline and post-baseline evaluable disease assessments (including clinical progressive disease \[PD\]).|
48216049|NCT02564744|100856379|FG001|Efficacy Evaluable (EE) Population|Overall Study||8|EE population included all participants who received at least one dose of Debio 1562 and rituximab and had both baseline and post-baseline evaluable disease assessments (including clinical progressive disease \[PD\]).|
48216050|NCT02564744|100856380|FG002|Efficacy Evaluable (EE) Population|Overall Study||11|EE population included all participants who received at least one dose of Debio 1562 and rituximab and had both baseline and post-baseline evaluable disease assessments (including clinical progressive disease \[PD\]).|
48216051|NCT02564744|100856381|FG003|Efficacy Evaluable (EE) Population|Overall Study||30|EE population included all participants who received at least one dose of Debio 1562 and rituximab and had both baseline and post-baseline evaluable disease assessments (including clinical progressive disease \[PD\]).|
48216052|NCT02564744|100856382|FG004|Efficacy Evaluable (EE) Population|Overall Study||30|EE population included all participants who received at least one dose of Debio 1562 and rituximab and had both baseline and post-baseline evaluable disease assessments (including clinical progressive disease \[PD\]).|
48216053|NCT02564744|100856378|FG000|Pharmacokinetic (PK) Population|Overall Study||17|PK population included all participants who received at least one dose of Debio 1562 or rituximab and had at least one PK concentration result available.|
48216054|NCT02564744|100856379|FG001|Pharmacokinetic (PK) Population|Overall Study||8|PK population included all participants who received at least one dose of Debio 1562 or rituximab and had at least one PK concentration result available.|
48216055|NCT02564744|100856380|FG002|Pharmacokinetic (PK) Population|Overall Study||12|PK population included all participants who received at least one dose of Debio 1562 or rituximab and had at least one PK concentration result available.|
48216056|NCT02564744|100856381|FG003|Pharmacokinetic (PK) Population|Overall Study||32|PK population included all participants who received at least one dose of Debio 1562 or rituximab and had at least one PK concentration result available.|
48216057|NCT02564744|100856382|FG004|Pharmacokinetic (PK) Population|Overall Study||29|PK population included all participants who received at least one dose of Debio 1562 or rituximab and had at least one PK concentration result available.|
48216058|NCT02564744|100856378|FG000|Anti-drug Antibody (ADA) Population|Overall Study||14|ADA population included all participants who received at least one dose of Debio 1562 or rituximab and had at least one ADA post exposure result available.|
48216059|NCT02564744|100856379|FG001|Anti-drug Antibody (ADA) Population|Overall Study||6|ADA population included all participants who received at least one dose of Debio 1562 or rituximab and had at least one ADA post exposure result available.|
48216060|NCT02564744|100856380|FG002|Anti-drug Antibody (ADA) Population|Overall Study||10|ADA population included all participants who received at least one dose of Debio 1562 or rituximab and had at least one ADA post exposure result available.|
48216061|NCT02564744|100856381|FG003|Anti-drug Antibody (ADA) Population|Overall Study||30|ADA population included all participants who received at least one dose of Debio 1562 or rituximab and had at least one ADA post exposure result available.|
48216062|NCT02564744|100856382|FG004|Anti-drug Antibody (ADA) Population|Overall Study||25|ADA population included all participants who received at least one dose of Debio 1562 or rituximab and had at least one ADA post exposure result available.|
48216063|NCT02564744|100856378|FG000|COMPLETED|Overall Study||5||
48216064|NCT02564744|100856379|FG001|COMPLETED|Overall Study||1||
48216065|NCT02564744|100856380|FG002|COMPLETED|Overall Study||4||
48216066|NCT02564744|100856381|FG003|COMPLETED|Overall Study||14||
48216067|NCT02564744|100856382|FG004|COMPLETED|Overall Study||10||
48216068|NCT02564744|100856378|FG000|NOT COMPLETED|Overall Study||12||
48216069|NCT02564744|100856379|FG001|NOT COMPLETED|Overall Study||7||
48216070|NCT02564744|100856380|FG002|NOT COMPLETED|Overall Study||8||
48216071|NCT02564744|100856381|FG003|NOT COMPLETED|Overall Study||19||
48216072|NCT02564744|100856382|FG004|NOT COMPLETED|Overall Study||20||
48216073|NCT03578536|100856383|FG000|STARTED|Overall Study||3||
48216074|NCT03578536|100856383|FG000|COMPLETED|Overall Study||2||
48216075|NCT03578536|100856383|FG000|NOT COMPLETED|Overall Study||1||
48216076|NCT01932970|100856384|FG000|STARTED|Overall Study||158||
48216077|NCT01932970|100856384|FG000|Received Treatment|Overall Study||148||
48216078|NCT01932970|100856384|FG000|COMPLETED|Overall Study||140||
48216079|NCT01932970|100856384|FG000|NOT COMPLETED|Overall Study||18||
48216080|NCT02291913|100856385|FG000|STARTED|Overall Study||48||
48216081|NCT02291913|100856385|FG000|COMPLETED|Overall Study||0||
48216082|NCT02291913|100856385|FG000|NOT COMPLETED|Overall Study||48||
48216083|NCT03628885|100856386|FG000|STARTED|Overall Study||306||
48216084|NCT03628885|100856387|FG001|STARTED|Overall Study||299||
48216085|NCT03628885|100856388|FG002|STARTED|Overall Study||303||
48216086|NCT03628885|100856386|FG000|COMPLETED|Overall Study||267||
48216087|NCT03628885|100856387|FG001|COMPLETED|Overall Study||252||
48216088|NCT03628885|100856388|FG002|COMPLETED|Overall Study||243||
48216089|NCT03628885|100856386|FG000|NOT COMPLETED|Overall Study||39||
48216090|NCT03628885|100856387|FG001|NOT COMPLETED|Overall Study||47||
48216091|NCT03628885|100856388|FG002|NOT COMPLETED|Overall Study||60||
48216092|NCT00174252|100856389|FG000|STARTED|Overall Study||57||
48216093|NCT00174252|100856389|FG000|COMPLETED|Overall Study||55||
48216094|NCT00174252|100856389|FG000|NOT COMPLETED|Overall Study||2||
48216095|NCT00684242|100856390|FG000|STARTED|Overall Study||3||
48216096|NCT00684242|100856390|FG000|COMPLETED|Overall Study||3||
48216097|NCT00684242|100856390|FG000|NOT COMPLETED|Overall Study||0||
48216098|NCT04019444|100856391|FG000|STARTED|Overall Study||14||
48216099|NCT04019444|100856392|FG001|STARTED|Overall Study||14||
48216100|NCT04019444|100856393|FG002|STARTED|Overall Study||10||
48216101|NCT04019444|100856394|FG003|STARTED|Overall Study||12||
48216102|NCT04019444|100856391|FG000|COMPLETED|Overall Study||14||
48216103|NCT04019444|100856392|FG001|COMPLETED|Overall Study||13||
48216104|NCT04019444|100856393|FG002|COMPLETED|Overall Study||8||
48216105|NCT04019444|100856394|FG003|COMPLETED|Overall Study||11||
48216106|NCT04019444|100856391|FG000|NOT COMPLETED|Overall Study||0||
48216107|NCT04019444|100856392|FG001|NOT COMPLETED|Overall Study||1||
48216108|NCT04019444|100856393|FG002|NOT COMPLETED|Overall Study||2||
48216109|NCT04019444|100856394|FG003|NOT COMPLETED|Overall Study||1||
48216110|NCT00939510|100856395|FG000|STARTED|Overall Study||32||
48216111|NCT00939510|100856395|FG000|COMPLETED|Overall Study||31||
48216112|NCT00939510|100856395|FG000|NOT COMPLETED|Overall Study||1||
48216113|NCT02966275|100856396|FG000|STARTED|Overall Study||10||
48216114|NCT02966275|100856396|FG000|COMPLETED|Overall Study||10||
48216115|NCT02966275|100856396|FG000|NOT COMPLETED|Overall Study||0||
48216116|NCT01762059|100856397|FG000|STARTED|Overall Study||20||
48216117|NCT01762059|100856397|FG000|COMPLETED|Overall Study||20||
48216118|NCT01762059|100856397|FG000|NOT COMPLETED|Overall Study||0||
48216119|NCT05783843|100856398|FG000|STARTED|Overall Study||396||
48216120|NCT05783843|100856399|FG001|STARTED|Overall Study||402||
48216121|NCT05783843|100856400|FG002|STARTED|Overall Study||417||
48216122|NCT05783843|100856398|FG000|COMPLETED|Overall Study||396||
48216123|NCT05783843|100856399|FG001|COMPLETED|Overall Study||402||
48216124|NCT05783843|100856400|FG002|COMPLETED|Overall Study||417||
48216125|NCT05783843|100856398|FG000|NOT COMPLETED|Overall Study||0||
48216126|NCT05783843|100856399|FG001|NOT COMPLETED|Overall Study||0||
48216127|NCT05783843|100856400|FG002|NOT COMPLETED|Overall Study||0||
48216128|NCT00818246|100856401|FG000|STARTED|Overall Study||40||
48216129|NCT00818246|100856401|FG000|COMPLETED|Overall Study||35||
48216130|NCT00818246|100856401|FG000|NOT COMPLETED|Overall Study||5||
48216131|NCT01514149|100856402|FG000|STARTED|Overall Study||15||
48216132|NCT01514149|100856403|FG001|STARTED|Overall Study||15||
48216133|NCT01514149|100856404|FG002|STARTED|Overall Study||14||
48216134|NCT01514149|100856405|FG003|STARTED|Overall Study||14||
48216135|NCT01514149|100856406|FG004|STARTED|Overall Study||15||
48216136|NCT01514149|100856402|FG000|COMPLETED|Overall Study||12||
48216137|NCT01514149|100856403|FG001|COMPLETED|Overall Study||14||
48216138|NCT01514149|100856404|FG002|COMPLETED|Overall Study||11||
48216139|NCT01514149|100856405|FG003|COMPLETED|Overall Study||13||
48216140|NCT01514149|100856406|FG004|COMPLETED|Overall Study||14||
48216141|NCT01514149|100856402|FG000|NOT COMPLETED|Overall Study||3||
48216142|NCT01514149|100856403|FG001|NOT COMPLETED|Overall Study||1||
48216143|NCT01514149|100856404|FG002|NOT COMPLETED|Overall Study||3||
48216144|NCT01514149|100856405|FG003|NOT COMPLETED|Overall Study||1||
48216145|NCT01514149|100856406|FG004|NOT COMPLETED|Overall Study||1||
48216146|NCT02008916|100856407|FG000|STARTED|Primary Assessment (up to Week 16)||74|Randomized set comprised all randomized patients|
48216147|NCT02008916|100856408|FG001|STARTED|Primary Assessment (up to Week 16)||76|Randomized set comprised all randomized patients|
48216148|NCT02008916|100856409|FG002|STARTED|Primary Assessment (up to Week 16)||76|Randomized set comprised all randomized patients|
48216149|NCT02008916|100856407|FG000|FAS|Primary Assessment (up to Week 16)||74|Full Analysis Set (FAS) all patients randomized and study treatment assigned.|
48216150|NCT02008916|100856408|FG001|FAS|Primary Assessment (up to Week 16)||76|Full Analysis Set (FAS) all patients randomized and study treatment assigned.|
48216151|NCT02008916|100856409|FG002|FAS|Primary Assessment (up to Week 16)||76|Full Analysis Set (FAS) all patients randomized and study treatment assigned.|
48216152|NCT02008916|100856407|FG000|Safety Set|Primary Assessment (up to Week 16)||74|all patients who received at least one dose of study treatment|
48216153|NCT02008916|100856408|FG001|Safety Set|Primary Assessment (up to Week 16)||76|all patients who received at least one dose of study treatment|
48216154|NCT02008916|100856409|FG002|Safety Set|Primary Assessment (up to Week 16)||75|all patients who received at least one dose of study treatment|
48216155|NCT02008916|100856407|FG000|COMPLETED|Primary Assessment (up to Week 16)||74||
48216156|NCT02008916|100856408|FG001|COMPLETED|Primary Assessment (up to Week 16)||75||
48216157|NCT02008916|100856409|FG002|COMPLETED|Primary Assessment (up to Week 16)||73||
48216158|NCT02008916|100856407|FG000|NOT COMPLETED|Primary Assessment (up to Week 16)||0||
48216159|NCT02008916|100856408|FG001|NOT COMPLETED|Primary Assessment (up to Week 16)||1||
48216160|NCT02008916|100856409|FG002|NOT COMPLETED|Primary Assessment (up to Week 16)||3||
48216161|NCT02008916|100856407|FG000|STARTED|Week 16 - 156||74||
48216162|NCT02008916|100856408|FG001|STARTED|Week 16 - 156||75||
48216163|NCT02008916|100856409|FG002|STARTED|Week 16 - 156||73||
48216164|NCT02008916|100856407|FG000|COMPLETED|Week 16 - 156||55||
48216165|NCT02008916|100856408|FG001|COMPLETED|Week 16 - 156||62||
48216166|NCT02008916|100856409|FG002|COMPLETED|Week 16 - 156||63||
48216167|NCT02008916|100856407|FG000|NOT COMPLETED|Week 16 - 156||19||
48216168|NCT02008916|100856408|FG001|NOT COMPLETED|Week 16 - 156||13||
48216169|NCT02008916|100856409|FG002|NOT COMPLETED|Week 16 - 156||10||
48216170|NCT03128359|100856410|FG000|STARTED|Overall Study||19||
48216171|NCT03128359|100856411|FG001|STARTED|Overall Study||0||
48216172|NCT03128359|100856412|FG002|STARTED|Overall Study||19||
48216173|NCT03128359|100856410|FG000|COMPLETED|Overall Study||19||
48216174|NCT03128359|100856411|FG001|COMPLETED|Overall Study||0||
48216175|NCT03128359|100856412|FG002|COMPLETED|Overall Study||19||
48216176|NCT03128359|100856410|FG000|NOT COMPLETED|Overall Study||0||
48216177|NCT03128359|100856411|FG001|NOT COMPLETED|Overall Study||0||
48216178|NCT03128359|100856412|FG002|NOT COMPLETED|Overall Study||0||
48216179|NCT01655563|100856413|FG000|STARTED|Overall Study||18||
48060429|NCT03452228|100470186|FG001|Actual Cohort 2|Double-Blind Treatment Period (12 Weeks)||9|Actual Cohort 2 included participants with heterozygous LOF mutations in genes in the LPL pathway as was determined based on genotype data.|
48060430|NCT03452228|100470187|FG002|Actual Cohort 2|Double-Blind Treatment Period (12 Weeks)||0|Actual Cohort 2 included participants with heterozygous LOF mutations in genes in the LPL pathway as was determined based on genotype data.|
48060431|NCT03452228|100470185|FG000|Actual Cohort 3|Double-Blind Treatment Period (12 Weeks)||5|Actual Cohort 3 included participants without LOF mutations in genes in the LPL pathway as was determined based on genotype data.|
48060432|NCT03452228|100470186|FG001|Actual Cohort 3|Double-Blind Treatment Period (12 Weeks)||14|Actual Cohort 3 included participants without LOF mutations in genes in the LPL pathway as was determined based on genotype data.|
48060433|NCT03452228|100470187|FG002|Actual Cohort 3|Double-Blind Treatment Period (12 Weeks)||0|Actual Cohort 3 included participants without LOF mutations in genes in the LPL pathway as was determined based on genotype data.|
48060434|NCT03452228|100470185|FG000|COMPLETED|Double-Blind Treatment Period (12 Weeks)||15||
48060435|NCT03452228|100470186|FG001|COMPLETED|Double-Blind Treatment Period (12 Weeks)||32||
48060436|NCT03452228|100470187|FG002|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0||
48216180|NCT01655563|100856414|FG001|STARTED|Overall Study||35||
48216181|NCT01655563|100856413|FG000|COMPLETED|Overall Study||18||
48216182|NCT01655563|100856414|FG001|COMPLETED|Overall Study||35||
48216183|NCT01655563|100856413|FG000|NOT COMPLETED|Overall Study||0||
48216184|NCT01655563|100856414|FG001|NOT COMPLETED|Overall Study||0||
48216185|NCT00642850|100856415|FG000|STARTED|Overall Study||188||
48216186|NCT00642850|100856415|FG000|COMPLETED|Overall Study||155||
48216187|NCT00642850|100856415|FG000|NOT COMPLETED|Overall Study||33||
48216188|NCT00077675|100856416|FG000|STARTED|Overall Study||103||
48216189|NCT00077675|100856417|FG001|STARTED|Overall Study||98||
48216190|NCT00077675|100856416|FG000|COMPLETED|Overall Study||92||
48216191|NCT00077675|100856417|FG001|COMPLETED|Overall Study||89||
48216192|NCT00077675|100856416|FG000|NOT COMPLETED|Overall Study||11||
48216193|NCT00077675|100856417|FG001|NOT COMPLETED|Overall Study||9||
48216194|NCT01095796|100856418|FG000|STARTED|Overall Study||353||
48216195|NCT01095796|100856419|FG001|STARTED|Overall Study||354||
48216196|NCT01095796|100856418|FG000|COMPLETED|Overall Study||58||
48216197|NCT01095796|100856419|FG001|COMPLETED|Overall Study||65||
48216198|NCT01095796|100856418|FG000|NOT COMPLETED|Overall Study||295||
48216199|NCT01095796|100856419|FG001|NOT COMPLETED|Overall Study||289||
48216200|NCT00976495|100856420|FG000|STARTED|Overall Study||25||
48216201|NCT00976495|100856421|FG001|STARTED|Overall Study||24||
48216202|NCT00976495|100856422|FG002|STARTED|Overall Study||26||
48216203|NCT00976495|100856420|FG000|COMPLETED|Overall Study||25||
48216204|NCT00976495|100856421|FG001|COMPLETED|Overall Study||23||
48216205|NCT00976495|100856422|FG002|COMPLETED|Overall Study||26||
48216206|NCT00976495|100856420|FG000|NOT COMPLETED|Overall Study||0||
48216207|NCT00976495|100856421|FG001|NOT COMPLETED|Overall Study||1||
48216208|NCT00976495|100856422|FG002|NOT COMPLETED|Overall Study||0||
48216209|NCT00593489|100856423|FG000|STARTED|Allocation||75||
48216210|NCT00593489|100856424|FG001|STARTED|Allocation||79||
48216211|NCT00593489|100856423|FG000|COMPLETED|Allocation||73||
48216212|NCT00593489|100856424|FG001|COMPLETED|Allocation||78||
48216213|NCT00593489|100856423|FG000|NOT COMPLETED|Allocation||2||
48216214|NCT00593489|100856424|FG001|NOT COMPLETED|Allocation||1||
48216215|NCT00593489|100856423|FG000|STARTED|Analysis||73||
48216216|NCT00593489|100856424|FG001|STARTED|Analysis||78||
48216217|NCT00593489|100856423|FG000|COMPLETED|Analysis||73||
48216218|NCT00593489|100856424|FG001|COMPLETED|Analysis||78||
48216219|NCT00593489|100856423|FG000|NOT COMPLETED|Analysis||0||
48216220|NCT00593489|100856424|FG001|NOT COMPLETED|Analysis||0||
48216221|NCT04121546|100856425|FG000|STARTED|Overall Study||2||
48216222|NCT04121546|100856426|FG001|STARTED|Overall Study||4||
48216223|NCT04121546|100856425|FG000|COMPLETED|Overall Study||1||
48216224|NCT04121546|100856426|FG001|COMPLETED|Overall Study||1||
48216225|NCT04121546|100856425|FG000|NOT COMPLETED|Overall Study||1||
48216226|NCT04121546|100856426|FG001|NOT COMPLETED|Overall Study||3||
48216227|NCT04638816|100856427|FG000|STARTED|Overall Study||30||
48216228|NCT04638816|100856428|FG001|STARTED|Overall Study||30||
48216229|NCT04638816|100856427|FG000|COMPLETED|Overall Study||30||
48216230|NCT04638816|100856428|FG001|COMPLETED|Overall Study||28||
48216231|NCT04638816|100856427|FG000|NOT COMPLETED|Overall Study||0||
48216232|NCT04638816|100856428|FG001|NOT COMPLETED|Overall Study||2||
48216233|NCT00402896|100856429|FG000|STARTED|Overall Study||20||
48216234|NCT00402896|100856429|FG000|COMPLETED|Overall Study||20||
48216235|NCT00402896|100856429|FG000|NOT COMPLETED|Overall Study||0||
48216236|NCT02538900|100856430|FG000|STARTED|Overall Study||116||
48216237|NCT02538900|100856431|FG001|STARTED|Overall Study||124||
48216238|NCT02538900|100856432|FG002|STARTED|Overall Study||65||
48216239|NCT02538900|100856430|FG000|COMPLETED|Overall Study||96||
48216240|NCT02538900|100856431|FG001|COMPLETED|Overall Study||106||
48216241|NCT02538900|100856432|FG002|COMPLETED|Overall Study||48||
48216242|NCT02538900|100856430|FG000|NOT COMPLETED|Overall Study||20||
48216243|NCT02538900|100856431|FG001|NOT COMPLETED|Overall Study||18||
48216244|NCT02538900|100856432|FG002|NOT COMPLETED|Overall Study||17||
48216245|NCT00589875|100856433|FG000|STARTED|Enrollment to Treatment Initiation||52||
48216246|NCT00589875|100856433|FG000|COMPLETED|Enrollment to Treatment Initiation||43||
48216247|NCT00589875|100856433|FG000|NOT COMPLETED|Enrollment to Treatment Initiation||9||
48216248|NCT00589875|100856433|FG000|STARTED|Treatment Initiation to Completion||43||
48216249|NCT00589875|100856433|FG000|COMPLETED|Treatment Initiation to Completion||36||
48216250|NCT00589875|100856433|FG000|NOT COMPLETED|Treatment Initiation to Completion||7||
48216251|NCT01074294|100856434|FG000|STARTED|Phase A (Day 1 to Week 5)||740||
48216252|NCT01074294|100856435|FG001|STARTED|Phase A (Day 1 to Week 5)||0||
48216253|NCT01074294|100856436|FG002|STARTED|Phase A (Day 1 to Week 5)||0||
48216254|NCT01074294|100856437|FG003|STARTED|Phase A (Day 1 to Week 5)||0||
48216255|NCT01074294|100856434|FG000|Analyzed for Safety|Phase A (Day 1 to Week 5)||733|Safety Sample consisted of randomized participants who received at least one dose of double-blind investigational medicinal product (IMP) as indicated on the dosing record.|
48216256|NCT01074294|100856435|FG001|Analyzed for Safety|Phase A (Day 1 to Week 5)||0|Safety Sample consisted of randomized participants who received at least one dose of double-blind investigational medicinal product (IMP) as indicated on the dosing record.|
48216257|NCT01074294|100856436|FG002|Analyzed for Safety|Phase A (Day 1 to Week 5)||0|Safety Sample consisted of randomized participants who received at least one dose of double-blind investigational medicinal product (IMP) as indicated on the dosing record.|
48216258|NCT01074294|100856437|FG003|Analyzed for Safety|Phase A (Day 1 to Week 5)||0|Safety Sample consisted of randomized participants who received at least one dose of double-blind investigational medicinal product (IMP) as indicated on the dosing record.|
48216259|NCT01074294|100856434|FG000|COMPLETED|Phase A (Day 1 to Week 5)||574||
48216260|NCT01074294|100856435|FG001|COMPLETED|Phase A (Day 1 to Week 5)||0||
48216261|NCT01074294|100856436|FG002|COMPLETED|Phase A (Day 1 to Week 5)||0||
48216262|NCT01074294|100856437|FG003|COMPLETED|Phase A (Day 1 to Week 5)||0||
48216263|NCT01074294|100856434|FG000|NOT COMPLETED|Phase A (Day 1 to Week 5)||166||
48216264|NCT01074294|100856435|FG001|NOT COMPLETED|Phase A (Day 1 to Week 5)||0||
48216265|NCT01074294|100856436|FG002|NOT COMPLETED|Phase A (Day 1 to Week 5)||0||
48216266|NCT01074294|100856437|FG003|NOT COMPLETED|Phase A (Day 1 to Week 5)||0||
48216267|NCT01074294|100856434|FG000|STARTED|Phase B and Phase A+ (Week 6 to Week 11)||0||
48216268|NCT01074294|100856435|FG001|STARTED|Phase B and Phase A+ (Week 6 to Week 11)||155||
48216269|NCT01074294|100856436|FG002|STARTED|Phase B and Phase A+ (Week 6 to Week 11)||80||
48216270|NCT01074294|100856437|FG003|STARTED|Phase B and Phase A+ (Week 6 to Week 11)||339||
48216271|NCT01074294|100856434|FG000|Analyzed for Safety|Phase B and Phase A+ (Week 6 to Week 11)||0|Safety Sample consisted of randomized participants who received at least one dose of double-blind IMP as indicated on the dosing record.|
48216272|NCT01074294|100856435|FG001|Analyzed for Safety|Phase B and Phase A+ (Week 6 to Week 11)||155|Safety Sample consisted of randomized participants who received at least one dose of double-blind IMP as indicated on the dosing record.|
48216273|NCT01074294|100856436|FG002|Analyzed for Safety|Phase B and Phase A+ (Week 6 to Week 11)||80|Safety Sample consisted of randomized participants who received at least one dose of double-blind IMP as indicated on the dosing record.|
48216274|NCT01074294|100856437|FG003|Analyzed for Safety|Phase B and Phase A+ (Week 6 to Week 11)||235|Safety Sample consisted of randomized participants who received at least one dose of double-blind IMP as indicated on the dosing record.|
48216275|NCT01074294|100856434|FG000|COMPLETED|Phase B and Phase A+ (Week 6 to Week 11)||0||
48216276|NCT01074294|100856435|FG001|COMPLETED|Phase B and Phase A+ (Week 6 to Week 11)||146||
48216277|NCT01074294|100856436|FG002|COMPLETED|Phase B and Phase A+ (Week 6 to Week 11)||70||
48216278|NCT01074294|100856437|FG003|COMPLETED|Phase B and Phase A+ (Week 6 to Week 11)||314||
48216279|NCT01074294|100856434|FG000|NOT COMPLETED|Phase B and Phase A+ (Week 6 to Week 11)||0||
48216280|NCT01074294|100856435|FG001|NOT COMPLETED|Phase B and Phase A+ (Week 6 to Week 11)||9||
48216281|NCT01074294|100856436|FG002|NOT COMPLETED|Phase B and Phase A+ (Week 6 to Week 11)||10||
48216282|NCT01074294|100856437|FG003|NOT COMPLETED|Phase B and Phase A+ (Week 6 to Week 11)||25||
48216283|NCT00589277|100856438|FG000|STARTED|Overall Study||1222||
48216284|NCT00589277|100856439|FG001|STARTED|Overall Study||810||
48216285|NCT00589277|100856438|FG000|Completed 2 Week Follow Up|Overall Study||603||
48060437|NCT03452228|100470185|FG000|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||2||
48060438|NCT03452228|100470186|FG001|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||3||
48060439|NCT03452228|100470187|FG002|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0||
48060440|NCT03452228|100470185|FG000|STARTED|Single-Blind Treatment Period (12 Weeks)||0||
48216286|NCT00589277|100856439|FG001|Completed 2 Week Follow Up|Overall Study||424||
48216287|NCT00589277|100856438|FG000|Completed 3 Month Follow Up|Overall Study||762||
48216288|NCT00589277|100856439|FG001|Completed 3 Month Follow Up|Overall Study||524||
48216289|NCT00589277|100856438|FG000|COMPLETED|Overall Study||762||
48216290|NCT00589277|100856439|FG001|COMPLETED|Overall Study||524||
48216291|NCT00589277|100856438|FG000|NOT COMPLETED|Overall Study||460||
48216292|NCT00589277|100856439|FG001|NOT COMPLETED|Overall Study||286||
48216293|NCT01881412|100856440|FG000|STARTED|Overall Study||59||
48060441|NCT03452228|100470186|FG001|STARTED|Single-Blind Treatment Period (12 Weeks)||0||
48060442|NCT03452228|100470187|FG002|STARTED|Single-Blind Treatment Period (12 Weeks)||47||
48060443|NCT03452228|100470185|FG000|Treated|Single-Blind Treatment Period (12 Weeks)||0||
48060444|NCT03452228|100470186|FG001|Treated|Single-Blind Treatment Period (12 Weeks)||0||
48060445|NCT03452228|100470187|FG002|Treated|Single-Blind Treatment Period (12 Weeks)||47||
48216294|NCT01881412|100856441|FG001|STARTED|Overall Study||59||
48216295|NCT01881412|100856440|FG000|COMPLETED|Overall Study||49||
48216296|NCT01881412|100856441|FG001|COMPLETED|Overall Study||57||
48216297|NCT01881412|100856440|FG000|NOT COMPLETED|Overall Study||10||
48216298|NCT01881412|100856441|FG001|NOT COMPLETED|Overall Study||2||
48216299|NCT00766649|100856442|FG000|STARTED|Overall Study||11||
48216300|NCT00766649|100856442|FG000|COMPLETED|Overall Study||1||
48216301|NCT00766649|100856442|FG000|NOT COMPLETED|Overall Study||10||
48216302|NCT00774397|100856443|FG000|STARTED|Overall Study||71||
48216303|NCT00774397|100856444|FG001|STARTED|Overall Study||69||
48216304|NCT00774397|100856445|FG002|STARTED|Overall Study||143||
48216305|NCT00774397|100856446|FG003|STARTED|Overall Study||146||
48216306|NCT00774397|100856447|FG004|STARTED|Overall Study||143||
48216307|NCT00774397|100856448|FG005|STARTED|Overall Study||76||
48216308|NCT00774397|100856449|FG006|STARTED|Overall Study||71||
48216309|NCT00774397|100856443|FG000|COMPLETED|Overall Study||57||
48216310|NCT00774397|100856444|FG001|COMPLETED|Overall Study||56||
48216311|NCT00774397|100856445|FG002|COMPLETED|Overall Study||113||
48216312|NCT00774397|100856446|FG003|COMPLETED|Overall Study||129||
48216313|NCT00774397|100856447|FG004|COMPLETED|Overall Study||97||
48216314|NCT00774397|100856448|FG005|COMPLETED|Overall Study||54||
48216315|NCT00774397|100856449|FG006|COMPLETED|Overall Study||41||
48216316|NCT00774397|100856443|FG000|NOT COMPLETED|Overall Study||14||
48216317|NCT00774397|100856444|FG001|NOT COMPLETED|Overall Study||13||
48216318|NCT00774397|100856445|FG002|NOT COMPLETED|Overall Study||30||
48216319|NCT00774397|100856446|FG003|NOT COMPLETED|Overall Study||17||
48216320|NCT00774397|100856447|FG004|NOT COMPLETED|Overall Study||46||
48216321|NCT00774397|100856448|FG005|NOT COMPLETED|Overall Study||22||
48216322|NCT00774397|100856449|FG006|NOT COMPLETED|Overall Study||30||
48216323|NCT03285542|100856450|FG000|STARTED|Overall Study||30||
48216324|NCT03285542|100856451|FG001|STARTED|Overall Study||30||
48216325|NCT03285542|100856450|FG000|COMPLETED|Overall Study||30||
48216326|NCT03285542|100856451|FG001|COMPLETED|Overall Study||30||
48216327|NCT03285542|100856450|FG000|NOT COMPLETED|Overall Study||0||
48216328|NCT03285542|100856451|FG001|NOT COMPLETED|Overall Study||0||
48216329|NCT02639637|100856452|FG000|STARTED|Overall Study||7||
48216330|NCT02639637|100856453|FG001|STARTED|Overall Study||6||
48216331|NCT02639637|100856454|FG002|STARTED|Overall Study||2||
48216332|NCT02639637|100856455|FG003|STARTED|Overall Study||3||
48216333|NCT02639637|100856452|FG000|COMPLETED|Overall Study||7||
48216334|NCT02639637|100856453|FG001|COMPLETED|Overall Study||6||
48216335|NCT02639637|100856454|FG002|COMPLETED|Overall Study||2||
48216336|NCT02639637|100856455|FG003|COMPLETED|Overall Study||3||
48216337|NCT02639637|100856452|FG000|NOT COMPLETED|Overall Study||0||
48216338|NCT02639637|100856453|FG001|NOT COMPLETED|Overall Study||0||
48216339|NCT02639637|100856454|FG002|NOT COMPLETED|Overall Study||0||
48216340|NCT02639637|100856455|FG003|NOT COMPLETED|Overall Study||0||
48216341|NCT02462759|100856456|FG000|STARTED|Part 1: Double Blind||7||
48216342|NCT02462759|100856457|FG001|STARTED|Part 1: Double Blind||14||
48216343|NCT02462759|100856458|FG002|STARTED|Part 1: Double Blind||0||
48216344|NCT02462759|100856456|FG000|COMPLETED|Part 1: Double Blind||6||
48216345|NCT02462759|100856457|FG001|COMPLETED|Part 1: Double Blind||14||
48216346|NCT02462759|100856458|FG002|COMPLETED|Part 1: Double Blind||0||
48216347|NCT02462759|100856456|FG000|NOT COMPLETED|Part 1: Double Blind||1||
48216348|NCT02462759|100856457|FG001|NOT COMPLETED|Part 1: Double Blind||0||
48216349|NCT02462759|100856458|FG002|NOT COMPLETED|Part 1: Double Blind||0||
48216350|NCT02462759|100856456|FG000|STARTED|Part 2: Open-Label Phase||0||
48216351|NCT02462759|100856457|FG001|STARTED|Part 2: Open-Label Phase||0||
48216352|NCT02462759|100856458|FG002|STARTED|Part 2: Open-Label Phase||20||
48216353|NCT02462759|100856456|FG000|COMPLETED|Part 2: Open-Label Phase||0||
48216354|NCT02462759|100856457|FG001|COMPLETED|Part 2: Open-Label Phase||0||
48216355|NCT02462759|100856458|FG002|COMPLETED|Part 2: Open-Label Phase||20||
48216356|NCT02462759|100856456|FG000|NOT COMPLETED|Part 2: Open-Label Phase||0||
48216357|NCT02462759|100856457|FG001|NOT COMPLETED|Part 2: Open-Label Phase||0||
48216358|NCT02462759|100856458|FG002|NOT COMPLETED|Part 2: Open-Label Phase||0||
48216359|NCT00366249|100856459|FG000|STARTED|Overall Study||553||
48216360|NCT00366249|100856460|FG001|STARTED|Overall Study||508||
48216361|NCT00366249|100856459|FG000|COMPLETED|Overall Study||422||
48216362|NCT00366249|100856460|FG001|COMPLETED|Overall Study||430||
48216363|NCT00366249|100856459|FG000|NOT COMPLETED|Overall Study||131||
48216364|NCT00366249|100856460|FG001|NOT COMPLETED|Overall Study||78||
48216365|NCT00249769|100856461|FG000|STARTED|Overall Study||100||
48216366|NCT00249769|100856462|FG001|STARTED|Overall Study||250||
48216367|NCT00249769|100856463|FG002|STARTED|Overall Study||250||
48216368|NCT00249769|100856461|FG000|Received LJEV|Overall Study||100|Live Japanese encephalitis vaccine (LJEV)|
48216369|NCT00249769|100856462|FG001|Received LJEV|Overall Study||236|Live Japanese encephalitis vaccine (LJEV)|
48216370|NCT00249769|100856463|FG002|Received LJEV|Overall Study||224|Live Japanese encephalitis vaccine (LJEV)|
48216371|NCT00249769|100856461|FG000|Received Measles Vaccine|Overall Study||97||
48216372|NCT00249769|100856462|FG001|Received Measles Vaccine|Overall Study||236||
48216373|NCT00249769|100856463|FG002|Received Measles Vaccine|Overall Study||235||
48216374|NCT00249769|100856461|FG000|COMPLETED|Overall Study||98||
48216375|NCT00249769|100856462|FG001|COMPLETED|Overall Study||235||
48216376|NCT00249769|100856463|FG002|COMPLETED|Overall Study||222||
48216377|NCT00249769|100856461|FG000|NOT COMPLETED|Overall Study||2||
48216378|NCT00249769|100856462|FG001|NOT COMPLETED|Overall Study||15||
48060446|NCT03452228|100470185|FG000|Actual Cohort 1: DB Placebo to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||0|Actual Cohort 1 included participants with homozygous or compound heterozygous LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 1 participants who received placebo in DBTP were shifted into single blind (SB) evinacumab group.|
48060447|NCT03452228|100470186|FG001|Actual Cohort 1: DB Placebo to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||0|Actual Cohort 1 included participants with homozygous or compound heterozygous LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 1 participants who received placebo in DBTP were shifted into single blind (SB) evinacumab group.|
48060448|NCT03452228|100470187|FG002|Actual Cohort 1: DB Placebo to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||4|Actual Cohort 1 included participants with homozygous or compound heterozygous LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 1 participants who received placebo in DBTP were shifted into single blind (SB) evinacumab group.|
48060449|NCT03452228|100470185|FG000|Actual Cohort 1: DB Evinacumab to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||0|Actual Cohort 1 included participants with homozygous or compound heterozygous LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 1 participants who received evinacumab in DBTP were shifted into SB evinacumab group.|
48060450|NCT03452228|100470186|FG001|Actual Cohort 1: DB Evinacumab to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||0|Actual Cohort 1 included participants with homozygous or compound heterozygous LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 1 participants who received evinacumab in DBTP were shifted into SB evinacumab group.|
48060451|NCT03452228|100470187|FG002|Actual Cohort 1: DB Evinacumab to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||11|Actual Cohort 1 included participants with homozygous or compound heterozygous LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 1 participants who received evinacumab in DBTP were shifted into SB evinacumab group.|
48060452|NCT03452228|100470185|FG000|Actual Cohort 2: DB Placebo to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||0|Actual Cohort 2 included participants with heterozygous LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 2 participants who received placebo in DBTP were shifted into SB evinacumab group.|
48060453|NCT03452228|100470186|FG001|Actual Cohort 2: DB Placebo to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||0|Actual Cohort 2 included participants with heterozygous LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 2 participants who received placebo in DBTP were shifted into SB evinacumab group.|
48060454|NCT03452228|100470187|FG002|Actual Cohort 2: DB Placebo to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||6|Actual Cohort 2 included participants with heterozygous LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 2 participants who received placebo in DBTP were shifted into SB evinacumab group.|
48060455|NCT03452228|100470185|FG000|Actual Cohort 2: DB Evinacumab to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||0|Actual Cohort 2 included participants with heterozygous LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 2 participants who received evinacumab in DBTP were shifted into SB evinacumab group.|
48060456|NCT03452228|100470186|FG001|Actual Cohort 2: DB Evinacumab to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||0|Actual Cohort 2 included participants with heterozygous LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 2 participants who received evinacumab in DBTP were shifted into SB evinacumab group.|
48060457|NCT03452228|100470187|FG002|Actual Cohort 2: DB Evinacumab to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||9|Actual Cohort 2 included participants with heterozygous LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 2 participants who received evinacumab in DBTP were shifted into SB evinacumab group.|
48060458|NCT03452228|100470185|FG000|Actual Cohort 3: DB Placebo to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||0|Actual Cohort 3 included participants without LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 3 participants who received placebo in DBTP were shifted into SB evinacumab group.|
48060459|NCT03452228|100470186|FG001|Actual Cohort 3: DB Placebo to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||0|Actual Cohort 3 included participants without LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 3 participants who received placebo in DBTP were shifted into SB evinacumab group.|
48060460|NCT03452228|100470187|FG002|Actual Cohort 3: DB Placebo to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||5|Actual Cohort 3 included participants without LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 3 participants who received placebo in DBTP were shifted into SB evinacumab group.|
48060461|NCT03452228|100470185|FG000|Actual Cohort 3: DB Evinacumab to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||0|Actual Cohort 3 included participants without LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 3 participants who received evinacumab in DBTP were shifted into SB evinacumab group.|
48060462|NCT03452228|100470186|FG001|Actual Cohort 3: DB Evinacumab to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||0|Actual Cohort 3 included participants without LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 3 participants who received evinacumab in DBTP were shifted into SB evinacumab group.|
48216379|NCT00249769|100856463|FG002|NOT COMPLETED|Overall Study||28||
48216380|NCT01082575|100856464|FG000|STARTED|Overall Study||100||
48216381|NCT01082575|100856464|FG000|COMPLETED|Overall Study||100||
48216382|NCT01082575|100856464|FG000|NOT COMPLETED|Overall Study||0||
48216383|NCT05360901|100856465|FG000|STARTED|Overall Study||12||
48216384|NCT05360901|100856465|FG000|COMPLETED|Overall Study||12||
48216385|NCT05360901|100856465|FG000|NOT COMPLETED|Overall Study||0||
48216386|NCT00630487|100856466|FG000|STARTED|Overall Study||0||
48216387|NCT00630487|100856467|FG001|STARTED|Overall Study||0||
48216388|NCT00630487|100856466|FG000|COMPLETED|Overall Study||0||
48216389|NCT00630487|100856467|FG001|COMPLETED|Overall Study||0||
48216390|NCT00630487|100856466|FG000|NOT COMPLETED|Overall Study||0||
48216391|NCT00630487|100856467|FG001|NOT COMPLETED|Overall Study||0||
48216392|NCT00988858|100856468|FG000|STARTED|Overall Study||55||
48216393|NCT00988858|100856468|FG000|COMPLETED|Overall Study||45||
48216394|NCT00988858|100856468|FG000|NOT COMPLETED|Overall Study||10||
48216395|NCT01619410|100856469|FG000|STARTED|Overall Study||14||
48216396|NCT01619410|100856470|FG001|STARTED|Overall Study||11||
48216397|NCT01619410|100856469|FG000|COMPLETED|Overall Study||7||
48216398|NCT01619410|100856470|FG001|COMPLETED|Overall Study||7||
48216399|NCT01619410|100856469|FG000|NOT COMPLETED|Overall Study||7||
48216400|NCT01619410|100856470|FG001|NOT COMPLETED|Overall Study||4||
48216401|NCT00083551|100856471|FG000|STARTED|Overall Study||323||
48216402|NCT00083551|100856472|FG001|STARTED|Overall Study||345||
48216403|NCT00083551|100856471|FG000|COMPLETED|Overall Study||323||
48216404|NCT00083551|100856472|FG001|COMPLETED|Overall Study||345||
48216405|NCT00083551|100856471|FG000|NOT COMPLETED|Overall Study||0||
48216406|NCT00083551|100856472|FG001|NOT COMPLETED|Overall Study||0||
48216407|NCT05051982|100856473|FG000|STARTED|Overall Study||55||
48216408|NCT05051982|100856474|FG001|STARTED|Overall Study||55||
48216409|NCT05051982|100856473|FG000|COMPLETED|Overall Study||51||
48216410|NCT05051982|100856474|FG001|COMPLETED|Overall Study||51||
48216411|NCT05051982|100856473|FG000|NOT COMPLETED|Overall Study||4||
48216412|NCT05051982|100856474|FG001|NOT COMPLETED|Overall Study||4||
48216413|NCT02891915|100856475|FG000|STARTED|Overall Study||192||
48216414|NCT02891915|100856476|FG001|STARTED|Overall Study||193||
48216415|NCT02891915|100856475|FG000|COMPLETED|Overall Study||179||
48216416|NCT02891915|100856476|FG001|COMPLETED|Overall Study||181||
48216417|NCT02891915|100856475|FG000|NOT COMPLETED|Overall Study||13||
48216418|NCT02891915|100856476|FG001|NOT COMPLETED|Overall Study||12||
48216419|NCT01550549|100856477|FG000|STARTED|Overall Study||151||
48216420|NCT01550549|100856477|FG000|COMPLETED|Overall Study||151||
48216421|NCT01550549|100856477|FG000|NOT COMPLETED|Overall Study||0||
48216422|NCT00909649|100856478|FG000|STARTED|Overall Study||25||
48216423|NCT00909649|100856479|FG001|STARTED|Overall Study||25||
48216424|NCT00909649|100856478|FG000|COMPLETED|Overall Study||25||
48216425|NCT00909649|100856479|FG001|COMPLETED|Overall Study||25||
48216426|NCT00909649|100856478|FG000|NOT COMPLETED|Overall Study||0||
48216427|NCT00909649|100856479|FG001|NOT COMPLETED|Overall Study||0||
48216428|NCT00792636|100856480|FG000|STARTED|Overall Study||135||
48216429|NCT00792636|100856481|FG001|STARTED|Overall Study||136||
48216430|NCT00792636|100856482|FG002|STARTED|Overall Study||136||
48216431|NCT00792636|100856480|FG000|COMPLETED|Overall Study||67||
48216432|NCT00792636|100856481|FG001|COMPLETED|Overall Study||55||
48216433|NCT00792636|100856482|FG002|COMPLETED|Overall Study||55||
48216434|NCT00792636|100856480|FG000|NOT COMPLETED|Overall Study||68||
48216435|NCT00792636|100856481|FG001|NOT COMPLETED|Overall Study||81||
48216436|NCT00792636|100856482|FG002|NOT COMPLETED|Overall Study||81||
48216437|NCT03951805|100856483|FG000|STARTED|Overall Study||51||
48216438|NCT03951805|100856484|FG001|STARTED|Overall Study||51||
48216439|NCT03951805|100856485|FG002|STARTED|Overall Study||52||
48216440|NCT03951805|100856486|FG003|STARTED|Overall Study||51||
48216441|NCT03951805|100856483|FG000|Full Analysis Set (FAS)|Overall Study||51||
48216442|NCT03951805|100856484|FG001|Full Analysis Set (FAS)|Overall Study||51||
48216443|NCT03951805|100856485|FG002|Full Analysis Set (FAS)|Overall Study||52||
48216444|NCT03951805|100856486|FG003|Full Analysis Set (FAS)|Overall Study||51||
48216445|NCT03951805|100856483|FG000|Safety Analysis Set (SAS)|Overall Study||51||
48216446|NCT03951805|100856484|FG001|Safety Analysis Set (SAS)|Overall Study||51||
48216447|NCT03951805|100856485|FG002|Safety Analysis Set (SAS)|Overall Study||52||
48216448|NCT03951805|100856486|FG003|Safety Analysis Set (SAS)|Overall Study||51||
48216449|NCT03951805|100856483|FG000|COMPLETED|Overall Study||50||
48216450|NCT03951805|100856484|FG001|COMPLETED|Overall Study||51||
48216451|NCT03951805|100856485|FG002|COMPLETED|Overall Study||52||
48216452|NCT03951805|100856486|FG003|COMPLETED|Overall Study||51||
48216453|NCT03951805|100856483|FG000|NOT COMPLETED|Overall Study||1||
48216454|NCT03951805|100856484|FG001|NOT COMPLETED|Overall Study||0||
48216455|NCT03951805|100856485|FG002|NOT COMPLETED|Overall Study||0||
48216456|NCT03951805|100856486|FG003|NOT COMPLETED|Overall Study||0||
48216457|NCT00073749|100856487|FG000|STARTED|Overall Study||2||
48216458|NCT00073749|100856488|FG001|STARTED|Overall Study||5||
48216459|NCT00073749|100856489|FG002|STARTED|Overall Study||11||
48216460|NCT00073749|100856490|FG003|STARTED|Overall Study||6||
48216461|NCT00073749|100856491|FG004|STARTED|Overall Study||6||
48216462|NCT00073749|100856492|FG005|STARTED|Overall Study||6||
48216463|NCT00073749|100856493|FG006|STARTED|Overall Study||43||
48216464|NCT00073749|100856487|FG000|COMPLETED|Overall Study||0||
48216465|NCT00073749|100856488|FG001|COMPLETED|Overall Study||0||
48216466|NCT00073749|100856489|FG002|COMPLETED|Overall Study||0||
48216467|NCT00073749|100856490|FG003|COMPLETED|Overall Study||0||
48216468|NCT00073749|100856491|FG004|COMPLETED|Overall Study||0||
48216469|NCT00073749|100856492|FG005|COMPLETED|Overall Study||0||
48216470|NCT00073749|100856493|FG006|COMPLETED|Overall Study||3||
48216471|NCT00073749|100856487|FG000|NOT COMPLETED|Overall Study||2||
48216472|NCT00073749|100856488|FG001|NOT COMPLETED|Overall Study||5||
48216473|NCT00073749|100856489|FG002|NOT COMPLETED|Overall Study||11||
48216474|NCT00073749|100856490|FG003|NOT COMPLETED|Overall Study||6||
48216475|NCT00073749|100856491|FG004|NOT COMPLETED|Overall Study||6||
48216476|NCT00073749|100856492|FG005|NOT COMPLETED|Overall Study||6||
48216477|NCT00073749|100856493|FG006|NOT COMPLETED|Overall Study||40||
48216478|NCT03283371|100856494|FG000|STARTED|Placebo-controlled||34||
48216479|NCT03283371|100856495|FG001|STARTED|Placebo-controlled||33||
48216480|NCT03283371|100856496|FG002|STARTED|Placebo-controlled||0||
48216481|NCT03283371|100856497|FG003|STARTED|Placebo-controlled||0||
48216482|NCT03283371|100856494|FG000|Number of Participants Dosed|Placebo-controlled||34||
48216483|NCT03283371|100856495|FG001|Number of Participants Dosed|Placebo-controlled||32||
48216484|NCT03283371|100856496|FG002|Number of Participants Dosed|Placebo-controlled||0||
48216485|NCT03283371|100856497|FG003|Number of Participants Dosed|Placebo-controlled||0||
48216486|NCT03283371|100856494|FG000|COMPLETED|Placebo-controlled||31||
48216487|NCT03283371|100856495|FG001|COMPLETED|Placebo-controlled||30||
48216488|NCT03283371|100856496|FG002|COMPLETED|Placebo-controlled||0||
48216489|NCT03283371|100856497|FG003|COMPLETED|Placebo-controlled||0||
48216490|NCT03283371|100856494|FG000|NOT COMPLETED|Placebo-controlled||3||
48216491|NCT03283371|100856495|FG001|NOT COMPLETED|Placebo-controlled||3||
48216492|NCT03283371|100856496|FG002|NOT COMPLETED|Placebo-controlled||0||
48216493|NCT03283371|100856497|FG003|NOT COMPLETED|Placebo-controlled||0||
48216494|NCT03283371|100856494|FG000|STARTED|Open-label Phase||0||
48216495|NCT03283371|100856495|FG001|STARTED|Open-label Phase||0||
48216496|NCT03283371|100856496|FG002|STARTED|Open-label Phase||31||
48216497|NCT03283371|100856497|FG003|STARTED|Open-label Phase||30||
48216498|NCT03283371|100856494|FG000|COMPLETED|Open-label Phase||0||
48216499|NCT03283371|100856495|FG001|COMPLETED|Open-label Phase||0||
48216500|NCT03283371|100856496|FG002|COMPLETED|Open-label Phase||27||
48216501|NCT03283371|100856497|FG003|COMPLETED|Open-label Phase||29||
48216502|NCT03283371|100856494|FG000|NOT COMPLETED|Open-label Phase||0||
48216503|NCT03283371|100856495|FG001|NOT COMPLETED|Open-label Phase||0||
48216504|NCT03283371|100856496|FG002|NOT COMPLETED|Open-label Phase||4||
48216505|NCT03283371|100856497|FG003|NOT COMPLETED|Open-label Phase||1||
48216506|NCT00439413|100856498|FG000|STARTED|Overall Study||121||
48216507|NCT00439413|100856499|FG001|STARTED|Overall Study||125||
48216508|NCT00439413|100856498|FG000|COMPLETED|Overall Study||90||
48216509|NCT00439413|100856499|FG001|COMPLETED|Overall Study||88||
48216510|NCT00439413|100856498|FG000|NOT COMPLETED|Overall Study||31||
48216511|NCT00439413|100856499|FG001|NOT COMPLETED|Overall Study||37||
48216512|NCT02713126|100856500|FG000|STARTED|Overall Study||36||
48216513|NCT02713126|100856501|FG001|STARTED|Overall Study||56||
48216514|NCT02713126|100856500|FG000|COMPLETED|Overall Study||36||
48216515|NCT02713126|100856501|FG001|COMPLETED|Overall Study||37||
48216516|NCT02713126|100856500|FG000|NOT COMPLETED|Overall Study||0||
48216517|NCT02713126|100856501|FG001|NOT COMPLETED|Overall Study||19||
48216518|NCT01262339|100856502|FG000|STARTED|Overall Study||2||
48216519|NCT01262339|100856502|FG000|COMPLETED|Overall Study||2||
48216520|NCT01262339|100856502|FG000|NOT COMPLETED|Overall Study||0||
48216521|NCT03939312|100856503|FG000|STARTED|OL Treatment Period (40 Weeks)||685||
48216522|NCT03939312|100856503|FG000|COMPLETED|OL Treatment Period (40 Weeks)||511||
48216523|NCT03939312|100856503|FG000|NOT COMPLETED|OL Treatment Period (40 Weeks)||174||
48216524|NCT03939312|100856503|FG000|STARTED|Safety Follow-up 4 Weeks (Up to Week 44)||640||
48216525|NCT03939312|100856503|FG000|COMPLETED|Safety Follow-up 4 Weeks (Up to Week 44)||624||
48216526|NCT03939312|100856503|FG000|NOT COMPLETED|Safety Follow-up 4 Weeks (Up to Week 44)||16||
48216527|NCT02748317|100856504|FG000|STARTED|Overall Study||96||
48216528|NCT02748317|100856504|FG000|COMPLETED|Overall Study||73||
48216529|NCT02748317|100856504|FG000|NOT COMPLETED|Overall Study||23||
48216530|NCT02664558|100856505|FG000|STARTED|Overall Study||41||
48216531|NCT02664558|100856506|FG001|STARTED|Overall Study||20||
48216532|NCT02664558|100856505|FG000|COMPLETED|Overall Study||36||
48216533|NCT02664558|100856506|FG001|COMPLETED|Overall Study||18||
48216534|NCT02664558|100856505|FG000|NOT COMPLETED|Overall Study||5||
48216535|NCT02664558|100856506|FG001|NOT COMPLETED|Overall Study||2||
48216536|NCT02269475|100856507|FG000|STARTED|Overall Study||868||
48216537|NCT02269475|100856508|FG001|STARTED|Overall Study||433||
48216538|NCT02269475|100856507|FG000|Received IP (Safety Population)|Overall Study||868||
48216539|NCT02269475|100856508|FG001|Received IP (Safety Population)|Overall Study||433||
48216540|NCT02269475|100856507|FG000|Per Protocol Population|Overall Study||849||
48216541|NCT02269475|100856508|FG001|Per Protocol Population|Overall Study||430||
48216542|NCT02269475|100856507|FG000|COMPLETED|Overall Study||865||
48216543|NCT02269475|100856508|FG001|COMPLETED|Overall Study||432||
48216544|NCT02269475|100856507|FG000|NOT COMPLETED|Overall Study||3||
48216545|NCT02269475|100856508|FG001|NOT COMPLETED|Overall Study||1||
48216546|NCT01079949|100856509|FG000|STARTED|Overall Study||46||
48216547|NCT01079949|100856510|FG001|STARTED|Overall Study||47||
48216548|NCT01079949|100856509|FG000|COMPLETED|Overall Study||31||
48216549|NCT01079949|100856510|FG001|COMPLETED|Overall Study||34||
48216550|NCT01079949|100856509|FG000|NOT COMPLETED|Overall Study||15||
48216551|NCT01079949|100856510|FG001|NOT COMPLETED|Overall Study||13||
48216552|NCT02928172|100856511|FG000|STARTED|Overall Study||60||
48216553|NCT02928172|100856511|FG000|COMPLETED|Overall Study||59||
48216554|NCT02928172|100856511|FG000|NOT COMPLETED|Overall Study||1||
48216555|NCT00975585|100856512|FG000|STARTED|Overall Study||184||
48216556|NCT00975585|100856513|FG001|STARTED|Overall Study||195||
48216557|NCT00975585|100856512|FG000|COMPLETED|Overall Study||177||
48216558|NCT00975585|100856513|FG001|COMPLETED|Overall Study||183||
48216559|NCT00975585|100856512|FG000|NOT COMPLETED|Overall Study||7||
48216560|NCT00975585|100856513|FG001|NOT COMPLETED|Overall Study||12||
48216561|NCT02463448|100856514|FG000|STARTED|Enrollment Through 6 Months||23||
48216562|NCT02463448|100856514|FG000|COMPLETED|Enrollment Through 6 Months||20||
48216563|NCT02463448|100856514|FG000|NOT COMPLETED|Enrollment Through 6 Months||3||
48216564|NCT02463448|100856514|FG000|STARTED|6 Months Through 12 Months||20||
48216565|NCT02463448|100856514|FG000|COMPLETED|6 Months Through 12 Months||18||
48216566|NCT02463448|100856514|FG000|NOT COMPLETED|6 Months Through 12 Months||2||
48216567|NCT02463448|100856514|FG000|STARTED|12 Months Through End of Study||18||
48216568|NCT02463448|100856514|FG000|COMPLETED|12 Months Through End of Study||17||
48216569|NCT02463448|100856514|FG000|NOT COMPLETED|12 Months Through End of Study||1||
48216570|NCT00421889|100856515|FG000|STARTED|Overall Study||5||
48216571|NCT00421889|100856516|FG001|STARTED|Overall Study||5||
48216572|NCT00421889|100856517|FG002|STARTED|Overall Study||3||
48216573|NCT00421889|100856518|FG003|STARTED|Overall Study||4||
48216574|NCT00421889|100856519|FG004|STARTED|Overall Study||6||
48216575|NCT00421889|100856520|FG005|STARTED|Overall Study||35||
48216576|NCT00421889|100856521|FG006|STARTED|Overall Study||4||
48216577|NCT00421889|100856522|FG007|STARTED|Overall Study||3||
48216578|NCT00421889|100856523|FG008|STARTED|Overall Study||15||
48216579|NCT00421889|100856515|FG000|COMPLETED|Overall Study||0||
48216580|NCT00421889|100856516|FG001|COMPLETED|Overall Study||0||
48216581|NCT00421889|100856517|FG002|COMPLETED|Overall Study||0||
48216582|NCT00421889|100856518|FG003|COMPLETED|Overall Study||0||
48216583|NCT00421889|100856519|FG004|COMPLETED|Overall Study||0||
48060463|NCT03452228|100470187|FG002|Actual Cohort 3: DB Evinacumab to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||12|Actual Cohort 3 included participants without LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 3 participants who received evinacumab in DBTP were shifted into SB evinacumab group.|
48060464|NCT03452228|100470185|FG000|COMPLETED|Single-Blind Treatment Period (12 Weeks)||0||
48216584|NCT00421889|100856520|FG005|COMPLETED|Overall Study||0||
48216585|NCT00421889|100856521|FG006|COMPLETED|Overall Study||0||
48060465|NCT03452228|100470186|FG001|COMPLETED|Single-Blind Treatment Period (12 Weeks)||0||
48060466|NCT03452228|100470187|FG002|COMPLETED|Single-Blind Treatment Period (12 Weeks)||43||
48060467|NCT03452228|100470185|FG000|NOT COMPLETED|Single-Blind Treatment Period (12 Weeks)||0||
48060468|NCT03452228|100470186|FG001|NOT COMPLETED|Single-Blind Treatment Period (12 Weeks)||0||
48060469|NCT03452228|100470187|FG002|NOT COMPLETED|Single-Blind Treatment Period (12 Weeks)||4||
48060470|NCT02203071|100470188|FG000|STARTED|Overall Study||13||
48060471|NCT02203071|100470189|FG001|STARTED|Overall Study||6||
48060472|NCT02203071|100470188|FG000|COMPLETED|Overall Study||10||
48060473|NCT02203071|100470189|FG001|COMPLETED|Overall Study||5||
48060474|NCT02203071|100470188|FG000|NOT COMPLETED|Overall Study||3||
48060475|NCT02203071|100470189|FG001|NOT COMPLETED|Overall Study||1||
48060476|NCT01200862|100470190|FG000|STARTED|Part 1||14|Part 1|
48060477|NCT01200862|100470191|FG001|STARTED|Part 1||0|Part 1|
48060478|NCT01200862|100470192|FG002|STARTED|Part 1||0|Part 1|
48060479|NCT01200862|100470190|FG000|COMPLETED|Part 1||13||
48060480|NCT01200862|100470191|FG001|COMPLETED|Part 1||0||
48060481|NCT01200862|100470192|FG002|COMPLETED|Part 1||0||
48060482|NCT01200862|100470190|FG000|NOT COMPLETED|Part 1||1||
48060483|NCT01200862|100470191|FG001|NOT COMPLETED|Part 1||0||
48060484|NCT01200862|100470192|FG002|NOT COMPLETED|Part 1||0||
48060485|NCT01200862|100470190|FG000|STARTED|Part 2||0||
48060486|NCT01200862|100470191|FG001|STARTED|Part 2||7||
48060487|NCT01200862|100470192|FG002|STARTED|Part 2||8||
48060488|NCT01200862|100470190|FG000|COMPLETED|Part 2||0||
48060489|NCT01200862|100470191|FG001|COMPLETED|Part 2||6||
48060490|NCT01200862|100470192|FG002|COMPLETED|Part 2||8||
48060491|NCT01200862|100470190|FG000|NOT COMPLETED|Part 2||0||
48060492|NCT01200862|100470191|FG001|NOT COMPLETED|Part 2||1||
48060493|NCT01200862|100470192|FG002|NOT COMPLETED|Part 2||0||
48060494|NCT03007407|100470193|FG000|STARTED|Overall Study||33||
48060495|NCT03007407|100470193|FG000|COMPLETED|Overall Study||21||
48060496|NCT03007407|100470193|FG000|NOT COMPLETED|Overall Study||12||
48216586|NCT00421889|100856522|FG007|COMPLETED|Overall Study||1||
48060497|NCT03438383|100470194|FG000|STARTED|Overall Study||23||
48060498|NCT03438383|100470195|FG001|STARTED|Overall Study||24||
48060499|NCT03438383|100470194|FG000|COMPLETED|Overall Study||14||
48216587|NCT00421889|100856523|FG008|COMPLETED|Overall Study||4||
48216588|NCT00421889|100856515|FG000|NOT COMPLETED|Overall Study||5||
48216589|NCT00421889|100856516|FG001|NOT COMPLETED|Overall Study||5||
48216590|NCT00421889|100856517|FG002|NOT COMPLETED|Overall Study||3||
48216591|NCT00421889|100856518|FG003|NOT COMPLETED|Overall Study||4||
48216592|NCT00421889|100856519|FG004|NOT COMPLETED|Overall Study||6||
48216593|NCT00421889|100856520|FG005|NOT COMPLETED|Overall Study||35||
48216594|NCT00421889|100856521|FG006|NOT COMPLETED|Overall Study||4||
48060500|NCT03438383|100470195|FG001|COMPLETED|Overall Study||21||
48060501|NCT03438383|100470194|FG000|NOT COMPLETED|Overall Study||9||
48060502|NCT03438383|100470195|FG001|NOT COMPLETED|Overall Study||3||
48060503|NCT02791399|100470196|FG000|STARTED|Overall Study||136||
48216595|NCT00421889|100856522|FG007|NOT COMPLETED|Overall Study||2||
48216596|NCT00421889|100856523|FG008|NOT COMPLETED|Overall Study||11||
48216597|NCT02119650|100856524|FG000|STARTED|Overall Study||39||
48216598|NCT02119650|100856525|FG001|STARTED|Overall Study||37||
48216599|NCT02119650|100856524|FG000|COMPLETED|Overall Study||14||
48216600|NCT02119650|100856525|FG001|COMPLETED|Overall Study||11||
48216601|NCT02119650|100856524|FG000|NOT COMPLETED|Overall Study||25||
48216602|NCT02119650|100856525|FG001|NOT COMPLETED|Overall Study||26||
48216603|NCT01318967|100856526|FG000|STARTED|Overall Study||10||
48216604|NCT01318967|100856526|FG000|COMPLETED|Overall Study||10||
48216605|NCT01318967|100856526|FG000|NOT COMPLETED|Overall Study||0||
48216606|NCT03750968|100856527|FG000|STARTED|Overall Study||24||
48216607|NCT03750968|100856528|FG001|STARTED|Overall Study||23||
48216608|NCT03750968|100856527|FG000|COMPLETED|Overall Study||21||
48216609|NCT03750968|100856528|FG001|COMPLETED|Overall Study||20||
48216610|NCT03750968|100856527|FG000|NOT COMPLETED|Overall Study||3||
48216611|NCT03750968|100856528|FG001|NOT COMPLETED|Overall Study||3||
48216612|NCT00586313|100856529|FG000|STARTED|Overall Study||21||
48216613|NCT00586313|100856529|FG000|COMPLETED|Overall Study||19||
48216614|NCT00586313|100856529|FG000|NOT COMPLETED|Overall Study||2||
48216615|NCT01964300|100856530|FG000|STARTED|Overall Study||7||
48216616|NCT01964300|100856531|FG001|STARTED|Overall Study||12||
48216617|NCT01964300|100856530|FG000|COMPLETED|Overall Study||1||
48216618|NCT01964300|100856531|FG001|COMPLETED|Overall Study||1||
48216619|NCT01964300|100856530|FG000|NOT COMPLETED|Overall Study||6||
48216620|NCT01964300|100856531|FG001|NOT COMPLETED|Overall Study||11||
48216621|NCT00274469|100856532|FG000|STARTED|Overall Study||102||
48216622|NCT00274469|100856533|FG001|STARTED|Overall Study||103||
48216623|NCT00274469|100856532|FG000|COMPLETED|Overall Study||23||
48216624|NCT00274469|100856533|FG001|COMPLETED|Overall Study||10||
48216625|NCT00274469|100856532|FG000|NOT COMPLETED|Overall Study||79||
48216626|NCT00274469|100856533|FG001|NOT COMPLETED|Overall Study||93||
48216627|NCT00620698|100856534|FG000|STARTED|Overall Study||89||
48216628|NCT00620698|100856534|FG000|COMPLETED|Overall Study||60||
48216629|NCT00620698|100856534|FG000|NOT COMPLETED|Overall Study||29||
48216630|NCT02999763|100856535|FG000|STARTED|Overall Study||70||
48216631|NCT02999763|100856535|FG000|COMPLETED|Overall Study||58||
48216632|NCT02999763|100856535|FG000|NOT COMPLETED|Overall Study||12||
48216633|NCT02115828|100856536|FG000|STARTED|Overall Study||9||
48216634|NCT02115828|100856536|FG000|COMPLETED|Overall Study||9||
48216635|NCT02115828|100856536|FG000|NOT COMPLETED|Overall Study||0||
48216636|NCT00623194|100856537|FG000|STARTED|Overall Study||146||
48216637|NCT00623194|100856537|FG000|COMPLETED|Overall Study||141||
48216638|NCT00623194|100856537|FG000|NOT COMPLETED|Overall Study||5||
48216639|NCT02454283|100856538|FG000|STARTED|Overall Study||26||
48216640|NCT02454283|100856539|FG001|STARTED|Overall Study||15||
48216641|NCT02454283|100856538|FG000|COMPLETED|Overall Study||26||
48216642|NCT02454283|100856539|FG001|COMPLETED|Overall Study||15||
48216643|NCT02454283|100856538|FG000|NOT COMPLETED|Overall Study||0||
48216644|NCT02454283|100856539|FG001|NOT COMPLETED|Overall Study||0||
48216645|NCT01952366|100856540|FG000|STARTED|Overall Study||169||
48216646|NCT01952366|100856540|FG000|COMPLETED|Overall Study||138||
48216647|NCT01952366|100856540|FG000|NOT COMPLETED|Overall Study||31||
48216648|NCT00588471|100856541|FG000|STARTED|Overall Study||28||
48216649|NCT00588471|100856542|FG001|STARTED|Overall Study||29||
48216650|NCT00588471|100856541|FG000|COMPLETED|Overall Study||28||
48216651|NCT00588471|100856542|FG001|COMPLETED|Overall Study||29||
48216652|NCT00588471|100856541|FG000|NOT COMPLETED|Overall Study||0||
48216653|NCT00588471|100856542|FG001|NOT COMPLETED|Overall Study||0||
48216654|NCT03631433|100856543|FG000|STARTED|Overall Study||49||
48216655|NCT03631433|100856544|FG001|STARTED|Overall Study||53||
48216656|NCT03631433|100856543|FG000|COMPLETED|Overall Study||49||
48216657|NCT03631433|100856544|FG001|COMPLETED|Overall Study||53||
48216658|NCT03631433|100856543|FG000|NOT COMPLETED|Overall Study||0||
48216659|NCT03631433|100856544|FG001|NOT COMPLETED|Overall Study||0||
48216660|NCT03594500|100856545|FG000|STARTED|Overall Study||66||
48216661|NCT03594500|100856546|FG001|STARTED|Overall Study||67||
48216662|NCT03594500|100856545|FG000|COMPLETED|Overall Study||60||
48216663|NCT03594500|100856546|FG001|COMPLETED|Overall Study||63||
48216664|NCT03594500|100856545|FG000|NOT COMPLETED|Overall Study||6||
48216665|NCT03594500|100856546|FG001|NOT COMPLETED|Overall Study||4||
48216666|NCT04059042|100856547|FG000|STARTED|Overall Study||5||
48216667|NCT04059042|100856548|FG001|STARTED|Overall Study||5||
48216668|NCT04059042|100856547|FG000|COMPLETED|Overall Study||4||
48216669|NCT04059042|100856548|FG001|COMPLETED|Overall Study||5||
48216670|NCT04059042|100856547|FG000|NOT COMPLETED|Overall Study||1||
48216671|NCT04059042|100856548|FG001|NOT COMPLETED|Overall Study||0||
48216672|NCT02932579|100856549|FG000|STARTED|Overall Study||33||
48216673|NCT02932579|100856550|FG001|STARTED|Overall Study||26||
48216674|NCT02932579|100856549|FG000|COMPLETED|Overall Study||29||
48216675|NCT02932579|100856550|FG001|COMPLETED|Overall Study||25||
48216676|NCT02932579|100856549|FG000|NOT COMPLETED|Overall Study||4||
48216677|NCT02932579|100856550|FG001|NOT COMPLETED|Overall Study||1||
48216678|NCT00574834|100856551|FG000|STARTED|Overall Study||9||
48216679|NCT00574834|100856552|FG001|STARTED|Overall Study||4||
48216680|NCT00574834|100856553|FG002|STARTED|Overall Study||4||
48216681|NCT00574834|100856551|FG000|COMPLETED|Overall Study||9||
48216682|NCT00574834|100856552|FG001|COMPLETED|Overall Study||4||
48216683|NCT00574834|100856553|FG002|COMPLETED|Overall Study||4||
48216684|NCT00574834|100856551|FG000|NOT COMPLETED|Overall Study||0||
48216685|NCT00574834|100856552|FG001|NOT COMPLETED|Overall Study||0||
48216686|NCT00574834|100856553|FG002|NOT COMPLETED|Overall Study||0||
48216687|NCT01113931|100856554|FG000|STARTED|Overall Study||247||
48216688|NCT01113931|100856555|FG001|STARTED|Overall Study||248||
48216689|NCT01113931|100856554|FG000|Safety Population|Overall Study||246||
48216690|NCT01113931|100856555|FG001|Safety Population|Overall Study||248||
48216691|NCT01113931|100856554|FG000|mITT Population|Overall Study||188||
48216692|NCT01113931|100856555|FG001|mITT Population|Overall Study||190||
48216693|NCT01113931|100856554|FG000|COMPLETED|Overall Study||228||
48216694|NCT01113931|100856555|FG001|COMPLETED|Overall Study||231||
48216695|NCT01113931|100856554|FG000|NOT COMPLETED|Overall Study||19||
48216696|NCT01113931|100856555|FG001|NOT COMPLETED|Overall Study||17||
48216697|NCT02652442|100856556|FG000|STARTED|Centrifugation - Distance||6||
48216698|NCT02652442|100856556|FG000|COMPLETED|Centrifugation - Distance||5||
48216699|NCT02652442|100856556|FG000|NOT COMPLETED|Centrifugation - Distance||1||
48216700|NCT02652442|100856556|FG000|STARTED|Centrifugation - Duration||5||
48216701|NCT02652442|100856556|FG000|COMPLETED|Centrifugation - Duration||5||
48216702|NCT02652442|100856556|FG000|NOT COMPLETED|Centrifugation - Duration||0||
48216703|NCT02652442|100856556|FG000|STARTED|Centrifugation - Schedule||5||
48216704|NCT02652442|100856556|FG000|COMPLETED|Centrifugation - Schedule||5||
48216705|NCT02652442|100856556|FG000|NOT COMPLETED|Centrifugation - Schedule||0||
48216706|NCT03351699|100856557|FG000|STARTED|Overall Study||6||
48216707|NCT03351699|100856558|FG001|STARTED|Overall Study||6||
48216708|NCT03351699|100856559|FG002|STARTED|Overall Study||6||
48216709|NCT03351699|100856560|FG003|STARTED|Overall Study||6||
48216710|NCT03351699|100856561|FG004|STARTED|Overall Study||0||
48216711|NCT03351699|100856557|FG000|COMPLETED|Overall Study||6||
48216712|NCT03351699|100856558|FG001|COMPLETED|Overall Study||6||
48216713|NCT03351699|100856559|FG002|COMPLETED|Overall Study||6||
48216714|NCT03351699|100856560|FG003|COMPLETED|Overall Study||6||
48216715|NCT03351699|100856561|FG004|COMPLETED|Overall Study||0||
48216716|NCT03351699|100856557|FG000|NOT COMPLETED|Overall Study||0||
48216717|NCT03351699|100856558|FG001|NOT COMPLETED|Overall Study||0||
48216718|NCT03351699|100856559|FG002|NOT COMPLETED|Overall Study||0||
48216719|NCT03351699|100856560|FG003|NOT COMPLETED|Overall Study||0||
48216720|NCT03351699|100856561|FG004|NOT COMPLETED|Overall Study||0||
48216721|NCT04881175|100856562|FG000|STARTED|Overall Study||3||
48216722|NCT04881175|100856562|FG000|COMPLETED|Overall Study||3||
48216723|NCT04881175|100856562|FG000|NOT COMPLETED|Overall Study||0||
48216724|NCT00739908|100856563|FG000|STARTED|Overall Study||142||
48216725|NCT00739908|100856564|FG001|STARTED|Overall Study||143||
48216726|NCT00739908|100856563|FG000|COMPLETED|Overall Study||117||
48216727|NCT00739908|100856564|FG001|COMPLETED|Overall Study||118||
48216728|NCT00739908|100856563|FG000|NOT COMPLETED|Overall Study||25||
48216729|NCT00739908|100856564|FG001|NOT COMPLETED|Overall Study||25||
48216730|NCT02107261|100856565|FG000|STARTED|Cycle 1: Week 1-4||11||
48216731|NCT02107261|100856566|FG001|STARTED|Cycle 1: Week 1-4||10||
48216732|NCT02107261|100856565|FG000|COMPLETED|Cycle 1: Week 1-4||11||
48216733|NCT02107261|100856566|FG001|COMPLETED|Cycle 1: Week 1-4||10||
48216734|NCT02107261|100856565|FG000|NOT COMPLETED|Cycle 1: Week 1-4||0||
48496263|NCT01586039|101548046|FG001|NOT COMPLETED|Overall Study||1||
48496264|NCT01586039|101548047|FG002|NOT COMPLETED|Overall Study||0||
48496265|NCT01586039|101548048|FG003|NOT COMPLETED|Overall Study||0||
48060504|NCT02791399|100470197|FG001|STARTED|Overall Study||150||
48060505|NCT02791399|100470196|FG000|COMPLETED|Overall Study||123||
48060506|NCT02791399|100470197|FG001|COMPLETED|Overall Study||135||
48060507|NCT02791399|100470196|FG000|NOT COMPLETED|Overall Study||13||
48060508|NCT02791399|100470197|FG001|NOT COMPLETED|Overall Study||15||
48060509|NCT02770170|100470198|FG000|STARTED|Overall Study||21||
48060510|NCT02770170|100470199|FG001|STARTED|Overall Study||20||
48060511|NCT02770170|100470200|FG002|STARTED|Overall Study||40||
48060512|NCT02770170|100470201|FG003|STARTED|Overall Study||40||
48060513|NCT02770170|100470198|FG000|COMPLETED|Overall Study||14||
48060514|NCT02770170|100470199|FG001|COMPLETED|Overall Study||17||
48060515|NCT02770170|100470200|FG002|COMPLETED|Overall Study||35||
48060516|NCT02770170|100470201|FG003|COMPLETED|Overall Study||33||
48060517|NCT02770170|100470198|FG000|NOT COMPLETED|Overall Study||7||
48060518|NCT02770170|100470199|FG001|NOT COMPLETED|Overall Study||3||
48060519|NCT02770170|100470200|FG002|NOT COMPLETED|Overall Study||5||
48060520|NCT02770170|100470201|FG003|NOT COMPLETED|Overall Study||7||
48060521|NCT05708586|100470202|FG000|STARTED|Overall Study||28||
48060522|NCT05708586|100470203|FG001|STARTED|Overall Study||35||
48060523|NCT05708586|100470202|FG000|COMPLETED|Overall Study||28||
48060524|NCT05708586|100470203|FG001|COMPLETED|Overall Study||35||
48216735|NCT02107261|100856566|FG001|NOT COMPLETED|Cycle 1: Week 1-4||0||
48216736|NCT02107261|100856565|FG000|STARTED|Washout: Weakness Back to Baseline||11||
48216737|NCT02107261|100856566|FG001|STARTED|Washout: Weakness Back to Baseline||10||
48216738|NCT02107261|100856565|FG000|COMPLETED|Washout: Weakness Back to Baseline||10||
48216739|NCT02107261|100856566|FG001|COMPLETED|Washout: Weakness Back to Baseline||10||
48216740|NCT02107261|100856565|FG000|NOT COMPLETED|Washout: Weakness Back to Baseline||1||
48216741|NCT02107261|100856566|FG001|NOT COMPLETED|Washout: Weakness Back to Baseline||0||
48216742|NCT02107261|100856565|FG000|STARTED|Cycle 2: Week 12-15||10||
48216743|NCT02107261|100856566|FG001|STARTED|Cycle 2: Week 12-15||10||
48216744|NCT02107261|100856565|FG000|COMPLETED|Cycle 2: Week 12-15||10||
48216745|NCT02107261|100856566|FG001|COMPLETED|Cycle 2: Week 12-15||9||
48216746|NCT02107261|100856565|FG000|NOT COMPLETED|Cycle 2: Week 12-15||0||
48216747|NCT02107261|100856566|FG001|NOT COMPLETED|Cycle 2: Week 12-15||1||
48216748|NCT03399604|100856567|FG000|STARTED|Overall Study||121||
48216749|NCT03399604|100856567|FG000|COMPLETED|Overall Study||92||
48216750|NCT03399604|100856567|FG000|NOT COMPLETED|Overall Study||29||
48216751|NCT00931710|100856568|FG000|STARTED|Overall Study||241||
48216752|NCT00931710|100856569|FG001|STARTED|Overall Study||247||
48216753|NCT00931710|100856568|FG000|COMPLETED|Overall Study||207||
48216754|NCT00931710|100856569|FG001|COMPLETED|Overall Study||209||
48216755|NCT00931710|100856568|FG000|NOT COMPLETED|Overall Study||34||
48216756|NCT00931710|100856569|FG001|NOT COMPLETED|Overall Study||38||
48216757|NCT01308567|100856570|FG000|STARTED|Overall Study||391||
48216758|NCT01308567|100856571|FG001|STARTED|Overall Study||389||
48216759|NCT01308567|100856572|FG002|STARTED|Overall Study||388||
48216760|NCT01308567|100856570|FG000|Treated|Overall Study||388||
48216761|NCT01308567|100856571|FG001|Treated|Overall Study||382||
48216762|NCT01308567|100856572|FG002|Treated|Overall Study||377||
48216763|NCT01308567|100856570|FG000|COMPLETED|Overall Study||389||
48216764|NCT01308567|100856571|FG001|COMPLETED|Overall Study||385||
48216765|NCT01308567|100856572|FG002|COMPLETED|Overall Study||384||
48216766|NCT01308567|100856570|FG000|NOT COMPLETED|Overall Study||2||
48216767|NCT01308567|100856571|FG001|NOT COMPLETED|Overall Study||4||
48216768|NCT01308567|100856572|FG002|NOT COMPLETED|Overall Study||4||
48216769|NCT03840902|100856573|FG000|STARTED|Overall Study||75||
48216770|NCT03840902|100856574|FG001|STARTED|Overall Study||78||
48216771|NCT03840902|100856573|FG000|Treated|Overall Study||74||
48216772|NCT03840902|100856574|FG001|Treated|Overall Study||77||
48216773|NCT03840902|100856573|FG000|COMPLETED|Overall Study||74||
48216774|NCT03840902|100856574|FG001|COMPLETED|Overall Study||77||
48216775|NCT03840902|100856573|FG000|NOT COMPLETED|Overall Study||1||
48216776|NCT03840902|100856574|FG001|NOT COMPLETED|Overall Study||1||
48216777|NCT00308997|100856575|FG000|STARTED|Overall Study||56||
48216778|NCT00308997|100856576|FG001|STARTED|Overall Study||29||
48216779|NCT00308997|100856575|FG000|COMPLETED|Overall Study||55||
48216780|NCT00308997|100856576|FG001|COMPLETED|Overall Study||28||
48216781|NCT00308997|100856575|FG000|NOT COMPLETED|Overall Study||1||
48216782|NCT00308997|100856576|FG001|NOT COMPLETED|Overall Study||1||
48216783|NCT00703820|100856577|FG000|STARTED|Overall Study||133||
48216784|NCT00703820|100856578|FG001|STARTED|Overall Study||129||
48216785|NCT00703820|100856577|FG000|COMPLETED|Overall Study||98|"For purposes of this report, a living subject \*completes\* the study three years after completion of therapy and the study is considered \*complete\* when all participants have died, been taken off study, or completed the study."|
48216786|NCT00703820|100856578|FG001|COMPLETED|Overall Study||95|"For purposes of this report, a living subject \*completes\* the study three years after completion of therapy and the study is considered \*complete\* when all participants have died, been taken off study, or completed the study."|
48216787|NCT00703820|100856577|FG000|NOT COMPLETED|Overall Study||35||
48216788|NCT00703820|100856578|FG001|NOT COMPLETED|Overall Study||34||
48216789|NCT00233090|100856579|FG000|STARTED|Overall Study||12||
48216790|NCT00233090|100856580|FG001|STARTED|Overall Study||9||
48216791|NCT00233090|100856579|FG000|COMPLETED|Overall Study||12||
48216792|NCT00233090|100856580|FG001|COMPLETED|Overall Study||9||
48216793|NCT00233090|100856579|FG000|NOT COMPLETED|Overall Study||0||
48216794|NCT00233090|100856580|FG001|NOT COMPLETED|Overall Study||0||
48216795|NCT03644849|100856581|FG000|STARTED|Overall Study||24||
48216796|NCT03644849|100856582|FG001|STARTED|Overall Study||24||
48216797|NCT03644849|100856581|FG000|COMPLETED|Overall Study||23||
48216798|NCT03644849|100856582|FG001|COMPLETED|Overall Study||21||
48216799|NCT03644849|100856581|FG000|NOT COMPLETED|Overall Study||1||
48216800|NCT03644849|100856582|FG001|NOT COMPLETED|Overall Study||3||
48216801|NCT01391832|100856583|FG000|STARTED|Overall Study||49||
48216802|NCT01391832|100856584|FG001|STARTED|Overall Study||54||
48216803|NCT01391832|100856583|FG000|1 Month Follow-Up|Overall Study||30||
48216804|NCT01391832|100856584|FG001|1 Month Follow-Up|Overall Study||31||
48216805|NCT01391832|100856583|FG000|3 Month Follow-Up|Overall Study||28||
48216806|NCT01391832|100856584|FG001|3 Month Follow-Up|Overall Study||29||
48216807|NCT01391832|100856583|FG000|COMPLETED|Overall Study||28||
48216808|NCT01391832|100856584|FG001|COMPLETED|Overall Study||31||
48216809|NCT01391832|100856583|FG000|NOT COMPLETED|Overall Study||21||
48216810|NCT01391832|100856584|FG001|NOT COMPLETED|Overall Study||23||
48216811|NCT04154384|100856585|FG000|STARTED|Overall Study||104||
48216812|NCT04154384|100856586|FG001|STARTED|Overall Study||108||
48216813|NCT04154384|100856587|FG002|STARTED|Overall Study||121||
48216814|NCT04154384|100856585|FG000|COMPLETED|Overall Study||72||
48216815|NCT04154384|100856586|FG001|COMPLETED|Overall Study||57||
48216816|NCT04154384|100856587|FG002|COMPLETED|Overall Study||121||
48216817|NCT04154384|100856585|FG000|NOT COMPLETED|Overall Study||32||
48216818|NCT04154384|100856586|FG001|NOT COMPLETED|Overall Study||51||
48216819|NCT04154384|100856587|FG002|NOT COMPLETED|Overall Study||0||
48216820|NCT00879333|100856588|FG000|STARTED|Overall Study||439||
48216821|NCT00879333|100856589|FG001|STARTED|Overall Study||217||
48216822|NCT00879333|100856588|FG000|Discontinued Study Treatment|Overall Study||428||
48216823|NCT00879333|100856589|FG001|Discontinued Study Treatment|Overall Study||217||
48216824|NCT00879333|100856588|FG000|COMPLETED|Overall Study||11||
48216825|NCT00879333|100856589|FG001|COMPLETED|Overall Study||0||
48060525|NCT05708586|100470202|FG000|NOT COMPLETED|Overall Study||0||
48060526|NCT05708586|100470203|FG001|NOT COMPLETED|Overall Study||0||
48060527|NCT03698331|100470204|FG000|STARTED|Overall Study||44||
48060528|NCT03698331|100470205|FG001|STARTED|Overall Study||45||
48060529|NCT03698331|100470204|FG000|Entered Withdrawal Period|Overall Study||42||
48060530|NCT03698331|100470205|FG001|Entered Withdrawal Period|Overall Study||39||
48060531|NCT03698331|100470204|FG000|COMPLETED|Overall Study||40||
48060532|NCT03698331|100470205|FG001|COMPLETED|Overall Study||39||
48060533|NCT03698331|100470204|FG000|NOT COMPLETED|Overall Study||4||
48060534|NCT03698331|100470205|FG001|NOT COMPLETED|Overall Study||6||
48060535|NCT03126370|100470206|FG000|STARTED|TDF With a Boosted PI||10||
48060536|NCT03126370|100470206|FG000|COMPLETED|TDF With a Boosted PI||10||
48060537|NCT03126370|100470206|FG000|NOT COMPLETED|TDF With a Boosted PI||0||
48060538|NCT03126370|100470206|FG000|STARTED|TAF With a Boosted PI||10||
48060539|NCT03126370|100470206|FG000|COMPLETED|TAF With a Boosted PI||10||
48060540|NCT03126370|100470206|FG000|NOT COMPLETED|TAF With a Boosted PI||0||
48060541|NCT03126370|100470206|FG000|STARTED|TAF With a Boosted PI and LDV/SOF||10||
48060542|NCT03126370|100470206|FG000|COMPLETED|TAF With a Boosted PI and LDV/SOF||10||
48060543|NCT03126370|100470206|FG000|NOT COMPLETED|TAF With a Boosted PI and LDV/SOF||0||
48060544|NCT03126370|100470206|FG000|STARTED|TAF With a Boosted PI||10||
48060545|NCT03126370|100470206|FG000|COMPLETED|TAF With a Boosted PI||10||
48060546|NCT03126370|100470206|FG000|NOT COMPLETED|TAF With a Boosted PI||0||
48060547|NCT01090973|100470207|FG000|STARTED|Overall Study||1||
48060548|NCT01090973|100470207|FG000|COMPLETED|Overall Study||0||
48060549|NCT01090973|100470207|FG000|NOT COMPLETED|Overall Study||1||
48060550|NCT02556736|100470208|FG000|STARTED|Overall Study||14||
48060551|NCT02556736|100470208|FG000|COMPLETED|Overall Study||14||
48060552|NCT02556736|100470208|FG000|NOT COMPLETED|Overall Study||0||
48060553|NCT04350606|100470209|FG000|STARTED|Overall Study||3||
48060554|NCT04350606|100470209|FG000|Treated|Overall Study||3||
48060555|NCT04350606|100470209|FG000|Follow-up|Overall Study||3||
48060556|NCT04350606|100470209|FG000|COMPLETED|Overall Study||3||
48060557|NCT04350606|100470209|FG000|NOT COMPLETED|Overall Study||0||
48216826|NCT00879333|100856588|FG000|NOT COMPLETED|Overall Study||428||
48216827|NCT00879333|100856589|FG001|NOT COMPLETED|Overall Study||217||
48216828|NCT04027439|100860015|FG000|STARTED|Part A (R, PC, PG) Single Dose||6|Started Part A|
48216829|NCT04027439|100860016|FG001|STARTED|Part A (R, PC, PG) Single Dose||6|Started Part A|
48216830|NCT04027439|100860017|FG002|STARTED|Part A (R, PC, PG) Single Dose||7|Started Part A|
48216831|NCT04027439|100860018|FG003|STARTED|Part A (R, PC, PG) Single Dose||6|Started Part A|
48216832|NCT04027439|100860019|FG004|STARTED|Part A (R, PC, PG) Single Dose||6|Started Part A|
48216833|NCT04027439|100860020|FG005|STARTED|Part A (R, PC, PG) Single Dose||6|Started Part A|
48216834|NCT04027439|100860021|FG006|STARTED|Part A (R, PC, PG) Single Dose||0|Started Part A|
48216835|NCT04027439|100860022|FG007|STARTED|Part A (R, PC, PG) Single Dose||0|Started Part A|
48216836|NCT04027439|100860023|FG008|STARTED|Part A (R, PC, PG) Single Dose||0|Started Part A|
48216837|NCT04027439|100860024|FG009|STARTED|Part A (R, PC, PG) Single Dose||0|Started Part A|
48216838|NCT04027439|100860025|FG010|STARTED|Part A (R, PC, PG) Single Dose||0|Started Part A|
48216839|NCT04027439|100860026|FG011|STARTED|Part A (R, PC, PG) Single Dose||0|Started Part A|
48216840|NCT04027439|100860027|FG012|STARTED|Part A (R, PC, PG) Single Dose||0|Started Part A|
48216841|NCT04027439|100860028|FG013|STARTED|Part A (R, PC, PG) Single Dose||0|Started Part A|
48216842|NCT04027439|100860029|FG014|STARTED|Part A (R, PC, PG) Single Dose||0|Started Part A|
48216843|NCT04027439|100860030|FG015|STARTED|Part A (R, PC, PG) Single Dose||0|Started Part A|
48216844|NCT04027439|100860015|FG000|COMPLETED|Part A (R, PC, PG) Single Dose||6|Completed Part A|
48216845|NCT04027439|100860016|FG001|COMPLETED|Part A (R, PC, PG) Single Dose||6|Completed Part A|
48216846|NCT04027439|100860017|FG002|COMPLETED|Part A (R, PC, PG) Single Dose||7|Completed Part A|
48216847|NCT04027439|100860018|FG003|COMPLETED|Part A (R, PC, PG) Single Dose||6|Completed Part A|
48496266|NCT02667951|101548049|FG000|STARTED|Overall Study||66||
48060558|NCT04925271|100470210|FG000|STARTED|Overall Study||20||
48060559|NCT04925271|100470211|FG001|STARTED|Overall Study||20||
48060560|NCT04925271|100470210|FG000|COMPLETED|Overall Study||20||
48060561|NCT04925271|100470211|FG001|COMPLETED|Overall Study||20||
48060562|NCT04925271|100470210|FG000|NOT COMPLETED|Overall Study||0||
48060563|NCT04925271|100470211|FG001|NOT COMPLETED|Overall Study||0||
48060564|NCT02239224|100470212|FG000|STARTED|Overall Study||3||
48060565|NCT02239224|100470213|FG001|STARTED|Overall Study||6||
48060566|NCT02239224|100470214|FG002|STARTED|Overall Study||6||
48060567|NCT02239224|100470215|FG003|STARTED|Overall Study||5||
48060568|NCT02239224|100470212|FG000|Received at Least One Dose of Study Drug|Overall Study||3||
48060569|NCT02239224|100470213|FG001|Received at Least One Dose of Study Drug|Overall Study||6||
48060570|NCT02239224|100470214|FG002|Received at Least One Dose of Study Drug|Overall Study||6||
48060571|NCT02239224|100470215|FG003|Received at Least One Dose of Study Drug|Overall Study||5||
48216848|NCT04027439|100860019|FG004|COMPLETED|Part A (R, PC, PG) Single Dose||6|Completed Part A|
48216849|NCT04027439|100860020|FG005|COMPLETED|Part A (R, PC, PG) Single Dose||6|Completed Part A|
48216850|NCT04027439|100860021|FG006|COMPLETED|Part A (R, PC, PG) Single Dose||0|Completed Part A|
48216851|NCT04027439|100860022|FG007|COMPLETED|Part A (R, PC, PG) Single Dose||0|Completed Part A|
48216852|NCT04027439|100860023|FG008|COMPLETED|Part A (R, PC, PG) Single Dose||0|Completed Part A|
48216853|NCT04027439|100860024|FG009|COMPLETED|Part A (R, PC, PG) Single Dose||0|Completed Part A|
48216854|NCT04027439|100860025|FG010|COMPLETED|Part A (R, PC, PG) Single Dose||0|Completed Part A|
48216855|NCT04027439|100860026|FG011|COMPLETED|Part A (R, PC, PG) Single Dose||0|Completed Part A|
48216856|NCT04027439|100860027|FG012|COMPLETED|Part A (R, PC, PG) Single Dose||0|Completed Part A|
48216857|NCT04027439|100860028|FG013|COMPLETED|Part A (R, PC, PG) Single Dose||0|Completed Part A|
48216858|NCT04027439|100860029|FG014|COMPLETED|Part A (R, PC, PG) Single Dose||0|Completed Part A|
48216859|NCT04027439|100860030|FG015|COMPLETED|Part A (R, PC, PG) Single Dose||0|Completed Part A|
48216860|NCT04027439|100860015|FG000|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
48216861|NCT04027439|100860016|FG001|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
48216862|NCT04027439|100860017|FG002|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
48216863|NCT04027439|100860018|FG003|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
48216864|NCT04027439|100860019|FG004|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
48216865|NCT04027439|100860020|FG005|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
48216866|NCT04027439|100860021|FG006|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
48216867|NCT04027439|100860022|FG007|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
48216868|NCT04027439|100860023|FG008|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
48216869|NCT04027439|100860024|FG009|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
48216870|NCT04027439|100860025|FG010|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
48216871|NCT04027439|100860026|FG011|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
48216872|NCT04027439|100860027|FG012|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
48216873|NCT04027439|100860028|FG013|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
48216874|NCT04027439|100860029|FG014|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
48216875|NCT04027439|100860030|FG015|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
48216876|NCT04027439|100860015|FG000|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
48216877|NCT04027439|100860016|FG001|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
48216878|NCT04027439|100860017|FG002|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
48216879|NCT04027439|100860018|FG003|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
48216880|NCT04027439|100860019|FG004|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
48216881|NCT04027439|100860020|FG005|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
48216882|NCT04027439|100860021|FG006|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4||
48216883|NCT04027439|100860022|FG007|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3||
48216884|NCT04027439|100860023|FG008|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4||
48216885|NCT04027439|100860024|FG009|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3||
48216886|NCT04027439|100860025|FG010|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4||
48216887|NCT04027439|100860026|FG011|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3||
48216888|NCT04027439|100860027|FG012|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3||
48216889|NCT04027439|100860028|FG013|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4||
48216890|NCT04027439|100860029|FG014|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4||
48216891|NCT04027439|100860030|FG015|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3||
48216892|NCT04027439|100860015|FG000|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
48216893|NCT04027439|100860016|FG001|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
48216894|NCT04027439|100860017|FG002|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
48216895|NCT04027439|100860018|FG003|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
48216896|NCT04027439|100860019|FG004|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
48216897|NCT04027439|100860020|FG005|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
48216898|NCT04027439|100860021|FG006|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4||
48216899|NCT04027439|100860022|FG007|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||1||
48216900|NCT04027439|100860023|FG008|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4||
48216901|NCT04027439|100860024|FG009|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3||
48216902|NCT04027439|100860025|FG010|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4||
48216903|NCT04027439|100860026|FG011|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3||
48216904|NCT04027439|100860027|FG012|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3||
48216905|NCT04027439|100860028|FG013|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4||
48216906|NCT04027439|100860029|FG014|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4||
48216907|NCT04027439|100860030|FG015|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3||
48216908|NCT04027439|100860015|FG000|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
48216909|NCT04027439|100860016|FG001|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
48216910|NCT04027439|100860017|FG002|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
48216911|NCT04027439|100860018|FG003|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
48216912|NCT04027439|100860019|FG004|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
48216913|NCT04027439|100860020|FG005|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
48496267|NCT02667951|101548050|FG001|STARTED|Overall Study||63||
48216914|NCT04027439|100860021|FG006|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
48216915|NCT04027439|100860022|FG007|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||2||
48216916|NCT04027439|100860023|FG008|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
48216917|NCT04027439|100860024|FG009|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
48216918|NCT04027439|100860025|FG010|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
48216919|NCT04027439|100860026|FG011|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
48216920|NCT04027439|100860027|FG012|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
48216921|NCT04027439|100860028|FG013|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
48216922|NCT04027439|100860029|FG014|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
48216923|NCT04027439|100860030|FG015|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
48216924|NCT02275611|100860031|FG000|STARTED|Inpatient Withdrawal||5||
48216925|NCT02275611|100860032|FG001|STARTED|Inpatient Withdrawal||4||
48216926|NCT02275611|100860033|FG002|STARTED|Inpatient Withdrawal||0||
48216927|NCT02275611|100860034|FG003|STARTED|Inpatient Withdrawal||0||
48216928|NCT02275611|100860031|FG000|COMPLETED|Inpatient Withdrawal||4||
48216929|NCT02275611|100860032|FG001|COMPLETED|Inpatient Withdrawal||4||
48216930|NCT02275611|100860033|FG002|COMPLETED|Inpatient Withdrawal||0||
48216931|NCT02275611|100860034|FG003|COMPLETED|Inpatient Withdrawal||0||
48216932|NCT02275611|100860031|FG000|NOT COMPLETED|Inpatient Withdrawal||1||
48216933|NCT02275611|100860032|FG001|NOT COMPLETED|Inpatient Withdrawal||0||
48216934|NCT02275611|100860033|FG002|NOT COMPLETED|Inpatient Withdrawal||0||
48216935|NCT02275611|100860034|FG003|NOT COMPLETED|Inpatient Withdrawal||0||
48216936|NCT02275611|100860031|FG000|STARTED|Outpatient Drinking||0||
48216937|NCT02275611|100860032|FG001|STARTED|Outpatient Drinking||0||
48216938|NCT02275611|100860033|FG002|STARTED|Outpatient Drinking||6||
48216939|NCT02275611|100860034|FG003|STARTED|Outpatient Drinking||3||
48216940|NCT02275611|100860031|FG000|COMPLETED|Outpatient Drinking||0||
48216941|NCT02275611|100860032|FG001|COMPLETED|Outpatient Drinking||0||
48216942|NCT02275611|100860033|FG002|COMPLETED|Outpatient Drinking||6||
48216943|NCT02275611|100860034|FG003|COMPLETED|Outpatient Drinking||3||
48216944|NCT02275611|100860031|FG000|NOT COMPLETED|Outpatient Drinking||0||
48216945|NCT02275611|100860032|FG001|NOT COMPLETED|Outpatient Drinking||0||
48216946|NCT02275611|100860033|FG002|NOT COMPLETED|Outpatient Drinking||0||
48216947|NCT02275611|100860034|FG003|NOT COMPLETED|Outpatient Drinking||0||
48216948|NCT00624442|100860035|FG000|STARTED|Overall Study||8||
48216949|NCT00624442|100860036|FG001|STARTED|Overall Study||9||
48216950|NCT00624442|100860037|FG002|STARTED|Overall Study||10||
48216951|NCT00624442|100860038|FG003|STARTED|Overall Study||8||
48216952|NCT00624442|100860039|FG004|STARTED|Overall Study||10||
48216953|NCT00624442|100860035|FG000|COMPLETED|Overall Study||8||
48216954|NCT00624442|100860036|FG001|COMPLETED|Overall Study||8||
48216955|NCT00624442|100860037|FG002|COMPLETED|Overall Study||8||
48216956|NCT00624442|100860038|FG003|COMPLETED|Overall Study||8||
48216957|NCT00624442|100860039|FG004|COMPLETED|Overall Study||8||
48216958|NCT00624442|100860035|FG000|NOT COMPLETED|Overall Study||0||
48216959|NCT00624442|100860036|FG001|NOT COMPLETED|Overall Study||1||
48216960|NCT00624442|100860037|FG002|NOT COMPLETED|Overall Study||2||
48216961|NCT00624442|100860038|FG003|NOT COMPLETED|Overall Study||0||
48216962|NCT00624442|100860039|FG004|NOT COMPLETED|Overall Study||2||
48216963|NCT00275392|100860040|FG000|STARTED|Overall Study||20||
48216964|NCT00275392|100860041|FG001|STARTED|Overall Study||19||
48216965|NCT00275392|100860040|FG000|COMPLETED|Overall Study||20||
48216966|NCT00275392|100860041|FG001|COMPLETED|Overall Study||17||
48216967|NCT00275392|100860040|FG000|NOT COMPLETED|Overall Study||0||
48216968|NCT00275392|100860041|FG001|NOT COMPLETED|Overall Study||2||
48060572|NCT02239224|100470212|FG000|COMPLETED|Overall Study||3||
48216969|NCT01574716|100860042|FG000|STARTED|Part 1||3||
48216970|NCT01574716|100860043|FG001|STARTED|Part 1||4||
48216971|NCT01574716|100860044|FG002|STARTED|Part 1||9||
48216972|NCT01574716|100860045|FG003|STARTED|Part 1||0||
48216973|NCT01574716|100860046|FG004|STARTED|Part 1||0||
48216974|NCT01574716|100860042|FG000|COMPLETED|Part 1||0||
48216975|NCT01574716|100860043|FG001|COMPLETED|Part 1||0||
48216976|NCT01574716|100860044|FG002|COMPLETED|Part 1||0||
48216977|NCT01574716|100860045|FG003|COMPLETED|Part 1||0||
48216978|NCT01574716|100860046|FG004|COMPLETED|Part 1||0||
48216979|NCT01574716|100860042|FG000|NOT COMPLETED|Part 1||3||
48216980|NCT01574716|100860043|FG001|NOT COMPLETED|Part 1||4||
48216981|NCT01574716|100860044|FG002|NOT COMPLETED|Part 1||9||
48216982|NCT01574716|100860045|FG003|NOT COMPLETED|Part 1||0||
48216983|NCT01574716|100860046|FG004|NOT COMPLETED|Part 1||0||
48216984|NCT01574716|100860042|FG000|STARTED|Part 2||0||
48216985|NCT01574716|100860043|FG001|STARTED|Part 2||0||
48216986|NCT01574716|100860044|FG002|STARTED|Part 2||0||
48216987|NCT01574716|100860045|FG003|STARTED|Part 2||139||
48216988|NCT01574716|100860046|FG004|STARTED|Part 2||70||
48216989|NCT01574716|100860042|FG000|Treated Participants|Part 2||0|MORAb: 2 discontinued prior to treatment. Placebo: 3 randomized but received MORAb are in MORAb.|
48216990|NCT01574716|100860043|FG001|Treated Participants|Part 2||0|MORAb: 2 discontinued prior to treatment. Placebo: 3 randomized but received MORAb are in MORAb.|
48216991|NCT01574716|100860044|FG002|Treated Participants|Part 2||0|MORAb: 2 discontinued prior to treatment. Placebo: 3 randomized but received MORAb are in MORAb.|
48496268|NCT02667951|101548049|FG000|COMPLETED|Overall Study||45||
48216992|NCT01574716|100860045|FG003|Treated Participants|Part 2||140|MORAb: 2 discontinued prior to treatment. Placebo: 3 randomized but received MORAb are in MORAb.|
48216993|NCT01574716|100860046|FG004|Treated Participants|Part 2||67|MORAb: 2 discontinued prior to treatment. Placebo: 3 randomized but received MORAb are in MORAb.|
48216994|NCT01574716|100860042|FG000|COMPLETED|Part 2||0||
48216995|NCT01574716|100860043|FG001|COMPLETED|Part 2||0||
48216996|NCT01574716|100860044|FG002|COMPLETED|Part 2||0||
48216997|NCT01574716|100860045|FG003|COMPLETED|Part 2||2||
48216998|NCT01574716|100860046|FG004|COMPLETED|Part 2||0||
48216999|NCT01574716|100860042|FG000|NOT COMPLETED|Part 2||0||
48217000|NCT01574716|100860043|FG001|NOT COMPLETED|Part 2||0||
48060573|NCT02239224|100470213|FG001|COMPLETED|Overall Study||6||
48060574|NCT02239224|100470214|FG002|COMPLETED|Overall Study||3||
48060575|NCT02239224|100470215|FG003|COMPLETED|Overall Study||4||
48060576|NCT02239224|100470212|FG000|NOT COMPLETED|Overall Study||0||
48060577|NCT02239224|100470213|FG001|NOT COMPLETED|Overall Study||0||
48060578|NCT02239224|100470214|FG002|NOT COMPLETED|Overall Study||3||
48060579|NCT02239224|100470215|FG003|NOT COMPLETED|Overall Study||1||
48060580|NCT01230710|100470216|FG000|STARTED|Overall Study||51||
48060581|NCT01230710|100470216|FG000|COMPLETED|Overall Study||2||
48060582|NCT01230710|100470216|FG000|NOT COMPLETED|Overall Study||49||
48060583|NCT02475031|100470217|FG000|STARTED|Overall Study||35||
48060584|NCT02475031|100470218|FG001|STARTED|Overall Study||35||
48060585|NCT02475031|100470217|FG000|COMPLETED|Overall Study||35||
48060586|NCT02475031|100470218|FG001|COMPLETED|Overall Study||35||
48060587|NCT02475031|100470217|FG000|NOT COMPLETED|Overall Study||0||
48060588|NCT02475031|100470218|FG001|NOT COMPLETED|Overall Study||0||
48060589|NCT01498601|100470219|FG000|STARTED|Overall Study||51||
48060590|NCT01498601|100470220|FG001|STARTED|Overall Study||32||
48060591|NCT01498601|100470219|FG000|COMPLETED|Overall Study||51||
48060592|NCT01498601|100470220|FG001|COMPLETED|Overall Study||32||
48060593|NCT01498601|100470219|FG000|NOT COMPLETED|Overall Study||0||
48060594|NCT01498601|100470220|FG001|NOT COMPLETED|Overall Study||0||
48060595|NCT01043146|100470221|FG000|STARTED|Overall Study||10||
48060596|NCT01043146|100470222|FG001|STARTED|Overall Study||8||
48060597|NCT01043146|100470223|FG002|STARTED|Overall Study||8||
48060598|NCT01043146|100470224|FG003|STARTED|Overall Study||8||
48060599|NCT01043146|100470225|FG004|STARTED|Overall Study||8||
48060600|NCT01043146|100470226|FG005|STARTED|Overall Study||8||
48060601|NCT01043146|100470221|FG000|COMPLETED|Overall Study||10||
48060602|NCT01043146|100470222|FG001|COMPLETED|Overall Study||8||
48060603|NCT01043146|100470223|FG002|COMPLETED|Overall Study||8||
48060604|NCT01043146|100470224|FG003|COMPLETED|Overall Study||8||
48060605|NCT01043146|100470225|FG004|COMPLETED|Overall Study||8||
48060606|NCT01043146|100470226|FG005|COMPLETED|Overall Study||8||
48060607|NCT01043146|100470221|FG000|NOT COMPLETED|Overall Study||0||
48060608|NCT01043146|100470222|FG001|NOT COMPLETED|Overall Study||0||
48060609|NCT01043146|100470223|FG002|NOT COMPLETED|Overall Study||0||
48060610|NCT01043146|100470224|FG003|NOT COMPLETED|Overall Study||0||
48060611|NCT01043146|100470225|FG004|NOT COMPLETED|Overall Study||0||
48060612|NCT01043146|100470226|FG005|NOT COMPLETED|Overall Study||0||
48060613|NCT00694707|100470227|FG000|STARTED|Overall Study||151||
48217001|NCT01574716|100860044|FG002|NOT COMPLETED|Part 2||0||
48217002|NCT01574716|100860045|FG003|NOT COMPLETED|Part 2||137||
48217003|NCT01574716|100860046|FG004|NOT COMPLETED|Part 2||70||
48217004|NCT00467272|100860047|FG000|STARTED|Overall Study||41||
48217005|NCT00467272|100860047|FG000|COMPLETED|Overall Study||38||
48496269|NCT02667951|101548050|FG001|COMPLETED|Overall Study||40||
48060614|NCT00694707|100470228|FG001|STARTED|Overall Study||145||
48060615|NCT00694707|100470229|FG002|STARTED|Overall Study||147||
48060616|NCT00694707|100470230|FG003|STARTED|Overall Study||148||
48060617|NCT00694707|100470231|FG004|STARTED|Overall Study||141||
48060618|NCT00694707|100470227|FG000|COMPLETED|Overall Study||79||
48060619|NCT00694707|100470228|FG001|COMPLETED|Overall Study||90||
48060620|NCT00694707|100470229|FG002|COMPLETED|Overall Study||96||
48060621|NCT00694707|100470230|FG003|COMPLETED|Overall Study||98||
48060622|NCT00694707|100470231|FG004|COMPLETED|Overall Study||101||
48060623|NCT00694707|100470227|FG000|NOT COMPLETED|Overall Study||72||
48060624|NCT00694707|100470228|FG001|NOT COMPLETED|Overall Study||55||
48060625|NCT00694707|100470229|FG002|NOT COMPLETED|Overall Study||51||
48060626|NCT00694707|100470230|FG003|NOT COMPLETED|Overall Study||50||
48060627|NCT00694707|100470231|FG004|NOT COMPLETED|Overall Study||40||
48217006|NCT00467272|100860047|FG000|NOT COMPLETED|Overall Study||3||
48217007|NCT01075152|100860048|FG000|STARTED|Overall Study||88||
48496270|NCT02667951|101548049|FG000|NOT COMPLETED|Overall Study||21||
48060628|NCT00828854|100470232|FG000|STARTED|Overall Study||27||
48060629|NCT00828854|100470232|FG000|COMPLETED|Overall Study||0|Completed=Completed Treatment|
48060630|NCT00828854|100470232|FG000|NOT COMPLETED|Overall Study||27||
48060631|NCT04839146|100470233|FG000|STARTED|Overall Study||3||
48060632|NCT04839146|100470234|FG001|STARTED|Overall Study||3||
48060633|NCT04839146|100470235|FG002|STARTED|Overall Study||3||
48060634|NCT04839146|100470236|FG003|STARTED|Overall Study||3||
48060635|NCT04839146|100470237|FG004|STARTED|Overall Study||3||
48060636|NCT04839146|100470238|FG005|STARTED|Overall Study||3||
48217008|NCT01075152|100860049|FG001|STARTED|Overall Study||89||
48060637|NCT04839146|100470239|FG006|STARTED|Overall Study||6||
48217009|NCT01075152|100860048|FG000|COMPLETED|Overall Study||87||
48217010|NCT01075152|100860049|FG001|COMPLETED|Overall Study||89||
48217011|NCT01075152|100860048|FG000|NOT COMPLETED|Overall Study||1||
48217012|NCT01075152|100860049|FG001|NOT COMPLETED|Overall Study||0||
48217013|NCT04452318|100860050|FG000|STARTED|Overall Study||1430||
48217014|NCT04452318|100860051|FG001|STARTED|Overall Study||1441||
48217015|NCT04452318|100860052|FG002|STARTED|Overall Study||1||
48217016|NCT04452318|100860053|FG003|STARTED|Overall Study||173||
48217017|NCT04452318|100860054|FG004|STARTED|Overall Study||166||
48217018|NCT04452318|100860055|FG005|STARTED|Overall Study||53||
48217019|NCT04452318|100860056|FG006|STARTED|Overall Study||34||
48217020|NCT04452318|100860050|FG000|Randomized and Treated|Overall Study||1428||
48217021|NCT04452318|100860051|FG001|Randomized and Treated|Overall Study||1439||
48217022|NCT04452318|100860052|FG002|Randomized and Treated|Overall Study||1||
48217023|NCT04452318|100860053|FG003|Randomized and Treated|Overall Study||170||
48217024|NCT04452318|100860054|FG004|Randomized and Treated|Overall Study||165||
48217025|NCT04452318|100860055|FG005|Randomized and Treated|Overall Study||44||
48217026|NCT04452318|100860056|FG006|Randomized and Treated|Overall Study||23||
48217027|NCT04452318|100860050|FG000|COMPLETED|Overall Study||1343||
48217028|NCT04452318|100860051|FG001|COMPLETED|Overall Study||1368||
48217029|NCT04452318|100860052|FG002|COMPLETED|Overall Study||1||
48217030|NCT04452318|100860053|FG003|COMPLETED|Overall Study||150||
48217031|NCT04452318|100860054|FG004|COMPLETED|Overall Study||157||
48217032|NCT04452318|100860055|FG005|COMPLETED|Overall Study||41||
48217033|NCT04452318|100860056|FG006|COMPLETED|Overall Study||22||
48217034|NCT04452318|100860050|FG000|NOT COMPLETED|Overall Study||87||
48217035|NCT04452318|100860051|FG001|NOT COMPLETED|Overall Study||73||
48217036|NCT04452318|100860052|FG002|NOT COMPLETED|Overall Study||0||
48217037|NCT04452318|100860053|FG003|NOT COMPLETED|Overall Study||23||
48217038|NCT04452318|100860054|FG004|NOT COMPLETED|Overall Study||9||
48217039|NCT04452318|100860055|FG005|NOT COMPLETED|Overall Study||12||
48217040|NCT04452318|100860056|FG006|NOT COMPLETED|Overall Study||12||
48217041|NCT02461628|100860057|FG000|STARTED|Overall Study||3733||16
48217042|NCT02461628|100860058|FG001|STARTED|Overall Study||3632||16
48217043|NCT02461628|100860057|FG000|Baseline Survey|Overall Study||1038||16
48217044|NCT02461628|100860058|FG001|Baseline Survey|Overall Study||974||16
48217045|NCT02461628|100860057|FG000|6 Month Survey|Overall Study||814||16
48217046|NCT02461628|100860058|FG001|6 Month Survey|Overall Study||832||16
48217047|NCT02461628|100860057|FG000|12 Month Survey|Overall Study||882||16
48217048|NCT02461628|100860058|FG001|12 Month Survey|Overall Study||914||16
48217049|NCT02461628|100860057|FG000|18 Month Survey|Overall Study||995||16
48217050|NCT02461628|100860058|FG001|18 Month Survey|Overall Study||905||16
48217051|NCT02461628|100860057|FG000|COMPLETED|Overall Study||3729||16
48217052|NCT02461628|100860058|FG001|COMPLETED|Overall Study||3625||16
48217053|NCT02461628|100860057|FG000|NOT COMPLETED|Overall Study||4||0
48217054|NCT02461628|100860058|FG001|NOT COMPLETED|Overall Study||7||0
48217055|NCT01823536|100860059|FG000|STARTED|Overall Study||73||
48217056|NCT01823536|100860060|FG001|STARTED|Overall Study||103||
48217057|NCT01823536|100860061|FG002|STARTED|Overall Study||120||
48217058|NCT01823536|100860062|FG003|STARTED|Overall Study||66||
48217059|NCT01823536|100860063|FG004|STARTED|Overall Study||101||
48217060|NCT01823536|100860064|FG005|STARTED|Overall Study||2||
48217061|NCT01823536|100860059|FG000|COMPLETED|Overall Study||71||
48217062|NCT01823536|100860060|FG001|COMPLETED|Overall Study||101||
48217063|NCT01823536|100860061|FG002|COMPLETED|Overall Study||119||
48217064|NCT01823536|100860062|FG003|COMPLETED|Overall Study||64||
48217065|NCT01823536|100860063|FG004|COMPLETED|Overall Study||99||
48217066|NCT01823536|100860064|FG005|COMPLETED|Overall Study||2||
48217067|NCT01823536|100860059|FG000|NOT COMPLETED|Overall Study||2||
48217068|NCT01823536|100860060|FG001|NOT COMPLETED|Overall Study||2||
48217069|NCT01823536|100860061|FG002|NOT COMPLETED|Overall Study||1||
48217070|NCT01823536|100860062|FG003|NOT COMPLETED|Overall Study||2||
48217071|NCT01823536|100860063|FG004|NOT COMPLETED|Overall Study||2||
48217072|NCT01823536|100860064|FG005|NOT COMPLETED|Overall Study||0||
48217073|NCT01121991|100860065|FG000|STARTED|Overall Study||52||
48217074|NCT01121991|100860065|FG000|COMPLETED|Overall Study||46||
48217075|NCT01121991|100860065|FG000|NOT COMPLETED|Overall Study||6||
48217076|NCT01260896|100860066|FG000|STARTED|First Intervention||12||
48217077|NCT01260896|100860067|FG001|STARTED|First Intervention||12||
48217078|NCT01260896|100860066|FG000|COMPLETED|First Intervention||10||
48496271|NCT02667951|101548050|FG001|NOT COMPLETED|Overall Study||23||
48217079|NCT01260896|100860067|FG001|COMPLETED|First Intervention||12||
48496272|NCT01923740|101548051|FG000|STARTED|Overall Study||227||
48217080|NCT01260896|100860066|FG000|NOT COMPLETED|First Intervention||2||
48217081|NCT01260896|100860067|FG001|NOT COMPLETED|First Intervention||0||
48217082|NCT01260896|100860066|FG000|STARTED|Washout of 7 Days||10||
48217083|NCT01260896|100860067|FG001|STARTED|Washout of 7 Days||12||
48217084|NCT01260896|100860066|FG000|COMPLETED|Washout of 7 Days||10||
48217085|NCT01260896|100860067|FG001|COMPLETED|Washout of 7 Days||12||
48217086|NCT01260896|100860066|FG000|NOT COMPLETED|Washout of 7 Days||0||
48217087|NCT01260896|100860067|FG001|NOT COMPLETED|Washout of 7 Days||0||
48217088|NCT01260896|100860066|FG000|STARTED|Second Intervention||10||
48217089|NCT01260896|100860067|FG001|STARTED|Second Intervention||12||
48496273|NCT01923740|101548052|FG001|STARTED|Overall Study||232||
48217090|NCT01260896|100860066|FG000|COMPLETED|Second Intervention||10||
48217091|NCT01260896|100860067|FG001|COMPLETED|Second Intervention||12||
48217092|NCT01260896|100860066|FG000|NOT COMPLETED|Second Intervention||0||
48217093|NCT01260896|100860067|FG001|NOT COMPLETED|Second Intervention||0||
48217094|NCT01296646|100860068|FG000|STARTED|Overall Study||40||
48217095|NCT01296646|100860069|FG001|STARTED|Overall Study||40||
48217096|NCT01296646|100860068|FG000|COMPLETED|Overall Study||29||
48217097|NCT01296646|100860069|FG001|COMPLETED|Overall Study||29||
48217098|NCT01296646|100860068|FG000|NOT COMPLETED|Overall Study||11||
48217099|NCT01296646|100860069|FG001|NOT COMPLETED|Overall Study||11||
48217100|NCT02317783|100860070|FG000|STARTED|Overall Study||10||
48217101|NCT02317783|100860070|FG000|COMPLETED|Overall Study||10||
48217102|NCT02317783|100860070|FG000|NOT COMPLETED|Overall Study||0||
48217103|NCT01065506|100860071|FG000|STARTED|Overall Study||64||
48217104|NCT01065506|100860072|FG001|STARTED|Overall Study||72||
48217105|NCT01065506|100860071|FG000|End of Treatment|Overall Study||44||
48217106|NCT01065506|100860072|FG001|End of Treatment|Overall Study||37||
48217107|NCT01065506|100860071|FG000|4-Month Follow-Up|Overall Study||35||
48217108|NCT01065506|100860072|FG001|4-Month Follow-Up|Overall Study||34||
48217109|NCT01065506|100860071|FG000|COMPLETED|Overall Study||32||
48217110|NCT01065506|100860072|FG001|COMPLETED|Overall Study||34||
48060638|NCT04839146|100470240|FG007|STARTED|Overall Study||6||
48060639|NCT04839146|100470241|FG008|STARTED|Overall Study||9||
48060640|NCT04839146|100470242|FG009|STARTED|Overall Study||6||
48060641|NCT04839146|100470233|FG000|COMPLETED|Overall Study||3||
48060642|NCT04839146|100470234|FG001|COMPLETED|Overall Study||3||
48060643|NCT04839146|100470235|FG002|COMPLETED|Overall Study||3||
48060644|NCT04839146|100470236|FG003|COMPLETED|Overall Study||3||
48060645|NCT04839146|100470237|FG004|COMPLETED|Overall Study||3||
48060646|NCT04839146|100470238|FG005|COMPLETED|Overall Study||3||
48060647|NCT04839146|100470239|FG006|COMPLETED|Overall Study||6||
48060648|NCT04839146|100470240|FG007|COMPLETED|Overall Study||6||
48217111|NCT01065506|100860071|FG000|NOT COMPLETED|Overall Study||32||
48217112|NCT01065506|100860072|FG001|NOT COMPLETED|Overall Study||38||
48217113|NCT01057433|100860073|FG000|STARTED|Overall Study||24||
48217114|NCT01057433|100860073|FG000|COMPLETED|Overall Study||23||
48217115|NCT01057433|100860073|FG000|NOT COMPLETED|Overall Study||1||
48217116|NCT02374463|100860074|FG000|STARTED|Overall Study||15||
48217117|NCT02374463|100860075|FG001|STARTED|Overall Study||12||
48217118|NCT02374463|100860074|FG000|COMPLETED|Overall Study||12||
48217119|NCT02374463|100860075|FG001|COMPLETED|Overall Study||9||
48217120|NCT02374463|100860074|FG000|NOT COMPLETED|Overall Study||3||
48217121|NCT02374463|100860075|FG001|NOT COMPLETED|Overall Study||3||
48217122|NCT01939899|100860076|FG000|STARTED|Lead-in Dose Finding Phase||3||
48217123|NCT01939899|100860077|FG001|STARTED|Lead-in Dose Finding Phase||7||
48217124|NCT01939899|100860078|FG002|STARTED|Lead-in Dose Finding Phase||6||
48217125|NCT01939899|100860079|FG003|STARTED|Lead-in Dose Finding Phase||0||
48217126|NCT01939899|100860080|FG004|STARTED|Lead-in Dose Finding Phase||0||
48217127|NCT01939899|100860076|FG000|COMPLETED|Lead-in Dose Finding Phase||1||
48217128|NCT01939899|100860077|FG001|COMPLETED|Lead-in Dose Finding Phase||0||
48217129|NCT01939899|100860078|FG002|COMPLETED|Lead-in Dose Finding Phase||1||
48217130|NCT01939899|100860079|FG003|COMPLETED|Lead-in Dose Finding Phase||0||
48217131|NCT01939899|100860080|FG004|COMPLETED|Lead-in Dose Finding Phase||0||
48217132|NCT01939899|100860076|FG000|NOT COMPLETED|Lead-in Dose Finding Phase||2||
48217133|NCT01939899|100860077|FG001|NOT COMPLETED|Lead-in Dose Finding Phase||7||
48217134|NCT01939899|100860078|FG002|NOT COMPLETED|Lead-in Dose Finding Phase||5||
48217135|NCT01939899|100860079|FG003|NOT COMPLETED|Lead-in Dose Finding Phase||0||
48217136|NCT01939899|100860080|FG004|NOT COMPLETED|Lead-in Dose Finding Phase||0||
48217137|NCT01939899|100860076|FG000|STARTED|Phase 2||0||
48217138|NCT01939899|100860077|FG001|STARTED|Phase 2||0||
48217139|NCT01939899|100860078|FG002|STARTED|Phase 2||0||
48217140|NCT01939899|100860079|FG003|STARTED|Phase 2||12||
48217141|NCT01939899|100860080|FG004|STARTED|Phase 2||1||
48217142|NCT01939899|100860076|FG000|COMPLETED|Phase 2||0||
48217143|NCT01939899|100860077|FG001|COMPLETED|Phase 2||0||
48217144|NCT01939899|100860078|FG002|COMPLETED|Phase 2||0||
48060649|NCT04839146|100470241|FG008|COMPLETED|Overall Study||9||
48060650|NCT04839146|100470242|FG009|COMPLETED|Overall Study||6||
48060651|NCT04839146|100470233|FG000|NOT COMPLETED|Overall Study||0||
48060652|NCT04839146|100470234|FG001|NOT COMPLETED|Overall Study||0||
48060653|NCT04839146|100470235|FG002|NOT COMPLETED|Overall Study||0||
48060654|NCT04839146|100470236|FG003|NOT COMPLETED|Overall Study||0||
48060655|NCT04839146|100470237|FG004|NOT COMPLETED|Overall Study||0||
48060656|NCT04839146|100470238|FG005|NOT COMPLETED|Overall Study||0||
48060657|NCT04839146|100470239|FG006|NOT COMPLETED|Overall Study||0||
48060658|NCT04839146|100470240|FG007|NOT COMPLETED|Overall Study||0||
48060659|NCT04839146|100470241|FG008|NOT COMPLETED|Overall Study||0||
48060660|NCT04839146|100470242|FG009|NOT COMPLETED|Overall Study||0||
48217145|NCT01939899|100860079|FG003|COMPLETED|Phase 2||1||
48217146|NCT01939899|100860080|FG004|COMPLETED|Phase 2||0||
48496274|NCT01923740|101548051|FG000|COMPLETED|Overall Study||221||
48217147|NCT01939899|100860076|FG000|NOT COMPLETED|Phase 2||0||
48217148|NCT01939899|100860077|FG001|NOT COMPLETED|Phase 2||0||
48217149|NCT01939899|100860078|FG002|NOT COMPLETED|Phase 2||0||
48217150|NCT01939899|100860079|FG003|NOT COMPLETED|Phase 2||11||
48217151|NCT01939899|100860080|FG004|NOT COMPLETED|Phase 2||1||
48217152|NCT01691079|100860081|FG000|STARTED|Overall Study||0||
48217153|NCT01691079|100860082|FG001|STARTED|Overall Study||0||
48060661|NCT04738734|100470243|FG000|STARTED|Overall Study||75||
48060662|NCT04738734|100470244|FG001|STARTED|Overall Study||75||
48060663|NCT04738734|100470243|FG000|COMPLETED|Overall Study||68||
48060664|NCT04738734|100470244|FG001|COMPLETED|Overall Study||67||
48060665|NCT04738734|100470243|FG000|NOT COMPLETED|Overall Study||7||
48060666|NCT04738734|100470244|FG001|NOT COMPLETED|Overall Study||8||
48060667|NCT01847001|100470245|FG000|STARTED|Overall Study||10||
48060668|NCT01847001|100470245|FG000|COMPLETED|Overall Study||10||
48060669|NCT01847001|100470245|FG000|NOT COMPLETED|Overall Study||0||
48060670|NCT00464269|100470246|FG000|STARTED|Overall Study||99||
48060671|NCT00464269|100470247|FG001|STARTED|Overall Study||99||
48060672|NCT00464269|100470248|FG002|STARTED|Overall Study||100||
48060673|NCT00464269|100470249|FG003|STARTED|Overall Study||102||
48060674|NCT00464269|100470246|FG000|COMPLETED|Overall Study||93||
48060675|NCT00464269|100470247|FG001|COMPLETED|Overall Study||82||
48060676|NCT00464269|100470248|FG002|COMPLETED|Overall Study||93||
48060677|NCT00464269|100470249|FG003|COMPLETED|Overall Study||93||
48060678|NCT00464269|100470246|FG000|NOT COMPLETED|Overall Study||6||
48060679|NCT00464269|100470247|FG001|NOT COMPLETED|Overall Study||17||
48060680|NCT00464269|100470248|FG002|NOT COMPLETED|Overall Study||7||
48060681|NCT00464269|100470249|FG003|NOT COMPLETED|Overall Study||9||
48060682|NCT00835159|100470250|FG000|STARTED|Overall Study||11||
48060683|NCT00835159|100470251|FG001|STARTED|Overall Study||17||
48060684|NCT00835159|100470250|FG000|COMPLETED|Overall Study||11||
48060685|NCT00835159|100470251|FG001|COMPLETED|Overall Study||17||
48060686|NCT00835159|100470250|FG000|NOT COMPLETED|Overall Study||0||
48060687|NCT00835159|100470251|FG001|NOT COMPLETED|Overall Study||0||
48060688|NCT01359007|100470252|FG000|STARTED|Overall Study||5||
48060689|NCT01359007|100470252|FG000|COMPLETED|Overall Study||3||
48060690|NCT01359007|100470252|FG000|NOT COMPLETED|Overall Study||2||
48060691|NCT01770652|100470253|FG000|STARTED|Overall Study||8||
48060692|NCT01770652|100470254|FG001|STARTED|Overall Study||8||
48060693|NCT01770652|100470255|FG002|STARTED|Overall Study||8||
48060694|NCT01770652|100470256|FG003|STARTED|Overall Study||8||
48060695|NCT01770652|100470253|FG000|COMPLETED|Overall Study||8||
48060696|NCT01770652|100470254|FG001|COMPLETED|Overall Study||8||
48060697|NCT01770652|100470255|FG002|COMPLETED|Overall Study||8||
48060698|NCT01770652|100470256|FG003|COMPLETED|Overall Study||8||
48060699|NCT01770652|100470253|FG000|NOT COMPLETED|Overall Study||0||
48060700|NCT01770652|100470254|FG001|NOT COMPLETED|Overall Study||0||
48060701|NCT01770652|100470255|FG002|NOT COMPLETED|Overall Study||0||
48060702|NCT01770652|100470256|FG003|NOT COMPLETED|Overall Study||0||
48060703|NCT03439657|100470257|FG000|STARTED|Overall Study||449||
48060704|NCT03439657|100470258|FG001|STARTED|Overall Study||463||
48060705|NCT03439657|100470257|FG000|COMPLETED|Overall Study||442||
48060706|NCT03439657|100470258|FG001|COMPLETED|Overall Study||459||
48060707|NCT03439657|100470257|FG000|NOT COMPLETED|Overall Study||7||
48060708|NCT03439657|100470258|FG001|NOT COMPLETED|Overall Study||4||
48060709|NCT03589469|100470259|FG000|STARTED|Overall Study||145||
48060710|NCT03589469|100470259|FG000|Participants Received Treatment|Overall Study||145||
48060711|NCT03589469|100470259|FG000|COMPLETED|Overall Study||11||
48060712|NCT03589469|100470259|FG000|NOT COMPLETED|Overall Study||134||
48060713|NCT05048082|100470260|FG000|STARTED|Overall Study||20||
48060714|NCT05048082|100470260|FG000|COMPLETED|Overall Study||20||
48060715|NCT05048082|100470260|FG000|NOT COMPLETED|Overall Study||0||
48060716|NCT04718961|100470261|FG000|STARTED|Overall Study||2||
48060717|NCT04718961|100470262|FG001|STARTED|Overall Study||2||
48060718|NCT04718961|100470263|FG002|STARTED|Overall Study||0||
48060719|NCT04718961|100470264|FG003|STARTED|Overall Study||0||
48060720|NCT04718961|100470261|FG000|COMPLETED|Overall Study||2||
48060721|NCT04718961|100470262|FG001|COMPLETED|Overall Study||2||
48060722|NCT04718961|100470263|FG002|COMPLETED|Overall Study||0||
48060723|NCT04718961|100470264|FG003|COMPLETED|Overall Study||0||
48060724|NCT04718961|100470261|FG000|NOT COMPLETED|Overall Study||0||
48060725|NCT04718961|100470262|FG001|NOT COMPLETED|Overall Study||0||
48060726|NCT04718961|100470263|FG002|NOT COMPLETED|Overall Study||0||
48060727|NCT04718961|100470264|FG003|NOT COMPLETED|Overall Study||0||
48060728|NCT02027376|100470265|FG000|STARTED|Overall Study||5||
48060729|NCT02027376|100470266|FG001|STARTED|Overall Study||4||
48060730|NCT02027376|100470267|FG002|STARTED|Overall Study||3||
48060731|NCT02027376|100470265|FG000|COMPLETED|Overall Study||4||
48060732|NCT02027376|100470266|FG001|COMPLETED|Overall Study||4||
48060733|NCT02027376|100470267|FG002|COMPLETED|Overall Study||3||
48060734|NCT02027376|100470265|FG000|NOT COMPLETED|Overall Study||1||
48060735|NCT02027376|100470266|FG001|NOT COMPLETED|Overall Study||0||
48060736|NCT02027376|100470267|FG002|NOT COMPLETED|Overall Study||0||
48060737|NCT04060862|100470268|FG000|STARTED|Overall Study||20||
48060738|NCT04060862|100470268|FG000|COMPLETED|Overall Study||0||
48060739|NCT04060862|100470268|FG000|NOT COMPLETED|Overall Study||20||
48060740|NCT01385371|100470269|FG000|STARTED|Overall Study||752||
48217154|NCT01691079|100860081|FG000|COMPLETED|Overall Study||0||
48217155|NCT01691079|100860082|FG001|COMPLETED|Overall Study||0||
48217156|NCT01691079|100860081|FG000|NOT COMPLETED|Overall Study||0||
48217157|NCT01691079|100860082|FG001|NOT COMPLETED|Overall Study||0||
48217158|NCT00982644|100860083|FG000|STARTED|Main: Week 0 to 52 (NN1250-3579)||773||
48217159|NCT00982644|100860084|FG001|STARTED|Main: Week 0 to 52 (NN1250-3579)||257||
48217160|NCT00982644|100860083|FG000|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||773||
48217161|NCT00982644|100860084|FG001|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||257||
48217162|NCT00982644|100860083|FG000|Exposed|Main: Week 0 to 52 (NN1250-3579)||766||
48217163|NCT00982644|100860084|FG001|Exposed|Main: Week 0 to 52 (NN1250-3579)||257||
48217164|NCT00982644|100860083|FG000|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||607||
48217165|NCT00982644|100860084|FG001|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||197||
48217166|NCT00982644|100860083|FG000|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||166||
48217167|NCT00982644|100860084|FG001|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||60||
48217168|NCT00982644|100860083|FG000|STARTED|Extension: Week 53 to 104 (NN1250-3643)||551||
48217169|NCT00982644|100860084|FG001|STARTED|Extension: Week 53 to 104 (NN1250-3643)||174||
48217170|NCT00982644|100860083|FG000|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||505||
48217171|NCT00982644|100860084|FG001|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||154||
48217172|NCT00982644|100860083|FG000|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||46||
48217173|NCT00982644|100860084|FG001|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||20||
48217174|NCT00687219|100860085|FG000|STARTED|Overall Study||102||
48217175|NCT00687219|100860085|FG000|COMPLETED|Overall Study||51||
48217176|NCT00687219|100860085|FG000|NOT COMPLETED|Overall Study||51||
48217177|NCT02426138|100860086|FG000|STARTED|First Intervention (12 Weeks)||21||
48217178|NCT02426138|100860087|FG001|STARTED|First Intervention (12 Weeks)||23||
48217179|NCT02426138|100860086|FG000|COMPLETED|First Intervention (12 Weeks)||20||
48217180|NCT02426138|100860087|FG001|COMPLETED|First Intervention (12 Weeks)||22||
48217181|NCT02426138|100860086|FG000|NOT COMPLETED|First Intervention (12 Weeks)||1||
48217182|NCT02426138|100860087|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1||
48217183|NCT02426138|100860086|FG000|STARTED|Second Intervention (12 Weeks)||20||
48217184|NCT02426138|100860087|FG001|STARTED|Second Intervention (12 Weeks)||22||
48217185|NCT02426138|100860086|FG000|COMPLETED|Second Intervention (12 Weeks)||20||
48217186|NCT02426138|100860087|FG001|COMPLETED|Second Intervention (12 Weeks)||22||
48060741|NCT01385371|100470270|FG001|STARTED|Overall Study||749||
48060742|NCT01385371|100470269|FG000|COMPLETED|Overall Study||603||
48060743|NCT01385371|100470270|FG001|COMPLETED|Overall Study||652||
48060744|NCT01385371|100470269|FG000|NOT COMPLETED|Overall Study||149||
48060745|NCT01385371|100470270|FG001|NOT COMPLETED|Overall Study||97||
48060746|NCT02563990|100470271|FG000|STARTED|Overall Study||12||
48060747|NCT02563990|100470272|FG001|STARTED|Overall Study||14||
48060748|NCT02563990|100470271|FG000|COMPLETED|Overall Study||12||
48060749|NCT02563990|100470272|FG001|COMPLETED|Overall Study||14||
48060750|NCT02563990|100470271|FG000|NOT COMPLETED|Overall Study||0||
48060751|NCT02563990|100470272|FG001|NOT COMPLETED|Overall Study||0||
48060752|NCT04447417|100470273|FG000|STARTED|Overall Study||26||
48060753|NCT04447417|100470274|FG001|STARTED|Overall Study||26||
48060754|NCT04447417|100470273|FG000|COMPLETED|Overall Study||23||
48060755|NCT04447417|100470274|FG001|COMPLETED|Overall Study||26||
48060756|NCT04447417|100470273|FG000|NOT COMPLETED|Overall Study||3||
48060757|NCT04447417|100470274|FG001|NOT COMPLETED|Overall Study||0||
48060758|NCT00071396|100470275|FG000|STARTED|Overall Study||44||
48060759|NCT00071396|100470275|FG000|COMPLETED|Overall Study||41||
48060760|NCT00071396|100470275|FG000|NOT COMPLETED|Overall Study||3||
48060761|NCT02572609|100470276|FG000|STARTED|Period 1: Treatment Period 1 + Washout||18||
48060762|NCT02572609|100470277|FG001|STARTED|Period 1: Treatment Period 1 + Washout||18||
48217187|NCT02426138|100860086|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0||
48217188|NCT02426138|100860087|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0||
48217189|NCT02426138|100860086|FG000|STARTED|Intent to Treat Population Milestone||20||
48217190|NCT02426138|100860087|FG001|STARTED|Intent to Treat Population Milestone||22||
48217191|NCT02426138|100860086|FG000|COMPLETED|Intent to Treat Population Milestone||20||
48217192|NCT02426138|100860087|FG001|COMPLETED|Intent to Treat Population Milestone||22||
48217193|NCT02426138|100860086|FG000|NOT COMPLETED|Intent to Treat Population Milestone||0||
48217194|NCT02426138|100860087|FG001|NOT COMPLETED|Intent to Treat Population Milestone||0||
48217195|NCT01974102|100860088|FG000|STARTED|Overall Study||22||
48217196|NCT01974102|100860089|FG001|STARTED|Overall Study||20||
48217197|NCT01974102|100860088|FG000|COMPLETED|Overall Study||15||
48217198|NCT01974102|100860089|FG001|COMPLETED|Overall Study||19||
48217199|NCT01974102|100860088|FG000|NOT COMPLETED|Overall Study||7||
48217200|NCT01974102|100860089|FG001|NOT COMPLETED|Overall Study||1||
48217201|NCT05262738|100860090|FG000|STARTED|Overall Study||92||
48217202|NCT05262738|100860091|FG001|STARTED|Overall Study||88||
48217203|NCT05262738|100860090|FG000|COMPLETED|Overall Study||91||
48217204|NCT05262738|100860091|FG001|COMPLETED|Overall Study||88||
48060763|NCT02572609|100470276|FG000|COMPLETED|Period 1: Treatment Period 1 + Washout||18||
48217205|NCT05262738|100860090|FG000|NOT COMPLETED|Overall Study||1||
48217206|NCT05262738|100860091|FG001|NOT COMPLETED|Overall Study||0||
48217207|NCT05343715|100860092|FG000|STARTED|Overall Study||12||
48060764|NCT02572609|100470277|FG001|COMPLETED|Period 1: Treatment Period 1 + Washout||18||
48060765|NCT02572609|100470276|FG000|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0||
48217208|NCT05343715|100860093|FG001|STARTED|Overall Study||12||
48217209|NCT05343715|100860092|FG000|COMPLETED|Overall Study||12||
48217210|NCT05343715|100860093|FG001|COMPLETED|Overall Study||12||
48217211|NCT05343715|100860092|FG000|NOT COMPLETED|Overall Study||0||
48217212|NCT05343715|100860093|FG001|NOT COMPLETED|Overall Study||0||
48217213|NCT03093428|100860094|FG000|STARTED|Overall Study||31||
48217214|NCT03093428|100860095|FG001|STARTED|Overall Study||14||
48217215|NCT03093428|100860094|FG000|COMPLETED|Overall Study||12||
48217216|NCT03093428|100860095|FG001|COMPLETED|Overall Study||8||
48217217|NCT03093428|100860094|FG000|NOT COMPLETED|Overall Study||19||
48217218|NCT03093428|100860095|FG001|NOT COMPLETED|Overall Study||6||
48217219|NCT00582972|100860096|FG000|STARTED|Overall Study||23||
48217220|NCT00582972|100860096|FG000|COMPLETED|Overall Study||21||
48217221|NCT00582972|100860096|FG000|NOT COMPLETED|Overall Study||2||
48217222|NCT01701401|100860097|FG000|STARTED|Overall Study||217||
48217223|NCT01701401|100860098|FG001|STARTED|Overall Study||218||
48217224|NCT01701401|100860099|FG002|STARTED|Overall Study||217||
48217225|NCT01701401|100860100|FG003|STARTED|Overall Study||218||
48217226|NCT01701401|100860097|FG000|COMPLETED|Overall Study||207||
48217227|NCT01701401|100860098|FG001|COMPLETED|Overall Study||209||
48217228|NCT01701401|100860099|FG002|COMPLETED|Overall Study||212||
48217229|NCT01701401|100860100|FG003|COMPLETED|Overall Study||212||
48217230|NCT01701401|100860097|FG000|NOT COMPLETED|Overall Study||10||
48217231|NCT01701401|100860098|FG001|NOT COMPLETED|Overall Study||9||
48217232|NCT01701401|100860099|FG002|NOT COMPLETED|Overall Study||5||
48217233|NCT01701401|100860100|FG003|NOT COMPLETED|Overall Study||6||
48217234|NCT03539952|100860101|FG000|STARTED|Penicillamine Baseline Period (Day1-W12)||77||
48217235|NCT03539952|100860102|FG001|STARTED|Penicillamine Baseline Period (Day1-W12)||0||
48217236|NCT03539952|100860101|FG000|COMPLETED|Penicillamine Baseline Period (Day1-W12)||53||
48217237|NCT03539952|100860102|FG001|COMPLETED|Penicillamine Baseline Period (Day1-W12)||0||
48217238|NCT03539952|100860101|FG000|NOT COMPLETED|Penicillamine Baseline Period (Day1-W12)||24||
48217239|NCT03539952|100860102|FG001|NOT COMPLETED|Penicillamine Baseline Period (Day1-W12)||0||
48217240|NCT03539952|100860101|FG000|STARTED|Post-randomization Period (Week 12-36)||27|The number of participants starting the Post-randomization period in one of the two arms is equal to the number of subjects that completed the baseline period, i.e. before randomisation|
48217241|NCT03539952|100860102|FG001|STARTED|Post-randomization Period (Week 12-36)||26|The number of participants starting the Post-randomization period in one of the two arms is equal to the number of subjects that completed the baseline period, i.e. before randomisation|
48217242|NCT03539952|100860101|FG000|COMPLETED|Post-randomization Period (Week 12-36)||26||
48217243|NCT03539952|100860102|FG001|COMPLETED|Post-randomization Period (Week 12-36)||26||
48217244|NCT03539952|100860101|FG000|NOT COMPLETED|Post-randomization Period (Week 12-36)||1||
48217245|NCT03539952|100860102|FG001|NOT COMPLETED|Post-randomization Period (Week 12-36)||0||
48217246|NCT03539952|100860101|FG000|STARTED|Extension Post Random. (Week 36-60)||26||
48217247|NCT03539952|100860102|FG001|STARTED|Extension Post Random. (Week 36-60)||26||
48217248|NCT03539952|100860101|FG000|COMPLETED|Extension Post Random. (Week 36-60)||19||
48217249|NCT03539952|100860102|FG001|COMPLETED|Extension Post Random. (Week 36-60)||23||
48217250|NCT03539952|100860101|FG000|NOT COMPLETED|Extension Post Random. (Week 36-60)||7||
48217251|NCT03539952|100860102|FG001|NOT COMPLETED|Extension Post Random. (Week 36-60)||3||
48217252|NCT03539952|100860101|FG000|STARTED|All on TETA 4HCl, From wk 60 Till 108max||19||
48217253|NCT03539952|100860102|FG001|STARTED|All on TETA 4HCl, From wk 60 Till 108max||23||
48217254|NCT03539952|100860101|FG000|COMPLETED|All on TETA 4HCl, From wk 60 Till 108max||19||
48217255|NCT03539952|100860102|FG001|COMPLETED|All on TETA 4HCl, From wk 60 Till 108max||21||
48217256|NCT03539952|100860101|FG000|NOT COMPLETED|All on TETA 4HCl, From wk 60 Till 108max||0||
48217257|NCT03539952|100860102|FG001|NOT COMPLETED|All on TETA 4HCl, From wk 60 Till 108max||2||
48217258|NCT01354444|100860103|FG000|STARTED|Overall Study||14||
48217259|NCT01354444|100860104|FG001|STARTED|Overall Study||15||
48217260|NCT01354444|100860103|FG000|COMPLETED|Overall Study||6||
48217261|NCT01354444|100860104|FG001|COMPLETED|Overall Study||11||
48217262|NCT01354444|100860103|FG000|NOT COMPLETED|Overall Study||8||
48217263|NCT01354444|100860104|FG001|NOT COMPLETED|Overall Study||4||
48217264|NCT00979121|100860105|FG000|STARTED|Overall Study||379||
48217265|NCT00979121|100860106|FG001|STARTED|Overall Study||366||
48217266|NCT00979121|100860105|FG000|COMPLETED|Overall Study||379||
48217267|NCT00979121|100860106|FG001|COMPLETED|Overall Study||366||
48217268|NCT00979121|100860105|FG000|NOT COMPLETED|Overall Study||0||
48217269|NCT00979121|100860106|FG001|NOT COMPLETED|Overall Study||0||
48217270|NCT04977700|100860107|FG000|STARTED|Overall Study||31||
48217271|NCT04977700|100860108|FG001|STARTED|Overall Study||10||
48217272|NCT04977700|100860107|FG000|COMPLETED|Overall Study||31||
48217273|NCT04977700|100860108|FG001|COMPLETED|Overall Study||10||
48217274|NCT04977700|100860107|FG000|NOT COMPLETED|Overall Study||0||
48217275|NCT04977700|100860108|FG001|NOT COMPLETED|Overall Study||0||
48217276|NCT00409838|100860109|FG000|STARTED|Short-term Period||56||
48217277|NCT00409838|100860110|FG001|STARTED|Short-term Period||57||
48217278|NCT00409838|100860109|FG000|Treated (Baseline) Population|Short-term Period||55||
48217279|NCT00409838|100860110|FG001|Treated (Baseline) Population|Short-term Period||57||
48217280|NCT00409838|100860109|FG000|COMPLETED|Short-term Period||53||
48217281|NCT00409838|100860110|FG001|COMPLETED|Short-term Period||52||
48217282|NCT00409838|100860109|FG000|NOT COMPLETED|Short-term Period||3||
48217283|NCT00409838|100860110|FG001|NOT COMPLETED|Short-term Period||5||
48217284|NCT00409838|100860109|FG000|STARTED|Long-term Extension Period||105||
48217285|NCT00409838|100860110|FG001|STARTED|Long-term Extension Period||0||
48217286|NCT00409838|100860109|FG000|COMPLETED|Long-term Extension Period||87||
48217287|NCT00409838|100860110|FG001|COMPLETED|Long-term Extension Period||0||
48217288|NCT00409838|100860109|FG000|NOT COMPLETED|Long-term Extension Period||18||
48217289|NCT00409838|100860110|FG001|NOT COMPLETED|Long-term Extension Period||0||
48217290|NCT02874534|100860111|FG000|STARTED|Overall Study||31||
48217291|NCT02874534|100860112|FG001|STARTED|Overall Study||26||
48217292|NCT02874534|100860111|FG000|COMPLETED|Overall Study||23||
48217293|NCT02874534|100860112|FG001|COMPLETED|Overall Study||15||
48217294|NCT02874534|100860111|FG000|NOT COMPLETED|Overall Study||8||
48217295|NCT02874534|100860112|FG001|NOT COMPLETED|Overall Study||11||
48217296|NCT00220740|100860113|FG000|STARTED|Efficacy Period||59||
48217297|NCT00220740|100860114|FG001|STARTED|Efficacy Period||58||
48217298|NCT00220740|100860113|FG000|COMPLETED|Efficacy Period||33||
48217299|NCT00220740|100860114|FG001|COMPLETED|Efficacy Period||12||
48217300|NCT00220740|100860113|FG000|NOT COMPLETED|Efficacy Period||26||
48217301|NCT00220740|100860114|FG001|NOT COMPLETED|Efficacy Period||46||
48217302|NCT00220740|100860113|FG000|STARTED|Rescue Treatment||45||
48217303|NCT00220740|100860114|FG001|STARTED|Rescue Treatment||23||
48217304|NCT00220740|100860113|FG000|COMPLETED|Rescue Treatment||26||
48217305|NCT00220740|100860114|FG001|COMPLETED|Rescue Treatment||5||
48217306|NCT00220740|100860113|FG000|NOT COMPLETED|Rescue Treatment||19||
48217307|NCT00220740|100860114|FG001|NOT COMPLETED|Rescue Treatment||18||
48217308|NCT00220740|100860113|FG000|STARTED|Withdrawal Period||43||
48217309|NCT00220740|100860114|FG001|STARTED|Withdrawal Period||31||
48217310|NCT00220740|100860113|FG000|COMPLETED|Withdrawal Period||37||
48217311|NCT00220740|100860114|FG001|COMPLETED|Withdrawal Period||16||
48217312|NCT00220740|100860113|FG000|NOT COMPLETED|Withdrawal Period||6||
48217313|NCT00220740|100860114|FG001|NOT COMPLETED|Withdrawal Period||15||
48217314|NCT01989455|100860115|FG000|STARTED|Overall Study||14||
48217315|NCT01989455|100860116|FG001|STARTED|Overall Study||14||
48217316|NCT01989455|100860117|FG002|STARTED|Overall Study||14||
48217317|NCT01989455|100860118|FG003|STARTED|Overall Study||14||
48217318|NCT01989455|100860119|FG004|STARTED|Overall Study||8||
48217319|NCT01989455|100860115|FG000|COMPLETED|Overall Study||14||
48217320|NCT01989455|100860116|FG001|COMPLETED|Overall Study||12||
48217321|NCT01989455|100860117|FG002|COMPLETED|Overall Study||13||
48217322|NCT01989455|100860118|FG003|COMPLETED|Overall Study||14||
48217323|NCT01989455|100860119|FG004|COMPLETED|Overall Study||7||
48217324|NCT01989455|100860115|FG000|NOT COMPLETED|Overall Study||0||
48217325|NCT01989455|100860116|FG001|NOT COMPLETED|Overall Study||2||
48217326|NCT01989455|100860117|FG002|NOT COMPLETED|Overall Study||1||
48217327|NCT01989455|100860118|FG003|NOT COMPLETED|Overall Study||0||
48217328|NCT01989455|100860119|FG004|NOT COMPLETED|Overall Study||1||
48217329|NCT00505934|100860120|FG000|STARTED|Overall Study||19||
48217330|NCT00505934|100860120|FG000|COMPLETED|Overall Study||16||
48217331|NCT00505934|100860120|FG000|NOT COMPLETED|Overall Study||3||
48217332|NCT01721291|100860121|FG000|STARTED|Overall Study||14||
48217333|NCT01721291|100860122|FG001|STARTED|Overall Study||12||
48217334|NCT01721291|100860121|FG000|COMPLETED|Overall Study||12||
48217335|NCT01721291|100860122|FG001|COMPLETED|Overall Study||12||
48217336|NCT01721291|100860121|FG000|NOT COMPLETED|Overall Study||2||
48217337|NCT01721291|100860122|FG001|NOT COMPLETED|Overall Study||0||
48217338|NCT00448669|100860123|FG000|STARTED|Overall Study||611||
48217339|NCT00448669|100860124|FG001|STARTED|Overall Study||608||
48217340|NCT00448669|100860123|FG000|COMPLETED|Overall Study||393||
48217341|NCT00448669|100860124|FG001|COMPLETED|Overall Study||410||
48217342|NCT00448669|100860123|FG000|NOT COMPLETED|Overall Study||218||
48217343|NCT00448669|100860124|FG001|NOT COMPLETED|Overall Study||198||
48217344|NCT01485887|100860125|FG000|STARTED|Overall Study||50||
48217345|NCT01485887|100860125|FG000|COMPLETED|Overall Study||38||
48217346|NCT01485887|100860125|FG000|NOT COMPLETED|Overall Study||12||
48217347|NCT01998958|100860126|FG000|STARTED|Period 1 (Panel A and B)||33||
48217348|NCT01998958|100860127|FG001|STARTED|Period 1 (Panel A and B)||11||
48217349|NCT01998958|100860128|FG002|STARTED|Period 1 (Panel A and B)||11||
48217350|NCT01998958|100860129|FG003|STARTED|Period 1 (Panel A and B)||12||
48217351|NCT01998958|100860130|FG004|STARTED|Period 1 (Panel A and B)||21||
48217352|NCT01998958|100860131|FG005|STARTED|Period 1 (Panel A and B)||11||
48217353|NCT01998958|100860132|FG006|STARTED|Period 1 (Panel A and B)||9||
48217354|NCT01998958|100860133|FG007|STARTED|Period 1 (Panel A and B)||0||
48217355|NCT01998958|100860134|FG008|STARTED|Period 1 (Panel A and B)||0||
48217356|NCT01998958|100860135|FG009|STARTED|Period 1 (Panel A and B)||0||
48217357|NCT01998958|100860136|FG010|STARTED|Period 1 (Panel A and B)||0||
48217358|NCT01998958|100860137|FG011|STARTED|Period 1 (Panel A and B)||0||
48217359|NCT01998958|100860138|FG012|STARTED|Period 1 (Panel A and B)||0||
48217360|NCT01998958|100860139|FG013|STARTED|Period 1 (Panel A and B)||0||
48217361|NCT01998958|100860140|FG014|STARTED|Period 1 (Panel A and B)||0||
48217362|NCT01998958|100860141|FG015|STARTED|Period 1 (Panel A and B)||0||
48217363|NCT01998958|100860142|FG016|STARTED|Period 1 (Panel A and B)||0||
48217364|NCT01998958|100860143|FG017|STARTED|Period 1 (Panel A and B)||0||
48217365|NCT01998958|100860144|FG018|STARTED|Period 1 (Panel A and B)||0||
48217366|NCT01998958|100860145|FG019|STARTED|Period 1 (Panel A and B)||0||
48217367|NCT01998958|100860146|FG020|STARTED|Period 1 (Panel A and B)||0||
48217368|NCT01998958|100860147|FG021|STARTED|Period 1 (Panel A and B)||0||
48217369|NCT01998958|100860148|FG022|STARTED|Period 1 (Panel A and B)||0||
48496275|NCT01923740|101548052|FG001|COMPLETED|Overall Study||223||
48060766|NCT02572609|100470277|FG001|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0||
48060767|NCT02572609|100470276|FG000|STARTED|Period 2: Treatment Period 2||18||
48060768|NCT02572609|100470277|FG001|STARTED|Period 2: Treatment Period 2||18||
48060769|NCT02572609|100470276|FG000|COMPLETED|Period 2: Treatment Period 2||18||
48060770|NCT02572609|100470277|FG001|COMPLETED|Period 2: Treatment Period 2||18||
48060771|NCT02572609|100470276|FG000|NOT COMPLETED|Period 2: Treatment Period 2||0||
48060772|NCT02572609|100470277|FG001|NOT COMPLETED|Period 2: Treatment Period 2||0||
48060773|NCT01485393|100470278|FG000|STARTED|Overall Study||5||
48060774|NCT01485393|100470279|FG001|STARTED|Overall Study||5||
48060775|NCT01485393|100470278|FG000|COMPLETED|Overall Study||5||
48060776|NCT01485393|100470279|FG001|COMPLETED|Overall Study||5||
48060777|NCT01485393|100470278|FG000|NOT COMPLETED|Overall Study||0||
48060778|NCT01485393|100470279|FG001|NOT COMPLETED|Overall Study||0||
48060779|NCT03648827|100470280|FG000|STARTED|Overall Study||20||
48060780|NCT03648827|100470280|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20||
48060781|NCT03648827|100470280|FG000|COMPLETED|Overall Study||20||
48060782|NCT03648827|100470280|FG000|NOT COMPLETED|Overall Study||0||
48060783|NCT04533685|100470281|FG000|STARTED|Overall Study||17848||
48060784|NCT04533685|100470282|FG001|STARTED|Overall Study||17842||
48060785|NCT04533685|100470283|FG002|STARTED|Overall Study||17832||
48060786|NCT04533685|100470284|FG003|STARTED|Overall Study||17827||
48060787|NCT04533685|100470285|FG004|STARTED|Overall Study||17821||
48060788|NCT04533685|100470286|FG005|STARTED|Overall Study||17819||
48060789|NCT04533685|100470287|FG006|STARTED|Overall Study||17812||
48060790|NCT04533685|100470288|FG007|STARTED|Overall Study||17805||
48060791|NCT04533685|100470289|FG008|STARTED|Overall Study||71167||
48060792|NCT04533685|100470281|FG000|COMPLETED|Overall Study||17848||
48060793|NCT04533685|100470282|FG001|COMPLETED|Overall Study||17842||
48060794|NCT04533685|100470283|FG002|COMPLETED|Overall Study||17832||
48060795|NCT04533685|100470284|FG003|COMPLETED|Overall Study||17827||
48060796|NCT04533685|100470285|FG004|COMPLETED|Overall Study||17821||
48060797|NCT04533685|100470286|FG005|COMPLETED|Overall Study||17819||
48060798|NCT04533685|100470287|FG006|COMPLETED|Overall Study||17812||
48060799|NCT04533685|100470288|FG007|COMPLETED|Overall Study||17805||
48060800|NCT04533685|100470289|FG008|COMPLETED|Overall Study||71167||
48060801|NCT04533685|100470281|FG000|NOT COMPLETED|Overall Study||0||
48060802|NCT04533685|100470282|FG001|NOT COMPLETED|Overall Study||0||
48060803|NCT04533685|100470283|FG002|NOT COMPLETED|Overall Study||0||
48060804|NCT04533685|100470284|FG003|NOT COMPLETED|Overall Study||0||
48060805|NCT04533685|100470285|FG004|NOT COMPLETED|Overall Study||0||
48060806|NCT04533685|100470286|FG005|NOT COMPLETED|Overall Study||0||
48060807|NCT04533685|100470287|FG006|NOT COMPLETED|Overall Study||0||
48060808|NCT04533685|100470288|FG007|NOT COMPLETED|Overall Study||0||
48060809|NCT04533685|100470289|FG008|NOT COMPLETED|Overall Study||0||
48060810|NCT00700570|100470290|FG000|STARTED|Overall Study||19||
48060811|NCT00700570|100470291|FG001|STARTED|Overall Study||26||
48060812|NCT00700570|100470290|FG000|COMPLETED|Overall Study||8||
48060813|NCT00700570|100470291|FG001|COMPLETED|Overall Study||0||
48060814|NCT00700570|100470290|FG000|NOT COMPLETED|Overall Study||11||
48060815|NCT00700570|100470291|FG001|NOT COMPLETED|Overall Study||26||
48060816|NCT03153956|100470292|FG000|STARTED|Overall Study||39||
48060817|NCT03153956|100470293|FG001|STARTED|Overall Study||38||
48060818|NCT03153956|100470292|FG000|COMPLETED|Overall Study||39||
48060819|NCT03153956|100470293|FG001|COMPLETED|Overall Study||38||
48060820|NCT03153956|100470292|FG000|NOT COMPLETED|Overall Study||0||
48060821|NCT03153956|100470293|FG001|NOT COMPLETED|Overall Study||0||
48060822|NCT01433731|100470294|FG000|STARTED|Overall Study||3||
48060823|NCT01433731|100470295|FG001|STARTED|Overall Study||5||
48060824|NCT01433731|100470296|FG002|STARTED|Overall Study||5||
48060825|NCT01433731|100470297|FG003|STARTED|Overall Study||5||
48060826|NCT01433731|100470294|FG000|COMPLETED|Overall Study||3||
48060827|NCT01433731|100470295|FG001|COMPLETED|Overall Study||5||
48060828|NCT01433731|100470296|FG002|COMPLETED|Overall Study||5||
48060829|NCT01433731|100470297|FG003|COMPLETED|Overall Study||5||
48060830|NCT01433731|100470294|FG000|NOT COMPLETED|Overall Study||0||
48060831|NCT01433731|100470295|FG001|NOT COMPLETED|Overall Study||0||
48217370|NCT01998958|100860149|FG023|STARTED|Period 1 (Panel A and B)||0||
48060832|NCT01433731|100470296|FG002|NOT COMPLETED|Overall Study||0||
48060833|NCT01433731|100470297|FG003|NOT COMPLETED|Overall Study||0||
48060834|NCT01925274|100470298|FG000|STARTED|Overall Study||7||
48060835|NCT01925274|100470299|FG001|STARTED|Overall Study||6||
48060836|NCT01925274|100470300|FG002|STARTED|Overall Study||6||
48060837|NCT01925274|100470298|FG000|COMPLETED|Overall Study||0||
48060838|NCT01925274|100470299|FG001|COMPLETED|Overall Study||0||
48060839|NCT01925274|100470300|FG002|COMPLETED|Overall Study||0||
48060840|NCT01925274|100470298|FG000|NOT COMPLETED|Overall Study||7||
48217371|NCT01998958|100860150|FG024|STARTED|Period 1 (Panel A and B)||0||
48217372|NCT01998958|100860151|FG025|STARTED|Period 1 (Panel A and B)||0||
48060841|NCT01925274|100470299|FG001|NOT COMPLETED|Overall Study||6||
48217373|NCT01998958|100860152|FG026|STARTED|Period 1 (Panel A and B)||0||
48217374|NCT01998958|100860153|FG027|STARTED|Period 1 (Panel A and B)||0||
48217375|NCT01998958|100860154|FG028|STARTED|Period 1 (Panel A and B)||0||
48217376|NCT01998958|100860155|FG029|STARTED|Period 1 (Panel A and B)||0||
48217377|NCT01998958|100860156|FG030|STARTED|Period 1 (Panel A and B)||0||
48217378|NCT01998958|100860157|FG031|STARTED|Period 1 (Panel A and B)||0||
48060842|NCT01925274|100470300|FG002|NOT COMPLETED|Overall Study||6||
48060843|NCT00805948|100470301|FG000|STARTED|Overall Study||154||
48060844|NCT00805948|100470302|FG001|STARTED|Overall Study||195||
48060845|NCT00805948|100470301|FG000|COMPLETED|Overall Study||86||
48060846|NCT00805948|100470302|FG001|COMPLETED|Overall Study||99||
48060847|NCT00805948|100470301|FG000|NOT COMPLETED|Overall Study||68||
48060848|NCT00805948|100470302|FG001|NOT COMPLETED|Overall Study||96||
48060849|NCT00437320|100470303|FG000|STARTED|Overall Study||11||11
48060850|NCT00437320|100470304|FG001|STARTED|Overall Study||9||9
48060851|NCT00437320|100470305|FG002|STARTED|Overall Study||12||12
48060852|NCT00437320|100470303|FG000|Metvix Cream (1 Hour)|Overall Study||11||11
48060853|NCT00437320|100470304|FG001|Metvix Cream (1 Hour)|Overall Study||0||0
48060854|NCT00437320|100470305|FG002|Metvix Cream (1 Hour)|Overall Study||0||0
48060855|NCT00437320|100470303|FG000|Metvix Vehicle Cream (1 Hour)|Overall Study||11||11
48060856|NCT00437320|100470304|FG001|Metvix Vehicle Cream (1 Hour)|Overall Study||0||0
48060857|NCT00437320|100470305|FG002|Metvix Vehicle Cream (1 Hour)|Overall Study||0||0
48060858|NCT00437320|100470303|FG000|Metvix Cream (2 Hour)|Overall Study||0||0
48060859|NCT00437320|100470304|FG001|Metvix Cream (2 Hour)|Overall Study||9||9
48060860|NCT00437320|100470305|FG002|Metvix Cream (2 Hour)|Overall Study||0||0
48060861|NCT00437320|100470303|FG000|Metvix Vehicle Cream (2 Hour)|Overall Study||0||0
48060862|NCT00437320|100470304|FG001|Metvix Vehicle Cream (2 Hour)|Overall Study||9||9
48060863|NCT00437320|100470305|FG002|Metvix Vehicle Cream (2 Hour)|Overall Study||0||0
48060864|NCT00437320|100470303|FG000|Metvix Cream (3 Hour)|Overall Study||0||0
48060865|NCT00437320|100470304|FG001|Metvix Cream (3 Hour)|Overall Study||0||0
48060866|NCT00437320|100470305|FG002|Metvix Cream (3 Hour)|Overall Study||12||12
48060867|NCT00437320|100470303|FG000|Metvix Vehicle Cream (3 Hour)|Overall Study||0||0
48060868|NCT00437320|100470304|FG001|Metvix Vehicle Cream (3 Hour)|Overall Study||0||0
48060869|NCT00437320|100470305|FG002|Metvix Vehicle Cream (3 Hour)|Overall Study||12||12
48060870|NCT00437320|100470303|FG000|COMPLETED|Overall Study||9||9
48060871|NCT00437320|100470304|FG001|COMPLETED|Overall Study||8||8
48060872|NCT00437320|100470305|FG002|COMPLETED|Overall Study||8||8
48060873|NCT00437320|100470303|FG000|NOT COMPLETED|Overall Study||2||2
48060874|NCT00437320|100470304|FG001|NOT COMPLETED|Overall Study||1||1
48060875|NCT00437320|100470305|FG002|NOT COMPLETED|Overall Study||4||4
48060876|NCT03150160|100470306|FG000|STARTED|Overall Study||0||
48060877|NCT03150160|100470307|FG001|STARTED|Overall Study||1||
48060878|NCT03150160|100470306|FG000|COMPLETED|Overall Study||0||
48060879|NCT03150160|100470307|FG001|COMPLETED|Overall Study||1||
48060880|NCT03150160|100470306|FG000|NOT COMPLETED|Overall Study||0||
48060881|NCT03150160|100470307|FG001|NOT COMPLETED|Overall Study||0||
48060882|NCT04396665|100470308|FG000|STARTED|Overall Study||134||
48060883|NCT04396665|100470309|FG001|STARTED|Overall Study||90||
48060884|NCT04396665|100470308|FG000|COMPLETED|Overall Study||99||
48060885|NCT04396665|100470309|FG001|COMPLETED|Overall Study||83||
48060886|NCT04396665|100470308|FG000|NOT COMPLETED|Overall Study||35||
48060887|NCT04396665|100470309|FG001|NOT COMPLETED|Overall Study||7||
48060888|NCT02517866|100470310|FG000|STARTED|Overall Study||289||
48060889|NCT02517866|100470311|FG001|STARTED|Overall Study||90||
48060890|NCT02517866|100470312|FG002|STARTED|Overall Study||1||
48060891|NCT02517866|100470310|FG000|COMPLETED|Overall Study||269||
48060892|NCT02517866|100470311|FG001|COMPLETED|Overall Study||84||
48060893|NCT02517866|100470312|FG002|COMPLETED|Overall Study||1||
48060894|NCT02517866|100470310|FG000|NOT COMPLETED|Overall Study||20||
48060895|NCT02517866|100470311|FG001|NOT COMPLETED|Overall Study||6||
48060896|NCT02517866|100470312|FG002|NOT COMPLETED|Overall Study||0||
48060897|NCT01397201|100470313|FG000|STARTED|Overall Study||6||
48060898|NCT01397201|100470314|FG001|STARTED|Overall Study||6||
48060899|NCT01397201|100470315|FG002|STARTED|Overall Study||6||
48060900|NCT01397201|100470316|FG003|STARTED|Overall Study||7||
48060901|NCT01397201|100470317|FG004|STARTED|Overall Study||5||
48060902|NCT01397201|100470313|FG000|Treated|Overall Study||6||
48217379|NCT01998958|100860126|FG000|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||9||
48217380|NCT01998958|100860127|FG001|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
48217381|NCT01998958|100860128|FG002|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
48496276|NCT01923740|101548051|FG000|NOT COMPLETED|Overall Study||6||
48060903|NCT01397201|100470314|FG001|Treated|Overall Study||6||
48060904|NCT01397201|100470315|FG002|Treated|Overall Study||5||
48060905|NCT01397201|100470316|FG003|Treated|Overall Study||7||
48060906|NCT01397201|100470317|FG004|Treated|Overall Study||5||
48060907|NCT01397201|100470313|FG000|COMPLETED|Overall Study||1||
48060908|NCT01397201|100470314|FG001|COMPLETED|Overall Study||0||
48060909|NCT01397201|100470315|FG002|COMPLETED|Overall Study||0||
48060910|NCT01397201|100470316|FG003|COMPLETED|Overall Study||2||
48060911|NCT01397201|100470317|FG004|COMPLETED|Overall Study||1||
48060912|NCT01397201|100470313|FG000|NOT COMPLETED|Overall Study||5||
48060913|NCT01397201|100470314|FG001|NOT COMPLETED|Overall Study||6||
48060914|NCT01397201|100470315|FG002|NOT COMPLETED|Overall Study||6||
48060915|NCT01397201|100470316|FG003|NOT COMPLETED|Overall Study||5||
48060916|NCT01397201|100470317|FG004|NOT COMPLETED|Overall Study||4||
48060917|NCT00810693|100470318|FG000|STARTED|Treatment Period||254||
48060918|NCT00810693|100470319|FG001|STARTED|Treatment Period||64||
48060919|NCT00810693|100470320|FG002|STARTED|Treatment Period||127||
48060920|NCT00810693|100470318|FG000|Participants Received Treatment|Treatment Period||254||
48060921|NCT00810693|100470319|FG001|Participants Received Treatment|Treatment Period||63||
48060922|NCT00810693|100470320|FG002|Participants Received Treatment|Treatment Period||126||
48217382|NCT01998958|100860129|FG003|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
48217383|NCT01998958|100860130|FG004|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
48217384|NCT01998958|100860131|FG005|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
48217385|NCT01998958|100860132|FG006|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
48217386|NCT01998958|100860133|FG007|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
48217387|NCT01998958|100860134|FG008|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
48217388|NCT01998958|100860135|FG009|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
48217389|NCT01998958|100860136|FG010|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
48217390|NCT01998958|100860137|FG011|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
48217391|NCT01998958|100860138|FG012|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
48217392|NCT01998958|100860139|FG013|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
48217393|NCT01998958|100860140|FG014|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
48217394|NCT01998958|100860141|FG015|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
48217395|NCT01998958|100860142|FG016|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
48217396|NCT01998958|100860143|FG017|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
48217397|NCT01998958|100860144|FG018|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
48217398|NCT01998958|100860145|FG019|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
48217399|NCT01998958|100860146|FG020|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
48217400|NCT01998958|100860147|FG021|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
48217401|NCT01998958|100860148|FG022|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
48217402|NCT01998958|100860149|FG023|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
48217403|NCT01998958|100860150|FG024|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
48217404|NCT01998958|100860151|FG025|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
48217405|NCT01998958|100860152|FG026|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
48217406|NCT01998958|100860153|FG027|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
48217407|NCT01998958|100860154|FG028|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
48217408|NCT01998958|100860155|FG029|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
48217409|NCT01998958|100860156|FG030|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
48217410|NCT01998958|100860157|FG031|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
48217411|NCT01998958|100860126|FG000|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||8||
48217412|NCT01998958|100860127|FG001|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
48217413|NCT01998958|100860128|FG002|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
48217414|NCT01998958|100860129|FG003|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
48217415|NCT01998958|100860130|FG004|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
48217416|NCT01998958|100860131|FG005|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
48217417|NCT01998958|100860132|FG006|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
48217418|NCT01998958|100860133|FG007|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
48217419|NCT01998958|100860134|FG008|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
48217420|NCT01998958|100860135|FG009|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
48217421|NCT01998958|100860136|FG010|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
48217422|NCT01998958|100860137|FG011|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
48217423|NCT01998958|100860138|FG012|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
48217424|NCT01998958|100860139|FG013|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
48217425|NCT01998958|100860140|FG014|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
48217426|NCT01998958|100860141|FG015|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
48217427|NCT01998958|100860142|FG016|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
48217428|NCT01998958|100860143|FG017|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
48217429|NCT01998958|100860144|FG018|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
48217430|NCT01998958|100860145|FG019|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
48217431|NCT01998958|100860146|FG020|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
48217432|NCT01998958|100860147|FG021|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
48217433|NCT01998958|100860148|FG022|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
48217434|NCT01998958|100860149|FG023|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
48217435|NCT01998958|100860150|FG024|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
48217436|NCT01998958|100860151|FG025|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
48217437|NCT01998958|100860152|FG026|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
48060923|NCT00810693|100470318|FG000|COMPLETED|Treatment Period||237||
48217438|NCT01998958|100860153|FG027|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
48217439|NCT01998958|100860154|FG028|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
48217440|NCT01998958|100860155|FG029|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
48217441|NCT01998958|100860156|FG030|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
48217442|NCT01998958|100860157|FG031|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
48217443|NCT01998958|100860126|FG000|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||5||
48217444|NCT01998958|100860127|FG001|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
48217445|NCT01998958|100860128|FG002|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
48217446|NCT01998958|100860129|FG003|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
48217447|NCT01998958|100860130|FG004|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
48217448|NCT01998958|100860131|FG005|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
48217449|NCT01998958|100860132|FG006|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
48217450|NCT01998958|100860133|FG007|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
48217451|NCT01998958|100860134|FG008|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
48217452|NCT01998958|100860135|FG009|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
48217453|NCT01998958|100860136|FG010|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
48217454|NCT01998958|100860137|FG011|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
48217455|NCT01998958|100860138|FG012|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
48217456|NCT01998958|100860139|FG013|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
48217457|NCT01998958|100860140|FG014|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
48217458|NCT01998958|100860141|FG015|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
48217459|NCT01998958|100860142|FG016|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
48217460|NCT01998958|100860143|FG017|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
48217461|NCT01998958|100860144|FG018|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
48217462|NCT01998958|100860145|FG019|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
48217463|NCT01998958|100860146|FG020|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
48217464|NCT01998958|100860147|FG021|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
48217465|NCT01998958|100860148|FG022|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
48217466|NCT01998958|100860149|FG023|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
48217467|NCT01998958|100860150|FG024|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
48217468|NCT01998958|100860151|FG025|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
48217469|NCT01998958|100860152|FG026|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
48217470|NCT01998958|100860153|FG027|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
48217471|NCT01998958|100860154|FG028|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
48217472|NCT01998958|100860155|FG029|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
48217473|NCT01998958|100860156|FG030|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
48217474|NCT01998958|100860157|FG031|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
48217475|NCT01998958|100860126|FG000|COMPLETED|Period 1 (Panel A and B)||32||
48217476|NCT01998958|100860127|FG001|COMPLETED|Period 1 (Panel A and B)||8||
48217477|NCT01998958|100860128|FG002|COMPLETED|Period 1 (Panel A and B)||11||
48217478|NCT01998958|100860129|FG003|COMPLETED|Period 1 (Panel A and B)||12||
48217479|NCT01998958|100860130|FG004|COMPLETED|Period 1 (Panel A and B)||21||
48217480|NCT01998958|100860131|FG005|COMPLETED|Period 1 (Panel A and B)||11||
48217481|NCT01998958|100860132|FG006|COMPLETED|Period 1 (Panel A and B)||9||
48217482|NCT01998958|100860133|FG007|COMPLETED|Period 1 (Panel A and B)||0||
48217483|NCT01998958|100860134|FG008|COMPLETED|Period 1 (Panel A and B)||0||
48217484|NCT01998958|100860135|FG009|COMPLETED|Period 1 (Panel A and B)||0||
48217485|NCT01998958|100860136|FG010|COMPLETED|Period 1 (Panel A and B)||0||
48217486|NCT01998958|100860137|FG011|COMPLETED|Period 1 (Panel A and B)||0||
48217487|NCT01998958|100860138|FG012|COMPLETED|Period 1 (Panel A and B)||0||
48217488|NCT01998958|100860139|FG013|COMPLETED|Period 1 (Panel A and B)||0||
48217489|NCT01998958|100860140|FG014|COMPLETED|Period 1 (Panel A and B)||0||
48217490|NCT01998958|100860141|FG015|COMPLETED|Period 1 (Panel A and B)||0||
48217491|NCT01998958|100860142|FG016|COMPLETED|Period 1 (Panel A and B)||0||
48217492|NCT01998958|100860143|FG017|COMPLETED|Period 1 (Panel A and B)||0||
48217493|NCT01998958|100860144|FG018|COMPLETED|Period 1 (Panel A and B)||0||
48217494|NCT01998958|100860145|FG019|COMPLETED|Period 1 (Panel A and B)||0||
48217495|NCT01998958|100860146|FG020|COMPLETED|Period 1 (Panel A and B)||0||
48217496|NCT01998958|100860147|FG021|COMPLETED|Period 1 (Panel A and B)||0||
48217497|NCT01998958|100860148|FG022|COMPLETED|Period 1 (Panel A and B)||0||
48217498|NCT01998958|100860149|FG023|COMPLETED|Period 1 (Panel A and B)||0||
48217499|NCT01998958|100860150|FG024|COMPLETED|Period 1 (Panel A and B)||0||
48217500|NCT01998958|100860151|FG025|COMPLETED|Period 1 (Panel A and B)||0||
48217501|NCT01998958|100860152|FG026|COMPLETED|Period 1 (Panel A and B)||0||
48217502|NCT01998958|100860153|FG027|COMPLETED|Period 1 (Panel A and B)||0||
48217503|NCT01998958|100860154|FG028|COMPLETED|Period 1 (Panel A and B)||0||
48217504|NCT01998958|100860155|FG029|COMPLETED|Period 1 (Panel A and B)||0||
48217505|NCT01998958|100860156|FG030|COMPLETED|Period 1 (Panel A and B)||0||
48217506|NCT01998958|100860157|FG031|COMPLETED|Period 1 (Panel A and B)||0||
48217507|NCT01998958|100860126|FG000|NOT COMPLETED|Period 1 (Panel A and B)||1||
48217508|NCT01998958|100860127|FG001|NOT COMPLETED|Period 1 (Panel A and B)||3||
48217509|NCT01998958|100860128|FG002|NOT COMPLETED|Period 1 (Panel A and B)||0||
48217510|NCT01998958|100860129|FG003|NOT COMPLETED|Period 1 (Panel A and B)||0||
48217511|NCT01998958|100860130|FG004|NOT COMPLETED|Period 1 (Panel A and B)||0||
48217512|NCT01998958|100860131|FG005|NOT COMPLETED|Period 1 (Panel A and B)||0||
48217513|NCT01998958|100860132|FG006|NOT COMPLETED|Period 1 (Panel A and B)||0||
48217514|NCT01998958|100860133|FG007|NOT COMPLETED|Period 1 (Panel A and B)||0||
48217515|NCT01998958|100860134|FG008|NOT COMPLETED|Period 1 (Panel A and B)||0||
48217516|NCT01998958|100860135|FG009|NOT COMPLETED|Period 1 (Panel A and B)||0||
48217517|NCT01998958|100860136|FG010|NOT COMPLETED|Period 1 (Panel A and B)||0||
48217518|NCT01998958|100860137|FG011|NOT COMPLETED|Period 1 (Panel A and B)||0||
48217519|NCT01998958|100860138|FG012|NOT COMPLETED|Period 1 (Panel A and B)||0||
48217520|NCT01998958|100860139|FG013|NOT COMPLETED|Period 1 (Panel A and B)||0||
48217521|NCT01998958|100860140|FG014|NOT COMPLETED|Period 1 (Panel A and B)||0||
48217522|NCT01998958|100860141|FG015|NOT COMPLETED|Period 1 (Panel A and B)||0||
48217523|NCT01998958|100860142|FG016|NOT COMPLETED|Period 1 (Panel A and B)||0||
48217524|NCT01998958|100860143|FG017|NOT COMPLETED|Period 1 (Panel A and B)||0||
48217525|NCT01998958|100860144|FG018|NOT COMPLETED|Period 1 (Panel A and B)||0||
48217526|NCT01998958|100860145|FG019|NOT COMPLETED|Period 1 (Panel A and B)||0||
48217527|NCT01998958|100860146|FG020|NOT COMPLETED|Period 1 (Panel A and B)||0||
48496277|NCT01923740|101548052|FG001|NOT COMPLETED|Overall Study||9||
48496278|NCT00654186|101548053|FG000|STARTED|Overall Study||32||
48496279|NCT00654186|101548053|FG000|COMPLETED|Overall Study||27||
48496280|NCT00654186|101548053|FG000|NOT COMPLETED|Overall Study||5||
48496281|NCT04697173|101548054|FG000|STARTED|Overall Study||166||
48217528|NCT01998958|100860147|FG021|NOT COMPLETED|Period 1 (Panel A and B)||0||
48217529|NCT01998958|100860148|FG022|NOT COMPLETED|Period 1 (Panel A and B)||0||
48217530|NCT01998958|100860149|FG023|NOT COMPLETED|Period 1 (Panel A and B)||0||
48217531|NCT01998958|100860150|FG024|NOT COMPLETED|Period 1 (Panel A and B)||0||
48217532|NCT01998958|100860151|FG025|NOT COMPLETED|Period 1 (Panel A and B)||0||
48217533|NCT01998958|100860152|FG026|NOT COMPLETED|Period 1 (Panel A and B)||0||
48217534|NCT01998958|100860153|FG027|NOT COMPLETED|Period 1 (Panel A and B)||0||
48217535|NCT01998958|100860154|FG028|NOT COMPLETED|Period 1 (Panel A and B)||0||
48217536|NCT01998958|100860155|FG029|NOT COMPLETED|Period 1 (Panel A and B)||0||
48217537|NCT01998958|100860156|FG030|NOT COMPLETED|Period 1 (Panel A and B)||0||
48217538|NCT01998958|100860157|FG031|NOT COMPLETED|Period 1 (Panel A and B)||0||
48217539|NCT01998958|100860126|FG000|STARTED|Period 2 (Panel A and B)||0||
48217540|NCT01998958|100860127|FG001|STARTED|Period 2 (Panel A and B)||0||
48217541|NCT01998958|100860128|FG002|STARTED|Period 2 (Panel A and B)||0||
48217542|NCT01998958|100860129|FG003|STARTED|Period 2 (Panel A and B)||0||
48217543|NCT01998958|100860130|FG004|STARTED|Period 2 (Panel A and B)||0||
48217544|NCT01998958|100860131|FG005|STARTED|Period 2 (Panel A and B)||0||
48217545|NCT01998958|100860132|FG006|STARTED|Period 2 (Panel A and B)||0||
48217546|NCT01998958|100860133|FG007|STARTED|Period 2 (Panel A and B)||6||
48217547|NCT01998958|100860134|FG008|STARTED|Period 2 (Panel A and B)||4||
48217548|NCT01998958|100860135|FG009|STARTED|Period 2 (Panel A and B)||8||
48217549|NCT01998958|100860136|FG010|STARTED|Period 2 (Panel A and B)||9||
48217550|NCT01998958|100860137|FG011|STARTED|Period 2 (Panel A and B)||5||
48217551|NCT01998958|100860138|FG012|STARTED|Period 2 (Panel A and B)||8||
48217552|NCT01998958|100860139|FG013|STARTED|Period 2 (Panel A and B)||11||
48217553|NCT01998958|100860140|FG014|STARTED|Period 2 (Panel A and B)||12||
48217554|NCT01998958|100860141|FG015|STARTED|Period 2 (Panel A and B)||5||
48217555|NCT01998958|100860142|FG016|STARTED|Period 2 (Panel A and B)||8||
48217556|NCT01998958|100860143|FG017|STARTED|Period 2 (Panel A and B)||5||
48217557|NCT01998958|100860144|FG018|STARTED|Period 2 (Panel A and B)||3||
48217558|NCT01998958|100860145|FG019|STARTED|Period 2 (Panel A and B)||11||
48217559|NCT01998958|100860146|FG020|STARTED|Period 2 (Panel A and B)||9||
48217560|NCT01998958|100860147|FG021|STARTED|Period 2 (Panel A and B)||0||
48496282|NCT04697173|101548055|FG001|STARTED|Overall Study||167||
48217561|NCT01998958|100860148|FG022|STARTED|Period 2 (Panel A and B)||0||
48217562|NCT01998958|100860149|FG023|STARTED|Period 2 (Panel A and B)||0||
48217563|NCT01998958|100860150|FG024|STARTED|Period 2 (Panel A and B)||0||
48217564|NCT01998958|100860151|FG025|STARTED|Period 2 (Panel A and B)||0||
48217565|NCT01998958|100860152|FG026|STARTED|Period 2 (Panel A and B)||0||
48217566|NCT01998958|100860153|FG027|STARTED|Period 2 (Panel A and B)||0||
48217567|NCT01998958|100860154|FG028|STARTED|Period 2 (Panel A and B)||0||
48217568|NCT01998958|100860155|FG029|STARTED|Period 2 (Panel A and B)||0||
48217569|NCT01998958|100860156|FG030|STARTED|Period 2 (Panel A and B)||0||
48217570|NCT01998958|100860157|FG031|STARTED|Period 2 (Panel A and B)||0||
48217571|NCT01998958|100860126|FG000|COMPLETED|Period 2 (Panel A and B)||0||
48217572|NCT01998958|100860127|FG001|COMPLETED|Period 2 (Panel A and B)||0||
48217573|NCT01998958|100860128|FG002|COMPLETED|Period 2 (Panel A and B)||0||
48217574|NCT01998958|100860129|FG003|COMPLETED|Period 2 (Panel A and B)||0||
48217575|NCT01998958|100860130|FG004|COMPLETED|Period 2 (Panel A and B)||0||
48217576|NCT01998958|100860131|FG005|COMPLETED|Period 2 (Panel A and B)||0||
48217577|NCT01998958|100860132|FG006|COMPLETED|Period 2 (Panel A and B)||0||
48496283|NCT04697173|101548054|FG000|COMPLETED|Overall Study||132||
48496284|NCT04697173|101548055|FG001|COMPLETED|Overall Study||129||
48217578|NCT01998958|100860133|FG007|COMPLETED|Period 2 (Panel A and B)||6||
48217579|NCT01998958|100860134|FG008|COMPLETED|Period 2 (Panel A and B)||4||
48217580|NCT01998958|100860135|FG009|COMPLETED|Period 2 (Panel A and B)||8||
48217581|NCT01998958|100860136|FG010|COMPLETED|Period 2 (Panel A and B)||8||
48217582|NCT01998958|100860137|FG011|COMPLETED|Period 2 (Panel A and B)||5||
48217583|NCT01998958|100860138|FG012|COMPLETED|Period 2 (Panel A and B)||8||
48217584|NCT01998958|100860139|FG013|COMPLETED|Period 2 (Panel A and B)||11||
48217585|NCT01998958|100860140|FG014|COMPLETED|Period 2 (Panel A and B)||10||
48217586|NCT01998958|100860141|FG015|COMPLETED|Period 2 (Panel A and B)||5||
48217587|NCT01998958|100860142|FG016|COMPLETED|Period 2 (Panel A and B)||8||
48217588|NCT01998958|100860143|FG017|COMPLETED|Period 2 (Panel A and B)||5||
48217589|NCT01998958|100860144|FG018|COMPLETED|Period 2 (Panel A and B)||2||
48217590|NCT01998958|100860145|FG019|COMPLETED|Period 2 (Panel A and B)||11||
48217591|NCT01998958|100860146|FG020|COMPLETED|Period 2 (Panel A and B)||9||
48217592|NCT01998958|100860147|FG021|COMPLETED|Period 2 (Panel A and B)||0||
48217593|NCT01998958|100860148|FG022|COMPLETED|Period 2 (Panel A and B)||0||
48217594|NCT01998958|100860149|FG023|COMPLETED|Period 2 (Panel A and B)||0||
48217595|NCT01998958|100860150|FG024|COMPLETED|Period 2 (Panel A and B)||0||
48217596|NCT01998958|100860151|FG025|COMPLETED|Period 2 (Panel A and B)||0||
48217597|NCT01998958|100860152|FG026|COMPLETED|Period 2 (Panel A and B)||0||
48217598|NCT01998958|100860153|FG027|COMPLETED|Period 2 (Panel A and B)||0||
48217599|NCT01998958|100860154|FG028|COMPLETED|Period 2 (Panel A and B)||0||
48217600|NCT01998958|100860155|FG029|COMPLETED|Period 2 (Panel A and B)||0||
48217601|NCT01998958|100860156|FG030|COMPLETED|Period 2 (Panel A and B)||0||
48217602|NCT01998958|100860157|FG031|COMPLETED|Period 2 (Panel A and B)||0||
48217603|NCT01998958|100860126|FG000|NOT COMPLETED|Period 2 (Panel A and B)||0||
48217604|NCT01998958|100860127|FG001|NOT COMPLETED|Period 2 (Panel A and B)||0||
48217605|NCT01998958|100860128|FG002|NOT COMPLETED|Period 2 (Panel A and B)||0||
48217606|NCT01998958|100860129|FG003|NOT COMPLETED|Period 2 (Panel A and B)||0||
48217607|NCT01998958|100860130|FG004|NOT COMPLETED|Period 2 (Panel A and B)||0||
48217608|NCT01998958|100860131|FG005|NOT COMPLETED|Period 2 (Panel A and B)||0||
48217609|NCT01998958|100860132|FG006|NOT COMPLETED|Period 2 (Panel A and B)||0||
48217610|NCT01998958|100860133|FG007|NOT COMPLETED|Period 2 (Panel A and B)||0||
48217611|NCT01998958|100860134|FG008|NOT COMPLETED|Period 2 (Panel A and B)||0||
48217612|NCT01998958|100860135|FG009|NOT COMPLETED|Period 2 (Panel A and B)||0||
48217613|NCT01998958|100860136|FG010|NOT COMPLETED|Period 2 (Panel A and B)||1||
48217614|NCT01998958|100860137|FG011|NOT COMPLETED|Period 2 (Panel A and B)||0||
48217615|NCT01998958|100860138|FG012|NOT COMPLETED|Period 2 (Panel A and B)||0||
48217616|NCT01998958|100860139|FG013|NOT COMPLETED|Period 2 (Panel A and B)||0||
48217617|NCT01998958|100860140|FG014|NOT COMPLETED|Period 2 (Panel A and B)||2||
48217618|NCT01998958|100860141|FG015|NOT COMPLETED|Period 2 (Panel A and B)||0||
48217619|NCT01998958|100860142|FG016|NOT COMPLETED|Period 2 (Panel A and B)||0||
48217620|NCT01998958|100860143|FG017|NOT COMPLETED|Period 2 (Panel A and B)||0||
48217621|NCT01998958|100860144|FG018|NOT COMPLETED|Period 2 (Panel A and B)||1||
48217622|NCT01998958|100860145|FG019|NOT COMPLETED|Period 2 (Panel A and B)||0||
48217623|NCT01998958|100860146|FG020|NOT COMPLETED|Period 2 (Panel A and B)||0||
48217624|NCT01998958|100860147|FG021|NOT COMPLETED|Period 2 (Panel A and B)||0||
48217625|NCT01998958|100860148|FG022|NOT COMPLETED|Period 2 (Panel A and B)||0||
48217626|NCT01998958|100860149|FG023|NOT COMPLETED|Period 2 (Panel A and B)||0||
48217627|NCT01998958|100860150|FG024|NOT COMPLETED|Period 2 (Panel A and B)||0||
48217628|NCT01998958|100860151|FG025|NOT COMPLETED|Period 2 (Panel A and B)||0||
48217629|NCT01998958|100860152|FG026|NOT COMPLETED|Period 2 (Panel A and B)||0||
48217630|NCT01998958|100860153|FG027|NOT COMPLETED|Period 2 (Panel A and B)||0||
48217631|NCT01998958|100860154|FG028|NOT COMPLETED|Period 2 (Panel A and B)||0||
48217632|NCT01998958|100860155|FG029|NOT COMPLETED|Period 2 (Panel A and B)||0||
48217633|NCT01998958|100860156|FG030|NOT COMPLETED|Period 2 (Panel A and B)||0||
48217634|NCT01998958|100860157|FG031|NOT COMPLETED|Period 2 (Panel A and B)||0||
48217635|NCT01998958|100860126|FG000|STARTED|Open Label Phase (Optional)||0||
48217636|NCT01998958|100860127|FG001|STARTED|Open Label Phase (Optional)||0||
48217637|NCT01998958|100860128|FG002|STARTED|Open Label Phase (Optional)||0||
48217638|NCT01998958|100860129|FG003|STARTED|Open Label Phase (Optional)||0||
48217639|NCT01998958|100860130|FG004|STARTED|Open Label Phase (Optional)||0||
48217640|NCT01998958|100860131|FG005|STARTED|Open Label Phase (Optional)||0||
48217641|NCT01998958|100860132|FG006|STARTED|Open Label Phase (Optional)||0||
48217642|NCT01998958|100860133|FG007|STARTED|Open Label Phase (Optional)||0||
48217643|NCT01998958|100860134|FG008|STARTED|Open Label Phase (Optional)||0||
48217644|NCT01998958|100860135|FG009|STARTED|Open Label Phase (Optional)||0||
48217645|NCT01998958|100860136|FG010|STARTED|Open Label Phase (Optional)||0||
48217646|NCT01998958|100860137|FG011|STARTED|Open Label Phase (Optional)||0||
48217647|NCT01998958|100860138|FG012|STARTED|Open Label Phase (Optional)||0||
48217648|NCT01998958|100860139|FG013|STARTED|Open Label Phase (Optional)||0||
48217649|NCT01998958|100860140|FG014|STARTED|Open Label Phase (Optional)||0||
48217650|NCT01998958|100860141|FG015|STARTED|Open Label Phase (Optional)||0||
48217651|NCT01998958|100860142|FG016|STARTED|Open Label Phase (Optional)||0||
48496285|NCT04697173|101548054|FG000|NOT COMPLETED|Overall Study||34||
48217652|NCT01998958|100860143|FG017|STARTED|Open Label Phase (Optional)||0||
48217653|NCT01998958|100860144|FG018|STARTED|Open Label Phase (Optional)||0||
48217654|NCT01998958|100860145|FG019|STARTED|Open Label Phase (Optional)||0||
48217655|NCT01998958|100860146|FG020|STARTED|Open Label Phase (Optional)||0||
48217656|NCT01998958|100860147|FG021|STARTED|Open Label Phase (Optional)||10||
48217657|NCT01998958|100860148|FG022|STARTED|Open Label Phase (Optional)||20||
48217658|NCT01998958|100860149|FG023|STARTED|Open Label Phase (Optional)||27||
48217659|NCT01998958|100860150|FG024|STARTED|Open Label Phase (Optional)||13||
48217660|NCT01998958|100860151|FG025|STARTED|Open Label Phase (Optional)||7||
48217661|NCT01998958|100860152|FG026|STARTED|Open Label Phase (Optional)||19||
48217662|NCT01998958|100860153|FG027|STARTED|Open Label Phase (Optional)||0||
48217663|NCT01998958|100860154|FG028|STARTED|Open Label Phase (Optional)||0||
48217664|NCT01998958|100860155|FG029|STARTED|Open Label Phase (Optional)||0||
48217665|NCT01998958|100860156|FG030|STARTED|Open Label Phase (Optional)||0||
48217666|NCT01998958|100860157|FG031|STARTED|Open Label Phase (Optional)||0||
48217667|NCT01998958|100860126|FG000|COMPLETED|Open Label Phase (Optional)||0||
48217668|NCT01998958|100860127|FG001|COMPLETED|Open Label Phase (Optional)||0||
48217669|NCT01998958|100860128|FG002|COMPLETED|Open Label Phase (Optional)||0||
48217670|NCT01998958|100860129|FG003|COMPLETED|Open Label Phase (Optional)||0||
48217671|NCT01998958|100860130|FG004|COMPLETED|Open Label Phase (Optional)||0||
48217672|NCT01998958|100860131|FG005|COMPLETED|Open Label Phase (Optional)||0||
48217673|NCT01998958|100860132|FG006|COMPLETED|Open Label Phase (Optional)||0||
48217674|NCT01998958|100860133|FG007|COMPLETED|Open Label Phase (Optional)||0||
48217675|NCT01998958|100860134|FG008|COMPLETED|Open Label Phase (Optional)||0||
48217676|NCT01998958|100860135|FG009|COMPLETED|Open Label Phase (Optional)||0||
48217677|NCT01998958|100860136|FG010|COMPLETED|Open Label Phase (Optional)||0||
48217678|NCT01998958|100860137|FG011|COMPLETED|Open Label Phase (Optional)||0||
48217679|NCT01998958|100860138|FG012|COMPLETED|Open Label Phase (Optional)||0||
48217680|NCT01998958|100860139|FG013|COMPLETED|Open Label Phase (Optional)||0||
48217681|NCT01998958|100860140|FG014|COMPLETED|Open Label Phase (Optional)||0||
48217682|NCT01998958|100860141|FG015|COMPLETED|Open Label Phase (Optional)||0||
48217683|NCT01998958|100860142|FG016|COMPLETED|Open Label Phase (Optional)||0||
48217684|NCT01998958|100860143|FG017|COMPLETED|Open Label Phase (Optional)||0||
48217685|NCT01998958|100860144|FG018|COMPLETED|Open Label Phase (Optional)||0||
48217686|NCT01998958|100860145|FG019|COMPLETED|Open Label Phase (Optional)||0||
48217687|NCT01998958|100860146|FG020|COMPLETED|Open Label Phase (Optional)||0||
48217688|NCT01998958|100860147|FG021|COMPLETED|Open Label Phase (Optional)||7||
48217689|NCT01998958|100860148|FG022|COMPLETED|Open Label Phase (Optional)||11||
48217690|NCT01998958|100860149|FG023|COMPLETED|Open Label Phase (Optional)||23||
48217691|NCT01998958|100860150|FG024|COMPLETED|Open Label Phase (Optional)||13||
48217692|NCT01998958|100860151|FG025|COMPLETED|Open Label Phase (Optional)||7||
48217693|NCT01998958|100860152|FG026|COMPLETED|Open Label Phase (Optional)||19||
48217694|NCT01998958|100860153|FG027|COMPLETED|Open Label Phase (Optional)||0||
48217695|NCT01998958|100860154|FG028|COMPLETED|Open Label Phase (Optional)||0||
48217696|NCT01998958|100860155|FG029|COMPLETED|Open Label Phase (Optional)||0||
48217697|NCT01998958|100860156|FG030|COMPLETED|Open Label Phase (Optional)||0||
48217698|NCT01998958|100860157|FG031|COMPLETED|Open Label Phase (Optional)||0||
48217699|NCT01998958|100860126|FG000|NOT COMPLETED|Open Label Phase (Optional)||0||
48217700|NCT01998958|100860127|FG001|NOT COMPLETED|Open Label Phase (Optional)||0||
48217701|NCT01998958|100860128|FG002|NOT COMPLETED|Open Label Phase (Optional)||0||
48217702|NCT01998958|100860129|FG003|NOT COMPLETED|Open Label Phase (Optional)||0||
48217703|NCT01998958|100860130|FG004|NOT COMPLETED|Open Label Phase (Optional)||0||
48217704|NCT01998958|100860131|FG005|NOT COMPLETED|Open Label Phase (Optional)||0||
48217705|NCT01998958|100860132|FG006|NOT COMPLETED|Open Label Phase (Optional)||0||
48217706|NCT01998958|100860133|FG007|NOT COMPLETED|Open Label Phase (Optional)||0||
48217707|NCT01998958|100860134|FG008|NOT COMPLETED|Open Label Phase (Optional)||0||
48217708|NCT01998958|100860135|FG009|NOT COMPLETED|Open Label Phase (Optional)||0||
48217709|NCT01998958|100860136|FG010|NOT COMPLETED|Open Label Phase (Optional)||0||
48217710|NCT01998958|100860137|FG011|NOT COMPLETED|Open Label Phase (Optional)||0||
48217711|NCT01998958|100860138|FG012|NOT COMPLETED|Open Label Phase (Optional)||0||
48217712|NCT01998958|100860139|FG013|NOT COMPLETED|Open Label Phase (Optional)||0||
48496286|NCT04697173|101548055|FG001|NOT COMPLETED|Overall Study||38||
48496287|NCT00829712|101548056|FG000|STARTED|First Intervention||12||
48217713|NCT01998958|100860140|FG014|NOT COMPLETED|Open Label Phase (Optional)||0||
48217714|NCT01998958|100860141|FG015|NOT COMPLETED|Open Label Phase (Optional)||0||
48217715|NCT01998958|100860142|FG016|NOT COMPLETED|Open Label Phase (Optional)||0||
48217716|NCT01998958|100860143|FG017|NOT COMPLETED|Open Label Phase (Optional)||0||
48217717|NCT01998958|100860144|FG018|NOT COMPLETED|Open Label Phase (Optional)||0||
48217718|NCT01998958|100860145|FG019|NOT COMPLETED|Open Label Phase (Optional)||0||
48217719|NCT01998958|100860146|FG020|NOT COMPLETED|Open Label Phase (Optional)||0||
48217720|NCT01998958|100860147|FG021|NOT COMPLETED|Open Label Phase (Optional)||3||
48217721|NCT01998958|100860148|FG022|NOT COMPLETED|Open Label Phase (Optional)||9||
48217722|NCT01998958|100860149|FG023|NOT COMPLETED|Open Label Phase (Optional)||4||
48217723|NCT01998958|100860150|FG024|NOT COMPLETED|Open Label Phase (Optional)||0||
48217724|NCT01998958|100860151|FG025|NOT COMPLETED|Open Label Phase (Optional)||0||
48217725|NCT01998958|100860152|FG026|NOT COMPLETED|Open Label Phase (Optional)||0||
48217726|NCT01998958|100860153|FG027|NOT COMPLETED|Open Label Phase (Optional)||0||
48217727|NCT01998958|100860154|FG028|NOT COMPLETED|Open Label Phase (Optional)||0||
48217728|NCT01998958|100860155|FG029|NOT COMPLETED|Open Label Phase (Optional)||0||
48217729|NCT01998958|100860156|FG030|NOT COMPLETED|Open Label Phase (Optional)||0||
48217730|NCT01998958|100860157|FG031|NOT COMPLETED|Open Label Phase (Optional)||0||
48217731|NCT01998958|100860126|FG000|STARTED|Follow-up Phase||0||
48217732|NCT01998958|100860127|FG001|STARTED|Follow-up Phase||0||
48217733|NCT01998958|100860128|FG002|STARTED|Follow-up Phase||0||
48217734|NCT01998958|100860129|FG003|STARTED|Follow-up Phase||0||
48217735|NCT01998958|100860130|FG004|STARTED|Follow-up Phase||0||
48217736|NCT01998958|100860131|FG005|STARTED|Follow-up Phase||0||
48217737|NCT01998958|100860132|FG006|STARTED|Follow-up Phase||0||
48217738|NCT01998958|100860133|FG007|STARTED|Follow-up Phase||0||
48217739|NCT01998958|100860134|FG008|STARTED|Follow-up Phase||0||
48217740|NCT01998958|100860135|FG009|STARTED|Follow-up Phase||0||
48217741|NCT01998958|100860136|FG010|STARTED|Follow-up Phase||0||
48217742|NCT01998958|100860137|FG011|STARTED|Follow-up Phase||0||
48217743|NCT01998958|100860138|FG012|STARTED|Follow-up Phase||0||
48217744|NCT01998958|100860139|FG013|STARTED|Follow-up Phase||0||
48217745|NCT01998958|100860140|FG014|STARTED|Follow-up Phase||0||
48217746|NCT01998958|100860141|FG015|STARTED|Follow-up Phase||0||
48217747|NCT01998958|100860142|FG016|STARTED|Follow-up Phase||0||
48217748|NCT01998958|100860143|FG017|STARTED|Follow-up Phase||0||
48217749|NCT01998958|100860144|FG018|STARTED|Follow-up Phase||0||
48217750|NCT01998958|100860145|FG019|STARTED|Follow-up Phase||0||
48217751|NCT01998958|100860146|FG020|STARTED|Follow-up Phase||0||
48217752|NCT01998958|100860147|FG021|STARTED|Follow-up Phase||0||
48217753|NCT01998958|100860148|FG022|STARTED|Follow-up Phase||0||
48217754|NCT01998958|100860149|FG023|STARTED|Follow-up Phase||0||
48217755|NCT01998958|100860150|FG024|STARTED|Follow-up Phase||0||
48217756|NCT01998958|100860151|FG025|STARTED|Follow-up Phase||0||
48217757|NCT01998958|100860152|FG026|STARTED|Follow-up Phase||0||
48217758|NCT01998958|100860153|FG027|STARTED|Follow-up Phase||1||
48217759|NCT01998958|100860154|FG028|STARTED|Follow-up Phase||4||
48217760|NCT01998958|100860155|FG029|STARTED|Follow-up Phase||12||
48217761|NCT01998958|100860156|FG030|STARTED|Follow-up Phase||39||
48217762|NCT01998958|100860157|FG031|STARTED|Follow-up Phase||42||
48217763|NCT01998958|100860126|FG000|COMPLETED|Follow-up Phase||0||
48217764|NCT01998958|100860127|FG001|COMPLETED|Follow-up Phase||0||
48217765|NCT01998958|100860128|FG002|COMPLETED|Follow-up Phase||0||
48217766|NCT01998958|100860129|FG003|COMPLETED|Follow-up Phase||0||
48217767|NCT01998958|100860130|FG004|COMPLETED|Follow-up Phase||0||
48217768|NCT01998958|100860131|FG005|COMPLETED|Follow-up Phase||0||
48217769|NCT01998958|100860132|FG006|COMPLETED|Follow-up Phase||0||
48217770|NCT01998958|100860133|FG007|COMPLETED|Follow-up Phase||0||
48217771|NCT01998958|100860134|FG008|COMPLETED|Follow-up Phase||0||
48217772|NCT01998958|100860135|FG009|COMPLETED|Follow-up Phase||0||
48217773|NCT01998958|100860136|FG010|COMPLETED|Follow-up Phase||0||
48217774|NCT01998958|100860137|FG011|COMPLETED|Follow-up Phase||0||
48217775|NCT01998958|100860138|FG012|COMPLETED|Follow-up Phase||0||
48217776|NCT01998958|100860139|FG013|COMPLETED|Follow-up Phase||0||
48217777|NCT01998958|100860140|FG014|COMPLETED|Follow-up Phase||0||
48217778|NCT01998958|100860141|FG015|COMPLETED|Follow-up Phase||0||
48217779|NCT01998958|100860142|FG016|COMPLETED|Follow-up Phase||0||
48217780|NCT01998958|100860143|FG017|COMPLETED|Follow-up Phase||0||
48217781|NCT01998958|100860144|FG018|COMPLETED|Follow-up Phase||0||
48217782|NCT01998958|100860145|FG019|COMPLETED|Follow-up Phase||0||
48217783|NCT01998958|100860146|FG020|COMPLETED|Follow-up Phase||0||
48217784|NCT01998958|100860147|FG021|COMPLETED|Follow-up Phase||0||
48217785|NCT01998958|100860148|FG022|COMPLETED|Follow-up Phase||0||
48217786|NCT01998958|100860149|FG023|COMPLETED|Follow-up Phase||0||
48217787|NCT01998958|100860150|FG024|COMPLETED|Follow-up Phase||0||
48217788|NCT01998958|100860151|FG025|COMPLETED|Follow-up Phase||0||
48217789|NCT01998958|100860152|FG026|COMPLETED|Follow-up Phase||0||
48217790|NCT01998958|100860153|FG027|COMPLETED|Follow-up Phase||1||
48217791|NCT01998958|100860154|FG028|COMPLETED|Follow-up Phase||4||
48217792|NCT01998958|100860155|FG029|COMPLETED|Follow-up Phase||12||
48217793|NCT01998958|100860156|FG030|COMPLETED|Follow-up Phase||39||
48217794|NCT01998958|100860157|FG031|COMPLETED|Follow-up Phase||42||
48217795|NCT01998958|100860126|FG000|NOT COMPLETED|Follow-up Phase||0||
48217796|NCT01998958|100860127|FG001|NOT COMPLETED|Follow-up Phase||0||
48217797|NCT01998958|100860128|FG002|NOT COMPLETED|Follow-up Phase||0||
48217798|NCT01998958|100860129|FG003|NOT COMPLETED|Follow-up Phase||0||
48217799|NCT01998958|100860130|FG004|NOT COMPLETED|Follow-up Phase||0||
48217800|NCT01998958|100860131|FG005|NOT COMPLETED|Follow-up Phase||0||
48217801|NCT01998958|100860132|FG006|NOT COMPLETED|Follow-up Phase||0||
48217802|NCT01998958|100860133|FG007|NOT COMPLETED|Follow-up Phase||0||
48217803|NCT01998958|100860134|FG008|NOT COMPLETED|Follow-up Phase||0||
48217804|NCT01998958|100860135|FG009|NOT COMPLETED|Follow-up Phase||0||
48217805|NCT01998958|100860136|FG010|NOT COMPLETED|Follow-up Phase||0||
48217806|NCT01998958|100860137|FG011|NOT COMPLETED|Follow-up Phase||0||
48217807|NCT01998958|100860138|FG012|NOT COMPLETED|Follow-up Phase||0||
48217808|NCT01998958|100860139|FG013|NOT COMPLETED|Follow-up Phase||0||
48217809|NCT01998958|100860140|FG014|NOT COMPLETED|Follow-up Phase||0||
48217810|NCT01998958|100860141|FG015|NOT COMPLETED|Follow-up Phase||0||
48217811|NCT01998958|100860142|FG016|NOT COMPLETED|Follow-up Phase||0||
48217812|NCT01998958|100860143|FG017|NOT COMPLETED|Follow-up Phase||0||
48217813|NCT01998958|100860144|FG018|NOT COMPLETED|Follow-up Phase||0||
48217814|NCT01998958|100860145|FG019|NOT COMPLETED|Follow-up Phase||0||
48217815|NCT01998958|100860146|FG020|NOT COMPLETED|Follow-up Phase||0||
48217816|NCT01998958|100860147|FG021|NOT COMPLETED|Follow-up Phase||0||
48217817|NCT01998958|100860148|FG022|NOT COMPLETED|Follow-up Phase||0||
48217818|NCT01998958|100860149|FG023|NOT COMPLETED|Follow-up Phase||0||
48217819|NCT01998958|100860150|FG024|NOT COMPLETED|Follow-up Phase||0||
48217820|NCT01998958|100860151|FG025|NOT COMPLETED|Follow-up Phase||0||
48217821|NCT01998958|100860152|FG026|NOT COMPLETED|Follow-up Phase||0||
48217822|NCT01998958|100860153|FG027|NOT COMPLETED|Follow-up Phase||0||
48217823|NCT01998958|100860154|FG028|NOT COMPLETED|Follow-up Phase||0||
48217824|NCT01998958|100860155|FG029|NOT COMPLETED|Follow-up Phase||0||
48217825|NCT01998958|100860156|FG030|NOT COMPLETED|Follow-up Phase||0||
48217826|NCT01998958|100860157|FG031|NOT COMPLETED|Follow-up Phase||0||
48217827|NCT00402246|100860158|FG000|STARTED|Overall Study||1014||
48217828|NCT00402246|100860159|FG001|STARTED|Overall Study||983||
48217829|NCT00402246|100860158|FG000|COMPLETED|Overall Study||794||
48217830|NCT00402246|100860159|FG001|COMPLETED|Overall Study||749||
48217831|NCT00402246|100860158|FG000|NOT COMPLETED|Overall Study||220||
48217832|NCT00402246|100860159|FG001|NOT COMPLETED|Overall Study||234||
48217833|NCT04425863|100860160|FG000|STARTED|Overall Study||135||
48217834|NCT04425863|100860161|FG001|STARTED|Overall Study||12||
48217835|NCT04425863|100860162|FG002|STARTED|Overall Study||20||
48217836|NCT04425863|100860160|FG000|COMPLETED|Overall Study||135||
48217837|NCT04425863|100860161|FG001|COMPLETED|Overall Study||12||
48217838|NCT04425863|100860162|FG002|COMPLETED|Overall Study||19||
48217839|NCT04425863|100860160|FG000|NOT COMPLETED|Overall Study||0||
48217840|NCT04425863|100860161|FG001|NOT COMPLETED|Overall Study||0||
48217841|NCT04425863|100860162|FG002|NOT COMPLETED|Overall Study||1||
48217842|NCT01965665|100860163|FG000|STARTED|Overall Study||20||
48217843|NCT01965665|100860163|FG000|COMPLETED|Overall Study||19||
48217844|NCT01965665|100860163|FG000|NOT COMPLETED|Overall Study||1||
48217845|NCT01083316|100860164|FG000|STARTED|Overall Study||35||
48217846|NCT01083316|100860164|FG000|COMPLETED|Overall Study||32||
48217847|NCT01083316|100860164|FG000|NOT COMPLETED|Overall Study||3||
48217848|NCT05741489|100860165|FG000|STARTED|Overall Study||20||
48217849|NCT05741489|100860166|FG001|STARTED|Overall Study||20||
48217850|NCT05741489|100860165|FG000|COMPLETED|Overall Study||20||
48217851|NCT05741489|100860166|FG001|COMPLETED|Overall Study||18||
48217852|NCT05741489|100860165|FG000|NOT COMPLETED|Overall Study||0||
48217853|NCT05741489|100860166|FG001|NOT COMPLETED|Overall Study||2||
48217854|NCT04579250|100860167|FG000|STARTED|Overall Study||3||
48217855|NCT04579250|100860168|FG001|STARTED|Overall Study||14||
48217856|NCT04579250|100860169|FG002|STARTED|Overall Study||8||
48217857|NCT04579250|100860167|FG000|Received First Product Administration|Overall Study||3||
48217858|NCT04579250|100860168|FG001|Received First Product Administration|Overall Study||14||
48217859|NCT04579250|100860169|FG002|Received First Product Administration|Overall Study||8||
48217860|NCT04579250|100860167|FG000|Completed Product Administrations|Overall Study||3||
48217861|NCT04579250|100860168|FG001|Completed Product Administrations|Overall Study||14||
48217862|NCT04579250|100860169|FG002|Completed Product Administrations|Overall Study||8||
48217863|NCT04579250|100860167|FG000|COMPLETED|Overall Study||1||
48217864|NCT04579250|100860168|FG001|COMPLETED|Overall Study||11||
48217865|NCT04579250|100860169|FG002|COMPLETED|Overall Study||6||
48217866|NCT04579250|100860167|FG000|NOT COMPLETED|Overall Study||2||
48217867|NCT04579250|100860168|FG001|NOT COMPLETED|Overall Study||3||
48496288|NCT00829712|101548057|FG001|STARTED|First Intervention||12||
48496289|NCT00829712|101548056|FG000|COMPLETED|First Intervention||12||
48496290|NCT00829712|101548057|FG001|COMPLETED|First Intervention||12||
48496291|NCT00829712|101548056|FG000|NOT COMPLETED|First Intervention||0||
48217868|NCT04579250|100860169|FG002|NOT COMPLETED|Overall Study||2||
48217869|NCT00645359|100860170|FG000|STARTED|Overall Study||9||
48217870|NCT00645359|100860170|FG000|COMPLETED|Overall Study||9||
48217871|NCT00645359|100860170|FG000|NOT COMPLETED|Overall Study||0||
48217872|NCT02285114|100860171|FG000|STARTED|Overall Study||29||
48217873|NCT02285114|100860172|FG001|STARTED|Overall Study||9||
48217874|NCT02285114|100860173|FG002|STARTED|Overall Study||3||
48217875|NCT02285114|100860171|FG000|COMPLETED|Overall Study||7||
48217876|NCT02285114|100860172|FG001|COMPLETED|Overall Study||2||
48496292|NCT00829712|101548057|FG001|NOT COMPLETED|First Intervention||0||
48496293|NCT00829712|101548056|FG000|STARTED|Washout of 7 Days||12||
48496294|NCT00829712|101548057|FG001|STARTED|Washout of 7 Days||12||
48217877|NCT02285114|100860173|FG002|COMPLETED|Overall Study||0||
48217878|NCT02285114|100860171|FG000|NOT COMPLETED|Overall Study||22||
48217879|NCT02285114|100860172|FG001|NOT COMPLETED|Overall Study||7||
48217880|NCT02285114|100860173|FG002|NOT COMPLETED|Overall Study||3||
48217881|NCT02409667|100860174|FG000|STARTED|Treatment Period 1, Baseline to Week 24||1647||
48217882|NCT02409667|100860175|FG001|STARTED|Treatment Period 1, Baseline to Week 24||0||
48217883|NCT02409667|100860176|FG002|STARTED|Treatment Period 1, Baseline to Week 24||0||
48217884|NCT02409667|100860177|FG003|STARTED|Treatment Period 1, Baseline to Week 24||0||
48217885|NCT02409667|100860178|FG004|STARTED|Treatment Period 1, Baseline to Week 24||0||
48217886|NCT02409667|100860174|FG000|COMPLETED|Treatment Period 1, Baseline to Week 24||1526||
48217887|NCT02409667|100860175|FG001|COMPLETED|Treatment Period 1, Baseline to Week 24||0||
48217888|NCT02409667|100860176|FG002|COMPLETED|Treatment Period 1, Baseline to Week 24||0||
48217889|NCT02409667|100860177|FG003|COMPLETED|Treatment Period 1, Baseline to Week 24||0||
48217890|NCT02409667|100860178|FG004|COMPLETED|Treatment Period 1, Baseline to Week 24||0||
48217891|NCT02409667|100860174|FG000|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||121||
48217892|NCT02409667|100860175|FG001|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0||
48217893|NCT02409667|100860176|FG002|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0||
48217894|NCT02409667|100860177|FG003|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0||
48217895|NCT02409667|100860178|FG004|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0||
48217896|NCT02409667|100860174|FG000|STARTED|Treatment Period 2, Week 24 to Week 52)||0||
48217897|NCT02409667|100860175|FG001|STARTED|Treatment Period 2, Week 24 to Week 52)||644||
48217898|NCT02409667|100860176|FG002|STARTED|Treatment Period 2, Week 24 to Week 52)||662||
48217899|NCT02409667|100860177|FG003|STARTED|Treatment Period 2, Week 24 to Week 52)||114||
48217900|NCT02409667|100860178|FG004|STARTED|Treatment Period 2, Week 24 to Week 52)||93||
48217901|NCT02409667|100860174|FG000|COMPLETED|Treatment Period 2, Week 24 to Week 52)||0||
48217902|NCT02409667|100860175|FG001|COMPLETED|Treatment Period 2, Week 24 to Week 52)||621||
48217903|NCT02409667|100860176|FG002|COMPLETED|Treatment Period 2, Week 24 to Week 52)||641||
48217904|NCT02409667|100860177|FG003|COMPLETED|Treatment Period 2, Week 24 to Week 52)||106||
48217905|NCT02409667|100860178|FG004|COMPLETED|Treatment Period 2, Week 24 to Week 52)||90||
48217906|NCT02409667|100860174|FG000|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||0||
48217907|NCT02409667|100860175|FG001|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||23||
48217908|NCT02409667|100860176|FG002|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||21||
48217909|NCT02409667|100860177|FG003|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||8||
48217910|NCT02409667|100860178|FG004|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||3||
48217911|NCT02757898|100860179|FG000|STARTED|Overall Study||5||
48217912|NCT02757898|100860179|FG000|COMPLETED|Overall Study||5||
48217913|NCT02757898|100860179|FG000|NOT COMPLETED|Overall Study||0||
48217914|NCT03333109|100860180|FG000|STARTED|Double-blind Treatment Period (DBTP)||338||
48217915|NCT03333109|100860181|FG001|STARTED|Double-blind Treatment Period (DBTP)||224||
48217916|NCT03333109|100860182|FG002|STARTED|Double-blind Treatment Period (DBTP)||338||
48496295|NCT00829712|101548056|FG000|COMPLETED|Washout of 7 Days||12||
48496296|NCT00829712|101548057|FG001|COMPLETED|Washout of 7 Days||11||
48060924|NCT00810693|100470319|FG001|COMPLETED|Treatment Period||57||
48496297|NCT00829712|101548056|FG000|NOT COMPLETED|Washout of 7 Days||0||
48060925|NCT00810693|100470320|FG002|COMPLETED|Treatment Period||111||
48060926|NCT00810693|100470318|FG000|NOT COMPLETED|Treatment Period||17||
48060927|NCT00810693|100470319|FG001|NOT COMPLETED|Treatment Period||7||
48060928|NCT00810693|100470320|FG002|NOT COMPLETED|Treatment Period||16||
48060929|NCT00810693|100470318|FG000|STARTED|Follow-up Period (FUP)||23||
48060930|NCT00810693|100470319|FG001|STARTED|Follow-up Period (FUP)||7||
48060931|NCT00810693|100470320|FG002|STARTED|Follow-up Period (FUP)||16||
48060932|NCT00810693|100470318|FG000|COMPLETED|Follow-up Period (FUP)||15||
48060933|NCT00810693|100470319|FG001|COMPLETED|Follow-up Period (FUP)||4||
48060934|NCT00810693|100470320|FG002|COMPLETED|Follow-up Period (FUP)||12||
48060935|NCT00810693|100470318|FG000|NOT COMPLETED|Follow-up Period (FUP)||8||
48060936|NCT00810693|100470319|FG001|NOT COMPLETED|Follow-up Period (FUP)||3||
48060937|NCT00810693|100470320|FG002|NOT COMPLETED|Follow-up Period (FUP)||4||
48060938|NCT03161093|100470321|FG000|STARTED|Overall Study||354||
48060939|NCT03161093|100470322|FG001|STARTED|Overall Study||1063||
48060940|NCT03161093|100470323|FG002|STARTED|Overall Study||551||
48060941|NCT03161093|100470324|FG003|STARTED|Overall Study||1054||
48060942|NCT03161093|100470325|FG004|STARTED|Overall Study||145||
48060943|NCT03161093|100470326|FG005|STARTED|Overall Study||140||
48060944|NCT03161093|100470321|FG000|As Treated|Overall Study||352||
48060945|NCT03161093|100470322|FG001|As Treated|Overall Study||1056||
48060946|NCT03161093|100470323|FG002|As Treated|Overall Study||554||
48060947|NCT03161093|100470324|FG003|As Treated|Overall Study||1052||
48060948|NCT03161093|100470325|FG004|As Treated|Overall Study||145||
48060949|NCT03161093|100470326|FG005|As Treated|Overall Study||139||
48060950|NCT03161093|100470321|FG000|COMPLETED|Overall Study||299||
48060951|NCT03161093|100470322|FG001|COMPLETED|Overall Study||919||
48060952|NCT03161093|100470323|FG002|COMPLETED|Overall Study||465||
48060953|NCT03161093|100470324|FG003|COMPLETED|Overall Study||867||
48060954|NCT03161093|100470325|FG004|COMPLETED|Overall Study||102||
48060955|NCT03161093|100470326|FG005|COMPLETED|Overall Study||99||
48060956|NCT03161093|100470321|FG000|NOT COMPLETED|Overall Study||55||
48060957|NCT03161093|100470322|FG001|NOT COMPLETED|Overall Study||144||
48060958|NCT03161093|100470323|FG002|NOT COMPLETED|Overall Study||86||
48060959|NCT03161093|100470324|FG003|NOT COMPLETED|Overall Study||187||
48060960|NCT03161093|100470325|FG004|NOT COMPLETED|Overall Study||43||
48060961|NCT03161093|100470326|FG005|NOT COMPLETED|Overall Study||41||
48060962|NCT03802227|100470327|FG000|STARTED|Overall Study||4||
48060963|NCT03802227|100470328|FG001|STARTED|Overall Study||4||
48060964|NCT03802227|100470327|FG000|COMPLETED|Overall Study||4||
48060965|NCT03802227|100470328|FG001|COMPLETED|Overall Study||4||
48060966|NCT03802227|100470327|FG000|NOT COMPLETED|Overall Study||0||
48217917|NCT03333109|100860180|FG000|Full Analysis Set|Double-blind Treatment Period (DBTP)||329|All participants who started the study medication and completed at least one post-baseline efficacy measurement|
48217918|NCT03333109|100860181|FG001|Full Analysis Set|Double-blind Treatment Period (DBTP)||219|All participants who started the study medication and completed at least one post-baseline efficacy measurement|
48217919|NCT03333109|100860182|FG002|Full Analysis Set|Double-blind Treatment Period (DBTP)||330|All participants who started the study medication and completed at least one post-baseline efficacy measurement|
48217920|NCT03333109|100860180|FG000|Safety Analysis Set|Double-blind Treatment Period (DBTP)||335|Safety analysis set consisted of all randomized subjects who received at least one dose of investigational product and were analyzed based on the actual treatment received|
48217921|NCT03333109|100860181|FG001|Safety Analysis Set|Double-blind Treatment Period (DBTP)||224|Safety analysis set consisted of all randomized subjects who received at least one dose of investigational product and were analyzed based on the actual treatment received|
48217922|NCT03333109|100860182|FG002|Safety Analysis Set|Double-blind Treatment Period (DBTP)||335|Safety analysis set consisted of all randomized subjects who received at least one dose of investigational product and were analyzed based on the actual treatment received|
48217923|NCT03333109|100860180|FG000|COMPLETED|Double-blind Treatment Period (DBTP)||321||
48217924|NCT03333109|100860181|FG001|COMPLETED|Double-blind Treatment Period (DBTP)||218||
48217925|NCT03333109|100860182|FG002|COMPLETED|Double-blind Treatment Period (DBTP)||326||
48217926|NCT03333109|100860180|FG000|NOT COMPLETED|Double-blind Treatment Period (DBTP)||17||
48217927|NCT03333109|100860181|FG001|NOT COMPLETED|Double-blind Treatment Period (DBTP)||6||
48217928|NCT03333109|100860182|FG002|NOT COMPLETED|Double-blind Treatment Period (DBTP)||12||
48217929|NCT03333109|100860180|FG000|STARTED|Safety Follow-up Period||324||
48217930|NCT03333109|100860181|FG001|STARTED|Safety Follow-up Period||218||
48217931|NCT03333109|100860182|FG002|STARTED|Safety Follow-up Period||328||
48217932|NCT03333109|100860180|FG000|COMPLETED|Safety Follow-up Period||311||
48217933|NCT03333109|100860181|FG001|COMPLETED|Safety Follow-up Period||214||
48217934|NCT03333109|100860182|FG002|COMPLETED|Safety Follow-up Period||315||
48217935|NCT03333109|100860180|FG000|NOT COMPLETED|Safety Follow-up Period||13||
48217936|NCT03333109|100860181|FG001|NOT COMPLETED|Safety Follow-up Period||4||
48217937|NCT03333109|100860182|FG002|NOT COMPLETED|Safety Follow-up Period||13||
48217938|NCT00124735|100860183|FG000|STARTED|Overall Study||5||
48217939|NCT00124735|100860184|FG001|STARTED|Overall Study||8||
48217940|NCT00124735|100860185|FG002|STARTED|Overall Study||18||
48217941|NCT00124735|100860186|FG003|STARTED|Overall Study||21||
48217942|NCT00124735|100860187|FG004|STARTED|Overall Study||19||
48217943|NCT00124735|100860188|FG005|STARTED|Overall Study||7||
48217944|NCT00124735|100860189|FG006|STARTED|Overall Study||6||
48217945|NCT00124735|100860190|FG007|STARTED|Overall Study||20||
48217946|NCT00124735|100860191|FG008|STARTED|Overall Study||25||
48217947|NCT00124735|100860192|FG009|STARTED|Overall Study||20||
48217948|NCT00124735|100860183|FG000|COMPLETED|Overall Study||4||
48217949|NCT00124735|100860184|FG001|COMPLETED|Overall Study||6||
48217950|NCT00124735|100860185|FG002|COMPLETED|Overall Study||18||
48217951|NCT00124735|100860186|FG003|COMPLETED|Overall Study||18||
48217952|NCT00124735|100860187|FG004|COMPLETED|Overall Study||17||
48217953|NCT00124735|100860188|FG005|COMPLETED|Overall Study||5||
48217954|NCT00124735|100860189|FG006|COMPLETED|Overall Study||6||
48217955|NCT00124735|100860190|FG007|COMPLETED|Overall Study||19||
48217956|NCT00124735|100860191|FG008|COMPLETED|Overall Study||22||
48217957|NCT00124735|100860192|FG009|COMPLETED|Overall Study||18||
48217958|NCT00124735|100860183|FG000|NOT COMPLETED|Overall Study||1||
48217959|NCT00124735|100860184|FG001|NOT COMPLETED|Overall Study||2||
48217960|NCT00124735|100860185|FG002|NOT COMPLETED|Overall Study||0||
48217961|NCT00124735|100860186|FG003|NOT COMPLETED|Overall Study||3||
48217962|NCT00124735|100860187|FG004|NOT COMPLETED|Overall Study||2||
48217963|NCT00124735|100860188|FG005|NOT COMPLETED|Overall Study||2||
48217964|NCT00124735|100860189|FG006|NOT COMPLETED|Overall Study||0||
48217965|NCT00124735|100860190|FG007|NOT COMPLETED|Overall Study||1||
48217966|NCT00124735|100860191|FG008|NOT COMPLETED|Overall Study||3||
48217967|NCT00124735|100860192|FG009|NOT COMPLETED|Overall Study||2||
48217968|NCT02675244|100860193|FG000|STARTED|Overall Study||203||
48217969|NCT02675244|100860194|FG001|STARTED|Overall Study||198||
48217970|NCT02675244|100860193|FG000|COMPLETED|Overall Study||0||
48217971|NCT02675244|100860194|FG001|COMPLETED|Overall Study||0||
48217972|NCT02675244|100860193|FG000|NOT COMPLETED|Overall Study||203||
48217973|NCT02675244|100860194|FG001|NOT COMPLETED|Overall Study||198||
48217974|NCT01737021|100860195|FG000|STARTED|Overall Study||22||
48217975|NCT01737021|100860196|FG001|STARTED|Overall Study||9||
48217976|NCT01737021|100860195|FG000|COMPLETED|Overall Study||17||
48217977|NCT01737021|100860196|FG001|COMPLETED|Overall Study||6||
48217978|NCT01737021|100860195|FG000|NOT COMPLETED|Overall Study||5||
48217979|NCT01737021|100860196|FG001|NOT COMPLETED|Overall Study||3||
48217980|NCT01154192|100860197|FG000|STARTED|Overall Study||14||
48217981|NCT01154192|100860198|FG001|STARTED|Overall Study||10||
48217982|NCT01154192|100860199|FG002|STARTED|Overall Study||0||
48217983|NCT01154192|100860197|FG000|COMPLETED|Overall Study||14||
48217984|NCT01154192|100860198|FG001|COMPLETED|Overall Study||10||
48217985|NCT01154192|100860199|FG002|COMPLETED|Overall Study||0||
48217986|NCT01154192|100860197|FG000|NOT COMPLETED|Overall Study||0||
48217987|NCT01154192|100860198|FG001|NOT COMPLETED|Overall Study||0||
48217988|NCT01154192|100860199|FG002|NOT COMPLETED|Overall Study||0||
48217989|NCT02754596|100860200|FG000|STARTED|Overall Study||51||
48217990|NCT02754596|100860201|FG001|STARTED|Overall Study||54||
48217991|NCT02754596|100860202|FG002|STARTED|Overall Study||49||
48217992|NCT02754596|100860200|FG000|Month 3|Overall Study||51||
48217993|NCT02754596|100860201|FG001|Month 3|Overall Study||54||
48217994|NCT02754596|100860202|FG002|Month 3|Overall Study||49||
48217995|NCT02754596|100860200|FG000|COMPLETED|Overall Study||44||
48217996|NCT02754596|100860201|FG001|COMPLETED|Overall Study||46||
48217997|NCT02754596|100860202|FG002|COMPLETED|Overall Study||45||
48217998|NCT02754596|100860200|FG000|NOT COMPLETED|Overall Study||7||
48217999|NCT02754596|100860201|FG001|NOT COMPLETED|Overall Study||8||
48218000|NCT02754596|100860202|FG002|NOT COMPLETED|Overall Study||4||
48218001|NCT02766517|100860203|FG000|STARTED|Overall Study||19||
48218002|NCT02766517|100860204|FG001|STARTED|Overall Study||9||
48218003|NCT02766517|100860205|FG002|STARTED|Overall Study||9||
48218004|NCT02766517|100860203|FG000|COMPLETED|Overall Study||19||
48218005|NCT02766517|100860204|FG001|COMPLETED|Overall Study||9||
48218006|NCT02766517|100860205|FG002|COMPLETED|Overall Study||9||
48218007|NCT02766517|100860203|FG000|NOT COMPLETED|Overall Study||0||
48218008|NCT02766517|100860204|FG001|NOT COMPLETED|Overall Study||0||
48218009|NCT02766517|100860205|FG002|NOT COMPLETED|Overall Study||0||
48218010|NCT03838978|100860206|FG000|STARTED|Overall Study||81||
48218011|NCT03838978|100860207|FG001|STARTED|Overall Study||81||
48218012|NCT03838978|100860206|FG000|COMPLETED|Overall Study||73||
48218013|NCT03838978|100860207|FG001|COMPLETED|Overall Study||65||
48218014|NCT03838978|100860206|FG000|NOT COMPLETED|Overall Study||8||
48218015|NCT03838978|100860207|FG001|NOT COMPLETED|Overall Study||16||
48218016|NCT01943994|100860208|FG000|STARTED|Period 1: Initial Treatment (6 Months)||42||
48218017|NCT01943994|100860209|FG001|STARTED|Period 1: Initial Treatment (6 Months)||40||
48218018|NCT01943994|100860208|FG000|COMPLETED|Period 1: Initial Treatment (6 Months)||35||
48218019|NCT01943994|100860209|FG001|COMPLETED|Period 1: Initial Treatment (6 Months)||34||
48218020|NCT01943994|100860208|FG000|NOT COMPLETED|Period 1: Initial Treatment (6 Months)||7||
48218021|NCT01943994|100860209|FG001|NOT COMPLETED|Period 1: Initial Treatment (6 Months)||6||
48218022|NCT01943994|100860208|FG000|STARTED|Period 2: Optional Cross-over (6 Months)||35||
48218023|NCT01943994|100860209|FG001|STARTED|Period 2: Optional Cross-over (6 Months)||34||
48218024|NCT01943994|100860208|FG000|Participants Who Completed the Optional Cross-over Psilocybin Session|Period 2: Optional Cross-over (6 Months)||0||
48218025|NCT01943994|100860209|FG001|Participants Who Completed the Optional Cross-over Psilocybin Session|Period 2: Optional Cross-over (6 Months)||26||
48218026|NCT01943994|100860208|FG000|COMPLETED|Period 2: Optional Cross-over (6 Months)||34||
48218027|NCT01943994|100860209|FG001|COMPLETED|Period 2: Optional Cross-over (6 Months)||28||
48218028|NCT01943994|100860208|FG000|NOT COMPLETED|Period 2: Optional Cross-over (6 Months)||1||
48218029|NCT01943994|100860209|FG001|NOT COMPLETED|Period 2: Optional Cross-over (6 Months)||6||
48218030|NCT03257410|100860210|FG000|STARTED|Overall Study||86||
48218031|NCT03257410|100860211|FG001|STARTED|Overall Study||86||
48218032|NCT03257410|100860210|FG000|COMPLETED|Overall Study||65||
48218033|NCT03257410|100860211|FG001|COMPLETED|Overall Study||65||
48218034|NCT03257410|100860210|FG000|NOT COMPLETED|Overall Study||21||
48218035|NCT03257410|100860211|FG001|NOT COMPLETED|Overall Study||21||
48218036|NCT00538759|100860212|FG000|STARTED|Overall Study||13||
48218037|NCT00538759|100860213|FG001|STARTED|Overall Study||8||
48218038|NCT00538759|100860212|FG000|COMPLETED|Overall Study||13||
48218039|NCT00538759|100860213|FG001|COMPLETED|Overall Study||8||
48218040|NCT00538759|100860212|FG000|NOT COMPLETED|Overall Study||0||
48218041|NCT00538759|100860213|FG001|NOT COMPLETED|Overall Study||0||
48218042|NCT03387189|100860214|FG000|STARTED|Pre-Simulation (7/1/2016 to 12/31/2017)||99||
48218043|NCT03387189|100860215|FG001|STARTED|Pre-Simulation (7/1/2016 to 12/31/2017)||106||
48218044|NCT03387189|100860216|FG002|STARTED|Pre-Simulation (7/1/2016 to 12/31/2017)||0||
48218045|NCT03387189|100860217|FG003|STARTED|Pre-Simulation (7/1/2016 to 12/31/2017)||0||
48218046|NCT03387189|100860214|FG000|COMPLETED|Pre-Simulation (7/1/2016 to 12/31/2017)||99||
48218047|NCT03387189|100860215|FG001|COMPLETED|Pre-Simulation (7/1/2016 to 12/31/2017)||106||
48218048|NCT03387189|100860216|FG002|COMPLETED|Pre-Simulation (7/1/2016 to 12/31/2017)||0||
48218049|NCT03387189|100860217|FG003|COMPLETED|Pre-Simulation (7/1/2016 to 12/31/2017)||0||
48218050|NCT03387189|100860214|FG000|NOT COMPLETED|Pre-Simulation (7/1/2016 to 12/31/2017)||0||
48218051|NCT03387189|100860215|FG001|NOT COMPLETED|Pre-Simulation (7/1/2016 to 12/31/2017)||0||
48218052|NCT03387189|100860216|FG002|NOT COMPLETED|Pre-Simulation (7/1/2016 to 12/31/2017)||0||
48218053|NCT03387189|100860217|FG003|NOT COMPLETED|Pre-Simulation (7/1/2016 to 12/31/2017)||0||
48218054|NCT03387189|100860214|FG000|STARTED|Post-Simulation (1/1/2018 to 6/30/2019)||0||
48218055|NCT03387189|100860215|FG001|STARTED|Post-Simulation (1/1/2018 to 6/30/2019)||0||
48218056|NCT03387189|100860216|FG002|STARTED|Post-Simulation (1/1/2018 to 6/30/2019)||73||
48218057|NCT03387189|100860217|FG003|STARTED|Post-Simulation (1/1/2018 to 6/30/2019)||131||
48218058|NCT03387189|100860214|FG000|COMPLETED|Post-Simulation (1/1/2018 to 6/30/2019)||0||
48218059|NCT03387189|100860215|FG001|COMPLETED|Post-Simulation (1/1/2018 to 6/30/2019)||0||
48218060|NCT03387189|100860216|FG002|COMPLETED|Post-Simulation (1/1/2018 to 6/30/2019)||73||
48218061|NCT03387189|100860217|FG003|COMPLETED|Post-Simulation (1/1/2018 to 6/30/2019)||131||
48218062|NCT03387189|100860214|FG000|NOT COMPLETED|Post-Simulation (1/1/2018 to 6/30/2019)||0||
48218063|NCT03387189|100860215|FG001|NOT COMPLETED|Post-Simulation (1/1/2018 to 6/30/2019)||0||
48218064|NCT03387189|100860216|FG002|NOT COMPLETED|Post-Simulation (1/1/2018 to 6/30/2019)||0||
48218065|NCT03387189|100860217|FG003|NOT COMPLETED|Post-Simulation (1/1/2018 to 6/30/2019)||0||
48218066|NCT02438137|100860218|FG000|STARTED|Overall Study||44||
48218067|NCT02438137|100860219|FG001|STARTED|Overall Study||21||
48218068|NCT02438137|100860218|FG000|COMPLETED|Overall Study||36||
48218069|NCT02438137|100860219|FG001|COMPLETED|Overall Study||15||
48218070|NCT02438137|100860218|FG000|NOT COMPLETED|Overall Study||8||
48218071|NCT02438137|100860219|FG001|NOT COMPLETED|Overall Study||6||
48218072|NCT02500758|100860220|FG000|STARTED|First Intervention (2 Minutes)||15||
48218073|NCT02500758|100860221|FG001|STARTED|First Intervention (2 Minutes)||15||
48218074|NCT02500758|100860220|FG000|COMPLETED|First Intervention (2 Minutes)||15||
48218075|NCT02500758|100860221|FG001|COMPLETED|First Intervention (2 Minutes)||14||
48218076|NCT02500758|100860220|FG000|NOT COMPLETED|First Intervention (2 Minutes)||0||
48218077|NCT02500758|100860221|FG001|NOT COMPLETED|First Intervention (2 Minutes)||1||
48218078|NCT02500758|100860220|FG000|STARTED|Washout (1 Week)||15||
48218079|NCT02500758|100860221|FG001|STARTED|Washout (1 Week)||14||
48218080|NCT02500758|100860220|FG000|COMPLETED|Washout (1 Week)||13||
48218081|NCT02500758|100860221|FG001|COMPLETED|Washout (1 Week)||12||
48218082|NCT02500758|100860220|FG000|NOT COMPLETED|Washout (1 Week)||2||
48218083|NCT02500758|100860221|FG001|NOT COMPLETED|Washout (1 Week)||2||
48218084|NCT02500758|100860220|FG000|STARTED|Second Intervention (2 Minutes)||13||
48218085|NCT02500758|100860221|FG001|STARTED|Second Intervention (2 Minutes)||12||
48218086|NCT02500758|100860220|FG000|COMPLETED|Second Intervention (2 Minutes)||10||
48218087|NCT02500758|100860221|FG001|COMPLETED|Second Intervention (2 Minutes)||10||
48218088|NCT02500758|100860220|FG000|NOT COMPLETED|Second Intervention (2 Minutes)||3||
48218089|NCT02500758|100860221|FG001|NOT COMPLETED|Second Intervention (2 Minutes)||2||
48218090|NCT02641912|100860222|FG000|STARTED|Overall Study||53||
48218091|NCT02641912|100860223|FG001|STARTED|Overall Study||47||
48218092|NCT02641912|100860222|FG000|COMPLETED|Overall Study||53||
48218093|NCT02641912|100860223|FG001|COMPLETED|Overall Study||47||
48218094|NCT02641912|100860222|FG000|NOT COMPLETED|Overall Study||0||
48218095|NCT02641912|100860223|FG001|NOT COMPLETED|Overall Study||0||
48218096|NCT04541303|100860224|FG000|STARTED|Overall Study||62||
48218097|NCT04541303|100860225|FG001|STARTED|Overall Study||62||
48218098|NCT04541303|100860224|FG000|COMPLETED|Overall Study||62||
48218099|NCT04541303|100860225|FG001|COMPLETED|Overall Study||62||
48218100|NCT04541303|100860224|FG000|NOT COMPLETED|Overall Study||0||
48218101|NCT04541303|100860225|FG001|NOT COMPLETED|Overall Study||0||
48218102|NCT01205048|100860226|FG000|STARTED|Overall Study||170||
48218103|NCT01205048|100860226|FG000|Emervel Classic Lidocaine in Left NLF Followed by Juvederm Ultra in Right NLF|Overall Study||84||
48218104|NCT01205048|100860226|FG000|Juvederm Ultra in Left NLF Followed by Emervel Classic Lidocaine in Right NLF|Overall Study||86||
48218105|NCT01205048|100860226|FG000|COMPLETED|Overall Study||149||
48218106|NCT01205048|100860226|FG000|NOT COMPLETED|Overall Study||21||
48218107|NCT04119063|100860227|FG000|STARTED|Overall Study||6||
48218108|NCT04119063|100860227|FG000|COMPLETED|Overall Study||6||
48218109|NCT04119063|100860227|FG000|NOT COMPLETED|Overall Study||0||
48218110|NCT00455650|100860228|FG000|STARTED|Week 1||10||
48218111|NCT00455650|100860229|FG001|STARTED|Week 1||10||
48218112|NCT00455650|100860230|FG002|STARTED|Week 1||10||
48218113|NCT00455650|100860231|FG003|STARTED|Week 1||14||
48218114|NCT00455650|100860232|FG004|STARTED|Week 1||14||
48218115|NCT00455650|100860233|FG005|STARTED|Week 1||13||
48218116|NCT00455650|100860228|FG000|COMPLETED|Week 1||10||
48218117|NCT00455650|100860229|FG001|COMPLETED|Week 1||10||
48218118|NCT00455650|100860230|FG002|COMPLETED|Week 1||10||
48218119|NCT00455650|100860231|FG003|COMPLETED|Week 1||14||
48218120|NCT00455650|100860232|FG004|COMPLETED|Week 1||14||
48218121|NCT00455650|100860233|FG005|COMPLETED|Week 1||13||
48218122|NCT00455650|100860228|FG000|NOT COMPLETED|Week 1||0||
48060967|NCT03802227|100470328|FG001|NOT COMPLETED|Overall Study||0||
48218123|NCT00455650|100860229|FG001|NOT COMPLETED|Week 1||0||
48060968|NCT00237185|100470329|FG000|STARTED|Core||74||
48218124|NCT00455650|100860230|FG002|NOT COMPLETED|Week 1||0||
48218125|NCT00455650|100860231|FG003|NOT COMPLETED|Week 1||0||
48218126|NCT00455650|100860232|FG004|NOT COMPLETED|Week 1||0||
48218127|NCT00455650|100860233|FG005|NOT COMPLETED|Week 1||0||
48218128|NCT00455650|100860228|FG000|STARTED|Week 2||10||
48218129|NCT00455650|100860229|FG001|STARTED|Week 2||10||
48218130|NCT00455650|100860230|FG002|STARTED|Week 2||10||
48218131|NCT00455650|100860231|FG003|STARTED|Week 2||14||
48218132|NCT00455650|100860232|FG004|STARTED|Week 2||14||
48218133|NCT00455650|100860233|FG005|STARTED|Week 2||13||
48218134|NCT00455650|100860228|FG000|COMPLETED|Week 2||10||
48218135|NCT00455650|100860229|FG001|COMPLETED|Week 2||10||
48218136|NCT00455650|100860230|FG002|COMPLETED|Week 2||10||
48218137|NCT00455650|100860231|FG003|COMPLETED|Week 2||14||
48218138|NCT00455650|100860232|FG004|COMPLETED|Week 2||14||
48218139|NCT00455650|100860233|FG005|COMPLETED|Week 2||13||
48218140|NCT00455650|100860228|FG000|NOT COMPLETED|Week 2||0||
48218141|NCT00455650|100860229|FG001|NOT COMPLETED|Week 2||0||
48218142|NCT00455650|100860230|FG002|NOT COMPLETED|Week 2||0||
48218143|NCT00455650|100860231|FG003|NOT COMPLETED|Week 2||0||
48218144|NCT00455650|100860232|FG004|NOT COMPLETED|Week 2||0||
48218145|NCT00455650|100860233|FG005|NOT COMPLETED|Week 2||0||
48218146|NCT00455650|100860228|FG000|STARTED|Week 3||10||
48218147|NCT00455650|100860229|FG001|STARTED|Week 3||10||
48218148|NCT00455650|100860230|FG002|STARTED|Week 3||10||
48218149|NCT00455650|100860231|FG003|STARTED|Week 3||14||
48218150|NCT00455650|100860232|FG004|STARTED|Week 3||14||
48218151|NCT00455650|100860233|FG005|STARTED|Week 3||13||
48218152|NCT00455650|100860228|FG000|COMPLETED|Week 3||10||
48218153|NCT00455650|100860229|FG001|COMPLETED|Week 3||10||
48218154|NCT00455650|100860230|FG002|COMPLETED|Week 3||10||
48218155|NCT00455650|100860231|FG003|COMPLETED|Week 3||14||
48218156|NCT00455650|100860232|FG004|COMPLETED|Week 3||14||
48218157|NCT00455650|100860233|FG005|COMPLETED|Week 3||13||
48218158|NCT00455650|100860228|FG000|NOT COMPLETED|Week 3||0||
48218159|NCT00455650|100860229|FG001|NOT COMPLETED|Week 3||0||
48218160|NCT00455650|100860230|FG002|NOT COMPLETED|Week 3||0||
48218161|NCT00455650|100860231|FG003|NOT COMPLETED|Week 3||0||
48218162|NCT00455650|100860232|FG004|NOT COMPLETED|Week 3||0||
48218163|NCT00455650|100860233|FG005|NOT COMPLETED|Week 3||0||
48218164|NCT00804648|100860234|FG000|STARTED|First Intervention||3||
48218165|NCT00804648|100860235|FG001|STARTED|First Intervention||5||
48218166|NCT00804648|100860236|FG002|STARTED|First Intervention||6||
48218167|NCT00804648|100860237|FG003|STARTED|First Intervention||4||
48218168|NCT00804648|100860238|FG004|STARTED|First Intervention||4||
48218169|NCT00804648|100860239|FG005|STARTED|First Intervention||8||
48218170|NCT00804648|100860234|FG000|COMPLETED|First Intervention||3||
48218171|NCT00804648|100860235|FG001|COMPLETED|First Intervention||5||
48218172|NCT00804648|100860236|FG002|COMPLETED|First Intervention||6||
48218173|NCT00804648|100860237|FG003|COMPLETED|First Intervention||4||
48218174|NCT00804648|100860238|FG004|COMPLETED|First Intervention||4||
48218175|NCT00804648|100860239|FG005|COMPLETED|First Intervention||8||
48218176|NCT00804648|100860234|FG000|NOT COMPLETED|First Intervention||0||
48218177|NCT00804648|100860235|FG001|NOT COMPLETED|First Intervention||0||
48218178|NCT00804648|100860236|FG002|NOT COMPLETED|First Intervention||0||
48218179|NCT00804648|100860237|FG003|NOT COMPLETED|First Intervention||0||
48218180|NCT00804648|100860238|FG004|NOT COMPLETED|First Intervention||0||
48218181|NCT00804648|100860239|FG005|NOT COMPLETED|First Intervention||0||
48218182|NCT00804648|100860234|FG000|STARTED|Second Intervention||3||
48218183|NCT00804648|100860235|FG001|STARTED|Second Intervention||5||
48218184|NCT00804648|100860236|FG002|STARTED|Second Intervention||6||
48218185|NCT00804648|100860237|FG003|STARTED|Second Intervention||4||
48218186|NCT00804648|100860238|FG004|STARTED|Second Intervention||4||
48218187|NCT00804648|100860239|FG005|STARTED|Second Intervention||8||
48218188|NCT00804648|100860234|FG000|COMPLETED|Second Intervention||3||
48218189|NCT00804648|100860235|FG001|COMPLETED|Second Intervention||5||
48218190|NCT00804648|100860236|FG002|COMPLETED|Second Intervention||6||
48218191|NCT00804648|100860237|FG003|COMPLETED|Second Intervention||4||
48218192|NCT00804648|100860238|FG004|COMPLETED|Second Intervention||4||
48218193|NCT00804648|100860239|FG005|COMPLETED|Second Intervention||8||
48218194|NCT00804648|100860234|FG000|NOT COMPLETED|Second Intervention||0||
48218195|NCT00804648|100860235|FG001|NOT COMPLETED|Second Intervention||0||
48218196|NCT00804648|100860236|FG002|NOT COMPLETED|Second Intervention||0||
48218197|NCT00804648|100860237|FG003|NOT COMPLETED|Second Intervention||0||
48218198|NCT00804648|100860238|FG004|NOT COMPLETED|Second Intervention||0||
48218199|NCT00804648|100860239|FG005|NOT COMPLETED|Second Intervention||0||
48218200|NCT00804648|100860234|FG000|STARTED|Third Invervention||3||
48496298|NCT00829712|101548057|FG001|NOT COMPLETED|Washout of 7 Days||1||
48218201|NCT00804648|100860235|FG001|STARTED|Third Invervention||5||
48218202|NCT00804648|100860236|FG002|STARTED|Third Invervention||6||
48218203|NCT00804648|100860237|FG003|STARTED|Third Invervention||4||
48218204|NCT00804648|100860238|FG004|STARTED|Third Invervention||4||
48218205|NCT00804648|100860239|FG005|STARTED|Third Invervention||8||
48218206|NCT00804648|100860234|FG000|COMPLETED|Third Invervention||3||
48218207|NCT00804648|100860235|FG001|COMPLETED|Third Invervention||5||
48218208|NCT00804648|100860236|FG002|COMPLETED|Third Invervention||6||
48218209|NCT00804648|100860237|FG003|COMPLETED|Third Invervention||4||
48218210|NCT00804648|100860238|FG004|COMPLETED|Third Invervention||4||
48218211|NCT00804648|100860239|FG005|COMPLETED|Third Invervention||8||
48218212|NCT00804648|100860234|FG000|NOT COMPLETED|Third Invervention||0||
48218213|NCT00804648|100860235|FG001|NOT COMPLETED|Third Invervention||0||
48218214|NCT00804648|100860236|FG002|NOT COMPLETED|Third Invervention||0||
48218215|NCT00804648|100860237|FG003|NOT COMPLETED|Third Invervention||0||
48218216|NCT00804648|100860238|FG004|NOT COMPLETED|Third Invervention||0||
48218217|NCT00804648|100860239|FG005|NOT COMPLETED|Third Invervention||0||
48218218|NCT01036724|100860240|FG000|STARTED|Overall Study||52||
48218219|NCT01036724|100860241|FG001|STARTED|Overall Study||55||
48496299|NCT00829712|101548056|FG000|STARTED|Second Intervention||12||
48496300|NCT00829712|101548057|FG001|STARTED|Second Intervention||11||
48496301|NCT00829712|101548056|FG000|COMPLETED|Second Intervention||12||
48496302|NCT00829712|101548057|FG001|COMPLETED|Second Intervention||11||
48218220|NCT01036724|100860240|FG000|COMPLETED|Overall Study||46||
48218221|NCT01036724|100860241|FG001|COMPLETED|Overall Study||47||
48218222|NCT01036724|100860240|FG000|NOT COMPLETED|Overall Study||6||
48218223|NCT01036724|100860241|FG001|NOT COMPLETED|Overall Study||8||
48218224|NCT00071799|100860242|FG000|STARTED|Overall Study||179||
48218225|NCT00071799|100860243|FG001|STARTED|Overall Study||179||
48218226|NCT00071799|100860242|FG000|COMPLETED|Overall Study||109||
48218227|NCT00071799|100860243|FG001|COMPLETED|Overall Study||81||
48218228|NCT00071799|100860242|FG000|NOT COMPLETED|Overall Study||70||
48218229|NCT00071799|100860243|FG001|NOT COMPLETED|Overall Study||98||
48218230|NCT00215787|100860244|FG000|STARTED|Overall Study||20||
48218231|NCT00215787|100860244|FG000|COMPLETED|Overall Study||20||
48218232|NCT00215787|100860244|FG000|NOT COMPLETED|Overall Study||0||
48218233|NCT02169869|100860245|FG000|STARTED|Overall Study||17||
48218234|NCT02169869|100860246|FG001|STARTED|Overall Study||16||
48218235|NCT02169869|100860245|FG000|COMPLETED|Overall Study||17||
48218236|NCT02169869|100860246|FG001|COMPLETED|Overall Study||16||
48218237|NCT02169869|100860245|FG000|NOT COMPLETED|Overall Study||0||
48218238|NCT02169869|100860246|FG001|NOT COMPLETED|Overall Study||0||
48218239|NCT01532388|100860247|FG000|STARTED|3-month Follow-up||101||
48218240|NCT01532388|100860248|FG001|STARTED|3-month Follow-up||101||
48218241|NCT01532388|100860247|FG000|COMPLETED|3-month Follow-up||33||
48218242|NCT01532388|100860248|FG001|COMPLETED|3-month Follow-up||33||
48218243|NCT01532388|100860247|FG000|NOT COMPLETED|3-month Follow-up||68||
48218244|NCT01532388|100860248|FG001|NOT COMPLETED|3-month Follow-up||68||
48218245|NCT01532388|100860247|FG000|STARTED|6-month Follow-up||101||
48218246|NCT01532388|100860248|FG001|STARTED|6-month Follow-up||101||
48218247|NCT01532388|100860247|FG000|COMPLETED|6-month Follow-up||27||
48218248|NCT01532388|100860248|FG001|COMPLETED|6-month Follow-up||35||
48218249|NCT01532388|100860247|FG000|NOT COMPLETED|6-month Follow-up||74||
48218250|NCT01532388|100860248|FG001|NOT COMPLETED|6-month Follow-up||66||
48218251|NCT01532388|100860247|FG000|STARTED|12-month Follow-up||101||
48218252|NCT01532388|100860248|FG001|STARTED|12-month Follow-up||101||
48218253|NCT01532388|100860247|FG000|COMPLETED|12-month Follow-up||32||
48218254|NCT01532388|100860248|FG001|COMPLETED|12-month Follow-up||34||
48218255|NCT01532388|100860247|FG000|NOT COMPLETED|12-month Follow-up||69||
48218256|NCT01532388|100860248|FG001|NOT COMPLETED|12-month Follow-up||67||
48218257|NCT00324350|100860249|FG000|STARTED|Overall Study||3655||
48218258|NCT00324350|100860250|FG001|STARTED|Overall Study||3632||
48218259|NCT00324350|100860249|FG000|Non-Vertebral Fracture Follow-Up|Overall Study||3655||
48218260|NCT00324350|100860250|FG001|Non-Vertebral Fracture Follow-Up|Overall Study||3632||
48218261|NCT00324350|100860249|FG000|Falls Follow-Up|Overall Study||3364||
48218262|NCT00324350|100860250|FG001|Falls Follow-Up|Overall Study||3418||
48218263|NCT00324350|100860249|FG000|COMPLETED|Overall Study||3655||
48218264|NCT00324350|100860250|FG001|COMPLETED|Overall Study||3632||
48218265|NCT00324350|100860249|FG000|NOT COMPLETED|Overall Study||0||
48218266|NCT00324350|100860250|FG001|NOT COMPLETED|Overall Study||0||
48218267|NCT02638337|100860251|FG000|STARTED|Overall Study||316||
48218268|NCT02638337|100860252|FG001|STARTED|Overall Study||315||
48218269|NCT02638337|100860251|FG000|Received Treatment|Overall Study||313||
48218270|NCT02638337|100860252|FG001|Received Treatment|Overall Study||315||
48218271|NCT02638337|100860251|FG000|COMPLETED|Overall Study||283||
48218272|NCT02638337|100860252|FG001|COMPLETED|Overall Study||279||
48218273|NCT02638337|100860251|FG000|NOT COMPLETED|Overall Study||33||
48218274|NCT02638337|100860252|FG001|NOT COMPLETED|Overall Study||36||
48218275|NCT02978716|100860253|FG000|STARTED|Overall Study||34||
48218276|NCT02978716|100860254|FG001|STARTED|Overall Study||33||
48218277|NCT02978716|100860255|FG002|STARTED|Overall Study||35||
48218278|NCT02978716|100860253|FG000|ITT Population|Overall Study||34|The Intent-to-Treat (ITT) analysis set included all randomized participants.|
48218279|NCT02978716|100860254|FG001|ITT Population|Overall Study||33|The Intent-to-Treat (ITT) analysis set included all randomized participants.|
48218280|NCT02978716|100860255|FG002|ITT Population|Overall Study||35|The Intent-to-Treat (ITT) analysis set included all randomized participants.|
48218281|NCT02978716|100860253|FG000|Safety Analysis Set|Overall Study||30|The safety analysis set included all enrolled participants who received at least 1 dose of study drug.|
48218282|NCT02978716|100860254|FG001|Safety Analysis Set|Overall Study||33|The safety analysis set included all enrolled participants who received at least 1 dose of study drug.|
48218283|NCT02978716|100860255|FG002|Safety Analysis Set|Overall Study||35|The safety analysis set included all enrolled participants who received at least 1 dose of study drug.|
48218284|NCT02978716|100860253|FG000|Treated|Overall Study||30||
48218285|NCT02978716|100860254|FG001|Treated|Overall Study||33||
48218286|NCT02978716|100860255|FG002|Treated|Overall Study||35||
48218287|NCT02978716|100860253|FG000|COMPLETED|Overall Study||0||
48218288|NCT02978716|100860254|FG001|COMPLETED|Overall Study||0||
48218289|NCT02978716|100860255|FG002|COMPLETED|Overall Study||0||
48218290|NCT02978716|100860253|FG000|NOT COMPLETED|Overall Study||34||
48218291|NCT02978716|100860254|FG001|NOT COMPLETED|Overall Study||33||
48218292|NCT02978716|100860255|FG002|NOT COMPLETED|Overall Study||35||
48218293|NCT00604669|100860256|FG000|STARTED|Overall Study||170||
48218294|NCT00604669|100860256|FG000|COMPLETED|Overall Study||163||
48218295|NCT00604669|100860256|FG000|NOT COMPLETED|Overall Study||7||
48218296|NCT01171976|100860257|FG000|STARTED|Overall Study||121||
48060969|NCT00237185|100470330|FG001|STARTED|Core||74||
48060970|NCT00237185|100470329|FG000|Treated Participants|Core||73||
48218297|NCT01171976|100860258|FG001|STARTED|Overall Study||128||
48218298|NCT01171976|100860259|FG002|STARTED|Overall Study||123||
48218299|NCT01171976|100860257|FG000|Safety Set|Overall Study||126||
48218300|NCT01171976|100860258|FG001|Safety Set|Overall Study||126||
48218301|NCT01171976|100860259|FG002|Safety Set|Overall Study||118||
48218302|NCT01171976|100860257|FG000|COMPLETED|Overall Study||107||
48218303|NCT01171976|100860258|FG001|COMPLETED|Overall Study||117||
48218304|NCT01171976|100860259|FG002|COMPLETED|Overall Study||108||
48218305|NCT01171976|100860257|FG000|NOT COMPLETED|Overall Study||14||
48218306|NCT01171976|100860258|FG001|NOT COMPLETED|Overall Study||11||
48218307|NCT01171976|100860259|FG002|NOT COMPLETED|Overall Study||15||
48218308|NCT00715884|100860260|FG000|STARTED|Overall Study||452||
48218309|NCT00715884|100860261|FG001|STARTED|Overall Study||226||
48218310|NCT00715884|100860260|FG000|COMPLETED|Overall Study||444||
48218311|NCT00715884|100860261|FG001|COMPLETED|Overall Study||225||
48218312|NCT00715884|100860260|FG000|NOT COMPLETED|Overall Study||8||
48218313|NCT00715884|100860261|FG001|NOT COMPLETED|Overall Study||1||
48218314|NCT00504023|100860262|FG000|STARTED|Overall Study||8||
48218315|NCT00504023|100860262|FG000|COMPLETED|Overall Study||8||
48218316|NCT00504023|100860262|FG000|NOT COMPLETED|Overall Study||0||
48218317|NCT01149759|100860263|FG000|STARTED|Overall Study||9||
48218318|NCT01149759|100860263|FG000|COMPLETED|Overall Study||9||
48218319|NCT01149759|100860263|FG000|NOT COMPLETED|Overall Study||0||
48218320|NCT00731341|100860264|FG000|STARTED|Overall Study||3||
48218321|NCT00731341|100860264|FG000|COMPLETED|Overall Study||3||
48218322|NCT00731341|100860264|FG000|NOT COMPLETED|Overall Study||0||
48218323|NCT01956032|100860265|FG000|STARTED|Overall Study||15||
48218324|NCT01956032|100860265|FG000|COMPLETED|Overall Study||15||
48218325|NCT01956032|100860265|FG000|NOT COMPLETED|Overall Study||0||
48218326|NCT04436289|100860266|FG000|STARTED|Overall Study||63||
48218327|NCT04436289|100860267|FG001|STARTED|Overall Study||62||
48218328|NCT04436289|100860268|FG002|STARTED|Overall Study||35||
48218329|NCT04436289|100860269|FG003|STARTED|Overall Study||35||
48218330|NCT04436289|100860266|FG000|COMPLETED|Overall Study||55||
48218331|NCT04436289|100860267|FG001|COMPLETED|Overall Study||51||
48218332|NCT04436289|100860268|FG002|COMPLETED|Overall Study||30||
48218333|NCT04436289|100860269|FG003|COMPLETED|Overall Study||31||
48218334|NCT04436289|100860266|FG000|NOT COMPLETED|Overall Study||8||
48218335|NCT04436289|100860267|FG001|NOT COMPLETED|Overall Study||11||
48218336|NCT04436289|100860268|FG002|NOT COMPLETED|Overall Study||5||
48218337|NCT04436289|100860269|FG003|NOT COMPLETED|Overall Study||4||
48218338|NCT04430634|100860270|FG000|STARTED|Overall Study||5||
48218339|NCT04430634|100860271|FG001|STARTED|Overall Study||5||
48218340|NCT04430634|100860272|FG002|STARTED|Overall Study||5||
48218341|NCT04430634|100860273|FG003|STARTED|Overall Study||5||
48218342|NCT04430634|100860274|FG004|STARTED|Overall Study||5||
48218343|NCT04430634|100860275|FG005|STARTED|Overall Study||5||
48218344|NCT04430634|100860276|FG006|STARTED|Overall Study||5||
48218345|NCT04430634|100860277|FG007|STARTED|Overall Study||5||
48218346|NCT04430634|100860270|FG000|COMPLETED|Overall Study||5||
48218347|NCT04430634|100860271|FG001|COMPLETED|Overall Study||5||
48218348|NCT04430634|100860272|FG002|COMPLETED|Overall Study||5||
48218349|NCT04430634|100860273|FG003|COMPLETED|Overall Study||4||
48218350|NCT04430634|100860274|FG004|COMPLETED|Overall Study||5||
48218351|NCT04430634|100860275|FG005|COMPLETED|Overall Study||5||
48218352|NCT04430634|100860276|FG006|COMPLETED|Overall Study||4||
48218353|NCT04430634|100860277|FG007|COMPLETED|Overall Study||5||
48218354|NCT04430634|100860270|FG000|NOT COMPLETED|Overall Study||0||
48218355|NCT04430634|100860271|FG001|NOT COMPLETED|Overall Study||0||
48218356|NCT04430634|100860272|FG002|NOT COMPLETED|Overall Study||0||
48218357|NCT04430634|100860273|FG003|NOT COMPLETED|Overall Study||1||
48218358|NCT04430634|100860274|FG004|NOT COMPLETED|Overall Study||0||
48218359|NCT04430634|100860275|FG005|NOT COMPLETED|Overall Study||0||
48218360|NCT04430634|100860276|FG006|NOT COMPLETED|Overall Study||1||
48218361|NCT04430634|100860277|FG007|NOT COMPLETED|Overall Study||0||
48218362|NCT00909324|100860278|FG000|STARTED|Overall Study||72||
48218363|NCT00909324|100860279|FG001|STARTED|Overall Study||90||
48218364|NCT00909324|100860278|FG000|COMPLETED|Overall Study||72||
48218365|NCT00909324|100860279|FG001|COMPLETED|Overall Study||90||
48218366|NCT00909324|100860278|FG000|NOT COMPLETED|Overall Study||0||
48218367|NCT00909324|100860279|FG001|NOT COMPLETED|Overall Study||0||
48218368|NCT05018910|100860280|FG000|STARTED|Overall Study||10||
48218369|NCT05018910|100860280|FG000|COMPLETED|Overall Study||10||
48218370|NCT05018910|100860280|FG000|NOT COMPLETED|Overall Study||0||
48218371|NCT01695954|100860281|FG000|STARTED|Overall Study||18||
48218372|NCT01695954|100860282|FG001|STARTED|Overall Study||16||
48218373|NCT01695954|100860281|FG000|COMPLETED|Overall Study||14||
48218374|NCT01695954|100860282|FG001|COMPLETED|Overall Study||14||
48218375|NCT01695954|100860281|FG000|NOT COMPLETED|Overall Study||4||
48218376|NCT01695954|100860282|FG001|NOT COMPLETED|Overall Study||2||
48218377|NCT01421667|100860283|FG000|STARTED|Overall Study||35||
48218378|NCT01421667|100860284|FG001|STARTED|Overall Study||68||
48218379|NCT01421667|100860285|FG002|STARTED|Overall Study||53||
48218380|NCT01421667|100860286|FG003|STARTED|Overall Study||16||
48218381|NCT01421667|100860283|FG000|COMPLETED|Overall Study||35||
48218382|NCT01421667|100860284|FG001|COMPLETED|Overall Study||66||
48218383|NCT01421667|100860285|FG002|COMPLETED|Overall Study||51||
48218384|NCT01421667|100860286|FG003|COMPLETED|Overall Study||15||
48218385|NCT01421667|100860283|FG000|NOT COMPLETED|Overall Study||0||
48218386|NCT01421667|100860284|FG001|NOT COMPLETED|Overall Study||2||
48218387|NCT01421667|100860285|FG002|NOT COMPLETED|Overall Study||2||
48218388|NCT01421667|100860286|FG003|NOT COMPLETED|Overall Study||1||
48218389|NCT01250769|100860287|FG000|STARTED|Overall Study||11||
48218390|NCT01250769|100860288|FG001|STARTED|Overall Study||73||
48218391|NCT01250769|100860289|FG002|STARTED|Overall Study||75||
48218392|NCT01250769|100860290|FG003|STARTED|Overall Study||11||
48218393|NCT01250769|100860287|FG000|Day 14|Overall Study||11||
48218394|NCT01250769|100860288|FG001|Day 14|Overall Study||72||
48218395|NCT01250769|100860289|FG002|Day 14|Overall Study||74||
48218396|NCT01250769|100860290|FG003|Day 14|Overall Study||11||
48218397|NCT01250769|100860287|FG000|COMPLETED|Overall Study||11||
48218398|NCT01250769|100860288|FG001|COMPLETED|Overall Study||72||
48218399|NCT01250769|100860289|FG002|COMPLETED|Overall Study||73||
48218400|NCT01250769|100860290|FG003|COMPLETED|Overall Study||11||
48218401|NCT01250769|100860287|FG000|NOT COMPLETED|Overall Study||0||
48218402|NCT01250769|100860288|FG001|NOT COMPLETED|Overall Study||1||
48218403|NCT01250769|100860289|FG002|NOT COMPLETED|Overall Study||2||
48218404|NCT01250769|100860290|FG003|NOT COMPLETED|Overall Study||0||
48218405|NCT05512962|100860291|FG000|STARTED|Overall Study||13|= Safety Population of all eligible subjects randomized|
48218406|NCT05512962|100860292|FG001|STARTED|Overall Study||12|= Safety Population of all eligible subjects randomized|
48218407|NCT05512962|100860291|FG000|Efficacy Evaluable Population|Overall Study||10|All subjects with completed administration of study treatment and at least 1 post baseline assessment|
48218408|NCT05512962|100860292|FG001|Efficacy Evaluable Population|Overall Study||10|All subjects with completed administration of study treatment and at least 1 post baseline assessment|
48218409|NCT05512962|100860291|FG000|Per Protocol Population|Overall Study||5|EEP subjects without major protocol deviations impacting efficacy outcomes|
48218410|NCT05512962|100860292|FG001|Per Protocol Population|Overall Study||9|EEP subjects without major protocol deviations impacting efficacy outcomes|
48218411|NCT05512962|100860291|FG000|COMPLETED|Overall Study||12|Based on Efficacy Evaluable Population|
48218412|NCT05512962|100860292|FG001|COMPLETED|Overall Study||12|Based on Efficacy Evaluable Population|
48218413|NCT05512962|100860291|FG000|NOT COMPLETED|Overall Study||1||
48218414|NCT05512962|100860292|FG001|NOT COMPLETED|Overall Study||0||
48218415|NCT03102034|100860293|FG000|STARTED|Overall Study||21||
48218416|NCT03102034|100860294|FG001|STARTED|Overall Study||11||
48218417|NCT03102034|100860293|FG000|COMPLETED|Overall Study||20||
48218418|NCT03102034|100860294|FG001|COMPLETED|Overall Study||11||
48218419|NCT03102034|100860293|FG000|NOT COMPLETED|Overall Study||1||
48218420|NCT03102034|100860294|FG001|NOT COMPLETED|Overall Study||0||
48060971|NCT00237185|100470330|FG001|Treated Participants|Core||74||
48060972|NCT00237185|100470329|FG000|COMPLETED|Core||30||
48060973|NCT00237185|100470330|FG001|COMPLETED|Core||37||
48060974|NCT00237185|100470329|FG000|NOT COMPLETED|Core||44||
48060975|NCT00237185|100470330|FG001|NOT COMPLETED|Core||37||
48060976|NCT00237185|100470329|FG000|STARTED|Extension||24||
48060977|NCT00237185|100470330|FG001|STARTED|Extension||32||
48060978|NCT00237185|100470329|FG000|COMPLETED|Extension||8||
48060979|NCT00237185|100470330|FG001|COMPLETED|Extension||13||
48060980|NCT00237185|100470329|FG000|NOT COMPLETED|Extension||16||
48060981|NCT00237185|100470330|FG001|NOT COMPLETED|Extension||19||
48060982|NCT00055224|100470331|FG000|STARTED|Overall Study Participants||557||
48060983|NCT00055224|100470332|FG001|STARTED|Overall Study Participants||361||
48060984|NCT00055224|100470331|FG000|COMPLETED|Overall Study Participants||557||
48060985|NCT00055224|100470332|FG001|COMPLETED|Overall Study Participants||361||
48060986|NCT00055224|100470331|FG000|NOT COMPLETED|Overall Study Participants||0||
48060987|NCT00055224|100470332|FG001|NOT COMPLETED|Overall Study Participants||0||
48060988|NCT00055224|100470331|FG000|STARTED|Substudy 1||23||
48060989|NCT00055224|100470332|FG001|STARTED|Substudy 1||78||
48060990|NCT00055224|100470331|FG000|COMPLETED|Substudy 1||23||
48060991|NCT00055224|100470332|FG001|COMPLETED|Substudy 1||78||
48060992|NCT00055224|100470331|FG000|NOT COMPLETED|Substudy 1||0||
48060993|NCT00055224|100470332|FG001|NOT COMPLETED|Substudy 1||0||
48060994|NCT00055224|100470331|FG000|STARTED|Substudy 2||42||
48060995|NCT00055224|100470332|FG001|STARTED|Substudy 2||35||
48060996|NCT00055224|100470331|FG000|COMPLETED|Substudy 2||42||
48060997|NCT00055224|100470332|FG001|COMPLETED|Substudy 2||35||
48218421|NCT00468052|100860295|FG000|STARTED|Overall Study||68||
48218422|NCT00468052|100860296|FG001|STARTED|Overall Study||69||
48218423|NCT00468052|100860295|FG000|Target Enrollment|Overall Study||70||
48218424|NCT00468052|100860296|FG001|Target Enrollment|Overall Study||70||
48218425|NCT00468052|100860295|FG000|COMPLETED|Overall Study||61||
48218426|NCT00468052|100860296|FG001|COMPLETED|Overall Study||61||
48218427|NCT00468052|100860295|FG000|NOT COMPLETED|Overall Study||7||
48218428|NCT00468052|100860296|FG001|NOT COMPLETED|Overall Study||8||
48218429|NCT03912831|100860297|FG000|STARTED|Overall Study||1||
48218430|NCT03912831|100860298|FG001|STARTED|Overall Study||1||
48218431|NCT03912831|100860299|FG002|STARTED|Overall Study||1||
48218432|NCT03912831|100860300|FG003|STARTED|Overall Study||1||
48218433|NCT03912831|100860301|FG004|STARTED|Overall Study||3||
48218434|NCT03912831|100860302|FG005|STARTED|Overall Study||1||
48218435|NCT03912831|100860297|FG000|COMPLETED|Overall Study||0||
48218436|NCT03912831|100860298|FG001|COMPLETED|Overall Study||0||
48060998|NCT00055224|100470331|FG000|NOT COMPLETED|Substudy 2||0||
48060999|NCT00055224|100470332|FG001|NOT COMPLETED|Substudy 2||0||
48061000|NCT00055224|100470331|FG000|STARTED|Substudy 5||33||
48061001|NCT00055224|100470332|FG001|STARTED|Substudy 5||36||
48061002|NCT00055224|100470331|FG000|COMPLETED|Substudy 5||33||
48218437|NCT03912831|100860299|FG002|COMPLETED|Overall Study||0||
48218438|NCT03912831|100860300|FG003|COMPLETED|Overall Study||0||
48218439|NCT03912831|100860301|FG004|COMPLETED|Overall Study||0||
48218440|NCT03912831|100860302|FG005|COMPLETED|Overall Study||0||
48218441|NCT03912831|100860297|FG000|NOT COMPLETED|Overall Study||1||
48218442|NCT03912831|100860298|FG001|NOT COMPLETED|Overall Study||1||
48496303|NCT00829712|101548056|FG000|NOT COMPLETED|Second Intervention||0||
48496304|NCT00829712|101548057|FG001|NOT COMPLETED|Second Intervention||0||
48496305|NCT01539239|101548058|FG000|STARTED|Overall Study||369||
48496306|NCT01539239|101548059|FG001|STARTED|Overall Study||187||
48496307|NCT01539239|101548058|FG000|COMPLETED|Overall Study||357||
48496308|NCT01539239|101548059|FG001|COMPLETED|Overall Study||170||
48496309|NCT01539239|101548058|FG000|NOT COMPLETED|Overall Study||12||
48496310|NCT01539239|101548059|FG001|NOT COMPLETED|Overall Study||17||
48496311|NCT01559363|101548060|FG000|STARTED|Phase 1b: Up to 36 Months||24||
48496312|NCT01559363|101548061|FG001|STARTED|Phase 1b: Up to 36 Months||8||
48496313|NCT01559363|101548062|FG002|STARTED|Phase 1b: Up to 36 Months||5||
48496314|NCT01559363|101548063|FG003|STARTED|Phase 1b: Up to 36 Months||0||
48496315|NCT01559363|101548064|FG004|STARTED|Phase 1b: Up to 36 Months||0||
48496316|NCT01559363|101548065|FG005|STARTED|Phase 1b: Up to 36 Months||0||
48496317|NCT01559363|101548060|FG000|COMPLETED|Phase 1b: Up to 36 Months||18||
48496318|NCT01559363|101548061|FG001|COMPLETED|Phase 1b: Up to 36 Months||5||
48496319|NCT01559363|101548062|FG002|COMPLETED|Phase 1b: Up to 36 Months||3||
48496320|NCT01559363|101548063|FG003|COMPLETED|Phase 1b: Up to 36 Months||0||
48496321|NCT01559363|101548064|FG004|COMPLETED|Phase 1b: Up to 36 Months||0||
48496322|NCT01559363|101548065|FG005|COMPLETED|Phase 1b: Up to 36 Months||0||
48496323|NCT01559363|101548060|FG000|NOT COMPLETED|Phase 1b: Up to 36 Months||6||
48496324|NCT01559363|101548061|FG001|NOT COMPLETED|Phase 1b: Up to 36 Months||3||
48496325|NCT01559363|101548062|FG002|NOT COMPLETED|Phase 1b: Up to 36 Months||2||
48496326|NCT01559363|101548063|FG003|NOT COMPLETED|Phase 1b: Up to 36 Months||0||
48496327|NCT01559363|101548064|FG004|NOT COMPLETED|Phase 1b: Up to 36 Months||0||
48496328|NCT01559363|101548065|FG005|NOT COMPLETED|Phase 1b: Up to 36 Months||0||
48496329|NCT01559363|101548060|FG000|STARTED|Phase 2a: Up to 28 Months||0||
48496330|NCT01559363|101548061|FG001|STARTED|Phase 2a: Up to 28 Months||0||
48496331|NCT01559363|101548062|FG002|STARTED|Phase 2a: Up to 28 Months||0||
48496332|NCT01559363|101548063|FG003|STARTED|Phase 2a: Up to 28 Months||10||
48496333|NCT01559363|101548064|FG004|STARTED|Phase 2a: Up to 28 Months||14||
48496334|NCT01559363|101548065|FG005|STARTED|Phase 2a: Up to 28 Months||8||
48496335|NCT01559363|101548060|FG000|COMPLETED|Phase 2a: Up to 28 Months||0||
48496336|NCT01559363|101548061|FG001|COMPLETED|Phase 2a: Up to 28 Months||0||
48496337|NCT01559363|101548062|FG002|COMPLETED|Phase 2a: Up to 28 Months||0||
48496338|NCT01559363|101548063|FG003|COMPLETED|Phase 2a: Up to 28 Months||8||
48496339|NCT01559363|101548064|FG004|COMPLETED|Phase 2a: Up to 28 Months||13||
48496340|NCT01559363|101548065|FG005|COMPLETED|Phase 2a: Up to 28 Months||8||
48496341|NCT01559363|101548060|FG000|NOT COMPLETED|Phase 2a: Up to 28 Months||0||
48496342|NCT01559363|101548061|FG001|NOT COMPLETED|Phase 2a: Up to 28 Months||0||
48496343|NCT01559363|101548062|FG002|NOT COMPLETED|Phase 2a: Up to 28 Months||0||
48218443|NCT03912831|100860299|FG002|NOT COMPLETED|Overall Study||1||
48218444|NCT03912831|100860300|FG003|NOT COMPLETED|Overall Study||1||
48218445|NCT03912831|100860301|FG004|NOT COMPLETED|Overall Study||3||
48218446|NCT03912831|100860302|FG005|NOT COMPLETED|Overall Study||1||
48218447|NCT00246805|100860303|FG000|STARTED|Phase 1||34||
48218448|NCT00246805|100860304|FG001|STARTED|Phase 1||33||
48218449|NCT00246805|100860303|FG000|COMPLETED|Phase 1||33||
48218450|NCT00246805|100860304|FG001|COMPLETED|Phase 1||33||
48218451|NCT00246805|100860303|FG000|NOT COMPLETED|Phase 1||1||
48218452|NCT00246805|100860304|FG001|NOT COMPLETED|Phase 1||0||
48218453|NCT00246805|100860303|FG000|STARTED|Phase 2||33||
48218454|NCT00246805|100860304|FG001|STARTED|Phase 2||33||
48218455|NCT00246805|100860303|FG000|COMPLETED|Phase 2||33||
48218456|NCT00246805|100860304|FG001|COMPLETED|Phase 2||33||
48218457|NCT00246805|100860303|FG000|NOT COMPLETED|Phase 2||0||
48218458|NCT00246805|100860304|FG001|NOT COMPLETED|Phase 2||0||
48218459|NCT02797184|100860305|FG000|STARTED|Overall Study||21||
48218460|NCT02797184|100860306|FG001|STARTED|Overall Study||21||
48218461|NCT02797184|100860305|FG000|COMPLETED|Overall Study||3||
48218462|NCT02797184|100860306|FG001|COMPLETED|Overall Study||3||
48218463|NCT02797184|100860305|FG000|NOT COMPLETED|Overall Study||18||
48218464|NCT02797184|100860306|FG001|NOT COMPLETED|Overall Study||18||
48218465|NCT02135679|100860307|FG000|STARTED|Overall Study||52||
48218466|NCT02135679|100860308|FG001|STARTED|Overall Study||69||
48218467|NCT02135679|100860309|FG002|STARTED|Overall Study||2||
48218468|NCT02135679|100860310|FG003|STARTED|Overall Study||0||
48218469|NCT02135679|100860311|FG004|STARTED|Overall Study||18||
48496344|NCT01559363|101548063|FG003|NOT COMPLETED|Phase 2a: Up to 28 Months||2||
48496345|NCT01559363|101548064|FG004|NOT COMPLETED|Phase 2a: Up to 28 Months||1||
48496346|NCT01559363|101548065|FG005|NOT COMPLETED|Phase 2a: Up to 28 Months||0||
48496347|NCT02451358|101548066|FG000|STARTED|Overall Study||100||
48496348|NCT02451358|101548067|FG001|STARTED|Overall Study||100||
48496349|NCT02451358|101548068|FG002|STARTED|Overall Study||100||
48496350|NCT02451358|101548069|FG003|STARTED|Overall Study||100||
48218470|NCT02135679|100860312|FG005|STARTED|Overall Study||63||
48496351|NCT02451358|101548066|FG000|Vaccinated at Day 0|Overall Study||100||
48496352|NCT02451358|101548067|FG001|Vaccinated at Day 0|Overall Study||100||
48496353|NCT02451358|101548068|FG002|Vaccinated at Day 0|Overall Study||100||
48496354|NCT02451358|101548069|FG003|Vaccinated at Day 0|Overall Study||100||
48496355|NCT02451358|101548066|FG000|Vaccinated at Day 28|Overall Study||99||
48496356|NCT02451358|101548067|FG001|Vaccinated at Day 28|Overall Study||98||
48496357|NCT02451358|101548068|FG002|Vaccinated at Day 28|Overall Study||0||
48496358|NCT02451358|101548069|FG003|Vaccinated at Day 28|Overall Study||0||
48496359|NCT02451358|101548066|FG000|COMPLETED|Overall Study||99||
48496360|NCT02451358|101548067|FG001|COMPLETED|Overall Study||98||
48496361|NCT02451358|101548068|FG002|COMPLETED|Overall Study||99||
48496362|NCT02451358|101548069|FG003|COMPLETED|Overall Study||100||
48496363|NCT02451358|101548066|FG000|NOT COMPLETED|Overall Study||1||
48496364|NCT02451358|101548067|FG001|NOT COMPLETED|Overall Study||2||
48496365|NCT02451358|101548068|FG002|NOT COMPLETED|Overall Study||1||
48496366|NCT02451358|101548069|FG003|NOT COMPLETED|Overall Study||0||
48496367|NCT00472212|101548070|FG000|STARTED|Overall Study||31||
48496368|NCT00472212|101548071|FG001|STARTED|Overall Study||27||
48496369|NCT00472212|101548070|FG000|COMPLETED|Overall Study||25||
48496370|NCT00472212|101548071|FG001|COMPLETED|Overall Study||23||
48496371|NCT00472212|101548070|FG000|NOT COMPLETED|Overall Study||6||
48496372|NCT00472212|101548071|FG001|NOT COMPLETED|Overall Study||4||
48496373|NCT01558635|101548072|FG000|STARTED|Overall Study||17||
48496374|NCT01558635|101548072|FG000|Treated|Overall Study||17||
48496375|NCT01558635|101548072|FG000|Discharge /1 Month Post-procedure|Overall Study||15||
48496376|NCT01558635|101548072|FG000|3 Months Post-procedure|Overall Study||14||
48496377|NCT01558635|101548072|FG000|6 Months Post-procedure|Overall Study||14||
48496378|NCT01558635|101548072|FG000|COMPLETED|Overall Study||11|12 months post-procedure|
48496379|NCT01558635|101548072|FG000|NOT COMPLETED|Overall Study||6||
48496380|NCT03669250|101548073|FG000|STARTED|Overall Study||3||
48496381|NCT03669250|101548074|FG001|STARTED|Overall Study||3||
48496382|NCT03669250|101548075|FG002|STARTED|Overall Study||4||
48496383|NCT03669250|101548076|FG003|STARTED|Overall Study||4||
48496384|NCT03669250|101548077|FG004|STARTED|Overall Study||4||
48496385|NCT03669250|101548078|FG005|STARTED|Overall Study||4||
48496386|NCT03669250|101548073|FG000|COMPLETED|Overall Study||3||
48496387|NCT03669250|101548074|FG001|COMPLETED|Overall Study||2||
48496388|NCT03669250|101548075|FG002|COMPLETED|Overall Study||4||
48496389|NCT03669250|101548076|FG003|COMPLETED|Overall Study||3||
48496390|NCT03669250|101548077|FG004|COMPLETED|Overall Study||3||
48496391|NCT03669250|101548078|FG005|COMPLETED|Overall Study||4||
48496392|NCT03669250|101548073|FG000|NOT COMPLETED|Overall Study||0||
48496393|NCT03669250|101548074|FG001|NOT COMPLETED|Overall Study||1||
48496394|NCT03669250|101548075|FG002|NOT COMPLETED|Overall Study||0||
48496395|NCT03669250|101548076|FG003|NOT COMPLETED|Overall Study||1||
48496396|NCT03669250|101548077|FG004|NOT COMPLETED|Overall Study||1||
48496397|NCT03669250|101548078|FG005|NOT COMPLETED|Overall Study||0||
48496398|NCT00200785|101548079|FG000|STARTED|First Intervention||9||
48496399|NCT00200785|101548080|FG001|STARTED|First Intervention||6||
48496400|NCT00200785|101548079|FG000|COMPLETED|First Intervention||9||
48496401|NCT00200785|101548080|FG001|COMPLETED|First Intervention||6||
48496402|NCT00200785|101548079|FG000|NOT COMPLETED|First Intervention||0||
48496403|NCT00200785|101548080|FG001|NOT COMPLETED|First Intervention||0||
48496404|NCT00200785|101548079|FG000|STARTED|Washout Period of 1 Week||9||
48496405|NCT00200785|101548080|FG001|STARTED|Washout Period of 1 Week||6||
48496406|NCT00200785|101548079|FG000|COMPLETED|Washout Period of 1 Week||9||
48496407|NCT00200785|101548080|FG001|COMPLETED|Washout Period of 1 Week||6||
48496408|NCT00200785|101548079|FG000|NOT COMPLETED|Washout Period of 1 Week||0||
48496409|NCT00200785|101548080|FG001|NOT COMPLETED|Washout Period of 1 Week||0||
48496410|NCT00200785|101548079|FG000|STARTED|Second Intervention||9||
48496411|NCT00200785|101548080|FG001|STARTED|Second Intervention||6||
48496412|NCT00200785|101548079|FG000|COMPLETED|Second Intervention||9||
48496413|NCT00200785|101548080|FG001|COMPLETED|Second Intervention||6||
48496414|NCT00200785|101548079|FG000|NOT COMPLETED|Second Intervention||0||
48496415|NCT00200785|101548080|FG001|NOT COMPLETED|Second Intervention||0||
48496416|NCT03644550|101548081|FG000|STARTED|Overall Study||18||
48496417|NCT03644550|101548081|FG000|COMPLETED|Overall Study||0||
48496418|NCT03644550|101548081|FG000|NOT COMPLETED|Overall Study||18||
48496419|NCT03873805|101548082|FG000|STARTED|Overall Study||3||
48496420|NCT03873805|101548083|FG001|STARTED|Overall Study||6||
48496421|NCT03873805|101548084|FG002|STARTED|Overall Study||5||
48496422|NCT03873805|101548082|FG000|COMPLETED|Overall Study||3||
48496423|NCT03873805|101548083|FG001|COMPLETED|Overall Study||6||
48496424|NCT03873805|101548084|FG002|COMPLETED|Overall Study||5||
48496425|NCT03873805|101548082|FG000|NOT COMPLETED|Overall Study||0||
48496426|NCT03873805|101548083|FG001|NOT COMPLETED|Overall Study||0||
48496427|NCT03873805|101548084|FG002|NOT COMPLETED|Overall Study||0||
48496428|NCT00635648|101548085|FG000|STARTED|Overall Study||63||
48496429|NCT00635648|101548085|FG000|COMPLETED|Overall Study||26||
48496430|NCT00635648|101548085|FG000|NOT COMPLETED|Overall Study||37||
48496431|NCT01266902|101550918|FG000|STARTED|Period 1 (Main Study)||119||
48496432|NCT01266902|101550919|FG001|STARTED|Period 1 (Main Study)||363||
48496433|NCT01266902|101550920|FG002|STARTED|Period 1 (Main Study)||0||
48496434|NCT01266902|101550918|FG000|COMPLETED|Period 1 (Main Study)||89||
48496435|NCT01266902|101550919|FG001|COMPLETED|Period 1 (Main Study)||282||
48496436|NCT01266902|101550920|FG002|COMPLETED|Period 1 (Main Study)||0||
48496437|NCT01266902|101550918|FG000|NOT COMPLETED|Period 1 (Main Study)||30||
48496438|NCT01266902|101550919|FG001|NOT COMPLETED|Period 1 (Main Study)||81||
48496439|NCT01266902|101550920|FG002|NOT COMPLETED|Period 1 (Main Study)||0||
48496440|NCT01266902|101550918|FG000|STARTED|Period 2 (After Protocol Amendment 3)||0||
48496441|NCT01266902|101550919|FG001|STARTED|Period 2 (After Protocol Amendment 3)||0||
48496442|NCT01266902|101550920|FG002|STARTED|Period 2 (After Protocol Amendment 3)||45||
48496443|NCT01266902|101550918|FG000|COMPLETED|Period 2 (After Protocol Amendment 3)||0||
48496444|NCT01266902|101550919|FG001|COMPLETED|Period 2 (After Protocol Amendment 3)||0||
48496445|NCT01266902|101550920|FG002|COMPLETED|Period 2 (After Protocol Amendment 3)||37||
48496446|NCT01266902|101550918|FG000|NOT COMPLETED|Period 2 (After Protocol Amendment 3)||0||
48496447|NCT01266902|101550919|FG001|NOT COMPLETED|Period 2 (After Protocol Amendment 3)||0||
48496448|NCT01266902|101550920|FG002|NOT COMPLETED|Period 2 (After Protocol Amendment 3)||8||
48496449|NCT02436200|101550921|FG000|STARTED|Overall Study||21||
48496450|NCT02436200|101550921|FG000|COMPLETED|Overall Study||20||
48496451|NCT02436200|101550921|FG000|NOT COMPLETED|Overall Study||1||
48496452|NCT00807495|101550922|FG000|STARTED|Overall Study||22||
48496453|NCT00807495|101550923|FG001|STARTED|Overall Study||13||
48496454|NCT00807495|101550924|FG002|STARTED|Overall Study||5||
48496455|NCT00807495|101550925|FG003|STARTED|Overall Study||1||
48496456|NCT00807495|101550926|FG004|STARTED|Overall Study||7||
48496457|NCT00807495|101550922|FG000|COMPLETED|Overall Study||14||
48496458|NCT00807495|101550923|FG001|COMPLETED|Overall Study||7||
48496459|NCT00807495|101550924|FG002|COMPLETED|Overall Study||1||
48496460|NCT00807495|101550925|FG003|COMPLETED|Overall Study||0||
48496461|NCT00807495|101550926|FG004|COMPLETED|Overall Study||2||
48496462|NCT00807495|101550922|FG000|NOT COMPLETED|Overall Study||8||
48496463|NCT00807495|101550923|FG001|NOT COMPLETED|Overall Study||6||
48496464|NCT00807495|101550924|FG002|NOT COMPLETED|Overall Study||4||
48496465|NCT00807495|101550925|FG003|NOT COMPLETED|Overall Study||1||
48496466|NCT00807495|101550926|FG004|NOT COMPLETED|Overall Study||5||
48496467|NCT04210557|101550927|FG000|STARTED|Overall Study||1||
48496468|NCT04210557|101550928|FG001|STARTED|Overall Study||0||
48496469|NCT04210557|101550927|FG000|COMPLETED|Overall Study||1||
48496470|NCT04210557|101550928|FG001|COMPLETED|Overall Study||0||
48496471|NCT04210557|101550927|FG000|NOT COMPLETED|Overall Study||0||
48496472|NCT04210557|101550928|FG001|NOT COMPLETED|Overall Study||0||
48496473|NCT03499873|101550929|FG000|STARTED|Overall Study||183||
48496474|NCT03499873|101550930|FG001|STARTED|Overall Study||182||
48496475|NCT03499873|101550931|FG002|STARTED|Overall Study||83||
48496476|NCT03499873|101550929|FG000|Safety Population|Overall Study||175||
48496477|NCT03499873|101550930|FG001|Safety Population|Overall Study||174||
48496478|NCT03499873|101550931|FG002|Safety Population|Overall Study||80||
48496479|NCT03499873|101550929|FG000|Per-Protocol Population|Overall Study||144||
48496480|NCT03499873|101550930|FG001|Per-Protocol Population|Overall Study||143||
48496481|NCT03499873|101550931|FG002|Per-Protocol Population|Overall Study||58||
48496482|NCT03499873|101550929|FG000|Modified-Intent-to-Treat|Overall Study||170||
48496483|NCT03499873|101550930|FG001|Modified-Intent-to-Treat|Overall Study||168||
48496484|NCT03499873|101550931|FG002|Modified-Intent-to-Treat|Overall Study||77||
48496485|NCT03499873|101550929|FG000|COMPLETED|Overall Study||163||
48496486|NCT03499873|101550930|FG001|COMPLETED|Overall Study||162||
48496487|NCT03499873|101550931|FG002|COMPLETED|Overall Study||56||
48496488|NCT03499873|101550929|FG000|NOT COMPLETED|Overall Study||20||
48496489|NCT03499873|101550930|FG001|NOT COMPLETED|Overall Study||20||
48496490|NCT03499873|101550931|FG002|NOT COMPLETED|Overall Study||27||
48496491|NCT02974907|101550932|FG000|STARTED|Overall Study||299||
48496492|NCT02974907|101550933|FG001|STARTED|Overall Study||302||
48496493|NCT02974907|101550932|FG000|COMPLETED|Overall Study||286||
48496494|NCT02974907|101550933|FG001|COMPLETED|Overall Study||292||
48496495|NCT02974907|101550932|FG000|NOT COMPLETED|Overall Study||13||
48496496|NCT02974907|101550933|FG001|NOT COMPLETED|Overall Study||10||
48496497|NCT00604162|101550934|FG000|STARTED|Overall Study||332||
48496498|NCT00604162|101550934|FG000|COMPLETED|Overall Study||328||
48496499|NCT00604162|101550934|FG000|NOT COMPLETED|Overall Study||4||
48496500|NCT03283982|101550935|FG000|STARTED|Overall Study||39||
48496501|NCT03283982|101550936|FG001|STARTED|Overall Study||36||
48496502|NCT03283982|101550935|FG000|COMPLETED|Overall Study||39||
48496503|NCT03283982|101550936|FG001|COMPLETED|Overall Study||36||
48496504|NCT03283982|101550935|FG000|NOT COMPLETED|Overall Study||0||
48496505|NCT03283982|101550936|FG001|NOT COMPLETED|Overall Study||0||
48496506|NCT02287480|101550937|FG000|STARTED|Overall Study||35||
48496507|NCT02287480|101550938|FG001|STARTED|Overall Study||16||
48496508|NCT02287480|101550939|FG002|STARTED|Overall Study||13||
48496509|NCT02287480|101550940|FG003|STARTED|Overall Study||51||
48496510|NCT02287480|101550937|FG000|COMPLETED|Overall Study||35||
48496511|NCT02287480|101550938|FG001|COMPLETED|Overall Study||16||
48496512|NCT02287480|101550939|FG002|COMPLETED|Overall Study||13||
48496513|NCT02287480|101550940|FG003|COMPLETED|Overall Study||51||
48496514|NCT02287480|101550937|FG000|NOT COMPLETED|Overall Study||0||
48496515|NCT02287480|101550938|FG001|NOT COMPLETED|Overall Study||0||
48496516|NCT02287480|101550939|FG002|NOT COMPLETED|Overall Study||0||
48496517|NCT02287480|101550940|FG003|NOT COMPLETED|Overall Study||0||
48496518|NCT01662960|101550941|FG000|STARTED|End of 4 Week Treatment Period||25||
48496519|NCT01662960|101550942|FG001|STARTED|End of 4 Week Treatment Period||23||
48496520|NCT01662960|101550943|FG002|STARTED|End of 4 Week Treatment Period||9||
48496521|NCT01662960|101550944|FG003|STARTED|End of 4 Week Treatment Period||15||
48496522|NCT01662960|101550941|FG000|COMPLETED|End of 4 Week Treatment Period||24||
48496523|NCT01662960|101550942|FG001|COMPLETED|End of 4 Week Treatment Period||19||
48496524|NCT01662960|101550943|FG002|COMPLETED|End of 4 Week Treatment Period||8||
48496525|NCT01662960|101550944|FG003|COMPLETED|End of 4 Week Treatment Period||15||
48496526|NCT01662960|101550941|FG000|NOT COMPLETED|End of 4 Week Treatment Period||1||
48496527|NCT01662960|101550942|FG001|NOT COMPLETED|End of 4 Week Treatment Period||4||
48496528|NCT01662960|101550943|FG002|NOT COMPLETED|End of 4 Week Treatment Period||1||
48496529|NCT01662960|101550944|FG003|NOT COMPLETED|End of 4 Week Treatment Period||0||
48496530|NCT01662960|101550941|FG000|STARTED|3 Month Follow-up||24||
48496531|NCT01662960|101550942|FG001|STARTED|3 Month Follow-up||19||
48496532|NCT01662960|101550943|FG002|STARTED|3 Month Follow-up||8||
48496533|NCT01662960|101550944|FG003|STARTED|3 Month Follow-up||15||
48496534|NCT01662960|101550941|FG000|COMPLETED|3 Month Follow-up||21||
48496535|NCT01662960|101550942|FG001|COMPLETED|3 Month Follow-up||16||
48496536|NCT01662960|101550943|FG002|COMPLETED|3 Month Follow-up||5||
48496537|NCT01662960|101550944|FG003|COMPLETED|3 Month Follow-up||13||
48496538|NCT01662960|101550941|FG000|NOT COMPLETED|3 Month Follow-up||3||
48496539|NCT01662960|101550942|FG001|NOT COMPLETED|3 Month Follow-up||3||
48496540|NCT01662960|101550943|FG002|NOT COMPLETED|3 Month Follow-up||3||
48496541|NCT01662960|101550944|FG003|NOT COMPLETED|3 Month Follow-up||2||
48496542|NCT00663234|101550945|FG000|STARTED|Overall Study||28||
48496543|NCT00663234|101550945|FG000|Dose Increased to 20 mg at Week 8|Overall Study||10||
48496544|NCT00663234|101550945|FG000|COMPLETED|Overall Study||27||
48496545|NCT00663234|101550945|FG000|NOT COMPLETED|Overall Study||1||
48496546|NCT01002287|101550946|FG000|STARTED|Overall Study||8||
48496547|NCT01002287|101550947|FG001|STARTED|Overall Study||3||
48496548|NCT01002287|101550946|FG000|COMPLETED|Overall Study||8||
48496549|NCT01002287|101550947|FG001|COMPLETED|Overall Study||3||
48496550|NCT01002287|101550946|FG000|NOT COMPLETED|Overall Study||0||
48496551|NCT01002287|101550947|FG001|NOT COMPLETED|Overall Study||0||
48496552|NCT02007863|101550948|FG000|STARTED|Overall Study||2||
48496553|NCT02007863|101550948|FG000|COMPLETED|Overall Study||2||
48496554|NCT02007863|101550948|FG000|NOT COMPLETED|Overall Study||0||
48496555|NCT02637141|101550949|FG000|STARTED|Overall Study||22||
48496556|NCT02637141|101550950|FG001|STARTED|Overall Study||22||
48496557|NCT02637141|101550951|FG002|STARTED|Overall Study||20||
48496558|NCT02637141|101550949|FG000|Received Study Drug|Overall Study||22||
48496559|NCT02637141|101550950|FG001|Received Study Drug|Overall Study||21||
48496560|NCT02637141|101550951|FG002|Received Study Drug|Overall Study||19||
48496561|NCT02637141|101550949|FG000|COMPLETED|Overall Study||20||
48496562|NCT02637141|101550950|FG001|COMPLETED|Overall Study||20||
48496563|NCT02637141|101550951|FG002|COMPLETED|Overall Study||19||
48496564|NCT02637141|101550949|FG000|NOT COMPLETED|Overall Study||2||
48496565|NCT02637141|101550950|FG001|NOT COMPLETED|Overall Study||2||
48496566|NCT02637141|101550951|FG002|NOT COMPLETED|Overall Study||1||
48496567|NCT01196390|101550952|FG000|STARTED|Overall Study||102||
48496568|NCT01196390|101550953|FG001|STARTED|Overall Study||101||
48496569|NCT01196390|101550952|FG000|Eligible|Overall Study||98||
48496570|NCT01196390|101550953|FG001|Eligible|Overall Study||96||
48496571|NCT01196390|101550952|FG000|Eligible and Started Study Treatment|Overall Study||95||
48496572|NCT01196390|101550953|FG001|Eligible and Started Study Treatment|Overall Study||96||
48496573|NCT01196390|101550952|FG000|Eligible and Had Surgery|Overall Study||82||
48496574|NCT01196390|101550953|FG001|Eligible and Had Surgery|Overall Study||78||
48496575|NCT01196390|101550952|FG000|Eligible and Consented to Quality of Life Component|Overall Study||88||
48496576|NCT01196390|101550953|FG001|Eligible and Consented to Quality of Life Component|Overall Study||83||
48496577|NCT01196390|101550952|FG000|COMPLETED|Overall Study||98|Participants contributing data to results are considered to have completed the study|
48496578|NCT01196390|101550953|FG001|COMPLETED|Overall Study||96|Participants contributing data to results are considered to have completed the study|
48496579|NCT01196390|101550952|FG000|NOT COMPLETED|Overall Study||4||
48496580|NCT01196390|101550953|FG001|NOT COMPLETED|Overall Study||5||
48496581|NCT03827395|101550954|FG000|STARTED|Overall Study||20||
48496582|NCT03827395|101550955|FG001|STARTED|Overall Study||5||
48496583|NCT03827395|101550954|FG000|COMPLETED|Overall Study||17||
48496584|NCT03827395|101550955|FG001|COMPLETED|Overall Study||3||
48496585|NCT03827395|101550954|FG000|NOT COMPLETED|Overall Study||3||
48496586|NCT03827395|101550955|FG001|NOT COMPLETED|Overall Study||2||
48496587|NCT00918684|101550956|FG000|STARTED|Two Week Drug Washout and Placebo Phase||106||
48496588|NCT00918684|101550956|FG000|COMPLETED|Two Week Drug Washout and Placebo Phase||90||
48496589|NCT00918684|101550956|FG000|NOT COMPLETED|Two Week Drug Washout and Placebo Phase||16||
48496590|NCT00918684|101550956|FG000|STARTED|Treatment Phase||90||
48496591|NCT00918684|101550956|FG000|COMPLETED|Treatment Phase||65||
48496592|NCT00918684|101550956|FG000|NOT COMPLETED|Treatment Phase||25||
48496593|NCT01867658|101550957|FG000|STARTED|Overall Study||112||
48496594|NCT01867658|101550957|FG000|COMPLETED|Overall Study||103||
48496595|NCT01867658|101550957|FG000|NOT COMPLETED|Overall Study||9||
48496596|NCT00840203|101550958|FG000|STARTED|First Intervention||37||
48496597|NCT00840203|101550959|FG001|STARTED|First Intervention||35||
48496598|NCT00840203|101550958|FG000|COMPLETED|First Intervention||36||
48496599|NCT00840203|101550959|FG001|COMPLETED|First Intervention||34||
48496600|NCT00840203|101550958|FG000|NOT COMPLETED|First Intervention||1||
48496601|NCT00840203|101550959|FG001|NOT COMPLETED|First Intervention||1||
48496602|NCT00840203|101550958|FG000|STARTED|Washout||36||
48496603|NCT00840203|101550959|FG001|STARTED|Washout||34||
48496604|NCT00840203|101550958|FG000|COMPLETED|Washout||35||
48496605|NCT00840203|101550959|FG001|COMPLETED|Washout||34||
48496606|NCT00840203|101550958|FG000|NOT COMPLETED|Washout||1||
48496607|NCT00840203|101550959|FG001|NOT COMPLETED|Washout||0||
48496608|NCT00840203|101550958|FG000|STARTED|Second Intervention||35||
48496609|NCT00840203|101550959|FG001|STARTED|Second Intervention||34||
48496610|NCT00840203|101550958|FG000|COMPLETED|Second Intervention||35||
48496611|NCT00840203|101550959|FG001|COMPLETED|Second Intervention||34||
48496612|NCT00840203|101550958|FG000|NOT COMPLETED|Second Intervention||0||
48496613|NCT00840203|101550959|FG001|NOT COMPLETED|Second Intervention||0||
48496614|NCT02888756|101550960|FG000|STARTED|Vaccination Period||16||
48496615|NCT02888756|101550961|FG001|STARTED|Vaccination Period||9||
48496616|NCT02888756|101550962|FG002|STARTED|Vaccination Period||8||
48496617|NCT02888756|101550960|FG000|COMPLETED|Vaccination Period||16||
48496618|NCT02888756|101550961|FG001|COMPLETED|Vaccination Period||9||
48496619|NCT02888756|101550962|FG002|COMPLETED|Vaccination Period||8||
48496620|NCT02888756|101550960|FG000|NOT COMPLETED|Vaccination Period||0||
48496621|NCT02888756|101550961|FG001|NOT COMPLETED|Vaccination Period||0||
48496622|NCT02888756|101550962|FG002|NOT COMPLETED|Vaccination Period||0||
48496623|NCT02888756|101550960|FG000|STARTED|Analytical Treatment Interruption||15|One participant did not start treatment interruption|
48496624|NCT02888756|101550961|FG001|STARTED|Analytical Treatment Interruption||9|One participant did not start treatment interruption|
48496625|NCT02888756|101550962|FG002|STARTED|Analytical Treatment Interruption||8|One participant did not start treatment interruption|
48496626|NCT02888756|101550960|FG000|COMPLETED|Analytical Treatment Interruption||5||
48496627|NCT02888756|101550961|FG001|COMPLETED|Analytical Treatment Interruption||3||
48496628|NCT02888756|101550962|FG002|COMPLETED|Analytical Treatment Interruption||3||
48496629|NCT02888756|101550960|FG000|NOT COMPLETED|Analytical Treatment Interruption||10||
48496630|NCT02888756|101550961|FG001|NOT COMPLETED|Analytical Treatment Interruption||6||
48496631|NCT02888756|101550962|FG002|NOT COMPLETED|Analytical Treatment Interruption||5||
48496632|NCT03276559|101550963|FG000|STARTED|T1 Assessment||0||
48496633|NCT03276559|101550964|FG001|STARTED|T1 Assessment||0||
48496634|NCT03276559|101550965|FG002|STARTED|T1 Assessment||0||
48496635|NCT03276559|101550966|FG003|STARTED|T1 Assessment||63||
48496636|NCT03276559|101550963|FG000|COMPLETED|T1 Assessment||0||
48496637|NCT03276559|101550964|FG001|COMPLETED|T1 Assessment||0||
48496638|NCT03276559|101550965|FG002|COMPLETED|T1 Assessment||0||
48496639|NCT03276559|101550966|FG003|COMPLETED|T1 Assessment||63||
48496640|NCT03276559|101550963|FG000|NOT COMPLETED|T1 Assessment||0||
48496641|NCT03276559|101550964|FG001|NOT COMPLETED|T1 Assessment||0||
48496642|NCT03276559|101550965|FG002|NOT COMPLETED|T1 Assessment||0||
48496643|NCT03276559|101550966|FG003|NOT COMPLETED|T1 Assessment||0||
48496644|NCT03276559|101550963|FG000|STARTED|Randomization||10|Please note that the 25 EMPOWER-Only subjects in the Open trial COVID-19 phase arm are different from the 17 subjects enrolled in the earlier period, and are different than the 20 subjects enrolled in the later period.|
48496645|NCT03276559|101550964|FG001|STARTED|Randomization||7|Please note that the 25 EMPOWER-Only subjects in the Open trial COVID-19 phase arm are different from the 17 subjects enrolled in the earlier period, and are different than the 20 subjects enrolled in the later period.|
48496646|NCT03276559|101550965|FG002|STARTED|Randomization||0|Please note that the 25 EMPOWER-Only subjects in the Open trial COVID-19 phase arm are different from the 17 subjects enrolled in the earlier period, and are different than the 20 subjects enrolled in the later period.|
48496647|NCT03276559|101550966|FG003|STARTED|Randomization||0|Please note that the 25 EMPOWER-Only subjects in the Open trial COVID-19 phase arm are different from the 17 subjects enrolled in the earlier period, and are different than the 20 subjects enrolled in the later period.|
48496648|NCT03276559|101550963|FG000|COMPLETED|Randomization||5||
48496649|NCT03276559|101550964|FG001|COMPLETED|Randomization||5||
48496650|NCT03276559|101550965|FG002|COMPLETED|Randomization||0||
48496651|NCT03276559|101550966|FG003|COMPLETED|Randomization||0||
48496652|NCT03276559|101550963|FG000|NOT COMPLETED|Randomization||5||
48496653|NCT03276559|101550964|FG001|NOT COMPLETED|Randomization||2||
48496654|NCT03276559|101550965|FG002|NOT COMPLETED|Randomization||0||
48496655|NCT03276559|101550966|FG003|NOT COMPLETED|Randomization||0||
48496656|NCT03276559|101550963|FG000|STARTED|EMPOWER Only||0||
48496657|NCT03276559|101550964|FG001|STARTED|EMPOWER Only||0||
48496658|NCT03276559|101550965|FG002|STARTED|EMPOWER Only||23||
48496659|NCT03276559|101550966|FG003|STARTED|EMPOWER Only||0||
48496660|NCT03276559|101550963|FG000|COMPLETED|EMPOWER Only||0||
48496661|NCT03276559|101550964|FG001|COMPLETED|EMPOWER Only||0||
48496662|NCT03276559|101550965|FG002|COMPLETED|EMPOWER Only||14||
48496663|NCT03276559|101550966|FG003|COMPLETED|EMPOWER Only||0||
48496664|NCT03276559|101550963|FG000|NOT COMPLETED|EMPOWER Only||0||
48666744|NCT03391882|101970467|FG002|Modified Intent-to-Treat Population Part A|Part A - Titration Phase||19||
48496665|NCT03276559|101550964|FG001|NOT COMPLETED|EMPOWER Only||0||
48496666|NCT03276559|101550965|FG002|NOT COMPLETED|EMPOWER Only||9||
48496667|NCT03276559|101550966|FG003|NOT COMPLETED|EMPOWER Only||0||
48496668|NCT03276559|101550963|FG000|STARTED|Randomization||10||
48496669|NCT03276559|101550964|FG001|STARTED|Randomization||10||
48496670|NCT03276559|101550965|FG002|STARTED|Randomization||0||
48496671|NCT03276559|101550966|FG003|STARTED|Randomization||0||
48496672|NCT03276559|101550963|FG000|COMPLETED|Randomization||5||
48496673|NCT03276559|101550964|FG001|COMPLETED|Randomization||6||
48496674|NCT03276559|101550965|FG002|COMPLETED|Randomization||0||
48496675|NCT03276559|101550966|FG003|COMPLETED|Randomization||0||
48496676|NCT03276559|101550963|FG000|NOT COMPLETED|Randomization||5||
48496677|NCT03276559|101550964|FG001|NOT COMPLETED|Randomization||4||
48496678|NCT03276559|101550965|FG002|NOT COMPLETED|Randomization||0||
48496679|NCT03276559|101550966|FG003|NOT COMPLETED|Randomization||0||
48496680|NCT04436198|101550967|FG000|STARTED|Overall Study||7|A single participant contributed 1 eye to treatment group and 1 eye to control group and is therefore double counted. There were actually 12 participants, not 13.|7
48496681|NCT04436198|101550968|FG001|STARTED|Overall Study||6|A single participant contributed 1 eye to treatment group and 1 eye to control group and is therefore double counted. There were actually 12 participants, not 13.|6
48496682|NCT04436198|101550967|FG000|COMPLETED|Overall Study||5||5
48496683|NCT04436198|101550968|FG001|COMPLETED|Overall Study||3||3
48496684|NCT04436198|101550967|FG000|NOT COMPLETED|Overall Study||2||2
48496685|NCT04436198|101550968|FG001|NOT COMPLETED|Overall Study||3||3
48496686|NCT01885897|101550969|FG000|STARTED|Overall Study||6||
48496687|NCT01885897|101550970|FG001|STARTED|Overall Study||3||
48496688|NCT01885897|101550971|FG002|STARTED|Overall Study||4||
48496689|NCT01885897|101550972|FG003|STARTED|Overall Study||3||
48496690|NCT01885897|101550973|FG004|STARTED|Overall Study||8||
48496691|NCT01885897|101550974|FG005|STARTED|Overall Study||9||
48496692|NCT01885897|101550969|FG000|COMPLETED|Overall Study||6||
48496693|NCT01885897|101550970|FG001|COMPLETED|Overall Study||3||
48496694|NCT01885897|101550971|FG002|COMPLETED|Overall Study||4||
48496695|NCT01885897|101550972|FG003|COMPLETED|Overall Study||3||
48496696|NCT01885897|101550973|FG004|COMPLETED|Overall Study||8||
48496697|NCT01885897|101550974|FG005|COMPLETED|Overall Study||9||
48496698|NCT01885897|101550969|FG000|NOT COMPLETED|Overall Study||0||
48496699|NCT01885897|101550970|FG001|NOT COMPLETED|Overall Study||0||
48496700|NCT01885897|101550971|FG002|NOT COMPLETED|Overall Study||0||
48496701|NCT01885897|101550972|FG003|NOT COMPLETED|Overall Study||0||
48496702|NCT01885897|101550973|FG004|NOT COMPLETED|Overall Study||0||
48496703|NCT01885897|101550974|FG005|NOT COMPLETED|Overall Study||0||
48496704|NCT00529191|101550975|FG000|STARTED|Overall Study||27||
48496705|NCT00529191|101550976|FG001|STARTED|Overall Study||13||
48061003|NCT00055224|100470332|FG001|COMPLETED|Substudy 5||36||
48061004|NCT00055224|100470331|FG000|NOT COMPLETED|Substudy 5||0||
48061005|NCT00055224|100470332|FG001|NOT COMPLETED|Substudy 5||0||
48061006|NCT00055224|100470331|FG000|STARTED|Substudy 7||65||
48061007|NCT00055224|100470332|FG001|STARTED|Substudy 7||91||
48061008|NCT00055224|100470331|FG000|COMPLETED|Substudy 7||65||
48061009|NCT00055224|100470332|FG001|COMPLETED|Substudy 7||91||
48496706|NCT00529191|101550975|FG000|COMPLETED|Overall Study||24||
48496707|NCT00529191|101550976|FG001|COMPLETED|Overall Study||13||
48496708|NCT00529191|101550975|FG000|NOT COMPLETED|Overall Study||3||
48496709|NCT00529191|101550976|FG001|NOT COMPLETED|Overall Study||0||
48496710|NCT00835146|101550977|FG000|STARTED|First Intervention||14||
48496711|NCT00835146|101550978|FG001|STARTED|First Intervention||14||
48496712|NCT00835146|101550977|FG000|COMPLETED|First Intervention||14||
48496713|NCT00835146|101550978|FG001|COMPLETED|First Intervention||14||
48496714|NCT00835146|101550977|FG000|NOT COMPLETED|First Intervention||0||
48496715|NCT00835146|101550978|FG001|NOT COMPLETED|First Intervention||0||
48496716|NCT00835146|101550977|FG000|STARTED|Washout of 5 Weeks||14||
48496717|NCT00835146|101550978|FG001|STARTED|Washout of 5 Weeks||14||
48496718|NCT00835146|101550977|FG000|COMPLETED|Washout of 5 Weeks||14||
48496719|NCT00835146|101550978|FG001|COMPLETED|Washout of 5 Weeks||14||
48496720|NCT00835146|101550977|FG000|NOT COMPLETED|Washout of 5 Weeks||0||
48496721|NCT00835146|101550978|FG001|NOT COMPLETED|Washout of 5 Weeks||0||
48496722|NCT00835146|101550977|FG000|STARTED|Second Intervention||14||
48496723|NCT00835146|101550978|FG001|STARTED|Second Intervention||14||
48496724|NCT00835146|101550977|FG000|COMPLETED|Second Intervention||14||
48496725|NCT00835146|101550978|FG001|COMPLETED|Second Intervention||14||
48496726|NCT00835146|101550977|FG000|NOT COMPLETED|Second Intervention||0||
48496727|NCT00835146|101550978|FG001|NOT COMPLETED|Second Intervention||0||
48496728|NCT01566435|101550979|FG000|STARTED|ACF Induction Therapy||30||
48496729|NCT01566435|101550979|FG000|COMPLETED|ACF Induction Therapy||30||
48496730|NCT01566435|101550979|FG000|NOT COMPLETED|ACF Induction Therapy||0||
48496731|NCT01566435|101550979|FG000|STARTED|ACF Definitive Chemoradiation-cisplatin||28||
48496732|NCT01566435|101550979|FG000|COMPLETED|ACF Definitive Chemoradiation-cisplatin||27||
48496733|NCT01566435|101550979|FG000|NOT COMPLETED|ACF Definitive Chemoradiation-cisplatin||1||
48496734|NCT01566435|101550979|FG000|STARTED|ACF Definitive Chemoradiation-cetuximab||2||
48061010|NCT00055224|100470331|FG000|NOT COMPLETED|Substudy 7||0||
48061011|NCT00055224|100470332|FG001|NOT COMPLETED|Substudy 7||0||
48061012|NCT00055224|100470331|FG000|STARTED|Pilot Tasks||406||
48496735|NCT01566435|101550979|FG000|COMPLETED|ACF Definitive Chemoradiation-cetuximab||2||
48496736|NCT01566435|101550979|FG000|NOT COMPLETED|ACF Definitive Chemoradiation-cetuximab||0||
48496737|NCT00731939|101550980|FG000|STARTED|Overall Study||124||
48496738|NCT00731939|101550980|FG000|COMPLETED|Overall Study||90||
48496739|NCT00731939|101550980|FG000|NOT COMPLETED|Overall Study||34||
48496740|NCT01490190|101550981|FG000|STARTED|Overall Study||252||
48496741|NCT01490190|101550981|FG000|COMPLETED|Overall Study||204||
48496742|NCT01490190|101550981|FG000|NOT COMPLETED|Overall Study||48||
48496743|NCT01046084|101550982|FG000|STARTED|First Intervention||25||
48496744|NCT01046084|101550983|FG001|STARTED|First Intervention||25||
48496745|NCT01046084|101550982|FG000|COMPLETED|First Intervention||25||
48496746|NCT01046084|101550983|FG001|COMPLETED|First Intervention||25||
48496747|NCT01046084|101550982|FG000|NOT COMPLETED|First Intervention||0||
48496748|NCT01046084|101550983|FG001|NOT COMPLETED|First Intervention||0||
48496749|NCT01046084|101550982|FG000|STARTED|First Washout of 7 Days||25||
48496750|NCT01046084|101550983|FG001|STARTED|First Washout of 7 Days||25||
48496751|NCT01046084|101550982|FG000|COMPLETED|First Washout of 7 Days||25||
48496752|NCT01046084|101550983|FG001|COMPLETED|First Washout of 7 Days||25||
48496753|NCT01046084|101550982|FG000|NOT COMPLETED|First Washout of 7 Days||0||
48496754|NCT01046084|101550983|FG001|NOT COMPLETED|First Washout of 7 Days||0||
48496755|NCT01046084|101550982|FG000|STARTED|Second Intervention||25||
48496756|NCT01046084|101550983|FG001|STARTED|Second Intervention||25||
48496757|NCT01046084|101550982|FG000|COMPLETED|Second Intervention||25||
48496758|NCT01046084|101550983|FG001|COMPLETED|Second Intervention||25||
48496759|NCT01046084|101550982|FG000|NOT COMPLETED|Second Intervention||0||
48496760|NCT01046084|101550983|FG001|NOT COMPLETED|Second Intervention||0||
48496761|NCT01046084|101550982|FG000|STARTED|Second Washout of 7 Days||25||
48496762|NCT01046084|101550983|FG001|STARTED|Second Washout of 7 Days||25||
48496763|NCT01046084|101550982|FG000|COMPLETED|Second Washout of 7 Days||25||
48496764|NCT01046084|101550983|FG001|COMPLETED|Second Washout of 7 Days||25||
48496765|NCT01046084|101550982|FG000|NOT COMPLETED|Second Washout of 7 Days||0||
48496766|NCT01046084|101550983|FG001|NOT COMPLETED|Second Washout of 7 Days||0||
48496767|NCT01046084|101550982|FG000|STARTED|Third Intervention||25||
48496768|NCT01046084|101550983|FG001|STARTED|Third Intervention||25||
48496769|NCT01046084|101550982|FG000|COMPLETED|Third Intervention||25||
48496770|NCT01046084|101550983|FG001|COMPLETED|Third Intervention||25||
48496771|NCT01046084|101550982|FG000|NOT COMPLETED|Third Intervention||0||
48496772|NCT01046084|101550983|FG001|NOT COMPLETED|Third Intervention||0||
48496773|NCT01046084|101550982|FG000|STARTED|Third Washout of 7 Days||25||
48496774|NCT01046084|101550983|FG001|STARTED|Third Washout of 7 Days||25||
48496775|NCT01046084|101550982|FG000|COMPLETED|Third Washout of 7 Days||23||
48496776|NCT01046084|101550983|FG001|COMPLETED|Third Washout of 7 Days||25||
48496777|NCT01046084|101550982|FG000|NOT COMPLETED|Third Washout of 7 Days||2||
48496778|NCT01046084|101550983|FG001|NOT COMPLETED|Third Washout of 7 Days||0||
48496779|NCT01046084|101550982|FG000|STARTED|Fourth Intervention||23||
48496780|NCT01046084|101550983|FG001|STARTED|Fourth Intervention||25||
48496781|NCT01046084|101550982|FG000|COMPLETED|Fourth Intervention||23||
48496782|NCT01046084|101550983|FG001|COMPLETED|Fourth Intervention||25||
48496783|NCT01046084|101550982|FG000|NOT COMPLETED|Fourth Intervention||0||
48496784|NCT01046084|101550983|FG001|NOT COMPLETED|Fourth Intervention||0||
48496785|NCT04299087|101550984|FG000|STARTED|Overall Study||11||
48496786|NCT04299087|101550985|FG001|STARTED|Overall Study||1||
48496787|NCT04299087|101550984|FG000|COMPLETED|Overall Study||9||
48496788|NCT04299087|101550985|FG001|COMPLETED|Overall Study||0||
48496789|NCT04299087|101550984|FG000|NOT COMPLETED|Overall Study||2||
48496790|NCT04299087|101550985|FG001|NOT COMPLETED|Overall Study||1||
48496791|NCT00284518|101550986|FG000|STARTED|Overall Study||97||
48496792|NCT00284518|101550987|FG001|STARTED|Overall Study||94||
48496793|NCT00284518|101550988|FG002|STARTED|Overall Study||95||
48496794|NCT00284518|101550989|FG003|STARTED|Overall Study||94||
48496795|NCT00284518|101550986|FG000|COMPLETED|Overall Study||71||
48496796|NCT00284518|101550987|FG001|COMPLETED|Overall Study||66||
48496797|NCT00284518|101550988|FG002|COMPLETED|Overall Study||67||
48496798|NCT00284518|101550989|FG003|COMPLETED|Overall Study||61||
48496799|NCT00284518|101550986|FG000|NOT COMPLETED|Overall Study||26||
48496800|NCT00284518|101550987|FG001|NOT COMPLETED|Overall Study||28||
48496801|NCT00284518|101550988|FG002|NOT COMPLETED|Overall Study||28||
48496802|NCT00284518|101550989|FG003|NOT COMPLETED|Overall Study||33||
48496803|NCT01174186|101550990|FG000|STARTED|Overall Study||15||
48496804|NCT01174186|101550991|FG001|STARTED|Overall Study||15||
48496805|NCT01174186|101550990|FG000|COMPLETED|Overall Study||15||
48496806|NCT01174186|101550991|FG001|COMPLETED|Overall Study||12||
48496807|NCT01174186|101550990|FG000|NOT COMPLETED|Overall Study||0||
48496808|NCT01174186|101550991|FG001|NOT COMPLETED|Overall Study||3||
48496809|NCT03209505|101550992|FG000|STARTED|Overall Study||10||20
48496810|NCT03209505|101550993|FG001|STARTED|Overall Study||10||20
48496811|NCT03209505|101550992|FG000|COMPLETED|Overall Study||10||20
48496812|NCT03209505|101550993|FG001|COMPLETED|Overall Study||10||20
48496813|NCT03209505|101550992|FG000|NOT COMPLETED|Overall Study||0||0
48496814|NCT03209505|101550993|FG001|NOT COMPLETED|Overall Study||0||0
48496815|NCT01083693|101550994|FG000|STARTED|Overall Study||93||
48496816|NCT01083693|101550995|FG001|STARTED|Overall Study||28||
48496817|NCT01083693|101550996|FG002|STARTED|Overall Study||40||
48496818|NCT01083693|101550994|FG000|COMPLETED|Overall Study||73||
48496819|NCT01083693|101550995|FG001|COMPLETED|Overall Study||22||
48496820|NCT01083693|101550996|FG002|COMPLETED|Overall Study||33||
48496821|NCT01083693|101550994|FG000|NOT COMPLETED|Overall Study||20||
48496822|NCT01083693|101550995|FG001|NOT COMPLETED|Overall Study||6||
48496823|NCT01083693|101550996|FG002|NOT COMPLETED|Overall Study||7||
48496824|NCT01442376|101550997|FG000|STARTED|Overall Study||169||
48496825|NCT01442376|101550998|FG001|STARTED|Overall Study||169||
48496826|NCT01442376|101550999|FG002|STARTED|Overall Study||164||
48496827|NCT01442376|101550997|FG000|COMPLETED|Overall Study||166||
48496828|NCT01442376|101550998|FG001|COMPLETED|Overall Study||160||
48496829|NCT01442376|101550999|FG002|COMPLETED|Overall Study||159||
48496830|NCT01442376|101550997|FG000|NOT COMPLETED|Overall Study||3||
48496831|NCT01442376|101550998|FG001|NOT COMPLETED|Overall Study||9||
48496832|NCT01442376|101550999|FG002|NOT COMPLETED|Overall Study||5||
48496833|NCT01562613|101551000|FG000|STARTED|Overall Study||533||
48496834|NCT01562613|101551000|FG000|COMPLETED|Overall Study||529||
48496835|NCT01562613|101551000|FG000|NOT COMPLETED|Overall Study||4||
48496836|NCT04808362|101551001|FG000|STARTED|Overall Study||22||
48496837|NCT04808362|101551001|FG000|COMPLETED|Overall Study||22||
48496838|NCT04808362|101551001|FG000|NOT COMPLETED|Overall Study||0||
48496839|NCT00070291|101551002|FG000|STARTED|Step 1||4||
48496840|NCT00070291|101551002|FG000|Treated|Step 1||3||
48496841|NCT00070291|101551002|FG000|COMPLETED|Step 1||2||
48496842|NCT00070291|101551002|FG000|NOT COMPLETED|Step 1||2||
48496843|NCT00070291|101551002|FG000|STARTED|Step 2||1||
48496844|NCT00070291|101551002|FG000|COMPLETED|Step 2||0||
48496845|NCT00070291|101551002|FG000|NOT COMPLETED|Step 2||1||
48496846|NCT02463981|101551003|FG000|STARTED|Overall Study||21||
48496847|NCT02463981|101551004|FG001|STARTED|Overall Study||16||
48496848|NCT02463981|101551003|FG000|COMPLETED|Overall Study||18||
48496849|NCT02463981|101551004|FG001|COMPLETED|Overall Study||14||
48496850|NCT02463981|101551003|FG000|NOT COMPLETED|Overall Study||3||
48496851|NCT02463981|101551004|FG001|NOT COMPLETED|Overall Study||2||
48496852|NCT01597791|101551005|FG000|STARTED|Overall Study||28||
48496853|NCT01597791|101551006|FG001|STARTED|Overall Study||28||
48496854|NCT01597791|101551005|FG000|COMPLETED|Overall Study||20||
48496855|NCT01597791|101551006|FG001|COMPLETED|Overall Study||18||
48496856|NCT01597791|101551005|FG000|NOT COMPLETED|Overall Study||8||
48496857|NCT01597791|101551006|FG001|NOT COMPLETED|Overall Study||10||
48496858|NCT00834444|101551007|FG000|STARTED|First Intervention||18||
48496859|NCT00834444|101551008|FG001|STARTED|First Intervention||18||
48496860|NCT00834444|101551007|FG000|COMPLETED|First Intervention||17||
48496861|NCT00834444|101551008|FG001|COMPLETED|First Intervention||17||
48496862|NCT00834444|101551007|FG000|NOT COMPLETED|First Intervention||1||
48496863|NCT00834444|101551008|FG001|NOT COMPLETED|First Intervention||1||
48496864|NCT00834444|101551007|FG000|STARTED|Washout of 7 Days||17||
48496865|NCT00834444|101551008|FG001|STARTED|Washout of 7 Days||17||
48496866|NCT00834444|101551007|FG000|COMPLETED|Washout of 7 Days||17||
48496867|NCT00834444|101551008|FG001|COMPLETED|Washout of 7 Days||16||
48496868|NCT00834444|101551007|FG000|NOT COMPLETED|Washout of 7 Days||0||
48496869|NCT00834444|101551008|FG001|NOT COMPLETED|Washout of 7 Days||1||
48496870|NCT00834444|101551007|FG000|STARTED|Second Intervention||17||
48496871|NCT00834444|101551008|FG001|STARTED|Second Intervention||16||
48496872|NCT00834444|101551007|FG000|COMPLETED|Second Intervention||16||
48496873|NCT00834444|101551008|FG001|COMPLETED|Second Intervention||16||
48496874|NCT00834444|101551007|FG000|NOT COMPLETED|Second Intervention||1||
48496875|NCT00834444|101551008|FG001|NOT COMPLETED|Second Intervention||0||
48496876|NCT01751087|101551009|FG000|STARTED|Overall Study||100||
48496877|NCT01751087|101551010|FG001|STARTED|Overall Study||100||
48496878|NCT01751087|101551011|FG002|STARTED|Overall Study||100||
48496879|NCT01751087|101551009|FG000|COMPLETED|Overall Study||99||
48496880|NCT01751087|101551010|FG001|COMPLETED|Overall Study||100||
48496881|NCT01751087|101551011|FG002|COMPLETED|Overall Study||99||
48496882|NCT01751087|101551009|FG000|NOT COMPLETED|Overall Study||1||
48496883|NCT01751087|101551010|FG001|NOT COMPLETED|Overall Study||0||
48496884|NCT01751087|101551011|FG002|NOT COMPLETED|Overall Study||1||
48496885|NCT00728754|101551012|FG000|STARTED|Implant Placement Surgery||29||
48496886|NCT00728754|101551013|FG001|STARTED|Implant Placement Surgery||32||
48496887|NCT00728754|101551012|FG000|COMPLETED|Implant Placement Surgery||29||
48496888|NCT00728754|101551013|FG001|COMPLETED|Implant Placement Surgery||32||
48496889|NCT00728754|101551012|FG000|NOT COMPLETED|Implant Placement Surgery||0||
48496890|NCT00728754|101551013|FG001|NOT COMPLETED|Implant Placement Surgery||0||
48496891|NCT00728754|101551012|FG000|STARTED|Permanent Prosthesis Placement||29||
48496892|NCT00728754|101551013|FG001|STARTED|Permanent Prosthesis Placement||32||
48496893|NCT00728754|101551012|FG000|COMPLETED|Permanent Prosthesis Placement||25||
48496894|NCT00728754|101551013|FG001|COMPLETED|Permanent Prosthesis Placement||28||
48496895|NCT00728754|101551012|FG000|NOT COMPLETED|Permanent Prosthesis Placement||4||
48496896|NCT00728754|101551013|FG001|NOT COMPLETED|Permanent Prosthesis Placement||4||
48496897|NCT00728754|101551012|FG000|STARTED|One Year Post Placement Follow-up||25||
48496898|NCT00728754|101551013|FG001|STARTED|One Year Post Placement Follow-up||28||
48496899|NCT00728754|101551012|FG000|COMPLETED|One Year Post Placement Follow-up||24||
48496900|NCT00728754|101551013|FG001|COMPLETED|One Year Post Placement Follow-up||28||
48496901|NCT00728754|101551012|FG000|NOT COMPLETED|One Year Post Placement Follow-up||1||
48496902|NCT00728754|101551013|FG001|NOT COMPLETED|One Year Post Placement Follow-up||0||
48496903|NCT00728754|101551012|FG000|STARTED|Two Year Post Placement Follow-up||24||
48496904|NCT00728754|101551013|FG001|STARTED|Two Year Post Placement Follow-up||28||
48496905|NCT00728754|101551012|FG000|COMPLETED|Two Year Post Placement Follow-up||24||
48496906|NCT00728754|101551013|FG001|COMPLETED|Two Year Post Placement Follow-up||28||
48496907|NCT00728754|101551012|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||0||
48496908|NCT00728754|101551013|FG001|NOT COMPLETED|Two Year Post Placement Follow-up||0||
48496909|NCT03544216|101551014|FG000|STARTED|Overall Study||42||
48496910|NCT03544216|101551015|FG001|STARTED|Overall Study||42||
48496911|NCT03544216|101551014|FG000|COMPLETED|Overall Study||42||
48496912|NCT03544216|101551015|FG001|COMPLETED|Overall Study||42||
48496913|NCT03544216|101551014|FG000|NOT COMPLETED|Overall Study||0||
48496914|NCT03544216|101551015|FG001|NOT COMPLETED|Overall Study||0||
48496915|NCT02277093|101551016|FG000|STARTED|Overall Study||11||
48496916|NCT02277093|101551016|FG000|COMPLETED|Overall Study||11||
48496917|NCT02277093|101551016|FG000|NOT COMPLETED|Overall Study||0||
48496918|NCT00795821|101551017|FG000|STARTED|Acute Treatment Phase||250||
48496919|NCT00795821|101551018|FG001|STARTED|Acute Treatment Phase||245||
48496920|NCT00795821|101551017|FG000|COMPLETED|Acute Treatment Phase||194||
48496921|NCT00795821|101551018|FG001|COMPLETED|Acute Treatment Phase||214||
48496922|NCT00795821|101551017|FG000|NOT COMPLETED|Acute Treatment Phase||56||
48496923|NCT00795821|101551018|FG001|NOT COMPLETED|Acute Treatment Phase||31||
48496924|NCT00795821|101551017|FG000|STARTED|Long-term Extension Phase||190||
48496925|NCT00795821|101551018|FG001|STARTED|Long-term Extension Phase||207||
48496926|NCT00795821|101551017|FG000|COMPLETED|Long-term Extension Phase||100||
48496927|NCT00795821|101551018|FG001|COMPLETED|Long-term Extension Phase||115||
48496928|NCT00795821|101551017|FG000|NOT COMPLETED|Long-term Extension Phase||90||
48496929|NCT00795821|101551018|FG001|NOT COMPLETED|Long-term Extension Phase||92||
48496930|NCT00795821|101551017|FG000|STARTED|Taper Phase||240||
48496931|NCT00795821|101551018|FG001|STARTED|Taper Phase||6||
48496932|NCT00795821|101551017|FG000|COMPLETED|Taper Phase||231||
48496933|NCT00795821|101551018|FG001|COMPLETED|Taper Phase||6||
48496934|NCT00795821|101551017|FG000|NOT COMPLETED|Taper Phase||9||
48496935|NCT00795821|101551018|FG001|NOT COMPLETED|Taper Phase||0||
48496936|NCT01007994|101551019|FG000|STARTED|Overall Study||17||
48496937|NCT01007994|101551020|FG001|STARTED|Overall Study||16||
48496938|NCT01007994|101551019|FG000|COMPLETED|Overall Study||15||
48496939|NCT01007994|101551020|FG001|COMPLETED|Overall Study||14||
48496940|NCT01007994|101551019|FG000|NOT COMPLETED|Overall Study||2||
48496941|NCT01007994|101551020|FG001|NOT COMPLETED|Overall Study||2||
48496942|NCT01412281|101551021|FG000|STARTED|Overall Study||110||
48496943|NCT01412281|101551022|FG001|STARTED|Overall Study||110||
48496944|NCT01412281|101551023|FG002|STARTED|Overall Study||110||
48496945|NCT01412281|101551024|FG003|STARTED|Overall Study||110||
48496946|NCT01412281|101551021|FG000|COMPLETED|Overall Study||110||
48496947|NCT01412281|101551022|FG001|COMPLETED|Overall Study||110||
48496948|NCT01412281|101551023|FG002|COMPLETED|Overall Study||110||
48496949|NCT01412281|101551024|FG003|COMPLETED|Overall Study||110||
48496950|NCT01412281|101551021|FG000|NOT COMPLETED|Overall Study||0||
48496951|NCT01412281|101551022|FG001|NOT COMPLETED|Overall Study||0||
48496952|NCT01412281|101551023|FG002|NOT COMPLETED|Overall Study||0||
48496953|NCT01412281|101551024|FG003|NOT COMPLETED|Overall Study||0||
48496954|NCT03405363|101551025|FG000|STARTED|Overall Study||14239||
48496955|NCT03405363|101551026|FG001|STARTED|Overall Study||51167||
48496956|NCT03405363|101551025|FG000|COMPLETED|Overall Study||14239||
48496957|NCT03405363|101551026|FG001|COMPLETED|Overall Study||51167||
48496958|NCT03405363|101551025|FG000|NOT COMPLETED|Overall Study||0||
48496959|NCT03405363|101551026|FG001|NOT COMPLETED|Overall Study||0||
48496960|NCT01285713|101551027|FG000|STARTED|Overall Study||42||
48496961|NCT01285713|101551028|FG001|STARTED|Overall Study||41||
48496962|NCT01285713|101551027|FG000|COMPLETED|Overall Study||42||
48496963|NCT01285713|101551028|FG001|COMPLETED|Overall Study||41||
48496964|NCT01285713|101551027|FG000|NOT COMPLETED|Overall Study||0||
48496965|NCT01285713|101551028|FG001|NOT COMPLETED|Overall Study||0||
48496966|NCT01647828|101551029|FG000|STARTED|Overall Study||5||
48496967|NCT01647828|101551030|FG001|STARTED|Overall Study||4||
48496968|NCT01647828|101551031|FG002|STARTED|Overall Study||4||
48496969|NCT01647828|101551032|FG003|STARTED|Overall Study||6||
48496970|NCT01647828|101551033|FG004|STARTED|Overall Study||6||
48496971|NCT01647828|101551034|FG005|STARTED|Overall Study||3||
48496972|NCT01647828|101551035|FG006|STARTED|Overall Study||12||
48496973|NCT01647828|101551036|FG007|STARTED|Overall Study||88||
48496974|NCT01647828|101551037|FG008|STARTED|Overall Study||89||
48496975|NCT01647828|101551029|FG000|COMPLETED|Overall Study||0||
48496976|NCT01647828|101551030|FG001|COMPLETED|Overall Study||0||
48496977|NCT01647828|101551031|FG002|COMPLETED|Overall Study||0||
48496978|NCT01647828|101551032|FG003|COMPLETED|Overall Study||0||
48496979|NCT01647828|101551033|FG004|COMPLETED|Overall Study||0||
48496980|NCT01647828|101551034|FG005|COMPLETED|Overall Study||0||
48496981|NCT01647828|101551035|FG006|COMPLETED|Overall Study||0||
48496982|NCT01647828|101551036|FG007|COMPLETED|Overall Study||0||
48496983|NCT01647828|101551037|FG008|COMPLETED|Overall Study||0||
48496984|NCT01647828|101551029|FG000|NOT COMPLETED|Overall Study||5||
48496985|NCT01647828|101551030|FG001|NOT COMPLETED|Overall Study||4||
48496986|NCT01647828|101551031|FG002|NOT COMPLETED|Overall Study||4||
48496987|NCT01647828|101551032|FG003|NOT COMPLETED|Overall Study||6||
48496988|NCT01647828|101551033|FG004|NOT COMPLETED|Overall Study||6||
48496989|NCT01647828|101551034|FG005|NOT COMPLETED|Overall Study||3||
48496990|NCT01647828|101551035|FG006|NOT COMPLETED|Overall Study||12||
48496991|NCT01647828|101551036|FG007|NOT COMPLETED|Overall Study||88||
48496992|NCT01647828|101551037|FG008|NOT COMPLETED|Overall Study||89||
48496993|NCT00673660|101551038|FG000|STARTED|Overall Study||375||
48496994|NCT00673660|101551038|FG000|COMPLETED|Overall Study||268||
48496995|NCT00673660|101551038|FG000|NOT COMPLETED|Overall Study||107||
48496996|NCT01456962|101551039|FG000|STARTED|Overall Study||16||
48496997|NCT01456962|101551040|FG001|STARTED|Overall Study||20||
48496998|NCT01456962|101551039|FG000|COMPLETED|Overall Study||14||
48496999|NCT01456962|101551040|FG001|COMPLETED|Overall Study||19||
48497000|NCT01456962|101551039|FG000|NOT COMPLETED|Overall Study||2||
48497001|NCT01456962|101551040|FG001|NOT COMPLETED|Overall Study||1||
48497002|NCT02280863|101551041|FG000|STARTED|Android Platform||8||
48497003|NCT02280863|101551042|FG001|STARTED|Android Platform||0||
48497004|NCT02280863|101551041|FG000|COMPLETED|Android Platform||8||
48497005|NCT02280863|101551042|FG001|COMPLETED|Android Platform||0||
48497006|NCT02280863|101551041|FG000|NOT COMPLETED|Android Platform||0||
48497007|NCT02280863|101551042|FG001|NOT COMPLETED|Android Platform||0||
48497008|NCT02280863|101551041|FG000|STARTED|Integrated Platform||9||
48497009|NCT02280863|101551042|FG001|STARTED|Integrated Platform||15||
48497010|NCT02280863|101551041|FG000|COMPLETED|Integrated Platform||9||
48497011|NCT02280863|101551042|FG001|COMPLETED|Integrated Platform||14||
48497012|NCT02280863|101551041|FG000|NOT COMPLETED|Integrated Platform||0||
48497013|NCT02280863|101551042|FG001|NOT COMPLETED|Integrated Platform||1||
48497014|NCT04511208|101551043|FG000|STARTED|First Surgery||8||
48497015|NCT04511208|101551044|FG001|STARTED|First Surgery||7||
48497016|NCT04511208|101551045|FG002|STARTED|First Surgery||8||
48497017|NCT04511208|101551046|FG003|STARTED|First Surgery||7||
48497018|NCT04511208|101551043|FG000|COMPLETED|First Surgery||8||
48497019|NCT04511208|101551044|FG001|COMPLETED|First Surgery||7||
48497020|NCT04511208|101551045|FG002|COMPLETED|First Surgery||8||
48497021|NCT04511208|101551046|FG003|COMPLETED|First Surgery||7||
48497022|NCT04511208|101551043|FG000|NOT COMPLETED|First Surgery||0||
48497023|NCT04511208|101551044|FG001|NOT COMPLETED|First Surgery||0||
48497024|NCT04511208|101551045|FG002|NOT COMPLETED|First Surgery||0||
48497025|NCT04511208|101551046|FG003|NOT COMPLETED|First Surgery||0||
48497026|NCT04511208|101551043|FG000|STARTED|Second Surgery||8||
48497027|NCT04511208|101551044|FG001|STARTED|Second Surgery||7||
48497028|NCT04511208|101551045|FG002|STARTED|Second Surgery||8||
48497029|NCT04511208|101551046|FG003|STARTED|Second Surgery||7||
48497030|NCT04511208|101551043|FG000|COMPLETED|Second Surgery||8||
48497031|NCT04511208|101551044|FG001|COMPLETED|Second Surgery||7||
48497032|NCT04511208|101551045|FG002|COMPLETED|Second Surgery||8||
48497033|NCT04511208|101551046|FG003|COMPLETED|Second Surgery||7||
48497034|NCT04511208|101551043|FG000|NOT COMPLETED|Second Surgery||0||
48497035|NCT04511208|101551044|FG001|NOT COMPLETED|Second Surgery||0||
48497036|NCT04511208|101551045|FG002|NOT COMPLETED|Second Surgery||0||
48497037|NCT04511208|101551046|FG003|NOT COMPLETED|Second Surgery||0||
48497038|NCT04511208|101551043|FG000|STARTED|Third Surgery||8||
48497039|NCT04511208|101551044|FG001|STARTED|Third Surgery||7||
48497040|NCT04511208|101551045|FG002|STARTED|Third Surgery||8||
48497041|NCT04511208|101551046|FG003|STARTED|Third Surgery||7||
48497042|NCT04511208|101551043|FG000|COMPLETED|Third Surgery||8||
48497043|NCT04511208|101551044|FG001|COMPLETED|Third Surgery||7||
48497044|NCT04511208|101551045|FG002|COMPLETED|Third Surgery||8||
48497045|NCT04511208|101551046|FG003|COMPLETED|Third Surgery||7||
48497046|NCT04511208|101551043|FG000|NOT COMPLETED|Third Surgery||0||
48497047|NCT04511208|101551044|FG001|NOT COMPLETED|Third Surgery||0||
48497048|NCT04511208|101551045|FG002|NOT COMPLETED|Third Surgery||0||
48497049|NCT04511208|101551046|FG003|NOT COMPLETED|Third Surgery||0||
48497050|NCT04511208|101551043|FG000|STARTED|Forth Surgery||8||
48497051|NCT04511208|101551044|FG001|STARTED|Forth Surgery||7||
48497052|NCT04511208|101551045|FG002|STARTED|Forth Surgery||8||
48497053|NCT04511208|101551046|FG003|STARTED|Forth Surgery||7||
48497054|NCT04511208|101551043|FG000|COMPLETED|Forth Surgery||8||
48497055|NCT04511208|101551044|FG001|COMPLETED|Forth Surgery||7||
48497056|NCT04511208|101551045|FG002|COMPLETED|Forth Surgery||8||
48497057|NCT04511208|101551046|FG003|COMPLETED|Forth Surgery||7||
48497058|NCT04511208|101551043|FG000|NOT COMPLETED|Forth Surgery||0||
48497059|NCT04511208|101551044|FG001|NOT COMPLETED|Forth Surgery||0||
48497060|NCT04511208|101551045|FG002|NOT COMPLETED|Forth Surgery||0||
48497061|NCT04511208|101551046|FG003|NOT COMPLETED|Forth Surgery||0||
48497062|NCT02367872|101551047|FG000|STARTED|Overall Study||6||
48497063|NCT02367872|101551048|FG001|STARTED|Overall Study||6||
48497064|NCT02367872|101551049|FG002|STARTED|Overall Study||6||
48497065|NCT02367872|101551050|FG003|STARTED|Overall Study||6||
48497066|NCT02367872|101551051|FG004|STARTED|Overall Study||6||
48497067|NCT02367872|101551052|FG005|STARTED|Overall Study||6||
48497068|NCT02367872|101551053|FG006|STARTED|Overall Study||6||
48497069|NCT02367872|101551054|FG007|STARTED|Overall Study||6||
48497070|NCT02367872|101551047|FG000|COMPLETED|Overall Study||6||
48497071|NCT02367872|101551048|FG001|COMPLETED|Overall Study||6||
48497072|NCT02367872|101551049|FG002|COMPLETED|Overall Study||6||
48497073|NCT02367872|101551050|FG003|COMPLETED|Overall Study||6||
48497074|NCT02367872|101551051|FG004|COMPLETED|Overall Study||6||
48497075|NCT02367872|101551052|FG005|COMPLETED|Overall Study||6||
48497076|NCT02367872|101551053|FG006|COMPLETED|Overall Study||6||
48497077|NCT02367872|101551054|FG007|COMPLETED|Overall Study||6||
48497078|NCT02367872|101551047|FG000|NOT COMPLETED|Overall Study||0||
48497079|NCT02367872|101551048|FG001|NOT COMPLETED|Overall Study||0||
48497080|NCT02367872|101551049|FG002|NOT COMPLETED|Overall Study||0||
48497081|NCT02367872|101551050|FG003|NOT COMPLETED|Overall Study||0||
48497082|NCT02367872|101551051|FG004|NOT COMPLETED|Overall Study||0||
48497083|NCT02367872|101551052|FG005|NOT COMPLETED|Overall Study||0||
48497084|NCT02367872|101551053|FG006|NOT COMPLETED|Overall Study||0||
48497085|NCT02367872|101551054|FG007|NOT COMPLETED|Overall Study||0||
48497086|NCT02153645|101551055|FG000|STARTED|Overall Study||30||
48497087|NCT02153645|101551056|FG001|STARTED|Overall Study||29||
48497088|NCT02153645|101551057|FG002|STARTED|Overall Study||28||
48497089|NCT02153645|101551055|FG000|COMPLETED|Overall Study||17||
48497090|NCT02153645|101551056|FG001|COMPLETED|Overall Study||19||
48497091|NCT02153645|101551057|FG002|COMPLETED|Overall Study||18||
48497092|NCT02153645|101551055|FG000|NOT COMPLETED|Overall Study||13||
48497093|NCT02153645|101551056|FG001|NOT COMPLETED|Overall Study||10||
48497094|NCT02153645|101551057|FG002|NOT COMPLETED|Overall Study||10||
48497095|NCT04590027|101551058|FG000|STARTED|Overall Study||47||
48497096|NCT04590027|101551059|FG001|STARTED|Overall Study||39||
48497097|NCT04590027|101551058|FG000|COMPLETED|Overall Study||30||
48497098|NCT04590027|101551059|FG001|COMPLETED|Overall Study||22||
48497099|NCT04590027|101551058|FG000|NOT COMPLETED|Overall Study||17||
48497100|NCT04590027|101551059|FG001|NOT COMPLETED|Overall Study||17||
48497101|NCT01859598|101551060|FG000|STARTED|Visit 2 at 3 Months||18995||
48497102|NCT01859598|101551060|FG000|COMPLETED|Visit 2 at 3 Months||17253||
48497103|NCT01859598|101551060|FG000|NOT COMPLETED|Visit 2 at 3 Months||1742||
48497104|NCT01859598|101551060|FG000|STARTED|Visit 3 at 6 Months||17253||
48497105|NCT01859598|101551060|FG000|COMPLETED|Visit 3 at 6 Months||16341||
48497106|NCT01859598|101551060|FG000|NOT COMPLETED|Visit 3 at 6 Months||912||
48497107|NCT01011413|101551061|FG000|STARTED|Overall Study||312||
48497108|NCT01011413|101551062|FG001|STARTED|Overall Study||324||
48666745|NCT03391882|101970468|FG003|Modified Intent-to-Treat Population Part A|Part A - Titration Phase||18||
48218471|NCT02135679|100860313|FG006|STARTED|Overall Study||0||
48218472|NCT02135679|100860307|FG000|COMPLETED|Overall Study||39||
48218473|NCT02135679|100860308|FG001|COMPLETED|Overall Study||51||
48218474|NCT02135679|100860309|FG002|COMPLETED|Overall Study||1||
48218475|NCT02135679|100860310|FG003|COMPLETED|Overall Study||0||
48218476|NCT02135679|100860311|FG004|COMPLETED|Overall Study||16||
48218477|NCT02135679|100860312|FG005|COMPLETED|Overall Study||57||
48218478|NCT02135679|100860313|FG006|COMPLETED|Overall Study||0||
48218479|NCT02135679|100860307|FG000|NOT COMPLETED|Overall Study||13||
48218480|NCT02135679|100860308|FG001|NOT COMPLETED|Overall Study||18||
48497109|NCT01011413|101551061|FG000|Did Not Start Study Drug|Overall Study||3||
48497110|NCT01011413|101551062|FG001|Did Not Start Study Drug|Overall Study||3||
48497111|NCT01011413|101551061|FG000|In Modified ITT|Overall Study||309||
48497112|NCT01011413|101551062|FG001|In Modified ITT|Overall Study||321||
48497113|NCT01011413|101551061|FG000|Died Before Week 48|Overall Study||3||
48497114|NCT01011413|101551062|FG001|Died Before Week 48|Overall Study||2||
48497115|NCT01011413|101551061|FG000|Lost to Follow up Before w48|Overall Study||3||
48497116|NCT01011413|101551062|FG001|Lost to Follow up Before w48|Overall Study||4||
48497117|NCT01011413|101551061|FG000|Withdrew Consent Before w48|Overall Study||3||
48497118|NCT01011413|101551062|FG001|Withdrew Consent Before w48|Overall Study||3||
48497119|NCT01011413|101551061|FG000|Attended w48 Visit|Overall Study||295||
48497120|NCT01011413|101551062|FG001|Attended w48 Visit|Overall Study||311||
48497121|NCT01011413|101551061|FG000|Died Between Week 48 and 96|Overall Study||2||
48497122|NCT01011413|101551062|FG001|Died Between Week 48 and 96|Overall Study||3||
48497123|NCT01011413|101551061|FG000|Withdrew Consent Between Week 48 and 96|Overall Study||2||
48497124|NCT01011413|101551062|FG001|Withdrew Consent Between Week 48 and 96|Overall Study||6||
48497125|NCT01011413|101551061|FG000|Lost to Follow-up Between Week 48 and 96|Overall Study||10||
48497126|NCT01011413|101551062|FG001|Lost to Follow-up Between Week 48 and 96|Overall Study||4||
48497127|NCT01011413|101551061|FG000|COMPLETED|Overall Study||286||
48497128|NCT01011413|101551062|FG001|COMPLETED|Overall Study||299||
48497129|NCT01011413|101551061|FG000|NOT COMPLETED|Overall Study||26||
48497130|NCT01011413|101551062|FG001|NOT COMPLETED|Overall Study||25||
48497131|NCT01488448|101551063|FG000|STARTED|Overall Study||113||
48497132|NCT01488448|101551064|FG001|STARTED|Overall Study||114||
48497133|NCT01488448|101551063|FG000|COMPLETED|Overall Study||93||
48497134|NCT01488448|101551064|FG001|COMPLETED|Overall Study||97||
48497135|NCT01488448|101551063|FG000|NOT COMPLETED|Overall Study||20||
48497136|NCT01488448|101551064|FG001|NOT COMPLETED|Overall Study||17||
48497137|NCT03068780|101551065|FG000|STARTED|Double-Blind Phase (DBP)||109||
48497138|NCT03068780|101551066|FG001|STARTED|Double-Blind Phase (DBP)||114||
48497139|NCT03068780|101551065|FG000|COMPLETED|Double-Blind Phase (DBP)||100||
48497140|NCT03068780|101551066|FG001|COMPLETED|Double-Blind Phase (DBP)||99||
48497141|NCT03068780|101551065|FG000|NOT COMPLETED|Double-Blind Phase (DBP)||9||
48497142|NCT03068780|101551066|FG001|NOT COMPLETED|Double-Blind Phase (DBP)||15||
48497143|NCT03068780|101551065|FG000|STARTED|Open-Label Phase (OLP)||100||
48497144|NCT03068780|101551066|FG001|STARTED|Open-Label Phase (OLP)||105||
48497145|NCT03068780|101551065|FG000|COMPLETED|Open-Label Phase (OLP)||66||
48497146|NCT03068780|101551066|FG001|COMPLETED|Open-Label Phase (OLP)||75||
48497147|NCT03068780|101551065|FG000|NOT COMPLETED|Open-Label Phase (OLP)||34||
48497148|NCT03068780|101551066|FG001|NOT COMPLETED|Open-Label Phase (OLP)||30||
48497149|NCT02046863|101551067|FG000|STARTED|Overall Study||7||
48497150|NCT02046863|101551067|FG000|COMPLETED|Overall Study||7||
48497151|NCT02046863|101551067|FG000|NOT COMPLETED|Overall Study||0||
48497152|NCT04442503|101551068|FG000|STARTED|Overall Study||101||
48497153|NCT04442503|101551069|FG001|STARTED|Overall Study||99||
48497154|NCT04442503|101551068|FG000|Number of Participants Received Investigational Product (IP)|Overall Study||98||
48497155|NCT04442503|101551069|FG001|Number of Participants Received Investigational Product (IP)|Overall Study||98||
48497156|NCT04442503|101551068|FG000|COMPLETED|Overall Study||86||
48497157|NCT04442503|101551069|FG001|COMPLETED|Overall Study||84||
48497158|NCT04442503|101551068|FG000|NOT COMPLETED|Overall Study||15||
48497159|NCT04442503|101551069|FG001|NOT COMPLETED|Overall Study||15||
48497160|NCT01390415|101551070|FG000|STARTED|Overall Study||99||
48497161|NCT01390415|101551071|FG001|STARTED|Overall Study||37||
48497162|NCT01390415|101551070|FG000|COMPLETED|Overall Study||99||
48497163|NCT01390415|101551071|FG001|COMPLETED|Overall Study||37||
48497164|NCT01390415|101551070|FG000|NOT COMPLETED|Overall Study||0||
48497165|NCT01390415|101551071|FG001|NOT COMPLETED|Overall Study||0||
48497166|NCT00849797|101551072|FG000|STARTED|First Intervention||60||
48497167|NCT00849797|101551073|FG001|STARTED|First Intervention||60||
48497168|NCT00849797|101551072|FG000|COMPLETED|First Intervention||59||
48497169|NCT00849797|101551073|FG001|COMPLETED|First Intervention||59||
48497170|NCT00849797|101551072|FG000|NOT COMPLETED|First Intervention||1||
48061013|NCT00055224|100470332|FG001|STARTED|Pilot Tasks||183||
48061014|NCT00055224|100470331|FG000|COMPLETED|Pilot Tasks||406||
48061015|NCT00055224|100470332|FG001|COMPLETED|Pilot Tasks||183||
48497171|NCT00849797|101551073|FG001|NOT COMPLETED|First Intervention||1||
48497172|NCT00849797|101551072|FG000|STARTED|Washout: One Week||59||
48497173|NCT00849797|101551073|FG001|STARTED|Washout: One Week||59||
48497174|NCT00849797|101551072|FG000|COMPLETED|Washout: One Week||59||
48497175|NCT00849797|101551073|FG001|COMPLETED|Washout: One Week||57||
48497176|NCT00849797|101551072|FG000|NOT COMPLETED|Washout: One Week||0||
48497177|NCT00849797|101551073|FG001|NOT COMPLETED|Washout: One Week||2||
48497178|NCT00849797|101551072|FG000|STARTED|Second Intervention||59||
48497179|NCT00849797|101551073|FG001|STARTED|Second Intervention||57||
48497180|NCT00849797|101551072|FG000|COMPLETED|Second Intervention||59||
48497181|NCT00849797|101551073|FG001|COMPLETED|Second Intervention||57||
48497182|NCT00849797|101551072|FG000|NOT COMPLETED|Second Intervention||0||
48497183|NCT00849797|101551073|FG001|NOT COMPLETED|Second Intervention||0||
48497184|NCT04632641|101551074|FG000|STARTED|Overall Study||52||
48497185|NCT04632641|101551075|FG001|STARTED|Overall Study||54||
48497186|NCT04632641|101551074|FG000|COMPLETED|Overall Study||47||
48497187|NCT04632641|101551075|FG001|COMPLETED|Overall Study||53||
48497188|NCT04632641|101551074|FG000|NOT COMPLETED|Overall Study||5||
48497189|NCT04632641|101551075|FG001|NOT COMPLETED|Overall Study||1||
48497190|NCT01592240|101551076|FG000|STARTED|Overall Study||50||
48497191|NCT01592240|101551077|FG001|STARTED|Overall Study||50||
48497192|NCT01592240|101551078|FG002|STARTED|Overall Study||52||
48497193|NCT01592240|101551079|FG003|STARTED|Overall Study||50||
48497194|NCT01592240|101551080|FG004|STARTED|Overall Study||51||
48497195|NCT01592240|101551081|FG005|STARTED|Overall Study||50||
48497196|NCT01592240|101551082|FG006|STARTED|Overall Study||51||
48497197|NCT01592240|101551076|FG000|COMPLETED|Overall Study||47||
48497198|NCT01592240|101551077|FG001|COMPLETED|Overall Study||39||
48497199|NCT01592240|101551078|FG002|COMPLETED|Overall Study||45||
48497200|NCT01592240|101551079|FG003|COMPLETED|Overall Study||47||
48497201|NCT01592240|101551080|FG004|COMPLETED|Overall Study||44||
48497202|NCT01592240|101551081|FG005|COMPLETED|Overall Study||47||
48497203|NCT01592240|101551082|FG006|COMPLETED|Overall Study||48||
48497204|NCT01592240|101551076|FG000|NOT COMPLETED|Overall Study||3||
48497205|NCT01592240|101551077|FG001|NOT COMPLETED|Overall Study||11||
48497206|NCT01592240|101551078|FG002|NOT COMPLETED|Overall Study||7||
48497207|NCT01592240|101551079|FG003|NOT COMPLETED|Overall Study||3||
48497208|NCT01592240|101551080|FG004|NOT COMPLETED|Overall Study||7||
48497209|NCT01592240|101551081|FG005|NOT COMPLETED|Overall Study||3||
48497210|NCT01592240|101551082|FG006|NOT COMPLETED|Overall Study||3||
48497211|NCT03497130|101551083|FG000|STARTED|Overall Study||40||
48497212|NCT03497130|101551084|FG001|STARTED|Overall Study||14||
48497213|NCT03497130|101551083|FG000|COMPLETED|Overall Study||39||
48497214|NCT03497130|101551084|FG001|COMPLETED|Overall Study||13||
48497215|NCT03497130|101551083|FG000|NOT COMPLETED|Overall Study||1||
48497216|NCT03497130|101551084|FG001|NOT COMPLETED|Overall Study||1||
48497217|NCT00840840|101551085|FG000|STARTED|Period 1||24||
48497218|NCT00840840|101551086|FG001|STARTED|Period 1||24||
48497219|NCT00840840|101551085|FG000|COMPLETED|Period 1||24||
48497220|NCT00840840|101551086|FG001|COMPLETED|Period 1||24||
48497221|NCT00840840|101551085|FG000|NOT COMPLETED|Period 1||0||
48497222|NCT00840840|101551086|FG001|NOT COMPLETED|Period 1||0||
48497223|NCT00840840|101551085|FG000|STARTED|Period 2||23||
48497224|NCT00840840|101551086|FG001|STARTED|Period 2||24||
48497225|NCT00840840|101551085|FG000|COMPLETED|Period 2||23||
48497226|NCT00840840|101551086|FG001|COMPLETED|Period 2||24||
48497227|NCT00840840|101551085|FG000|NOT COMPLETED|Period 2||0||
48497228|NCT00840840|101551086|FG001|NOT COMPLETED|Period 2||0||
48497229|NCT04277507|101551087|FG000|STARTED|Overall Study||122||
48497230|NCT04277507|101551087|FG000|COMPLETED|Overall Study||91||
48497231|NCT04277507|101551087|FG000|NOT COMPLETED|Overall Study||31||
48497232|NCT02651987|101551088|FG000|STARTED|Overall Study||48||
48497233|NCT02651987|101551089|FG001|STARTED|Overall Study||51||
48497234|NCT02651987|101551088|FG000|COMPLETED|Overall Study||43||
48497235|NCT02651987|101551089|FG001|COMPLETED|Overall Study||46||
48497236|NCT02651987|101551088|FG000|NOT COMPLETED|Overall Study||5||
48497237|NCT02651987|101551089|FG001|NOT COMPLETED|Overall Study||5||
48497238|NCT03807440|101551090|FG000|STARTED|Overall Study||4055|Patients included in the prescribed patient set (PPS)|
48497239|NCT03807440|101551090|FG000|COMPLETED|Overall Study||3618|Patients included in the full analysis set (FAS)|
48497240|NCT03807440|101551090|FG000|NOT COMPLETED|Overall Study||437||
48497241|NCT01297504|101551091|FG000|STARTED|Overall Study||464||
48497242|NCT01297504|101551091|FG000|Participants Studied|Overall Study||458||
48497243|NCT01297504|101551091|FG000|COMPLETED|Overall Study||397||
48497244|NCT01297504|101551091|FG000|NOT COMPLETED|Overall Study||67||
48497245|NCT04540094|101551092|FG000|STARTED|Overall Study||150||
48497246|NCT04540094|101551093|FG001|STARTED|Overall Study||150||
48497247|NCT04540094|101551092|FG000|COMPLETED|Overall Study||150||
48497248|NCT04540094|101551093|FG001|COMPLETED|Overall Study||150||
48497249|NCT04540094|101551092|FG000|NOT COMPLETED|Overall Study||0||
48497250|NCT04540094|101551093|FG001|NOT COMPLETED|Overall Study||0||
48497251|NCT01852799|101551094|FG000|STARTED|Overall Study||18||
48497252|NCT01852799|101551094|FG000|COMPLETED|Overall Study||0||
48497253|NCT01852799|101551094|FG000|NOT COMPLETED|Overall Study||18||
48497254|NCT01695239|101551095|FG000|STARTED|Double-Blind (DB) Treatment Period||106||
48497255|NCT01695239|101551096|FG001|STARTED|Double-Blind (DB) Treatment Period||101||
48497256|NCT01695239|101551097|FG002|STARTED|Double-Blind (DB) Treatment Period||107||
48497257|NCT01695239|101551098|FG003|STARTED|Double-Blind (DB) Treatment Period||103||
48497258|NCT01695239|101551099|FG004|STARTED|Double-Blind (DB) Treatment Period||0||
48497259|NCT01695239|101551100|FG005|STARTED|Double-Blind (DB) Treatment Period||0||
48497260|NCT01695239|101551101|FG006|STARTED|Double-Blind (DB) Treatment Period||0||
48497261|NCT01695239|101551102|FG007|STARTED|Double-Blind (DB) Treatment Period||0||
48497262|NCT01695239|101551103|FG008|STARTED|Double-Blind (DB) Treatment Period||0||
48497263|NCT01695239|101551104|FG009|STARTED|Double-Blind (DB) Treatment Period||0||
48497264|NCT01695239|101551105|FG010|STARTED|Double-Blind (DB) Treatment Period||0||
48497265|NCT01695239|101551106|FG011|STARTED|Double-Blind (DB) Treatment Period||0||
48497266|NCT01695239|101551107|FG012|STARTED|Double-Blind (DB) Treatment Period||0||
48497267|NCT01695239|101551108|FG013|STARTED|Double-Blind (DB) Treatment Period||0||
48497268|NCT01695239|101551095|FG000|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||106||
48497269|NCT01695239|101551096|FG001|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||101||
48497270|NCT01695239|101551097|FG002|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||107||
48497271|NCT01695239|101551098|FG003|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||102||
48497272|NCT01695239|101551099|FG004|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0||
48497273|NCT01695239|101551100|FG005|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0||
48497274|NCT01695239|101551101|FG006|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0||
48497275|NCT01695239|101551102|FG007|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0||
48497276|NCT01695239|101551103|FG008|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0||
48497277|NCT01695239|101551104|FG009|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0||
48497278|NCT01695239|101551105|FG010|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0||
48497279|NCT01695239|101551106|FG011|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0||
48497280|NCT01695239|101551107|FG012|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0||
48497281|NCT01695239|101551108|FG013|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0||
48497282|NCT01695239|101551095|FG000|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||27||
48497283|NCT01695239|101551096|FG001|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||9||
48497284|NCT01695239|101551097|FG002|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||11||
48497285|NCT01695239|101551098|FG003|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||10||
48497286|NCT01695239|101551099|FG004|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0||
48497287|NCT01695239|101551100|FG005|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0||
48497288|NCT01695239|101551101|FG006|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0||
48497289|NCT01695239|101551102|FG007|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0||
48497290|NCT01695239|101551103|FG008|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0||
48497291|NCT01695239|101551104|FG009|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0||
48497292|NCT01695239|101551105|FG010|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0||
48497293|NCT01695239|101551106|FG011|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0||
48497294|NCT01695239|101551107|FG012|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0||
48497295|NCT01695239|101551108|FG013|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0||
48497296|NCT01695239|101551095|FG000|COMPLETED|Double-Blind (DB) Treatment Period||91||
48497297|NCT01695239|101551096|FG001|COMPLETED|Double-Blind (DB) Treatment Period||97||
48497298|NCT01695239|101551097|FG002|COMPLETED|Double-Blind (DB) Treatment Period||97||
48497299|NCT01695239|101551098|FG003|COMPLETED|Double-Blind (DB) Treatment Period||96||
48497300|NCT01695239|101551099|FG004|COMPLETED|Double-Blind (DB) Treatment Period||0||
48497301|NCT01695239|101551100|FG005|COMPLETED|Double-Blind (DB) Treatment Period||0||
48497302|NCT01695239|101551101|FG006|COMPLETED|Double-Blind (DB) Treatment Period||0||
48497303|NCT01695239|101551102|FG007|COMPLETED|Double-Blind (DB) Treatment Period||0||
48497304|NCT01695239|101551103|FG008|COMPLETED|Double-Blind (DB) Treatment Period||0||
48497305|NCT01695239|101551104|FG009|COMPLETED|Double-Blind (DB) Treatment Period||0||
48497306|NCT01695239|101551105|FG010|COMPLETED|Double-Blind (DB) Treatment Period||0||
48497307|NCT01695239|101551106|FG011|COMPLETED|Double-Blind (DB) Treatment Period||0||
48497308|NCT01695239|101551107|FG012|COMPLETED|Double-Blind (DB) Treatment Period||0||
48497309|NCT01695239|101551108|FG013|COMPLETED|Double-Blind (DB) Treatment Period||0||
48497310|NCT01695239|101551095|FG000|NOT COMPLETED|Double-Blind (DB) Treatment Period||15||
48497311|NCT01695239|101551096|FG001|NOT COMPLETED|Double-Blind (DB) Treatment Period||4||
48497312|NCT01695239|101551097|FG002|NOT COMPLETED|Double-Blind (DB) Treatment Period||10||
48497313|NCT01695239|101551098|FG003|NOT COMPLETED|Double-Blind (DB) Treatment Period||7||
48497314|NCT01695239|101551099|FG004|NOT COMPLETED|Double-Blind (DB) Treatment Period||0||
48497315|NCT01695239|101551100|FG005|NOT COMPLETED|Double-Blind (DB) Treatment Period||0||
48497316|NCT01695239|101551101|FG006|NOT COMPLETED|Double-Blind (DB) Treatment Period||0||
48497317|NCT01695239|101551102|FG007|NOT COMPLETED|Double-Blind (DB) Treatment Period||0||
48497318|NCT01695239|101551103|FG008|NOT COMPLETED|Double-Blind (DB) Treatment Period||0||
48497319|NCT01695239|101551104|FG009|NOT COMPLETED|Double-Blind (DB) Treatment Period||0||
48497320|NCT01695239|101551105|FG010|NOT COMPLETED|Double-Blind (DB) Treatment Period||0||
48497321|NCT01695239|101551106|FG011|NOT COMPLETED|Double-Blind (DB) Treatment Period||0||
48497322|NCT01695239|101551107|FG012|NOT COMPLETED|Double-Blind (DB) Treatment Period||0||
48497323|NCT01695239|101551108|FG013|NOT COMPLETED|Double-Blind (DB) Treatment Period||0||
48497324|NCT01695239|101551095|FG000|STARTED|IR Participants (Week 16 Up To Week 24)||0||
48497325|NCT01695239|101551096|FG001|STARTED|IR Participants (Week 16 Up To Week 24)||0||
48497326|NCT01695239|101551097|FG002|STARTED|IR Participants (Week 16 Up To Week 24)||0||
48497327|NCT01695239|101551098|FG003|STARTED|IR Participants (Week 16 Up To Week 24)||0||
48497328|NCT01695239|101551099|FG004|STARTED|IR Participants (Week 16 Up To Week 24)||24||
48497329|NCT01695239|101551100|FG005|STARTED|IR Participants (Week 16 Up To Week 24)||24||
48497330|NCT01695239|101551101|FG006|STARTED|IR Participants (Week 16 Up To Week 24)||9||
48497331|NCT01695239|101551102|FG007|STARTED|IR Participants (Week 16 Up To Week 24)||0||
48497332|NCT01695239|101551103|FG008|STARTED|IR Participants (Week 16 Up To Week 24)||0||
48497333|NCT01695239|101551104|FG009|STARTED|IR Participants (Week 16 Up To Week 24)||0||
48497334|NCT01695239|101551105|FG010|STARTED|IR Participants (Week 16 Up To Week 24)||0||
48497335|NCT01695239|101551106|FG011|STARTED|IR Participants (Week 16 Up To Week 24)||0||
48497336|NCT01695239|101551107|FG012|STARTED|IR Participants (Week 16 Up To Week 24)||0||
48497337|NCT01695239|101551108|FG013|STARTED|IR Participants (Week 16 Up To Week 24)||0||
48497338|NCT01695239|101551095|FG000|COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
48497339|NCT01695239|101551096|FG001|COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
48497340|NCT01695239|101551097|FG002|COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
48497341|NCT01695239|101551098|FG003|COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
48497342|NCT01695239|101551099|FG004|COMPLETED|IR Participants (Week 16 Up To Week 24)||24||
48497343|NCT01695239|101551100|FG005|COMPLETED|IR Participants (Week 16 Up To Week 24)||24||
48497344|NCT01695239|101551101|FG006|COMPLETED|IR Participants (Week 16 Up To Week 24)||9||
48497345|NCT01695239|101551102|FG007|COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
48497346|NCT01695239|101551103|FG008|COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
48497347|NCT01695239|101551104|FG009|COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
48497348|NCT01695239|101551105|FG010|COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
48497349|NCT01695239|101551106|FG011|COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
48497350|NCT01695239|101551107|FG012|COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
48497351|NCT01695239|101551108|FG013|COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
48497352|NCT01695239|101551095|FG000|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
48497353|NCT01695239|101551096|FG001|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
48497354|NCT01695239|101551097|FG002|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
48497355|NCT01695239|101551098|FG003|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
48497356|NCT01695239|101551099|FG004|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
48497357|NCT01695239|101551100|FG005|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
48497358|NCT01695239|101551101|FG006|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
48497359|NCT01695239|101551102|FG007|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
48497360|NCT01695239|101551103|FG008|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
48497361|NCT01695239|101551104|FG009|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
48497362|NCT01695239|101551105|FG010|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
48497363|NCT01695239|101551106|FG011|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
48497364|NCT01695239|101551107|FG012|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
48497365|NCT01695239|101551108|FG013|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
48497366|NCT01695239|101551095|FG000|STARTED|Placebo Washout (Week 24 Up To Week 32)||0||
48497367|NCT01695239|101551096|FG001|STARTED|Placebo Washout (Week 24 Up To Week 32)||0||
48497368|NCT01695239|101551097|FG002|STARTED|Placebo Washout (Week 24 Up To Week 32)||0||
48497369|NCT01695239|101551098|FG003|STARTED|Placebo Washout (Week 24 Up To Week 32)||0||
48497370|NCT01695239|101551099|FG004|STARTED|Placebo Washout (Week 24 Up To Week 32)||0||
48497371|NCT01695239|101551100|FG005|STARTED|Placebo Washout (Week 24 Up To Week 32)||0||
48497372|NCT01695239|101551101|FG006|STARTED|Placebo Washout (Week 24 Up To Week 32)||0||
48497373|NCT01695239|101551102|FG007|STARTED|Placebo Washout (Week 24 Up To Week 32)||88||
48497374|NCT01695239|101551103|FG008|STARTED|Placebo Washout (Week 24 Up To Week 32)||0||
48497375|NCT01695239|101551104|FG009|STARTED|Placebo Washout (Week 24 Up To Week 32)||0||
48497376|NCT01695239|101551105|FG010|STARTED|Placebo Washout (Week 24 Up To Week 32)||0||
48497377|NCT01695239|101551106|FG011|STARTED|Placebo Washout (Week 24 Up To Week 32)||0||
48497378|NCT01695239|101551107|FG012|STARTED|Placebo Washout (Week 24 Up To Week 32)||0||
48497379|NCT01695239|101551108|FG013|STARTED|Placebo Washout (Week 24 Up To Week 32)||0||
48497380|NCT01695239|101551095|FG000|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
48497381|NCT01695239|101551096|FG001|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
48497382|NCT01695239|101551097|FG002|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
48497383|NCT01695239|101551098|FG003|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
48497384|NCT01695239|101551099|FG004|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
48497385|NCT01695239|101551100|FG005|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
48497386|NCT01695239|101551101|FG006|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
48497387|NCT01695239|101551102|FG007|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||77||
48497388|NCT01695239|101551103|FG008|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
48497389|NCT01695239|101551104|FG009|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
48497390|NCT01695239|101551105|FG010|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
48497391|NCT01695239|101551106|FG011|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
48497392|NCT01695239|101551107|FG012|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
48497393|NCT01695239|101551108|FG013|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
48497394|NCT01695239|101551095|FG000|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
48497395|NCT01695239|101551096|FG001|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
48497396|NCT01695239|101551097|FG002|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
48497397|NCT01695239|101551098|FG003|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
48497398|NCT01695239|101551099|FG004|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
48497399|NCT01695239|101551100|FG005|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
48497400|NCT01695239|101551101|FG006|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
48497401|NCT01695239|101551102|FG007|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||11||
48497402|NCT01695239|101551103|FG008|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
48497403|NCT01695239|101551104|FG009|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
48497404|NCT01695239|101551105|FG010|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
48497405|NCT01695239|101551106|FG011|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
48497406|NCT01695239|101551107|FG012|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
48497407|NCT01695239|101551108|FG013|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
48497408|NCT01695239|101551095|FG000|STARTED|Extension Long-Term Extension Periods||0||
48497409|NCT01695239|101551096|FG001|STARTED|Extension Long-Term Extension Periods||0||
48497410|NCT01695239|101551097|FG002|STARTED|Extension Long-Term Extension Periods||0||
48497411|NCT01695239|101551098|FG003|STARTED|Extension Long-Term Extension Periods||0||
48497412|NCT01695239|101551099|FG004|STARTED|Extension Long-Term Extension Periods||0||
48497413|NCT01695239|101551100|FG005|STARTED|Extension Long-Term Extension Periods||0||
48497414|NCT01695239|101551101|FG006|STARTED|Extension Long-Term Extension Periods||0||
48497415|NCT01695239|101551102|FG007|STARTED|Extension Long-Term Extension Periods||0||
48497416|NCT01695239|101551103|FG008|STARTED|Extension Long-Term Extension Periods||187||
48497417|NCT01695239|101551104|FG009|STARTED|Extension Long-Term Extension Periods||183||
48497418|NCT01695239|101551105|FG010|STARTED|Extension Long-Term Extension Periods||0||
48497419|NCT01695239|101551106|FG011|STARTED|Extension Long-Term Extension Periods||0||
48497420|NCT01695239|101551107|FG012|STARTED|Extension Long-Term Extension Periods||0||
48497421|NCT01695239|101551108|FG013|STARTED|Extension Long-Term Extension Periods||0||
48497422|NCT01695239|101551095|FG000|COMPLETED|Extension Long-Term Extension Periods||0||
48497423|NCT01695239|101551096|FG001|COMPLETED|Extension Long-Term Extension Periods||0||
48497424|NCT01695239|101551097|FG002|COMPLETED|Extension Long-Term Extension Periods||0||
48061016|NCT00055224|100470331|FG000|NOT COMPLETED|Pilot Tasks||0||
48497425|NCT01695239|101551098|FG003|COMPLETED|Extension Long-Term Extension Periods||0||
48497426|NCT01695239|101551099|FG004|COMPLETED|Extension Long-Term Extension Periods||0||
48497427|NCT01695239|101551100|FG005|COMPLETED|Extension Long-Term Extension Periods||0||
48497428|NCT01695239|101551101|FG006|COMPLETED|Extension Long-Term Extension Periods||0||
48497429|NCT01695239|101551102|FG007|COMPLETED|Extension Long-Term Extension Periods||0||
48497430|NCT01695239|101551103|FG008|COMPLETED|Extension Long-Term Extension Periods||121||
48497431|NCT01695239|101551104|FG009|COMPLETED|Extension Long-Term Extension Periods||122||
48497432|NCT01695239|101551105|FG010|COMPLETED|Extension Long-Term Extension Periods||0||
48497433|NCT01695239|101551106|FG011|COMPLETED|Extension Long-Term Extension Periods||0||
48497434|NCT01695239|101551107|FG012|COMPLETED|Extension Long-Term Extension Periods||0||
48497435|NCT01695239|101551108|FG013|COMPLETED|Extension Long-Term Extension Periods||0||
48497436|NCT01695239|101551095|FG000|NOT COMPLETED|Extension Long-Term Extension Periods||0||
48497437|NCT01695239|101551096|FG001|NOT COMPLETED|Extension Long-Term Extension Periods||0||
48497438|NCT01695239|101551097|FG002|NOT COMPLETED|Extension Long-Term Extension Periods||0||
48497439|NCT01695239|101551098|FG003|NOT COMPLETED|Extension Long-Term Extension Periods||0||
48497440|NCT01695239|101551099|FG004|NOT COMPLETED|Extension Long-Term Extension Periods||0||
48497441|NCT01695239|101551100|FG005|NOT COMPLETED|Extension Long-Term Extension Periods||0||
48497442|NCT01695239|101551101|FG006|NOT COMPLETED|Extension Long-Term Extension Periods||0||
48497443|NCT01695239|101551102|FG007|NOT COMPLETED|Extension Long-Term Extension Periods||0||
48497444|NCT01695239|101551103|FG008|NOT COMPLETED|Extension Long-Term Extension Periods||66||
48497445|NCT01695239|101551104|FG009|NOT COMPLETED|Extension Long-Term Extension Periods||61||
48497446|NCT01695239|101551105|FG010|NOT COMPLETED|Extension Long-Term Extension Periods||0||
48497447|NCT01695239|101551106|FG011|NOT COMPLETED|Extension Long-Term Extension Periods||0||
48497448|NCT01695239|101551107|FG012|NOT COMPLETED|Extension Long-Term Extension Periods||0||
48497449|NCT01695239|101551108|FG013|NOT COMPLETED|Extension Long-Term Extension Periods||0||
48497450|NCT01695239|101551095|FG000|STARTED|Post-Treatment Follow-Up Period||0||
48497451|NCT01695239|101551096|FG001|STARTED|Post-Treatment Follow-Up Period||0||
48497452|NCT01695239|101551097|FG002|STARTED|Post-Treatment Follow-Up Period||0||
48497453|NCT01695239|101551098|FG003|STARTED|Post-Treatment Follow-Up Period||0||
48497454|NCT01695239|101551099|FG004|STARTED|Post-Treatment Follow-Up Period||0||
48497455|NCT01695239|101551100|FG005|STARTED|Post-Treatment Follow-Up Period||0||
48497456|NCT01695239|101551101|FG006|STARTED|Post-Treatment Follow-Up Period||0||
48497457|NCT01695239|101551102|FG007|STARTED|Post-Treatment Follow-Up Period||0||
48497458|NCT01695239|101551103|FG008|STARTED|Post-Treatment Follow-Up Period||0||
48497459|NCT01695239|101551104|FG009|STARTED|Post-Treatment Follow-Up Period||0||
48497460|NCT01695239|101551105|FG010|STARTED|Post-Treatment Follow-Up Period||20||
48497461|NCT01695239|101551106|FG011|STARTED|Post-Treatment Follow-Up Period||1||
48497462|NCT01695239|101551107|FG012|STARTED|Post-Treatment Follow-Up Period||165||
48497463|NCT01695239|101551108|FG013|STARTED|Post-Treatment Follow-Up Period||171||
48497464|NCT01695239|101551095|FG000|COMPLETED|Post-Treatment Follow-Up Period||0||
48497465|NCT01695239|101551096|FG001|COMPLETED|Post-Treatment Follow-Up Period||0||
48497466|NCT01695239|101551097|FG002|COMPLETED|Post-Treatment Follow-Up Period||0||
48497467|NCT01695239|101551098|FG003|COMPLETED|Post-Treatment Follow-Up Period||0||
48497468|NCT01695239|101551099|FG004|COMPLETED|Post-Treatment Follow-Up Period||0||
48497469|NCT01695239|101551100|FG005|COMPLETED|Post-Treatment Follow-Up Period||0||
48497470|NCT01695239|101551101|FG006|COMPLETED|Post-Treatment Follow-Up Period||0||
48497471|NCT01695239|101551102|FG007|COMPLETED|Post-Treatment Follow-Up Period||0||
48497472|NCT01695239|101551103|FG008|COMPLETED|Post-Treatment Follow-Up Period||0||
48497473|NCT01695239|101551104|FG009|COMPLETED|Post-Treatment Follow-Up Period||0||
48497474|NCT01695239|101551105|FG010|COMPLETED|Post-Treatment Follow-Up Period||20||
48497475|NCT01695239|101551106|FG011|COMPLETED|Post-Treatment Follow-Up Period||0||
48497476|NCT01695239|101551107|FG012|COMPLETED|Post-Treatment Follow-Up Period||156||
48497477|NCT01695239|101551108|FG013|COMPLETED|Post-Treatment Follow-Up Period||166||
48497478|NCT01695239|101551095|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
48497479|NCT01695239|101551096|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
48497480|NCT01695239|101551097|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
48497481|NCT01695239|101551098|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
48497482|NCT01695239|101551099|FG004|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
48497483|NCT01695239|101551100|FG005|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
48497484|NCT01695239|101551101|FG006|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
48497485|NCT01695239|101551102|FG007|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
48497486|NCT01695239|101551103|FG008|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
48497487|NCT01695239|101551104|FG009|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
48497488|NCT01695239|101551105|FG010|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
48497489|NCT01695239|101551106|FG011|NOT COMPLETED|Post-Treatment Follow-Up Period||1||
48497490|NCT01695239|101551107|FG012|NOT COMPLETED|Post-Treatment Follow-Up Period||9||
48497491|NCT01695239|101551108|FG013|NOT COMPLETED|Post-Treatment Follow-Up Period||5||
48497492|NCT00645853|101551109|FG000|STARTED|Overall Study||288||
48497493|NCT00645853|101551110|FG001|STARTED|Overall Study||235||
48497494|NCT00645853|101551109|FG000|No of Patients After Dose Switch|Overall Study||209||
48497495|NCT00645853|101551110|FG001|No of Patients After Dose Switch|Overall Study||188||
48497496|NCT00645853|101551109|FG000|Discontinued Patient No Due to Closure|Overall Study||196||
48497497|NCT00645853|101551110|FG001|Discontinued Patient No Due to Closure|Overall Study||178||
48497498|NCT00645853|101551109|FG000|AZ Study Closure in Hungary|Overall Study||60||
48497499|NCT00645853|101551110|FG001|AZ Study Closure in Hungary|Overall Study||40||
48497500|NCT00645853|101551109|FG000|COMPLETED|Overall Study||196||
48497501|NCT00645853|101551110|FG001|COMPLETED|Overall Study||178||
48497502|NCT00645853|101551109|FG000|NOT COMPLETED|Overall Study||92||
48497503|NCT00645853|101551110|FG001|NOT COMPLETED|Overall Study||57||
48497504|NCT00239005|101551111|FG000|STARTED|Overall Study||69||
48497505|NCT00239005|101551112|FG001|STARTED|Overall Study||65||
48497506|NCT00239005|101551111|FG000|Intention-to-treat Population (ITT)|Overall Study||68||
48497507|NCT00239005|101551112|FG001|Intention-to-treat Population (ITT)|Overall Study||61||
48497508|NCT00239005|101551111|FG000|COMPLETED|Overall Study||57||
48497509|NCT00239005|101551112|FG001|COMPLETED|Overall Study||53||
48497510|NCT00239005|101551111|FG000|NOT COMPLETED|Overall Study||12||
48497511|NCT00239005|101551112|FG001|NOT COMPLETED|Overall Study||12||
48497512|NCT04411680|101551113|FG000|STARTED|Treatment Period||78||
48497513|NCT04411680|101551114|FG001|STARTED|Treatment Period||44||
48497514|NCT04411680|101551113|FG000|COMPLETED|Treatment Period||49||
48497515|NCT04411680|101551114|FG001|COMPLETED|Treatment Period||36||
48497516|NCT04411680|101551113|FG000|NOT COMPLETED|Treatment Period||29||
48497517|NCT04411680|101551114|FG001|NOT COMPLETED|Treatment Period||8||
48497518|NCT04411680|101551113|FG000|STARTED|Follow up Period||78||
48497519|NCT04411680|101551114|FG001|STARTED|Follow up Period||44||
48497520|NCT04411680|101551113|FG000|COMPLETED|Follow up Period||60||
48497521|NCT04411680|101551114|FG001|COMPLETED|Follow up Period||30||
48497522|NCT04411680|101551113|FG000|NOT COMPLETED|Follow up Period||18||
48497523|NCT04411680|101551114|FG001|NOT COMPLETED|Follow up Period||14||
48497524|NCT02488239|101551115|FG000|STARTED|Overall Study||64||
48497525|NCT02488239|101551115|FG000|COMPLETED|Overall Study||54||
48497526|NCT02488239|101551115|FG000|NOT COMPLETED|Overall Study||10||
48497527|NCT00387153|101551116|FG000|STARTED|Overall Study||8||
48497528|NCT00387153|101551116|FG000|COMPLETED|Overall Study||0||
48497529|NCT00387153|101551116|FG000|NOT COMPLETED|Overall Study||8||
48497530|NCT00985439|101551117|FG000|STARTED|Overall Study||49||
48497531|NCT00985439|101551118|FG001|STARTED|Overall Study||51||
48497532|NCT00985439|101551119|FG002|STARTED|Overall Study||51||
48497533|NCT00985439|101551120|FG003|STARTED|Overall Study||51||
48497534|NCT00985439|101551117|FG000|COMPLETED|Overall Study||49||
48497535|NCT00985439|101551118|FG001|COMPLETED|Overall Study||51||
48497536|NCT00985439|101551119|FG002|COMPLETED|Overall Study||50||
48497537|NCT00985439|101551120|FG003|COMPLETED|Overall Study||51||
48497538|NCT00985439|101551117|FG000|NOT COMPLETED|Overall Study||0||
48497539|NCT00985439|101551118|FG001|NOT COMPLETED|Overall Study||0||
48497540|NCT00985439|101551119|FG002|NOT COMPLETED|Overall Study||1||
48497541|NCT00985439|101551120|FG003|NOT COMPLETED|Overall Study||0||
48497542|NCT04025021|101551121|FG000|STARTED|Overall Study||2||
48497543|NCT04025021|101551122|FG001|STARTED|Overall Study||1||
48497544|NCT04025021|101551121|FG000|COMPLETED|Overall Study||0||
48497545|NCT04025021|101551122|FG001|COMPLETED|Overall Study||0||
48497546|NCT04025021|101551121|FG000|NOT COMPLETED|Overall Study||2||
48497547|NCT04025021|101551122|FG001|NOT COMPLETED|Overall Study||1||
48497548|NCT01851772|101551123|FG000|STARTED|Overall Study||3||
48497549|NCT01851772|101551123|FG000|COMPLETED|Overall Study||3||
48497550|NCT01851772|101551123|FG000|NOT COMPLETED|Overall Study||0||
48497551|NCT02768701|101551124|FG000|STARTED|Overall Study||40||
48497552|NCT02768701|101551124|FG000|COMPLETED|Overall Study||32||
48497553|NCT02768701|101551124|FG000|NOT COMPLETED|Overall Study||8||
48497554|NCT00608322|101551125|FG000|STARTED|Overall Study||26||
48497555|NCT00608322|101551126|FG001|STARTED|Overall Study||23||
48497556|NCT00608322|101551125|FG000|COMPLETED|Overall Study||24||
48497557|NCT00608322|101551126|FG001|COMPLETED|Overall Study||22||
48497558|NCT00608322|101551125|FG000|NOT COMPLETED|Overall Study||2||
48497559|NCT00608322|101551126|FG001|NOT COMPLETED|Overall Study||1||
48497560|NCT03694197|101551127|FG000|STARTED|Overall Study||1385|Safety analysis set (SAF): all participants who received any study drug|
48497561|NCT03694197|101551127|FG000|COMPLETED|Overall Study||0|The study was terminated early by the Sponsor before any participants completed the originally planned treatment period of up to 192 weeks.|
48497562|NCT03694197|101551127|FG000|NOT COMPLETED|Overall Study||1385||
48497563|NCT03098485|101551128|FG000|STARTED|Overall Study||5||
48497564|NCT03098485|101551129|FG001|STARTED|Overall Study||5||
48497565|NCT03098485|101551130|FG002|STARTED|Overall Study||5||
48497566|NCT03098485|101551131|FG003|STARTED|Overall Study||5||
48497567|NCT03098485|101551128|FG000|COMPLETED|Overall Study||5||
48497568|NCT03098485|101551129|FG001|COMPLETED|Overall Study||5||
48497569|NCT03098485|101551130|FG002|COMPLETED|Overall Study||5||
48497570|NCT03098485|101551131|FG003|COMPLETED|Overall Study||5||
48497571|NCT03098485|101551128|FG000|NOT COMPLETED|Overall Study||0||
48497572|NCT03098485|101551129|FG001|NOT COMPLETED|Overall Study||0||
48497573|NCT03098485|101551130|FG002|NOT COMPLETED|Overall Study||0||
48497574|NCT03098485|101551131|FG003|NOT COMPLETED|Overall Study||0||
48497575|NCT03966911|101551132|FG000|STARTED|Overall Study||169||
48497576|NCT03966911|101551133|FG001|STARTED|Overall Study||142||
48497577|NCT03966911|101551132|FG000|COMPLETED|Overall Study||160||
48497578|NCT03966911|101551133|FG001|COMPLETED|Overall Study||126||
48497579|NCT03966911|101551132|FG000|NOT COMPLETED|Overall Study||9||
48497580|NCT03966911|101551133|FG001|NOT COMPLETED|Overall Study||16||
48497581|NCT02627963|101551134|FG000|STARTED|Overall Study||175||
48497582|NCT02627963|101551135|FG001|STARTED|Overall Study||175||
48497583|NCT02627963|101551134|FG000|COMPLETED|Overall Study||173||
48497584|NCT02627963|101551135|FG001|COMPLETED|Overall Study||169||
48497585|NCT02627963|101551134|FG000|NOT COMPLETED|Overall Study||2||
48497586|NCT02627963|101551135|FG001|NOT COMPLETED|Overall Study||6||
48497587|NCT03259165|101551136|FG000|STARTED|Overall Study||27||
48497588|NCT03259165|101551137|FG001|STARTED|Overall Study||25||
48497589|NCT03259165|101551136|FG000|COMPLETED|Overall Study||26||
48497590|NCT03259165|101551137|FG001|COMPLETED|Overall Study||24||
48497591|NCT03259165|101551136|FG000|NOT COMPLETED|Overall Study||1||
48497592|NCT03259165|101551137|FG001|NOT COMPLETED|Overall Study||1||
48497593|NCT04133311|101551138|FG000|STARTED|Period 1 Double Masked Treatment Period||193||
48497594|NCT04133311|101551139|FG001|STARTED|Period 1 Double Masked Treatment Period||193||
48497595|NCT04133311|101551140|FG002|STARTED|Period 1 Double Masked Treatment Period||0||
48497596|NCT04133311|101551141|FG003|STARTED|Period 1 Double Masked Treatment Period||0||
48497597|NCT04133311|101551138|FG000|COMPLETED|Period 1 Double Masked Treatment Period||190||
48497598|NCT04133311|101551139|FG001|COMPLETED|Period 1 Double Masked Treatment Period||190||
48497599|NCT04133311|101551140|FG002|COMPLETED|Period 1 Double Masked Treatment Period||0||
48497600|NCT04133311|101551141|FG003|COMPLETED|Period 1 Double Masked Treatment Period||0||
48497601|NCT04133311|101551138|FG000|NOT COMPLETED|Period 1 Double Masked Treatment Period||3||
48497602|NCT04133311|101551139|FG001|NOT COMPLETED|Period 1 Double Masked Treatment Period||3||
48497603|NCT04133311|101551140|FG002|NOT COMPLETED|Period 1 Double Masked Treatment Period||0||
48497604|NCT04133311|101551141|FG003|NOT COMPLETED|Period 1 Double Masked Treatment Period||0||
48497605|NCT04133311|101551138|FG000|STARTED|Period 2 Open Label Treatment Period||0||
48497606|NCT04133311|101551139|FG001|STARTED|Period 2 Open Label Treatment Period||0||
48497607|NCT04133311|101551140|FG002|STARTED|Period 2 Open Label Treatment Period||71||
48497608|NCT04133311|101551141|FG003|STARTED|Period 2 Open Label Treatment Period||66||
48497609|NCT04133311|101551138|FG000|COMPLETED|Period 2 Open Label Treatment Period||0||
48497610|NCT04133311|101551139|FG001|COMPLETED|Period 2 Open Label Treatment Period||0||
48497611|NCT04133311|101551140|FG002|COMPLETED|Period 2 Open Label Treatment Period||67||
48497612|NCT04133311|101551141|FG003|COMPLETED|Period 2 Open Label Treatment Period||62||
48497613|NCT04133311|101551138|FG000|NOT COMPLETED|Period 2 Open Label Treatment Period||0||
48497614|NCT04133311|101551139|FG001|NOT COMPLETED|Period 2 Open Label Treatment Period||0||
48497615|NCT04133311|101551140|FG002|NOT COMPLETED|Period 2 Open Label Treatment Period||4||
48497616|NCT04133311|101551141|FG003|NOT COMPLETED|Period 2 Open Label Treatment Period||4||
48497617|NCT03669861|101551142|FG000|STARTED|Overall Study||10||
48497618|NCT03669861|101551142|FG000|COMPLETED|Overall Study||3||
48497619|NCT03669861|101551142|FG000|NOT COMPLETED|Overall Study||7||
48497620|NCT00796328|101551143|FG000|STARTED|Overall Study||46||
48497621|NCT00796328|101551143|FG000|COMPLETED|Overall Study||40||
48497622|NCT00796328|101551143|FG000|NOT COMPLETED|Overall Study||6||
48497623|NCT02471807|101551144|FG000|STARTED|Overall Study||34||
48497624|NCT02471807|101551144|FG000|COMPLETED|Overall Study||12||
48497625|NCT02471807|101551144|FG000|NOT COMPLETED|Overall Study||22||
48497626|NCT02741687|101551145|FG000|STARTED|Overall Study||36||
48497627|NCT02741687|101551146|FG001|STARTED|Overall Study||44||
48497628|NCT02741687|101551145|FG000|COMPLETED|Overall Study||36||
48497629|NCT02741687|101551146|FG001|COMPLETED|Overall Study||44||
48497630|NCT02741687|101551145|FG000|NOT COMPLETED|Overall Study||0||
48497631|NCT02741687|101551146|FG001|NOT COMPLETED|Overall Study||0||
48497632|NCT00913627|101551147|FG000|STARTED|Overall Study||29||
48497633|NCT00913627|101551148|FG001|STARTED|Overall Study||53||
48497634|NCT00913627|101551149|FG002|STARTED|Overall Study||56||
48497635|NCT00913627|101551150|FG003|STARTED|Overall Study||58||
48497636|NCT00913627|101551147|FG000|COMPLETED|Overall Study||29||
48497637|NCT00913627|101551148|FG001|COMPLETED|Overall Study||53||
48497638|NCT00913627|101551149|FG002|COMPLETED|Overall Study||56||
48497639|NCT00913627|101551150|FG003|COMPLETED|Overall Study||58||
48497640|NCT00913627|101551147|FG000|NOT COMPLETED|Overall Study||0||
48497641|NCT00913627|101551148|FG001|NOT COMPLETED|Overall Study||0||
48497642|NCT00913627|101551149|FG002|NOT COMPLETED|Overall Study||0||
48497643|NCT00913627|101551150|FG003|NOT COMPLETED|Overall Study||0||
48497644|NCT03500094|101551151|FG000|STARTED|Overall Study||22||
48497645|NCT03500094|101551151|FG000|Received At Least 1 Dose of Study Drug|Overall Study||21||
48497646|NCT03500094|101551151|FG000|COMPLETED|Overall Study||19||
48497647|NCT03500094|101551151|FG000|NOT COMPLETED|Overall Study||3||
48497648|NCT01912807|101551152|FG000|STARTED|Overall Study||150||
48497649|NCT01912807|101551153|FG001|STARTED|Overall Study||150||
48497650|NCT01912807|101551152|FG000|Randomized|Overall Study||144|10 participants were excluded as did not meet the eligibility criteria|
48497651|NCT01912807|101551153|FG001|Randomized|Overall Study||146|10 participants were excluded as did not meet the eligibility criteria|
48497652|NCT01912807|101551152|FG000|COMPLETED|Overall Study||108||
48497653|NCT01912807|101551153|FG001|COMPLETED|Overall Study||109||
48497654|NCT01912807|101551152|FG000|NOT COMPLETED|Overall Study||42||
48497655|NCT01912807|101551153|FG001|NOT COMPLETED|Overall Study||41||
48497656|NCT02964039|101551154|FG000|STARTED|Overall Study||18||
48497657|NCT02964039|101551155|FG001|STARTED|Overall Study||18||
48497658|NCT02964039|101551156|FG002|STARTED|Overall Study||18||
48497659|NCT02964039|101551154|FG000|Received Allocated Intervention|Overall Study||15||
48497660|NCT02964039|101551155|FG001|Received Allocated Intervention|Overall Study||17||
48497661|NCT02964039|101551156|FG002|Received Allocated Intervention|Overall Study||14||
48497662|NCT02964039|101551154|FG000|COMPLETED|Overall Study||14|Re-assessed after 12-week follow-up period|
48497663|NCT02964039|101551155|FG001|COMPLETED|Overall Study||17|Re-assessed after 12-week follow-up period|
48497664|NCT02964039|101551156|FG002|COMPLETED|Overall Study||13|Re-assessed after 12-week follow-up period|
48497665|NCT02964039|101551154|FG000|NOT COMPLETED|Overall Study||4||
48497666|NCT02964039|101551155|FG001|NOT COMPLETED|Overall Study||1||
48497667|NCT02964039|101551156|FG002|NOT COMPLETED|Overall Study||5||
48497668|NCT00484679|101551157|FG000|STARTED|Overall Study||18||
48497669|NCT00484679|101551157|FG000|COMPLETED|Overall Study||15||
48497670|NCT00484679|101551157|FG000|NOT COMPLETED|Overall Study||3||
48497671|NCT01149057|101551158|FG000|STARTED|Overall Study||145||
48497672|NCT01149057|101551158|FG000|COMPLETED|Overall Study||88||
48497673|NCT01149057|101551158|FG000|NOT COMPLETED|Overall Study||57||
48497674|NCT00789776|101551159|FG000|STARTED|Overall Study||5||
48497675|NCT00789776|101551160|FG001|STARTED|Overall Study||36||
48497676|NCT00789776|101551159|FG000|COMPLETED|Overall Study||5||
48497677|NCT00789776|101551160|FG001|COMPLETED|Overall Study||35||
48497678|NCT00789776|101551159|FG000|NOT COMPLETED|Overall Study||0||
48497679|NCT00789776|101551160|FG001|NOT COMPLETED|Overall Study||1||
48497680|NCT01253564|101551161|FG000|STARTED|Overall Study||24||
48497681|NCT01253564|101551161|FG000|COMPLETED|Overall Study||0||
48497682|NCT01253564|101551161|FG000|NOT COMPLETED|Overall Study||24||
48497683|NCT03616379|101551162|FG000|STARTED|Overall Study||39||
48497684|NCT03616379|101551163|FG001|STARTED|Overall Study||40||
48497685|NCT03616379|101551164|FG002|STARTED|Overall Study||40||
48497686|NCT03616379|101551162|FG000|COMPLETED|Overall Study||39||
48497687|NCT03616379|101551163|FG001|COMPLETED|Overall Study||40||
48497688|NCT03616379|101551164|FG002|COMPLETED|Overall Study||40||
48497689|NCT03616379|101551162|FG000|NOT COMPLETED|Overall Study||0||
48497690|NCT03616379|101551163|FG001|NOT COMPLETED|Overall Study||0||
48497691|NCT03616379|101551164|FG002|NOT COMPLETED|Overall Study||0||
48497692|NCT04807777|101551165|FG000|STARTED|Safety Lead-in: Ruxolitinib 15mg||3||
48497693|NCT04807777|101551165|FG000|COMPLETED|Safety Lead-in: Ruxolitinib 15mg||3||
48497694|NCT04807777|101551165|FG000|NOT COMPLETED|Safety Lead-in: Ruxolitinib 15mg||0||
48497695|NCT04807777|101551165|FG000|STARTED|Stage 1||0||
48497696|NCT04807777|101551165|FG000|COMPLETED|Stage 1||0||
48497697|NCT04807777|101551165|FG000|NOT COMPLETED|Stage 1||0||
48497698|NCT00736190|101551166|FG000|STARTED|Overall Study||90||
48497699|NCT00736190|101551166|FG000|COMPLETED|Overall Study||87||
48497700|NCT00736190|101551166|FG000|NOT COMPLETED|Overall Study||3||
48497701|NCT01374451|101551167|FG000|STARTED|Overall Study||79||
48497702|NCT01374451|101551168|FG001|STARTED|Overall Study||81||
48497703|NCT01374451|101551167|FG000|COMPLETED|Overall Study||78||
48497704|NCT01374451|101551168|FG001|COMPLETED|Overall Study||81||
48497705|NCT01374451|101551167|FG000|NOT COMPLETED|Overall Study||1||
48497706|NCT01374451|101551168|FG001|NOT COMPLETED|Overall Study||0||
48497707|NCT01151280|101551169|FG000|STARTED|Overall Study||10||
48497708|NCT01151280|101551169|FG000|COMPLETED|Overall Study||6||
48497709|NCT01151280|101551169|FG000|NOT COMPLETED|Overall Study||4||
48497710|NCT01439620|101551170|FG000|STARTED|Overall Study||7||
48497711|NCT01439620|101551170|FG000|COMPLETED|Overall Study||7||
48497712|NCT01439620|101551170|FG000|NOT COMPLETED|Overall Study||0||
48497713|NCT01528735|101551171|FG000|STARTED|Treatment Period 1: Faldap/Del/RBV||12||
48497714|NCT01528735|101551172|FG001|STARTED|Treatment Period 1: Faldap/Del/RBV||13||
48497715|NCT01528735|101551171|FG000|COMPLETED|Treatment Period 1: Faldap/Del/RBV||11||
48497716|NCT01528735|101551172|FG001|COMPLETED|Treatment Period 1: Faldap/Del/RBV||12||
48497717|NCT01528735|101551171|FG000|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1||
48497718|NCT01528735|101551172|FG001|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1||
48497719|NCT01528735|101551171|FG000|STARTED|Treatment Period 2: Faldap/PegIFN/RBV||11||
48497720|NCT01528735|101551172|FG001|STARTED|Treatment Period 2: Faldap/PegIFN/RBV||12||
48497721|NCT01528735|101551171|FG000|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||10||
48497722|NCT01528735|101551172|FG001|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||12||
48497723|NCT01528735|101551171|FG000|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||1||
48497724|NCT01528735|101551172|FG001|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||0||
48497725|NCT02911701|101551173|FG000|STARTED|Overall Study||50||
48497726|NCT02911701|101551174|FG001|STARTED|Overall Study||50||
48497727|NCT02911701|101551173|FG000|COMPLETED|Overall Study||47||
48497728|NCT02911701|101551174|FG001|COMPLETED|Overall Study||46||
48497729|NCT02911701|101551173|FG000|NOT COMPLETED|Overall Study||3||
48061017|NCT00055224|100470332|FG001|NOT COMPLETED|Pilot Tasks||0||
48497730|NCT02911701|101551174|FG001|NOT COMPLETED|Overall Study||4||
48497731|NCT05274763|101551175|FG000|STARTED|Overall Study||30||
48497732|NCT05274763|101551175|FG000|COMPLETED|Overall Study||29||
48061018|NCT01193842|100470333|FG000|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3||
48218481|NCT02135679|100860309|FG002|NOT COMPLETED|Overall Study||1||
48497733|NCT05274763|101551175|FG000|NOT COMPLETED|Overall Study||1||
48497734|NCT00452348|101551176|FG000|STARTED|Overall Study||310||
48497735|NCT00452348|101551177|FG001|STARTED|Overall Study||318||
48497736|NCT00452348|101551176|FG000|COMPLETED|Overall Study||231||
48497737|NCT00452348|101551177|FG001|COMPLETED|Overall Study||234||
48497738|NCT00452348|101551176|FG000|NOT COMPLETED|Overall Study||79||
48497739|NCT00452348|101551177|FG001|NOT COMPLETED|Overall Study||84||
48497740|NCT00396162|101551178|FG000|STARTED|Overall Study||39||
48497741|NCT00396162|101551179|FG001|STARTED|Overall Study||38||
48497742|NCT00396162|101551178|FG000|COMPLETED|Overall Study||37||
48497743|NCT00396162|101551179|FG001|COMPLETED|Overall Study||35||
48497744|NCT00396162|101551178|FG000|NOT COMPLETED|Overall Study||2||
48497745|NCT00396162|101551179|FG001|NOT COMPLETED|Overall Study||3||
48497746|NCT01370811|101551180|FG000|STARTED|First Intervention||6||
48497747|NCT01370811|101551181|FG001|STARTED|First Intervention||6||
48497748|NCT01370811|101551182|FG002|STARTED|First Intervention||6||
48497749|NCT01370811|101551183|FG003|STARTED|First Intervention||6||
48497750|NCT01370811|101551180|FG000|COMPLETED|First Intervention||6||
48497751|NCT01370811|101551181|FG001|COMPLETED|First Intervention||6||
48497752|NCT01370811|101551182|FG002|COMPLETED|First Intervention||6||
48497753|NCT01370811|101551183|FG003|COMPLETED|First Intervention||6||
48497754|NCT01370811|101551180|FG000|NOT COMPLETED|First Intervention||0||
48497755|NCT01370811|101551181|FG001|NOT COMPLETED|First Intervention||0||
48497756|NCT01370811|101551182|FG002|NOT COMPLETED|First Intervention||0||
48497757|NCT01370811|101551183|FG003|NOT COMPLETED|First Intervention||0||
48497758|NCT01370811|101551180|FG000|STARTED|Washout Period of >=5 Days||6||
48497759|NCT01370811|101551181|FG001|STARTED|Washout Period of >=5 Days||6||
48497760|NCT01370811|101551182|FG002|STARTED|Washout Period of >=5 Days||6||
48497761|NCT01370811|101551183|FG003|STARTED|Washout Period of >=5 Days||6||
48497762|NCT01370811|101551180|FG000|COMPLETED|Washout Period of >=5 Days||6||
48497763|NCT01370811|101551181|FG001|COMPLETED|Washout Period of >=5 Days||6||
48497764|NCT01370811|101551182|FG002|COMPLETED|Washout Period of >=5 Days||6||
48497765|NCT01370811|101551183|FG003|COMPLETED|Washout Period of >=5 Days||6||
48497766|NCT01370811|101551180|FG000|NOT COMPLETED|Washout Period of >=5 Days||0||
48497767|NCT01370811|101551181|FG001|NOT COMPLETED|Washout Period of >=5 Days||0||
48497768|NCT01370811|101551182|FG002|NOT COMPLETED|Washout Period of >=5 Days||0||
48497769|NCT01370811|101551183|FG003|NOT COMPLETED|Washout Period of >=5 Days||0||
48497770|NCT01370811|101551180|FG000|STARTED|Second Intervention||6||
48497771|NCT01370811|101551181|FG001|STARTED|Second Intervention||6||
48497772|NCT01370811|101551182|FG002|STARTED|Second Intervention||6||
48497773|NCT01370811|101551183|FG003|STARTED|Second Intervention||6||
48497774|NCT01370811|101551180|FG000|COMPLETED|Second Intervention||6||
48497775|NCT01370811|101551181|FG001|COMPLETED|Second Intervention||6||
48497776|NCT01370811|101551182|FG002|COMPLETED|Second Intervention||6||
48497777|NCT01370811|101551183|FG003|COMPLETED|Second Intervention||6||
48497778|NCT01370811|101551180|FG000|NOT COMPLETED|Second Intervention||0||
48497779|NCT01370811|101551181|FG001|NOT COMPLETED|Second Intervention||0||
48497780|NCT01370811|101551182|FG002|NOT COMPLETED|Second Intervention||0||
48497781|NCT01370811|101551183|FG003|NOT COMPLETED|Second Intervention||0||
48497782|NCT01370811|101551180|FG000|STARTED|Washout Period of >=5 Days||6||
48497783|NCT01370811|101551181|FG001|STARTED|Washout Period of >=5 Days||6||
48497784|NCT01370811|101551182|FG002|STARTED|Washout Period of >=5 Days||6||
48497785|NCT01370811|101551183|FG003|STARTED|Washout Period of >=5 Days||6||
48497786|NCT01370811|101551180|FG000|COMPLETED|Washout Period of >=5 Days||6||
48497787|NCT01370811|101551181|FG001|COMPLETED|Washout Period of >=5 Days||6||
48497788|NCT01370811|101551182|FG002|COMPLETED|Washout Period of >=5 Days||6||
48497789|NCT01370811|101551183|FG003|COMPLETED|Washout Period of >=5 Days||6||
48497790|NCT01370811|101551180|FG000|NOT COMPLETED|Washout Period of >=5 Days||0||
48497791|NCT01370811|101551181|FG001|NOT COMPLETED|Washout Period of >=5 Days||0||
48497792|NCT01370811|101551182|FG002|NOT COMPLETED|Washout Period of >=5 Days||0||
48497793|NCT01370811|101551183|FG003|NOT COMPLETED|Washout Period of >=5 Days||0||
48497794|NCT01370811|101551180|FG000|STARTED|Third Intervention||6||
48497795|NCT01370811|101551181|FG001|STARTED|Third Intervention||6||
48497796|NCT01370811|101551182|FG002|STARTED|Third Intervention||6||
48497797|NCT01370811|101551183|FG003|STARTED|Third Intervention||6||
48497798|NCT01370811|101551180|FG000|COMPLETED|Third Intervention||6||
48497799|NCT01370811|101551181|FG001|COMPLETED|Third Intervention||5||
48497800|NCT01370811|101551182|FG002|COMPLETED|Third Intervention||6||
48497801|NCT01370811|101551183|FG003|COMPLETED|Third Intervention||6||
48497802|NCT01370811|101551180|FG000|NOT COMPLETED|Third Intervention||0||
48497803|NCT01370811|101551181|FG001|NOT COMPLETED|Third Intervention||1||
48497804|NCT01370811|101551182|FG002|NOT COMPLETED|Third Intervention||0||
48497805|NCT01370811|101551183|FG003|NOT COMPLETED|Third Intervention||0||
48497806|NCT01370811|101551180|FG000|STARTED|Washout Period of >=5 Days||6||
48497807|NCT01370811|101551181|FG001|STARTED|Washout Period of >=5 Days||5||
48497808|NCT01370811|101551182|FG002|STARTED|Washout Period of >=5 Days||6||
48497809|NCT01370811|101551183|FG003|STARTED|Washout Period of >=5 Days||6||
48497810|NCT01370811|101551180|FG000|COMPLETED|Washout Period of >=5 Days||6||
48497811|NCT01370811|101551181|FG001|COMPLETED|Washout Period of >=5 Days||5||
48497812|NCT01370811|101551182|FG002|COMPLETED|Washout Period of >=5 Days||6||
48497813|NCT01370811|101551183|FG003|COMPLETED|Washout Period of >=5 Days||6||
48497814|NCT01370811|101551180|FG000|NOT COMPLETED|Washout Period of >=5 Days||0||
48497815|NCT01370811|101551181|FG001|NOT COMPLETED|Washout Period of >=5 Days||0||
48497816|NCT01370811|101551182|FG002|NOT COMPLETED|Washout Period of >=5 Days||0||
48497817|NCT01370811|101551183|FG003|NOT COMPLETED|Washout Period of >=5 Days||0||
48497818|NCT01370811|101551180|FG000|STARTED|Fourth Intervention||6||
48497819|NCT01370811|101551181|FG001|STARTED|Fourth Intervention||5||
48497820|NCT01370811|101551182|FG002|STARTED|Fourth Intervention||6||
48497821|NCT01370811|101551183|FG003|STARTED|Fourth Intervention||6||
48497822|NCT01370811|101551180|FG000|COMPLETED|Fourth Intervention||6||
48497823|NCT01370811|101551181|FG001|COMPLETED|Fourth Intervention||5||
48497824|NCT01370811|101551182|FG002|COMPLETED|Fourth Intervention||6||
48497825|NCT01370811|101551183|FG003|COMPLETED|Fourth Intervention||6||
48497826|NCT01370811|101551180|FG000|NOT COMPLETED|Fourth Intervention||0||
48497827|NCT01370811|101551181|FG001|NOT COMPLETED|Fourth Intervention||0||
48497828|NCT01370811|101551182|FG002|NOT COMPLETED|Fourth Intervention||0||
48497829|NCT01370811|101551183|FG003|NOT COMPLETED|Fourth Intervention||0||
48497830|NCT01402050|101554164|FG000|STARTED|Overall Study||185||
48497831|NCT01402050|101554165|FG001|STARTED|Overall Study||191||
48497832|NCT01402050|101554164|FG000|COMPLETED|Overall Study||185||
48497833|NCT01402050|101554165|FG001|COMPLETED|Overall Study||191||
48497834|NCT01402050|101554164|FG000|NOT COMPLETED|Overall Study||0||
48497835|NCT01402050|101554165|FG001|NOT COMPLETED|Overall Study||0||
48497836|NCT02311894|101554166|FG000|STARTED|Overall Study||82||
48497837|NCT02311894|101554166|FG000|Modified ITT Population|Overall Study||81|Participants who took at least one dose of study drug and had at least one post-baseline assessment.|
48497838|NCT02311894|101554166|FG000|COMPLETED|Overall Study||78||
48497839|NCT02311894|101554166|FG000|NOT COMPLETED|Overall Study||4||
48497840|NCT01378962|101554167|FG000|STARTED|Overall Study||50||
48497841|NCT01378962|101554167|FG000|COMPLETED|Overall Study||33||
48497842|NCT01378962|101554167|FG000|NOT COMPLETED|Overall Study||17||
48497843|NCT05604014|101554168|FG000|STARTED|Overall Study||43||
48497844|NCT05604014|101554168|FG000|Baseline Surveys|Overall Study||39||
48497845|NCT05604014|101554168|FG000|Installed App|Overall Study||33||
48497846|NCT05604014|101554168|FG000|6-Week Follow-up Surveys|Overall Study||30||
48497847|NCT05604014|101554168|FG000|COMPLETED|Overall Study||30||
48497848|NCT05604014|101554168|FG000|NOT COMPLETED|Overall Study||13||
48497849|NCT03167606|101554169|FG000|STARTED|Overall Study||382||
48497850|NCT03167606|101554170|FG001|STARTED|Overall Study||381||
48497851|NCT03167606|101554169|FG000|COMPLETED|Overall Study||303||
48497852|NCT03167606|101554170|FG001|COMPLETED|Overall Study||310||
48497853|NCT03167606|101554169|FG000|NOT COMPLETED|Overall Study||79||
48497854|NCT03167606|101554170|FG001|NOT COMPLETED|Overall Study||71||
48497855|NCT02701101|101554171|FG000|STARTED|Overall Study||189||
48497856|NCT02701101|101554171|FG000|COMPLETED|Overall Study||189||
48497857|NCT02701101|101554171|FG000|NOT COMPLETED|Overall Study||0||
48497858|NCT02177617|101554172|FG000|STARTED|Overall Study||8||
48497859|NCT02177617|101554173|FG001|STARTED|Overall Study||8||
48497860|NCT02177617|101554172|FG000|COMPLETED|Overall Study||8||
48497861|NCT02177617|101554173|FG001|COMPLETED|Overall Study||8||
48497862|NCT02177617|101554172|FG000|NOT COMPLETED|Overall Study||0||
48497863|NCT02177617|101554173|FG001|NOT COMPLETED|Overall Study||0||
48497864|NCT00433745|101554174|FG000|STARTED|Overall Study||4||
48497865|NCT00433745|101554174|FG000|COMPLETED|Overall Study||4||
48497866|NCT00433745|101554174|FG000|NOT COMPLETED|Overall Study||0||
48497867|NCT02294981|101554175|FG000|STARTED|Overall Study||4||
48497868|NCT02294981|101554175|FG000|COMPLETED|Overall Study||3||
48497869|NCT02294981|101554175|FG000|NOT COMPLETED|Overall Study||1||
48497870|NCT01003938|101554176|FG000|STARTED|Overall Study||6||
48497871|NCT01003938|101554176|FG000|COMPLETED|Overall Study||6||
48497872|NCT01003938|101554176|FG000|NOT COMPLETED|Overall Study||0||
48497873|NCT01024855|101554177|FG000|STARTED|Overall Study||30||
48497874|NCT01024855|101554177|FG000|COMPLETED|Overall Study||29||
48497875|NCT01024855|101554177|FG000|NOT COMPLETED|Overall Study||1||
48497876|NCT03067987|101554178|FG000|STARTED|Overall Study||50||
48497877|NCT03067987|101554179|FG001|STARTED|Overall Study||53||
48497878|NCT03067987|101554178|FG000|COMPLETED|Overall Study||40||
48497879|NCT03067987|101554179|FG001|COMPLETED|Overall Study||40||
48497880|NCT03067987|101554178|FG000|NOT COMPLETED|Overall Study||10||
48497881|NCT03067987|101554179|FG001|NOT COMPLETED|Overall Study||13||
48497882|NCT04171115|101554180|FG000|STARTED|Overall Study||7||
48497883|NCT04171115|101554181|FG001|STARTED|Overall Study||8||
48497884|NCT04171115|101554182|FG002|STARTED|Overall Study||8||
48497885|NCT04171115|101554183|FG003|STARTED|Overall Study||8||
48497886|NCT04171115|101554184|FG004|STARTED|Overall Study||8||
48497887|NCT04171115|101554180|FG000|COMPLETED|Overall Study||7||
48497888|NCT04171115|101554181|FG001|COMPLETED|Overall Study||8||
48497889|NCT04171115|101554182|FG002|COMPLETED|Overall Study||8||
48497890|NCT04171115|101554183|FG003|COMPLETED|Overall Study||8||
48497891|NCT04171115|101554184|FG004|COMPLETED|Overall Study||7||
48497892|NCT04171115|101554180|FG000|NOT COMPLETED|Overall Study||0||
48497893|NCT04171115|101554181|FG001|NOT COMPLETED|Overall Study||0||
48497894|NCT04171115|101554182|FG002|NOT COMPLETED|Overall Study||0||
48497895|NCT04171115|101554183|FG003|NOT COMPLETED|Overall Study||0||
48497896|NCT04171115|101554184|FG004|NOT COMPLETED|Overall Study||1||
48497897|NCT02625298|101554185|FG000|STARTED|Overall Study||11||
48497898|NCT02625298|101554186|FG001|STARTED|Overall Study||13||
48497899|NCT02625298|101554185|FG000|COMPLETED|Overall Study||10||
48497900|NCT02625298|101554186|FG001|COMPLETED|Overall Study||13||
48497901|NCT02625298|101554185|FG000|NOT COMPLETED|Overall Study||1||
48497902|NCT02625298|101554186|FG001|NOT COMPLETED|Overall Study||0||
48497903|NCT01139762|101554187|FG000|STARTED|Washout and Placebo Lead-In Period||1070||
48497904|NCT01139762|101554188|FG001|STARTED|Washout and Placebo Lead-In Period||0||
48497905|NCT01139762|101554189|FG002|STARTED|Washout and Placebo Lead-In Period||0||
48497906|NCT01139762|101554187|FG000|COMPLETED|Washout and Placebo Lead-In Period||696||
48497907|NCT01139762|101554188|FG001|COMPLETED|Washout and Placebo Lead-In Period||0||
48497908|NCT01139762|101554189|FG002|COMPLETED|Washout and Placebo Lead-In Period||0||
48497909|NCT01139762|101554187|FG000|NOT COMPLETED|Washout and Placebo Lead-In Period||374||
48497910|NCT01139762|101554188|FG001|NOT COMPLETED|Washout and Placebo Lead-In Period||0||
48497911|NCT01139762|101554189|FG002|NOT COMPLETED|Washout and Placebo Lead-In Period||0||
48497912|NCT01139762|101554187|FG000|STARTED|Double-Blind Randomized Active Treatment||0||
48497913|NCT01139762|101554188|FG001|STARTED|Double-Blind Randomized Active Treatment||346||
48497914|NCT01139762|101554189|FG002|STARTED|Double-Blind Randomized Active Treatment||350||
48497915|NCT01139762|101554187|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||0||
48497916|NCT01139762|101554188|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||345||
48497917|NCT01139762|101554189|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||350||
48497918|NCT01139762|101554187|FG000|COMPLETED|Double-Blind Randomized Active Treatment||0||
48497919|NCT01139762|101554188|FG001|COMPLETED|Double-Blind Randomized Active Treatment||306||
48061019|NCT01193842|100470334|FG001|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0||
48061020|NCT01193842|100470335|FG002|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0||
48061021|NCT01193842|100470336|FG003|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0||
48061022|NCT01193842|100470337|FG004|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0||
48497920|NCT01139762|101554189|FG002|COMPLETED|Double-Blind Randomized Active Treatment||286||
48497921|NCT01139762|101554187|FG000|NOT COMPLETED|Double-Blind Randomized Active Treatment||0||
48497922|NCT01139762|101554188|FG001|NOT COMPLETED|Double-Blind Randomized Active Treatment||40||
48497923|NCT01139762|101554189|FG002|NOT COMPLETED|Double-Blind Randomized Active Treatment||64||
48497924|NCT02484807|101554190|FG000|STARTED|Overall Study||39||
48497925|NCT02484807|101554191|FG001|STARTED|Overall Study||7||
48497926|NCT02484807|101554192|FG002|STARTED|Overall Study||19||
48497927|NCT02484807|101554193|FG003|STARTED|Overall Study||21||
48497928|NCT02484807|101554194|FG004|STARTED|Overall Study||33||
48497929|NCT02484807|101554195|FG005|STARTED|Overall Study||6||
48497930|NCT02484807|101554190|FG000|COMPLETED|Overall Study||39||
48497931|NCT02484807|101554191|FG001|COMPLETED|Overall Study||7||
48497932|NCT02484807|101554192|FG002|COMPLETED|Overall Study||19||
48497933|NCT02484807|101554193|FG003|COMPLETED|Overall Study||21||
48497934|NCT02484807|101554194|FG004|COMPLETED|Overall Study||33||
48497935|NCT02484807|101554195|FG005|COMPLETED|Overall Study||6||
48497936|NCT02484807|101554190|FG000|NOT COMPLETED|Overall Study||0||
48497937|NCT02484807|101554191|FG001|NOT COMPLETED|Overall Study||0||
48497938|NCT02484807|101554192|FG002|NOT COMPLETED|Overall Study||0||
48497939|NCT02484807|101554193|FG003|NOT COMPLETED|Overall Study||0||
48497940|NCT02484807|101554194|FG004|NOT COMPLETED|Overall Study||0||
48497941|NCT02484807|101554195|FG005|NOT COMPLETED|Overall Study||0||
48497942|NCT02099318|101554196|FG000|STARTED|Overall Study||20||
48497943|NCT02099318|101554197|FG001|STARTED|Overall Study||20||
48497944|NCT02099318|101554196|FG000|COMPLETED|Overall Study||20||
48497945|NCT02099318|101554197|FG001|COMPLETED|Overall Study||20||
48497946|NCT02099318|101554196|FG000|NOT COMPLETED|Overall Study||0||
48497947|NCT02099318|101554197|FG001|NOT COMPLETED|Overall Study||0||
48497948|NCT02132910|101554198|FG000|STARTED|Overall Study||34||
48497949|NCT02132910|101554199|FG001|STARTED|Overall Study||34||
48497950|NCT02132910|101554198|FG000|COMPLETED|Overall Study||34||
48497951|NCT02132910|101554199|FG001|COMPLETED|Overall Study||34||
48497952|NCT02132910|101554198|FG000|NOT COMPLETED|Overall Study||0||
48497953|NCT02132910|101554199|FG001|NOT COMPLETED|Overall Study||0||
48497954|NCT02623218|101554200|FG000|STARTED|Overall Study||5||
48497955|NCT02623218|101554201|FG001|STARTED|Overall Study||4||
48497956|NCT02623218|101554202|FG002|STARTED|Overall Study||4||
48497957|NCT02623218|101554203|FG003|STARTED|Overall Study||4||
48497958|NCT02623218|101554204|FG004|STARTED|Overall Study||4||
48497959|NCT02623218|101554200|FG000|COMPLETED|Overall Study||5||
48497960|NCT02623218|101554201|FG001|COMPLETED|Overall Study||3||
48497961|NCT02623218|101554202|FG002|COMPLETED|Overall Study||4||
48497962|NCT02623218|101554203|FG003|COMPLETED|Overall Study||4||
48497963|NCT02623218|101554204|FG004|COMPLETED|Overall Study||4||
48497964|NCT02623218|101554200|FG000|NOT COMPLETED|Overall Study||0||
48497965|NCT02623218|101554201|FG001|NOT COMPLETED|Overall Study||1||
48497966|NCT02623218|101554202|FG002|NOT COMPLETED|Overall Study||0||
48497967|NCT02623218|101554203|FG003|NOT COMPLETED|Overall Study||0||
48497968|NCT02623218|101554204|FG004|NOT COMPLETED|Overall Study||0||
48497969|NCT00503867|101554205|FG000|STARTED|Overall Study||10||
48497970|NCT00503867|101554205|FG000|COMPLETED|Overall Study||8||
48497971|NCT00503867|101554205|FG000|NOT COMPLETED|Overall Study||2||
48497972|NCT02664415|101554206|FG000|STARTED|Overall Study||14||
48497973|NCT02664415|101554207|FG001|STARTED|Overall Study||5||
48497974|NCT02664415|101554206|FG000|COMPLETED|Overall Study||13||
48497975|NCT02664415|101554207|FG001|COMPLETED|Overall Study||5||
48497976|NCT02664415|101554206|FG000|NOT COMPLETED|Overall Study||1||
48497977|NCT02664415|101554207|FG001|NOT COMPLETED|Overall Study||0||
48497978|NCT01438060|101554208|FG000|STARTED|Acute Phase: Double-blind, 10 Weeks||102||
48497979|NCT01438060|101554209|FG001|STARTED|Acute Phase: Double-blind, 10 Weeks||106||
48497980|NCT01438060|101554208|FG000|COMPLETED|Acute Phase: Double-blind, 10 Weeks||84||
48497981|NCT01438060|101554209|FG001|COMPLETED|Acute Phase: Double-blind, 10 Weeks||88||
48497982|NCT01438060|101554208|FG000|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18||
48497983|NCT01438060|101554209|FG001|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18||
48497984|NCT01438060|101554208|FG000|STARTED|Extension Phase: Week 10 to Week 130||80||
48497985|NCT01438060|101554209|FG001|STARTED|Extension Phase: Week 10 to Week 130||81||
48497986|NCT01438060|101554208|FG000|COMPLETED|Extension Phase: Week 10 to Week 130||22||
48497987|NCT01438060|101554209|FG001|COMPLETED|Extension Phase: Week 10 to Week 130||25||
48218482|NCT02135679|100860310|FG003|NOT COMPLETED|Overall Study||0||
48497988|NCT01438060|101554208|FG000|NOT COMPLETED|Extension Phase: Week 10 to Week 130||58||
48497989|NCT01438060|101554209|FG001|NOT COMPLETED|Extension Phase: Week 10 to Week 130||56||
48497990|NCT01438060|101554208|FG000|STARTED|On Study Beyond Week 140||0||
48497991|NCT01438060|101554209|FG001|STARTED|On Study Beyond Week 140||9||
48497992|NCT01438060|101554208|FG000|COMPLETED|On Study Beyond Week 140||0||
48497993|NCT01438060|101554209|FG001|COMPLETED|On Study Beyond Week 140||1||
48497994|NCT01438060|101554208|FG000|NOT COMPLETED|On Study Beyond Week 140||0||
48497995|NCT01438060|101554209|FG001|NOT COMPLETED|On Study Beyond Week 140||8||
48061023|NCT01193842|100470333|FG000|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3||
48061024|NCT01193842|100470334|FG001|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0||
48061025|NCT01193842|100470335|FG002|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0||
48061026|NCT01193842|100470336|FG003|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0||
48061027|NCT01193842|100470337|FG004|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0||
48061028|NCT01193842|100470333|FG000|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0||
48061029|NCT01193842|100470334|FG001|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0||
48061030|NCT01193842|100470335|FG002|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0||
48061031|NCT01193842|100470336|FG003|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0||
48218483|NCT02135679|100860311|FG004|NOT COMPLETED|Overall Study||2||
48497996|NCT03498560|101554210|FG000|STARTED|Overall Study||38||
48497997|NCT03498560|101554210|FG000|Completed Baseline Assessment|Overall Study||32||
48497998|NCT03498560|101554210|FG000|Completed PSG|Overall Study||25||
48497999|NCT03498560|101554210|FG000|COMPLETED|Overall Study||17||
48498000|NCT03498560|101554210|FG000|NOT COMPLETED|Overall Study||21||
48498001|NCT01717313|101554211|FG000|STARTED|Phase A (Weeks 0 to 24)||165||
48498002|NCT01717313|101554212|FG001|STARTED|Phase A (Weeks 0 to 24)||164||
48498003|NCT01717313|101554211|FG000|COMPLETED|Phase A (Weeks 0 to 24)||147||
48498004|NCT01717313|101554212|FG001|COMPLETED|Phase A (Weeks 0 to 24)||151||
48498005|NCT01717313|101554211|FG000|NOT COMPLETED|Phase A (Weeks 0 to 24)||18||
48498006|NCT01717313|101554212|FG001|NOT COMPLETED|Phase A (Weeks 0 to 24)||13||
48498007|NCT01717313|101554211|FG000|STARTED|Interphase||147||
48498008|NCT01717313|101554212|FG001|STARTED|Interphase||151||
48498009|NCT01717313|101554211|FG000|COMPLETED|Interphase||146||
48498010|NCT01717313|101554212|FG001|COMPLETED|Interphase||151||
48498011|NCT01717313|101554211|FG000|NOT COMPLETED|Interphase||1||
48498012|NCT01717313|101554212|FG001|NOT COMPLETED|Interphase||0||
48498013|NCT01717313|101554211|FG000|STARTED|Phase B (Weeks 24 to 54)||146||
48498014|NCT01717313|101554212|FG001|STARTED|Phase B (Weeks 24 to 54)||151||
48498015|NCT01717313|101554211|FG000|COMPLETED|Phase B (Weeks 24 to 54)||134||
48498016|NCT01717313|101554212|FG001|COMPLETED|Phase B (Weeks 24 to 54)||135||
48498017|NCT01717313|101554211|FG000|NOT COMPLETED|Phase B (Weeks 24 to 54)||12||
48498018|NCT01717313|101554212|FG001|NOT COMPLETED|Phase B (Weeks 24 to 54)||16||
48498019|NCT02452463|101554213|FG000|STARTED|Overall Study||5||
48498020|NCT02452463|101554214|FG001|STARTED|Overall Study||3||
48498021|NCT02452463|101554215|FG002|STARTED|Overall Study||0||
48498022|NCT02452463|101554213|FG000|COMPLETED|Overall Study||3||
48498023|NCT02452463|101554214|FG001|COMPLETED|Overall Study||1||
48498024|NCT02452463|101554215|FG002|COMPLETED|Overall Study||0||
48498025|NCT02452463|101554213|FG000|NOT COMPLETED|Overall Study||2||
48498026|NCT02452463|101554214|FG001|NOT COMPLETED|Overall Study||2||
48498027|NCT02452463|101554215|FG002|NOT COMPLETED|Overall Study||0||
48498028|NCT01936662|101554216|FG000|STARTED|Overall Study||42||
48498029|NCT01936662|101554217|FG001|STARTED|Overall Study||42||
48498030|NCT01936662|101554216|FG000|COMPLETED|Overall Study||42||
48498031|NCT01936662|101554217|FG001|COMPLETED|Overall Study||42||
48498032|NCT01936662|101554216|FG000|NOT COMPLETED|Overall Study||0||
48498033|NCT01936662|101554217|FG001|NOT COMPLETED|Overall Study||0||
48498034|NCT02674711|101554218|FG000|STARTED|Overall Study||60||
48498035|NCT02674711|101554219|FG001|STARTED|Overall Study||60||
48498036|NCT02674711|101554218|FG000|COMPLETED|Overall Study||60||
48498037|NCT02674711|101554219|FG001|COMPLETED|Overall Study||60||
48498038|NCT02674711|101554218|FG000|NOT COMPLETED|Overall Study||0||
48498039|NCT02674711|101554219|FG001|NOT COMPLETED|Overall Study||0||
48498040|NCT01087502|101554220|FG000|STARTED|Up to Interim Analysis (Week 12)||123||
48498041|NCT01087502|101554221|FG001|STARTED|Up to Interim Analysis (Week 12)||118||
48498042|NCT01087502|101554220|FG000|COMPLETED|Up to Interim Analysis (Week 12)||114||
48498043|NCT01087502|101554221|FG001|COMPLETED|Up to Interim Analysis (Week 12)||110||
48498044|NCT01087502|101554220|FG000|NOT COMPLETED|Up to Interim Analysis (Week 12)||9||
48498045|NCT01087502|101554221|FG001|NOT COMPLETED|Up to Interim Analysis (Week 12)||8||
48498046|NCT01087502|101554220|FG000|STARTED|Up to Final Analysis (Week 52)||123||
48498047|NCT01087502|101554221|FG001|STARTED|Up to Final Analysis (Week 52)||118||
48498048|NCT01087502|101554220|FG000|COMPLETED|Up to Final Analysis (Week 52)||90||
48498049|NCT01087502|101554221|FG001|COMPLETED|Up to Final Analysis (Week 52)||95||
48498050|NCT01087502|101554220|FG000|NOT COMPLETED|Up to Final Analysis (Week 52)||33||
48498051|NCT01087502|101554221|FG001|NOT COMPLETED|Up to Final Analysis (Week 52)||23||
48498052|NCT04435782|101554222|FG000|STARTED|Overall Study||9||
48498053|NCT04435782|101554222|FG000|COMPLETED|Overall Study||5||
48498054|NCT04435782|101554222|FG000|NOT COMPLETED|Overall Study||4||
48498055|NCT03101358|101554223|FG000|STARTED|Overall Study||4||
48498056|NCT03101358|101554224|FG001|STARTED|Overall Study||3||
48498057|NCT03101358|101554225|FG002|STARTED|Overall Study||5||
48498058|NCT03101358|101554226|FG003|STARTED|Overall Study||11||
48498059|NCT03101358|101554223|FG000|Completed All Dosing|Overall Study||3||
48498060|NCT03101358|101554224|FG001|Completed All Dosing|Overall Study||3||
48498061|NCT03101358|101554225|FG002|Completed All Dosing|Overall Study||3||
48498062|NCT03101358|101554226|FG003|Completed All Dosing|Overall Study||10||
48498063|NCT03101358|101554223|FG000|COMPLETED|Overall Study||1||
48498064|NCT03101358|101554224|FG001|COMPLETED|Overall Study||3||
48498065|NCT03101358|101554225|FG002|COMPLETED|Overall Study||3||
48498066|NCT03101358|101554226|FG003|COMPLETED|Overall Study||5||
48498067|NCT03101358|101554223|FG000|NOT COMPLETED|Overall Study||3||
48498068|NCT03101358|101554224|FG001|NOT COMPLETED|Overall Study||0||
48498069|NCT03101358|101554225|FG002|NOT COMPLETED|Overall Study||2||
48498070|NCT03101358|101554226|FG003|NOT COMPLETED|Overall Study||6||
48061032|NCT01193842|100470337|FG004|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0||
48218484|NCT02135679|100860312|FG005|NOT COMPLETED|Overall Study||6||
48218485|NCT02135679|100860313|FG006|NOT COMPLETED|Overall Study||0||
48498071|NCT04608448|101554227|FG000|STARTED|Overall Study||22||44
48498072|NCT04608448|101554227|FG000|COMPLETED|Overall Study||20||40
48498073|NCT04608448|101554227|FG000|NOT COMPLETED|Overall Study||2||4
48498074|NCT01124786|101554228|FG000|STARTED|Overall Study||182||
48498075|NCT01124786|101554229|FG001|STARTED|Overall Study||185||
48498076|NCT01124786|101554228|FG000|Intent-to-Treat (ITT) Population|Overall Study||182||
48498077|NCT01124786|101554229|FG001|Intent-to-Treat (ITT) Population|Overall Study||185||
48498078|NCT01124786|101554228|FG000|Safety Population|Overall Study||179||
48498079|NCT01124786|101554229|FG001|Safety Population|Overall Study||181||
48498080|NCT01124786|101554228|FG000|Tumor Evaluable Population|Overall Study||178||
48498081|NCT01124786|101554229|FG001|Tumor Evaluable Population|Overall Study||180||
48498082|NCT01124786|101554228|FG000|COMPLETED|Overall Study||178||
48498083|NCT01124786|101554229|FG001|COMPLETED|Overall Study||180||
48498084|NCT01124786|101554228|FG000|NOT COMPLETED|Overall Study||4||
48498085|NCT01124786|101554229|FG001|NOT COMPLETED|Overall Study||5||
48498086|NCT00660660|101554230|FG000|STARTED|Overall Study||143||
48498087|NCT00660660|101554231|FG001|STARTED|Overall Study||133||
48498088|NCT00660660|101554230|FG000|Met Criteria for MITT Population|Overall Study||137||
48498089|NCT00660660|101554231|FG001|Met Criteria for MITT Population|Overall Study||125||
48498090|NCT00660660|101554230|FG000|COMPLETED|Overall Study||138||
48498091|NCT00660660|101554231|FG001|COMPLETED|Overall Study||124||
48498092|NCT00660660|101554230|FG000|NOT COMPLETED|Overall Study||5||
48498093|NCT00660660|101554231|FG001|NOT COMPLETED|Overall Study||9||
48498094|NCT00533507|101554232|FG000|STARTED|Overall Study||230||
48498095|NCT00533507|101554232|FG000|COMPLETED|Overall Study||229||
48498096|NCT00533507|101554232|FG000|NOT COMPLETED|Overall Study||1||
48498097|NCT05293106|101554233|FG000|STARTED|Overall Study||1||
48498098|NCT05293106|101554234|FG001|STARTED|Overall Study||1||
48498099|NCT05293106|101554235|FG002|STARTED|Overall Study||7||
48498100|NCT05293106|101554233|FG000|COMPLETED|Overall Study||1||
48498101|NCT05293106|101554234|FG001|COMPLETED|Overall Study||1||
48498102|NCT05293106|101554235|FG002|COMPLETED|Overall Study||7||
48498103|NCT05293106|101554233|FG000|NOT COMPLETED|Overall Study||0||
48498104|NCT05293106|101554234|FG001|NOT COMPLETED|Overall Study||0||
48498105|NCT05293106|101554235|FG002|NOT COMPLETED|Overall Study||0||
48498106|NCT02616380|101554236|FG000|STARTED|Overall Study||100||
48498107|NCT02616380|101554236|FG000|COMPLETED|Overall Study||97||
48498108|NCT02616380|101554236|FG000|NOT COMPLETED|Overall Study||3||
48498109|NCT03555695|101554237|FG000|STARTED|Overall Study||19||
48498110|NCT03555695|101554237|FG000|COMPLETED|Overall Study||15||
48498111|NCT03555695|101554237|FG000|NOT COMPLETED|Overall Study||4||
48498112|NCT01632215|101554238|FG000|STARTED|Overall Study||20||
48498113|NCT01632215|101554239|FG001|STARTED|Overall Study||20||
48498114|NCT01632215|101554238|FG000|COMPLETED|Overall Study||18||
48498115|NCT01632215|101554239|FG001|COMPLETED|Overall Study||19||
48498116|NCT01632215|101554238|FG000|NOT COMPLETED|Overall Study||2||
48498117|NCT01632215|101554239|FG001|NOT COMPLETED|Overall Study||1||
48498118|NCT01709903|101554240|FG000|STARTED|Overall Study||372||
48498119|NCT01709903|101554241|FG001|STARTED|Overall Study||372||
48498120|NCT01709903|101554240|FG000|COMPLETED|Overall Study||343||
48498121|NCT01709903|101554241|FG001|COMPLETED|Overall Study||333||
48498122|NCT01709903|101554240|FG000|NOT COMPLETED|Overall Study||29||
48498123|NCT01709903|101554241|FG001|NOT COMPLETED|Overall Study||39||
48498124|NCT01370863|101554242|FG000|STARTED|Overall Study||34||
48498125|NCT01370863|101554243|FG001|STARTED|Overall Study||33||
48498126|NCT01370863|101554242|FG000|COMPLETED|Overall Study||32||
48498127|NCT01370863|101554243|FG001|COMPLETED|Overall Study||30||
48498128|NCT01370863|101554242|FG000|NOT COMPLETED|Overall Study||2||
48498129|NCT01370863|101554243|FG001|NOT COMPLETED|Overall Study||3||
48498130|NCT02997176|101554244|FG000|STARTED|Overall Study||7||
48498131|NCT02997176|101554245|FG001|STARTED|Overall Study||10||
48498132|NCT02997176|101554246|FG002|STARTED|Overall Study||5||
48498133|NCT02997176|101554247|FG003|STARTED|Overall Study||16||
48498134|NCT02997176|101554244|FG000|COMPLETED|Overall Study||6||
48498135|NCT02997176|101554245|FG001|COMPLETED|Overall Study||8||
48498136|NCT02997176|101554246|FG002|COMPLETED|Overall Study||3||
48498137|NCT02997176|101554247|FG003|COMPLETED|Overall Study||5||
48498138|NCT02997176|101554244|FG000|NOT COMPLETED|Overall Study||1||
48498139|NCT02997176|101554245|FG001|NOT COMPLETED|Overall Study||2||
48498140|NCT02997176|101554246|FG002|NOT COMPLETED|Overall Study||2||
48498141|NCT02997176|101554247|FG003|NOT COMPLETED|Overall Study||11||
48498142|NCT01131260|101554248|FG000|STARTED|Overall Study||5532||
48498143|NCT01131260|101554249|FG001|STARTED|Overall Study||5576||
48498144|NCT01131260|101554248|FG000|COMPLETED|Overall Study||5488||
48498145|NCT01131260|101554249|FG001|COMPLETED|Overall Study||5529||
48498146|NCT01131260|101554248|FG000|NOT COMPLETED|Overall Study||44||
48498147|NCT01131260|101554249|FG001|NOT COMPLETED|Overall Study||47||
48498148|NCT04431518|101554250|FG000|STARTED|Overall Study||4||
48498149|NCT04431518|101554251|FG001|STARTED|Overall Study||4||
48498150|NCT04431518|101554250|FG000|COMPLETED|Overall Study||4||
48498151|NCT04431518|101554251|FG001|COMPLETED|Overall Study||4||
48498152|NCT04431518|101554250|FG000|NOT COMPLETED|Overall Study||0||
48498153|NCT04431518|101554251|FG001|NOT COMPLETED|Overall Study||0||
48498154|NCT01513239|101554252|FG000|STARTED|Period 1: Main Phase||397||
48498155|NCT01513239|101554253|FG001|STARTED|Period 1: Main Phase||407||
48498156|NCT01513239|101554254|FG002|STARTED|Period 1: Main Phase||399||
48498157|NCT01513239|101554255|FG003|STARTED|Period 1: Main Phase||0||
48498158|NCT01513239|101554256|FG004|STARTED|Period 1: Main Phase||0||
48498159|NCT01513239|101554257|FG005|STARTED|Period 1: Main Phase||0||
48498160|NCT01513239|101554252|FG000|Treated|Period 1: Main Phase||391||
48498161|NCT01513239|101554253|FG001|Treated|Period 1: Main Phase||396||
48498162|NCT01513239|101554254|FG002|Treated|Period 1: Main Phase||381||
48498163|NCT01513239|101554255|FG003|Treated|Period 1: Main Phase||0||
48498164|NCT01513239|101554256|FG004|Treated|Period 1: Main Phase||0||
48498165|NCT01513239|101554257|FG005|Treated|Period 1: Main Phase||0||
48498166|NCT01513239|101554252|FG000|All Participants as Treated|Period 1: Main Phase||390||
48498167|NCT01513239|101554253|FG001|All Participants as Treated|Period 1: Main Phase||396||
48498168|NCT01513239|101554254|FG002|All Participants as Treated|Period 1: Main Phase||381||
48498169|NCT01513239|101554255|FG003|All Participants as Treated|Period 1: Main Phase||0||
48498170|NCT01513239|101554256|FG004|All Participants as Treated|Period 1: Main Phase||0||
48498171|NCT01513239|101554257|FG005|All Participants as Treated|Period 1: Main Phase||0||
48498172|NCT01513239|101554252|FG000|COMPLETED|Period 1: Main Phase||322||
48498173|NCT01513239|101554253|FG001|COMPLETED|Period 1: Main Phase||337||
48498174|NCT01513239|101554254|FG002|COMPLETED|Period 1: Main Phase||311||
48498175|NCT01513239|101554255|FG003|COMPLETED|Period 1: Main Phase||0||
48498176|NCT01513239|101554256|FG004|COMPLETED|Period 1: Main Phase||0||
48498177|NCT01513239|101554257|FG005|COMPLETED|Period 1: Main Phase||0||
48498178|NCT01513239|101554252|FG000|NOT COMPLETED|Period 1: Main Phase||75||
48498179|NCT01513239|101554253|FG001|NOT COMPLETED|Period 1: Main Phase||70||
48498180|NCT01513239|101554254|FG002|NOT COMPLETED|Period 1: Main Phase||88||
48498181|NCT01513239|101554255|FG003|NOT COMPLETED|Period 1: Main Phase||0||
48498182|NCT01513239|101554256|FG004|NOT COMPLETED|Period 1: Main Phase||0||
48498183|NCT01513239|101554257|FG005|NOT COMPLETED|Period 1: Main Phase||0||
48498184|NCT01513239|101554252|FG000|STARTED|Period 2: 9 Month Extension Phase||0||
48498185|NCT01513239|101554253|FG001|STARTED|Period 2: 9 Month Extension Phase||0||
48498186|NCT01513239|101554254|FG002|STARTED|Period 2: 9 Month Extension Phase||0||
48498187|NCT01513239|101554255|FG003|STARTED|Period 2: 9 Month Extension Phase||112||
48498188|NCT01513239|101554256|FG004|STARTED|Period 2: 9 Month Extension Phase||100||
48498189|NCT01513239|101554257|FG005|STARTED|Period 2: 9 Month Extension Phase||83||
48498190|NCT01513239|101554252|FG000|COMPLETED|Period 2: 9 Month Extension Phase||0||
48498191|NCT01513239|101554253|FG001|COMPLETED|Period 2: 9 Month Extension Phase||0||
48498192|NCT01513239|101554254|FG002|COMPLETED|Period 2: 9 Month Extension Phase||0||
48498193|NCT01513239|101554255|FG003|COMPLETED|Period 2: 9 Month Extension Phase||102||
48498194|NCT01513239|101554256|FG004|COMPLETED|Period 2: 9 Month Extension Phase||90||
48498195|NCT01513239|101554257|FG005|COMPLETED|Period 2: 9 Month Extension Phase||78||
48498196|NCT01513239|101554252|FG000|NOT COMPLETED|Period 2: 9 Month Extension Phase||0||
48498197|NCT01513239|101554253|FG001|NOT COMPLETED|Period 2: 9 Month Extension Phase||0||
48498198|NCT01513239|101554254|FG002|NOT COMPLETED|Period 2: 9 Month Extension Phase||0||
48498199|NCT01513239|101554255|FG003|NOT COMPLETED|Period 2: 9 Month Extension Phase||10||
48498200|NCT01513239|101554256|FG004|NOT COMPLETED|Period 2: 9 Month Extension Phase||10||
48498201|NCT01513239|101554257|FG005|NOT COMPLETED|Period 2: 9 Month Extension Phase||5||
48498202|NCT00177164|101554258|FG000|STARTED|Overall Study||23||
48498203|NCT00177164|101554259|FG001|STARTED|Overall Study||25||
48498204|NCT00177164|101554258|FG000|COMPLETED|Overall Study||14||
48498205|NCT00177164|101554259|FG001|COMPLETED|Overall Study||9||
48498206|NCT00177164|101554258|FG000|NOT COMPLETED|Overall Study||9||
48498207|NCT00177164|101554259|FG001|NOT COMPLETED|Overall Study||16||
48498208|NCT01993186|101554260|FG000|STARTED|Double-Blind Placebo-Controlled Period||25||
48498209|NCT01993186|101554261|FG001|STARTED|Double-Blind Placebo-Controlled Period||11||
48498210|NCT01993186|101554260|FG000|COMPLETED|Double-Blind Placebo-Controlled Period||23||
48498211|NCT01993186|101554261|FG001|COMPLETED|Double-Blind Placebo-Controlled Period||11||
48498212|NCT01993186|101554260|FG000|NOT COMPLETED|Double-Blind Placebo-Controlled Period||2||
48498213|NCT01993186|101554261|FG001|NOT COMPLETED|Double-Blind Placebo-Controlled Period||0||
48498214|NCT01993186|101554260|FG000|STARTED|Open-Label Extension Period||23||
48498215|NCT01993186|101554261|FG001|STARTED|Open-Label Extension Period||11||
48498216|NCT01993186|101554260|FG000|COMPLETED|Open-Label Extension Period||16||
48498217|NCT01993186|101554261|FG001|COMPLETED|Open-Label Extension Period||5||
48498218|NCT01993186|101554260|FG000|NOT COMPLETED|Open-Label Extension Period||7||
48498219|NCT01993186|101554261|FG001|NOT COMPLETED|Open-Label Extension Period||6||
48498220|NCT03821675|101554262|FG000|STARTED|Overall Study||19||
48498221|NCT03821675|101554263|FG001|STARTED|Overall Study||19||
48498222|NCT03821675|101554262|FG000|COMPLETED|Overall Study||16||
48498223|NCT03821675|101554263|FG001|COMPLETED|Overall Study||17||
48498224|NCT03821675|101554262|FG000|NOT COMPLETED|Overall Study||3||
48498225|NCT03821675|101554263|FG001|NOT COMPLETED|Overall Study||2||
48498226|NCT01158118|101554264|FG000|STARTED|Overall Study||24||
48498227|NCT01158118|101554265|FG001|STARTED|Overall Study||24||
48498228|NCT01158118|101554264|FG000|COMPLETED|Overall Study||23||
48498229|NCT01158118|101554265|FG001|COMPLETED|Overall Study||21||
48498230|NCT01158118|101554264|FG000|NOT COMPLETED|Overall Study||1||
48498231|NCT01158118|101554265|FG001|NOT COMPLETED|Overall Study||3||
48498232|NCT01215721|101554266|FG000|STARTED|Overall Study||40||
48498233|NCT01215721|101554266|FG000|COMPLETED|Overall Study||38||
48498234|NCT01215721|101554266|FG000|NOT COMPLETED|Overall Study||2||
48498235|NCT00749658|101554267|FG000|STARTED|Overall Study||60||
48498236|NCT00749658|101554268|FG001|STARTED|Overall Study||61||
48498237|NCT00749658|101554267|FG000|COMPLETED|Overall Study||60||
48498238|NCT00749658|101554268|FG001|COMPLETED|Overall Study||61||
48498239|NCT00749658|101554267|FG000|NOT COMPLETED|Overall Study||0||
48498240|NCT00749658|101554268|FG001|NOT COMPLETED|Overall Study||0||
48498241|NCT03193021|101554269|FG000|STARTED|Overall Study||100||
48498242|NCT03193021|101554270|FG001|STARTED|Overall Study||104||
48498243|NCT03193021|101554269|FG000|COMPLETED|Overall Study||99||
48498244|NCT03193021|101554270|FG001|COMPLETED|Overall Study||103||
48498245|NCT03193021|101554269|FG000|NOT COMPLETED|Overall Study||1||
48498246|NCT03193021|101554270|FG001|NOT COMPLETED|Overall Study||1||
48498247|NCT00474058|101554271|FG000|STARTED|Overall Study||190||
48498248|NCT00474058|101554272|FG001|STARTED|Overall Study||97||
48498249|NCT00474058|101554271|FG000|COMPLETED|Overall Study||166||
48498250|NCT00474058|101554272|FG001|COMPLETED|Overall Study||80||
48498251|NCT00474058|101554271|FG000|NOT COMPLETED|Overall Study||24||
48498252|NCT00474058|101554272|FG001|NOT COMPLETED|Overall Study||17||
48498253|NCT02798458|101554273|FG000|STARTED|Smart Pill Test (1 Day)||35|48 patients total enrolled, 35 started and completed the SmartPill only and 13 started and completed the EMR and SmartPill.|
48498254|NCT02798458|101554274|FG001|STARTED|Smart Pill Test (1 Day)||13|48 patients total enrolled, 35 started and completed the SmartPill only and 13 started and completed the EMR and SmartPill.|
48498255|NCT02798458|101554273|FG000|COMPLETED|Smart Pill Test (1 Day)||35|48 patients total enrolled, 35 started and completed the SmartPill only and 13 started and completed the EMR and SmartPill.|
48498256|NCT02798458|101554274|FG001|COMPLETED|Smart Pill Test (1 Day)||13|48 patients total enrolled, 35 started and completed the SmartPill only and 13 started and completed the EMR and SmartPill.|
48498257|NCT02798458|101554273|FG000|NOT COMPLETED|Smart Pill Test (1 Day)||0||
48498258|NCT02798458|101554274|FG001|NOT COMPLETED|Smart Pill Test (1 Day)||0||
48666746|NCT03391882|101970469|FG004|Modified Intent-to-Treat Population Part A|Part A - Titration Phase||18||
48666747|NCT03391882|101970470|FG005|Modified Intent-to-Treat Population Part A|Part A - Titration Phase||19||
48218486|NCT01426412|100860314|FG000|STARTED|Overall Study||6||
48218487|NCT01426412|100860315|FG001|STARTED|Overall Study||6||
48498259|NCT02798458|101554273|FG000|STARTED|Endoscopic Mucosal Resection (1 Day)||0||
48498260|NCT02798458|101554274|FG001|STARTED|Endoscopic Mucosal Resection (1 Day)||13||
48498261|NCT02798458|101554273|FG000|COMPLETED|Endoscopic Mucosal Resection (1 Day)||0||
48498262|NCT02798458|101554274|FG001|COMPLETED|Endoscopic Mucosal Resection (1 Day)||13||
48498263|NCT02798458|101554273|FG000|NOT COMPLETED|Endoscopic Mucosal Resection (1 Day)||0||
48498264|NCT02798458|101554274|FG001|NOT COMPLETED|Endoscopic Mucosal Resection (1 Day)||0||
48498265|NCT01756885|101554275|FG000|STARTED|Overall Study||102||
48498266|NCT01756885|101554276|FG001|STARTED|Overall Study||105||
48498267|NCT01756885|101554275|FG000|COMPLETED|Overall Study||79||
48498268|NCT01756885|101554276|FG001|COMPLETED|Overall Study||79||
48498269|NCT01756885|101554275|FG000|NOT COMPLETED|Overall Study||23||
48498270|NCT01756885|101554276|FG001|NOT COMPLETED|Overall Study||26||
48498271|NCT04739735|101554277|FG000|STARTED|Overall Study||25||
48498272|NCT04739735|101554278|FG001|STARTED|Overall Study||25||
48498273|NCT04739735|101554277|FG000|COMPLETED|Overall Study||25||
48498274|NCT04739735|101554278|FG001|COMPLETED|Overall Study||25||
48498275|NCT04739735|101554277|FG000|NOT COMPLETED|Overall Study||0||
48498276|NCT04739735|101554278|FG001|NOT COMPLETED|Overall Study||0||
48498277|NCT01942135|101554279|FG000|STARTED|Overall Study||347||
48498278|NCT01942135|101554280|FG001|STARTED|Overall Study||174||
48498279|NCT01942135|101554279|FG000|Treated|Overall Study||345||
48498280|NCT01942135|101554280|FG001|Treated|Overall Study||172||
48498281|NCT01942135|101554279|FG000|COMPLETED|Overall Study||0||
48498282|NCT01942135|101554280|FG001|COMPLETED|Overall Study||0||
48498283|NCT01942135|101554279|FG000|NOT COMPLETED|Overall Study||347||
48498284|NCT01942135|101554280|FG001|NOT COMPLETED|Overall Study||174||
48498285|NCT00354159|101554281|FG000|STARTED|Randomized Study Period||202||
48498286|NCT00354159|101554282|FG001|STARTED|Randomized Study Period||198||
48498287|NCT00354159|101554281|FG000|COMPLETED|Randomized Study Period||180||
48498288|NCT00354159|101554282|FG001|COMPLETED|Randomized Study Period||176||
48498289|NCT00354159|101554281|FG000|NOT COMPLETED|Randomized Study Period||22||
48498290|NCT00354159|101554282|FG001|NOT COMPLETED|Randomized Study Period||22||
48498291|NCT00354159|101554281|FG000|STARTED|Long-term Follow-up||180||
48498292|NCT00354159|101554282|FG001|STARTED|Long-term Follow-up||176||
48498293|NCT00354159|101554281|FG000|COMPLETED|Long-term Follow-up||0||
48498294|NCT00354159|101554282|FG001|COMPLETED|Long-term Follow-up||0||
48498295|NCT00354159|101554281|FG000|NOT COMPLETED|Long-term Follow-up||180||
48498296|NCT00354159|101554282|FG001|NOT COMPLETED|Long-term Follow-up||176||
48498297|NCT00075608|101554283|FG000|STARTED|Overall Study||12||
48498298|NCT00075608|101554283|FG000|COMPLETED|Overall Study||12||
48498299|NCT00075608|101554283|FG000|NOT COMPLETED|Overall Study||0||
48498300|NCT00295490|101554284|FG000|STARTED|Overall Study||15||
48498301|NCT00295490|101554285|FG001|STARTED|Overall Study||19||
48498302|NCT00295490|101554286|FG002|STARTED|Overall Study||16||
48666748|NCT03391882|101970465|FG000|COMPLETED|Part A - Titration Phase||2|Part A|
48666749|NCT03391882|101970466|FG001|COMPLETED|Part A - Titration Phase||3|Part A|
48061033|NCT01193842|100470333|FG000|STARTED|Phase I: VR-DA-EPOCH, DL 2||0||
48061034|NCT01193842|100470334|FG001|STARTED|Phase I: VR-DA-EPOCH, DL 2||7||
48061035|NCT01193842|100470335|FG002|STARTED|Phase I: VR-DA-EPOCH, DL 2||0||
48061036|NCT01193842|100470336|FG003|STARTED|Phase I: VR-DA-EPOCH, DL 2||0||
48061037|NCT01193842|100470337|FG004|STARTED|Phase I: VR-DA-EPOCH, DL 2||0||
48061038|NCT01193842|100470333|FG000|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0||
48498303|NCT00295490|101554287|FG003|STARTED|Overall Study||17||
48498304|NCT00295490|101554284|FG000|COMPLETED|Overall Study||14||
48498305|NCT00295490|101554285|FG001|COMPLETED|Overall Study||15||
48498306|NCT00295490|101554286|FG002|COMPLETED|Overall Study||12||
48498307|NCT00295490|101554287|FG003|COMPLETED|Overall Study||12||
48498308|NCT00295490|101554284|FG000|NOT COMPLETED|Overall Study||1||
48498309|NCT00295490|101554285|FG001|NOT COMPLETED|Overall Study||4||
48498310|NCT00295490|101554286|FG002|NOT COMPLETED|Overall Study||4||
48498311|NCT00295490|101554287|FG003|NOT COMPLETED|Overall Study||5||
48498312|NCT02255149|101554288|FG000|STARTED|Overall Study||10||
48498313|NCT02255149|101554288|FG000|COMPLETED|Overall Study||5||
48498314|NCT02255149|101554288|FG000|NOT COMPLETED|Overall Study||5||
48498315|NCT03366792|101554289|FG000|STARTED|Overall Study||46||
48498316|NCT03366792|101554289|FG000|COMPLETED|Overall Study||31||
48498317|NCT03366792|101554289|FG000|NOT COMPLETED|Overall Study||15||
48498318|NCT02760433|101554290|FG000|STARTED|Overall Study||161||
48498319|NCT02760433|101554291|FG001|STARTED|Overall Study||138||
48498320|NCT02760433|101554292|FG002|STARTED|Overall Study||26||
48498321|NCT02760433|101554293|FG003|STARTED|Overall Study||32||
48498322|NCT02760433|101554294|FG004|STARTED|Overall Study||11||
48498323|NCT02760433|101554290|FG000|COMPLETED|Overall Study||134||
48498324|NCT02760433|101554291|FG001|COMPLETED|Overall Study||128||
48498325|NCT02760433|101554292|FG002|COMPLETED|Overall Study||25||
48498326|NCT02760433|101554293|FG003|COMPLETED|Overall Study||30||
48498327|NCT02760433|101554294|FG004|COMPLETED|Overall Study||1||
48498328|NCT02760433|101554290|FG000|NOT COMPLETED|Overall Study||27||
48498329|NCT02760433|101554291|FG001|NOT COMPLETED|Overall Study||10||
48498330|NCT02760433|101554292|FG002|NOT COMPLETED|Overall Study||1||
48498331|NCT02760433|101554293|FG003|NOT COMPLETED|Overall Study||2||
48498332|NCT02760433|101554294|FG004|NOT COMPLETED|Overall Study||10||
48498333|NCT01911429|101554295|FG000|STARTED|Overall Study||108||
48498334|NCT01911429|101554296|FG001|STARTED|Overall Study||106||
48498335|NCT01911429|101554297|FG002|STARTED|Overall Study||113||
48498336|NCT01911429|101554295|FG000|COMPLETED|Overall Study||96||
48498337|NCT01911429|101554296|FG001|COMPLETED|Overall Study||96||
48498338|NCT01911429|101554297|FG002|COMPLETED|Overall Study||93||
48498339|NCT01911429|101554295|FG000|NOT COMPLETED|Overall Study||12||
48498340|NCT01911429|101554296|FG001|NOT COMPLETED|Overall Study||10||
48498341|NCT01911429|101554297|FG002|NOT COMPLETED|Overall Study||20||
48498342|NCT03056144|101554298|FG000|STARTED|Overall Study||1||
48498343|NCT03056144|101554298|FG000|COMPLETED|Overall Study||1||
48498344|NCT03056144|101554298|FG000|NOT COMPLETED|Overall Study||0||
48498345|NCT04404907|101554299|FG000|STARTED|Overall Study||442||
48498346|NCT04404907|101554300|FG001|STARTED|Overall Study||95||
48498347|NCT04404907|101554299|FG000|Occasional Tan|Overall Study||0|2-10 times in 3 months|
48498348|NCT04404907|101554300|FG001|Occasional Tan|Overall Study||88|2-10 times in 3 months|
48498349|NCT04404907|101554299|FG000|Frequent Tan|Overall Study||0|\>10 times in 3 months|
48498350|NCT04404907|101554300|FG001|Frequent Tan|Overall Study||7|\>10 times in 3 months|
48498351|NCT04404907|101554299|FG000|COMPLETED|Overall Study||442||
48498352|NCT04404907|101554300|FG001|COMPLETED|Overall Study||95||
48498353|NCT04404907|101554299|FG000|NOT COMPLETED|Overall Study||0||
48498354|NCT04404907|101554300|FG001|NOT COMPLETED|Overall Study||0||
48498355|NCT00582205|101554301|FG000|STARTED|Overall Study||21||
48498356|NCT00582205|101554301|FG000|COMPLETED|Overall Study||11||
48498357|NCT00582205|101554301|FG000|NOT COMPLETED|Overall Study||10||
48498358|NCT01401062|101554302|FG000|STARTED|Overall Study||11||
48498359|NCT01401062|101554303|FG001|STARTED|Overall Study||12||
48498360|NCT01401062|101554302|FG000|COMPLETED|Overall Study||0||
48498361|NCT01401062|101554303|FG001|COMPLETED|Overall Study||4||
48498362|NCT01401062|101554302|FG000|NOT COMPLETED|Overall Study||11||
48498363|NCT01401062|101554303|FG001|NOT COMPLETED|Overall Study||8||
48498364|NCT00909038|101554304|FG000|STARTED|Overall Study||2411||
48498365|NCT00909038|101554304|FG000|COMPLETED|Overall Study||1994||
48498366|NCT00909038|101554304|FG000|NOT COMPLETED|Overall Study||417||
48498367|NCT02351700|101554305|FG000|STARTED|Overall Study||28||
48498368|NCT02351700|101554306|FG001|STARTED|Overall Study||34||
48498369|NCT02351700|101554305|FG000|COMPLETED|Overall Study||28||
48498370|NCT02351700|101554306|FG001|COMPLETED|Overall Study||34||
48498371|NCT02351700|101554305|FG000|NOT COMPLETED|Overall Study||0||
48498372|NCT02351700|101554306|FG001|NOT COMPLETED|Overall Study||0||
48498373|NCT03602339|101554307|FG000|STARTED|Overall Study||157|Started period 1 (Gadoterate)|
48498374|NCT03602339|101554307|FG000|Completed Period 1 (Gadoterate)|Overall Study||155||
48498375|NCT03602339|101554307|FG000|Started Period 2 (Gadobutrol)|Overall Study||142||
48498376|NCT03602339|101554307|FG000|COMPLETED|Overall Study||142|Completed period 2 (Gadobutrol)|
48498377|NCT03602339|101554307|FG000|NOT COMPLETED|Overall Study||15||
48498378|NCT00863330|101554308|FG000|STARTED|Overall Study||6||
48498379|NCT00863330|101554308|FG000|COMPLETED|Overall Study||0||
48498380|NCT00863330|101554308|FG000|NOT COMPLETED|Overall Study||6||
48498381|NCT02331108|101554309|FG000|STARTED|Overall Study||51||
48498382|NCT02331108|101554310|FG001|STARTED|Overall Study||52||
48498383|NCT02331108|101554311|FG002|STARTED|Overall Study||51||
48498384|NCT02331108|101554312|FG003|STARTED|Overall Study||51||
48498385|NCT02331108|101554313|FG004|STARTED|Overall Study||52||
48498386|NCT02331108|101554314|FG005|STARTED|Overall Study||52||
48498387|NCT02331108|101554309|FG000|COMPLETED|Overall Study||50||
48498388|NCT02331108|101554310|FG001|COMPLETED|Overall Study||50||
48498389|NCT02331108|101554311|FG002|COMPLETED|Overall Study||50||
48498390|NCT02331108|101554312|FG003|COMPLETED|Overall Study||50||
48498391|NCT02331108|101554313|FG004|COMPLETED|Overall Study||50||
48498392|NCT02331108|101554314|FG005|COMPLETED|Overall Study||50||
48498393|NCT02331108|101554309|FG000|NOT COMPLETED|Overall Study||1||
48498394|NCT02331108|101554310|FG001|NOT COMPLETED|Overall Study||2||
48498395|NCT02331108|101554311|FG002|NOT COMPLETED|Overall Study||1||
48498396|NCT02331108|101554312|FG003|NOT COMPLETED|Overall Study||1||
48498397|NCT02331108|101554313|FG004|NOT COMPLETED|Overall Study||2||
48498398|NCT02331108|101554314|FG005|NOT COMPLETED|Overall Study||2||
48498399|NCT00301964|101554315|FG000|STARTED|Overall Study||56||
48498400|NCT00301964|101554315|FG000|COMPLETED|Overall Study||52||
48498401|NCT00301964|101554315|FG000|NOT COMPLETED|Overall Study||4||
48498402|NCT03801707|101554316|FG000|STARTED|Overall Study||36||
48498403|NCT03801707|101554316|FG000|COMPLETED|Overall Study||30||
48498404|NCT03801707|101554316|FG000|NOT COMPLETED|Overall Study||6||
48498405|NCT00858780|101554317|FG000|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||91||
48498406|NCT00858780|101554318|FG001|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0||
48498407|NCT00858780|101554319|FG002|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0||
48498408|NCT00858780|101554320|FG003|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0||
48498409|NCT00858780|101554321|FG004|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0||
48498410|NCT00858780|101554317|FG000|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||73||
48498411|NCT00858780|101554318|FG001|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0||
48498412|NCT00858780|101554319|FG002|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0||
48498413|NCT00858780|101554320|FG003|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0||
48498414|NCT00858780|101554321|FG004|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0||
48498415|NCT00858780|101554317|FG000|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||18||
48498416|NCT00858780|101554318|FG001|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0||
48498417|NCT00858780|101554319|FG002|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0||
48061039|NCT01193842|100470334|FG001|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||6||
48061040|NCT01193842|100470335|FG002|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0||
48061041|NCT01193842|100470336|FG003|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0||
48498418|NCT00858780|101554320|FG003|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0||
48498419|NCT00858780|101554321|FG004|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0||
48498420|NCT00858780|101554317|FG000|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0||
48498421|NCT00858780|101554318|FG001|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23||
48498422|NCT00858780|101554319|FG002|STARTED|Double-Blind (Week 0 to Failure/Week 48)||27||
48498423|NCT00858780|101554320|FG003|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23||
48498424|NCT00858780|101554321|FG004|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0||
48498425|NCT00858780|101554317|FG000|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0||
48498426|NCT00858780|101554318|FG001|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||21||
48498427|NCT00858780|101554319|FG002|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||25||
48498428|NCT00858780|101554320|FG003|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||22||
48498429|NCT00858780|101554321|FG004|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0||
48498430|NCT00858780|101554317|FG000|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0||
48498431|NCT00858780|101554318|FG001|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2||
48498432|NCT00858780|101554319|FG002|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2||
48498433|NCT00858780|101554320|FG003|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||1||
48498434|NCT00858780|101554321|FG004|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0||
48498435|NCT00858780|101554317|FG000|STARTED|OL Re-Treatment (Failure to Week 48)||0||
48498436|NCT00858780|101554318|FG001|STARTED|OL Re-Treatment (Failure to Week 48)||0||
48498437|NCT00858780|101554319|FG002|STARTED|OL Re-Treatment (Failure to Week 48)||0||
48498438|NCT00858780|101554320|FG003|STARTED|OL Re-Treatment (Failure to Week 48)||0||
48498439|NCT00858780|101554321|FG004|STARTED|OL Re-Treatment (Failure to Week 48)||43||
48498440|NCT00858780|101554317|FG000|COMPLETED|OL Re-Treatment (Failure to Week 48)||0||
48498441|NCT00858780|101554318|FG001|COMPLETED|OL Re-Treatment (Failure to Week 48)||0||
48498442|NCT00858780|101554319|FG002|COMPLETED|OL Re-Treatment (Failure to Week 48)||0||
48498443|NCT00858780|101554320|FG003|COMPLETED|OL Re-Treatment (Failure to Week 48)||0||
48498444|NCT00858780|101554321|FG004|COMPLETED|OL Re-Treatment (Failure to Week 48)||41||
48498445|NCT00858780|101554317|FG000|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0||
48498446|NCT00858780|101554318|FG001|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0||
48498447|NCT00858780|101554319|FG002|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0||
48498448|NCT00858780|101554320|FG003|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0||
48498449|NCT00858780|101554321|FG004|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||2||
48498450|NCT04388787|101554322|FG000|STARTED|Blinded Period||16||
48498451|NCT04388787|101554322|FG000|Completed First Assessment - Approximately 15 Minutes (Specific Treatment Unknown)|Blinded Period||15||
48498452|NCT04388787|101554322|FG000|Completed Second Assessment - Approximately 15 Minutes (Specific Treatment Unknown)|Blinded Period||15||
48498453|NCT04388787|101554322|FG000|COMPLETED|Blinded Period||15||
48498454|NCT04388787|101554322|FG000|NOT COMPLETED|Blinded Period||1||
48498455|NCT04388787|101554322|FG000|STARTED|Unblinded Period||15||
48498456|NCT04388787|101554322|FG000|COMPLETED|Unblinded Period||6||
48498457|NCT04388787|101554322|FG000|NOT COMPLETED|Unblinded Period||9||
48498458|NCT04750239|101554323|FG000|STARTED|Overall Study||3||
48498459|NCT04750239|101554323|FG000|COMPLETED|Overall Study||0||
48498460|NCT04750239|101554323|FG000|NOT COMPLETED|Overall Study||3||
48498461|NCT04002648|101554324|FG000|STARTED|Overall Study||104||
48498462|NCT04002648|101554325|FG001|STARTED|Overall Study||104||
48498463|NCT04002648|101554324|FG000|COMPLETED|Overall Study||102||
48498464|NCT04002648|101554325|FG001|COMPLETED|Overall Study||104||
48498465|NCT04002648|101554324|FG000|NOT COMPLETED|Overall Study||2||
48498466|NCT04002648|101554325|FG001|NOT COMPLETED|Overall Study||0||
48498467|NCT00595153|101554326|FG000|STARTED|Overall Study||24||
48498468|NCT00595153|101554327|FG001|STARTED|Overall Study||42||
48498469|NCT00595153|101554328|FG002|STARTED|Overall Study||61||
48498470|NCT00595153|101554326|FG000|COMPLETED|Overall Study||20||
48498471|NCT00595153|101554327|FG001|COMPLETED|Overall Study||26||
48498472|NCT00595153|101554328|FG002|COMPLETED|Overall Study||36||
48498473|NCT00595153|101554326|FG000|NOT COMPLETED|Overall Study||4||
48498474|NCT00595153|101554327|FG001|NOT COMPLETED|Overall Study||16||
48498475|NCT00595153|101554328|FG002|NOT COMPLETED|Overall Study||25||
48498476|NCT00924638|101554329|FG000|STARTED|Overall Study||221||
48498477|NCT00924638|101554330|FG001|STARTED|Overall Study||220||
48498478|NCT00924638|101554329|FG000|COMPLETED|Overall Study||209||
48498479|NCT00924638|101554330|FG001|COMPLETED|Overall Study||207||
48498480|NCT00924638|101554329|FG000|NOT COMPLETED|Overall Study||12||
48498481|NCT00924638|101554330|FG001|NOT COMPLETED|Overall Study||13||
48498482|NCT02011945|101554331|FG000|STARTED|Overall Study||2||
48498483|NCT02011945|101554332|FG001|STARTED|Overall Study||13||
48498484|NCT02011945|101554333|FG002|STARTED|Overall Study||16||
48498485|NCT02011945|101554331|FG000|COMPLETED|Overall Study||0||
48498486|NCT02011945|101554332|FG001|COMPLETED|Overall Study||3||
48498487|NCT02011945|101554333|FG002|COMPLETED|Overall Study||6||
48498488|NCT02011945|101554331|FG000|NOT COMPLETED|Overall Study||2||
48498489|NCT02011945|101554332|FG001|NOT COMPLETED|Overall Study||10||
48498490|NCT02011945|101554333|FG002|NOT COMPLETED|Overall Study||10||
48498491|NCT02704091|101554334|FG000|STARTED|Overall Study||430||
48498492|NCT02704091|101554335|FG001|STARTED|Overall Study||423||
48498493|NCT02704091|101554334|FG000|COMPLETED|Overall Study||402||
48498494|NCT02704091|101554335|FG001|COMPLETED|Overall Study||400||
48498495|NCT02704091|101554334|FG000|NOT COMPLETED|Overall Study||28||
48498496|NCT02704091|101554335|FG001|NOT COMPLETED|Overall Study||23||
48498497|NCT03531827|101554336|FG000|STARTED|Overall Study||4||
48498498|NCT03531827|101554337|FG001|STARTED|Overall Study||0||
48498499|NCT03531827|101554336|FG000|COMPLETED|Overall Study||1||
48498500|NCT03531827|101554337|FG001|COMPLETED|Overall Study||0||
48498501|NCT03531827|101554336|FG000|NOT COMPLETED|Overall Study||3||
48498502|NCT03531827|101554337|FG001|NOT COMPLETED|Overall Study||0||
48498503|NCT01426360|101554338|FG000|STARTED|Overall Study||38||
48498504|NCT01426360|101554339|FG001|STARTED|Overall Study||41||
48498505|NCT01426360|101554338|FG000|COMPLETED|Overall Study||38||
48498506|NCT01426360|101554339|FG001|COMPLETED|Overall Study||41||
48498507|NCT01426360|101554338|FG000|NOT COMPLETED|Overall Study||0||
48498508|NCT01426360|101554339|FG001|NOT COMPLETED|Overall Study||0||
48498509|NCT00965757|101554340|FG000|STARTED|Double-blind Phase||165||
48498510|NCT00965757|101554341|FG001|STARTED|Double-blind Phase||88||
48498511|NCT00965757|101554342|FG002|STARTED|Double-blind Phase||0||
48498512|NCT00965757|101554343|FG003|STARTED|Double-blind Phase||0||
48498513|NCT00965757|101554340|FG000|COMPLETED|Double-blind Phase||148||
48498514|NCT00965757|101554341|FG001|COMPLETED|Double-blind Phase||70||
48498515|NCT00965757|101554342|FG002|COMPLETED|Double-blind Phase||0||
48498516|NCT00965757|101554343|FG003|COMPLETED|Double-blind Phase||0||
48498517|NCT00965757|101554340|FG000|NOT COMPLETED|Double-blind Phase||17||
48498518|NCT00965757|101554341|FG001|NOT COMPLETED|Double-blind Phase||18||
48498519|NCT00965757|101554342|FG002|NOT COMPLETED|Double-blind Phase||0||
48498520|NCT00965757|101554343|FG003|NOT COMPLETED|Double-blind Phase||0||
48498521|NCT00965757|101554340|FG000|STARTED|Extension Phase||0||
48498522|NCT00965757|101554341|FG001|STARTED|Extension Phase||0||
48498523|NCT00965757|101554342|FG002|STARTED|Extension Phase||165||
48498524|NCT00965757|101554343|FG003|STARTED|Extension Phase||88||
48498525|NCT00965757|101554340|FG000|COMPLETED|Extension Phase||0||
48498526|NCT00965757|101554341|FG001|COMPLETED|Extension Phase||0||
48498527|NCT00965757|101554342|FG002|COMPLETED|Extension Phase||132||
48498528|NCT00965757|101554343|FG003|COMPLETED|Extension Phase||64||
48498529|NCT00965757|101554340|FG000|NOT COMPLETED|Extension Phase||0||
48498530|NCT00965757|101554341|FG001|NOT COMPLETED|Extension Phase||0||
48498531|NCT00965757|101554342|FG002|NOT COMPLETED|Extension Phase||33||
48498532|NCT00965757|101554343|FG003|NOT COMPLETED|Extension Phase||24||
48498533|NCT03255733|101554344|FG000|STARTED|Overall Study||29||
48498534|NCT03255733|101554344|FG000|COMPLETED|Overall Study||25||
48498535|NCT03255733|101554344|FG000|NOT COMPLETED|Overall Study||4||
48498536|NCT00112437|101554345|FG000|STARTED|Year 1 (12-Month Base Study)||83||
48498537|NCT00112437|101554346|FG001|STARTED|Year 1 (12-Month Base Study)||82||
48498538|NCT00112437|101554347|FG002|STARTED|Year 1 (12-Month Base Study)||77||
48498539|NCT00112437|101554348|FG003|STARTED|Year 1 (12-Month Base Study)||79||
48498540|NCT00112437|101554349|FG004|STARTED|Year 1 (12-Month Base Study)||78||
48498541|NCT00112437|101554350|FG005|STARTED|Year 1 (12-Month Base Study)||0||
48498542|NCT00112437|101554351|FG006|STARTED|Year 1 (12-Month Base Study)||0||
48498543|NCT00112437|101554352|FG007|STARTED|Year 1 (12-Month Base Study)||0||
48498544|NCT00112437|101554353|FG008|STARTED|Year 1 (12-Month Base Study)||0||
48498545|NCT00112437|101554354|FG009|STARTED|Year 1 (12-Month Base Study)||0||
48498546|NCT00112437|101554355|FG010|STARTED|Year 1 (12-Month Base Study)||0||
48498547|NCT00112437|101554356|FG011|STARTED|Year 1 (12-Month Base Study)||0||
48498548|NCT00112437|101554357|FG012|STARTED|Year 1 (12-Month Base Study)||0||
48498549|NCT00112437|101554358|FG013|STARTED|Year 1 (12-Month Base Study)||0||
48498550|NCT00112437|101554359|FG014|STARTED|Year 1 (12-Month Base Study)||0||
48498551|NCT00112437|101554360|FG015|STARTED|Year 1 (12-Month Base Study)||0||
48498552|NCT00112437|101554361|FG016|STARTED|Year 1 (12-Month Base Study)||0||
48498553|NCT00112437|101554362|FG017|STARTED|Year 1 (12-Month Base Study)||0||
48498554|NCT00112437|101554363|FG018|STARTED|Year 1 (12-Month Base Study)||0||
48498555|NCT00112437|101554364|FG019|STARTED|Year 1 (12-Month Base Study)||0||
48498556|NCT00112437|101554365|FG020|STARTED|Year 1 (12-Month Base Study)||0||
48498557|NCT00112437|101554366|FG021|STARTED|Year 1 (12-Month Base Study)||0||
48498558|NCT00112437|101554367|FG022|STARTED|Year 1 (12-Month Base Study)||0||
48498559|NCT00112437|101554368|FG023|STARTED|Year 1 (12-Month Base Study)||0||
48498560|NCT00112437|101554369|FG024|STARTED|Year 1 (12-Month Base Study)||0||
48498561|NCT00112437|101554370|FG025|STARTED|Year 1 (12-Month Base Study)||0||
48498562|NCT00112437|101554345|FG000|COMPLETED|Year 1 (12-Month Base Study)||68||
48498563|NCT00112437|101554346|FG001|COMPLETED|Year 1 (12-Month Base Study)||64||
48498564|NCT00112437|101554347|FG002|COMPLETED|Year 1 (12-Month Base Study)||65||
48498565|NCT00112437|101554348|FG003|COMPLETED|Year 1 (12-Month Base Study)||71||
48498566|NCT00112437|101554349|FG004|COMPLETED|Year 1 (12-Month Base Study)||66||
48498567|NCT00112437|101554350|FG005|COMPLETED|Year 1 (12-Month Base Study)||0||
48498568|NCT00112437|101554351|FG006|COMPLETED|Year 1 (12-Month Base Study)||0||
48498569|NCT00112437|101554352|FG007|COMPLETED|Year 1 (12-Month Base Study)||0||
48498570|NCT00112437|101554353|FG008|COMPLETED|Year 1 (12-Month Base Study)||0||
48498571|NCT00112437|101554354|FG009|COMPLETED|Year 1 (12-Month Base Study)||0||
48498572|NCT00112437|101554355|FG010|COMPLETED|Year 1 (12-Month Base Study)||0||
48498573|NCT00112437|101554356|FG011|COMPLETED|Year 1 (12-Month Base Study)||0||
48498574|NCT00112437|101554357|FG012|COMPLETED|Year 1 (12-Month Base Study)||0||
48498575|NCT00112437|101554358|FG013|COMPLETED|Year 1 (12-Month Base Study)||0||
48498576|NCT00112437|101554359|FG014|COMPLETED|Year 1 (12-Month Base Study)||0||
48498577|NCT00112437|101554360|FG015|COMPLETED|Year 1 (12-Month Base Study)||0||
48498578|NCT00112437|101554361|FG016|COMPLETED|Year 1 (12-Month Base Study)||0||
48498579|NCT00112437|101554362|FG017|COMPLETED|Year 1 (12-Month Base Study)||0||
48498580|NCT00112437|101554363|FG018|COMPLETED|Year 1 (12-Month Base Study)||0||
48498581|NCT00112437|101554364|FG019|COMPLETED|Year 1 (12-Month Base Study)||0||
48498582|NCT00112437|101554365|FG020|COMPLETED|Year 1 (12-Month Base Study)||0||
48498583|NCT00112437|101554366|FG021|COMPLETED|Year 1 (12-Month Base Study)||0||
48498584|NCT00112437|101554367|FG022|COMPLETED|Year 1 (12-Month Base Study)||0||
48498585|NCT00112437|101554368|FG023|COMPLETED|Year 1 (12-Month Base Study)||0||
48498586|NCT00112437|101554369|FG024|COMPLETED|Year 1 (12-Month Base Study)||0||
48498587|NCT00112437|101554370|FG025|COMPLETED|Year 1 (12-Month Base Study)||0||
48498588|NCT00112437|101554345|FG000|NOT COMPLETED|Year 1 (12-Month Base Study)||15||
48498589|NCT00112437|101554346|FG001|NOT COMPLETED|Year 1 (12-Month Base Study)||18||
48498590|NCT00112437|101554347|FG002|NOT COMPLETED|Year 1 (12-Month Base Study)||12||
48498591|NCT00112437|101554348|FG003|NOT COMPLETED|Year 1 (12-Month Base Study)||8||
48498592|NCT00112437|101554349|FG004|NOT COMPLETED|Year 1 (12-Month Base Study)||12||
48498593|NCT00112437|101554350|FG005|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
48498594|NCT00112437|101554351|FG006|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
48498595|NCT00112437|101554352|FG007|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
48498596|NCT00112437|101554353|FG008|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
48498597|NCT00112437|101554354|FG009|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
48498598|NCT00112437|101554355|FG010|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
48498599|NCT00112437|101554356|FG011|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
48498600|NCT00112437|101554357|FG012|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
48498601|NCT00112437|101554358|FG013|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
48498602|NCT00112437|101554359|FG014|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
48498603|NCT00112437|101554360|FG015|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
48498604|NCT00112437|101554361|FG016|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
48498605|NCT00112437|101554362|FG017|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
48498606|NCT00112437|101554363|FG018|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
48498607|NCT00112437|101554364|FG019|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
48498608|NCT00112437|101554365|FG020|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
48498609|NCT00112437|101554366|FG021|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
48498610|NCT00112437|101554367|FG022|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
48498611|NCT00112437|101554368|FG023|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
48498612|NCT00112437|101554369|FG024|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
48498613|NCT00112437|101554370|FG025|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
48498614|NCT00112437|101554345|FG000|STARTED|Year 2 (12-Month Extension)||0||
48498615|NCT00112437|101554346|FG001|STARTED|Year 2 (12-Month Extension)||0||
48498616|NCT00112437|101554347|FG002|STARTED|Year 2 (12-Month Extension)||0||
48498617|NCT00112437|101554348|FG003|STARTED|Year 2 (12-Month Extension)||0||
48498618|NCT00112437|101554349|FG004|STARTED|Year 2 (12-Month Extension)||0||
48498619|NCT00112437|101554350|FG005|STARTED|Year 2 (12-Month Extension)||63||
48498620|NCT00112437|101554351|FG006|STARTED|Year 2 (12-Month Extension)||62||
48498621|NCT00112437|101554352|FG007|STARTED|Year 2 (12-Month Extension)||63||
48498622|NCT00112437|101554353|FG008|STARTED|Year 2 (12-Month Extension)||69||
48498623|NCT00112437|101554354|FG009|STARTED|Year 2 (12-Month Extension)||63||
48498624|NCT00112437|101554355|FG010|STARTED|Year 2 (12-Month Extension)||0||
48498625|NCT00112437|101554356|FG011|STARTED|Year 2 (12-Month Extension)||0||
48498626|NCT00112437|101554357|FG012|STARTED|Year 2 (12-Month Extension)||0||
48498627|NCT00112437|101554358|FG013|STARTED|Year 2 (12-Month Extension)||0||
48498628|NCT00112437|101554359|FG014|STARTED|Year 2 (12-Month Extension)||0||
48498629|NCT00112437|101554360|FG015|STARTED|Year 2 (12-Month Extension)||0||
48498630|NCT00112437|101554361|FG016|STARTED|Year 2 (12-Month Extension)||0||
48498631|NCT00112437|101554362|FG017|STARTED|Year 2 (12-Month Extension)||0||
48498632|NCT00112437|101554363|FG018|STARTED|Year 2 (12-Month Extension)||0||
48498633|NCT00112437|101554364|FG019|STARTED|Year 2 (12-Month Extension)||0||
48498634|NCT00112437|101554365|FG020|STARTED|Year 2 (12-Month Extension)||0||
48498635|NCT00112437|101554366|FG021|STARTED|Year 2 (12-Month Extension)||0||
48498636|NCT00112437|101554367|FG022|STARTED|Year 2 (12-Month Extension)||0||
48498637|NCT00112437|101554368|FG023|STARTED|Year 2 (12-Month Extension)||0||
48498638|NCT00112437|101554369|FG024|STARTED|Year 2 (12-Month Extension)||0||
48498639|NCT00112437|101554370|FG025|STARTED|Year 2 (12-Month Extension)||0||
48498640|NCT00112437|101554345|FG000|COMPLETED|Year 2 (12-Month Extension)||0||
48498641|NCT00112437|101554346|FG001|COMPLETED|Year 2 (12-Month Extension)||0||
48498642|NCT00112437|101554347|FG002|COMPLETED|Year 2 (12-Month Extension)||0||
48498643|NCT00112437|101554348|FG003|COMPLETED|Year 2 (12-Month Extension)||0||
48498644|NCT00112437|101554349|FG004|COMPLETED|Year 2 (12-Month Extension)||0||
48498645|NCT00112437|101554350|FG005|COMPLETED|Year 2 (12-Month Extension)||60||
48498646|NCT00112437|101554351|FG006|COMPLETED|Year 2 (12-Month Extension)||53||
48498647|NCT00112437|101554352|FG007|COMPLETED|Year 2 (12-Month Extension)||55||
48498648|NCT00112437|101554353|FG008|COMPLETED|Year 2 (12-Month Extension)||62||
48498649|NCT00112437|101554354|FG009|COMPLETED|Year 2 (12-Month Extension)||50||
48498650|NCT00112437|101554355|FG010|COMPLETED|Year 2 (12-Month Extension)||0||
48498651|NCT00112437|101554356|FG011|COMPLETED|Year 2 (12-Month Extension)||0||
48498652|NCT00112437|101554357|FG012|COMPLETED|Year 2 (12-Month Extension)||0||
48498653|NCT00112437|101554358|FG013|COMPLETED|Year 2 (12-Month Extension)||0||
48498654|NCT00112437|101554359|FG014|COMPLETED|Year 2 (12-Month Extension)||0||
48498655|NCT00112437|101554360|FG015|COMPLETED|Year 2 (12-Month Extension)||0||
48498656|NCT00112437|101554361|FG016|COMPLETED|Year 2 (12-Month Extension)||0||
48498657|NCT00112437|101554362|FG017|COMPLETED|Year 2 (12-Month Extension)||0||
48498658|NCT00112437|101554363|FG018|COMPLETED|Year 2 (12-Month Extension)||0||
48498659|NCT00112437|101554364|FG019|COMPLETED|Year 2 (12-Month Extension)||0||
48498660|NCT00112437|101554365|FG020|COMPLETED|Year 2 (12-Month Extension)||0||
48498661|NCT00112437|101554366|FG021|COMPLETED|Year 2 (12-Month Extension)||0||
48498662|NCT00112437|101554367|FG022|COMPLETED|Year 2 (12-Month Extension)||0||
48498663|NCT00112437|101554368|FG023|COMPLETED|Year 2 (12-Month Extension)||0||
48498664|NCT00112437|101554369|FG024|COMPLETED|Year 2 (12-Month Extension)||0||
48498665|NCT00112437|101554370|FG025|COMPLETED|Year 2 (12-Month Extension)||0||
48498666|NCT00112437|101554345|FG000|NOT COMPLETED|Year 2 (12-Month Extension)||0||
48498667|NCT00112437|101554346|FG001|NOT COMPLETED|Year 2 (12-Month Extension)||0||
48498668|NCT00112437|101554347|FG002|NOT COMPLETED|Year 2 (12-Month Extension)||0||
48498669|NCT00112437|101554348|FG003|NOT COMPLETED|Year 2 (12-Month Extension)||0||
48498670|NCT00112437|101554349|FG004|NOT COMPLETED|Year 2 (12-Month Extension)||0||
48498671|NCT00112437|101554350|FG005|NOT COMPLETED|Year 2 (12-Month Extension)||3||
48498672|NCT00112437|101554351|FG006|NOT COMPLETED|Year 2 (12-Month Extension)||9||
48498673|NCT00112437|101554352|FG007|NOT COMPLETED|Year 2 (12-Month Extension)||8||
48498674|NCT00112437|101554353|FG008|NOT COMPLETED|Year 2 (12-Month Extension)||7||
48498675|NCT00112437|101554354|FG009|NOT COMPLETED|Year 2 (12-Month Extension)||13||
48498676|NCT00112437|101554355|FG010|NOT COMPLETED|Year 2 (12-Month Extension)||0||
48498677|NCT00112437|101554356|FG011|NOT COMPLETED|Year 2 (12-Month Extension)||0||
48498678|NCT00112437|101554357|FG012|NOT COMPLETED|Year 2 (12-Month Extension)||0||
48498679|NCT00112437|101554358|FG013|NOT COMPLETED|Year 2 (12-Month Extension)||0||
48498680|NCT00112437|101554359|FG014|NOT COMPLETED|Year 2 (12-Month Extension)||0||
48498681|NCT00112437|101554360|FG015|NOT COMPLETED|Year 2 (12-Month Extension)||0||
48498682|NCT00112437|101554361|FG016|NOT COMPLETED|Year 2 (12-Month Extension)||0||
48498683|NCT00112437|101554362|FG017|NOT COMPLETED|Year 2 (12-Month Extension)||0||
48498684|NCT00112437|101554363|FG018|NOT COMPLETED|Year 2 (12-Month Extension)||0||
48498685|NCT00112437|101554364|FG019|NOT COMPLETED|Year 2 (12-Month Extension)||0||
48498686|NCT00112437|101554365|FG020|NOT COMPLETED|Year 2 (12-Month Extension)||0||
48498687|NCT00112437|101554366|FG021|NOT COMPLETED|Year 2 (12-Month Extension)||0||
48498688|NCT00112437|101554367|FG022|NOT COMPLETED|Year 2 (12-Month Extension)||0||
48498689|NCT00112437|101554368|FG023|NOT COMPLETED|Year 2 (12-Month Extension)||0||
48498690|NCT00112437|101554369|FG024|NOT COMPLETED|Year 2 (12-Month Extension)||0||
48498691|NCT00112437|101554370|FG025|NOT COMPLETED|Year 2 (12-Month Extension)||0||
48498692|NCT00112437|101554345|FG000|STARTED|Year 3 (12-Month Extension)||0||
48498693|NCT00112437|101554346|FG001|STARTED|Year 3 (12-Month Extension)||0||
48498694|NCT00112437|101554347|FG002|STARTED|Year 3 (12-Month Extension)||0||
48498695|NCT00112437|101554348|FG003|STARTED|Year 3 (12-Month Extension)||0||
48498696|NCT00112437|101554349|FG004|STARTED|Year 3 (12-Month Extension)||0||
48498697|NCT00112437|101554350|FG005|STARTED|Year 3 (12-Month Extension)||0||
48498698|NCT00112437|101554351|FG006|STARTED|Year 3 (12-Month Extension)||0||
48498699|NCT00112437|101554352|FG007|STARTED|Year 3 (12-Month Extension)||0||
48498700|NCT00112437|101554353|FG008|STARTED|Year 3 (12-Month Extension)||0||
48498701|NCT00112437|101554354|FG009|STARTED|Year 3 (12-Month Extension)||0||
48498702|NCT00112437|101554355|FG010|STARTED|Year 3 (12-Month Extension)||19||
48498703|NCT00112437|101554356|FG011|STARTED|Year 3 (12-Month Extension)||22||
48498704|NCT00112437|101554357|FG012|STARTED|Year 3 (12-Month Extension)||18||
48498705|NCT00112437|101554358|FG013|STARTED|Year 3 (12-Month Extension)||17||
48498706|NCT00112437|101554359|FG014|STARTED|Year 3 (12-Month Extension)||18||
48498707|NCT00112437|101554360|FG015|STARTED|Year 3 (12-Month Extension)||17||
48498708|NCT00112437|101554361|FG016|STARTED|Year 3 (12-Month Extension)||19||
48498709|NCT00112437|101554362|FG017|STARTED|Year 3 (12-Month Extension)||21||
48498710|NCT00112437|101554363|FG018|STARTED|Year 3 (12-Month Extension)||18||
48498711|NCT00112437|101554364|FG019|STARTED|Year 3 (12-Month Extension)||20||
48498712|NCT00112437|101554365|FG020|STARTED|Year 3 (12-Month Extension)||0||
48498713|NCT00112437|101554366|FG021|STARTED|Year 3 (12-Month Extension)||0||
48498714|NCT00112437|101554367|FG022|STARTED|Year 3 (12-Month Extension)||0||
48498715|NCT00112437|101554368|FG023|STARTED|Year 3 (12-Month Extension)||0||
48498716|NCT00112437|101554369|FG024|STARTED|Year 3 (12-Month Extension)||0||
48498717|NCT00112437|101554370|FG025|STARTED|Year 3 (12-Month Extension)||0||
48498718|NCT00112437|101554345|FG000|COMPLETED|Year 3 (12-Month Extension)||0||
48498719|NCT00112437|101554346|FG001|COMPLETED|Year 3 (12-Month Extension)||0||
48498720|NCT00112437|101554347|FG002|COMPLETED|Year 3 (12-Month Extension)||0||
48498721|NCT00112437|101554348|FG003|COMPLETED|Year 3 (12-Month Extension)||0||
48498722|NCT00112437|101554349|FG004|COMPLETED|Year 3 (12-Month Extension)||0||
48498723|NCT00112437|101554350|FG005|COMPLETED|Year 3 (12-Month Extension)||0||
48498724|NCT00112437|101554351|FG006|COMPLETED|Year 3 (12-Month Extension)||0||
48498725|NCT00112437|101554352|FG007|COMPLETED|Year 3 (12-Month Extension)||0||
48498726|NCT00112437|101554353|FG008|COMPLETED|Year 3 (12-Month Extension)||0||
48498727|NCT00112437|101554354|FG009|COMPLETED|Year 3 (12-Month Extension)||0||
48498728|NCT00112437|101554355|FG010|COMPLETED|Year 3 (12-Month Extension)||17||
48498729|NCT00112437|101554356|FG011|COMPLETED|Year 3 (12-Month Extension)||17||
48498730|NCT00112437|101554357|FG012|COMPLETED|Year 3 (12-Month Extension)||18||
48498731|NCT00112437|101554358|FG013|COMPLETED|Year 3 (12-Month Extension)||16||
48498732|NCT00112437|101554359|FG014|COMPLETED|Year 3 (12-Month Extension)||17||
48498733|NCT00112437|101554360|FG015|COMPLETED|Year 3 (12-Month Extension)||13||
48498734|NCT00112437|101554361|FG016|COMPLETED|Year 3 (12-Month Extension)||16||
48498735|NCT00112437|101554362|FG017|COMPLETED|Year 3 (12-Month Extension)||20||
48498736|NCT00112437|101554363|FG018|COMPLETED|Year 3 (12-Month Extension)||16||
48498737|NCT00112437|101554364|FG019|COMPLETED|Year 3 (12-Month Extension)||19||
48498738|NCT00112437|101554365|FG020|COMPLETED|Year 3 (12-Month Extension)||0||
48498739|NCT00112437|101554366|FG021|COMPLETED|Year 3 (12-Month Extension)||0||
48498740|NCT00112437|101554367|FG022|COMPLETED|Year 3 (12-Month Extension)||0||
48498741|NCT00112437|101554368|FG023|COMPLETED|Year 3 (12-Month Extension)||0||
48498742|NCT00112437|101554369|FG024|COMPLETED|Year 3 (12-Month Extension)||0||
48498743|NCT00112437|101554370|FG025|COMPLETED|Year 3 (12-Month Extension)||0||
48498744|NCT00112437|101554345|FG000|NOT COMPLETED|Year 3 (12-Month Extension)||0||
48498745|NCT00112437|101554346|FG001|NOT COMPLETED|Year 3 (12-Month Extension)||0||
48498746|NCT00112437|101554347|FG002|NOT COMPLETED|Year 3 (12-Month Extension)||0||
48498747|NCT00112437|101554348|FG003|NOT COMPLETED|Year 3 (12-Month Extension)||0||
48498748|NCT00112437|101554349|FG004|NOT COMPLETED|Year 3 (12-Month Extension)||0||
48498749|NCT00112437|101554350|FG005|NOT COMPLETED|Year 3 (12-Month Extension)||0||
48498750|NCT00112437|101554351|FG006|NOT COMPLETED|Year 3 (12-Month Extension)||0||
48498751|NCT00112437|101554352|FG007|NOT COMPLETED|Year 3 (12-Month Extension)||0||
48498752|NCT00112437|101554353|FG008|NOT COMPLETED|Year 3 (12-Month Extension)||0||
48498753|NCT00112437|101554354|FG009|NOT COMPLETED|Year 3 (12-Month Extension)||0||
48498754|NCT00112437|101554355|FG010|NOT COMPLETED|Year 3 (12-Month Extension)||2||
48498755|NCT00112437|101554356|FG011|NOT COMPLETED|Year 3 (12-Month Extension)||5||
48498756|NCT00112437|101554357|FG012|NOT COMPLETED|Year 3 (12-Month Extension)||0||
48498757|NCT00112437|101554358|FG013|NOT COMPLETED|Year 3 (12-Month Extension)||1||
48498758|NCT00112437|101554359|FG014|NOT COMPLETED|Year 3 (12-Month Extension)||1||
48498759|NCT00112437|101554360|FG015|NOT COMPLETED|Year 3 (12-Month Extension)||4||
48498760|NCT00112437|101554361|FG016|NOT COMPLETED|Year 3 (12-Month Extension)||3||
48498761|NCT00112437|101554362|FG017|NOT COMPLETED|Year 3 (12-Month Extension)||1||
48498762|NCT00112437|101554363|FG018|NOT COMPLETED|Year 3 (12-Month Extension)||2||
48498763|NCT00112437|101554364|FG019|NOT COMPLETED|Year 3 (12-Month Extension)||1||
48498764|NCT00112437|101554365|FG020|NOT COMPLETED|Year 3 (12-Month Extension)||0||
48498765|NCT00112437|101554366|FG021|NOT COMPLETED|Year 3 (12-Month Extension)||0||
48498766|NCT00112437|101554367|FG022|NOT COMPLETED|Year 3 (12-Month Extension)||0||
48498767|NCT00112437|101554368|FG023|NOT COMPLETED|Year 3 (12-Month Extension)||0||
48498768|NCT00112437|101554369|FG024|NOT COMPLETED|Year 3 (12-Month Extension)||0||
48498769|NCT00112437|101554370|FG025|NOT COMPLETED|Year 3 (12-Month Extension)||0||
48498770|NCT00112437|101554345|FG000|STARTED|Years 4-5 (24-Month Extension)||0||
48498771|NCT00112437|101554346|FG001|STARTED|Years 4-5 (24-Month Extension)||0||
48498772|NCT00112437|101554347|FG002|STARTED|Years 4-5 (24-Month Extension)||0||
48498773|NCT00112437|101554348|FG003|STARTED|Years 4-5 (24-Month Extension)||0||
48498774|NCT00112437|101554349|FG004|STARTED|Years 4-5 (24-Month Extension)||0||
48498775|NCT00112437|101554350|FG005|STARTED|Years 4-5 (24-Month Extension)||0||
48498776|NCT00112437|101554351|FG006|STARTED|Years 4-5 (24-Month Extension)||0||
48498777|NCT00112437|101554352|FG007|STARTED|Years 4-5 (24-Month Extension)||0||
48498778|NCT00112437|101554353|FG008|STARTED|Years 4-5 (24-Month Extension)||0||
48498779|NCT00112437|101554354|FG009|STARTED|Years 4-5 (24-Month Extension)||0||
48498780|NCT00112437|101554355|FG010|STARTED|Years 4-5 (24-Month Extension)||0||
48498781|NCT00112437|101554356|FG011|STARTED|Years 4-5 (24-Month Extension)||0||
48498782|NCT00112437|101554357|FG012|STARTED|Years 4-5 (24-Month Extension)||0||
48498783|NCT00112437|101554358|FG013|STARTED|Years 4-5 (24-Month Extension)||0||
48498784|NCT00112437|101554359|FG014|STARTED|Years 4-5 (24-Month Extension)||0||
48498785|NCT00112437|101554360|FG015|STARTED|Years 4-5 (24-Month Extension)||0||
48498786|NCT00112437|101554361|FG016|STARTED|Years 4-5 (24-Month Extension)||0||
48498787|NCT00112437|101554362|FG017|STARTED|Years 4-5 (24-Month Extension)||0||
48498788|NCT00112437|101554363|FG018|STARTED|Years 4-5 (24-Month Extension)||0||
48498789|NCT00112437|101554364|FG019|STARTED|Years 4-5 (24-Month Extension)||0||
48498790|NCT00112437|101554365|FG020|STARTED|Years 4-5 (24-Month Extension)||41||
48498791|NCT00112437|101554366|FG021|STARTED|Years 4-5 (24-Month Extension)||100||
48498792|NCT00112437|101554367|FG022|STARTED|Years 4-5 (24-Month Extension)||0||
48498793|NCT00112437|101554368|FG023|STARTED|Years 4-5 (24-Month Extension)||0||
48498794|NCT00112437|101554369|FG024|STARTED|Years 4-5 (24-Month Extension)||0||
48498795|NCT00112437|101554370|FG025|STARTED|Years 4-5 (24-Month Extension)||0||
48498796|NCT00112437|101554345|FG000|COMPLETED|Years 4-5 (24-Month Extension)||0||
48498797|NCT00112437|101554346|FG001|COMPLETED|Years 4-5 (24-Month Extension)||0||
48498798|NCT00112437|101554347|FG002|COMPLETED|Years 4-5 (24-Month Extension)||0||
48498799|NCT00112437|101554348|FG003|COMPLETED|Years 4-5 (24-Month Extension)||0||
48498800|NCT00112437|101554349|FG004|COMPLETED|Years 4-5 (24-Month Extension)||0||
48498801|NCT00112437|101554350|FG005|COMPLETED|Years 4-5 (24-Month Extension)||0||
48498802|NCT00112437|101554351|FG006|COMPLETED|Years 4-5 (24-Month Extension)||0||
48498803|NCT00112437|101554352|FG007|COMPLETED|Years 4-5 (24-Month Extension)||0||
48498804|NCT00112437|101554353|FG008|COMPLETED|Years 4-5 (24-Month Extension)||0||
48498805|NCT00112437|101554354|FG009|COMPLETED|Years 4-5 (24-Month Extension)||0||
48498806|NCT00112437|101554355|FG010|COMPLETED|Years 4-5 (24-Month Extension)||0||
48498807|NCT00112437|101554356|FG011|COMPLETED|Years 4-5 (24-Month Extension)||0||
48498808|NCT00112437|101554357|FG012|COMPLETED|Years 4-5 (24-Month Extension)||0||
48498809|NCT00112437|101554358|FG013|COMPLETED|Years 4-5 (24-Month Extension)||0||
48498810|NCT00112437|101554359|FG014|COMPLETED|Years 4-5 (24-Month Extension)||0||
48498811|NCT00112437|101554360|FG015|COMPLETED|Years 4-5 (24-Month Extension)||0||
48498812|NCT00112437|101554361|FG016|COMPLETED|Years 4-5 (24-Month Extension)||0||
48498813|NCT00112437|101554362|FG017|COMPLETED|Years 4-5 (24-Month Extension)||0||
48498814|NCT00112437|101554363|FG018|COMPLETED|Years 4-5 (24-Month Extension)||0||
48498815|NCT00112437|101554364|FG019|COMPLETED|Years 4-5 (24-Month Extension)||0||
48498816|NCT00112437|101554365|FG020|COMPLETED|Years 4-5 (24-Month Extension)||37||
48498817|NCT00112437|101554366|FG021|COMPLETED|Years 4-5 (24-Month Extension)||92||
48498818|NCT00112437|101554367|FG022|COMPLETED|Years 4-5 (24-Month Extension)||0||
48498819|NCT00112437|101554368|FG023|COMPLETED|Years 4-5 (24-Month Extension)||0||
48498820|NCT00112437|101554369|FG024|COMPLETED|Years 4-5 (24-Month Extension)||0||
48498821|NCT00112437|101554370|FG025|COMPLETED|Years 4-5 (24-Month Extension)||0||
48498822|NCT00112437|101554345|FG000|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
48498823|NCT00112437|101554346|FG001|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
48498824|NCT00112437|101554347|FG002|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
48498825|NCT00112437|101554348|FG003|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
48498826|NCT00112437|101554349|FG004|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
48498827|NCT00112437|101554350|FG005|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
48498828|NCT00112437|101554351|FG006|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
48498829|NCT00112437|101554352|FG007|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
48498830|NCT00112437|101554353|FG008|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
48498831|NCT00112437|101554354|FG009|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
48498832|NCT00112437|101554355|FG010|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
48498833|NCT00112437|101554356|FG011|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
48498834|NCT00112437|101554357|FG012|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
48498835|NCT00112437|101554358|FG013|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
48498836|NCT00112437|101554359|FG014|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
48498837|NCT00112437|101554360|FG015|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
48498838|NCT00112437|101554361|FG016|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
48498839|NCT00112437|101554362|FG017|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
48498840|NCT00112437|101554363|FG018|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
48498841|NCT00112437|101554364|FG019|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
48498842|NCT00112437|101554365|FG020|NOT COMPLETED|Years 4-5 (24-Month Extension)||4||
48498843|NCT00112437|101554366|FG021|NOT COMPLETED|Years 4-5 (24-Month Extension)||8||
48498844|NCT00112437|101554367|FG022|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
48498845|NCT00112437|101554368|FG023|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
48498846|NCT00112437|101554369|FG024|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
48498847|NCT00112437|101554370|FG025|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
48498848|NCT00112437|101554345|FG000|STARTED|Years 6-10 (60-Month Extension)||0||
48498849|NCT00112437|101554346|FG001|STARTED|Years 6-10 (60-Month Extension)||0||
48498850|NCT00112437|101554347|FG002|STARTED|Years 6-10 (60-Month Extension)||0||
48498851|NCT00112437|101554348|FG003|STARTED|Years 6-10 (60-Month Extension)||0||
48498852|NCT00112437|101554349|FG004|STARTED|Years 6-10 (60-Month Extension)||0||
48498853|NCT00112437|101554350|FG005|STARTED|Years 6-10 (60-Month Extension)||0||
48498854|NCT00112437|101554351|FG006|STARTED|Years 6-10 (60-Month Extension)||0||
48498855|NCT00112437|101554352|FG007|STARTED|Years 6-10 (60-Month Extension)||0||
48498856|NCT00112437|101554353|FG008|STARTED|Years 6-10 (60-Month Extension)||0||
48498857|NCT00112437|101554354|FG009|STARTED|Years 6-10 (60-Month Extension)||0||
48498858|NCT00112437|101554355|FG010|STARTED|Years 6-10 (60-Month Extension)||0||
48498859|NCT00112437|101554356|FG011|STARTED|Years 6-10 (60-Month Extension)||0||
48498860|NCT00112437|101554357|FG012|STARTED|Years 6-10 (60-Month Extension)||0||
48498861|NCT00112437|101554358|FG013|STARTED|Years 6-10 (60-Month Extension)||0||
48498862|NCT00112437|101554359|FG014|STARTED|Years 6-10 (60-Month Extension)||0||
48498863|NCT00112437|101554360|FG015|STARTED|Years 6-10 (60-Month Extension)||0||
48498864|NCT00112437|101554361|FG016|STARTED|Years 6-10 (60-Month Extension)||0||
48498865|NCT00112437|101554362|FG017|STARTED|Years 6-10 (60-Month Extension)||0||
48498866|NCT00112437|101554363|FG018|STARTED|Years 6-10 (60-Month Extension)||0||
48498867|NCT00112437|101554364|FG019|STARTED|Years 6-10 (60-Month Extension)||0||
48498868|NCT00112437|101554365|FG020|STARTED|Years 6-10 (60-Month Extension)||0||
48498869|NCT00112437|101554366|FG021|STARTED|Years 6-10 (60-Month Extension)||0||
48498870|NCT00112437|101554367|FG022|STARTED|Years 6-10 (60-Month Extension)||28||
48498871|NCT00112437|101554368|FG023|STARTED|Years 6-10 (60-Month Extension)||34||
48498872|NCT00112437|101554369|FG024|STARTED|Years 6-10 (60-Month Extension)||23||
48498873|NCT00112437|101554370|FG025|STARTED|Years 6-10 (60-Month Extension)||32||
48498874|NCT00112437|101554345|FG000|COMPLETED|Years 6-10 (60-Month Extension)||0||
48498875|NCT00112437|101554346|FG001|COMPLETED|Years 6-10 (60-Month Extension)||0||
48498876|NCT00112437|101554347|FG002|COMPLETED|Years 6-10 (60-Month Extension)||0||
48498877|NCT00112437|101554348|FG003|COMPLETED|Years 6-10 (60-Month Extension)||0||
48498878|NCT00112437|101554349|FG004|COMPLETED|Years 6-10 (60-Month Extension)||0||
48498879|NCT00112437|101554350|FG005|COMPLETED|Years 6-10 (60-Month Extension)||0||
48498880|NCT00112437|101554351|FG006|COMPLETED|Years 6-10 (60-Month Extension)||0||
48498881|NCT00112437|101554352|FG007|COMPLETED|Years 6-10 (60-Month Extension)||0||
48498882|NCT00112437|101554353|FG008|COMPLETED|Years 6-10 (60-Month Extension)||0||
48498883|NCT00112437|101554354|FG009|COMPLETED|Years 6-10 (60-Month Extension)||0||
48498884|NCT00112437|101554355|FG010|COMPLETED|Years 6-10 (60-Month Extension)||0||
48498885|NCT00112437|101554356|FG011|COMPLETED|Years 6-10 (60-Month Extension)||0||
48498886|NCT00112437|101554357|FG012|COMPLETED|Years 6-10 (60-Month Extension)||0||
48498887|NCT00112437|101554358|FG013|COMPLETED|Years 6-10 (60-Month Extension)||0||
48498888|NCT00112437|101554359|FG014|COMPLETED|Years 6-10 (60-Month Extension)||0||
48498889|NCT00112437|101554360|FG015|COMPLETED|Years 6-10 (60-Month Extension)||0||
48498890|NCT00112437|101554361|FG016|COMPLETED|Years 6-10 (60-Month Extension)||0||
48498891|NCT00112437|101554362|FG017|COMPLETED|Years 6-10 (60-Month Extension)||0||
48498892|NCT00112437|101554363|FG018|COMPLETED|Years 6-10 (60-Month Extension)||0||
48498893|NCT00112437|101554364|FG019|COMPLETED|Years 6-10 (60-Month Extension)||0||
48498894|NCT00112437|101554365|FG020|COMPLETED|Years 6-10 (60-Month Extension)||0||
48498895|NCT00112437|101554366|FG021|COMPLETED|Years 6-10 (60-Month Extension)||0||
48498896|NCT00112437|101554367|FG022|COMPLETED|Years 6-10 (60-Month Extension)||23||
48498897|NCT00112437|101554368|FG023|COMPLETED|Years 6-10 (60-Month Extension)||22||
48498898|NCT00112437|101554369|FG024|COMPLETED|Years 6-10 (60-Month Extension)||22||
48498899|NCT00112437|101554370|FG025|COMPLETED|Years 6-10 (60-Month Extension)||27||
48498900|NCT00112437|101554345|FG000|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
48498901|NCT00112437|101554346|FG001|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
48498902|NCT00112437|101554347|FG002|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
48498903|NCT00112437|101554348|FG003|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
48498904|NCT00112437|101554349|FG004|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
48498905|NCT00112437|101554350|FG005|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
48498906|NCT00112437|101554351|FG006|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
48498907|NCT00112437|101554352|FG007|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
48498908|NCT00112437|101554353|FG008|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
48498909|NCT00112437|101554354|FG009|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
48498910|NCT00112437|101554355|FG010|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
48498911|NCT00112437|101554356|FG011|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
48498912|NCT00112437|101554357|FG012|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
48498913|NCT00112437|101554358|FG013|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
48498914|NCT00112437|101554359|FG014|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
48498915|NCT00112437|101554360|FG015|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
48498916|NCT00112437|101554361|FG016|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
48498917|NCT00112437|101554362|FG017|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
48498918|NCT00112437|101554363|FG018|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
48498919|NCT00112437|101554364|FG019|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
48498920|NCT00112437|101554365|FG020|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
48061042|NCT01193842|100470337|FG004|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0||
48061043|NCT01193842|100470333|FG000|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0||
48061044|NCT01193842|100470334|FG001|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||1||
48061045|NCT01193842|100470335|FG002|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0||
48061046|NCT01193842|100470336|FG003|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0||
48061047|NCT01193842|100470337|FG004|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0||
48061048|NCT01193842|100470333|FG000|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||4||
48061049|NCT01193842|100470334|FG001|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0||
48061050|NCT01193842|100470335|FG002|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0||
48061051|NCT01193842|100470336|FG003|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0||
48061052|NCT01193842|100470337|FG004|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0||
48061053|NCT01193842|100470333|FG000|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||3||
48061054|NCT01193842|100470334|FG001|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0||
48498921|NCT00112437|101554366|FG021|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
48061055|NCT01193842|100470335|FG002|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0||
48061056|NCT01193842|100470336|FG003|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0||
48061057|NCT01193842|100470337|FG004|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0||
48061058|NCT01193842|100470333|FG000|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||1||
48498922|NCT00112437|101554367|FG022|NOT COMPLETED|Years 6-10 (60-Month Extension)||5||
48498923|NCT00112437|101554368|FG023|NOT COMPLETED|Years 6-10 (60-Month Extension)||12||
48218488|NCT01426412|100860316|FG002|STARTED|Overall Study||6||
48498924|NCT00112437|101554369|FG024|NOT COMPLETED|Years 6-10 (60-Month Extension)||1||
48498925|NCT00112437|101554370|FG025|NOT COMPLETED|Years 6-10 (60-Month Extension)||5||
48498926|NCT03541252|101554371|FG000|STARTED|Overall Study||20||
48498927|NCT03541252|101554371|FG000|COMPLETED|Overall Study||19||
48498928|NCT03541252|101554371|FG000|NOT COMPLETED|Overall Study||1||
48498929|NCT02589067|101554372|FG000|STARTED|Overall Study||33||
48498930|NCT02589067|101554373|FG001|STARTED|Overall Study||34||
48498931|NCT02589067|101554372|FG000|COMPLETED|Overall Study||28||
48498932|NCT02589067|101554373|FG001|COMPLETED|Overall Study||28||
48498933|NCT02589067|101554372|FG000|NOT COMPLETED|Overall Study||5||
48498934|NCT02589067|101554373|FG001|NOT COMPLETED|Overall Study||6||
48498935|NCT01250730|101554374|FG000|STARTED|Overall Study||6||
48498936|NCT01250730|101554375|FG001|STARTED|Overall Study||6||
48498937|NCT01250730|101554376|FG002|STARTED|Overall Study||6||
48498938|NCT01250730|101554374|FG000|COMPLETED|Overall Study||6||
48498939|NCT01250730|101554375|FG001|COMPLETED|Overall Study||6||
48498940|NCT01250730|101554376|FG002|COMPLETED|Overall Study||6||
48498941|NCT01250730|101554374|FG000|NOT COMPLETED|Overall Study||0||
48498942|NCT01250730|101554375|FG001|NOT COMPLETED|Overall Study||0||
48498943|NCT01250730|101554376|FG002|NOT COMPLETED|Overall Study||0||
48498944|NCT01229150|101554377|FG000|STARTED|Overall Study||30||
48498945|NCT01229150|101554378|FG001|STARTED|Overall Study||11||
48498946|NCT01229150|101554379|FG002|STARTED|Overall Study||19||
48498947|NCT01229150|101554380|FG003|STARTED|Overall Study||19||
48498948|NCT01229150|101554377|FG000|COMPLETED|Overall Study||28||
48498949|NCT01229150|101554378|FG001|COMPLETED|Overall Study||9||
48498950|NCT01229150|101554379|FG002|COMPLETED|Overall Study||19||
48498951|NCT01229150|101554380|FG003|COMPLETED|Overall Study||19||
48498952|NCT01229150|101554377|FG000|NOT COMPLETED|Overall Study||2||
48498953|NCT01229150|101554378|FG001|NOT COMPLETED|Overall Study||2||
48498954|NCT01229150|101554379|FG002|NOT COMPLETED|Overall Study||0||
48498955|NCT01229150|101554380|FG003|NOT COMPLETED|Overall Study||0||
48498956|NCT02663349|101554381|FG000|STARTED|Overall Study||22||
48498957|NCT02663349|101554381|FG000|Attended First Treatment Session|Overall Study||18||
48498958|NCT02663349|101554381|FG000|Completed Intervention|Overall Study||16||
48498959|NCT02663349|101554381|FG000|Completed Follow-up Assessment 3 Months Post-intervention|Overall Study||16||
48498960|NCT02663349|101554381|FG000|COMPLETED|Overall Study||16||
48498961|NCT02663349|101554381|FG000|NOT COMPLETED|Overall Study||6||
48498962|NCT00874276|101554382|FG000|STARTED|Overall Study||6||
48498963|NCT00874276|101554383|FG001|STARTED|Overall Study||8||
48498964|NCT00874276|101554382|FG000|COMPLETED|Overall Study||5||
48498965|NCT00874276|101554383|FG001|COMPLETED|Overall Study||7||
48498966|NCT00874276|101554382|FG000|NOT COMPLETED|Overall Study||1||
48498967|NCT00874276|101554383|FG001|NOT COMPLETED|Overall Study||1||
48498968|NCT02725580|101554384|FG000|STARTED|Overall Study||13||
48498969|NCT02725580|101554384|FG000|Received at Least 1 Dose of Study Drug|Overall Study||13||
48498970|NCT02725580|101554384|FG000|COMPLETED|Overall Study||13||
48498971|NCT02725580|101554384|FG000|NOT COMPLETED|Overall Study||0||
48498972|NCT00630253|101554385|FG000|STARTED|Overall Study||16||
48498973|NCT00630253|101554386|FG001|STARTED|Overall Study||9||
48498974|NCT00630253|101554387|FG002|STARTED|Overall Study||6||
48498975|NCT00630253|101554385|FG000|COMPLETED|Overall Study||16||
48498976|NCT00630253|101554386|FG001|COMPLETED|Overall Study||9||
48498977|NCT00630253|101554387|FG002|COMPLETED|Overall Study||6||
48498978|NCT00630253|101554385|FG000|NOT COMPLETED|Overall Study||0||
48498979|NCT00630253|101554386|FG001|NOT COMPLETED|Overall Study||0||
48498980|NCT00630253|101554387|FG002|NOT COMPLETED|Overall Study||0||
48498981|NCT00642993|101554388|FG000|STARTED|Overall Study||267||
48498982|NCT00642993|101554389|FG001|STARTED|Overall Study||134||
48498983|NCT00642993|101554388|FG000|COMPLETED|Overall Study||161||
48498984|NCT00642993|101554389|FG001|COMPLETED|Overall Study||118||
48498985|NCT00642993|101554388|FG000|NOT COMPLETED|Overall Study||106||
48498986|NCT00642993|101554389|FG001|NOT COMPLETED|Overall Study||16||
48498987|NCT03415308|101554390|FG000|STARTED|Overall Study||50||
48498988|NCT03415308|101554391|FG001|STARTED|Overall Study||27||
48498989|NCT03415308|101554392|FG002|STARTED|Overall Study||37||
48498990|NCT03415308|101554390|FG000|COMPLETED|Overall Study||50||
48498991|NCT03415308|101554391|FG001|COMPLETED|Overall Study||27||
48498992|NCT03415308|101554392|FG002|COMPLETED|Overall Study||29||
48061059|NCT01193842|100470334|FG001|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0||
48498993|NCT03415308|101554390|FG000|NOT COMPLETED|Overall Study||0||
48498994|NCT03415308|101554391|FG001|NOT COMPLETED|Overall Study||0||
48498995|NCT03415308|101554392|FG002|NOT COMPLETED|Overall Study||8||
48498996|NCT01460628|101554393|FG000|STARTED|Overall Study||25||
48498997|NCT01460628|101554393|FG000|COMPLETED|Overall Study||20||
48498998|NCT01460628|101554393|FG000|NOT COMPLETED|Overall Study||5||
48498999|NCT01963260|101554394|FG000|STARTED|Overall Study||6||
48499000|NCT01963260|101554395|FG001|STARTED|Overall Study||6||
48499001|NCT01963260|101554396|FG002|STARTED|Overall Study||6||
48499002|NCT01963260|101554397|FG003|STARTED|Overall Study||6||
48499003|NCT01963260|101554398|FG004|STARTED|Overall Study||6||
48499004|NCT01963260|101554399|FG005|STARTED|Overall Study||10||
48499005|NCT01963260|101554400|FG006|STARTED|Overall Study||3||
48499006|NCT01963260|101554401|FG007|STARTED|Overall Study||2||
48499007|NCT01963260|101554402|FG008|STARTED|Overall Study||1||
48499008|NCT01963260|101554403|FG009|STARTED|Overall Study||4||
48499009|NCT01963260|101554394|FG000|Treated|Overall Study||6||
48499010|NCT01963260|101554395|FG001|Treated|Overall Study||6||
48499011|NCT01963260|101554396|FG002|Treated|Overall Study||6||
48499012|NCT01963260|101554397|FG003|Treated|Overall Study||6||
48499013|NCT01963260|101554398|FG004|Treated|Overall Study||6||
48499014|NCT01963260|101554399|FG005|Treated|Overall Study||10||
48499015|NCT01963260|101554400|FG006|Treated|Overall Study||3||
48499016|NCT01963260|101554401|FG007|Treated|Overall Study||2||
48499017|NCT01963260|101554402|FG008|Treated|Overall Study||1||
48499018|NCT01963260|101554403|FG009|Treated|Overall Study||4||
48499019|NCT01963260|101554394|FG000|COMPLETED|Overall Study||4||
48499020|NCT01963260|101554395|FG001|COMPLETED|Overall Study||6||
48499021|NCT01963260|101554396|FG002|COMPLETED|Overall Study||6||
48499022|NCT01963260|101554397|FG003|COMPLETED|Overall Study||5||
48499023|NCT01963260|101554398|FG004|COMPLETED|Overall Study||4||
48499024|NCT01963260|101554399|FG005|COMPLETED|Overall Study||10||
48499025|NCT01963260|101554400|FG006|COMPLETED|Overall Study||3||
48499026|NCT01963260|101554401|FG007|COMPLETED|Overall Study||2||
48499027|NCT01963260|101554402|FG008|COMPLETED|Overall Study||1||
48499028|NCT01963260|101554403|FG009|COMPLETED|Overall Study||4||
48499029|NCT01963260|101554394|FG000|NOT COMPLETED|Overall Study||2||
48499030|NCT01963260|101554395|FG001|NOT COMPLETED|Overall Study||0||
48499031|NCT01963260|101554396|FG002|NOT COMPLETED|Overall Study||0||
48499032|NCT01963260|101554397|FG003|NOT COMPLETED|Overall Study||1||
48499033|NCT01963260|101554398|FG004|NOT COMPLETED|Overall Study||2||
48499034|NCT01963260|101554399|FG005|NOT COMPLETED|Overall Study||0||
48499035|NCT01963260|101554400|FG006|NOT COMPLETED|Overall Study||0||
48499036|NCT01963260|101554401|FG007|NOT COMPLETED|Overall Study||0||
48499037|NCT01963260|101554402|FG008|NOT COMPLETED|Overall Study||0||
48499038|NCT01963260|101554403|FG009|NOT COMPLETED|Overall Study||0||
48499039|NCT01049581|101554404|FG000|STARTED|Overall Study||13||
48499040|NCT01049581|101554405|FG001|STARTED|Overall Study||14||
48499041|NCT01049581|101554404|FG000|COMPLETED|Overall Study||11||
48499042|NCT01049581|101554405|FG001|COMPLETED|Overall Study||13||
48499043|NCT01049581|101554404|FG000|NOT COMPLETED|Overall Study||2||
48499044|NCT01049581|101554405|FG001|NOT COMPLETED|Overall Study||1||
48499045|NCT01426854|101554406|FG000|STARTED|Overall Study||131||
48499046|NCT01426854|101554407|FG001|STARTED|Overall Study||129||
48499047|NCT01426854|101554406|FG000|COMPLETED|Overall Study||119||
48499048|NCT01426854|101554407|FG001|COMPLETED|Overall Study||98||
48499049|NCT01426854|101554406|FG000|NOT COMPLETED|Overall Study||12||
48499050|NCT01426854|101554407|FG001|NOT COMPLETED|Overall Study||31||
48499051|NCT02030535|101554408|FG000|STARTED|Treatment Period 1 (1 Day)||53||
48499052|NCT02030535|101554408|FG000|COMPLETED|Treatment Period 1 (1 Day)||53||
48499053|NCT02030535|101554408|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
48499054|NCT02030535|101554408|FG000|STARTED|Washout Period 1 (21 Days)||53||
48499055|NCT02030535|101554408|FG000|COMPLETED|Washout Period 1 (21 Days)||52||
48499056|NCT02030535|101554408|FG000|NOT COMPLETED|Washout Period 1 (21 Days)||1||
48499057|NCT02030535|101554408|FG000|STARTED|Treatment Period 2 (1 Day)||52||
48499058|NCT02030535|101554408|FG000|COMPLETED|Treatment Period 2 (1 Day)||52||
48499059|NCT02030535|101554408|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
48499060|NCT02030535|101554408|FG000|STARTED|Washout Period 2 (21 Days)||52||
48499061|NCT02030535|101554408|FG000|COMPLETED|Washout Period 2 (21 Days)||52||
48499062|NCT02030535|101554408|FG000|NOT COMPLETED|Washout Period 2 (21 Days)||0||
48499063|NCT02030535|101554408|FG000|STARTED|Treatment Period 3 (1 Day)||52||
48499064|NCT02030535|101554408|FG000|COMPLETED|Treatment Period 3 (1 Day)||52||
48499065|NCT02030535|101554408|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
48499066|NCT01945580|101554409|FG000|STARTED|Overall Study||228||
48499067|NCT01945580|101554410|FG001|STARTED|Overall Study||485||
48499068|NCT01945580|101554409|FG000|COMPLETED|Overall Study||176||
48499069|NCT01945580|101554410|FG001|COMPLETED|Overall Study||401||
48499070|NCT01945580|101554409|FG000|NOT COMPLETED|Overall Study||52||
48499071|NCT01945580|101554410|FG001|NOT COMPLETED|Overall Study||84||
48499072|NCT00577655|101554411|FG000|STARTED|Overall Study||52||
48499073|NCT00577655|101554412|FG001|STARTED|Overall Study||51||
48499074|NCT00577655|101554411|FG000|COMPLETED|Overall Study||51||
48499075|NCT00577655|101554412|FG001|COMPLETED|Overall Study||47||
48499076|NCT00577655|101554411|FG000|NOT COMPLETED|Overall Study||1||
48499077|NCT00577655|101554412|FG001|NOT COMPLETED|Overall Study||4||
48499078|NCT02761915|101554413|FG000|STARTED|Overall Study||4||
48499079|NCT02761915|101554414|FG001|STARTED|Overall Study||1||
48499080|NCT02761915|101554415|FG002|STARTED|Overall Study||1||
48499081|NCT02761915|101554416|FG003|STARTED|Overall Study||3||
48499082|NCT02761915|101554417|FG004|STARTED|Overall Study||3||
48499083|NCT02761915|101554418|FG005|STARTED|Overall Study||5||
48499084|NCT02761915|101554413|FG000|Underwent Leukapheresis|Overall Study||4||
48499085|NCT02761915|101554414|FG001|Underwent Leukapheresis|Overall Study||1||
48499086|NCT02761915|101554415|FG002|Underwent Leukapheresis|Overall Study||1||
48499087|NCT02761915|101554416|FG003|Underwent Leukapheresis|Overall Study||3||
48499088|NCT02761915|101554417|FG004|Underwent Leukapheresis|Overall Study||3||
48499089|NCT02761915|101554418|FG005|Underwent Leukapheresis|Overall Study||5||
48499090|NCT02761915|101554413|FG000|Received Investigational Medicinal Product|Overall Study||4||
48499091|NCT02761915|101554414|FG001|Received Investigational Medicinal Product|Overall Study||1||
48499092|NCT02761915|101554415|FG002|Received Investigational Medicinal Product|Overall Study||1||
48499093|NCT02761915|101554416|FG003|Received Investigational Medicinal Product|Overall Study||3||
48499094|NCT02761915|101554417|FG004|Received Investigational Medicinal Product|Overall Study||3||
48499095|NCT02761915|101554418|FG005|Received Investigational Medicinal Product|Overall Study||0||
48499096|NCT02761915|101554413|FG000|COMPLETED|Overall Study||0||
48499097|NCT02761915|101554414|FG001|COMPLETED|Overall Study||0||
48499098|NCT02761915|101554415|FG002|COMPLETED|Overall Study||0||
48499099|NCT02761915|101554416|FG003|COMPLETED|Overall Study||0||
48499100|NCT02761915|101554417|FG004|COMPLETED|Overall Study||0||
48499101|NCT02761915|101554418|FG005|COMPLETED|Overall Study||0||
48499102|NCT02761915|101554413|FG000|NOT COMPLETED|Overall Study||4||
48499103|NCT02761915|101554414|FG001|NOT COMPLETED|Overall Study||1||
48499104|NCT02761915|101554415|FG002|NOT COMPLETED|Overall Study||1||
48499105|NCT02761915|101554416|FG003|NOT COMPLETED|Overall Study||3||
48499106|NCT02761915|101554417|FG004|NOT COMPLETED|Overall Study||3||
48499107|NCT02761915|101554418|FG005|NOT COMPLETED|Overall Study||5||
48499108|NCT00323258|101554419|FG000|STARTED|Primary Outcome (Phone Call at 6 Months)||71||
48499109|NCT00323258|101554420|FG001|STARTED|Primary Outcome (Phone Call at 6 Months)||72||
48499110|NCT00323258|101554419|FG000|COMPLETED|Primary Outcome (Phone Call at 6 Months)||55||
48499111|NCT00323258|101554420|FG001|COMPLETED|Primary Outcome (Phone Call at 6 Months)||53||
48499112|NCT00323258|101554419|FG000|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||16||
48499113|NCT00323258|101554420|FG001|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||19||
48499114|NCT00323258|101554419|FG000|STARTED|Secondary Outcome (6 Mon Refill Records)||71||
48499115|NCT00323258|101554420|FG001|STARTED|Secondary Outcome (6 Mon Refill Records)||72||
48499116|NCT00323258|101554419|FG000|COMPLETED|Secondary Outcome (6 Mon Refill Records)||57||
48499117|NCT00323258|101554420|FG001|COMPLETED|Secondary Outcome (6 Mon Refill Records)||58||
48499118|NCT00323258|101554419|FG000|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14||
48499119|NCT00323258|101554420|FG001|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14||
48499120|NCT03573544|101554421|FG000|STARTED|Overall Study||5||
48499121|NCT03573544|101554422|FG001|STARTED|Overall Study||3||
48499122|NCT03573544|101554423|FG002|STARTED|Overall Study||6||
48499123|NCT03573544|101554424|FG003|STARTED|Overall Study||8||
48499124|NCT03573544|101554425|FG004|STARTED|Overall Study||7||
48499125|NCT03573544|101554426|FG005|STARTED|Overall Study||8||
48499126|NCT03573544|101554427|FG006|STARTED|Overall Study||9||
48499127|NCT03573544|101554428|FG007|STARTED|Overall Study||8||
48499128|NCT03573544|101554421|FG000|COMPLETED|Overall Study||0||
48499129|NCT03573544|101554422|FG001|COMPLETED|Overall Study||0||
48499130|NCT03573544|101554423|FG002|COMPLETED|Overall Study||0||
48499131|NCT03573544|101554424|FG003|COMPLETED|Overall Study||0||
48499132|NCT03573544|101554425|FG004|COMPLETED|Overall Study||0||
48499133|NCT03573544|101554426|FG005|COMPLETED|Overall Study||0||
48499134|NCT03573544|101554427|FG006|COMPLETED|Overall Study||0||
48499135|NCT03573544|101554428|FG007|COMPLETED|Overall Study||0||
48499136|NCT03573544|101554421|FG000|NOT COMPLETED|Overall Study||5||
48499137|NCT03573544|101554422|FG001|NOT COMPLETED|Overall Study||3||
48499138|NCT03573544|101554423|FG002|NOT COMPLETED|Overall Study||6||
48499139|NCT03573544|101554424|FG003|NOT COMPLETED|Overall Study||8||
48499140|NCT03573544|101554425|FG004|NOT COMPLETED|Overall Study||7||
48499141|NCT03573544|101554426|FG005|NOT COMPLETED|Overall Study||8||
48499142|NCT03573544|101554427|FG006|NOT COMPLETED|Overall Study||9||
48499143|NCT03573544|101554428|FG007|NOT COMPLETED|Overall Study||8||
48499144|NCT02235870|101554429|FG000|STARTED|Overall Study||198|Subjects, Registered Dietitians and Adverse Event Assessors were blinded of device assignment|
48499145|NCT02235870|101554430|FG001|STARTED|Overall Study||189|Subjects, Registered Dietitians and Adverse Event Assessors were blinded of device assignment|
48499146|NCT02235870|101554429|FG000|Completed Phase I (Week 24)|Overall Study||182|Device assignment unblinding and Obalon Balloon removal for Treatment Group|
48499147|NCT02235870|101554430|FG001|Completed Phase I (Week 24)|Overall Study||179|Device assignment unblinding and Obalon Balloon removal for Treatment Group|
48499148|NCT02235870|101554429|FG000|Crossover (Week 24)|Overall Study||170|Sham Group received Obalon Balloon \& Treatment Group followed after balloon removal (WLBM for both)|
48499149|NCT02235870|101554430|FG001|Crossover (Week 24)|Overall Study||138|Sham Group received Obalon Balloon \& Treatment Group followed after balloon removal (WLBM for both)|
48499150|NCT02235870|101554429|FG000|COMPLETED|Overall Study||160|Completed Phase II (Week 48), Obalon Balloon removal for Sham Group|
48499151|NCT02235870|101554430|FG001|COMPLETED|Overall Study||128|Completed Phase II (Week 48), Obalon Balloon removal for Sham Group|
48499152|NCT02235870|101554429|FG000|NOT COMPLETED|Overall Study||38||
48499153|NCT02235870|101554430|FG001|NOT COMPLETED|Overall Study||61||
48499154|NCT02992067|101554431|FG000|STARTED|Overall Study||359||
48499155|NCT02992067|101554431|FG000|COMPLETED|Overall Study||359||
48499156|NCT02992067|101554431|FG000|NOT COMPLETED|Overall Study||0||
48499157|NCT03885934|101554432|FG000|STARTED|Overall Study||64||
48499158|NCT03885934|101554433|FG001|STARTED|Overall Study||64||
48499159|NCT03885934|101554434|FG002|STARTED|Overall Study||62||
48061060|NCT01193842|100470335|FG002|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0||
48218489|NCT01426412|100860317|FG003|STARTED|Overall Study||6||
48499160|NCT03885934|101554435|FG003|STARTED|Overall Study||64||
48499161|NCT03885934|101554436|FG004|STARTED|Overall Study||177||
48499162|NCT03885934|101554437|FG005|STARTED|Overall Study||175||
48499163|NCT03885934|101554432|FG000|PCV Dose 1|Overall Study||64||
48499164|NCT03885934|101554433|FG001|PCV Dose 1|Overall Study||64||
48499165|NCT03885934|101554434|FG002|PCV Dose 1|Overall Study||62||
48499166|NCT03885934|101554435|FG003|PCV Dose 1|Overall Study||64||
48499167|NCT03885934|101554436|FG004|PCV Dose 1|Overall Study||177||
48499168|NCT03885934|101554437|FG005|PCV Dose 1|Overall Study||175||
48499169|NCT03885934|101554432|FG000|PCV Dose 2|Overall Study||63||
48499170|NCT03885934|101554433|FG001|PCV Dose 2|Overall Study||64||
48499171|NCT03885934|101554434|FG002|PCV Dose 2|Overall Study||62||
48499172|NCT03885934|101554435|FG003|PCV Dose 2|Overall Study||64||
48499173|NCT03885934|101554436|FG004|PCV Dose 2|Overall Study||0||
48499174|NCT03885934|101554437|FG005|PCV Dose 2|Overall Study||0||
48499175|NCT03885934|101554432|FG000|PCV Dose 3|Overall Study||63||
48499176|NCT03885934|101554433|FG001|PCV Dose 3|Overall Study||64||
48499177|NCT03885934|101554434|FG002|PCV Dose 3|Overall Study||0||
48499178|NCT03885934|101554435|FG003|PCV Dose 3|Overall Study||0||
48499179|NCT03885934|101554436|FG004|PCV Dose 3|Overall Study||0||
48499180|NCT03885934|101554437|FG005|PCV Dose 3|Overall Study||0||
48499181|NCT03885934|101554432|FG000|COMPLETED|Overall Study||63||
48499182|NCT03885934|101554433|FG001|COMPLETED|Overall Study||64||
48499183|NCT03885934|101554434|FG002|COMPLETED|Overall Study||62||
48499184|NCT03885934|101554435|FG003|COMPLETED|Overall Study||64||
48499185|NCT03885934|101554436|FG004|COMPLETED|Overall Study||177||
48499186|NCT03885934|101554437|FG005|COMPLETED|Overall Study||175||
48499187|NCT03885934|101554432|FG000|NOT COMPLETED|Overall Study||1||
48499188|NCT03885934|101554433|FG001|NOT COMPLETED|Overall Study||0||
48499189|NCT03885934|101554434|FG002|NOT COMPLETED|Overall Study||0||
48499190|NCT03885934|101554435|FG003|NOT COMPLETED|Overall Study||0||
48499191|NCT03885934|101554436|FG004|NOT COMPLETED|Overall Study||0||
48499192|NCT03885934|101554437|FG005|NOT COMPLETED|Overall Study||0||
48499193|NCT00487435|101554438|FG000|STARTED|Overall Study||1154||
48499194|NCT00487435|101554438|FG000|COMPLETED|Overall Study||669||
48499195|NCT00487435|101554438|FG000|NOT COMPLETED|Overall Study||485||
48499196|NCT00516295|101554439|FG000|STARTED|Overall Study||7||
48499197|NCT00516295|101554440|FG001|STARTED|Overall Study||0||
48499198|NCT00516295|101554441|FG002|STARTED|Overall Study||0||
48499199|NCT00516295|101554439|FG000|COMPLETED|Overall Study||4||
48499200|NCT00516295|101554440|FG001|COMPLETED|Overall Study||0||
48499201|NCT00516295|101554441|FG002|COMPLETED|Overall Study||0||
48499202|NCT00516295|101554439|FG000|NOT COMPLETED|Overall Study||3||
48499203|NCT00516295|101554440|FG001|NOT COMPLETED|Overall Study||0||
48499204|NCT00516295|101554441|FG002|NOT COMPLETED|Overall Study||0||
48499205|NCT00874822|101554442|FG000|STARTED|Overall Study||216||
48499206|NCT00874822|101554442|FG000|COMPLETED|Overall Study||208||
48499207|NCT00874822|101554442|FG000|NOT COMPLETED|Overall Study||8||
48499208|NCT01456949|101554443|FG000|STARTED|Enrollment||402||
48499209|NCT01456949|101554443|FG000|Treated|Enrollment||359|Enrolled subjects who underwent a study cryoablation procedure whether or not they met I/E criteria.|
48499210|NCT01456949|101554443|FG000|Modified Intent to Treat Group (mITT)|Enrollment||354|Enrolled subjects who met all I/E criteria and underwent a study cryoablation procedure.|
48499211|NCT01456949|101554443|FG000|COMPLETED|Enrollment||365||
48499212|NCT01456949|101554443|FG000|NOT COMPLETED|Enrollment||37||
48499213|NCT01456949|101554443|FG000|STARTED|Study Cryoablation Procedure & Follow-up||365||
48499214|NCT01456949|101554443|FG000|3-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up||344||
48499215|NCT01456949|101554443|FG000|6-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up||342||
48499216|NCT01456949|101554443|FG000|12-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up||325||
48499217|NCT01456949|101554443|FG000|24-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up||309||
48499218|NCT01456949|101554443|FG000|36-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up||298||
48499219|NCT01456949|101554443|FG000|COMPLETED|Study Cryoablation Procedure & Follow-up||303|Of mITT group.|
48499220|NCT01456949|101554443|FG000|NOT COMPLETED|Study Cryoablation Procedure & Follow-up||62||
48499221|NCT00529763|101554444|FG000|STARTED|Overall Study||25||
48499222|NCT00529763|101554445|FG001|STARTED|Overall Study||37||
48499223|NCT00529763|101554446|FG002|STARTED|Overall Study||59||
48499224|NCT00529763|101554444|FG000|COMPLETED|Overall Study||4|All participants who completed treatment were transitioned to the patient support program of Sprycel.|
48499225|NCT00529763|101554445|FG001|COMPLETED|Overall Study||0|All participants who completed treatment were transitioned to the patient support program of Sprycel.|
48499226|NCT00529763|101554446|FG002|COMPLETED|Overall Study||27|All participants who completed treatment were transitioned to the patient support program of Sprycel.|
48499227|NCT00529763|101554444|FG000|NOT COMPLETED|Overall Study||21||
48499228|NCT00529763|101554445|FG001|NOT COMPLETED|Overall Study||37||
48499229|NCT00529763|101554446|FG002|NOT COMPLETED|Overall Study||32||
48499230|NCT01632423|101554447|FG000|STARTED|Overall Study||10337||
48499231|NCT01632423|101554447|FG000|COMPLETED|Overall Study||10091||
48499232|NCT01632423|101554447|FG000|NOT COMPLETED|Overall Study||246||
48499233|NCT01816230|101554448|FG000|STARTED|Overall Study||36||
48499234|NCT01816230|101554448|FG000|COMPLETED|Overall Study||36||
48499235|NCT01816230|101554448|FG000|NOT COMPLETED|Overall Study||0||
48499236|NCT01120028|101554449|FG000|STARTED|Period 1: Alemtuzumab or Basiliximab||426||
48499237|NCT01120028|101554450|FG001|STARTED|Period 1: Alemtuzumab or Basiliximab||426||
48499238|NCT01120028|101554451|FG002|STARTED|Period 1: Alemtuzumab or Basiliximab||0||
48499239|NCT01120028|101554452|FG003|STARTED|Period 1: Alemtuzumab or Basiliximab||0||
48499240|NCT01120028|101554449|FG000|COMPLETED|Period 1: Alemtuzumab or Basiliximab||412||
48499241|NCT01120028|101554450|FG001|COMPLETED|Period 1: Alemtuzumab or Basiliximab||403||
48499242|NCT01120028|101554451|FG002|COMPLETED|Period 1: Alemtuzumab or Basiliximab||0||
48499243|NCT01120028|101554452|FG003|COMPLETED|Period 1: Alemtuzumab or Basiliximab||0||
48499244|NCT01120028|101554449|FG000|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||14||
48499245|NCT01120028|101554450|FG001|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||23||
48499246|NCT01120028|101554451|FG002|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||0||
48499247|NCT01120028|101554452|FG003|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||0||
48499248|NCT01120028|101554449|FG000|STARTED|Period 2: Tacrolimus or Sirolimus||0||
48499249|NCT01120028|101554450|FG001|STARTED|Period 2: Tacrolimus or Sirolimus||0||
48499250|NCT01120028|101554451|FG002|STARTED|Period 2: Tacrolimus or Sirolimus||197||
48499251|NCT01120028|101554452|FG003|STARTED|Period 2: Tacrolimus or Sirolimus||197||
48499252|NCT01120028|101554449|FG000|COMPLETED|Period 2: Tacrolimus or Sirolimus||0||
48499253|NCT01120028|101554450|FG001|COMPLETED|Period 2: Tacrolimus or Sirolimus||0||
48499254|NCT01120028|101554451|FG002|COMPLETED|Period 2: Tacrolimus or Sirolimus||197||
48499255|NCT01120028|101554452|FG003|COMPLETED|Period 2: Tacrolimus or Sirolimus||197||
48499256|NCT01120028|101554449|FG000|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0||
48499257|NCT01120028|101554450|FG001|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0||
48499258|NCT01120028|101554451|FG002|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0||
48499259|NCT01120028|101554452|FG003|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0||
48499260|NCT01750294|101554453|FG000|STARTED|Overall Study||14||
48499261|NCT01750294|101554453|FG000|COMPLETED|Overall Study||12||
48499262|NCT01750294|101554453|FG000|NOT COMPLETED|Overall Study||2||
48499263|NCT04162899|101554454|FG000|STARTED|Overall Study||35||
48499264|NCT04162899|101554455|FG001|STARTED|Overall Study||35||
48499265|NCT04162899|101554456|FG002|STARTED|Overall Study||35||
48499266|NCT04162899|101554454|FG000|COMPLETED|Overall Study||29||
48499267|NCT04162899|101554455|FG001|COMPLETED|Overall Study||32||
48499268|NCT04162899|101554456|FG002|COMPLETED|Overall Study||23||
48499269|NCT04162899|101554454|FG000|NOT COMPLETED|Overall Study||6||
48499270|NCT04162899|101554455|FG001|NOT COMPLETED|Overall Study||3||
48499271|NCT04162899|101554456|FG002|NOT COMPLETED|Overall Study||12||
48499272|NCT00057941|101554457|FG000|STARTED|Overall Study||74||
48499273|NCT00057941|101554458|FG001|STARTED|Overall Study||74||
48499274|NCT00057941|101554457|FG000|Treated|Overall Study||74||
48499275|NCT00057941|101554458|FG001|Treated|Overall Study||74||
48499276|NCT00057941|101554457|FG000|Eligible|Overall Study||72||
48499277|NCT00057941|101554458|FG001|Eligible|Overall Study||69||
48499278|NCT00057941|101554457|FG000|COMPLETED|Overall Study||0||
48499279|NCT00057941|101554458|FG001|COMPLETED|Overall Study||0||
48499280|NCT00057941|101554457|FG000|NOT COMPLETED|Overall Study||74||
48499281|NCT00057941|101554458|FG001|NOT COMPLETED|Overall Study||74||
48499282|NCT02573779|101554459|FG000|STARTED|Overall Study||74||
48499283|NCT02573779|101554460|FG001|STARTED|Overall Study||43||
48499284|NCT02573779|101554459|FG000|COMPLETED|Overall Study||74||
48499285|NCT02573779|101554460|FG001|COMPLETED|Overall Study||43||
48499286|NCT02573779|101554459|FG000|NOT COMPLETED|Overall Study||0||
48499287|NCT02573779|101554460|FG001|NOT COMPLETED|Overall Study||0||
48499288|NCT01943435|101554461|FG000|STARTED|Baseline Eligibility and Randomization||88||
48499289|NCT01943435|101554462|FG001|STARTED|Baseline Eligibility and Randomization||84||
48499290|NCT01943435|101554463|FG002|STARTED|Baseline Eligibility and Randomization||87||
48499291|NCT01943435|101554461|FG000|COMPLETED|Baseline Eligibility and Randomization||84||
48499292|NCT01943435|101554462|FG001|COMPLETED|Baseline Eligibility and Randomization||72||
48499293|NCT01943435|101554463|FG002|COMPLETED|Baseline Eligibility and Randomization||84||
48499294|NCT01943435|101554461|FG000|NOT COMPLETED|Baseline Eligibility and Randomization||4||
48499295|NCT01943435|101554462|FG001|NOT COMPLETED|Baseline Eligibility and Randomization||12||
48499296|NCT01943435|101554463|FG002|NOT COMPLETED|Baseline Eligibility and Randomization||3||
48499297|NCT01943435|101554461|FG000|STARTED|Intervention Period||84||
48499298|NCT01943435|101554462|FG001|STARTED|Intervention Period||72||
48499299|NCT01943435|101554463|FG002|STARTED|Intervention Period||84||
48499300|NCT01943435|101554461|FG000|COMPLETED|Intervention Period||81||
48499301|NCT01943435|101554462|FG001|COMPLETED|Intervention Period||69||
48499302|NCT01943435|101554463|FG002|COMPLETED|Intervention Period||80||
48499303|NCT01943435|101554461|FG000|NOT COMPLETED|Intervention Period||3||
48499304|NCT01943435|101554462|FG001|NOT COMPLETED|Intervention Period||3||
48499305|NCT01943435|101554463|FG002|NOT COMPLETED|Intervention Period||4||
48499306|NCT01943435|101554461|FG000|STARTED|2 Month Follow up||81||
48499307|NCT01943435|101554462|FG001|STARTED|2 Month Follow up||69||
48499308|NCT01943435|101554463|FG002|STARTED|2 Month Follow up||80||
48499309|NCT01943435|101554461|FG000|COMPLETED|2 Month Follow up||79||
48499310|NCT01943435|101554462|FG001|COMPLETED|2 Month Follow up||66||
48499311|NCT01943435|101554463|FG002|COMPLETED|2 Month Follow up||80||
48499312|NCT01943435|101554461|FG000|NOT COMPLETED|2 Month Follow up||2||
48061061|NCT01193842|100470336|FG003|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0||
48499313|NCT01943435|101554462|FG001|NOT COMPLETED|2 Month Follow up||3||
48499314|NCT01943435|101554463|FG002|NOT COMPLETED|2 Month Follow up||0||
48499315|NCT01943435|101554461|FG000|STARTED|6 Month Follow up||79||
48499316|NCT01943435|101554462|FG001|STARTED|6 Month Follow up||66||
48499317|NCT01943435|101554463|FG002|STARTED|6 Month Follow up||80||
48499318|NCT01943435|101554461|FG000|COMPLETED|6 Month Follow up||67||
48499319|NCT01943435|101554462|FG001|COMPLETED|6 Month Follow up||59||
48499320|NCT01943435|101554463|FG002|COMPLETED|6 Month Follow up||65||
48499321|NCT01943435|101554461|FG000|NOT COMPLETED|6 Month Follow up||12||
48499322|NCT01943435|101554462|FG001|NOT COMPLETED|6 Month Follow up||7||
48499323|NCT01943435|101554463|FG002|NOT COMPLETED|6 Month Follow up||15||
48499324|NCT01728636|101554464|FG000|STARTED|Overall Study||31||
48499325|NCT01728636|101554465|FG001|STARTED|Overall Study||30||
48499326|NCT01728636|101554464|FG000|COMPLETED|Overall Study||31||
48499327|NCT01728636|101554465|FG001|COMPLETED|Overall Study||30||
48499328|NCT01728636|101554464|FG000|NOT COMPLETED|Overall Study||0||
48499329|NCT01728636|101554465|FG001|NOT COMPLETED|Overall Study||0||
48499330|NCT03008005|101554466|FG000|STARTED|Overall Study||14||
48499331|NCT03008005|101554467|FG001|STARTED|Overall Study||17||
48499332|NCT03008005|101554468|FG002|STARTED|Overall Study||15||
48499333|NCT03008005|101554466|FG000|COMPLETED|Overall Study||12||
48499334|NCT03008005|101554467|FG001|COMPLETED|Overall Study||16||
48499335|NCT03008005|101554468|FG002|COMPLETED|Overall Study||15||
48499336|NCT03008005|101554466|FG000|NOT COMPLETED|Overall Study||2||
48499337|NCT03008005|101554467|FG001|NOT COMPLETED|Overall Study||1||
48499338|NCT03008005|101554468|FG002|NOT COMPLETED|Overall Study||0||
48499339|NCT00178711|101554469|FG000|STARTED|Overall Study||52||
48499340|NCT00178711|101554470|FG001|STARTED|Overall Study||45||
48499341|NCT00178711|101554469|FG000|COMPLETED|Overall Study||52||
48499342|NCT00178711|101554470|FG001|COMPLETED|Overall Study||45||
48499343|NCT00178711|101554469|FG000|NOT COMPLETED|Overall Study||0||
48499344|NCT00178711|101554470|FG001|NOT COMPLETED|Overall Study||0||
48499345|NCT00958724|101554471|FG000|STARTED|Overall Study||6||
48499346|NCT00958724|101554471|FG000|COMPLETED|Overall Study||0||
48499347|NCT00958724|101554471|FG000|NOT COMPLETED|Overall Study||6||
48499348|NCT01004510|101554472|FG000|STARTED|Overall Study||3||
48499349|NCT01004510|101554472|FG000|COMPLETED|Overall Study||2||
48499350|NCT01004510|101554472|FG000|NOT COMPLETED|Overall Study||1||
48499351|NCT03718039|101554473|FG000|STARTED|Overall Study||30||
48499352|NCT03718039|101554474|FG001|STARTED|Overall Study||17||
48499353|NCT03718039|101554475|FG002|STARTED|Overall Study||31||
48499354|NCT03718039|101554473|FG000|COMPLETED|Overall Study||30||
48499355|NCT03718039|101554474|FG001|COMPLETED|Overall Study||17||
48499356|NCT03718039|101554475|FG002|COMPLETED|Overall Study||31||
48499357|NCT03718039|101554473|FG000|NOT COMPLETED|Overall Study||0||
48499358|NCT03718039|101554474|FG001|NOT COMPLETED|Overall Study||0||
48499359|NCT03718039|101554475|FG002|NOT COMPLETED|Overall Study||0||
48499360|NCT00469898|101557632|FG000|STARTED|Overall Study||50||
48499361|NCT00469898|101557632|FG000|COMPLETED|Overall Study||25||
48499362|NCT00469898|101557632|FG000|NOT COMPLETED|Overall Study||25||
48499363|NCT02372006|101557633|FG000|STARTED|Overall Study||8||
48499364|NCT02372006|101557634|FG001|STARTED|Overall Study||9||
48499365|NCT02372006|101557635|FG002|STARTED|Overall Study||39||
48499366|NCT02372006|101557633|FG000|COMPLETED|Overall Study||0||
48499367|NCT02372006|101557634|FG001|COMPLETED|Overall Study||0||
48499368|NCT02372006|101557635|FG002|COMPLETED|Overall Study||0||
48499369|NCT02372006|101557633|FG000|NOT COMPLETED|Overall Study||8||
48499370|NCT02372006|101557634|FG001|NOT COMPLETED|Overall Study||9||
48499371|NCT02372006|101557635|FG002|NOT COMPLETED|Overall Study||39||
48499372|NCT01891357|101557636|FG000|STARTED|Overall Study||64||
48499373|NCT01891357|101557636|FG000|COMPLETED|Overall Study||61||
48499374|NCT01891357|101557636|FG000|NOT COMPLETED|Overall Study||3||
48499375|NCT01653405|101557637|FG000|STARTED|Overall Study||11794||8
48499376|NCT01653405|101557638|FG001|STARTED|Overall Study||1248782||116
48499377|NCT01653405|101557637|FG000|COMPLETED|Overall Study||8029||8
48499378|NCT01653405|101557638|FG001|COMPLETED|Overall Study||179979||116
48499379|NCT01653405|101557637|FG000|NOT COMPLETED|Overall Study||3765||0
48499380|NCT01653405|101557638|FG001|NOT COMPLETED|Overall Study||1068803||0
48499381|NCT04968925|101557639|FG000|STARTED|Phase I- Period 1||35||
48499382|NCT04968925|101557640|FG001|STARTED|Phase I- Period 1||40||
48499383|NCT04968925|101557641|FG002|STARTED|Phase I- Period 1||0||
48499384|NCT04968925|101557642|FG003|STARTED|Phase I- Period 1||0||
48499385|NCT04968925|101557639|FG000|COMPLETED|Phase I- Period 1||34||
48499386|NCT04968925|101557640|FG001|COMPLETED|Phase I- Period 1||38||
48499387|NCT04968925|101557641|FG002|COMPLETED|Phase I- Period 1||0||
48499388|NCT04968925|101557642|FG003|COMPLETED|Phase I- Period 1||0||
48499389|NCT04968925|101557639|FG000|NOT COMPLETED|Phase I- Period 1||1||
48499390|NCT04968925|101557640|FG001|NOT COMPLETED|Phase I- Period 1||2||
48499391|NCT04968925|101557641|FG002|NOT COMPLETED|Phase I- Period 1||0||
48499392|NCT04968925|101557642|FG003|NOT COMPLETED|Phase I- Period 1||0||
48499393|NCT04968925|101557639|FG000|STARTED|Phase I- Period 2||34||
48499394|NCT04968925|101557640|FG001|STARTED|Phase I- Period 2||38||
48499395|NCT04968925|101557641|FG002|STARTED|Phase I- Period 2||0||
48499396|NCT04968925|101557642|FG003|STARTED|Phase I- Period 2||0||
48499397|NCT04968925|101557639|FG000|COMPLETED|Phase I- Period 2||34||
48499398|NCT04968925|101557640|FG001|COMPLETED|Phase I- Period 2||38||
48499399|NCT04968925|101557641|FG002|COMPLETED|Phase I- Period 2||0||
48499400|NCT04968925|101557642|FG003|COMPLETED|Phase I- Period 2||0||
48499401|NCT04968925|101557639|FG000|NOT COMPLETED|Phase I- Period 2||0||
48499402|NCT04968925|101557640|FG001|NOT COMPLETED|Phase I- Period 2||0||
48499403|NCT04968925|101557641|FG002|NOT COMPLETED|Phase I- Period 2||0||
48499404|NCT04968925|101557642|FG003|NOT COMPLETED|Phase I- Period 2||0||
48499405|NCT04968925|101557639|FG000|STARTED|Phase II- Period 1||0||
48499406|NCT04968925|101557640|FG001|STARTED|Phase II- Period 1||0||
48499407|NCT04968925|101557641|FG002|STARTED|Phase II- Period 1||112||
48499408|NCT04968925|101557642|FG003|STARTED|Phase II- Period 1||115||
48499409|NCT04968925|101557639|FG000|COMPLETED|Phase II- Period 1||0||
48499410|NCT04968925|101557640|FG001|COMPLETED|Phase II- Period 1||0||
48499411|NCT04968925|101557641|FG002|COMPLETED|Phase II- Period 1||105||
48499412|NCT04968925|101557642|FG003|COMPLETED|Phase II- Period 1||109||
48499413|NCT04968925|101557639|FG000|NOT COMPLETED|Phase II- Period 1||0||
48499414|NCT04968925|101557640|FG001|NOT COMPLETED|Phase II- Period 1||0||
48499415|NCT04968925|101557641|FG002|NOT COMPLETED|Phase II- Period 1||7||
48499416|NCT04968925|101557642|FG003|NOT COMPLETED|Phase II- Period 1||6||
48499417|NCT04968925|101557639|FG000|STARTED|Phase II -Period 2||0||
48499418|NCT04968925|101557640|FG001|STARTED|Phase II -Period 2||0||
48499419|NCT04968925|101557641|FG002|STARTED|Phase II -Period 2||105||
48499420|NCT04968925|101557642|FG003|STARTED|Phase II -Period 2||109||
48499421|NCT04968925|101557639|FG000|COMPLETED|Phase II -Period 2||0||
48499422|NCT04968925|101557640|FG001|COMPLETED|Phase II -Period 2||0||
48499423|NCT04968925|101557641|FG002|COMPLETED|Phase II -Period 2||101||
48499424|NCT04968925|101557642|FG003|COMPLETED|Phase II -Period 2||105||
48499425|NCT04968925|101557639|FG000|NOT COMPLETED|Phase II -Period 2||0||
48499426|NCT04968925|101557640|FG001|NOT COMPLETED|Phase II -Period 2||0||
48499427|NCT04968925|101557641|FG002|NOT COMPLETED|Phase II -Period 2||4||
48499428|NCT04968925|101557642|FG003|NOT COMPLETED|Phase II -Period 2||4||
48499429|NCT00406393|101557643|FG000|STARTED|Overall Study||151||
48499430|NCT00406393|101557644|FG001|STARTED|Overall Study||153||
48499431|NCT00406393|101557643|FG000|COMPLETED|Overall Study||149||
48499432|NCT00406393|101557644|FG001|COMPLETED|Overall Study||152||
48499433|NCT00406393|101557643|FG000|NOT COMPLETED|Overall Study||2||
48499434|NCT00406393|101557644|FG001|NOT COMPLETED|Overall Study||1||
48499435|NCT01189747|101557645|FG000|STARTED|Overall Study||222||
48499436|NCT01189747|101557646|FG001|STARTED|Overall Study||224||
48499437|NCT01189747|101557645|FG000|COMPLETED|Overall Study||210||
48499438|NCT01189747|101557646|FG001|COMPLETED|Overall Study||206||
48499439|NCT01189747|101557645|FG000|NOT COMPLETED|Overall Study||12||
48499440|NCT01189747|101557646|FG001|NOT COMPLETED|Overall Study||18||
48499441|NCT04200833|101557647|FG000|STARTED|Overall Study||10||
48499442|NCT04200833|101557647|FG000|COMPLETED|Overall Study||10||
48499443|NCT04200833|101557647|FG000|NOT COMPLETED|Overall Study||0||
48499444|NCT03224624|101557648|FG000|STARTED|Overall Study||60||
48499445|NCT03224624|101557649|FG001|STARTED|Overall Study||61||
48499446|NCT03224624|101557648|FG000|Baseline Visit|Overall Study||59|Loss to in-person baseline visits due to COVID-19|
48499447|NCT03224624|101557649|FG001|Baseline Visit|Overall Study||60|Loss to in-person baseline visits due to COVID-19|
48499448|NCT03224624|101557648|FG000|6 Month Visit Completed|Overall Study||50|some 6 month visits modified to telephone or passive follow-up due to COVID-19|
48499449|NCT03224624|101557649|FG001|6 Month Visit Completed|Overall Study||55|some 6 month visits modified to telephone or passive follow-up due to COVID-19|
48499450|NCT03224624|101557648|FG000|COMPLETED|Overall Study||50|some 12 month visits completed as telephone or passive followup due to COVID-19|
48499451|NCT03224624|101557649|FG001|COMPLETED|Overall Study||57|some 12 month visits completed as telephone or passive followup due to COVID-19|
48499452|NCT03224624|101557648|FG000|NOT COMPLETED|Overall Study||10||
48499453|NCT03224624|101557649|FG001|NOT COMPLETED|Overall Study||4||
48499454|NCT00999687|101557650|FG000|STARTED|First Intervention||31||
48499455|NCT00999687|101557650|FG000|COMPLETED|First Intervention||30||
48499456|NCT00999687|101557650|FG000|NOT COMPLETED|First Intervention||1||
48499457|NCT00999687|101557650|FG000|STARTED|Second Intervention||30||
48499458|NCT00999687|101557650|FG000|COMPLETED|Second Intervention||27||
48499459|NCT00999687|101557650|FG000|NOT COMPLETED|Second Intervention||3||
48499460|NCT02920476|101557651|FG000|STARTED|Overall Study||4||
48499461|NCT02920476|101557651|FG000|COMPLETED|Overall Study||3||
48499462|NCT02920476|101557651|FG000|NOT COMPLETED|Overall Study||1||
48499463|NCT03334734|101557652|FG000|STARTED|Overall Study||4||
48499464|NCT03334734|101557653|FG001|STARTED|Overall Study||4||
48499465|NCT03334734|101557654|FG002|STARTED|Overall Study||7||
48499466|NCT03334734|101557655|FG003|STARTED|Overall Study||1||
48499467|NCT03334734|101557652|FG000|COMPLETED|Overall Study||4||
48499468|NCT03334734|101557653|FG001|COMPLETED|Overall Study||4||
48499469|NCT03334734|101557654|FG002|COMPLETED|Overall Study||5||
48499470|NCT03334734|101557655|FG003|COMPLETED|Overall Study||1||
48499471|NCT03334734|101557652|FG000|NOT COMPLETED|Overall Study||0||
48499472|NCT03334734|101557653|FG001|NOT COMPLETED|Overall Study||0||
48499473|NCT03334734|101557654|FG002|NOT COMPLETED|Overall Study||2||
48499474|NCT03334734|101557655|FG003|NOT COMPLETED|Overall Study||0||
48499475|NCT00759707|101557656|FG000|STARTED|Overall Study||19||
48499476|NCT00759707|101557656|FG000|COMPLETED|Overall Study||19||
48499477|NCT00759707|101557656|FG000|NOT COMPLETED|Overall Study||0||
48499478|NCT03306277|101557657|FG000|STARTED|Overall Study||22||
48499479|NCT03306277|101557657|FG000|COMPLETED|Overall Study||19||
48499480|NCT03306277|101557657|FG000|NOT COMPLETED|Overall Study||3||
48499481|NCT00748566|101557658|FG000|STARTED|Overall Study||172||
48499482|NCT00748566|101557658|FG000|COMPLETED|Overall Study||60||
48499483|NCT00748566|101557658|FG000|NOT COMPLETED|Overall Study||112||
48499484|NCT02811003|101557659|FG000|STARTED|Overall Study||20||
48499485|NCT02811003|101557659|FG000|COMPLETED|Overall Study||15||
48499486|NCT02811003|101557659|FG000|NOT COMPLETED|Overall Study||5||
48499487|NCT01282086|101557660|FG000|STARTED|Overall Study||1365||
48499488|NCT01282086|101557660|FG000|COMPLETED|Overall Study||1365||
48499489|NCT01282086|101557660|FG000|NOT COMPLETED|Overall Study||0||
48499490|NCT01986647|101557661|FG000|STARTED|Overall Study||152||
48499491|NCT01986647|101557662|FG001|STARTED|Overall Study||146||
48499492|NCT01986647|101557663|FG002|STARTED|Overall Study||49||
48499493|NCT01986647|101557664|FG003|STARTED|Overall Study||77||
48499494|NCT01986647|101557661|FG000|COMPLETED|Overall Study||142||
48499495|NCT01986647|101557662|FG001|COMPLETED|Overall Study||139||
48499496|NCT01986647|101557663|FG002|COMPLETED|Overall Study||37||
48499497|NCT01986647|101557664|FG003|COMPLETED|Overall Study||66||
48499498|NCT01986647|101557661|FG000|NOT COMPLETED|Overall Study||10||
48499499|NCT01986647|101557662|FG001|NOT COMPLETED|Overall Study||7||
48499500|NCT01986647|101557663|FG002|NOT COMPLETED|Overall Study||12||
48499501|NCT01986647|101557664|FG003|NOT COMPLETED|Overall Study||11||
48499502|NCT04224753|101557665|FG000|STARTED|Overall Study||51||
48499503|NCT04224753|101557665|FG000|COMPLETED|Overall Study||51||
48499504|NCT04224753|101557665|FG000|NOT COMPLETED|Overall Study||0||
48499505|NCT00642811|101557666|FG000|STARTED|Overall Study||20||
48499506|NCT00642811|101557667|FG001|STARTED|Overall Study||21||
48499507|NCT00642811|101557668|FG002|STARTED|Overall Study||13||
48499508|NCT00642811|101557669|FG003|STARTED|Overall Study||16||
48499509|NCT00642811|101557670|FG004|STARTED|Overall Study||14||
48499510|NCT00642811|101557671|FG005|STARTED|Overall Study||14||
48499511|NCT00642811|101557666|FG000|COMPLETED|Overall Study||17||
48499512|NCT00642811|101557667|FG001|COMPLETED|Overall Study||17||
48499513|NCT00642811|101557668|FG002|COMPLETED|Overall Study||13||
48499514|NCT00642811|101557669|FG003|COMPLETED|Overall Study||15||
48499515|NCT00642811|101557670|FG004|COMPLETED|Overall Study||13||
48499516|NCT00642811|101557671|FG005|COMPLETED|Overall Study||13||
48499517|NCT00642811|101557666|FG000|NOT COMPLETED|Overall Study||3||
48499518|NCT00642811|101557667|FG001|NOT COMPLETED|Overall Study||4||
48499519|NCT00642811|101557668|FG002|NOT COMPLETED|Overall Study||0||
48499520|NCT00642811|101557669|FG003|NOT COMPLETED|Overall Study||1||
48499521|NCT00642811|101557670|FG004|NOT COMPLETED|Overall Study||1||
48499522|NCT00642811|101557671|FG005|NOT COMPLETED|Overall Study||1||
48499523|NCT02911909|101557672|FG000|STARTED|Overall Study||4||
48499524|NCT02911909|101557673|FG001|STARTED|Overall Study||3||
48499525|NCT02911909|101557672|FG000|COMPLETED|Overall Study||2||
48499526|NCT02911909|101557673|FG001|COMPLETED|Overall Study||0||
48499527|NCT02911909|101557672|FG000|NOT COMPLETED|Overall Study||2||
48499528|NCT02911909|101557673|FG001|NOT COMPLETED|Overall Study||3||
48499529|NCT02670551|101557674|FG000|STARTED|Overall Study||163||
48499530|NCT02670551|101557675|FG001|STARTED|Overall Study||160||
48499531|NCT02670551|101557676|FG002|STARTED|Overall Study||165||
48499532|NCT02670551|101557674|FG000|Received Treatment (Safety Population)|Overall Study||158||
48499533|NCT02670551|101557675|FG001|Received Treatment (Safety Population)|Overall Study||157||
48499534|NCT02670551|101557676|FG002|Received Treatment (Safety Population)|Overall Study||165||
48499535|NCT02670551|101557674|FG000|COMPLETED|Overall Study||135||
48499536|NCT02670551|101557675|FG001|COMPLETED|Overall Study||134||
48499537|NCT02670551|101557676|FG002|COMPLETED|Overall Study||134||
48499538|NCT02670551|101557674|FG000|NOT COMPLETED|Overall Study||28||
48499539|NCT02670551|101557675|FG001|NOT COMPLETED|Overall Study||26||
48499540|NCT02670551|101557676|FG002|NOT COMPLETED|Overall Study||31||
48499541|NCT01685008|101557677|FG000|STARTED|Main Study Treatment (Cycles 1 - 2)||34||
48499542|NCT01685008|101557678|FG001|STARTED|Main Study Treatment (Cycles 1 - 2)||35||
48499543|NCT01685008|101557679|FG002|STARTED|Main Study Treatment (Cycles 1 - 2)||12||
48499544|NCT01685008|101557680|FG003|STARTED|Main Study Treatment (Cycles 1 - 2)||11||
48499545|NCT01685008|101557677|FG000|COMPLETED|Main Study Treatment (Cycles 1 - 2)||30|Patients were considered to have completed the study if they finished the first 2 cycles of treatment plus the end of cycle 2 assessments.|
48499546|NCT01685008|101557678|FG001|COMPLETED|Main Study Treatment (Cycles 1 - 2)||25|Patients were considered to have completed the study if they finished the first 2 cycles of treatment plus the end of cycle 2 assessments.|
48499547|NCT01685008|101557679|FG002|COMPLETED|Main Study Treatment (Cycles 1 - 2)||10|Patients were considered to have completed the study if they finished the first 2 cycles of treatment plus the end of cycle 2 assessments.|
48499548|NCT01685008|101557680|FG003|COMPLETED|Main Study Treatment (Cycles 1 - 2)||10|Patients were considered to have completed the study if they finished the first 2 cycles of treatment plus the end of cycle 2 assessments.|
48499549|NCT01685008|101557677|FG000|NOT COMPLETED|Main Study Treatment (Cycles 1 - 2)||4||
48499550|NCT01685008|101557678|FG001|NOT COMPLETED|Main Study Treatment (Cycles 1 - 2)||10||
48499551|NCT01685008|101557679|FG002|NOT COMPLETED|Main Study Treatment (Cycles 1 - 2)||2||
48499552|NCT01685008|101557680|FG003|NOT COMPLETED|Main Study Treatment (Cycles 1 - 2)||1||
48499553|NCT01685008|101557677|FG000|STARTED|Cycle 3 and Maintenance Treatment||30|Includes all patients that completed the first 2 cycles of treatment.|
48499554|NCT01685008|101557678|FG001|STARTED|Cycle 3 and Maintenance Treatment||25|Includes all patients that completed the first 2 cycles of treatment.|
48499555|NCT01685008|101557679|FG002|STARTED|Cycle 3 and Maintenance Treatment||10|Includes all patients that completed the first 2 cycles of treatment.|
48499556|NCT01685008|101557680|FG003|STARTED|Cycle 3 and Maintenance Treatment||10|Includes all patients that completed the first 2 cycles of treatment.|
48499557|NCT01685008|101557677|FG000|Began Cycle 3 Treatment|Cycle 3 and Maintenance Treatment||25||
48499558|NCT01685008|101557678|FG001|Began Cycle 3 Treatment|Cycle 3 and Maintenance Treatment||13||
48499559|NCT01685008|101557679|FG002|Began Cycle 3 Treatment|Cycle 3 and Maintenance Treatment||5||
48499560|NCT01685008|101557680|FG003|Began Cycle 3 Treatment|Cycle 3 and Maintenance Treatment||7||
48499561|NCT01685008|101557677|FG000|Entered Maintenance Phase Treatment|Cycle 3 and Maintenance Treatment||8||
48499562|NCT01685008|101557678|FG001|Entered Maintenance Phase Treatment|Cycle 3 and Maintenance Treatment||6||
48499563|NCT01685008|101557679|FG002|Entered Maintenance Phase Treatment|Cycle 3 and Maintenance Treatment||0||
48499564|NCT01685008|101557680|FG003|Entered Maintenance Phase Treatment|Cycle 3 and Maintenance Treatment||2||
48499565|NCT01685008|101557677|FG000|COMPLETED|Cycle 3 and Maintenance Treatment||0||
48499566|NCT01685008|101557678|FG001|COMPLETED|Cycle 3 and Maintenance Treatment||1||
48499567|NCT01685008|101557679|FG002|COMPLETED|Cycle 3 and Maintenance Treatment||0||
48499568|NCT01685008|101557680|FG003|COMPLETED|Cycle 3 and Maintenance Treatment||0||
48499569|NCT01685008|101557677|FG000|NOT COMPLETED|Cycle 3 and Maintenance Treatment||30||
48499570|NCT01685008|101557678|FG001|NOT COMPLETED|Cycle 3 and Maintenance Treatment||24||
48499571|NCT01685008|101557679|FG002|NOT COMPLETED|Cycle 3 and Maintenance Treatment||10||
48499572|NCT01685008|101557680|FG003|NOT COMPLETED|Cycle 3 and Maintenance Treatment||10||
48499573|NCT01859637|101557681|FG000|STARTED|Overall Study||6||
48499574|NCT01859637|101557681|FG000|COMPLETED|Overall Study||6||
48499575|NCT01859637|101557681|FG000|NOT COMPLETED|Overall Study||0||
48499576|NCT04145635|101557682|FG000|STARTED|Overall Study||21||
48499577|NCT04145635|101557682|FG000|COMPLETED|Overall Study||18||
48499578|NCT04145635|101557682|FG000|NOT COMPLETED|Overall Study||3||
48499579|NCT00826241|101557683|FG000|STARTED|Overall Study||58||
48499580|NCT00826241|101557683|FG000|COMPLETED|Overall Study||31||
48499581|NCT00826241|101557683|FG000|NOT COMPLETED|Overall Study||27||
48499582|NCT05014438|101557684|FG000|STARTED|Overall Study||4||
48499583|NCT05014438|101557685|FG001|STARTED|Overall Study||3||
48499584|NCT05014438|101557686|FG002|STARTED|Overall Study||4||
48499585|NCT05014438|101557687|FG003|STARTED|Overall Study||3||
48499586|NCT05014438|101557688|FG004|STARTED|Overall Study||3||
48499587|NCT05014438|101557684|FG000|COMPLETED|Overall Study||3||
48499588|NCT05014438|101557685|FG001|COMPLETED|Overall Study||3||
48499589|NCT05014438|101557686|FG002|COMPLETED|Overall Study||3||
48499590|NCT05014438|101557687|FG003|COMPLETED|Overall Study||1||
48499591|NCT05014438|101557688|FG004|COMPLETED|Overall Study||3||
48499592|NCT05014438|101557684|FG000|NOT COMPLETED|Overall Study||1||
48499593|NCT05014438|101557685|FG001|NOT COMPLETED|Overall Study||0||
48499594|NCT05014438|101557686|FG002|NOT COMPLETED|Overall Study||1||
48499595|NCT05014438|101557687|FG003|NOT COMPLETED|Overall Study||2||
48499596|NCT05014438|101557688|FG004|NOT COMPLETED|Overall Study||0||
48499597|NCT02167594|101557689|FG000|STARTED|Overall Study||20||
48499598|NCT02167594|101557690|FG001|STARTED|Overall Study||6||
48499599|NCT02167594|101557691|FG002|STARTED|Overall Study||3||
48499600|NCT02167594|101557689|FG000|COMPLETED|Overall Study||18|Completed = 9 month flortaucipir PET scan acquired|
48499601|NCT02167594|101557690|FG001|COMPLETED|Overall Study||5|Completed = 9 month flortaucipir PET scan acquired|
48499602|NCT02167594|101557691|FG002|COMPLETED|Overall Study||3|Completed = 9 month flortaucipir PET scan acquired|
48499603|NCT02167594|101557689|FG000|NOT COMPLETED|Overall Study||2||
48499604|NCT02167594|101557690|FG001|NOT COMPLETED|Overall Study||1||
48499605|NCT02167594|101557691|FG002|NOT COMPLETED|Overall Study||0||
48499606|NCT02795858|101557692|FG000|STARTED|Overall Study||43||
48499607|NCT02795858|101557692|FG000|COMPLETED|Overall Study||43||
48499608|NCT02795858|101557692|FG000|NOT COMPLETED|Overall Study||0||
48499609|NCT00876265|101557693|FG000|STARTED|Overall Study||118||
48499610|NCT00876265|101557693|FG000|COMPLETED|Overall Study||106||
48499611|NCT00876265|101557693|FG000|NOT COMPLETED|Overall Study||12||
48499612|NCT02957331|101557694|FG000|STARTED|Overall Study||14||
48499613|NCT02957331|101557695|FG001|STARTED|Overall Study||12||
48499614|NCT02957331|101557694|FG000|COMPLETED|Overall Study||13||
48499615|NCT02957331|101557695|FG001|COMPLETED|Overall Study||12||
48499616|NCT02957331|101557694|FG000|NOT COMPLETED|Overall Study||1||
48499617|NCT02957331|101557695|FG001|NOT COMPLETED|Overall Study||0||
48499618|NCT01598896|101557696|FG000|STARTED|Overall Study||3||
48499619|NCT01598896|101557697|FG001|STARTED|Overall Study||4||
48499620|NCT01598896|101557696|FG000|COMPLETED|Overall Study||3||
48499621|NCT01598896|101557697|FG001|COMPLETED|Overall Study||2||
48499622|NCT01598896|101557696|FG000|NOT COMPLETED|Overall Study||0||
48499623|NCT01598896|101557697|FG001|NOT COMPLETED|Overall Study||2||
48499624|NCT01694563|101557698|FG000|STARTED|Overall Study||365||
48499625|NCT01694563|101557698|FG000|COMPLETED|Overall Study||278||
48499626|NCT01694563|101557698|FG000|NOT COMPLETED|Overall Study||87||
48499627|NCT01590563|101557699|FG000|STARTED|Overall Study||15||
48499628|NCT01590563|101557699|FG000|COMPLETED|Overall Study||14||
48499629|NCT01590563|101557699|FG000|NOT COMPLETED|Overall Study||1||
48499630|NCT02109458|101557700|FG000|STARTED|Overall Study||24||
48499631|NCT02109458|101557700|FG000|COMPLETED|Overall Study||24||
48499632|NCT02109458|101557700|FG000|NOT COMPLETED|Overall Study||0||
48499633|NCT02416934|101557701|FG000|STARTED|Overall Study||36||
48499634|NCT02416934|101557702|FG001|STARTED|Overall Study||38||
48499635|NCT02416934|101557701|FG000|Double Blind (0-52 Weeks)|Overall Study||36||
48499636|NCT02416934|101557702|FG001|Double Blind (0-52 Weeks)|Overall Study||38||
48499637|NCT02416934|101557701|FG000|Last Participant Completed 1 yr|Overall Study||33||
48499638|NCT02416934|101557702|FG001|Last Participant Completed 1 yr|Overall Study||31||
48499639|NCT02416934|101557701|FG000|COMPLETED|Overall Study||33||
48499640|NCT02416934|101557702|FG001|COMPLETED|Overall Study||31||
48499641|NCT02416934|101557701|FG000|NOT COMPLETED|Overall Study||3||
48499642|NCT02416934|101557702|FG001|NOT COMPLETED|Overall Study||7||
48499643|NCT00466167|101557703|FG000|STARTED|Overall Study||165||
48499644|NCT00466167|101557704|FG001|STARTED|Overall Study||175||
48499645|NCT00466167|101557705|FG002|STARTED|Overall Study||178||
48499646|NCT00466167|101557703|FG000|COMPLETED|Overall Study||145||
48499647|NCT00466167|101557704|FG001|COMPLETED|Overall Study||163||
48499648|NCT00466167|101557705|FG002|COMPLETED|Overall Study||157||
48499649|NCT00466167|101557703|FG000|NOT COMPLETED|Overall Study||20||
48499650|NCT00466167|101557704|FG001|NOT COMPLETED|Overall Study||12||
48499651|NCT00466167|101557705|FG002|NOT COMPLETED|Overall Study||21||
48499652|NCT00059332|101557706|FG000|STARTED|Overall Study||843||
48499653|NCT00059332|101557707|FG001|STARTED|Overall Study||857||
48499654|NCT00059332|101557706|FG000|COMPLETED|Overall Study||840||
48499655|NCT00059332|101557707|FG001|COMPLETED|Overall Study||855||
48499656|NCT00059332|101557706|FG000|NOT COMPLETED|Overall Study||3||
48499657|NCT00059332|101557707|FG001|NOT COMPLETED|Overall Study||2||
48499658|NCT03544242|101557708|FG000|STARTED|Overall Study||1||
48499659|NCT03544242|101557709|FG001|STARTED|Overall Study||1||
48499660|NCT03544242|101557710|FG002|STARTED|Overall Study||2||
48499661|NCT03544242|101557708|FG000|COMPLETED|Overall Study||1||
48499662|NCT03544242|101557709|FG001|COMPLETED|Overall Study||1||
48499663|NCT03544242|101557710|FG002|COMPLETED|Overall Study||2||
48499664|NCT03544242|101557708|FG000|NOT COMPLETED|Overall Study||0||
48499665|NCT03544242|101557709|FG001|NOT COMPLETED|Overall Study||0||
48499666|NCT03544242|101557710|FG002|NOT COMPLETED|Overall Study||0||
48499667|NCT01328782|101557711|FG000|STARTED|Overall Study||43||
48499668|NCT01328782|101557712|FG001|STARTED|Overall Study||42||
48499669|NCT01328782|101557713|FG002|STARTED|Overall Study||39||
48499670|NCT01328782|101557711|FG000|COMPLETED|Overall Study||43||
48499671|NCT01328782|101557712|FG001|COMPLETED|Overall Study||42||
48499672|NCT01328782|101557713|FG002|COMPLETED|Overall Study||39||
48499673|NCT01328782|101557711|FG000|NOT COMPLETED|Overall Study||0||
48499674|NCT01328782|101557712|FG001|NOT COMPLETED|Overall Study||0||
48499675|NCT01328782|101557713|FG002|NOT COMPLETED|Overall Study||0||
48499676|NCT00508651|101557714|FG000|STARTED|Overall Study||20||
48499677|NCT00508651|101557715|FG001|STARTED|Overall Study||10||
48499678|NCT00508651|101557714|FG000|COMPLETED|Overall Study||16||
48499679|NCT00508651|101557715|FG001|COMPLETED|Overall Study||8||
48499680|NCT00508651|101557714|FG000|NOT COMPLETED|Overall Study||4||
48499681|NCT00508651|101557715|FG001|NOT COMPLETED|Overall Study||2||
48499682|NCT00845130|101557716|FG000|STARTED|Overall Study||20||
48499683|NCT00845130|101557717|FG001|STARTED|Overall Study||22||
48499684|NCT00845130|101557716|FG000|COMPLETED|Overall Study||16||
48499685|NCT00845130|101557717|FG001|COMPLETED|Overall Study||19||
48499686|NCT00845130|101557716|FG000|NOT COMPLETED|Overall Study||4||
48499687|NCT00845130|101557717|FG001|NOT COMPLETED|Overall Study||3||
48499688|NCT01085539|101557718|FG000|STARTED|Sat Secs Off--No Alarm Evaluation||50||
48499689|NCT01085539|101557718|FG000|COMPLETED|Sat Secs Off--No Alarm Evaluation||50||
48499690|NCT01085539|101557718|FG000|NOT COMPLETED|Sat Secs Off--No Alarm Evaluation||0||
48499691|NCT01085539|101557718|FG000|STARTED|10 Sat Secs--10 Second Alarm Evaluation||50||
48499692|NCT01085539|101557718|FG000|COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||50||
48499693|NCT01085539|101557718|FG000|NOT COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||0||
48499694|NCT01085539|101557718|FG000|STARTED|25 Sat Secs--25 Second Alarm Evaluation||50||
48499695|NCT01085539|101557718|FG000|COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||50||
48499696|NCT01085539|101557718|FG000|NOT COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||0||
48499697|NCT01085539|101557718|FG000|STARTED|50 Sat Secs--50 Second Alarm Evaluation||50||
48499698|NCT01085539|101557718|FG000|COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||50||
48499699|NCT01085539|101557718|FG000|NOT COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||0||
48499700|NCT01085539|101557718|FG000|STARTED|100Sat Secs-100 Second Alarm Evaluation||50||
48499701|NCT01085539|101557718|FG000|COMPLETED|100Sat Secs-100 Second Alarm Evaluation||50||
48499702|NCT01085539|101557718|FG000|NOT COMPLETED|100Sat Secs-100 Second Alarm Evaluation||0||
48666750|NCT03391882|101970467|FG002|COMPLETED|Part A - Titration Phase||19|Part A|
48666751|NCT03391882|101970468|FG003|COMPLETED|Part A - Titration Phase||18|Part A|
48499703|NCT02050321|101557719|FG000|STARTED|Overall Study||2||
48499704|NCT02050321|101557719|FG000|COMPLETED|Overall Study||0||
48499705|NCT02050321|101557719|FG000|NOT COMPLETED|Overall Study||2||
48499706|NCT00974350|101557720|FG000|STARTED|Overall Study||45||
48499707|NCT00974350|101557721|FG001|STARTED|Overall Study||47||
48499708|NCT00974350|101557722|FG002|STARTED|Overall Study||32||
48499709|NCT00974350|101557720|FG000|COMPLETED|Overall Study||42||
48499710|NCT00974350|101557721|FG001|COMPLETED|Overall Study||47||
48499711|NCT00974350|101557722|FG002|COMPLETED|Overall Study||31||
48499712|NCT00974350|101557720|FG000|NOT COMPLETED|Overall Study||3||
48499713|NCT00974350|101557721|FG001|NOT COMPLETED|Overall Study||0||
48499714|NCT00974350|101557722|FG002|NOT COMPLETED|Overall Study||1||
48499715|NCT00757172|101557723|FG000|STARTED|Overall Study||65||
48499716|NCT00757172|101557723|FG000|COMPLETED|Overall Study||54||
48499717|NCT00757172|101557723|FG000|NOT COMPLETED|Overall Study||11||
48499718|NCT04179396|101557724|FG000|STARTED|Overall Study||8||
48499719|NCT04179396|101557725|FG001|STARTED|Overall Study||0||
48499720|NCT04179396|101557724|FG000|COMPLETED|Overall Study||8||
48499721|NCT04179396|101557725|FG001|COMPLETED|Overall Study||0||
48499722|NCT04179396|101557724|FG000|NOT COMPLETED|Overall Study||0||
48499723|NCT04179396|101557725|FG001|NOT COMPLETED|Overall Study||0||
48499724|NCT01151618|101557726|FG000|STARTED|Overall Study||22||
48499725|NCT01151618|101557726|FG000|COMPLETED|Overall Study||13||
48499726|NCT01151618|101557726|FG000|NOT COMPLETED|Overall Study||9||
48499727|NCT03082586|101557727|FG000|STARTED|Overall Study||3||
48499728|NCT03082586|101557728|FG001|STARTED|Overall Study||3||
48499729|NCT03082586|101557729|FG002|STARTED|Overall Study||3||
48499730|NCT03082586|101557730|FG003|STARTED|Overall Study||6||
48499731|NCT03082586|101557731|FG004|STARTED|Overall Study||13||
48499732|NCT03082586|101557732|FG005|STARTED|Overall Study||3||
48499733|NCT03082586|101557727|FG000|COMPLETED|Overall Study||3||
48499734|NCT03082586|101557728|FG001|COMPLETED|Overall Study||3||
48499735|NCT03082586|101557729|FG002|COMPLETED|Overall Study||3||
48499736|NCT03082586|101557730|FG003|COMPLETED|Overall Study||6||
48499737|NCT03082586|101557731|FG004|COMPLETED|Overall Study||13||
48499738|NCT03082586|101557732|FG005|COMPLETED|Overall Study||3||
48499739|NCT03082586|101557727|FG000|NOT COMPLETED|Overall Study||0||
48499740|NCT03082586|101557728|FG001|NOT COMPLETED|Overall Study||0||
48499741|NCT03082586|101557729|FG002|NOT COMPLETED|Overall Study||0||
48499742|NCT03082586|101557730|FG003|NOT COMPLETED|Overall Study||0||
48499743|NCT03082586|101557731|FG004|NOT COMPLETED|Overall Study||0||
48499744|NCT03082586|101557732|FG005|NOT COMPLETED|Overall Study||0||
48499745|NCT02845336|101557733|FG000|STARTED|Overall Study||6||
48499746|NCT02845336|101557734|FG001|STARTED|Overall Study||1||
48499747|NCT02845336|101557733|FG000|COMPLETED|Overall Study||1||
48499748|NCT02845336|101557734|FG001|COMPLETED|Overall Study||0||
48499749|NCT02845336|101557733|FG000|NOT COMPLETED|Overall Study||5||
48499750|NCT02845336|101557734|FG001|NOT COMPLETED|Overall Study||1||
48499751|NCT00884390|101557735|FG000|STARTED|Overall Study||146||
48499752|NCT00884390|101557736|FG001|STARTED|Overall Study||62||
48499753|NCT00884390|101557735|FG000|COMPLETED|Overall Study||123||
48499754|NCT00884390|101557736|FG001|COMPLETED|Overall Study||54||
48499755|NCT00884390|101557735|FG000|NOT COMPLETED|Overall Study||23||
48499756|NCT00884390|101557736|FG001|NOT COMPLETED|Overall Study||8||
48499757|NCT04207333|101557737|FG000|STARTED|First Intervention (Single 1-Day Visit)||3||
48499758|NCT04207333|101557738|FG001|STARTED|First Intervention (Single 1-Day Visit)||3||
48499759|NCT04207333|101557737|FG000|COMPLETED|First Intervention (Single 1-Day Visit)||3||
48499760|NCT04207333|101557738|FG001|COMPLETED|First Intervention (Single 1-Day Visit)||3||
48499761|NCT04207333|101557737|FG000|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0||
48499762|NCT04207333|101557738|FG001|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0||
48499763|NCT04207333|101557737|FG000|STARTED|Washout (2-7 Days)||3||
48499764|NCT04207333|101557738|FG001|STARTED|Washout (2-7 Days)||3||
48499765|NCT04207333|101557737|FG000|COMPLETED|Washout (2-7 Days)||3||
48499766|NCT04207333|101557738|FG001|COMPLETED|Washout (2-7 Days)||3||
48499767|NCT04207333|101557737|FG000|NOT COMPLETED|Washout (2-7 Days)||0||
48499768|NCT04207333|101557738|FG001|NOT COMPLETED|Washout (2-7 Days)||0||
48499769|NCT04207333|101557737|FG000|STARTED|Second Intervention (Single 1-Day Visit)||3||
48499770|NCT04207333|101557738|FG001|STARTED|Second Intervention (Single 1-Day Visit)||3||
48499771|NCT04207333|101557737|FG000|COMPLETED|Second Intervention (Single 1-Day Visit)||3||
48499772|NCT04207333|101557738|FG001|COMPLETED|Second Intervention (Single 1-Day Visit)||3||
48499773|NCT04207333|101557737|FG000|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0||
48499774|NCT04207333|101557738|FG001|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0||
48499775|NCT02155257|101557739|FG000|STARTED|Overall Study||10||
48499776|NCT02155257|101557740|FG001|STARTED|Overall Study||10||
48499777|NCT02155257|101557741|FG002|STARTED|Overall Study||10||
48499778|NCT02155257|101557739|FG000|COMPLETED|Overall Study||10||
48499779|NCT02155257|101557740|FG001|COMPLETED|Overall Study||10||
48499780|NCT02155257|101557741|FG002|COMPLETED|Overall Study||10||
48499781|NCT02155257|101557739|FG000|NOT COMPLETED|Overall Study||0||
48499782|NCT02155257|101557740|FG001|NOT COMPLETED|Overall Study||0||
48499783|NCT02155257|101557741|FG002|NOT COMPLETED|Overall Study||0||
48499784|NCT03279250|101557742|FG000|STARTED|Overall Study||34||
48499785|NCT03279250|101557743|FG001|STARTED|Overall Study||34||
48499786|NCT03279250|101557742|FG000|COMPLETED|Overall Study||34||
48499787|NCT03279250|101557743|FG001|COMPLETED|Overall Study||34||
48499788|NCT03279250|101557742|FG000|NOT COMPLETED|Overall Study||0||
48499789|NCT03279250|101557743|FG001|NOT COMPLETED|Overall Study||0||
48499790|NCT03980522|101557744|FG000|STARTED|Treatment Period||13||
48499791|NCT03980522|101557745|FG001|STARTED|Treatment Period||3||
48499792|NCT03980522|101557746|FG002|STARTED|Treatment Period||6||
48499793|NCT03980522|101557747|FG003|STARTED|Treatment Period||1||
48499794|NCT03980522|101557748|FG004|STARTED|Treatment Period||3||
48499795|NCT03980522|101557744|FG000|COMPLETED|Treatment Period||12||
48499796|NCT03980522|101557745|FG001|COMPLETED|Treatment Period||3||
48499797|NCT03980522|101557746|FG002|COMPLETED|Treatment Period||6||
48499798|NCT03980522|101557747|FG003|COMPLETED|Treatment Period||1||
48499799|NCT03980522|101557748|FG004|COMPLETED|Treatment Period||3||
48499800|NCT03980522|101557744|FG000|NOT COMPLETED|Treatment Period||1||
48499801|NCT03980522|101557745|FG001|NOT COMPLETED|Treatment Period||0||
48499802|NCT03980522|101557746|FG002|NOT COMPLETED|Treatment Period||0||
48499803|NCT03980522|101557747|FG003|NOT COMPLETED|Treatment Period||0||
48499804|NCT03980522|101557748|FG004|NOT COMPLETED|Treatment Period||0||
48499805|NCT03980522|101557744|FG000|STARTED|Extension Period||12||
48499806|NCT03980522|101557745|FG001|STARTED|Extension Period||3||
48499807|NCT03980522|101557746|FG002|STARTED|Extension Period||5||
48499808|NCT03980522|101557747|FG003|STARTED|Extension Period||1||
48499809|NCT03980522|101557748|FG004|STARTED|Extension Period||3||
48499810|NCT03980522|101557744|FG000|COMPLETED|Extension Period||12||
48499811|NCT03980522|101557745|FG001|COMPLETED|Extension Period||3||
48499812|NCT03980522|101557746|FG002|COMPLETED|Extension Period||5||
48499813|NCT03980522|101557747|FG003|COMPLETED|Extension Period||1||
48499814|NCT03980522|101557748|FG004|COMPLETED|Extension Period||3||
48499815|NCT03980522|101557744|FG000|NOT COMPLETED|Extension Period||0||
48499816|NCT03980522|101557745|FG001|NOT COMPLETED|Extension Period||0||
48499817|NCT03980522|101557746|FG002|NOT COMPLETED|Extension Period||0||
48499818|NCT03980522|101557747|FG003|NOT COMPLETED|Extension Period||0||
48499819|NCT03980522|101557748|FG004|NOT COMPLETED|Extension Period||0||
48499820|NCT03201003|101557749|FG000|STARTED|Overall Study||132||
48499821|NCT03201003|101557750|FG001|STARTED|Overall Study||43||
48499822|NCT03201003|101557749|FG000|COMPLETED|Overall Study||106||
48499823|NCT03201003|101557750|FG001|COMPLETED|Overall Study||40||
48499824|NCT03201003|101557749|FG000|NOT COMPLETED|Overall Study||26||
48499825|NCT03201003|101557750|FG001|NOT COMPLETED|Overall Study||3||
48499826|NCT00252564|101557751|FG000|STARTED|Overall Study||124||
48499827|NCT00252564|101557752|FG001|STARTED|Overall Study||123||
48499828|NCT00252564|101557751|FG000|COMPLETED|Overall Study||85||
48499829|NCT00252564|101557752|FG001|COMPLETED|Overall Study||79||
48499830|NCT00252564|101557751|FG000|NOT COMPLETED|Overall Study||39||
48499831|NCT00252564|101557752|FG001|NOT COMPLETED|Overall Study||44||
48499832|NCT00721162|101557753|FG000|STARTED|Overall Study||60||
48499833|NCT00721162|101557753|FG000|Received Any Amount of Study Drug|Overall Study||60||
48499834|NCT00721162|101557753|FG000|COMPLETED|Overall Study||60||
48499835|NCT00721162|101557753|FG000|NOT COMPLETED|Overall Study||0||
48499836|NCT01127087|101557754|FG000|STARTED|Overall Study||8||
48499837|NCT01127087|101557755|FG001|STARTED|Overall Study||2||
48499838|NCT01127087|101557754|FG000|COMPLETED|Overall Study||8||
48499839|NCT01127087|101557755|FG001|COMPLETED|Overall Study||2||
48499840|NCT01127087|101557754|FG000|NOT COMPLETED|Overall Study||0||
48499841|NCT01127087|101557755|FG001|NOT COMPLETED|Overall Study||0||
48499842|NCT01970592|101557756|FG000|STARTED|Overall Study||56||
48499843|NCT01970592|101557756|FG000|COMPLETED|Overall Study||50|Completed all training sessions|
48499844|NCT01970592|101557756|FG000|NOT COMPLETED|Overall Study||6||
48499845|NCT03828539|101557757|FG000|STARTED|Overall Study||389|All patients who received a randomization number, regardless of receiving study medication were included in the Randomized Set|
48499846|NCT03828539|101557758|FG001|STARTED|Overall Study||388|All patients who received a randomization number, regardless of receiving study medication were included in the Randomized Set|
48499847|NCT03828539|101557757|FG000|Full Analysis Set (FAS)|Overall Study||388|All patients who received at least one dose of active study medication. In FAS, patients were analyzed according to randomized treatment, regardless of the actual treatment received.|
48499848|NCT03828539|101557758|FG001|Full Analysis Set (FAS)|Overall Study||388|All patients who received at least one dose of active study medication. In FAS, patients were analyzed according to randomized treatment, regardless of the actual treatment received.|
48499849|NCT03828539|101557757|FG000|Safety Analysis Set (SAF)|Overall Study||388|All randomized patients who received at least one dose of active study medication. In the SAF, patients were analyzed based on actual treatment received.|
48499850|NCT03828539|101557758|FG001|Safety Analysis Set (SAF)|Overall Study||388|All randomized patients who received at least one dose of active study medication. In the SAF, patients were analyzed based on actual treatment received.|
48499851|NCT03828539|101557757|FG000|COMPLETED|Overall Study||373||
48499852|NCT03828539|101557758|FG001|COMPLETED|Overall Study||366||
48499853|NCT03828539|101557757|FG000|NOT COMPLETED|Overall Study||16||
48499854|NCT03828539|101557758|FG001|NOT COMPLETED|Overall Study||22||
48499855|NCT03124758|101557759|FG000|STARTED|Overall Study||354||
48499856|NCT03124758|101557759|FG000|COMPLETED|Overall Study||354||
48499857|NCT03124758|101557759|FG000|NOT COMPLETED|Overall Study||0||
48499858|NCT05053360|101557760|FG000|STARTED|Overall Study||105||
48499859|NCT05053360|101557761|FG001|STARTED|Overall Study||105||
48061062|NCT01193842|100470337|FG004|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0||
48499860|NCT05053360|101557760|FG000|COMPLETED|Overall Study||74||
48499861|NCT05053360|101557761|FG001|COMPLETED|Overall Study||55||
48499862|NCT05053360|101557760|FG000|NOT COMPLETED|Overall Study||31||
48499863|NCT05053360|101557761|FG001|NOT COMPLETED|Overall Study||50||
48499864|NCT00491738|101557762|FG000|STARTED|Overall Study||7||
48499865|NCT00491738|101557763|FG001|STARTED|Overall Study||9||
48499866|NCT00491738|101557762|FG000|COMPLETED|Overall Study||7||
48499867|NCT00491738|101557763|FG001|COMPLETED|Overall Study||9||
48499868|NCT00491738|101557762|FG000|NOT COMPLETED|Overall Study||0||
48499869|NCT00491738|101557763|FG001|NOT COMPLETED|Overall Study||0||
48499870|NCT03702816|101557764|FG000|STARTED|Overall Study||10||
48499871|NCT03702816|101557765|FG001|STARTED|Overall Study||7||
48499872|NCT03702816|101557766|FG002|STARTED|Overall Study||3||
48499873|NCT03702816|101557767|FG003|STARTED|Overall Study||4||
48499874|NCT03702816|101557764|FG000|COMPLETED|Overall Study||10||
48499875|NCT03702816|101557765|FG001|COMPLETED|Overall Study||7||
48499876|NCT03702816|101557766|FG002|COMPLETED|Overall Study||3||
48499877|NCT03702816|101557767|FG003|COMPLETED|Overall Study||4||
48499878|NCT03702816|101557764|FG000|NOT COMPLETED|Overall Study||0||
48499879|NCT03702816|101557765|FG001|NOT COMPLETED|Overall Study||0||
48499880|NCT03702816|101557766|FG002|NOT COMPLETED|Overall Study||0||
48499881|NCT03702816|101557767|FG003|NOT COMPLETED|Overall Study||0||
48499882|NCT00858403|101557768|FG000|STARTED|Overall Study||7||
48499883|NCT00858403|101557768|FG000|COMPLETED|Overall Study||2||
48499884|NCT00858403|101557768|FG000|NOT COMPLETED|Overall Study||5||
48499885|NCT03636386|101557769|FG000|STARTED|Overall Study||24||
48499886|NCT03636386|101557770|FG001|STARTED|Overall Study||24||
48499887|NCT03636386|101557769|FG000|COMPLETED|Overall Study||24||
48499888|NCT03636386|101557770|FG001|COMPLETED|Overall Study||24||
48499889|NCT03636386|101557769|FG000|NOT COMPLETED|Overall Study||0||
48499890|NCT03636386|101557770|FG001|NOT COMPLETED|Overall Study||0||
48499891|NCT02420353|101557771|FG000|STARTED|Overall Study||10||
48499892|NCT02420353|101557772|FG001|STARTED|Overall Study||10||
48499893|NCT02420353|101557771|FG000|Allocation to Intervention|Overall Study||10||
48499894|NCT02420353|101557772|FG001|Allocation to Intervention|Overall Study||10||
48499895|NCT02420353|101557771|FG000|COMPLETED|Overall Study||10||
48499896|NCT02420353|101557772|FG001|COMPLETED|Overall Study||9||
48499897|NCT02420353|101557771|FG000|NOT COMPLETED|Overall Study||0||
48499898|NCT02420353|101557772|FG001|NOT COMPLETED|Overall Study||1||
48499899|NCT02045108|101557773|FG000|STARTED|Overall Study||22||
48499900|NCT02045108|101557774|FG001|STARTED|Overall Study||15||
48499901|NCT02045108|101557775|FG002|STARTED|Overall Study||20||
48499902|NCT02045108|101557776|FG003|STARTED|Overall Study||20||
48499903|NCT02045108|101557773|FG000|COMPLETED|Overall Study||21||
48499904|NCT02045108|101557774|FG001|COMPLETED|Overall Study||12||
48499905|NCT02045108|101557775|FG002|COMPLETED|Overall Study||18||
48499906|NCT02045108|101557776|FG003|COMPLETED|Overall Study||19||
48499907|NCT02045108|101557773|FG000|NOT COMPLETED|Overall Study||1||
48499908|NCT02045108|101557774|FG001|NOT COMPLETED|Overall Study||3||
48499909|NCT02045108|101557775|FG002|NOT COMPLETED|Overall Study||2||
48499910|NCT02045108|101557776|FG003|NOT COMPLETED|Overall Study||1||
48499911|NCT00045162|101557777|FG000|STARTED|Overall Study||336||
48499912|NCT00045162|101557778|FG001|STARTED|Overall Study||335||
48499913|NCT00045162|101557777|FG000|COMPLETED|Overall Study||194||
48499914|NCT00045162|101557778|FG001|COMPLETED|Overall Study||217||
48499915|NCT00045162|101557777|FG000|NOT COMPLETED|Overall Study||142||
48499916|NCT00045162|101557778|FG001|NOT COMPLETED|Overall Study||118||
48499917|NCT03660787|101557779|FG000|STARTED|Overall Study||26||
48499918|NCT03660787|101557780|FG001|STARTED|Overall Study||26||
48499919|NCT03660787|101557781|FG002|STARTED|Overall Study||26||
48499920|NCT03660787|101557782|FG003|STARTED|Overall Study||26||
48499921|NCT03660787|101557779|FG000|COMPLETED|Overall Study||25||
48499922|NCT03660787|101557780|FG001|COMPLETED|Overall Study||25||
48499923|NCT03660787|101557781|FG002|COMPLETED|Overall Study||25||
48499924|NCT03660787|101557782|FG003|COMPLETED|Overall Study||26||
48499925|NCT03660787|101557779|FG000|NOT COMPLETED|Overall Study||1||
48499926|NCT03660787|101557780|FG001|NOT COMPLETED|Overall Study||1||
48499927|NCT03660787|101557781|FG002|NOT COMPLETED|Overall Study||1||
48499928|NCT03660787|101557782|FG003|NOT COMPLETED|Overall Study||0||
48499929|NCT00114504|101557783|FG000|STARTED|Overall Study||21||
48499930|NCT00114504|101557784|FG001|STARTED|Overall Study||22||
48499931|NCT00114504|101557783|FG000|COMPLETED|Overall Study||21||
48499932|NCT00114504|101557784|FG001|COMPLETED|Overall Study||22||
48499933|NCT00114504|101557783|FG000|NOT COMPLETED|Overall Study||0||
48499934|NCT00114504|101557784|FG001|NOT COMPLETED|Overall Study||0||
48061063|NCT01193842|100470333|FG000|STARTED|Phase I: VR-CHOP, DL 1||0||
48499935|NCT01698554|101557785|FG000|STARTED|Overall Study||153||
48499936|NCT01698554|101557786|FG001|STARTED|Overall Study||157||
48499937|NCT01698554|101557787|FG002|STARTED|Overall Study||75||
48499938|NCT01698554|101557788|FG003|STARTED|Overall Study||79||
48499939|NCT01698554|101557785|FG000|COMPLETED|Overall Study||147||
48499940|NCT01698554|101557786|FG001|COMPLETED|Overall Study||147||
48499941|NCT01698554|101557787|FG002|COMPLETED|Overall Study||73||
48499942|NCT01698554|101557788|FG003|COMPLETED|Overall Study||77||
48499943|NCT01698554|101557785|FG000|NOT COMPLETED|Overall Study||6||
48499944|NCT01698554|101557786|FG001|NOT COMPLETED|Overall Study||10||
48499945|NCT01698554|101557787|FG002|NOT COMPLETED|Overall Study||2||
48499946|NCT01698554|101557788|FG003|NOT COMPLETED|Overall Study||2||
48499947|NCT02856594|101557789|FG000|STARTED|Overall Study||234||
48499948|NCT02856594|101557790|FG001|STARTED|Overall Study||235||
48499949|NCT02856594|101557789|FG000|Analysis Population|Overall Study||188||
48499950|NCT02856594|101557790|FG001|Analysis Population|Overall Study||206||
48499951|NCT02856594|101557789|FG000|COMPLETED|Overall Study||188||
48499952|NCT02856594|101557790|FG001|COMPLETED|Overall Study||206||
48499953|NCT02856594|101557789|FG000|NOT COMPLETED|Overall Study||46||
48499954|NCT02856594|101557790|FG001|NOT COMPLETED|Overall Study||29||
48499955|NCT00726830|101557791|FG000|STARTED|Overall Study||1||
48499956|NCT00726830|101557792|FG001|STARTED|Overall Study||0||
48499957|NCT00726830|101557791|FG000|COMPLETED|Overall Study||1||
48499958|NCT00726830|101557792|FG001|COMPLETED|Overall Study||0||
48499959|NCT00726830|101557791|FG000|NOT COMPLETED|Overall Study||0||
48499960|NCT00726830|101557792|FG001|NOT COMPLETED|Overall Study||0||
48499961|NCT01993940|101557793|FG000|STARTED|Overall Study||277||
48499962|NCT01993940|101557794|FG001|STARTED|Overall Study||276||
48499963|NCT01993940|101557793|FG000|Received Treatment|Overall Study||272||
48499964|NCT01993940|101557794|FG001|Received Treatment|Overall Study||276||
48499965|NCT01993940|101557793|FG000|COMPLETED|Overall Study||237||
48499966|NCT01993940|101557794|FG001|COMPLETED|Overall Study||232||
48499967|NCT01993940|101557793|FG000|NOT COMPLETED|Overall Study||40||
48499968|NCT01993940|101557794|FG001|NOT COMPLETED|Overall Study||44||
48499969|NCT03246503|101557795|FG000|STARTED|Overall Study||203||
48499970|NCT03246503|101557795|FG000|COMPLETED|Overall Study||150||
48499971|NCT03246503|101557795|FG000|NOT COMPLETED|Overall Study||53||
48499972|NCT02339038|101557796|FG000|STARTED|Overall Study||600||
48499973|NCT02339038|101557796|FG000|COMPLETED|Overall Study||0||
48499974|NCT02339038|101557796|FG000|NOT COMPLETED|Overall Study||600||
48499975|NCT01320722|101557797|FG000|STARTED|Overall Study||46||
48499976|NCT01320722|101557798|FG001|STARTED|Overall Study||47||
48499977|NCT01320722|101557799|FG002|STARTED|Overall Study||47||
48499978|NCT01320722|101557800|FG003|STARTED|Overall Study||49||
48499979|NCT01320722|101557801|FG004|STARTED|Overall Study||53||
48499980|NCT01320722|101557797|FG000|Received Intervention|Overall Study||43||
48499981|NCT01320722|101557798|FG001|Received Intervention|Overall Study||45||
48499982|NCT01320722|101557799|FG002|Received Intervention|Overall Study||46||
48499983|NCT01320722|101557800|FG003|Received Intervention|Overall Study||48||
48499984|NCT01320722|101557801|FG004|Received Intervention|Overall Study||51||
48499985|NCT01320722|101557797|FG000|COMPLETED|Overall Study||43||
48499986|NCT01320722|101557798|FG001|COMPLETED|Overall Study||41||
48499987|NCT01320722|101557799|FG002|COMPLETED|Overall Study||40||
48499988|NCT01320722|101557800|FG003|COMPLETED|Overall Study||35||
48499989|NCT01320722|101557801|FG004|COMPLETED|Overall Study||45||
48499990|NCT01320722|101557797|FG000|NOT COMPLETED|Overall Study||3||
48499991|NCT01320722|101557798|FG001|NOT COMPLETED|Overall Study||6||
48499992|NCT01320722|101557799|FG002|NOT COMPLETED|Overall Study||7||
48499993|NCT01320722|101557800|FG003|NOT COMPLETED|Overall Study||14||
48499994|NCT01320722|101557801|FG004|NOT COMPLETED|Overall Study||8||
48499995|NCT00867360|101557802|FG000|STARTED|Overall Study||4||
48499996|NCT00867360|101557803|FG001|STARTED|Overall Study||6||
48499997|NCT00867360|101557802|FG000|COMPLETED|Overall Study||3||
48499998|NCT00867360|101557803|FG001|COMPLETED|Overall Study||5||
48499999|NCT00867360|101557802|FG000|NOT COMPLETED|Overall Study||1||
48500000|NCT00867360|101557803|FG001|NOT COMPLETED|Overall Study||1||
48500001|NCT02054715|101557804|FG000|STARTED|Baseline/Follow-up 1||219||
48500002|NCT02054715|101557805|FG001|STARTED|Baseline/Follow-up 1||199||
48500003|NCT02054715|101557804|FG000|COMPLETED|Baseline/Follow-up 1||211||
48500004|NCT02054715|101557805|FG001|COMPLETED|Baseline/Follow-up 1||192||
48500005|NCT02054715|101557804|FG000|NOT COMPLETED|Baseline/Follow-up 1||8||
48500006|NCT02054715|101557805|FG001|NOT COMPLETED|Baseline/Follow-up 1||7||
48500007|NCT02054715|101557804|FG000|STARTED|Follow-up 2||211||
48500008|NCT02054715|101557805|FG001|STARTED|Follow-up 2||192||
48500009|NCT02054715|101557804|FG000|COMPLETED|Follow-up 2||192||
48500010|NCT02054715|101557805|FG001|COMPLETED|Follow-up 2||173||
48500011|NCT02054715|101557804|FG000|NOT COMPLETED|Follow-up 2||19||
48500012|NCT02054715|101557805|FG001|NOT COMPLETED|Follow-up 2||19||
48500013|NCT01800838|101557806|FG000|STARTED|Overall Study||1||
48500014|NCT01800838|101557807|FG001|STARTED|Overall Study||1||
48500015|NCT01800838|101557808|FG002|STARTED|Overall Study||7||
48500016|NCT01800838|101557809|FG003|STARTED|Overall Study||2||
48500017|NCT01800838|101557806|FG000|COMPLETED|Overall Study||1||
48500018|NCT01800838|101557807|FG001|COMPLETED|Overall Study||1||
48500019|NCT01800838|101557808|FG002|COMPLETED|Overall Study||7||
48500020|NCT01800838|101557809|FG003|COMPLETED|Overall Study||2||
48500021|NCT01800838|101557806|FG000|NOT COMPLETED|Overall Study||0||
48500022|NCT01800838|101557807|FG001|NOT COMPLETED|Overall Study||0||
48500023|NCT01800838|101557808|FG002|NOT COMPLETED|Overall Study||0||
48500024|NCT01800838|101557809|FG003|NOT COMPLETED|Overall Study||0||
48500025|NCT00438633|101557810|FG000|STARTED|Overall Study||32||
48500026|NCT00438633|101557811|FG001|STARTED|Overall Study||31||
48500027|NCT00438633|101557810|FG000|3-month Follow-up|Overall Study||26||
48500028|NCT00438633|101557811|FG001|3-month Follow-up|Overall Study||24||
48500029|NCT00438633|101557810|FG000|COMPLETED|Overall Study||16||
48500030|NCT00438633|101557811|FG001|COMPLETED|Overall Study||14||
48500031|NCT00438633|101557810|FG000|NOT COMPLETED|Overall Study||16||
48500032|NCT00438633|101557811|FG001|NOT COMPLETED|Overall Study||17||
48500033|NCT00591760|101557812|FG000|STARTED|Overall Study||28||
48500034|NCT00591760|101557813|FG001|STARTED|Overall Study||28||
48500035|NCT00591760|101557812|FG000|COMPLETED|Overall Study||28||
48500036|NCT00591760|101557813|FG001|COMPLETED|Overall Study||28||
48500037|NCT00591760|101557812|FG000|NOT COMPLETED|Overall Study||0||
48500038|NCT00591760|101557813|FG001|NOT COMPLETED|Overall Study||0||
48500039|NCT04567329|101557814|FG000|STARTED|Overall Study||311||
48500040|NCT04567329|101557815|FG001|STARTED|Overall Study||309||
48500041|NCT04567329|101557814|FG000|COMPLETED|Overall Study||302||
48500042|NCT04567329|101557815|FG001|COMPLETED|Overall Study||296||
48500043|NCT04567329|101557814|FG000|NOT COMPLETED|Overall Study||9||
48500044|NCT04567329|101557815|FG001|NOT COMPLETED|Overall Study||13||
48500045|NCT02614898|101557816|FG000|STARTED|Overall Study||15||
48500046|NCT02614898|101557817|FG001|STARTED|Overall Study||52||
48500047|NCT02614898|101557816|FG000|Safety Population|Overall Study||15||
48500048|NCT02614898|101557817|FG001|Safety Population|Overall Study||52||
48500049|NCT02614898|101557816|FG000|COMPLETED|Overall Study||0||
48500050|NCT02614898|101557817|FG001|COMPLETED|Overall Study||1||
48500051|NCT02614898|101557816|FG000|NOT COMPLETED|Overall Study||15||
48500052|NCT02614898|101557817|FG001|NOT COMPLETED|Overall Study||51||
48500053|NCT04039022|101557818|FG000|STARTED|Overall Study||876||
48500054|NCT04039022|101557818|FG000|COMPLETED|Overall Study||53||
48500055|NCT04039022|101557818|FG000|NOT COMPLETED|Overall Study||823||
48500056|NCT02143726|101557819|FG000|STARTED|Overall Study||18||
48500057|NCT02143726|101557820|FG001|STARTED|Overall Study||17||
48500058|NCT02143726|101557819|FG000|Received Everolimus After Disease Progression|Overall Study||11||
48500059|NCT02143726|101557820|FG001|Received Everolimus After Disease Progression|Overall Study||0||
48500060|NCT02143726|101557819|FG000|COMPLETED|Overall Study||16||
48500061|NCT02143726|101557820|FG001|COMPLETED|Overall Study||17||
48500062|NCT02143726|101557819|FG000|NOT COMPLETED|Overall Study||2||
48500063|NCT02143726|101557820|FG001|NOT COMPLETED|Overall Study||0||
48061064|NCT01193842|100470334|FG001|STARTED|Phase I: VR-CHOP, DL 1||0||
48500064|NCT01377441|101557821|FG000|STARTED|Overall Study||0||
48500065|NCT01377441|101557822|FG001|STARTED|Overall Study||0||
48500066|NCT01377441|101557821|FG000|COMPLETED|Overall Study||0||
48500067|NCT01377441|101557822|FG001|COMPLETED|Overall Study||0||
48500068|NCT01377441|101557821|FG000|NOT COMPLETED|Overall Study||0||
48500069|NCT01377441|101557822|FG001|NOT COMPLETED|Overall Study||0||
48500070|NCT05485662|101557823|FG000|STARTED|Phase 1 Allocation||8||
48500071|NCT05485662|101557824|FG001|STARTED|Phase 1 Allocation||7||
48500072|NCT05485662|101557823|FG000|COMPLETED|Phase 1 Allocation||8||
48500073|NCT05485662|101557824|FG001|COMPLETED|Phase 1 Allocation||7||
48500074|NCT05485662|101557823|FG000|NOT COMPLETED|Phase 1 Allocation||0||
48500075|NCT05485662|101557824|FG001|NOT COMPLETED|Phase 1 Allocation||0||
48500076|NCT05485662|101557823|FG000|STARTED|Washout Period||8||
48500077|NCT05485662|101557824|FG001|STARTED|Washout Period||7||
48500078|NCT05485662|101557823|FG000|COMPLETED|Washout Period||8||
48500079|NCT05485662|101557824|FG001|COMPLETED|Washout Period||7||
48500080|NCT05485662|101557823|FG000|NOT COMPLETED|Washout Period||0||
48500081|NCT05485662|101557824|FG001|NOT COMPLETED|Washout Period||0||
48061065|NCT01193842|100470335|FG002|STARTED|Phase I: VR-CHOP, DL 1||2||
48061066|NCT01193842|100470336|FG003|STARTED|Phase I: VR-CHOP, DL 1||0||
48061067|NCT01193842|100470337|FG004|STARTED|Phase I: VR-CHOP, DL 1||0||
48500082|NCT05485662|101557823|FG000|STARTED|Phase 2 Allocation||7||
48500083|NCT05485662|101557824|FG001|STARTED|Phase 2 Allocation||8||
48500084|NCT05485662|101557823|FG000|COMPLETED|Phase 2 Allocation||7||
48500085|NCT05485662|101557824|FG001|COMPLETED|Phase 2 Allocation||8||
48500086|NCT05485662|101557823|FG000|NOT COMPLETED|Phase 2 Allocation||0||
48500087|NCT05485662|101557824|FG001|NOT COMPLETED|Phase 2 Allocation||0||
48500088|NCT01155531|101557825|FG000|STARTED|Overall Study||10||
48500089|NCT01155531|101557826|FG001|STARTED|Overall Study||10||
48500090|NCT01155531|101557827|FG002|STARTED|Overall Study||10||
48500091|NCT01155531|101557828|FG003|STARTED|Overall Study||10||
48500092|NCT01155531|101557825|FG000|COMPLETED|Overall Study||9||
48500093|NCT01155531|101557826|FG001|COMPLETED|Overall Study||10||
48500094|NCT01155531|101557827|FG002|COMPLETED|Overall Study||8||
48500095|NCT01155531|101557828|FG003|COMPLETED|Overall Study||9||
48500096|NCT01155531|101557825|FG000|NOT COMPLETED|Overall Study||1||
48500097|NCT01155531|101557826|FG001|NOT COMPLETED|Overall Study||0||
48500098|NCT01155531|101557827|FG002|NOT COMPLETED|Overall Study||2||
48500099|NCT01155531|101557828|FG003|NOT COMPLETED|Overall Study||1||
48500100|NCT02518139|101557829|FG000|STARTED|Overall Study||364||
48500101|NCT02518139|101557830|FG001|STARTED|Overall Study||335||
48500102|NCT02518139|101557831|FG002|STARTED|Overall Study||356||
48061068|NCT01193842|100470333|FG000|COMPLETED|Phase I: VR-CHOP, DL 1||0||
48500103|NCT02518139|101557829|FG000|COMPLETED|Overall Study||219||
48500104|NCT02518139|101557830|FG001|COMPLETED|Overall Study||191||
48500105|NCT02518139|101557831|FG002|COMPLETED|Overall Study||262||
48500106|NCT02518139|101557829|FG000|NOT COMPLETED|Overall Study||145||
48500107|NCT02518139|101557830|FG001|NOT COMPLETED|Overall Study||144||
48500108|NCT02518139|101557831|FG002|NOT COMPLETED|Overall Study||94||
48500109|NCT03314857|101557832|FG000|STARTED|Overall Study||67||
48500110|NCT03314857|101557832|FG000|Analysis Population|Overall Study||61|6/67 patients were roll-in patients. Roll-in patients were not included in the analysis.|
48500111|NCT03314857|101557832|FG000|COMPLETED|Overall Study||62||
48500112|NCT03314857|101557832|FG000|NOT COMPLETED|Overall Study||5||
48500113|NCT01186458|101557833|FG000|STARTED|Overall Study||4||
48500114|NCT01186458|101557833|FG000|COMPLETED|Overall Study||3||
48500115|NCT01186458|101557833|FG000|NOT COMPLETED|Overall Study||1||
48500116|NCT00412464|101557834|FG000|STARTED|Overall Study||24||
48500117|NCT00412464|101557834|FG000|COMPLETED|Overall Study||24||
48500118|NCT00412464|101557834|FG000|NOT COMPLETED|Overall Study||0||
48500119|NCT01026402|101557835|FG000|STARTED|Overall Study||6||
48500120|NCT01026402|101557836|FG001|STARTED|Overall Study||8||
48500121|NCT01026402|101557837|FG002|STARTED|Overall Study||33||
48500122|NCT01026402|101557838|FG003|STARTED|Overall Study||18||
48500123|NCT01026402|101557839|FG004|STARTED|Overall Study||3||
48500124|NCT01026402|101557840|FG005|STARTED|Overall Study||5||
48500125|NCT01026402|101557841|FG006|STARTED|Overall Study||8||
48061069|NCT01193842|100470334|FG001|COMPLETED|Phase I: VR-CHOP, DL 1||0||
48061070|NCT01193842|100470335|FG002|COMPLETED|Phase I: VR-CHOP, DL 1||1||
48061071|NCT01193842|100470336|FG003|COMPLETED|Phase I: VR-CHOP, DL 1||0||
48061072|NCT01193842|100470337|FG004|COMPLETED|Phase I: VR-CHOP, DL 1||0||
48061073|NCT01193842|100470333|FG000|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0||
48500126|NCT01026402|101557842|FG007|STARTED|Overall Study||3||
48500127|NCT01026402|101557843|FG008|STARTED|Overall Study||7||
48500128|NCT01026402|101557844|FG009|STARTED|Overall Study||3||
48500129|NCT01026402|101557845|FG010|STARTED|Overall Study||7||
48500130|NCT01026402|101557846|FG011|STARTED|Overall Study||8||
48500131|NCT01026402|101557847|FG012|STARTED|Overall Study||8||
48500132|NCT01026402|101557848|FG013|STARTED|Overall Study||6||
48500133|NCT01026402|101557849|FG014|STARTED|Overall Study||3||
48500134|NCT01026402|101557850|FG015|STARTED|Overall Study||5||
48500135|NCT01026402|101557851|FG016|STARTED|Overall Study||4||
48500136|NCT01026402|101557835|FG000|COMPLETED|Overall Study||6||
48500137|NCT01026402|101557836|FG001|COMPLETED|Overall Study||8||
48500138|NCT01026402|101557837|FG002|COMPLETED|Overall Study||33||
48500139|NCT01026402|101557838|FG003|COMPLETED|Overall Study||18||
48500140|NCT01026402|101557839|FG004|COMPLETED|Overall Study||3||
48500141|NCT01026402|101557840|FG005|COMPLETED|Overall Study||5||
48500142|NCT01026402|101557841|FG006|COMPLETED|Overall Study||8||
48500143|NCT01026402|101557842|FG007|COMPLETED|Overall Study||3||
48500144|NCT01026402|101557843|FG008|COMPLETED|Overall Study||7||
48500145|NCT01026402|101557844|FG009|COMPLETED|Overall Study||3||
48500146|NCT01026402|101557845|FG010|COMPLETED|Overall Study||7||
48500147|NCT01026402|101557846|FG011|COMPLETED|Overall Study||8||
48500148|NCT01026402|101557847|FG012|COMPLETED|Overall Study||8||
48500149|NCT01026402|101557848|FG013|COMPLETED|Overall Study||6||
48500150|NCT01026402|101557849|FG014|COMPLETED|Overall Study||3||
48500151|NCT01026402|101557850|FG015|COMPLETED|Overall Study||5||
48500152|NCT01026402|101557851|FG016|COMPLETED|Overall Study||4||
48500153|NCT01026402|101557835|FG000|NOT COMPLETED|Overall Study||0||
48500154|NCT01026402|101557836|FG001|NOT COMPLETED|Overall Study||0||
48500155|NCT01026402|101557837|FG002|NOT COMPLETED|Overall Study||0||
48500156|NCT01026402|101557838|FG003|NOT COMPLETED|Overall Study||0||
48500157|NCT01026402|101557839|FG004|NOT COMPLETED|Overall Study||0||
48500158|NCT01026402|101557840|FG005|NOT COMPLETED|Overall Study||0||
48500159|NCT01026402|101557841|FG006|NOT COMPLETED|Overall Study||0||
48500160|NCT01026402|101557842|FG007|NOT COMPLETED|Overall Study||0||
48500161|NCT01026402|101557843|FG008|NOT COMPLETED|Overall Study||0||
48500162|NCT01026402|101557844|FG009|NOT COMPLETED|Overall Study||0||
48500163|NCT01026402|101557845|FG010|NOT COMPLETED|Overall Study||0||
48500164|NCT01026402|101557846|FG011|NOT COMPLETED|Overall Study||0||
48500165|NCT01026402|101557847|FG012|NOT COMPLETED|Overall Study||0||
48500166|NCT01026402|101557848|FG013|NOT COMPLETED|Overall Study||0||
48500167|NCT01026402|101557849|FG014|NOT COMPLETED|Overall Study||0||
48500168|NCT01026402|101557850|FG015|NOT COMPLETED|Overall Study||0||
48500169|NCT01026402|101557851|FG016|NOT COMPLETED|Overall Study||0||
48500170|NCT03488108|101557852|FG000|STARTED|First Intervention (12 Weeks)||10||
48500171|NCT03488108|101557853|FG001|STARTED|First Intervention (12 Weeks)||10||
48500172|NCT03488108|101557852|FG000|COMPLETED|First Intervention (12 Weeks)||10||
48500173|NCT03488108|101557853|FG001|COMPLETED|First Intervention (12 Weeks)||9||
48500174|NCT03488108|101557852|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0||
48500175|NCT03488108|101557853|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1||
48500176|NCT03488108|101557852|FG000|STARTED|Washout (2 Months)||10||
48500177|NCT03488108|101557853|FG001|STARTED|Washout (2 Months)||9||
48500178|NCT03488108|101557852|FG000|COMPLETED|Washout (2 Months)||10||
48500179|NCT03488108|101557853|FG001|COMPLETED|Washout (2 Months)||9||
48500180|NCT03488108|101557852|FG000|NOT COMPLETED|Washout (2 Months)||0||
48500181|NCT03488108|101557853|FG001|NOT COMPLETED|Washout (2 Months)||0||
48500182|NCT03488108|101557852|FG000|STARTED|Second Intervention (12 Weeks)||10||
48500183|NCT03488108|101557853|FG001|STARTED|Second Intervention (12 Weeks)||9||
48500184|NCT03488108|101557852|FG000|COMPLETED|Second Intervention (12 Weeks)||9||
48500185|NCT03488108|101557853|FG001|COMPLETED|Second Intervention (12 Weeks)||9||
48500186|NCT03488108|101557852|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||1||
48500187|NCT03488108|101557853|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0||
48500188|NCT02227238|101557854|FG000|STARTED|Randomized Phase (Up to Week 52)||312|Randomized|
48500189|NCT02227238|101557855|FG001|STARTED|Randomized Phase (Up to Week 52)||315|Randomized|
48500190|NCT02227238|101557856|FG002|STARTED|Randomized Phase (Up to Week 52)||0|Randomized|
48500191|NCT02227238|101557854|FG000|ITT-E Population|Randomized Phase (Up to Week 52)||312||
48500192|NCT02227238|101557855|FG001|ITT-E Population|Randomized Phase (Up to Week 52)||312||
48500193|NCT02227238|101557856|FG002|ITT-E Population|Randomized Phase (Up to Week 52)||0||
48500194|NCT02227238|101557854|FG000|COMPLETED|Randomized Phase (Up to Week 52)||275||
48500195|NCT02227238|101557855|FG001|COMPLETED|Randomized Phase (Up to Week 52)||245||
48500196|NCT02227238|101557856|FG002|COMPLETED|Randomized Phase (Up to Week 52)||0||
48500197|NCT02227238|101557854|FG000|NOT COMPLETED|Randomized Phase (Up to Week 52)||37||
48500198|NCT02227238|101557855|FG001|NOT COMPLETED|Randomized Phase (Up to Week 52)||70||
48500199|NCT02227238|101557856|FG002|NOT COMPLETED|Randomized Phase (Up to Week 52)||0||
48500200|NCT02227238|101557854|FG000|STARTED|Continuation Phase(From Weeks 52 to 295)||0||
48500201|NCT02227238|101557855|FG001|STARTED|Continuation Phase(From Weeks 52 to 295)||0||
48500202|NCT02227238|101557856|FG002|STARTED|Continuation Phase(From Weeks 52 to 295)||274||
48500203|NCT02227238|101557854|FG000|COMPLETED|Continuation Phase(From Weeks 52 to 295)||0||
48500204|NCT02227238|101557855|FG001|COMPLETED|Continuation Phase(From Weeks 52 to 295)||0||
48500205|NCT02227238|101557856|FG002|COMPLETED|Continuation Phase(From Weeks 52 to 295)||225||
48500206|NCT02227238|101557854|FG000|NOT COMPLETED|Continuation Phase(From Weeks 52 to 295)||0||
48500207|NCT02227238|101557855|FG001|NOT COMPLETED|Continuation Phase(From Weeks 52 to 295)||0||
48500208|NCT02227238|101557856|FG002|NOT COMPLETED|Continuation Phase(From Weeks 52 to 295)||49||
48500209|NCT01275664|101557857|FG000|STARTED|Overall Study||4||
48500210|NCT01275664|101557857|FG000|COMPLETED|Overall Study||4||
48500211|NCT01275664|101557857|FG000|NOT COMPLETED|Overall Study||0||
48500212|NCT04198701|101557858|FG000|STARTED|Overall Study||38||
48500213|NCT04198701|101557859|FG001|STARTED|Overall Study||60||
48500214|NCT04198701|101557860|FG002|STARTED|Overall Study||164||
48500215|NCT04198701|101557861|FG003|STARTED|Overall Study||159||
48500216|NCT04198701|101557858|FG000|Had Ablation Procedure|Overall Study||38||
48500217|NCT04198701|101557859|FG001|Had Ablation Procedure|Overall Study||60||
48500218|NCT04198701|101557860|FG002|Had Ablation Procedure|Overall Study||150||
48500219|NCT04198701|101557861|FG003|Had Ablation Procedure|Overall Study||150||
48500220|NCT04198701|101557858|FG000|COMPLETED|Overall Study||35||
48500221|NCT04198701|101557859|FG001|COMPLETED|Overall Study||57||
48500222|NCT04198701|101557860|FG002|COMPLETED|Overall Study||146||
48500223|NCT04198701|101557861|FG003|COMPLETED|Overall Study||141||
48500224|NCT04198701|101557858|FG000|NOT COMPLETED|Overall Study||3||
48500225|NCT04198701|101557859|FG001|NOT COMPLETED|Overall Study||3||
48500226|NCT04198701|101557860|FG002|NOT COMPLETED|Overall Study||18||
48500227|NCT04198701|101557861|FG003|NOT COMPLETED|Overall Study||18||
48500228|NCT01807026|101557862|FG000|STARTED|Overall Study||10||
48500229|NCT01807026|101557863|FG001|STARTED|Overall Study||2||
48500230|NCT01807026|101557864|FG002|STARTED|Overall Study||10||
48500231|NCT01807026|101557865|FG003|STARTED|Overall Study||2||
48500232|NCT01807026|101557866|FG004|STARTED|Overall Study||9||
48500233|NCT01807026|101557867|FG005|STARTED|Overall Study||3||
48500234|NCT01807026|101557862|FG000|Received at Least One Dose of Study Drug|Overall Study||10||
48500235|NCT01807026|101557863|FG001|Received at Least One Dose of Study Drug|Overall Study||2||
48500236|NCT01807026|101557864|FG002|Received at Least One Dose of Study Drug|Overall Study||10||
48500237|NCT01807026|101557865|FG003|Received at Least One Dose of Study Drug|Overall Study||2||
48500238|NCT01807026|101557866|FG004|Received at Least One Dose of Study Drug|Overall Study||9||
48500239|NCT01807026|101557867|FG005|Received at Least One Dose of Study Drug|Overall Study||3||
48500240|NCT01807026|101557862|FG000|COMPLETED|Overall Study||10||
48500241|NCT01807026|101557863|FG001|COMPLETED|Overall Study||2||
48500242|NCT01807026|101557864|FG002|COMPLETED|Overall Study||10||
48500243|NCT01807026|101557865|FG003|COMPLETED|Overall Study||2||
48500244|NCT01807026|101557866|FG004|COMPLETED|Overall Study||9||
48500245|NCT01807026|101557867|FG005|COMPLETED|Overall Study||3||
48500246|NCT01807026|101557862|FG000|NOT COMPLETED|Overall Study||0||
48500247|NCT01807026|101557863|FG001|NOT COMPLETED|Overall Study||0||
48500248|NCT01807026|101557864|FG002|NOT COMPLETED|Overall Study||0||
48500249|NCT01807026|101557865|FG003|NOT COMPLETED|Overall Study||0||
48500250|NCT01807026|101557866|FG004|NOT COMPLETED|Overall Study||0||
48500251|NCT01807026|101557867|FG005|NOT COMPLETED|Overall Study||0||
48218490|NCT01426412|100860318|FG004|STARTED|Overall Study||6||
48218491|NCT01426412|100860319|FG005|STARTED|Overall Study||6||
48500252|NCT00467597|101557868|FG000|STARTED|Overall Study||26||
48500253|NCT00467597|101557869|FG001|STARTED|Overall Study||6||
48500254|NCT00467597|101557868|FG000|COMPLETED|Overall Study||24||
48500255|NCT00467597|101557869|FG001|COMPLETED|Overall Study||6||
48500256|NCT00467597|101557868|FG000|NOT COMPLETED|Overall Study||2||
48500257|NCT00467597|101557869|FG001|NOT COMPLETED|Overall Study||0||
48500258|NCT02121184|101557870|FG000|STARTED|Overall Study||86||
48500259|NCT02121184|101557871|FG001|STARTED|Overall Study||86||
48500260|NCT02121184|101557870|FG000|COMPLETED|Overall Study||84||
48500261|NCT02121184|101557871|FG001|COMPLETED|Overall Study||83||
48500262|NCT02121184|101557870|FG000|NOT COMPLETED|Overall Study||2||
48500263|NCT02121184|101557871|FG001|NOT COMPLETED|Overall Study||3||
48500264|NCT00009945|101557872|FG000|STARTED|Overall Study||1662||
48500265|NCT00009945|101557873|FG001|STARTED|Overall Study||1661||
48500266|NCT00009945|101557872|FG000|COMPLETED|Overall Study||1655||
48500267|NCT00009945|101557873|FG001|COMPLETED|Overall Study||1656||
48500268|NCT00009945|101557872|FG000|NOT COMPLETED|Overall Study||7||
48500269|NCT00009945|101557873|FG001|NOT COMPLETED|Overall Study||5||
48500270|NCT03985657|101557874|FG000|STARTED|Intervention 1 (One Night)||20||
48500271|NCT03985657|101557875|FG001|STARTED|Intervention 1 (One Night)||11||
48500272|NCT03985657|101557874|FG000|COMPLETED|Intervention 1 (One Night)||20||
48500273|NCT03985657|101557875|FG001|COMPLETED|Intervention 1 (One Night)||10||
48500274|NCT03985657|101557874|FG000|NOT COMPLETED|Intervention 1 (One Night)||0||
48500275|NCT03985657|101557875|FG001|NOT COMPLETED|Intervention 1 (One Night)||1||
48500276|NCT03985657|101557874|FG000|STARTED|Washout (Up to 1 Week)||20||
48500277|NCT03985657|101557875|FG001|STARTED|Washout (Up to 1 Week)||10||
48500278|NCT03985657|101557874|FG000|COMPLETED|Washout (Up to 1 Week)||20||
48500279|NCT03985657|101557875|FG001|COMPLETED|Washout (Up to 1 Week)||10||
48500280|NCT03985657|101557874|FG000|NOT COMPLETED|Washout (Up to 1 Week)||0||
48500281|NCT03985657|101557875|FG001|NOT COMPLETED|Washout (Up to 1 Week)||0||
48500282|NCT03985657|101557874|FG000|STARTED|Intervention 2 (One Night)||20||
48500283|NCT03985657|101557875|FG001|STARTED|Intervention 2 (One Night)||10||
48500284|NCT03985657|101557874|FG000|COMPLETED|Intervention 2 (One Night)||20||
48500285|NCT03985657|101557875|FG001|COMPLETED|Intervention 2 (One Night)||10||
48500286|NCT03985657|101557874|FG000|NOT COMPLETED|Intervention 2 (One Night)||0||
48500287|NCT03985657|101557875|FG001|NOT COMPLETED|Intervention 2 (One Night)||0||
48500288|NCT02252016|101557876|FG000|STARTED|Overall Study||107||
48500289|NCT02252016|101557877|FG001|STARTED|Overall Study||52||
48500290|NCT02252016|101557876|FG000|COMPLETED|Overall Study||104||
48500291|NCT02252016|101557877|FG001|COMPLETED|Overall Study||49||
48500292|NCT02252016|101557876|FG000|NOT COMPLETED|Overall Study||3||
48500293|NCT02252016|101557877|FG001|NOT COMPLETED|Overall Study||3||
48500294|NCT01971554|101557878|FG000|STARTED|Overall Study||9||
48500295|NCT01971554|101557879|FG001|STARTED|Overall Study||18||
48500296|NCT01971554|101557880|FG002|STARTED|Overall Study||18||
48500297|NCT01971554|101557881|FG003|STARTED|Overall Study||18||
48500298|NCT01971554|101557878|FG000|COMPLETED|Overall Study||8||
48500299|NCT01971554|101557879|FG001|COMPLETED|Overall Study||18||
48500300|NCT01971554|101557880|FG002|COMPLETED|Overall Study||18||
48500301|NCT01971554|101557881|FG003|COMPLETED|Overall Study||18||
48500302|NCT01971554|101557878|FG000|NOT COMPLETED|Overall Study||1||
48500303|NCT01971554|101557879|FG001|NOT COMPLETED|Overall Study||0||
48500304|NCT01971554|101557880|FG002|NOT COMPLETED|Overall Study||0||
48500305|NCT01971554|101557881|FG003|NOT COMPLETED|Overall Study||0||
48500306|NCT01472432|101557882|FG000|STARTED|Overall Study||53||
48500307|NCT01472432|101557883|FG001|STARTED|Overall Study||53||
48500308|NCT01472432|101557882|FG000|Ulcer Reduction|Overall Study||13||
48500309|NCT01472432|101557883|FG001|Ulcer Reduction|Overall Study||33||
48500310|NCT01472432|101557882|FG000|COMPLETED|Overall Study||53||
48500311|NCT01472432|101557883|FG001|COMPLETED|Overall Study||53||
48500312|NCT01472432|101557882|FG000|NOT COMPLETED|Overall Study||0||
48500313|NCT01472432|101557883|FG001|NOT COMPLETED|Overall Study||0||
48500314|NCT03382041|101557884|FG000|STARTED|Overall Study||7||
48500315|NCT03382041|101557885|FG001|STARTED|Overall Study||13||
48500316|NCT03382041|101557884|FG000|COMPLETED|Overall Study||3||
48500317|NCT03382041|101557885|FG001|COMPLETED|Overall Study||4||
48500318|NCT03382041|101557884|FG000|NOT COMPLETED|Overall Study||4||
48500319|NCT03382041|101557885|FG001|NOT COMPLETED|Overall Study||9||
48500320|NCT03169816|101557886|FG000|STARTED|Overall Study||33||
48500321|NCT03169816|101557887|FG001|STARTED|Overall Study||16||
48500322|NCT03169816|101557886|FG000|COMPLETED|Overall Study||6||
48500323|NCT03169816|101557887|FG001|COMPLETED|Overall Study||3||
48500324|NCT03169816|101557886|FG000|NOT COMPLETED|Overall Study||27||
48500325|NCT03169816|101557887|FG001|NOT COMPLETED|Overall Study||13||
48500326|NCT03248128|101557888|FG000|STARTED|Overall Study||455||
48500327|NCT03248128|101557889|FG001|STARTED|Overall Study||451||
48500328|NCT03248128|101557888|FG000|ITT Population|Overall Study||454||
48500329|NCT03248128|101557889|FG001|ITT Population|Overall Study||448||
48500330|NCT03248128|101557888|FG000|COMPLETED|Overall Study||433||
48500331|NCT03248128|101557889|FG001|COMPLETED|Overall Study||431||
48500332|NCT03248128|101557888|FG000|NOT COMPLETED|Overall Study||22||
48500333|NCT03248128|101557889|FG001|NOT COMPLETED|Overall Study||20||
48500334|NCT01675596|101557890|FG000|STARTED|Overall Study||199||
48500335|NCT01675596|101557890|FG000|COMPLETED|Overall Study||191|30 day follow-up|
48500336|NCT01675596|101557890|FG000|NOT COMPLETED|Overall Study||8||
48500337|NCT04060251|101557891|FG000|STARTED|Overall Study||8||
48500338|NCT04060251|101557892|FG001|STARTED|Overall Study||6||
48500339|NCT04060251|101557893|FG002|STARTED|Overall Study||7||
48500340|NCT04060251|101557891|FG000|COMPLETED|Overall Study||0||
48500341|NCT04060251|101557892|FG001|COMPLETED|Overall Study||0||
48500342|NCT04060251|101557893|FG002|COMPLETED|Overall Study||0||
48500343|NCT04060251|101557891|FG000|NOT COMPLETED|Overall Study||8||
48500344|NCT04060251|101557892|FG001|NOT COMPLETED|Overall Study||6||
48500345|NCT04060251|101557893|FG002|NOT COMPLETED|Overall Study||7||
48500346|NCT00096460|101557894|FG000|STARTED|Overall Study||22||
48500347|NCT00096460|101557895|FG001|STARTED|Overall Study||8||
48500348|NCT00096460|101557894|FG000|COMPLETED|Overall Study||15||
48500349|NCT00096460|101557895|FG001|COMPLETED|Overall Study||7||
48500350|NCT00096460|101557894|FG000|NOT COMPLETED|Overall Study||7||
48500351|NCT00096460|101557895|FG001|NOT COMPLETED|Overall Study||1||
48500352|NCT00950300|101557896|FG000|STARTED|Neoadjuvant/Adjuvant Treatment Periods||299||
48500353|NCT00950300|101557897|FG001|STARTED|Neoadjuvant/Adjuvant Treatment Periods||297||
48500354|NCT00950300|101557896|FG000|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||298||
48500355|NCT00950300|101557897|FG001|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||297||
48500356|NCT00950300|101557896|FG000|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||277||
48500357|NCT00950300|101557897|FG001|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||273||
48500358|NCT00950300|101557896|FG000|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||277||
48500359|NCT00950300|101557897|FG001|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||274||
48500360|NCT00950300|101557896|FG000|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||257||
48500361|NCT00950300|101557897|FG001|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||255||
48500362|NCT00950300|101557896|FG000|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42||
48500363|NCT00950300|101557897|FG001|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42||
48500364|NCT00950300|101557896|FG000|STARTED|TFFU Period||265||
48500365|NCT00950300|101557897|FG001|STARTED|TFFU Period||268||
48500366|NCT00950300|101557896|FG000|COMPLETED|TFFU Period||165||
48500367|NCT00950300|101557897|FG001|COMPLETED|TFFU Period||161||
48500368|NCT00950300|101557896|FG000|NOT COMPLETED|TFFU Period||100||
48500369|NCT00950300|101557897|FG001|NOT COMPLETED|TFFU Period||107||
48500370|NCT00950300|101557896|FG000|STARTED|SFU Period||118||
48500371|NCT00950300|101557897|FG001|STARTED|SFU Period||123||
48500372|NCT00950300|101557896|FG000|COMPLETED|SFU Period||40||
48500373|NCT00950300|101557897|FG001|COMPLETED|SFU Period||45||
48500374|NCT00950300|101557896|FG000|NOT COMPLETED|SFU Period||78||
48500375|NCT00950300|101557897|FG001|NOT COMPLETED|SFU Period||78||
48500376|NCT00072514|101557898|FG000|STARTED|Overall Study||55||
48500377|NCT00072514|101557898|FG000|COMPLETED|Overall Study||51||
48500378|NCT00072514|101557898|FG000|NOT COMPLETED|Overall Study||4||
48500379|NCT01753362|101557899|FG000|STARTED|Overall Study||36||
48500380|NCT01753362|101557900|FG001|STARTED|Overall Study||48||
48500381|NCT01753362|101557899|FG000|COMPLETED|Overall Study||26||
48500382|NCT01753362|101557900|FG001|COMPLETED|Overall Study||40||
48500383|NCT01753362|101557899|FG000|NOT COMPLETED|Overall Study||10||
48500384|NCT01753362|101557900|FG001|NOT COMPLETED|Overall Study||8||
48500385|NCT00902538|101557901|FG000|STARTED|1-Single-blind, Run-in, Single-Treatment||2204||
48500386|NCT00902538|101557902|FG001|STARTED|1-Single-blind, Run-in, Single-Treatment||0||
48500387|NCT00902538|101557903|FG002|STARTED|1-Single-blind, Run-in, Single-Treatment||0||
48500388|NCT00902538|101557904|FG003|STARTED|1-Single-blind, Run-in, Single-Treatment||0||
48500389|NCT00902538|101557905|FG004|STARTED|1-Single-blind, Run-in, Single-Treatment||0||
48500390|NCT00902538|101557906|FG005|STARTED|1-Single-blind, Run-in, Single-Treatment||0||
48500391|NCT00902538|101557901|FG000|COMPLETED|1-Single-blind, Run-in, Single-Treatment||2086||
48500392|NCT00902538|101557902|FG001|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0||
48500393|NCT00902538|101557903|FG002|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0||
48500394|NCT00902538|101557904|FG003|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0||
48500395|NCT00902538|101557905|FG004|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0||
48500396|NCT00902538|101557906|FG005|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0||
48500397|NCT00902538|101557901|FG000|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||118||
48500398|NCT00902538|101557902|FG001|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0||
48500399|NCT00902538|101557903|FG002|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0||
48500400|NCT00902538|101557904|FG003|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0||
48500401|NCT00902538|101557905|FG004|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0||
48500402|NCT00902538|101557906|FG005|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0||
48500403|NCT00902538|101557901|FG000|STARTED|2-Randomized Double-blind 3 Treatments||269||
48500404|NCT00902538|101557902|FG001|STARTED|2-Randomized Double-blind 3 Treatments||269||
48500405|NCT00902538|101557903|FG002|STARTED|2-Randomized Double-blind 3 Treatments||270||
48500406|NCT00902538|101557904|FG003|STARTED|2-Randomized Double-blind 3 Treatments||0||
48500407|NCT00902538|101557905|FG004|STARTED|2-Randomized Double-blind 3 Treatments||0||
48500408|NCT00902538|101557906|FG005|STARTED|2-Randomized Double-blind 3 Treatments||0||
48500409|NCT00902538|101557901|FG000|COMPLETED|2-Randomized Double-blind 3 Treatments||260||
48500410|NCT00902538|101557902|FG001|COMPLETED|2-Randomized Double-blind 3 Treatments||263||
48500411|NCT00902538|101557903|FG002|COMPLETED|2-Randomized Double-blind 3 Treatments||262||
48500412|NCT00902538|101557904|FG003|COMPLETED|2-Randomized Double-blind 3 Treatments||0||
48500413|NCT00902538|101557905|FG004|COMPLETED|2-Randomized Double-blind 3 Treatments||0||
48500414|NCT00902538|101557906|FG005|COMPLETED|2-Randomized Double-blind 3 Treatments||0||
48500415|NCT00902538|101557901|FG000|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||9||
48500416|NCT00902538|101557902|FG001|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||6||
48500417|NCT00902538|101557903|FG002|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||8||
48500418|NCT00902538|101557904|FG003|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0||
48500419|NCT00902538|101557905|FG004|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0||
48500420|NCT00902538|101557906|FG005|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0||
48500421|NCT00902538|101557901|FG000|STARTED|3-Single-blind, Single Treatment||0||
48500422|NCT00902538|101557902|FG001|STARTED|3-Single-blind, Single Treatment||782||
48500423|NCT00902538|101557903|FG002|STARTED|3-Single-blind, Single Treatment||0||
48500424|NCT00902538|101557904|FG003|STARTED|3-Single-blind, Single Treatment||0||
48500425|NCT00902538|101557905|FG004|STARTED|3-Single-blind, Single Treatment||0||
48500426|NCT00902538|101557906|FG005|STARTED|3-Single-blind, Single Treatment||0||
48500427|NCT00902538|101557901|FG000|COMPLETED|3-Single-blind, Single Treatment||0||
48500428|NCT00902538|101557902|FG001|COMPLETED|3-Single-blind, Single Treatment||767||
48500429|NCT00902538|101557903|FG002|COMPLETED|3-Single-blind, Single Treatment||0||
48500430|NCT00902538|101557904|FG003|COMPLETED|3-Single-blind, Single Treatment||0||
48500431|NCT00902538|101557905|FG004|COMPLETED|3-Single-blind, Single Treatment||0||
48500432|NCT00902538|101557906|FG005|COMPLETED|3-Single-blind, Single Treatment||0||
48500433|NCT00902538|101557901|FG000|NOT COMPLETED|3-Single-blind, Single Treatment||0||
48500434|NCT00902538|101557902|FG001|NOT COMPLETED|3-Single-blind, Single Treatment||15||
48500435|NCT00902538|101557903|FG002|NOT COMPLETED|3-Single-blind, Single Treatment||0||
48500436|NCT00902538|101557904|FG003|NOT COMPLETED|3-Single-blind, Single Treatment||0||
48500437|NCT00902538|101557905|FG004|NOT COMPLETED|3-Single-blind, Single Treatment||0||
48500438|NCT00902538|101557906|FG005|NOT COMPLETED|3-Single-blind, Single Treatment||0||
48500439|NCT00902538|101557901|FG000|STARTED|4-Randomized Double-blind 2 Treatments||0||
48500440|NCT00902538|101557902|FG001|STARTED|4-Randomized Double-blind 2 Treatments||0||
48500441|NCT00902538|101557903|FG002|STARTED|4-Randomized Double-blind 2 Treatments||0||
48500442|NCT00902538|101557904|FG003|STARTED|4-Randomized Double-blind 2 Treatments||467||
48500443|NCT00902538|101557905|FG004|STARTED|4-Randomized Double-blind 2 Treatments||97||
48500444|NCT00902538|101557906|FG005|STARTED|4-Randomized Double-blind 2 Treatments||197||
48500445|NCT00902538|101557901|FG000|COMPLETED|4-Randomized Double-blind 2 Treatments||0||
48500446|NCT00902538|101557902|FG001|COMPLETED|4-Randomized Double-blind 2 Treatments||0||
48500447|NCT00902538|101557903|FG002|COMPLETED|4-Randomized Double-blind 2 Treatments||0||
48500448|NCT00902538|101557904|FG003|COMPLETED|4-Randomized Double-blind 2 Treatments||458||
48500449|NCT00902538|101557905|FG004|COMPLETED|4-Randomized Double-blind 2 Treatments||95||
48500450|NCT00902538|101557906|FG005|COMPLETED|4-Randomized Double-blind 2 Treatments||196||
48500451|NCT00902538|101557901|FG000|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0||
48500452|NCT00902538|101557902|FG001|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0||
48500453|NCT00902538|101557903|FG002|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0||
48500454|NCT00902538|101557904|FG003|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||9||
48500455|NCT00902538|101557905|FG004|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||2||
48500456|NCT00902538|101557906|FG005|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||1||
48500457|NCT01949532|101557907|FG000|STARTED|Overall Study||15||
48500458|NCT01949532|101557908|FG001|STARTED|Overall Study||11||
48500459|NCT01949532|101557907|FG000|COMPLETED|Overall Study||12||
48500460|NCT01949532|101557908|FG001|COMPLETED|Overall Study||8||
48500461|NCT01949532|101557907|FG000|NOT COMPLETED|Overall Study||3||
48500462|NCT01949532|101557908|FG001|NOT COMPLETED|Overall Study||3||
48500463|NCT01345539|101557909|FG000|STARTED|Overall Study||24||
48500464|NCT01345539|101557909|FG000|COMPLETED|Overall Study||24||
48500465|NCT01345539|101557909|FG000|NOT COMPLETED|Overall Study||0||
48500466|NCT03428750|101557910|FG000|STARTED|Overall Study||210||
48500467|NCT03428750|101557911|FG001|STARTED|Overall Study||213||
48500468|NCT03428750|101557910|FG000|COMPLETED|Overall Study||186||
48500469|NCT03428750|101557911|FG001|COMPLETED|Overall Study||192||
48500470|NCT03428750|101557910|FG000|NOT COMPLETED|Overall Study||24||
48500471|NCT03428750|101557911|FG001|NOT COMPLETED|Overall Study||21||
48500472|NCT03053245|101557912|FG000|STARTED|Overall Study||233||
48500473|NCT03053245|101557913|FG001|STARTED|Overall Study||233||
48500474|NCT03053245|101557912|FG000|COMPLETED|Overall Study||153||
48500475|NCT03053245|101557913|FG001|COMPLETED|Overall Study||147||
48500476|NCT03053245|101557912|FG000|NOT COMPLETED|Overall Study||80||
48500477|NCT03053245|101557913|FG001|NOT COMPLETED|Overall Study||86||
48500478|NCT02611362|101557914|FG000|STARTED|Overall Study||41||
48500479|NCT02611362|101557915|FG001|STARTED|Overall Study||41||
48500480|NCT02611362|101557914|FG000|Immediate Posttest (3 Months)|Overall Study||33||
48500481|NCT02611362|101557915|FG001|Immediate Posttest (3 Months)|Overall Study||34||
48500482|NCT02611362|101557914|FG000|6-month Follow-up|Overall Study||32||
48500483|NCT02611362|101557915|FG001|6-month Follow-up|Overall Study||35||
48500484|NCT02611362|101557914|FG000|COMPLETED|Overall Study||32||
48500485|NCT02611362|101557915|FG001|COMPLETED|Overall Study||35||
48500486|NCT02611362|101557914|FG000|NOT COMPLETED|Overall Study||9||
48500487|NCT02611362|101557915|FG001|NOT COMPLETED|Overall Study||6||
48500488|NCT05562011|101557916|FG000|STARTED|Overall Study||61||
48500489|NCT05562011|101557916|FG000|COMPLETED|Overall Study||39||
48500490|NCT05562011|101557916|FG000|NOT COMPLETED|Overall Study||22||
48500491|NCT01205035|101557917|FG000|STARTED|Overall Study||3||
48500492|NCT01205035|101557918|FG001|STARTED|Overall Study||3||
48500493|NCT01205035|101557917|FG000|COMPLETED|Overall Study||1||
48500494|NCT01205035|101557918|FG001|COMPLETED|Overall Study||3||
48500495|NCT01205035|101557917|FG000|NOT COMPLETED|Overall Study||2||
48500496|NCT01205035|101557918|FG001|NOT COMPLETED|Overall Study||0||
48500497|NCT01243151|101557919|FG000|STARTED|Overall Study||12||
48500498|NCT01243151|101557920|FG001|STARTED|Overall Study||14||
48500499|NCT01243151|101557921|FG002|STARTED|Overall Study||14||
48500500|NCT01243151|101557922|FG003|STARTED|Overall Study||14||
48500501|NCT01243151|101557923|FG004|STARTED|Overall Study||14||
48500502|NCT01243151|101557919|FG000|Treated|Overall Study||12||
48500503|NCT01243151|101557920|FG001|Treated|Overall Study||14||
48500504|NCT01243151|101557921|FG002|Treated|Overall Study||14||
48500505|NCT01243151|101557922|FG003|Treated|Overall Study||13||
48500506|NCT01243151|101557923|FG004|Treated|Overall Study||14||
48500507|NCT01243151|101557919|FG000|COMPLETED|Overall Study||12||
48500508|NCT01243151|101557920|FG001|COMPLETED|Overall Study||13||
48500509|NCT01243151|101557921|FG002|COMPLETED|Overall Study||13||
48500510|NCT01243151|101557922|FG003|COMPLETED|Overall Study||12||
48500511|NCT01243151|101557923|FG004|COMPLETED|Overall Study||14||
48500512|NCT01243151|101557919|FG000|NOT COMPLETED|Overall Study||0||
48500513|NCT01243151|101557920|FG001|NOT COMPLETED|Overall Study||1||
48500514|NCT01243151|101557921|FG002|NOT COMPLETED|Overall Study||1||
48500515|NCT01243151|101557922|FG003|NOT COMPLETED|Overall Study||2||
48500516|NCT01243151|101557923|FG004|NOT COMPLETED|Overall Study||0||
48500517|NCT02429583|101557924|FG000|STARTED|Overall Study||1||
48500518|NCT02429583|101557925|FG001|STARTED|Overall Study||23||
48500519|NCT02429583|101557924|FG000|COMPLETED|Overall Study||1||
48500520|NCT02429583|101557925|FG001|COMPLETED|Overall Study||3||
48500521|NCT02429583|101557924|FG000|NOT COMPLETED|Overall Study||0||
48500522|NCT02429583|101557925|FG001|NOT COMPLETED|Overall Study||20||
48500523|NCT02092857|101560666|FG000|STARTED|Overall Study||30||
48500524|NCT02092857|101560667|FG001|STARTED|Overall Study||30||
48500525|NCT02092857|101560668|FG002|STARTED|Overall Study||29||
48500526|NCT02092857|101560666|FG000|COMPLETED|Overall Study||20||
48500527|NCT02092857|101560667|FG001|COMPLETED|Overall Study||18||
48500528|NCT02092857|101560668|FG002|COMPLETED|Overall Study||16||
48500529|NCT02092857|101560666|FG000|NOT COMPLETED|Overall Study||10||
48500530|NCT02092857|101560667|FG001|NOT COMPLETED|Overall Study||12||
48500531|NCT02092857|101560668|FG002|NOT COMPLETED|Overall Study||13||
48500532|NCT02083809|101560669|FG000|STARTED|Overall Study||82||
48500533|NCT02083809|101560670|FG001|STARTED|Overall Study||84||
48500534|NCT02083809|101560669|FG000|COMPLETED|Overall Study||78||
48500535|NCT02083809|101560670|FG001|COMPLETED|Overall Study||82||
48500536|NCT02083809|101560669|FG000|NOT COMPLETED|Overall Study||4||
48500537|NCT02083809|101560670|FG001|NOT COMPLETED|Overall Study||2||
48500538|NCT04428645|101560671|FG000|STARTED|Run in Visit Training (2 Hours)||25||
48500539|NCT04428645|101560671|FG000|COMPLETED|Run in Visit Training (2 Hours)||25||
48500540|NCT04428645|101560671|FG000|NOT COMPLETED|Run in Visit Training (2 Hours)||0||
48500541|NCT04428645|101560671|FG000|STARTED|First at Home Period (~2 Weeks)||25||
48500542|NCT04428645|101560671|FG000|COMPLETED|First at Home Period (~2 Weeks)||25||
48500543|NCT04428645|101560671|FG000|NOT COMPLETED|First at Home Period (~2 Weeks)||0||
48500544|NCT04428645|101560671|FG000|STARTED|DailyDose Training Visit (2 Hours)||25||
48500545|NCT04428645|101560671|FG000|COMPLETED|DailyDose Training Visit (2 Hours)||25||
48500546|NCT04428645|101560671|FG000|NOT COMPLETED|DailyDose Training Visit (2 Hours)||0||
48500547|NCT04428645|101560671|FG000|STARTED|Second at Home Period (8 Weeks)||25||
48500548|NCT04428645|101560671|FG000|COMPLETED|Second at Home Period (8 Weeks)||24||
48500549|NCT04428645|101560671|FG000|NOT COMPLETED|Second at Home Period (8 Weeks)||1||
48500550|NCT04428645|101560671|FG000|STARTED|Study Close-out Visit (30 Minutes)||24||
48500551|NCT04428645|101560671|FG000|COMPLETED|Study Close-out Visit (30 Minutes)||24||
48500552|NCT04428645|101560671|FG000|NOT COMPLETED|Study Close-out Visit (30 Minutes)||0||
48500553|NCT01944722|101560672|FG000|STARTED|Overall Study||33858||
48500554|NCT01944722|101560672|FG000|COMPLETED|Overall Study||24343||
48500555|NCT01944722|101560672|FG000|NOT COMPLETED|Overall Study||9515||
48500556|NCT01457196|101560673|FG000|STARTED|Overall Study||2074||
48500557|NCT01457196|101560673|FG000|COMPLETED|Overall Study||2074||
48500558|NCT01457196|101560673|FG000|NOT COMPLETED|Overall Study||0||
48500559|NCT01194908|101560674|FG000|STARTED|Overall Study||5||
48500560|NCT01194908|101560674|FG000|COMPLETED|Overall Study||5||
48500561|NCT01194908|101560674|FG000|NOT COMPLETED|Overall Study||0||
48500562|NCT01143337|101560675|FG000|STARTED|Overall Study||49||
48500563|NCT01143337|101560676|FG001|STARTED|Overall Study||50||
48500564|NCT01143337|101560677|FG002|STARTED|Overall Study||13||
48500565|NCT01143337|101560675|FG000|COMPLETED|Overall Study||39||
48500566|NCT01143337|101560676|FG001|COMPLETED|Overall Study||39||
48500567|NCT01143337|101560677|FG002|COMPLETED|Overall Study||1||
48500568|NCT01143337|101560675|FG000|NOT COMPLETED|Overall Study||10||
48500569|NCT01143337|101560676|FG001|NOT COMPLETED|Overall Study||11||
48500570|NCT01143337|101560677|FG002|NOT COMPLETED|Overall Study||12||
48500571|NCT03141151|101560678|FG000|STARTED|Overall Study||59||
48500572|NCT03141151|101560679|FG001|STARTED|Overall Study||58||
48500573|NCT03141151|101560678|FG000|COMPLETED|Overall Study||53||
48500574|NCT03141151|101560679|FG001|COMPLETED|Overall Study||54||
48500575|NCT03141151|101560678|FG000|NOT COMPLETED|Overall Study||6||
48500576|NCT03141151|101560679|FG001|NOT COMPLETED|Overall Study||4||
48500577|NCT00835796|101560680|FG000|STARTED|First Intervention||10||
48500578|NCT00835796|101560681|FG001|STARTED|First Intervention||10||
48500579|NCT00835796|101560680|FG000|COMPLETED|First Intervention||10||
48500580|NCT00835796|101560681|FG001|COMPLETED|First Intervention||9||
48500581|NCT00835796|101560680|FG000|NOT COMPLETED|First Intervention||0||
48500582|NCT00835796|101560681|FG001|NOT COMPLETED|First Intervention||1||
48500583|NCT00835796|101560680|FG000|STARTED|Washout||10||
48500584|NCT00835796|101560681|FG001|STARTED|Washout||9||
48500585|NCT00835796|101560680|FG000|COMPLETED|Washout||10||
48500586|NCT00835796|101560681|FG001|COMPLETED|Washout||9||
48500587|NCT00835796|101560680|FG000|NOT COMPLETED|Washout||0||
48500588|NCT00835796|101560681|FG001|NOT COMPLETED|Washout||0||
48500589|NCT00835796|101560680|FG000|STARTED|Second Intervention||10||
48500590|NCT00835796|101560681|FG001|STARTED|Second Intervention||9||
48500591|NCT00835796|101560680|FG000|COMPLETED|Second Intervention||10||
48500592|NCT00835796|101560681|FG001|COMPLETED|Second Intervention||9||
48500593|NCT00835796|101560680|FG000|NOT COMPLETED|Second Intervention||0||
48500594|NCT00835796|101560681|FG001|NOT COMPLETED|Second Intervention||0||
48500595|NCT05070754|101560682|FG000|STARTED|Overall Study||2|Patients could have up to 20 lesions enrolled. The lesions were randomized 1:1 to receive either CAP or standard of care therapy (cryotherapy for verruca or cantharidin for molluscum). Patients with only one lesion enrolled had that lesion randomized to either CAP or SOC.|2
48500596|NCT05070754|101560683|FG001|STARTED|Overall Study||1|Patients could have up to 20 lesions enrolled. The lesions were randomized 1:1 to receive either CAP or standard of care therapy (cryotherapy for verruca or cantharidin for molluscum). Patients with only one lesion enrolled had that lesion randomized to either CAP or SOC.|1
48500597|NCT05070754|101560684|FG002|STARTED|Overall Study||11|Patients could have up to 20 lesions enrolled. The lesions were randomized 1:1 to receive either CAP or standard of care therapy (cryotherapy for verruca or cantharidin for molluscum). Patients with only one lesion enrolled had that lesion randomized to either CAP or SOC.|109
48500598|NCT05070754|101560685|FG003|STARTED|Overall Study||3|Patients could have up to 20 lesions enrolled. The lesions were randomized 1:1 to receive either CAP or standard of care therapy (cryotherapy for verruca or cantharidin for molluscum). Patients with only one lesion enrolled had that lesion randomized to either CAP or SOC.|37
48500599|NCT05070754|101560682|FG000|CAP|Overall Study||2||2
48500600|NCT05070754|101560683|FG001|CAP|Overall Study||0||0
48500601|NCT05070754|101560684|FG002|CAP|Overall Study||11||54
48500602|NCT05070754|101560685|FG003|CAP|Overall Study||3||19
48500603|NCT05070754|101560682|FG000|Cryotherapy|Overall Study||0||0
48500604|NCT05070754|101560683|FG001|Cryotherapy|Overall Study||1||1
48500605|NCT05070754|101560684|FG002|Cryotherapy|Overall Study||11||55
48500606|NCT05070754|101560685|FG003|Cryotherapy|Overall Study||0||0
48500607|NCT05070754|101560682|FG000|Cantharidin|Overall Study||0||0
48500608|NCT05070754|101560683|FG001|Cantharidin|Overall Study||0||0
48500609|NCT05070754|101560684|FG002|Cantharidin|Overall Study||0||0
48500610|NCT05070754|101560685|FG003|Cantharidin|Overall Study||3||18
48500611|NCT05070754|101560682|FG000|COMPLETED|Overall Study||2||2
48500612|NCT05070754|101560683|FG001|COMPLETED|Overall Study||1||1
48500613|NCT05070754|101560684|FG002|COMPLETED|Overall Study||11||109
48500614|NCT05070754|101560685|FG003|COMPLETED|Overall Study||1||20
48500615|NCT05070754|101560682|FG000|NOT COMPLETED|Overall Study||0||0
48500616|NCT05070754|101560683|FG001|NOT COMPLETED|Overall Study||0||0
48500617|NCT05070754|101560684|FG002|NOT COMPLETED|Overall Study||0||0
48500618|NCT05070754|101560685|FG003|NOT COMPLETED|Overall Study||2||17
48500619|NCT00326872|101560686|FG000|STARTED|Overall Study||26||
48500620|NCT00326872|101560686|FG000|COMPLETED|Overall Study||26||
48500621|NCT00326872|101560686|FG000|NOT COMPLETED|Overall Study||0||
48500622|NCT04010227|101560687|FG000|STARTED|Overall Study||40||
48500623|NCT04010227|101560688|FG001|STARTED|Overall Study||40||
48500624|NCT04010227|101560687|FG000|Patients Started|Overall Study||20||
48500625|NCT04010227|101560688|FG001|Patients Started|Overall Study||20||
48500626|NCT04010227|101560687|FG000|Caregivers Started|Overall Study||20||
48500627|NCT04010227|101560688|FG001|Caregivers Started|Overall Study||20||
48500628|NCT04010227|101560687|FG000|COMPLETED|Overall Study||28||
48500629|NCT04010227|101560688|FG001|COMPLETED|Overall Study||30||
48500630|NCT04010227|101560687|FG000|NOT COMPLETED|Overall Study||12||
48500631|NCT04010227|101560688|FG001|NOT COMPLETED|Overall Study||10||
48500632|NCT02661022|101560689|FG000|STARTED|Overall Study||7||
48500633|NCT02661022|101560690|FG001|STARTED|Overall Study||2||
48500634|NCT02661022|101560689|FG000|COMPLETED|Overall Study||0||
48500635|NCT02661022|101560690|FG001|COMPLETED|Overall Study||0||
48500636|NCT02661022|101560689|FG000|NOT COMPLETED|Overall Study||7||
48500637|NCT02661022|101560690|FG001|NOT COMPLETED|Overall Study||2||
48500638|NCT01496118|101560691|FG000|STARTED|Overall Study||4||
48500639|NCT01496118|101560692|FG001|STARTED|Overall Study||3||
48500640|NCT01496118|101560693|FG002|STARTED|Overall Study||3||
48500641|NCT01496118|101560694|FG003|STARTED|Overall Study||3||
48500642|NCT01496118|101560695|FG004|STARTED|Overall Study||3||
48500643|NCT01496118|101560696|FG005|STARTED|Overall Study||3||
48500644|NCT01496118|101560697|FG006|STARTED|Overall Study||31||
48500645|NCT01496118|101560698|FG007|STARTED|Overall Study||30||
48500646|NCT01496118|101560691|FG000|COMPLETED|Overall Study||0||
48061074|NCT01193842|100470334|FG001|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0||
48500647|NCT01496118|101560692|FG001|COMPLETED|Overall Study||0||
48500648|NCT01496118|101560693|FG002|COMPLETED|Overall Study||0||
48500649|NCT01496118|101560694|FG003|COMPLETED|Overall Study||0||
48500650|NCT01496118|101560695|FG004|COMPLETED|Overall Study||0||
48500651|NCT01496118|101560696|FG005|COMPLETED|Overall Study||0||
48500652|NCT01496118|101560697|FG006|COMPLETED|Overall Study||0||
48500653|NCT01496118|101560698|FG007|COMPLETED|Overall Study||0||
48500654|NCT01496118|101560691|FG000|NOT COMPLETED|Overall Study||4||
48500655|NCT01496118|101560692|FG001|NOT COMPLETED|Overall Study||3||
48500656|NCT01496118|101560693|FG002|NOT COMPLETED|Overall Study||3||
48500657|NCT01496118|101560694|FG003|NOT COMPLETED|Overall Study||3||
48500658|NCT01496118|101560695|FG004|NOT COMPLETED|Overall Study||3||
48500659|NCT01496118|101560696|FG005|NOT COMPLETED|Overall Study||3||
48500660|NCT01496118|101560697|FG006|NOT COMPLETED|Overall Study||31||
48500661|NCT01496118|101560698|FG007|NOT COMPLETED|Overall Study||30||
48500662|NCT02015832|101560699|FG000|STARTED|Overall Study||454||
48500663|NCT02015832|101560699|FG000|COMPLETED|Overall Study||443||
48500664|NCT02015832|101560699|FG000|NOT COMPLETED|Overall Study||11||
48500665|NCT04408924|101560700|FG000|STARTED|Overall Study||44||
48500666|NCT04408924|101560700|FG000|Received at Least One Dose of Study Drug|Overall Study||44||
48500667|NCT04408924|101560700|FG000|COMPLETED|Overall Study||31||
48500668|NCT04408924|101560700|FG000|NOT COMPLETED|Overall Study||13||
48500669|NCT02560051|101560701|FG000|STARTED|Overall Study||6||
48500670|NCT02560051|101560702|FG001|STARTED|Overall Study||8||
48500671|NCT02560051|101560703|FG002|STARTED|Overall Study||5||
48500672|NCT02560051|101560701|FG000|COMPLETED|Overall Study||3||
48500673|NCT02560051|101560702|FG001|COMPLETED|Overall Study||4||
48500674|NCT02560051|101560703|FG002|COMPLETED|Overall Study||4||
48500675|NCT02560051|101560701|FG000|NOT COMPLETED|Overall Study||3||
48500676|NCT02560051|101560702|FG001|NOT COMPLETED|Overall Study||4||
48500677|NCT02560051|101560703|FG002|NOT COMPLETED|Overall Study||1||
48500678|NCT04878211|101560704|FG000|STARTED|Overall Study||5||
48500679|NCT04878211|101560705|FG001|STARTED|Overall Study||2||
48500680|NCT04878211|101560706|FG002|STARTED|Overall Study||0||
48500681|NCT04878211|101560707|FG003|STARTED|Overall Study||1||
48500682|NCT04878211|101560708|FG004|STARTED|Overall Study||11||
48500683|NCT04878211|101560709|FG005|STARTED|Overall Study||5||
48500684|NCT04878211|101560704|FG000|COMPLETED|Overall Study||4||
48500685|NCT04878211|101560705|FG001|COMPLETED|Overall Study||2||
48500686|NCT04878211|101560706|FG002|COMPLETED|Overall Study||0||
48500687|NCT04878211|101560707|FG003|COMPLETED|Overall Study||0||
48500688|NCT04878211|101560708|FG004|COMPLETED|Overall Study||1||
48500689|NCT04878211|101560709|FG005|COMPLETED|Overall Study||0||
48500690|NCT04878211|101560704|FG000|NOT COMPLETED|Overall Study||1||
48500691|NCT04878211|101560705|FG001|NOT COMPLETED|Overall Study||0||
48500692|NCT04878211|101560706|FG002|NOT COMPLETED|Overall Study||0||
48500693|NCT04878211|101560707|FG003|NOT COMPLETED|Overall Study||1||
48500694|NCT04878211|101560708|FG004|NOT COMPLETED|Overall Study||10||
48500695|NCT04878211|101560709|FG005|NOT COMPLETED|Overall Study||5||
48500696|NCT04535986|101560710|FG000|STARTED|Overall Study||479||
48500697|NCT04535986|101560711|FG001|STARTED|Overall Study||284||
48500698|NCT04535986|101560710|FG000|Received Treatment|Overall Study||477||
48500699|NCT04535986|101560711|FG001|Received Treatment|Overall Study||283||
48500700|NCT04535986|101560710|FG000|COMPLETED|Overall Study||400||
48500701|NCT04535986|101560711|FG001|COMPLETED|Overall Study||245||
48500702|NCT04535986|101560710|FG000|NOT COMPLETED|Overall Study||79||
48500703|NCT04535986|101560711|FG001|NOT COMPLETED|Overall Study||39||
48500704|NCT02161705|101560712|FG000|STARTED|Overall Study||9||
48500705|NCT02161705|101560713|FG001|STARTED|Overall Study||9||
48500706|NCT02161705|101560712|FG000|COMPLETED|Overall Study||9||
48500707|NCT02161705|101560713|FG001|COMPLETED|Overall Study||9||
48500708|NCT02161705|101560712|FG000|NOT COMPLETED|Overall Study||0||
48500709|NCT02161705|101560713|FG001|NOT COMPLETED|Overall Study||0||
48500710|NCT00538863|101560714|FG000|STARTED|Open-label Titration||229||
48500711|NCT00538863|101560714|FG000|COMPLETED|Open-label Titration||184||
48500712|NCT00538863|101560714|FG000|NOT COMPLETED|Open-label Titration||45||
48500713|NCT00538863|101560714|FG000|STARTED|Open-label Maintenance||269||
48500714|NCT00538863|101560714|FG000|COMPLETED|Open-label Maintenance||163||
48500715|NCT00538863|101560714|FG000|NOT COMPLETED|Open-label Maintenance||106||
48500716|NCT04203667|101560715|FG000|STARTED|Overall Study||66|Intent to Treat Population|
48500717|NCT04203667|101560715|FG000|Per Protocol Population|Overall Study||45||
48500718|NCT04203667|101560715|FG000|COMPLETED|Overall Study||62||
48500719|NCT04203667|101560715|FG000|NOT COMPLETED|Overall Study||4||
48500720|NCT01327976|101560716|FG000|STARTED|Overall Study||162||
48500721|NCT01327976|101560717|FG001|STARTED|Overall Study||77||
48500722|NCT01327976|101560716|FG000|COMPLETED|Overall Study||154||
48500723|NCT01327976|101560717|FG001|COMPLETED|Overall Study||70||
48500724|NCT01327976|101560716|FG000|NOT COMPLETED|Overall Study||8||
48500725|NCT01327976|101560717|FG001|NOT COMPLETED|Overall Study||7||
48500726|NCT00862563|101560718|FG000|STARTED|Overall Study||19||
48500727|NCT00862563|101560719|FG001|STARTED|Overall Study||21||
48500728|NCT00862563|101560720|FG002|STARTED|Overall Study||21||
48500729|NCT00862563|101560721|FG003|STARTED|Overall Study||24||
48500730|NCT00862563|101560718|FG000|COMPLETED|Overall Study||15||
48500731|NCT00862563|101560719|FG001|COMPLETED|Overall Study||17||
48500732|NCT00862563|101560720|FG002|COMPLETED|Overall Study||15||
48500733|NCT00862563|101560721|FG003|COMPLETED|Overall Study||19||
48500734|NCT00862563|101560718|FG000|NOT COMPLETED|Overall Study||4||
48500735|NCT00862563|101560719|FG001|NOT COMPLETED|Overall Study||4||
48500736|NCT00862563|101560720|FG002|NOT COMPLETED|Overall Study||6||
48500737|NCT00862563|101560721|FG003|NOT COMPLETED|Overall Study||5||
48500738|NCT00486434|101560722|FG000|STARTED|Overall Study||588||
48500739|NCT00486434|101560723|FG001|STARTED|Overall Study||588||
48500740|NCT00486434|101560722|FG000|COMPLETED|Overall Study||394||
48500741|NCT00486434|101560723|FG001|COMPLETED|Overall Study||454||
48500742|NCT00486434|101560722|FG000|NOT COMPLETED|Overall Study||194||
48500743|NCT00486434|101560723|FG001|NOT COMPLETED|Overall Study||134||
48500744|NCT00288704|101560724|FG000|STARTED|Part A, Double Blind, Weeks 1-6||24||
48061075|NCT01193842|100470335|FG002|NOT COMPLETED|Phase I: VR-CHOP, DL 1||1||
48061076|NCT01193842|100470336|FG003|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0||
48061077|NCT01193842|100470337|FG004|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0||
48061078|NCT01193842|100470333|FG000|STARTED|Phase II: Randomized Groups||0||
48061079|NCT01193842|100470334|FG001|STARTED|Phase II: Randomized Groups||0||
48061080|NCT01193842|100470335|FG002|STARTED|Phase II: Randomized Groups||0||
48061081|NCT01193842|100470336|FG003|STARTED|Phase II: Randomized Groups||45||
48500745|NCT00288704|101560725|FG001|STARTED|Part A, Double Blind, Weeks 1-6||23||
48500746|NCT00288704|101560726|FG002|STARTED|Part A, Double Blind, Weeks 1-6||0||
48500747|NCT00288704|101560724|FG000|COMPLETED|Part A, Double Blind, Weeks 1-6||24||
48500748|NCT00288704|101560725|FG001|COMPLETED|Part A, Double Blind, Weeks 1-6||22||
48500749|NCT00288704|101560726|FG002|COMPLETED|Part A, Double Blind, Weeks 1-6||0||
48500750|NCT00288704|101560724|FG000|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0||
48500751|NCT00288704|101560725|FG001|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||1||
48500752|NCT00288704|101560726|FG002|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0||
48500753|NCT00288704|101560724|FG000|STARTED|Part B, Randomized Withdrawal, Wks 15-24||23||
48500754|NCT00288704|101560725|FG001|STARTED|Part B, Randomized Withdrawal, Wks 15-24||22||
48500755|NCT00288704|101560726|FG002|STARTED|Part B, Randomized Withdrawal, Wks 15-24||0||
48500756|NCT00288704|101560724|FG000|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||23||
48500757|NCT00288704|101560725|FG001|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||21||
48500758|NCT00288704|101560726|FG002|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0||
48500759|NCT00288704|101560724|FG000|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0||
48500760|NCT00288704|101560725|FG001|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||1||
48500761|NCT00288704|101560726|FG002|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0||
48500762|NCT00288704|101560724|FG000|STARTED|Open-Label Extension (OLE) Weeks 24-117||0||
48500763|NCT00288704|101560725|FG001|STARTED|Open-Label Extension (OLE) Weeks 24-117||0||
48500764|NCT00288704|101560726|FG002|STARTED|Open-Label Extension (OLE) Weeks 24-117||101||
48500765|NCT00288704|101560724|FG000|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0||
48500766|NCT00288704|101560725|FG001|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0||
48500767|NCT00288704|101560726|FG002|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||81||
48500768|NCT00288704|101560724|FG000|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0||
48500769|NCT00288704|101560725|FG001|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0||
48500770|NCT00288704|101560726|FG002|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||20||
48500771|NCT03888235|101560727|FG000|STARTED|Overall Study||21||
48500772|NCT03888235|101560728|FG001|STARTED|Overall Study||21||
48500773|NCT03888235|101560729|FG002|STARTED|Overall Study||20||
48500774|NCT03888235|101560727|FG000|COMPLETED|Overall Study||20||
48500775|NCT03888235|101560728|FG001|COMPLETED|Overall Study||20||
48500776|NCT03888235|101560729|FG002|COMPLETED|Overall Study||20||
48500777|NCT03888235|101560727|FG000|NOT COMPLETED|Overall Study||1||
48500778|NCT03888235|101560728|FG001|NOT COMPLETED|Overall Study||1||
48500779|NCT03888235|101560729|FG002|NOT COMPLETED|Overall Study||0||
48500780|NCT01790685|101560730|FG000|STARTED|Overall Study||23||
48500781|NCT01790685|101560731|FG001|STARTED|Overall Study||17||
48500782|NCT01790685|101560730|FG000|COMPLETED|Overall Study||23||
48500783|NCT01790685|101560731|FG001|COMPLETED|Overall Study||17||
48500784|NCT01790685|101560730|FG000|NOT COMPLETED|Overall Study||0||
48500785|NCT01790685|101560731|FG001|NOT COMPLETED|Overall Study||0||
48500786|NCT02627001|101560732|FG000|STARTED|Overall Study||13||
48500787|NCT02627001|101560733|FG001|STARTED|Overall Study||14||
48500788|NCT02627001|101560732|FG000|COMPLETED|Overall Study||13||
48500789|NCT02627001|101560733|FG001|COMPLETED|Overall Study||14||
48500790|NCT02627001|101560732|FG000|NOT COMPLETED|Overall Study||0||
48500791|NCT02627001|101560733|FG001|NOT COMPLETED|Overall Study||0||
48500792|NCT01286805|101560734|FG000|STARTED|Overall Study||41||
48500793|NCT01286805|101560735|FG001|STARTED|Overall Study||42||
48500794|NCT01286805|101560734|FG000|COMPLETED|Overall Study||41||
48500795|NCT01286805|101560735|FG001|COMPLETED|Overall Study||41||
48500796|NCT01286805|101560734|FG000|NOT COMPLETED|Overall Study||0||
48500797|NCT01286805|101560735|FG001|NOT COMPLETED|Overall Study||1||
48500798|NCT01015287|101560736|FG000|STARTED|Overall Study||1996||
48500799|NCT01015287|101560737|FG001|STARTED|Overall Study||2037||
48500800|NCT01015287|101560736|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1996||
48500801|NCT01015287|101560737|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2037||
48500802|NCT01015287|101560736|FG000|COMPLETED|Overall Study||1924||
48500803|NCT01015287|101560737|FG001|COMPLETED|Overall Study||1958||
48500804|NCT01015287|101560736|FG000|NOT COMPLETED|Overall Study||72||
48500805|NCT01015287|101560737|FG001|NOT COMPLETED|Overall Study||79||
48500806|NCT03234907|101560738|FG000|STARTED|Induction Phase (Week 0 to Week 10)||71||
48500807|NCT03234907|101560739|FG001|STARTED|Induction Phase (Week 0 to Week 10)||144||
48500808|NCT03234907|101560740|FG002|STARTED|Induction Phase (Week 0 to Week 10)||0||
48500809|NCT03234907|101560741|FG003|STARTED|Induction Phase (Week 0 to Week 10)||0||
48500810|NCT03234907|101560742|FG004|STARTED|Induction Phase (Week 0 to Week 10)||0||
48500811|NCT03234907|101560743|FG005|STARTED|Induction Phase (Week 0 to Week 10)||0||
48500812|NCT03234907|101560738|FG000|Treated|Induction Phase (Week 0 to Week 10)||70|Full Analysis Set (FAS) for the induction phase study included all randomized participants who received any amount of blinded study drug during the Induction Phase.|
48500813|NCT03234907|101560739|FG001|Treated|Induction Phase (Week 0 to Week 10)||144|Full Analysis Set (FAS) for the induction phase study included all randomized participants who received any amount of blinded study drug during the Induction Phase.|
48500814|NCT03234907|101560740|FG002|Treated|Induction Phase (Week 0 to Week 10)||0|Full Analysis Set (FAS) for the induction phase study included all randomized participants who received any amount of blinded study drug during the Induction Phase.|
48500815|NCT03234907|101560741|FG003|Treated|Induction Phase (Week 0 to Week 10)||0|Full Analysis Set (FAS) for the induction phase study included all randomized participants who received any amount of blinded study drug during the Induction Phase.|
48500816|NCT03234907|101560742|FG004|Treated|Induction Phase (Week 0 to Week 10)||0|Full Analysis Set (FAS) for the induction phase study included all randomized participants who received any amount of blinded study drug during the Induction Phase.|
48500817|NCT03234907|101560743|FG005|Treated|Induction Phase (Week 0 to Week 10)||0|Full Analysis Set (FAS) for the induction phase study included all randomized participants who received any amount of blinded study drug during the Induction Phase.|
48500818|NCT03234907|101560738|FG000|COMPLETED|Induction Phase (Week 0 to Week 10)||61|Completed = Participants who completed the treatment.|
48500819|NCT03234907|101560739|FG001|COMPLETED|Induction Phase (Week 0 to Week 10)||138|Completed = Participants who completed the treatment.|
48500820|NCT03234907|101560740|FG002|COMPLETED|Induction Phase (Week 0 to Week 10)||0|Completed = Participants who completed the treatment.|
48500821|NCT03234907|101560741|FG003|COMPLETED|Induction Phase (Week 0 to Week 10)||0|Completed = Participants who completed the treatment.|
48500822|NCT03234907|101560742|FG004|COMPLETED|Induction Phase (Week 0 to Week 10)||0|Completed = Participants who completed the treatment.|
48500823|NCT03234907|101560743|FG005|COMPLETED|Induction Phase (Week 0 to Week 10)||0|Completed = Participants who completed the treatment.|
48500824|NCT03234907|101560738|FG000|NOT COMPLETED|Induction Phase (Week 0 to Week 10)||10||
48500825|NCT03234907|101560739|FG001|NOT COMPLETED|Induction Phase (Week 0 to Week 10)||6||
48500826|NCT03234907|101560740|FG002|NOT COMPLETED|Induction Phase (Week 0 to Week 10)||0||
48500827|NCT03234907|101560741|FG003|NOT COMPLETED|Induction Phase (Week 0 to Week 10)||0||
48500828|NCT03234907|101560742|FG004|NOT COMPLETED|Induction Phase (Week 0 to Week 10)||0||
48500829|NCT03234907|101560743|FG005|NOT COMPLETED|Induction Phase (Week 0 to Week 10)||0||
48500830|NCT03234907|101560738|FG000|STARTED|Maintenance Phase (Week 10 to Week 60)||0||
48500831|NCT03234907|101560739|FG001|STARTED|Maintenance Phase (Week 10 to Week 60)||0||
48500832|NCT03234907|101560740|FG002|STARTED|Maintenance Phase (Week 10 to Week 60)||18||
48500833|NCT03234907|101560741|FG003|STARTED|Maintenance Phase (Week 10 to Week 60)||38||
48500834|NCT03234907|101560742|FG004|STARTED|Maintenance Phase (Week 10 to Week 60)||46||
48500835|NCT03234907|101560743|FG005|STARTED|Maintenance Phase (Week 10 to Week 60)||88||
48500836|NCT03234907|101560738|FG000|COMPLETED|Maintenance Phase (Week 10 to Week 60)||0||
48500837|NCT03234907|101560739|FG001|COMPLETED|Maintenance Phase (Week 10 to Week 60)||0||
48500838|NCT03234907|101560740|FG002|COMPLETED|Maintenance Phase (Week 10 to Week 60)||17||
48500839|NCT03234907|101560741|FG003|COMPLETED|Maintenance Phase (Week 10 to Week 60)||27||
48500840|NCT03234907|101560742|FG004|COMPLETED|Maintenance Phase (Week 10 to Week 60)||36||
48500841|NCT03234907|101560743|FG005|COMPLETED|Maintenance Phase (Week 10 to Week 60)||67||
48500842|NCT03234907|101560738|FG000|NOT COMPLETED|Maintenance Phase (Week 10 to Week 60)||0||
48500843|NCT03234907|101560739|FG001|NOT COMPLETED|Maintenance Phase (Week 10 to Week 60)||0||
48500844|NCT03234907|101560740|FG002|NOT COMPLETED|Maintenance Phase (Week 10 to Week 60)||1||
48500845|NCT03234907|101560741|FG003|NOT COMPLETED|Maintenance Phase (Week 10 to Week 60)||11||
48500846|NCT03234907|101560742|FG004|NOT COMPLETED|Maintenance Phase (Week 10 to Week 60)||10||
48500847|NCT03234907|101560743|FG005|NOT COMPLETED|Maintenance Phase (Week 10 to Week 60)||21||
48500848|NCT04768114|101560744|FG000|STARTED|Overall Study||74||
48500849|NCT04768114|101560745|FG001|STARTED|Overall Study||74||
48500850|NCT04768114|101560744|FG000|COMPLETED|Overall Study||69||
48500851|NCT04768114|101560745|FG001|COMPLETED|Overall Study||63||
48500852|NCT04768114|101560744|FG000|NOT COMPLETED|Overall Study||5||
48500853|NCT04768114|101560745|FG001|NOT COMPLETED|Overall Study||11||
48500854|NCT02533466|101560746|FG000|STARTED|Overall Study||16||
48500855|NCT02533466|101560747|FG001|STARTED|Overall Study||14||
48500856|NCT02533466|101560746|FG000|COMPLETED|Overall Study||16||
48500857|NCT02533466|101560747|FG001|COMPLETED|Overall Study||14||
48500858|NCT02533466|101560746|FG000|NOT COMPLETED|Overall Study||0||
48500859|NCT02533466|101560747|FG001|NOT COMPLETED|Overall Study||0||
48500860|NCT00697827|101560748|FG000|STARTED|Overall Study||28||
48500861|NCT00697827|101560749|FG001|STARTED|Overall Study||16||
48500862|NCT00697827|101560748|FG000|COMPLETED|Overall Study||26||
48500863|NCT00697827|101560749|FG001|COMPLETED|Overall Study||15||
48500864|NCT00697827|101560748|FG000|NOT COMPLETED|Overall Study||2||
48500865|NCT00697827|101560749|FG001|NOT COMPLETED|Overall Study||1||
48500866|NCT00385736|101560750|FG000|STARTED|Efficacy Analysis Set - Induction||130||
48500867|NCT00385736|101560751|FG001|STARTED|Efficacy Analysis Set - Induction||130||
48500868|NCT00385736|101560752|FG002|STARTED|Efficacy Analysis Set - Induction||130||
48500869|NCT00385736|101560750|FG000|COMPLETED|Efficacy Analysis Set - Induction||121||
48500870|NCT00385736|101560751|FG001|COMPLETED|Efficacy Analysis Set - Induction||118||
48500871|NCT00385736|101560752|FG002|COMPLETED|Efficacy Analysis Set - Induction||121||
48500872|NCT00385736|101560750|FG000|NOT COMPLETED|Efficacy Analysis Set - Induction||9||
48500873|NCT00385736|101560751|FG001|NOT COMPLETED|Efficacy Analysis Set - Induction||12||
48500874|NCT00385736|101560752|FG002|NOT COMPLETED|Efficacy Analysis Set - Induction||9||
48500875|NCT00385736|101560750|FG000|STARTED|Efficacy Analysis Set - Maintenance||222||
48500876|NCT00385736|101560751|FG001|STARTED|Efficacy Analysis Set - Maintenance||130||
48500877|NCT00385736|101560752|FG002|STARTED|Efficacy Analysis Set - Maintenance||223||
48500878|NCT00385736|101560750|FG000|COMPLETED|Efficacy Analysis Set - Maintenance||153||
48500879|NCT00385736|101560751|FG001|COMPLETED|Efficacy Analysis Set - Maintenance||86||
48500880|NCT00385736|101560752|FG002|COMPLETED|Efficacy Analysis Set - Maintenance||143||
48500881|NCT00385736|101560750|FG000|NOT COMPLETED|Efficacy Analysis Set - Maintenance||69||
48500882|NCT00385736|101560751|FG001|NOT COMPLETED|Efficacy Analysis Set - Maintenance||44||
48500883|NCT00385736|101560752|FG002|NOT COMPLETED|Efficacy Analysis Set - Maintenance||80||
48500884|NCT00385736|101560750|FG000|STARTED|Safety Analysis Set||223||
48500885|NCT00385736|101560751|FG001|STARTED|Safety Analysis Set||130||
48500886|NCT00385736|101560752|FG002|STARTED|Safety Analysis Set||223||
48500887|NCT00385736|101560750|FG000|COMPLETED|Safety Analysis Set||153||
48500888|NCT00385736|101560751|FG001|COMPLETED|Safety Analysis Set||86||
48500889|NCT00385736|101560752|FG002|COMPLETED|Safety Analysis Set||143||
48500890|NCT00385736|101560750|FG000|NOT COMPLETED|Safety Analysis Set||70||
48500891|NCT00385736|101560751|FG001|NOT COMPLETED|Safety Analysis Set||44||
48500892|NCT00385736|101560752|FG002|NOT COMPLETED|Safety Analysis Set||80||
48500893|NCT00287053|101560753|FG000|STARTED|Overall Study||30||
48500894|NCT00287053|101560754|FG001|STARTED|Overall Study||27||
48500895|NCT00287053|101560753|FG000|COMPLETED|Overall Study||26||
48500896|NCT00287053|101560754|FG001|COMPLETED|Overall Study||26||
48500897|NCT00287053|101560753|FG000|NOT COMPLETED|Overall Study||4||
48500898|NCT00287053|101560754|FG001|NOT COMPLETED|Overall Study||1||
48500899|NCT02483416|101560755|FG000|STARTED|Overall Study||21||
48500900|NCT02483416|101560756|FG001|STARTED|Overall Study||7||
48500901|NCT02483416|101560755|FG000|COMPLETED|Overall Study||18||
48500902|NCT02483416|101560756|FG001|COMPLETED|Overall Study||6||
48500903|NCT02483416|101560755|FG000|NOT COMPLETED|Overall Study||3||
48500904|NCT02483416|101560756|FG001|NOT COMPLETED|Overall Study||1||
48500905|NCT00659828|101560757|FG000|STARTED|Overall Study||1||
48500906|NCT00659828|101560757|FG000|COMPLETED|Overall Study||1||
48500907|NCT00659828|101560757|FG000|NOT COMPLETED|Overall Study||0||
48500908|NCT01492439|101560758|FG000|STARTED|Overall Study||19||
48500909|NCT01492439|101560759|FG001|STARTED|Overall Study||18||
48500910|NCT01492439|101560758|FG000|Post-intervention|Overall Study||18||
48500911|NCT01492439|101560759|FG001|Post-intervention|Overall Study||13||
48500912|NCT01492439|101560758|FG000|COMPLETED|Overall Study||15||
48500913|NCT01492439|101560759|FG001|COMPLETED|Overall Study||9||
48500914|NCT01492439|101560758|FG000|NOT COMPLETED|Overall Study||4||
48500915|NCT01492439|101560759|FG001|NOT COMPLETED|Overall Study||9||
48500916|NCT05665387|101560760|FG000|STARTED|Overall Study||30||
48500917|NCT05665387|101560761|FG001|STARTED|Overall Study||33||
48500918|NCT05665387|101560762|FG002|STARTED|Overall Study||16||
48500919|NCT05665387|101560760|FG000|COMPLETED|Overall Study||29||
48500920|NCT05665387|101560761|FG001|COMPLETED|Overall Study||33||
48500921|NCT05665387|101560762|FG002|COMPLETED|Overall Study||15||
48500922|NCT05665387|101560760|FG000|NOT COMPLETED|Overall Study||1||
48500923|NCT05665387|101560761|FG001|NOT COMPLETED|Overall Study||0||
48500924|NCT05665387|101560762|FG002|NOT COMPLETED|Overall Study||1||
48500925|NCT05278858|101560763|FG000|STARTED|Overall Study||3||
48500926|NCT05278858|101560763|FG000|COMPLETED|Overall Study||2||
48500927|NCT05278858|101560763|FG000|NOT COMPLETED|Overall Study||1||
48500928|NCT03504085|101560764|FG000|STARTED|End of Intervention - 12 Weeks||24||
48500929|NCT03504085|101560765|FG001|STARTED|End of Intervention - 12 Weeks||25||
48500930|NCT03504085|101560764|FG000|COMPLETED|End of Intervention - 12 Weeks||21||
48500931|NCT03504085|101560765|FG001|COMPLETED|End of Intervention - 12 Weeks||21||
48500932|NCT03504085|101560764|FG000|NOT COMPLETED|End of Intervention - 12 Weeks||3||
48500933|NCT03504085|101560765|FG001|NOT COMPLETED|End of Intervention - 12 Weeks||4||
48500934|NCT03504085|101560764|FG000|STARTED|Final Assessment - 6 Months||24||
48500935|NCT03504085|101560765|FG001|STARTED|Final Assessment - 6 Months||25||
48500936|NCT03504085|101560764|FG000|COMPLETED|Final Assessment - 6 Months||19||
48500937|NCT03504085|101560765|FG001|COMPLETED|Final Assessment - 6 Months||20||
48500938|NCT03504085|101560764|FG000|NOT COMPLETED|Final Assessment - 6 Months||5||
48500939|NCT03504085|101560765|FG001|NOT COMPLETED|Final Assessment - 6 Months||5||
48500940|NCT01909713|101560766|FG000|STARTED|Overall Study||35||
48500941|NCT01909713|101560766|FG000|COMPLETED|Overall Study||35||
48500942|NCT01909713|101560766|FG000|NOT COMPLETED|Overall Study||0||
48666752|NCT03391882|101970469|FG004|COMPLETED|Part A - Titration Phase||18|Part A|
48061082|NCT01193842|100470337|FG004|STARTED|Phase II: Randomized Groups||46||
48061083|NCT01193842|100470333|FG000|COMPLETED|Phase II: Randomized Groups||0||
48500943|NCT02705716|101560767|FG000|STARTED|Overall Study||72||
48500944|NCT02705716|101560768|FG001|STARTED|Overall Study||70||
48500945|NCT02705716|101560767|FG000|COMPLETED|Overall Study||68||
48500946|NCT02705716|101560768|FG001|COMPLETED|Overall Study||68||
48500947|NCT02705716|101560767|FG000|NOT COMPLETED|Overall Study||4||
48500948|NCT02705716|101560768|FG001|NOT COMPLETED|Overall Study||2||
48500949|NCT01050764|101560769|FG000|STARTED|Overall Study||10||
48500950|NCT01050764|101560769|FG000|Received HSCT Graft|Overall Study||8||
48500951|NCT01050764|101560769|FG000|Received Infusion of T-reg Cells|Overall Study||7||
48500952|NCT01050764|101560769|FG000|Received Infusion of T-con Cells|Overall Study||7||
48500953|NCT01050764|101560769|FG000|COMPLETED|Overall Study||7||
48500954|NCT01050764|101560769|FG000|NOT COMPLETED|Overall Study||3||
48500955|NCT03439085|101560770|FG000|STARTED|Overall Study||41||
48500956|NCT03439085|101560770|FG000|COMPLETED|Overall Study||19||
48500957|NCT03439085|101560770|FG000|NOT COMPLETED|Overall Study||22||
48500958|NCT03264092|101560771|FG000|STARTED|Overall Study||17||
48500959|NCT03264092|101560772|FG001|STARTED|Overall Study||20||
48500960|NCT03264092|101560773|FG002|STARTED|Overall Study||18||
48500961|NCT03264092|101560771|FG000|COMPLETED|Overall Study||17||
48500962|NCT03264092|101560772|FG001|COMPLETED|Overall Study||20||
48500963|NCT03264092|101560773|FG002|COMPLETED|Overall Study||18||
48500964|NCT03264092|101560771|FG000|NOT COMPLETED|Overall Study||0||
48500965|NCT03264092|101560772|FG001|NOT COMPLETED|Overall Study||0||
48500966|NCT03264092|101560773|FG002|NOT COMPLETED|Overall Study||0||
48500967|NCT01169038|101560774|FG000|STARTED|Overall Study||15||
48500968|NCT01169038|101560774|FG000|COMPLETED|Overall Study||8||
48500969|NCT01169038|101560774|FG000|NOT COMPLETED|Overall Study||7||
48500970|NCT01533038|101560775|FG000|STARTED|Overall Study||45||
48500971|NCT01533038|101560776|FG001|STARTED|Overall Study||35||
48500972|NCT01533038|101560775|FG000|COMPLETED|Overall Study||45||
48500973|NCT01533038|101560776|FG001|COMPLETED|Overall Study||34||
48500974|NCT01533038|101560775|FG000|NOT COMPLETED|Overall Study||0||
48500975|NCT01533038|101560776|FG001|NOT COMPLETED|Overall Study||1||
48500976|NCT00414726|101560777|FG000|STARTED|Overall Study||43||
48500977|NCT00414726|101560778|FG001|STARTED|Overall Study||42||
48500978|NCT00414726|101560777|FG000|COMPLETED|Overall Study||43||
48500979|NCT00414726|101560778|FG001|COMPLETED|Overall Study||41||
48500980|NCT00414726|101560777|FG000|NOT COMPLETED|Overall Study||0||
48500981|NCT00414726|101560778|FG001|NOT COMPLETED|Overall Study||1||
48500982|NCT02005276|101560779|FG000|STARTED|Overall Study||65||
48500983|NCT02005276|101560780|FG001|STARTED|Overall Study||41||
48500984|NCT02005276|101560781|FG002|STARTED|Overall Study||59||
48500985|NCT02005276|101560782|FG003|STARTED|Overall Study||44||
48500986|NCT02005276|101560779|FG000|Completed Intervention|Overall Study||61||
48500987|NCT02005276|101560780|FG001|Completed Intervention|Overall Study||39||
48500988|NCT02005276|101560781|FG002|Completed Intervention|Overall Study||56||
48500989|NCT02005276|101560782|FG003|Completed Intervention|Overall Study||42||
48500990|NCT02005276|101560779|FG000|COMPLETED|Overall Study||60|Completed follow-up|
48500991|NCT02005276|101560780|FG001|COMPLETED|Overall Study||39|Completed follow-up|
48500992|NCT02005276|101560781|FG002|COMPLETED|Overall Study||56|Completed follow-up|
48500993|NCT02005276|101560782|FG003|COMPLETED|Overall Study||41|Completed follow-up|
48500994|NCT02005276|101560779|FG000|NOT COMPLETED|Overall Study||5||
48500995|NCT02005276|101560780|FG001|NOT COMPLETED|Overall Study||2||
48500996|NCT02005276|101560781|FG002|NOT COMPLETED|Overall Study||3||
48500997|NCT02005276|101560782|FG003|NOT COMPLETED|Overall Study||3||
48500998|NCT03031795|101560783|FG000|STARTED|Overall Study||35||
48500999|NCT03031795|101560784|FG001|STARTED|Overall Study||36||
48501000|NCT03031795|101560783|FG000|COMPLETED|Overall Study||35||
48501001|NCT03031795|101560784|FG001|COMPLETED|Overall Study||35||
48501002|NCT03031795|101560783|FG000|NOT COMPLETED|Overall Study||0||
48501003|NCT03031795|101560784|FG001|NOT COMPLETED|Overall Study||1||
48501004|NCT02694536|101560785|FG000|STARTED|Overall Study||80||
48501005|NCT02694536|101560785|FG000|COMPLETED|Overall Study||0||
48501006|NCT02694536|101560785|FG000|NOT COMPLETED|Overall Study||80||
48501007|NCT00548431|101560786|FG000|STARTED|Overall Study||38||
48501008|NCT00548431|101560786|FG000|COMPLETED|Overall Study||38||
48501009|NCT00548431|101560786|FG000|NOT COMPLETED|Overall Study||0||
48501010|NCT02003391|101560787|FG000|STARTED|Overall Study||81||
48501011|NCT02003391|101560788|FG001|STARTED|Overall Study||75||
48501012|NCT02003391|101560787|FG000|Safety Population|Overall Study||81||
48501013|NCT02003391|101560788|FG001|Safety Population|Overall Study||75||
48501014|NCT02003391|101560787|FG000|Intent to Treat Population|Overall Study||78||
48501015|NCT02003391|101560788|FG001|Intent to Treat Population|Overall Study||73||
48501016|NCT02003391|101560787|FG000|COMPLETED|Overall Study||78||
48501017|NCT02003391|101560788|FG001|COMPLETED|Overall Study||73||
48501018|NCT02003391|101560787|FG000|NOT COMPLETED|Overall Study||3||
48501019|NCT02003391|101560788|FG001|NOT COMPLETED|Overall Study||2||
48501020|NCT00420095|101560789|FG000|STARTED|Overall Study||57||
48501021|NCT00420095|101560790|FG001|STARTED|Overall Study||60||
48501022|NCT00420095|101560789|FG000|COMPLETED|Overall Study||54||
48501023|NCT00420095|101560790|FG001|COMPLETED|Overall Study||59||
48501024|NCT00420095|101560789|FG000|NOT COMPLETED|Overall Study||3||
48501025|NCT00420095|101560790|FG001|NOT COMPLETED|Overall Study||1||
48501026|NCT01055834|101560791|FG000|STARTED|Treatment Period I||21||
48501027|NCT01055834|101560792|FG001|STARTED|Treatment Period I||21||
48501028|NCT01055834|101560791|FG000|COMPLETED|Treatment Period I||20||
48501029|NCT01055834|101560792|FG001|COMPLETED|Treatment Period I||21||
48501030|NCT01055834|101560791|FG000|NOT COMPLETED|Treatment Period I||1||
48501031|NCT01055834|101560792|FG001|NOT COMPLETED|Treatment Period I||0||
48501032|NCT01055834|101560791|FG000|STARTED|Treatment Period II||20||
48501033|NCT01055834|101560792|FG001|STARTED|Treatment Period II||21||
48501034|NCT01055834|101560791|FG000|COMPLETED|Treatment Period II||20||
48501035|NCT01055834|101560792|FG001|COMPLETED|Treatment Period II||21||
48501036|NCT01055834|101560791|FG000|NOT COMPLETED|Treatment Period II||0||
48501037|NCT01055834|101560792|FG001|NOT COMPLETED|Treatment Period II||0||
48501038|NCT01055834|101560791|FG000|STARTED|Treatment Period III||0||
48501039|NCT01055834|101560792|FG001|STARTED|Treatment Period III||14||
48501040|NCT01055834|101560791|FG000|COMPLETED|Treatment Period III||0||
48501041|NCT01055834|101560792|FG001|COMPLETED|Treatment Period III||14||
48501042|NCT01055834|101560791|FG000|NOT COMPLETED|Treatment Period III||0||
48501043|NCT01055834|101560792|FG001|NOT COMPLETED|Treatment Period III||0||
48501044|NCT00688844|101560793|FG000|STARTED|Overall Study||58||
48501045|NCT00688844|101560793|FG000|COMPLETED|Overall Study||48||
48061084|NCT01193842|100470334|FG001|COMPLETED|Phase II: Randomized Groups||0||
48061085|NCT01193842|100470335|FG002|COMPLETED|Phase II: Randomized Groups||0||
48061086|NCT01193842|100470336|FG003|COMPLETED|Phase II: Randomized Groups||33||
48061087|NCT01193842|100470337|FG004|COMPLETED|Phase II: Randomized Groups||36||
48061088|NCT01193842|100470333|FG000|NOT COMPLETED|Phase II: Randomized Groups||0||
48061089|NCT01193842|100470334|FG001|NOT COMPLETED|Phase II: Randomized Groups||0||
48061090|NCT01193842|100470335|FG002|NOT COMPLETED|Phase II: Randomized Groups||0||
48061091|NCT01193842|100470336|FG003|NOT COMPLETED|Phase II: Randomized Groups||12||
48061092|NCT01193842|100470337|FG004|NOT COMPLETED|Phase II: Randomized Groups||10||
48061093|NCT03113916|100470338|FG000|STARTED|Overall Study||99||
48061094|NCT03113916|100470339|FG001|STARTED|Overall Study||96||
48218492|NCT01426412|100860320|FG006|STARTED|Overall Study||6||
48501046|NCT00688844|101560793|FG000|NOT COMPLETED|Overall Study||10||
48501047|NCT00690495|101560794|FG000|STARTED|Overall Study||50||
48501048|NCT00690495|101560795|FG001|STARTED|Overall Study||50||
48501049|NCT00690495|101560794|FG000|Primary Endpoint|Overall Study||50||
48501050|NCT00690495|101560795|FG001|Primary Endpoint|Overall Study||50||
48501051|NCT00690495|101560794|FG000|COMPLETED|Overall Study||50||
48501052|NCT00690495|101560795|FG001|COMPLETED|Overall Study||50||
48501053|NCT00690495|101560794|FG000|NOT COMPLETED|Overall Study||0||
48501054|NCT00690495|101560795|FG001|NOT COMPLETED|Overall Study||0||
48501055|NCT04476277|101560796|FG000|STARTED|Overall Study||6||
48501056|NCT04476277|101560797|FG001|STARTED|Overall Study||6||
48501057|NCT04476277|101560798|FG002|STARTED|Overall Study||7||
48501058|NCT04476277|101560799|FG003|STARTED|Overall Study||3||
48501059|NCT04476277|101560796|FG000|COMPLETED|Overall Study||6||
48501060|NCT04476277|101560797|FG001|COMPLETED|Overall Study||6||
48501061|NCT04476277|101560798|FG002|COMPLETED|Overall Study||6||
48501062|NCT04476277|101560799|FG003|COMPLETED|Overall Study||3||
48501063|NCT04476277|101560796|FG000|NOT COMPLETED|Overall Study||0||
48501064|NCT04476277|101560797|FG001|NOT COMPLETED|Overall Study||0||
48501065|NCT04476277|101560798|FG002|NOT COMPLETED|Overall Study||1||
48501066|NCT04476277|101560799|FG003|NOT COMPLETED|Overall Study||0||
48501067|NCT04364191|101560800|FG000|STARTED|Overall Study||13||
48501068|NCT04364191|101560801|FG001|STARTED|Overall Study||14||
48501069|NCT04364191|101560800|FG000|COMPLETED|Overall Study||12||
48501070|NCT04364191|101560801|FG001|COMPLETED|Overall Study||12||
48501071|NCT04364191|101560800|FG000|NOT COMPLETED|Overall Study||1||
48501072|NCT04364191|101560801|FG001|NOT COMPLETED|Overall Study||2||
48666753|NCT03391882|101970470|FG005|COMPLETED|Part A - Titration Phase||19|Part A|
48061095|NCT03113916|100470338|FG000|COMPLETED|Overall Study||88||
48218493|NCT01426412|100860321|FG007|STARTED|Overall Study||10||
48501073|NCT01483820|101560802|FG000|STARTED|Overall Study||8||
48501074|NCT01483820|101560802|FG000|COMPLETED|Overall Study||0||
48501075|NCT01483820|101560802|FG000|NOT COMPLETED|Overall Study||8||
48501076|NCT02369458|101560803|FG000|STARTED|Overall Study||35||
48501077|NCT02369458|101560804|FG001|STARTED|Overall Study||13||
48501078|NCT02369458|101560803|FG000|COMPLETED|Overall Study||34||
48501079|NCT02369458|101560804|FG001|COMPLETED|Overall Study||13||
48501080|NCT02369458|101560803|FG000|NOT COMPLETED|Overall Study||1||
48501081|NCT02369458|101560804|FG001|NOT COMPLETED|Overall Study||0||
48501082|NCT04720547|101560805|FG000|STARTED|Overall Study||6||
48501083|NCT04720547|101560806|FG001|STARTED|Overall Study||8||
48501084|NCT04720547|101560805|FG000|COMPLETED|Overall Study||6||
48501085|NCT04720547|101560806|FG001|COMPLETED|Overall Study||5||
48501086|NCT04720547|101560805|FG000|NOT COMPLETED|Overall Study||0||
48501087|NCT04720547|101560806|FG001|NOT COMPLETED|Overall Study||3||
48501088|NCT00198133|101560807|FG000|STARTED|Overall Study||16||
48501089|NCT00198133|101560808|FG001|STARTED|Overall Study||11||
48501090|NCT00198133|101560807|FG000|COMPLETED|Overall Study||11||
48501091|NCT00198133|101560808|FG001|COMPLETED|Overall Study||3||
48501092|NCT00198133|101560807|FG000|NOT COMPLETED|Overall Study||5||
48501093|NCT00198133|101560808|FG001|NOT COMPLETED|Overall Study||8||
48061096|NCT03113916|100470339|FG001|COMPLETED|Overall Study||84||
48061097|NCT03113916|100470338|FG000|NOT COMPLETED|Overall Study||11||
48501094|NCT01828112|101560809|FG000|STARTED|Overall Study||115||
48501095|NCT01828112|101560810|FG001|STARTED|Overall Study||116||
48501096|NCT01828112|101560809|FG000|Entered Extension Treatment Phase|Overall Study||0||
48501097|NCT01828112|101560810|FG001|Entered Extension Treatment Phase|Overall Study||74||
48501098|NCT01828112|101560809|FG000|Entered Post-treatment Follow-up Phase|Overall Study||7||
48501099|NCT01828112|101560810|FG001|Entered Post-treatment Follow-up Phase|Overall Study||5||
48501100|NCT01828112|101560809|FG000|Entered Survival Follow-up Phase|Overall Study||61||
48501101|NCT01828112|101560810|FG001|Entered Survival Follow-up Phase|Overall Study||19||
48501102|NCT01828112|101560809|FG000|Discontinued From Study|Overall Study||14||
48501103|NCT01828112|101560810|FG001|Discontinued From Study|Overall Study||10||
48501104|NCT01828112|101560809|FG000|Untreated Patients|Overall Study||0||
48501105|NCT01828112|101560810|FG001|Untreated Patients|Overall Study||3||
48501106|NCT01828112|101560809|FG000|Untreated|Overall Study||0||
48061098|NCT03113916|100470339|FG001|NOT COMPLETED|Overall Study||12||
48061099|NCT04068610|100470340|FG000|STARTED|Overall Study||7||
48061100|NCT04068610|100470341|FG001|STARTED|Overall Study||26||
48501107|NCT01828112|101560810|FG001|Untreated|Overall Study||3||
48501108|NCT01828112|101560809|FG000|Treated|Overall Study||115||
48501109|NCT01828112|101560810|FG001|Treated|Overall Study||113||
48501110|NCT01828112|101560809|FG000|COMPLETED|Overall Study||33||
48501111|NCT01828112|101560810|FG001|COMPLETED|Overall Study||8||
48501112|NCT01828112|101560809|FG000|NOT COMPLETED|Overall Study||82||
48501113|NCT01828112|101560810|FG001|NOT COMPLETED|Overall Study||108||
48501114|NCT00936351|101560811|FG000|STARTED|Overall Study||18||
48501115|NCT00936351|101560812|FG001|STARTED|Overall Study||16||
48501116|NCT00936351|101560811|FG000|COMPLETED|Overall Study||15||
48501117|NCT00936351|101560812|FG001|COMPLETED|Overall Study||14||
48501118|NCT00936351|101560811|FG000|NOT COMPLETED|Overall Study||3||
48501119|NCT00936351|101560812|FG001|NOT COMPLETED|Overall Study||2||
48501120|NCT00919711|101560813|FG000|STARTED|Overall Study||435||
48501121|NCT00919711|101560814|FG001|STARTED|Overall Study||435||
48501122|NCT00919711|101560813|FG000|COMPLETED|Overall Study||402||
48501123|NCT00919711|101560814|FG001|COMPLETED|Overall Study||422||
48501124|NCT00919711|101560813|FG000|NOT COMPLETED|Overall Study||33||
48501125|NCT00919711|101560814|FG001|NOT COMPLETED|Overall Study||13||
48501126|NCT04892147|101560815|FG000|STARTED|Overall Study||15||
48501127|NCT04892147|101560816|FG001|STARTED|Overall Study||11||
48501128|NCT04892147|101560815|FG000|COMPLETED|Overall Study||13||
48501129|NCT04892147|101560816|FG001|COMPLETED|Overall Study||11||
48501130|NCT04892147|101560815|FG000|NOT COMPLETED|Overall Study||2||
48501131|NCT04892147|101560816|FG001|NOT COMPLETED|Overall Study||0||
48501132|NCT05248399|101560817|FG000|STARTED|Overall Study||101||
48501133|NCT05248399|101560818|FG001|STARTED|Overall Study||99||
48501134|NCT05248399|101560817|FG000|COMPLETED|Overall Study||84||
48501135|NCT05248399|101560818|FG001|COMPLETED|Overall Study||82||
48501136|NCT05248399|101560817|FG000|NOT COMPLETED|Overall Study||17||
48501137|NCT05248399|101560818|FG001|NOT COMPLETED|Overall Study||17||
48501138|NCT00458822|101560819|FG000|STARTED|Overall Study||40||
48501139|NCT00458822|101560819|FG000|COMPLETED|Overall Study||40||
48501140|NCT00458822|101560819|FG000|NOT COMPLETED|Overall Study||0||
48501141|NCT03408730|101560820|FG000|STARTED|Overall Study||712||
48501142|NCT03408730|101560821|FG001|STARTED|Overall Study||711||
48501143|NCT03408730|101560822|FG002|STARTED|Overall Study||709||
48501144|NCT03408730|101560823|FG003|STARTED|Overall Study||706||
48501145|NCT03408730|101560820|FG000|COMPLETED|Overall Study||643||
48501146|NCT03408730|101560821|FG001|COMPLETED|Overall Study||636||
48501147|NCT03408730|101560822|FG002|COMPLETED|Overall Study||637||
48501148|NCT03408730|101560823|FG003|COMPLETED|Overall Study||625||
48501149|NCT03408730|101560820|FG000|NOT COMPLETED|Overall Study||69||
48501150|NCT03408730|101560821|FG001|NOT COMPLETED|Overall Study||75||
48501151|NCT03408730|101560822|FG002|NOT COMPLETED|Overall Study||72||
48501152|NCT03408730|101560823|FG003|NOT COMPLETED|Overall Study||81||
48501153|NCT05471349|101560824|FG000|STARTED|Overall Study||280||
48501154|NCT05471349|101560825|FG001|STARTED|Overall Study||274||
48501155|NCT05471349|101560826|FG002|STARTED|Overall Study||266||
48501156|NCT05471349|101560824|FG000|COMPLETED|Overall Study||280||
48061101|NCT04068610|100470342|FG002|STARTED|Overall Study||26||
48501157|NCT05471349|101560825|FG001|COMPLETED|Overall Study||272||
48501158|NCT05471349|101560826|FG002|COMPLETED|Overall Study||264||
48501159|NCT05471349|101560824|FG000|NOT COMPLETED|Overall Study||0||
48501160|NCT05471349|101560825|FG001|NOT COMPLETED|Overall Study||2||
48501161|NCT05471349|101560826|FG002|NOT COMPLETED|Overall Study||2||
48501162|NCT01525628|101560827|FG000|STARTED|Overall Study||16||
48501163|NCT01525628|101560828|FG001|STARTED|Overall Study||19||
48501164|NCT01525628|101560829|FG002|STARTED|Overall Study||16||
48501165|NCT01525628|101560830|FG003|STARTED|Overall Study||14||
48501166|NCT01525628|101560831|FG004|STARTED|Overall Study||7||
48501167|NCT01525628|101560827|FG000|COMPLETED|Overall Study||14||
48501168|NCT01525628|101560828|FG001|COMPLETED|Overall Study||14||
48501169|NCT01525628|101560829|FG002|COMPLETED|Overall Study||11||
48501170|NCT01525628|101560830|FG003|COMPLETED|Overall Study||10||
48501171|NCT01525628|101560831|FG004|COMPLETED|Overall Study||4||
48501172|NCT01525628|101560827|FG000|NOT COMPLETED|Overall Study||2||
48501173|NCT01525628|101560828|FG001|NOT COMPLETED|Overall Study||5||
48501174|NCT01525628|101560829|FG002|NOT COMPLETED|Overall Study||5||
48501175|NCT01525628|101560830|FG003|NOT COMPLETED|Overall Study||4||
48501176|NCT01525628|101560831|FG004|NOT COMPLETED|Overall Study||3||
48501177|NCT05128058|101560832|FG000|STARTED|Overall Study||8||
48501178|NCT05128058|101560833|FG001|STARTED|Overall Study||8||
48501179|NCT05128058|101560832|FG000|COMPLETED|Overall Study||8||
48501180|NCT05128058|101560833|FG001|COMPLETED|Overall Study||8||
48501181|NCT05128058|101560832|FG000|NOT COMPLETED|Overall Study||0||
48501182|NCT05128058|101560833|FG001|NOT COMPLETED|Overall Study||0||
48501183|NCT01971645|101560834|FG000|STARTED|Overall Study||25||
48501184|NCT01971645|101560835|FG001|STARTED|Overall Study||27||
48501185|NCT01971645|101560836|FG002|STARTED|Overall Study||25||
48501186|NCT01971645|101560834|FG000|COMPLETED|Overall Study||23||
48501187|NCT01971645|101560835|FG001|COMPLETED|Overall Study||27||
48501188|NCT01971645|101560836|FG002|COMPLETED|Overall Study||23||
48501189|NCT01971645|101560834|FG000|NOT COMPLETED|Overall Study||2||
48501190|NCT01971645|101560835|FG001|NOT COMPLETED|Overall Study||0||
48501191|NCT01971645|101560836|FG002|NOT COMPLETED|Overall Study||2||
48501192|NCT04235660|101560837|FG000|STARTED|Overall Study||1||
48501193|NCT04235660|101560838|FG001|STARTED|Overall Study||1||
48501194|NCT04235660|101560837|FG000|COMPLETED|Overall Study||0||
48501195|NCT04235660|101560838|FG001|COMPLETED|Overall Study||0||
48501196|NCT04235660|101560837|FG000|NOT COMPLETED|Overall Study||1||
48501197|NCT04235660|101560838|FG001|NOT COMPLETED|Overall Study||1||
48501198|NCT04203823|101560839|FG000|STARTED|Overall Study||54||
48501199|NCT04203823|101560840|FG001|STARTED|Overall Study||72||
48501200|NCT04203823|101560839|FG000|COMPLETED|Overall Study||51||
48501201|NCT04203823|101560840|FG001|COMPLETED|Overall Study||65||
48501202|NCT04203823|101560839|FG000|NOT COMPLETED|Overall Study||3||
48501203|NCT04203823|101560840|FG001|NOT COMPLETED|Overall Study||7||
48501204|NCT02472639|101560841|FG000|STARTED|Overall Study||4||
48501205|NCT02472639|101560842|FG001|STARTED|Overall Study||3||
48501206|NCT02472639|101560841|FG000|COMPLETED|Overall Study||0||
48501207|NCT02472639|101560842|FG001|COMPLETED|Overall Study||0||
48501208|NCT02472639|101560841|FG000|NOT COMPLETED|Overall Study||4||
48501209|NCT02472639|101560842|FG001|NOT COMPLETED|Overall Study||3||
48501210|NCT00804973|101560843|FG000|STARTED|Overall Study||40||
48501211|NCT00804973|101560844|FG001|STARTED|Overall Study||40||
48501212|NCT00804973|101560845|FG002|STARTED|Overall Study||40||
48501213|NCT00804973|101560843|FG000|Received at Least 1 Dose of Study Drug|Overall Study||40||
48501214|NCT00804973|101560844|FG001|Received at Least 1 Dose of Study Drug|Overall Study||40||
48501215|NCT00804973|101560845|FG002|Received at Least 1 Dose of Study Drug|Overall Study||40||
48501216|NCT00804973|101560843|FG000|COMPLETED|Overall Study||40||
48501217|NCT00804973|101560844|FG001|COMPLETED|Overall Study||40||
48501218|NCT00804973|101560845|FG002|COMPLETED|Overall Study||40||
48501219|NCT00804973|101560843|FG000|NOT COMPLETED|Overall Study||0||
48501220|NCT00804973|101560844|FG001|NOT COMPLETED|Overall Study||0||
48501221|NCT00804973|101560845|FG002|NOT COMPLETED|Overall Study||0||
48501222|NCT01958476|101560846|FG000|STARTED|Overall Study||59||
48501223|NCT01958476|101560847|FG001|STARTED|Overall Study||58||
48501224|NCT01958476|101560846|FG000|COMPLETED|Overall Study||58||
48501225|NCT01958476|101560847|FG001|COMPLETED|Overall Study||58||
48501226|NCT01958476|101560846|FG000|NOT COMPLETED|Overall Study||1||
48501227|NCT01958476|101560847|FG001|NOT COMPLETED|Overall Study||0||
48501228|NCT00994604|101560848|FG000|STARTED|Overall Study||51||
48501229|NCT00994604|101560848|FG000|COMPLETED|Overall Study||45||
48501230|NCT00994604|101560848|FG000|NOT COMPLETED|Overall Study||6||
48501231|NCT02151149|101560849|FG000|STARTED|Treatment Period||71||
48501232|NCT02151149|101560850|FG001|STARTED|Treatment Period||72||
48501233|NCT02151149|101560849|FG000|Treated Population|Treatment Period||68||
48501234|NCT02151149|101560850|FG001|Treated Population|Treatment Period||70||
48501235|NCT02151149|101560849|FG000|COMPLETED|Treatment Period||1|Completed indicates participants with missing disposition data.|
48501236|NCT02151149|101560850|FG001|COMPLETED|Treatment Period||1|Completed indicates participants with missing disposition data.|
48501237|NCT02151149|101560849|FG000|NOT COMPLETED|Treatment Period||70||
48501238|NCT02151149|101560850|FG001|NOT COMPLETED|Treatment Period||71||
48501239|NCT02151149|101560849|FG000|STARTED|Follow-Up Period||58||
48501240|NCT02151149|101560850|FG001|STARTED|Follow-Up Period||55||
48501241|NCT02151149|101560849|FG000|COMPLETED|Follow-Up Period||19||
48501242|NCT02151149|101560850|FG001|COMPLETED|Follow-Up Period||18||
48501243|NCT02151149|101560849|FG000|NOT COMPLETED|Follow-Up Period||39||
48501244|NCT02151149|101560850|FG001|NOT COMPLETED|Follow-Up Period||37||
48501245|NCT01202253|101560851|FG000|STARTED|Overall Study||50||
48501246|NCT01202253|101560851|FG000|COMPLETED|Overall Study||50||
48501247|NCT01202253|101560851|FG000|NOT COMPLETED|Overall Study||0||
48501248|NCT01395017|101560852|FG000|STARTED|Overall Study||100||
48501249|NCT01395017|101560853|FG001|STARTED|Overall Study||102||
48501250|NCT01395017|101560852|FG000|Treated|Overall Study||98||
48501251|NCT01395017|101560853|FG001|Treated|Overall Study||101||
48501252|NCT01395017|101560852|FG000|COMPLETED|Overall Study||0||
48501253|NCT01395017|101560853|FG001|COMPLETED|Overall Study||0||
48501254|NCT01395017|101560852|FG000|NOT COMPLETED|Overall Study||100||
48501255|NCT01395017|101560853|FG001|NOT COMPLETED|Overall Study||102||
48501256|NCT01881763|101560854|FG000|STARTED|Overall Study||16||
48501257|NCT01881763|101560855|FG001|STARTED|Overall Study||15||
48501258|NCT01881763|101560854|FG000|COMPLETED|Overall Study||10||
48501259|NCT01881763|101560855|FG001|COMPLETED|Overall Study||11||
48501260|NCT01881763|101560854|FG000|NOT COMPLETED|Overall Study||6||
48501261|NCT01881763|101560855|FG001|NOT COMPLETED|Overall Study||4||
48501262|NCT00755235|101560856|FG000|STARTED|Overall Study||106||
48501263|NCT00755235|101560857|FG001|STARTED|Overall Study||102||
48501264|NCT00755235|101560856|FG000|COMPLETED|Overall Study||104||
48501265|NCT00755235|101560857|FG001|COMPLETED|Overall Study||93||
48501266|NCT00755235|101560856|FG000|NOT COMPLETED|Overall Study||2||
48501267|NCT00755235|101560857|FG001|NOT COMPLETED|Overall Study||9||
48501268|NCT01499043|101560858|FG000|STARTED|Overall Study||6||
48501269|NCT01499043|101560858|FG000|COMPLETED|Overall Study||0||
48501270|NCT01499043|101560858|FG000|NOT COMPLETED|Overall Study||6||
48501271|NCT00487695|101560859|FG000|STARTED|First Procedure||23||
48501272|NCT00487695|101560860|FG001|STARTED|First Procedure||23||
48501273|NCT00487695|101560859|FG000|COMPLETED|First Procedure||20||
48501274|NCT00487695|101560860|FG001|COMPLETED|First Procedure||23||
48501275|NCT00487695|101560859|FG000|NOT COMPLETED|First Procedure||3||
48501276|NCT00487695|101560860|FG001|NOT COMPLETED|First Procedure||0||
48501277|NCT00487695|101560859|FG000|STARTED|Second Procedure||20||
48501278|NCT00487695|101560860|FG001|STARTED|Second Procedure||23||
48501279|NCT00487695|101560859|FG000|COMPLETED|Second Procedure||19||
48501280|NCT00487695|101560860|FG001|COMPLETED|Second Procedure||20||
48501281|NCT00487695|101560859|FG000|NOT COMPLETED|Second Procedure||1||
48501282|NCT00487695|101560860|FG001|NOT COMPLETED|Second Procedure||3||
48501283|NCT00715676|101560861|FG000|STARTED|Overall Study||49||
48501284|NCT00715676|101560862|FG001|STARTED|Overall Study||54||
48501285|NCT00715676|101560863|FG002|STARTED|Overall Study||53||
48501286|NCT00715676|101560861|FG000|COMPLETED|Overall Study||43||
48501287|NCT00715676|101560862|FG001|COMPLETED|Overall Study||43||
48501288|NCT00715676|101560863|FG002|COMPLETED|Overall Study||21||
48501289|NCT00715676|101560861|FG000|NOT COMPLETED|Overall Study||6||
48501290|NCT00715676|101560862|FG001|NOT COMPLETED|Overall Study||11||
48501291|NCT00715676|101560863|FG002|NOT COMPLETED|Overall Study||32||
48501292|NCT03614728|101560864|FG000|STARTED|Part 1 (Up to 30.8 Months)||13||
48501293|NCT03614728|101560865|FG001|STARTED|Part 1 (Up to 30.8 Months)||17||
48501294|NCT03614728|101560866|FG002|STARTED|Part 1 (Up to 30.8 Months)||0||
48501295|NCT03614728|101560867|FG003|STARTED|Part 1 (Up to 30.8 Months)||0||
48501296|NCT03614728|101560864|FG000|COMPLETED|Part 1 (Up to 30.8 Months)||12||
48501297|NCT03614728|101560865|FG001|COMPLETED|Part 1 (Up to 30.8 Months)||16||
48501298|NCT03614728|101560866|FG002|COMPLETED|Part 1 (Up to 30.8 Months)||0||
48501299|NCT03614728|101560867|FG003|COMPLETED|Part 1 (Up to 30.8 Months)||0||
48501300|NCT03614728|101560864|FG000|NOT COMPLETED|Part 1 (Up to 30.8 Months)||1||
48501301|NCT03614728|101560865|FG001|NOT COMPLETED|Part 1 (Up to 30.8 Months)||1||
48501302|NCT03614728|101560866|FG002|NOT COMPLETED|Part 1 (Up to 30.8 Months)||0||
48501303|NCT03614728|101560867|FG003|NOT COMPLETED|Part 1 (Up to 30.8 Months)||0||
48501304|NCT03614728|101560864|FG000|STARTED|Part 2 (Up to 3 Years and 2 Months)||0||
48501305|NCT03614728|101560865|FG001|STARTED|Part 2 (Up to 3 Years and 2 Months)||0||
48501306|NCT03614728|101560866|FG002|STARTED|Part 2 (Up to 3 Years and 2 Months)||0||
48501307|NCT03614728|101560867|FG003|STARTED|Part 2 (Up to 3 Years and 2 Months)||0||
48501308|NCT03614728|101560864|FG000|COMPLETED|Part 2 (Up to 3 Years and 2 Months)||0||
48501309|NCT03614728|101560865|FG001|COMPLETED|Part 2 (Up to 3 Years and 2 Months)||0||
48501310|NCT03614728|101560866|FG002|COMPLETED|Part 2 (Up to 3 Years and 2 Months)||0||
48501311|NCT03614728|101560867|FG003|COMPLETED|Part 2 (Up to 3 Years and 2 Months)||0||
48501312|NCT03614728|101560864|FG000|NOT COMPLETED|Part 2 (Up to 3 Years and 2 Months)||0||
48501313|NCT03614728|101560865|FG001|NOT COMPLETED|Part 2 (Up to 3 Years and 2 Months)||0||
48501314|NCT03614728|101560866|FG002|NOT COMPLETED|Part 2 (Up to 3 Years and 2 Months)||0||
48501315|NCT03614728|101560867|FG003|NOT COMPLETED|Part 2 (Up to 3 Years and 2 Months)||0||
48501316|NCT01670097|101560868|FG000|STARTED|Overall Study||20||
48501317|NCT01670097|101560869|FG001|STARTED|Overall Study||21||
48501318|NCT01670097|101560868|FG000|Completed Week 1 Intervention|Overall Study||18||
48501319|NCT01670097|101560869|FG001|Completed Week 1 Intervention|Overall Study||17||
48501320|NCT01670097|101560868|FG000|Completed Week 2 Intervention|Overall Study||13||
48501321|NCT01670097|101560869|FG001|Completed Week 2 Intervention|Overall Study||15||
48501322|NCT01670097|101560868|FG000|COMPLETED|Overall Study||18||
48501323|NCT01670097|101560869|FG001|COMPLETED|Overall Study||17||
48501324|NCT01670097|101560868|FG000|NOT COMPLETED|Overall Study||2||
48501325|NCT01670097|101560869|FG001|NOT COMPLETED|Overall Study||4||
48501326|NCT02587143|101560870|FG000|STARTED|Overall Study||66||
48501327|NCT02587143|101560871|FG001|STARTED|Overall Study||60||
48501328|NCT02587143|101560870|FG000|COMPLETED|Overall Study||65||
48501329|NCT02587143|101560871|FG001|COMPLETED|Overall Study||60||
48501330|NCT02587143|101560870|FG000|NOT COMPLETED|Overall Study||1||
48501331|NCT02587143|101560871|FG001|NOT COMPLETED|Overall Study||0||
48501332|NCT05004649|101560872|FG000|STARTED|Overall Study||19||
48501333|NCT05004649|101560872|FG000|COMPLETED|Overall Study||11||
48501334|NCT05004649|101560872|FG000|NOT COMPLETED|Overall Study||8||
48501335|NCT02699866|101560873|FG000|STARTED|Overall Study||46||
48501336|NCT02699866|101560873|FG000|Included|Overall Study||41||
48501337|NCT02699866|101560873|FG000|COMPLETED|Overall Study||38||
48501338|NCT02699866|101560873|FG000|NOT COMPLETED|Overall Study||8||
48501339|NCT02933060|101560874|FG000|STARTED|Overall Study||25||
48501340|NCT02933060|101560875|FG001|STARTED|Overall Study||25||
48501341|NCT02933060|101560874|FG000|COMPLETED|Overall Study||25||
48501342|NCT02933060|101560875|FG001|COMPLETED|Overall Study||24||
48501343|NCT02933060|101560874|FG000|NOT COMPLETED|Overall Study||0||
48501344|NCT02933060|101560875|FG001|NOT COMPLETED|Overall Study||1||
48501345|NCT02096692|101560876|FG000|STARTED|Overall Study||154||
48501346|NCT02096692|101560876|FG000|COMPLETED|Overall Study||150||
48501347|NCT02096692|101560876|FG000|NOT COMPLETED|Overall Study||4||
48501348|NCT00860262|101560877|FG000|STARTED|Overall Study||421||
48501349|NCT00860262|101560878|FG001|STARTED|Overall Study||217||
48501350|NCT00860262|101560879|FG002|STARTED|Overall Study||220||
48501351|NCT00860262|101560877|FG000|COMPLETED|Overall Study||401||
48501352|NCT00860262|101560878|FG001|COMPLETED|Overall Study||195||
48501353|NCT00860262|101560879|FG002|COMPLETED|Overall Study||202||
48501354|NCT00860262|101560877|FG000|NOT COMPLETED|Overall Study||20||
48501355|NCT00860262|101560878|FG001|NOT COMPLETED|Overall Study||22||
48501356|NCT00860262|101560879|FG002|NOT COMPLETED|Overall Study||18||
48218494|NCT01426412|100860322|FG008|STARTED|Overall Study||17||
48218495|NCT01426412|100860314|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
48218496|NCT01426412|100860315|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
48501357|NCT00714051|101560880|FG000|STARTED|Overall Study||27||
48501358|NCT00714051|101560881|FG001|STARTED|Overall Study||28||
48501359|NCT00714051|101560880|FG000|COMPLETED|Overall Study||26||
48501360|NCT00714051|101560881|FG001|COMPLETED|Overall Study||27||
48501361|NCT00714051|101560880|FG000|NOT COMPLETED|Overall Study||1||
48501362|NCT00714051|101560881|FG001|NOT COMPLETED|Overall Study||1||
48501363|NCT02218216|101560882|FG000|STARTED|Overall Study||14||
48501364|NCT02218216|101560883|FG001|STARTED|Overall Study||2||
48501365|NCT02218216|101560884|FG002|STARTED|Overall Study||3||
48501366|NCT02218216|101560882|FG000|COMPLETED|Overall Study||8||
48501367|NCT02218216|101560883|FG001|COMPLETED|Overall Study||2||
48501368|NCT02218216|101560884|FG002|COMPLETED|Overall Study||3||
48501369|NCT02218216|101560882|FG000|NOT COMPLETED|Overall Study||6||
48501370|NCT02218216|101560883|FG001|NOT COMPLETED|Overall Study||0||
48501371|NCT02218216|101560884|FG002|NOT COMPLETED|Overall Study||0||
48501372|NCT00613730|101560885|FG000|STARTED|Overall Study||3||
48501373|NCT00613730|101560885|FG000|COMPLETED|Overall Study||0||
48501374|NCT00613730|101560885|FG000|NOT COMPLETED|Overall Study||3||
48501375|NCT03174158|101560886|FG000|STARTED|Overall Study||39||
48501376|NCT03174158|101560887|FG001|STARTED|Overall Study||39||
48501377|NCT03174158|101560888|FG002|STARTED|Overall Study||36||
48501378|NCT03174158|101560889|FG003|STARTED|Overall Study||39||
48501379|NCT03174158|101560886|FG000|COMPLETED|Overall Study||35||
48501380|NCT03174158|101560887|FG001|COMPLETED|Overall Study||37||
48501381|NCT03174158|101560888|FG002|COMPLETED|Overall Study||34||
48501382|NCT03174158|101560889|FG003|COMPLETED|Overall Study||38||
48501383|NCT03174158|101560886|FG000|NOT COMPLETED|Overall Study||4||
48501384|NCT03174158|101560887|FG001|NOT COMPLETED|Overall Study||2||
48501385|NCT03174158|101560888|FG002|NOT COMPLETED|Overall Study||2||
48501386|NCT03174158|101560889|FG003|NOT COMPLETED|Overall Study||1||
48501387|NCT00702507|101560890|FG000|STARTED|Initial Treatment Phase||200||
48501388|NCT00702507|101560890|FG000|COMPLETED|Initial Treatment Phase||159||
48501389|NCT00702507|101560890|FG000|NOT COMPLETED|Initial Treatment Phase||41||
48501390|NCT00702507|101560890|FG000|STARTED|Follow-up Phase||159||
48501391|NCT00702507|101560890|FG000|COMPLETED|Follow-up Phase||132||
48218497|NCT01426412|100860316|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
48501392|NCT00702507|101560890|FG000|NOT COMPLETED|Follow-up Phase||27||
48501393|NCT02028455|101560891|FG000|STARTED|Enrollment and Preliminary Assessments||7||
48501394|NCT02028455|101560892|FG001|STARTED|Enrollment and Preliminary Assessments||12||
48501395|NCT02028455|101560893|FG002|STARTED|Enrollment and Preliminary Assessments||7||
48501396|NCT02028455|101560894|FG003|STARTED|Enrollment and Preliminary Assessments||5||
48501397|NCT02028455|101560895|FG004|STARTED|Enrollment and Preliminary Assessments||6||
48501398|NCT02028455|101560896|FG005|STARTED|Enrollment and Preliminary Assessments||6||
48501399|NCT02028455|101560897|FG006|STARTED|Enrollment and Preliminary Assessments||4||
48501400|NCT02028455|101560898|FG007|STARTED|Enrollment and Preliminary Assessments||120||
48501401|NCT02028455|101560891|FG000|COMPLETED|Enrollment and Preliminary Assessments||7||
48501402|NCT02028455|101560892|FG001|COMPLETED|Enrollment and Preliminary Assessments||12||
48501403|NCT02028455|101560893|FG002|COMPLETED|Enrollment and Preliminary Assessments||7||
48501404|NCT02028455|101560894|FG003|COMPLETED|Enrollment and Preliminary Assessments||5||
48501405|NCT02028455|101560895|FG004|COMPLETED|Enrollment and Preliminary Assessments||6||
48501406|NCT02028455|101560896|FG005|COMPLETED|Enrollment and Preliminary Assessments||6||
48501407|NCT02028455|101560897|FG006|COMPLETED|Enrollment and Preliminary Assessments||0||
48501408|NCT02028455|101560898|FG007|COMPLETED|Enrollment and Preliminary Assessments||103||
48501409|NCT02028455|101560891|FG000|NOT COMPLETED|Enrollment and Preliminary Assessments||0||
48501410|NCT02028455|101560892|FG001|NOT COMPLETED|Enrollment and Preliminary Assessments||0||
48501411|NCT02028455|101560893|FG002|NOT COMPLETED|Enrollment and Preliminary Assessments||0||
48501412|NCT02028455|101560894|FG003|NOT COMPLETED|Enrollment and Preliminary Assessments||0||
48501413|NCT02028455|101560895|FG004|NOT COMPLETED|Enrollment and Preliminary Assessments||0||
48501414|NCT02028455|101560896|FG005|NOT COMPLETED|Enrollment and Preliminary Assessments||0||
48501415|NCT02028455|101560897|FG006|NOT COMPLETED|Enrollment and Preliminary Assessments||4||
48501416|NCT02028455|101560898|FG007|NOT COMPLETED|Enrollment and Preliminary Assessments||17||
48501417|NCT02028455|101560891|FG000|STARTED|Treatment(T Cell Infusion) and Follow up||7||
48501418|NCT02028455|101560892|FG001|STARTED|Treatment(T Cell Infusion) and Follow up||12||
48501419|NCT02028455|101560893|FG002|STARTED|Treatment(T Cell Infusion) and Follow up||7||
48501420|NCT02028455|101560894|FG003|STARTED|Treatment(T Cell Infusion) and Follow up||5||
48501421|NCT02028455|101560895|FG004|STARTED|Treatment(T Cell Infusion) and Follow up||6||
48501422|NCT02028455|101560896|FG005|STARTED|Treatment(T Cell Infusion) and Follow up||6||
48501423|NCT02028455|101560897|FG006|STARTED|Treatment(T Cell Infusion) and Follow up||0||
48501424|NCT02028455|101560898|FG007|STARTED|Treatment(T Cell Infusion) and Follow up||103||
48501425|NCT02028455|101560891|FG000|COMPLETED|Treatment(T Cell Infusion) and Follow up||0||
48501426|NCT02028455|101560892|FG001|COMPLETED|Treatment(T Cell Infusion) and Follow up||0||
48501427|NCT02028455|101560893|FG002|COMPLETED|Treatment(T Cell Infusion) and Follow up||0||
48501428|NCT02028455|101560894|FG003|COMPLETED|Treatment(T Cell Infusion) and Follow up||0||
48501429|NCT02028455|101560895|FG004|COMPLETED|Treatment(T Cell Infusion) and Follow up||0||
48501430|NCT02028455|101560896|FG005|COMPLETED|Treatment(T Cell Infusion) and Follow up||0||
48501431|NCT02028455|101560897|FG006|COMPLETED|Treatment(T Cell Infusion) and Follow up||0||
48501432|NCT02028455|101560898|FG007|COMPLETED|Treatment(T Cell Infusion) and Follow up||0||
48501433|NCT02028455|101560891|FG000|NOT COMPLETED|Treatment(T Cell Infusion) and Follow up||7||
48501434|NCT02028455|101560892|FG001|NOT COMPLETED|Treatment(T Cell Infusion) and Follow up||12||
48501435|NCT02028455|101560893|FG002|NOT COMPLETED|Treatment(T Cell Infusion) and Follow up||7||
48501436|NCT02028455|101560894|FG003|NOT COMPLETED|Treatment(T Cell Infusion) and Follow up||5||
48501437|NCT02028455|101560895|FG004|NOT COMPLETED|Treatment(T Cell Infusion) and Follow up||6||
48501438|NCT02028455|101560896|FG005|NOT COMPLETED|Treatment(T Cell Infusion) and Follow up||6||
48501439|NCT02028455|101560897|FG006|NOT COMPLETED|Treatment(T Cell Infusion) and Follow up||0||
48501440|NCT02028455|101560898|FG007|NOT COMPLETED|Treatment(T Cell Infusion) and Follow up||103||
48501441|NCT03366428|101560899|FG000|STARTED|Overall Study||51||
48061102|NCT04068610|100470340|FG000|COMPLETED|Overall Study||0||
48061103|NCT04068610|100470341|FG001|COMPLETED|Overall Study||0||
48061104|NCT04068610|100470342|FG002|COMPLETED|Overall Study||0||
48061105|NCT04068610|100470340|FG000|NOT COMPLETED|Overall Study||7||
48501442|NCT03366428|101560899|FG000|COMPLETED|Overall Study||0||
48501443|NCT03366428|101560899|FG000|NOT COMPLETED|Overall Study||51||
48501444|NCT01653704|101560900|FG000|STARTED|Overall Study||21||
48501445|NCT01653704|101560901|FG001|STARTED|Overall Study||21||
48501446|NCT01653704|101560900|FG000|COMPLETED|Overall Study||19||
48501447|NCT01653704|101560901|FG001|COMPLETED|Overall Study||20||
48501448|NCT01653704|101560900|FG000|NOT COMPLETED|Overall Study||2||
48501449|NCT01653704|101560901|FG001|NOT COMPLETED|Overall Study||1||
48501450|NCT01977456|101560902|FG000|STARTED|Overall Study||27||
48501451|NCT01977456|101560902|FG000|COMPLETED|Overall Study||22||
48501452|NCT01977456|101560902|FG000|NOT COMPLETED|Overall Study||5||
48501453|NCT00238615|101560903|FG000|STARTED|Overall Study||13||
48501454|NCT00238615|101560903|FG000|COMPLETED|Overall Study||13||
48501455|NCT00238615|101560903|FG000|NOT COMPLETED|Overall Study||0||
48501456|NCT03515044|101560904|FG000|STARTED|Double-Blind Period||15||
48501457|NCT03515044|101560905|FG001|STARTED|Double-Blind Period||15||
48501458|NCT03515044|101560906|FG002|STARTED|Double-Blind Period||14||
48501459|NCT03515044|101560907|FG003|STARTED|Double-Blind Period||13||
48501460|NCT03515044|101560908|FG004|STARTED|Double-Blind Period||14||
48501461|NCT03515044|101560909|FG005|STARTED|Double-Blind Period||0||
48501462|NCT03515044|101560904|FG000|COMPLETED|Double-Blind Period||13||
48501463|NCT03515044|101560905|FG001|COMPLETED|Double-Blind Period||13||
48501464|NCT03515044|101560906|FG002|COMPLETED|Double-Blind Period||8||
48501465|NCT03515044|101560907|FG003|COMPLETED|Double-Blind Period||11||
48501466|NCT03515044|101560908|FG004|COMPLETED|Double-Blind Period||8||
48501467|NCT03515044|101560909|FG005|COMPLETED|Double-Blind Period||0||
48501468|NCT03515044|101560904|FG000|NOT COMPLETED|Double-Blind Period||2||
48501469|NCT03515044|101560905|FG001|NOT COMPLETED|Double-Blind Period||2||
48501470|NCT03515044|101560906|FG002|NOT COMPLETED|Double-Blind Period||6||
48501471|NCT03515044|101560907|FG003|NOT COMPLETED|Double-Blind Period||2||
48501472|NCT03515044|101560908|FG004|NOT COMPLETED|Double-Blind Period||6||
48501473|NCT03515044|101560909|FG005|NOT COMPLETED|Double-Blind Period||0||
48061106|NCT04068610|100470341|FG001|NOT COMPLETED|Overall Study||26||
48061107|NCT04068610|100470342|FG002|NOT COMPLETED|Overall Study||26||
48061108|NCT01251744|100470343|FG000|STARTED|Overall Study||77||
48501474|NCT03515044|101560904|FG000|STARTED|Open-label Extension Period||0||
48501475|NCT03515044|101560905|FG001|STARTED|Open-label Extension Period||0||
48501476|NCT03515044|101560906|FG002|STARTED|Open-label Extension Period||0||
48501477|NCT03515044|101560907|FG003|STARTED|Open-label Extension Period||0||
48501478|NCT03515044|101560908|FG004|STARTED|Open-label Extension Period||0||
48501479|NCT03515044|101560909|FG005|STARTED|Open-label Extension Period||53||
48501480|NCT03515044|101560904|FG000|COMPLETED|Open-label Extension Period||0||
48501481|NCT03515044|101560905|FG001|COMPLETED|Open-label Extension Period||0||
48501482|NCT03515044|101560906|FG002|COMPLETED|Open-label Extension Period||0||
48501483|NCT03515044|101560907|FG003|COMPLETED|Open-label Extension Period||0||
48501484|NCT03515044|101560908|FG004|COMPLETED|Open-label Extension Period||0||
48501485|NCT03515044|101560909|FG005|COMPLETED|Open-label Extension Period||31||
48501486|NCT03515044|101560904|FG000|NOT COMPLETED|Open-label Extension Period||0||
48501487|NCT03515044|101560905|FG001|NOT COMPLETED|Open-label Extension Period||0||
48501488|NCT03515044|101560906|FG002|NOT COMPLETED|Open-label Extension Period||0||
48501489|NCT03515044|101560907|FG003|NOT COMPLETED|Open-label Extension Period||0||
48501490|NCT03515044|101560908|FG004|NOT COMPLETED|Open-label Extension Period||0||
48501491|NCT03515044|101560909|FG005|NOT COMPLETED|Open-label Extension Period||22||
48501492|NCT00834613|101560910|FG000|STARTED|First Intervention||16||
48501493|NCT00834613|101560911|FG001|STARTED|First Intervention||16||
48501494|NCT00834613|101560910|FG000|COMPLETED|First Intervention||15||
48501495|NCT00834613|101560911|FG001|COMPLETED|First Intervention||16||
48501496|NCT00834613|101560910|FG000|NOT COMPLETED|First Intervention||1||
48501497|NCT00834613|101560911|FG001|NOT COMPLETED|First Intervention||0||
48501498|NCT00834613|101560910|FG000|STARTED|Washout of 7 Days||15||
48501499|NCT00834613|101560911|FG001|STARTED|Washout of 7 Days||16||
48501500|NCT00834613|101560910|FG000|COMPLETED|Washout of 7 Days||15||
48501501|NCT00834613|101560911|FG001|COMPLETED|Washout of 7 Days||16||
48501502|NCT00834613|101560910|FG000|NOT COMPLETED|Washout of 7 Days||0||
48501503|NCT00834613|101560911|FG001|NOT COMPLETED|Washout of 7 Days||0||
48501504|NCT00834613|101560910|FG000|STARTED|Second Intervention||15||
48501505|NCT00834613|101560911|FG001|STARTED|Second Intervention||16||
48501506|NCT00834613|101560910|FG000|COMPLETED|Second Intervention||15||
48501507|NCT00834613|101560911|FG001|COMPLETED|Second Intervention||16||
48501508|NCT00834613|101560910|FG000|NOT COMPLETED|Second Intervention||0||
48501509|NCT00834613|101560911|FG001|NOT COMPLETED|Second Intervention||0||
48501510|NCT00840658|101560912|FG000|STARTED|Overall Study||144||
48501511|NCT00840658|101560913|FG001|STARTED|Overall Study||146||
48501512|NCT00840658|101560914|FG002|STARTED|Overall Study||148||
48501513|NCT00840658|101560915|FG003|STARTED|Overall Study||146||
48501514|NCT00840658|101560912|FG000|COMPLETED|Overall Study||139||
48501515|NCT00840658|101560913|FG001|COMPLETED|Overall Study||143||
48501516|NCT00840658|101560914|FG002|COMPLETED|Overall Study||143||
48501517|NCT00840658|101560915|FG003|COMPLETED|Overall Study||142||
48501518|NCT00840658|101560912|FG000|NOT COMPLETED|Overall Study||5||
48501519|NCT00840658|101560913|FG001|NOT COMPLETED|Overall Study||3||
48501520|NCT00840658|101560914|FG002|NOT COMPLETED|Overall Study||5||
48501521|NCT00840658|101560915|FG003|NOT COMPLETED|Overall Study||4||
48501522|NCT05344118|101560916|FG000|STARTED|Overall Study||125||
48501523|NCT05344118|101560916|FG000|COMPLETED|Overall Study||125||
48501524|NCT05344118|101560916|FG000|NOT COMPLETED|Overall Study||0||
48501525|NCT00400634|101560917|FG000|STARTED|Overall Study||38||
48501526|NCT00400634|101560918|FG001|STARTED|Overall Study||20||
48501527|NCT00400634|101560917|FG000|COMPLETED|Overall Study||34||
48501528|NCT00400634|101560918|FG001|COMPLETED|Overall Study||19||
48501529|NCT00400634|101560917|FG000|NOT COMPLETED|Overall Study||4||
48501530|NCT00400634|101560918|FG001|NOT COMPLETED|Overall Study||1||
48501531|NCT02013050|101560919|FG000|STARTED|Overall Study||42||
48501532|NCT02013050|101560920|FG001|STARTED|Overall Study||41||
48501533|NCT02013050|101560921|FG002|STARTED|Overall Study||3||
48501534|NCT02013050|101560922|FG003|STARTED|Overall Study||23||
48501535|NCT02013050|101560919|FG000|COMPLETED|Overall Study||38||
48501536|NCT02013050|101560920|FG001|COMPLETED|Overall Study||36||
48501537|NCT02013050|101560921|FG002|COMPLETED|Overall Study||3||
48666754|NCT03391882|101970465|FG000|NOT COMPLETED|Part A - Titration Phase||18||
48061109|NCT01251744|100470344|FG001|STARTED|Overall Study||78||
48501538|NCT02013050|101560922|FG003|COMPLETED|Overall Study||19||
48501539|NCT02013050|101560919|FG000|NOT COMPLETED|Overall Study||4||
48501540|NCT02013050|101560920|FG001|NOT COMPLETED|Overall Study||5||
48501541|NCT02013050|101560921|FG002|NOT COMPLETED|Overall Study||0||
48501542|NCT02013050|101560922|FG003|NOT COMPLETED|Overall Study||4||
48501543|NCT01583530|101560923|FG000|STARTED|Overall Study||19||
48501544|NCT01583530|101560924|FG001|STARTED|Overall Study||20||
48501545|NCT01583530|101560925|FG002|STARTED|Overall Study||20||
48501546|NCT01583530|101560926|FG003|STARTED|Overall Study||19||
48501547|NCT01583530|101560927|FG004|STARTED|Overall Study||20||
48501548|NCT01583530|101560928|FG005|STARTED|Overall Study||20||
48501549|NCT01583530|101560923|FG000|COMPLETED|Overall Study||19||
48501550|NCT01583530|101560924|FG001|COMPLETED|Overall Study||17||
48501551|NCT01583530|101560925|FG002|COMPLETED|Overall Study||20||
48501552|NCT01583530|101560926|FG003|COMPLETED|Overall Study||18||
48501553|NCT01583530|101560927|FG004|COMPLETED|Overall Study||15||
48501554|NCT01583530|101560928|FG005|COMPLETED|Overall Study||17||
48501555|NCT01583530|101560923|FG000|NOT COMPLETED|Overall Study||0||
48501556|NCT01583530|101560924|FG001|NOT COMPLETED|Overall Study||3||
48501557|NCT01583530|101560925|FG002|NOT COMPLETED|Overall Study||0||
48501558|NCT01583530|101560926|FG003|NOT COMPLETED|Overall Study||1||
48501559|NCT01583530|101560927|FG004|NOT COMPLETED|Overall Study||5||
48501560|NCT01583530|101560928|FG005|NOT COMPLETED|Overall Study||3||
48501561|NCT01055886|101560929|FG000|STARTED|Overall Study||33||
48501562|NCT01055886|101560930|FG001|STARTED|Overall Study||32||
48501563|NCT01055886|101560929|FG000|Reached Pre-quit Period|Overall Study||30||
48501564|NCT01055886|101560930|FG001|Reached Pre-quit Period|Overall Study||31||
48501565|NCT01055886|101560929|FG000|COMPLETED|Overall Study||28||
48501566|NCT01055886|101560930|FG001|COMPLETED|Overall Study||21||
48501567|NCT01055886|101560929|FG000|NOT COMPLETED|Overall Study||5||
48501568|NCT01055886|101560930|FG001|NOT COMPLETED|Overall Study||11||
48501569|NCT00868998|101560931|FG000|STARTED|Overall Study||5||
48501570|NCT00868998|101560931|FG000|COMPLETED|Overall Study||0||
48501571|NCT00868998|101560931|FG000|NOT COMPLETED|Overall Study||5||
48501572|NCT01214980|101560932|FG000|STARTED|Overall Study||16||
48501573|NCT01214980|101560933|FG001|STARTED|Overall Study||16||
48501574|NCT01214980|101560932|FG000|COMPLETED|Overall Study||13||
48501575|NCT01214980|101560933|FG001|COMPLETED|Overall Study||14||
48501576|NCT01214980|101560932|FG000|NOT COMPLETED|Overall Study||3||
48501577|NCT01214980|101560933|FG001|NOT COMPLETED|Overall Study||2||
48501578|NCT01781234|101560934|FG000|STARTED|Overall Study||27||
48501579|NCT01781234|101560935|FG001|STARTED|Overall Study||24||
48501580|NCT01781234|101560934|FG000|COMPLETED|Overall Study||18||
48501581|NCT01781234|101560935|FG001|COMPLETED|Overall Study||21||
48501582|NCT01781234|101560934|FG000|NOT COMPLETED|Overall Study||9||
48501583|NCT01781234|101560935|FG001|NOT COMPLETED|Overall Study||3||
48501584|NCT01868243|101560936|FG000|STARTED|Overall Study||15||
48501585|NCT01868243|101560937|FG001|STARTED|Overall Study||12||
48501586|NCT01868243|101560936|FG000|COMPLETED|Overall Study||15||
48501587|NCT01868243|101560937|FG001|COMPLETED|Overall Study||11||
48501588|NCT01868243|101560936|FG000|NOT COMPLETED|Overall Study||0||
48501589|NCT01868243|101560937|FG001|NOT COMPLETED|Overall Study||1||
48501590|NCT01964950|101560938|FG000|STARTED|Overall Study||1101||
48501591|NCT01964950|101560938|FG000|COMPLETED|Overall Study||1076||
48501592|NCT01964950|101560938|FG000|NOT COMPLETED|Overall Study||25||
48501593|NCT02818894|101560939|FG000|STARTED|Overall Study||67||
48501594|NCT02818894|101560940|FG001|STARTED|Overall Study||68||
48501595|NCT02818894|101560939|FG000|COMPLETED|Overall Study||11||
48501596|NCT02818894|101560940|FG001|COMPLETED|Overall Study||12||
48501597|NCT02818894|101560939|FG000|NOT COMPLETED|Overall Study||56||
48501598|NCT02818894|101560940|FG001|NOT COMPLETED|Overall Study||56||
48501599|NCT03922750|101560941|FG000|STARTED|Overall Study||50||
48501600|NCT03922750|101560942|FG001|STARTED|Overall Study||54||
48501601|NCT03922750|101560943|FG002|STARTED|Overall Study||50||
48501602|NCT03922750|101560941|FG000|Full Analysis Set (FAS)|Overall Study||50||
48501603|NCT03922750|101560942|FG001|Full Analysis Set (FAS)|Overall Study||54||
48501604|NCT03922750|101560943|FG002|Full Analysis Set (FAS)|Overall Study||50||
48501605|NCT03922750|101560941|FG000|Safety Analysis Set (SAS)|Overall Study||50||
48501606|NCT03922750|101560942|FG001|Safety Analysis Set (SAS)|Overall Study||54||
48501607|NCT03922750|101560943|FG002|Safety Analysis Set (SAS)|Overall Study||50||
48501608|NCT03922750|101560941|FG000|COMPLETED|Overall Study||50||
48501609|NCT03922750|101560942|FG001|COMPLETED|Overall Study||53||
48501610|NCT03922750|101560943|FG002|COMPLETED|Overall Study||49||
48501611|NCT03922750|101560941|FG000|NOT COMPLETED|Overall Study||0||
48501612|NCT03922750|101560942|FG001|NOT COMPLETED|Overall Study||1||
48501613|NCT03922750|101560943|FG002|NOT COMPLETED|Overall Study||1||
48501614|NCT01728116|101560944|FG000|STARTED|Overall Study||213||
48501615|NCT01728116|101560945|FG001|STARTED|Overall Study||107||
48501616|NCT01728116|101560944|FG000|COMPLETED|Overall Study||52||
48501617|NCT01728116|101560945|FG001|COMPLETED|Overall Study||60||
48501618|NCT01728116|101560944|FG000|NOT COMPLETED|Overall Study||161||
48501619|NCT01728116|101560945|FG001|NOT COMPLETED|Overall Study||47||
48501620|NCT02416180|101560946|FG000|STARTED|Overall Study||111||
48501621|NCT02416180|101560946|FG000|COMPLETED|Overall Study||110||
48501622|NCT02416180|101560946|FG000|NOT COMPLETED|Overall Study||1||
48501623|NCT02096705|101560947|FG000|STARTED|Treatment||133||
48501624|NCT02096705|101560948|FG001|STARTED|Treatment||139||
48501625|NCT02096705|101560947|FG000|COMPLETED|Treatment||124||
48501626|NCT02096705|101560948|FG001|COMPLETED|Treatment||134||
48501627|NCT02096705|101560947|FG000|NOT COMPLETED|Treatment||9||
48501628|NCT02096705|101560948|FG001|NOT COMPLETED|Treatment||5||
48501629|NCT02096705|101560947|FG000|STARTED|Follow-up||129||
48501630|NCT02096705|101560948|FG001|STARTED|Follow-up||139||
48501631|NCT02096705|101560947|FG000|COMPLETED|Follow-up||125||
48501632|NCT02096705|101560948|FG001|COMPLETED|Follow-up||135||
48501633|NCT02096705|101560947|FG000|NOT COMPLETED|Follow-up||4||
48501634|NCT02096705|101560948|FG001|NOT COMPLETED|Follow-up||4||
48501635|NCT04129554|101560949|FG000|STARTED|Overall Study||85||
48501636|NCT04129554|101560950|FG001|STARTED|Overall Study||45||
48501637|NCT04129554|101560949|FG000|COMPLETED|Overall Study||81||
48501638|NCT04129554|101560950|FG001|COMPLETED|Overall Study||40||
48501639|NCT04129554|101560949|FG000|NOT COMPLETED|Overall Study||4||
48501640|NCT04129554|101560950|FG001|NOT COMPLETED|Overall Study||5||
48501641|NCT03093025|101560951|FG000|STARTED|Overall Study||16||
48501642|NCT03093025|101560952|FG001|STARTED|Overall Study||17||
48501643|NCT03093025|101560953|FG002|STARTED|Overall Study||18||
48501644|NCT03093025|101560951|FG000|COMPLETED|Overall Study||12||
48501645|NCT03093025|101560952|FG001|COMPLETED|Overall Study||15||
48501646|NCT03093025|101560953|FG002|COMPLETED|Overall Study||16||
48501647|NCT03093025|101560951|FG000|NOT COMPLETED|Overall Study||4||
48501648|NCT03093025|101560952|FG001|NOT COMPLETED|Overall Study||2||
48501649|NCT03093025|101560953|FG002|NOT COMPLETED|Overall Study||2||
48501650|NCT04561115|101560954|FG000|STARTED|GC Run-in Phase (Up to 4.5 Months)||22||
48501651|NCT04561115|101560955|FG001|STARTED|GC Run-in Phase (Up to 4.5 Months)||0||
48501652|NCT04561115|101560954|FG000|COMPLETED|GC Run-in Phase (Up to 4.5 Months)||22||
48501653|NCT04561115|101560955|FG001|COMPLETED|GC Run-in Phase (Up to 4.5 Months)||0||
48501654|NCT04561115|101560954|FG000|NOT COMPLETED|GC Run-in Phase (Up to 4.5 Months)||0||
48501655|NCT04561115|101560955|FG001|NOT COMPLETED|GC Run-in Phase (Up to 4.5 Months)||0||
48501656|NCT04561115|101560954|FG000|STARTED|GC Run-In + PK Phase (Up to 6 Months)||33||
48501657|NCT04561115|101560955|FG001|STARTED|GC Run-In + PK Phase (Up to 6 Months)||0||
48501658|NCT04561115|101560954|FG000|COMPLETED|GC Run-In + PK Phase (Up to 6 Months)||32||
48501659|NCT04561115|101560955|FG001|COMPLETED|GC Run-In + PK Phase (Up to 6 Months)||0||
48501660|NCT04561115|101560954|FG000|NOT COMPLETED|GC Run-In + PK Phase (Up to 6 Months)||1||
48501661|NCT04561115|101560955|FG001|NOT COMPLETED|GC Run-In + PK Phase (Up to 6 Months)||0||
48501662|NCT04561115|101560954|FG000|STARTED|IVIG-PEG Treatment (Up to 4.5 Months)||0||
48501663|NCT04561115|101560955|FG001|STARTED|IVIG-PEG Treatment (Up to 4.5 Months)||32||
48501664|NCT04561115|101560954|FG000|COMPLETED|IVIG-PEG Treatment (Up to 4.5 Months)||0||
48501665|NCT04561115|101560955|FG001|COMPLETED|IVIG-PEG Treatment (Up to 4.5 Months)||31||
48501666|NCT04561115|101560954|FG000|NOT COMPLETED|IVIG-PEG Treatment (Up to 4.5 Months)||0||
48501667|NCT04561115|101560955|FG001|NOT COMPLETED|IVIG-PEG Treatment (Up to 4.5 Months)||1||
48501668|NCT04561115|101560954|FG000|STARTED|IVIG-PEG + PK Phase (Up to 6 Months)||0||
48501669|NCT04561115|101560955|FG001|STARTED|IVIG-PEG + PK Phase (Up to 6 Months)||32||
48501670|NCT04561115|101560954|FG000|COMPLETED|IVIG-PEG + PK Phase (Up to 6 Months)||0||
48501671|NCT04561115|101560955|FG001|COMPLETED|IVIG-PEG + PK Phase (Up to 6 Months)||31||
48501672|NCT04561115|101560954|FG000|NOT COMPLETED|IVIG-PEG + PK Phase (Up to 6 Months)||0||
48501673|NCT04561115|101560955|FG001|NOT COMPLETED|IVIG-PEG + PK Phase (Up to 6 Months)||1||
48501674|NCT02858037|101560956|FG000|STARTED|Overall Study||1456||
48501675|NCT02858037|101560956|FG000|Exposed Primary Cohort|Overall Study||1368||
48501676|NCT02858037|101560956|FG000|COMPLETED|Overall Study||1404||
48501677|NCT02858037|101560956|FG000|NOT COMPLETED|Overall Study||52||
48501678|NCT02387762|101560957|FG000|STARTED|Overall Study||16||
48501679|NCT02387762|101560958|FG001|STARTED|Overall Study||15||
48501680|NCT02387762|101560957|FG000|COMPLETED|Overall Study||15||
48501681|NCT02387762|101560958|FG001|COMPLETED|Overall Study||15||
48501682|NCT02387762|101560957|FG000|NOT COMPLETED|Overall Study||1||
48501683|NCT02387762|101560958|FG001|NOT COMPLETED|Overall Study||0||
48501684|NCT00550147|101560959|FG000|STARTED|OROS Methylphenidate Monotherapy||30||
48501685|NCT00550147|101560959|FG000|COMPLETED|OROS Methylphenidate Monotherapy||24||
48501686|NCT00550147|101560959|FG000|NOT COMPLETED|OROS Methylphenidate Monotherapy||6||
48501687|NCT00550147|101560959|FG000|STARTED|Quetiapine Addition Treatment Period||24||
48501688|NCT00550147|101560959|FG000|COMPLETED|Quetiapine Addition Treatment Period||18||
48501689|NCT00550147|101560959|FG000|NOT COMPLETED|Quetiapine Addition Treatment Period||6||
48501690|NCT03185741|101560960|FG000|STARTED|Baseline||246||
48501691|NCT03185741|101560961|FG001|STARTED|Baseline||272||
48501692|NCT03185741|101560962|FG002|STARTED|Baseline||249||
48501693|NCT03185741|101560960|FG000|COMPLETED|Baseline||244||
48501694|NCT03185741|101560961|FG001|COMPLETED|Baseline||267||
48501695|NCT03185741|101560962|FG002|COMPLETED|Baseline||244||
48501696|NCT03185741|101560960|FG000|NOT COMPLETED|Baseline||2||
48501697|NCT03185741|101560961|FG001|NOT COMPLETED|Baseline||5||
48501698|NCT03185741|101560962|FG002|NOT COMPLETED|Baseline||5||
48501699|NCT03185741|101560960|FG000|STARTED|3Month||244||
48501700|NCT03185741|101560961|FG001|STARTED|3Month||267||
48501701|NCT03185741|101560962|FG002|STARTED|3Month||244||
48501702|NCT03185741|101560960|FG000|COMPLETED|3Month||224||
48501703|NCT03185741|101560961|FG001|COMPLETED|3Month||242||
48501704|NCT03185741|101560962|FG002|COMPLETED|3Month||219||
48501705|NCT03185741|101560960|FG000|NOT COMPLETED|3Month||20||
48501706|NCT03185741|101560961|FG001|NOT COMPLETED|3Month||25||
48501707|NCT03185741|101560962|FG002|NOT COMPLETED|3Month||25||
48501708|NCT03185741|101560960|FG000|STARTED|6Month||235||
48501709|NCT03185741|101560961|FG001|STARTED|6Month||252||
48061110|NCT01251744|100470343|FG000|COMPLETED|Overall Study||76||
48061111|NCT01251744|100470344|FG001|COMPLETED|Overall Study||78||
48061112|NCT01251744|100470343|FG000|NOT COMPLETED|Overall Study||1||
48061113|NCT01251744|100470344|FG001|NOT COMPLETED|Overall Study||0||
48501710|NCT03185741|101560962|FG002|STARTED|6Month||230||
48501711|NCT03185741|101560960|FG000|COMPLETED|6Month||216||
48501712|NCT03185741|101560961|FG001|COMPLETED|6Month||233||
48501713|NCT03185741|101560962|FG002|COMPLETED|6Month||211||
48501714|NCT03185741|101560960|FG000|NOT COMPLETED|6Month||19||
48501715|NCT03185741|101560961|FG001|NOT COMPLETED|6Month||19||
48501716|NCT03185741|101560962|FG002|NOT COMPLETED|6Month||19||
48501717|NCT00283842|101560963|FG000|STARTED|Overall Study||63||
48501718|NCT00283842|101560964|FG001|STARTED|Overall Study||87||
48501719|NCT00283842|101560965|FG002|STARTED|Overall Study||99||
48501720|NCT00283842|101560966|FG003|STARTED|Overall Study||69||
48501721|NCT00283842|101560967|FG004|STARTED|Overall Study||90||
48501722|NCT00283842|101560963|FG000|COMPLETED|Overall Study||51||
48501723|NCT00283842|101560964|FG001|COMPLETED|Overall Study||69||
48501724|NCT00283842|101560965|FG002|COMPLETED|Overall Study||68||
48501725|NCT00283842|101560966|FG003|COMPLETED|Overall Study||42||
48501726|NCT00283842|101560967|FG004|COMPLETED|Overall Study||75||
48501727|NCT00283842|101560963|FG000|NOT COMPLETED|Overall Study||12||
48501728|NCT00283842|101560964|FG001|NOT COMPLETED|Overall Study||18||
48501729|NCT00283842|101560965|FG002|NOT COMPLETED|Overall Study||31||
48501730|NCT00283842|101560966|FG003|NOT COMPLETED|Overall Study||27||
48501731|NCT00283842|101560967|FG004|NOT COMPLETED|Overall Study||15||
48501732|NCT00562718|101560968|FG000|STARTED|Overall Study||50||
48501733|NCT00562718|101560968|FG000|COMPLETED|Overall Study||39||
48501734|NCT00562718|101560968|FG000|NOT COMPLETED|Overall Study||11||
48501735|NCT01292837|101560969|FG000|STARTED|Overall Study||13||
48501736|NCT01292837|101560969|FG000|COMPLETED|Overall Study||11||
48501737|NCT01292837|101560969|FG000|NOT COMPLETED|Overall Study||2||
48501738|NCT02308241|101560970|FG000|STARTED|Overall Study||12||
48501739|NCT02308241|101560970|FG000|COMPLETED|Overall Study||9||
48501740|NCT02308241|101560970|FG000|NOT COMPLETED|Overall Study||3||
48501741|NCT00494013|101560971|FG000|STARTED|Overall Study||223||
48501742|NCT00494013|101560972|FG001|STARTED|Overall Study||219||
48501743|NCT00494013|101560971|FG000|Full Analysis Set (Intent to Treat)|Overall Study||219||
48501744|NCT00494013|101560972|FG001|Full Analysis Set (Intent to Treat)|Overall Study||210||
48501745|NCT00494013|101560971|FG000|COMPLETED|Overall Study||193||
48501746|NCT00494013|101560972|FG001|COMPLETED|Overall Study||183||
48501747|NCT00494013|101560971|FG000|NOT COMPLETED|Overall Study||30||
48501748|NCT00494013|101560972|FG001|NOT COMPLETED|Overall Study||36||
48501749|NCT00393705|101560973|FG000|STARTED|Overall Study||151||
48501750|NCT00393705|101560974|FG001|STARTED|Overall Study||151||
48501751|NCT00393705|101560973|FG000|Received at Least One Dose of Study Drug|Overall Study||139||
48501752|NCT00393705|101560974|FG001|Received at Least One Dose of Study Drug|Overall Study||139||
48501753|NCT00393705|101560973|FG000|COMPLETED|Overall Study||128||
48501754|NCT00393705|101560974|FG001|COMPLETED|Overall Study||128||
48501755|NCT00393705|101560973|FG000|NOT COMPLETED|Overall Study||23||
48501756|NCT00393705|101560974|FG001|NOT COMPLETED|Overall Study||23||
48501757|NCT01624233|101560975|FG000|STARTED|Period 2 - Induction||91||
48501758|NCT01624233|101560975|FG000|Received at Least 1 Dose of Study Drug|Period 2 - Induction||91||
48501759|NCT01624233|101560975|FG000|Erythrodermic Psoriasis (Ps)|Period 2 - Induction||8||
48501760|NCT01624233|101560975|FG000|Pustular Ps|Period 2 - Induction||5||
48501761|NCT01624233|101560975|FG000|Plaque Ps|Period 2 - Induction||78||
48501762|NCT01624233|101560975|FG000|COMPLETED|Period 2 - Induction||90||
48501763|NCT01624233|101560975|FG000|NOT COMPLETED|Period 2 - Induction||1||
48501764|NCT01624233|101560975|FG000|STARTED|Period 3 - Maintenance||90||
48501765|NCT01624233|101560975|FG000|Received at Least 1 Dose of Study Drug|Period 3 - Maintenance||90||
48501766|NCT01624233|101560975|FG000|COMPLETED|Period 3 - Maintenance||83||
48501767|NCT01624233|101560975|FG000|NOT COMPLETED|Period 3 - Maintenance||7||
48501768|NCT01624233|101560975|FG000|STARTED|Period 4 - Drug Free Period||70||
48501769|NCT01624233|101560975|FG000|Adverse Event|Period 4 - Drug Free Period||1||
48501770|NCT01624233|101560975|FG000|Physician Decision|Period 4 - Drug Free Period||1||
48501771|NCT01624233|101560975|FG000|COMPLETED|Period 4 - Drug Free Period||9||
48501772|NCT01624233|101560975|FG000|NOT COMPLETED|Period 4 - Drug Free Period||61||
48501773|NCT01624233|101560975|FG000|STARTED|Period 5 - Retreatment Period||80||
48501774|NCT01624233|101560975|FG000|COMPLETED|Period 5 - Retreatment Period||70||
48501775|NCT01624233|101560975|FG000|NOT COMPLETED|Period 5 - Retreatment Period||10||
48501776|NCT01624233|101560975|FG000|STARTED|Period 6: Follow-up||88||
48501777|NCT01624233|101560975|FG000|COMPLETED|Period 6: Follow-up||79||
48501778|NCT01624233|101560975|FG000|NOT COMPLETED|Period 6: Follow-up||9||
48501779|NCT00556673|101560976|FG000|STARTED|Overall Study||16||
48501780|NCT00556673|101560977|FG001|STARTED|Overall Study||15||
48501781|NCT00556673|101560976|FG000|Pharmacodynamic (PD) Population|Overall Study||12||
48501782|NCT00556673|101560977|FG001|Pharmacodynamic (PD) Population|Overall Study||12||
48501783|NCT00556673|101560976|FG000|COMPLETED|Overall Study||13||
48501784|NCT00556673|101560977|FG001|COMPLETED|Overall Study||13||
48501785|NCT00556673|101560976|FG000|NOT COMPLETED|Overall Study||3||
48501786|NCT00556673|101560977|FG001|NOT COMPLETED|Overall Study||2||
48501787|NCT00735696|101560978|FG000|STARTED|Overall Study||41||
48501788|NCT00735696|101560978|FG000|Received Any Quantity of Study Drug|Overall Study||40||
48501789|NCT00735696|101560978|FG000|COMPLETED|Overall Study||39||
48666755|NCT03391882|101970466|FG001|NOT COMPLETED|Part A - Titration Phase||16||
48666756|NCT03391882|101970467|FG002|NOT COMPLETED|Part A - Titration Phase||0||
48501790|NCT00735696|101560978|FG000|NOT COMPLETED|Overall Study||2||
48501791|NCT01296841|101560979|FG000|STARTED|Overall Study||19||
48501792|NCT01296841|101560980|FG001|STARTED|Overall Study||15||
48501793|NCT01296841|101560979|FG000|COMPLETED|Overall Study||19||
48501794|NCT01296841|101560980|FG001|COMPLETED|Overall Study||15||
48501795|NCT01296841|101560979|FG000|NOT COMPLETED|Overall Study||0||
48501796|NCT01296841|101560980|FG001|NOT COMPLETED|Overall Study||0||
48501797|NCT02896296|101564184|FG000|STARTED|Overall Study||208||
48501798|NCT02896296|101564184|FG000|COMPLETED|Overall Study||166||
48501799|NCT02896296|101564184|FG000|NOT COMPLETED|Overall Study||42||
48501800|NCT02218541|101564185|FG000|STARTED|Overall Study||11||
48501801|NCT02218541|101564186|FG001|STARTED|Overall Study||11||
48501802|NCT02218541|101564185|FG000|COMPLETED|Overall Study||5||
48501803|NCT02218541|101564186|FG001|COMPLETED|Overall Study||9||
48501804|NCT02218541|101564185|FG000|NOT COMPLETED|Overall Study||6||
48501805|NCT02218541|101564186|FG001|NOT COMPLETED|Overall Study||2||
48501806|NCT02614196|101564187|FG000|STARTED|Double Blind Treatment Phase||463||
48501807|NCT02614196|101564188|FG001|STARTED|Double Blind Treatment Phase||233||
48501808|NCT02614196|101564189|FG002|STARTED|Double Blind Treatment Phase||226||
48501809|NCT02614196|101564190|FG003|STARTED|Double Blind Treatment Phase||30||
48501810|NCT02614196|101564191|FG004|STARTED|Double Blind Treatment Phase||15||
48501811|NCT02614196|101564192|FG005|STARTED|Double Blind Treatment Phase||19||
48501812|NCT02614196|101564187|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||461||
48501813|NCT02614196|101564188|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||231||
48501814|NCT02614196|101564189|FG002|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||223||
48501815|NCT02614196|101564190|FG003|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||30||
48501816|NCT02614196|101564191|FG004|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||14||
48501817|NCT02614196|101564192|FG005|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||19||
48501818|NCT02614196|101564187|FG000|COMPLETED|Double Blind Treatment Phase||387||
48501819|NCT02614196|101564188|FG001|COMPLETED|Double Blind Treatment Phase||203||
48501820|NCT02614196|101564189|FG002|COMPLETED|Double Blind Treatment Phase||195||
48501821|NCT02614196|101564190|FG003|COMPLETED|Double Blind Treatment Phase||26||
48501822|NCT02614196|101564191|FG004|COMPLETED|Double Blind Treatment Phase||14||
48501823|NCT02614196|101564192|FG005|COMPLETED|Double Blind Treatment Phase||19||
48501824|NCT02614196|101564187|FG000|NOT COMPLETED|Double Blind Treatment Phase||76||
48501825|NCT02614196|101564188|FG001|NOT COMPLETED|Double Blind Treatment Phase||30||
48501826|NCT02614196|101564189|FG002|NOT COMPLETED|Double Blind Treatment Phase||31||
48501827|NCT02614196|101564190|FG003|NOT COMPLETED|Double Blind Treatment Phase||4||
48501828|NCT02614196|101564191|FG004|NOT COMPLETED|Double Blind Treatment Phase||1||
48501829|NCT02614196|101564192|FG005|NOT COMPLETED|Double Blind Treatment Phase||0||
48501830|NCT02614196|101564187|FG000|STARTED|Post Treatment Follow-up Phase||410||
48501831|NCT02614196|101564188|FG001|STARTED|Post Treatment Follow-up Phase||213||
48501832|NCT02614196|101564189|FG002|STARTED|Post Treatment Follow-up Phase||207||
48501833|NCT02614196|101564190|FG003|STARTED|Post Treatment Follow-up Phase||25||
48501834|NCT02614196|101564191|FG004|STARTED|Post Treatment Follow-up Phase||15||
48501835|NCT02614196|101564192|FG005|STARTED|Post Treatment Follow-up Phase||19||
48501836|NCT02614196|101564187|FG000|COMPLETED|Post Treatment Follow-up Phase||390||
48501837|NCT02614196|101564188|FG001|COMPLETED|Post Treatment Follow-up Phase||208||
48501838|NCT02614196|101564189|FG002|COMPLETED|Post Treatment Follow-up Phase||199||
48501839|NCT02614196|101564190|FG003|COMPLETED|Post Treatment Follow-up Phase||24||
48501840|NCT02614196|101564191|FG004|COMPLETED|Post Treatment Follow-up Phase||13||
48501841|NCT02614196|101564192|FG005|COMPLETED|Post Treatment Follow-up Phase||19||
48501842|NCT02614196|101564187|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||20||
48501843|NCT02614196|101564188|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||5||
48501844|NCT02614196|101564189|FG002|NOT COMPLETED|Post Treatment Follow-up Phase||8||
48501845|NCT02614196|101564190|FG003|NOT COMPLETED|Post Treatment Follow-up Phase||1||
48501846|NCT02614196|101564191|FG004|NOT COMPLETED|Post Treatment Follow-up Phase||2||
48501847|NCT02614196|101564192|FG005|NOT COMPLETED|Post Treatment Follow-up Phase||0||
48501848|NCT02525263|101564193|FG000|STARTED|Overall Study||1||
48501849|NCT02525263|101564193|FG000|COMPLETED|Overall Study||1||
48501850|NCT02525263|101564193|FG000|NOT COMPLETED|Overall Study||0||
48501851|NCT03493919|101564194|FG000|STARTED|Overall Study||470||
48501852|NCT03493919|101564195|FG001|STARTED|Overall Study||165||
48501853|NCT03493919|101564196|FG002|STARTED|Overall Study||165||
48501854|NCT03493919|101564197|FG003|STARTED|Overall Study||161||
48501855|NCT03493919|101564194|FG000|COMPLETED|Overall Study||454||
48501856|NCT03493919|101564195|FG001|COMPLETED|Overall Study||161||
48501857|NCT03493919|101564196|FG002|COMPLETED|Overall Study||163||
48501858|NCT03493919|101564197|FG003|COMPLETED|Overall Study||157||
48501859|NCT03493919|101564194|FG000|NOT COMPLETED|Overall Study||16||
48501860|NCT03493919|101564195|FG001|NOT COMPLETED|Overall Study||4||
48501861|NCT03493919|101564196|FG002|NOT COMPLETED|Overall Study||2||
48501862|NCT03493919|101564197|FG003|NOT COMPLETED|Overall Study||4||
48501863|NCT04721145|101564198|FG000|STARTED|Overall Study||26||
48501864|NCT04721145|101564198|FG000|COMPLETED|Overall Study||26||
48501865|NCT04721145|101564198|FG000|NOT COMPLETED|Overall Study||0||
48501866|NCT01834027|101564199|FG000|STARTED|Overall Study||28||
48501867|NCT01834027|101564200|FG001|STARTED|Overall Study||28||
48501868|NCT01834027|101564199|FG000|COMPLETED|Overall Study||28||
48501869|NCT01834027|101564200|FG001|COMPLETED|Overall Study||28||
48501870|NCT01834027|101564199|FG000|NOT COMPLETED|Overall Study||0||
48501871|NCT01834027|101564200|FG001|NOT COMPLETED|Overall Study||0||
48501872|NCT01310855|101564201|FG000|STARTED|Overall Study||19|112 patients were to be recruited but 38 recruited due to the early discontinuation of cediranib|
48501873|NCT01310855|101564202|FG001|STARTED|Overall Study||19|112 patients were to be recruited but 38 recruited due to the early discontinuation of cediranib|
48501874|NCT01310855|101564201|FG000|COMPLETED|Overall Study||19||
48501875|NCT01310855|101564202|FG001|COMPLETED|Overall Study||19||
48501876|NCT01310855|101564201|FG000|NOT COMPLETED|Overall Study||0||
48501877|NCT01310855|101564202|FG001|NOT COMPLETED|Overall Study||0||
48501878|NCT02179190|101564203|FG000|STARTED|Enrollment||138|Participants Consented and Assessed for Eligibility|
48501879|NCT02179190|101564203|FG000|COMPLETED|Enrollment||127|Attempted with the Study Device - Intent to Treat Population|
48501880|NCT02179190|101564203|FG000|NOT COMPLETED|Enrollment||11||
48501881|NCT02179190|101564203|FG000|STARTED|Index Procedure With Barrel VRD Attempt||127|Participants with an attempted Barrel VRD Implant|
48501882|NCT02179190|101564203|FG000|COMPLETED|Index Procedure With Barrel VRD Attempt||120|Participants with a Successful Barrel Implant|
48501883|NCT02179190|101564203|FG000|NOT COMPLETED|Index Procedure With Barrel VRD Attempt||7||
48501884|NCT02179190|101564203|FG000|STARTED|Follow-Up Post Barrel VRD Implanted||120|Participants Implanted with the Barrel VRD Expected to Complete the 12 Month Visit|
48501885|NCT02179190|101564203|FG000|COMPLETED|Follow-Up Post Barrel VRD Implanted||111|Participants Implanted with the Barrel VRD that Completed the 12 Month Visit|
48501886|NCT02179190|101564203|FG000|NOT COMPLETED|Follow-Up Post Barrel VRD Implanted||9||
48501887|NCT03257254|101564204|FG000|STARTED|Overall Study||76||
48501888|NCT03257254|101564204|FG000|COMPLETED|Overall Study||55||
48501889|NCT03257254|101564204|FG000|NOT COMPLETED|Overall Study||21||
48501890|NCT02473393|101564205|FG000|STARTED|Overall Study||5||
48501891|NCT02473393|101564206|FG001|STARTED|Overall Study||12||
48501892|NCT02473393|101564207|FG002|STARTED|Overall Study||13||
48501893|NCT02473393|101564208|FG003|STARTED|Overall Study||13||
48501894|NCT02473393|101564205|FG000|COMPLETED|Overall Study||5||
48501895|NCT02473393|101564206|FG001|COMPLETED|Overall Study||12||
48501896|NCT02473393|101564207|FG002|COMPLETED|Overall Study||11||
48501897|NCT02473393|101564208|FG003|COMPLETED|Overall Study||12||
48501898|NCT02473393|101564205|FG000|NOT COMPLETED|Overall Study||0||
48501899|NCT02473393|101564206|FG001|NOT COMPLETED|Overall Study||0||
48501900|NCT02473393|101564207|FG002|NOT COMPLETED|Overall Study||2||
48501901|NCT02473393|101564208|FG003|NOT COMPLETED|Overall Study||1||
48501902|NCT04974580|101564209|FG000|STARTED|Overall Study||134||
48501903|NCT04974580|101564210|FG001|STARTED|Overall Study||126||
48501904|NCT04974580|101564211|FG002|STARTED|Overall Study||126||
48501905|NCT04974580|101564212|FG003|STARTED|Overall Study||122||
48501906|NCT04974580|101564209|FG000|COMPLETED|Overall Study||101||
48501907|NCT04974580|101564210|FG001|COMPLETED|Overall Study||87||
48501908|NCT04974580|101564211|FG002|COMPLETED|Overall Study||96||
48501909|NCT04974580|101564212|FG003|COMPLETED|Overall Study||93||
48501910|NCT04974580|101564209|FG000|NOT COMPLETED|Overall Study||33||
48501911|NCT04974580|101564210|FG001|NOT COMPLETED|Overall Study||39||
48501912|NCT04974580|101564211|FG002|NOT COMPLETED|Overall Study||30||
48501913|NCT04974580|101564212|FG003|NOT COMPLETED|Overall Study||29||
48501914|NCT00413049|101564213|FG000|STARTED|Overall Study||349||
48501915|NCT00413049|101564214|FG001|STARTED|Overall Study||349||
48501916|NCT00413049|101564213|FG000|COMPLETED|Overall Study||325||
48501917|NCT00413049|101564214|FG001|COMPLETED|Overall Study||331||
48501918|NCT00413049|101564213|FG000|NOT COMPLETED|Overall Study||24||
48501919|NCT00413049|101564214|FG001|NOT COMPLETED|Overall Study||18||
48501920|NCT02817828|101564215|FG000|STARTED|Overall Study||1553||
48501921|NCT02817828|101564215|FG000|COMPLETED|Overall Study||1218||
48501922|NCT02817828|101564215|FG000|NOT COMPLETED|Overall Study||335||
48501923|NCT01617096|101564216|FG000|STARTED|Overall Study||1313||
48501924|NCT01617096|101564217|FG001|STARTED|Overall Study||1316||
48501925|NCT01617096|101564216|FG000|COMPLETED|Overall Study||1165||
48501926|NCT01617096|101564217|FG001|COMPLETED|Overall Study||1179||
48501927|NCT01617096|101564216|FG000|NOT COMPLETED|Overall Study||148||
48501928|NCT01617096|101564217|FG001|NOT COMPLETED|Overall Study||137||
48501929|NCT00128219|101564218|FG000|STARTED|Overall Study||333||
48501930|NCT00128219|101564219|FG001|STARTED|Overall Study||334||
48501931|NCT00128219|101564218|FG000|COMPLETED|Overall Study||264||
48501932|NCT00128219|101564219|FG001|COMPLETED|Overall Study||263||
48501933|NCT00128219|101564218|FG000|NOT COMPLETED|Overall Study||69||
48501934|NCT00128219|101564219|FG001|NOT COMPLETED|Overall Study||71||
48501935|NCT02161549|101564220|FG000|STARTED|Overall Study||40||
48501936|NCT02161549|101564221|FG001|STARTED|Overall Study||31||
48501937|NCT02161549|101564220|FG000|COMPLETED|Overall Study||34||
48501938|NCT02161549|101564221|FG001|COMPLETED|Overall Study||29||
48501939|NCT02161549|101564220|FG000|NOT COMPLETED|Overall Study||6||
48501940|NCT02161549|101564221|FG001|NOT COMPLETED|Overall Study||2||
48501941|NCT00938782|101564222|FG000|STARTED|Overall Study||32||
48501942|NCT00938782|101564223|FG001|STARTED|Overall Study||35||
48501943|NCT00938782|101564222|FG000|COMPLETED|Overall Study||32||
48501944|NCT00938782|101564223|FG001|COMPLETED|Overall Study||35||
48501945|NCT00938782|101564222|FG000|NOT COMPLETED|Overall Study||0||
48501946|NCT00938782|101564223|FG001|NOT COMPLETED|Overall Study||0||
48501947|NCT00751023|101564224|FG000|STARTED|Overall Study||20||
48501948|NCT00751023|101564225|FG001|STARTED|Overall Study||20||
48501949|NCT00751023|101564224|FG000|COMPLETED|Overall Study||9||
48501950|NCT00751023|101564225|FG001|COMPLETED|Overall Study||13||
48501951|NCT00751023|101564224|FG000|NOT COMPLETED|Overall Study||11||
48501952|NCT00751023|101564225|FG001|NOT COMPLETED|Overall Study||7||
48501953|NCT00452543|101564226|FG000|STARTED|Overall Study||12||
48501954|NCT00452543|101564227|FG001|STARTED|Overall Study||11||
48501955|NCT00452543|101564226|FG000|COMPLETED|Overall Study||7||
48501956|NCT00452543|101564227|FG001|COMPLETED|Overall Study||5||
48501957|NCT00452543|101564226|FG000|NOT COMPLETED|Overall Study||5||
48501958|NCT00452543|101564227|FG001|NOT COMPLETED|Overall Study||6||
48501959|NCT02727192|101564228|FG000|STARTED|Overall Study||54||
48501960|NCT02727192|101564229|FG001|STARTED|Overall Study||54||
48501961|NCT02727192|101564230|FG002|STARTED|Overall Study||1||
48501962|NCT02727192|101564228|FG000|COMPLETED|Overall Study||53||
48501963|NCT02727192|101564229|FG001|COMPLETED|Overall Study||54||
48501964|NCT02727192|101564230|FG002|COMPLETED|Overall Study||1||
48501965|NCT02727192|101564228|FG000|NOT COMPLETED|Overall Study||1||
48501966|NCT02727192|101564229|FG001|NOT COMPLETED|Overall Study||0||
48501967|NCT02727192|101564230|FG002|NOT COMPLETED|Overall Study||0||
48501968|NCT01835548|101564231|FG000|STARTED|Screening/Washout Period||0||
48501969|NCT01835548|101564232|FG001|STARTED|Screening/Washout Period||0||
48501970|NCT01835548|101564233|FG002|STARTED|Screening/Washout Period||87||
48501971|NCT01835548|101564231|FG000|COMPLETED|Screening/Washout Period||0||
48501972|NCT01835548|101564232|FG001|COMPLETED|Screening/Washout Period||0||
48501973|NCT01835548|101564233|FG002|COMPLETED|Screening/Washout Period||87||
48501974|NCT01835548|101564231|FG000|NOT COMPLETED|Screening/Washout Period||0||
48501975|NCT01835548|101564232|FG001|NOT COMPLETED|Screening/Washout Period||0||
48501976|NCT01835548|101564233|FG002|NOT COMPLETED|Screening/Washout Period||0||
48501977|NCT01835548|101564231|FG000|STARTED|Dose Optimization Period||0||
48501978|NCT01835548|101564232|FG001|STARTED|Dose Optimization Period||0||
48501979|NCT01835548|101564233|FG002|STARTED|Dose Optimization Period||87||
48501980|NCT01835548|101564231|FG000|COMPLETED|Dose Optimization Period||0||
48501981|NCT01835548|101564232|FG001|COMPLETED|Dose Optimization Period||0||
48501982|NCT01835548|101564233|FG002|COMPLETED|Dose Optimization Period||85||
48501983|NCT01835548|101564231|FG000|NOT COMPLETED|Dose Optimization Period||0||
48501984|NCT01835548|101564232|FG001|NOT COMPLETED|Dose Optimization Period||0||
48501985|NCT01835548|101564233|FG002|NOT COMPLETED|Dose Optimization Period||2||
48501986|NCT01835548|101564231|FG000|STARTED|Dose Stabilization Period||0||
48501987|NCT01835548|101564232|FG001|STARTED|Dose Stabilization Period||0||
48501988|NCT01835548|101564233|FG002|STARTED|Dose Stabilization Period||85||
48501989|NCT01835548|101564231|FG000|COMPLETED|Dose Stabilization Period||0||
48501990|NCT01835548|101564232|FG001|COMPLETED|Dose Stabilization Period||0||
48501991|NCT01835548|101564233|FG002|COMPLETED|Dose Stabilization Period||85||
48501992|NCT01835548|101564231|FG000|NOT COMPLETED|Dose Stabilization Period||0||
48501993|NCT01835548|101564232|FG001|NOT COMPLETED|Dose Stabilization Period||0||
48501994|NCT01835548|101564233|FG002|NOT COMPLETED|Dose Stabilization Period||0||
48501995|NCT01835548|101564231|FG000|STARTED|Double-Blind Treatment Period||44||
48501996|NCT01835548|101564232|FG001|STARTED|Double-Blind Treatment Period||41||
48501997|NCT01835548|101564233|FG002|STARTED|Double-Blind Treatment Period||0||
48501998|NCT01835548|101564231|FG000|COMPLETED|Double-Blind Treatment Period||44||
48501999|NCT01835548|101564232|FG001|COMPLETED|Double-Blind Treatment Period||39||
48502000|NCT01835548|101564233|FG002|COMPLETED|Double-Blind Treatment Period||0||
48502001|NCT01835548|101564231|FG000|NOT COMPLETED|Double-Blind Treatment Period||0||
48502002|NCT01835548|101564232|FG001|NOT COMPLETED|Double-Blind Treatment Period||2||
48502003|NCT01835548|101564233|FG002|NOT COMPLETED|Double-Blind Treatment Period||0||
48502004|NCT02985749|101564234|FG000|STARTED|Overall Study||2||
48502005|NCT02985749|101564235|FG001|STARTED|Overall Study||5||
48502006|NCT02985749|101564234|FG000|COMPLETED|Overall Study||2||
48502007|NCT02985749|101564235|FG001|COMPLETED|Overall Study||3||
48502008|NCT02985749|101564234|FG000|NOT COMPLETED|Overall Study||0||
48502009|NCT02985749|101564235|FG001|NOT COMPLETED|Overall Study||2||
48502010|NCT03540160|101564236|FG000|STARTED|Overall Study||558||
48502011|NCT03540160|101564236|FG000|COMPLETED|Overall Study||179||
48502012|NCT03540160|101564236|FG000|NOT COMPLETED|Overall Study||379||
48502013|NCT02898740|101564237|FG000|STARTED|Overall Study||21||
48502014|NCT02898740|101564238|FG001|STARTED|Overall Study||19||
48502015|NCT02898740|101564237|FG000|COMPLETED|Overall Study||21||
48502016|NCT02898740|101564238|FG001|COMPLETED|Overall Study||19||
48502017|NCT02898740|101564237|FG000|NOT COMPLETED|Overall Study||0||
48502018|NCT02898740|101564238|FG001|NOT COMPLETED|Overall Study||0||
48502019|NCT04736537|101564239|FG000|STARTED|Overall Study||31||
48061114|NCT02169284|100470345|FG000|STARTED|Overall Study||24||
48061115|NCT02169284|100470346|FG001|STARTED|Overall Study||13||
48061116|NCT02169284|100470345|FG000|COMPLETED|Overall Study||24||
48502020|NCT04736537|101564239|FG000|COMPLETED|Overall Study||31||
48502021|NCT04736537|101564239|FG000|NOT COMPLETED|Overall Study||0||
48502022|NCT04148287|101564240|FG000|STARTED|Overall Study||9||
48502023|NCT04148287|101564240|FG000|COMPLETED|Overall Study||7||
48502024|NCT04148287|101564240|FG000|NOT COMPLETED|Overall Study||2||
48502025|NCT00879684|101564241|FG000|STARTED|Stage 1: Dose Escalation||3||
48502026|NCT00879684|101564242|FG001|STARTED|Stage 1: Dose Escalation||3||
48502027|NCT00879684|101564243|FG002|STARTED|Stage 1: Dose Escalation||3||
48502028|NCT00879684|101564244|FG003|STARTED|Stage 1: Dose Escalation||6||
48502029|NCT00879684|101564245|FG004|STARTED|Stage 1: Dose Escalation||3||
48502030|NCT00879684|101564246|FG005|STARTED|Stage 1: Dose Escalation||3||
48502031|NCT00879684|101564247|FG006|STARTED|Stage 1: Dose Escalation||0||
48502032|NCT00879684|101564241|FG000|COMPLETED|Stage 1: Dose Escalation||0||
48502033|NCT00879684|101564242|FG001|COMPLETED|Stage 1: Dose Escalation||0||
48502034|NCT00879684|101564243|FG002|COMPLETED|Stage 1: Dose Escalation||0||
48502035|NCT00879684|101564244|FG003|COMPLETED|Stage 1: Dose Escalation||0||
48502036|NCT00879684|101564245|FG004|COMPLETED|Stage 1: Dose Escalation||0||
48502037|NCT00879684|101564246|FG005|COMPLETED|Stage 1: Dose Escalation||0||
48502038|NCT00879684|101564247|FG006|COMPLETED|Stage 1: Dose Escalation||0||
48502039|NCT00879684|101564241|FG000|NOT COMPLETED|Stage 1: Dose Escalation||3||
48502040|NCT00879684|101564242|FG001|NOT COMPLETED|Stage 1: Dose Escalation||3||
48502041|NCT00879684|101564243|FG002|NOT COMPLETED|Stage 1: Dose Escalation||3||
48502042|NCT00879684|101564244|FG003|NOT COMPLETED|Stage 1: Dose Escalation||6||
48502043|NCT00879684|101564245|FG004|NOT COMPLETED|Stage 1: Dose Escalation||3||
48502044|NCT00879684|101564246|FG005|NOT COMPLETED|Stage 1: Dose Escalation||3||
48502045|NCT00879684|101564247|FG006|NOT COMPLETED|Stage 1: Dose Escalation||0||
48502046|NCT00879684|101564241|FG000|STARTED|Stage 2: Expanded Cohort||0||
48502047|NCT00879684|101564242|FG001|STARTED|Stage 2: Expanded Cohort||0||
48502048|NCT00879684|101564243|FG002|STARTED|Stage 2: Expanded Cohort||0||
48502049|NCT00879684|101564244|FG003|STARTED|Stage 2: Expanded Cohort||0||
48502050|NCT00879684|101564245|FG004|STARTED|Stage 2: Expanded Cohort||0||
48502051|NCT00879684|101564246|FG005|STARTED|Stage 2: Expanded Cohort||0||
48502052|NCT00879684|101564247|FG006|STARTED|Stage 2: Expanded Cohort||13||
48502053|NCT00879684|101564241|FG000|COMPLETED|Stage 2: Expanded Cohort||0||
48502054|NCT00879684|101564242|FG001|COMPLETED|Stage 2: Expanded Cohort||0||
48502055|NCT00879684|101564243|FG002|COMPLETED|Stage 2: Expanded Cohort||0||
48502056|NCT00879684|101564244|FG003|COMPLETED|Stage 2: Expanded Cohort||0||
48502057|NCT00879684|101564245|FG004|COMPLETED|Stage 2: Expanded Cohort||0||
48502058|NCT00879684|101564246|FG005|COMPLETED|Stage 2: Expanded Cohort||0||
48502059|NCT00879684|101564247|FG006|COMPLETED|Stage 2: Expanded Cohort||0||
48502060|NCT00879684|101564241|FG000|NOT COMPLETED|Stage 2: Expanded Cohort||0||
48502061|NCT00879684|101564242|FG001|NOT COMPLETED|Stage 2: Expanded Cohort||0||
48502062|NCT00879684|101564243|FG002|NOT COMPLETED|Stage 2: Expanded Cohort||0||
48502063|NCT00879684|101564244|FG003|NOT COMPLETED|Stage 2: Expanded Cohort||0||
48502064|NCT00879684|101564245|FG004|NOT COMPLETED|Stage 2: Expanded Cohort||0||
48502065|NCT00879684|101564246|FG005|NOT COMPLETED|Stage 2: Expanded Cohort||0||
48502066|NCT00879684|101564247|FG006|NOT COMPLETED|Stage 2: Expanded Cohort||13||
48502067|NCT03294317|101564248|FG000|STARTED|Overall Study||70||
48502068|NCT03294317|101564248|FG000|Implanted With Lead at HIS Bundle|Overall Study||61||
48502069|NCT03294317|101564248|FG000|Subjects With Available CT|Overall Study||51||
48502070|NCT03294317|101564248|FG000|COMPLETED|Overall Study||50||
48502071|NCT03294317|101564248|FG000|NOT COMPLETED|Overall Study||20||
48502072|NCT02119936|101564249|FG000|STARTED|Overall Study||10||
48502073|NCT02119936|101564249|FG000|COMPLETED|Overall Study||0||
48502074|NCT02119936|101564249|FG000|NOT COMPLETED|Overall Study||10||
48502075|NCT01968031|101564250|FG000|STARTED|Overall Study||204||
48502076|NCT01968031|101564251|FG001|STARTED|Overall Study||202||
48502077|NCT01968031|101564252|FG002|STARTED|Overall Study||207||
48502078|NCT01968031|101564250|FG000|Completed Week 2|Overall Study||197||
48502079|NCT01968031|101564251|FG001|Completed Week 2|Overall Study||190||
48502080|NCT01968031|101564252|FG002|Completed Week 2|Overall Study||199||
48502081|NCT01968031|101564250|FG000|Completed Week 6|Overall Study||191||
48502082|NCT01968031|101564251|FG001|Completed Week 6|Overall Study||183||
48502083|NCT01968031|101564252|FG002|Completed Week 6|Overall Study||187||
48502084|NCT01968031|101564250|FG000|Completed Week 10|Overall Study||187||
48502085|NCT01968031|101564251|FG001|Completed Week 10|Overall Study||181||
48502086|NCT01968031|101564252|FG002|Completed Week 10|Overall Study||181||
48502087|NCT01968031|101564250|FG000|COMPLETED|Overall Study||186||
48502088|NCT01968031|101564251|FG001|COMPLETED|Overall Study||182||
48502089|NCT01968031|101564252|FG002|COMPLETED|Overall Study||178||
48502090|NCT01968031|101564250|FG000|NOT COMPLETED|Overall Study||18||
48502091|NCT01968031|101564251|FG001|NOT COMPLETED|Overall Study||20||
48502092|NCT01968031|101564252|FG002|NOT COMPLETED|Overall Study||29||
48502093|NCT02046122|101564253|FG000|STARTED|Overall Study||17||
48502094|NCT02046122|101564253|FG000|COMPLETED|Overall Study||8||
48502095|NCT02046122|101564253|FG000|NOT COMPLETED|Overall Study||9||
48502096|NCT01742208|101564254|FG000|STARTED|Overall Study||3||
48502097|NCT01742208|101564255|FG001|STARTED|Overall Study||17||
48502098|NCT01742208|101564256|FG002|STARTED|Overall Study||16||
48502099|NCT01742208|101564254|FG000|COMPLETED|Overall Study||3||
48502100|NCT01742208|101564255|FG001|COMPLETED|Overall Study||17||
48502101|NCT01742208|101564256|FG002|COMPLETED|Overall Study||16||
48502102|NCT01742208|101564254|FG000|NOT COMPLETED|Overall Study||0||
48502103|NCT01742208|101564255|FG001|NOT COMPLETED|Overall Study||0||
48502104|NCT01742208|101564256|FG002|NOT COMPLETED|Overall Study||0||
48502105|NCT04046094|101564257|FG000|STARTED|Overall Study||12||
48502106|NCT04046094|101564257|FG000|COMPLETED|Overall Study||12||
48502107|NCT04046094|101564257|FG000|NOT COMPLETED|Overall Study||0||
48502108|NCT02542462|101564258|FG000|STARTED|Overall Study||25||
48502109|NCT02542462|101564259|FG001|STARTED|Overall Study||25||
48502110|NCT02542462|101564260|FG002|STARTED|Overall Study||25||
48502111|NCT02542462|101564261|FG003|STARTED|Overall Study||26||
48502112|NCT02542462|101564258|FG000|COMPLETED|Overall Study||25||
48502113|NCT02542462|101564259|FG001|COMPLETED|Overall Study||25||
48502114|NCT02542462|101564260|FG002|COMPLETED|Overall Study||25||
48502115|NCT02542462|101564261|FG003|COMPLETED|Overall Study||25||
48502116|NCT02542462|101564258|FG000|NOT COMPLETED|Overall Study||0||
48502117|NCT02542462|101564259|FG001|NOT COMPLETED|Overall Study||0||
48502118|NCT02542462|101564260|FG002|NOT COMPLETED|Overall Study||0||
48502119|NCT02542462|101564261|FG003|NOT COMPLETED|Overall Study||1||
48502120|NCT02233751|101564262|FG000|STARTED|Overall Study||6||
48502121|NCT02233751|101564263|FG001|STARTED|Overall Study||6||
48502122|NCT02233751|101564262|FG000|COMPLETED|Overall Study||6||
48502123|NCT02233751|101564263|FG001|COMPLETED|Overall Study||6||
48502124|NCT02233751|101564262|FG000|NOT COMPLETED|Overall Study||0||
48502125|NCT02233751|101564263|FG001|NOT COMPLETED|Overall Study||0||
48502126|NCT02725515|101564264|FG000|STARTED|Overall Study||53||
48502127|NCT02725515|101564265|FG001|STARTED|Overall Study||52||
48502128|NCT02725515|101564264|FG000|COMPLETED|Overall Study||28||
48502129|NCT02725515|101564265|FG001|COMPLETED|Overall Study||17||
48502130|NCT02725515|101564264|FG000|NOT COMPLETED|Overall Study||25||
48502131|NCT02725515|101564265|FG001|NOT COMPLETED|Overall Study||35||
48502132|NCT03123874|101564266|FG000|STARTED|Overall Study||27||
48502133|NCT03123874|101564267|FG001|STARTED|Overall Study||25||
48502134|NCT03123874|101564266|FG000|COMPLETED|Overall Study||27||
48502135|NCT03123874|101564267|FG001|COMPLETED|Overall Study||25||
48502136|NCT03123874|101564266|FG000|NOT COMPLETED|Overall Study||0||
48502137|NCT03123874|101564267|FG001|NOT COMPLETED|Overall Study||0||
48502138|NCT01881737|101564268|FG000|STARTED|Overall Study||15||
48502139|NCT01881737|101564268|FG000|Number Screened|Overall Study||15||
48502140|NCT01881737|101564268|FG000|COMPLETED|Overall Study||10||
48502141|NCT01881737|101564268|FG000|NOT COMPLETED|Overall Study||5||
48502142|NCT01519947|101564269|FG000|STARTED|Overall Study||19||
48502143|NCT01519947|101564270|FG001|STARTED|Overall Study||11||
48502144|NCT01519947|101564271|FG002|STARTED|Overall Study||15||
48502145|NCT01519947|101564272|FG003|STARTED|Overall Study||42||
48502146|NCT01519947|101564269|FG000|COMPLETED|Overall Study||17||
48502147|NCT01519947|101564270|FG001|COMPLETED|Overall Study||7||
48502148|NCT01519947|101564271|FG002|COMPLETED|Overall Study||8||
48502149|NCT01519947|101564272|FG003|COMPLETED|Overall Study||34||
48502150|NCT01519947|101564269|FG000|NOT COMPLETED|Overall Study||2||
48502151|NCT01519947|101564270|FG001|NOT COMPLETED|Overall Study||4||
48502152|NCT01519947|101564271|FG002|NOT COMPLETED|Overall Study||7||
48502153|NCT01519947|101564272|FG003|NOT COMPLETED|Overall Study||8||
48502154|NCT01507662|101564273|FG000|STARTED|Overall Study||3898||
48502155|NCT01507662|101564274|FG001|STARTED|Overall Study||3851||
48502156|NCT01507662|101564273|FG000|COMPLETED|Overall Study||3082||
48502157|NCT01507662|101564274|FG001|COMPLETED|Overall Study||3020||
48502158|NCT01507662|101564273|FG000|NOT COMPLETED|Overall Study||816||
48502159|NCT01507662|101564274|FG001|NOT COMPLETED|Overall Study||831||
48502160|NCT01596127|101564275|FG000|STARTED|Overall Study||4||
48502161|NCT01596127|101564275|FG000|COMPLETED|Overall Study||3||
48502162|NCT01596127|101564275|FG000|NOT COMPLETED|Overall Study||1||
48502163|NCT03937791|101564276|FG000|STARTED|Overall Study||1||
48502164|NCT03937791|101564276|FG000|COMPLETED|Overall Study||1||
48502165|NCT03937791|101564276|FG000|NOT COMPLETED|Overall Study||0||
48502166|NCT04404725|101564277|FG000|STARTED|First Intervention||32||
48502167|NCT04404725|101564278|FG001|STARTED|First Intervention||31||
48502168|NCT04404725|101564277|FG000|COMPLETED|First Intervention||32||
48502169|NCT04404725|101564278|FG001|COMPLETED|First Intervention||29||
48502170|NCT04404725|101564277|FG000|NOT COMPLETED|First Intervention||0||
48502171|NCT04404725|101564278|FG001|NOT COMPLETED|First Intervention||2||
48502172|NCT04404725|101564277|FG000|STARTED|Second Intervention||32||
48502173|NCT04404725|101564278|FG001|STARTED|Second Intervention||29||
48502174|NCT04404725|101564277|FG000|COMPLETED|Second Intervention||31||
48502175|NCT04404725|101564278|FG001|COMPLETED|Second Intervention||27||
48502176|NCT04404725|101564277|FG000|NOT COMPLETED|Second Intervention||1||
48502177|NCT04404725|101564278|FG001|NOT COMPLETED|Second Intervention||2||
48502178|NCT03617419|101564279|FG000|STARTED|Part 1||2||
48502179|NCT03617419|101564279|FG000|COMPLETED|Part 1||2||
48502180|NCT03617419|101564279|FG000|NOT COMPLETED|Part 1||0||
48502181|NCT03617419|101564279|FG000|STARTED|Part 2||14||
48502182|NCT03617419|101564279|FG000|COMPLETED|Part 2||14||
48502183|NCT03617419|101564279|FG000|NOT COMPLETED|Part 2||0||
48502184|NCT00674128|101564280|FG000|STARTED|Overall Study||50||
48502185|NCT00674128|101564281|FG001|STARTED|Overall Study||44||
48502186|NCT00674128|101564280|FG000|COMPLETED|Overall Study||25||
48502187|NCT00674128|101564281|FG001|COMPLETED|Overall Study||21||
48502188|NCT00674128|101564280|FG000|NOT COMPLETED|Overall Study||25||
48502189|NCT00674128|101564281|FG001|NOT COMPLETED|Overall Study||23||
48502190|NCT01559116|101564282|FG000|STARTED|Overall Study||219||
48502191|NCT01559116|101564282|FG000|COMPLETED|Overall Study||193||
48502192|NCT01559116|101564282|FG000|NOT COMPLETED|Overall Study||26||
48502193|NCT00268762|101564283|FG000|STARTED|Overall Study||65||
48502194|NCT00268762|101564283|FG000|COMPLETED|Overall Study||65||
48502195|NCT00268762|101564283|FG000|NOT COMPLETED|Overall Study||0||
48502196|NCT00372996|101564284|FG000|STARTED|Overall Study||79||
48502197|NCT00372996|101564285|FG001|STARTED|Overall Study||36||
48502198|NCT00372996|101564286|FG002|STARTED|Overall Study||61||
48502199|NCT00372996|101564287|FG003|STARTED|Overall Study||43||
48502200|NCT00372996|101564284|FG000|COMPLETED|Overall Study||42||
48502201|NCT00372996|101564285|FG001|COMPLETED|Overall Study||22||
48502202|NCT00372996|101564286|FG002|COMPLETED|Overall Study||33||
48502203|NCT00372996|101564287|FG003|COMPLETED|Overall Study||23||
48502204|NCT00372996|101564284|FG000|NOT COMPLETED|Overall Study||37||
48502205|NCT00372996|101564285|FG001|NOT COMPLETED|Overall Study||14||
48502206|NCT00372996|101564286|FG002|NOT COMPLETED|Overall Study||28||
48502207|NCT00372996|101564287|FG003|NOT COMPLETED|Overall Study||20||
48502208|NCT00660387|101564288|FG000|STARTED|Overall Study||37||
48502209|NCT00660387|101564289|FG001|STARTED|Overall Study||34||
48502210|NCT00660387|101564288|FG000|COMPLETED|Overall Study||35||
48502211|NCT00660387|101564289|FG001|COMPLETED|Overall Study||31||
48502212|NCT00660387|101564288|FG000|NOT COMPLETED|Overall Study||2||
48502213|NCT00660387|101564289|FG001|NOT COMPLETED|Overall Study||3||
48502214|NCT01721772|101564290|FG000|STARTED|Pre-Treatment||210|Randomized|
48502215|NCT01721772|101564291|FG001|STARTED|Pre-Treatment||208|Randomized|
48502216|NCT01721772|101564290|FG000|COMPLETED|Pre-Treatment||206|Moving to the treatment period|
48502217|NCT01721772|101564291|FG001|COMPLETED|Pre-Treatment||205|Moving to the treatment period|
48502218|NCT01721772|101564290|FG000|NOT COMPLETED|Pre-Treatment||4||
48502219|NCT01721772|101564291|FG001|NOT COMPLETED|Pre-Treatment||3||
48502220|NCT01721772|101564290|FG000|STARTED|Treatment||206|Treated|
48502221|NCT01721772|101564291|FG001|STARTED|Treatment||205|Treated|
48502222|NCT01721772|101564290|FG000|COMPLETED|Treatment||0||
48502223|NCT01721772|101564291|FG001|COMPLETED|Treatment||0||
48502224|NCT01721772|101564290|FG000|NOT COMPLETED|Treatment||206||
48502225|NCT01721772|101564291|FG001|NOT COMPLETED|Treatment||205||
48502226|NCT00838162|101564292|FG000|STARTED|Overall Study||9||
48502227|NCT00838162|101564293|FG001|STARTED|Overall Study||8||
48502228|NCT00838162|101564294|FG002|STARTED|Overall Study||8||
48502229|NCT00838162|101564295|FG003|STARTED|Overall Study||8||
48502230|NCT00838162|101564292|FG000|COMPLETED|Overall Study||9||
48502231|NCT00838162|101564293|FG001|COMPLETED|Overall Study||8||
48502232|NCT00838162|101564294|FG002|COMPLETED|Overall Study||8||
48502233|NCT00838162|101564295|FG003|COMPLETED|Overall Study||8||
48502234|NCT00838162|101564292|FG000|NOT COMPLETED|Overall Study||0||
48502235|NCT00838162|101564293|FG001|NOT COMPLETED|Overall Study||0||
48502236|NCT00838162|101564294|FG002|NOT COMPLETED|Overall Study||0||
48502237|NCT00838162|101564295|FG003|NOT COMPLETED|Overall Study||0||
48502238|NCT04661202|101564296|FG000|STARTED|Overall Study||14||
48502239|NCT04661202|101564297|FG001|STARTED|Overall Study||13||
48502240|NCT04661202|101564296|FG000|COMPLETED|Overall Study||11||
48502241|NCT04661202|101564297|FG001|COMPLETED|Overall Study||12||
48502242|NCT04661202|101564296|FG000|NOT COMPLETED|Overall Study||3||
48502243|NCT04661202|101564297|FG001|NOT COMPLETED|Overall Study||1||
48502244|NCT04049097|101564298|FG000|STARTED|Overall Study||121||
48502245|NCT04049097|101564298|FG000|COMPLETED|Overall Study||0||
48502246|NCT04049097|101564298|FG000|NOT COMPLETED|Overall Study||121||
48502247|NCT00685334|101564299|FG000|STARTED|Overall Study||12||
48502248|NCT00685334|101564300|FG001|STARTED|Overall Study||10||
48502249|NCT00685334|101564299|FG000|COMPLETED|Overall Study||2||
48502250|NCT00685334|101564300|FG001|COMPLETED|Overall Study||3||
48502251|NCT00685334|101564299|FG000|NOT COMPLETED|Overall Study||10||
48502252|NCT00685334|101564300|FG001|NOT COMPLETED|Overall Study||7||
48502253|NCT05109104|101564301|FG000|STARTED|Overall Study||13||61
48502254|NCT05109104|101564301|FG000|CAP UnScented|Overall Study||11||10
48502255|NCT05109104|101564301|FG000|CAP Herbal Mint|Overall Study||11||10
48502256|NCT05109104|101564301|FG000|CAP Mountain Berry|Overall Study||13||11
48502257|NCT05109104|101564301|FG000|SPF Standard|Overall Study||13||13
48061117|NCT02169284|100470346|FG001|COMPLETED|Overall Study||12||
48061118|NCT02169284|100470345|FG000|NOT COMPLETED|Overall Study||0||
48061119|NCT02169284|100470346|FG001|NOT COMPLETED|Overall Study||1||
48061120|NCT00147251|100470347|FG000|STARTED|Recruitment and Enrollment||271||
48061121|NCT00147251|100470348|FG001|STARTED|Recruitment and Enrollment||277||
48061122|NCT00147251|100470347|FG000|COMPLETED|Recruitment and Enrollment||247||
48061123|NCT00147251|100470348|FG001|COMPLETED|Recruitment and Enrollment||252||
48061124|NCT00147251|100470347|FG000|NOT COMPLETED|Recruitment and Enrollment||24||
48061125|NCT00147251|100470348|FG001|NOT COMPLETED|Recruitment and Enrollment||25||
48061126|NCT00147251|100470347|FG000|STARTED|Follow up||247||
48061127|NCT00147251|100470348|FG001|STARTED|Follow up||252||
48061128|NCT00147251|100470347|FG000|COMPLETED|Follow up||247||
48061129|NCT00147251|100470348|FG001|COMPLETED|Follow up||252||
48502258|NCT05109104|101564301|FG000|Untreated|Overall Study||13||12
48502259|NCT05109104|101564301|FG000|COMPLETED|Overall Study||13||56
48502260|NCT05109104|101564301|FG000|NOT COMPLETED|Overall Study||0||5
48502261|NCT00985751|101564302|FG000|STARTED|Overall Study||51||
48502262|NCT00985751|101564303|FG001|STARTED|Overall Study||52||
48666757|NCT03391882|101970468|FG003|NOT COMPLETED|Part A - Titration Phase||0||
48061130|NCT00147251|100470347|FG000|NOT COMPLETED|Follow up||0||
48061131|NCT00147251|100470348|FG001|NOT COMPLETED|Follow up||0||
48061132|NCT00915356|100470349|FG000|STARTED|Overall Study||26||
48061133|NCT00915356|100470350|FG001|STARTED|Overall Study||45||
48502263|NCT00985751|101564304|FG002|STARTED|Overall Study||52||
48502264|NCT00985751|101564305|FG003|STARTED|Overall Study||51||
48502265|NCT00985751|101564306|FG004|STARTED|Overall Study||51||
48502266|NCT00985751|101564302|FG000|COMPLETED|Overall Study||51||
48502267|NCT00985751|101564303|FG001|COMPLETED|Overall Study||52||
48502268|NCT00985751|101564304|FG002|COMPLETED|Overall Study||52||
48502269|NCT00985751|101564305|FG003|COMPLETED|Overall Study||51||
48502270|NCT00985751|101564306|FG004|COMPLETED|Overall Study||50||
48502271|NCT00985751|101564302|FG000|NOT COMPLETED|Overall Study||0||
48502272|NCT00985751|101564303|FG001|NOT COMPLETED|Overall Study||0||
48502273|NCT00985751|101564304|FG002|NOT COMPLETED|Overall Study||0||
48502274|NCT00985751|101564305|FG003|NOT COMPLETED|Overall Study||0||
48502275|NCT00985751|101564306|FG004|NOT COMPLETED|Overall Study||1||
48502276|NCT02299869|101564307|FG000|STARTED|Overall Study||10||
48502277|NCT02299869|101564308|FG001|STARTED|Overall Study||10||
48502278|NCT02299869|101564309|FG002|STARTED|Overall Study||10||
48502279|NCT02299869|101564310|FG003|STARTED|Overall Study||10||
48502280|NCT02299869|101564307|FG000|COMPLETED|Overall Study||10||
48502281|NCT02299869|101564308|FG001|COMPLETED|Overall Study||10||
48502282|NCT02299869|101564309|FG002|COMPLETED|Overall Study||10||
48502283|NCT02299869|101564310|FG003|COMPLETED|Overall Study||10||
48502284|NCT02299869|101564307|FG000|NOT COMPLETED|Overall Study||0||
48502285|NCT02299869|101564308|FG001|NOT COMPLETED|Overall Study||0||
48502286|NCT02299869|101564309|FG002|NOT COMPLETED|Overall Study||0||
48502287|NCT02299869|101564310|FG003|NOT COMPLETED|Overall Study||0||
48502288|NCT00193492|101564311|FG000|STARTED|Overall Study||31||
48502289|NCT00193492|101564312|FG001|STARTED|Overall Study||29||
48502290|NCT00193492|101564311|FG000|COMPLETED|Overall Study||14||
48502291|NCT00193492|101564312|FG001|COMPLETED|Overall Study||14||
48502292|NCT00193492|101564311|FG000|NOT COMPLETED|Overall Study||17||
48502293|NCT00193492|101564312|FG001|NOT COMPLETED|Overall Study||15||
48502294|NCT05776901|101564313|FG000|STARTED|Overall Study||3|Milestone 1 (Week 1): Completion of the C-STRESS app orientation session and the SUS questionnaire at the baseline.|
48502295|NCT05776901|101564313|FG000|Week 3|Overall Study||3|Milestone 2 (Week 3): Completion of the SUS questionnaire at week 3|
48502296|NCT05776901|101564313|FG000|Week 6|Overall Study||0|Milestone 3: Completion of the SUS questionnaire at week 6. The collection of data was not completed due to grant termination.|
48502297|NCT05776901|101564313|FG000|COMPLETED|Overall Study||0||
48502298|NCT05776901|101564313|FG000|NOT COMPLETED|Overall Study||3||
48502299|NCT04320745|101564314|FG000|STARTED|Overall Study||168||
48502300|NCT04320745|101564314|FG000|COMPLETED|Overall Study||121||
48502301|NCT04320745|101564314|FG000|NOT COMPLETED|Overall Study||47||
48502302|NCT03786770|101564315|FG000|STARTED|Overall Study||14||
48502303|NCT03786770|101564316|FG001|STARTED|Overall Study||15||
48502304|NCT03786770|101564317|FG002|STARTED|Overall Study||16||
48502305|NCT03786770|101564318|FG003|STARTED|Overall Study||16||
48502306|NCT03786770|101564315|FG000|COMPLETED|Overall Study||13||
48502307|NCT03786770|101564316|FG001|COMPLETED|Overall Study||15||
48502308|NCT03786770|101564317|FG002|COMPLETED|Overall Study||16||
48502309|NCT03786770|101564318|FG003|COMPLETED|Overall Study||16||
48502310|NCT03786770|101564315|FG000|NOT COMPLETED|Overall Study||1||
48502311|NCT03786770|101564316|FG001|NOT COMPLETED|Overall Study||0||
48502312|NCT03786770|101564317|FG002|NOT COMPLETED|Overall Study||0||
48502313|NCT03786770|101564318|FG003|NOT COMPLETED|Overall Study||0||
48502314|NCT02359864|101564319|FG000|STARTED|Overall Study||2||
48502315|NCT02359864|101564320|FG001|STARTED|Overall Study||0||
48502316|NCT02359864|101564319|FG000|COMPLETED|Overall Study||1||
48502317|NCT02359864|101564320|FG001|COMPLETED|Overall Study||0||
48502318|NCT02359864|101564319|FG000|NOT COMPLETED|Overall Study||1||
48502319|NCT02359864|101564320|FG001|NOT COMPLETED|Overall Study||0||
48502320|NCT01896934|101564321|FG000|STARTED|Overall Study||21||
48502321|NCT01896934|101564321|FG000|COMPLETED|Overall Study||19||
48502322|NCT01896934|101564321|FG000|NOT COMPLETED|Overall Study||2||
48502323|NCT01780350|101564322|FG000|STARTED|Overall Study||200||
48502324|NCT01780350|101564322|FG000|COMPLETED|Overall Study||200||
48502325|NCT01780350|101564322|FG000|NOT COMPLETED|Overall Study||0||
48502326|NCT04129944|101564323|FG000|STARTED|Overall Study||46||
48502327|NCT04129944|101564324|FG001|STARTED|Overall Study||45||
48502328|NCT04129944|101564325|FG002|STARTED|Overall Study||46||
48502329|NCT04129944|101564326|FG003|STARTED|Overall Study||46||
48502330|NCT04129944|101564323|FG000|COMPLETED|Overall Study||44||
48502331|NCT04129944|101564324|FG001|COMPLETED|Overall Study||45||
48502332|NCT04129944|101564325|FG002|COMPLETED|Overall Study||45||
48502333|NCT04129944|101564326|FG003|COMPLETED|Overall Study||43||
48502334|NCT04129944|101564323|FG000|NOT COMPLETED|Overall Study||2||
48502335|NCT04129944|101564324|FG001|NOT COMPLETED|Overall Study||0||
48502336|NCT04129944|101564325|FG002|NOT COMPLETED|Overall Study||1||
48502337|NCT04129944|101564326|FG003|NOT COMPLETED|Overall Study||3||
48502338|NCT01344018|101564327|FG000|STARTED|Overall Study||133||
48502339|NCT01344018|101564328|FG001|STARTED|Overall Study||133||
48502340|NCT01344018|101564327|FG000|COMPLETED|Overall Study||107||
48502341|NCT01344018|101564328|FG001|COMPLETED|Overall Study||101||
48502342|NCT01344018|101564327|FG000|NOT COMPLETED|Overall Study||26||
48502343|NCT01344018|101564328|FG001|NOT COMPLETED|Overall Study||32||
48502344|NCT02676973|101564329|FG000|STARTED|Overall Study||123||
48502345|NCT02676973|101564330|FG001|STARTED|Overall Study||121||
48502346|NCT02676973|101564331|FG002|STARTED|Overall Study||116||
48502347|NCT02676973|101564329|FG000|COMPLETED|Overall Study||104||
48502348|NCT02676973|101564330|FG001|COMPLETED|Overall Study||100||
48502349|NCT02676973|101564331|FG002|COMPLETED|Overall Study||92||
48502350|NCT02676973|101564329|FG000|NOT COMPLETED|Overall Study||19||
48502351|NCT02676973|101564330|FG001|NOT COMPLETED|Overall Study||21||
48502352|NCT02676973|101564331|FG002|NOT COMPLETED|Overall Study||24||
48502353|NCT04090658|101564332|FG000|STARTED|Overall Study||20||
48502354|NCT04090658|101564333|FG001|STARTED|Overall Study||20||
48502355|NCT04090658|101564332|FG000|COMPLETED|Overall Study||20||
48502356|NCT04090658|101564333|FG001|COMPLETED|Overall Study||20||
48502357|NCT04090658|101564332|FG000|NOT COMPLETED|Overall Study||0||
48502358|NCT04090658|101564333|FG001|NOT COMPLETED|Overall Study||0||
48502359|NCT01547728|101564334|FG000|STARTED|Overall Study||42||
48502360|NCT01547728|101564334|FG000|COMPLETED|Overall Study||1||
48502361|NCT01547728|101564334|FG000|NOT COMPLETED|Overall Study||41||
48502362|NCT00216060|101564335|FG000|STARTED|Overall Study||32||
48502363|NCT00216060|101564336|FG001|STARTED|Overall Study||31||
48502364|NCT00216060|101564335|FG000|COMPLETED|Overall Study||32||
48502365|NCT00216060|101564336|FG001|COMPLETED|Overall Study||31||
48502366|NCT00216060|101564335|FG000|NOT COMPLETED|Overall Study||0||
48502367|NCT00216060|101564336|FG001|NOT COMPLETED|Overall Study||0||
48502368|NCT02016235|101564337|FG000|STARTED|Overall Study||10||
48502369|NCT02016235|101564338|FG001|STARTED|Overall Study||10||
48502370|NCT02016235|101564339|FG002|STARTED|Overall Study||10||
48502371|NCT02016235|101564337|FG000|COMPLETED|Overall Study||10||
48502372|NCT02016235|101564338|FG001|COMPLETED|Overall Study||10||
48502373|NCT02016235|101564339|FG002|COMPLETED|Overall Study||10||
48502374|NCT02016235|101564337|FG000|NOT COMPLETED|Overall Study||0||
48502375|NCT02016235|101564338|FG001|NOT COMPLETED|Overall Study||0||
48502376|NCT02016235|101564339|FG002|NOT COMPLETED|Overall Study||0||
48502377|NCT00106106|101564340|FG000|STARTED|Overall Study||26||
48502378|NCT00106106|101564341|FG001|STARTED|Overall Study||23||
48502379|NCT00106106|101564340|FG000|Completed Both MRS Scans|Overall Study||18||
48502380|NCT00106106|101564341|FG001|Completed Both MRS Scans|Overall Study||15||
48502381|NCT00106106|101564340|FG000|COMPLETED|Overall Study||22||
48502382|NCT00106106|101564341|FG001|COMPLETED|Overall Study||19||
48502383|NCT00106106|101564340|FG000|NOT COMPLETED|Overall Study||4||
48502384|NCT00106106|101564341|FG001|NOT COMPLETED|Overall Study||4||
48502385|NCT01992094|101564342|FG000|STARTED|Overall Study||1335||
48502386|NCT01992094|101564343|FG001|STARTED|Overall Study||676||
48502387|NCT01992094|101564344|FG002|STARTED|Overall Study||669||
48502388|NCT01992094|101564342|FG000|COMPLETED|Overall Study||1285||
48502389|NCT01992094|101564343|FG001|COMPLETED|Overall Study||652||
48502390|NCT01992094|101564344|FG002|COMPLETED|Overall Study||648||
48502391|NCT01992094|101564342|FG000|NOT COMPLETED|Overall Study||50||
48502392|NCT01992094|101564343|FG001|NOT COMPLETED|Overall Study||24||
48502393|NCT01992094|101564344|FG002|NOT COMPLETED|Overall Study||21||
48502394|NCT05511935|101564345|FG000|STARTED|Overall Study||71||
48502395|NCT05511935|101564346|FG001|STARTED|Overall Study||72||
48502396|NCT05511935|101564345|FG000|COMPLETED|Overall Study||62||
48502397|NCT05511935|101564346|FG001|COMPLETED|Overall Study||45||
48502398|NCT05511935|101564345|FG000|NOT COMPLETED|Overall Study||9||
48502399|NCT05511935|101564346|FG001|NOT COMPLETED|Overall Study||27||
48502400|NCT00695110|101564347|FG000|STARTED|Treatment Period 1||29||
48502401|NCT00695110|101564347|FG000|COMPLETED|Treatment Period 1||26||
48502402|NCT00695110|101564347|FG000|NOT COMPLETED|Treatment Period 1||3||
48502403|NCT00695110|101564347|FG000|STARTED|Treatment Period 2||26||
48502404|NCT00695110|101564347|FG000|COMPLETED|Treatment Period 2||26||
48502405|NCT00695110|101564347|FG000|NOT COMPLETED|Treatment Period 2||0||
48502406|NCT00695110|101564347|FG000|STARTED|Treatment Period 3||26||
48502407|NCT00695110|101564347|FG000|COMPLETED|Treatment Period 3||25||
48502408|NCT00695110|101564347|FG000|NOT COMPLETED|Treatment Period 3||1||
48502409|NCT00695110|101564347|FG000|STARTED|Treatment Period 4||25||
48502410|NCT00695110|101564347|FG000|COMPLETED|Treatment Period 4||24||
48502411|NCT00695110|101564347|FG000|NOT COMPLETED|Treatment Period 4||1||
48502412|NCT01884844|101564348|FG000|STARTED|Overall Study||16||
48502413|NCT01884844|101564349|FG001|STARTED|Overall Study||17||
48502414|NCT01884844|101564348|FG000|COMPLETED|Overall Study||13||
48502415|NCT01884844|101564349|FG001|COMPLETED|Overall Study||12||
48502416|NCT01884844|101564348|FG000|NOT COMPLETED|Overall Study||3||
48502417|NCT01884844|101564349|FG001|NOT COMPLETED|Overall Study||5||
48502418|NCT01567527|101564350|FG000|STARTED|Conversion Phase.||466||
48502419|NCT01567527|101564351|FG001|STARTED|Conversion Phase.||0||
48502420|NCT01567527|101564352|FG002|STARTED|Conversion Phase.||0||
48502421|NCT01567527|101564353|FG003|STARTED|Conversion Phase.||0||
48502422|NCT01567527|101564354|FG004|STARTED|Conversion Phase.||0||
48502423|NCT01567527|101564350|FG000|COMPLETED|Conversion Phase.||367||
48502424|NCT01567527|101564351|FG001|COMPLETED|Conversion Phase.||0||
48502425|NCT01567527|101564352|FG002|COMPLETED|Conversion Phase.||0||
48502426|NCT01567527|101564353|FG003|COMPLETED|Conversion Phase.||0||
48502427|NCT01567527|101564354|FG004|COMPLETED|Conversion Phase.||0||
48502428|NCT01567527|101564350|FG000|NOT COMPLETED|Conversion Phase.||99||
48502429|NCT01567527|101564351|FG001|NOT COMPLETED|Conversion Phase.||0||
48502430|NCT01567527|101564352|FG002|NOT COMPLETED|Conversion Phase.||0||
48502431|NCT01567527|101564353|FG003|NOT COMPLETED|Conversion Phase.||0||
48502432|NCT01567527|101564354|FG004|NOT COMPLETED|Conversion Phase.||0||
48502433|NCT01567527|101564350|FG000|STARTED|Oral Aripiprazole Stabilization Phase.||0||
48502434|NCT01567527|101564351|FG001|STARTED|Oral Aripiprazole Stabilization Phase.||632||
48502435|NCT01567527|101564352|FG002|STARTED|Oral Aripiprazole Stabilization Phase.||0||
48502436|NCT01567527|101564353|FG003|STARTED|Oral Aripiprazole Stabilization Phase.||0||
48502437|NCT01567527|101564354|FG004|STARTED|Oral Aripiprazole Stabilization Phase.||0||
48502438|NCT01567527|101564350|FG000|COMPLETED|Oral Aripiprazole Stabilization Phase.||0||
48502439|NCT01567527|101564351|FG001|COMPLETED|Oral Aripiprazole Stabilization Phase.||425||
48502440|NCT01567527|101564352|FG002|COMPLETED|Oral Aripiprazole Stabilization Phase.||0||
48502441|NCT01567527|101564353|FG003|COMPLETED|Oral Aripiprazole Stabilization Phase.||0||
48502442|NCT01567527|101564354|FG004|COMPLETED|Oral Aripiprazole Stabilization Phase.||0||
48502443|NCT01567527|101564350|FG000|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0||
48502444|NCT01567527|101564351|FG001|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||207||
48502445|NCT01567527|101564352|FG002|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0||
48502446|NCT01567527|101564353|FG003|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0||
48502447|NCT01567527|101564354|FG004|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0||
48502448|NCT01567527|101564350|FG000|STARTED|IM Depot Stabilization.||0||
48502449|NCT01567527|101564351|FG001|STARTED|IM Depot Stabilization.||0||
48502450|NCT01567527|101564352|FG002|STARTED|IM Depot Stabilization.||425||
48502451|NCT01567527|101564353|FG003|STARTED|IM Depot Stabilization.||0||
48502452|NCT01567527|101564354|FG004|STARTED|IM Depot Stabilization.||0||
48502453|NCT01567527|101564350|FG000|COMPLETED|IM Depot Stabilization.||0||
48502454|NCT01567527|101564351|FG001|COMPLETED|IM Depot Stabilization.||0||
48502455|NCT01567527|101564352|FG002|COMPLETED|IM Depot Stabilization.||266||
48502456|NCT01567527|101564353|FG003|COMPLETED|IM Depot Stabilization.||0||
48502457|NCT01567527|101564354|FG004|COMPLETED|IM Depot Stabilization.||0||
48502458|NCT01567527|101564350|FG000|NOT COMPLETED|IM Depot Stabilization.||0||
48502459|NCT01567527|101564351|FG001|NOT COMPLETED|IM Depot Stabilization.||0||
48502460|NCT01567527|101564352|FG002|NOT COMPLETED|IM Depot Stabilization.||159||
48502461|NCT01567527|101564353|FG003|NOT COMPLETED|IM Depot Stabilization.||0||
48502462|NCT01567527|101564354|FG004|NOT COMPLETED|IM Depot Stabilization.||0||
48502463|NCT01567527|101564350|FG000|STARTED|Double-blind, Placebo-controlled Phase||0||
48502464|NCT01567527|101564351|FG001|STARTED|Double-blind, Placebo-controlled Phase||0||
48502465|NCT01567527|101564352|FG002|STARTED|Double-blind, Placebo-controlled Phase||0||
48502466|NCT01567527|101564353|FG003|STARTED|Double-blind, Placebo-controlled Phase||133||
48502467|NCT01567527|101564354|FG004|STARTED|Double-blind, Placebo-controlled Phase||133||
48502468|NCT01567527|101564350|FG000|COMPLETED|Double-blind, Placebo-controlled Phase||0||
48502469|NCT01567527|101564351|FG001|COMPLETED|Double-blind, Placebo-controlled Phase||0||
48502470|NCT01567527|101564352|FG002|COMPLETED|Double-blind, Placebo-controlled Phase||0||
48502471|NCT01567527|101564353|FG003|COMPLETED|Double-blind, Placebo-controlled Phase||64||
48502472|NCT01567527|101564354|FG004|COMPLETED|Double-blind, Placebo-controlled Phase||38||
48502473|NCT01567527|101564350|FG000|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0||
48502474|NCT01567527|101564351|FG001|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0||
48502475|NCT01567527|101564352|FG002|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0||
48502476|NCT01567527|101564353|FG003|NOT COMPLETED|Double-blind, Placebo-controlled Phase||69||
48502477|NCT01567527|101564354|FG004|NOT COMPLETED|Double-blind, Placebo-controlled Phase||95||
48502478|NCT04808908|101564355|FG000|STARTED|Overall Study||10||
48502479|NCT04808908|101564355|FG000|COMPLETED|Overall Study||10||
48502480|NCT04808908|101564355|FG000|NOT COMPLETED|Overall Study||0||
48502481|NCT02943096|101564356|FG000|STARTED|Overall Study||3||
48502482|NCT02943096|101564357|FG001|STARTED|Overall Study||3||
48502483|NCT02943096|101564356|FG000|COMPLETED|Overall Study||3||
48502484|NCT02943096|101564357|FG001|COMPLETED|Overall Study||2||
48502485|NCT02943096|101564356|FG000|NOT COMPLETED|Overall Study||0||
48502486|NCT02943096|101564357|FG001|NOT COMPLETED|Overall Study||1||
48502487|NCT01073631|101564358|FG000|STARTED|Overall Study||543||
48502488|NCT01073631|101564358|FG000|COMPLETED|Overall Study||374||
48502489|NCT01073631|101564358|FG000|NOT COMPLETED|Overall Study||169||
48502490|NCT01929681|101564359|FG000|STARTED|Overall Study||28||
48061134|NCT00915356|100470351|FG002|STARTED|Overall Study||45||
48502491|NCT01929681|101564360|FG001|STARTED|Overall Study||25||
48502492|NCT01929681|101564359|FG000|COMPLETED|Overall Study||26||
48502493|NCT01929681|101564360|FG001|COMPLETED|Overall Study||24||
48502494|NCT01929681|101564359|FG000|NOT COMPLETED|Overall Study||2||
48502495|NCT01929681|101564360|FG001|NOT COMPLETED|Overall Study||1||
48502496|NCT01156987|101564361|FG000|STARTED|Overall Study||8||
48502497|NCT01156987|101564362|FG001|STARTED|Overall Study||23||
48502498|NCT01156987|101564361|FG000|COMPLETED|Overall Study||8||
48502499|NCT01156987|101564362|FG001|COMPLETED|Overall Study||12||
48502500|NCT01156987|101564361|FG000|NOT COMPLETED|Overall Study||0||
48502501|NCT01156987|101564362|FG001|NOT COMPLETED|Overall Study||11||
48502502|NCT01664039|101564363|FG000|STARTED|Overall Study||52||
48502503|NCT01664039|101564364|FG001|STARTED|Overall Study||52||
48502504|NCT01664039|101564363|FG000|COMPLETED|Overall Study||46||
48502505|NCT01664039|101564364|FG001|COMPLETED|Overall Study||43||
48502506|NCT01664039|101564363|FG000|NOT COMPLETED|Overall Study||6||
48502507|NCT01664039|101564364|FG001|NOT COMPLETED|Overall Study||9||
48061135|NCT00915356|100470352|FG003|STARTED|Overall Study||12||
48502508|NCT01824498|101564365|FG000|STARTED|1st Intervention (8 Weeks)||5||
48502509|NCT01824498|101564366|FG001|STARTED|1st Intervention (8 Weeks)||2||
48502510|NCT01824498|101564367|FG002|STARTED|1st Intervention (8 Weeks)||6||
48502511|NCT01824498|101564368|FG003|STARTED|1st Intervention (8 Weeks)||3||
48502512|NCT01824498|101564369|FG004|STARTED|1st Intervention (8 Weeks)||4||
48502513|NCT01824498|101564370|FG005|STARTED|1st Intervention (8 Weeks)||4||
48502514|NCT01824498|101564365|FG000|COMPLETED|1st Intervention (8 Weeks)||5||
48502515|NCT01824498|101564366|FG001|COMPLETED|1st Intervention (8 Weeks)||2||
48502516|NCT01824498|101564367|FG002|COMPLETED|1st Intervention (8 Weeks)||6||
48502517|NCT01824498|101564368|FG003|COMPLETED|1st Intervention (8 Weeks)||3||
48502518|NCT01824498|101564369|FG004|COMPLETED|1st Intervention (8 Weeks)||4||
48502519|NCT01824498|101564370|FG005|COMPLETED|1st Intervention (8 Weeks)||4||
48502520|NCT01824498|101564365|FG000|NOT COMPLETED|1st Intervention (8 Weeks)||0||
48502521|NCT01824498|101564366|FG001|NOT COMPLETED|1st Intervention (8 Weeks)||0||
48502522|NCT01824498|101564367|FG002|NOT COMPLETED|1st Intervention (8 Weeks)||0||
48502523|NCT01824498|101564368|FG003|NOT COMPLETED|1st Intervention (8 Weeks)||0||
48502524|NCT01824498|101564369|FG004|NOT COMPLETED|1st Intervention (8 Weeks)||0||
48502525|NCT01824498|101564370|FG005|NOT COMPLETED|1st Intervention (8 Weeks)||0||
48502526|NCT01824498|101564365|FG000|STARTED|Washout (8 Weeks)||5||
48502527|NCT01824498|101564366|FG001|STARTED|Washout (8 Weeks)||2||
48502528|NCT01824498|101564367|FG002|STARTED|Washout (8 Weeks)||6||
48502529|NCT01824498|101564368|FG003|STARTED|Washout (8 Weeks)||3||
48502530|NCT01824498|101564369|FG004|STARTED|Washout (8 Weeks)||4||
48502531|NCT01824498|101564370|FG005|STARTED|Washout (8 Weeks)||4||
48502532|NCT01824498|101564365|FG000|COMPLETED|Washout (8 Weeks)||3||
48502533|NCT01824498|101564366|FG001|COMPLETED|Washout (8 Weeks)||2||
48502534|NCT01824498|101564367|FG002|COMPLETED|Washout (8 Weeks)||4||
48502535|NCT01824498|101564368|FG003|COMPLETED|Washout (8 Weeks)||2||
48502536|NCT01824498|101564369|FG004|COMPLETED|Washout (8 Weeks)||3||
48502537|NCT01824498|101564370|FG005|COMPLETED|Washout (8 Weeks)||4||
48502538|NCT01824498|101564365|FG000|NOT COMPLETED|Washout (8 Weeks)||2||
48502539|NCT01824498|101564366|FG001|NOT COMPLETED|Washout (8 Weeks)||0||
48502540|NCT01824498|101564367|FG002|NOT COMPLETED|Washout (8 Weeks)||2||
48502541|NCT01824498|101564368|FG003|NOT COMPLETED|Washout (8 Weeks)||1||
48502542|NCT01824498|101564369|FG004|NOT COMPLETED|Washout (8 Weeks)||1||
48502543|NCT01824498|101564370|FG005|NOT COMPLETED|Washout (8 Weeks)||0||
48502544|NCT01824498|101564365|FG000|STARTED|2nd Intervention (8 Weeks)||3||
48502545|NCT01824498|101564366|FG001|STARTED|2nd Intervention (8 Weeks)||2||
48502546|NCT01824498|101564367|FG002|STARTED|2nd Intervention (8 Weeks)||4||
48502547|NCT01824498|101564368|FG003|STARTED|2nd Intervention (8 Weeks)||2||
48502548|NCT01824498|101564369|FG004|STARTED|2nd Intervention (8 Weeks)||3||
48502549|NCT01824498|101564370|FG005|STARTED|2nd Intervention (8 Weeks)||4||
48502550|NCT01824498|101564365|FG000|COMPLETED|2nd Intervention (8 Weeks)||3||
48502551|NCT01824498|101564366|FG001|COMPLETED|2nd Intervention (8 Weeks)||2||
48502552|NCT01824498|101564367|FG002|COMPLETED|2nd Intervention (8 Weeks)||4||
48502553|NCT01824498|101564368|FG003|COMPLETED|2nd Intervention (8 Weeks)||2||
48502554|NCT01824498|101564369|FG004|COMPLETED|2nd Intervention (8 Weeks)||3||
48502555|NCT01824498|101564370|FG005|COMPLETED|2nd Intervention (8 Weeks)||4||
48502556|NCT01824498|101564365|FG000|NOT COMPLETED|2nd Intervention (8 Weeks)||0||
48502557|NCT01824498|101564366|FG001|NOT COMPLETED|2nd Intervention (8 Weeks)||0||
48502558|NCT01824498|101564367|FG002|NOT COMPLETED|2nd Intervention (8 Weeks)||0||
48502559|NCT01824498|101564368|FG003|NOT COMPLETED|2nd Intervention (8 Weeks)||0||
48502560|NCT01824498|101564369|FG004|NOT COMPLETED|2nd Intervention (8 Weeks)||0||
48502561|NCT01824498|101564370|FG005|NOT COMPLETED|2nd Intervention (8 Weeks)||0||
48502562|NCT01824498|101564365|FG000|STARTED|Washout (8 Weeks)||3||
48502563|NCT01824498|101564366|FG001|STARTED|Washout (8 Weeks)||2||
48502564|NCT01824498|101564367|FG002|STARTED|Washout (8 Weeks)||4||
48502565|NCT01824498|101564368|FG003|STARTED|Washout (8 Weeks)||2||
48061136|NCT00915356|100470353|FG004|STARTED|Overall Study||43||
48502566|NCT01824498|101564369|FG004|STARTED|Washout (8 Weeks)||3||
48502567|NCT01824498|101564370|FG005|STARTED|Washout (8 Weeks)||4||
48502568|NCT01824498|101564365|FG000|COMPLETED|Washout (8 Weeks)||3||
48502569|NCT01824498|101564366|FG001|COMPLETED|Washout (8 Weeks)||2||
48502570|NCT01824498|101564367|FG002|COMPLETED|Washout (8 Weeks)||4||
48502571|NCT01824498|101564368|FG003|COMPLETED|Washout (8 Weeks)||2||
48502572|NCT01824498|101564369|FG004|COMPLETED|Washout (8 Weeks)||3||
48502573|NCT01824498|101564370|FG005|COMPLETED|Washout (8 Weeks)||4||
48502574|NCT01824498|101564365|FG000|NOT COMPLETED|Washout (8 Weeks)||0||
48502575|NCT01824498|101564366|FG001|NOT COMPLETED|Washout (8 Weeks)||0||
48502576|NCT01824498|101564367|FG002|NOT COMPLETED|Washout (8 Weeks)||0||
48502577|NCT01824498|101564368|FG003|NOT COMPLETED|Washout (8 Weeks)||0||
48502578|NCT01824498|101564369|FG004|NOT COMPLETED|Washout (8 Weeks)||0||
48502579|NCT01824498|101564370|FG005|NOT COMPLETED|Washout (8 Weeks)||0||
48502580|NCT01824498|101564365|FG000|STARTED|3rd Intervention (8 Weeks)||3||
48502581|NCT01824498|101564366|FG001|STARTED|3rd Intervention (8 Weeks)||2||
48502582|NCT01824498|101564367|FG002|STARTED|3rd Intervention (8 Weeks)||4||
48502583|NCT01824498|101564368|FG003|STARTED|3rd Intervention (8 Weeks)||2||
48502584|NCT01824498|101564369|FG004|STARTED|3rd Intervention (8 Weeks)||3||
48502585|NCT01824498|101564370|FG005|STARTED|3rd Intervention (8 Weeks)||4||
48502586|NCT01824498|101564365|FG000|COMPLETED|3rd Intervention (8 Weeks)||3||
48502587|NCT01824498|101564366|FG001|COMPLETED|3rd Intervention (8 Weeks)||2||
48502588|NCT01824498|101564367|FG002|COMPLETED|3rd Intervention (8 Weeks)||4||
48502589|NCT01824498|101564368|FG003|COMPLETED|3rd Intervention (8 Weeks)||2||
48502590|NCT01824498|101564369|FG004|COMPLETED|3rd Intervention (8 Weeks)||3||
48502591|NCT01824498|101564370|FG005|COMPLETED|3rd Intervention (8 Weeks)||4||
48502592|NCT01824498|101564365|FG000|NOT COMPLETED|3rd Intervention (8 Weeks)||0||
48502593|NCT01824498|101564366|FG001|NOT COMPLETED|3rd Intervention (8 Weeks)||0||
48502594|NCT01824498|101564367|FG002|NOT COMPLETED|3rd Intervention (8 Weeks)||0||
48502595|NCT01824498|101564368|FG003|NOT COMPLETED|3rd Intervention (8 Weeks)||0||
48502596|NCT01824498|101564369|FG004|NOT COMPLETED|3rd Intervention (8 Weeks)||0||
48502597|NCT01824498|101564370|FG005|NOT COMPLETED|3rd Intervention (8 Weeks)||0||
48502598|NCT03504020|101564371|FG000|STARTED|Overall Study||200||
48502599|NCT03504020|101564372|FG001|STARTED|Overall Study||208||
48502600|NCT03504020|101564371|FG000|COMPLETED|Overall Study||161||
48502601|NCT03504020|101564372|FG001|COMPLETED|Overall Study||172||
48502602|NCT03504020|101564371|FG000|NOT COMPLETED|Overall Study||39||
48502603|NCT03504020|101564372|FG001|NOT COMPLETED|Overall Study||36||
48502604|NCT01361633|101564373|FG000|STARTED|Overall Study||25||
48502605|NCT01361633|101564374|FG001|STARTED|Overall Study||26||
48502606|NCT01361633|101564373|FG000|COMPLETED|Overall Study||19||
48502607|NCT01361633|101564374|FG001|COMPLETED|Overall Study||23||
48502608|NCT01361633|101564373|FG000|NOT COMPLETED|Overall Study||6||
48502609|NCT01361633|101564374|FG001|NOT COMPLETED|Overall Study||3||
48502610|NCT03387462|101564375|FG000|STARTED|Overall Study||20||
48502611|NCT03387462|101564375|FG000|4 Weeks|Overall Study||20||
48502612|NCT03387462|101564375|FG000|8 Weeks|Overall Study||19||
48502613|NCT03387462|101564375|FG000|COMPLETED|Overall Study||19||
48502614|NCT03387462|101564375|FG000|NOT COMPLETED|Overall Study||1||
48061137|NCT00915356|100470349|FG000|COMPLETED|Overall Study||25||
48061138|NCT00915356|100470350|FG001|COMPLETED|Overall Study||45||
48061139|NCT00915356|100470351|FG002|COMPLETED|Overall Study||45||
48061140|NCT00915356|100470352|FG003|COMPLETED|Overall Study||12||
48061141|NCT00915356|100470353|FG004|COMPLETED|Overall Study||43||
48061142|NCT00915356|100470349|FG000|NOT COMPLETED|Overall Study||1||
48061143|NCT00915356|100470350|FG001|NOT COMPLETED|Overall Study||0||
48061144|NCT00915356|100470351|FG002|NOT COMPLETED|Overall Study||0||
48061145|NCT00915356|100470352|FG003|NOT COMPLETED|Overall Study||0||
48061146|NCT00915356|100470353|FG004|NOT COMPLETED|Overall Study||0||
48061147|NCT01977937|100470354|FG000|STARTED|Overall Study||27||
48061148|NCT01977937|100470355|FG001|STARTED|Overall Study||28||
48061149|NCT01977937|100470354|FG000|COMPLETED|Overall Study||24||
48061150|NCT01977937|100470355|FG001|COMPLETED|Overall Study||26||
48061151|NCT01977937|100470354|FG000|NOT COMPLETED|Overall Study||3||
48061152|NCT01977937|100470355|FG001|NOT COMPLETED|Overall Study||2||
48061153|NCT00586066|100470356|FG000|STARTED|Overall Study||48||
48061154|NCT00586066|100470357|FG001|STARTED|Overall Study||24||
48061155|NCT00586066|100470356|FG000|COMPLETED|Overall Study||30||
48061156|NCT00586066|100470357|FG001|COMPLETED|Overall Study||14||
48502615|NCT00651183|101564376|FG000|STARTED|Overall Study||189||
48502616|NCT00651183|101564377|FG001|STARTED|Overall Study||97||
48502617|NCT00651183|101564376|FG000|COMPLETED|Overall Study||169||
48502618|NCT00651183|101564377|FG001|COMPLETED|Overall Study||87||
48502619|NCT00651183|101564376|FG000|NOT COMPLETED|Overall Study||20||
48502620|NCT00651183|101564377|FG001|NOT COMPLETED|Overall Study||10||
48502621|NCT00924053|101564378|FG000|STARTED|Overall Study||6||
48061157|NCT00586066|100470356|FG000|NOT COMPLETED|Overall Study||18||
48061158|NCT00586066|100470357|FG001|NOT COMPLETED|Overall Study||10||
48061159|NCT05430022|100470358|FG000|STARTED|Overall Study||24||
48061160|NCT05430022|100470359|FG001|STARTED|Overall Study||24||
48061161|NCT05430022|100470358|FG000|COMPLETED|Overall Study||20||
48061162|NCT05430022|100470359|FG001|COMPLETED|Overall Study||20||
48061163|NCT05430022|100470358|FG000|NOT COMPLETED|Overall Study||4||
48061164|NCT05430022|100470359|FG001|NOT COMPLETED|Overall Study||4||
48061165|NCT02439879|100470360|FG000|STARTED|Overall Study||16||
48061166|NCT02439879|100470361|FG001|STARTED|Overall Study||17||
48061167|NCT02439879|100470360|FG000|COMPLETED|Overall Study||16||
48061168|NCT02439879|100470361|FG001|COMPLETED|Overall Study||17||
48061169|NCT02439879|100470360|FG000|NOT COMPLETED|Overall Study||0||
48061170|NCT02439879|100470361|FG001|NOT COMPLETED|Overall Study||0||
48061171|NCT04137224|100470362|FG000|STARTED|Treatment Period 1 (Week 1 to Week 16)||13||
48061172|NCT04137224|100470363|FG001|STARTED|Treatment Period 1 (Week 1 to Week 16)||14||
48061173|NCT04137224|100470362|FG000|COMPLETED|Treatment Period 1 (Week 1 to Week 16)||12||
48061174|NCT04137224|100470363|FG001|COMPLETED|Treatment Period 1 (Week 1 to Week 16)||13||
48502622|NCT00924053|101564379|FG001|STARTED|Overall Study||6||
48502623|NCT00924053|101564380|FG002|STARTED|Overall Study||6||
48666758|NCT03391882|101970469|FG004|NOT COMPLETED|Part A - Titration Phase||0||
48061175|NCT04137224|100470362|FG000|NOT COMPLETED|Treatment Period 1 (Week 1 to Week 16)||1||
48061176|NCT04137224|100470363|FG001|NOT COMPLETED|Treatment Period 1 (Week 1 to Week 16)||1||
48061177|NCT04137224|100470362|FG000|STARTED|Treatment Period 2 (Week 17 to Week 32)||13||
48061178|NCT04137224|100470363|FG001|STARTED|Treatment Period 2 (Week 17 to Week 32)||13||
48666759|NCT03391882|101970470|FG005|NOT COMPLETED|Part A - Titration Phase||0||
48061179|NCT04137224|100470362|FG000|COMPLETED|Treatment Period 2 (Week 17 to Week 32)||13||
48061180|NCT04137224|100470363|FG001|COMPLETED|Treatment Period 2 (Week 17 to Week 32)||12||
48061181|NCT04137224|100470362|FG000|NOT COMPLETED|Treatment Period 2 (Week 17 to Week 32)||0||
48061182|NCT04137224|100470363|FG001|NOT COMPLETED|Treatment Period 2 (Week 17 to Week 32)||1||
48061183|NCT02046733|100470364|FG000|STARTED|Overall Study||75||
48061184|NCT02046733|100470365|FG001|STARTED|Overall Study||78||
48061185|NCT02046733|100470364|FG000|COMPLETED|Overall Study||69||
48061186|NCT02046733|100470365|FG001|COMPLETED|Overall Study||78||
48061187|NCT02046733|100470364|FG000|NOT COMPLETED|Overall Study||6||
48061188|NCT02046733|100470365|FG001|NOT COMPLETED|Overall Study||0||
48061189|NCT04502979|100470366|FG000|STARTED|Overall Study||37||
48061190|NCT04502979|100470367|FG001|STARTED|Overall Study||34||
48061191|NCT04502979|100470366|FG000|COMPLETED|Overall Study||34||
48061192|NCT04502979|100470367|FG001|COMPLETED|Overall Study||30||
48061193|NCT04502979|100470366|FG000|NOT COMPLETED|Overall Study||3||
48061194|NCT04502979|100470367|FG001|NOT COMPLETED|Overall Study||4||
48061195|NCT01795638|100470368|FG000|STARTED|Overall Study||27||
48061196|NCT01795638|100470369|FG001|STARTED|Overall Study||26||
48061197|NCT01795638|100470368|FG000|COMPLETED|Overall Study||14||
48061198|NCT01795638|100470369|FG001|COMPLETED|Overall Study||15||
48061199|NCT01795638|100470368|FG000|NOT COMPLETED|Overall Study||13||
48061200|NCT01795638|100470369|FG001|NOT COMPLETED|Overall Study||11||
48061201|NCT00559754|100470370|FG000|STARTED|Overall Study||72||
48061202|NCT00559754|100470370|FG000|COMPLETED|Overall Study||61||
48061203|NCT00559754|100470370|FG000|NOT COMPLETED|Overall Study||11||
48061204|NCT00678080|100470371|FG000|STARTED|Overall Study||11||
48061205|NCT00678080|100470372|FG001|STARTED|Overall Study||14||
48061206|NCT00678080|100470371|FG000|COMPLETED|Overall Study||8||
48061207|NCT00678080|100470372|FG001|COMPLETED|Overall Study||13||
48061208|NCT00678080|100470371|FG000|NOT COMPLETED|Overall Study||3||
48061209|NCT00678080|100470372|FG001|NOT COMPLETED|Overall Study||1||
48061210|NCT02428608|100470373|FG000|STARTED|Overall Study||570||
48061211|NCT02428608|100470373|FG000|COMPLETED|Overall Study||487||
48061212|NCT02428608|100470373|FG000|NOT COMPLETED|Overall Study||83||
48061213|NCT00470847|100470374|FG000|STARTED|Overall Study||35||
48061214|NCT00470847|100470374|FG000|COMPLETED|Overall Study||34||
48061215|NCT00470847|100470374|FG000|NOT COMPLETED|Overall Study||1||
48061216|NCT02360111|100470375|FG000|STARTED|Overall Study||3||
48061217|NCT02360111|100470375|FG000|COMPLETED|Overall Study||1||
48061218|NCT02360111|100470375|FG000|NOT COMPLETED|Overall Study||2||
48061219|NCT02239627|100470376|FG000|STARTED|Overall Study||0||
48061220|NCT02239627|100470377|FG001|STARTED|Overall Study||0||
48061221|NCT02239627|100470376|FG000|COMPLETED|Overall Study||0||
48061222|NCT02239627|100470377|FG001|COMPLETED|Overall Study||0||
48061223|NCT02239627|100470376|FG000|NOT COMPLETED|Overall Study||0||
48061224|NCT02239627|100470377|FG001|NOT COMPLETED|Overall Study||0||
48061225|NCT00689078|100470378|FG000|STARTED|Overall Study||9||
48061226|NCT00689078|100470379|FG001|STARTED|Overall Study||9||
48061227|NCT00689078|100470380|FG002|STARTED|Overall Study||9||
48061228|NCT00689078|100470381|FG003|STARTED|Overall Study||9||
48061229|NCT00689078|100470378|FG000|Intent to Treat|Overall Study||9||
48061230|NCT00689078|100470379|FG001|Intent to Treat|Overall Study||7||
48061231|NCT00689078|100470380|FG002|Intent to Treat|Overall Study||8||
48061232|NCT00689078|100470381|FG003|Intent to Treat|Overall Study||8||
48061233|NCT00689078|100470378|FG000|COMPLETED|Overall Study||9||
48061234|NCT00689078|100470379|FG001|COMPLETED|Overall Study||7||
48061235|NCT00689078|100470380|FG002|COMPLETED|Overall Study||8||
48061236|NCT00689078|100470381|FG003|COMPLETED|Overall Study||8||
48061237|NCT00689078|100470378|FG000|NOT COMPLETED|Overall Study||0||
48061238|NCT00689078|100470379|FG001|NOT COMPLETED|Overall Study||2||
48061239|NCT00689078|100470380|FG002|NOT COMPLETED|Overall Study||1||
48061240|NCT00689078|100470381|FG003|NOT COMPLETED|Overall Study||1||
48061241|NCT03971071|100470382|FG000|STARTED|Double-blind Treatment Period (DBTP)||206||
48061242|NCT03971071|100470383|FG001|STARTED|Double-blind Treatment Period (DBTP)||207||
48061243|NCT03971071|100470384|FG002|STARTED|Double-blind Treatment Period (DBTP)||207||
48061244|NCT03971071|100470385|FG003|STARTED|Double-blind Treatment Period (DBTP)||0||
48061245|NCT03971071|100470386|FG004|STARTED|Double-blind Treatment Period (DBTP)||0||
48061246|NCT03971071|100470382|FG000|Opioid-treated Cohort|Double-blind Treatment Period (DBTP)||12|\> 4 days/month opioid medication use in baseline period; included for purposes of exploratory analyses only|
48061247|NCT03971071|100470383|FG001|Opioid-treated Cohort|Double-blind Treatment Period (DBTP)||12|\> 4 days/month opioid medication use in baseline period; included for purposes of exploratory analyses only|
48061248|NCT03971071|100470384|FG002|Opioid-treated Cohort|Double-blind Treatment Period (DBTP)||12|\> 4 days/month opioid medication use in baseline period; included for purposes of exploratory analyses only|
48061249|NCT03971071|100470385|FG003|Opioid-treated Cohort|Double-blind Treatment Period (DBTP)||0|\> 4 days/month opioid medication use in baseline period; included for purposes of exploratory analyses only|
48061250|NCT03971071|100470386|FG004|Opioid-treated Cohort|Double-blind Treatment Period (DBTP)||0|\> 4 days/month opioid medication use in baseline period; included for purposes of exploratory analyses only|
48061251|NCT03971071|100470382|FG000|Nonopioid-treated Cohort|Double-blind Treatment Period (DBTP)||194|≤ 4 days/month opioid medication use in baseline period|
48061252|NCT03971071|100470383|FG001|Nonopioid-treated Cohort|Double-blind Treatment Period (DBTP)||195|≤ 4 days/month opioid medication use in baseline period|
48061253|NCT03971071|100470384|FG002|Nonopioid-treated Cohort|Double-blind Treatment Period (DBTP)||195|≤ 4 days/month opioid medication use in baseline period|
48061254|NCT03971071|100470385|FG003|Nonopioid-treated Cohort|Double-blind Treatment Period (DBTP)||0|≤ 4 days/month opioid medication use in baseline period|
48061255|NCT03971071|100470386|FG004|Nonopioid-treated Cohort|Double-blind Treatment Period (DBTP)||0|≤ 4 days/month opioid medication use in baseline period|
48061256|NCT03971071|100470382|FG000|COMPLETED|Double-blind Treatment Period (DBTP)||197|Completed DBTP (Week 24)|
48061257|NCT03971071|100470383|FG001|COMPLETED|Double-blind Treatment Period (DBTP)||193|Completed DBTP (Week 24)|
48061258|NCT03971071|100470384|FG002|COMPLETED|Double-blind Treatment Period (DBTP)||201|Completed DBTP (Week 24)|
48061259|NCT03971071|100470385|FG003|COMPLETED|Double-blind Treatment Period (DBTP)||0|Completed DBTP (Week 24)|
48061260|NCT03971071|100470386|FG004|COMPLETED|Double-blind Treatment Period (DBTP)||0|Completed DBTP (Week 24)|
48061261|NCT03971071|100470382|FG000|NOT COMPLETED|Double-blind Treatment Period (DBTP)||9||
48061262|NCT03971071|100470383|FG001|NOT COMPLETED|Double-blind Treatment Period (DBTP)||14||
48061263|NCT03971071|100470384|FG002|NOT COMPLETED|Double-blind Treatment Period (DBTP)||6||
48061264|NCT03971071|100470385|FG003|NOT COMPLETED|Double-blind Treatment Period (DBTP)||0||
48061265|NCT03971071|100470386|FG004|NOT COMPLETED|Double-blind Treatment Period (DBTP)||0||
48061266|NCT03971071|100470382|FG000|STARTED|Open-label Treatment Period||0||
48061267|NCT03971071|100470383|FG001|STARTED|Open-label Treatment Period||0||
48061268|NCT03971071|100470384|FG002|STARTED|Open-label Treatment Period||0||
48061269|NCT03971071|100470385|FG003|STARTED|Open-label Treatment Period||291||
48061270|NCT03971071|100470386|FG004|STARTED|Open-label Treatment Period||296||
48061271|NCT03971071|100470382|FG000|COMPLETED|Open-label Treatment Period||0||
48061272|NCT03971071|100470383|FG001|COMPLETED|Open-label Treatment Period||0||
48061273|NCT03971071|100470384|FG002|COMPLETED|Open-label Treatment Period||0||
48061274|NCT03971071|100470385|FG003|COMPLETED|Open-label Treatment Period||281||
48061275|NCT03971071|100470386|FG004|COMPLETED|Open-label Treatment Period||281||
48061276|NCT03971071|100470382|FG000|NOT COMPLETED|Open-label Treatment Period||0||
48061277|NCT03971071|100470383|FG001|NOT COMPLETED|Open-label Treatment Period||0||
48061278|NCT03971071|100470384|FG002|NOT COMPLETED|Open-label Treatment Period||0||
48061279|NCT03971071|100470385|FG003|NOT COMPLETED|Open-label Treatment Period||10||
48061280|NCT03971071|100470386|FG004|NOT COMPLETED|Open-label Treatment Period||15||
48061281|NCT01209923|100470387|FG000|STARTED|Overall Study||362||
48061282|NCT01209923|100470387|FG000|COMPLETED|Overall Study||362||
48061283|NCT01209923|100470387|FG000|NOT COMPLETED|Overall Study||0||
48061284|NCT02367131|100470388|FG000|STARTED|Overall Study||419|Registered|
48061285|NCT02367131|100470388|FG000|Treated|Overall Study||417||
48061286|NCT02367131|100470388|FG000|COMPLETED|Overall Study||197||
48061287|NCT02367131|100470388|FG000|NOT COMPLETED|Overall Study||222||
48061288|NCT03417804|100470389|FG000|STARTED|Overall Study||366||
48061289|NCT03417804|100470389|FG000|COMPLETED|Overall Study||366||
48061290|NCT03417804|100470389|FG000|NOT COMPLETED|Overall Study||0||
48061291|NCT01368432|100470390|FG000|STARTED|Overall Study||6||
48061292|NCT01368432|100470391|FG001|STARTED|Overall Study||8||
48061293|NCT01368432|100470390|FG000|COMPLETED|Overall Study||6||
48061294|NCT01368432|100470391|FG001|COMPLETED|Overall Study||7||
48061295|NCT01368432|100470390|FG000|NOT COMPLETED|Overall Study||0||
48061296|NCT01368432|100470391|FG001|NOT COMPLETED|Overall Study||1||
48061297|NCT01810432|100470392|FG000|STARTED|Period 1||20||
48061298|NCT01810432|100470393|FG001|STARTED|Period 1||20||
48061299|NCT01810432|100470392|FG000|Received at Least 1 Dose of Study Drug|Period 1||20||
48061300|NCT01810432|100470393|FG001|Received at Least 1 Dose of Study Drug|Period 1||20||
48061301|NCT01810432|100470392|FG000|COMPLETED|Period 1||20||
48061302|NCT01810432|100470393|FG001|COMPLETED|Period 1||20||
48061303|NCT01810432|100470392|FG000|NOT COMPLETED|Period 1||0||
48061304|NCT01810432|100470393|FG001|NOT COMPLETED|Period 1||0||
48061305|NCT01810432|100470392|FG000|STARTED|Washout||20||
48061306|NCT01810432|100470393|FG001|STARTED|Washout||20||
48061307|NCT01810432|100470392|FG000|COMPLETED|Washout||19||
48061308|NCT01810432|100470393|FG001|COMPLETED|Washout||19||
48061309|NCT01810432|100470392|FG000|NOT COMPLETED|Washout||1||
48061310|NCT01810432|100470393|FG001|NOT COMPLETED|Washout||1||
48061311|NCT01810432|100470392|FG000|STARTED|Period 2||19||
48061312|NCT01810432|100470393|FG001|STARTED|Period 2||19||
48061313|NCT01810432|100470392|FG000|Received at Least 1 Dose of Study Drug|Period 2||19||
48061314|NCT01810432|100470393|FG001|Received at Least 1 Dose of Study Drug|Period 2||19||
48061315|NCT01810432|100470392|FG000|COMPLETED|Period 2||15||
48061316|NCT01810432|100470393|FG001|COMPLETED|Period 2||17||
48061317|NCT01810432|100470392|FG000|NOT COMPLETED|Period 2||4||
48061318|NCT01810432|100470393|FG001|NOT COMPLETED|Period 2||2||
48061319|NCT00702689|100470394|FG000|STARTED|Overall Study||20||
48061320|NCT00702689|100470394|FG000|COMPLETED|Overall Study||14||
48061321|NCT00702689|100470394|FG000|NOT COMPLETED|Overall Study||6||
48061322|NCT00629772|100470395|FG000|STARTED|First Intervention - Day 0 - Week 14||12||
48061323|NCT00629772|100470396|FG001|STARTED|First Intervention - Day 0 - Week 14||12||
48061324|NCT00629772|100470395|FG000|COMPLETED|First Intervention - Day 0 - Week 14||12||
48061325|NCT00629772|100470396|FG001|COMPLETED|First Intervention - Day 0 - Week 14||12||
48061326|NCT00629772|100470395|FG000|NOT COMPLETED|First Intervention - Day 0 - Week 14||0||
48061327|NCT00629772|100470396|FG001|NOT COMPLETED|First Intervention - Day 0 - Week 14||0||
48061328|NCT00629772|100470395|FG000|STARTED|Second Intervention Week 14 - Week 26||12||
48061329|NCT00629772|100470396|FG001|STARTED|Second Intervention Week 14 - Week 26||12||
48061330|NCT00629772|100470395|FG000|COMPLETED|Second Intervention Week 14 - Week 26||11||
48061331|NCT00629772|100470396|FG001|COMPLETED|Second Intervention Week 14 - Week 26||10||
48061332|NCT00629772|100470395|FG000|NOT COMPLETED|Second Intervention Week 14 - Week 26||1||
48061333|NCT00629772|100470396|FG001|NOT COMPLETED|Second Intervention Week 14 - Week 26||2||
48061334|NCT01134315|100470397|FG000|STARTED|Overall Study||21||
48061335|NCT01134315|100470398|FG001|STARTED|Overall Study||40||
48061336|NCT01134315|100470397|FG000|COMPLETED|Overall Study||12||
48061337|NCT01134315|100470398|FG001|COMPLETED|Overall Study||21||
48061338|NCT01134315|100470397|FG000|NOT COMPLETED|Overall Study||9||
48061339|NCT01134315|100470398|FG001|NOT COMPLETED|Overall Study||19||
48061340|NCT00569270|100470399|FG000|STARTED|Period: First Intervention||15||
48061341|NCT00569270|100470400|FG001|STARTED|Period: First Intervention||15||
48061342|NCT00569270|100470399|FG000|COMPLETED|Period: First Intervention||15||
48061343|NCT00569270|100470400|FG001|COMPLETED|Period: First Intervention||14||
48061344|NCT00569270|100470399|FG000|NOT COMPLETED|Period: First Intervention||0||
48061345|NCT00569270|100470400|FG001|NOT COMPLETED|Period: First Intervention||1||
48061346|NCT00569270|100470399|FG000|STARTED|Period: Second Intervention||15||
48061347|NCT00569270|100470400|FG001|STARTED|Period: Second Intervention||14||
48061348|NCT00569270|100470399|FG000|29 Days|Period: Second Intervention||15||
48061349|NCT00569270|100470400|FG001|29 Days|Period: Second Intervention||14||
48061350|NCT00569270|100470399|FG000|COMPLETED|Period: Second Intervention||15||
48061351|NCT00569270|100470400|FG001|COMPLETED|Period: Second Intervention||14||
48061352|NCT00569270|100470399|FG000|NOT COMPLETED|Period: Second Intervention||0||
48061353|NCT00569270|100470400|FG001|NOT COMPLETED|Period: Second Intervention||0||
48061354|NCT04558281|100470401|FG000|STARTED|Overall Study||2||
48061355|NCT04558281|100470402|FG001|STARTED|Overall Study||2||
48502624|NCT00924053|101564381|FG003|STARTED|Overall Study||6||
48502625|NCT00924053|101564378|FG000|COMPLETED|Overall Study||6||
48502626|NCT00924053|101564379|FG001|COMPLETED|Overall Study||6||
48061356|NCT04558281|100470401|FG000|COMPLETED|Overall Study||2||
48061357|NCT04558281|100470402|FG001|COMPLETED|Overall Study||2||
48061358|NCT04558281|100470401|FG000|NOT COMPLETED|Overall Study||0||
48061359|NCT04558281|100470402|FG001|NOT COMPLETED|Overall Study||0||
48061360|NCT02966873|100470403|FG000|STARTED|Overall Study||93||
48061361|NCT02966873|100470404|FG001|STARTED|Overall Study||89||
48061362|NCT02966873|100470403|FG000|COMPLETED|Overall Study||77||
48061363|NCT02966873|100470404|FG001|COMPLETED|Overall Study||74||
48061364|NCT02966873|100470403|FG000|NOT COMPLETED|Overall Study||16||
48061365|NCT02966873|100470404|FG001|NOT COMPLETED|Overall Study||15||
48061366|NCT04228783|100470405|FG000|STARTED|Overall Study||287||
48061367|NCT04228783|100470406|FG001|STARTED|Overall Study||288||
48061368|NCT04228783|100470407|FG002|STARTED|Overall Study||287||
48061369|NCT04228783|100470408|FG003|STARTED|Overall Study||48||
48061370|NCT04228783|100470409|FG004|STARTED|Overall Study||50||
48061371|NCT04228783|100470410|FG005|STARTED|Overall Study||10||
48502627|NCT00924053|101564380|FG002|COMPLETED|Overall Study||6||
48502628|NCT00924053|101564381|FG003|COMPLETED|Overall Study||6||
48061372|NCT04228783|100470405|FG000|COMPLETED|Overall Study||239||
48061373|NCT04228783|100470406|FG001|COMPLETED|Overall Study||237||
48061374|NCT04228783|100470407|FG002|COMPLETED|Overall Study||236||
48061375|NCT04228783|100470408|FG003|COMPLETED|Overall Study||39||
48061376|NCT04228783|100470409|FG004|COMPLETED|Overall Study||33||
48061377|NCT04228783|100470410|FG005|COMPLETED|Overall Study||6||
48061378|NCT04228783|100470405|FG000|NOT COMPLETED|Overall Study||48||
48061379|NCT04228783|100470406|FG001|NOT COMPLETED|Overall Study||51||
48061380|NCT04228783|100470407|FG002|NOT COMPLETED|Overall Study||51||
48061381|NCT04228783|100470408|FG003|NOT COMPLETED|Overall Study||9||
48061382|NCT04228783|100470409|FG004|NOT COMPLETED|Overall Study||17||
48061383|NCT04228783|100470410|FG005|NOT COMPLETED|Overall Study||4||
48061384|NCT01436006|100470411|FG000|STARTED|Overall Study||6700||
48061385|NCT01436006|100470411|FG000|COMPLETED|Overall Study||6663||
48061386|NCT01436006|100470411|FG000|NOT COMPLETED|Overall Study||37||
48061387|NCT02030938|100470412|FG000|STARTED|Overall Study||34||
48061388|NCT02030938|100470412|FG000|COMPLETED|Overall Study||29||
48061389|NCT02030938|100470412|FG000|NOT COMPLETED|Overall Study||5||
48061390|NCT03496571|100472802|FG000|STARTED|Overall Study||22||
48061391|NCT03496571|100472803|FG001|STARTED|Overall Study||21||
48061392|NCT03496571|100472804|FG002|STARTED|Overall Study||22||
48502629|NCT00924053|101564378|FG000|NOT COMPLETED|Overall Study||0||
48502630|NCT00924053|101564379|FG001|NOT COMPLETED|Overall Study||0||
48061393|NCT03496571|100472802|FG000|COMPLETED|Overall Study||20||
48061394|NCT03496571|100472803|FG001|COMPLETED|Overall Study||19||
48061395|NCT03496571|100472804|FG002|COMPLETED|Overall Study||20||
48061396|NCT03496571|100472802|FG000|NOT COMPLETED|Overall Study||2||
48061397|NCT03496571|100472803|FG001|NOT COMPLETED|Overall Study||2||
48061398|NCT03496571|100472804|FG002|NOT COMPLETED|Overall Study||2||
48061399|NCT01756053|100472805|FG000|STARTED|Period 1 (10 Days)||8||
48061400|NCT01756053|100472806|FG001|STARTED|Period 1 (10 Days)||9||
48061401|NCT01756053|100472805|FG000|COMPLETED|Period 1 (10 Days)||7||
48218498|NCT01426412|100860317|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6||
48061402|NCT01756053|100472806|FG001|COMPLETED|Period 1 (10 Days)||8||
48061403|NCT01756053|100472805|FG000|NOT COMPLETED|Period 1 (10 Days)||1||
48061404|NCT01756053|100472806|FG001|NOT COMPLETED|Period 1 (10 Days)||1||
48061405|NCT01756053|100472805|FG000|STARTED|Washout Period (~21 Days)||7||
48061406|NCT01756053|100472806|FG001|STARTED|Washout Period (~21 Days)||8||
48061407|NCT01756053|100472805|FG000|COMPLETED|Washout Period (~21 Days)||7||
48061408|NCT01756053|100472806|FG001|COMPLETED|Washout Period (~21 Days)||8||
48061409|NCT01756053|100472805|FG000|NOT COMPLETED|Washout Period (~21 Days)||0||
48061410|NCT01756053|100472806|FG001|NOT COMPLETED|Washout Period (~21 Days)||0||
48061411|NCT01756053|100472805|FG000|STARTED|Period 2 (10 Days)||7||
48061412|NCT01756053|100472806|FG001|STARTED|Period 2 (10 Days)||8||
48061413|NCT01756053|100472805|FG000|COMPLETED|Period 2 (10 Days)||7||
48061414|NCT01756053|100472806|FG001|COMPLETED|Period 2 (10 Days)||6||
48061415|NCT01756053|100472805|FG000|NOT COMPLETED|Period 2 (10 Days)||0||
48061416|NCT01756053|100472806|FG001|NOT COMPLETED|Period 2 (10 Days)||2||
48061417|NCT02781779|100472807|FG000|STARTED|Overall Study||78||
48061418|NCT02781779|100472808|FG001|STARTED|Overall Study||69||
48061419|NCT02781779|100472807|FG000|COMPLETED|Overall Study||78||
48061420|NCT02781779|100472808|FG001|COMPLETED|Overall Study||69||
48061421|NCT02781779|100472807|FG000|NOT COMPLETED|Overall Study||0||
48061422|NCT02781779|100472808|FG001|NOT COMPLETED|Overall Study||0||
48061423|NCT04128371|100472809|FG000|STARTED|Overall Study||5||
48061424|NCT04128371|100472809|FG000|COMPLETED|Overall Study||4||
48061425|NCT04128371|100472809|FG000|NOT COMPLETED|Overall Study||1||
48061426|NCT01348607|100472810|FG000|STARTED|Overall Study||1||
48061427|NCT01348607|100472811|FG001|STARTED|Overall Study||0||
48061428|NCT01348607|100472812|FG002|STARTED|Overall Study||0||
48061429|NCT01348607|100472810|FG000|COMPLETED|Overall Study||1||
48061430|NCT01348607|100472811|FG001|COMPLETED|Overall Study||0||
48061431|NCT01348607|100472812|FG002|COMPLETED|Overall Study||0||
48061432|NCT01348607|100472810|FG000|NOT COMPLETED|Overall Study||0||
48061433|NCT01348607|100472811|FG001|NOT COMPLETED|Overall Study||0||
48061434|NCT01348607|100472812|FG002|NOT COMPLETED|Overall Study||0||
48061435|NCT02979197|100472813|FG000|STARTED|Overall Study||48||
48061436|NCT02979197|100472814|FG001|STARTED|Overall Study||49||
48061437|NCT02979197|100472815|FG002|STARTED|Overall Study||8||
48061438|NCT02979197|100472813|FG000|COMPLETED|Overall Study||44||
48061439|NCT02979197|100472814|FG001|COMPLETED|Overall Study||45||
48061440|NCT02979197|100472815|FG002|COMPLETED|Overall Study||8||
48061441|NCT02979197|100472813|FG000|NOT COMPLETED|Overall Study||4||
48061442|NCT02979197|100472814|FG001|NOT COMPLETED|Overall Study||4||
48061443|NCT02979197|100472815|FG002|NOT COMPLETED|Overall Study||0||
48061444|NCT03845543|100472816|FG000|STARTED|Overall Study||150||
48061445|NCT03845543|100472816|FG000|COMPLETED|Overall Study||94||
48061446|NCT03845543|100472816|FG000|NOT COMPLETED|Overall Study||56||
48061447|NCT03911154|100472817|FG000|STARTED|Overall Study||9||
48061448|NCT03911154|100472817|FG000|Continuous Fixed Interval|Overall Study||9|Each participant will receive the SmartSleep Continuous fixed interval modality during one night of sleep restriction|
48061449|NCT03911154|100472817|FG000|Block|Overall Study||9|Each participant will receive the SmartSleep Block modality during one night of sleep restriction|
48061450|NCT03911154|100472817|FG000|In-Phase Adjustable|Overall Study||9|Each participant will receive the SmartSleep In-Phase Adjustable modality during one night of sleep restriction|
48061451|NCT03911154|100472817|FG000|SHAM|Overall Study||9|Each participant will receive the SmartSleep SHAM modality during one night of sleep restriction|
48061452|NCT03911154|100472817|FG000|COMPLETED|Overall Study||8||
48061453|NCT03911154|100472817|FG000|NOT COMPLETED|Overall Study||1||
48061454|NCT03181893|100472818|FG000|STARTED|Baseline to Week 12 (All Stages)||10||
48061455|NCT03181893|100472819|FG001|STARTED|Baseline to Week 12 (All Stages)||22||
48061456|NCT03181893|100472820|FG002|STARTED|Baseline to Week 12 (All Stages)||1||
48061457|NCT03181893|100472821|FG003|STARTED|Baseline to Week 12 (All Stages)||5||
48061458|NCT03181893|100472822|FG004|STARTED|Baseline to Week 12 (All Stages)||3||
48061459|NCT03181893|100472823|FG005|STARTED|Baseline to Week 12 (All Stages)||2||
48061460|NCT03181893|100472824|FG006|STARTED|Baseline to Week 12 (All Stages)||1||
48061461|NCT03181893|100472825|FG007|STARTED|Baseline to Week 12 (All Stages)||10||
48061462|NCT03181893|100472826|FG008|STARTED|Baseline to Week 12 (All Stages)||3||
48061463|NCT03181893|100472827|FG009|STARTED|Baseline to Week 12 (All Stages)||9||
48061464|NCT03181893|100472828|FG010|STARTED|Baseline to Week 12 (All Stages)||9||
48061465|NCT03181893|100472818|FG000|COMPLETED|Baseline to Week 12 (All Stages)||9||
48061466|NCT03181893|100472819|FG001|COMPLETED|Baseline to Week 12 (All Stages)||20||
48061467|NCT03181893|100472820|FG002|COMPLETED|Baseline to Week 12 (All Stages)||1||
48061468|NCT03181893|100472821|FG003|COMPLETED|Baseline to Week 12 (All Stages)||5||
48061469|NCT03181893|100472822|FG004|COMPLETED|Baseline to Week 12 (All Stages)||3||
48061470|NCT03181893|100472823|FG005|COMPLETED|Baseline to Week 12 (All Stages)||2||
48061471|NCT03181893|100472824|FG006|COMPLETED|Baseline to Week 12 (All Stages)||1||
48061472|NCT03181893|100472825|FG007|COMPLETED|Baseline to Week 12 (All Stages)||10||
48218499|NCT01426412|100860318|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6||
48061473|NCT03181893|100472826|FG008|COMPLETED|Baseline to Week 12 (All Stages)||3||
48061474|NCT03181893|100472827|FG009|COMPLETED|Baseline to Week 12 (All Stages)||9||
48061475|NCT03181893|100472828|FG010|COMPLETED|Baseline to Week 12 (All Stages)||9||
48061476|NCT03181893|100472818|FG000|NOT COMPLETED|Baseline to Week 12 (All Stages)||1||
48061477|NCT03181893|100472819|FG001|NOT COMPLETED|Baseline to Week 12 (All Stages)||2||
48061478|NCT03181893|100472820|FG002|NOT COMPLETED|Baseline to Week 12 (All Stages)||0||
48061479|NCT03181893|100472821|FG003|NOT COMPLETED|Baseline to Week 12 (All Stages)||0||
48061480|NCT03181893|100472822|FG004|NOT COMPLETED|Baseline to Week 12 (All Stages)||0||
48061481|NCT03181893|100472823|FG005|NOT COMPLETED|Baseline to Week 12 (All Stages)||0||
48061482|NCT03181893|100472824|FG006|NOT COMPLETED|Baseline to Week 12 (All Stages)||0||
48061483|NCT03181893|100472825|FG007|NOT COMPLETED|Baseline to Week 12 (All Stages)||0||
48061484|NCT03181893|100472826|FG008|NOT COMPLETED|Baseline to Week 12 (All Stages)||0||
48061485|NCT03181893|100472827|FG009|NOT COMPLETED|Baseline to Week 12 (All Stages)||0||
48061486|NCT03181893|100472828|FG010|NOT COMPLETED|Baseline to Week 12 (All Stages)||0||
48061487|NCT03181893|100472818|FG000|STARTED|Weeks 12-24 (Amended Stage 2, Stage 3)||0|Participants from Stage 1 or Stage 2 did not participate in the treatment switch from Week 12 to 24. Therefore, not applicable for this period.|
48061488|NCT03181893|100472819|FG001|STARTED|Weeks 12-24 (Amended Stage 2, Stage 3)||0|Participants from Stage 1 or Stage 2 did not participate in the treatment switch from Week 12 to 24. Therefore, not applicable for this period.|
48061489|NCT03181893|100472820|FG002|STARTED|Weeks 12-24 (Amended Stage 2, Stage 3)||0|Participants from Stage 1 or Stage 2 did not participate in the treatment switch from Week 12 to 24. Therefore, not applicable for this period.|
48061490|NCT03181893|100472821|FG003|STARTED|Weeks 12-24 (Amended Stage 2, Stage 3)||0|Participants from Stage 1 or Stage 2 did not participate in the treatment switch from Week 12 to 24. Therefore, not applicable for this period.|
48061491|NCT03181893|100472822|FG004|STARTED|Weeks 12-24 (Amended Stage 2, Stage 3)||0|Participants from Stage 1 or Stage 2 did not participate in the treatment switch from Week 12 to 24. Therefore, not applicable for this period.|
48061492|NCT03181893|100472823|FG005|STARTED|Weeks 12-24 (Amended Stage 2, Stage 3)||2|Participants from Stage 1 or Stage 2 did not participate in the treatment switch from Week 12 to 24. Therefore, not applicable for this period.|
48061493|NCT03181893|100472824|FG006|STARTED|Weeks 12-24 (Amended Stage 2, Stage 3)||1|Participants from Stage 1 or Stage 2 did not participate in the treatment switch from Week 12 to 24. Therefore, not applicable for this period.|
48061494|NCT03181893|100472825|FG007|STARTED|Weeks 12-24 (Amended Stage 2, Stage 3)||10|Participants from Stage 1 or Stage 2 did not participate in the treatment switch from Week 12 to 24. Therefore, not applicable for this period.|
48061495|NCT03181893|100472826|FG008|STARTED|Weeks 12-24 (Amended Stage 2, Stage 3)||3|Participants from Stage 1 or Stage 2 did not participate in the treatment switch from Week 12 to 24. Therefore, not applicable for this period.|
48061496|NCT03181893|100472827|FG009|STARTED|Weeks 12-24 (Amended Stage 2, Stage 3)||9|Participants from Stage 1 or Stage 2 did not participate in the treatment switch from Week 12 to 24. Therefore, not applicable for this period.|
48061497|NCT03181893|100472828|FG010|STARTED|Weeks 12-24 (Amended Stage 2, Stage 3)||9|Participants from Stage 1 or Stage 2 did not participate in the treatment switch from Week 12 to 24. Therefore, not applicable for this period.|
48061498|NCT03181893|100472818|FG000|COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||0||
48061499|NCT03181893|100472819|FG001|COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||0||
48061500|NCT03181893|100472820|FG002|COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||0||
48061501|NCT03181893|100472821|FG003|COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||0||
48061502|NCT03181893|100472822|FG004|COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||0||
48061503|NCT03181893|100472823|FG005|COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||2||
48061504|NCT03181893|100472824|FG006|COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||1||
48061505|NCT03181893|100472825|FG007|COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||9||
48061506|NCT03181893|100472826|FG008|COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||2||
48061507|NCT03181893|100472827|FG009|COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||8||
48061508|NCT03181893|100472828|FG010|COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||8||
48061509|NCT03181893|100472818|FG000|NOT COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||0||
48061510|NCT03181893|100472819|FG001|NOT COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||0||
48061511|NCT03181893|100472820|FG002|NOT COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||0||
48061512|NCT03181893|100472821|FG003|NOT COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||0||
48061513|NCT03181893|100472822|FG004|NOT COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||0||
48061514|NCT03181893|100472823|FG005|NOT COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||0||
48061515|NCT03181893|100472824|FG006|NOT COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||0||
48061516|NCT03181893|100472825|FG007|NOT COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||1||
48061517|NCT03181893|100472826|FG008|NOT COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||1||
48061518|NCT03181893|100472827|FG009|NOT COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||1||
48061519|NCT03181893|100472828|FG010|NOT COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||1||
48061520|NCT00547196|100472829|FG000|STARTED|Overall Study||5||
48061521|NCT00547196|100472830|FG001|STARTED|Overall Study||0||
48218500|NCT01426412|100860319|FG005|Received at Least 1 Dose of Study Drug|Overall Study||6||
48218501|NCT01426412|100860320|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6||
48061522|NCT00547196|100472831|FG002|STARTED|Overall Study||1||
48061523|NCT00547196|100472832|FG003|STARTED|Overall Study||2||
48061524|NCT00547196|100472833|FG004|STARTED|Overall Study||2||
48061525|NCT00547196|100472829|FG000|COMPLETED|Overall Study||5||
48061526|NCT00547196|100472830|FG001|COMPLETED|Overall Study||0||
48061527|NCT00547196|100472831|FG002|COMPLETED|Overall Study||1||
48061528|NCT00547196|100472832|FG003|COMPLETED|Overall Study||2||
48061529|NCT00547196|100472833|FG004|COMPLETED|Overall Study||2||
48061530|NCT00547196|100472829|FG000|NOT COMPLETED|Overall Study||0||
48061531|NCT00547196|100472830|FG001|NOT COMPLETED|Overall Study||0||
48061532|NCT00547196|100472831|FG002|NOT COMPLETED|Overall Study||0||
48061533|NCT00547196|100472832|FG003|NOT COMPLETED|Overall Study||0||
48061534|NCT00547196|100472833|FG004|NOT COMPLETED|Overall Study||0||
48061535|NCT01892865|100472834|FG000|STARTED|Overall Study||356||107
48061536|NCT01892865|100472835|FG001|STARTED|Overall Study||379||100
48061537|NCT01892865|100472834|FG000|COMPLETED|Overall Study||356||107
48061538|NCT01892865|100472835|FG001|COMPLETED|Overall Study||379||100
48061539|NCT01892865|100472834|FG000|NOT COMPLETED|Overall Study||0||0
48061540|NCT01892865|100472835|FG001|NOT COMPLETED|Overall Study||0||0
48061541|NCT01609231|100472836|FG000|STARTED|Overall Study||6||
48061542|NCT01609231|100472837|FG001|STARTED|Overall Study||5||
48061543|NCT01609231|100472836|FG000|COMPLETED|Overall Study||3||
48061544|NCT01609231|100472837|FG001|COMPLETED|Overall Study||2||
48061545|NCT01609231|100472836|FG000|NOT COMPLETED|Overall Study||3||
48061546|NCT01609231|100472837|FG001|NOT COMPLETED|Overall Study||3||
48061547|NCT01528215|100472838|FG000|STARTED|Enrollment to 1 Year Follow-up||59||
48061548|NCT01528215|100472839|FG001|STARTED|Enrollment to 1 Year Follow-up||61||
48061549|NCT01528215|100472838|FG000|COMPLETED|Enrollment to 1 Year Follow-up||55||
48061550|NCT01528215|100472839|FG001|COMPLETED|Enrollment to 1 Year Follow-up||60||
48061551|NCT01528215|100472838|FG000|NOT COMPLETED|Enrollment to 1 Year Follow-up||4||
48061552|NCT01528215|100472839|FG001|NOT COMPLETED|Enrollment to 1 Year Follow-up||1||
48061553|NCT01528215|100472838|FG000|STARTED|1 Year Follow-up to 5 Year Follow-up||55||
48061554|NCT01528215|100472839|FG001|STARTED|1 Year Follow-up to 5 Year Follow-up||60||
48061555|NCT01528215|100472838|FG000|COMPLETED|1 Year Follow-up to 5 Year Follow-up||40||
48061556|NCT01528215|100472839|FG001|COMPLETED|1 Year Follow-up to 5 Year Follow-up||45||
48061557|NCT01528215|100472838|FG000|NOT COMPLETED|1 Year Follow-up to 5 Year Follow-up||15||
48061558|NCT01528215|100472839|FG001|NOT COMPLETED|1 Year Follow-up to 5 Year Follow-up||15||
48061559|NCT04048122|100472840|FG000|STARTED|Overall Study||28||
48061560|NCT04048122|100472841|FG001|STARTED|Overall Study||29||
48061561|NCT04048122|100472840|FG000|COMPLETED|Overall Study||25||
48061562|NCT04048122|100472841|FG001|COMPLETED|Overall Study||26||
48061563|NCT04048122|100472840|FG000|NOT COMPLETED|Overall Study||3||
48061564|NCT04048122|100472841|FG001|NOT COMPLETED|Overall Study||3||
48061565|NCT02047227|100472842|FG000|STARTED|Overall Study||462||
48061566|NCT02047227|100472843|FG001|STARTED|Overall Study||477||
48061567|NCT02047227|100472842|FG000|Completed Ovarian Stimulation Phase|Overall Study||424||
48061568|NCT02047227|100472843|FG001|Completed Ovarian Stimulation Phase|Overall Study||440||
48061569|NCT02047227|100472842|FG000|COMPLETED|Overall Study||318||
48061570|NCT02047227|100472843|FG001|COMPLETED|Overall Study||347||
48061571|NCT02047227|100472842|FG000|NOT COMPLETED|Overall Study||144||
48061572|NCT02047227|100472843|FG001|NOT COMPLETED|Overall Study||130||
48061573|NCT02148107|100472844|FG000|STARTED|Overall Study||8||
48061574|NCT02148107|100472845|FG001|STARTED|Overall Study||7||
48061575|NCT02148107|100472846|FG002|STARTED|Overall Study||3||
48061576|NCT02148107|100472844|FG000|COMPLETED|Overall Study||8||
48502631|NCT00924053|101564380|FG002|NOT COMPLETED|Overall Study||0||
48502632|NCT00924053|101564381|FG003|NOT COMPLETED|Overall Study||0||
48061577|NCT02148107|100472845|FG001|COMPLETED|Overall Study||7||
48061578|NCT02148107|100472846|FG002|COMPLETED|Overall Study||3||
48061579|NCT02148107|100472844|FG000|NOT COMPLETED|Overall Study||0||
48061580|NCT02148107|100472845|FG001|NOT COMPLETED|Overall Study||0||
48061581|NCT02148107|100472846|FG002|NOT COMPLETED|Overall Study||0||
48061582|NCT01614600|100472847|FG000|STARTED|Overall Study||88||
48061583|NCT01614600|100472847|FG000|COMPLETED|Overall Study||84||
48061584|NCT01614600|100472847|FG000|NOT COMPLETED|Overall Study||4||
48061585|NCT01303861|100472848|FG000|STARTED|Overall Study||109||
48061586|NCT01303861|100472849|FG001|STARTED|Overall Study||50||
48061587|NCT01303861|100472850|FG002|STARTED|Overall Study||55||
48061588|NCT01303861|100472851|FG003|STARTED|Overall Study||113||
48061589|NCT01303861|100472848|FG000|Finished Treatment Phase|Overall Study||71||
48502633|NCT01851876|101564382|FG000|STARTED|Overall Study||56||
48502634|NCT01851876|101564383|FG001|STARTED|Overall Study||62||
48061590|NCT01303861|100472849|FG001|Finished Treatment Phase|Overall Study||34||
48061591|NCT01303861|100472850|FG002|Finished Treatment Phase|Overall Study||39||
48061592|NCT01303861|100472851|FG003|Finished Treatment Phase|Overall Study||72||
48061593|NCT01303861|100472848|FG000|COMPLETED|Overall Study||51||
48061594|NCT01303861|100472849|FG001|COMPLETED|Overall Study||25||
48061595|NCT01303861|100472850|FG002|COMPLETED|Overall Study||19||
48061596|NCT01303861|100472851|FG003|COMPLETED|Overall Study||54||
48061597|NCT01303861|100472848|FG000|NOT COMPLETED|Overall Study||58||
48061598|NCT01303861|100472849|FG001|NOT COMPLETED|Overall Study||25||
48061599|NCT01303861|100472850|FG002|NOT COMPLETED|Overall Study||36||
48061600|NCT01303861|100472851|FG003|NOT COMPLETED|Overall Study||59||
48061601|NCT03343067|100472852|FG000|STARTED|Open Label Period: Day 1 to Month 3||7||
48061602|NCT03343067|100472853|FG001|STARTED|Open Label Period: Day 1 to Month 3||3||
48061603|NCT03343067|100472854|FG002|STARTED|Open Label Period: Day 1 to Month 3||1||
48061604|NCT03343067|100472852|FG000|COMPLETED|Open Label Period: Day 1 to Month 3||0||
48061605|NCT03343067|100472853|FG001|COMPLETED|Open Label Period: Day 1 to Month 3||3||
48061606|NCT03343067|100472854|FG002|COMPLETED|Open Label Period: Day 1 to Month 3||1||
48061607|NCT03343067|100472852|FG000|NOT COMPLETED|Open Label Period: Day 1 to Month 3||7||
48061608|NCT03343067|100472853|FG001|NOT COMPLETED|Open Label Period: Day 1 to Month 3||0||
48061609|NCT03343067|100472854|FG002|NOT COMPLETED|Open Label Period: Day 1 to Month 3||0||
48061610|NCT03343067|100472852|FG000|STARTED|Double Blind Period: Month 3 to Month 6||0||
48061611|NCT03343067|100472853|FG001|STARTED|Double Blind Period: Month 3 to Month 6||3||
48061612|NCT03343067|100472854|FG002|STARTED|Double Blind Period: Month 3 to Month 6||1||
48061613|NCT03343067|100472852|FG000|COMPLETED|Double Blind Period: Month 3 to Month 6||0||
48061614|NCT03343067|100472853|FG001|COMPLETED|Double Blind Period: Month 3 to Month 6||0||
48061615|NCT03343067|100472854|FG002|COMPLETED|Double Blind Period: Month 3 to Month 6||0||
48061616|NCT03343067|100472852|FG000|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||0||
48061617|NCT03343067|100472853|FG001|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||3||
48061618|NCT03343067|100472854|FG002|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||1||
48061619|NCT01187433|100472855|FG000|STARTED|Overall Study||100||
48061620|NCT01187433|100472856|FG001|STARTED|Overall Study||50||
48061621|NCT01187433|100472855|FG000|COMPLETED|Overall Study||89||
48061622|NCT01187433|100472856|FG001|COMPLETED|Overall Study||46||
48061623|NCT01187433|100472855|FG000|NOT COMPLETED|Overall Study||11||
48061624|NCT01187433|100472856|FG001|NOT COMPLETED|Overall Study||4||
48061625|NCT04562792|100472857|FG000|STARTED|Overall Study||1||
48061626|NCT04562792|100472857|FG000|COMPLETED|Overall Study||1||
48061627|NCT04562792|100472857|FG000|NOT COMPLETED|Overall Study||0||
48061628|NCT03072732|100472858|FG000|STARTED|Overall Study||20||
48061629|NCT03072732|100472859|FG001|STARTED|Overall Study||20||
48061630|NCT03072732|100472858|FG000|COMPLETED|Overall Study||20||
48061631|NCT03072732|100472859|FG001|COMPLETED|Overall Study||20||
48061632|NCT03072732|100472858|FG000|NOT COMPLETED|Overall Study||0||
48061633|NCT03072732|100472859|FG001|NOT COMPLETED|Overall Study||0||
48061634|NCT00902668|100472860|FG000|STARTED|Overall Study||3||
48061635|NCT00902668|100472860|FG000|COMPLETED|Overall Study||0||
48061636|NCT00902668|100472860|FG000|NOT COMPLETED|Overall Study||3||
48061637|NCT04181320|100472861|FG000|STARTED|Overall Study||66||
48061638|NCT04181320|100472862|FG001|STARTED|Overall Study||62||
48061639|NCT04181320|100472861|FG000|COMPLETED|Overall Study||57||
48061640|NCT04181320|100472862|FG001|COMPLETED|Overall Study||57||
48061641|NCT04181320|100472861|FG000|NOT COMPLETED|Overall Study||9||
48061642|NCT04181320|100472862|FG001|NOT COMPLETED|Overall Study||5||
48061643|NCT02840240|100472863|FG000|STARTED|Overall Study||56||
48061644|NCT02840240|100472864|FG001|STARTED|Overall Study||51||
48061645|NCT02840240|100472863|FG000|COMPLETED|Overall Study||28||
48061646|NCT02840240|100472864|FG001|COMPLETED|Overall Study||32||
48061647|NCT02840240|100472863|FG000|NOT COMPLETED|Overall Study||28||
48061648|NCT02840240|100472864|FG001|NOT COMPLETED|Overall Study||19||
48061649|NCT00057954|100472865|FG000|STARTED|Overall Study||6||
48061650|NCT00057954|100472865|FG000|COMPLETED|Overall Study||4||
48061651|NCT00057954|100472865|FG000|NOT COMPLETED|Overall Study||2||
48061652|NCT05027464|100472866|FG000|STARTED|Overall Study||148291|In this cluster randomized trial, VAHCS sites are randomized to the intervention arm where providers employed by facilities associated with the VAHCS, however outcomes are measured on the Veteran-level where Veterans are seen by providers.|5
48061653|NCT05027464|100472867|FG001|STARTED|Overall Study||190427|In this cluster randomized trial, VAHCS sites are randomized to the intervention arm where providers employed by facilities associated with the VAHCS, however outcomes are measured on the Veteran-level where Veterans are seen by providers.|5
48061654|NCT05027464|100472866|FG000|COMPLETED|Overall Study||148291||5
48061655|NCT05027464|100472867|FG001|COMPLETED|Overall Study||190427||5
48061656|NCT05027464|100472866|FG000|NOT COMPLETED|Overall Study||0||0
48061657|NCT05027464|100472867|FG001|NOT COMPLETED|Overall Study||0||0
48061658|NCT02395666|100472868|FG000|STARTED|Overall Study||101||
48061659|NCT02395666|100472869|FG001|STARTED|Overall Study||39||
48061660|NCT02395666|100472868|FG000|COMPLETED|Overall Study||95||
48061661|NCT02395666|100472869|FG001|COMPLETED|Overall Study||38||
48061662|NCT02395666|100472868|FG000|NOT COMPLETED|Overall Study||6||
48061663|NCT02395666|100472869|FG001|NOT COMPLETED|Overall Study||1||
48061664|NCT03553927|100472870|FG000|STARTED|Study A (Men With a Normal Sperm Conc.)||14||
48061665|NCT03553927|100472871|FG001|STARTED|Study A (Men With a Normal Sperm Conc.)||14||
48061666|NCT03553927|100472870|FG000|COMPLETED|Study A (Men With a Normal Sperm Conc.)||12||
48061667|NCT03553927|100472871|FG001|COMPLETED|Study A (Men With a Normal Sperm Conc.)||12||
48061668|NCT03553927|100472870|FG000|NOT COMPLETED|Study A (Men With a Normal Sperm Conc.)||2||
48061669|NCT03553927|100472871|FG001|NOT COMPLETED|Study A (Men With a Normal Sperm Conc.)||2||
48061670|NCT03553927|100472870|FG000|STARTED|Study B (Men With a Low Sperm Conc.)||22||
48061671|NCT03553927|100472871|FG001|STARTED|Study B (Men With a Low Sperm Conc.)||23||
48061672|NCT03553927|100472870|FG000|COMPLETED|Study B (Men With a Low Sperm Conc.)||20||
48061673|NCT03553927|100472871|FG001|COMPLETED|Study B (Men With a Low Sperm Conc.)||23||
48061674|NCT03553927|100472870|FG000|NOT COMPLETED|Study B (Men With a Low Sperm Conc.)||2||
48061675|NCT03553927|100472871|FG001|NOT COMPLETED|Study B (Men With a Low Sperm Conc.)||0||
48061676|NCT00914485|100472872|FG000|STARTED|Overall Study||369||
48061677|NCT00914485|100472872|FG000|COMPLETED|Overall Study||369||
48502635|NCT01851876|101564382|FG000|COMPLETED|Overall Study||56||
48502636|NCT01851876|101564383|FG001|COMPLETED|Overall Study||62||
48502637|NCT01851876|101564382|FG000|NOT COMPLETED|Overall Study||0||
48502638|NCT01851876|101564383|FG001|NOT COMPLETED|Overall Study||0||
48502639|NCT02107196|101564384|FG000|STARTED|12-week Treatment Period||271||
48502640|NCT02107196|101564385|FG001|STARTED|12-week Treatment Period||264||
48502641|NCT02107196|101564384|FG000|Intention To Treat (ITT)|12-week Treatment Period||271||
48502642|NCT02107196|101564385|FG001|Intention To Treat (ITT)|12-week Treatment Period||264||
48502643|NCT02107196|101564384|FG000|Modified ITT|12-week Treatment Period||221||
48502644|NCT02107196|101564385|FG001|Modified ITT|12-week Treatment Period||216||
48502645|NCT02107196|101564384|FG000|COMPLETED|12-week Treatment Period||227||
48502646|NCT02107196|101564385|FG001|COMPLETED|12-week Treatment Period||225||
48502647|NCT02107196|101564384|FG000|NOT COMPLETED|12-week Treatment Period||44||
48502648|NCT02107196|101564385|FG001|NOT COMPLETED|12-week Treatment Period||39||
48061678|NCT00914485|100472872|FG000|NOT COMPLETED|Overall Study||0||
48061679|NCT00659360|100472873|FG000|STARTED|Overall Study||17||
48061680|NCT00659360|100472873|FG000|COMPLETED|Overall Study||17||
48061681|NCT00659360|100472873|FG000|NOT COMPLETED|Overall Study||0||
48061682|NCT01147640|100472874|FG000|STARTED|Overall Study||83||
48061683|NCT01147640|100472875|FG001|STARTED|Overall Study||39||
48502649|NCT02107196|101564384|FG000|STARTED|4-week Randomized Withdrawal (RW) Period||338||
48502650|NCT02107196|101564385|FG001|STARTED|4-week Randomized Withdrawal (RW) Period||114||
48502651|NCT02107196|101564384|FG000|RW Population|4-week Randomized Withdrawal (RW) Period||338||
48502652|NCT02107196|101564385|FG001|RW Population|4-week Randomized Withdrawal (RW) Period||114||
48502653|NCT02107196|101564384|FG000|Modified RW Population|4-week Randomized Withdrawal (RW) Period||272||
48502654|NCT02107196|101564385|FG001|Modified RW Population|4-week Randomized Withdrawal (RW) Period||90||
48502655|NCT02107196|101564384|FG000|COMPLETED|4-week Randomized Withdrawal (RW) Period||315||
48502656|NCT02107196|101564385|FG001|COMPLETED|4-week Randomized Withdrawal (RW) Period||109||
48502657|NCT02107196|101564384|FG000|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||23||
48061684|NCT01147640|100472874|FG000|COMPLETED|Overall Study||78||
48061685|NCT01147640|100472875|FG001|COMPLETED|Overall Study||38||
48061686|NCT01147640|100472874|FG000|NOT COMPLETED|Overall Study||5||
48061687|NCT01147640|100472875|FG001|NOT COMPLETED|Overall Study||1||
48061688|NCT02268955|100472876|FG000|STARTED|Overall Study||11||
48061689|NCT02268955|100472877|FG001|STARTED|Overall Study||11||
48061690|NCT02268955|100472876|FG000|COMPLETED|Overall Study||9||
48061691|NCT02268955|100472877|FG001|COMPLETED|Overall Study||9||
48061692|NCT02268955|100472876|FG000|NOT COMPLETED|Overall Study||2||
48061693|NCT02268955|100472877|FG001|NOT COMPLETED|Overall Study||2||
48061694|NCT00591266|100472878|FG000|STARTED|Overall Study||189||
48061695|NCT00591266|100472879|FG001|STARTED|Overall Study||188||
48061696|NCT00591266|100472880|FG002|STARTED|Overall Study||189||
48061697|NCT00591266|100472878|FG000|COMPLETED|Overall Study||180||
48061698|NCT00591266|100472879|FG001|COMPLETED|Overall Study||177||
48061699|NCT00591266|100472880|FG002|COMPLETED|Overall Study||175||
48061700|NCT00591266|100472878|FG000|NOT COMPLETED|Overall Study||9||
48061701|NCT00591266|100472879|FG001|NOT COMPLETED|Overall Study||11||
48061702|NCT00591266|100472880|FG002|NOT COMPLETED|Overall Study||14||
48061703|NCT02633501|100472881|FG000|STARTED|Overall Study||14||
48061704|NCT02633501|100472882|FG001|STARTED|Overall Study||14||
48061705|NCT02633501|100472883|FG002|STARTED|Overall Study||62||
48061706|NCT02633501|100472884|FG003|STARTED|Overall Study||63||
48061707|NCT02633501|100472885|FG004|STARTED|Overall Study||64||
48061708|NCT02633501|100472886|FG005|STARTED|Overall Study||63||
48061709|NCT02633501|100472881|FG000|COMPLETED|Overall Study||12||
48061710|NCT02633501|100472882|FG001|COMPLETED|Overall Study||11||
48061711|NCT02633501|100472883|FG002|COMPLETED|Overall Study||55||
48061712|NCT02633501|100472884|FG003|COMPLETED|Overall Study||59||
48218502|NCT01426412|100860321|FG007|Received at Least 1 Dose of Study Drug|Overall Study||10||
48218503|NCT01426412|100860322|FG008|Received at Least 1 Dose of Study Drug|Overall Study||17||
48218504|NCT01426412|100860314|FG000|COMPLETED|Overall Study||5||
48502658|NCT02107196|101564385|FG001|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||5||
48502659|NCT00640926|101564386|FG000|STARTED|Overall Study||53||
48502660|NCT00640926|101564387|FG001|STARTED|Overall Study||52||
48502661|NCT00640926|101564388|FG002|STARTED|Overall Study||53||
48502662|NCT00640926|101564386|FG000|COMPLETED|Overall Study||45||
48502663|NCT00640926|101564387|FG001|COMPLETED|Overall Study||46||
48666760|NCT03391882|101970465|FG000|STARTED|Post Part A / Pre Part B||2||
48061713|NCT02633501|100472885|FG004|COMPLETED|Overall Study||53||
48061714|NCT02633501|100472886|FG005|COMPLETED|Overall Study||48||
48061715|NCT02633501|100472881|FG000|NOT COMPLETED|Overall Study||2||
48061716|NCT02633501|100472882|FG001|NOT COMPLETED|Overall Study||3||
48061717|NCT02633501|100472883|FG002|NOT COMPLETED|Overall Study||7||
48061718|NCT02633501|100472884|FG003|NOT COMPLETED|Overall Study||4||
48061719|NCT02633501|100472885|FG004|NOT COMPLETED|Overall Study||11||
48061720|NCT02633501|100472886|FG005|NOT COMPLETED|Overall Study||15||
48061721|NCT03793556|100472887|FG000|STARTED|Overall Study||35||
48061722|NCT03793556|100472888|FG001|STARTED|Overall Study||36||
48061723|NCT03793556|100472887|FG000|COMPLETED|Overall Study||22||
48061724|NCT03793556|100472888|FG001|COMPLETED|Overall Study||34||
48061725|NCT03793556|100472887|FG000|NOT COMPLETED|Overall Study||13||
48061726|NCT03793556|100472888|FG001|NOT COMPLETED|Overall Study||2||
48061727|NCT01710046|100472889|FG000|STARTED|Overall Study||9||
48061728|NCT01710046|100472890|FG001|STARTED|Overall Study||3||
48061729|NCT01710046|100472889|FG000|COMPLETED|Overall Study||8||
48061730|NCT01710046|100472890|FG001|COMPLETED|Overall Study||3||
48061731|NCT01710046|100472889|FG000|NOT COMPLETED|Overall Study||1||
48061732|NCT01710046|100472890|FG001|NOT COMPLETED|Overall Study||0||
48061733|NCT01033851|100472891|FG000|STARTED|Overall Study||48||
48061734|NCT01033851|100472892|FG001|STARTED|Overall Study||41||
48061735|NCT01033851|100472891|FG000|COMPLETED|Overall Study||45||
48061736|NCT01033851|100472892|FG001|COMPLETED|Overall Study||34||
48061737|NCT01033851|100472891|FG000|NOT COMPLETED|Overall Study||3||
48061738|NCT01033851|100472892|FG001|NOT COMPLETED|Overall Study||7||
48061739|NCT01927627|100472893|FG000|STARTED|Overall Study||42||
48061740|NCT01927627|100472893|FG000|COMPLETED|Overall Study||37||
48061741|NCT01927627|100472893|FG000|NOT COMPLETED|Overall Study||5||
48061742|NCT00215683|100472894|FG000|STARTED|Overall Study||45||
48061743|NCT00215683|100472895|FG001|STARTED|Overall Study||48||
48061744|NCT00215683|100472896|FG002|STARTED|Overall Study||44||
48061745|NCT00215683|100472894|FG000|Switched to 160 mg|Overall Study||32||
48061746|NCT00215683|100472895|FG001|Switched to 160 mg|Overall Study||41||
48061747|NCT00215683|100472896|FG002|Switched to 160 mg|Overall Study||36||
48061748|NCT00215683|100472894|FG000|COMPLETED|Overall Study||16||
48061749|NCT00215683|100472895|FG001|COMPLETED|Overall Study||22||
48061750|NCT00215683|100472896|FG002|COMPLETED|Overall Study||12||
48061751|NCT00215683|100472894|FG000|NOT COMPLETED|Overall Study||29||
48061752|NCT00215683|100472895|FG001|NOT COMPLETED|Overall Study||26||
48061753|NCT00215683|100472896|FG002|NOT COMPLETED|Overall Study||32||
48061754|NCT01134731|100472897|FG000|STARTED|Overall Study||23||
48061755|NCT01134731|100472898|FG001|STARTED|Overall Study||21||
48061756|NCT01134731|100472899|FG002|STARTED|Overall Study||10||
48061757|NCT01134731|100472897|FG000|COMPLETED|Overall Study||10||
48061758|NCT01134731|100472898|FG001|COMPLETED|Overall Study||10||
48061759|NCT01134731|100472899|FG002|COMPLETED|Overall Study||2||
48061760|NCT01134731|100472897|FG000|NOT COMPLETED|Overall Study||13||
48061761|NCT01134731|100472898|FG001|NOT COMPLETED|Overall Study||11||
48061762|NCT01134731|100472899|FG002|NOT COMPLETED|Overall Study||8||
48061763|NCT04093414|100472900|FG000|STARTED|3 Month Follow up||3||
48061764|NCT04093414|100472901|FG001|STARTED|3 Month Follow up||6||
48061765|NCT04093414|100472900|FG000|COMPLETED|3 Month Follow up||3||
48061766|NCT04093414|100472901|FG001|COMPLETED|3 Month Follow up||5||
48061767|NCT04093414|100472900|FG000|NOT COMPLETED|3 Month Follow up||0||
48061768|NCT04093414|100472901|FG001|NOT COMPLETED|3 Month Follow up||1||
48061769|NCT04093414|100472900|FG000|STARTED|6month Follow up||3||
48061770|NCT04093414|100472901|FG001|STARTED|6month Follow up||5||
48061771|NCT04093414|100472900|FG000|COMPLETED|6month Follow up||2||
48061772|NCT04093414|100472901|FG001|COMPLETED|6month Follow up||2||
48061773|NCT04093414|100472900|FG000|NOT COMPLETED|6month Follow up||1||
48061774|NCT04093414|100472901|FG001|NOT COMPLETED|6month Follow up||3||
48061775|NCT04093414|100472900|FG000|STARTED|12 Month Follow up||2||
48061776|NCT04093414|100472901|FG001|STARTED|12 Month Follow up||2||
48061777|NCT04093414|100472900|FG000|COMPLETED|12 Month Follow up||2||
48061778|NCT04093414|100472901|FG001|COMPLETED|12 Month Follow up||2||
48061779|NCT04093414|100472900|FG000|NOT COMPLETED|12 Month Follow up||0||
48061780|NCT04093414|100472901|FG001|NOT COMPLETED|12 Month Follow up||0||
48061781|NCT01024231|100472902|FG000|STARTED|Overall Study||14||
48061782|NCT01024231|100472903|FG001|STARTED|Overall Study||17||
48061783|NCT01024231|100472904|FG002|STARTED|Overall Study||16||
48061784|NCT01024231|100472905|FG003|STARTED|Overall Study||6||
48061785|NCT01024231|100472906|FG004|STARTED|Overall Study||17||
48061786|NCT01024231|100472907|FG005|STARTED|Overall Study||16||
48061787|NCT01024231|100472908|FG006|STARTED|Overall Study||41||
48061788|NCT01024231|100472902|FG000|COMPLETED|Overall Study||2||
48061789|NCT01024231|100472903|FG001|COMPLETED|Overall Study||2||
48061790|NCT01024231|100472904|FG002|COMPLETED|Overall Study||6||
48061791|NCT01024231|100472905|FG003|COMPLETED|Overall Study||1||
48502664|NCT00640926|101564388|FG002|COMPLETED|Overall Study||45||
48061792|NCT01024231|100472906|FG004|COMPLETED|Overall Study||0||
48061793|NCT01024231|100472907|FG005|COMPLETED|Overall Study||0||
48061794|NCT01024231|100472908|FG006|COMPLETED|Overall Study||20||
48061795|NCT01024231|100472902|FG000|NOT COMPLETED|Overall Study||12||
48061796|NCT01024231|100472903|FG001|NOT COMPLETED|Overall Study||15||
48061797|NCT01024231|100472904|FG002|NOT COMPLETED|Overall Study||10||
48061798|NCT01024231|100472905|FG003|NOT COMPLETED|Overall Study||5||
48061799|NCT01024231|100472906|FG004|NOT COMPLETED|Overall Study||17||
48061800|NCT01024231|100472907|FG005|NOT COMPLETED|Overall Study||16||
48061801|NCT01024231|100472908|FG006|NOT COMPLETED|Overall Study||21||
48061802|NCT01400815|100472909|FG000|STARTED|Overall Study||118||
48061803|NCT01400815|100472910|FG001|STARTED|Overall Study||116||
48061804|NCT01400815|100472909|FG000|COMPLETED|Overall Study||80||
48061805|NCT01400815|100472910|FG001|COMPLETED|Overall Study||95||
48061806|NCT01400815|100472909|FG000|NOT COMPLETED|Overall Study||38||
48061807|NCT01400815|100472910|FG001|NOT COMPLETED|Overall Study||21||
48061808|NCT01417936|100472911|FG000|STARTED|Overall Study||26||
48061809|NCT01417936|100472911|FG000|COMPLETED|Overall Study||26||
48061810|NCT01417936|100472911|FG000|NOT COMPLETED|Overall Study||0||
48061811|NCT03326726|100472912|FG000|STARTED|Overall Study||30||
48061812|NCT03326726|100472912|FG000|COMPLETED|Overall Study||30||
48061813|NCT03326726|100472912|FG000|NOT COMPLETED|Overall Study||0||
48061814|NCT00277446|100472913|FG000|STARTED|Overall Study||13||
48061815|NCT00277446|100472913|FG000|COMPLETED|Overall Study||13||
48061816|NCT00277446|100472913|FG000|NOT COMPLETED|Overall Study||0||
48061817|NCT03633617|100472914|FG000|STARTED|Part A||39|Started Part A|
48061818|NCT03633617|100472915|FG001|STARTED|Part A||42|Started Part A|
48061819|NCT03633617|100472916|FG002|STARTED|Part A||0|Started Part A|
48061820|NCT03633617|100472917|FG003|STARTED|Part A||0|Started Part A|
48061821|NCT03633617|100472918|FG004|STARTED|Part A||0|Started Part A|
48061822|NCT03633617|100472919|FG005|STARTED|Part A||0|Started Part A|
48061823|NCT03633617|100472920|FG006|STARTED|Part A||0|Started Part A|
48061824|NCT03633617|100472921|FG007|STARTED|Part A||0|Started Part A|
48061825|NCT03633617|100472922|FG008|STARTED|Part A||0|Started Part A|
48061826|NCT03633617|100472923|FG009|STARTED|Part A||0|Started Part A|
48061827|NCT03633617|100472924|FG010|STARTED|Part A||0|Started Part A|
48061828|NCT03633617|100472914|FG000|COMPLETED|Part A||36|Completed week 24 visit for Part A|
48061829|NCT03633617|100472915|FG001|COMPLETED|Part A||37|Completed week 24 visit for Part A|
48061830|NCT03633617|100472916|FG002|COMPLETED|Part A||0|Completed week 24 visit for Part A|
48061831|NCT03633617|100472917|FG003|COMPLETED|Part A||0|Completed week 24 visit for Part A|
48061832|NCT03633617|100472918|FG004|COMPLETED|Part A||0|Completed week 24 visit for Part A|
48061833|NCT03633617|100472919|FG005|COMPLETED|Part A||0|Completed week 24 visit for Part A|
48061834|NCT03633617|100472920|FG006|COMPLETED|Part A||0|Completed week 24 visit for Part A|
48061835|NCT03633617|100472921|FG007|COMPLETED|Part A||0|Completed week 24 visit for Part A|
48061836|NCT03633617|100472922|FG008|COMPLETED|Part A||0|Completed week 24 visit for Part A|
48061837|NCT03633617|100472923|FG009|COMPLETED|Part A||0|Completed week 24 visit for Part A|
48061838|NCT03633617|100472924|FG010|COMPLETED|Part A||0|Completed week 24 visit for Part A|
48061839|NCT03633617|100472914|FG000|NOT COMPLETED|Part A||3||
48061840|NCT03633617|100472915|FG001|NOT COMPLETED|Part A||5||
48061841|NCT03633617|100472916|FG002|NOT COMPLETED|Part A||0||
48061842|NCT03633617|100472917|FG003|NOT COMPLETED|Part A||0||
48061843|NCT03633617|100472918|FG004|NOT COMPLETED|Part A||0||
48061844|NCT03633617|100472919|FG005|NOT COMPLETED|Part A||0||
48061845|NCT03633617|100472920|FG006|NOT COMPLETED|Part A||0||
48061846|NCT03633617|100472921|FG007|NOT COMPLETED|Part A||0||
48061847|NCT03633617|100472922|FG008|NOT COMPLETED|Part A||0||
48061848|NCT03633617|100472923|FG009|NOT COMPLETED|Part A||0||
48061849|NCT03633617|100472924|FG010|NOT COMPLETED|Part A||0||
48061850|NCT03633617|100472914|FG000|STARTED|Part B||0|Started Part B (Participants from Part A were not eligible for Part B)|
48061851|NCT03633617|100472915|FG001|STARTED|Part B||0|Started Part B (Participants from Part A were not eligible for Part B)|
48061852|NCT03633617|100472916|FG002|STARTED|Part B||79|Started Part B (Participants from Part A were not eligible for Part B)|
48061853|NCT03633617|100472917|FG003|STARTED|Part B||81|Started Part B (Participants from Part A were not eligible for Part B)|
48502665|NCT00640926|101564386|FG000|NOT COMPLETED|Overall Study||8||
48502666|NCT00640926|101564387|FG001|NOT COMPLETED|Overall Study||6||
48061854|NCT03633617|100472918|FG004|STARTED|Part B||80|Started Part B (Participants from Part A were not eligible for Part B)|
48061855|NCT03633617|100472919|FG005|STARTED|Part B||0|Started Part B (Participants from Part A were not eligible for Part B)|
48061856|NCT03633617|100472920|FG006|STARTED|Part B||0|Started Part B (Participants from Part A were not eligible for Part B)|
48061857|NCT03633617|100472921|FG007|STARTED|Part B||0|Started Part B (Participants from Part A were not eligible for Part B)|
48061858|NCT03633617|100472922|FG008|STARTED|Part B||0|Started Part B (Participants from Part A were not eligible for Part B)|
48061859|NCT03633617|100472923|FG009|STARTED|Part B||0|Started Part B (Participants from Part A were not eligible for Part B)|
48061860|NCT03633617|100472924|FG010|STARTED|Part B||0|Started Part B (Participants from Part A were not eligible for Part B)|
48061861|NCT03633617|100472914|FG000|COMPLETED|Part B||0|Completed week 24 visit for Part B|
48061862|NCT03633617|100472915|FG001|COMPLETED|Part B||0|Completed week 24 visit for Part B|
48061863|NCT03633617|100472916|FG002|COMPLETED|Part B||74|Completed week 24 visit for Part B|
48061864|NCT03633617|100472917|FG003|COMPLETED|Part B||79|Completed week 24 visit for Part B|
48061865|NCT03633617|100472918|FG004|COMPLETED|Part B||75|Completed week 24 visit for Part B|
48061866|NCT03633617|100472919|FG005|COMPLETED|Part B||0|Completed week 24 visit for Part B|
48061867|NCT03633617|100472920|FG006|COMPLETED|Part B||0|Completed week 24 visit for Part B|
48061868|NCT03633617|100472921|FG007|COMPLETED|Part B||0|Completed week 24 visit for Part B|
48061869|NCT03633617|100472922|FG008|COMPLETED|Part B||0|Completed week 24 visit for Part B|
48061870|NCT03633617|100472923|FG009|COMPLETED|Part B||0|Completed week 24 visit for Part B|
48061871|NCT03633617|100472924|FG010|COMPLETED|Part B||0|Completed week 24 visit for Part B|
48061872|NCT03633617|100472914|FG000|NOT COMPLETED|Part B||0||
48061873|NCT03633617|100472915|FG001|NOT COMPLETED|Part B||0||
48061874|NCT03633617|100472916|FG002|NOT COMPLETED|Part B||5||
48061875|NCT03633617|100472917|FG003|NOT COMPLETED|Part B||2||
48061876|NCT03633617|100472918|FG004|NOT COMPLETED|Part B||5||
48502667|NCT00640926|101564388|FG002|NOT COMPLETED|Overall Study||8||
48502668|NCT01663896|101564389|FG000|STARTED|Overall Study||418||
48502669|NCT01663896|101564389|FG000|COMPLETED|Overall Study||375||
48502670|NCT01663896|101564389|FG000|NOT COMPLETED|Overall Study||43||
48502671|NCT00784095|101564390|FG000|STARTED|Overall Study||12||
48502672|NCT00784095|101564391|FG001|STARTED|Overall Study||12||
48502673|NCT00784095|101564392|FG002|STARTED|Overall Study||12||
48502674|NCT00784095|101564390|FG000|COMPLETED|Overall Study||12||
48502675|NCT00784095|101564391|FG001|COMPLETED|Overall Study||11||
48502676|NCT00784095|101564392|FG002|COMPLETED|Overall Study||11||
48502677|NCT00784095|101564390|FG000|NOT COMPLETED|Overall Study||0||
48061877|NCT03633617|100472919|FG005|NOT COMPLETED|Part B||0||
48061878|NCT03633617|100472920|FG006|NOT COMPLETED|Part B||0||
48061879|NCT03633617|100472921|FG007|NOT COMPLETED|Part B||0||
48061880|NCT03633617|100472922|FG008|NOT COMPLETED|Part B||0||
48061881|NCT03633617|100472923|FG009|NOT COMPLETED|Part B||0||
48061882|NCT03633617|100472924|FG010|NOT COMPLETED|Part B||0||
48502678|NCT00784095|101564391|FG001|NOT COMPLETED|Overall Study||1||
48502679|NCT00784095|101564392|FG002|NOT COMPLETED|Overall Study||1||
48502680|NCT00105157|101564393|FG000|STARTED|Double-Blind (DB)||44||
48502681|NCT00105157|101564394|FG001|STARTED|Double-Blind (DB)||45||
48502682|NCT00105157|101564395|FG002|STARTED|Double-Blind (DB)||45||
48502683|NCT00105157|101564396|FG003|STARTED|Double-Blind (DB)||45||
48061883|NCT03633617|100472914|FG000|STARTED|Part C (& Follow-up)||0||
48061884|NCT03633617|100472915|FG001|STARTED|Part C (& Follow-up)||0||
48061885|NCT03633617|100472916|FG002|STARTED|Part C (& Follow-up)||0||
48061886|NCT03633617|100472917|FG003|STARTED|Part C (& Follow-up)||0||
48061887|NCT03633617|100472918|FG004|STARTED|Part C (& Follow-up)||0||
48061888|NCT03633617|100472919|FG005|STARTED|Part C (& Follow-up)||37||
48061889|NCT03633617|100472920|FG006|STARTED|Part C (& Follow-up)||40||
48061890|NCT03633617|100472921|FG007|STARTED|Part C (& Follow-up)||37||
48061891|NCT03633617|100472922|FG008|STARTED|Part C (& Follow-up)||37||
48061892|NCT03633617|100472923|FG009|STARTED|Part C (& Follow-up)||79||
48061893|NCT03633617|100472924|FG010|STARTED|Part C (& Follow-up)||74||
48061894|NCT03633617|100472914|FG000|Completed Week 52 (End of Treatment)|Part C (& Follow-up)||0||
48061895|NCT03633617|100472915|FG001|Completed Week 52 (End of Treatment)|Part C (& Follow-up)||0||
48061896|NCT03633617|100472916|FG002|Completed Week 52 (End of Treatment)|Part C (& Follow-up)||0||
48061897|NCT03633617|100472917|FG003|Completed Week 52 (End of Treatment)|Part C (& Follow-up)||0||
48061898|NCT03633617|100472918|FG004|Completed Week 52 (End of Treatment)|Part C (& Follow-up)||0||
48061899|NCT03633617|100472919|FG005|Completed Week 52 (End of Treatment)|Part C (& Follow-up)||32||
48061900|NCT03633617|100472920|FG006|Completed Week 52 (End of Treatment)|Part C (& Follow-up)||38||
48061901|NCT03633617|100472921|FG007|Completed Week 52 (End of Treatment)|Part C (& Follow-up)||34||
48061902|NCT03633617|100472922|FG008|Completed Week 52 (End of Treatment)|Part C (& Follow-up)||36||
48061903|NCT03633617|100472923|FG009|Completed Week 52 (End of Treatment)|Part C (& Follow-up)||74||
48061904|NCT03633617|100472924|FG010|Completed Week 52 (End of Treatment)|Part C (& Follow-up)||65||
48061905|NCT03633617|100472914|FG000|COMPLETED|Part C (& Follow-up)||0|Completed follow-up (end of study)|
48061906|NCT03633617|100472915|FG001|COMPLETED|Part C (& Follow-up)||0|Completed follow-up (end of study)|
48061907|NCT03633617|100472916|FG002|COMPLETED|Part C (& Follow-up)||0|Completed follow-up (end of study)|
48061908|NCT03633617|100472917|FG003|COMPLETED|Part C (& Follow-up)||0|Completed follow-up (end of study)|
48218505|NCT01426412|100860315|FG001|COMPLETED|Overall Study||6||
48218506|NCT01426412|100860316|FG002|COMPLETED|Overall Study||6||
48218507|NCT01426412|100860317|FG003|COMPLETED|Overall Study||6||
48502684|NCT00105157|101564393|FG000|Treated|Double-Blind (DB)||43||
48502685|NCT00105157|101564394|FG001|Treated|Double-Blind (DB)||45||
48502686|NCT00105157|101564395|FG002|Treated|Double-Blind (DB)||45||
48502687|NCT00105157|101564396|FG003|Treated|Double-Blind (DB)||45||
48502688|NCT00105157|101564393|FG000|COMPLETED|Double-Blind (DB)||30||
48502689|NCT00105157|101564394|FG001|COMPLETED|Double-Blind (DB)||31||
48502690|NCT00105157|101564395|FG002|COMPLETED|Double-Blind (DB)||33||
48502691|NCT00105157|101564396|FG003|COMPLETED|Double-Blind (DB)||6||
48502692|NCT00105157|101564393|FG000|NOT COMPLETED|Double-Blind (DB)||14||
48502693|NCT00105157|101564394|FG001|NOT COMPLETED|Double-Blind (DB)||14||
48502694|NCT00105157|101564395|FG002|NOT COMPLETED|Double-Blind (DB)||12||
48502695|NCT00105157|101564396|FG003|NOT COMPLETED|Double-Blind (DB)||39||
48502696|NCT00105157|101564393|FG000|STARTED|Open-Label Continuation of DB||30||
48502697|NCT00105157|101564394|FG001|STARTED|Open-Label Continuation of DB||31||
48502698|NCT00105157|101564395|FG002|STARTED|Open-Label Continuation of DB||33||
48502699|NCT00105157|101564396|FG003|STARTED|Open-Label Continuation of DB||6||
48502700|NCT00105157|101564393|FG000|COMPLETED|Open-Label Continuation of DB||23||
48502701|NCT00105157|101564394|FG001|COMPLETED|Open-Label Continuation of DB||21||
48502702|NCT00105157|101564395|FG002|COMPLETED|Open-Label Continuation of DB||24||
48502703|NCT00105157|101564396|FG003|COMPLETED|Open-Label Continuation of DB||5||
48218508|NCT01426412|100860318|FG004|COMPLETED|Overall Study||5||
48502704|NCT00105157|101564393|FG000|NOT COMPLETED|Open-Label Continuation of DB||7||
48502705|NCT00105157|101564394|FG001|NOT COMPLETED|Open-Label Continuation of DB||10||
48502706|NCT00105157|101564395|FG002|NOT COMPLETED|Open-Label Continuation of DB||9||
48502707|NCT00105157|101564396|FG003|NOT COMPLETED|Open-Label Continuation of DB||1||
48502708|NCT00105157|101564393|FG000|STARTED|Open-Label Post Virologic Failure(OLPVF)||11||
48502709|NCT00105157|101564394|FG001|STARTED|Open-Label Post Virologic Failure(OLPVF)||13||
48502710|NCT00105157|101564395|FG002|STARTED|Open-Label Post Virologic Failure(OLPVF)||11||
48502711|NCT00105157|101564396|FG003|STARTED|Open-Label Post Virologic Failure(OLPVF)||37||
48502712|NCT00105157|101564393|FG000|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||2||
48502713|NCT00105157|101564394|FG001|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||7||
48502714|NCT00105157|101564395|FG002|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||5||
48502715|NCT00105157|101564396|FG003|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||19||
48502716|NCT00105157|101564393|FG000|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||9||
48502717|NCT00105157|101564394|FG001|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6||
48502718|NCT00105157|101564395|FG002|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6||
48502719|NCT00105157|101564396|FG003|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||18||
48502720|NCT02448563|101564397|FG000|STARTED|Overall Study||32||
48502721|NCT02448563|101564398|FG001|STARTED|Overall Study||30||
48502722|NCT02448563|101564397|FG000|COMPLETED|Overall Study||16||
48502723|NCT02448563|101564398|FG001|COMPLETED|Overall Study||19||
48502724|NCT02448563|101564397|FG000|NOT COMPLETED|Overall Study||16||
48502725|NCT02448563|101564398|FG001|NOT COMPLETED|Overall Study||11||
48502726|NCT03732833|101564399|FG000|STARTED|Overall Study||86||
48502727|NCT03732833|101564400|FG001|STARTED|Overall Study||171||
48502728|NCT03732833|101564401|FG002|STARTED|Overall Study||167||
48502729|NCT03732833|101564399|FG000|COMPLETED|Overall Study||68||
48502730|NCT03732833|101564400|FG001|COMPLETED|Overall Study||138||
48502731|NCT03732833|101564401|FG002|COMPLETED|Overall Study||150||
48502732|NCT03732833|101564399|FG000|NOT COMPLETED|Overall Study||18||
48502733|NCT03732833|101564400|FG001|NOT COMPLETED|Overall Study||33||
48502734|NCT03732833|101564401|FG002|NOT COMPLETED|Overall Study||17||
48502735|NCT00722436|101564402|FG000|STARTED|Overall Study||9||
48502736|NCT00722436|101564403|FG001|STARTED|Overall Study||11||
48502737|NCT00722436|101564402|FG000|COMPLETED|Overall Study||9||
48502738|NCT00722436|101564403|FG001|COMPLETED|Overall Study||11||
48502739|NCT00722436|101564402|FG000|NOT COMPLETED|Overall Study||0||
48502740|NCT00722436|101564403|FG001|NOT COMPLETED|Overall Study||0||
48502741|NCT01962298|101564404|FG000|STARTED|Overall Study||15||
48502742|NCT01962298|101564405|FG001|STARTED|Overall Study||15||
48502743|NCT01962298|101564406|FG002|STARTED|Overall Study||15||
48502744|NCT01962298|101564407|FG003|STARTED|Overall Study||15||
48502745|NCT01962298|101564408|FG004|STARTED|Overall Study||15||
48502746|NCT01962298|101564404|FG000|Received Intervention|Overall Study||14||
48502747|NCT01962298|101564405|FG001|Received Intervention|Overall Study||15||
48502748|NCT01962298|101564406|FG002|Received Intervention|Overall Study||15||
48502749|NCT01962298|101564407|FG003|Received Intervention|Overall Study||15||
48502750|NCT01962298|101564408|FG004|Received Intervention|Overall Study||15||
48502751|NCT01962298|101564404|FG000|COMPLETED|Overall Study||12||
48502752|NCT01962298|101564405|FG001|COMPLETED|Overall Study||11||
48502753|NCT01962298|101564406|FG002|COMPLETED|Overall Study||10||
48502754|NCT01962298|101564407|FG003|COMPLETED|Overall Study||13||
48502755|NCT01962298|101564408|FG004|COMPLETED|Overall Study||9||
48502756|NCT01962298|101564404|FG000|NOT COMPLETED|Overall Study||3||
48502757|NCT01962298|101564405|FG001|NOT COMPLETED|Overall Study||4||
48502758|NCT01962298|101564406|FG002|NOT COMPLETED|Overall Study||5||
48502759|NCT01962298|101564407|FG003|NOT COMPLETED|Overall Study||2||
48502760|NCT01962298|101564408|FG004|NOT COMPLETED|Overall Study||6||
48502761|NCT03370510|101564409|FG000|STARTED|Overall Study||3||
48502762|NCT03370510|101564410|FG001|STARTED|Overall Study||2||
48502763|NCT03370510|101564409|FG000|COMPLETED|Overall Study||1||
48502764|NCT03370510|101564410|FG001|COMPLETED|Overall Study||2||
48502765|NCT03370510|101564409|FG000|NOT COMPLETED|Overall Study||2||
48502766|NCT03370510|101564410|FG001|NOT COMPLETED|Overall Study||0||
48502767|NCT03944057|101564411|FG000|STARTED|Overall Study||82||
48502768|NCT03944057|101564411|FG000|COMPLETED|Overall Study||82||
48502769|NCT03944057|101564411|FG000|NOT COMPLETED|Overall Study||0||
48502770|NCT04994431|101564412|FG000|STARTED|Overall Study||8||
48502771|NCT04994431|101564413|FG001|STARTED|Overall Study||101||
48502772|NCT04994431|101564412|FG000|COMPLETED|Overall Study||7||
48502773|NCT04994431|101564413|FG001|COMPLETED|Overall Study||101||
48502774|NCT04994431|101564412|FG000|NOT COMPLETED|Overall Study||1||
48502775|NCT04994431|101564413|FG001|NOT COMPLETED|Overall Study||0||
48502776|NCT01091363|101564414|FG000|STARTED|Overall Study||55||
48502777|NCT01091363|101564415|FG001|STARTED|Overall Study||54||
48502778|NCT01091363|101564414|FG000|COMPLETED|Overall Study||42||
48502779|NCT01091363|101564415|FG001|COMPLETED|Overall Study||37||
48502780|NCT01091363|101564414|FG000|NOT COMPLETED|Overall Study||13||
48502781|NCT01091363|101564415|FG001|NOT COMPLETED|Overall Study||17||
48502782|NCT01277510|101564416|FG000|STARTED|Double-blind Phase||21||
48502783|NCT01277510|101564417|FG001|STARTED|Double-blind Phase||22||
48502784|NCT01277510|101564416|FG000|Received Investigational Product|Double-blind Phase||21||
48502785|NCT01277510|101564417|FG001|Received Investigational Product|Double-blind Phase||22||
48502786|NCT01277510|101564416|FG000|COMPLETED|Double-blind Phase||8||
48502787|NCT01277510|101564417|FG001|COMPLETED|Double-blind Phase||4||
48502788|NCT01277510|101564416|FG000|NOT COMPLETED|Double-blind Phase||13||
48502789|NCT01277510|101564417|FG001|NOT COMPLETED|Double-blind Phase||18||
48502790|NCT01277510|101564416|FG000|STARTED|Open-label Phase||8||
48502791|NCT01277510|101564417|FG001|STARTED|Open-label Phase||4||
48502792|NCT01277510|101564416|FG000|Received Investigational Product|Open-label Phase||6||
48502793|NCT01277510|101564417|FG001|Received Investigational Product|Open-label Phase||4||
48502794|NCT01277510|101564416|FG000|COMPLETED|Open-label Phase||1||
48502795|NCT01277510|101564417|FG001|COMPLETED|Open-label Phase||1||
48502796|NCT01277510|101564416|FG000|NOT COMPLETED|Open-label Phase||7||
48502797|NCT01277510|101564417|FG001|NOT COMPLETED|Open-label Phase||3||
48502798|NCT03820258|101564418|FG000|STARTED|Overall Study||21||
48502799|NCT03820258|101564418|FG000|COMPLETED|Overall Study||21||
48502800|NCT03820258|101564418|FG000|NOT COMPLETED|Overall Study||0||
48502801|NCT02174276|101564419|FG000|STARTED|Study Treatment Phase (Weeks 1 to 48)||27||
48502802|NCT02174276|101564420|FG001|STARTED|Study Treatment Phase (Weeks 1 to 48)||57||
48502803|NCT02174276|101564421|FG002|STARTED|Study Treatment Phase (Weeks 1 to 48)||56||
48061909|NCT03633617|100472918|FG004|COMPLETED|Part C (& Follow-up)||0|Completed follow-up (end of study)|
48061910|NCT03633617|100472919|FG005|COMPLETED|Part C (& Follow-up)||30|Completed follow-up (end of study)|
48061911|NCT03633617|100472920|FG006|COMPLETED|Part C (& Follow-up)||35|Completed follow-up (end of study)|
48061912|NCT03633617|100472921|FG007|COMPLETED|Part C (& Follow-up)||33|Completed follow-up (end of study)|
48061913|NCT03633617|100472922|FG008|COMPLETED|Part C (& Follow-up)||36|Completed follow-up (end of study)|
48061914|NCT03633617|100472923|FG009|COMPLETED|Part C (& Follow-up)||67|Completed follow-up (end of study)|
48061915|NCT03633617|100472924|FG010|COMPLETED|Part C (& Follow-up)||64|Completed follow-up (end of study)|
48061916|NCT03633617|100472914|FG000|NOT COMPLETED|Part C (& Follow-up)||0||
48061917|NCT03633617|100472915|FG001|NOT COMPLETED|Part C (& Follow-up)||0||
48061918|NCT03633617|100472916|FG002|NOT COMPLETED|Part C (& Follow-up)||0||
48061919|NCT03633617|100472917|FG003|NOT COMPLETED|Part C (& Follow-up)||0||
48061920|NCT03633617|100472918|FG004|NOT COMPLETED|Part C (& Follow-up)||0||
48061921|NCT03633617|100472919|FG005|NOT COMPLETED|Part C (& Follow-up)||7||
48061922|NCT03633617|100472920|FG006|NOT COMPLETED|Part C (& Follow-up)||5||
48061923|NCT03633617|100472921|FG007|NOT COMPLETED|Part C (& Follow-up)||4||
48061924|NCT03633617|100472922|FG008|NOT COMPLETED|Part C (& Follow-up)||1||
48061925|NCT03633617|100472923|FG009|NOT COMPLETED|Part C (& Follow-up)||12||
48061926|NCT03633617|100472924|FG010|NOT COMPLETED|Part C (& Follow-up)||10||
48061927|NCT00675259|100472925|FG000|STARTED|Overall Study||33||
48061928|NCT00675259|100472925|FG000|COMPLETED|Overall Study||19||
48061929|NCT00675259|100472925|FG000|NOT COMPLETED|Overall Study||14||
48061930|NCT04040244|100472926|FG000|STARTED|Overall Study||16||
48061931|NCT04040244|100472926|FG000|COMPLETED|Overall Study||16||
48061932|NCT04040244|100472926|FG000|NOT COMPLETED|Overall Study||0||
48061933|NCT00783965|100472927|FG000|STARTED|First Intervention (12 Months)||5||
48061934|NCT00783965|100472928|FG001|STARTED|First Intervention (12 Months)||29||
48061935|NCT00783965|100472927|FG000|COMPLETED|First Intervention (12 Months)||2||
48061936|NCT00783965|100472928|FG001|COMPLETED|First Intervention (12 Months)||25||
48061937|NCT00783965|100472927|FG000|NOT COMPLETED|First Intervention (12 Months)||3||
48061938|NCT00783965|100472928|FG001|NOT COMPLETED|First Intervention (12 Months)||4||
48061939|NCT00783965|100472927|FG000|STARTED|Second Intervention (24 Months)||2||
48061940|NCT00783965|100472928|FG001|STARTED|Second Intervention (24 Months)||25||
48061941|NCT00783965|100472927|FG000|COMPLETED|Second Intervention (24 Months)||2||
48061942|NCT00783965|100472928|FG001|COMPLETED|Second Intervention (24 Months)||16||
48061943|NCT00783965|100472927|FG000|NOT COMPLETED|Second Intervention (24 Months)||0||
48061944|NCT00783965|100472928|FG001|NOT COMPLETED|Second Intervention (24 Months)||9||
48061945|NCT02395016|100472929|FG000|STARTED|Overall Study||45||
48061946|NCT02395016|100472930|FG001|STARTED|Overall Study||45||
48061947|NCT02395016|100472929|FG000|COMPLETED|Overall Study||30||
48061948|NCT02395016|100472930|FG001|COMPLETED|Overall Study||33||
48061949|NCT02395016|100472929|FG000|NOT COMPLETED|Overall Study||15||
48061950|NCT02395016|100472930|FG001|NOT COMPLETED|Overall Study||12||
48061951|NCT01470859|100472931|FG000|STARTED|Overall Study||15||
48061952|NCT01470859|100472932|FG001|STARTED|Overall Study||15||
48061953|NCT01470859|100472931|FG000|COMPLETED|Overall Study||14||
48061954|NCT01470859|100472932|FG001|COMPLETED|Overall Study||15||
48061955|NCT01470859|100472931|FG000|NOT COMPLETED|Overall Study||1||
48061956|NCT01470859|100472932|FG001|NOT COMPLETED|Overall Study||0||
48061957|NCT01904058|100472933|FG000|STARTED|Overall Study||21||
48061958|NCT01904058|100472934|FG001|STARTED|Overall Study||21||
48061959|NCT01904058|100472935|FG002|STARTED|Overall Study||11||
48061960|NCT01904058|100472936|FG003|STARTED|Overall Study||13||
48061961|NCT01904058|100472933|FG000|COMPLETED|Overall Study||18||
48061962|NCT01904058|100472934|FG001|COMPLETED|Overall Study||21||
48502804|NCT02174276|101564422|FG003|STARTED|Study Treatment Phase (Weeks 1 to 48)||55||
48061963|NCT01904058|100472935|FG002|COMPLETED|Overall Study||10||
48061964|NCT01904058|100472936|FG003|COMPLETED|Overall Study||12||
48061965|NCT01904058|100472933|FG000|NOT COMPLETED|Overall Study||3||
48061966|NCT01904058|100472934|FG001|NOT COMPLETED|Overall Study||0||
48502805|NCT02174276|101564419|FG000|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||26||
48502806|NCT02174276|101564420|FG001|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||56||
48502807|NCT02174276|101564421|FG002|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||53||
48502808|NCT02174276|101564422|FG003|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||55||
48502809|NCT02174276|101564419|FG000|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||1||
48502810|NCT02174276|101564420|FG001|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||1||
48502811|NCT02174276|101564421|FG002|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||3||
48502812|NCT02174276|101564422|FG003|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||0||
48502813|NCT02174276|101564419|FG000|STARTED|OTEP (Weeks 48 to 144)||26||
48502814|NCT02174276|101564420|FG001|STARTED|OTEP (Weeks 48 to 144)||54||
48502815|NCT02174276|101564421|FG002|STARTED|OTEP (Weeks 48 to 144)||51||
48502816|NCT02174276|101564422|FG003|STARTED|OTEP (Weeks 48 to 144)||52||
48502817|NCT02174276|101564419|FG000|COMPLETED|OTEP (Weeks 48 to 144)||25||
48502818|NCT02174276|101564420|FG001|COMPLETED|OTEP (Weeks 48 to 144)||54||
48502819|NCT02174276|101564421|FG002|COMPLETED|OTEP (Weeks 48 to 144)||48||
48502820|NCT02174276|101564422|FG003|COMPLETED|OTEP (Weeks 48 to 144)||50||
48502821|NCT02174276|101564419|FG000|NOT COMPLETED|OTEP (Weeks 48 to 144)||1||
48502822|NCT02174276|101564420|FG001|NOT COMPLETED|OTEP (Weeks 48 to 144)||0||
48502823|NCT02174276|101564421|FG002|NOT COMPLETED|OTEP (Weeks 48 to 144)||3||
48502824|NCT02174276|101564422|FG003|NOT COMPLETED|OTEP (Weeks 48 to 144)||2||
48502825|NCT02490800|101564423|FG000|STARTED|Overall Study||3||
48502826|NCT02490800|101564424|FG001|STARTED|Overall Study||3||
48502827|NCT02490800|101564425|FG002|STARTED|Overall Study||3||
48502828|NCT02490800|101564426|FG003|STARTED|Overall Study||7||
48502829|NCT02490800|101564427|FG004|STARTED|Overall Study||7||
48502830|NCT02490800|101564428|FG005|STARTED|Overall Study||3||
48502831|NCT02490800|101564429|FG006|STARTED|Overall Study||4||
48502832|NCT02490800|101564430|FG007|STARTED|Overall Study||3||
48502833|NCT02490800|101564431|FG008|STARTED|Overall Study||7||
48502834|NCT02490800|101564432|FG009|STARTED|Overall Study||3||
48502835|NCT02490800|101564433|FG010|STARTED|Overall Study||8||
48502836|NCT02490800|101564434|FG011|STARTED|Overall Study||3||
48502837|NCT02490800|101564435|FG012|STARTED|Overall Study||18||
48502838|NCT02490800|101564423|FG000|COMPLETED|Overall Study||0||
48502839|NCT02490800|101564424|FG001|COMPLETED|Overall Study||0||
48502840|NCT02490800|101564425|FG002|COMPLETED|Overall Study||0||
48502841|NCT02490800|101564426|FG003|COMPLETED|Overall Study||0||
48502842|NCT02490800|101564427|FG004|COMPLETED|Overall Study||0||
48502843|NCT02490800|101564428|FG005|COMPLETED|Overall Study||0||
48502844|NCT02490800|101564429|FG006|COMPLETED|Overall Study||0||
48502845|NCT02490800|101564430|FG007|COMPLETED|Overall Study||0||
48502846|NCT02490800|101564431|FG008|COMPLETED|Overall Study||0||
48502847|NCT02490800|101564432|FG009|COMPLETED|Overall Study||0||
48502848|NCT02490800|101564433|FG010|COMPLETED|Overall Study||0||
48502849|NCT02490800|101564434|FG011|COMPLETED|Overall Study||0||
48502850|NCT02490800|101564435|FG012|COMPLETED|Overall Study||0||
48502851|NCT02490800|101564423|FG000|NOT COMPLETED|Overall Study||3||
48502852|NCT02490800|101564424|FG001|NOT COMPLETED|Overall Study||3||
48502853|NCT02490800|101564425|FG002|NOT COMPLETED|Overall Study||3||
48502854|NCT02490800|101564426|FG003|NOT COMPLETED|Overall Study||7||
48502855|NCT02490800|101564427|FG004|NOT COMPLETED|Overall Study||7||
48502856|NCT02490800|101564428|FG005|NOT COMPLETED|Overall Study||3||
48502857|NCT02490800|101564429|FG006|NOT COMPLETED|Overall Study||4||
48502858|NCT02490800|101564430|FG007|NOT COMPLETED|Overall Study||3||
48502859|NCT02490800|101564431|FG008|NOT COMPLETED|Overall Study||7||
48502860|NCT02490800|101564432|FG009|NOT COMPLETED|Overall Study||3||
48502861|NCT02490800|101564433|FG010|NOT COMPLETED|Overall Study||8||
48502862|NCT02490800|101564434|FG011|NOT COMPLETED|Overall Study||3||
48502863|NCT02490800|101564435|FG012|NOT COMPLETED|Overall Study||18||
48502864|NCT00772148|101564436|FG000|STARTED|Pharmacokinetic Phase (14 Days)||29||
48502865|NCT00772148|101564437|FG001|STARTED|Pharmacokinetic Phase (14 Days)||29||
48502866|NCT00772148|101564436|FG000|COMPLETED|Pharmacokinetic Phase (14 Days)||21||
48502867|NCT00772148|101564437|FG001|COMPLETED|Pharmacokinetic Phase (14 Days)||23||
48502868|NCT00772148|101564436|FG000|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||8||
48502869|NCT00772148|101564437|FG001|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||6||
48502870|NCT00772148|101564436|FG000|STARTED|Maintenance Phase (Week 52)||21||
48502871|NCT00772148|101564437|FG001|STARTED|Maintenance Phase (Week 52)||23||
48502872|NCT00772148|101564436|FG000|COMPLETED|Maintenance Phase (Week 52)||17||
48502873|NCT00772148|101564437|FG001|COMPLETED|Maintenance Phase (Week 52)||18||
48502874|NCT00772148|101564436|FG000|NOT COMPLETED|Maintenance Phase (Week 52)||4||
48502875|NCT00772148|101564437|FG001|NOT COMPLETED|Maintenance Phase (Week 52)||5||
48502876|NCT02212457|101564438|FG000|STARTED|Overall Study||228||
48502877|NCT02212457|101564439|FG001|STARTED|Overall Study||232||
48502878|NCT02212457|101564440|FG002|STARTED|Overall Study||157||
48502879|NCT02212457|101564441|FG003|STARTED|Overall Study||134||
48502880|NCT02212457|101564442|FG004|STARTED|Overall Study||152||
48502881|NCT02212457|101564443|FG005|STARTED|Overall Study||160||
48502882|NCT02212457|101564438|FG000|COMPLETED|Overall Study||209||
48502883|NCT02212457|101564439|FG001|COMPLETED|Overall Study||211||
48502884|NCT02212457|101564440|FG002|COMPLETED|Overall Study||141||
48502885|NCT02212457|101564441|FG003|COMPLETED|Overall Study||123||
48502886|NCT02212457|101564442|FG004|COMPLETED|Overall Study||137||
48502887|NCT02212457|101564443|FG005|COMPLETED|Overall Study||147||
48502888|NCT02212457|101564438|FG000|NOT COMPLETED|Overall Study||19||
48502889|NCT02212457|101564439|FG001|NOT COMPLETED|Overall Study||21||
48502890|NCT02212457|101564440|FG002|NOT COMPLETED|Overall Study||16||
48502891|NCT02212457|101564441|FG003|NOT COMPLETED|Overall Study||11||
48502892|NCT02212457|101564442|FG004|NOT COMPLETED|Overall Study||15||
48502893|NCT02212457|101564443|FG005|NOT COMPLETED|Overall Study||13||
48502894|NCT00960154|101564444|FG000|STARTED|Overall Study||25||
48502895|NCT00960154|101564445|FG001|STARTED|Overall Study||25||
48502896|NCT00960154|101564444|FG000|COMPLETED|Overall Study||0||
48502897|NCT00960154|101564445|FG001|COMPLETED|Overall Study||0||
48502898|NCT00960154|101564444|FG000|NOT COMPLETED|Overall Study||25||
48502899|NCT00960154|101564445|FG001|NOT COMPLETED|Overall Study||25||
48502900|NCT00292227|101564446|FG000|STARTED|Patch Period||66||
48502901|NCT00292227|101564447|FG001|STARTED|Patch Period||31||
48502902|NCT00292227|101564448|FG002|STARTED|Patch Period||33||
48502903|NCT00292227|101564446|FG000|COMPLETED|Patch Period||65||
48502904|NCT00292227|101564447|FG001|COMPLETED|Patch Period||31||
48502905|NCT00292227|101564448|FG002|COMPLETED|Patch Period||30||
48502906|NCT00292227|101564446|FG000|NOT COMPLETED|Patch Period||1||
48502907|NCT00292227|101564447|FG001|NOT COMPLETED|Patch Period||0||
48502908|NCT00292227|101564448|FG002|NOT COMPLETED|Patch Period||3||
48502909|NCT00292227|101564446|FG000|STARTED|Cross-over Period 1 (Day 32)||65||
48502910|NCT00292227|101564447|FG001|STARTED|Cross-over Period 1 (Day 32)||31||
48502911|NCT00292227|101564448|FG002|STARTED|Cross-over Period 1 (Day 32)||30||
48502912|NCT00292227|101564446|FG000|COMPLETED|Cross-over Period 1 (Day 32)||65||
48502913|NCT00292227|101564447|FG001|COMPLETED|Cross-over Period 1 (Day 32)||31||
48502914|NCT00292227|101564448|FG002|COMPLETED|Cross-over Period 1 (Day 32)||30||
48502915|NCT00292227|101564446|FG000|NOT COMPLETED|Cross-over Period 1 (Day 32)||0||
48502916|NCT00292227|101564447|FG001|NOT COMPLETED|Cross-over Period 1 (Day 32)||0||
48502917|NCT00292227|101564448|FG002|NOT COMPLETED|Cross-over Period 1 (Day 32)||0||
48502918|NCT00292227|101564446|FG000|STARTED|Cross-over Period 2 (Day 39)||65||
48502919|NCT00292227|101564447|FG001|STARTED|Cross-over Period 2 (Day 39)||31||
48502920|NCT00292227|101564448|FG002|STARTED|Cross-over Period 2 (Day 39)||30||
48502921|NCT00292227|101564446|FG000|COMPLETED|Cross-over Period 2 (Day 39)||65||
48502922|NCT00292227|101564447|FG001|COMPLETED|Cross-over Period 2 (Day 39)||31||
48502923|NCT00292227|101564448|FG002|COMPLETED|Cross-over Period 2 (Day 39)||30||
48502924|NCT00292227|101564446|FG000|NOT COMPLETED|Cross-over Period 2 (Day 39)||0||
48502925|NCT00292227|101564447|FG001|NOT COMPLETED|Cross-over Period 2 (Day 39)||0||
48502926|NCT00292227|101564448|FG002|NOT COMPLETED|Cross-over Period 2 (Day 39)||0||
48502927|NCT01119625|101564449|FG000|STARTED|Overall Study||118||
48502928|NCT01119625|101564450|FG001|STARTED|Overall Study||120||
48502929|NCT01119625|101564449|FG000|COMPLETED|Overall Study||115||
48502930|NCT01119625|101564450|FG001|COMPLETED|Overall Study||116||
48502931|NCT01119625|101564449|FG000|NOT COMPLETED|Overall Study||3||
48502932|NCT01119625|101564450|FG001|NOT COMPLETED|Overall Study||4||
48502933|NCT02786953|101564451|FG000|STARTED|Overall Study||20||
48502934|NCT02786953|101564452|FG001|STARTED|Overall Study||19||
48502935|NCT02786953|101564451|FG000|Baseline Teen Survey Data Completed|Overall Study||20||
48502936|NCT02786953|101564452|FG001|Baseline Teen Survey Data Completed|Overall Study||18||
48502937|NCT02786953|101564451|FG000|Baseline Parent Survey Completed|Overall Study||20||
48502938|NCT02786953|101564452|FG001|Baseline Parent Survey Completed|Overall Study||18||
48502939|NCT02786953|101564451|FG000|Actigraph Data Complete|Overall Study||14||
48502940|NCT02786953|101564452|FG001|Actigraph Data Complete|Overall Study||17||
48502941|NCT02786953|101564451|FG000|A1C Data Baseline|Overall Study||20||
48502942|NCT02786953|101564452|FG001|A1C Data Baseline|Overall Study||18||
48502943|NCT02786953|101564451|FG000|Session 1 Completed|Overall Study||17||
48502944|NCT02786953|101564452|FG001|Session 1 Completed|Overall Study||0||
48502945|NCT02786953|101564451|FG000|Session 2 Completed|Overall Study||16||
48502946|NCT02786953|101564452|FG001|Session 2 Completed|Overall Study||0||
48502947|NCT02786953|101564451|FG000|Session 3 Completed|Overall Study||16||
48502948|NCT02786953|101564452|FG001|Session 3 Completed|Overall Study||0||
48502949|NCT02786953|101564451|FG000|3 Month Teen Survey Completed|Overall Study||17||
48502950|NCT02786953|101564452|FG001|3 Month Teen Survey Completed|Overall Study||18||
48502951|NCT02786953|101564451|FG000|3 Month Parent Survey Completed|Overall Study||17||
48502952|NCT02786953|101564452|FG001|3 Month Parent Survey Completed|Overall Study||18||
48502953|NCT02786953|101564451|FG000|A1C 3 Month|Overall Study||15||
48502954|NCT02786953|101564452|FG001|A1C 3 Month|Overall Study||17||
48502955|NCT02786953|101564451|FG000|COMPLETED|Overall Study||17||
48502956|NCT02786953|101564452|FG001|COMPLETED|Overall Study||18||
48502957|NCT02786953|101564451|FG000|NOT COMPLETED|Overall Study||3||
48502958|NCT02786953|101564452|FG001|NOT COMPLETED|Overall Study||1||
48502959|NCT02707276|101564453|FG000|STARTED|Overall Study||3||
48502960|NCT02707276|101564454|FG001|STARTED|Overall Study||5||
48502961|NCT02707276|101564455|FG002|STARTED|Overall Study||3||
48502962|NCT02707276|101564456|FG003|STARTED|Overall Study||2||
48502963|NCT02707276|101564453|FG000|COMPLETED|Overall Study||3||
48502964|NCT02707276|101564454|FG001|COMPLETED|Overall Study||5||
48502965|NCT02707276|101564455|FG002|COMPLETED|Overall Study||3||
48502966|NCT02707276|101564456|FG003|COMPLETED|Overall Study||2||
48502967|NCT02707276|101564453|FG000|NOT COMPLETED|Overall Study||0||
48502968|NCT02707276|101564454|FG001|NOT COMPLETED|Overall Study||0||
48502969|NCT02707276|101564455|FG002|NOT COMPLETED|Overall Study||0||
48502970|NCT02707276|101564456|FG003|NOT COMPLETED|Overall Study||0||
48502971|NCT01556906|101564457|FG000|STARTED|Overall Study||6||
48502972|NCT01556906|101564457|FG000|COMPLETED|Overall Study||6||
48502973|NCT01556906|101564457|FG000|NOT COMPLETED|Overall Study||0||
48502974|NCT04541173|101564458|FG000|STARTED|Overall Study||3||
48502975|NCT04541173|101564459|FG001|STARTED|Overall Study||3||
48502976|NCT04541173|101564458|FG000|COMPLETED|Overall Study||3||
48502977|NCT04541173|101564459|FG001|COMPLETED|Overall Study||3||
48502978|NCT04541173|101564458|FG000|NOT COMPLETED|Overall Study||0||
48502979|NCT04541173|101564459|FG001|NOT COMPLETED|Overall Study||0||
48502980|NCT03277248|101564460|FG000|STARTED|Overall Study||272||
48502981|NCT03277248|101564461|FG001|STARTED|Overall Study||273||
48502982|NCT03277248|101564460|FG000|COMPLETED|Overall Study||254|Completed = Number of participants who completed the 96 weeks Treatment Period|
48502983|NCT03277248|101564461|FG001|COMPLETED|Overall Study||239|Completed = Number of participants who completed the 96 weeks Treatment Period|
48502984|NCT03277248|101564460|FG000|NOT COMPLETED|Overall Study||18||
48502985|NCT03277248|101564461|FG001|NOT COMPLETED|Overall Study||34||
48502986|NCT03203642|101564462|FG000|STARTED|Overall Study||40||
48502987|NCT03203642|101564463|FG001|STARTED|Overall Study||40||
48502988|NCT03203642|101564462|FG000|Treated|Overall Study||38||
48502989|NCT03203642|101564463|FG001|Treated|Overall Study||40||
48502990|NCT03203642|101564462|FG000|COMPLETED|Overall Study||25||
48502991|NCT03203642|101564463|FG001|COMPLETED|Overall Study||29||
48502992|NCT03203642|101564462|FG000|NOT COMPLETED|Overall Study||15||
48502993|NCT03203642|101564463|FG001|NOT COMPLETED|Overall Study||11||
48502994|NCT00160524|101564464|FG000|STARTED|Overall Study||595||
48502995|NCT00160524|101564464|FG000|COMPLETED|Overall Study||117||
48502996|NCT00160524|101564464|FG000|NOT COMPLETED|Overall Study||478||
48502997|NCT00210639|101564465|FG000|STARTED|Overall Study||124||
48502998|NCT00210639|101564466|FG001|STARTED|Overall Study||83||
48502999|NCT00210639|101564465|FG000|COMPLETED|Overall Study||61||
48503000|NCT00210639|101564466|FG001|COMPLETED|Overall Study||41||
48503001|NCT00210639|101564465|FG000|NOT COMPLETED|Overall Study||63||
48503002|NCT00210639|101564466|FG001|NOT COMPLETED|Overall Study||42||
48503003|NCT00396630|101564467|FG000|STARTED|Overall Study||100||
48503004|NCT00396630|101564468|FG001|STARTED|Overall Study||100||
48503005|NCT00396630|101564467|FG000|COMPLETED|Overall Study||95||
48503006|NCT00396630|101564468|FG001|COMPLETED|Overall Study||95||
48503007|NCT00396630|101564467|FG000|NOT COMPLETED|Overall Study||5||
48503008|NCT00396630|101564468|FG001|NOT COMPLETED|Overall Study||5||
48503009|NCT02946255|101564469|FG000|STARTED|Overall Study||23||
48503010|NCT02946255|101564470|FG001|STARTED|Overall Study||41||
48503011|NCT02946255|101564471|FG002|STARTED|Overall Study||46||
48503012|NCT02946255|101564469|FG000|4 Week Follow-Up|Overall Study||16||
48503013|NCT02946255|101564470|FG001|4 Week Follow-Up|Overall Study||33||
48503014|NCT02946255|101564471|FG002|4 Week Follow-Up|Overall Study||33||
48503015|NCT02946255|101564469|FG000|COMPLETED|Overall Study||16||
48503016|NCT02946255|101564470|FG001|COMPLETED|Overall Study||31||
48503017|NCT02946255|101564471|FG002|COMPLETED|Overall Study||27||
48503018|NCT02946255|101564469|FG000|NOT COMPLETED|Overall Study||7||
48503019|NCT02946255|101564470|FG001|NOT COMPLETED|Overall Study||10||
48503020|NCT02946255|101564471|FG002|NOT COMPLETED|Overall Study||19||
48503021|NCT01837537|101564472|FG000|STARTED|Overall Study||90||
48503022|NCT01837537|101564472|FG000|COMPLETED|Overall Study||90||
48503023|NCT01837537|101564472|FG000|NOT COMPLETED|Overall Study||0||
48503024|NCT00777855|101564473|FG000|STARTED|First Intervention||5||
48503025|NCT00777855|101564474|FG001|STARTED|First Intervention||5||
48503026|NCT00777855|101564473|FG000|COMPLETED|First Intervention||5||
48503027|NCT00777855|101564474|FG001|COMPLETED|First Intervention||5||
48503028|NCT00777855|101564473|FG000|NOT COMPLETED|First Intervention||0||
48503029|NCT00777855|101564474|FG001|NOT COMPLETED|First Intervention||0||
48503030|NCT00777855|101564473|FG000|STARTED|Washout Period (>= 14 Days)||5||
48503031|NCT00777855|101564474|FG001|STARTED|Washout Period (>= 14 Days)||5||
48503032|NCT00777855|101564473|FG000|COMPLETED|Washout Period (>= 14 Days)||5||
48503033|NCT00777855|101564474|FG001|COMPLETED|Washout Period (>= 14 Days)||5||
48503034|NCT00777855|101564473|FG000|NOT COMPLETED|Washout Period (>= 14 Days)||0||
48503035|NCT00777855|101564474|FG001|NOT COMPLETED|Washout Period (>= 14 Days)||0||
48503036|NCT00777855|101564473|FG000|STARTED|Second Intervention||5||
48503037|NCT00777855|101564474|FG001|STARTED|Second Intervention||5||
48503038|NCT00777855|101564473|FG000|COMPLETED|Second Intervention||5||
48503039|NCT00777855|101564474|FG001|COMPLETED|Second Intervention||5||
48503040|NCT00777855|101564473|FG000|NOT COMPLETED|Second Intervention||0||
48503041|NCT00777855|101564474|FG001|NOT COMPLETED|Second Intervention||0||
48503042|NCT00274625|101564475|FG000|STARTED|Overall Study||199||
48503043|NCT00274625|101564476|FG001|STARTED|Overall Study||203||
48503044|NCT00274625|101564475|FG000|COMPLETED|Overall Study||139||
48503045|NCT00274625|101564476|FG001|COMPLETED|Overall Study||141||
48503046|NCT00274625|101564475|FG000|NOT COMPLETED|Overall Study||60||
48503047|NCT00274625|101564476|FG001|NOT COMPLETED|Overall Study||62||
48503048|NCT02413034|101564477|FG000|STARTED|Overall Study||14||
48503049|NCT02413034|101564478|FG001|STARTED|Overall Study||14||
48503050|NCT02413034|101564477|FG000|COMPLETED|Overall Study||14||
48503051|NCT02413034|101564478|FG001|COMPLETED|Overall Study||14||
48503052|NCT02413034|101564477|FG000|NOT COMPLETED|Overall Study||0||
48503053|NCT02413034|101564478|FG001|NOT COMPLETED|Overall Study||0||
48503054|NCT00766493|101564479|FG000|STARTED|Pre-Discharge||250||
48503055|NCT00766493|101564479|FG000|COMPLETED|Pre-Discharge||250||
48503056|NCT00766493|101564479|FG000|NOT COMPLETED|Pre-Discharge||0||
48503057|NCT00766493|101564479|FG000|STARTED|30 Days Post-Procedure||250||
48503058|NCT00766493|101564479|FG000|COMPLETED|30 Days Post-Procedure||238||
48503059|NCT00766493|101564479|FG000|NOT COMPLETED|30 Days Post-Procedure||12||
48503060|NCT02061358|101564480|FG000|STARTED|Overall Study||6||
48503061|NCT02061358|101564481|FG001|STARTED|Overall Study||6||
48503062|NCT02061358|101564482|FG002|STARTED|Overall Study||6||
48503063|NCT02061358|101564483|FG003|STARTED|Overall Study||6||
48503064|NCT02061358|101564484|FG004|STARTED|Overall Study||6||
48503065|NCT02061358|101564485|FG005|STARTED|Overall Study||6||
48503066|NCT02061358|101564486|FG006|STARTED|Overall Study||6||
48503067|NCT02061358|101564487|FG007|STARTED|Overall Study||6||
48503068|NCT02061358|101564488|FG008|STARTED|Overall Study||16||
48503069|NCT02061358|101564480|FG000|COMPLETED|Overall Study||6||
48503070|NCT02061358|101564481|FG001|COMPLETED|Overall Study||6||
48503071|NCT02061358|101564482|FG002|COMPLETED|Overall Study||6||
48503072|NCT02061358|101564483|FG003|COMPLETED|Overall Study||6||
48503073|NCT02061358|101564484|FG004|COMPLETED|Overall Study||6||
48503074|NCT02061358|101564485|FG005|COMPLETED|Overall Study||6||
48503075|NCT02061358|101564486|FG006|COMPLETED|Overall Study||6||
48503076|NCT02061358|101564487|FG007|COMPLETED|Overall Study||6||
48503077|NCT02061358|101564488|FG008|COMPLETED|Overall Study||16||
48503078|NCT02061358|101564480|FG000|NOT COMPLETED|Overall Study||0||
48503079|NCT02061358|101564481|FG001|NOT COMPLETED|Overall Study||0||
48503080|NCT02061358|101564482|FG002|NOT COMPLETED|Overall Study||0||
48503081|NCT02061358|101564483|FG003|NOT COMPLETED|Overall Study||0||
48503082|NCT02061358|101564484|FG004|NOT COMPLETED|Overall Study||0||
48503083|NCT02061358|101564485|FG005|NOT COMPLETED|Overall Study||0||
48503084|NCT02061358|101564486|FG006|NOT COMPLETED|Overall Study||0||
48503085|NCT02061358|101564487|FG007|NOT COMPLETED|Overall Study||0||
48503086|NCT02061358|101564488|FG008|NOT COMPLETED|Overall Study||0||
48503087|NCT05497557|101564489|FG000|STARTED|Period 1: Sotorasib Alone||16||
48503088|NCT05497557|101564490|FG001|STARTED|Period 1: Sotorasib Alone||0||
48503089|NCT05497557|101564491|FG002|STARTED|Period 1: Sotorasib Alone||0||
48503090|NCT05497557|101564489|FG000|COMPLETED|Period 1: Sotorasib Alone||16|Participants who completed Period 1, in which they received sotorasib alone on Day 1. All completed participants continued onto Period 2.|
48503091|NCT05497557|101564490|FG001|COMPLETED|Period 1: Sotorasib Alone||0|Participants who completed Period 1, in which they received sotorasib alone on Day 1. All completed participants continued onto Period 2.|
48503092|NCT05497557|101564491|FG002|COMPLETED|Period 1: Sotorasib Alone||0|Participants who completed Period 1, in which they received sotorasib alone on Day 1. All completed participants continued onto Period 2.|
48503093|NCT05497557|101564489|FG000|NOT COMPLETED|Period 1: Sotorasib Alone||0||
48503094|NCT05497557|101564490|FG001|NOT COMPLETED|Period 1: Sotorasib Alone||0||
48503095|NCT05497557|101564491|FG002|NOT COMPLETED|Period 1: Sotorasib Alone||0||
48503096|NCT05497557|101564489|FG000|STARTED|Period 2: Omeprazole Alone||0||
48503097|NCT05497557|101564490|FG001|STARTED|Period 2: Omeprazole Alone||16||
48503098|NCT05497557|101564491|FG002|STARTED|Period 2: Omeprazole Alone||0||
48503099|NCT05497557|101564489|FG000|COMPLETED|Period 2: Omeprazole Alone||0|Participants who completed Period 2, in which they received omeprazole alone on Days 4 to 8. All completed participants continued onto Period 3.|
48503100|NCT05497557|101564490|FG001|COMPLETED|Period 2: Omeprazole Alone||14|Participants who completed Period 2, in which they received omeprazole alone on Days 4 to 8. All completed participants continued onto Period 3.|
48503101|NCT05497557|101564491|FG002|COMPLETED|Period 2: Omeprazole Alone||0|Participants who completed Period 2, in which they received omeprazole alone on Days 4 to 8. All completed participants continued onto Period 3.|
48503102|NCT05497557|101564489|FG000|NOT COMPLETED|Period 2: Omeprazole Alone||0||
48503103|NCT05497557|101564490|FG001|NOT COMPLETED|Period 2: Omeprazole Alone||2||
48503104|NCT05497557|101564491|FG002|NOT COMPLETED|Period 2: Omeprazole Alone||0||
48503105|NCT05497557|101564489|FG000|STARTED|Period 3: Omeprazole With Sotorasib||0||
48503106|NCT05497557|101564490|FG001|STARTED|Period 3: Omeprazole With Sotorasib||0||
48503107|NCT05497557|101564491|FG002|STARTED|Period 3: Omeprazole With Sotorasib||14||
48503108|NCT05497557|101564489|FG000|COMPLETED|Period 3: Omeprazole With Sotorasib||0|Participants who completed Period 3, in which they received omeprazole co-administered with sotorasib on Day 9.|
48503109|NCT05497557|101564490|FG001|COMPLETED|Period 3: Omeprazole With Sotorasib||0|Participants who completed Period 3, in which they received omeprazole co-administered with sotorasib on Day 9.|
48503110|NCT05497557|101564491|FG002|COMPLETED|Period 3: Omeprazole With Sotorasib||14|Participants who completed Period 3, in which they received omeprazole co-administered with sotorasib on Day 9.|
48503111|NCT05497557|101564489|FG000|NOT COMPLETED|Period 3: Omeprazole With Sotorasib||0||
48503112|NCT05497557|101564490|FG001|NOT COMPLETED|Period 3: Omeprazole With Sotorasib||0||
48503113|NCT05497557|101564491|FG002|NOT COMPLETED|Period 3: Omeprazole With Sotorasib||0||
48503114|NCT01726803|101564492|FG000|STARTED|Overall Study||112||
48503115|NCT01726803|101564493|FG001|STARTED|Overall Study||108||
48503116|NCT01726803|101564492|FG000|COMPLETED|Overall Study||105||
48503117|NCT01726803|101564493|FG001|COMPLETED|Overall Study||107||
48503118|NCT01726803|101564492|FG000|NOT COMPLETED|Overall Study||7||
48503119|NCT01726803|101564493|FG001|NOT COMPLETED|Overall Study||1||
48503120|NCT02260258|101567934|FG000|STARTED|Overall Study||39||
48503121|NCT02260258|101567935|FG001|STARTED|Overall Study||44||
48503122|NCT02260258|101567934|FG000|COMPLETED|Overall Study||37||
48503123|NCT02260258|101567935|FG001|COMPLETED|Overall Study||43||
48503124|NCT02260258|101567934|FG000|NOT COMPLETED|Overall Study||2||
48503125|NCT02260258|101567935|FG001|NOT COMPLETED|Overall Study||1||
48503126|NCT01402128|101567936|FG000|STARTED|Overall Study||40||
48503127|NCT01402128|101567937|FG001|STARTED|Overall Study||40||
48503128|NCT01402128|101567936|FG000|COMPLETED|Overall Study||39||
48503129|NCT01402128|101567937|FG001|COMPLETED|Overall Study||40||
48503130|NCT01402128|101567936|FG000|NOT COMPLETED|Overall Study||1||
48503131|NCT01402128|101567937|FG001|NOT COMPLETED|Overall Study||0||
48503132|NCT01285076|101567938|FG000|STARTED|Overall Study||834||
48503133|NCT01285076|101567938|FG000|COMPLETED|Overall Study||834||
48503134|NCT01285076|101567938|FG000|NOT COMPLETED|Overall Study||0||
48503135|NCT01398787|101567939|FG000|STARTED|Overall Study||198||
48503136|NCT01398787|101567939|FG000|COMPLETED|Overall Study||197||
48503137|NCT01398787|101567939|FG000|NOT COMPLETED|Overall Study||1||
48503138|NCT01341405|101567940|FG000|STARTED|Overall Study||40||
48503139|NCT01341405|101567941|FG001|STARTED|Overall Study||42||
48503140|NCT01341405|101567942|FG002|STARTED|Overall Study||43||
48503141|NCT01341405|101567940|FG000|COMPLETED|Overall Study||37||
48503142|NCT01341405|101567941|FG001|COMPLETED|Overall Study||39||
48503143|NCT01341405|101567942|FG002|COMPLETED|Overall Study||41||
48503144|NCT01341405|101567940|FG000|NOT COMPLETED|Overall Study||3||
48503145|NCT01341405|101567941|FG001|NOT COMPLETED|Overall Study||3||
48503146|NCT01341405|101567942|FG002|NOT COMPLETED|Overall Study||2||
48503147|NCT00716625|101567943|FG000|STARTED|Overall Study||1674||
48503148|NCT00716625|101567943|FG000|COMPLETED|Overall Study||1673||
48503149|NCT00716625|101567943|FG000|NOT COMPLETED|Overall Study||1||
48503150|NCT02340962|101567944|FG000|STARTED|Overall Study||13||
48503151|NCT02340962|101567945|FG001|STARTED|Overall Study||12||
48503152|NCT02340962|101567944|FG000|COMPLETED|Overall Study||12||
48503153|NCT02340962|101567945|FG001|COMPLETED|Overall Study||12||
48503154|NCT02340962|101567944|FG000|NOT COMPLETED|Overall Study||1||
48503155|NCT02340962|101567945|FG001|NOT COMPLETED|Overall Study||0||
48503156|NCT04553406|101567946|FG000|STARTED|Overall Study||1||
48503157|NCT04553406|101567947|FG001|STARTED|Overall Study||1||
48503158|NCT04553406|101567946|FG000|COMPLETED|Overall Study||1||
48503159|NCT04553406|101567947|FG001|COMPLETED|Overall Study||0||
48503160|NCT04553406|101567946|FG000|NOT COMPLETED|Overall Study||0||
48503161|NCT04553406|101567947|FG001|NOT COMPLETED|Overall Study||1||
48503162|NCT03250117|101567948|FG000|STARTED|Requip IR [7-10 Days]||3||
48503163|NCT03250117|101567949|FG001|STARTED|Requip IR [7-10 Days]||0||
48503164|NCT03250117|101567950|FG002|STARTED|Requip IR [7-10 Days]||0||
48503165|NCT03250117|101567951|FG003|STARTED|Requip IR [7-10 Days]||0||
48503166|NCT03250117|101567948|FG000|COMPLETED|Requip IR [7-10 Days]||3||
48503167|NCT03250117|101567949|FG001|COMPLETED|Requip IR [7-10 Days]||0||
48503168|NCT03250117|101567950|FG002|COMPLETED|Requip IR [7-10 Days]||0||
48503169|NCT03250117|101567951|FG003|COMPLETED|Requip IR [7-10 Days]||0||
48503170|NCT03250117|101567948|FG000|NOT COMPLETED|Requip IR [7-10 Days]||0||
48503171|NCT03250117|101567949|FG001|NOT COMPLETED|Requip IR [7-10 Days]||0||
48503172|NCT03250117|101567950|FG002|NOT COMPLETED|Requip IR [7-10 Days]||0||
48503173|NCT03250117|101567951|FG003|NOT COMPLETED|Requip IR [7-10 Days]||0||
48503174|NCT03250117|101567948|FG000|STARTED|Ropinirole Implant 12 Weeks||3||
48503175|NCT03250117|101567949|FG001|STARTED|Ropinirole Implant 12 Weeks||0||
48503176|NCT03250117|101567950|FG002|STARTED|Ropinirole Implant 12 Weeks||0||
48503177|NCT03250117|101567951|FG003|STARTED|Ropinirole Implant 12 Weeks||0||
48503178|NCT03250117|101567948|FG000|COMPLETED|Ropinirole Implant 12 Weeks||2||
48503179|NCT03250117|101567949|FG001|COMPLETED|Ropinirole Implant 12 Weeks||0||
48503180|NCT03250117|101567950|FG002|COMPLETED|Ropinirole Implant 12 Weeks||0||
48503181|NCT03250117|101567951|FG003|COMPLETED|Ropinirole Implant 12 Weeks||0||
48503182|NCT03250117|101567948|FG000|NOT COMPLETED|Ropinirole Implant 12 Weeks||1||
48503183|NCT03250117|101567949|FG001|NOT COMPLETED|Ropinirole Implant 12 Weeks||0||
48503184|NCT03250117|101567950|FG002|NOT COMPLETED|Ropinirole Implant 12 Weeks||0||
48503185|NCT03250117|101567951|FG003|NOT COMPLETED|Ropinirole Implant 12 Weeks||0||
48503186|NCT02034513|101567952|FG000|STARTED|Overall Study||249||
48503187|NCT02034513|101567953|FG001|STARTED|Overall Study||252||
48503188|NCT02034513|101567952|FG000|Exposed|Overall Study||249||
48503189|NCT02034513|101567953|FG001|Exposed|Overall Study||251||
48503190|NCT02034513|101567952|FG000|COMPLETED|Overall Study||200||
48503191|NCT02034513|101567953|FG001|COMPLETED|Overall Study||195||
48503192|NCT02034513|101567952|FG000|NOT COMPLETED|Overall Study||49||
48503193|NCT02034513|101567953|FG001|NOT COMPLETED|Overall Study||57||
48503194|NCT02583048|101567954|FG000|STARTED|Overall Study||28||
48503195|NCT02583048|101567955|FG001|STARTED|Overall Study||28||
48503196|NCT02583048|101567956|FG002|STARTED|Overall Study||28||
48503197|NCT02583048|101567954|FG000|COMPLETED|Overall Study||28||
48503198|NCT02583048|101567955|FG001|COMPLETED|Overall Study||27||
48503199|NCT02583048|101567956|FG002|COMPLETED|Overall Study||27||
48503200|NCT02583048|101567954|FG000|NOT COMPLETED|Overall Study||0||
48503201|NCT02583048|101567955|FG001|NOT COMPLETED|Overall Study||1||
48503202|NCT02583048|101567956|FG002|NOT COMPLETED|Overall Study||1||
48503203|NCT00668395|101567957|FG000|STARTED|Overall Study||45||
48503204|NCT00668395|101567958|FG001|STARTED|Overall Study||22||
48503205|NCT00668395|101567959|FG002|STARTED|Overall Study||6||
48503206|NCT00668395|101567957|FG000|COMPLETED|Overall Study||39||
48503207|NCT00668395|101567958|FG001|COMPLETED|Overall Study||16||
48503208|NCT00668395|101567959|FG002|COMPLETED|Overall Study||5||
48503209|NCT00668395|101567957|FG000|NOT COMPLETED|Overall Study||6||
48503210|NCT00668395|101567958|FG001|NOT COMPLETED|Overall Study||6||
48503211|NCT00668395|101567959|FG002|NOT COMPLETED|Overall Study||1||
48503212|NCT00724958|101567960|FG000|STARTED|Overall Study||348||
48503213|NCT00724958|101567960|FG000|COMPLETED|Overall Study||166||
48503214|NCT00724958|101567960|FG000|NOT COMPLETED|Overall Study||182||
48503215|NCT00569660|101567961|FG000|STARTED|Overall Study||34||
48503216|NCT00569660|101567961|FG000|COMPLETED|Overall Study||34||
48503217|NCT00569660|101567961|FG000|NOT COMPLETED|Overall Study||0||
48503218|NCT00438750|101567962|FG000|STARTED|Overall Study||48||
48503219|NCT00438750|101567963|FG001|STARTED|Overall Study||46||
48503220|NCT00438750|101567962|FG000|COMPLETED|Overall Study||39||
48503221|NCT00438750|101567963|FG001|COMPLETED|Overall Study||37||
48503222|NCT00438750|101567962|FG000|NOT COMPLETED|Overall Study||9||
48503223|NCT00438750|101567963|FG001|NOT COMPLETED|Overall Study||9||
48503224|NCT03538262|101567964|FG000|STARTED|Overall Study||226||
48503225|NCT03538262|101567964|FG000|COMPLETED|Overall Study||203||
48503226|NCT03538262|101567964|FG000|NOT COMPLETED|Overall Study||23||
48503227|NCT00965731|101567965|FG000|STARTED|Overall Study||7||
48503228|NCT00965731|101567966|FG001|STARTED|Overall Study||20||
48503229|NCT00965731|101567965|FG000|COMPLETED|Overall Study||0||
48503230|NCT00965731|101567966|FG001|COMPLETED|Overall Study||0||
48503231|NCT00965731|101567965|FG000|NOT COMPLETED|Overall Study||7||
48503232|NCT00965731|101567966|FG001|NOT COMPLETED|Overall Study||20||
48503233|NCT00697619|101567967|FG000|STARTED|Overall Study||30||
48503234|NCT00697619|101567968|FG001|STARTED|Overall Study||30||
48503235|NCT00697619|101567967|FG000|COMPLETED|Overall Study||24||
48503236|NCT00697619|101567968|FG001|COMPLETED|Overall Study||22||
48503237|NCT00697619|101567967|FG000|NOT COMPLETED|Overall Study||6||
48503238|NCT00697619|101567968|FG001|NOT COMPLETED|Overall Study||8||
48503239|NCT04473326|101567969|FG000|STARTED|Overall Study||29||
48503240|NCT04473326|101567970|FG001|STARTED|Overall Study||31||
48503241|NCT04473326|101567969|FG000|COMPLETED|Overall Study||28||
48503242|NCT04473326|101567970|FG001|COMPLETED|Overall Study||28||
48503243|NCT04473326|101567969|FG000|NOT COMPLETED|Overall Study||1||
48503244|NCT04473326|101567970|FG001|NOT COMPLETED|Overall Study||3||
48503245|NCT01528293|101567971|FG000|STARTED|Overall Study||1||
48503246|NCT01528293|101567972|FG001|STARTED|Overall Study||1||
48503247|NCT01528293|101567971|FG000|COMPLETED|Overall Study||0||
48503248|NCT01528293|101567972|FG001|COMPLETED|Overall Study||1||
48503249|NCT01528293|101567971|FG000|NOT COMPLETED|Overall Study||1||
48503250|NCT01528293|101567972|FG001|NOT COMPLETED|Overall Study||0||
48503251|NCT00000136|101567973|FG000|STARTED|Overall Study||107||
48503252|NCT00000136|101567974|FG001|STARTED|Overall Study||127||
48503253|NCT00000136|101567973|FG000|COMPLETED|Overall Study||107||
48503254|NCT00000136|101567974|FG001|COMPLETED|Overall Study||127||
48503255|NCT00000136|101567973|FG000|NOT COMPLETED|Overall Study||0||
48503256|NCT00000136|101567974|FG001|NOT COMPLETED|Overall Study||0||
48503257|NCT04728620|101567975|FG000|STARTED|Overall Study||50||
48503258|NCT04728620|101567975|FG000|COMPLETED|Overall Study||50||
48503259|NCT04728620|101567975|FG000|NOT COMPLETED|Overall Study||0||
48503260|NCT01451541|101567976|FG000|STARTED|Overall Study||283||
48503261|NCT01451541|101567977|FG001|STARTED|Overall Study||282||
48503262|NCT01451541|101567978|FG002|STARTED|Overall Study||281||
48503263|NCT01451541|101567976|FG000|COMPLETED|Overall Study||247||
48503264|NCT01451541|101567977|FG001|COMPLETED|Overall Study||257||
48503265|NCT01451541|101567978|FG002|COMPLETED|Overall Study||254||
48503266|NCT01451541|101567976|FG000|NOT COMPLETED|Overall Study||36||
48503267|NCT01451541|101567977|FG001|NOT COMPLETED|Overall Study||25||
48503268|NCT01451541|101567978|FG002|NOT COMPLETED|Overall Study||27||
48503269|NCT02889393|101567979|FG000|STARTED|Overall Study||3||
48503270|NCT02889393|101567980|FG001|STARTED|Overall Study||3||
48503271|NCT02889393|101567979|FG000|COMPLETED|Overall Study||3||
48503272|NCT02889393|101567980|FG001|COMPLETED|Overall Study||3||
48503273|NCT02889393|101567979|FG000|NOT COMPLETED|Overall Study||0||
48503274|NCT02889393|101567980|FG001|NOT COMPLETED|Overall Study||0||
48503275|NCT01541215|101567981|FG000|STARTED|Treatment Period (52 Weeks)||66||
48503276|NCT01541215|101567982|FG001|STARTED|Treatment Period (52 Weeks)||69||
48503277|NCT01541215|101567981|FG000|Exposed|Treatment Period (52 Weeks)||66||
48503278|NCT01541215|101567982|FG001|Exposed|Treatment Period (52 Weeks)||68||
48503279|NCT01541215|101567981|FG000|COMPLETED|Treatment Period (52 Weeks)||56||
48503280|NCT01541215|101567982|FG001|COMPLETED|Treatment Period (52 Weeks)||53||
48503281|NCT01541215|101567981|FG000|NOT COMPLETED|Treatment Period (52 Weeks)||10||
48503282|NCT01541215|101567982|FG001|NOT COMPLETED|Treatment Period (52 Weeks)||16||
48503283|NCT01541215|101567981|FG000|STARTED|Follow up 1 (Weeks 53-104)||52||
48503284|NCT01541215|101567982|FG001|STARTED|Follow up 1 (Weeks 53-104)||0||
48503285|NCT01541215|101567981|FG000|COMPLETED|Follow up 1 (Weeks 53-104)||50||
48503286|NCT01541215|101567982|FG001|COMPLETED|Follow up 1 (Weeks 53-104)||0||
48503287|NCT01541215|101567981|FG000|NOT COMPLETED|Follow up 1 (Weeks 53-104)||2||
48503288|NCT01541215|101567982|FG001|NOT COMPLETED|Follow up 1 (Weeks 53-104)||0||
48503289|NCT01541215|101567981|FG000|STARTED|Follow up 2 (Weeks 105-156)||48||
48503290|NCT01541215|101567982|FG001|STARTED|Follow up 2 (Weeks 105-156)||0||
48503291|NCT01541215|101567981|FG000|COMPLETED|Follow up 2 (Weeks 105-156)||48||
48503292|NCT01541215|101567982|FG001|COMPLETED|Follow up 2 (Weeks 105-156)||0||
48503293|NCT01541215|101567981|FG000|NOT COMPLETED|Follow up 2 (Weeks 105-156)||0||
48503294|NCT01541215|101567982|FG001|NOT COMPLETED|Follow up 2 (Weeks 105-156)||0||
48503295|NCT02132650|101567983|FG000|STARTED|Overall Study||20|Baseline Assessment|
48503296|NCT02132650|101567984|FG001|STARTED|Overall Study||18|Baseline Assessment|
48503297|NCT02132650|101567983|FG000|Post-Intervention Assessment|Overall Study||19||
48503298|NCT02132650|101567984|FG001|Post-Intervention Assessment|Overall Study||17||
48503299|NCT02132650|101567983|FG000|COMPLETED|Overall Study||17|3-Month Follow Up Assessment|
48503300|NCT02132650|101567984|FG001|COMPLETED|Overall Study||14|3-Month Follow Up Assessment|
48503301|NCT02132650|101567983|FG000|NOT COMPLETED|Overall Study||3||
48503302|NCT02132650|101567984|FG001|NOT COMPLETED|Overall Study||4||
48503303|NCT04364763|101567985|FG000|STARTED|Overall Study||28||
48503304|NCT04364763|101567986|FG001|STARTED|Overall Study||14||
48503305|NCT04364763|101567985|FG000|COMPLETED|Overall Study||26|Day 56 Study Visit|
48503306|NCT04364763|101567986|FG001|COMPLETED|Overall Study||12|Day 56 Study Visit|
48503307|NCT04364763|101567985|FG000|NOT COMPLETED|Overall Study||2||
48503308|NCT04364763|101567986|FG001|NOT COMPLETED|Overall Study||2||
48503309|NCT00515216|101567987|FG000|STARTED|Overall Study||26||
48503310|NCT00515216|101567987|FG000|COMPLETED|Overall Study||25||
48503311|NCT00515216|101567987|FG000|NOT COMPLETED|Overall Study||1||
48503312|NCT02597049|101567988|FG000|STARTED|Overall Study||142||
48503313|NCT02597049|101567989|FG001|STARTED|Overall Study||142||
48503314|NCT02597049|101567990|FG002|STARTED|Overall Study||140||
48503315|NCT02597049|101567988|FG000|Received at Least One Dose of Study Drug|Overall Study||142||
48503316|NCT02597049|101567989|FG001|Received at Least One Dose of Study Drug|Overall Study||141||
48503317|NCT02597049|101567990|FG002|Received at Least One Dose of Study Drug|Overall Study||140||
48503318|NCT02597049|101567988|FG000|COMPLETED|Overall Study||135||
48503319|NCT02597049|101567989|FG001|COMPLETED|Overall Study||137||
48503320|NCT02597049|101567990|FG002|COMPLETED|Overall Study||137||
48503321|NCT02597049|101567988|FG000|NOT COMPLETED|Overall Study||7||
48503322|NCT02597049|101567989|FG001|NOT COMPLETED|Overall Study||5||
48503323|NCT02597049|101567990|FG002|NOT COMPLETED|Overall Study||3||
48503324|NCT04956289|101567991|FG000|STARTED|Overall Study||20||
48503325|NCT04956289|101567991|FG000|Ambulant|Overall Study||10||
48503326|NCT04956289|101567991|FG000|Non-ambulant|Overall Study||10||
48503327|NCT04956289|101567991|FG000|COMPLETED|Overall Study||20||
48503328|NCT04956289|101567991|FG000|NOT COMPLETED|Overall Study||0||
48503329|NCT01390948|101567992|FG000|STARTED|Overall Study||59||
48503330|NCT01390948|101567993|FG001|STARTED|Overall Study||62||
48503331|NCT01390948|101567994|FG002|STARTED|Overall Study||3||
48503332|NCT01390948|101567992|FG000|Treated|Overall Study||56||
48503333|NCT01390948|101567993|FG001|Treated|Overall Study||60||
48503334|NCT01390948|101567994|FG002|Treated|Overall Study||3||
48503335|NCT01390948|101567992|FG000|COMPLETED|Overall Study||44||
48503336|NCT01390948|101567993|FG001|COMPLETED|Overall Study||44||
48503337|NCT01390948|101567994|FG002|COMPLETED|Overall Study||2||
48503338|NCT01390948|101567992|FG000|NOT COMPLETED|Overall Study||15||
48503339|NCT01390948|101567993|FG001|NOT COMPLETED|Overall Study||18||
48503340|NCT01390948|101567994|FG002|NOT COMPLETED|Overall Study||1||
48503341|NCT01841060|101567995|FG000|STARTED|Overall Study||42||
48503342|NCT01841060|101567995|FG000|COMPLETED|Overall Study||32||
48503343|NCT01841060|101567995|FG000|NOT COMPLETED|Overall Study||10||
48061967|NCT01904058|100472935|FG002|NOT COMPLETED|Overall Study||1||
48061968|NCT01904058|100472936|FG003|NOT COMPLETED|Overall Study||1||
48061969|NCT00309738|100472937|FG000|STARTED|Overall Study||236||
48061970|NCT00309738|100472938|FG001|STARTED|Overall Study||119||
48061971|NCT00309738|100472937|FG000|Safety Population|Overall Study||233||
48061972|NCT00309738|100472938|FG001|Safety Population|Overall Study||119||
48061973|NCT00309738|100472937|FG000|COMPLETED|Overall Study||223||
48061974|NCT00309738|100472938|FG001|COMPLETED|Overall Study||107||
48061975|NCT00309738|100472937|FG000|NOT COMPLETED|Overall Study||13||
48061976|NCT00309738|100472938|FG001|NOT COMPLETED|Overall Study||12||
48503344|NCT00474188|101567996|FG000|STARTED|Overall Study||26||
48503345|NCT00474188|101567996|FG000|COMPLETED|Overall Study||20||
48503346|NCT00474188|101567996|FG000|NOT COMPLETED|Overall Study||6||
48503347|NCT04795245|101567997|FG000|STARTED|Overall Study||805||
48503348|NCT04795245|101567997|FG000|COMPLETED|Overall Study||85|Participants still on afatinib treatment at end of observation period.|
48061977|NCT04416633|100472939|FG000|STARTED|Overall Study||100||
48061978|NCT04416633|100472939|FG000|COMPLETED|Overall Study||69||
48061979|NCT04416633|100472939|FG000|NOT COMPLETED|Overall Study||31||
48061980|NCT00736957|100472940|FG000|STARTED|Overall Study||219||
48061981|NCT00736957|100472940|FG000|Treated|Overall Study||190||
48503349|NCT04795245|101567997|FG000|NOT COMPLETED|Overall Study||720||
48503350|NCT03255980|101567998|FG000|STARTED|Overall Study||20||
48503351|NCT03255980|101567999|FG001|STARTED|Overall Study||20||
48503352|NCT03255980|101568000|FG002|STARTED|Overall Study||20||
48503353|NCT03255980|101568001|FG003|STARTED|Overall Study||20||
48503354|NCT03255980|101567998|FG000|COMPLETED|Overall Study||17||
48503355|NCT03255980|101567999|FG001|COMPLETED|Overall Study||12||
48503356|NCT03255980|101568000|FG002|COMPLETED|Overall Study||14||
48503357|NCT03255980|101568001|FG003|COMPLETED|Overall Study||8||
48503358|NCT03255980|101567998|FG000|NOT COMPLETED|Overall Study||3||
48503359|NCT03255980|101567999|FG001|NOT COMPLETED|Overall Study||8||
48503360|NCT03255980|101568000|FG002|NOT COMPLETED|Overall Study||6||
48503361|NCT03255980|101568001|FG003|NOT COMPLETED|Overall Study||12||
48503362|NCT02451696|101568002|FG000|STARTED|Overall Study||5||
48503363|NCT02451696|101568003|FG001|STARTED|Overall Study||10||
48503364|NCT02451696|101568002|FG000|COMPLETED|Overall Study||4||
48503365|NCT02451696|101568003|FG001|COMPLETED|Overall Study||10||
48503366|NCT02451696|101568002|FG000|NOT COMPLETED|Overall Study||1||
48503367|NCT02451696|101568003|FG001|NOT COMPLETED|Overall Study||0||
48503368|NCT00113919|101568004|FG000|STARTED|Overall Study||14||
48503369|NCT00113919|101568004|FG000|COMPLETED|Overall Study||0||
48503370|NCT00113919|101568004|FG000|NOT COMPLETED|Overall Study||14||
48503371|NCT01450800|101568005|FG000|STARTED|Overall Study||82||
48503372|NCT01450800|101568006|FG001|STARTED|Overall Study||81||
48503373|NCT01450800|101568005|FG000|COMPLETED|Overall Study||81||
48503374|NCT01450800|101568006|FG001|COMPLETED|Overall Study||78||
48503375|NCT01450800|101568005|FG000|NOT COMPLETED|Overall Study||1||
48503376|NCT01450800|101568006|FG001|NOT COMPLETED|Overall Study||3||
48503377|NCT00325780|101568007|FG000|STARTED|Overall Study||1355||
48503378|NCT00325780|101568007|FG000|Safety Population|Overall Study||1353||
48503379|NCT00325780|101568007|FG000|COMPLETED|Overall Study||1200||
48503380|NCT00325780|101568007|FG000|NOT COMPLETED|Overall Study||155||
48503381|NCT01981044|101568008|FG000|STARTED|Overall Study||1||
48503382|NCT01981044|101568008|FG000|COMPLETED|Overall Study||1||
48503383|NCT01981044|101568008|FG000|NOT COMPLETED|Overall Study||0||
48503384|NCT00897676|101568009|FG000|STARTED|Intervention 1(6 Hours)||9||
48503385|NCT00897676|101568010|FG001|STARTED|Intervention 1(6 Hours)||7||
48503386|NCT00897676|101568009|FG000|COMPLETED|Intervention 1(6 Hours)||9||
48503387|NCT00897676|101568010|FG001|COMPLETED|Intervention 1(6 Hours)||7||
48503388|NCT00897676|101568009|FG000|NOT COMPLETED|Intervention 1(6 Hours)||0||
48503389|NCT00897676|101568010|FG001|NOT COMPLETED|Intervention 1(6 Hours)||0||
48503390|NCT00897676|101568009|FG000|STARTED|Intervention 2(6 Hours)||9||
48503391|NCT00897676|101568010|FG001|STARTED|Intervention 2(6 Hours)||7||
48503392|NCT00897676|101568009|FG000|COMPLETED|Intervention 2(6 Hours)||9||
48503393|NCT00897676|101568010|FG001|COMPLETED|Intervention 2(6 Hours)||7||
48503394|NCT00897676|101568009|FG000|NOT COMPLETED|Intervention 2(6 Hours)||0||
48503395|NCT00897676|101568010|FG001|NOT COMPLETED|Intervention 2(6 Hours)||0||
48503396|NCT01435928|101568011|FG000|STARTED|Open Label Phase - up to 24 Weeks||676||
48503397|NCT01435928|101568012|FG001|STARTED|Open Label Phase - up to 24 Weeks||0||
48503398|NCT01435928|101568013|FG002|STARTED|Open Label Phase - up to 24 Weeks||0||
48503399|NCT01435928|101568011|FG000|COMPLETED|Open Label Phase - up to 24 Weeks||287||
48503400|NCT01435928|101568012|FG001|COMPLETED|Open Label Phase - up to 24 Weeks||0||
48503401|NCT01435928|101568013|FG002|COMPLETED|Open Label Phase - up to 24 Weeks||0||
48503402|NCT01435928|101568011|FG000|NOT COMPLETED|Open Label Phase - up to 24 Weeks||389||
48503403|NCT01435928|101568012|FG001|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0||
48503404|NCT01435928|101568013|FG002|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0||
48503405|NCT01435928|101568011|FG000|STARTED|Double Blind Phase - 28 Weeks||0||
48503406|NCT01435928|101568012|FG001|STARTED|Double Blind Phase - 28 Weeks||144||
48503407|NCT01435928|101568013|FG002|STARTED|Double Blind Phase - 28 Weeks||141||
48503408|NCT01435928|101568011|FG000|COMPLETED|Double Blind Phase - 28 Weeks||0||
48503409|NCT01435928|101568012|FG001|COMPLETED|Double Blind Phase - 28 Weeks||28||
48503410|NCT01435928|101568013|FG002|COMPLETED|Double Blind Phase - 28 Weeks||20||
48503411|NCT01435928|101568011|FG000|NOT COMPLETED|Double Blind Phase - 28 Weeks||0||
48503412|NCT01435928|101568012|FG001|NOT COMPLETED|Double Blind Phase - 28 Weeks||116||
48503413|NCT01435928|101568013|FG002|NOT COMPLETED|Double Blind Phase - 28 Weeks||121||
48503414|NCT03349632|101568014|FG000|STARTED|Period 1, First Week of Wear||11||
48503415|NCT03349632|101568015|FG001|STARTED|Period 1, First Week of Wear||11||
48503416|NCT03349632|101568016|FG002|STARTED|Period 1, First Week of Wear||11||
48503417|NCT03349632|101568017|FG003|STARTED|Period 1, First Week of Wear||11||
48503418|NCT03349632|101568018|FG004|STARTED|Period 1, First Week of Wear||11||
48503419|NCT03349632|101568019|FG005|STARTED|Period 1, First Week of Wear||11||
48503420|NCT03349632|101568014|FG000|COMPLETED|Period 1, First Week of Wear||11||
48503421|NCT03349632|101568015|FG001|COMPLETED|Period 1, First Week of Wear||11||
48503422|NCT03349632|101568016|FG002|COMPLETED|Period 1, First Week of Wear||11||
48503423|NCT03349632|101568017|FG003|COMPLETED|Period 1, First Week of Wear||11||
48503424|NCT03349632|101568018|FG004|COMPLETED|Period 1, First Week of Wear||11||
48503425|NCT03349632|101568019|FG005|COMPLETED|Period 1, First Week of Wear||11||
48503426|NCT03349632|101568014|FG000|NOT COMPLETED|Period 1, First Week of Wear||0||
48503427|NCT03349632|101568015|FG001|NOT COMPLETED|Period 1, First Week of Wear||0||
48503428|NCT03349632|101568016|FG002|NOT COMPLETED|Period 1, First Week of Wear||0||
48503429|NCT03349632|101568017|FG003|NOT COMPLETED|Period 1, First Week of Wear||0||
48503430|NCT03349632|101568018|FG004|NOT COMPLETED|Period 1, First Week of Wear||0||
48503431|NCT03349632|101568019|FG005|NOT COMPLETED|Period 1, First Week of Wear||0||
48503432|NCT03349632|101568014|FG000|STARTED|Period 2, Second Week of Wear||11||
48061982|NCT00736957|100472940|FG000|COMPLETED|Overall Study||97||
48061983|NCT00736957|100472940|FG000|NOT COMPLETED|Overall Study||122||
48061984|NCT00725504|100472941|FG000|STARTED|Overall Study||71||
48061985|NCT00725504|100472941|FG000|COMPLETED|Overall Study||71||
48061986|NCT00725504|100472941|FG000|NOT COMPLETED|Overall Study||0||
48061987|NCT03516812|100472942|FG000|STARTED|Overall Study||36||
48061988|NCT03516812|100472942|FG000|COMPLETED|Overall Study||30||
48061989|NCT03516812|100472942|FG000|NOT COMPLETED|Overall Study||6||
48061990|NCT03366012|100472943|FG000|STARTED|Overall Study||51||
48061991|NCT03366012|100472943|FG000|COMPLETED|Overall Study||51||
48061992|NCT03366012|100472943|FG000|NOT COMPLETED|Overall Study||0||
48061993|NCT04697056|100472944|FG000|STARTED|Overall Study||4||
48061994|NCT04697056|100472945|FG001|STARTED|Overall Study||1||
48061995|NCT04697056|100472944|FG000|COMPLETED|Overall Study||0||
48061996|NCT04697056|100472945|FG001|COMPLETED|Overall Study||0||
48061997|NCT04697056|100472944|FG000|NOT COMPLETED|Overall Study||4||
48061998|NCT04697056|100472945|FG001|NOT COMPLETED|Overall Study||1||
48061999|NCT01642407|100472946|FG000|STARTED|Part 1 (Screening Till Week 16)||6||
48062000|NCT01642407|100472946|FG000|COMPLETED|Part 1 (Screening Till Week 16)||3||
48062001|NCT01642407|100472946|FG000|NOT COMPLETED|Part 1 (Screening Till Week 16)||3||
48062002|NCT01642407|100472946|FG000|STARTED|Part 2(Week17 to Maximum of 119.6 Weeks)||3||
48062003|NCT01642407|100472946|FG000|COMPLETED|Part 2(Week17 to Maximum of 119.6 Weeks)||1||
48062004|NCT01642407|100472946|FG000|NOT COMPLETED|Part 2(Week17 to Maximum of 119.6 Weeks)||2||
48062005|NCT00718302|100472947|FG000|STARTED|Overall Study||119||
48062006|NCT00718302|100472948|FG001|STARTED|Overall Study||114||
48062007|NCT00718302|100472947|FG000|COMPLETED|Overall Study||119||
48062008|NCT00718302|100472948|FG001|COMPLETED|Overall Study||114||
48062009|NCT00718302|100472947|FG000|NOT COMPLETED|Overall Study||0||
48062010|NCT00718302|100472948|FG001|NOT COMPLETED|Overall Study||0||
48062011|NCT01066000|100472949|FG000|STARTED|Overall Study||33||
48062012|NCT01066000|100472949|FG000|COMPLETED|Overall Study||24||
48062013|NCT01066000|100472949|FG000|NOT COMPLETED|Overall Study||9||
48062014|NCT00763048|100472950|FG000|STARTED|Overall Study||21||
48062015|NCT00763048|100472951|FG001|STARTED|Overall Study||18||
48062016|NCT00763048|100472950|FG000|COMPLETED|Overall Study||21||
48062017|NCT00763048|100472951|FG001|COMPLETED|Overall Study||18||
48062018|NCT00763048|100472950|FG000|NOT COMPLETED|Overall Study||0||
48062019|NCT00763048|100472951|FG001|NOT COMPLETED|Overall Study||0||
48062020|NCT02955797|100472952|FG000|STARTED|Overall Study||306||
48062021|NCT02955797|100472953|FG001|STARTED|Overall Study||306||
48062022|NCT02955797|100472954|FG002|STARTED|Overall Study||203||
48062023|NCT02955797|100472955|FG003|STARTED|Overall Study||103||
48062024|NCT02955797|100472952|FG000|Safety Analysis Set (SafAS)|Overall Study||303|SafAS:participants who received at least 1 dose of study vaccine(s) \& had any safety data available.|
48062025|NCT02955797|100472953|FG001|Safety Analysis Set (SafAS)|Overall Study||306|SafAS:participants who received at least 1 dose of study vaccine(s) \& had any safety data available.|
48062026|NCT02955797|100472954|FG002|Safety Analysis Set (SafAS)|Overall Study||203|SafAS:participants who received at least 1 dose of study vaccine(s) \& had any safety data available.|
48062027|NCT02955797|100472955|FG003|Safety Analysis Set (SafAS)|Overall Study||102|SafAS:participants who received at least 1 dose of study vaccine(s) \& had any safety data available.|
48062028|NCT02955797|100472952|FG000|Per Protocol Analysis Set (PPAS)|Overall Study||293|Who had at least 1 dose of vaccine, valid post-vaccination serology data with no protocol deviation.|
48062029|NCT02955797|100472953|FG001|Per Protocol Analysis Set (PPAS)|Overall Study||296|Who had at least 1 dose of vaccine, valid post-vaccination serology data with no protocol deviation.|
48062030|NCT02955797|100472954|FG002|Per Protocol Analysis Set (PPAS)|Overall Study||198|Who had at least 1 dose of vaccine, valid post-vaccination serology data with no protocol deviation.|
48062031|NCT02955797|100472955|FG003|Per Protocol Analysis Set (PPAS)|Overall Study||99|Who had at least 1 dose of vaccine, valid post-vaccination serology data with no protocol deviation.|
48062032|NCT02955797|100472952|FG000|COMPLETED|Overall Study||303||
48062033|NCT02955797|100472953|FG001|COMPLETED|Overall Study||303||
48062034|NCT02955797|100472954|FG002|COMPLETED|Overall Study||203||
48062035|NCT02955797|100472955|FG003|COMPLETED|Overall Study||101||
48062036|NCT02955797|100472952|FG000|NOT COMPLETED|Overall Study||3||
48062037|NCT02955797|100472953|FG001|NOT COMPLETED|Overall Study||3||
48062038|NCT02955797|100472954|FG002|NOT COMPLETED|Overall Study||0||
48062039|NCT02955797|100472955|FG003|NOT COMPLETED|Overall Study||2||
48062040|NCT04043728|100472956|FG000|STARTED|Overall Study||6||
48062041|NCT04043728|100472957|FG001|STARTED|Overall Study||6||
48062042|NCT04043728|100472958|FG002|STARTED|Overall Study||6||
48062043|NCT04043728|100472956|FG000|COMPLETED|Overall Study||5||
48062044|NCT04043728|100472957|FG001|COMPLETED|Overall Study||4||
48062045|NCT04043728|100472958|FG002|COMPLETED|Overall Study||6||
48062046|NCT04043728|100472956|FG000|NOT COMPLETED|Overall Study||1||
48062047|NCT04043728|100472957|FG001|NOT COMPLETED|Overall Study||2||
48062048|NCT04043728|100472958|FG002|NOT COMPLETED|Overall Study||0||
48062049|NCT05490771|100472959|FG000|STARTED|Overall Study||35||
48503433|NCT03349632|101568015|FG001|STARTED|Period 2, Second Week of Wear||11||
48503434|NCT03349632|101568016|FG002|STARTED|Period 2, Second Week of Wear||11||
48503435|NCT03349632|101568017|FG003|STARTED|Period 2, Second Week of Wear||11||
48503436|NCT03349632|101568018|FG004|STARTED|Period 2, Second Week of Wear||11||
48503437|NCT03349632|101568019|FG005|STARTED|Period 2, Second Week of Wear||11||
48503438|NCT03349632|101568014|FG000|COMPLETED|Period 2, Second Week of Wear||11||
48503439|NCT03349632|101568015|FG001|COMPLETED|Period 2, Second Week of Wear||11||
48503440|NCT03349632|101568016|FG002|COMPLETED|Period 2, Second Week of Wear||11||
48503441|NCT03349632|101568017|FG003|COMPLETED|Period 2, Second Week of Wear||11||
48503442|NCT03349632|101568018|FG004|COMPLETED|Period 2, Second Week of Wear||11||
48503443|NCT03349632|101568019|FG005|COMPLETED|Period 2, Second Week of Wear||11||
48503444|NCT03349632|101568014|FG000|NOT COMPLETED|Period 2, Second Week of Wear||0||
48503445|NCT03349632|101568015|FG001|NOT COMPLETED|Period 2, Second Week of Wear||0||
48503446|NCT03349632|101568016|FG002|NOT COMPLETED|Period 2, Second Week of Wear||0||
48503447|NCT03349632|101568017|FG003|NOT COMPLETED|Period 2, Second Week of Wear||0||
48503448|NCT03349632|101568018|FG004|NOT COMPLETED|Period 2, Second Week of Wear||0||
48503449|NCT03349632|101568019|FG005|NOT COMPLETED|Period 2, Second Week of Wear||0||
48503450|NCT01540045|101568020|FG000|STARTED|Overall Study||40||
48503451|NCT01540045|101568020|FG000|COMPLETED|Overall Study||40||
48503452|NCT01540045|101568020|FG000|NOT COMPLETED|Overall Study||0||
48503453|NCT03428945|101568021|FG000|STARTED|Overall Study||183||
48503454|NCT03428945|101568022|FG001|STARTED|Overall Study||90||
48503455|NCT03428945|101568021|FG000|COMPLETED|Overall Study||168||
48503456|NCT03428945|101568022|FG001|COMPLETED|Overall Study||77||
48503457|NCT03428945|101568021|FG000|NOT COMPLETED|Overall Study||15||
48503458|NCT03428945|101568022|FG001|NOT COMPLETED|Overall Study||13||
48503459|NCT04947150|101568023|FG000|STARTED|Overall Study||4||
48503460|NCT04947150|101568024|FG001|STARTED|Overall Study||7||
48503461|NCT04947150|101568025|FG002|STARTED|Overall Study||2||
48503462|NCT04947150|101568026|FG003|STARTED|Overall Study||2||
48503463|NCT04947150|101568027|FG004|STARTED|Overall Study||7||
48503464|NCT04947150|101568028|FG005|STARTED|Overall Study||2||
48503465|NCT04947150|101568029|FG006|STARTED|Overall Study||5||
48503466|NCT04947150|101568030|FG007|STARTED|Overall Study||2||
48503467|NCT04947150|101568031|FG008|STARTED|Overall Study||3||
48503468|NCT04947150|101568032|FG009|STARTED|Overall Study||5||
48503469|NCT04947150|101568033|FG010|STARTED|Overall Study||6||
48503470|NCT04947150|101568034|FG011|STARTED|Overall Study||2||
48503471|NCT04947150|101568035|FG012|STARTED|Overall Study||5||
48503472|NCT04947150|101568036|FG013|STARTED|Overall Study||2||
48503473|NCT04947150|101568037|FG014|STARTED|Overall Study||4||
48503474|NCT04947150|101568038|FG015|STARTED|Overall Study||4||
48503475|NCT04947150|101568023|FG000|Wave 1|Overall Study||2||
48503476|NCT04947150|101568024|FG001|Wave 1|Overall Study||2||
48503477|NCT04947150|101568025|FG002|Wave 1|Overall Study||1||
48503478|NCT04947150|101568026|FG003|Wave 1|Overall Study||2||
48503479|NCT04947150|101568027|FG004|Wave 1|Overall Study||2||
48503480|NCT04947150|101568028|FG005|Wave 1|Overall Study||2||
48503481|NCT04947150|101568029|FG006|Wave 1|Overall Study||2||
48503482|NCT04947150|101568030|FG007|Wave 1|Overall Study||1||
48503483|NCT04947150|101568031|FG008|Wave 1|Overall Study||2||
48503484|NCT04947150|101568032|FG009|Wave 1|Overall Study||2||
48503485|NCT04947150|101568033|FG010|Wave 1|Overall Study||2||
48503486|NCT04947150|101568034|FG011|Wave 1|Overall Study||1||
48503487|NCT04947150|101568035|FG012|Wave 1|Overall Study||2||
48503488|NCT04947150|101568036|FG013|Wave 1|Overall Study||1||
48503489|NCT04947150|101568037|FG014|Wave 1|Overall Study||2||
48503490|NCT04947150|101568038|FG015|Wave 1|Overall Study||2||
48503491|NCT04947150|101568023|FG000|Wave 2|Overall Study||2||
48503492|NCT04947150|101568024|FG001|Wave 2|Overall Study||5||
48503493|NCT04947150|101568025|FG002|Wave 2|Overall Study||1||
48503494|NCT04947150|101568026|FG003|Wave 2|Overall Study||0||
48503495|NCT04947150|101568027|FG004|Wave 2|Overall Study||5||
48503496|NCT04947150|101568028|FG005|Wave 2|Overall Study||0||
48503497|NCT04947150|101568029|FG006|Wave 2|Overall Study||3||
48503498|NCT04947150|101568030|FG007|Wave 2|Overall Study||1||
48503499|NCT04947150|101568031|FG008|Wave 2|Overall Study||1||
48503500|NCT04947150|101568032|FG009|Wave 2|Overall Study||3||
48503501|NCT04947150|101568033|FG010|Wave 2|Overall Study||4||
48503502|NCT04947150|101568034|FG011|Wave 2|Overall Study||1||
48503503|NCT04947150|101568035|FG012|Wave 2|Overall Study||3||
48503504|NCT04947150|101568036|FG013|Wave 2|Overall Study||1||
48503505|NCT04947150|101568037|FG014|Wave 2|Overall Study||2||
48503506|NCT04947150|101568038|FG015|Wave 2|Overall Study||2||
48503507|NCT04947150|101568023|FG000|COMPLETED|Overall Study||4||
48503508|NCT04947150|101568024|FG001|COMPLETED|Overall Study||7||
48503509|NCT04947150|101568025|FG002|COMPLETED|Overall Study||1||
48503510|NCT04947150|101568026|FG003|COMPLETED|Overall Study||2||
48503511|NCT04947150|101568027|FG004|COMPLETED|Overall Study||7||
48503512|NCT04947150|101568028|FG005|COMPLETED|Overall Study||0||
48503513|NCT04947150|101568029|FG006|COMPLETED|Overall Study||4||
48503514|NCT04947150|101568030|FG007|COMPLETED|Overall Study||2||
48503515|NCT04947150|101568031|FG008|COMPLETED|Overall Study||3||
48503516|NCT04947150|101568032|FG009|COMPLETED|Overall Study||5||
48503517|NCT04947150|101568033|FG010|COMPLETED|Overall Study||5||
48503518|NCT04947150|101568034|FG011|COMPLETED|Overall Study||1||
48503519|NCT04947150|101568035|FG012|COMPLETED|Overall Study||5||
48503520|NCT04947150|101568036|FG013|COMPLETED|Overall Study||1||
48503521|NCT04947150|101568037|FG014|COMPLETED|Overall Study||4||
48503522|NCT04947150|101568038|FG015|COMPLETED|Overall Study||4||
48503523|NCT04947150|101568023|FG000|NOT COMPLETED|Overall Study||0||
48503524|NCT04947150|101568024|FG001|NOT COMPLETED|Overall Study||0||
48503525|NCT04947150|101568025|FG002|NOT COMPLETED|Overall Study||1||
48503526|NCT04947150|101568026|FG003|NOT COMPLETED|Overall Study||0||
48503527|NCT04947150|101568027|FG004|NOT COMPLETED|Overall Study||0||
48503528|NCT04947150|101568028|FG005|NOT COMPLETED|Overall Study||2||
48503529|NCT04947150|101568029|FG006|NOT COMPLETED|Overall Study||1||
48503530|NCT04947150|101568030|FG007|NOT COMPLETED|Overall Study||0||
48503531|NCT04947150|101568031|FG008|NOT COMPLETED|Overall Study||0||
48503532|NCT04947150|101568032|FG009|NOT COMPLETED|Overall Study||0||
48503533|NCT04947150|101568033|FG010|NOT COMPLETED|Overall Study||1||
48503534|NCT04947150|101568034|FG011|NOT COMPLETED|Overall Study||1||
48503535|NCT04947150|101568035|FG012|NOT COMPLETED|Overall Study||0||
48503536|NCT04947150|101568036|FG013|NOT COMPLETED|Overall Study||1||
48503537|NCT04947150|101568037|FG014|NOT COMPLETED|Overall Study||0||
48503538|NCT04947150|101568038|FG015|NOT COMPLETED|Overall Study||0||
48503539|NCT02805517|101568039|FG000|STARTED|Overall Study||6||
48503540|NCT02805517|101568039|FG000|COMPLETED|Overall Study||6||
48503541|NCT02805517|101568039|FG000|NOT COMPLETED|Overall Study||0||
48503542|NCT02751424|101568040|FG000|STARTED|Part 1||6||
48503543|NCT02751424|101568041|FG001|STARTED|Part 1||6||
48503544|NCT02751424|101568042|FG002|STARTED|Part 1||6||
48503545|NCT02751424|101568043|FG003|STARTED|Part 1||6||
48503546|NCT02751424|101568044|FG004|STARTED|Part 1||6||
48503547|NCT02751424|101568045|FG005|STARTED|Part 1||6||
48503548|NCT02751424|101568046|FG006|STARTED|Part 1||12||
48503549|NCT02751424|101568047|FG007|STARTED|Part 1||0||
48503550|NCT02751424|101568048|FG008|STARTED|Part 1||0||
48503551|NCT02751424|101568040|FG000|COMPLETED|Part 1||6||
48503552|NCT02751424|101568041|FG001|COMPLETED|Part 1||6||
48503553|NCT02751424|101568042|FG002|COMPLETED|Part 1||6||
48503554|NCT02751424|101568043|FG003|COMPLETED|Part 1||6||
48503555|NCT02751424|101568044|FG004|COMPLETED|Part 1||6||
48503556|NCT02751424|101568045|FG005|COMPLETED|Part 1||6||
48503557|NCT02751424|101568046|FG006|COMPLETED|Part 1||12||
48503558|NCT02751424|101568047|FG007|COMPLETED|Part 1||0||
48503559|NCT02751424|101568048|FG008|COMPLETED|Part 1||0||
48503560|NCT02751424|101568040|FG000|NOT COMPLETED|Part 1||0||
48503561|NCT02751424|101568041|FG001|NOT COMPLETED|Part 1||0||
48503562|NCT02751424|101568042|FG002|NOT COMPLETED|Part 1||0||
48503563|NCT02751424|101568043|FG003|NOT COMPLETED|Part 1||0||
48503564|NCT02751424|101568044|FG004|NOT COMPLETED|Part 1||0||
48503565|NCT02751424|101568045|FG005|NOT COMPLETED|Part 1||0||
48062050|NCT05490771|100472959|FG000|Eligible|Overall Study||31||
48062051|NCT05490771|100472959|FG000|Started Protocol Therapy|Overall Study||30||
48062052|NCT05490771|100472959|FG000|Eligible and Treated|Overall Study||28||
48062053|NCT05490771|100472959|FG000|Mutation Status Confirmed|Overall Study||30||
48062054|NCT05490771|100472959|FG000|Eligible, Treated and Mutation Status Confirmed|Overall Study||25||
48062055|NCT05490771|100472959|FG000|COMPLETED|Overall Study||0||
48062056|NCT05490771|100472959|FG000|NOT COMPLETED|Overall Study||35||
48503566|NCT02751424|101568046|FG006|NOT COMPLETED|Part 1||0||
48503567|NCT02751424|101568047|FG007|NOT COMPLETED|Part 1||0||
48503568|NCT02751424|101568048|FG008|NOT COMPLETED|Part 1||0||
48503569|NCT02751424|101568040|FG000|STARTED|Part 2||0||
48503570|NCT02751424|101568041|FG001|STARTED|Part 2||0||
48503571|NCT02751424|101568042|FG002|STARTED|Part 2||0||
48503572|NCT02751424|101568043|FG003|STARTED|Part 2||0||
48503573|NCT02751424|101568044|FG004|STARTED|Part 2||0||
48503574|NCT02751424|101568045|FG005|STARTED|Part 2||0||
48503575|NCT02751424|101568046|FG006|STARTED|Part 2||0||
48503576|NCT02751424|101568047|FG007|STARTED|Part 2||11||
48503577|NCT02751424|101568048|FG008|STARTED|Part 2||3||
48503578|NCT02751424|101568040|FG000|COMPLETED|Part 2||0||
48503579|NCT02751424|101568041|FG001|COMPLETED|Part 2||0||
48503580|NCT02751424|101568042|FG002|COMPLETED|Part 2||0||
48503581|NCT02751424|101568043|FG003|COMPLETED|Part 2||0||
48503582|NCT02751424|101568044|FG004|COMPLETED|Part 2||0||
48503583|NCT02751424|101568045|FG005|COMPLETED|Part 2||0||
48503584|NCT02751424|101568046|FG006|COMPLETED|Part 2||0||
48503585|NCT02751424|101568047|FG007|COMPLETED|Part 2||6||
48503586|NCT02751424|101568048|FG008|COMPLETED|Part 2||3||
48503587|NCT02751424|101568040|FG000|NOT COMPLETED|Part 2||0||
48503588|NCT02751424|101568041|FG001|NOT COMPLETED|Part 2||0||
48503589|NCT02751424|101568042|FG002|NOT COMPLETED|Part 2||0||
48503590|NCT02751424|101568043|FG003|NOT COMPLETED|Part 2||0||
48503591|NCT02751424|101568044|FG004|NOT COMPLETED|Part 2||0||
48503592|NCT02751424|101568045|FG005|NOT COMPLETED|Part 2||0||
48503593|NCT02751424|101568046|FG006|NOT COMPLETED|Part 2||0||
48503594|NCT02751424|101568047|FG007|NOT COMPLETED|Part 2||5||
48503595|NCT02751424|101568048|FG008|NOT COMPLETED|Part 2||0||
48503596|NCT02986139|101568049|FG000|STARTED|Overall Study||56||
48503597|NCT02986139|101568050|FG001|STARTED|Overall Study||55||
48503598|NCT02986139|101568049|FG000|Received Etanercept|Overall Study||56||
48503599|NCT02986139|101568050|FG001|Received Etanercept|Overall Study||53||
48503600|NCT02986139|101568049|FG000|COMPLETED|Overall Study||55||
48503601|NCT02986139|101568050|FG001|COMPLETED|Overall Study||51||
48503602|NCT02986139|101568049|FG000|NOT COMPLETED|Overall Study||1||
48503603|NCT02986139|101568050|FG001|NOT COMPLETED|Overall Study||4||
48503604|NCT00982228|101568051|FG000|STARTED|Main: Week 0 to 52 (NN1250-3583)||472||
48503605|NCT00982228|101568052|FG001|STARTED|Main: Week 0 to 52 (NN1250-3583)||157||
48503606|NCT00982228|101568051|FG000|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||472||
48503607|NCT00982228|101568052|FG001|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||157||
48503608|NCT00982228|101568051|FG000|Exposed|Main: Week 0 to 52 (NN1250-3583)||472||
48503609|NCT00982228|101568052|FG001|Exposed|Main: Week 0 to 52 (NN1250-3583)||154||
48503610|NCT00982228|101568051|FG000|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||404||
48503611|NCT00982228|101568052|FG001|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||137||
48503612|NCT00982228|101568051|FG000|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||68||
48503613|NCT00982228|101568052|FG001|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||20||
48503614|NCT00982228|101568051|FG000|STARTED|Extension: Week 53 to 104 (NN1250-3644)||351||
48503615|NCT00982228|101568052|FG001|STARTED|Extension: Week 53 to 104 (NN1250-3644)||118||
48503616|NCT00982228|101568051|FG000|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||330||
48503617|NCT00982228|101568052|FG001|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||113||
48503618|NCT00982228|101568051|FG000|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||21||
48503619|NCT00982228|101568052|FG001|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||5||
48503620|NCT02229084|101568053|FG000|STARTED|Overall Study||5||
48503621|NCT02229084|101568054|FG001|STARTED|Overall Study||5||
48503622|NCT02229084|101568055|FG002|STARTED|Overall Study||5||
48503623|NCT02229084|101568056|FG003|STARTED|Overall Study||5||
48503624|NCT02229084|101568057|FG004|STARTED|Overall Study||5||
48503625|NCT02229084|101568058|FG005|STARTED|Overall Study||19||
48503626|NCT02229084|101568059|FG006|STARTED|Overall Study||14||
48503627|NCT02229084|101568053|FG000|COMPLETED|Overall Study||4||
48503628|NCT02229084|101568054|FG001|COMPLETED|Overall Study||5||
48503629|NCT02229084|101568055|FG002|COMPLETED|Overall Study||3||
48503630|NCT02229084|101568056|FG003|COMPLETED|Overall Study||3||
48503631|NCT02229084|101568057|FG004|COMPLETED|Overall Study||1||
48503632|NCT02229084|101568058|FG005|COMPLETED|Overall Study||18||
48503633|NCT02229084|101568059|FG006|COMPLETED|Overall Study||10||
48503634|NCT02229084|101568053|FG000|NOT COMPLETED|Overall Study||1||
48503635|NCT02229084|101568054|FG001|NOT COMPLETED|Overall Study||0||
48503636|NCT02229084|101568055|FG002|NOT COMPLETED|Overall Study||2||
48503637|NCT02229084|101568056|FG003|NOT COMPLETED|Overall Study||2||
48503638|NCT02229084|101568057|FG004|NOT COMPLETED|Overall Study||4||
48503639|NCT02229084|101568058|FG005|NOT COMPLETED|Overall Study||1||
48503640|NCT02229084|101568059|FG006|NOT COMPLETED|Overall Study||4||
48503641|NCT01717040|101568060|FG000|STARTED|Overall Study||17||
48503642|NCT01717040|101568061|FG001|STARTED|Overall Study||20||
48503643|NCT01717040|101568060|FG000|COMPLETED|Overall Study||12||
48503644|NCT01717040|101568061|FG001|COMPLETED|Overall Study||15||
48503645|NCT01717040|101568060|FG000|NOT COMPLETED|Overall Study||5||
48503646|NCT01717040|101568061|FG001|NOT COMPLETED|Overall Study||5||
48503647|NCT04254809|101568062|FG000|STARTED|Overall Study||48||
48503648|NCT04254809|101568063|FG001|STARTED|Overall Study||48||
48503649|NCT04254809|101568062|FG000|COMPLETED|Overall Study||43||
48503650|NCT04254809|101568063|FG001|COMPLETED|Overall Study||38||
48503651|NCT04254809|101568062|FG000|NOT COMPLETED|Overall Study||5||
48503652|NCT04254809|101568063|FG001|NOT COMPLETED|Overall Study||10||
48503653|NCT01608906|101568064|FG000|STARTED|Overall Study||152||
48503654|NCT01608906|101568064|FG000|COMPLETED|Overall Study||113||
48503655|NCT01608906|101568064|FG000|NOT COMPLETED|Overall Study||39||
48503656|NCT00659815|101568065|FG000|STARTED|Overall Study||157||
48503657|NCT00659815|101568066|FG001|STARTED|Overall Study||151||
48503658|NCT00659815|101568065|FG000|COMPLETED|Overall Study||153||
48503659|NCT00659815|101568066|FG001|COMPLETED|Overall Study||147||
48503660|NCT00659815|101568065|FG000|NOT COMPLETED|Overall Study||4||
48503661|NCT00659815|101568066|FG001|NOT COMPLETED|Overall Study||4||
48503662|NCT01181596|101568067|FG000|STARTED|Overall Study||31||
48503663|NCT01181596|101568067|FG000|COMPLETED|Overall Study||31||
48503664|NCT01181596|101568067|FG000|NOT COMPLETED|Overall Study||0||
48503665|NCT00089973|101568068|FG000|STARTED|Overall Study||50||
48503666|NCT00089973|101568068|FG000|COMPLETED|Overall Study||0||
48503667|NCT00089973|101568068|FG000|NOT COMPLETED|Overall Study||50||
48503668|NCT00645944|101568069|FG000|STARTED|Randomized||20||
48503669|NCT00645944|101568070|FG001|STARTED|Randomized||19||
48503670|NCT00645944|101568069|FG000|COMPLETED|Randomized||19||
48503671|NCT00645944|101568070|FG001|COMPLETED|Randomized||17||
48503672|NCT00645944|101568069|FG000|NOT COMPLETED|Randomized||1||
48503673|NCT00645944|101568070|FG001|NOT COMPLETED|Randomized||2||
48218509|NCT01426412|100860319|FG005|COMPLETED|Overall Study||6||
48503674|NCT00645944|101568069|FG000|STARTED|Received Medication||19||
48503675|NCT00645944|101568070|FG001|STARTED|Received Medication||17||
48503676|NCT00645944|101568069|FG000|COMPLETED|Received Medication||13||
48218510|NCT01426412|100860320|FG006|COMPLETED|Overall Study||6||
48503677|NCT00645944|101568070|FG001|COMPLETED|Received Medication||14||
48503678|NCT00645944|101568069|FG000|NOT COMPLETED|Received Medication||6||
48666761|NCT03391882|101970466|FG001|STARTED|Post Part A / Pre Part B||3||
48503679|NCT00645944|101568070|FG001|NOT COMPLETED|Received Medication||3||
48503680|NCT04194008|101568071|FG000|STARTED|Baseline (Run-in) Phase||126||
48503681|NCT04194008|101568071|FG000|COMPLETED|Baseline (Run-in) Phase||99||
48503682|NCT04194008|101568071|FG000|NOT COMPLETED|Baseline (Run-in) Phase||27||
48503683|NCT04194008|101568071|FG000|STARTED|Treatment Phase With Nerivio||99||
48503684|NCT04194008|101568071|FG000|COMPLETED|Treatment Phase With Nerivio||91||
48503685|NCT04194008|101568071|FG000|NOT COMPLETED|Treatment Phase With Nerivio||8||
48503686|NCT02418754|101568072|FG000|STARTED|Period 1 (Day 1 to Week 12)||103|Safety Analysis Set (SAF): all initially randomized participants who received any study drug|103
48503687|NCT02418754|101568073|FG001|STARTED|Period 1 (Day 1 to Week 12)||200|Safety Analysis Set (SAF): all initially randomized participants who received any study drug|200
48503688|NCT02418754|101568074|FG002|STARTED|Period 1 (Day 1 to Week 12)||202|Safety Analysis Set (SAF): all initially randomized participants who received any study drug|202
48503689|NCT02418754|101568075|FG003|STARTED|Period 1 (Day 1 to Week 12)||0|Safety Analysis Set (SAF): all initially randomized participants who received any study drug|0
48503690|NCT02418754|101568076|FG004|STARTED|Period 1 (Day 1 to Week 12)||0|Safety Analysis Set (SAF): all initially randomized participants who received any study drug|0
48503691|NCT02418754|101568072|FG000|COMPLETED|Period 1 (Day 1 to Week 12)||101|Completed week 12 in the SAF|101
48503692|NCT02418754|101568073|FG001|COMPLETED|Period 1 (Day 1 to Week 12)||196|Completed week 12 in the SAF|196
48503693|NCT02418754|101568074|FG002|COMPLETED|Period 1 (Day 1 to Week 12)||200|Completed week 12 in the SAF|200
48503694|NCT02418754|101568075|FG003|COMPLETED|Period 1 (Day 1 to Week 12)||0|Completed week 12 in the SAF|0
48503695|NCT02418754|101568076|FG004|COMPLETED|Period 1 (Day 1 to Week 12)||0|Completed week 12 in the SAF|0
48503696|NCT02418754|101568072|FG000|NOT COMPLETED|Period 1 (Day 1 to Week 12)||2||2
48503697|NCT02418754|101568073|FG001|NOT COMPLETED|Period 1 (Day 1 to Week 12)||4||4
48503698|NCT02418754|101568074|FG002|NOT COMPLETED|Period 1 (Day 1 to Week 12)||2||2
48503699|NCT02418754|101568075|FG003|NOT COMPLETED|Period 1 (Day 1 to Week 12)||0||0
48503700|NCT02418754|101568076|FG004|NOT COMPLETED|Period 1 (Day 1 to Week 12)||0||0
48503701|NCT02418754|101568072|FG000|STARTED|Period 2 (Day 1 to Week 52/End of Study)||103|SAF (includes all initially randomized participants who received any study drug)|103
48503702|NCT02418754|101568073|FG001|STARTED|Period 2 (Day 1 to Week 52/End of Study)||106|SAF (includes all initially randomized participants who received any study drug)|106
48503703|NCT02418754|101568074|FG002|STARTED|Period 2 (Day 1 to Week 52/End of Study)||108|SAF (includes all initially randomized participants who received any study drug)|108
48503704|NCT02418754|101568075|FG003|STARTED|Period 2 (Day 1 to Week 52/End of Study)||94|SAF (includes all initially randomized participants who received any study drug)|94
48503705|NCT02418754|101568076|FG004|STARTED|Period 2 (Day 1 to Week 52/End of Study)||94|SAF (includes all initially randomized participants who received any study drug)|94
48503706|NCT02418754|101568072|FG000|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||70|Completed week 52 in the SAF|70
48503707|NCT02418754|101568073|FG001|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||64|Completed week 52 in the SAF|64
48503708|NCT02418754|101568074|FG002|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||71|Completed week 52 in the SAF|71
48503709|NCT02418754|101568075|FG003|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||67|Completed week 52 in the SAF|67
48503710|NCT02418754|101568076|FG004|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||67|Completed week 52 in the SAF|67
48503711|NCT02418754|101568072|FG000|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||33||33
48503712|NCT02418754|101568073|FG001|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||42||42
48503713|NCT02418754|101568074|FG002|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||37||37
48503714|NCT02418754|101568075|FG003|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||27||27
48503715|NCT02418754|101568076|FG004|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||27||27
48503716|NCT05889039|101568077|FG000|STARTED|Overall Study||12||
48503717|NCT05889039|101568078|FG001|STARTED|Overall Study||12||
48503718|NCT05889039|101568079|FG002|STARTED|Overall Study||10||
48503719|NCT05889039|101568080|FG003|STARTED|Overall Study||10||
48503720|NCT05889039|101568077|FG000|COMPLETED|Overall Study||8||
48503721|NCT05889039|101568078|FG001|COMPLETED|Overall Study||10||
48503722|NCT05889039|101568079|FG002|COMPLETED|Overall Study||10||
48503723|NCT05889039|101568080|FG003|COMPLETED|Overall Study||10||
48503724|NCT05889039|101568077|FG000|NOT COMPLETED|Overall Study||4||
48503725|NCT05889039|101568078|FG001|NOT COMPLETED|Overall Study||2||
48503726|NCT05889039|101568079|FG002|NOT COMPLETED|Overall Study||0||
48503727|NCT05889039|101568080|FG003|NOT COMPLETED|Overall Study||0||
48503728|NCT00890916|101568081|FG000|STARTED|"Rehab - Neuroprosthesis (NP) On"||10||
48503729|NCT00890916|101568081|FG000|"Grasp Release Pre-Test ON"|"Rehab - Neuroprosthesis (NP) On"||10|Grasp Release Pre-Test results - Neuroprosthesis turned on. See Peckham et al.,Arch PM\&R,2001|
48503730|NCT00890916|101568081|FG000|COMPLETED|"Rehab - Neuroprosthesis (NP) On"||10||
48503731|NCT00890916|101568081|FG000|NOT COMPLETED|"Rehab - Neuroprosthesis (NP) On"||0||
48503732|NCT00890916|101568081|FG000|STARTED|"Rehab - NP Off"||10||
48503733|NCT00890916|101568081|FG000|"Grasp Release Pre-Test OFF"|"Rehab - NP Off"||10||
48503734|NCT00890916|101568081|FG000|COMPLETED|"Rehab - NP Off"||10||
48503735|NCT00890916|101568081|FG000|NOT COMPLETED|"Rehab - NP Off"||0||
48503736|NCT05259852|101568082|FG000|STARTED|Overall Study||28||
48503737|NCT05259852|101568083|FG001|STARTED|Overall Study||27||
48503738|NCT05259852|101568082|FG000|COMPLETED|Overall Study||25||
48062057|NCT03078907|100472960|FG000|STARTED|Overall Study||53||
48062058|NCT03078907|100472961|FG001|STARTED|Overall Study||55||
48503739|NCT05259852|101568083|FG001|COMPLETED|Overall Study||19||
48503740|NCT05259852|101568082|FG000|NOT COMPLETED|Overall Study||3||
48503741|NCT05259852|101568083|FG001|NOT COMPLETED|Overall Study||8||
48503742|NCT00158925|101568084|FG000|STARTED|Overall Study||96||
48503743|NCT00158925|101568084|FG000|COMPLETED|Overall Study||84||
48503744|NCT00158925|101568084|FG000|NOT COMPLETED|Overall Study||12||
48503745|NCT00721955|101568085|FG000|STARTED|Overall Study||105||
48503746|NCT00721955|101568086|FG001|STARTED|Overall Study||104||
48503747|NCT00721955|101568087|FG002|STARTED|Overall Study||105||
48503748|NCT00721955|101568085|FG000|COMPLETED|Overall Study||105||
48503749|NCT00721955|101568086|FG001|COMPLETED|Overall Study||104||
48503750|NCT00721955|101568087|FG002|COMPLETED|Overall Study||103||
48503751|NCT00721955|101568085|FG000|NOT COMPLETED|Overall Study||0||
48503752|NCT00721955|101568086|FG001|NOT COMPLETED|Overall Study||0||
48503753|NCT00721955|101568087|FG002|NOT COMPLETED|Overall Study||2||
48503754|NCT01160640|101568088|FG000|STARTED|Overall Study||117||
48503755|NCT01160640|101568089|FG001|STARTED|Overall Study||116||
48503756|NCT01160640|101568088|FG000|COMPLETED|Overall Study||113||
48503757|NCT01160640|101568089|FG001|COMPLETED|Overall Study||110||
48503758|NCT01160640|101568088|FG000|NOT COMPLETED|Overall Study||4||
48503759|NCT01160640|101568089|FG001|NOT COMPLETED|Overall Study||6||
48503760|NCT01710358|101568090|FG000|STARTED|Treatment Period Part A (Weeks 0 to 24)||489||
48503761|NCT01710358|101568091|FG001|STARTED|Treatment Period Part A (Weeks 0 to 24)||488||
48503762|NCT01710358|101568092|FG002|STARTED|Treatment Period Part A (Weeks 0 to 24)||330||
48503763|NCT01710358|101568090|FG000|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||488||
48503764|NCT01710358|101568091|FG001|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||487||
48503765|NCT01710358|101568092|FG002|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||330||
48503766|NCT01710358|101568090|FG000|Rescued|Treatment Period Part A (Weeks 0 to 24)||128||
48503767|NCT01710358|101568091|FG001|Rescued|Treatment Period Part A (Weeks 0 to 24)||35||
48503768|NCT01710358|101568092|FG002|Rescued|Treatment Period Part A (Weeks 0 to 24)||40||
48503769|NCT01710358|101568090|FG000|COMPLETED|Treatment Period Part A (Weeks 0 to 24)||438||
48503770|NCT01710358|101568091|FG001|COMPLETED|Treatment Period Part A (Weeks 0 to 24)||459||
48503771|NCT01710358|101568092|FG002|COMPLETED|Treatment Period Part A (Weeks 0 to 24)||307||
48503772|NCT01710358|101568090|FG000|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||51||
48503773|NCT01710358|101568091|FG001|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||29||
48503774|NCT01710358|101568092|FG002|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||23||
48503775|NCT01710358|101568090|FG000|STARTED|Treatment Period Part B (Weeks 24 to 52)||310||
48503776|NCT01710358|101568091|FG001|STARTED|Treatment Period Part B (Weeks 24 to 52)||424||
48503777|NCT01710358|101568092|FG002|STARTED|Treatment Period Part B (Weeks 24 to 52)||267||
48503778|NCT01710358|101568090|FG000|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||306||
48503779|NCT01710358|101568091|FG001|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||424||
48503780|NCT01710358|101568092|FG002|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||267||
48503781|NCT01710358|101568090|FG000|Rescued|Treatment Period Part B (Weeks 24 to 52)||5||
48503782|NCT01710358|101568091|FG001|Rescued|Treatment Period Part B (Weeks 24 to 52)||8||
48503783|NCT01710358|101568092|FG002|Rescued|Treatment Period Part B (Weeks 24 to 52)||11||
48503784|NCT01710358|101568090|FG000|COMPLETED|Treatment Period Part B (Weeks 24 to 52)||294||
48503785|NCT01710358|101568091|FG001|COMPLETED|Treatment Period Part B (Weeks 24 to 52)||402||
48503786|NCT01710358|101568092|FG002|COMPLETED|Treatment Period Part B (Weeks 24 to 52)||252||
48503787|NCT01710358|101568090|FG000|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||16||
48503788|NCT01710358|101568091|FG001|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||22||
48503789|NCT01710358|101568092|FG002|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||15||
48503790|NCT01710358|101568090|FG000|STARTED|Rescue Period||0||
48503791|NCT01710358|101568091|FG001|STARTED|Rescue Period||227||
48503792|NCT01710358|101568092|FG002|STARTED|Rescue Period||0||
48503793|NCT01710358|101568090|FG000|COMPLETED|Rescue Period||0||
48503794|NCT01710358|101568091|FG001|COMPLETED|Rescue Period||196||
48503795|NCT01710358|101568092|FG002|COMPLETED|Rescue Period||0||
48503796|NCT01710358|101568090|FG000|NOT COMPLETED|Rescue Period||0||
48503797|NCT01710358|101568091|FG001|NOT COMPLETED|Rescue Period||31||
48503798|NCT01710358|101568092|FG002|NOT COMPLETED|Rescue Period||0||
48503799|NCT01710358|101568090|FG000|STARTED|Follow-up Period||33||
48503800|NCT01710358|101568091|FG001|STARTED|Follow-up Period||76||
48503801|NCT01710358|101568092|FG002|STARTED|Follow-up Period||20||
48503802|NCT01710358|101568090|FG000|COMPLETED|Follow-up Period||33||
48503803|NCT01710358|101568091|FG001|COMPLETED|Follow-up Period||76||
48503804|NCT01710358|101568092|FG002|COMPLETED|Follow-up Period||20||
48503805|NCT01710358|101568090|FG000|NOT COMPLETED|Follow-up Period||0||
48503806|NCT01710358|101568091|FG001|NOT COMPLETED|Follow-up Period||0||
48503807|NCT01710358|101568092|FG002|NOT COMPLETED|Follow-up Period||0||
48503808|NCT01095887|101568093|FG000|STARTED|Overall Study||6||
48503809|NCT01095887|101568093|FG000|COMPLETED|Overall Study||6||
48503810|NCT01095887|101568093|FG000|NOT COMPLETED|Overall Study||0||
48503811|NCT00530348|101568094|FG000|STARTED|Overall Study||195||
48503812|NCT00530348|101568095|FG001|STARTED|Overall Study||386||
48503813|NCT00530348|101568094|FG000|Treated|Overall Study||187||
48503814|NCT00530348|101568095|FG001|Treated|Overall Study||376||
48503815|NCT00530348|101568094|FG000|COMPLETED|Overall Study||173||
48503816|NCT00530348|101568095|FG001|COMPLETED|Overall Study||367||
48503817|NCT00530348|101568094|FG000|NOT COMPLETED|Overall Study||22||
48503818|NCT00530348|101568095|FG001|NOT COMPLETED|Overall Study||19||
48503819|NCT03390257|101568096|FG000|STARTED|Overall Study||14||
48503820|NCT03390257|101568096|FG000|COMPLETED|Overall Study||14||
48503821|NCT03390257|101568096|FG000|NOT COMPLETED|Overall Study||0||
48503822|NCT04142658|101568097|FG000|STARTED|Overall Study||433||
48503823|NCT04142658|101568098|FG001|STARTED|Overall Study||430||
48503824|NCT04142658|101568097|FG000|COMPLETED|Overall Study||418||
48503825|NCT04142658|101568098|FG001|COMPLETED|Overall Study||400||
48503826|NCT04142658|101568097|FG000|NOT COMPLETED|Overall Study||15||
48503827|NCT04142658|101568098|FG001|NOT COMPLETED|Overall Study||30||
48503828|NCT05068661|101568099|FG000|STARTED|Overall Study||49||
48503829|NCT05068661|101568100|FG001|STARTED|Overall Study||52||
48503830|NCT05068661|101568099|FG000|COMPLETED|Overall Study||48||
48503831|NCT05068661|101568100|FG001|COMPLETED|Overall Study||52||
48503832|NCT05068661|101568099|FG000|NOT COMPLETED|Overall Study||1||
48503833|NCT05068661|101568100|FG001|NOT COMPLETED|Overall Study||0||
48503834|NCT03727139|101568101|FG000|STARTED|Overall Study||1021||
48503835|NCT03727139|101568101|FG000|COMPLETED|Overall Study||961||
48503836|NCT03727139|101568101|FG000|NOT COMPLETED|Overall Study||60||
48503837|NCT02435433|101568102|FG000|STARTED|Overall Study||197||
48503838|NCT02435433|101568103|FG001|STARTED|Overall Study||95||
48503839|NCT02435433|101568104|FG002|STARTED|Overall Study||47||
48503840|NCT02435433|101568105|FG003|STARTED|Overall Study||39||
48503841|NCT02435433|101568106|FG004|STARTED|Overall Study||21||
48503842|NCT02435433|101568102|FG000|Participants Who Received Study Drug|Overall Study||197||
48503843|NCT02435433|101568103|FG001|Participants Who Received Study Drug|Overall Study||95||
48503844|NCT02435433|101568104|FG002|Participants Who Received Study Drug|Overall Study||47||
48503845|NCT02435433|101568105|FG003|Participants Who Received Study Drug|Overall Study||39||
48503846|NCT02435433|101568106|FG004|Participants Who Received Study Drug|Overall Study||21||
48503847|NCT02435433|101568102|FG000|COMPLETED|Overall Study||193|Completers include participants who had died due to any cause or alive and on study at the end of study, but off treatment.|
48503848|NCT02435433|101568103|FG001|COMPLETED|Overall Study||90|Completers include participants who had died due to any cause or alive and on study at the end of study, but off treatment.|
48503849|NCT02435433|101568104|FG002|COMPLETED|Overall Study||42|Completers include participants who had died due to any cause or alive and on study at the end of study, but off treatment.|
48503850|NCT02435433|101568105|FG003|COMPLETED|Overall Study||38|Completers include participants who had died due to any cause or alive and on study at the end of study, but off treatment.|
48503851|NCT02435433|101568106|FG004|COMPLETED|Overall Study||21|Completers include participants who had died due to any cause or alive and on study at the end of study, but off treatment.|
48503852|NCT02435433|101568102|FG000|NOT COMPLETED|Overall Study||4||
48503853|NCT02435433|101568103|FG001|NOT COMPLETED|Overall Study||5||
48503854|NCT02435433|101568104|FG002|NOT COMPLETED|Overall Study||5||
48503855|NCT02435433|101568105|FG003|NOT COMPLETED|Overall Study||1||
48503856|NCT02435433|101568106|FG004|NOT COMPLETED|Overall Study||0||
48503857|NCT00379353|101568107|FG000|STARTED|Overall Study||16||
48503858|NCT00379353|101568108|FG001|STARTED|Overall Study||15||
48503859|NCT00379353|101568107|FG000|COMPLETED|Overall Study||5||
48503860|NCT00379353|101568108|FG001|COMPLETED|Overall Study||9||
48503861|NCT00379353|101568107|FG000|NOT COMPLETED|Overall Study||11||
48503862|NCT00379353|101568108|FG001|NOT COMPLETED|Overall Study||6||
48503863|NCT01899053|101568109|FG000|STARTED|Overall Study||7||
48503864|NCT01899053|101568110|FG001|STARTED|Overall Study||3||
48503865|NCT01899053|101568111|FG002|STARTED|Overall Study||7||
48503866|NCT01899053|101568112|FG003|STARTED|Overall Study||3||
48503867|NCT01899053|101568113|FG004|STARTED|Overall Study||6||
48503868|NCT01899053|101568114|FG005|STARTED|Overall Study||3||
48503869|NCT01899053|101568115|FG006|STARTED|Overall Study||3||
48503870|NCT01899053|101568116|FG007|STARTED|Overall Study||3||
48503871|NCT01899053|101568117|FG008|STARTED|Overall Study||6||
48503872|NCT01899053|101568118|FG009|STARTED|Overall Study||3||
48503873|NCT01899053|101568119|FG010|STARTED|Overall Study||16||
48503874|NCT01899053|101568120|FG011|STARTED|Overall Study||7||
48503875|NCT01899053|101568121|FG012|STARTED|Overall Study||14||
48503876|NCT01899053|101568122|FG013|STARTED|Overall Study||20||
48503877|NCT01899053|101568109|FG000|COMPLETED|Overall Study||0|Completed=Participants who completed the study treatment.|
48062059|NCT03078907|100472960|FG000|COMPLETED|Overall Study||50||
48062060|NCT03078907|100472961|FG001|COMPLETED|Overall Study||54||
48503878|NCT01899053|101568110|FG001|COMPLETED|Overall Study||0|Completed=Participants who completed the study treatment.|
48503879|NCT01899053|101568111|FG002|COMPLETED|Overall Study||0|Completed=Participants who completed the study treatment.|
48503880|NCT01899053|101568112|FG003|COMPLETED|Overall Study||0|Completed=Participants who completed the study treatment.|
48503881|NCT01899053|101568113|FG004|COMPLETED|Overall Study||0|Completed=Participants who completed the study treatment.|
48503882|NCT01899053|101568114|FG005|COMPLETED|Overall Study||0|Completed=Participants who completed the study treatment.|
48503883|NCT01899053|101568115|FG006|COMPLETED|Overall Study||0|Completed=Participants who completed the study treatment.|
48503884|NCT01899053|101568116|FG007|COMPLETED|Overall Study||0|Completed=Participants who completed the study treatment.|
48666762|NCT03391882|101970467|FG002|STARTED|Post Part A / Pre Part B||19||
48503885|NCT01899053|101568117|FG008|COMPLETED|Overall Study||0|Completed=Participants who completed the study treatment.|
48503886|NCT01899053|101568118|FG009|COMPLETED|Overall Study||0|Completed=Participants who completed the study treatment.|
48503887|NCT01899053|101568119|FG010|COMPLETED|Overall Study||0|Completed=Participants who completed the study treatment.|
48503888|NCT01899053|101568120|FG011|COMPLETED|Overall Study||0|Completed=Participants who completed the study treatment.|
48503889|NCT01899053|101568121|FG012|COMPLETED|Overall Study||0|Completed=Participants who completed the study treatment.|
48503890|NCT01899053|101568122|FG013|COMPLETED|Overall Study||0|Completed=Participants who completed the study treatment.|
48503891|NCT01899053|101568109|FG000|NOT COMPLETED|Overall Study||7||
48503892|NCT01899053|101568110|FG001|NOT COMPLETED|Overall Study||3||
48503893|NCT01899053|101568111|FG002|NOT COMPLETED|Overall Study||7||
48503894|NCT01899053|101568112|FG003|NOT COMPLETED|Overall Study||3||
48503895|NCT01899053|101568113|FG004|NOT COMPLETED|Overall Study||6||
48503896|NCT01899053|101568114|FG005|NOT COMPLETED|Overall Study||3||
48503897|NCT01899053|101568115|FG006|NOT COMPLETED|Overall Study||3||
48503898|NCT01899053|101568116|FG007|NOT COMPLETED|Overall Study||3||
48503899|NCT01899053|101568117|FG008|NOT COMPLETED|Overall Study||6||
48503900|NCT01899053|101568118|FG009|NOT COMPLETED|Overall Study||3||
48503901|NCT01899053|101568119|FG010|NOT COMPLETED|Overall Study||16||
48503902|NCT01899053|101568120|FG011|NOT COMPLETED|Overall Study||7||
48503903|NCT01899053|101568121|FG012|NOT COMPLETED|Overall Study||14||
48503904|NCT01899053|101568122|FG013|NOT COMPLETED|Overall Study||20||
48503905|NCT01532908|101568123|FG000|STARTED|Overall Study||9||
48503906|NCT01532908|101568124|FG001|STARTED|Overall Study||2||
48503907|NCT01532908|101568123|FG000|Infused|Overall Study||9||
48503908|NCT01532908|101568124|FG001|Infused|Overall Study||2||
48503909|NCT01532908|101568123|FG000|Transplanted|Overall Study||8||
48503910|NCT01532908|101568124|FG001|Transplanted|Overall Study||2||
48503911|NCT01532908|101568123|FG000|COMPLETED|Overall Study||8||
48503912|NCT01532908|101568124|FG001|COMPLETED|Overall Study||2||
48503913|NCT01532908|101568123|FG000|NOT COMPLETED|Overall Study||1||
48503914|NCT01532908|101568124|FG001|NOT COMPLETED|Overall Study||0||
48503915|NCT00365053|101568125|FG000|STARTED|Overall Study||13||
48503916|NCT00365053|101568125|FG000|COMPLETED|Overall Study||13||
48503917|NCT00365053|101568125|FG000|NOT COMPLETED|Overall Study||0||
48503918|NCT01097694|101568126|FG000|STARTED|Overall Study||32||
48503919|NCT01097694|101568127|FG001|STARTED|Overall Study||30||
48503920|NCT01097694|101568126|FG000|COMPLETED|Overall Study||24||
48503921|NCT01097694|101568127|FG001|COMPLETED|Overall Study||26||
48503922|NCT01097694|101568126|FG000|NOT COMPLETED|Overall Study||8||
48503923|NCT01097694|101568127|FG001|NOT COMPLETED|Overall Study||4||
48503924|NCT03950674|101568128|FG000|STARTED|Overall Study||25||
48503925|NCT03950674|101568129|FG001|STARTED|Overall Study||15||
48503926|NCT03950674|101568128|FG000|Treated|Overall Study||25||
48503927|NCT03950674|101568129|FG001|Treated|Overall Study||15||
48503928|NCT03950674|101568128|FG000|Switched to Pembrolizumab Monotherapy|Overall Study||0||
48503929|NCT03950674|101568129|FG001|Switched to Pembrolizumab Monotherapy|Overall Study||4||
48503930|NCT03950674|101568128|FG000|Second Course Treatment With Pembrolizumab Monotherapy|Overall Study||1||
48503931|NCT03950674|101568129|FG001|Second Course Treatment With Pembrolizumab Monotherapy|Overall Study||0||
48503932|NCT03950674|101568128|FG000|COMPLETED|Overall Study||0||
48503933|NCT03950674|101568129|FG001|COMPLETED|Overall Study||0||
48503934|NCT03950674|101568128|FG000|NOT COMPLETED|Overall Study||25||
48503935|NCT03950674|101568129|FG001|NOT COMPLETED|Overall Study||15||
48503936|NCT01120691|101568130|FG000|STARTED|Overall Study||741||
48503937|NCT01120691|101568131|FG001|STARTED|Overall Study||741||
48503938|NCT01120691|101568132|FG002|STARTED|Overall Study||742||
48503939|NCT01120691|101568130|FG000|Full Analysis Set (FAS)|Overall Study||736||
48503940|NCT01120691|101568131|FG001|Full Analysis Set (FAS)|Overall Study||739||
48503941|NCT01120691|101568132|FG002|Full Analysis Set (FAS)|Overall Study||739||
48503942|NCT01120691|101568130|FG000|Safety Set (SAF)|Overall Study||736||
48503943|NCT01120691|101568131|FG001|Safety Set (SAF)|Overall Study||740||
48503944|NCT01120691|101568132|FG002|Safety Set (SAF)|Overall Study||739||
48503945|NCT01120691|101568130|FG000|Modified Safety Set (mSAF)|Overall Study||729||
48503946|NCT01120691|101568131|FG001|Modified Safety Set (mSAF)|Overall Study||740||
48503947|NCT01120691|101568132|FG002|Modified Safety Set (mSAF)|Overall Study||737||
48503948|NCT01120691|101568130|FG000|Modified Full Analysis Set (mFAS)|Overall Study||729||
48503949|NCT01120691|101568131|FG001|Modified Full Analysis Set (mFAS)|Overall Study||739||
48503950|NCT01120691|101568132|FG002|Modified Full Analysis Set (mFAS)|Overall Study||737||
48503951|NCT01120691|101568130|FG000|COMPLETED|Overall Study||570||
48503952|NCT01120691|101568131|FG001|COMPLETED|Overall Study||538||
48503953|NCT01120691|101568132|FG002|COMPLETED|Overall Study||559||
48503954|NCT01120691|101568130|FG000|NOT COMPLETED|Overall Study||171||
48503955|NCT01120691|101568131|FG001|NOT COMPLETED|Overall Study||203||
48503956|NCT01120691|101568132|FG002|NOT COMPLETED|Overall Study||183||
48503957|NCT03247686|101568133|FG000|STARTED|Overall Study||8||
48503958|NCT03247686|101568134|FG001|STARTED|Overall Study||20||
48503959|NCT03247686|101568133|FG000|COMPLETED|Overall Study||7||
48503960|NCT03247686|101568134|FG001|COMPLETED|Overall Study||18||
48503961|NCT03247686|101568133|FG000|NOT COMPLETED|Overall Study||1||
48503962|NCT03247686|101568134|FG001|NOT COMPLETED|Overall Study||2||
48503963|NCT01632306|101568135|FG000|STARTED|Overall Study||3||
48503964|NCT01632306|101568136|FG001|STARTED|Overall Study||10||
48503965|NCT01632306|101568137|FG002|STARTED|Overall Study||0||
48503966|NCT01632306|101568135|FG000|Received at Least One Dose of Study Drug|Overall Study||3||
48503967|NCT01632306|101568136|FG001|Received at Least One Dose of Study Drug|Overall Study||10||
48503968|NCT01632306|101568137|FG002|Received at Least One Dose of Study Drug|Overall Study||0||
48503969|NCT01632306|101568135|FG000|COMPLETED|Overall Study||2||
48503970|NCT01632306|101568136|FG001|COMPLETED|Overall Study||10||
48503971|NCT01632306|101568137|FG002|COMPLETED|Overall Study||0||
48503972|NCT01632306|101568135|FG000|NOT COMPLETED|Overall Study||1||
48503973|NCT01632306|101568136|FG001|NOT COMPLETED|Overall Study||0||
48503974|NCT01632306|101568137|FG002|NOT COMPLETED|Overall Study||0||
48503975|NCT03419962|101568138|FG000|STARTED|Overall Study||1359||
48503976|NCT03419962|101568138|FG000|COMPLETED|Overall Study||1322||
48503977|NCT03419962|101568138|FG000|NOT COMPLETED|Overall Study||37||
48503978|NCT00555893|101568139|FG000|STARTED|Overall Study||130||
48503979|NCT00555893|101568140|FG001|STARTED|Overall Study||63||
48503980|NCT00555893|101568139|FG000|Final Analysis|Overall Study||114||
48503981|NCT00555893|101568140|FG001|Final Analysis|Overall Study||51||
48503982|NCT00555893|101568139|FG000|COMPLETED|Overall Study||130||
48503983|NCT00555893|101568140|FG001|COMPLETED|Overall Study||63||
48503984|NCT00555893|101568139|FG000|NOT COMPLETED|Overall Study||0||
48503985|NCT00555893|101568140|FG001|NOT COMPLETED|Overall Study||0||
48503986|NCT01211262|101568141|FG000|STARTED|Overall Study||66||
48503987|NCT01211262|101568142|FG001|STARTED|Overall Study||18||
48503988|NCT01211262|101568141|FG000|COMPLETED|Overall Study||43||
48503989|NCT01211262|101568142|FG001|COMPLETED|Overall Study||8||
48503990|NCT01211262|101568141|FG000|NOT COMPLETED|Overall Study||23||
48503991|NCT01211262|101568142|FG001|NOT COMPLETED|Overall Study||10||
48503992|NCT00021541|101568143|FG000|STARTED|Period 1-First Treatment||31||
48503993|NCT00021541|101568144|FG001|STARTED|Period 1-First Treatment||31||
48503994|NCT00021541|101568143|FG000|Pts Who Progressed to Second Treatment|Period 1-First Treatment||20||
48503995|NCT00021541|101568144|FG001|Pts Who Progressed to Second Treatment|Period 1-First Treatment||23||
48503996|NCT00021541|101568143|FG000|Ineligible Patients|Period 1-First Treatment||0||
48503997|NCT00021541|101568144|FG001|Ineligible Patients|Period 1-First Treatment||2||
48503998|NCT00021541|101568143|FG000|COMPLETED|Period 1-First Treatment||20||
48503999|NCT00021541|101568144|FG001|COMPLETED|Period 1-First Treatment||23||
48504000|NCT00021541|101568143|FG000|NOT COMPLETED|Period 1-First Treatment||11||
48504001|NCT00021541|101568144|FG001|NOT COMPLETED|Period 1-First Treatment||8||
48504002|NCT00021541|101568143|FG000|STARTED|Period 2-crossover||20||
48504003|NCT00021541|101568144|FG001|STARTED|Period 2-crossover||23||
48504004|NCT00021541|101568143|FG000|COMPLETED|Period 2-crossover||10||
48504005|NCT00021541|101568144|FG001|COMPLETED|Period 2-crossover||12||
48504006|NCT00021541|101568143|FG000|NOT COMPLETED|Period 2-crossover||10||
48504007|NCT00021541|101568144|FG001|NOT COMPLETED|Period 2-crossover||11||
48504008|NCT04531527|101568145|FG000|STARTED|Overall Study||32||
48504009|NCT04531527|101568145|FG000|Treated|Overall Study||29||
48504010|NCT04531527|101568145|FG000|COMPLETED|Overall Study||29||
48504011|NCT04531527|101568145|FG000|NOT COMPLETED|Overall Study||3||
48504012|NCT01152112|101568146|FG000|STARTED|Overall Study||42||
48504013|NCT01152112|101568147|FG001|STARTED|Overall Study||32||
48504014|NCT01152112|101568146|FG000|COMPLETED|Overall Study||42||
48504015|NCT01152112|101568147|FG001|COMPLETED|Overall Study||32||
48504016|NCT01152112|101568146|FG000|NOT COMPLETED|Overall Study||0||
48504017|NCT01152112|101568147|FG001|NOT COMPLETED|Overall Study||0||
48504018|NCT00046839|101568148|FG000|STARTED|Overall Study||8||
48504019|NCT00046839|101568149|FG001|STARTED|Overall Study||13||
48504020|NCT00046839|101568148|FG000|COMPLETED|Overall Study||7||
48504021|NCT00046839|101568149|FG001|COMPLETED|Overall Study||11||
48504022|NCT00046839|101568148|FG000|NOT COMPLETED|Overall Study||1||
48504023|NCT00046839|101568149|FG001|NOT COMPLETED|Overall Study||2||
48504024|NCT00787605|101568150|FG000|STARTED|Overall Study||428||
48504025|NCT00787605|101568151|FG001|STARTED|Overall Study||432||
48504026|NCT00787605|101568150|FG000|COMPLETED|Overall Study||382||
48504027|NCT00787605|101568151|FG001|COMPLETED|Overall Study||376||
48504028|NCT00787605|101568150|FG000|NOT COMPLETED|Overall Study||46||
48504029|NCT00787605|101568151|FG001|NOT COMPLETED|Overall Study||56||
48504030|NCT00640341|101568152|FG000|STARTED|Overall Study||170||
48504031|NCT00640341|101568153|FG001|STARTED|Overall Study||170||
48504032|NCT00640341|101568154|FG002|STARTED|Overall Study||170||
48504033|NCT00640341|101568152|FG000|Eligible Participants at Baseline|Overall Study||165||
48504034|NCT00640341|101568153|FG001|Eligible Participants at Baseline|Overall Study||167||
48504035|NCT00640341|101568154|FG002|Eligible Participants at Baseline|Overall Study||168||
48504036|NCT00640341|101568152|FG000|COMPLETED|Overall Study||149||
48504037|NCT00640341|101568153|FG001|COMPLETED|Overall Study||165||
48504038|NCT00640341|101568154|FG002|COMPLETED|Overall Study||163||
48504039|NCT00640341|101568152|FG000|NOT COMPLETED|Overall Study||21||
48504040|NCT00640341|101568153|FG001|NOT COMPLETED|Overall Study||5||
48504041|NCT00640341|101568154|FG002|NOT COMPLETED|Overall Study||7||
48504042|NCT02340780|101568155|FG000|STARTED|Overall Study||14||
48504043|NCT02340780|101568155|FG000|COMPLETED|Overall Study||13||
48504044|NCT02340780|101568155|FG000|NOT COMPLETED|Overall Study||1||
48504045|NCT02906917|101568156|FG000|STARTED|Initiation Period (Week 0-26)||267||
48504046|NCT02906917|101568157|FG001|STARTED|Initiation Period (Week 0-26)||265||
48504047|NCT02906917|101568156|FG000|Exposed|Initiation Period (Week 0-26)||265||
48504048|NCT02906917|101568157|FG001|Exposed|Initiation Period (Week 0-26)||263||
48504049|NCT02906917|101568156|FG000|COMPLETED|Initiation Period (Week 0-26)||261||
48504050|NCT02906917|101568157|FG001|COMPLETED|Initiation Period (Week 0-26)||254||
48504051|NCT02906917|101568156|FG000|NOT COMPLETED|Initiation Period (Week 0-26)||6||
48504052|NCT02906917|101568157|FG001|NOT COMPLETED|Initiation Period (Week 0-26)||11||
48504053|NCT02906917|101568156|FG000|STARTED|Intensification Period (Week 26-38)||261||
48504054|NCT02906917|101568157|FG001|STARTED|Intensification Period (Week 26-38)||254||
48504055|NCT02906917|101568156|FG000|COMPLETED|Intensification Period (Week 26-38)||252||
48504056|NCT02906917|101568157|FG001|COMPLETED|Intensification Period (Week 26-38)||247||
48504057|NCT02906917|101568156|FG000|NOT COMPLETED|Intensification Period (Week 26-38)||9||
48504058|NCT02906917|101568157|FG001|NOT COMPLETED|Intensification Period (Week 26-38)||7||
48504059|NCT03448692|101568158|FG000|STARTED|Disposition Phase:Screening:up to 43Days||23||
48504060|NCT03448692|101568159|FG001|STARTED|Disposition Phase:Screening:up to 43Days||24||
48504061|NCT03448692|101568158|FG000|COMPLETED|Disposition Phase:Screening:up to 43Days||23||
48504062|NCT03448692|101568159|FG001|COMPLETED|Disposition Phase:Screening:up to 43Days||24||
48504063|NCT03448692|101568158|FG000|NOT COMPLETED|Disposition Phase:Screening:up to 43Days||0||
48504064|NCT03448692|101568159|FG001|NOT COMPLETED|Disposition Phase:Screening:up to 43Days||0||
48504065|NCT03448692|101568158|FG000|STARTED|Lead in Period:8 Weeks (W)||23||
48504066|NCT03448692|101568159|FG001|STARTED|Lead in Period:8 Weeks (W)||24||
48504067|NCT03448692|101568158|FG000|COMPLETED|Lead in Period:8 Weeks (W)||23||
48504068|NCT03448692|101568159|FG001|COMPLETED|Lead in Period:8 Weeks (W)||24||
48504069|NCT03448692|101568158|FG000|NOT COMPLETED|Lead in Period:8 Weeks (W)||0||
48504070|NCT03448692|101568159|FG001|NOT COMPLETED|Lead in Period:8 Weeks (W)||0||
48504071|NCT03448692|101568158|FG000|STARTED|Investigational Treatment Period:Upto24W||23||
48504072|NCT03448692|101568159|FG001|STARTED|Investigational Treatment Period:Upto24W||24||
48504073|NCT03448692|101568158|FG000|COMPLETED|Investigational Treatment Period:Upto24W||22||
48504074|NCT03448692|101568159|FG001|COMPLETED|Investigational Treatment Period:Upto24W||15||
48504075|NCT03448692|101568158|FG000|NOT COMPLETED|Investigational Treatment Period:Upto24W||1||
48504076|NCT03448692|101568159|FG001|NOT COMPLETED|Investigational Treatment Period:Upto24W||9||
48504077|NCT03448692|101568158|FG000|STARTED|Follow up Period:9 Weeks||23||
48504078|NCT03448692|101568159|FG001|STARTED|Follow up Period:9 Weeks||23||
48504079|NCT03448692|101568158|FG000|COMPLETED|Follow up Period:9 Weeks||23||
48504080|NCT03448692|101568159|FG001|COMPLETED|Follow up Period:9 Weeks||23||
48504081|NCT03448692|101568158|FG000|NOT COMPLETED|Follow up Period:9 Weeks||0||
48504082|NCT03448692|101568159|FG001|NOT COMPLETED|Follow up Period:9 Weeks||0||
48504083|NCT00522041|101568160|FG000|STARTED|Overall Study||123||
48504084|NCT00522041|101568161|FG001|STARTED|Overall Study||125||
48504085|NCT00522041|101568160|FG000|Received Treatment|Overall Study||123||
48504086|NCT00522041|101568161|FG001|Received Treatment|Overall Study||124||
48504087|NCT00522041|101568160|FG000|COMPLETED|Overall Study||106||
48504088|NCT00522041|101568161|FG001|COMPLETED|Overall Study||113||
48504089|NCT00522041|101568160|FG000|NOT COMPLETED|Overall Study||17||
48504090|NCT00522041|101568161|FG001|NOT COMPLETED|Overall Study||12||
48504091|NCT01206439|101568162|FG000|STARTED|Overall Study||2||
48504092|NCT01206439|101568162|FG000|COMPLETED|Overall Study||1||
48504093|NCT01206439|101568162|FG000|NOT COMPLETED|Overall Study||1||
48504094|NCT04848688|101568163|FG000|STARTED|Overall Study||166||
48504095|NCT04848688|101568164|FG001|STARTED|Overall Study||166||
48504096|NCT04848688|101568163|FG000|COMPLETED|Overall Study||154||
48504097|NCT04848688|101568164|FG001|COMPLETED|Overall Study||161||
48504098|NCT04848688|101568163|FG000|NOT COMPLETED|Overall Study||12||
48504099|NCT04848688|101568164|FG001|NOT COMPLETED|Overall Study||5||
48504100|NCT02383706|101568165|FG000|STARTED|Overall Study||108||
48504101|NCT02383706|101568165|FG000|COMPLETED|Overall Study||80||
48504102|NCT02383706|101568165|FG000|NOT COMPLETED|Overall Study||28||
48504103|NCT01067521|101568166|FG000|STARTED|Double-Blind Placebo-Controlled Period||943||
48504104|NCT01067521|101568167|FG001|STARTED|Double-Blind Placebo-Controlled Period||461||
48504105|NCT01067521|101568166|FG000|COMPLETED|Double-Blind Placebo-Controlled Period||859||
48504106|NCT01067521|101568167|FG001|COMPLETED|Double-Blind Placebo-Controlled Period||430||
48504107|NCT01067521|101568166|FG000|NOT COMPLETED|Double-Blind Placebo-Controlled Period||84||
48504108|NCT01067521|101568167|FG001|NOT COMPLETED|Double-Blind Placebo-Controlled Period||31||
48504109|NCT01067521|101568166|FG000|STARTED|Open-Label Period||834||
48504110|NCT01067521|101568167|FG001|STARTED|Open-Label Period||419||
48504111|NCT01067521|101568166|FG000|COMPLETED|Open-Label Period||580||
48504112|NCT01067521|101568167|FG001|COMPLETED|Open-Label Period||261||
48504113|NCT01067521|101568166|FG000|NOT COMPLETED|Open-Label Period||254||
48504114|NCT01067521|101568167|FG001|NOT COMPLETED|Open-Label Period||158||
48504115|NCT00544167|101568168|FG000|STARTED|Overall Study||45||
48504116|NCT00544167|101568168|FG000|COMPLETED|Overall Study||16||
48504117|NCT00544167|101568168|FG000|NOT COMPLETED|Overall Study||29||
48504118|NCT02837913|101568169|FG000|STARTED|Overall Study||10||
48504119|NCT02837913|101568170|FG001|STARTED|Overall Study||9||
48504120|NCT02837913|101568169|FG000|COMPLETED|Overall Study||10||
48504121|NCT02837913|101568170|FG001|COMPLETED|Overall Study||9||
48504122|NCT02837913|101568169|FG000|NOT COMPLETED|Overall Study||0||
48504123|NCT02837913|101568170|FG001|NOT COMPLETED|Overall Study||0||
48504124|NCT00757705|101568171|FG000|STARTED|Overall Study||299||
48504125|NCT00757705|101568171|FG000|COMPLETED|Overall Study||178||
48504126|NCT00757705|101568171|FG000|NOT COMPLETED|Overall Study||121||
48504127|NCT04230876|101568172|FG000|STARTED|Overall Study||15||
48504128|NCT04230876|101568173|FG001|STARTED|Overall Study||15||
48504129|NCT04230876|101568172|FG000|COMPLETED|Overall Study||14||
48504130|NCT04230876|101568173|FG001|COMPLETED|Overall Study||14||
48504131|NCT04230876|101568172|FG000|NOT COMPLETED|Overall Study||1||
48504132|NCT04230876|101568173|FG001|NOT COMPLETED|Overall Study||1||
48504133|NCT02832167|101568174|FG000|STARTED|Treatment Period 1||239||
48504134|NCT02832167|101568174|FG000|COMPLETED|Treatment Period 1||110||
48504135|NCT02832167|101568174|FG000|NOT COMPLETED|Treatment Period 1||129||
48504136|NCT02832167|101568174|FG000|STARTED|Transition From Period 1 to Period 2||110||
48504137|NCT02832167|101568174|FG000|COMPLETED|Transition From Period 1 to Period 2||103|Completed = moved to Treatment Period 2|
48504138|NCT02832167|101568174|FG000|NOT COMPLETED|Transition From Period 1 to Period 2||7||
48504139|NCT02832167|101568174|FG000|STARTED|Treatment Period 2||103||
48504140|NCT02832167|101568174|FG000|COMPLETED|Treatment Period 2||19||
48504141|NCT02832167|101568174|FG000|NOT COMPLETED|Treatment Period 2||84||
48504142|NCT05065619|101568175|FG000|STARTED|Up to Day 42||102||
48504143|NCT05065619|101568176|FG001|STARTED|Up to Day 42||26||
48504144|NCT05065619|101568175|FG000|COMPLETED|Up to Day 42||100||
48504145|NCT05065619|101568176|FG001|COMPLETED|Up to Day 42||26||
48504146|NCT05065619|101568175|FG000|NOT COMPLETED|Up to Day 42||2||
48504147|NCT05065619|101568176|FG001|NOT COMPLETED|Up to Day 42||0||
48504148|NCT05065619|101568175|FG000|STARTED|After Day 43||100||
48504149|NCT05065619|101568176|FG001|STARTED|After Day 43||26||
48504150|NCT05065619|101568175|FG000|COMPLETED|After Day 43||0||
48504151|NCT05065619|101568176|FG001|COMPLETED|After Day 43||0||
48504152|NCT05065619|101568175|FG000|NOT COMPLETED|After Day 43||100||
48504153|NCT05065619|101568176|FG001|NOT COMPLETED|After Day 43||26||
48504154|NCT01775722|101568177|FG000|STARTED|Overall Study||22||44
48504155|NCT01775722|101568177|FG000|COMPLETED|Overall Study||20||40
48504156|NCT01775722|101568177|FG000|NOT COMPLETED|Overall Study||2||4
48504157|NCT02308696|101568178|FG000|STARTED|Overall Study||222||
48504158|NCT02308696|101568179|FG001|STARTED|Overall Study||234||
48504159|NCT02308696|101568178|FG000|COMPLETED|Overall Study||169||
48504160|NCT02308696|101568179|FG001|COMPLETED|Overall Study||203||
48504161|NCT02308696|101568178|FG000|NOT COMPLETED|Overall Study||53||
48504162|NCT02308696|101568179|FG001|NOT COMPLETED|Overall Study||31||
48504163|NCT03183141|101568180|FG000|STARTED|Overall Study||29||
48504164|NCT03183141|101568181|FG001|STARTED|Overall Study||234||
48504165|NCT03183141|101568180|FG000|Completed 8-week Follow-up|Overall Study||29||
48504166|NCT03183141|101568181|FG001|Completed 8-week Follow-up|Overall Study||228||
48504167|NCT03183141|101568180|FG000|COMPLETED|Overall Study||27|Completed 24-week Follow-up|
48504168|NCT03183141|101568181|FG001|COMPLETED|Overall Study||222|Completed 24-week Follow-up|
48504169|NCT03183141|101568180|FG000|NOT COMPLETED|Overall Study||2||
48504170|NCT03183141|101568181|FG001|NOT COMPLETED|Overall Study||12||
48504171|NCT01183884|101568182|FG000|STARTED|Overall Study||46||
48504172|NCT01183884|101568182|FG000|COMPLETED|Overall Study||8||
48504173|NCT01183884|101568182|FG000|NOT COMPLETED|Overall Study||38||
48504174|NCT00115869|101568183|FG000|STARTED|Overall Study||4211||
48504175|NCT00115869|101568184|FG001|STARTED|Overall Study||4177||
48504176|NCT00115869|101568183|FG000|Completed Data Collection at 12th Grade|Overall Study||3876||
48504177|NCT00115869|101568184|FG001|Completed Data Collection at 12th Grade|Overall Study||3847||
48504178|NCT00115869|101568183|FG000|COMPLETED|Overall Study||3894||
48504179|NCT00115869|101568184|FG001|COMPLETED|Overall Study||3881||
48504180|NCT00115869|101568183|FG000|NOT COMPLETED|Overall Study||317||
48504181|NCT00115869|101568184|FG001|NOT COMPLETED|Overall Study||296||
48504182|NCT00127166|101568185|FG000|STARTED|Period I||78||
48504183|NCT00127166|101568186|FG001|STARTED|Period I||76||
48504184|NCT00127166|101568185|FG000|COMPLETED|Period I||75||
48504185|NCT00127166|101568186|FG001|COMPLETED|Period I||74||
48504186|NCT00127166|101568185|FG000|NOT COMPLETED|Period I||3||
48504187|NCT00127166|101568186|FG001|NOT COMPLETED|Period I||2||
48504188|NCT00127166|101568185|FG000|STARTED|Washout Period||75||
48504189|NCT00127166|101568186|FG001|STARTED|Washout Period||74||
48504190|NCT00127166|101568185|FG000|COMPLETED|Washout Period||75||
48504191|NCT00127166|101568186|FG001|COMPLETED|Washout Period||73||
48504192|NCT00127166|101568185|FG000|NOT COMPLETED|Washout Period||0||
48504193|NCT00127166|101568186|FG001|NOT COMPLETED|Washout Period||1||
48504194|NCT00127166|101568185|FG000|STARTED|Period II||75||
48504195|NCT00127166|101568186|FG001|STARTED|Period II||73||
48504196|NCT00127166|101568185|FG000|COMPLETED|Period II||72||
48504197|NCT00127166|101568186|FG001|COMPLETED|Period II||73||
48504198|NCT00127166|101568185|FG000|NOT COMPLETED|Period II||3||
48504199|NCT00127166|101568186|FG001|NOT COMPLETED|Period II||0||
48504200|NCT03750695|101568187|FG000|STARTED|Overall Study||8||
48504201|NCT03750695|101568188|FG001|STARTED|Overall Study||8||
48504202|NCT03750695|101568187|FG000|COMPLETED|Overall Study||8||
48504203|NCT03750695|101568188|FG001|COMPLETED|Overall Study||7||
48504204|NCT03750695|101568187|FG000|NOT COMPLETED|Overall Study||0||
48504205|NCT03750695|101568188|FG001|NOT COMPLETED|Overall Study||1||
48504206|NCT01769222|101568189|FG000|STARTED|Study Phase 1||3||
48504207|NCT01769222|101568190|FG001|STARTED|Study Phase 1||0||
48504208|NCT01769222|101568189|FG000|COMPLETED|Study Phase 1||3||
48504209|NCT01769222|101568190|FG001|COMPLETED|Study Phase 1||0||
48504210|NCT01769222|101568189|FG000|NOT COMPLETED|Study Phase 1||0||
48504211|NCT01769222|101568190|FG001|NOT COMPLETED|Study Phase 1||0||
48504212|NCT01769222|101568189|FG000|STARTED|Study Phase 2||0||
48504213|NCT01769222|101568190|FG001|STARTED|Study Phase 2||0||
48504214|NCT01769222|101568189|FG000|COMPLETED|Study Phase 2||0||
48504215|NCT01769222|101568190|FG001|COMPLETED|Study Phase 2||0||
48504216|NCT01769222|101568189|FG000|NOT COMPLETED|Study Phase 2||0||
48504217|NCT01769222|101568190|FG001|NOT COMPLETED|Study Phase 2||0||
48504218|NCT00218335|101568191|FG000|STARTED|Overall Study||114||
48504219|NCT00218335|101568192|FG001|STARTED|Overall Study||113||
48504220|NCT00218335|101568193|FG002|STARTED|Overall Study||373||
48504221|NCT00218335|101568194|FG003|STARTED|Overall Study||424||
48504222|NCT00218335|101568191|FG000|6 Month Follow-up|Overall Study||103||
48504223|NCT00218335|101568192|FG001|6 Month Follow-up|Overall Study||99||
48504224|NCT00218335|101568193|FG002|6 Month Follow-up|Overall Study||219||
48504225|NCT00218335|101568194|FG003|6 Month Follow-up|Overall Study||301||
48504226|NCT00218335|101568191|FG000|12 Month Follow-up|Overall Study||95||
48504227|NCT00218335|101568192|FG001|12 Month Follow-up|Overall Study||102||
48504228|NCT00218335|101568193|FG002|12 Month Follow-up|Overall Study||244||
48504229|NCT00218335|101568194|FG003|12 Month Follow-up|Overall Study||303||
48504230|NCT00218335|101568191|FG000|18 Month Follow-up|Overall Study||101||
48504231|NCT00218335|101568192|FG001|18 Month Follow-up|Overall Study||108||
48504232|NCT00218335|101568193|FG002|18 Month Follow-up|Overall Study||296||
48504233|NCT00218335|101568194|FG003|18 Month Follow-up|Overall Study||368||
48504234|NCT00218335|101568191|FG000|COMPLETED|Overall Study||108||
48504235|NCT00218335|101568192|FG001|COMPLETED|Overall Study||110||
48504236|NCT00218335|101568193|FG002|COMPLETED|Overall Study||319||
48504237|NCT00218335|101568194|FG003|COMPLETED|Overall Study||388||
48504238|NCT00218335|101568191|FG000|NOT COMPLETED|Overall Study||6||
48504239|NCT00218335|101568192|FG001|NOT COMPLETED|Overall Study||3||
48504240|NCT00218335|101568193|FG002|NOT COMPLETED|Overall Study||54||
48504241|NCT00218335|101568194|FG003|NOT COMPLETED|Overall Study||36||
48504242|NCT01223027|101568195|FG000|STARTED|Overall Study||284||
48504243|NCT01223027|101568196|FG001|STARTED|Overall Study||286||
48504244|NCT01223027|101568195|FG000|COMPLETED|Overall Study||10||
48504245|NCT01223027|101568196|FG001|COMPLETED|Overall Study||9||
48504246|NCT01223027|101568195|FG000|NOT COMPLETED|Overall Study||274||
48504247|NCT01223027|101568196|FG001|NOT COMPLETED|Overall Study||277||
48504248|NCT03275623|101568197|FG000|STARTED|Overall Study||30||
48504249|NCT03275623|101568198|FG001|STARTED|Overall Study||30||
48504250|NCT03275623|101568197|FG000|COMPLETED|Overall Study||25||
48504251|NCT03275623|101568198|FG001|COMPLETED|Overall Study||28||
48504252|NCT03275623|101568197|FG000|NOT COMPLETED|Overall Study||5||
48504253|NCT03275623|101568198|FG001|NOT COMPLETED|Overall Study||2||
48504254|NCT00942734|101568199|FG000|STARTED|Overall Study||43||
48504255|NCT00942734|101568199|FG000|COMPLETED|Overall Study||35||
48504256|NCT00942734|101568199|FG000|NOT COMPLETED|Overall Study||8||
48504257|NCT03573336|101568200|FG000|STARTED|Overall Study||2||
48666763|NCT03391882|101970468|FG003|STARTED|Post Part A / Pre Part B||18||
48062061|NCT03078907|100472960|FG000|NOT COMPLETED|Overall Study||3||
48504258|NCT03573336|101568201|FG001|STARTED|Overall Study||4||
48504259|NCT03573336|101568202|FG002|STARTED|Overall Study||2||
48504260|NCT03573336|101568200|FG000|Treated|Overall Study||2||
48504261|NCT03573336|101568201|FG001|Treated|Overall Study||4||
48504262|NCT03573336|101568202|FG002|Treated|Overall Study||2||
48504263|NCT03573336|101568200|FG000|COMPLETED|Overall Study||0||
48504264|NCT03573336|101568201|FG001|COMPLETED|Overall Study||0||
48504265|NCT03573336|101568202|FG002|COMPLETED|Overall Study||0||
48504266|NCT03573336|101568200|FG000|NOT COMPLETED|Overall Study||2||
48504267|NCT03573336|101568201|FG001|NOT COMPLETED|Overall Study||4||
48504268|NCT03573336|101568202|FG002|NOT COMPLETED|Overall Study||2||
48504269|NCT04640194|101568203|FG000|STARTED|Overall Study||20||
48504270|NCT04640194|101568204|FG001|STARTED|Overall Study||20||
48504271|NCT04640194|101568205|FG002|STARTED|Overall Study||22||
48504272|NCT04640194|101568206|FG003|STARTED|Overall Study||17||
48504273|NCT04640194|101568207|FG004|STARTED|Overall Study||8||
48504274|NCT04640194|101568208|FG005|STARTED|Overall Study||12||
48504275|NCT04640194|101568209|FG006|STARTED|Overall Study||5||
48504276|NCT04640194|101568203|FG000|COMPLETED|Overall Study||17|Completed treatment|
48504277|NCT04640194|101568204|FG001|COMPLETED|Overall Study||12|Completed treatment|
48504278|NCT04640194|101568205|FG002|COMPLETED|Overall Study||22|Completed treatment|
48504279|NCT04640194|101568206|FG003|COMPLETED|Overall Study||9|Completed treatment|
48504280|NCT04640194|101568207|FG004|COMPLETED|Overall Study||8|Completed treatment|
48504281|NCT04640194|101568208|FG005|COMPLETED|Overall Study||8|Completed treatment|
48504282|NCT04640194|101568209|FG006|COMPLETED|Overall Study||5|Completed treatment|
48504283|NCT04640194|101568203|FG000|NOT COMPLETED|Overall Study||3||
48504284|NCT04640194|101568204|FG001|NOT COMPLETED|Overall Study||8||
48504285|NCT04640194|101568205|FG002|NOT COMPLETED|Overall Study||0||
48504286|NCT04640194|101568206|FG003|NOT COMPLETED|Overall Study||8||
48504287|NCT04640194|101568207|FG004|NOT COMPLETED|Overall Study||0||
48504288|NCT04640194|101568208|FG005|NOT COMPLETED|Overall Study||4||
48504289|NCT04640194|101568209|FG006|NOT COMPLETED|Overall Study||0||
48504290|NCT00380588|101568210|FG000|STARTED|Overall Study||42||
48504291|NCT00380588|101568211|FG001|STARTED|Overall Study||42||
48504292|NCT00380588|101568210|FG000|Received at Least One Dose of Study Drug|Overall Study||41||
48504293|NCT00380588|101568211|FG001|Received at Least One Dose of Study Drug|Overall Study||42||
48504294|NCT00380588|101568210|FG000|COMPLETED|Overall Study||3||
48504295|NCT00380588|101568211|FG001|COMPLETED|Overall Study||2||
48504296|NCT00380588|101568210|FG000|NOT COMPLETED|Overall Study||39||
48504297|NCT00380588|101568211|FG001|NOT COMPLETED|Overall Study||40||
48504298|NCT00645827|101568212|FG000|STARTED|Overall Study||14||
48504299|NCT00645827|101568213|FG001|STARTED|Overall Study||17||
48504300|NCT00645827|101568212|FG000|COMPLETED|Overall Study||14||
48504301|NCT00645827|101568213|FG001|COMPLETED|Overall Study||17||
48504302|NCT00645827|101568212|FG000|NOT COMPLETED|Overall Study||0||
48504303|NCT00645827|101568213|FG001|NOT COMPLETED|Overall Study||0||
48504304|NCT00434590|101568214|FG000|STARTED|Overall Study||5||
48504305|NCT00434590|101568215|FG001|STARTED|Overall Study||5||
48504306|NCT00434590|101568214|FG000|COMPLETED|Overall Study||0||
48504307|NCT00434590|101568215|FG001|COMPLETED|Overall Study||0||
48504308|NCT00434590|101568214|FG000|NOT COMPLETED|Overall Study||5||
48504309|NCT00434590|101568215|FG001|NOT COMPLETED|Overall Study||5||
48504310|NCT02324335|101568216|FG000|STARTED|Overall Study||30||
48504311|NCT02324335|101568217|FG001|STARTED|Overall Study||29||
48504312|NCT02324335|101568216|FG000|COMPLETED|Overall Study||21||
48504313|NCT02324335|101568217|FG001|COMPLETED|Overall Study||20||
48504314|NCT02324335|101568216|FG000|NOT COMPLETED|Overall Study||9||
48504315|NCT02324335|101568217|FG001|NOT COMPLETED|Overall Study||9||
48504316|NCT00176891|101568218|FG000|STARTED|Overall Study||25||
48504317|NCT00176891|101568218|FG000|COMPLETED|Overall Study||22||
48504318|NCT00176891|101568218|FG000|NOT COMPLETED|Overall Study||3||
48504319|NCT03061903|101568219|FG000|STARTED|Overall Study||61||
48504320|NCT03061903|101568220|FG001|STARTED|Overall Study||61||
48504321|NCT03061903|101568219|FG000|COMPLETED|Overall Study||60||
48504322|NCT03061903|101568220|FG001|COMPLETED|Overall Study||60||
48504323|NCT03061903|101568219|FG000|NOT COMPLETED|Overall Study||1||
48504324|NCT03061903|101568220|FG001|NOT COMPLETED|Overall Study||1||
48504325|NCT01198873|101568221|FG000|STARTED|Overall Study||41||
48504326|NCT01198873|101568222|FG001|STARTED|Overall Study||35||
48504327|NCT01198873|101568221|FG000|Treated|Overall Study||41||
48504328|NCT01198873|101568222|FG001|Treated|Overall Study||35||
48504329|NCT01198873|101568221|FG000|Evaluable for Efficacy|Overall Study||33||
48504330|NCT01198873|101568222|FG001|Evaluable for Efficacy|Overall Study||26||
48504331|NCT01198873|101568221|FG000|COMPLETED|Overall Study||4||
48504332|NCT01198873|101568222|FG001|COMPLETED|Overall Study||3||
48504333|NCT01198873|101568221|FG000|NOT COMPLETED|Overall Study||37||
48504334|NCT01198873|101568222|FG001|NOT COMPLETED|Overall Study||32||
48504335|NCT02197416|101568223|FG000|STARTED|Overall Study||9||
48504336|NCT02197416|101568224|FG001|STARTED|Overall Study||43||
48504337|NCT02197416|101568225|FG002|STARTED|Overall Study||161||
48504338|NCT02197416|101568223|FG000|COMPLETED|Overall Study||8||
48504339|NCT02197416|101568224|FG001|COMPLETED|Overall Study||39||
48504340|NCT02197416|101568225|FG002|COMPLETED|Overall Study||153||
48504341|NCT02197416|101568223|FG000|NOT COMPLETED|Overall Study||1||
48504342|NCT02197416|101568224|FG001|NOT COMPLETED|Overall Study||4||
48504343|NCT02197416|101568225|FG002|NOT COMPLETED|Overall Study||8||
48504344|NCT03206749|101568226|FG000|STARTED|Overall Study||80||
48504345|NCT03206749|101568227|FG001|STARTED|Overall Study||81||
48504346|NCT03206749|101568228|FG002|STARTED|Overall Study||82||
48504347|NCT03206749|101568226|FG000|COMPLETED|Overall Study||75||
48504348|NCT03206749|101568227|FG001|COMPLETED|Overall Study||78||
48504349|NCT03206749|101568228|FG002|COMPLETED|Overall Study||75||
48504350|NCT03206749|101568226|FG000|NOT COMPLETED|Overall Study||5||
48504351|NCT03206749|101568227|FG001|NOT COMPLETED|Overall Study||3||
48504352|NCT03206749|101568228|FG002|NOT COMPLETED|Overall Study||7||
48504353|NCT04232540|101568229|FG000|STARTED|Overall Study||37||
48504354|NCT04232540|101568230|FG001|STARTED|Overall Study||20||
48504355|NCT04232540|101568229|FG000|Received MedViewer|Overall Study||34|The MedViewer report was received as planned if results were: (1) delivered to the research team member within 2 hours of initiation of hair sample processing; and (2) discussed between the patient and provider/pharmacist during their clinic visit.|
48504356|NCT04232540|101568230|FG001|Received MedViewer|Overall Study||16|The MedViewer report was received as planned if results were: (1) delivered to the research team member within 2 hours of initiation of hair sample processing; and (2) discussed between the patient and provider/pharmacist during their clinic visit.|
48504357|NCT04232540|101568229|FG000|Completed In-Depth Interview|Overall Study||24||
48504358|NCT04232540|101568230|FG001|Completed In-Depth Interview|Overall Study||14||
48504359|NCT04232540|101568229|FG000|COMPLETED|Overall Study||36||
48504360|NCT04232540|101568230|FG001|COMPLETED|Overall Study||20||
48504361|NCT04232540|101568229|FG000|NOT COMPLETED|Overall Study||1||
48504362|NCT04232540|101568230|FG001|NOT COMPLETED|Overall Study||0||
48504363|NCT01086969|101568231|FG000|STARTED|Overall Study||100||
48504364|NCT01086969|101568232|FG001|STARTED|Overall Study||100||
48504365|NCT01086969|101568233|FG002|STARTED|Overall Study||100||
48504366|NCT01086969|101568231|FG000|COMPLETED|Overall Study||99||
48504367|NCT01086969|101568232|FG001|COMPLETED|Overall Study||98||
48504368|NCT01086969|101568233|FG002|COMPLETED|Overall Study||100||
48504369|NCT01086969|101568231|FG000|NOT COMPLETED|Overall Study||1||
48504370|NCT01086969|101568232|FG001|NOT COMPLETED|Overall Study||2||
48504371|NCT01086969|101568233|FG002|NOT COMPLETED|Overall Study||0||
48504372|NCT03646162|101568234|FG000|STARTED|Overall Study||31||
48504373|NCT03646162|101568235|FG001|STARTED|Overall Study||31||
48504374|NCT03646162|101568236|FG002|STARTED|Overall Study||31||
48504375|NCT03646162|101568234|FG000|COMPLETED|Overall Study||26||
48504376|NCT03646162|101568235|FG001|COMPLETED|Overall Study||27||
48504377|NCT03646162|101568236|FG002|COMPLETED|Overall Study||30||
48504378|NCT03646162|101568234|FG000|NOT COMPLETED|Overall Study||5||
48504379|NCT03646162|101568235|FG001|NOT COMPLETED|Overall Study||4||
48504380|NCT03646162|101568236|FG002|NOT COMPLETED|Overall Study||1||
48504381|NCT01251393|101568237|FG000|STARTED|Overall Study||56||
48504382|NCT01251393|101568238|FG001|STARTED|Overall Study||55||
48504383|NCT01251393|101568237|FG000|COMPLETED|Overall Study||24||
48504384|NCT01251393|101568238|FG001|COMPLETED|Overall Study||11||
48504385|NCT01251393|101568237|FG000|NOT COMPLETED|Overall Study||32||
48504386|NCT01251393|101568238|FG001|NOT COMPLETED|Overall Study||44||
48504387|NCT00856349|101568239|FG000|STARTED|Overall Study||4132||
48504388|NCT00856349|101568239|FG000|12 Month Follow-up|Overall Study||3228||
48504389|NCT00856349|101568239|FG000|18 Month Follow-up|Overall Study||2467||
48504390|NCT00856349|101568239|FG000|24 Month Follow-up|Overall Study||1698||
48504391|NCT00856349|101568239|FG000|COMPLETED|Overall Study||3111||
48504392|NCT00856349|101568239|FG000|NOT COMPLETED|Overall Study||1021||
48504393|NCT03450629|101568240|FG000|STARTED|Overall Study||341||
48504394|NCT03450629|101568241|FG001|STARTED|Overall Study||341||
48504395|NCT03450629|101568240|FG000|COMPLETED|Overall Study||293|Completed Visit 5|
48504396|NCT03450629|101568241|FG001|COMPLETED|Overall Study||307|Completed Visit 5|
48504397|NCT03450629|101568240|FG000|NOT COMPLETED|Overall Study||48||
48504398|NCT03450629|101568241|FG001|NOT COMPLETED|Overall Study||34||
48504399|NCT03490227|101568242|FG000|STARTED|Overall Study||10||
48504400|NCT03490227|101568242|FG000|COMPLETED|Overall Study||10||
48504401|NCT03490227|101568242|FG000|NOT COMPLETED|Overall Study||0||
48504402|NCT02941523|101568243|FG000|STARTED|Monotherapy||8||
48504403|NCT02941523|101568244|FG001|STARTED|Monotherapy||8||
48504404|NCT02941523|101568243|FG000|COMPLETED|Monotherapy||8||
48504405|NCT02941523|101568244|FG001|COMPLETED|Monotherapy||7||
48504406|NCT02941523|101568243|FG000|NOT COMPLETED|Monotherapy||0||
48504407|NCT02941523|101568244|FG001|NOT COMPLETED|Monotherapy||1||
48504408|NCT02941523|101568243|FG000|STARTED|Carboplatin Combination Therapy||8||
48504409|NCT02941523|101568244|FG001|STARTED|Carboplatin Combination Therapy||10||
48504410|NCT02941523|101568243|FG000|COMPLETED|Carboplatin Combination Therapy||3||
48504411|NCT02941523|101568244|FG001|COMPLETED|Carboplatin Combination Therapy||6||
48504412|NCT02941523|101568243|FG000|NOT COMPLETED|Carboplatin Combination Therapy||5||
48504413|NCT02941523|101568244|FG001|NOT COMPLETED|Carboplatin Combination Therapy||4||
48504414|NCT01332968|101568245|FG000|STARTED|Induction Period||699||
48504415|NCT01332968|101568246|FG001|STARTED|Induction Period||702||
48504416|NCT01332968|101568247|FG002|STARTED|Induction Period||0||
48504417|NCT01332968|101568248|FG003|STARTED|Induction Period||0||
48504418|NCT01332968|101568249|FG004|STARTED|Induction Period||0||
48504419|NCT01332968|101568250|FG005|STARTED|Induction Period||0||
48504420|NCT01332968|101568251|FG006|STARTED|Induction Period||0||
48504421|NCT01332968|101568252|FG007|STARTED|Induction Period||0||
48504422|NCT01332968|101568245|FG000|COMPLETED|Induction Period||641||
48504423|NCT01332968|101568246|FG001|COMPLETED|Induction Period||646||
48504424|NCT01332968|101568247|FG002|COMPLETED|Induction Period||0||
48504425|NCT01332968|101568248|FG003|COMPLETED|Induction Period||0||
48504426|NCT01332968|101568249|FG004|COMPLETED|Induction Period||0||
48504427|NCT01332968|101568250|FG005|COMPLETED|Induction Period||0||
48504428|NCT01332968|101568251|FG006|COMPLETED|Induction Period||0||
48504429|NCT01332968|101568252|FG007|COMPLETED|Induction Period||0||
48504430|NCT01332968|101568245|FG000|NOT COMPLETED|Induction Period||58||
48504431|NCT01332968|101568246|FG001|NOT COMPLETED|Induction Period||56||
48504432|NCT01332968|101568247|FG002|NOT COMPLETED|Induction Period||0||
48504433|NCT01332968|101568248|FG003|NOT COMPLETED|Induction Period||0||
48504434|NCT01332968|101568249|FG004|NOT COMPLETED|Induction Period||0||
48504435|NCT01332968|101568250|FG005|NOT COMPLETED|Induction Period||0||
48504436|NCT01332968|101568251|FG006|NOT COMPLETED|Induction Period||0||
48504437|NCT01332968|101568252|FG007|NOT COMPLETED|Induction Period||0||
48504438|NCT01332968|101568245|FG000|STARTED|Maintenance/Observation Period||0||
48504439|NCT01332968|101568246|FG001|STARTED|Maintenance/Observation Period||0||
48504440|NCT01332968|101568247|FG002|STARTED|Maintenance/Observation Period||612||
48504441|NCT01332968|101568248|FG003|STARTED|Maintenance/Observation Period||624||
48504442|NCT01332968|101568249|FG004|STARTED|Maintenance/Observation Period||12||
48504443|NCT01332968|101568250|FG005|STARTED|Maintenance/Observation Period||11||
48504444|NCT01332968|101568251|FG006|STARTED|Maintenance/Observation Period||0||
48504445|NCT01332968|101568252|FG007|STARTED|Maintenance/Observation Period||0||
48504446|NCT01332968|101568245|FG000|COMPLETED|Maintenance/Observation Period||0||
48504447|NCT01332968|101568246|FG001|COMPLETED|Maintenance/Observation Period||0||
48504448|NCT01332968|101568247|FG002|COMPLETED|Maintenance/Observation Period||451||
48504449|NCT01332968|101568248|FG003|COMPLETED|Maintenance/Observation Period||475||
48504450|NCT01332968|101568249|FG004|COMPLETED|Maintenance/Observation Period||12||
48504451|NCT01332968|101568250|FG005|COMPLETED|Maintenance/Observation Period||10||
48504452|NCT01332968|101568251|FG006|COMPLETED|Maintenance/Observation Period||0||
48504453|NCT01332968|101568252|FG007|COMPLETED|Maintenance/Observation Period||0||
48504454|NCT01332968|101568245|FG000|NOT COMPLETED|Maintenance/Observation Period||0||
48504455|NCT01332968|101568246|FG001|NOT COMPLETED|Maintenance/Observation Period||0||
48504456|NCT01332968|101568247|FG002|NOT COMPLETED|Maintenance/Observation Period||161||
48504457|NCT01332968|101568248|FG003|NOT COMPLETED|Maintenance/Observation Period||149||
48504458|NCT01332968|101568249|FG004|NOT COMPLETED|Maintenance/Observation Period||0||
48504459|NCT01332968|101568250|FG005|NOT COMPLETED|Maintenance/Observation Period||1||
48504460|NCT01332968|101568251|FG006|NOT COMPLETED|Maintenance/Observation Period||0||
48504461|NCT01332968|101568252|FG007|NOT COMPLETED|Maintenance/Observation Period||0||
48504462|NCT01332968|101568245|FG000|STARTED|Follow-Up Period||0||
48504463|NCT01332968|101568246|FG001|STARTED|Follow-Up Period||0||
48504464|NCT01332968|101568247|FG002|STARTED|Follow-Up Period||0||
48504465|NCT01332968|101568248|FG003|STARTED|Follow-Up Period||0||
48504466|NCT01332968|101568249|FG004|STARTED|Follow-Up Period||0||
48504467|NCT01332968|101568250|FG005|STARTED|Follow-Up Period||0||
48504468|NCT01332968|101568251|FG006|STARTED|Follow-Up Period||554||
48504469|NCT01332968|101568252|FG007|STARTED|Follow-Up Period||602||
48504470|NCT01332968|101568245|FG000|COMPLETED|Follow-Up Period||0||
48504471|NCT01332968|101568246|FG001|COMPLETED|Follow-Up Period||0||
48504472|NCT01332968|101568247|FG002|COMPLETED|Follow-Up Period||0||
48504473|NCT01332968|101568248|FG003|COMPLETED|Follow-Up Period||0||
48504474|NCT01332968|101568249|FG004|COMPLETED|Follow-Up Period||0||
48504475|NCT01332968|101568250|FG005|COMPLETED|Follow-Up Period||0||
48504476|NCT01332968|101568251|FG006|COMPLETED|Follow-Up Period||324||
48504477|NCT01332968|101568252|FG007|COMPLETED|Follow-Up Period||367||
48504478|NCT01332968|101568245|FG000|NOT COMPLETED|Follow-Up Period||0||
48504479|NCT01332968|101568246|FG001|NOT COMPLETED|Follow-Up Period||0||
48504480|NCT01332968|101568247|FG002|NOT COMPLETED|Follow-Up Period||0||
48504481|NCT01332968|101568248|FG003|NOT COMPLETED|Follow-Up Period||0||
48504482|NCT01332968|101568249|FG004|NOT COMPLETED|Follow-Up Period||0||
48504483|NCT01332968|101568250|FG005|NOT COMPLETED|Follow-Up Period||0||
48504484|NCT01332968|101568251|FG006|NOT COMPLETED|Follow-Up Period||230||
48504485|NCT01332968|101568252|FG007|NOT COMPLETED|Follow-Up Period||235||
48504486|NCT02988882|101568253|FG000|STARTED|Overall Study||44||
48504487|NCT02988882|101568254|FG001|STARTED|Overall Study||42||
48504488|NCT02988882|101568253|FG000|COMPLETED|Overall Study||41||
48504489|NCT02988882|101568254|FG001|COMPLETED|Overall Study||40||
48504490|NCT02988882|101568253|FG000|NOT COMPLETED|Overall Study||3||
48504491|NCT02988882|101568254|FG001|NOT COMPLETED|Overall Study||2||
48504492|NCT03868631|101568255|FG000|STARTED|Baseline to Week 6||30||
48504493|NCT03868631|101568256|FG001|STARTED|Baseline to Week 6||31||
48504494|NCT03868631|101568255|FG000|COMPLETED|Baseline to Week 6||26||
48504495|NCT03868631|101568256|FG001|COMPLETED|Baseline to Week 6||27||
48504496|NCT03868631|101568255|FG000|NOT COMPLETED|Baseline to Week 6||4||
48504497|NCT03868631|101568256|FG001|NOT COMPLETED|Baseline to Week 6||4||
48504498|NCT03868631|101568255|FG000|STARTED|Week 6 to Week 12 (Study Completion)||26||
48504499|NCT03868631|101568256|FG001|STARTED|Week 6 to Week 12 (Study Completion)||27||
48504500|NCT03868631|101568255|FG000|COMPLETED|Week 6 to Week 12 (Study Completion)||22||
48504501|NCT03868631|101568256|FG001|COMPLETED|Week 6 to Week 12 (Study Completion)||26||
48504502|NCT03868631|101568255|FG000|NOT COMPLETED|Week 6 to Week 12 (Study Completion)||4||
48504503|NCT03868631|101568256|FG001|NOT COMPLETED|Week 6 to Week 12 (Study Completion)||1||
48504504|NCT01853176|101570575|FG000|STARTED|Overall Study||4||
48504505|NCT01853176|101570576|FG001|STARTED|Overall Study||0||
48504506|NCT01853176|101570575|FG000|COMPLETED|Overall Study||0||
48504507|NCT01853176|101570576|FG001|COMPLETED|Overall Study||0||
48504508|NCT01853176|101570575|FG000|NOT COMPLETED|Overall Study||4||
48504509|NCT01853176|101570576|FG001|NOT COMPLETED|Overall Study||0||
48062062|NCT03078907|100472961|FG001|NOT COMPLETED|Overall Study||1||
48504510|NCT02180230|101570577|FG000|STARTED|Overall Study||38||
48504511|NCT02180230|101570577|FG000|COMPLETED|Overall Study||31||
48504512|NCT02180230|101570577|FG000|NOT COMPLETED|Overall Study||7||
48504513|NCT03168906|101570578|FG000|STARTED|Overall Study||6||
48504514|NCT03168906|101570579|FG001|STARTED|Overall Study||6||
48504515|NCT03168906|101570578|FG000|COMPLETED|Overall Study||0||
48504516|NCT03168906|101570579|FG001|COMPLETED|Overall Study||0||
48504517|NCT03168906|101570578|FG000|NOT COMPLETED|Overall Study||6||
48504518|NCT03168906|101570579|FG001|NOT COMPLETED|Overall Study||6||
48504519|NCT02528409|101570580|FG000|STARTED|Overall Study||40||
48504520|NCT02528409|101570581|FG001|STARTED|Overall Study||40||
48504521|NCT02528409|101570580|FG000|COMPLETED|Overall Study||18||
48504522|NCT02528409|101570581|FG001|COMPLETED|Overall Study||24||
48504523|NCT02528409|101570580|FG000|NOT COMPLETED|Overall Study||22||
48504524|NCT02528409|101570581|FG001|NOT COMPLETED|Overall Study||16||
48504525|NCT04158687|101570582|FG000|STARTED|Overall Study||81||
48504526|NCT04158687|101570583|FG001|STARTED|Overall Study||81||
48504527|NCT04158687|101570584|FG002|STARTED|Overall Study||85||
48504528|NCT04158687|101570585|FG003|STARTED|Overall Study||79||
48504529|NCT04158687|101570582|FG000|Safety Population|Overall Study||81|Safety population included all participants who received at least one dose of study medication.|
48504530|NCT04158687|101570583|FG001|Safety Population|Overall Study||81|Safety population included all participants who received at least one dose of study medication.|
48504531|NCT04158687|101570584|FG002|Safety Population|Overall Study||85|Safety population included all participants who received at least one dose of study medication.|
48504532|NCT04158687|101570585|FG003|Safety Population|Overall Study||78|Safety population included all participants who received at least one dose of study medication.|
48504533|NCT04158687|101570582|FG000|Efficacy Population|Overall Study||80|Efficacy population included all participants who received the study medication and had at least one available post-baseline Positive and Negative Syndrome Scale (PANSS) assessment.|
48504534|NCT04158687|101570583|FG001|Efficacy Population|Overall Study||81|Efficacy population included all participants who received the study medication and had at least one available post-baseline Positive and Negative Syndrome Scale (PANSS) assessment.|
48504535|NCT04158687|101570584|FG002|Efficacy Population|Overall Study||83|Efficacy population included all participants who received the study medication and had at least one available post-baseline Positive and Negative Syndrome Scale (PANSS) assessment.|
48504536|NCT04158687|101570585|FG003|Efficacy Population|Overall Study||77|Efficacy population included all participants who received the study medication and had at least one available post-baseline Positive and Negative Syndrome Scale (PANSS) assessment.|
48504537|NCT04158687|101570582|FG000|COMPLETED|Overall Study||64||
48504538|NCT04158687|101570583|FG001|COMPLETED|Overall Study||54||
48504539|NCT04158687|101570584|FG002|COMPLETED|Overall Study||65||
48504540|NCT04158687|101570585|FG003|COMPLETED|Overall Study||66||
48504541|NCT04158687|101570582|FG000|NOT COMPLETED|Overall Study||17||
48504542|NCT04158687|101570583|FG001|NOT COMPLETED|Overall Study||27||
48504543|NCT04158687|101570584|FG002|NOT COMPLETED|Overall Study||20||
48504544|NCT04158687|101570585|FG003|NOT COMPLETED|Overall Study||13||
48504545|NCT00381849|101570586|FG000|STARTED|First Intervention||10||
48504546|NCT00381849|101570587|FG001|STARTED|First Intervention||10||
48504547|NCT00381849|101570586|FG000|COMPLETED|First Intervention||10||
48504548|NCT00381849|101570587|FG001|COMPLETED|First Intervention||10||
48504549|NCT00381849|101570586|FG000|NOT COMPLETED|First Intervention||0||
48504550|NCT00381849|101570587|FG001|NOT COMPLETED|First Intervention||0||
48504551|NCT00381849|101570586|FG000|STARTED|Wash Out||10||
48504552|NCT00381849|101570587|FG001|STARTED|Wash Out||10||
48504553|NCT00381849|101570586|FG000|COMPLETED|Wash Out||10||
48504554|NCT00381849|101570587|FG001|COMPLETED|Wash Out||9||
48504555|NCT00381849|101570586|FG000|NOT COMPLETED|Wash Out||0||
48504556|NCT00381849|101570587|FG001|NOT COMPLETED|Wash Out||1||
48504557|NCT00381849|101570586|FG000|STARTED|Second Intervention||10||
48504558|NCT00381849|101570587|FG001|STARTED|Second Intervention||9||
48504559|NCT00381849|101570586|FG000|COMPLETED|Second Intervention||10||
48504560|NCT00381849|101570587|FG001|COMPLETED|Second Intervention||9||
48504561|NCT00381849|101570586|FG000|NOT COMPLETED|Second Intervention||0||
48504562|NCT00381849|101570587|FG001|NOT COMPLETED|Second Intervention||0||
48504563|NCT00381849|101570586|FG000|STARTED|Open-label||10||
48504564|NCT00381849|101570587|FG001|STARTED|Open-label||9||
48504565|NCT00381849|101570586|FG000|COMPLETED|Open-label||10||
48504566|NCT00381849|101570587|FG001|COMPLETED|Open-label||9||
48504567|NCT00381849|101570586|FG000|NOT COMPLETED|Open-label||0||
48504568|NCT00381849|101570587|FG001|NOT COMPLETED|Open-label||0||
48504569|NCT00398073|101570588|FG000|STARTED|Overall Study||18||
48504570|NCT00398073|101570589|FG001|STARTED|Overall Study||17||
48504571|NCT00398073|101570588|FG000|COMPLETED|Overall Study||17||
48504572|NCT00398073|101570589|FG001|COMPLETED|Overall Study||17||
48504573|NCT00398073|101570588|FG000|NOT COMPLETED|Overall Study||1||
48504574|NCT00398073|101570589|FG001|NOT COMPLETED|Overall Study||0||
48504575|NCT02466087|101570590|FG000|STARTED|First Intervention: Weeks 1-6||62||
48504576|NCT02466087|101570591|FG001|STARTED|First Intervention: Weeks 1-6||64||
48504577|NCT02466087|101570590|FG000|COMPLETED|First Intervention: Weeks 1-6||55||
48504578|NCT02466087|101570591|FG001|COMPLETED|First Intervention: Weeks 1-6||57||
48504579|NCT02466087|101570590|FG000|NOT COMPLETED|First Intervention: Weeks 1-6||7||
48504580|NCT02466087|101570591|FG001|NOT COMPLETED|First Intervention: Weeks 1-6||7||
48504581|NCT02466087|101570590|FG000|STARTED|Second Intervention: Weeks 7-12||55||
48504582|NCT02466087|101570591|FG001|STARTED|Second Intervention: Weeks 7-12||57||
48504583|NCT02466087|101570590|FG000|COMPLETED|Second Intervention: Weeks 7-12||55||
48504584|NCT02466087|101570591|FG001|COMPLETED|Second Intervention: Weeks 7-12||57||
48504585|NCT02466087|101570590|FG000|NOT COMPLETED|Second Intervention: Weeks 7-12||0||
48504586|NCT02466087|101570591|FG001|NOT COMPLETED|Second Intervention: Weeks 7-12||0||
48504587|NCT01237080|101570592|FG000|STARTED|Overall Study||50||
48504588|NCT01237080|101570593|FG001|STARTED|Overall Study||50||
48504589|NCT01237080|101570592|FG000|COMPLETED|Overall Study||50||
48504590|NCT01237080|101570593|FG001|COMPLETED|Overall Study||50||
48504591|NCT01237080|101570592|FG000|NOT COMPLETED|Overall Study||0||
48504592|NCT01237080|101570593|FG001|NOT COMPLETED|Overall Study||0||
48504593|NCT02046317|101570594|FG000|STARTED|Overall Study||4||
48504594|NCT02046317|101570595|FG001|STARTED|Overall Study||8||
48504595|NCT02046317|101570594|FG000|COMPLETED|Overall Study||4||
48504596|NCT02046317|101570595|FG001|COMPLETED|Overall Study||8||
48504597|NCT02046317|101570594|FG000|NOT COMPLETED|Overall Study||0||
48504598|NCT02046317|101570595|FG001|NOT COMPLETED|Overall Study||0||
48504599|NCT03920280|101570596|FG000|STARTED|Overall Study||41||82
48504600|NCT03920280|101570597|FG001|STARTED|Overall Study||78||156
48504601|NCT03920280|101570596|FG000|COMPLETED|Overall Study||38||76
48504602|NCT03920280|101570597|FG001|COMPLETED|Overall Study||72||144
48504603|NCT03920280|101570596|FG000|NOT COMPLETED|Overall Study||3||6
48504604|NCT03920280|101570597|FG001|NOT COMPLETED|Overall Study||6||12
48504605|NCT03023137|101570598|FG000|STARTED|Overall Study||178||
48504606|NCT03023137|101570599|FG001|STARTED|Overall Study||171||
48504607|NCT03023137|101570598|FG000|COMPLETED|Overall Study||174||
48504608|NCT03023137|101570599|FG001|COMPLETED|Overall Study||162||
48504609|NCT03023137|101570598|FG000|NOT COMPLETED|Overall Study||4||
48504610|NCT03023137|101570599|FG001|NOT COMPLETED|Overall Study||9||
48504611|NCT02328040|101570600|FG000|STARTED|First Intervention (2 Days)||8||
48504612|NCT02328040|101570601|FG001|STARTED|First Intervention (2 Days)||9||
48504613|NCT02328040|101570600|FG000|COMPLETED|First Intervention (2 Days)||7||
48504614|NCT02328040|101570601|FG001|COMPLETED|First Intervention (2 Days)||8||
48504615|NCT02328040|101570600|FG000|NOT COMPLETED|First Intervention (2 Days)||1||
48504616|NCT02328040|101570601|FG001|NOT COMPLETED|First Intervention (2 Days)||1||
48504617|NCT02328040|101570600|FG000|STARTED|Second Intervention (2 Days)||7||
48504618|NCT02328040|101570601|FG001|STARTED|Second Intervention (2 Days)||8||
48504619|NCT02328040|101570600|FG000|COMPLETED|Second Intervention (2 Days)||7||
48504620|NCT02328040|101570601|FG001|COMPLETED|Second Intervention (2 Days)||8||
48504621|NCT02328040|101570600|FG000|NOT COMPLETED|Second Intervention (2 Days)||0||
48504622|NCT02328040|101570601|FG001|NOT COMPLETED|Second Intervention (2 Days)||0||
48504623|NCT01759251|101570602|FG000|STARTED|30 Days Treatment Period||309||
48504624|NCT01759251|101570602|FG000|COMPLETED|30 Days Treatment Period||305||
48504625|NCT01759251|101570602|FG000|NOT COMPLETED|30 Days Treatment Period||4||
48504626|NCT01759251|101570602|FG000|STARTED|60 Days Treatment Period||305||
48504627|NCT01759251|101570602|FG000|COMPLETED|60 Days Treatment Period||305||
48504628|NCT01759251|101570602|FG000|NOT COMPLETED|60 Days Treatment Period||0||
48504629|NCT01759251|101570602|FG000|STARTED|Follow-up Period||305||
48504630|NCT01759251|101570602|FG000|COMPLETED|Follow-up Period||305||
48504631|NCT01759251|101570602|FG000|NOT COMPLETED|Follow-up Period||0||
48504632|NCT02509260|101570603|FG000|STARTED|Overall Study||149||
48504633|NCT02509260|101570604|FG001|STARTED|Overall Study||149||
48504634|NCT02509260|101570603|FG000|COMPLETED|Overall Study||149||
48504635|NCT02509260|101570604|FG001|COMPLETED|Overall Study||149||
48504636|NCT02509260|101570603|FG000|NOT COMPLETED|Overall Study||0||
48504637|NCT02509260|101570604|FG001|NOT COMPLETED|Overall Study||0||
48504638|NCT02834390|101570605|FG000|STARTED|Induction Phase||4||
48504639|NCT02834390|101570606|FG001|STARTED|Induction Phase||3||
48504640|NCT02834390|101570605|FG000|COMPLETED|Induction Phase||2||
48504641|NCT02834390|101570606|FG001|COMPLETED|Induction Phase||1||
48504642|NCT02834390|101570605|FG000|NOT COMPLETED|Induction Phase||2||
48504643|NCT02834390|101570606|FG001|NOT COMPLETED|Induction Phase||2||
48504644|NCT02834390|101570605|FG000|STARTED|Consolidation Phase||2||
48504645|NCT02834390|101570606|FG001|STARTED|Consolidation Phase||1||
48504646|NCT02834390|101570605|FG000|COMPLETED|Consolidation Phase||1||
48504647|NCT02834390|101570606|FG001|COMPLETED|Consolidation Phase||0||
48504648|NCT02834390|101570605|FG000|NOT COMPLETED|Consolidation Phase||1||
48504649|NCT02834390|101570606|FG001|NOT COMPLETED|Consolidation Phase||1||
48504650|NCT03930849|101570607|FG000|STARTED|Overall Study||17||
48504651|NCT03930849|101570608|FG001|STARTED|Overall Study||18||
48504652|NCT03930849|101570609|FG002|STARTED|Overall Study||18||
48504653|NCT03930849|101570607|FG000|COMPLETED|Overall Study||13||
48504654|NCT03930849|101570608|FG001|COMPLETED|Overall Study||18||
48504655|NCT03930849|101570609|FG002|COMPLETED|Overall Study||14||
48504656|NCT03930849|101570607|FG000|NOT COMPLETED|Overall Study||4||
48504657|NCT03930849|101570608|FG001|NOT COMPLETED|Overall Study||0||
48504658|NCT03930849|101570609|FG002|NOT COMPLETED|Overall Study||4||
48504659|NCT04449341|101570610|FG000|STARTED|Overall Study||31||
48504660|NCT04449341|101570611|FG001|STARTED|Overall Study||28||
48504661|NCT04449341|101570610|FG000|COMPLETED|Overall Study||30||
48504662|NCT04449341|101570611|FG001|COMPLETED|Overall Study||28||
48504663|NCT04449341|101570610|FG000|NOT COMPLETED|Overall Study||1||
48504664|NCT04449341|101570611|FG001|NOT COMPLETED|Overall Study||0||
48504665|NCT03256227|101570612|FG000|STARTED|Overall Study||64||
48504666|NCT03256227|101570613|FG001|STARTED|Overall Study||64||
48504667|NCT03256227|101570612|FG000|COMPLETED|Overall Study||36|Completed treatment therapy|
48504668|NCT03256227|101570613|FG001|COMPLETED|Overall Study||25|Completed treatment therapy|
48504669|NCT03256227|101570612|FG000|NOT COMPLETED|Overall Study||28||
48504670|NCT03256227|101570613|FG001|NOT COMPLETED|Overall Study||39||
48504671|NCT00654641|101570614|FG000|STARTED|Overall Study||28||
48504672|NCT00654641|101570615|FG001|STARTED|Overall Study||26||
48504673|NCT00654641|101570614|FG000|COMPLETED|Overall Study||26||
48504674|NCT00654641|101570615|FG001|COMPLETED|Overall Study||23||
48504675|NCT00654641|101570614|FG000|NOT COMPLETED|Overall Study||2||
48504676|NCT00654641|101570615|FG001|NOT COMPLETED|Overall Study||3||
48504677|NCT02786927|101570616|FG000|STARTED|Overall Study||212||
48504678|NCT02786927|101570616|FG000|COMPLETED|Overall Study||207||
48504679|NCT02786927|101570616|FG000|NOT COMPLETED|Overall Study||5||
48504680|NCT01639664|101570617|FG000|STARTED|Overall Study||63||
48504681|NCT01639664|101570618|FG001|STARTED|Overall Study||52||
48504682|NCT01639664|101570617|FG000|COMPLETED|Overall Study||63||
48504683|NCT01639664|101570618|FG001|COMPLETED|Overall Study||52||
48504684|NCT01639664|101570617|FG000|NOT COMPLETED|Overall Study||0||
48504685|NCT01639664|101570618|FG001|NOT COMPLETED|Overall Study||0||
48504686|NCT01170715|101570619|FG000|STARTED|Overall Study||21||
48504687|NCT01170715|101570619|FG000|COMPLETED|Overall Study||14||
48504688|NCT01170715|101570619|FG000|NOT COMPLETED|Overall Study||7||
48504689|NCT04729101|101570620|FG000|STARTED|Overall Study||23||
48504690|NCT04729101|101570621|FG001|STARTED|Overall Study||21||
48504691|NCT04729101|101570620|FG000|Received Treatment|Overall Study||23||
48504692|NCT04729101|101570621|FG001|Received Treatment|Overall Study||21||
48504693|NCT04729101|101570620|FG000|COMPLETED|Overall Study||20||
48504694|NCT04729101|101570621|FG001|COMPLETED|Overall Study||21||
48504695|NCT04729101|101570620|FG000|NOT COMPLETED|Overall Study||3||
48504696|NCT04729101|101570621|FG001|NOT COMPLETED|Overall Study||0||
48504697|NCT05263505|101570622|FG000|STARTED|Overall Study||1||
48504698|NCT05263505|101570623|FG001|STARTED|Overall Study||1||
48504699|NCT05263505|101570622|FG000|COMPLETED|Overall Study||1||
48504700|NCT05263505|101570623|FG001|COMPLETED|Overall Study||0||
48504701|NCT05263505|101570622|FG000|NOT COMPLETED|Overall Study||0||
48504702|NCT05263505|101570623|FG001|NOT COMPLETED|Overall Study||1||
48504703|NCT00834236|101570624|FG000|STARTED|Overall Study||29||
48504704|NCT00834236|101570625|FG001|STARTED|Overall Study||47||
48504705|NCT00834236|101570624|FG000|COMPLETED|Overall Study||29||
48504706|NCT00834236|101570625|FG001|COMPLETED|Overall Study||47||
48504707|NCT00834236|101570624|FG000|NOT COMPLETED|Overall Study||0||
48504708|NCT00834236|101570625|FG001|NOT COMPLETED|Overall Study||0||
48504709|NCT00725764|101570626|FG000|STARTED|Overall Study||14||
48504710|NCT00725764|101570626|FG000|COMPLETED|Overall Study||0||
48504711|NCT00725764|101570626|FG000|NOT COMPLETED|Overall Study||14||
48504712|NCT02888743|101570627|FG000|STARTED|Overall Study||30||
48504713|NCT02888743|101570628|FG001|STARTED|Overall Study||30||
48504714|NCT02888743|101570629|FG002|STARTED|Overall Study||30||
48504715|NCT02888743|101570630|FG003|STARTED|Overall Study||10||
48504716|NCT02888743|101570631|FG004|STARTED|Overall Study||10||
48504717|NCT02888743|101570627|FG000|Received Protocol Therapy|Overall Study||26||
48504718|NCT02888743|101570628|FG001|Received Protocol Therapy|Overall Study||26||
48504719|NCT02888743|101570629|FG002|Received Protocol Therapy|Overall Study||26||
48504720|NCT02888743|101570630|FG003|Received Protocol Therapy|Overall Study||10||
48504721|NCT02888743|101570631|FG004|Received Protocol Therapy|Overall Study||9||
48504722|NCT02888743|101570627|FG000|COMPLETED|Overall Study||26||
48504723|NCT02888743|101570628|FG001|COMPLETED|Overall Study||26||
48504724|NCT02888743|101570629|FG002|COMPLETED|Overall Study||26||
48504725|NCT02888743|101570630|FG003|COMPLETED|Overall Study||10||
48504726|NCT02888743|101570631|FG004|COMPLETED|Overall Study||9||
48504727|NCT02888743|101570627|FG000|NOT COMPLETED|Overall Study||4||
48504728|NCT02888743|101570628|FG001|NOT COMPLETED|Overall Study||4||
48504729|NCT02888743|101570629|FG002|NOT COMPLETED|Overall Study||4||
48504730|NCT02888743|101570630|FG003|NOT COMPLETED|Overall Study||0||
48504731|NCT02888743|101570631|FG004|NOT COMPLETED|Overall Study||1||
48504732|NCT01691612|101570632|FG000|STARTED|Overall Study||14||
48504733|NCT01691612|101570632|FG000|First Visit (Allergen Challenge)|Overall Study||8||
48504734|NCT01691612|101570632|FG000|Second Visit (Bronchoscopy)|Overall Study||7||
48504735|NCT01691612|101570632|FG000|COMPLETED|Overall Study||7||
48504736|NCT01691612|101570632|FG000|NOT COMPLETED|Overall Study||7||
48504737|NCT05258630|101570633|FG000|STARTED|Overall Study||19||
48504738|NCT05258630|101570634|FG001|STARTED|Overall Study||19||
48504739|NCT05258630|101570633|FG000|COMPLETED|Overall Study||18||
48504740|NCT05258630|101570634|FG001|COMPLETED|Overall Study||16||
48504741|NCT05258630|101570633|FG000|NOT COMPLETED|Overall Study||1||
48504742|NCT05258630|101570634|FG001|NOT COMPLETED|Overall Study||3||
48504743|NCT01201486|101570635|FG000|STARTED|Overall Study||6781||
48504744|NCT01201486|101570635|FG000|COMPLETED|Overall Study||6781||
48504745|NCT01201486|101570635|FG000|NOT COMPLETED|Overall Study||0||
48504746|NCT02054754|101570636|FG000|STARTED|Overall Study||6||
48504747|NCT02054754|101570637|FG001|STARTED|Overall Study||6||
48504748|NCT02054754|101570638|FG002|STARTED|Overall Study||6||
48504749|NCT02054754|101570639|FG003|STARTED|Overall Study||6||
48504750|NCT02054754|101570640|FG004|STARTED|Overall Study||6||
48504751|NCT02054754|101570641|FG005|STARTED|Overall Study||10||
48504752|NCT02054754|101570636|FG000|COMPLETED|Overall Study||6||
48504753|NCT02054754|101570637|FG001|COMPLETED|Overall Study||6||
48504754|NCT02054754|101570638|FG002|COMPLETED|Overall Study||6||
48504755|NCT02054754|101570639|FG003|COMPLETED|Overall Study||6||
48504756|NCT02054754|101570640|FG004|COMPLETED|Overall Study||6||
48504757|NCT02054754|101570641|FG005|COMPLETED|Overall Study||10||
48504758|NCT02054754|101570636|FG000|NOT COMPLETED|Overall Study||0||
48504759|NCT02054754|101570637|FG001|NOT COMPLETED|Overall Study||0||
48504760|NCT02054754|101570638|FG002|NOT COMPLETED|Overall Study||0||
48504761|NCT02054754|101570639|FG003|NOT COMPLETED|Overall Study||0||
48504762|NCT02054754|101570640|FG004|NOT COMPLETED|Overall Study||0||
48504763|NCT02054754|101570641|FG005|NOT COMPLETED|Overall Study||0||
48504764|NCT01897077|101570642|FG000|STARTED|Overall Study||0||
48504765|NCT01897077|101570643|FG001|STARTED|Overall Study||5||
48504766|NCT01897077|101570642|FG000|COMPLETED|Overall Study||0||
48504767|NCT01897077|101570643|FG001|COMPLETED|Overall Study||5||
48504768|NCT01897077|101570642|FG000|NOT COMPLETED|Overall Study||0||
48504769|NCT01897077|101570643|FG001|NOT COMPLETED|Overall Study||0||
48504770|NCT03329209|101570644|FG000|STARTED|Overall Study||16||
48504771|NCT03329209|101570644|FG000|COMPLETED|Overall Study||16||
48504772|NCT03329209|101570644|FG000|NOT COMPLETED|Overall Study||0||
48504773|NCT00987480|101570645|FG000|STARTED|Overall Study||45||
48504774|NCT00987480|101570645|FG000|COMPLETED|Overall Study||45||
48504775|NCT00987480|101570645|FG000|NOT COMPLETED|Overall Study||0||
48504776|NCT01044433|101570646|FG000|STARTED|Overall Study||44||
48504777|NCT01044433|101570646|FG000|COMPLETED|Overall Study||38||
48504778|NCT01044433|101570646|FG000|NOT COMPLETED|Overall Study||6||
48504779|NCT02093962|101570647|FG000|STARTED|Overall Study||134||
48504780|NCT02093962|101570648|FG001|STARTED|Overall Study||131||
48504781|NCT02093962|101570647|FG000|Received Treatment|Overall Study||130||
48504782|NCT02093962|101570648|FG001|Received Treatment|Overall Study||130||
48504783|NCT02093962|101570647|FG000|COMPLETED|Overall Study||0||
48504784|NCT02093962|101570648|FG001|COMPLETED|Overall Study||0||
48504785|NCT02093962|101570647|FG000|NOT COMPLETED|Overall Study||134||
48504786|NCT02093962|101570648|FG001|NOT COMPLETED|Overall Study||131||
48504787|NCT03105297|101570649|FG000|STARTED|Baseline Phase (Day 1)||91||
48504788|NCT03105297|101570649|FG000|COMPLETED|Baseline Phase (Day 1)||70||
48504789|NCT03105297|101570649|FG000|NOT COMPLETED|Baseline Phase (Day 1)||21||
48504790|NCT03105297|101570649|FG000|STARTED|Active Phase (Day 2-29)||70||
48504791|NCT03105297|101570649|FG000|COMPLETED|Active Phase (Day 2-29)||70||
48504792|NCT03105297|101570649|FG000|NOT COMPLETED|Active Phase (Day 2-29)||0||
48504793|NCT03105297|101570649|FG000|STARTED|Nasal Resistance Phase (Day 30, 31)||56||
48504794|NCT03105297|101570649|FG000|Treated|Nasal Resistance Phase (Day 30, 31)||55||
48504795|NCT03105297|101570649|FG000|COMPLETED|Nasal Resistance Phase (Day 30, 31)||48||
48504796|NCT03105297|101570649|FG000|NOT COMPLETED|Nasal Resistance Phase (Day 30, 31)||8||
48504797|NCT02297230|101570650|FG000|STARTED|Overall Study||11||
48504798|NCT02297230|101570651|FG001|STARTED|Overall Study||11||
48504799|NCT02297230|101570652|FG002|STARTED|Overall Study||11||
48504800|NCT02297230|101570653|FG003|STARTED|Overall Study||11||
48504801|NCT02297230|101570650|FG000|COMPLETED|Overall Study||11||
48504802|NCT02297230|101570651|FG001|COMPLETED|Overall Study||11||
48504803|NCT02297230|101570652|FG002|COMPLETED|Overall Study||11||
48504804|NCT02297230|101570653|FG003|COMPLETED|Overall Study||11||
48504805|NCT02297230|101570650|FG000|NOT COMPLETED|Overall Study||0||
48504806|NCT02297230|101570651|FG001|NOT COMPLETED|Overall Study||0||
48504807|NCT02297230|101570652|FG002|NOT COMPLETED|Overall Study||0||
48504808|NCT02297230|101570653|FG003|NOT COMPLETED|Overall Study||0||
48504809|NCT02697617|101570654|FG000|STARTED|Overall Study||9||
48504810|NCT02697617|101570655|FG001|STARTED|Overall Study||9||
48504811|NCT02697617|101570654|FG000|COMPLETED|Overall Study||8||
48504812|NCT02697617|101570655|FG001|COMPLETED|Overall Study||7||
48504813|NCT02697617|101570654|FG000|NOT COMPLETED|Overall Study||1||
48504814|NCT02697617|101570655|FG001|NOT COMPLETED|Overall Study||2||
48504815|NCT01824576|101570656|FG000|STARTED|Overall Study||9||
48504816|NCT01824576|101570656|FG000|COMPLETED|Overall Study||7||
48504817|NCT01824576|101570656|FG000|NOT COMPLETED|Overall Study||2||
48504818|NCT03358147|101570657|FG000|STARTED|Overall Study||235|6 subjects were excluded due to overlapping IP exposure|
48504819|NCT03358147|101570658|FG001|STARTED|Overall Study||240|6 subjects were excluded due to overlapping IP exposure|
48504820|NCT03358147|101570659|FG002|STARTED|Overall Study||240|6 subjects were excluded due to overlapping IP exposure|
48504821|NCT03358147|101570660|FG003|STARTED|Overall Study||237|6 subjects were excluded due to overlapping IP exposure|
48504822|NCT03358147|101570661|FG004|STARTED|Overall Study||119|6 subjects were excluded due to overlapping IP exposure|
48504823|NCT03358147|101570657|FG000|COMPLETED|Overall Study||201||
48504824|NCT03358147|101570658|FG001|COMPLETED|Overall Study||201||
48504825|NCT03358147|101570659|FG002|COMPLETED|Overall Study||206||
48504826|NCT03358147|101570660|FG003|COMPLETED|Overall Study||201||
48504827|NCT03358147|101570661|FG004|COMPLETED|Overall Study||105||
48504828|NCT03358147|101570657|FG000|NOT COMPLETED|Overall Study||34||
48504829|NCT03358147|101570658|FG001|NOT COMPLETED|Overall Study||39||
48504830|NCT03358147|101570659|FG002|NOT COMPLETED|Overall Study||34||
48504831|NCT03358147|101570660|FG003|NOT COMPLETED|Overall Study||36||
48666764|NCT03391882|101970469|FG004|STARTED|Post Part A / Pre Part B||18||
48666765|NCT03391882|101970470|FG005|STARTED|Post Part A / Pre Part B||19||
48504832|NCT03358147|101570661|FG004|NOT COMPLETED|Overall Study||14||
48504833|NCT00691704|101570662|FG000|STARTED|Induction Therapy||18||
48504834|NCT00691704|101570662|FG000|COMPLETED|Induction Therapy||16||
48504835|NCT00691704|101570662|FG000|NOT COMPLETED|Induction Therapy||2||
48504836|NCT00691704|101570662|FG000|STARTED|Two Years of Maintenance Therapy||16||
48504837|NCT00691704|101570662|FG000|COMPLETED|Two Years of Maintenance Therapy||3||
48504838|NCT00691704|101570662|FG000|NOT COMPLETED|Two Years of Maintenance Therapy||13||
48504839|NCT01214239|101570663|FG000|STARTED|Overall Study||99||
48504840|NCT01214239|101570664|FG001|STARTED|Overall Study||200||
48504841|NCT01214239|101570663|FG000|COMPLETED|Overall Study||87||
48504842|NCT01214239|101570664|FG001|COMPLETED|Overall Study||182||
48504843|NCT01214239|101570663|FG000|NOT COMPLETED|Overall Study||12||
48504844|NCT01214239|101570664|FG001|NOT COMPLETED|Overall Study||18||
48504845|NCT00377156|101570665|FG000|STARTED|Overall Study||111||
48504846|NCT00377156|101570666|FG001|STARTED|Overall Study||102||
48504847|NCT00377156|101570665|FG000|COMPLETED|Overall Study||63||
48504848|NCT00377156|101570666|FG001|COMPLETED|Overall Study||48||
48504849|NCT00377156|101570665|FG000|NOT COMPLETED|Overall Study||48||
48504850|NCT00377156|101570666|FG001|NOT COMPLETED|Overall Study||54||
48504851|NCT00926367|101570667|FG000|STARTED|Overall Study||25||
48504852|NCT00926367|101570668|FG001|STARTED|Overall Study||27||
48504853|NCT00926367|101570667|FG000|COMPLETED|Overall Study||23||
48504854|NCT00926367|101570668|FG001|COMPLETED|Overall Study||24||
48504855|NCT00926367|101570667|FG000|NOT COMPLETED|Overall Study||2||
48504856|NCT00926367|101570668|FG001|NOT COMPLETED|Overall Study||3||
48504857|NCT02571634|101570669|FG000|STARTED|Overall Study||23||
48504858|NCT02571634|101570669|FG000|COMPLETED|Overall Study||23||
48504859|NCT02571634|101570669|FG000|NOT COMPLETED|Overall Study||0||
48504860|NCT01833754|101570670|FG000|STARTED|Overall Study||8||
48504861|NCT01833754|101570671|FG001|STARTED|Overall Study||8||
48504862|NCT01833754|101570672|FG002|STARTED|Overall Study||8||
48504863|NCT01833754|101570670|FG000|COMPLETED|Overall Study||8||
48504864|NCT01833754|101570671|FG001|COMPLETED|Overall Study||8||
48504865|NCT01833754|101570672|FG002|COMPLETED|Overall Study||8||
48504866|NCT01833754|101570670|FG000|NOT COMPLETED|Overall Study||0||
48504867|NCT01833754|101570671|FG001|NOT COMPLETED|Overall Study||0||
48504868|NCT01833754|101570672|FG002|NOT COMPLETED|Overall Study||0||
48504869|NCT02630316|101570673|FG000|STARTED|Overall Study||163||
48504870|NCT02630316|101570674|FG001|STARTED|Overall Study||163||
48504871|NCT02630316|101570673|FG000|COMPLETED|Overall Study||128||
48504872|NCT02630316|101570674|FG001|COMPLETED|Overall Study||130||
48504873|NCT02630316|101570673|FG000|NOT COMPLETED|Overall Study||35||
48504874|NCT02630316|101570674|FG001|NOT COMPLETED|Overall Study||33||
48504875|NCT01557751|101570675|FG000|STARTED|Overall Study||156||
48504876|NCT01557751|101570675|FG000|COMPLETED|Overall Study||153||
48504877|NCT01557751|101570675|FG000|NOT COMPLETED|Overall Study||3||
48504878|NCT01507233|101570676|FG000|STARTED|Overall Study||5||
48504879|NCT01507233|101570677|FG001|STARTED|Overall Study||0||
48504880|NCT01507233|101570676|FG000|COMPLETED|Overall Study||5||
48504881|NCT01507233|101570677|FG001|COMPLETED|Overall Study||0||
48504882|NCT01507233|101570676|FG000|NOT COMPLETED|Overall Study||0||
48504883|NCT01507233|101570677|FG001|NOT COMPLETED|Overall Study||0||
48504884|NCT02413008|101570678|FG000|STARTED|Overall Study||50||
48504885|NCT02413008|101570679|FG001|STARTED|Overall Study||11||
48504886|NCT02413008|101570678|FG000|COMPLETED|Overall Study||43||
48504887|NCT02413008|101570679|FG001|COMPLETED|Overall Study||9||
48504888|NCT02413008|101570678|FG000|NOT COMPLETED|Overall Study||7||
48504889|NCT02413008|101570679|FG001|NOT COMPLETED|Overall Study||2||
48504890|NCT04194151|101570680|FG000|STARTED|Overall Study||32||
48504891|NCT04194151|101570681|FG001|STARTED|Overall Study||32||
48504892|NCT04194151|101570682|FG002|STARTED|Overall Study||32||
48504893|NCT04194151|101570683|FG003|STARTED|Overall Study||32||
48504894|NCT04194151|101570684|FG004|STARTED|Overall Study||32||
48504895|NCT04194151|101570685|FG005|STARTED|Overall Study||32||
48504896|NCT04194151|101570680|FG000|COMPLETED|Overall Study||31||
48062063|NCT01863953|100472962|FG000|STARTED|Overall Study||38||
48062064|NCT01863953|100472963|FG001|STARTED|Overall Study||36||
48504897|NCT04194151|101570681|FG001|COMPLETED|Overall Study||30||
48504898|NCT04194151|101570682|FG002|COMPLETED|Overall Study||31||
48504899|NCT04194151|101570683|FG003|COMPLETED|Overall Study||31||
48504900|NCT04194151|101570684|FG004|COMPLETED|Overall Study||32||
48504901|NCT04194151|101570685|FG005|COMPLETED|Overall Study||31||
48504902|NCT04194151|101570680|FG000|NOT COMPLETED|Overall Study||1||
48504903|NCT04194151|101570681|FG001|NOT COMPLETED|Overall Study||2||
48504904|NCT04194151|101570682|FG002|NOT COMPLETED|Overall Study||1||
48504905|NCT04194151|101570683|FG003|NOT COMPLETED|Overall Study||1||
48504906|NCT04194151|101570684|FG004|NOT COMPLETED|Overall Study||0||
48504907|NCT04194151|101570685|FG005|NOT COMPLETED|Overall Study||1||
48504908|NCT02005562|101570686|FG000|STARTED|Overall Study||127||
48504909|NCT02005562|101570687|FG001|STARTED|Overall Study||125||
48504910|NCT02005562|101570686|FG000|Transplanted|Overall Study||126||
48504911|NCT02005562|101570687|FG001|Transplanted|Overall Study||121||
48504912|NCT02005562|101570686|FG000|COMPLETED|Overall Study||115||
48504913|NCT02005562|101570687|FG001|COMPLETED|Overall Study||110||
48504914|NCT02005562|101570686|FG000|NOT COMPLETED|Overall Study||12||
48504915|NCT02005562|101570687|FG001|NOT COMPLETED|Overall Study||15||
48504916|NCT00397254|101570688|FG000|STARTED|Overall Study||79||
48504917|NCT00397254|101570689|FG001|STARTED|Overall Study||76||
48504918|NCT00397254|101570688|FG000|COMPLETED|Overall Study||77||
48504919|NCT00397254|101570689|FG001|COMPLETED|Overall Study||74||
48504920|NCT00397254|101570688|FG000|NOT COMPLETED|Overall Study||2||
48504921|NCT00397254|101570689|FG001|NOT COMPLETED|Overall Study||2||
48504922|NCT01562132|101570690|FG000|STARTED|Overall Study||3||
48504923|NCT01562132|101570691|FG001|STARTED|Overall Study||3||
48504924|NCT01562132|101570690|FG000|COMPLETED|Overall Study||3||
48504925|NCT01562132|101570691|FG001|COMPLETED|Overall Study||3||
48504926|NCT01562132|101570690|FG000|NOT COMPLETED|Overall Study||0||
48504927|NCT01562132|101570691|FG001|NOT COMPLETED|Overall Study||0||
48504928|NCT02219009|101570692|FG000|STARTED|Overall Study||37||
48504929|NCT02219009|101570693|FG001|STARTED|Overall Study||30||
48504930|NCT02219009|101570692|FG000|COMPLETED|Overall Study||27||
48504931|NCT02219009|101570693|FG001|COMPLETED|Overall Study||22||
48504932|NCT02219009|101570692|FG000|NOT COMPLETED|Overall Study||10||
48504933|NCT02219009|101570693|FG001|NOT COMPLETED|Overall Study||8||
48504934|NCT02166606|101570694|FG000|STARTED|Overall Study||1184||
48504935|NCT02166606|101570694|FG000|Actively Enrolled|Overall Study||1180||
48504936|NCT02166606|101570694|FG000|Consent Eligible|Overall Study||1174||
48504937|NCT02166606|101570694|FG000|COMPLETED|Overall Study||1106||
48504938|NCT02166606|101570694|FG000|NOT COMPLETED|Overall Study||78||
48504939|NCT03110380|101570695|FG000|STARTED|Double-Blind Treatment Phase||284||
48504940|NCT03110380|101570696|FG001|STARTED|Double-Blind Treatment Phase||283||
48504941|NCT03110380|101570697|FG002|STARTED|Double-Blind Treatment Phase||0||
48504942|NCT03110380|101570698|FG003|STARTED|Double-Blind Treatment Phase||0||
48504943|NCT03110380|101570695|FG000|Safety Analysis Set|Double-Blind Treatment Phase||284||
48504944|NCT03110380|101570696|FG001|Safety Analysis Set|Double-Blind Treatment Phase||281||
48504945|NCT03110380|101570697|FG002|Safety Analysis Set|Double-Blind Treatment Phase||0||
48504946|NCT03110380|101570698|FG003|Safety Analysis Set|Double-Blind Treatment Phase||0||
48504947|NCT03110380|101570695|FG000|COMPLETED|Double-Blind Treatment Phase||263||
48504948|NCT03110380|101570696|FG001|COMPLETED|Double-Blind Treatment Phase||253||
48504949|NCT03110380|101570697|FG002|COMPLETED|Double-Blind Treatment Phase||0||
48504950|NCT03110380|101570698|FG003|COMPLETED|Double-Blind Treatment Phase||0||
48504951|NCT03110380|101570695|FG000|NOT COMPLETED|Double-Blind Treatment Phase||21||
48504952|NCT03110380|101570696|FG001|NOT COMPLETED|Double-Blind Treatment Phase||30||
48504953|NCT03110380|101570697|FG002|NOT COMPLETED|Double-Blind Treatment Phase||0||
48504954|NCT03110380|101570698|FG003|NOT COMPLETED|Double-Blind Treatment Phase||0||
48504955|NCT03110380|101570695|FG000|STARTED|Open-label B/F/TAF Extension Phase||0||
48504956|NCT03110380|101570696|FG001|STARTED|Open-label B/F/TAF Extension Phase||0||
48504957|NCT03110380|101570697|FG002|STARTED|Open-label B/F/TAF Extension Phase||125||
48504958|NCT03110380|101570698|FG003|STARTED|Open-label B/F/TAF Extension Phase||116||
48504959|NCT03110380|101570695|FG000|COMPLETED|Open-label B/F/TAF Extension Phase||0||
48504960|NCT03110380|101570696|FG001|COMPLETED|Open-label B/F/TAF Extension Phase||0||
48504961|NCT03110380|101570697|FG002|COMPLETED|Open-label B/F/TAF Extension Phase||121||
48504962|NCT03110380|101570698|FG003|COMPLETED|Open-label B/F/TAF Extension Phase||113||
48504963|NCT03110380|101570695|FG000|NOT COMPLETED|Open-label B/F/TAF Extension Phase||0||
48504964|NCT03110380|101570696|FG001|NOT COMPLETED|Open-label B/F/TAF Extension Phase||0||
48504965|NCT03110380|101570697|FG002|NOT COMPLETED|Open-label B/F/TAF Extension Phase||4||
48504966|NCT03110380|101570698|FG003|NOT COMPLETED|Open-label B/F/TAF Extension Phase||3||
48504967|NCT02578641|101570699|FG000|STARTED|Overall Study||164||
48504968|NCT02578641|101570700|FG001|STARTED|Overall Study||166||
48504969|NCT02578641|101570699|FG000|Treatment Received: Gemcitabine/ Carboplatin|Overall Study||163||
48504970|NCT02578641|101570700|FG001|Treatment Received: Gemcitabine/ Carboplatin|Overall Study||162||
48504971|NCT02578641|101570699|FG000|Treatment Received: EBV-CTL|Overall Study||133||
48504972|NCT02578641|101570700|FG001|Treatment Received: EBV-CTL|Overall Study||0||
48504973|NCT02578641|101570699|FG000|COMPLETED|Overall Study||55||
48504974|NCT02578641|101570700|FG001|COMPLETED|Overall Study||99||
48504975|NCT02578641|101570699|FG000|NOT COMPLETED|Overall Study||109||
48504976|NCT02578641|101570700|FG001|NOT COMPLETED|Overall Study||67||
48504977|NCT04084990|101570701|FG000|STARTED|Overall Study||2||
48504978|NCT04084990|101570702|FG001|STARTED|Overall Study||1||
48504979|NCT04084990|101570701|FG000|COMPLETED|Overall Study||2||
48504980|NCT04084990|101570702|FG001|COMPLETED|Overall Study||1||
48504981|NCT04084990|101570701|FG000|NOT COMPLETED|Overall Study||0||
48504982|NCT04084990|101570702|FG001|NOT COMPLETED|Overall Study||0||
48504983|NCT03237156|101570703|FG000|STARTED|Overall Study||6||
48504984|NCT03237156|101570704|FG001|STARTED|Overall Study||6||
48504985|NCT03237156|101570705|FG002|STARTED|Overall Study||6||
48504986|NCT03237156|101570706|FG003|STARTED|Overall Study||6||
48504987|NCT03237156|101570703|FG000|COMPLETED|Overall Study||6||
48504988|NCT03237156|101570704|FG001|COMPLETED|Overall Study||6||
48504989|NCT03237156|101570705|FG002|COMPLETED|Overall Study||6||
48504990|NCT03237156|101570706|FG003|COMPLETED|Overall Study||6||
48504991|NCT03237156|101570703|FG000|NOT COMPLETED|Overall Study||0||
48504992|NCT03237156|101570704|FG001|NOT COMPLETED|Overall Study||0||
48504993|NCT03237156|101570705|FG002|NOT COMPLETED|Overall Study||0||
48504994|NCT03237156|101570706|FG003|NOT COMPLETED|Overall Study||0||
48504995|NCT05692154|101570707|FG000|STARTED|Overall Study||47||
48504996|NCT05692154|101570708|FG001|STARTED|Overall Study||48||
48504997|NCT05692154|101570707|FG000|Intent To Treat (ITT) Analysis Set|Overall Study||47|The ITT set contained all eligible participants (passed screening and confirmation challenge) who had been allocated to a randomized treatment regardless of whether study drug wallet was used or not.|
48504998|NCT05692154|101570708|FG001|Intent To Treat (ITT) Analysis Set|Overall Study||48|The ITT set contained all eligible participants (passed screening and confirmation challenge) who had been allocated to a randomized treatment regardless of whether study drug wallet was used or not.|
48666766|NCT03391882|101970465|FG000|COMPLETED|Post Part A / Pre Part B||0||
48504999|NCT05692154|101570707|FG000|Safety Analysis (SAF) Set|Overall Study||47|The SAF set contained all participants in the ITT set who received at least one dose of study drug and participants were classified according to treatment received.|
48505000|NCT05692154|101570708|FG001|Safety Analysis (SAF) Set|Overall Study||47|The SAF set contained all participants in the ITT set who received at least one dose of study drug and participants were classified according to treatment received.|
48505001|NCT05692154|101570707|FG000|Modified Intent-to-Treat (mITT) Analysis Set|Overall Study||47|The mITT analysis set contained all eligible, ITT, and treated participants with Total Nasal Symptom Score of 3 symptoms (TNSS-3) evaluation Hour 0 (H0) at visit 4 (V4) and at least a further time point at Visit 4.|
48505002|NCT05692154|101570708|FG001|Modified Intent-to-Treat (mITT) Analysis Set|Overall Study||47|The mITT analysis set contained all eligible, ITT, and treated participants with Total Nasal Symptom Score of 3 symptoms (TNSS-3) evaluation Hour 0 (H0) at visit 4 (V4) and at least a further time point at Visit 4.|
48505003|NCT05692154|101570707|FG000|COMPLETED|Overall Study||47||
48505004|NCT05692154|101570708|FG001|COMPLETED|Overall Study||47||
48505005|NCT05692154|101570707|FG000|NOT COMPLETED|Overall Study||0||
48505006|NCT05692154|101570708|FG001|NOT COMPLETED|Overall Study||1||
48505007|NCT03496298|101570709|FG000|STARTED|Overall Study||1359|Randomized.|
48505008|NCT03496298|101570710|FG001|STARTED|Overall Study||1359|Randomized.|
48505009|NCT03496298|101570711|FG002|STARTED|Overall Study||1358|Randomized.|
48505010|NCT03496298|101570709|FG000|Randomized and Treated|Overall Study||1358||
48505011|NCT03496298|101570710|FG001|Randomized and Treated|Overall Study||1358||
48505012|NCT03496298|101570711|FG002|Randomized and Treated|Overall Study||1357||
48505013|NCT03496298|101570709|FG000|Safety Population|Overall Study||1355|Safety population included all randomized participants who had received at least 1 dose of double-blind treatment, regardless of the amount of treatment administered and were analyzed according to treatment actually received.|
48062065|NCT01863953|100472964|FG002|STARTED|Overall Study||38||
48062066|NCT01863953|100472962|FG000|COMPLETED|Overall Study||38||
48062067|NCT01863953|100472963|FG001|COMPLETED|Overall Study||36||
48505014|NCT03496298|101570710|FG001|Safety Population|Overall Study||1360|Safety population included all randomized participants who had received at least 1 dose of double-blind treatment, regardless of the amount of treatment administered and were analyzed according to treatment actually received.|
48505015|NCT03496298|101570711|FG002|Safety Population|Overall Study||1358|Safety population included all randomized participants who had received at least 1 dose of double-blind treatment, regardless of the amount of treatment administered and were analyzed according to treatment actually received.|
48505016|NCT03496298|101570709|FG000|COMPLETED|Overall Study||42||
48505017|NCT03496298|101570710|FG001|COMPLETED|Overall Study||36||
48505018|NCT03496298|101570711|FG002|COMPLETED|Overall Study||23||
48505019|NCT03496298|101570709|FG000|NOT COMPLETED|Overall Study||1317||
48505020|NCT03496298|101570710|FG001|NOT COMPLETED|Overall Study||1323||
48505021|NCT03496298|101570711|FG002|NOT COMPLETED|Overall Study||1335||
48505022|NCT02361736|101570712|FG000|STARTED|Overall Study||60||
48505023|NCT02361736|101570713|FG001|STARTED|Overall Study||60||
48505024|NCT02361736|101570712|FG000|COMPLETED|Overall Study||59||
48505025|NCT02361736|101570713|FG001|COMPLETED|Overall Study||59||
48505026|NCT02361736|101570712|FG000|NOT COMPLETED|Overall Study||1||
48505027|NCT02361736|101570713|FG001|NOT COMPLETED|Overall Study||1||
48505028|NCT01098539|101570714|FG000|STARTED|Overall Study||249||
48505029|NCT01098539|101570715|FG001|STARTED|Overall Study||246||
48505030|NCT01098539|101570714|FG000|COMPLETED|Overall Study||198||
48505031|NCT01098539|101570715|FG001|COMPLETED|Overall Study||178||
48505032|NCT01098539|101570714|FG000|NOT COMPLETED|Overall Study||51||
48505033|NCT01098539|101570715|FG001|NOT COMPLETED|Overall Study||68||
48505034|NCT01041209|101570716|FG000|STARTED|Overall Study||60||
48505035|NCT01041209|101570717|FG001|STARTED|Overall Study||60||
48505036|NCT01041209|101570716|FG000|COMPLETED|Overall Study||60||
48505037|NCT01041209|101570717|FG001|COMPLETED|Overall Study||60||
48505038|NCT01041209|101570716|FG000|NOT COMPLETED|Overall Study||0||
48505039|NCT01041209|101570717|FG001|NOT COMPLETED|Overall Study||0||
48505040|NCT02377349|101570718|FG000|STARTED|Overall Study||341||
48505041|NCT02377349|101570719|FG001|STARTED|Overall Study||346||
48505042|NCT02377349|101570718|FG000|COMPLETED|Overall Study||325||
48505043|NCT02377349|101570719|FG001|COMPLETED|Overall Study||335||
48505044|NCT02377349|101570718|FG000|NOT COMPLETED|Overall Study||16||
48505045|NCT02377349|101570719|FG001|NOT COMPLETED|Overall Study||11||
48505046|NCT01451996|101570720|FG000|STARTED|Overall Study||83||
48505047|NCT01451996|101570721|FG001|STARTED|Overall Study||87||
48505048|NCT01451996|101570722|FG002|STARTED|Overall Study||85||
48505049|NCT01451996|101570723|FG003|STARTED|Overall Study||85||
48505050|NCT01451996|101570720|FG000|COMPLETED|Overall Study||83||
48505051|NCT01451996|101570721|FG001|COMPLETED|Overall Study||87||
48505052|NCT01451996|101570722|FG002|COMPLETED|Overall Study||85||
48505053|NCT01451996|101570723|FG003|COMPLETED|Overall Study||85||
48505054|NCT01451996|101570720|FG000|NOT COMPLETED|Overall Study||0||
48505055|NCT01451996|101570721|FG001|NOT COMPLETED|Overall Study||0||
48505056|NCT01451996|101570722|FG002|NOT COMPLETED|Overall Study||0||
48505057|NCT01451996|101570723|FG003|NOT COMPLETED|Overall Study||0||
48505058|NCT01142908|101570724|FG000|STARTED|Overall Study||215||
48505059|NCT01142908|101570725|FG001|STARTED|Overall Study||213||
48505060|NCT01142908|101570724|FG000|6 Month f/u|Overall Study||188||
48505061|NCT01142908|101570725|FG001|6 Month f/u|Overall Study||196||
48062068|NCT01863953|100472964|FG002|COMPLETED|Overall Study||37||
48062069|NCT01863953|100472962|FG000|NOT COMPLETED|Overall Study||0||
48505062|NCT01142908|101570724|FG000|COMPLETED|Overall Study||183||
48505063|NCT01142908|101570725|FG001|COMPLETED|Overall Study||191||
48505064|NCT01142908|101570724|FG000|NOT COMPLETED|Overall Study||32||
48505065|NCT01142908|101570725|FG001|NOT COMPLETED|Overall Study||22||
48505066|NCT01833169|101570726|FG000|STARTED|Overall Study||146||
48505067|NCT01833169|101570726|FG000|Consented to be Followed for Survival|Overall Study||128||
48505068|NCT01833169|101570726|FG000|COMPLETED|Overall Study||0||
48505069|NCT01833169|101570726|FG000|NOT COMPLETED|Overall Study||146||
48505070|NCT03366194|101570727|FG000|STARTED|Overall Study||36||
48505071|NCT03366194|101570727|FG000|COMPLETED|Overall Study||34||
48505072|NCT03366194|101570727|FG000|NOT COMPLETED|Overall Study||2||
48505073|NCT01952691|101570728|FG000|STARTED|Overall Study||22||
48505074|NCT01952691|101570728|FG000|COMPLETED|Overall Study||20||
48505075|NCT01952691|101570728|FG000|NOT COMPLETED|Overall Study||2||
48505076|NCT03234608|101570729|FG000|STARTED|Overall Study||127||
48505077|NCT03234608|101570730|FG001|STARTED|Overall Study||117||
48505078|NCT03234608|101570729|FG000|COMPLETED|Overall Study||104||
48505079|NCT03234608|101570730|FG001|COMPLETED|Overall Study||96||
48505080|NCT03234608|101570729|FG000|NOT COMPLETED|Overall Study||23||
48505081|NCT03234608|101570730|FG001|NOT COMPLETED|Overall Study||21||
48505082|NCT01109849|101570731|FG000|STARTED|Initial Randomization: ADHD Treatment||50||
48505083|NCT01109849|101570732|FG001|STARTED|Initial Randomization: ADHD Treatment||180||
48505084|NCT01109849|101570733|FG002|STARTED|Initial Randomization: ADHD Treatment||0||
48505085|NCT01109849|101570734|FG003|STARTED|Initial Randomization: ADHD Treatment||0||
48505086|NCT01109849|101570735|FG004|STARTED|Initial Randomization: ADHD Treatment||0||
48505087|NCT01109849|101570731|FG000|COMPLETED|Initial Randomization: ADHD Treatment||32||
48505088|NCT01109849|101570732|FG001|COMPLETED|Initial Randomization: ADHD Treatment||131||
48505089|NCT01109849|101570733|FG002|COMPLETED|Initial Randomization: ADHD Treatment||0||
48505090|NCT01109849|101570734|FG003|COMPLETED|Initial Randomization: ADHD Treatment||0||
48505091|NCT01109849|101570735|FG004|COMPLETED|Initial Randomization: ADHD Treatment||0||
48505092|NCT01109849|101570731|FG000|NOT COMPLETED|Initial Randomization: ADHD Treatment||18||
48505093|NCT01109849|101570732|FG001|NOT COMPLETED|Initial Randomization: ADHD Treatment||49||
48505094|NCT01109849|101570733|FG002|NOT COMPLETED|Initial Randomization: ADHD Treatment||0||
48505095|NCT01109849|101570734|FG003|NOT COMPLETED|Initial Randomization: ADHD Treatment||0||
48505096|NCT01109849|101570735|FG004|NOT COMPLETED|Initial Randomization: ADHD Treatment||0||
48505097|NCT01109849|101570731|FG000|STARTED|Adaptive Randomization: Weight Recovery||0||
48505098|NCT01109849|101570732|FG001|STARTED|Adaptive Randomization: Weight Recovery||0||
48505099|NCT01109849|101570733|FG002|STARTED|Adaptive Randomization: Weight Recovery||24||
48505100|NCT01109849|101570734|FG003|STARTED|Adaptive Randomization: Weight Recovery||23||
48505101|NCT01109849|101570735|FG004|STARTED|Adaptive Randomization: Weight Recovery||25||
48505102|NCT01109849|101570731|FG000|COMPLETED|Adaptive Randomization: Weight Recovery||0||
48505103|NCT01109849|101570732|FG001|COMPLETED|Adaptive Randomization: Weight Recovery||0||
48505104|NCT01109849|101570733|FG002|COMPLETED|Adaptive Randomization: Weight Recovery||23||
48505105|NCT01109849|101570734|FG003|COMPLETED|Adaptive Randomization: Weight Recovery||20||
48505106|NCT01109849|101570735|FG004|COMPLETED|Adaptive Randomization: Weight Recovery||24||
48505107|NCT01109849|101570731|FG000|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0||
48505108|NCT01109849|101570732|FG001|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0||
48505109|NCT01109849|101570733|FG002|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1||
48505110|NCT01109849|101570734|FG003|NOT COMPLETED|Adaptive Randomization: Weight Recovery||3||
48505111|NCT01109849|101570735|FG004|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1||
48505112|NCT02000115|101570736|FG000|STARTED|Overall Study||381||
48505113|NCT02000115|101570737|FG001|STARTED|Overall Study||369||
48505114|NCT02000115|101570738|FG002|STARTED|Overall Study||100||
48505115|NCT02000115|101570739|FG003|STARTED|Overall Study||53||
48505116|NCT02000115|101570736|FG000|COMPLETED|Overall Study||302||
48505117|NCT02000115|101570737|FG001|COMPLETED|Overall Study||301||
48505118|NCT02000115|101570738|FG002|COMPLETED|Overall Study||99||
48505119|NCT02000115|101570739|FG003|COMPLETED|Overall Study||0||
48505120|NCT02000115|101570736|FG000|NOT COMPLETED|Overall Study||79||
48505121|NCT02000115|101570737|FG001|NOT COMPLETED|Overall Study||68||
48505122|NCT02000115|101570738|FG002|NOT COMPLETED|Overall Study||1||
48505123|NCT02000115|101570739|FG003|NOT COMPLETED|Overall Study||53||
48505124|NCT01819064|101570740|FG000|STARTED|Overall Study||60||
48505125|NCT01819064|101570740|FG000|COMPLETED|Overall Study||60||
48505126|NCT01819064|101570740|FG000|NOT COMPLETED|Overall Study||0||
48505127|NCT01898598|101570741|FG000|STARTED|Overall Study||12||
48505128|NCT01898598|101570742|FG001|STARTED|Overall Study||6||
48505129|NCT01898598|101570741|FG000|Treated|Overall Study||11||
48505130|NCT01898598|101570742|FG001|Treated|Overall Study||5||
48505131|NCT01898598|101570741|FG000|COMPLETED|Overall Study||8||
48505132|NCT01898598|101570742|FG001|COMPLETED|Overall Study||4||
48505133|NCT01898598|101570741|FG000|NOT COMPLETED|Overall Study||4||
48505134|NCT01898598|101570742|FG001|NOT COMPLETED|Overall Study||2||
48505135|NCT02914457|101570743|FG000|STARTED|Overall Study||31||
48505136|NCT02914457|101570743|FG000|COMPLETED|Overall Study||25||
48505137|NCT02914457|101570743|FG000|NOT COMPLETED|Overall Study||6||
48505138|NCT00851006|101570744|FG000|STARTED|Overall Study||7||
48505139|NCT00851006|101570745|FG001|STARTED|Overall Study||6||
48505140|NCT00851006|101570744|FG000|COMPLETED|Overall Study||7||
48505141|NCT00851006|101570745|FG001|COMPLETED|Overall Study||6||
48505142|NCT00851006|101570744|FG000|NOT COMPLETED|Overall Study||0||
48505143|NCT00851006|101570745|FG001|NOT COMPLETED|Overall Study||0||
48505144|NCT01398839|101570746|FG000|STARTED|Overall Study||35||
48505145|NCT01398839|101570747|FG001|STARTED|Overall Study||37||
48505146|NCT01398839|101570746|FG000|COMPLETED|Overall Study||35||
48505147|NCT01398839|101570747|FG001|COMPLETED|Overall Study||37||
48505148|NCT01398839|101570746|FG000|NOT COMPLETED|Overall Study||0||
48505149|NCT01398839|101570747|FG001|NOT COMPLETED|Overall Study||0||
48505150|NCT02105701|101570748|FG000|STARTED|Overall Study||105||
48505151|NCT02105701|101570749|FG001|STARTED|Overall Study||104||
48505152|NCT02105701|101570750|FG002|STARTED|Overall Study||105||
48505153|NCT02105701|101570751|FG003|STARTED|Overall Study||106||
48505154|NCT02105701|101570748|FG000|COMPLETED|Overall Study||101||
48505155|NCT02105701|101570749|FG001|COMPLETED|Overall Study||103||
48505156|NCT02105701|101570750|FG002|COMPLETED|Overall Study||102||
48505157|NCT02105701|101570751|FG003|COMPLETED|Overall Study||104||
48505158|NCT02105701|101570748|FG000|NOT COMPLETED|Overall Study||4||
48505159|NCT02105701|101570749|FG001|NOT COMPLETED|Overall Study||1||
48505160|NCT02105701|101570750|FG002|NOT COMPLETED|Overall Study||3||
48505161|NCT02105701|101570751|FG003|NOT COMPLETED|Overall Study||2||
48505162|NCT02248714|101570752|FG000|STARTED|Overall Study||66||
48505163|NCT02248714|101570753|FG001|STARTED|Overall Study||65||
48505164|NCT02248714|101570752|FG000|COMPLETED|Overall Study||62||
48505165|NCT02248714|101570753|FG001|COMPLETED|Overall Study||61||
48505166|NCT02248714|101570752|FG000|NOT COMPLETED|Overall Study||4||
48505167|NCT02248714|101570753|FG001|NOT COMPLETED|Overall Study||4||
48505168|NCT01578317|101570754|FG000|STARTED|Overall Study||22||
48505169|NCT01578317|101570755|FG001|STARTED|Overall Study||21||
48505170|NCT01578317|101570754|FG000|Analysis Population|Overall Study||22||
48505171|NCT01578317|101570755|FG001|Analysis Population|Overall Study||20||
48505172|NCT01578317|101570754|FG000|COMPLETED|Overall Study||22||
48505173|NCT01578317|101570755|FG001|COMPLETED|Overall Study||20||
48062070|NCT01863953|100472963|FG001|NOT COMPLETED|Overall Study||0||
48062071|NCT01863953|100472964|FG002|NOT COMPLETED|Overall Study||1||
48505174|NCT01578317|101570754|FG000|NOT COMPLETED|Overall Study||0||
48505175|NCT01578317|101570755|FG001|NOT COMPLETED|Overall Study||1||
48505176|NCT03790137|101570756|FG000|STARTED|Overall Study||20||
48505177|NCT03790137|101570756|FG000|COMPLETED|Overall Study||19||
48505178|NCT03790137|101570756|FG000|NOT COMPLETED|Overall Study||1||
48505179|NCT01408888|101570757|FG000|STARTED|First Intervention||18||
48505180|NCT01408888|101570758|FG001|STARTED|First Intervention||11||
48505181|NCT01408888|101570757|FG000|Received at Least 1 Dose of Drug|First Intervention||18||
48505182|NCT01408888|101570758|FG001|Received at Least 1 Dose of Drug|First Intervention||11||
48505183|NCT01408888|101570757|FG000|COMPLETED|First Intervention||18||
48505184|NCT01408888|101570758|FG001|COMPLETED|First Intervention||8||
48505185|NCT01408888|101570757|FG000|NOT COMPLETED|First Intervention||0||
48505186|NCT01408888|101570758|FG001|NOT COMPLETED|First Intervention||3||
48505187|NCT01408888|101570757|FG000|STARTED|Washout of at Least 21 Days||18||
48505188|NCT01408888|101570758|FG001|STARTED|Washout of at Least 21 Days||8||
48505189|NCT01408888|101570757|FG000|COMPLETED|Washout of at Least 21 Days||18||
48505190|NCT01408888|101570758|FG001|COMPLETED|Washout of at Least 21 Days||8||
48505191|NCT01408888|101570757|FG000|NOT COMPLETED|Washout of at Least 21 Days||0||
48505192|NCT01408888|101570758|FG001|NOT COMPLETED|Washout of at Least 21 Days||0||
48505193|NCT01408888|101570757|FG000|STARTED|Second Intervention||18||
48505194|NCT01408888|101570758|FG001|STARTED|Second Intervention||8||
48505195|NCT01408888|101570757|FG000|COMPLETED|Second Intervention||16||
48505196|NCT01408888|101570758|FG001|COMPLETED|Second Intervention||8||
48505197|NCT01408888|101570757|FG000|NOT COMPLETED|Second Intervention||2||
48505198|NCT01408888|101570758|FG001|NOT COMPLETED|Second Intervention||0||
48505199|NCT02169336|101570759|FG000|STARTED|Overall Study||31||
48505200|NCT02169336|101570760|FG001|STARTED|Overall Study||32||
48505201|NCT02169336|101570761|FG002|STARTED|Overall Study||32||
48505202|NCT02169336|101570759|FG000|COMPLETED|Overall Study||27||
48505203|NCT02169336|101570760|FG001|COMPLETED|Overall Study||28||
48505204|NCT02169336|101570761|FG002|COMPLETED|Overall Study||29||
48505205|NCT02169336|101570759|FG000|NOT COMPLETED|Overall Study||4||
48505206|NCT02169336|101570760|FG001|NOT COMPLETED|Overall Study||4||
48505207|NCT02169336|101570761|FG002|NOT COMPLETED|Overall Study||3||
48505208|NCT01176981|101570762|FG000|STARTED|Overall Study||6||
48505209|NCT01176981|101570762|FG000|COMPLETED|Overall Study||6||
48505210|NCT01176981|101570762|FG000|NOT COMPLETED|Overall Study||0||
48505211|NCT00842309|101570763|FG000|STARTED|Overall Study||14||
48505212|NCT00842309|101570764|FG001|STARTED|Overall Study||14||
48505213|NCT00842309|101570763|FG000|COMPLETED|Overall Study||11||
48505214|NCT00842309|101570764|FG001|COMPLETED|Overall Study||13||
48505215|NCT00842309|101570763|FG000|NOT COMPLETED|Overall Study||3||
48505216|NCT00842309|101570764|FG001|NOT COMPLETED|Overall Study||1||
48505217|NCT01634854|101570765|FG000|STARTED|Overall Study||64||
48505218|NCT01634854|101570766|FG001|STARTED|Overall Study||66||
48505219|NCT01634854|101570765|FG000|COMPLETED|Overall Study||62||
48505220|NCT01634854|101570766|FG001|COMPLETED|Overall Study||59||
48505221|NCT01634854|101570765|FG000|NOT COMPLETED|Overall Study||2||
48505222|NCT01634854|101570766|FG001|NOT COMPLETED|Overall Study||7||
48505223|NCT00743145|101570767|FG000|STARTED|Overall Study||23||
48505224|NCT00743145|101570767|FG000|COMPLETED|Overall Study||19||
48505225|NCT00743145|101570767|FG000|NOT COMPLETED|Overall Study||4||
48505226|NCT00090753|101570768|FG000|STARTED|First Treatment Period||748||
48505227|NCT00090753|101570769|FG001|STARTED|First Treatment Period||480||
48505228|NCT00090753|101570768|FG000|COMPLETED|First Treatment Period||492||
48505229|NCT00090753|101570769|FG001|COMPLETED|First Treatment Period||302||
48505230|NCT00090753|101570768|FG000|NOT COMPLETED|First Treatment Period||256||
48505231|NCT00090753|101570769|FG001|NOT COMPLETED|First Treatment Period||178||
48505232|NCT00090753|101570768|FG000|STARTED|Extended Treatment Period||453||
48505233|NCT00090753|101570769|FG001|STARTED|Extended Treatment Period||250||
48505234|NCT00090753|101570768|FG000|COMPLETED|Extended Treatment Period||94||
48505235|NCT00090753|101570769|FG001|COMPLETED|Extended Treatment Period||59||
48505236|NCT00090753|101570768|FG000|NOT COMPLETED|Extended Treatment Period||359||
48505237|NCT00090753|101570769|FG001|NOT COMPLETED|Extended Treatment Period||191||
48505238|NCT00762411|101570770|FG000|STARTED|Initial Treatment||556||
48505239|NCT00762411|101570771|FG001|STARTED|Initial Treatment||555||
48505240|NCT00762411|101570770|FG000|Intent-to-treat (ITT)|Initial Treatment||555||
48505241|NCT00762411|101570771|FG001|Intent-to-treat (ITT)|Initial Treatment||553||
48505242|NCT00762411|101570770|FG000|COMPLETED|Initial Treatment||22||
48505243|NCT00762411|101570771|FG001|COMPLETED|Initial Treatment||34||
48505244|NCT00762411|101570770|FG000|NOT COMPLETED|Initial Treatment||534||
48505245|NCT00762411|101570771|FG001|NOT COMPLETED|Initial Treatment||521||
48505246|NCT00762411|101570770|FG000|STARTED|Delayed Start||22||
48505247|NCT00762411|101570771|FG001|STARTED|Delayed Start||34||
48505248|NCT00762411|101570770|FG000|COMPLETED|Delayed Start||5||
48505249|NCT00762411|101570771|FG001|COMPLETED|Delayed Start||8||
48505250|NCT00762411|101570770|FG000|NOT COMPLETED|Delayed Start||17||
48505251|NCT00762411|101570771|FG001|NOT COMPLETED|Delayed Start||26||
48505252|NCT00762411|101570770|FG000|STARTED|Safety Follow Up (SFU)-Optional||312||
48505253|NCT00762411|101570771|FG001|STARTED|Safety Follow Up (SFU)-Optional||430||
48505254|NCT00762411|101570770|FG000|COMPLETED|Safety Follow Up (SFU)-Optional||228||
48505255|NCT00762411|101570771|FG001|COMPLETED|Safety Follow Up (SFU)-Optional||312||
48505256|NCT00762411|101570770|FG000|NOT COMPLETED|Safety Follow Up (SFU)-Optional||84||
48505257|NCT00762411|101570771|FG001|NOT COMPLETED|Safety Follow Up (SFU)-Optional||118||
48505258|NCT00357955|101570772|FG000|STARTED|Overall Study||64||
48505259|NCT00357955|101570773|FG001|STARTED|Overall Study||54||
48505260|NCT00357955|101570772|FG000|COMPLETED|Overall Study||58||
48505261|NCT00357955|101570773|FG001|COMPLETED|Overall Study||51||
48505262|NCT00357955|101570772|FG000|NOT COMPLETED|Overall Study||6||
48505263|NCT00357955|101570773|FG001|NOT COMPLETED|Overall Study||3||
48505264|NCT01802216|101570774|FG000|STARTED|Baseline||17||
48505265|NCT01802216|101570775|FG001|STARTED|Baseline||34||
48505266|NCT01802216|101570774|FG000|COMPLETED|Baseline||17||
48505267|NCT01802216|101570775|FG001|COMPLETED|Baseline||34||
48505268|NCT01802216|101570774|FG000|NOT COMPLETED|Baseline||0||
48505269|NCT01802216|101570775|FG001|NOT COMPLETED|Baseline||0||
48505270|NCT01802216|101570774|FG000|STARTED|4 Month Visit||17||
48505271|NCT01802216|101570775|FG001|STARTED|4 Month Visit||34||
48505272|NCT01802216|101570774|FG000|COMPLETED|4 Month Visit||14||
48505273|NCT01802216|101570775|FG001|COMPLETED|4 Month Visit||30||
48505274|NCT01802216|101570774|FG000|NOT COMPLETED|4 Month Visit||3||
48505275|NCT01802216|101570775|FG001|NOT COMPLETED|4 Month Visit||4||
48505276|NCT01802216|101570774|FG000|STARTED|8 Month Visit||17||
48505277|NCT01802216|101570775|FG001|STARTED|8 Month Visit||34||
48505278|NCT01802216|101570774|FG000|COMPLETED|8 Month Visit||14||
48505279|NCT01802216|101570775|FG001|COMPLETED|8 Month Visit||29||
48505280|NCT01802216|101570774|FG000|NOT COMPLETED|8 Month Visit||3||
48505281|NCT01802216|101570775|FG001|NOT COMPLETED|8 Month Visit||5||
48505282|NCT01802216|101570774|FG000|STARTED|12 Month Visit||17||
48505283|NCT01802216|101570775|FG001|STARTED|12 Month Visit||34||
48505284|NCT01802216|101570774|FG000|COMPLETED|12 Month Visit||14||
48505285|NCT01802216|101570775|FG001|COMPLETED|12 Month Visit||30||
48505286|NCT01802216|101570774|FG000|NOT COMPLETED|12 Month Visit||3||
48505287|NCT01802216|101570775|FG001|NOT COMPLETED|12 Month Visit||4||
48505288|NCT04155840|101570776|FG000|STARTED|Overall Study||1||
48505289|NCT04155840|101570776|FG000|COMPLETED|Overall Study||1||
48505290|NCT04155840|101570776|FG000|NOT COMPLETED|Overall Study||0||
48505291|NCT00608634|101570777|FG000|STARTED|Overall Study||28||
48505292|NCT00608634|101570778|FG001|STARTED|Overall Study||27||
48505293|NCT00608634|101570779|FG002|STARTED|Overall Study||28||
48062072|NCT02507973|100472965|FG000|STARTED|Overall Study||8||
48505294|NCT00608634|101570777|FG000|COMPLETED|Overall Study||26||
48505295|NCT00608634|101570778|FG001|COMPLETED|Overall Study||26||
48505296|NCT00608634|101570779|FG002|COMPLETED|Overall Study||27||
48505297|NCT00608634|101570777|FG000|NOT COMPLETED|Overall Study||2||
48505298|NCT00608634|101570778|FG001|NOT COMPLETED|Overall Study||1||
48505299|NCT00608634|101570779|FG002|NOT COMPLETED|Overall Study||1||
48505300|NCT03119662|101570780|FG000|STARTED|Overall Study||2||
48505301|NCT03119662|101570781|FG001|STARTED|Overall Study||2||
48505302|NCT03119662|101570780|FG000|COMPLETED|Overall Study||2||
48505303|NCT03119662|101570781|FG001|COMPLETED|Overall Study||1||
48505304|NCT03119662|101570780|FG000|NOT COMPLETED|Overall Study||0||
48505305|NCT03119662|101570781|FG001|NOT COMPLETED|Overall Study||1||
48505306|NCT00874549|101570782|FG000|STARTED|Overall Study||51||
48505307|NCT00874549|101570783|FG001|STARTED|Overall Study||56||
48505308|NCT00874549|101570784|FG002|STARTED|Overall Study||51||
48505309|NCT00874549|101570785|FG003|STARTED|Overall Study||58||
48505310|NCT00874549|101570782|FG000|COMPLETED|Overall Study||50||
48505311|NCT00874549|101570783|FG001|COMPLETED|Overall Study||55||
48505312|NCT00874549|101570784|FG002|COMPLETED|Overall Study||47||
48505313|NCT00874549|101570785|FG003|COMPLETED|Overall Study||56||
48505314|NCT00874549|101570782|FG000|NOT COMPLETED|Overall Study||1||
48505315|NCT00874549|101570783|FG001|NOT COMPLETED|Overall Study||1||
48505316|NCT00874549|101570784|FG002|NOT COMPLETED|Overall Study||4||
48505317|NCT00874549|101570785|FG003|NOT COMPLETED|Overall Study||2||
48505318|NCT03108820|101570786|FG000|STARTED|Overall Study||216||
48505319|NCT03108820|101570787|FG001|STARTED|Overall Study||214||
48505320|NCT03108820|101570786|FG000|6 Month Assessment|Overall Study||158||
48505321|NCT03108820|101570787|FG001|6 Month Assessment|Overall Study||166||
48505322|NCT03108820|101570786|FG000|COMPLETED|Overall Study||148||
48505323|NCT03108820|101570787|FG001|COMPLETED|Overall Study||151||
48505324|NCT03108820|101570786|FG000|NOT COMPLETED|Overall Study||68||
48505325|NCT03108820|101570787|FG001|NOT COMPLETED|Overall Study||63||
48505326|NCT00928057|101570788|FG000|STARTED|Overall Study||84||
48505327|NCT00928057|101570789|FG001|STARTED|Overall Study||89||
48505328|NCT00928057|101570788|FG000|COMPLETED|Overall Study||82||
48505329|NCT00928057|101570789|FG001|COMPLETED|Overall Study||85||
48505330|NCT00928057|101570788|FG000|NOT COMPLETED|Overall Study||2||
48505331|NCT00928057|101570789|FG001|NOT COMPLETED|Overall Study||4||
48505332|NCT00534430|101570790|FG000|STARTED|Overall Study||30||
48505333|NCT00534430|101570790|FG000|COMPLETED|Overall Study||30||
48505334|NCT00534430|101570790|FG000|NOT COMPLETED|Overall Study||0||
48505335|NCT02244554|101570791|FG000|STARTED|Overall Study||10||20
48505336|NCT02244554|101570791|FG000|Treatment With Picosecond Pulse Duration|Overall Study||10||10
48505337|NCT02244554|101570791|FG000|Treatment With Nanosecond Pulse Duration|Overall Study||10||10
48505338|NCT02244554|101570791|FG000|COMPLETED|Overall Study||10||20
48505339|NCT02244554|101570791|FG000|NOT COMPLETED|Overall Study||0||0
48505340|NCT02287636|101570792|FG000|STARTED|Overall Study||13||
48505341|NCT02287636|101570792|FG000|COMPLETED|Overall Study||13||
48505342|NCT02287636|101570792|FG000|NOT COMPLETED|Overall Study||0||
48505343|NCT01928615|101570793|FG000|STARTED|Overall Study||2||
48505344|NCT01928615|101570793|FG000|COMPLETED|Overall Study||0||
48505345|NCT01928615|101570793|FG000|NOT COMPLETED|Overall Study||2||
48505346|NCT02004691|101570794|FG000|STARTED|PAP: Up to 52 Weeks||18||
48505347|NCT02004691|101570795|FG001|STARTED|PAP: Up to 52 Weeks||18||
48505348|NCT02004691|101570794|FG000|COMPLETED|PAP: Up to 52 Weeks||17||
48505349|NCT02004691|101570795|FG001|COMPLETED|PAP: Up to 52 Weeks||18||
48505350|NCT02004691|101570794|FG000|NOT COMPLETED|PAP: Up to 52 Weeks||1||
48505351|NCT02004691|101570795|FG001|NOT COMPLETED|PAP: Up to 52 Weeks||0||
48505352|NCT02004691|101570794|FG000|STARTED|ETP: From Week 52 up to 5 Years||17||
48505353|NCT02004691|101570795|FG001|STARTED|ETP: From Week 52 up to 5 Years||18||
48505354|NCT02004691|101570794|FG000|COMPLETED|ETP: From Week 52 up to 5 Years||13||
48505355|NCT02004691|101570795|FG001|COMPLETED|ETP: From Week 52 up to 5 Years||16||
48505356|NCT02004691|101570794|FG000|NOT COMPLETED|ETP: From Week 52 up to 5 Years||4||
48505357|NCT02004691|101570795|FG001|NOT COMPLETED|ETP: From Week 52 up to 5 Years||2||
48505358|NCT01386125|101570796|FG000|STARTED|Overall Study||375||
48505359|NCT01386125|101570797|FG001|STARTED|Overall Study||373||
48505360|NCT01386125|101570796|FG000|COMPLETED|Overall Study||350||
48505361|NCT01386125|101570797|FG001|COMPLETED|Overall Study||336||
48505362|NCT01386125|101570796|FG000|NOT COMPLETED|Overall Study||25||
48505363|NCT01386125|101570797|FG001|NOT COMPLETED|Overall Study||37||
48505364|NCT01362296|101570798|FG000|STARTED|Randomized Phase (RP)||87||
48505365|NCT01362296|101570799|FG001|STARTED|Randomized Phase (RP)||43||
48505366|NCT01362296|101570800|FG002|STARTED|Randomized Phase (RP)||0||
48505367|NCT01362296|101570801|FG003|STARTED|Randomized Phase (RP)||0||
48505368|NCT01362296|101570798|FG000|COMPLETED|Randomized Phase (RP)||0||
48505369|NCT01362296|101570799|FG001|COMPLETED|Randomized Phase (RP)||0||
48505370|NCT01362296|101570800|FG002|COMPLETED|Randomized Phase (RP)||0||
48505371|NCT01362296|101570801|FG003|COMPLETED|Randomized Phase (RP)||0||
48505372|NCT01362296|101570798|FG000|NOT COMPLETED|Randomized Phase (RP)||87||
48505373|NCT01362296|101570799|FG001|NOT COMPLETED|Randomized Phase (RP)||43||
48505374|NCT01362296|101570800|FG002|NOT COMPLETED|Randomized Phase (RP)||0||
48505375|NCT01362296|101570801|FG003|NOT COMPLETED|Randomized Phase (RP)||0||
48505376|NCT01362296|101570798|FG000|STARTED|Crossover Phase||0||
48505377|NCT01362296|101570799|FG001|STARTED|Crossover Phase||0||
48505378|NCT01362296|101570800|FG002|STARTED|Crossover Phase||23||
48505379|NCT01362296|101570801|FG003|STARTED|Crossover Phase||2||
48505380|NCT01362296|101570798|FG000|COMPLETED|Crossover Phase||0||
48505381|NCT01362296|101570799|FG001|COMPLETED|Crossover Phase||0||
48505382|NCT01362296|101570800|FG002|COMPLETED|Crossover Phase||0||
48505383|NCT01362296|101570801|FG003|COMPLETED|Crossover Phase||0||
48505384|NCT01362296|101570798|FG000|NOT COMPLETED|Crossover Phase||0||
48505385|NCT01362296|101570799|FG001|NOT COMPLETED|Crossover Phase||0||
48505386|NCT01362296|101570800|FG002|NOT COMPLETED|Crossover Phase||23||
48505387|NCT01362296|101570801|FG003|NOT COMPLETED|Crossover Phase||2||
48505388|NCT01499160|101570802|FG000|STARTED|Overall Study||7||
48505389|NCT01499160|101570802|FG000|COMPLETED|Overall Study||5|number of who completed all study treatments|
48505390|NCT01499160|101570802|FG000|NOT COMPLETED|Overall Study||2||
48505391|NCT01475487|101570803|FG000|STARTED|Overall Study||25||
48505392|NCT01475487|101570804|FG001|STARTED|Overall Study||25||
48505393|NCT01475487|101570803|FG000|COMPLETED|Overall Study||23||
48505394|NCT01475487|101570804|FG001|COMPLETED|Overall Study||24||
48505395|NCT01475487|101570803|FG000|NOT COMPLETED|Overall Study||2||
48505396|NCT01475487|101570804|FG001|NOT COMPLETED|Overall Study||1||
48505397|NCT00640393|101570805|FG000|STARTED|Part 1||99||
48505398|NCT00640393|101570806|FG001|STARTED|Part 1||0||
48505399|NCT00640393|101570807|FG002|STARTED|Part 1||0||
48505400|NCT00640393|101570805|FG000|COMPLETED|Part 1||94||
48505401|NCT00640393|101570806|FG001|COMPLETED|Part 1||0||
48505402|NCT00640393|101570807|FG002|COMPLETED|Part 1||0||
48505403|NCT00640393|101570805|FG000|NOT COMPLETED|Part 1||5||
48505404|NCT00640393|101570806|FG001|NOT COMPLETED|Part 1||0||
48505405|NCT00640393|101570807|FG002|NOT COMPLETED|Part 1||0||
48505406|NCT00640393|101570805|FG000|STARTED|Randomization||94||
48505407|NCT00640393|101570806|FG001|STARTED|Randomization||0||
48505408|NCT00640393|101570807|FG002|STARTED|Randomization||0||
48505409|NCT00640393|101570805|FG000|COMPLETED|Randomization||75||
48505410|NCT00640393|101570806|FG001|COMPLETED|Randomization||0||
48505411|NCT00640393|101570807|FG002|COMPLETED|Randomization||0||
48505412|NCT00640393|101570805|FG000|NOT COMPLETED|Randomization||19||
48505413|NCT00640393|101570806|FG001|NOT COMPLETED|Randomization||0||
48505414|NCT00640393|101570807|FG002|NOT COMPLETED|Randomization||0||
48505415|NCT00640393|101570805|FG000|STARTED|Part 2||0||
48505416|NCT00640393|101570806|FG001|STARTED|Part 2||37||
48505417|NCT00640393|101570807|FG002|STARTED|Part 2||38||
48505418|NCT00640393|101570805|FG000|COMPLETED|Part 2||0||
48505419|NCT00640393|101570806|FG001|COMPLETED|Part 2||27||
48505420|NCT00640393|101570807|FG002|COMPLETED|Part 2||35||
48505421|NCT00640393|101570805|FG000|NOT COMPLETED|Part 2||0||
48505422|NCT00640393|101570806|FG001|NOT COMPLETED|Part 2||10||
48505423|NCT00640393|101570807|FG002|NOT COMPLETED|Part 2||3||
48505424|NCT03843125|101570808|FG000|STARTED|Overall Study||388||
48505425|NCT03843125|101570809|FG001|STARTED|Overall Study||379||
48505426|NCT03843125|101570810|FG002|STARTED|Overall Study||189||
48505427|NCT03843125|101570811|FG003|STARTED|Overall Study||191||
48505428|NCT03843125|101570808|FG000|Safety Population|Overall Study||388|All participants who received at least one dose of study drug and who did not discontinue from the study for the reason 'Lost to Follow-up' at the first postbaseline visit.|
48505429|NCT03843125|101570809|FG001|Safety Population|Overall Study||378|All participants who received at least one dose of study drug and who did not discontinue from the study for the reason 'Lost to Follow-up' at the first postbaseline visit.|
48505430|NCT03843125|101570810|FG002|Safety Population|Overall Study||189|All participants who received at least one dose of study drug and who did not discontinue from the study for the reason 'Lost to Follow-up' at the first postbaseline visit.|
48505431|NCT03843125|101570811|FG003|Safety Population|Overall Study||191|All participants who received at least one dose of study drug and who did not discontinue from the study for the reason 'Lost to Follow-up' at the first postbaseline visit.|
48505432|NCT03843125|101570808|FG000|COMPLETED|Overall Study||0||
48505433|NCT03843125|101570809|FG001|COMPLETED|Overall Study||0||
48505434|NCT03843125|101570810|FG002|COMPLETED|Overall Study||0||
48505435|NCT03843125|101570811|FG003|COMPLETED|Overall Study||0||
48505436|NCT03843125|101570808|FG000|NOT COMPLETED|Overall Study||388||
48505437|NCT03843125|101570809|FG001|NOT COMPLETED|Overall Study||379||
48505438|NCT03843125|101570810|FG002|NOT COMPLETED|Overall Study||189||
48505439|NCT03843125|101570811|FG003|NOT COMPLETED|Overall Study||191||
48505440|NCT01726257|101570812|FG000|STARTED|Overall Study||150||
48505441|NCT01726257|101570813|FG001|STARTED|Overall Study||29||
48505442|NCT01726257|101570814|FG002|STARTED|Overall Study||154||
48505443|NCT01726257|101570812|FG000|COMPLETED|Overall Study||86||
48218511|NCT01426412|100860321|FG007|COMPLETED|Overall Study||7||
48218512|NCT01426412|100860322|FG008|COMPLETED|Overall Study||16||
48218513|NCT01426412|100860314|FG000|NOT COMPLETED|Overall Study||1||
48218514|NCT01426412|100860315|FG001|NOT COMPLETED|Overall Study||0||
48505444|NCT01726257|101570813|FG001|COMPLETED|Overall Study||8||
48505445|NCT01726257|101570814|FG002|COMPLETED|Overall Study||75||
48505446|NCT01726257|101570812|FG000|NOT COMPLETED|Overall Study||64||
48505447|NCT01726257|101570813|FG001|NOT COMPLETED|Overall Study||21||
48505448|NCT01726257|101570814|FG002|NOT COMPLETED|Overall Study||79||
48505449|NCT03922139|101570815|FG000|STARTED|Overall Study||7||
48505450|NCT03922139|101570815|FG000|Completed 2 Month Surveys|Overall Study||7||
48505451|NCT03922139|101570815|FG000|Completed 4 Month Surveys|Overall Study||6||
48505452|NCT03922139|101570815|FG000|Completed 6 Month Surveys|Overall Study||7||
48505453|NCT03922139|101570815|FG000|COMPLETED|Overall Study||7||
48505454|NCT03922139|101570815|FG000|NOT COMPLETED|Overall Study||0||
48218515|NCT01426412|100860316|FG002|NOT COMPLETED|Overall Study||0||
48218516|NCT01426412|100860317|FG003|NOT COMPLETED|Overall Study||0||
48218517|NCT01426412|100860318|FG004|NOT COMPLETED|Overall Study||1||
48218518|NCT01426412|100860319|FG005|NOT COMPLETED|Overall Study||0||
48218519|NCT01426412|100860320|FG006|NOT COMPLETED|Overall Study||0||
48505455|NCT05061992|101570816|FG000|STARTED|Overall Study||28||
48505456|NCT05061992|101570817|FG001|STARTED|Overall Study||28||
48505457|NCT05061992|101570816|FG000|COMPLETED|Overall Study||25||
48505458|NCT05061992|101570817|FG001|COMPLETED|Overall Study||27||
48505459|NCT05061992|101570816|FG000|NOT COMPLETED|Overall Study||3||
48505460|NCT05061992|101570817|FG001|NOT COMPLETED|Overall Study||1||
48505461|NCT01628549|101570818|FG000|STARTED|Overall Study||73||
48505462|NCT01628549|101570819|FG001|STARTED|Overall Study||76||
48505463|NCT01628549|101570820|FG002|STARTED|Overall Study||70||
48505464|NCT01628549|101570821|FG003|STARTED|Overall Study||66||
48505465|NCT01628549|101570818|FG000|COMPLETED|Overall Study||64||
48505466|NCT01628549|101570819|FG001|COMPLETED|Overall Study||64||
48505467|NCT01628549|101570820|FG002|COMPLETED|Overall Study||60||
48505468|NCT01628549|101570821|FG003|COMPLETED|Overall Study||57||
48505469|NCT01628549|101570818|FG000|NOT COMPLETED|Overall Study||9||
48505470|NCT01628549|101570819|FG001|NOT COMPLETED|Overall Study||12||
48505471|NCT01628549|101570820|FG002|NOT COMPLETED|Overall Study||10||
48505472|NCT01628549|101570821|FG003|NOT COMPLETED|Overall Study||9||
48505473|NCT01151449|101570822|FG000|STARTED|Overall Study||6||
48505474|NCT01151449|101570822|FG000|COMPLETED|Overall Study||6||
48505475|NCT01151449|101570822|FG000|NOT COMPLETED|Overall Study||0||
48505476|NCT00609154|101570823|FG000|STARTED|Overall Study||3||
48505477|NCT00609154|101570824|FG001|STARTED|Overall Study||17||
48505478|NCT00609154|101570823|FG000|COMPLETED|Overall Study||2||
48505479|NCT00609154|101570824|FG001|COMPLETED|Overall Study||9||
48505480|NCT00609154|101570823|FG000|NOT COMPLETED|Overall Study||1||
48505481|NCT00609154|101570824|FG001|NOT COMPLETED|Overall Study||8||
48505482|NCT04439123|101570825|FG000|STARTED|Overall Study||35||
48505483|NCT04439123|101570825|FG000|COMPLETED|Overall Study||0||
48505484|NCT04439123|101570825|FG000|NOT COMPLETED|Overall Study||35||
48505485|NCT01924364|101570826|FG000|STARTED|Overall Study||7||
48505486|NCT01924364|101570826|FG000|COMPLETED|Overall Study||4||
48505487|NCT01924364|101570826|FG000|NOT COMPLETED|Overall Study||3||
48505488|NCT02684396|101570827|FG000|STARTED|Overall Study||6||
48505489|NCT02684396|101570828|FG001|STARTED|Overall Study||6||
48505490|NCT02684396|101570829|FG002|STARTED|Overall Study||6||
48505491|NCT02684396|101570830|FG003|STARTED|Overall Study||6||
48505492|NCT02684396|101570831|FG004|STARTED|Overall Study||5||
48505493|NCT02684396|101570832|FG005|STARTED|Overall Study||10||
48505494|NCT02684396|101570827|FG000|COMPLETED|Overall Study||6||
48505495|NCT02684396|101570828|FG001|COMPLETED|Overall Study||6||
48505496|NCT02684396|101570829|FG002|COMPLETED|Overall Study||6||
48505497|NCT02684396|101570830|FG003|COMPLETED|Overall Study||6||
48505498|NCT02684396|101570831|FG004|COMPLETED|Overall Study||5||
48505499|NCT02684396|101570832|FG005|COMPLETED|Overall Study||10||
48505500|NCT02684396|101570827|FG000|NOT COMPLETED|Overall Study||0||
48505501|NCT02684396|101570828|FG001|NOT COMPLETED|Overall Study||0||
48505502|NCT02684396|101570829|FG002|NOT COMPLETED|Overall Study||0||
48505503|NCT02684396|101570830|FG003|NOT COMPLETED|Overall Study||0||
48505504|NCT02684396|101570831|FG004|NOT COMPLETED|Overall Study||0||
48505505|NCT02684396|101570832|FG005|NOT COMPLETED|Overall Study||0||
48505506|NCT00159419|101570833|FG000|STARTED|Overall Study||9||
48505507|NCT00159419|101570834|FG001|STARTED|Overall Study||9||
48505508|NCT00159419|101570833|FG000|COMPLETED|Overall Study||9||
48505509|NCT00159419|101570834|FG001|COMPLETED|Overall Study||9||
48505510|NCT00159419|101570833|FG000|NOT COMPLETED|Overall Study||0||
48505511|NCT00159419|101570834|FG001|NOT COMPLETED|Overall Study||0||
48505512|NCT03693950|101573669|FG000|STARTED|Overall Study||29||
48505513|NCT03693950|101573670|FG001|STARTED|Overall Study||28||
48505514|NCT03693950|101573669|FG000|COMPLETED|Overall Study||28||
48505515|NCT03693950|101573670|FG001|COMPLETED|Overall Study||28||
48505516|NCT03693950|101573669|FG000|NOT COMPLETED|Overall Study||1||
48505517|NCT03693950|101573670|FG001|NOT COMPLETED|Overall Study||0||
48505518|NCT02153723|101573671|FG000|STARTED|Overall Study||10||
48505519|NCT02153723|101573671|FG000|COMPLETED|Overall Study||10||
48505520|NCT02153723|101573671|FG000|NOT COMPLETED|Overall Study||0||
48505521|NCT04313296|101573672|FG000|STARTED|Overall Study||209||
48505522|NCT04313296|101573672|FG000|COMPLETED|Overall Study||209||
48505523|NCT04313296|101573672|FG000|NOT COMPLETED|Overall Study||0||
48505524|NCT01436643|101573673|FG000|STARTED|2-week Pre-treatment||0||
48505525|NCT01436643|101573674|FG001|STARTED|2-week Pre-treatment||0||
48505526|NCT01436643|101573675|FG002|STARTED|2-week Pre-treatment||0||
48505527|NCT01436643|101573676|FG003|STARTED|2-week Pre-treatment||54||
48505528|NCT01436643|101573673|FG000|COMPLETED|2-week Pre-treatment||0||
48505529|NCT01436643|101573674|FG001|COMPLETED|2-week Pre-treatment||0||
48505530|NCT01436643|101573675|FG002|COMPLETED|2-week Pre-treatment||0||
48505531|NCT01436643|101573676|FG003|COMPLETED|2-week Pre-treatment||44||
48505532|NCT01436643|101573673|FG000|NOT COMPLETED|2-week Pre-treatment||0||
48505533|NCT01436643|101573674|FG001|NOT COMPLETED|2-week Pre-treatment||0||
48505534|NCT01436643|101573675|FG002|NOT COMPLETED|2-week Pre-treatment||0||
48505535|NCT01436643|101573676|FG003|NOT COMPLETED|2-week Pre-treatment||10||
48505536|NCT01436643|101573673|FG000|STARTED|Core Phase (16 Weeks)||17||
48505537|NCT01436643|101573674|FG001|STARTED|Core Phase (16 Weeks)||15||
48505538|NCT01436643|101573675|FG002|STARTED|Core Phase (16 Weeks)||20||
48505539|NCT01436643|101573676|FG003|STARTED|Core Phase (16 Weeks)||0||
48505540|NCT01436643|101573673|FG000|COMPLETED|Core Phase (16 Weeks)||16||
48505541|NCT01436643|101573674|FG001|COMPLETED|Core Phase (16 Weeks)||11||
48505542|NCT01436643|101573675|FG002|COMPLETED|Core Phase (16 Weeks)||17||
48505543|NCT01436643|101573676|FG003|COMPLETED|Core Phase (16 Weeks)||0||
48505544|NCT01436643|101573673|FG000|NOT COMPLETED|Core Phase (16 Weeks)||1||
48505545|NCT01436643|101573674|FG001|NOT COMPLETED|Core Phase (16 Weeks)||4||
48505546|NCT01436643|101573675|FG002|NOT COMPLETED|Core Phase (16 Weeks)||3||
48505547|NCT01436643|101573676|FG003|NOT COMPLETED|Core Phase (16 Weeks)||0||
48505548|NCT01160445|101573677|FG000|STARTED|Overall Study||7||
48505549|NCT01160445|101573678|FG001|STARTED|Overall Study||2||
48505550|NCT01160445|101573677|FG000|COMPLETED|Overall Study||7||
48505551|NCT01160445|101573678|FG001|COMPLETED|Overall Study||2||
48505552|NCT01160445|101573677|FG000|NOT COMPLETED|Overall Study||0||
48505553|NCT01160445|101573678|FG001|NOT COMPLETED|Overall Study||0||
48505554|NCT01579006|101573679|FG000|STARTED|Overall Study||184||
48505555|NCT01579006|101573679|FG000|COMPLETED|Overall Study||151||
48505556|NCT01579006|101573679|FG000|NOT COMPLETED|Overall Study||33||
48505557|NCT02203578|101573680|FG000|STARTED|Overall Study||1||
48505558|NCT02203578|101573680|FG000|COMPLETED|Overall Study||1||
48505559|NCT02203578|101573680|FG000|NOT COMPLETED|Overall Study||0||
48505560|NCT03578809|101573681|FG000|STARTED|Overall Study||94||
48505561|NCT03578809|101573682|FG001|STARTED|Overall Study||185||
48505562|NCT03578809|101573683|FG002|STARTED|Overall Study||112||
48505563|NCT03578809|101573684|FG003|STARTED|Overall Study||202||
48505564|NCT03578809|101573681|FG000|Treated|Overall Study||90||
48505565|NCT03578809|101573682|FG001|Treated|Overall Study||179||
48505566|NCT03578809|101573683|FG002|Treated|Overall Study||111||
48505567|NCT03578809|101573684|FG003|Treated|Overall Study||195||
48505568|NCT03578809|101573681|FG000|COMPLETED|Overall Study||88||
48505569|NCT03578809|101573682|FG001|COMPLETED|Overall Study||171||
48505570|NCT03578809|101573683|FG002|COMPLETED|Overall Study||108||
48505571|NCT03578809|101573684|FG003|COMPLETED|Overall Study||193||
48505572|NCT03578809|101573681|FG000|NOT COMPLETED|Overall Study||6||
48505573|NCT03578809|101573682|FG001|NOT COMPLETED|Overall Study||14||
48505574|NCT03578809|101573683|FG002|NOT COMPLETED|Overall Study||4||
48505575|NCT03578809|101573684|FG003|NOT COMPLETED|Overall Study||9||
48505576|NCT02250651|101573685|FG000|STARTED|Treatment Period 1 (Day 1 to Week 15)||176||
48505577|NCT02250651|101573686|FG001|STARTED|Treatment Period 1 (Day 1 to Week 15)||176||
48505578|NCT02250651|101573687|FG002|STARTED|Treatment Period 1 (Day 1 to Week 15)||176||
48505579|NCT02250651|101573685|FG000|Received Sham or Bimatoprost SR|Treatment Period 1 (Day 1 to Week 15)||176||
48505580|NCT02250651|101573686|FG001|Received Sham or Bimatoprost SR|Treatment Period 1 (Day 1 to Week 15)||175||
48505581|NCT02250651|101573687|FG002|Received Sham or Bimatoprost SR|Treatment Period 1 (Day 1 to Week 15)||173||
48505582|NCT02250651|101573685|FG000|COMPLETED|Treatment Period 1 (Day 1 to Week 15)||172||
48505583|NCT02250651|101573686|FG001|COMPLETED|Treatment Period 1 (Day 1 to Week 15)||170||
48505584|NCT02250651|101573687|FG002|COMPLETED|Treatment Period 1 (Day 1 to Week 15)||165||
48505585|NCT02250651|101573685|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 to Week 15)||4||
48505586|NCT02250651|101573686|FG001|NOT COMPLETED|Treatment Period 1 (Day 1 to Week 15)||6||
48505587|NCT02250651|101573687|FG002|NOT COMPLETED|Treatment Period 1 (Day 1 to Week 15)||11||
48505588|NCT02250651|101573685|FG000|STARTED|Treatment Period 2 (Week 16 to Week 31)||165|Started=received administration (Sham or Bimatoprost SR) in the cycle|
48505589|NCT02250651|101573686|FG001|STARTED|Treatment Period 2 (Week 16 to Week 31)||168|Started=received administration (Sham or Bimatoprost SR) in the cycle|
48505590|NCT02250651|101573687|FG002|STARTED|Treatment Period 2 (Week 16 to Week 31)||165|Started=received administration (Sham or Bimatoprost SR) in the cycle|
48505591|NCT02250651|101573685|FG000|COMPLETED|Treatment Period 2 (Week 16 to Week 31)||159||
48505592|NCT02250651|101573686|FG001|COMPLETED|Treatment Period 2 (Week 16 to Week 31)||162||
48505593|NCT02250651|101573687|FG002|COMPLETED|Treatment Period 2 (Week 16 to Week 31)||160||
48505594|NCT02250651|101573685|FG000|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 31)||6||
48505595|NCT02250651|101573686|FG001|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 31)||6||
48505596|NCT02250651|101573687|FG002|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 31)||5||
48505597|NCT02250651|101573685|FG000|STARTED|Treatment Period 3 (Week 32 to Week 52)||147|Started=received administration (Sham or Bimatoprost SR) in the cycle|
48505598|NCT02250651|101573686|FG001|STARTED|Treatment Period 3 (Week 32 to Week 52)||156|Started=received administration (Sham or Bimatoprost SR) in the cycle|
48505599|NCT02250651|101573687|FG002|STARTED|Treatment Period 3 (Week 32 to Week 52)||159|Started=received administration (Sham or Bimatoprost SR) in the cycle|
48505600|NCT02250651|101573685|FG000|COMPLETED|Treatment Period 3 (Week 32 to Week 52)||138||
48505601|NCT02250651|101573686|FG001|COMPLETED|Treatment Period 3 (Week 32 to Week 52)||152||
48505602|NCT02250651|101573687|FG002|COMPLETED|Treatment Period 3 (Week 32 to Week 52)||154||
48505603|NCT02250651|101573685|FG000|NOT COMPLETED|Treatment Period 3 (Week 32 to Week 52)||9||
48505604|NCT02250651|101573686|FG001|NOT COMPLETED|Treatment Period 3 (Week 32 to Week 52)||4||
48505605|NCT02250651|101573687|FG002|NOT COMPLETED|Treatment Period 3 (Week 32 to Week 52)||5||
48505606|NCT04547036|101573688|FG000|STARTED|Overall Study||129||155
48505607|NCT04547036|101573688|FG000|COMPLETED|Overall Study||129||155
48505608|NCT04547036|101573688|FG000|NOT COMPLETED|Overall Study||0||0
48505609|NCT01362192|101573689|FG000|STARTED|Overall Study||20||
48666767|NCT03391882|101970466|FG001|COMPLETED|Post Part A / Pre Part B||0||
48505610|NCT01362192|101573689|FG000|COMPLETED|Overall Study||16||
48505611|NCT01362192|101573689|FG000|NOT COMPLETED|Overall Study||4||
48505612|NCT01203917|101573690|FG000|STARTED|Overall Study||107||
48505613|NCT01203917|101573690|FG000|COMPLETED|Overall Study||71||
48505614|NCT01203917|101573690|FG000|NOT COMPLETED|Overall Study||36||
48505615|NCT03538795|101573691|FG000|STARTED|Overall Study||3||
48505616|NCT03538795|101573691|FG000|COMPLETED|Overall Study||3||
48505617|NCT03538795|101573691|FG000|NOT COMPLETED|Overall Study||0||
48505618|NCT05194202|101573692|FG000|STARTED|Overall Study||88||
48505619|NCT05194202|101573693|FG001|STARTED|Overall Study||87||
48505620|NCT05194202|101573692|FG000|COMPLETED|Overall Study||39||
48505621|NCT05194202|101573693|FG001|COMPLETED|Overall Study||39||
48505622|NCT05194202|101573692|FG000|NOT COMPLETED|Overall Study||49||
48505623|NCT05194202|101573693|FG001|NOT COMPLETED|Overall Study||48||
48505624|NCT01992874|101573694|FG000|STARTED|Part A||21||
48505625|NCT01992874|101573695|FG001|STARTED|Part A||17||
48505626|NCT01992874|101573696|FG002|STARTED|Part A||0||
48505627|NCT01992874|101573694|FG000|COMPLETED|Part A||21||
48505628|NCT01992874|101573695|FG001|COMPLETED|Part A||17||
48505629|NCT01992874|101573696|FG002|COMPLETED|Part A||0||
48505630|NCT01992874|101573694|FG000|NOT COMPLETED|Part A||0||
48505631|NCT01992874|101573695|FG001|NOT COMPLETED|Part A||0||
48505632|NCT01992874|101573696|FG002|NOT COMPLETED|Part A||0||
48505633|NCT01992874|101573694|FG000|STARTED|Part B||0||
48505634|NCT01992874|101573695|FG001|STARTED|Part B||0||
48505635|NCT01992874|101573696|FG002|STARTED|Part B||38||
48505636|NCT01992874|101573694|FG000|COMPLETED|Part B||0||
48505637|NCT01992874|101573695|FG001|COMPLETED|Part B||0||
48505638|NCT01992874|101573696|FG002|COMPLETED|Part B||38||
48505639|NCT01992874|101573694|FG000|NOT COMPLETED|Part B||0||
48505640|NCT01992874|101573695|FG001|NOT COMPLETED|Part B||0||
48505641|NCT01992874|101573696|FG002|NOT COMPLETED|Part B||0||
48505642|NCT01958060|101573697|FG000|STARTED|Overall Study||10||
48505643|NCT01958060|101573698|FG001|STARTED|Overall Study||6||
48505644|NCT01958060|101573699|FG002|STARTED|Overall Study||6||
48505645|NCT01958060|101573700|FG003|STARTED|Overall Study||5||
48505646|NCT01958060|101573701|FG004|STARTED|Overall Study||7||
48505647|NCT01958060|101573702|FG005|STARTED|Overall Study||1||
48505648|NCT01958060|101573697|FG000|COMPLETED|Overall Study||8||
48505649|NCT01958060|101573698|FG001|COMPLETED|Overall Study||6||
48505650|NCT01958060|101573699|FG002|COMPLETED|Overall Study||6||
48505651|NCT01958060|101573700|FG003|COMPLETED|Overall Study||5||
48505652|NCT01958060|101573701|FG004|COMPLETED|Overall Study||6||
48505653|NCT01958060|101573702|FG005|COMPLETED|Overall Study||1||
48505654|NCT01958060|101573697|FG000|NOT COMPLETED|Overall Study||2||
48505655|NCT01958060|101573698|FG001|NOT COMPLETED|Overall Study||0||
48505656|NCT01958060|101573699|FG002|NOT COMPLETED|Overall Study||0||
48505657|NCT01958060|101573700|FG003|NOT COMPLETED|Overall Study||0||
48505658|NCT01958060|101573701|FG004|NOT COMPLETED|Overall Study||1||
48505659|NCT01958060|101573702|FG005|NOT COMPLETED|Overall Study||0||
48505660|NCT02754492|101573703|FG000|STARTED|Overall Study||97||
48505661|NCT02754492|101573704|FG001|STARTED|Overall Study||95||
48505662|NCT02754492|101573705|FG002|STARTED|Overall Study||95||
48505663|NCT02754492|101573706|FG003|STARTED|Overall Study||23||
48505664|NCT02754492|101573703|FG000|COMPLETED|Overall Study||93||
48505665|NCT02754492|101573704|FG001|COMPLETED|Overall Study||93||
48505666|NCT02754492|101573705|FG002|COMPLETED|Overall Study||93||
48505667|NCT02754492|101573706|FG003|COMPLETED|Overall Study||0||
48505668|NCT02754492|101573703|FG000|NOT COMPLETED|Overall Study||4||
48505669|NCT02754492|101573704|FG001|NOT COMPLETED|Overall Study||2||
48505670|NCT02754492|101573705|FG002|NOT COMPLETED|Overall Study||2||
48505671|NCT02754492|101573706|FG003|NOT COMPLETED|Overall Study||23||
48505672|NCT00708682|101573707|FG000|STARTED|Infant Series||225||
48505673|NCT00708682|101573707|FG000|Vaccinated Dose 1|Infant Series||223||
48505674|NCT00708682|101573707|FG000|Vaccinated Dose 2|Infant Series||214||
48505675|NCT00708682|101573707|FG000|Vaccinated Dose 3|Infant Series||194||
48505676|NCT00708682|101573707|FG000|COMPLETED|Infant Series||192||
48505677|NCT00708682|101573707|FG000|NOT COMPLETED|Infant Series||33||
48505678|NCT00708682|101573707|FG000|STARTED|After Infant Series||192||
48505679|NCT00708682|101573707|FG000|COMPLETED|After Infant Series||191||
48505680|NCT00708682|101573707|FG000|NOT COMPLETED|After Infant Series||1||
48505681|NCT00708682|101573707|FG000|STARTED|Toddler Dose||191||
48505682|NCT00708682|101573707|FG000|COMPLETED|Toddler Dose||183||
48505683|NCT00708682|101573707|FG000|NOT COMPLETED|Toddler Dose||8||
48505684|NCT03942211|101573708|FG000|STARTED|Overall Study||6||
48505685|NCT03942211|101573709|FG001|STARTED|Overall Study||4||
48505686|NCT03942211|101573708|FG000|COMPLETED|Overall Study||0||
48505687|NCT03942211|101573709|FG001|COMPLETED|Overall Study||0||
48505688|NCT03942211|101573708|FG000|NOT COMPLETED|Overall Study||6||
48505689|NCT03942211|101573709|FG001|NOT COMPLETED|Overall Study||4||
48505690|NCT03200535|101573710|FG000|STARTED|Overall Study||1863||
48505691|NCT03200535|101573711|FG001|STARTED|Overall Study||1863||
48505692|NCT03200535|101573712|FG002|STARTED|Overall Study||1862||
48505693|NCT03200535|101573713|FG003|STARTED|Overall Study||1000||
48505694|NCT03200535|101573710|FG000|COMPLETED|Overall Study||1863||
48505695|NCT03200535|101573711|FG001|COMPLETED|Overall Study||1863||
48505696|NCT03200535|101573712|FG002|COMPLETED|Overall Study||1862||
48505697|NCT03200535|101573713|FG003|COMPLETED|Overall Study||1000||
48505698|NCT03200535|101573710|FG000|NOT COMPLETED|Overall Study||0||
48505699|NCT03200535|101573711|FG001|NOT COMPLETED|Overall Study||0||
48505700|NCT03200535|101573712|FG002|NOT COMPLETED|Overall Study||0||
48505701|NCT03200535|101573713|FG003|NOT COMPLETED|Overall Study||0||
48505702|NCT01337596|101573714|FG000|STARTED|Overall Study||7||
48505703|NCT01337596|101573715|FG001|STARTED|Overall Study||7||
48505704|NCT01337596|101573716|FG002|STARTED|Overall Study||7||
48505705|NCT01337596|101573717|FG003|STARTED|Overall Study||7||
48505706|NCT01337596|101573718|FG004|STARTED|Overall Study||7||
48505707|NCT01337596|101573719|FG005|STARTED|Overall Study||7||
48505708|NCT01337596|101573720|FG006|STARTED|Overall Study||12||
48505709|NCT01337596|101573721|FG007|STARTED|Overall Study||2||
48505710|NCT01337596|101573722|FG008|STARTED|Overall Study||7||
48505711|NCT01337596|101573714|FG000|Safety Population|Overall Study||7||
48505712|NCT01337596|101573715|FG001|Safety Population|Overall Study||7||
48505713|NCT01337596|101573716|FG002|Safety Population|Overall Study||7||
48505714|NCT01337596|101573717|FG003|Safety Population|Overall Study||7||
48505715|NCT01337596|101573718|FG004|Safety Population|Overall Study||7||
48505716|NCT01337596|101573719|FG005|Safety Population|Overall Study||7||
48505717|NCT01337596|101573720|FG006|Safety Population|Overall Study||12||
48505718|NCT01337596|101573721|FG007|Safety Population|Overall Study||2||
48505719|NCT01337596|101573722|FG008|Safety Population|Overall Study||7||
48505720|NCT01337596|101573714|FG000|COMPLETED|Overall Study||7||
48505721|NCT01337596|101573715|FG001|COMPLETED|Overall Study||7||
48505722|NCT01337596|101573716|FG002|COMPLETED|Overall Study||7||
48505723|NCT01337596|101573717|FG003|COMPLETED|Overall Study||7||
48505724|NCT01337596|101573718|FG004|COMPLETED|Overall Study||5||
48505725|NCT01337596|101573719|FG005|COMPLETED|Overall Study||7||
48505726|NCT01337596|101573720|FG006|COMPLETED|Overall Study||12||
48505727|NCT01337596|101573721|FG007|COMPLETED|Overall Study||2||
48505728|NCT01337596|101573722|FG008|COMPLETED|Overall Study||7||
48505729|NCT01337596|101573714|FG000|NOT COMPLETED|Overall Study||0||
48505730|NCT01337596|101573715|FG001|NOT COMPLETED|Overall Study||0||
48505731|NCT01337596|101573716|FG002|NOT COMPLETED|Overall Study||0||
48505732|NCT01337596|101573717|FG003|NOT COMPLETED|Overall Study||0||
48505733|NCT01337596|101573718|FG004|NOT COMPLETED|Overall Study||2||
48505734|NCT01337596|101573719|FG005|NOT COMPLETED|Overall Study||0||
48505735|NCT01337596|101573720|FG006|NOT COMPLETED|Overall Study||0||
48505736|NCT01337596|101573721|FG007|NOT COMPLETED|Overall Study||0||
48505737|NCT01337596|101573722|FG008|NOT COMPLETED|Overall Study||0||
48505738|NCT00448227|101573723|FG000|STARTED|Overall Study||18||
48505739|NCT00448227|101573723|FG000|COMPLETED|Overall Study||18||
48505740|NCT00448227|101573723|FG000|NOT COMPLETED|Overall Study||0||
48505741|NCT02937506|101573724|FG000|STARTED|Overall Study||300||
48505742|NCT02937506|101573725|FG001|STARTED|Overall Study||300||
48505743|NCT02937506|101573724|FG000|COMPLETED|Overall Study||300||
48505744|NCT02937506|101573725|FG001|COMPLETED|Overall Study||300||
48505745|NCT02937506|101573724|FG000|NOT COMPLETED|Overall Study||0||
48505746|NCT02937506|101573725|FG001|NOT COMPLETED|Overall Study||0||
48062073|NCT02507973|100472965|FG000|COMPLETED|Overall Study||7||
48062074|NCT02507973|100472965|FG000|NOT COMPLETED|Overall Study||1||
48505747|NCT00681473|101573726|FG000|STARTED|Overall Study||20||
48505748|NCT00681473|101573726|FG000|COMPLETED|Overall Study||20||
48505749|NCT00681473|101573726|FG000|NOT COMPLETED|Overall Study||0||
48062075|NCT00737438|100472966|FG000|STARTED|Overall Study||23||
48062076|NCT00737438|100472966|FG000|COMPLETED|Overall Study||20||
48062077|NCT00737438|100472966|FG000|NOT COMPLETED|Overall Study||3||
48505750|NCT04610580|101573727|FG000|STARTED|Two-way Crossover Period||24||
48505751|NCT04610580|101573728|FG001|STARTED|Two-way Crossover Period||24||
48505752|NCT04610580|101573729|FG002|STARTED|Two-way Crossover Period||0||
48505753|NCT04610580|101573730|FG003|STARTED|Two-way Crossover Period||0||
48505754|NCT04610580|101573731|FG004|STARTED|Two-way Crossover Period||0||
48505755|NCT04610580|101573732|FG005|STARTED|Two-way Crossover Period||0||
48505756|NCT04610580|101573727|FG000|Received at Least 1 Dose of Study Drug|Two-way Crossover Period||24||
48062078|NCT02213042|100472967|FG000|STARTED|Overall Study||17||
48505757|NCT04610580|101573728|FG001|Received at Least 1 Dose of Study Drug|Two-way Crossover Period||24||
48505758|NCT04610580|101573729|FG002|Received at Least 1 Dose of Study Drug|Two-way Crossover Period||0||
48505759|NCT04610580|101573730|FG003|Received at Least 1 Dose of Study Drug|Two-way Crossover Period||0||
48505760|NCT04610580|101573731|FG004|Received at Least 1 Dose of Study Drug|Two-way Crossover Period||0||
48505761|NCT04610580|101573732|FG005|Received at Least 1 Dose of Study Drug|Two-way Crossover Period||0||
48505762|NCT04610580|101573727|FG000|COMPLETED|Two-way Crossover Period||22||
48505763|NCT04610580|101573728|FG001|COMPLETED|Two-way Crossover Period||22||
48505764|NCT04610580|101573729|FG002|COMPLETED|Two-way Crossover Period||0||
48505765|NCT04610580|101573730|FG003|COMPLETED|Two-way Crossover Period||0||
48505766|NCT04610580|101573731|FG004|COMPLETED|Two-way Crossover Period||0||
48505767|NCT04610580|101573732|FG005|COMPLETED|Two-way Crossover Period||0||
48505768|NCT04610580|101573727|FG000|NOT COMPLETED|Two-way Crossover Period||2||
48505769|NCT04610580|101573728|FG001|NOT COMPLETED|Two-way Crossover Period||2||
48505770|NCT04610580|101573729|FG002|NOT COMPLETED|Two-way Crossover Period||0||
48062079|NCT02213042|100472968|FG001|STARTED|Overall Study||15||
48505771|NCT04610580|101573730|FG003|NOT COMPLETED|Two-way Crossover Period||0||
48505772|NCT04610580|101573731|FG004|NOT COMPLETED|Two-way Crossover Period||0||
48505773|NCT04610580|101573732|FG005|NOT COMPLETED|Two-way Crossover Period||0||
48505774|NCT04610580|101573727|FG000|STARTED|Washout Before Extension Period||22||
48505775|NCT04610580|101573728|FG001|STARTED|Washout Before Extension Period||22||
48505776|NCT04610580|101573729|FG002|STARTED|Washout Before Extension Period||0||
48505777|NCT04610580|101573730|FG003|STARTED|Washout Before Extension Period||0||
48505778|NCT04610580|101573731|FG004|STARTED|Washout Before Extension Period||0||
48505779|NCT04610580|101573732|FG005|STARTED|Washout Before Extension Period||0||
48505780|NCT04610580|101573727|FG000|COMPLETED|Washout Before Extension Period||22||
48505781|NCT04610580|101573728|FG001|COMPLETED|Washout Before Extension Period||19||
48505782|NCT04610580|101573729|FG002|COMPLETED|Washout Before Extension Period||0||
48505783|NCT04610580|101573730|FG003|COMPLETED|Washout Before Extension Period||0||
48505784|NCT04610580|101573731|FG004|COMPLETED|Washout Before Extension Period||0||
48505785|NCT04610580|101573732|FG005|COMPLETED|Washout Before Extension Period||0||
48505786|NCT04610580|101573727|FG000|NOT COMPLETED|Washout Before Extension Period||0||
48505787|NCT04610580|101573728|FG001|NOT COMPLETED|Washout Before Extension Period||3||
48505788|NCT04610580|101573729|FG002|NOT COMPLETED|Washout Before Extension Period||0||
48505789|NCT04610580|101573730|FG003|NOT COMPLETED|Washout Before Extension Period||0||
48505790|NCT04610580|101573731|FG004|NOT COMPLETED|Washout Before Extension Period||0||
48505791|NCT04610580|101573732|FG005|NOT COMPLETED|Washout Before Extension Period||0||
48505792|NCT04610580|101573727|FG000|STARTED|Dose-Proportionality Extension Period||0||
48505793|NCT04610580|101573728|FG001|STARTED|Dose-Proportionality Extension Period||0||
48505794|NCT04610580|101573729|FG002|STARTED|Dose-Proportionality Extension Period||10||
48505795|NCT04610580|101573730|FG003|STARTED|Dose-Proportionality Extension Period||11||
48505796|NCT04610580|101573731|FG004|STARTED|Dose-Proportionality Extension Period||9||
48505797|NCT04610580|101573732|FG005|STARTED|Dose-Proportionality Extension Period||11||
48505798|NCT04610580|101573727|FG000|Received at Least 1 Dose of Study Drug|Dose-Proportionality Extension Period||0||
48505799|NCT04610580|101573728|FG001|Received at Least 1 Dose of Study Drug|Dose-Proportionality Extension Period||0||
48505800|NCT04610580|101573729|FG002|Received at Least 1 Dose of Study Drug|Dose-Proportionality Extension Period||10||
48505801|NCT04610580|101573730|FG003|Received at Least 1 Dose of Study Drug|Dose-Proportionality Extension Period||11||
48505802|NCT04610580|101573731|FG004|Received at Least 1 Dose of Study Drug|Dose-Proportionality Extension Period||9||
48505803|NCT04610580|101573732|FG005|Received at Least 1 Dose of Study Drug|Dose-Proportionality Extension Period||11||
48505804|NCT04610580|101573727|FG000|COMPLETED|Dose-Proportionality Extension Period||0||
48505805|NCT04610580|101573728|FG001|COMPLETED|Dose-Proportionality Extension Period||0||
48505806|NCT04610580|101573729|FG002|COMPLETED|Dose-Proportionality Extension Period||10||
48505807|NCT04610580|101573730|FG003|COMPLETED|Dose-Proportionality Extension Period||11||
48505808|NCT04610580|101573731|FG004|COMPLETED|Dose-Proportionality Extension Period||8||
48505809|NCT04610580|101573732|FG005|COMPLETED|Dose-Proportionality Extension Period||11||
48505810|NCT04610580|101573727|FG000|NOT COMPLETED|Dose-Proportionality Extension Period||0||
48505811|NCT04610580|101573728|FG001|NOT COMPLETED|Dose-Proportionality Extension Period||0||
48505812|NCT04610580|101573729|FG002|NOT COMPLETED|Dose-Proportionality Extension Period||0||
48505813|NCT04610580|101573730|FG003|NOT COMPLETED|Dose-Proportionality Extension Period||0||
48505814|NCT04610580|101573731|FG004|NOT COMPLETED|Dose-Proportionality Extension Period||1||
48505815|NCT04610580|101573732|FG005|NOT COMPLETED|Dose-Proportionality Extension Period||0||
48505816|NCT01376037|101573733|FG000|STARTED|Overall Study||31||
48505817|NCT01376037|101573734|FG001|STARTED|Overall Study||31||
48505818|NCT01376037|101573733|FG000|COMPLETED|Overall Study||31||
48505819|NCT01376037|101573734|FG001|COMPLETED|Overall Study||29||
48505820|NCT01376037|101573733|FG000|NOT COMPLETED|Overall Study||0||
48505821|NCT01376037|101573734|FG001|NOT COMPLETED|Overall Study||2||
48505822|NCT03433703|101573735|FG000|STARTED|Overall Study||2||
48505823|NCT03433703|101573735|FG000|COMPLETED|Overall Study||0||
48505824|NCT03433703|101573735|FG000|NOT COMPLETED|Overall Study||2||
48505825|NCT03231345|101573736|FG000|STARTED|Overall Study||35||
48505826|NCT03231345|101573736|FG000|COMPLETED|Overall Study||35||
48505827|NCT03231345|101573736|FG000|NOT COMPLETED|Overall Study||0||
48505828|NCT00597428|101573737|FG000|STARTED|Overall Study||214||
48505829|NCT00597428|101573738|FG001|STARTED|Overall Study||223||
48505830|NCT00597428|101573737|FG000|COMPLETED|Overall Study||153||
48505831|NCT00597428|101573738|FG001|COMPLETED|Overall Study||152||
48505832|NCT00597428|101573737|FG000|NOT COMPLETED|Overall Study||61||
48505833|NCT00597428|101573738|FG001|NOT COMPLETED|Overall Study||71||
48505834|NCT02255487|101573739|FG000|STARTED|Overall Study||309||
48505835|NCT02255487|101573740|FG001|STARTED|Overall Study||308||
48505836|NCT02255487|101573739|FG000|Modified Intent to Treat (mITT)|Overall Study||293||
48505837|NCT02255487|101573740|FG001|Modified Intent to Treat (mITT)|Overall Study||291||
48505838|NCT02255487|101573739|FG000|COMPLETED|Overall Study||218||
48505839|NCT02255487|101573740|FG001|COMPLETED|Overall Study||230||
48505840|NCT02255487|101573739|FG000|NOT COMPLETED|Overall Study||91||
48505841|NCT02255487|101573740|FG001|NOT COMPLETED|Overall Study||78||
48505842|NCT04707846|101573741|FG000|STARTED|Overall Study||28||
48505843|NCT04707846|101573742|FG001|STARTED|Overall Study||32||
48505844|NCT04707846|101573741|FG000|COMPLETED|Overall Study||28||
48505845|NCT04707846|101573742|FG001|COMPLETED|Overall Study||32||
48505846|NCT04707846|101573741|FG000|NOT COMPLETED|Overall Study||0||
48505847|NCT04707846|101573742|FG001|NOT COMPLETED|Overall Study||0||
48505848|NCT02376257|101573743|FG000|STARTED|Overall Study||13||
48505849|NCT02376257|101573744|FG001|STARTED|Overall Study||12||
48505850|NCT02376257|101573745|FG002|STARTED|Overall Study||11||
48505851|NCT02376257|101573743|FG000|COMPLETED|Overall Study||13||
48505852|NCT02376257|101573744|FG001|COMPLETED|Overall Study||12||
48505853|NCT02376257|101573745|FG002|COMPLETED|Overall Study||11||
48505854|NCT02376257|101573743|FG000|NOT COMPLETED|Overall Study||0||
48505855|NCT02376257|101573744|FG001|NOT COMPLETED|Overall Study||0||
48505856|NCT02376257|101573745|FG002|NOT COMPLETED|Overall Study||0||
48505857|NCT03388008|101573746|FG000|STARTED|Overall Study||14||
48505858|NCT03388008|101573747|FG001|STARTED|Overall Study||13||
48505859|NCT03388008|101573746|FG000|COMPLETED|Overall Study||14||
48505860|NCT03388008|101573747|FG001|COMPLETED|Overall Study||13||
48505861|NCT03388008|101573746|FG000|NOT COMPLETED|Overall Study||0||
48505862|NCT03388008|101573747|FG001|NOT COMPLETED|Overall Study||0||
48505863|NCT01517867|101573748|FG000|STARTED|Overall Study||81||
48505864|NCT01517867|101573749|FG001|STARTED|Overall Study||80||
48505865|NCT01517867|101573748|FG000|COMPLETED|Overall Study||18||
48505866|NCT01517867|101573749|FG001|COMPLETED|Overall Study||15||
48505867|NCT01517867|101573748|FG000|NOT COMPLETED|Overall Study||63||
48505868|NCT01517867|101573749|FG001|NOT COMPLETED|Overall Study||65||
48505869|NCT02488109|101573750|FG000|STARTED|Treatment in Hospital||60||
48505870|NCT02488109|101573751|FG001|STARTED|Treatment in Hospital||56||
48505871|NCT02488109|101573750|FG000|Received Treatment|Treatment in Hospital||60||
48505872|NCT02488109|101573751|FG001|Received Treatment|Treatment in Hospital||51||
48505873|NCT02488109|101573750|FG000|Included in mITT Analysis|Treatment in Hospital||60||
48505874|NCT02488109|101573751|FG001|Included in mITT Analysis|Treatment in Hospital||51||
48505875|NCT02488109|101573750|FG000|COMPLETED|Treatment in Hospital||60||
48505876|NCT02488109|101573751|FG001|COMPLETED|Treatment in Hospital||51||
48505877|NCT02488109|101573750|FG000|NOT COMPLETED|Treatment in Hospital||0||
48505878|NCT02488109|101573751|FG001|NOT COMPLETED|Treatment in Hospital||5||
48505879|NCT02488109|101573750|FG000|STARTED|12-month Follow-Up||60|Discharge from hospital|
48505880|NCT02488109|101573751|FG001|STARTED|12-month Follow-Up||51|Discharge from hospital|
48505881|NCT02488109|101573750|FG000|Included in mITT Analysis|12-month Follow-Up||60||
48505882|NCT02488109|101573751|FG001|Included in mITT Analysis|12-month Follow-Up||51||
48505883|NCT02488109|101573750|FG000|COMPLETED|12-month Follow-Up||56|Retained in trial through 12 months|
48505884|NCT02488109|101573751|FG001|COMPLETED|12-month Follow-Up||44|Retained in trial through 12 months|
48505885|NCT02488109|101573750|FG000|NOT COMPLETED|12-month Follow-Up||4||
48505886|NCT02488109|101573751|FG001|NOT COMPLETED|12-month Follow-Up||7||
48505887|NCT02611323|101573752|FG000|STARTED|Overall Study||7||
48505888|NCT02611323|101573753|FG001|STARTED|Overall Study||3||
48505889|NCT02611323|101573754|FG002|STARTED|Overall Study||3||
48505890|NCT02611323|101573755|FG003|STARTED|Overall Study||3||
48505891|NCT02611323|101573756|FG004|STARTED|Overall Study||9||
48505892|NCT02611323|101573757|FG005|STARTED|Overall Study||8||
48505893|NCT02611323|101573758|FG006|STARTED|Overall Study||41||
48505894|NCT02611323|101573759|FG007|STARTED|Overall Study||3||
48505895|NCT02611323|101573760|FG008|STARTED|Overall Study||6||
48505896|NCT02611323|101573761|FG009|STARTED|Overall Study||8||
48505897|NCT02611323|101573762|FG010|STARTED|Overall Study||40||
48505898|NCT02611323|101573752|FG000|COMPLETED|Overall Study||2||
48505899|NCT02611323|101573753|FG001|COMPLETED|Overall Study||2||
48505900|NCT02611323|101573754|FG002|COMPLETED|Overall Study||3||
48505901|NCT02611323|101573755|FG003|COMPLETED|Overall Study||3||
48505902|NCT02611323|101573756|FG004|COMPLETED|Overall Study||8||
48505903|NCT02611323|101573757|FG005|COMPLETED|Overall Study||7||
48505904|NCT02611323|101573758|FG006|COMPLETED|Overall Study||30||
48505905|NCT02611323|101573759|FG007|COMPLETED|Overall Study||2||
48505906|NCT02611323|101573760|FG008|COMPLETED|Overall Study||2||
48505907|NCT02611323|101573761|FG009|COMPLETED|Overall Study||0||
48505908|NCT02611323|101573762|FG010|COMPLETED|Overall Study||11||
48505909|NCT02611323|101573752|FG000|NOT COMPLETED|Overall Study||5||
48505910|NCT02611323|101573753|FG001|NOT COMPLETED|Overall Study||1||
48062080|NCT02213042|100472969|FG002|STARTED|Overall Study||10||
48062081|NCT02213042|100472967|FG000|Total Deaths|Overall Study||11||
48505911|NCT02611323|101573754|FG002|NOT COMPLETED|Overall Study||0||
48505912|NCT02611323|101573755|FG003|NOT COMPLETED|Overall Study||0||
48505913|NCT02611323|101573756|FG004|NOT COMPLETED|Overall Study||1||
48505914|NCT02611323|101573757|FG005|NOT COMPLETED|Overall Study||1||
48505915|NCT02611323|101573758|FG006|NOT COMPLETED|Overall Study||11||
48505916|NCT02611323|101573759|FG007|NOT COMPLETED|Overall Study||1||
48505917|NCT02611323|101573760|FG008|NOT COMPLETED|Overall Study||4||
48505918|NCT02611323|101573761|FG009|NOT COMPLETED|Overall Study||8||
48505919|NCT02611323|101573762|FG010|NOT COMPLETED|Overall Study||29||
48505920|NCT03346850|101573763|FG000|STARTED|Overall Study||20||
48505921|NCT03346850|101573764|FG001|STARTED|Overall Study||20||
48505922|NCT03346850|101573763|FG000|COMPLETED|Overall Study||18||
48505923|NCT03346850|101573764|FG001|COMPLETED|Overall Study||17||
48062082|NCT02213042|100472968|FG001|Total Deaths|Overall Study||9||
48505924|NCT03346850|101573763|FG000|NOT COMPLETED|Overall Study||2||
48505925|NCT03346850|101573764|FG001|NOT COMPLETED|Overall Study||3||
48505926|NCT01588548|101573765|FG000|STARTED|Overall Study||3||
48505927|NCT01588548|101573766|FG001|STARTED|Overall Study||7||
48505928|NCT01588548|101573767|FG002|STARTED|Overall Study||6||
48505929|NCT01588548|101573768|FG003|STARTED|Overall Study||7||
48505930|NCT01588548|101573769|FG004|STARTED|Overall Study||6||
48505931|NCT01588548|101573770|FG005|STARTED|Overall Study||6||
48505932|NCT01588548|101573765|FG000|Cycle 1 Day 21|Overall Study||3||
48505933|NCT01588548|101573766|FG001|Cycle 1 Day 21|Overall Study||5||
48505934|NCT01588548|101573767|FG002|Cycle 1 Day 21|Overall Study||2||
48505935|NCT01588548|101573768|FG003|Cycle 1 Day 21|Overall Study||5||
48505936|NCT01588548|101573769|FG004|Cycle 1 Day 21|Overall Study||3||
48505937|NCT01588548|101573770|FG005|Cycle 1 Day 21|Overall Study||3||
48505938|NCT01588548|101573765|FG000|COMPLETED|Overall Study||0||
48505939|NCT01588548|101573766|FG001|COMPLETED|Overall Study||0||
48505940|NCT01588548|101573767|FG002|COMPLETED|Overall Study||0||
48505941|NCT01588548|101573768|FG003|COMPLETED|Overall Study||0||
48505942|NCT01588548|101573769|FG004|COMPLETED|Overall Study||0||
48505943|NCT01588548|101573770|FG005|COMPLETED|Overall Study||0||
48505944|NCT01588548|101573765|FG000|NOT COMPLETED|Overall Study||3||
48505945|NCT01588548|101573766|FG001|NOT COMPLETED|Overall Study||7||
48505946|NCT01588548|101573767|FG002|NOT COMPLETED|Overall Study||6||
48505947|NCT01588548|101573768|FG003|NOT COMPLETED|Overall Study||7||
48505948|NCT01588548|101573769|FG004|NOT COMPLETED|Overall Study||6||
48505949|NCT01588548|101573770|FG005|NOT COMPLETED|Overall Study||6||
48505950|NCT00939523|101573771|FG000|STARTED|Overall Study||9||
48505951|NCT00939523|101573771|FG000|COMPLETED|Overall Study||6||
48505952|NCT00939523|101573771|FG000|NOT COMPLETED|Overall Study||3||
48505953|NCT03303417|101573772|FG000|STARTED|Overall Study||8||
48505954|NCT03303417|101573773|FG001|STARTED|Overall Study||8||
48505955|NCT03303417|101573772|FG000|COMPLETED|Overall Study||7||
48505956|NCT03303417|101573773|FG001|COMPLETED|Overall Study||7||
48505957|NCT03303417|101573772|FG000|NOT COMPLETED|Overall Study||1||
48505958|NCT03303417|101573773|FG001|NOT COMPLETED|Overall Study||1||
48505959|NCT01917084|101573774|FG000|STARTED|Overall Study||20||
48505960|NCT01917084|101573774|FG000|COMPLETED|Overall Study||19||
48505961|NCT01917084|101573774|FG000|NOT COMPLETED|Overall Study||1||
48505962|NCT03414034|101573775|FG000|STARTED|Overall Study||24||
48062083|NCT02213042|100472969|FG002|Total Deaths|Overall Study||6||
48062084|NCT02213042|100472967|FG000|COMPLETED|Overall Study||0||
48062085|NCT02213042|100472968|FG001|COMPLETED|Overall Study||0||
48062086|NCT02213042|100472969|FG002|COMPLETED|Overall Study||0||
48062087|NCT02213042|100472967|FG000|NOT COMPLETED|Overall Study||17||
48062088|NCT02213042|100472968|FG001|NOT COMPLETED|Overall Study||15||
48062089|NCT02213042|100472969|FG002|NOT COMPLETED|Overall Study||10||
48062090|NCT03265665|100472970|FG000|STARTED|24-week Data Collection||25||
48062091|NCT03265665|100472971|FG001|STARTED|24-week Data Collection||28||
48062092|NCT03265665|100472970|FG000|COMPLETED|24-week Data Collection||19||
48062093|NCT03265665|100472971|FG001|COMPLETED|24-week Data Collection||21||
48062094|NCT03265665|100472970|FG000|NOT COMPLETED|24-week Data Collection||6||
48062095|NCT03265665|100472971|FG001|NOT COMPLETED|24-week Data Collection||7||
48062096|NCT03265665|100472970|FG000|STARTED|36-week Data Collection||23||
48062097|NCT03265665|100472971|FG001|STARTED|36-week Data Collection||26||
48062098|NCT03265665|100472970|FG000|COMPLETED|36-week Data Collection||17||
48062099|NCT03265665|100472971|FG001|COMPLETED|36-week Data Collection||18||
48062100|NCT03265665|100472970|FG000|NOT COMPLETED|36-week Data Collection||6||
48062101|NCT03265665|100472971|FG001|NOT COMPLETED|36-week Data Collection||8||
48062102|NCT02791594|100472972|FG000|STARTED|Overall Study||21||
48062103|NCT02791594|100472972|FG000|COMPLETED|Overall Study||19||
48062104|NCT02791594|100472972|FG000|NOT COMPLETED|Overall Study||2||
48062105|NCT04810481|100472973|FG000|STARTED|Overall Study||86||
48062106|NCT04810481|100472974|FG001|STARTED|Overall Study||84||
48062107|NCT04810481|100472973|FG000|COMPLETED|Overall Study||76||
48062108|NCT04810481|100472974|FG001|COMPLETED|Overall Study||56||
48062109|NCT04810481|100472973|FG000|NOT COMPLETED|Overall Study||10||
48062110|NCT04810481|100472974|FG001|NOT COMPLETED|Overall Study||28||
48062111|NCT01704521|100472975|FG000|STARTED|Overall Study||3||
48218520|NCT01426412|100860321|FG007|NOT COMPLETED|Overall Study||3||
48505963|NCT03414034|101573776|FG001|STARTED|Overall Study||20||
48505964|NCT03414034|101573777|FG002|STARTED|Overall Study||28||
48505965|NCT03414034|101573775|FG000|Transferred to Arm B|Overall Study||2||
48505966|NCT03414034|101573776|FG001|Transferred to Arm B|Overall Study||0||
48505967|NCT03414034|101573777|FG002|Transferred to Arm B|Overall Study||0||
48505968|NCT03414034|101573775|FG000|COMPLETED|Overall Study||0||
48505969|NCT03414034|101573776|FG001|COMPLETED|Overall Study||0||
48505970|NCT03414034|101573777|FG002|COMPLETED|Overall Study||0||
48505971|NCT03414034|101573775|FG000|NOT COMPLETED|Overall Study||24||
48505972|NCT03414034|101573776|FG001|NOT COMPLETED|Overall Study||20||
48062112|NCT01704521|100472976|FG001|STARTED|Overall Study||2||
48062113|NCT01704521|100472975|FG000|COMPLETED|Overall Study||3||
48062114|NCT01704521|100472976|FG001|COMPLETED|Overall Study||2||
48062115|NCT01704521|100472975|FG000|NOT COMPLETED|Overall Study||0||
48505973|NCT03414034|101573777|FG002|NOT COMPLETED|Overall Study||28||
48505974|NCT02033317|101573778|FG000|STARTED|Overall Study||6||
48505975|NCT02033317|101573778|FG000|COMPLETED|Overall Study||6||
48505976|NCT02033317|101573778|FG000|NOT COMPLETED|Overall Study||0||
48505977|NCT00108550|101573779|FG000|STARTED|Overall Study||55||
48505978|NCT00108550|101573780|FG001|STARTED|Overall Study||53||
48505979|NCT00108550|101573779|FG000|COMPLETED|Overall Study||39||
48505980|NCT00108550|101573780|FG001|COMPLETED|Overall Study||37||
48505981|NCT00108550|101573779|FG000|NOT COMPLETED|Overall Study||16||
48505982|NCT00108550|101573780|FG001|NOT COMPLETED|Overall Study||16||
48505983|NCT03833427|101573781|FG000|STARTED|Overall Study||4||
48505984|NCT03833427|101573782|FG001|STARTED|Overall Study||3||
48505985|NCT03833427|101573783|FG002|STARTED|Overall Study||11||
48505986|NCT03833427|101573784|FG003|STARTED|Overall Study||14||
48505987|NCT03833427|101573785|FG004|STARTED|Overall Study||0||
48505988|NCT03833427|101573786|FG005|STARTED|Overall Study||0||
48505989|NCT03833427|101573787|FG006|STARTED|Overall Study||0||
48505990|NCT03833427|101573781|FG000|Discontinued|Overall Study||4||
48505991|NCT03833427|101573782|FG001|Discontinued|Overall Study||3||
48505992|NCT03833427|101573783|FG002|Discontinued|Overall Study||11||
48505993|NCT03833427|101573784|FG003|Discontinued|Overall Study||14||
48505994|NCT03833427|101573785|FG004|Discontinued|Overall Study||0||
48505995|NCT03833427|101573786|FG005|Discontinued|Overall Study||0||
48505996|NCT03833427|101573787|FG006|Discontinued|Overall Study||0||
48505997|NCT03833427|101573781|FG000|COMPLETED|Overall Study||0||
48505998|NCT03833427|101573782|FG001|COMPLETED|Overall Study||0||
48505999|NCT03833427|101573783|FG002|COMPLETED|Overall Study||0||
48506000|NCT03833427|101573784|FG003|COMPLETED|Overall Study||0||
48506001|NCT03833427|101573785|FG004|COMPLETED|Overall Study||0||
48506002|NCT03833427|101573786|FG005|COMPLETED|Overall Study||0||
48506003|NCT03833427|101573787|FG006|COMPLETED|Overall Study||0||
48506004|NCT03833427|101573781|FG000|NOT COMPLETED|Overall Study||4||
48506005|NCT03833427|101573782|FG001|NOT COMPLETED|Overall Study||3||
48506006|NCT03833427|101573783|FG002|NOT COMPLETED|Overall Study||11||
48506007|NCT03833427|101573784|FG003|NOT COMPLETED|Overall Study||14||
48506008|NCT03833427|101573785|FG004|NOT COMPLETED|Overall Study||0||
48506009|NCT03833427|101573786|FG005|NOT COMPLETED|Overall Study||0||
48506010|NCT03833427|101573787|FG006|NOT COMPLETED|Overall Study||0||
48506011|NCT02539368|101573788|FG000|STARTED|Overall Study||1522||
48506012|NCT02539368|101573789|FG001|STARTED|Overall Study||494||
48506013|NCT02539368|101573790|FG002|STARTED|Overall Study||358||
48506014|NCT02539368|101573791|FG003|STARTED|Overall Study||67||
48506015|NCT02539368|101573792|FG004|STARTED|Overall Study||102||
48506016|NCT02539368|101573788|FG000|COMPLETED|Overall Study||1117||
48506017|NCT02539368|101573789|FG001|COMPLETED|Overall Study||393||
48506018|NCT02539368|101573790|FG002|COMPLETED|Overall Study||291||
48506019|NCT02539368|101573791|FG003|COMPLETED|Overall Study||60||
48506020|NCT02539368|101573792|FG004|COMPLETED|Overall Study||88||
48506021|NCT02539368|101573788|FG000|NOT COMPLETED|Overall Study||405||
48506022|NCT02539368|101573789|FG001|NOT COMPLETED|Overall Study||101||
48506023|NCT02539368|101573790|FG002|NOT COMPLETED|Overall Study||67||
48506024|NCT02539368|101573791|FG003|NOT COMPLETED|Overall Study||7||
48506025|NCT02539368|101573792|FG004|NOT COMPLETED|Overall Study||14||
48506026|NCT01272076|101573793|FG000|STARTED|Overall Study||52||
48506027|NCT01272076|101573793|FG000|COMPLETED|Overall Study||52||
48506028|NCT01272076|101573793|FG000|NOT COMPLETED|Overall Study||0||
48506029|NCT00084864|101573794|FG000|STARTED|Overall Study||10||
48506030|NCT00084864|101573795|FG001|STARTED|Overall Study||7||
48506031|NCT00084864|101573796|FG002|STARTED|Overall Study||4||
48506032|NCT00084864|101573797|FG003|STARTED|Overall Study||4||
48506033|NCT00084864|101573794|FG000|COMPLETED|Overall Study||9||
48506034|NCT00084864|101573795|FG001|COMPLETED|Overall Study||7||
48506035|NCT00084864|101573796|FG002|COMPLETED|Overall Study||4||
48506036|NCT00084864|101573797|FG003|COMPLETED|Overall Study||4||
48506037|NCT00084864|101573794|FG000|NOT COMPLETED|Overall Study||1||
48506038|NCT00084864|101573795|FG001|NOT COMPLETED|Overall Study||0||
48506039|NCT00084864|101573796|FG002|NOT COMPLETED|Overall Study||0||
48506040|NCT00084864|101573797|FG003|NOT COMPLETED|Overall Study||0||
48506041|NCT04784637|101573798|FG000|STARTED|Overall Study||15||
48506042|NCT04784637|101573799|FG001|STARTED|Overall Study||15||
48506043|NCT04784637|101573798|FG000|COMPLETED|Overall Study||15||
48506044|NCT04784637|101573799|FG001|COMPLETED|Overall Study||15||
48506045|NCT04784637|101573798|FG000|NOT COMPLETED|Overall Study||0||
48506046|NCT04784637|101573799|FG001|NOT COMPLETED|Overall Study||0||
48506047|NCT04307849|101573800|FG000|STARTED|Overall Study||25||
48506048|NCT04307849|101573801|FG001|STARTED|Overall Study||25||
48506049|NCT04307849|101573802|FG002|STARTED|Overall Study||25||
48506050|NCT04307849|101573803|FG003|STARTED|Overall Study||25||
48506051|NCT04307849|101573804|FG004|STARTED|Overall Study||41||
48506052|NCT04307849|101573805|FG005|STARTED|Overall Study||20||
48506053|NCT04307849|101573800|FG000|# Participants Started Intervention Period 1:|Overall Study||25||
48506054|NCT04307849|101573801|FG001|# Participants Started Intervention Period 1:|Overall Study||25||
48506055|NCT04307849|101573802|FG002|# Participants Started Intervention Period 1:|Overall Study||0||
48506056|NCT04307849|101573803|FG003|# Participants Started Intervention Period 1:|Overall Study||0||
48506057|NCT04307849|101573804|FG004|# Participants Started Intervention Period 1:|Overall Study||0||
48506058|NCT04307849|101573805|FG005|# Participants Started Intervention Period 1:|Overall Study||0||
48506059|NCT04307849|101573800|FG000|# Participants Completed Intervention Period 1:|Overall Study||23||
48506060|NCT04307849|101573801|FG001|# Participants Completed Intervention Period 1:|Overall Study||25||
48506061|NCT04307849|101573802|FG002|# Participants Completed Intervention Period 1:|Overall Study||0||
48506062|NCT04307849|101573803|FG003|# Participants Completed Intervention Period 1:|Overall Study||0||
48506063|NCT04307849|101573804|FG004|# Participants Completed Intervention Period 1:|Overall Study||0||
48506064|NCT04307849|101573805|FG005|# Participants Completed Intervention Period 1:|Overall Study||0||
48506065|NCT04307849|101573800|FG000|# Participants Started Intervention Period 2:|Overall Study||0||
48506066|NCT04307849|101573801|FG001|# Participants Started Intervention Period 2:|Overall Study||25||
48506067|NCT04307849|101573802|FG002|# Participants Started Intervention Period 2:|Overall Study||25||
48506068|NCT04307849|101573803|FG003|# Participants Started Intervention Period 2:|Overall Study||0||
48506069|NCT04307849|101573804|FG004|# Participants Started Intervention Period 2:|Overall Study||23||
48506070|NCT04307849|101573805|FG005|# Participants Started Intervention Period 2:|Overall Study||20||
48506071|NCT04307849|101573800|FG000|# Participants Completed Intervention Period 2:|Overall Study||0||
48506072|NCT04307849|101573801|FG001|# Participants Completed Intervention Period 2:|Overall Study||23||
48506073|NCT04307849|101573802|FG002|# Participants Completed Intervention Period 2:|Overall Study||25||
48506074|NCT04307849|101573803|FG003|# Participants Completed Intervention Period 2:|Overall Study||0||
48506075|NCT04307849|101573804|FG004|# Participants Completed Intervention Period 2:|Overall Study||21||
48506076|NCT04307849|101573805|FG005|# Participants Completed Intervention Period 2:|Overall Study||19||
48506077|NCT04307849|101573800|FG000|# Participants Started Intervention Period 3:|Overall Study||0||
48506078|NCT04307849|101573801|FG001|# Participants Started Intervention Period 3:|Overall Study||0||
48506079|NCT04307849|101573802|FG002|# Participants Started Intervention Period 3:|Overall Study||25||
48506080|NCT04307849|101573803|FG003|# Participants Started Intervention Period 3:|Overall Study||25||
48506081|NCT04307849|101573804|FG004|# Participants Started Intervention Period 3:|Overall Study||0||
48506082|NCT04307849|101573805|FG005|# Participants Started Intervention Period 3:|Overall Study||0||
48506083|NCT04307849|101573800|FG000|# Participants Completed Intervention Period 3:|Overall Study||0||
48506084|NCT04307849|101573801|FG001|# Participants Completed Intervention Period 3:|Overall Study||0||
48506085|NCT04307849|101573802|FG002|# Participants Completed Intervention Period 3:|Overall Study||19||
48506086|NCT04307849|101573803|FG003|# Participants Completed Intervention Period 3:|Overall Study||25||
48506087|NCT04307849|101573804|FG004|# Participants Completed Intervention Period 3:|Overall Study||0||
48506088|NCT04307849|101573805|FG005|# Participants Completed Intervention Period 3:|Overall Study||0||
48062116|NCT01704521|100472976|FG001|NOT COMPLETED|Overall Study||0||
48062117|NCT01193660|100472977|FG000|STARTED|Overall Study||35||
48062118|NCT01193660|100472978|FG001|STARTED|Overall Study||36||
48062119|NCT01193660|100472979|FG002|STARTED|Overall Study||34||
48062120|NCT01193660|100472977|FG000|COMPLETED|Overall Study||31||
48062121|NCT01193660|100472978|FG001|COMPLETED|Overall Study||33||
48062122|NCT01193660|100472979|FG002|COMPLETED|Overall Study||32||
48062123|NCT01193660|100472977|FG000|NOT COMPLETED|Overall Study||4||
48062124|NCT01193660|100472978|FG001|NOT COMPLETED|Overall Study||3||
48062125|NCT01193660|100472979|FG002|NOT COMPLETED|Overall Study||2||
48062126|NCT02853344|100472980|FG000|STARTED|Overall Study||110||
48062127|NCT02853344|100472981|FG001|STARTED|Overall Study||165||
48062128|NCT02853344|100472980|FG000|Received Second Course of Pembrolizumab|Overall Study||3||
48062129|NCT02853344|100472981|FG001|Received Second Course of Pembrolizumab|Overall Study||5||
48062130|NCT02853344|100472980|FG000|COMPLETED|Overall Study||0||
48062131|NCT02853344|100472981|FG001|COMPLETED|Overall Study||0||
48062132|NCT02853344|100472980|FG000|NOT COMPLETED|Overall Study||110||
48062133|NCT02853344|100472981|FG001|NOT COMPLETED|Overall Study||165||
48062134|NCT01069627|100472982|FG000|STARTED|Overall Study||20||
48062135|NCT01069627|100472982|FG000|COMPLETED|Overall Study||0||
48062136|NCT01069627|100472982|FG000|NOT COMPLETED|Overall Study||20||
48062137|NCT01469234|100472983|FG000|STARTED|Overall Study||85||
48062138|NCT01469234|100472984|FG001|STARTED|Overall Study||85||
48062139|NCT01469234|100472985|FG002|STARTED|Overall Study||85||
48062140|NCT01469234|100472983|FG000|COMPLETED|Overall Study||85||
48062141|NCT01469234|100472984|FG001|COMPLETED|Overall Study||85||
48062142|NCT01469234|100472985|FG002|COMPLETED|Overall Study||85||
48062143|NCT01469234|100472983|FG000|NOT COMPLETED|Overall Study||0||
48062144|NCT01469234|100472984|FG001|NOT COMPLETED|Overall Study||0||
48062145|NCT01469234|100472985|FG002|NOT COMPLETED|Overall Study||0||
48062146|NCT01498978|100472986|FG000|STARTED|Overall Study||10||
48062147|NCT01498978|100472986|FG000|COMPLETED|Overall Study||8||
48062148|NCT01498978|100472986|FG000|NOT COMPLETED|Overall Study||2||
48062149|NCT00161473|100472987|FG000|STARTED|Overall Study||12||
48062150|NCT00161473|100472988|FG001|STARTED|Overall Study||12||
48062151|NCT00161473|100472987|FG000|COMPLETED|Overall Study||7||
48062152|NCT00161473|100472988|FG001|COMPLETED|Overall Study||6||
48062153|NCT00161473|100472987|FG000|NOT COMPLETED|Overall Study||5||
48506089|NCT04307849|101573800|FG000|# Participants Started Intervention Period 4:|Overall Study||0||
48506090|NCT04307849|101573801|FG001|# Participants Started Intervention Period 4:|Overall Study||0||
48506091|NCT04307849|101573802|FG002|# Participants Started Intervention Period 4:|Overall Study||0||
48506092|NCT04307849|101573803|FG003|# Participants Started Intervention Period 4:|Overall Study||25||
48506093|NCT04307849|101573804|FG004|# Participants Started Intervention Period 4:|Overall Study||18||
48506094|NCT04307849|101573805|FG005|# Participants Started Intervention Period 4:|Overall Study||0||
48506095|NCT04307849|101573800|FG000|# Participants Completed Intervention Period 4:|Overall Study||0||
48506096|NCT04307849|101573801|FG001|# Participants Completed Intervention Period 4:|Overall Study||0||
48506097|NCT04307849|101573802|FG002|# Participants Completed Intervention Period 4:|Overall Study||0||
48506098|NCT04307849|101573803|FG003|# Participants Completed Intervention Period 4:|Overall Study||22||
48506099|NCT04307849|101573804|FG004|# Participants Completed Intervention Period 4:|Overall Study||16||
48506100|NCT04307849|101573805|FG005|# Participants Completed Intervention Period 4:|Overall Study||0||
48506101|NCT04307849|101573800|FG000|COMPLETED|Overall Study||23||
48506102|NCT04307849|101573801|FG001|COMPLETED|Overall Study||23||
48506103|NCT04307849|101573802|FG002|COMPLETED|Overall Study||19||
48506104|NCT04307849|101573803|FG003|COMPLETED|Overall Study||22||
48506105|NCT04307849|101573804|FG004|COMPLETED|Overall Study||37||
48506106|NCT04307849|101573805|FG005|COMPLETED|Overall Study||19||
48506107|NCT04307849|101573800|FG000|NOT COMPLETED|Overall Study||2||
48506108|NCT04307849|101573801|FG001|NOT COMPLETED|Overall Study||2||
48506109|NCT04307849|101573802|FG002|NOT COMPLETED|Overall Study||6||
48506110|NCT04307849|101573803|FG003|NOT COMPLETED|Overall Study||3||
48506111|NCT04307849|101573804|FG004|NOT COMPLETED|Overall Study||4||
48506112|NCT04307849|101573805|FG005|NOT COMPLETED|Overall Study||1||
48506113|NCT00799708|101573806|FG000|STARTED|Overall Study||10||
48506114|NCT00799708|101573807|FG001|STARTED|Overall Study||6||
48506115|NCT00799708|101573808|FG002|STARTED|Overall Study||11||
48506116|NCT00799708|101573806|FG000|COMPLETED|Overall Study||9||
48506117|NCT00799708|101573807|FG001|COMPLETED|Overall Study||6||
48506118|NCT00799708|101573808|FG002|COMPLETED|Overall Study||11||
48506119|NCT00799708|101573806|FG000|NOT COMPLETED|Overall Study||1||
48506120|NCT00799708|101573807|FG001|NOT COMPLETED|Overall Study||0||
48506121|NCT00799708|101573808|FG002|NOT COMPLETED|Overall Study||0||
48506122|NCT03460899|101573809|FG000|STARTED|Euglycaemic Clamp||14||
48506123|NCT03460899|101573809|FG000|COMPLETED|Euglycaemic Clamp||14||
48506124|NCT03460899|101573809|FG000|NOT COMPLETED|Euglycaemic Clamp||0||
48506125|NCT03460899|101573809|FG000|STARTED|Hyperinsulinaemic/Hypoglycaemic Clamp||14||
48506126|NCT03460899|101573809|FG000|COMPLETED|Hyperinsulinaemic/Hypoglycaemic Clamp||14||
48506127|NCT03460899|101573809|FG000|NOT COMPLETED|Hyperinsulinaemic/Hypoglycaemic Clamp||0||
48506128|NCT01148225|101573810|FG000|STARTED|Overall Study||424||
48506129|NCT01148225|101573810|FG000|COMPLETED|Overall Study||239||
48506130|NCT01148225|101573810|FG000|NOT COMPLETED|Overall Study||185||
48506131|NCT02658019|101573811|FG000|STARTED|Overall Study||29||
48506132|NCT02658019|101573811|FG000|COMPLETED|Overall Study||28||
48506133|NCT02658019|101573811|FG000|NOT COMPLETED|Overall Study||1||
48506134|NCT02973269|101573812|FG000|STARTED|Overall Study||3||
48506135|NCT02973269|101573813|FG001|STARTED|Overall Study||4||
48506136|NCT02973269|101573812|FG000|COMPLETED|Overall Study||3||
48506137|NCT02973269|101573813|FG001|COMPLETED|Overall Study||4||
48506138|NCT02973269|101573812|FG000|NOT COMPLETED|Overall Study||0||
48506139|NCT02973269|101573813|FG001|NOT COMPLETED|Overall Study||0||
48506140|NCT02710240|101573814|FG000|STARTED|Overall Study||336||
48506141|NCT02710240|101573814|FG000|COMPLETED|Overall Study||336||
48506142|NCT02710240|101573814|FG000|NOT COMPLETED|Overall Study||0||
48506143|NCT04523480|101573815|FG000|STARTED|Overall Study||33||
48506144|NCT04523480|101573816|FG001|STARTED|Overall Study||42||
48506145|NCT04523480|101573817|FG002|STARTED|Overall Study||0||
48506146|NCT04523480|101573815|FG000|COMPLETED|Overall Study||3||
48506147|NCT04523480|101573816|FG001|COMPLETED|Overall Study||7||
48506148|NCT04523480|101573817|FG002|COMPLETED|Overall Study||0||
48506149|NCT04523480|101573815|FG000|NOT COMPLETED|Overall Study||30||
48506150|NCT04523480|101573816|FG001|NOT COMPLETED|Overall Study||35||
48506151|NCT04523480|101573817|FG002|NOT COMPLETED|Overall Study||0||
48506152|NCT04233216|101573818|FG000|STARTED|Overall Study||7||
48506153|NCT04233216|101573819|FG001|STARTED|Overall Study||14||
48506154|NCT04233216|101573820|FG002|STARTED|Overall Study||7||
48506155|NCT04233216|101573821|FG003|STARTED|Overall Study||7||
48506156|NCT04233216|101573818|FG000|COMPLETED|Overall Study||6||
48506157|NCT04233216|101573819|FG001|COMPLETED|Overall Study||9||
48506158|NCT04233216|101573820|FG002|COMPLETED|Overall Study||4||
48506159|NCT04233216|101573821|FG003|COMPLETED|Overall Study||5||
48506160|NCT04233216|101573818|FG000|NOT COMPLETED|Overall Study||1||
48506161|NCT04233216|101573819|FG001|NOT COMPLETED|Overall Study||5||
48506162|NCT04233216|101573820|FG002|NOT COMPLETED|Overall Study||3||
48506163|NCT04233216|101573821|FG003|NOT COMPLETED|Overall Study||2||
48506164|NCT00562120|101573822|FG000|STARTED|First Intervention Period||6||
48506165|NCT00562120|101573823|FG001|STARTED|First Intervention Period||5||
48506166|NCT00562120|101573824|FG002|STARTED|First Intervention Period||5||
48506167|NCT00562120|101573825|FG003|STARTED|First Intervention Period||5||
48506168|NCT00562120|101573822|FG000|Treated|First Intervention Period||5||
48506169|NCT00562120|101573823|FG001|Treated|First Intervention Period||5||
48506170|NCT00562120|101573824|FG002|Treated|First Intervention Period||5||
48506171|NCT00562120|101573825|FG003|Treated|First Intervention Period||5||
48506172|NCT00562120|101573822|FG000|COMPLETED|First Intervention Period||4||
48506173|NCT00562120|101573823|FG001|COMPLETED|First Intervention Period||5||
48506174|NCT00562120|101573824|FG002|COMPLETED|First Intervention Period||5||
48506175|NCT00562120|101573825|FG003|COMPLETED|First Intervention Period||5||
48506176|NCT00562120|101573822|FG000|NOT COMPLETED|First Intervention Period||2||
48506177|NCT00562120|101573823|FG001|NOT COMPLETED|First Intervention Period||0||
48506178|NCT00562120|101573824|FG002|NOT COMPLETED|First Intervention Period||0||
48506179|NCT00562120|101573825|FG003|NOT COMPLETED|First Intervention Period||0||
48506180|NCT00562120|101573822|FG000|STARTED|Washout Period 1 (At Least 14 Days)||4||
48506181|NCT00562120|101573823|FG001|STARTED|Washout Period 1 (At Least 14 Days)||5||
48506182|NCT00562120|101573824|FG002|STARTED|Washout Period 1 (At Least 14 Days)||5||
48506183|NCT00562120|101573825|FG003|STARTED|Washout Period 1 (At Least 14 Days)||5||
48506184|NCT00562120|101573822|FG000|COMPLETED|Washout Period 1 (At Least 14 Days)||4||
48506185|NCT00562120|101573823|FG001|COMPLETED|Washout Period 1 (At Least 14 Days)||5||
48506186|NCT00562120|101573824|FG002|COMPLETED|Washout Period 1 (At Least 14 Days)||5||
48506187|NCT00562120|101573825|FG003|COMPLETED|Washout Period 1 (At Least 14 Days)||5||
48506188|NCT00562120|101573822|FG000|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0||
48506189|NCT00562120|101573823|FG001|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0||
48506190|NCT00562120|101573824|FG002|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0||
48506191|NCT00562120|101573825|FG003|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0||
48506192|NCT00562120|101573822|FG000|STARTED|Second Intervention Period||4||
48506193|NCT00562120|101573823|FG001|STARTED|Second Intervention Period||5||
48506194|NCT00562120|101573824|FG002|STARTED|Second Intervention Period||5||
48506195|NCT00562120|101573825|FG003|STARTED|Second Intervention Period||5||
48506196|NCT00562120|101573822|FG000|COMPLETED|Second Intervention Period||4||
48506197|NCT00562120|101573823|FG001|COMPLETED|Second Intervention Period||5||
48506198|NCT00562120|101573824|FG002|COMPLETED|Second Intervention Period||5||
48506199|NCT00562120|101573825|FG003|COMPLETED|Second Intervention Period||5||
48506200|NCT00562120|101573822|FG000|NOT COMPLETED|Second Intervention Period||0||
48506201|NCT00562120|101573823|FG001|NOT COMPLETED|Second Intervention Period||0||
48506202|NCT00562120|101573824|FG002|NOT COMPLETED|Second Intervention Period||0||
48506203|NCT00562120|101573825|FG003|NOT COMPLETED|Second Intervention Period||0||
48506204|NCT00562120|101573822|FG000|STARTED|Washout Period 2 (At Least 14 Days)||4||
48506205|NCT00562120|101573823|FG001|STARTED|Washout Period 2 (At Least 14 Days)||5||
48506206|NCT00562120|101573824|FG002|STARTED|Washout Period 2 (At Least 14 Days)||5||
48506207|NCT00562120|101573825|FG003|STARTED|Washout Period 2 (At Least 14 Days)||5||
48506208|NCT00562120|101573822|FG000|COMPLETED|Washout Period 2 (At Least 14 Days)||4||
48506209|NCT00562120|101573823|FG001|COMPLETED|Washout Period 2 (At Least 14 Days)||5||
48506210|NCT00562120|101573824|FG002|COMPLETED|Washout Period 2 (At Least 14 Days)||5||
48506211|NCT00562120|101573825|FG003|COMPLETED|Washout Period 2 (At Least 14 Days)||5||
48506212|NCT00562120|101573822|FG000|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0||
48506213|NCT00562120|101573823|FG001|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0||
48506214|NCT00562120|101573824|FG002|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0||
48506215|NCT00562120|101573825|FG003|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0||
48506216|NCT00562120|101573822|FG000|STARTED|Third Intervention Period||4||
48506217|NCT00562120|101573823|FG001|STARTED|Third Intervention Period||5||
48506218|NCT00562120|101573824|FG002|STARTED|Third Intervention Period||5||
48506219|NCT00562120|101573825|FG003|STARTED|Third Intervention Period||5||
48506220|NCT00562120|101573822|FG000|COMPLETED|Third Intervention Period||4||
48506221|NCT00562120|101573823|FG001|COMPLETED|Third Intervention Period||5||
48506222|NCT00562120|101573824|FG002|COMPLETED|Third Intervention Period||5||
48506223|NCT00562120|101573825|FG003|COMPLETED|Third Intervention Period||5||
48506224|NCT00562120|101573822|FG000|NOT COMPLETED|Third Intervention Period||0||
48506225|NCT00562120|101573823|FG001|NOT COMPLETED|Third Intervention Period||0||
48506226|NCT00562120|101573824|FG002|NOT COMPLETED|Third Intervention Period||0||
48506227|NCT00562120|101573825|FG003|NOT COMPLETED|Third Intervention Period||0||
48506228|NCT00562120|101573822|FG000|STARTED|Washout Period 3 (At Least 14 Days)||4||
48506229|NCT00562120|101573823|FG001|STARTED|Washout Period 3 (At Least 14 Days)||5||
48506230|NCT00562120|101573824|FG002|STARTED|Washout Period 3 (At Least 14 Days)||5||
48506231|NCT00562120|101573825|FG003|STARTED|Washout Period 3 (At Least 14 Days)||5||
48506232|NCT00562120|101573822|FG000|COMPLETED|Washout Period 3 (At Least 14 Days)||4||
48506233|NCT00562120|101573823|FG001|COMPLETED|Washout Period 3 (At Least 14 Days)||5||
48506234|NCT00562120|101573824|FG002|COMPLETED|Washout Period 3 (At Least 14 Days)||5||
48506235|NCT00562120|101573825|FG003|COMPLETED|Washout Period 3 (At Least 14 Days)||5||
48062154|NCT00161473|100472988|FG001|NOT COMPLETED|Overall Study||6||
48506236|NCT00562120|101573822|FG000|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0||
48506237|NCT00562120|101573823|FG001|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0||
48506238|NCT00562120|101573824|FG002|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0||
48506239|NCT00562120|101573825|FG003|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0||
48506240|NCT00562120|101573822|FG000|STARTED|Fourth Intervention Period||4||
48506241|NCT00562120|101573823|FG001|STARTED|Fourth Intervention Period||5||
48506242|NCT00562120|101573824|FG002|STARTED|Fourth Intervention Period||5||
48506243|NCT00562120|101573825|FG003|STARTED|Fourth Intervention Period||5||
48506244|NCT00562120|101573822|FG000|COMPLETED|Fourth Intervention Period||4||
48506245|NCT00562120|101573823|FG001|COMPLETED|Fourth Intervention Period||5||
48506246|NCT00562120|101573824|FG002|COMPLETED|Fourth Intervention Period||5||
48506247|NCT00562120|101573825|FG003|COMPLETED|Fourth Intervention Period||5||
48506248|NCT00562120|101573822|FG000|NOT COMPLETED|Fourth Intervention Period||0||
48506249|NCT00562120|101573823|FG001|NOT COMPLETED|Fourth Intervention Period||0||
48506250|NCT00562120|101573824|FG002|NOT COMPLETED|Fourth Intervention Period||0||
48506251|NCT00562120|101573825|FG003|NOT COMPLETED|Fourth Intervention Period||0||
48506252|NCT01115933|101573826|FG000|STARTED|Overall Study||65||
48506253|NCT01115933|101573826|FG000|COMPLETED|Overall Study||64||
48506254|NCT01115933|101573826|FG000|NOT COMPLETED|Overall Study||1||
48506255|NCT03316976|101573827|FG000|STARTED|Overall Study||20||
48506256|NCT03316976|101573828|FG001|STARTED|Overall Study||20||
48506257|NCT03316976|101573827|FG000|COMPLETED|Overall Study||20||
48506258|NCT03316976|101573828|FG001|COMPLETED|Overall Study||20||
48506259|NCT03316976|101573827|FG000|NOT COMPLETED|Overall Study||0||
48506260|NCT03316976|101573828|FG001|NOT COMPLETED|Overall Study||0||
48506261|NCT01785615|101573829|FG000|STARTED|Dietary Phase||0||
48506262|NCT01785615|101573830|FG001|STARTED|Dietary Phase||0||
48506263|NCT01785615|101573831|FG002|STARTED|Dietary Phase||35||
48506264|NCT01785615|101573832|FG003|STARTED|Dietary Phase||140||
48506265|NCT01785615|101573829|FG000|COMPLETED|Dietary Phase||0||
48506266|NCT01785615|101573830|FG001|COMPLETED|Dietary Phase||0||
48506267|NCT01785615|101573831|FG002|COMPLETED|Dietary Phase||35||
48506268|NCT01785615|101573832|FG003|COMPLETED|Dietary Phase||116||
48506269|NCT01785615|101573829|FG000|NOT COMPLETED|Dietary Phase||0||
48506270|NCT01785615|101573830|FG001|NOT COMPLETED|Dietary Phase||0||
48506271|NCT01785615|101573831|FG002|NOT COMPLETED|Dietary Phase||0||
48506272|NCT01785615|101573832|FG003|NOT COMPLETED|Dietary Phase||24||
48506273|NCT01785615|101573829|FG000|STARTED|Atorvastatin Phase||44||
48506274|NCT01785615|101573830|FG001|STARTED|Atorvastatin Phase||44||
48506275|NCT01785615|101573831|FG002|STARTED|Atorvastatin Phase||0||
48506276|NCT01785615|101573832|FG003|STARTED|Atorvastatin Phase||0||
48506277|NCT01785615|101573829|FG000|COMPLETED|Atorvastatin Phase||44||
48506278|NCT01785615|101573830|FG001|COMPLETED|Atorvastatin Phase||44||
48506279|NCT01785615|101573831|FG002|COMPLETED|Atorvastatin Phase||0||
48506280|NCT01785615|101573832|FG003|COMPLETED|Atorvastatin Phase||0||
48506281|NCT01785615|101573829|FG000|NOT COMPLETED|Atorvastatin Phase||0||
48506282|NCT01785615|101573830|FG001|NOT COMPLETED|Atorvastatin Phase||0||
48506283|NCT01785615|101573831|FG002|NOT COMPLETED|Atorvastatin Phase||0||
48506284|NCT01785615|101573832|FG003|NOT COMPLETED|Atorvastatin Phase||0||
48506285|NCT02569541|101573833|FG000|STARTED|Overall Study||30||
48506286|NCT02569541|101573833|FG000|COMPLETED|Overall Study||9||
48506287|NCT02569541|101573833|FG000|NOT COMPLETED|Overall Study||21||
48506288|NCT00683592|101573834|FG000|STARTED|Overall Study||240||
48506289|NCT00683592|101573835|FG001|STARTED|Overall Study||241||
48506290|NCT00683592|101573834|FG000|Intent to Treat Population|Overall Study||231||
48506291|NCT00683592|101573835|FG001|Intent to Treat Population|Overall Study||232||
48506292|NCT00683592|101573834|FG000|Safety Population|Overall Study||235||
48506293|NCT00683592|101573835|FG001|Safety Population|Overall Study||233||
48506294|NCT00683592|101573834|FG000|COMPLETED|Overall Study||193||
48506295|NCT00683592|101573835|FG001|COMPLETED|Overall Study||195||
48506296|NCT00683592|101573834|FG000|NOT COMPLETED|Overall Study||47||
48506297|NCT00683592|101573835|FG001|NOT COMPLETED|Overall Study||46||
48506298|NCT00781079|101573836|FG000|STARTED|Overall Study||149||
48506299|NCT00781079|101573837|FG001|STARTED|Overall Study||133||
48062155|NCT02130024|100472989|FG000|STARTED|Overall Study||142||
48506300|NCT00781079|101573836|FG000|COMPLETED|Overall Study||122||
48506301|NCT00781079|101573837|FG001|COMPLETED|Overall Study||116||
48506302|NCT00781079|101573836|FG000|NOT COMPLETED|Overall Study||27||
48506303|NCT00781079|101573837|FG001|NOT COMPLETED|Overall Study||17||
48506304|NCT04573309|101573838|FG000|STARTED|Overall Study||8||
48506305|NCT04573309|101573839|FG001|STARTED|Overall Study||1||
48506306|NCT04573309|101573838|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8||
48506307|NCT04573309|101573839|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1||
48506308|NCT04573309|101573838|FG000|COMPLETED|Overall Study||7||
48506309|NCT04573309|101573839|FG001|COMPLETED|Overall Study||1||
48506310|NCT04573309|101573838|FG000|NOT COMPLETED|Overall Study||1||
48062156|NCT02130024|100472990|FG001|STARTED|Overall Study||139||
48506311|NCT04573309|101573839|FG001|NOT COMPLETED|Overall Study||0||
48506312|NCT01688882|101573840|FG000|STARTED|Overall Study||13||
48506313|NCT01688882|101573841|FG001|STARTED|Overall Study||7||
48506314|NCT01688882|101573840|FG000|Safety Follow-up|Overall Study||11||
48506315|NCT01688882|101573841|FG001|Safety Follow-up|Overall Study||5||
48506316|NCT01688882|101573840|FG000|COMPLETED|Overall Study||10||
48506317|NCT01688882|101573841|FG001|COMPLETED|Overall Study||6||
48506318|NCT01688882|101573840|FG000|NOT COMPLETED|Overall Study||3||
48506319|NCT01688882|101573841|FG001|NOT COMPLETED|Overall Study||1||
48506320|NCT03852524|101573842|FG000|STARTED|Overall Study||41||
48506321|NCT03852524|101573843|FG001|STARTED|Overall Study||41||
48506322|NCT03852524|101573842|FG000|COMPLETED|Overall Study||41||
48506323|NCT03852524|101573843|FG001|COMPLETED|Overall Study||41||
48506324|NCT03852524|101573842|FG000|NOT COMPLETED|Overall Study||0||
48506325|NCT03852524|101573843|FG001|NOT COMPLETED|Overall Study||0||
48506326|NCT02058160|101573844|FG000|STARTED|Overall Study||367||
48506327|NCT02058160|101573845|FG001|STARTED|Overall Study||369||
48506328|NCT02058160|101573844|FG000|Treated|Overall Study||365||
48506329|NCT02058160|101573845|FG001|Treated|Overall Study||365||
48506330|NCT02058160|101573844|FG000|COMPLETED|Overall Study||336||
48506331|NCT02058160|101573845|FG001|COMPLETED|Overall Study||355||
48506332|NCT02058160|101573844|FG000|NOT COMPLETED|Overall Study||31||
48506333|NCT02058160|101573845|FG001|NOT COMPLETED|Overall Study||14||
48506334|NCT00199901|101573846|FG000|STARTED|Overall Study||56||
48506335|NCT00199901|101573847|FG001|STARTED|Overall Study||54||
48506336|NCT00199901|101573846|FG000|COMPLETED|Overall Study||29||
48506337|NCT00199901|101573847|FG001|COMPLETED|Overall Study||30||
48506338|NCT00199901|101573846|FG000|NOT COMPLETED|Overall Study||27||
48506339|NCT00199901|101573847|FG001|NOT COMPLETED|Overall Study||24||
48506340|NCT01186562|101573848|FG000|STARTED|Overall Study||54||
48506341|NCT01186562|101573849|FG001|STARTED|Overall Study||29||
48506342|NCT01186562|101573848|FG000|COMPLETED|Overall Study||50||
48506343|NCT01186562|101573849|FG001|COMPLETED|Overall Study||27||
48506344|NCT01186562|101573848|FG000|NOT COMPLETED|Overall Study||4||
48506345|NCT01186562|101573849|FG001|NOT COMPLETED|Overall Study||2||
48506346|NCT04592419|101573850|FG000|STARTED|Primary Study (Through Year 1)||284||
48506347|NCT04592419|101573851|FG001|STARTED|Primary Study (Through Year 1)||284||
48506348|NCT04592419|101573850|FG000|Completed Treatment at Week 20|Primary Study (Through Year 1)||270||
48506349|NCT04592419|101573851|FG001|Completed Treatment at Week 20|Primary Study (Through Year 1)||274||
48506350|NCT04592419|101573850|FG000|Did Not Discontinue Treatment Before Week 24|Primary Study (Through Year 1)||270||
48506351|NCT04592419|101573851|FG001|Did Not Discontinue Treatment Before Week 24|Primary Study (Through Year 1)||276||
48506352|NCT04592419|101573850|FG000|Did Not Discontinue Study Before Week 24|Primary Study (Through Year 1)||275||
48506353|NCT04592419|101573851|FG001|Did Not Discontinue Study Before Week 24|Primary Study (Through Year 1)||276||
48506354|NCT04592419|101573850|FG000|COMPLETED|Primary Study (Through Year 1)||255||
48506355|NCT04592419|101573851|FG001|COMPLETED|Primary Study (Through Year 1)||255||
48506356|NCT04592419|101573850|FG000|NOT COMPLETED|Primary Study (Through Year 1)||29||
48506357|NCT04592419|101573851|FG001|NOT COMPLETED|Primary Study (Through Year 1)||29||
48506358|NCT04592419|101573850|FG000|STARTED|Open-Label Extension Period||216||
48506359|NCT04592419|101573851|FG001|STARTED|Open-Label Extension Period||228||
48506360|NCT04592419|101573850|FG000|COMPLETED|Open-Label Extension Period||135||
48506361|NCT04592419|101573851|FG001|COMPLETED|Open-Label Extension Period||130||
48506362|NCT04592419|101573850|FG000|NOT COMPLETED|Open-Label Extension Period||81||
48506363|NCT04592419|101573851|FG001|NOT COMPLETED|Open-Label Extension Period||98||
48506364|NCT00758758|101573852|FG000|STARTED|Overall Study||14||
48506365|NCT00758758|101573853|FG001|STARTED|Overall Study||74||
48506366|NCT00758758|101573854|FG002|STARTED|Overall Study||53||
48506367|NCT00758758|101573855|FG003|STARTED|Overall Study||6||
48506368|NCT00758758|101573856|FG004|STARTED|Overall Study||3||
48506369|NCT00758758|101573857|FG005|STARTED|Overall Study||50||
48506370|NCT00758758|101573858|FG006|STARTED|Overall Study||31||
48506371|NCT00758758|101573859|FG007|STARTED|Overall Study||0||
48506372|NCT00758758|101573852|FG000|COMPLETED|Overall Study||11||
48506373|NCT00758758|101573853|FG001|COMPLETED|Overall Study||49||
48506374|NCT00758758|101573854|FG002|COMPLETED|Overall Study||35||
48506375|NCT00758758|101573855|FG003|COMPLETED|Overall Study||4||
48506376|NCT00758758|101573856|FG004|COMPLETED|Overall Study||1||
48506377|NCT00758758|101573857|FG005|COMPLETED|Overall Study||36||
48506378|NCT00758758|101573858|FG006|COMPLETED|Overall Study||17||
48506379|NCT00758758|101573859|FG007|COMPLETED|Overall Study||0||
48506380|NCT00758758|101573852|FG000|NOT COMPLETED|Overall Study||3||
48506381|NCT00758758|101573853|FG001|NOT COMPLETED|Overall Study||25||
48506382|NCT00758758|101573854|FG002|NOT COMPLETED|Overall Study||18||
48506383|NCT00758758|101573855|FG003|NOT COMPLETED|Overall Study||2||
48506384|NCT00758758|101573856|FG004|NOT COMPLETED|Overall Study||2||
48506385|NCT00758758|101573857|FG005|NOT COMPLETED|Overall Study||14||
48506386|NCT00758758|101573858|FG006|NOT COMPLETED|Overall Study||14||
48506387|NCT00758758|101573859|FG007|NOT COMPLETED|Overall Study||0||
48506388|NCT03343639|101573860|FG000|STARTED|Overall Study||102||
48506389|NCT03343639|101573861|FG001|STARTED|Overall Study||102||
48506390|NCT03343639|101573860|FG000|COMPLETED|Overall Study||88||
48506391|NCT03343639|101573861|FG001|COMPLETED|Overall Study||90||
48506392|NCT03343639|101573860|FG000|NOT COMPLETED|Overall Study||14||
48506393|NCT03343639|101573861|FG001|NOT COMPLETED|Overall Study||12||
48506394|NCT01263561|101573862|FG000|STARTED|Overall Study||31||
48506395|NCT01263561|101573863|FG001|STARTED|Overall Study||33||
48506396|NCT01263561|101573862|FG000|COMPLETED|Overall Study||30||
48506397|NCT01263561|101573863|FG001|COMPLETED|Overall Study||31||
48506398|NCT01263561|101573862|FG000|NOT COMPLETED|Overall Study||1||
48506399|NCT01263561|101573863|FG001|NOT COMPLETED|Overall Study||2||
48506400|NCT01256060|101573864|FG000|STARTED|Overall Study||3||
48506401|NCT01256060|101573865|FG001|STARTED|Overall Study||3||
48506402|NCT01256060|101573866|FG002|STARTED|Overall Study||3||
48506403|NCT01256060|101573867|FG003|STARTED|Overall Study||6||
48506404|NCT01256060|101573864|FG000|COMPLETED|Overall Study||3||
48506405|NCT01256060|101573865|FG001|COMPLETED|Overall Study||2||
48506406|NCT01256060|101573866|FG002|COMPLETED|Overall Study||3||
48506407|NCT01256060|101573867|FG003|COMPLETED|Overall Study||6||
48506408|NCT01256060|101573864|FG000|NOT COMPLETED|Overall Study||0||
48506409|NCT01256060|101573865|FG001|NOT COMPLETED|Overall Study||1||
48506410|NCT01256060|101573866|FG002|NOT COMPLETED|Overall Study||0||
48506411|NCT01256060|101573867|FG003|NOT COMPLETED|Overall Study||0||
48506412|NCT01889797|101573868|FG000|STARTED|Overall Study||16||
48506413|NCT01889797|101573869|FG001|STARTED|Overall Study||16||
48506414|NCT01889797|101573868|FG000|COMPLETED|Overall Study||16||
48506415|NCT01889797|101573869|FG001|COMPLETED|Overall Study||16||
48506416|NCT01889797|101573868|FG000|NOT COMPLETED|Overall Study||0||
48506417|NCT01889797|101573869|FG001|NOT COMPLETED|Overall Study||0||
48506418|NCT02875028|101573870|FG000|STARTED|First Intervention (24 Hours)||8|One subject did not participate in the second study period, therefore only 15 started vorapaxar|
48062157|NCT02130024|100472989|FG000|Safety Set|Overall Study||141||
48062158|NCT02130024|100472990|FG001|Safety Set|Overall Study||139||
48062159|NCT02130024|100472989|FG000|Full Analysis Set (FAS)|Overall Study||141||
48062160|NCT02130024|100472990|FG001|Full Analysis Set (FAS)|Overall Study||137||
48062161|NCT02130024|100472989|FG000|COMPLETED|Overall Study||117||
48062162|NCT02130024|100472990|FG001|COMPLETED|Overall Study||108||
48062163|NCT02130024|100472989|FG000|NOT COMPLETED|Overall Study||25||
48062164|NCT02130024|100472990|FG001|NOT COMPLETED|Overall Study||31||
48062165|NCT04635059|100472991|FG000|STARTED|Overall Study||6||
48062166|NCT04635059|100472991|FG000|COMPLETED|Overall Study||2||
48062167|NCT04635059|100472991|FG000|NOT COMPLETED|Overall Study||4||
48062168|NCT00333177|100472992|FG000|STARTED|Overall Study||12||
48062169|NCT00333177|100472993|FG001|STARTED|Overall Study||17||
48062170|NCT00333177|100472994|FG002|STARTED|Overall Study||17||
48062171|NCT00333177|100472995|FG003|STARTED|Overall Study||14||
48062172|NCT00333177|100472992|FG000|Received Intervention|Overall Study||12||
48062173|NCT00333177|100472993|FG001|Received Intervention|Overall Study||16||
48062174|NCT00333177|100472994|FG002|Received Intervention|Overall Study||16||
48062175|NCT00333177|100472995|FG003|Received Intervention|Overall Study||12||
48062176|NCT00333177|100472992|FG000|COMPLETED|Overall Study||12||
48062177|NCT00333177|100472993|FG001|COMPLETED|Overall Study||16||
48062178|NCT00333177|100472994|FG002|COMPLETED|Overall Study||16||
48062179|NCT00333177|100472995|FG003|COMPLETED|Overall Study||12||
48062180|NCT00333177|100472992|FG000|NOT COMPLETED|Overall Study||0||
48062181|NCT00333177|100472993|FG001|NOT COMPLETED|Overall Study||1||
48062182|NCT00333177|100472994|FG002|NOT COMPLETED|Overall Study||1||
48062183|NCT00333177|100472995|FG003|NOT COMPLETED|Overall Study||2||
48062184|NCT00784641|100472996|FG000|STARTED|Overall Study||189||
48062185|NCT00784641|100472997|FG001|STARTED|Overall Study||189||
48062186|NCT00784641|100472998|FG002|STARTED|Overall Study||189||
48062187|NCT00784641|100472996|FG000|COMPLETED|Overall Study||183||
48062188|NCT00784641|100472997|FG001|COMPLETED|Overall Study||186||
48062189|NCT00784641|100472998|FG002|COMPLETED|Overall Study||187||
48062190|NCT00784641|100472996|FG000|NOT COMPLETED|Overall Study||6||
48062191|NCT00784641|100472997|FG001|NOT COMPLETED|Overall Study||3||
48062192|NCT00784641|100472998|FG002|NOT COMPLETED|Overall Study||2||
48062193|NCT01200524|100472999|FG000|STARTED|Overall Study||41||
48062194|NCT01200524|100473000|FG001|STARTED|Overall Study||48||
48062195|NCT01200524|100473001|FG002|STARTED|Overall Study||44||
48062196|NCT01200524|100472999|FG000|COMPLETED|Overall Study||39||
48062197|NCT01200524|100473000|FG001|COMPLETED|Overall Study||47||
48062198|NCT01200524|100473001|FG002|COMPLETED|Overall Study||40||
48062199|NCT01200524|100472999|FG000|NOT COMPLETED|Overall Study||2||
48062200|NCT01200524|100473000|FG001|NOT COMPLETED|Overall Study||1||
48062201|NCT01200524|100473001|FG002|NOT COMPLETED|Overall Study||4||
48062202|NCT02059902|100473002|FG000|STARTED|Overall Study||18||
48062203|NCT02059902|100473003|FG001|STARTED|Overall Study||18||
48062204|NCT02059902|100473002|FG000|COMPLETED|Overall Study||14||
48062205|NCT02059902|100473003|FG001|COMPLETED|Overall Study||14||
48062206|NCT02059902|100473002|FG000|NOT COMPLETED|Overall Study||4||
48062207|NCT02059902|100473003|FG001|NOT COMPLETED|Overall Study||4||
48062208|NCT03467048|100473004|FG000|STARTED|Overall Study||66||
48062209|NCT03467048|100473005|FG001|STARTED|Overall Study||64||
48062210|NCT03467048|100473004|FG000|COMPLETED|Overall Study||66||
48062211|NCT03467048|100473005|FG001|COMPLETED|Overall Study||63||
48062212|NCT03467048|100473004|FG000|NOT COMPLETED|Overall Study||0||
48062213|NCT03467048|100473005|FG001|NOT COMPLETED|Overall Study||1||
48062214|NCT04171765|100473006|FG000|STARTED|Overall Study||13||
48062215|NCT04171765|100473007|FG001|STARTED|Overall Study||11||
48062216|NCT04171765|100473008|FG002|STARTED|Overall Study||11||
48062217|NCT04171765|100473009|FG003|STARTED|Overall Study||11||
48062218|NCT04171765|100473006|FG000|COMPLETED|Overall Study||8||
48062219|NCT04171765|100473007|FG001|COMPLETED|Overall Study||9||
48062220|NCT04171765|100473008|FG002|COMPLETED|Overall Study||7||
48062221|NCT04171765|100473009|FG003|COMPLETED|Overall Study||6||
48062222|NCT04171765|100473006|FG000|NOT COMPLETED|Overall Study||5||
48062223|NCT04171765|100473007|FG001|NOT COMPLETED|Overall Study||2||
48062224|NCT04171765|100473008|FG002|NOT COMPLETED|Overall Study||4||
48506419|NCT02875028|101573871|FG001|STARTED|First Intervention (24 Hours)||8|One subject did not participate in the second study period, therefore only 15 started vorapaxar|
48506420|NCT02875028|101573870|FG000|COMPLETED|First Intervention (24 Hours)||8||
48506421|NCT02875028|101573871|FG001|COMPLETED|First Intervention (24 Hours)||8||
48506422|NCT02875028|101573870|FG000|NOT COMPLETED|First Intervention (24 Hours)||0||
48506423|NCT02875028|101573871|FG001|NOT COMPLETED|First Intervention (24 Hours)||0||
48506424|NCT02875028|101573870|FG000|STARTED|Washout Period||8||
48506425|NCT02875028|101573871|FG001|STARTED|Washout Period||8||
48506426|NCT02875028|101573870|FG000|COMPLETED|Washout Period||8||
48506427|NCT02875028|101573871|FG001|COMPLETED|Washout Period||7||
48506428|NCT02875028|101573870|FG000|NOT COMPLETED|Washout Period||0||
48506429|NCT02875028|101573871|FG001|NOT COMPLETED|Washout Period||1||
48506430|NCT02875028|101573870|FG000|STARTED|Second Intervention (24 Hours)||8||
48506431|NCT02875028|101573871|FG001|STARTED|Second Intervention (24 Hours)||7||
48506432|NCT02875028|101573870|FG000|COMPLETED|Second Intervention (24 Hours)||8||
48506433|NCT02875028|101573871|FG001|COMPLETED|Second Intervention (24 Hours)||7||
48506434|NCT02875028|101573870|FG000|NOT COMPLETED|Second Intervention (24 Hours)||0||
48506435|NCT02875028|101573871|FG001|NOT COMPLETED|Second Intervention (24 Hours)||0||
48506436|NCT00963430|101573872|FG000|STARTED|Overall Study||60||
48506437|NCT00963430|101573873|FG001|STARTED|Overall Study||60||
48506438|NCT00963430|101573872|FG000|COMPLETED|Overall Study||59||
48506439|NCT00963430|101573873|FG001|COMPLETED|Overall Study||57||
48506440|NCT00963430|101573872|FG000|NOT COMPLETED|Overall Study||1||
48506441|NCT00963430|101573873|FG001|NOT COMPLETED|Overall Study||3||
48506442|NCT02725411|101573874|FG000|STARTED|Treatment Period (56 Weeks)||92||
48506443|NCT02725411|101573875|FG001|STARTED|Treatment Period (56 Weeks)||93||
48506444|NCT02725411|101573876|FG002|STARTED|Treatment Period (56 Weeks)||92||
48506445|NCT02725411|101573874|FG000|Treated|Treatment Period (56 Weeks)||92||
48506446|NCT02725411|101573875|FG001|Treated|Treatment Period (56 Weeks)||93||
48506447|NCT02725411|101573876|FG002|Treated|Treatment Period (56 Weeks)||92||
48506448|NCT02725411|101573874|FG000|COMPLETED|Treatment Period (56 Weeks)||62||
48506449|NCT02725411|101573875|FG001|COMPLETED|Treatment Period (56 Weeks)||43||
48506450|NCT02725411|101573876|FG002|COMPLETED|Treatment Period (56 Weeks)||43||
48506451|NCT02725411|101573874|FG000|NOT COMPLETED|Treatment Period (56 Weeks)||30||
48506452|NCT02725411|101573875|FG001|NOT COMPLETED|Treatment Period (56 Weeks)||50||
48506453|NCT02725411|101573876|FG002|NOT COMPLETED|Treatment Period (56 Weeks)||49||
48506454|NCT02725411|101573874|FG000|STARTED|Follow-up Period (24 Weeks)||92||
48506455|NCT02725411|101573875|FG001|STARTED|Follow-up Period (24 Weeks)||93||
48506456|NCT02725411|101573876|FG002|STARTED|Follow-up Period (24 Weeks)||92||
48506457|NCT02725411|101573874|FG000|COMPLETED|Follow-up Period (24 Weeks)||88||
48506458|NCT02725411|101573875|FG001|COMPLETED|Follow-up Period (24 Weeks)||82||
48506459|NCT02725411|101573876|FG002|COMPLETED|Follow-up Period (24 Weeks)||87||
48506460|NCT02725411|101573874|FG000|NOT COMPLETED|Follow-up Period (24 Weeks)||4||
48506461|NCT02725411|101573875|FG001|NOT COMPLETED|Follow-up Period (24 Weeks)||11||
48506462|NCT02725411|101573876|FG002|NOT COMPLETED|Follow-up Period (24 Weeks)||5||
48506463|NCT00676494|101573877|FG000|STARTED|Overall Study||172||
48506464|NCT00676494|101573877|FG000|COMPLETED|Overall Study||158||
48506465|NCT00676494|101573877|FG000|NOT COMPLETED|Overall Study||14||
48506466|NCT01966809|101573878|FG000|STARTED|Overall Study||1||
48506467|NCT01966809|101573878|FG000|COMPLETED|Overall Study||1||
48506468|NCT01966809|101573878|FG000|NOT COMPLETED|Overall Study||0||
48506469|NCT04480307|101573879|FG000|STARTED|Overall Study||11||
48506470|NCT04480307|101573880|FG001|STARTED|Overall Study||10||
48506471|NCT04480307|101573881|FG002|STARTED|Overall Study||10||
48506472|NCT04480307|101573882|FG003|STARTED|Overall Study||10||
48506473|NCT04480307|101573879|FG000|COMPLETED|Overall Study||11||
48506474|NCT04480307|101573880|FG001|COMPLETED|Overall Study||9||
48506475|NCT04480307|101573881|FG002|COMPLETED|Overall Study||10||
48506476|NCT04480307|101573882|FG003|COMPLETED|Overall Study||9||
48506477|NCT04480307|101573879|FG000|NOT COMPLETED|Overall Study||0||
48506478|NCT04480307|101573880|FG001|NOT COMPLETED|Overall Study||1||
48506479|NCT04480307|101573881|FG002|NOT COMPLETED|Overall Study||0||
48506480|NCT04480307|101573882|FG003|NOT COMPLETED|Overall Study||1||
48506481|NCT01839838|101573883|FG000|STARTED|Overall Study||12||
48506482|NCT01839838|101573884|FG001|STARTED|Overall Study||28||
48506483|NCT01839838|101573883|FG000|COMPLETED|Overall Study||12||
48506484|NCT01839838|101573884|FG001|COMPLETED|Overall Study||28||
48506485|NCT01839838|101573883|FG000|NOT COMPLETED|Overall Study||0||
48506486|NCT01839838|101573884|FG001|NOT COMPLETED|Overall Study||0||
48506487|NCT00680524|101573885|FG000|STARTED|Overall Study||20||
48506488|NCT00680524|101573885|FG000|COMPLETED|Overall Study||17||
48506489|NCT00680524|101573885|FG000|NOT COMPLETED|Overall Study||3||
48506490|NCT03480022|101573886|FG000|STARTED|Overall Study||55||
48506491|NCT03480022|101573887|FG001|STARTED|Overall Study||27||
48506492|NCT03480022|101573886|FG000|COMPLETED|Overall Study||44||
48506493|NCT03480022|101573887|FG001|COMPLETED|Overall Study||23||
48506494|NCT03480022|101573886|FG000|NOT COMPLETED|Overall Study||11||
48506495|NCT03480022|101573887|FG001|NOT COMPLETED|Overall Study||4||
48506496|NCT01475786|101573888|FG000|STARTED|Overall Study||43||
48506497|NCT01475786|101573889|FG001|STARTED|Overall Study||40||
48506498|NCT01475786|101573890|FG002|STARTED|Overall Study||21||
48506499|NCT01475786|101573888|FG000|COMPLETED|Overall Study||41||
48506500|NCT01475786|101573889|FG001|COMPLETED|Overall Study||36||
48506501|NCT01475786|101573890|FG002|COMPLETED|Overall Study||19||
48506502|NCT01475786|101573888|FG000|NOT COMPLETED|Overall Study||2||
48506503|NCT01475786|101573889|FG001|NOT COMPLETED|Overall Study||4||
48506504|NCT01475786|101573890|FG002|NOT COMPLETED|Overall Study||2||
48506505|NCT03407729|101573891|FG000|STARTED|Overall Study||11||
48506506|NCT03407729|101573892|FG001|STARTED|Overall Study||10||
48506507|NCT03407729|101573891|FG000|COMPLETED|Overall Study||9||
48506508|NCT03407729|101573892|FG001|COMPLETED|Overall Study||7||
48506509|NCT03407729|101573891|FG000|NOT COMPLETED|Overall Study||2||
48506510|NCT03407729|101573892|FG001|NOT COMPLETED|Overall Study||3||
48506511|NCT01266603|101573893|FG000|STARTED|Overall Study||44||
48506512|NCT01266603|101573893|FG000|MAGE-A3 Positive Tumor|Overall Study||18||
48506513|NCT01266603|101573893|FG000|Patients Evaluable for Safety|Overall Study||17||
48506514|NCT01266603|101573893|FG000|Patients Evaluable for Response|Overall Study||16||
48506515|NCT01266603|101573893|FG000|Continued to Maintenance- MAGE-A3|Overall Study||4||
48506516|NCT01266603|101573893|FG000|Maintenance Completion|Overall Study||2||
48506517|NCT01266603|101573893|FG000|COMPLETED|Overall Study||2||
48506518|NCT01266603|101573893|FG000|NOT COMPLETED|Overall Study||42||
48506519|NCT02327325|101573894|FG000|STARTED|Overall Study||20||
48506520|NCT02327325|101573895|FG001|STARTED|Overall Study||20||
48506521|NCT02327325|101573896|FG002|STARTED|Overall Study||20||
48506522|NCT02327325|101573894|FG000|COMPLETED|Overall Study||19||
48506523|NCT02327325|101573895|FG001|COMPLETED|Overall Study||16||
48506524|NCT02327325|101573896|FG002|COMPLETED|Overall Study||15||
48506525|NCT02327325|101573894|FG000|NOT COMPLETED|Overall Study||1||
48506526|NCT02327325|101573895|FG001|NOT COMPLETED|Overall Study||4||
48506527|NCT02327325|101573896|FG002|NOT COMPLETED|Overall Study||5||
48506528|NCT01685216|101573897|FG000|STARTED|Overall Study||7||
48506529|NCT01685216|101573897|FG000|COMPLETED|Overall Study||6||
48506530|NCT01685216|101573897|FG000|NOT COMPLETED|Overall Study||1||
48506531|NCT01427881|101573898|FG000|STARTED|Overall Study||43||
48506532|NCT01427881|101573898|FG000|COMPLETED|Overall Study||43||
48506533|NCT01427881|101573898|FG000|NOT COMPLETED|Overall Study||0||
48506534|NCT02400463|101573899|FG000|STARTED|Overall Study||6||
48506535|NCT02400463|101573899|FG000|COMPLETED|Overall Study||6||
48506536|NCT02400463|101573899|FG000|NOT COMPLETED|Overall Study||0||
48506537|NCT03391115|101573900|FG000|STARTED|Overall Study||20||
48506538|NCT03391115|101573901|FG001|STARTED|Overall Study||18||
48506539|NCT03391115|101573900|FG000|COMPLETED|Overall Study||20||
48506540|NCT03391115|101573901|FG001|COMPLETED|Overall Study||18||
48506541|NCT03391115|101573900|FG000|NOT COMPLETED|Overall Study||0||
48506542|NCT03391115|101573901|FG001|NOT COMPLETED|Overall Study||0||
48506543|NCT00605150|101573902|FG000|STARTED|Overall Study||11||
48506544|NCT00605150|101573902|FG000|COMPLETED|Overall Study||10||
48506545|NCT00605150|101573902|FG000|NOT COMPLETED|Overall Study||1||
48506546|NCT02075840|101573903|FG000|STARTED|Overall Study||152||
48506547|NCT02075840|101573904|FG001|STARTED|Overall Study||151||
48506548|NCT02075840|101573903|FG000|COMPLETED|Overall Study||0||
48506549|NCT02075840|101573904|FG001|COMPLETED|Overall Study||0||
48506550|NCT02075840|101573903|FG000|NOT COMPLETED|Overall Study||152||
48506551|NCT02075840|101573904|FG001|NOT COMPLETED|Overall Study||151||
48506552|NCT00712244|101573905|FG000|STARTED|Overall Study||29||
48506553|NCT00712244|101573906|FG001|STARTED|Overall Study||29||
48506554|NCT00712244|101573907|FG002|STARTED|Overall Study||27||
48506555|NCT00712244|101573908|FG003|STARTED|Overall Study||27||
48506556|NCT00712244|101573905|FG000|COMPLETED|Overall Study||25||
48506557|NCT00712244|101573906|FG001|COMPLETED|Overall Study||28||
48506558|NCT00712244|101573907|FG002|COMPLETED|Overall Study||25||
48506559|NCT00712244|101573908|FG003|COMPLETED|Overall Study||26||
48506560|NCT00712244|101573905|FG000|NOT COMPLETED|Overall Study||4||
48506561|NCT00712244|101573906|FG001|NOT COMPLETED|Overall Study||1||
48506562|NCT00712244|101573907|FG002|NOT COMPLETED|Overall Study||2||
48506563|NCT00712244|101573908|FG003|NOT COMPLETED|Overall Study||1||
48506564|NCT00499473|101573909|FG000|STARTED|Overall Study||27||
48506565|NCT00499473|101573910|FG001|STARTED|Overall Study||4||
48506566|NCT00499473|101573909|FG000|COMPLETED|Overall Study||21||
48506567|NCT00499473|101573910|FG001|COMPLETED|Overall Study||4||
48506568|NCT00499473|101573909|FG000|NOT COMPLETED|Overall Study||6||
48506569|NCT00499473|101573910|FG001|NOT COMPLETED|Overall Study||0||
48506570|NCT02774850|101573911|FG000|STARTED|Overall Study||610||
48506571|NCT02774850|101573911|FG000|Induction I|Overall Study||585|Patients whose Induction I course was included in chart abstractions.|
48506572|NCT02774850|101573911|FG000|Early Discharge Eligible at Induction I|Overall Study||276|Study population after early discharge criteria were applied at Induction I.|
48506573|NCT02774850|101573911|FG000|Induction II|Overall Study||564|Patients whose Induction II course was included in chart abstractions.|
48506574|NCT02774850|101573911|FG000|Early Discharge Eligible at Induction II|Overall Study||493|Study population after early discharge criteria were applied at Induction II.|
48506575|NCT02774850|101573911|FG000|Intensification I|Overall Study||476|Patients whose Intensification I course was included in chart abstractions.|
48506576|NCT02774850|101573911|FG000|Early Discharge Eligible at Int I|Overall Study||374|Study population after early discharge criteria were applied at Intensification I.|
48506577|NCT02774850|101573911|FG000|Intensification II|Overall Study||342|Patients whose Intensification II course was included in chart abstractions.|
48506578|NCT02774850|101573911|FG000|Early Discharge Eligible at Int II|Overall Study||285|Study population after early discharge criteria were applied at Intensification II.|
48506579|NCT02774850|101573911|FG000|Intensification III|Overall Study||48|Patients whose Intensification III course was included in chart abstractions.|
48506580|NCT02774850|101573911|FG000|Early Discharge Eligible at Int III|Overall Study||44|Study population after early discharge criteria were applied at Intensification III.|
48506581|NCT02774850|101573911|FG000|COMPLETED|Overall Study||575|This milestone reflects the total early discharge-eligible study population in the overall study.|
48506582|NCT02774850|101573911|FG000|NOT COMPLETED|Overall Study||35||
48506583|NCT04019054|101573912|FG000|STARTED|Overall Study||11||
48506584|NCT04019054|101573913|FG001|STARTED|Overall Study||11||
48506585|NCT04019054|101573912|FG000|COMPLETED|Overall Study||8||
48506586|NCT04019054|101573913|FG001|COMPLETED|Overall Study||9||
48506587|NCT04019054|101573912|FG000|NOT COMPLETED|Overall Study||3||
48506588|NCT04019054|101573913|FG001|NOT COMPLETED|Overall Study||2||
48506589|NCT04200911|101573914|FG000|STARTED|Overall Study||10||
48506590|NCT04200911|101573914|FG000|COMPLETED|Overall Study||10||
48506591|NCT04200911|101573914|FG000|NOT COMPLETED|Overall Study||0||
48506592|NCT02922582|101573915|FG000|STARTED|Overall Study||4||
48506593|NCT02922582|101573916|FG001|STARTED|Overall Study||4||
48506594|NCT02922582|101573917|FG002|STARTED|Overall Study||4||
48506595|NCT02922582|101573918|FG003|STARTED|Overall Study||4||
48506596|NCT02922582|101573915|FG000|COMPLETED|Overall Study||4||
48506597|NCT02922582|101573916|FG001|COMPLETED|Overall Study||3||
48506598|NCT02922582|101573917|FG002|COMPLETED|Overall Study||4||
48506599|NCT02922582|101573918|FG003|COMPLETED|Overall Study||4||
48506600|NCT02922582|101573915|FG000|NOT COMPLETED|Overall Study||0||
48506601|NCT02922582|101573916|FG001|NOT COMPLETED|Overall Study||1||
48506602|NCT02922582|101573917|FG002|NOT COMPLETED|Overall Study||0||
48506603|NCT02922582|101573918|FG003|NOT COMPLETED|Overall Study||0||
48506604|NCT02463487|101573919|FG000|STARTED|Overall Study||75||
48506605|NCT02463487|101573920|FG001|STARTED|Overall Study||75||
48506606|NCT02463487|101573919|FG000|COMPLETED|Overall Study||65||
48506607|NCT02463487|101573920|FG001|COMPLETED|Overall Study||65||
48506608|NCT02463487|101573919|FG000|NOT COMPLETED|Overall Study||10||
48506609|NCT02463487|101573920|FG001|NOT COMPLETED|Overall Study||10||
48506610|NCT03182751|101573921|FG000|STARTED|Overall Study||64||
48506611|NCT03182751|101573922|FG001|STARTED|Overall Study||64||
48506612|NCT03182751|101573921|FG000|COMPLETED|Overall Study||64||
48506613|NCT03182751|101573922|FG001|COMPLETED|Overall Study||64||
48506614|NCT03182751|101573921|FG000|NOT COMPLETED|Overall Study||0||
48506615|NCT03182751|101573922|FG001|NOT COMPLETED|Overall Study||0||
48506616|NCT01705717|101573923|FG000|STARTED|Overall Study||37||
48506617|NCT01705717|101573924|FG001|STARTED|Overall Study||12||
48506618|NCT01705717|101573923|FG000|COMPLETED|Overall Study||35||
48506619|NCT01705717|101573924|FG001|COMPLETED|Overall Study||7||
48506620|NCT01705717|101573923|FG000|NOT COMPLETED|Overall Study||2||
48506621|NCT01705717|101573924|FG001|NOT COMPLETED|Overall Study||5||
48506622|NCT02767947|101573925|FG000|STARTED|Overall Study||60||
48506623|NCT02767947|101573926|FG001|STARTED|Overall Study||15||
48506624|NCT02767947|101573925|FG000|Safety Population|Overall Study||60|Received at least 1 application of study drug.|
48506625|NCT02767947|101573926|FG001|Safety Population|Overall Study||15|Received at least 1 application of study drug.|
48506626|NCT02767947|101573925|FG000|Pharmacokinetic (PK) Population|Overall Study||12|Received at least 1 dose of study drug, and had blood samples obtained both pre and 6 hrs post-dose.|
48218521|NCT01426412|100860322|FG008|NOT COMPLETED|Overall Study||1||
48218522|NCT01929759|100860323|FG000|STARTED|Overall Study||10||
48218523|NCT01929759|100860323|FG000|COMPLETED|Overall Study||10||
48506627|NCT02767947|101573926|FG001|Pharmacokinetic (PK) Population|Overall Study||3|Received at least 1 dose of study drug, and had blood samples obtained both pre and 6 hrs post-dose.|
48506628|NCT02767947|101573925|FG000|COMPLETED|Overall Study||60||
48506629|NCT02767947|101573926|FG001|COMPLETED|Overall Study||15||
48506630|NCT02767947|101573925|FG000|NOT COMPLETED|Overall Study||0||
48506631|NCT02767947|101573926|FG001|NOT COMPLETED|Overall Study||0||
48218524|NCT01929759|100860323|FG000|NOT COMPLETED|Overall Study||0||
48218525|NCT00701701|100860324|FG000|STARTED|Overall Study||1||
48218526|NCT00701701|100860325|FG001|STARTED|Overall Study||3||
48218527|NCT00701701|100860324|FG000|COMPLETED|Overall Study||1||
48218528|NCT00701701|100860325|FG001|COMPLETED|Overall Study||1||
48218529|NCT00701701|100860324|FG000|NOT COMPLETED|Overall Study||0||
48218530|NCT00701701|100860325|FG001|NOT COMPLETED|Overall Study||2||
48218531|NCT02433613|100860326|FG000|STARTED|Overall Study||1071||
48218532|NCT02433613|100860326|FG000|COMPLETED|Overall Study||1054||
48218533|NCT02433613|100860326|FG000|NOT COMPLETED|Overall Study||17||
48506632|NCT04841967|101573927|FG000|STARTED|Overall Study||41||
48506633|NCT04841967|101573928|FG001|STARTED|Overall Study||34||
48506634|NCT04841967|101573927|FG000|Recruitment Goal Achieved|Overall Study||41||
48506635|NCT04841967|101573928|FG001|Recruitment Goal Achieved|Overall Study||34||
48506636|NCT04841967|101573927|FG000|COMPLETED|Overall Study||30||
48506637|NCT04841967|101573928|FG001|COMPLETED|Overall Study||30||
48506638|NCT04841967|101573927|FG000|NOT COMPLETED|Overall Study||11||
48506639|NCT04841967|101573928|FG001|NOT COMPLETED|Overall Study||4||
48506640|NCT04149535|101573929|FG000|STARTED|Overall Study||1501||
48506641|NCT04149535|101573930|FG001|STARTED|Overall Study||1499||
48506642|NCT04149535|101573929|FG000|COMPLETED|Overall Study||1472||
48506643|NCT04149535|101573930|FG001|COMPLETED|Overall Study||1481||
48506644|NCT04149535|101573929|FG000|NOT COMPLETED|Overall Study||29||
48506645|NCT04149535|101573930|FG001|NOT COMPLETED|Overall Study||18||
48506646|NCT04499482|101573931|FG000|STARTED|Foods Containing 10 g Soy Flour||8||
48506647|NCT04499482|101573931|FG000|COMPLETED|Foods Containing 10 g Soy Flour||7||
48506648|NCT04499482|101573931|FG000|NOT COMPLETED|Foods Containing 10 g Soy Flour||1||
48506649|NCT04499482|101573931|FG000|STARTED|Foods Containing 20 g Soy Flour||7||
48506650|NCT04499482|101573931|FG000|COMPLETED|Foods Containing 20 g Soy Flour||7||
48506651|NCT04499482|101573931|FG000|NOT COMPLETED|Foods Containing 20 g Soy Flour||0||
48506652|NCT04499482|101573931|FG000|STARTED|Foods Containing 30g Soy Flour||7||
48506653|NCT04499482|101573931|FG000|COMPLETED|Foods Containing 30g Soy Flour||7||
48506654|NCT04499482|101573931|FG000|NOT COMPLETED|Foods Containing 30g Soy Flour||0||
48506655|NCT04164758|101573932|FG000|STARTED|Overall Study||4||
48506656|NCT04164758|101573933|FG001|STARTED|Overall Study||4||
48506657|NCT04164758|101573934|FG002|STARTED|Overall Study||3||
48506658|NCT04164758|101573932|FG000|COMPLETED|Overall Study||3||
48506659|NCT04164758|101573933|FG001|COMPLETED|Overall Study||3||
48506660|NCT04164758|101573934|FG002|COMPLETED|Overall Study||3||
48506661|NCT04164758|101573932|FG000|NOT COMPLETED|Overall Study||1||
48506662|NCT04164758|101573933|FG001|NOT COMPLETED|Overall Study||1||
48506663|NCT04164758|101573934|FG002|NOT COMPLETED|Overall Study||0||
48506664|NCT04079452|101573935|FG000|STARTED|Overall Study||15||
48506665|NCT04079452|101573935|FG000|COMPLETED|Overall Study||15||
48506666|NCT04079452|101573935|FG000|NOT COMPLETED|Overall Study||0||
48506667|NCT01872715|101573936|FG000|STARTED|Overall Study||24||
48506668|NCT01872715|101573936|FG000|COMPLETED|Overall Study||20||
48506669|NCT01872715|101573936|FG000|NOT COMPLETED|Overall Study||4||
48506670|NCT01207492|101573937|FG000|STARTED|Overall Study||17||
48506671|NCT01207492|101573937|FG000|COMPLETED|Overall Study||2||
48506672|NCT01207492|101573937|FG000|NOT COMPLETED|Overall Study||15||
48506673|NCT00496262|101573938|FG000|STARTED|Overall Study||15||
48506674|NCT00496262|101573938|FG000|COMPLETED|Overall Study||15||
48506675|NCT00496262|101573938|FG000|NOT COMPLETED|Overall Study||0||
48506676|NCT01910831|101573939|FG000|STARTED|Overall Study||20||
48506677|NCT01910831|101573939|FG000|COMPLETED|Overall Study||19||
48506678|NCT01910831|101573939|FG000|NOT COMPLETED|Overall Study||1||
48506679|NCT01745094|101573940|FG000|STARTED|Overall Study||35||
48506680|NCT01745094|101573941|FG001|STARTED|Overall Study||37||
48506681|NCT01745094|101573942|FG002|STARTED|Overall Study||58||
48506682|NCT01745094|101573943|FG003|STARTED|Overall Study||93||
48506683|NCT01745094|101573940|FG000|COMPLETED|Overall Study||30||
48506684|NCT01745094|101573941|FG001|COMPLETED|Overall Study||37||
48506685|NCT01745094|101573942|FG002|COMPLETED|Overall Study||46||
48506686|NCT01745094|101573943|FG003|COMPLETED|Overall Study||90||
48506687|NCT01745094|101573940|FG000|NOT COMPLETED|Overall Study||5||
48506688|NCT01745094|101573941|FG001|NOT COMPLETED|Overall Study||0||
48506689|NCT01745094|101573942|FG002|NOT COMPLETED|Overall Study||12||
48506690|NCT01745094|101573943|FG003|NOT COMPLETED|Overall Study||3||
48506691|NCT02795676|101573944|FG000|STARTED|Overall Study||53||
48506692|NCT02795676|101573945|FG001|STARTED|Overall Study||25||
48506693|NCT02795676|101573944|FG000|Treated|Overall Study||52|One patient from PRX-102 arm withdrew consent before receiving the study product|
48506694|NCT02795676|101573945|FG001|Treated|Overall Study||25|One patient from PRX-102 arm withdrew consent before receiving the study product|
48506695|NCT02795676|101573944|FG000|COMPLETED|Overall Study||48||
48506696|NCT02795676|101573945|FG001|COMPLETED|Overall Study||24||
48062225|NCT04171765|100473009|FG003|NOT COMPLETED|Overall Study||5||
48062226|NCT01346969|100473010|FG000|STARTED|Overall Study||28||
48062227|NCT01346969|100473011|FG001|STARTED|Overall Study||14||
48062228|NCT01346969|100473012|FG002|STARTED|Overall Study||13||
48062229|NCT01346969|100473013|FG003|STARTED|Overall Study||13||
48062230|NCT01346969|100473010|FG000|Safety Population|Overall Study||27||
48062231|NCT01346969|100473011|FG001|Safety Population|Overall Study||14||
48506697|NCT02795676|101573944|FG000|NOT COMPLETED|Overall Study||5||
48506698|NCT02795676|101573945|FG001|NOT COMPLETED|Overall Study||1||
48506699|NCT00258856|101573946|FG000|STARTED|Overall Study||59||
48506700|NCT00258856|101573947|FG001|STARTED|Overall Study||58||
48506701|NCT00258856|101573948|FG002|STARTED|Overall Study||58||
48506702|NCT00258856|101573949|FG003|STARTED|Overall Study||59||
48506703|NCT00258856|101573946|FG000|COMPLETED|Overall Study||56||
48506704|NCT00258856|101573947|FG001|COMPLETED|Overall Study||58||
48506705|NCT00258856|101573948|FG002|COMPLETED|Overall Study||56||
48506706|NCT00258856|101573949|FG003|COMPLETED|Overall Study||58||
48506707|NCT00258856|101573946|FG000|NOT COMPLETED|Overall Study||3||
48506708|NCT00258856|101573947|FG001|NOT COMPLETED|Overall Study||0||
48506709|NCT00258856|101573948|FG002|NOT COMPLETED|Overall Study||2||
48506710|NCT00258856|101573949|FG003|NOT COMPLETED|Overall Study||1||
48506711|NCT01279109|101573950|FG000|STARTED|Overall Study||68||
48506712|NCT01279109|101573951|FG001|STARTED|Overall Study||67||
48506713|NCT01279109|101573950|FG000|COMPLETED|Overall Study||55||
48506714|NCT01279109|101573951|FG001|COMPLETED|Overall Study||55||
48506715|NCT01279109|101573950|FG000|NOT COMPLETED|Overall Study||13||
48062232|NCT01346969|100473012|FG002|Safety Population|Overall Study||13||
48062233|NCT01346969|100473013|FG003|Safety Population|Overall Study||13||
48062234|NCT01346969|100473010|FG000|COMPLETED|Overall Study||26||
48062235|NCT01346969|100473011|FG001|COMPLETED|Overall Study||14||
48062236|NCT01346969|100473012|FG002|COMPLETED|Overall Study||10||
48218534|NCT03621735|100860327|FG000|STARTED|Overall Study||50||
48506716|NCT01279109|101573951|FG001|NOT COMPLETED|Overall Study||12||
48506717|NCT04330157|101573952|FG000|STARTED|Overall Study||50||
48506718|NCT04330157|101573952|FG000|COMPLETED|Overall Study||43||
48506719|NCT04330157|101573952|FG000|NOT COMPLETED|Overall Study||7||
48506720|NCT02756949|101573953|FG000|STARTED|Overall Study||181||
48506721|NCT02756949|101573954|FG001|STARTED|Overall Study||172||
48506722|NCT02756949|101573953|FG000|COMPLETED|Overall Study||181||
48506723|NCT02756949|101573954|FG001|COMPLETED|Overall Study||164||
48506724|NCT02756949|101573953|FG000|NOT COMPLETED|Overall Study||0||
48506725|NCT02756949|101573954|FG001|NOT COMPLETED|Overall Study||8||
48506726|NCT04936594|101573955|FG000|STARTED|Overall Study||8||
48506727|NCT04936594|101573955|FG000|COMPLETED|Overall Study||8||
48506728|NCT04936594|101573955|FG000|NOT COMPLETED|Overall Study||0||
48506729|NCT01006967|101573956|FG000|STARTED|Overall Study||253||
48506730|NCT01006967|101573957|FG001|STARTED|Overall Study||253||
48506731|NCT01006967|101573956|FG000|Received Treatment|Overall Study||245||
48506732|NCT01006967|101573957|FG001|Received Treatment|Overall Study||245||
48506733|NCT01006967|101573956|FG000|3 Month Follow-up|Overall Study||212||
48506734|NCT01006967|101573957|FG001|3 Month Follow-up|Overall Study||210||
48506735|NCT01006967|101573956|FG000|COMPLETED|Overall Study||187||
48506736|NCT01006967|101573957|FG001|COMPLETED|Overall Study||190||
48506737|NCT01006967|101573956|FG000|NOT COMPLETED|Overall Study||66||
48506738|NCT01006967|101573957|FG001|NOT COMPLETED|Overall Study||63||
48062237|NCT01346969|100473013|FG003|COMPLETED|Overall Study||12||
48062238|NCT01346969|100473010|FG000|NOT COMPLETED|Overall Study||2||
48062239|NCT01346969|100473011|FG001|NOT COMPLETED|Overall Study||0||
48062240|NCT01346969|100473012|FG002|NOT COMPLETED|Overall Study||3||
48062241|NCT01346969|100473013|FG003|NOT COMPLETED|Overall Study||1||
48062242|NCT04638400|100473014|FG000|STARTED|Overall Study||5||
48062243|NCT04638400|100473015|FG001|STARTED|Overall Study||5||
48062244|NCT04638400|100473014|FG000|COMPLETED|Overall Study||5||
48506739|NCT04387617|101573958|FG000|STARTED|Overall Study||45||
48506740|NCT04387617|101573959|FG001|STARTED|Overall Study||45||
48506741|NCT04387617|101573958|FG000|COMPLETED|Overall Study||45||
48506742|NCT04387617|101573959|FG001|COMPLETED|Overall Study||45||
48506743|NCT04387617|101573958|FG000|NOT COMPLETED|Overall Study||0||
48506744|NCT04387617|101573959|FG001|NOT COMPLETED|Overall Study||0||
48506745|NCT00593827|101573960|FG000|STARTED|Overall Study||85||
48506746|NCT00593827|101573961|FG001|STARTED|Overall Study||91||
48506747|NCT00593827|101573960|FG000|Safety Population|Overall Study||82||
48506748|NCT00593827|101573961|FG001|Safety Population|Overall Study||89||
48506749|NCT00593827|101573960|FG000|Evaluable Population|Overall Study||79||
48506750|NCT00593827|101573961|FG001|Evaluable Population|Overall Study||89||
48506751|NCT00593827|101573960|FG000|COMPLETED|Overall Study||85||
48506752|NCT00593827|101573961|FG001|COMPLETED|Overall Study||89||
48506753|NCT00593827|101573960|FG000|NOT COMPLETED|Overall Study||0||
48506754|NCT00593827|101573961|FG001|NOT COMPLETED|Overall Study||2||
48506755|NCT05766787|101573962|FG000|STARTED|First Wear Period, Approximately 7 Days||94||188
48506756|NCT05766787|101573963|FG001|STARTED|First Wear Period, Approximately 7 Days||92||184
48506757|NCT05766787|101573962|FG000|COMPLETED|First Wear Period, Approximately 7 Days||93||186
48062245|NCT04638400|100473015|FG001|COMPLETED|Overall Study||5||
48506758|NCT05766787|101573963|FG001|COMPLETED|First Wear Period, Approximately 7 Days||89||178
48506759|NCT05766787|101573962|FG000|NOT COMPLETED|First Wear Period, Approximately 7 Days||1||2
48506760|NCT05766787|101573963|FG001|NOT COMPLETED|First Wear Period, Approximately 7 Days||3||6
48506761|NCT05766787|101573962|FG000|STARTED|Second Wear Period, Approximately 7 Days||93||186
48506762|NCT05766787|101573963|FG001|STARTED|Second Wear Period, Approximately 7 Days||88||176
48506763|NCT05766787|101573962|FG000|COMPLETED|Second Wear Period, Approximately 7 Days||93||186
48506764|NCT05766787|101573963|FG001|COMPLETED|Second Wear Period, Approximately 7 Days||87||174
48506765|NCT05766787|101573962|FG000|NOT COMPLETED|Second Wear Period, Approximately 7 Days||0||0
48506766|NCT05766787|101573963|FG001|NOT COMPLETED|Second Wear Period, Approximately 7 Days||1||2
48506767|NCT02578745|101573964|FG000|STARTED|Overall Study||60||
48506768|NCT02578745|101573965|FG001|STARTED|Overall Study||60||
48506769|NCT02578745|101573964|FG000|COMPLETED|Overall Study||60||
48506770|NCT02578745|101573965|FG001|COMPLETED|Overall Study||60||
48506771|NCT02578745|101573964|FG000|NOT COMPLETED|Overall Study||0||
48506772|NCT02578745|101573965|FG001|NOT COMPLETED|Overall Study||0||
48506773|NCT05653362|101576649|FG000|STARTED|Overall Study||20||
48506774|NCT05653362|101576650|FG001|STARTED|Overall Study||20||
48506775|NCT05653362|101576649|FG000|COMPLETED|Overall Study||20||
48506776|NCT05653362|101576650|FG001|COMPLETED|Overall Study||20||
48506777|NCT05653362|101576649|FG000|NOT COMPLETED|Overall Study||0||
48506778|NCT05653362|101576650|FG001|NOT COMPLETED|Overall Study||0||
48062246|NCT04638400|100473014|FG000|NOT COMPLETED|Overall Study||0||
48062247|NCT04638400|100473015|FG001|NOT COMPLETED|Overall Study||0||
48062248|NCT01736124|100473016|FG000|STARTED|Baseline||90||
48506779|NCT02497235|101576651|FG000|STARTED|Overall Study||2||
48506780|NCT02497235|101576652|FG001|STARTED|Overall Study||2||
48506781|NCT02497235|101576653|FG002|STARTED|Overall Study||2||
48506782|NCT02497235|101576654|FG003|STARTED|Overall Study||2||
48506783|NCT02497235|101576655|FG004|STARTED|Overall Study||3||
48506784|NCT02497235|101576651|FG000|COMPLETED|Overall Study||2||
48506785|NCT02497235|101576652|FG001|COMPLETED|Overall Study||2||
48506786|NCT02497235|101576653|FG002|COMPLETED|Overall Study||2||
48506787|NCT02497235|101576654|FG003|COMPLETED|Overall Study||2||
48506788|NCT02497235|101576655|FG004|COMPLETED|Overall Study||3||
48506789|NCT02497235|101576651|FG000|NOT COMPLETED|Overall Study||0||
48506790|NCT02497235|101576652|FG001|NOT COMPLETED|Overall Study||0||
48506791|NCT02497235|101576653|FG002|NOT COMPLETED|Overall Study||0||
48506792|NCT02497235|101576654|FG003|NOT COMPLETED|Overall Study||0||
48506793|NCT02497235|101576655|FG004|NOT COMPLETED|Overall Study||0||
48506794|NCT01294449|101576656|FG000|STARTED|Overall Study||156||
48506795|NCT01294449|101576657|FG001|STARTED|Overall Study||252||
48506796|NCT01294449|101576656|FG000|Consent to Registry|Overall Study||149||
48506797|NCT01294449|101576657|FG001|Consent to Registry|Overall Study||245||
48506798|NCT01294449|101576656|FG000|COMPLETED|Overall Study||144||
48506799|NCT01294449|101576657|FG001|COMPLETED|Overall Study||237||
48506800|NCT01294449|101576656|FG000|NOT COMPLETED|Overall Study||12||
48506801|NCT01294449|101576657|FG001|NOT COMPLETED|Overall Study||15||
48506802|NCT01023061|101576658|FG000|STARTED|Overall Study||24||
48506803|NCT01023061|101576658|FG000|COMPLETED|Overall Study||22|2 patients enrolled but withdrew from study prior to receiving study therapy|
48506804|NCT01023061|101576658|FG000|NOT COMPLETED|Overall Study||2||
48506805|NCT02725645|101576659|FG000|STARTED|Overall Study||14||
48506806|NCT02725645|101576659|FG000|COMPLETED|Overall Study||14||
48506807|NCT02725645|101576659|FG000|NOT COMPLETED|Overall Study||0||
48506808|NCT01808248|101576660|FG000|STARTED|Overall Study||47||
48506809|NCT01808248|101576660|FG000|Completed Posttreatment Week 12 Visit|Overall Study||45||
48506810|NCT01808248|101576660|FG000|COMPLETED|Overall Study||42||
48506811|NCT01808248|101576660|FG000|NOT COMPLETED|Overall Study||5||
48506812|NCT01487499|101576661|FG000|STARTED|Overall Study||4||
48506813|NCT01487499|101576661|FG000|COMPLETED|Overall Study||4||
48506814|NCT01487499|101576661|FG000|NOT COMPLETED|Overall Study||0||
48506815|NCT02129062|101576662|FG000|STARTED|Overall Study||3||
48506816|NCT02129062|101576662|FG000|COMPLETED|Overall Study||0||
48506817|NCT02129062|101576662|FG000|NOT COMPLETED|Overall Study||3||
48506818|NCT02846233|101576663|FG000|STARTED|Overall Study||12||
48506819|NCT02846233|101576664|FG001|STARTED|Overall Study||10||
48506820|NCT02846233|101576663|FG000|COMPLETED|Overall Study||10||
48506821|NCT02846233|101576664|FG001|COMPLETED|Overall Study||8||
48506822|NCT02846233|101576663|FG000|NOT COMPLETED|Overall Study||2||
48506823|NCT02846233|101576664|FG001|NOT COMPLETED|Overall Study||2||
48506824|NCT01520987|101576665|FG000|STARTED|Overall Study||13||
48506825|NCT01520987|101576666|FG001|STARTED|Overall Study||12||
48506826|NCT01520987|101576667|FG002|STARTED|Overall Study||11||
48506827|NCT01520987|101576668|FG003|STARTED|Overall Study||15||
48506828|NCT01520987|101576669|FG004|STARTED|Overall Study||14||
48506829|NCT01520987|101576670|FG005|STARTED|Overall Study||14||
48506830|NCT01520987|101576671|FG006|STARTED|Overall Study||12||
48506831|NCT01520987|101576672|FG007|STARTED|Overall Study||14||
48506832|NCT01520987|101576665|FG000|Dosed|Overall Study||13||
48506833|NCT01520987|101576666|FG001|Dosed|Overall Study||12||
48506834|NCT01520987|101576667|FG002|Dosed|Overall Study||11||
48506835|NCT01520987|101576668|FG003|Dosed|Overall Study||15||
48506836|NCT01520987|101576669|FG004|Dosed|Overall Study||14||
48506837|NCT01520987|101576670|FG005|Dosed|Overall Study||14||
48506838|NCT01520987|101576671|FG006|Dosed|Overall Study||12||
48506839|NCT01520987|101576672|FG007|Dosed|Overall Study||14||
48506840|NCT01520987|101576665|FG000|COMPLETED|Overall Study||12||
48506841|NCT01520987|101576666|FG001|COMPLETED|Overall Study||12||
48506842|NCT01520987|101576667|FG002|COMPLETED|Overall Study||11||
48506843|NCT01520987|101576668|FG003|COMPLETED|Overall Study||15||
48506844|NCT01520987|101576669|FG004|COMPLETED|Overall Study||14||
48506845|NCT01520987|101576670|FG005|COMPLETED|Overall Study||13||
48506846|NCT01520987|101576671|FG006|COMPLETED|Overall Study||12||
48506847|NCT01520987|101576672|FG007|COMPLETED|Overall Study||14||
48506848|NCT01520987|101576665|FG000|NOT COMPLETED|Overall Study||1||
48506849|NCT01520987|101576666|FG001|NOT COMPLETED|Overall Study||0||
48506850|NCT01520987|101576667|FG002|NOT COMPLETED|Overall Study||0||
48506851|NCT01520987|101576668|FG003|NOT COMPLETED|Overall Study||0||
48506852|NCT01520987|101576669|FG004|NOT COMPLETED|Overall Study||0||
48506853|NCT01520987|101576670|FG005|NOT COMPLETED|Overall Study||1||
48506854|NCT01520987|101576671|FG006|NOT COMPLETED|Overall Study||0||
48506855|NCT01520987|101576672|FG007|NOT COMPLETED|Overall Study||0||
48506856|NCT00329160|101576673|FG000|STARTED|Overall Study||214||
48506857|NCT00329160|101576673|FG000|Observation Period|Overall Study||214||
48506858|NCT00329160|101576673|FG000|Treatment Period|Overall Study||214||
48506859|NCT00329160|101576673|FG000|COMPLETED|Overall Study||126||
48506860|NCT00329160|101576673|FG000|NOT COMPLETED|Overall Study||88||
48506861|NCT00676650|101576674|FG000|STARTED|Overall Study||584||
48506862|NCT00676650|101576675|FG001|STARTED|Overall Study||289||
48506863|NCT00676650|101576674|FG000|Treated|Overall Study||581||
48506864|NCT00676650|101576675|FG001|Treated|Overall Study||285||
48506865|NCT00676650|101576674|FG000|COMPLETED|Overall Study||0||
48506866|NCT00676650|101576675|FG001|COMPLETED|Overall Study||0||
48506867|NCT00676650|101576674|FG000|NOT COMPLETED|Overall Study||584||
48506868|NCT00676650|101576675|FG001|NOT COMPLETED|Overall Study||289||
48506869|NCT02664987|101576676|FG000|STARTED|Overall Study||462||
48506870|NCT02664987|101576676|FG000|COMPLETED|Overall Study||462||
48506871|NCT02664987|101576676|FG000|NOT COMPLETED|Overall Study||0||
48506872|NCT00096122|101576677|FG000|STARTED|Overall Study||95||
48506873|NCT00096122|101576677|FG000|COMPLETED|Overall Study||95||
48506874|NCT00096122|101576677|FG000|NOT COMPLETED|Overall Study||0||
48506875|NCT03969641|101576678|FG000|STARTED|Overall Study||193||
48506876|NCT03969641|101576679|FG001|STARTED|Overall Study||191||
48506877|NCT03969641|101576678|FG000|COMPLETED|Overall Study||184||
48506878|NCT03969641|101576679|FG001|COMPLETED|Overall Study||181||
48506879|NCT03969641|101576678|FG000|NOT COMPLETED|Overall Study||9||
48506880|NCT03969641|101576679|FG001|NOT COMPLETED|Overall Study||10||
48506881|NCT04106817|101576680|FG000|STARTED|Overall Study||12||
48506882|NCT04106817|101576681|FG001|STARTED|Overall Study||11||
48506883|NCT04106817|101576682|FG002|STARTED|Overall Study||12||
48506884|NCT04106817|101576680|FG000|COMPLETED|Overall Study||11|All participants completed the influenza challenge, and 1 participant was lost in AE follow-up|
48506885|NCT04106817|101576681|FG001|COMPLETED|Overall Study||11|All participants completed the influenza challenge, and 1 participant was lost in AE follow-up|
48506886|NCT04106817|101576682|FG002|COMPLETED|Overall Study||12|All participants completed the influenza challenge, and 1 participant was lost in AE follow-up|
48506887|NCT04106817|101576680|FG000|NOT COMPLETED|Overall Study||1||
48506888|NCT04106817|101576681|FG001|NOT COMPLETED|Overall Study||0||
48506889|NCT04106817|101576682|FG002|NOT COMPLETED|Overall Study||0||
48506890|NCT00859040|101576683|FG000|STARTED|Overall Study||18||
48506891|NCT00859040|101576684|FG001|STARTED|Overall Study||16||
48506892|NCT00859040|101576683|FG000|COMPLETED|Overall Study||18||
48506893|NCT00859040|101576684|FG001|COMPLETED|Overall Study||16||
48506894|NCT00859040|101576683|FG000|NOT COMPLETED|Overall Study||0||
48506895|NCT00859040|101576684|FG001|NOT COMPLETED|Overall Study||0||
48506896|NCT00462839|101576685|FG000|STARTED|Viewed First||53||
48506897|NCT00462839|101576686|FG001|STARTED|Viewed First||53||
48506898|NCT00462839|101576685|FG000|COMPLETED|Viewed First||53||
48506899|NCT00462839|101576686|FG001|COMPLETED|Viewed First||53||
48506900|NCT00462839|101576685|FG000|NOT COMPLETED|Viewed First||0||
48506901|NCT00462839|101576686|FG001|NOT COMPLETED|Viewed First||0||
48506902|NCT00462839|101576685|FG000|STARTED|Viewed Second||53||
48506903|NCT00462839|101576686|FG001|STARTED|Viewed Second||53||
48506904|NCT00462839|101576685|FG000|COMPLETED|Viewed Second||53||
48506905|NCT00462839|101576686|FG001|COMPLETED|Viewed Second||53||
48506906|NCT00462839|101576685|FG000|NOT COMPLETED|Viewed Second||0||
48506907|NCT00462839|101576686|FG001|NOT COMPLETED|Viewed Second||0||
48506908|NCT02633241|101576687|FG000|STARTED|Overall Study||15||
48506909|NCT02633241|101576688|FG001|STARTED|Overall Study||15||
48506910|NCT02633241|101576689|FG002|STARTED|Overall Study||41||
48506911|NCT02633241|101576687|FG000|COMPLETED|Overall Study||13||
48506912|NCT02633241|101576688|FG001|COMPLETED|Overall Study||14||
48506913|NCT02633241|101576689|FG002|COMPLETED|Overall Study||28||
48506914|NCT02633241|101576687|FG000|NOT COMPLETED|Overall Study||2||
48506915|NCT02633241|101576688|FG001|NOT COMPLETED|Overall Study||1||
48506916|NCT02633241|101576689|FG002|NOT COMPLETED|Overall Study||13||
48506917|NCT02412722|101576690|FG000|STARTED|Overall Study||11||
48506918|NCT02412722|101576691|FG001|STARTED|Overall Study||8||
48506919|NCT02412722|101576692|FG002|STARTED|Overall Study||7||
48506920|NCT02412722|101576693|FG003|STARTED|Overall Study||15||
48506921|NCT02412722|101576694|FG004|STARTED|Overall Study||7||
48506922|NCT02412722|101576695|FG005|STARTED|Overall Study||13||
48506923|NCT02412722|101576690|FG000|Safety Population|Overall Study||11||
48506924|NCT02412722|101576691|FG001|Safety Population|Overall Study||6||
48506925|NCT02412722|101576692|FG002|Safety Population|Overall Study||7||
48506926|NCT02412722|101576693|FG003|Safety Population|Overall Study||15||
48506927|NCT02412722|101576694|FG004|Safety Population|Overall Study||7||
48506928|NCT02412722|101576695|FG005|Safety Population|Overall Study||13||
48506929|NCT02412722|101576690|FG000|COMPLETED|Overall Study||0|Completed=Participants who completed study treatment.|
48506930|NCT02412722|101576691|FG001|COMPLETED|Overall Study||0|Completed=Participants who completed study treatment.|
48062249|NCT01736124|100473017|FG001|STARTED|Baseline||90||
48506931|NCT02412722|101576692|FG002|COMPLETED|Overall Study||0|Completed=Participants who completed study treatment.|
48506932|NCT02412722|101576693|FG003|COMPLETED|Overall Study||0|Completed=Participants who completed study treatment.|
48506933|NCT02412722|101576694|FG004|COMPLETED|Overall Study||0|Completed=Participants who completed study treatment.|
48506934|NCT02412722|101576695|FG005|COMPLETED|Overall Study||0|Completed=Participants who completed study treatment.|
48506935|NCT02412722|101576690|FG000|NOT COMPLETED|Overall Study||11||
48506936|NCT02412722|101576691|FG001|NOT COMPLETED|Overall Study||8||
48506937|NCT02412722|101576692|FG002|NOT COMPLETED|Overall Study||7||
48506938|NCT02412722|101576693|FG003|NOT COMPLETED|Overall Study||15||
48062250|NCT01736124|100473016|FG000|COMPLETED|Baseline||90||
48506939|NCT02412722|101576694|FG004|NOT COMPLETED|Overall Study||7||
48506940|NCT02412722|101576695|FG005|NOT COMPLETED|Overall Study||13||
48506941|NCT03253744|101576696|FG000|STARTED|SBRT Treatment||6||
48506942|NCT03253744|101576697|FG001|STARTED|SBRT Treatment||2||
48506943|NCT03253744|101576698|FG002|STARTED|SBRT Treatment||3||
48506944|NCT03253744|101576699|FG003|STARTED|SBRT Treatment||6||
48506945|NCT03253744|101576696|FG000|COMPLETED|SBRT Treatment||6||
48506946|NCT03253744|101576697|FG001|COMPLETED|SBRT Treatment||2||
48506947|NCT03253744|101576698|FG002|COMPLETED|SBRT Treatment||3||
48506948|NCT03253744|101576699|FG003|COMPLETED|SBRT Treatment||6||
48506949|NCT03253744|101576696|FG000|NOT COMPLETED|SBRT Treatment||0||
48506950|NCT03253744|101576697|FG001|NOT COMPLETED|SBRT Treatment||0||
48506951|NCT03253744|101576698|FG002|NOT COMPLETED|SBRT Treatment||0||
48506952|NCT03253744|101576699|FG003|NOT COMPLETED|SBRT Treatment||0||
48506953|NCT03253744|101576696|FG000|STARTED|Completed Dose-Limiting Toxicity Assess.||6||
48506954|NCT03253744|101576697|FG001|STARTED|Completed Dose-Limiting Toxicity Assess.||2||
48506955|NCT03253744|101576698|FG002|STARTED|Completed Dose-Limiting Toxicity Assess.||3||
48506956|NCT03253744|101576699|FG003|STARTED|Completed Dose-Limiting Toxicity Assess.||6||
48506957|NCT03253744|101576696|FG000|COMPLETED|Completed Dose-Limiting Toxicity Assess.||6||
48506958|NCT03253744|101576697|FG001|COMPLETED|Completed Dose-Limiting Toxicity Assess.||2||
48506959|NCT03253744|101576698|FG002|COMPLETED|Completed Dose-Limiting Toxicity Assess.||3||
48506960|NCT03253744|101576699|FG003|COMPLETED|Completed Dose-Limiting Toxicity Assess.||6||
48506961|NCT03253744|101576696|FG000|NOT COMPLETED|Completed Dose-Limiting Toxicity Assess.||0||
48506962|NCT03253744|101576697|FG001|NOT COMPLETED|Completed Dose-Limiting Toxicity Assess.||0||
48506963|NCT03253744|101576698|FG002|NOT COMPLETED|Completed Dose-Limiting Toxicity Assess.||0||
48506964|NCT03253744|101576699|FG003|NOT COMPLETED|Completed Dose-Limiting Toxicity Assess.||0||
48506965|NCT03253744|101576696|FG000|STARTED|Completion of Follow-Up||6||
48506966|NCT03253744|101576697|FG001|STARTED|Completion of Follow-Up||2||
48506967|NCT03253744|101576698|FG002|STARTED|Completion of Follow-Up||3||
48506968|NCT03253744|101576699|FG003|STARTED|Completion of Follow-Up||6||
48506969|NCT03253744|101576696|FG000|COMPLETED|Completion of Follow-Up||4||
48506970|NCT03253744|101576697|FG001|COMPLETED|Completion of Follow-Up||2||
48506971|NCT03253744|101576698|FG002|COMPLETED|Completion of Follow-Up||3||
48506972|NCT03253744|101576699|FG003|COMPLETED|Completion of Follow-Up||2||
48506973|NCT03253744|101576696|FG000|NOT COMPLETED|Completion of Follow-Up||2||
48506974|NCT03253744|101576697|FG001|NOT COMPLETED|Completion of Follow-Up||0||
48506975|NCT03253744|101576698|FG002|NOT COMPLETED|Completion of Follow-Up||0||
48506976|NCT03253744|101576699|FG003|NOT COMPLETED|Completion of Follow-Up||4||
48506977|NCT02427399|101576700|FG000|STARTED|Overall Study||220||
48506978|NCT02427399|101576701|FG001|STARTED|Overall Study||220||
48506979|NCT02427399|101576702|FG002|STARTED|Overall Study||220||
48506980|NCT02427399|101576703|FG003|STARTED|Overall Study||220||
48506981|NCT02427399|101576704|FG004|STARTED|Overall Study||220||
48506982|NCT02427399|101576700|FG000|COMPLETED|Overall Study||206||
48506983|NCT02427399|101576701|FG001|COMPLETED|Overall Study||204||
48506984|NCT02427399|101576702|FG002|COMPLETED|Overall Study||208||
48506985|NCT02427399|101576703|FG003|COMPLETED|Overall Study||202||
48506986|NCT02427399|101576704|FG004|COMPLETED|Overall Study||205||
48062251|NCT01736124|100473017|FG001|COMPLETED|Baseline||90||
48062252|NCT01736124|100473016|FG000|NOT COMPLETED|Baseline||0||
48062253|NCT01736124|100473017|FG001|NOT COMPLETED|Baseline||0||
48062254|NCT01736124|100473016|FG000|STARTED|Post-intervention Assessment||90||
48506987|NCT02427399|101576700|FG000|NOT COMPLETED|Overall Study||14||
48506988|NCT02427399|101576701|FG001|NOT COMPLETED|Overall Study||16||
48506989|NCT02427399|101576702|FG002|NOT COMPLETED|Overall Study||12||
48506990|NCT02427399|101576703|FG003|NOT COMPLETED|Overall Study||18||
48506991|NCT02427399|101576704|FG004|NOT COMPLETED|Overall Study||15||
48506992|NCT01691430|101576705|FG000|STARTED|Overall Study||92||
48506993|NCT01691430|101576706|FG001|STARTED|Overall Study||93||
48506994|NCT01691430|101576705|FG000|Received Medication|Overall Study||92||
48506995|NCT01691430|101576706|FG001|Received Medication|Overall Study||93||
48506996|NCT01691430|101576705|FG000|COMPLETED|Overall Study||70||
48506997|NCT01691430|101576706|FG001|COMPLETED|Overall Study||73||
48506998|NCT01691430|101576705|FG000|NOT COMPLETED|Overall Study||22||
48506999|NCT01691430|101576706|FG001|NOT COMPLETED|Overall Study||20||
48507000|NCT01493596|101576707|FG000|STARTED|Overall Study||8||
48507001|NCT01493596|101576708|FG001|STARTED|Overall Study||8||
48507002|NCT01493596|101576709|FG002|STARTED|Overall Study||7||
48507003|NCT01493596|101576710|FG003|STARTED|Overall Study||8||
48507004|NCT01493596|101576711|FG004|STARTED|Overall Study||8||
48507005|NCT01493596|101576712|FG005|STARTED|Overall Study||8||
48507006|NCT01493596|101576713|FG006|STARTED|Overall Study||8||
48507007|NCT01493596|101576707|FG000|COMPLETED|Overall Study||8||
48507008|NCT01493596|101576708|FG001|COMPLETED|Overall Study||8||
48507009|NCT01493596|101576709|FG002|COMPLETED|Overall Study||7||
48507010|NCT01493596|101576710|FG003|COMPLETED|Overall Study||8||
48507011|NCT01493596|101576711|FG004|COMPLETED|Overall Study||8||
48507012|NCT01493596|101576712|FG005|COMPLETED|Overall Study||8||
48507013|NCT01493596|101576713|FG006|COMPLETED|Overall Study||8||
48507014|NCT01493596|101576707|FG000|NOT COMPLETED|Overall Study||0||
48507015|NCT01493596|101576708|FG001|NOT COMPLETED|Overall Study||0||
48507016|NCT01493596|101576709|FG002|NOT COMPLETED|Overall Study||0||
48062255|NCT01736124|100473017|FG001|STARTED|Post-intervention Assessment||90||
48507017|NCT01493596|101576710|FG003|NOT COMPLETED|Overall Study||0||
48507018|NCT01493596|101576711|FG004|NOT COMPLETED|Overall Study||0||
48507019|NCT01493596|101576712|FG005|NOT COMPLETED|Overall Study||0||
48507020|NCT01493596|101576713|FG006|NOT COMPLETED|Overall Study||0||
48507021|NCT00557245|101576714|FG000|STARTED|Overall Study||1589||
48507022|NCT00557245|101576715|FG001|STARTED|Overall Study||1583||
48507023|NCT00557245|101576716|FG002|STARTED|Overall Study||1586||
48507024|NCT00557245|101576714|FG000|COMPLETED|Overall Study||1577||
48507025|NCT00557245|101576715|FG001|COMPLETED|Overall Study||1571||
48507026|NCT00557245|101576716|FG002|COMPLETED|Overall Study||1574||
48507027|NCT00557245|101576714|FG000|NOT COMPLETED|Overall Study||12||
48507028|NCT00557245|101576715|FG001|NOT COMPLETED|Overall Study||12||
48507029|NCT00557245|101576716|FG002|NOT COMPLETED|Overall Study||12||
48507030|NCT02351167|101576717|FG000|STARTED|Overall Study||275||
48507031|NCT02351167|101576718|FG001|STARTED|Overall Study||274||
48507032|NCT02351167|101576719|FG002|STARTED|Overall Study||273||
48507033|NCT02351167|101576717|FG000|COMPLETED|Overall Study||256||
48507034|NCT02351167|101576718|FG001|COMPLETED|Overall Study||256||
48507035|NCT02351167|101576719|FG002|COMPLETED|Overall Study||252||
48507036|NCT02351167|101576717|FG000|NOT COMPLETED|Overall Study||19||
48507037|NCT02351167|101576718|FG001|NOT COMPLETED|Overall Study||18||
48507038|NCT02351167|101576719|FG002|NOT COMPLETED|Overall Study||21||
48507039|NCT00570128|101576720|FG000|STARTED|Overall Study||64||
48507040|NCT00570128|101576721|FG001|STARTED|Overall Study||65||
48507041|NCT00570128|101576720|FG000|Intent to Treat (ITT) Population|Overall Study||62||
48507042|NCT00570128|101576721|FG001|Intent to Treat (ITT) Population|Overall Study||65||
48507043|NCT00570128|101576720|FG000|COMPLETED|Overall Study||60||
48507044|NCT00570128|101576721|FG001|COMPLETED|Overall Study||65||
48507045|NCT00570128|101576720|FG000|NOT COMPLETED|Overall Study||4||
48507046|NCT00570128|101576721|FG001|NOT COMPLETED|Overall Study||0||
48507047|NCT03297541|101576722|FG000|STARTED|Overall Study||10||
48507048|NCT03297541|101576722|FG000|COMPLETED|Overall Study||10||
48507049|NCT03297541|101576722|FG000|NOT COMPLETED|Overall Study||0||
48507050|NCT04155073|101576723|FG000|STARTED|Overall Study||85||
48507051|NCT04155073|101576724|FG001|STARTED|Overall Study||40||
48507052|NCT04155073|101576723|FG000|COMPLETED|Overall Study||85||
48507053|NCT04155073|101576724|FG001|COMPLETED|Overall Study||40||
48507054|NCT04155073|101576723|FG000|NOT COMPLETED|Overall Study||0||
48507055|NCT04155073|101576724|FG001|NOT COMPLETED|Overall Study||0||
48507056|NCT01514513|101576725|FG000|STARTED|Overall Study||21||
48507057|NCT01514513|101576726|FG001|STARTED|Overall Study||21||
48507058|NCT01514513|101576725|FG000|COMPLETED|Overall Study||20||
48507059|NCT01514513|101576726|FG001|COMPLETED|Overall Study||20||
48507060|NCT01514513|101576725|FG000|NOT COMPLETED|Overall Study||1||
48507061|NCT01514513|101576726|FG001|NOT COMPLETED|Overall Study||1||
48507062|NCT03604549|101576727|FG000|STARTED|Overall Study||29||
48507063|NCT03604549|101576728|FG001|STARTED|Overall Study||29||
48507064|NCT03604549|101576727|FG000|COMPLETED|Overall Study||24||
48507065|NCT03604549|101576728|FG001|COMPLETED|Overall Study||24||
48062256|NCT01736124|100473016|FG000|COMPLETED|Post-intervention Assessment||59||
48062257|NCT01736124|100473017|FG001|COMPLETED|Post-intervention Assessment||69||
48062258|NCT01736124|100473016|FG000|NOT COMPLETED|Post-intervention Assessment||31||
48507066|NCT03604549|101576727|FG000|NOT COMPLETED|Overall Study||5||
48507067|NCT03604549|101576728|FG001|NOT COMPLETED|Overall Study||5||
48507068|NCT00831987|101576729|FG000|STARTED|Overall Study||60||
48507069|NCT00831987|101576730|FG001|STARTED|Overall Study||60||
48507070|NCT00831987|101576729|FG000|COMPLETED|Overall Study||60||
48507071|NCT00831987|101576730|FG001|COMPLETED|Overall Study||60||
48507072|NCT00831987|101576729|FG000|NOT COMPLETED|Overall Study||0||
48507073|NCT00831987|101576730|FG001|NOT COMPLETED|Overall Study||0||
48507074|NCT01734694|101576731|FG000|STARTED|Overall Study||51||
48507075|NCT01734694|101576732|FG001|STARTED|Overall Study||49||
48507076|NCT01734694|101576731|FG000|COMPLETED|Overall Study||51||
48507077|NCT01734694|101576732|FG001|COMPLETED|Overall Study||49||
48507078|NCT01734694|101576731|FG000|NOT COMPLETED|Overall Study||0||
48507079|NCT01734694|101576732|FG001|NOT COMPLETED|Overall Study||0||
48507080|NCT01849458|101576733|FG000|STARTED|Overall Study||50||50
48507081|NCT01849458|101576733|FG000|6 Months Follow-up|Overall Study||50||50
48507082|NCT01849458|101576733|FG000|COMPLETED|Overall Study||46||46
48507083|NCT01849458|101576733|FG000|NOT COMPLETED|Overall Study||4||4
48507084|NCT00569777|101576734|FG000|STARTED|Overall Study||206||
48507085|NCT00569777|101576735|FG001|STARTED|Overall Study||104||
48507086|NCT00569777|101576734|FG000|COMPLETED|Overall Study||196||
48507087|NCT00569777|101576735|FG001|COMPLETED|Overall Study||101||
48507088|NCT00569777|101576734|FG000|NOT COMPLETED|Overall Study||10||
48507089|NCT00569777|101576735|FG001|NOT COMPLETED|Overall Study||3||
48507090|NCT02824640|101576736|FG000|STARTED|Overall Study||379||
48507091|NCT02824640|101576737|FG001|STARTED|Overall Study||376||
48507092|NCT02824640|101576736|FG000|COMPLETED|Overall Study||264||
48507093|NCT02824640|101576737|FG001|COMPLETED|Overall Study||251||
48218535|NCT03621735|100860328|FG001|STARTED|Overall Study||50||
48507094|NCT02824640|101576736|FG000|NOT COMPLETED|Overall Study||115||
48507095|NCT02824640|101576737|FG001|NOT COMPLETED|Overall Study||125||
48507096|NCT03033134|101576738|FG000|STARTED|Overall Study||42||
48507097|NCT03033134|101576739|FG001|STARTED|Overall Study||12||
48507098|NCT03033134|101576738|FG000|6-month Primary Endpoints|Overall Study||42||
48507099|NCT03033134|101576739|FG001|6-month Primary Endpoints|Overall Study||12||
48507100|NCT03033134|101576738|FG000|COMPLETED|Overall Study||0||
48507101|NCT03033134|101576739|FG001|COMPLETED|Overall Study||0||
48507102|NCT03033134|101576738|FG000|NOT COMPLETED|Overall Study||42||
48507103|NCT03033134|101576739|FG001|NOT COMPLETED|Overall Study||12||
48507104|NCT02564016|101576740|FG000|STARTED|Overall Study||22||
48507105|NCT02564016|101576741|FG001|STARTED|Overall Study||14||
48507106|NCT02564016|101576740|FG000|COMPLETED|Overall Study||4||
48507107|NCT02564016|101576741|FG001|COMPLETED|Overall Study||4||
48507108|NCT02564016|101576740|FG000|NOT COMPLETED|Overall Study||18||
48507109|NCT02564016|101576741|FG001|NOT COMPLETED|Overall Study||10||
48507110|NCT00250705|101576742|FG000|STARTED|Overall Study||12||
48507111|NCT00250705|101576742|FG000|COMPLETED|Overall Study||10||
48507112|NCT00250705|101576742|FG000|NOT COMPLETED|Overall Study||2||
48507113|NCT00566722|101576743|FG000|STARTED|Overall Study||41||
48507114|NCT00566722|101576744|FG001|STARTED|Overall Study||29||
48507115|NCT00566722|101576745|FG002|STARTED|Overall Study||82||
48507116|NCT00566722|101576743|FG000|COMPLETED|Overall Study||39||
48507117|NCT00566722|101576744|FG001|COMPLETED|Overall Study||24||
48507118|NCT00566722|101576745|FG002|COMPLETED|Overall Study||73||
48507119|NCT00566722|101576743|FG000|NOT COMPLETED|Overall Study||2||
48507120|NCT00566722|101576744|FG001|NOT COMPLETED|Overall Study||5||
48507121|NCT00566722|101576745|FG002|NOT COMPLETED|Overall Study||9||
48507122|NCT02938013|101576746|FG000|STARTED|Overall Study||5||
48507123|NCT02938013|101576747|FG001|STARTED|Overall Study||5||
48507124|NCT02938013|101576748|FG002|STARTED|Overall Study||5||
48507125|NCT02938013|101576746|FG000|COMPLETED|Overall Study||5||
48507126|NCT02938013|101576747|FG001|COMPLETED|Overall Study||5||
48507127|NCT02938013|101576748|FG002|COMPLETED|Overall Study||5||
48507128|NCT02938013|101576746|FG000|NOT COMPLETED|Overall Study||0||
48507129|NCT02938013|101576747|FG001|NOT COMPLETED|Overall Study||0||
48507130|NCT02938013|101576748|FG002|NOT COMPLETED|Overall Study||0||
48507131|NCT03086135|101576749|FG000|STARTED|Overall Study||51||
48507132|NCT03086135|101576749|FG000|COMPLETED|Overall Study||48||
48507133|NCT03086135|101576749|FG000|NOT COMPLETED|Overall Study||3||
48507134|NCT02259348|101576750|FG000|STARTED|Overall Study||12||
48507135|NCT02259348|101576750|FG000|One Year Post-transplant|Overall Study||2||
48507136|NCT02259348|101576750|FG000|COMPLETED|Overall Study||2||
48507137|NCT02259348|101576750|FG000|NOT COMPLETED|Overall Study||10||
48507138|NCT04205162|101576751|FG000|STARTED|Overall Study||18||36
48507139|NCT04205162|101576752|FG001|STARTED|Overall Study||18||36
48507140|NCT04205162|101576751|FG000|COMPLETED|Overall Study||14||28
48507141|NCT04205162|101576752|FG001|COMPLETED|Overall Study||18||36
48507142|NCT04205162|101576751|FG000|NOT COMPLETED|Overall Study||4||8
48507143|NCT04205162|101576752|FG001|NOT COMPLETED|Overall Study||0||0
48507144|NCT01689155|101576753|FG000|STARTED|Overall Study||116||
48507145|NCT01689155|101576753|FG000|COMPLETED|Overall Study||116||
48507146|NCT01689155|101576753|FG000|NOT COMPLETED|Overall Study||0||
48507147|NCT00493792|101576754|FG000|STARTED|Overall Study||254||
48507148|NCT00493792|101576755|FG001|STARTED|Overall Study||264||
48507149|NCT00493792|101576754|FG000|Year 2|Overall Study||245||
48507150|NCT00493792|101576755|FG001|Year 2|Overall Study||256||
48507151|NCT00493792|101576754|FG000|Year 5|Overall Study||233||
48507152|NCT00493792|101576755|FG001|Year 5|Overall Study||241||
48507153|NCT00493792|101576754|FG000|Year 7|Overall Study||207||
48507154|NCT00493792|101576755|FG001|Year 7|Overall Study||211||
48507155|NCT00493792|101576754|FG000|COMPLETED|Overall Study||163|Participants who had study data available at the 10 year post-operation mark.|
48507156|NCT00493792|101576755|FG001|COMPLETED|Overall Study||163|Participants who had study data available at the 10 year post-operation mark.|
48507157|NCT00493792|101576754|FG000|NOT COMPLETED|Overall Study||91||
48507158|NCT00493792|101576755|FG001|NOT COMPLETED|Overall Study||101||
48507159|NCT03460990|101576756|FG000|STARTED|Overall Study||57||
48507160|NCT03460990|101576757|FG001|STARTED|Overall Study||54||
48507161|NCT03460990|101576756|FG000|COMPLETED|Overall Study||57||
48507162|NCT03460990|101576757|FG001|COMPLETED|Overall Study||54||
48507163|NCT03460990|101576756|FG000|NOT COMPLETED|Overall Study||0||
48507164|NCT03460990|101576757|FG001|NOT COMPLETED|Overall Study||0||
48507165|NCT04660032|101576758|FG000|STARTED|Overall Study||105||
48507166|NCT04660032|101576759|FG001|STARTED|Overall Study||119||
48507167|NCT04660032|101576758|FG000|COMPLETED|Overall Study||104||
48507168|NCT04660032|101576759|FG001|COMPLETED|Overall Study||118||
48507169|NCT04660032|101576758|FG000|NOT COMPLETED|Overall Study||1||
48507170|NCT04660032|101576759|FG001|NOT COMPLETED|Overall Study||1||
48507171|NCT01853371|101576760|FG000|STARTED|Overall Study||10||
48507172|NCT01853371|101576761|FG001|STARTED|Overall Study||10||
48507173|NCT01853371|101576760|FG000|COMPLETED|Overall Study||10||
48507174|NCT01853371|101576761|FG001|COMPLETED|Overall Study||8||
48507175|NCT01853371|101576760|FG000|NOT COMPLETED|Overall Study||0||
48507176|NCT01853371|101576761|FG001|NOT COMPLETED|Overall Study||2||
48507177|NCT02940522|101576762|FG000|STARTED|Overall Study||59||
48507178|NCT02940522|101576763|FG001|STARTED|Overall Study||61||
48507179|NCT02940522|101576762|FG000|COMPLETED|Overall Study||57||
48507180|NCT02940522|101576763|FG001|COMPLETED|Overall Study||59||
48507181|NCT02940522|101576762|FG000|NOT COMPLETED|Overall Study||2||
48507182|NCT02940522|101576763|FG001|NOT COMPLETED|Overall Study||2||
48507183|NCT00265785|101576764|FG000|STARTED|Overall Study||27||
48507184|NCT00265785|101576764|FG000|Eligible|Overall Study||26||
48507185|NCT00265785|101576764|FG000|Eligible and Began Protocol Treatment|Overall Study||24||
48507186|NCT00265785|101576764|FG000|COMPLETED|Overall Study||0||
48507187|NCT00265785|101576764|FG000|NOT COMPLETED|Overall Study||27||
48507188|NCT01812473|101576765|FG000|STARTED|Overall Study||22||
48507189|NCT01812473|101576766|FG001|STARTED|Overall Study||13||
48507190|NCT01812473|101576765|FG000|COMPLETED|Overall Study||22||
48507191|NCT01812473|101576766|FG001|COMPLETED|Overall Study||13||
48507192|NCT01812473|101576765|FG000|NOT COMPLETED|Overall Study||0||
48507193|NCT01812473|101576766|FG001|NOT COMPLETED|Overall Study||0||
48507194|NCT02959840|101576767|FG000|STARTED|Overall Study||60||
48507195|NCT02959840|101576768|FG001|STARTED|Overall Study||60||
48507196|NCT02959840|101576769|FG002|STARTED|Overall Study||60||
48507197|NCT02959840|101576767|FG000|COMPLETED|Overall Study||60||
48507198|NCT02959840|101576768|FG001|COMPLETED|Overall Study||60||
48507199|NCT02959840|101576769|FG002|COMPLETED|Overall Study||60||
48507200|NCT02959840|101576767|FG000|NOT COMPLETED|Overall Study||0||
48507201|NCT02959840|101576768|FG001|NOT COMPLETED|Overall Study||0||
48507202|NCT02959840|101576769|FG002|NOT COMPLETED|Overall Study||0||
48507203|NCT01175473|101576770|FG000|STARTED|Overall Study||77||
48507204|NCT01175473|101576771|FG001|STARTED|Overall Study||71||
48507205|NCT01175473|101576770|FG000|Safety Population|Overall Study||77||
48507206|NCT01175473|101576771|FG001|Safety Population|Overall Study||71||
48507207|NCT01175473|101576770|FG000|Pharmacodynamic (PD) Population|Overall Study||75||
48507208|NCT01175473|101576771|FG001|Pharmacodynamic (PD) Population|Overall Study||68||
48507209|NCT01175473|101576770|FG000|COMPLETED|Overall Study||75||
48507210|NCT01175473|101576771|FG001|COMPLETED|Overall Study||69||
48507211|NCT01175473|101576770|FG000|NOT COMPLETED|Overall Study||2||
48507212|NCT01175473|101576771|FG001|NOT COMPLETED|Overall Study||2||
48507213|NCT02907073|101576772|FG000|STARTED|Overall Study||8||
48507214|NCT02907073|101576773|FG001|STARTED|Overall Study||0||
48507215|NCT02907073|101576774|FG002|STARTED|Overall Study||0||
48507216|NCT02907073|101576772|FG000|COMPLETED|Overall Study||8||
48507217|NCT02907073|101576773|FG001|COMPLETED|Overall Study||0||
48507218|NCT02907073|101576774|FG002|COMPLETED|Overall Study||0||
48507219|NCT02907073|101576772|FG000|NOT COMPLETED|Overall Study||0||
48507220|NCT02907073|101576773|FG001|NOT COMPLETED|Overall Study||0||
48507221|NCT02907073|101576774|FG002|NOT COMPLETED|Overall Study||0||
48507222|NCT01098851|101576775|FG000|STARTED|Overall Study||11||
48507223|NCT01098851|101576776|FG001|STARTED|Overall Study||10||
48507224|NCT01098851|101576775|FG000|COMPLETED|Overall Study||10||
48507225|NCT01098851|101576776|FG001|COMPLETED|Overall Study||10||
48507226|NCT01098851|101576775|FG000|NOT COMPLETED|Overall Study||1||
48507227|NCT01098851|101576776|FG001|NOT COMPLETED|Overall Study||0||
48507228|NCT04117945|101576777|FG000|STARTED|Overall Study||12||
48507229|NCT04117945|101576778|FG001|STARTED|Overall Study||10||
48507230|NCT04117945|101576777|FG000|Crossed Over to Other Treatment|Overall Study||4||
48507231|NCT04117945|101576778|FG001|Crossed Over to Other Treatment|Overall Study||8||
48507232|NCT04117945|101576777|FG000|COMPLETED|Overall Study||0||
48507233|NCT04117945|101576778|FG001|COMPLETED|Overall Study||0||
48507234|NCT04117945|101576777|FG000|NOT COMPLETED|Overall Study||12||
48507235|NCT04117945|101576778|FG001|NOT COMPLETED|Overall Study||10||
48507236|NCT01937117|101576779|FG000|STARTED|Overall Study||88||
48507237|NCT01937117|101576779|FG000|COMPLETED|Overall Study||75||
48507238|NCT01937117|101576779|FG000|NOT COMPLETED|Overall Study||13||
48507239|NCT03310619|101576780|FG000|STARTED|Pre-Treatment Period||11|Started = Leukopheresed|
48507240|NCT03310619|101576781|FG001|STARTED|Pre-Treatment Period||9|Started = Leukopheresed|
48507241|NCT03310619|101576782|FG002|STARTED|Pre-Treatment Period||13|Started = Leukopheresed|
48507242|NCT03310619|101576783|FG003|STARTED|Pre-Treatment Period||1|Started = Leukopheresed|
48507243|NCT03310619|101576784|FG004|STARTED|Pre-Treatment Period||17|Started = Leukopheresed|
48507244|NCT03310619|101576785|FG005|STARTED|Pre-Treatment Period||2|Started = Leukopheresed|
48507245|NCT03310619|101576786|FG006|STARTED|Pre-Treatment Period||7|Started = Leukopheresed|
48507246|NCT03310619|101576787|FG007|STARTED|Pre-Treatment Period||2|Started = Leukopheresed|
48507247|NCT03310619|101576780|FG000|COMPLETED|Pre-Treatment Period||8||
48507248|NCT03310619|101576781|FG001|COMPLETED|Pre-Treatment Period||8||
48507249|NCT03310619|101576782|FG002|COMPLETED|Pre-Treatment Period||11||
48507250|NCT03310619|101576783|FG003|COMPLETED|Pre-Treatment Period||1||
48507251|NCT03310619|101576784|FG004|COMPLETED|Pre-Treatment Period||16||
48218536|NCT03621735|100860327|FG000|Received Device or Sham Device to Use|Overall Study||49||
48507252|NCT03310619|101576785|FG005|COMPLETED|Pre-Treatment Period||2||
48507253|NCT03310619|101576786|FG006|COMPLETED|Pre-Treatment Period||5||
48507254|NCT03310619|101576787|FG007|COMPLETED|Pre-Treatment Period||2||
48507255|NCT03310619|101576780|FG000|NOT COMPLETED|Pre-Treatment Period||3||
48507256|NCT03310619|101576781|FG001|NOT COMPLETED|Pre-Treatment Period||1||
48507257|NCT03310619|101576782|FG002|NOT COMPLETED|Pre-Treatment Period||2||
48507258|NCT03310619|101576783|FG003|NOT COMPLETED|Pre-Treatment Period||0||
48062259|NCT01736124|100473017|FG001|NOT COMPLETED|Post-intervention Assessment||21||
48507259|NCT03310619|101576784|FG004|NOT COMPLETED|Pre-Treatment Period||1||
48507260|NCT03310619|101576785|FG005|NOT COMPLETED|Pre-Treatment Period||0||
48507261|NCT03310619|101576786|FG006|NOT COMPLETED|Pre-Treatment Period||2||
48507262|NCT03310619|101576787|FG007|NOT COMPLETED|Pre-Treatment Period||0||
48507263|NCT03310619|101576780|FG000|STARTED|Treatment Period||8|Started = entered treatment period|
48507264|NCT03310619|101576781|FG001|STARTED|Treatment Period||8|Started = entered treatment period|
48507265|NCT03310619|101576782|FG002|STARTED|Treatment Period||11|Started = entered treatment period|
48507266|NCT03310619|101576783|FG003|STARTED|Treatment Period||1|Started = entered treatment period|
48507267|NCT03310619|101576784|FG004|STARTED|Treatment Period||16|Started = entered treatment period|
48507268|NCT03310619|101576785|FG005|STARTED|Treatment Period||2|Started = entered treatment period|
48507269|NCT03310619|101576786|FG006|STARTED|Treatment Period||5|Started = entered treatment period|
48507270|NCT03310619|101576787|FG007|STARTED|Treatment Period||2|Started = entered treatment period|
48507271|NCT03310619|101576780|FG000|Safety Set|Treatment Period||8|Received a dose of JCAR017 Cell Product or at least one dose of the combination agent.|
48507272|NCT03310619|101576781|FG001|Safety Set|Treatment Period||8|Received a dose of JCAR017 Cell Product or at least one dose of the combination agent.|
48507273|NCT03310619|101576782|FG002|Safety Set|Treatment Period||11|Received a dose of JCAR017 Cell Product or at least one dose of the combination agent.|
48507274|NCT03310619|101576783|FG003|Safety Set|Treatment Period||1|Received a dose of JCAR017 Cell Product or at least one dose of the combination agent.|
48507275|NCT03310619|101576784|FG004|Safety Set|Treatment Period||17|Received a dose of JCAR017 Cell Product or at least one dose of the combination agent.|
48507276|NCT03310619|101576785|FG005|Safety Set|Treatment Period||2|Received a dose of JCAR017 Cell Product or at least one dose of the combination agent.|
48666768|NCT03391882|101970467|FG002|COMPLETED|Post Part A / Pre Part B||19||
48218537|NCT03621735|100860328|FG001|Received Device or Sham Device to Use|Overall Study||50||
48062260|NCT01736124|100473016|FG000|STARTED|6 Mo. Post-Intervention Assessment||62||
48062261|NCT01736124|100473017|FG001|STARTED|6 Mo. Post-Intervention Assessment||70||
48062262|NCT01736124|100473016|FG000|COMPLETED|6 Mo. Post-Intervention Assessment||57||
48062263|NCT01736124|100473017|FG001|COMPLETED|6 Mo. Post-Intervention Assessment||58||
48062264|NCT01736124|100473016|FG000|NOT COMPLETED|6 Mo. Post-Intervention Assessment||5||
48062265|NCT01736124|100473017|FG001|NOT COMPLETED|6 Mo. Post-Intervention Assessment||12||
48062266|NCT01736124|100473016|FG000|STARTED|12 Mo. Post-Intervention Assessment||58||
48062267|NCT01736124|100473017|FG001|STARTED|12 Mo. Post-Intervention Assessment||62||
48062268|NCT01736124|100473016|FG000|COMPLETED|12 Mo. Post-Intervention Assessment||46||
48062269|NCT01736124|100473017|FG001|COMPLETED|12 Mo. Post-Intervention Assessment||50||
48062270|NCT01736124|100473016|FG000|NOT COMPLETED|12 Mo. Post-Intervention Assessment||12||
48062271|NCT01736124|100473017|FG001|NOT COMPLETED|12 Mo. Post-Intervention Assessment||12||
48062272|NCT02337738|100473018|FG000|STARTED|Overall Study||141||
48062273|NCT02337738|100473019|FG001|STARTED|Overall Study||134||
48062274|NCT02337738|100473020|FG002|STARTED|Overall Study||129||
48062275|NCT02337738|100473018|FG000|COMPLETED|Overall Study||119||
48062276|NCT02337738|100473019|FG001|COMPLETED|Overall Study||104||
48062277|NCT02337738|100473020|FG002|COMPLETED|Overall Study||103||
48062278|NCT02337738|100473018|FG000|NOT COMPLETED|Overall Study||22||
48062279|NCT02337738|100473019|FG001|NOT COMPLETED|Overall Study||30||
48062280|NCT02337738|100473020|FG002|NOT COMPLETED|Overall Study||26||
48062281|NCT00532155|100473021|FG000|STARTED|Overall Study||457||
48062282|NCT00532155|100473022|FG001|STARTED|Overall Study||456||
48062283|NCT00532155|100473021|FG000|SAFETY POPULATION|Overall Study||455||
48062284|NCT00532155|100473022|FG001|SAFETY POPULATION|Overall Study||450||
48062285|NCT00532155|100473021|FG000|COMPLETED|Overall Study||0||
48062286|NCT00532155|100473022|FG001|COMPLETED|Overall Study||0||
48062287|NCT00532155|100473021|FG000|NOT COMPLETED|Overall Study||457||
48062288|NCT00532155|100473022|FG001|NOT COMPLETED|Overall Study||456||
48062289|NCT04070144|100473023|FG000|STARTED|Overall Study||50||152
48062290|NCT04070144|100473023|FG000|COMPLETED|Overall Study||50||152
48062291|NCT04070144|100473023|FG000|NOT COMPLETED|Overall Study||0||0
48062292|NCT01626495|100473024|FG000|STARTED|Overall Study||73||
48062293|NCT01626495|100473024|FG000|Intervention|Overall Study||62||
48062294|NCT01626495|100473024|FG000|COMPLETED|Overall Study||21||
48062295|NCT01626495|100473024|FG000|NOT COMPLETED|Overall Study||52||
48062296|NCT00735254|100473025|FG000|STARTED|Overall Study||1||
48062297|NCT00735254|100473026|FG001|STARTED|Overall Study||1||
48062298|NCT00735254|100473027|FG002|STARTED|Overall Study||1||
48062299|NCT00735254|100473028|FG003|STARTED|Overall Study||0||
48062300|NCT00735254|100473025|FG000|COMPLETED|Overall Study||0||
48062301|NCT00735254|100473026|FG001|COMPLETED|Overall Study||0||
48062302|NCT00735254|100473027|FG002|COMPLETED|Overall Study||0||
48062303|NCT00735254|100473028|FG003|COMPLETED|Overall Study||0||
48062304|NCT00735254|100473025|FG000|NOT COMPLETED|Overall Study||1||
48062305|NCT00735254|100473026|FG001|NOT COMPLETED|Overall Study||1||
48218538|NCT03621735|100860327|FG000|Began First Washout Period|Overall Study||41||
48218539|NCT03621735|100860328|FG001|Began First Washout Period|Overall Study||44||
48062306|NCT00735254|100473027|FG002|NOT COMPLETED|Overall Study||1||
48062307|NCT00735254|100473028|FG003|NOT COMPLETED|Overall Study||0||
48062308|NCT02409810|100473029|FG000|STARTED|Overall Study||20||
48062309|NCT02409810|100473029|FG000|COMPLETED|Overall Study||19||
48507277|NCT03310619|101576786|FG006|Safety Set|Treatment Period||4|Received a dose of JCAR017 Cell Product or at least one dose of the combination agent.|
48507278|NCT03310619|101576787|FG007|Safety Set|Treatment Period||2|Received a dose of JCAR017 Cell Product or at least one dose of the combination agent.|
48507279|NCT03310619|101576780|FG000|COMPLETED|Treatment Period||6||
48507280|NCT03310619|101576781|FG001|COMPLETED|Treatment Period||5||
48507281|NCT03310619|101576782|FG002|COMPLETED|Treatment Period||4||
48507282|NCT03310619|101576783|FG003|COMPLETED|Treatment Period||0||
48507283|NCT03310619|101576784|FG004|COMPLETED|Treatment Period||12||
48507284|NCT03310619|101576785|FG005|COMPLETED|Treatment Period||2||
48507285|NCT03310619|101576786|FG006|COMPLETED|Treatment Period||3||
48507286|NCT03310619|101576787|FG007|COMPLETED|Treatment Period||0||
48507287|NCT03310619|101576780|FG000|NOT COMPLETED|Treatment Period||2||
48507288|NCT03310619|101576781|FG001|NOT COMPLETED|Treatment Period||3||
48507289|NCT03310619|101576782|FG002|NOT COMPLETED|Treatment Period||7||
48507290|NCT03310619|101576783|FG003|NOT COMPLETED|Treatment Period||1||
48507291|NCT03310619|101576784|FG004|NOT COMPLETED|Treatment Period||4||
48507292|NCT03310619|101576785|FG005|NOT COMPLETED|Treatment Period||0||
48507293|NCT03310619|101576786|FG006|NOT COMPLETED|Treatment Period||2||
48507294|NCT03310619|101576787|FG007|NOT COMPLETED|Treatment Period||2||
48507295|NCT03711396|101576788|FG000|STARTED|Overall Study||13||
48507296|NCT03711396|101576789|FG001|STARTED|Overall Study||13||
48507297|NCT03711396|101576788|FG000|COMPLETED|Overall Study||13||
48507298|NCT03711396|101576789|FG001|COMPLETED|Overall Study||13||
48507299|NCT03711396|101576788|FG000|NOT COMPLETED|Overall Study||0||
48507300|NCT03711396|101576789|FG001|NOT COMPLETED|Overall Study||0||
48507301|NCT02369354|101576790|FG000|STARTED|Overall Study||100||
48507302|NCT02369354|101576791|FG001|STARTED|Overall Study||100||
48507303|NCT02369354|101576792|FG002|STARTED|Overall Study||100||
48507304|NCT02369354|101576790|FG000|COMPLETED|Overall Study||88||
48507305|NCT02369354|101576791|FG001|COMPLETED|Overall Study||86||
48507306|NCT02369354|101576792|FG002|COMPLETED|Overall Study||86||
48507307|NCT02369354|101576790|FG000|NOT COMPLETED|Overall Study||12||
48507308|NCT02369354|101576791|FG001|NOT COMPLETED|Overall Study||14||
48507309|NCT02369354|101576792|FG002|NOT COMPLETED|Overall Study||14||
48507310|NCT02102932|101576793|FG000|STARTED|Overall Study||12||
48507311|NCT02102932|101576794|FG001|STARTED|Overall Study||12||
48507312|NCT02102932|101576795|FG002|STARTED|Overall Study||12||
48507313|NCT02102932|101576796|FG003|STARTED|Overall Study||12||
48507314|NCT02102932|101576797|FG004|STARTED|Overall Study||12||
48507315|NCT02102932|101576798|FG005|STARTED|Overall Study||12||
48507316|NCT02102932|101576799|FG006|STARTED|Overall Study||12||
48507317|NCT02102932|101576800|FG007|STARTED|Overall Study||12||
48507318|NCT02102932|101576793|FG000|COMPLETED|Overall Study||12||
48507319|NCT02102932|101576794|FG001|COMPLETED|Overall Study||12||
48507320|NCT02102932|101576795|FG002|COMPLETED|Overall Study||12||
48507321|NCT02102932|101576796|FG003|COMPLETED|Overall Study||12||
48507322|NCT02102932|101576797|FG004|COMPLETED|Overall Study||12||
48507323|NCT02102932|101576798|FG005|COMPLETED|Overall Study||12||
48507324|NCT02102932|101576799|FG006|COMPLETED|Overall Study||12||
48507325|NCT02102932|101576800|FG007|COMPLETED|Overall Study||12||
48507326|NCT02102932|101576793|FG000|NOT COMPLETED|Overall Study||0||
48507327|NCT02102932|101576794|FG001|NOT COMPLETED|Overall Study||0||
48507328|NCT02102932|101576795|FG002|NOT COMPLETED|Overall Study||0||
48507329|NCT02102932|101576796|FG003|NOT COMPLETED|Overall Study||0||
48507330|NCT02102932|101576797|FG004|NOT COMPLETED|Overall Study||0||
48507331|NCT02102932|101576798|FG005|NOT COMPLETED|Overall Study||0||
48507332|NCT02102932|101576799|FG006|NOT COMPLETED|Overall Study||0||
48507333|NCT02102932|101576800|FG007|NOT COMPLETED|Overall Study||0||
48507334|NCT00243152|101576801|FG000|STARTED|Overall Study||3||
48507335|NCT00243152|101576802|FG001|STARTED|Overall Study||3||
48507336|NCT00243152|101576801|FG000|Scan 1: Drug or Placebo|Overall Study||3||
48507337|NCT00243152|101576802|FG001|Scan 1: Drug or Placebo|Overall Study||3||
48507338|NCT00243152|101576801|FG000|Scan 2: Placebo or Drug|Overall Study||3||
48507339|NCT00243152|101576802|FG001|Scan 2: Placebo or Drug|Overall Study||3||
48507340|NCT00243152|101576801|FG000|COMPLETED|Overall Study||3||
48507341|NCT00243152|101576802|FG001|COMPLETED|Overall Study||3||
48507342|NCT00243152|101576801|FG000|NOT COMPLETED|Overall Study||0||
48507343|NCT00243152|101576802|FG001|NOT COMPLETED|Overall Study||0||
48507344|NCT01740791|101576803|FG000|STARTED|Overall Study||22||
48507345|NCT01740791|101576804|FG001|STARTED|Overall Study||7||
48507346|NCT01740791|101576805|FG002|STARTED|Overall Study||17||
48507347|NCT01740791|101576806|FG003|STARTED|Overall Study||14||
48507348|NCT01740791|101576807|FG004|STARTED|Overall Study||9||
48507349|NCT01740791|101576808|FG005|STARTED|Overall Study||34||
48507350|NCT01740791|101576803|FG000|COMPLETED|Overall Study||10||
48507351|NCT01740791|101576804|FG001|COMPLETED|Overall Study||4||
48507352|NCT01740791|101576805|FG002|COMPLETED|Overall Study||11||
48507353|NCT01740791|101576806|FG003|COMPLETED|Overall Study||7||
48507354|NCT01740791|101576807|FG004|COMPLETED|Overall Study||6||
48507355|NCT01740791|101576808|FG005|COMPLETED|Overall Study||23||
48507356|NCT01740791|101576803|FG000|NOT COMPLETED|Overall Study||12||
48507357|NCT01740791|101576804|FG001|NOT COMPLETED|Overall Study||3||
48507358|NCT01740791|101576805|FG002|NOT COMPLETED|Overall Study||6||
48507359|NCT01740791|101576806|FG003|NOT COMPLETED|Overall Study||7||
48507360|NCT01740791|101576807|FG004|NOT COMPLETED|Overall Study||3||
48507361|NCT01740791|101576808|FG005|NOT COMPLETED|Overall Study||11||
48507362|NCT00438659|101576809|FG000|STARTED|Overall Study||90||
48507363|NCT00438659|101576810|FG001|STARTED|Overall Study||86||
48507364|NCT00438659|101576809|FG000|COMPLETED|Overall Study||84||
48507365|NCT00438659|101576810|FG001|COMPLETED|Overall Study||82||
48507366|NCT00438659|101576809|FG000|NOT COMPLETED|Overall Study||6||
48507367|NCT00438659|101576810|FG001|NOT COMPLETED|Overall Study||4||
48507368|NCT04381481|101576811|FG000|STARTED|Overall Study||200||
48507369|NCT04381481|101576812|FG001|STARTED|Overall Study||205||
48507370|NCT04381481|101576813|FG002|STARTED|Overall Study||199||
48507371|NCT04381481|101576814|FG003|STARTED|Overall Study||197||
48507372|NCT04381481|101576815|FG004|STARTED|Overall Study||199||
48507373|NCT04381481|101576816|FG005|STARTED|Overall Study||195||
48507374|NCT04381481|101576817|FG006|STARTED|Overall Study||194||
48507375|NCT04381481|101576818|FG007|STARTED|Overall Study||193||
48507376|NCT04381481|101576819|FG008|STARTED|Overall Study||214||
48507377|NCT04381481|101576820|FG009|STARTED|Overall Study||198||
48507378|NCT04381481|101576821|FG010|STARTED|Overall Study||192||
48507379|NCT04381481|101576822|FG011|STARTED|Overall Study||188||
48507380|NCT04381481|101576811|FG000|COMPLETED|Overall Study||185||
48507381|NCT04381481|101576812|FG001|COMPLETED|Overall Study||190||
48507382|NCT04381481|101576813|FG002|COMPLETED|Overall Study||190||
48507383|NCT04381481|101576814|FG003|COMPLETED|Overall Study||183||
48507384|NCT04381481|101576815|FG004|COMPLETED|Overall Study||191||
48507385|NCT04381481|101576816|FG005|COMPLETED|Overall Study||180||
48507386|NCT04381481|101576817|FG006|COMPLETED|Overall Study||184||
48507387|NCT04381481|101576818|FG007|COMPLETED|Overall Study||177||
48507388|NCT04381481|101576819|FG008|COMPLETED|Overall Study||195||
48507389|NCT04381481|101576820|FG009|COMPLETED|Overall Study||188||
48507390|NCT04381481|101576821|FG010|COMPLETED|Overall Study||183||
48507391|NCT04381481|101576822|FG011|COMPLETED|Overall Study||173||
48507392|NCT04381481|101576811|FG000|NOT COMPLETED|Overall Study||15||
48507393|NCT04381481|101576812|FG001|NOT COMPLETED|Overall Study||15||
48507394|NCT04381481|101576813|FG002|NOT COMPLETED|Overall Study||9||
48507395|NCT04381481|101576814|FG003|NOT COMPLETED|Overall Study||14||
48507396|NCT04381481|101576815|FG004|NOT COMPLETED|Overall Study||8||
48507397|NCT04381481|101576816|FG005|NOT COMPLETED|Overall Study||15||
48507398|NCT04381481|101576817|FG006|NOT COMPLETED|Overall Study||10||
48507399|NCT04381481|101576818|FG007|NOT COMPLETED|Overall Study||16||
48507400|NCT04381481|101576819|FG008|NOT COMPLETED|Overall Study||19||
48507401|NCT04381481|101576820|FG009|NOT COMPLETED|Overall Study||10||
48507402|NCT04381481|101576821|FG010|NOT COMPLETED|Overall Study||9||
48507403|NCT04381481|101576822|FG011|NOT COMPLETED|Overall Study||15||
48507404|NCT04315272|101576823|FG000|STARTED|Overall Study||221||
48507405|NCT04315272|101576824|FG001|STARTED|Overall Study||228||
48507406|NCT04315272|101576823|FG000|COMPLETED|Overall Study||220||
48507407|NCT04315272|101576824|FG001|COMPLETED|Overall Study||227||
48507408|NCT04315272|101576823|FG000|NOT COMPLETED|Overall Study||1||
48507409|NCT04315272|101576824|FG001|NOT COMPLETED|Overall Study||1||
48507410|NCT01149434|101576825|FG000|STARTED|Overall Study||4||
48507411|NCT01149434|101576826|FG001|STARTED|Overall Study||15||
48507412|NCT01149434|101576825|FG000|COMPLETED|Overall Study||4||
48507413|NCT01149434|101576826|FG001|COMPLETED|Overall Study||10||
48507414|NCT01149434|101576825|FG000|NOT COMPLETED|Overall Study||0||
48507415|NCT01149434|101576826|FG001|NOT COMPLETED|Overall Study||5||
48507416|NCT01235442|101576827|FG000|STARTED|Overall Study||297||
48507417|NCT01235442|101576828|FG001|STARTED|Overall Study||295||
48507418|NCT01235442|101576827|FG000|COMPLETED|Overall Study||253||
48507419|NCT01235442|101576828|FG001|COMPLETED|Overall Study||251||
48507420|NCT01235442|101576827|FG000|NOT COMPLETED|Overall Study||44||
48507421|NCT01235442|101576828|FG001|NOT COMPLETED|Overall Study||44||
48507422|NCT01598545|101576829|FG000|STARTED|Overall Study||20||
48507423|NCT01598545|101576829|FG000|COMPLETED|Overall Study||20||
48507424|NCT01598545|101576829|FG000|NOT COMPLETED|Overall Study||0||
48507425|NCT02289820|101576830|FG000|STARTED|Overall Study||39||
48507426|NCT02289820|101576831|FG001|STARTED|Overall Study||20||
48507427|NCT02289820|101576832|FG002|STARTED|Overall Study||44||
48507428|NCT02289820|101576833|FG003|STARTED|Overall Study||39||
48507429|NCT02289820|101576834|FG004|STARTED|Overall Study||40||
48507430|NCT02289820|101576835|FG005|STARTED|Overall Study||40||
48507431|NCT02289820|101576836|FG006|STARTED|Overall Study||39||
48507432|NCT02289820|101576830|FG000|COMPLETED|Overall Study||37||
48507433|NCT02289820|101576831|FG001|COMPLETED|Overall Study||18||
48507434|NCT02289820|101576832|FG002|COMPLETED|Overall Study||38||
48507435|NCT02289820|101576833|FG003|COMPLETED|Overall Study||37||
48507436|NCT02289820|101576834|FG004|COMPLETED|Overall Study||40||
48507437|NCT02289820|101576835|FG005|COMPLETED|Overall Study||39||
48507438|NCT02289820|101576836|FG006|COMPLETED|Overall Study||37||
48507439|NCT02289820|101576830|FG000|NOT COMPLETED|Overall Study||2||
48507440|NCT02289820|101576831|FG001|NOT COMPLETED|Overall Study||2||
48507441|NCT02289820|101576832|FG002|NOT COMPLETED|Overall Study||6||
48507442|NCT02289820|101576833|FG003|NOT COMPLETED|Overall Study||2||
48507443|NCT02289820|101576834|FG004|NOT COMPLETED|Overall Study||0||
48507444|NCT02289820|101576835|FG005|NOT COMPLETED|Overall Study||1||
48507445|NCT02289820|101576836|FG006|NOT COMPLETED|Overall Study||2||
48507446|NCT02906813|101576837|FG000|STARTED|Intervention Period 1 (3 Days)||3||
48507447|NCT02906813|101576838|FG001|STARTED|Intervention Period 1 (3 Days)||3||
48507448|NCT02906813|101576839|FG002|STARTED|Intervention Period 1 (3 Days)||3||
48507449|NCT02906813|101576837|FG000|COMPLETED|Intervention Period 1 (3 Days)||3||
48507450|NCT02906813|101576838|FG001|COMPLETED|Intervention Period 1 (3 Days)||3||
48507451|NCT02906813|101576839|FG002|COMPLETED|Intervention Period 1 (3 Days)||3||
48507452|NCT02906813|101576837|FG000|NOT COMPLETED|Intervention Period 1 (3 Days)||0||
48507453|NCT02906813|101576838|FG001|NOT COMPLETED|Intervention Period 1 (3 Days)||0||
48507454|NCT02906813|101576839|FG002|NOT COMPLETED|Intervention Period 1 (3 Days)||0||
48507455|NCT02906813|101576837|FG000|STARTED|Washout Period 1 (at Least 3 Days)||3||
48507456|NCT02906813|101576838|FG001|STARTED|Washout Period 1 (at Least 3 Days)||3||
48507457|NCT02906813|101576839|FG002|STARTED|Washout Period 1 (at Least 3 Days)||3||
48507458|NCT02906813|101576837|FG000|COMPLETED|Washout Period 1 (at Least 3 Days)||3||
48507459|NCT02906813|101576838|FG001|COMPLETED|Washout Period 1 (at Least 3 Days)||3||
48507460|NCT02906813|101576839|FG002|COMPLETED|Washout Period 1 (at Least 3 Days)||3||
48507461|NCT02906813|101576837|FG000|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0||
48507462|NCT02906813|101576838|FG001|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0||
48507463|NCT02906813|101576839|FG002|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0||
48507464|NCT02906813|101576837|FG000|STARTED|Intervention Period 2 (3 Days)||3||
48507465|NCT02906813|101576838|FG001|STARTED|Intervention Period 2 (3 Days)||3||
48507466|NCT02906813|101576839|FG002|STARTED|Intervention Period 2 (3 Days)||3||
48507467|NCT02906813|101576837|FG000|COMPLETED|Intervention Period 2 (3 Days)||3||
48507468|NCT02906813|101576838|FG001|COMPLETED|Intervention Period 2 (3 Days)||3||
48507469|NCT02906813|101576839|FG002|COMPLETED|Intervention Period 2 (3 Days)||3||
48507470|NCT02906813|101576837|FG000|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
48507471|NCT02906813|101576838|FG001|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
48507472|NCT02906813|101576839|FG002|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
48507473|NCT02906813|101576837|FG000|STARTED|Washout Period 2 (at Least 3 Days)||3||
48507474|NCT02906813|101576838|FG001|STARTED|Washout Period 2 (at Least 3 Days)||3||
48507475|NCT02906813|101576839|FG002|STARTED|Washout Period 2 (at Least 3 Days)||3||
48507476|NCT02906813|101576837|FG000|COMPLETED|Washout Period 2 (at Least 3 Days)||3||
48507477|NCT02906813|101576838|FG001|COMPLETED|Washout Period 2 (at Least 3 Days)||3||
48507478|NCT02906813|101576839|FG002|COMPLETED|Washout Period 2 (at Least 3 Days)||3||
48507479|NCT02906813|101576837|FG000|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0||
48507480|NCT02906813|101576838|FG001|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0||
48507481|NCT02906813|101576839|FG002|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0||
48507482|NCT02906813|101576837|FG000|STARTED|Intervention Period 3 (3 Days)||3||
48507483|NCT02906813|101576838|FG001|STARTED|Intervention Period 3 (3 Days)||3||
48507484|NCT02906813|101576839|FG002|STARTED|Intervention Period 3 (3 Days)||3||
48507485|NCT02906813|101576837|FG000|COMPLETED|Intervention Period 3 (3 Days)||3||
48507486|NCT02906813|101576838|FG001|COMPLETED|Intervention Period 3 (3 Days)||3||
48507487|NCT02906813|101576839|FG002|COMPLETED|Intervention Period 3 (3 Days)||3||
48507488|NCT02906813|101576837|FG000|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
48507489|NCT02906813|101576838|FG001|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
48507490|NCT02906813|101576839|FG002|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
48507491|NCT04405739|101576840|FG000|STARTED|Overall Study||4||
48507492|NCT04405739|101576841|FG001|STARTED|Overall Study||18||
48507493|NCT04405739|101576842|FG002|STARTED|Overall Study||25||
48507494|NCT04405739|101576843|FG003|STARTED|Overall Study||24||
48507495|NCT04405739|101576840|FG000|COMPLETED|Overall Study||4||
48507496|NCT04405739|101576841|FG001|COMPLETED|Overall Study||13||
48507497|NCT04405739|101576842|FG002|COMPLETED|Overall Study||22||
48507498|NCT04405739|101576843|FG003|COMPLETED|Overall Study||18||
48507499|NCT04405739|101576840|FG000|NOT COMPLETED|Overall Study||0||
48507500|NCT04405739|101576841|FG001|NOT COMPLETED|Overall Study||5||
48507501|NCT04405739|101576842|FG002|NOT COMPLETED|Overall Study||3||
48507502|NCT04405739|101576843|FG003|NOT COMPLETED|Overall Study||6||
48507503|NCT01857206|101576844|FG000|STARTED|Overall Study||1372||
48507504|NCT01857206|101576845|FG001|STARTED|Overall Study||683||
48507505|NCT01857206|101576844|FG000|COMPLETED|Overall Study||1359||
48507506|NCT01857206|101576845|FG001|COMPLETED|Overall Study||673||
48507507|NCT01857206|101576844|FG000|NOT COMPLETED|Overall Study||13||
48507508|NCT01857206|101576845|FG001|NOT COMPLETED|Overall Study||10||
48507509|NCT01181531|101576846|FG000|STARTED|Overall Study||157||
48507510|NCT01181531|101576847|FG001|STARTED|Overall Study||155||
48507511|NCT01181531|101576846|FG000|Received Investigational Product|Overall Study||155||
48507512|NCT01181531|101576847|FG001|Received Investigational Product|Overall Study||153||
48507513|NCT01181531|101576846|FG000|COMPLETED|Overall Study||96||
48507514|NCT01181531|101576847|FG001|COMPLETED|Overall Study||102||
48507515|NCT01181531|101576846|FG000|NOT COMPLETED|Overall Study||61||
48507516|NCT01181531|101576847|FG001|NOT COMPLETED|Overall Study||53||
48507517|NCT00754052|101576848|FG000|STARTED|Overall Study||5||
48507518|NCT00754052|101576849|FG001|STARTED|Overall Study||3||
48507519|NCT00754052|101576848|FG000|COMPLETED|Overall Study||0||
48507520|NCT00754052|101576849|FG001|COMPLETED|Overall Study||0||
48507521|NCT00754052|101576848|FG000|NOT COMPLETED|Overall Study||5||
48507522|NCT00754052|101576849|FG001|NOT COMPLETED|Overall Study||3||
48507523|NCT01321437|101576850|FG000|STARTED|Overall Study||11||
48507524|NCT01321437|101576850|FG000|COMPLETED|Overall Study||11||
48507525|NCT01321437|101576850|FG000|NOT COMPLETED|Overall Study||0||
48507526|NCT00889252|101576851|FG000|STARTED|Overall Study||168||
48507527|NCT00889252|101576852|FG001|STARTED|Overall Study||82||
48507528|NCT00889252|101576851|FG000|COMPLETED|Overall Study||161||
48507529|NCT00889252|101576852|FG001|COMPLETED|Overall Study||78||
48507530|NCT00889252|101576851|FG000|NOT COMPLETED|Overall Study||7||
48507531|NCT00889252|101576852|FG001|NOT COMPLETED|Overall Study||4||
48507532|NCT02169791|101576853|FG000|STARTED|Overall Study||25||
48507533|NCT02169791|101576853|FG000|COMPLETED|Overall Study||18|18 patients completed the full study including follow up.|
48507534|NCT02169791|101576853|FG000|NOT COMPLETED|Overall Study||7||
48507535|NCT01658995|101576854|FG000|STARTED|Overall Study||42||
48507536|NCT01658995|101576855|FG001|STARTED|Overall Study||40||
48507537|NCT01658995|101576854|FG000|COMPLETED|Overall Study||42||
48062310|NCT02409810|100473029|FG000|NOT COMPLETED|Overall Study||1||
48062311|NCT03906461|100473030|FG000|STARTED|Enrollment to Completed Procedure||143||
48062312|NCT03906461|100473030|FG000|COMPLETED|Enrollment to Completed Procedure||143||
48062313|NCT03906461|100473030|FG000|NOT COMPLETED|Enrollment to Completed Procedure||0||
48218540|NCT03621735|100860327|FG000|Began Crossover Assignment|Overall Study||39||
48507538|NCT01658995|101576855|FG001|COMPLETED|Overall Study||40||
48507539|NCT01658995|101576854|FG000|NOT COMPLETED|Overall Study||0||
48507540|NCT01658995|101576855|FG001|NOT COMPLETED|Overall Study||0||
48507541|NCT00345033|101576856|FG000|STARTED|Overall Study||20||
48507542|NCT00345033|101576857|FG001|STARTED|Overall Study||18||
48507543|NCT00345033|101576856|FG000|COMPLETED|Overall Study||16||
48507544|NCT00345033|101576857|FG001|COMPLETED|Overall Study||14||
48507545|NCT00345033|101576856|FG000|NOT COMPLETED|Overall Study||4||
48507546|NCT00345033|101576857|FG001|NOT COMPLETED|Overall Study||4||
48507547|NCT05203146|101576858|FG000|STARTED|Overall Study||5||
48507548|NCT05203146|101576859|FG001|STARTED|Overall Study||5||
48507549|NCT05203146|101576858|FG000|COMPLETED|Overall Study||5||
48507550|NCT05203146|101576859|FG001|COMPLETED|Overall Study||5||
48507551|NCT05203146|101576858|FG000|NOT COMPLETED|Overall Study||0||
48507552|NCT05203146|101576859|FG001|NOT COMPLETED|Overall Study||0||
48507553|NCT01630616|101576860|FG000|STARTED|Overall Study||5||
48507554|NCT01630616|101576861|FG001|STARTED|Overall Study||3||
48507555|NCT01630616|101576862|FG002|STARTED|Overall Study||3||
48507556|NCT01630616|101576863|FG003|STARTED|Overall Study||12||
48507557|NCT01630616|101576864|FG004|STARTED|Overall Study||6||
48507558|NCT01630616|101576865|FG005|STARTED|Overall Study||2||
48507559|NCT01630616|101576860|FG000|COMPLETED|Overall Study||5||
48507560|NCT01630616|101576861|FG001|COMPLETED|Overall Study||3||
48507561|NCT01630616|101576862|FG002|COMPLETED|Overall Study||3||
48507562|NCT01630616|101576863|FG003|COMPLETED|Overall Study||9||
48507563|NCT01630616|101576864|FG004|COMPLETED|Overall Study||6||
48507564|NCT01630616|101576865|FG005|COMPLETED|Overall Study||2||
48507565|NCT01630616|101576860|FG000|NOT COMPLETED|Overall Study||0||
48507566|NCT01630616|101576861|FG001|NOT COMPLETED|Overall Study||0||
48507567|NCT01630616|101576862|FG002|NOT COMPLETED|Overall Study||0||
48507568|NCT01630616|101576863|FG003|NOT COMPLETED|Overall Study||3||
48507569|NCT01630616|101576864|FG004|NOT COMPLETED|Overall Study||0||
48507570|NCT01630616|101576865|FG005|NOT COMPLETED|Overall Study||0||
48507571|NCT02224053|101576866|FG000|STARTED|AZD9291 and Omeprazole Co-administration||68||
48507572|NCT02224053|101576866|FG000|COMPLETED|AZD9291 and Omeprazole Co-administration||47||
48507573|NCT02224053|101576866|FG000|NOT COMPLETED|AZD9291 and Omeprazole Co-administration||21||
48507574|NCT02224053|101576866|FG000|STARTED|AZD9291 Alone||47||
48507575|NCT02224053|101576866|FG000|COMPLETED|AZD9291 Alone||47||
48507576|NCT02224053|101576866|FG000|NOT COMPLETED|AZD9291 Alone||0||
48507577|NCT01186016|101576867|FG000|STARTED|Overall Study||57||
48507578|NCT01186016|101576868|FG001|STARTED|Overall Study||46||
48507579|NCT01186016|101576867|FG000|Started Original Protocol|Overall Study||50|This milestone indicates the number of participants included in the original protocol.|
48507580|NCT01186016|101576868|FG001|Started Original Protocol|Overall Study||39|This milestone indicates the number of participants included in the original protocol.|
48507581|NCT01186016|101576867|FG000|Completed Original Protocol|Overall Study||10|This milestone indicates the number of participants who completed the original protocol.|
48507582|NCT01186016|101576868|FG001|Completed Original Protocol|Overall Study||12|This milestone indicates the number of participants who completed the original protocol.|
48507583|NCT01186016|101576867|FG000|COMPLETED|Overall Study||11|This row indicates the number of participants who completed the study (i.e., both the original protocol and the revised protocol that occurred at the end of the funding period) as stated in the Pre-Assignment Details.|
48507584|NCT01186016|101576868|FG001|COMPLETED|Overall Study||17|This row indicates the number of participants who completed the study (i.e., both the original protocol and the revised protocol that occurred at the end of the funding period) as stated in the Pre-Assignment Details.|
48062314|NCT03906461|100473030|FG000|STARTED|Completed 12-month Follow-up||143||
48062315|NCT03906461|100473030|FG000|COMPLETED|Completed 12-month Follow-up||133||
48062316|NCT03906461|100473030|FG000|NOT COMPLETED|Completed 12-month Follow-up||10||
48062317|NCT02256072|100473031|FG000|STARTED|Overall Study||194||
48218541|NCT03621735|100860328|FG001|Began Crossover Assignment|Overall Study||40||
48507585|NCT01186016|101576867|FG000|NOT COMPLETED|Overall Study||46||
48507586|NCT01186016|101576868|FG001|NOT COMPLETED|Overall Study||29||
48062318|NCT02256072|100473032|FG001|STARTED|Overall Study||191||
48062319|NCT02256072|100473031|FG000|Completed 1 Month Follow-Up|Overall Study||167||
48062320|NCT02256072|100473032|FG001|Completed 1 Month Follow-Up|Overall Study||179||
48062321|NCT02256072|100473031|FG000|COMPLETED|Overall Study||152||
48062322|NCT02256072|100473032|FG001|COMPLETED|Overall Study||162||
48062323|NCT02256072|100473031|FG000|NOT COMPLETED|Overall Study||42||
48062324|NCT02256072|100473032|FG001|NOT COMPLETED|Overall Study||29||
48062325|NCT03468985|100473033|FG000|STARTED|Overall Study||0||
48062326|NCT03468985|100473034|FG001|STARTED|Overall Study||2||
48062327|NCT03468985|100473035|FG002|STARTED|Overall Study||0||
48062328|NCT03468985|100473036|FG003|STARTED|Overall Study||1||
48062329|NCT03468985|100473033|FG000|COMPLETED|Overall Study||0||
48062330|NCT03468985|100473034|FG001|COMPLETED|Overall Study||0||
48062331|NCT03468985|100473035|FG002|COMPLETED|Overall Study||0||
48062332|NCT03468985|100473036|FG003|COMPLETED|Overall Study||0||
48062333|NCT03468985|100473033|FG000|NOT COMPLETED|Overall Study||0||
48062334|NCT03468985|100473034|FG001|NOT COMPLETED|Overall Study||2||
48507587|NCT02522780|101576869|FG000|STARTED|Overall Study||138||
48507588|NCT02522780|101576870|FG001|STARTED|Overall Study||138||
48507589|NCT02522780|101576869|FG000|Treated|Overall Study||137||
48507590|NCT02522780|101576870|FG001|Treated|Overall Study||135||
48507591|NCT02522780|101576869|FG000|Intention-to-treat (ITT) Population|Overall Study||136||
48507592|NCT02522780|101576870|FG001|Intention-to-treat (ITT) Population|Overall Study||136||
48507593|NCT02522780|101576869|FG000|COMPLETED|Overall Study||121||
48507594|NCT02522780|101576870|FG001|COMPLETED|Overall Study||111||
48507595|NCT02522780|101576869|FG000|NOT COMPLETED|Overall Study||17||
48507596|NCT02522780|101576870|FG001|NOT COMPLETED|Overall Study||27||
48507597|NCT00133679|101576871|FG000|STARTED|Overall Study||0||
48507598|NCT00133679|101576872|FG001|STARTED|Overall Study||0||
48507599|NCT00133679|101576871|FG000|COMPLETED|Overall Study||0||
48062335|NCT03468985|100473035|FG002|NOT COMPLETED|Overall Study||0||
48507600|NCT00133679|101576872|FG001|COMPLETED|Overall Study||0||
48507601|NCT00133679|101576871|FG000|NOT COMPLETED|Overall Study||0||
48507602|NCT00133679|101576872|FG001|NOT COMPLETED|Overall Study||0||
48507603|NCT01264835|101576873|FG000|STARTED|Overall Study||2||
48507604|NCT01264835|101576873|FG000|COMPLETED|Overall Study||1||
48507605|NCT01264835|101576873|FG000|NOT COMPLETED|Overall Study||1||
48507606|NCT00526162|101576874|FG000|STARTED|Overall Study||83||
48507607|NCT00526162|101576874|FG000|COMPLETED|Overall Study||80||
48507608|NCT00526162|101576874|FG000|NOT COMPLETED|Overall Study||3||
48507609|NCT00264381|101576875|FG000|STARTED|Overall Study||35||
48507610|NCT00264381|101576876|FG001|STARTED|Overall Study||37||
48507611|NCT00264381|101576875|FG000|COMPLETED|Overall Study||35||
48507612|NCT00264381|101576876|FG001|COMPLETED|Overall Study||37||
48507613|NCT00264381|101576875|FG000|NOT COMPLETED|Overall Study||0||
48507614|NCT00264381|101576876|FG001|NOT COMPLETED|Overall Study||0||
48507615|NCT01321177|101576877|FG000|STARTED|Overall Study||223||
48507616|NCT01321177|101576878|FG001|STARTED|Overall Study||181||
48507617|NCT01321177|101576877|FG000|COMPLETED|Overall Study||147||
48507618|NCT01321177|101576878|FG001|COMPLETED|Overall Study||84||
48507619|NCT01321177|101576877|FG000|NOT COMPLETED|Overall Study||76||
48507620|NCT01321177|101576878|FG001|NOT COMPLETED|Overall Study||97||
48507621|NCT04012931|101576879|FG000|STARTED|Overall Study||26||
48507622|NCT04012931|101576879|FG000|Participants Aged 2 to <6 Years|Overall Study||1||
48507623|NCT04012931|101576879|FG000|Participants Aged >=6 to <12 Years|Overall Study||25||
48507624|NCT04012931|101576879|FG000|Participants >=25 kg Who Received 25 mg Rilpivirine|Overall Study||18||
48507625|NCT04012931|101576879|FG000|Participants 20 to <25 kg Who Received 15 mg Rilpivirine|Overall Study||5||
48507626|NCT04012931|101576879|FG000|Participants <20 kg Who Received 15 mg Rilpivirine|Overall Study||2||
48507627|NCT04012931|101576879|FG000|Participants <20 kg Who Received 12.5 mg Rilpivirine|Overall Study||1||
48507628|NCT04012931|101576879|FG000|COMPLETED|Overall Study||26||
48507629|NCT04012931|101576879|FG000|NOT COMPLETED|Overall Study||0||
48507630|NCT01863433|101576880|FG000|STARTED|Overall Study||120||
48062336|NCT03468985|100473036|FG003|NOT COMPLETED|Overall Study||1||
48062337|NCT03630042|100473037|FG000|STARTED|Overall Study||17||
48062338|NCT03630042|100473037|FG000|COMPLETED|Overall Study||17||
48062339|NCT03630042|100473037|FG000|NOT COMPLETED|Overall Study||0||
48062340|NCT01123850|100473038|FG000|STARTED|Overall Study||45||
48062341|NCT01123850|100473038|FG000|COMPLETED|Overall Study||0||
48062342|NCT01123850|100473038|FG000|NOT COMPLETED|Overall Study||45||
48062343|NCT00644657|100473039|FG000|STARTED|Overall Study||27||
48062344|NCT00644657|100473039|FG000|COMPLETED|Overall Study||27||
48507631|NCT01863433|101576880|FG000|COMPLETED|Overall Study||119||
48507632|NCT01863433|101576880|FG000|NOT COMPLETED|Overall Study||1||
48507633|NCT00142116|101576881|FG000|STARTED|Overall Study||25||
48507634|NCT00142116|101576881|FG000|COMPLETED|Overall Study||25||
48062345|NCT00644657|100473039|FG000|NOT COMPLETED|Overall Study||0||
48062346|NCT00338104|100473040|FG000|STARTED|Overall Study||25||
48062347|NCT00338104|100473041|FG001|STARTED|Overall Study||25||
48507635|NCT00142116|101576881|FG000|NOT COMPLETED|Overall Study||0||
48062348|NCT00338104|100473042|FG002|STARTED|Overall Study||25||
48062349|NCT00338104|100473040|FG000|COMPLETED|Overall Study||23||
48062350|NCT00338104|100473041|FG001|COMPLETED|Overall Study||24||
48062351|NCT00338104|100473042|FG002|COMPLETED|Overall Study||22||
48062352|NCT00338104|100473040|FG000|NOT COMPLETED|Overall Study||2||
48062353|NCT00338104|100473041|FG001|NOT COMPLETED|Overall Study||1||
48507636|NCT02655224|101576882|FG000|STARTED|Overall Study||33||
48507637|NCT02655224|101576883|FG001|STARTED|Overall Study||32||
48507638|NCT02655224|101576882|FG000|COMPLETED|Overall Study||32|Completed=Completed Treatment|
48507639|NCT02655224|101576883|FG001|COMPLETED|Overall Study||31|Completed=Completed Treatment|
48507640|NCT02655224|101576882|FG000|NOT COMPLETED|Overall Study||1||
48507641|NCT02655224|101576883|FG001|NOT COMPLETED|Overall Study||1||
48507642|NCT05412121|101576884|FG000|STARTED|Overall Study||14||
48507643|NCT05412121|101576884|FG000|Day 42 - End of Treatment|Overall Study||6||
48507644|NCT05412121|101576884|FG000|COMPLETED|Overall Study||4||
48507645|NCT05412121|101576884|FG000|NOT COMPLETED|Overall Study||10||
48507646|NCT00324896|101576885|FG000|STARTED|Overall Study||15||
48507647|NCT00324896|101576886|FG001|STARTED|Overall Study||15||
48507648|NCT00324896|101576885|FG000|COMPLETED|Overall Study||12||
48507649|NCT00324896|101576886|FG001|COMPLETED|Overall Study||7||
48507650|NCT00324896|101576885|FG000|NOT COMPLETED|Overall Study||3||
48507651|NCT00324896|101576886|FG001|NOT COMPLETED|Overall Study||8||
48507652|NCT02966340|101576887|FG000|STARTED|Overall Study||37||
48507653|NCT02966340|101576888|FG001|STARTED|Overall Study||33||
48507654|NCT02966340|101576887|FG000|COMPLETED|Overall Study||34||
48507655|NCT02966340|101576888|FG001|COMPLETED|Overall Study||30||
48507656|NCT02966340|101576887|FG000|NOT COMPLETED|Overall Study||3||
48507657|NCT02966340|101576888|FG001|NOT COMPLETED|Overall Study||3||
48507658|NCT00605176|101576889|FG000|STARTED|Overall Study||160||
48507659|NCT00605176|101576890|FG001|STARTED|Overall Study||160||
48507660|NCT00605176|101576891|FG002|STARTED|Overall Study||159||
48507661|NCT00605176|101576889|FG000|COMPLETED|Overall Study||149||
48507662|NCT00605176|101576890|FG001|COMPLETED|Overall Study||154||
48507663|NCT00605176|101576891|FG002|COMPLETED|Overall Study||150||
48507664|NCT00605176|101576889|FG000|NOT COMPLETED|Overall Study||11||
48507665|NCT00605176|101576890|FG001|NOT COMPLETED|Overall Study||6||
48507666|NCT00605176|101576891|FG002|NOT COMPLETED|Overall Study||9||
48507667|NCT05862844|101576892|FG000|STARTED|Overall Study||20||
48507668|NCT05862844|101576892|FG000|COMPLETED|Overall Study||20||
48507669|NCT05862844|101576892|FG000|NOT COMPLETED|Overall Study||0||
48507670|NCT01609582|101576893|FG000|STARTED|Overall Study||1603||
48507671|NCT01609582|101576894|FG001|STARTED|Overall Study||1604||
48507672|NCT01609582|101576893|FG000|Treated|Overall Study||1603||
48507673|NCT01609582|101576894|FG001|Treated|Overall Study||1601||
48507674|NCT01609582|101576893|FG000|COMPLETED|Overall Study||0||
48507675|NCT01609582|101576894|FG001|COMPLETED|Overall Study||0||
48507676|NCT01609582|101576893|FG000|NOT COMPLETED|Overall Study||1603||
48507677|NCT01609582|101576894|FG001|NOT COMPLETED|Overall Study||1604||
48507678|NCT02329431|101576895|FG000|STARTED|Overall Study||92||
48507679|NCT02329431|101576896|FG001|STARTED|Overall Study||89||
48507680|NCT02329431|101576895|FG000|Baseline Interview|Overall Study||87||
48507681|NCT02329431|101576896|FG001|Baseline Interview|Overall Study||85||
48507682|NCT02329431|101576895|FG000|COMPLETED|Overall Study||72||
48507683|NCT02329431|101576896|FG001|COMPLETED|Overall Study||76||
48507684|NCT02329431|101576895|FG000|NOT COMPLETED|Overall Study||20||
48507685|NCT02329431|101576896|FG001|NOT COMPLETED|Overall Study||13||
48507686|NCT02726386|101576897|FG000|STARTED|Overall Study||90||
48507687|NCT02726386|101576898|FG001|STARTED|Overall Study||124||
48507688|NCT02726386|101576897|FG000|COMPLETED|Overall Study||52||
48507689|NCT02726386|101576898|FG001|COMPLETED|Overall Study||68||
48507690|NCT02726386|101576897|FG000|NOT COMPLETED|Overall Study||38||
48507691|NCT02726386|101576898|FG001|NOT COMPLETED|Overall Study||56||
48507692|NCT02608476|101576899|FG000|STARTED|Overall Study||369||
48507693|NCT02608476|101576900|FG001|STARTED|Overall Study||363||
48507694|NCT02608476|101576899|FG000|COMPLETED|Overall Study||302||
48062354|NCT00338104|100473042|FG002|NOT COMPLETED|Overall Study||3||
48062355|NCT02477839|100473043|FG000|STARTED|Overall Study||127||
48062356|NCT02477839|100473044|FG001|STARTED|Overall Study||128||
48507695|NCT02608476|101576900|FG001|COMPLETED|Overall Study||282||
48507696|NCT02608476|101576899|FG000|NOT COMPLETED|Overall Study||67||
48507697|NCT02608476|101576900|FG001|NOT COMPLETED|Overall Study||81||
48507698|NCT01622660|101576901|FG000|STARTED|Overall Study||2||
48507699|NCT01622660|101576901|FG000|COMPLETED|Overall Study||1||
48507700|NCT01622660|101576901|FG000|NOT COMPLETED|Overall Study||1||
48507701|NCT04556734|101576902|FG000|STARTED|DB Treatment Period (24 Weeks)||31||
48507702|NCT04556734|101576903|FG001|STARTED|DB Treatment Period (24 Weeks)||25||
48507703|NCT04556734|101576904|FG002|STARTED|DB Treatment Period (24 Weeks)||24||
48507704|NCT04556734|101576905|FG003|STARTED|DB Treatment Period (24 Weeks)||0||
48507705|NCT04556734|101576906|FG004|STARTED|DB Treatment Period (24 Weeks)||0||
48507706|NCT04556734|101576907|FG005|STARTED|DB Treatment Period (24 Weeks)||0||
48507707|NCT04556734|101576908|FG006|STARTED|DB Treatment Period (24 Weeks)||0||
48507708|NCT04556734|101576909|FG007|STARTED|DB Treatment Period (24 Weeks)||0||
48507709|NCT04556734|101576902|FG000|Treated|DB Treatment Period (24 Weeks)||31||
48507710|NCT04556734|101576903|FG001|Treated|DB Treatment Period (24 Weeks)||25||
48507711|NCT04556734|101576904|FG002|Treated|DB Treatment Period (24 Weeks)||23||
48507712|NCT04556734|101576905|FG003|Treated|DB Treatment Period (24 Weeks)||0||
48507713|NCT04556734|101576906|FG004|Treated|DB Treatment Period (24 Weeks)||0||
48507714|NCT04556734|101576907|FG005|Treated|DB Treatment Period (24 Weeks)||0||
48507715|NCT04556734|101576908|FG006|Treated|DB Treatment Period (24 Weeks)||0||
48507716|NCT04556734|101576909|FG007|Treated|DB Treatment Period (24 Weeks)||0||
48507717|NCT04556734|101576902|FG000|COMPLETED|DB Treatment Period (24 Weeks)||24|Completed Treatment|
48507718|NCT04556734|101576903|FG001|COMPLETED|DB Treatment Period (24 Weeks)||24|Completed Treatment|
48507719|NCT04556734|101576904|FG002|COMPLETED|DB Treatment Period (24 Weeks)||17|Completed Treatment|
48507720|NCT04556734|101576905|FG003|COMPLETED|DB Treatment Period (24 Weeks)||0|Completed Treatment|
48507721|NCT04556734|101576906|FG004|COMPLETED|DB Treatment Period (24 Weeks)||0|Completed Treatment|
48507722|NCT04556734|101576907|FG005|COMPLETED|DB Treatment Period (24 Weeks)||0|Completed Treatment|
48507723|NCT04556734|101576908|FG006|COMPLETED|DB Treatment Period (24 Weeks)||0|Completed Treatment|
48507724|NCT04556734|101576909|FG007|COMPLETED|DB Treatment Period (24 Weeks)||0|Completed Treatment|
48507725|NCT04556734|101576902|FG000|NOT COMPLETED|DB Treatment Period (24 Weeks)||7||
48062357|NCT02477839|100473043|FG000|Completed Transition Period|Overall Study||124||
48062358|NCT02477839|100473044|FG001|Completed Transition Period|Overall Study||117||
48062359|NCT02477839|100473043|FG000|Completed Taper After Maintenance|Overall Study||0||
48062360|NCT02477839|100473044|FG001|Completed Taper After Maintenance|Overall Study||1||
48062361|NCT02477839|100473043|FG000|COMPLETED|Overall Study||124||
48062362|NCT02477839|100473044|FG001|COMPLETED|Overall Study||118||
48062363|NCT02477839|100473043|FG000|NOT COMPLETED|Overall Study||3||
48062364|NCT02477839|100473044|FG001|NOT COMPLETED|Overall Study||10||
48062365|NCT03595774|100473045|FG000|STARTED|Overall Study||3||
48062366|NCT03595774|100473046|FG001|STARTED|Overall Study||4||
48062367|NCT03595774|100473047|FG002|STARTED|Overall Study||3||
48062368|NCT03595774|100473048|FG003|STARTED|Overall Study||3||
48062369|NCT03595774|100473045|FG000|COMPLETED|Overall Study||2||
48062370|NCT03595774|100473046|FG001|COMPLETED|Overall Study||3||
48062371|NCT03595774|100473047|FG002|COMPLETED|Overall Study||2||
48062372|NCT03595774|100473048|FG003|COMPLETED|Overall Study||2||
48062373|NCT03595774|100473045|FG000|NOT COMPLETED|Overall Study||1||
48062374|NCT03595774|100473046|FG001|NOT COMPLETED|Overall Study||1||
48062375|NCT03595774|100473047|FG002|NOT COMPLETED|Overall Study||1||
48062376|NCT03595774|100473048|FG003|NOT COMPLETED|Overall Study||1||
48062377|NCT02396251|100473049|FG000|STARTED|Overall Study||36||
48062378|NCT02396251|100473050|FG001|STARTED|Overall Study||12||
48062379|NCT02396251|100473049|FG000|COMPLETED|Overall Study||23||
48062380|NCT02396251|100473050|FG001|COMPLETED|Overall Study||7||
48062381|NCT02396251|100473049|FG000|NOT COMPLETED|Overall Study||13||
48062382|NCT02396251|100473050|FG001|NOT COMPLETED|Overall Study||5||
48062383|NCT04439279|100473051|FG000|STARTED|Overall Study||35||
48062384|NCT04439279|100473051|FG000|Started Protocol Therapy|Overall Study||35||
48062385|NCT04439279|100473051|FG000|Eligible|Overall Study||33||
48062386|NCT04439279|100473051|FG000|Reported Adverse Events Data|Overall Study||34||
48062387|NCT04439279|100473051|FG000|COMPLETED|Overall Study||0||
48062388|NCT04439279|100473051|FG000|NOT COMPLETED|Overall Study||35||
48062389|NCT03387683|100473052|FG000|STARTED|Overall Study||27||
48062390|NCT03387683|100473053|FG001|STARTED|Overall Study||26||
48062391|NCT03387683|100473052|FG000|COMPLETED|Overall Study||25||
48062392|NCT03387683|100473053|FG001|COMPLETED|Overall Study||26||
48062393|NCT03387683|100473052|FG000|NOT COMPLETED|Overall Study||2||
48062394|NCT03387683|100473053|FG001|NOT COMPLETED|Overall Study||0||
48062395|NCT03331250|100473054|FG000|STARTED|Overall Study||13||
48062396|NCT03331250|100473054|FG000|COMPLETED|Overall Study||12||
48062397|NCT03331250|100473054|FG000|NOT COMPLETED|Overall Study||1||
48062398|NCT00994318|100473055|FG000|STARTED|Overall Study||155||
48062399|NCT00994318|100473056|FG001|STARTED|Overall Study||154||
48062400|NCT00994318|100473057|FG002|STARTED|Overall Study||317||
48062401|NCT00994318|100473055|FG000|COMPLETED|Overall Study||133||
48062402|NCT00994318|100473056|FG001|COMPLETED|Overall Study||136||
48062403|NCT00994318|100473057|FG002|COMPLETED|Overall Study||250||
48062404|NCT00994318|100473055|FG000|NOT COMPLETED|Overall Study||22||
48062405|NCT00994318|100473056|FG001|NOT COMPLETED|Overall Study||18||
48062406|NCT00994318|100473057|FG002|NOT COMPLETED|Overall Study||67||
48062407|NCT02001181|100473058|FG000|STARTED|Overall Study||35||
48062408|NCT02001181|100473059|FG001|STARTED|Overall Study||34||
48062409|NCT02001181|100473058|FG000|COMPLETED|Overall Study||34||
48062410|NCT02001181|100473059|FG001|COMPLETED|Overall Study||31||
48062411|NCT02001181|100473058|FG000|NOT COMPLETED|Overall Study||1||
48062412|NCT02001181|100473059|FG001|NOT COMPLETED|Overall Study||3||
48062413|NCT01076231|100475411|FG000|STARTED|Overall Study||34||
48062414|NCT01076231|100475411|FG000|COMPLETED|Overall Study||0||
48062415|NCT01076231|100475411|FG000|NOT COMPLETED|Overall Study||34||
48062416|NCT02090075|100475412|FG000|STARTED|Overall Study||33||
48062417|NCT02090075|100475413|FG001|STARTED|Overall Study||33||
48062418|NCT02090075|100475412|FG000|COMPLETED|Overall Study||26||
48062419|NCT02090075|100475413|FG001|COMPLETED|Overall Study||30||
48062420|NCT02090075|100475412|FG000|NOT COMPLETED|Overall Study||7||
48062421|NCT02090075|100475413|FG001|NOT COMPLETED|Overall Study||3||
48062422|NCT04836312|100475414|FG000|STARTED|Overall Study||20||
48062423|NCT04836312|100475415|FG001|STARTED|Overall Study||17||
48062424|NCT04836312|100475414|FG000|COMPLETED|Overall Study||20||
48507726|NCT04556734|101576903|FG001|NOT COMPLETED|DB Treatment Period (24 Weeks)||1||
48507727|NCT04556734|101576904|FG002|NOT COMPLETED|DB Treatment Period (24 Weeks)||7||
48507728|NCT04556734|101576905|FG003|NOT COMPLETED|DB Treatment Period (24 Weeks)||0||
48507729|NCT04556734|101576906|FG004|NOT COMPLETED|DB Treatment Period (24 Weeks)||0||
48507730|NCT04556734|101576907|FG005|NOT COMPLETED|DB Treatment Period (24 Weeks)||0||
48507731|NCT04556734|101576908|FG006|NOT COMPLETED|DB Treatment Period (24 Weeks)||0||
48507732|NCT04556734|101576909|FG007|NOT COMPLETED|DB Treatment Period (24 Weeks)||0||
48507733|NCT04556734|101576902|FG000|STARTED|OLE Period (28 Weeks)||0||
48507734|NCT04556734|101576903|FG001|STARTED|OLE Period (28 Weeks)||0||
48507735|NCT04556734|101576904|FG002|STARTED|OLE Period (28 Weeks)||0||
48507736|NCT04556734|101576905|FG003|STARTED|OLE Period (28 Weeks)||4||
48507737|NCT04556734|101576906|FG004|STARTED|OLE Period (28 Weeks)||4||
48507738|NCT04556734|101576907|FG005|STARTED|OLE Period (28 Weeks)||24||
48507739|NCT04556734|101576908|FG006|STARTED|OLE Period (28 Weeks)||20||
48507740|NCT04556734|101576909|FG007|STARTED|OLE Period (28 Weeks)||13||
48507741|NCT04556734|101576902|FG000|Treated|OLE Period (28 Weeks)||0||
48507742|NCT04556734|101576903|FG001|Treated|OLE Period (28 Weeks)||0||
48507743|NCT04556734|101576904|FG002|Treated|OLE Period (28 Weeks)||0||
48507744|NCT04556734|101576905|FG003|Treated|OLE Period (28 Weeks)||4||
48507745|NCT04556734|101576906|FG004|Treated|OLE Period (28 Weeks)||4||
48507746|NCT04556734|101576907|FG005|Treated|OLE Period (28 Weeks)||24||
48507747|NCT04556734|101576908|FG006|Treated|OLE Period (28 Weeks)||20||
48507748|NCT04556734|101576909|FG007|Treated|OLE Period (28 Weeks)||13||
48507749|NCT04556734|101576902|FG000|COMPLETED|OLE Period (28 Weeks)||0|Completed treatment|
48507750|NCT04556734|101576903|FG001|COMPLETED|OLE Period (28 Weeks)||0|Completed treatment|
48507751|NCT04556734|101576904|FG002|COMPLETED|OLE Period (28 Weeks)||0|Completed treatment|
48507752|NCT04556734|101576905|FG003|COMPLETED|OLE Period (28 Weeks)||2|Completed treatment|
48507753|NCT04556734|101576906|FG004|COMPLETED|OLE Period (28 Weeks)||1|Completed treatment|
48507754|NCT04556734|101576907|FG005|COMPLETED|OLE Period (28 Weeks)||21|Completed treatment|
48507755|NCT04556734|101576908|FG006|COMPLETED|OLE Period (28 Weeks)||19|Completed treatment|
48507756|NCT04556734|101576909|FG007|COMPLETED|OLE Period (28 Weeks)||9|Completed treatment|
48507757|NCT04556734|101576902|FG000|NOT COMPLETED|OLE Period (28 Weeks)||0||
48507758|NCT04556734|101576903|FG001|NOT COMPLETED|OLE Period (28 Weeks)||0||
48507759|NCT04556734|101576904|FG002|NOT COMPLETED|OLE Period (28 Weeks)||0||
48507760|NCT04556734|101576905|FG003|NOT COMPLETED|OLE Period (28 Weeks)||2||
48507761|NCT04556734|101576906|FG004|NOT COMPLETED|OLE Period (28 Weeks)||3||
48507762|NCT04556734|101576907|FG005|NOT COMPLETED|OLE Period (28 Weeks)||3||
48507763|NCT04556734|101576908|FG006|NOT COMPLETED|OLE Period (28 Weeks)||1||
48507764|NCT04556734|101576909|FG007|NOT COMPLETED|OLE Period (28 Weeks)||4||
48507765|NCT02972515|101576910|FG000|STARTED|Overall Study||166||
48507766|NCT02972515|101576910|FG000|COMPLETED|Overall Study||88||
48507767|NCT02972515|101576910|FG000|NOT COMPLETED|Overall Study||78||
48507768|NCT00804999|101576911|FG000|STARTED|Overall Study||15||
48507769|NCT00804999|101576912|FG001|STARTED|Overall Study||12||
48507770|NCT00804999|101576913|FG002|STARTED|Overall Study||14||
48507771|NCT00804999|101576914|FG003|STARTED|Overall Study||10||
48507772|NCT00804999|101576911|FG000|COMPLETED|Overall Study||15||
48507773|NCT00804999|101576912|FG001|COMPLETED|Overall Study||12||
48507774|NCT00804999|101576913|FG002|COMPLETED|Overall Study||14||
48507775|NCT00804999|101576914|FG003|COMPLETED|Overall Study||10||
48507776|NCT00804999|101576911|FG000|NOT COMPLETED|Overall Study||0||
48507777|NCT00804999|101576912|FG001|NOT COMPLETED|Overall Study||0||
48507778|NCT00804999|101576913|FG002|NOT COMPLETED|Overall Study||0||
48507779|NCT00804999|101576914|FG003|NOT COMPLETED|Overall Study||0||
48507780|NCT01077258|101576915|FG000|STARTED|Overall Study||4208||
48507781|NCT01077258|101576915|FG000|COMPLETED|Overall Study||1640||
48507782|NCT01077258|101576915|FG000|NOT COMPLETED|Overall Study||2568||
48507783|NCT01504711|101576916|FG000|STARTED|Overall Study||30||
48507784|NCT01504711|101576916|FG000|COMPLETED|Overall Study||27||
48507785|NCT01504711|101576916|FG000|NOT COMPLETED|Overall Study||3||
48507786|NCT00152516|101576917|FG000|STARTED|Overall Study||255||
48507787|NCT00152516|101576917|FG000|COMPLETED|Overall Study||180||
48507788|NCT00152516|101576917|FG000|NOT COMPLETED|Overall Study||75||
48507789|NCT00024258|101576918|FG000|STARTED|Overall Study||22||
48507790|NCT00024258|101576918|FG000|COMPLETED|Overall Study||13||
48507791|NCT00024258|101576918|FG000|NOT COMPLETED|Overall Study||9||
48507792|NCT02221817|101576919|FG000|STARTED|Overall Study||0||
48507793|NCT02221817|101576920|FG001|STARTED|Overall Study||0||
48507794|NCT02221817|101576919|FG000|COMPLETED|Overall Study||0||
48507795|NCT02221817|101576920|FG001|COMPLETED|Overall Study||0||
48507796|NCT02221817|101576919|FG000|NOT COMPLETED|Overall Study||0||
48507797|NCT02221817|101576920|FG001|NOT COMPLETED|Overall Study||0||
48507798|NCT02260635|101576921|FG000|STARTED|Double-Blind Treatment Period||27||
48507799|NCT02260635|101576922|FG001|STARTED|Double-Blind Treatment Period||27||
48507800|NCT02260635|101576921|FG000|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||27||
48507801|NCT02260635|101576922|FG001|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||26||
48507802|NCT02260635|101576921|FG000|COMPLETED|Double-Blind Treatment Period||26||
48507803|NCT02260635|101576922|FG001|COMPLETED|Double-Blind Treatment Period||25||
48507804|NCT02260635|101576921|FG000|NOT COMPLETED|Double-Blind Treatment Period||1||
48507805|NCT02260635|101576922|FG001|NOT COMPLETED|Double-Blind Treatment Period||2||
48507806|NCT02260635|101576921|FG000|STARTED|Open-Label Extension||26||
48507807|NCT02260635|101576922|FG001|STARTED|Open-Label Extension||25||
48507808|NCT02260635|101576921|FG000|Received at Least One Dose of Study Drug|Open-Label Extension||26||
48507809|NCT02260635|101576922|FG001|Received at Least One Dose of Study Drug|Open-Label Extension||25||
48507810|NCT02260635|101576921|FG000|COMPLETED|Open-Label Extension||0||
48507811|NCT02260635|101576922|FG001|COMPLETED|Open-Label Extension||0||
48507812|NCT02260635|101576921|FG000|NOT COMPLETED|Open-Label Extension||26||
48507813|NCT02260635|101576922|FG001|NOT COMPLETED|Open-Label Extension||25||
48507814|NCT00360490|101576923|FG000|STARTED|Overall Study||82||
48507815|NCT00360490|101576924|FG001|STARTED|Overall Study||83||
48507816|NCT00360490|101576923|FG000|COMPLETED|Overall Study||73||
48507817|NCT00360490|101576924|FG001|COMPLETED|Overall Study||72||
48507818|NCT00360490|101576923|FG000|NOT COMPLETED|Overall Study||9||
48507819|NCT00360490|101576924|FG001|NOT COMPLETED|Overall Study||11||
48507820|NCT02408120|101576925|FG000|STARTED|Overall Study||112||
48062425|NCT04836312|100475415|FG001|COMPLETED|Overall Study||17||
48062426|NCT04836312|100475414|FG000|NOT COMPLETED|Overall Study||0||
48062427|NCT04836312|100475415|FG001|NOT COMPLETED|Overall Study||0||
48062428|NCT02664610|100475416|FG000|STARTED|Overall Study||46||
48062429|NCT02664610|100475417|FG001|STARTED|Overall Study||48||
48062430|NCT02664610|100475416|FG000|COMPLETED|Overall Study||32||
48062431|NCT02664610|100475417|FG001|COMPLETED|Overall Study||41||
48062432|NCT02664610|100475416|FG000|NOT COMPLETED|Overall Study||14||
48062433|NCT02664610|100475417|FG001|NOT COMPLETED|Overall Study||7||
48062434|NCT01440452|100475418|FG000|STARTED|Overall Study||6||
48062435|NCT01440452|100475419|FG001|STARTED|Overall Study||7||
48062436|NCT01440452|100475420|FG002|STARTED|Overall Study||8||
48062437|NCT01440452|100475421|FG003|STARTED|Overall Study||4||
48062438|NCT01440452|100475418|FG000|COMPLETED|Overall Study||6||
48062439|NCT01440452|100475419|FG001|COMPLETED|Overall Study||7||
48062440|NCT01440452|100475420|FG002|COMPLETED|Overall Study||8||
48062441|NCT01440452|100475421|FG003|COMPLETED|Overall Study||4||
48062442|NCT01440452|100475418|FG000|NOT COMPLETED|Overall Study||0||
48062443|NCT01440452|100475419|FG001|NOT COMPLETED|Overall Study||0||
48062444|NCT01440452|100475420|FG002|NOT COMPLETED|Overall Study||0||
48062445|NCT01440452|100475421|FG003|NOT COMPLETED|Overall Study||0||
48062446|NCT01824342|100475422|FG000|STARTED|Overall Study||11||
48062447|NCT01824342|100475423|FG001|STARTED|Overall Study||7||
48062448|NCT01824342|100475422|FG000|COMPLETED|Overall Study||2||
48062449|NCT01824342|100475423|FG001|COMPLETED|Overall Study||2||
48062450|NCT01824342|100475422|FG000|NOT COMPLETED|Overall Study||9||
48062451|NCT01824342|100475423|FG001|NOT COMPLETED|Overall Study||5||
48062452|NCT00471146|100475424|FG000|STARTED|Overall Study||314||
48062453|NCT00471146|100475425|FG001|STARTED|Overall Study||316||
48062454|NCT00471146|100475424|FG000|Treated|Overall Study||305||
48062455|NCT00471146|100475425|FG001|Treated|Overall Study||308||
48062456|NCT00471146|100475424|FG000|COMPLETED|Overall Study||142||
48062457|NCT00471146|100475425|FG001|COMPLETED|Overall Study||142||
48062458|NCT00471146|100475424|FG000|NOT COMPLETED|Overall Study||172||
48062459|NCT00471146|100475425|FG001|NOT COMPLETED|Overall Study||174||
48062460|NCT04357782|100475426|FG000|STARTED|Overall Study||10||
48062461|NCT04357782|100475427|FG001|STARTED|Overall Study||10||
48062462|NCT04357782|100475426|FG000|COMPLETED|Overall Study||9||
48507821|NCT02408120|101576926|FG001|STARTED|Overall Study||112||
48507822|NCT02408120|101576925|FG000|COMPLETED|Overall Study||108||
48507823|NCT02408120|101576926|FG001|COMPLETED|Overall Study||107||
48507824|NCT02408120|101576925|FG000|NOT COMPLETED|Overall Study||4||
48507825|NCT02408120|101576926|FG001|NOT COMPLETED|Overall Study||5||
48507826|NCT03486938|101576927|FG000|STARTED|Overall Study||83||
48062463|NCT04357782|100475427|FG001|COMPLETED|Overall Study||8||
48062464|NCT04357782|100475426|FG000|NOT COMPLETED|Overall Study||1||
48218542|NCT03621735|100860327|FG000|Began Second Washout Period|Overall Study||39||
48218543|NCT03621735|100860328|FG001|Began Second Washout Period|Overall Study||39||
48507827|NCT03486938|101576928|FG001|STARTED|Overall Study||81||
48507828|NCT03486938|101576927|FG000|COMPLETED|Overall Study||66||
48062465|NCT04357782|100475427|FG001|NOT COMPLETED|Overall Study||2||
48062466|NCT01309165|100475428|FG000|STARTED|Overall Study||19||
48062467|NCT01309165|100475429|FG001|STARTED|Overall Study||16||
48062468|NCT01309165|100475428|FG000|Received Allocated Intervention|Overall Study||16||
48062469|NCT01309165|100475429|FG001|Received Allocated Intervention|Overall Study||14||
48062470|NCT01309165|100475428|FG000|Included in Primary Analysis|Overall Study||14||
48062471|NCT01309165|100475429|FG001|Included in Primary Analysis|Overall Study||12||
48062472|NCT01309165|100475428|FG000|COMPLETED|Overall Study||13||
48062473|NCT01309165|100475429|FG001|COMPLETED|Overall Study||9||
48062474|NCT01309165|100475428|FG000|NOT COMPLETED|Overall Study||6||
48062475|NCT01309165|100475429|FG001|NOT COMPLETED|Overall Study||7||
48062476|NCT01783054|100475430|FG000|STARTED|Overall Study||2||
48062477|NCT01783054|100475430|FG000|COMPLETED|Overall Study||2||
48062478|NCT01783054|100475430|FG000|NOT COMPLETED|Overall Study||0||
48062479|NCT01461980|100475431|FG000|STARTED|Overall Study||888||
48062480|NCT01461980|100475432|FG001|STARTED|Overall Study||878||
48507829|NCT03486938|101576928|FG001|COMPLETED|Overall Study||55||
48507830|NCT03486938|101576927|FG000|NOT COMPLETED|Overall Study||17||
48507831|NCT03486938|101576928|FG001|NOT COMPLETED|Overall Study||26||
48507832|NCT02814708|101576929|FG000|STARTED|Overall Study||20||
48507833|NCT02814708|101576930|FG001|STARTED|Overall Study||20||
48507834|NCT02814708|101576931|FG002|STARTED|Overall Study||20||
48507835|NCT02814708|101576932|FG003|STARTED|Overall Study||20||
48507836|NCT02814708|101576933|FG004|STARTED|Overall Study||20||
48507837|NCT02814708|101576934|FG005|STARTED|Overall Study||20||
48507838|NCT02814708|101576935|FG006|STARTED|Overall Study||20||
48507839|NCT02814708|101576929|FG000|COMPLETED|Overall Study||18||
48507840|NCT02814708|101576930|FG001|COMPLETED|Overall Study||17||
48507841|NCT02814708|101576931|FG002|COMPLETED|Overall Study||19||
48507842|NCT02814708|101576932|FG003|COMPLETED|Overall Study||20||
48507843|NCT02814708|101576933|FG004|COMPLETED|Overall Study||17||
48507844|NCT02814708|101576934|FG005|COMPLETED|Overall Study||16||
48507845|NCT02814708|101576935|FG006|COMPLETED|Overall Study||19||
48507846|NCT02814708|101576929|FG000|NOT COMPLETED|Overall Study||2||
48507847|NCT02814708|101576930|FG001|NOT COMPLETED|Overall Study||3||
48507848|NCT02814708|101576931|FG002|NOT COMPLETED|Overall Study||1||
48507849|NCT02814708|101576932|FG003|NOT COMPLETED|Overall Study||0||
48507850|NCT02814708|101576933|FG004|NOT COMPLETED|Overall Study||3||
48507851|NCT02814708|101576934|FG005|NOT COMPLETED|Overall Study||4||
48507852|NCT02814708|101576935|FG006|NOT COMPLETED|Overall Study||1||
48507853|NCT02585245|101576936|FG000|STARTED|Overall Study||607||
48507854|NCT02585245|101576936|FG000|COMPLETED|Overall Study||594||
48507855|NCT02585245|101576936|FG000|NOT COMPLETED|Overall Study||13||
48507856|NCT02212106|101576937|FG000|STARTED|Overall Study||302||
48507857|NCT02212106|101576938|FG001|STARTED|Overall Study||100||
48507858|NCT02212106|101576937|FG000|COMPLETED|Overall Study||292||
48507859|NCT02212106|101576938|FG001|COMPLETED|Overall Study||96||
48507860|NCT02212106|101576937|FG000|NOT COMPLETED|Overall Study||10||
48507861|NCT02212106|101576938|FG001|NOT COMPLETED|Overall Study||4||
48507862|NCT02300987|101576939|FG000|STARTED|Primary Phase : Prior to Cross-over||8||
48507863|NCT02300987|101576940|FG001|STARTED|Primary Phase : Prior to Cross-over||2||
48507864|NCT02300987|101576939|FG000|COMPLETED|Primary Phase : Prior to Cross-over||2||
48507865|NCT02300987|101576940|FG001|COMPLETED|Primary Phase : Prior to Cross-over||0||
48507866|NCT02300987|101576939|FG000|NOT COMPLETED|Primary Phase : Prior to Cross-over||6||
48507867|NCT02300987|101576940|FG001|NOT COMPLETED|Primary Phase : Prior to Cross-over||2||
48507868|NCT02300987|101576939|FG000|STARTED|Secondary Phase : Cross-over to LEE011||1||
48507869|NCT02300987|101576940|FG001|STARTED|Secondary Phase : Cross-over to LEE011||2||
48507870|NCT02300987|101576939|FG000|COMPLETED|Secondary Phase : Cross-over to LEE011||0||
48507871|NCT02300987|101576940|FG001|COMPLETED|Secondary Phase : Cross-over to LEE011||1||
48507872|NCT02300987|101576939|FG000|NOT COMPLETED|Secondary Phase : Cross-over to LEE011||1||
48507873|NCT02300987|101576940|FG001|NOT COMPLETED|Secondary Phase : Cross-over to LEE011||1||
48507874|NCT02274558|101576941|FG000|STARTED|Overall Study||78||
48507875|NCT02274558|101576942|FG001|STARTED|Overall Study||76||
48507876|NCT02274558|101576943|FG002|STARTED|Overall Study||80||
48507877|NCT02274558|101576941|FG000|Included in the Safety Analysis Set|Overall Study||76||
48507878|NCT02274558|101576942|FG001|Included in the Safety Analysis Set|Overall Study||72||
48507879|NCT02274558|101576943|FG002|Included in the Safety Analysis Set|Overall Study||79||
48507880|NCT02274558|101576941|FG000|COMPLETED|Overall Study||71||
48507881|NCT02274558|101576942|FG001|COMPLETED|Overall Study||63||
48507882|NCT02274558|101576943|FG002|COMPLETED|Overall Study||71||
48507883|NCT02274558|101576941|FG000|NOT COMPLETED|Overall Study||7||
48507884|NCT02274558|101576942|FG001|NOT COMPLETED|Overall Study||13||
48507885|NCT02274558|101576943|FG002|NOT COMPLETED|Overall Study||9||
48507886|NCT02318550|101576944|FG000|STARTED|Overall Study||262||
48507887|NCT02318550|101576944|FG000|COMPLETED|Overall Study||262||
48507888|NCT02318550|101576944|FG000|NOT COMPLETED|Overall Study||0||
48507889|NCT00292591|101576945|FG000|STARTED|Overall Study||166||
48507890|NCT00292591|101576946|FG001|STARTED|Overall Study||167||
48507891|NCT00292591|101576947|FG002|STARTED|Overall Study||168||
48507892|NCT00292591|101576945|FG000|COMPLETED|Overall Study||102||
48507893|NCT00292591|101576946|FG001|COMPLETED|Overall Study||111||
48507894|NCT00292591|101576947|FG002|COMPLETED|Overall Study||110||
48507895|NCT00292591|101576945|FG000|NOT COMPLETED|Overall Study||64||
48507896|NCT00292591|101576946|FG001|NOT COMPLETED|Overall Study||56||
48507897|NCT00292591|101576947|FG002|NOT COMPLETED|Overall Study||58||
48218544|NCT03621735|100860327|FG000|Began 12-Week Follow Up|Overall Study||38||
48507898|NCT00917735|101576948|FG000|STARTED|Overall Study||538||
48507899|NCT00917735|101576949|FG001|STARTED|Overall Study||537||
48507900|NCT00917735|101576948|FG000|COMPLETED|Overall Study||463||
48507901|NCT00917735|101576949|FG001|COMPLETED|Overall Study||474||
48218545|NCT03621735|100860328|FG001|Began 12-Week Follow Up|Overall Study||39||
48507902|NCT00917735|101576948|FG000|NOT COMPLETED|Overall Study||75||
48507903|NCT00917735|101576949|FG001|NOT COMPLETED|Overall Study||63||
48507904|NCT01120899|101576950|FG000|STARTED|Overall Study||6||
48507905|NCT01120899|101576950|FG000|Month 6|Overall Study||5||
48507906|NCT01120899|101576950|FG000|Month 12|Overall Study||3||
48507907|NCT01120899|101576950|FG000|Month 18|Overall Study||3||
48218546|NCT03621735|100860327|FG000|COMPLETED|Overall Study||37||
48507908|NCT01120899|101576950|FG000|COMPLETED|Overall Study||3||
48507909|NCT01120899|101576950|FG000|NOT COMPLETED|Overall Study||3||
48507910|NCT01754376|101576951|FG000|STARTED|Overall Study||6||
48507911|NCT01754376|101576951|FG000|Completed 2-week Lead in of Vemurafenib|Overall Study||6||
48507912|NCT01754376|101576951|FG000|COMPLETED|Overall Study||3||
48507913|NCT01754376|101576951|FG000|NOT COMPLETED|Overall Study||3||
48507914|NCT02657005|101576952|FG000|STARTED|Overall Study||3||
48507915|NCT02657005|101576953|FG001|STARTED|Overall Study||3||
48507916|NCT02657005|101576954|FG002|STARTED|Overall Study||3||
48507917|NCT02657005|101576955|FG003|STARTED|Overall Study||3||
48507918|NCT02657005|101576956|FG004|STARTED|Overall Study||4||
48507919|NCT02657005|101576957|FG005|STARTED|Overall Study||4||
48507920|NCT02657005|101576958|FG006|STARTED|Overall Study||3||
48507921|NCT02657005|101576959|FG007|STARTED|Overall Study||3||
48507922|NCT02657005|101576960|FG008|STARTED|Overall Study||7||
48507923|NCT02657005|101576961|FG009|STARTED|Overall Study||44||
48507924|NCT02657005|101576962|FG010|STARTED|Overall Study||8||
48507925|NCT02657005|101576952|FG000|COMPLETED|Overall Study||0||
48507926|NCT02657005|101576953|FG001|COMPLETED|Overall Study||0||
48507927|NCT02657005|101576954|FG002|COMPLETED|Overall Study||0||
48507928|NCT02657005|101576955|FG003|COMPLETED|Overall Study||0||
48507929|NCT02657005|101576956|FG004|COMPLETED|Overall Study||0||
48507930|NCT02657005|101576957|FG005|COMPLETED|Overall Study||0||
48507931|NCT02657005|101576958|FG006|COMPLETED|Overall Study||0||
48507932|NCT02657005|101576959|FG007|COMPLETED|Overall Study||0||
48507933|NCT02657005|101576960|FG008|COMPLETED|Overall Study||0||
48507934|NCT02657005|101576961|FG009|COMPLETED|Overall Study||0||
48507935|NCT02657005|101576962|FG010|COMPLETED|Overall Study||0||
48507936|NCT02657005|101576952|FG000|NOT COMPLETED|Overall Study||3||
48507937|NCT02657005|101576953|FG001|NOT COMPLETED|Overall Study||3||
48507938|NCT02657005|101576954|FG002|NOT COMPLETED|Overall Study||3||
48507939|NCT02657005|101576955|FG003|NOT COMPLETED|Overall Study||3||
48507940|NCT02657005|101576956|FG004|NOT COMPLETED|Overall Study||4||
48507941|NCT02657005|101576957|FG005|NOT COMPLETED|Overall Study||4||
48507942|NCT02657005|101576958|FG006|NOT COMPLETED|Overall Study||3||
48507943|NCT02657005|101576959|FG007|NOT COMPLETED|Overall Study||3||
48507944|NCT02657005|101576960|FG008|NOT COMPLETED|Overall Study||7||
48507945|NCT02657005|101576961|FG009|NOT COMPLETED|Overall Study||44||
48507946|NCT02657005|101576962|FG010|NOT COMPLETED|Overall Study||8||
48507947|NCT01117987|101580010|FG000|STARTED|Overall Study||66||
48507948|NCT01117987|101580011|FG001|STARTED|Overall Study||78||
48507949|NCT01117987|101580010|FG000|COMPLETED|Overall Study||5||
48507950|NCT01117987|101580011|FG001|COMPLETED|Overall Study||4||
48507951|NCT01117987|101580010|FG000|NOT COMPLETED|Overall Study||61||
48507952|NCT01117987|101580011|FG001|NOT COMPLETED|Overall Study||74||
48507953|NCT01680016|101580012|FG000|STARTED|Overall Study||121||
48507954|NCT01680016|101580013|FG001|STARTED|Overall Study||122||
48507955|NCT01680016|101580014|FG002|STARTED|Overall Study||201||
48507956|NCT01680016|101580015|FG003|STARTED|Overall Study||200||
48507957|NCT01680016|101580012|FG000|COMPLETED|Overall Study||115||
48507958|NCT01680016|101580013|FG001|COMPLETED|Overall Study||114||
48507959|NCT01680016|101580014|FG002|COMPLETED|Overall Study||196||
48507960|NCT01680016|101580015|FG003|COMPLETED|Overall Study||195||
48507961|NCT01680016|101580012|FG000|NOT COMPLETED|Overall Study||6||
48507962|NCT01680016|101580013|FG001|NOT COMPLETED|Overall Study||8||
48507963|NCT01680016|101580014|FG002|NOT COMPLETED|Overall Study||5||
48507964|NCT01680016|101580015|FG003|NOT COMPLETED|Overall Study||5||
48507965|NCT03222037|101580016|FG000|STARTED|Period 1||21||
48507966|NCT03222037|101580017|FG001|STARTED|Period 1||22||
48507967|NCT03222037|101580016|FG000|COMPLETED|Period 1||21||
48507968|NCT03222037|101580017|FG001|COMPLETED|Period 1||22||
48507969|NCT03222037|101580016|FG000|NOT COMPLETED|Period 1||0||
48218547|NCT03621735|100860328|FG001|COMPLETED|Overall Study||37||
48507970|NCT03222037|101580017|FG001|NOT COMPLETED|Period 1||0||
48507971|NCT03222037|101580016|FG000|STARTED|Period 2||21||
48507972|NCT03222037|101580017|FG001|STARTED|Period 2||22||
48507973|NCT03222037|101580016|FG000|COMPLETED|Period 2||21||
48507974|NCT03222037|101580017|FG001|COMPLETED|Period 2||22||
48507975|NCT03222037|101580016|FG000|NOT COMPLETED|Period 2||0||
48507976|NCT03222037|101580017|FG001|NOT COMPLETED|Period 2||0||
48507977|NCT02681406|101580018|FG000|STARTED|Overall Study||65||
48507978|NCT02681406|101580019|FG001|STARTED|Overall Study||59||
48507979|NCT02681406|101580020|FG002|STARTED|Overall Study||68||
48507980|NCT02681406|101580021|FG003|STARTED|Overall Study||70||
48507981|NCT02681406|101580018|FG000|COMPLETED|Overall Study||49||
48507982|NCT02681406|101580019|FG001|COMPLETED|Overall Study||35||
48507983|NCT02681406|101580020|FG002|COMPLETED|Overall Study||42||
48507984|NCT02681406|101580021|FG003|COMPLETED|Overall Study||58||
48507985|NCT02681406|101580018|FG000|NOT COMPLETED|Overall Study||16||
48507986|NCT02681406|101580019|FG001|NOT COMPLETED|Overall Study||24||
48507987|NCT02681406|101580020|FG002|NOT COMPLETED|Overall Study||26||
48507988|NCT02681406|101580021|FG003|NOT COMPLETED|Overall Study||12||
48507989|NCT05317195|101580022|FG000|STARTED|Product Test (Enrolled Subjects)||31||
48218548|NCT03621735|100860327|FG000|NOT COMPLETED|Overall Study||13||
48507990|NCT05317195|101580022|FG000|COMPLETED|Product Test (Enrolled Subjects)||31||
48507991|NCT05317195|101580022|FG000|NOT COMPLETED|Product Test (Enrolled Subjects)||0||
48507992|NCT05317195|101580022|FG000|STARTED|Randomization||31||
48507993|NCT05317195|101580022|FG000|COMPLETED|Randomization||24||
48507994|NCT05317195|101580022|FG000|NOT COMPLETED|Randomization||7||
48507995|NCT05317195|101580022|FG000|STARTED|Admission||24||
48218549|NCT03621735|100860328|FG001|NOT COMPLETED|Overall Study||13||
48218550|NCT03476798|100860329|FG000|STARTED|Overall Study||33||
48218551|NCT03476798|100860329|FG000|COMPLETED|Overall Study||28||
48507996|NCT05317195|101580022|FG000|COMPLETED|Admission||22||
48507997|NCT05317195|101580022|FG000|NOT COMPLETED|Admission||2||
48507998|NCT05317195|101580022|FG000|STARTED|Product Use (Randomized Subjects)||22||
48507999|NCT05317195|101580022|FG000|NP-1|Product Use (Randomized Subjects)||22||
48508000|NCT05317195|101580022|FG000|NP-2|Product Use (Randomized Subjects)||22||
48508001|NCT05317195|101580022|FG000|NP-3|Product Use (Randomized Subjects)||22||
48508002|NCT05317195|101580022|FG000|NP-4|Product Use (Randomized Subjects)||22||
48508003|NCT05317195|101580022|FG000|Velo-NP|Product Use (Randomized Subjects)||22||
48508004|NCT05317195|101580022|FG000|Zyn-NP|Product Use (Randomized Subjects)||22||
48508005|NCT05317195|101580022|FG000|COMPLETED|Product Use (Randomized Subjects)||22||
48508006|NCT05317195|101580022|FG000|NOT COMPLETED|Product Use (Randomized Subjects)||0||
48508007|NCT01857973|101580023|FG000|STARTED|Overall Study||78||
48508008|NCT01857973|101580023|FG000|Exploratory A Phase|Overall Study||9||
48508009|NCT01857973|101580023|FG000|Xploratory B Phase|Overall Study||9||
48508010|NCT01857973|101580023|FG000|Phase 1|Overall Study||17||
48508011|NCT01857973|101580023|FG000|Phase 2|Overall Study||14||
48508012|NCT01857973|101580023|FG000|Phase 3|Overall Study||10||
48508013|NCT01857973|101580023|FG000|Phase 4|Overall Study||10||
48508014|NCT01857973|101580023|FG000|Phase 6|Overall Study||4||
48508015|NCT01857973|101580023|FG000|Phase 7|Overall Study||4||
48508016|NCT01857973|101580023|FG000|COMPLETED|Overall Study||73||
48508017|NCT01857973|101580023|FG000|NOT COMPLETED|Overall Study||5||
48508018|NCT00784979|101580024|FG000|STARTED|Overall Study||26||
48508019|NCT00784979|101580024|FG000|COMPLETED|Overall Study||20||
48508020|NCT00784979|101580024|FG000|NOT COMPLETED|Overall Study||6||
48508021|NCT03604432|101580025|FG000|STARTED|Overall Study||31||
48508022|NCT03604432|101580026|FG001|STARTED|Overall Study||29||
48508023|NCT03604432|101580025|FG000|COMPLETED|Overall Study||31||
48508024|NCT03604432|101580026|FG001|COMPLETED|Overall Study||29||
48508025|NCT03604432|101580025|FG000|NOT COMPLETED|Overall Study||0||
48508026|NCT03604432|101580026|FG001|NOT COMPLETED|Overall Study||0||
48508027|NCT03417739|101580027|FG000|STARTED|Overall Study||13||
48508028|NCT03417739|101580027|FG000|COMPLETED|Overall Study||13||
48508029|NCT03417739|101580027|FG000|NOT COMPLETED|Overall Study||0||
48508030|NCT01157234|101580028|FG000|STARTED|Overall Study||15||
48508031|NCT01157234|101580029|FG001|STARTED|Overall Study||15||
48508032|NCT01157234|101580028|FG000|COMPLETED|Overall Study||14||
48508033|NCT01157234|101580029|FG001|COMPLETED|Overall Study||15||
48508034|NCT01157234|101580028|FG000|NOT COMPLETED|Overall Study||1||
48508035|NCT01157234|101580029|FG001|NOT COMPLETED|Overall Study||0||
48508036|NCT02302716|101580030|FG000|STARTED|Overall Study||249||
48508037|NCT02302716|101580031|FG001|STARTED|Overall Study||244||
48508038|NCT02302716|101580030|FG000|Received at Least 1 Dose of Study Drug|Overall Study||249||
48508039|NCT02302716|101580031|FG001|Received at Least 1 Dose of Study Drug|Overall Study||244||
48508040|NCT02302716|101580030|FG000|COMPLETED|Overall Study||230||
48508041|NCT02302716|101580031|FG001|COMPLETED|Overall Study||225||
48508042|NCT02302716|101580030|FG000|NOT COMPLETED|Overall Study||19||
48508043|NCT02302716|101580031|FG001|NOT COMPLETED|Overall Study||19||
48508044|NCT04668274|101580032|FG000|STARTED|Part 1 Study Period 1||21||
48508045|NCT04668274|101580033|FG001|STARTED|Part 1 Study Period 1||0||
48508046|NCT04668274|101580034|FG002|STARTED|Part 1 Study Period 1||0||
48508047|NCT04668274|101580035|FG003|STARTED|Part 1 Study Period 1||0||
48508048|NCT04668274|101580032|FG000|COMPLETED|Part 1 Study Period 1||16||
48508049|NCT04668274|101580033|FG001|COMPLETED|Part 1 Study Period 1||0||
48508050|NCT04668274|101580034|FG002|COMPLETED|Part 1 Study Period 1||0||
48508051|NCT04668274|101580035|FG003|COMPLETED|Part 1 Study Period 1||0||
48508052|NCT04668274|101580032|FG000|NOT COMPLETED|Part 1 Study Period 1||5||
48508053|NCT04668274|101580033|FG001|NOT COMPLETED|Part 1 Study Period 1||0||
48508054|NCT04668274|101580034|FG002|NOT COMPLETED|Part 1 Study Period 1||0||
48508055|NCT04668274|101580035|FG003|NOT COMPLETED|Part 1 Study Period 1||0||
48508056|NCT04668274|101580032|FG000|STARTED|Part 1 Study Period 2||0||
48508057|NCT04668274|101580033|FG001|STARTED|Part 1 Study Period 2||16||
48508058|NCT04668274|101580034|FG002|STARTED|Part 1 Study Period 2||0||
48508059|NCT04668274|101580035|FG003|STARTED|Part 1 Study Period 2||0||
48508060|NCT04668274|101580032|FG000|COMPLETED|Part 1 Study Period 2||0||
48508061|NCT04668274|101580033|FG001|COMPLETED|Part 1 Study Period 2||15||
48508062|NCT04668274|101580034|FG002|COMPLETED|Part 1 Study Period 2||0||
48508063|NCT04668274|101580035|FG003|COMPLETED|Part 1 Study Period 2||0||
48508064|NCT04668274|101580032|FG000|NOT COMPLETED|Part 1 Study Period 2||0||
48508065|NCT04668274|101580033|FG001|NOT COMPLETED|Part 1 Study Period 2||1||
48508066|NCT04668274|101580034|FG002|NOT COMPLETED|Part 1 Study Period 2||0||
48508067|NCT04668274|101580035|FG003|NOT COMPLETED|Part 1 Study Period 2||0||
48508068|NCT04668274|101580032|FG000|STARTED|Part 1 Study Period 3||0||
48508069|NCT04668274|101580033|FG001|STARTED|Part 1 Study Period 3||0||
48508070|NCT04668274|101580034|FG002|STARTED|Part 1 Study Period 3||18||
48508071|NCT04668274|101580035|FG003|STARTED|Part 1 Study Period 3||0||
48508072|NCT04668274|101580032|FG000|COMPLETED|Part 1 Study Period 3||0||
48508073|NCT04668274|101580033|FG001|COMPLETED|Part 1 Study Period 3||0||
48508074|NCT04668274|101580034|FG002|COMPLETED|Part 1 Study Period 3||15||
48508075|NCT04668274|101580035|FG003|COMPLETED|Part 1 Study Period 3||0||
48508076|NCT04668274|101580032|FG000|NOT COMPLETED|Part 1 Study Period 3||0||
48508077|NCT04668274|101580033|FG001|NOT COMPLETED|Part 1 Study Period 3||0||
48508078|NCT04668274|101580034|FG002|NOT COMPLETED|Part 1 Study Period 3||3||
48508079|NCT04668274|101580035|FG003|NOT COMPLETED|Part 1 Study Period 3||0||
48508080|NCT04668274|101580032|FG000|STARTED|Part 2 Study Period 4||0||
48508081|NCT04668274|101580033|FG001|STARTED|Part 2 Study Period 4||0||
48508082|NCT04668274|101580034|FG002|STARTED|Part 2 Study Period 4||0||
48508083|NCT04668274|101580035|FG003|STARTED|Part 2 Study Period 4||15||
48508084|NCT04668274|101580032|FG000|COMPLETED|Part 2 Study Period 4||0||
48508085|NCT04668274|101580033|FG001|COMPLETED|Part 2 Study Period 4||0||
48508086|NCT04668274|101580034|FG002|COMPLETED|Part 2 Study Period 4||0||
48508087|NCT04668274|101580035|FG003|COMPLETED|Part 2 Study Period 4||14||
48508088|NCT04668274|101580032|FG000|NOT COMPLETED|Part 2 Study Period 4||0||
48508089|NCT04668274|101580033|FG001|NOT COMPLETED|Part 2 Study Period 4||0||
48508090|NCT04668274|101580034|FG002|NOT COMPLETED|Part 2 Study Period 4||0||
48508091|NCT04668274|101580035|FG003|NOT COMPLETED|Part 2 Study Period 4||1||
48508092|NCT00857818|101580036|FG000|STARTED|Overall Study||14||
48508093|NCT00857818|101580037|FG001|STARTED|Overall Study||14||
48508094|NCT00857818|101580036|FG000|Received Treatment|Overall Study||14||
48508095|NCT00857818|101580037|FG001|Received Treatment|Overall Study||12||
48508096|NCT00857818|101580036|FG000|COMPLETED|Overall Study||3||
48508097|NCT00857818|101580037|FG001|COMPLETED|Overall Study||6||
48508098|NCT00857818|101580036|FG000|NOT COMPLETED|Overall Study||11||
48508099|NCT00857818|101580037|FG001|NOT COMPLETED|Overall Study||8||
48508100|NCT02762994|101580038|FG000|STARTED|Overall Study||31||
48508101|NCT02762994|101580039|FG001|STARTED|Overall Study||31||
48508102|NCT02762994|101580040|FG002|STARTED|Overall Study||30||
48508103|NCT02762994|101580041|FG003|STARTED|Overall Study||28||
48508104|NCT02762994|101580038|FG000|COMPLETED|Overall Study||30||
48508105|NCT02762994|101580039|FG001|COMPLETED|Overall Study||30||
48508106|NCT02762994|101580040|FG002|COMPLETED|Overall Study||28||
48508107|NCT02762994|101580041|FG003|COMPLETED|Overall Study||26||
48508108|NCT02762994|101580038|FG000|NOT COMPLETED|Overall Study||1||
48508109|NCT02762994|101580039|FG001|NOT COMPLETED|Overall Study||1||
48508110|NCT02762994|101580040|FG002|NOT COMPLETED|Overall Study||2||
48508111|NCT02762994|101580041|FG003|NOT COMPLETED|Overall Study||2||
48508112|NCT00003404|101580042|FG000|STARTED|Overall Study||46||
48508113|NCT00003404|101580042|FG000|COMPLETED|Overall Study||46||
48508114|NCT00003404|101580042|FG000|NOT COMPLETED|Overall Study||0||
48508115|NCT02913131|101580043|FG000|STARTED|Overall Study||18||
48508116|NCT02913131|101580044|FG001|STARTED|Overall Study||5||
48508117|NCT02913131|101580043|FG000|COMPLETED|Overall Study||18||
48508118|NCT02913131|101580044|FG001|COMPLETED|Overall Study||5||
48508119|NCT02913131|101580043|FG000|NOT COMPLETED|Overall Study||0||
48508120|NCT02913131|101580044|FG001|NOT COMPLETED|Overall Study||0||
48508121|NCT05427045|101580045|FG000|STARTED|Overall Study||7||
48508122|NCT05427045|101580045|FG000|COMPLETED|Overall Study||1||
48508123|NCT05427045|101580045|FG000|NOT COMPLETED|Overall Study||6||
48508124|NCT02020967|101580046|FG000|STARTED|Overall Study||367||
48508125|NCT02020967|101580046|FG000|Examined Participants|Overall Study||329||
48508126|NCT02020967|101580046|FG000|COMPLETED|Overall Study||316|Completed Participation in the Survey.|
48508127|NCT02020967|101580046|FG000|NOT COMPLETED|Overall Study||51||
48508128|NCT00603512|101580047|FG000|STARTED|Overall Study||28||
48508129|NCT00603512|101580048|FG001|STARTED|Overall Study||28||
48508130|NCT00603512|101580049|FG002|STARTED|Overall Study||28||
48508131|NCT00603512|101580050|FG003|STARTED|Overall Study||28||
48508132|NCT00603512|101580051|FG004|STARTED|Overall Study||28||
48508133|NCT00603512|101580047|FG000|Treated|Overall Study||28||
48508134|NCT00603512|101580048|FG001|Treated|Overall Study||27||
48508135|NCT00603512|101580049|FG002|Treated|Overall Study||27||
48508136|NCT00603512|101580050|FG003|Treated|Overall Study||26||
48508137|NCT00603512|101580051|FG004|Treated|Overall Study||28||
48508138|NCT00603512|101580047|FG000|COMPLETED|Overall Study||26||
48508139|NCT00603512|101580048|FG001|COMPLETED|Overall Study||23||
48508140|NCT00603512|101580049|FG002|COMPLETED|Overall Study||23||
48508141|NCT00603512|101580050|FG003|COMPLETED|Overall Study||21||
48508142|NCT00603512|101580051|FG004|COMPLETED|Overall Study||23||
48508143|NCT00603512|101580047|FG000|NOT COMPLETED|Overall Study||2||
48508144|NCT00603512|101580048|FG001|NOT COMPLETED|Overall Study||5||
48508145|NCT00603512|101580049|FG002|NOT COMPLETED|Overall Study||5||
48508146|NCT00603512|101580050|FG003|NOT COMPLETED|Overall Study||7||
48508147|NCT00603512|101580051|FG004|NOT COMPLETED|Overall Study||5||
48508148|NCT02339740|101580052|FG000|STARTED|Overall Study||101||
48508149|NCT02339740|101580053|FG001|STARTED|Overall Study||57||
48508150|NCT02339740|101580052|FG000|COMPLETED|Overall Study||92||
48508151|NCT02339740|101580053|FG001|COMPLETED|Overall Study||53||
48508152|NCT02339740|101580052|FG000|NOT COMPLETED|Overall Study||9||
48508153|NCT02339740|101580053|FG001|NOT COMPLETED|Overall Study||4||
48508154|NCT01662024|101580054|FG000|STARTED|Overall Study||20||
48508155|NCT01662024|101580054|FG000|COMPLETED|Overall Study||15||
48508156|NCT01662024|101580054|FG000|NOT COMPLETED|Overall Study||5||
48508157|NCT00697801|101580055|FG000|STARTED|Overall Study||69||
48508158|NCT00697801|101580056|FG001|STARTED|Overall Study||70||
48508159|NCT00697801|101580057|FG002|STARTED|Overall Study||69||
48508160|NCT00697801|101580055|FG000|COMPLETED|Overall Study||57||
48508161|NCT00697801|101580056|FG001|COMPLETED|Overall Study||58||
48508162|NCT00697801|101580057|FG002|COMPLETED|Overall Study||45||
48508163|NCT00697801|101580055|FG000|NOT COMPLETED|Overall Study||12||
48508164|NCT00697801|101580056|FG001|NOT COMPLETED|Overall Study||12||
48508165|NCT00697801|101580057|FG002|NOT COMPLETED|Overall Study||24||
48508166|NCT02460835|101580058|FG000|STARTED|Overall Study||77||
48508167|NCT02460835|101580058|FG000|COMPLETED|Overall Study||56||
48508168|NCT02460835|101580058|FG000|NOT COMPLETED|Overall Study||21||
48508169|NCT03429049|101580059|FG000|STARTED|Overall Study||138||
48508170|NCT03429049|101580060|FG001|STARTED|Overall Study||194||
48508171|NCT03429049|101580059|FG000|Treated|Overall Study||136||
48508172|NCT03429049|101580060|FG001|Treated|Overall Study||189||
48508173|NCT03429049|101580059|FG000|COMPLETED|Overall Study||110||
48508174|NCT03429049|101580060|FG001|COMPLETED|Overall Study||152||
48508175|NCT03429049|101580059|FG000|NOT COMPLETED|Overall Study||28||
48508176|NCT03429049|101580060|FG001|NOT COMPLETED|Overall Study||42||
48508177|NCT01086228|101580061|FG000|STARTED|8 Month Follow-up||2009||
48508178|NCT01086228|101580061|FG000|COMPLETED|8 Month Follow-up||1938||
48508179|NCT01086228|101580061|FG000|NOT COMPLETED|8 Month Follow-up||71||
48508180|NCT01086228|101580061|FG000|STARTED|1-year Follow-up||1938||
48508181|NCT01086228|101580061|FG000|COMPLETED|1-year Follow-up||1894||
48508182|NCT01086228|101580061|FG000|NOT COMPLETED|1-year Follow-up||44||
48508183|NCT01086228|101580061|FG000|STARTED|2-year Follow-up||1894||
48508184|NCT01086228|101580061|FG000|COMPLETED|2-year Follow-up||1834||
48508185|NCT01086228|101580061|FG000|NOT COMPLETED|2-year Follow-up||60||
48508186|NCT01086228|101580061|FG000|STARTED|3-year Follow-up||1834||
48508187|NCT01086228|101580061|FG000|COMPLETED|3-year Follow-up||1767||
48508188|NCT01086228|101580061|FG000|NOT COMPLETED|3-year Follow-up||67||
48508189|NCT01086228|101580061|FG000|STARTED|4-year Follow-up||1767||
48508190|NCT01086228|101580061|FG000|COMPLETED|4-year Follow-up||1664||
48508191|NCT01086228|101580061|FG000|NOT COMPLETED|4-year Follow-up||103||
48508192|NCT01086228|101580061|FG000|STARTED|5-year Follow-up||1664||
48508193|NCT01086228|101580061|FG000|COMPLETED|5-year Follow-up||1012||
48062481|NCT01461980|100475433|FG002|STARTED|Overall Study||882||
48062482|NCT01461980|100475431|FG000|Vaccination 1|Overall Study||884||
48062483|NCT01461980|100475432|FG001|Vaccination 1|Overall Study||870||
48062484|NCT01461980|100475433|FG002|Vaccination 1|Overall Study||875||
48062485|NCT01461980|100475431|FG000|Vaccination 2|Overall Study||802||
48062486|NCT01461980|100475432|FG001|Vaccination 2|Overall Study||819||
48062487|NCT01461980|100475433|FG002|Vaccination 2|Overall Study||799||
48062488|NCT01461980|100475431|FG000|Vaccination 3|Overall Study||757||
48218552|NCT03476798|100860329|FG000|NOT COMPLETED|Overall Study||5||
48218553|NCT03801148|100860330|FG000|STARTED|Period 1 (2 Days)||31||
48218554|NCT03801148|100860331|FG001|STARTED|Period 1 (2 Days)||31||
48218555|NCT03801148|100860332|FG002|STARTED|Period 1 (2 Days)||30||
48508194|NCT01086228|101580061|FG000|NOT COMPLETED|5-year Follow-up||652||
48508195|NCT00880334|101580062|FG000|STARTED|Randomized Phase||74||
48508196|NCT00880334|101580063|FG001|STARTED|Randomized Phase||75||
48508197|NCT00880334|101580062|FG000|Eligible & Treated|Randomized Phase||70||
48508198|NCT00880334|101580063|FG001|Eligible & Treated|Randomized Phase||72||
48508199|NCT00880334|101580062|FG000|COMPLETED|Randomized Phase||70||
48062489|NCT01461980|100475432|FG001|Vaccination 3|Overall Study||777||
48062490|NCT01461980|100475433|FG002|Vaccination 3|Overall Study||748||
48062491|NCT01461980|100475431|FG000|COMPLETED|Overall Study||722||
48062492|NCT01461980|100475432|FG001|COMPLETED|Overall Study||733||
48062493|NCT01461980|100475433|FG002|COMPLETED|Overall Study||717||
48062494|NCT01461980|100475431|FG000|NOT COMPLETED|Overall Study||166||
48062495|NCT01461980|100475432|FG001|NOT COMPLETED|Overall Study||145||
48062496|NCT01461980|100475433|FG002|NOT COMPLETED|Overall Study||165||
48062497|NCT01051466|100475434|FG000|STARTED|Overall Study||32||
48062498|NCT01051466|100475435|FG001|STARTED|Overall Study||28||
48062499|NCT01051466|100475434|FG000|COMPLETED|Overall Study||24||
48062500|NCT01051466|100475435|FG001|COMPLETED|Overall Study||23||
48062501|NCT01051466|100475434|FG000|NOT COMPLETED|Overall Study||8||
48062502|NCT01051466|100475435|FG001|NOT COMPLETED|Overall Study||5||
48062503|NCT03875768|100475436|FG000|STARTED|Overall Study||150||
48062504|NCT03875768|100475437|FG001|STARTED|Overall Study||151||
48062505|NCT03875768|100475436|FG000|COMPLETED|Overall Study||102||
48062506|NCT03875768|100475437|FG001|COMPLETED|Overall Study||105||
48062507|NCT03875768|100475436|FG000|NOT COMPLETED|Overall Study||48||
48062508|NCT03875768|100475437|FG001|NOT COMPLETED|Overall Study||46||
48062509|NCT04676412|100475438|FG000|STARTED|Overall Study||49||
48062510|NCT04676412|100475439|FG001|STARTED|Overall Study||58||
48062511|NCT04676412|100475438|FG000|COMPLETED|Overall Study||0||
48062512|NCT04676412|100475439|FG001|COMPLETED|Overall Study||0||
48062513|NCT04676412|100475438|FG000|NOT COMPLETED|Overall Study||49||
48062514|NCT04676412|100475439|FG001|NOT COMPLETED|Overall Study||58||
48062515|NCT01262573|100475440|FG000|STARTED|Overall Study||32||
48062516|NCT01262573|100475441|FG001|STARTED|Overall Study||32||
48062517|NCT01262573|100475440|FG000|COMPLETED|Overall Study||32||
48062518|NCT01262573|100475441|FG001|COMPLETED|Overall Study||31||
48062519|NCT01262573|100475440|FG000|NOT COMPLETED|Overall Study||0||
48062520|NCT01262573|100475441|FG001|NOT COMPLETED|Overall Study||1||
48062521|NCT01318642|100475442|FG000|STARTED|Overall Study||5||
48062522|NCT01318642|100475443|FG001|STARTED|Overall Study||3||
48062523|NCT01318642|100475442|FG000|COMPLETED|Overall Study||5|Completed defined as receiving at least one dose of study drug.|
48062524|NCT01318642|100475443|FG001|COMPLETED|Overall Study||3|Completed defined as receiving at least one dose of study drug.|
48062525|NCT01318642|100475442|FG000|NOT COMPLETED|Overall Study||0||
48062526|NCT01318642|100475443|FG001|NOT COMPLETED|Overall Study||0||
48062527|NCT02910362|100475444|FG000|STARTED|Overall Study||8||16
48062528|NCT02910362|100475445|FG001|STARTED|Overall Study||7||14
48062529|NCT02910362|100475444|FG000|COMPLETED|Overall Study||8||16
48062530|NCT02910362|100475445|FG001|COMPLETED|Overall Study||7||14
48062531|NCT02910362|100475444|FG000|NOT COMPLETED|Overall Study||0||0
48062532|NCT02910362|100475445|FG001|NOT COMPLETED|Overall Study||0||0
48062533|NCT00611533|100475446|FG000|STARTED|First Intervention (6 Weeks)||8||
48062534|NCT00611533|100475447|FG001|STARTED|First Intervention (6 Weeks)||8||
48062535|NCT00611533|100475446|FG000|COMPLETED|First Intervention (6 Weeks)||8||
48062536|NCT00611533|100475447|FG001|COMPLETED|First Intervention (6 Weeks)||6||
48062537|NCT00611533|100475446|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0||
48062538|NCT00611533|100475447|FG001|NOT COMPLETED|First Intervention (6 Weeks)||2||
48062539|NCT00611533|100475446|FG000|STARTED|Second Intervention (6 Weeks)||8||
48062540|NCT00611533|100475447|FG001|STARTED|Second Intervention (6 Weeks)||6||
48062541|NCT00611533|100475446|FG000|COMPLETED|Second Intervention (6 Weeks)||8||
48062542|NCT00611533|100475447|FG001|COMPLETED|Second Intervention (6 Weeks)||4||
48062543|NCT00611533|100475446|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0||
48062544|NCT00611533|100475447|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||2||
48062545|NCT00745940|100475448|FG000|STARTED|Overall Study||57||
48062546|NCT00745940|100475449|FG001|STARTED|Overall Study||48||
48062547|NCT00745940|100475448|FG000|COMPLETED|Overall Study||38||
48062548|NCT00745940|100475449|FG001|COMPLETED|Overall Study||38||
48062549|NCT00745940|100475448|FG000|NOT COMPLETED|Overall Study||19||
48062550|NCT00745940|100475449|FG001|NOT COMPLETED|Overall Study||10||
48062551|NCT01386008|100475450|FG000|STARTED|Overall Study||20||
48062552|NCT01386008|100475450|FG000|COMPLETED|Overall Study||0||
48062553|NCT01386008|100475450|FG000|NOT COMPLETED|Overall Study||20||
48062554|NCT01021306|100475451|FG000|STARTED|2 Month (Primary Outcome)||20||
48062555|NCT01021306|100475452|FG001|STARTED|2 Month (Primary Outcome)||20||
48508200|NCT00880334|101580063|FG001|COMPLETED|Randomized Phase||35||
48062556|NCT01021306|100475453|FG002|STARTED|2 Month (Primary Outcome)||19||
48062557|NCT01021306|100475454|FG003|STARTED|2 Month (Primary Outcome)||21||
48062558|NCT01021306|100475451|FG000|COMPLETED|2 Month (Primary Outcome)||14||
48062559|NCT01021306|100475452|FG001|COMPLETED|2 Month (Primary Outcome)||14||
48062560|NCT01021306|100475453|FG002|COMPLETED|2 Month (Primary Outcome)||14||
48062561|NCT01021306|100475454|FG003|COMPLETED|2 Month (Primary Outcome)||17||
48062562|NCT01021306|100475451|FG000|NOT COMPLETED|2 Month (Primary Outcome)||6||
48062563|NCT01021306|100475452|FG001|NOT COMPLETED|2 Month (Primary Outcome)||6||
48062564|NCT01021306|100475453|FG002|NOT COMPLETED|2 Month (Primary Outcome)||5||
48062565|NCT01021306|100475454|FG003|NOT COMPLETED|2 Month (Primary Outcome)||4||
48062566|NCT01021306|100475451|FG000|STARTED|6 Month (Follow-up)||14||
48062567|NCT01021306|100475452|FG001|STARTED|6 Month (Follow-up)||14||
48062568|NCT01021306|100475453|FG002|STARTED|6 Month (Follow-up)||14||
48062569|NCT01021306|100475454|FG003|STARTED|6 Month (Follow-up)||17||
48508201|NCT00880334|101580062|FG000|NOT COMPLETED|Randomized Phase||4||
48508202|NCT00880334|101580063|FG001|NOT COMPLETED|Randomized Phase||40||
48508203|NCT00880334|101580062|FG000|STARTED|Crossover Phase||0||
48508204|NCT00880334|101580063|FG001|STARTED|Crossover Phase||37||
48062570|NCT01021306|100475451|FG000|COMPLETED|6 Month (Follow-up)||11||
48062571|NCT01021306|100475452|FG001|COMPLETED|6 Month (Follow-up)||13||
48062572|NCT01021306|100475453|FG002|COMPLETED|6 Month (Follow-up)||14||
48062573|NCT01021306|100475454|FG003|COMPLETED|6 Month (Follow-up)||14||
48062574|NCT01021306|100475451|FG000|NOT COMPLETED|6 Month (Follow-up)||3||
48062575|NCT01021306|100475452|FG001|NOT COMPLETED|6 Month (Follow-up)||1||
48062576|NCT01021306|100475453|FG002|NOT COMPLETED|6 Month (Follow-up)||0||
48062577|NCT01021306|100475454|FG003|NOT COMPLETED|6 Month (Follow-up)||3||
48062578|NCT00331422|100475455|FG000|STARTED|Overall Study||7||
48062579|NCT00331422|100475455|FG000|COMPLETED|Overall Study||2||
48062580|NCT00331422|100475455|FG000|NOT COMPLETED|Overall Study||5||
48062581|NCT01898208|100475456|FG000|STARTED|Overall Study||247||
48062582|NCT01898208|100475457|FG001|STARTED|Overall Study||247||
48062583|NCT01898208|100475458|FG002|STARTED|Overall Study||249||
48062584|NCT01898208|100475456|FG000|COMPLETED|Overall Study||207||
48062585|NCT01898208|100475457|FG001|COMPLETED|Overall Study||198||
48062586|NCT01898208|100475458|FG002|COMPLETED|Overall Study||212||
48062587|NCT01898208|100475456|FG000|NOT COMPLETED|Overall Study||40||
48508205|NCT00880334|101580062|FG000|COMPLETED|Crossover Phase||0||
48508206|NCT00880334|101580063|FG001|COMPLETED|Crossover Phase||37||
48062588|NCT01898208|100475457|FG001|NOT COMPLETED|Overall Study||49||
48062589|NCT01898208|100475458|FG002|NOT COMPLETED|Overall Study||37||
48062590|NCT00973674|100475459|FG000|STARTED|Overall Study||24||
48062591|NCT00973674|100475460|FG001|STARTED|Overall Study||26||
48062592|NCT00973674|100475459|FG000|COMPLETED|Overall Study||22||
48062593|NCT00973674|100475460|FG001|COMPLETED|Overall Study||26||
48062594|NCT00973674|100475459|FG000|NOT COMPLETED|Overall Study||2||
48062595|NCT00973674|100475460|FG001|NOT COMPLETED|Overall Study||0||
48062596|NCT03783975|100475461|FG000|STARTED|Overall Study||131||
48062597|NCT03783975|100475461|FG000|COMPLETED|Overall Study||131||
48062598|NCT03783975|100475461|FG000|NOT COMPLETED|Overall Study||0||
48062599|NCT03672643|100475462|FG000|STARTED|Overall Study||41||
48062600|NCT03672643|100475462|FG000|COMPLETED|Overall Study||0||
48062601|NCT03672643|100475462|FG000|NOT COMPLETED|Overall Study||41||
48062602|NCT05015530|100475463|FG000|STARTED|Overall Study||12||
48062603|NCT05015530|100475463|FG000|Safety Set|Overall Study||12|All subjects who will have used the investigational medical device at least once.|
48062604|NCT05015530|100475463|FG000|Full Analysis Set (FAS)|Overall Study||12|All subjects from the Safety Set who will have at least one post baseline Sino Nasal Outcome Test-22 (SNOT-22) evaluation.|
48062605|NCT05015530|100475463|FG000|Per Protocol Set (PP)|Overall Study||3|All subjects from the FAS without any major protocol deviation.|
48062606|NCT05015530|100475463|FG000|COMPLETED|Overall Study||12||
48062607|NCT05015530|100475463|FG000|NOT COMPLETED|Overall Study||0||
48062608|NCT03318900|100475464|FG000|STARTED|Overall Study||3||
48062609|NCT03318900|100475465|FG001|STARTED|Overall Study||2||
48062610|NCT03318900|100475466|FG002|STARTED|Overall Study||0||
48062611|NCT03318900|100475464|FG000|COMPLETED|Overall Study||3||
48062612|NCT03318900|100475465|FG001|COMPLETED|Overall Study||2||
48062613|NCT03318900|100475466|FG002|COMPLETED|Overall Study||0||
48062614|NCT03318900|100475464|FG000|NOT COMPLETED|Overall Study||0||
48062615|NCT03318900|100475465|FG001|NOT COMPLETED|Overall Study||0||
48062616|NCT03318900|100475466|FG002|NOT COMPLETED|Overall Study||0||
48062617|NCT03021304|100475467|FG000|STARTED|Overall Study||56||
48062618|NCT03021304|100475467|FG000|COMPLETED|Overall Study||55||
48062619|NCT03021304|100475467|FG000|NOT COMPLETED|Overall Study||1||
48062620|NCT02448810|100475468|FG000|STARTED|Overall Study||3||
48062621|NCT02448810|100475469|FG001|STARTED|Overall Study||3||
48062622|NCT02448810|100475470|FG002|STARTED|Overall Study||3||
48218556|NCT03801148|100860333|FG003|STARTED|Period 1 (2 Days)||30||
48218557|NCT03801148|100860330|FG000|COMPLETED|Period 1 (2 Days)||30||
48218558|NCT03801148|100860331|FG001|COMPLETED|Period 1 (2 Days)||30||
48218559|NCT03801148|100860332|FG002|COMPLETED|Period 1 (2 Days)||30||
48218560|NCT03801148|100860333|FG003|COMPLETED|Period 1 (2 Days)||30||
48218561|NCT03801148|100860330|FG000|NOT COMPLETED|Period 1 (2 Days)||1||
48218562|NCT03801148|100860331|FG001|NOT COMPLETED|Period 1 (2 Days)||1||
48218563|NCT03801148|100860332|FG002|NOT COMPLETED|Period 1 (2 Days)||0||
48218564|NCT03801148|100860333|FG003|NOT COMPLETED|Period 1 (2 Days)||0||
48218565|NCT03801148|100860330|FG000|STARTED|Washout Period (at Least 5 Days)||30||
48218566|NCT03801148|100860331|FG001|STARTED|Washout Period (at Least 5 Days)||30||
48218567|NCT03801148|100860332|FG002|STARTED|Washout Period (at Least 5 Days)||30||
48218568|NCT03801148|100860333|FG003|STARTED|Washout Period (at Least 5 Days)||30||
48218569|NCT03801148|100860330|FG000|COMPLETED|Washout Period (at Least 5 Days)||30||
48218570|NCT03801148|100860331|FG001|COMPLETED|Washout Period (at Least 5 Days)||30||
48218571|NCT03801148|100860332|FG002|COMPLETED|Washout Period (at Least 5 Days)||29||
48218572|NCT03801148|100860333|FG003|COMPLETED|Washout Period (at Least 5 Days)||29||
48218573|NCT03801148|100860330|FG000|NOT COMPLETED|Washout Period (at Least 5 Days)||0||
48218574|NCT03801148|100860331|FG001|NOT COMPLETED|Washout Period (at Least 5 Days)||0||
48218575|NCT03801148|100860332|FG002|NOT COMPLETED|Washout Period (at Least 5 Days)||1||
48218576|NCT03801148|100860333|FG003|NOT COMPLETED|Washout Period (at Least 5 Days)||1||
48218577|NCT03801148|100860330|FG000|STARTED|Period 2 (2 Days)||30||
48218578|NCT03801148|100860331|FG001|STARTED|Period 2 (2 Days)||30||
48218579|NCT03801148|100860332|FG002|STARTED|Period 2 (2 Days)||29||
48218580|NCT03801148|100860333|FG003|STARTED|Period 2 (2 Days)||29||
48218581|NCT03801148|100860330|FG000|COMPLETED|Period 2 (2 Days)||30||
48218582|NCT03801148|100860331|FG001|COMPLETED|Period 2 (2 Days)||30||
48218583|NCT03801148|100860332|FG002|COMPLETED|Period 2 (2 Days)||29||
48218584|NCT03801148|100860333|FG003|COMPLETED|Period 2 (2 Days)||29||
48218585|NCT03801148|100860330|FG000|NOT COMPLETED|Period 2 (2 Days)||0||
48218586|NCT03801148|100860331|FG001|NOT COMPLETED|Period 2 (2 Days)||0||
48218587|NCT03801148|100860332|FG002|NOT COMPLETED|Period 2 (2 Days)||0||
48218588|NCT03801148|100860333|FG003|NOT COMPLETED|Period 2 (2 Days)||0||
48218589|NCT03801148|100860330|FG000|STARTED|Follow-Up (12 Days)||30||
48218590|NCT03801148|100860331|FG001|STARTED|Follow-Up (12 Days)||30||
48218591|NCT03801148|100860332|FG002|STARTED|Follow-Up (12 Days)||29||
48218592|NCT03801148|100860333|FG003|STARTED|Follow-Up (12 Days)||29||
48218593|NCT03801148|100860330|FG000|COMPLETED|Follow-Up (12 Days)||30||
48218594|NCT03801148|100860331|FG001|COMPLETED|Follow-Up (12 Days)||29||
48218595|NCT03801148|100860332|FG002|COMPLETED|Follow-Up (12 Days)||28||
48218596|NCT03801148|100860333|FG003|COMPLETED|Follow-Up (12 Days)||29||
48218597|NCT03801148|100860330|FG000|NOT COMPLETED|Follow-Up (12 Days)||0||
48218598|NCT03801148|100860331|FG001|NOT COMPLETED|Follow-Up (12 Days)||1||
48218599|NCT03801148|100860332|FG002|NOT COMPLETED|Follow-Up (12 Days)||1||
48062623|NCT02448810|100475471|FG003|STARTED|Overall Study||3||
48062624|NCT02448810|100475472|FG004|STARTED|Overall Study||31||
48062625|NCT02448810|100475473|FG005|STARTED|Overall Study||16||
48062626|NCT02448810|100475474|FG006|STARTED|Overall Study||18||
48062627|NCT02448810|100475475|FG007|STARTED|Overall Study||8||
48062628|NCT02448810|100475468|FG000|Treated|Overall Study||3||
48062629|NCT02448810|100475469|FG001|Treated|Overall Study||3||
48062630|NCT02448810|100475470|FG002|Treated|Overall Study||3||
48062631|NCT02448810|100475471|FG003|Treated|Overall Study||3||
48062632|NCT02448810|100475472|FG004|Treated|Overall Study||29||
48062633|NCT02448810|100475473|FG005|Treated|Overall Study||13||
48062634|NCT02448810|100475474|FG006|Treated|Overall Study||18||
48062635|NCT02448810|100475475|FG007|Treated|Overall Study||7||
48062636|NCT02448810|100475468|FG000|COMPLETED|Overall Study||0||
48062637|NCT02448810|100475469|FG001|COMPLETED|Overall Study||0||
48062638|NCT02448810|100475470|FG002|COMPLETED|Overall Study||0||
48062639|NCT02448810|100475471|FG003|COMPLETED|Overall Study||0||
48062640|NCT02448810|100475472|FG004|COMPLETED|Overall Study||0||
48062641|NCT02448810|100475473|FG005|COMPLETED|Overall Study||0||
48062642|NCT02448810|100475474|FG006|COMPLETED|Overall Study||0||
48062643|NCT02448810|100475475|FG007|COMPLETED|Overall Study||0||
48062644|NCT02448810|100475468|FG000|NOT COMPLETED|Overall Study||3||
48062645|NCT02448810|100475469|FG001|NOT COMPLETED|Overall Study||3||
48062646|NCT02448810|100475470|FG002|NOT COMPLETED|Overall Study||3||
48062647|NCT02448810|100475471|FG003|NOT COMPLETED|Overall Study||3||
48062648|NCT02448810|100475472|FG004|NOT COMPLETED|Overall Study||31||
48062649|NCT02448810|100475473|FG005|NOT COMPLETED|Overall Study||16||
48062650|NCT02448810|100475474|FG006|NOT COMPLETED|Overall Study||18||
48062651|NCT02448810|100475475|FG007|NOT COMPLETED|Overall Study||8||
48062652|NCT04517500|100475476|FG000|STARTED|Overall Study||48||
48062653|NCT04517500|100475477|FG001|STARTED|Overall Study||51||
48062654|NCT04517500|100475476|FG000|COMPLETED|Overall Study||48||
48062655|NCT04517500|100475477|FG001|COMPLETED|Overall Study||51||
48062656|NCT04517500|100475476|FG000|NOT COMPLETED|Overall Study||0||
48062657|NCT04517500|100475477|FG001|NOT COMPLETED|Overall Study||0||
48062658|NCT01484041|100475478|FG000|STARTED|Overall Study||12||
48062659|NCT01484041|100475478|FG000|COMPLETED|Overall Study||12||
48062660|NCT01484041|100475478|FG000|NOT COMPLETED|Overall Study||0||
48062661|NCT01466179|100475479|FG000|STARTED|Overall Study||189||
48062662|NCT01466179|100475479|FG000|COMPLETED|Overall Study||10||
48062663|NCT01466179|100475479|FG000|NOT COMPLETED|Overall Study||179||
48062664|NCT00723398|100475480|FG000|STARTED|Overall Study||53||
48062665|NCT00723398|100475481|FG001|STARTED|Overall Study||53||
48062666|NCT00723398|100475482|FG002|STARTED|Overall Study||53||
48062667|NCT00723398|100475483|FG003|STARTED|Overall Study||54||
48062668|NCT00723398|100475484|FG004|STARTED|Overall Study||53||
48062669|NCT00723398|100475480|FG000|COMPLETED|Overall Study||47||
48062670|NCT00723398|100475481|FG001|COMPLETED|Overall Study||38||
48062671|NCT00723398|100475482|FG002|COMPLETED|Overall Study||36||
48062672|NCT00723398|100475483|FG003|COMPLETED|Overall Study||49||
48062673|NCT00723398|100475484|FG004|COMPLETED|Overall Study||44||
48062674|NCT00723398|100475480|FG000|NOT COMPLETED|Overall Study||6||
48062675|NCT00723398|100475481|FG001|NOT COMPLETED|Overall Study||15||
48062676|NCT00723398|100475482|FG002|NOT COMPLETED|Overall Study||17||
48062677|NCT00723398|100475483|FG003|NOT COMPLETED|Overall Study||5||
48062678|NCT00723398|100475484|FG004|NOT COMPLETED|Overall Study||9||
48062679|NCT02298023|100475485|FG000|STARTED|Overall Study||8||
48062680|NCT02298023|100475486|FG001|STARTED|Overall Study||8||
48062681|NCT02298023|100475487|FG002|STARTED|Overall Study||8||
48062682|NCT02298023|100475485|FG000|Intervention|Overall Study||7||
48062683|NCT02298023|100475486|FG001|Intervention|Overall Study||8||
48062684|NCT02298023|100475487|FG002|Intervention|Overall Study||8||
48062685|NCT02298023|100475485|FG000|COMPLETED|Overall Study||7||
48062686|NCT02298023|100475486|FG001|COMPLETED|Overall Study||8||
48062687|NCT02298023|100475487|FG002|COMPLETED|Overall Study||8||
48062688|NCT02298023|100475485|FG000|NOT COMPLETED|Overall Study||1||
48062689|NCT02298023|100475486|FG001|NOT COMPLETED|Overall Study||0||
48062690|NCT02298023|100475487|FG002|NOT COMPLETED|Overall Study||0||
48062691|NCT02913612|100475488|FG000|STARTED|Overall Study||44||
48062692|NCT02913612|100475489|FG001|STARTED|Overall Study||51||
48062693|NCT02913612|100475490|FG002|STARTED|Overall Study||10||
48062694|NCT02913612|100475491|FG003|STARTED|Overall Study||36||
48062695|NCT02913612|100475488|FG000|COMPLETED|Overall Study||32||
48062696|NCT02913612|100475489|FG001|COMPLETED|Overall Study||33||
48062697|NCT02913612|100475490|FG002|COMPLETED|Overall Study||7||
48062698|NCT02913612|100475491|FG003|COMPLETED|Overall Study||36||
48062699|NCT02913612|100475488|FG000|NOT COMPLETED|Overall Study||12||
48062700|NCT02913612|100475489|FG001|NOT COMPLETED|Overall Study||18||
48062701|NCT02913612|100475490|FG002|NOT COMPLETED|Overall Study||3||
48062702|NCT02913612|100475491|FG003|NOT COMPLETED|Overall Study||0||
48062703|NCT01180647|100475492|FG000|STARTED|Overall Study||17||
48062704|NCT01180647|100475493|FG001|STARTED|Overall Study||17||
48062705|NCT01180647|100475492|FG000|COMPLETED|Overall Study||12||
48062706|NCT01180647|100475493|FG001|COMPLETED|Overall Study||11||
48062707|NCT01180647|100475492|FG000|NOT COMPLETED|Overall Study||5||
48062708|NCT01180647|100475493|FG001|NOT COMPLETED|Overall Study||6||
48062709|NCT00467857|100475494|FG000|STARTED|Overall Study||146||
48062710|NCT00467857|100475495|FG001|STARTED|Overall Study||147||
48062711|NCT00467857|100475494|FG000|COMPLETED|Overall Study||143||
48062712|NCT00467857|100475495|FG001|COMPLETED|Overall Study||139||
48062713|NCT00467857|100475494|FG000|NOT COMPLETED|Overall Study||3||
48062714|NCT00467857|100475495|FG001|NOT COMPLETED|Overall Study||8||
48062715|NCT05021081|100475496|FG000|STARTED|Phase 1||0||0
48062716|NCT05021081|100475497|FG001|STARTED|Phase 1||0||0
48062717|NCT05021081|100475498|FG002|STARTED|Phase 1||20||40
48062718|NCT05021081|100475496|FG000|COMPLETED|Phase 1||0||0
48062719|NCT05021081|100475497|FG001|COMPLETED|Phase 1||0||0
48062720|NCT05021081|100475498|FG002|COMPLETED|Phase 1||20||40
48062721|NCT05021081|100475496|FG000|NOT COMPLETED|Phase 1||0||0
48062722|NCT05021081|100475497|FG001|NOT COMPLETED|Phase 1||0||0
48062723|NCT05021081|100475498|FG002|NOT COMPLETED|Phase 1||0||0
48062724|NCT05021081|100475496|FG000|STARTED|Phase 2||31||62
48062725|NCT05021081|100475497|FG001|STARTED|Phase 2||31||62
48062726|NCT05021081|100475498|FG002|STARTED|Phase 2||0||0
48062727|NCT05021081|100475496|FG000|COMPLETED|Phase 2||30||60
48062728|NCT05021081|100475497|FG001|COMPLETED|Phase 2||30||60
48062729|NCT05021081|100475498|FG002|COMPLETED|Phase 2||0||0
48062730|NCT05021081|100475496|FG000|NOT COMPLETED|Phase 2||1||2
48062731|NCT05021081|100475497|FG001|NOT COMPLETED|Phase 2||1||2
48062732|NCT05021081|100475498|FG002|NOT COMPLETED|Phase 2||0||0
48062733|NCT01281137|100475499|FG000|STARTED|Baseline Population||25||
48062734|NCT01281137|100475500|FG001|STARTED|Baseline Population||79||
48062735|NCT01281137|100475499|FG000|COMPLETED|Baseline Population||25||
48062736|NCT01281137|100475500|FG001|COMPLETED|Baseline Population||78||
48062737|NCT01281137|100475499|FG000|NOT COMPLETED|Baseline Population||0||
48062738|NCT01281137|100475500|FG001|NOT COMPLETED|Baseline Population||1||
48062739|NCT01281137|100475499|FG000|STARTED|Analysis Population (Baseline)||25|13 patients excluded from the longitudinal analyses, baseline sample only|
48062740|NCT01281137|100475500|FG001|STARTED|Analysis Population (Baseline)||78|13 patients excluded from the longitudinal analyses, baseline sample only|
48062741|NCT01281137|100475499|FG000|COMPLETED|Analysis Population (Baseline)||21||
48062742|NCT01281137|100475500|FG001|COMPLETED|Analysis Population (Baseline)||69||
48062743|NCT01281137|100475499|FG000|NOT COMPLETED|Analysis Population (Baseline)||4||
48062744|NCT01281137|100475500|FG001|NOT COMPLETED|Analysis Population (Baseline)||9||
48062745|NCT01281137|100475499|FG000|STARTED|Analysis Population (9 Months)||21||
48062746|NCT01281137|100475500|FG001|STARTED|Analysis Population (9 Months)||69||
48062747|NCT01281137|100475499|FG000|COMPLETED|Analysis Population (9 Months)||21||
48062748|NCT01281137|100475500|FG001|COMPLETED|Analysis Population (9 Months)||64||
48062749|NCT01281137|100475499|FG000|NOT COMPLETED|Analysis Population (9 Months)||0||
48062750|NCT01281137|100475500|FG001|NOT COMPLETED|Analysis Population (9 Months)||5||
48062751|NCT01281137|100475499|FG000|STARTED|Analysis Population (10.5 Months)||21||
48062752|NCT01281137|100475500|FG001|STARTED|Analysis Population (10.5 Months)||64||
48062753|NCT01281137|100475499|FG000|COMPLETED|Analysis Population (10.5 Months)||20||
48062754|NCT01281137|100475500|FG001|COMPLETED|Analysis Population (10.5 Months)||64||
48062755|NCT01281137|100475499|FG000|NOT COMPLETED|Analysis Population (10.5 Months)||1||
48062756|NCT01281137|100475500|FG001|NOT COMPLETED|Analysis Population (10.5 Months)||0||
48062757|NCT01281137|100475499|FG000|STARTED|Analysis Population (12 Months)||20||
48062758|NCT01281137|100475500|FG001|STARTED|Analysis Population (12 Months)||64||
48062759|NCT01281137|100475499|FG000|COMPLETED|Analysis Population (12 Months)||19||
48062760|NCT01281137|100475500|FG001|COMPLETED|Analysis Population (12 Months)||62||
48062761|NCT01281137|100475499|FG000|NOT COMPLETED|Analysis Population (12 Months)||1||
48062762|NCT01281137|100475500|FG001|NOT COMPLETED|Analysis Population (12 Months)||2||
48062763|NCT04889222|100475501|FG000|STARTED|Overall Study||54||
48062764|NCT04889222|100475501|FG000|COMPLETED|Overall Study||38||
48062765|NCT04889222|100475501|FG000|NOT COMPLETED|Overall Study||16||
48062766|NCT02600351|100475502|FG000|STARTED|Overall Study||17||
48062767|NCT02600351|100475503|FG001|STARTED|Overall Study||17||
48062768|NCT02600351|100475504|FG002|STARTED|Overall Study||26||
48062769|NCT02600351|100475505|FG003|STARTED|Overall Study||27||
48062770|NCT02600351|100475502|FG000|COMPLETED|Overall Study||12||
48062771|NCT02600351|100475503|FG001|COMPLETED|Overall Study||17||
48062772|NCT02600351|100475504|FG002|COMPLETED|Overall Study||20||
48062773|NCT02600351|100475505|FG003|COMPLETED|Overall Study||22||
48062774|NCT02600351|100475502|FG000|NOT COMPLETED|Overall Study||5||
48062775|NCT02600351|100475503|FG001|NOT COMPLETED|Overall Study||0||
48062776|NCT02600351|100475504|FG002|NOT COMPLETED|Overall Study||6||
48062777|NCT02600351|100475505|FG003|NOT COMPLETED|Overall Study||5||
48062778|NCT05394350|100475506|FG000|STARTED|Overall Study||3||
48062779|NCT05394350|100475507|FG001|STARTED|Overall Study||3||
48062780|NCT05394350|100475508|FG002|STARTED|Overall Study||11||
48062781|NCT05394350|100475509|FG003|STARTED|Overall Study||3||
48062782|NCT05394350|100475510|FG004|STARTED|Overall Study||3||
48062783|NCT05394350|100475511|FG005|STARTED|Overall Study||4||
48218600|NCT03801148|100860333|FG003|NOT COMPLETED|Follow-Up (12 Days)||0||
48062784|NCT05394350|100475506|FG000|Switch Over to MK-1088 100 mg + Pembrolizumab|Overall Study||0||
48062785|NCT05394350|100475507|FG001|Switch Over to MK-1088 100 mg + Pembrolizumab|Overall Study||1||
48062786|NCT05394350|100475508|FG002|Switch Over to MK-1088 100 mg + Pembrolizumab|Overall Study||1||
48062787|NCT05394350|100475509|FG003|Switch Over to MK-1088 100 mg + Pembrolizumab|Overall Study||0||
48062788|NCT05394350|100475510|FG004|Switch Over to MK-1088 100 mg + Pembrolizumab|Overall Study||0||
48062789|NCT05394350|100475511|FG005|Switch Over to MK-1088 100 mg + Pembrolizumab|Overall Study||0||
48062790|NCT05394350|100475506|FG000|COMPLETED|Overall Study||0||
48062791|NCT05394350|100475507|FG001|COMPLETED|Overall Study||0||
48062792|NCT05394350|100475508|FG002|COMPLETED|Overall Study||0||
48062793|NCT05394350|100475509|FG003|COMPLETED|Overall Study||0||
48062794|NCT05394350|100475510|FG004|COMPLETED|Overall Study||0||
48062795|NCT05394350|100475511|FG005|COMPLETED|Overall Study||0||
48062796|NCT05394350|100475506|FG000|NOT COMPLETED|Overall Study||3||
48062797|NCT05394350|100475507|FG001|NOT COMPLETED|Overall Study||3||
48062798|NCT05394350|100475508|FG002|NOT COMPLETED|Overall Study||11||
48062799|NCT05394350|100475509|FG003|NOT COMPLETED|Overall Study||3||
48062800|NCT05394350|100475510|FG004|NOT COMPLETED|Overall Study||3||
48062801|NCT05394350|100475511|FG005|NOT COMPLETED|Overall Study||4||
48062802|NCT05061966|100475512|FG000|STARTED|Overall Study||135||
48062803|NCT05061966|100475513|FG001|STARTED|Overall Study||135||
48062804|NCT05061966|100475512|FG000|COMPLETED|Overall Study||122||
48062805|NCT05061966|100475513|FG001|COMPLETED|Overall Study||122||
48062806|NCT05061966|100475512|FG000|NOT COMPLETED|Overall Study||13||
48062807|NCT05061966|100475513|FG001|NOT COMPLETED|Overall Study||13||
48062808|NCT02282358|100475514|FG000|STARTED|Overall Study||7||
48062809|NCT02282358|100475514|FG000|COMPLETED|Overall Study||6||
48062810|NCT02282358|100475514|FG000|NOT COMPLETED|Overall Study||1||
48062811|NCT03070444|100475515|FG000|STARTED|Overall Study||52||
48062812|NCT03070444|100475516|FG001|STARTED|Overall Study||52||
48062813|NCT03070444|100475515|FG000|COMPLETED|Overall Study||39||
48062814|NCT03070444|100475516|FG001|COMPLETED|Overall Study||35||
48062815|NCT03070444|100475515|FG000|NOT COMPLETED|Overall Study||13||
48062816|NCT03070444|100475516|FG001|NOT COMPLETED|Overall Study||17||
48062817|NCT01719783|100475517|FG000|STARTED|Dose 1||30||
48062818|NCT01719783|100475518|FG001|STARTED|Dose 1||10||
48062819|NCT01719783|100475517|FG000|COMPLETED|Dose 1||30||
48062820|NCT01719783|100475518|FG001|COMPLETED|Dose 1||10||
48062821|NCT01719783|100475517|FG000|NOT COMPLETED|Dose 1||0||
48062822|NCT01719783|100475518|FG001|NOT COMPLETED|Dose 1||0||
48062823|NCT01719783|100475517|FG000|STARTED|Dose 2||30||
48062824|NCT01719783|100475518|FG001|STARTED|Dose 2||10||
48062825|NCT01719783|100475517|FG000|COMPLETED|Dose 2||29||
48062826|NCT01719783|100475518|FG001|COMPLETED|Dose 2||10||
48062827|NCT01719783|100475517|FG000|NOT COMPLETED|Dose 2||1||
48062828|NCT01719783|100475518|FG001|NOT COMPLETED|Dose 2||0||
48062829|NCT00590889|100475519|FG000|STARTED|Overall Study||404||
48062830|NCT00590889|100475520|FG001|STARTED|Overall Study||403||
48062831|NCT00590889|100475519|FG000|COMPLETED|Overall Study||118||
48062832|NCT00590889|100475520|FG001|COMPLETED|Overall Study||104||
48062833|NCT00590889|100475519|FG000|NOT COMPLETED|Overall Study||286||
48062834|NCT00590889|100475520|FG001|NOT COMPLETED|Overall Study||299||
48062835|NCT02617888|100475521|FG000|STARTED|Overall Study||50||
48062836|NCT02617888|100475522|FG001|STARTED|Overall Study||51||
48062837|NCT02617888|100475523|FG002|STARTED|Overall Study||127||
48062838|NCT02617888|100475521|FG000|COMPLETED|Overall Study||49||
48062839|NCT02617888|100475522|FG001|COMPLETED|Overall Study||44||
48062840|NCT02617888|100475523|FG002|COMPLETED|Overall Study||127||
48062841|NCT02617888|100475521|FG000|NOT COMPLETED|Overall Study||1||
48062842|NCT02617888|100475522|FG001|NOT COMPLETED|Overall Study||7||
48062843|NCT02617888|100475523|FG002|NOT COMPLETED|Overall Study||0||
48062844|NCT03800173|100475524|FG000|STARTED|Overall Study||8||
48062845|NCT03800173|100475525|FG001|STARTED|Overall Study||6||
48062846|NCT03800173|100475526|FG002|STARTED|Overall Study||6||
48062847|NCT03800173|100475527|FG003|STARTED|Overall Study||6||
48062848|NCT03800173|100475528|FG004|STARTED|Overall Study||6||
48062849|NCT03800173|100475524|FG000|Safety Population|Overall Study||8|Safety Population includes all subjects who received study drug.|
48062850|NCT03800173|100475525|FG001|Safety Population|Overall Study||6|Safety Population includes all subjects who received study drug.|
48062851|NCT03800173|100475526|FG002|Safety Population|Overall Study||6|Safety Population includes all subjects who received study drug.|
48062852|NCT03800173|100475527|FG003|Safety Population|Overall Study||6|Safety Population includes all subjects who received study drug.|
48062853|NCT03800173|100475528|FG004|Safety Population|Overall Study||6|Safety Population includes all subjects who received study drug.|
48062854|NCT03800173|100475524|FG000|PK Population|Overall Study||0|PK population included all subjects from whom at least 1 galidesivir PK parameter was estimated.|
48062855|NCT03800173|100475525|FG001|PK Population|Overall Study||6|PK population included all subjects from whom at least 1 galidesivir PK parameter was estimated.|
48062856|NCT03800173|100475526|FG002|PK Population|Overall Study||6|PK population included all subjects from whom at least 1 galidesivir PK parameter was estimated.|
48062857|NCT03800173|100475527|FG003|PK Population|Overall Study||6|PK population included all subjects from whom at least 1 galidesivir PK parameter was estimated.|
48062858|NCT03800173|100475528|FG004|PK Population|Overall Study||6|PK population included all subjects from whom at least 1 galidesivir PK parameter was estimated.|
48062859|NCT03800173|100475524|FG000|COMPLETED|Overall Study||8||
48062860|NCT03800173|100475525|FG001|COMPLETED|Overall Study||6||
48062861|NCT03800173|100475526|FG002|COMPLETED|Overall Study||6||
48062862|NCT03800173|100475527|FG003|COMPLETED|Overall Study||6||
48062863|NCT03800173|100475528|FG004|COMPLETED|Overall Study||5||
48062864|NCT03800173|100475524|FG000|NOT COMPLETED|Overall Study||0||
48062865|NCT03800173|100475525|FG001|NOT COMPLETED|Overall Study||0||
48062866|NCT03800173|100475526|FG002|NOT COMPLETED|Overall Study||0||
48062867|NCT03800173|100475527|FG003|NOT COMPLETED|Overall Study||0||
48062868|NCT03800173|100475528|FG004|NOT COMPLETED|Overall Study||1||
48062869|NCT03228420|100475529|FG000|STARTED|Overall Study||113||
48062870|NCT03228420|100475530|FG001|STARTED|Overall Study||103||
48062871|NCT03228420|100475529|FG000|Month-1|Overall Study||95||
48062872|NCT03228420|100475530|FG001|Month-1|Overall Study||101||
48062873|NCT03228420|100475529|FG000|Month-3|Overall Study||93||
48062874|NCT03228420|100475530|FG001|Month-3|Overall Study||98||
48062875|NCT03228420|100475529|FG000|COMPLETED|Overall Study||93||
48062876|NCT03228420|100475530|FG001|COMPLETED|Overall Study||98||
48062877|NCT03228420|100475529|FG000|NOT COMPLETED|Overall Study||20||
48062878|NCT03228420|100475530|FG001|NOT COMPLETED|Overall Study||5||
48062879|NCT01085435|100475531|FG000|STARTED|Overall Study||994|signed consent|
48062880|NCT01085435|100475531|FG000|Baseline|Overall Study||984|implanted \& followed|
48062881|NCT01085435|100475531|FG000|COMPLETED|Overall Study||703||
48062882|NCT01085435|100475531|FG000|NOT COMPLETED|Overall Study||291||
48062883|NCT00107783|100475532|FG000|STARTED|Overall Study||20||
48062884|NCT00107783|100475533|FG001|STARTED|Overall Study||20||
48062885|NCT00107783|100475532|FG000|COMPLETED|Overall Study||17||
48062886|NCT00107783|100475533|FG001|COMPLETED|Overall Study||16||
48062887|NCT00107783|100475532|FG000|NOT COMPLETED|Overall Study||3||
48062888|NCT00107783|100475533|FG001|NOT COMPLETED|Overall Study||4||
48062889|NCT03530800|100475534|FG000|STARTED|Overall Study||25||
48062890|NCT03530800|100475535|FG001|STARTED|Overall Study||25||
48062891|NCT03530800|100475534|FG000|COMPLETED|Overall Study||14||
48062892|NCT03530800|100475535|FG001|COMPLETED|Overall Study||16||
48062893|NCT03530800|100475534|FG000|NOT COMPLETED|Overall Study||11||
48062894|NCT03530800|100475535|FG001|NOT COMPLETED|Overall Study||9||
48062895|NCT00335478|100475536|FG000|STARTED|Overall Study||54||
48062896|NCT00335478|100475536|FG000|COMPLETED|Overall Study||30||
48062897|NCT00335478|100475536|FG000|NOT COMPLETED|Overall Study||24||
48062898|NCT00320931|100475537|FG000|STARTED|Overall Study||30||
48062899|NCT00320931|100475537|FG000|COMPLETED|Overall Study||30||
48062900|NCT00320931|100475537|FG000|NOT COMPLETED|Overall Study||0||
48062901|NCT00722800|100475538|FG000|STARTED|Overall Study||2||
48062902|NCT00722800|100475539|FG001|STARTED|Overall Study||2||
48062903|NCT00722800|100475538|FG000|COMPLETED|Overall Study||0||
48062904|NCT00722800|100475539|FG001|COMPLETED|Overall Study||2||
48062905|NCT00722800|100475538|FG000|NOT COMPLETED|Overall Study||2||
48062906|NCT00722800|100475539|FG001|NOT COMPLETED|Overall Study||0||
48062907|NCT00285818|100475540|FG000|STARTED|Overall Study||6||
48062908|NCT00285818|100475541|FG001|STARTED|Overall Study||5||
48062909|NCT00285818|100475540|FG000|COMPLETED|Overall Study||2||
48062910|NCT00285818|100475541|FG001|COMPLETED|Overall Study||3||
48062911|NCT00285818|100475540|FG000|NOT COMPLETED|Overall Study||4||
48062912|NCT00285818|100475541|FG001|NOT COMPLETED|Overall Study||2||
48062913|NCT02024555|100475542|FG000|STARTED|Overall Study||49||
48062914|NCT02024555|100475543|FG001|STARTED|Overall Study||48||
48062915|NCT02024555|100475542|FG000|COMPLETED|Overall Study||43|includes those who did not complete the entire study drug regime but did complete study visits|
48062916|NCT02024555|100475543|FG001|COMPLETED|Overall Study||46|includes those who did not complete the entire study drug regime but did complete study visits|
48062917|NCT02024555|100475542|FG000|NOT COMPLETED|Overall Study||6||
48062918|NCT02024555|100475543|FG001|NOT COMPLETED|Overall Study||2||
48062919|NCT02020577|100475544|FG000|STARTED|Overall Study||3||
48062920|NCT02020577|100475545|FG001|STARTED|Overall Study||55||
48218601|NCT02345720|100860334|FG000|STARTED|Overall Study||20||
48218602|NCT02345720|100860334|FG000|COMPLETED|Overall Study||20||
48508207|NCT00880334|101580062|FG000|NOT COMPLETED|Crossover Phase||0||
48508208|NCT00880334|101580063|FG001|NOT COMPLETED|Crossover Phase||0||
48508209|NCT04290494|101580064|FG000|STARTED|Overall Study||10968||
48508210|NCT04290494|101580065|FG001|STARTED|Overall Study||17823||
48062921|NCT02020577|100475544|FG000|COMPLETED|Overall Study||0||
48062922|NCT02020577|100475545|FG001|COMPLETED|Overall Study||0||
48062923|NCT02020577|100475544|FG000|NOT COMPLETED|Overall Study||3||
48062924|NCT02020577|100475545|FG001|NOT COMPLETED|Overall Study||55||
48062925|NCT02437513|100475546|FG000|STARTED|Overall Study||2||
48062926|NCT02437513|100475546|FG000|COMPLETED|Overall Study||0||
48062927|NCT02437513|100475546|FG000|NOT COMPLETED|Overall Study||2||
48062928|NCT01044706|100475547|FG000|STARTED|Overall Study||30||
48062929|NCT01044706|100475548|FG001|STARTED|Overall Study||30||
48062930|NCT01044706|100475547|FG000|COMPLETED|Overall Study||30||
48062931|NCT01044706|100475548|FG001|COMPLETED|Overall Study||30||
48062932|NCT01044706|100475547|FG000|NOT COMPLETED|Overall Study||0||
48062933|NCT01044706|100475548|FG001|NOT COMPLETED|Overall Study||0||
48062934|NCT01336296|100475549|FG000|STARTED|Overall Study||40||
48062935|NCT01336296|100475550|FG001|STARTED|Overall Study||21||
48062936|NCT01336296|100475549|FG000|COMPLETED|Overall Study||35||
48062937|NCT01336296|100475550|FG001|COMPLETED|Overall Study||17||
48062938|NCT01336296|100475549|FG000|NOT COMPLETED|Overall Study||5||
48508211|NCT04290494|101580066|FG002|STARTED|Overall Study||13397||
48062939|NCT01336296|100475550|FG001|NOT COMPLETED|Overall Study||4||
48062940|NCT01013350|100475551|FG000|STARTED|Overall Study||198||
48062941|NCT01013350|100475552|FG001|STARTED|Overall Study||963||
48062942|NCT01013350|100475551|FG000|Safety Analysis Set|Overall Study||198||
48062943|NCT01013350|100475552|FG001|Safety Analysis Set|Overall Study||950||
48062944|NCT01013350|100475551|FG000|COMPLETED|Overall Study||160||
48062945|NCT01013350|100475552|FG001|COMPLETED|Overall Study||771||
48062946|NCT01013350|100475551|FG000|NOT COMPLETED|Overall Study||38||
48062947|NCT01013350|100475552|FG001|NOT COMPLETED|Overall Study||192||
48062948|NCT03403374|100475553|FG000|STARTED|Overall Study||30||
48062949|NCT03403374|100475553|FG000|COMPLETED|Overall Study||29||
48062950|NCT03403374|100475553|FG000|NOT COMPLETED|Overall Study||1||
48062951|NCT01558739|100475554|FG000|STARTED|Overall Study||48||
48062952|NCT01558739|100475554|FG000|COMPLETED|Overall Study||31||
48062953|NCT01558739|100475554|FG000|NOT COMPLETED|Overall Study||17||
48062954|NCT05055128|100475555|FG000|STARTED|Overall Study||51||
48062955|NCT05055128|100475556|FG001|STARTED|Overall Study||48||
48062956|NCT05055128|100475557|FG002|STARTED|Overall Study||52||
48062957|NCT05055128|100475558|FG003|STARTED|Overall Study||47||
48062958|NCT05055128|100475559|FG004|STARTED|Overall Study||50||
48062959|NCT05055128|100475555|FG000|COMPLETED|Overall Study||45||
48062960|NCT05055128|100475556|FG001|COMPLETED|Overall Study||45||
48062961|NCT05055128|100475557|FG002|COMPLETED|Overall Study||50||
48062962|NCT05055128|100475558|FG003|COMPLETED|Overall Study||41||
48062963|NCT05055128|100475559|FG004|COMPLETED|Overall Study||47||
48062964|NCT05055128|100475555|FG000|NOT COMPLETED|Overall Study||6||
48062965|NCT05055128|100475556|FG001|NOT COMPLETED|Overall Study||3||
48062966|NCT05055128|100475557|FG002|NOT COMPLETED|Overall Study||2||
48062967|NCT05055128|100475558|FG003|NOT COMPLETED|Overall Study||6||
48062968|NCT05055128|100475559|FG004|NOT COMPLETED|Overall Study||3||
48062969|NCT01691898|100475560|FG000|STARTED|Overall Study||63||
48062970|NCT01691898|100475561|FG001|STARTED|Overall Study||59||
48062971|NCT01691898|100475562|FG002|STARTED|Overall Study||20||
48062972|NCT01691898|100475563|FG003|STARTED|Overall Study||9||
48062973|NCT01691898|100475564|FG004|STARTED|Overall Study||40||
48062974|NCT01691898|100475565|FG005|STARTED|Overall Study||40||
48062975|NCT01691898|100475560|FG000|COMPLETED|Overall Study||16||
48062976|NCT01691898|100475561|FG001|COMPLETED|Overall Study||15||
48062977|NCT01691898|100475562|FG002|COMPLETED|Overall Study||11||
48062978|NCT01691898|100475563|FG003|COMPLETED|Overall Study||4||
48062979|NCT01691898|100475564|FG004|COMPLETED|Overall Study||26||
48062980|NCT01691898|100475565|FG005|COMPLETED|Overall Study||5||
48062981|NCT01691898|100475560|FG000|NOT COMPLETED|Overall Study||47||
48062982|NCT01691898|100475561|FG001|NOT COMPLETED|Overall Study||44||
48062983|NCT01691898|100475562|FG002|NOT COMPLETED|Overall Study||9||
48062984|NCT01691898|100475563|FG003|NOT COMPLETED|Overall Study||5||
48062985|NCT01691898|100475564|FG004|NOT COMPLETED|Overall Study||14||
48062986|NCT01691898|100475565|FG005|NOT COMPLETED|Overall Study||35||
48062987|NCT01297920|100475566|FG000|STARTED|Overall Study||221||
48062988|NCT01297920|100475567|FG001|STARTED|Overall Study||234||
48062989|NCT01297920|100475568|FG002|STARTED|Overall Study||235||
48062990|NCT01297920|100475566|FG000|COMPLETED|Overall Study||163||
48062991|NCT01297920|100475567|FG001|COMPLETED|Overall Study||207||
48062992|NCT01297920|100475568|FG002|COMPLETED|Overall Study||178||
48062993|NCT01297920|100475566|FG000|NOT COMPLETED|Overall Study||58||
48062994|NCT01297920|100475567|FG001|NOT COMPLETED|Overall Study||27||
48062995|NCT01297920|100475568|FG002|NOT COMPLETED|Overall Study||57||
48062996|NCT01845818|100475569|FG000|STARTED|Overall Study||126||
48062997|NCT01845818|100475570|FG001|STARTED|Overall Study||57||
48062998|NCT01845818|100475569|FG000|COMPLETED|Overall Study||81||
48062999|NCT01845818|100475570|FG001|COMPLETED|Overall Study||40||
48063000|NCT01845818|100475569|FG000|NOT COMPLETED|Overall Study||45||
48063001|NCT01845818|100475570|FG001|NOT COMPLETED|Overall Study||17||
48063002|NCT00580970|100475571|FG000|STARTED|Pre-treatment||73||
48063003|NCT00580970|100475571|FG000|COMPLETED|Pre-treatment||72||
48063004|NCT00580970|100475571|FG000|NOT COMPLETED|Pre-treatment||1||
48063005|NCT00580970|100475571|FG000|STARTED|Treatment (Lovastatin)||72||
48063006|NCT00580970|100475571|FG000|6 Months of Treatment|Treatment (Lovastatin)||53||
48063007|NCT00580970|100475571|FG000|COMPLETED|Treatment (Lovastatin)||53||
48063008|NCT00580970|100475571|FG000|NOT COMPLETED|Treatment (Lovastatin)||19||
48063009|NCT02155881|100475572|FG000|STARTED|Overall Study||40||
48063010|NCT02155881|100475573|FG001|STARTED|Overall Study||40||
48063011|NCT02155881|100475572|FG000|COMPLETED|Overall Study||38||
48063012|NCT02155881|100475573|FG001|COMPLETED|Overall Study||36||
48063013|NCT02155881|100475572|FG000|NOT COMPLETED|Overall Study||2||
48063014|NCT02155881|100475573|FG001|NOT COMPLETED|Overall Study||4||
48063015|NCT02149875|100475574|FG000|STARTED|Overall Study||27||
48063016|NCT02149875|100475575|FG001|STARTED|Overall Study||28||
48063017|NCT02149875|100475576|FG002|STARTED|Overall Study||29||
48063018|NCT02149875|100475574|FG000|COMPLETED|Overall Study||20||
48063019|NCT02149875|100475575|FG001|COMPLETED|Overall Study||20||
48063020|NCT02149875|100475576|FG002|COMPLETED|Overall Study||20||
48063021|NCT02149875|100475574|FG000|NOT COMPLETED|Overall Study||7||
48063022|NCT02149875|100475575|FG001|NOT COMPLETED|Overall Study||8||
48063023|NCT02149875|100475576|FG002|NOT COMPLETED|Overall Study||9||
48063024|NCT01669928|100475577|FG000|STARTED|First Intervention||51||
48063025|NCT01669928|100475578|FG001|STARTED|First Intervention||52||
48063026|NCT01669928|100475577|FG000|COMPLETED|First Intervention||48||
48063027|NCT01669928|100475578|FG001|COMPLETED|First Intervention||47||
48063028|NCT01669928|100475577|FG000|NOT COMPLETED|First Intervention||3||
48063029|NCT01669928|100475578|FG001|NOT COMPLETED|First Intervention||5||
48063030|NCT01669928|100475577|FG000|STARTED|Second Intervention||48||
48063031|NCT01669928|100475578|FG001|STARTED|Second Intervention||47||
48063032|NCT01669928|100475577|FG000|COMPLETED|Second Intervention||48||
48063033|NCT01669928|100475578|FG001|COMPLETED|Second Intervention||47||
48063034|NCT01669928|100475577|FG000|NOT COMPLETED|Second Intervention||0||
48063035|NCT01669928|100475578|FG001|NOT COMPLETED|Second Intervention||0||
48063036|NCT03841448|100475579|FG000|STARTED|Double-blind Treatment (DBT) Period||9||
48063037|NCT03841448|100475580|FG001|STARTED|Double-blind Treatment (DBT) Period||22||
48063038|NCT03841448|100475581|FG002|STARTED|Double-blind Treatment (DBT) Period||0||
48063039|NCT03841448|100475582|FG003|STARTED|Double-blind Treatment (DBT) Period||0||
48063040|NCT03841448|100475579|FG000|Modified Intent-to-treat (mITT) Analysis Set|Double-blind Treatment (DBT) Period||9|mITT Analysis Set included all participants who received any amount of study drug and had at least one post baseline 24-hour urine protein/creatinine ratio (UPCR) assessment.|
48063041|NCT03841448|100475580|FG001|Modified Intent-to-treat (mITT) Analysis Set|Double-blind Treatment (DBT) Period||22|mITT Analysis Set included all participants who received any amount of study drug and had at least one post baseline 24-hour urine protein/creatinine ratio (UPCR) assessment.|
48063042|NCT03841448|100475581|FG002|Modified Intent-to-treat (mITT) Analysis Set|Double-blind Treatment (DBT) Period||0|mITT Analysis Set included all participants who received any amount of study drug and had at least one post baseline 24-hour urine protein/creatinine ratio (UPCR) assessment.|
48063043|NCT03841448|100475582|FG003|Modified Intent-to-treat (mITT) Analysis Set|Double-blind Treatment (DBT) Period||0|mITT Analysis Set included all participants who received any amount of study drug and had at least one post baseline 24-hour urine protein/creatinine ratio (UPCR) assessment.|
48063044|NCT03841448|100475579|FG000|COMPLETED|Double-blind Treatment (DBT) Period||8||
48063045|NCT03841448|100475580|FG001|COMPLETED|Double-blind Treatment (DBT) Period||21||
48063046|NCT03841448|100475581|FG002|COMPLETED|Double-blind Treatment (DBT) Period||0||
48063047|NCT03841448|100475582|FG003|COMPLETED|Double-blind Treatment (DBT) Period||0||
48063048|NCT03841448|100475579|FG000|NOT COMPLETED|Double-blind Treatment (DBT) Period||1||
48063049|NCT03841448|100475580|FG001|NOT COMPLETED|Double-blind Treatment (DBT) Period||1||
48063050|NCT03841448|100475581|FG002|NOT COMPLETED|Double-blind Treatment (DBT) Period||0||
48063051|NCT03841448|100475582|FG003|NOT COMPLETED|Double-blind Treatment (DBT) Period||0||
48063052|NCT03841448|100475579|FG000|STARTED|Open-Label Extension (OLE) Period||0||
48063053|NCT03841448|100475580|FG001|STARTED|Open-Label Extension (OLE) Period||0||
48063054|NCT03841448|100475581|FG002|STARTED|Open-Label Extension (OLE) Period||8||
48063055|NCT03841448|100475582|FG003|STARTED|Open-Label Extension (OLE) Period||20||
48063056|NCT03841448|100475579|FG000|COMPLETED|Open-Label Extension (OLE) Period||0||
48063057|NCT03841448|100475580|FG001|COMPLETED|Open-Label Extension (OLE) Period||0||
48063058|NCT03841448|100475581|FG002|COMPLETED|Open-Label Extension (OLE) Period||0||
48063059|NCT03841448|100475582|FG003|COMPLETED|Open-Label Extension (OLE) Period||0||
48063060|NCT03841448|100475579|FG000|NOT COMPLETED|Open-Label Extension (OLE) Period||0||
48063061|NCT03841448|100475580|FG001|NOT COMPLETED|Open-Label Extension (OLE) Period||0||
48063062|NCT03841448|100475581|FG002|NOT COMPLETED|Open-Label Extension (OLE) Period||8||
48063063|NCT03841448|100475582|FG003|NOT COMPLETED|Open-Label Extension (OLE) Period||20||
48063064|NCT02635776|100475583|FG000|STARTED|Overall Study||416||
48063065|NCT02635776|100475584|FG001|STARTED|Overall Study||139||
48063066|NCT02635776|100475583|FG000|COMPLETED|Overall Study||314||
48063067|NCT02635776|100475584|FG001|COMPLETED|Overall Study||128||
48063068|NCT02635776|100475583|FG000|NOT COMPLETED|Overall Study||102||
48063069|NCT02635776|100475584|FG001|NOT COMPLETED|Overall Study||11||
48063070|NCT03540030|100475585|FG000|STARTED|Overall Study||48||
48063071|NCT03540030|100475586|FG001|STARTED|Overall Study||38||
48063072|NCT03540030|100475585|FG000|COMPLETED|Overall Study||30||
48063073|NCT03540030|100475586|FG001|COMPLETED|Overall Study||35||
48063074|NCT03540030|100475585|FG000|NOT COMPLETED|Overall Study||18||
48063075|NCT03540030|100475586|FG001|NOT COMPLETED|Overall Study||3||
48063076|NCT01460368|100475587|FG000|STARTED|Part A||7||
48063077|NCT01460368|100475588|FG001|STARTED|Part A||0||
48063078|NCT01460368|100475589|FG002|STARTED|Part A||0||
48063079|NCT01460368|100475590|FG003|STARTED|Part A||0||
48063080|NCT01460368|100475591|FG004|STARTED|Part A||0||
48063081|NCT01460368|100475592|FG005|STARTED|Part A||0||
48063082|NCT01460368|100475593|FG006|STARTED|Part A||0||
48063083|NCT01460368|100475587|FG000|Received at Least One Dose of Study Drug|Part A||7||
48063084|NCT01460368|100475588|FG001|Received at Least One Dose of Study Drug|Part A||0||
48063085|NCT01460368|100475589|FG002|Received at Least One Dose of Study Drug|Part A||0||
48063086|NCT01460368|100475590|FG003|Received at Least One Dose of Study Drug|Part A||0||
48063087|NCT01460368|100475591|FG004|Received at Least One Dose of Study Drug|Part A||0||
48063088|NCT01460368|100475592|FG005|Received at Least One Dose of Study Drug|Part A||0||
48063089|NCT01460368|100475593|FG006|Received at Least One Dose of Study Drug|Part A||0||
48063090|NCT01460368|100475587|FG000|COMPLETED|Part A||7||
48063091|NCT01460368|100475588|FG001|COMPLETED|Part A||0||
48218603|NCT02345720|100860334|FG000|NOT COMPLETED|Overall Study||0||
48063092|NCT01460368|100475589|FG002|COMPLETED|Part A||0||
48063093|NCT01460368|100475590|FG003|COMPLETED|Part A||0||
48063094|NCT01460368|100475591|FG004|COMPLETED|Part A||0||
48063095|NCT01460368|100475592|FG005|COMPLETED|Part A||0||
48063096|NCT01460368|100475593|FG006|COMPLETED|Part A||0||
48063097|NCT01460368|100475587|FG000|NOT COMPLETED|Part A||0||
48063098|NCT01460368|100475588|FG001|NOT COMPLETED|Part A||0||
48063099|NCT01460368|100475589|FG002|NOT COMPLETED|Part A||0||
48063100|NCT01460368|100475590|FG003|NOT COMPLETED|Part A||0||
48063101|NCT01460368|100475591|FG004|NOT COMPLETED|Part A||0||
48063102|NCT01460368|100475592|FG005|NOT COMPLETED|Part A||0||
48063103|NCT01460368|100475593|FG006|NOT COMPLETED|Part A||0||
48063104|NCT01460368|100475587|FG000|STARTED|Part B: First Intervention (Period 1)||0||
48063105|NCT01460368|100475588|FG001|STARTED|Part B: First Intervention (Period 1)||10||
48063106|NCT01460368|100475589|FG002|STARTED|Part B: First Intervention (Period 1)||10||
48063107|NCT01460368|100475590|FG003|STARTED|Part B: First Intervention (Period 1)||10||
48063108|NCT01460368|100475591|FG004|STARTED|Part B: First Intervention (Period 1)||10||
48063109|NCT01460368|100475592|FG005|STARTED|Part B: First Intervention (Period 1)||10||
48063110|NCT01460368|100475593|FG006|STARTED|Part B: First Intervention (Period 1)||10||
48063111|NCT01460368|100475587|FG000|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||0||
48063112|NCT01460368|100475588|FG001|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10||
48063113|NCT01460368|100475589|FG002|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10||
48063114|NCT01460368|100475590|FG003|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10||
48063115|NCT01460368|100475591|FG004|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10||
48063116|NCT01460368|100475592|FG005|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10||
48063117|NCT01460368|100475593|FG006|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10||
48063118|NCT01460368|100475587|FG000|COMPLETED|Part B: First Intervention (Period 1)||0||
48063119|NCT01460368|100475588|FG001|COMPLETED|Part B: First Intervention (Period 1)||10||
48063120|NCT01460368|100475589|FG002|COMPLETED|Part B: First Intervention (Period 1)||10||
48063121|NCT01460368|100475590|FG003|COMPLETED|Part B: First Intervention (Period 1)||10||
48063122|NCT01460368|100475591|FG004|COMPLETED|Part B: First Intervention (Period 1)||9||
48063123|NCT01460368|100475592|FG005|COMPLETED|Part B: First Intervention (Period 1)||10||
48063124|NCT01460368|100475593|FG006|COMPLETED|Part B: First Intervention (Period 1)||10||
48063125|NCT01460368|100475587|FG000|NOT COMPLETED|Part B: First Intervention (Period 1)||0||
48063126|NCT01460368|100475588|FG001|NOT COMPLETED|Part B: First Intervention (Period 1)||0||
48063127|NCT01460368|100475589|FG002|NOT COMPLETED|Part B: First Intervention (Period 1)||0||
48063128|NCT01460368|100475590|FG003|NOT COMPLETED|Part B: First Intervention (Period 1)||0||
48063129|NCT01460368|100475591|FG004|NOT COMPLETED|Part B: First Intervention (Period 1)||1||
48063130|NCT01460368|100475592|FG005|NOT COMPLETED|Part B: First Intervention (Period 1)||0||
48063131|NCT01460368|100475593|FG006|NOT COMPLETED|Part B: First Intervention (Period 1)||0||
48063132|NCT01460368|100475587|FG000|STARTED|Part B: Washout (up to 15 Days)||0||
48063133|NCT01460368|100475588|FG001|STARTED|Part B: Washout (up to 15 Days)||10||
48063134|NCT01460368|100475589|FG002|STARTED|Part B: Washout (up to 15 Days)||10||
48063135|NCT01460368|100475590|FG003|STARTED|Part B: Washout (up to 15 Days)||10||
48063136|NCT01460368|100475591|FG004|STARTED|Part B: Washout (up to 15 Days)||9||
48063137|NCT01460368|100475592|FG005|STARTED|Part B: Washout (up to 15 Days)||10||
48063138|NCT01460368|100475593|FG006|STARTED|Part B: Washout (up to 15 Days)||10||
48063139|NCT01460368|100475587|FG000|COMPLETED|Part B: Washout (up to 15 Days)||0||
48063140|NCT01460368|100475588|FG001|COMPLETED|Part B: Washout (up to 15 Days)||10||
48063141|NCT01460368|100475589|FG002|COMPLETED|Part B: Washout (up to 15 Days)||10||
48063142|NCT01460368|100475590|FG003|COMPLETED|Part B: Washout (up to 15 Days)||10||
48063143|NCT01460368|100475591|FG004|COMPLETED|Part B: Washout (up to 15 Days)||9||
48218604|NCT01290341|100860335|FG000|STARTED|Overall Study||573||
48218605|NCT01290341|100860336|FG001|STARTED|Overall Study||287||
48218606|NCT01290341|100860335|FG000|COMPLETED|Overall Study||481||
48218607|NCT01290341|100860336|FG001|COMPLETED|Overall Study||258||
48063144|NCT01460368|100475592|FG005|COMPLETED|Part B: Washout (up to 15 Days)||10||
48063145|NCT01460368|100475593|FG006|COMPLETED|Part B: Washout (up to 15 Days)||10||
48063146|NCT01460368|100475587|FG000|NOT COMPLETED|Part B: Washout (up to 15 Days)||0||
48063147|NCT01460368|100475588|FG001|NOT COMPLETED|Part B: Washout (up to 15 Days)||0||
48063148|NCT01460368|100475589|FG002|NOT COMPLETED|Part B: Washout (up to 15 Days)||0||
48063149|NCT01460368|100475590|FG003|NOT COMPLETED|Part B: Washout (up to 15 Days)||0||
48063150|NCT01460368|100475591|FG004|NOT COMPLETED|Part B: Washout (up to 15 Days)||0||
48063151|NCT01460368|100475592|FG005|NOT COMPLETED|Part B: Washout (up to 15 Days)||0||
48063152|NCT01460368|100475593|FG006|NOT COMPLETED|Part B: Washout (up to 15 Days)||0||
48063153|NCT01460368|100475587|FG000|STARTED|Part B: Second Intervention (Period 2)||0||
48063154|NCT01460368|100475588|FG001|STARTED|Part B: Second Intervention (Period 2)||10||
48063155|NCT01460368|100475589|FG002|STARTED|Part B: Second Intervention (Period 2)||10||
48063156|NCT01460368|100475590|FG003|STARTED|Part B: Second Intervention (Period 2)||10||
48063157|NCT01460368|100475591|FG004|STARTED|Part B: Second Intervention (Period 2)||9||
48063158|NCT01460368|100475592|FG005|STARTED|Part B: Second Intervention (Period 2)||10||
48063159|NCT01460368|100475593|FG006|STARTED|Part B: Second Intervention (Period 2)||10||
48063160|NCT01460368|100475587|FG000|COMPLETED|Part B: Second Intervention (Period 2)||0||
48063161|NCT01460368|100475588|FG001|COMPLETED|Part B: Second Intervention (Period 2)||8||
48063162|NCT01460368|100475589|FG002|COMPLETED|Part B: Second Intervention (Period 2)||10||
48063163|NCT01460368|100475590|FG003|COMPLETED|Part B: Second Intervention (Period 2)||10||
48063164|NCT01460368|100475591|FG004|COMPLETED|Part B: Second Intervention (Period 2)||9||
48063165|NCT01460368|100475592|FG005|COMPLETED|Part B: Second Intervention (Period 2)||10||
48063166|NCT01460368|100475593|FG006|COMPLETED|Part B: Second Intervention (Period 2)||9||
48063167|NCT01460368|100475587|FG000|NOT COMPLETED|Part B: Second Intervention (Period 2)||0||
48063168|NCT01460368|100475588|FG001|NOT COMPLETED|Part B: Second Intervention (Period 2)||2||
48063169|NCT01460368|100475589|FG002|NOT COMPLETED|Part B: Second Intervention (Period 2)||0||
48063170|NCT01460368|100475590|FG003|NOT COMPLETED|Part B: Second Intervention (Period 2)||0||
48063171|NCT01460368|100475591|FG004|NOT COMPLETED|Part B: Second Intervention (Period 2)||0||
48063172|NCT01460368|100475592|FG005|NOT COMPLETED|Part B: Second Intervention (Period 2)||0||
48063173|NCT01460368|100475593|FG006|NOT COMPLETED|Part B: Second Intervention (Period 2)||1||
48063174|NCT01460368|100475587|FG000|STARTED|Part B: Washout (up to 15 Days)||0||
48063175|NCT01460368|100475588|FG001|STARTED|Part B: Washout (up to 15 Days)||8||
48063176|NCT01460368|100475589|FG002|STARTED|Part B: Washout (up to 15 Days)||10||
48063177|NCT01460368|100475590|FG003|STARTED|Part B: Washout (up to 15 Days)||10||
48063178|NCT01460368|100475591|FG004|STARTED|Part B: Washout (up to 15 Days)||9||
48063179|NCT01460368|100475592|FG005|STARTED|Part B: Washout (up to 15 Days)||10||
48063180|NCT01460368|100475593|FG006|STARTED|Part B: Washout (up to 15 Days)||9||
48063181|NCT01460368|100475587|FG000|COMPLETED|Part B: Washout (up to 15 Days)||0||
48063182|NCT01460368|100475588|FG001|COMPLETED|Part B: Washout (up to 15 Days)||8||
48063183|NCT01460368|100475589|FG002|COMPLETED|Part B: Washout (up to 15 Days)||9||
48063184|NCT01460368|100475590|FG003|COMPLETED|Part B: Washout (up to 15 Days)||10||
48063185|NCT01460368|100475591|FG004|COMPLETED|Part B: Washout (up to 15 Days)||9||
48063186|NCT01460368|100475592|FG005|COMPLETED|Part B: Washout (up to 15 Days)||10||
48063187|NCT01460368|100475593|FG006|COMPLETED|Part B: Washout (up to 15 Days)||9||
48063188|NCT01460368|100475587|FG000|NOT COMPLETED|Part B: Washout (up to 15 Days)||0||
48063189|NCT01460368|100475588|FG001|NOT COMPLETED|Part B: Washout (up to 15 Days)||0||
48063190|NCT01460368|100475589|FG002|NOT COMPLETED|Part B: Washout (up to 15 Days)||1||
48063191|NCT01460368|100475590|FG003|NOT COMPLETED|Part B: Washout (up to 15 Days)||0||
48063192|NCT01460368|100475591|FG004|NOT COMPLETED|Part B: Washout (up to 15 Days)||0||
48063193|NCT01460368|100475592|FG005|NOT COMPLETED|Part B: Washout (up to 15 Days)||0||
48063194|NCT01460368|100475593|FG006|NOT COMPLETED|Part B: Washout (up to 15 Days)||0||
48063195|NCT01460368|100475587|FG000|STARTED|Part B: Third Interventions (Period 3)||0||
48063196|NCT01460368|100475588|FG001|STARTED|Part B: Third Interventions (Period 3)||8||
48063197|NCT01460368|100475589|FG002|STARTED|Part B: Third Interventions (Period 3)||9||
48063198|NCT01460368|100475590|FG003|STARTED|Part B: Third Interventions (Period 3)||10||
48063199|NCT01460368|100475591|FG004|STARTED|Part B: Third Interventions (Period 3)||9||
48063200|NCT01460368|100475592|FG005|STARTED|Part B: Third Interventions (Period 3)||10||
48063201|NCT01460368|100475593|FG006|STARTED|Part B: Third Interventions (Period 3)||9||
48063202|NCT01460368|100475587|FG000|COMPLETED|Part B: Third Interventions (Period 3)||0||
48063203|NCT01460368|100475588|FG001|COMPLETED|Part B: Third Interventions (Period 3)||8||
48063204|NCT01460368|100475589|FG002|COMPLETED|Part B: Third Interventions (Period 3)||8||
48063205|NCT01460368|100475590|FG003|COMPLETED|Part B: Third Interventions (Period 3)||9||
48063206|NCT01460368|100475591|FG004|COMPLETED|Part B: Third Interventions (Period 3)||9||
48063207|NCT01460368|100475592|FG005|COMPLETED|Part B: Third Interventions (Period 3)||9||
48063208|NCT01460368|100475593|FG006|COMPLETED|Part B: Third Interventions (Period 3)||9||
48063209|NCT01460368|100475587|FG000|NOT COMPLETED|Part B: Third Interventions (Period 3)||0||
48063210|NCT01460368|100475588|FG001|NOT COMPLETED|Part B: Third Interventions (Period 3)||0||
48063211|NCT01460368|100475589|FG002|NOT COMPLETED|Part B: Third Interventions (Period 3)||1||
48063212|NCT01460368|100475590|FG003|NOT COMPLETED|Part B: Third Interventions (Period 3)||1||
48063213|NCT01460368|100475591|FG004|NOT COMPLETED|Part B: Third Interventions (Period 3)||0||
48063214|NCT01460368|100475592|FG005|NOT COMPLETED|Part B: Third Interventions (Period 3)||1||
48063215|NCT01460368|100475593|FG006|NOT COMPLETED|Part B: Third Interventions (Period 3)||0||
48063216|NCT00543543|100475594|FG000|STARTED|Base Study||315||
48063217|NCT00543543|100475595|FG001|STARTED|Base Study||7106||
48063218|NCT00543543|100475596|FG002|STARTED|Base Study||310||
48063219|NCT00543543|100475597|FG003|STARTED|Base Study||7109||
48063220|NCT00543543|100475594|FG000|Completed 3 Vaccinations|Base Study||300||
48063221|NCT00543543|100475595|FG001|Completed 3 Vaccinations|Base Study||6928||
48063222|NCT00543543|100475596|FG002|Completed 3 Vaccinations|Base Study||297||
48063223|NCT00543543|100475597|FG003|Completed 3 Vaccinations|Base Study||6934||
48063224|NCT00543543|100475594|FG000|COMPLETED|Base Study||295||
48063225|NCT00543543|100475595|FG001|COMPLETED|Base Study||5854||
48063226|NCT00543543|100475596|FG002|COMPLETED|Base Study||296||
48063227|NCT00543543|100475597|FG003|COMPLETED|Base Study||5887||
48063228|NCT00543543|100475594|FG000|NOT COMPLETED|Base Study||20||
48063229|NCT00543543|100475595|FG001|NOT COMPLETED|Base Study||1252||
48063230|NCT00543543|100475596|FG002|NOT COMPLETED|Base Study||14||
48063231|NCT00543543|100475597|FG003|NOT COMPLETED|Base Study||1222||
48063232|NCT00543543|100475594|FG000|STARTED|Extension Study||0||
48063233|NCT00543543|100475595|FG001|STARTED|Extension Study||150||
48063234|NCT00543543|100475596|FG002|STARTED|Extension Study||0||
48063235|NCT00543543|100475597|FG003|STARTED|Extension Study||3050||
48063236|NCT00543543|100475594|FG000|COMPLETED|Extension Study||0||
48508212|NCT04290494|101580064|FG000|COMPLETED|Overall Study||10968||
48508213|NCT04290494|101580065|FG001|COMPLETED|Overall Study||17823||
48508214|NCT04290494|101580066|FG002|COMPLETED|Overall Study||13397||
48508215|NCT04290494|101580064|FG000|NOT COMPLETED|Overall Study||0||
48508216|NCT04290494|101580065|FG001|NOT COMPLETED|Overall Study||0||
48063237|NCT00543543|100475595|FG001|COMPLETED|Extension Study||150||
48508217|NCT04290494|101580066|FG002|NOT COMPLETED|Overall Study||0||
48508218|NCT01937351|101580067|FG000|STARTED|Overall Study||134|Intention-to-Treat|
48508219|NCT01937351|101580068|FG001|STARTED|Overall Study||28|Intention-to-Treat|
48063238|NCT00543543|100475596|FG002|COMPLETED|Extension Study||0||
48063239|NCT00543543|100475597|FG003|COMPLETED|Extension Study||2824||
48063240|NCT00543543|100475594|FG000|NOT COMPLETED|Extension Study||0||
48218608|NCT01290341|100860335|FG000|NOT COMPLETED|Overall Study||92||
48508220|NCT01937351|101580067|FG000|Treated w Study Device|Overall Study||130|Per Protocol|
48508221|NCT01937351|101580068|FG001|Treated w Study Device|Overall Study||28|Per Protocol|
48508222|NCT01937351|101580067|FG000|30-Day Follow-up|Overall Study||128||
48063241|NCT00543543|100475595|FG001|NOT COMPLETED|Extension Study||0||
48508223|NCT01937351|101580068|FG001|30-Day Follow-up|Overall Study||27||
48063242|NCT00543543|100475596|FG002|NOT COMPLETED|Extension Study||0||
48063243|NCT00543543|100475597|FG003|NOT COMPLETED|Extension Study||226||
48063244|NCT02919696|100475598|FG000|STARTED|Overall Study||12||
48063245|NCT02919696|100475599|FG001|STARTED|Overall Study||14||
48063246|NCT02919696|100475598|FG000|Received at Least One Dose of Study Drug|Overall Study||12||
48063247|NCT02919696|100475599|FG001|Received at Least One Dose of Study Drug|Overall Study||13||
48063248|NCT02919696|100475598|FG000|PK 100 mg Abemaciclib Dose|Overall Study||5||
48063249|NCT02919696|100475599|FG001|PK 100 mg Abemaciclib Dose|Overall Study||0||
48063250|NCT02919696|100475598|FG000|PK 150 mg Abemaciclib Dose|Overall Study||0||
48063251|NCT02919696|100475599|FG001|PK 150 mg Abemaciclib Dose|Overall Study||2||
48063252|NCT02919696|100475598|FG000|Death On Treatment|Overall Study||1||
48063253|NCT02919696|100475599|FG001|Death On Treatment|Overall Study||0||
48063254|NCT02919696|100475598|FG000|Progressive Disease|Overall Study||7||
48063255|NCT02919696|100475599|FG001|Progressive Disease|Overall Study||9||
48063256|NCT02919696|100475598|FG000|COMPLETED|Overall Study||8||
48063257|NCT02919696|100475599|FG001|COMPLETED|Overall Study||9||
48063258|NCT02919696|100475598|FG000|NOT COMPLETED|Overall Study||4||
48063259|NCT02919696|100475599|FG001|NOT COMPLETED|Overall Study||5||
48063260|NCT03954132|100475600|FG000|STARTED|Overall Study||329|Patients with Visit 1 and treated (=Treated Set)|
48063261|NCT03954132|100475601|FG001|STARTED|Overall Study||134|Patients with Visit 1 and treated (=Treated Set)|
48063262|NCT03954132|100475600|FG000|Per Protocol Set|Overall Study||309||
48063263|NCT03954132|100475601|FG001|Per Protocol Set|Overall Study||129||
48063264|NCT03954132|100475600|FG000|Treated Subjects With Protocol Violations|Overall Study||19|Treated patients with protocol violations, patients were excluded from the per protocol set.|
48063265|NCT03954132|100475601|FG001|Treated Subjects With Protocol Violations|Overall Study||5|Treated patients with protocol violations, patients were excluded from the per protocol set.|
48063266|NCT03954132|100475600|FG000|Treated Subjects Excluded From Per Protocol Set|Overall Study||1|Patient excluded from per protocol set due to open query related to in-/exclusion criteria.|
48063267|NCT03954132|100475601|FG001|Treated Subjects Excluded From Per Protocol Set|Overall Study||0|Patient excluded from per protocol set due to open query related to in-/exclusion criteria.|
48063268|NCT03954132|100475600|FG000|COMPLETED|Overall Study||303|Patients with Visit 2|
48063269|NCT03954132|100475601|FG001|COMPLETED|Overall Study||129|Patients with Visit 2|
48063270|NCT03954132|100475600|FG000|NOT COMPLETED|Overall Study||26||
48063271|NCT03954132|100475601|FG001|NOT COMPLETED|Overall Study||5||
48063272|NCT02387710|100475602|FG000|STARTED|First Study Night||9||
48063273|NCT02387710|100475603|FG001|STARTED|First Study Night||9||
48063274|NCT02387710|100475602|FG000|COMPLETED|First Study Night||9||
48063275|NCT02387710|100475603|FG001|COMPLETED|First Study Night||9||
48063276|NCT02387710|100475602|FG000|NOT COMPLETED|First Study Night||0||
48063277|NCT02387710|100475603|FG001|NOT COMPLETED|First Study Night||0||
48063278|NCT02387710|100475602|FG000|STARTED|Second Study Night||9||
48063279|NCT02387710|100475603|FG001|STARTED|Second Study Night||7||
48063280|NCT02387710|100475602|FG000|COMPLETED|Second Study Night||9||
48063281|NCT02387710|100475603|FG001|COMPLETED|Second Study Night||7||
48063282|NCT02387710|100475602|FG000|NOT COMPLETED|Second Study Night||0||
48063283|NCT02387710|100475603|FG001|NOT COMPLETED|Second Study Night||0||
48063284|NCT02435147|100475604|FG000|STARTED|Overall Study||86||
48063285|NCT02435147|100475604|FG000|COMPLETED|Overall Study||75||
48063286|NCT02435147|100475604|FG000|NOT COMPLETED|Overall Study||11||
48063287|NCT01924988|100475605|FG000|STARTED|Overall Study||15||
48063288|NCT01924988|100475605|FG000|COMPLETED|Overall Study||15||
48063289|NCT01924988|100475605|FG000|NOT COMPLETED|Overall Study||0||
48063290|NCT00447005|100475606|FG000|STARTED|Overall Study||12||
48063291|NCT00447005|100475606|FG000|COMPLETED|Overall Study||0||
48063292|NCT00447005|100475606|FG000|NOT COMPLETED|Overall Study||12||
48063293|NCT01761175|100475607|FG000|STARTED|Overall Study||112||
48063294|NCT01761175|100475608|FG001|STARTED|Overall Study||112||
48063295|NCT01761175|100475607|FG000|COMPLETED|Overall Study||112||
48063296|NCT01761175|100475608|FG001|COMPLETED|Overall Study||112||
48063297|NCT01761175|100475607|FG000|NOT COMPLETED|Overall Study||0||
48063298|NCT01761175|100475608|FG001|NOT COMPLETED|Overall Study||0||
48063299|NCT01050543|100475609|FG000|STARTED|Overall Study||64||
48063300|NCT01050543|100475610|FG001|STARTED|Overall Study||64||
48063301|NCT01050543|100475609|FG000|COMPLETED|Overall Study||60||
48063302|NCT01050543|100475610|FG001|COMPLETED|Overall Study||60||
48063303|NCT01050543|100475609|FG000|NOT COMPLETED|Overall Study||4||
48063304|NCT01050543|100475610|FG001|NOT COMPLETED|Overall Study||4||
48063305|NCT02907268|100475611|FG000|STARTED|Overall Study||5||
48063306|NCT02907268|100475612|FG001|STARTED|Overall Study||5||
48063307|NCT02907268|100475611|FG000|COMPLETED|Overall Study||5||
48063308|NCT02907268|100475612|FG001|COMPLETED|Overall Study||5||
48063309|NCT02907268|100475611|FG000|NOT COMPLETED|Overall Study||0||
48063310|NCT02907268|100475612|FG001|NOT COMPLETED|Overall Study||0||
48063311|NCT01031706|100475613|FG000|STARTED|Overall Study||14||
48063312|NCT01031706|100475614|FG001|STARTED|Overall Study||9||
48063313|NCT01031706|100475613|FG000|COMPLETED|Overall Study||12||
48063314|NCT01031706|100475614|FG001|COMPLETED|Overall Study||8||
48063315|NCT01031706|100475613|FG000|NOT COMPLETED|Overall Study||2||
48063316|NCT01031706|100475614|FG001|NOT COMPLETED|Overall Study||1||
48063317|NCT00958789|100475615|FG000|STARTED|Overall Study||180||
48218609|NCT01290341|100860336|FG001|NOT COMPLETED|Overall Study||29||
48063318|NCT00958789|100475615|FG000|COMPLETED|Overall Study||130|1 bilateral participant had a knee complete primary endpoint; other knee was revised|
48063319|NCT00958789|100475615|FG000|NOT COMPLETED|Overall Study||50||
48063320|NCT05203289|100475616|FG000|STARTED|Overall Study||99||
48063321|NCT05203289|100475617|FG001|STARTED|Overall Study||101||
48063322|NCT05203289|100475616|FG000|COMPLETED|Overall Study||99|Completed Treatment|
48063323|NCT05203289|100475617|FG001|COMPLETED|Overall Study||101|Completed Treatment|
48063324|NCT05203289|100475616|FG000|NOT COMPLETED|Overall Study||0||
48063325|NCT05203289|100475617|FG001|NOT COMPLETED|Overall Study||0||
48063326|NCT02900976|100475618|FG000|STARTED|Overall Study||2||
48063327|NCT02900976|100475619|FG001|STARTED|Overall Study||16||
48063328|NCT02900976|100475618|FG000|COMPLETED|Overall Study||2||
48063329|NCT02900976|100475619|FG001|COMPLETED|Overall Study||7||
48063330|NCT02900976|100475618|FG000|NOT COMPLETED|Overall Study||0||
48063331|NCT02900976|100475619|FG001|NOT COMPLETED|Overall Study||9||
48063332|NCT02081183|100475620|FG000|STARTED|Overall Study||5||
48063333|NCT02081183|100475621|FG001|STARTED|Overall Study||6||
48063334|NCT02081183|100475620|FG000|COMPLETED|Overall Study||1||
48063335|NCT02081183|100475621|FG001|COMPLETED|Overall Study||2||
48063336|NCT02081183|100475620|FG000|NOT COMPLETED|Overall Study||4||
48063337|NCT02081183|100475621|FG001|NOT COMPLETED|Overall Study||4||
48063338|NCT01938573|100475622|FG000|STARTED|Overall Study||15||
48063339|NCT01938573|100475623|FG001|STARTED|Overall Study||6||
48063340|NCT01938573|100475622|FG000|COMPLETED|Overall Study||13||
48063341|NCT01938573|100475623|FG001|COMPLETED|Overall Study||6||
48063342|NCT01938573|100475622|FG000|NOT COMPLETED|Overall Study||2||
48063343|NCT01938573|100475623|FG001|NOT COMPLETED|Overall Study||0||
48063344|NCT02572388|100475624|FG000|STARTED|Overall Study||11||
48063345|NCT02572388|100475625|FG001|STARTED|Overall Study||4||
48063346|NCT02572388|100475626|FG002|STARTED|Overall Study||10||
48063347|NCT02572388|100475627|FG003|STARTED|Overall Study||6||
48063348|NCT02572388|100475624|FG000|COMPLETED|Overall Study||10||
48063349|NCT02572388|100475625|FG001|COMPLETED|Overall Study||3||
48063350|NCT02572388|100475626|FG002|COMPLETED|Overall Study||8||
48063351|NCT02572388|100475627|FG003|COMPLETED|Overall Study||4||
48063352|NCT02572388|100475624|FG000|NOT COMPLETED|Overall Study||1||
48063353|NCT02572388|100475625|FG001|NOT COMPLETED|Overall Study||1||
48063354|NCT02572388|100475626|FG002|NOT COMPLETED|Overall Study||2||
48063355|NCT02572388|100475627|FG003|NOT COMPLETED|Overall Study||2||
48063356|NCT00753766|100475628|FG000|STARTED|Overall Study||1||
48063357|NCT00753766|100475629|FG001|STARTED|Overall Study||0||
48063358|NCT00753766|100475628|FG000|COMPLETED|Overall Study||0||
48063359|NCT00753766|100475629|FG001|COMPLETED|Overall Study||0||
48063360|NCT00753766|100475628|FG000|NOT COMPLETED|Overall Study||1||
48063361|NCT00753766|100475629|FG001|NOT COMPLETED|Overall Study||0||
48063362|NCT01683019|100475630|FG000|STARTED|Overall Study||18||
48063363|NCT01683019|100475631|FG001|STARTED|Overall Study||15||
48063364|NCT01683019|100475632|FG002|STARTED|Overall Study||19||
48063365|NCT01683019|100475630|FG000|COMPLETED|Overall Study||16||
48063366|NCT01683019|100475631|FG001|COMPLETED|Overall Study||14||
48063367|NCT01683019|100475632|FG002|COMPLETED|Overall Study||15||
48063368|NCT01683019|100475630|FG000|NOT COMPLETED|Overall Study||2||
48063369|NCT01683019|100475631|FG001|NOT COMPLETED|Overall Study||1||
48063370|NCT01683019|100475632|FG002|NOT COMPLETED|Overall Study||4||
48063371|NCT03421340|100475633|FG000|STARTED|Overall Study||126||
48063372|NCT03421340|100475634|FG001|STARTED|Overall Study||124||
48063373|NCT03421340|100475633|FG000|COMPLETED|Overall Study||115||
48063374|NCT03421340|100475634|FG001|COMPLETED|Overall Study||117||
48063375|NCT03421340|100475633|FG000|NOT COMPLETED|Overall Study||11||
48063376|NCT03421340|100475634|FG001|NOT COMPLETED|Overall Study||7||
48063377|NCT04543838|100475635|FG000|STARTED|Overall Study||0||
48063378|NCT04543838|100475636|FG001|STARTED|Overall Study||19||
48063379|NCT04543838|100475635|FG000|COMPLETED|Overall Study||0||
48063380|NCT04543838|100475636|FG001|COMPLETED|Overall Study||0||
48063381|NCT04543838|100475635|FG000|NOT COMPLETED|Overall Study||0||
48063382|NCT04543838|100475636|FG001|NOT COMPLETED|Overall Study||19||
48063383|NCT02239354|100475637|FG000|STARTED|Overall Study||19||
48063384|NCT02239354|100475638|FG001|STARTED|Overall Study||0||
48063385|NCT02239354|100475637|FG000|COMPLETED|Overall Study||9||
48063386|NCT02239354|100475638|FG001|COMPLETED|Overall Study||0||
48063387|NCT02239354|100475637|FG000|NOT COMPLETED|Overall Study||10||
48063388|NCT02239354|100475638|FG001|NOT COMPLETED|Overall Study||0||
48063389|NCT01749631|100475639|FG000|STARTED|Overall Study||97||
48063390|NCT01749631|100475639|FG000|COMPLETED|Overall Study||97||
48063391|NCT01749631|100475639|FG000|NOT COMPLETED|Overall Study||0||
48063392|NCT00423514|100475640|FG000|STARTED|Overall Study||31||
48063393|NCT00423514|100475641|FG001|STARTED|Overall Study||7||
48063394|NCT00423514|100475640|FG000|COMPLETED|Overall Study||30||
48063395|NCT00423514|100475641|FG001|COMPLETED|Overall Study||7||
48063396|NCT00423514|100475640|FG000|NOT COMPLETED|Overall Study||1||
48063397|NCT00423514|100475641|FG001|NOT COMPLETED|Overall Study||0||
48063398|NCT00131508|100475642|FG000|STARTED|Overall Study||12||
48063399|NCT00131508|100475643|FG001|STARTED|Overall Study||13||
48063400|NCT00131508|100475642|FG000|COMPLETED|Overall Study||9||
48063401|NCT00131508|100475643|FG001|COMPLETED|Overall Study||5||
48063402|NCT00131508|100475642|FG000|NOT COMPLETED|Overall Study||3||
48063403|NCT00131508|100475643|FG001|NOT COMPLETED|Overall Study||8||
48063404|NCT01565642|100475644|FG000|STARTED|Overall Study||151||11
48063405|NCT01565642|100475645|FG001|STARTED|Overall Study||151||11
48063406|NCT01565642|100475644|FG000|COMPLETED|Overall Study||149||11
48063407|NCT01565642|100475645|FG001|COMPLETED|Overall Study||150||11
48063408|NCT01565642|100475644|FG000|NOT COMPLETED|Overall Study||2||0
48063409|NCT01565642|100475645|FG001|NOT COMPLETED|Overall Study||1||0
48063410|NCT00299182|100475646|FG000|STARTED|Overall Study||6||
48063411|NCT00299182|100475647|FG001|STARTED|Overall Study||4||
48063412|NCT00299182|100475648|FG002|STARTED|Overall Study||6||
48063413|NCT00299182|100475649|FG003|STARTED|Overall Study||14||
48063414|NCT00299182|100475650|FG004|STARTED|Overall Study||8||
48063415|NCT00299182|100475651|FG005|STARTED|Overall Study||7||
48063416|NCT00299182|100475652|FG006|STARTED|Overall Study||5||
48063417|NCT00299182|100475646|FG000|COMPLETED|Overall Study||6||
48063418|NCT00299182|100475647|FG001|COMPLETED|Overall Study||4||
48063419|NCT00299182|100475648|FG002|COMPLETED|Overall Study||4||
48063420|NCT00299182|100475649|FG003|COMPLETED|Overall Study||14||
48063421|NCT00299182|100475650|FG004|COMPLETED|Overall Study||5||
48063422|NCT00299182|100475651|FG005|COMPLETED|Overall Study||4||
48063423|NCT00299182|100475652|FG006|COMPLETED|Overall Study||4||
48063424|NCT00299182|100475646|FG000|NOT COMPLETED|Overall Study||0||
48063425|NCT00299182|100475647|FG001|NOT COMPLETED|Overall Study||0||
48063426|NCT00299182|100475648|FG002|NOT COMPLETED|Overall Study||2||
48063427|NCT00299182|100475649|FG003|NOT COMPLETED|Overall Study||0||
48063428|NCT00299182|100475650|FG004|NOT COMPLETED|Overall Study||3||
48063429|NCT00299182|100475651|FG005|NOT COMPLETED|Overall Study||3||
48063430|NCT00299182|100475652|FG006|NOT COMPLETED|Overall Study||1||
48063431|NCT04308304|100475653|FG000|STARTED|Overall Study||22||
48063432|NCT04308304|100475654|FG001|STARTED|Overall Study||5||
48063433|NCT04308304|100475653|FG000|COMPLETED|Overall Study||17||
48063434|NCT04308304|100475654|FG001|COMPLETED|Overall Study||5||
48063435|NCT04308304|100475653|FG000|NOT COMPLETED|Overall Study||5||
48063436|NCT04308304|100475654|FG001|NOT COMPLETED|Overall Study||0||
48063437|NCT02805972|100475655|FG000|STARTED|Intervention Visit 1||23||
48063438|NCT02805972|100475656|FG001|STARTED|Intervention Visit 1||18||
48063439|NCT02805972|100475655|FG000|COMPLETED|Intervention Visit 1||23||
48063440|NCT02805972|100475656|FG001|COMPLETED|Intervention Visit 1||18||
48063441|NCT02805972|100475655|FG000|NOT COMPLETED|Intervention Visit 1||0||
48063442|NCT02805972|100475656|FG001|NOT COMPLETED|Intervention Visit 1||0||
48063443|NCT02805972|100475655|FG000|STARTED|Washout Period||23||
48063444|NCT02805972|100475656|FG001|STARTED|Washout Period||18||
48063445|NCT02805972|100475655|FG000|COMPLETED|Washout Period||20||
48063446|NCT02805972|100475656|FG001|COMPLETED|Washout Period||18||
48063447|NCT02805972|100475655|FG000|NOT COMPLETED|Washout Period||3||
48063448|NCT02805972|100475656|FG001|NOT COMPLETED|Washout Period||0||
48063449|NCT02805972|100475655|FG000|STARTED|Intervention Visit 2||20||
48063450|NCT02805972|100475656|FG001|STARTED|Intervention Visit 2||18||
48063451|NCT02805972|100475655|FG000|COMPLETED|Intervention Visit 2||20||
48063452|NCT02805972|100475656|FG001|COMPLETED|Intervention Visit 2||18||
48063453|NCT02805972|100475655|FG000|NOT COMPLETED|Intervention Visit 2||0||
48063454|NCT02805972|100475656|FG001|NOT COMPLETED|Intervention Visit 2||0||
48063455|NCT00195273|100475657|FG000|STARTED|Overall Study||31||
48063456|NCT00195273|100475658|FG001|STARTED|Overall Study||30||
48063457|NCT00195273|100475657|FG000|COMPLETED|Overall Study||10||
48063458|NCT00195273|100475658|FG001|COMPLETED|Overall Study||16||
48063459|NCT00195273|100475657|FG000|NOT COMPLETED|Overall Study||21||
48063460|NCT00195273|100475658|FG001|NOT COMPLETED|Overall Study||14||
48063461|NCT01833988|100475659|FG000|STARTED|Overall Study||16||
48063462|NCT01833988|100475660|FG001|STARTED|Overall Study||16||
48063463|NCT01833988|100475659|FG000|COMPLETED|Overall Study||16||
48063464|NCT01833988|100475660|FG001|COMPLETED|Overall Study||16||
48063465|NCT01833988|100475659|FG000|NOT COMPLETED|Overall Study||0||
48063466|NCT01833988|100475660|FG001|NOT COMPLETED|Overall Study||0||
48063467|NCT00910273|100475661|FG000|STARTED|Overall Study||18||
48063468|NCT00910273|100475662|FG001|STARTED|Overall Study||16||
48063469|NCT00910273|100475661|FG000|COMPLETED|Overall Study||0||
48063470|NCT00910273|100475662|FG001|COMPLETED|Overall Study||3||
48063471|NCT00910273|100475661|FG000|NOT COMPLETED|Overall Study||18||
48063472|NCT00910273|100475662|FG001|NOT COMPLETED|Overall Study||13||
48063473|NCT00322101|100475663|FG000|STARTED|Overall Study||14||
48063474|NCT00322101|100475664|FG001|STARTED|Overall Study||11||
48063475|NCT00322101|100475663|FG000|COMPLETED|Overall Study||14||
48063476|NCT00322101|100475664|FG001|COMPLETED|Overall Study||11||
48063477|NCT00322101|100475663|FG000|NOT COMPLETED|Overall Study||0||
48063478|NCT00322101|100475664|FG001|NOT COMPLETED|Overall Study||0||
48063479|NCT02478372|100475665|FG000|STARTED|Overall Study||121||
48063480|NCT02478372|100475666|FG001|STARTED|Overall Study||121||
48063481|NCT02478372|100475665|FG000|Recieved Allocation Intervention|Overall Study||109||
48063482|NCT02478372|100475666|FG001|Recieved Allocation Intervention|Overall Study||113||
48063483|NCT02478372|100475665|FG000|Reviewed at Six Weeks|Overall Study||108||
48063484|NCT02478372|100475666|FG001|Reviewed at Six Weeks|Overall Study||113||
48063485|NCT02478372|100475665|FG000|Reviewed at One Year|Overall Study||108||
48063486|NCT02478372|100475666|FG001|Reviewed at One Year|Overall Study||107||
48063487|NCT02478372|100475665|FG000|COMPLETED|Overall Study||108||
48063488|NCT02478372|100475666|FG001|COMPLETED|Overall Study||107||
48063489|NCT02478372|100475665|FG000|NOT COMPLETED|Overall Study||13||
48063490|NCT02478372|100475666|FG001|NOT COMPLETED|Overall Study||14||
48063491|NCT00617851|100475667|FG000|STARTED|Overall Study||430||
48063492|NCT00617851|100475668|FG001|STARTED|Overall Study||431||
48063493|NCT00617851|100475669|FG002|STARTED|Overall Study||429||
48063494|NCT00617851|100475670|FG003|STARTED|Overall Study||217||
48063495|NCT00617851|100475667|FG000|COMPLETED|Overall Study||383||
48063496|NCT00617851|100475668|FG001|COMPLETED|Overall Study||391||
48063497|NCT00617851|100475669|FG002|COMPLETED|Overall Study||384||
48063498|NCT00617851|100475670|FG003|COMPLETED|Overall Study||192||
48063499|NCT00617851|100475667|FG000|NOT COMPLETED|Overall Study||47||
48063500|NCT00617851|100475668|FG001|NOT COMPLETED|Overall Study||40||
48063501|NCT00617851|100475669|FG002|NOT COMPLETED|Overall Study||45||
48063502|NCT00617851|100475670|FG003|NOT COMPLETED|Overall Study||25||
48063503|NCT03945266|100479306|FG000|STARTED|Overall Study||15||
48063504|NCT03945266|100479307|FG001|STARTED|Overall Study||16||
48063505|NCT03945266|100479306|FG000|COMPLETED|Overall Study||13||
48063506|NCT03945266|100479307|FG001|COMPLETED|Overall Study||14||
48508224|NCT01937351|101580067|FG000|6-Month Follow-up|Overall Study||125||
48508225|NCT01937351|101580068|FG001|6-Month Follow-up|Overall Study||26||
48063507|NCT03945266|100479306|FG000|NOT COMPLETED|Overall Study||2||
48063508|NCT03945266|100479307|FG001|NOT COMPLETED|Overall Study||2||
48063509|NCT04081324|100479308|FG000|STARTED|Overall Study||6||
48063510|NCT04081324|100479309|FG001|STARTED|Overall Study||10||
48063511|NCT04081324|100479310|FG002|STARTED|Overall Study||10||
48063512|NCT04081324|100479311|FG003|STARTED|Overall Study||10||
48063513|NCT04081324|100479308|FG000|Received At Least One Dose of Study Drug|Overall Study||6||
48063514|NCT04081324|100479309|FG001|Received At Least One Dose of Study Drug|Overall Study||10||
48063515|NCT04081324|100479310|FG002|Received At Least One Dose of Study Drug|Overall Study||10||
48063516|NCT04081324|100479311|FG003|Received At Least One Dose of Study Drug|Overall Study||10||
48063517|NCT04081324|100479308|FG000|COMPLETED|Overall Study||6||
48063518|NCT04081324|100479309|FG001|COMPLETED|Overall Study||10||
48063519|NCT04081324|100479310|FG002|COMPLETED|Overall Study||10||
48063520|NCT04081324|100479311|FG003|COMPLETED|Overall Study||10||
48063521|NCT04081324|100479308|FG000|NOT COMPLETED|Overall Study||0||
48063522|NCT04081324|100479309|FG001|NOT COMPLETED|Overall Study||0||
48063523|NCT04081324|100479310|FG002|NOT COMPLETED|Overall Study||0||
48063524|NCT04081324|100479311|FG003|NOT COMPLETED|Overall Study||0||
48063525|NCT02540226|100479312|FG000|STARTED|Overall Study||33||
48063526|NCT02540226|100479313|FG001|STARTED|Overall Study||33||
48063527|NCT02540226|100479312|FG000|COMPLETED|Overall Study||31||
48063528|NCT02540226|100479313|FG001|COMPLETED|Overall Study||32||
48063529|NCT02540226|100479312|FG000|NOT COMPLETED|Overall Study||2||
48063530|NCT02540226|100479313|FG001|NOT COMPLETED|Overall Study||1||
48063531|NCT01431131|100479314|FG000|STARTED|Overall Study||12||
48063532|NCT01431131|100479315|FG001|STARTED|Overall Study||12||
48063533|NCT01431131|100479314|FG000|COMPLETED|Overall Study||12||
48063534|NCT01431131|100479315|FG001|COMPLETED|Overall Study||12||
48063535|NCT01431131|100479314|FG000|NOT COMPLETED|Overall Study||0||
48063536|NCT01431131|100479315|FG001|NOT COMPLETED|Overall Study||0||
48063537|NCT02841189|100479316|FG000|STARTED|Overall Study||100||
48063538|NCT02841189|100479316|FG000|COMPLETED|Overall Study||65||
48063539|NCT02841189|100479316|FG000|NOT COMPLETED|Overall Study||35||
48063540|NCT02413372|100479317|FG000|STARTED|Treatment||25||
48063541|NCT02413372|100479318|FG001|STARTED|Treatment||24||
48063542|NCT02413372|100479319|FG002|STARTED|Treatment||26||
48063543|NCT02413372|100479317|FG000|COMPLETED|Treatment||24||
48063544|NCT02413372|100479318|FG001|COMPLETED|Treatment||22||
48063545|NCT02413372|100479319|FG002|COMPLETED|Treatment||25||
48063546|NCT02413372|100479317|FG000|NOT COMPLETED|Treatment||1||
48063547|NCT02413372|100479318|FG001|NOT COMPLETED|Treatment||2||
48063548|NCT02413372|100479319|FG002|NOT COMPLETED|Treatment||1||
48063549|NCT02413372|100479317|FG000|STARTED|Follow-up||22||
48063550|NCT02413372|100479318|FG001|STARTED|Follow-up||21||
48063551|NCT02413372|100479319|FG002|STARTED|Follow-up||25||
48063552|NCT02413372|100479317|FG000|COMPLETED|Follow-up||20||
48063553|NCT02413372|100479318|FG001|COMPLETED|Follow-up||20||
48063554|NCT02413372|100479319|FG002|COMPLETED|Follow-up||23||
48063555|NCT02413372|100479317|FG000|NOT COMPLETED|Follow-up||2||
48063556|NCT02413372|100479318|FG001|NOT COMPLETED|Follow-up||1||
48063557|NCT02413372|100479319|FG002|NOT COMPLETED|Follow-up||2||
48063558|NCT03257371|100479320|FG000|STARTED|Overall Study||10||
48063559|NCT03257371|100479320|FG000|COMPLETED|Overall Study||9||
48063560|NCT03257371|100479320|FG000|NOT COMPLETED|Overall Study||1||
48063561|NCT06448078|100479321|FG000|STARTED|Overall Study||14||
48063562|NCT06448078|100479322|FG001|STARTED|Overall Study||20||
48063563|NCT06448078|100479321|FG000|COMPLETED|Overall Study||14||
48063564|NCT06448078|100479322|FG001|COMPLETED|Overall Study||20||
48063565|NCT06448078|100479321|FG000|NOT COMPLETED|Overall Study||0||
48063566|NCT06448078|100479322|FG001|NOT COMPLETED|Overall Study||0||
48063567|NCT01739361|100479323|FG000|STARTED|Overall Study||21||
48063568|NCT01739361|100479324|FG001|STARTED|Overall Study||23||
48063569|NCT01739361|100479323|FG000|COMPLETED|Overall Study||18||
48063570|NCT01739361|100479324|FG001|COMPLETED|Overall Study||22||
48063571|NCT01739361|100479323|FG000|NOT COMPLETED|Overall Study||3||
48063572|NCT01739361|100479324|FG001|NOT COMPLETED|Overall Study||1||
48063573|NCT01578330|100479325|FG000|STARTED|Overall Study||42||
48063574|NCT01578330|100479325|FG000|Per Protocol Population|Overall Study||35||
48063575|NCT01578330|100479325|FG000|COMPLETED|Overall Study||35||
48063576|NCT01578330|100479325|FG000|NOT COMPLETED|Overall Study||7||
48063577|NCT01528033|100479326|FG000|STARTED|Primary Endpoint Assessment ITT||273||
48063578|NCT01528033|100479327|FG001|STARTED|Primary Endpoint Assessment ITT||266||
48218610|NCT00873782|100860337|FG000|STARTED|Overall Study||16||
48218611|NCT00873782|100860337|FG000|COMPLETED|Overall Study||16||
48508226|NCT01937351|101580067|FG000|COMPLETED|Overall Study||125||
48508227|NCT01937351|101580068|FG001|COMPLETED|Overall Study||26||
48063579|NCT01528033|100479326|FG000|COMPLETED|Primary Endpoint Assessment ITT||256||
48063580|NCT01528033|100479327|FG001|COMPLETED|Primary Endpoint Assessment ITT||251||
48063581|NCT01528033|100479326|FG000|NOT COMPLETED|Primary Endpoint Assessment ITT||17||
48063582|NCT01528033|100479327|FG001|NOT COMPLETED|Primary Endpoint Assessment ITT||15||
48063583|NCT01528033|100479326|FG000|STARTED|Follow Up||256||
48063584|NCT01528033|100479327|FG001|STARTED|Follow Up||251||
48063585|NCT01528033|100479326|FG000|COMPLETED|Follow Up||210||
48063586|NCT01528033|100479327|FG001|COMPLETED|Follow Up||207||
48063587|NCT01528033|100479326|FG000|NOT COMPLETED|Follow Up||46||
48063588|NCT01528033|100479327|FG001|NOT COMPLETED|Follow Up||44||
48063589|NCT03001882|100479328|FG000|STARTED|Overall Study||31||
48063590|NCT03001882|100479329|FG001|STARTED|Overall Study||28||
48063591|NCT03001882|100479330|FG002|STARTED|Overall Study||1||
48063592|NCT03001882|100479331|FG003|STARTED|Overall Study||170||
48063593|NCT03001882|100479328|FG000|COMPLETED|Overall Study||0|Continuing in treatment period|
48063594|NCT03001882|100479329|FG001|COMPLETED|Overall Study||0|Continuing in treatment period|
48063595|NCT03001882|100479330|FG002|COMPLETED|Overall Study||0|Continuing in treatment period|
48063596|NCT03001882|100479331|FG003|COMPLETED|Overall Study||0|Continuing in treatment period|
48063597|NCT03001882|100479328|FG000|NOT COMPLETED|Overall Study||31||
48063598|NCT03001882|100479329|FG001|NOT COMPLETED|Overall Study||28||
48218612|NCT00873782|100860337|FG000|NOT COMPLETED|Overall Study||0||
48063599|NCT03001882|100479330|FG002|NOT COMPLETED|Overall Study||1||
48063600|NCT03001882|100479331|FG003|NOT COMPLETED|Overall Study||170||
48063601|NCT01680887|100479332|FG000|STARTED|Overall Study||80||
48063602|NCT01680887|100479333|FG001|STARTED|Overall Study||76||
48063603|NCT01680887|100479332|FG000|COMPLETED|Overall Study||51||
48063604|NCT01680887|100479333|FG001|COMPLETED|Overall Study||52||
48063605|NCT01680887|100479332|FG000|NOT COMPLETED|Overall Study||29||
48063606|NCT01680887|100479333|FG001|NOT COMPLETED|Overall Study||24||
48063607|NCT05012657|100479334|FG000|STARTED|Overall Study||5||
48063608|NCT05012657|100479334|FG000|COMPLETED|Overall Study||5||
48063609|NCT05012657|100479334|FG000|NOT COMPLETED|Overall Study||0||
48063610|NCT02003365|100479335|FG000|STARTED|Overall Study||10||
48218613|NCT02789020|100860338|FG000|STARTED|Overall Study||45||
48063611|NCT02003365|100479336|FG001|STARTED|Overall Study||30||
48063612|NCT02003365|100479337|FG002|STARTED|Overall Study||10||
48063613|NCT02003365|100479335|FG000|COMPLETED|Overall Study||10||
48063614|NCT02003365|100479336|FG001|COMPLETED|Overall Study||30||
48063615|NCT02003365|100479337|FG002|COMPLETED|Overall Study||9||
48063616|NCT02003365|100479335|FG000|NOT COMPLETED|Overall Study||0||
48063617|NCT02003365|100479336|FG001|NOT COMPLETED|Overall Study||0||
48063618|NCT02003365|100479337|FG002|NOT COMPLETED|Overall Study||1||
48063619|NCT00989157|100479338|FG000|STARTED|Overall Study||10||
48063620|NCT00989157|100479339|FG001|STARTED|Overall Study||10||
48063621|NCT00989157|100479338|FG000|COMPLETED|Overall Study||10||
48063622|NCT00989157|100479339|FG001|COMPLETED|Overall Study||10||
48063623|NCT00989157|100479338|FG000|NOT COMPLETED|Overall Study||0||
48063624|NCT00989157|100479339|FG001|NOT COMPLETED|Overall Study||0||
48063625|NCT00484094|100479340|FG000|STARTED|Overall Study||209||
48063626|NCT00484094|100479340|FG000|COMPLETED|Overall Study||167||
48063627|NCT00484094|100479340|FG000|NOT COMPLETED|Overall Study||42||
48063628|NCT05764408|100479341|FG000|STARTED|Overall Study||74||
48063629|NCT05764408|100479342|FG001|STARTED|Overall Study||76||
48063630|NCT05764408|100479341|FG000|COMPLETED|Overall Study||74||
48063631|NCT05764408|100479342|FG001|COMPLETED|Overall Study||76||
48063632|NCT05764408|100479341|FG000|NOT COMPLETED|Overall Study||0||
48063633|NCT05764408|100479342|FG001|NOT COMPLETED|Overall Study||0||
48063634|NCT02586064|100479343|FG000|STARTED|Overall Study||61||
48063635|NCT02586064|100479344|FG001|STARTED|Overall Study||54||
48063636|NCT02586064|100479343|FG000|COMPLETED|Overall Study||43||
48063637|NCT02586064|100479344|FG001|COMPLETED|Overall Study||26||
48218614|NCT02789020|100860339|FG001|STARTED|Overall Study||45||
48218615|NCT02789020|100860338|FG000|COMPLETED|Overall Study||39||
48218616|NCT02789020|100860339|FG001|COMPLETED|Overall Study||40||
48063638|NCT02586064|100479343|FG000|NOT COMPLETED|Overall Study||18||
48063639|NCT02586064|100479344|FG001|NOT COMPLETED|Overall Study||28||
48063640|NCT00502944|100479345|FG000|STARTED|Overall Study||2446||
48063641|NCT00502944|100479346|FG001|STARTED|Overall Study||2409||
48063642|NCT00502944|100479345|FG000|COMPLETED|Overall Study||1382||
48063643|NCT00502944|100479346|FG001|COMPLETED|Overall Study||643||
48063644|NCT00502944|100479345|FG000|NOT COMPLETED|Overall Study||1064||
48063645|NCT00502944|100479346|FG001|NOT COMPLETED|Overall Study||1766||
48063646|NCT00834678|100479347|FG000|STARTED|Overall Study||11||
48063647|NCT00834678|100479347|FG000|COMPLETED|Overall Study||11||
48063648|NCT00834678|100479347|FG000|NOT COMPLETED|Overall Study||0||
48063649|NCT03911713|100479348|FG000|STARTED|Overall Study||12||
48063650|NCT03911713|100479349|FG001|STARTED|Overall Study||6||
48063651|NCT03911713|100479350|FG002|STARTED|Overall Study||11||
48063652|NCT03911713|100479351|FG003|STARTED|Overall Study||24||
48063653|NCT03911713|100479352|FG004|STARTED|Overall Study||24||
48063654|NCT03911713|100479348|FG000|Full Analysis Set|Overall Study||11|Received at least 1 dose of study drug in treatment period.|
48063655|NCT03911713|100479349|FG001|Full Analysis Set|Overall Study||6|Received at least 1 dose of study drug in treatment period.|
48063656|NCT03911713|100479350|FG002|Full Analysis Set|Overall Study||11|Received at least 1 dose of study drug in treatment period.|
48063657|NCT03911713|100479351|FG003|Full Analysis Set|Overall Study||23|Received at least 1 dose of study drug in treatment period.|
48063658|NCT03911713|100479352|FG004|Full Analysis Set|Overall Study||24|Received at least 1 dose of study drug in treatment period.|
48063659|NCT03911713|100479348|FG000|COMPLETED|Overall Study||11||
48063660|NCT03911713|100479349|FG001|COMPLETED|Overall Study||4||
48063661|NCT03911713|100479350|FG002|COMPLETED|Overall Study||11||
48063662|NCT03911713|100479351|FG003|COMPLETED|Overall Study||22||
48063663|NCT03911713|100479352|FG004|COMPLETED|Overall Study||24||
48063664|NCT03911713|100479348|FG000|NOT COMPLETED|Overall Study||1||
48063665|NCT03911713|100479349|FG001|NOT COMPLETED|Overall Study||2||
48063666|NCT03911713|100479350|FG002|NOT COMPLETED|Overall Study||0||
48063667|NCT03911713|100479351|FG003|NOT COMPLETED|Overall Study||2||
48063668|NCT03911713|100479352|FG004|NOT COMPLETED|Overall Study||0||
48063669|NCT02149719|100479353|FG000|STARTED|Overall Study||32||
48063670|NCT02149719|100479354|FG001|STARTED|Overall Study||15||
48063671|NCT02149719|100479353|FG000|COMPLETED|Overall Study||24||
48063672|NCT02149719|100479354|FG001|COMPLETED|Overall Study||14||
48063673|NCT02149719|100479353|FG000|NOT COMPLETED|Overall Study||8||
48063674|NCT02149719|100479354|FG001|NOT COMPLETED|Overall Study||1||
48063675|NCT00100178|100479355|FG000|STARTED|Overall Study||41||
48218617|NCT02789020|100860338|FG000|NOT COMPLETED|Overall Study||6||
48063676|NCT00100178|100479356|FG001|STARTED|Overall Study||31||
48063677|NCT00100178|100479357|FG002|STARTED|Overall Study||42||
48063678|NCT00100178|100479355|FG000|COMPLETED|Overall Study||32||
48063679|NCT00100178|100479356|FG001|COMPLETED|Overall Study||21||
48063680|NCT00100178|100479357|FG002|COMPLETED|Overall Study||32||
48063681|NCT00100178|100479355|FG000|NOT COMPLETED|Overall Study||9||
48063682|NCT00100178|100479356|FG001|NOT COMPLETED|Overall Study||10||
48063683|NCT00100178|100479357|FG002|NOT COMPLETED|Overall Study||10||
48063684|NCT00891462|100479358|FG000|STARTED|Overall Study||186||
48063685|NCT00891462|100479359|FG001|STARTED|Overall Study||185||
48063686|NCT00891462|100479360|FG002|STARTED|Overall Study||190||
48063687|NCT00891462|100479358|FG000|COMPLETED|Overall Study||149||
48063688|NCT00891462|100479359|FG001|COMPLETED|Overall Study||152||
48218618|NCT02789020|100860339|FG001|NOT COMPLETED|Overall Study||5||
48218619|NCT02765100|100860340|FG000|STARTED|Overall Study||9||
48063689|NCT00891462|100479360|FG002|COMPLETED|Overall Study||166||
48063690|NCT00891462|100479358|FG000|NOT COMPLETED|Overall Study||37||
48063691|NCT00891462|100479359|FG001|NOT COMPLETED|Overall Study||33||
48063692|NCT00891462|100479360|FG002|NOT COMPLETED|Overall Study||24||
48063693|NCT01967433|100479361|FG000|STARTED|Overall Study||61||
48063694|NCT01967433|100479362|FG001|STARTED|Overall Study||59||
48063695|NCT01967433|100479361|FG000|COMPLETED|Overall Study||61||
48063696|NCT01967433|100479362|FG001|COMPLETED|Overall Study||58||
48063697|NCT01967433|100479361|FG000|NOT COMPLETED|Overall Study||0||
48063698|NCT01967433|100479362|FG001|NOT COMPLETED|Overall Study||1||
48063699|NCT00315146|100479363|FG000|STARTED|Overall Study||22||
48063700|NCT00315146|100479364|FG001|STARTED|Overall Study||22||
48063701|NCT00315146|100479365|FG002|STARTED|Overall Study||22||
48063702|NCT00315146|100479366|FG003|STARTED|Overall Study||22||
48063703|NCT00315146|100479363|FG000|COMPLETED|Overall Study||20||
48063704|NCT00315146|100479364|FG001|COMPLETED|Overall Study||19||
48063705|NCT00315146|100479365|FG002|COMPLETED|Overall Study||20||
48063706|NCT00315146|100479366|FG003|COMPLETED|Overall Study||22||
48063707|NCT00315146|100479363|FG000|NOT COMPLETED|Overall Study||2||
48063708|NCT00315146|100479364|FG001|NOT COMPLETED|Overall Study||3||
48063709|NCT00315146|100479365|FG002|NOT COMPLETED|Overall Study||2||
48063710|NCT00315146|100479366|FG003|NOT COMPLETED|Overall Study||0||
48063711|NCT02349542|100479367|FG000|STARTED|Overall Study||20||
48063712|NCT02349542|100479367|FG000|COMPLETED|Overall Study||15|Patients were withdrawn from the study if they did not schedule surgery or canceled their surgery.|
48063713|NCT02349542|100479367|FG000|NOT COMPLETED|Overall Study||5||
48063714|NCT00257608|100479368|FG000|STARTED|Chemotherapy Phase||1145||
48063715|NCT00257608|100479369|FG001|STARTED|Chemotherapy Phase||0||
48063716|NCT00257608|100479370|FG002|STARTED|Chemotherapy Phase||0||
48063717|NCT00257608|100479368|FG000|COMPLETED|Chemotherapy Phase||769||
48063718|NCT00257608|100479369|FG001|COMPLETED|Chemotherapy Phase||0||
48063719|NCT00257608|100479370|FG002|COMPLETED|Chemotherapy Phase||0||
48063720|NCT00257608|100479368|FG000|NOT COMPLETED|Chemotherapy Phase||376||
48063721|NCT00257608|100479369|FG001|NOT COMPLETED|Chemotherapy Phase||0||
48063722|NCT00257608|100479370|FG002|NOT COMPLETED|Chemotherapy Phase||0||
48063723|NCT00257608|100479368|FG000|STARTED|Post Chemotherapy Phase||0||
48063724|NCT00257608|100479369|FG001|STARTED|Post Chemotherapy Phase||373||
48063725|NCT00257608|100479370|FG002|STARTED|Post Chemotherapy Phase||370||
48063726|NCT00257608|100479368|FG000|COMPLETED|Post Chemotherapy Phase||0||
48063727|NCT00257608|100479369|FG001|COMPLETED|Post Chemotherapy Phase||109||
48063728|NCT00257608|100479370|FG002|COMPLETED|Post Chemotherapy Phase||126||
48063729|NCT00257608|100479368|FG000|NOT COMPLETED|Post Chemotherapy Phase||0||
48063730|NCT00257608|100479369|FG001|NOT COMPLETED|Post Chemotherapy Phase||264||
48063731|NCT00257608|100479370|FG002|NOT COMPLETED|Post Chemotherapy Phase||244||
48063732|NCT00946478|100479371|FG000|STARTED|Overall Study||20||
48063733|NCT00946478|100479372|FG001|STARTED|Overall Study||20||
48063734|NCT00946478|100479371|FG000|COMPLETED|Overall Study||20||
48063735|NCT00946478|100479372|FG001|COMPLETED|Overall Study||20||
48063736|NCT00946478|100479371|FG000|NOT COMPLETED|Overall Study||0||
48063737|NCT00946478|100479372|FG001|NOT COMPLETED|Overall Study||0||
48063738|NCT03750461|100479373|FG000|STARTED|Overall Study||20||
48063739|NCT03750461|100479374|FG001|STARTED|Overall Study||92||
48063740|NCT03750461|100479373|FG000|Primary Endpoint|Overall Study||20||
48063741|NCT03750461|100479374|FG001|Primary Endpoint|Overall Study||92||
48063742|NCT03750461|100479373|FG000|Secondary Endpoint|Overall Study||19||
48063743|NCT03750461|100479374|FG001|Secondary Endpoint|Overall Study||0||
48063744|NCT03750461|100479373|FG000|COMPLETED|Overall Study||19|Ongoing Follow-up|
48063745|NCT03750461|100479374|FG001|COMPLETED|Overall Study||0|Ongoing Follow-up|
48063746|NCT03750461|100479373|FG000|NOT COMPLETED|Overall Study||1||
48063747|NCT03750461|100479374|FG001|NOT COMPLETED|Overall Study||92||
48063748|NCT01973569|100479375|FG000|STARTED|Overall Study||228||
48063749|NCT01973569|100479376|FG001|STARTED|Overall Study||225||
48063750|NCT01973569|100479377|FG002|STARTED|Overall Study||226||
48063751|NCT01973569|100479375|FG000|Received Study Drug|Overall Study||222||
48063752|NCT01973569|100479376|FG001|Received Study Drug|Overall Study||222||
48063753|NCT01973569|100479377|FG002|Received Study Drug|Overall Study||223||
48063754|NCT01973569|100479375|FG000|Did Not Receive Study Drug|Overall Study||6||
48063755|NCT01973569|100479376|FG001|Did Not Receive Study Drug|Overall Study||3||
48063756|NCT01973569|100479377|FG002|Did Not Receive Study Drug|Overall Study||3||
48063757|NCT01973569|100479375|FG000|Discontinued Study Treatment|Overall Study||23||
48063758|NCT01973569|100479376|FG001|Discontinued Study Treatment|Overall Study||22||
48063759|NCT01973569|100479377|FG002|Discontinued Study Treatment|Overall Study||15||
48063760|NCT01973569|100479375|FG000|Discontinued Study|Overall Study||23||
48063761|NCT01973569|100479376|FG001|Discontinued Study|Overall Study||22||
48063762|NCT01973569|100479377|FG002|Discontinued Study|Overall Study||15||
48063763|NCT01973569|100479375|FG000|COMPLETED|Overall Study||199||
48063764|NCT01973569|100479376|FG001|COMPLETED|Overall Study||200||
48063765|NCT01973569|100479377|FG002|COMPLETED|Overall Study||208||
48063766|NCT01973569|100479375|FG000|NOT COMPLETED|Overall Study||29||
48063767|NCT01973569|100479376|FG001|NOT COMPLETED|Overall Study||25||
48218620|NCT02765100|100860341|FG001|STARTED|Overall Study||12||
48218621|NCT02765100|100860340|FG000|COMPLETED|Overall Study||8||
48218622|NCT02765100|100860341|FG001|COMPLETED|Overall Study||10||
48218623|NCT02765100|100860340|FG000|NOT COMPLETED|Overall Study||1||
48218624|NCT02765100|100860341|FG001|NOT COMPLETED|Overall Study||2||
48508228|NCT01937351|101580067|FG000|NOT COMPLETED|Overall Study||9||
48508229|NCT01937351|101580068|FG001|NOT COMPLETED|Overall Study||2||
48508230|NCT03241745|101580069|FG000|STARTED|Overall Study||35||
48508231|NCT03241745|101580069|FG000|COMPLETED|Overall Study||6||
48508232|NCT03241745|101580069|FG000|NOT COMPLETED|Overall Study||29||
48508233|NCT03438006|101580070|FG000|STARTED|Overall Study||3013||
48063768|NCT01973569|100479377|FG002|NOT COMPLETED|Overall Study||18||
48063769|NCT00302107|100479378|FG000|STARTED|Overall Study||39||
48063770|NCT00302107|100479379|FG001|STARTED|Overall Study||39||
48063771|NCT00302107|100479378|FG000|COMPLETED|Overall Study||31||
48063772|NCT00302107|100479379|FG001|COMPLETED|Overall Study||30||
48063773|NCT00302107|100479378|FG000|NOT COMPLETED|Overall Study||8||
48063774|NCT00302107|100479379|FG001|NOT COMPLETED|Overall Study||9||
48063775|NCT02127710|100479380|FG000|STARTED|Overall Study||46||
48063776|NCT02127710|100479381|FG001|STARTED|Overall Study||47||
48063777|NCT02127710|100479382|FG002|STARTED|Overall Study||16||
48063778|NCT02127710|100479380|FG000|COMPLETED|Overall Study||46||
48063779|NCT02127710|100479381|FG001|COMPLETED|Overall Study||47||
48063780|NCT02127710|100479382|FG002|COMPLETED|Overall Study||16||
48063781|NCT02127710|100479380|FG000|NOT COMPLETED|Overall Study||0||
48063782|NCT02127710|100479381|FG001|NOT COMPLETED|Overall Study||0||
48063783|NCT02127710|100479382|FG002|NOT COMPLETED|Overall Study||0||
48063784|NCT00864721|100479383|FG000|STARTED|Overall Study||63||
48063785|NCT00864721|100479383|FG000|COMPLETED|Overall Study||29||
48063786|NCT00864721|100479383|FG000|NOT COMPLETED|Overall Study||34||
48063787|NCT00287365|100479384|FG000|STARTED|Overall Study||25||
48063788|NCT00287365|100479384|FG000|COMPLETED|Overall Study||12||
48063789|NCT00287365|100479384|FG000|NOT COMPLETED|Overall Study||13||
48063790|NCT01759511|100479385|FG000|STARTED|Overall Study||34||
48063791|NCT01759511|100479385|FG000|COMPLETED|Overall Study||0||
48063792|NCT01759511|100479385|FG000|NOT COMPLETED|Overall Study||34||
48063793|NCT01934972|100479386|FG000|STARTED|Overall Study||13||
48063794|NCT01934972|100479387|FG001|STARTED|Overall Study||11||
48063795|NCT01934972|100479386|FG000|COMPLETED|Overall Study||4||
48063796|NCT01934972|100479387|FG001|COMPLETED|Overall Study||5||
48063797|NCT01934972|100479386|FG000|NOT COMPLETED|Overall Study||9||
48063798|NCT01934972|100479387|FG001|NOT COMPLETED|Overall Study||6||
48063799|NCT01464996|100479388|FG000|STARTED|Overall Study||24||
48063800|NCT01464996|100479388|FG000|OptiBond XTR|Overall Study||23||
48063801|NCT01464996|100479388|FG000|OptiBond FL|Overall Study||24||
48063802|NCT01464996|100479388|FG000|COMPLETED|Overall Study||24||
48063803|NCT01464996|100479388|FG000|NOT COMPLETED|Overall Study||0||
48063804|NCT01254630|100479389|FG000|STARTED|Overall Study||1348||
48063805|NCT01254630|100479390|FG001|STARTED|Overall Study||1288||
48063806|NCT01254630|100479391|FG002|STARTED|Overall Study||1364||
48063807|NCT01254630|100479392|FG003|STARTED|Overall Study||1285||
48063808|NCT01254630|100479389|FG000|Received Vaccination 1|Overall Study||1328||
48063809|NCT01254630|100479390|FG001|Received Vaccination 1|Overall Study||1277||
48063810|NCT01254630|100479391|FG002|Received Vaccination 1|Overall Study||1350||
48063811|NCT01254630|100479392|FG003|Received Vaccination 1|Overall Study||1275||
48063812|NCT01254630|100479389|FG000|Received Vaccination 2|Overall Study||1255||
48063813|NCT01254630|100479390|FG001|Received Vaccination 2|Overall Study||1217||
48063814|NCT01254630|100479391|FG002|Received Vaccination 2|Overall Study||1286||
48063815|NCT01254630|100479392|FG003|Received Vaccination 2|Overall Study||1226||
48063816|NCT01254630|100479389|FG000|Received Vaccination 3|Overall Study||1198||
48063817|NCT01254630|100479390|FG001|Received Vaccination 3|Overall Study||1178||
48063818|NCT01254630|100479391|FG002|Received Vaccination 3|Overall Study||1247||
48063819|NCT01254630|100479392|FG003|Received Vaccination 3|Overall Study||1194||
48063820|NCT01254630|100479389|FG000|Received Vaccination 4|Overall Study||1155||
48063821|NCT01254630|100479390|FG001|Received Vaccination 4|Overall Study||1145||
48063822|NCT01254630|100479391|FG002|Received Vaccination 4|Overall Study||1212||
48063823|NCT01254630|100479392|FG003|Received Vaccination 4|Overall Study||1160||
48063824|NCT01254630|100479389|FG000|COMPLETED|Overall Study||546||
48063825|NCT01254630|100479390|FG001|COMPLETED|Overall Study||0||
48063826|NCT01254630|100479391|FG002|COMPLETED|Overall Study||552||
48218625|NCT01738438|100860342|FG000|STARTED|Overall Study||35||
48508234|NCT03438006|101580070|FG000|COMPLETED|Overall Study||2895||
48508235|NCT03438006|101580070|FG000|NOT COMPLETED|Overall Study||118||
48508236|NCT03431337|101580071|FG000|STARTED|Overall Study||78||
48508237|NCT03431337|101580072|FG001|STARTED|Overall Study||79||
48508238|NCT03431337|101580071|FG000|COMPLETED|Overall Study||49||
48508239|NCT03431337|101580072|FG001|COMPLETED|Overall Study||57||
48508240|NCT03431337|101580071|FG000|NOT COMPLETED|Overall Study||29||
48508241|NCT03431337|101580072|FG001|NOT COMPLETED|Overall Study||22||
48508242|NCT00517192|101580073|FG000|STARTED|Overall Study||19||
48508243|NCT00517192|101580074|FG001|STARTED|Overall Study||20||
48508244|NCT00517192|101580073|FG000|COMPLETED|Overall Study||0||
48508245|NCT00517192|101580074|FG001|COMPLETED|Overall Study||0||
48508246|NCT00517192|101580073|FG000|NOT COMPLETED|Overall Study||19||
48508247|NCT00517192|101580074|FG001|NOT COMPLETED|Overall Study||20||
48508248|NCT03840382|101580075|FG000|STARTED|Overall Study||74||
48508249|NCT03840382|101580075|FG000|COMPLETED|Overall Study||63||
48508250|NCT03840382|101580075|FG000|NOT COMPLETED|Overall Study||11||
48508251|NCT01261624|101580076|FG000|STARTED|Week 0 to Week 12||10||
48508252|NCT01261624|101580077|FG001|STARTED|Week 0 to Week 12||6||
48508253|NCT01261624|101580076|FG000|COMPLETED|Week 0 to Week 12||9||
48508254|NCT01261624|101580077|FG001|COMPLETED|Week 0 to Week 12||3||
48508255|NCT01261624|101580076|FG000|NOT COMPLETED|Week 0 to Week 12||1||
48508256|NCT01261624|101580077|FG001|NOT COMPLETED|Week 0 to Week 12||3||
48508257|NCT01261624|101580076|FG000|STARTED|Week 13 to Week 24||1||
48508258|NCT01261624|101580077|FG001|STARTED|Week 13 to Week 24||11||
48508259|NCT01261624|101580076|FG000|COMPLETED|Week 13 to Week 24||1||
48063827|NCT01254630|100479392|FG003|COMPLETED|Overall Study||0||
48063828|NCT01254630|100479389|FG000|NOT COMPLETED|Overall Study||802||
48063829|NCT01254630|100479390|FG001|NOT COMPLETED|Overall Study||1288||
48063830|NCT01254630|100479391|FG002|NOT COMPLETED|Overall Study||812||
48063831|NCT01254630|100479392|FG003|NOT COMPLETED|Overall Study||1285||
48063832|NCT02180165|100479393|FG000|STARTED|Overall Study||15|Randomized participants|
48063833|NCT02180165|100479394|FG001|STARTED|Overall Study||7|Randomized participants|
48063834|NCT02180165|100479395|FG002|STARTED|Overall Study||63|Randomized participants|
48063835|NCT02180165|100479396|FG003|STARTED|Overall Study||31|Randomized participants|
48063836|NCT02180165|100479393|FG000|Treated Participants|Overall Study||15||
48063837|NCT02180165|100479394|FG001|Treated Participants|Overall Study||7||
48063838|NCT02180165|100479395|FG002|Treated Participants|Overall Study||62||
48063839|NCT02180165|100479396|FG003|Treated Participants|Overall Study||31||
48063840|NCT02180165|100479393|FG000|Type of Aspergillosis|Overall Study||15||
48063841|NCT02180165|100479394|FG001|Type of Aspergillosis|Overall Study||7||
48063842|NCT02180165|100479395|FG002|Type of Aspergillosis|Overall Study||57||
48063843|NCT02180165|100479396|FG003|Type of Aspergillosis|Overall Study||27||
48508260|NCT01261624|101580077|FG001|COMPLETED|Week 13 to Week 24||10||
48508261|NCT01261624|101580076|FG000|NOT COMPLETED|Week 13 to Week 24||0||
48508262|NCT01261624|101580077|FG001|NOT COMPLETED|Week 13 to Week 24||1||
48508263|NCT00351351|101580078|FG000|STARTED|Overall Study||34||
48508264|NCT00351351|101580079|FG001|STARTED|Overall Study||36||
48508265|NCT00351351|101580078|FG000|COMPLETED|Overall Study||25||
48508266|NCT00351351|101580079|FG001|COMPLETED|Overall Study||32||
48508267|NCT00351351|101580078|FG000|NOT COMPLETED|Overall Study||9||
48508268|NCT00351351|101580079|FG001|NOT COMPLETED|Overall Study||4||
48508269|NCT05135273|101580080|FG000|STARTED|Overall Study||5||
48508270|NCT05135273|101580081|FG001|STARTED|Overall Study||5||
48508271|NCT05135273|101580082|FG002|STARTED|Overall Study||5||
48508272|NCT05135273|101580083|FG003|STARTED|Overall Study||4||
48508273|NCT05135273|101580084|FG004|STARTED|Overall Study||14||
48508274|NCT05135273|101580085|FG005|STARTED|Overall Study||14||
48508275|NCT05135273|101580086|FG006|STARTED|Overall Study||15||
48508276|NCT05135273|101580087|FG007|STARTED|Overall Study||16||
48063844|NCT02180165|100479393|FG000|COMPLETED|Overall Study||4|Completed Through Day 84|
48063845|NCT02180165|100479394|FG001|COMPLETED|Overall Study||6|Completed Through Day 84|
48063846|NCT02180165|100479395|FG002|COMPLETED|Overall Study||34|Completed Through Day 84|
48063847|NCT02180165|100479396|FG003|COMPLETED|Overall Study||25|Completed Through Day 84|
48063848|NCT02180165|100479393|FG000|NOT COMPLETED|Overall Study||11||
48063849|NCT02180165|100479394|FG001|NOT COMPLETED|Overall Study||1||
48063850|NCT02180165|100479395|FG002|NOT COMPLETED|Overall Study||29||
48063851|NCT02180165|100479396|FG003|NOT COMPLETED|Overall Study||6||
48063852|NCT01419626|100479397|FG000|STARTED|Overall Study||46||
48063853|NCT01419626|100479398|FG001|STARTED|Overall Study||47||
48063854|NCT01419626|100479399|FG002|STARTED|Overall Study||47||
48063855|NCT01419626|100479397|FG000|COMPLETED|Overall Study||42||
48063856|NCT01419626|100479398|FG001|COMPLETED|Overall Study||44||
48063857|NCT01419626|100479399|FG002|COMPLETED|Overall Study||44||
48063858|NCT01419626|100479397|FG000|NOT COMPLETED|Overall Study||4||
48063859|NCT01419626|100479398|FG001|NOT COMPLETED|Overall Study||3||
48063860|NCT01419626|100479399|FG002|NOT COMPLETED|Overall Study||3||
48508277|NCT05135273|101580080|FG000|COMPLETED|Overall Study||5||
48508278|NCT05135273|101580081|FG001|COMPLETED|Overall Study||5||
48508279|NCT05135273|101580082|FG002|COMPLETED|Overall Study||5||
48508280|NCT05135273|101580083|FG003|COMPLETED|Overall Study||4||
48508281|NCT05135273|101580084|FG004|COMPLETED|Overall Study||13||
48508282|NCT05135273|101580085|FG005|COMPLETED|Overall Study||13||
48508283|NCT05135273|101580086|FG006|COMPLETED|Overall Study||14||
48508284|NCT05135273|101580087|FG007|COMPLETED|Overall Study||15||
48508285|NCT05135273|101580080|FG000|NOT COMPLETED|Overall Study||0||
48508286|NCT05135273|101580081|FG001|NOT COMPLETED|Overall Study||0||
48508287|NCT05135273|101580082|FG002|NOT COMPLETED|Overall Study||0||
48508288|NCT05135273|101580083|FG003|NOT COMPLETED|Overall Study||0||
48508289|NCT05135273|101580084|FG004|NOT COMPLETED|Overall Study||1||
48508290|NCT05135273|101580085|FG005|NOT COMPLETED|Overall Study||1||
48508291|NCT05135273|101580086|FG006|NOT COMPLETED|Overall Study||1||
48508292|NCT05135273|101580087|FG007|NOT COMPLETED|Overall Study||1||
48508293|NCT04072315|101580088|FG000|STARTED|Overall Study||1||
48508294|NCT04072315|101580089|FG001|STARTED|Overall Study||1||
48508295|NCT04072315|101580090|FG002|STARTED|Overall Study||1||
48508296|NCT04072315|101580091|FG003|STARTED|Overall Study||2||
48508297|NCT04072315|101580092|FG004|STARTED|Overall Study||1||
48508298|NCT04072315|101580093|FG005|STARTED|Overall Study||1||
48508299|NCT04072315|101580094|FG006|STARTED|Overall Study||1||
48508300|NCT04072315|101580095|FG007|STARTED|Overall Study||1||
48508301|NCT04072315|101580088|FG000|COMPLETED|Overall Study||1||
48508302|NCT04072315|101580089|FG001|COMPLETED|Overall Study||1||
48508303|NCT04072315|101580090|FG002|COMPLETED|Overall Study||0||
48508304|NCT04072315|101580091|FG003|COMPLETED|Overall Study||2||
48508305|NCT04072315|101580092|FG004|COMPLETED|Overall Study||1||
48508306|NCT04072315|101580093|FG005|COMPLETED|Overall Study||1||
48508307|NCT04072315|101580094|FG006|COMPLETED|Overall Study||1||
48508308|NCT04072315|101580095|FG007|COMPLETED|Overall Study||1||
48508309|NCT04072315|101580088|FG000|NOT COMPLETED|Overall Study||0||
48508310|NCT04072315|101580089|FG001|NOT COMPLETED|Overall Study||0||
48508311|NCT04072315|101580090|FG002|NOT COMPLETED|Overall Study||1||
48508312|NCT04072315|101580091|FG003|NOT COMPLETED|Overall Study||0||
48508313|NCT04072315|101580092|FG004|NOT COMPLETED|Overall Study||0||
48508314|NCT04072315|101580093|FG005|NOT COMPLETED|Overall Study||0||
48508315|NCT04072315|101580094|FG006|NOT COMPLETED|Overall Study||0||
48508316|NCT04072315|101580095|FG007|NOT COMPLETED|Overall Study||0||
48508317|NCT01265667|101580096|FG000|STARTED|Overall Study||145||
48508318|NCT01265667|101580097|FG001|STARTED|Overall Study||148||
48508319|NCT01265667|101580096|FG000|COMPLETED|Overall Study||125||
48508320|NCT01265667|101580097|FG001|COMPLETED|Overall Study||135||
48508321|NCT01265667|101580096|FG000|NOT COMPLETED|Overall Study||20||
48508322|NCT01265667|101580097|FG001|NOT COMPLETED|Overall Study||13||
48508323|NCT04214288|101580098|FG000|STARTED|Overall Study||74||
48508324|NCT04214288|101580099|FG001|STARTED|Overall Study||73||
48508325|NCT04214288|101580100|FG002|STARTED|Overall Study||20||
48508326|NCT04214288|101580101|FG003|STARTED|Overall Study||73||
48508327|NCT04214288|101580098|FG000|COMPLETED|Overall Study||0||
48508328|NCT04214288|101580099|FG001|COMPLETED|Overall Study||0||
48508329|NCT04214288|101580100|FG002|COMPLETED|Overall Study||0||
48508330|NCT04214288|101580101|FG003|COMPLETED|Overall Study||0||
48508331|NCT04214288|101580098|FG000|NOT COMPLETED|Overall Study||74||
48508332|NCT04214288|101580099|FG001|NOT COMPLETED|Overall Study||73||
48508333|NCT04214288|101580100|FG002|NOT COMPLETED|Overall Study||20||
48508334|NCT04214288|101580101|FG003|NOT COMPLETED|Overall Study||73||
48508335|NCT02690935|101580102|FG000|STARTED|Overall Study||51||
48508336|NCT02690935|101580103|FG001|STARTED|Overall Study||51||
48508337|NCT02690935|101580102|FG000|COMPLETED|Overall Study||51||
48508338|NCT02690935|101580103|FG001|COMPLETED|Overall Study||51||
48508339|NCT02690935|101580102|FG000|NOT COMPLETED|Overall Study||0||
48508340|NCT02690935|101580103|FG001|NOT COMPLETED|Overall Study||0||
48508341|NCT00480324|101580104|FG000|STARTED|Overall Study||508||
48508342|NCT00480324|101580105|FG001|STARTED|Overall Study||257||
48508343|NCT00480324|101580104|FG000|COMPLETED|Overall Study||476||
48508344|NCT00480324|101580105|FG001|COMPLETED|Overall Study||241||
48508345|NCT00480324|101580104|FG000|NOT COMPLETED|Overall Study||32||
48508346|NCT00480324|101580105|FG001|NOT COMPLETED|Overall Study||16||
48508347|NCT01557920|101580106|FG000|STARTED|Overall Study||9||
48508348|NCT01557920|101580107|FG001|STARTED|Overall Study||9||
48508349|NCT01557920|101580106|FG000|COMPLETED|Overall Study||6||
48508350|NCT01557920|101580107|FG001|COMPLETED|Overall Study||6||
48508351|NCT01557920|101580106|FG000|NOT COMPLETED|Overall Study||3||
48508352|NCT01557920|101580107|FG001|NOT COMPLETED|Overall Study||3||
48508353|NCT01463982|101580108|FG000|STARTED|Overall Study||3||
48508354|NCT01463982|101580109|FG001|STARTED|Overall Study||8||
48508355|NCT01463982|101580110|FG002|STARTED|Overall Study||4||
48508356|NCT01463982|101580111|FG003|STARTED|Overall Study||6||
48508357|NCT01463982|101580108|FG000|COMPLETED|Overall Study||3||
48508358|NCT01463982|101580109|FG001|COMPLETED|Overall Study||7||
48508359|NCT01463982|101580110|FG002|COMPLETED|Overall Study||2||
48508360|NCT01463982|101580111|FG003|COMPLETED|Overall Study||6||
48508361|NCT01463982|101580108|FG000|NOT COMPLETED|Overall Study||0||
48508362|NCT01463982|101580109|FG001|NOT COMPLETED|Overall Study||1||
48508363|NCT01463982|101580110|FG002|NOT COMPLETED|Overall Study||2||
48508364|NCT01463982|101580111|FG003|NOT COMPLETED|Overall Study||0||
48508365|NCT05467982|101580112|FG000|STARTED|Overall Study||80||
48508366|NCT05467982|101580113|FG001|STARTED|Overall Study||82||
48508367|NCT05467982|101580112|FG000|COMPLETED|Overall Study||77||
48508368|NCT05467982|101580113|FG001|COMPLETED|Overall Study||80||
48508369|NCT05467982|101580112|FG000|NOT COMPLETED|Overall Study||3||
48508370|NCT05467982|101580113|FG001|NOT COMPLETED|Overall Study||2||
48508371|NCT00585312|101580114|FG000|STARTED|Overall Study||55||
48508372|NCT00585312|101580115|FG001|STARTED|Overall Study||51||
48508373|NCT00585312|101580114|FG000|Treated|Overall Study||53||
48508374|NCT00585312|101580115|FG001|Treated|Overall Study||48||
48508375|NCT00585312|101580114|FG000|COMPLETED|Overall Study||4||
48508376|NCT00585312|101580115|FG001|COMPLETED|Overall Study||7||
48508377|NCT00585312|101580114|FG000|NOT COMPLETED|Overall Study||51||
48508378|NCT00585312|101580115|FG001|NOT COMPLETED|Overall Study||44||
48508379|NCT00220727|101580116|FG000|STARTED|First Infusion (Week 0)||4||
48508380|NCT00220727|101580117|FG001|STARTED|First Infusion (Week 0)||4||
48508381|NCT00220727|101580116|FG000|COMPLETED|First Infusion (Week 0)||4||
48508382|NCT00220727|101580117|FG001|COMPLETED|First Infusion (Week 0)||4||
48508383|NCT00220727|101580116|FG000|NOT COMPLETED|First Infusion (Week 0)||0||
48508384|NCT00220727|101580117|FG001|NOT COMPLETED|First Infusion (Week 0)||0||
48508385|NCT00220727|101580116|FG000|STARTED|Second Infusion (Week <6)||4||
48508386|NCT00220727|101580117|FG001|STARTED|Second Infusion (Week <6)||4||
48508387|NCT00220727|101580116|FG000|COMPLETED|Second Infusion (Week <6)||3||
48508388|NCT00220727|101580117|FG001|COMPLETED|Second Infusion (Week <6)||4||
48508389|NCT00220727|101580116|FG000|NOT COMPLETED|Second Infusion (Week <6)||1||
48508390|NCT00220727|101580117|FG001|NOT COMPLETED|Second Infusion (Week <6)||0||
48508391|NCT04492397|101580118|FG000|STARTED|First Intervention||17||
48508392|NCT04492397|101580119|FG001|STARTED|First Intervention||18||
48508393|NCT04492397|101580118|FG000|COMPLETED|First Intervention||17||
48508394|NCT04492397|101580119|FG001|COMPLETED|First Intervention||18||
48508395|NCT04492397|101580118|FG000|NOT COMPLETED|First Intervention||0||
48508396|NCT04492397|101580119|FG001|NOT COMPLETED|First Intervention||0||
48508397|NCT04492397|101580118|FG000|STARTED|Second Intervention||17||
48508398|NCT04492397|101580119|FG001|STARTED|Second Intervention||18||
48508399|NCT04492397|101580118|FG000|COMPLETED|Second Intervention||17||
48508400|NCT04492397|101580119|FG001|COMPLETED|Second Intervention||18||
48508401|NCT04492397|101580118|FG000|NOT COMPLETED|Second Intervention||0||
48508402|NCT04492397|101580119|FG001|NOT COMPLETED|Second Intervention||0||
48508403|NCT01122316|101580120|FG000|STARTED|Overall Study||10||
48508404|NCT01122316|101580120|FG000|COMPLETED|Overall Study||8||
48508405|NCT01122316|101580120|FG000|NOT COMPLETED|Overall Study||2||
48508406|NCT02297841|101580121|FG000|STARTED|Overall Study||209||
48508407|NCT02297841|101580121|FG000|Induction Phase|Overall Study||209||
48508408|NCT02297841|101580121|FG000|Challenge Phase|Overall Study||201||
48508409|NCT02297841|101580121|FG000|COMPLETED|Overall Study||201||
48508410|NCT02297841|101580121|FG000|NOT COMPLETED|Overall Study||8||
48508411|NCT01109576|101580122|FG000|STARTED|Overall Study||13||
48508412|NCT01109576|101580122|FG000|COMPLETED|Overall Study||12||
48508413|NCT01109576|101580122|FG000|NOT COMPLETED|Overall Study||1||
48508414|NCT01679054|101580123|FG000|STARTED|Overall Study||45||
48508415|NCT01679054|101580124|FG001|STARTED|Overall Study||13||
48508416|NCT01679054|101580123|FG000|COMPLETED|Overall Study||45||
48508417|NCT01679054|101580124|FG001|COMPLETED|Overall Study||13||
48508418|NCT01679054|101580123|FG000|NOT COMPLETED|Overall Study||0||
48508419|NCT01679054|101580124|FG001|NOT COMPLETED|Overall Study||0||
48508420|NCT02124902|101580125|FG000|STARTED|Overall Study||123|Completion is considered receiving 6 cycles of treatment.|
48508421|NCT02124902|101580126|FG001|STARTED|Overall Study||25|Completion is considered receiving 6 cycles of treatment.|
48508422|NCT02124902|101580125|FG000|COMPLETED|Overall Study||106||
48508423|NCT02124902|101580126|FG001|COMPLETED|Overall Study||19||
48508424|NCT02124902|101580125|FG000|NOT COMPLETED|Overall Study||17||
48508425|NCT02124902|101580126|FG001|NOT COMPLETED|Overall Study||6||
48508426|NCT03904550|101580127|FG000|STARTED|Overall Study||23||
48508427|NCT03904550|101580128|FG001|STARTED|Overall Study||26||
48508428|NCT03904550|101580127|FG000|COMPLETED|Overall Study||23||
48508429|NCT03904550|101580128|FG001|COMPLETED|Overall Study||26||
48508430|NCT03904550|101580127|FG000|NOT COMPLETED|Overall Study||0||
48508431|NCT03904550|101580128|FG001|NOT COMPLETED|Overall Study||0||
48508432|NCT02948426|101580129|FG000|STARTED|Overall Study||3||
48508433|NCT02948426|101580130|FG001|STARTED|Overall Study||6||
48508434|NCT02948426|101580131|FG002|STARTED|Overall Study||3||
48508435|NCT02948426|101580132|FG003|STARTED|Overall Study||6||
48508436|NCT02948426|101580129|FG000|COMPLETED|Overall Study||3||
48508437|NCT02948426|101580130|FG001|COMPLETED|Overall Study||6||
48508438|NCT02948426|101580131|FG002|COMPLETED|Overall Study||3||
48508439|NCT02948426|101580132|FG003|COMPLETED|Overall Study||6||
48508440|NCT02948426|101580129|FG000|NOT COMPLETED|Overall Study||0||
48508441|NCT02948426|101580130|FG001|NOT COMPLETED|Overall Study||0||
48063861|NCT03881670|100479400|FG000|STARTED|Overall Study||12||
48063862|NCT03881670|100479401|FG001|STARTED|Overall Study||12||
48063863|NCT03881670|100479400|FG000|Completed First Intervention|Overall Study||12||
48508442|NCT02948426|101580131|FG002|NOT COMPLETED|Overall Study||0||
48508443|NCT02948426|101580132|FG003|NOT COMPLETED|Overall Study||0||
48508444|NCT03847974|101580133|FG000|STARTED|Overall Study||32||
48508445|NCT03847974|101580133|FG000|COMPLETED|Overall Study||26||
48508446|NCT03847974|101580133|FG000|NOT COMPLETED|Overall Study||6||
48508447|NCT04439110|101580134|FG000|STARTED|Overall Study||38||
48508448|NCT04439110|101580134|FG000|Eligible|Overall Study||36||
48508449|NCT04439110|101580134|FG000|COMPLETED|Overall Study||0|Treatment continued until disease progression or intolerability.|
48508450|NCT04439110|101580134|FG000|NOT COMPLETED|Overall Study||38||
48508451|NCT03365791|101580135|FG000|STARTED|Overall Study||76||
48508452|NCT03365791|101580135|FG000|Full Analysis Set (FAS)|Overall Study||75|The FAS includes all participants who received at least one dose of study treatment and had at least one valid post-baseline efficacy assessment.|
48508453|NCT03365791|101580135|FG000|COMPLETED|Overall Study||4||
48508454|NCT03365791|101580135|FG000|NOT COMPLETED|Overall Study||72||
48508455|NCT03180528|101580136|FG000|STARTED|Overall Study||30||
48508456|NCT03180528|101580136|FG000|COMPLETED|Overall Study||27||
48508457|NCT03180528|101580136|FG000|NOT COMPLETED|Overall Study||3||
48508458|NCT00559364|101580137|FG000|STARTED|Overall Study||30||
48508459|NCT00559364|101580138|FG001|STARTED|Overall Study||20||
48508460|NCT00559364|101580137|FG000|COMPLETED|Overall Study||29||
48508461|NCT00559364|101580138|FG001|COMPLETED|Overall Study||20||
48508462|NCT00559364|101580137|FG000|NOT COMPLETED|Overall Study||1||
48508463|NCT00559364|101580138|FG001|NOT COMPLETED|Overall Study||0||
48508464|NCT01341587|101580139|FG000|STARTED|Overall Study||4||
48508465|NCT01341587|101580140|FG001|STARTED|Overall Study||10||
48508466|NCT01341587|101580139|FG000|COMPLETED|Overall Study||0||
48508467|NCT01341587|101580140|FG001|COMPLETED|Overall Study||0||
48508468|NCT01341587|101580139|FG000|NOT COMPLETED|Overall Study||4||
48508469|NCT01341587|101580140|FG001|NOT COMPLETED|Overall Study||10||
48508470|NCT01411488|101580141|FG000|STARTED|Overall Study||41||
48508471|NCT01411488|101580142|FG001|STARTED|Overall Study||38||
48508472|NCT01411488|101580141|FG000|COMPLETED|Overall Study||41||
48508473|NCT01411488|101580142|FG001|COMPLETED|Overall Study||38||
48508474|NCT01411488|101580141|FG000|NOT COMPLETED|Overall Study||0||
48508475|NCT01411488|101580142|FG001|NOT COMPLETED|Overall Study||0||
48508476|NCT00683787|101580143|FG000|STARTED|Overall Study||3||
48508477|NCT00683787|101580144|FG001|STARTED|Overall Study||3||
48508478|NCT00683787|101580145|FG002|STARTED|Overall Study||2||
48508479|NCT00683787|101580143|FG000|COMPLETED|Overall Study||0||
48508480|NCT00683787|101580144|FG001|COMPLETED|Overall Study||0||
48508481|NCT00683787|101580145|FG002|COMPLETED|Overall Study||0||
48508482|NCT00683787|101580143|FG000|NOT COMPLETED|Overall Study||3||
48508483|NCT00683787|101580144|FG001|NOT COMPLETED|Overall Study||3||
48508484|NCT00683787|101580145|FG002|NOT COMPLETED|Overall Study||2||
48508485|NCT05103657|101580146|FG000|STARTED|Overall Study||160|Randomised|
48508486|NCT05103657|101580147|FG001|STARTED|Overall Study||158|Randomised|
48508487|NCT05103657|101580146|FG000|Treated|Overall Study||159||
48508488|NCT05103657|101580147|FG001|Treated|Overall Study||157||
48508489|NCT05103657|101580146|FG000|COMPLETED|Overall Study||133|completed planned treatment|
48508490|NCT05103657|101580147|FG001|COMPLETED|Overall Study||127|completed planned treatment|
48508491|NCT05103657|101580146|FG000|NOT COMPLETED|Overall Study||27||
48508492|NCT05103657|101580147|FG001|NOT COMPLETED|Overall Study||31||
48508493|NCT02654015|101580148|FG000|STARTED|Overall Study||50||
48508494|NCT02654015|101580148|FG000|COMPLETED|Overall Study||35||
48508495|NCT02654015|101580148|FG000|NOT COMPLETED|Overall Study||15||
48508496|NCT04220775|101580149|FG000|STARTED|Overall Study||2||
48508497|NCT04220775|101580150|FG001|STARTED|Overall Study||0||
48508498|NCT04220775|101580149|FG000|COMPLETED|Overall Study||0||
48508499|NCT04220775|101580150|FG001|COMPLETED|Overall Study||0||
48508500|NCT04220775|101580149|FG000|NOT COMPLETED|Overall Study||2||
48508501|NCT04220775|101580150|FG001|NOT COMPLETED|Overall Study||0||
48508502|NCT01755975|101580151|FG000|STARTED|Overall Study||0||
48508503|NCT01755975|101580152|FG001|STARTED|Overall Study||3||
48508504|NCT01755975|101580153|FG002|STARTED|Overall Study||7||
48508505|NCT01755975|101580154|FG003|STARTED|Overall Study||3||
48508506|NCT01755975|101580155|FG004|STARTED|Overall Study||36||
48508507|NCT01755975|101580151|FG000|COMPLETED|Overall Study||0||
48508508|NCT01755975|101580152|FG001|COMPLETED|Overall Study||3||
48508509|NCT01755975|101580153|FG002|COMPLETED|Overall Study||6||
48508510|NCT01755975|101580154|FG003|COMPLETED|Overall Study||3||
48508511|NCT01755975|101580155|FG004|COMPLETED|Overall Study||34||
48508512|NCT01755975|101580151|FG000|NOT COMPLETED|Overall Study||0||
48508513|NCT01755975|101580152|FG001|NOT COMPLETED|Overall Study||0||
48508514|NCT01755975|101580153|FG002|NOT COMPLETED|Overall Study||1||
48508515|NCT01755975|101580154|FG003|NOT COMPLETED|Overall Study||0||
48508516|NCT01755975|101580155|FG004|NOT COMPLETED|Overall Study||2||
48508517|NCT03686215|101580156|FG000|STARTED|Overall Study||357||
48508518|NCT03686215|101580157|FG001|STARTED|Overall Study||35||
48508519|NCT03686215|101580158|FG002|STARTED|Overall Study||14||
48508520|NCT03686215|101580156|FG000|COMPLETED|Overall Study||356||
48508521|NCT03686215|101580157|FG001|COMPLETED|Overall Study||35||
48508522|NCT03686215|101580158|FG002|COMPLETED|Overall Study||0||
48508523|NCT03686215|101580156|FG000|NOT COMPLETED|Overall Study||1||
48508524|NCT03686215|101580157|FG001|NOT COMPLETED|Overall Study||0||
48508525|NCT03686215|101580158|FG002|NOT COMPLETED|Overall Study||14||
48508526|NCT02093923|101580159|FG000|STARTED|Overall Study||4||
48508527|NCT02093923|101580160|FG001|STARTED|Overall Study||4||
48508528|NCT02093923|101580161|FG002|STARTED|Overall Study||5||
48508529|NCT02093923|101580162|FG003|STARTED|Overall Study||12||
48508530|NCT02093923|101580163|FG004|STARTED|Overall Study||13||
48508531|NCT02093923|101580159|FG000|Total Treated|Overall Study||4||
48508532|NCT02093923|101580160|FG001|Total Treated|Overall Study||4||
48508533|NCT02093923|101580161|FG002|Total Treated|Overall Study||5||
48508534|NCT02093923|101580162|FG003|Total Treated|Overall Study||11||
48508535|NCT02093923|101580163|FG004|Total Treated|Overall Study||13||
48508536|NCT02093923|101580159|FG000|Treated - 1 Dose Only:|Overall Study||0||
48508537|NCT02093923|101580160|FG001|Treated - 1 Dose Only:|Overall Study||0||
48508538|NCT02093923|101580161|FG002|Treated - 1 Dose Only:|Overall Study||0||
48508539|NCT02093923|101580162|FG003|Treated - 1 Dose Only:|Overall Study||1||
48508540|NCT02093923|101580163|FG004|Treated - 1 Dose Only:|Overall Study||0||
48508541|NCT02093923|101580159|FG000|Treated - 2 Doses:|Overall Study||4||
48508542|NCT02093923|101580160|FG001|Treated - 2 Doses:|Overall Study||4||
48508543|NCT02093923|101580161|FG002|Treated - 2 Doses:|Overall Study||5||
48508544|NCT02093923|101580162|FG003|Treated - 2 Doses:|Overall Study||10||
48508545|NCT02093923|101580163|FG004|Treated - 2 Doses:|Overall Study||13||
48508546|NCT02093923|101580159|FG000|COMPLETED|Overall Study||4||
48508547|NCT02093923|101580160|FG001|COMPLETED|Overall Study||4||
48508548|NCT02093923|101580161|FG002|COMPLETED|Overall Study||5||
48508549|NCT02093923|101580162|FG003|COMPLETED|Overall Study||10||
48508550|NCT02093923|101580163|FG004|COMPLETED|Overall Study||13||
48508551|NCT02093923|101580159|FG000|NOT COMPLETED|Overall Study||0||
48508552|NCT02093923|101580160|FG001|NOT COMPLETED|Overall Study||0||
48508553|NCT02093923|101580161|FG002|NOT COMPLETED|Overall Study||0||
48508554|NCT02093923|101580162|FG003|NOT COMPLETED|Overall Study||2||
48508555|NCT02093923|101580163|FG004|NOT COMPLETED|Overall Study||0||
48508556|NCT00035555|101580164|FG000|STARTED|Overall Study||74||
48508557|NCT00035555|101580165|FG001|STARTED|Overall Study||71||
48508558|NCT00035555|101580166|FG002|STARTED|Overall Study||73||
48508559|NCT00035555|101580164|FG000|Number Who Had Undergone Transplantation|Overall Study||74||
48508560|NCT00035555|101580165|FG001|Number Who Had Undergone Transplantation|Overall Study||71||
48508561|NCT00035555|101580166|FG002|Number Who Had Undergone Transplantation|Overall Study||73||
48508562|NCT00035555|101580164|FG000|Number Who Received Study Drug|Overall Study||74||
48508563|NCT00035555|101580165|FG001|Number Who Received Study Drug|Overall Study||71||
48508564|NCT00035555|101580166|FG002|Number Who Received Study Drug|Overall Study||71||
48508565|NCT00035555|101580164|FG000|COMPLETED|Overall Study||58||
48508566|NCT00035555|101580165|FG001|COMPLETED|Overall Study||55||
48508567|NCT00035555|101580166|FG002|COMPLETED|Overall Study||51||
48508568|NCT00035555|101580164|FG000|NOT COMPLETED|Overall Study||16||
48508569|NCT00035555|101580165|FG001|NOT COMPLETED|Overall Study||16||
48508570|NCT00035555|101580166|FG002|NOT COMPLETED|Overall Study||22||
48508571|NCT02710214|101580167|FG000|STARTED|Overall Study||12||
48508572|NCT02710214|101580168|FG001|STARTED|Overall Study||12||
48508573|NCT02710214|101580167|FG000|COMPLETED|Overall Study||11||
48508574|NCT02710214|101580168|FG001|COMPLETED|Overall Study||10||
48508575|NCT02710214|101580167|FG000|NOT COMPLETED|Overall Study||1||
48508576|NCT02710214|101580168|FG001|NOT COMPLETED|Overall Study||2||
48508577|NCT00756717|101580169|FG000|STARTED|Overall Study||22||
48508578|NCT00756717|101580169|FG000|COMPLETED|Overall Study||20||
48508579|NCT00756717|101580169|FG000|NOT COMPLETED|Overall Study||2||
48508580|NCT03430011|101580170|FG000|STARTED|Pre-Treatment||15|Underwent Leukapheresis|
48508581|NCT03430011|101580171|FG001|STARTED|Pre-Treatment||30|Underwent Leukapheresis|
48508582|NCT03430011|101580172|FG002|STARTED|Pre-Treatment||27|Underwent Leukapheresis|
48508583|NCT03430011|101580173|FG003|STARTED|Pre-Treatment||22|Underwent Leukapheresis|
48508584|NCT03430011|101580174|FG004|STARTED|Pre-Treatment||22|Underwent Leukapheresis|
48508585|NCT03430011|101580175|FG005|STARTED|Pre-Treatment||14|Underwent Leukapheresis|
48508586|NCT03430011|101580176|FG006|STARTED|Pre-Treatment||25|Underwent Leukapheresis|
48508587|NCT03430011|101580177|FG007|STARTED|Pre-Treatment||10|Underwent Leukapheresis|
48508588|NCT03430011|101580170|FG000|Received Lymphodepleting Chemotherapy (LDC)|Pre-Treatment||15||
48508589|NCT03430011|101580171|FG001|Received Lymphodepleting Chemotherapy (LDC)|Pre-Treatment||30||
48508590|NCT03430011|101580172|FG002|Received Lymphodepleting Chemotherapy (LDC)|Pre-Treatment||26||
48508591|NCT03430011|101580173|FG003|Received Lymphodepleting Chemotherapy (LDC)|Pre-Treatment||21||
48508592|NCT03430011|101580174|FG004|Received Lymphodepleting Chemotherapy (LDC)|Pre-Treatment||20||
48508593|NCT03430011|101580175|FG005|Received Lymphodepleting Chemotherapy (LDC)|Pre-Treatment||14||
48508594|NCT03430011|101580176|FG006|Received Lymphodepleting Chemotherapy (LDC)|Pre-Treatment||24||
48508595|NCT03430011|101580177|FG007|Received Lymphodepleting Chemotherapy (LDC)|Pre-Treatment||10||
48508596|NCT03430011|101580170|FG000|COMPLETED|Pre-Treatment||14|Received JCARH125|
48508597|NCT03430011|101580171|FG001|COMPLETED|Pre-Treatment||30|Received JCARH125|
48508598|NCT03430011|101580172|FG002|COMPLETED|Pre-Treatment||26|Received JCARH125|
48508599|NCT03430011|101580173|FG003|COMPLETED|Pre-Treatment||21|Received JCARH125|
48508600|NCT03430011|101580174|FG004|COMPLETED|Pre-Treatment||20|Received JCARH125|
48508601|NCT03430011|101580175|FG005|COMPLETED|Pre-Treatment||14|Received JCARH125|
48508602|NCT03430011|101580176|FG006|COMPLETED|Pre-Treatment||24|Received JCARH125|
48508603|NCT03430011|101580177|FG007|COMPLETED|Pre-Treatment||10|Received JCARH125|
48508604|NCT03430011|101580170|FG000|NOT COMPLETED|Pre-Treatment||1||
48508605|NCT03430011|101580171|FG001|NOT COMPLETED|Pre-Treatment||0||
48508606|NCT03430011|101580172|FG002|NOT COMPLETED|Pre-Treatment||1||
48508607|NCT03430011|101580173|FG003|NOT COMPLETED|Pre-Treatment||1||
48508608|NCT03430011|101580174|FG004|NOT COMPLETED|Pre-Treatment||2||
48508609|NCT03430011|101580175|FG005|NOT COMPLETED|Pre-Treatment||0||
48508610|NCT03430011|101580176|FG006|NOT COMPLETED|Pre-Treatment||1||
48508611|NCT03430011|101580177|FG007|NOT COMPLETED|Pre-Treatment||0||
48508612|NCT03430011|101580170|FG000|STARTED|JCARH125 Treatment||14|Received JCARH125|
48508613|NCT03430011|101580171|FG001|STARTED|JCARH125 Treatment||30|Received JCARH125|
48508614|NCT03430011|101580172|FG002|STARTED|JCARH125 Treatment||26|Received JCARH125|
48508615|NCT03430011|101580173|FG003|STARTED|JCARH125 Treatment||21|Received JCARH125|
48508616|NCT03430011|101580174|FG004|STARTED|JCARH125 Treatment||20|Received JCARH125|
48508617|NCT03430011|101580175|FG005|STARTED|JCARH125 Treatment||14|Received JCARH125|
48508618|NCT03430011|101580176|FG006|STARTED|JCARH125 Treatment||24|Received JCARH125|
48508619|NCT03430011|101580177|FG007|STARTED|JCARH125 Treatment||10|Received JCARH125|
48508620|NCT03430011|101580170|FG000|COMPLETED|JCARH125 Treatment||8||
48508621|NCT03430011|101580171|FG001|COMPLETED|JCARH125 Treatment||9||
48508622|NCT03430011|101580172|FG002|COMPLETED|JCARH125 Treatment||7||
48508623|NCT03430011|101580173|FG003|COMPLETED|JCARH125 Treatment||6||
48508624|NCT03430011|101580174|FG004|COMPLETED|JCARH125 Treatment||9||
48508625|NCT03430011|101580175|FG005|COMPLETED|JCARH125 Treatment||6||
48508626|NCT03430011|101580176|FG006|COMPLETED|JCARH125 Treatment||11||
48508627|NCT03430011|101580177|FG007|COMPLETED|JCARH125 Treatment||3||
48508628|NCT03430011|101580170|FG000|NOT COMPLETED|JCARH125 Treatment||6||
48508629|NCT03430011|101580171|FG001|NOT COMPLETED|JCARH125 Treatment||21||
48508630|NCT03430011|101580172|FG002|NOT COMPLETED|JCARH125 Treatment||19||
48508631|NCT03430011|101580173|FG003|NOT COMPLETED|JCARH125 Treatment||15||
48508632|NCT03430011|101580174|FG004|NOT COMPLETED|JCARH125 Treatment||11||
48508633|NCT03430011|101580175|FG005|NOT COMPLETED|JCARH125 Treatment||8||
48508634|NCT03430011|101580176|FG006|NOT COMPLETED|JCARH125 Treatment||13||
48508635|NCT03430011|101580177|FG007|NOT COMPLETED|JCARH125 Treatment||7||
48508636|NCT02466386|101580178|FG000|STARTED|Overall Study||113||
48508637|NCT02466386|101580178|FG000|COMPLETED|Overall Study||69||
48508638|NCT02466386|101580178|FG000|NOT COMPLETED|Overall Study||44||
48508639|NCT01589601|101580179|FG000|STARTED|Overall Study||75||
48508640|NCT01589601|101580180|FG001|STARTED|Overall Study||75||
48508641|NCT01589601|101580179|FG000|COMPLETED|Overall Study||28||
48508642|NCT01589601|101580180|FG001|COMPLETED|Overall Study||26||
48508643|NCT01589601|101580179|FG000|NOT COMPLETED|Overall Study||47||
48508644|NCT01589601|101580180|FG001|NOT COMPLETED|Overall Study||49||
48508645|NCT01896505|101580181|FG000|STARTED|Overall Study||10||
48508646|NCT01896505|101580182|FG001|STARTED|Overall Study||9||
48508647|NCT01896505|101580183|FG002|STARTED|Overall Study||17||
48508648|NCT01896505|101580184|FG003|STARTED|Overall Study||7||
48508649|NCT01896505|101580185|FG004|STARTED|Overall Study||5||
48508650|NCT01896505|101580186|FG005|STARTED|Overall Study||6||
48508651|NCT01896505|101580181|FG000|COMPLETED|Overall Study||0||
48508652|NCT01896505|101580182|FG001|COMPLETED|Overall Study||0||
48508653|NCT01896505|101580183|FG002|COMPLETED|Overall Study||0||
48508654|NCT01896505|101580184|FG003|COMPLETED|Overall Study||0||
48508655|NCT01896505|101580185|FG004|COMPLETED|Overall Study||0||
48508656|NCT01896505|101580186|FG005|COMPLETED|Overall Study||0||
48508657|NCT01896505|101580181|FG000|NOT COMPLETED|Overall Study||10||
48508658|NCT01896505|101580182|FG001|NOT COMPLETED|Overall Study||9||
48508659|NCT01896505|101580183|FG002|NOT COMPLETED|Overall Study||17||
48508660|NCT01896505|101580184|FG003|NOT COMPLETED|Overall Study||7||
48508661|NCT01896505|101580185|FG004|NOT COMPLETED|Overall Study||5||
48666769|NCT03391882|101970468|FG003|COMPLETED|Post Part A / Pre Part B||18||
48666770|NCT03391882|101970469|FG004|COMPLETED|Post Part A / Pre Part B||18||
48666771|NCT03391882|101970470|FG005|COMPLETED|Post Part A / Pre Part B||19||
48666772|NCT03391882|101970465|FG000|NOT COMPLETED|Post Part A / Pre Part B||2||
48508662|NCT01896505|101580186|FG005|NOT COMPLETED|Overall Study||6||
48508663|NCT01601691|101580187|FG000|STARTED|Overall Study||10||
48508664|NCT01601691|101580187|FG000|COMPLETED|Overall Study||10||
48508665|NCT01601691|101580187|FG000|NOT COMPLETED|Overall Study||0||
48508666|NCT01908205|101580188|FG000|STARTED|Overall Study||30||
48508667|NCT01908205|101580189|FG001|STARTED|Overall Study||30||
48508668|NCT01908205|101580188|FG000|COMPLETED|Overall Study||25||
48508669|NCT01908205|101580189|FG001|COMPLETED|Overall Study||29||
48508670|NCT01908205|101580188|FG000|NOT COMPLETED|Overall Study||5||
48508671|NCT01908205|101580189|FG001|NOT COMPLETED|Overall Study||1||
48508672|NCT00631007|101580190|FG000|STARTED|Overall Study||60||
48508673|NCT00631007|101580191|FG001|STARTED|Overall Study||61||
48508674|NCT00631007|101580192|FG002|STARTED|Overall Study||63||
48508675|NCT00631007|101580193|FG003|STARTED|Overall Study||62||
48508676|NCT00631007|101580194|FG004|STARTED|Overall Study||60||
48508677|NCT00631007|101580195|FG005|STARTED|Overall Study||61||
48508678|NCT00631007|101580190|FG000|COMPLETED|Overall Study||49||
48508679|NCT00631007|101580191|FG001|COMPLETED|Overall Study||50||
48508680|NCT00631007|101580192|FG002|COMPLETED|Overall Study||53||
48508681|NCT00631007|101580193|FG003|COMPLETED|Overall Study||53||
48508682|NCT00631007|101580194|FG004|COMPLETED|Overall Study||48||
48508683|NCT00631007|101580195|FG005|COMPLETED|Overall Study||46||
48508684|NCT00631007|101580190|FG000|NOT COMPLETED|Overall Study||11||
48508685|NCT00631007|101580191|FG001|NOT COMPLETED|Overall Study||11||
48508686|NCT00631007|101580192|FG002|NOT COMPLETED|Overall Study||10||
48508687|NCT00631007|101580193|FG003|NOT COMPLETED|Overall Study||9||
48508688|NCT00631007|101580194|FG004|NOT COMPLETED|Overall Study||12||
48508689|NCT00631007|101580195|FG005|NOT COMPLETED|Overall Study||15||
48508690|NCT01560819|101580196|FG000|STARTED|Overall Study||10||
48508691|NCT01560819|101580197|FG001|STARTED|Overall Study||10||
48508692|NCT01560819|101580196|FG000|COMPLETED|Overall Study||9||
48508693|NCT01560819|101580197|FG001|COMPLETED|Overall Study||10||
48508694|NCT01560819|101580196|FG000|NOT COMPLETED|Overall Study||1||
48508695|NCT01560819|101580197|FG001|NOT COMPLETED|Overall Study||0||
48508696|NCT04443569|101580198|FG000|STARTED|Overall Study||46||
48508697|NCT04443569|101580199|FG001|STARTED|Overall Study||47||
48508698|NCT04443569|101580198|FG000|COMPLETED|Overall Study||46||
48508699|NCT04443569|101580199|FG001|COMPLETED|Overall Study||47||
48508700|NCT04443569|101580198|FG000|NOT COMPLETED|Overall Study||0||
48508701|NCT04443569|101580199|FG001|NOT COMPLETED|Overall Study||0||
48508702|NCT00983528|101580200|FG000|STARTED|Overall Study||6||
48508703|NCT00983528|101580200|FG000|COMPLETED|Overall Study||0||
48508704|NCT00983528|101580200|FG000|NOT COMPLETED|Overall Study||6||
48508705|NCT00726895|101580201|FG000|STARTED|First Intervention||12||
48508706|NCT00726895|101580202|FG001|STARTED|First Intervention||12||
48508707|NCT00726895|101580201|FG000|COMPLETED|First Intervention||12||
48508708|NCT00726895|101580202|FG001|COMPLETED|First Intervention||12||
48508709|NCT00726895|101580201|FG000|NOT COMPLETED|First Intervention||0||
48508710|NCT00726895|101580202|FG001|NOT COMPLETED|First Intervention||0||
48508711|NCT00726895|101580201|FG000|STARTED|Washout Period of 7 Days||12||
48508712|NCT00726895|101580202|FG001|STARTED|Washout Period of 7 Days||12||
48508713|NCT00726895|101580201|FG000|COMPLETED|Washout Period of 7 Days||12||
48508714|NCT00726895|101580202|FG001|COMPLETED|Washout Period of 7 Days||11||
48508715|NCT00726895|101580201|FG000|NOT COMPLETED|Washout Period of 7 Days||0||
48508716|NCT00726895|101580202|FG001|NOT COMPLETED|Washout Period of 7 Days||1||
48508717|NCT00726895|101580201|FG000|STARTED|Second Intervention||12||
48508718|NCT00726895|101580202|FG001|STARTED|Second Intervention||11||
48508719|NCT00726895|101580201|FG000|COMPLETED|Second Intervention||12||
48508720|NCT00726895|101580202|FG001|COMPLETED|Second Intervention||11||
48508721|NCT00726895|101580201|FG000|NOT COMPLETED|Second Intervention||0||
48508722|NCT00726895|101580202|FG001|NOT COMPLETED|Second Intervention||0||
48508723|NCT03907241|101580203|FG000|STARTED|Overall Study||27||
48508724|NCT03907241|101580203|FG000|COMPLETED|Overall Study||23||
48508725|NCT03907241|101580203|FG000|NOT COMPLETED|Overall Study||4||
48508726|NCT03623035|101580204|FG000|STARTED|Overall Study||10||
48508727|NCT03623035|101580204|FG000|COMPLETED|Overall Study||10||
48508728|NCT03623035|101580204|FG000|NOT COMPLETED|Overall Study||0||
48508729|NCT02121041|101580205|FG000|STARTED|Overall Study||14||
48508730|NCT02121041|101580206|FG001|STARTED|Overall Study||14||
48508731|NCT02121041|101580205|FG000|COMPLETED|Overall Study||13||
48508732|NCT02121041|101580206|FG001|COMPLETED|Overall Study||8||
48508733|NCT02121041|101580205|FG000|NOT COMPLETED|Overall Study||1||
48508734|NCT02121041|101580206|FG001|NOT COMPLETED|Overall Study||6||
48508735|NCT01023776|101580207|FG000|STARTED|Overall Study||20||
48508736|NCT01023776|101580207|FG000|COMPLETED|Overall Study||20||
48508737|NCT01023776|101580207|FG000|NOT COMPLETED|Overall Study||0||
48508738|NCT00769314|101580208|FG000|STARTED|Overall Study||378||
48508739|NCT00769314|101580209|FG001|STARTED|Overall Study||397||
48508740|NCT00769314|101580208|FG000|COMPLETED|Overall Study||361||
48508741|NCT00769314|101580209|FG001|COMPLETED|Overall Study||384||
48508742|NCT00769314|101580208|FG000|NOT COMPLETED|Overall Study||17||
48508743|NCT00769314|101580209|FG001|NOT COMPLETED|Overall Study||13||
48508744|NCT03232736|101580210|FG000|STARTED|Overall Study||9||
48508745|NCT03232736|101580211|FG001|STARTED|Overall Study||13||
48508746|NCT03232736|101580210|FG000|COMPLETED|Overall Study||9||
48508747|NCT03232736|101580211|FG001|COMPLETED|Overall Study||13||
48508748|NCT03232736|101580210|FG000|NOT COMPLETED|Overall Study||0||
48508749|NCT03232736|101580211|FG001|NOT COMPLETED|Overall Study||0||
48508750|NCT01438476|101580212|FG000|STARTED|Overall Study||116||
48508751|NCT01438476|101580213|FG001|STARTED|Overall Study||45||
48508752|NCT01438476|101580212|FG000|COMPLETED|Overall Study||106||
48508753|NCT01438476|101580213|FG001|COMPLETED|Overall Study||34||
48508754|NCT01438476|101580212|FG000|NOT COMPLETED|Overall Study||10||
48508755|NCT01438476|101580213|FG001|NOT COMPLETED|Overall Study||11||
48508756|NCT04599166|101580214|FG000|STARTED|Overall Study||207||
48508757|NCT04599166|101580214|FG000|COMPLETED|Overall Study||127||
48508758|NCT04599166|101580214|FG000|NOT COMPLETED|Overall Study||80||
48508759|NCT03023709|101580215|FG000|STARTED|Overall Study||3||
48508760|NCT03023709|101580216|FG001|STARTED|Overall Study||0||
48508761|NCT03023709|101580215|FG000|COMPLETED|Overall Study||3||
48508762|NCT03023709|101580216|FG001|COMPLETED|Overall Study||0||
48508763|NCT03023709|101580215|FG000|NOT COMPLETED|Overall Study||0||
48508764|NCT03023709|101580216|FG001|NOT COMPLETED|Overall Study||0||
48508765|NCT01550367|101580217|FG000|STARTED|Overall Study||30||
48508766|NCT01550367|101580217|FG000|1200 mg/d HCQ|Overall Study||13||
48508767|NCT01550367|101580217|FG000|600 mg/d HCQ|Overall Study||17||
48508768|NCT01550367|101580217|FG000|COMPLETED|Overall Study||30||
48508769|NCT01550367|101580217|FG000|NOT COMPLETED|Overall Study||0||
48508770|NCT01466036|101580218|FG000|STARTED|Overall Study||20||
48508771|NCT01466036|101580219|FG001|STARTED|Overall Study||41||
48508772|NCT01466036|101580218|FG000|COMPLETED|Overall Study||0|treatment was indefinite|
48508773|NCT01466036|101580219|FG001|COMPLETED|Overall Study||0|treatment was indefinite|
48508774|NCT01466036|101580218|FG000|NOT COMPLETED|Overall Study||20||
48508775|NCT01466036|101580219|FG001|NOT COMPLETED|Overall Study||41||
48508776|NCT01989676|101580220|FG000|STARTED|Overall Study||352||
48508777|NCT01989676|101580221|FG001|STARTED|Overall Study||355||
48508778|NCT01989676|101580220|FG000|Treated|Overall Study||349||
48508779|NCT01989676|101580221|FG001|Treated|Overall Study||353||
48508780|NCT01989676|101580220|FG000|COMPLETED|Overall Study||234||
48508781|NCT01989676|101580221|FG001|COMPLETED|Overall Study||217||
48508782|NCT01989676|101580220|FG000|NOT COMPLETED|Overall Study||118||
48508783|NCT01989676|101580221|FG001|NOT COMPLETED|Overall Study||138||
48508784|NCT05444543|101580222|FG000|STARTED|Overall Study||11||
48508785|NCT05444543|101580223|FG001|STARTED|Overall Study||12||
48508786|NCT05444543|101580222|FG000|COMPLETED|Overall Study||9||
48508787|NCT05444543|101580223|FG001|COMPLETED|Overall Study||10||
48063864|NCT03881670|100479401|FG001|Completed First Intervention|Overall Study||12||
48063865|NCT03881670|100479400|FG000|Completed Second Intervetion|Overall Study||12||
48063866|NCT03881670|100479401|FG001|Completed Second Intervetion|Overall Study||12||
48063867|NCT03881670|100479400|FG000|COMPLETED|Overall Study||12||
48063868|NCT03881670|100479401|FG001|COMPLETED|Overall Study||12||
48063869|NCT03881670|100479400|FG000|NOT COMPLETED|Overall Study||0||
48063870|NCT03881670|100479401|FG001|NOT COMPLETED|Overall Study||0||
48063871|NCT00928395|100479402|FG000|STARTED|Overall Study||50||
48063872|NCT00928395|100479402|FG000|COMPLETED|Overall Study||29||
48063873|NCT00928395|100479402|FG000|NOT COMPLETED|Overall Study||21||
48063874|NCT03344796|100479403|FG000|STARTED|Overall Study||32||
48063875|NCT03344796|100479404|FG001|STARTED|Overall Study||10||
48063876|NCT03344796|100479405|FG002|STARTED|Overall Study||31||
48063877|NCT03344796|100479406|FG003|STARTED|Overall Study||29||
48063878|NCT03344796|100479407|FG004|STARTED|Overall Study||20||
48063879|NCT03344796|100479408|FG005|STARTED|Overall Study||42||
48063880|NCT03344796|100479403|FG000|COMPLETED|Overall Study||32||
48063881|NCT03344796|100479404|FG001|COMPLETED|Overall Study||10||
48063882|NCT03344796|100479405|FG002|COMPLETED|Overall Study||31||
48063883|NCT03344796|100479406|FG003|COMPLETED|Overall Study||29||
48063884|NCT03344796|100479407|FG004|COMPLETED|Overall Study||20||
48063885|NCT03344796|100479408|FG005|COMPLETED|Overall Study||40||
48063886|NCT03344796|100479403|FG000|NOT COMPLETED|Overall Study||0||
48063887|NCT03344796|100479404|FG001|NOT COMPLETED|Overall Study||0||
48508788|NCT05444543|101580222|FG000|NOT COMPLETED|Overall Study||2||
48508789|NCT05444543|101580223|FG001|NOT COMPLETED|Overall Study||2||
48508790|NCT00623636|101580224|FG000|STARTED|Double Blind||452||
48508791|NCT00623636|101580225|FG001|STARTED|Double Blind||450||
48508792|NCT00623636|101580224|FG000|COMPLETED|Double Blind||419||
48508793|NCT00623636|101580225|FG001|COMPLETED|Double Blind||422||
48508794|NCT00623636|101580224|FG000|NOT COMPLETED|Double Blind||33||
48063888|NCT03344796|100479405|FG002|NOT COMPLETED|Overall Study||0||
48063889|NCT03344796|100479406|FG003|NOT COMPLETED|Overall Study||0||
48063890|NCT03344796|100479407|FG004|NOT COMPLETED|Overall Study||0||
48063891|NCT03344796|100479408|FG005|NOT COMPLETED|Overall Study||2||
48063892|NCT02764333|100479409|FG000|STARTED|Overall Study||29||
48063893|NCT02764333|100479409|FG000|COMPLETED|Overall Study||28||
48063894|NCT02764333|100479409|FG000|NOT COMPLETED|Overall Study||1||
48063895|NCT00120523|100479410|FG000|STARTED|Treatment Period||1205||
48063896|NCT00120523|100479411|FG001|STARTED|Treatment Period||1213||
48063897|NCT00120523|100479410|FG000|COMPLETED|Treatment Period||836||
48063898|NCT00120523|100479411|FG001|COMPLETED|Treatment Period||874||
48063899|NCT00120523|100479410|FG000|NOT COMPLETED|Treatment Period||369||
48063900|NCT00120523|100479411|FG001|NOT COMPLETED|Treatment Period||339||
48063901|NCT00120523|100479410|FG000|STARTED|Follow-Up Period||120||
48063902|NCT00120523|100479411|FG001|STARTED|Follow-Up Period||70||
48063903|NCT00120523|100479410|FG000|COMPLETED|Follow-Up Period||90||
48063904|NCT00120523|100479411|FG001|COMPLETED|Follow-Up Period||46||
48063905|NCT00120523|100479410|FG000|NOT COMPLETED|Follow-Up Period||30||
48063906|NCT00120523|100479411|FG001|NOT COMPLETED|Follow-Up Period||24||
48063907|NCT00787761|100479412|FG000|STARTED|Overall Study||24||
48063908|NCT00787761|100479412|FG000|COMPLETED|Overall Study||24||
48063909|NCT00787761|100479412|FG000|NOT COMPLETED|Overall Study||0||
48063910|NCT03576495|100479413|FG000|STARTED|Period 1 (0 Months)||1489||4
48063911|NCT03576495|100479414|FG001|STARTED|Period 1 (0 Months)||1412||4
48063912|NCT03576495|100479413|FG000|Residents|Period 1 (0 Months)||192||4
48508795|NCT00623636|101580225|FG001|NOT COMPLETED|Double Blind||28||
48508796|NCT00623636|101580224|FG000|STARTED|Open Label||0||
48508797|NCT00623636|101580225|FG001|STARTED|Open Label||675||
48063913|NCT03576495|100479414|FG001|Residents|Period 1 (0 Months)||214||4
48063914|NCT03576495|100479413|FG000|Patients|Period 1 (0 Months)||1297||4
48063915|NCT03576495|100479414|FG001|Patients|Period 1 (0 Months)||1198||4
48063916|NCT03576495|100479413|FG000|COMPLETED|Period 1 (0 Months)||1438||4
48063917|NCT03576495|100479414|FG001|COMPLETED|Period 1 (0 Months)||1372||4
48508798|NCT00623636|101580224|FG000|COMPLETED|Open Label||0||
48508799|NCT00623636|101580225|FG001|COMPLETED|Open Label||263||
48508800|NCT00623636|101580224|FG000|NOT COMPLETED|Open Label||0||
48508801|NCT00623636|101580225|FG001|NOT COMPLETED|Open Label||412||
48508802|NCT02767934|101580226|FG000|STARTED|Overall Study||12||
48508803|NCT02767934|101580226|FG000|COMPLETED|Overall Study||12||
48508804|NCT02767934|101580226|FG000|NOT COMPLETED|Overall Study||0||
48508805|NCT00754468|101580227|FG000|STARTED|Overall Study||4||
48508806|NCT00754468|101580228|FG001|STARTED|Overall Study||3||
48508807|NCT00754468|101580227|FG000|COMPLETED|Overall Study||4||
48508808|NCT00754468|101580228|FG001|COMPLETED|Overall Study||3||
48508809|NCT00754468|101580227|FG000|NOT COMPLETED|Overall Study||0||
48063918|NCT03576495|100479413|FG000|NOT COMPLETED|Period 1 (0 Months)||51||0
48063919|NCT03576495|100479414|FG001|NOT COMPLETED|Period 1 (0 Months)||40||0
48063920|NCT03576495|100479413|FG000|STARTED|Period 2 (18 Months)||1438||4
48063921|NCT03576495|100479414|FG001|STARTED|Period 2 (18 Months)||1372||4
48063922|NCT03576495|100479413|FG000|Residents|Period 2 (18 Months)||141||4
48063923|NCT03576495|100479414|FG001|Residents|Period 2 (18 Months)||174||4
48063924|NCT03576495|100479413|FG000|Patients|Period 2 (18 Months)||1297||4
48063925|NCT03576495|100479414|FG001|Patients|Period 2 (18 Months)||1198||4
48063926|NCT03576495|100479413|FG000|COMPLETED|Period 2 (18 Months)||1438||4
48063927|NCT03576495|100479414|FG001|COMPLETED|Period 2 (18 Months)||1372||4
48063928|NCT03576495|100479413|FG000|NOT COMPLETED|Period 2 (18 Months)||0||0
48063929|NCT03576495|100479414|FG001|NOT COMPLETED|Period 2 (18 Months)||0||0
48063930|NCT03576495|100479413|FG000|STARTED|Period 3 (36 Months)||1438||4
48063931|NCT03576495|100479414|FG001|STARTED|Period 3 (36 Months)||1372||4
48063932|NCT03576495|100479413|FG000|Residents|Period 3 (36 Months)||141||4
48063933|NCT03576495|100479414|FG001|Residents|Period 3 (36 Months)||174||4
48063934|NCT03576495|100479413|FG000|Patients|Period 3 (36 Months)||1297||4
48063935|NCT03576495|100479414|FG001|Patients|Period 3 (36 Months)||1198||4
48063936|NCT03576495|100479413|FG000|COMPLETED|Period 3 (36 Months)||1438||4
48063937|NCT03576495|100479414|FG001|COMPLETED|Period 3 (36 Months)||1372||4
48063938|NCT03576495|100479413|FG000|NOT COMPLETED|Period 3 (36 Months)||0||0
48063939|NCT03576495|100479414|FG001|NOT COMPLETED|Period 3 (36 Months)||0||0
48063940|NCT04087213|100479415|FG000|STARTED|In-Facility Introduction||36||
48063941|NCT04087213|100479415|FG000|COMPLETED|In-Facility Introduction||34||
48063942|NCT04087213|100479415|FG000|NOT COMPLETED|In-Facility Introduction||2||
48063943|NCT04087213|100479415|FG000|STARTED|Transition Period A||34||
48063944|NCT04087213|100479415|FG000|COMPLETED|Transition Period A||34||
48063945|NCT04087213|100479415|FG000|NOT COMPLETED|Transition Period A||0||
48063946|NCT04087213|100479415|FG000|STARTED|Assisted Evaluable Period||34||
48063947|NCT04087213|100479415|FG000|COMPLETED|Assisted Evaluable Period||29||
48063948|NCT04087213|100479415|FG000|NOT COMPLETED|Assisted Evaluable Period||5||
48063949|NCT04087213|100479415|FG000|STARTED|Transition Period B||29||
48063950|NCT04087213|100479415|FG000|COMPLETED|Transition Period B||28||
48063951|NCT04087213|100479415|FG000|NOT COMPLETED|Transition Period B||1||
48063952|NCT04087213|100479415|FG000|STARTED|Unassisted Home Evaluable Period||28||
48063953|NCT04087213|100479415|FG000|COMPLETED|Unassisted Home Evaluable Period||28||
48063954|NCT04087213|100479415|FG000|NOT COMPLETED|Unassisted Home Evaluable Period||0||
48063955|NCT01955564|100479416|FG000|STARTED|Overall Study||18||
48063956|NCT01955564|100479417|FG001|STARTED|Overall Study||6||
48063957|NCT01955564|100479418|FG002|STARTED|Overall Study||6||
48063958|NCT01955564|100479419|FG003|STARTED|Overall Study||6||
48063959|NCT01955564|100479420|FG004|STARTED|Overall Study||6||
48063960|NCT01955564|100479421|FG005|STARTED|Overall Study||6||
48063961|NCT01955564|100479422|FG006|STARTED|Overall Study||6||
48063962|NCT01955564|100479416|FG000|COMPLETED|Overall Study||18||
48063963|NCT01955564|100479417|FG001|COMPLETED|Overall Study||6||
48063964|NCT01955564|100479418|FG002|COMPLETED|Overall Study||6||
48063965|NCT01955564|100479419|FG003|COMPLETED|Overall Study||6||
48063966|NCT01955564|100479420|FG004|COMPLETED|Overall Study||6||
48063967|NCT01955564|100479421|FG005|COMPLETED|Overall Study||6||
48063968|NCT01955564|100479422|FG006|COMPLETED|Overall Study||6||
48063969|NCT01955564|100479416|FG000|NOT COMPLETED|Overall Study||0||
48063970|NCT01955564|100479417|FG001|NOT COMPLETED|Overall Study||0||
48063971|NCT01955564|100479418|FG002|NOT COMPLETED|Overall Study||0||
48063972|NCT01955564|100479419|FG003|NOT COMPLETED|Overall Study||0||
48063973|NCT01955564|100479420|FG004|NOT COMPLETED|Overall Study||0||
48063974|NCT01955564|100479421|FG005|NOT COMPLETED|Overall Study||0||
48508810|NCT00754468|101580228|FG001|NOT COMPLETED|Overall Study||0||
48508811|NCT00820599|101580229|FG000|STARTED|Overall Study||211||
48508812|NCT00820599|101580229|FG000|COMPLETED|Overall Study||80||
48508813|NCT00820599|101580229|FG000|NOT COMPLETED|Overall Study||131||
48508814|NCT01801917|101580230|FG000|STARTED|Period 1 - Randomized||7||
48508815|NCT01801917|101580231|FG001|STARTED|Period 1 - Randomized||2||
48508816|NCT01801917|101580232|FG002|STARTED|Period 1 - Randomized||4||
48063975|NCT01955564|100479422|FG006|NOT COMPLETED|Overall Study||0||
48063976|NCT00747812|100479423|FG000|STARTED|Overall Study||5||
48063977|NCT00747812|100479424|FG001|STARTED|Overall Study||3||
48063978|NCT00747812|100479423|FG000|COMPLETED|Overall Study||0||
48063979|NCT00747812|100479424|FG001|COMPLETED|Overall Study||0||
48508817|NCT01801917|101580233|FG003|STARTED|Period 1 - Randomized||1||
48508818|NCT01801917|101580230|FG000|COMPLETED|Period 1 - Randomized||6||
48063980|NCT00747812|100479423|FG000|NOT COMPLETED|Overall Study||5||
48063981|NCT00747812|100479424|FG001|NOT COMPLETED|Overall Study||3||
48063982|NCT04873700|100479425|FG000|STARTED|Overall Study||43||
48063983|NCT04873700|100479426|FG001|STARTED|Overall Study||52||
48063984|NCT04873700|100479427|FG002|STARTED|Overall Study||42||
48063985|NCT04873700|100479428|FG003|STARTED|Overall Study||189||
48063986|NCT04873700|100479425|FG000|COMPLETED|Overall Study||43||
48063987|NCT04873700|100479426|FG001|COMPLETED|Overall Study||52||
48063988|NCT04873700|100479427|FG002|COMPLETED|Overall Study||42||
48063989|NCT04873700|100479428|FG003|COMPLETED|Overall Study||189||
48063990|NCT04873700|100479425|FG000|NOT COMPLETED|Overall Study||0||
48063991|NCT04873700|100479426|FG001|NOT COMPLETED|Overall Study||0||
48063992|NCT04873700|100479427|FG002|NOT COMPLETED|Overall Study||0||
48063993|NCT04873700|100479428|FG003|NOT COMPLETED|Overall Study||0||
48063994|NCT00002651|100479429|FG000|STARTED|Induction||3040||
48063995|NCT00002651|100479430|FG001|STARTED|Induction||0||
48063996|NCT00002651|100479431|FG002|STARTED|Induction||0||
48063997|NCT00002651|100479429|FG000|Eligible|Induction||2950||
48063998|NCT00002651|100479430|FG001|Eligible|Induction||0||
48063999|NCT00002651|100479431|FG002|Eligible|Induction||0||
48064000|NCT00002651|100479429|FG000|Eligible and Began Protocol Therapy|Induction||2950||
48064001|NCT00002651|100479430|FG001|Eligible and Began Protocol Therapy|Induction||0||
48064002|NCT00002651|100479431|FG002|Eligible and Began Protocol Therapy|Induction||0||
48064003|NCT00002651|100479429|FG000|COMPLETED|Induction||1697||
48064004|NCT00002651|100479430|FG001|COMPLETED|Induction||0||
48064005|NCT00002651|100479431|FG002|COMPLETED|Induction||0||
48064006|NCT00002651|100479429|FG000|NOT COMPLETED|Induction||1343||
48064007|NCT00002651|100479430|FG001|NOT COMPLETED|Induction||0||
48064008|NCT00002651|100479431|FG002|NOT COMPLETED|Induction||0||
48064009|NCT00002651|100479429|FG000|STARTED|Consolidation and Randomization||0||
48064010|NCT00002651|100479430|FG001|STARTED|Consolidation and Randomization||867||
48064011|NCT00002651|100479431|FG002|STARTED|Consolidation and Randomization||882||
48064012|NCT00002651|100479429|FG000|Eligible|Consolidation and Randomization||0||
48064013|NCT00002651|100479430|FG001|Eligible|Consolidation and Randomization||765||
48064014|NCT00002651|100479431|FG002|Eligible|Consolidation and Randomization||770||
48064015|NCT00002651|100479429|FG000|Assessable for Toxicity|Consolidation and Randomization||0|Patients with no AE evaluations, received wrong protocol arm, or received non-protocol trt excluded|
48508819|NCT01801917|101580231|FG001|COMPLETED|Period 1 - Randomized||2||
48508820|NCT01801917|101580232|FG002|COMPLETED|Period 1 - Randomized||3||
48508821|NCT01801917|101580233|FG003|COMPLETED|Period 1 - Randomized||1||
48508822|NCT01801917|101580230|FG000|NOT COMPLETED|Period 1 - Randomized||1||
48508823|NCT01801917|101580231|FG001|NOT COMPLETED|Period 1 - Randomized||0||
48508824|NCT01801917|101580232|FG002|NOT COMPLETED|Period 1 - Randomized||1||
48508825|NCT01801917|101580233|FG003|NOT COMPLETED|Period 1 - Randomized||0||
48508826|NCT01801917|101580230|FG000|STARTED|Extension - All Active||6||
48508827|NCT01801917|101580231|FG001|STARTED|Extension - All Active||0||
48508828|NCT01801917|101580232|FG002|STARTED|Extension - All Active||3||
48064016|NCT00002651|100479430|FG001|Assessable for Toxicity|Consolidation and Randomization||732|Patients with no AE evaluations, received wrong protocol arm, or received non-protocol trt excluded|
48064017|NCT00002651|100479431|FG002|Assessable for Toxicity|Consolidation and Randomization||702|Patients with no AE evaluations, received wrong protocol arm, or received non-protocol trt excluded|
48064018|NCT00002651|100479429|FG000|COMPLETED|Consolidation and Randomization||0||
48064019|NCT00002651|100479430|FG001|COMPLETED|Consolidation and Randomization||29||
48064020|NCT00002651|100479431|FG002|COMPLETED|Consolidation and Randomization||22||
48064021|NCT00002651|100479429|FG000|NOT COMPLETED|Consolidation and Randomization||0||
48218626|NCT01738438|100860342|FG000|COMPLETED|Overall Study||0||
48508829|NCT01801917|101580233|FG003|STARTED|Extension - All Active||0||
48508830|NCT01801917|101580230|FG000|COMPLETED|Extension - All Active||6||
48508831|NCT01801917|101580231|FG001|COMPLETED|Extension - All Active||0||
48508832|NCT01801917|101580232|FG002|COMPLETED|Extension - All Active||3||
48508833|NCT01801917|101580233|FG003|COMPLETED|Extension - All Active||0||
48508834|NCT01801917|101580230|FG000|NOT COMPLETED|Extension - All Active||0||
48508835|NCT01801917|101580231|FG001|NOT COMPLETED|Extension - All Active||0||
48508836|NCT01801917|101580232|FG002|NOT COMPLETED|Extension - All Active||0||
48508837|NCT01801917|101580233|FG003|NOT COMPLETED|Extension - All Active||0||
48508838|NCT03507686|101580234|FG000|STARTED|Treatment Period 1(Day 1 up to Month 12)||60||
48508839|NCT03507686|101580235|FG001|STARTED|Treatment Period 1(Day 1 up to Month 12)||0||
48508840|NCT03507686|101580234|FG000|COMPLETED|Treatment Period 1(Day 1 up to Month 12)||50||
48508841|NCT03507686|101580235|FG001|COMPLETED|Treatment Period 1(Day 1 up to Month 12)||0||
48508842|NCT03507686|101580234|FG000|NOT COMPLETED|Treatment Period 1(Day 1 up to Month 12)||10||
48508843|NCT03507686|101580235|FG001|NOT COMPLETED|Treatment Period 1(Day 1 up to Month 12)||0||
48064022|NCT00002651|100479430|FG001|NOT COMPLETED|Consolidation and Randomization||838||
48064023|NCT00002651|100479431|FG002|NOT COMPLETED|Consolidation and Randomization||860||
48064024|NCT00913380|100479432|FG000|STARTED|CT Examination||444||
48064025|NCT00913380|100479433|FG001|STARTED|CT Examination||447||
48064026|NCT00913380|100479432|FG000|COMPLETED|CT Examination||444||
48064027|NCT00913380|100479433|FG001|COMPLETED|CT Examination||447||
48218627|NCT01738438|100860342|FG000|NOT COMPLETED|Overall Study||35||
48508844|NCT03507686|101580234|FG000|STARTED|Treatment Period 2 (Month13 to Month24)||0||
48064028|NCT00913380|100479432|FG000|NOT COMPLETED|CT Examination||0||
48064029|NCT00913380|100479433|FG001|NOT COMPLETED|CT Examination||0||
48064030|NCT00913380|100479432|FG000|STARTED|Clinical Outcomes||444||
48064031|NCT00913380|100479433|FG001|STARTED|Clinical Outcomes||447||
48064032|NCT00913380|100479432|FG000|COMPLETED|Clinical Outcomes||438||
48064033|NCT00913380|100479433|FG001|COMPLETED|Clinical Outcomes||441||
48064034|NCT00913380|100479432|FG000|NOT COMPLETED|Clinical Outcomes||6||
48064035|NCT00913380|100479433|FG001|NOT COMPLETED|Clinical Outcomes||6||
48064036|NCT03860597|100479434|FG000|STARTED|Overall Study||11||
48064037|NCT03860597|100479435|FG001|STARTED|Overall Study||11||
48064038|NCT03860597|100479436|FG002|STARTED|Overall Study||10||
48064039|NCT03860597|100479437|FG003|STARTED|Overall Study||10||
48064040|NCT03860597|100479434|FG000|COMPLETED|Overall Study||11||
48064041|NCT03860597|100479435|FG001|COMPLETED|Overall Study||11||
48064042|NCT03860597|100479436|FG002|COMPLETED|Overall Study||10||
48064043|NCT03860597|100479437|FG003|COMPLETED|Overall Study||10||
48064044|NCT03860597|100479434|FG000|NOT COMPLETED|Overall Study||0||
48064045|NCT03860597|100479435|FG001|NOT COMPLETED|Overall Study||0||
48064046|NCT03860597|100479436|FG002|NOT COMPLETED|Overall Study||0||
48064047|NCT03860597|100479437|FG003|NOT COMPLETED|Overall Study||0||
48064048|NCT02503410|100479438|FG000|STARTED|Overall Study||4||
48064049|NCT02503410|100479439|FG001|STARTED|Overall Study||3||
48064050|NCT02503410|100479438|FG000|COMPLETED|Overall Study||4||
48064051|NCT02503410|100479439|FG001|COMPLETED|Overall Study||3||
48064052|NCT02503410|100479438|FG000|NOT COMPLETED|Overall Study||0||
48064053|NCT02503410|100479439|FG001|NOT COMPLETED|Overall Study||0||
48064054|NCT02083081|100479440|FG000|STARTED|Overall Study||188||
48064055|NCT02083081|100479441|FG001|STARTED|Overall Study||164||
48064056|NCT02083081|100479440|FG000|COMPLETED|Overall Study||157||
48064057|NCT02083081|100479441|FG001|COMPLETED|Overall Study||155||
48064058|NCT02083081|100479440|FG000|NOT COMPLETED|Overall Study||31||
48064059|NCT02083081|100479441|FG001|NOT COMPLETED|Overall Study||9||
48064060|NCT02068027|100479442|FG000|STARTED|Overall Study||130||
48064061|NCT02068027|100479443|FG001|STARTED|Overall Study||130||
48064062|NCT02068027|100479442|FG000|COMPLETED|Overall Study||117||
48064063|NCT02068027|100479443|FG001|COMPLETED|Overall Study||114||
48064064|NCT02068027|100479442|FG000|NOT COMPLETED|Overall Study||13||
48064065|NCT02068027|100479443|FG001|NOT COMPLETED|Overall Study||16||
48064066|NCT00304239|100479444|FG000|STARTED|Overall Study||73||
48064067|NCT00304239|100479445|FG001|STARTED|Overall Study||58||
48064068|NCT00304239|100479444|FG000|COMPLETED|Overall Study||56||
48064069|NCT00304239|100479445|FG001|COMPLETED|Overall Study||58||
48064070|NCT00304239|100479444|FG000|NOT COMPLETED|Overall Study||17||
48064071|NCT00304239|100479445|FG001|NOT COMPLETED|Overall Study||0||
48064072|NCT01219673|100479446|FG000|STARTED|Overall Study||0||
48064073|NCT01219673|100479447|FG001|STARTED|Overall Study||0||
48064074|NCT01219673|100479448|FG002|STARTED|Overall Study||1||
48064075|NCT01219673|100479449|FG003|STARTED|Overall Study||0||
48064076|NCT01219673|100479450|FG004|STARTED|Overall Study||0||
48064077|NCT01219673|100479451|FG005|STARTED|Overall Study||0||
48064078|NCT01219673|100479452|FG006|STARTED|Overall Study||0||
48064079|NCT01219673|100479453|FG007|STARTED|Overall Study||0||
48064080|NCT01219673|100479446|FG000|COMPLETED|Overall Study||0||
48064081|NCT01219673|100479447|FG001|COMPLETED|Overall Study||0||
48064082|NCT01219673|100479448|FG002|COMPLETED|Overall Study||1||
48064083|NCT01219673|100479449|FG003|COMPLETED|Overall Study||0||
48064084|NCT01219673|100479450|FG004|COMPLETED|Overall Study||0||
48064085|NCT01219673|100479451|FG005|COMPLETED|Overall Study||0||
48064086|NCT01219673|100479452|FG006|COMPLETED|Overall Study||0||
48064087|NCT01219673|100479453|FG007|COMPLETED|Overall Study||0||
48064088|NCT01219673|100479446|FG000|NOT COMPLETED|Overall Study||0||
48064089|NCT01219673|100479447|FG001|NOT COMPLETED|Overall Study||0||
48064090|NCT01219673|100479448|FG002|NOT COMPLETED|Overall Study||0||
48064091|NCT01219673|100479449|FG003|NOT COMPLETED|Overall Study||0||
48064092|NCT01219673|100479450|FG004|NOT COMPLETED|Overall Study||0||
48064093|NCT01219673|100479451|FG005|NOT COMPLETED|Overall Study||0||
48064094|NCT01219673|100479452|FG006|NOT COMPLETED|Overall Study||0||
48064095|NCT01219673|100479453|FG007|NOT COMPLETED|Overall Study||0||
48064096|NCT00970073|100479454|FG000|STARTED|Overall Study||10||
48064097|NCT00970073|100479455|FG001|STARTED|Overall Study||10||
48064098|NCT00970073|100479456|FG002|STARTED|Overall Study||10||
48064099|NCT00970073|100479454|FG000|COMPLETED|Overall Study||10||
48064100|NCT00970073|100479455|FG001|COMPLETED|Overall Study||10||
48064101|NCT00970073|100479456|FG002|COMPLETED|Overall Study||10||
48064102|NCT00970073|100479454|FG000|NOT COMPLETED|Overall Study||0||
48064103|NCT00970073|100479455|FG001|NOT COMPLETED|Overall Study||0||
48064104|NCT00970073|100479456|FG002|NOT COMPLETED|Overall Study||0||
48064105|NCT00422097|100479457|FG000|STARTED|Dose Level 1||3||
48064106|NCT00422097|100479458|FG001|STARTED|Dose Level 1||0||
48064107|NCT00422097|100479459|FG002|STARTED|Dose Level 1||0||
48064108|NCT00422097|100479460|FG003|STARTED|Dose Level 1||0||
48064109|NCT00422097|100479461|FG004|STARTED|Dose Level 1||0||
48064110|NCT00422097|100479462|FG005|STARTED|Dose Level 1||0||
48064111|NCT00422097|100479463|FG006|STARTED|Dose Level 1||0||
48064112|NCT00422097|100479464|FG007|STARTED|Dose Level 1||0||
48064113|NCT00422097|100479457|FG000|COMPLETED|Dose Level 1||3||
48064114|NCT00422097|100479458|FG001|COMPLETED|Dose Level 1||0||
48064115|NCT00422097|100479459|FG002|COMPLETED|Dose Level 1||0||
48064116|NCT00422097|100479460|FG003|COMPLETED|Dose Level 1||0||
48064117|NCT00422097|100479461|FG004|COMPLETED|Dose Level 1||0||
48064118|NCT00422097|100479462|FG005|COMPLETED|Dose Level 1||0||
48064119|NCT00422097|100479463|FG006|COMPLETED|Dose Level 1||0||
48064120|NCT00422097|100479464|FG007|COMPLETED|Dose Level 1||0||
48064121|NCT00422097|100479457|FG000|NOT COMPLETED|Dose Level 1||0||
48064122|NCT00422097|100479458|FG001|NOT COMPLETED|Dose Level 1||0||
48064123|NCT00422097|100479459|FG002|NOT COMPLETED|Dose Level 1||0||
48064124|NCT00422097|100479460|FG003|NOT COMPLETED|Dose Level 1||0||
48064125|NCT00422097|100479461|FG004|NOT COMPLETED|Dose Level 1||0||
48064126|NCT00422097|100479462|FG005|NOT COMPLETED|Dose Level 1||0||
48064127|NCT00422097|100479463|FG006|NOT COMPLETED|Dose Level 1||0||
48064128|NCT00422097|100479464|FG007|NOT COMPLETED|Dose Level 1||0||
48064129|NCT00422097|100479457|FG000|STARTED|Dose Level 2||0||
48064130|NCT00422097|100479458|FG001|STARTED|Dose Level 2||6||
48064131|NCT00422097|100479459|FG002|STARTED|Dose Level 2||0||
48064132|NCT00422097|100479460|FG003|STARTED|Dose Level 2||0||
48064133|NCT00422097|100479461|FG004|STARTED|Dose Level 2||0||
48064134|NCT00422097|100479462|FG005|STARTED|Dose Level 2||0||
48064135|NCT00422097|100479463|FG006|STARTED|Dose Level 2||0||
48064136|NCT00422097|100479464|FG007|STARTED|Dose Level 2||0||
48064137|NCT00422097|100479457|FG000|COMPLETED|Dose Level 2||0||
48064138|NCT00422097|100479458|FG001|COMPLETED|Dose Level 2||5||
48064139|NCT00422097|100479459|FG002|COMPLETED|Dose Level 2||0||
48064140|NCT00422097|100479460|FG003|COMPLETED|Dose Level 2||0||
48064141|NCT00422097|100479461|FG004|COMPLETED|Dose Level 2||0||
48064142|NCT00422097|100479462|FG005|COMPLETED|Dose Level 2||0||
48064143|NCT00422097|100479463|FG006|COMPLETED|Dose Level 2||0||
48064144|NCT00422097|100479464|FG007|COMPLETED|Dose Level 2||0||
48064145|NCT00422097|100479457|FG000|NOT COMPLETED|Dose Level 2||0||
48064146|NCT00422097|100479458|FG001|NOT COMPLETED|Dose Level 2||1||
48064147|NCT00422097|100479459|FG002|NOT COMPLETED|Dose Level 2||0||
48064148|NCT00422097|100479460|FG003|NOT COMPLETED|Dose Level 2||0||
48064149|NCT00422097|100479461|FG004|NOT COMPLETED|Dose Level 2||0||
48064150|NCT00422097|100479462|FG005|NOT COMPLETED|Dose Level 2||0||
48064151|NCT00422097|100479463|FG006|NOT COMPLETED|Dose Level 2||0||
48064152|NCT00422097|100479464|FG007|NOT COMPLETED|Dose Level 2||0||
48064153|NCT00422097|100479457|FG000|STARTED|Dose Level 3||0||
48064154|NCT00422097|100479458|FG001|STARTED|Dose Level 3||0||
48064155|NCT00422097|100479459|FG002|STARTED|Dose Level 3||3||
48064156|NCT00422097|100479460|FG003|STARTED|Dose Level 3||0||
48064157|NCT00422097|100479461|FG004|STARTED|Dose Level 3||0||
48064158|NCT00422097|100479462|FG005|STARTED|Dose Level 3||0||
48064159|NCT00422097|100479463|FG006|STARTED|Dose Level 3||0||
48064160|NCT00422097|100479464|FG007|STARTED|Dose Level 3||0||
48064161|NCT00422097|100479457|FG000|COMPLETED|Dose Level 3||0||
48064162|NCT00422097|100479458|FG001|COMPLETED|Dose Level 3||0||
48064163|NCT00422097|100479459|FG002|COMPLETED|Dose Level 3||3||
48064164|NCT00422097|100479460|FG003|COMPLETED|Dose Level 3||0||
48064165|NCT00422097|100479461|FG004|COMPLETED|Dose Level 3||0||
48064166|NCT00422097|100479462|FG005|COMPLETED|Dose Level 3||0||
48064167|NCT00422097|100479463|FG006|COMPLETED|Dose Level 3||0||
48064168|NCT00422097|100479464|FG007|COMPLETED|Dose Level 3||0||
48064169|NCT00422097|100479457|FG000|NOT COMPLETED|Dose Level 3||0||
48064170|NCT00422097|100479458|FG001|NOT COMPLETED|Dose Level 3||0||
48064171|NCT00422097|100479459|FG002|NOT COMPLETED|Dose Level 3||0||
48064172|NCT00422097|100479460|FG003|NOT COMPLETED|Dose Level 3||0||
48064173|NCT00422097|100479461|FG004|NOT COMPLETED|Dose Level 3||0||
48064174|NCT00422097|100479462|FG005|NOT COMPLETED|Dose Level 3||0||
48064175|NCT00422097|100479463|FG006|NOT COMPLETED|Dose Level 3||0||
48064176|NCT00422097|100479464|FG007|NOT COMPLETED|Dose Level 3||0||
48064177|NCT00422097|100479457|FG000|STARTED|Dose Level 4||0||
48064178|NCT00422097|100479458|FG001|STARTED|Dose Level 4||0||
48064179|NCT00422097|100479459|FG002|STARTED|Dose Level 4||0||
48064180|NCT00422097|100479460|FG003|STARTED|Dose Level 4||3||
48064181|NCT00422097|100479461|FG004|STARTED|Dose Level 4||0||
48064182|NCT00422097|100479462|FG005|STARTED|Dose Level 4||0||
48064183|NCT00422097|100479463|FG006|STARTED|Dose Level 4||0||
48064184|NCT00422097|100479464|FG007|STARTED|Dose Level 4||0||
48064185|NCT00422097|100479457|FG000|COMPLETED|Dose Level 4||0||
48064186|NCT00422097|100479458|FG001|COMPLETED|Dose Level 4||0||
48064187|NCT00422097|100479459|FG002|COMPLETED|Dose Level 4||0||
48064188|NCT00422097|100479460|FG003|COMPLETED|Dose Level 4||3||
48064189|NCT00422097|100479461|FG004|COMPLETED|Dose Level 4||0||
48064190|NCT00422097|100479462|FG005|COMPLETED|Dose Level 4||0||
48064191|NCT00422097|100479463|FG006|COMPLETED|Dose Level 4||0||
48064192|NCT00422097|100479464|FG007|COMPLETED|Dose Level 4||0||
48064193|NCT00422097|100479457|FG000|NOT COMPLETED|Dose Level 4||0||
48064194|NCT00422097|100479458|FG001|NOT COMPLETED|Dose Level 4||0||
48064195|NCT00422097|100479459|FG002|NOT COMPLETED|Dose Level 4||0||
48064196|NCT00422097|100479460|FG003|NOT COMPLETED|Dose Level 4||0||
48064197|NCT00422097|100479461|FG004|NOT COMPLETED|Dose Level 4||0||
48064198|NCT00422097|100479462|FG005|NOT COMPLETED|Dose Level 4||0||
48064199|NCT00422097|100479463|FG006|NOT COMPLETED|Dose Level 4||0||
48064200|NCT00422097|100479464|FG007|NOT COMPLETED|Dose Level 4||0||
48064201|NCT00422097|100479457|FG000|STARTED|Dose Level 5||0||
48064202|NCT00422097|100479458|FG001|STARTED|Dose Level 5||0||
48064203|NCT00422097|100479459|FG002|STARTED|Dose Level 5||0||
48064204|NCT00422097|100479460|FG003|STARTED|Dose Level 5||0||
48064205|NCT00422097|100479461|FG004|STARTED|Dose Level 5||23||
48064206|NCT00422097|100479462|FG005|STARTED|Dose Level 5||0||
48064207|NCT00422097|100479463|FG006|STARTED|Dose Level 5||0||
48064208|NCT00422097|100479464|FG007|STARTED|Dose Level 5||0||
48064209|NCT00422097|100479457|FG000|COMPLETED|Dose Level 5||0||
48064210|NCT00422097|100479458|FG001|COMPLETED|Dose Level 5||0||
48064211|NCT00422097|100479459|FG002|COMPLETED|Dose Level 5||0||
48064212|NCT00422097|100479460|FG003|COMPLETED|Dose Level 5||0||
48064213|NCT00422097|100479461|FG004|COMPLETED|Dose Level 5||23||
48064214|NCT00422097|100479462|FG005|COMPLETED|Dose Level 5||0||
48064215|NCT00422097|100479463|FG006|COMPLETED|Dose Level 5||0||
48064216|NCT00422097|100479464|FG007|COMPLETED|Dose Level 5||0||
48064217|NCT00422097|100479457|FG000|NOT COMPLETED|Dose Level 5||0||
48064218|NCT00422097|100479458|FG001|NOT COMPLETED|Dose Level 5||0||
48064219|NCT00422097|100479459|FG002|NOT COMPLETED|Dose Level 5||0||
48064220|NCT00422097|100479460|FG003|NOT COMPLETED|Dose Level 5||0||
48064221|NCT00422097|100479461|FG004|NOT COMPLETED|Dose Level 5||0||
48064222|NCT00422097|100479462|FG005|NOT COMPLETED|Dose Level 5||0||
48064223|NCT00422097|100479463|FG006|NOT COMPLETED|Dose Level 5||0||
48064224|NCT00422097|100479464|FG007|NOT COMPLETED|Dose Level 5||0||
48064225|NCT00422097|100479457|FG000|STARTED|Dose Level 6||0||
48064226|NCT00422097|100479458|FG001|STARTED|Dose Level 6||0||
48064227|NCT00422097|100479459|FG002|STARTED|Dose Level 6||0||
48064228|NCT00422097|100479460|FG003|STARTED|Dose Level 6||0||
48064229|NCT00422097|100479461|FG004|STARTED|Dose Level 6||0||
48064230|NCT00422097|100479462|FG005|STARTED|Dose Level 6||6||
48064231|NCT00422097|100479463|FG006|STARTED|Dose Level 6||0||
48064232|NCT00422097|100479464|FG007|STARTED|Dose Level 6||0||
48064233|NCT00422097|100479457|FG000|COMPLETED|Dose Level 6||0||
48064234|NCT00422097|100479458|FG001|COMPLETED|Dose Level 6||0||
48064235|NCT00422097|100479459|FG002|COMPLETED|Dose Level 6||0||
48064236|NCT00422097|100479460|FG003|COMPLETED|Dose Level 6||0||
48064237|NCT00422097|100479461|FG004|COMPLETED|Dose Level 6||0||
48064238|NCT00422097|100479462|FG005|COMPLETED|Dose Level 6||6||
48064239|NCT00422097|100479463|FG006|COMPLETED|Dose Level 6||0||
48064240|NCT00422097|100479464|FG007|COMPLETED|Dose Level 6||0||
48064241|NCT00422097|100479457|FG000|NOT COMPLETED|Dose Level 6||0||
48064242|NCT00422097|100479458|FG001|NOT COMPLETED|Dose Level 6||0||
48064243|NCT00422097|100479459|FG002|NOT COMPLETED|Dose Level 6||0||
48064244|NCT00422097|100479460|FG003|NOT COMPLETED|Dose Level 6||0||
48064245|NCT00422097|100479461|FG004|NOT COMPLETED|Dose Level 6||0||
48064246|NCT00422097|100479462|FG005|NOT COMPLETED|Dose Level 6||0||
48064247|NCT00422097|100479463|FG006|NOT COMPLETED|Dose Level 6||0||
48064248|NCT00422097|100479464|FG007|NOT COMPLETED|Dose Level 6||0||
48064249|NCT00422097|100479457|FG000|STARTED|Ixabepilone With Famotidine or Food||0||
48064250|NCT00422097|100479458|FG001|STARTED|Ixabepilone With Famotidine or Food||0||
48064251|NCT00422097|100479459|FG002|STARTED|Ixabepilone With Famotidine or Food||0||
48064252|NCT00422097|100479460|FG003|STARTED|Ixabepilone With Famotidine or Food||0||
48064253|NCT00422097|100479461|FG004|STARTED|Ixabepilone With Famotidine or Food||0||
48064254|NCT00422097|100479462|FG005|STARTED|Ixabepilone With Famotidine or Food||0||
48064255|NCT00422097|100479463|FG006|STARTED|Ixabepilone With Famotidine or Food||8||
48064256|NCT00422097|100479464|FG007|STARTED|Ixabepilone With Famotidine or Food||7||
48064257|NCT00422097|100479457|FG000|COMPLETED|Ixabepilone With Famotidine or Food||0||
48064258|NCT00422097|100479458|FG001|COMPLETED|Ixabepilone With Famotidine or Food||0||
48064259|NCT00422097|100479459|FG002|COMPLETED|Ixabepilone With Famotidine or Food||0||
48064260|NCT00422097|100479460|FG003|COMPLETED|Ixabepilone With Famotidine or Food||0||
48064261|NCT00422097|100479461|FG004|COMPLETED|Ixabepilone With Famotidine or Food||0||
48064262|NCT00422097|100479462|FG005|COMPLETED|Ixabepilone With Famotidine or Food||0||
48064263|NCT00422097|100479463|FG006|COMPLETED|Ixabepilone With Famotidine or Food||8||
48064264|NCT00422097|100479464|FG007|COMPLETED|Ixabepilone With Famotidine or Food||7||
48064265|NCT00422097|100479457|FG000|NOT COMPLETED|Ixabepilone With Famotidine or Food||0||
48064266|NCT00422097|100479458|FG001|NOT COMPLETED|Ixabepilone With Famotidine or Food||0||
48064267|NCT00422097|100479459|FG002|NOT COMPLETED|Ixabepilone With Famotidine or Food||0||
48064268|NCT00422097|100479460|FG003|NOT COMPLETED|Ixabepilone With Famotidine or Food||0||
48064269|NCT00422097|100479461|FG004|NOT COMPLETED|Ixabepilone With Famotidine or Food||0||
48064270|NCT00422097|100479462|FG005|NOT COMPLETED|Ixabepilone With Famotidine or Food||0||
48064271|NCT00422097|100479463|FG006|NOT COMPLETED|Ixabepilone With Famotidine or Food||0||
48064272|NCT00422097|100479464|FG007|NOT COMPLETED|Ixabepilone With Famotidine or Food||0||
48064273|NCT00669396|100479465|FG000|STARTED|Overall Study||23||
48064274|NCT00669396|100479466|FG001|STARTED|Overall Study||34||
48064275|NCT00669396|100479465|FG000|COMPLETED|Overall Study||13||
48064276|NCT00669396|100479466|FG001|COMPLETED|Overall Study||22||
48064277|NCT00669396|100479465|FG000|NOT COMPLETED|Overall Study||10||
48064278|NCT00669396|100479466|FG001|NOT COMPLETED|Overall Study||12||
48064279|NCT00810355|100479467|FG000|STARTED|Overall Study||25||
48064280|NCT00810355|100479468|FG001|STARTED|Overall Study||25||
48064281|NCT00810355|100479469|FG002|STARTED|Overall Study||25||
48064282|NCT00810355|100479467|FG000|COMPLETED|Overall Study||11||
48064283|NCT00810355|100479468|FG001|COMPLETED|Overall Study||8||
48064284|NCT00810355|100479469|FG002|COMPLETED|Overall Study||14||
48064285|NCT00810355|100479467|FG000|NOT COMPLETED|Overall Study||14||
48064286|NCT00810355|100479468|FG001|NOT COMPLETED|Overall Study||17||
48064287|NCT00810355|100479469|FG002|NOT COMPLETED|Overall Study||11||
48064288|NCT01146912|100479470|FG000|STARTED|Overall Study||4607||
48064289|NCT01146912|100479471|FG001|STARTED|Overall Study||4606||
48064290|NCT01146912|100479472|FG002|STARTED|Overall Study||593||
48064291|NCT01146912|100479473|FG003|STARTED|Overall Study||594||
48064292|NCT01146912|100479474|FG004|STARTED|Overall Study||1821||
48064293|NCT01146912|100479475|FG005|STARTED|Overall Study||1821||
48064294|NCT01146912|100479476|FG006|STARTED|Overall Study||1820||
48064295|NCT01146912|100479477|FG007|STARTED|Overall Study||14675||
48064296|NCT01146912|100479470|FG000|COMPLETED|Overall Study||3790||
48064297|NCT01146912|100479471|FG001|COMPLETED|Overall Study||3784||
48064298|NCT01146912|100479472|FG002|COMPLETED|Overall Study||576||
48064299|NCT01146912|100479473|FG003|COMPLETED|Overall Study||577||
48064300|NCT01146912|100479474|FG004|COMPLETED|Overall Study||1780||
48064301|NCT01146912|100479475|FG005|COMPLETED|Overall Study||1760||
48064302|NCT01146912|100479476|FG006|COMPLETED|Overall Study||1764||
48064303|NCT01146912|100479477|FG007|COMPLETED|Overall Study||14675||
48064304|NCT01146912|100479470|FG000|NOT COMPLETED|Overall Study||817||
48064305|NCT01146912|100479471|FG001|NOT COMPLETED|Overall Study||822||
48064306|NCT01146912|100479472|FG002|NOT COMPLETED|Overall Study||17||
48064307|NCT01146912|100479473|FG003|NOT COMPLETED|Overall Study||17||
48064308|NCT01146912|100479474|FG004|NOT COMPLETED|Overall Study||41||
48064309|NCT01146912|100479475|FG005|NOT COMPLETED|Overall Study||61||
48064310|NCT01146912|100479476|FG006|NOT COMPLETED|Overall Study||56||
48064311|NCT01146912|100479477|FG007|NOT COMPLETED|Overall Study||0||
48064312|NCT00122109|100479478|FG000|STARTED|Overall Study||61||
48064313|NCT00122109|100479479|FG001|STARTED|Overall Study||64||
48064314|NCT00122109|100479478|FG000|COMPLETED|Overall Study||55||
48064315|NCT00122109|100479479|FG001|COMPLETED|Overall Study||57||
48064316|NCT00122109|100479478|FG000|NOT COMPLETED|Overall Study||6||
48064317|NCT00122109|100479479|FG001|NOT COMPLETED|Overall Study||7||
48064318|NCT02436681|100479480|FG000|STARTED|Overall Study||41||
48064319|NCT02436681|100479480|FG000|COMPLETED|Overall Study||27||
48064320|NCT02436681|100479480|FG000|NOT COMPLETED|Overall Study||14||
48064321|NCT03570697|100479481|FG000|STARTED|Overall Study||82||
48064322|NCT03570697|100479482|FG001|STARTED|Overall Study||82||
48064323|NCT03570697|100479481|FG000|Received at Least 1 Dose of Study Drug|Overall Study||81||
48064324|NCT03570697|100479482|FG001|Received at Least 1 Dose of Study Drug|Overall Study||80||
48064325|NCT03570697|100479481|FG000|COMPLETED|Overall Study||76||
48064326|NCT03570697|100479482|FG001|COMPLETED|Overall Study||79||
48064327|NCT03570697|100479481|FG000|NOT COMPLETED|Overall Study||6||
48064328|NCT03570697|100479482|FG001|NOT COMPLETED|Overall Study||3||
48064329|NCT02589405|100479483|FG000|STARTED|Overall Study||50||
48064330|NCT02589405|100479483|FG000|COMPLETED|Overall Study||46||
48064331|NCT02589405|100479483|FG000|NOT COMPLETED|Overall Study||4||
48064332|NCT03285984|100479484|FG000|STARTED|Overall Study||56||
48064333|NCT03285984|100479484|FG000|Received Test Product 1|Overall Study||56||
48064334|NCT03285984|100479484|FG000|Received Test Product 2|Overall Study||56||
48064335|NCT03285984|100479484|FG000|Received Test Product 3|Overall Study||56||
48064336|NCT03285984|100479484|FG000|Received Test Product 4|Overall Study||56||
48064337|NCT03285984|100479484|FG000|COMPLETED|Overall Study||56||
48064338|NCT03285984|100479484|FG000|NOT COMPLETED|Overall Study||0||
48064339|NCT02486302|100479485|FG000|STARTED|Overall Study||1534||
48064340|NCT02486302|100479485|FG000|Treated|Overall Study||1523||
48064341|NCT02486302|100479485|FG000|COMPLETED|Overall Study||858||
48064342|NCT02486302|100479485|FG000|NOT COMPLETED|Overall Study||676||
48064343|NCT02653183|100479486|FG000|STARTED|Overall Study||53||
48064344|NCT02653183|100479487|FG001|STARTED|Overall Study||50||
48064345|NCT02653183|100479486|FG000|COMPLETED|Overall Study||49||
48064346|NCT02653183|100479487|FG001|COMPLETED|Overall Study||46||
48064347|NCT02653183|100479486|FG000|NOT COMPLETED|Overall Study||4||
48064348|NCT02653183|100479487|FG001|NOT COMPLETED|Overall Study||4||
48064349|NCT00082342|100479488|FG000|STARTED|Overall Study||13||
48064350|NCT00082342|100479489|FG001|STARTED|Overall Study||12||
48064351|NCT00082342|100479488|FG000|COMPLETED|Overall Study||13||
48064352|NCT00082342|100479489|FG001|COMPLETED|Overall Study||12||
48064353|NCT00082342|100479488|FG000|NOT COMPLETED|Overall Study||0||
48064354|NCT00082342|100479489|FG001|NOT COMPLETED|Overall Study||0||
48064355|NCT03212690|100479490|FG000|STARTED|Overall Study||57||
48064356|NCT03212690|100479490|FG000|COMPLETED|Overall Study||56||
48064357|NCT03212690|100479490|FG000|NOT COMPLETED|Overall Study||1||
48064358|NCT03198078|100479491|FG000|STARTED|Overall Study||110||
48064359|NCT03198078|100479492|FG001|STARTED|Overall Study||102||
48064360|NCT03198078|100479493|FG002|STARTED|Overall Study||104||
48218628|NCT00391898|100860343|FG000|STARTED|Overall Study||46||
48218629|NCT00391898|100860344|FG001|STARTED|Overall Study||49||
48064361|NCT03198078|100479491|FG000|Safety Sample|Overall Study||110|Safety sample included all randomized participants who received at least 1 dose of investigational medicinal product (IMP).|
48064362|NCT03198078|100479492|FG001|Safety Sample|Overall Study||102|Safety sample included all randomized participants who received at least 1 dose of investigational medicinal product (IMP).|
48064363|NCT03198078|100479493|FG002|Safety Sample|Overall Study||104|Safety sample included all randomized participants who received at least 1 dose of investigational medicinal product (IMP).|
48064364|NCT03198078|100479491|FG000|Efficacy Sample|Overall Study||110|Efficacy sample included all randomized participants who received at least 1 dose of IMP, had a baseline assessment, and at least one post-baseline assessment of the Positive and Negative Syndrome Scale (PANSS) Total Score.|
48064365|NCT03198078|100479492|FG001|Efficacy Sample|Overall Study||101|Efficacy sample included all randomized participants who received at least 1 dose of IMP, had a baseline assessment, and at least one post-baseline assessment of the Positive and Negative Syndrome Scale (PANSS) Total Score.|
48064366|NCT03198078|100479493|FG002|Efficacy Sample|Overall Study||103|Efficacy sample included all randomized participants who received at least 1 dose of IMP, had a baseline assessment, and at least one post-baseline assessment of the Positive and Negative Syndrome Scale (PANSS) Total Score.|
48064367|NCT03198078|100479491|FG000|COMPLETED|Overall Study||107||
48064368|NCT03198078|100479492|FG001|COMPLETED|Overall Study||97||
48064369|NCT03198078|100479493|FG002|COMPLETED|Overall Study||92||
48064370|NCT03198078|100479491|FG000|NOT COMPLETED|Overall Study||3||
48064371|NCT03198078|100479492|FG001|NOT COMPLETED|Overall Study||5||
48064372|NCT03198078|100479493|FG002|NOT COMPLETED|Overall Study||12||
48064373|NCT01160211|100479494|FG000|STARTED|Overall Study||120||
48064374|NCT01160211|100479495|FG001|STARTED|Overall Study||118||
48064375|NCT01160211|100479496|FG002|STARTED|Overall Study||117||
48064376|NCT01160211|100479494|FG000|Ongoing|Overall Study||90||
48064377|NCT01160211|100479495|FG001|Ongoing|Overall Study||75||
48064378|NCT01160211|100479496|FG002|Ongoing|Overall Study||79||
48064379|NCT01160211|100479494|FG000|COMPLETED|Overall Study||21||
48064380|NCT01160211|100479495|FG001|COMPLETED|Overall Study||31||
48064381|NCT01160211|100479496|FG002|COMPLETED|Overall Study||30||
48064382|NCT01160211|100479494|FG000|NOT COMPLETED|Overall Study||99||
48064383|NCT01160211|100479495|FG001|NOT COMPLETED|Overall Study||87||
48064384|NCT01160211|100479496|FG002|NOT COMPLETED|Overall Study||87||
48064385|NCT02260440|100479497|FG000|STARTED|Overall Study||31||
48064386|NCT02260440|100479497|FG000|COMPLETED|Overall Study||31||
48064387|NCT02260440|100479497|FG000|NOT COMPLETED|Overall Study||0||
48064388|NCT03605212|100479498|FG000|STARTED|Baseline Period||3||
48064389|NCT03605212|100479499|FG001|STARTED|Baseline Period||0||
48064390|NCT03605212|100479500|FG002|STARTED|Baseline Period||3||
48064391|NCT03605212|100479501|FG003|STARTED|Baseline Period||0||
48064392|NCT03605212|100479502|FG004|STARTED|Baseline Period||24||
48064393|NCT03605212|100479498|FG000|COMPLETED|Baseline Period||3||
48064394|NCT03605212|100479499|FG001|COMPLETED|Baseline Period||0||
48064395|NCT03605212|100479500|FG002|COMPLETED|Baseline Period||3||
48064396|NCT03605212|100479501|FG003|COMPLETED|Baseline Period||0||
48064397|NCT03605212|100479502|FG004|COMPLETED|Baseline Period||24||
48064398|NCT03605212|100479498|FG000|NOT COMPLETED|Baseline Period||0||
48064399|NCT03605212|100479499|FG001|NOT COMPLETED|Baseline Period||0||
48064400|NCT03605212|100479500|FG002|NOT COMPLETED|Baseline Period||0||
48064401|NCT03605212|100479501|FG003|NOT COMPLETED|Baseline Period||0||
48064402|NCT03605212|100479502|FG004|NOT COMPLETED|Baseline Period||0||
48064403|NCT03605212|100479498|FG000|STARTED|Treatment Period||3||
48064404|NCT03605212|100479499|FG001|STARTED|Treatment Period||0||
48064405|NCT03605212|100479500|FG002|STARTED|Treatment Period||3||
48064406|NCT03605212|100479501|FG003|STARTED|Treatment Period||0||
48064407|NCT03605212|100479502|FG004|STARTED|Treatment Period||24||
48064408|NCT03605212|100479498|FG000|COMPLETED|Treatment Period||2||
48064409|NCT03605212|100479499|FG001|COMPLETED|Treatment Period||0||
48064410|NCT03605212|100479500|FG002|COMPLETED|Treatment Period||3||
48064411|NCT03605212|100479501|FG003|COMPLETED|Treatment Period||0||
48064412|NCT03605212|100479502|FG004|COMPLETED|Treatment Period||23||
48064413|NCT03605212|100479498|FG000|NOT COMPLETED|Treatment Period||1||
48064414|NCT03605212|100479499|FG001|NOT COMPLETED|Treatment Period||0||
48064415|NCT03605212|100479500|FG002|NOT COMPLETED|Treatment Period||0||
48064416|NCT03605212|100479501|FG003|NOT COMPLETED|Treatment Period||0||
48064417|NCT03605212|100479502|FG004|NOT COMPLETED|Treatment Period||1||
48064418|NCT02935842|100479503|FG000|STARTED|Testing and Therapy Period 1||8||
48064419|NCT02935842|100479504|FG001|STARTED|Testing and Therapy Period 1||6||
48064420|NCT02935842|100479505|FG002|STARTED|Testing and Therapy Period 1||6||
48064421|NCT02935842|100479506|FG003|STARTED|Testing and Therapy Period 1||0||
48064422|NCT02935842|100479503|FG000|COMPLETED|Testing and Therapy Period 1||8||
48064423|NCT02935842|100479504|FG001|COMPLETED|Testing and Therapy Period 1||6||
48064424|NCT02935842|100479505|FG002|COMPLETED|Testing and Therapy Period 1||6||
48064425|NCT02935842|100479506|FG003|COMPLETED|Testing and Therapy Period 1||0||
48064426|NCT02935842|100479503|FG000|NOT COMPLETED|Testing and Therapy Period 1||0||
48064427|NCT02935842|100479504|FG001|NOT COMPLETED|Testing and Therapy Period 1||0||
48064428|NCT02935842|100479505|FG002|NOT COMPLETED|Testing and Therapy Period 1||0||
48064429|NCT02935842|100479506|FG003|NOT COMPLETED|Testing and Therapy Period 1||0||
48064430|NCT02935842|100479503|FG000|STARTED|Testing and Therapy Period 2||8||
48064431|NCT02935842|100479504|FG001|STARTED|Testing and Therapy Period 2||6||
48064432|NCT02935842|100479505|FG002|STARTED|Testing and Therapy Period 2||6||
48064433|NCT02935842|100479506|FG003|STARTED|Testing and Therapy Period 2||0||
48064434|NCT02935842|100479503|FG000|COMPLETED|Testing and Therapy Period 2||6||
48064435|NCT02935842|100479504|FG001|COMPLETED|Testing and Therapy Period 2||6||
48064436|NCT02935842|100479505|FG002|COMPLETED|Testing and Therapy Period 2||6||
48064437|NCT02935842|100479506|FG003|COMPLETED|Testing and Therapy Period 2||0||
48064438|NCT02935842|100479503|FG000|NOT COMPLETED|Testing and Therapy Period 2||2||
48064439|NCT02935842|100479504|FG001|NOT COMPLETED|Testing and Therapy Period 2||0||
48064440|NCT02935842|100479505|FG002|NOT COMPLETED|Testing and Therapy Period 2||0||
48064441|NCT02935842|100479506|FG003|NOT COMPLETED|Testing and Therapy Period 2||0||
48064442|NCT02935842|100479503|FG000|STARTED|Testing and Therapy Period 3||6||
48064443|NCT02935842|100479504|FG001|STARTED|Testing and Therapy Period 3||6||
48064444|NCT02935842|100479505|FG002|STARTED|Testing and Therapy Period 3||6||
48064445|NCT02935842|100479506|FG003|STARTED|Testing and Therapy Period 3||18||
48064446|NCT02935842|100479503|FG000|COMPLETED|Testing and Therapy Period 3||3||
48064447|NCT02935842|100479504|FG001|COMPLETED|Testing and Therapy Period 3||2||
48064448|NCT02935842|100479505|FG002|COMPLETED|Testing and Therapy Period 3||1||
48064449|NCT02935842|100479506|FG003|COMPLETED|Testing and Therapy Period 3||17||
48064450|NCT02935842|100479503|FG000|NOT COMPLETED|Testing and Therapy Period 3||3||
48064451|NCT02935842|100479504|FG001|NOT COMPLETED|Testing and Therapy Period 3||4||
48064452|NCT02935842|100479505|FG002|NOT COMPLETED|Testing and Therapy Period 3||5||
48064453|NCT02935842|100479506|FG003|NOT COMPLETED|Testing and Therapy Period 3||1||
48064454|NCT02100579|100479507|FG000|STARTED|Overall Study||20||
48064455|NCT02100579|100479508|FG001|STARTED|Overall Study||20||
48064456|NCT02100579|100479507|FG000|COMPLETED|Overall Study||20||
48064457|NCT02100579|100479508|FG001|COMPLETED|Overall Study||20||
48064458|NCT02100579|100479507|FG000|NOT COMPLETED|Overall Study||0||
48064459|NCT02100579|100479508|FG001|NOT COMPLETED|Overall Study||0||
48064460|NCT00397215|100479509|FG000|STARTED|Month 0 (Day 0)||165||
48064461|NCT00397215|100479510|FG001|STARTED|Month 0 (Day 0)||61||
48064462|NCT00397215|100479511|FG002|STARTED|Month 0 (Day 0)||159||
48064463|NCT00397215|100479512|FG003|STARTED|Month 0 (Day 0)||52||
48064464|NCT00397215|100479509|FG000|COMPLETED|Month 0 (Day 0)||158||
48064465|NCT00397215|100479510|FG001|COMPLETED|Month 0 (Day 0)||56||
48064466|NCT00397215|100479511|FG002|COMPLETED|Month 0 (Day 0)||153||
48064467|NCT00397215|100479512|FG003|COMPLETED|Month 0 (Day 0)||48||
48064468|NCT00397215|100479509|FG000|NOT COMPLETED|Month 0 (Day 0)||7||
48064469|NCT00397215|100479510|FG001|NOT COMPLETED|Month 0 (Day 0)||5||
48064470|NCT00397215|100479511|FG002|NOT COMPLETED|Month 0 (Day 0)||6||
48064471|NCT00397215|100479512|FG003|NOT COMPLETED|Month 0 (Day 0)||4||
48064472|NCT00397215|100479509|FG000|STARTED|Month 6 (Day 180)||164||
48064473|NCT00397215|100479510|FG001|STARTED|Month 6 (Day 180)||58||
48064474|NCT00397215|100479511|FG002|STARTED|Month 6 (Day 180)||158||
48064475|NCT00397215|100479512|FG003|STARTED|Month 6 (Day 180)||51||
48064476|NCT00397215|100479509|FG000|COMPLETED|Month 6 (Day 180)||162||
48064477|NCT00397215|100479510|FG001|COMPLETED|Month 6 (Day 180)||55||
48064478|NCT00397215|100479511|FG002|COMPLETED|Month 6 (Day 180)||153||
48064479|NCT00397215|100479512|FG003|COMPLETED|Month 6 (Day 180)||51||
48064480|NCT00397215|100479509|FG000|NOT COMPLETED|Month 6 (Day 180)||2||
48064481|NCT00397215|100479510|FG001|NOT COMPLETED|Month 6 (Day 180)||3||
48064482|NCT00397215|100479511|FG002|NOT COMPLETED|Month 6 (Day 180)||5||
48064483|NCT00397215|100479512|FG003|NOT COMPLETED|Month 6 (Day 180)||0||
48064484|NCT00397215|100479509|FG000|STARTED|Month 12 (Day 360)||130||
48064485|NCT00397215|100479510|FG001|STARTED|Month 12 (Day 360)||48||
48064486|NCT00397215|100479511|FG002|STARTED|Month 12 (Day 360)||125||
48064487|NCT00397215|100479512|FG003|STARTED|Month 12 (Day 360)||42||
48218630|NCT00391898|100860343|FG000|COMPLETED|Overall Study||35||
48508845|NCT03507686|101580235|FG001|STARTED|Treatment Period 2 (Month13 to Month24)||56||
48064488|NCT00397215|100479509|FG000|COMPLETED|Month 12 (Day 360)||130||
48064489|NCT00397215|100479510|FG001|COMPLETED|Month 12 (Day 360)||48||
48064490|NCT00397215|100479511|FG002|COMPLETED|Month 12 (Day 360)||125||
48064491|NCT00397215|100479512|FG003|COMPLETED|Month 12 (Day 360)||42||
48064492|NCT00397215|100479509|FG000|NOT COMPLETED|Month 12 (Day 360)||0||
48064493|NCT00397215|100479510|FG001|NOT COMPLETED|Month 12 (Day 360)||0||
48064494|NCT00397215|100479511|FG002|NOT COMPLETED|Month 12 (Day 360)||0||
48064495|NCT00397215|100479512|FG003|NOT COMPLETED|Month 12 (Day 360)||0||
48064496|NCT00397215|100479509|FG000|STARTED|Month 24 (Day 720)||122||
48064497|NCT00397215|100479510|FG001|STARTED|Month 24 (Day 720)||45||
48064498|NCT00397215|100479511|FG002|STARTED|Month 24 (Day 720)||117||
48064499|NCT00397215|100479512|FG003|STARTED|Month 24 (Day 720)||36||
48064500|NCT00397215|100479509|FG000|COMPLETED|Month 24 (Day 720)||122||
48064501|NCT00397215|100479510|FG001|COMPLETED|Month 24 (Day 720)||45||
48064502|NCT00397215|100479511|FG002|COMPLETED|Month 24 (Day 720)||117||
48064503|NCT00397215|100479512|FG003|COMPLETED|Month 24 (Day 720)||36||
48064504|NCT00397215|100479509|FG000|NOT COMPLETED|Month 24 (Day 720)||0||
48064505|NCT00397215|100479510|FG001|NOT COMPLETED|Month 24 (Day 720)||0||
48064506|NCT00397215|100479511|FG002|NOT COMPLETED|Month 24 (Day 720)||0||
48064507|NCT00397215|100479512|FG003|NOT COMPLETED|Month 24 (Day 720)||0||
48064508|NCT01881373|100479513|FG000|STARTED|Baseline||1517|community randomized trial with 2 cross sectional samples at baseline and 24 months.|9
48218631|NCT00391898|100860344|FG001|COMPLETED|Overall Study||39||
48064509|NCT01881373|100479514|FG001|STARTED|Baseline||1491|community randomized trial with 2 cross sectional samples at baseline and 24 months.|9
48064510|NCT01881373|100479515|FG002|STARTED|Baseline||1321|community randomized trial with 2 cross sectional samples at baseline and 24 months.|9
48064511|NCT01881373|100479513|FG000|COMPLETED|Baseline||1517||9
48064512|NCT01881373|100479514|FG001|COMPLETED|Baseline||1491||9
48064513|NCT01881373|100479515|FG002|COMPLETED|Baseline||1321||9
48064514|NCT01881373|100479513|FG000|NOT COMPLETED|Baseline||0||0
48064515|NCT01881373|100479514|FG001|NOT COMPLETED|Baseline||0||0
48064516|NCT01881373|100479515|FG002|NOT COMPLETED|Baseline||0||0
48064517|NCT01881373|100479513|FG000|STARTED|24 Months||1342||9
48064518|NCT01881373|100479514|FG001|STARTED|24 Months||1295||9
48064519|NCT01881373|100479515|FG002|STARTED|24 Months||1405||9
48064520|NCT01881373|100479513|FG000|COMPLETED|24 Months||1342||9
48064521|NCT01881373|100479514|FG001|COMPLETED|24 Months||1295||9
48064522|NCT01881373|100479515|FG002|COMPLETED|24 Months||1405||9
48064523|NCT01881373|100479513|FG000|NOT COMPLETED|24 Months||0||0
48064524|NCT01881373|100479514|FG001|NOT COMPLETED|24 Months||0||0
48064525|NCT01881373|100479515|FG002|NOT COMPLETED|24 Months||0||0
48064526|NCT01881373|100479513|FG000|STARTED|78 Months||500||9
48064527|NCT01881373|100479514|FG001|STARTED|78 Months||479||9
48064528|NCT01881373|100479515|FG002|STARTED|78 Months||490||9
48064529|NCT01881373|100479513|FG000|COMPLETED|78 Months||500||9
48064530|NCT01881373|100479514|FG001|COMPLETED|78 Months||479||9
48064531|NCT01881373|100479515|FG002|COMPLETED|78 Months||490||9
48064532|NCT01881373|100479513|FG000|NOT COMPLETED|78 Months||0||0
48064533|NCT01881373|100479514|FG001|NOT COMPLETED|78 Months||0||0
48064534|NCT01881373|100479515|FG002|NOT COMPLETED|78 Months||0||0
48064535|NCT01146275|100479516|FG000|STARTED|Overall Study||6||
48064536|NCT01146275|100479516|FG000|COMPLETED|Overall Study||6||
48064537|NCT01146275|100479516|FG000|NOT COMPLETED|Overall Study||0||
48064538|NCT01680965|100479517|FG000|STARTED|Overall Study||3||
48064539|NCT01680965|100479518|FG001|STARTED|Overall Study||3||
48064540|NCT01680965|100479519|FG002|STARTED|Overall Study||6||
48064541|NCT01680965|100479520|FG003|STARTED|Overall Study||32||
48064542|NCT01680965|100479517|FG000|COMPLETED|Overall Study||3||
48064543|NCT01680965|100479518|FG001|COMPLETED|Overall Study||3||
48064544|NCT01680965|100479519|FG002|COMPLETED|Overall Study||6||
48064545|NCT01680965|100479520|FG003|COMPLETED|Overall Study||26||
48064546|NCT01680965|100479517|FG000|NOT COMPLETED|Overall Study||0||
48064547|NCT01680965|100479518|FG001|NOT COMPLETED|Overall Study||0||
48064548|NCT01680965|100479519|FG002|NOT COMPLETED|Overall Study||0||
48064549|NCT01680965|100479520|FG003|NOT COMPLETED|Overall Study||6||
48064550|NCT00994929|100479521|FG000|STARTED|Overall Study||9||
48064551|NCT00994929|100479521|FG000|COMPLETED|Overall Study||9||
48064552|NCT00994929|100479521|FG000|NOT COMPLETED|Overall Study||0||
48064553|NCT00408460|100479522|FG000|STARTED|Overall Study||34||
48064554|NCT00408460|100479522|FG000|COMPLETED|Overall Study||34||
48064555|NCT00408460|100479522|FG000|NOT COMPLETED|Overall Study||0||
48064556|NCT02121522|100479523|FG000|STARTED|Overall Study||14||
48064557|NCT02121522|100479523|FG000|COMPLETED|Overall Study||13||
48064558|NCT02121522|100479523|FG000|NOT COMPLETED|Overall Study||1||
48064559|NCT00516074|100479524|FG000|STARTED|Overall Study||28||
48064560|NCT00516074|100479525|FG001|STARTED|Overall Study||26||
48064561|NCT00516074|100479524|FG000|COMPLETED|Overall Study||22||
48064562|NCT00516074|100479525|FG001|COMPLETED|Overall Study||23||
48064563|NCT00516074|100479524|FG000|NOT COMPLETED|Overall Study||6||
48064564|NCT00516074|100479525|FG001|NOT COMPLETED|Overall Study||3||
48064565|NCT02147184|100479526|FG000|STARTED|Overall Study||127||
48064566|NCT02147184|100479527|FG001|STARTED|Overall Study||137||
48064567|NCT02147184|100479526|FG000|COMPLETED|Overall Study||78||
48064568|NCT02147184|100479527|FG001|COMPLETED|Overall Study||110||
48064569|NCT02147184|100479526|FG000|NOT COMPLETED|Overall Study||49||
48064570|NCT02147184|100479527|FG001|NOT COMPLETED|Overall Study||27||
48064571|NCT04122534|100479528|FG000|STARTED|Overall Study||48||
48064572|NCT04122534|100479528|FG000|COMPLETED|Overall Study||44||
48064573|NCT04122534|100479528|FG000|NOT COMPLETED|Overall Study||4||
48064574|NCT01268150|100479529|FG000|STARTED|Treatment Phase||56||
48064575|NCT01268150|100479529|FG000|COMPLETED|Treatment Phase||28||
48064576|NCT01268150|100479529|FG000|NOT COMPLETED|Treatment Phase||28||
48064577|NCT01268150|100479529|FG000|STARTED|Extension Phase||28||
48064578|NCT01268150|100479529|FG000|Treatment Ongoing at Data Cutoff Date|Extension Phase||1||
48064579|NCT01268150|100479529|FG000|COMPLETED|Extension Phase||1||
48064580|NCT01268150|100479529|FG000|NOT COMPLETED|Extension Phase||27||
48064581|NCT03061097|100479530|FG000|STARTED|Overall Study||4||
48064582|NCT03061097|100479531|FG001|STARTED|Overall Study||3||
48064583|NCT03061097|100479530|FG000|COMPLETED|Overall Study||4||
48064584|NCT03061097|100479531|FG001|COMPLETED|Overall Study||0||
48064585|NCT03061097|100479530|FG000|NOT COMPLETED|Overall Study||0||
48064586|NCT03061097|100479531|FG001|NOT COMPLETED|Overall Study||3||
48064587|NCT04439344|100479532|FG000|STARTED|Overall Study||53||
48064588|NCT04439344|100479532|FG000|Started Protocol Therapy|Overall Study||50||
48064589|NCT04439344|100479532|FG000|Eligible|Overall Study||47||
48064590|NCT04439344|100479532|FG000|COMPLETED|Overall Study||0|Treatment continued until disease progression or intolerability.|
48064591|NCT04439344|100479532|FG000|NOT COMPLETED|Overall Study||53||
48064592|NCT04242173|100479533|FG000|STARTED|Overall Study||3||
48064593|NCT04242173|100479533|FG000|COMPLETED|Overall Study||3||
48064594|NCT04242173|100479533|FG000|NOT COMPLETED|Overall Study||0||
48064595|NCT01229371|100479534|FG000|STARTED|Overall Study||109||
48064596|NCT01229371|100479535|FG001|STARTED|Overall Study||111||
48064597|NCT01229371|100479536|FG002|STARTED|Overall Study||110||
48064598|NCT01229371|100479537|FG003|STARTED|Overall Study||110||
48064599|NCT01229371|100479534|FG000|COMPLETED|Overall Study||109||
48064600|NCT01229371|100479535|FG001|COMPLETED|Overall Study||110||
48064601|NCT01229371|100479536|FG002|COMPLETED|Overall Study||110||
48064602|NCT01229371|100479537|FG003|COMPLETED|Overall Study||110||
48064603|NCT01229371|100479534|FG000|NOT COMPLETED|Overall Study||0||
48064604|NCT01229371|100479535|FG001|NOT COMPLETED|Overall Study||1||
48064605|NCT01229371|100479536|FG002|NOT COMPLETED|Overall Study||0||
48064606|NCT01229371|100479537|FG003|NOT COMPLETED|Overall Study||0||
48064607|NCT01032174|100479538|FG000|STARTED|Overall Study||63||
48064608|NCT01032174|100479539|FG001|STARTED|Overall Study||60||
48064609|NCT01032174|100479538|FG000|COMPLETED|Overall Study||63||
48064610|NCT01032174|100479539|FG001|COMPLETED|Overall Study||59||
48064611|NCT01032174|100479538|FG000|NOT COMPLETED|Overall Study||0||
48064612|NCT01032174|100479539|FG001|NOT COMPLETED|Overall Study||1||
48064613|NCT00809848|100479540|FG000|STARTED|Overall Study||36||
48064614|NCT00809848|100479541|FG001|STARTED|Overall Study||34||
48064615|NCT00809848|100479542|FG002|STARTED|Overall Study||34||
48064616|NCT00809848|100479543|FG003|STARTED|Overall Study||31||
48064617|NCT00809848|100479544|FG004|STARTED|Overall Study||37||
48064618|NCT00809848|100479540|FG000|COMPLETED|Overall Study||36||
48064619|NCT00809848|100479541|FG001|COMPLETED|Overall Study||34||
48064620|NCT00809848|100479542|FG002|COMPLETED|Overall Study||34||
48064621|NCT00809848|100479543|FG003|COMPLETED|Overall Study||30||
48064622|NCT00809848|100479544|FG004|COMPLETED|Overall Study||34||
48064623|NCT00809848|100479540|FG000|NOT COMPLETED|Overall Study||0||
48064624|NCT00809848|100479541|FG001|NOT COMPLETED|Overall Study||0||
48064625|NCT00809848|100479542|FG002|NOT COMPLETED|Overall Study||0||
48064626|NCT00809848|100479543|FG003|NOT COMPLETED|Overall Study||1||
48064627|NCT00809848|100479544|FG004|NOT COMPLETED|Overall Study||3||
48064628|NCT04398316|100479545|FG000|STARTED|Overall Study||3||
48064629|NCT04398316|100479546|FG001|STARTED|Overall Study||1||
48064630|NCT04398316|100479545|FG000|COMPLETED|Overall Study||3||
48064631|NCT04398316|100479546|FG001|COMPLETED|Overall Study||1||
48064632|NCT04398316|100479545|FG000|NOT COMPLETED|Overall Study||0||
48064633|NCT04398316|100479546|FG001|NOT COMPLETED|Overall Study||0||
48064634|NCT02628938|100479547|FG000|STARTED|Overall Study||15||
48064635|NCT02628938|100479548|FG001|STARTED|Overall Study||15||
48064636|NCT02628938|100479549|FG002|STARTED|Overall Study||15||
48064637|NCT02628938|100479547|FG000|COMPLETED|Overall Study||10||
48064638|NCT02628938|100479548|FG001|COMPLETED|Overall Study||13||
48064639|NCT02628938|100479549|FG002|COMPLETED|Overall Study||11||
48064640|NCT02628938|100479547|FG000|NOT COMPLETED|Overall Study||5||
48064641|NCT02628938|100479548|FG001|NOT COMPLETED|Overall Study||2||
48064642|NCT02628938|100479549|FG002|NOT COMPLETED|Overall Study||4||
48064643|NCT02927327|100479550|FG000|STARTED|Overall Study||30||
48064644|NCT02927327|100479551|FG001|STARTED|Overall Study||31||
48064645|NCT02927327|100479550|FG000|COMPLETED|Overall Study||30||
48064646|NCT02927327|100479551|FG001|COMPLETED|Overall Study||31||
48064647|NCT02927327|100479550|FG000|NOT COMPLETED|Overall Study||0||
48064648|NCT02927327|100479551|FG001|NOT COMPLETED|Overall Study||0||
48064649|NCT01006369|100479552|FG000|STARTED|Overall Study||13||
48064650|NCT01006369|100479553|FG001|STARTED|Overall Study||25||
48064651|NCT01006369|100479552|FG000|COMPLETED|Overall Study||1||
48064652|NCT01006369|100479553|FG001|COMPLETED|Overall Study||0||
48064653|NCT01006369|100479552|FG000|NOT COMPLETED|Overall Study||12||
48064654|NCT01006369|100479553|FG001|NOT COMPLETED|Overall Study||25||
48064655|NCT03491215|100479554|FG000|STARTED|Overall Study||18||
48064656|NCT03491215|100479555|FG001|STARTED|Overall Study||12||
48064657|NCT03491215|100479556|FG002|STARTED|Overall Study||15||
48064658|NCT03491215|100479557|FG003|STARTED|Overall Study||0||
48064659|NCT03491215|100479554|FG000|Rux Formulation - Received Tablet|Overall Study||18||
48064660|NCT03491215|100479555|FG001|Rux Formulation - Received Tablet|Overall Study||10||
48064661|NCT03491215|100479556|FG002|Rux Formulation - Received Tablet|Overall Study||0||
48064662|NCT03491215|100479557|FG003|Rux Formulation - Received Tablet|Overall Study||0||
48064663|NCT03491215|100479554|FG000|Rux Formulation - Received Capsule|Overall Study||0||
48064664|NCT03491215|100479555|FG001|Rux Formulation - Received Capsule|Overall Study||2||
48064665|NCT03491215|100479556|FG002|Rux Formulation - Received Capsule|Overall Study||7||
48064666|NCT03491215|100479557|FG003|Rux Formulation - Received Capsule|Overall Study||0||
48064667|NCT03491215|100479554|FG000|Rux Formulation - Received Oral Solution|Overall Study||0||
48064668|NCT03491215|100479555|FG001|Rux Formulation - Received Oral Solution|Overall Study||0||
48064669|NCT03491215|100479556|FG002|Rux Formulation - Received Oral Solution|Overall Study||8||
48064670|NCT03491215|100479557|FG003|Rux Formulation - Received Oral Solution|Overall Study||0||
48064671|NCT03491215|100479554|FG000|COMPLETED|Overall Study||11||
48064672|NCT03491215|100479555|FG001|COMPLETED|Overall Study||10||
48064673|NCT03491215|100479556|FG002|COMPLETED|Overall Study||14||
48064674|NCT03491215|100479557|FG003|COMPLETED|Overall Study||0||
48064675|NCT03491215|100479554|FG000|NOT COMPLETED|Overall Study||7||
48064676|NCT03491215|100479555|FG001|NOT COMPLETED|Overall Study||2||
48064677|NCT03491215|100479556|FG002|NOT COMPLETED|Overall Study||1||
48064678|NCT03491215|100479557|FG003|NOT COMPLETED|Overall Study||0||
48064679|NCT00590135|100479558|FG000|STARTED|Overall Study||59||
48064680|NCT00590135|100479558|FG000|COMPLETED|Overall Study||0||
48508846|NCT03507686|101580234|FG000|COMPLETED|Treatment Period 2 (Month13 to Month24)||0||
48508847|NCT03507686|101580235|FG001|COMPLETED|Treatment Period 2 (Month13 to Month24)||53||
48508848|NCT03507686|101580234|FG000|NOT COMPLETED|Treatment Period 2 (Month13 to Month24)||0||
48064681|NCT00590135|100479558|FG000|NOT COMPLETED|Overall Study||59||
48064682|NCT03398200|100479559|FG000|STARTED|Overall Study||52||
48064683|NCT03398200|100479560|FG001|STARTED|Overall Study||47||
48064684|NCT03398200|100479559|FG000|COMPLETED|Overall Study||52||
48064685|NCT03398200|100479560|FG001|COMPLETED|Overall Study||46||
48064686|NCT03398200|100479559|FG000|NOT COMPLETED|Overall Study||0||
48064687|NCT03398200|100479560|FG001|NOT COMPLETED|Overall Study||1||
48064688|NCT02247531|100479561|FG000|STARTED|Overall Study||321||
48064689|NCT02247531|100479562|FG001|STARTED|Overall Study||330||
48064690|NCT02247531|100479563|FG002|STARTED|Overall Study||324||
48064691|NCT02247531|100479561|FG000|COMPLETED|Overall Study||215||
48064692|NCT02247531|100479562|FG001|COMPLETED|Overall Study||205||
48064693|NCT02247531|100479563|FG002|COMPLETED|Overall Study||214||
48064694|NCT02247531|100479561|FG000|NOT COMPLETED|Overall Study||106||
48064695|NCT02247531|100479562|FG001|NOT COMPLETED|Overall Study||125||
48064696|NCT02247531|100479563|FG002|NOT COMPLETED|Overall Study||110||
48064697|NCT00578383|100479564|FG000|STARTED|Overall Study||37||
48064698|NCT00578383|100479565|FG001|STARTED|Overall Study||36||
48064699|NCT00578383|100479566|FG002|STARTED|Overall Study||19||
48064700|NCT00578383|100479567|FG003|STARTED|Overall Study||15||
48064701|NCT00578383|100479564|FG000|COMPLETED|Overall Study||21||
48064702|NCT00578383|100479565|FG001|COMPLETED|Overall Study||20||
48064703|NCT00578383|100479566|FG002|COMPLETED|Overall Study||13||
48064704|NCT00578383|100479567|FG003|COMPLETED|Overall Study||9||
48064705|NCT00578383|100479564|FG000|NOT COMPLETED|Overall Study||16||
48064706|NCT00578383|100479565|FG001|NOT COMPLETED|Overall Study||16||
48064707|NCT00578383|100479566|FG002|NOT COMPLETED|Overall Study||6||
48064708|NCT00578383|100479567|FG003|NOT COMPLETED|Overall Study||6||
48064709|NCT00398411|100479568|FG000|STARTED|Overall Study||34||
48064710|NCT00398411|100479569|FG001|STARTED|Overall Study||32||
48064711|NCT00398411|100479568|FG000|COMPLETED|Overall Study||34||
48064712|NCT00398411|100479569|FG001|COMPLETED|Overall Study||31||
48064713|NCT00398411|100479568|FG000|NOT COMPLETED|Overall Study||0||
48064714|NCT00398411|100479569|FG001|NOT COMPLETED|Overall Study||1||
48064715|NCT00721123|100479570|FG000|STARTED|Overall Study||538||
48064716|NCT00721123|100479570|FG000|COMPLETED|Overall Study||355||
48064717|NCT00721123|100479570|FG000|NOT COMPLETED|Overall Study||183||
48064718|NCT04879225|100479571|FG000|STARTED|Fruit, Dessert, Mint, Menthol, Tobacco||52||
48064719|NCT04879225|100479571|FG000|COMPLETED|Fruit, Dessert, Mint, Menthol, Tobacco||52||
48064720|NCT04879225|100479571|FG000|NOT COMPLETED|Fruit, Dessert, Mint, Menthol, Tobacco||0||
48064721|NCT04879225|100479571|FG000|STARTED|Mint, Menthol, Tobacco||52||
48064722|NCT04879225|100479571|FG000|COMPLETED|Mint, Menthol, Tobacco||51||
48064723|NCT04879225|100479571|FG000|NOT COMPLETED|Mint, Menthol, Tobacco||1||
48064724|NCT04879225|100479571|FG000|STARTED|Menthol and Tobacco||52||
48064725|NCT04879225|100479571|FG000|COMPLETED|Menthol and Tobacco||51||
48064726|NCT04879225|100479571|FG000|NOT COMPLETED|Menthol and Tobacco||1||
48064727|NCT04879225|100479571|FG000|STARTED|Only Tobacco||52||
48064728|NCT04879225|100479571|FG000|COMPLETED|Only Tobacco||52||
48064729|NCT04879225|100479571|FG000|NOT COMPLETED|Only Tobacco||0||
48508849|NCT03507686|101580235|FG001|NOT COMPLETED|Treatment Period 2 (Month13 to Month24)||3||
48508850|NCT03712124|101580236|FG000|STARTED|Overall Study||10||
48508851|NCT03712124|101580237|FG001|STARTED|Overall Study||11||
48508852|NCT03712124|101580236|FG000|Received at Least 1 Dose of Study Drug|Overall Study||10||
48508853|NCT03712124|101580237|FG001|Received at Least 1 Dose of Study Drug|Overall Study||11||
48508854|NCT03712124|101580236|FG000|COMPLETED|Overall Study||9||
48508855|NCT03712124|101580237|FG001|COMPLETED|Overall Study||11||
48508856|NCT03712124|101580236|FG000|NOT COMPLETED|Overall Study||1||
48508857|NCT03712124|101580237|FG001|NOT COMPLETED|Overall Study||0||
48508858|NCT00537017|101580238|FG000|STARTED|Treatment Phase||140||
48064730|NCT03643159|100479572|FG000|STARTED|Overall Study||2||
48064731|NCT03643159|100479572|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||2||
48064732|NCT03643159|100479572|FG000|COMPLETED|Overall Study||0||
48064733|NCT03643159|100479572|FG000|NOT COMPLETED|Overall Study||2||
48064734|NCT04327674|100479573|FG000|STARTED|Overall Study||417||
48064735|NCT04327674|100479573|FG000|COMPLETED|Overall Study||398||
48064736|NCT04327674|100479573|FG000|NOT COMPLETED|Overall Study||19||
48064737|NCT02350569|100479574|FG000|STARTED|Main Study (LDV/SOF 4 Weeks)||16||
48064738|NCT02350569|100479574|FG000|COMPLETED|Main Study (LDV/SOF 4 Weeks)||16||
48064739|NCT02350569|100479574|FG000|NOT COMPLETED|Main Study (LDV/SOF 4 Weeks)||0||
48064740|NCT02350569|100479574|FG000|STARTED|Retreatment (LDV/SOF 12 Weeks)||1||
48064741|NCT02350569|100479574|FG000|COMPLETED|Retreatment (LDV/SOF 12 Weeks)||1||
48064742|NCT02350569|100479574|FG000|NOT COMPLETED|Retreatment (LDV/SOF 12 Weeks)||0||
48508859|NCT00537017|101580238|FG000|COMPLETED|Treatment Phase||106||
48508860|NCT00537017|101580238|FG000|NOT COMPLETED|Treatment Phase||34||
48508861|NCT00537017|101580238|FG000|STARTED|Follow-up Phase||135||
48508862|NCT00537017|101580238|FG000|COMPLETED|Follow-up Phase||126||
48508863|NCT00537017|101580238|FG000|NOT COMPLETED|Follow-up Phase||9||
48508864|NCT03619876|101580239|FG000|STARTED|Overall Study||4||
48508865|NCT03619876|101580240|FG001|STARTED|Overall Study||6||
48508866|NCT03619876|101580239|FG000|COMPLETED|Overall Study||3||
48508867|NCT03619876|101580240|FG001|COMPLETED|Overall Study||2||
48508868|NCT03619876|101580239|FG000|NOT COMPLETED|Overall Study||1||
48508869|NCT03619876|101580240|FG001|NOT COMPLETED|Overall Study||4||
48508870|NCT02688387|101580241|FG000|STARTED|Part 1, Period 1 (up to 6 Days)||3||
48508871|NCT02688387|101580242|FG001|STARTED|Part 1, Period 1 (up to 6 Days)||3||
48508872|NCT02688387|101580243|FG002|STARTED|Part 1, Period 1 (up to 6 Days)||4||
48508873|NCT02688387|101580244|FG003|STARTED|Part 1, Period 1 (up to 6 Days)||3||
48508874|NCT02688387|101580245|FG004|STARTED|Part 1, Period 1 (up to 6 Days)||3||
48508875|NCT02688387|101580246|FG005|STARTED|Part 1, Period 1 (up to 6 Days)||2||
48508876|NCT02688387|101580247|FG006|STARTED|Part 1, Period 1 (up to 6 Days)||2||
48508877|NCT02688387|101580248|FG007|STARTED|Part 1, Period 1 (up to 6 Days)||2||
48508878|NCT02688387|101580249|FG008|STARTED|Part 1, Period 1 (up to 6 Days)||2||
48508879|NCT02688387|101580250|FG009|STARTED|Part 1, Period 1 (up to 6 Days)||2||
48508880|NCT02688387|101580251|FG010|STARTED|Part 1, Period 1 (up to 6 Days)||0||
48508881|NCT02688387|101580252|FG011|STARTED|Part 1, Period 1 (up to 6 Days)||0||
48508882|NCT02688387|101580253|FG012|STARTED|Part 1, Period 1 (up to 6 Days)||0||
48508883|NCT02688387|101580254|FG013|STARTED|Part 1, Period 1 (up to 6 Days)||0||
48508884|NCT02688387|101580255|FG014|STARTED|Part 1, Period 1 (up to 6 Days)||0||
48508885|NCT02688387|101580256|FG015|STARTED|Part 1, Period 1 (up to 6 Days)||0||
48508886|NCT02688387|101580257|FG016|STARTED|Part 1, Period 1 (up to 6 Days)||0||
48508887|NCT02688387|101580258|FG017|STARTED|Part 1, Period 1 (up to 6 Days)||0||
48508888|NCT02688387|101580259|FG018|STARTED|Part 1, Period 1 (up to 6 Days)||0||
48508889|NCT02688387|101580260|FG019|STARTED|Part 1, Period 1 (up to 6 Days)||0||
48508890|NCT02688387|101580261|FG020|STARTED|Part 1, Period 1 (up to 6 Days)||0||
48508891|NCT02688387|101580262|FG021|STARTED|Part 1, Period 1 (up to 6 Days)||0||
48508892|NCT02688387|101580241|FG000|COMPLETED|Part 1, Period 1 (up to 6 Days)||3||
48508893|NCT02688387|101580242|FG001|COMPLETED|Part 1, Period 1 (up to 6 Days)||3||
48508894|NCT02688387|101580243|FG002|COMPLETED|Part 1, Period 1 (up to 6 Days)||3||
48508895|NCT02688387|101580244|FG003|COMPLETED|Part 1, Period 1 (up to 6 Days)||2||
48508896|NCT02688387|101580245|FG004|COMPLETED|Part 1, Period 1 (up to 6 Days)||3||
48508897|NCT02688387|101580246|FG005|COMPLETED|Part 1, Period 1 (up to 6 Days)||2||
48508898|NCT02688387|101580247|FG006|COMPLETED|Part 1, Period 1 (up to 6 Days)||2||
48508899|NCT02688387|101580248|FG007|COMPLETED|Part 1, Period 1 (up to 6 Days)||2||
48508900|NCT02688387|101580249|FG008|COMPLETED|Part 1, Period 1 (up to 6 Days)||2||
48508901|NCT02688387|101580250|FG009|COMPLETED|Part 1, Period 1 (up to 6 Days)||2||
48508902|NCT02688387|101580251|FG010|COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
48508903|NCT02688387|101580252|FG011|COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
48508904|NCT02688387|101580253|FG012|COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
48508905|NCT02688387|101580254|FG013|COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
48508906|NCT02688387|101580255|FG014|COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
48508907|NCT02688387|101580256|FG015|COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
48508908|NCT02688387|101580257|FG016|COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
48508909|NCT02688387|101580258|FG017|COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
48508910|NCT02688387|101580259|FG018|COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
48508911|NCT02688387|101580260|FG019|COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
48508912|NCT02688387|101580261|FG020|COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
48508913|NCT02688387|101580262|FG021|COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
48508914|NCT02688387|101580241|FG000|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
48508915|NCT02688387|101580242|FG001|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
48508916|NCT02688387|101580243|FG002|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||1||
48508917|NCT02688387|101580244|FG003|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||1||
48508918|NCT02688387|101580245|FG004|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
48508919|NCT02688387|101580246|FG005|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
48508920|NCT02688387|101580247|FG006|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
48508921|NCT02688387|101580248|FG007|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
48508922|NCT02688387|101580249|FG008|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
48508923|NCT02688387|101580250|FG009|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
48508924|NCT02688387|101580251|FG010|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
48508925|NCT02688387|101580252|FG011|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
48508926|NCT02688387|101580253|FG012|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
48508927|NCT02688387|101580254|FG013|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
48508928|NCT02688387|101580255|FG014|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
48508929|NCT02688387|101580256|FG015|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
48508930|NCT02688387|101580257|FG016|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
48508931|NCT02688387|101580258|FG017|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
48508932|NCT02688387|101580259|FG018|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
48508933|NCT02688387|101580260|FG019|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
48508934|NCT02688387|101580261|FG020|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
48508935|NCT02688387|101580262|FG021|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
48508936|NCT02688387|101580241|FG000|STARTED|Part 1, Washout Period 1 (7 Days)||3||
48508937|NCT02688387|101580242|FG001|STARTED|Part 1, Washout Period 1 (7 Days)||3||
48508938|NCT02688387|101580243|FG002|STARTED|Part 1, Washout Period 1 (7 Days)||3||
48508939|NCT02688387|101580244|FG003|STARTED|Part 1, Washout Period 1 (7 Days)||2||
48508940|NCT02688387|101580245|FG004|STARTED|Part 1, Washout Period 1 (7 Days)||3||
48508941|NCT02688387|101580246|FG005|STARTED|Part 1, Washout Period 1 (7 Days)||2||
48508942|NCT02688387|101580247|FG006|STARTED|Part 1, Washout Period 1 (7 Days)||2||
48508943|NCT02688387|101580248|FG007|STARTED|Part 1, Washout Period 1 (7 Days)||2||
48508944|NCT02688387|101580249|FG008|STARTED|Part 1, Washout Period 1 (7 Days)||2||
48508945|NCT02688387|101580250|FG009|STARTED|Part 1, Washout Period 1 (7 Days)||2||
48508946|NCT02688387|101580251|FG010|STARTED|Part 1, Washout Period 1 (7 Days)||0||
48508947|NCT02688387|101580252|FG011|STARTED|Part 1, Washout Period 1 (7 Days)||0||
48508948|NCT02688387|101580253|FG012|STARTED|Part 1, Washout Period 1 (7 Days)||0||
48508949|NCT02688387|101580254|FG013|STARTED|Part 1, Washout Period 1 (7 Days)||0||
48508950|NCT02688387|101580255|FG014|STARTED|Part 1, Washout Period 1 (7 Days)||0||
48508951|NCT02688387|101580256|FG015|STARTED|Part 1, Washout Period 1 (7 Days)||0||
48508952|NCT02688387|101580257|FG016|STARTED|Part 1, Washout Period 1 (7 Days)||0||
48508953|NCT02688387|101580258|FG017|STARTED|Part 1, Washout Period 1 (7 Days)||0||
48508954|NCT02688387|101580259|FG018|STARTED|Part 1, Washout Period 1 (7 Days)||0||
48508955|NCT02688387|101580260|FG019|STARTED|Part 1, Washout Period 1 (7 Days)||0||
48508956|NCT02688387|101580261|FG020|STARTED|Part 1, Washout Period 1 (7 Days)||0||
48508957|NCT02688387|101580262|FG021|STARTED|Part 1, Washout Period 1 (7 Days)||0||
48508958|NCT02688387|101580241|FG000|COMPLETED|Part 1, Washout Period 1 (7 Days)||3||
48508959|NCT02688387|101580242|FG001|COMPLETED|Part 1, Washout Period 1 (7 Days)||2||
48508960|NCT02688387|101580243|FG002|COMPLETED|Part 1, Washout Period 1 (7 Days)||3||
48508961|NCT02688387|101580244|FG003|COMPLETED|Part 1, Washout Period 1 (7 Days)||2||
48508962|NCT02688387|101580245|FG004|COMPLETED|Part 1, Washout Period 1 (7 Days)||3||
48508963|NCT02688387|101580246|FG005|COMPLETED|Part 1, Washout Period 1 (7 Days)||2||
48508964|NCT02688387|101580247|FG006|COMPLETED|Part 1, Washout Period 1 (7 Days)||2||
48508965|NCT02688387|101580248|FG007|COMPLETED|Part 1, Washout Period 1 (7 Days)||2||
48508966|NCT02688387|101580249|FG008|COMPLETED|Part 1, Washout Period 1 (7 Days)||2||
48508967|NCT02688387|101580250|FG009|COMPLETED|Part 1, Washout Period 1 (7 Days)||2||
48508968|NCT02688387|101580251|FG010|COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48508969|NCT02688387|101580252|FG011|COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48508970|NCT02688387|101580253|FG012|COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48508971|NCT02688387|101580254|FG013|COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48508972|NCT02688387|101580255|FG014|COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48508973|NCT02688387|101580256|FG015|COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48508974|NCT02688387|101580257|FG016|COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48508975|NCT02688387|101580258|FG017|COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48508976|NCT02688387|101580259|FG018|COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48064743|NCT01092507|100479575|FG000|STARTED|Overall Study||149||
48064744|NCT01092507|100479576|FG001|STARTED|Overall Study||150||
48064745|NCT01092507|100479575|FG000|COMPLETED|Overall Study||147||
48064746|NCT01092507|100479576|FG001|COMPLETED|Overall Study||150||
48064747|NCT01092507|100479575|FG000|NOT COMPLETED|Overall Study||2||
48064748|NCT01092507|100479576|FG001|NOT COMPLETED|Overall Study||0||
48064749|NCT00347360|100479577|FG000|STARTED|Overall Study||44||
48064750|NCT00347360|100479578|FG001|STARTED|Overall Study||43||
48064751|NCT00347360|100479579|FG002|STARTED|Overall Study||43||
48064752|NCT00347360|100479580|FG003|STARTED|Overall Study||43||
48064753|NCT00347360|100479581|FG004|STARTED|Overall Study||44||
48064754|NCT00347360|100479582|FG005|STARTED|Overall Study||44||
48064755|NCT00347360|100479583|FG006|STARTED|Overall Study||44||
48064756|NCT00347360|100479584|FG007|STARTED|Overall Study||43||
48064757|NCT00347360|100479585|FG008|STARTED|Overall Study||44||
48064758|NCT00347360|100479586|FG009|STARTED|Overall Study||44||
48064759|NCT00347360|100479587|FG010|STARTED|Overall Study||44||
48064760|NCT00347360|100479588|FG011|STARTED|Overall Study||43||
48064761|NCT00347360|100479589|FG012|STARTED|Overall Study||44||
48064762|NCT00347360|100479590|FG013|STARTED|Overall Study||44||
48064763|NCT00347360|100479591|FG014|STARTED|Overall Study||43||
48064764|NCT00347360|100479577|FG000|COMPLETED|Overall Study||39||
48064765|NCT00347360|100479578|FG001|COMPLETED|Overall Study||35||
48064766|NCT00347360|100479579|FG002|COMPLETED|Overall Study||37||
48064767|NCT00347360|100479580|FG003|COMPLETED|Overall Study||30||
48064768|NCT00347360|100479581|FG004|COMPLETED|Overall Study||39||
48064769|NCT00347360|100479582|FG005|COMPLETED|Overall Study||36||
48064770|NCT00347360|100479583|FG006|COMPLETED|Overall Study||37||
48064771|NCT00347360|100479584|FG007|COMPLETED|Overall Study||40||
48064772|NCT00347360|100479585|FG008|COMPLETED|Overall Study||38||
48064773|NCT00347360|100479586|FG009|COMPLETED|Overall Study||35||
48064774|NCT00347360|100479587|FG010|COMPLETED|Overall Study||39||
48064775|NCT00347360|100479588|FG011|COMPLETED|Overall Study||37||
48064776|NCT00347360|100479589|FG012|COMPLETED|Overall Study||34||
48064777|NCT00347360|100479590|FG013|COMPLETED|Overall Study||36||
48064778|NCT00347360|100479591|FG014|COMPLETED|Overall Study||39||
48064779|NCT00347360|100479577|FG000|NOT COMPLETED|Overall Study||5||
48064780|NCT00347360|100479578|FG001|NOT COMPLETED|Overall Study||8||
48064781|NCT00347360|100479579|FG002|NOT COMPLETED|Overall Study||6||
48064782|NCT00347360|100479580|FG003|NOT COMPLETED|Overall Study||13||
48064783|NCT00347360|100479581|FG004|NOT COMPLETED|Overall Study||5||
48064784|NCT00347360|100479582|FG005|NOT COMPLETED|Overall Study||8||
48064785|NCT00347360|100479583|FG006|NOT COMPLETED|Overall Study||7||
48064786|NCT00347360|100479584|FG007|NOT COMPLETED|Overall Study||3||
48064787|NCT00347360|100479585|FG008|NOT COMPLETED|Overall Study||6||
48064788|NCT00347360|100479586|FG009|NOT COMPLETED|Overall Study||9||
48064789|NCT00347360|100479587|FG010|NOT COMPLETED|Overall Study||5||
48064790|NCT00347360|100479588|FG011|NOT COMPLETED|Overall Study||6||
48064791|NCT00347360|100479589|FG012|NOT COMPLETED|Overall Study||10||
48064792|NCT00347360|100479590|FG013|NOT COMPLETED|Overall Study||8||
48064793|NCT00347360|100479591|FG014|NOT COMPLETED|Overall Study||4||
48064794|NCT02405780|100479592|FG000|STARTED|Period I||216||
48064795|NCT02405780|100479593|FG001|STARTED|Period I||108||
48508977|NCT02688387|101580260|FG019|COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48064796|NCT02405780|100479594|FG002|STARTED|Period I||108||
48064797|NCT02405780|100479595|FG003|STARTED|Period I||213||
48064798|NCT02405780|100479592|FG000|COMPLETED|Period I||189||
48064799|NCT02405780|100479593|FG001|COMPLETED|Period I||100||
48064800|NCT02405780|100479594|FG002|COMPLETED|Period I||93||
48064801|NCT02405780|100479595|FG003|COMPLETED|Period I||190||
48064802|NCT02405780|100479592|FG000|NOT COMPLETED|Period I||27||
48064803|NCT02405780|100479593|FG001|NOT COMPLETED|Period I||8||
48064804|NCT02405780|100479594|FG002|NOT COMPLETED|Period I||15||
48064805|NCT02405780|100479595|FG003|NOT COMPLETED|Period I||23||
48064806|NCT02405780|100479592|FG000|STARTED|Period II||189||
48064807|NCT02405780|100479593|FG001|STARTED|Period II||100||
48064808|NCT02405780|100479594|FG002|STARTED|Period II||93||
48064809|NCT02405780|100479595|FG003|STARTED|Period II||190||
48064810|NCT02405780|100479592|FG000|COMPLETED|Period II||174||
48064811|NCT02405780|100479593|FG001|COMPLETED|Period II||88||
48064812|NCT02405780|100479594|FG002|COMPLETED|Period II||81||
48064813|NCT02405780|100479595|FG003|COMPLETED|Period II||172||
48064814|NCT02405780|100479592|FG000|NOT COMPLETED|Period II||15||
48064815|NCT02405780|100479593|FG001|NOT COMPLETED|Period II||12||
48064816|NCT02405780|100479594|FG002|NOT COMPLETED|Period II||12||
48064817|NCT02405780|100479595|FG003|NOT COMPLETED|Period II||18||
48064818|NCT04269707|100479596|FG000|STARTED|Overall Study||7||
48064819|NCT04269707|100479596|FG000|COMPLETED|Overall Study||7||
48064820|NCT04269707|100479596|FG000|NOT COMPLETED|Overall Study||0||
48064821|NCT04729621|100479597|FG000|STARTED|Main Treatment Period (Week1 to Week 52)||166||
48064822|NCT04729621|100479598|FG001|STARTED|Main Treatment Period (Week1 to Week 52)||166||
48064823|NCT04729621|100479599|FG002|STARTED|Main Treatment Period (Week1 to Week 52)||0||
48064824|NCT04729621|100479600|FG003|STARTED|Main Treatment Period (Week1 to Week 52)||0||
48064825|NCT04729621|100479601|FG004|STARTED|Main Treatment Period (Week1 to Week 52)||0||
48064826|NCT04729621|100479597|FG000|COMPLETED|Main Treatment Period (Week1 to Week 52)||148||
48064827|NCT04729621|100479598|FG001|COMPLETED|Main Treatment Period (Week1 to Week 52)||143||
48064828|NCT04729621|100479599|FG002|COMPLETED|Main Treatment Period (Week1 to Week 52)||0||
48064829|NCT04729621|100479600|FG003|COMPLETED|Main Treatment Period (Week1 to Week 52)||0||
48064830|NCT04729621|100479601|FG004|COMPLETED|Main Treatment Period (Week1 to Week 52)||0||
48064831|NCT04729621|100479597|FG000|NOT COMPLETED|Main Treatment Period (Week1 to Week 52)||18||
48064832|NCT04729621|100479598|FG001|NOT COMPLETED|Main Treatment Period (Week1 to Week 52)||23||
48064833|NCT04729621|100479599|FG002|NOT COMPLETED|Main Treatment Period (Week1 to Week 52)||0||
48064834|NCT04729621|100479600|FG003|NOT COMPLETED|Main Treatment Period (Week1 to Week 52)||0||
48064835|NCT04729621|100479601|FG004|NOT COMPLETED|Main Treatment Period (Week1 to Week 52)||0||
48064836|NCT04729621|100479597|FG000|STARTED|Transition Period (Week 52 to Week 78)||0|Subjects who completed the Main Treatment Period were re-randomized to one of 3 new arms.|
48064837|NCT04729621|100479598|FG001|STARTED|Transition Period (Week 52 to Week 78)||0|Subjects who completed the Main Treatment Period were re-randomized to one of 3 new arms.|
48064838|NCT04729621|100479599|FG002|STARTED|Transition Period (Week 52 to Week 78)||148|Subjects who completed the Main Treatment Period were re-randomized to one of 3 new arms.|
48064839|NCT04729621|100479600|FG003|STARTED|Transition Period (Week 52 to Week 78)||72|Subjects who completed the Main Treatment Period were re-randomized to one of 3 new arms.|
48064840|NCT04729621|100479601|FG004|STARTED|Transition Period (Week 52 to Week 78)||71|Subjects who completed the Main Treatment Period were re-randomized to one of 3 new arms.|
48064841|NCT04729621|100479597|FG000|COMPLETED|Transition Period (Week 52 to Week 78)||0||
48064842|NCT04729621|100479598|FG001|COMPLETED|Transition Period (Week 52 to Week 78)||0||
48064843|NCT04729621|100479599|FG002|COMPLETED|Transition Period (Week 52 to Week 78)||140||
48064844|NCT04729621|100479600|FG003|COMPLETED|Transition Period (Week 52 to Week 78)||67||
48064845|NCT04729621|100479601|FG004|COMPLETED|Transition Period (Week 52 to Week 78)||69||
48064846|NCT04729621|100479597|FG000|NOT COMPLETED|Transition Period (Week 52 to Week 78)||0||
48064847|NCT04729621|100479598|FG001|NOT COMPLETED|Transition Period (Week 52 to Week 78)||0||
48064848|NCT04729621|100479599|FG002|NOT COMPLETED|Transition Period (Week 52 to Week 78)||8||
48064849|NCT04729621|100479600|FG003|NOT COMPLETED|Transition Period (Week 52 to Week 78)||5||
48064850|NCT04729621|100479601|FG004|NOT COMPLETED|Transition Period (Week 52 to Week 78)||2||
48064851|NCT01811225|100479602|FG000|STARTED|Treatment Period 1||49||
48064852|NCT01811225|100479603|FG001|STARTED|Treatment Period 1||46||
48064853|NCT01811225|100479602|FG000|COMPLETED|Treatment Period 1||24||
48064854|NCT01811225|100479603|FG001|COMPLETED|Treatment Period 1||29||
48064855|NCT01811225|100479602|FG000|NOT COMPLETED|Treatment Period 1||25||
48064856|NCT01811225|100479603|FG001|NOT COMPLETED|Treatment Period 1||17||
48064857|NCT01811225|100479602|FG000|STARTED|Treatment Period 2||24||
48064858|NCT01811225|100479603|FG001|STARTED|Treatment Period 2||29||
48064859|NCT01811225|100479602|FG000|COMPLETED|Treatment Period 2||20||
48064860|NCT01811225|100479603|FG001|COMPLETED|Treatment Period 2||23||
48064861|NCT01811225|100479602|FG000|NOT COMPLETED|Treatment Period 2||4||
48064862|NCT01811225|100479603|FG001|NOT COMPLETED|Treatment Period 2||6||
48064863|NCT01914757|100479604|FG000|STARTED|Overall Study||425||
48064864|NCT01914757|100479605|FG001|STARTED|Overall Study||441||
48064865|NCT01914757|100479606|FG002|STARTED|Overall Study||440||
48064866|NCT01914757|100479604|FG000|COMPLETED|Overall Study||389||
48064867|NCT01914757|100479605|FG001|COMPLETED|Overall Study||390||
48064868|NCT01914757|100479606|FG002|COMPLETED|Overall Study||402||
48064869|NCT01914757|100479604|FG000|NOT COMPLETED|Overall Study||36||
48064870|NCT01914757|100479605|FG001|NOT COMPLETED|Overall Study||51||
48064871|NCT01914757|100479606|FG002|NOT COMPLETED|Overall Study||38||
48064872|NCT01772160|100479607|FG000|STARTED|Overall Study||394||
48064873|NCT01772160|100479607|FG000|COMPLETED|Overall Study||346||
48218632|NCT00391898|100860343|FG000|NOT COMPLETED|Overall Study||11||
48064874|NCT01772160|100479607|FG000|NOT COMPLETED|Overall Study||48||
48064875|NCT00451451|100479608|FG000|STARTED|Overall Study||363||
48218633|NCT00391898|100860344|FG001|NOT COMPLETED|Overall Study||10||
48218634|NCT01951170|100860345|FG000|STARTED|Overall Study||52||
48218635|NCT01951170|100860345|FG000|COMPLETED|Overall Study||51||
48064876|NCT00451451|100479609|FG001|STARTED|Overall Study||359||
48508978|NCT02688387|101580261|FG020|COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48508979|NCT02688387|101580262|FG021|COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48508980|NCT02688387|101580241|FG000|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48508981|NCT02688387|101580242|FG001|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||1||
48508982|NCT02688387|101580243|FG002|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48508983|NCT02688387|101580244|FG003|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48508984|NCT02688387|101580245|FG004|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48508985|NCT02688387|101580246|FG005|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48508986|NCT02688387|101580247|FG006|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48508987|NCT02688387|101580248|FG007|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48508988|NCT02688387|101580249|FG008|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48508989|NCT02688387|101580250|FG009|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48508990|NCT02688387|101580251|FG010|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48508991|NCT02688387|101580252|FG011|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48508992|NCT02688387|101580253|FG012|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48508993|NCT02688387|101580254|FG013|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48508994|NCT02688387|101580255|FG014|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48508995|NCT02688387|101580256|FG015|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48508996|NCT02688387|101580257|FG016|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48508997|NCT02688387|101580258|FG017|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48508998|NCT02688387|101580259|FG018|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48508999|NCT02688387|101580260|FG019|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48509000|NCT02688387|101580261|FG020|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48509001|NCT02688387|101580262|FG021|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
48509002|NCT02688387|101580241|FG000|STARTED|Part 1, Period 2 (up to 6 Days)||3||
48509003|NCT02688387|101580242|FG001|STARTED|Part 1, Period 2 (up to 6 Days)||2||
48509004|NCT02688387|101580243|FG002|STARTED|Part 1, Period 2 (up to 6 Days)||3||
48509005|NCT02688387|101580244|FG003|STARTED|Part 1, Period 2 (up to 6 Days)||2||
48509006|NCT02688387|101580245|FG004|STARTED|Part 1, Period 2 (up to 6 Days)||3||
48509007|NCT02688387|101580246|FG005|STARTED|Part 1, Period 2 (up to 6 Days)||2||
48509008|NCT02688387|101580247|FG006|STARTED|Part 1, Period 2 (up to 6 Days)||2||
48509009|NCT02688387|101580248|FG007|STARTED|Part 1, Period 2 (up to 6 Days)||2||
48509010|NCT02688387|101580249|FG008|STARTED|Part 1, Period 2 (up to 6 Days)||2||
48509011|NCT02688387|101580250|FG009|STARTED|Part 1, Period 2 (up to 6 Days)||2||
48509012|NCT02688387|101580251|FG010|STARTED|Part 1, Period 2 (up to 6 Days)||0||
48509013|NCT02688387|101580252|FG011|STARTED|Part 1, Period 2 (up to 6 Days)||0||
48509014|NCT02688387|101580253|FG012|STARTED|Part 1, Period 2 (up to 6 Days)||0||
48509015|NCT02688387|101580254|FG013|STARTED|Part 1, Period 2 (up to 6 Days)||0||
48509016|NCT02688387|101580255|FG014|STARTED|Part 1, Period 2 (up to 6 Days)||0||
48509017|NCT02688387|101580256|FG015|STARTED|Part 1, Period 2 (up to 6 Days)||0||
48509018|NCT02688387|101580257|FG016|STARTED|Part 1, Period 2 (up to 6 Days)||0||
48064877|NCT00451451|100479610|FG002|STARTED|Overall Study||345||
48064878|NCT00451451|100479611|FG003|STARTED|Overall Study||350||
48064879|NCT00451451|100479608|FG000|COMPLETED|Overall Study||278||
48064880|NCT00451451|100479609|FG001|COMPLETED|Overall Study||284||
48064881|NCT00451451|100479610|FG002|COMPLETED|Overall Study||273||
48064882|NCT00451451|100479611|FG003|COMPLETED|Overall Study||292||
48064883|NCT00451451|100479608|FG000|NOT COMPLETED|Overall Study||85||
48064884|NCT00451451|100479609|FG001|NOT COMPLETED|Overall Study||75||
48064885|NCT00451451|100479610|FG002|NOT COMPLETED|Overall Study||72||
48064886|NCT00451451|100479611|FG003|NOT COMPLETED|Overall Study||58||
48064887|NCT00607815|100479612|FG000|STARTED|Overall Study||43||
48064888|NCT00607815|100479613|FG001|STARTED|Overall Study||36||
48064889|NCT00607815|100479612|FG000|COMPLETED|Overall Study||20||
48064890|NCT00607815|100479613|FG001|COMPLETED|Overall Study||25||
48064891|NCT00607815|100479612|FG000|NOT COMPLETED|Overall Study||23||
48064892|NCT00607815|100479613|FG001|NOT COMPLETED|Overall Study||11||
48064893|NCT04288752|100479614|FG000|STARTED|Overall Study||87||
48064894|NCT04288752|100479615|FG001|STARTED|Overall Study||88||
48064895|NCT04288752|100479614|FG000|COMPLETED|Overall Study||81||
48064896|NCT04288752|100479615|FG001|COMPLETED|Overall Study||85||
48064897|NCT04288752|100479614|FG000|NOT COMPLETED|Overall Study||6||
48064898|NCT04288752|100479615|FG001|NOT COMPLETED|Overall Study||3||
48064899|NCT02234570|100479616|FG000|STARTED|Overall Study||8||
48064900|NCT02234570|100479617|FG001|STARTED|Overall Study||8||
48064901|NCT02234570|100479618|FG002|STARTED|Overall Study||8||
48064902|NCT02234570|100479619|FG003|STARTED|Overall Study||8||
48064903|NCT02234570|100479620|FG004|STARTED|Overall Study||8||
48064904|NCT02234570|100479621|FG005|STARTED|Overall Study||8||
48064905|NCT02234570|100479622|FG006|STARTED|Overall Study||8||
48064906|NCT02234570|100479623|FG007|STARTED|Overall Study||14||
48064907|NCT02234570|100479616|FG000|COMPLETED|Overall Study||8||
48509019|NCT02688387|101580258|FG017|STARTED|Part 1, Period 2 (up to 6 Days)||0||
48064908|NCT02234570|100479617|FG001|COMPLETED|Overall Study||8||
48064909|NCT02234570|100479618|FG002|COMPLETED|Overall Study||8||
48064910|NCT02234570|100479619|FG003|COMPLETED|Overall Study||8||
48064911|NCT02234570|100479620|FG004|COMPLETED|Overall Study||8||
48509020|NCT02688387|101580259|FG018|STARTED|Part 1, Period 2 (up to 6 Days)||0||
48509021|NCT02688387|101580260|FG019|STARTED|Part 1, Period 2 (up to 6 Days)||0||
48509022|NCT02688387|101580261|FG020|STARTED|Part 1, Period 2 (up to 6 Days)||0||
48509023|NCT02688387|101580262|FG021|STARTED|Part 1, Period 2 (up to 6 Days)||0||
48064912|NCT02234570|100479621|FG005|COMPLETED|Overall Study||8||
48064913|NCT02234570|100479622|FG006|COMPLETED|Overall Study||8||
48064914|NCT02234570|100479623|FG007|COMPLETED|Overall Study||14||
48064915|NCT02234570|100479616|FG000|NOT COMPLETED|Overall Study||0||
48064916|NCT02234570|100479617|FG001|NOT COMPLETED|Overall Study||0||
48064917|NCT02234570|100479618|FG002|NOT COMPLETED|Overall Study||0||
48064918|NCT02234570|100479619|FG003|NOT COMPLETED|Overall Study||0||
48064919|NCT02234570|100479620|FG004|NOT COMPLETED|Overall Study||0||
48064920|NCT02234570|100479621|FG005|NOT COMPLETED|Overall Study||0||
48064921|NCT02234570|100479622|FG006|NOT COMPLETED|Overall Study||0||
48064922|NCT02234570|100479623|FG007|NOT COMPLETED|Overall Study||0||
48064923|NCT00839852|100479624|FG000|STARTED|Overall Study||93||
48064924|NCT00839852|100479624|FG000|COMPLETED|Overall Study||46||
48064925|NCT00839852|100479624|FG000|NOT COMPLETED|Overall Study||47||
48064926|NCT02160990|100479625|FG000|STARTED|Overall Study||10||
48064927|NCT02160990|100479626|FG001|STARTED|Overall Study||10||
48064928|NCT02160990|100479625|FG000|COMPLETED|Overall Study||10||
48064929|NCT02160990|100479626|FG001|COMPLETED|Overall Study||10||
48064930|NCT02160990|100479625|FG000|NOT COMPLETED|Overall Study||0||
48064931|NCT02160990|100479626|FG001|NOT COMPLETED|Overall Study||0||
48064932|NCT03307785|100479627|FG000|STARTED|Part A: Up to 28.5 Months||16||
48064933|NCT03307785|100479628|FG001|STARTED|Part A: Up to 28.5 Months||6||
48064934|NCT03307785|100479629|FG002|STARTED|Part A: Up to 28.5 Months||0||
48064935|NCT03307785|100479630|FG003|STARTED|Part A: Up to 28.5 Months||0||
48064936|NCT03307785|100479631|FG004|STARTED|Part A: Up to 28.5 Months||0||
48064937|NCT03307785|100479632|FG005|STARTED|Part A: Up to 28.5 Months||0||
48064938|NCT03307785|100479633|FG006|STARTED|Part A: Up to 28.5 Months||0||
48064939|NCT03307785|100479634|FG007|STARTED|Part A: Up to 28.5 Months||0||
48064940|NCT03307785|100479635|FG008|STARTED|Part A: Up to 28.5 Months||0||
48064941|NCT03307785|100479636|FG009|STARTED|Part A: Up to 28.5 Months||0||
48064942|NCT03307785|100479637|FG010|STARTED|Part A: Up to 28.5 Months||0||
48064943|NCT03307785|100479627|FG000|COMPLETED|Part A: Up to 28.5 Months||0||
48064944|NCT03307785|100479628|FG001|COMPLETED|Part A: Up to 28.5 Months||0||
48064945|NCT03307785|100479629|FG002|COMPLETED|Part A: Up to 28.5 Months||0||
48064946|NCT03307785|100479630|FG003|COMPLETED|Part A: Up to 28.5 Months||0||
48064947|NCT03307785|100479631|FG004|COMPLETED|Part A: Up to 28.5 Months||0||
48064948|NCT03307785|100479632|FG005|COMPLETED|Part A: Up to 28.5 Months||0||
48064949|NCT03307785|100479633|FG006|COMPLETED|Part A: Up to 28.5 Months||0||
48064950|NCT03307785|100479634|FG007|COMPLETED|Part A: Up to 28.5 Months||0||
48064951|NCT03307785|100479635|FG008|COMPLETED|Part A: Up to 28.5 Months||0||
48064952|NCT03307785|100479636|FG009|COMPLETED|Part A: Up to 28.5 Months||0||
48064953|NCT03307785|100479637|FG010|COMPLETED|Part A: Up to 28.5 Months||0||
48218636|NCT01951170|100860345|FG000|NOT COMPLETED|Overall Study||1||
48509024|NCT02688387|101580241|FG000|COMPLETED|Part 1, Period 2 (up to 6 Days)||3||
48064954|NCT03307785|100479627|FG000|NOT COMPLETED|Part A: Up to 28.5 Months||16||
48064955|NCT03307785|100479628|FG001|NOT COMPLETED|Part A: Up to 28.5 Months||6||
48064956|NCT03307785|100479629|FG002|NOT COMPLETED|Part A: Up to 28.5 Months||0||
48064957|NCT03307785|100479630|FG003|NOT COMPLETED|Part A: Up to 28.5 Months||0||
48064958|NCT03307785|100479631|FG004|NOT COMPLETED|Part A: Up to 28.5 Months||0||
48064959|NCT03307785|100479632|FG005|NOT COMPLETED|Part A: Up to 28.5 Months||0||
48064960|NCT03307785|100479633|FG006|NOT COMPLETED|Part A: Up to 28.5 Months||0||
48064961|NCT03307785|100479634|FG007|NOT COMPLETED|Part A: Up to 28.5 Months||0||
48064962|NCT03307785|100479635|FG008|NOT COMPLETED|Part A: Up to 28.5 Months||0||
48064963|NCT03307785|100479636|FG009|NOT COMPLETED|Part A: Up to 28.5 Months||0||
48218637|NCT01627561|100860346|FG000|STARTED|Overall Study||74||
48509025|NCT02688387|101580242|FG001|COMPLETED|Part 1, Period 2 (up to 6 Days)||2||
48509026|NCT02688387|101580243|FG002|COMPLETED|Part 1, Period 2 (up to 6 Days)||2||
48509027|NCT02688387|101580244|FG003|COMPLETED|Part 1, Period 2 (up to 6 Days)||2||
48509028|NCT02688387|101580245|FG004|COMPLETED|Part 1, Period 2 (up to 6 Days)||2||
48509029|NCT02688387|101580246|FG005|COMPLETED|Part 1, Period 2 (up to 6 Days)||2||
48509030|NCT02688387|101580247|FG006|COMPLETED|Part 1, Period 2 (up to 6 Days)||2||
48509031|NCT02688387|101580248|FG007|COMPLETED|Part 1, Period 2 (up to 6 Days)||2||
48509032|NCT02688387|101580249|FG008|COMPLETED|Part 1, Period 2 (up to 6 Days)||2||
48509033|NCT02688387|101580250|FG009|COMPLETED|Part 1, Period 2 (up to 6 Days)||2||
48509034|NCT02688387|101580251|FG010|COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
48509035|NCT02688387|101580252|FG011|COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
48064964|NCT03307785|100479637|FG010|NOT COMPLETED|Part A: Up to 28.5 Months||0||
48064965|NCT03307785|100479627|FG000|STARTED|Part B: Up to Approx. 66 Months||0||
48064966|NCT03307785|100479628|FG001|STARTED|Part B: Up to Approx. 66 Months||0||
48064967|NCT03307785|100479629|FG002|STARTED|Part B: Up to Approx. 66 Months||14||
48064968|NCT03307785|100479630|FG003|STARTED|Part B: Up to Approx. 66 Months||0||
48064969|NCT03307785|100479631|FG004|STARTED|Part B: Up to Approx. 66 Months||0||
48064970|NCT03307785|100479632|FG005|STARTED|Part B: Up to Approx. 66 Months||0||
48064971|NCT03307785|100479633|FG006|STARTED|Part B: Up to Approx. 66 Months||0||
48064972|NCT03307785|100479634|FG007|STARTED|Part B: Up to Approx. 66 Months||0||
48064973|NCT03307785|100479635|FG008|STARTED|Part B: Up to Approx. 66 Months||0||
48064974|NCT03307785|100479636|FG009|STARTED|Part B: Up to Approx. 66 Months||0||
48064975|NCT03307785|100479637|FG010|STARTED|Part B: Up to Approx. 66 Months||0||
48064976|NCT03307785|100479627|FG000|COMPLETED|Part B: Up to Approx. 66 Months||0||
48064977|NCT03307785|100479628|FG001|COMPLETED|Part B: Up to Approx. 66 Months||0||
48064978|NCT03307785|100479629|FG002|COMPLETED|Part B: Up to Approx. 66 Months||0||
48064979|NCT03307785|100479630|FG003|COMPLETED|Part B: Up to Approx. 66 Months||0||
48064980|NCT03307785|100479631|FG004|COMPLETED|Part B: Up to Approx. 66 Months||0||
48064981|NCT03307785|100479632|FG005|COMPLETED|Part B: Up to Approx. 66 Months||0||
48064982|NCT03307785|100479633|FG006|COMPLETED|Part B: Up to Approx. 66 Months||0||
48064983|NCT03307785|100479634|FG007|COMPLETED|Part B: Up to Approx. 66 Months||0||
48064984|NCT03307785|100479635|FG008|COMPLETED|Part B: Up to Approx. 66 Months||0||
48064985|NCT03307785|100479636|FG009|COMPLETED|Part B: Up to Approx. 66 Months||0||
48064986|NCT03307785|100479637|FG010|COMPLETED|Part B: Up to Approx. 66 Months||0||
48064987|NCT03307785|100479627|FG000|NOT COMPLETED|Part B: Up to Approx. 66 Months||0||
48064988|NCT03307785|100479628|FG001|NOT COMPLETED|Part B: Up to Approx. 66 Months||0||
48064989|NCT03307785|100479629|FG002|NOT COMPLETED|Part B: Up to Approx. 66 Months||14||
48064990|NCT03307785|100479630|FG003|NOT COMPLETED|Part B: Up to Approx. 66 Months||0||
48064991|NCT03307785|100479631|FG004|NOT COMPLETED|Part B: Up to Approx. 66 Months||0||
48064992|NCT03307785|100479632|FG005|NOT COMPLETED|Part B: Up to Approx. 66 Months||0||
48064993|NCT03307785|100479633|FG006|NOT COMPLETED|Part B: Up to Approx. 66 Months||0||
48064994|NCT03307785|100479634|FG007|NOT COMPLETED|Part B: Up to Approx. 66 Months||0||
48064995|NCT03307785|100479635|FG008|NOT COMPLETED|Part B: Up to Approx. 66 Months||0||
48064996|NCT03307785|100479636|FG009|NOT COMPLETED|Part B: Up to Approx. 66 Months||0||
48064997|NCT03307785|100479637|FG010|NOT COMPLETED|Part B: Up to Approx. 66 Months||0||
48064998|NCT03307785|100479627|FG000|STARTED|Part C: Up to Approx. 60 Months||0||
48064999|NCT03307785|100479628|FG001|STARTED|Part C: Up to Approx. 60 Months||0||
48065000|NCT03307785|100479629|FG002|STARTED|Part C: Up to Approx. 60 Months||0||
48065001|NCT03307785|100479630|FG003|STARTED|Part C: Up to Approx. 60 Months||6||
48065002|NCT03307785|100479631|FG004|STARTED|Part C: Up to Approx. 60 Months||7||
48065003|NCT03307785|100479632|FG005|STARTED|Part C: Up to Approx. 60 Months||0||
48065004|NCT03307785|100479633|FG006|STARTED|Part C: Up to Approx. 60 Months||0||
48065005|NCT03307785|100479634|FG007|STARTED|Part C: Up to Approx. 60 Months||0||
48065006|NCT03307785|100479635|FG008|STARTED|Part C: Up to Approx. 60 Months||0||
48065007|NCT03307785|100479636|FG009|STARTED|Part C: Up to Approx. 60 Months||0||
48065008|NCT03307785|100479637|FG010|STARTED|Part C: Up to Approx. 60 Months||0||
48065009|NCT03307785|100479627|FG000|COMPLETED|Part C: Up to Approx. 60 Months||0||
48065010|NCT03307785|100479628|FG001|COMPLETED|Part C: Up to Approx. 60 Months||0||
48065011|NCT03307785|100479629|FG002|COMPLETED|Part C: Up to Approx. 60 Months||0||
48065012|NCT03307785|100479630|FG003|COMPLETED|Part C: Up to Approx. 60 Months||0||
48065013|NCT03307785|100479631|FG004|COMPLETED|Part C: Up to Approx. 60 Months||0||
48065014|NCT03307785|100479632|FG005|COMPLETED|Part C: Up to Approx. 60 Months||0||
48065015|NCT03307785|100479633|FG006|COMPLETED|Part C: Up to Approx. 60 Months||0||
48065016|NCT03307785|100479634|FG007|COMPLETED|Part C: Up to Approx. 60 Months||0||
48065017|NCT03307785|100479635|FG008|COMPLETED|Part C: Up to Approx. 60 Months||0||
48065018|NCT03307785|100479636|FG009|COMPLETED|Part C: Up to Approx. 60 Months||0||
48065019|NCT03307785|100479637|FG010|COMPLETED|Part C: Up to Approx. 60 Months||0||
48065020|NCT03307785|100479627|FG000|NOT COMPLETED|Part C: Up to Approx. 60 Months||0||
48065021|NCT03307785|100479628|FG001|NOT COMPLETED|Part C: Up to Approx. 60 Months||0||
48065022|NCT03307785|100479629|FG002|NOT COMPLETED|Part C: Up to Approx. 60 Months||0||
48065023|NCT03307785|100479630|FG003|NOT COMPLETED|Part C: Up to Approx. 60 Months||6||
48065024|NCT03307785|100479631|FG004|NOT COMPLETED|Part C: Up to Approx. 60 Months||7||
48065025|NCT03307785|100479632|FG005|NOT COMPLETED|Part C: Up to Approx. 60 Months||0||
48065026|NCT03307785|100479633|FG006|NOT COMPLETED|Part C: Up to Approx. 60 Months||0||
48065027|NCT03307785|100479634|FG007|NOT COMPLETED|Part C: Up to Approx. 60 Months||0||
48065028|NCT03307785|100479635|FG008|NOT COMPLETED|Part C: Up to Approx. 60 Months||0||
48065029|NCT03307785|100479636|FG009|NOT COMPLETED|Part C: Up to Approx. 60 Months||0||
48065030|NCT03307785|100479637|FG010|NOT COMPLETED|Part C: Up to Approx. 60 Months||0||
48065031|NCT03307785|100479627|FG000|STARTED|Part D: Up to Approx. 62.5 Months||0||
48065032|NCT03307785|100479628|FG001|STARTED|Part D: Up to Approx. 62.5 Months||0||
48065033|NCT03307785|100479629|FG002|STARTED|Part D: Up to Approx. 62.5 Months||0||
48065034|NCT03307785|100479630|FG003|STARTED|Part D: Up to Approx. 62.5 Months||0||
48065035|NCT03307785|100479631|FG004|STARTED|Part D: Up to Approx. 62.5 Months||0||
48065036|NCT03307785|100479632|FG005|STARTED|Part D: Up to Approx. 62.5 Months||6||
48065037|NCT03307785|100479633|FG006|STARTED|Part D: Up to Approx. 62.5 Months||0||
48065038|NCT03307785|100479634|FG007|STARTED|Part D: Up to Approx. 62.5 Months||0||
48065039|NCT03307785|100479635|FG008|STARTED|Part D: Up to Approx. 62.5 Months||0||
48065040|NCT03307785|100479636|FG009|STARTED|Part D: Up to Approx. 62.5 Months||0||
48065041|NCT03307785|100479637|FG010|STARTED|Part D: Up to Approx. 62.5 Months||0||
48218638|NCT01627561|100860347|FG001|STARTED|Overall Study||74||
48065042|NCT03307785|100479627|FG000|COMPLETED|Part D: Up to Approx. 62.5 Months||0||
48065043|NCT03307785|100479628|FG001|COMPLETED|Part D: Up to Approx. 62.5 Months||0||
48065044|NCT03307785|100479629|FG002|COMPLETED|Part D: Up to Approx. 62.5 Months||0||
48065045|NCT03307785|100479630|FG003|COMPLETED|Part D: Up to Approx. 62.5 Months||0||
48065046|NCT03307785|100479631|FG004|COMPLETED|Part D: Up to Approx. 62.5 Months||0||
48065047|NCT03307785|100479632|FG005|COMPLETED|Part D: Up to Approx. 62.5 Months||0||
48065048|NCT03307785|100479633|FG006|COMPLETED|Part D: Up to Approx. 62.5 Months||0||
48065049|NCT03307785|100479634|FG007|COMPLETED|Part D: Up to Approx. 62.5 Months||0||
48065050|NCT03307785|100479635|FG008|COMPLETED|Part D: Up to Approx. 62.5 Months||0||
48065051|NCT03307785|100479636|FG009|COMPLETED|Part D: Up to Approx. 62.5 Months||0||
48065052|NCT03307785|100479637|FG010|COMPLETED|Part D: Up to Approx. 62.5 Months||0||
48065053|NCT03307785|100479627|FG000|NOT COMPLETED|Part D: Up to Approx. 62.5 Months||0||
48065054|NCT03307785|100479628|FG001|NOT COMPLETED|Part D: Up to Approx. 62.5 Months||0||
48065055|NCT03307785|100479629|FG002|NOT COMPLETED|Part D: Up to Approx. 62.5 Months||0||
48065056|NCT03307785|100479630|FG003|NOT COMPLETED|Part D: Up to Approx. 62.5 Months||0||
48065057|NCT03307785|100479631|FG004|NOT COMPLETED|Part D: Up to Approx. 62.5 Months||0||
48065058|NCT03307785|100479632|FG005|NOT COMPLETED|Part D: Up to Approx. 62.5 Months||6||
48065059|NCT03307785|100479633|FG006|NOT COMPLETED|Part D: Up to Approx. 62.5 Months||0||
48065060|NCT03307785|100479634|FG007|NOT COMPLETED|Part D: Up to Approx. 62.5 Months||0||
48065061|NCT03307785|100479635|FG008|NOT COMPLETED|Part D: Up to Approx. 62.5 Months||0||
48065062|NCT03307785|100479636|FG009|NOT COMPLETED|Part D: Up to Approx. 62.5 Months||0||
48065063|NCT03307785|100479637|FG010|NOT COMPLETED|Part D: Up to Approx. 62.5 Months||0||
48065064|NCT03307785|100479627|FG000|STARTED|Part E: Up to 4.4 Months||0||
48065065|NCT03307785|100479628|FG001|STARTED|Part E: Up to 4.4 Months||0||
48065066|NCT03307785|100479629|FG002|STARTED|Part E: Up to 4.4 Months||0||
48065067|NCT03307785|100479630|FG003|STARTED|Part E: Up to 4.4 Months||0||
48065068|NCT03307785|100479631|FG004|STARTED|Part E: Up to 4.4 Months||0||
48065069|NCT03307785|100479632|FG005|STARTED|Part E: Up to 4.4 Months||0||
48065070|NCT03307785|100479633|FG006|STARTED|Part E: Up to 4.4 Months||2||
48065071|NCT03307785|100479634|FG007|STARTED|Part E: Up to 4.4 Months||0||
48065072|NCT03307785|100479635|FG008|STARTED|Part E: Up to 4.4 Months||0||
48065073|NCT03307785|100479636|FG009|STARTED|Part E: Up to 4.4 Months||0||
48065074|NCT03307785|100479637|FG010|STARTED|Part E: Up to 4.4 Months||0||
48065075|NCT03307785|100479627|FG000|COMPLETED|Part E: Up to 4.4 Months||0||
48065076|NCT03307785|100479628|FG001|COMPLETED|Part E: Up to 4.4 Months||0||
48065077|NCT03307785|100479629|FG002|COMPLETED|Part E: Up to 4.4 Months||0||
48065078|NCT03307785|100479630|FG003|COMPLETED|Part E: Up to 4.4 Months||0||
48065079|NCT03307785|100479631|FG004|COMPLETED|Part E: Up to 4.4 Months||0||
48065080|NCT03307785|100479632|FG005|COMPLETED|Part E: Up to 4.4 Months||0||
48065081|NCT03307785|100479633|FG006|COMPLETED|Part E: Up to 4.4 Months||0||
48065082|NCT03307785|100479634|FG007|COMPLETED|Part E: Up to 4.4 Months||0||
48065083|NCT03307785|100479635|FG008|COMPLETED|Part E: Up to 4.4 Months||0||
48065084|NCT03307785|100479636|FG009|COMPLETED|Part E: Up to 4.4 Months||0||
48509036|NCT02688387|101580253|FG012|COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
48509037|NCT02688387|101580254|FG013|COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
48509038|NCT02688387|101580255|FG014|COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
48065085|NCT03307785|100479637|FG010|COMPLETED|Part E: Up to 4.4 Months||0||
48065086|NCT03307785|100479627|FG000|NOT COMPLETED|Part E: Up to 4.4 Months||0||
48065087|NCT03307785|100479628|FG001|NOT COMPLETED|Part E: Up to 4.4 Months||0||
48065088|NCT03307785|100479629|FG002|NOT COMPLETED|Part E: Up to 4.4 Months||0||
48065089|NCT03307785|100479630|FG003|NOT COMPLETED|Part E: Up to 4.4 Months||0||
48065090|NCT03307785|100479631|FG004|NOT COMPLETED|Part E: Up to 4.4 Months||0||
48065091|NCT03307785|100479632|FG005|NOT COMPLETED|Part E: Up to 4.4 Months||0||
48065092|NCT03307785|100479633|FG006|NOT COMPLETED|Part E: Up to 4.4 Months||2||
48065093|NCT03307785|100479634|FG007|NOT COMPLETED|Part E: Up to 4.4 Months||0||
48065094|NCT03307785|100479635|FG008|NOT COMPLETED|Part E: Up to 4.4 Months||0||
48065095|NCT03307785|100479636|FG009|NOT COMPLETED|Part E: Up to 4.4 Months||0||
48065096|NCT03307785|100479637|FG010|NOT COMPLETED|Part E: Up to 4.4 Months||0||
48065097|NCT03307785|100479627|FG000|STARTED|Part F: Up to 3.5 Months||0||
48065098|NCT03307785|100479628|FG001|STARTED|Part F: Up to 3.5 Months||0||
48065099|NCT03307785|100479629|FG002|STARTED|Part F: Up to 3.5 Months||0||
48065100|NCT03307785|100479630|FG003|STARTED|Part F: Up to 3.5 Months||0||
48509039|NCT02688387|101580256|FG015|COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
48509040|NCT02688387|101580257|FG016|COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
48065101|NCT03307785|100479631|FG004|STARTED|Part F: Up to 3.5 Months||0||
48065102|NCT03307785|100479632|FG005|STARTED|Part F: Up to 3.5 Months||0||
48065103|NCT03307785|100479633|FG006|STARTED|Part F: Up to 3.5 Months||0||
48065104|NCT03307785|100479634|FG007|STARTED|Part F: Up to 3.5 Months||1||
48065105|NCT03307785|100479635|FG008|STARTED|Part F: Up to 3.5 Months||0||
48065106|NCT03307785|100479636|FG009|STARTED|Part F: Up to 3.5 Months||0||
48065107|NCT03307785|100479637|FG010|STARTED|Part F: Up to 3.5 Months||0||
48065108|NCT03307785|100479627|FG000|COMPLETED|Part F: Up to 3.5 Months||0||
48065109|NCT03307785|100479628|FG001|COMPLETED|Part F: Up to 3.5 Months||0||
48509041|NCT02688387|101580258|FG017|COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
48509042|NCT02688387|101580259|FG018|COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
48509043|NCT02688387|101580260|FG019|COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
48509044|NCT02688387|101580261|FG020|COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
48509045|NCT02688387|101580262|FG021|COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
48509046|NCT02688387|101580241|FG000|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
48509047|NCT02688387|101580242|FG001|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
48509048|NCT02688387|101580243|FG002|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||1||
48509049|NCT02688387|101580244|FG003|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
48509050|NCT02688387|101580245|FG004|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||1||
48509051|NCT02688387|101580246|FG005|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
48509052|NCT02688387|101580247|FG006|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
48509053|NCT02688387|101580248|FG007|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
48509054|NCT02688387|101580249|FG008|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
48509055|NCT02688387|101580250|FG009|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
48509056|NCT02688387|101580251|FG010|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
48509057|NCT02688387|101580252|FG011|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
48509058|NCT02688387|101580253|FG012|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
48509059|NCT02688387|101580254|FG013|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
48509060|NCT02688387|101580255|FG014|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
48509061|NCT02688387|101580256|FG015|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
48509062|NCT02688387|101580257|FG016|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
48509063|NCT02688387|101580258|FG017|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
48509064|NCT02688387|101580259|FG018|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
48509065|NCT02688387|101580260|FG019|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
48509066|NCT02688387|101580261|FG020|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
48509067|NCT02688387|101580262|FG021|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
48509068|NCT02688387|101580241|FG000|STARTED|Part 1, Washout Period 2 (7 Days)||3||
48509069|NCT02688387|101580242|FG001|STARTED|Part 1, Washout Period 2 (7 Days)||2||
48509070|NCT02688387|101580243|FG002|STARTED|Part 1, Washout Period 2 (7 Days)||2||
48509071|NCT02688387|101580244|FG003|STARTED|Part 1, Washout Period 2 (7 Days)||2||
48509072|NCT02688387|101580245|FG004|STARTED|Part 1, Washout Period 2 (7 Days)||2||
48065110|NCT03307785|100479629|FG002|COMPLETED|Part F: Up to 3.5 Months||0||
48065111|NCT03307785|100479630|FG003|COMPLETED|Part F: Up to 3.5 Months||0||
48065112|NCT03307785|100479631|FG004|COMPLETED|Part F: Up to 3.5 Months||0||
48065113|NCT03307785|100479632|FG005|COMPLETED|Part F: Up to 3.5 Months||0||
48065114|NCT03307785|100479633|FG006|COMPLETED|Part F: Up to 3.5 Months||0||
48065115|NCT03307785|100479634|FG007|COMPLETED|Part F: Up to 3.5 Months||0||
48065116|NCT03307785|100479635|FG008|COMPLETED|Part F: Up to 3.5 Months||0||
48065117|NCT03307785|100479636|FG009|COMPLETED|Part F: Up to 3.5 Months||0||
48065118|NCT03307785|100479637|FG010|COMPLETED|Part F: Up to 3.5 Months||0||
48065119|NCT03307785|100479627|FG000|NOT COMPLETED|Part F: Up to 3.5 Months||0||
48065120|NCT03307785|100479628|FG001|NOT COMPLETED|Part F: Up to 3.5 Months||0||
48065121|NCT03307785|100479629|FG002|NOT COMPLETED|Part F: Up to 3.5 Months||0||
48065122|NCT03307785|100479630|FG003|NOT COMPLETED|Part F: Up to 3.5 Months||0||
48065123|NCT03307785|100479631|FG004|NOT COMPLETED|Part F: Up to 3.5 Months||0||
48065124|NCT03307785|100479632|FG005|NOT COMPLETED|Part F: Up to 3.5 Months||0||
48509073|NCT02688387|101580246|FG005|STARTED|Part 1, Washout Period 2 (7 Days)||2||
48509074|NCT02688387|101580247|FG006|STARTED|Part 1, Washout Period 2 (7 Days)||2||
48509075|NCT02688387|101580248|FG007|STARTED|Part 1, Washout Period 2 (7 Days)||2||
48509076|NCT02688387|101580249|FG008|STARTED|Part 1, Washout Period 2 (7 Days)||2||
48509077|NCT02688387|101580250|FG009|STARTED|Part 1, Washout Period 2 (7 Days)||2||
48509078|NCT02688387|101580251|FG010|STARTED|Part 1, Washout Period 2 (7 Days)||0||
48509079|NCT02688387|101580252|FG011|STARTED|Part 1, Washout Period 2 (7 Days)||0||
48509080|NCT02688387|101580253|FG012|STARTED|Part 1, Washout Period 2 (7 Days)||0||
48509081|NCT02688387|101580254|FG013|STARTED|Part 1, Washout Period 2 (7 Days)||0||
48509082|NCT02688387|101580255|FG014|STARTED|Part 1, Washout Period 2 (7 Days)||0||
48509083|NCT02688387|101580256|FG015|STARTED|Part 1, Washout Period 2 (7 Days)||0||
48509084|NCT02688387|101580257|FG016|STARTED|Part 1, Washout Period 2 (7 Days)||0||
48509085|NCT02688387|101580258|FG017|STARTED|Part 1, Washout Period 2 (7 Days)||0||
48509086|NCT02688387|101580259|FG018|STARTED|Part 1, Washout Period 2 (7 Days)||0||
48509087|NCT02688387|101580260|FG019|STARTED|Part 1, Washout Period 2 (7 Days)||0||
48509088|NCT02688387|101580261|FG020|STARTED|Part 1, Washout Period 2 (7 Days)||0||
48509089|NCT02688387|101580262|FG021|STARTED|Part 1, Washout Period 2 (7 Days)||0||
48509090|NCT02688387|101580241|FG000|COMPLETED|Part 1, Washout Period 2 (7 Days)||3||
48509091|NCT02688387|101580242|FG001|COMPLETED|Part 1, Washout Period 2 (7 Days)||2||
48509092|NCT02688387|101580243|FG002|COMPLETED|Part 1, Washout Period 2 (7 Days)||2||
48509093|NCT02688387|101580244|FG003|COMPLETED|Part 1, Washout Period 2 (7 Days)||2||
48509094|NCT02688387|101580245|FG004|COMPLETED|Part 1, Washout Period 2 (7 Days)||2||
48509095|NCT02688387|101580246|FG005|COMPLETED|Part 1, Washout Period 2 (7 Days)||2||
48509096|NCT02688387|101580247|FG006|COMPLETED|Part 1, Washout Period 2 (7 Days)||2||
48509097|NCT02688387|101580248|FG007|COMPLETED|Part 1, Washout Period 2 (7 Days)||2||
48509098|NCT02688387|101580249|FG008|COMPLETED|Part 1, Washout Period 2 (7 Days)||2||
48509099|NCT02688387|101580250|FG009|COMPLETED|Part 1, Washout Period 2 (7 Days)||2||
48509100|NCT02688387|101580251|FG010|COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48509101|NCT02688387|101580252|FG011|COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48509102|NCT02688387|101580253|FG012|COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48509103|NCT02688387|101580254|FG013|COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48509104|NCT02688387|101580255|FG014|COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48509105|NCT02688387|101580256|FG015|COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48509106|NCT02688387|101580257|FG016|COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48509107|NCT02688387|101580258|FG017|COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48509108|NCT02688387|101580259|FG018|COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48509109|NCT02688387|101580260|FG019|COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48509110|NCT02688387|101580261|FG020|COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48509111|NCT02688387|101580262|FG021|COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48509112|NCT02688387|101580241|FG000|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48509113|NCT02688387|101580242|FG001|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48509114|NCT02688387|101580243|FG002|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48509115|NCT02688387|101580244|FG003|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48509116|NCT02688387|101580245|FG004|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48509117|NCT02688387|101580246|FG005|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48509118|NCT02688387|101580247|FG006|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48509119|NCT02688387|101580248|FG007|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48509120|NCT02688387|101580249|FG008|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48509121|NCT02688387|101580250|FG009|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48509122|NCT02688387|101580251|FG010|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48509123|NCT02688387|101580252|FG011|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48509124|NCT02688387|101580253|FG012|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48509125|NCT02688387|101580254|FG013|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48509126|NCT02688387|101580255|FG014|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48509127|NCT02688387|101580256|FG015|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48509128|NCT02688387|101580257|FG016|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48509129|NCT02688387|101580258|FG017|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48509130|NCT02688387|101580259|FG018|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48509131|NCT02688387|101580260|FG019|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48509132|NCT02688387|101580261|FG020|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48509133|NCT02688387|101580262|FG021|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
48509134|NCT02688387|101580241|FG000|STARTED|Part 1, Period 3 (up to 6 Days)||3||
48509135|NCT02688387|101580242|FG001|STARTED|Part 1, Period 3 (up to 6 Days)||2||
48509136|NCT02688387|101580243|FG002|STARTED|Part 1, Period 3 (up to 6 Days)||2||
48509137|NCT02688387|101580244|FG003|STARTED|Part 1, Period 3 (up to 6 Days)||2||
48509138|NCT02688387|101580245|FG004|STARTED|Part 1, Period 3 (up to 6 Days)||2||
48509139|NCT02688387|101580246|FG005|STARTED|Part 1, Period 3 (up to 6 Days)||2||
48509140|NCT02688387|101580247|FG006|STARTED|Part 1, Period 3 (up to 6 Days)||2||
48509141|NCT02688387|101580248|FG007|STARTED|Part 1, Period 3 (up to 6 Days)||2||
48509142|NCT02688387|101580249|FG008|STARTED|Part 1, Period 3 (up to 6 Days)||2||
48509143|NCT02688387|101580250|FG009|STARTED|Part 1, Period 3 (up to 6 Days)||2||
48509144|NCT02688387|101580251|FG010|STARTED|Part 1, Period 3 (up to 6 Days)||0||
48509145|NCT02688387|101580252|FG011|STARTED|Part 1, Period 3 (up to 6 Days)||0||
48509146|NCT02688387|101580253|FG012|STARTED|Part 1, Period 3 (up to 6 Days)||0||
48509147|NCT02688387|101580254|FG013|STARTED|Part 1, Period 3 (up to 6 Days)||0||
48509148|NCT02688387|101580255|FG014|STARTED|Part 1, Period 3 (up to 6 Days)||0||
48509149|NCT02688387|101580256|FG015|STARTED|Part 1, Period 3 (up to 6 Days)||0||
48509150|NCT02688387|101580257|FG016|STARTED|Part 1, Period 3 (up to 6 Days)||0||
48509151|NCT02688387|101580258|FG017|STARTED|Part 1, Period 3 (up to 6 Days)||0||
48509152|NCT02688387|101580259|FG018|STARTED|Part 1, Period 3 (up to 6 Days)||0||
48509153|NCT02688387|101580260|FG019|STARTED|Part 1, Period 3 (up to 6 Days)||0||
48509154|NCT02688387|101580261|FG020|STARTED|Part 1, Period 3 (up to 6 Days)||0||
48509155|NCT02688387|101580262|FG021|STARTED|Part 1, Period 3 (up to 6 Days)||0||
48509156|NCT02688387|101580241|FG000|COMPLETED|Part 1, Period 3 (up to 6 Days)||3||
48509157|NCT02688387|101580242|FG001|COMPLETED|Part 1, Period 3 (up to 6 Days)||2||
48509158|NCT02688387|101580243|FG002|COMPLETED|Part 1, Period 3 (up to 6 Days)||2||
48509159|NCT02688387|101580244|FG003|COMPLETED|Part 1, Period 3 (up to 6 Days)||2||
48509160|NCT02688387|101580245|FG004|COMPLETED|Part 1, Period 3 (up to 6 Days)||2||
48509161|NCT02688387|101580246|FG005|COMPLETED|Part 1, Period 3 (up to 6 Days)||2||
48509162|NCT02688387|101580247|FG006|COMPLETED|Part 1, Period 3 (up to 6 Days)||2||
48509163|NCT02688387|101580248|FG007|COMPLETED|Part 1, Period 3 (up to 6 Days)||2||
48509164|NCT02688387|101580249|FG008|COMPLETED|Part 1, Period 3 (up to 6 Days)||2||
48509165|NCT02688387|101580250|FG009|COMPLETED|Part 1, Period 3 (up to 6 Days)||2||
48509166|NCT02688387|101580251|FG010|COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
48509167|NCT02688387|101580252|FG011|COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
48509168|NCT02688387|101580253|FG012|COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
48509169|NCT02688387|101580254|FG013|COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
48509170|NCT02688387|101580255|FG014|COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
48509171|NCT02688387|101580256|FG015|COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
48509172|NCT02688387|101580257|FG016|COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
48509173|NCT02688387|101580258|FG017|COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
48509174|NCT02688387|101580259|FG018|COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
48509175|NCT02688387|101580260|FG019|COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
48509176|NCT02688387|101580261|FG020|COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
48509177|NCT02688387|101580262|FG021|COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
48509178|NCT02688387|101580241|FG000|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
48509179|NCT02688387|101580242|FG001|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
48509180|NCT02688387|101580243|FG002|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
48509181|NCT02688387|101580244|FG003|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
48509182|NCT02688387|101580245|FG004|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
48509183|NCT02688387|101580246|FG005|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
48509184|NCT02688387|101580247|FG006|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
48509185|NCT02688387|101580248|FG007|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
48509186|NCT02688387|101580249|FG008|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
48509187|NCT02688387|101580250|FG009|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
48509188|NCT02688387|101580251|FG010|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
48509189|NCT02688387|101580252|FG011|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
48509190|NCT02688387|101580253|FG012|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
48509191|NCT02688387|101580254|FG013|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
48509192|NCT02688387|101580255|FG014|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
48509193|NCT02688387|101580256|FG015|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
48509194|NCT02688387|101580257|FG016|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
48509195|NCT02688387|101580258|FG017|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
48509196|NCT02688387|101580259|FG018|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
48509197|NCT02688387|101580260|FG019|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
48509198|NCT02688387|101580261|FG020|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
48509199|NCT02688387|101580262|FG021|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
48509200|NCT02688387|101580241|FG000|STARTED|Part 1, Washout Period 3 (7 Days)||3||
48509201|NCT02688387|101580242|FG001|STARTED|Part 1, Washout Period 3 (7 Days)||2||
48509202|NCT02688387|101580243|FG002|STARTED|Part 1, Washout Period 3 (7 Days)||2||
48509203|NCT02688387|101580244|FG003|STARTED|Part 1, Washout Period 3 (7 Days)||2||
48509204|NCT02688387|101580245|FG004|STARTED|Part 1, Washout Period 3 (7 Days)||2||
48509205|NCT02688387|101580246|FG005|STARTED|Part 1, Washout Period 3 (7 Days)||2||
48509206|NCT02688387|101580247|FG006|STARTED|Part 1, Washout Period 3 (7 Days)||2||
48509207|NCT02688387|101580248|FG007|STARTED|Part 1, Washout Period 3 (7 Days)||2||
48509208|NCT02688387|101580249|FG008|STARTED|Part 1, Washout Period 3 (7 Days)||2||
48509209|NCT02688387|101580250|FG009|STARTED|Part 1, Washout Period 3 (7 Days)||2||
48509210|NCT02688387|101580251|FG010|STARTED|Part 1, Washout Period 3 (7 Days)||0||
48509211|NCT02688387|101580252|FG011|STARTED|Part 1, Washout Period 3 (7 Days)||0||
48509212|NCT02688387|101580253|FG012|STARTED|Part 1, Washout Period 3 (7 Days)||0||
48509213|NCT02688387|101580254|FG013|STARTED|Part 1, Washout Period 3 (7 Days)||0||
48509214|NCT02688387|101580255|FG014|STARTED|Part 1, Washout Period 3 (7 Days)||0||
48509215|NCT02688387|101580256|FG015|STARTED|Part 1, Washout Period 3 (7 Days)||0||
48509216|NCT02688387|101580257|FG016|STARTED|Part 1, Washout Period 3 (7 Days)||0||
48509217|NCT02688387|101580258|FG017|STARTED|Part 1, Washout Period 3 (7 Days)||0||
48509218|NCT02688387|101580259|FG018|STARTED|Part 1, Washout Period 3 (7 Days)||0||
48509219|NCT02688387|101580260|FG019|STARTED|Part 1, Washout Period 3 (7 Days)||0||
48509220|NCT02688387|101580261|FG020|STARTED|Part 1, Washout Period 3 (7 Days)||0||
48509221|NCT02688387|101580262|FG021|STARTED|Part 1, Washout Period 3 (7 Days)||0||
48509222|NCT02688387|101580241|FG000|COMPLETED|Part 1, Washout Period 3 (7 Days)||2||
48509223|NCT02688387|101580242|FG001|COMPLETED|Part 1, Washout Period 3 (7 Days)||2||
48509224|NCT02688387|101580243|FG002|COMPLETED|Part 1, Washout Period 3 (7 Days)||2||
48509225|NCT02688387|101580244|FG003|COMPLETED|Part 1, Washout Period 3 (7 Days)||2||
48509226|NCT02688387|101580245|FG004|COMPLETED|Part 1, Washout Period 3 (7 Days)||2||
48509227|NCT02688387|101580246|FG005|COMPLETED|Part 1, Washout Period 3 (7 Days)||2||
48509228|NCT02688387|101580247|FG006|COMPLETED|Part 1, Washout Period 3 (7 Days)||2||
48509229|NCT02688387|101580248|FG007|COMPLETED|Part 1, Washout Period 3 (7 Days)||2||
48509230|NCT02688387|101580249|FG008|COMPLETED|Part 1, Washout Period 3 (7 Days)||2||
48509231|NCT02688387|101580250|FG009|COMPLETED|Part 1, Washout Period 3 (7 Days)||2||
48509232|NCT02688387|101580251|FG010|COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
48509233|NCT02688387|101580252|FG011|COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
48509234|NCT02688387|101580253|FG012|COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
48509235|NCT02688387|101580254|FG013|COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
48509236|NCT02688387|101580255|FG014|COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
48509237|NCT02688387|101580256|FG015|COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
48509238|NCT02688387|101580257|FG016|COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
48509239|NCT02688387|101580258|FG017|COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
48509240|NCT02688387|101580259|FG018|COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
48509241|NCT02688387|101580260|FG019|COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
48509242|NCT02688387|101580261|FG020|COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
48509243|NCT02688387|101580262|FG021|COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
48509244|NCT02688387|101580241|FG000|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||1||
48065125|NCT03307785|100479633|FG006|NOT COMPLETED|Part F: Up to 3.5 Months||0||
48509245|NCT02688387|101580242|FG001|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
48509246|NCT02688387|101580243|FG002|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
48509247|NCT02688387|101580244|FG003|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
48509248|NCT02688387|101580245|FG004|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
48509249|NCT02688387|101580246|FG005|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
48509250|NCT02688387|101580247|FG006|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
48509251|NCT02688387|101580248|FG007|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
48509252|NCT02688387|101580249|FG008|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
48509253|NCT02688387|101580250|FG009|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
48509254|NCT02688387|101580251|FG010|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
48509255|NCT02688387|101580252|FG011|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
48509256|NCT02688387|101580253|FG012|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
48509257|NCT02688387|101580254|FG013|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
48509258|NCT02688387|101580255|FG014|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
48509259|NCT02688387|101580256|FG015|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
48509260|NCT02688387|101580257|FG016|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
48509261|NCT02688387|101580258|FG017|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
48509262|NCT02688387|101580259|FG018|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
48509263|NCT02688387|101580260|FG019|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
48509264|NCT02688387|101580261|FG020|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
48509265|NCT02688387|101580262|FG021|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
48509266|NCT02688387|101580241|FG000|STARTED|Part 1, Period 4 (up to 6 Days)||2||
48509267|NCT02688387|101580242|FG001|STARTED|Part 1, Period 4 (up to 6 Days)||2||
48509268|NCT02688387|101580243|FG002|STARTED|Part 1, Period 4 (up to 6 Days)||2||
48509269|NCT02688387|101580244|FG003|STARTED|Part 1, Period 4 (up to 6 Days)||2||
48509270|NCT02688387|101580245|FG004|STARTED|Part 1, Period 4 (up to 6 Days)||2||
48509271|NCT02688387|101580246|FG005|STARTED|Part 1, Period 4 (up to 6 Days)||2||
48509272|NCT02688387|101580247|FG006|STARTED|Part 1, Period 4 (up to 6 Days)||2||
48509273|NCT02688387|101580248|FG007|STARTED|Part 1, Period 4 (up to 6 Days)||2||
48509274|NCT02688387|101580249|FG008|STARTED|Part 1, Period 4 (up to 6 Days)||2||
48509275|NCT02688387|101580250|FG009|STARTED|Part 1, Period 4 (up to 6 Days)||2||
48509276|NCT02688387|101580251|FG010|STARTED|Part 1, Period 4 (up to 6 Days)||0||
48509277|NCT02688387|101580252|FG011|STARTED|Part 1, Period 4 (up to 6 Days)||0||
48509278|NCT02688387|101580253|FG012|STARTED|Part 1, Period 4 (up to 6 Days)||0||
48509279|NCT02688387|101580254|FG013|STARTED|Part 1, Period 4 (up to 6 Days)||0||
48509280|NCT02688387|101580255|FG014|STARTED|Part 1, Period 4 (up to 6 Days)||0||
48509281|NCT02688387|101580256|FG015|STARTED|Part 1, Period 4 (up to 6 Days)||0||
48509282|NCT02688387|101580257|FG016|STARTED|Part 1, Period 4 (up to 6 Days)||0||
48509283|NCT02688387|101580258|FG017|STARTED|Part 1, Period 4 (up to 6 Days)||0||
48509284|NCT02688387|101580259|FG018|STARTED|Part 1, Period 4 (up to 6 Days)||0||
48509285|NCT02688387|101580260|FG019|STARTED|Part 1, Period 4 (up to 6 Days)||0||
48509286|NCT02688387|101580261|FG020|STARTED|Part 1, Period 4 (up to 6 Days)||0||
48509287|NCT02688387|101580262|FG021|STARTED|Part 1, Period 4 (up to 6 Days)||0||
48509288|NCT02688387|101580241|FG000|COMPLETED|Part 1, Period 4 (up to 6 Days)||2||
48509289|NCT02688387|101580242|FG001|COMPLETED|Part 1, Period 4 (up to 6 Days)||2||
48509290|NCT02688387|101580243|FG002|COMPLETED|Part 1, Period 4 (up to 6 Days)||2||
48509291|NCT02688387|101580244|FG003|COMPLETED|Part 1, Period 4 (up to 6 Days)||2||
48509292|NCT02688387|101580245|FG004|COMPLETED|Part 1, Period 4 (up to 6 Days)||2||
48065126|NCT03307785|100479634|FG007|NOT COMPLETED|Part F: Up to 3.5 Months||1||
48065127|NCT03307785|100479635|FG008|NOT COMPLETED|Part F: Up to 3.5 Months||0||
48065128|NCT03307785|100479636|FG009|NOT COMPLETED|Part F: Up to 3.5 Months||0||
48065129|NCT03307785|100479637|FG010|NOT COMPLETED|Part F: Up to 3.5 Months||0||
48065130|NCT03307785|100479627|FG000|STARTED|Part G: Up to 24 Months||0||
48509293|NCT02688387|101580246|FG005|COMPLETED|Part 1, Period 4 (up to 6 Days)||2||
48065131|NCT03307785|100479628|FG001|STARTED|Part G: Up to 24 Months||0||
48065132|NCT03307785|100479629|FG002|STARTED|Part G: Up to 24 Months||0||
48065133|NCT03307785|100479630|FG003|STARTED|Part G: Up to 24 Months||0||
48065134|NCT03307785|100479631|FG004|STARTED|Part G: Up to 24 Months||0||
48065135|NCT03307785|100479632|FG005|STARTED|Part G: Up to 24 Months||0||
48065136|NCT03307785|100479633|FG006|STARTED|Part G: Up to 24 Months||0||
48065137|NCT03307785|100479634|FG007|STARTED|Part G: Up to 24 Months||0||
48065138|NCT03307785|100479635|FG008|STARTED|Part G: Up to 24 Months||0||
48065139|NCT03307785|100479636|FG009|STARTED|Part G: Up to 24 Months||0||
48065140|NCT03307785|100479637|FG010|STARTED|Part G: Up to 24 Months||0||
48065141|NCT03307785|100479627|FG000|COMPLETED|Part G: Up to 24 Months||0||
48065142|NCT03307785|100479628|FG001|COMPLETED|Part G: Up to 24 Months||0||
48065143|NCT03307785|100479629|FG002|COMPLETED|Part G: Up to 24 Months||0||
48065144|NCT03307785|100479630|FG003|COMPLETED|Part G: Up to 24 Months||0||
48065145|NCT03307785|100479631|FG004|COMPLETED|Part G: Up to 24 Months||0||
48218639|NCT01627561|100860346|FG000|COMPLETED|Overall Study||73||
48509294|NCT02688387|101580247|FG006|COMPLETED|Part 1, Period 4 (up to 6 Days)||2||
48509295|NCT02688387|101580248|FG007|COMPLETED|Part 1, Period 4 (up to 6 Days)||2||
48509296|NCT02688387|101580249|FG008|COMPLETED|Part 1, Period 4 (up to 6 Days)||2||
48509297|NCT02688387|101580250|FG009|COMPLETED|Part 1, Period 4 (up to 6 Days)||2||
48065146|NCT03307785|100479632|FG005|COMPLETED|Part G: Up to 24 Months||0||
48065147|NCT03307785|100479633|FG006|COMPLETED|Part G: Up to 24 Months||0||
48065148|NCT03307785|100479634|FG007|COMPLETED|Part G: Up to 24 Months||0||
48065149|NCT03307785|100479635|FG008|COMPLETED|Part G: Up to 24 Months||0||
48065150|NCT03307785|100479636|FG009|COMPLETED|Part G: Up to 24 Months||0||
48065151|NCT03307785|100479637|FG010|COMPLETED|Part G: Up to 24 Months||0||
48065152|NCT03307785|100479627|FG000|NOT COMPLETED|Part G: Up to 24 Months||0||
48065153|NCT03307785|100479628|FG001|NOT COMPLETED|Part G: Up to 24 Months||0||
48065154|NCT03307785|100479629|FG002|NOT COMPLETED|Part G: Up to 24 Months||0||
48065155|NCT03307785|100479630|FG003|NOT COMPLETED|Part G: Up to 24 Months||0||
48065156|NCT03307785|100479631|FG004|NOT COMPLETED|Part G: Up to 24 Months||0||
48065157|NCT03307785|100479632|FG005|NOT COMPLETED|Part G: Up to 24 Months||0||
48065158|NCT03307785|100479633|FG006|NOT COMPLETED|Part G: Up to 24 Months||0||
48065159|NCT03307785|100479634|FG007|NOT COMPLETED|Part G: Up to 24 Months||0||
48065160|NCT03307785|100479635|FG008|NOT COMPLETED|Part G: Up to 24 Months||0||
48065161|NCT03307785|100479636|FG009|NOT COMPLETED|Part G: Up to 24 Months||0||
48065162|NCT03307785|100479637|FG010|NOT COMPLETED|Part G: Up to 24 Months||0||
48065163|NCT03307785|100479627|FG000|STARTED|Part H: Up to 24 Months||0||
48065164|NCT03307785|100479628|FG001|STARTED|Part H: Up to 24 Months||0||
48065165|NCT03307785|100479629|FG002|STARTED|Part H: Up to 24 Months||0||
48509298|NCT02688387|101580251|FG010|COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
48509299|NCT02688387|101580252|FG011|COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
48509300|NCT02688387|101580253|FG012|COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
48509301|NCT02688387|101580254|FG013|COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
48509302|NCT02688387|101580255|FG014|COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
48509303|NCT02688387|101580256|FG015|COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
48509304|NCT02688387|101580257|FG016|COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
48509305|NCT02688387|101580258|FG017|COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
48509306|NCT02688387|101580259|FG018|COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
48509307|NCT02688387|101580260|FG019|COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
48509308|NCT02688387|101580261|FG020|COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
48509309|NCT02688387|101580262|FG021|COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
48509310|NCT02688387|101580241|FG000|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
48509311|NCT02688387|101580242|FG001|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
48509312|NCT02688387|101580243|FG002|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
48509313|NCT02688387|101580244|FG003|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
48509314|NCT02688387|101580245|FG004|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
48509315|NCT02688387|101580246|FG005|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
48509316|NCT02688387|101580247|FG006|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
48509317|NCT02688387|101580248|FG007|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
48509318|NCT02688387|101580249|FG008|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
48509319|NCT02688387|101580250|FG009|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
48509320|NCT02688387|101580251|FG010|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
48509321|NCT02688387|101580252|FG011|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
48509322|NCT02688387|101580253|FG012|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
48509323|NCT02688387|101580254|FG013|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
48509324|NCT02688387|101580255|FG014|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
48509325|NCT02688387|101580256|FG015|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
48509326|NCT02688387|101580257|FG016|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
48509327|NCT02688387|101580258|FG017|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
48509328|NCT02688387|101580259|FG018|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
48509329|NCT02688387|101580260|FG019|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
48509330|NCT02688387|101580261|FG020|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
48509331|NCT02688387|101580262|FG021|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
48509332|NCT02688387|101580241|FG000|STARTED|Part 1, Washout Period 4 (7 Days)||2||
48509333|NCT02688387|101580242|FG001|STARTED|Part 1, Washout Period 4 (7 Days)||2||
48509334|NCT02688387|101580243|FG002|STARTED|Part 1, Washout Period 4 (7 Days)||2||
48509335|NCT02688387|101580244|FG003|STARTED|Part 1, Washout Period 4 (7 Days)||2||
48509336|NCT02688387|101580245|FG004|STARTED|Part 1, Washout Period 4 (7 Days)||2||
48509337|NCT02688387|101580246|FG005|STARTED|Part 1, Washout Period 4 (7 Days)||2||
48509338|NCT02688387|101580247|FG006|STARTED|Part 1, Washout Period 4 (7 Days)||2||
48509339|NCT02688387|101580248|FG007|STARTED|Part 1, Washout Period 4 (7 Days)||2||
48509340|NCT02688387|101580249|FG008|STARTED|Part 1, Washout Period 4 (7 Days)||2||
48065166|NCT03307785|100479630|FG003|STARTED|Part H: Up to 24 Months||0||
48065167|NCT03307785|100479631|FG004|STARTED|Part H: Up to 24 Months||0||
48065168|NCT03307785|100479632|FG005|STARTED|Part H: Up to 24 Months||0||
48065169|NCT03307785|100479633|FG006|STARTED|Part H: Up to 24 Months||0||
48065170|NCT03307785|100479634|FG007|STARTED|Part H: Up to 24 Months||0||
48065171|NCT03307785|100479635|FG008|STARTED|Part H: Up to 24 Months||0||
48065172|NCT03307785|100479636|FG009|STARTED|Part H: Up to 24 Months||0||
48065173|NCT03307785|100479637|FG010|STARTED|Part H: Up to 24 Months||0||
48065174|NCT03307785|100479627|FG000|COMPLETED|Part H: Up to 24 Months||0||
48065175|NCT03307785|100479628|FG001|COMPLETED|Part H: Up to 24 Months||0||
48065176|NCT03307785|100479629|FG002|COMPLETED|Part H: Up to 24 Months||0||
48065177|NCT03307785|100479630|FG003|COMPLETED|Part H: Up to 24 Months||0||
48065178|NCT03307785|100479631|FG004|COMPLETED|Part H: Up to 24 Months||0||
48509341|NCT02688387|101580250|FG009|STARTED|Part 1, Washout Period 4 (7 Days)||2||
48509342|NCT02688387|101580251|FG010|STARTED|Part 1, Washout Period 4 (7 Days)||0||
48509343|NCT02688387|101580252|FG011|STARTED|Part 1, Washout Period 4 (7 Days)||0||
48509344|NCT02688387|101580253|FG012|STARTED|Part 1, Washout Period 4 (7 Days)||0||
48509345|NCT02688387|101580254|FG013|STARTED|Part 1, Washout Period 4 (7 Days)||0||
48509346|NCT02688387|101580255|FG014|STARTED|Part 1, Washout Period 4 (7 Days)||0||
48509347|NCT02688387|101580256|FG015|STARTED|Part 1, Washout Period 4 (7 Days)||0||
48509348|NCT02688387|101580257|FG016|STARTED|Part 1, Washout Period 4 (7 Days)||0||
48509349|NCT02688387|101580258|FG017|STARTED|Part 1, Washout Period 4 (7 Days)||0||
48509350|NCT02688387|101580259|FG018|STARTED|Part 1, Washout Period 4 (7 Days)||0||
48509351|NCT02688387|101580260|FG019|STARTED|Part 1, Washout Period 4 (7 Days)||0||
48509352|NCT02688387|101580261|FG020|STARTED|Part 1, Washout Period 4 (7 Days)||0||
48509353|NCT02688387|101580262|FG021|STARTED|Part 1, Washout Period 4 (7 Days)||0||
48509354|NCT02688387|101580241|FG000|COMPLETED|Part 1, Washout Period 4 (7 Days)||2||
48509355|NCT02688387|101580242|FG001|COMPLETED|Part 1, Washout Period 4 (7 Days)||2||
48509356|NCT02688387|101580243|FG002|COMPLETED|Part 1, Washout Period 4 (7 Days)||2||
48509357|NCT02688387|101580244|FG003|COMPLETED|Part 1, Washout Period 4 (7 Days)||2||
48509358|NCT02688387|101580245|FG004|COMPLETED|Part 1, Washout Period 4 (7 Days)||2||
48509359|NCT02688387|101580246|FG005|COMPLETED|Part 1, Washout Period 4 (7 Days)||2||
48509360|NCT02688387|101580247|FG006|COMPLETED|Part 1, Washout Period 4 (7 Days)||2||
48509361|NCT02688387|101580248|FG007|COMPLETED|Part 1, Washout Period 4 (7 Days)||2||
48509362|NCT02688387|101580249|FG008|COMPLETED|Part 1, Washout Period 4 (7 Days)||2||
48509363|NCT02688387|101580250|FG009|COMPLETED|Part 1, Washout Period 4 (7 Days)||2||
48509364|NCT02688387|101580251|FG010|COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
48509365|NCT02688387|101580252|FG011|COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
48509366|NCT02688387|101580253|FG012|COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
48509367|NCT02688387|101580254|FG013|COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
48509368|NCT02688387|101580255|FG014|COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
48509369|NCT02688387|101580256|FG015|COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
48509370|NCT02688387|101580257|FG016|COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
48509371|NCT02688387|101580258|FG017|COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
48509372|NCT02688387|101580259|FG018|COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
48509373|NCT02688387|101580260|FG019|COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
48509374|NCT02688387|101580261|FG020|COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
48509375|NCT02688387|101580262|FG021|COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
48509376|NCT02688387|101580241|FG000|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
48509377|NCT02688387|101580242|FG001|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
48509378|NCT02688387|101580243|FG002|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
48509379|NCT02688387|101580244|FG003|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
48509380|NCT02688387|101580245|FG004|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
48509381|NCT02688387|101580246|FG005|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
48509382|NCT02688387|101580247|FG006|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
48509383|NCT02688387|101580248|FG007|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
48509384|NCT02688387|101580249|FG008|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
48509385|NCT02688387|101580250|FG009|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
48509386|NCT02688387|101580251|FG010|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
48509387|NCT02688387|101580252|FG011|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
48509388|NCT02688387|101580253|FG012|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
48509389|NCT02688387|101580254|FG013|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
48509390|NCT02688387|101580255|FG014|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
48509391|NCT02688387|101580256|FG015|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
48509392|NCT02688387|101580257|FG016|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
48509393|NCT02688387|101580258|FG017|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
48509394|NCT02688387|101580259|FG018|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
48509395|NCT02688387|101580260|FG019|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
48509396|NCT02688387|101580261|FG020|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
48509397|NCT02688387|101580262|FG021|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
48509398|NCT02688387|101580241|FG000|STARTED|Part 1, Period 5 (up to 6 Days)||2||
48509399|NCT02688387|101580242|FG001|STARTED|Part 1, Period 5 (up to 6 Days)||2||
48065179|NCT03307785|100479632|FG005|COMPLETED|Part H: Up to 24 Months||0||
48065180|NCT03307785|100479633|FG006|COMPLETED|Part H: Up to 24 Months||0||
48065181|NCT03307785|100479634|FG007|COMPLETED|Part H: Up to 24 Months||0||
48065182|NCT03307785|100479635|FG008|COMPLETED|Part H: Up to 24 Months||0||
48065183|NCT03307785|100479636|FG009|COMPLETED|Part H: Up to 24 Months||0||
48509400|NCT02688387|101580243|FG002|STARTED|Part 1, Period 5 (up to 6 Days)||2||
48509401|NCT02688387|101580244|FG003|STARTED|Part 1, Period 5 (up to 6 Days)||2||
48509402|NCT02688387|101580245|FG004|STARTED|Part 1, Period 5 (up to 6 Days)||2||
48509403|NCT02688387|101580246|FG005|STARTED|Part 1, Period 5 (up to 6 Days)||2||
48509404|NCT02688387|101580247|FG006|STARTED|Part 1, Period 5 (up to 6 Days)||2||
48509405|NCT02688387|101580248|FG007|STARTED|Part 1, Period 5 (up to 6 Days)||2||
48509406|NCT02688387|101580249|FG008|STARTED|Part 1, Period 5 (up to 6 Days)||2||
48065184|NCT03307785|100479637|FG010|COMPLETED|Part H: Up to 24 Months||0||
48509407|NCT02688387|101580250|FG009|STARTED|Part 1, Period 5 (up to 6 Days)||2||
48509408|NCT02688387|101580251|FG010|STARTED|Part 1, Period 5 (up to 6 Days)||0||
48509409|NCT02688387|101580252|FG011|STARTED|Part 1, Period 5 (up to 6 Days)||0||
48509410|NCT02688387|101580253|FG012|STARTED|Part 1, Period 5 (up to 6 Days)||0||
48509411|NCT02688387|101580254|FG013|STARTED|Part 1, Period 5 (up to 6 Days)||0||
48509412|NCT02688387|101580255|FG014|STARTED|Part 1, Period 5 (up to 6 Days)||0||
48509413|NCT02688387|101580256|FG015|STARTED|Part 1, Period 5 (up to 6 Days)||0||
48509414|NCT02688387|101580257|FG016|STARTED|Part 1, Period 5 (up to 6 Days)||0||
48509415|NCT02688387|101580258|FG017|STARTED|Part 1, Period 5 (up to 6 Days)||0||
48509416|NCT02688387|101580259|FG018|STARTED|Part 1, Period 5 (up to 6 Days)||0||
48509417|NCT02688387|101580260|FG019|STARTED|Part 1, Period 5 (up to 6 Days)||0||
48509418|NCT02688387|101580261|FG020|STARTED|Part 1, Period 5 (up to 6 Days)||0||
48509419|NCT02688387|101580262|FG021|STARTED|Part 1, Period 5 (up to 6 Days)||0||
48509420|NCT02688387|101580241|FG000|COMPLETED|Part 1, Period 5 (up to 6 Days)||2||
48509421|NCT02688387|101580242|FG001|COMPLETED|Part 1, Period 5 (up to 6 Days)||2||
48509422|NCT02688387|101580243|FG002|COMPLETED|Part 1, Period 5 (up to 6 Days)||2||
48509423|NCT02688387|101580244|FG003|COMPLETED|Part 1, Period 5 (up to 6 Days)||2||
48509424|NCT02688387|101580245|FG004|COMPLETED|Part 1, Period 5 (up to 6 Days)||2||
48509425|NCT02688387|101580246|FG005|COMPLETED|Part 1, Period 5 (up to 6 Days)||2||
48509426|NCT02688387|101580247|FG006|COMPLETED|Part 1, Period 5 (up to 6 Days)||2||
48509427|NCT02688387|101580248|FG007|COMPLETED|Part 1, Period 5 (up to 6 Days)||2||
48509428|NCT02688387|101580249|FG008|COMPLETED|Part 1, Period 5 (up to 6 Days)||2||
48509429|NCT02688387|101580250|FG009|COMPLETED|Part 1, Period 5 (up to 6 Days)||2||
48509430|NCT02688387|101580251|FG010|COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
48509431|NCT02688387|101580252|FG011|COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
48509432|NCT02688387|101580253|FG012|COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
48509433|NCT02688387|101580254|FG013|COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
48509434|NCT02688387|101580255|FG014|COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
48509435|NCT02688387|101580256|FG015|COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
48509436|NCT02688387|101580257|FG016|COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
48509437|NCT02688387|101580258|FG017|COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
48509438|NCT02688387|101580259|FG018|COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
48509439|NCT02688387|101580260|FG019|COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
48509440|NCT02688387|101580261|FG020|COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
48509441|NCT02688387|101580262|FG021|COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
48509442|NCT02688387|101580241|FG000|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
48509443|NCT02688387|101580242|FG001|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
48509444|NCT02688387|101580243|FG002|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
48509445|NCT02688387|101580244|FG003|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
48509446|NCT02688387|101580245|FG004|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
48509447|NCT02688387|101580246|FG005|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
48509448|NCT02688387|101580247|FG006|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
48509449|NCT02688387|101580248|FG007|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
48509450|NCT02688387|101580249|FG008|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
48509451|NCT02688387|101580250|FG009|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
48509452|NCT02688387|101580251|FG010|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
48509453|NCT02688387|101580252|FG011|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
48509454|NCT02688387|101580253|FG012|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
48509455|NCT02688387|101580254|FG013|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
48509456|NCT02688387|101580255|FG014|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
48509457|NCT02688387|101580256|FG015|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
48509458|NCT02688387|101580257|FG016|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
48509459|NCT02688387|101580258|FG017|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
48509460|NCT02688387|101580259|FG018|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
48509461|NCT02688387|101580260|FG019|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
48509462|NCT02688387|101580261|FG020|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
48509463|NCT02688387|101580262|FG021|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
48509464|NCT02688387|101580241|FG000|STARTED|Part 2, Period 1 (up to 6 Days)||0||
48509465|NCT02688387|101580242|FG001|STARTED|Part 2, Period 1 (up to 6 Days)||0||
48509466|NCT02688387|101580243|FG002|STARTED|Part 2, Period 1 (up to 6 Days)||0||
48509467|NCT02688387|101580244|FG003|STARTED|Part 2, Period 1 (up to 6 Days)||0||
48509468|NCT02688387|101580245|FG004|STARTED|Part 2, Period 1 (up to 6 Days)||0||
48509469|NCT02688387|101580246|FG005|STARTED|Part 2, Period 1 (up to 6 Days)||0||
48509470|NCT02688387|101580247|FG006|STARTED|Part 2, Period 1 (up to 6 Days)||0||
48509471|NCT02688387|101580248|FG007|STARTED|Part 2, Period 1 (up to 6 Days)||0||
48509472|NCT02688387|101580249|FG008|STARTED|Part 2, Period 1 (up to 6 Days)||0||
48509473|NCT02688387|101580250|FG009|STARTED|Part 2, Period 1 (up to 6 Days)||0||
48509474|NCT02688387|101580251|FG010|STARTED|Part 2, Period 1 (up to 6 Days)||6||
48509475|NCT02688387|101580252|FG011|STARTED|Part 2, Period 1 (up to 6 Days)||5||
48509476|NCT02688387|101580253|FG012|STARTED|Part 2, Period 1 (up to 6 Days)||5||
48065185|NCT03307785|100479627|FG000|NOT COMPLETED|Part H: Up to 24 Months||0||
48065186|NCT03307785|100479628|FG001|NOT COMPLETED|Part H: Up to 24 Months||0||
48509477|NCT02688387|101580254|FG013|STARTED|Part 2, Period 1 (up to 6 Days)||5||
48509478|NCT02688387|101580255|FG014|STARTED|Part 2, Period 1 (up to 6 Days)||0||
48065187|NCT03307785|100479629|FG002|NOT COMPLETED|Part H: Up to 24 Months||0||
48065188|NCT03307785|100479630|FG003|NOT COMPLETED|Part H: Up to 24 Months||0||
48065189|NCT03307785|100479631|FG004|NOT COMPLETED|Part H: Up to 24 Months||0||
48065190|NCT03307785|100479632|FG005|NOT COMPLETED|Part H: Up to 24 Months||0||
48065191|NCT03307785|100479633|FG006|NOT COMPLETED|Part H: Up to 24 Months||0||
48065192|NCT03307785|100479634|FG007|NOT COMPLETED|Part H: Up to 24 Months||0||
48065193|NCT03307785|100479635|FG008|NOT COMPLETED|Part H: Up to 24 Months||0||
48065194|NCT03307785|100479636|FG009|NOT COMPLETED|Part H: Up to 24 Months||0||
48065195|NCT03307785|100479637|FG010|NOT COMPLETED|Part H: Up to 24 Months||0||
48065196|NCT03307785|100479627|FG000|STARTED|Part I: Up to 24 Months||0||
48065197|NCT03307785|100479628|FG001|STARTED|Part I: Up to 24 Months||0||
48065198|NCT03307785|100479629|FG002|STARTED|Part I: Up to 24 Months||0||
48509479|NCT02688387|101580256|FG015|STARTED|Part 2, Period 1 (up to 6 Days)||0||
48509480|NCT02688387|101580257|FG016|STARTED|Part 2, Period 1 (up to 6 Days)||0||
48509481|NCT02688387|101580258|FG017|STARTED|Part 2, Period 1 (up to 6 Days)||0||
48509482|NCT02688387|101580259|FG018|STARTED|Part 2, Period 1 (up to 6 Days)||0||
48509483|NCT02688387|101580260|FG019|STARTED|Part 2, Period 1 (up to 6 Days)||0||
48509484|NCT02688387|101580261|FG020|STARTED|Part 2, Period 1 (up to 6 Days)||0||
48509485|NCT02688387|101580262|FG021|STARTED|Part 2, Period 1 (up to 6 Days)||0||
48509486|NCT02688387|101580241|FG000|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509487|NCT02688387|101580242|FG001|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509488|NCT02688387|101580243|FG002|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509489|NCT02688387|101580244|FG003|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509490|NCT02688387|101580245|FG004|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509491|NCT02688387|101580246|FG005|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509492|NCT02688387|101580247|FG006|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509493|NCT02688387|101580248|FG007|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509494|NCT02688387|101580249|FG008|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509495|NCT02688387|101580250|FG009|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509496|NCT02688387|101580251|FG010|COMPLETED|Part 2, Period 1 (up to 6 Days)||5||
48509497|NCT02688387|101580252|FG011|COMPLETED|Part 2, Period 1 (up to 6 Days)||5||
48509498|NCT02688387|101580253|FG012|COMPLETED|Part 2, Period 1 (up to 6 Days)||5||
48509499|NCT02688387|101580254|FG013|COMPLETED|Part 2, Period 1 (up to 6 Days)||5||
48509500|NCT02688387|101580255|FG014|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509501|NCT02688387|101580256|FG015|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509502|NCT02688387|101580257|FG016|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509503|NCT02688387|101580258|FG017|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509504|NCT02688387|101580259|FG018|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509505|NCT02688387|101580260|FG019|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509506|NCT02688387|101580261|FG020|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509507|NCT02688387|101580262|FG021|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509508|NCT02688387|101580241|FG000|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509509|NCT02688387|101580242|FG001|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509510|NCT02688387|101580243|FG002|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509511|NCT02688387|101580244|FG003|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509512|NCT02688387|101580245|FG004|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509513|NCT02688387|101580246|FG005|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509514|NCT02688387|101580247|FG006|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509515|NCT02688387|101580248|FG007|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509516|NCT02688387|101580249|FG008|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509517|NCT02688387|101580250|FG009|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509518|NCT02688387|101580251|FG010|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||1||
48509519|NCT02688387|101580252|FG011|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509520|NCT02688387|101580253|FG012|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509521|NCT02688387|101580254|FG013|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509522|NCT02688387|101580255|FG014|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509523|NCT02688387|101580256|FG015|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509524|NCT02688387|101580257|FG016|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509525|NCT02688387|101580258|FG017|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509526|NCT02688387|101580259|FG018|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509527|NCT02688387|101580260|FG019|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509528|NCT02688387|101580261|FG020|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509529|NCT02688387|101580262|FG021|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
48509530|NCT02688387|101580241|FG000|STARTED|Part 2, Washout Period 1 (10 Days)||0||
48509531|NCT02688387|101580242|FG001|STARTED|Part 2, Washout Period 1 (10 Days)||0||
48509532|NCT02688387|101580243|FG002|STARTED|Part 2, Washout Period 1 (10 Days)||0||
48509533|NCT02688387|101580244|FG003|STARTED|Part 2, Washout Period 1 (10 Days)||0||
48509534|NCT02688387|101580245|FG004|STARTED|Part 2, Washout Period 1 (10 Days)||0||
48509535|NCT02688387|101580246|FG005|STARTED|Part 2, Washout Period 1 (10 Days)||0||
48509536|NCT02688387|101580247|FG006|STARTED|Part 2, Washout Period 1 (10 Days)||0||
48509537|NCT02688387|101580248|FG007|STARTED|Part 2, Washout Period 1 (10 Days)||0||
48065199|NCT03307785|100479630|FG003|STARTED|Part I: Up to 24 Months||0||
48509538|NCT02688387|101580249|FG008|STARTED|Part 2, Washout Period 1 (10 Days)||0||
48509539|NCT02688387|101580250|FG009|STARTED|Part 2, Washout Period 1 (10 Days)||0||
48509540|NCT02688387|101580251|FG010|STARTED|Part 2, Washout Period 1 (10 Days)||5||
48509541|NCT02688387|101580252|FG011|STARTED|Part 2, Washout Period 1 (10 Days)||5||
48509542|NCT02688387|101580253|FG012|STARTED|Part 2, Washout Period 1 (10 Days)||5||
48509543|NCT02688387|101580254|FG013|STARTED|Part 2, Washout Period 1 (10 Days)||5||
48509544|NCT02688387|101580255|FG014|STARTED|Part 2, Washout Period 1 (10 Days)||0||
48509545|NCT02688387|101580256|FG015|STARTED|Part 2, Washout Period 1 (10 Days)||0||
48509546|NCT02688387|101580257|FG016|STARTED|Part 2, Washout Period 1 (10 Days)||0||
48509547|NCT02688387|101580258|FG017|STARTED|Part 2, Washout Period 1 (10 Days)||0||
48509548|NCT02688387|101580259|FG018|STARTED|Part 2, Washout Period 1 (10 Days)||0||
48509549|NCT02688387|101580260|FG019|STARTED|Part 2, Washout Period 1 (10 Days)||0||
48509550|NCT02688387|101580261|FG020|STARTED|Part 2, Washout Period 1 (10 Days)||0||
48509551|NCT02688387|101580262|FG021|STARTED|Part 2, Washout Period 1 (10 Days)||0||
48509552|NCT02688387|101580241|FG000|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509553|NCT02688387|101580242|FG001|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509554|NCT02688387|101580243|FG002|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509555|NCT02688387|101580244|FG003|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509556|NCT02688387|101580245|FG004|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509557|NCT02688387|101580246|FG005|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509558|NCT02688387|101580247|FG006|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509559|NCT02688387|101580248|FG007|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509560|NCT02688387|101580249|FG008|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509561|NCT02688387|101580250|FG009|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509562|NCT02688387|101580251|FG010|COMPLETED|Part 2, Washout Period 1 (10 Days)||5||
48509563|NCT02688387|101580252|FG011|COMPLETED|Part 2, Washout Period 1 (10 Days)||5||
48509564|NCT02688387|101580253|FG012|COMPLETED|Part 2, Washout Period 1 (10 Days)||5||
48509565|NCT02688387|101580254|FG013|COMPLETED|Part 2, Washout Period 1 (10 Days)||5||
48509566|NCT02688387|101580255|FG014|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509567|NCT02688387|101580256|FG015|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509568|NCT02688387|101580257|FG016|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509569|NCT02688387|101580258|FG017|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509570|NCT02688387|101580259|FG018|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509571|NCT02688387|101580260|FG019|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509572|NCT02688387|101580261|FG020|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509573|NCT02688387|101580262|FG021|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509574|NCT02688387|101580241|FG000|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509575|NCT02688387|101580242|FG001|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509576|NCT02688387|101580243|FG002|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509577|NCT02688387|101580244|FG003|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509578|NCT02688387|101580245|FG004|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509579|NCT02688387|101580246|FG005|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509580|NCT02688387|101580247|FG006|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509581|NCT02688387|101580248|FG007|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509582|NCT02688387|101580249|FG008|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509583|NCT02688387|101580250|FG009|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509584|NCT02688387|101580251|FG010|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509585|NCT02688387|101580252|FG011|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509586|NCT02688387|101580253|FG012|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509587|NCT02688387|101580254|FG013|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509588|NCT02688387|101580255|FG014|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509589|NCT02688387|101580256|FG015|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509590|NCT02688387|101580257|FG016|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509591|NCT02688387|101580258|FG017|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509592|NCT02688387|101580259|FG018|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509593|NCT02688387|101580260|FG019|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509594|NCT02688387|101580261|FG020|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509595|NCT02688387|101580262|FG021|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
48509596|NCT02688387|101580241|FG000|STARTED|Part 2, Period 2 (up to 6 Days)||0||
48509597|NCT02688387|101580242|FG001|STARTED|Part 2, Period 2 (up to 6 Days)||0||
48509598|NCT02688387|101580243|FG002|STARTED|Part 2, Period 2 (up to 6 Days)||0||
48509599|NCT02688387|101580244|FG003|STARTED|Part 2, Period 2 (up to 6 Days)||0||
48509600|NCT02688387|101580245|FG004|STARTED|Part 2, Period 2 (up to 6 Days)||0||
48065200|NCT03307785|100479631|FG004|STARTED|Part I: Up to 24 Months||0||
48065201|NCT03307785|100479632|FG005|STARTED|Part I: Up to 24 Months||0||
48065202|NCT03307785|100479633|FG006|STARTED|Part I: Up to 24 Months||0||
48065203|NCT03307785|100479634|FG007|STARTED|Part I: Up to 24 Months||0||
48065204|NCT03307785|100479635|FG008|STARTED|Part I: Up to 24 Months||0||
48218640|NCT01627561|100860347|FG001|COMPLETED|Overall Study||71||
48065205|NCT03307785|100479636|FG009|STARTED|Part I: Up to 24 Months||0||
48065206|NCT03307785|100479637|FG010|STARTED|Part I: Up to 24 Months||0||
48218641|NCT01627561|100860346|FG000|NOT COMPLETED|Overall Study||1||
48065207|NCT03307785|100479627|FG000|COMPLETED|Part I: Up to 24 Months||0||
48065208|NCT03307785|100479628|FG001|COMPLETED|Part I: Up to 24 Months||0||
48065209|NCT03307785|100479629|FG002|COMPLETED|Part I: Up to 24 Months||0||
48065210|NCT03307785|100479630|FG003|COMPLETED|Part I: Up to 24 Months||0||
48065211|NCT03307785|100479631|FG004|COMPLETED|Part I: Up to 24 Months||0||
48065212|NCT03307785|100479632|FG005|COMPLETED|Part I: Up to 24 Months||0||
48065213|NCT03307785|100479633|FG006|COMPLETED|Part I: Up to 24 Months||0||
48065214|NCT03307785|100479634|FG007|COMPLETED|Part I: Up to 24 Months||0||
48065215|NCT03307785|100479635|FG008|COMPLETED|Part I: Up to 24 Months||0||
48065216|NCT03307785|100479636|FG009|COMPLETED|Part I: Up to 24 Months||0||
48065217|NCT03307785|100479637|FG010|COMPLETED|Part I: Up to 24 Months||0||
48065218|NCT03307785|100479627|FG000|NOT COMPLETED|Part I: Up to 24 Months||0||
48065219|NCT03307785|100479628|FG001|NOT COMPLETED|Part I: Up to 24 Months||0||
48065220|NCT03307785|100479629|FG002|NOT COMPLETED|Part I: Up to 24 Months||0||
48065221|NCT03307785|100479630|FG003|NOT COMPLETED|Part I: Up to 24 Months||0||
48065222|NCT03307785|100479631|FG004|NOT COMPLETED|Part I: Up to 24 Months||0||
48065223|NCT03307785|100479632|FG005|NOT COMPLETED|Part I: Up to 24 Months||0||
48065224|NCT03307785|100479633|FG006|NOT COMPLETED|Part I: Up to 24 Months||0||
48065225|NCT03307785|100479634|FG007|NOT COMPLETED|Part I: Up to 24 Months||0||
48065226|NCT03307785|100479635|FG008|NOT COMPLETED|Part I: Up to 24 Months||0||
48065227|NCT03307785|100479636|FG009|NOT COMPLETED|Part I: Up to 24 Months||0||
48065228|NCT03307785|100479637|FG010|NOT COMPLETED|Part I: Up to 24 Months||0||
48065229|NCT00406718|100479638|FG000|STARTED|Overall Study||47||
48065230|NCT00406718|100479639|FG001|STARTED|Overall Study||48||
48065231|NCT00406718|100479640|FG002|STARTED|Overall Study||47||
48065232|NCT00406718|100479638|FG000|COMPLETED|Overall Study||43||
48065233|NCT00406718|100479639|FG001|COMPLETED|Overall Study||34||
48065234|NCT00406718|100479640|FG002|COMPLETED|Overall Study||39||
48065235|NCT00406718|100479638|FG000|NOT COMPLETED|Overall Study||4||
48065236|NCT00406718|100479639|FG001|NOT COMPLETED|Overall Study||14||
48065237|NCT00406718|100479640|FG002|NOT COMPLETED|Overall Study||8||
48065238|NCT00922233|100479641|FG000|STARTED|Overall Study||72||
48065239|NCT00922233|100479641|FG000|COMPLETED|Overall Study||68||
48065240|NCT00922233|100479641|FG000|NOT COMPLETED|Overall Study||4||
48065241|NCT01601132|100479642|FG000|STARTED|Overall Study||30||
48065242|NCT01601132|100479642|FG000|COMPLETED|Overall Study||28||
48065243|NCT01601132|100479642|FG000|NOT COMPLETED|Overall Study||2||
48065244|NCT01453725|100479643|FG000|STARTED|Overall Study||98||
48065245|NCT01453725|100479644|FG001|STARTED|Overall Study||100||
48065246|NCT01453725|100479643|FG000|COMPLETED|Overall Study||85||
48065247|NCT01453725|100479644|FG001|COMPLETED|Overall Study||89||
48065248|NCT01453725|100479643|FG000|NOT COMPLETED|Overall Study||13||
48065249|NCT01453725|100479644|FG001|NOT COMPLETED|Overall Study||11||
48065250|NCT01436396|100479645|FG000|STARTED|Overall Study||396||
48065251|NCT01436396|100479646|FG001|STARTED|Overall Study||396||
48065252|NCT01436396|100479645|FG000|Vaccinated|Overall Study||394||
48065253|NCT01436396|100479646|FG001|Vaccinated|Overall Study||393||
48065254|NCT01436396|100479645|FG000|COMPLETED|Overall Study||364||
48065255|NCT01436396|100479646|FG001|COMPLETED|Overall Study||354||
48065256|NCT01436396|100479645|FG000|NOT COMPLETED|Overall Study||32||
48065257|NCT01436396|100479646|FG001|NOT COMPLETED|Overall Study||42||
48065258|NCT00333801|100479647|FG000|STARTED|Overall Study||43||
48065259|NCT00333801|100479648|FG001|STARTED|Overall Study||42||
48065260|NCT00333801|100479647|FG000|COMPLETED|Overall Study||35||
48065261|NCT00333801|100479648|FG001|COMPLETED|Overall Study||36||
48065262|NCT00333801|100479647|FG000|NOT COMPLETED|Overall Study||8||
48065263|NCT00333801|100479648|FG001|NOT COMPLETED|Overall Study||6||
48065264|NCT00936611|100479649|FG000|STARTED|Overall Study||39||
48065265|NCT00936611|100479649|FG000|Treated|Overall Study||36|3 patients deemed ineligible|
48065266|NCT00936611|100479649|FG000|Starting Dose Reduction: 30 mg to 25 mg|Overall Study||12|Protocol Amendment 6/15/2010. Study drug starting dose reduced.|
48065267|NCT00936611|100479649|FG000|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all participants were considered as 'Not Completed' and reason off-treatment is provided.|
48218642|NCT01627561|100860347|FG001|NOT COMPLETED|Overall Study||3||
48065268|NCT00936611|100479649|FG000|NOT COMPLETED|Overall Study||39||
48065269|NCT00601198|100479650|FG000|STARTED|Overall Study||4||
48065270|NCT00601198|100479650|FG000|COMPLETED|Overall Study||4||
48509601|NCT02688387|101580246|FG005|STARTED|Part 2, Period 2 (up to 6 Days)||0||
48065271|NCT00601198|100479650|FG000|NOT COMPLETED|Overall Study||0||
48065272|NCT02856698|100479651|FG000|STARTED|Overall Study||55||
48065273|NCT02856698|100479652|FG001|STARTED|Overall Study||56||
48065274|NCT02856698|100479651|FG000|COMPLETED|Overall Study||48||
48065275|NCT02856698|100479652|FG001|COMPLETED|Overall Study||46||
48065276|NCT02856698|100479651|FG000|NOT COMPLETED|Overall Study||7||
48065277|NCT02856698|100479652|FG001|NOT COMPLETED|Overall Study||10||
48065278|NCT01254292|100479653|FG000|STARTED|Comparative Phase||282||
48065279|NCT01254292|100479654|FG001|STARTED|Comparative Phase||285||
48065280|NCT01254292|100479653|FG000|Participants Received Treatment|Comparative Phase||279||
48065281|NCT01254292|100479654|FG001|Participants Received Treatment|Comparative Phase||281||
48065282|NCT01254292|100479653|FG000|COMPLETED|Comparative Phase||227||
48065283|NCT01254292|100479654|FG001|COMPLETED|Comparative Phase||204||
48218643|NCT00176800|100860348|FG000|STARTED|Overall Study||69||
48065284|NCT01254292|100479653|FG000|NOT COMPLETED|Comparative Phase||55||
48065285|NCT01254292|100479654|FG001|NOT COMPLETED|Comparative Phase||81||
48065286|NCT01254292|100479653|FG000|STARTED|LCS12 Extension Phase||200||
48218644|NCT00176800|100860348|FG000|COMPLETED|Overall Study||69||
48218645|NCT00176800|100860348|FG000|NOT COMPLETED|Overall Study||0||
48509602|NCT02688387|101580247|FG006|STARTED|Part 2, Period 2 (up to 6 Days)||0||
48509603|NCT02688387|101580248|FG007|STARTED|Part 2, Period 2 (up to 6 Days)||0||
48509604|NCT02688387|101580249|FG008|STARTED|Part 2, Period 2 (up to 6 Days)||0||
48509605|NCT02688387|101580250|FG009|STARTED|Part 2, Period 2 (up to 6 Days)||0||
48509606|NCT02688387|101580251|FG010|STARTED|Part 2, Period 2 (up to 6 Days)||5||
48509607|NCT02688387|101580252|FG011|STARTED|Part 2, Period 2 (up to 6 Days)||5||
48509608|NCT02688387|101580253|FG012|STARTED|Part 2, Period 2 (up to 6 Days)||5||
48509609|NCT02688387|101580254|FG013|STARTED|Part 2, Period 2 (up to 6 Days)||5||
48509610|NCT02688387|101580255|FG014|STARTED|Part 2, Period 2 (up to 6 Days)||0||
48509611|NCT02688387|101580256|FG015|STARTED|Part 2, Period 2 (up to 6 Days)||0||
48509612|NCT02688387|101580257|FG016|STARTED|Part 2, Period 2 (up to 6 Days)||0||
48509613|NCT02688387|101580258|FG017|STARTED|Part 2, Period 2 (up to 6 Days)||0||
48509614|NCT02688387|101580259|FG018|STARTED|Part 2, Period 2 (up to 6 Days)||0||
48509615|NCT02688387|101580260|FG019|STARTED|Part 2, Period 2 (up to 6 Days)||0||
48509616|NCT02688387|101580261|FG020|STARTED|Part 2, Period 2 (up to 6 Days)||0||
48509617|NCT02688387|101580262|FG021|STARTED|Part 2, Period 2 (up to 6 Days)||0||
48509618|NCT02688387|101580241|FG000|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509619|NCT02688387|101580242|FG001|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509620|NCT02688387|101580243|FG002|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509621|NCT02688387|101580244|FG003|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509622|NCT02688387|101580245|FG004|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509623|NCT02688387|101580246|FG005|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509624|NCT02688387|101580247|FG006|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509625|NCT02688387|101580248|FG007|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509626|NCT02688387|101580249|FG008|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509627|NCT02688387|101580250|FG009|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509628|NCT02688387|101580251|FG010|COMPLETED|Part 2, Period 2 (up to 6 Days)||5||
48509629|NCT02688387|101580252|FG011|COMPLETED|Part 2, Period 2 (up to 6 Days)||5||
48509630|NCT02688387|101580253|FG012|COMPLETED|Part 2, Period 2 (up to 6 Days)||5||
48509631|NCT02688387|101580254|FG013|COMPLETED|Part 2, Period 2 (up to 6 Days)||5||
48509632|NCT02688387|101580255|FG014|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509633|NCT02688387|101580256|FG015|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509634|NCT02688387|101580257|FG016|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509635|NCT02688387|101580258|FG017|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509636|NCT02688387|101580259|FG018|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509637|NCT02688387|101580260|FG019|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509638|NCT02688387|101580261|FG020|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509639|NCT02688387|101580262|FG021|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509640|NCT02688387|101580241|FG000|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509641|NCT02688387|101580242|FG001|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509642|NCT02688387|101580243|FG002|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509643|NCT02688387|101580244|FG003|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509644|NCT02688387|101580245|FG004|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509645|NCT02688387|101580246|FG005|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509646|NCT02688387|101580247|FG006|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509647|NCT02688387|101580248|FG007|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509648|NCT02688387|101580249|FG008|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509649|NCT02688387|101580250|FG009|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509650|NCT02688387|101580251|FG010|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509651|NCT02688387|101580252|FG011|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509652|NCT02688387|101580253|FG012|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509653|NCT02688387|101580254|FG013|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509654|NCT02688387|101580255|FG014|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509655|NCT02688387|101580256|FG015|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509656|NCT02688387|101580257|FG016|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509657|NCT02688387|101580258|FG017|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509658|NCT02688387|101580259|FG018|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48065287|NCT01254292|100479654|FG001|STARTED|LCS12 Extension Phase||0||
48065288|NCT01254292|100479653|FG000|COMPLETED|LCS12 Extension Phase||163||
48065289|NCT01254292|100479654|FG001|COMPLETED|LCS12 Extension Phase||0||
48065290|NCT01254292|100479653|FG000|NOT COMPLETED|LCS12 Extension Phase||37||
48065291|NCT01254292|100479654|FG001|NOT COMPLETED|LCS12 Extension Phase||0||
48065292|NCT02664545|100479655|FG000|STARTED|Overall Study||65||
48065293|NCT02664545|100479656|FG001|STARTED|Overall Study||35||
48065294|NCT02664545|100479655|FG000|Surgery|Overall Study||65||
48509659|NCT02688387|101580260|FG019|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48065295|NCT02664545|100479656|FG001|Surgery|Overall Study||35||
48218646|NCT03122236|100860349|FG000|STARTED|Overall Study||7||
48218647|NCT03122236|100860350|FG001|STARTED|Overall Study||6||
48065296|NCT02664545|100479655|FG000|COMPLETED|Overall Study||58|Completed 2-year Primary Endpoint.|
48509660|NCT02688387|101580261|FG020|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509661|NCT02688387|101580262|FG021|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
48509662|NCT02688387|101580241|FG000|STARTED|Part 2, Washout Period 2 (10 Days)||0||
48509663|NCT02688387|101580242|FG001|STARTED|Part 2, Washout Period 2 (10 Days)||0||
48509664|NCT02688387|101580243|FG002|STARTED|Part 2, Washout Period 2 (10 Days)||0||
48509665|NCT02688387|101580244|FG003|STARTED|Part 2, Washout Period 2 (10 Days)||0||
48509666|NCT02688387|101580245|FG004|STARTED|Part 2, Washout Period 2 (10 Days)||0||
48509667|NCT02688387|101580246|FG005|STARTED|Part 2, Washout Period 2 (10 Days)||0||
48509668|NCT02688387|101580247|FG006|STARTED|Part 2, Washout Period 2 (10 Days)||0||
48509669|NCT02688387|101580248|FG007|STARTED|Part 2, Washout Period 2 (10 Days)||0||
48509670|NCT02688387|101580249|FG008|STARTED|Part 2, Washout Period 2 (10 Days)||0||
48509671|NCT02688387|101580250|FG009|STARTED|Part 2, Washout Period 2 (10 Days)||0||
48509672|NCT02688387|101580251|FG010|STARTED|Part 2, Washout Period 2 (10 Days)||5||
48509673|NCT02688387|101580252|FG011|STARTED|Part 2, Washout Period 2 (10 Days)||5||
48509674|NCT02688387|101580253|FG012|STARTED|Part 2, Washout Period 2 (10 Days)||5||
48509675|NCT02688387|101580254|FG013|STARTED|Part 2, Washout Period 2 (10 Days)||5||
48509676|NCT02688387|101580255|FG014|STARTED|Part 2, Washout Period 2 (10 Days)||0||
48509677|NCT02688387|101580256|FG015|STARTED|Part 2, Washout Period 2 (10 Days)||0||
48509678|NCT02688387|101580257|FG016|STARTED|Part 2, Washout Period 2 (10 Days)||0||
48509679|NCT02688387|101580258|FG017|STARTED|Part 2, Washout Period 2 (10 Days)||0||
48509680|NCT02688387|101580259|FG018|STARTED|Part 2, Washout Period 2 (10 Days)||0||
48509681|NCT02688387|101580260|FG019|STARTED|Part 2, Washout Period 2 (10 Days)||0||
48509682|NCT02688387|101580261|FG020|STARTED|Part 2, Washout Period 2 (10 Days)||0||
48509683|NCT02688387|101580262|FG021|STARTED|Part 2, Washout Period 2 (10 Days)||0||
48509684|NCT02688387|101580241|FG000|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509685|NCT02688387|101580242|FG001|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509686|NCT02688387|101580243|FG002|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509687|NCT02688387|101580244|FG003|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509688|NCT02688387|101580245|FG004|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509689|NCT02688387|101580246|FG005|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509690|NCT02688387|101580247|FG006|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509691|NCT02688387|101580248|FG007|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509692|NCT02688387|101580249|FG008|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509693|NCT02688387|101580250|FG009|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509694|NCT02688387|101580251|FG010|COMPLETED|Part 2, Washout Period 2 (10 Days)||5||
48509695|NCT02688387|101580252|FG011|COMPLETED|Part 2, Washout Period 2 (10 Days)||5||
48509696|NCT02688387|101580253|FG012|COMPLETED|Part 2, Washout Period 2 (10 Days)||5||
48509697|NCT02688387|101580254|FG013|COMPLETED|Part 2, Washout Period 2 (10 Days)||5||
48509698|NCT02688387|101580255|FG014|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509699|NCT02688387|101580256|FG015|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509700|NCT02688387|101580257|FG016|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509701|NCT02688387|101580258|FG017|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509702|NCT02688387|101580259|FG018|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509703|NCT02688387|101580260|FG019|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509704|NCT02688387|101580261|FG020|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509705|NCT02688387|101580262|FG021|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509706|NCT02688387|101580241|FG000|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509707|NCT02688387|101580242|FG001|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509708|NCT02688387|101580243|FG002|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509709|NCT02688387|101580244|FG003|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509710|NCT02688387|101580245|FG004|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509711|NCT02688387|101580246|FG005|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509712|NCT02688387|101580247|FG006|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509713|NCT02688387|101580248|FG007|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509714|NCT02688387|101580249|FG008|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509715|NCT02688387|101580250|FG009|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509716|NCT02688387|101580251|FG010|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509717|NCT02688387|101580252|FG011|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509718|NCT02688387|101580253|FG012|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509719|NCT02688387|101580254|FG013|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509720|NCT02688387|101580255|FG014|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509721|NCT02688387|101580256|FG015|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509722|NCT02688387|101580257|FG016|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509723|NCT02688387|101580258|FG017|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509724|NCT02688387|101580259|FG018|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509725|NCT02688387|101580260|FG019|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509726|NCT02688387|101580261|FG020|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509727|NCT02688387|101580262|FG021|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
48509728|NCT02688387|101580241|FG000|STARTED|Part 2, Period 3 (up to 6 Days)||0||
48509729|NCT02688387|101580242|FG001|STARTED|Part 2, Period 3 (up to 6 Days)||0||
48509730|NCT02688387|101580243|FG002|STARTED|Part 2, Period 3 (up to 6 Days)||0||
48509731|NCT02688387|101580244|FG003|STARTED|Part 2, Period 3 (up to 6 Days)||0||
48509732|NCT02688387|101580245|FG004|STARTED|Part 2, Period 3 (up to 6 Days)||0||
48509733|NCT02688387|101580246|FG005|STARTED|Part 2, Period 3 (up to 6 Days)||0||
48509734|NCT02688387|101580247|FG006|STARTED|Part 2, Period 3 (up to 6 Days)||0||
48509735|NCT02688387|101580248|FG007|STARTED|Part 2, Period 3 (up to 6 Days)||0||
48509736|NCT02688387|101580249|FG008|STARTED|Part 2, Period 3 (up to 6 Days)||0||
48509737|NCT02688387|101580250|FG009|STARTED|Part 2, Period 3 (up to 6 Days)||0||
48509738|NCT02688387|101580251|FG010|STARTED|Part 2, Period 3 (up to 6 Days)||5||
48509739|NCT02688387|101580252|FG011|STARTED|Part 2, Period 3 (up to 6 Days)||5||
48509740|NCT02688387|101580253|FG012|STARTED|Part 2, Period 3 (up to 6 Days)||5||
48509741|NCT02688387|101580254|FG013|STARTED|Part 2, Period 3 (up to 6 Days)||5||
48509742|NCT02688387|101580255|FG014|STARTED|Part 2, Period 3 (up to 6 Days)||0||
48509743|NCT02688387|101580256|FG015|STARTED|Part 2, Period 3 (up to 6 Days)||0||
48509744|NCT02688387|101580257|FG016|STARTED|Part 2, Period 3 (up to 6 Days)||0||
48509745|NCT02688387|101580258|FG017|STARTED|Part 2, Period 3 (up to 6 Days)||0||
48509746|NCT02688387|101580259|FG018|STARTED|Part 2, Period 3 (up to 6 Days)||0||
48509747|NCT02688387|101580260|FG019|STARTED|Part 2, Period 3 (up to 6 Days)||0||
48509748|NCT02688387|101580261|FG020|STARTED|Part 2, Period 3 (up to 6 Days)||0||
48509749|NCT02688387|101580262|FG021|STARTED|Part 2, Period 3 (up to 6 Days)||0||
48509750|NCT02688387|101580241|FG000|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48509751|NCT02688387|101580242|FG001|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48509752|NCT02688387|101580243|FG002|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48065297|NCT02664545|100479656|FG001|COMPLETED|Overall Study||32|Completed 2-year Primary Endpoint.|
48065298|NCT02664545|100479655|FG000|NOT COMPLETED|Overall Study||7||
48065299|NCT02664545|100479656|FG001|NOT COMPLETED|Overall Study||3||
48065300|NCT01561378|100479657|FG000|STARTED|Overall Study||11||
48065301|NCT01561378|100479658|FG001|STARTED|Overall Study||11||
48065302|NCT01561378|100479657|FG000|COMPLETED|Overall Study||11||
48065303|NCT01561378|100479658|FG001|COMPLETED|Overall Study||11||
48065304|NCT01561378|100479657|FG000|NOT COMPLETED|Overall Study||0||
48065305|NCT01561378|100479658|FG001|NOT COMPLETED|Overall Study||0||
48065306|NCT02905149|100479659|FG000|STARTED|Overall Study||30||
48065307|NCT02905149|100479660|FG001|STARTED|Overall Study||30||
48065308|NCT02905149|100479659|FG000|COMPLETED|Overall Study||28||
48065309|NCT02905149|100479660|FG001|COMPLETED|Overall Study||30||
48065310|NCT02905149|100479659|FG000|NOT COMPLETED|Overall Study||2||
48065311|NCT02905149|100479660|FG001|NOT COMPLETED|Overall Study||0||
48065312|NCT02186873|100482393|FG000|STARTED|Overall Study||103||
48065313|NCT02186873|100482394|FG001|STARTED|Overall Study||105||
48065314|NCT02186873|100482393|FG000|End of Control Period|Overall Study||99||
48065315|NCT02186873|100482394|FG001|End of Control Period|Overall Study||105||
48065316|NCT02186873|100482393|FG000|COMPLETED|Overall Study||94||
48065317|NCT02186873|100482394|FG001|COMPLETED|Overall Study||97||
48065318|NCT02186873|100482393|FG000|NOT COMPLETED|Overall Study||9||
48065319|NCT02186873|100482394|FG001|NOT COMPLETED|Overall Study||8||
48065320|NCT01234831|100482395|FG000|STARTED|Overall Study||261||
48065321|NCT01234831|100482396|FG001|STARTED|Overall Study||202||
48065322|NCT01234831|100482395|FG000|COMPLETED|Overall Study||259||
48065323|NCT01234831|100482396|FG001|COMPLETED|Overall Study||198||
48065324|NCT01234831|100482395|FG000|NOT COMPLETED|Overall Study||2||
48065325|NCT01234831|100482396|FG001|NOT COMPLETED|Overall Study||4||
48065326|NCT03509883|100482397|FG000|STARTED|Initial Treatment||15||
48065327|NCT03509883|100482398|FG001|STARTED|Initial Treatment||15||
48065328|NCT03509883|100482397|FG000|COMPLETED|Initial Treatment||15||
48065329|NCT03509883|100482398|FG001|COMPLETED|Initial Treatment||15||
48065330|NCT03509883|100482397|FG000|NOT COMPLETED|Initial Treatment||0||
48065331|NCT03509883|100482398|FG001|NOT COMPLETED|Initial Treatment||0||
48065332|NCT03509883|100482397|FG000|STARTED|Initial Treatment Washout||15||
48065333|NCT03509883|100482398|FG001|STARTED|Initial Treatment Washout||15||
48065334|NCT03509883|100482397|FG000|COMPLETED|Initial Treatment Washout||15||
48065335|NCT03509883|100482398|FG001|COMPLETED|Initial Treatment Washout||15||
48065336|NCT03509883|100482397|FG000|NOT COMPLETED|Initial Treatment Washout||0||
48065337|NCT03509883|100482398|FG001|NOT COMPLETED|Initial Treatment Washout||0||
48065338|NCT03509883|100482397|FG000|STARTED|Cross-over and Treatment||15||
48065339|NCT03509883|100482398|FG001|STARTED|Cross-over and Treatment||15||
48065340|NCT03509883|100482397|FG000|COMPLETED|Cross-over and Treatment||15||
48065341|NCT03509883|100482398|FG001|COMPLETED|Cross-over and Treatment||15||
48065342|NCT03509883|100482397|FG000|NOT COMPLETED|Cross-over and Treatment||0||
48065343|NCT03509883|100482398|FG001|NOT COMPLETED|Cross-over and Treatment||0||
48065344|NCT02640573|100482399|FG000|STARTED|Overall Study||1||
48065345|NCT02640573|100482399|FG000|COMPLETED|Overall Study||0||
48509753|NCT02688387|101580244|FG003|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48509754|NCT02688387|101580245|FG004|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48065346|NCT02640573|100482399|FG000|NOT COMPLETED|Overall Study||1||
48065347|NCT00808483|100482400|FG000|STARTED|From 3 to 5 Months After Surgery||35||
48065348|NCT00808483|100482401|FG001|STARTED|From 3 to 5 Months After Surgery||33||
48065349|NCT00808483|100482400|FG000|COMPLETED|From 3 to 5 Months After Surgery||33||
48065350|NCT00808483|100482401|FG001|COMPLETED|From 3 to 5 Months After Surgery||32||
48065351|NCT00808483|100482400|FG000|NOT COMPLETED|From 3 to 5 Months After Surgery||2||
48065352|NCT00808483|100482401|FG001|NOT COMPLETED|From 3 to 5 Months After Surgery||1||
48065353|NCT00808483|100482400|FG000|STARTED|From 5 Months to 12 Months||33||
48065354|NCT00808483|100482401|FG001|STARTED|From 5 Months to 12 Months||32||
48065355|NCT00808483|100482400|FG000|COMPLETED|From 5 Months to 12 Months||32||
48065356|NCT00808483|100482401|FG001|COMPLETED|From 5 Months to 12 Months||32||
48065357|NCT00808483|100482400|FG000|NOT COMPLETED|From 5 Months to 12 Months||1||
48065358|NCT00808483|100482401|FG001|NOT COMPLETED|From 5 Months to 12 Months||0||
48065359|NCT02019277|100482402|FG000|STARTED|Overall Study||50||
48065360|NCT02019277|100482402|FG000|COMPLETED|Overall Study||38||
48065361|NCT02019277|100482402|FG000|NOT COMPLETED|Overall Study||12||
48065362|NCT05438888|100482403|FG000|STARTED|Overall Study||39936||
48065363|NCT05438888|100482404|FG001|STARTED|Overall Study||37878||
48065364|NCT05438888|100482403|FG000|COMPLETED|Overall Study||39936||
48065365|NCT05438888|100482404|FG001|COMPLETED|Overall Study||37878||
48065366|NCT05438888|100482403|FG000|NOT COMPLETED|Overall Study||0||
48065367|NCT05438888|100482404|FG001|NOT COMPLETED|Overall Study||0||
48065368|NCT00968890|100482405|FG000|STARTED|Overall Study||84||
48065369|NCT00968890|100482406|FG001|STARTED|Overall Study||84||
48065370|NCT00968890|100482405|FG000|COMPLETED|Overall Study||84||
48065371|NCT00968890|100482406|FG001|COMPLETED|Overall Study||84||
48065372|NCT00968890|100482405|FG000|NOT COMPLETED|Overall Study||0||
48065373|NCT00968890|100482406|FG001|NOT COMPLETED|Overall Study||0||
48065374|NCT03039192|100482407|FG000|STARTED|Overall Study||112||
48065375|NCT03039192|100482408|FG001|STARTED|Overall Study||114||
48065376|NCT03039192|100482407|FG000|Treated|Overall Study||112||
48065377|NCT03039192|100482408|FG001|Treated|Overall Study||113||
48065378|NCT03039192|100482407|FG000|COMPLETED|Overall Study||80||
48065379|NCT03039192|100482408|FG001|COMPLETED|Overall Study||84||
48065380|NCT03039192|100482407|FG000|NOT COMPLETED|Overall Study||32||
48065381|NCT03039192|100482408|FG001|NOT COMPLETED|Overall Study||30||
48065382|NCT02219438|100482409|FG000|STARTED|Overall Study||13||
48065383|NCT02219438|100482410|FG001|STARTED|Overall Study||11||
48065384|NCT02219438|100482409|FG000|COMPLETED|Overall Study||13||
48065385|NCT02219438|100482410|FG001|COMPLETED|Overall Study||11||
48065386|NCT02219438|100482409|FG000|NOT COMPLETED|Overall Study||0||
48065387|NCT02219438|100482410|FG001|NOT COMPLETED|Overall Study||0||
48065388|NCT00895232|100482411|FG000|STARTED|Overall Study||7||
48065389|NCT00895232|100482412|FG001|STARTED|Overall Study||6||
48065390|NCT00895232|100482413|FG002|STARTED|Overall Study||8||
48065391|NCT00895232|100482411|FG000|COMPLETED|Overall Study||4||
48065392|NCT00895232|100482412|FG001|COMPLETED|Overall Study||2||
48065393|NCT00895232|100482413|FG002|COMPLETED|Overall Study||3||
48065394|NCT00895232|100482411|FG000|NOT COMPLETED|Overall Study||3||
48065395|NCT00895232|100482412|FG001|NOT COMPLETED|Overall Study||4||
48065396|NCT00895232|100482413|FG002|NOT COMPLETED|Overall Study||5||
48065397|NCT00631696|100482414|FG000|STARTED|Overall Study||112||
48065398|NCT00631696|100482415|FG001|STARTED|Overall Study||110||
48065399|NCT00631696|100482414|FG000|Received Study Treatment (Tx)|Overall Study||111||
48065400|NCT00631696|100482415|FG001|Received Study Treatment (Tx)|Overall Study||109||
48065401|NCT00631696|100482414|FG000|Ongoing at Database Release 18Oct2011|Overall Study||2||
48065402|NCT00631696|100482415|FG001|Ongoing at Database Release 18Oct2011|Overall Study||0||
48065403|NCT00631696|100482414|FG000|COMPLETED|Overall Study||75||
48065404|NCT00631696|100482415|FG001|COMPLETED|Overall Study||70||
48065405|NCT00631696|100482414|FG000|NOT COMPLETED|Overall Study||37||
48065406|NCT00631696|100482415|FG001|NOT COMPLETED|Overall Study||40||
48065407|NCT02639546|100482416|FG000|STARTED|Overall Study||6||
48065408|NCT02639546|100482417|FG001|STARTED|Overall Study||6||
48065409|NCT02639546|100482418|FG002|STARTED|Overall Study||6||
48065410|NCT02639546|100482419|FG003|STARTED|Overall Study||6||
48065411|NCT02639546|100482420|FG004|STARTED|Overall Study||7||
48065412|NCT02639546|100482421|FG005|STARTED|Overall Study||8||
48065413|NCT02639546|100482422|FG006|STARTED|Overall Study||5||
48065414|NCT02639546|100482423|FG007|STARTED|Overall Study||12||
48065415|NCT02639546|100482416|FG000|Tumor Type - Neuroblastoma|Overall Study||0||
48065416|NCT02639546|100482417|FG001|Tumor Type - Neuroblastoma|Overall Study||0||
48065417|NCT02639546|100482418|FG002|Tumor Type - Neuroblastoma|Overall Study||1||
48065418|NCT02639546|100482419|FG003|Tumor Type - Neuroblastoma|Overall Study||0||
48065419|NCT02639546|100482420|FG004|Tumor Type - Neuroblastoma|Overall Study||0||
48065420|NCT02639546|100482421|FG005|Tumor Type - Neuroblastoma|Overall Study||0||
48065421|NCT02639546|100482422|FG006|Tumor Type - Neuroblastoma|Overall Study||0||
48065422|NCT02639546|100482423|FG007|Tumor Type - Neuroblastoma|Overall Study||0||
48065423|NCT02639546|100482416|FG000|Tumor Type - High-Grade Glioma|Overall Study||3||
48065424|NCT02639546|100482417|FG001|Tumor Type - High-Grade Glioma|Overall Study||1||
48065425|NCT02639546|100482418|FG002|Tumor Type - High-Grade Glioma|Overall Study||0||
48065426|NCT02639546|100482419|FG003|Tumor Type - High-Grade Glioma|Overall Study||0||
48065427|NCT02639546|100482420|FG004|Tumor Type - High-Grade Glioma|Overall Study||1||
48065428|NCT02639546|100482421|FG005|Tumor Type - High-Grade Glioma|Overall Study||0||
48065429|NCT02639546|100482422|FG006|Tumor Type - High-Grade Glioma|Overall Study||0||
48065430|NCT02639546|100482423|FG007|Tumor Type - High-Grade Glioma|Overall Study||0||
48065431|NCT02639546|100482416|FG000|Tumor Type - Low-Grade Glioma|Overall Study||1||
48065432|NCT02639546|100482417|FG001|Tumor Type - Low-Grade Glioma|Overall Study||2||
48065433|NCT02639546|100482418|FG002|Tumor Type - Low-Grade Glioma|Overall Study||4||
48065434|NCT02639546|100482419|FG003|Tumor Type - Low-Grade Glioma|Overall Study||5||
48065435|NCT02639546|100482420|FG004|Tumor Type - Low-Grade Glioma|Overall Study||3||
48065436|NCT02639546|100482421|FG005|Tumor Type - Low-Grade Glioma|Overall Study||2||
48065437|NCT02639546|100482422|FG006|Tumor Type - Low-Grade Glioma|Overall Study||3||
48065438|NCT02639546|100482423|FG007|Tumor Type - Low-Grade Glioma|Overall Study||12||
48065439|NCT02639546|100482416|FG000|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0||
48065440|NCT02639546|100482417|FG001|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0||
48065441|NCT02639546|100482418|FG002|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0||
48065442|NCT02639546|100482419|FG003|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0||
48065443|NCT02639546|100482420|FG004|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0||
48065444|NCT02639546|100482421|FG005|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0||
48065445|NCT02639546|100482422|FG006|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||1||
48065446|NCT02639546|100482423|FG007|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0||
48065447|NCT02639546|100482416|FG000|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0||
48065448|NCT02639546|100482417|FG001|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0||
48065449|NCT02639546|100482418|FG002|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0||
48065450|NCT02639546|100482419|FG003|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0||
48065451|NCT02639546|100482420|FG004|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||1||
48065452|NCT02639546|100482421|FG005|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||1||
48065453|NCT02639546|100482422|FG006|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0||
48065454|NCT02639546|100482423|FG007|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0||
48065455|NCT02639546|100482416|FG000|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||1||
48065456|NCT02639546|100482417|FG001|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0||
48065457|NCT02639546|100482418|FG002|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0||
48065458|NCT02639546|100482419|FG003|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0||
48065459|NCT02639546|100482420|FG004|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0||
48065460|NCT02639546|100482421|FG005|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0||
48065461|NCT02639546|100482422|FG006|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0||
48065462|NCT02639546|100482423|FG007|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0||
48065463|NCT02639546|100482416|FG000|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0||
48065464|NCT02639546|100482417|FG001|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||1||
48065465|NCT02639546|100482418|FG002|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0||
48065466|NCT02639546|100482419|FG003|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0||
48065467|NCT02639546|100482420|FG004|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0||
48065468|NCT02639546|100482421|FG005|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0||
48065469|NCT02639546|100482422|FG006|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0||
48065470|NCT02639546|100482423|FG007|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0||
48065471|NCT02639546|100482416|FG000|Tumor Type - Plexiform Neurofibroma|Overall Study||1||
48065472|NCT02639546|100482417|FG001|Tumor Type - Plexiform Neurofibroma|Overall Study||2||
48065473|NCT02639546|100482418|FG002|Tumor Type - Plexiform Neurofibroma|Overall Study||1||
48065474|NCT02639546|100482419|FG003|Tumor Type - Plexiform Neurofibroma|Overall Study||1||
48065475|NCT02639546|100482420|FG004|Tumor Type - Plexiform Neurofibroma|Overall Study||2||
48065476|NCT02639546|100482421|FG005|Tumor Type - Plexiform Neurofibroma|Overall Study||4||
48065477|NCT02639546|100482422|FG006|Tumor Type - Plexiform Neurofibroma|Overall Study||1||
48065478|NCT02639546|100482423|FG007|Tumor Type - Plexiform Neurofibroma|Overall Study||0||
48065479|NCT02639546|100482416|FG000|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0||
48065480|NCT02639546|100482417|FG001|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0||
48065481|NCT02639546|100482418|FG002|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0||
48065482|NCT02639546|100482419|FG003|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0||
48065483|NCT02639546|100482420|FG004|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0||
48065484|NCT02639546|100482421|FG005|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||1||
48065485|NCT02639546|100482422|FG006|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0||
48065486|NCT02639546|100482423|FG007|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0||
48065487|NCT02639546|100482416|FG000|COMPLETED|Overall Study||0||
48065488|NCT02639546|100482417|FG001|COMPLETED|Overall Study||0||
48065489|NCT02639546|100482418|FG002|COMPLETED|Overall Study||0||
48065490|NCT02639546|100482419|FG003|COMPLETED|Overall Study||0||
48065491|NCT02639546|100482420|FG004|COMPLETED|Overall Study||0||
48065492|NCT02639546|100482421|FG005|COMPLETED|Overall Study||0||
48065493|NCT02639546|100482422|FG006|COMPLETED|Overall Study||0||
48065494|NCT02639546|100482423|FG007|COMPLETED|Overall Study||0||
48065495|NCT02639546|100482416|FG000|NOT COMPLETED|Overall Study||6||
48065496|NCT02639546|100482417|FG001|NOT COMPLETED|Overall Study||6||
48065497|NCT02639546|100482418|FG002|NOT COMPLETED|Overall Study||6||
48065498|NCT02639546|100482419|FG003|NOT COMPLETED|Overall Study||6||
48065499|NCT02639546|100482420|FG004|NOT COMPLETED|Overall Study||7||
48065500|NCT02639546|100482421|FG005|NOT COMPLETED|Overall Study||8||
48065501|NCT02639546|100482422|FG006|NOT COMPLETED|Overall Study||5||
48065502|NCT02639546|100482423|FG007|NOT COMPLETED|Overall Study||12||
48065503|NCT03855228|100482424|FG000|STARTED|Overall Study||169||
48065504|NCT03855228|100482425|FG001|STARTED|Overall Study||176||
48065505|NCT03855228|100482426|FG002|STARTED|Overall Study||182||
48065506|NCT03855228|100482427|FG003|STARTED|Overall Study||177||
48065507|NCT03855228|100482424|FG000|Treated|Overall Study||169||
48065508|NCT03855228|100482425|FG001|Treated|Overall Study||176||
48065509|NCT03855228|100482426|FG002|Treated|Overall Study||181||
48065510|NCT03855228|100482427|FG003|Treated|Overall Study||176||
48065511|NCT03855228|100482424|FG000|COMPLETED|Overall Study||166||
48065512|NCT03855228|100482425|FG001|COMPLETED|Overall Study||167||
48065513|NCT03855228|100482426|FG002|COMPLETED|Overall Study||174||
48065514|NCT03855228|100482427|FG003|COMPLETED|Overall Study||158||
48065515|NCT03855228|100482424|FG000|NOT COMPLETED|Overall Study||3||
48065516|NCT03855228|100482425|FG001|NOT COMPLETED|Overall Study||9||
48065517|NCT03855228|100482426|FG002|NOT COMPLETED|Overall Study||8||
48065518|NCT03855228|100482427|FG003|NOT COMPLETED|Overall Study||19||
48065519|NCT00149734|100482428|FG000|STARTED|Overall Study||4||
48065520|NCT00149734|100482429|FG001|STARTED|Overall Study||4||
48065521|NCT00149734|100482428|FG000|Started Intervention 2|Overall Study||4||
48065522|NCT00149734|100482429|FG001|Started Intervention 2|Overall Study||4||
48065523|NCT00149734|100482428|FG000|COMPLETED|Overall Study||4||
48065524|NCT00149734|100482429|FG001|COMPLETED|Overall Study||4||
48065525|NCT00149734|100482428|FG000|NOT COMPLETED|Overall Study||0||
48065526|NCT00149734|100482429|FG001|NOT COMPLETED|Overall Study||0||
48065527|NCT01212107|100482430|FG000|STARTED|Overall Study||3||
48065528|NCT01212107|100482431|FG001|STARTED|Overall Study||3||
48065529|NCT01212107|100482432|FG002|STARTED|Overall Study||6||
48065530|NCT01212107|100482433|FG003|STARTED|Overall Study||3||
48065531|NCT01212107|100482434|FG004|STARTED|Overall Study||3||
48065532|NCT01212107|100482435|FG005|STARTED|Overall Study||3||
48065533|NCT01212107|100482436|FG006|STARTED|Overall Study||3||
48065534|NCT01212107|100482437|FG007|STARTED|Overall Study||3||
48065535|NCT01212107|100482438|FG008|STARTED|Overall Study||3||
48065536|NCT01212107|100482439|FG009|STARTED|Overall Study||3||
48065537|NCT01212107|100482440|FG010|STARTED|Overall Study||3||
48065538|NCT01212107|100482441|FG011|STARTED|Overall Study||58||
48065539|NCT01212107|100482430|FG000|COMPLETED|Overall Study||2||
48065540|NCT01212107|100482431|FG001|COMPLETED|Overall Study||2||
48065541|NCT01212107|100482432|FG002|COMPLETED|Overall Study||3||
48065542|NCT01212107|100482433|FG003|COMPLETED|Overall Study||3||
48065543|NCT01212107|100482434|FG004|COMPLETED|Overall Study||2||
48065544|NCT01212107|100482435|FG005|COMPLETED|Overall Study||2||
48065545|NCT01212107|100482436|FG006|COMPLETED|Overall Study||3||
48065546|NCT01212107|100482437|FG007|COMPLETED|Overall Study||2||
48065547|NCT01212107|100482438|FG008|COMPLETED|Overall Study||1||
48065548|NCT01212107|100482439|FG009|COMPLETED|Overall Study||1||
48065549|NCT01212107|100482440|FG010|COMPLETED|Overall Study||2||
48065550|NCT01212107|100482441|FG011|COMPLETED|Overall Study||26||
48065551|NCT01212107|100482430|FG000|NOT COMPLETED|Overall Study||1||
48065552|NCT01212107|100482431|FG001|NOT COMPLETED|Overall Study||1||
48065553|NCT01212107|100482432|FG002|NOT COMPLETED|Overall Study||3||
48065554|NCT01212107|100482433|FG003|NOT COMPLETED|Overall Study||0||
48065555|NCT01212107|100482434|FG004|NOT COMPLETED|Overall Study||1||
48065556|NCT01212107|100482435|FG005|NOT COMPLETED|Overall Study||1||
48065557|NCT01212107|100482436|FG006|NOT COMPLETED|Overall Study||0||
48065558|NCT01212107|100482437|FG007|NOT COMPLETED|Overall Study||1||
48065559|NCT01212107|100482438|FG008|NOT COMPLETED|Overall Study||2||
48065560|NCT01212107|100482439|FG009|NOT COMPLETED|Overall Study||2||
48065561|NCT01212107|100482440|FG010|NOT COMPLETED|Overall Study||1||
48065562|NCT01212107|100482441|FG011|NOT COMPLETED|Overall Study||32||
48065563|NCT02717273|100482442|FG000|STARTED|Overall Study||52||
48065564|NCT02717273|100482443|FG001|STARTED|Overall Study||50||
48065565|NCT02717273|100482442|FG000|COMPLETED|Overall Study||49||
48065566|NCT02717273|100482443|FG001|COMPLETED|Overall Study||48||
48065567|NCT02717273|100482442|FG000|NOT COMPLETED|Overall Study||3||
48065568|NCT02717273|100482443|FG001|NOT COMPLETED|Overall Study||2||
48218648|NCT03122236|100860351|FG002|STARTED|Overall Study||7||
48065569|NCT01788046|100482444|FG000|STARTED|Overall Study||260||
48065570|NCT01788046|100482445|FG001|STARTED|Overall Study||255||
48065571|NCT01788046|100482444|FG000|Received Treatment|Overall Study||259||
48065572|NCT01788046|100482445|FG001|Received Treatment|Overall Study||252||
48065573|NCT01788046|100482444|FG000|COMPLETED|Overall Study||204||
48065574|NCT01788046|100482445|FG001|COMPLETED|Overall Study||218||
48065575|NCT01788046|100482444|FG000|NOT COMPLETED|Overall Study||56||
48065576|NCT01788046|100482445|FG001|NOT COMPLETED|Overall Study||37||
48065577|NCT00113087|100482446|FG000|STARTED|Overall Study||115||
48065578|NCT00113087|100482447|FG001|STARTED|Overall Study||115||
48065579|NCT00113087|100482446|FG000|COMPLETED|Overall Study||91||
48065580|NCT00113087|100482447|FG001|COMPLETED|Overall Study||94||
48065581|NCT00113087|100482446|FG000|NOT COMPLETED|Overall Study||24||
48065582|NCT00113087|100482447|FG001|NOT COMPLETED|Overall Study||21||
48065583|NCT01790932|100482448|FG000|STARTED|Overall Study||50||
48065584|NCT01790932|100482448|FG000|COMPLETED|Overall Study||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed'.|
48065585|NCT01790932|100482448|FG000|NOT COMPLETED|Overall Study||50||
48065586|NCT00413244|100482449|FG000|STARTED|Overall Study||31||
48065587|NCT00413244|100482450|FG001|STARTED|Overall Study||20||
48065588|NCT00413244|100482449|FG000|COMPLETED|Overall Study||21||
48065589|NCT00413244|100482450|FG001|COMPLETED|Overall Study||19||
48065590|NCT00413244|100482449|FG000|NOT COMPLETED|Overall Study||10||
48065591|NCT00413244|100482450|FG001|NOT COMPLETED|Overall Study||1||
48065592|NCT00843531|100482451|FG000|STARTED|Overall Study||17||
48065593|NCT00843531|100482451|FG000|COMPLETED|Overall Study||17||
48065594|NCT00843531|100482451|FG000|NOT COMPLETED|Overall Study||0||
48065595|NCT02175628|100482452|FG000|STARTED|Overall Study||6||
48065596|NCT02175628|100482453|FG001|STARTED|Overall Study||17||
48065597|NCT02175628|100482452|FG000|COMPLETED|Overall Study||6||
48065598|NCT02175628|100482453|FG001|COMPLETED|Overall Study||17||
48065599|NCT02175628|100482452|FG000|NOT COMPLETED|Overall Study||0||
48065600|NCT02175628|100482453|FG001|NOT COMPLETED|Overall Study||0||
48065601|NCT03714620|100482454|FG000|STARTED|Overall Study||49||
48065602|NCT03714620|100482455|FG001|STARTED|Overall Study||49||
48065603|NCT03714620|100482454|FG000|COMPLETED|Overall Study||49||
48065604|NCT03714620|100482455|FG001|COMPLETED|Overall Study||49||
48065605|NCT03714620|100482454|FG000|NOT COMPLETED|Overall Study||0||
48065606|NCT03714620|100482455|FG001|NOT COMPLETED|Overall Study||0||
48065607|NCT00676338|100482456|FG000|STARTED|Overall Study||248||
48065608|NCT00676338|100482457|FG001|STARTED|Overall Study||246||
48065609|NCT00676338|100482458|FG002|STARTED|Overall Study||163||
48065610|NCT00676338|100482459|FG003|STARTED|Overall Study||163||
48065611|NCT00676338|100482456|FG000|COMPLETED|Overall Study||210||
48065612|NCT00676338|100482457|FG001|COMPLETED|Overall Study||213||
48065613|NCT00676338|100482458|FG002|COMPLETED|Overall Study||133||
48065614|NCT00676338|100482459|FG003|COMPLETED|Overall Study||140||
48065615|NCT00676338|100482456|FG000|NOT COMPLETED|Overall Study||38||
48065616|NCT00676338|100482457|FG001|NOT COMPLETED|Overall Study||33||
48065617|NCT00676338|100482458|FG002|NOT COMPLETED|Overall Study||30||
48218649|NCT03122236|100860349|FG000|COMPLETED|Overall Study||7||
48218650|NCT03122236|100860350|FG001|COMPLETED|Overall Study||5||
48218651|NCT03122236|100860351|FG002|COMPLETED|Overall Study||6||
48218652|NCT03122236|100860349|FG000|NOT COMPLETED|Overall Study||0||
48065618|NCT00676338|100482459|FG003|NOT COMPLETED|Overall Study||23||
48065619|NCT03896165|100482460|FG000|STARTED|Overall Study||20||
48065620|NCT03896165|100482460|FG000|COMPLETED|Overall Study||18||
48065621|NCT03896165|100482460|FG000|NOT COMPLETED|Overall Study||2||
48065622|NCT02002832|100482461|FG000|STARTED|Overall Study||194||
48065623|NCT02002832|100482462|FG001|STARTED|Overall Study||194||
48065624|NCT02002832|100482461|FG000|COMPLETED|Overall Study||166||
48065625|NCT02002832|100482462|FG001|COMPLETED|Overall Study||168||
48065626|NCT02002832|100482461|FG000|NOT COMPLETED|Overall Study||28||
48065627|NCT02002832|100482462|FG001|NOT COMPLETED|Overall Study||26||
48065628|NCT00423722|100482463|FG000|STARTED|Overall Study||63||
48065629|NCT00423722|100482464|FG001|STARTED|Overall Study||66||
48065630|NCT00423722|100482463|FG000|COMPLETED|Overall Study||49||
48065631|NCT00423722|100482464|FG001|COMPLETED|Overall Study||53||
48065632|NCT00423722|100482463|FG000|NOT COMPLETED|Overall Study||14||
48218653|NCT03122236|100860350|FG001|NOT COMPLETED|Overall Study||1||
48218654|NCT03122236|100860351|FG002|NOT COMPLETED|Overall Study||1||
48218655|NCT01948661|100860352|FG000|STARTED|Overall Study||17||
48218656|NCT01948661|100860353|FG001|STARTED|Overall Study||18||
48218657|NCT01948661|100860352|FG000|COMPLETED|Overall Study||15||
48218658|NCT01948661|100860353|FG001|COMPLETED|Overall Study||14||
48218659|NCT01948661|100860352|FG000|NOT COMPLETED|Overall Study||2||
48218660|NCT01948661|100860353|FG001|NOT COMPLETED|Overall Study||4||
48065633|NCT00423722|100482464|FG001|NOT COMPLETED|Overall Study||13||
48065634|NCT00289016|100482465|FG000|STARTED|Overall Study||50||
48065635|NCT00289016|100482465|FG000|COMPLETED|Overall Study||13||
48065636|NCT00289016|100482465|FG000|NOT COMPLETED|Overall Study||37||
48065637|NCT03330288|100482466|FG000|STARTED|Overall Study||824||
48065638|NCT03330288|100482467|FG001|STARTED|Overall Study||278||
48065639|NCT03330288|100482466|FG000|COMPLETED|Overall Study||794||
48065640|NCT03330288|100482467|FG001|COMPLETED|Overall Study||270||
48065641|NCT03330288|100482466|FG000|NOT COMPLETED|Overall Study||30||
48065642|NCT03330288|100482467|FG001|NOT COMPLETED|Overall Study||8||
48065643|NCT01967342|100482468|FG000|STARTED|Overall Study||98||
48065644|NCT01967342|100482469|FG001|STARTED|Overall Study||95||
48065645|NCT01967342|100482470|FG002|STARTED|Overall Study||97||
48065646|NCT01967342|100482468|FG000|5-week Follow-up|Overall Study||83||
48065647|NCT01967342|100482469|FG001|5-week Follow-up|Overall Study||78||
48065648|NCT01967342|100482470|FG002|5-week Follow-up|Overall Study||76||
48065649|NCT01967342|100482468|FG000|10-week Follow-up|Overall Study||78||
48065650|NCT01967342|100482469|FG001|10-week Follow-up|Overall Study||83||
48065651|NCT01967342|100482470|FG002|10-week Follow-up|Overall Study||80||
48065652|NCT01967342|100482468|FG000|COMPLETED|Overall Study||71|6-month follow-up|
48065653|NCT01967342|100482469|FG001|COMPLETED|Overall Study||70|6-month follow-up|
48065654|NCT01967342|100482470|FG002|COMPLETED|Overall Study||68|6-month follow-up|
48065655|NCT01967342|100482468|FG000|NOT COMPLETED|Overall Study||27||
48065656|NCT01967342|100482469|FG001|NOT COMPLETED|Overall Study||25||
48065657|NCT01967342|100482470|FG002|NOT COMPLETED|Overall Study||29||
48065658|NCT00961649|100482471|FG000|STARTED|Overall Study||41||
48065659|NCT00961649|100482472|FG001|STARTED|Overall Study||44||
48065660|NCT00961649|100482473|FG002|STARTED|Overall Study||44||
48065661|NCT00961649|100482474|FG003|STARTED|Overall Study||41||
48509755|NCT02688387|101580246|FG005|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48509756|NCT02688387|101580247|FG006|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48509757|NCT02688387|101580248|FG007|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48509758|NCT02688387|101580249|FG008|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48509759|NCT02688387|101580250|FG009|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48065662|NCT00961649|100482471|FG000|COMPLETED|Overall Study||32||
48065663|NCT00961649|100482472|FG001|COMPLETED|Overall Study||40||
48065664|NCT00961649|100482473|FG002|COMPLETED|Overall Study||39||
48065665|NCT00961649|100482474|FG003|COMPLETED|Overall Study||37||
48065666|NCT00961649|100482471|FG000|NOT COMPLETED|Overall Study||9||
48065667|NCT00961649|100482472|FG001|NOT COMPLETED|Overall Study||4||
48065668|NCT00961649|100482473|FG002|NOT COMPLETED|Overall Study||5||
48218661|NCT00692185|100860354|FG000|STARTED|Overall Study||11||
48065669|NCT00961649|100482474|FG003|NOT COMPLETED|Overall Study||4||
48065670|NCT03546062|100482475|FG000|STARTED|Overall Study||41||
48065671|NCT03546062|100482476|FG001|STARTED|Overall Study||46||
48065672|NCT03546062|100482477|FG002|STARTED|Overall Study||90||
48065673|NCT03546062|100482475|FG000|COMPLETED|Overall Study||35||
48065674|NCT03546062|100482476|FG001|COMPLETED|Overall Study||41||
48065675|NCT03546062|100482477|FG002|COMPLETED|Overall Study||82||
48065676|NCT03546062|100482475|FG000|NOT COMPLETED|Overall Study||6||
48065677|NCT03546062|100482476|FG001|NOT COMPLETED|Overall Study||5||
48065678|NCT03546062|100482477|FG002|NOT COMPLETED|Overall Study||8||
48065679|NCT00621959|100482478|FG000|STARTED|Overall Study||295||
48065680|NCT00621959|100482479|FG001|STARTED|Overall Study||301||
48065681|NCT00621959|100482478|FG000|COMPLETED|Overall Study||288||
48065682|NCT00621959|100482479|FG001|COMPLETED|Overall Study||292||
48065683|NCT00621959|100482478|FG000|NOT COMPLETED|Overall Study||7||
48065684|NCT00621959|100482479|FG001|NOT COMPLETED|Overall Study||9||
48065685|NCT02833350|100482480|FG000|STARTED|Overall Study||40|SAF population|
48065686|NCT02833350|100482481|FG001|STARTED|Overall Study||109|SAF population|
48065687|NCT02833350|100482482|FG002|STARTED|Overall Study||110|SAF population|
48065688|NCT02833350|100482483|FG003|STARTED|Overall Study||110|SAF population|
48065689|NCT02833350|100482484|FG004|STARTED|Overall Study||111|SAF population|
48065690|NCT02833350|100482485|FG005|STARTED|Overall Study||49|SAF population|
48065691|NCT02833350|100482486|FG006|STARTED|Overall Study||49|SAF population|
48065692|NCT02833350|100482480|FG000|Randomized|Overall Study||40|ITT population|
48065693|NCT02833350|100482481|FG001|Randomized|Overall Study||109|ITT population|
48065694|NCT02833350|100482482|FG002|Randomized|Overall Study||110|ITT population|
48065695|NCT02833350|100482483|FG003|Randomized|Overall Study||110|ITT population|
48065696|NCT02833350|100482484|FG004|Randomized|Overall Study||111|ITT population|
48065697|NCT02833350|100482485|FG005|Randomized|Overall Study||48|ITT population|
48065698|NCT02833350|100482486|FG006|Randomized|Overall Study||50|ITT population|
48065699|NCT02833350|100482480|FG000|COMPLETED|Overall Study||37||
48065700|NCT02833350|100482481|FG001|COMPLETED|Overall Study||100||
48065701|NCT02833350|100482482|FG002|COMPLETED|Overall Study||102||
48065702|NCT02833350|100482483|FG003|COMPLETED|Overall Study||102||
48065703|NCT02833350|100482484|FG004|COMPLETED|Overall Study||108||
48065704|NCT02833350|100482485|FG005|COMPLETED|Overall Study||48||
48065705|NCT02833350|100482486|FG006|COMPLETED|Overall Study||44||
48065706|NCT02833350|100482480|FG000|NOT COMPLETED|Overall Study||3||
48065707|NCT02833350|100482481|FG001|NOT COMPLETED|Overall Study||9||
48065708|NCT02833350|100482482|FG002|NOT COMPLETED|Overall Study||8||
48218662|NCT00692185|100860355|FG001|STARTED|Overall Study||12||
48218663|NCT00692185|100860354|FG000|COMPLETED|Overall Study||8||
48065709|NCT02833350|100482483|FG003|NOT COMPLETED|Overall Study||8||
48065710|NCT02833350|100482484|FG004|NOT COMPLETED|Overall Study||3||
48065711|NCT02833350|100482485|FG005|NOT COMPLETED|Overall Study||1||
48065712|NCT02833350|100482486|FG006|NOT COMPLETED|Overall Study||5||
48065713|NCT01858376|100482487|FG000|STARTED|Overall Study||24||
48065714|NCT01858376|100482487|FG000|COMPLETED|Overall Study||20||
48065715|NCT01858376|100482487|FG000|NOT COMPLETED|Overall Study||4||
48065716|NCT04032652|100482488|FG000|STARTED|Overall Study||1||
48065717|NCT04032652|100482489|FG001|STARTED|Overall Study||1||
48065718|NCT04032652|100482488|FG000|COMPLETED|Overall Study||0||
48065719|NCT04032652|100482489|FG001|COMPLETED|Overall Study||0||
48065720|NCT04032652|100482488|FG000|NOT COMPLETED|Overall Study||1||
48065721|NCT04032652|100482489|FG001|NOT COMPLETED|Overall Study||1||
48065722|NCT01457573|100482490|FG000|STARTED|Overall Study||10||
48065723|NCT01457573|100482490|FG000|COMPLETED|Overall Study||10||
48065724|NCT01457573|100482490|FG000|NOT COMPLETED|Overall Study||0||
48065725|NCT02949700|100482491|FG000|STARTED|Phase I||9||
48065726|NCT02949700|100482492|FG001|STARTED|Phase I||3||
48065727|NCT02949700|100482493|FG002|STARTED|Phase I||0||
48065728|NCT02949700|100482494|FG003|STARTED|Phase I||0||
48065729|NCT02949700|100482491|FG000|COMPLETED|Phase I||7||
48065730|NCT02949700|100482492|FG001|COMPLETED|Phase I||2||
48065731|NCT02949700|100482493|FG002|COMPLETED|Phase I||0||
48065732|NCT02949700|100482494|FG003|COMPLETED|Phase I||0||
48065733|NCT02949700|100482491|FG000|NOT COMPLETED|Phase I||2||
48065734|NCT02949700|100482492|FG001|NOT COMPLETED|Phase I||1||
48065735|NCT02949700|100482493|FG002|NOT COMPLETED|Phase I||0||
48065736|NCT02949700|100482494|FG003|NOT COMPLETED|Phase I||0||
48065737|NCT02949700|100482491|FG000|STARTED|Phase II||0||
48065738|NCT02949700|100482492|FG001|STARTED|Phase II||0||
48065739|NCT02949700|100482493|FG002|STARTED|Phase II||1||
48065740|NCT02949700|100482494|FG003|STARTED|Phase II||12||
48065741|NCT02949700|100482491|FG000|COMPLETED|Phase II||0||
48065742|NCT02949700|100482492|FG001|COMPLETED|Phase II||0||
48065743|NCT02949700|100482493|FG002|COMPLETED|Phase II||0||
48065744|NCT02949700|100482494|FG003|COMPLETED|Phase II||7||
48065745|NCT02949700|100482491|FG000|NOT COMPLETED|Phase II||0||
48218664|NCT00692185|100860355|FG001|COMPLETED|Overall Study||9||
48218665|NCT00692185|100860354|FG000|NOT COMPLETED|Overall Study||3||
48065746|NCT02949700|100482492|FG001|NOT COMPLETED|Phase II||0||
48065747|NCT02949700|100482493|FG002|NOT COMPLETED|Phase II||1||
48218666|NCT00692185|100860355|FG001|NOT COMPLETED|Overall Study||3||
48218667|NCT01198366|100860356|FG000|STARTED|Overall Study||52||
48065748|NCT02949700|100482494|FG003|NOT COMPLETED|Phase II||5||
48065749|NCT03082261|100482495|FG000|STARTED|Overall Study||269||
48065750|NCT03082261|100482495|FG000|COMPLETED|Overall Study||149||
48065751|NCT03082261|100482495|FG000|NOT COMPLETED|Overall Study||120||
48065752|NCT01612858|100482496|FG000|STARTED|Overall Study||16||
48065753|NCT01612858|100482497|FG001|STARTED|Overall Study||4||
48065754|NCT01612858|100482496|FG000|COMPLETED|Overall Study||11||
48065755|NCT01612858|100482497|FG001|COMPLETED|Overall Study||3||
48065756|NCT01612858|100482496|FG000|NOT COMPLETED|Overall Study||5||
48065757|NCT01612858|100482497|FG001|NOT COMPLETED|Overall Study||1||
48065758|NCT00381550|100482498|FG000|STARTED|Overall Study||35||
48065759|NCT00381550|100482498|FG000|COMPLETED|Overall Study||35||
48065760|NCT00381550|100482498|FG000|NOT COMPLETED|Overall Study||0||
48065761|NCT00395733|100482499|FG000|STARTED|Period 1||41||
48065762|NCT00395733|100482500|FG001|STARTED|Period 1||42||
48065763|NCT00395733|100482499|FG000|COMPLETED|Period 1||41||
48065764|NCT00395733|100482500|FG001|COMPLETED|Period 1||42||
48065765|NCT00395733|100482499|FG000|NOT COMPLETED|Period 1||0||
48065766|NCT00395733|100482500|FG001|NOT COMPLETED|Period 1||0||
48065767|NCT00395733|100482499|FG000|STARTED|Period 2||41||
48065768|NCT00395733|100482500|FG001|STARTED|Period 2||42||
48065769|NCT00395733|100482499|FG000|COMPLETED|Period 2||39||
48065770|NCT00395733|100482500|FG001|COMPLETED|Period 2||37||
48065771|NCT00395733|100482499|FG000|NOT COMPLETED|Period 2||2||
48065772|NCT00395733|100482500|FG001|NOT COMPLETED|Period 2||5||
48065773|NCT00354614|100482501|FG000|STARTED|Overall Study||81||
48065774|NCT00354614|100482501|FG000|COMPLETED|Overall Study||53||
48065775|NCT00354614|100482501|FG000|NOT COMPLETED|Overall Study||28||
48065776|NCT03417219|100482502|FG000|STARTED|Overall Study||8||
48065777|NCT03417219|100482503|FG001|STARTED|Overall Study||8||
48065778|NCT03417219|100482502|FG000|COMPLETED|Overall Study||8||
48065779|NCT03417219|100482503|FG001|COMPLETED|Overall Study||5||
48065780|NCT03417219|100482502|FG000|NOT COMPLETED|Overall Study||0||
48065781|NCT03417219|100482503|FG001|NOT COMPLETED|Overall Study||3||
48065782|NCT01332331|100482504|FG000|STARTED|Overall Study||21||
48065783|NCT01332331|100482505|FG001|STARTED|Overall Study||20||
48065784|NCT01332331|100482504|FG000|COMPLETED|Overall Study||19||
48065785|NCT01332331|100482505|FG001|COMPLETED|Overall Study||18||
48065786|NCT01332331|100482504|FG000|NOT COMPLETED|Overall Study||2||
48065787|NCT01332331|100482505|FG001|NOT COMPLETED|Overall Study||2||
48065788|NCT00905827|100482506|FG000|STARTED|Overall Study||70||
48065789|NCT00905827|100482507|FG001|STARTED|Overall Study||69||
48065790|NCT00905827|100482508|FG002|STARTED|Overall Study||73||
48065791|NCT00905827|100482506|FG000|COMPLETED|Overall Study||70||
48065792|NCT00905827|100482507|FG001|COMPLETED|Overall Study||69||
48065793|NCT00905827|100482508|FG002|COMPLETED|Overall Study||73||
48065794|NCT00905827|100482506|FG000|NOT COMPLETED|Overall Study||0||
48065795|NCT00905827|100482507|FG001|NOT COMPLETED|Overall Study||0||
48065796|NCT00905827|100482508|FG002|NOT COMPLETED|Overall Study||0||
48065797|NCT00485433|100482509|FG000|STARTED|Overall Study||24||
48065798|NCT00485433|100482510|FG001|STARTED|Overall Study||25||
48065799|NCT00485433|100482511|FG002|STARTED|Overall Study||24||
48065800|NCT00485433|100482512|FG003|STARTED|Overall Study||25||
48065801|NCT00485433|100482509|FG000|COMPLETED|Overall Study||24||
48065802|NCT00485433|100482510|FG001|COMPLETED|Overall Study||25||
48065803|NCT00485433|100482511|FG002|COMPLETED|Overall Study||24||
48065804|NCT00485433|100482512|FG003|COMPLETED|Overall Study||25||
48065805|NCT00485433|100482509|FG000|NOT COMPLETED|Overall Study||0||
48065806|NCT00485433|100482510|FG001|NOT COMPLETED|Overall Study||0||
48065807|NCT00485433|100482511|FG002|NOT COMPLETED|Overall Study||0||
48065808|NCT00485433|100482512|FG003|NOT COMPLETED|Overall Study||0||
48065809|NCT01967173|100482513|FG000|STARTED|Overall Study||69||
48065810|NCT01967173|100482514|FG001|STARTED|Overall Study||69||
48065811|NCT01967173|100482515|FG002|STARTED|Overall Study||71||
48065812|NCT01967173|100482516|FG003|STARTED|Overall Study||71||
48065813|NCT01967173|100482517|FG004|STARTED|Overall Study||73||
48065814|NCT01967173|100482518|FG005|STARTED|Overall Study||72||
48065815|NCT01967173|100482519|FG006|STARTED|Overall Study||75||
48065816|NCT01967173|100482520|FG007|STARTED|Overall Study||74||
48065817|NCT01967173|100482513|FG000|Completed 1st Period|Overall Study||58||
48065818|NCT01967173|100482514|FG001|Completed 1st Period|Overall Study||60||
48065819|NCT01967173|100482515|FG002|Completed 1st Period|Overall Study||67||
48065820|NCT01967173|100482516|FG003|Completed 1st Period|Overall Study||65||
48065821|NCT01967173|100482517|FG004|Completed 1st Period|Overall Study||64||
48065822|NCT01967173|100482518|FG005|Completed 1st Period|Overall Study||62||
48065823|NCT01967173|100482519|FG006|Completed 1st Period|Overall Study||67||
48065824|NCT01967173|100482520|FG007|Completed 1st Period|Overall Study||69||
48065825|NCT01967173|100482513|FG000|Completed 2nd Period|Overall Study||52||
48065826|NCT01967173|100482514|FG001|Completed 2nd Period|Overall Study||58||
48065827|NCT01967173|100482515|FG002|Completed 2nd Period|Overall Study||63||
48065828|NCT01967173|100482516|FG003|Completed 2nd Period|Overall Study||62||
48065829|NCT01967173|100482517|FG004|Completed 2nd Period|Overall Study||63||
48065830|NCT01967173|100482518|FG005|Completed 2nd Period|Overall Study||57||
48065831|NCT01967173|100482519|FG006|Completed 2nd Period|Overall Study||63||
48065832|NCT01967173|100482520|FG007|Completed 2nd Period|Overall Study||61||
48065833|NCT01967173|100482513|FG000|Completed 3rd Period|Overall Study||48||
48065834|NCT01967173|100482514|FG001|Completed 3rd Period|Overall Study||54||
48065835|NCT01967173|100482515|FG002|Completed 3rd Period|Overall Study||60||
48065836|NCT01967173|100482516|FG003|Completed 3rd Period|Overall Study||61||
48065837|NCT01967173|100482517|FG004|Completed 3rd Period|Overall Study||59||
48065838|NCT01967173|100482518|FG005|Completed 3rd Period|Overall Study||56||
48065839|NCT01967173|100482519|FG006|Completed 3rd Period|Overall Study||59||
48065840|NCT01967173|100482520|FG007|Completed 3rd Period|Overall Study||56||
48065841|NCT01967173|100482513|FG000|Completed 4th Period|Overall Study||45||
48065842|NCT01967173|100482514|FG001|Completed 4th Period|Overall Study||52||
48065843|NCT01967173|100482515|FG002|Completed 4th Period|Overall Study||55||
48065844|NCT01967173|100482516|FG003|Completed 4th Period|Overall Study||57||
48065845|NCT01967173|100482517|FG004|Completed 4th Period|Overall Study||56||
48065846|NCT01967173|100482518|FG005|Completed 4th Period|Overall Study||49||
48065847|NCT01967173|100482519|FG006|Completed 4th Period|Overall Study||57||
48065848|NCT01967173|100482520|FG007|Completed 4th Period|Overall Study||50||
48065849|NCT01967173|100482513|FG000|COMPLETED|Overall Study||45||
48065850|NCT01967173|100482514|FG001|COMPLETED|Overall Study||52||
48065851|NCT01967173|100482515|FG002|COMPLETED|Overall Study||55||
48065852|NCT01967173|100482516|FG003|COMPLETED|Overall Study||57||
48065853|NCT01967173|100482517|FG004|COMPLETED|Overall Study||56||
48065854|NCT01967173|100482518|FG005|COMPLETED|Overall Study||49||
48065855|NCT01967173|100482519|FG006|COMPLETED|Overall Study||57||
48065856|NCT01967173|100482520|FG007|COMPLETED|Overall Study||50||
48065857|NCT01967173|100482513|FG000|NOT COMPLETED|Overall Study||24||
48065858|NCT01967173|100482514|FG001|NOT COMPLETED|Overall Study||17||
48065859|NCT01967173|100482515|FG002|NOT COMPLETED|Overall Study||16||
48065860|NCT01967173|100482516|FG003|NOT COMPLETED|Overall Study||14||
48065861|NCT01967173|100482517|FG004|NOT COMPLETED|Overall Study||17||
48065862|NCT01967173|100482518|FG005|NOT COMPLETED|Overall Study||23||
48065863|NCT01967173|100482519|FG006|NOT COMPLETED|Overall Study||18||
48065864|NCT01967173|100482520|FG007|NOT COMPLETED|Overall Study||24||
48065865|NCT02197273|100482521|FG000|STARTED|Overall Study||107||
48065866|NCT02197273|100482522|FG001|STARTED|Overall Study||104||
48065867|NCT02197273|100482521|FG000|COMPLETED|Overall Study||107||
48065868|NCT02197273|100482522|FG001|COMPLETED|Overall Study||104||
48065869|NCT02197273|100482521|FG000|NOT COMPLETED|Overall Study||0||
48065870|NCT02197273|100482522|FG001|NOT COMPLETED|Overall Study||0||
48065871|NCT03993132|100482523|FG000|STARTED|Overall Study||14148|Propensity score balanced cohort|
48065872|NCT03993132|100482524|FG001|STARTED|Overall Study||12626|Propensity score balanced cohort|
48065873|NCT03993132|100482523|FG000|COMPLETED|Overall Study||14148||
48065874|NCT03993132|100482524|FG001|COMPLETED|Overall Study||12626||
48065875|NCT03993132|100482523|FG000|NOT COMPLETED|Overall Study||0||
48065876|NCT03993132|100482524|FG001|NOT COMPLETED|Overall Study||0||
48065877|NCT04402060|100482525|FG000|STARTED|Overall Study||6||
48065878|NCT04402060|100482526|FG001|STARTED|Overall Study||34||
48065879|NCT04402060|100482527|FG002|STARTED|Overall Study||32||
48065880|NCT04402060|100482525|FG000|Received Treatment|Overall Study||6||
48065881|NCT04402060|100482526|FG001|Received Treatment|Overall Study||33||
48065882|NCT04402060|100482527|FG002|Received Treatment|Overall Study||32||
48065883|NCT04402060|100482525|FG000|COMPLETED|Overall Study||5|Completed the study|
48065884|NCT04402060|100482526|FG001|COMPLETED|Overall Study||18|Completed the study|
48065885|NCT04402060|100482527|FG002|COMPLETED|Overall Study||21|Completed the study|
48065886|NCT04402060|100482525|FG000|NOT COMPLETED|Overall Study||1||
48065887|NCT04402060|100482526|FG001|NOT COMPLETED|Overall Study||16||
48065888|NCT04402060|100482527|FG002|NOT COMPLETED|Overall Study||11||
48065889|NCT02046902|100482528|FG000|STARTED|Overall Study||336||
48065890|NCT02046902|100482529|FG001|STARTED|Overall Study||113||
48065891|NCT02046902|100482530|FG002|STARTED|Overall Study||137||
48065892|NCT02046902|100482528|FG000|COMPLETED|Overall Study||336||
48065893|NCT02046902|100482529|FG001|COMPLETED|Overall Study||113||
48065894|NCT02046902|100482530|FG002|COMPLETED|Overall Study||137||
48065895|NCT02046902|100482528|FG000|NOT COMPLETED|Overall Study||0||
48065896|NCT02046902|100482529|FG001|NOT COMPLETED|Overall Study||0||
48065897|NCT02046902|100482530|FG002|NOT COMPLETED|Overall Study||0||
48065898|NCT05246397|100482531|FG000|STARTED|Overall Study||100||
48065899|NCT05246397|100482531|FG000|COMPLETED|Overall Study||97||
48065900|NCT05246397|100482531|FG000|NOT COMPLETED|Overall Study||3||
48065901|NCT02231918|100482532|FG000|STARTED|Overall Study||9||
48065902|NCT02231918|100482533|FG001|STARTED|Overall Study||15||
48065903|NCT02231918|100482534|FG002|STARTED|Overall Study||2||
48065904|NCT02231918|100482532|FG000|COMPLETED|Overall Study||9||
48065905|NCT02231918|100482533|FG001|COMPLETED|Overall Study||14||
48065906|NCT02231918|100482534|FG002|COMPLETED|Overall Study||1||
48065907|NCT02231918|100482532|FG000|NOT COMPLETED|Overall Study||0||
48065908|NCT02231918|100482533|FG001|NOT COMPLETED|Overall Study||1||
48065909|NCT02231918|100482534|FG002|NOT COMPLETED|Overall Study||1||
48065910|NCT02215096|100482535|FG000|STARTED|Run-In Period (Up to Week 2)||37||
48065911|NCT02215096|100482536|FG001|STARTED|Run-In Period (Up to Week 2)||0||
48065912|NCT02215096|100482537|FG002|STARTED|Run-In Period (Up to Week 2)||0||
48065913|NCT02215096|100482538|FG003|STARTED|Run-In Period (Up to Week 2)||0||
48065914|NCT02215096|100482539|FG004|STARTED|Run-In Period (Up to Week 2)||0||
48065915|NCT02215096|100482535|FG000|COMPLETED|Run-In Period (Up to Week 2)||36||
48065916|NCT02215096|100482536|FG001|COMPLETED|Run-In Period (Up to Week 2)||0||
48065917|NCT02215096|100482537|FG002|COMPLETED|Run-In Period (Up to Week 2)||0||
48065918|NCT02215096|100482538|FG003|COMPLETED|Run-In Period (Up to Week 2)||0||
48065919|NCT02215096|100482539|FG004|COMPLETED|Run-In Period (Up to Week 2)||0||
48065920|NCT02215096|100482535|FG000|NOT COMPLETED|Run-In Period (Up to Week 2)||1||
48065921|NCT02215096|100482536|FG001|NOT COMPLETED|Run-In Period (Up to Week 2)||0||
48065922|NCT02215096|100482537|FG002|NOT COMPLETED|Run-In Period (Up to Week 2)||0||
48065923|NCT02215096|100482538|FG003|NOT COMPLETED|Run-In Period (Up to Week 2)||0||
48065924|NCT02215096|100482539|FG004|NOT COMPLETED|Run-In Period (Up to Week 2)||0||
48065925|NCT02215096|100482535|FG000|STARTED|Combination TP (Up to Maximum 654 Days)||0||
48065926|NCT02215096|100482536|FG001|STARTED|Combination TP (Up to Maximum 654 Days)||11||
48065927|NCT02215096|100482537|FG002|STARTED|Combination TP (Up to Maximum 654 Days)||11||
48065928|NCT02215096|100482538|FG003|STARTED|Combination TP (Up to Maximum 654 Days)||12||
48065929|NCT02215096|100482539|FG004|STARTED|Combination TP (Up to Maximum 654 Days)||2||
48065930|NCT02215096|100482535|FG000|COMPLETED|Combination TP (Up to Maximum 654 Days)||0||
48065931|NCT02215096|100482536|FG001|COMPLETED|Combination TP (Up to Maximum 654 Days)||9||
48065932|NCT02215096|100482537|FG002|COMPLETED|Combination TP (Up to Maximum 654 Days)||10||
48065933|NCT02215096|100482538|FG003|COMPLETED|Combination TP (Up to Maximum 654 Days)||10||
48065934|NCT02215096|100482539|FG004|COMPLETED|Combination TP (Up to Maximum 654 Days)||1||
48065935|NCT02215096|100482535|FG000|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||0||
48065936|NCT02215096|100482536|FG001|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||2||
48065937|NCT02215096|100482537|FG002|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||1||
48065938|NCT02215096|100482538|FG003|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||2||
48065939|NCT02215096|100482539|FG004|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||1||
48065940|NCT01191411|100482540|FG000|STARTED|Overall Study||1593||
48065941|NCT01191411|100482541|FG001|STARTED|Overall Study||479||
48065942|NCT01191411|100482542|FG002|STARTED|Overall Study||3898||
48065943|NCT01191411|100482540|FG000|COMPLETED|Overall Study||648||
48065944|NCT01191411|100482541|FG001|COMPLETED|Overall Study||118||
48065945|NCT01191411|100482542|FG002|COMPLETED|Overall Study||471||
48065946|NCT01191411|100482540|FG000|NOT COMPLETED|Overall Study||945||
48065947|NCT01191411|100482541|FG001|NOT COMPLETED|Overall Study||361||
48065948|NCT01191411|100482542|FG002|NOT COMPLETED|Overall Study||3427||
48065949|NCT01892267|100482543|FG000|STARTED|Overall Study||9||
48065950|NCT01892267|100482544|FG001|STARTED|Overall Study||10||
48065951|NCT01892267|100482543|FG000|COMPLETED|Overall Study||9||
48065952|NCT01892267|100482544|FG001|COMPLETED|Overall Study||10||
48065953|NCT01892267|100482543|FG000|NOT COMPLETED|Overall Study||0||
48065954|NCT01892267|100482544|FG001|NOT COMPLETED|Overall Study||0||
48065955|NCT02956070|100482545|FG000|STARTED|Overall Study||35||
48065956|NCT02956070|100482546|FG001|STARTED|Overall Study||35||
48065957|NCT02956070|100482545|FG000|COMPLETED|Overall Study||35||
48065958|NCT02956070|100482546|FG001|COMPLETED|Overall Study||35||
48065959|NCT02956070|100482545|FG000|NOT COMPLETED|Overall Study||0||
48065960|NCT02956070|100482546|FG001|NOT COMPLETED|Overall Study||0||
48065961|NCT03666624|100482547|FG000|STARTED|Overall Study||15||
48065962|NCT03666624|100482548|FG001|STARTED|Overall Study||15||
48065963|NCT03666624|100482547|FG000|COMPLETED|Overall Study||14||
48065964|NCT03666624|100482548|FG001|COMPLETED|Overall Study||15||
48065965|NCT03666624|100482547|FG000|NOT COMPLETED|Overall Study||1||
48065966|NCT03666624|100482548|FG001|NOT COMPLETED|Overall Study||0||
48065967|NCT02959983|100482549|FG000|STARTED|Overall Study||172||
48065968|NCT02959983|100482550|FG001|STARTED|Overall Study||174||
48065969|NCT02959983|100482549|FG000|COMPLETED|Overall Study||146||
48065970|NCT02959983|100482550|FG001|COMPLETED|Overall Study||149||
48065971|NCT02959983|100482549|FG000|NOT COMPLETED|Overall Study||26||
48065972|NCT02959983|100482550|FG001|NOT COMPLETED|Overall Study||25||
48065973|NCT00191906|100482551|FG000|STARTED|Study Period II||39||
48065974|NCT00191906|100482552|FG001|STARTED|Study Period II||37||
48065975|NCT00191906|100482553|FG002|STARTED|Study Period II||27||
48065976|NCT00191906|100482554|FG003|STARTED|Study Period II||18||
48065977|NCT00191906|100482551|FG000|COMPLETED|Study Period II||39||
48065978|NCT00191906|100482552|FG001|COMPLETED|Study Period II||32||
48065979|NCT00191906|100482553|FG002|COMPLETED|Study Period II||26||
48065980|NCT00191906|100482554|FG003|COMPLETED|Study Period II||18||
48065981|NCT00191906|100482551|FG000|NOT COMPLETED|Study Period II||0||
48065982|NCT00191906|100482552|FG001|NOT COMPLETED|Study Period II||5||
48065983|NCT00191906|100482553|FG002|NOT COMPLETED|Study Period II||1||
48065984|NCT00191906|100482554|FG003|NOT COMPLETED|Study Period II||0||
48065985|NCT00191906|100482551|FG000|STARTED|Study Period III||14||
48065986|NCT00191906|100482552|FG001|STARTED|Study Period III||11||
48065987|NCT00191906|100482553|FG002|STARTED|Study Period III||0||
48065988|NCT00191906|100482554|FG003|STARTED|Study Period III||0||
48065989|NCT00191906|100482551|FG000|COMPLETED|Study Period III||9||
48065990|NCT00191906|100482552|FG001|COMPLETED|Study Period III||7||
48065991|NCT00191906|100482553|FG002|COMPLETED|Study Period III||0||
48065992|NCT00191906|100482554|FG003|COMPLETED|Study Period III||0||
48065993|NCT00191906|100482551|FG000|NOT COMPLETED|Study Period III||5||
48065994|NCT00191906|100482552|FG001|NOT COMPLETED|Study Period III||4||
48065995|NCT00191906|100482553|FG002|NOT COMPLETED|Study Period III||0||
48065996|NCT00191906|100482554|FG003|NOT COMPLETED|Study Period III||0||
48065997|NCT00566111|100482555|FG000|STARTED|Overall Study||2||
48065998|NCT00566111|100482556|FG001|STARTED|Overall Study||3||
48065999|NCT00566111|100482555|FG000|COMPLETED|Overall Study||2||
48066000|NCT00566111|100482556|FG001|COMPLETED|Overall Study||1||
48066001|NCT00566111|100482555|FG000|NOT COMPLETED|Overall Study||0||
48066002|NCT00566111|100482556|FG001|NOT COMPLETED|Overall Study||2||
48066003|NCT03273543|100482557|FG000|STARTED|Overall Study||10||
48066004|NCT03273543|100482558|FG001|STARTED|Overall Study||10||
48066005|NCT03273543|100482557|FG000|COMPLETED|Overall Study||10||
48066006|NCT03273543|100482558|FG001|COMPLETED|Overall Study||10||
48066007|NCT03273543|100482557|FG000|NOT COMPLETED|Overall Study||0||
48066008|NCT03273543|100482558|FG001|NOT COMPLETED|Overall Study||0||
48066009|NCT01349231|100482559|FG000|STARTED|Overall Study||10||
48066010|NCT01349231|100482559|FG000|COMPLETED|Overall Study||10||
48066011|NCT01349231|100482559|FG000|NOT COMPLETED|Overall Study||0||
48066012|NCT03420625|100482560|FG000|STARTED|Overall Study||10||
48066013|NCT03420625|100482560|FG000|Baseline|Overall Study||10|Venous flow in the popliteal vein during supine position|
48066014|NCT03420625|100482560|FG000|Foot IPC|Overall Study||10|Intermittent pneumatic compression of the foot using A-V Impulse™, Covidien®, New Haven, CT, USA|
48066015|NCT03420625|100482560|FG000|Rapid Calf IPC|Overall Study||10|Intermittent pneumatic compression of the calf using the VenaFlow® Elite, DJO Global, USA|
48066016|NCT03420625|100482560|FG000|Slow Calf IPC|Overall Study||10|Intermittent pneumatic compression of the calf using the Kendall SCD™ 700, Covidien, Medtronic, USA|
48066017|NCT03420625|100482560|FG000|Calf NMES|Overall Study||10|Neuromuscular electrical stimulation of the calf using the CefarCompex Mi-Theta 500 stimulator|
48066018|NCT03420625|100482560|FG000|COMPLETED|Overall Study||10||
48066019|NCT03420625|100482560|FG000|NOT COMPLETED|Overall Study||0||
48066020|NCT01954160|100482561|FG000|STARTED|Overall Study||5||
48066021|NCT01954160|100482562|FG001|STARTED|Overall Study||0||
48066022|NCT01954160|100482561|FG000|COMPLETED|Overall Study||0||
48066023|NCT01954160|100482562|FG001|COMPLETED|Overall Study||0||
48066024|NCT01954160|100482561|FG000|NOT COMPLETED|Overall Study||5||
48066025|NCT01954160|100482562|FG001|NOT COMPLETED|Overall Study||0||
48066026|NCT00644189|100482563|FG000|STARTED|Phase I||3||
48066027|NCT00644189|100482564|FG001|STARTED|Phase I||3||
48066028|NCT00644189|100482565|FG002|STARTED|Phase I||6||
48066029|NCT00644189|100482566|FG003|STARTED|Phase I||18||
48066030|NCT00644189|100482563|FG000|COMPLETED|Phase I||3||
48066031|NCT00644189|100482564|FG001|COMPLETED|Phase I||3||
48066032|NCT00644189|100482565|FG002|COMPLETED|Phase I||6||
48066033|NCT00644189|100482566|FG003|COMPLETED|Phase I||18||
48066034|NCT00644189|100482563|FG000|NOT COMPLETED|Phase I||0||
48066035|NCT00644189|100482564|FG001|NOT COMPLETED|Phase I||0||
48218668|NCT01198366|100860357|FG001|STARTED|Overall Study||51||
48218669|NCT01198366|100860358|FG002|STARTED|Overall Study||51||
48066036|NCT00644189|100482565|FG002|NOT COMPLETED|Phase I||0||
48066037|NCT00644189|100482566|FG003|NOT COMPLETED|Phase I||0||
48066038|NCT00644189|100482563|FG000|STARTED|Phase II||0||
48066039|NCT00644189|100482564|FG001|STARTED|Phase II||0||
48066040|NCT00644189|100482565|FG002|STARTED|Phase II||0||
48066041|NCT00644189|100482566|FG003|STARTED|Phase II||50||
48066042|NCT00644189|100482563|FG000|Completed All 6 Cycles of Treatment|Phase II||0||
48066043|NCT00644189|100482564|FG001|Completed All 6 Cycles of Treatment|Phase II||0||
48066044|NCT00644189|100482565|FG002|Completed All 6 Cycles of Treatment|Phase II||0||
48066045|NCT00644189|100482566|FG003|Completed All 6 Cycles of Treatment|Phase II||19||
48066046|NCT00644189|100482563|FG000|COMPLETED|Phase II||0||
48066047|NCT00644189|100482564|FG001|COMPLETED|Phase II||0||
48066048|NCT00644189|100482565|FG002|COMPLETED|Phase II||0||
48066049|NCT00644189|100482566|FG003|COMPLETED|Phase II||50||
48066050|NCT00644189|100482563|FG000|NOT COMPLETED|Phase II||0||
48066051|NCT00644189|100482564|FG001|NOT COMPLETED|Phase II||0||
48066052|NCT00644189|100482565|FG002|NOT COMPLETED|Phase II||0||
48066053|NCT00644189|100482566|FG003|NOT COMPLETED|Phase II||0||
48066054|NCT03511664|100482567|FG000|STARTED|Overall Study||551|All randomized patients were included in the Full Analysis Set (FAS). Patients were included in the treatment arm to which they were randomized regardless of actual treatment received.|
48066055|NCT03511664|100482568|FG001|STARTED|Overall Study||280|All randomized patients were included in the Full Analysis Set (FAS). Patients were included in the treatment arm to which they were randomized regardless of actual treatment received.|
48066056|NCT03511664|100482567|FG000|FAS Safety Analysis Set|Overall Study||529||
48066057|NCT03511664|100482568|FG001|FAS Safety Analysis Set|Overall Study||205||
48066058|NCT03511664|100482567|FG000|Progression-Free Survival (PFS) Full Analysis Set (PFS-FAS)|Overall Study||385||
48066059|NCT03511664|100482568|FG001|Progression-Free Survival (PFS) Full Analysis Set (PFS-FAS)|Overall Study||196||
48066060|NCT03511664|100482567|FG000|Response Evaluable Analysis Set|Overall Study||319||
48066061|NCT03511664|100482568|FG001|Response Evaluable Analysis Set|Overall Study||120||
48066062|NCT03511664|100482567|FG000|COMPLETED|Overall Study||329||
48066063|NCT03511664|100482568|FG001|COMPLETED|Overall Study||167||
48066064|NCT03511664|100482567|FG000|NOT COMPLETED|Overall Study||222||
48066065|NCT03511664|100482568|FG001|NOT COMPLETED|Overall Study||113||
48066066|NCT04644003|100482569|FG000|STARTED|Overall Study||6||
48066067|NCT04644003|100482570|FG001|STARTED|Overall Study||3||
48066068|NCT04644003|100482571|FG002|STARTED|Overall Study||3||
48066069|NCT04644003|100482569|FG000|COMPLETED|Overall Study||6||
48066070|NCT04644003|100482570|FG001|COMPLETED|Overall Study||3||
48066071|NCT04644003|100482571|FG002|COMPLETED|Overall Study||3||
48066072|NCT04644003|100482569|FG000|NOT COMPLETED|Overall Study||0||
48066073|NCT04644003|100482570|FG001|NOT COMPLETED|Overall Study||0||
48066074|NCT04644003|100482571|FG002|NOT COMPLETED|Overall Study||0||
48066075|NCT02840721|100482572|FG000|STARTED|Treatment Period||50||
48066076|NCT02840721|100482572|FG000|COMPLETED|Treatment Period||49||
48066077|NCT02840721|100482572|FG000|NOT COMPLETED|Treatment Period||1||
48066078|NCT02840721|100482572|FG000|STARTED|Follow-Up||49||
48066079|NCT02840721|100482572|FG000|COMPLETED|Follow-Up||42||
48066080|NCT02840721|100482572|FG000|NOT COMPLETED|Follow-Up||7||
48066081|NCT01497275|100482573|FG000|STARTED|Overall Study||5||
48066082|NCT01497275|100482573|FG000|COMPLETED|Overall Study||3||
48066083|NCT01497275|100482573|FG000|NOT COMPLETED|Overall Study||2||
48066084|NCT01414608|100482574|FG000|STARTED|Overall Study||461||
48066085|NCT01414608|100482575|FG001|STARTED|Overall Study||465||
48066086|NCT01414608|100482574|FG000|COMPLETED|Overall Study||456||
48066087|NCT01414608|100482575|FG001|COMPLETED|Overall Study||463||
48066088|NCT01414608|100482574|FG000|NOT COMPLETED|Overall Study||5||
48066089|NCT01414608|100482575|FG001|NOT COMPLETED|Overall Study||2||
48066090|NCT03626168|100482576|FG000|STARTED|First Intervention (4 Weeks)||9||
48066091|NCT03626168|100482577|FG001|STARTED|First Intervention (4 Weeks)||12||
48066092|NCT03626168|100482576|FG000|COMPLETED|First Intervention (4 Weeks)||8||
48066093|NCT03626168|100482577|FG001|COMPLETED|First Intervention (4 Weeks)||11||
48066094|NCT03626168|100482576|FG000|NOT COMPLETED|First Intervention (4 Weeks)||1||
48066095|NCT03626168|100482577|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1||
48066096|NCT03626168|100482576|FG000|STARTED|Washout (2 Weeks)||8||
48066097|NCT03626168|100482577|FG001|STARTED|Washout (2 Weeks)||11||
48066098|NCT03626168|100482576|FG000|COMPLETED|Washout (2 Weeks)||8||
48066099|NCT03626168|100482577|FG001|COMPLETED|Washout (2 Weeks)||11||
48066100|NCT03626168|100482576|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
48066101|NCT03626168|100482577|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
48066102|NCT03626168|100482576|FG000|STARTED|Second Intervention (4 Weeks)||8||
48066103|NCT03626168|100482577|FG001|STARTED|Second Intervention (4 Weeks)||11||
48066104|NCT03626168|100482576|FG000|COMPLETED|Second Intervention (4 Weeks)||8||
48066105|NCT03626168|100482577|FG001|COMPLETED|Second Intervention (4 Weeks)||9||
48066106|NCT03626168|100482576|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0||
48066107|NCT03626168|100482577|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||2||
48066108|NCT01252147|100482578|FG000|STARTED|Overall Study||68||
48066109|NCT01252147|100482578|FG000|COMPLETED|Overall Study||68||
48066110|NCT01252147|100482578|FG000|NOT COMPLETED|Overall Study||0||
48066111|NCT03270644|100482579|FG000|STARTED|Day 1 Lasmiditan Reference||44||
48066112|NCT03270644|100482579|FG000|Received at Least One Dose of Study Drug|Day 1 Lasmiditan Reference||44||
48066113|NCT03270644|100482579|FG000|COMPLETED|Day 1 Lasmiditan Reference||43||
48066114|NCT03270644|100482579|FG000|NOT COMPLETED|Day 1 Lasmiditan Reference||1||
48066115|NCT03270644|100482579|FG000|STARTED|Day 4 - 10 Propranolol Reference||43||
48066116|NCT03270644|100482579|FG000|Received at Least One Dose of Study Drug|Day 4 - 10 Propranolol Reference||43||
48066117|NCT03270644|100482579|FG000|Day 9 Lasmiditan + Propranolol Test|Day 4 - 10 Propranolol Reference||42||
48066118|NCT03270644|100482579|FG000|COMPLETED|Day 4 - 10 Propranolol Reference||42||
48066119|NCT03270644|100482579|FG000|NOT COMPLETED|Day 4 - 10 Propranolol Reference||1||
48066120|NCT04141046|100482580|FG000|STARTED|Overall Study||1||
48066121|NCT04141046|100482581|FG001|STARTED|Overall Study||0||
48066122|NCT04141046|100482582|FG002|STARTED|Overall Study||3||
48066123|NCT04141046|100482580|FG000|COMPLETED|Overall Study||1||
48066124|NCT04141046|100482581|FG001|COMPLETED|Overall Study||0||
48066125|NCT04141046|100482582|FG002|COMPLETED|Overall Study||3||
48066126|NCT04141046|100482580|FG000|NOT COMPLETED|Overall Study||0||
48066127|NCT04141046|100482581|FG001|NOT COMPLETED|Overall Study||0||
48066128|NCT04141046|100482582|FG002|NOT COMPLETED|Overall Study||0||
48066129|NCT01287078|100482583|FG000|STARTED|Overall Study||20||
48066130|NCT01287078|100482584|FG001|STARTED|Overall Study||3||
48066131|NCT01287078|100482583|FG000|COMPLETED|Overall Study||10||
48066132|NCT01287078|100482584|FG001|COMPLETED|Overall Study||1||
48066133|NCT01287078|100482583|FG000|NOT COMPLETED|Overall Study||10||
48066134|NCT01287078|100482584|FG001|NOT COMPLETED|Overall Study||2||
48066135|NCT03257696|100482585|FG000|STARTED|Overall Study||123||
48066136|NCT03257696|100482586|FG001|STARTED|Overall Study||29||
48066137|NCT03257696|100482585|FG000|COMPLETED|Overall Study||123||
48066138|NCT03257696|100482586|FG001|COMPLETED|Overall Study||29||
48066139|NCT03257696|100482585|FG000|NOT COMPLETED|Overall Study||0||
48066140|NCT03257696|100482586|FG001|NOT COMPLETED|Overall Study||0||
48066141|NCT03656107|100482587|FG000|STARTED|Overall Study||28||
48066142|NCT03656107|100482588|FG001|STARTED|Overall Study||28||
48066143|NCT03656107|100482587|FG000|COMPLETED|Overall Study||25||
48066144|NCT03656107|100482588|FG001|COMPLETED|Overall Study||27||
48066145|NCT03656107|100482587|FG000|NOT COMPLETED|Overall Study||3||
48066146|NCT03656107|100482588|FG001|NOT COMPLETED|Overall Study||1||
48066147|NCT04223973|100482589|FG000|STARTED|Overall Study||48||
48066148|NCT04223973|100482590|FG001|STARTED|Overall Study||45||
48066149|NCT04223973|100482589|FG000|COMPLETED|Overall Study||35||
48066150|NCT04223973|100482590|FG001|COMPLETED|Overall Study||43||
48066151|NCT04223973|100482589|FG000|NOT COMPLETED|Overall Study||13||
48066152|NCT04223973|100482590|FG001|NOT COMPLETED|Overall Study||2||
48066153|NCT04553679|100482591|FG000|STARTED|Overall Study||13||
48066154|NCT04553679|100482592|FG001|STARTED|Overall Study||3||
48066155|NCT04553679|100482591|FG000|COMPLETED|Overall Study||11||
48066156|NCT04553679|100482592|FG001|COMPLETED|Overall Study||2||
48066157|NCT04553679|100482591|FG000|NOT COMPLETED|Overall Study||2||
48066158|NCT04553679|100482592|FG001|NOT COMPLETED|Overall Study||1||
48066159|NCT01856907|100482593|FG000|STARTED|Overall Study||12||
48066160|NCT01856907|100482594|FG001|STARTED|Overall Study||12||
48066161|NCT01856907|100482595|FG002|STARTED|Overall Study||12||
48066162|NCT01856907|100482593|FG000|COMPLETED|Overall Study||12||
48066163|NCT01856907|100482594|FG001|COMPLETED|Overall Study||9||
48066164|NCT01856907|100482595|FG002|COMPLETED|Overall Study||12||
48066165|NCT01856907|100482593|FG000|NOT COMPLETED|Overall Study||0||
48066166|NCT01856907|100482594|FG001|NOT COMPLETED|Overall Study||3||
48066167|NCT01856907|100482595|FG002|NOT COMPLETED|Overall Study||0||
48066168|NCT00595465|100482596|FG000|STARTED|Overall Study||130||
48066169|NCT00595465|100482597|FG001|STARTED|Overall Study||129||
48066170|NCT00595465|100482598|FG002|STARTED|Overall Study||128||
48066171|NCT00595465|100482596|FG000|COMPLETED|Overall Study||124||
48066172|NCT00595465|100482597|FG001|COMPLETED|Overall Study||125||
48066173|NCT00595465|100482598|FG002|COMPLETED|Overall Study||121||
48066174|NCT00595465|100482596|FG000|NOT COMPLETED|Overall Study||6||
48066175|NCT00595465|100482597|FG001|NOT COMPLETED|Overall Study||4||
48066176|NCT00595465|100482598|FG002|NOT COMPLETED|Overall Study||7||
48066177|NCT03848065|100482599|FG000|STARTED|Overall Study||44||
48066178|NCT03848065|100482600|FG001|STARTED|Overall Study||45||
48066179|NCT03848065|100482601|FG002|STARTED|Overall Study||44||
48066180|NCT03848065|100482599|FG000|Vaccination 1|Overall Study||44||
48066181|NCT03848065|100482600|FG001|Vaccination 1|Overall Study||45||
48066182|NCT03848065|100482601|FG002|Vaccination 1|Overall Study||43||
48066183|NCT03848065|100482599|FG000|Vaccination 2|Overall Study||44||
48066184|NCT03848065|100482600|FG001|Vaccination 2|Overall Study||45||
48066185|NCT03848065|100482601|FG002|Vaccination 2|Overall Study||43||
48066186|NCT03848065|100482599|FG000|Vaccination 3|Overall Study||44||
48066187|NCT03848065|100482600|FG001|Vaccination 3|Overall Study||45||
48218670|NCT01198366|100860359|FG003|STARTED|Overall Study||52||
48218671|NCT01198366|100860360|FG004|STARTED|Overall Study||140||
48218672|NCT01198366|100860361|FG005|STARTED|Overall Study||141||
48218673|NCT01198366|100860356|FG000|COMPLETED|Overall Study||40||
48066188|NCT03848065|100482601|FG002|Vaccination 3|Overall Study||42||
48066189|NCT03848065|100482599|FG000|Vaccination 4|Overall Study||44||
48066190|NCT03848065|100482600|FG001|Vaccination 4|Overall Study||44||
48066191|NCT03848065|100482601|FG002|Vaccination 4|Overall Study||42||
48066192|NCT03848065|100482599|FG000|COMPLETED|Overall Study||44||
48066193|NCT03848065|100482600|FG001|COMPLETED|Overall Study||44||
48066194|NCT03848065|100482601|FG002|COMPLETED|Overall Study||42||
48066195|NCT03848065|100482599|FG000|NOT COMPLETED|Overall Study||0||
48066196|NCT03848065|100482600|FG001|NOT COMPLETED|Overall Study||1||
48066197|NCT03848065|100482601|FG002|NOT COMPLETED|Overall Study||2||
48066198|NCT04569253|100482602|FG000|STARTED|Overall Study||65||130
48066199|NCT04569253|100482602|FG000|Control Flanks|Overall Study||65||65
48066200|NCT04569253|100482602|FG000|Treatment Flanks|Overall Study||65||65
48066201|NCT04569253|100482602|FG000|COMPLETED|Overall Study||57||114
48066202|NCT04569253|100482602|FG000|NOT COMPLETED|Overall Study||8||16
48066203|NCT01254331|100482603|FG000|STARTED|Initial Phase||51||
48066204|NCT01254331|100482603|FG000|COMPLETED|Initial Phase||46||
48066205|NCT01254331|100482603|FG000|NOT COMPLETED|Initial Phase||5||
48066206|NCT01254331|100482603|FG000|STARTED|Extension Phase||45||
48066207|NCT01254331|100482603|FG000|COMPLETED|Extension Phase||41||
48066208|NCT01254331|100482603|FG000|NOT COMPLETED|Extension Phase||4||
48066209|NCT00331864|100482604|FG000|STARTED|Overall Study||513||
48066210|NCT00331864|100482605|FG001|STARTED|Overall Study||18||
48066211|NCT00331864|100482604|FG000|COMPLETED|Overall Study||455||
48066212|NCT00331864|100482605|FG001|COMPLETED|Overall Study||14||
48066213|NCT00331864|100482604|FG000|NOT COMPLETED|Overall Study||58||
48066214|NCT00331864|100482605|FG001|NOT COMPLETED|Overall Study||4||
48066215|NCT01117948|100482606|FG000|STARTED|Double Blind||111||
48066216|NCT01117948|100482607|FG001|STARTED|Double Blind||108||
48066217|NCT01117948|100482606|FG000|COMPLETED|Double Blind||93||
48066218|NCT01117948|100482607|FG001|COMPLETED|Double Blind||98||
48066219|NCT01117948|100482606|FG000|NOT COMPLETED|Double Blind||18||
48066220|NCT01117948|100482607|FG001|NOT COMPLETED|Double Blind||10||
48066221|NCT01117948|100482606|FG000|STARTED|Open Label||93||
48066222|NCT01117948|100482607|FG001|STARTED|Open Label||98||
48066223|NCT01117948|100482606|FG000|COMPLETED|Open Label||41||
48066224|NCT01117948|100482607|FG001|COMPLETED|Open Label||51||
48066225|NCT01117948|100482606|FG000|NOT COMPLETED|Open Label||52||
48066226|NCT01117948|100482607|FG001|NOT COMPLETED|Open Label||47||
48066227|NCT03584100|100482608|FG000|STARTED|Overall Study||12||
48066228|NCT03584100|100482608|FG000|COMPLETED|Overall Study||12||
48066229|NCT03584100|100482608|FG000|NOT COMPLETED|Overall Study||0||
48066230|NCT00515177|100482609|FG000|STARTED|Overall Study||20||
48066231|NCT00515177|100482610|FG001|STARTED|Overall Study||10||
48066232|NCT00515177|100482609|FG000|COMPLETED|Overall Study||18||
48066233|NCT00515177|100482610|FG001|COMPLETED|Overall Study||9||
48066234|NCT00515177|100482609|FG000|NOT COMPLETED|Overall Study||2||
48066235|NCT00515177|100482610|FG001|NOT COMPLETED|Overall Study||1||
48066236|NCT00788073|100482611|FG000|STARTED|STX209 Then Placebo||30||
48066237|NCT00788073|100482612|FG001|STARTED|STX209 Then Placebo||33||
48066238|NCT00788073|100482611|FG000|COMPLETED|STX209 Then Placebo||29||
48066239|NCT00788073|100482612|FG001|COMPLETED|STX209 Then Placebo||30||
48066240|NCT00788073|100482611|FG000|NOT COMPLETED|STX209 Then Placebo||1||
48066241|NCT00788073|100482612|FG001|NOT COMPLETED|STX209 Then Placebo||3||
48066242|NCT00788073|100482611|FG000|STARTED|Placebo Then STX209||29||
48066243|NCT00788073|100482612|FG001|STARTED|Placebo Then STX209||30||
48066244|NCT00788073|100482611|FG000|COMPLETED|Placebo Then STX209||27||
48066245|NCT00788073|100482612|FG001|COMPLETED|Placebo Then STX209||29||
48066246|NCT00788073|100482611|FG000|NOT COMPLETED|Placebo Then STX209||2||
48066247|NCT00788073|100482612|FG001|NOT COMPLETED|Placebo Then STX209||1||
48066248|NCT02651467|100482613|FG000|STARTED|Overall Study||74||
48066249|NCT02651467|100482614|FG001|STARTED|Overall Study||74||
48066250|NCT02651467|100482615|FG002|STARTED|Overall Study||73||
48066251|NCT02651467|100482613|FG000|COMPLETED|Overall Study||73||
48066252|NCT02651467|100482614|FG001|COMPLETED|Overall Study||74||
48066253|NCT02651467|100482615|FG002|COMPLETED|Overall Study||69||
48066254|NCT02651467|100482613|FG000|NOT COMPLETED|Overall Study||1||
48066255|NCT02651467|100482614|FG001|NOT COMPLETED|Overall Study||0||
48066256|NCT02651467|100482615|FG002|NOT COMPLETED|Overall Study||4||
48066257|NCT01025154|100482616|FG000|STARTED|Overall Study||59||
48066258|NCT01025154|100482616|FG000|COMPLETED|Overall Study||57||
48066259|NCT01025154|100482616|FG000|NOT COMPLETED|Overall Study||2||
48066260|NCT03437512|100482617|FG000|STARTED|Randomized||12||
48066261|NCT03437512|100482618|FG001|STARTED|Randomized||13||
48066262|NCT03437512|100482617|FG000|COMPLETED|Randomized||12||
48066263|NCT03437512|100482618|FG001|COMPLETED|Randomized||11||
48066264|NCT03437512|100482617|FG000|NOT COMPLETED|Randomized||0||
48066265|NCT03437512|100482618|FG001|NOT COMPLETED|Randomized||2||
48066266|NCT03437512|100482617|FG000|STARTED|Received First tDCS Session||12||
48066267|NCT03437512|100482618|FG001|STARTED|Received First tDCS Session||11||
48066268|NCT03437512|100482617|FG000|COMPLETED|Received First tDCS Session||12||
48066269|NCT03437512|100482618|FG001|COMPLETED|Received First tDCS Session||11||
48218674|NCT01198366|100860357|FG001|COMPLETED|Overall Study||44||
48509760|NCT02688387|101580251|FG010|COMPLETED|Part 2, Period 3 (up to 6 Days)||5||
48509761|NCT02688387|101580252|FG011|COMPLETED|Part 2, Period 3 (up to 6 Days)||5||
48066270|NCT03437512|100482617|FG000|NOT COMPLETED|Received First tDCS Session||0||
48066271|NCT03437512|100482618|FG001|NOT COMPLETED|Received First tDCS Session||0||
48066272|NCT03437512|100482617|FG000|STARTED|Received Final tDCS Session||12||
48066273|NCT03437512|100482618|FG001|STARTED|Received Final tDCS Session||11||
48066274|NCT03437512|100482617|FG000|COMPLETED|Received Final tDCS Session||12||
48066275|NCT03437512|100482618|FG001|COMPLETED|Received Final tDCS Session||11||
48066276|NCT03437512|100482617|FG000|NOT COMPLETED|Received Final tDCS Session||0||
48066277|NCT03437512|100482618|FG001|NOT COMPLETED|Received Final tDCS Session||0||
48066278|NCT03437512|100482617|FG000|STARTED|Completed Study Follow up||12||
48066279|NCT03437512|100482618|FG001|STARTED|Completed Study Follow up||11||
48066280|NCT03437512|100482617|FG000|COMPLETED|Completed Study Follow up||10||
48218675|NCT01198366|100860358|FG002|COMPLETED|Overall Study||43||
48066281|NCT03437512|100482618|FG001|COMPLETED|Completed Study Follow up||10||
48066282|NCT03437512|100482617|FG000|NOT COMPLETED|Completed Study Follow up||2||
48066283|NCT03437512|100482618|FG001|NOT COMPLETED|Completed Study Follow up||1||
48066284|NCT00181155|100482619|FG000|STARTED|Overall Study||15||
48066285|NCT00181155|100482620|FG001|STARTED|Overall Study||3||
48066286|NCT00181155|100482619|FG000|COMPLETED|Overall Study||13||
48066287|NCT00181155|100482620|FG001|COMPLETED|Overall Study||3||
48066288|NCT00181155|100482619|FG000|NOT COMPLETED|Overall Study||2||
48066289|NCT00181155|100482620|FG001|NOT COMPLETED|Overall Study||0||
48066290|NCT01890746|100482621|FG000|STARTED|Overall Study||74||
48066291|NCT01890746|100482622|FG001|STARTED|Overall Study||74||
48066292|NCT01890746|100482621|FG000|COMPLETED|Overall Study||22||
48066293|NCT01890746|100482622|FG001|COMPLETED|Overall Study||33||
48066294|NCT01890746|100482621|FG000|NOT COMPLETED|Overall Study||52||
48066295|NCT01890746|100482622|FG001|NOT COMPLETED|Overall Study||41||
48066296|NCT04587271|100482623|FG000|STARTED|Overall Study||25||
48066297|NCT04587271|100482624|FG001|STARTED|Overall Study||25||
48066298|NCT04587271|100482625|FG002|STARTED|Overall Study||0||
48066299|NCT04587271|100482626|FG003|STARTED|Overall Study||25||
48066300|NCT04587271|100482627|FG004|STARTED|Overall Study||25||
48066301|NCT04587271|100482628|FG005|STARTED|Overall Study||0||
48066302|NCT04587271|100482623|FG000|COMPLETED|Overall Study||23||
48066303|NCT04587271|100482624|FG001|COMPLETED|Overall Study||23||
48066304|NCT04587271|100482625|FG002|COMPLETED|Overall Study||0||
48066305|NCT04587271|100482626|FG003|COMPLETED|Overall Study||22||
48066306|NCT04587271|100482627|FG004|COMPLETED|Overall Study||23||
48066307|NCT04587271|100482628|FG005|COMPLETED|Overall Study||0||
48066308|NCT04587271|100482623|FG000|NOT COMPLETED|Overall Study||2||
48066309|NCT04587271|100482624|FG001|NOT COMPLETED|Overall Study||2||
48066310|NCT04587271|100482625|FG002|NOT COMPLETED|Overall Study||0||
48066311|NCT04587271|100482626|FG003|NOT COMPLETED|Overall Study||3||
48066312|NCT04587271|100482627|FG004|NOT COMPLETED|Overall Study||2||
48066313|NCT04587271|100482628|FG005|NOT COMPLETED|Overall Study||0||
48066314|NCT03608254|100482629|FG000|STARTED|Overall Study||11||
48066315|NCT03608254|100482629|FG000|COMPLETED|Overall Study||8||
48066316|NCT03608254|100482629|FG000|NOT COMPLETED|Overall Study||3||
48066317|NCT01823146|100482630|FG000|STARTED|Overall Study||55||
48066318|NCT01823146|100482631|FG001|STARTED|Overall Study||51||
48218676|NCT01198366|100860359|FG003|COMPLETED|Overall Study||47||
48218677|NCT01198366|100860360|FG004|COMPLETED|Overall Study||125||
48218678|NCT01198366|100860361|FG005|COMPLETED|Overall Study||128||
48218679|NCT01198366|100860356|FG000|NOT COMPLETED|Overall Study||12||
48218680|NCT01198366|100860357|FG001|NOT COMPLETED|Overall Study||7||
48509762|NCT02688387|101580253|FG012|COMPLETED|Part 2, Period 3 (up to 6 Days)||5||
48509763|NCT02688387|101580254|FG013|COMPLETED|Part 2, Period 3 (up to 6 Days)||5||
48509764|NCT02688387|101580255|FG014|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48066319|NCT01823146|100482630|FG000|COMPLETED|Overall Study||53||
48066320|NCT01823146|100482631|FG001|COMPLETED|Overall Study||49||
48066321|NCT01823146|100482630|FG000|NOT COMPLETED|Overall Study||2||
48066322|NCT01823146|100482631|FG001|NOT COMPLETED|Overall Study||2||
48218681|NCT01198366|100860358|FG002|NOT COMPLETED|Overall Study||8||
48218682|NCT01198366|100860359|FG003|NOT COMPLETED|Overall Study||5||
48218683|NCT01198366|100860360|FG004|NOT COMPLETED|Overall Study||15||
48218684|NCT01198366|100860361|FG005|NOT COMPLETED|Overall Study||13||
48218685|NCT00411151|100860362|FG000|STARTED|Overall Study||52||
48218686|NCT00411151|100860362|FG000|COMPLETED|Overall Study||5||
48218687|NCT00411151|100860362|FG000|NOT COMPLETED|Overall Study||47||
48218688|NCT03756571|100860363|FG000|STARTED|Overall Study||10||
48218689|NCT03756571|100860364|FG001|STARTED|Overall Study||11||
48218690|NCT03756571|100860363|FG000|COMPLETED|Overall Study||9||
48218691|NCT03756571|100860364|FG001|COMPLETED|Overall Study||10||
48218692|NCT03756571|100860363|FG000|NOT COMPLETED|Overall Study||1||
48218693|NCT03756571|100860364|FG001|NOT COMPLETED|Overall Study||1||
48218694|NCT02910713|100860365|FG000|STARTED|Overall Study||185||
48218695|NCT02910713|100860365|FG000|Safety Population: Entered CAE|Overall Study||171||
48218696|NCT02910713|100860365|FG000|COMPLETED|Overall Study||143||
48218697|NCT02910713|100860365|FG000|NOT COMPLETED|Overall Study||42||
48218698|NCT03921866|100860366|FG000|STARTED|Overall Study||191||
48218699|NCT03921866|100860366|FG000|COMPLETED|Overall Study||191||
48218700|NCT03921866|100860366|FG000|NOT COMPLETED|Overall Study||0||
48218701|NCT03158805|100860367|FG000|STARTED|Overall Study||29||
48218702|NCT03158805|100860368|FG001|STARTED|Overall Study||31||
48066323|NCT01706978|100482632|FG000|STARTED|Overall Study||47||
48066324|NCT01706978|100482633|FG001|STARTED|Overall Study||41||
48066325|NCT01706978|100482632|FG000|COMPLETED|Overall Study||38||
48066326|NCT01706978|100482633|FG001|COMPLETED|Overall Study||35||
48066327|NCT01706978|100482632|FG000|NOT COMPLETED|Overall Study||9||
48066328|NCT01706978|100482633|FG001|NOT COMPLETED|Overall Study||6||
48066329|NCT00333840|100482634|FG000|STARTED|First-line Treatment Period||553||
48218703|NCT03158805|100860367|FG000|COMPLETED|Overall Study||13||
48218704|NCT03158805|100860368|FG001|COMPLETED|Overall Study||8||
48218705|NCT03158805|100860367|FG000|NOT COMPLETED|Overall Study||16||
48218706|NCT03158805|100860368|FG001|NOT COMPLETED|Overall Study||23||
48218707|NCT03794024|100860369|FG000|STARTED|Overall Study||1||
48218708|NCT03794024|100860370|FG001|STARTED|Overall Study||0||
48218709|NCT03794024|100860369|FG000|COMPLETED|Overall Study||0||
48218710|NCT03794024|100860370|FG001|COMPLETED|Overall Study||0||
48218711|NCT03794024|100860369|FG000|NOT COMPLETED|Overall Study||1||
48218712|NCT03794024|100860370|FG001|NOT COMPLETED|Overall Study||0||
48218713|NCT02376790|100860371|FG000|STARTED|Overall Study||284||
48218714|NCT02376790|100860372|FG001|STARTED|Overall Study||284||
48218715|NCT02376790|100860373|FG002|STARTED|Overall Study||283||
48218716|NCT02376790|100860371|FG000|Received Treatment|Overall Study||282||
48218717|NCT02376790|100860372|FG001|Received Treatment|Overall Study||284||
48218718|NCT02376790|100860373|FG002|Received Treatment|Overall Study||282||
48218719|NCT02376790|100860371|FG000|COMPLETED|Overall Study||224||
48218720|NCT02376790|100860372|FG001|COMPLETED|Overall Study||237||
48218721|NCT02376790|100860373|FG002|COMPLETED|Overall Study||230||
48218722|NCT02376790|100860371|FG000|NOT COMPLETED|Overall Study||60||
48218723|NCT02376790|100860372|FG001|NOT COMPLETED|Overall Study||47||
48218724|NCT02376790|100860373|FG002|NOT COMPLETED|Overall Study||53||
48218725|NCT03631407|100863670|FG000|STARTED|Overall Study||21||
48218726|NCT03631407|100863671|FG001|STARTED|Overall Study||20||
48218727|NCT03631407|100863670|FG000|Treated|Overall Study||20||
48218728|NCT03631407|100863671|FG001|Treated|Overall Study||20||
48218729|NCT03631407|100863670|FG000|COMPLETED|Overall Study||1||
48218730|NCT03631407|100863671|FG001|COMPLETED|Overall Study||0||
48218731|NCT03631407|100863670|FG000|NOT COMPLETED|Overall Study||20||
48218732|NCT03631407|100863671|FG001|NOT COMPLETED|Overall Study||20||
48218733|NCT00439270|100863672|FG000|STARTED|Phase 1 (18.1 Months)||3||
48218734|NCT00439270|100863673|FG001|STARTED|Phase 1 (18.1 Months)||3||
48218735|NCT00439270|100863674|FG002|STARTED|Phase 1 (18.1 Months)||3||
48218736|NCT00439270|100863675|FG003|STARTED|Phase 1 (18.1 Months)||4||
48218737|NCT00439270|100863676|FG004|STARTED|Phase 1 (18.1 Months)||3||
48218738|NCT00439270|100863672|FG000|COMPLETED|Phase 1 (18.1 Months)||0||
48218739|NCT00439270|100863673|FG001|COMPLETED|Phase 1 (18.1 Months)||0||
48218740|NCT00439270|100863674|FG002|COMPLETED|Phase 1 (18.1 Months)||0||
48218741|NCT00439270|100863675|FG003|COMPLETED|Phase 1 (18.1 Months)||4||
48218742|NCT00439270|100863676|FG004|COMPLETED|Phase 1 (18.1 Months)||0||
48218743|NCT00439270|100863672|FG000|NOT COMPLETED|Phase 1 (18.1 Months)||3||
48218744|NCT00439270|100863673|FG001|NOT COMPLETED|Phase 1 (18.1 Months)||3||
48218745|NCT00439270|100863674|FG002|NOT COMPLETED|Phase 1 (18.1 Months)||3||
48218746|NCT00439270|100863675|FG003|NOT COMPLETED|Phase 1 (18.1 Months)||0||
48066330|NCT00333840|100482635|FG001|STARTED|First-line Treatment Period||553||
48066331|NCT00333840|100482636|FG002|STARTED|First-line Treatment Period||0||
48218747|NCT00439270|100863676|FG004|NOT COMPLETED|Phase 1 (18.1 Months)||3||
48218748|NCT00439270|100863672|FG000|STARTED|Phase 2 (51.6 Months)||0||
48218749|NCT00439270|100863673|FG001|STARTED|Phase 2 (51.6 Months)||0||
48218750|NCT00439270|100863674|FG002|STARTED|Phase 2 (51.6 Months)||0||
48218751|NCT00439270|100863675|FG003|STARTED|Phase 2 (51.6 Months)||34||
48218752|NCT00439270|100863676|FG004|STARTED|Phase 2 (51.6 Months)||0||
48218753|NCT00439270|100863672|FG000|COMPLETED|Phase 2 (51.6 Months)||0||
48218754|NCT00439270|100863673|FG001|COMPLETED|Phase 2 (51.6 Months)||0||
48218755|NCT00439270|100863674|FG002|COMPLETED|Phase 2 (51.6 Months)||0||
48218756|NCT00439270|100863675|FG003|COMPLETED|Phase 2 (51.6 Months)||0||
48218757|NCT00439270|100863676|FG004|COMPLETED|Phase 2 (51.6 Months)||0||
48218758|NCT00439270|100863672|FG000|NOT COMPLETED|Phase 2 (51.6 Months)||0||
48218759|NCT00439270|100863673|FG001|NOT COMPLETED|Phase 2 (51.6 Months)||0||
48218760|NCT00439270|100863674|FG002|NOT COMPLETED|Phase 2 (51.6 Months)||0||
48218761|NCT00439270|100863675|FG003|NOT COMPLETED|Phase 2 (51.6 Months)||34||
48218762|NCT00439270|100863676|FG004|NOT COMPLETED|Phase 2 (51.6 Months)||0||
48218763|NCT03689920|100863677|FG000|STARTED|Overall Study||47||
48218764|NCT03689920|100863678|FG001|STARTED|Overall Study||52||
48218765|NCT03689920|100863677|FG000|COMPLETED|Overall Study||41||
48218766|NCT03689920|100863678|FG001|COMPLETED|Overall Study||48||
48218767|NCT03689920|100863677|FG000|NOT COMPLETED|Overall Study||6||
48218768|NCT03689920|100863678|FG001|NOT COMPLETED|Overall Study||4||
48218769|NCT00670046|100863679|FG000|STARTED|Overall Study||7||
48218770|NCT00670046|100863680|FG001|STARTED|Overall Study||8||
48218771|NCT00670046|100863679|FG000|COMPLETED|Overall Study||6||
48218772|NCT00670046|100863680|FG001|COMPLETED|Overall Study||6||
48218773|NCT00670046|100863679|FG000|NOT COMPLETED|Overall Study||1||
48218774|NCT00670046|100863680|FG001|NOT COMPLETED|Overall Study||2||
48218775|NCT02767765|100863681|FG000|STARTED|Overall Study||61||
48218776|NCT02767765|100863681|FG000|COMPLETED|Overall Study||50||
48218777|NCT02767765|100863681|FG000|NOT COMPLETED|Overall Study||11||
48218778|NCT04278755|100863682|FG000|STARTED|Overall Study||8||
48218779|NCT04278755|100863682|FG000|COMPLETED|Overall Study||7||
48218780|NCT04278755|100863682|FG000|NOT COMPLETED|Overall Study||1||
48218781|NCT02962284|100863683|FG000|STARTED|Overall Study||9||
48218782|NCT02962284|100863684|FG001|STARTED|Overall Study||11||
48218783|NCT02962284|100863683|FG000|COMPLETED|Overall Study||4||
48218784|NCT02962284|100863684|FG001|COMPLETED|Overall Study||8||
48218785|NCT02962284|100863683|FG000|NOT COMPLETED|Overall Study||5||
48218786|NCT02962284|100863684|FG001|NOT COMPLETED|Overall Study||3||
48218787|NCT02566902|100863685|FG000|STARTED|Overall Study||60||
48218788|NCT02566902|100863686|FG001|STARTED|Overall Study||58||
48066332|NCT00333840|100482637|FG003|STARTED|First-line Treatment Period||0||
48066333|NCT00333840|100482634|FG000|Safety Population; Received Study Drug|First-line Treatment Period||551||
48066334|NCT00333840|100482635|FG001|Safety Population; Received Study Drug|First-line Treatment Period||533||
48066335|NCT00333840|100482636|FG002|Safety Population; Received Study Drug|First-line Treatment Period||0||
48066336|NCT00333840|100482637|FG003|Safety Population; Received Study Drug|First-line Treatment Period||0||
48066337|NCT00333840|100482634|FG000|COMPLETED|First-line Treatment Period||267||
48218789|NCT02566902|100863685|FG000|COMPLETED|Overall Study||58||
48218790|NCT02566902|100863686|FG001|COMPLETED|Overall Study||57||
48218791|NCT02566902|100863685|FG000|NOT COMPLETED|Overall Study||2||
48218792|NCT02566902|100863686|FG001|NOT COMPLETED|Overall Study||1||
48218793|NCT03689946|100863687|FG000|STARTED|Overall Study||55||
48218794|NCT03689946|100863687|FG000|COMPLETED|Overall Study||47||
48218795|NCT03689946|100863687|FG000|NOT COMPLETED|Overall Study||8||
48218796|NCT01532648|100863688|FG000|STARTED|Overall Study||255||
48218797|NCT01532648|100863689|FG001|STARTED|Overall Study||255||
48218798|NCT01532648|100863688|FG000|Safety Population|Overall Study||255|All randomized participants who received at least 1 dose of study drug|
48218799|NCT01532648|100863689|FG001|Safety Population|Overall Study||255|All randomized participants who received at least 1 dose of study drug|
48218800|NCT01532648|100863688|FG000|Intent-To-Treat Population|Overall Study||230|Participants in Safety Population with active ulcerative colitis at study entry as cause of symptoms|
48218801|NCT01532648|100863689|FG001|Intent-To-Treat Population|Overall Study||228|Participants in Safety Population with active ulcerative colitis at study entry as cause of symptoms|
48066338|NCT00333840|100482635|FG001|COMPLETED|First-line Treatment Period||7||
48066339|NCT00333840|100482636|FG002|COMPLETED|First-line Treatment Period||0||
48066340|NCT00333840|100482637|FG003|COMPLETED|First-line Treatment Period||0||
48066341|NCT00333840|100482634|FG000|NOT COMPLETED|First-line Treatment Period||286||
48066342|NCT00333840|100482635|FG001|NOT COMPLETED|First-line Treatment Period||546||
48066343|NCT00333840|100482636|FG002|NOT COMPLETED|First-line Treatment Period||0||
48066344|NCT00333840|100482637|FG003|NOT COMPLETED|First-line Treatment Period||0||
48066345|NCT00333840|100482634|FG000|STARTED|Second-line Treatment Period||0||
48218802|NCT01532648|100863688|FG000|COMPLETED|Overall Study||219||
48218803|NCT01532648|100863689|FG001|COMPLETED|Overall Study||238||
48218804|NCT01532648|100863688|FG000|NOT COMPLETED|Overall Study||36||
48218805|NCT01532648|100863689|FG001|NOT COMPLETED|Overall Study||17||
48218806|NCT01119755|100863690|FG000|STARTED|Overall Study||80||
48218807|NCT01119755|100863690|FG000|COMPLETED|Overall Study||80||
48218808|NCT01119755|100863690|FG000|NOT COMPLETED|Overall Study||0||
48218809|NCT01596972|100863691|FG000|STARTED|Overall Study||25||
48218810|NCT01596972|100863692|FG001|STARTED|Overall Study||26||
48218811|NCT01596972|100863691|FG000|COMPLETED|Overall Study||24||
48218812|NCT01596972|100863692|FG001|COMPLETED|Overall Study||12||
48218813|NCT01596972|100863691|FG000|NOT COMPLETED|Overall Study||1||
48218814|NCT01596972|100863692|FG001|NOT COMPLETED|Overall Study||14||
48218815|NCT00491894|100863693|FG000|STARTED|Overall Study||137||
48218816|NCT00491894|100863693|FG000|COMPLETED|Overall Study||103||
48218817|NCT00491894|100863693|FG000|NOT COMPLETED|Overall Study||34||
48218818|NCT02251652|100863694|FG000|STARTED|Overall Study||17||
48218819|NCT02251652|100863694|FG000|COMPLETED|Overall Study||16||
48218820|NCT02251652|100863694|FG000|NOT COMPLETED|Overall Study||1||
48218821|NCT01637402|100863695|FG000|STARTED|Standard Dose Regimen||41||
48218822|NCT01637402|100863696|FG001|STARTED|Standard Dose Regimen||0||
48218823|NCT01637402|100863695|FG000|COMPLETED|Standard Dose Regimen||38||
48218824|NCT01637402|100863696|FG001|COMPLETED|Standard Dose Regimen||0||
48218825|NCT01637402|100863695|FG000|NOT COMPLETED|Standard Dose Regimen||3||
48218826|NCT01637402|100863696|FG001|NOT COMPLETED|Standard Dose Regimen||0||
48218827|NCT01637402|100863695|FG000|STARTED|Week 12 Evaluation||38||
48218828|NCT01637402|100863696|FG001|STARTED|Week 12 Evaluation||0||
48218829|NCT01637402|100863695|FG000|COMPLETED|Week 12 Evaluation||32||
48218830|NCT01637402|100863696|FG001|COMPLETED|Week 12 Evaluation||0||
48218831|NCT01637402|100863695|FG000|NOT COMPLETED|Week 12 Evaluation||6||
48218832|NCT01637402|100863696|FG001|NOT COMPLETED|Week 12 Evaluation||0||
48218833|NCT01637402|100863695|FG000|STARTED|Treatment Regiments Post Week 12||14||
48218834|NCT01637402|100863696|FG001|STARTED|Treatment Regiments Post Week 12||18||
48218835|NCT01637402|100863695|FG000|COMPLETED|Treatment Regiments Post Week 12||5||
48218836|NCT01637402|100863696|FG001|COMPLETED|Treatment Regiments Post Week 12||14||
48218837|NCT01637402|100863695|FG000|NOT COMPLETED|Treatment Regiments Post Week 12||9||
48218838|NCT01637402|100863696|FG001|NOT COMPLETED|Treatment Regiments Post Week 12||4||
48218839|NCT05824559|100863697|FG000|STARTED|Overall Study||23||
48218840|NCT05824559|100863697|FG000|COMPLETED|Overall Study||0||
48218841|NCT05824559|100863697|FG000|NOT COMPLETED|Overall Study||23||
48218842|NCT01629589|100863698|FG000|STARTED|Overall Study||212||
48218843|NCT01629589|100863699|FG001|STARTED|Overall Study||211||
48218844|NCT01629589|100863698|FG000|COMPLETED|Overall Study||204||
48218845|NCT01629589|100863699|FG001|COMPLETED|Overall Study||204||
48218846|NCT01629589|100863698|FG000|NOT COMPLETED|Overall Study||8||
48218847|NCT01629589|100863699|FG001|NOT COMPLETED|Overall Study||7||
48218848|NCT02852824|100863700|FG000|STARTED|Overall Study||8|Number of entered/treated subjects|
48218849|NCT02852824|100863701|FG001|STARTED|Overall Study||6|Number of entered/treated subjects|
48218850|NCT02852824|100863702|FG002|STARTED|Overall Study||6|Number of entered/treated subjects|
48218851|NCT02852824|100863703|FG003|STARTED|Overall Study||6|Number of entered/treated subjects|
48218852|NCT02852824|100863704|FG004|STARTED|Overall Study||6|Number of entered/treated subjects|
48218853|NCT02852824|100863705|FG005|STARTED|Overall Study||2|Number of entered/treated subjects|
48218854|NCT02852824|100863706|FG006|STARTED|Overall Study||6|Number of entered/treated subjects|
48218855|NCT02852824|100863700|FG000|COMPLETED|Overall Study||7|Completed planned observation time|
48218856|NCT02852824|100863701|FG001|COMPLETED|Overall Study||6|Completed planned observation time|
48218857|NCT02852824|100863702|FG002|COMPLETED|Overall Study||6|Completed planned observation time|
48218858|NCT02852824|100863703|FG003|COMPLETED|Overall Study||6|Completed planned observation time|
48218859|NCT02852824|100863704|FG004|COMPLETED|Overall Study||4|Completed planned observation time|
48218860|NCT02852824|100863705|FG005|COMPLETED|Overall Study||2|Completed planned observation time|
48218861|NCT02852824|100863706|FG006|COMPLETED|Overall Study||6|Completed planned observation time|
48218862|NCT02852824|100863700|FG000|NOT COMPLETED|Overall Study||1||
48218863|NCT02852824|100863701|FG001|NOT COMPLETED|Overall Study||0||
48218864|NCT02852824|100863702|FG002|NOT COMPLETED|Overall Study||0||
48218865|NCT02852824|100863703|FG003|NOT COMPLETED|Overall Study||0||
48218866|NCT02852824|100863704|FG004|NOT COMPLETED|Overall Study||2||
48218867|NCT02852824|100863705|FG005|NOT COMPLETED|Overall Study||0||
48218868|NCT02852824|100863706|FG006|NOT COMPLETED|Overall Study||0||
48218869|NCT03803475|100863707|FG000|STARTED|Overall Study||485||
48218870|NCT03803475|100863707|FG000|COMPLETED|Overall Study||484||
48218871|NCT03803475|100863707|FG000|NOT COMPLETED|Overall Study||1||
48218872|NCT02499159|100863708|FG000|STARTED|Randomization||50||
48218873|NCT02499159|100863709|FG001|STARTED|Randomization||50||
48218874|NCT02499159|100863708|FG000|COMPLETED|Randomization||49||
48218875|NCT02499159|100863709|FG001|COMPLETED|Randomization||49||
48218876|NCT02499159|100863708|FG000|NOT COMPLETED|Randomization||1||
48218877|NCT02499159|100863709|FG001|NOT COMPLETED|Randomization||1||
48218878|NCT02499159|100863708|FG000|STARTED|30-Day Follow-Up Phone Call||49||
48218879|NCT02499159|100863709|FG001|STARTED|30-Day Follow-Up Phone Call||49||
48218880|NCT02499159|100863708|FG000|COMPLETED|30-Day Follow-Up Phone Call||42||
48218881|NCT02499159|100863709|FG001|COMPLETED|30-Day Follow-Up Phone Call||47||
48218882|NCT02499159|100863708|FG000|NOT COMPLETED|30-Day Follow-Up Phone Call||7||
48218883|NCT02499159|100863709|FG001|NOT COMPLETED|30-Day Follow-Up Phone Call||2||
48218884|NCT03509909|100863710|FG000|STARTED|Overall Study||67||
48218885|NCT03509909|100863711|FG001|STARTED|Overall Study||50||
48218886|NCT03509909|100863710|FG000|COMPLETED|Overall Study||46||
48218887|NCT03509909|100863711|FG001|COMPLETED|Overall Study||37||
48218888|NCT03509909|100863710|FG000|NOT COMPLETED|Overall Study||21||
48218889|NCT03509909|100863711|FG001|NOT COMPLETED|Overall Study||13||
48218890|NCT04110743|100863712|FG000|STARTED|Overall Study||15||
48218891|NCT04110743|100863713|FG001|STARTED|Overall Study||15||
48218892|NCT04110743|100863714|FG002|STARTED|Overall Study||0||
48218893|NCT04110743|100863712|FG000|COMPLETED|Overall Study||15||
48218894|NCT04110743|100863713|FG001|COMPLETED|Overall Study||15||
48218895|NCT04110743|100863714|FG002|COMPLETED|Overall Study||0||
48218896|NCT04110743|100863712|FG000|NOT COMPLETED|Overall Study||0||
48218897|NCT04110743|100863713|FG001|NOT COMPLETED|Overall Study||0||
48218898|NCT04110743|100863714|FG002|NOT COMPLETED|Overall Study||0||
48218899|NCT02494336|100863715|FG000|STARTED|Overall Study||24||
48218900|NCT02494336|100863716|FG001|STARTED|Overall Study||24||
48218901|NCT02494336|100863715|FG000|COMPLETED|Overall Study||24||
48218902|NCT02494336|100863716|FG001|COMPLETED|Overall Study||24||
48218903|NCT02494336|100863715|FG000|NOT COMPLETED|Overall Study||0||
48218904|NCT02494336|100863716|FG001|NOT COMPLETED|Overall Study||0||
48218905|NCT02299349|100863717|FG000|STARTED|Overall Study||35||
48218906|NCT02299349|100863718|FG001|STARTED|Overall Study||35||
48218907|NCT02299349|100863717|FG000|COMPLETED|Overall Study||35||
48218908|NCT02299349|100863718|FG001|COMPLETED|Overall Study||35||
48218909|NCT02299349|100863717|FG000|NOT COMPLETED|Overall Study||0||
48218910|NCT02299349|100863718|FG001|NOT COMPLETED|Overall Study||0||
48218911|NCT04612868|100863719|FG000|STARTED|Overall Study||531||
48218912|NCT04612868|100863719|FG000|Analyzable|Overall Study||468||
48218913|NCT04612868|100863719|FG000|COMPLETED|Overall Study||462||
48218914|NCT04612868|100863719|FG000|NOT COMPLETED|Overall Study||69||
48218915|NCT00879710|100863720|FG000|STARTED|Phase 1 - 6 Weeks||12||
48218916|NCT00879710|100863721|FG001|STARTED|Phase 1 - 6 Weeks||17||
48218917|NCT00879710|100863722|FG002|STARTED|Phase 1 - 6 Weeks||11||
48218918|NCT00879710|100863723|FG003|STARTED|Phase 1 - 6 Weeks||17||
48218919|NCT00879710|100863720|FG000|COMPLETED|Phase 1 - 6 Weeks||10||
48218920|NCT00879710|100863721|FG001|COMPLETED|Phase 1 - 6 Weeks||14||
48218921|NCT00879710|100863722|FG002|COMPLETED|Phase 1 - 6 Weeks||9||
48218922|NCT00879710|100863723|FG003|COMPLETED|Phase 1 - 6 Weeks||13||
48218923|NCT00879710|100863720|FG000|NOT COMPLETED|Phase 1 - 6 Weeks||2||
48218924|NCT00879710|100863721|FG001|NOT COMPLETED|Phase 1 - 6 Weeks||3||
48218925|NCT00879710|100863722|FG002|NOT COMPLETED|Phase 1 - 6 Weeks||2||
48218926|NCT00879710|100863723|FG003|NOT COMPLETED|Phase 1 - 6 Weeks||4||
48218927|NCT00879710|100863720|FG000|STARTED|Wash Out Period of 4 Weeks||10||
48218928|NCT00879710|100863721|FG001|STARTED|Wash Out Period of 4 Weeks||14||
48218929|NCT00879710|100863722|FG002|STARTED|Wash Out Period of 4 Weeks||10||
48218930|NCT00879710|100863723|FG003|STARTED|Wash Out Period of 4 Weeks||13||
48218931|NCT00879710|100863720|FG000|COMPLETED|Wash Out Period of 4 Weeks||10||
48218932|NCT00879710|100863721|FG001|COMPLETED|Wash Out Period of 4 Weeks||14||
48218933|NCT00879710|100863722|FG002|COMPLETED|Wash Out Period of 4 Weeks||10||
48218934|NCT00879710|100863723|FG003|COMPLETED|Wash Out Period of 4 Weeks||13||
48218935|NCT00879710|100863720|FG000|NOT COMPLETED|Wash Out Period of 4 Weeks||0||
48218936|NCT00879710|100863721|FG001|NOT COMPLETED|Wash Out Period of 4 Weeks||0||
48218937|NCT00879710|100863722|FG002|NOT COMPLETED|Wash Out Period of 4 Weeks||0||
48218938|NCT00879710|100863723|FG003|NOT COMPLETED|Wash Out Period of 4 Weeks||0||
48218939|NCT00879710|100863720|FG000|STARTED|Phase 2 6 Weeks||10||
48218940|NCT00879710|100863721|FG001|STARTED|Phase 2 6 Weeks||14||
48218941|NCT00879710|100863722|FG002|STARTED|Phase 2 6 Weeks||10||
48218942|NCT00879710|100863723|FG003|STARTED|Phase 2 6 Weeks||13||
48218943|NCT00879710|100863720|FG000|COMPLETED|Phase 2 6 Weeks||10||
48218944|NCT00879710|100863721|FG001|COMPLETED|Phase 2 6 Weeks||14||
48218945|NCT00879710|100863722|FG002|COMPLETED|Phase 2 6 Weeks||10||
48218946|NCT00879710|100863723|FG003|COMPLETED|Phase 2 6 Weeks||13||
48218947|NCT00879710|100863720|FG000|NOT COMPLETED|Phase 2 6 Weeks||0||
48218948|NCT00879710|100863721|FG001|NOT COMPLETED|Phase 2 6 Weeks||0||
48218949|NCT00879710|100863722|FG002|NOT COMPLETED|Phase 2 6 Weeks||0||
48218950|NCT00879710|100863723|FG003|NOT COMPLETED|Phase 2 6 Weeks||0||
48218951|NCT04876417|100863724|FG000|STARTED|Overall Study||27||
48218952|NCT04876417|100863725|FG001|STARTED|Overall Study||27||
48218953|NCT04876417|100863726|FG002|STARTED|Overall Study||10||
48218954|NCT04876417|100863727|FG003|STARTED|Overall Study||10||
48218955|NCT04876417|100863724|FG000|COMPLETED|Overall Study||22||
48218956|NCT04876417|100863725|FG001|COMPLETED|Overall Study||19||
48218957|NCT04876417|100863726|FG002|COMPLETED|Overall Study||10||
48218958|NCT04876417|100863727|FG003|COMPLETED|Overall Study||10||
48218959|NCT04876417|100863724|FG000|NOT COMPLETED|Overall Study||5||
48218960|NCT04876417|100863725|FG001|NOT COMPLETED|Overall Study||8||
48218961|NCT04876417|100863726|FG002|NOT COMPLETED|Overall Study||0||
48218962|NCT04876417|100863727|FG003|NOT COMPLETED|Overall Study||0||
48218963|NCT00918203|100863728|FG000|STARTED|Treatment With or Without Olaratumab||70||
48218964|NCT00918203|100863729|FG001|STARTED|Treatment With or Without Olaratumab||67||
48218965|NCT00918203|100863730|FG002|STARTED|Treatment With or Without Olaratumab||0||
48218966|NCT00918203|100863728|FG000|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||67||
48218967|NCT00918203|100863729|FG001|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||64||
48218968|NCT00918203|100863730|FG002|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||0||
48218969|NCT00918203|100863728|FG000|Death Due to Any Cause|Treatment With or Without Olaratumab||53||
48218970|NCT00918203|100863729|FG001|Death Due to Any Cause|Treatment With or Without Olaratumab||47||
48218971|NCT00918203|100863730|FG002|Death Due to Any Cause|Treatment With or Without Olaratumab||0||
48218972|NCT00918203|100863728|FG000|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||11||
48218973|NCT00918203|100863729|FG001|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||10||
48218974|NCT00918203|100863730|FG002|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||0||
48218975|NCT00918203|100863728|FG000|COMPLETED|Treatment With or Without Olaratumab||64||
48218976|NCT00918203|100863729|FG001|COMPLETED|Treatment With or Without Olaratumab||57||
48218977|NCT00918203|100863730|FG002|COMPLETED|Treatment With or Without Olaratumab||0||
48218978|NCT00918203|100863728|FG000|NOT COMPLETED|Treatment With or Without Olaratumab||6||
48218979|NCT00918203|100863729|FG001|NOT COMPLETED|Treatment With or Without Olaratumab||10||
48218980|NCT00918203|100863730|FG002|NOT COMPLETED|Treatment With or Without Olaratumab||0||
48218981|NCT00918203|100863728|FG000|STARTED|Crossover to Olaratumab Monotherapy||0||
48218982|NCT00918203|100863729|FG001|STARTED|Crossover to Olaratumab Monotherapy||0||
48218983|NCT00918203|100863730|FG002|STARTED|Crossover to Olaratumab Monotherapy||18||
48218984|NCT00918203|100863728|FG000|COMPLETED|Crossover to Olaratumab Monotherapy||0||
48218985|NCT00918203|100863729|FG001|COMPLETED|Crossover to Olaratumab Monotherapy||0||
48218986|NCT00918203|100863730|FG002|COMPLETED|Crossover to Olaratumab Monotherapy||18||
48218987|NCT00918203|100863728|FG000|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0||
48218988|NCT00918203|100863729|FG001|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0||
48218989|NCT00918203|100863730|FG002|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0||
48218990|NCT03611075|100863731|FG000|STARTED|Overall Study||16||
48218991|NCT03611075|100863732|FG001|STARTED|Overall Study||15||
48218992|NCT03611075|100863733|FG002|STARTED|Overall Study||16||
48218993|NCT03611075|100863734|FG003|STARTED|Overall Study||17||
48218994|NCT03611075|100863735|FG004|STARTED|Overall Study||13||
48218995|NCT03611075|100863736|FG005|STARTED|Overall Study||18||
48218996|NCT03611075|100863737|FG006|STARTED|Overall Study||15||
48218997|NCT03611075|100863738|FG007|STARTED|Overall Study||17||
48218998|NCT03611075|100863739|FG008|STARTED|Overall Study||17||
48218999|NCT03611075|100863731|FG000|COMPLETED|Overall Study||15||
48219000|NCT03611075|100863732|FG001|COMPLETED|Overall Study||13||
48219001|NCT03611075|100863733|FG002|COMPLETED|Overall Study||14||
48219002|NCT03611075|100863734|FG003|COMPLETED|Overall Study||13||
48219003|NCT03611075|100863735|FG004|COMPLETED|Overall Study||13||
48219004|NCT03611075|100863736|FG005|COMPLETED|Overall Study||18||
48219005|NCT03611075|100863737|FG006|COMPLETED|Overall Study||13||
48219006|NCT03611075|100863738|FG007|COMPLETED|Overall Study||17||
48219007|NCT03611075|100863739|FG008|COMPLETED|Overall Study||17||
48219008|NCT03611075|100863731|FG000|NOT COMPLETED|Overall Study||1||
48219009|NCT03611075|100863732|FG001|NOT COMPLETED|Overall Study||2||
48219010|NCT03611075|100863733|FG002|NOT COMPLETED|Overall Study||2||
48219011|NCT03611075|100863734|FG003|NOT COMPLETED|Overall Study||4||
48219012|NCT03611075|100863735|FG004|NOT COMPLETED|Overall Study||0||
48219013|NCT03611075|100863736|FG005|NOT COMPLETED|Overall Study||0||
48219014|NCT03611075|100863737|FG006|NOT COMPLETED|Overall Study||2||
48219015|NCT03611075|100863738|FG007|NOT COMPLETED|Overall Study||0||
48219016|NCT03611075|100863739|FG008|NOT COMPLETED|Overall Study||0||
48219017|NCT02348632|100863740|FG000|STARTED|Open-label Period||643||
48219018|NCT02348632|100863741|FG001|STARTED|Open-label Period||0||
48219019|NCT02348632|100863740|FG000|COMPLETED|Open-label Period||458||
48219020|NCT02348632|100863741|FG001|COMPLETED|Open-label Period||0||
48219021|NCT02348632|100863740|FG000|NOT COMPLETED|Open-label Period||185||
48219022|NCT02348632|100863741|FG001|NOT COMPLETED|Open-label Period||0||
48219023|NCT02348632|100863740|FG000|STARTED|Randomized Withdrawal Period||140||
48219024|NCT02348632|100863741|FG001|STARTED|Randomized Withdrawal Period||142||
48219025|NCT02348632|100863740|FG000|COMPLETED|Randomized Withdrawal Period||137||
48219026|NCT02348632|100863741|FG001|COMPLETED|Randomized Withdrawal Period||141||
48219027|NCT02348632|100863740|FG000|NOT COMPLETED|Randomized Withdrawal Period||3||
48219028|NCT02348632|100863741|FG001|NOT COMPLETED|Randomized Withdrawal Period||1||
48219029|NCT00093496|100863742|FG000|STARTED|Overall Study||15||
48219030|NCT00093496|100863743|FG001|STARTED|Overall Study||14||
48219031|NCT00093496|100863742|FG000|COMPLETED|Overall Study||14||
48219032|NCT00093496|100863743|FG001|COMPLETED|Overall Study||11||
48219033|NCT00093496|100863742|FG000|NOT COMPLETED|Overall Study||1||
48219034|NCT00093496|100863743|FG001|NOT COMPLETED|Overall Study||3||
48219035|NCT00811941|100863744|FG000|STARTED|All Randomised Patients||166||
48219036|NCT00811941|100863745|FG001|STARTED|All Randomised Patients||509||
48219037|NCT00811941|100863744|FG000|COMPLETED|All Randomised Patients||164||
48219038|NCT00811941|100863745|FG001|COMPLETED|All Randomised Patients||501||
48219039|NCT00811941|100863744|FG000|NOT COMPLETED|All Randomised Patients||2||
48219040|NCT00811941|100863745|FG001|NOT COMPLETED|All Randomised Patients||8||
48219041|NCT00811941|100863744|FG000|STARTED|All Treated Patients||164||
48219042|NCT00811941|100863745|FG001|STARTED|All Treated Patients||501||
48219043|NCT00811941|100863744|FG000|COMPLETED|All Treated Patients||112||
48219044|NCT00811941|100863745|FG001|COMPLETED|All Treated Patients||310||
48219045|NCT00811941|100863744|FG000|NOT COMPLETED|All Treated Patients||52||
48219046|NCT00811941|100863745|FG001|NOT COMPLETED|All Treated Patients||191||
48219047|NCT02130557|100863746|FG000|STARTED|Overall Study||268||
48219048|NCT02130557|100863747|FG001|STARTED|Overall Study||268||
48219049|NCT02130557|100863746|FG000|Treated|Overall Study||268||
48219050|NCT02130557|100863747|FG001|Treated|Overall Study||265||
48219051|NCT02130557|100863746|FG000|mITT Population|Overall Study||246||
48219052|NCT02130557|100863747|FG001|mITT Population|Overall Study||241||
48219053|NCT02130557|100863746|FG000|COMPLETED|Overall Study||232||
48219054|NCT02130557|100863747|FG001|COMPLETED|Overall Study||231||
48219055|NCT02130557|100863746|FG000|NOT COMPLETED|Overall Study||36||
48219056|NCT02130557|100863747|FG001|NOT COMPLETED|Overall Study||37||
48219057|NCT05580003|100863748|FG000|STARTED|Part (P) 1 Treatment Period 1 (Day 1)||2||
48219058|NCT05580003|100863749|FG001|STARTED|Part (P) 1 Treatment Period 1 (Day 1)||2||
48219059|NCT05580003|100863750|FG002|STARTED|Part (P) 1 Treatment Period 1 (Day 1)||2||
48219060|NCT05580003|100863751|FG003|STARTED|Part (P) 1 Treatment Period 1 (Day 1)||2||
48219061|NCT05580003|100863752|FG004|STARTED|Part (P) 1 Treatment Period 1 (Day 1)||2||
48219062|NCT05580003|100863753|FG005|STARTED|Part (P) 1 Treatment Period 1 (Day 1)||2||
48219063|NCT05580003|100863754|FG006|STARTED|Part (P) 1 Treatment Period 1 (Day 1)||4||
48219064|NCT05580003|100863755|FG007|STARTED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219065|NCT05580003|100863756|FG008|STARTED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219066|NCT05580003|100863757|FG009|STARTED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219067|NCT05580003|100863758|FG010|STARTED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219068|NCT05580003|100863759|FG011|STARTED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219069|NCT05580003|100863760|FG012|STARTED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219070|NCT05580003|100863761|FG013|STARTED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219071|NCT05580003|100863762|FG014|STARTED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219072|NCT05580003|100863763|FG015|STARTED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219073|NCT05580003|100863764|FG016|STARTED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219074|NCT05580003|100863765|FG017|STARTED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219075|NCT05580003|100863766|FG018|STARTED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219076|NCT05580003|100863767|FG019|STARTED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219077|NCT05580003|100863768|FG020|STARTED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219078|NCT05580003|100863769|FG021|STARTED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219079|NCT05580003|100863770|FG022|STARTED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219080|NCT05580003|100863771|FG023|STARTED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219081|NCT05580003|100863772|FG024|STARTED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219082|NCT05580003|100863773|FG025|STARTED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219083|NCT05580003|100863774|FG026|STARTED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219084|NCT05580003|100863775|FG027|STARTED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219085|NCT05580003|100863748|FG000|COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||2||
48219086|NCT05580003|100863749|FG001|COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||2||
48219087|NCT05580003|100863750|FG002|COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||2||
48219088|NCT05580003|100863751|FG003|COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||2||
48219089|NCT05580003|100863752|FG004|COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||2||
48219090|NCT05580003|100863753|FG005|COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||2||
48219091|NCT05580003|100863754|FG006|COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||3||
48219092|NCT05580003|100863755|FG007|COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219093|NCT05580003|100863756|FG008|COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219094|NCT05580003|100863757|FG009|COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219095|NCT05580003|100863758|FG010|COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219096|NCT05580003|100863759|FG011|COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219097|NCT05580003|100863760|FG012|COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219098|NCT05580003|100863761|FG013|COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219099|NCT05580003|100863762|FG014|COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219100|NCT05580003|100863763|FG015|COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219101|NCT05580003|100863764|FG016|COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219102|NCT05580003|100863765|FG017|COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219103|NCT05580003|100863766|FG018|COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219104|NCT05580003|100863767|FG019|COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219105|NCT05580003|100863768|FG020|COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219106|NCT05580003|100863769|FG021|COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219107|NCT05580003|100863770|FG022|COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219108|NCT05580003|100863771|FG023|COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219109|NCT05580003|100863772|FG024|COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219110|NCT05580003|100863773|FG025|COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219111|NCT05580003|100863774|FG026|COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219112|NCT05580003|100863775|FG027|COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219113|NCT05580003|100863748|FG000|NOT COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219114|NCT05580003|100863749|FG001|NOT COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219115|NCT05580003|100863750|FG002|NOT COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219116|NCT05580003|100863751|FG003|NOT COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219117|NCT05580003|100863752|FG004|NOT COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219118|NCT05580003|100863753|FG005|NOT COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219119|NCT05580003|100863754|FG006|NOT COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||1||
48219120|NCT05580003|100863755|FG007|NOT COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219121|NCT05580003|100863756|FG008|NOT COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219122|NCT05580003|100863757|FG009|NOT COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219123|NCT05580003|100863758|FG010|NOT COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219124|NCT05580003|100863759|FG011|NOT COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219125|NCT05580003|100863760|FG012|NOT COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219126|NCT05580003|100863761|FG013|NOT COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219127|NCT05580003|100863762|FG014|NOT COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219128|NCT05580003|100863763|FG015|NOT COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219129|NCT05580003|100863764|FG016|NOT COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219130|NCT05580003|100863765|FG017|NOT COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219131|NCT05580003|100863766|FG018|NOT COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219132|NCT05580003|100863767|FG019|NOT COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219133|NCT05580003|100863768|FG020|NOT COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219134|NCT05580003|100863769|FG021|NOT COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219135|NCT05580003|100863770|FG022|NOT COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219136|NCT05580003|100863771|FG023|NOT COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219137|NCT05580003|100863772|FG024|NOT COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219138|NCT05580003|100863773|FG025|NOT COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219139|NCT05580003|100863774|FG026|NOT COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219140|NCT05580003|100863775|FG027|NOT COMPLETED|Part (P) 1 Treatment Period 1 (Day 1)||0||
48219141|NCT05580003|100863748|FG000|STARTED|Part 1: Washout 1 (up to 5 Days)||2||
48219142|NCT05580003|100863749|FG001|STARTED|Part 1: Washout 1 (up to 5 Days)||2||
48219143|NCT05580003|100863750|FG002|STARTED|Part 1: Washout 1 (up to 5 Days)||2||
48219144|NCT05580003|100863751|FG003|STARTED|Part 1: Washout 1 (up to 5 Days)||2||
48219145|NCT05580003|100863752|FG004|STARTED|Part 1: Washout 1 (up to 5 Days)||2||
48219146|NCT05580003|100863753|FG005|STARTED|Part 1: Washout 1 (up to 5 Days)||2||
48219147|NCT05580003|100863754|FG006|STARTED|Part 1: Washout 1 (up to 5 Days)||3||
48219148|NCT05580003|100863755|FG007|STARTED|Part 1: Washout 1 (up to 5 Days)||0||
48219149|NCT05580003|100863756|FG008|STARTED|Part 1: Washout 1 (up to 5 Days)||0||
48219150|NCT05580003|100863757|FG009|STARTED|Part 1: Washout 1 (up to 5 Days)||0||
48219151|NCT05580003|100863758|FG010|STARTED|Part 1: Washout 1 (up to 5 Days)||0||
48219152|NCT05580003|100863759|FG011|STARTED|Part 1: Washout 1 (up to 5 Days)||0||
48219153|NCT05580003|100863760|FG012|STARTED|Part 1: Washout 1 (up to 5 Days)||0||
48219154|NCT05580003|100863761|FG013|STARTED|Part 1: Washout 1 (up to 5 Days)||0||
48219155|NCT05580003|100863762|FG014|STARTED|Part 1: Washout 1 (up to 5 Days)||0||
48219156|NCT05580003|100863763|FG015|STARTED|Part 1: Washout 1 (up to 5 Days)||0||
48219157|NCT05580003|100863764|FG016|STARTED|Part 1: Washout 1 (up to 5 Days)||0||
48219158|NCT05580003|100863765|FG017|STARTED|Part 1: Washout 1 (up to 5 Days)||0||
48219159|NCT05580003|100863766|FG018|STARTED|Part 1: Washout 1 (up to 5 Days)||0||
48219160|NCT05580003|100863767|FG019|STARTED|Part 1: Washout 1 (up to 5 Days)||0||
48219161|NCT05580003|100863768|FG020|STARTED|Part 1: Washout 1 (up to 5 Days)||0||
48219162|NCT05580003|100863769|FG021|STARTED|Part 1: Washout 1 (up to 5 Days)||0||
48219163|NCT05580003|100863770|FG022|STARTED|Part 1: Washout 1 (up to 5 Days)||0||
48219164|NCT05580003|100863771|FG023|STARTED|Part 1: Washout 1 (up to 5 Days)||0||
48219165|NCT05580003|100863772|FG024|STARTED|Part 1: Washout 1 (up to 5 Days)||0||
48219166|NCT05580003|100863773|FG025|STARTED|Part 1: Washout 1 (up to 5 Days)||0||
48219167|NCT05580003|100863774|FG026|STARTED|Part 1: Washout 1 (up to 5 Days)||0||
48219168|NCT05580003|100863775|FG027|STARTED|Part 1: Washout 1 (up to 5 Days)||0||
48219169|NCT05580003|100863748|FG000|COMPLETED|Part 1: Washout 1 (up to 5 Days)||2||
48219170|NCT05580003|100863749|FG001|COMPLETED|Part 1: Washout 1 (up to 5 Days)||2||
48219171|NCT05580003|100863750|FG002|COMPLETED|Part 1: Washout 1 (up to 5 Days)||2||
48219172|NCT05580003|100863751|FG003|COMPLETED|Part 1: Washout 1 (up to 5 Days)||2||
48219173|NCT05580003|100863752|FG004|COMPLETED|Part 1: Washout 1 (up to 5 Days)||2||
48219174|NCT05580003|100863753|FG005|COMPLETED|Part 1: Washout 1 (up to 5 Days)||2||
48219175|NCT05580003|100863754|FG006|COMPLETED|Part 1: Washout 1 (up to 5 Days)||3||
48219176|NCT05580003|100863755|FG007|COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219177|NCT05580003|100863756|FG008|COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219178|NCT05580003|100863757|FG009|COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219179|NCT05580003|100863758|FG010|COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219180|NCT05580003|100863759|FG011|COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219181|NCT05580003|100863760|FG012|COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219182|NCT05580003|100863761|FG013|COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219183|NCT05580003|100863762|FG014|COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219184|NCT05580003|100863763|FG015|COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219185|NCT05580003|100863764|FG016|COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219186|NCT05580003|100863765|FG017|COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219187|NCT05580003|100863766|FG018|COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219188|NCT05580003|100863767|FG019|COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219189|NCT05580003|100863768|FG020|COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219190|NCT05580003|100863769|FG021|COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219191|NCT05580003|100863770|FG022|COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219192|NCT05580003|100863771|FG023|COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219193|NCT05580003|100863772|FG024|COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219194|NCT05580003|100863773|FG025|COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219195|NCT05580003|100863774|FG026|COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219196|NCT05580003|100863775|FG027|COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219197|NCT05580003|100863748|FG000|NOT COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219198|NCT05580003|100863749|FG001|NOT COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219199|NCT05580003|100863750|FG002|NOT COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219200|NCT05580003|100863751|FG003|NOT COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219201|NCT05580003|100863752|FG004|NOT COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219202|NCT05580003|100863753|FG005|NOT COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219203|NCT05580003|100863754|FG006|NOT COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219204|NCT05580003|100863755|FG007|NOT COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219205|NCT05580003|100863756|FG008|NOT COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219206|NCT05580003|100863757|FG009|NOT COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219207|NCT05580003|100863758|FG010|NOT COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219208|NCT05580003|100863759|FG011|NOT COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219209|NCT05580003|100863760|FG012|NOT COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219210|NCT05580003|100863761|FG013|NOT COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219211|NCT05580003|100863762|FG014|NOT COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219212|NCT05580003|100863763|FG015|NOT COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219213|NCT05580003|100863764|FG016|NOT COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219214|NCT05580003|100863765|FG017|NOT COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219215|NCT05580003|100863766|FG018|NOT COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219216|NCT05580003|100863767|FG019|NOT COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219217|NCT05580003|100863768|FG020|NOT COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219218|NCT05580003|100863769|FG021|NOT COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219219|NCT05580003|100863770|FG022|NOT COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219220|NCT05580003|100863771|FG023|NOT COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219221|NCT05580003|100863772|FG024|NOT COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219222|NCT05580003|100863773|FG025|NOT COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219223|NCT05580003|100863774|FG026|NOT COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219224|NCT05580003|100863775|FG027|NOT COMPLETED|Part 1: Washout 1 (up to 5 Days)||0||
48219225|NCT05580003|100863748|FG000|STARTED|Part 1 Treatment Period 2 (Day 1)||2||
48219226|NCT05580003|100863749|FG001|STARTED|Part 1 Treatment Period 2 (Day 1)||2||
48219227|NCT05580003|100863750|FG002|STARTED|Part 1 Treatment Period 2 (Day 1)||2||
48219228|NCT05580003|100863751|FG003|STARTED|Part 1 Treatment Period 2 (Day 1)||2||
48219229|NCT05580003|100863752|FG004|STARTED|Part 1 Treatment Period 2 (Day 1)||2||
48219230|NCT05580003|100863753|FG005|STARTED|Part 1 Treatment Period 2 (Day 1)||2||
48219231|NCT05580003|100863754|FG006|STARTED|Part 1 Treatment Period 2 (Day 1)||3||
48219232|NCT05580003|100863755|FG007|STARTED|Part 1 Treatment Period 2 (Day 1)||0||
48219233|NCT05580003|100863756|FG008|STARTED|Part 1 Treatment Period 2 (Day 1)||0||
48219234|NCT05580003|100863757|FG009|STARTED|Part 1 Treatment Period 2 (Day 1)||0||
48219235|NCT05580003|100863758|FG010|STARTED|Part 1 Treatment Period 2 (Day 1)||0||
48219236|NCT05580003|100863759|FG011|STARTED|Part 1 Treatment Period 2 (Day 1)||0||
48219237|NCT05580003|100863760|FG012|STARTED|Part 1 Treatment Period 2 (Day 1)||0||
48219238|NCT05580003|100863761|FG013|STARTED|Part 1 Treatment Period 2 (Day 1)||0||
48219239|NCT05580003|100863762|FG014|STARTED|Part 1 Treatment Period 2 (Day 1)||0||
48219240|NCT05580003|100863763|FG015|STARTED|Part 1 Treatment Period 2 (Day 1)||0||
48219241|NCT05580003|100863764|FG016|STARTED|Part 1 Treatment Period 2 (Day 1)||0||
48219242|NCT05580003|100863765|FG017|STARTED|Part 1 Treatment Period 2 (Day 1)||0||
48219243|NCT05580003|100863766|FG018|STARTED|Part 1 Treatment Period 2 (Day 1)||0||
48219244|NCT05580003|100863767|FG019|STARTED|Part 1 Treatment Period 2 (Day 1)||0||
48219245|NCT05580003|100863768|FG020|STARTED|Part 1 Treatment Period 2 (Day 1)||0||
48219246|NCT05580003|100863769|FG021|STARTED|Part 1 Treatment Period 2 (Day 1)||0||
48219247|NCT05580003|100863770|FG022|STARTED|Part 1 Treatment Period 2 (Day 1)||0||
48219248|NCT05580003|100863771|FG023|STARTED|Part 1 Treatment Period 2 (Day 1)||0||
48219249|NCT05580003|100863772|FG024|STARTED|Part 1 Treatment Period 2 (Day 1)||0||
48219250|NCT05580003|100863773|FG025|STARTED|Part 1 Treatment Period 2 (Day 1)||0||
48219251|NCT05580003|100863774|FG026|STARTED|Part 1 Treatment Period 2 (Day 1)||0||
48219252|NCT05580003|100863775|FG027|STARTED|Part 1 Treatment Period 2 (Day 1)||0||
48219253|NCT05580003|100863748|FG000|COMPLETED|Part 1 Treatment Period 2 (Day 1)||2||
48219254|NCT05580003|100863749|FG001|COMPLETED|Part 1 Treatment Period 2 (Day 1)||2||
48219255|NCT05580003|100863750|FG002|COMPLETED|Part 1 Treatment Period 2 (Day 1)||2||
48219256|NCT05580003|100863751|FG003|COMPLETED|Part 1 Treatment Period 2 (Day 1)||1||
48219257|NCT05580003|100863752|FG004|COMPLETED|Part 1 Treatment Period 2 (Day 1)||2||
48219258|NCT05580003|100863753|FG005|COMPLETED|Part 1 Treatment Period 2 (Day 1)||1||
48219259|NCT05580003|100863754|FG006|COMPLETED|Part 1 Treatment Period 2 (Day 1)||3||
48219260|NCT05580003|100863755|FG007|COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219261|NCT05580003|100863756|FG008|COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219262|NCT05580003|100863757|FG009|COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219263|NCT05580003|100863758|FG010|COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219264|NCT05580003|100863759|FG011|COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219265|NCT05580003|100863760|FG012|COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219266|NCT05580003|100863761|FG013|COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219267|NCT05580003|100863762|FG014|COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219268|NCT05580003|100863763|FG015|COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219269|NCT05580003|100863764|FG016|COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219270|NCT05580003|100863765|FG017|COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219271|NCT05580003|100863766|FG018|COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219272|NCT05580003|100863767|FG019|COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219273|NCT05580003|100863768|FG020|COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219274|NCT05580003|100863769|FG021|COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219275|NCT05580003|100863770|FG022|COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219276|NCT05580003|100863771|FG023|COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219277|NCT05580003|100863772|FG024|COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219278|NCT05580003|100863773|FG025|COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219279|NCT05580003|100863774|FG026|COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219280|NCT05580003|100863775|FG027|COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219281|NCT05580003|100863748|FG000|NOT COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219282|NCT05580003|100863749|FG001|NOT COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219283|NCT05580003|100863750|FG002|NOT COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219284|NCT05580003|100863751|FG003|NOT COMPLETED|Part 1 Treatment Period 2 (Day 1)||1||
48219285|NCT05580003|100863752|FG004|NOT COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219286|NCT05580003|100863753|FG005|NOT COMPLETED|Part 1 Treatment Period 2 (Day 1)||1||
48219287|NCT05580003|100863754|FG006|NOT COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219288|NCT05580003|100863755|FG007|NOT COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219289|NCT05580003|100863756|FG008|NOT COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219290|NCT05580003|100863757|FG009|NOT COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219291|NCT05580003|100863758|FG010|NOT COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219292|NCT05580003|100863759|FG011|NOT COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219293|NCT05580003|100863760|FG012|NOT COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219294|NCT05580003|100863761|FG013|NOT COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219295|NCT05580003|100863762|FG014|NOT COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219296|NCT05580003|100863763|FG015|NOT COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219297|NCT05580003|100863764|FG016|NOT COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219298|NCT05580003|100863765|FG017|NOT COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219299|NCT05580003|100863766|FG018|NOT COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219300|NCT05580003|100863767|FG019|NOT COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219301|NCT05580003|100863768|FG020|NOT COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219302|NCT05580003|100863769|FG021|NOT COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219303|NCT05580003|100863770|FG022|NOT COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219304|NCT05580003|100863771|FG023|NOT COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219305|NCT05580003|100863772|FG024|NOT COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219306|NCT05580003|100863773|FG025|NOT COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219307|NCT05580003|100863774|FG026|NOT COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219308|NCT05580003|100863775|FG027|NOT COMPLETED|Part 1 Treatment Period 2 (Day 1)||0||
48219309|NCT05580003|100863748|FG000|STARTED|Part 1: Washout 2 (up to 5 Days)||2||
48219310|NCT05580003|100863749|FG001|STARTED|Part 1: Washout 2 (up to 5 Days)||2||
48219311|NCT05580003|100863750|FG002|STARTED|Part 1: Washout 2 (up to 5 Days)||2||
48219312|NCT05580003|100863751|FG003|STARTED|Part 1: Washout 2 (up to 5 Days)||1||
48219313|NCT05580003|100863752|FG004|STARTED|Part 1: Washout 2 (up to 5 Days)||2||
48219314|NCT05580003|100863753|FG005|STARTED|Part 1: Washout 2 (up to 5 Days)||1||
48219315|NCT05580003|100863754|FG006|STARTED|Part 1: Washout 2 (up to 5 Days)||3||
48219316|NCT05580003|100863755|FG007|STARTED|Part 1: Washout 2 (up to 5 Days)||0||
48219317|NCT05580003|100863756|FG008|STARTED|Part 1: Washout 2 (up to 5 Days)||0||
48219318|NCT05580003|100863757|FG009|STARTED|Part 1: Washout 2 (up to 5 Days)||0||
48219319|NCT05580003|100863758|FG010|STARTED|Part 1: Washout 2 (up to 5 Days)||0||
48219320|NCT05580003|100863759|FG011|STARTED|Part 1: Washout 2 (up to 5 Days)||0||
48219321|NCT05580003|100863760|FG012|STARTED|Part 1: Washout 2 (up to 5 Days)||0||
48219322|NCT05580003|100863761|FG013|STARTED|Part 1: Washout 2 (up to 5 Days)||0||
48219323|NCT05580003|100863762|FG014|STARTED|Part 1: Washout 2 (up to 5 Days)||0||
48219324|NCT05580003|100863763|FG015|STARTED|Part 1: Washout 2 (up to 5 Days)||0||
48219325|NCT05580003|100863764|FG016|STARTED|Part 1: Washout 2 (up to 5 Days)||0||
48219326|NCT05580003|100863765|FG017|STARTED|Part 1: Washout 2 (up to 5 Days)||0||
48219327|NCT05580003|100863766|FG018|STARTED|Part 1: Washout 2 (up to 5 Days)||0||
48219328|NCT05580003|100863767|FG019|STARTED|Part 1: Washout 2 (up to 5 Days)||0||
48219329|NCT05580003|100863768|FG020|STARTED|Part 1: Washout 2 (up to 5 Days)||0||
48219330|NCT05580003|100863769|FG021|STARTED|Part 1: Washout 2 (up to 5 Days)||0||
48219331|NCT05580003|100863770|FG022|STARTED|Part 1: Washout 2 (up to 5 Days)||0||
48219332|NCT05580003|100863771|FG023|STARTED|Part 1: Washout 2 (up to 5 Days)||0||
48219333|NCT05580003|100863772|FG024|STARTED|Part 1: Washout 2 (up to 5 Days)||0||
48219334|NCT05580003|100863773|FG025|STARTED|Part 1: Washout 2 (up to 5 Days)||0||
48219335|NCT05580003|100863774|FG026|STARTED|Part 1: Washout 2 (up to 5 Days)||0||
48219336|NCT05580003|100863775|FG027|STARTED|Part 1: Washout 2 (up to 5 Days)||0||
48219337|NCT05580003|100863748|FG000|COMPLETED|Part 1: Washout 2 (up to 5 Days)||2||
48219338|NCT05580003|100863749|FG001|COMPLETED|Part 1: Washout 2 (up to 5 Days)||2||
48219339|NCT05580003|100863750|FG002|COMPLETED|Part 1: Washout 2 (up to 5 Days)||2||
48219340|NCT05580003|100863751|FG003|COMPLETED|Part 1: Washout 2 (up to 5 Days)||1||
48219341|NCT05580003|100863752|FG004|COMPLETED|Part 1: Washout 2 (up to 5 Days)||2||
48509765|NCT02688387|101580256|FG015|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48219342|NCT05580003|100863753|FG005|COMPLETED|Part 1: Washout 2 (up to 5 Days)||1||
48219343|NCT05580003|100863754|FG006|COMPLETED|Part 1: Washout 2 (up to 5 Days)||3||
48219344|NCT05580003|100863755|FG007|COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219345|NCT05580003|100863756|FG008|COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219346|NCT05580003|100863757|FG009|COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219347|NCT05580003|100863758|FG010|COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219348|NCT05580003|100863759|FG011|COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219349|NCT05580003|100863760|FG012|COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219350|NCT05580003|100863761|FG013|COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219351|NCT05580003|100863762|FG014|COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219352|NCT05580003|100863763|FG015|COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219353|NCT05580003|100863764|FG016|COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219354|NCT05580003|100863765|FG017|COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219355|NCT05580003|100863766|FG018|COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219356|NCT05580003|100863767|FG019|COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219357|NCT05580003|100863768|FG020|COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219358|NCT05580003|100863769|FG021|COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219359|NCT05580003|100863770|FG022|COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219360|NCT05580003|100863771|FG023|COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219361|NCT05580003|100863772|FG024|COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219362|NCT05580003|100863773|FG025|COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219363|NCT05580003|100863774|FG026|COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219364|NCT05580003|100863775|FG027|COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219365|NCT05580003|100863748|FG000|NOT COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219366|NCT05580003|100863749|FG001|NOT COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219367|NCT05580003|100863750|FG002|NOT COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219368|NCT05580003|100863751|FG003|NOT COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219369|NCT05580003|100863752|FG004|NOT COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219370|NCT05580003|100863753|FG005|NOT COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219371|NCT05580003|100863754|FG006|NOT COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219372|NCT05580003|100863755|FG007|NOT COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219373|NCT05580003|100863756|FG008|NOT COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219374|NCT05580003|100863757|FG009|NOT COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219375|NCT05580003|100863758|FG010|NOT COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219376|NCT05580003|100863759|FG011|NOT COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219377|NCT05580003|100863760|FG012|NOT COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219378|NCT05580003|100863761|FG013|NOT COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219379|NCT05580003|100863762|FG014|NOT COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219380|NCT05580003|100863763|FG015|NOT COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219381|NCT05580003|100863764|FG016|NOT COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219382|NCT05580003|100863765|FG017|NOT COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219383|NCT05580003|100863766|FG018|NOT COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219384|NCT05580003|100863767|FG019|NOT COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219385|NCT05580003|100863768|FG020|NOT COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219386|NCT05580003|100863769|FG021|NOT COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219387|NCT05580003|100863770|FG022|NOT COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219388|NCT05580003|100863771|FG023|NOT COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219389|NCT05580003|100863772|FG024|NOT COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219390|NCT05580003|100863773|FG025|NOT COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219391|NCT05580003|100863774|FG026|NOT COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219392|NCT05580003|100863775|FG027|NOT COMPLETED|Part 1: Washout 2 (up to 5 Days)||0||
48219393|NCT05580003|100863748|FG000|STARTED|Part 1: Treatment Period 3 (Day 1)||2||
48219394|NCT05580003|100863749|FG001|STARTED|Part 1: Treatment Period 3 (Day 1)||2||
48219395|NCT05580003|100863750|FG002|STARTED|Part 1: Treatment Period 3 (Day 1)||2||
48219396|NCT05580003|100863751|FG003|STARTED|Part 1: Treatment Period 3 (Day 1)||1||
48219397|NCT05580003|100863752|FG004|STARTED|Part 1: Treatment Period 3 (Day 1)||2||
48219398|NCT05580003|100863753|FG005|STARTED|Part 1: Treatment Period 3 (Day 1)||1||
48219399|NCT05580003|100863754|FG006|STARTED|Part 1: Treatment Period 3 (Day 1)||3||
48219400|NCT05580003|100863755|FG007|STARTED|Part 1: Treatment Period 3 (Day 1)||0||
48219401|NCT05580003|100863756|FG008|STARTED|Part 1: Treatment Period 3 (Day 1)||0||
48219402|NCT05580003|100863757|FG009|STARTED|Part 1: Treatment Period 3 (Day 1)||0||
48219403|NCT05580003|100863758|FG010|STARTED|Part 1: Treatment Period 3 (Day 1)||0||
48219404|NCT05580003|100863759|FG011|STARTED|Part 1: Treatment Period 3 (Day 1)||0||
48219405|NCT05580003|100863760|FG012|STARTED|Part 1: Treatment Period 3 (Day 1)||0||
48219406|NCT05580003|100863761|FG013|STARTED|Part 1: Treatment Period 3 (Day 1)||0||
48219407|NCT05580003|100863762|FG014|STARTED|Part 1: Treatment Period 3 (Day 1)||0||
48219408|NCT05580003|100863763|FG015|STARTED|Part 1: Treatment Period 3 (Day 1)||0||
48219409|NCT05580003|100863764|FG016|STARTED|Part 1: Treatment Period 3 (Day 1)||0||
48219410|NCT05580003|100863765|FG017|STARTED|Part 1: Treatment Period 3 (Day 1)||0||
48219411|NCT05580003|100863766|FG018|STARTED|Part 1: Treatment Period 3 (Day 1)||0||
48219412|NCT05580003|100863767|FG019|STARTED|Part 1: Treatment Period 3 (Day 1)||0||
48219413|NCT05580003|100863768|FG020|STARTED|Part 1: Treatment Period 3 (Day 1)||0||
48219414|NCT05580003|100863769|FG021|STARTED|Part 1: Treatment Period 3 (Day 1)||0||
48219415|NCT05580003|100863770|FG022|STARTED|Part 1: Treatment Period 3 (Day 1)||0||
48219416|NCT05580003|100863771|FG023|STARTED|Part 1: Treatment Period 3 (Day 1)||0||
48219417|NCT05580003|100863772|FG024|STARTED|Part 1: Treatment Period 3 (Day 1)||0||
48219418|NCT05580003|100863773|FG025|STARTED|Part 1: Treatment Period 3 (Day 1)||0||
48219419|NCT05580003|100863774|FG026|STARTED|Part 1: Treatment Period 3 (Day 1)||0||
48219420|NCT05580003|100863775|FG027|STARTED|Part 1: Treatment Period 3 (Day 1)||0||
48219421|NCT05580003|100863748|FG000|COMPLETED|Part 1: Treatment Period 3 (Day 1)||2||
48219422|NCT05580003|100863749|FG001|COMPLETED|Part 1: Treatment Period 3 (Day 1)||1||
48219423|NCT05580003|100863750|FG002|COMPLETED|Part 1: Treatment Period 3 (Day 1)||2||
48219424|NCT05580003|100863751|FG003|COMPLETED|Part 1: Treatment Period 3 (Day 1)||1||
48219425|NCT05580003|100863752|FG004|COMPLETED|Part 1: Treatment Period 3 (Day 1)||2||
48219426|NCT05580003|100863753|FG005|COMPLETED|Part 1: Treatment Period 3 (Day 1)||1||
48219427|NCT05580003|100863754|FG006|COMPLETED|Part 1: Treatment Period 3 (Day 1)||3||
48219428|NCT05580003|100863755|FG007|COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219429|NCT05580003|100863756|FG008|COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219430|NCT05580003|100863757|FG009|COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219431|NCT05580003|100863758|FG010|COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219432|NCT05580003|100863759|FG011|COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219433|NCT05580003|100863760|FG012|COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219434|NCT05580003|100863761|FG013|COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219435|NCT05580003|100863762|FG014|COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219436|NCT05580003|100863763|FG015|COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219437|NCT05580003|100863764|FG016|COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219438|NCT05580003|100863765|FG017|COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219439|NCT05580003|100863766|FG018|COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219440|NCT05580003|100863767|FG019|COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219441|NCT05580003|100863768|FG020|COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219442|NCT05580003|100863769|FG021|COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219443|NCT05580003|100863770|FG022|COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219444|NCT05580003|100863771|FG023|COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219445|NCT05580003|100863772|FG024|COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219446|NCT05580003|100863773|FG025|COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219447|NCT05580003|100863774|FG026|COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219448|NCT05580003|100863775|FG027|COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219449|NCT05580003|100863748|FG000|NOT COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219450|NCT05580003|100863749|FG001|NOT COMPLETED|Part 1: Treatment Period 3 (Day 1)||1||
48219451|NCT05580003|100863750|FG002|NOT COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219452|NCT05580003|100863751|FG003|NOT COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219453|NCT05580003|100863752|FG004|NOT COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219454|NCT05580003|100863753|FG005|NOT COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219455|NCT05580003|100863754|FG006|NOT COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219456|NCT05580003|100863755|FG007|NOT COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219457|NCT05580003|100863756|FG008|NOT COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219458|NCT05580003|100863757|FG009|NOT COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219459|NCT05580003|100863758|FG010|NOT COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219460|NCT05580003|100863759|FG011|NOT COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219461|NCT05580003|100863760|FG012|NOT COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219462|NCT05580003|100863761|FG013|NOT COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219463|NCT05580003|100863762|FG014|NOT COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219464|NCT05580003|100863763|FG015|NOT COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219465|NCT05580003|100863764|FG016|NOT COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219466|NCT05580003|100863765|FG017|NOT COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219467|NCT05580003|100863766|FG018|NOT COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219468|NCT05580003|100863767|FG019|NOT COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219469|NCT05580003|100863768|FG020|NOT COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219470|NCT05580003|100863769|FG021|NOT COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219471|NCT05580003|100863770|FG022|NOT COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219472|NCT05580003|100863771|FG023|NOT COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219473|NCT05580003|100863772|FG024|NOT COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219474|NCT05580003|100863773|FG025|NOT COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219475|NCT05580003|100863774|FG026|NOT COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219476|NCT05580003|100863775|FG027|NOT COMPLETED|Part 1: Treatment Period 3 (Day 1)||0||
48219477|NCT05580003|100863748|FG000|STARTED|Part 2 (up to 10 Days)||0||
48219478|NCT05580003|100863749|FG001|STARTED|Part 2 (up to 10 Days)||0||
48219479|NCT05580003|100863750|FG002|STARTED|Part 2 (up to 10 Days)||0||
48219480|NCT05580003|100863751|FG003|STARTED|Part 2 (up to 10 Days)||0||
48219481|NCT05580003|100863752|FG004|STARTED|Part 2 (up to 10 Days)||0||
48219482|NCT05580003|100863753|FG005|STARTED|Part 2 (up to 10 Days)||0||
48219483|NCT05580003|100863754|FG006|STARTED|Part 2 (up to 10 Days)||0||
48219484|NCT05580003|100863755|FG007|STARTED|Part 2 (up to 10 Days)||6||
48219485|NCT05580003|100863756|FG008|STARTED|Part 2 (up to 10 Days)||4||
48219486|NCT05580003|100863757|FG009|STARTED|Part 2 (up to 10 Days)||4||
48219487|NCT05580003|100863758|FG010|STARTED|Part 2 (up to 10 Days)||4||
48219488|NCT05580003|100863759|FG011|STARTED|Part 2 (up to 10 Days)||1||
48219489|NCT05580003|100863760|FG012|STARTED|Part 2 (up to 10 Days)||3||
48219490|NCT05580003|100863761|FG013|STARTED|Part 2 (up to 10 Days)||0||
48219491|NCT05580003|100863762|FG014|STARTED|Part 2 (up to 10 Days)||0||
48219492|NCT05580003|100863763|FG015|STARTED|Part 2 (up to 10 Days)||0||
48219493|NCT05580003|100863764|FG016|STARTED|Part 2 (up to 10 Days)||0||
48219494|NCT05580003|100863765|FG017|STARTED|Part 2 (up to 10 Days)||0||
48219495|NCT05580003|100863766|FG018|STARTED|Part 2 (up to 10 Days)||0||
48219496|NCT05580003|100863767|FG019|STARTED|Part 2 (up to 10 Days)||0||
48219497|NCT05580003|100863768|FG020|STARTED|Part 2 (up to 10 Days)||0||
48219498|NCT05580003|100863769|FG021|STARTED|Part 2 (up to 10 Days)||0||
48219499|NCT05580003|100863770|FG022|STARTED|Part 2 (up to 10 Days)||0||
48219500|NCT05580003|100863771|FG023|STARTED|Part 2 (up to 10 Days)||0||
48219501|NCT05580003|100863772|FG024|STARTED|Part 2 (up to 10 Days)||0||
48219502|NCT05580003|100863773|FG025|STARTED|Part 2 (up to 10 Days)||0||
48219503|NCT05580003|100863774|FG026|STARTED|Part 2 (up to 10 Days)||0||
48219504|NCT05580003|100863775|FG027|STARTED|Part 2 (up to 10 Days)||0||
48219505|NCT05580003|100863748|FG000|COMPLETED|Part 2 (up to 10 Days)||0||
48219506|NCT05580003|100863749|FG001|COMPLETED|Part 2 (up to 10 Days)||0||
48219507|NCT05580003|100863750|FG002|COMPLETED|Part 2 (up to 10 Days)||0||
48219508|NCT05580003|100863751|FG003|COMPLETED|Part 2 (up to 10 Days)||0||
48219509|NCT05580003|100863752|FG004|COMPLETED|Part 2 (up to 10 Days)||0||
48219510|NCT05580003|100863753|FG005|COMPLETED|Part 2 (up to 10 Days)||0||
48219511|NCT05580003|100863754|FG006|COMPLETED|Part 2 (up to 10 Days)||0||
48219512|NCT05580003|100863755|FG007|COMPLETED|Part 2 (up to 10 Days)||6||
48219513|NCT05580003|100863756|FG008|COMPLETED|Part 2 (up to 10 Days)||4||
48219514|NCT05580003|100863757|FG009|COMPLETED|Part 2 (up to 10 Days)||3||
48219515|NCT05580003|100863758|FG010|COMPLETED|Part 2 (up to 10 Days)||4||
48219516|NCT05580003|100863759|FG011|COMPLETED|Part 2 (up to 10 Days)||1||
48219517|NCT05580003|100863760|FG012|COMPLETED|Part 2 (up to 10 Days)||3||
48219518|NCT05580003|100863761|FG013|COMPLETED|Part 2 (up to 10 Days)||0||
48219519|NCT05580003|100863762|FG014|COMPLETED|Part 2 (up to 10 Days)||0||
48219520|NCT05580003|100863763|FG015|COMPLETED|Part 2 (up to 10 Days)||0||
48219521|NCT05580003|100863764|FG016|COMPLETED|Part 2 (up to 10 Days)||0||
48219522|NCT05580003|100863765|FG017|COMPLETED|Part 2 (up to 10 Days)||0||
48219523|NCT05580003|100863766|FG018|COMPLETED|Part 2 (up to 10 Days)||0||
48219524|NCT05580003|100863767|FG019|COMPLETED|Part 2 (up to 10 Days)||0||
48219525|NCT05580003|100863768|FG020|COMPLETED|Part 2 (up to 10 Days)||0||
48219526|NCT05580003|100863769|FG021|COMPLETED|Part 2 (up to 10 Days)||0||
48219527|NCT05580003|100863770|FG022|COMPLETED|Part 2 (up to 10 Days)||0||
48219528|NCT05580003|100863771|FG023|COMPLETED|Part 2 (up to 10 Days)||0||
48219529|NCT05580003|100863772|FG024|COMPLETED|Part 2 (up to 10 Days)||0||
48219530|NCT05580003|100863773|FG025|COMPLETED|Part 2 (up to 10 Days)||0||
48219531|NCT05580003|100863774|FG026|COMPLETED|Part 2 (up to 10 Days)||0||
48219532|NCT05580003|100863775|FG027|COMPLETED|Part 2 (up to 10 Days)||0||
48219533|NCT05580003|100863748|FG000|NOT COMPLETED|Part 2 (up to 10 Days)||0||
48219534|NCT05580003|100863749|FG001|NOT COMPLETED|Part 2 (up to 10 Days)||0||
48219535|NCT05580003|100863750|FG002|NOT COMPLETED|Part 2 (up to 10 Days)||0||
48219536|NCT05580003|100863751|FG003|NOT COMPLETED|Part 2 (up to 10 Days)||0||
48219537|NCT05580003|100863752|FG004|NOT COMPLETED|Part 2 (up to 10 Days)||0||
48219538|NCT05580003|100863753|FG005|NOT COMPLETED|Part 2 (up to 10 Days)||0||
48219539|NCT05580003|100863754|FG006|NOT COMPLETED|Part 2 (up to 10 Days)||0||
48219540|NCT05580003|100863755|FG007|NOT COMPLETED|Part 2 (up to 10 Days)||0||
48219541|NCT05580003|100863756|FG008|NOT COMPLETED|Part 2 (up to 10 Days)||0||
48219542|NCT05580003|100863757|FG009|NOT COMPLETED|Part 2 (up to 10 Days)||1||
48219543|NCT05580003|100863758|FG010|NOT COMPLETED|Part 2 (up to 10 Days)||0||
48219544|NCT05580003|100863759|FG011|NOT COMPLETED|Part 2 (up to 10 Days)||0||
48219545|NCT05580003|100863760|FG012|NOT COMPLETED|Part 2 (up to 10 Days)||0||
48219546|NCT05580003|100863761|FG013|NOT COMPLETED|Part 2 (up to 10 Days)||0||
48219547|NCT05580003|100863762|FG014|NOT COMPLETED|Part 2 (up to 10 Days)||0||
48219548|NCT05580003|100863763|FG015|NOT COMPLETED|Part 2 (up to 10 Days)||0||
48219549|NCT05580003|100863764|FG016|NOT COMPLETED|Part 2 (up to 10 Days)||0||
48219550|NCT05580003|100863765|FG017|NOT COMPLETED|Part 2 (up to 10 Days)||0||
48219551|NCT05580003|100863766|FG018|NOT COMPLETED|Part 2 (up to 10 Days)||0||
48219552|NCT05580003|100863767|FG019|NOT COMPLETED|Part 2 (up to 10 Days)||0||
48219553|NCT05580003|100863768|FG020|NOT COMPLETED|Part 2 (up to 10 Days)||0||
48219554|NCT05580003|100863769|FG021|NOT COMPLETED|Part 2 (up to 10 Days)||0||
48219555|NCT05580003|100863770|FG022|NOT COMPLETED|Part 2 (up to 10 Days)||0||
48219556|NCT05580003|100863771|FG023|NOT COMPLETED|Part 2 (up to 10 Days)||0||
48219557|NCT05580003|100863772|FG024|NOT COMPLETED|Part 2 (up to 10 Days)||0||
48219558|NCT05580003|100863773|FG025|NOT COMPLETED|Part 2 (up to 10 Days)||0||
48219559|NCT05580003|100863774|FG026|NOT COMPLETED|Part 2 (up to 10 Days)||0||
48219560|NCT05580003|100863775|FG027|NOT COMPLETED|Part 2 (up to 10 Days)||0||
48219561|NCT05580003|100863748|FG000|STARTED|Part 3 Period 1 (Day 1)||0||
48219562|NCT05580003|100863749|FG001|STARTED|Part 3 Period 1 (Day 1)||0||
48219563|NCT05580003|100863750|FG002|STARTED|Part 3 Period 1 (Day 1)||0||
48219564|NCT05580003|100863751|FG003|STARTED|Part 3 Period 1 (Day 1)||0||
48219565|NCT05580003|100863752|FG004|STARTED|Part 3 Period 1 (Day 1)||0||
48219566|NCT05580003|100863753|FG005|STARTED|Part 3 Period 1 (Day 1)||0||
48219567|NCT05580003|100863754|FG006|STARTED|Part 3 Period 1 (Day 1)||0||
48219568|NCT05580003|100863755|FG007|STARTED|Part 3 Period 1 (Day 1)||0||
48219569|NCT05580003|100863756|FG008|STARTED|Part 3 Period 1 (Day 1)||0||
48219570|NCT05580003|100863757|FG009|STARTED|Part 3 Period 1 (Day 1)||0||
48219571|NCT05580003|100863758|FG010|STARTED|Part 3 Period 1 (Day 1)||0||
48219572|NCT05580003|100863759|FG011|STARTED|Part 3 Period 1 (Day 1)||0||
48219573|NCT05580003|100863760|FG012|STARTED|Part 3 Period 1 (Day 1)||0||
48219574|NCT05580003|100863761|FG013|STARTED|Part 3 Period 1 (Day 1)||2||
48219575|NCT05580003|100863762|FG014|STARTED|Part 3 Period 1 (Day 1)||2||
48219576|NCT05580003|100863763|FG015|STARTED|Part 3 Period 1 (Day 1)||2||
48219577|NCT05580003|100863764|FG016|STARTED|Part 3 Period 1 (Day 1)||2||
48219578|NCT05580003|100863765|FG017|STARTED|Part 3 Period 1 (Day 1)||2||
48219579|NCT05580003|100863766|FG018|STARTED|Part 3 Period 1 (Day 1)||2||
48219580|NCT05580003|100863767|FG019|STARTED|Part 3 Period 1 (Day 1)||0||
48219581|NCT05580003|100863768|FG020|STARTED|Part 3 Period 1 (Day 1)||0||
48219582|NCT05580003|100863769|FG021|STARTED|Part 3 Period 1 (Day 1)||0||
48219583|NCT05580003|100863770|FG022|STARTED|Part 3 Period 1 (Day 1)||0||
48219584|NCT05580003|100863771|FG023|STARTED|Part 3 Period 1 (Day 1)||0||
48219585|NCT05580003|100863772|FG024|STARTED|Part 3 Period 1 (Day 1)||0||
48219586|NCT05580003|100863773|FG025|STARTED|Part 3 Period 1 (Day 1)||0||
48219587|NCT05580003|100863774|FG026|STARTED|Part 3 Period 1 (Day 1)||0||
48219588|NCT05580003|100863775|FG027|STARTED|Part 3 Period 1 (Day 1)||0||
48219589|NCT05580003|100863748|FG000|COMPLETED|Part 3 Period 1 (Day 1)||0||
48219590|NCT05580003|100863749|FG001|COMPLETED|Part 3 Period 1 (Day 1)||0||
48219591|NCT05580003|100863750|FG002|COMPLETED|Part 3 Period 1 (Day 1)||0||
48219592|NCT05580003|100863751|FG003|COMPLETED|Part 3 Period 1 (Day 1)||0||
48219593|NCT05580003|100863752|FG004|COMPLETED|Part 3 Period 1 (Day 1)||0||
48219594|NCT05580003|100863753|FG005|COMPLETED|Part 3 Period 1 (Day 1)||0||
48219595|NCT05580003|100863754|FG006|COMPLETED|Part 3 Period 1 (Day 1)||0||
48219596|NCT05580003|100863755|FG007|COMPLETED|Part 3 Period 1 (Day 1)||0||
48219597|NCT05580003|100863756|FG008|COMPLETED|Part 3 Period 1 (Day 1)||0||
48219598|NCT05580003|100863757|FG009|COMPLETED|Part 3 Period 1 (Day 1)||0||
48219599|NCT05580003|100863758|FG010|COMPLETED|Part 3 Period 1 (Day 1)||0||
48219600|NCT05580003|100863759|FG011|COMPLETED|Part 3 Period 1 (Day 1)||0||
48219601|NCT05580003|100863760|FG012|COMPLETED|Part 3 Period 1 (Day 1)||0||
48219602|NCT05580003|100863761|FG013|COMPLETED|Part 3 Period 1 (Day 1)||2||
48219603|NCT05580003|100863762|FG014|COMPLETED|Part 3 Period 1 (Day 1)||2||
48219604|NCT05580003|100863763|FG015|COMPLETED|Part 3 Period 1 (Day 1)||2||
48219605|NCT05580003|100863764|FG016|COMPLETED|Part 3 Period 1 (Day 1)||2||
48219606|NCT05580003|100863765|FG017|COMPLETED|Part 3 Period 1 (Day 1)||2||
48219607|NCT05580003|100863766|FG018|COMPLETED|Part 3 Period 1 (Day 1)||2||
48219608|NCT05580003|100863767|FG019|COMPLETED|Part 3 Period 1 (Day 1)||0||
48219609|NCT05580003|100863768|FG020|COMPLETED|Part 3 Period 1 (Day 1)||0||
48219610|NCT05580003|100863769|FG021|COMPLETED|Part 3 Period 1 (Day 1)||0||
48219611|NCT05580003|100863770|FG022|COMPLETED|Part 3 Period 1 (Day 1)||0||
48219612|NCT05580003|100863771|FG023|COMPLETED|Part 3 Period 1 (Day 1)||0||
48219613|NCT05580003|100863772|FG024|COMPLETED|Part 3 Period 1 (Day 1)||0||
48219614|NCT05580003|100863773|FG025|COMPLETED|Part 3 Period 1 (Day 1)||0||
48219615|NCT05580003|100863774|FG026|COMPLETED|Part 3 Period 1 (Day 1)||0||
48219616|NCT05580003|100863775|FG027|COMPLETED|Part 3 Period 1 (Day 1)||0||
48219617|NCT05580003|100863748|FG000|NOT COMPLETED|Part 3 Period 1 (Day 1)||0||
48219618|NCT05580003|100863749|FG001|NOT COMPLETED|Part 3 Period 1 (Day 1)||0||
48219619|NCT05580003|100863750|FG002|NOT COMPLETED|Part 3 Period 1 (Day 1)||0||
48219620|NCT05580003|100863751|FG003|NOT COMPLETED|Part 3 Period 1 (Day 1)||0||
48219621|NCT05580003|100863752|FG004|NOT COMPLETED|Part 3 Period 1 (Day 1)||0||
48219622|NCT05580003|100863753|FG005|NOT COMPLETED|Part 3 Period 1 (Day 1)||0||
48219623|NCT05580003|100863754|FG006|NOT COMPLETED|Part 3 Period 1 (Day 1)||0||
48219624|NCT05580003|100863755|FG007|NOT COMPLETED|Part 3 Period 1 (Day 1)||0||
48219625|NCT05580003|100863756|FG008|NOT COMPLETED|Part 3 Period 1 (Day 1)||0||
48219626|NCT05580003|100863757|FG009|NOT COMPLETED|Part 3 Period 1 (Day 1)||0||
48219627|NCT05580003|100863758|FG010|NOT COMPLETED|Part 3 Period 1 (Day 1)||0||
48219628|NCT05580003|100863759|FG011|NOT COMPLETED|Part 3 Period 1 (Day 1)||0||
48219629|NCT05580003|100863760|FG012|NOT COMPLETED|Part 3 Period 1 (Day 1)||0||
48219630|NCT05580003|100863761|FG013|NOT COMPLETED|Part 3 Period 1 (Day 1)||0||
48219631|NCT05580003|100863762|FG014|NOT COMPLETED|Part 3 Period 1 (Day 1)||0||
48219632|NCT05580003|100863763|FG015|NOT COMPLETED|Part 3 Period 1 (Day 1)||0||
48219633|NCT05580003|100863764|FG016|NOT COMPLETED|Part 3 Period 1 (Day 1)||0||
48219634|NCT05580003|100863765|FG017|NOT COMPLETED|Part 3 Period 1 (Day 1)||0||
48219635|NCT05580003|100863766|FG018|NOT COMPLETED|Part 3 Period 1 (Day 1)||0||
48219636|NCT05580003|100863767|FG019|NOT COMPLETED|Part 3 Period 1 (Day 1)||0||
48219637|NCT05580003|100863768|FG020|NOT COMPLETED|Part 3 Period 1 (Day 1)||0||
48219638|NCT05580003|100863769|FG021|NOT COMPLETED|Part 3 Period 1 (Day 1)||0||
48219639|NCT05580003|100863770|FG022|NOT COMPLETED|Part 3 Period 1 (Day 1)||0||
48219640|NCT05580003|100863771|FG023|NOT COMPLETED|Part 3 Period 1 (Day 1)||0||
48219641|NCT05580003|100863772|FG024|NOT COMPLETED|Part 3 Period 1 (Day 1)||0||
48219642|NCT05580003|100863773|FG025|NOT COMPLETED|Part 3 Period 1 (Day 1)||0||
48219643|NCT05580003|100863774|FG026|NOT COMPLETED|Part 3 Period 1 (Day 1)||0||
48219644|NCT05580003|100863775|FG027|NOT COMPLETED|Part 3 Period 1 (Day 1)||0||
48219645|NCT05580003|100863748|FG000|STARTED|Part 3: Washout 1 (up to 3 Days)||0||
48219646|NCT05580003|100863749|FG001|STARTED|Part 3: Washout 1 (up to 3 Days)||0||
48219647|NCT05580003|100863750|FG002|STARTED|Part 3: Washout 1 (up to 3 Days)||0||
48219648|NCT05580003|100863751|FG003|STARTED|Part 3: Washout 1 (up to 3 Days)||0||
48219649|NCT05580003|100863752|FG004|STARTED|Part 3: Washout 1 (up to 3 Days)||0||
48219650|NCT05580003|100863753|FG005|STARTED|Part 3: Washout 1 (up to 3 Days)||0||
48219651|NCT05580003|100863754|FG006|STARTED|Part 3: Washout 1 (up to 3 Days)||0||
48219652|NCT05580003|100863755|FG007|STARTED|Part 3: Washout 1 (up to 3 Days)||0||
48219653|NCT05580003|100863756|FG008|STARTED|Part 3: Washout 1 (up to 3 Days)||0||
48219654|NCT05580003|100863757|FG009|STARTED|Part 3: Washout 1 (up to 3 Days)||0||
48219655|NCT05580003|100863758|FG010|STARTED|Part 3: Washout 1 (up to 3 Days)||0||
48219656|NCT05580003|100863759|FG011|STARTED|Part 3: Washout 1 (up to 3 Days)||0||
48219657|NCT05580003|100863760|FG012|STARTED|Part 3: Washout 1 (up to 3 Days)||0||
48219658|NCT05580003|100863761|FG013|STARTED|Part 3: Washout 1 (up to 3 Days)||2||
48219659|NCT05580003|100863762|FG014|STARTED|Part 3: Washout 1 (up to 3 Days)||2||
48219660|NCT05580003|100863763|FG015|STARTED|Part 3: Washout 1 (up to 3 Days)||2||
48509766|NCT02688387|101580257|FG016|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48219661|NCT05580003|100863764|FG016|STARTED|Part 3: Washout 1 (up to 3 Days)||2||
48219662|NCT05580003|100863765|FG017|STARTED|Part 3: Washout 1 (up to 3 Days)||2||
48219663|NCT05580003|100863766|FG018|STARTED|Part 3: Washout 1 (up to 3 Days)||2||
48219664|NCT05580003|100863767|FG019|STARTED|Part 3: Washout 1 (up to 3 Days)||0||
48219665|NCT05580003|100863768|FG020|STARTED|Part 3: Washout 1 (up to 3 Days)||0||
48219666|NCT05580003|100863769|FG021|STARTED|Part 3: Washout 1 (up to 3 Days)||0||
48219667|NCT05580003|100863770|FG022|STARTED|Part 3: Washout 1 (up to 3 Days)||0||
48219668|NCT05580003|100863771|FG023|STARTED|Part 3: Washout 1 (up to 3 Days)||0||
48219669|NCT05580003|100863772|FG024|STARTED|Part 3: Washout 1 (up to 3 Days)||0||
48219670|NCT05580003|100863773|FG025|STARTED|Part 3: Washout 1 (up to 3 Days)||0||
48219671|NCT05580003|100863774|FG026|STARTED|Part 3: Washout 1 (up to 3 Days)||0||
48219672|NCT05580003|100863775|FG027|STARTED|Part 3: Washout 1 (up to 3 Days)||0||
48219673|NCT05580003|100863748|FG000|COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219674|NCT05580003|100863749|FG001|COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219675|NCT05580003|100863750|FG002|COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219676|NCT05580003|100863751|FG003|COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219677|NCT05580003|100863752|FG004|COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219678|NCT05580003|100863753|FG005|COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219679|NCT05580003|100863754|FG006|COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219680|NCT05580003|100863755|FG007|COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219681|NCT05580003|100863756|FG008|COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219682|NCT05580003|100863757|FG009|COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219683|NCT05580003|100863758|FG010|COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219684|NCT05580003|100863759|FG011|COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219685|NCT05580003|100863760|FG012|COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219686|NCT05580003|100863761|FG013|COMPLETED|Part 3: Washout 1 (up to 3 Days)||2||
48219687|NCT05580003|100863762|FG014|COMPLETED|Part 3: Washout 1 (up to 3 Days)||2||
48219688|NCT05580003|100863763|FG015|COMPLETED|Part 3: Washout 1 (up to 3 Days)||2||
48219689|NCT05580003|100863764|FG016|COMPLETED|Part 3: Washout 1 (up to 3 Days)||2||
48219690|NCT05580003|100863765|FG017|COMPLETED|Part 3: Washout 1 (up to 3 Days)||2||
48219691|NCT05580003|100863766|FG018|COMPLETED|Part 3: Washout 1 (up to 3 Days)||2||
48219692|NCT05580003|100863767|FG019|COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219693|NCT05580003|100863768|FG020|COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219694|NCT05580003|100863769|FG021|COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219695|NCT05580003|100863770|FG022|COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219696|NCT05580003|100863771|FG023|COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219697|NCT05580003|100863772|FG024|COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219698|NCT05580003|100863773|FG025|COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219699|NCT05580003|100863774|FG026|COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219700|NCT05580003|100863775|FG027|COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219701|NCT05580003|100863748|FG000|NOT COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219702|NCT05580003|100863749|FG001|NOT COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219703|NCT05580003|100863750|FG002|NOT COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219704|NCT05580003|100863751|FG003|NOT COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219705|NCT05580003|100863752|FG004|NOT COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219706|NCT05580003|100863753|FG005|NOT COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219707|NCT05580003|100863754|FG006|NOT COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219708|NCT05580003|100863755|FG007|NOT COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219709|NCT05580003|100863756|FG008|NOT COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219710|NCT05580003|100863757|FG009|NOT COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219711|NCT05580003|100863758|FG010|NOT COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219712|NCT05580003|100863759|FG011|NOT COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219713|NCT05580003|100863760|FG012|NOT COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219714|NCT05580003|100863761|FG013|NOT COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219715|NCT05580003|100863762|FG014|NOT COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219716|NCT05580003|100863763|FG015|NOT COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219717|NCT05580003|100863764|FG016|NOT COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219718|NCT05580003|100863765|FG017|NOT COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219719|NCT05580003|100863766|FG018|NOT COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219720|NCT05580003|100863767|FG019|NOT COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219721|NCT05580003|100863768|FG020|NOT COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219722|NCT05580003|100863769|FG021|NOT COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219723|NCT05580003|100863770|FG022|NOT COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219724|NCT05580003|100863771|FG023|NOT COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219725|NCT05580003|100863772|FG024|NOT COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219726|NCT05580003|100863773|FG025|NOT COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219727|NCT05580003|100863774|FG026|NOT COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219728|NCT05580003|100863775|FG027|NOT COMPLETED|Part 3: Washout 1 (up to 3 Days)||0||
48219729|NCT05580003|100863748|FG000|STARTED|Part 3: Period 2 (Day 1)||0||
48219730|NCT05580003|100863749|FG001|STARTED|Part 3: Period 2 (Day 1)||0||
48219731|NCT05580003|100863750|FG002|STARTED|Part 3: Period 2 (Day 1)||0||
48219732|NCT05580003|100863751|FG003|STARTED|Part 3: Period 2 (Day 1)||0||
48219733|NCT05580003|100863752|FG004|STARTED|Part 3: Period 2 (Day 1)||0||
48509767|NCT02688387|101580258|FG017|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48509768|NCT02688387|101580259|FG018|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48219734|NCT05580003|100863753|FG005|STARTED|Part 3: Period 2 (Day 1)||0||
48219735|NCT05580003|100863754|FG006|STARTED|Part 3: Period 2 (Day 1)||0||
48219736|NCT05580003|100863755|FG007|STARTED|Part 3: Period 2 (Day 1)||0||
48219737|NCT05580003|100863756|FG008|STARTED|Part 3: Period 2 (Day 1)||0||
48219738|NCT05580003|100863757|FG009|STARTED|Part 3: Period 2 (Day 1)||0||
48219739|NCT05580003|100863758|FG010|STARTED|Part 3: Period 2 (Day 1)||0||
48219740|NCT05580003|100863759|FG011|STARTED|Part 3: Period 2 (Day 1)||0||
48219741|NCT05580003|100863760|FG012|STARTED|Part 3: Period 2 (Day 1)||0||
48219742|NCT05580003|100863761|FG013|STARTED|Part 3: Period 2 (Day 1)||2||
48219743|NCT05580003|100863762|FG014|STARTED|Part 3: Period 2 (Day 1)||2||
48219744|NCT05580003|100863763|FG015|STARTED|Part 3: Period 2 (Day 1)||2||
48219745|NCT05580003|100863764|FG016|STARTED|Part 3: Period 2 (Day 1)||2||
48219746|NCT05580003|100863765|FG017|STARTED|Part 3: Period 2 (Day 1)||2||
48219747|NCT05580003|100863766|FG018|STARTED|Part 3: Period 2 (Day 1)||2||
48219748|NCT05580003|100863767|FG019|STARTED|Part 3: Period 2 (Day 1)||0||
48219749|NCT05580003|100863768|FG020|STARTED|Part 3: Period 2 (Day 1)||0||
48219750|NCT05580003|100863769|FG021|STARTED|Part 3: Period 2 (Day 1)||0||
48219751|NCT05580003|100863770|FG022|STARTED|Part 3: Period 2 (Day 1)||0||
48219752|NCT05580003|100863771|FG023|STARTED|Part 3: Period 2 (Day 1)||0||
48219753|NCT05580003|100863772|FG024|STARTED|Part 3: Period 2 (Day 1)||0||
48219754|NCT05580003|100863773|FG025|STARTED|Part 3: Period 2 (Day 1)||0||
48219755|NCT05580003|100863774|FG026|STARTED|Part 3: Period 2 (Day 1)||0||
48219756|NCT05580003|100863775|FG027|STARTED|Part 3: Period 2 (Day 1)||0||
48219757|NCT05580003|100863748|FG000|COMPLETED|Part 3: Period 2 (Day 1)||0||
48219758|NCT05580003|100863749|FG001|COMPLETED|Part 3: Period 2 (Day 1)||0||
48219759|NCT05580003|100863750|FG002|COMPLETED|Part 3: Period 2 (Day 1)||0||
48219760|NCT05580003|100863751|FG003|COMPLETED|Part 3: Period 2 (Day 1)||0||
48219761|NCT05580003|100863752|FG004|COMPLETED|Part 3: Period 2 (Day 1)||0||
48219762|NCT05580003|100863753|FG005|COMPLETED|Part 3: Period 2 (Day 1)||0||
48219763|NCT05580003|100863754|FG006|COMPLETED|Part 3: Period 2 (Day 1)||0||
48219764|NCT05580003|100863755|FG007|COMPLETED|Part 3: Period 2 (Day 1)||0||
48219765|NCT05580003|100863756|FG008|COMPLETED|Part 3: Period 2 (Day 1)||0||
48219766|NCT05580003|100863757|FG009|COMPLETED|Part 3: Period 2 (Day 1)||0||
48219767|NCT05580003|100863758|FG010|COMPLETED|Part 3: Period 2 (Day 1)||0||
48219768|NCT05580003|100863759|FG011|COMPLETED|Part 3: Period 2 (Day 1)||0||
48219769|NCT05580003|100863760|FG012|COMPLETED|Part 3: Period 2 (Day 1)||0||
48219770|NCT05580003|100863761|FG013|COMPLETED|Part 3: Period 2 (Day 1)||2||
48219771|NCT05580003|100863762|FG014|COMPLETED|Part 3: Period 2 (Day 1)||2||
48219772|NCT05580003|100863763|FG015|COMPLETED|Part 3: Period 2 (Day 1)||2||
48219773|NCT05580003|100863764|FG016|COMPLETED|Part 3: Period 2 (Day 1)||2||
48219774|NCT05580003|100863765|FG017|COMPLETED|Part 3: Period 2 (Day 1)||2||
48219775|NCT05580003|100863766|FG018|COMPLETED|Part 3: Period 2 (Day 1)||2||
48219776|NCT05580003|100863767|FG019|COMPLETED|Part 3: Period 2 (Day 1)||0||
48219777|NCT05580003|100863768|FG020|COMPLETED|Part 3: Period 2 (Day 1)||0||
48219778|NCT05580003|100863769|FG021|COMPLETED|Part 3: Period 2 (Day 1)||0||
48219779|NCT05580003|100863770|FG022|COMPLETED|Part 3: Period 2 (Day 1)||0||
48219780|NCT05580003|100863771|FG023|COMPLETED|Part 3: Period 2 (Day 1)||0||
48219781|NCT05580003|100863772|FG024|COMPLETED|Part 3: Period 2 (Day 1)||0||
48219782|NCT05580003|100863773|FG025|COMPLETED|Part 3: Period 2 (Day 1)||0||
48219783|NCT05580003|100863774|FG026|COMPLETED|Part 3: Period 2 (Day 1)||0||
48219784|NCT05580003|100863775|FG027|COMPLETED|Part 3: Period 2 (Day 1)||0||
48219785|NCT05580003|100863748|FG000|NOT COMPLETED|Part 3: Period 2 (Day 1)||0||
48219786|NCT05580003|100863749|FG001|NOT COMPLETED|Part 3: Period 2 (Day 1)||0||
48219787|NCT05580003|100863750|FG002|NOT COMPLETED|Part 3: Period 2 (Day 1)||0||
48219788|NCT05580003|100863751|FG003|NOT COMPLETED|Part 3: Period 2 (Day 1)||0||
48219789|NCT05580003|100863752|FG004|NOT COMPLETED|Part 3: Period 2 (Day 1)||0||
48219790|NCT05580003|100863753|FG005|NOT COMPLETED|Part 3: Period 2 (Day 1)||0||
48219791|NCT05580003|100863754|FG006|NOT COMPLETED|Part 3: Period 2 (Day 1)||0||
48219792|NCT05580003|100863755|FG007|NOT COMPLETED|Part 3: Period 2 (Day 1)||0||
48219793|NCT05580003|100863756|FG008|NOT COMPLETED|Part 3: Period 2 (Day 1)||0||
48219794|NCT05580003|100863757|FG009|NOT COMPLETED|Part 3: Period 2 (Day 1)||0||
48219795|NCT05580003|100863758|FG010|NOT COMPLETED|Part 3: Period 2 (Day 1)||0||
48219796|NCT05580003|100863759|FG011|NOT COMPLETED|Part 3: Period 2 (Day 1)||0||
48219797|NCT05580003|100863760|FG012|NOT COMPLETED|Part 3: Period 2 (Day 1)||0||
48219798|NCT05580003|100863761|FG013|NOT COMPLETED|Part 3: Period 2 (Day 1)||0||
48219799|NCT05580003|100863762|FG014|NOT COMPLETED|Part 3: Period 2 (Day 1)||0||
48219800|NCT05580003|100863763|FG015|NOT COMPLETED|Part 3: Period 2 (Day 1)||0||
48219801|NCT05580003|100863764|FG016|NOT COMPLETED|Part 3: Period 2 (Day 1)||0||
48219802|NCT05580003|100863765|FG017|NOT COMPLETED|Part 3: Period 2 (Day 1)||0||
48219803|NCT05580003|100863766|FG018|NOT COMPLETED|Part 3: Period 2 (Day 1)||0||
48219804|NCT05580003|100863767|FG019|NOT COMPLETED|Part 3: Period 2 (Day 1)||0||
48219805|NCT05580003|100863768|FG020|NOT COMPLETED|Part 3: Period 2 (Day 1)||0||
48219806|NCT05580003|100863769|FG021|NOT COMPLETED|Part 3: Period 2 (Day 1)||0||
48219807|NCT05580003|100863770|FG022|NOT COMPLETED|Part 3: Period 2 (Day 1)||0||
48219808|NCT05580003|100863771|FG023|NOT COMPLETED|Part 3: Period 2 (Day 1)||0||
48219809|NCT05580003|100863772|FG024|NOT COMPLETED|Part 3: Period 2 (Day 1)||0||
48219810|NCT05580003|100863773|FG025|NOT COMPLETED|Part 3: Period 2 (Day 1)||0||
48219811|NCT05580003|100863774|FG026|NOT COMPLETED|Part 3: Period 2 (Day 1)||0||
48219812|NCT05580003|100863775|FG027|NOT COMPLETED|Part 3: Period 2 (Day 1)||0||
48219813|NCT05580003|100863748|FG000|STARTED|Part 3: Washout 2 (up to 3 Days)||0||
48219814|NCT05580003|100863749|FG001|STARTED|Part 3: Washout 2 (up to 3 Days)||0||
48219815|NCT05580003|100863750|FG002|STARTED|Part 3: Washout 2 (up to 3 Days)||0||
48219816|NCT05580003|100863751|FG003|STARTED|Part 3: Washout 2 (up to 3 Days)||0||
48219817|NCT05580003|100863752|FG004|STARTED|Part 3: Washout 2 (up to 3 Days)||0||
48219818|NCT05580003|100863753|FG005|STARTED|Part 3: Washout 2 (up to 3 Days)||0||
48219819|NCT05580003|100863754|FG006|STARTED|Part 3: Washout 2 (up to 3 Days)||0||
48219820|NCT05580003|100863755|FG007|STARTED|Part 3: Washout 2 (up to 3 Days)||0||
48219821|NCT05580003|100863756|FG008|STARTED|Part 3: Washout 2 (up to 3 Days)||0||
48219822|NCT05580003|100863757|FG009|STARTED|Part 3: Washout 2 (up to 3 Days)||0||
48219823|NCT05580003|100863758|FG010|STARTED|Part 3: Washout 2 (up to 3 Days)||0||
48219824|NCT05580003|100863759|FG011|STARTED|Part 3: Washout 2 (up to 3 Days)||0||
48219825|NCT05580003|100863760|FG012|STARTED|Part 3: Washout 2 (up to 3 Days)||0||
48219826|NCT05580003|100863761|FG013|STARTED|Part 3: Washout 2 (up to 3 Days)||2||
48219827|NCT05580003|100863762|FG014|STARTED|Part 3: Washout 2 (up to 3 Days)||2||
48219828|NCT05580003|100863763|FG015|STARTED|Part 3: Washout 2 (up to 3 Days)||2||
48219829|NCT05580003|100863764|FG016|STARTED|Part 3: Washout 2 (up to 3 Days)||2||
48219830|NCT05580003|100863765|FG017|STARTED|Part 3: Washout 2 (up to 3 Days)||2||
48219831|NCT05580003|100863766|FG018|STARTED|Part 3: Washout 2 (up to 3 Days)||2||
48219832|NCT05580003|100863767|FG019|STARTED|Part 3: Washout 2 (up to 3 Days)||0||
48219833|NCT05580003|100863768|FG020|STARTED|Part 3: Washout 2 (up to 3 Days)||0||
48219834|NCT05580003|100863769|FG021|STARTED|Part 3: Washout 2 (up to 3 Days)||0||
48219835|NCT05580003|100863770|FG022|STARTED|Part 3: Washout 2 (up to 3 Days)||0||
48219836|NCT05580003|100863771|FG023|STARTED|Part 3: Washout 2 (up to 3 Days)||0||
48219837|NCT05580003|100863772|FG024|STARTED|Part 3: Washout 2 (up to 3 Days)||0||
48219838|NCT05580003|100863773|FG025|STARTED|Part 3: Washout 2 (up to 3 Days)||0||
48219839|NCT05580003|100863774|FG026|STARTED|Part 3: Washout 2 (up to 3 Days)||0||
48219840|NCT05580003|100863775|FG027|STARTED|Part 3: Washout 2 (up to 3 Days)||0||
48509769|NCT02688387|101580260|FG019|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48509770|NCT02688387|101580261|FG020|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48509771|NCT02688387|101580262|FG021|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48509772|NCT02688387|101580241|FG000|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48066346|NCT00333840|100482635|FG001|STARTED|Second-line Treatment Period||0||
48066347|NCT00333840|100482636|FG002|STARTED|Second-line Treatment Period||14||
48066348|NCT00333840|100482637|FG003|STARTED|Second-line Treatment Period||363||
48066349|NCT00333840|100482634|FG000|COMPLETED|Second-line Treatment Period||0||
48066350|NCT00333840|100482635|FG001|COMPLETED|Second-line Treatment Period||0||
48066351|NCT00333840|100482636|FG002|COMPLETED|Second-line Treatment Period||0||
48066352|NCT00333840|100482637|FG003|COMPLETED|Second-line Treatment Period||175||
48066353|NCT00333840|100482634|FG000|NOT COMPLETED|Second-line Treatment Period||0||
48066354|NCT00333840|100482635|FG001|NOT COMPLETED|Second-line Treatment Period||0||
48219841|NCT05580003|100863748|FG000|COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219842|NCT05580003|100863749|FG001|COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219843|NCT05580003|100863750|FG002|COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219844|NCT05580003|100863751|FG003|COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219845|NCT05580003|100863752|FG004|COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219846|NCT05580003|100863753|FG005|COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219847|NCT05580003|100863754|FG006|COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219848|NCT05580003|100863755|FG007|COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219849|NCT05580003|100863756|FG008|COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219850|NCT05580003|100863757|FG009|COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219851|NCT05580003|100863758|FG010|COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219852|NCT05580003|100863759|FG011|COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219853|NCT05580003|100863760|FG012|COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219854|NCT05580003|100863761|FG013|COMPLETED|Part 3: Washout 2 (up to 3 Days)||2||
48219855|NCT05580003|100863762|FG014|COMPLETED|Part 3: Washout 2 (up to 3 Days)||2||
48219856|NCT05580003|100863763|FG015|COMPLETED|Part 3: Washout 2 (up to 3 Days)||2||
48219857|NCT05580003|100863764|FG016|COMPLETED|Part 3: Washout 2 (up to 3 Days)||2||
48219858|NCT05580003|100863765|FG017|COMPLETED|Part 3: Washout 2 (up to 3 Days)||2||
48219859|NCT05580003|100863766|FG018|COMPLETED|Part 3: Washout 2 (up to 3 Days)||2||
48219860|NCT05580003|100863767|FG019|COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219861|NCT05580003|100863768|FG020|COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219862|NCT05580003|100863769|FG021|COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219863|NCT05580003|100863770|FG022|COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219864|NCT05580003|100863771|FG023|COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219865|NCT05580003|100863772|FG024|COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48509773|NCT02688387|101580242|FG001|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48219866|NCT05580003|100863773|FG025|COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219867|NCT05580003|100863774|FG026|COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219868|NCT05580003|100863775|FG027|COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219869|NCT05580003|100863748|FG000|NOT COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48066355|NCT00333840|100482636|FG002|NOT COMPLETED|Second-line Treatment Period||14||
48066356|NCT00333840|100482637|FG003|NOT COMPLETED|Second-line Treatment Period||188||
48066357|NCT04289623|100482638|FG000|STARTED|Wave 1 Emails||6782||
48066358|NCT04289623|100482639|FG001|STARTED|Wave 1 Emails||6764||
48066359|NCT04289623|100482640|FG002|STARTED|Wave 1 Emails||0||
48066360|NCT04289623|100482641|FG003|STARTED|Wave 1 Emails||0||
48219870|NCT05580003|100863749|FG001|NOT COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219871|NCT05580003|100863750|FG002|NOT COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219872|NCT05580003|100863751|FG003|NOT COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219873|NCT05580003|100863752|FG004|NOT COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219874|NCT05580003|100863753|FG005|NOT COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219875|NCT05580003|100863754|FG006|NOT COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219876|NCT05580003|100863755|FG007|NOT COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219877|NCT05580003|100863756|FG008|NOT COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219878|NCT05580003|100863757|FG009|NOT COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219879|NCT05580003|100863758|FG010|NOT COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219880|NCT05580003|100863759|FG011|NOT COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48509774|NCT02688387|101580243|FG002|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48509775|NCT02688387|101580244|FG003|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48509776|NCT02688387|101580245|FG004|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48509777|NCT02688387|101580246|FG005|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48509778|NCT02688387|101580247|FG006|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48509779|NCT02688387|101580248|FG007|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48509780|NCT02688387|101580249|FG008|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48509781|NCT02688387|101580250|FG009|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48509782|NCT02688387|101580251|FG010|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48509783|NCT02688387|101580252|FG011|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48509784|NCT02688387|101580253|FG012|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48509785|NCT02688387|101580254|FG013|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48509786|NCT02688387|101580255|FG014|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48509787|NCT02688387|101580256|FG015|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48509788|NCT02688387|101580257|FG016|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48509789|NCT02688387|101580258|FG017|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48509790|NCT02688387|101580259|FG018|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48509791|NCT02688387|101580260|FG019|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48509792|NCT02688387|101580261|FG020|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48509793|NCT02688387|101580262|FG021|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
48509794|NCT02688387|101580241|FG000|STARTED|Part 2, Washout Period 3 (10 Days)||0||
48509795|NCT02688387|101580242|FG001|STARTED|Part 2, Washout Period 3 (10 Days)||0||
48219881|NCT05580003|100863760|FG012|NOT COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219882|NCT05580003|100863761|FG013|NOT COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219883|NCT05580003|100863762|FG014|NOT COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219884|NCT05580003|100863763|FG015|NOT COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219885|NCT05580003|100863764|FG016|NOT COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219886|NCT05580003|100863765|FG017|NOT COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219887|NCT05580003|100863766|FG018|NOT COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219888|NCT05580003|100863767|FG019|NOT COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219889|NCT05580003|100863768|FG020|NOT COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219890|NCT05580003|100863769|FG021|NOT COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219891|NCT05580003|100863770|FG022|NOT COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219892|NCT05580003|100863771|FG023|NOT COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219893|NCT05580003|100863772|FG024|NOT COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219894|NCT05580003|100863773|FG025|NOT COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219895|NCT05580003|100863774|FG026|NOT COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219896|NCT05580003|100863775|FG027|NOT COMPLETED|Part 3: Washout 2 (up to 3 Days)||0||
48219897|NCT05580003|100863748|FG000|STARTED|Part 3: Period 3 (Day 1)||0||
48219898|NCT05580003|100863749|FG001|STARTED|Part 3: Period 3 (Day 1)||0||
48219899|NCT05580003|100863750|FG002|STARTED|Part 3: Period 3 (Day 1)||0||
48219900|NCT05580003|100863751|FG003|STARTED|Part 3: Period 3 (Day 1)||0||
48219901|NCT05580003|100863752|FG004|STARTED|Part 3: Period 3 (Day 1)||0||
48219902|NCT05580003|100863753|FG005|STARTED|Part 3: Period 3 (Day 1)||0||
48219903|NCT05580003|100863754|FG006|STARTED|Part 3: Period 3 (Day 1)||0||
48219904|NCT05580003|100863755|FG007|STARTED|Part 3: Period 3 (Day 1)||0||
48219905|NCT05580003|100863756|FG008|STARTED|Part 3: Period 3 (Day 1)||0||
48219906|NCT05580003|100863757|FG009|STARTED|Part 3: Period 3 (Day 1)||0||
48219907|NCT05580003|100863758|FG010|STARTED|Part 3: Period 3 (Day 1)||0||
48219908|NCT05580003|100863759|FG011|STARTED|Part 3: Period 3 (Day 1)||0||
48509796|NCT02688387|101580243|FG002|STARTED|Part 2, Washout Period 3 (10 Days)||0||
48509797|NCT02688387|101580244|FG003|STARTED|Part 2, Washout Period 3 (10 Days)||0||
48509798|NCT02688387|101580245|FG004|STARTED|Part 2, Washout Period 3 (10 Days)||0||
48509799|NCT02688387|101580246|FG005|STARTED|Part 2, Washout Period 3 (10 Days)||0||
48066361|NCT04289623|100482642|FG004|STARTED|Wave 1 Emails||0||
48066362|NCT04289623|100482643|FG005|STARTED|Wave 1 Emails||0||
48509800|NCT02688387|101580247|FG006|STARTED|Part 2, Washout Period 3 (10 Days)||0||
48509801|NCT02688387|101580248|FG007|STARTED|Part 2, Washout Period 3 (10 Days)||0||
48509802|NCT02688387|101580249|FG008|STARTED|Part 2, Washout Period 3 (10 Days)||0||
48509803|NCT02688387|101580250|FG009|STARTED|Part 2, Washout Period 3 (10 Days)||0||
48509804|NCT02688387|101580251|FG010|STARTED|Part 2, Washout Period 3 (10 Days)||5||
48509805|NCT02688387|101580252|FG011|STARTED|Part 2, Washout Period 3 (10 Days)||5||
48509806|NCT02688387|101580253|FG012|STARTED|Part 2, Washout Period 3 (10 Days)||5||
48509807|NCT02688387|101580254|FG013|STARTED|Part 2, Washout Period 3 (10 Days)||5||
48509808|NCT02688387|101580255|FG014|STARTED|Part 2, Washout Period 3 (10 Days)||0||
48509809|NCT02688387|101580256|FG015|STARTED|Part 2, Washout Period 3 (10 Days)||0||
48509810|NCT02688387|101580257|FG016|STARTED|Part 2, Washout Period 3 (10 Days)||0||
48509811|NCT02688387|101580258|FG017|STARTED|Part 2, Washout Period 3 (10 Days)||0||
48509812|NCT02688387|101580259|FG018|STARTED|Part 2, Washout Period 3 (10 Days)||0||
48509813|NCT02688387|101580260|FG019|STARTED|Part 2, Washout Period 3 (10 Days)||0||
48509814|NCT02688387|101580261|FG020|STARTED|Part 2, Washout Period 3 (10 Days)||0||
48509815|NCT02688387|101580262|FG021|STARTED|Part 2, Washout Period 3 (10 Days)||0||
48509816|NCT02688387|101580241|FG000|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509817|NCT02688387|101580242|FG001|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509818|NCT02688387|101580243|FG002|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509819|NCT02688387|101580244|FG003|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509820|NCT02688387|101580245|FG004|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509821|NCT02688387|101580246|FG005|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509822|NCT02688387|101580247|FG006|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509823|NCT02688387|101580248|FG007|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509824|NCT02688387|101580249|FG008|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509825|NCT02688387|101580250|FG009|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509826|NCT02688387|101580251|FG010|COMPLETED|Part 2, Washout Period 3 (10 Days)||5||
48509827|NCT02688387|101580252|FG011|COMPLETED|Part 2, Washout Period 3 (10 Days)||5||
48509828|NCT02688387|101580253|FG012|COMPLETED|Part 2, Washout Period 3 (10 Days)||5||
48509829|NCT02688387|101580254|FG013|COMPLETED|Part 2, Washout Period 3 (10 Days)||5||
48509830|NCT02688387|101580255|FG014|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509831|NCT02688387|101580256|FG015|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509832|NCT02688387|101580257|FG016|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509833|NCT02688387|101580258|FG017|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509834|NCT02688387|101580259|FG018|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509835|NCT02688387|101580260|FG019|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509836|NCT02688387|101580261|FG020|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509837|NCT02688387|101580262|FG021|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509838|NCT02688387|101580241|FG000|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509839|NCT02688387|101580242|FG001|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509840|NCT02688387|101580243|FG002|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509841|NCT02688387|101580244|FG003|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509842|NCT02688387|101580245|FG004|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509843|NCT02688387|101580246|FG005|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509844|NCT02688387|101580247|FG006|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509845|NCT02688387|101580248|FG007|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509846|NCT02688387|101580249|FG008|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509847|NCT02688387|101580250|FG009|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509848|NCT02688387|101580251|FG010|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509849|NCT02688387|101580252|FG011|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509850|NCT02688387|101580253|FG012|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509851|NCT02688387|101580254|FG013|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509852|NCT02688387|101580255|FG014|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509853|NCT02688387|101580256|FG015|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509854|NCT02688387|101580257|FG016|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509855|NCT02688387|101580258|FG017|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509856|NCT02688387|101580259|FG018|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509857|NCT02688387|101580260|FG019|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509858|NCT02688387|101580261|FG020|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509859|NCT02688387|101580262|FG021|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
48509860|NCT02688387|101580241|FG000|STARTED|Part 2, Period 4 (up to 6 Days)||0||
48509861|NCT02688387|101580242|FG001|STARTED|Part 2, Period 4 (up to 6 Days)||0||
48509862|NCT02688387|101580243|FG002|STARTED|Part 2, Period 4 (up to 6 Days)||0||
48509863|NCT02688387|101580244|FG003|STARTED|Part 2, Period 4 (up to 6 Days)||0||
48509864|NCT02688387|101580245|FG004|STARTED|Part 2, Period 4 (up to 6 Days)||0||
48509865|NCT02688387|101580246|FG005|STARTED|Part 2, Period 4 (up to 6 Days)||0||
48509866|NCT02688387|101580247|FG006|STARTED|Part 2, Period 4 (up to 6 Days)||0||
48509867|NCT02688387|101580248|FG007|STARTED|Part 2, Period 4 (up to 6 Days)||0||
48509868|NCT02688387|101580249|FG008|STARTED|Part 2, Period 4 (up to 6 Days)||0||
48509869|NCT02688387|101580250|FG009|STARTED|Part 2, Period 4 (up to 6 Days)||0||
48509870|NCT02688387|101580251|FG010|STARTED|Part 2, Period 4 (up to 6 Days)||5||
48509871|NCT02688387|101580252|FG011|STARTED|Part 2, Period 4 (up to 6 Days)||5||
48509872|NCT02688387|101580253|FG012|STARTED|Part 2, Period 4 (up to 6 Days)||5||
48509873|NCT02688387|101580254|FG013|STARTED|Part 2, Period 4 (up to 6 Days)||5||
48509874|NCT02688387|101580255|FG014|STARTED|Part 2, Period 4 (up to 6 Days)||0||
48509875|NCT02688387|101580256|FG015|STARTED|Part 2, Period 4 (up to 6 Days)||0||
48509876|NCT02688387|101580257|FG016|STARTED|Part 2, Period 4 (up to 6 Days)||0||
48509877|NCT02688387|101580258|FG017|STARTED|Part 2, Period 4 (up to 6 Days)||0||
48509878|NCT02688387|101580259|FG018|STARTED|Part 2, Period 4 (up to 6 Days)||0||
48509879|NCT02688387|101580260|FG019|STARTED|Part 2, Period 4 (up to 6 Days)||0||
48509880|NCT02688387|101580261|FG020|STARTED|Part 2, Period 4 (up to 6 Days)||0||
48509881|NCT02688387|101580262|FG021|STARTED|Part 2, Period 4 (up to 6 Days)||0||
48509882|NCT02688387|101580241|FG000|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509883|NCT02688387|101580242|FG001|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509884|NCT02688387|101580243|FG002|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509885|NCT02688387|101580244|FG003|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509886|NCT02688387|101580245|FG004|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509887|NCT02688387|101580246|FG005|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509888|NCT02688387|101580247|FG006|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509889|NCT02688387|101580248|FG007|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509890|NCT02688387|101580249|FG008|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509891|NCT02688387|101580250|FG009|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509892|NCT02688387|101580251|FG010|COMPLETED|Part 2, Period 4 (up to 6 Days)||5||
48509893|NCT02688387|101580252|FG011|COMPLETED|Part 2, Period 4 (up to 6 Days)||5||
48509894|NCT02688387|101580253|FG012|COMPLETED|Part 2, Period 4 (up to 6 Days)||5||
48509895|NCT02688387|101580254|FG013|COMPLETED|Part 2, Period 4 (up to 6 Days)||5||
48509896|NCT02688387|101580255|FG014|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509897|NCT02688387|101580256|FG015|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509898|NCT02688387|101580257|FG016|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509899|NCT02688387|101580258|FG017|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509900|NCT02688387|101580259|FG018|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509901|NCT02688387|101580260|FG019|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509902|NCT02688387|101580261|FG020|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509903|NCT02688387|101580262|FG021|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509904|NCT02688387|101580241|FG000|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509905|NCT02688387|101580242|FG001|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509906|NCT02688387|101580243|FG002|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509907|NCT02688387|101580244|FG003|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509908|NCT02688387|101580245|FG004|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509909|NCT02688387|101580246|FG005|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509910|NCT02688387|101580247|FG006|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509911|NCT02688387|101580248|FG007|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509912|NCT02688387|101580249|FG008|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509913|NCT02688387|101580250|FG009|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509914|NCT02688387|101580251|FG010|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509915|NCT02688387|101580252|FG011|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509916|NCT02688387|101580253|FG012|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509917|NCT02688387|101580254|FG013|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509918|NCT02688387|101580255|FG014|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509919|NCT02688387|101580256|FG015|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509920|NCT02688387|101580257|FG016|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509921|NCT02688387|101580258|FG017|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509922|NCT02688387|101580259|FG018|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509923|NCT02688387|101580260|FG019|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509924|NCT02688387|101580261|FG020|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509925|NCT02688387|101580262|FG021|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
48509926|NCT02688387|101580241|FG000|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
48509927|NCT02688387|101580242|FG001|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
48509928|NCT02688387|101580243|FG002|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
48509929|NCT02688387|101580244|FG003|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
48509930|NCT02688387|101580245|FG004|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
48509931|NCT02688387|101580246|FG005|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
48509932|NCT02688387|101580247|FG006|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
48509933|NCT02688387|101580248|FG007|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
48509934|NCT02688387|101580249|FG008|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
48509935|NCT02688387|101580250|FG009|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
48509936|NCT02688387|101580251|FG010|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
48509937|NCT02688387|101580252|FG011|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
48509938|NCT02688387|101580253|FG012|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
48509939|NCT02688387|101580254|FG013|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
48509940|NCT02688387|101580255|FG014|STARTED|Part 3A, Period 1 (up to 6 Days)||9||
48509941|NCT02688387|101580256|FG015|STARTED|Part 3A, Period 1 (up to 6 Days)||8||
48509942|NCT02688387|101580257|FG016|STARTED|Part 3A, Period 1 (up to 6 Days)||8||
48509943|NCT02688387|101580258|FG017|STARTED|Part 3A, Period 1 (up to 6 Days)||8||
48509944|NCT02688387|101580259|FG018|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
48509945|NCT02688387|101580260|FG019|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
48509946|NCT02688387|101580261|FG020|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
48509947|NCT02688387|101580262|FG021|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
48509948|NCT02688387|101580241|FG000|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509949|NCT02688387|101580242|FG001|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509950|NCT02688387|101580243|FG002|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509951|NCT02688387|101580244|FG003|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509952|NCT02688387|101580245|FG004|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509953|NCT02688387|101580246|FG005|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509954|NCT02688387|101580247|FG006|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509955|NCT02688387|101580248|FG007|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509956|NCT02688387|101580249|FG008|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509957|NCT02688387|101580250|FG009|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509958|NCT02688387|101580251|FG010|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509959|NCT02688387|101580252|FG011|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509960|NCT02688387|101580253|FG012|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509961|NCT02688387|101580254|FG013|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509962|NCT02688387|101580255|FG014|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8||
48509963|NCT02688387|101580256|FG015|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8||
48509964|NCT02688387|101580257|FG016|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8||
48509965|NCT02688387|101580258|FG017|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8||
48509966|NCT02688387|101580259|FG018|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48066363|NCT04289623|100482638|FG000|COMPLETED|Wave 1 Emails||6514||
48066364|NCT04289623|100482639|FG001|COMPLETED|Wave 1 Emails||6507||
48219909|NCT05580003|100863760|FG012|STARTED|Part 3: Period 3 (Day 1)||0||
48509967|NCT02688387|101580260|FG019|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509968|NCT02688387|101580261|FG020|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509969|NCT02688387|101580262|FG021|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509970|NCT02688387|101580241|FG000|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509971|NCT02688387|101580242|FG001|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509972|NCT02688387|101580243|FG002|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509973|NCT02688387|101580244|FG003|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509974|NCT02688387|101580245|FG004|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509975|NCT02688387|101580246|FG005|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509976|NCT02688387|101580247|FG006|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509977|NCT02688387|101580248|FG007|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509978|NCT02688387|101580249|FG008|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509979|NCT02688387|101580250|FG009|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509980|NCT02688387|101580251|FG010|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509981|NCT02688387|101580252|FG011|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509982|NCT02688387|101580253|FG012|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509983|NCT02688387|101580254|FG013|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509984|NCT02688387|101580255|FG014|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||1||
48509985|NCT02688387|101580256|FG015|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509986|NCT02688387|101580257|FG016|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509987|NCT02688387|101580258|FG017|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509988|NCT02688387|101580259|FG018|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509989|NCT02688387|101580260|FG019|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509990|NCT02688387|101580261|FG020|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509991|NCT02688387|101580262|FG021|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
48509992|NCT02688387|101580241|FG000|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
48509993|NCT02688387|101580242|FG001|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
48509994|NCT02688387|101580243|FG002|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
48509995|NCT02688387|101580244|FG003|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
48509996|NCT02688387|101580245|FG004|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
48509997|NCT02688387|101580246|FG005|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
48509998|NCT02688387|101580247|FG006|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
48509999|NCT02688387|101580248|FG007|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
48510000|NCT02688387|101580249|FG008|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
48510001|NCT02688387|101580250|FG009|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
48510002|NCT02688387|101580251|FG010|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
48510003|NCT02688387|101580252|FG011|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
48510004|NCT02688387|101580253|FG012|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
48510005|NCT02688387|101580254|FG013|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
48510006|NCT02688387|101580255|FG014|STARTED|Part 3A, Washout Period 1 (10 Days)||8||
48510007|NCT02688387|101580256|FG015|STARTED|Part 3A, Washout Period 1 (10 Days)||8||
48510008|NCT02688387|101580257|FG016|STARTED|Part 3A, Washout Period 1 (10 Days)||8||
48510009|NCT02688387|101580258|FG017|STARTED|Part 3A, Washout Period 1 (10 Days)||8||
48510010|NCT02688387|101580259|FG018|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
48066365|NCT04289623|100482640|FG002|COMPLETED|Wave 1 Emails||0||
48510011|NCT02688387|101580260|FG019|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
48510012|NCT02688387|101580261|FG020|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
48510013|NCT02688387|101580262|FG021|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
48510014|NCT02688387|101580241|FG000|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510015|NCT02688387|101580242|FG001|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510016|NCT02688387|101580243|FG002|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510017|NCT02688387|101580244|FG003|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510018|NCT02688387|101580245|FG004|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510019|NCT02688387|101580246|FG005|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510020|NCT02688387|101580247|FG006|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510021|NCT02688387|101580248|FG007|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510022|NCT02688387|101580249|FG008|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510023|NCT02688387|101580250|FG009|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510024|NCT02688387|101580251|FG010|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510025|NCT02688387|101580252|FG011|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510026|NCT02688387|101580253|FG012|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510027|NCT02688387|101580254|FG013|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510028|NCT02688387|101580255|FG014|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8||
48510029|NCT02688387|101580256|FG015|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8||
48510030|NCT02688387|101580257|FG016|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8||
48510031|NCT02688387|101580258|FG017|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8||
48510032|NCT02688387|101580259|FG018|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510033|NCT02688387|101580260|FG019|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510034|NCT02688387|101580261|FG020|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510035|NCT02688387|101580262|FG021|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510036|NCT02688387|101580241|FG000|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510037|NCT02688387|101580242|FG001|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510038|NCT02688387|101580243|FG002|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510039|NCT02688387|101580244|FG003|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510040|NCT02688387|101580245|FG004|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510041|NCT02688387|101580246|FG005|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510042|NCT02688387|101580247|FG006|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510043|NCT02688387|101580248|FG007|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510044|NCT02688387|101580249|FG008|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510045|NCT02688387|101580250|FG009|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510046|NCT02688387|101580251|FG010|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510047|NCT02688387|101580252|FG011|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510048|NCT02688387|101580253|FG012|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510049|NCT02688387|101580254|FG013|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510050|NCT02688387|101580255|FG014|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510051|NCT02688387|101580256|FG015|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510052|NCT02688387|101580257|FG016|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510053|NCT02688387|101580258|FG017|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510054|NCT02688387|101580259|FG018|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510055|NCT02688387|101580260|FG019|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510056|NCT02688387|101580261|FG020|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510057|NCT02688387|101580262|FG021|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
48510058|NCT02688387|101580241|FG000|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
48510059|NCT02688387|101580242|FG001|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
48510060|NCT02688387|101580243|FG002|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
48510061|NCT02688387|101580244|FG003|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
48510062|NCT02688387|101580245|FG004|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
48510063|NCT02688387|101580246|FG005|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
48510064|NCT02688387|101580247|FG006|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
48510065|NCT02688387|101580248|FG007|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
48510066|NCT02688387|101580249|FG008|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
48510067|NCT02688387|101580250|FG009|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
48510068|NCT02688387|101580251|FG010|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
48510069|NCT02688387|101580252|FG011|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
48510070|NCT02688387|101580253|FG012|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
48510071|NCT02688387|101580254|FG013|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
48510072|NCT02688387|101580255|FG014|STARTED|Part 3A, Period 2 (up to 6 Days)||8||
48510073|NCT02688387|101580256|FG015|STARTED|Part 3A, Period 2 (up to 6 Days)||8||
48510074|NCT02688387|101580257|FG016|STARTED|Part 3A, Period 2 (up to 6 Days)||8||
48510075|NCT02688387|101580258|FG017|STARTED|Part 3A, Period 2 (up to 6 Days)||8||
48510076|NCT02688387|101580259|FG018|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
48510077|NCT02688387|101580260|FG019|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
48510078|NCT02688387|101580261|FG020|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
48510079|NCT02688387|101580262|FG021|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
48510080|NCT02688387|101580241|FG000|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510081|NCT02688387|101580242|FG001|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510082|NCT02688387|101580243|FG002|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510083|NCT02688387|101580244|FG003|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510084|NCT02688387|101580245|FG004|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510085|NCT02688387|101580246|FG005|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510086|NCT02688387|101580247|FG006|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510087|NCT02688387|101580248|FG007|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510088|NCT02688387|101580249|FG008|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510089|NCT02688387|101580250|FG009|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510090|NCT02688387|101580251|FG010|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510091|NCT02688387|101580252|FG011|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510092|NCT02688387|101580253|FG012|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510093|NCT02688387|101580254|FG013|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510094|NCT02688387|101580255|FG014|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8||
48510095|NCT02688387|101580256|FG015|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8||
48510096|NCT02688387|101580257|FG016|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8||
48510097|NCT02688387|101580258|FG017|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8||
48510098|NCT02688387|101580259|FG018|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510099|NCT02688387|101580260|FG019|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510100|NCT02688387|101580261|FG020|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510101|NCT02688387|101580262|FG021|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510102|NCT02688387|101580241|FG000|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510103|NCT02688387|101580242|FG001|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510104|NCT02688387|101580243|FG002|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510105|NCT02688387|101580244|FG003|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510106|NCT02688387|101580245|FG004|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510107|NCT02688387|101580246|FG005|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510108|NCT02688387|101580247|FG006|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510109|NCT02688387|101580248|FG007|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510110|NCT02688387|101580249|FG008|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510111|NCT02688387|101580250|FG009|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510112|NCT02688387|101580251|FG010|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510113|NCT02688387|101580252|FG011|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510114|NCT02688387|101580253|FG012|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510115|NCT02688387|101580254|FG013|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510116|NCT02688387|101580255|FG014|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510117|NCT02688387|101580256|FG015|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510118|NCT02688387|101580257|FG016|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510119|NCT02688387|101580258|FG017|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510120|NCT02688387|101580259|FG018|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510121|NCT02688387|101580260|FG019|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510122|NCT02688387|101580261|FG020|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510123|NCT02688387|101580262|FG021|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
48510124|NCT02688387|101580241|FG000|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
48510125|NCT02688387|101580242|FG001|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
48510126|NCT02688387|101580243|FG002|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
48510127|NCT02688387|101580244|FG003|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
48510128|NCT02688387|101580245|FG004|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
48510129|NCT02688387|101580246|FG005|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
48510130|NCT02688387|101580247|FG006|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
48510131|NCT02688387|101580248|FG007|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
48510132|NCT02688387|101580249|FG008|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
48510133|NCT02688387|101580250|FG009|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
48510134|NCT02688387|101580251|FG010|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
48510135|NCT02688387|101580252|FG011|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
48510136|NCT02688387|101580253|FG012|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
48510137|NCT02688387|101580254|FG013|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
48510138|NCT02688387|101580255|FG014|STARTED|Part 3A, Washout Period 2 (10 Days)||8||
48510139|NCT02688387|101580256|FG015|STARTED|Part 3A, Washout Period 2 (10 Days)||8||
48510140|NCT02688387|101580257|FG016|STARTED|Part 3A, Washout Period 2 (10 Days)||8||
48510141|NCT02688387|101580258|FG017|STARTED|Part 3A, Washout Period 2 (10 Days)||8||
48510142|NCT02688387|101580259|FG018|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
48510143|NCT02688387|101580260|FG019|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
48510144|NCT02688387|101580261|FG020|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
48510145|NCT02688387|101580262|FG021|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
48510146|NCT02688387|101580241|FG000|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510147|NCT02688387|101580242|FG001|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510148|NCT02688387|101580243|FG002|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510149|NCT02688387|101580244|FG003|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510150|NCT02688387|101580245|FG004|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510151|NCT02688387|101580246|FG005|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510152|NCT02688387|101580247|FG006|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510153|NCT02688387|101580248|FG007|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510154|NCT02688387|101580249|FG008|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510155|NCT02688387|101580250|FG009|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510156|NCT02688387|101580251|FG010|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510157|NCT02688387|101580252|FG011|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510158|NCT02688387|101580253|FG012|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510159|NCT02688387|101580254|FG013|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510160|NCT02688387|101580255|FG014|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8||
48510161|NCT02688387|101580256|FG015|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8||
48510162|NCT02688387|101580257|FG016|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8||
48510163|NCT02688387|101580258|FG017|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8||
48510164|NCT02688387|101580259|FG018|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510165|NCT02688387|101580260|FG019|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510166|NCT02688387|101580261|FG020|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510167|NCT02688387|101580262|FG021|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510168|NCT02688387|101580241|FG000|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510169|NCT02688387|101580242|FG001|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510170|NCT02688387|101580243|FG002|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510171|NCT02688387|101580244|FG003|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510172|NCT02688387|101580245|FG004|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510173|NCT02688387|101580246|FG005|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510174|NCT02688387|101580247|FG006|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510175|NCT02688387|101580248|FG007|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510176|NCT02688387|101580249|FG008|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510177|NCT02688387|101580250|FG009|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510178|NCT02688387|101580251|FG010|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510179|NCT02688387|101580252|FG011|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510180|NCT02688387|101580253|FG012|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510181|NCT02688387|101580254|FG013|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510182|NCT02688387|101580255|FG014|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510183|NCT02688387|101580256|FG015|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510184|NCT02688387|101580257|FG016|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510185|NCT02688387|101580258|FG017|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510186|NCT02688387|101580259|FG018|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510187|NCT02688387|101580260|FG019|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510188|NCT02688387|101580261|FG020|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510189|NCT02688387|101580262|FG021|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
48510190|NCT02688387|101580241|FG000|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
48510191|NCT02688387|101580242|FG001|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
48510192|NCT02688387|101580243|FG002|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
48510193|NCT02688387|101580244|FG003|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
48510194|NCT02688387|101580245|FG004|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
48510195|NCT02688387|101580246|FG005|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
48510196|NCT02688387|101580247|FG006|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
48510197|NCT02688387|101580248|FG007|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
48510198|NCT02688387|101580249|FG008|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
48510199|NCT02688387|101580250|FG009|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
48510200|NCT02688387|101580251|FG010|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
48510201|NCT02688387|101580252|FG011|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
48510202|NCT02688387|101580253|FG012|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
48510203|NCT02688387|101580254|FG013|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
48510204|NCT02688387|101580255|FG014|STARTED|Part 3A, Period 3 (up to 6 Days)||8||
48510205|NCT02688387|101580256|FG015|STARTED|Part 3A, Period 3 (up to 6 Days)||8||
48510206|NCT02688387|101580257|FG016|STARTED|Part 3A, Period 3 (up to 6 Days)||8||
48510207|NCT02688387|101580258|FG017|STARTED|Part 3A, Period 3 (up to 6 Days)||8||
48510208|NCT02688387|101580259|FG018|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
48510209|NCT02688387|101580260|FG019|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
48510210|NCT02688387|101580261|FG020|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
48510211|NCT02688387|101580262|FG021|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
48510212|NCT02688387|101580241|FG000|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510213|NCT02688387|101580242|FG001|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510214|NCT02688387|101580243|FG002|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510215|NCT02688387|101580244|FG003|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510216|NCT02688387|101580245|FG004|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510217|NCT02688387|101580246|FG005|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510218|NCT02688387|101580247|FG006|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510219|NCT02688387|101580248|FG007|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510220|NCT02688387|101580249|FG008|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510221|NCT02688387|101580250|FG009|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510222|NCT02688387|101580251|FG010|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510223|NCT02688387|101580252|FG011|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510224|NCT02688387|101580253|FG012|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510225|NCT02688387|101580254|FG013|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510226|NCT02688387|101580255|FG014|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8||
48510227|NCT02688387|101580256|FG015|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8||
48510228|NCT02688387|101580257|FG016|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8||
48510229|NCT02688387|101580258|FG017|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8||
48510230|NCT02688387|101580259|FG018|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510231|NCT02688387|101580260|FG019|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510232|NCT02688387|101580261|FG020|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510233|NCT02688387|101580262|FG021|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510234|NCT02688387|101580241|FG000|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510235|NCT02688387|101580242|FG001|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510236|NCT02688387|101580243|FG002|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510237|NCT02688387|101580244|FG003|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510238|NCT02688387|101580245|FG004|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510239|NCT02688387|101580246|FG005|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510240|NCT02688387|101580247|FG006|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510241|NCT02688387|101580248|FG007|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510242|NCT02688387|101580249|FG008|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510243|NCT02688387|101580250|FG009|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510244|NCT02688387|101580251|FG010|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510245|NCT02688387|101580252|FG011|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510246|NCT02688387|101580253|FG012|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510247|NCT02688387|101580254|FG013|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510248|NCT02688387|101580255|FG014|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510249|NCT02688387|101580256|FG015|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510250|NCT02688387|101580257|FG016|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510251|NCT02688387|101580258|FG017|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510252|NCT02688387|101580259|FG018|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510253|NCT02688387|101580260|FG019|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510254|NCT02688387|101580261|FG020|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510255|NCT02688387|101580262|FG021|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
48510256|NCT02688387|101580241|FG000|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
48510257|NCT02688387|101580242|FG001|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
48510258|NCT02688387|101580243|FG002|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
48510259|NCT02688387|101580244|FG003|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
48510260|NCT02688387|101580245|FG004|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
48510261|NCT02688387|101580246|FG005|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
48510262|NCT02688387|101580247|FG006|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
48510263|NCT02688387|101580248|FG007|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
48510264|NCT02688387|101580249|FG008|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
48510265|NCT02688387|101580250|FG009|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
48510266|NCT02688387|101580251|FG010|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
48510267|NCT02688387|101580252|FG011|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
48510268|NCT02688387|101580253|FG012|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
48510269|NCT02688387|101580254|FG013|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
48510270|NCT02688387|101580255|FG014|STARTED|Part 3A, Washout Period 3 (10 Days)||8||
48510271|NCT02688387|101580256|FG015|STARTED|Part 3A, Washout Period 3 (10 Days)||8||
48510272|NCT02688387|101580257|FG016|STARTED|Part 3A, Washout Period 3 (10 Days)||8||
48510273|NCT02688387|101580258|FG017|STARTED|Part 3A, Washout Period 3 (10 Days)||8||
48510274|NCT02688387|101580259|FG018|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
48510275|NCT02688387|101580260|FG019|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
48510276|NCT02688387|101580261|FG020|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
48510277|NCT02688387|101580262|FG021|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
48510278|NCT02688387|101580241|FG000|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510279|NCT02688387|101580242|FG001|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510280|NCT02688387|101580243|FG002|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510281|NCT02688387|101580244|FG003|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510282|NCT02688387|101580245|FG004|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510283|NCT02688387|101580246|FG005|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510284|NCT02688387|101580247|FG006|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510285|NCT02688387|101580248|FG007|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510286|NCT02688387|101580249|FG008|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510287|NCT02688387|101580250|FG009|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510288|NCT02688387|101580251|FG010|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510289|NCT02688387|101580252|FG011|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510290|NCT02688387|101580253|FG012|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510291|NCT02688387|101580254|FG013|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510292|NCT02688387|101580255|FG014|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8||
48510293|NCT02688387|101580256|FG015|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8||
48510294|NCT02688387|101580257|FG016|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8||
48510295|NCT02688387|101580258|FG017|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8||
48510296|NCT02688387|101580259|FG018|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510297|NCT02688387|101580260|FG019|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510298|NCT02688387|101580261|FG020|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510299|NCT02688387|101580262|FG021|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510300|NCT02688387|101580241|FG000|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510301|NCT02688387|101580242|FG001|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510302|NCT02688387|101580243|FG002|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510303|NCT02688387|101580244|FG003|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510304|NCT02688387|101580245|FG004|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510305|NCT02688387|101580246|FG005|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510306|NCT02688387|101580247|FG006|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510307|NCT02688387|101580248|FG007|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510308|NCT02688387|101580249|FG008|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510309|NCT02688387|101580250|FG009|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510310|NCT02688387|101580251|FG010|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510311|NCT02688387|101580252|FG011|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510312|NCT02688387|101580253|FG012|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510313|NCT02688387|101580254|FG013|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510314|NCT02688387|101580255|FG014|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510315|NCT02688387|101580256|FG015|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510316|NCT02688387|101580257|FG016|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510317|NCT02688387|101580258|FG017|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510318|NCT02688387|101580259|FG018|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510319|NCT02688387|101580260|FG019|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510320|NCT02688387|101580261|FG020|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510321|NCT02688387|101580262|FG021|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
48510322|NCT02688387|101580241|FG000|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
48510323|NCT02688387|101580242|FG001|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
48510324|NCT02688387|101580243|FG002|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
48510325|NCT02688387|101580244|FG003|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
48510326|NCT02688387|101580245|FG004|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
48510327|NCT02688387|101580246|FG005|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
48510328|NCT02688387|101580247|FG006|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
48510329|NCT02688387|101580248|FG007|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
48510330|NCT02688387|101580249|FG008|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
48510331|NCT02688387|101580250|FG009|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
48510332|NCT02688387|101580251|FG010|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
48510333|NCT02688387|101580252|FG011|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
48510334|NCT02688387|101580253|FG012|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
48510335|NCT02688387|101580254|FG013|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
48510336|NCT02688387|101580255|FG014|STARTED|Part 3A, Period 4 (up to 6 Days)||8||
48510337|NCT02688387|101580256|FG015|STARTED|Part 3A, Period 4 (up to 6 Days)||8||
48510338|NCT02688387|101580257|FG016|STARTED|Part 3A, Period 4 (up to 6 Days)||8||
48510339|NCT02688387|101580258|FG017|STARTED|Part 3A, Period 4 (up to 6 Days)||8||
48510340|NCT02688387|101580259|FG018|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
48510341|NCT02688387|101580260|FG019|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
48510342|NCT02688387|101580261|FG020|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
48510343|NCT02688387|101580262|FG021|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
48510344|NCT02688387|101580241|FG000|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510345|NCT02688387|101580242|FG001|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510346|NCT02688387|101580243|FG002|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510347|NCT02688387|101580244|FG003|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510348|NCT02688387|101580245|FG004|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510349|NCT02688387|101580246|FG005|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510350|NCT02688387|101580247|FG006|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510351|NCT02688387|101580248|FG007|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510352|NCT02688387|101580249|FG008|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510353|NCT02688387|101580250|FG009|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510354|NCT02688387|101580251|FG010|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510355|NCT02688387|101580252|FG011|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510356|NCT02688387|101580253|FG012|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510357|NCT02688387|101580254|FG013|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510358|NCT02688387|101580255|FG014|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8||
48510359|NCT02688387|101580256|FG015|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8||
48510360|NCT02688387|101580257|FG016|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8||
48510361|NCT02688387|101580258|FG017|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8||
48510362|NCT02688387|101580259|FG018|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510363|NCT02688387|101580260|FG019|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510364|NCT02688387|101580261|FG020|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510365|NCT02688387|101580262|FG021|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510366|NCT02688387|101580241|FG000|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510367|NCT02688387|101580242|FG001|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510368|NCT02688387|101580243|FG002|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510369|NCT02688387|101580244|FG003|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510370|NCT02688387|101580245|FG004|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510371|NCT02688387|101580246|FG005|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510372|NCT02688387|101580247|FG006|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510373|NCT02688387|101580248|FG007|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510374|NCT02688387|101580249|FG008|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510375|NCT02688387|101580250|FG009|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510376|NCT02688387|101580251|FG010|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510377|NCT02688387|101580252|FG011|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510378|NCT02688387|101580253|FG012|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510379|NCT02688387|101580254|FG013|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510380|NCT02688387|101580255|FG014|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510381|NCT02688387|101580256|FG015|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510382|NCT02688387|101580257|FG016|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510383|NCT02688387|101580258|FG017|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510384|NCT02688387|101580259|FG018|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510385|NCT02688387|101580260|FG019|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510386|NCT02688387|101580261|FG020|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510387|NCT02688387|101580262|FG021|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
48510388|NCT02688387|101580241|FG000|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
48510389|NCT02688387|101580242|FG001|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
48510390|NCT02688387|101580243|FG002|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
48510391|NCT02688387|101580244|FG003|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
48510392|NCT02688387|101580245|FG004|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
48510393|NCT02688387|101580246|FG005|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
48510394|NCT02688387|101580247|FG006|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
48510395|NCT02688387|101580248|FG007|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
48510396|NCT02688387|101580249|FG008|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
48510397|NCT02688387|101580250|FG009|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
48510398|NCT02688387|101580251|FG010|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
48510399|NCT02688387|101580252|FG011|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
48510400|NCT02688387|101580253|FG012|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
48510401|NCT02688387|101580254|FG013|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
48510402|NCT02688387|101580255|FG014|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
48510403|NCT02688387|101580256|FG015|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
48510404|NCT02688387|101580257|FG016|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
48510405|NCT02688387|101580258|FG017|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
48510406|NCT02688387|101580259|FG018|STARTED|Part 3B, Period 1 (up to 6 Days)||8||
48510407|NCT02688387|101580260|FG019|STARTED|Part 3B, Period 1 (up to 6 Days)||8||
48510408|NCT02688387|101580261|FG020|STARTED|Part 3B, Period 1 (up to 6 Days)||8||
48510409|NCT02688387|101580262|FG021|STARTED|Part 3B, Period 1 (up to 6 Days)||8||
48510410|NCT02688387|101580241|FG000|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510411|NCT02688387|101580242|FG001|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510412|NCT02688387|101580243|FG002|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510413|NCT02688387|101580244|FG003|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510414|NCT02688387|101580245|FG004|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510415|NCT02688387|101580246|FG005|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510416|NCT02688387|101580247|FG006|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510417|NCT02688387|101580248|FG007|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510418|NCT02688387|101580249|FG008|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510419|NCT02688387|101580250|FG009|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510420|NCT02688387|101580251|FG010|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510421|NCT02688387|101580252|FG011|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510422|NCT02688387|101580253|FG012|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510423|NCT02688387|101580254|FG013|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510424|NCT02688387|101580255|FG014|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510425|NCT02688387|101580256|FG015|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510426|NCT02688387|101580257|FG016|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510427|NCT02688387|101580258|FG017|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510428|NCT02688387|101580259|FG018|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8||
48510429|NCT02688387|101580260|FG019|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8||
48510430|NCT02688387|101580261|FG020|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8||
48510431|NCT02688387|101580262|FG021|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8||
48510432|NCT02688387|101580241|FG000|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510433|NCT02688387|101580242|FG001|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510434|NCT02688387|101580243|FG002|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510435|NCT02688387|101580244|FG003|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510436|NCT02688387|101580245|FG004|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510437|NCT02688387|101580246|FG005|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510438|NCT02688387|101580247|FG006|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510439|NCT02688387|101580248|FG007|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510440|NCT02688387|101580249|FG008|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510441|NCT02688387|101580250|FG009|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510442|NCT02688387|101580251|FG010|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510443|NCT02688387|101580252|FG011|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510444|NCT02688387|101580253|FG012|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510445|NCT02688387|101580254|FG013|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510446|NCT02688387|101580255|FG014|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510447|NCT02688387|101580256|FG015|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510448|NCT02688387|101580257|FG016|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510449|NCT02688387|101580258|FG017|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510450|NCT02688387|101580259|FG018|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510451|NCT02688387|101580260|FG019|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510452|NCT02688387|101580261|FG020|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510453|NCT02688387|101580262|FG021|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
48510454|NCT02688387|101580241|FG000|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
48510455|NCT02688387|101580242|FG001|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
48510456|NCT02688387|101580243|FG002|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
48510457|NCT02688387|101580244|FG003|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
48510458|NCT02688387|101580245|FG004|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
48510459|NCT02688387|101580246|FG005|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
48510460|NCT02688387|101580247|FG006|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
48510461|NCT02688387|101580248|FG007|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
48510462|NCT02688387|101580249|FG008|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
48510463|NCT02688387|101580250|FG009|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
48510464|NCT02688387|101580251|FG010|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
48510465|NCT02688387|101580252|FG011|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
48510466|NCT02688387|101580253|FG012|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
48510467|NCT02688387|101580254|FG013|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
48510468|NCT02688387|101580255|FG014|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
48510469|NCT02688387|101580256|FG015|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
48510470|NCT02688387|101580257|FG016|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
48510471|NCT02688387|101580258|FG017|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
48510472|NCT02688387|101580259|FG018|STARTED|Part 3B, Washout Period 1 (10 Days)||8||
48510473|NCT02688387|101580260|FG019|STARTED|Part 3B, Washout Period 1 (10 Days)||8||
48510474|NCT02688387|101580261|FG020|STARTED|Part 3B, Washout Period 1 (10 Days)||8||
48510475|NCT02688387|101580262|FG021|STARTED|Part 3B, Washout Period 1 (10 Days)||8||
48510476|NCT02688387|101580241|FG000|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510477|NCT02688387|101580242|FG001|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510478|NCT02688387|101580243|FG002|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510479|NCT02688387|101580244|FG003|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510480|NCT02688387|101580245|FG004|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510481|NCT02688387|101580246|FG005|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510482|NCT02688387|101580247|FG006|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510483|NCT02688387|101580248|FG007|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510484|NCT02688387|101580249|FG008|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510485|NCT02688387|101580250|FG009|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510486|NCT02688387|101580251|FG010|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510487|NCT02688387|101580252|FG011|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510488|NCT02688387|101580253|FG012|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510489|NCT02688387|101580254|FG013|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510490|NCT02688387|101580255|FG014|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510491|NCT02688387|101580256|FG015|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510492|NCT02688387|101580257|FG016|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510493|NCT02688387|101580258|FG017|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510494|NCT02688387|101580259|FG018|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8||
48510495|NCT02688387|101580260|FG019|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8||
48510496|NCT02688387|101580261|FG020|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8||
48510497|NCT02688387|101580262|FG021|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8||
48510498|NCT02688387|101580241|FG000|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510499|NCT02688387|101580242|FG001|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510500|NCT02688387|101580243|FG002|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510501|NCT02688387|101580244|FG003|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510502|NCT02688387|101580245|FG004|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510503|NCT02688387|101580246|FG005|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48066366|NCT04289623|100482641|FG003|COMPLETED|Wave 1 Emails||0||
48510504|NCT02688387|101580247|FG006|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510505|NCT02688387|101580248|FG007|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510506|NCT02688387|101580249|FG008|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510507|NCT02688387|101580250|FG009|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510508|NCT02688387|101580251|FG010|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510509|NCT02688387|101580252|FG011|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510510|NCT02688387|101580253|FG012|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510511|NCT02688387|101580254|FG013|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510512|NCT02688387|101580255|FG014|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510513|NCT02688387|101580256|FG015|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510514|NCT02688387|101580257|FG016|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510515|NCT02688387|101580258|FG017|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510516|NCT02688387|101580259|FG018|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510517|NCT02688387|101580260|FG019|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510518|NCT02688387|101580261|FG020|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510519|NCT02688387|101580262|FG021|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
48510520|NCT02688387|101580241|FG000|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
48510521|NCT02688387|101580242|FG001|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
48510522|NCT02688387|101580243|FG002|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
48510523|NCT02688387|101580244|FG003|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
48510524|NCT02688387|101580245|FG004|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
48510525|NCT02688387|101580246|FG005|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
48510526|NCT02688387|101580247|FG006|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
48510527|NCT02688387|101580248|FG007|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
48510528|NCT02688387|101580249|FG008|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
48510529|NCT02688387|101580250|FG009|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
48510530|NCT02688387|101580251|FG010|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
48510531|NCT02688387|101580252|FG011|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
48510532|NCT02688387|101580253|FG012|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
48510533|NCT02688387|101580254|FG013|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
48510534|NCT02688387|101580255|FG014|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
48510535|NCT02688387|101580256|FG015|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
48510536|NCT02688387|101580257|FG016|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
48510537|NCT02688387|101580258|FG017|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
48510538|NCT02688387|101580259|FG018|STARTED|Part 3B, Period 2 (up to 6 Days)||8||
48510539|NCT02688387|101580260|FG019|STARTED|Part 3B, Period 2 (up to 6 Days)||8||
48510540|NCT02688387|101580261|FG020|STARTED|Part 3B, Period 2 (up to 6 Days)||8||
48510541|NCT02688387|101580262|FG021|STARTED|Part 3B, Period 2 (up to 6 Days)||8||
48510542|NCT02688387|101580241|FG000|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510543|NCT02688387|101580242|FG001|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510544|NCT02688387|101580243|FG002|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510545|NCT02688387|101580244|FG003|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510546|NCT02688387|101580245|FG004|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510547|NCT02688387|101580246|FG005|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510548|NCT02688387|101580247|FG006|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510549|NCT02688387|101580248|FG007|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510550|NCT02688387|101580249|FG008|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510551|NCT02688387|101580250|FG009|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510552|NCT02688387|101580251|FG010|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510553|NCT02688387|101580252|FG011|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510554|NCT02688387|101580253|FG012|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510555|NCT02688387|101580254|FG013|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510556|NCT02688387|101580255|FG014|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510557|NCT02688387|101580256|FG015|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510558|NCT02688387|101580257|FG016|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510559|NCT02688387|101580258|FG017|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510560|NCT02688387|101580259|FG018|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8||
48510561|NCT02688387|101580260|FG019|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8||
48510562|NCT02688387|101580261|FG020|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8||
48510563|NCT02688387|101580262|FG021|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8||
48510564|NCT02688387|101580241|FG000|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510565|NCT02688387|101580242|FG001|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510566|NCT02688387|101580243|FG002|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510567|NCT02688387|101580244|FG003|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510568|NCT02688387|101580245|FG004|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510569|NCT02688387|101580246|FG005|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510570|NCT02688387|101580247|FG006|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510571|NCT02688387|101580248|FG007|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510572|NCT02688387|101580249|FG008|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510573|NCT02688387|101580250|FG009|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510574|NCT02688387|101580251|FG010|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510575|NCT02688387|101580252|FG011|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510576|NCT02688387|101580253|FG012|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510577|NCT02688387|101580254|FG013|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510578|NCT02688387|101580255|FG014|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510579|NCT02688387|101580256|FG015|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510580|NCT02688387|101580257|FG016|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510581|NCT02688387|101580258|FG017|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510582|NCT02688387|101580259|FG018|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510583|NCT02688387|101580260|FG019|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510584|NCT02688387|101580261|FG020|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510585|NCT02688387|101580262|FG021|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
48510586|NCT02688387|101580241|FG000|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
48510587|NCT02688387|101580242|FG001|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
48510588|NCT02688387|101580243|FG002|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
48510589|NCT02688387|101580244|FG003|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
48510590|NCT02688387|101580245|FG004|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
48510591|NCT02688387|101580246|FG005|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
48510592|NCT02688387|101580247|FG006|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
48510593|NCT02688387|101580248|FG007|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
48510594|NCT02688387|101580249|FG008|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
48510595|NCT02688387|101580250|FG009|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
48510596|NCT02688387|101580251|FG010|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
48510597|NCT02688387|101580252|FG011|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
48510598|NCT02688387|101580253|FG012|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
48510599|NCT02688387|101580254|FG013|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
48510600|NCT02688387|101580255|FG014|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
48510601|NCT02688387|101580256|FG015|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
48510602|NCT02688387|101580257|FG016|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
48510603|NCT02688387|101580258|FG017|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
48510604|NCT02688387|101580259|FG018|STARTED|Part 3B, Washout Period 2 (10 Days)||8||
48510605|NCT02688387|101580260|FG019|STARTED|Part 3B, Washout Period 2 (10 Days)||8||
48510606|NCT02688387|101580261|FG020|STARTED|Part 3B, Washout Period 2 (10 Days)||8||
48510607|NCT02688387|101580262|FG021|STARTED|Part 3B, Washout Period 2 (10 Days)||8||
48510608|NCT02688387|101580241|FG000|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510609|NCT02688387|101580242|FG001|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510610|NCT02688387|101580243|FG002|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510611|NCT02688387|101580244|FG003|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510612|NCT02688387|101580245|FG004|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510613|NCT02688387|101580246|FG005|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510614|NCT02688387|101580247|FG006|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510615|NCT02688387|101580248|FG007|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510616|NCT02688387|101580249|FG008|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510617|NCT02688387|101580250|FG009|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510618|NCT02688387|101580251|FG010|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510619|NCT02688387|101580252|FG011|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510620|NCT02688387|101580253|FG012|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510621|NCT02688387|101580254|FG013|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510622|NCT02688387|101580255|FG014|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510623|NCT02688387|101580256|FG015|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510624|NCT02688387|101580257|FG016|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510625|NCT02688387|101580258|FG017|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510626|NCT02688387|101580259|FG018|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8||
48510627|NCT02688387|101580260|FG019|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8||
48510628|NCT02688387|101580261|FG020|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8||
48510629|NCT02688387|101580262|FG021|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8||
48510630|NCT02688387|101580241|FG000|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510631|NCT02688387|101580242|FG001|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510632|NCT02688387|101580243|FG002|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510633|NCT02688387|101580244|FG003|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510634|NCT02688387|101580245|FG004|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510635|NCT02688387|101580246|FG005|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510636|NCT02688387|101580247|FG006|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510637|NCT02688387|101580248|FG007|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510638|NCT02688387|101580249|FG008|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510639|NCT02688387|101580250|FG009|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510640|NCT02688387|101580251|FG010|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510641|NCT02688387|101580252|FG011|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510642|NCT02688387|101580253|FG012|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510643|NCT02688387|101580254|FG013|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510644|NCT02688387|101580255|FG014|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510645|NCT02688387|101580256|FG015|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510646|NCT02688387|101580257|FG016|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510647|NCT02688387|101580258|FG017|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510648|NCT02688387|101580259|FG018|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510649|NCT02688387|101580260|FG019|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510650|NCT02688387|101580261|FG020|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510651|NCT02688387|101580262|FG021|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
48510652|NCT02688387|101580241|FG000|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
48510653|NCT02688387|101580242|FG001|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
48510654|NCT02688387|101580243|FG002|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
48510655|NCT02688387|101580244|FG003|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
48510656|NCT02688387|101580245|FG004|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
48510657|NCT02688387|101580246|FG005|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
48510658|NCT02688387|101580247|FG006|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
48510659|NCT02688387|101580248|FG007|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
48510660|NCT02688387|101580249|FG008|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
48510661|NCT02688387|101580250|FG009|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
48510662|NCT02688387|101580251|FG010|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
48510663|NCT02688387|101580252|FG011|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
48510664|NCT02688387|101580253|FG012|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
48510665|NCT02688387|101580254|FG013|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
48510666|NCT02688387|101580255|FG014|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
48510667|NCT02688387|101580256|FG015|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
48510668|NCT02688387|101580257|FG016|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
48510669|NCT02688387|101580258|FG017|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
48510670|NCT02688387|101580259|FG018|STARTED|Part 3B, Period 3 (up to 6 Days)||8||
48510671|NCT02688387|101580260|FG019|STARTED|Part 3B, Period 3 (up to 6 Days)||8||
48510672|NCT02688387|101580261|FG020|STARTED|Part 3B, Period 3 (up to 6 Days)||8||
48510673|NCT02688387|101580262|FG021|STARTED|Part 3B, Period 3 (up to 6 Days)||8||
48510674|NCT02688387|101580241|FG000|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510675|NCT02688387|101580242|FG001|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510676|NCT02688387|101580243|FG002|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510677|NCT02688387|101580244|FG003|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510678|NCT02688387|101580245|FG004|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510679|NCT02688387|101580246|FG005|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510680|NCT02688387|101580247|FG006|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510681|NCT02688387|101580248|FG007|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510682|NCT02688387|101580249|FG008|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510683|NCT02688387|101580250|FG009|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510684|NCT02688387|101580251|FG010|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510685|NCT02688387|101580252|FG011|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510686|NCT02688387|101580253|FG012|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510687|NCT02688387|101580254|FG013|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510688|NCT02688387|101580255|FG014|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510689|NCT02688387|101580256|FG015|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510690|NCT02688387|101580257|FG016|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510691|NCT02688387|101580258|FG017|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510692|NCT02688387|101580259|FG018|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8||
48510693|NCT02688387|101580260|FG019|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8||
48510694|NCT02688387|101580261|FG020|COMPLETED|Part 3B, Period 3 (up to 6 Days)||7||
48510695|NCT02688387|101580262|FG021|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8||
48510696|NCT02688387|101580241|FG000|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510697|NCT02688387|101580242|FG001|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510698|NCT02688387|101580243|FG002|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510699|NCT02688387|101580244|FG003|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510700|NCT02688387|101580245|FG004|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510701|NCT02688387|101580246|FG005|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510702|NCT02688387|101580247|FG006|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510703|NCT02688387|101580248|FG007|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510704|NCT02688387|101580249|FG008|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510705|NCT02688387|101580250|FG009|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510706|NCT02688387|101580251|FG010|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510707|NCT02688387|101580252|FG011|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510708|NCT02688387|101580253|FG012|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510709|NCT02688387|101580254|FG013|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510710|NCT02688387|101580255|FG014|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510711|NCT02688387|101580256|FG015|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510712|NCT02688387|101580257|FG016|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510713|NCT02688387|101580258|FG017|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510714|NCT02688387|101580259|FG018|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510715|NCT02688387|101580260|FG019|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510716|NCT02688387|101580261|FG020|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||1||
48510717|NCT02688387|101580262|FG021|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
48510718|NCT02688387|101580241|FG000|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
48510719|NCT02688387|101580242|FG001|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
48510720|NCT02688387|101580243|FG002|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
48510721|NCT02688387|101580244|FG003|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
48510722|NCT02688387|101580245|FG004|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
48510723|NCT02688387|101580246|FG005|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
48510724|NCT02688387|101580247|FG006|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
48510725|NCT02688387|101580248|FG007|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
48510726|NCT02688387|101580249|FG008|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
48510727|NCT02688387|101580250|FG009|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
48510728|NCT02688387|101580251|FG010|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
48510729|NCT02688387|101580252|FG011|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
48510730|NCT02688387|101580253|FG012|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
48510731|NCT02688387|101580254|FG013|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
48510732|NCT02688387|101580255|FG014|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
48510733|NCT02688387|101580256|FG015|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
48510734|NCT02688387|101580257|FG016|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
48510735|NCT02688387|101580258|FG017|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
48510736|NCT02688387|101580259|FG018|STARTED|Part 3B, Washout Period 3 (10 Days)||8||
48510737|NCT02688387|101580260|FG019|STARTED|Part 3B, Washout Period 3 (10 Days)||8||
48510738|NCT02688387|101580261|FG020|STARTED|Part 3B, Washout Period 3 (10 Days)||7||
48510739|NCT02688387|101580262|FG021|STARTED|Part 3B, Washout Period 3 (10 Days)||8||
48066367|NCT04289623|100482642|FG004|COMPLETED|Wave 1 Emails||0||
48066368|NCT04289623|100482643|FG005|COMPLETED|Wave 1 Emails||0||
48066369|NCT04289623|100482638|FG000|NOT COMPLETED|Wave 1 Emails||268||
48066370|NCT04289623|100482639|FG001|NOT COMPLETED|Wave 1 Emails||257||
48066371|NCT04289623|100482640|FG002|NOT COMPLETED|Wave 1 Emails||0||
48066372|NCT04289623|100482641|FG003|NOT COMPLETED|Wave 1 Emails||0||
48066373|NCT04289623|100482642|FG004|NOT COMPLETED|Wave 1 Emails||0||
48066374|NCT04289623|100482643|FG005|NOT COMPLETED|Wave 1 Emails||0||
48066375|NCT04289623|100482638|FG000|STARTED|Wave 2 Emails||0|The participants who were sent the standard email and the loss frame email but did not respond to the intervention were pooled into one group and randomly assigned to either receive the testimonial (medical expert) email or the testimonial (rank-and-file) email.|
48066376|NCT04289623|100482639|FG001|STARTED|Wave 2 Emails||0|The participants who were sent the standard email and the loss frame email but did not respond to the intervention were pooled into one group and randomly assigned to either receive the testimonial (medical expert) email or the testimonial (rank-and-file) email.|
48066377|NCT04289623|100482640|FG002|STARTED|Wave 2 Emails||6099|The participants who were sent the standard email and the loss frame email but did not respond to the intervention were pooled into one group and randomly assigned to either receive the testimonial (medical expert) email or the testimonial (rank-and-file) email.|
48066378|NCT04289623|100482641|FG003|STARTED|Wave 2 Emails||6117|The participants who were sent the standard email and the loss frame email but did not respond to the intervention were pooled into one group and randomly assigned to either receive the testimonial (medical expert) email or the testimonial (rank-and-file) email.|
48066379|NCT04289623|100482642|FG004|STARTED|Wave 2 Emails||0|The participants who were sent the standard email and the loss frame email but did not respond to the intervention were pooled into one group and randomly assigned to either receive the testimonial (medical expert) email or the testimonial (rank-and-file) email.|
48510740|NCT02688387|101580241|FG000|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510741|NCT02688387|101580242|FG001|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510742|NCT02688387|101580243|FG002|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510743|NCT02688387|101580244|FG003|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510744|NCT02688387|101580245|FG004|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510745|NCT02688387|101580246|FG005|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510746|NCT02688387|101580247|FG006|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510747|NCT02688387|101580248|FG007|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510748|NCT02688387|101580249|FG008|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510749|NCT02688387|101580250|FG009|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510750|NCT02688387|101580251|FG010|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510751|NCT02688387|101580252|FG011|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510752|NCT02688387|101580253|FG012|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510753|NCT02688387|101580254|FG013|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510754|NCT02688387|101580255|FG014|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510755|NCT02688387|101580256|FG015|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510756|NCT02688387|101580257|FG016|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48219910|NCT05580003|100863761|FG013|STARTED|Part 3: Period 3 (Day 1)||2||
48510757|NCT02688387|101580258|FG017|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510758|NCT02688387|101580259|FG018|COMPLETED|Part 3B, Washout Period 3 (10 Days)||7||
48510759|NCT02688387|101580260|FG019|COMPLETED|Part 3B, Washout Period 3 (10 Days)||7||
48510760|NCT02688387|101580261|FG020|COMPLETED|Part 3B, Washout Period 3 (10 Days)||6||
48510761|NCT02688387|101580262|FG021|COMPLETED|Part 3B, Washout Period 3 (10 Days)||8||
48510762|NCT02688387|101580241|FG000|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510763|NCT02688387|101580242|FG001|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510764|NCT02688387|101580243|FG002|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510765|NCT02688387|101580244|FG003|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510766|NCT02688387|101580245|FG004|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510767|NCT02688387|101580246|FG005|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510768|NCT02688387|101580247|FG006|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510769|NCT02688387|101580248|FG007|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510770|NCT02688387|101580249|FG008|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510771|NCT02688387|101580250|FG009|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510772|NCT02688387|101580251|FG010|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510773|NCT02688387|101580252|FG011|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510774|NCT02688387|101580253|FG012|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510775|NCT02688387|101580254|FG013|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510776|NCT02688387|101580255|FG014|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510777|NCT02688387|101580256|FG015|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510778|NCT02688387|101580257|FG016|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510779|NCT02688387|101580258|FG017|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510780|NCT02688387|101580259|FG018|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1||
48510781|NCT02688387|101580260|FG019|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1||
48510782|NCT02688387|101580261|FG020|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1||
48510783|NCT02688387|101580262|FG021|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
48510784|NCT02688387|101580241|FG000|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
48510785|NCT02688387|101580242|FG001|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
48510786|NCT02688387|101580243|FG002|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
48510787|NCT02688387|101580244|FG003|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
48510788|NCT02688387|101580245|FG004|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
48510789|NCT02688387|101580246|FG005|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
48510790|NCT02688387|101580247|FG006|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
48510791|NCT02688387|101580248|FG007|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
48510792|NCT02688387|101580249|FG008|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
48510793|NCT02688387|101580250|FG009|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
48510794|NCT02688387|101580251|FG010|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
48510795|NCT02688387|101580252|FG011|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
48510796|NCT02688387|101580253|FG012|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
48510797|NCT02688387|101580254|FG013|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
48510798|NCT02688387|101580255|FG014|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
48510799|NCT02688387|101580256|FG015|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
48510800|NCT02688387|101580257|FG016|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
48510801|NCT02688387|101580258|FG017|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
48510802|NCT02688387|101580259|FG018|STARTED|Part 3B, Period 4 (up to 6 Days)||7||
48510803|NCT02688387|101580260|FG019|STARTED|Part 3B, Period 4 (up to 6 Days)||7||
48510804|NCT02688387|101580261|FG020|STARTED|Part 3B, Period 4 (up to 6 Days)||6||
48510805|NCT02688387|101580262|FG021|STARTED|Part 3B, Period 4 (up to 6 Days)||8||
48510806|NCT02688387|101580241|FG000|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510807|NCT02688387|101580242|FG001|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510808|NCT02688387|101580243|FG002|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510809|NCT02688387|101580244|FG003|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510810|NCT02688387|101580245|FG004|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510811|NCT02688387|101580246|FG005|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510812|NCT02688387|101580247|FG006|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510813|NCT02688387|101580248|FG007|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510814|NCT02688387|101580249|FG008|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510815|NCT02688387|101580250|FG009|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510816|NCT02688387|101580251|FG010|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510817|NCT02688387|101580252|FG011|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510818|NCT02688387|101580253|FG012|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510819|NCT02688387|101580254|FG013|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510820|NCT02688387|101580255|FG014|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510821|NCT02688387|101580256|FG015|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510822|NCT02688387|101580257|FG016|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510823|NCT02688387|101580258|FG017|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510824|NCT02688387|101580259|FG018|COMPLETED|Part 3B, Period 4 (up to 6 Days)||7||
48510825|NCT02688387|101580260|FG019|COMPLETED|Part 3B, Period 4 (up to 6 Days)||7||
48510826|NCT02688387|101580261|FG020|COMPLETED|Part 3B, Period 4 (up to 6 Days)||6||
48510827|NCT02688387|101580262|FG021|COMPLETED|Part 3B, Period 4 (up to 6 Days)||8||
48510828|NCT02688387|101580241|FG000|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510829|NCT02688387|101580242|FG001|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510830|NCT02688387|101580243|FG002|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510831|NCT02688387|101580244|FG003|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510832|NCT02688387|101580245|FG004|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510833|NCT02688387|101580246|FG005|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510834|NCT02688387|101580247|FG006|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510835|NCT02688387|101580248|FG007|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510836|NCT02688387|101580249|FG008|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510837|NCT02688387|101580250|FG009|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510838|NCT02688387|101580251|FG010|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510839|NCT02688387|101580252|FG011|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510840|NCT02688387|101580253|FG012|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510841|NCT02688387|101580254|FG013|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510842|NCT02688387|101580255|FG014|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510843|NCT02688387|101580256|FG015|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510844|NCT02688387|101580257|FG016|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510845|NCT02688387|101580258|FG017|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510846|NCT02688387|101580259|FG018|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510847|NCT02688387|101580260|FG019|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510848|NCT02688387|101580261|FG020|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510849|NCT02688387|101580262|FG021|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
48510850|NCT01029392|101580263|FG000|STARTED|Overall Study||37||
48510851|NCT01029392|101580264|FG001|STARTED|Overall Study||38||
48510852|NCT01029392|101580263|FG000|COMPLETED|Overall Study||17||
48510853|NCT01029392|101580264|FG001|COMPLETED|Overall Study||27||
48510854|NCT01029392|101580263|FG000|NOT COMPLETED|Overall Study||20||
48510855|NCT01029392|101580264|FG001|NOT COMPLETED|Overall Study||11||
48510856|NCT01195116|101580265|FG000|STARTED|Overall Study||21||
48510857|NCT01195116|101580266|FG001|STARTED|Overall Study||20||
48510858|NCT01195116|101580265|FG000|COMPLETED|Overall Study||21||
48510859|NCT01195116|101580266|FG001|COMPLETED|Overall Study||20||
48510860|NCT01195116|101580265|FG000|NOT COMPLETED|Overall Study||0||
48510861|NCT01195116|101580266|FG001|NOT COMPLETED|Overall Study||0||
48510862|NCT04501094|101580267|FG000|STARTED|Overall Study||1||
48510863|NCT04501094|101580268|FG001|STARTED|Overall Study||1||
48510864|NCT04501094|101580267|FG000|COMPLETED|Overall Study||0||
48510865|NCT04501094|101580268|FG001|COMPLETED|Overall Study||1||
48510866|NCT04501094|101580267|FG000|NOT COMPLETED|Overall Study||1||
48510867|NCT04501094|101580268|FG001|NOT COMPLETED|Overall Study||0||
48510868|NCT01894230|101580269|FG000|STARTED|Overall Study||83||
48510869|NCT01894230|101580270|FG001|STARTED|Overall Study||76||
48510870|NCT01894230|101580269|FG000|COMPLETED|Overall Study||76||
48510871|NCT01894230|101580270|FG001|COMPLETED|Overall Study||69||
48510872|NCT01894230|101580269|FG000|NOT COMPLETED|Overall Study||7||
48510873|NCT01894230|101580270|FG001|NOT COMPLETED|Overall Study||7||
48510874|NCT02484430|101580271|FG000|STARTED|Overall Study||16||
48510875|NCT02484430|101580271|FG000|COMPLETED|Overall Study||16||
48510876|NCT02484430|101580271|FG000|NOT COMPLETED|Overall Study||0||
48510877|NCT00685750|101580272|FG000|STARTED|Overall Study||17||
48510878|NCT00685750|101580273|FG001|STARTED|Overall Study||3||
48510879|NCT00685750|101580274|FG002|STARTED|Overall Study||21||
48510880|NCT00685750|101580275|FG003|STARTED|Overall Study||2||
48510881|NCT00685750|101580276|FG004|STARTED|Overall Study||15||
48510882|NCT00685750|101580277|FG005|STARTED|Overall Study||20||
48510883|NCT00685750|101580278|FG006|STARTED|Overall Study||10||
48510884|NCT00685750|101580272|FG000|COMPLETED|Overall Study||17||
48510885|NCT00685750|101580273|FG001|COMPLETED|Overall Study||3||
48510886|NCT00685750|101580274|FG002|COMPLETED|Overall Study||19||
48510887|NCT00685750|101580275|FG003|COMPLETED|Overall Study||2||
48510888|NCT00685750|101580276|FG004|COMPLETED|Overall Study||15||
48510889|NCT00685750|101580277|FG005|COMPLETED|Overall Study||20||
48510890|NCT00685750|101580278|FG006|COMPLETED|Overall Study||9||
48510891|NCT00685750|101580272|FG000|NOT COMPLETED|Overall Study||0||
48219911|NCT05580003|100863762|FG014|STARTED|Part 3: Period 3 (Day 1)||2||
48510892|NCT00685750|101580273|FG001|NOT COMPLETED|Overall Study||0||
48510893|NCT00685750|101580274|FG002|NOT COMPLETED|Overall Study||2||
48510894|NCT00685750|101580275|FG003|NOT COMPLETED|Overall Study||0||
48510895|NCT00685750|101580276|FG004|NOT COMPLETED|Overall Study||0||
48510896|NCT00685750|101580277|FG005|NOT COMPLETED|Overall Study||0||
48510897|NCT00685750|101580278|FG006|NOT COMPLETED|Overall Study||1||
48510898|NCT01074008|101580279|FG000|STARTED|Overall Study||8||
48510899|NCT01074008|101580280|FG001|STARTED|Overall Study||8||
48510900|NCT01074008|101580281|FG002|STARTED|Overall Study||8||
48510901|NCT01074008|101580282|FG003|STARTED|Overall Study||8||
48510902|NCT01074008|101580283|FG004|STARTED|Overall Study||8||
48510903|NCT01074008|101580284|FG005|STARTED|Overall Study||7||
48219912|NCT05580003|100863763|FG015|STARTED|Part 3: Period 3 (Day 1)||2||
48510904|NCT01074008|101580285|FG006|STARTED|Overall Study||8||
48510905|NCT01074008|101580286|FG007|STARTED|Overall Study||8||
48510906|NCT01074008|101580287|FG008|STARTED|Overall Study||11||
48510907|NCT01074008|101580279|FG000|Completed Direct-acting Antiviral Agent|Overall Study||8||
48510908|NCT01074008|101580280|FG001|Completed Direct-acting Antiviral Agent|Overall Study||7||
48510909|NCT01074008|101580281|FG002|Completed Direct-acting Antiviral Agent|Overall Study||7||
48510910|NCT01074008|101580282|FG003|Completed Direct-acting Antiviral Agent|Overall Study||8||
48510911|NCT01074008|101580283|FG004|Completed Direct-acting Antiviral Agent|Overall Study||8||
48510912|NCT01074008|101580284|FG005|Completed Direct-acting Antiviral Agent|Overall Study||5||
48510913|NCT01074008|101580285|FG006|Completed Direct-acting Antiviral Agent|Overall Study||8||
48510914|NCT01074008|101580286|FG007|Completed Direct-acting Antiviral Agent|Overall Study||7||
48510915|NCT01074008|101580287|FG008|Completed Direct-acting Antiviral Agent|Overall Study||5||
48510916|NCT01074008|101580279|FG000|COMPLETED|Overall Study||7||
48510917|NCT01074008|101580280|FG001|COMPLETED|Overall Study||5||
48510918|NCT01074008|101580281|FG002|COMPLETED|Overall Study||6||
48510919|NCT01074008|101580282|FG003|COMPLETED|Overall Study||7||
48510920|NCT01074008|101580283|FG004|COMPLETED|Overall Study||6||
48510921|NCT01074008|101580284|FG005|COMPLETED|Overall Study||7||
48510922|NCT01074008|101580285|FG006|COMPLETED|Overall Study||7||
48510923|NCT01074008|101580286|FG007|COMPLETED|Overall Study||8||
48510924|NCT01074008|101580287|FG008|COMPLETED|Overall Study||7||
48066380|NCT04289623|100482643|FG005|STARTED|Wave 2 Emails||0|The participants who were sent the standard email and the loss frame email but did not respond to the intervention were pooled into one group and randomly assigned to either receive the testimonial (medical expert) email or the testimonial (rank-and-file) email.|
48066381|NCT04289623|100482638|FG000|COMPLETED|Wave 2 Emails||0||
48066382|NCT04289623|100482639|FG001|COMPLETED|Wave 2 Emails||0||
48066383|NCT04289623|100482640|FG002|COMPLETED|Wave 2 Emails||6099||
48066384|NCT04289623|100482641|FG003|COMPLETED|Wave 2 Emails||6117||
48066385|NCT04289623|100482642|FG004|COMPLETED|Wave 2 Emails||0||
48066386|NCT04289623|100482643|FG005|COMPLETED|Wave 2 Emails||0||
48066387|NCT04289623|100482638|FG000|NOT COMPLETED|Wave 2 Emails||0||
48066388|NCT04289623|100482639|FG001|NOT COMPLETED|Wave 2 Emails||0||
48066389|NCT04289623|100482640|FG002|NOT COMPLETED|Wave 2 Emails||0||
48066390|NCT04289623|100482641|FG003|NOT COMPLETED|Wave 2 Emails||0||
48066391|NCT04289623|100482642|FG004|NOT COMPLETED|Wave 2 Emails||0||
48066392|NCT04289623|100482643|FG005|NOT COMPLETED|Wave 2 Emails||0||
48066393|NCT01903031|100482644|FG000|STARTED|Overall Study||27||
48066394|NCT01903031|100482645|FG001|STARTED|Overall Study||28||
48066395|NCT01903031|100482646|FG002|STARTED|Overall Study||29||
48066396|NCT01903031|100482644|FG000|COMPLETED|Overall Study||25||
48066397|NCT01903031|100482645|FG001|COMPLETED|Overall Study||25||
48066398|NCT01903031|100482646|FG002|COMPLETED|Overall Study||24||
48066399|NCT01903031|100482644|FG000|NOT COMPLETED|Overall Study||2||
48066400|NCT01903031|100482645|FG001|NOT COMPLETED|Overall Study||3||
48066401|NCT01903031|100482646|FG002|NOT COMPLETED|Overall Study||5||
48066402|NCT03451578|100482647|FG000|STARTED|Overall Study||54||
48066403|NCT03451578|100482647|FG000|COMPLETED|Overall Study||54||
48066404|NCT03451578|100482647|FG000|NOT COMPLETED|Overall Study||0||
48066405|NCT00241358|100482648|FG000|STARTED|Overall Study||25||
48066406|NCT00241358|100482649|FG001|STARTED|Overall Study||46||
48066407|NCT00241358|100482650|FG002|STARTED|Overall Study||21||
48066408|NCT00241358|100482648|FG000|COMPLETED|Overall Study||25||
48066409|NCT00241358|100482649|FG001|COMPLETED|Overall Study||45||
48066410|NCT00241358|100482650|FG002|COMPLETED|Overall Study||20||
48066411|NCT00241358|100482648|FG000|NOT COMPLETED|Overall Study||0||
48510925|NCT01074008|101580279|FG000|NOT COMPLETED|Overall Study||1||
48510926|NCT01074008|101580280|FG001|NOT COMPLETED|Overall Study||3||
48510927|NCT01074008|101580281|FG002|NOT COMPLETED|Overall Study||2||
48510928|NCT01074008|101580282|FG003|NOT COMPLETED|Overall Study||1||
48510929|NCT01074008|101580283|FG004|NOT COMPLETED|Overall Study||2||
48510930|NCT01074008|101580284|FG005|NOT COMPLETED|Overall Study||0||
48510931|NCT01074008|101580285|FG006|NOT COMPLETED|Overall Study||1||
48510932|NCT01074008|101580286|FG007|NOT COMPLETED|Overall Study||0||
48510933|NCT01074008|101580287|FG008|NOT COMPLETED|Overall Study||4||
48510934|NCT00985231|101580288|FG000|STARTED|Overall Study||133||
48510935|NCT00985231|101580289|FG001|STARTED|Overall Study||132||
48510936|NCT00985231|101580288|FG000|COMPLETED|Overall Study||130||
48510937|NCT00985231|101580289|FG001|COMPLETED|Overall Study||129||
48510938|NCT00985231|101580288|FG000|NOT COMPLETED|Overall Study||3||
48510939|NCT00985231|101580289|FG001|NOT COMPLETED|Overall Study||3||
48510940|NCT01863186|101580290|FG000|STARTED|Double-blind Phase||229||
48510941|NCT01863186|101580291|FG001|STARTED|Double-blind Phase||222||
48510942|NCT01863186|101580292|FG002|STARTED|Double-blind Phase||151||
48510943|NCT01863186|101580293|FG003|STARTED|Double-blind Phase||0||
48510944|NCT01863186|101580290|FG000|COMPLETED|Double-blind Phase||95||
48510945|NCT01863186|101580291|FG001|COMPLETED|Double-blind Phase||88||
48510946|NCT01863186|101580292|FG002|COMPLETED|Double-blind Phase||42||
48510947|NCT01863186|101580293|FG003|COMPLETED|Double-blind Phase||0||
48510948|NCT01863186|101580290|FG000|NOT COMPLETED|Double-blind Phase||134||
48510949|NCT01863186|101580291|FG001|NOT COMPLETED|Double-blind Phase||134||
48066412|NCT00241358|100482649|FG001|NOT COMPLETED|Overall Study||1||
48066413|NCT00241358|100482650|FG002|NOT COMPLETED|Overall Study||1||
48066414|NCT01361568|100482651|FG000|STARTED|Overall Study||71||
48066415|NCT01361568|100482652|FG001|STARTED|Overall Study||71||
48066416|NCT01361568|100482653|FG002|STARTED|Overall Study||20||
48066417|NCT01361568|100482654|FG003|STARTED|Overall Study||21||
48510950|NCT01863186|101580292|FG002|NOT COMPLETED|Double-blind Phase||109||
48510951|NCT01863186|101580293|FG003|NOT COMPLETED|Double-blind Phase||0||
48510952|NCT01863186|101580290|FG000|STARTED|Open-label Phase||0||
48510953|NCT01863186|101580291|FG001|STARTED|Open-label Phase||0||
48510954|NCT01863186|101580292|FG002|STARTED|Open-label Phase||0||
48510955|NCT01863186|101580293|FG003|STARTED|Open-label Phase||83||
48510956|NCT01863186|101580290|FG000|COMPLETED|Open-label Phase||0||
48510957|NCT01863186|101580291|FG001|COMPLETED|Open-label Phase||0||
48510958|NCT01863186|101580292|FG002|COMPLETED|Open-label Phase||0||
48510959|NCT01863186|101580293|FG003|COMPLETED|Open-label Phase||70||
48510960|NCT01863186|101580290|FG000|NOT COMPLETED|Open-label Phase||0||
48510961|NCT01863186|101580291|FG001|NOT COMPLETED|Open-label Phase||0||
48510962|NCT01863186|101580292|FG002|NOT COMPLETED|Open-label Phase||0||
48510963|NCT01863186|101580293|FG003|NOT COMPLETED|Open-label Phase||13||
48510964|NCT00367016|101580294|FG000|STARTED|Overall Study||3||
48510965|NCT00367016|101580295|FG001|STARTED|Overall Study||3||
48510966|NCT00367016|101580294|FG000|First Intervention|Overall Study||3||
48510967|NCT00367016|101580295|FG001|First Intervention|Overall Study||3||
48510968|NCT00367016|101580294|FG000|Second Intervention|Overall Study||3||
48510969|NCT00367016|101580295|FG001|Second Intervention|Overall Study||3||
48510970|NCT00367016|101580294|FG000|COMPLETED|Overall Study||3||
48510971|NCT00367016|101580295|FG001|COMPLETED|Overall Study||3||
48510972|NCT00367016|101580294|FG000|NOT COMPLETED|Overall Study||0||
48510973|NCT00367016|101580295|FG001|NOT COMPLETED|Overall Study||0||
48510974|NCT02156154|101580296|FG000|STARTED|Overall Study||291||
48510975|NCT02156154|101580297|FG001|STARTED|Overall Study||289||
48510976|NCT02156154|101580296|FG000|COMPLETED|Overall Study||287||
48510977|NCT02156154|101580297|FG001|COMPLETED|Overall Study||283||
48510978|NCT02156154|101580296|FG000|NOT COMPLETED|Overall Study||4||
48510979|NCT02156154|101580297|FG001|NOT COMPLETED|Overall Study||6||
48510980|NCT01899326|101580298|FG000|STARTED|Overall Study||10||
48510981|NCT01899326|101580298|FG000|COMPLETED|Overall Study||6||
48510982|NCT01899326|101580298|FG000|NOT COMPLETED|Overall Study||4||
48510983|NCT01334957|101580299|FG000|STARTED|Overall Study||300||
48510984|NCT01334957|101580299|FG000|Received Single Dose|Overall Study||252||
48510985|NCT01334957|101580299|FG000|Received Multiple Doses|Overall Study||48||
48510986|NCT01334957|101580299|FG000|COMPLETED|Overall Study||300||
48510987|NCT01334957|101580299|FG000|NOT COMPLETED|Overall Study||0||
48510988|NCT00819767|101580300|FG000|STARTED|Overall Study||33||
48510989|NCT00819767|101580301|FG001|STARTED|Overall Study||35||
48510990|NCT00819767|101580300|FG000|COMPLETED|Overall Study||32||
48510991|NCT00819767|101580301|FG001|COMPLETED|Overall Study||33||
48510992|NCT00819767|101580300|FG000|NOT COMPLETED|Overall Study||1||
48510993|NCT00819767|101580301|FG001|NOT COMPLETED|Overall Study||2||
48510994|NCT03069417|101580302|FG000|STARTED|Overall Study||14||
48510995|NCT03069417|101580303|FG001|STARTED|Overall Study||9||
48510996|NCT03069417|101580302|FG000|Post-Treatment Assessment|Overall Study||12||
48510997|NCT03069417|101580303|FG001|Post-Treatment Assessment|Overall Study||6||
48510998|NCT03069417|101580302|FG000|COMPLETED|Overall Study||8||
48510999|NCT03069417|101580303|FG001|COMPLETED|Overall Study||2||
48511000|NCT03069417|101580302|FG000|NOT COMPLETED|Overall Study||6||
48511001|NCT03069417|101580303|FG001|NOT COMPLETED|Overall Study||7||
48511002|NCT00559637|101580304|FG000|STARTED|Overall Study||184||
48511003|NCT00559637|101580304|FG000|COMPLETED|Overall Study||130||
48511004|NCT00559637|101580304|FG000|NOT COMPLETED|Overall Study||54||
48511005|NCT04590781|101580305|FG000|STARTED|Overall Study||2||
48511006|NCT04590781|101580306|FG001|STARTED|Overall Study||2||
48511007|NCT04590781|101580305|FG000|COMPLETED|Overall Study||0||
48511008|NCT04590781|101580306|FG001|COMPLETED|Overall Study||0||
48511009|NCT04590781|101580305|FG000|NOT COMPLETED|Overall Study||2||
48511010|NCT04590781|101580306|FG001|NOT COMPLETED|Overall Study||2||
48511011|NCT00232479|101580307|FG000|STARTED|Overall Study||44||
48511012|NCT00232479|101580307|FG000|COMPLETED|Overall Study||44||
48511013|NCT00232479|101580307|FG000|NOT COMPLETED|Overall Study||0||
48511014|NCT01719562|101580308|FG000|STARTED|Overall Study||20||
48511015|NCT01719562|101580309|FG001|STARTED|Overall Study||8||
48511016|NCT01719562|101580308|FG000|COMPLETED|Overall Study||17||
48511017|NCT01719562|101580309|FG001|COMPLETED|Overall Study||8||
48511018|NCT01719562|101580308|FG000|NOT COMPLETED|Overall Study||3||
48511019|NCT01719562|101580309|FG001|NOT COMPLETED|Overall Study||0||
48511020|NCT02911935|101580310|FG000|STARTED|Overall Study||101||
48511021|NCT02911935|101580311|FG001|STARTED|Overall Study||99||
48511022|NCT02911935|101580310|FG000|COMPLETED|Overall Study||96||
48511023|NCT02911935|101580311|FG001|COMPLETED|Overall Study||92||
48511024|NCT02911935|101580310|FG000|NOT COMPLETED|Overall Study||5||
48511025|NCT02911935|101580311|FG001|NOT COMPLETED|Overall Study||7||
48511026|NCT00964353|101580312|FG000|STARTED|Overall Study||181||
48511027|NCT00964353|101580313|FG001|STARTED|Overall Study||178||
48511028|NCT00964353|101580312|FG000|COMPLETED|Overall Study||181||
48511029|NCT00964353|101580313|FG001|COMPLETED|Overall Study||178||
48511030|NCT00964353|101580312|FG000|NOT COMPLETED|Overall Study||0||
48511031|NCT00964353|101580313|FG001|NOT COMPLETED|Overall Study||0||
48511032|NCT00838981|101580314|FG000|STARTED|Week 1 Days 1-3||26||
48511033|NCT00838981|101580315|FG001|STARTED|Week 1 Days 1-3||19||
48511034|NCT00838981|101580316|FG002|STARTED|Week 1 Days 1-3||27||
48511035|NCT00838981|101580317|FG003|STARTED|Week 1 Days 1-3||19||
48511036|NCT00838981|101580314|FG000|COMPLETED|Week 1 Days 1-3||26||
48511037|NCT00838981|101580315|FG001|COMPLETED|Week 1 Days 1-3||19||
48511038|NCT00838981|101580316|FG002|COMPLETED|Week 1 Days 1-3||27||
48511039|NCT00838981|101580317|FG003|COMPLETED|Week 1 Days 1-3||19||
48511040|NCT00838981|101580314|FG000|NOT COMPLETED|Week 1 Days 1-3||0||
48511041|NCT00838981|101580315|FG001|NOT COMPLETED|Week 1 Days 1-3||0||
48511042|NCT00838981|101580316|FG002|NOT COMPLETED|Week 1 Days 1-3||0||
48511043|NCT00838981|101580317|FG003|NOT COMPLETED|Week 1 Days 1-3||0||
48511044|NCT00838981|101580314|FG000|STARTED|Day 4 to Week 11||26||
48511045|NCT00838981|101580315|FG001|STARTED|Day 4 to Week 11||19||
48511046|NCT00838981|101580316|FG002|STARTED|Day 4 to Week 11||27||
48511047|NCT00838981|101580317|FG003|STARTED|Day 4 to Week 11||19||
48511048|NCT00838981|101580314|FG000|Completed Main Treatment on 400mg|Day 4 to Week 11||22||
48511049|NCT00838981|101580315|FG001|Completed Main Treatment on 400mg|Day 4 to Week 11||13||
48511050|NCT00838981|101580316|FG002|Completed Main Treatment on 400mg|Day 4 to Week 11||17||
48511051|NCT00838981|101580317|FG003|Completed Main Treatment on 400mg|Day 4 to Week 11||14||
48511052|NCT00838981|101580314|FG000|COMPLETED|Day 4 to Week 11||19|'Completed' numbers reflect those that completed the post treatment assessments and 'Not Completed' numbers reflect those that did not complete the post treatment assessments.|
48511053|NCT00838981|101580315|FG001|COMPLETED|Day 4 to Week 11||11|'Completed' numbers reflect those that completed the post treatment assessments and 'Not Completed' numbers reflect those that did not complete the post treatment assessments.|
48511054|NCT00838981|101580316|FG002|COMPLETED|Day 4 to Week 11||16|'Completed' numbers reflect those that completed the post treatment assessments and 'Not Completed' numbers reflect those that did not complete the post treatment assessments.|
48511055|NCT00838981|101580317|FG003|COMPLETED|Day 4 to Week 11||12|'Completed' numbers reflect those that completed the post treatment assessments and 'Not Completed' numbers reflect those that did not complete the post treatment assessments.|
48511056|NCT00838981|101580314|FG000|NOT COMPLETED|Day 4 to Week 11||7||
48511057|NCT00838981|101580315|FG001|NOT COMPLETED|Day 4 to Week 11||8||
48511058|NCT00838981|101580316|FG002|NOT COMPLETED|Day 4 to Week 11||11||
48511059|NCT00838981|101580317|FG003|NOT COMPLETED|Day 4 to Week 11||7||
48511060|NCT02248662|101580318|FG000|STARTED|Overall Study||5320||
48511061|NCT02248662|101580319|FG001|STARTED|Overall Study||33194||
48511062|NCT02248662|101580318|FG000|COMPLETED|Overall Study||757||
48511063|NCT02248662|101580319|FG001|COMPLETED|Overall Study||2679||
48511064|NCT02248662|101580318|FG000|NOT COMPLETED|Overall Study||4563||
48511065|NCT02248662|101580319|FG001|NOT COMPLETED|Overall Study||30515||
48511066|NCT00084799|101580320|FG000|STARTED|Overall Study||5||
48511067|NCT00084799|101580321|FG001|STARTED|Overall Study||5||
48511068|NCT00084799|101580320|FG000|COMPLETED|Overall Study||4||
48511069|NCT00084799|101580321|FG001|COMPLETED|Overall Study||5||
48511070|NCT00084799|101580320|FG000|NOT COMPLETED|Overall Study||1||
48511071|NCT00084799|101580321|FG001|NOT COMPLETED|Overall Study||0||
48511072|NCT03102879|101580322|FG000|STARTED|Overall Study||18||
48511073|NCT03102879|101580323|FG001|STARTED|Overall Study||18||
48511074|NCT03102879|101580322|FG000|COMPLETED|Overall Study||18||
48511075|NCT03102879|101580323|FG001|COMPLETED|Overall Study||18||
48511076|NCT03102879|101580322|FG000|NOT COMPLETED|Overall Study||0||
48511077|NCT03102879|101580323|FG001|NOT COMPLETED|Overall Study||0||
48511078|NCT04167618|101583268|FG000|STARTED|Overall Study||1||
48511079|NCT04167618|101583269|FG001|STARTED|Overall Study||1||
48511080|NCT04167618|101583268|FG000|COMPLETED|Overall Study||0||
48511081|NCT04167618|101583269|FG001|COMPLETED|Overall Study||0||
48511082|NCT04167618|101583268|FG000|NOT COMPLETED|Overall Study||1||
48511083|NCT04167618|101583269|FG001|NOT COMPLETED|Overall Study||1||
48511084|NCT01503333|101583270|FG000|STARTED|Overall Study||777||
48511085|NCT01503333|101583271|FG001|STARTED|Overall Study||766||
48511086|NCT01503333|101583270|FG000|Completed Baseline|Overall Study||766||
48511087|NCT01503333|101583271|FG001|Completed Baseline|Overall Study||753||
48511088|NCT01503333|101583270|FG000|Completed Post-intervention|Overall Study||680||
48511089|NCT01503333|101583271|FG001|Completed Post-intervention|Overall Study||706||
48511090|NCT01503333|101583270|FG000|COMPLETED|Overall Study||437|Completed 9-month post-intervention follow-up measures|
48511091|NCT01503333|101583271|FG001|COMPLETED|Overall Study||461|Completed 9-month post-intervention follow-up measures|
48511092|NCT01503333|101583270|FG000|NOT COMPLETED|Overall Study||340||
48511093|NCT01503333|101583271|FG001|NOT COMPLETED|Overall Study||305||
48511094|NCT01134198|101583272|FG000|STARTED|Phase 1||16|randomized in phase 1, inpatient stay|
48511095|NCT01134198|101583273|FG001|STARTED|Phase 1||13|randomized in phase 1, inpatient stay|
48511096|NCT01134198|101583272|FG000|COMPLETED|Phase 1||9|started phase 2, outpatient treatment|
48511097|NCT01134198|101583273|FG001|COMPLETED|Phase 1||11|started phase 2, outpatient treatment|
48511098|NCT01134198|101583272|FG000|NOT COMPLETED|Phase 1||7||
48511099|NCT01134198|101583273|FG001|NOT COMPLETED|Phase 1||2||
48511100|NCT01134198|101583272|FG000|STARTED|Phase 2||9||
48511101|NCT01134198|101583273|FG001|STARTED|Phase 2||11||
48511102|NCT01134198|101583272|FG000|COMPLETED|Phase 2||9|completed phase 2|
48511103|NCT01134198|101583273|FG001|COMPLETED|Phase 2||7|completed phase 2|
48511104|NCT01134198|101583272|FG000|NOT COMPLETED|Phase 2||0||
48511105|NCT01134198|101583273|FG001|NOT COMPLETED|Phase 2||4||
48511106|NCT00908882|101583274|FG000|STARTED|Overall Study||89||
48511107|NCT00908882|101583275|FG001|STARTED|Overall Study||89||
48511108|NCT00908882|101583274|FG000|COMPLETED|Overall Study||61||
48511109|NCT00908882|101583275|FG001|COMPLETED|Overall Study||59||
48511110|NCT00908882|101583274|FG000|NOT COMPLETED|Overall Study||28||
48511111|NCT00908882|101583275|FG001|NOT COMPLETED|Overall Study||30||
48511112|NCT00685035|101583276|FG000|STARTED|Period 1: First Intervention: 30 Minutes||9||
48511113|NCT00685035|101583277|FG001|STARTED|Period 1: First Intervention: 30 Minutes||8||
48511114|NCT00685035|101583276|FG000|COMPLETED|Period 1: First Intervention: 30 Minutes||8||
48511115|NCT00685035|101583277|FG001|COMPLETED|Period 1: First Intervention: 30 Minutes||8||
48511116|NCT00685035|101583276|FG000|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||1||
48511117|NCT00685035|101583277|FG001|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||0||
48511118|NCT00685035|101583276|FG000|STARTED|Period 2: 2-day Washout||8||
48511119|NCT00685035|101583277|FG001|STARTED|Period 2: 2-day Washout||8||
48511120|NCT00685035|101583276|FG000|COMPLETED|Period 2: 2-day Washout||8||
48511121|NCT00685035|101583277|FG001|COMPLETED|Period 2: 2-day Washout||8||
48511122|NCT00685035|101583276|FG000|NOT COMPLETED|Period 2: 2-day Washout||0||
48511123|NCT00685035|101583277|FG001|NOT COMPLETED|Period 2: 2-day Washout||0||
48511124|NCT00685035|101583276|FG000|STARTED|Period 3: 2nd Intervention||8||
48511125|NCT00685035|101583277|FG001|STARTED|Period 3: 2nd Intervention||8||
48511126|NCT00685035|101583276|FG000|COMPLETED|Period 3: 2nd Intervention||8||
48511127|NCT00685035|101583277|FG001|COMPLETED|Period 3: 2nd Intervention||8||
48511128|NCT00685035|101583276|FG000|NOT COMPLETED|Period 3: 2nd Intervention||0||
48511129|NCT00685035|101583277|FG001|NOT COMPLETED|Period 3: 2nd Intervention||0||
48511130|NCT01188226|101583278|FG000|STARTED|Overall Study||10||
48511131|NCT01188226|101583278|FG000|COMPLETED|Overall Study||6||
48511132|NCT01188226|101583278|FG000|NOT COMPLETED|Overall Study||4||
48511133|NCT03877926|101583279|FG000|STARTED|Overall Study||1103||
48511134|NCT03877926|101583280|FG001|STARTED|Overall Study||1103||
48511135|NCT03877926|101583281|FG002|STARTED|Overall Study||1098||
48511136|NCT03877926|101583282|FG003|STARTED|Overall Study||558||
48511137|NCT03877926|101583279|FG000|Received at Least One Study Vaccination|Overall Study||1100||
48511138|NCT03877926|101583280|FG001|Received at Least One Study Vaccination|Overall Study||1102||
48511139|NCT03877926|101583281|FG002|Received at Least One Study Vaccination|Overall Study||1097||
48511140|NCT03877926|101583282|FG003|Received at Least One Study Vaccination|Overall Study||558||
48511141|NCT03877926|101583279|FG000|Did Not Receive Any Study Vaccination|Overall Study||3||
48511142|NCT03877926|101583280|FG001|Did Not Receive Any Study Vaccination|Overall Study||1||
48511143|NCT03877926|101583281|FG002|Did Not Receive Any Study Vaccination|Overall Study||1||
48511144|NCT03877926|101583282|FG003|Did Not Receive Any Study Vaccination|Overall Study||0||
48511145|NCT03877926|101583279|FG000|COMPLETED|Overall Study||1032|Number of participants who completed 12-month follow-up after last study vaccination|
48511146|NCT03877926|101583280|FG001|COMPLETED|Overall Study||1026|Number of participants who completed 12-month follow-up after last study vaccination|
48511147|NCT03877926|101583281|FG002|COMPLETED|Overall Study||1035|Number of participants who completed 12-month follow-up after last study vaccination|
48511148|NCT03877926|101583282|FG003|COMPLETED|Overall Study||537|Number of participants who completed 12-month follow-up after last study vaccination|
48511149|NCT03877926|101583279|FG000|NOT COMPLETED|Overall Study||71||
48511150|NCT03877926|101583280|FG001|NOT COMPLETED|Overall Study||77||
48511151|NCT03877926|101583281|FG002|NOT COMPLETED|Overall Study||63||
48511152|NCT03877926|101583282|FG003|NOT COMPLETED|Overall Study||21||
48511153|NCT01213836|101583283|FG000|STARTED|Period 1, First Intervention||34||
48511154|NCT01213836|101583284|FG001|STARTED|Period 1, First Intervention||32||
48511155|NCT01213836|101583283|FG000|COMPLETED|Period 1, First Intervention||31||
48511156|NCT01213836|101583284|FG001|COMPLETED|Period 1, First Intervention||29||
48511157|NCT01213836|101583283|FG000|NOT COMPLETED|Period 1, First Intervention||3||
48511158|NCT01213836|101583284|FG001|NOT COMPLETED|Period 1, First Intervention||3||
48511159|NCT01213836|101583283|FG000|STARTED|Period 2, Second Intervention||31||
48511160|NCT01213836|101583284|FG001|STARTED|Period 2, Second Intervention||29||
48511161|NCT01213836|101583283|FG000|COMPLETED|Period 2, Second Intervention||31||
48511162|NCT01213836|101583284|FG001|COMPLETED|Period 2, Second Intervention||29||
48511163|NCT01213836|101583283|FG000|NOT COMPLETED|Period 2, Second Intervention||0||
48511164|NCT01213836|101583284|FG001|NOT COMPLETED|Period 2, Second Intervention||0||
48511165|NCT03170869|101583285|FG000|STARTED|Overall Study||11||
48511166|NCT03170869|101583285|FG000|COMPLETED|Overall Study||3||
48511167|NCT03170869|101583285|FG000|NOT COMPLETED|Overall Study||8||
48511168|NCT02508116|101583286|FG000|STARTED|Overall Study||252||
48511169|NCT02508116|101583287|FG001|STARTED|Overall Study||257||
48511170|NCT02508116|101583286|FG000|Received Intervention as Randomized|Overall Study||249||
48511171|NCT02508116|101583287|FG001|Received Intervention as Randomized|Overall Study||255||
48511172|NCT02508116|101583286|FG000|COMPLETED|Overall Study||244||
48511173|NCT02508116|101583287|FG001|COMPLETED|Overall Study||250||
48511174|NCT02508116|101583286|FG000|NOT COMPLETED|Overall Study||8||
48511175|NCT02508116|101583287|FG001|NOT COMPLETED|Overall Study||7||
48511176|NCT00894933|101583288|FG000|STARTED|Overall Study||33||
48511177|NCT00894933|101583288|FG000|COMPLETED|Overall Study||29||
48511178|NCT00894933|101583288|FG000|NOT COMPLETED|Overall Study||4||
48511179|NCT04253236|101583289|FG000|STARTED|Overall Study||5||
48511180|NCT04253236|101583290|FG001|STARTED|Overall Study||0||
48511181|NCT04253236|101583289|FG000|COMPLETED|Overall Study||2||
48511182|NCT04253236|101583290|FG001|COMPLETED|Overall Study||0||
48511183|NCT04253236|101583289|FG000|NOT COMPLETED|Overall Study||3||
48511184|NCT04253236|101583290|FG001|NOT COMPLETED|Overall Study||0||
48511185|NCT02919111|101583291|FG000|STARTED|Overall Study||299||
48511186|NCT02919111|101583291|FG000|COMPLETED|Overall Study||299||
48511187|NCT02919111|101583291|FG000|NOT COMPLETED|Overall Study||0||
48511188|NCT03558139|101583292|FG000|STARTED|Overall Study||6||
48511189|NCT03558139|101583293|FG001|STARTED|Overall Study||7||
48511190|NCT03558139|101583294|FG002|STARTED|Overall Study||21||
48511191|NCT03558139|101583292|FG000|COMPLETED|Overall Study||0|"One participant withdrew the consent and died after the last dose of study drug. The primary reason for study discontinuation was considered as Consent Withdrawn."|
48511192|NCT03558139|101583293|FG001|COMPLETED|Overall Study||0|"One participant withdrew the consent and died after the last dose of study drug. The primary reason for study discontinuation was considered as Consent Withdrawn."|
48511193|NCT03558139|101583294|FG002|COMPLETED|Overall Study||0|"One participant withdrew the consent and died after the last dose of study drug. The primary reason for study discontinuation was considered as Consent Withdrawn."|
48511194|NCT03558139|101583292|FG000|NOT COMPLETED|Overall Study||6||
48511195|NCT03558139|101583293|FG001|NOT COMPLETED|Overall Study||7||
48511196|NCT03558139|101583294|FG002|NOT COMPLETED|Overall Study||21||
48511197|NCT02240186|101583295|FG000|STARTED|Overall Study||50||
48511198|NCT02240186|101583295|FG000|COMPLETED|Overall Study||23||
48511199|NCT02240186|101583295|FG000|NOT COMPLETED|Overall Study||27||
48511200|NCT03078478|101583296|FG000|STARTED|Titration Period (16 Weeks)||805||
48511201|NCT03078478|101583297|FG001|STARTED|Titration Period (16 Weeks)||804||
48511202|NCT03078478|101583296|FG000|Full Analysis Set|Titration Period (16 Weeks)||805||
48511203|NCT03078478|101583297|FG001|Full Analysis Set|Titration Period (16 Weeks)||804||
48511204|NCT03078478|101583296|FG000|Safety Analysis Set|Titration Period (16 Weeks)||802||
48511205|NCT03078478|101583297|FG001|Safety Analysis Set|Titration Period (16 Weeks)||798||
48511206|NCT03078478|101583296|FG000|COMPLETED|Titration Period (16 Weeks)||805||
48511207|NCT03078478|101583297|FG001|COMPLETED|Titration Period (16 Weeks)||804||
48511208|NCT03078478|101583296|FG000|NOT COMPLETED|Titration Period (16 Weeks)||0||
48511209|NCT03078478|101583297|FG001|NOT COMPLETED|Titration Period (16 Weeks)||0||
48511210|NCT03078478|101583296|FG000|STARTED|Maintenance Period 1 (36 Weeks)||805||
48511211|NCT03078478|101583297|FG001|STARTED|Maintenance Period 1 (36 Weeks)||804||
48511212|NCT03078478|101583296|FG000|COMPLETED|Maintenance Period 1 (36 Weeks)||758||
48511213|NCT03078478|101583297|FG001|COMPLETED|Maintenance Period 1 (36 Weeks)||761||
48511214|NCT03078478|101583296|FG000|NOT COMPLETED|Maintenance Period 1 (36 Weeks)||47||
48511215|NCT03078478|101583297|FG001|NOT COMPLETED|Maintenance Period 1 (36 Weeks)||43||
48511216|NCT03078478|101583296|FG000|STARTED|Maintencance Period 2 (36 Weeks)||758||
48511217|NCT03078478|101583297|FG001|STARTED|Maintencance Period 2 (36 Weeks)||761||
48511218|NCT03078478|101583296|FG000|COMPLETED|Maintencance Period 2 (36 Weeks)||733||
48511219|NCT03078478|101583297|FG001|COMPLETED|Maintencance Period 2 (36 Weeks)||734||
48511220|NCT03078478|101583296|FG000|NOT COMPLETED|Maintencance Period 2 (36 Weeks)||25||
48511221|NCT03078478|101583297|FG001|NOT COMPLETED|Maintencance Period 2 (36 Weeks)||27||
48511222|NCT01447225|101583298|FG000|STARTED|Overall Study||3||
48511223|NCT01447225|101583299|FG001|STARTED|Overall Study||8||
48511224|NCT01447225|101583300|FG002|STARTED|Overall Study||5||
48511225|NCT01447225|101583301|FG003|STARTED|Overall Study||3||
48511226|NCT01447225|101583302|FG004|STARTED|Overall Study||3||
48511227|NCT01447225|101583303|FG005|STARTED|Overall Study||3||
48511228|NCT01447225|101583304|FG006|STARTED|Overall Study||7||
48511229|NCT01447225|101583305|FG007|STARTED|Overall Study||4||
48511230|NCT01447225|101583306|FG008|STARTED|Overall Study||3||
48511231|NCT01447225|101583307|FG009|STARTED|Overall Study||4||
48511232|NCT01447225|101583298|FG000|COMPLETED|Overall Study||3||
48511233|NCT01447225|101583299|FG001|COMPLETED|Overall Study||8||
48511234|NCT01447225|101583300|FG002|COMPLETED|Overall Study||5||
48511235|NCT01447225|101583301|FG003|COMPLETED|Overall Study||3||
48511236|NCT01447225|101583302|FG004|COMPLETED|Overall Study||3||
48511237|NCT01447225|101583303|FG005|COMPLETED|Overall Study||3||
48511238|NCT01447225|101583304|FG006|COMPLETED|Overall Study||7||
48511239|NCT01447225|101583305|FG007|COMPLETED|Overall Study||4||
48511240|NCT01447225|101583306|FG008|COMPLETED|Overall Study||3||
48511241|NCT01447225|101583307|FG009|COMPLETED|Overall Study||4||
48511242|NCT01447225|101583298|FG000|NOT COMPLETED|Overall Study||0||
48511243|NCT01447225|101583299|FG001|NOT COMPLETED|Overall Study||0||
48511244|NCT01447225|101583300|FG002|NOT COMPLETED|Overall Study||0||
48511245|NCT01447225|101583301|FG003|NOT COMPLETED|Overall Study||0||
48511246|NCT01447225|101583302|FG004|NOT COMPLETED|Overall Study||0||
48511247|NCT01447225|101583303|FG005|NOT COMPLETED|Overall Study||0||
48511248|NCT01447225|101583304|FG006|NOT COMPLETED|Overall Study||0||
48511249|NCT01447225|101583305|FG007|NOT COMPLETED|Overall Study||0||
48511250|NCT01447225|101583306|FG008|NOT COMPLETED|Overall Study||0||
48511251|NCT01447225|101583307|FG009|NOT COMPLETED|Overall Study||0||
48511252|NCT02621463|101583308|FG000|STARTED|Overall Study||29||
48511253|NCT02621463|101583308|FG000|COMPLETED|Overall Study||29||
48511254|NCT02621463|101583308|FG000|NOT COMPLETED|Overall Study||0||
48511255|NCT00399893|101583309|FG000|STARTED|Overall Study||2||
48511256|NCT00399893|101583310|FG001|STARTED|Overall Study||3||
48511257|NCT00399893|101583309|FG000|COMPLETED|Overall Study||1||
48511258|NCT00399893|101583310|FG001|COMPLETED|Overall Study||3||
48511259|NCT00399893|101583309|FG000|NOT COMPLETED|Overall Study||1||
48511260|NCT00399893|101583310|FG001|NOT COMPLETED|Overall Study||0||
48511261|NCT00129116|101583311|FG000|STARTED|Primary Phase||78||
48511262|NCT00129116|101583312|FG001|STARTED|Primary Phase||77||
48511263|NCT00129116|101583313|FG002|STARTED|Primary Phase||78||
48511264|NCT00129116|101583314|FG003|STARTED|Primary Phase||78||
48511265|NCT00129116|101583315|FG004|STARTED|Primary Phase||77||
48511266|NCT00129116|101583311|FG000|COMPLETED|Primary Phase||76||
48511267|NCT00129116|101583312|FG001|COMPLETED|Primary Phase||73||
48511268|NCT00129116|101583313|FG002|COMPLETED|Primary Phase||77||
48511269|NCT00129116|101583314|FG003|COMPLETED|Primary Phase||77||
48511270|NCT00129116|101583315|FG004|COMPLETED|Primary Phase||76||
48511271|NCT00129116|101583311|FG000|NOT COMPLETED|Primary Phase||2||
48511272|NCT00129116|101583312|FG001|NOT COMPLETED|Primary Phase||4||
48511273|NCT00129116|101583313|FG002|NOT COMPLETED|Primary Phase||1||
48511274|NCT00129116|101583314|FG003|NOT COMPLETED|Primary Phase||1||
48511275|NCT00129116|101583315|FG004|NOT COMPLETED|Primary Phase||1||
48511276|NCT00129116|101583311|FG000|STARTED|Booster Phase||47||
48511277|NCT00129116|101583312|FG001|STARTED|Booster Phase||42||
48511278|NCT00129116|101583313|FG002|STARTED|Booster Phase||44||
48511279|NCT00129116|101583314|FG003|STARTED|Booster Phase||44||
48511280|NCT00129116|101583315|FG004|STARTED|Booster Phase||44||
48511281|NCT00129116|101583311|FG000|COMPLETED|Booster Phase||45||
48511282|NCT00129116|101583312|FG001|COMPLETED|Booster Phase||42||
48511283|NCT00129116|101583313|FG002|COMPLETED|Booster Phase||44||
48511284|NCT00129116|101583314|FG003|COMPLETED|Booster Phase||44||
48066418|NCT01361568|100482655|FG004|STARTED|Overall Study||7||
48066419|NCT01361568|100482656|FG005|STARTED|Overall Study||13||
48066420|NCT01361568|100482651|FG000|COMPLETED|Overall Study||69||
48066421|NCT01361568|100482652|FG001|COMPLETED|Overall Study||70||
48066422|NCT01361568|100482653|FG002|COMPLETED|Overall Study||20||
48066423|NCT01361568|100482654|FG003|COMPLETED|Overall Study||21||
48066424|NCT01361568|100482655|FG004|COMPLETED|Overall Study||6||
48066425|NCT01361568|100482656|FG005|COMPLETED|Overall Study||11||
48066426|NCT01361568|100482651|FG000|NOT COMPLETED|Overall Study||2||
48066427|NCT01361568|100482652|FG001|NOT COMPLETED|Overall Study||1||
48066428|NCT01361568|100482653|FG002|NOT COMPLETED|Overall Study||0||
48066429|NCT01361568|100482654|FG003|NOT COMPLETED|Overall Study||0||
48066430|NCT01361568|100482655|FG004|NOT COMPLETED|Overall Study||1||
48066431|NCT01361568|100482656|FG005|NOT COMPLETED|Overall Study||2||
48066432|NCT01373489|100482657|FG000|STARTED|Overall Study||59||
48066433|NCT01373489|100482658|FG001|STARTED|Overall Study||54||
48066434|NCT01373489|100482657|FG000|COMPLETED|Overall Study||44||
48066435|NCT01373489|100482658|FG001|COMPLETED|Overall Study||41||
48066436|NCT01373489|100482657|FG000|NOT COMPLETED|Overall Study||15||
48066437|NCT01373489|100482658|FG001|NOT COMPLETED|Overall Study||13||
48066438|NCT01495975|100482659|FG000|STARTED|Overall Study||15||
48066439|NCT01495975|100482660|FG001|STARTED|Overall Study||14||
48066440|NCT01495975|100482659|FG000|COMPLETED|Overall Study||14||
48066441|NCT01495975|100482660|FG001|COMPLETED|Overall Study||14||
48066442|NCT01495975|100482659|FG000|NOT COMPLETED|Overall Study||1||
48066443|NCT01495975|100482660|FG001|NOT COMPLETED|Overall Study||0||
48066444|NCT03643575|100485384|FG000|STARTED|Period 1||5||
48066445|NCT03643575|100485385|FG001|STARTED|Period 1||5||
48066446|NCT03643575|100485386|FG002|STARTED|Period 1||5||
48066447|NCT03643575|100485387|FG003|STARTED|Period 1||5||
48066448|NCT03643575|100485388|FG004|STARTED|Period 1||5||
48066449|NCT03643575|100485389|FG005|STARTED|Period 1||5||
48066450|NCT03643575|100485384|FG000|COMPLETED|Period 1||5||
48066451|NCT03643575|100485385|FG001|COMPLETED|Period 1||5||
48066452|NCT03643575|100485386|FG002|COMPLETED|Period 1||5||
48066453|NCT03643575|100485387|FG003|COMPLETED|Period 1||5||
48066454|NCT03643575|100485388|FG004|COMPLETED|Period 1||5||
48066455|NCT03643575|100485389|FG005|COMPLETED|Period 1||5||
48066456|NCT03643575|100485384|FG000|NOT COMPLETED|Period 1||0||
48066457|NCT03643575|100485385|FG001|NOT COMPLETED|Period 1||0||
48066458|NCT03643575|100485386|FG002|NOT COMPLETED|Period 1||0||
48066459|NCT03643575|100485387|FG003|NOT COMPLETED|Period 1||0||
48066460|NCT03643575|100485388|FG004|NOT COMPLETED|Period 1||0||
48066461|NCT03643575|100485389|FG005|NOT COMPLETED|Period 1||0||
48066462|NCT03643575|100485384|FG000|STARTED|Washout: 7 Days||5||
48066463|NCT03643575|100485385|FG001|STARTED|Washout: 7 Days||5||
48066464|NCT03643575|100485386|FG002|STARTED|Washout: 7 Days||5||
48066465|NCT03643575|100485387|FG003|STARTED|Washout: 7 Days||5||
48066466|NCT03643575|100485388|FG004|STARTED|Washout: 7 Days||5||
48066467|NCT03643575|100485389|FG005|STARTED|Washout: 7 Days||5||
48066468|NCT03643575|100485384|FG000|COMPLETED|Washout: 7 Days||4||
48066469|NCT03643575|100485385|FG001|COMPLETED|Washout: 7 Days||5||
48066470|NCT03643575|100485386|FG002|COMPLETED|Washout: 7 Days||5||
48066471|NCT03643575|100485387|FG003|COMPLETED|Washout: 7 Days||4||
48066472|NCT03643575|100485388|FG004|COMPLETED|Washout: 7 Days||5||
48066473|NCT03643575|100485389|FG005|COMPLETED|Washout: 7 Days||5||
48066474|NCT03643575|100485384|FG000|NOT COMPLETED|Washout: 7 Days||1||
48066475|NCT03643575|100485385|FG001|NOT COMPLETED|Washout: 7 Days||0||
48066476|NCT03643575|100485386|FG002|NOT COMPLETED|Washout: 7 Days||0||
48066477|NCT03643575|100485387|FG003|NOT COMPLETED|Washout: 7 Days||1||
48066478|NCT03643575|100485388|FG004|NOT COMPLETED|Washout: 7 Days||0||
48511285|NCT00129116|101583315|FG004|COMPLETED|Booster Phase||43||
48511286|NCT00129116|101583311|FG000|NOT COMPLETED|Booster Phase||2||
48511287|NCT00129116|101583312|FG001|NOT COMPLETED|Booster Phase||0||
48511288|NCT00129116|101583313|FG002|NOT COMPLETED|Booster Phase||0||
48511289|NCT00129116|101583314|FG003|NOT COMPLETED|Booster Phase||0||
48511290|NCT00129116|101583315|FG004|NOT COMPLETED|Booster Phase||1||
48511291|NCT03388502|101583316|FG000|STARTED|Overall Study||76||
48511292|NCT03388502|101583317|FG001|STARTED|Overall Study||83||
48511293|NCT03388502|101583316|FG000|COMPLETED|Overall Study||76||
48511294|NCT03388502|101583317|FG001|COMPLETED|Overall Study||83||
48511295|NCT03388502|101583316|FG000|NOT COMPLETED|Overall Study||0||
48511296|NCT03388502|101583317|FG001|NOT COMPLETED|Overall Study||0||
48511297|NCT01216410|101583318|FG000|STARTED|Overall Study||103||
48511298|NCT01216410|101583319|FG001|STARTED|Overall Study||100||
48511299|NCT01216410|101583320|FG002|STARTED|Overall Study||103||
48511300|NCT01216410|101583318|FG000|COMPLETED|Overall Study||101||
48511301|NCT01216410|101583319|FG001|COMPLETED|Overall Study||99||
48511302|NCT01216410|101583320|FG002|COMPLETED|Overall Study||100||
48511303|NCT01216410|101583318|FG000|NOT COMPLETED|Overall Study||2||
48511304|NCT01216410|101583319|FG001|NOT COMPLETED|Overall Study||1||
48511305|NCT01216410|101583320|FG002|NOT COMPLETED|Overall Study||3||
48511306|NCT01405469|101583321|FG000|STARTED|Overall Study||16||
48511307|NCT01405469|101583321|FG000|COMPLETED|Overall Study||16||
48511308|NCT01405469|101583321|FG000|NOT COMPLETED|Overall Study||0||
48511309|NCT02438540|101583322|FG000|STARTED|Overall Study||19||
48511310|NCT02438540|101583323|FG001|STARTED|Overall Study||20||
48511311|NCT02438540|101583322|FG000|COMPLETED|Overall Study||19||
48511312|NCT02438540|101583323|FG001|COMPLETED|Overall Study||20||
48511313|NCT02438540|101583322|FG000|NOT COMPLETED|Overall Study||0||
48511314|NCT02438540|101583323|FG001|NOT COMPLETED|Overall Study||0||
48511315|NCT04832971|101583324|FG000|STARTED|Overall Study||51||
48511316|NCT04832971|101583325|FG001|STARTED|Overall Study||51||
48511317|NCT04832971|101583326|FG002|STARTED|Overall Study||51||
48511318|NCT04832971|101583327|FG003|STARTED|Overall Study||51||
48511319|NCT04832971|101583324|FG000|COMPLETED|Overall Study||48|Completed Double-Blind (DB) Treatment Period|
48511320|NCT04832971|101583325|FG001|COMPLETED|Overall Study||47|Completed Double-Blind (DB) Treatment Period|
48511321|NCT04832971|101583326|FG002|COMPLETED|Overall Study||47|Completed Double-Blind (DB) Treatment Period|
48511322|NCT04832971|101583327|FG003|COMPLETED|Overall Study||49|Completed Double-Blind (DB) Treatment Period|
48511323|NCT04832971|101583324|FG000|NOT COMPLETED|Overall Study||3||
48511324|NCT04832971|101583325|FG001|NOT COMPLETED|Overall Study||4||
48511325|NCT04832971|101583326|FG002|NOT COMPLETED|Overall Study||4||
48511326|NCT04832971|101583327|FG003|NOT COMPLETED|Overall Study||2||
48511327|NCT00529217|101583328|FG000|STARTED|Overall Study||12||
48511328|NCT00529217|101583328|FG000|COMPLETED|Overall Study||8||
48511329|NCT00529217|101583328|FG000|NOT COMPLETED|Overall Study||4||
48511330|NCT01009515|101583329|FG000|STARTED|Overall Study||19||
48511331|NCT01009515|101583329|FG000|COMPLETED|Overall Study||16||
48511332|NCT01009515|101583329|FG000|NOT COMPLETED|Overall Study||3||
48511333|NCT01231373|101583330|FG000|STARTED|Overall Study||59||
48511334|NCT01231373|101583331|FG001|STARTED|Overall Study||58||
48511335|NCT01231373|101583332|FG002|STARTED|Overall Study||60||
48511336|NCT01231373|101583333|FG003|STARTED|Overall Study||58||
48511337|NCT01231373|101583330|FG000|Patients Receiving Blinded Treatment|Overall Study||57||
48511338|NCT01231373|101583331|FG001|Patients Receiving Blinded Treatment|Overall Study||57||
48511339|NCT01231373|101583332|FG002|Patients Receiving Blinded Treatment|Overall Study||60||
48511340|NCT01231373|101583333|FG003|Patients Receiving Blinded Treatment|Overall Study||58||
48511341|NCT01231373|101583330|FG000|COMPLETED|Overall Study||56||
48511342|NCT01231373|101583331|FG001|COMPLETED|Overall Study||57||
48511343|NCT01231373|101583332|FG002|COMPLETED|Overall Study||60||
48511344|NCT01231373|101583333|FG003|COMPLETED|Overall Study||57||
48511345|NCT01231373|101583330|FG000|NOT COMPLETED|Overall Study||3||
48511346|NCT01231373|101583331|FG001|NOT COMPLETED|Overall Study||1||
48511347|NCT01231373|101583332|FG002|NOT COMPLETED|Overall Study||0||
48511348|NCT01231373|101583333|FG003|NOT COMPLETED|Overall Study||1||
48511349|NCT03767062|101583334|FG000|STARTED|Overall Study||45||
48511350|NCT03767062|101583335|FG001|STARTED|Overall Study||45||
48511351|NCT03767062|101583334|FG000|COMPLETED|Overall Study||37||
48511352|NCT03767062|101583335|FG001|COMPLETED|Overall Study||41||
48511353|NCT03767062|101583334|FG000|NOT COMPLETED|Overall Study||8||
48511354|NCT03767062|101583335|FG001|NOT COMPLETED|Overall Study||4||
48511355|NCT00117806|101583336|FG000|STARTED|Overall Study||81||
48511356|NCT00117806|101583337|FG001|STARTED|Overall Study||76||
48511357|NCT00117806|101583336|FG000|COMPLETED|Overall Study||43||
48511358|NCT00117806|101583337|FG001|COMPLETED|Overall Study||60||
48511359|NCT00117806|101583336|FG000|NOT COMPLETED|Overall Study||38||
48511360|NCT00117806|101583337|FG001|NOT COMPLETED|Overall Study||16||
48511361|NCT00602537|101583338|FG000|STARTED|12 Week Double Blind Comparison||65||
48511362|NCT00602537|101583339|FG001|STARTED|12 Week Double Blind Comparison||64||
48511363|NCT00602537|101583338|FG000|Responded|12 Week Double Blind Comparison||44||
48511364|NCT00602537|101583339|FG001|Responded|12 Week Double Blind Comparison||22||
48511365|NCT00602537|101583338|FG000|COMPLETED|12 Week Double Blind Comparison||42||
48511366|NCT00602537|101583339|FG001|COMPLETED|12 Week Double Blind Comparison||17||
48511367|NCT00602537|101583338|FG000|NOT COMPLETED|12 Week Double Blind Comparison||23||
48511368|NCT00602537|101583339|FG001|NOT COMPLETED|12 Week Double Blind Comparison||47||
48511369|NCT00602537|101583338|FG000|STARTED|Follow Up Study Comparison||42||
48511370|NCT00602537|101583339|FG001|STARTED|Follow Up Study Comparison||17||
48511371|NCT00602537|101583338|FG000|COMPLETED|Follow Up Study Comparison||31||
48511372|NCT00602537|101583339|FG001|COMPLETED|Follow Up Study Comparison||14||
48511373|NCT00602537|101583338|FG000|NOT COMPLETED|Follow Up Study Comparison||11||
48511374|NCT00602537|101583339|FG001|NOT COMPLETED|Follow Up Study Comparison||3||
48511375|NCT00983476|101583340|FG000|STARTED|Overall Study||95||
48511376|NCT00983476|101583341|FG001|STARTED|Overall Study||93||
48511377|NCT00983476|101583342|FG002|STARTED|Overall Study||88||
48511378|NCT00983476|101583340|FG000|6 Month Follow up Assessment|Overall Study||71||
48511379|NCT00983476|101583341|FG001|6 Month Follow up Assessment|Overall Study||62||
48511380|NCT00983476|101583342|FG002|6 Month Follow up Assessment|Overall Study||74||
48511381|NCT00983476|101583340|FG000|COMPLETED|Overall Study||78||
48511382|NCT00983476|101583341|FG001|COMPLETED|Overall Study||71||
48511383|NCT00983476|101583342|FG002|COMPLETED|Overall Study||88||
48511384|NCT00983476|101583340|FG000|NOT COMPLETED|Overall Study||17||
48511385|NCT00983476|101583341|FG001|NOT COMPLETED|Overall Study||22||
48511386|NCT00983476|101583342|FG002|NOT COMPLETED|Overall Study||0||
48511387|NCT00440115|101583343|FG000|STARTED|Overall Study||251||
48511388|NCT00440115|101583344|FG001|STARTED|Overall Study||249||
48511389|NCT00440115|101583345|FG002|STARTED|Overall Study||250||
48511390|NCT00440115|101583343|FG000|COMPLETED|Overall Study||244||
48511391|NCT00440115|101583344|FG001|COMPLETED|Overall Study||238||
48511392|NCT00440115|101583345|FG002|COMPLETED|Overall Study||244||
48511393|NCT00440115|101583343|FG000|NOT COMPLETED|Overall Study||7||
48511394|NCT00440115|101583344|FG001|NOT COMPLETED|Overall Study||11||
48511395|NCT00440115|101583345|FG002|NOT COMPLETED|Overall Study||6||
48511396|NCT04823130|101583346|FG000|STARTED|Overall Study||19||
48511397|NCT04823130|101583347|FG001|STARTED|Overall Study||35||
48511398|NCT04823130|101583346|FG000|Safety Population|Overall Study||13|Safety population included all participants, who actually received at least 1 dose of investigational medicinal product (IMP) or had at least 1 skin biopsy and all healthy participants who had a skin biopsy or another safety assessment performed.|
48511399|NCT04823130|101583347|FG001|Safety Population|Overall Study||31|Safety population included all participants, who actually received at least 1 dose of investigational medicinal product (IMP) or had at least 1 skin biopsy and all healthy participants who had a skin biopsy or another safety assessment performed.|
48511400|NCT04823130|101583346|FG000|COMPLETED|Overall Study||10||
48511401|NCT04823130|101583347|FG001|COMPLETED|Overall Study||28||
48511402|NCT04823130|101583346|FG000|NOT COMPLETED|Overall Study||9||
48511403|NCT04823130|101583347|FG001|NOT COMPLETED|Overall Study||7||
48511404|NCT01867606|101583348|FG000|STARTED|Overall Study||26||
48511405|NCT01867606|101583349|FG001|STARTED|Overall Study||32||
48511406|NCT01867606|101583348|FG000|COMPLETED|Overall Study||16||
48511407|NCT01867606|101583349|FG001|COMPLETED|Overall Study||17||
48511408|NCT01867606|101583348|FG000|NOT COMPLETED|Overall Study||10||
48511409|NCT01867606|101583349|FG001|NOT COMPLETED|Overall Study||15||
48511410|NCT00807209|101583350|FG000|STARTED|Overall Study||1||
48511411|NCT00807209|101583351|FG001|STARTED|Overall Study||1||
48511412|NCT00807209|101583352|FG002|STARTED|Overall Study||1||
48511413|NCT00807209|101583350|FG000|COMPLETED|Overall Study||1||
48511414|NCT00807209|101583351|FG001|COMPLETED|Overall Study||1||
48511415|NCT00807209|101583352|FG002|COMPLETED|Overall Study||1||
48511416|NCT00807209|101583350|FG000|NOT COMPLETED|Overall Study||0||
48511417|NCT00807209|101583351|FG001|NOT COMPLETED|Overall Study||0||
48511418|NCT00807209|101583352|FG002|NOT COMPLETED|Overall Study||0||
48511419|NCT01439724|101583353|FG000|STARTED|Overall Study||47||
48511420|NCT01439724|101583354|FG001|STARTED|Overall Study||47||
48511421|NCT01439724|101583353|FG000|COMPLETED|Overall Study||38||
48511422|NCT01439724|101583354|FG001|COMPLETED|Overall Study||39||
48511423|NCT01439724|101583353|FG000|NOT COMPLETED|Overall Study||9||
48511424|NCT01439724|101583354|FG001|NOT COMPLETED|Overall Study||8||
48511425|NCT03480685|101583355|FG000|STARTED|Overall Study||12||
48511426|NCT03480685|101583355|FG000|COMPLETED|Overall Study||12||
48511427|NCT03480685|101583355|FG000|NOT COMPLETED|Overall Study||0||
48511428|NCT00704496|101583356|FG000|STARTED|Overall Study||0||
48511429|NCT00704496|101583357|FG001|STARTED|Overall Study||0||
48511430|NCT00704496|101583356|FG000|COMPLETED|Overall Study||0||
48511431|NCT00704496|101583357|FG001|COMPLETED|Overall Study||0||
48511432|NCT00704496|101583356|FG000|NOT COMPLETED|Overall Study||0||
48511433|NCT00704496|101583357|FG001|NOT COMPLETED|Overall Study||0||
48511434|NCT04211766|101583358|FG000|STARTED|Overall Study||19||
48511435|NCT04211766|101583359|FG001|STARTED|Overall Study||16||
48511436|NCT04211766|101583358|FG000|Completed Only Period 1|Overall Study||1||
48511437|NCT04211766|101583359|FG001|Completed Only Period 1|Overall Study||1||
48511438|NCT04211766|101583358|FG000|COMPLETED|Overall Study||14|This total does not include the participants that only completed only study Period 1 and dropped out during the washout. The 2 participants who dropped out during the washout have partial measures (blood and stools) that may be included in some of the statistical analysis.|
48511439|NCT04211766|101583359|FG001|COMPLETED|Overall Study||15|This total does not include the participants that only completed only study Period 1 and dropped out during the washout. The 2 participants who dropped out during the washout have partial measures (blood and stools) that may be included in some of the statistical analysis.|
48511440|NCT04211766|101583358|FG000|NOT COMPLETED|Overall Study||5||
48511441|NCT04211766|101583359|FG001|NOT COMPLETED|Overall Study||1||
48511442|NCT01876368|101583360|FG000|STARTED|Overall Study||188||
48511443|NCT01876368|101583361|FG001|STARTED|Overall Study||188||
48511444|NCT01876368|101583360|FG000|Full Analysis Set (FAS)|Overall Study||188||
48511445|NCT01876368|101583361|FG001|Full Analysis Set (FAS)|Overall Study||187||
48511446|NCT01876368|101583360|FG000|Safety Set (SAF)|Overall Study||188||
48511447|NCT01876368|101583361|FG001|Safety Set (SAF)|Overall Study||187||
48511448|NCT01876368|101583360|FG000|COMPLETED|Overall Study||179||
48511449|NCT01876368|101583361|FG001|COMPLETED|Overall Study||175||
48511450|NCT01876368|101583360|FG000|NOT COMPLETED|Overall Study||9||
48511451|NCT01876368|101583361|FG001|NOT COMPLETED|Overall Study||13||
48511452|NCT02293460|101583362|FG000|STARTED|Overall Study||43||
48511453|NCT02293460|101583362|FG000|COMPLETED|Overall Study||37||
48511454|NCT02293460|101583362|FG000|NOT COMPLETED|Overall Study||6||
48511455|NCT01999894|101583363|FG000|STARTED|Overall Study||102||
48511456|NCT01999894|101583363|FG000|COMPLETED|Overall Study||66||
48511457|NCT01999894|101583363|FG000|NOT COMPLETED|Overall Study||36||
48511458|NCT03815240|101583364|FG000|STARTED|Intervention no Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511459|NCT03815240|101583365|FG001|STARTED|Intervention no Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511460|NCT03815240|101583366|FG002|STARTED|Intervention no Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511461|NCT03815240|101583367|FG003|STARTED|Intervention no Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511462|NCT03815240|101583368|FG004|STARTED|Intervention no Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511463|NCT03815240|101583369|FG005|STARTED|Intervention no Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511464|NCT03815240|101583370|FG006|STARTED|Intervention no Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511465|NCT03815240|101583371|FG007|STARTED|Intervention no Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511466|NCT03815240|101583372|FG008|STARTED|Intervention no Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511467|NCT03815240|101583364|FG000|COMPLETED|Intervention no Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511468|NCT03815240|101583365|FG001|COMPLETED|Intervention no Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511469|NCT03815240|101583366|FG002|COMPLETED|Intervention no Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511470|NCT03815240|101583367|FG003|COMPLETED|Intervention no Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511471|NCT03815240|101583368|FG004|COMPLETED|Intervention no Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511472|NCT03815240|101583369|FG005|COMPLETED|Intervention no Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511473|NCT03815240|101583370|FG006|COMPLETED|Intervention no Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511474|NCT03815240|101583371|FG007|COMPLETED|Intervention no Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511475|NCT03815240|101583372|FG008|COMPLETED|Intervention no Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511476|NCT03815240|101583364|FG000|NOT COMPLETED|Intervention no Dressing||0||
48511477|NCT03815240|101583365|FG001|NOT COMPLETED|Intervention no Dressing||0||
48511478|NCT03815240|101583366|FG002|NOT COMPLETED|Intervention no Dressing||0||
48511479|NCT03815240|101583367|FG003|NOT COMPLETED|Intervention no Dressing||0||
48511480|NCT03815240|101583368|FG004|NOT COMPLETED|Intervention no Dressing||0||
48511481|NCT03815240|101583369|FG005|NOT COMPLETED|Intervention no Dressing||0||
48511482|NCT03815240|101583370|FG006|NOT COMPLETED|Intervention no Dressing||0||
48511483|NCT03815240|101583371|FG007|NOT COMPLETED|Intervention no Dressing||0||
48511484|NCT03815240|101583372|FG008|NOT COMPLETED|Intervention no Dressing||0||
48511485|NCT03815240|101583364|FG000|STARTED|Intervention Mepilex Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511486|NCT03815240|101583365|FG001|STARTED|Intervention Mepilex Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511487|NCT03815240|101583366|FG002|STARTED|Intervention Mepilex Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511488|NCT03815240|101583367|FG003|STARTED|Intervention Mepilex Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511489|NCT03815240|101583368|FG004|STARTED|Intervention Mepilex Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511490|NCT03815240|101583369|FG005|STARTED|Intervention Mepilex Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511491|NCT03815240|101583370|FG006|STARTED|Intervention Mepilex Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511492|NCT03815240|101583371|FG007|STARTED|Intervention Mepilex Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511493|NCT03815240|101583372|FG008|STARTED|Intervention Mepilex Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511494|NCT03815240|101583364|FG000|COMPLETED|Intervention Mepilex Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511495|NCT03815240|101583365|FG001|COMPLETED|Intervention Mepilex Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511496|NCT03815240|101583366|FG002|COMPLETED|Intervention Mepilex Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511497|NCT03815240|101583367|FG003|COMPLETED|Intervention Mepilex Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511498|NCT03815240|101583368|FG004|COMPLETED|Intervention Mepilex Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511499|NCT03815240|101583369|FG005|COMPLETED|Intervention Mepilex Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511500|NCT03815240|101583370|FG006|COMPLETED|Intervention Mepilex Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511501|NCT03815240|101583371|FG007|COMPLETED|Intervention Mepilex Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511502|NCT03815240|101583372|FG008|COMPLETED|Intervention Mepilex Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511503|NCT03815240|101583364|FG000|NOT COMPLETED|Intervention Mepilex Dressing||0||
48511504|NCT03815240|101583365|FG001|NOT COMPLETED|Intervention Mepilex Dressing||0||
48511505|NCT03815240|101583366|FG002|NOT COMPLETED|Intervention Mepilex Dressing||0||
48511506|NCT03815240|101583367|FG003|NOT COMPLETED|Intervention Mepilex Dressing||0||
48511507|NCT03815240|101583368|FG004|NOT COMPLETED|Intervention Mepilex Dressing||0||
48511508|NCT03815240|101583369|FG005|NOT COMPLETED|Intervention Mepilex Dressing||0||
48511509|NCT03815240|101583370|FG006|NOT COMPLETED|Intervention Mepilex Dressing||0||
48511510|NCT03815240|101583371|FG007|NOT COMPLETED|Intervention Mepilex Dressing||0||
48511511|NCT03815240|101583372|FG008|NOT COMPLETED|Intervention Mepilex Dressing||0||
48511512|NCT03815240|101583364|FG000|STARTED|Intervention Allevyn Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511513|NCT03815240|101583365|FG001|STARTED|Intervention Allevyn Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511514|NCT03815240|101583366|FG002|STARTED|Intervention Allevyn Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511515|NCT03815240|101583367|FG003|STARTED|Intervention Allevyn Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511516|NCT03815240|101583368|FG004|STARTED|Intervention Allevyn Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511517|NCT03815240|101583369|FG005|STARTED|Intervention Allevyn Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511518|NCT03815240|101583370|FG006|STARTED|Intervention Allevyn Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511519|NCT03815240|101583371|FG007|STARTED|Intervention Allevyn Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511520|NCT03815240|101583372|FG008|STARTED|Intervention Allevyn Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511521|NCT03815240|101583364|FG000|COMPLETED|Intervention Allevyn Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511522|NCT03815240|101583365|FG001|COMPLETED|Intervention Allevyn Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511523|NCT03815240|101583366|FG002|COMPLETED|Intervention Allevyn Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511524|NCT03815240|101583367|FG003|COMPLETED|Intervention Allevyn Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511525|NCT03815240|101583368|FG004|COMPLETED|Intervention Allevyn Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511526|NCT03815240|101583369|FG005|COMPLETED|Intervention Allevyn Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511527|NCT03815240|101583370|FG006|COMPLETED|Intervention Allevyn Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511528|NCT03815240|101583371|FG007|COMPLETED|Intervention Allevyn Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511529|NCT03815240|101583372|FG008|COMPLETED|Intervention Allevyn Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511530|NCT03815240|101583364|FG000|NOT COMPLETED|Intervention Allevyn Dressing||0||
48511531|NCT03815240|101583365|FG001|NOT COMPLETED|Intervention Allevyn Dressing||0||
48511532|NCT03815240|101583366|FG002|NOT COMPLETED|Intervention Allevyn Dressing||0||
48511533|NCT03815240|101583367|FG003|NOT COMPLETED|Intervention Allevyn Dressing||0||
48511534|NCT03815240|101583368|FG004|NOT COMPLETED|Intervention Allevyn Dressing||0||
48511535|NCT03815240|101583369|FG005|NOT COMPLETED|Intervention Allevyn Dressing||0||
48511536|NCT03815240|101583370|FG006|NOT COMPLETED|Intervention Allevyn Dressing||0||
48511537|NCT03815240|101583371|FG007|NOT COMPLETED|Intervention Allevyn Dressing||0||
48511538|NCT03815240|101583372|FG008|NOT COMPLETED|Intervention Allevyn Dressing||0||
48511539|NCT03815240|101583364|FG000|STARTED|Intervention Optifoam Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511540|NCT03815240|101583365|FG001|STARTED|Intervention Optifoam Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511541|NCT03815240|101583366|FG002|STARTED|Intervention Optifoam Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511542|NCT03815240|101583367|FG003|STARTED|Intervention Optifoam Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511543|NCT03815240|101583368|FG004|STARTED|Intervention Optifoam Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511544|NCT03815240|101583369|FG005|STARTED|Intervention Optifoam Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511545|NCT03815240|101583370|FG006|STARTED|Intervention Optifoam Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511546|NCT03815240|101583371|FG007|STARTED|Intervention Optifoam Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511547|NCT03815240|101583372|FG008|STARTED|Intervention Optifoam Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511548|NCT03815240|101583364|FG000|COMPLETED|Intervention Optifoam Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511549|NCT03815240|101583365|FG001|COMPLETED|Intervention Optifoam Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511550|NCT03815240|101583366|FG002|COMPLETED|Intervention Optifoam Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511551|NCT03815240|101583367|FG003|COMPLETED|Intervention Optifoam Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511552|NCT03815240|101583368|FG004|COMPLETED|Intervention Optifoam Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511553|NCT03815240|101583369|FG005|COMPLETED|Intervention Optifoam Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511554|NCT03815240|101583370|FG006|COMPLETED|Intervention Optifoam Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511555|NCT03815240|101583371|FG007|COMPLETED|Intervention Optifoam Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511556|NCT03815240|101583372|FG008|COMPLETED|Intervention Optifoam Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
48511557|NCT03815240|101583364|FG000|NOT COMPLETED|Intervention Optifoam Dressing||0||
48511558|NCT03815240|101583365|FG001|NOT COMPLETED|Intervention Optifoam Dressing||0||
48511559|NCT03815240|101583366|FG002|NOT COMPLETED|Intervention Optifoam Dressing||0||
48511560|NCT03815240|101583367|FG003|NOT COMPLETED|Intervention Optifoam Dressing||0||
48511561|NCT03815240|101583368|FG004|NOT COMPLETED|Intervention Optifoam Dressing||0||
48511562|NCT03815240|101583369|FG005|NOT COMPLETED|Intervention Optifoam Dressing||0||
48511563|NCT03815240|101583370|FG006|NOT COMPLETED|Intervention Optifoam Dressing||0||
48511564|NCT03815240|101583371|FG007|NOT COMPLETED|Intervention Optifoam Dressing||0||
48511565|NCT03815240|101583372|FG008|NOT COMPLETED|Intervention Optifoam Dressing||0||
48511566|NCT00468208|101583373|FG000|STARTED|Overall Study||20||
48511567|NCT00468208|101583373|FG000|COMPLETED|Overall Study||20||
48511568|NCT00468208|101583373|FG000|NOT COMPLETED|Overall Study||0||
48511569|NCT00263887|101583374|FG000|STARTED|Overall Study||38||
48511570|NCT00263887|101583375|FG001|STARTED|Overall Study||39||
48511571|NCT00263887|101583374|FG000|COMPLETED|Overall Study||35||
48511572|NCT00263887|101583375|FG001|COMPLETED|Overall Study||32||
48511573|NCT00263887|101583374|FG000|NOT COMPLETED|Overall Study||3||
48511574|NCT00263887|101583375|FG001|NOT COMPLETED|Overall Study||7||
48511575|NCT00578968|101583376|FG000|STARTED|Baseline (Prior to Intervention)||12||
48511576|NCT00578968|101583377|FG001|STARTED|Baseline (Prior to Intervention)||12||
48511577|NCT00578968|101583378|FG002|STARTED|Baseline (Prior to Intervention)||12||
48511578|NCT00578968|101583376|FG000|COMPLETED|Baseline (Prior to Intervention)||12||
48511579|NCT00578968|101583377|FG001|COMPLETED|Baseline (Prior to Intervention)||12||
48511580|NCT00578968|101583378|FG002|COMPLETED|Baseline (Prior to Intervention)||12||
48511581|NCT00578968|101583376|FG000|NOT COMPLETED|Baseline (Prior to Intervention)||0||
48511582|NCT00578968|101583377|FG001|NOT COMPLETED|Baseline (Prior to Intervention)||0||
48511583|NCT00578968|101583378|FG002|NOT COMPLETED|Baseline (Prior to Intervention)||0||
48511584|NCT00578968|101583376|FG000|STARTED|Intervention||12||
48511585|NCT00578968|101583377|FG001|STARTED|Intervention||12||
48511586|NCT00578968|101583378|FG002|STARTED|Intervention||0||
48511587|NCT00578968|101583376|FG000|COMPLETED|Intervention||12||
48511588|NCT00578968|101583377|FG001|COMPLETED|Intervention||12||
48511589|NCT00578968|101583378|FG002|COMPLETED|Intervention||0||
48511590|NCT00578968|101583376|FG000|NOT COMPLETED|Intervention||0||
48511591|NCT00578968|101583377|FG001|NOT COMPLETED|Intervention||0||
48511592|NCT00578968|101583378|FG002|NOT COMPLETED|Intervention||0||
48511593|NCT01474915|101583379|FG000|STARTED|Overall Study||60||
48511594|NCT01474915|101583380|FG001|STARTED|Overall Study||61||
48511595|NCT01474915|101583379|FG000|COMPLETED|Overall Study||50||
48511596|NCT01474915|101583380|FG001|COMPLETED|Overall Study||51||
48511597|NCT01474915|101583379|FG000|NOT COMPLETED|Overall Study||10||
48511598|NCT01474915|101583380|FG001|NOT COMPLETED|Overall Study||10||
48511599|NCT04406194|101583381|FG000|STARTED|Period 1||15||
48511600|NCT04406194|101583382|FG001|STARTED|Period 1||15||
48511601|NCT04406194|101583381|FG000|COMPLETED|Period 1||15||
48511602|NCT04406194|101583382|FG001|COMPLETED|Period 1||14||
48511603|NCT04406194|101583381|FG000|NOT COMPLETED|Period 1||0||
48511604|NCT04406194|101583382|FG001|NOT COMPLETED|Period 1||1||
48511605|NCT04406194|101583381|FG000|STARTED|Period 2||15||
48511606|NCT04406194|101583382|FG001|STARTED|Period 2||14||
48511607|NCT04406194|101583381|FG000|COMPLETED|Period 2||15||
48511608|NCT04406194|101583382|FG001|COMPLETED|Period 2||14||
48511609|NCT04406194|101583381|FG000|NOT COMPLETED|Period 2||0||
48511610|NCT04406194|101583382|FG001|NOT COMPLETED|Period 2||0||
48511611|NCT03635983|101583383|FG000|STARTED|Pre-Treatment Period||391|Started=randomized|
48511612|NCT03635983|101583384|FG001|STARTED|Pre-Treatment Period||392|Started=randomized|
48511613|NCT03635983|101583383|FG000|COMPLETED|Pre-Treatment Period||387|Completed=treated|
48511614|NCT03635983|101583384|FG001|COMPLETED|Pre-Treatment Period||382|Completed=treated|
48511615|NCT03635983|101583383|FG000|NOT COMPLETED|Pre-Treatment Period||4||
48511616|NCT03635983|101583384|FG001|NOT COMPLETED|Pre-Treatment Period||10||
48511617|NCT03635983|101583383|FG000|STARTED|Treatment Period||387|Started=treated|
48511618|NCT03635983|101583384|FG001|STARTED|Treatment Period||382|Started=treated|
48511619|NCT03635983|101583383|FG000|COMPLETED|Treatment Period||135|Completed=on-going treatment|
48511620|NCT03635983|101583384|FG001|COMPLETED|Treatment Period||135|Completed=on-going treatment|
48511621|NCT03635983|101583383|FG000|NOT COMPLETED|Treatment Period||252||
48511622|NCT03635983|101583384|FG001|NOT COMPLETED|Treatment Period||247||
48511623|NCT02252445|101583385|FG000|STARTED|Overall Study||41||
48511624|NCT02252445|101583386|FG001|STARTED|Overall Study||41||
48511625|NCT02252445|101583385|FG000|COMPLETED|Overall Study||41||
48511626|NCT02252445|101583386|FG001|COMPLETED|Overall Study||41||
48511627|NCT02252445|101583385|FG000|NOT COMPLETED|Overall Study||0||
48511628|NCT02252445|101583386|FG001|NOT COMPLETED|Overall Study||0||
48511629|NCT04336332|101583387|FG000|STARTED|Overall Study||16||
48511630|NCT04336332|101583388|FG001|STARTED|Overall Study||30||
48511631|NCT04336332|101583389|FG002|STARTED|Overall Study||29||
48511632|NCT04336332|101583387|FG000|COMPLETED|Overall Study||16||
48511633|NCT04336332|101583388|FG001|COMPLETED|Overall Study||30||
48511634|NCT04336332|101583389|FG002|COMPLETED|Overall Study||29||
48511635|NCT04336332|101583387|FG000|NOT COMPLETED|Overall Study||0||
48511636|NCT04336332|101583388|FG001|NOT COMPLETED|Overall Study||0||
48511637|NCT04336332|101583389|FG002|NOT COMPLETED|Overall Study||0||
48511638|NCT03111381|101583390|FG000|STARTED|Overall Study||46||
48511639|NCT03111381|101583391|FG001|STARTED|Overall Study||48||
48511640|NCT03111381|101583390|FG000|COMPLETED|Overall Study||46||
48511641|NCT03111381|101583391|FG001|COMPLETED|Overall Study||48||
48511642|NCT03111381|101583390|FG000|NOT COMPLETED|Overall Study||0||
48511643|NCT03111381|101583391|FG001|NOT COMPLETED|Overall Study||0||
48511644|NCT03941834|101583392|FG000|STARTED|DBT Phase: 1st Treatment Period (2Weeks)||15||
48511645|NCT03941834|101583393|FG001|STARTED|DBT Phase: 1st Treatment Period (2Weeks)||15||
48511646|NCT03941834|101583394|FG002|STARTED|DBT Phase: 1st Treatment Period (2Weeks)||0||
48511647|NCT03941834|101583392|FG000|Treated|DBT Phase: 1st Treatment Period (2Weeks)||15||
48511648|NCT03941834|101583393|FG001|Treated|DBT Phase: 1st Treatment Period (2Weeks)||14||
48511649|NCT03941834|101583394|FG002|Treated|DBT Phase: 1st Treatment Period (2Weeks)||0||
48511650|NCT03941834|101583392|FG000|COMPLETED|DBT Phase: 1st Treatment Period (2Weeks)||14||
48511651|NCT03941834|101583393|FG001|COMPLETED|DBT Phase: 1st Treatment Period (2Weeks)||14||
48511652|NCT03941834|101583394|FG002|COMPLETED|DBT Phase: 1st Treatment Period (2Weeks)||0||
48511653|NCT03941834|101583392|FG000|NOT COMPLETED|DBT Phase: 1st Treatment Period (2Weeks)||1||
48511654|NCT03941834|101583393|FG001|NOT COMPLETED|DBT Phase: 1st Treatment Period (2Weeks)||1||
48511655|NCT03941834|101583394|FG002|NOT COMPLETED|DBT Phase: 1st Treatment Period (2Weeks)||0||
48511656|NCT03941834|101583392|FG000|STARTED|DBT Phase: Washout Period (7 Days)||14||
48511657|NCT03941834|101583393|FG001|STARTED|DBT Phase: Washout Period (7 Days)||14||
48511658|NCT03941834|101583394|FG002|STARTED|DBT Phase: Washout Period (7 Days)||0||
48511659|NCT03941834|101583392|FG000|COMPLETED|DBT Phase: Washout Period (7 Days)||14||
48511660|NCT03941834|101583393|FG001|COMPLETED|DBT Phase: Washout Period (7 Days)||14||
48511661|NCT03941834|101583394|FG002|COMPLETED|DBT Phase: Washout Period (7 Days)||0||
48511662|NCT03941834|101583392|FG000|NOT COMPLETED|DBT Phase: Washout Period (7 Days)||0||
48511663|NCT03941834|101583393|FG001|NOT COMPLETED|DBT Phase: Washout Period (7 Days)||0||
48511664|NCT03941834|101583394|FG002|NOT COMPLETED|DBT Phase: Washout Period (7 Days)||0||
48511665|NCT03941834|101583392|FG000|STARTED|2nd Treatment Period (2Weeks)||14||
48511666|NCT03941834|101583393|FG001|STARTED|2nd Treatment Period (2Weeks)||14||
48511667|NCT03941834|101583394|FG002|STARTED|2nd Treatment Period (2Weeks)||0||
48511668|NCT03941834|101583392|FG000|COMPLETED|2nd Treatment Period (2Weeks)||14||
48511669|NCT03941834|101583393|FG001|COMPLETED|2nd Treatment Period (2Weeks)||14||
48511670|NCT03941834|101583394|FG002|COMPLETED|2nd Treatment Period (2Weeks)||0||
48511671|NCT03941834|101583392|FG000|NOT COMPLETED|2nd Treatment Period (2Weeks)||0||
48511672|NCT03941834|101583393|FG001|NOT COMPLETED|2nd Treatment Period (2Weeks)||0||
48511673|NCT03941834|101583394|FG002|NOT COMPLETED|2nd Treatment Period (2Weeks)||0||
48511674|NCT03941834|101583392|FG000|STARTED|OLE Phase (12 Weeks)||0||
48511675|NCT03941834|101583393|FG001|STARTED|OLE Phase (12 Weeks)||0||
48511676|NCT03941834|101583394|FG002|STARTED|OLE Phase (12 Weeks)||13||
48511677|NCT03941834|101583392|FG000|COMPLETED|OLE Phase (12 Weeks)||0||
48511678|NCT03941834|101583393|FG001|COMPLETED|OLE Phase (12 Weeks)||0||
48511679|NCT03941834|101583394|FG002|COMPLETED|OLE Phase (12 Weeks)||9||
48511680|NCT03941834|101583392|FG000|NOT COMPLETED|OLE Phase (12 Weeks)||0||
48511681|NCT03941834|101583393|FG001|NOT COMPLETED|OLE Phase (12 Weeks)||0||
48511682|NCT03941834|101583394|FG002|NOT COMPLETED|OLE Phase (12 Weeks)||4||
48511683|NCT00709306|101583395|FG000|STARTED|Overall Study||48||
48511684|NCT00709306|101583396|FG001|STARTED|Overall Study||44||
48511685|NCT00709306|101583397|FG002|STARTED|Overall Study||58||
48511686|NCT00709306|101583398|FG003|STARTED|Overall Study||47||
48511687|NCT00709306|101583395|FG000|COMPLETED|Overall Study||39||
48511688|NCT00709306|101583396|FG001|COMPLETED|Overall Study||30||
48511689|NCT00709306|101583397|FG002|COMPLETED|Overall Study||48||
48511690|NCT00709306|101583398|FG003|COMPLETED|Overall Study||37||
48511691|NCT00709306|101583395|FG000|NOT COMPLETED|Overall Study||9||
48511692|NCT00709306|101583396|FG001|NOT COMPLETED|Overall Study||14||
48511693|NCT00709306|101583397|FG002|NOT COMPLETED|Overall Study||10||
48511694|NCT00709306|101583398|FG003|NOT COMPLETED|Overall Study||10||
48511695|NCT02148445|101583399|FG000|STARTED|Overall Study||198||
48511696|NCT02148445|101583400|FG001|STARTED|Overall Study||200||
48511697|NCT02148445|101583399|FG000|COMPLETED|Overall Study||197||
48511698|NCT02148445|101583400|FG001|COMPLETED|Overall Study||197||
48511699|NCT02148445|101583399|FG000|NOT COMPLETED|Overall Study||1||
48511700|NCT02148445|101583400|FG001|NOT COMPLETED|Overall Study||3||
48511701|NCT00545688|101583401|FG000|STARTED|Neo-Adjuvant Treatment Period||107||
48511702|NCT00545688|101583402|FG001|STARTED|Neo-Adjuvant Treatment Period||107||
48511703|NCT00545688|101583403|FG002|STARTED|Neo-Adjuvant Treatment Period||108||
48511704|NCT00545688|101583404|FG003|STARTED|Neo-Adjuvant Treatment Period||94||
48511705|NCT00545688|101583401|FG000|COMPLETED|Neo-Adjuvant Treatment Period||103||
48511706|NCT00545688|101583402|FG001|COMPLETED|Neo-Adjuvant Treatment Period||102||
48511707|NCT00545688|101583403|FG002|COMPLETED|Neo-Adjuvant Treatment Period||94||
48511708|NCT00545688|101583404|FG003|COMPLETED|Neo-Adjuvant Treatment Period||88||
48511709|NCT00545688|101583401|FG000|NOT COMPLETED|Neo-Adjuvant Treatment Period||4||
48511710|NCT00545688|101583402|FG001|NOT COMPLETED|Neo-Adjuvant Treatment Period||5||
48511711|NCT00545688|101583403|FG002|NOT COMPLETED|Neo-Adjuvant Treatment Period||14||
48511712|NCT00545688|101583404|FG003|NOT COMPLETED|Neo-Adjuvant Treatment Period||6||
48511713|NCT00545688|101583401|FG000|STARTED|Adjuvant Treatment Period||103||
48511714|NCT00545688|101583402|FG001|STARTED|Adjuvant Treatment Period||102||
48511715|NCT00545688|101583403|FG002|STARTED|Adjuvant Treatment Period||94||
48511716|NCT00545688|101583404|FG003|STARTED|Adjuvant Treatment Period||88||
48511717|NCT00545688|101583401|FG000|COMPLETED|Adjuvant Treatment Period||98||
48511718|NCT00545688|101583402|FG001|COMPLETED|Adjuvant Treatment Period||94||
48511719|NCT00545688|101583403|FG002|COMPLETED|Adjuvant Treatment Period||90||
48511720|NCT00545688|101583404|FG003|COMPLETED|Adjuvant Treatment Period||74||
48511721|NCT00545688|101583401|FG000|NOT COMPLETED|Adjuvant Treatment Period||5||
48511722|NCT00545688|101583402|FG001|NOT COMPLETED|Adjuvant Treatment Period||8||
48511723|NCT00545688|101583403|FG002|NOT COMPLETED|Adjuvant Treatment Period||4||
48511724|NCT00545688|101583404|FG003|NOT COMPLETED|Adjuvant Treatment Period||14||
48511725|NCT00545688|101583401|FG000|STARTED|Follow-Up Period||98||
48511726|NCT00545688|101583402|FG001|STARTED|Follow-Up Period||102||
48511727|NCT00545688|101583403|FG002|STARTED|Follow-Up Period||98||
48511728|NCT00545688|101583404|FG003|STARTED|Follow-Up Period||87||
48511729|NCT00545688|101583401|FG000|COMPLETED|Follow-Up Period||77||
48511730|NCT00545688|101583402|FG001|COMPLETED|Follow-Up Period||83||
48511731|NCT00545688|101583403|FG002|COMPLETED|Follow-Up Period||78||
48511732|NCT00545688|101583404|FG003|COMPLETED|Follow-Up Period||60||
48511733|NCT00545688|101583401|FG000|NOT COMPLETED|Follow-Up Period||21||
48511734|NCT00545688|101583402|FG001|NOT COMPLETED|Follow-Up Period||19||
48511735|NCT00545688|101583403|FG002|NOT COMPLETED|Follow-Up Period||20||
48511736|NCT00545688|101583404|FG003|NOT COMPLETED|Follow-Up Period||27||
48511737|NCT01884064|101583405|FG000|STARTED|Overall Study||12||
48511738|NCT01884064|101583406|FG001|STARTED|Overall Study||5||
48511739|NCT01884064|101583405|FG000|COMPLETED|Overall Study||12||
48511740|NCT01884064|101583406|FG001|COMPLETED|Overall Study||5||
48511741|NCT01884064|101583405|FG000|NOT COMPLETED|Overall Study||0||
48511742|NCT01884064|101583406|FG001|NOT COMPLETED|Overall Study||0||
48511743|NCT03139240|101583407|FG000|STARTED|Overall Study||48||
48511744|NCT03139240|101583408|FG001|STARTED|Overall Study||48||
48511745|NCT03139240|101583409|FG002|STARTED|Overall Study||38||
48511746|NCT03139240|101583410|FG003|STARTED|Overall Study||38||
48511747|NCT03139240|101583407|FG000|COMPLETED|Overall Study||48||
48511748|NCT03139240|101583408|FG001|COMPLETED|Overall Study||47||
48511749|NCT03139240|101583409|FG002|COMPLETED|Overall Study||37||
48511750|NCT03139240|101583410|FG003|COMPLETED|Overall Study||38||
48511751|NCT03139240|101583407|FG000|NOT COMPLETED|Overall Study||0||
48511752|NCT03139240|101583408|FG001|NOT COMPLETED|Overall Study||1||
48511753|NCT03139240|101583409|FG002|NOT COMPLETED|Overall Study||1||
48511754|NCT03139240|101583410|FG003|NOT COMPLETED|Overall Study||0||
48511755|NCT00830167|101583411|FG000|STARTED|Overall Study||248||
48511756|NCT00830167|101583412|FG001|STARTED|Overall Study||250||
48511757|NCT00830167|101583411|FG000|COMPLETED|Overall Study||208||
48511758|NCT00830167|101583412|FG001|COMPLETED|Overall Study||207||
48511759|NCT00830167|101583411|FG000|NOT COMPLETED|Overall Study||40||
48511760|NCT00830167|101583412|FG001|NOT COMPLETED|Overall Study||43||
48511761|NCT01114997|101583413|FG000|STARTED|Overall Study||11||
48511762|NCT01114997|101583414|FG001|STARTED|Overall Study||10||
48511763|NCT01114997|101583415|FG002|STARTED|Overall Study||11||
48511764|NCT01114997|101583413|FG000|COMPLETED|Overall Study||11||
48511765|NCT01114997|101583414|FG001|COMPLETED|Overall Study||10||
48511766|NCT01114997|101583415|FG002|COMPLETED|Overall Study||11||
48511767|NCT01114997|101583413|FG000|NOT COMPLETED|Overall Study||0||
48511768|NCT01114997|101583414|FG001|NOT COMPLETED|Overall Study||0||
48511769|NCT01114997|101583415|FG002|NOT COMPLETED|Overall Study||0||
48511770|NCT01876953|101583416|FG000|STARTED|Overall Study||17||
48511771|NCT01876953|101583417|FG001|STARTED|Overall Study||3||
48511772|NCT01876953|101583416|FG000|COMPLETED|Overall Study||17||
48511773|NCT01876953|101583417|FG001|COMPLETED|Overall Study||3||
48511774|NCT01876953|101583416|FG000|NOT COMPLETED|Overall Study||0||
48511775|NCT01876953|101583417|FG001|NOT COMPLETED|Overall Study||0||
48511776|NCT06442410|101583418|FG000|STARTED|Overall Non-Crossover||55||
48511777|NCT06442410|101583419|FG001|STARTED|Overall Non-Crossover||57||
48511778|NCT06442410|101583418|FG000|COMPLETED|Overall Non-Crossover||40|50 subjects in Control Group crossed over to Test Group at 6-month optional crossover timepoint. No Test Group subject crossed over to Control Group at 6-month optional crossover time point.|
48511779|NCT06442410|101583419|FG001|COMPLETED|Overall Non-Crossover||4|50 subjects in Control Group crossed over to Test Group at 6-month optional crossover timepoint. No Test Group subject crossed over to Control Group at 6-month optional crossover time point.|
48511780|NCT06442410|101583418|FG000|NOT COMPLETED|Overall Non-Crossover||15||
48511781|NCT06442410|101583419|FG001|NOT COMPLETED|Overall Non-Crossover||53||
48511782|NCT06442410|101583418|FG000|STARTED|Optional Crossover at 6 Month||0||
48511783|NCT06442410|101583419|FG001|STARTED|Optional Crossover at 6 Month||50||
48511784|NCT06442410|101583418|FG000|COMPLETED|Optional Crossover at 6 Month||0||
48511785|NCT06442410|101583419|FG001|COMPLETED|Optional Crossover at 6 Month||39||
48511786|NCT06442410|101583418|FG000|NOT COMPLETED|Optional Crossover at 6 Month||0||
48511787|NCT06442410|101583419|FG001|NOT COMPLETED|Optional Crossover at 6 Month||11||
48511788|NCT02056652|101583420|FG000|STARTED|Overall Study||61||
48511789|NCT02056652|101583421|FG001|STARTED|Overall Study||61||
48511790|NCT02056652|101583420|FG000|COMPLETED|Overall Study||60||
48511791|NCT02056652|101583421|FG001|COMPLETED|Overall Study||58||
48511792|NCT02056652|101583420|FG000|NOT COMPLETED|Overall Study||1||
48511793|NCT02056652|101583421|FG001|NOT COMPLETED|Overall Study||3||
48511794|NCT02063217|101583422|FG000|STARTED|Overall Study||12||
48511795|NCT02063217|101583423|FG001|STARTED|Overall Study||12||
48511796|NCT02063217|101583424|FG002|STARTED|Overall Study||12||
48511797|NCT02063217|101583422|FG000|COMPLETED|Overall Study||11|All participants invited to repeat the study; enrollment totals include repeat participants.|
48511798|NCT02063217|101583423|FG001|COMPLETED|Overall Study||12|All participants invited to repeat the study; enrollment totals include repeat participants.|
48511799|NCT02063217|101583424|FG002|COMPLETED|Overall Study||12|All participants invited to repeat the study; enrollment totals include repeat participants.|
48511800|NCT02063217|101583422|FG000|NOT COMPLETED|Overall Study||1||
48511801|NCT02063217|101583423|FG001|NOT COMPLETED|Overall Study||0||
48511802|NCT02063217|101583424|FG002|NOT COMPLETED|Overall Study||0||
48511803|NCT02462486|101583425|FG000|STARTED|Overall Study||316||
48511804|NCT02462486|101583426|FG001|STARTED|Overall Study||315||
48511805|NCT02462486|101583427|FG002|STARTED|Overall Study||318||
48511806|NCT02462486|101583425|FG000|COMPLETED|Overall Study||222||
48511807|NCT02462486|101583426|FG001|COMPLETED|Overall Study||223||
48511808|NCT02462486|101583427|FG002|COMPLETED|Overall Study||266||
48511809|NCT02462486|101583425|FG000|NOT COMPLETED|Overall Study||94||
48511810|NCT02462486|101583426|FG001|NOT COMPLETED|Overall Study||92||
48511811|NCT02462486|101583427|FG002|NOT COMPLETED|Overall Study||52||
48511812|NCT01706263|101583428|FG000|STARTED|Overall Study||28||
48511813|NCT01706263|101583428|FG000|COMPLETED|Overall Study||28||
48511814|NCT01706263|101583428|FG000|NOT COMPLETED|Overall Study||0||
48511815|NCT00260689|101583429|FG000|STARTED|Overall Study||60||
48511816|NCT00260689|101583430|FG001|STARTED|Overall Study||60||
48511817|NCT00260689|101583431|FG002|STARTED|Overall Study||16||
48511818|NCT00260689|101583429|FG000|COMPLETED|Overall Study||19||
48511819|NCT00260689|101583430|FG001|COMPLETED|Overall Study||11||
48511820|NCT00260689|101583431|FG002|COMPLETED|Overall Study||1||
48511821|NCT00260689|101583429|FG000|NOT COMPLETED|Overall Study||41||
48511822|NCT00260689|101583430|FG001|NOT COMPLETED|Overall Study||49||
48511823|NCT00260689|101583431|FG002|NOT COMPLETED|Overall Study||15||
48511824|NCT02722616|101583432|FG000|STARTED|Overall Study||2||
48511825|NCT02722616|101583433|FG001|STARTED|Overall Study||0||
48511826|NCT02722616|101583434|FG002|STARTED|Overall Study||0||
48511827|NCT02722616|101583432|FG000|COMPLETED|Overall Study||0||
48511828|NCT02722616|101583433|FG001|COMPLETED|Overall Study||0||
48511829|NCT02722616|101583434|FG002|COMPLETED|Overall Study||0||
48511830|NCT02722616|101583432|FG000|NOT COMPLETED|Overall Study||2||
48511831|NCT02722616|101583433|FG001|NOT COMPLETED|Overall Study||0||
48511832|NCT02722616|101583434|FG002|NOT COMPLETED|Overall Study||0||
48511833|NCT00076245|101583435|FG000|STARTED|Overall Study||16||
48511834|NCT00076245|101583436|FG001|STARTED|Overall Study||15||
48511835|NCT00076245|101583437|FG002|STARTED|Overall Study||15||
48511836|NCT00076245|101583438|FG003|STARTED|Overall Study||15||
48511837|NCT00076245|101583435|FG000|COMPLETED|Overall Study||16||
48511838|NCT00076245|101583436|FG001|COMPLETED|Overall Study||15||
48511839|NCT00076245|101583437|FG002|COMPLETED|Overall Study||15||
48511840|NCT00076245|101583438|FG003|COMPLETED|Overall Study||14||
48511841|NCT00076245|101583435|FG000|NOT COMPLETED|Overall Study||0||
48511842|NCT00076245|101583436|FG001|NOT COMPLETED|Overall Study||0||
48511843|NCT00076245|101583437|FG002|NOT COMPLETED|Overall Study||0||
48511844|NCT00076245|101583438|FG003|NOT COMPLETED|Overall Study||1||
48511845|NCT02010996|101583439|FG000|STARTED|Overall Study||36||
48511846|NCT02010996|101583440|FG001|STARTED|Overall Study||36||
48511847|NCT02010996|101583439|FG000|COMPLETED|Overall Study||36||
48511848|NCT02010996|101583440|FG001|COMPLETED|Overall Study||36||
48511849|NCT02010996|101583439|FG000|NOT COMPLETED|Overall Study||0||
48511850|NCT02010996|101583440|FG001|NOT COMPLETED|Overall Study||0||
48511851|NCT02618382|101583441|FG000|STARTED|Overall Study||32||
48511852|NCT02618382|101583441|FG000|COMPLETED|Overall Study||29||
48511853|NCT02618382|101583441|FG000|NOT COMPLETED|Overall Study||3||
48511854|NCT04284553|101583442|FG000|STARTED|Stage 1: October 2020-August 2021||8|"The numbers reflect the number of primary care providers assigned to each arm in Stage 1 of trial (n=201). Primary care providers were identified from electronic health record data and cluster randomized but were not evaluated for effectiveness outcomes. The number of patients cared for by these providers and evaluated for outcomes are shown in the next row (Number of Patients Analyzed)."|
48511855|NCT04284553|101583443|FG001|STARTED|Stage 1: October 2020-August 2021||8|"The numbers reflect the number of primary care providers assigned to each arm in Stage 1 of trial (n=201). Primary care providers were identified from electronic health record data and cluster randomized but were not evaluated for effectiveness outcomes. The number of patients cared for by these providers and evaluated for outcomes are shown in the next row (Number of Patients Analyzed)."|
48511856|NCT04284553|101583444|FG002|STARTED|Stage 1: October 2020-August 2021||8|"The numbers reflect the number of primary care providers assigned to each arm in Stage 1 of trial (n=201). Primary care providers were identified from electronic health record data and cluster randomized but were not evaluated for effectiveness outcomes. The number of patients cared for by these providers and evaluated for outcomes are shown in the next row (Number of Patients Analyzed)."|
48511857|NCT04284553|101583445|FG003|STARTED|Stage 1: October 2020-August 2021||8|"The numbers reflect the number of primary care providers assigned to each arm in Stage 1 of trial (n=201). Primary care providers were identified from electronic health record data and cluster randomized but were not evaluated for effectiveness outcomes. The number of patients cared for by these providers and evaluated for outcomes are shown in the next row (Number of Patients Analyzed)."|
48511858|NCT04284553|101583446|FG004|STARTED|Stage 1: October 2020-August 2021||8|"The numbers reflect the number of primary care providers assigned to each arm in Stage 1 of trial (n=201). Primary care providers were identified from electronic health record data and cluster randomized but were not evaluated for effectiveness outcomes. The number of patients cared for by these providers and evaluated for outcomes are shown in the next row (Number of Patients Analyzed)."|
48511859|NCT04284553|101583447|FG005|STARTED|Stage 1: October 2020-August 2021||8|"The numbers reflect the number of primary care providers assigned to each arm in Stage 1 of trial (n=201). Primary care providers were identified from electronic health record data and cluster randomized but were not evaluated for effectiveness outcomes. The number of patients cared for by these providers and evaluated for outcomes are shown in the next row (Number of Patients Analyzed)."|
48666773|NCT03391882|101970466|FG001|NOT COMPLETED|Post Part A / Pre Part B||3||
48066479|NCT03643575|100485389|FG005|NOT COMPLETED|Washout: 7 Days||0||
48066480|NCT03643575|100485384|FG000|STARTED|Period 2||4||
48066481|NCT03643575|100485385|FG001|STARTED|Period 2||5||
48066482|NCT03643575|100485386|FG002|STARTED|Period 2||5||
48066483|NCT03643575|100485387|FG003|STARTED|Period 2||4||
48066484|NCT03643575|100485388|FG004|STARTED|Period 2||5||
48066485|NCT03643575|100485389|FG005|STARTED|Period 2||5||
48066486|NCT03643575|100485384|FG000|COMPLETED|Period 2||4||
48066487|NCT03643575|100485385|FG001|COMPLETED|Period 2||5||
48066488|NCT03643575|100485386|FG002|COMPLETED|Period 2||5||
48066489|NCT03643575|100485387|FG003|COMPLETED|Period 2||4||
48066490|NCT03643575|100485388|FG004|COMPLETED|Period 2||5||
48066491|NCT03643575|100485389|FG005|COMPLETED|Period 2||5||
48066492|NCT03643575|100485384|FG000|NOT COMPLETED|Period 2||0||
48066493|NCT03643575|100485385|FG001|NOT COMPLETED|Period 2||0||
48066494|NCT03643575|100485386|FG002|NOT COMPLETED|Period 2||0||
48066495|NCT03643575|100485387|FG003|NOT COMPLETED|Period 2||0||
48066496|NCT03643575|100485388|FG004|NOT COMPLETED|Period 2||0||
48066497|NCT03643575|100485389|FG005|NOT COMPLETED|Period 2||0||
48066498|NCT03643575|100485384|FG000|STARTED|Washout: 7 Days||4||
48066499|NCT03643575|100485385|FG001|STARTED|Washout: 7 Days||5||
48066500|NCT03643575|100485386|FG002|STARTED|Washout: 7 Days||5||
48066501|NCT03643575|100485387|FG003|STARTED|Washout: 7 Days||4||
48066502|NCT03643575|100485388|FG004|STARTED|Washout: 7 Days||5||
48066503|NCT03643575|100485389|FG005|STARTED|Washout: 7 Days||5||
48066504|NCT03643575|100485384|FG000|COMPLETED|Washout: 7 Days||4||
48066505|NCT03643575|100485385|FG001|COMPLETED|Washout: 7 Days||4||
48066506|NCT03643575|100485386|FG002|COMPLETED|Washout: 7 Days||5||
48066507|NCT03643575|100485387|FG003|COMPLETED|Washout: 7 Days||4||
48066508|NCT03643575|100485388|FG004|COMPLETED|Washout: 7 Days||5||
48066509|NCT03643575|100485389|FG005|COMPLETED|Washout: 7 Days||5||
48066510|NCT03643575|100485384|FG000|NOT COMPLETED|Washout: 7 Days||0||
48066511|NCT03643575|100485385|FG001|NOT COMPLETED|Washout: 7 Days||1||
48066512|NCT03643575|100485386|FG002|NOT COMPLETED|Washout: 7 Days||0||
48066513|NCT03643575|100485387|FG003|NOT COMPLETED|Washout: 7 Days||0||
48066514|NCT03643575|100485388|FG004|NOT COMPLETED|Washout: 7 Days||0||
48066515|NCT03643575|100485389|FG005|NOT COMPLETED|Washout: 7 Days||0||
48066516|NCT03643575|100485384|FG000|STARTED|Period 3||4||
48066517|NCT03643575|100485385|FG001|STARTED|Period 3||4||
48066518|NCT03643575|100485386|FG002|STARTED|Period 3||5||
48066519|NCT03643575|100485387|FG003|STARTED|Period 3||4||
48066520|NCT03643575|100485388|FG004|STARTED|Period 3||5||
48066521|NCT03643575|100485389|FG005|STARTED|Period 3||5||
48066522|NCT03643575|100485384|FG000|COMPLETED|Period 3||4||
48066523|NCT03643575|100485385|FG001|COMPLETED|Period 3||4||
48066524|NCT03643575|100485386|FG002|COMPLETED|Period 3||5||
48066525|NCT03643575|100485387|FG003|COMPLETED|Period 3||4||
48066526|NCT03643575|100485388|FG004|COMPLETED|Period 3||5||
48066527|NCT03643575|100485389|FG005|COMPLETED|Period 3||5||
48066528|NCT03643575|100485384|FG000|NOT COMPLETED|Period 3||0||
48066529|NCT03643575|100485385|FG001|NOT COMPLETED|Period 3||0||
48066530|NCT03643575|100485386|FG002|NOT COMPLETED|Period 3||0||
48066531|NCT03643575|100485387|FG003|NOT COMPLETED|Period 3||0||
48066532|NCT03643575|100485388|FG004|NOT COMPLETED|Period 3||0||
48066533|NCT03643575|100485389|FG005|NOT COMPLETED|Period 3||0||
48066534|NCT02432742|100485390|FG000|STARTED|Overall Study||100||
48066535|NCT02432742|100485390|FG000|COMPLETED|Overall Study||95||
48066536|NCT02432742|100485390|FG000|NOT COMPLETED|Overall Study||5||
48066537|NCT02308189|100485391|FG000|STARTED|Overall Study||17||
48066538|NCT02308189|100485392|FG001|STARTED|Overall Study||15||
48066539|NCT02308189|100485391|FG000|COMPLETED|Overall Study||16||
48066540|NCT02308189|100485392|FG001|COMPLETED|Overall Study||14||
48066541|NCT02308189|100485391|FG000|NOT COMPLETED|Overall Study||1||
48066542|NCT02308189|100485392|FG001|NOT COMPLETED|Overall Study||1||
48066543|NCT02360995|100485393|FG000|STARTED|Overall Study||43||
48066544|NCT02360995|100485394|FG001|STARTED|Overall Study||43||
48066545|NCT02360995|100485395|FG002|STARTED|Overall Study||43||
48066546|NCT02360995|100485393|FG000|COMPLETED|Overall Study||41||
48066547|NCT02360995|100485394|FG001|COMPLETED|Overall Study||42||
48066548|NCT02360995|100485395|FG002|COMPLETED|Overall Study||41||
48066549|NCT02360995|100485393|FG000|NOT COMPLETED|Overall Study||2||
48066550|NCT02360995|100485394|FG001|NOT COMPLETED|Overall Study||1||
48066551|NCT02360995|100485395|FG002|NOT COMPLETED|Overall Study||2||
48066552|NCT02124161|100485396|FG000|STARTED|Overall Study||441||
48066553|NCT02124161|100485397|FG001|STARTED|Overall Study||441||
48066554|NCT02124161|100485396|FG000|Vaccination 1|Overall Study||439||
48066555|NCT02124161|100485397|FG001|Vaccination 1|Overall Study||437||
48066556|NCT02124161|100485396|FG000|Vaccination 2|Overall Study||431||
48066557|NCT02124161|100485397|FG001|Vaccination 2|Overall Study||432||
48066558|NCT02124161|100485396|FG000|COMPLETED|Overall Study||425||
48066559|NCT02124161|100485397|FG001|COMPLETED|Overall Study||426||
48066560|NCT02124161|100485396|FG000|NOT COMPLETED|Overall Study||16||
48066561|NCT02124161|100485397|FG001|NOT COMPLETED|Overall Study||15||
48066562|NCT02410551|100485398|FG000|STARTED|Overall Study||4||
48066563|NCT02410551|100485398|FG000|COMPLETED|Overall Study||0||
48066564|NCT02410551|100485398|FG000|NOT COMPLETED|Overall Study||4||
48066565|NCT02846545|100485399|FG000|STARTED|Active Treatment Period: Week 0-52||28||
48066566|NCT02846545|100485400|FG001|STARTED|Active Treatment Period: Week 0-52||56||
48066567|NCT02846545|100485399|FG000|COMPLETED|Active Treatment Period: Week 0-52||25||
48066568|NCT02846545|100485400|FG001|COMPLETED|Active Treatment Period: Week 0-52||50||
48066569|NCT02846545|100485399|FG000|NOT COMPLETED|Active Treatment Period: Week 0-52||3||
48066570|NCT02846545|100485400|FG001|NOT COMPLETED|Active Treatment Period: Week 0-52||6||
48066571|NCT02846545|100485399|FG000|STARTED|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||25||
48066572|NCT02846545|100485400|FG001|STARTED|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||49||
48066573|NCT02846545|100485399|FG000|Participants Who Entered OLE Period|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||0||
48066574|NCT02846545|100485400|FG001|Participants Who Entered OLE Period|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||5||
48066575|NCT02846545|100485399|FG000|Participants Who Completed OLE Period|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||0||
48066576|NCT02846545|100485400|FG001|Participants Who Completed OLE Period|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||1||
48066577|NCT02846545|100485399|FG000|COMPLETED|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||23||
48066578|NCT02846545|100485400|FG001|COMPLETED|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||47||
48066579|NCT02846545|100485399|FG000|NOT COMPLETED|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||2||
48066580|NCT02846545|100485400|FG001|NOT COMPLETED|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||2||
48066581|NCT04203498|100485401|FG000|STARTED|Overall Study||69||
48066582|NCT04203498|100485402|FG001|STARTED|Overall Study||70||
48066583|NCT04203498|100485401|FG000|Safety Analysis Set|Overall Study||67||
48066584|NCT04203498|100485402|FG001|Safety Analysis Set|Overall Study||70||
48066585|NCT04203498|100485401|FG000|COMPLETED|Overall Study||55||
48066586|NCT04203498|100485402|FG001|COMPLETED|Overall Study||66||
48066587|NCT04203498|100485401|FG000|NOT COMPLETED|Overall Study||14||
48066588|NCT04203498|100485402|FG001|NOT COMPLETED|Overall Study||4||
48066589|NCT05095454|100485403|FG000|STARTED|Overall Study||3||
48066590|NCT05095454|100485404|FG001|STARTED|Overall Study||3||
48066591|NCT05095454|100485403|FG000|COMPLETED|Overall Study||3||
48066592|NCT05095454|100485404|FG001|COMPLETED|Overall Study||2||
48066593|NCT05095454|100485403|FG000|NOT COMPLETED|Overall Study||0||
48066594|NCT05095454|100485404|FG001|NOT COMPLETED|Overall Study||1||
48066595|NCT00075218|100485405|FG000|STARTED|Double-Blind Treatment||243||
48066596|NCT00075218|100485406|FG001|STARTED|Double-Blind Treatment||118||
48066597|NCT00075218|100485407|FG002|STARTED|Double-Blind Treatment||0||
48066598|NCT00075218|100485405|FG000|Received Double-Blind Treatment|Double-Blind Treatment||228||
48066599|NCT00075218|100485406|FG001|Received Double-Blind Treatment|Double-Blind Treatment||114||
48066600|NCT00075218|100485407|FG002|Received Double-Blind Treatment|Double-Blind Treatment||0||
48066601|NCT00075218|100485405|FG000|Crossed Over to Open-Label Treatment|Double-Blind Treatment||152||
48066602|NCT00075218|100485406|FG001|Crossed Over to Open-Label Treatment|Double-Blind Treatment||103||
48066603|NCT00075218|100485407|FG002|Crossed Over to Open-Label Treatment|Double-Blind Treatment||0||
48066604|NCT00075218|100485405|FG000|COMPLETED|Double-Blind Treatment||152||
48066605|NCT00075218|100485406|FG001|COMPLETED|Double-Blind Treatment||103||
48066606|NCT00075218|100485407|FG002|COMPLETED|Double-Blind Treatment||0||
48066607|NCT00075218|100485405|FG000|NOT COMPLETED|Double-Blind Treatment||91||
48066608|NCT00075218|100485406|FG001|NOT COMPLETED|Double-Blind Treatment||15||
48066609|NCT00075218|100485407|FG002|NOT COMPLETED|Double-Blind Treatment||0||
48066610|NCT00075218|100485405|FG000|STARTED|Open-Label Treatment||0||
48066611|NCT00075218|100485406|FG001|STARTED|Open-Label Treatment||0||
48066612|NCT00075218|100485407|FG002|STARTED|Open-Label Treatment||255||
48066613|NCT00075218|100485405|FG000|COMPLETED|Open-Label Treatment||0||
48066614|NCT00075218|100485406|FG001|COMPLETED|Open-Label Treatment||0||
48066615|NCT00075218|100485407|FG002|COMPLETED|Open-Label Treatment||0||
48066616|NCT00075218|100485405|FG000|NOT COMPLETED|Open-Label Treatment||0||
48066617|NCT00075218|100485406|FG001|NOT COMPLETED|Open-Label Treatment||0||
48066618|NCT00075218|100485407|FG002|NOT COMPLETED|Open-Label Treatment||255||
48066619|NCT00723580|100485408|FG000|STARTED|Overall Study||1||
48066620|NCT00723580|100485408|FG000|Baseline Measurements|Overall Study||1||
48066621|NCT00723580|100485408|FG000|COMPLETED|Overall Study||1||
48066622|NCT00723580|100485408|FG000|NOT COMPLETED|Overall Study||0||
48066623|NCT02777333|100485409|FG000|STARTED|Overall Study||15||
48066624|NCT02777333|100485410|FG001|STARTED|Overall Study||15||
48066625|NCT02777333|100485409|FG000|COMPLETED|Overall Study||15||
48066626|NCT02777333|100485410|FG001|COMPLETED|Overall Study||13||
48066627|NCT02777333|100485409|FG000|NOT COMPLETED|Overall Study||0||
48066628|NCT02777333|100485410|FG001|NOT COMPLETED|Overall Study||2||
48066629|NCT02758132|100485411|FG000|STARTED|Overall Study||0||
48066630|NCT02758132|100485412|FG001|STARTED|Overall Study||1||
48066631|NCT02758132|100485411|FG000|COMPLETED|Overall Study||0||
48066632|NCT02758132|100485412|FG001|COMPLETED|Overall Study||0||
48066633|NCT02758132|100485411|FG000|NOT COMPLETED|Overall Study||0||
48066634|NCT02758132|100485412|FG001|NOT COMPLETED|Overall Study||1||
48066635|NCT02437383|100485413|FG000|STARTED|Overall Study||100||
48066636|NCT02437383|100485414|FG001|STARTED|Overall Study||100||
48066637|NCT02437383|100485413|FG000|COMPLETED|Overall Study||87||
48066638|NCT02437383|100485414|FG001|COMPLETED|Overall Study||87||
48066639|NCT02437383|100485413|FG000|NOT COMPLETED|Overall Study||13||
48066640|NCT02437383|100485414|FG001|NOT COMPLETED|Overall Study||13||
48066641|NCT03080454|100485415|FG000|STARTED|Baseline||26||
48066642|NCT03080454|100485415|FG000|COMPLETED|Baseline||24||
48066643|NCT03080454|100485415|FG000|NOT COMPLETED|Baseline||2||
48066644|NCT03080454|100485415|FG000|STARTED|Sham Doublestim (5days)||24||
48066645|NCT03080454|100485415|FG000|COMPLETED|Sham Doublestim (5days)||24||
48066646|NCT03080454|100485415|FG000|NOT COMPLETED|Sham Doublestim (5days)||0||
48066647|NCT03080454|100485415|FG000|STARTED|Sham FU (7days)||24||
48066648|NCT03080454|100485415|FG000|COMPLETED|Sham FU (7days)||24||
48066649|NCT03080454|100485415|FG000|NOT COMPLETED|Sham FU (7days)||0||
48066650|NCT03080454|100485415|FG000|STARTED|Anodal Doublestim (5 Days)||24||
48066651|NCT03080454|100485415|FG000|COMPLETED|Anodal Doublestim (5 Days)||23||
48066652|NCT03080454|100485415|FG000|NOT COMPLETED|Anodal Doublestim (5 Days)||1||
48066653|NCT03080454|100485415|FG000|STARTED|Anodal FU (7 Days)||23||
48066654|NCT03080454|100485415|FG000|COMPLETED|Anodal FU (7 Days)||19||
48066655|NCT03080454|100485415|FG000|NOT COMPLETED|Anodal FU (7 Days)||4||
48066656|NCT04545385|100485416|FG000|STARTED|Overall Study||32||
48066657|NCT04545385|100485417|FG001|STARTED|Overall Study||33||
48066658|NCT04545385|100485416|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31||
48066659|NCT04545385|100485417|FG001|Received at Least 1 Dose of Study Drug|Overall Study||33||
48066660|NCT04545385|100485416|FG000|COMPLETED|Overall Study||17||
48066661|NCT04545385|100485417|FG001|COMPLETED|Overall Study||20||
48066662|NCT04545385|100485416|FG000|NOT COMPLETED|Overall Study||15||
48066663|NCT04545385|100485417|FG001|NOT COMPLETED|Overall Study||13||
48219913|NCT05580003|100863764|FG016|STARTED|Part 3: Period 3 (Day 1)||2||
48219914|NCT05580003|100863765|FG017|STARTED|Part 3: Period 3 (Day 1)||2||
48066664|NCT00761631|100485418|FG000|STARTED|Overall Study||126||
48066665|NCT00761631|100485419|FG001|STARTED|Overall Study||181||
48066666|NCT00761631|100485420|FG002|STARTED|Overall Study||176||
48066667|NCT00761631|100485421|FG003|STARTED|Overall Study||119||
48066668|NCT00761631|100485422|FG004|STARTED|Overall Study||299||
48066669|NCT00761631|100485423|FG005|STARTED|Overall Study||299||
48066670|NCT00761631|100485418|FG000|Vaccinated Dose 1|Overall Study||124||
48066671|NCT00761631|100485419|FG001|Vaccinated Dose 1|Overall Study||179||
48066672|NCT00761631|100485420|FG002|Vaccinated Dose 1|Overall Study||175||
48066673|NCT00761631|100485421|FG003|Vaccinated Dose 1|Overall Study||118||
48066674|NCT00761631|100485422|FG004|Vaccinated Dose 1|Overall Study||294||
48066675|NCT00761631|100485423|FG005|Vaccinated Dose 1|Overall Study||298||
48066676|NCT00761631|100485418|FG000|Vaccinated Dose 2|Overall Study||112||
48066677|NCT00761631|100485419|FG001|Vaccinated Dose 2|Overall Study||0||
48066678|NCT00761631|100485420|FG002|Vaccinated Dose 2|Overall Study||165||
48066679|NCT00761631|100485421|FG003|Vaccinated Dose 2|Overall Study||0||
48066680|NCT00761631|100485422|FG004|Vaccinated Dose 2|Overall Study||0||
48066681|NCT00761631|100485423|FG005|Vaccinated Dose 2|Overall Study||0||
48066682|NCT00761631|100485418|FG000|COMPLETED|Overall Study||111||
48066683|NCT00761631|100485419|FG001|COMPLETED|Overall Study||174||
48066684|NCT00761631|100485420|FG002|COMPLETED|Overall Study||160||
48066685|NCT00761631|100485421|FG003|COMPLETED|Overall Study||116||
48066686|NCT00761631|100485422|FG004|COMPLETED|Overall Study||277||
48066687|NCT00761631|100485423|FG005|COMPLETED|Overall Study||294||
48066688|NCT00761631|100485418|FG000|NOT COMPLETED|Overall Study||15||
48066689|NCT00761631|100485419|FG001|NOT COMPLETED|Overall Study||7||
48066690|NCT00761631|100485420|FG002|NOT COMPLETED|Overall Study||16||
48066691|NCT00761631|100485421|FG003|NOT COMPLETED|Overall Study||3||
48066692|NCT00761631|100485422|FG004|NOT COMPLETED|Overall Study||22||
48066693|NCT00761631|100485423|FG005|NOT COMPLETED|Overall Study||5||
48066694|NCT02423109|100485424|FG000|STARTED|Lens 1||19||
48066695|NCT02423109|100485425|FG001|STARTED|Lens 1||14||
48066696|NCT02423109|100485424|FG000|COMPLETED|Lens 1||18||
48066697|NCT02423109|100485425|FG001|COMPLETED|Lens 1||14||
48066698|NCT02423109|100485424|FG000|NOT COMPLETED|Lens 1||1||
48066699|NCT02423109|100485425|FG001|NOT COMPLETED|Lens 1||0||
48066700|NCT02423109|100485424|FG000|STARTED|Lens 2||18||
48066701|NCT02423109|100485425|FG001|STARTED|Lens 2||14||
48066702|NCT02423109|100485424|FG000|COMPLETED|Lens 2||18||
48066703|NCT02423109|100485425|FG001|COMPLETED|Lens 2||14||
48066704|NCT02423109|100485424|FG000|NOT COMPLETED|Lens 2||0||
48066705|NCT02423109|100485425|FG001|NOT COMPLETED|Lens 2||0||
48066706|NCT04584970|100485426|FG000|STARTED|Overall Study||11||
48066707|NCT04584970|100485427|FG001|STARTED|Overall Study||12||
48066708|NCT04584970|100485426|FG000|COMPLETED|Overall Study||10||
48066709|NCT04584970|100485427|FG001|COMPLETED|Overall Study||9||
48066710|NCT04584970|100485426|FG000|NOT COMPLETED|Overall Study||1||
48066711|NCT04584970|100485427|FG001|NOT COMPLETED|Overall Study||3||
48066712|NCT00579098|100485428|FG000|STARTED|Overall Study||62||
48066713|NCT00579098|100485429|FG001|STARTED|Overall Study||63||
48066714|NCT00579098|100485428|FG000|COMPLETED|Overall Study||53||
48066715|NCT00579098|100485429|FG001|COMPLETED|Overall Study||55||
48066716|NCT00579098|100485428|FG000|NOT COMPLETED|Overall Study||9||
48066717|NCT00579098|100485429|FG001|NOT COMPLETED|Overall Study||8||
48066718|NCT02083965|100485430|FG000|STARTED|PK Period 1||10||
48066719|NCT02083965|100485431|FG001|STARTED|PK Period 1||9||
48066720|NCT02083965|100485430|FG000|COMPLETED|PK Period 1||10||
48066721|NCT02083965|100485431|FG001|COMPLETED|PK Period 1||9||
48066722|NCT02083965|100485430|FG000|NOT COMPLETED|PK Period 1||0||
48066723|NCT02083965|100485431|FG001|NOT COMPLETED|PK Period 1||0||
48066724|NCT02083965|100485430|FG000|STARTED|Washout Period||10||
48066725|NCT02083965|100485431|FG001|STARTED|Washout Period||9||
48066726|NCT02083965|100485430|FG000|COMPLETED|Washout Period||10||
48066727|NCT02083965|100485431|FG001|COMPLETED|Washout Period||9||
48066728|NCT02083965|100485430|FG000|NOT COMPLETED|Washout Period||0||
48066729|NCT02083965|100485431|FG001|NOT COMPLETED|Washout Period||0||
48066730|NCT02083965|100485430|FG000|STARTED|PK Period 2||10||
48066731|NCT02083965|100485431|FG001|STARTED|PK Period 2||9||
48066732|NCT02083965|100485430|FG000|COMPLETED|PK Period 2||10||
48066733|NCT02083965|100485431|FG001|COMPLETED|PK Period 2||9||
48066734|NCT02083965|100485430|FG000|NOT COMPLETED|PK Period 2||0||
48066735|NCT02083965|100485431|FG001|NOT COMPLETED|PK Period 2||0||
48066736|NCT02083965|100485430|FG000|STARTED|Treatment Period||10||
48066737|NCT02083965|100485431|FG001|STARTED|Treatment Period||8||
48066738|NCT02083965|100485430|FG000|COMPLETED|Treatment Period||9||
48066739|NCT02083965|100485431|FG001|COMPLETED|Treatment Period||8||
48066740|NCT02083965|100485430|FG000|NOT COMPLETED|Treatment Period||1||
48066741|NCT02083965|100485431|FG001|NOT COMPLETED|Treatment Period||0||
48066742|NCT00697788|100485432|FG000|STARTED|Dexmedetomidine Bolus 1 mcg/kg||8||
48066743|NCT00697788|100485433|FG001|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0||
48066744|NCT00697788|100485434|FG002|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0||
48066745|NCT00697788|100485435|FG003|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0||
48066746|NCT00697788|100485436|FG004|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0||
48066747|NCT00697788|100485437|FG005|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0||
48066748|NCT00697788|100485438|FG006|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0||
48066749|NCT00697788|100485439|FG007|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0||
48066750|NCT00697788|100485432|FG000|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||8||
48066751|NCT00697788|100485433|FG001|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0||
48066752|NCT00697788|100485434|FG002|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0||
48066753|NCT00697788|100485435|FG003|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0||
48066754|NCT00697788|100485436|FG004|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0||
48066755|NCT00697788|100485437|FG005|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0||
48066756|NCT00697788|100485438|FG006|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0||
48066757|NCT00697788|100485439|FG007|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0||
48066758|NCT00697788|100485432|FG000|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0||
48066759|NCT00697788|100485433|FG001|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0||
48066760|NCT00697788|100485434|FG002|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0||
48066761|NCT00697788|100485435|FG003|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0||
48066762|NCT00697788|100485436|FG004|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0||
48066763|NCT00697788|100485437|FG005|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0||
48066764|NCT00697788|100485438|FG006|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0||
48066765|NCT00697788|100485439|FG007|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0||
48066766|NCT00697788|100485432|FG000|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
48066767|NCT00697788|100485433|FG001|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||7||
48066768|NCT00697788|100485434|FG002|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
48511860|NCT04284553|101583448|FG006|STARTED|Stage 1: October 2020-August 2021||8|"The numbers reflect the number of primary care providers assigned to each arm in Stage 1 of trial (n=201). Primary care providers were identified from electronic health record data and cluster randomized but were not evaluated for effectiveness outcomes. The number of patients cared for by these providers and evaluated for outcomes are shown in the next row (Number of Patients Analyzed)."|
48511861|NCT04284553|101583449|FG007|STARTED|Stage 1: October 2020-August 2021||8|"The numbers reflect the number of primary care providers assigned to each arm in Stage 1 of trial (n=201). Primary care providers were identified from electronic health record data and cluster randomized but were not evaluated for effectiveness outcomes. The number of patients cared for by these providers and evaluated for outcomes are shown in the next row (Number of Patients Analyzed)."|
48511862|NCT04284553|101583450|FG008|STARTED|Stage 1: October 2020-August 2021||8|"The numbers reflect the number of primary care providers assigned to each arm in Stage 1 of trial (n=201). Primary care providers were identified from electronic health record data and cluster randomized but were not evaluated for effectiveness outcomes. The number of patients cared for by these providers and evaluated for outcomes are shown in the next row (Number of Patients Analyzed)."|
48511863|NCT04284553|101583451|FG009|STARTED|Stage 1: October 2020-August 2021||8|"The numbers reflect the number of primary care providers assigned to each arm in Stage 1 of trial (n=201). Primary care providers were identified from electronic health record data and cluster randomized but were not evaluated for effectiveness outcomes. The number of patients cared for by these providers and evaluated for outcomes are shown in the next row (Number of Patients Analyzed)."|
48666774|NCT03391882|101970467|FG002|NOT COMPLETED|Post Part A / Pre Part B||0||
48666775|NCT03391882|101970468|FG003|NOT COMPLETED|Post Part A / Pre Part B||0||
48666776|NCT03391882|101970469|FG004|NOT COMPLETED|Post Part A / Pre Part B||0||
48066769|NCT00697788|100485435|FG003|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
48066770|NCT00697788|100485436|FG004|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
48066771|NCT00697788|100485437|FG005|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
48066772|NCT00697788|100485438|FG006|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
48066773|NCT00697788|100485439|FG007|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
48066774|NCT00697788|100485432|FG000|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
48066775|NCT00697788|100485433|FG001|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||5||
48066776|NCT00697788|100485434|FG002|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
48066777|NCT00697788|100485435|FG003|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
48066778|NCT00697788|100485436|FG004|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
48066779|NCT00697788|100485437|FG005|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
48066780|NCT00697788|100485438|FG006|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
48066781|NCT00697788|100485439|FG007|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
48066782|NCT00697788|100485432|FG000|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
48066783|NCT00697788|100485433|FG001|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||2||
48066784|NCT00697788|100485434|FG002|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
48066785|NCT00697788|100485435|FG003|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
48066786|NCT00697788|100485436|FG004|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
48066787|NCT00697788|100485437|FG005|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
48066788|NCT00697788|100485438|FG006|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
48066789|NCT00697788|100485439|FG007|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
48066790|NCT00697788|100485432|FG000|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
48066791|NCT00697788|100485433|FG001|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
48066792|NCT00697788|100485434|FG002|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||3||
48066793|NCT00697788|100485435|FG003|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
48066794|NCT00697788|100485436|FG004|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
48066795|NCT00697788|100485437|FG005|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
48066796|NCT00697788|100485438|FG006|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
48066797|NCT00697788|100485439|FG007|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
48066798|NCT00697788|100485432|FG000|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
48066799|NCT00697788|100485433|FG001|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
48066800|NCT00697788|100485434|FG002|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||3||
48066801|NCT00697788|100485435|FG003|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
48066802|NCT00697788|100485436|FG004|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
48066803|NCT00697788|100485437|FG005|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
48066804|NCT00697788|100485438|FG006|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
48066805|NCT00697788|100485439|FG007|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
48066806|NCT00697788|100485432|FG000|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
48066807|NCT00697788|100485433|FG001|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
48511864|NCT04284553|101583452|FG010|STARTED|Stage 1: October 2020-August 2021||8|"The numbers reflect the number of primary care providers assigned to each arm in Stage 1 of trial (n=201). Primary care providers were identified from electronic health record data and cluster randomized but were not evaluated for effectiveness outcomes. The number of patients cared for by these providers and evaluated for outcomes are shown in the next row (Number of Patients Analyzed)."|
48511865|NCT04284553|101583453|FG011|STARTED|Stage 1: October 2020-August 2021||8|"The numbers reflect the number of primary care providers assigned to each arm in Stage 1 of trial (n=201). Primary care providers were identified from electronic health record data and cluster randomized but were not evaluated for effectiveness outcomes. The number of patients cared for by these providers and evaluated for outcomes are shown in the next row (Number of Patients Analyzed)."|
48511866|NCT04284553|101583454|FG012|STARTED|Stage 1: October 2020-August 2021||8|"The numbers reflect the number of primary care providers assigned to each arm in Stage 1 of trial (n=201). Primary care providers were identified from electronic health record data and cluster randomized but were not evaluated for effectiveness outcomes. The number of patients cared for by these providers and evaluated for outcomes are shown in the next row (Number of Patients Analyzed)."|
48511867|NCT04284553|101583455|FG013|STARTED|Stage 1: October 2020-August 2021||8|"The numbers reflect the number of primary care providers assigned to each arm in Stage 1 of trial (n=201). Primary care providers were identified from electronic health record data and cluster randomized but were not evaluated for effectiveness outcomes. The number of patients cared for by these providers and evaluated for outcomes are shown in the next row (Number of Patients Analyzed)."|
48511868|NCT04284553|101583456|FG014|STARTED|Stage 1: October 2020-August 2021||8|"The numbers reflect the number of primary care providers assigned to each arm in Stage 1 of trial (n=201). Primary care providers were identified from electronic health record data and cluster randomized but were not evaluated for effectiveness outcomes. The number of patients cared for by these providers and evaluated for outcomes are shown in the next row (Number of Patients Analyzed)."|
48511869|NCT04284553|101583457|FG015|STARTED|Stage 1: October 2020-August 2021||81|"The numbers reflect the number of primary care providers assigned to each arm in Stage 1 of trial (n=201). Primary care providers were identified from electronic health record data and cluster randomized but were not evaluated for effectiveness outcomes. The number of patients cared for by these providers and evaluated for outcomes are shown in the next row (Number of Patients Analyzed)."|
48511870|NCT04284553|101583442|FG000|Number of Patients Analyzed|Stage 1: October 2020-August 2021||91|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 1. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled.|
48511871|NCT04284553|101583443|FG001|Number of Patients Analyzed|Stage 1: October 2020-August 2021||91|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 1. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled.|
48511872|NCT04284553|101583444|FG002|Number of Patients Analyzed|Stage 1: October 2020-August 2021||87|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 1. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled.|
48511873|NCT04284553|101583445|FG003|Number of Patients Analyzed|Stage 1: October 2020-August 2021||140|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 1. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled.|
48511874|NCT04284553|101583446|FG004|Number of Patients Analyzed|Stage 1: October 2020-August 2021||174|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 1. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled.|
48511875|NCT04284553|101583447|FG005|Number of Patients Analyzed|Stage 1: October 2020-August 2021||102|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 1. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled.|
48511876|NCT04284553|101583448|FG006|Number of Patients Analyzed|Stage 1: October 2020-August 2021||130|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 1. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled.|
48511877|NCT04284553|101583449|FG007|Number of Patients Analyzed|Stage 1: October 2020-August 2021||104|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 1. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled.|
48511878|NCT04284553|101583450|FG008|Number of Patients Analyzed|Stage 1: October 2020-August 2021||153|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 1. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled.|
48511879|NCT04284553|101583451|FG009|Number of Patients Analyzed|Stage 1: October 2020-August 2021||113|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 1. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled.|
48511880|NCT04284553|101583452|FG010|Number of Patients Analyzed|Stage 1: October 2020-August 2021||118|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 1. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled.|
48511881|NCT04284553|101583453|FG011|Number of Patients Analyzed|Stage 1: October 2020-August 2021||147|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 1. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled.|
48511882|NCT04284553|101583454|FG012|Number of Patients Analyzed|Stage 1: October 2020-August 2021||87|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 1. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled.|
48511883|NCT04284553|101583455|FG013|Number of Patients Analyzed|Stage 1: October 2020-August 2021||90|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 1. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled.|
48511884|NCT04284553|101583456|FG014|Number of Patients Analyzed|Stage 1: October 2020-August 2021||109|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 1. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled.|
48511885|NCT04284553|101583457|FG015|Number of Patients Analyzed|Stage 1: October 2020-August 2021||1173|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 1. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled.|
48511886|NCT04284553|101583442|FG000|COMPLETED|Stage 1: October 2020-August 2021||8||
48511887|NCT04284553|101583443|FG001|COMPLETED|Stage 1: October 2020-August 2021||8||
48511888|NCT04284553|101583444|FG002|COMPLETED|Stage 1: October 2020-August 2021||8||
48511889|NCT04284553|101583445|FG003|COMPLETED|Stage 1: October 2020-August 2021||8||
48511890|NCT04284553|101583446|FG004|COMPLETED|Stage 1: October 2020-August 2021||8||
48511891|NCT04284553|101583447|FG005|COMPLETED|Stage 1: October 2020-August 2021||8||
48511892|NCT04284553|101583448|FG006|COMPLETED|Stage 1: October 2020-August 2021||8||
48511893|NCT04284553|101583449|FG007|COMPLETED|Stage 1: October 2020-August 2021||8||
48511894|NCT04284553|101583450|FG008|COMPLETED|Stage 1: October 2020-August 2021||8||
48511895|NCT04284553|101583451|FG009|COMPLETED|Stage 1: October 2020-August 2021||8||
48511896|NCT04284553|101583452|FG010|COMPLETED|Stage 1: October 2020-August 2021||8||
48511897|NCT04284553|101583453|FG011|COMPLETED|Stage 1: October 2020-August 2021||8||
48511898|NCT04284553|101583454|FG012|COMPLETED|Stage 1: October 2020-August 2021||8||
48511899|NCT04284553|101583455|FG013|COMPLETED|Stage 1: October 2020-August 2021||8||
48511900|NCT04284553|101583456|FG014|COMPLETED|Stage 1: October 2020-August 2021||8||
48511901|NCT04284553|101583457|FG015|COMPLETED|Stage 1: October 2020-August 2021||81||
48511902|NCT04284553|101583442|FG000|NOT COMPLETED|Stage 1: October 2020-August 2021||0||
48511903|NCT04284553|101583443|FG001|NOT COMPLETED|Stage 1: October 2020-August 2021||0||
48511904|NCT04284553|101583444|FG002|NOT COMPLETED|Stage 1: October 2020-August 2021||0||
48511905|NCT04284553|101583445|FG003|NOT COMPLETED|Stage 1: October 2020-August 2021||0||
48511906|NCT04284553|101583446|FG004|NOT COMPLETED|Stage 1: October 2020-August 2021||0||
48511907|NCT04284553|101583447|FG005|NOT COMPLETED|Stage 1: October 2020-August 2021||0||
48511908|NCT04284553|101583448|FG006|NOT COMPLETED|Stage 1: October 2020-August 2021||0||
48511909|NCT04284553|101583449|FG007|NOT COMPLETED|Stage 1: October 2020-August 2021||0||
48511910|NCT04284553|101583450|FG008|NOT COMPLETED|Stage 1: October 2020-August 2021||0||
48511911|NCT04284553|101583451|FG009|NOT COMPLETED|Stage 1: October 2020-August 2021||0||
48511912|NCT04284553|101583452|FG010|NOT COMPLETED|Stage 1: October 2020-August 2021||0||
48511913|NCT04284553|101583453|FG011|NOT COMPLETED|Stage 1: October 2020-August 2021||0||
48511914|NCT04284553|101583454|FG012|NOT COMPLETED|Stage 1: October 2020-August 2021||0||
48511915|NCT04284553|101583455|FG013|NOT COMPLETED|Stage 1: October 2020-August 2021||0||
48511916|NCT04284553|101583456|FG014|NOT COMPLETED|Stage 1: October 2020-August 2021||0||
48511917|NCT04284553|101583457|FG015|NOT COMPLETED|Stage 1: October 2020-August 2021||0||
48511918|NCT04284553|101583442|FG000|STARTED|Stage 2: September 2021-August 2022||0|The numbers reflect the number of primary care providers assigned to each arm in Stage 2 of trial. As in Stage 1, providers were not evaluated for effectiveness outcomes. The number of patients cared for by them and evaluated for outcomes are shown in the next row. The number of providers in each arm for Stage 2 differs from Stage 1 because not all arms were selected for Stage 2, and not all of the providers from Stage 1 were eligible after interim analysis. 15 new providers were also added.|
48511919|NCT04284553|101583443|FG001|STARTED|Stage 2: September 2021-August 2022||27|The numbers reflect the number of primary care providers assigned to each arm in Stage 2 of trial. As in Stage 1, providers were not evaluated for effectiveness outcomes. The number of patients cared for by them and evaluated for outcomes are shown in the next row. The number of providers in each arm for Stage 2 differs from Stage 1 because not all arms were selected for Stage 2, and not all of the providers from Stage 1 were eligible after interim analysis. 15 new providers were also added.|
48666777|NCT03391882|101970470|FG005|NOT COMPLETED|Post Part A / Pre Part B||0||
48666778|NCT03391882|101970465|FG000|STARTED|Part B - Treatment Phase||0||
48511920|NCT04284553|101583444|FG002|STARTED|Stage 2: September 2021-August 2022||0|The numbers reflect the number of primary care providers assigned to each arm in Stage 2 of trial. As in Stage 1, providers were not evaluated for effectiveness outcomes. The number of patients cared for by them and evaluated for outcomes are shown in the next row. The number of providers in each arm for Stage 2 differs from Stage 1 because not all arms were selected for Stage 2, and not all of the providers from Stage 1 were eligible after interim analysis. 15 new providers were also added.|
48511921|NCT04284553|101583445|FG003|STARTED|Stage 2: September 2021-August 2022||27|The numbers reflect the number of primary care providers assigned to each arm in Stage 2 of trial. As in Stage 1, providers were not evaluated for effectiveness outcomes. The number of patients cared for by them and evaluated for outcomes are shown in the next row. The number of providers in each arm for Stage 2 differs from Stage 1 because not all arms were selected for Stage 2, and not all of the providers from Stage 1 were eligible after interim analysis. 15 new providers were also added.|
48511922|NCT04284553|101583446|FG004|STARTED|Stage 2: September 2021-August 2022||0|The numbers reflect the number of primary care providers assigned to each arm in Stage 2 of trial. As in Stage 1, providers were not evaluated for effectiveness outcomes. The number of patients cared for by them and evaluated for outcomes are shown in the next row. The number of providers in each arm for Stage 2 differs from Stage 1 because not all arms were selected for Stage 2, and not all of the providers from Stage 1 were eligible after interim analysis. 15 new providers were also added.|
48511923|NCT04284553|101583447|FG005|STARTED|Stage 2: September 2021-August 2022||0|The numbers reflect the number of primary care providers assigned to each arm in Stage 2 of trial. As in Stage 1, providers were not evaluated for effectiveness outcomes. The number of patients cared for by them and evaluated for outcomes are shown in the next row. The number of providers in each arm for Stage 2 differs from Stage 1 because not all arms were selected for Stage 2, and not all of the providers from Stage 1 were eligible after interim analysis. 15 new providers were also added.|
48511924|NCT04284553|101583448|FG006|STARTED|Stage 2: September 2021-August 2022||0|The numbers reflect the number of primary care providers assigned to each arm in Stage 2 of trial. As in Stage 1, providers were not evaluated for effectiveness outcomes. The number of patients cared for by them and evaluated for outcomes are shown in the next row. The number of providers in each arm for Stage 2 differs from Stage 1 because not all arms were selected for Stage 2, and not all of the providers from Stage 1 were eligible after interim analysis. 15 new providers were also added.|
48511925|NCT04284553|101583449|FG007|STARTED|Stage 2: September 2021-August 2022||28|The numbers reflect the number of primary care providers assigned to each arm in Stage 2 of trial. As in Stage 1, providers were not evaluated for effectiveness outcomes. The number of patients cared for by them and evaluated for outcomes are shown in the next row. The number of providers in each arm for Stage 2 differs from Stage 1 because not all arms were selected for Stage 2, and not all of the providers from Stage 1 were eligible after interim analysis. 15 new providers were also added.|
48511926|NCT04284553|101583450|FG008|STARTED|Stage 2: September 2021-August 2022||0|The numbers reflect the number of primary care providers assigned to each arm in Stage 2 of trial. As in Stage 1, providers were not evaluated for effectiveness outcomes. The number of patients cared for by them and evaluated for outcomes are shown in the next row. The number of providers in each arm for Stage 2 differs from Stage 1 because not all arms were selected for Stage 2, and not all of the providers from Stage 1 were eligible after interim analysis. 15 new providers were also added.|
48511927|NCT04284553|101583451|FG009|STARTED|Stage 2: September 2021-August 2022||28|The numbers reflect the number of primary care providers assigned to each arm in Stage 2 of trial. As in Stage 1, providers were not evaluated for effectiveness outcomes. The number of patients cared for by them and evaluated for outcomes are shown in the next row. The number of providers in each arm for Stage 2 differs from Stage 1 because not all arms were selected for Stage 2, and not all of the providers from Stage 1 were eligible after interim analysis. 15 new providers were also added.|
48511928|NCT04284553|101583452|FG010|STARTED|Stage 2: September 2021-August 2022||0|The numbers reflect the number of primary care providers assigned to each arm in Stage 2 of trial. As in Stage 1, providers were not evaluated for effectiveness outcomes. The number of patients cared for by them and evaluated for outcomes are shown in the next row. The number of providers in each arm for Stage 2 differs from Stage 1 because not all arms were selected for Stage 2, and not all of the providers from Stage 1 were eligible after interim analysis. 15 new providers were also added.|
48511929|NCT04284553|101583453|FG011|STARTED|Stage 2: September 2021-August 2022||27|The numbers reflect the number of primary care providers assigned to each arm in Stage 2 of trial. As in Stage 1, providers were not evaluated for effectiveness outcomes. The number of patients cared for by them and evaluated for outcomes are shown in the next row. The number of providers in each arm for Stage 2 differs from Stage 1 because not all arms were selected for Stage 2, and not all of the providers from Stage 1 were eligible after interim analysis. 15 new providers were also added.|
48511930|NCT04284553|101583454|FG012|STARTED|Stage 2: September 2021-August 2022||0|The numbers reflect the number of primary care providers assigned to each arm in Stage 2 of trial. As in Stage 1, providers were not evaluated for effectiveness outcomes. The number of patients cared for by them and evaluated for outcomes are shown in the next row. The number of providers in each arm for Stage 2 differs from Stage 1 because not all arms were selected for Stage 2, and not all of the providers from Stage 1 were eligible after interim analysis. 15 new providers were also added.|
48511931|NCT04284553|101583455|FG013|STARTED|Stage 2: September 2021-August 2022||0|The numbers reflect the number of primary care providers assigned to each arm in Stage 2 of trial. As in Stage 1, providers were not evaluated for effectiveness outcomes. The number of patients cared for by them and evaluated for outcomes are shown in the next row. The number of providers in each arm for Stage 2 differs from Stage 1 because not all arms were selected for Stage 2, and not all of the providers from Stage 1 were eligible after interim analysis. 15 new providers were also added.|
48511932|NCT04284553|101583456|FG014|STARTED|Stage 2: September 2021-August 2022||0|The numbers reflect the number of primary care providers assigned to each arm in Stage 2 of trial. As in Stage 1, providers were not evaluated for effectiveness outcomes. The number of patients cared for by them and evaluated for outcomes are shown in the next row. The number of providers in each arm for Stage 2 differs from Stage 1 because not all arms were selected for Stage 2, and not all of the providers from Stage 1 were eligible after interim analysis. 15 new providers were also added.|
48666779|NCT03391882|101970466|FG001|STARTED|Part B - Treatment Phase||0||
48666780|NCT03391882|101970467|FG002|STARTED|Part B - Treatment Phase||19||
48511933|NCT04284553|101583457|FG015|STARTED|Stage 2: September 2021-August 2022||60|The numbers reflect the number of primary care providers assigned to each arm in Stage 2 of trial. As in Stage 1, providers were not evaluated for effectiveness outcomes. The number of patients cared for by them and evaluated for outcomes are shown in the next row. The number of providers in each arm for Stage 2 differs from Stage 1 because not all arms were selected for Stage 2, and not all of the providers from Stage 1 were eligible after interim analysis. 15 new providers were also added.|
48511934|NCT04284553|101583442|FG000|Number of Patients Analyzed|Stage 2: September 2021-August 2022||0|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 2. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled. These numbers represent unique patients not previously identified in Stage 1.|
48511935|NCT04284553|101583443|FG001|Number of Patients Analyzed|Stage 2: September 2021-August 2022||15|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 2. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled. These numbers represent unique patients not previously identified in Stage 1.|
48511936|NCT04284553|101583444|FG002|Number of Patients Analyzed|Stage 2: September 2021-August 2022||0|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 2. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled. These numbers represent unique patients not previously identified in Stage 1.|
48511937|NCT04284553|101583445|FG003|Number of Patients Analyzed|Stage 2: September 2021-August 2022||35|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 2. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled. These numbers represent unique patients not previously identified in Stage 1.|
48511938|NCT04284553|101583446|FG004|Number of Patients Analyzed|Stage 2: September 2021-August 2022||0|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 2. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled. These numbers represent unique patients not previously identified in Stage 1.|
48511939|NCT04284553|101583447|FG005|Number of Patients Analyzed|Stage 2: September 2021-August 2022||0|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 2. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled. These numbers represent unique patients not previously identified in Stage 1.|
48511940|NCT04284553|101583448|FG006|Number of Patients Analyzed|Stage 2: September 2021-August 2022||0|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 2. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled. These numbers represent unique patients not previously identified in Stage 1.|
48511941|NCT04284553|101583449|FG007|Number of Patients Analyzed|Stage 2: September 2021-August 2022||33|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 2. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled. These numbers represent unique patients not previously identified in Stage 1.|
48511942|NCT04284553|101583450|FG008|Number of Patients Analyzed|Stage 2: September 2021-August 2022||0|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 2. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled. These numbers represent unique patients not previously identified in Stage 1.|
48511943|NCT04284553|101583451|FG009|Number of Patients Analyzed|Stage 2: September 2021-August 2022||23|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 2. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled. These numbers represent unique patients not previously identified in Stage 1.|
48511944|NCT04284553|101583452|FG010|Number of Patients Analyzed|Stage 2: September 2021-August 2022||0|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 2. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled. These numbers represent unique patients not previously identified in Stage 1.|
48511945|NCT04284553|101583453|FG011|Number of Patients Analyzed|Stage 2: September 2021-August 2022||17|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 2. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled. These numbers represent unique patients not previously identified in Stage 1.|
48666781|NCT03391882|101970468|FG003|STARTED|Part B - Treatment Phase||18||
48666782|NCT03391882|101970469|FG004|STARTED|Part B - Treatment Phase||18||
48666783|NCT03391882|101970470|FG005|STARTED|Part B - Treatment Phase||19||
48511946|NCT04284553|101583454|FG012|Number of Patients Analyzed|Stage 2: September 2021-August 2022||0|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 2. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled. These numbers represent unique patients not previously identified in Stage 1.|
48511947|NCT04284553|101583455|FG013|Number of Patients Analyzed|Stage 2: September 2021-August 2022||0|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 2. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled. These numbers represent unique patients not previously identified in Stage 1.|
48511948|NCT04284553|101583456|FG014|Number of Patients Analyzed|Stage 2: September 2021-August 2022||0|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 2. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled. These numbers represent unique patients not previously identified in Stage 1.|
48511949|NCT04284553|101583457|FG015|Number of Patients Analyzed|Stage 2: September 2021-August 2022||31|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 2. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled. These numbers represent unique patients not previously identified in Stage 1.|
48511950|NCT04284553|101583442|FG000|COMPLETED|Stage 2: September 2021-August 2022||0||
48511951|NCT04284553|101583443|FG001|COMPLETED|Stage 2: September 2021-August 2022||27||
48511952|NCT04284553|101583444|FG002|COMPLETED|Stage 2: September 2021-August 2022||0||
48511953|NCT04284553|101583445|FG003|COMPLETED|Stage 2: September 2021-August 2022||27||
48511954|NCT04284553|101583446|FG004|COMPLETED|Stage 2: September 2021-August 2022||0||
48511955|NCT04284553|101583447|FG005|COMPLETED|Stage 2: September 2021-August 2022||0||
48511956|NCT04284553|101583448|FG006|COMPLETED|Stage 2: September 2021-August 2022||0||
48511957|NCT04284553|101583449|FG007|COMPLETED|Stage 2: September 2021-August 2022||28||
48511958|NCT04284553|101583450|FG008|COMPLETED|Stage 2: September 2021-August 2022||0||
48511959|NCT04284553|101583451|FG009|COMPLETED|Stage 2: September 2021-August 2022||28||
48511960|NCT04284553|101583452|FG010|COMPLETED|Stage 2: September 2021-August 2022||0||
48511961|NCT04284553|101583453|FG011|COMPLETED|Stage 2: September 2021-August 2022||27||
48511962|NCT04284553|101583454|FG012|COMPLETED|Stage 2: September 2021-August 2022||0||
48511963|NCT04284553|101583455|FG013|COMPLETED|Stage 2: September 2021-August 2022||0||
48511964|NCT04284553|101583456|FG014|COMPLETED|Stage 2: September 2021-August 2022||0||
48511965|NCT04284553|101583457|FG015|COMPLETED|Stage 2: September 2021-August 2022||60||
48511966|NCT04284553|101583442|FG000|NOT COMPLETED|Stage 2: September 2021-August 2022||0||
48511967|NCT04284553|101583443|FG001|NOT COMPLETED|Stage 2: September 2021-August 2022||0||
48511968|NCT04284553|101583444|FG002|NOT COMPLETED|Stage 2: September 2021-August 2022||0||
48511969|NCT04284553|101583445|FG003|NOT COMPLETED|Stage 2: September 2021-August 2022||0||
48511970|NCT04284553|101583446|FG004|NOT COMPLETED|Stage 2: September 2021-August 2022||0||
48511971|NCT04284553|101583447|FG005|NOT COMPLETED|Stage 2: September 2021-August 2022||0||
48511972|NCT04284553|101583448|FG006|NOT COMPLETED|Stage 2: September 2021-August 2022||0||
48511973|NCT04284553|101583449|FG007|NOT COMPLETED|Stage 2: September 2021-August 2022||0||
48511974|NCT04284553|101583450|FG008|NOT COMPLETED|Stage 2: September 2021-August 2022||0||
48511975|NCT04284553|101583451|FG009|NOT COMPLETED|Stage 2: September 2021-August 2022||0||
48511976|NCT04284553|101583452|FG010|NOT COMPLETED|Stage 2: September 2021-August 2022||0||
48511977|NCT04284553|101583453|FG011|NOT COMPLETED|Stage 2: September 2021-August 2022||0||
48511978|NCT04284553|101583454|FG012|NOT COMPLETED|Stage 2: September 2021-August 2022||0||
48511979|NCT04284553|101583455|FG013|NOT COMPLETED|Stage 2: September 2021-August 2022||0||
48511980|NCT04284553|101583456|FG014|NOT COMPLETED|Stage 2: September 2021-August 2022||0||
48511981|NCT04284553|101583457|FG015|NOT COMPLETED|Stage 2: September 2021-August 2022||0||
48511982|NCT00109850|101583458|FG000|STARTED|Overall Study||22||
48511983|NCT00109850|101583458|FG000|Eligible|Overall Study||21||
48511984|NCT00109850|101583458|FG000|Eligible and Began Protocol Therapy|Overall Study||21||
48511985|NCT00109850|101583458|FG000|COMPLETED|Overall Study||18||
48511986|NCT00109850|101583458|FG000|NOT COMPLETED|Overall Study||4||
48511987|NCT00587431|101583459|FG000|STARTED|Overall Study||63||
48511988|NCT00587431|101583460|FG001|STARTED|Overall Study||39||
48511989|NCT00587431|101583459|FG000|COMPLETED|Overall Study||62||
48511990|NCT00587431|101583460|FG001|COMPLETED|Overall Study||38||
48511991|NCT00587431|101583459|FG000|NOT COMPLETED|Overall Study||1||
48511992|NCT00587431|101583460|FG001|NOT COMPLETED|Overall Study||1||
48511993|NCT00732160|101583461|FG000|STARTED|Overall Study||7||
48511994|NCT00732160|101583462|FG001|STARTED|Overall Study||5||
48511995|NCT00732160|101583463|FG002|STARTED|Overall Study||6||
48511996|NCT00732160|101583464|FG003|STARTED|Overall Study||5||
48511997|NCT00732160|101583461|FG000|HS Vehicle|Overall Study||7||
48511998|NCT00732160|101583462|FG001|HS Vehicle|Overall Study||5||
48511999|NCT00732160|101583463|FG002|HS Vehicle|Overall Study||3||
48512000|NCT00732160|101583464|FG003|HS Vehicle|Overall Study||3||
48512001|NCT00732160|101583461|FG000|HS Aldosterone|Overall Study||7||
48666784|NCT03391882|101970465|FG000|Safety Population Part B|Part B - Treatment Phase||0||
48666785|NCT03391882|101970466|FG001|Safety Population Part B|Part B - Treatment Phase||0||
48512002|NCT00732160|101583462|FG001|HS Aldosterone|Overall Study||5||
48512003|NCT00732160|101583463|FG002|HS Aldosterone|Overall Study||3||
48512004|NCT00732160|101583464|FG003|HS Aldosterone|Overall Study||3||
48512005|NCT00732160|101583461|FG000|LS Vehicle|Overall Study||2||
48512006|NCT00732160|101583462|FG001|LS Vehicle|Overall Study||1||
48512007|NCT00732160|101583463|FG002|LS Vehicle|Overall Study||6||
48512008|NCT00732160|101583464|FG003|LS Vehicle|Overall Study||5||
48512009|NCT00732160|101583461|FG000|LS Aldosterone|Overall Study||2||
48512010|NCT00732160|101583462|FG001|LS Aldosterone|Overall Study||1||
48512011|NCT00732160|101583463|FG002|LS Aldosterone|Overall Study||6||
48512012|NCT00732160|101583464|FG003|LS Aldosterone|Overall Study||5||
48512013|NCT00732160|101583461|FG000|COMPLETED|Overall Study||2||
48512014|NCT00732160|101583462|FG001|COMPLETED|Overall Study||1||
48512015|NCT00732160|101583463|FG002|COMPLETED|Overall Study||3||
48512016|NCT00732160|101583464|FG003|COMPLETED|Overall Study||3||
48512017|NCT00732160|101583461|FG000|NOT COMPLETED|Overall Study||5||
48512018|NCT00732160|101583462|FG001|NOT COMPLETED|Overall Study||4||
48512019|NCT00732160|101583463|FG002|NOT COMPLETED|Overall Study||3||
48512020|NCT00732160|101583464|FG003|NOT COMPLETED|Overall Study||2||
48512021|NCT05157048|101583465|FG000|STARTED|Overall Study||21||
48512022|NCT05157048|101583466|FG001|STARTED|Overall Study||19||
48512023|NCT05157048|101583465|FG000|COMPLETED|Overall Study||21||
48512024|NCT05157048|101583466|FG001|COMPLETED|Overall Study||19||
48512025|NCT05157048|101583465|FG000|NOT COMPLETED|Overall Study||0||
48512026|NCT05157048|101583466|FG001|NOT COMPLETED|Overall Study||0||
48512027|NCT02447887|101583467|FG000|STARTED|Overall Study||3||
48512028|NCT02447887|101583467|FG000|COMPLETED|Overall Study||0||
48512029|NCT02447887|101583467|FG000|NOT COMPLETED|Overall Study||3||
48512030|NCT02951195|101583468|FG000|STARTED|Overall Study||8||
48512031|NCT02951195|101583469|FG001|STARTED|Overall Study||6||
48512032|NCT02951195|101583470|FG002|STARTED|Overall Study||10||
48512033|NCT02951195|101583471|FG003|STARTED|Overall Study||10||
48512034|NCT02951195|101583472|FG004|STARTED|Overall Study||4||
48512035|NCT02951195|101583473|FG005|STARTED|Overall Study||10||
48512036|NCT02951195|101583474|FG006|STARTED|Overall Study||7||
48512037|NCT02951195|101583475|FG007|STARTED|Overall Study||21||
48512038|NCT02951195|101583468|FG000|COMPLETED|Overall Study||8||
48512039|NCT02951195|101583469|FG001|COMPLETED|Overall Study||6||
48512040|NCT02951195|101583470|FG002|COMPLETED|Overall Study||10||
48512041|NCT02951195|101583471|FG003|COMPLETED|Overall Study||10||
48512042|NCT02951195|101583472|FG004|COMPLETED|Overall Study||4||
48512043|NCT02951195|101583473|FG005|COMPLETED|Overall Study||10||
48512044|NCT02951195|101583474|FG006|COMPLETED|Overall Study||7||
48512045|NCT02951195|101583475|FG007|COMPLETED|Overall Study||21||
48512046|NCT02951195|101583468|FG000|NOT COMPLETED|Overall Study||0||
48512047|NCT02951195|101583469|FG001|NOT COMPLETED|Overall Study||0||
48512048|NCT02951195|101583470|FG002|NOT COMPLETED|Overall Study||0||
48512049|NCT02951195|101583471|FG003|NOT COMPLETED|Overall Study||0||
48512050|NCT02951195|101583472|FG004|NOT COMPLETED|Overall Study||0||
48512051|NCT02951195|101583473|FG005|NOT COMPLETED|Overall Study||0||
48512052|NCT02951195|101583474|FG006|NOT COMPLETED|Overall Study||0||
48512053|NCT02951195|101583475|FG007|NOT COMPLETED|Overall Study||0||
48512054|NCT00179673|101583476|FG000|STARTED|Overall Study||43||
48512055|NCT00179673|101583476|FG000|Received Study Drug|Overall Study||43||
48512056|NCT00179673|101583476|FG000|COMPLETED|Overall Study||0||
48512057|NCT00179673|101583476|FG000|NOT COMPLETED|Overall Study||43||
48512058|NCT02805309|101583477|FG000|STARTED|Overall Study||18||
48512059|NCT02805309|101583478|FG001|STARTED|Overall Study||17||
48512060|NCT02805309|101583479|FG002|STARTED|Overall Study||19||
48512061|NCT02805309|101583477|FG000|COMPLETED|Overall Study||16||
48512062|NCT02805309|101583478|FG001|COMPLETED|Overall Study||13||
48512063|NCT02805309|101583479|FG002|COMPLETED|Overall Study||16||
48512064|NCT02805309|101583477|FG000|NOT COMPLETED|Overall Study||2||
48512065|NCT02805309|101583478|FG001|NOT COMPLETED|Overall Study||4||
48512066|NCT02805309|101583479|FG002|NOT COMPLETED|Overall Study||3||
48512067|NCT01040793|101583480|FG000|STARTED|Overall Study||26||
48512068|NCT01040793|101583481|FG001|STARTED|Overall Study||26||
48512069|NCT01040793|101583482|FG002|STARTED|Overall Study||26||
48512070|NCT01040793|101583483|FG003|STARTED|Overall Study||26||
48219915|NCT05580003|100863766|FG018|STARTED|Part 3: Period 3 (Day 1)||2||
48512071|NCT01040793|101583484|FG004|STARTED|Overall Study||26||
48512072|NCT01040793|101583485|FG005|STARTED|Overall Study||27||
48512073|NCT01040793|101583480|FG000|COMPLETED|Overall Study||20||
48512074|NCT01040793|101583481|FG001|COMPLETED|Overall Study||21||
48512075|NCT01040793|101583482|FG002|COMPLETED|Overall Study||23||
48512076|NCT01040793|101583483|FG003|COMPLETED|Overall Study||22||
48512077|NCT01040793|101583484|FG004|COMPLETED|Overall Study||22||
48512078|NCT01040793|101583485|FG005|COMPLETED|Overall Study||26||
48512079|NCT01040793|101583480|FG000|NOT COMPLETED|Overall Study||6||
48512080|NCT01040793|101583481|FG001|NOT COMPLETED|Overall Study||5||
48512081|NCT01040793|101583482|FG002|NOT COMPLETED|Overall Study||3||
48512082|NCT01040793|101583483|FG003|NOT COMPLETED|Overall Study||4||
48512083|NCT01040793|101583484|FG004|NOT COMPLETED|Overall Study||4||
48512084|NCT01040793|101583485|FG005|NOT COMPLETED|Overall Study||1||
48666786|NCT03391882|101970467|FG002|Safety Population Part B|Part B - Treatment Phase||19||
48512085|NCT04979858|101583486|FG000|STARTED|Pre-Treatment||201|"At the beginning of the study, 201 participants were enrolled. One of the participants was in quarantine at that time. Additionally, during Pre-Treatment, all participants were considered to be in the Control Group. After Pre-Treatment, the participants were randomly assigned to either remain in the Control Group or be assigned to the Treatment Group."|
48512086|NCT04979858|101583487|FG001|STARTED|Pre-Treatment||0|"At the beginning of the study, 201 participants were enrolled. One of the participants was in quarantine at that time. Additionally, during Pre-Treatment, all participants were considered to be in the Control Group. After Pre-Treatment, the participants were randomly assigned to either remain in the Control Group or be assigned to the Treatment Group."|
48512087|NCT04979858|101583486|FG000|COMPLETED|Pre-Treatment||200|The participant who had been quarantining developed contracted COVID-19 and withdrew from the Study in accordance with the Study Protocol. Hence the number at the end of the Pre-Treatment phase was 200.|
48512088|NCT04979858|101583487|FG001|COMPLETED|Pre-Treatment||0|The participant who had been quarantining developed contracted COVID-19 and withdrew from the Study in accordance with the Study Protocol. Hence the number at the end of the Pre-Treatment phase was 200.|
48512089|NCT04979858|101583486|FG000|NOT COMPLETED|Pre-Treatment||1||
48512090|NCT04979858|101583487|FG001|NOT COMPLETED|Pre-Treatment||0||
48512091|NCT04979858|101583486|FG000|STARTED|Treatment||100|The participant who contracted COVID-19 in the Pre-Treatment phase withdrew from the study in accordance with the Study Protocol.|
48512092|NCT04979858|101583487|FG001|STARTED|Treatment||100|The participant who contracted COVID-19 in the Pre-Treatment phase withdrew from the study in accordance with the Study Protocol.|
48512093|NCT04979858|101583486|FG000|COMPLETED|Treatment||100||
48512094|NCT04979858|101583487|FG001|COMPLETED|Treatment||100||
48512095|NCT04979858|101583486|FG000|NOT COMPLETED|Treatment||0||
48512096|NCT04979858|101583487|FG001|NOT COMPLETED|Treatment||0||
48512097|NCT04979858|101583486|FG000|STARTED|Post-Treatment||100||
48512098|NCT04979858|101583487|FG001|STARTED|Post-Treatment||100||
48512099|NCT04979858|101583486|FG000|COMPLETED|Post-Treatment||100||
48512100|NCT04979858|101583487|FG001|COMPLETED|Post-Treatment||100||
48512101|NCT04979858|101583486|FG000|NOT COMPLETED|Post-Treatment||0||
48512102|NCT04979858|101583487|FG001|NOT COMPLETED|Post-Treatment||0||
48512103|NCT02310763|101583488|FG000|STARTED|Period 1 (Weeks 1 to 48)||41||
48512104|NCT02310763|101583489|FG001|STARTED|Period 1 (Weeks 1 to 48)||39||
48512105|NCT02310763|101583490|FG002|STARTED|Period 1 (Weeks 1 to 48)||40||
48512106|NCT02310763|101583488|FG000|COMPLETED|Period 1 (Weeks 1 to 48)||38||
48512107|NCT02310763|101583489|FG001|COMPLETED|Period 1 (Weeks 1 to 48)||37||
48512108|NCT02310763|101583490|FG002|COMPLETED|Period 1 (Weeks 1 to 48)||38||
48512109|NCT02310763|101583488|FG000|NOT COMPLETED|Period 1 (Weeks 1 to 48)||3||
48512110|NCT02310763|101583489|FG001|NOT COMPLETED|Period 1 (Weeks 1 to 48)||2||
48512111|NCT02310763|101583490|FG002|NOT COMPLETED|Period 1 (Weeks 1 to 48)||2||
48512112|NCT02310763|101583488|FG000|STARTED|Period 2 (Weeks 49 to 96)||38||
48512113|NCT02310763|101583489|FG001|STARTED|Period 2 (Weeks 49 to 96)||37||
48512114|NCT02310763|101583490|FG002|STARTED|Period 2 (Weeks 49 to 96)||38||
48512115|NCT02310763|101583488|FG000|COMPLETED|Period 2 (Weeks 49 to 96)||22||
48512116|NCT02310763|101583489|FG001|COMPLETED|Period 2 (Weeks 49 to 96)||21||
48512117|NCT02310763|101583490|FG002|COMPLETED|Period 2 (Weeks 49 to 96)||22||
48512118|NCT02310763|101583488|FG000|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16||
48512119|NCT02310763|101583489|FG001|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16||
48512120|NCT02310763|101583490|FG002|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16||
48512121|NCT01142661|101583491|FG000|STARTED|Overall Study||9||
48512122|NCT01142661|101583491|FG000|COMPLETED|Overall Study||5||
48512123|NCT01142661|101583491|FG000|NOT COMPLETED|Overall Study||4||
48512124|NCT00503113|101583492|FG000|STARTED|Overall Study||268||
48512125|NCT00503113|101583493|FG001|STARTED|Overall Study||264||
48512126|NCT00503113|101583494|FG002|STARTED|Overall Study||269||
48512127|NCT00503113|101583492|FG000|Intent to Treat Population (ITT)|Overall Study||262||
48512128|NCT00503113|101583493|FG001|Intent to Treat Population (ITT)|Overall Study||261||
48512129|NCT00503113|101583494|FG002|Intent to Treat Population (ITT)|Overall Study||268||
48512130|NCT00503113|101583492|FG000|Per Protocol Population (PP)|Overall Study||246||
48512131|NCT00503113|101583493|FG001|Per Protocol Population (PP)|Overall Study||243||
48512132|NCT00503113|101583494|FG002|Per Protocol Population (PP)|Overall Study||241||
48512133|NCT00503113|101583492|FG000|Safety Population|Overall Study||263||
48512134|NCT00503113|101583493|FG001|Safety Population|Overall Study||263||
48512135|NCT00503113|101583494|FG002|Safety Population|Overall Study||267||
48512136|NCT00503113|101583492|FG000|COMPLETED|Overall Study||235||
48512137|NCT00503113|101583493|FG001|COMPLETED|Overall Study||236||
48512138|NCT00503113|101583494|FG002|COMPLETED|Overall Study||241||
48512139|NCT00503113|101583492|FG000|NOT COMPLETED|Overall Study||33||
48512140|NCT00503113|101583493|FG001|NOT COMPLETED|Overall Study||28||
48512141|NCT00503113|101583494|FG002|NOT COMPLETED|Overall Study||28||
48512142|NCT02094261|101583495|FG000|STARTED|Overall Study||210||
48512143|NCT02094261|101583495|FG000|COMPLETED|Overall Study||0||
48512144|NCT02094261|101583495|FG000|NOT COMPLETED|Overall Study||210||
48512145|NCT04100096|101583496|FG000|STARTED|Overall Study||159|Started participants were those who were randomized.|
48512146|NCT04100096|101583497|FG001|STARTED|Overall Study||165|Started participants were those who were randomized.|
48512147|NCT04100096|101583496|FG000|Safety Population|Overall Study||157||
48512148|NCT04100096|101583497|FG001|Safety Population|Overall Study||165||
48512149|NCT04100096|101583496|FG000|Full Analysis Set (FAS) for Enriched Participants|Overall Study||112||
48512150|NCT04100096|101583497|FG001|Full Analysis Set (FAS) for Enriched Participants|Overall Study||111||
48512151|NCT04100096|101583496|FG000|COMPLETED|Overall Study||112||
48512152|NCT04100096|101583497|FG001|COMPLETED|Overall Study||127||
48512153|NCT04100096|101583496|FG000|NOT COMPLETED|Overall Study||47||
48512154|NCT04100096|101583497|FG001|NOT COMPLETED|Overall Study||38||
48512155|NCT02508259|101583498|FG000|STARTED|Overall Study||5||
48512156|NCT02508259|101583499|FG001|STARTED|Overall Study||5||
48512157|NCT02508259|101583498|FG000|COMPLETED|Overall Study||5||
48512158|NCT02508259|101583499|FG001|COMPLETED|Overall Study||5||
48512159|NCT02508259|101583498|FG000|NOT COMPLETED|Overall Study||0||
48512160|NCT02508259|101583499|FG001|NOT COMPLETED|Overall Study||0||
48512161|NCT04264819|101583500|FG000|STARTED|Overall Study||295||
48512162|NCT04264819|101583500|FG000|Full Analysis Set (FAS)|Overall Study||289||
48512163|NCT04264819|101583500|FG000|COMPLETED|Overall Study||249||
48512164|NCT04264819|101583500|FG000|NOT COMPLETED|Overall Study||46||
48512165|NCT03554317|101583501|FG000|STARTED|Overall Study||45||
48512166|NCT03554317|101583501|FG000|COMPLETED|Overall Study||37||
48512167|NCT03554317|101583501|FG000|NOT COMPLETED|Overall Study||8||
48512168|NCT00927251|101583502|FG000|STARTED|Overall Study||90||
48512169|NCT00927251|101583502|FG000|COMPLETED|Overall Study||82||
48512170|NCT00927251|101583502|FG000|NOT COMPLETED|Overall Study||8||
48512171|NCT00460109|101583503|FG000|STARTED|Overall Study||24||
48512172|NCT00460109|101583503|FG000|COMPLETED|Overall Study||23||
48512173|NCT00460109|101583503|FG000|NOT COMPLETED|Overall Study||1||
48512174|NCT04980456|101583504|FG000|STARTED|Period 1 (Approximately 30 Days)||122||244
48512175|NCT04980456|101583505|FG001|STARTED|Period 1 (Approximately 30 Days)||127||254
48512176|NCT04980456|101583504|FG000|COMPLETED|Period 1 (Approximately 30 Days)||119||238
48512177|NCT04980456|101583505|FG001|COMPLETED|Period 1 (Approximately 30 Days)||124||248
48512178|NCT04980456|101583504|FG000|NOT COMPLETED|Period 1 (Approximately 30 Days)||3||6
48512179|NCT04980456|101583505|FG001|NOT COMPLETED|Period 1 (Approximately 30 Days)||3||6
48512180|NCT04980456|101583504|FG000|STARTED|Period 2 (Approximately 30 Days)||119||238
48512181|NCT04980456|101583505|FG001|STARTED|Period 2 (Approximately 30 Days)||123||246
48512182|NCT04980456|101583504|FG000|COMPLETED|Period 2 (Approximately 30 Days)||119||238
48512183|NCT04980456|101583505|FG001|COMPLETED|Period 2 (Approximately 30 Days)||122||244
48512184|NCT04980456|101583504|FG000|NOT COMPLETED|Period 2 (Approximately 30 Days)||0||0
48512185|NCT04980456|101583505|FG001|NOT COMPLETED|Period 2 (Approximately 30 Days)||1||2
48512186|NCT00089076|101583506|FG000|STARTED|Overall Study||18||
48512187|NCT00089076|101583506|FG000|COMPLETED|Overall Study||8||
48512188|NCT00089076|101583506|FG000|NOT COMPLETED|Overall Study||10||
48512189|NCT01148524|101583507|FG000|STARTED|Overall Study||49||
48512190|NCT01148524|101583508|FG001|STARTED|Overall Study||95||
48512191|NCT01148524|101583509|FG002|STARTED|Overall Study||53||
48512192|NCT01148524|101583510|FG003|STARTED|Overall Study||102||
48512193|NCT01148524|101583511|FG004|STARTED|Overall Study||57||
48512194|NCT01148524|101583512|FG005|STARTED|Overall Study||106||
48512195|NCT01148524|101583513|FG006|STARTED|Overall Study||153||
48512196|NCT01148524|101583514|FG007|STARTED|Overall Study||51||
48512197|NCT01148524|101583515|FG008|STARTED|Overall Study||151||
48512198|NCT01148524|101583507|FG000|COMPLETED|Overall Study||49||
48512199|NCT01148524|101583508|FG001|COMPLETED|Overall Study||95||
48512200|NCT01148524|101583509|FG002|COMPLETED|Overall Study||53||
48512201|NCT01148524|101583510|FG003|COMPLETED|Overall Study||102||
48512202|NCT01148524|101583511|FG004|COMPLETED|Overall Study||57||
48512203|NCT01148524|101583512|FG005|COMPLETED|Overall Study||106||
48512204|NCT01148524|101583513|FG006|COMPLETED|Overall Study||153||
48512205|NCT01148524|101583514|FG007|COMPLETED|Overall Study||51||
48512206|NCT01148524|101583515|FG008|COMPLETED|Overall Study||151||
48512207|NCT01148524|101583507|FG000|NOT COMPLETED|Overall Study||0||
48512208|NCT01148524|101583508|FG001|NOT COMPLETED|Overall Study||0||
48512209|NCT01148524|101583509|FG002|NOT COMPLETED|Overall Study||0||
48512210|NCT01148524|101583510|FG003|NOT COMPLETED|Overall Study||0||
48512211|NCT01148524|101583511|FG004|NOT COMPLETED|Overall Study||0||
48512212|NCT01148524|101583512|FG005|NOT COMPLETED|Overall Study||0||
48512213|NCT01148524|101583513|FG006|NOT COMPLETED|Overall Study||0||
48512214|NCT01148524|101583514|FG007|NOT COMPLETED|Overall Study||0||
48512215|NCT01148524|101583515|FG008|NOT COMPLETED|Overall Study||0||
48512216|NCT00500318|101583516|FG000|STARTED|Overall Study||86||
48512217|NCT00500318|101583517|FG001|STARTED|Overall Study||95||
48512218|NCT00500318|101583516|FG000|COMPLETED|Overall Study||81||
48512219|NCT00500318|101583517|FG001|COMPLETED|Overall Study||78||
48512220|NCT00500318|101583516|FG000|NOT COMPLETED|Overall Study||5||
48512221|NCT00500318|101583517|FG001|NOT COMPLETED|Overall Study||17||
48512222|NCT01903564|101583518|FG000|STARTED|Overall Study||10||
48512223|NCT01903564|101583519|FG001|STARTED|Overall Study||29||
48512224|NCT01903564|101583518|FG000|COMPLETED|Overall Study||10||
48219916|NCT05580003|100863767|FG019|STARTED|Part 3: Period 3 (Day 1)||0||
48512225|NCT01903564|101583519|FG001|COMPLETED|Overall Study||29||
48512226|NCT01903564|101583518|FG000|NOT COMPLETED|Overall Study||0||
48512227|NCT01903564|101583519|FG001|NOT COMPLETED|Overall Study||0||
48512228|NCT02998541|101583520|FG000|STARTED|Overall Study||86||
48512229|NCT02998541|101583521|FG001|STARTED|Overall Study||90||
48512230|NCT02998541|101583522|FG002|STARTED|Overall Study||43||
48512231|NCT02998541|101583520|FG000|COMPLETED|Overall Study||78||
48512232|NCT02998541|101583521|FG001|COMPLETED|Overall Study||81||
48512233|NCT02998541|101583522|FG002|COMPLETED|Overall Study||37||
48512234|NCT02998541|101583520|FG000|NOT COMPLETED|Overall Study||8||
48512235|NCT02998541|101583521|FG001|NOT COMPLETED|Overall Study||9||
48512236|NCT02998541|101583522|FG002|NOT COMPLETED|Overall Study||6||
48512237|NCT02820740|101583523|FG000|STARTED|Overall Study||4||
48512238|NCT02820740|101583523|FG000|COMPLETED|Overall Study||2||
48512239|NCT02820740|101583523|FG000|NOT COMPLETED|Overall Study||2||
48512240|NCT00183196|101583524|FG000|STARTED|Overall Study||50||
48512241|NCT00183196|101583525|FG001|STARTED|Overall Study||50||
48512242|NCT00183196|101583526|FG002|STARTED|Overall Study||50||
48512243|NCT00183196|101583524|FG000|COMPLETED|Overall Study||30||
48512244|NCT00183196|101583525|FG001|COMPLETED|Overall Study||35||
48512245|NCT00183196|101583526|FG002|COMPLETED|Overall Study||32||
48512246|NCT00183196|101583524|FG000|NOT COMPLETED|Overall Study||20||
48512247|NCT00183196|101583525|FG001|NOT COMPLETED|Overall Study||15||
48512248|NCT00183196|101583526|FG002|NOT COMPLETED|Overall Study||18||
48512249|NCT04225260|101583527|FG000|STARTED|Overall Study||902||
48512250|NCT04225260|101583527|FG000|COMPLETED|Overall Study||790||
48512251|NCT04225260|101583527|FG000|NOT COMPLETED|Overall Study||112||
48512252|NCT01848210|101583528|FG000|STARTED|Overall Study||411||
48512253|NCT01848210|101583529|FG001|STARTED|Overall Study||418||
48512254|NCT01848210|101583528|FG000|Safety Population-Received Study Drug|Overall Study||394||
48512255|NCT01848210|101583529|FG001|Safety Population-Received Study Drug|Overall Study||398||
48512256|NCT01848210|101583528|FG000|Intent-to-Treat (ITT) Population|Overall Study||383||
48512257|NCT01848210|101583529|FG001|Intent-to-Treat (ITT) Population|Overall Study||388||
48512258|NCT01848210|101583528|FG000|Per Protocol Population|Overall Study||222||
48512259|NCT01848210|101583529|FG001|Per Protocol Population|Overall Study||245||
48512260|NCT01848210|101583528|FG000|COMPLETED|Overall Study||323||
48512261|NCT01848210|101583529|FG001|COMPLETED|Overall Study||340||
48512262|NCT01848210|101583528|FG000|NOT COMPLETED|Overall Study||88||
48512263|NCT01848210|101583529|FG001|NOT COMPLETED|Overall Study||78||
48512264|NCT00575380|101583530|FG000|STARTED|Overall Study||58||
48512265|NCT00575380|101583531|FG001|STARTED|Overall Study||58||
48512266|NCT00575380|101583530|FG000|COMPLETED|Overall Study||57||
48512267|NCT00575380|101583531|FG001|COMPLETED|Overall Study||55||
48512268|NCT00575380|101583530|FG000|NOT COMPLETED|Overall Study||1||
48512269|NCT00575380|101583531|FG001|NOT COMPLETED|Overall Study||3||
48512270|NCT01923311|101583532|FG000|STARTED|Overall Study||17||
48512271|NCT01923311|101583533|FG001|STARTED|Overall Study||14||
48512272|NCT01923311|101583532|FG000|COMPLETED|Overall Study||0||
48512273|NCT01923311|101583533|FG001|COMPLETED|Overall Study||13||
48512274|NCT01923311|101583532|FG000|NOT COMPLETED|Overall Study||17||
48512275|NCT01923311|101583533|FG001|NOT COMPLETED|Overall Study||1||
48512276|NCT02426541|101583534|FG000|STARTED|Overall Study||16||
48512277|NCT02426541|101583535|FG001|STARTED|Overall Study||16||
48512278|NCT02426541|101583534|FG000|COMPLETED|Overall Study||15||
48512279|NCT02426541|101583535|FG001|COMPLETED|Overall Study||16||
48512280|NCT02426541|101583534|FG000|NOT COMPLETED|Overall Study||1||
48512281|NCT02426541|101583535|FG001|NOT COMPLETED|Overall Study||0||
48512282|NCT05218109|101583536|FG000|STARTED|Overall Study||16||
48512283|NCT05218109|101583537|FG001|STARTED|Overall Study||20||
48512284|NCT05218109|101583538|FG002|STARTED|Overall Study||20||
48512285|NCT05218109|101583539|FG003|STARTED|Overall Study||20||
48512286|NCT05218109|101583536|FG000|Week 1|Overall Study||14||
48512287|NCT05218109|101583537|FG001|Week 1|Overall Study||15||
48512288|NCT05218109|101583538|FG002|Week 1|Overall Study||19||
48512289|NCT05218109|101583539|FG003|Week 1|Overall Study||20||
48512290|NCT05218109|101583536|FG000|Week 2|Overall Study||13||
48512291|NCT05218109|101583537|FG001|Week 2|Overall Study||14||
48512292|NCT05218109|101583538|FG002|Week 2|Overall Study||19||
48512293|NCT05218109|101583539|FG003|Week 2|Overall Study||20||
48512294|NCT05218109|101583536|FG000|Week 3|Overall Study||12||
48512295|NCT05218109|101583537|FG001|Week 3|Overall Study||13||
48512296|NCT05218109|101583538|FG002|Week 3|Overall Study||19||
48512297|NCT05218109|101583539|FG003|Week 3|Overall Study||18||
48512298|NCT05218109|101583536|FG000|Week 4|Overall Study||13||
48512299|NCT05218109|101583537|FG001|Week 4|Overall Study||14||
48512300|NCT05218109|101583538|FG002|Week 4|Overall Study||19||
48512301|NCT05218109|101583539|FG003|Week 4|Overall Study||19||
48066808|NCT00697788|100485434|FG002|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
48066809|NCT00697788|100485435|FG003|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
48512302|NCT05218109|101583536|FG000|Week 8 (Follow Up)|Overall Study||14||
48512303|NCT05218109|101583537|FG001|Week 8 (Follow Up)|Overall Study||14||
48512304|NCT05218109|101583538|FG002|Week 8 (Follow Up)|Overall Study||17||
48512305|NCT05218109|101583539|FG003|Week 8 (Follow Up)|Overall Study||20||
48512306|NCT05218109|101583536|FG000|COMPLETED|Overall Study||14||
48512307|NCT05218109|101583537|FG001|COMPLETED|Overall Study||14||
48512308|NCT05218109|101583538|FG002|COMPLETED|Overall Study||17||
48512309|NCT05218109|101583539|FG003|COMPLETED|Overall Study||20||
48512310|NCT05218109|101583536|FG000|NOT COMPLETED|Overall Study||2||
48512311|NCT05218109|101583537|FG001|NOT COMPLETED|Overall Study||6||
48512312|NCT05218109|101583538|FG002|NOT COMPLETED|Overall Study||3||
48512313|NCT05218109|101583539|FG003|NOT COMPLETED|Overall Study||0||
48512314|NCT00745134|101583540|FG000|STARTED|Overall Study||15||
48512315|NCT00745134|101583541|FG001|STARTED|Overall Study||7||
48512316|NCT00745134|101583540|FG000|COMPLETED|Overall Study||15||
48512317|NCT00745134|101583541|FG001|COMPLETED|Overall Study||7||
48512318|NCT00745134|101583540|FG000|NOT COMPLETED|Overall Study||0||
48512319|NCT00745134|101583541|FG001|NOT COMPLETED|Overall Study||0||
48512320|NCT04291508|101583542|FG000|STARTED|Overall Study||228||
48512321|NCT04291508|101583543|FG001|STARTED|Overall Study||40||
48512322|NCT04291508|101583544|FG002|STARTED|Overall Study||199||
48512323|NCT04291508|101583545|FG003|STARTED|Overall Study||21||
48512324|NCT04291508|101583542|FG000|COMPLETED|Overall Study||223||
48512325|NCT04291508|101583543|FG001|COMPLETED|Overall Study||40||
48512326|NCT04291508|101583544|FG002|COMPLETED|Overall Study||197||
48512327|NCT04291508|101583545|FG003|COMPLETED|Overall Study||21||
48512328|NCT04291508|101583542|FG000|NOT COMPLETED|Overall Study||5||
48512329|NCT04291508|101583543|FG001|NOT COMPLETED|Overall Study||0||
48512330|NCT04291508|101583544|FG002|NOT COMPLETED|Overall Study||2||
48512331|NCT04291508|101583545|FG003|NOT COMPLETED|Overall Study||0||
48512332|NCT00979212|101583546|FG000|STARTED|Overall Study||24||
48512333|NCT00979212|101583547|FG001|STARTED|Overall Study||47||
48512334|NCT00979212|101583546|FG000|COMPLETED|Overall Study||22||
48512335|NCT00979212|101583547|FG001|COMPLETED|Overall Study||39||
48512336|NCT00979212|101583546|FG000|NOT COMPLETED|Overall Study||2||
48512337|NCT00979212|101583547|FG001|NOT COMPLETED|Overall Study||8||
48512338|NCT02969876|101583548|FG000|STARTED|Overall Study||2||
48512339|NCT02969876|101583548|FG000|COMPLETED|Overall Study||2||
48512340|NCT02969876|101583548|FG000|NOT COMPLETED|Overall Study||0||
48512341|NCT02756637|101583549|FG000|STARTED|Overall Study||317||
48512342|NCT02756637|101583550|FG001|STARTED|Overall Study||317||
48512343|NCT02756637|101583549|FG000|Eligible for SWOG 8710|Overall Study||307||
48512344|NCT02756637|101583550|FG001|Eligible for SWOG 8710|Overall Study||307||
48512345|NCT02756637|101583549|FG000|Had NLR Value|Overall Study||263||
48512346|NCT02756637|101583550|FG001|Had NLR Value|Overall Study||263||
48512347|NCT02756637|101583549|FG000|Completed Curative Treatment|Overall Study||230||
48512348|NCT02756637|101583550|FG001|Completed Curative Treatment|Overall Study||0||
48512349|NCT02756637|101583549|FG000|COMPLETED|Overall Study||230||
48512350|NCT02756637|101583550|FG001|COMPLETED|Overall Study||263||
48512351|NCT02756637|101583549|FG000|NOT COMPLETED|Overall Study||87||
48512352|NCT02756637|101583550|FG001|NOT COMPLETED|Overall Study||54||
48512353|NCT03496987|101583551|FG000|STARTED|Overall Study||49||
48512354|NCT03496987|101583552|FG001|STARTED|Overall Study||51||
48512355|NCT03496987|101583551|FG000|COMPLETED|Overall Study||49||
48512356|NCT03496987|101583552|FG001|COMPLETED|Overall Study||51||
48512357|NCT03496987|101583551|FG000|NOT COMPLETED|Overall Study||0||
48512358|NCT03496987|101583552|FG001|NOT COMPLETED|Overall Study||0||
48512359|NCT03689894|101583553|FG000|STARTED|Overall Study||2||
48512360|NCT03689894|101583553|FG000|Completed Study Treatment|Overall Study||1||
48512361|NCT03689894|101583553|FG000|COMPLETED|Overall Study||1||
48512362|NCT03689894|101583553|FG000|NOT COMPLETED|Overall Study||1||
48512363|NCT00981227|101583554|FG000|STARTED|Overall Study||102||
48512364|NCT00981227|101583555|FG001|STARTED|Overall Study||94||
48512365|NCT00981227|101583556|FG002|STARTED|Overall Study||94||
48512366|NCT00981227|101583557|FG003|STARTED|Overall Study||94||
48512367|NCT00981227|101583558|FG004|STARTED|Overall Study||90||
48512368|NCT00981227|101583559|FG005|STARTED|Overall Study||93||
48512369|NCT00981227|101583554|FG000|Randomized|Overall Study||102||
48512370|NCT00981227|101583555|FG001|Randomized|Overall Study||94||
48512371|NCT00981227|101583556|FG002|Randomized|Overall Study||94||
48512372|NCT00981227|101583557|FG003|Randomized|Overall Study||94||
48512373|NCT00981227|101583558|FG004|Randomized|Overall Study||90||
48512374|NCT00981227|101583559|FG005|Randomized|Overall Study||93||
48512375|NCT00981227|101583554|FG000|Safety Population|Overall Study||102||
48512376|NCT00981227|101583555|FG001|Safety Population|Overall Study||94||
48512377|NCT00981227|101583556|FG002|Safety Population|Overall Study||94||
48512378|NCT00981227|101583557|FG003|Safety Population|Overall Study||94||
48512379|NCT00981227|101583558|FG004|Safety Population|Overall Study||90||
48512380|NCT00981227|101583559|FG005|Safety Population|Overall Study||93||
48512381|NCT00981227|101583554|FG000|Per-Protocol|Overall Study||69||
48512382|NCT00981227|101583555|FG001|Per-Protocol|Overall Study||72||
48512383|NCT00981227|101583556|FG002|Per-Protocol|Overall Study||67||
48512384|NCT00981227|101583557|FG003|Per-Protocol|Overall Study||68||
48512385|NCT00981227|101583558|FG004|Per-Protocol|Overall Study||50||
48512386|NCT00981227|101583559|FG005|Per-Protocol|Overall Study||70||
48512387|NCT00981227|101583554|FG000|COMPLETED|Overall Study||80||
48512388|NCT00981227|101583555|FG001|COMPLETED|Overall Study||75||
48512389|NCT00981227|101583556|FG002|COMPLETED|Overall Study||73||
48512390|NCT00981227|101583557|FG003|COMPLETED|Overall Study||73||
48512391|NCT00981227|101583558|FG004|COMPLETED|Overall Study||60||
48512392|NCT00981227|101583559|FG005|COMPLETED|Overall Study||75||
48512393|NCT00981227|101583554|FG000|NOT COMPLETED|Overall Study||22||
48512394|NCT00981227|101583555|FG001|NOT COMPLETED|Overall Study||19||
48512395|NCT00981227|101583556|FG002|NOT COMPLETED|Overall Study||21||
48512396|NCT00981227|101583557|FG003|NOT COMPLETED|Overall Study||21||
48512397|NCT00981227|101583558|FG004|NOT COMPLETED|Overall Study||30||
48512398|NCT00981227|101583559|FG005|NOT COMPLETED|Overall Study||18||
48512399|NCT00392782|101583560|FG000|STARTED|Overall Study||24||
48512400|NCT00392782|101583560|FG000|COMPLETED|Overall Study||24||
48512401|NCT00392782|101583560|FG000|NOT COMPLETED|Overall Study||0||
48512402|NCT00377572|101583561|FG000|STARTED|Overall Study||208||
48512403|NCT00377572|101583562|FG001|STARTED|Overall Study||211||
48512404|NCT00377572|101583561|FG000|COMPLETED|Overall Study||155||
48512405|NCT00377572|101583562|FG001|COMPLETED|Overall Study||157||
48512406|NCT00377572|101583561|FG000|NOT COMPLETED|Overall Study||53||
48512407|NCT00377572|101583562|FG001|NOT COMPLETED|Overall Study||54||
48512408|NCT01625507|101585969|FG000|STARTED|Overall Study||73||
48512409|NCT01625507|101585969|FG000|COMPLETED|Overall Study||63||
48512410|NCT01625507|101585969|FG000|NOT COMPLETED|Overall Study||10||
48512411|NCT00176930|101585970|FG000|STARTED|Overall Study||12||
48512412|NCT00176930|101585971|FG001|STARTED|Overall Study||13||
48512413|NCT00176930|101585972|FG002|STARTED|Overall Study||1||
48512414|NCT00176930|101585973|FG003|STARTED|Overall Study||1||
48512415|NCT00176930|101585974|FG004|STARTED|Overall Study||213||
48512416|NCT00176930|101585975|FG005|STARTED|Overall Study||85||
48512417|NCT00176930|101585976|FG006|STARTED|Overall Study||2||
48512418|NCT00176930|101585977|FG007|STARTED|Overall Study||2||
48512419|NCT00176930|101585970|FG000|COMPLETED|Overall Study||12||
48512420|NCT00176930|101585971|FG001|COMPLETED|Overall Study||13||
48512421|NCT00176930|101585972|FG002|COMPLETED|Overall Study||1||
48512422|NCT00176930|101585973|FG003|COMPLETED|Overall Study||1||
48512423|NCT00176930|101585974|FG004|COMPLETED|Overall Study||213||
48512424|NCT00176930|101585975|FG005|COMPLETED|Overall Study||85||
48512425|NCT00176930|101585976|FG006|COMPLETED|Overall Study||2||
48512426|NCT00176930|101585977|FG007|COMPLETED|Overall Study||2||
48512427|NCT00176930|101585970|FG000|NOT COMPLETED|Overall Study||0||
48512428|NCT00176930|101585971|FG001|NOT COMPLETED|Overall Study||0||
48512429|NCT00176930|101585972|FG002|NOT COMPLETED|Overall Study||0||
48512430|NCT00176930|101585973|FG003|NOT COMPLETED|Overall Study||0||
48512431|NCT00176930|101585974|FG004|NOT COMPLETED|Overall Study||0||
48512432|NCT00176930|101585975|FG005|NOT COMPLETED|Overall Study||0||
48512433|NCT00176930|101585976|FG006|NOT COMPLETED|Overall Study||0||
48512434|NCT00176930|101585977|FG007|NOT COMPLETED|Overall Study||0||
48512435|NCT03847194|101585978|FG000|STARTED|Overall Study||85||
48512436|NCT03847194|101585979|FG001|STARTED|Overall Study||87||
48512437|NCT03847194|101585978|FG000|COMPLETED|Overall Study||82||
48512438|NCT03847194|101585979|FG001|COMPLETED|Overall Study||79||
48512439|NCT03847194|101585978|FG000|NOT COMPLETED|Overall Study||3||
48512440|NCT03847194|101585979|FG001|NOT COMPLETED|Overall Study||8||
48512441|NCT02966184|101585980|FG000|STARTED|Overall Study||0||
48512442|NCT02966184|101585981|FG001|STARTED|Overall Study||8||
48512443|NCT02966184|101585980|FG000|COMPLETED|Overall Study||0||
48512444|NCT02966184|101585981|FG001|COMPLETED|Overall Study||0||
48512445|NCT02966184|101585980|FG000|NOT COMPLETED|Overall Study||0||
48512446|NCT02966184|101585981|FG001|NOT COMPLETED|Overall Study||8||
48512447|NCT01813435|101585982|FG000|STARTED|Overall Study||7980||
48512448|NCT01813435|101585983|FG001|STARTED|Overall Study||7988||
48512449|NCT01813435|101585982|FG000|COMPLETED|Overall Study||5810||
48512450|NCT01813435|101585983|FG001|COMPLETED|Overall Study||6981||
48512451|NCT01813435|101585982|FG000|NOT COMPLETED|Overall Study||2170||
48512452|NCT01813435|101585983|FG001|NOT COMPLETED|Overall Study||1007||
48512453|NCT01765270|101585984|FG000|STARTED|Overall Study||5||
48512454|NCT01765270|101585985|FG001|STARTED|Overall Study||7||
48512455|NCT01765270|101585984|FG000|COMPLETED|Overall Study||4||
48512456|NCT01765270|101585985|FG001|COMPLETED|Overall Study||6||
48512457|NCT01765270|101585984|FG000|NOT COMPLETED|Overall Study||1||
48512458|NCT01765270|101585985|FG001|NOT COMPLETED|Overall Study||1||
48512459|NCT02039063|101585986|FG000|STARTED|Treatment Phase||6||
48512460|NCT02039063|101585987|FG001|STARTED|Treatment Phase||8||
48512461|NCT02039063|101585988|FG002|STARTED|Treatment Phase||7||
48512462|NCT02039063|101585989|FG003|STARTED|Treatment Phase||7||
48512463|NCT02039063|101585986|FG000|COMPLETED|Treatment Phase||3||
48512464|NCT02039063|101585987|FG001|COMPLETED|Treatment Phase||6||
48512465|NCT02039063|101585988|FG002|COMPLETED|Treatment Phase||5||
48512466|NCT02039063|101585989|FG003|COMPLETED|Treatment Phase||5||
48512467|NCT02039063|101585986|FG000|NOT COMPLETED|Treatment Phase||3||
48512468|NCT02039063|101585987|FG001|NOT COMPLETED|Treatment Phase||2||
48512469|NCT02039063|101585988|FG002|NOT COMPLETED|Treatment Phase||2||
48512470|NCT02039063|101585989|FG003|NOT COMPLETED|Treatment Phase||2||
48512471|NCT02039063|101585986|FG000|STARTED|Extension Phase||1||
48512472|NCT02039063|101585987|FG001|STARTED|Extension Phase||3||
48512473|NCT02039063|101585988|FG002|STARTED|Extension Phase||5||
48512474|NCT02039063|101585989|FG003|STARTED|Extension Phase||3||
48512475|NCT02039063|101585986|FG000|COMPLETED|Extension Phase||1||
48512476|NCT02039063|101585987|FG001|COMPLETED|Extension Phase||2||
48512477|NCT02039063|101585988|FG002|COMPLETED|Extension Phase||2||
48512478|NCT02039063|101585989|FG003|COMPLETED|Extension Phase||2||
48512479|NCT02039063|101585986|FG000|NOT COMPLETED|Extension Phase||0||
48512480|NCT02039063|101585987|FG001|NOT COMPLETED|Extension Phase||1||
48512481|NCT02039063|101585988|FG002|NOT COMPLETED|Extension Phase||3||
48512482|NCT02039063|101585989|FG003|NOT COMPLETED|Extension Phase||1||
48512483|NCT00108628|101585990|FG000|STARTED|Overall Study||61||
48512484|NCT00108628|101585991|FG001|STARTED|Overall Study||63||
48512485|NCT00108628|101585990|FG000|Received One or More Sessions|Overall Study||53||
48512486|NCT00108628|101585991|FG001|Received One or More Sessions|Overall Study||58||
48512487|NCT00108628|101585990|FG000|Completed Treatment|Overall Study||42||
48512488|NCT00108628|101585991|FG001|Completed Treatment|Overall Study||57||
48512489|NCT00108628|101585990|FG000|COMPLETED|Overall Study||41||
48512490|NCT00108628|101585991|FG001|COMPLETED|Overall Study||53||
48512491|NCT00108628|101585990|FG000|NOT COMPLETED|Overall Study||20||
48512492|NCT00108628|101585991|FG001|NOT COMPLETED|Overall Study||10||
48512493|NCT00895037|101585992|FG000|STARTED|Overall Study||22||
48512494|NCT00895037|101585993|FG001|STARTED|Overall Study||77||
48512495|NCT00895037|101585994|FG002|STARTED|Overall Study||2||
48512496|NCT00895037|101585992|FG000|COMPLETED|Overall Study||22||
48512497|NCT00895037|101585993|FG001|COMPLETED|Overall Study||75||
48512498|NCT00895037|101585994|FG002|COMPLETED|Overall Study||1||
48512499|NCT00895037|101585992|FG000|NOT COMPLETED|Overall Study||0||
48512500|NCT00895037|101585993|FG001|NOT COMPLETED|Overall Study||2||
48512501|NCT00895037|101585994|FG002|NOT COMPLETED|Overall Study||1||
48512502|NCT00251316|101585995|FG000|STARTED|Overall Study||17||
48512503|NCT00251316|101585996|FG001|STARTED|Overall Study||17||
48512504|NCT00251316|101585995|FG000|COMPLETED|Overall Study||15||
48512505|NCT00251316|101585996|FG001|COMPLETED|Overall Study||14||
48512506|NCT00251316|101585995|FG000|NOT COMPLETED|Overall Study||2||
48512507|NCT00251316|101585996|FG001|NOT COMPLETED|Overall Study||3||
48512508|NCT01701973|101585997|FG000|STARTED|Aim 1: First Intervention (1 Day)||23||
48512509|NCT01701973|101585998|FG001|STARTED|Aim 1: First Intervention (1 Day)||21||
48512510|NCT01701973|101585999|FG002|STARTED|Aim 1: First Intervention (1 Day)||0||
48512511|NCT01701973|101586000|FG003|STARTED|Aim 1: First Intervention (1 Day)||0||
48512512|NCT01701973|101586001|FG004|STARTED|Aim 1: First Intervention (1 Day)||0||
48512513|NCT01701973|101586002|FG005|STARTED|Aim 1: First Intervention (1 Day)||0||
48512514|NCT01701973|101586003|FG006|STARTED|Aim 1: First Intervention (1 Day)||0||
48512515|NCT01701973|101586004|FG007|STARTED|Aim 1: First Intervention (1 Day)||0||
48512516|NCT01701973|101585997|FG000|COMPLETED|Aim 1: First Intervention (1 Day)||23||
48512517|NCT01701973|101585998|FG001|COMPLETED|Aim 1: First Intervention (1 Day)||20||
48512518|NCT01701973|101585999|FG002|COMPLETED|Aim 1: First Intervention (1 Day)||0||
48512519|NCT01701973|101586000|FG003|COMPLETED|Aim 1: First Intervention (1 Day)||0||
48512520|NCT01701973|101586001|FG004|COMPLETED|Aim 1: First Intervention (1 Day)||0||
48512521|NCT01701973|101586002|FG005|COMPLETED|Aim 1: First Intervention (1 Day)||0||
48512522|NCT01701973|101586003|FG006|COMPLETED|Aim 1: First Intervention (1 Day)||0||
48512523|NCT01701973|101586004|FG007|COMPLETED|Aim 1: First Intervention (1 Day)||0||
48512524|NCT01701973|101585997|FG000|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0||
48512525|NCT01701973|101585998|FG001|NOT COMPLETED|Aim 1: First Intervention (1 Day)||1||
48512526|NCT01701973|101585999|FG002|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0||
48512527|NCT01701973|101586000|FG003|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0||
48512528|NCT01701973|101586001|FG004|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0||
48512529|NCT01701973|101586002|FG005|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0||
48512530|NCT01701973|101586003|FG006|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0||
48512531|NCT01701973|101586004|FG007|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0||
48512532|NCT01701973|101585997|FG000|STARTED|Aim 1: Second Intervention (1 Day)||22||
48512533|NCT01701973|101585998|FG001|STARTED|Aim 1: Second Intervention (1 Day)||17||
48512534|NCT01701973|101585999|FG002|STARTED|Aim 1: Second Intervention (1 Day)||0||
48512535|NCT01701973|101586000|FG003|STARTED|Aim 1: Second Intervention (1 Day)||0||
48512536|NCT01701973|101586001|FG004|STARTED|Aim 1: Second Intervention (1 Day)||0||
48512537|NCT01701973|101586002|FG005|STARTED|Aim 1: Second Intervention (1 Day)||0||
48512538|NCT01701973|101586003|FG006|STARTED|Aim 1: Second Intervention (1 Day)||0||
48512539|NCT01701973|101586004|FG007|STARTED|Aim 1: Second Intervention (1 Day)||0||
48512540|NCT01701973|101585997|FG000|COMPLETED|Aim 1: Second Intervention (1 Day)||22||
48512541|NCT01701973|101585998|FG001|COMPLETED|Aim 1: Second Intervention (1 Day)||17||
48512542|NCT01701973|101585999|FG002|COMPLETED|Aim 1: Second Intervention (1 Day)||0||
48512543|NCT01701973|101586000|FG003|COMPLETED|Aim 1: Second Intervention (1 Day)||0||
48512544|NCT01701973|101586001|FG004|COMPLETED|Aim 1: Second Intervention (1 Day)||0||
48512545|NCT01701973|101586002|FG005|COMPLETED|Aim 1: Second Intervention (1 Day)||0||
48512546|NCT01701973|101586003|FG006|COMPLETED|Aim 1: Second Intervention (1 Day)||0||
48512547|NCT01701973|101586004|FG007|COMPLETED|Aim 1: Second Intervention (1 Day)||0||
48512548|NCT01701973|101585997|FG000|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0||
48512549|NCT01701973|101585998|FG001|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0||
48512550|NCT01701973|101585999|FG002|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0||
48512551|NCT01701973|101586000|FG003|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0||
48512552|NCT01701973|101586001|FG004|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0||
48512553|NCT01701973|101586002|FG005|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0||
48512554|NCT01701973|101586003|FG006|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0||
48512555|NCT01701973|101586004|FG007|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0||
48512556|NCT01701973|101585997|FG000|STARTED|Aim 2: First Intervention (1 Day)||0||
48512557|NCT01701973|101585998|FG001|STARTED|Aim 2: First Intervention (1 Day)||0||
48512558|NCT01701973|101585999|FG002|STARTED|Aim 2: First Intervention (1 Day)||5||
48512559|NCT01701973|101586000|FG003|STARTED|Aim 2: First Intervention (1 Day)||4||
48512560|NCT01701973|101586001|FG004|STARTED|Aim 2: First Intervention (1 Day)||2||
48512561|NCT01701973|101586002|FG005|STARTED|Aim 2: First Intervention (1 Day)||3||
48512562|NCT01701973|101586003|FG006|STARTED|Aim 2: First Intervention (1 Day)||5||
48512563|NCT01701973|101586004|FG007|STARTED|Aim 2: First Intervention (1 Day)||4||
48512564|NCT01701973|101585997|FG000|COMPLETED|Aim 2: First Intervention (1 Day)||0||
48512565|NCT01701973|101585998|FG001|COMPLETED|Aim 2: First Intervention (1 Day)||0||
48512566|NCT01701973|101585999|FG002|COMPLETED|Aim 2: First Intervention (1 Day)||5||
48512567|NCT01701973|101586000|FG003|COMPLETED|Aim 2: First Intervention (1 Day)||4||
48512568|NCT01701973|101586001|FG004|COMPLETED|Aim 2: First Intervention (1 Day)||2||
48512569|NCT01701973|101586002|FG005|COMPLETED|Aim 2: First Intervention (1 Day)||3||
48512570|NCT01701973|101586003|FG006|COMPLETED|Aim 2: First Intervention (1 Day)||5||
48512571|NCT01701973|101586004|FG007|COMPLETED|Aim 2: First Intervention (1 Day)||4||
48512572|NCT01701973|101585997|FG000|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0||
48512573|NCT01701973|101585998|FG001|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0||
48512574|NCT01701973|101585999|FG002|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0||
48512575|NCT01701973|101586000|FG003|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0||
48512576|NCT01701973|101586001|FG004|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0||
48512577|NCT01701973|101586002|FG005|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0||
48512578|NCT01701973|101586003|FG006|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0||
48512579|NCT01701973|101586004|FG007|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0||
48512580|NCT01701973|101585997|FG000|STARTED|Aim 2: Second Intervention (1 Day)||0||
48512581|NCT01701973|101585998|FG001|STARTED|Aim 2: Second Intervention (1 Day)||0||
48512582|NCT01701973|101585999|FG002|STARTED|Aim 2: Second Intervention (1 Day)||5||
48512583|NCT01701973|101586000|FG003|STARTED|Aim 2: Second Intervention (1 Day)||4||
48512584|NCT01701973|101586001|FG004|STARTED|Aim 2: Second Intervention (1 Day)||2||
48512585|NCT01701973|101586002|FG005|STARTED|Aim 2: Second Intervention (1 Day)||3||
48512586|NCT01701973|101586003|FG006|STARTED|Aim 2: Second Intervention (1 Day)||5||
48512587|NCT01701973|101586004|FG007|STARTED|Aim 2: Second Intervention (1 Day)||3||
48512588|NCT01701973|101585997|FG000|COMPLETED|Aim 2: Second Intervention (1 Day)||0||
48512589|NCT01701973|101585998|FG001|COMPLETED|Aim 2: Second Intervention (1 Day)||0||
48512590|NCT01701973|101585999|FG002|COMPLETED|Aim 2: Second Intervention (1 Day)||5||
48512591|NCT01701973|101586000|FG003|COMPLETED|Aim 2: Second Intervention (1 Day)||4||
48512592|NCT01701973|101586001|FG004|COMPLETED|Aim 2: Second Intervention (1 Day)||2||
48512593|NCT01701973|101586002|FG005|COMPLETED|Aim 2: Second Intervention (1 Day)||3||
48512594|NCT01701973|101586003|FG006|COMPLETED|Aim 2: Second Intervention (1 Day)||5||
48512595|NCT01701973|101586004|FG007|COMPLETED|Aim 2: Second Intervention (1 Day)||3||
48512596|NCT01701973|101585997|FG000|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0||
48512597|NCT01701973|101585998|FG001|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0||
48512598|NCT01701973|101585999|FG002|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0||
48512599|NCT01701973|101586000|FG003|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0||
48512600|NCT01701973|101586001|FG004|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0||
48512601|NCT01701973|101586002|FG005|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0||
48512602|NCT01701973|101586003|FG006|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0||
48512603|NCT01701973|101586004|FG007|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0||
48512604|NCT01114581|101586005|FG000|STARTED|Overall Study||19||
48512605|NCT01114581|101586006|FG001|STARTED|Overall Study||19||
48512606|NCT01114581|101586005|FG000|COMPLETED|Overall Study||19||
48512607|NCT01114581|101586006|FG001|COMPLETED|Overall Study||19||
48512608|NCT01114581|101586005|FG000|NOT COMPLETED|Overall Study||0||
48512609|NCT01114581|101586006|FG001|NOT COMPLETED|Overall Study||0||
48512610|NCT00063258|101586007|FG000|STARTED|Overall Study||5||
48512611|NCT00063258|101586008|FG001|STARTED|Overall Study||0||
48512612|NCT00063258|101586007|FG000|COMPLETED|Overall Study||1||
48512613|NCT00063258|101586008|FG001|COMPLETED|Overall Study||0||
48512614|NCT00063258|101586007|FG000|NOT COMPLETED|Overall Study||4||
48512615|NCT00063258|101586008|FG001|NOT COMPLETED|Overall Study||0||
48512616|NCT01273857|101586009|FG000|STARTED|Overall Study||7||
48512617|NCT01273857|101586010|FG001|STARTED|Overall Study||7||
48512618|NCT01273857|101586009|FG000|COMPLETED|Overall Study||7||
48512619|NCT01273857|101586010|FG001|COMPLETED|Overall Study||7||
48512620|NCT01273857|101586009|FG000|NOT COMPLETED|Overall Study||0||
48512621|NCT01273857|101586010|FG001|NOT COMPLETED|Overall Study||0||
48512622|NCT00706719|101586011|FG000|STARTED|Overall Study||5||
48512623|NCT00706719|101586012|FG001|STARTED|Overall Study||7||
48512624|NCT00706719|101586013|FG002|STARTED|Overall Study||5||
48512625|NCT00706719|101586011|FG000|COMPLETED|Overall Study||5||
48512626|NCT00706719|101586012|FG001|COMPLETED|Overall Study||6||
48512627|NCT00706719|101586013|FG002|COMPLETED|Overall Study||1||
48512628|NCT00706719|101586011|FG000|NOT COMPLETED|Overall Study||0||
48512629|NCT00706719|101586012|FG001|NOT COMPLETED|Overall Study||1||
48512630|NCT00706719|101586013|FG002|NOT COMPLETED|Overall Study||4||
48512631|NCT00202839|101586014|FG000|STARTED|Overall Study||78||
48512632|NCT00202839|101586015|FG001|STARTED|Overall Study||82||
48512633|NCT00202839|101586014|FG000|COMPLETED|Overall Study||54||
48512634|NCT00202839|101586015|FG001|COMPLETED|Overall Study||72||
48512635|NCT00202839|101586014|FG000|NOT COMPLETED|Overall Study||24||
48512636|NCT00202839|101586015|FG001|NOT COMPLETED|Overall Study||10||
48512637|NCT01961687|101586016|FG000|STARTED|Overall Study||121||
48512638|NCT01961687|101586016|FG000|COMPLETED|Overall Study||60||
48512639|NCT01961687|101586016|FG000|NOT COMPLETED|Overall Study||61||
48512640|NCT02225106|101586017|FG000|STARTED|Overall Study||11||
48512641|NCT02225106|101586017|FG000|COMPLETED|Overall Study||11||
48512642|NCT02225106|101586017|FG000|NOT COMPLETED|Overall Study||0||
48512643|NCT02510261|101586018|FG000|STARTED|Overall Study||49||
48512644|NCT02510261|101586019|FG001|STARTED|Overall Study||137||
48512645|NCT02510261|101586020|FG002|STARTED|Overall Study||25||
48512646|NCT02510261|101586018|FG000|Full Analysis Set|Overall Study||49|Full analysis set included all participants who were enrolled in this study.|
48512647|NCT02510261|101586019|FG001|Full Analysis Set|Overall Study||137|Full analysis set included all participants who were enrolled in this study.|
48512648|NCT02510261|101586020|FG002|Full Analysis Set|Overall Study||25|Full analysis set included all participants who were enrolled in this study.|
48512649|NCT02510261|101586018|FG000|Safety Analysis Set|Overall Study||49|Safety analysis set included all the enrolled participants who received at least 1 dose of patisiran in this study.|
48512650|NCT02510261|101586019|FG001|Safety Analysis Set|Overall Study||137|Safety analysis set included all the enrolled participants who received at least 1 dose of patisiran in this study.|
48512651|NCT02510261|101586020|FG002|Safety Analysis Set|Overall Study||25|Safety analysis set included all the enrolled participants who received at least 1 dose of patisiran in this study.|
48512652|NCT02510261|101586018|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||40|PD analysis set included all participants who received at least 1 dose of patisiran in this study and have had both baseline and at least 1 post-baseline PD assessment (either transthyretin \[TTR\] or vitamin A).|
48512653|NCT02510261|101586019|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||128|PD analysis set included all participants who received at least 1 dose of patisiran in this study and have had both baseline and at least 1 post-baseline PD assessment (either transthyretin \[TTR\] or vitamin A).|
48512654|NCT02510261|101586020|FG002|Pharmacodynamic (PD) Analysis Set|Overall Study||24|PD analysis set included all participants who received at least 1 dose of patisiran in this study and have had both baseline and at least 1 post-baseline PD assessment (either transthyretin \[TTR\] or vitamin A).|
48512655|NCT02510261|101586018|FG000|COMPLETED|Overall Study||21||
48512656|NCT02510261|101586019|FG001|COMPLETED|Overall Study||95||
48512657|NCT02510261|101586020|FG002|COMPLETED|Overall Study||22||
48512658|NCT02510261|101586018|FG000|NOT COMPLETED|Overall Study||28||
48512659|NCT02510261|101586019|FG001|NOT COMPLETED|Overall Study||42||
48512660|NCT02510261|101586020|FG002|NOT COMPLETED|Overall Study||3||
48512661|NCT04126343|101586021|FG000|STARTED|Overall Study||9||
48512662|NCT04126343|101586022|FG001|STARTED|Overall Study||9||
48512663|NCT04126343|101586023|FG002|STARTED|Overall Study||9||
48512664|NCT04126343|101586024|FG003|STARTED|Overall Study||9||
48512665|NCT04126343|101586025|FG004|STARTED|Overall Study||9||
48512666|NCT04126343|101586026|FG005|STARTED|Overall Study||9||
48512667|NCT04126343|101586021|FG000|Completed Padsevonil Period|Overall Study||9||
48512668|NCT04126343|101586022|FG001|Completed Padsevonil Period|Overall Study||9||
48512669|NCT04126343|101586023|FG002|Completed Padsevonil Period|Overall Study||9||
48512670|NCT04126343|101586024|FG003|Completed Padsevonil Period|Overall Study||7||
48512671|NCT04126343|101586025|FG004|Completed Padsevonil Period|Overall Study||9||
48512672|NCT04126343|101586026|FG005|Completed Padsevonil Period|Overall Study||8||
48512673|NCT04126343|101586021|FG000|Completed Placebo Period|Overall Study||9||
48512674|NCT04126343|101586022|FG001|Completed Placebo Period|Overall Study||7||
48512675|NCT04126343|101586023|FG002|Completed Placebo Period|Overall Study||9||
48512676|NCT04126343|101586024|FG003|Completed Placebo Period|Overall Study||9||
48512677|NCT04126343|101586025|FG004|Completed Placebo Period|Overall Study||7||
48512678|NCT04126343|101586026|FG005|Completed Placebo Period|Overall Study||9||
48512679|NCT04126343|101586021|FG000|Completed Moxifloxacin Period|Overall Study||8||
48512680|NCT04126343|101586022|FG001|Completed Moxifloxacin Period|Overall Study||9||
48512681|NCT04126343|101586023|FG002|Completed Moxifloxacin Period|Overall Study||7||
48512682|NCT04126343|101586024|FG003|Completed Moxifloxacin Period|Overall Study||9||
48512683|NCT04126343|101586025|FG004|Completed Moxifloxacin Period|Overall Study||9||
48512684|NCT04126343|101586026|FG005|Completed Moxifloxacin Period|Overall Study||9||
48512685|NCT04126343|101586021|FG000|COMPLETED|Overall Study||6||
48512686|NCT04126343|101586022|FG001|COMPLETED|Overall Study||5||
48512687|NCT04126343|101586023|FG002|COMPLETED|Overall Study||6||
48512688|NCT04126343|101586024|FG003|COMPLETED|Overall Study||5||
48512689|NCT04126343|101586025|FG004|COMPLETED|Overall Study||6||
48512690|NCT04126343|101586026|FG005|COMPLETED|Overall Study||5||
48512691|NCT04126343|101586021|FG000|NOT COMPLETED|Overall Study||3||
48512692|NCT04126343|101586022|FG001|NOT COMPLETED|Overall Study||4||
48512693|NCT04126343|101586023|FG002|NOT COMPLETED|Overall Study||3||
48512694|NCT04126343|101586024|FG003|NOT COMPLETED|Overall Study||4||
48512695|NCT04126343|101586025|FG004|NOT COMPLETED|Overall Study||3||
48512696|NCT04126343|101586026|FG005|NOT COMPLETED|Overall Study||4||
48512697|NCT04703855|101586027|FG000|STARTED|Overall Study||3||
48512698|NCT04703855|101586027|FG000|COMPLETED|Overall Study||2||
48512699|NCT04703855|101586027|FG000|NOT COMPLETED|Overall Study||1||
48666787|NCT03391882|101970468|FG003|Safety Population Part B|Part B - Treatment Phase||18||
48666788|NCT03391882|101970469|FG004|Safety Population Part B|Part B - Treatment Phase||18||
48512700|NCT03224520|101586028|FG000|STARTED|Overall Study||371||
48512701|NCT03224520|101586029|FG001|STARTED|Overall Study||370||
48512702|NCT03224520|101586030|FG002|STARTED|Overall Study||374||
48512703|NCT03224520|101586031|FG003|STARTED|Overall Study||372||
48512704|NCT03224520|101586028|FG000|COMPLETED|Overall Study||205||
48512705|NCT03224520|101586029|FG001|COMPLETED|Overall Study||207||
48512706|NCT03224520|101586030|FG002|COMPLETED|Overall Study||190||
48512707|NCT03224520|101586031|FG003|COMPLETED|Overall Study||199||
48512708|NCT03224520|101586028|FG000|NOT COMPLETED|Overall Study||166||
48512709|NCT03224520|101586029|FG001|NOT COMPLETED|Overall Study||163||
48512710|NCT03224520|101586030|FG002|NOT COMPLETED|Overall Study||184||
48512711|NCT03224520|101586031|FG003|NOT COMPLETED|Overall Study||173||
48512712|NCT00808509|101586032|FG000|STARTED|Randomized Phase||17||
48512713|NCT00808509|101586033|FG001|STARTED|Randomized Phase||16||
48512714|NCT00808509|101586032|FG000|Received Rescue Therapy|Randomized Phase||0||
48512715|NCT00808509|101586033|FG001|Received Rescue Therapy|Randomized Phase||9||
48512716|NCT00808509|101586032|FG000|COMPLETED|Randomized Phase||15||
48512717|NCT00808509|101586033|FG001|COMPLETED|Randomized Phase||11||
48512718|NCT00808509|101586032|FG000|NOT COMPLETED|Randomized Phase||2||
48512719|NCT00808509|101586033|FG001|NOT COMPLETED|Randomized Phase||5||
48512720|NCT00808509|101586032|FG000|STARTED|Observation Phase||16||
48512721|NCT00808509|101586033|FG001|STARTED|Observation Phase||15||
48512722|NCT00808509|101586032|FG000|COMPLETED|Observation Phase||16||
48512723|NCT00808509|101586033|FG001|COMPLETED|Observation Phase||15||
48512724|NCT00808509|101586032|FG000|NOT COMPLETED|Observation Phase||0||
48512725|NCT00808509|101586033|FG001|NOT COMPLETED|Observation Phase||0||
48512726|NCT01886937|101586034|FG000|STARTED|Overall Study||7||
48512727|NCT01886937|101586035|FG001|STARTED|Overall Study||6||
48512728|NCT01886937|101586034|FG000|COMPLETED|Overall Study||7||
48512729|NCT01886937|101586035|FG001|COMPLETED|Overall Study||6||
48512730|NCT01886937|101586034|FG000|NOT COMPLETED|Overall Study||0||
48512731|NCT01886937|101586035|FG001|NOT COMPLETED|Overall Study||0||
48512732|NCT00673764|101586036|FG000|STARTED|Overall Study||24||
48512733|NCT00673764|101586037|FG001|STARTED|Overall Study||24||
48512734|NCT00673764|101586036|FG000|COMPLETED|Overall Study||24||
48512735|NCT00673764|101586037|FG001|COMPLETED|Overall Study||24||
48512736|NCT00673764|101586036|FG000|NOT COMPLETED|Overall Study||0||
48512737|NCT00673764|101586037|FG001|NOT COMPLETED|Overall Study||0||
48512738|NCT02812771|101586038|FG000|STARTED|Overall Study||62||
48512739|NCT02812771|101586038|FG000|COMPLETED|Overall Study||50||
48512740|NCT02812771|101586038|FG000|NOT COMPLETED|Overall Study||12||
48512741|NCT01020526|101586039|FG000|STARTED|Overall Study||63||
48512742|NCT01020526|101586039|FG000|COMPLETED|Overall Study||49||
48512743|NCT01020526|101586039|FG000|NOT COMPLETED|Overall Study||14||
48512744|NCT02246764|101586040|FG000|STARTED|Overall Study||34||
48512745|NCT02246764|101586041|FG001|STARTED|Overall Study||36||
48512746|NCT02246764|101586042|FG002|STARTED|Overall Study||23||
48512747|NCT02246764|101586040|FG000|COMPLETED|Overall Study||16||
48512748|NCT02246764|101586041|FG001|COMPLETED|Overall Study||4||
48512749|NCT02246764|101586042|FG002|COMPLETED|Overall Study||19||
48512750|NCT02246764|101586040|FG000|NOT COMPLETED|Overall Study||18||
48512751|NCT02246764|101586041|FG001|NOT COMPLETED|Overall Study||32||
48512752|NCT02246764|101586042|FG002|NOT COMPLETED|Overall Study||4||
48512753|NCT03860207|101586043|FG000|STARTED|Overall Study||1||
48512754|NCT03860207|101586044|FG001|STARTED|Overall Study||1||
48512755|NCT03860207|101586045|FG002|STARTED|Overall Study||1||
48512756|NCT03860207|101586046|FG003|STARTED|Overall Study||3||
48512757|NCT03860207|101586047|FG004|STARTED|Overall Study||2||
48512758|NCT03860207|101586048|FG005|STARTED|Overall Study||3||
48512759|NCT03860207|101586043|FG000|Safety Analysis Set|Overall Study||1||
48512760|NCT03860207|101586044|FG001|Safety Analysis Set|Overall Study||1||
48512761|NCT03860207|101586045|FG002|Safety Analysis Set|Overall Study||1||
48512762|NCT03860207|101586046|FG003|Safety Analysis Set|Overall Study||3||
48512763|NCT03860207|101586047|FG004|Safety Analysis Set|Overall Study||2||
48512764|NCT03860207|101586048|FG005|Safety Analysis Set|Overall Study||3||
48512765|NCT03860207|101586043|FG000|Discontinued the Treatment|Overall Study||1||
48512766|NCT03860207|101586044|FG001|Discontinued the Treatment|Overall Study||1||
48512767|NCT03860207|101586045|FG002|Discontinued the Treatment|Overall Study||1||
48512768|NCT03860207|101586046|FG003|Discontinued the Treatment|Overall Study||3||
48512769|NCT03860207|101586047|FG004|Discontinued the Treatment|Overall Study||2||
48512770|NCT03860207|101586048|FG005|Discontinued the Treatment|Overall Study||3||
48512771|NCT03860207|101586043|FG000|Discontinued Treatment - Adverse Events|Overall Study||0||
48512772|NCT03860207|101586044|FG001|Discontinued Treatment - Adverse Events|Overall Study||0||
48512773|NCT03860207|101586045|FG002|Discontinued Treatment - Adverse Events|Overall Study||0||
48512774|NCT03860207|101586046|FG003|Discontinued Treatment - Adverse Events|Overall Study||0||
48512775|NCT03860207|101586047|FG004|Discontinued Treatment - Adverse Events|Overall Study||0||
48512776|NCT03860207|101586048|FG005|Discontinued Treatment - Adverse Events|Overall Study||2||
48512777|NCT03860207|101586043|FG000|Discontinued Treatment - Progressive Disease|Overall Study||1||
48512778|NCT03860207|101586044|FG001|Discontinued Treatment - Progressive Disease|Overall Study||1||
48512779|NCT03860207|101586045|FG002|Discontinued Treatment - Progressive Disease|Overall Study||1||
48512780|NCT03860207|101586046|FG003|Discontinued Treatment - Progressive Disease|Overall Study||3||
48512781|NCT03860207|101586047|FG004|Discontinued Treatment - Progressive Disease|Overall Study||2||
48512782|NCT03860207|101586048|FG005|Discontinued Treatment - Progressive Disease|Overall Study||1||
48512783|NCT03860207|101586043|FG000|COMPLETED|Overall Study||1|Completed minimum 30 days of follow-up from end of treatment.|
48512784|NCT03860207|101586044|FG001|COMPLETED|Overall Study||1|Completed minimum 30 days of follow-up from end of treatment.|
48512785|NCT03860207|101586045|FG002|COMPLETED|Overall Study||1|Completed minimum 30 days of follow-up from end of treatment.|
48512786|NCT03860207|101586046|FG003|COMPLETED|Overall Study||2|Completed minimum 30 days of follow-up from end of treatment.|
48512787|NCT03860207|101586047|FG004|COMPLETED|Overall Study||2|Completed minimum 30 days of follow-up from end of treatment.|
48512788|NCT03860207|101586048|FG005|COMPLETED|Overall Study||3|Completed minimum 30 days of follow-up from end of treatment.|
48512789|NCT03860207|101586043|FG000|NOT COMPLETED|Overall Study||0||
48512790|NCT03860207|101586044|FG001|NOT COMPLETED|Overall Study||0||
48512791|NCT03860207|101586045|FG002|NOT COMPLETED|Overall Study||0||
48512792|NCT03860207|101586046|FG003|NOT COMPLETED|Overall Study||1||
48512793|NCT03860207|101586047|FG004|NOT COMPLETED|Overall Study||0||
48512794|NCT03860207|101586048|FG005|NOT COMPLETED|Overall Study||0||
48512795|NCT01363011|101586049|FG000|STARTED|Main Study||33||
48512796|NCT01363011|101586050|FG001|STARTED|Main Study||73||
48512797|NCT01363011|101586049|FG000|COMPLETED|Main Study||29||
48512798|NCT01363011|101586050|FG001|COMPLETED|Main Study||64||
48512799|NCT01363011|101586049|FG000|NOT COMPLETED|Main Study||4||
48512800|NCT01363011|101586050|FG001|NOT COMPLETED|Main Study||9||
48512801|NCT01363011|101586049|FG000|STARTED|Extension Phase||18||
48512802|NCT01363011|101586050|FG001|STARTED|Extension Phase||49||
48512803|NCT01363011|101586049|FG000|COMPLETED|Extension Phase||13||
48512804|NCT01363011|101586050|FG001|COMPLETED|Extension Phase||41||
48512805|NCT01363011|101586049|FG000|NOT COMPLETED|Extension Phase||5||
48512806|NCT01363011|101586050|FG001|NOT COMPLETED|Extension Phase||8||
48512807|NCT01839695|101586051|FG000|STARTED|Overall Study||9||
48512808|NCT01839695|101586051|FG000|COMPLETED|Overall Study||9||
48512809|NCT01839695|101586051|FG000|NOT COMPLETED|Overall Study||0||
48512810|NCT00981799|101586052|FG000|STARTED|Overall Study||6||
48512811|NCT00981799|101586053|FG001|STARTED|Overall Study||7||
48512812|NCT00981799|101586054|FG002|STARTED|Overall Study||10||
48512813|NCT00981799|101586055|FG003|STARTED|Overall Study||0||
48512814|NCT00981799|101586052|FG000|COMPLETED|Overall Study||5||
48512815|NCT00981799|101586053|FG001|COMPLETED|Overall Study||6||
48512816|NCT00981799|101586054|FG002|COMPLETED|Overall Study||10||
48512817|NCT00981799|101586055|FG003|COMPLETED|Overall Study||0||
48512818|NCT00981799|101586052|FG000|NOT COMPLETED|Overall Study||1||
48512819|NCT00981799|101586053|FG001|NOT COMPLETED|Overall Study||1||
48512820|NCT00981799|101586054|FG002|NOT COMPLETED|Overall Study||0||
48512821|NCT00981799|101586055|FG003|NOT COMPLETED|Overall Study||0||
48512822|NCT02244424|101586056|FG000|STARTED|Overall Study||102|Teen mothers were the participants in the study; data were collected on their infants.|
48512823|NCT02244424|101586057|FG001|STARTED|Overall Study||62|Teen mothers were the participants in the study; data were collected on their infants.|
48512824|NCT02244424|101586056|FG000|Infants|Overall Study||51||
48512825|NCT02244424|101586057|FG001|Infants|Overall Study||31||
48512826|NCT02244424|101586056|FG000|Mothers|Overall Study||51||
48512827|NCT02244424|101586057|FG001|Mothers|Overall Study||31||
48512828|NCT02244424|101586056|FG000|COMPLETED|Overall Study||82|Numbers include both mothers and infants in the study only.|
48512829|NCT02244424|101586057|FG001|COMPLETED|Overall Study||52|Numbers include both mothers and infants in the study only.|
48512830|NCT02244424|101586056|FG000|NOT COMPLETED|Overall Study||20||
48512831|NCT02244424|101586057|FG001|NOT COMPLETED|Overall Study||10||
48512832|NCT00224484|101586058|FG000|STARTED|Overall Study||2977|5960 subjects were randomized, but only 5955 received vaccination|
48512833|NCT00224484|101586059|FG001|STARTED|Overall Study||1491|5960 subjects were randomized, but only 5955 received vaccination|
48512834|NCT00224484|101586060|FG002|STARTED|Overall Study||1487|5960 subjects were randomized, but only 5955 received vaccination|
48512835|NCT00224484|101586058|FG000|COMPLETED|Overall Study||2831||
48512836|NCT00224484|101586059|FG001|COMPLETED|Overall Study||1426||
48512837|NCT00224484|101586060|FG002|COMPLETED|Overall Study||1425||
48512838|NCT00224484|101586058|FG000|NOT COMPLETED|Overall Study||146||
48512839|NCT00224484|101586059|FG001|NOT COMPLETED|Overall Study||65||
48512840|NCT00224484|101586060|FG002|NOT COMPLETED|Overall Study||62||
48512841|NCT02001051|101586061|FG000|STARTED|Overall Study||2||
48512842|NCT02001051|101586062|FG001|STARTED|Overall Study||2||
48512843|NCT02001051|101586061|FG000|COMPLETED|Overall Study||2||
48512844|NCT02001051|101586062|FG001|COMPLETED|Overall Study||1||
48066810|NCT00697788|100485436|FG004|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
48066811|NCT00697788|100485437|FG005|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
48066812|NCT00697788|100485438|FG006|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
48066813|NCT00697788|100485439|FG007|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
48066814|NCT00697788|100485432|FG000|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
48066815|NCT00697788|100485433|FG001|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
48066816|NCT00697788|100485434|FG002|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
48219917|NCT05580003|100863768|FG020|STARTED|Part 3: Period 3 (Day 1)||0||
48512845|NCT02001051|101586061|FG000|NOT COMPLETED|Overall Study||0||
48512846|NCT02001051|101586062|FG001|NOT COMPLETED|Overall Study||1||
48066817|NCT00697788|100485435|FG003|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3||
48066818|NCT00697788|100485436|FG004|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
48066819|NCT00697788|100485437|FG005|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
48066820|NCT00697788|100485438|FG006|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
48066821|NCT00697788|100485439|FG007|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
48066822|NCT00697788|100485432|FG000|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
48066823|NCT00697788|100485433|FG001|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
48066824|NCT00697788|100485434|FG002|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
48066825|NCT00697788|100485435|FG003|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3||
48066826|NCT00697788|100485436|FG004|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
48066827|NCT00697788|100485437|FG005|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
48066828|NCT00697788|100485438|FG006|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
48066829|NCT00697788|100485439|FG007|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
48066830|NCT00697788|100485432|FG000|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
48066831|NCT00697788|100485433|FG001|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
48066832|NCT00697788|100485434|FG002|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
48066833|NCT00697788|100485435|FG003|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
48066834|NCT00697788|100485436|FG004|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
48066835|NCT00697788|100485437|FG005|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
48066836|NCT00697788|100485438|FG006|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
48066837|NCT00697788|100485439|FG007|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
48066838|NCT00697788|100485432|FG000|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
48066839|NCT00697788|100485433|FG001|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
48066840|NCT00697788|100485434|FG002|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
48066841|NCT00697788|100485435|FG003|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
48066842|NCT00697788|100485436|FG004|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||3||
48066843|NCT00697788|100485437|FG005|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
48066844|NCT00697788|100485438|FG006|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
48066845|NCT00697788|100485439|FG007|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
48066846|NCT00697788|100485432|FG000|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
48066847|NCT00697788|100485433|FG001|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
48066848|NCT00697788|100485434|FG002|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
48066849|NCT00697788|100485435|FG003|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
48066850|NCT00697788|100485436|FG004|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||2||
48066851|NCT00697788|100485437|FG005|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
48066852|NCT00697788|100485438|FG006|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
48066853|NCT00697788|100485439|FG007|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
48066854|NCT00697788|100485432|FG000|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
48066855|NCT00697788|100485433|FG001|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
48066856|NCT00697788|100485434|FG002|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
48066857|NCT00697788|100485435|FG003|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
48066858|NCT00697788|100485436|FG004|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||1||
48066859|NCT00697788|100485437|FG005|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
48066860|NCT00697788|100485438|FG006|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
48066861|NCT00697788|100485439|FG007|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
48066862|NCT00697788|100485432|FG000|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
48066863|NCT00697788|100485433|FG001|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
48066864|NCT00697788|100485434|FG002|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
48066865|NCT00697788|100485435|FG003|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
48066866|NCT00697788|100485436|FG004|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
48066867|NCT00697788|100485437|FG005|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2||
48066868|NCT00697788|100485438|FG006|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
48066869|NCT00697788|100485439|FG007|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
48066870|NCT00697788|100485432|FG000|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
48066871|NCT00697788|100485433|FG001|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
48066872|NCT00697788|100485434|FG002|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
48066873|NCT00697788|100485435|FG003|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
48066874|NCT00697788|100485436|FG004|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
48066875|NCT00697788|100485437|FG005|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2||
48066876|NCT00697788|100485438|FG006|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
48066877|NCT00697788|100485439|FG007|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
48066878|NCT00697788|100485432|FG000|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
48066879|NCT00697788|100485433|FG001|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
48066880|NCT00697788|100485434|FG002|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
48066881|NCT00697788|100485435|FG003|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
48066882|NCT00697788|100485436|FG004|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
48066883|NCT00697788|100485437|FG005|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
48066884|NCT00697788|100485438|FG006|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
48066885|NCT00697788|100485439|FG007|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
48066886|NCT00697788|100485432|FG000|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
48066887|NCT00697788|100485433|FG001|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
48066888|NCT00697788|100485434|FG002|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
48066889|NCT00697788|100485435|FG003|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
48066890|NCT00697788|100485436|FG004|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
48066891|NCT00697788|100485437|FG005|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
48066892|NCT00697788|100485438|FG006|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2||
48066893|NCT00697788|100485439|FG007|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
48066894|NCT00697788|100485432|FG000|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
48066895|NCT00697788|100485433|FG001|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
48066896|NCT00697788|100485434|FG002|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
48066897|NCT00697788|100485435|FG003|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
48066898|NCT00697788|100485436|FG004|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
48066899|NCT00697788|100485437|FG005|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
48066900|NCT00697788|100485438|FG006|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2||
48066901|NCT00697788|100485439|FG007|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
48066902|NCT00697788|100485432|FG000|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
48066903|NCT00697788|100485433|FG001|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
48066904|NCT00697788|100485434|FG002|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
48066905|NCT00697788|100485435|FG003|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
48066906|NCT00697788|100485436|FG004|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
48066907|NCT00697788|100485437|FG005|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
48066908|NCT00697788|100485438|FG006|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
48066909|NCT00697788|100485439|FG007|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
48066910|NCT00697788|100485432|FG000|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
48066911|NCT00697788|100485433|FG001|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
48066912|NCT00697788|100485434|FG002|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
48066913|NCT00697788|100485435|FG003|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
48066914|NCT00697788|100485436|FG004|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
48066915|NCT00697788|100485437|FG005|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
48066916|NCT00697788|100485438|FG006|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
48066917|NCT00697788|100485439|FG007|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2||
48066918|NCT00697788|100485432|FG000|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
48066919|NCT00697788|100485433|FG001|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
48066920|NCT00697788|100485434|FG002|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
48066921|NCT00697788|100485435|FG003|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
48066922|NCT00697788|100485436|FG004|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
48066923|NCT00697788|100485437|FG005|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
48066924|NCT00697788|100485438|FG006|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
48066925|NCT00697788|100485439|FG007|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2||
48066926|NCT00697788|100485432|FG000|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
48066927|NCT00697788|100485433|FG001|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
48066928|NCT00697788|100485434|FG002|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
48066929|NCT00697788|100485435|FG003|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
48066930|NCT00697788|100485436|FG004|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
48066931|NCT00697788|100485437|FG005|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
48066932|NCT00697788|100485438|FG006|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
48066933|NCT00697788|100485439|FG007|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
48066934|NCT02006888|100485440|FG000|STARTED|Overall Study||158||
48066935|NCT02006888|100485441|FG001|STARTED|Overall Study||156||
48066936|NCT02006888|100485442|FG002|STARTED|Overall Study||80||
48066937|NCT02006888|100485440|FG000|COMPLETED|Overall Study||122||
48066938|NCT02006888|100485441|FG001|COMPLETED|Overall Study||122||
48066939|NCT02006888|100485442|FG002|COMPLETED|Overall Study||58||
48066940|NCT02006888|100485440|FG000|NOT COMPLETED|Overall Study||36||
48066941|NCT02006888|100485441|FG001|NOT COMPLETED|Overall Study||34||
48066942|NCT02006888|100485442|FG002|NOT COMPLETED|Overall Study||22||
48066943|NCT02104752|100485443|FG000|STARTED|Overall Study||18||
48066944|NCT02104752|100485444|FG001|STARTED|Overall Study||21||
48066945|NCT02104752|100485443|FG000|COMPLETED|Overall Study||17||
48066946|NCT02104752|100485444|FG001|COMPLETED|Overall Study||19||
48066947|NCT02104752|100485443|FG000|NOT COMPLETED|Overall Study||1||
48066948|NCT02104752|100485444|FG001|NOT COMPLETED|Overall Study||2||
48066949|NCT01649804|100485445|FG000|STARTED|Overall Study||12||
48066950|NCT01649804|100485445|FG000|COMPLETED|Overall Study||4||
48066951|NCT01649804|100485445|FG000|NOT COMPLETED|Overall Study||8||
48066952|NCT00887653|100485446|FG000|STARTED|Overall Study||20||
48066953|NCT00887653|100485446|FG000|COMPLETED|Overall Study||20||
48066954|NCT00887653|100485446|FG000|NOT COMPLETED|Overall Study||0||
48066955|NCT01042678|100485447|FG000|STARTED|Overall Study||6||
48066956|NCT01042678|100485448|FG001|STARTED|Overall Study||6||
48066957|NCT01042678|100485449|FG002|STARTED|Overall Study||6||
48066958|NCT01042678|100485450|FG003|STARTED|Overall Study||0||
48066959|NCT01042678|100485451|FG004|STARTED|Overall Study||0||
48066960|NCT01042678|100485452|FG005|STARTED|Overall Study||0||
48066961|NCT01042678|100485447|FG000|COMPLETED|Overall Study||5||
48066962|NCT01042678|100485448|FG001|COMPLETED|Overall Study||6||
48066963|NCT01042678|100485449|FG002|COMPLETED|Overall Study||6||
48066964|NCT01042678|100485450|FG003|COMPLETED|Overall Study||0||
48066965|NCT01042678|100485451|FG004|COMPLETED|Overall Study||0||
48066966|NCT01042678|100485452|FG005|COMPLETED|Overall Study||0||
48066967|NCT01042678|100485447|FG000|NOT COMPLETED|Overall Study||1||
48066968|NCT01042678|100485448|FG001|NOT COMPLETED|Overall Study||0||
48066969|NCT01042678|100485449|FG002|NOT COMPLETED|Overall Study||0||
48066970|NCT01042678|100485450|FG003|NOT COMPLETED|Overall Study||0||
48066971|NCT01042678|100485451|FG004|NOT COMPLETED|Overall Study||0||
48066972|NCT01042678|100485452|FG005|NOT COMPLETED|Overall Study||0||
48066973|NCT02357979|100485453|FG000|STARTED|Overall Study||60|Each participant provided two units - one right, one left second molar|60
48066974|NCT02357979|100485454|FG001|STARTED|Overall Study||60|Each participant provided two units - one right, one left second molar|60
48066975|NCT02357979|100485453|FG000|COMPLETED|Overall Study||55||55
48066976|NCT02357979|100485454|FG001|COMPLETED|Overall Study||55||55
48066977|NCT02357979|100485453|FG000|NOT COMPLETED|Overall Study||5||5
48066978|NCT02357979|100485454|FG001|NOT COMPLETED|Overall Study||5||5
48066979|NCT03945214|100485455|FG000|STARTED|Overall Study||39||
48066980|NCT03945214|100485456|FG001|STARTED|Overall Study||41||
48066981|NCT03945214|100485457|FG002|STARTED|Overall Study||41||
48066982|NCT03945214|100485458|FG003|STARTED|Overall Study||42||
48066983|NCT03945214|100485455|FG000|COMPLETED|Overall Study||36||
48066984|NCT03945214|100485456|FG001|COMPLETED|Overall Study||37||
48066985|NCT03945214|100485457|FG002|COMPLETED|Overall Study||34||
48066986|NCT03945214|100485458|FG003|COMPLETED|Overall Study||38||
48066987|NCT03945214|100485455|FG000|NOT COMPLETED|Overall Study||3||
48066988|NCT03945214|100485456|FG001|NOT COMPLETED|Overall Study||4||
48066989|NCT03945214|100485457|FG002|NOT COMPLETED|Overall Study||7||
48066990|NCT03945214|100485458|FG003|NOT COMPLETED|Overall Study||4||
48066991|NCT01083485|100485459|FG000|STARTED|Overall Study||70||
48066992|NCT01083485|100485460|FG001|STARTED|Overall Study||67||
48066993|NCT01083485|100485459|FG000|COMPLETED|Overall Study||63||
48066994|NCT01083485|100485460|FG001|COMPLETED|Overall Study||64||
48066995|NCT01083485|100485459|FG000|NOT COMPLETED|Overall Study||7||
48066996|NCT01083485|100485460|FG001|NOT COMPLETED|Overall Study||3||
48066997|NCT04154930|100485461|FG000|STARTED|Overall Study||287||
48066998|NCT04154930|100485462|FG001|STARTED|Overall Study||46||
48066999|NCT04154930|100485461|FG000|COMPLETED|Overall Study||250||
48067000|NCT04154930|100485462|FG001|COMPLETED|Overall Study||33||
48067001|NCT04154930|100485461|FG000|NOT COMPLETED|Overall Study||37||
48067002|NCT04154930|100485462|FG001|NOT COMPLETED|Overall Study||13||
48067003|NCT00810108|100485463|FG000|STARTED|Overall Study||6||
48067004|NCT00810108|100485464|FG001|STARTED|Overall Study||7||
48067005|NCT00810108|100485463|FG000|COMPLETED|Overall Study||5||
48067006|NCT00810108|100485464|FG001|COMPLETED|Overall Study||7||
48067007|NCT00810108|100485463|FG000|NOT COMPLETED|Overall Study||1||
48067008|NCT00810108|100485464|FG001|NOT COMPLETED|Overall Study||0||
48067009|NCT03917459|100485465|FG000|STARTED|Overall Study||13||
48067010|NCT03917459|100485466|FG001|STARTED|Overall Study||14||
48067011|NCT03917459|100485465|FG000|COMPLETED|Overall Study||12||
48067012|NCT03917459|100485466|FG001|COMPLETED|Overall Study||13||
48067013|NCT03917459|100485465|FG000|NOT COMPLETED|Overall Study||1||
48067014|NCT03917459|100485466|FG001|NOT COMPLETED|Overall Study||1||
48067015|NCT00074984|100485467|FG000|STARTED|Overall Study||31||
48067016|NCT00074984|100485468|FG001|STARTED|Overall Study||51||
48067017|NCT00074984|100485467|FG000|COMPLETED|Overall Study||28||
48067018|NCT00074984|100485468|FG001|COMPLETED|Overall Study||43||
48067019|NCT00074984|100485467|FG000|NOT COMPLETED|Overall Study||3||
48067020|NCT00074984|100485468|FG001|NOT COMPLETED|Overall Study||8||
48067021|NCT03221270|100485469|FG000|STARTED|Overall Study||8||
48067022|NCT03221270|100485470|FG001|STARTED|Overall Study||6||
48067023|NCT03221270|100485471|FG002|STARTED|Overall Study||5||
48067024|NCT03221270|100485472|FG003|STARTED|Overall Study||6||
48067025|NCT03221270|100485469|FG000|Completed 5-Day Treatment|Overall Study||8||
48067026|NCT03221270|100485470|FG001|Completed 5-Day Treatment|Overall Study||6||
48067027|NCT03221270|100485471|FG002|Completed 5-Day Treatment|Overall Study||5||
48067028|NCT03221270|100485472|FG003|Completed 5-Day Treatment|Overall Study||6||
48067029|NCT03221270|100485469|FG000|Completed 8-Week Maintenance|Overall Study||4||
48067030|NCT03221270|100485470|FG001|Completed 8-Week Maintenance|Overall Study||6||
48067031|NCT03221270|100485471|FG002|Completed 8-Week Maintenance|Overall Study||5||
48067032|NCT03221270|100485472|FG003|Completed 8-Week Maintenance|Overall Study||5||
48067033|NCT03221270|100485469|FG000|COMPLETED|Overall Study||4||
48067034|NCT03221270|100485470|FG001|COMPLETED|Overall Study||6||
48067035|NCT03221270|100485471|FG002|COMPLETED|Overall Study||5||
48067036|NCT03221270|100485472|FG003|COMPLETED|Overall Study||5||
48067037|NCT03221270|100485469|FG000|NOT COMPLETED|Overall Study||4||
48067038|NCT03221270|100485470|FG001|NOT COMPLETED|Overall Study||0||
48067039|NCT03221270|100485471|FG002|NOT COMPLETED|Overall Study||0||
48067040|NCT03221270|100485472|FG003|NOT COMPLETED|Overall Study||1||
48067041|NCT04172623|100485473|FG000|STARTED|Overall Study||29||
48067042|NCT04172623|100485474|FG001|STARTED|Overall Study||29||
48067043|NCT04172623|100485473|FG000|COMPLETED|Overall Study||29||
48067044|NCT04172623|100485474|FG001|COMPLETED|Overall Study||29||
48067045|NCT04172623|100485473|FG000|NOT COMPLETED|Overall Study||0||
48067046|NCT04172623|100485474|FG001|NOT COMPLETED|Overall Study||0||
48067047|NCT04046055|100485475|FG000|STARTED|Overall Study||7||
48067048|NCT04046055|100485475|FG000|Sham|Overall Study||7||
48067049|NCT04046055|100485475|FG000|Unilateral, 2 mA|Overall Study||7||
48067050|NCT04046055|100485475|FG000|Bilateral, 2 mA|Overall Study||7||
48067051|NCT04046055|100485475|FG000|Unilateral, 4 mA|Overall Study||7||
48067052|NCT04046055|100485475|FG000|Bilateral, 4 mA|Overall Study||7||
48067053|NCT04046055|100485475|FG000|COMPLETED|Overall Study||7||
48067054|NCT04046055|100485475|FG000|NOT COMPLETED|Overall Study||0||
48067055|NCT03764007|100485476|FG000|STARTED|Overall Study||98||
48067056|NCT03764007|100485476|FG000|Imaging Completed|Overall Study||98||
48067057|NCT03764007|100485476|FG000|Underwent Parathyroidectomy Surgery|Overall Study||77||
48067058|NCT03764007|100485476|FG000|COMPLETED|Overall Study||77||
48067059|NCT03764007|100485476|FG000|NOT COMPLETED|Overall Study||21||
48067060|NCT01479127|100485477|FG000|STARTED|Overall Study||8||
48067061|NCT01479127|100485477|FG000|Started LCIG|Overall Study||6||
48067062|NCT01479127|100485477|FG000|COMPLETED|Overall Study||5||
48067063|NCT01479127|100485477|FG000|NOT COMPLETED|Overall Study||3||
48067064|NCT01611155|100485478|FG000|STARTED|Overall Study||25||
48067065|NCT01611155|100485479|FG001|STARTED|Overall Study||25||
48067066|NCT01611155|100485478|FG000|Received Treatment|Overall Study||25||
48067067|NCT01611155|100485479|FG001|Received Treatment|Overall Study||25||
48067068|NCT01611155|100485478|FG000|COMPLETED|Overall Study||16|Evaluable for primary endpoint|
48067069|NCT01611155|100485479|FG001|COMPLETED|Overall Study||18|Evaluable for primary endpoint|
48067070|NCT01611155|100485478|FG000|NOT COMPLETED|Overall Study||9||
48067071|NCT01611155|100485479|FG001|NOT COMPLETED|Overall Study||7||
48067072|NCT02391701|100485480|FG000|STARTED|Overall Study||367||
48067073|NCT02391701|100485481|FG001|STARTED|Overall Study||353||
48067074|NCT02391701|100485480|FG000|COMPLETED|Overall Study||346||
48067075|NCT02391701|100485481|FG001|COMPLETED|Overall Study||315||
48067076|NCT02391701|100485480|FG000|NOT COMPLETED|Overall Study||21||
48067077|NCT02391701|100485481|FG001|NOT COMPLETED|Overall Study||38||
48067078|NCT01328431|100485482|FG000|STARTED|Baseline||390||
48067079|NCT01328431|100485483|FG001|STARTED|Baseline||390||
48067080|NCT01328431|100485482|FG000|COMPLETED|Baseline||390||
48067081|NCT01328431|100485483|FG001|COMPLETED|Baseline||388||
48067082|NCT01328431|100485482|FG000|NOT COMPLETED|Baseline||0||
48067083|NCT01328431|100485483|FG001|NOT COMPLETED|Baseline||2||
48067084|NCT01328431|100485482|FG000|STARTED|1 Month (1M)||390||
48067085|NCT01328431|100485483|FG001|STARTED|1 Month (1M)||388||
48067086|NCT01328431|100485482|FG000|COMPLETED|1 Month (1M)||335||
48067087|NCT01328431|100485483|FG001|COMPLETED|1 Month (1M)||330||
48067088|NCT01328431|100485482|FG000|NOT COMPLETED|1 Month (1M)||55||
48067089|NCT01328431|100485483|FG001|NOT COMPLETED|1 Month (1M)||58||
48067090|NCT01328431|100485482|FG000|STARTED|3 Month (3M)||390||
48067091|NCT01328431|100485483|FG001|STARTED|3 Month (3M)||388||
48067092|NCT01328431|100485482|FG000|COMPLETED|3 Month (3M)||313||
48067093|NCT01328431|100485483|FG001|COMPLETED|3 Month (3M)||316||
48067094|NCT01328431|100485482|FG000|NOT COMPLETED|3 Month (3M)||77||
48067095|NCT01328431|100485483|FG001|NOT COMPLETED|3 Month (3M)||72||
48067096|NCT01328431|100485482|FG000|STARTED|12 Month (12M)||388||
48067097|NCT01328431|100485483|FG001|STARTED|12 Month (12M)||386||
48067098|NCT01328431|100485482|FG000|COMPLETED|12 Month (12M)||304||
48067099|NCT01328431|100485483|FG001|COMPLETED|12 Month (12M)||289||
48067100|NCT01328431|100485482|FG000|NOT COMPLETED|12 Month (12M)||84||
48067101|NCT01328431|100485483|FG001|NOT COMPLETED|12 Month (12M)||97||
48067102|NCT01024335|100485484|FG000|STARTED|Overall Study||20||
48067103|NCT01024335|100485485|FG001|STARTED|Overall Study||40||
48067104|NCT01024335|100485484|FG000|COMPLETED|Overall Study||7||
48067105|NCT01024335|100485485|FG001|COMPLETED|Overall Study||14||
48067106|NCT01024335|100485484|FG000|NOT COMPLETED|Overall Study||13||
48067107|NCT01024335|100485485|FG001|NOT COMPLETED|Overall Study||26||
48067108|NCT01980940|100485486|FG000|STARTED|Overall Study||5||
48067109|NCT01980940|100485487|FG001|STARTED|Overall Study||5||
48067110|NCT01980940|100485488|FG002|STARTED|Overall Study||5||
48067111|NCT01980940|100485489|FG003|STARTED|Overall Study||3||
48067112|NCT01980940|100485490|FG004|STARTED|Overall Study||2||
48067113|NCT01980940|100485491|FG005|STARTED|Overall Study||2||
48067114|NCT01980940|100485492|FG006|STARTED|Overall Study||24||
48067115|NCT01980940|100485493|FG007|STARTED|Overall Study||24||
48067116|NCT01980940|100485486|FG000|Treated|Overall Study||5||
48067117|NCT01980940|100485487|FG001|Treated|Overall Study||5||
48067118|NCT01980940|100485488|FG002|Treated|Overall Study||5||
48067119|NCT01980940|100485489|FG003|Treated|Overall Study||3||
48067120|NCT01980940|100485490|FG004|Treated|Overall Study||2||
48067121|NCT01980940|100485491|FG005|Treated|Overall Study||2||
48067122|NCT01980940|100485492|FG006|Treated|Overall Study||24||
48067123|NCT01980940|100485493|FG007|Treated|Overall Study||24||
48067124|NCT01980940|100485486|FG000|COMPLETED|Overall Study||5||
48067125|NCT01980940|100485487|FG001|COMPLETED|Overall Study||5||
48067126|NCT01980940|100485488|FG002|COMPLETED|Overall Study||5||
48067127|NCT01980940|100485489|FG003|COMPLETED|Overall Study||3||
48067128|NCT01980940|100485490|FG004|COMPLETED|Overall Study||2||
48067129|NCT01980940|100485491|FG005|COMPLETED|Overall Study||0||
48067130|NCT01980940|100485492|FG006|COMPLETED|Overall Study||24||
48067131|NCT01980940|100485493|FG007|COMPLETED|Overall Study||24||
48067132|NCT01980940|100485486|FG000|NOT COMPLETED|Overall Study||0||
48067133|NCT01980940|100485487|FG001|NOT COMPLETED|Overall Study||0||
48067134|NCT01980940|100485488|FG002|NOT COMPLETED|Overall Study||0||
48067135|NCT01980940|100485489|FG003|NOT COMPLETED|Overall Study||0||
48067136|NCT01980940|100485490|FG004|NOT COMPLETED|Overall Study||0||
48067137|NCT01980940|100485491|FG005|NOT COMPLETED|Overall Study||2||
48067138|NCT01980940|100485492|FG006|NOT COMPLETED|Overall Study||0||
48067139|NCT01980940|100485493|FG007|NOT COMPLETED|Overall Study||0||
48067140|NCT04806503|100485494|FG000|STARTED|Overall Study||48||
48067141|NCT04806503|100485495|FG001|STARTED|Overall Study||48||
48067142|NCT04806503|100485496|FG002|STARTED|Overall Study||44||
48067143|NCT04806503|100485497|FG003|STARTED|Overall Study||48||
48067144|NCT04806503|100485498|FG004|STARTED|Overall Study||46||
48067145|NCT04806503|100485494|FG000|COMPLETED|Overall Study||46||
48067146|NCT04806503|100485495|FG001|COMPLETED|Overall Study||47||
48067147|NCT04806503|100485496|FG002|COMPLETED|Overall Study||42||
48067148|NCT04806503|100485497|FG003|COMPLETED|Overall Study||46||
48067149|NCT04806503|100485498|FG004|COMPLETED|Overall Study||45||
48067150|NCT04806503|100485494|FG000|NOT COMPLETED|Overall Study||2||
48067151|NCT04806503|100485495|FG001|NOT COMPLETED|Overall Study||1||
48067152|NCT04806503|100485496|FG002|NOT COMPLETED|Overall Study||2||
48067153|NCT04806503|100485497|FG003|NOT COMPLETED|Overall Study||2||
48067154|NCT04806503|100485498|FG004|NOT COMPLETED|Overall Study||1||
48067155|NCT03948581|100485499|FG000|STARTED|Overall Study||51||
48067156|NCT03948581|100485500|FG001|STARTED|Overall Study||51||
48067157|NCT03948581|100485499|FG000|COMPLETED|Overall Study||51||
48067158|NCT03948581|100485500|FG001|COMPLETED|Overall Study||50||
48067159|NCT03948581|100485499|FG000|NOT COMPLETED|Overall Study||0||
48067160|NCT03948581|100485500|FG001|NOT COMPLETED|Overall Study||1||
48067161|NCT00494299|100485501|FG000|STARTED|Overall Study||229||
48067162|NCT00494299|100485502|FG001|STARTED|Overall Study||229||
48067163|NCT00494299|100485501|FG000|Received Treatment|Overall Study||229||
48067164|NCT00494299|100485502|FG001|Received Treatment|Overall Study||227||
48067165|NCT00494299|100485501|FG000|COMPLETED|Overall Study||0||
48067166|NCT00494299|100485502|FG001|COMPLETED|Overall Study||0||
48067167|NCT00494299|100485501|FG000|NOT COMPLETED|Overall Study||229||
48067168|NCT00494299|100485502|FG001|NOT COMPLETED|Overall Study||229||
48067169|NCT03386474|100485503|FG000|STARTED|Overall Study||107||
48067170|NCT03386474|100485504|FG001|STARTED|Overall Study||43||
48067171|NCT03386474|100485503|FG000|COMPLETED|Overall Study||106|Completed exWeek 24|
48067172|NCT03386474|100485504|FG001|COMPLETED|Overall Study||42|Completed exWeek 24|
48067173|NCT03386474|100485503|FG000|NOT COMPLETED|Overall Study||1||
48067174|NCT03386474|100485504|FG001|NOT COMPLETED|Overall Study||1||
48067175|NCT00799422|100485505|FG000|STARTED|First Week of Wear||4||
48067176|NCT00799422|100485506|FG001|STARTED|First Week of Wear||4||
48067177|NCT00799422|100485507|FG002|STARTED|First Week of Wear||4||
48067178|NCT00799422|100485508|FG003|STARTED|First Week of Wear||5||
48067179|NCT00799422|100485509|FG004|STARTED|First Week of Wear||4||
48067180|NCT00799422|100485510|FG005|STARTED|First Week of Wear||5||
48067181|NCT00799422|100485505|FG000|COMPLETED|First Week of Wear||4||
48067182|NCT00799422|100485506|FG001|COMPLETED|First Week of Wear||4||
48067183|NCT00799422|100485507|FG002|COMPLETED|First Week of Wear||3||
48067184|NCT00799422|100485508|FG003|COMPLETED|First Week of Wear||4||
48067185|NCT00799422|100485509|FG004|COMPLETED|First Week of Wear||4||
48067186|NCT00799422|100485510|FG005|COMPLETED|First Week of Wear||5||
48067187|NCT00799422|100485505|FG000|NOT COMPLETED|First Week of Wear||0||
48067188|NCT00799422|100485506|FG001|NOT COMPLETED|First Week of Wear||0||
48067189|NCT00799422|100485507|FG002|NOT COMPLETED|First Week of Wear||1||
48067190|NCT00799422|100485508|FG003|NOT COMPLETED|First Week of Wear||1||
48067191|NCT00799422|100485509|FG004|NOT COMPLETED|First Week of Wear||0||
48067192|NCT00799422|100485510|FG005|NOT COMPLETED|First Week of Wear||0||
48067193|NCT00799422|100485505|FG000|STARTED|Second Week of Wear||4||
48067194|NCT00799422|100485506|FG001|STARTED|Second Week of Wear||4||
48067195|NCT00799422|100485507|FG002|STARTED|Second Week of Wear||3||
48067196|NCT00799422|100485508|FG003|STARTED|Second Week of Wear||3||
48067197|NCT00799422|100485509|FG004|STARTED|Second Week of Wear||4||
48067198|NCT00799422|100485510|FG005|STARTED|Second Week of Wear||4||
48067199|NCT00799422|100485505|FG000|COMPLETED|Second Week of Wear||4||
48067200|NCT00799422|100485506|FG001|COMPLETED|Second Week of Wear||4||
48067201|NCT00799422|100485507|FG002|COMPLETED|Second Week of Wear||3||
48067202|NCT00799422|100485508|FG003|COMPLETED|Second Week of Wear||3||
48067203|NCT00799422|100485509|FG004|COMPLETED|Second Week of Wear||4||
48067204|NCT00799422|100485510|FG005|COMPLETED|Second Week of Wear||4||
48067205|NCT00799422|100485505|FG000|NOT COMPLETED|Second Week of Wear||0||
48067206|NCT00799422|100485506|FG001|NOT COMPLETED|Second Week of Wear||0||
48067207|NCT00799422|100485507|FG002|NOT COMPLETED|Second Week of Wear||0||
48067208|NCT00799422|100485508|FG003|NOT COMPLETED|Second Week of Wear||0||
48067209|NCT00799422|100485509|FG004|NOT COMPLETED|Second Week of Wear||0||
48067210|NCT00799422|100485510|FG005|NOT COMPLETED|Second Week of Wear||0||
48067211|NCT00799422|100485505|FG000|STARTED|Third Week of Wear||4||
48067212|NCT00799422|100485506|FG001|STARTED|Third Week of Wear||4||
48067213|NCT00799422|100485507|FG002|STARTED|Third Week of Wear||3||
48067214|NCT00799422|100485508|FG003|STARTED|Third Week of Wear||3||
48067215|NCT00799422|100485509|FG004|STARTED|Third Week of Wear||4||
48067216|NCT00799422|100485510|FG005|STARTED|Third Week of Wear||4||
48067217|NCT00799422|100485505|FG000|COMPLETED|Third Week of Wear||4||
48067218|NCT00799422|100485506|FG001|COMPLETED|Third Week of Wear||4||
48067219|NCT00799422|100485507|FG002|COMPLETED|Third Week of Wear||3||
48067220|NCT00799422|100485508|FG003|COMPLETED|Third Week of Wear||3||
48067221|NCT00799422|100485509|FG004|COMPLETED|Third Week of Wear||4||
48067222|NCT00799422|100485510|FG005|COMPLETED|Third Week of Wear||4||
48067223|NCT00799422|100485505|FG000|NOT COMPLETED|Third Week of Wear||0||
48512847|NCT00455962|101586063|FG000|STARTED|Overall Study||10||
48512848|NCT00455962|101586064|FG001|STARTED|Overall Study||13||
48512849|NCT00455962|101586063|FG000|COMPLETED|Overall Study||10||
48512850|NCT00455962|101586064|FG001|COMPLETED|Overall Study||13||
48512851|NCT00455962|101586063|FG000|NOT COMPLETED|Overall Study||0||
48512852|NCT00455962|101586064|FG001|NOT COMPLETED|Overall Study||0||
48512853|NCT03259789|101586065|FG000|STARTED|Overall Study||158||
48512854|NCT03259789|101586066|FG001|STARTED|Overall Study||159||
48512855|NCT03259789|101586067|FG002|STARTED|Overall Study||34||
48512856|NCT03259789|101586065|FG000|COMPLETED|Overall Study||141||
48512857|NCT03259789|101586066|FG001|COMPLETED|Overall Study||142||
48512858|NCT03259789|101586067|FG002|COMPLETED|Overall Study||28||
48512859|NCT03259789|101586065|FG000|NOT COMPLETED|Overall Study||17||
48512860|NCT03259789|101586066|FG001|NOT COMPLETED|Overall Study||17||
48512861|NCT03259789|101586067|FG002|NOT COMPLETED|Overall Study||6||
48512862|NCT02938442|101586068|FG000|STARTED|Overall Study||5||
48512863|NCT02938442|101586069|FG001|STARTED|Overall Study||11||
48512864|NCT02938442|101586068|FG000|COMPLETED|Overall Study||3||
48512865|NCT02938442|101586069|FG001|COMPLETED|Overall Study||8||
48512866|NCT02938442|101586068|FG000|NOT COMPLETED|Overall Study||2||
48512867|NCT02938442|101586069|FG001|NOT COMPLETED|Overall Study||3||
48512868|NCT03287687|101586070|FG000|STARTED|Overall Study||88||89
48512869|NCT03287687|101586071|FG001|STARTED|Overall Study||90||91
48512870|NCT03287687|101586070|FG000|Procedures|Overall Study||88||89
48512871|NCT03287687|101586071|FG001|Procedures|Overall Study||90||91
48512872|NCT03287687|101586070|FG000|COMPLETED|Overall Study||88||89
48512873|NCT03287687|101586071|FG001|COMPLETED|Overall Study||90||91
48512874|NCT03287687|101586070|FG000|NOT COMPLETED|Overall Study||0||0
48512875|NCT03287687|101586071|FG001|NOT COMPLETED|Overall Study||0||0
48512876|NCT02485158|101586072|FG000|STARTED|Overall Study||28||
48512877|NCT02485158|101586072|FG000|COMPLETED|Overall Study||24||
48512878|NCT02485158|101586072|FG000|NOT COMPLETED|Overall Study||4||
48512879|NCT04625673|101586073|FG000|STARTED|Overall Study||3||
48512880|NCT04625673|101586074|FG001|STARTED|Overall Study||9||
48512881|NCT04625673|101586075|FG002|STARTED|Overall Study||11||
48512882|NCT04625673|101586073|FG000|COMPLETED|Overall Study||3||
48512883|NCT04625673|101586074|FG001|COMPLETED|Overall Study||9||
48512884|NCT04625673|101586075|FG002|COMPLETED|Overall Study||10||
48512885|NCT04625673|101586073|FG000|NOT COMPLETED|Overall Study||0||
48512886|NCT04625673|101586074|FG001|NOT COMPLETED|Overall Study||0||
48512887|NCT04625673|101586075|FG002|NOT COMPLETED|Overall Study||1||
48512888|NCT01621906|101586076|FG000|STARTED|Overall Study||12||
48512889|NCT01621906|101586077|FG001|STARTED|Overall Study||5||
48512890|NCT01621906|101586076|FG000|COMPLETED|Overall Study||12||
48512891|NCT01621906|101586077|FG001|COMPLETED|Overall Study||5||
48512892|NCT01621906|101586076|FG000|NOT COMPLETED|Overall Study||0||
48512893|NCT01621906|101586077|FG001|NOT COMPLETED|Overall Study||0||
48512894|NCT01011556|101586078|FG000|STARTED|Overall Study||58||
48512895|NCT01011556|101586079|FG001|STARTED|Overall Study||56||
48512896|NCT01011556|101586080|FG002|STARTED|Overall Study||55||
48512897|NCT01011556|101586081|FG003|STARTED|Overall Study||64||
48512898|NCT01011556|101586078|FG000|Received at Least 1 Dose of Study Drug|Overall Study||57||
48512899|NCT01011556|101586079|FG001|Received at Least 1 Dose of Study Drug|Overall Study||56||
48512900|NCT01011556|101586080|FG002|Received at Least 1 Dose of Study Drug|Overall Study||54||
48512901|NCT01011556|101586081|FG003|Received at Least 1 Dose of Study Drug|Overall Study||64||
48512902|NCT01011556|101586078|FG000|COMPLETED|Overall Study||52||
48512903|NCT01011556|101586079|FG001|COMPLETED|Overall Study||48||
48067224|NCT00799422|100485506|FG001|NOT COMPLETED|Third Week of Wear||0||
48067225|NCT00799422|100485507|FG002|NOT COMPLETED|Third Week of Wear||0||
48219918|NCT05580003|100863769|FG021|STARTED|Part 3: Period 3 (Day 1)||0||
48067226|NCT00799422|100485508|FG003|NOT COMPLETED|Third Week of Wear||0||
48067227|NCT00799422|100485509|FG004|NOT COMPLETED|Third Week of Wear||0||
48067228|NCT00799422|100485510|FG005|NOT COMPLETED|Third Week of Wear||0||
48512904|NCT01011556|101586080|FG002|COMPLETED|Overall Study||45||
48512905|NCT01011556|101586081|FG003|COMPLETED|Overall Study||51||
48512906|NCT01011556|101586078|FG000|NOT COMPLETED|Overall Study||6||
48512907|NCT01011556|101586079|FG001|NOT COMPLETED|Overall Study||8||
48512908|NCT01011556|101586080|FG002|NOT COMPLETED|Overall Study||10||
48512909|NCT01011556|101586081|FG003|NOT COMPLETED|Overall Study||13||
48512910|NCT02839798|101586082|FG000|STARTED|Overall Study||6||
48512911|NCT02839798|101586082|FG000|COMPLETED|Overall Study||4||
48512912|NCT02839798|101586082|FG000|NOT COMPLETED|Overall Study||2||
48512913|NCT03087786|101586083|FG000|STARTED|Overall Study||50||
48512914|NCT03087786|101586084|FG001|STARTED|Overall Study||50||
48512915|NCT03087786|101586083|FG000|COMPLETED|Overall Study||48||
48512916|NCT03087786|101586084|FG001|COMPLETED|Overall Study||50||
48512917|NCT03087786|101586083|FG000|NOT COMPLETED|Overall Study||2||
48512918|NCT03087786|101586084|FG001|NOT COMPLETED|Overall Study||0||
48512919|NCT00063882|101586085|FG000|STARTED|Overall Study||292||
48512920|NCT00063882|101586086|FG001|STARTED|Overall Study||296||
48512921|NCT00063882|101586085|FG000|Eligible Patients|Overall Study||287||
48512922|NCT00063882|101586086|FG001|Eligible Patients|Overall Study||292||
48512923|NCT00063882|101586085|FG000|Has Acute Adverse Event Data|Overall Study||282|Eligible patients who started study treatment|
48512924|NCT00063882|101586086|FG001|Has Acute Adverse Event Data|Overall Study||288|Eligible patients who started study treatment|
48512925|NCT00063882|101586085|FG000|Has Late Adverse Event Data|Overall Study||282|Eligible patients who started study treatment and are alive 181 days after start of radiation|
48512926|NCT00063882|101586086|FG001|Has Late Adverse Event Data|Overall Study||287|Eligible patients who started study treatment and are alive 181 days after start of radiation|
48512927|NCT00063882|101586085|FG000|COMPLETED|Overall Study||287|Subjects contributing any data to analysis are considered to have completed the study.|
48512928|NCT00063882|101586086|FG001|COMPLETED|Overall Study||292|Subjects contributing any data to analysis are considered to have completed the study.|
48512929|NCT00063882|101586085|FG000|NOT COMPLETED|Overall Study||5||
48512930|NCT00063882|101586086|FG001|NOT COMPLETED|Overall Study||4||
48512931|NCT03239496|101586087|FG000|STARTED|Overall Study||200||
48512932|NCT03239496|101586088|FG001|STARTED|Overall Study||178||
48512933|NCT03239496|101586089|FG002|STARTED|Overall Study||178||
48512934|NCT03239496|101586090|FG003|STARTED|Overall Study||217||
48512935|NCT03239496|101586087|FG000|COMPLETED|Overall Study||186||
48512936|NCT03239496|101586088|FG001|COMPLETED|Overall Study||168||
48512937|NCT03239496|101586089|FG002|COMPLETED|Overall Study||166||
48512938|NCT03239496|101586090|FG003|COMPLETED|Overall Study||203||
48512939|NCT03239496|101586087|FG000|NOT COMPLETED|Overall Study||14||
48512940|NCT03239496|101586088|FG001|NOT COMPLETED|Overall Study||10||
48512941|NCT03239496|101586089|FG002|NOT COMPLETED|Overall Study||12||
48512942|NCT03239496|101586090|FG003|NOT COMPLETED|Overall Study||14||
48512943|NCT01043926|101586091|FG000|STARTED|Overall Study||8||
48512944|NCT01043926|101586092|FG001|STARTED|Overall Study||8||
48512945|NCT01043926|101586093|FG002|STARTED|Overall Study||0||
48512946|NCT01043926|101586094|FG003|STARTED|Overall Study||0||
48512947|NCT01043926|101586091|FG000|COMPLETED|Overall Study||8||
48512948|NCT01043926|101586092|FG001|COMPLETED|Overall Study||8||
48512949|NCT01043926|101586093|FG002|COMPLETED|Overall Study||0||
48512950|NCT01043926|101586094|FG003|COMPLETED|Overall Study||0||
48512951|NCT01043926|101586091|FG000|NOT COMPLETED|Overall Study||0||
48512952|NCT01043926|101586092|FG001|NOT COMPLETED|Overall Study||0||
48512953|NCT01043926|101586093|FG002|NOT COMPLETED|Overall Study||0||
48512954|NCT01043926|101586094|FG003|NOT COMPLETED|Overall Study||0||
48512955|NCT01957150|101586095|FG000|STARTED|Overall Study||142||
48512956|NCT01957150|101586096|FG001|STARTED|Overall Study||141||
48512957|NCT01957150|101586095|FG000|COMPLETED|Overall Study||87||
48512958|NCT01957150|101586096|FG001|COMPLETED|Overall Study||83||
48512959|NCT01957150|101586095|FG000|NOT COMPLETED|Overall Study||55||
48512960|NCT01957150|101586096|FG001|NOT COMPLETED|Overall Study||58||
48512961|NCT00784030|101586097|FG000|STARTED|Overall Study||13||
48512962|NCT00784030|101586098|FG001|STARTED|Overall Study||10||
48512963|NCT00784030|101586097|FG000|COMPLETED|Overall Study||13||
48512964|NCT00784030|101586098|FG001|COMPLETED|Overall Study||10||
48512965|NCT00784030|101586097|FG000|NOT COMPLETED|Overall Study||0||
48512966|NCT00784030|101586098|FG001|NOT COMPLETED|Overall Study||0||
48512967|NCT03208673|101586099|FG000|STARTED|Overall Study||32||
48512968|NCT03208673|101586099|FG000|COMPLETED|Overall Study||32||
48512969|NCT03208673|101586099|FG000|NOT COMPLETED|Overall Study||0||
48512970|NCT00277524|101586100|FG000|STARTED|Overall Study||621||
48512971|NCT00277524|101586101|FG001|STARTED|Overall Study||324||
48512972|NCT00277524|101586102|FG002|STARTED|Overall Study||1088||
48512973|NCT00277524|101586103|FG003|STARTED|Overall Study||850||
48512974|NCT00277524|101586100|FG000|COMPLETED|Overall Study||621||
48512975|NCT00277524|101586101|FG001|COMPLETED|Overall Study||324||
48512976|NCT00277524|101586102|FG002|COMPLETED|Overall Study||1088||
48512977|NCT00277524|101586103|FG003|COMPLETED|Overall Study||850||
48512978|NCT00277524|101586100|FG000|NOT COMPLETED|Overall Study||0||
48512979|NCT00277524|101586101|FG001|NOT COMPLETED|Overall Study||0||
48512980|NCT00277524|101586102|FG002|NOT COMPLETED|Overall Study||0||
48512981|NCT00277524|101586103|FG003|NOT COMPLETED|Overall Study||0||
48512982|NCT02344745|101586104|FG000|STARTED|Overall Study||40||
48067229|NCT01500031|100485511|FG000|STARTED|Overall Study||92||
48512983|NCT02344745|101586105|FG001|STARTED|Overall Study||40||
48512984|NCT02344745|101586104|FG000|COMPLETED|Overall Study||38||
48666789|NCT03391882|101970470|FG005|Safety Population Part B|Part B - Treatment Phase||19||
48067230|NCT01500031|100485511|FG000|COMPLETED|Overall Study||87||
48067231|NCT01500031|100485511|FG000|NOT COMPLETED|Overall Study||5||
48067232|NCT01631110|100485512|FG000|STARTED|Overall Study||55||
48067233|NCT01631110|100485513|FG001|STARTED|Overall Study||55||
48067234|NCT01631110|100485512|FG000|COMPLETED|Overall Study||55||
48067235|NCT01631110|100485513|FG001|COMPLETED|Overall Study||55||
48067236|NCT01631110|100485512|FG000|NOT COMPLETED|Overall Study||0||
48067237|NCT01631110|100485513|FG001|NOT COMPLETED|Overall Study||0||
48067238|NCT00098956|100485514|FG000|STARTED|Overall Study||19||
48067239|NCT00098956|100485514|FG000|COMPLETED|Overall Study||19||
48067240|NCT00098956|100485514|FG000|NOT COMPLETED|Overall Study||0||
48067241|NCT03319173|100485515|FG000|STARTED|Overall Study||48||
48067242|NCT03319173|100485516|FG001|STARTED|Overall Study||50||
48067243|NCT03319173|100485515|FG000|COMPLETED|Overall Study||48||
48067244|NCT03319173|100485516|FG001|COMPLETED|Overall Study||50||
48067245|NCT03319173|100485515|FG000|NOT COMPLETED|Overall Study||0||
48067246|NCT03319173|100485516|FG001|NOT COMPLETED|Overall Study||0||
48067247|NCT02169479|100485517|FG000|STARTED|Overall Study||4||
48067248|NCT02169479|100485518|FG001|STARTED|Overall Study||4||
48067249|NCT02169479|100485519|FG002|STARTED|Overall Study||4||
48067250|NCT02169479|100485520|FG003|STARTED|Overall Study||4||
48067251|NCT02169479|100485517|FG000|25 mg BIA 9-1067|Overall Study||4||
48067252|NCT02169479|100485518|FG001|25 mg BIA 9-1067|Overall Study||3||
48067253|NCT02169479|100485519|FG002|25 mg BIA 9-1067|Overall Study||4||
48067254|NCT02169479|100485520|FG003|25 mg BIA 9-1067|Overall Study||4||
48067255|NCT02169479|100485517|FG000|50 mg BIA 9-1067|Overall Study||4||
48067256|NCT02169479|100485518|FG001|50 mg BIA 9-1067|Overall Study||4||
48067257|NCT02169479|100485519|FG002|50 mg BIA 9-1067|Overall Study||4||
48067258|NCT02169479|100485520|FG003|50 mg BIA 9-1067|Overall Study||4||
48067259|NCT02169479|100485517|FG000|100 mg BIA 9-1067|Overall Study||3||
48067260|NCT02169479|100485518|FG001|100 mg BIA 9-1067|Overall Study||4||
48067261|NCT02169479|100485519|FG002|100 mg BIA 9-1067|Overall Study||4||
48067262|NCT02169479|100485520|FG003|100 mg BIA 9-1067|Overall Study||4||
48067263|NCT02169479|100485517|FG000|Placebo|Overall Study||3||
48067264|NCT02169479|100485518|FG001|Placebo|Overall Study||3||
48067265|NCT02169479|100485519|FG002|Placebo|Overall Study||4||
48067266|NCT02169479|100485520|FG003|Placebo|Overall Study||4||
48067267|NCT02169479|100485517|FG000|COMPLETED|Overall Study||3||
48067268|NCT02169479|100485518|FG001|COMPLETED|Overall Study||3||
48067269|NCT02169479|100485519|FG002|COMPLETED|Overall Study||4||
48067270|NCT02169479|100485520|FG003|COMPLETED|Overall Study||4||
48067271|NCT02169479|100485517|FG000|NOT COMPLETED|Overall Study||1||
48067272|NCT02169479|100485518|FG001|NOT COMPLETED|Overall Study||1||
48067273|NCT02169479|100485519|FG002|NOT COMPLETED|Overall Study||0||
48067274|NCT02169479|100485520|FG003|NOT COMPLETED|Overall Study||0||
48067275|NCT04667481|100485521|FG000|STARTED|Overall Study||9||
48067276|NCT04667481|100485522|FG001|STARTED|Overall Study||9||
48067277|NCT04667481|100485523|FG002|STARTED|Overall Study||9||
48067278|NCT04667481|100485521|FG000|COMPLETED|Overall Study||9||
48067279|NCT04667481|100485522|FG001|COMPLETED|Overall Study||8||
48067280|NCT04667481|100485523|FG002|COMPLETED|Overall Study||8||
48067281|NCT04667481|100485521|FG000|NOT COMPLETED|Overall Study||0||
48067282|NCT04667481|100485522|FG001|NOT COMPLETED|Overall Study||1||
48067283|NCT04667481|100485523|FG002|NOT COMPLETED|Overall Study||1||
48067284|NCT01323959|100485524|FG000|STARTED|Overall Study||67||
48067285|NCT01323959|100485525|FG001|STARTED|Overall Study||72||
48067286|NCT01323959|100485526|FG002|STARTED|Overall Study||72||
48067287|NCT01323959|100485524|FG000|COMPLETED|Overall Study||67||
48067288|NCT01323959|100485525|FG001|COMPLETED|Overall Study||72||
48067289|NCT01323959|100485526|FG002|COMPLETED|Overall Study||72||
48067290|NCT01323959|100485524|FG000|NOT COMPLETED|Overall Study||0||
48067291|NCT01323959|100485525|FG001|NOT COMPLETED|Overall Study||0||
48067292|NCT01323959|100485526|FG002|NOT COMPLETED|Overall Study||0||
48067293|NCT01484275|100485527|FG000|STARTED|Overall Study||43||
48067294|NCT01484275|100485528|FG001|STARTED|Overall Study||42||
48067295|NCT01484275|100485527|FG000|COMPLETED|Overall Study||0||
48067296|NCT01484275|100485528|FG001|COMPLETED|Overall Study||0||
48067297|NCT01484275|100485527|FG000|NOT COMPLETED|Overall Study||43||
48067298|NCT01484275|100485528|FG001|NOT COMPLETED|Overall Study||42||
48067299|NCT01713608|100485529|FG000|STARTED|Overall Study||8||
48067300|NCT01713608|100485530|FG001|STARTED|Overall Study||6||
48067301|NCT01713608|100485531|FG002|STARTED|Overall Study||8||
48067302|NCT01713608|100485532|FG003|STARTED|Overall Study||12||
48067303|NCT01713608|100485529|FG000|COMPLETED|Overall Study||8||
48067304|NCT01713608|100485530|FG001|COMPLETED|Overall Study||6||
48512985|NCT02344745|101586105|FG001|COMPLETED|Overall Study||40||
48512986|NCT02344745|101586104|FG000|NOT COMPLETED|Overall Study||2||
48067305|NCT01713608|100485531|FG002|COMPLETED|Overall Study||8||
48067306|NCT01713608|100485532|FG003|COMPLETED|Overall Study||12||
48067307|NCT01713608|100485529|FG000|NOT COMPLETED|Overall Study||0||
48067308|NCT01713608|100485530|FG001|NOT COMPLETED|Overall Study||0||
48067309|NCT01713608|100485531|FG002|NOT COMPLETED|Overall Study||0||
48067310|NCT01713608|100485532|FG003|NOT COMPLETED|Overall Study||0||
48067311|NCT00044083|100485533|FG000|STARTED|First Intervention (One Week)- HV's||74||
48067312|NCT00044083|100485534|FG001|STARTED|First Intervention (One Week)- HV's||73||
48067313|NCT00044083|100485533|FG000|COMPLETED|First Intervention (One Week)- HV's||64||
48067314|NCT00044083|100485534|FG001|COMPLETED|First Intervention (One Week)- HV's||66||
48067315|NCT00044083|100485533|FG000|NOT COMPLETED|First Intervention (One Week)- HV's||10||
48067316|NCT00044083|100485534|FG001|NOT COMPLETED|First Intervention (One Week)- HV's||7||
48067317|NCT00044083|100485533|FG000|STARTED|Second Intervention (One Week) HV's||64||
48067318|NCT00044083|100485534|FG001|STARTED|Second Intervention (One Week) HV's||66||
48067319|NCT00044083|100485533|FG000|COMPLETED|Second Intervention (One Week) HV's||64||
48067320|NCT00044083|100485534|FG001|COMPLETED|Second Intervention (One Week) HV's||66||
48067321|NCT00044083|100485533|FG000|NOT COMPLETED|Second Intervention (One Week) HV's||0||
48067322|NCT00044083|100485534|FG001|NOT COMPLETED|Second Intervention (One Week) HV's||0||
48067323|NCT00044083|100485533|FG000|STARTED|First Intervention (One Week) Patients||31||
48067324|NCT00044083|100485534|FG001|STARTED|First Intervention (One Week) Patients||32||
48067325|NCT00044083|100485533|FG000|COMPLETED|First Intervention (One Week) Patients||30||
48067326|NCT00044083|100485534|FG001|COMPLETED|First Intervention (One Week) Patients||30||
48067327|NCT00044083|100485533|FG000|NOT COMPLETED|First Intervention (One Week) Patients||1||
48067328|NCT00044083|100485534|FG001|NOT COMPLETED|First Intervention (One Week) Patients||2||
48067329|NCT00044083|100485533|FG000|STARTED|Second Intervention (One Week) Patients||30||
48067330|NCT00044083|100485534|FG001|STARTED|Second Intervention (One Week) Patients||30||
48067331|NCT00044083|100485533|FG000|COMPLETED|Second Intervention (One Week) Patients||30||
48067332|NCT00044083|100485534|FG001|COMPLETED|Second Intervention (One Week) Patients||29||
48067333|NCT00044083|100485533|FG000|NOT COMPLETED|Second Intervention (One Week) Patients||0||
48067334|NCT00044083|100485534|FG001|NOT COMPLETED|Second Intervention (One Week) Patients||1||
48067335|NCT01854242|100485535|FG000|STARTED|Overall Study||50||
48067336|NCT01854242|100485535|FG000|COMPLETED|Overall Study||50||
48067337|NCT01854242|100485535|FG000|NOT COMPLETED|Overall Study||0||
48067338|NCT00917501|100485536|FG000|STARTED|Overall Study||29||
48067339|NCT00917501|100485537|FG001|STARTED|Overall Study||26||
48067340|NCT00917501|100485536|FG000|COMPLETED|Overall Study||21||
48067341|NCT00917501|100485537|FG001|COMPLETED|Overall Study||21||
48067342|NCT00917501|100485536|FG000|NOT COMPLETED|Overall Study||8||
48067343|NCT00917501|100485537|FG001|NOT COMPLETED|Overall Study||5||
48067344|NCT02202837|100485538|FG000|STARTED|Overall Study||140||
48067345|NCT02202837|100485539|FG001|STARTED|Overall Study||17||
48067346|NCT02202837|100485538|FG000|COMPLETED|Overall Study||87||
48067347|NCT02202837|100485539|FG001|COMPLETED|Overall Study||12||
48067348|NCT02202837|100485538|FG000|NOT COMPLETED|Overall Study||53||
48067349|NCT02202837|100485539|FG001|NOT COMPLETED|Overall Study||5||
48067350|NCT00657358|100485540|FG000|STARTED|Overall Study||22||
48067351|NCT00657358|100485540|FG000|COMPLETED|Overall Study||16||
48067352|NCT00657358|100485540|FG000|NOT COMPLETED|Overall Study||6||
48067353|NCT02716805|100485541|FG000|STARTED|Overall Study||6||
48067354|NCT02716805|100485542|FG001|STARTED|Overall Study||0||
48067355|NCT02716805|100485543|FG002|STARTED|Overall Study||0||
48067356|NCT02716805|100485544|FG003|STARTED|Overall Study||0||
48067357|NCT02716805|100485541|FG000|COMPLETED|Overall Study||4||
48067358|NCT02716805|100485542|FG001|COMPLETED|Overall Study||0||
48067359|NCT02716805|100485543|FG002|COMPLETED|Overall Study||0||
48067360|NCT02716805|100485544|FG003|COMPLETED|Overall Study||0||
48067361|NCT02716805|100485541|FG000|NOT COMPLETED|Overall Study||2||
48067362|NCT02716805|100485542|FG001|NOT COMPLETED|Overall Study||0||
48067363|NCT02716805|100485543|FG002|NOT COMPLETED|Overall Study||0||
48067364|NCT02716805|100485544|FG003|NOT COMPLETED|Overall Study||0||
48067365|NCT02765269|100485545|FG000|STARTED|Overall Study||25||
48067366|NCT02765269|100485546|FG001|STARTED|Overall Study||21||
48067367|NCT02765269|100485545|FG000|COMPLETED|Overall Study||25||
48067368|NCT02765269|100485546|FG001|COMPLETED|Overall Study||21||
48067369|NCT02765269|100485545|FG000|NOT COMPLETED|Overall Study||0||
48067370|NCT02765269|100485546|FG001|NOT COMPLETED|Overall Study||0||
48067371|NCT02605304|100485547|FG000|STARTED|Overall Study||4||
48067372|NCT02605304|100485548|FG001|STARTED|Overall Study||3||
48067373|NCT02605304|100485547|FG000|COMPLETED|Overall Study||4||
48067374|NCT02605304|100485548|FG001|COMPLETED|Overall Study||3||
48067375|NCT02605304|100485547|FG000|NOT COMPLETED|Overall Study||0||
48067376|NCT02605304|100485548|FG001|NOT COMPLETED|Overall Study||0||
48067377|NCT02229383|100485549|FG000|STARTED|Overall Study||232||
48067378|NCT02229383|100485550|FG001|STARTED|Overall Study||229||
48067379|NCT02229383|100485549|FG000|Received Treatment|Overall Study||231||
48067380|NCT02229383|100485550|FG001|Received Treatment|Overall Study||229||
48067381|NCT02229383|100485549|FG000|Safety Analysis Set|Overall Study||231||
48067382|NCT02229383|100485550|FG001|Safety Analysis Set|Overall Study||229||
48067383|NCT02229383|100485549|FG000|Intent-to-treat (ITT) Analysis Set|Overall Study||230||
48067384|NCT02229383|100485550|FG001|Intent-to-treat (ITT) Analysis Set|Overall Study||228||
48067385|NCT02229383|100485549|FG000|COMPLETED|Overall Study||212||
48067386|NCT02229383|100485550|FG001|COMPLETED|Overall Study||207||
48067387|NCT02229383|100485549|FG000|NOT COMPLETED|Overall Study||20||
48067388|NCT02229383|100485550|FG001|NOT COMPLETED|Overall Study||22||
48067389|NCT03638622|100485551|FG000|STARTED|Overall Study||30||
48067390|NCT03638622|100485551|FG000|COMPLETED|Overall Study||29||
48067391|NCT03638622|100485551|FG000|NOT COMPLETED|Overall Study||1||
48067392|NCT03650556|100485552|FG000|STARTED|Overall Study||224||
48067393|NCT03650556|100485552|FG000|Ablation Procedure|Overall Study||223||
48067394|NCT03650556|100485552|FG000|Pre-Discharge|Overall Study||223||
48067395|NCT03650556|100485552|FG000|7-day Follow-Up|Overall Study||223||
48067396|NCT03650556|100485552|FG000|3-month Follow-Up|Overall Study||210||
48067397|NCT03650556|100485552|FG000|6-month Follow-up|Overall Study||197||
48067398|NCT03650556|100485552|FG000|12-month Follow-Up|Overall Study||189||
48067399|NCT03650556|100485552|FG000|15-month Follow-Up|Overall Study||187||
48067400|NCT03650556|100485552|FG000|COMPLETED|Overall Study||187||
48067401|NCT03650556|100485552|FG000|NOT COMPLETED|Overall Study||37||
48067402|NCT04638660|100485553|FG000|STARTED|Overall Study||71||
48512987|NCT02344745|101586105|FG001|NOT COMPLETED|Overall Study||0||
48512988|NCT01997723|101586106|FG000|STARTED|Overall Study||75||
48512989|NCT01997723|101586106|FG000|COMPLETED|Overall Study||75||
48067403|NCT04638660|100485554|FG001|STARTED|Overall Study||73||
48067404|NCT04638660|100485553|FG000|COMPLETED|Overall Study||68||
48067405|NCT04638660|100485554|FG001|COMPLETED|Overall Study||73||
48067406|NCT04638660|100485553|FG000|NOT COMPLETED|Overall Study||3||
48067407|NCT04638660|100485554|FG001|NOT COMPLETED|Overall Study||0||
48067408|NCT01031381|100485555|FG000|STARTED|Overall Study||59||
48067409|NCT01031381|100485555|FG000|COMPLETED|Overall Study||50||
48067410|NCT01031381|100485555|FG000|NOT COMPLETED|Overall Study||9||
48067411|NCT02128932|100485556|FG000|STARTED|Overall Study||362||
48067412|NCT02128932|100485557|FG001|STARTED|Overall Study||360||
48067413|NCT02128932|100485558|FG002|STARTED|Overall Study||360||
48067414|NCT02128932|100485556|FG000|COMPLETED|Overall Study||335||
48067415|NCT02128932|100485557|FG001|COMPLETED|Overall Study||341||
48067416|NCT02128932|100485558|FG002|COMPLETED|Overall Study||342||
48067417|NCT02128932|100485556|FG000|NOT COMPLETED|Overall Study||27||
48067418|NCT02128932|100485557|FG001|NOT COMPLETED|Overall Study||19||
48067419|NCT02128932|100485558|FG002|NOT COMPLETED|Overall Study||18||
48067420|NCT03488355|100485559|FG000|STARTED|Overall Study||54||
48067421|NCT03488355|100485560|FG001|STARTED|Overall Study||46||
48512990|NCT01997723|101586106|FG000|NOT COMPLETED|Overall Study||0||
48512991|NCT01301482|101586107|FG000|STARTED|Overall Study||3||
48512992|NCT01301482|101586107|FG000|COMPLETED|Overall Study||2||
48512993|NCT01301482|101586107|FG000|NOT COMPLETED|Overall Study||1||
48512994|NCT02051595|101586108|FG000|STARTED|Overall Study||25||
48512995|NCT02051595|101586108|FG000|COMPLETED|Overall Study||25||
48512996|NCT02051595|101586108|FG000|NOT COMPLETED|Overall Study||0||
48512997|NCT02076776|101586109|FG000|STARTED|Overall Study||6||
48512998|NCT02076776|101586110|FG001|STARTED|Overall Study||8||
48512999|NCT02076776|101586111|FG002|STARTED|Overall Study||6||
48513000|NCT02076776|101586109|FG000|COMPLETED|Overall Study||5||
48513001|NCT02076776|101586110|FG001|COMPLETED|Overall Study||6||
48513002|NCT02076776|101586111|FG002|COMPLETED|Overall Study||6||
48513003|NCT02076776|101586109|FG000|NOT COMPLETED|Overall Study||1||
48513004|NCT02076776|101586110|FG001|NOT COMPLETED|Overall Study||2||
48513005|NCT02076776|101586111|FG002|NOT COMPLETED|Overall Study||0||
48513006|NCT00442351|101586112|FG000|STARTED|Overall Study||17||
48513007|NCT00442351|101586113|FG001|STARTED|Overall Study||9||
48513008|NCT00442351|101586112|FG000|COMPLETED|Overall Study||10||
48513009|NCT00442351|101586113|FG001|COMPLETED|Overall Study||3||
48513010|NCT00442351|101586112|FG000|NOT COMPLETED|Overall Study||7||
48513011|NCT00442351|101586113|FG001|NOT COMPLETED|Overall Study||6||
48513012|NCT02419573|101586114|FG000|STARTED|Overall Study||1499||
48513013|NCT02419573|101586115|FG001|STARTED|Overall Study||1505||
48513014|NCT02419573|101586114|FG000|COMPLETED|Overall Study||1495||
48513015|NCT02419573|101586115|FG001|COMPLETED|Overall Study||1505||
48513016|NCT02419573|101586114|FG000|NOT COMPLETED|Overall Study||4||
48513017|NCT02419573|101586115|FG001|NOT COMPLETED|Overall Study||0||
48513018|NCT03566238|101586116|FG000|STARTED|Overall Study||23||
48513019|NCT03566238|101586117|FG001|STARTED|Overall Study||19||
48513020|NCT03566238|101586118|FG002|STARTED|Overall Study||20||
48513021|NCT03566238|101586116|FG000|Received Treatment|Overall Study||23||
48513022|NCT03566238|101586117|FG001|Received Treatment|Overall Study||19||
48513023|NCT03566238|101586118|FG002|Received Treatment|Overall Study||20||
48067422|NCT03488355|100485559|FG000|COMPLETED|Overall Study||54||
48067423|NCT03488355|100485560|FG001|COMPLETED|Overall Study||46||
48513024|NCT03566238|101586116|FG000|COMPLETED|Overall Study||18||
48513025|NCT03566238|101586117|FG001|COMPLETED|Overall Study||16||
48513026|NCT03566238|101586118|FG002|COMPLETED|Overall Study||15||
48513027|NCT03566238|101586116|FG000|NOT COMPLETED|Overall Study||5||
48513028|NCT03566238|101586117|FG001|NOT COMPLETED|Overall Study||3||
48513029|NCT03566238|101586118|FG002|NOT COMPLETED|Overall Study||5||
48513030|NCT04403399|101586119|FG000|STARTED|Period 1||18||
48513031|NCT04403399|101586120|FG001|STARTED|Period 1||16||
48513032|NCT04403399|101586119|FG000|COMPLETED|Period 1||18||
48513033|NCT04403399|101586120|FG001|COMPLETED|Period 1||16||
48513034|NCT04403399|101586119|FG000|NOT COMPLETED|Period 1||0||
48513035|NCT04403399|101586120|FG001|NOT COMPLETED|Period 1||0||
48513036|NCT04403399|101586119|FG000|STARTED|Period 2||18||
48513037|NCT04403399|101586120|FG001|STARTED|Period 2||16||
48067424|NCT03488355|100485559|FG000|NOT COMPLETED|Overall Study||0||
48067425|NCT03488355|100485560|FG001|NOT COMPLETED|Overall Study||0||
48513038|NCT04403399|101586119|FG000|COMPLETED|Period 2||18||
48513039|NCT04403399|101586120|FG001|COMPLETED|Period 2||15||
48513040|NCT04403399|101586119|FG000|NOT COMPLETED|Period 2||0||
48513041|NCT04403399|101586120|FG001|NOT COMPLETED|Period 2||1||
48513042|NCT04099641|101586121|FG000|STARTED|Overall Study||61||
48067426|NCT00165984|100485561|FG000|STARTED|Overall Study||165||
48067427|NCT00165984|100485561|FG000|COMPLETED|Overall Study||150||
48067428|NCT00165984|100485561|FG000|NOT COMPLETED|Overall Study||15||
48067429|NCT00785928|100485562|FG000|STARTED|Treatment Phase||36||
48067430|NCT00785928|100485563|FG001|STARTED|Treatment Phase||30||
48067431|NCT00785928|100485564|FG002|STARTED|Treatment Phase||20||
48513043|NCT04099641|101586122|FG001|STARTED|Overall Study||19||
48513044|NCT04099641|101586121|FG000|Safety Population|Overall Study||61||
48513045|NCT04099641|101586122|FG001|Safety Population|Overall Study||19||
48513046|NCT04099641|101586121|FG000|DLT-evaluable Population|Overall Study||3||
48513047|NCT04099641|101586122|FG001|DLT-evaluable Population|Overall Study||0||
48513048|NCT04099641|101586121|FG000|Efficacy Population|Overall Study||61||
48513049|NCT04099641|101586122|FG001|Efficacy Population|Overall Study||19||
48513050|NCT04099641|101586121|FG000|COMPLETED|Overall Study||12||
48513051|NCT04099641|101586122|FG001|COMPLETED|Overall Study||7||
48513052|NCT04099641|101586121|FG000|NOT COMPLETED|Overall Study||49||
48513053|NCT04099641|101586122|FG001|NOT COMPLETED|Overall Study||12||
48513054|NCT00802178|101586123|FG000|STARTED|Overall Study||2448||
48513055|NCT00802178|101586123|FG000|COMPLETED|Overall Study||2335||
48513056|NCT00802178|101586123|FG000|NOT COMPLETED|Overall Study||113||
48513057|NCT00843830|101586124|FG000|STARTED|Overall Study||4||
48513058|NCT00843830|101586124|FG000|COMPLETED|Overall Study||4||
48513059|NCT00843830|101586124|FG000|NOT COMPLETED|Overall Study||0||
48513060|NCT00513617|101586125|FG000|STARTED|Overall Study||36||
48513061|NCT00513617|101586126|FG001|STARTED|Overall Study||35||
48513062|NCT00513617|101586127|FG002|STARTED|Overall Study||38||
48513063|NCT00513617|101586125|FG000|COMPLETED|Overall Study||25||
48513064|NCT00513617|101586126|FG001|COMPLETED|Overall Study||25||
48513065|NCT00513617|101586127|FG002|COMPLETED|Overall Study||30||
48513066|NCT00513617|101586125|FG000|NOT COMPLETED|Overall Study||11||
48513067|NCT00513617|101586126|FG001|NOT COMPLETED|Overall Study||10||
48513068|NCT00513617|101586127|FG002|NOT COMPLETED|Overall Study||8||
48513069|NCT03381196|101586128|FG000|STARTED|Overall Study||276||
48513070|NCT03381196|101586129|FG001|STARTED|Overall Study||277||
48513071|NCT03381196|101586128|FG000|Treated|Overall Study||273||
48513072|NCT03381196|101586129|FG001|Treated|Overall Study||271||
48513073|NCT03381196|101586128|FG000|COMPLETED|Overall Study||260||
48513074|NCT03381196|101586129|FG001|COMPLETED|Overall Study||258||
48513075|NCT03381196|101586128|FG000|NOT COMPLETED|Overall Study||16||
48513076|NCT03381196|101586129|FG001|NOT COMPLETED|Overall Study||19||
48513077|NCT04542694|101586130|FG000|STARTED|Overall Study||100||
48513078|NCT04542694|101586131|FG001|STARTED|Overall Study||100||
48513079|NCT04542694|101586130|FG000|COMPLETED|Overall Study||96||
48513080|NCT04542694|101586131|FG001|COMPLETED|Overall Study||100||
48513081|NCT04542694|101586130|FG000|NOT COMPLETED|Overall Study||4||
48513082|NCT04542694|101586131|FG001|NOT COMPLETED|Overall Study||0||
48513083|NCT03546647|101586132|FG000|STARTED|Overall Study||18||
48513084|NCT03546647|101586133|FG001|STARTED|Overall Study||17||
48513085|NCT03546647|101586132|FG000|COMPLETED|Overall Study||17||
48513086|NCT03546647|101586133|FG001|COMPLETED|Overall Study||17||
48513087|NCT03546647|101586132|FG000|NOT COMPLETED|Overall Study||1||
48513088|NCT03546647|101586133|FG001|NOT COMPLETED|Overall Study||0||
48513089|NCT01115855|101586134|FG000|STARTED|Overall Study||111||
48513090|NCT01115855|101586135|FG001|STARTED|Overall Study||110||
48513091|NCT01115855|101586134|FG000|COMPLETED|Overall Study||75||
48067432|NCT00785928|100485565|FG003|STARTED|Treatment Phase||15||
48067433|NCT00785928|100485566|FG004|STARTED|Treatment Phase||18||
48513092|NCT01115855|101586135|FG001|COMPLETED|Overall Study||74||
48513093|NCT01115855|101586134|FG000|NOT COMPLETED|Overall Study||36||
48513094|NCT01115855|101586135|FG001|NOT COMPLETED|Overall Study||36||
48513095|NCT01662362|101586136|FG000|STARTED|Overall Study||63||
48513096|NCT01662362|101586136|FG000|COMPLETED|Overall Study||25||
48513097|NCT01662362|101586136|FG000|NOT COMPLETED|Overall Study||38||
48513098|NCT01011335|101586137|FG000|STARTED|Overall Study||11||
48513099|NCT01011335|101586138|FG001|STARTED|Overall Study||12||
48513100|NCT01011335|101586139|FG002|STARTED|Overall Study||12||
48513101|NCT01011335|101586140|FG003|STARTED|Overall Study||12||
48513102|NCT01011335|101586141|FG004|STARTED|Overall Study||13||
48513103|NCT01011335|101586142|FG005|STARTED|Overall Study||12||
48513104|NCT01011335|101586143|FG006|STARTED|Overall Study||12||
48513105|NCT01011335|101586144|FG007|STARTED|Overall Study||12||
48513106|NCT01011335|101586145|FG008|STARTED|Overall Study||12||
48513107|NCT01011335|101586146|FG009|STARTED|Overall Study||12||
48513108|NCT01011335|101586147|FG010|STARTED|Overall Study||12||
48513109|NCT01011335|101586148|FG011|STARTED|Overall Study||22||
48513110|NCT01011335|101586149|FG012|STARTED|Overall Study||22||
48513111|NCT01011335|101586137|FG000|COMPLETED|Overall Study||10||
48513112|NCT01011335|101586138|FG001|COMPLETED|Overall Study||11||
48067434|NCT00785928|100485567|FG005|STARTED|Treatment Phase||13||
48513113|NCT01011335|101586139|FG002|COMPLETED|Overall Study||11||
48513114|NCT01011335|101586140|FG003|COMPLETED|Overall Study||10||
48513115|NCT01011335|101586141|FG004|COMPLETED|Overall Study||12||
48513116|NCT01011335|101586142|FG005|COMPLETED|Overall Study||11||
48513117|NCT01011335|101586143|FG006|COMPLETED|Overall Study||9||
48513118|NCT01011335|101586144|FG007|COMPLETED|Overall Study||10||
48513119|NCT01011335|101586145|FG008|COMPLETED|Overall Study||10||
48513120|NCT01011335|101586146|FG009|COMPLETED|Overall Study||12||
48513121|NCT01011335|101586147|FG010|COMPLETED|Overall Study||6||
48513122|NCT01011335|101586148|FG011|COMPLETED|Overall Study||21||
48513123|NCT01011335|101586149|FG012|COMPLETED|Overall Study||19||
48513124|NCT01011335|101586137|FG000|NOT COMPLETED|Overall Study||1||
48513125|NCT01011335|101586138|FG001|NOT COMPLETED|Overall Study||1||
48513126|NCT01011335|101586139|FG002|NOT COMPLETED|Overall Study||1||
48513127|NCT01011335|101586140|FG003|NOT COMPLETED|Overall Study||2||
48513128|NCT01011335|101586141|FG004|NOT COMPLETED|Overall Study||1||
48513129|NCT01011335|101586142|FG005|NOT COMPLETED|Overall Study||1||
48513130|NCT01011335|101586143|FG006|NOT COMPLETED|Overall Study||3||
48513131|NCT01011335|101586144|FG007|NOT COMPLETED|Overall Study||2||
48513132|NCT01011335|101586145|FG008|NOT COMPLETED|Overall Study||2||
48513133|NCT01011335|101586146|FG009|NOT COMPLETED|Overall Study||0||
48513134|NCT01011335|101586147|FG010|NOT COMPLETED|Overall Study||6||
48513135|NCT01011335|101586148|FG011|NOT COMPLETED|Overall Study||1||
48513136|NCT01011335|101586149|FG012|NOT COMPLETED|Overall Study||3||
48513137|NCT02423317|101586150|FG000|STARTED|Overall Study||30||
48513138|NCT02423317|101586151|FG001|STARTED|Overall Study||30||
48513139|NCT02423317|101586150|FG000|COMPLETED|Overall Study||30||
48513140|NCT02423317|101586151|FG001|COMPLETED|Overall Study||30||
48513141|NCT02423317|101586150|FG000|NOT COMPLETED|Overall Study||0||
48513142|NCT02423317|101586151|FG001|NOT COMPLETED|Overall Study||0||
48513143|NCT02985398|101586152|FG000|STARTED|Overall Study||128||
48513144|NCT02985398|101586152|FG000|Participants Treated|Overall Study||128||
48513145|NCT02985398|101586152|FG000|COMPLETED|Overall Study||106||
48513146|NCT02985398|101586152|FG000|NOT COMPLETED|Overall Study||22||
48513147|NCT00703976|101586153|FG000|STARTED|Overall Study||37||
48513148|NCT00703976|101586154|FG001|STARTED|Overall Study||41||
48513149|NCT00703976|101586153|FG000|COMPLETED|Overall Study||37||
48513150|NCT00703976|101586154|FG001|COMPLETED|Overall Study||41||
48513151|NCT00703976|101586153|FG000|NOT COMPLETED|Overall Study||0||
48513152|NCT00703976|101586154|FG001|NOT COMPLETED|Overall Study||0||
48513153|NCT01321697|101586155|FG000|STARTED|Overall Study||7||
48513154|NCT01321697|101586155|FG000|COMPLETED|Overall Study||0||
48513155|NCT01321697|101586155|FG000|NOT COMPLETED|Overall Study||7||
48513156|NCT00754494|101586156|FG000|STARTED|Overall Study||15||
48513157|NCT00754494|101586157|FG001|STARTED|Overall Study||15||
48513158|NCT00754494|101586158|FG002|STARTED|Overall Study||15||
48513159|NCT00754494|101586156|FG000|COMPLETED|Overall Study||13||
48513160|NCT00754494|101586157|FG001|COMPLETED|Overall Study||15||
48067435|NCT00785928|100485568|FG006|STARTED|Treatment Phase||26||
48067436|NCT00785928|100485562|FG000|COMPLETED|Treatment Phase||33||
48067437|NCT00785928|100485563|FG001|COMPLETED|Treatment Phase||25||
48067438|NCT00785928|100485564|FG002|COMPLETED|Treatment Phase||17||
48067439|NCT00785928|100485565|FG003|COMPLETED|Treatment Phase||15||
48067440|NCT00785928|100485566|FG004|COMPLETED|Treatment Phase||16||
48067441|NCT00785928|100485567|FG005|COMPLETED|Treatment Phase||13||
48067442|NCT00785928|100485568|FG006|COMPLETED|Treatment Phase||23||
48067443|NCT00785928|100485562|FG000|NOT COMPLETED|Treatment Phase||3||
48067444|NCT00785928|100485563|FG001|NOT COMPLETED|Treatment Phase||5||
48067445|NCT00785928|100485564|FG002|NOT COMPLETED|Treatment Phase||3||
48067446|NCT00785928|100485565|FG003|NOT COMPLETED|Treatment Phase||0||
48067447|NCT00785928|100485566|FG004|NOT COMPLETED|Treatment Phase||2||
48067448|NCT00785928|100485567|FG005|NOT COMPLETED|Treatment Phase||0||
48513161|NCT00754494|101586158|FG002|COMPLETED|Overall Study||14||
48513162|NCT00754494|101586156|FG000|NOT COMPLETED|Overall Study||2||
48513163|NCT00754494|101586157|FG001|NOT COMPLETED|Overall Study||0||
48513164|NCT00754494|101586158|FG002|NOT COMPLETED|Overall Study||1||
48513165|NCT01644149|101586159|FG000|STARTED|Overall Study||43||
48513166|NCT01644149|101586160|FG001|STARTED|Overall Study||40||
48513167|NCT01644149|101586159|FG000|COMPLETED|Overall Study||39||
48513168|NCT01644149|101586160|FG001|COMPLETED|Overall Study||39||
48513169|NCT01644149|101586159|FG000|NOT COMPLETED|Overall Study||4||
48513170|NCT01644149|101586160|FG001|NOT COMPLETED|Overall Study||1||
48513171|NCT00996437|101586161|FG000|STARTED|Overall Study||125||
48513172|NCT00996437|101586162|FG001|STARTED|Overall Study||136||
48513173|NCT00996437|101586161|FG000|COMPLETED|Overall Study||120||
48513174|NCT00996437|101586162|FG001|COMPLETED|Overall Study||129||
48513175|NCT00996437|101586161|FG000|NOT COMPLETED|Overall Study||5||
48513176|NCT00996437|101586162|FG001|NOT COMPLETED|Overall Study||7||
48513177|NCT01355302|101586163|FG000|STARTED|Phase 1b||7||
48513178|NCT01355302|101586164|FG001|STARTED|Phase 1b||0||
48513179|NCT01355302|101586165|FG002|STARTED|Phase 1b||0||
48513180|NCT01355302|101586163|FG000|COMPLETED|Phase 1b||1||
48513181|NCT01355302|101586164|FG001|COMPLETED|Phase 1b||0||
48513182|NCT01355302|101586165|FG002|COMPLETED|Phase 1b||0||
48513183|NCT01355302|101586163|FG000|NOT COMPLETED|Phase 1b||6||
48513184|NCT01355302|101586164|FG001|NOT COMPLETED|Phase 1b||0||
48513185|NCT01355302|101586165|FG002|NOT COMPLETED|Phase 1b||0||
48513186|NCT01355302|101586163|FG000|STARTED|Phase 2||0||
48513187|NCT01355302|101586164|FG001|STARTED|Phase 2||0||
48067449|NCT00785928|100485568|FG006|NOT COMPLETED|Treatment Phase||3||
48067450|NCT00785928|100485562|FG000|STARTED|Follow-up Phases (Weeks 24-72)||8||
48067451|NCT00785928|100485563|FG001|STARTED|Follow-up Phases (Weeks 24-72)||8||
48067452|NCT00785928|100485564|FG002|STARTED|Follow-up Phases (Weeks 24-72)||6||
48067453|NCT00785928|100485565|FG003|STARTED|Follow-up Phases (Weeks 24-72)||4||
48067454|NCT00785928|100485566|FG004|STARTED|Follow-up Phases (Weeks 24-72)||6||
48067455|NCT00785928|100485567|FG005|STARTED|Follow-up Phases (Weeks 24-72)||0||
48067456|NCT00785928|100485568|FG006|STARTED|Follow-up Phases (Weeks 24-72)||14||
48067457|NCT00785928|100485562|FG000|COMPLETED|Follow-up Phases (Weeks 24-72)||7||
48067458|NCT00785928|100485563|FG001|COMPLETED|Follow-up Phases (Weeks 24-72)||5||
48067459|NCT00785928|100485564|FG002|COMPLETED|Follow-up Phases (Weeks 24-72)||4||
48067460|NCT00785928|100485565|FG003|COMPLETED|Follow-up Phases (Weeks 24-72)||4||
48067461|NCT00785928|100485566|FG004|COMPLETED|Follow-up Phases (Weeks 24-72)||4||
48067462|NCT00785928|100485567|FG005|COMPLETED|Follow-up Phases (Weeks 24-72)||0||
48067463|NCT00785928|100485568|FG006|COMPLETED|Follow-up Phases (Weeks 24-72)||9||
48067464|NCT00785928|100485562|FG000|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||1||
48067465|NCT00785928|100485563|FG001|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||3||
48067466|NCT00785928|100485564|FG002|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||2||
48067467|NCT00785928|100485565|FG003|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||0||
48067468|NCT00785928|100485566|FG004|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||2||
48067469|NCT00785928|100485567|FG005|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||0||
48067470|NCT00785928|100485568|FG006|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||5||
48067471|NCT02480920|100485569|FG000|STARTED|Overall Study||2738||
48067472|NCT02480920|100485569|FG000|COMPLETED|Overall Study||2738||
48067473|NCT02480920|100485569|FG000|NOT COMPLETED|Overall Study||0||
48067474|NCT02264639|100485570|FG000|STARTED|Overall Study||2||
48067475|NCT02264639|100485571|FG001|STARTED|Overall Study||1||
48067476|NCT02264639|100485572|FG002|STARTED|Overall Study||1||
48067477|NCT02264639|100485573|FG003|STARTED|Overall Study||1||
48067478|NCT02264639|100485574|FG004|STARTED|Overall Study||4||
48067479|NCT02264639|100485570|FG000|COMPLETED|Overall Study||0|Completed the study (with reference to the last cohort in which a subject participated).|
48067480|NCT02264639|100485571|FG001|COMPLETED|Overall Study||1|Completed the study (with reference to the last cohort in which a subject participated).|
48067481|NCT02264639|100485572|FG002|COMPLETED|Overall Study||0|Completed the study (with reference to the last cohort in which a subject participated).|
48067482|NCT02264639|100485573|FG003|COMPLETED|Overall Study||1|Completed the study (with reference to the last cohort in which a subject participated).|
48067483|NCT02264639|100485574|FG004|COMPLETED|Overall Study||3|Completed the study (with reference to the last cohort in which a subject participated).|
48067484|NCT02264639|100485570|FG000|NOT COMPLETED|Overall Study||2||
48067485|NCT02264639|100485571|FG001|NOT COMPLETED|Overall Study||0||
48067486|NCT02264639|100485572|FG002|NOT COMPLETED|Overall Study||1||
48067487|NCT02264639|100485573|FG003|NOT COMPLETED|Overall Study||0||
48067488|NCT02264639|100485574|FG004|NOT COMPLETED|Overall Study||1||
48067489|NCT00932126|100485575|FG000|STARTED|Overall Study||3||
48067490|NCT00932126|100485576|FG001|STARTED|Overall Study||3||
48067491|NCT00932126|100485577|FG002|STARTED|Overall Study||3||
48067492|NCT00932126|100485578|FG003|STARTED|Overall Study||3||
48067493|NCT00932126|100485579|FG004|STARTED|Overall Study||5||
48067494|NCT00932126|100485580|FG005|STARTED|Overall Study||3||
48067495|NCT00932126|100485581|FG006|STARTED|Overall Study||5||
48067496|NCT00932126|100485582|FG007|STARTED|Overall Study||10||
48067497|NCT00932126|100485575|FG000|COMPLETED|Overall Study||0||
48067498|NCT00932126|100485576|FG001|COMPLETED|Overall Study||0||
48067499|NCT00932126|100485577|FG002|COMPLETED|Overall Study||0||
48067500|NCT00932126|100485578|FG003|COMPLETED|Overall Study||0||
48067501|NCT00932126|100485579|FG004|COMPLETED|Overall Study||0||
48067502|NCT00932126|100485580|FG005|COMPLETED|Overall Study||0||
48067503|NCT00932126|100485581|FG006|COMPLETED|Overall Study||0||
48067504|NCT00932126|100485582|FG007|COMPLETED|Overall Study||0||
48067505|NCT00932126|100485575|FG000|NOT COMPLETED|Overall Study||3||
48067506|NCT00932126|100485576|FG001|NOT COMPLETED|Overall Study||3||
48067507|NCT00932126|100485577|FG002|NOT COMPLETED|Overall Study||3||
48067508|NCT00932126|100485578|FG003|NOT COMPLETED|Overall Study||3||
48067509|NCT00932126|100485579|FG004|NOT COMPLETED|Overall Study||5||
48067510|NCT00932126|100485580|FG005|NOT COMPLETED|Overall Study||3||
48067511|NCT00932126|100485581|FG006|NOT COMPLETED|Overall Study||5||
48067512|NCT00932126|100485582|FG007|NOT COMPLETED|Overall Study||10||
48067513|NCT03711318|100485583|FG000|STARTED|Overall Study||8||
48067514|NCT03711318|100485583|FG000|COMPLETED|Overall Study||1||
48067515|NCT03711318|100485583|FG000|NOT COMPLETED|Overall Study||7||
48513188|NCT01355302|101586165|FG002|STARTED|Phase 2||0||
48513189|NCT01355302|101586163|FG000|COMPLETED|Phase 2||0||
48513190|NCT01355302|101586164|FG001|COMPLETED|Phase 2||0||
48513191|NCT01355302|101586165|FG002|COMPLETED|Phase 2||0||
48513192|NCT01355302|101586163|FG000|NOT COMPLETED|Phase 2||0||
48513193|NCT01355302|101586164|FG001|NOT COMPLETED|Phase 2||0||
48513194|NCT01355302|101586165|FG002|NOT COMPLETED|Phase 2||0||
48513195|NCT02280187|101586166|FG000|STARTED|Overall Study||400||
48513196|NCT02280187|101586166|FG000|COMPLETED|Overall Study||182||
48513197|NCT02280187|101586166|FG000|NOT COMPLETED|Overall Study||218||
48513198|NCT05838456|101586167|FG000|STARTED|Step 1: Months 1-3||38||1
48513199|NCT05838456|101586168|FG001|STARTED|Step 1: Months 1-3||8||1
48513200|NCT05838456|101586169|FG002|STARTED|Step 1: Months 1-3||11||1
48513201|NCT05838456|101586170|FG003|STARTED|Step 1: Months 1-3||23||1
48513202|NCT05838456|101586167|FG000|COMPLETED|Step 1: Months 1-3||38||1
48513203|NCT05838456|101586168|FG001|COMPLETED|Step 1: Months 1-3||8||1
48513204|NCT05838456|101586169|FG002|COMPLETED|Step 1: Months 1-3||11||1
48513205|NCT05838456|101586170|FG003|COMPLETED|Step 1: Months 1-3||23||1
48513206|NCT05838456|101586167|FG000|NOT COMPLETED|Step 1: Months 1-3||0||0
48513207|NCT05838456|101586168|FG001|NOT COMPLETED|Step 1: Months 1-3||0||0
48513208|NCT05838456|101586169|FG002|NOT COMPLETED|Step 1: Months 1-3||0||0
48513209|NCT05838456|101586170|FG003|NOT COMPLETED|Step 1: Months 1-3||0||0
48513210|NCT05838456|101586167|FG000|STARTED|Step 2: Months 4-6||9||1
48513211|NCT05838456|101586168|FG001|STARTED|Step 2: Months 4-6||3||1
48513212|NCT05838456|101586169|FG002|STARTED|Step 2: Months 4-6||4||1
48513213|NCT05838456|101586170|FG003|STARTED|Step 2: Months 4-6||20||1
48513214|NCT05838456|101586167|FG000|COMPLETED|Step 2: Months 4-6||9||1
48513215|NCT05838456|101586168|FG001|COMPLETED|Step 2: Months 4-6||3||1
48513216|NCT05838456|101586169|FG002|COMPLETED|Step 2: Months 4-6||4||1
48513217|NCT05838456|101586170|FG003|COMPLETED|Step 2: Months 4-6||20||1
48513218|NCT05838456|101586167|FG000|NOT COMPLETED|Step 2: Months 4-6||0||0
48513219|NCT05838456|101586168|FG001|NOT COMPLETED|Step 2: Months 4-6||0||0
48513220|NCT05838456|101586169|FG002|NOT COMPLETED|Step 2: Months 4-6||0||0
48513221|NCT05838456|101586170|FG003|NOT COMPLETED|Step 2: Months 4-6||0||0
48513222|NCT05838456|101586167|FG000|STARTED|Step 3: Months 7-9||11||1
48513223|NCT05838456|101586168|FG001|STARTED|Step 3: Months 7-9||2||1
48513224|NCT05838456|101586169|FG002|STARTED|Step 3: Months 7-9||5||1
48513225|NCT05838456|101586170|FG003|STARTED|Step 3: Months 7-9||19||1
48513226|NCT05838456|101586167|FG000|COMPLETED|Step 3: Months 7-9||11||1
48513227|NCT05838456|101586168|FG001|COMPLETED|Step 3: Months 7-9||2||1
48513228|NCT05838456|101586169|FG002|COMPLETED|Step 3: Months 7-9||5||1
48513229|NCT05838456|101586170|FG003|COMPLETED|Step 3: Months 7-9||19||1
48513230|NCT05838456|101586167|FG000|NOT COMPLETED|Step 3: Months 7-9||0||0
48513231|NCT05838456|101586168|FG001|NOT COMPLETED|Step 3: Months 7-9||0||0
48513232|NCT05838456|101586169|FG002|NOT COMPLETED|Step 3: Months 7-9||0||0
48513233|NCT05838456|101586170|FG003|NOT COMPLETED|Step 3: Months 7-9||0||0
48513234|NCT05838456|101586167|FG000|STARTED|Step 4: Months 10-12||7||1
48513235|NCT05838456|101586168|FG001|STARTED|Step 4: Months 10-12||2||1
48513236|NCT05838456|101586169|FG002|STARTED|Step 4: Months 10-12||5||1
48513237|NCT05838456|101586170|FG003|STARTED|Step 4: Months 10-12||9||1
48513238|NCT05838456|101586167|FG000|COMPLETED|Step 4: Months 10-12||7||1
48513239|NCT05838456|101586168|FG001|COMPLETED|Step 4: Months 10-12||2||1
48513240|NCT05838456|101586169|FG002|COMPLETED|Step 4: Months 10-12||5||1
48513241|NCT05838456|101586170|FG003|COMPLETED|Step 4: Months 10-12||9||1
48513242|NCT05838456|101586167|FG000|NOT COMPLETED|Step 4: Months 10-12||0||0
48513243|NCT05838456|101586168|FG001|NOT COMPLETED|Step 4: Months 10-12||0||0
48513244|NCT05838456|101586169|FG002|NOT COMPLETED|Step 4: Months 10-12||0||0
48513245|NCT05838456|101586170|FG003|NOT COMPLETED|Step 4: Months 10-12||0||0
48513246|NCT05838456|101586167|FG000|STARTED|Step 4: Months 13-15||16||1
48513247|NCT05838456|101586168|FG001|STARTED|Step 4: Months 13-15||7||1
48513248|NCT05838456|101586169|FG002|STARTED|Step 4: Months 13-15||10||1
48513249|NCT05838456|101586170|FG003|STARTED|Step 4: Months 13-15||34||1
48513250|NCT05838456|101586167|FG000|COMPLETED|Step 4: Months 13-15||16||1
48513251|NCT05838456|101586168|FG001|COMPLETED|Step 4: Months 13-15||7||1
48513252|NCT05838456|101586169|FG002|COMPLETED|Step 4: Months 13-15||10||1
48513253|NCT05838456|101586170|FG003|COMPLETED|Step 4: Months 13-15||34||1
48513254|NCT05838456|101586167|FG000|NOT COMPLETED|Step 4: Months 13-15||0||0
48513255|NCT05838456|101586168|FG001|NOT COMPLETED|Step 4: Months 13-15||0||0
48513256|NCT05838456|101586169|FG002|NOT COMPLETED|Step 4: Months 13-15||0||0
48513257|NCT05838456|101586170|FG003|NOT COMPLETED|Step 4: Months 13-15||0||0
48513258|NCT00595335|101586171|FG000|STARTED|Baseline to Six Months||13||
48513259|NCT00595335|101586172|FG001|STARTED|Baseline to Six Months||12||
48513260|NCT00595335|101586171|FG000|COMPLETED|Baseline to Six Months||11||
48513261|NCT00595335|101586172|FG001|COMPLETED|Baseline to Six Months||10||
48513262|NCT00595335|101586171|FG000|NOT COMPLETED|Baseline to Six Months||2||
48513263|NCT00595335|101586172|FG001|NOT COMPLETED|Baseline to Six Months||2||
48513264|NCT00595335|101586171|FG000|STARTED|Six Months to Twelve Months||11||
48513265|NCT00595335|101586172|FG001|STARTED|Six Months to Twelve Months||10||
48513266|NCT00595335|101586171|FG000|COMPLETED|Six Months to Twelve Months||10||
48513267|NCT00595335|101586172|FG001|COMPLETED|Six Months to Twelve Months||9||
48513268|NCT00595335|101586171|FG000|NOT COMPLETED|Six Months to Twelve Months||1||
48513269|NCT00595335|101586172|FG001|NOT COMPLETED|Six Months to Twelve Months||1||
48513270|NCT00851409|101586173|FG000|STARTED|Overall Study||25||
48513271|NCT00851409|101586173|FG000|COMPLETED|Overall Study||25||
48513272|NCT00851409|101586173|FG000|NOT COMPLETED|Overall Study||0||
48513273|NCT05050227|101586174|FG000|STARTED|Overall Study||29||
48513274|NCT05050227|101586175|FG001|STARTED|Overall Study||28||
48513275|NCT05050227|101586174|FG000|COMPLETED|Overall Study||21||
48513276|NCT05050227|101586175|FG001|COMPLETED|Overall Study||21||
48513277|NCT05050227|101586174|FG000|NOT COMPLETED|Overall Study||8||
48513278|NCT05050227|101586175|FG001|NOT COMPLETED|Overall Study||7||
48513279|NCT04234464|101586176|FG000|STARTED|Period 1 (First Treatment Intervention)||29||
48513280|NCT04234464|101586177|FG001|STARTED|Period 1 (First Treatment Intervention)||31||
48513281|NCT04234464|101586176|FG000|COMPLETED|Period 1 (First Treatment Intervention)||29||
48513282|NCT04234464|101586177|FG001|COMPLETED|Period 1 (First Treatment Intervention)||31||
48513283|NCT04234464|101586176|FG000|NOT COMPLETED|Period 1 (First Treatment Intervention)||0||
48513284|NCT04234464|101586177|FG001|NOT COMPLETED|Period 1 (First Treatment Intervention)||0||
48513285|NCT04234464|101586176|FG000|STARTED|Period 2 (Second Treatment Intervention)||29||
48513286|NCT04234464|101586177|FG001|STARTED|Period 2 (Second Treatment Intervention)||31||
48513287|NCT04234464|101586176|FG000|COMPLETED|Period 2 (Second Treatment Intervention)||28||
48513288|NCT04234464|101586177|FG001|COMPLETED|Period 2 (Second Treatment Intervention)||31||
48513289|NCT04234464|101586176|FG000|NOT COMPLETED|Period 2 (Second Treatment Intervention)||1||
48513290|NCT04234464|101586177|FG001|NOT COMPLETED|Period 2 (Second Treatment Intervention)||0||
48513291|NCT01192399|101586178|FG000|STARTED|Overall Study||29||
48513292|NCT01192399|101586178|FG000|COMPLETED|Overall Study||27||
48513293|NCT01192399|101586178|FG000|NOT COMPLETED|Overall Study||2||
48513294|NCT02576717|101586179|FG000|STARTED|Overall Study||740|Started = ITT Participants were included in the treatment group based on the planned treatment (received at randomization) in the parent study.|
48513295|NCT02576717|101586180|FG001|STARTED|Overall Study||875|Started = ITT Participants were included in the treatment group based on the planned treatment (received at randomization) in the parent study.|
48513296|NCT02576717|101586181|FG002|STARTED|Overall Study||879|Started = ITT Participants were included in the treatment group based on the planned treatment (received at randomization) in the parent study.|
48513297|NCT02576717|101586179|FG000|Transferred From IFN β-1a Parent Group|Overall Study||0||
48666790|NCT03391882|101970465|FG000|Modified Intent-to-Treat Population Part B|Part B - Treatment Phase||0||
48666791|NCT03391882|101970466|FG001|Modified Intent-to-Treat Population Part B|Part B - Treatment Phase||0||
48513298|NCT02576717|101586180|FG001|Transferred From IFN β-1a Parent Group|Overall Study||3||
48513299|NCT02576717|101586181|FG002|Transferred From IFN β-1a Parent Group|Overall Study||1||
48513300|NCT02576717|101586179|FG000|Transferred From RPC1063 0.5 mg Parent Group|Overall Study||0||
48513301|NCT02576717|101586180|FG001|Transferred From RPC1063 0.5 mg Parent Group|Overall Study||0||
48513302|NCT02576717|101586181|FG002|Transferred From RPC1063 0.5 mg Parent Group|Overall Study||1||
48513303|NCT02576717|101586179|FG000|Randomized to Placebo in the Parent Study|Overall Study||0||
48513304|NCT02576717|101586180|FG001|Randomized to Placebo in the Parent Study|Overall Study||37||
48513305|NCT02576717|101586181|FG002|Randomized to Placebo in the Parent Study|Overall Study||35||
48513306|NCT02576717|101586179|FG000|Safety Population|Overall Study||736|Participants were included in the treatment group based on the treatment that they actually received in the parent study.|
48513307|NCT02576717|101586180|FG001|Safety Population|Overall Study||877|Participants were included in the treatment group based on the treatment that they actually received in the parent study.|
48513308|NCT02576717|101586181|FG002|Safety Population|Overall Study||881|Participants were included in the treatment group based on the treatment that they actually received in the parent study.|
48513309|NCT02576717|101586179|FG000|COMPLETED|Overall Study||564||
48513310|NCT02576717|101586180|FG001|COMPLETED|Overall Study||691||
48513311|NCT02576717|101586181|FG002|COMPLETED|Overall Study||695||
48513312|NCT02576717|101586179|FG000|NOT COMPLETED|Overall Study||176||
48513313|NCT02576717|101586180|FG001|NOT COMPLETED|Overall Study||184||
48513314|NCT02576717|101586181|FG002|NOT COMPLETED|Overall Study||184||
48513315|NCT01134627|101586182|FG000|STARTED|Overall Study||149||
48513316|NCT01134627|101586183|FG001|STARTED|Overall Study||155||
48513317|NCT01134627|101586182|FG000|COMPLETED|Overall Study||80||
48513318|NCT01134627|101586183|FG001|COMPLETED|Overall Study||88||
48513319|NCT01134627|101586182|FG000|NOT COMPLETED|Overall Study||69||
48513320|NCT01134627|101586183|FG001|NOT COMPLETED|Overall Study||67||
48513321|NCT03760016|101586184|FG000|STARTED|Overall Study||27||
48513322|NCT03760016|101586185|FG001|STARTED|Overall Study||28||
48513323|NCT03760016|101586184|FG000|Completed 4-week Testing|Overall Study||26||
48513324|NCT03760016|101586185|FG001|Completed 4-week Testing|Overall Study||27||
48513325|NCT03760016|101586184|FG000|Completed 8-week Testing|Overall Study||23||
48666792|NCT03391882|101970467|FG002|Modified Intent-to-Treat Population Part B|Part B - Treatment Phase||19||
48513326|NCT03760016|101586185|FG001|Completed 8-week Testing|Overall Study||24||
48513327|NCT03760016|101586184|FG000|COMPLETED|Overall Study||19||
48513328|NCT03760016|101586185|FG001|COMPLETED|Overall Study||23||
48513329|NCT03760016|101586184|FG000|NOT COMPLETED|Overall Study||8||
48513330|NCT03760016|101586185|FG001|NOT COMPLETED|Overall Study||5||
48513331|NCT00388037|101586186|FG000|STARTED|Overall Study||31||
48513332|NCT00388037|101586186|FG000|COMPLETED|Overall Study||30||
48513333|NCT00388037|101586186|FG000|NOT COMPLETED|Overall Study||1||
48513334|NCT04458467|101586187|FG000|STARTED|Overall Study||35||
48513335|NCT04458467|101586188|FG001|STARTED|Overall Study||35||
48513336|NCT04458467|101586187|FG000|COMPLETED|Overall Study||35||
48513337|NCT04458467|101586188|FG001|COMPLETED|Overall Study||35||
48513338|NCT04458467|101586187|FG000|NOT COMPLETED|Overall Study||0||
48513339|NCT04458467|101586188|FG001|NOT COMPLETED|Overall Study||0||
48513340|NCT02415387|101586189|FG000|STARTED|Overall Study||87||
48513341|NCT02415387|101586190|FG001|STARTED|Overall Study||85||
48513342|NCT02415387|101586189|FG000|COMPLETED|Overall Study||80||
48513343|NCT02415387|101586190|FG001|COMPLETED|Overall Study||83||
48513344|NCT02415387|101586189|FG000|NOT COMPLETED|Overall Study||7||
48513345|NCT02415387|101586190|FG001|NOT COMPLETED|Overall Study||2||
48067516|NCT05447897|100485584|FG000|STARTED|Overall Study||9||
48067517|NCT05447897|100485584|FG000|COMPLETED|Overall Study||7||
48067518|NCT05447897|100485584|FG000|NOT COMPLETED|Overall Study||2||
48067519|NCT02699593|100485585|FG000|STARTED|Period 1||72||
48067520|NCT02699593|100485586|FG001|STARTED|Period 1||69||
48067521|NCT02699593|100485585|FG000|COMPLETED|Period 1||67||
48067522|NCT02699593|100485586|FG001|COMPLETED|Period 1||62||
48067523|NCT02699593|100485585|FG000|NOT COMPLETED|Period 1||5||
48067524|NCT02699593|100485586|FG001|NOT COMPLETED|Period 1||7||
48067525|NCT02699593|100485585|FG000|STARTED|Period 2||67||
48067526|NCT02699593|100485586|FG001|STARTED|Period 2||62||
48067527|NCT02699593|100485585|FG000|COMPLETED|Period 2||65||
48067528|NCT02699593|100485586|FG001|COMPLETED|Period 2||60||
48067529|NCT02699593|100485585|FG000|NOT COMPLETED|Period 2||2||
48067530|NCT02699593|100485586|FG001|NOT COMPLETED|Period 2||2||
48067531|NCT02727842|100485587|FG000|STARTED|Overall Study||30||1
48067532|NCT02727842|100485587|FG000|COMPLETED|Overall Study||30||1
48067533|NCT02727842|100485587|FG000|NOT COMPLETED|Overall Study||0||0
48067534|NCT02284516|100485588|FG000|STARTED|Overall Study||356||
48067535|NCT02284516|100485589|FG001|STARTED|Overall Study||355||
48067536|NCT02284516|100485588|FG000|Safety Population|Overall Study||354||
48067537|NCT02284516|100485589|FG001|Safety Population|Overall Study||357||
48067538|NCT02284516|100485588|FG000|COMPLETED|Overall Study||318||
48067539|NCT02284516|100485589|FG001|COMPLETED|Overall Study||319||
48067540|NCT02284516|100485588|FG000|NOT COMPLETED|Overall Study||38||
48067541|NCT02284516|100485589|FG001|NOT COMPLETED|Overall Study||36||
48067542|NCT03558087|100485590|FG000|STARTED|Overall Study||76||
48067543|NCT03558087|100485590|FG000|COMPLETED|Overall Study||76||
48067544|NCT03558087|100485590|FG000|NOT COMPLETED|Overall Study||0||
48067545|NCT01102270|100485591|FG000|STARTED|Overall Study||8||
48067546|NCT01102270|100485592|FG001|STARTED|Overall Study||9||
48067547|NCT01102270|100485591|FG000|COMPLETED|Overall Study||8||
48067548|NCT01102270|100485592|FG001|COMPLETED|Overall Study||9||
48067549|NCT01102270|100485591|FG000|NOT COMPLETED|Overall Study||0||
48067550|NCT01102270|100485592|FG001|NOT COMPLETED|Overall Study||0||
48067551|NCT00004635|100485593|FG000|STARTED|Period One||79||
48067552|NCT00004635|100485594|FG001|STARTED|Period One||80||
48067553|NCT00004635|100485593|FG000|Received Treatment|Period One||73||
48067554|NCT00004635|100485594|FG001|Received Treatment|Period One||75||
48067555|NCT00004635|100485593|FG000|COMPLETED|Period One||73||
48067556|NCT00004635|100485594|FG001|COMPLETED|Period One||74||
48067557|NCT00004635|100485593|FG000|NOT COMPLETED|Period One||6||
48067558|NCT00004635|100485594|FG001|NOT COMPLETED|Period One||6||
48067559|NCT00004635|100485593|FG000|STARTED|Period Two||44||
48067560|NCT00004635|100485594|FG001|STARTED|Period Two||59||
48067561|NCT00004635|100485593|FG000|COMPLETED|Period Two||38||
48067562|NCT00004635|100485594|FG001|COMPLETED|Period Two||50||
48067563|NCT00004635|100485593|FG000|NOT COMPLETED|Period Two||6||
48067564|NCT00004635|100485594|FG001|NOT COMPLETED|Period Two||9||
48067565|NCT01468675|100485595|FG000|STARTED|Overall Study||2699||
48067566|NCT01468675|100485596|FG001|STARTED|Overall Study||3376||
48067567|NCT01468675|100485595|FG000|COMPLETED|Overall Study||1699||
48067568|NCT01468675|100485596|FG001|COMPLETED|Overall Study||2004||
48067569|NCT01468675|100485595|FG000|NOT COMPLETED|Overall Study||1000||
48067570|NCT01468675|100485596|FG001|NOT COMPLETED|Overall Study||1372||
48067571|NCT04789499|100485597|FG000|STARTED|Overall Study||26||
48067572|NCT04789499|100485598|FG001|STARTED|Overall Study||25||
48067573|NCT04789499|100485597|FG000|COMPLETED|Overall Study||22||
48067574|NCT04789499|100485598|FG001|COMPLETED|Overall Study||23||
48067575|NCT04789499|100485597|FG000|NOT COMPLETED|Overall Study||4||
48067576|NCT04789499|100485598|FG001|NOT COMPLETED|Overall Study||2||
48067577|NCT01172522|100485599|FG000|STARTED|Overall Study||15||
48067578|NCT01172522|100485600|FG001|STARTED|Overall Study||15||
48067579|NCT01172522|100485599|FG000|COMPLETED|Overall Study||15||
48067580|NCT01172522|100485600|FG001|COMPLETED|Overall Study||15||
48067581|NCT01172522|100485599|FG000|NOT COMPLETED|Overall Study||0||
48067582|NCT01172522|100485600|FG001|NOT COMPLETED|Overall Study||0||
48067583|NCT00239590|100485601|FG000|STARTED|Randomized||14||
48067584|NCT00239590|100485602|FG001|STARTED|Randomized||14||
48513346|NCT00348816|101586191|FG000|STARTED|Overall Study||20||
48513347|NCT00348816|101586191|FG000|COMPLETED|Overall Study||19||
48513348|NCT00348816|101586191|FG000|NOT COMPLETED|Overall Study||1||
48513349|NCT00588731|101586192|FG000|STARTED|Overall Study||21||
48513350|NCT00588731|101586193|FG001|STARTED|Overall Study||20||
48513351|NCT00588731|101586192|FG000|COMPLETED|Overall Study||18||
48513352|NCT00588731|101586193|FG001|COMPLETED|Overall Study||18||
48513353|NCT00588731|101586192|FG000|NOT COMPLETED|Overall Study||3||
48513354|NCT00588731|101586193|FG001|NOT COMPLETED|Overall Study||2||
48513355|NCT00346164|101586194|FG000|STARTED|Overall Study||222||
48067585|NCT00239590|100485601|FG000|COMPLETED|Randomized||14||
48067586|NCT00239590|100485602|FG001|COMPLETED|Randomized||12||
48067587|NCT00239590|100485601|FG000|NOT COMPLETED|Randomized||0||
48067588|NCT00239590|100485602|FG001|NOT COMPLETED|Randomized||2||
48513356|NCT00346164|101586195|FG001|STARTED|Overall Study||21||
48067589|NCT00239590|100485601|FG000|STARTED|Started Intervention After Randomization||14||
48067590|NCT00239590|100485602|FG001|STARTED|Started Intervention After Randomization||12||
48067591|NCT00239590|100485601|FG000|COMPLETED|Started Intervention After Randomization||14||
48067592|NCT00239590|100485602|FG001|COMPLETED|Started Intervention After Randomization||12||
48219919|NCT05580003|100863770|FG022|STARTED|Part 3: Period 3 (Day 1)||0||
48219920|NCT05580003|100863771|FG023|STARTED|Part 3: Period 3 (Day 1)||0||
48513357|NCT00346164|101586196|FG002|STARTED|Overall Study||122||
48513358|NCT00346164|101586197|FG003|STARTED|Overall Study||223||
48513359|NCT00346164|101586194|FG000|COMPLETED|Overall Study||205||
48513360|NCT00346164|101586195|FG001|COMPLETED|Overall Study||14||
48513361|NCT00346164|101586196|FG002|COMPLETED|Overall Study||96||
48513362|NCT00346164|101586197|FG003|COMPLETED|Overall Study||117||
48513363|NCT00346164|101586194|FG000|NOT COMPLETED|Overall Study||17||
48513364|NCT00346164|101586195|FG001|NOT COMPLETED|Overall Study||7||
48513365|NCT00346164|101586196|FG002|NOT COMPLETED|Overall Study||26||
48513366|NCT00346164|101586197|FG003|NOT COMPLETED|Overall Study||106||
48513367|NCT01392326|101586198|FG000|STARTED|Overall Study||202||
48513368|NCT01392326|101586199|FG001|STARTED|Overall Study||202||
48513369|NCT01392326|101586200|FG002|STARTED|Overall Study||202||
48513370|NCT01392326|101586198|FG000|COMPLETED|Overall Study||155||
48513371|NCT01392326|101586199|FG001|COMPLETED|Overall Study||167||
48513372|NCT01392326|101586200|FG002|COMPLETED|Overall Study||154||
48513373|NCT01392326|101586198|FG000|NOT COMPLETED|Overall Study||47||
48513374|NCT01392326|101586199|FG001|NOT COMPLETED|Overall Study||35||
48513375|NCT01392326|101586200|FG002|NOT COMPLETED|Overall Study||48||
48513376|NCT02147587|101586201|FG000|STARTED|Overall Study||57||
48513377|NCT02147587|101586202|FG001|STARTED|Overall Study||55||
48513378|NCT02147587|101586201|FG000|COMPLETED|Overall Study||46||
48513379|NCT02147587|101586202|FG001|COMPLETED|Overall Study||50||
48513380|NCT02147587|101586201|FG000|NOT COMPLETED|Overall Study||11||
48513381|NCT02147587|101586202|FG001|NOT COMPLETED|Overall Study||5||
48513382|NCT00739973|101586203|FG000|STARTED|Single-blind Period (2 to 4 Weeks)||2694||
48513383|NCT00739973|101586204|FG001|STARTED|Single-blind Period (2 to 4 Weeks)||0||
48513384|NCT00739973|101586205|FG002|STARTED|Single-blind Period (2 to 4 Weeks)||0||
48513385|NCT00739973|101586206|FG003|STARTED|Single-blind Period (2 to 4 Weeks)||0||
48513386|NCT00739973|101586207|FG004|STARTED|Single-blind Period (2 to 4 Weeks)||0||
48513387|NCT00739973|101586208|FG005|STARTED|Single-blind Period (2 to 4 Weeks)||0||
48513388|NCT00739973|101586209|FG006|STARTED|Single-blind Period (2 to 4 Weeks)||0||
48513389|NCT00739973|101586210|FG007|STARTED|Single-blind Period (2 to 4 Weeks)||0||
48513390|NCT00739973|101586211|FG008|STARTED|Single-blind Period (2 to 4 Weeks)||0||
48513391|NCT00739973|101586203|FG000|COMPLETED|Single-blind Period (2 to 4 Weeks)||1685||
48513392|NCT00739973|101586204|FG001|COMPLETED|Single-blind Period (2 to 4 Weeks)||0||
48513393|NCT00739973|101586205|FG002|COMPLETED|Single-blind Period (2 to 4 Weeks)||0||
48513394|NCT00739973|101586206|FG003|COMPLETED|Single-blind Period (2 to 4 Weeks)||0||
48513395|NCT00739973|101586207|FG004|COMPLETED|Single-blind Period (2 to 4 Weeks)||0||
48513396|NCT00739973|101586208|FG005|COMPLETED|Single-blind Period (2 to 4 Weeks)||0||
48513397|NCT00739973|101586209|FG006|COMPLETED|Single-blind Period (2 to 4 Weeks)||0||
48513398|NCT00739973|101586210|FG007|COMPLETED|Single-blind Period (2 to 4 Weeks)||0||
48513399|NCT00739973|101586211|FG008|COMPLETED|Single-blind Period (2 to 4 Weeks)||0||
48513400|NCT00739973|101586203|FG000|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||1009||
48513401|NCT00739973|101586204|FG001|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0||
48513402|NCT00739973|101586205|FG002|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0||
48513403|NCT00739973|101586206|FG003|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0||
48513404|NCT00739973|101586207|FG004|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0||
48513405|NCT00739973|101586208|FG005|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0||
48513406|NCT00739973|101586209|FG006|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0||
48513407|NCT00739973|101586210|FG007|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0||
48513408|NCT00739973|101586211|FG008|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0||
48513409|NCT00739973|101586203|FG000|STARTED|Double-blind:Randomized Period (8 Weeks)||198||
48513410|NCT00739973|101586204|FG001|STARTED|Double-blind:Randomized Period (8 Weeks)||195||
48513411|NCT00739973|101586205|FG002|STARTED|Double-blind:Randomized Period (8 Weeks)||203||
48513412|NCT00739973|101586206|FG003|STARTED|Double-blind:Randomized Period (8 Weeks)||185||
48513413|NCT00739973|101586207|FG004|STARTED|Double-blind:Randomized Period (8 Weeks)||181||
48513414|NCT00739973|101586208|FG005|STARTED|Double-blind:Randomized Period (8 Weeks)||181||
48513415|NCT00739973|101586209|FG006|STARTED|Double-blind:Randomized Period (8 Weeks)||183||
48513416|NCT00739973|101586210|FG007|STARTED|Double-blind:Randomized Period (8 Weeks)||178||
48513417|NCT00739973|101586211|FG008|STARTED|Double-blind:Randomized Period (8 Weeks)||184||
48513418|NCT00739973|101586203|FG000|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168||
48513419|NCT00739973|101586204|FG001|COMPLETED|Double-blind:Randomized Period (8 Weeks)||175||
48513420|NCT00739973|101586205|FG002|COMPLETED|Double-blind:Randomized Period (8 Weeks)||184||
48513421|NCT00739973|101586206|FG003|COMPLETED|Double-blind:Randomized Period (8 Weeks)||173||
48513422|NCT00739973|101586207|FG004|COMPLETED|Double-blind:Randomized Period (8 Weeks)||162||
48513423|NCT00739973|101586208|FG005|COMPLETED|Double-blind:Randomized Period (8 Weeks)||169||
48513424|NCT00739973|101586209|FG006|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170||
48513425|NCT00739973|101586210|FG007|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168||
48513426|NCT00739973|101586211|FG008|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170||
48513427|NCT00739973|101586203|FG000|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||30||
48513428|NCT00739973|101586204|FG001|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||20||
48513429|NCT00739973|101586205|FG002|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19||
48513430|NCT00739973|101586206|FG003|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12||
48513431|NCT00739973|101586207|FG004|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19||
48513432|NCT00739973|101586208|FG005|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12||
48513433|NCT00739973|101586209|FG006|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||13||
48513434|NCT00739973|101586210|FG007|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||10||
48513435|NCT00739973|101586211|FG008|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||14||
48513436|NCT00611325|101586212|FG000|STARTED|Overall Study||28||
48513437|NCT00611325|101586213|FG001|STARTED|Overall Study||28||
48513438|NCT00611325|101586212|FG000|COMPLETED|Overall Study||28||
48513439|NCT00611325|101586213|FG001|COMPLETED|Overall Study||28||
48513440|NCT00611325|101586212|FG000|NOT COMPLETED|Overall Study||0||
48513441|NCT00611325|101586213|FG001|NOT COMPLETED|Overall Study||0||
48513442|NCT00136760|101586214|FG000|STARTED|Overall Study||12||
48513443|NCT00136760|101586215|FG001|STARTED|Overall Study||16||
48513444|NCT00136760|101586216|FG002|STARTED|Overall Study||11||
48513445|NCT00136760|101586217|FG003|STARTED|Overall Study||13||
48513446|NCT00136760|101586214|FG000|COMPLETED|Overall Study||12||
48513447|NCT00136760|101586215|FG001|COMPLETED|Overall Study||16||
48513448|NCT00136760|101586216|FG002|COMPLETED|Overall Study||11||
48513449|NCT00136760|101586217|FG003|COMPLETED|Overall Study||13||
48513450|NCT00136760|101586214|FG000|NOT COMPLETED|Overall Study||0||
48513451|NCT00136760|101586215|FG001|NOT COMPLETED|Overall Study||0||
48513452|NCT00136760|101586216|FG002|NOT COMPLETED|Overall Study||0||
48513453|NCT00136760|101586217|FG003|NOT COMPLETED|Overall Study||0||
48513454|NCT02136238|101586218|FG000|STARTED|Overall Study||4||
48513455|NCT02136238|101586219|FG001|STARTED|Overall Study||4||
48513456|NCT02136238|101586220|FG002|STARTED|Overall Study||10||
48513457|NCT02136238|101586218|FG000|COMPLETED|Overall Study||4||
48513458|NCT02136238|101586219|FG001|COMPLETED|Overall Study||4||
48513459|NCT02136238|101586220|FG002|COMPLETED|Overall Study||10||
48513460|NCT02136238|101586218|FG000|NOT COMPLETED|Overall Study||0||
48513461|NCT02136238|101586219|FG001|NOT COMPLETED|Overall Study||0||
48513462|NCT02136238|101586220|FG002|NOT COMPLETED|Overall Study||0||
48513463|NCT00862537|101586221|FG000|STARTED|Overall Study||18||
48513464|NCT00862537|101586221|FG000|COMPLETED|Overall Study||11||
48513465|NCT00862537|101586221|FG000|NOT COMPLETED|Overall Study||7||
48513466|NCT00476593|101586222|FG000|STARTED|Overall Study||32||
48513467|NCT00476593|101586223|FG001|STARTED|Overall Study||19||
48513468|NCT00476593|101586224|FG002|STARTED|Overall Study||38||
48513469|NCT00476593|101586225|FG003|STARTED|Overall Study||129||
48513470|NCT00476593|101586222|FG000|COMPLETED|Overall Study||22||
48513471|NCT00476593|101586223|FG001|COMPLETED|Overall Study||17||
48513472|NCT00476593|101586224|FG002|COMPLETED|Overall Study||30||
48513473|NCT00476593|101586225|FG003|COMPLETED|Overall Study||107||
48513474|NCT00476593|101586222|FG000|NOT COMPLETED|Overall Study||10||
48513475|NCT00476593|101586223|FG001|NOT COMPLETED|Overall Study||2||
48513476|NCT00476593|101586224|FG002|NOT COMPLETED|Overall Study||8||
48513477|NCT00476593|101586225|FG003|NOT COMPLETED|Overall Study||22||
48513478|NCT01453153|101586226|FG000|STARTED|Overall Study||4||
48513479|NCT01453153|101586227|FG001|STARTED|Overall Study||4||
48513480|NCT01453153|101586228|FG002|STARTED|Overall Study||20||
48513481|NCT01453153|101586226|FG000|COMPLETED|Overall Study||0||
48513482|NCT01453153|101586227|FG001|COMPLETED|Overall Study||0||
48067593|NCT00239590|100485601|FG000|NOT COMPLETED|Started Intervention After Randomization||0||
48067594|NCT00239590|100485602|FG001|NOT COMPLETED|Started Intervention After Randomization||0||
48067595|NCT00239590|100485601|FG000|STARTED|Completed Study Protocol||14||
48067596|NCT00239590|100485602|FG001|STARTED|Completed Study Protocol||12||
48067597|NCT00239590|100485601|FG000|COMPLETED|Completed Study Protocol||13||
48067598|NCT00239590|100485602|FG001|COMPLETED|Completed Study Protocol||10||
48067599|NCT00239590|100485601|FG000|NOT COMPLETED|Completed Study Protocol||1||
48067600|NCT00239590|100485602|FG001|NOT COMPLETED|Completed Study Protocol||2||
48067601|NCT02846324|100485603|FG000|STARTED|Overall Study||9||
48067602|NCT02846324|100485604|FG001|STARTED|Overall Study||6||
48219921|NCT05580003|100863772|FG024|STARTED|Part 3: Period 3 (Day 1)||0||
48219922|NCT05580003|100863773|FG025|STARTED|Part 3: Period 3 (Day 1)||0||
48219923|NCT05580003|100863774|FG026|STARTED|Part 3: Period 3 (Day 1)||0||
48513483|NCT01453153|101586228|FG002|COMPLETED|Overall Study||0||
48513484|NCT01453153|101586226|FG000|NOT COMPLETED|Overall Study||4||
48513485|NCT01453153|101586227|FG001|NOT COMPLETED|Overall Study||4||
48513486|NCT01453153|101586228|FG002|NOT COMPLETED|Overall Study||20||
48513487|NCT01332721|101586229|FG000|STARTED|Overall Study||38||
48513488|NCT01332721|101586229|FG000|COMPLETED|Overall Study||38||
48513489|NCT01332721|101586229|FG000|NOT COMPLETED|Overall Study||0||
48513490|NCT04046549|101586230|FG000|STARTED|Overall Study||23|enrolled and treated|
48067603|NCT02846324|100485605|FG002|STARTED|Overall Study||14||
48067604|NCT02846324|100485606|FG003|STARTED|Overall Study||10||
48067605|NCT02846324|100485603|FG000|Completed Study Treatment|Overall Study||7||
48067606|NCT02846324|100485604|FG001|Completed Study Treatment|Overall Study||5||
48067607|NCT02846324|100485605|FG002|Completed Study Treatment|Overall Study||11||
48067608|NCT02846324|100485606|FG003|Completed Study Treatment|Overall Study||10||
48067609|NCT02846324|100485603|FG000|COMPLETED|Overall Study||7|Completed Study|
48067610|NCT02846324|100485604|FG001|COMPLETED|Overall Study||6|Completed Study|
48067611|NCT02846324|100485605|FG002|COMPLETED|Overall Study||10|Completed Study|
48067612|NCT02846324|100485606|FG003|COMPLETED|Overall Study||10|Completed Study|
48067613|NCT02846324|100485603|FG000|NOT COMPLETED|Overall Study||2||
48067614|NCT02846324|100485604|FG001|NOT COMPLETED|Overall Study||0||
48067615|NCT02846324|100485605|FG002|NOT COMPLETED|Overall Study||4||
48067616|NCT02846324|100485606|FG003|NOT COMPLETED|Overall Study||0||
48067617|NCT01521546|100485607|FG000|STARTED|Overall Study||22||
48067618|NCT01521546|100485608|FG001|STARTED|Overall Study||20||
48067619|NCT01521546|100485607|FG000|COMPLETED|Overall Study||20||
48067620|NCT01521546|100485608|FG001|COMPLETED|Overall Study||20||
48067621|NCT01521546|100485607|FG000|NOT COMPLETED|Overall Study||2||
48067622|NCT01521546|100485608|FG001|NOT COMPLETED|Overall Study||0||
48067623|NCT02762578|100485609|FG000|STARTED|Overall Study||361||
48067624|NCT02762578|100485610|FG001|STARTED|Overall Study||182||
48067625|NCT02762578|100485609|FG000|Exposed|Overall Study||360||
48067626|NCT02762578|100485610|FG001|Exposed|Overall Study||181||
48067627|NCT02762578|100485609|FG000|COMPLETED|Overall Study||346||
48067628|NCT02762578|100485610|FG001|COMPLETED|Overall Study||172||
48067629|NCT02762578|100485609|FG000|NOT COMPLETED|Overall Study||15||
48067630|NCT02762578|100485610|FG001|NOT COMPLETED|Overall Study||10||
48067631|NCT00875979|100485611|FG000|STARTED|Dose Escalation Phase - 3.0 mg/kg||3||
48067632|NCT00875979|100485612|FG001|STARTED|Dose Escalation Phase - 3.0 mg/kg||0||
48067633|NCT00875979|100485611|FG000|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0||
48067634|NCT00875979|100485612|FG001|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0||
48067635|NCT00875979|100485611|FG000|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||3||
48067636|NCT00875979|100485612|FG001|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0||
48067637|NCT00875979|100485611|FG000|STARTED|Dose Escalation Phase - 3.6 mg/kg||0||
48067638|NCT00875979|100485612|FG001|STARTED|Dose Escalation Phase - 3.6 mg/kg||6||
48067639|NCT00875979|100485611|FG000|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0||
48067640|NCT00875979|100485612|FG001|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0||
48219924|NCT05580003|100863775|FG027|STARTED|Part 3: Period 3 (Day 1)||0||
48513491|NCT04046549|101586230|FG000|Enrolled Prior to Protocol V3.0|Overall Study||3||
48513492|NCT04046549|101586230|FG000|COMPLETED|Overall Study||13||
48513493|NCT04046549|101586230|FG000|NOT COMPLETED|Overall Study||10||
48513494|NCT03756883|101586231|FG000|STARTED|Overall Study||485||
48513495|NCT03756883|101586232|FG001|STARTED|Overall Study||413||
48513496|NCT03756883|101586233|FG002|STARTED|Overall Study||101||
48513497|NCT03756883|101586231|FG000|COMPLETED|Overall Study||472||
48513498|NCT03756883|101586232|FG001|COMPLETED|Overall Study||402||
48513499|NCT03756883|101586233|FG002|COMPLETED|Overall Study||94||
48513500|NCT03756883|101586231|FG000|NOT COMPLETED|Overall Study||13||
48513501|NCT03756883|101586232|FG001|NOT COMPLETED|Overall Study||11||
48513502|NCT03756883|101586233|FG002|NOT COMPLETED|Overall Study||7||
48513503|NCT02315261|101586234|FG000|STARTED|Overall Study||364||
48513504|NCT02315261|101586234|FG000|COMPLETED|Overall Study||364||
48513505|NCT02315261|101586234|FG000|NOT COMPLETED|Overall Study||0||
48513506|NCT01118117|101586235|FG000|STARTED|Overall Study||261||
48513507|NCT01118117|101586236|FG001|STARTED|Overall Study||15||
48513508|NCT01118117|101586235|FG000|COMPLETED|Overall Study||240||
48513509|NCT01118117|101586236|FG001|COMPLETED|Overall Study||15||
48513510|NCT01118117|101586235|FG000|NOT COMPLETED|Overall Study||21||
48513511|NCT01118117|101586236|FG001|NOT COMPLETED|Overall Study||0||
48513512|NCT00931463|101589514|FG000|STARTED|Overall Study||271||
48513513|NCT00931463|101589515|FG001|STARTED|Overall Study||270||
48513514|NCT00931463|101589514|FG000|COMPLETED|Overall Study||254||
48513515|NCT00931463|101589515|FG001|COMPLETED|Overall Study||265||
48067641|NCT00875979|100485611|FG000|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0||
48067642|NCT00875979|100485612|FG001|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||6||
48067643|NCT00875979|100485611|FG000|STARTED|Dose Expansion Phase - 3.6 mg/kg||0||
48067644|NCT00875979|100485612|FG001|STARTED|Dose Expansion Phase - 3.6 mg/kg||58||
48513516|NCT00931463|101589514|FG000|NOT COMPLETED|Overall Study||17||
48513517|NCT00931463|101589515|FG001|NOT COMPLETED|Overall Study||5||
48513518|NCT00537199|101589516|FG000|STARTED|Overall Study||1||
48513519|NCT00537199|101589516|FG000|COMPLETED|Overall Study||0||
48513520|NCT00537199|101589516|FG000|NOT COMPLETED|Overall Study||1||
48513521|NCT02663882|101589517|FG000|STARTED|Overall Study||39||
48513522|NCT02663882|101589518|FG001|STARTED|Overall Study||36||
48513523|NCT02663882|101589517|FG000|COMPLETED|Overall Study||35||
48513524|NCT02663882|101589518|FG001|COMPLETED|Overall Study||34||
48513525|NCT02663882|101589517|FG000|NOT COMPLETED|Overall Study||4||
48513526|NCT02663882|101589518|FG001|NOT COMPLETED|Overall Study||2||
48513527|NCT01235715|101589519|FG000|STARTED|Overall Study||98||
48513528|NCT01235715|101589520|FG001|STARTED|Overall Study||102||
48513529|NCT01235715|101589519|FG000|COMPLETED|Overall Study||98||
48513530|NCT01235715|101589520|FG001|COMPLETED|Overall Study||100||
48513531|NCT01235715|101589519|FG000|NOT COMPLETED|Overall Study||0||
48513532|NCT01235715|101589520|FG001|NOT COMPLETED|Overall Study||2||
48513533|NCT00603564|101589521|FG000|STARTED|Overall Study||20||
48513534|NCT00603564|101589522|FG001|STARTED|Overall Study||27||
48513535|NCT00603564|101589521|FG000|COMPLETED|Overall Study||20||
48513536|NCT00603564|101589522|FG001|COMPLETED|Overall Study||27||
48513537|NCT00603564|101589521|FG000|NOT COMPLETED|Overall Study||0||
48513538|NCT00603564|101589522|FG001|NOT COMPLETED|Overall Study||0||
48513539|NCT02339090|101589523|FG000|STARTED|Overall Study||104||
48513540|NCT02339090|101589524|FG001|STARTED|Overall Study||34||
48513541|NCT02339090|101589523|FG000|Received a Least 1 Dose of Study Drug|Overall Study||104||
48513542|NCT02339090|101589524|FG001|Received a Least 1 Dose of Study Drug|Overall Study||32||
48513543|NCT02339090|101589523|FG000|COMPLETED|Overall Study||98||
48513544|NCT02339090|101589524|FG001|COMPLETED|Overall Study||29||
48513545|NCT02339090|101589523|FG000|NOT COMPLETED|Overall Study||6||
48513546|NCT02339090|101589524|FG001|NOT COMPLETED|Overall Study||5||
48513547|NCT03519282|101589525|FG000|STARTED|First Intervention||5||
48513548|NCT03519282|101589526|FG001|STARTED|First Intervention||5||
48513549|NCT03519282|101589525|FG000|COMPLETED|First Intervention||5||
48513550|NCT03519282|101589526|FG001|COMPLETED|First Intervention||5||
48513551|NCT03519282|101589525|FG000|NOT COMPLETED|First Intervention||0||
48513552|NCT03519282|101589526|FG001|NOT COMPLETED|First Intervention||0||
48513553|NCT03519282|101589525|FG000|STARTED|Second Intervention||5||
48513554|NCT03519282|101589526|FG001|STARTED|Second Intervention||5||
48513555|NCT03519282|101589525|FG000|COMPLETED|Second Intervention||5||
48513556|NCT03519282|101589526|FG001|COMPLETED|Second Intervention||5||
48513557|NCT03519282|101589525|FG000|NOT COMPLETED|Second Intervention||0||
48513558|NCT03519282|101589526|FG001|NOT COMPLETED|Second Intervention||0||
48513559|NCT02999984|101589527|FG000|STARTED|Overall Study||10||
48513560|NCT02999984|101589527|FG000|COMPLETED|Overall Study||9||
48513561|NCT02999984|101589527|FG000|NOT COMPLETED|Overall Study||1||
48513562|NCT02429375|101589528|FG000|STARTED|Overall Study||3||
48513563|NCT02429375|101589529|FG001|STARTED|Overall Study||3||
48513564|NCT02429375|101589530|FG002|STARTED|Overall Study||1||
48513565|NCT02429375|101589528|FG000|COMPLETED|Overall Study||3||
48513566|NCT02429375|101589529|FG001|COMPLETED|Overall Study||3||
48513567|NCT02429375|101589530|FG002|COMPLETED|Overall Study||1||
48513568|NCT02429375|101589528|FG000|NOT COMPLETED|Overall Study||0||
48513569|NCT02429375|101589529|FG001|NOT COMPLETED|Overall Study||0||
48513570|NCT02429375|101589530|FG002|NOT COMPLETED|Overall Study||0||
48513571|NCT03223909|101589531|FG000|STARTED|Overall Study||120||
48513572|NCT03223909|101589532|FG001|STARTED|Overall Study||109||
48513573|NCT03223909|101589533|FG002|STARTED|Overall Study||97||
48513574|NCT03223909|101589531|FG000|COMPLETED|Overall Study||72||
48513575|NCT03223909|101589532|FG001|COMPLETED|Overall Study||64||
48513576|NCT03223909|101589533|FG002|COMPLETED|Overall Study||81||
48513577|NCT03223909|101589531|FG000|NOT COMPLETED|Overall Study||48||
48513578|NCT03223909|101589532|FG001|NOT COMPLETED|Overall Study||45||
48513579|NCT03223909|101589533|FG002|NOT COMPLETED|Overall Study||16||
48513580|NCT00749411|101589534|FG000|STARTED|Overall Study||21||
48513581|NCT00749411|101589535|FG001|STARTED|Overall Study||40||
48513582|NCT00749411|101589534|FG000|COMPLETED|Overall Study||20||
48513583|NCT00749411|101589535|FG001|COMPLETED|Overall Study||35||
48513584|NCT00749411|101589534|FG000|NOT COMPLETED|Overall Study||1||
48513585|NCT00749411|101589535|FG001|NOT COMPLETED|Overall Study||5||
48513586|NCT03417830|101589536|FG000|STARTED|Part A (up to 26 Days)||2||
48513587|NCT03417830|101589537|FG001|STARTED|Part A (up to 26 Days)||0||
48513588|NCT03417830|101589536|FG000|COMPLETED|Part A (up to 26 Days)||1||
48513589|NCT03417830|101589537|FG001|COMPLETED|Part A (up to 26 Days)||0||
48513590|NCT03417830|101589536|FG000|NOT COMPLETED|Part A (up to 26 Days)||1||
48513591|NCT03417830|101589537|FG001|NOT COMPLETED|Part A (up to 26 Days)||0||
48513592|NCT03417830|101589536|FG000|STARTED|Part B (up to 26 Days)||0||
48513593|NCT03417830|101589537|FG001|STARTED|Part B (up to 26 Days)||0||
48513594|NCT03417830|101589536|FG000|COMPLETED|Part B (up to 26 Days)||0||
48513595|NCT03417830|101589537|FG001|COMPLETED|Part B (up to 26 Days)||0||
48513596|NCT03417830|101589536|FG000|NOT COMPLETED|Part B (up to 26 Days)||0||
48513597|NCT03417830|101589537|FG001|NOT COMPLETED|Part B (up to 26 Days)||0||
48513598|NCT00436917|101589538|FG000|STARTED|Overall Study||53||
48513599|NCT00436917|101589538|FG000|COMPLETED|Overall Study||32||
48513600|NCT00436917|101589538|FG000|NOT COMPLETED|Overall Study||21||
48513601|NCT02457819|101589539|FG000|STARTED|Overall Study||237||
48513602|NCT02457819|101589539|FG000|Safety Population|Overall Study||236||
48513603|NCT02457819|101589539|FG000|COMPLETED|Overall Study||138||
48513604|NCT02457819|101589539|FG000|NOT COMPLETED|Overall Study||99||
48513605|NCT00574067|101589540|FG000|STARTED|Overall Study||53||
48513606|NCT00574067|101589541|FG001|STARTED|Overall Study||53||
48513607|NCT00574067|101589542|FG002|STARTED|Overall Study||54||
48513608|NCT00574067|101589543|FG003|STARTED|Overall Study||53||
48513609|NCT00574067|101589540|FG000|COMPLETED|Overall Study||52||
48513610|NCT00574067|101589541|FG001|COMPLETED|Overall Study||52||
48513611|NCT00574067|101589542|FG002|COMPLETED|Overall Study||54||
48513612|NCT00574067|101589543|FG003|COMPLETED|Overall Study||53||
48513613|NCT00574067|101589540|FG000|NOT COMPLETED|Overall Study||1||
48513614|NCT00574067|101589541|FG001|NOT COMPLETED|Overall Study||1||
48513615|NCT00574067|101589542|FG002|NOT COMPLETED|Overall Study||0||
48513616|NCT00574067|101589543|FG003|NOT COMPLETED|Overall Study||0||
48513617|NCT00544817|101589544|FG000|STARTED|Combined Modality||47||
48513618|NCT00544817|101589544|FG000|COMPLETED|Combined Modality||40||
48513619|NCT00544817|101589544|FG000|NOT COMPLETED|Combined Modality||7||
48513620|NCT00544817|101589544|FG000|STARTED|No Treatment Interval||40||
48513621|NCT00544817|101589544|FG000|COMPLETED|No Treatment Interval||28||
48513622|NCT00544817|101589544|FG000|NOT COMPLETED|No Treatment Interval||12||
48513623|NCT00544817|101589544|FG000|STARTED|Follow-up Systemic Therapy||28||
48513624|NCT00544817|101589544|FG000|COMPLETED|Follow-up Systemic Therapy||9||
48513625|NCT00544817|101589544|FG000|NOT COMPLETED|Follow-up Systemic Therapy||19||
48513626|NCT00779402|101589545|FG000|STARTED|Treatment Phase 1||117||
48513627|NCT00779402|101589546|FG001|STARTED|Treatment Phase 1||59||
48513628|NCT00779402|101589545|FG000|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||116||
48513629|NCT00779402|101589546|FG001|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||59||
48513630|NCT00779402|101589545|FG000|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||113||
48513631|NCT00779402|101589546|FG001|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||59||
48513632|NCT00779402|101589545|FG000|Received Booster Infusion|Treatment Phase 1||50||
48513633|NCT00779402|101589546|FG001|Received Booster Infusion|Treatment Phase 1||30||
48513634|NCT00779402|101589545|FG000|COMPLETED|Treatment Phase 1||84|Completed 3 scheduled infusion treatments and had confirmed Biochemical Failure (BF).|
48513635|NCT00779402|101589546|FG001|COMPLETED|Treatment Phase 1||44|Completed 3 scheduled infusion treatments and had confirmed Biochemical Failure (BF).|
48513636|NCT00779402|101589545|FG000|NOT COMPLETED|Treatment Phase 1||33||
48513637|NCT00779402|101589546|FG001|NOT COMPLETED|Treatment Phase 1||15||
48513638|NCT00779402|101589545|FG000|STARTED|Surveillance Phase||84||
48513639|NCT00779402|101589546|FG001|STARTED|Surveillance Phase||44||
48513640|NCT00779402|101589545|FG000|COMPLETED|Surveillance Phase||41|Reached Distant Failure (DF) following Treatment Phase.|
48513641|NCT00779402|101589546|FG001|COMPLETED|Surveillance Phase||13|Reached Distant Failure (DF) following Treatment Phase.|
48513642|NCT00779402|101589545|FG000|NOT COMPLETED|Surveillance Phase||43||
48513643|NCT00779402|101589546|FG001|NOT COMPLETED|Surveillance Phase||31||
48513644|NCT00779402|101589545|FG000|STARTED|Long-term Follow-up||41||
48513645|NCT00779402|101589546|FG001|STARTED|Long-term Follow-up||13||
48513646|NCT00779402|101589545|FG000|COMPLETED|Long-term Follow-up||20|Subject survival status was assessed by phone Q6 months until death of subject. Death=Completion.|
48513647|NCT00779402|101589546|FG001|COMPLETED|Long-term Follow-up||7|Subject survival status was assessed by phone Q6 months until death of subject. Death=Completion.|
48513648|NCT00779402|101589545|FG000|NOT COMPLETED|Long-term Follow-up||21||
48513649|NCT00779402|101589546|FG001|NOT COMPLETED|Long-term Follow-up||6||
48513650|NCT00493064|101589547|FG000|STARTED|Overall Study||63||
48513651|NCT00493064|101589547|FG000|COMPLETED|Overall Study||52||
48513652|NCT00493064|101589547|FG000|NOT COMPLETED|Overall Study||11||
48513653|NCT04569786|101589548|FG000|STARTED|Overall Study||39||
48513654|NCT04569786|101589549|FG001|STARTED|Overall Study||39||
48513655|NCT04569786|101589550|FG002|STARTED|Overall Study||42||
48513656|NCT04569786|101589551|FG003|STARTED|Overall Study||56||
48513657|NCT04569786|101589552|FG004|STARTED|Overall Study||56||
48513658|NCT04569786|101589548|FG000|COMPLETED|Overall Study||38||
48513659|NCT04569786|101589549|FG001|COMPLETED|Overall Study||39||
48513660|NCT04569786|101589550|FG002|COMPLETED|Overall Study||38||
48513661|NCT04569786|101589551|FG003|COMPLETED|Overall Study||49||
48513662|NCT04569786|101589552|FG004|COMPLETED|Overall Study||55||
48513663|NCT04569786|101589548|FG000|NOT COMPLETED|Overall Study||1||
48513664|NCT04569786|101589549|FG001|NOT COMPLETED|Overall Study||0||
48513665|NCT04569786|101589550|FG002|NOT COMPLETED|Overall Study||4||
48513666|NCT04569786|101589551|FG003|NOT COMPLETED|Overall Study||7||
48513667|NCT04569786|101589552|FG004|NOT COMPLETED|Overall Study||1||
48513668|NCT04231409|101589553|FG000|STARTED|Overall Study||5||
48513669|NCT04231409|101589554|FG001|STARTED|Overall Study||4||
48513670|NCT04231409|101589553|FG000|COMPLETED|Overall Study||0||
48513671|NCT04231409|101589554|FG001|COMPLETED|Overall Study||0||
48513672|NCT04231409|101589553|FG000|NOT COMPLETED|Overall Study||5||
48513673|NCT04231409|101589554|FG001|NOT COMPLETED|Overall Study||4||
48513674|NCT00268892|101589555|FG000|STARTED|Overall Study||90||
48513675|NCT00268892|101589556|FG001|STARTED|Overall Study||95||
48513676|NCT00268892|101589557|FG002|STARTED|Overall Study||93||
48513677|NCT00268892|101589555|FG000|Switched to Higher Dose|Overall Study||59||
48513678|NCT00268892|101589556|FG001|Switched to Higher Dose|Overall Study||68||
48513679|NCT00268892|101589557|FG002|Switched to Higher Dose|Overall Study||76||
48513680|NCT00268892|101589555|FG000|COMPLETED|Overall Study||51||
48513681|NCT00268892|101589556|FG001|COMPLETED|Overall Study||53||
48513682|NCT00268892|101589557|FG002|COMPLETED|Overall Study||54||
48513683|NCT00268892|101589555|FG000|NOT COMPLETED|Overall Study||39||
48513684|NCT00268892|101589556|FG001|NOT COMPLETED|Overall Study||42||
48513685|NCT00268892|101589557|FG002|NOT COMPLETED|Overall Study||39||
48513686|NCT00606138|101589558|FG000|STARTED|Overall Study||6||
48513687|NCT00606138|101589559|FG001|STARTED|Overall Study||2||
48513688|NCT00606138|101589558|FG000|COMPLETED|Overall Study||4||
48513689|NCT00606138|101589559|FG001|COMPLETED|Overall Study||2||
48513690|NCT00606138|101589558|FG000|NOT COMPLETED|Overall Study||2||
48513691|NCT00606138|101589559|FG001|NOT COMPLETED|Overall Study||0||
48513692|NCT02413294|101589560|FG000|STARTED|Overall Study||12||
48513693|NCT02413294|101589560|FG000|COMPLETED|Overall Study||11||
48513694|NCT02413294|101589560|FG000|NOT COMPLETED|Overall Study||1||
48513695|NCT01196117|101589561|FG000|STARTED|Placebo, Then CPAP||18||
48513696|NCT01196117|101589562|FG001|STARTED|Placebo, Then CPAP||0||
48513697|NCT01196117|101589561|FG000|COMPLETED|Placebo, Then CPAP||18||
48513698|NCT01196117|101589562|FG001|COMPLETED|Placebo, Then CPAP||0||
48513699|NCT01196117|101589561|FG000|NOT COMPLETED|Placebo, Then CPAP||0||
48513700|NCT01196117|101589562|FG001|NOT COMPLETED|Placebo, Then CPAP||0||
48513701|NCT01196117|101589561|FG000|STARTED|CPAP||0||
48513702|NCT01196117|101589562|FG001|STARTED|CPAP||18||
48513703|NCT01196117|101589561|FG000|COMPLETED|CPAP||0||
48513704|NCT01196117|101589562|FG001|COMPLETED|CPAP||18||
48513705|NCT01196117|101589561|FG000|NOT COMPLETED|CPAP||0||
48513706|NCT01196117|101589562|FG001|NOT COMPLETED|CPAP||0||
48513707|NCT02451150|101589563|FG000|STARTED|Overall Study||3||
48513708|NCT02451150|101589564|FG001|STARTED|Overall Study||3||
48513709|NCT02451150|101589563|FG000|COMPLETED|Overall Study||3||
48513710|NCT02451150|101589564|FG001|COMPLETED|Overall Study||3||
48513711|NCT02451150|101589563|FG000|NOT COMPLETED|Overall Study||0||
48513712|NCT02451150|101589564|FG001|NOT COMPLETED|Overall Study||0||
48513713|NCT02087176|101589565|FG000|STARTED|Overall Study||32||
48513714|NCT02087176|101589565|FG000|COMPLETED|Overall Study||0||
48513715|NCT02087176|101589565|FG000|NOT COMPLETED|Overall Study||32||
48513716|NCT02654587|101589566|FG000|STARTED|Overall Study||139|Patients with ICI secondary resistance|
48513717|NCT02654587|101589567|FG001|STARTED|Overall Study||80|Patients with ICI secondary resistance|
48513718|NCT02654587|101589566|FG000|COMPLETED|Overall Study||116|primary endpoint is overall survival patient completed has been defined as patient deceased at the end of study|
48513719|NCT02654587|101589567|FG001|COMPLETED|Overall Study||65|primary endpoint is overall survival patient completed has been defined as patient deceased at the end of study|
48513720|NCT02654587|101589566|FG000|NOT COMPLETED|Overall Study||23||
48513721|NCT02654587|101589567|FG001|NOT COMPLETED|Overall Study||15||
48513722|NCT03068949|101589568|FG000|STARTED|Overall Study||113||
48513723|NCT03068949|101589569|FG001|STARTED|Overall Study||102||
48513724|NCT03068949|101589570|FG002|STARTED|Overall Study||122||
48513725|NCT03068949|101589571|FG003|STARTED|Overall Study||76||
48513726|NCT03068949|101589568|FG000|COMPLETED|Overall Study||105||
48513727|NCT03068949|101589569|FG001|COMPLETED|Overall Study||90||
48513728|NCT03068949|101589570|FG002|COMPLETED|Overall Study||113||
48513729|NCT03068949|101589571|FG003|COMPLETED|Overall Study||63||
48513730|NCT03068949|101589568|FG000|NOT COMPLETED|Overall Study||8||
48513731|NCT03068949|101589569|FG001|NOT COMPLETED|Overall Study||12||
48513732|NCT03068949|101589570|FG002|NOT COMPLETED|Overall Study||9||
48513733|NCT03068949|101589571|FG003|NOT COMPLETED|Overall Study||13||
48513734|NCT00784134|101589572|FG000|STARTED|Overall Study||249||
48513735|NCT00784134|101589573|FG001|STARTED|Overall Study||251||
48513736|NCT00784134|101589572|FG000|COMPLETED|Overall Study||246||
48513737|NCT00784134|101589573|FG001|COMPLETED|Overall Study||245||
48513738|NCT00784134|101589572|FG000|NOT COMPLETED|Overall Study||3||
48513739|NCT00784134|101589573|FG001|NOT COMPLETED|Overall Study||6||
48513740|NCT04314843|101589574|FG000|STARTED|Overall Study||3||
48513741|NCT04314843|101589575|FG001|STARTED|Overall Study||3||
48513742|NCT04314843|101589574|FG000|COMPLETED|Overall Study||0||
48513743|NCT04314843|101589575|FG001|COMPLETED|Overall Study||0||
48513744|NCT04314843|101589574|FG000|NOT COMPLETED|Overall Study||3||
48513745|NCT04314843|101589575|FG001|NOT COMPLETED|Overall Study||3||
48513746|NCT02080507|101589576|FG000|STARTED|Overall Study||5||
48513747|NCT02080507|101589577|FG001|STARTED|Overall Study||7||
48513748|NCT02080507|101589576|FG000|COMPLETED|Overall Study||5||
48513749|NCT02080507|101589577|FG001|COMPLETED|Overall Study||7||
48513750|NCT02080507|101589576|FG000|NOT COMPLETED|Overall Study||0||
48513751|NCT02080507|101589577|FG001|NOT COMPLETED|Overall Study||0||
48513752|NCT00831233|101589578|FG000|STARTED|Overall Study||29||
48513753|NCT00831233|101589579|FG001|STARTED|Overall Study||13||
48513754|NCT00831233|101589578|FG000|Full Analysis Set (FAS)|Overall Study||27||
48513755|NCT00831233|101589579|FG001|Full Analysis Set (FAS)|Overall Study||13||
48513756|NCT00831233|101589578|FG000|Per Protocol (PP) Analysis Set|Overall Study||26||
48513757|NCT00831233|101589579|FG001|Per Protocol (PP) Analysis Set|Overall Study||11||
48513758|NCT00831233|101589578|FG000|COMPLETED|Overall Study||26||
48513759|NCT00831233|101589579|FG001|COMPLETED|Overall Study||12||
48513760|NCT00831233|101589578|FG000|NOT COMPLETED|Overall Study||3||
48513761|NCT00831233|101589579|FG001|NOT COMPLETED|Overall Study||1||
48513762|NCT01191476|101589580|FG000|STARTED|Overall Study||112||
48067645|NCT00875979|100485611|FG000|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0||
48067646|NCT00875979|100485612|FG001|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||11||
48067647|NCT00875979|100485611|FG000|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0||
48067648|NCT00875979|100485612|FG001|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||47||
48067649|NCT01573260|100485613|FG000|STARTED|Overall Study||18||
48219925|NCT05580003|100863748|FG000|COMPLETED|Part 3: Period 3 (Day 1)||0||
48219926|NCT05580003|100863749|FG001|COMPLETED|Part 3: Period 3 (Day 1)||0||
48219927|NCT05580003|100863750|FG002|COMPLETED|Part 3: Period 3 (Day 1)||0||
48513763|NCT01191476|101589581|FG001|STARTED|Overall Study||111||
48513764|NCT01191476|101589582|FG002|STARTED|Overall Study||111||
48513765|NCT01191476|101589580|FG000|COMPLETED|Overall Study||109||
48513766|NCT01191476|101589581|FG001|COMPLETED|Overall Study||107||
48513767|NCT01191476|101589582|FG002|COMPLETED|Overall Study||111||
48513768|NCT01191476|101589580|FG000|NOT COMPLETED|Overall Study||3||
48513769|NCT01191476|101589581|FG001|NOT COMPLETED|Overall Study||4||
48513770|NCT01191476|101589582|FG002|NOT COMPLETED|Overall Study||0||
48513771|NCT00508027|101589583|FG000|STARTED|Dose Level 1||20||
48513772|NCT00508027|101589583|FG000|COMPLETED|Dose Level 1||12||
48513773|NCT00508027|101589583|FG000|NOT COMPLETED|Dose Level 1||8||
48513774|NCT00508027|101589583|FG000|STARTED|Dose Level 2||20||
48513775|NCT00508027|101589583|FG000|COMPLETED|Dose Level 2||16||
48513776|NCT00508027|101589583|FG000|NOT COMPLETED|Dose Level 2||4||
48513777|NCT00508027|101589583|FG000|STARTED|Dose Level 3||2||
48513778|NCT00508027|101589583|FG000|COMPLETED|Dose Level 3||2||
48067650|NCT01573260|100485614|FG001|STARTED|Overall Study||15||
48067651|NCT01573260|100485613|FG000|COMPLETED|Overall Study||18||
48067652|NCT01573260|100485614|FG001|COMPLETED|Overall Study||15||
48067653|NCT01573260|100485613|FG000|NOT COMPLETED|Overall Study||0||
48219928|NCT05580003|100863751|FG003|COMPLETED|Part 3: Period 3 (Day 1)||0||
48219929|NCT05580003|100863752|FG004|COMPLETED|Part 3: Period 3 (Day 1)||0||
48219930|NCT05580003|100863753|FG005|COMPLETED|Part 3: Period 3 (Day 1)||0||
48219931|NCT05580003|100863754|FG006|COMPLETED|Part 3: Period 3 (Day 1)||0||
48219932|NCT05580003|100863755|FG007|COMPLETED|Part 3: Period 3 (Day 1)||0||
48219933|NCT05580003|100863756|FG008|COMPLETED|Part 3: Period 3 (Day 1)||0||
48219934|NCT05580003|100863757|FG009|COMPLETED|Part 3: Period 3 (Day 1)||0||
48219935|NCT05580003|100863758|FG010|COMPLETED|Part 3: Period 3 (Day 1)||0||
48219936|NCT05580003|100863759|FG011|COMPLETED|Part 3: Period 3 (Day 1)||0||
48219937|NCT05580003|100863760|FG012|COMPLETED|Part 3: Period 3 (Day 1)||0||
48219938|NCT05580003|100863761|FG013|COMPLETED|Part 3: Period 3 (Day 1)||2||
48219939|NCT05580003|100863762|FG014|COMPLETED|Part 3: Period 3 (Day 1)||2||
48219940|NCT05580003|100863763|FG015|COMPLETED|Part 3: Period 3 (Day 1)||2||
48219941|NCT05580003|100863764|FG016|COMPLETED|Part 3: Period 3 (Day 1)||2||
48219942|NCT05580003|100863765|FG017|COMPLETED|Part 3: Period 3 (Day 1)||2||
48513779|NCT00508027|101589583|FG000|NOT COMPLETED|Dose Level 3||0||
48513780|NCT02443324|101589584|FG000|STARTED|Overall Study||24||
48513781|NCT02443324|101589585|FG001|STARTED|Overall Study||26||
48513782|NCT02443324|101589586|FG002|STARTED|Overall Study||29||
48513783|NCT02443324|101589587|FG003|STARTED|Overall Study||17||
48513784|NCT02443324|101589588|FG004|STARTED|Overall Study||28||
48513785|NCT02443324|101589589|FG005|STARTED|Overall Study||24||
48513786|NCT02443324|101589590|FG006|STARTED|Overall Study||27||
48513787|NCT02443324|101589584|FG000|Received at Least One Dose of Study Drug|Overall Study||24||
48513788|NCT02443324|101589585|FG001|Received at Least One Dose of Study Drug|Overall Study||26||
48513789|NCT02443324|101589586|FG002|Received at Least One Dose of Study Drug|Overall Study||28||
48513790|NCT02443324|101589587|FG003|Received at Least One Dose of Study Drug|Overall Study||17||
48513791|NCT02443324|101589588|FG004|Received at Least One Dose of Study Drug|Overall Study||27||
48513792|NCT02443324|101589589|FG005|Received at Least One Dose of Study Drug|Overall Study||24||
48513793|NCT02443324|101589590|FG006|Received at Least One Dose of Study Drug|Overall Study||26||
48513794|NCT02443324|101589584|FG000|Phase 1a|Overall Study||8||
48513795|NCT02443324|101589585|FG001|Phase 1a|Overall Study||0||
48513796|NCT02443324|101589586|FG002|Phase 1a|Overall Study||0||
48513797|NCT02443324|101589587|FG003|Phase 1a|Overall Study||0||
48513798|NCT02443324|101589588|FG004|Phase 1a|Overall Study||3||
48513799|NCT02443324|101589589|FG005|Phase 1a|Overall Study||0||
48513800|NCT02443324|101589590|FG006|Phase 1a|Overall Study||0||
48513801|NCT02443324|101589584|FG000|Phase 1b|Overall Study||16||
48513802|NCT02443324|101589585|FG001|Phase 1b|Overall Study||26||
48513803|NCT02443324|101589586|FG002|Phase 1b|Overall Study||28||
48513804|NCT02443324|101589587|FG003|Phase 1b|Overall Study||17||
48513805|NCT02443324|101589588|FG004|Phase 1b|Overall Study||24||
48513806|NCT02443324|101589589|FG005|Phase 1b|Overall Study||24||
48513807|NCT02443324|101589590|FG006|Phase 1b|Overall Study||26||
48513808|NCT02443324|101589584|FG000|COMPLETED|Overall Study||0||
48513809|NCT02443324|101589585|FG001|COMPLETED|Overall Study||1||
48513810|NCT02443324|101589586|FG002|COMPLETED|Overall Study||4||
48513811|NCT02443324|101589587|FG003|COMPLETED|Overall Study||1||
48513812|NCT02443324|101589588|FG004|COMPLETED|Overall Study||7||
48513813|NCT02443324|101589589|FG005|COMPLETED|Overall Study||0||
48513814|NCT02443324|101589590|FG006|COMPLETED|Overall Study||8||
48513815|NCT02443324|101589584|FG000|NOT COMPLETED|Overall Study||24||
48513816|NCT02443324|101589585|FG001|NOT COMPLETED|Overall Study||25||
48513817|NCT02443324|101589586|FG002|NOT COMPLETED|Overall Study||25||
48513818|NCT02443324|101589587|FG003|NOT COMPLETED|Overall Study||16||
48513819|NCT02443324|101589588|FG004|NOT COMPLETED|Overall Study||21||
48513820|NCT02443324|101589589|FG005|NOT COMPLETED|Overall Study||24||
48513821|NCT02443324|101589590|FG006|NOT COMPLETED|Overall Study||19||
48513822|NCT01501110|101589591|FG000|STARTED|Overall Study||34||
48513823|NCT01501110|101589592|FG001|STARTED|Overall Study||34||
48513824|NCT01501110|101589591|FG000|COMPLETED|Overall Study||34||
48513825|NCT01501110|101589592|FG001|COMPLETED|Overall Study||33||
48513826|NCT01501110|101589591|FG000|NOT COMPLETED|Overall Study||0||
48513827|NCT01501110|101589592|FG001|NOT COMPLETED|Overall Study||1||
48513828|NCT00775528|101589593|FG000|STARTED|Overall Study||19||
48513829|NCT00775528|101589593|FG000|COMPLETED|Overall Study||18||
48513830|NCT00775528|101589593|FG000|NOT COMPLETED|Overall Study||1||
48513831|NCT03785145|101589594|FG000|STARTED|Cycle 1 - Double Blind (Days 1-180)||77||
48513832|NCT03785145|101589595|FG001|STARTED|Cycle 1 - Double Blind (Days 1-180)||158||
48513833|NCT03785145|101589594|FG000|COMPLETED|Cycle 1 - Double Blind (Days 1-180)||68||
48513834|NCT03785145|101589595|FG001|COMPLETED|Cycle 1 - Double Blind (Days 1-180)||145||
48513835|NCT03785145|101589594|FG000|NOT COMPLETED|Cycle 1 - Double Blind (Days 1-180)||9||
48513836|NCT03785145|101589595|FG001|NOT COMPLETED|Cycle 1 - Double Blind (Days 1-180)||13||
48513837|NCT03785145|101589594|FG000|STARTED|Cycle 2 - Open Label Treatment 1||65||
48513838|NCT03785145|101589595|FG001|STARTED|Cycle 2 - Open Label Treatment 1||144||
48513839|NCT03785145|101589594|FG000|COMPLETED|Cycle 2 - Open Label Treatment 1||61||
48513840|NCT03785145|101589595|FG001|COMPLETED|Cycle 2 - Open Label Treatment 1||130||
48513841|NCT03785145|101589594|FG000|NOT COMPLETED|Cycle 2 - Open Label Treatment 1||4||
48513842|NCT03785145|101589595|FG001|NOT COMPLETED|Cycle 2 - Open Label Treatment 1||14||
48513843|NCT03785145|101589594|FG000|STARTED|Cycle 3 - Open Label Treatment 2||49||
48513844|NCT03785145|101589595|FG001|STARTED|Cycle 3 - Open Label Treatment 2||91||
48513845|NCT03785145|101589594|FG000|COMPLETED|Cycle 3 - Open Label Treatment 2||49||
48513846|NCT03785145|101589595|FG001|COMPLETED|Cycle 3 - Open Label Treatment 2||88||
48513847|NCT03785145|101589594|FG000|NOT COMPLETED|Cycle 3 - Open Label Treatment 2||0||
48513848|NCT03785145|101589595|FG001|NOT COMPLETED|Cycle 3 - Open Label Treatment 2||3||
48513849|NCT03573817|101589596|FG000|STARTED|Overall Study||63||
48513850|NCT03573817|101589597|FG001|STARTED|Overall Study||59||
48513851|NCT03573817|101589596|FG000|Randomized and Treated With Study Drug|Overall Study||63||
48513852|NCT03573817|101589597|FG001|Randomized and Treated With Study Drug|Overall Study||59||
48513853|NCT03573817|101589596|FG000|COMPLETED|Overall Study||62||
48513854|NCT03573817|101589597|FG001|COMPLETED|Overall Study||55||
48513855|NCT03573817|101589596|FG000|NOT COMPLETED|Overall Study||1||
48513856|NCT03573817|101589597|FG001|NOT COMPLETED|Overall Study||4||
48513857|NCT01813071|101589598|FG000|STARTED|Overall Study||10||
48513858|NCT01813071|101589599|FG001|STARTED|Overall Study||10||
48513859|NCT01813071|101589600|FG002|STARTED|Overall Study||10||
48513860|NCT01813071|101589601|FG003|STARTED|Overall Study||9||
48513861|NCT01813071|101589602|FG004|STARTED|Overall Study||12||
48513862|NCT01813071|101589603|FG005|STARTED|Overall Study||12||
48513863|NCT01813071|101589604|FG006|STARTED|Overall Study||12||
48513864|NCT01813071|101589605|FG007|STARTED|Overall Study||12||
48513865|NCT01813071|101589606|FG008|STARTED|Overall Study||16||
48513866|NCT01813071|101589598|FG000|COMPLETED|Overall Study||10||
48513867|NCT01813071|101589599|FG001|COMPLETED|Overall Study||10||
48513868|NCT01813071|101589600|FG002|COMPLETED|Overall Study||10||
48513869|NCT01813071|101589601|FG003|COMPLETED|Overall Study||9||
48513870|NCT01813071|101589602|FG004|COMPLETED|Overall Study||11||
48513871|NCT01813071|101589603|FG005|COMPLETED|Overall Study||5||
48513872|NCT01813071|101589604|FG006|COMPLETED|Overall Study||9||
48513873|NCT01813071|101589605|FG007|COMPLETED|Overall Study||7||
48513874|NCT01813071|101589606|FG008|COMPLETED|Overall Study||13||
48513875|NCT01813071|101589598|FG000|NOT COMPLETED|Overall Study||0||
48513876|NCT01813071|101589599|FG001|NOT COMPLETED|Overall Study||0||
48513877|NCT01813071|101589600|FG002|NOT COMPLETED|Overall Study||0||
48513878|NCT01813071|101589601|FG003|NOT COMPLETED|Overall Study||0||
48513879|NCT01813071|101589602|FG004|NOT COMPLETED|Overall Study||1||
48513880|NCT01813071|101589603|FG005|NOT COMPLETED|Overall Study||7||
48513881|NCT01813071|101589604|FG006|NOT COMPLETED|Overall Study||3||
48513882|NCT01813071|101589605|FG007|NOT COMPLETED|Overall Study||5||
48513883|NCT01813071|101589606|FG008|NOT COMPLETED|Overall Study||3||
48513884|NCT03404401|101589607|FG000|STARTED|Overall Study||281|Safety population - all patients that took preparation.|
48513885|NCT03404401|101589608|FG001|STARTED|Overall Study||271|Safety population - all patients that took preparation.|
48513886|NCT03404401|101589607|FG000|COMPLETED|Overall Study||263||
48513887|NCT03404401|101589608|FG001|COMPLETED|Overall Study||252||
48513888|NCT03404401|101589607|FG000|NOT COMPLETED|Overall Study||18||
48513889|NCT03404401|101589608|FG001|NOT COMPLETED|Overall Study||19||
48513890|NCT00939627|101589609|FG000|STARTED|Overall Study||27||
48513891|NCT00939627|101589610|FG001|STARTED|Overall Study||28||
48513892|NCT00939627|101589611|FG002|STARTED|Overall Study||0||
48513893|NCT00939627|101589609|FG000|COMPLETED|Overall Study||0||
48513894|NCT00939627|101589610|FG001|COMPLETED|Overall Study||0||
48513895|NCT00939627|101589611|FG002|COMPLETED|Overall Study||0||
48513896|NCT00939627|101589609|FG000|NOT COMPLETED|Overall Study||27||
48513897|NCT00939627|101589610|FG001|NOT COMPLETED|Overall Study||28||
48513898|NCT00939627|101589611|FG002|NOT COMPLETED|Overall Study||0||
48513899|NCT01118026|101589612|FG000|STARTED|Overall Study||101||
48513900|NCT01118026|101589612|FG000|COMPLETED|Overall Study||101||
48513901|NCT01118026|101589612|FG000|NOT COMPLETED|Overall Study||0||
48513902|NCT01257581|101589613|FG000|STARTED|Overall Study||22||
48513903|NCT01257581|101589614|FG001|STARTED|Overall Study||21||
48513904|NCT01257581|101589615|FG002|STARTED|Overall Study||17||
48513905|NCT01257581|101589613|FG000|COMPLETED|Overall Study||17||
48513906|NCT01257581|101589614|FG001|COMPLETED|Overall Study||18||
48513907|NCT01257581|101589615|FG002|COMPLETED|Overall Study||11||
48513908|NCT01257581|101589613|FG000|NOT COMPLETED|Overall Study||5||
48513909|NCT01257581|101589614|FG001|NOT COMPLETED|Overall Study||3||
48513910|NCT01257581|101589615|FG002|NOT COMPLETED|Overall Study||6||
48513911|NCT04102345|101589616|FG000|STARTED|Overall Study||26||
48513912|NCT04102345|101589617|FG001|STARTED|Overall Study||32||
48513913|NCT04102345|101589616|FG000|COMPLETED|Overall Study||25||
48513914|NCT04102345|101589617|FG001|COMPLETED|Overall Study||32||
48513915|NCT04102345|101589616|FG000|NOT COMPLETED|Overall Study||1||
48513916|NCT04102345|101589617|FG001|NOT COMPLETED|Overall Study||0||
48513917|NCT00217724|101589618|FG000|STARTED|Course 1, (Glutamine/Placebo Arms)||8||
48513918|NCT00217724|101589619|FG001|STARTED|Course 1, (Glutamine/Placebo Arms)||10||
48513919|NCT00217724|101589618|FG000|COMPLETED|Course 1, (Glutamine/Placebo Arms)||5||
48513920|NCT00217724|101589619|FG001|COMPLETED|Course 1, (Glutamine/Placebo Arms)||9||
48513921|NCT00217724|101589618|FG000|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||3||
48513922|NCT00217724|101589619|FG001|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||1||
48513923|NCT00217724|101589618|FG000|STARTED|Course 2, (Glutamine/Placebo Crossover)||9||
48513924|NCT00217724|101589619|FG001|STARTED|Course 2, (Glutamine/Placebo Crossover)||5||
48513925|NCT00217724|101589618|FG000|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||8||
48513926|NCT00217724|101589619|FG001|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||5||
48513927|NCT00217724|101589618|FG000|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||1||
48513928|NCT00217724|101589619|FG001|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||0||
48513929|NCT02031237|101589620|FG000|STARTED|Overall Study||14||
48513930|NCT02031237|101589621|FG001|STARTED|Overall Study||35||
48513931|NCT02031237|101589622|FG002|STARTED|Overall Study||3||
48513932|NCT02031237|101589620|FG000|COMPLETED|Overall Study||9||
48513933|NCT02031237|101589621|FG001|COMPLETED|Overall Study||21||
48513934|NCT02031237|101589622|FG002|COMPLETED|Overall Study||0||
48513935|NCT02031237|101589620|FG000|NOT COMPLETED|Overall Study||5||
48513936|NCT02031237|101589621|FG001|NOT COMPLETED|Overall Study||14||
48513937|NCT02031237|101589622|FG002|NOT COMPLETED|Overall Study||3||
48513938|NCT02339415|101589623|FG000|STARTED|First Period||22||
48513939|NCT02339415|101589624|FG001|STARTED|First Period||22||
48513940|NCT02339415|101589623|FG000|Received at Least One Dose|First Period||21||
48513941|NCT02339415|101589624|FG001|Received at Least One Dose|First Period||20||
48513942|NCT02339415|101589623|FG000|COMPLETED|First Period||20||
48513943|NCT02339415|101589624|FG001|COMPLETED|First Period||20||
48513944|NCT02339415|101589623|FG000|NOT COMPLETED|First Period||2||
48513945|NCT02339415|101589624|FG001|NOT COMPLETED|First Period||2||
48513946|NCT02339415|101589623|FG000|STARTED|Washout||20||
48513947|NCT02339415|101589624|FG001|STARTED|Washout||20||
48513948|NCT02339415|101589623|FG000|COMPLETED|Washout||20||
48513949|NCT02339415|101589624|FG001|COMPLETED|Washout||20||
48513950|NCT02339415|101589623|FG000|NOT COMPLETED|Washout||0||
48513951|NCT02339415|101589624|FG001|NOT COMPLETED|Washout||0||
48513952|NCT02339415|101589623|FG000|STARTED|Second Period||20||
48513953|NCT02339415|101589624|FG001|STARTED|Second Period||20||
48513954|NCT02339415|101589623|FG000|COMPLETED|Second Period||19||
48513955|NCT02339415|101589624|FG001|COMPLETED|Second Period||18||
48513956|NCT02339415|101589623|FG000|NOT COMPLETED|Second Period||1||
48513957|NCT02339415|101589624|FG001|NOT COMPLETED|Second Period||2||
48513958|NCT01139294|101589625|FG000|STARTED|Overall Study||0||
48513959|NCT01139294|101589626|FG001|STARTED|Overall Study||0||
48513960|NCT01139294|101589625|FG000|COMPLETED|Overall Study||0||
48513961|NCT01139294|101589626|FG001|COMPLETED|Overall Study||0||
48513962|NCT01139294|101589625|FG000|NOT COMPLETED|Overall Study||0||
48513963|NCT01139294|101589626|FG001|NOT COMPLETED|Overall Study||0||
48513964|NCT02452528|101589627|FG000|STARTED|Overall Study||2||
48513965|NCT02452528|101589628|FG001|STARTED|Overall Study||2||
48513966|NCT02452528|101589627|FG000|COMPLETED|Overall Study||1||
48513967|NCT02452528|101589628|FG001|COMPLETED|Overall Study||1||
48513968|NCT02452528|101589627|FG000|NOT COMPLETED|Overall Study||1||
48513969|NCT02452528|101589628|FG001|NOT COMPLETED|Overall Study||1||
48513970|NCT00931996|101589629|FG000|STARTED|Overall Study||12||
48513971|NCT00931996|101589629|FG000|COMPLETED|Overall Study||5||
48513972|NCT00931996|101589629|FG000|NOT COMPLETED|Overall Study||7||
48513973|NCT02218307|101589630|FG000|STARTED|Overall Study||34||
48513974|NCT02218307|101589631|FG001|STARTED|Overall Study||34||
48513975|NCT02218307|101589630|FG000|COMPLETED|Overall Study||25||
48513976|NCT02218307|101589631|FG001|COMPLETED|Overall Study||33||
48513977|NCT02218307|101589630|FG000|NOT COMPLETED|Overall Study||9||
48513978|NCT02218307|101589631|FG001|NOT COMPLETED|Overall Study||1||
48513979|NCT05816200|101589632|FG000|STARTED|Overall Study||14||
48513980|NCT05816200|101589633|FG001|STARTED|Overall Study||14||
48513981|NCT05816200|101589632|FG000|COMPLETED|Overall Study||12||
48513982|NCT05816200|101589633|FG001|COMPLETED|Overall Study||13||
48513983|NCT05816200|101589632|FG000|NOT COMPLETED|Overall Study||2||
48513984|NCT05816200|101589633|FG001|NOT COMPLETED|Overall Study||1||
48513985|NCT03166124|101589634|FG000|STARTED|Treatment Period 1||20||
48513986|NCT03166124|101589635|FG001|STARTED|Treatment Period 1||20||
48513987|NCT03166124|101589636|FG002|STARTED|Treatment Period 1||19||
48513988|NCT03166124|101589637|FG003|STARTED|Treatment Period 1||21||
48513989|NCT03166124|101589634|FG000|Received at Least One Dose of Study Drug|Treatment Period 1||20||
48513990|NCT03166124|101589635|FG001|Received at Least One Dose of Study Drug|Treatment Period 1||20||
48513991|NCT03166124|101589636|FG002|Received at Least One Dose of Study Drug|Treatment Period 1||18||
48513992|NCT03166124|101589637|FG003|Received at Least One Dose of Study Drug|Treatment Period 1||21||
48513993|NCT03166124|101589634|FG000|COMPLETED|Treatment Period 1||20||
48513994|NCT03166124|101589635|FG001|COMPLETED|Treatment Period 1||20||
48513995|NCT03166124|101589636|FG002|COMPLETED|Treatment Period 1||18||
48513996|NCT03166124|101589637|FG003|COMPLETED|Treatment Period 1||21||
48513997|NCT03166124|101589634|FG000|NOT COMPLETED|Treatment Period 1||0||
48513998|NCT03166124|101589635|FG001|NOT COMPLETED|Treatment Period 1||0||
48513999|NCT03166124|101589636|FG002|NOT COMPLETED|Treatment Period 1||1||
48514000|NCT03166124|101589637|FG003|NOT COMPLETED|Treatment Period 1||0||
48514001|NCT03166124|101589634|FG000|STARTED|Wash-out Period||20||
48514002|NCT03166124|101589635|FG001|STARTED|Wash-out Period||20||
48514003|NCT03166124|101589636|FG002|STARTED|Wash-out Period||18||
48514004|NCT03166124|101589637|FG003|STARTED|Wash-out Period||21||
48514005|NCT03166124|101589634|FG000|COMPLETED|Wash-out Period||20||
48514006|NCT03166124|101589635|FG001|COMPLETED|Wash-out Period||18||
48514007|NCT03166124|101589636|FG002|COMPLETED|Wash-out Period||17||
48514008|NCT03166124|101589637|FG003|COMPLETED|Wash-out Period||20||
48514009|NCT03166124|101589634|FG000|NOT COMPLETED|Wash-out Period||0||
48514010|NCT03166124|101589635|FG001|NOT COMPLETED|Wash-out Period||2||
48514011|NCT03166124|101589636|FG002|NOT COMPLETED|Wash-out Period||1||
48514012|NCT03166124|101589637|FG003|NOT COMPLETED|Wash-out Period||1||
48514013|NCT03166124|101589634|FG000|STARTED|Treatment Period 2||20||
48514014|NCT03166124|101589635|FG001|STARTED|Treatment Period 2||18||
48514015|NCT03166124|101589636|FG002|STARTED|Treatment Period 2||17||
48514016|NCT03166124|101589637|FG003|STARTED|Treatment Period 2||20||
48514017|NCT03166124|101589634|FG000|COMPLETED|Treatment Period 2||20||
48514018|NCT03166124|101589635|FG001|COMPLETED|Treatment Period 2||18||
48514019|NCT03166124|101589636|FG002|COMPLETED|Treatment Period 2||17||
48514020|NCT03166124|101589637|FG003|COMPLETED|Treatment Period 2||20||
48514021|NCT03166124|101589634|FG000|NOT COMPLETED|Treatment Period 2||0||
48514022|NCT03166124|101589635|FG001|NOT COMPLETED|Treatment Period 2||0||
48514023|NCT03166124|101589636|FG002|NOT COMPLETED|Treatment Period 2||0||
48514024|NCT03166124|101589637|FG003|NOT COMPLETED|Treatment Period 2||0||
48514025|NCT02846883|101589638|FG000|STARTED|Overall Study||6||
48514026|NCT02846883|101589639|FG001|STARTED|Overall Study||10||
48514027|NCT02846883|101589640|FG002|STARTED|Overall Study||12||
48514028|NCT02846883|101589638|FG000|COMPLETED|Overall Study||0||
48514029|NCT02846883|101589639|FG001|COMPLETED|Overall Study||0||
48514030|NCT02846883|101589640|FG002|COMPLETED|Overall Study||0||
48514031|NCT02846883|101589638|FG000|NOT COMPLETED|Overall Study||6||
48514032|NCT02846883|101589639|FG001|NOT COMPLETED|Overall Study||10||
48514033|NCT02846883|101589640|FG002|NOT COMPLETED|Overall Study||12||
48514034|NCT03442569|101589641|FG000|STARTED|Overall Study||56||
48514035|NCT03442569|101589641|FG000|Started Treatment|Overall Study||55||
48514036|NCT03442569|101589641|FG000|COMPLETED|Overall Study||55||
48514037|NCT03442569|101589641|FG000|NOT COMPLETED|Overall Study||1||
48514038|NCT03823287|101589642|FG000|STARTED|Overall Study||334|Intent-to-Treat (ITT) Population|
48514039|NCT03823287|101589643|FG001|STARTED|Overall Study||337|Intent-to-Treat (ITT) Population|
48514040|NCT03823287|101589642|FG000|Received at Least One Dose of Study Drug|Overall Study||333|Safety Population|
48514041|NCT03823287|101589643|FG001|Received at Least One Dose of Study Drug|Overall Study||336|Safety Population|
48514042|NCT03823287|101589642|FG000|Completed up to Week 48|Overall Study||319|Primary Completion Date Cutoff|
48514043|NCT03823287|101589643|FG001|Completed up to Week 48|Overall Study||323|Primary Completion Date Cutoff|
48514044|NCT03823287|101589642|FG000|COMPLETED|Overall Study||274||
48514045|NCT03823287|101589643|FG001|COMPLETED|Overall Study||291||
48514046|NCT03823287|101589642|FG000|NOT COMPLETED|Overall Study||60||
48514047|NCT03823287|101589643|FG001|NOT COMPLETED|Overall Study||46||
48514048|NCT00271024|101589644|FG000|STARTED|Overall Study||80||
48514049|NCT00271024|101589645|FG001|STARTED|Overall Study||77||
48514050|NCT00271024|101589646|FG002|STARTED|Overall Study||88||
48514051|NCT00271024|101589647|FG003|STARTED|Overall Study||88||
48514052|NCT00271024|101589644|FG000|Received Study Treatment|Overall Study||76||
48514053|NCT00271024|101589645|FG001|Received Study Treatment|Overall Study||71||
48514054|NCT00271024|101589646|FG002|Received Study Treatment|Overall Study||85||
48514055|NCT00271024|101589647|FG003|Received Study Treatment|Overall Study||83||
48514056|NCT00271024|101589644|FG000|COMPLETED|Overall Study||58||
48514057|NCT00271024|101589645|FG001|COMPLETED|Overall Study||51||
48514058|NCT00271024|101589646|FG002|COMPLETED|Overall Study||65||
48514059|NCT00271024|101589647|FG003|COMPLETED|Overall Study||64||
48514060|NCT00271024|101589644|FG000|NOT COMPLETED|Overall Study||22||
48514061|NCT00271024|101589645|FG001|NOT COMPLETED|Overall Study||26||
48514062|NCT00271024|101589646|FG002|NOT COMPLETED|Overall Study||23||
48514063|NCT00271024|101589647|FG003|NOT COMPLETED|Overall Study||24||
48514064|NCT02304406|101589648|FG000|STARTED|Overall Study||449||
48514065|NCT02304406|101589648|FG000|COMPLETED|Overall Study||449||
48514066|NCT02304406|101589648|FG000|NOT COMPLETED|Overall Study||0||
48514067|NCT00929981|101589649|FG000|STARTED|Overall Study||80||
48514068|NCT00929981|101589649|FG000|COMPLETED|Overall Study||80||
48514069|NCT00929981|101589649|FG000|NOT COMPLETED|Overall Study||0||
48514070|NCT00761176|101589650|FG000|STARTED|Overall Study||4||
48514071|NCT00761176|101589651|FG001|STARTED|Overall Study||4||
48514072|NCT00761176|101589650|FG000|COMPLETED|Overall Study||2||
48514073|NCT00761176|101589651|FG001|COMPLETED|Overall Study||3||
48514074|NCT00761176|101589650|FG000|NOT COMPLETED|Overall Study||2||
48514075|NCT00761176|101589651|FG001|NOT COMPLETED|Overall Study||1||
48514076|NCT01483625|101589652|FG000|STARTED|Overall Study||72||
48514077|NCT01483625|101589653|FG001|STARTED|Overall Study||68||
48514078|NCT01483625|101589652|FG000|COMPLETED|Overall Study||68||
48514079|NCT01483625|101589653|FG001|COMPLETED|Overall Study||66||
48514080|NCT01483625|101589652|FG000|NOT COMPLETED|Overall Study||4||
48514081|NCT01483625|101589653|FG001|NOT COMPLETED|Overall Study||2||
48514082|NCT00656968|101589654|FG000|STARTED|Overall Study||115||
48514083|NCT00656968|101589655|FG001|STARTED|Overall Study||117||
48514084|NCT00656968|101589654|FG000|COMPLETED|Overall Study||115||
48514085|NCT00656968|101589655|FG001|COMPLETED|Overall Study||117||
48514086|NCT00656968|101589654|FG000|NOT COMPLETED|Overall Study||0||
48514087|NCT00656968|101589655|FG001|NOT COMPLETED|Overall Study||0||
48514088|NCT00402025|101589656|FG000|STARTED|Overall Study||3||
48514089|NCT00402025|101589657|FG001|STARTED|Overall Study||4||
48514090|NCT00402025|101589658|FG002|STARTED|Overall Study||10||
48514091|NCT00402025|101589656|FG000|COMPLETED|Overall Study||1||
48514092|NCT00402025|101589657|FG001|COMPLETED|Overall Study||1||
48514093|NCT00402025|101589658|FG002|COMPLETED|Overall Study||0||
48514094|NCT00402025|101589656|FG000|NOT COMPLETED|Overall Study||2||
48514095|NCT00402025|101589657|FG001|NOT COMPLETED|Overall Study||3||
48514096|NCT00402025|101589658|FG002|NOT COMPLETED|Overall Study||10||
48514097|NCT01435824|101589659|FG000|STARTED|First Intervention||8||
48514098|NCT01435824|101589660|FG001|STARTED|First Intervention||8||
48514099|NCT01435824|101589659|FG000|COMPLETED|First Intervention||8||
48514100|NCT01435824|101589660|FG001|COMPLETED|First Intervention||8||
48514101|NCT01435824|101589659|FG000|NOT COMPLETED|First Intervention||0||
48514102|NCT01435824|101589660|FG001|NOT COMPLETED|First Intervention||0||
48514103|NCT01435824|101589659|FG000|STARTED|Washout of 1-2 Weeks||8||
48514104|NCT01435824|101589660|FG001|STARTED|Washout of 1-2 Weeks||8||
48514105|NCT01435824|101589659|FG000|COMPLETED|Washout of 1-2 Weeks||8||
48514106|NCT01435824|101589660|FG001|COMPLETED|Washout of 1-2 Weeks||8||
48514107|NCT01435824|101589659|FG000|NOT COMPLETED|Washout of 1-2 Weeks||0||
48514108|NCT01435824|101589660|FG001|NOT COMPLETED|Washout of 1-2 Weeks||0||
48514109|NCT01435824|101589659|FG000|STARTED|Second Intervention||8||
48514110|NCT01435824|101589660|FG001|STARTED|Second Intervention||8||
48514111|NCT01435824|101589659|FG000|COMPLETED|Second Intervention||8||
48514112|NCT01435824|101589660|FG001|COMPLETED|Second Intervention||8||
48514113|NCT01435824|101589659|FG000|NOT COMPLETED|Second Intervention||0||
48514114|NCT01435824|101589660|FG001|NOT COMPLETED|Second Intervention||0||
48514115|NCT00551616|101589661|FG000|STARTED|Overall Study||1104||
48514116|NCT00551616|101589662|FG001|STARTED|Overall Study||1117||
48514117|NCT00551616|101589661|FG000|COMPLETED|Overall Study||1056||
48514118|NCT00551616|101589662|FG001|COMPLETED|Overall Study||1077||
48514119|NCT00551616|101589661|FG000|NOT COMPLETED|Overall Study||48||
48514120|NCT00551616|101589662|FG001|NOT COMPLETED|Overall Study||40||
48514121|NCT02710591|101589663|FG000|STARTED|Overall Study||5||
48514122|NCT02710591|101589664|FG001|STARTED|Overall Study||5||
48514123|NCT02710591|101589665|FG002|STARTED|Overall Study||5||
48514124|NCT02710591|101589666|FG003|STARTED|Overall Study||5||
48514125|NCT02710591|101589663|FG000|COMPLETED|Overall Study||5||
48514126|NCT02710591|101589664|FG001|COMPLETED|Overall Study||5||
48514127|NCT02710591|101589665|FG002|COMPLETED|Overall Study||5||
48514128|NCT02710591|101589666|FG003|COMPLETED|Overall Study||5||
48514129|NCT02710591|101589663|FG000|NOT COMPLETED|Overall Study||0||
48514130|NCT02710591|101589664|FG001|NOT COMPLETED|Overall Study||0||
48514131|NCT02710591|101589665|FG002|NOT COMPLETED|Overall Study||0||
48514132|NCT02710591|101589666|FG003|NOT COMPLETED|Overall Study||0||
48514133|NCT00124462|101589667|FG000|STARTED|Overall Study||40||
48514134|NCT00124462|101589668|FG001|STARTED|Overall Study||40||
48514135|NCT00124462|101589667|FG000|COMPLETED|Overall Study||29||
48514136|NCT00124462|101589668|FG001|COMPLETED|Overall Study||27||
48514137|NCT00124462|101589667|FG000|NOT COMPLETED|Overall Study||11||
48514138|NCT00124462|101589668|FG001|NOT COMPLETED|Overall Study||13||
48514139|NCT01143649|101589669|FG000|STARTED|Overall Study||7||
48514140|NCT01143649|101589670|FG001|STARTED|Overall Study||7||
48514141|NCT01143649|101589671|FG002|STARTED|Overall Study||10||
48514142|NCT01143649|101589672|FG003|STARTED|Overall Study||10||
48514143|NCT01143649|101589673|FG004|STARTED|Overall Study||5||
48514144|NCT01143649|101589674|FG005|STARTED|Overall Study||5||
48514145|NCT01143649|101589669|FG000|COMPLETED|Overall Study||7||
48514146|NCT01143649|101589670|FG001|COMPLETED|Overall Study||7||
48514147|NCT01143649|101589671|FG002|COMPLETED|Overall Study||10||
48514148|NCT01143649|101589672|FG003|COMPLETED|Overall Study||10||
48514149|NCT01143649|101589673|FG004|COMPLETED|Overall Study||4||
48514150|NCT01143649|101589674|FG005|COMPLETED|Overall Study||3||
48514151|NCT01143649|101589669|FG000|NOT COMPLETED|Overall Study||0||
48514152|NCT01143649|101589670|FG001|NOT COMPLETED|Overall Study||0||
48514153|NCT01143649|101589671|FG002|NOT COMPLETED|Overall Study||0||
48514154|NCT01143649|101589672|FG003|NOT COMPLETED|Overall Study||0||
48514155|NCT01143649|101589673|FG004|NOT COMPLETED|Overall Study||1||
48514156|NCT01143649|101589674|FG005|NOT COMPLETED|Overall Study||2||
48514157|NCT01396382|101589675|FG000|STARTED|Overall Study||97||
48514158|NCT01396382|101589675|FG000|COMPLETED|Overall Study||97||
48514159|NCT01396382|101589675|FG000|NOT COMPLETED|Overall Study||0||
48514160|NCT05070390|101589676|FG000|STARTED|Overall Study||10||
48514161|NCT05070390|101589677|FG001|STARTED|Overall Study||8||
48514162|NCT05070390|101589676|FG000|COMPLETED|Overall Study||10||
48514163|NCT05070390|101589677|FG001|COMPLETED|Overall Study||8||
48514164|NCT05070390|101589676|FG000|NOT COMPLETED|Overall Study||0||
48514165|NCT05070390|101589677|FG001|NOT COMPLETED|Overall Study||0||
48514166|NCT02190279|101589678|FG000|STARTED|Overall Study||16||
48514167|NCT02190279|101589679|FG001|STARTED|Overall Study||69||
48514168|NCT02190279|101589680|FG002|STARTED|Overall Study||31||
48514169|NCT02190279|101589678|FG000|COMPLETED|Overall Study||13||
48514170|NCT02190279|101589679|FG001|COMPLETED|Overall Study||69||
48514171|NCT02190279|101589680|FG002|COMPLETED|Overall Study||28||
48514172|NCT02190279|101589678|FG000|NOT COMPLETED|Overall Study||3||
48514173|NCT02190279|101589679|FG001|NOT COMPLETED|Overall Study||0||
48514174|NCT02190279|101589680|FG002|NOT COMPLETED|Overall Study||3||
48514175|NCT02095340|101589681|FG000|STARTED|Overall Study||51||
48514176|NCT02095340|101589682|FG001|STARTED|Overall Study||54||
48514177|NCT02095340|101589683|FG002|STARTED|Overall Study||105||
48514178|NCT02095340|101589681|FG000|COMPLETED|Overall Study||51||
48514179|NCT02095340|101589682|FG001|COMPLETED|Overall Study||54||
48514180|NCT02095340|101589683|FG002|COMPLETED|Overall Study||105||
48514181|NCT02095340|101589681|FG000|NOT COMPLETED|Overall Study||0||
48514182|NCT02095340|101589682|FG001|NOT COMPLETED|Overall Study||0||
48514183|NCT02095340|101589683|FG002|NOT COMPLETED|Overall Study||0||
48514184|NCT00515034|101589684|FG000|STARTED|Overall Study||49||
48514185|NCT00515034|101589685|FG001|STARTED|Overall Study||15||
48514186|NCT00515034|101589686|FG002|STARTED|Overall Study||62||
48514187|NCT00515034|101589687|FG003|STARTED|Overall Study||20||
48514188|NCT00515034|101589684|FG000|TREATED|Overall Study||48||
48514189|NCT00515034|101589685|FG001|TREATED|Overall Study||15||
48514190|NCT00515034|101589686|FG002|TREATED|Overall Study||61||
48514191|NCT00515034|101589687|FG003|TREATED|Overall Study||19||
48514192|NCT00515034|101589684|FG000|COMPLETED|Overall Study||41||
48514193|NCT00515034|101589685|FG001|COMPLETED|Overall Study||13||
48514194|NCT00515034|101589686|FG002|COMPLETED|Overall Study||54||
48514195|NCT00515034|101589687|FG003|COMPLETED|Overall Study||15||
48514196|NCT00515034|101589684|FG000|NOT COMPLETED|Overall Study||8||
48514197|NCT00515034|101589685|FG001|NOT COMPLETED|Overall Study||2||
48514198|NCT00515034|101589686|FG002|NOT COMPLETED|Overall Study||8||
48514199|NCT00515034|101589687|FG003|NOT COMPLETED|Overall Study||5||
48514200|NCT01491633|101589688|FG000|STARTED|Overall Study||5||
48514201|NCT01491633|101589688|FG000|COMPLETED|Overall Study||0||
48514202|NCT01491633|101589688|FG000|NOT COMPLETED|Overall Study||5||
48514203|NCT01546922|101589689|FG000|STARTED|First Period of 10 Weeks||30||
48514204|NCT01546922|101589690|FG001|STARTED|First Period of 10 Weeks||30||
48514205|NCT01546922|101589689|FG000|COMPLETED|First Period of 10 Weeks||25||
48514206|NCT01546922|101589690|FG001|COMPLETED|First Period of 10 Weeks||28||
48514207|NCT01546922|101589689|FG000|NOT COMPLETED|First Period of 10 Weeks||5||
48514208|NCT01546922|101589690|FG001|NOT COMPLETED|First Period of 10 Weeks||2||
48514209|NCT01546922|101589689|FG000|STARTED|Second Period of 10 Weeks||25||
48514210|NCT01546922|101589690|FG001|STARTED|Second Period of 10 Weeks||28||
48514211|NCT01546922|101589689|FG000|COMPLETED|Second Period of 10 Weeks||22||
48514212|NCT01546922|101589690|FG001|COMPLETED|Second Period of 10 Weeks||25||
48514213|NCT01546922|101589689|FG000|NOT COMPLETED|Second Period of 10 Weeks||3||
48514214|NCT01546922|101589690|FG001|NOT COMPLETED|Second Period of 10 Weeks||3||
48514215|NCT01098110|101589691|FG000|STARTED|Overall Study||176||
48514216|NCT01098110|101589692|FG001|STARTED|Overall Study||182||
48514217|NCT01098110|101589693|FG002|STARTED|Overall Study||174||
48514218|NCT01098110|101589691|FG000|Treated|Overall Study||175||
48514219|NCT01098110|101589692|FG001|Treated|Overall Study||181||
48514220|NCT01098110|101589693|FG002|Treated|Overall Study||174||
48514221|NCT01098110|101589691|FG000|COMPLETED|Overall Study||114||
48514222|NCT01098110|101589692|FG001|COMPLETED|Overall Study||109||
48514223|NCT01098110|101589693|FG002|COMPLETED|Overall Study||80||
48514224|NCT01098110|101589691|FG000|NOT COMPLETED|Overall Study||62||
48514225|NCT01098110|101589692|FG001|NOT COMPLETED|Overall Study||73||
48514226|NCT01098110|101589693|FG002|NOT COMPLETED|Overall Study||94||
48514227|NCT00104247|101589694|FG000|STARTED|Overall Study||42||
48514228|NCT00104247|101589695|FG001|STARTED|Overall Study||47||
48514229|NCT00104247|101589694|FG000|COMPLETED|Overall Study||41||
48514230|NCT00104247|101589695|FG001|COMPLETED|Overall Study||46||
48514231|NCT00104247|101589694|FG000|NOT COMPLETED|Overall Study||1||
48514232|NCT00104247|101589695|FG001|NOT COMPLETED|Overall Study||1||
48514233|NCT00275275|101589696|FG000|STARTED|Overall Study||20||
48514234|NCT00275275|101589697|FG001|STARTED|Overall Study||20||
48514235|NCT00275275|101589698|FG002|STARTED|Overall Study||21||
48514236|NCT00275275|101589696|FG000|COMPLETED|Overall Study||14||
48514237|NCT00275275|101589697|FG001|COMPLETED|Overall Study||18||
48514238|NCT00275275|101589698|FG002|COMPLETED|Overall Study||15||
48514239|NCT00275275|101589696|FG000|NOT COMPLETED|Overall Study||6||
48514240|NCT00275275|101589697|FG001|NOT COMPLETED|Overall Study||2||
48514241|NCT00275275|101589698|FG002|NOT COMPLETED|Overall Study||6||
48514242|NCT03653026|101589699|FG000|STARTED|Part 1: Placebo-controlled Period||345||
48514243|NCT03653026|101589700|FG001|STARTED|Part 1: Placebo-controlled Period||177||
48514244|NCT03653026|101589701|FG002|STARTED|Part 1: Placebo-controlled Period||0||
48514245|NCT03653026|101589702|FG003|STARTED|Part 1: Placebo-controlled Period||0||
48514246|NCT03653026|101589699|FG000|Received Treatment|Part 1: Placebo-controlled Period||344||
48514247|NCT03653026|101589700|FG001|Received Treatment|Part 1: Placebo-controlled Period||177||
48514248|NCT03653026|101589701|FG002|Received Treatment|Part 1: Placebo-controlled Period||0||
48514249|NCT03653026|101589702|FG003|Received Treatment|Part 1: Placebo-controlled Period||0||
48514250|NCT03653026|101589699|FG000|COMPLETED|Part 1: Placebo-controlled Period||334||
48514251|NCT03653026|101589700|FG001|COMPLETED|Part 1: Placebo-controlled Period||164||
48514252|NCT03653026|101589701|FG002|COMPLETED|Part 1: Placebo-controlled Period||0||
48514253|NCT03653026|101589702|FG003|COMPLETED|Part 1: Placebo-controlled Period||0||
48514254|NCT03653026|101589699|FG000|NOT COMPLETED|Part 1: Placebo-controlled Period||11||
48514255|NCT03653026|101589700|FG001|NOT COMPLETED|Part 1: Placebo-controlled Period||13||
48514256|NCT03653026|101589701|FG002|NOT COMPLETED|Part 1: Placebo-controlled Period||0||
48514257|NCT03653026|101589702|FG003|NOT COMPLETED|Part 1: Placebo-controlled Period||0||
48514258|NCT03653026|101589699|FG000|STARTED|Part 2: Open-label Extension||0|Part 2 was an extended treatment period for participants who did not achieve clinical response per Adapted Mayo score at Week 8 in Part 1.|
48514259|NCT03653026|101589700|FG001|STARTED|Part 2: Open-label Extension||0|Part 2 was an extended treatment period for participants who did not achieve clinical response per Adapted Mayo score at Week 8 in Part 1.|
48514260|NCT03653026|101589701|FG002|STARTED|Part 2: Open-label Extension||68|Part 2 was an extended treatment period for participants who did not achieve clinical response per Adapted Mayo score at Week 8 in Part 1.|
48514261|NCT03653026|101589702|FG003|STARTED|Part 2: Open-label Extension||116|Part 2 was an extended treatment period for participants who did not achieve clinical response per Adapted Mayo score at Week 8 in Part 1.|
48514262|NCT03653026|101589699|FG000|COMPLETED|Part 2: Open-label Extension||0||
48514263|NCT03653026|101589700|FG001|COMPLETED|Part 2: Open-label Extension||0||
48514264|NCT03653026|101589701|FG002|COMPLETED|Part 2: Open-label Extension||65||
48514265|NCT03653026|101589702|FG003|COMPLETED|Part 2: Open-label Extension||111||
48514266|NCT03653026|101589699|FG000|NOT COMPLETED|Part 2: Open-label Extension||0||
48514267|NCT03653026|101589700|FG001|NOT COMPLETED|Part 2: Open-label Extension||0||
48514268|NCT03653026|101589701|FG002|NOT COMPLETED|Part 2: Open-label Extension||3||
48514269|NCT03653026|101589702|FG003|NOT COMPLETED|Part 2: Open-label Extension||5||
48514270|NCT01765751|101589703|FG000|STARTED|Overall Study||16||
48514271|NCT01765751|101589704|FG001|STARTED|Overall Study||16||
48514272|NCT01765751|101589705|FG002|STARTED|Overall Study||16||
48514273|NCT01765751|101589703|FG000|COMPLETED|Overall Study||16||
48514274|NCT01765751|101589704|FG001|COMPLETED|Overall Study||14||
48514275|NCT01765751|101589705|FG002|COMPLETED|Overall Study||15||
48514276|NCT01765751|101589703|FG000|NOT COMPLETED|Overall Study||0||
48514277|NCT01765751|101589704|FG001|NOT COMPLETED|Overall Study||2||
48514278|NCT01765751|101589705|FG002|NOT COMPLETED|Overall Study||1||
48514279|NCT04675775|101589706|FG000|STARTED|Overall Study||17||
48514280|NCT04675775|101589706|FG000|Participants Who Did Not Withdraw Prior to MTM|Overall Study||12||
48514281|NCT04675775|101589706|FG000|Participants Who Did Not Withdraw During MTM|Overall Study||10||
48514282|NCT04675775|101589706|FG000|COMPLETED|Overall Study||10||
48514283|NCT04675775|101589706|FG000|NOT COMPLETED|Overall Study||7||
48514284|NCT04815850|101589707|FG000|STARTED|Overall Study||94||
48514285|NCT04815850|101589707|FG000|COMPLETED|Overall Study||94||
48514286|NCT04815850|101589707|FG000|NOT COMPLETED|Overall Study||0||
48514287|NCT01955044|101589708|FG000|STARTED|Overall Study||10||
48514288|NCT01955044|101589709|FG001|STARTED|Overall Study||10||
48514289|NCT01955044|101589710|FG002|STARTED|Overall Study||10||
48514290|NCT01955044|101589708|FG000|COMPLETED|Overall Study||9||
48666793|NCT03391882|101970468|FG003|Modified Intent-to-Treat Population Part B|Part B - Treatment Phase||18||
48666794|NCT03391882|101970469|FG004|Modified Intent-to-Treat Population Part B|Part B - Treatment Phase||18||
48514291|NCT01955044|101589709|FG001|COMPLETED|Overall Study||9||
48514292|NCT01955044|101589710|FG002|COMPLETED|Overall Study||10||
48514293|NCT01955044|101589708|FG000|NOT COMPLETED|Overall Study||1||
48514294|NCT01955044|101589709|FG001|NOT COMPLETED|Overall Study||1||
48514295|NCT01955044|101589710|FG002|NOT COMPLETED|Overall Study||0||
48514296|NCT04252287|101589711|FG000|STARTED|Overall Study||238||
48514297|NCT04252287|101589712|FG001|STARTED|Overall Study||238||
48514298|NCT04252287|101589711|FG000|Treated (Safety Analysis Set)|Overall Study||231|Safety analysis set included all randomized participants who received at least 1 dose of study intervention.|
48514299|NCT04252287|101589712|FG001|Treated (Safety Analysis Set)|Overall Study||224|Safety analysis set included all randomized participants who received at least 1 dose of study intervention.|
48514300|NCT04252287|101589711|FG000|COMPLETED|Overall Study||207||
48514301|NCT04252287|101589712|FG001|COMPLETED|Overall Study||209||
48514302|NCT04252287|101589711|FG000|NOT COMPLETED|Overall Study||31||
48514303|NCT04252287|101589712|FG001|NOT COMPLETED|Overall Study||29||
48514304|NCT05265065|101589713|FG000|STARTED|Overall Study||65||
48514305|NCT05265065|101589714|FG001|STARTED|Overall Study||65||
48514306|NCT05265065|101589715|FG002|STARTED|Overall Study||201||
48514307|NCT05265065|101589716|FG003|STARTED|Overall Study||200||
48514308|NCT05265065|101589717|FG004|STARTED|Overall Study||34||
48514309|NCT05265065|101589718|FG005|STARTED|Overall Study||36||
48514310|NCT05265065|101589713|FG000|COMPLETED|Overall Study||65||
48514311|NCT05265065|101589714|FG001|COMPLETED|Overall Study||62||
48514312|NCT05265065|101589715|FG002|COMPLETED|Overall Study||194||
48514313|NCT05265065|101589716|FG003|COMPLETED|Overall Study||198||
48514314|NCT05265065|101589717|FG004|COMPLETED|Overall Study||33||
48514315|NCT05265065|101589718|FG005|COMPLETED|Overall Study||35||
48514316|NCT05265065|101589713|FG000|NOT COMPLETED|Overall Study||0||
48514317|NCT05265065|101589714|FG001|NOT COMPLETED|Overall Study||3||
48514318|NCT05265065|101589715|FG002|NOT COMPLETED|Overall Study||7||
48514319|NCT05265065|101589716|FG003|NOT COMPLETED|Overall Study||2||
48514320|NCT05265065|101589717|FG004|NOT COMPLETED|Overall Study||1||
48514321|NCT05265065|101589718|FG005|NOT COMPLETED|Overall Study||1||
48514322|NCT01168687|101589719|FG000|STARTED|Overall Study||23||
48514323|NCT01168687|101589720|FG001|STARTED|Overall Study||23||
48514324|NCT01168687|101589719|FG000|COMPLETED|Overall Study||23||
48514325|NCT01168687|101589720|FG001|COMPLETED|Overall Study||23||
48514326|NCT01168687|101589719|FG000|NOT COMPLETED|Overall Study||0||
48514327|NCT01168687|101589720|FG001|NOT COMPLETED|Overall Study||0||
48514328|NCT01731886|101589721|FG000|STARTED|Overall Study||31||
48514329|NCT01731886|101589722|FG001|STARTED|Overall Study||29||
48514330|NCT01731886|101589721|FG000|COMPLETED|Overall Study||29||
48514331|NCT01731886|101589722|FG001|COMPLETED|Overall Study||28||
48514332|NCT01731886|101589721|FG000|NOT COMPLETED|Overall Study||2||
48514333|NCT01731886|101589722|FG001|NOT COMPLETED|Overall Study||1||
48514334|NCT01290237|101589723|FG000|STARTED|Overall Study||30||
48514335|NCT01290237|101589724|FG001|STARTED|Overall Study||29||
48514336|NCT01290237|101589723|FG000|COMPLETED|Overall Study||19||
48514337|NCT01290237|101589724|FG001|COMPLETED|Overall Study||27||
48514338|NCT01290237|101589723|FG000|NOT COMPLETED|Overall Study||11||
48514339|NCT01290237|101589724|FG001|NOT COMPLETED|Overall Study||2||
48514340|NCT00894517|101589725|FG000|STARTED|Overall Study||30||
48514341|NCT00894517|101589726|FG001|STARTED|Overall Study||31||
48514342|NCT00894517|101589725|FG000|COMPLETED|Overall Study||28||
48514343|NCT00894517|101589726|FG001|COMPLETED|Overall Study||26||
48514344|NCT00894517|101589725|FG000|NOT COMPLETED|Overall Study||2||
48514345|NCT00894517|101589726|FG001|NOT COMPLETED|Overall Study||5||
48514346|NCT00810602|101589727|FG000|STARTED|Overall Study||27||
48514347|NCT00810602|101589728|FG001|STARTED|Overall Study||34||
48514348|NCT00810602|101589727|FG000|COMPLETED|Overall Study||19||
48514349|NCT00810602|101589728|FG001|COMPLETED|Overall Study||31||
48514350|NCT00810602|101589727|FG000|NOT COMPLETED|Overall Study||8||
48514351|NCT00810602|101589728|FG001|NOT COMPLETED|Overall Study||3||
48514352|NCT01636934|101589729|FG000|STARTED|Overall Study||25||
48514353|NCT01636934|101589730|FG001|STARTED|Overall Study||24||
48514354|NCT01636934|101589729|FG000|COMPLETED|Overall Study||19||
48514355|NCT01636934|101589730|FG001|COMPLETED|Overall Study||21||
48514356|NCT01636934|101589729|FG000|NOT COMPLETED|Overall Study||6||
48514357|NCT01636934|101589730|FG001|NOT COMPLETED|Overall Study||3||
48514358|NCT00968019|101589731|FG000|STARTED|Overall Study||318||
48514359|NCT00968019|101589731|FG000|COMPLETED|Overall Study||303||
48514360|NCT00968019|101589731|FG000|NOT COMPLETED|Overall Study||15||
48514361|NCT04403763|101589732|FG000|STARTED|Stage 1||10||
48514362|NCT04403763|101589733|FG001|STARTED|Stage 1||9||
48514363|NCT04403763|101589734|FG002|STARTED|Stage 1||10||
48514364|NCT04403763|101589735|FG003|STARTED|Stage 1||9||
48514365|NCT04403763|101589736|FG004|STARTED|Stage 1||0||
48514366|NCT04403763|101589737|FG005|STARTED|Stage 1||0||
48514367|NCT04403763|101589738|FG006|STARTED|Stage 1||0||
48514368|NCT04403763|101589732|FG000|COMPLETED|Stage 1||9||
48514369|NCT04403763|101589733|FG001|COMPLETED|Stage 1||8||
48514370|NCT04403763|101589734|FG002|COMPLETED|Stage 1||9||
48514371|NCT04403763|101589735|FG003|COMPLETED|Stage 1||9||
48514372|NCT04403763|101589736|FG004|COMPLETED|Stage 1||0||
48514373|NCT04403763|101589737|FG005|COMPLETED|Stage 1||0||
48514374|NCT04403763|101589738|FG006|COMPLETED|Stage 1||0||
48514375|NCT04403763|101589732|FG000|NOT COMPLETED|Stage 1||1||
48514376|NCT04403763|101589733|FG001|NOT COMPLETED|Stage 1||1||
48514377|NCT04403763|101589734|FG002|NOT COMPLETED|Stage 1||1||
48514378|NCT04403763|101589735|FG003|NOT COMPLETED|Stage 1||0||
48514379|NCT04403763|101589736|FG004|NOT COMPLETED|Stage 1||0||
48514380|NCT04403763|101589737|FG005|NOT COMPLETED|Stage 1||0||
48514381|NCT04403763|101589738|FG006|NOT COMPLETED|Stage 1||0||
48514382|NCT04403763|101589732|FG000|STARTED|Stage 2A||9||
48514383|NCT04403763|101589733|FG001|STARTED|Stage 2A||0||
48514384|NCT04403763|101589734|FG002|STARTED|Stage 2A||0||
48514385|NCT04403763|101589735|FG003|STARTED|Stage 2A||0||
48514386|NCT04403763|101589736|FG004|STARTED|Stage 2A||12||
48514387|NCT04403763|101589737|FG005|STARTED|Stage 2A||11||
48514388|NCT04403763|101589738|FG006|STARTED|Stage 2A||10||
48514389|NCT04403763|101589732|FG000|COMPLETED|Stage 2A||9||
48514390|NCT04403763|101589733|FG001|COMPLETED|Stage 2A||0||
48514391|NCT04403763|101589734|FG002|COMPLETED|Stage 2A||0||
48514392|NCT04403763|101589735|FG003|COMPLETED|Stage 2A||0||
48514393|NCT04403763|101589736|FG004|COMPLETED|Stage 2A||12||
48514394|NCT04403763|101589737|FG005|COMPLETED|Stage 2A||11||
48514395|NCT04403763|101589738|FG006|COMPLETED|Stage 2A||9||
48514396|NCT04403763|101589732|FG000|NOT COMPLETED|Stage 2A||0||
48514397|NCT04403763|101589733|FG001|NOT COMPLETED|Stage 2A||0||
48514398|NCT04403763|101589734|FG002|NOT COMPLETED|Stage 2A||0||
48514399|NCT04403763|101589735|FG003|NOT COMPLETED|Stage 2A||0||
48514400|NCT04403763|101589736|FG004|NOT COMPLETED|Stage 2A||0||
48514401|NCT04403763|101589737|FG005|NOT COMPLETED|Stage 2A||0||
48514402|NCT04403763|101589738|FG006|NOT COMPLETED|Stage 2A||1||
48514403|NCT01546519|101589739|FG000|STARTED|Overall Study||9||
48514404|NCT01546519|101589740|FG001|STARTED|Overall Study||8||
48514405|NCT01546519|101589741|FG002|STARTED|Overall Study||8||
48514406|NCT01546519|101589742|FG003|STARTED|Overall Study||6||
48514407|NCT01546519|101589739|FG000|Safety-Evaluable Participants|Overall Study||9||
48514408|NCT01546519|101589740|FG001|Safety-Evaluable Participants|Overall Study||8||
48514409|NCT01546519|101589741|FG002|Safety-Evaluable Participants|Overall Study||8||
48514410|NCT01546519|101589742|FG003|Safety-Evaluable Participants|Overall Study||6||
48514411|NCT01546519|101589739|FG000|COMPLETED|Overall Study||0||
48514412|NCT01546519|101589740|FG001|COMPLETED|Overall Study||0||
48514413|NCT01546519|101589741|FG002|COMPLETED|Overall Study||0||
48514414|NCT01546519|101589742|FG003|COMPLETED|Overall Study||0||
48514415|NCT01546519|101589739|FG000|NOT COMPLETED|Overall Study||9||
48514416|NCT01546519|101589740|FG001|NOT COMPLETED|Overall Study||8||
48514417|NCT01546519|101589741|FG002|NOT COMPLETED|Overall Study||8||
48514418|NCT01546519|101589742|FG003|NOT COMPLETED|Overall Study||6||
48514419|NCT01845116|101589743|FG000|STARTED|Overall Study||11||
48514420|NCT01845116|101589743|FG000|COMPLETED|Overall Study||11||
48514421|NCT01845116|101589743|FG000|NOT COMPLETED|Overall Study||0||
48514422|NCT02551679|101589744|FG000|STARTED|Overall Study||46||
48514423|NCT02551679|101589745|FG001|STARTED|Overall Study||21||
48514424|NCT02551679|101589744|FG000|COMPLETED|Overall Study||27||
48514425|NCT02551679|101589745|FG001|COMPLETED|Overall Study||19||
48514426|NCT02551679|101589744|FG000|NOT COMPLETED|Overall Study||19||
48514427|NCT02551679|101589745|FG001|NOT COMPLETED|Overall Study||2||
48514428|NCT01104090|101589746|FG000|STARTED|Overall Study||25||
48514429|NCT01104090|101589747|FG001|STARTED|Overall Study||25||
48514430|NCT01104090|101589746|FG000|COMPLETED|Overall Study||25||
48514431|NCT01104090|101589747|FG001|COMPLETED|Overall Study||25||
48514432|NCT01104090|101589746|FG000|NOT COMPLETED|Overall Study||0||
48514433|NCT01104090|101589747|FG001|NOT COMPLETED|Overall Study||0||
48514434|NCT00576303|101589748|FG000|STARTED|Dose Titration Period||200||
48514435|NCT00576303|101589748|FG000|COMPLETED|Dose Titration Period||183||
48514436|NCT00576303|101589748|FG000|NOT COMPLETED|Dose Titration Period||17||
48514437|NCT00576303|101589748|FG000|STARTED|Efficacy Evaluation Period||183||
48514438|NCT00576303|101589748|FG000|COMPLETED|Efficacy Evaluation Period||178||
48514439|NCT00576303|101589748|FG000|NOT COMPLETED|Efficacy Evaluation Period||5||
48514440|NCT00576303|101589748|FG000|STARTED|Long Term Safety Period||178||
48514441|NCT00576303|101589748|FG000|COMPLETED|Long Term Safety Period||162||
48514442|NCT00576303|101589748|FG000|NOT COMPLETED|Long Term Safety Period||16||
48514443|NCT02409329|101589749|FG000|STARTED|Overall Study||127||
48514444|NCT02409329|101589750|FG001|STARTED|Overall Study||126||
48219943|NCT05580003|100863766|FG018|COMPLETED|Part 3: Period 3 (Day 1)||2||
48514445|NCT02409329|101589751|FG002|STARTED|Overall Study||253||
48514446|NCT02409329|101589749|FG000|COMPLETED|Overall Study||122||
48514447|NCT02409329|101589750|FG001|COMPLETED|Overall Study||120||
48514448|NCT02409329|101589751|FG002|COMPLETED|Overall Study||244||
48514449|NCT02409329|101589749|FG000|NOT COMPLETED|Overall Study||5||
48514450|NCT02409329|101589750|FG001|NOT COMPLETED|Overall Study||6||
48514451|NCT02409329|101589751|FG002|NOT COMPLETED|Overall Study||9||
48514452|NCT02994290|101589752|FG000|STARTED|Overall Study||491||
48514453|NCT02994290|101589753|FG001|STARTED|Overall Study||296||
48514454|NCT02994290|101589754|FG002|STARTED|Overall Study||30||
48514455|NCT02994290|101589752|FG000|COMPLETED|Overall Study||491||
48514456|NCT02994290|101589753|FG001|COMPLETED|Overall Study||296||
48514457|NCT02994290|101589754|FG002|COMPLETED|Overall Study||30||
48514458|NCT02994290|101589752|FG000|NOT COMPLETED|Overall Study||0||
48514459|NCT02994290|101589753|FG001|NOT COMPLETED|Overall Study||0||
48514460|NCT02994290|101589754|FG002|NOT COMPLETED|Overall Study||0||
48514461|NCT02997722|101589755|FG000|STARTED|Overall Study||3||
48514462|NCT02997722|101589756|FG001|STARTED|Overall Study||1||
48514463|NCT02997722|101589755|FG000|COMPLETED|Overall Study||3||
48514464|NCT02997722|101589756|FG001|COMPLETED|Overall Study||1||
48514465|NCT02997722|101589755|FG000|NOT COMPLETED|Overall Study||0||
48514466|NCT02997722|101589756|FG001|NOT COMPLETED|Overall Study||0||
48514467|NCT02363439|101589757|FG000|STARTED|Overall Study||5||
48514468|NCT02363439|101589757|FG000|COMPLETED|Overall Study||1||
48514469|NCT02363439|101589757|FG000|NOT COMPLETED|Overall Study||4||
48514470|NCT01470417|101589758|FG000|STARTED|Overall Study||3||
48514471|NCT01470417|101589759|FG001|STARTED|Overall Study||7||
48514472|NCT01470417|101589758|FG000|COMPLETED|Overall Study||3||
48514473|NCT01470417|101589759|FG001|COMPLETED|Overall Study||5||
48514474|NCT01470417|101589758|FG000|NOT COMPLETED|Overall Study||0||
48514475|NCT01470417|101589759|FG001|NOT COMPLETED|Overall Study||2||
48514476|NCT02457611|101589760|FG000|STARTED|Overall Study||26||
48514477|NCT02457611|101589760|FG000|COMPLETED|Overall Study||23||
48514478|NCT02457611|101589760|FG000|NOT COMPLETED|Overall Study||3||
48514479|NCT01557582|101589761|FG000|STARTED|Overall Study||103||
48514480|NCT01557582|101589761|FG000|COMPLETED|Overall Study||97||
48514481|NCT01557582|101589761|FG000|NOT COMPLETED|Overall Study||6||
48514482|NCT04763278|101589762|FG000|STARTED|Overall Study||7||
48514483|NCT04763278|101589762|FG000|COMPLETED|Overall Study||7||
48514484|NCT04763278|101589762|FG000|NOT COMPLETED|Overall Study||0||
48514485|NCT01118845|101589763|FG000|STARTED|Overall Study||59||
48514486|NCT01118845|101589763|FG000|COMPLETED|Overall Study||17||
48514487|NCT01118845|101589763|FG000|NOT COMPLETED|Overall Study||42||
48514488|NCT02488824|101589764|FG000|STARTED|Overall Study||21||
48514489|NCT02488824|101589765|FG001|STARTED|Overall Study||20||
48514490|NCT02488824|101589764|FG000|COMPLETED|Overall Study||20||
48514491|NCT02488824|101589765|FG001|COMPLETED|Overall Study||19||
48514492|NCT02488824|101589764|FG000|NOT COMPLETED|Overall Study||1||
48514493|NCT02488824|101589765|FG001|NOT COMPLETED|Overall Study||1||
48514494|NCT02953678|101589766|FG000|STARTED|Overall Study||71||
48514495|NCT02953678|101589766|FG000|COMPLETED|Overall Study||0||
48514496|NCT02953678|101589766|FG000|NOT COMPLETED|Overall Study||71||
48514497|NCT02487082|101589767|FG000|STARTED|Run-In Phase (5 Weeks)||4||
48514498|NCT02487082|101589768|FG001|STARTED|Run-In Phase (5 Weeks)||8||
48514499|NCT02487082|101589767|FG000|COMPLETED|Run-In Phase (5 Weeks)||3||
48514500|NCT02487082|101589768|FG001|COMPLETED|Run-In Phase (5 Weeks)||6||
48514501|NCT02487082|101589767|FG000|NOT COMPLETED|Run-In Phase (5 Weeks)||1||
48514502|NCT02487082|101589768|FG001|NOT COMPLETED|Run-In Phase (5 Weeks)||2||
48514503|NCT02487082|101589767|FG000|STARTED|Phase 1 (5 Weeks)||3||
48514504|NCT02487082|101589768|FG001|STARTED|Phase 1 (5 Weeks)||6||
48514505|NCT02487082|101589767|FG000|COMPLETED|Phase 1 (5 Weeks)||2||
48514506|NCT02487082|101589768|FG001|COMPLETED|Phase 1 (5 Weeks)||6||
48514507|NCT02487082|101589767|FG000|NOT COMPLETED|Phase 1 (5 Weeks)||1||
48514508|NCT02487082|101589768|FG001|NOT COMPLETED|Phase 1 (5 Weeks)||0||
48514509|NCT02487082|101589767|FG000|STARTED|Phase 2 (5 Weeks)||2||
48514510|NCT02487082|101589768|FG001|STARTED|Phase 2 (5 Weeks)||6||
48514511|NCT02487082|101589767|FG000|COMPLETED|Phase 2 (5 Weeks)||2||
48514512|NCT02487082|101589768|FG001|COMPLETED|Phase 2 (5 Weeks)||6||
48514513|NCT02487082|101589767|FG000|NOT COMPLETED|Phase 2 (5 Weeks)||0||
48514514|NCT02487082|101589768|FG001|NOT COMPLETED|Phase 2 (5 Weeks)||0||
48514515|NCT02487082|101589767|FG000|STARTED|Wash-Out Phase (2-12 Weeks)||2||
48514516|NCT02487082|101589768|FG001|STARTED|Wash-Out Phase (2-12 Weeks)||6||
48514517|NCT02487082|101589767|FG000|COMPLETED|Wash-Out Phase (2-12 Weeks)||2||
48514518|NCT02487082|101589768|FG001|COMPLETED|Wash-Out Phase (2-12 Weeks)||6||
48514519|NCT02487082|101589767|FG000|NOT COMPLETED|Wash-Out Phase (2-12 Weeks)||0||
48514520|NCT02487082|101589768|FG001|NOT COMPLETED|Wash-Out Phase (2-12 Weeks)||0||
48514521|NCT03297294|101589769|FG000|STARTED|Double-Blind Treatment Period (DB)||70||
48514522|NCT03297294|101589770|FG001|STARTED|Double-Blind Treatment Period (DB)||67||
48514523|NCT03297294|101589771|FG002|STARTED|Double-Blind Treatment Period (DB)||0||
48514524|NCT03297294|101589772|FG003|STARTED|Double-Blind Treatment Period (DB)||0||
48514525|NCT03297294|101589773|FG004|STARTED|Double-Blind Treatment Period (DB)||0||
48514526|NCT03297294|101589769|FG000|COMPLETED|Double-Blind Treatment Period (DB)||32|Study completers completed the treatment phase regardless of completion of study treatment.|
48514527|NCT03297294|101589770|FG001|COMPLETED|Double-Blind Treatment Period (DB)||30|Study completers completed the treatment phase regardless of completion of study treatment.|
48514528|NCT03297294|101589771|FG002|COMPLETED|Double-Blind Treatment Period (DB)||0|Study completers completed the treatment phase regardless of completion of study treatment.|
48514529|NCT03297294|101589772|FG003|COMPLETED|Double-Blind Treatment Period (DB)||0|Study completers completed the treatment phase regardless of completion of study treatment.|
48514530|NCT03297294|101589773|FG004|COMPLETED|Double-Blind Treatment Period (DB)||0|Study completers completed the treatment phase regardless of completion of study treatment.|
48514531|NCT03297294|101589769|FG000|NOT COMPLETED|Double-Blind Treatment Period (DB)||38||
48514532|NCT03297294|101589770|FG001|NOT COMPLETED|Double-Blind Treatment Period (DB)||37||
48514533|NCT03297294|101589771|FG002|NOT COMPLETED|Double-Blind Treatment Period (DB)||0||
48514534|NCT03297294|101589772|FG003|NOT COMPLETED|Double-Blind Treatment Period (DB)||0||
48514535|NCT03297294|101589773|FG004|NOT COMPLETED|Double-Blind Treatment Period (DB)||0||
48514536|NCT03297294|101589769|FG000|STARTED|Treatment Withdrawal Period (TW)||0||
48514537|NCT03297294|101589770|FG001|STARTED|Treatment Withdrawal Period (TW)||0||
48514538|NCT03297294|101589771|FG002|STARTED|Treatment Withdrawal Period (TW)||14||
48514539|NCT03297294|101589772|FG003|STARTED|Treatment Withdrawal Period (TW)||12||
48514540|NCT03297294|101589773|FG004|STARTED|Treatment Withdrawal Period (TW)||27||
48514541|NCT03297294|101589769|FG000|COMPLETED|Treatment Withdrawal Period (TW)||0||
48514542|NCT03297294|101589770|FG001|COMPLETED|Treatment Withdrawal Period (TW)||0||
48514543|NCT03297294|101589771|FG002|COMPLETED|Treatment Withdrawal Period (TW)||14||
48514544|NCT03297294|101589772|FG003|COMPLETED|Treatment Withdrawal Period (TW)||11||
48514545|NCT03297294|101589773|FG004|COMPLETED|Treatment Withdrawal Period (TW)||27||
48514546|NCT03297294|101589769|FG000|NOT COMPLETED|Treatment Withdrawal Period (TW)||0||
48514547|NCT03297294|101589770|FG001|NOT COMPLETED|Treatment Withdrawal Period (TW)||0||
48514548|NCT03297294|101589771|FG002|NOT COMPLETED|Treatment Withdrawal Period (TW)||0||
48514549|NCT03297294|101589772|FG003|NOT COMPLETED|Treatment Withdrawal Period (TW)||1||
48514550|NCT03297294|101589773|FG004|NOT COMPLETED|Treatment Withdrawal Period (TW)||0||
48514551|NCT02219308|101589774|FG000|STARTED|Overall Study||32||
48514552|NCT02219308|101589775|FG001|STARTED|Overall Study||35||
48514553|NCT02219308|101589774|FG000|COMPLETED|Overall Study||31||
48514554|NCT02219308|101589775|FG001|COMPLETED|Overall Study||33||
48514555|NCT02219308|101589774|FG000|NOT COMPLETED|Overall Study||1||
48514556|NCT02219308|101589775|FG001|NOT COMPLETED|Overall Study||2||
48514557|NCT00925756|101589776|FG000|STARTED|Overall Study||32||
48514558|NCT00925756|101589776|FG000|COMPLETED|Overall Study||32||
48514559|NCT00925756|101589776|FG000|NOT COMPLETED|Overall Study||0||
48514560|NCT00707447|101589777|FG000|STARTED|Overall Study||89||
48514561|NCT00707447|101589778|FG001|STARTED|Overall Study||93||
48514562|NCT00707447|101589777|FG000|COMPLETED|Overall Study||81||
48514563|NCT00707447|101589778|FG001|COMPLETED|Overall Study||85||
48514564|NCT00707447|101589777|FG000|NOT COMPLETED|Overall Study||8||
48514565|NCT00707447|101589778|FG001|NOT COMPLETED|Overall Study||8||
48514566|NCT00401245|101589779|FG000|STARTED|Double Blind Titration Phase||126||
48514567|NCT00401245|101589780|FG001|STARTED|Double Blind Titration Phase||121||
48514568|NCT00401245|101589781|FG002|STARTED|Double Blind Titration Phase||124||
48514569|NCT00401245|101589782|FG003|STARTED|Double Blind Titration Phase||122||
48514570|NCT00401245|101589783|FG004|STARTED|Double Blind Titration Phase||0||
48514571|NCT00401245|101589784|FG005|STARTED|Double Blind Titration Phase||0||
48514572|NCT00401245|101589785|FG006|STARTED|Double Blind Titration Phase||0||
48514573|NCT00401245|101589786|FG007|STARTED|Double Blind Titration Phase||0||
48514574|NCT00401245|101589779|FG000|COMPLETED|Double Blind Titration Phase||122||
48514575|NCT00401245|101589780|FG001|COMPLETED|Double Blind Titration Phase||118||
48514576|NCT00401245|101589781|FG002|COMPLETED|Double Blind Titration Phase||118||
48514577|NCT00401245|101589782|FG003|COMPLETED|Double Blind Titration Phase||107||
48514578|NCT00401245|101589783|FG004|COMPLETED|Double Blind Titration Phase||0||
48514579|NCT00401245|101589784|FG005|COMPLETED|Double Blind Titration Phase||0||
48514580|NCT00401245|101589785|FG006|COMPLETED|Double Blind Titration Phase||0||
48514581|NCT00401245|101589786|FG007|COMPLETED|Double Blind Titration Phase||0||
48514582|NCT00401245|101589779|FG000|NOT COMPLETED|Double Blind Titration Phase||4||
48514583|NCT00401245|101589780|FG001|NOT COMPLETED|Double Blind Titration Phase||3||
48514584|NCT00401245|101589781|FG002|NOT COMPLETED|Double Blind Titration Phase||6||
48514585|NCT00401245|101589782|FG003|NOT COMPLETED|Double Blind Titration Phase||15||
48514586|NCT00401245|101589783|FG004|NOT COMPLETED|Double Blind Titration Phase||0||
48514587|NCT00401245|101589784|FG005|NOT COMPLETED|Double Blind Titration Phase||0||
48514588|NCT00401245|101589785|FG006|NOT COMPLETED|Double Blind Titration Phase||0||
48514589|NCT00401245|101589786|FG007|NOT COMPLETED|Double Blind Titration Phase||0||
48514590|NCT00401245|101589779|FG000|STARTED|Between Titration and Open Label Phase||122||
48514591|NCT00401245|101589780|FG001|STARTED|Between Titration and Open Label Phase||118||
48514592|NCT00401245|101589781|FG002|STARTED|Between Titration and Open Label Phase||118||
48514593|NCT00401245|101589782|FG003|STARTED|Between Titration and Open Label Phase||107||
48514594|NCT00401245|101589783|FG004|STARTED|Between Titration and Open Label Phase||0||
48514595|NCT00401245|101589784|FG005|STARTED|Between Titration and Open Label Phase||0||
48514596|NCT00401245|101589785|FG006|STARTED|Between Titration and Open Label Phase||0||
48514597|NCT00401245|101589786|FG007|STARTED|Between Titration and Open Label Phase||0||
48514598|NCT00401245|101589779|FG000|COMPLETED|Between Titration and Open Label Phase||122||
48514599|NCT00401245|101589780|FG001|COMPLETED|Between Titration and Open Label Phase||116||
48514600|NCT00401245|101589781|FG002|COMPLETED|Between Titration and Open Label Phase||118||
48514601|NCT00401245|101589782|FG003|COMPLETED|Between Titration and Open Label Phase||105||
48514602|NCT00401245|101589783|FG004|COMPLETED|Between Titration and Open Label Phase||0||
48514603|NCT00401245|101589784|FG005|COMPLETED|Between Titration and Open Label Phase||0||
48514604|NCT00401245|101589785|FG006|COMPLETED|Between Titration and Open Label Phase||0||
48514605|NCT00401245|101589786|FG007|COMPLETED|Between Titration and Open Label Phase||0||
48514606|NCT00401245|101589779|FG000|NOT COMPLETED|Between Titration and Open Label Phase||0||
48514607|NCT00401245|101589780|FG001|NOT COMPLETED|Between Titration and Open Label Phase||2||
48514608|NCT00401245|101589781|FG002|NOT COMPLETED|Between Titration and Open Label Phase||0||
48514609|NCT00401245|101589782|FG003|NOT COMPLETED|Between Titration and Open Label Phase||2||
48514610|NCT00401245|101589783|FG004|NOT COMPLETED|Between Titration and Open Label Phase||0||
48067654|NCT01573260|100485614|FG001|NOT COMPLETED|Overall Study||0||
48514611|NCT00401245|101589784|FG005|NOT COMPLETED|Between Titration and Open Label Phase||0||
48514612|NCT00401245|101589785|FG006|NOT COMPLETED|Between Titration and Open Label Phase||0||
48514613|NCT00401245|101589786|FG007|NOT COMPLETED|Between Titration and Open Label Phase||0||
48514614|NCT00401245|101589779|FG000|STARTED|Open Label Phase||122||
48514615|NCT00401245|101589780|FG001|STARTED|Open Label Phase||116||
48514616|NCT00401245|101589781|FG002|STARTED|Open Label Phase||118||
48514617|NCT00401245|101589782|FG003|STARTED|Open Label Phase||105||
48514618|NCT00401245|101589783|FG004|STARTED|Open Label Phase||0||
48514619|NCT00401245|101589784|FG005|STARTED|Open Label Phase||0||
48514620|NCT00401245|101589785|FG006|STARTED|Open Label Phase||0||
48514621|NCT00401245|101589786|FG007|STARTED|Open Label Phase||0||
48514622|NCT00401245|101589779|FG000|COMPLETED|Open Label Phase||101||
48514623|NCT00401245|101589780|FG001|COMPLETED|Open Label Phase||81||
48514624|NCT00401245|101589781|FG002|COMPLETED|Open Label Phase||95||
48514625|NCT00401245|101589782|FG003|COMPLETED|Open Label Phase||84||
48514626|NCT00401245|101589783|FG004|COMPLETED|Open Label Phase||0||
48514627|NCT00401245|101589784|FG005|COMPLETED|Open Label Phase||0||
48514628|NCT00401245|101589785|FG006|COMPLETED|Open Label Phase||0||
48514629|NCT00401245|101589786|FG007|COMPLETED|Open Label Phase||0||
48514630|NCT00401245|101589779|FG000|NOT COMPLETED|Open Label Phase||21||
48514631|NCT00401245|101589780|FG001|NOT COMPLETED|Open Label Phase||35||
48514632|NCT00401245|101589781|FG002|NOT COMPLETED|Open Label Phase||23||
48514633|NCT00401245|101589782|FG003|NOT COMPLETED|Open Label Phase||21||
48514634|NCT00401245|101589783|FG004|NOT COMPLETED|Open Label Phase||0||
48514635|NCT00401245|101589784|FG005|NOT COMPLETED|Open Label Phase||0||
48514636|NCT00401245|101589785|FG006|NOT COMPLETED|Open Label Phase||0||
48514637|NCT00401245|101589786|FG007|NOT COMPLETED|Open Label Phase||0||
48514638|NCT00401245|101589779|FG000|STARTED|Double Blind Tapering Phase||0||
48514639|NCT00401245|101589780|FG001|STARTED|Double Blind Tapering Phase||0||
48514640|NCT00401245|101589781|FG002|STARTED|Double Blind Tapering Phase||0||
48514641|NCT00401245|101589782|FG003|STARTED|Double Blind Tapering Phase||0||
48514642|NCT00401245|101589783|FG004|STARTED|Double Blind Tapering Phase||101||
48514643|NCT00401245|101589784|FG005|STARTED|Double Blind Tapering Phase||94||
48514644|NCT00401245|101589785|FG006|STARTED|Double Blind Tapering Phase||87||
48514645|NCT00401245|101589786|FG007|STARTED|Double Blind Tapering Phase||102||
48514646|NCT00401245|101589779|FG000|COMPLETED|Double Blind Tapering Phase||0||
48514647|NCT00401245|101589780|FG001|COMPLETED|Double Blind Tapering Phase||0||
48514648|NCT00401245|101589781|FG002|COMPLETED|Double Blind Tapering Phase||0||
48514649|NCT00401245|101589782|FG003|COMPLETED|Double Blind Tapering Phase||0||
48514650|NCT00401245|101589783|FG004|COMPLETED|Double Blind Tapering Phase||97||
48514651|NCT00401245|101589784|FG005|COMPLETED|Double Blind Tapering Phase||90||
48514652|NCT00401245|101589785|FG006|COMPLETED|Double Blind Tapering Phase||80||
48514653|NCT00401245|101589786|FG007|COMPLETED|Double Blind Tapering Phase||95||
48514654|NCT00401245|101589779|FG000|NOT COMPLETED|Double Blind Tapering Phase||0||
48514655|NCT00401245|101589780|FG001|NOT COMPLETED|Double Blind Tapering Phase||0||
48514656|NCT00401245|101589781|FG002|NOT COMPLETED|Double Blind Tapering Phase||0||
48514657|NCT00401245|101589782|FG003|NOT COMPLETED|Double Blind Tapering Phase||0||
48514658|NCT00401245|101589783|FG004|NOT COMPLETED|Double Blind Tapering Phase||4||
48514659|NCT00401245|101589784|FG005|NOT COMPLETED|Double Blind Tapering Phase||4||
48514660|NCT00401245|101589785|FG006|NOT COMPLETED|Double Blind Tapering Phase||7||
48514661|NCT00401245|101589786|FG007|NOT COMPLETED|Double Blind Tapering Phase||7||
48514662|NCT02210052|101589787|FG000|STARTED|Overall Study||6||
48514663|NCT02210052|101589787|FG000|COMPLETED|Overall Study||6||
48514664|NCT02210052|101589787|FG000|NOT COMPLETED|Overall Study||0||
48514665|NCT03253094|101589788|FG000|STARTED|Overall Study||32||
48514666|NCT03253094|101589789|FG001|STARTED|Overall Study||30||
48514667|NCT03253094|101589790|FG002|STARTED|Overall Study||28||
48514668|NCT03253094|101589791|FG003|STARTED|Overall Study||32||
48514669|NCT03253094|101589792|FG004|STARTED|Overall Study||32||
48514670|NCT03253094|101589793|FG005|STARTED|Overall Study||32||
48514671|NCT03253094|101589788|FG000|Subjects Discontinued|Overall Study||4||
48514672|NCT03253094|101589789|FG001|Subjects Discontinued|Overall Study||3||
48514673|NCT03253094|101589790|FG002|Subjects Discontinued|Overall Study||6||
48514674|NCT03253094|101589791|FG003|Subjects Discontinued|Overall Study||4||
48514675|NCT03253094|101589792|FG004|Subjects Discontinued|Overall Study||5||
48514676|NCT03253094|101589793|FG005|Subjects Discontinued|Overall Study||4||
48514677|NCT03253094|101589788|FG000|COMPLETED|Overall Study||28||
48514678|NCT03253094|101589789|FG001|COMPLETED|Overall Study||27||
48514679|NCT03253094|101589790|FG002|COMPLETED|Overall Study||22||
48514680|NCT03253094|101589791|FG003|COMPLETED|Overall Study||28||
48514681|NCT03253094|101589792|FG004|COMPLETED|Overall Study||27||
48514682|NCT03253094|101589793|FG005|COMPLETED|Overall Study||28||
48514683|NCT03253094|101589788|FG000|NOT COMPLETED|Overall Study||4||
48514684|NCT03253094|101589789|FG001|NOT COMPLETED|Overall Study||3||
48514685|NCT03253094|101589790|FG002|NOT COMPLETED|Overall Study||6||
48514686|NCT03253094|101589791|FG003|NOT COMPLETED|Overall Study||4||
48514687|NCT03253094|101589792|FG004|NOT COMPLETED|Overall Study||5||
48514688|NCT03253094|101589793|FG005|NOT COMPLETED|Overall Study||4||
48514689|NCT01144403|101589794|FG000|STARTED|Overall Study||8||
48514690|NCT01144403|101589794|FG000|COMPLETED|Overall Study||3||
48514691|NCT01144403|101589794|FG000|NOT COMPLETED|Overall Study||5||
48514692|NCT01913795|101589795|FG000|STARTED|Overall Study||4||
48514693|NCT01913795|101589796|FG001|STARTED|Overall Study||10||
48514694|NCT01913795|101589797|FG002|STARTED|Overall Study||9||
48514695|NCT01913795|101589798|FG003|STARTED|Overall Study||6||
48514696|NCT01913795|101589795|FG000|COMPLETED|Overall Study||4||
48514697|NCT01913795|101589796|FG001|COMPLETED|Overall Study||7||
48514698|NCT01913795|101589797|FG002|COMPLETED|Overall Study||9||
48514699|NCT01913795|101589798|FG003|COMPLETED|Overall Study||5||
48514700|NCT01913795|101589795|FG000|NOT COMPLETED|Overall Study||0||
48514701|NCT01913795|101589796|FG001|NOT COMPLETED|Overall Study||3||
48514702|NCT01913795|101589797|FG002|NOT COMPLETED|Overall Study||0||
48514703|NCT01913795|101589798|FG003|NOT COMPLETED|Overall Study||1||
48514704|NCT00122447|101589799|FG000|STARTED|Overall Study||18||
48514705|NCT00122447|101589800|FG001|STARTED|Overall Study||18||
48514706|NCT00122447|101589801|FG002|STARTED|Overall Study||17||
48514707|NCT00122447|101589802|FG003|STARTED|Overall Study||17||
48514708|NCT00122447|101589799|FG000|COMPLETED|Overall Study||17||
48514709|NCT00122447|101589800|FG001|COMPLETED|Overall Study||13||
48514710|NCT00122447|101589801|FG002|COMPLETED|Overall Study||16||
48514711|NCT00122447|101589802|FG003|COMPLETED|Overall Study||14||
48514712|NCT00122447|101589799|FG000|NOT COMPLETED|Overall Study||1||
48514713|NCT00122447|101589800|FG001|NOT COMPLETED|Overall Study||5||
48514714|NCT00122447|101589801|FG002|NOT COMPLETED|Overall Study||1||
48514715|NCT00122447|101589802|FG003|NOT COMPLETED|Overall Study||3||
48514716|NCT01790113|101589803|FG000|STARTED|Overall Study||79||
48514717|NCT01790113|101589804|FG001|STARTED|Overall Study||224||
48514718|NCT01790113|101589803|FG000|COMPLETED|Overall Study||76||
48514719|NCT01790113|101589804|FG001|COMPLETED|Overall Study||149||
48514720|NCT01790113|101589803|FG000|NOT COMPLETED|Overall Study||3||
48514721|NCT01790113|101589804|FG001|NOT COMPLETED|Overall Study||75||
48514722|NCT00869440|101589805|FG000|STARTED|Overall Study||25||
48514723|NCT00869440|101589806|FG001|STARTED|Overall Study||25||
48514724|NCT00869440|101589807|FG002|STARTED|Overall Study||25||
48514725|NCT00869440|101589808|FG003|STARTED|Overall Study||25||
48514726|NCT00869440|101589805|FG000|COMPLETED|Overall Study||23||
48514727|NCT00869440|101589806|FG001|COMPLETED|Overall Study||24||
48514728|NCT00869440|101589807|FG002|COMPLETED|Overall Study||25||
48514729|NCT00869440|101589808|FG003|COMPLETED|Overall Study||25||
48514730|NCT00869440|101589805|FG000|NOT COMPLETED|Overall Study||2||
48514731|NCT00869440|101589806|FG001|NOT COMPLETED|Overall Study||1||
48514732|NCT00869440|101589807|FG002|NOT COMPLETED|Overall Study||0||
48514733|NCT00869440|101589808|FG003|NOT COMPLETED|Overall Study||0||
48514734|NCT04034355|101589809|FG000|STARTED|Overall Study||151||
48514735|NCT04034355|101589810|FG001|STARTED|Overall Study||150||
48514736|NCT04034355|101589809|FG000|Treated|Overall Study||147||
48514737|NCT04034355|101589810|FG001|Treated|Overall Study||150||
48514738|NCT04034355|101589809|FG000|COMPLETED|Overall Study||117||
48514739|NCT04034355|101589810|FG001|COMPLETED|Overall Study||115||
48514740|NCT04034355|101589809|FG000|NOT COMPLETED|Overall Study||34||
48514741|NCT04034355|101589810|FG001|NOT COMPLETED|Overall Study||35||
48514742|NCT02733627|101589811|FG000|STARTED|Overall Study||9||
48514743|NCT02733627|101589812|FG001|STARTED|Overall Study||9||
48514744|NCT02733627|101589813|FG002|STARTED|Overall Study||9||
48514745|NCT02733627|101589814|FG003|STARTED|Overall Study||9||
48514746|NCT02733627|101589811|FG000|COMPLETED|Overall Study||9||
48514747|NCT02733627|101589812|FG001|COMPLETED|Overall Study||8||
48514748|NCT02733627|101589813|FG002|COMPLETED|Overall Study||7||
48514749|NCT02733627|101589814|FG003|COMPLETED|Overall Study||9||
48514750|NCT02733627|101589811|FG000|NOT COMPLETED|Overall Study||0||
48514751|NCT02733627|101589812|FG001|NOT COMPLETED|Overall Study||1||
48514752|NCT02733627|101589813|FG002|NOT COMPLETED|Overall Study||2||
48514753|NCT02733627|101589814|FG003|NOT COMPLETED|Overall Study||0||
48514754|NCT00867048|101589815|FG000|STARTED|Overall Study||2326||
48514755|NCT00867048|101589816|FG001|STARTED|Overall Study||2362||
48514756|NCT00867048|101589815|FG000|COMPLETED|Overall Study||2325||
48514757|NCT00867048|101589816|FG001|COMPLETED|Overall Study||2359||
48514758|NCT00867048|101589815|FG000|NOT COMPLETED|Overall Study||1||
48514759|NCT00867048|101589816|FG001|NOT COMPLETED|Overall Study||3||
48514760|NCT02776553|101589817|FG000|STARTED|Overall Study||9||
48514761|NCT02776553|101589818|FG001|STARTED|Overall Study||8||
48514762|NCT02776553|101589817|FG000|COMPLETED|Overall Study||6||
48514763|NCT02776553|101589818|FG001|COMPLETED|Overall Study||5||
48514764|NCT02776553|101589817|FG000|NOT COMPLETED|Overall Study||3||
48514765|NCT02776553|101589818|FG001|NOT COMPLETED|Overall Study||3||
48514766|NCT01396421|101589819|FG000|STARTED|Overall Study||180||
48514767|NCT01396421|101589820|FG001|STARTED|Overall Study||182||
48514768|NCT01396421|101589821|FG002|STARTED|Overall Study||90||
48514769|NCT01396421|101589822|FG003|STARTED|Overall Study||184||
48514770|NCT01396421|101589819|FG000|COMPLETED|Overall Study||121||
48666795|NCT03391882|101970470|FG005|Modified Intent-to-Treat Population Part B|Part B - Treatment Phase||19||
48514771|NCT01396421|101589820|FG001|COMPLETED|Overall Study||124||
48514772|NCT01396421|101589821|FG002|COMPLETED|Overall Study||56||
48514773|NCT01396421|101589822|FG003|COMPLETED|Overall Study||109||
48514774|NCT01396421|101589819|FG000|NOT COMPLETED|Overall Study||59||
48514775|NCT01396421|101589820|FG001|NOT COMPLETED|Overall Study||58||
48514776|NCT01396421|101589821|FG002|NOT COMPLETED|Overall Study||34||
48514777|NCT01396421|101589822|FG003|NOT COMPLETED|Overall Study||75||
48514778|NCT02400476|101589823|FG000|STARTED|Overall Study||137||
48514779|NCT02400476|101589824|FG001|STARTED|Overall Study||64||
48514780|NCT02400476|101589825|FG002|STARTED|Overall Study||136||
48514781|NCT02400476|101589826|FG003|STARTED|Overall Study||104||
48514782|NCT02400476|101589827|FG004|STARTED|Overall Study||60||
48514783|NCT02400476|101589828|FG005|STARTED|Overall Study||62||
48514784|NCT02400476|101589823|FG000|COMPLETED|Overall Study||76||
48514785|NCT02400476|101589824|FG001|COMPLETED|Overall Study||52||
48514786|NCT02400476|101589825|FG002|COMPLETED|Overall Study||95||
48514787|NCT02400476|101589826|FG003|COMPLETED|Overall Study||74||
48514788|NCT02400476|101589827|FG004|COMPLETED|Overall Study||45||
48514789|NCT02400476|101589828|FG005|COMPLETED|Overall Study||46||
48514790|NCT02400476|101589823|FG000|NOT COMPLETED|Overall Study||61||
48514791|NCT02400476|101589824|FG001|NOT COMPLETED|Overall Study||12||
48514792|NCT02400476|101589825|FG002|NOT COMPLETED|Overall Study||41||
48514793|NCT02400476|101589826|FG003|NOT COMPLETED|Overall Study||30||
48514794|NCT02400476|101589827|FG004|NOT COMPLETED|Overall Study||15||
48514795|NCT02400476|101589828|FG005|NOT COMPLETED|Overall Study||16||
48514796|NCT00955721|101589829|FG000|STARTED|Overall Study||9||
48514797|NCT00955721|101589830|FG001|STARTED|Overall Study||0||
48514798|NCT00955721|101589829|FG000|COMPLETED|Overall Study||6||
48514799|NCT00955721|101589830|FG001|COMPLETED|Overall Study||0||
48514800|NCT00955721|101589829|FG000|NOT COMPLETED|Overall Study||3||
48514801|NCT00955721|101589830|FG001|NOT COMPLETED|Overall Study||0||
48514802|NCT00330460|101589831|FG000|STARTED|Overall Study||595||
48514803|NCT00330460|101589832|FG001|STARTED|Overall Study||594||
48514804|NCT00330460|101589831|FG000|COMPLETED|Overall Study||553||
48514805|NCT00330460|101589832|FG001|COMPLETED|Overall Study||561||
48514806|NCT00330460|101589831|FG000|NOT COMPLETED|Overall Study||42||
48514807|NCT00330460|101589832|FG001|NOT COMPLETED|Overall Study||33||
48514808|NCT01566526|101589833|FG000|STARTED|Overall Study||26||
48514809|NCT01566526|101589833|FG000|COMPLETED|Overall Study||26||
48514810|NCT01566526|101589833|FG000|NOT COMPLETED|Overall Study||0||
48514811|NCT02013531|101589834|FG000|STARTED|Overall Study||37||
48514812|NCT02013531|101589834|FG000|COMPLETED|Overall Study||32||
48514813|NCT02013531|101589834|FG000|NOT COMPLETED|Overall Study||5||
48514814|NCT00337987|101589835|FG000|STARTED|Overall Study||49||
48514815|NCT00337987|101589835|FG000|COMPLETED|Overall Study||49||
48514816|NCT00337987|101589835|FG000|NOT COMPLETED|Overall Study||0||
48514817|NCT00934596|101589836|FG000|STARTED|Overall Study||10||
48514818|NCT00934596|101589837|FG001|STARTED|Overall Study||10||
48514819|NCT00934596|101589836|FG000|COMPLETED|Overall Study||10||
48514820|NCT00934596|101589837|FG001|COMPLETED|Overall Study||10||
48514821|NCT00934596|101589836|FG000|NOT COMPLETED|Overall Study||0||
48514822|NCT00934596|101589837|FG001|NOT COMPLETED|Overall Study||0||
48514823|NCT03211039|101589838|FG000|STARTED|Overall Study||94||
48514824|NCT03211039|101589839|FG001|STARTED|Overall Study||95||
48514825|NCT03211039|101589840|FG002|STARTED|Overall Study||24||
48514826|NCT03211039|101589838|FG000|COMPLETED|Overall Study||94|Diagnostic report issued|
48514827|NCT03211039|101589839|FG001|COMPLETED|Overall Study||95|Diagnostic report issued|
48514828|NCT03211039|101589840|FG002|COMPLETED|Overall Study||24|Diagnostic report issued|
48514829|NCT03211039|101589838|FG000|NOT COMPLETED|Overall Study||0||
48514830|NCT03211039|101589839|FG001|NOT COMPLETED|Overall Study||0||
48514831|NCT03211039|101589840|FG002|NOT COMPLETED|Overall Study||0||
48514832|NCT01010750|101589841|FG000|STARTED|First Intervention||3||
48514833|NCT01010750|101589842|FG001|STARTED|First Intervention||4||
48514834|NCT01010750|101589843|FG002|STARTED|First Intervention||3||
48514835|NCT01010750|101589844|FG003|STARTED|First Intervention||3||
48514836|NCT01010750|101589845|FG004|STARTED|First Intervention||2||
48514837|NCT01010750|101589846|FG005|STARTED|First Intervention||3||
48514838|NCT01010750|101589841|FG000|COMPLETED|First Intervention||3||
48514839|NCT01010750|101589842|FG001|COMPLETED|First Intervention||4||
48514840|NCT01010750|101589843|FG002|COMPLETED|First Intervention||3||
48514841|NCT01010750|101589844|FG003|COMPLETED|First Intervention||3||
48514842|NCT01010750|101589845|FG004|COMPLETED|First Intervention||2||
48514843|NCT01010750|101589846|FG005|COMPLETED|First Intervention||3||
48514844|NCT01010750|101589841|FG000|NOT COMPLETED|First Intervention||0||
48514845|NCT01010750|101589842|FG001|NOT COMPLETED|First Intervention||0||
48514846|NCT01010750|101589843|FG002|NOT COMPLETED|First Intervention||0||
48514847|NCT01010750|101589844|FG003|NOT COMPLETED|First Intervention||0||
48514848|NCT01010750|101589845|FG004|NOT COMPLETED|First Intervention||0||
48514849|NCT01010750|101589846|FG005|NOT COMPLETED|First Intervention||0||
48514850|NCT01010750|101589841|FG000|STARTED|Second Intervention||3||
48514851|NCT01010750|101589842|FG001|STARTED|Second Intervention||4||
48514852|NCT01010750|101589843|FG002|STARTED|Second Intervention||3||
48514853|NCT01010750|101589844|FG003|STARTED|Second Intervention||3||
48514854|NCT01010750|101589845|FG004|STARTED|Second Intervention||2||
48514855|NCT01010750|101589846|FG005|STARTED|Second Intervention||3||
48514856|NCT01010750|101589841|FG000|COMPLETED|Second Intervention||3||
48514857|NCT01010750|101589842|FG001|COMPLETED|Second Intervention||3||
48514858|NCT01010750|101589843|FG002|COMPLETED|Second Intervention||3||
48514859|NCT01010750|101589844|FG003|COMPLETED|Second Intervention||3||
48514860|NCT01010750|101589845|FG004|COMPLETED|Second Intervention||2||
48514861|NCT01010750|101589846|FG005|COMPLETED|Second Intervention||3||
48514862|NCT01010750|101589841|FG000|NOT COMPLETED|Second Intervention||0||
48514863|NCT01010750|101589842|FG001|NOT COMPLETED|Second Intervention||1||
48514864|NCT01010750|101589843|FG002|NOT COMPLETED|Second Intervention||0||
48514865|NCT01010750|101589844|FG003|NOT COMPLETED|Second Intervention||0||
48514866|NCT01010750|101589845|FG004|NOT COMPLETED|Second Intervention||0||
48514867|NCT01010750|101589846|FG005|NOT COMPLETED|Second Intervention||0||
48514868|NCT01010750|101589841|FG000|STARTED|Third Intervention||3||
48514869|NCT01010750|101589842|FG001|STARTED|Third Intervention||3||
48514870|NCT01010750|101589843|FG002|STARTED|Third Intervention||3||
48514871|NCT01010750|101589844|FG003|STARTED|Third Intervention||3||
48514872|NCT01010750|101589845|FG004|STARTED|Third Intervention||2||
48514873|NCT01010750|101589846|FG005|STARTED|Third Intervention||3||
48514874|NCT01010750|101589841|FG000|COMPLETED|Third Intervention||3||
48514875|NCT01010750|101589842|FG001|COMPLETED|Third Intervention||3||
48514876|NCT01010750|101589843|FG002|COMPLETED|Third Intervention||3||
48514877|NCT01010750|101589844|FG003|COMPLETED|Third Intervention||3||
48514878|NCT01010750|101589845|FG004|COMPLETED|Third Intervention||2||
48514879|NCT01010750|101589846|FG005|COMPLETED|Third Intervention||3||
48514880|NCT01010750|101589841|FG000|NOT COMPLETED|Third Intervention||0||
48514881|NCT01010750|101589842|FG001|NOT COMPLETED|Third Intervention||0||
48514882|NCT01010750|101589843|FG002|NOT COMPLETED|Third Intervention||0||
48514883|NCT01010750|101589844|FG003|NOT COMPLETED|Third Intervention||0||
48514884|NCT01010750|101589845|FG004|NOT COMPLETED|Third Intervention||0||
48514885|NCT01010750|101589846|FG005|NOT COMPLETED|Third Intervention||0||
48514886|NCT02274948|101589847|FG000|STARTED|Overall Study||166||
48514887|NCT02274948|101589848|FG001|STARTED|Overall Study||173||
48514888|NCT02274948|101589847|FG000|COMPLETED|Overall Study||68||
48514889|NCT02274948|101589848|FG001|COMPLETED|Overall Study||82||
48514890|NCT02274948|101589847|FG000|NOT COMPLETED|Overall Study||98||
48514891|NCT02274948|101589848|FG001|NOT COMPLETED|Overall Study||91||
48514892|NCT01714739|101589849|FG000|STARTED|Overall Study||4||
48514893|NCT01714739|101589850|FG001|STARTED|Overall Study||16||
48514894|NCT01714739|101589851|FG002|STARTED|Overall Study||15||
48514895|NCT01714739|101589852|FG003|STARTED|Overall Study||287||
48514896|NCT01714739|101589853|FG004|STARTED|Overall Study||2||
48514897|NCT01714739|101589854|FG005|STARTED|Overall Study||3||
48514898|NCT01714739|101589855|FG006|STARTED|Overall Study||10||
48514899|NCT01714739|101589849|FG000|COMPLETED|Overall Study||0||
48514900|NCT01714739|101589850|FG001|COMPLETED|Overall Study||6||
48514901|NCT01714739|101589851|FG002|COMPLETED|Overall Study||5||
48514902|NCT01714739|101589852|FG003|COMPLETED|Overall Study||23||
48514903|NCT01714739|101589853|FG004|COMPLETED|Overall Study||0||
48514904|NCT01714739|101589854|FG005|COMPLETED|Overall Study||0||
48514905|NCT01714739|101589855|FG006|COMPLETED|Overall Study||0||
48514906|NCT01714739|101589849|FG000|NOT COMPLETED|Overall Study||4||
48514907|NCT01714739|101589850|FG001|NOT COMPLETED|Overall Study||10||
48514908|NCT01714739|101589851|FG002|NOT COMPLETED|Overall Study||10||
48514909|NCT01714739|101589852|FG003|NOT COMPLETED|Overall Study||264||
48514910|NCT01714739|101589853|FG004|NOT COMPLETED|Overall Study||2||
48514911|NCT01714739|101589854|FG005|NOT COMPLETED|Overall Study||3||
48514912|NCT01714739|101589855|FG006|NOT COMPLETED|Overall Study||10||
48514913|NCT00991510|101589856|FG000|STARTED|Period I (Days 1-14)||22||
48514914|NCT00991510|101589857|FG001|STARTED|Period I (Days 1-14)||21||
48514915|NCT00991510|101589856|FG000|COMPLETED|Period I (Days 1-14)||21||
48514916|NCT00991510|101589857|FG001|COMPLETED|Period I (Days 1-14)||21||
48514917|NCT00991510|101589856|FG000|NOT COMPLETED|Period I (Days 1-14)||1||
48514918|NCT00991510|101589857|FG001|NOT COMPLETED|Period I (Days 1-14)||0||
48514919|NCT00991510|101589856|FG000|STARTED|Period II (Days 15-28)||21||
48514920|NCT00991510|101589857|FG001|STARTED|Period II (Days 15-28)||21||
48514921|NCT00991510|101589856|FG000|COMPLETED|Period II (Days 15-28)||21||
48514922|NCT00991510|101589857|FG001|COMPLETED|Period II (Days 15-28)||21||
48514923|NCT00991510|101589856|FG000|NOT COMPLETED|Period II (Days 15-28)||0||
48514924|NCT00991510|101589857|FG001|NOT COMPLETED|Period II (Days 15-28)||0||
48514925|NCT00991510|101589856|FG000|STARTED|Period III (Days 29-112)||21||
48514926|NCT00991510|101589857|FG001|STARTED|Period III (Days 29-112)||21||
48514927|NCT00991510|101589856|FG000|COMPLETED|Period III (Days 29-112)||20||
48514928|NCT00991510|101589857|FG001|COMPLETED|Period III (Days 29-112)||20||
48514929|NCT00991510|101589856|FG000|NOT COMPLETED|Period III (Days 29-112)||1||
48514930|NCT00991510|101589857|FG001|NOT COMPLETED|Period III (Days 29-112)||1||
48514931|NCT03185182|101593417|FG000|STARTED|Overall Study||5||
48514932|NCT03185182|101593417|FG000|COMPLETED|Overall Study||5||
48514933|NCT03185182|101593417|FG000|NOT COMPLETED|Overall Study||0||
48514934|NCT00611884|101593418|FG000|STARTED|Overall Study||61||
48514935|NCT00611884|101593419|FG001|STARTED|Overall Study||60||
48514936|NCT00611884|101593420|FG002|STARTED|Overall Study||62||
48514937|NCT00611884|101593421|FG003|STARTED|Overall Study||62||
48514938|NCT00611884|101593418|FG000|Exposed|Overall Study||58||
48514939|NCT00611884|101593419|FG001|Exposed|Overall Study||59||
48514940|NCT00611884|101593420|FG002|Exposed|Overall Study||61||
48514941|NCT00611884|101593421|FG003|Exposed|Overall Study||61||
48514942|NCT00611884|101593418|FG000|COMPLETED|Overall Study||52||
48514943|NCT00611884|101593419|FG001|COMPLETED|Overall Study||51||
48514944|NCT00611884|101593420|FG002|COMPLETED|Overall Study||58||
48514945|NCT00611884|101593421|FG003|COMPLETED|Overall Study||56||
48514946|NCT00611884|101593418|FG000|NOT COMPLETED|Overall Study||9||
48514947|NCT00611884|101593419|FG001|NOT COMPLETED|Overall Study||9||
48514948|NCT00611884|101593420|FG002|NOT COMPLETED|Overall Study||4||
48514949|NCT00611884|101593421|FG003|NOT COMPLETED|Overall Study||6||
48514950|NCT02563769|101593422|FG000|STARTED|IV Cocaine Only (Day 1)||3||
48514951|NCT02563769|101593423|FG001|STARTED|IV Cocaine Only (Day 1)||3||
48514952|NCT02563769|101593424|FG002|STARTED|IV Cocaine Only (Day 1)||4||
48514953|NCT02563769|101593422|FG000|COMPLETED|IV Cocaine Only (Day 1)||3||
48514954|NCT02563769|101593423|FG001|COMPLETED|IV Cocaine Only (Day 1)||3||
48514955|NCT02563769|101593424|FG002|COMPLETED|IV Cocaine Only (Day 1)||4||
48514956|NCT02563769|101593422|FG000|NOT COMPLETED|IV Cocaine Only (Day 1)||0||
48514957|NCT02563769|101593423|FG001|NOT COMPLETED|IV Cocaine Only (Day 1)||0||
48514958|NCT02563769|101593424|FG002|NOT COMPLETED|IV Cocaine Only (Day 1)||0||
48514959|NCT02563769|101593422|FG000|STARTED|FIrst Treatment (Day 2)||3||
48514960|NCT02563769|101593423|FG001|STARTED|FIrst Treatment (Day 2)||3||
48514961|NCT02563769|101593424|FG002|STARTED|FIrst Treatment (Day 2)||4||
48514962|NCT02563769|101593422|FG000|COMPLETED|FIrst Treatment (Day 2)||3||
48514963|NCT02563769|101593423|FG001|COMPLETED|FIrst Treatment (Day 2)||3||
48514964|NCT02563769|101593424|FG002|COMPLETED|FIrst Treatment (Day 2)||4||
48514965|NCT02563769|101593422|FG000|NOT COMPLETED|FIrst Treatment (Day 2)||0||
48514966|NCT02563769|101593423|FG001|NOT COMPLETED|FIrst Treatment (Day 2)||0||
48514967|NCT02563769|101593424|FG002|NOT COMPLETED|FIrst Treatment (Day 2)||0||
48514968|NCT02563769|101593422|FG000|STARTED|Second Treatment (Day 3)||3||
48514969|NCT02563769|101593423|FG001|STARTED|Second Treatment (Day 3)||3||
48514970|NCT02563769|101593424|FG002|STARTED|Second Treatment (Day 3)||4||
48514971|NCT02563769|101593422|FG000|COMPLETED|Second Treatment (Day 3)||3||
48514972|NCT02563769|101593423|FG001|COMPLETED|Second Treatment (Day 3)||3||
48514973|NCT02563769|101593424|FG002|COMPLETED|Second Treatment (Day 3)||4||
48514974|NCT02563769|101593422|FG000|NOT COMPLETED|Second Treatment (Day 3)||0||
48514975|NCT02563769|101593423|FG001|NOT COMPLETED|Second Treatment (Day 3)||0||
48514976|NCT02563769|101593424|FG002|NOT COMPLETED|Second Treatment (Day 3)||0||
48514977|NCT02563769|101593422|FG000|STARTED|Third Treatment (Day 4)||3||
48514978|NCT02563769|101593423|FG001|STARTED|Third Treatment (Day 4)||3||
48514979|NCT02563769|101593424|FG002|STARTED|Third Treatment (Day 4)||4||
48514980|NCT02563769|101593422|FG000|COMPLETED|Third Treatment (Day 4)||3||
48514981|NCT02563769|101593423|FG001|COMPLETED|Third Treatment (Day 4)||3||
48514982|NCT02563769|101593424|FG002|COMPLETED|Third Treatment (Day 4)||4||
48514983|NCT02563769|101593422|FG000|NOT COMPLETED|Third Treatment (Day 4)||0||
48514984|NCT02563769|101593423|FG001|NOT COMPLETED|Third Treatment (Day 4)||0||
48514985|NCT02563769|101593424|FG002|NOT COMPLETED|Third Treatment (Day 4)||0||
48514986|NCT02563769|101593422|FG000|STARTED|Added 750mg Dose of CLAV (Day 5)||1||
48514987|NCT02563769|101593423|FG001|STARTED|Added 750mg Dose of CLAV (Day 5)||1||
48514988|NCT02563769|101593424|FG002|STARTED|Added 750mg Dose of CLAV (Day 5)||3||
48514989|NCT02563769|101593422|FG000|COMPLETED|Added 750mg Dose of CLAV (Day 5)||1||
48514990|NCT02563769|101593423|FG001|COMPLETED|Added 750mg Dose of CLAV (Day 5)||1||
48514991|NCT02563769|101593424|FG002|COMPLETED|Added 750mg Dose of CLAV (Day 5)||2||
48514992|NCT02563769|101593422|FG000|NOT COMPLETED|Added 750mg Dose of CLAV (Day 5)||0||
48514993|NCT02563769|101593423|FG001|NOT COMPLETED|Added 750mg Dose of CLAV (Day 5)||0||
48514994|NCT02563769|101593424|FG002|NOT COMPLETED|Added 750mg Dose of CLAV (Day 5)||1||
48514995|NCT01998243|101593425|FG000|STARTED|Overall Study||42||
48514996|NCT01998243|101593426|FG001|STARTED|Overall Study||39||
48514997|NCT01998243|101593425|FG000|COMPLETED|Overall Study||34||
48514998|NCT01998243|101593426|FG001|COMPLETED|Overall Study||32||
48514999|NCT01998243|101593425|FG000|NOT COMPLETED|Overall Study||8||
48515000|NCT01998243|101593426|FG001|NOT COMPLETED|Overall Study||7||
48515001|NCT01754987|101593427|FG000|STARTED|Overall Study||5||
48515002|NCT01754987|101593428|FG001|STARTED|Overall Study||0||
48515003|NCT01754987|101593427|FG000|COMPLETED|Overall Study||5||
48515004|NCT01754987|101593428|FG001|COMPLETED|Overall Study||0||
48515005|NCT01754987|101593427|FG000|NOT COMPLETED|Overall Study||0||
48515006|NCT01754987|101593428|FG001|NOT COMPLETED|Overall Study||0||
48515007|NCT04814459|101593429|FG000|STARTED|Overall Study||72||
48515008|NCT04814459|101593430|FG001|STARTED|Overall Study||72||
48515009|NCT04814459|101593429|FG000|COMPLETED|Overall Study||72||
48515010|NCT04814459|101593430|FG001|COMPLETED|Overall Study||72||
48515011|NCT04814459|101593429|FG000|NOT COMPLETED|Overall Study||0||
48515012|NCT04814459|101593430|FG001|NOT COMPLETED|Overall Study||0||
48515013|NCT00860743|101593431|FG000|STARTED|Overall Study||40||
48515014|NCT00860743|101593432|FG001|STARTED|Overall Study||23||
48515015|NCT00860743|101593431|FG000|COMPLETED|Overall Study||37||
48515016|NCT00860743|101593432|FG001|COMPLETED|Overall Study||23||
48515017|NCT00860743|101593431|FG000|NOT COMPLETED|Overall Study||3||
48515018|NCT00860743|101593432|FG001|NOT COMPLETED|Overall Study||0||
48515019|NCT00094094|101593433|FG000|STARTED|Overall Study||32||
48515020|NCT00094094|101593433|FG000|COMPLETED|Overall Study||0||
48515021|NCT00094094|101593433|FG000|NOT COMPLETED|Overall Study||32||
48515022|NCT02642237|101593434|FG000|STARTED|Overall Study||15||
48515023|NCT02642237|101593435|FG001|STARTED|Overall Study||15||
48515024|NCT02642237|101593434|FG000|COMPLETED|Overall Study||15||
48515025|NCT02642237|101593435|FG001|COMPLETED|Overall Study||15||
48515026|NCT02642237|101593434|FG000|NOT COMPLETED|Overall Study||0||
48515027|NCT02642237|101593435|FG001|NOT COMPLETED|Overall Study||0||
48515028|NCT00483548|101593436|FG000|STARTED|Overall Study||148||
48515029|NCT00483548|101593437|FG001|STARTED|Overall Study||150||
48515030|NCT00483548|101593436|FG000|Received Study Treatment|Overall Study||147||
48515031|NCT00483548|101593437|FG001|Received Study Treatment|Overall Study||147||
48515032|NCT00483548|101593436|FG000|COMPLETED|Overall Study||88||
48515033|NCT00483548|101593437|FG001|COMPLETED|Overall Study||104||
48515034|NCT00483548|101593436|FG000|NOT COMPLETED|Overall Study||60||
48515035|NCT00483548|101593437|FG001|NOT COMPLETED|Overall Study||46||
48515036|NCT02752802|101593438|FG000|STARTED|Overall Study||48||
48515037|NCT02752802|101593439|FG001|STARTED|Overall Study||48||
48515038|NCT02752802|101593438|FG000|COMPLETED|Overall Study||47||
48515039|NCT02752802|101593439|FG001|COMPLETED|Overall Study||48||
48515040|NCT02752802|101593438|FG000|NOT COMPLETED|Overall Study||1||
48515041|NCT02752802|101593439|FG001|NOT COMPLETED|Overall Study||0||
48515042|NCT00003531|101593440|FG000|STARTED|Overall Study||15||
48515043|NCT00003531|101593440|FG000|COMPLETED|Overall Study||5||
48515044|NCT00003531|101593440|FG000|NOT COMPLETED|Overall Study||10||
48515045|NCT00700817|101593441|FG000|STARTED|Week 0-26 (Main Period)||225||
48515046|NCT00700817|101593442|FG001|STARTED|Week 0-26 (Main Period)||221||
48515047|NCT00700817|101593443|FG002|STARTED|Week 0-26 (Main Period)||219||
48515048|NCT00700817|101593444|FG003|STARTED|Week 0-26 (Main Period)||0||
48515049|NCT00700817|101593445|FG004|STARTED|Week 0-26 (Main Period)||0||
48515050|NCT00700817|101593441|FG000|Exposed|Week 0-26 (Main Period)||221||
48515051|NCT00700817|101593442|FG001|Exposed|Week 0-26 (Main Period)||218||
48515052|NCT00700817|101593443|FG002|Exposed|Week 0-26 (Main Period)||219||
48515053|NCT00700817|101593444|FG003|Exposed|Week 0-26 (Main Period)||0||
48515054|NCT00700817|101593445|FG004|Exposed|Week 0-26 (Main Period)||0||
48515055|NCT00700817|101593441|FG000|COMPLETED|Week 0-26 (Main Period)||169||
48515056|NCT00700817|101593442|FG001|COMPLETED|Week 0-26 (Main Period)||191||
48515057|NCT00700817|101593443|FG002|COMPLETED|Week 0-26 (Main Period)||194||
48515058|NCT00700817|101593444|FG003|COMPLETED|Week 0-26 (Main Period)||0||
48515059|NCT00700817|101593445|FG004|COMPLETED|Week 0-26 (Main Period)||0||
48515060|NCT00700817|101593441|FG000|NOT COMPLETED|Week 0-26 (Main Period)||56||
48515061|NCT00700817|101593442|FG001|NOT COMPLETED|Week 0-26 (Main Period)||30||
48515062|NCT00700817|101593443|FG002|NOT COMPLETED|Week 0-26 (Main Period)||25||
48515063|NCT00700817|101593444|FG003|NOT COMPLETED|Week 0-26 (Main Period)||0||
48515064|NCT00700817|101593445|FG004|NOT COMPLETED|Week 0-26 (Main Period)||0||
48515065|NCT00700817|101593441|FG000|STARTED|Week 26-52 (Extension Period 1)||155||
48515066|NCT00700817|101593442|FG001|STARTED|Week 26-52 (Extension Period 1)||176||
48515067|NCT00700817|101593443|FG002|STARTED|Week 26-52 (Extension Period 1)||166||
48515068|NCT00700817|101593444|FG003|STARTED|Week 26-52 (Extension Period 1)||0||
48515069|NCT00700817|101593445|FG004|STARTED|Week 26-52 (Extension Period 1)||0||
48515070|NCT00700817|101593441|FG000|COMPLETED|Week 26-52 (Extension Period 1)||135||
48515071|NCT00700817|101593442|FG001|COMPLETED|Week 26-52 (Extension Period 1)||150||
48515072|NCT00700817|101593443|FG002|COMPLETED|Week 26-52 (Extension Period 1)||151||
48515073|NCT00700817|101593444|FG003|COMPLETED|Week 26-52 (Extension Period 1)||0||
48515074|NCT00700817|101593445|FG004|COMPLETED|Week 26-52 (Extension Period 1)||0||
48515075|NCT00700817|101593441|FG000|NOT COMPLETED|Week 26-52 (Extension Period 1)||20||
48515076|NCT00700817|101593442|FG001|NOT COMPLETED|Week 26-52 (Extension Period 1)||26||
48515077|NCT00700817|101593443|FG002|NOT COMPLETED|Week 26-52 (Extension Period 1)||15||
48515078|NCT00700817|101593444|FG003|NOT COMPLETED|Week 26-52 (Extension Period 1)||0||
48515079|NCT00700817|101593445|FG004|NOT COMPLETED|Week 26-52 (Extension Period 1)||0||
48515080|NCT00700817|101593441|FG000|STARTED|Week 52-78 (Extension Period 2)||134||
48515081|NCT00700817|101593442|FG001|STARTED|Week 52-78 (Extension Period 2)||150||
48515082|NCT00700817|101593443|FG002|STARTED|Week 52-78 (Extension Period 2)||0||
48515083|NCT00700817|101593444|FG003|STARTED|Week 52-78 (Extension Period 2)||67||
48515084|NCT00700817|101593445|FG004|STARTED|Week 52-78 (Extension Period 2)||68||
48515085|NCT00700817|101593441|FG000|COMPLETED|Week 52-78 (Extension Period 2)||124||
48515086|NCT00700817|101593442|FG001|COMPLETED|Week 52-78 (Extension Period 2)||135||
48515087|NCT00700817|101593443|FG002|COMPLETED|Week 52-78 (Extension Period 2)||0||
48515088|NCT00700817|101593444|FG003|COMPLETED|Week 52-78 (Extension Period 2)||59||
48515089|NCT00700817|101593445|FG004|COMPLETED|Week 52-78 (Extension Period 2)||63||
48515090|NCT00700817|101593441|FG000|NOT COMPLETED|Week 52-78 (Extension Period 2)||10||
48219944|NCT05580003|100863767|FG019|COMPLETED|Part 3: Period 3 (Day 1)||0||
48515091|NCT00700817|101593442|FG001|NOT COMPLETED|Week 52-78 (Extension Period 2)||15||
48515092|NCT00700817|101593443|FG002|NOT COMPLETED|Week 52-78 (Extension Period 2)||0||
48515093|NCT00700817|101593444|FG003|NOT COMPLETED|Week 52-78 (Extension Period 2)||8||
48515094|NCT00700817|101593445|FG004|NOT COMPLETED|Week 52-78 (Extension Period 2)||5||
48515095|NCT02419924|101593446|FG000|STARTED|Overall Study||12||
48515096|NCT02419924|101593446|FG000|COMPLETED|Overall Study||12||
48515097|NCT02419924|101593446|FG000|NOT COMPLETED|Overall Study||0||
48515098|NCT04057248|101593447|FG000|STARTED|Overall Study||14||
48515099|NCT04057248|101593447|FG000|COMPLETED|Overall Study||12||
48515100|NCT04057248|101593447|FG000|NOT COMPLETED|Overall Study||2||
48515101|NCT04350008|101593448|FG000|STARTED|Overall Study||110||
48515102|NCT04350008|101593448|FG000|COMPLETED|Overall Study||110||
48515103|NCT04350008|101593448|FG000|NOT COMPLETED|Overall Study||0||
48515104|NCT00670241|101593449|FG000|STARTED|Overall Study||183||
48515105|NCT00670241|101593450|FG001|STARTED|Overall Study||184||
48515106|NCT00670241|101593451|FG002|STARTED|Overall Study||91||
48515107|NCT00670241|101593449|FG000|COMPLETED|Overall Study||171||
48515108|NCT00670241|101593450|FG001|COMPLETED|Overall Study||163||
48515109|NCT00670241|101593451|FG002|COMPLETED|Overall Study||64||
48515110|NCT00670241|101593449|FG000|NOT COMPLETED|Overall Study||12||
48515111|NCT00670241|101593450|FG001|NOT COMPLETED|Overall Study||21||
48515112|NCT00670241|101593451|FG002|NOT COMPLETED|Overall Study||27||
48515113|NCT06217796|101593452|FG000|STARTED|Overall Study||30||
48515114|NCT06217796|101593452|FG000|COMPLETED|Overall Study||30||
48515115|NCT06217796|101593452|FG000|NOT COMPLETED|Overall Study||0||
48515116|NCT02928536|101593453|FG000|STARTED|Overall Study||11902||
48515117|NCT02928536|101593453|FG000|COMPLETED|Overall Study||11902||
48515118|NCT02928536|101593453|FG000|NOT COMPLETED|Overall Study||0||
48515119|NCT03008837|101593454|FG000|STARTED|Overall Study||12||
48515120|NCT03008837|101593455|FG001|STARTED|Overall Study||9||
48515121|NCT03008837|101593454|FG000|COMPLETED|Overall Study||9||
48515122|NCT03008837|101593455|FG001|COMPLETED|Overall Study||5||
48515123|NCT03008837|101593454|FG000|NOT COMPLETED|Overall Study||3||
48515124|NCT03008837|101593455|FG001|NOT COMPLETED|Overall Study||4||
48515125|NCT02137382|101593456|FG000|STARTED|Cross-over Period 1||20||
48515126|NCT02137382|101593457|FG001|STARTED|Cross-over Period 1||21||
48515127|NCT02137382|101593456|FG000|COMPLETED|Cross-over Period 1||18||
48515128|NCT02137382|101593457|FG001|COMPLETED|Cross-over Period 1||21||
48515129|NCT02137382|101593456|FG000|NOT COMPLETED|Cross-over Period 1||2||
48515130|NCT02137382|101593457|FG001|NOT COMPLETED|Cross-over Period 1||0||
48515131|NCT02137382|101593456|FG000|STARTED|Wash Out||18||
48515132|NCT02137382|101593457|FG001|STARTED|Wash Out||21||
48515133|NCT02137382|101593456|FG000|COMPLETED|Wash Out||18||
48515134|NCT02137382|101593457|FG001|COMPLETED|Wash Out||21||
48515135|NCT02137382|101593456|FG000|NOT COMPLETED|Wash Out||0||
48515136|NCT02137382|101593457|FG001|NOT COMPLETED|Wash Out||0||
48515137|NCT02137382|101593456|FG000|STARTED|Cross-over Period 2||18||
48515138|NCT02137382|101593457|FG001|STARTED|Cross-over Period 2||21||
48515139|NCT02137382|101593456|FG000|COMPLETED|Cross-over Period 2||18||
48515140|NCT02137382|101593457|FG001|COMPLETED|Cross-over Period 2||21||
48515141|NCT02137382|101593456|FG000|NOT COMPLETED|Cross-over Period 2||0||
48515142|NCT02137382|101593457|FG001|NOT COMPLETED|Cross-over Period 2||0||
48515143|NCT02127073|101593458|FG000|STARTED|Overall Study||8||
48515144|NCT02127073|101593458|FG000|COMPLETED|Overall Study||8||
48515145|NCT02127073|101593458|FG000|NOT COMPLETED|Overall Study||0||
48515146|NCT00368316|101593459|FG000|STARTED|Overall Study||1434||
48515147|NCT00368316|101593460|FG001|STARTED|Overall Study||1365||
48515148|NCT00368316|101593459|FG000|COMPLETED|Overall Study||1392||
48515149|NCT00368316|101593460|FG001|COMPLETED|Overall Study||1319||
48515150|NCT00368316|101593459|FG000|NOT COMPLETED|Overall Study||42||
48515151|NCT00368316|101593460|FG001|NOT COMPLETED|Overall Study||46||
48515152|NCT01297322|101593461|FG000|STARTED|Overall Study||142||
48515153|NCT01297322|101593462|FG001|STARTED|Overall Study||278||
48515154|NCT01297322|101593461|FG000|COMPLETED|Overall Study||141||
48515155|NCT01297322|101593462|FG001|COMPLETED|Overall Study||274||
48515156|NCT01297322|101593461|FG000|NOT COMPLETED|Overall Study||1||
48515157|NCT01297322|101593462|FG001|NOT COMPLETED|Overall Study||4||
48515158|NCT02717078|101593463|FG000|STARTED|Overall Study||24||
48515159|NCT02717078|101593464|FG001|STARTED|Overall Study||24||
48515160|NCT02717078|101593463|FG000|COMPLETED|Overall Study||20||
48515161|NCT02717078|101593464|FG001|COMPLETED|Overall Study||18||
48515162|NCT02717078|101593463|FG000|NOT COMPLETED|Overall Study||4||
48515163|NCT02717078|101593464|FG001|NOT COMPLETED|Overall Study||6||
48515164|NCT01067716|101593465|FG000|STARTED|Overall Study||57||
48515165|NCT01067716|101593466|FG001|STARTED|Overall Study||13||
48515166|NCT01067716|101593467|FG002|STARTED|Overall Study||9||
48515167|NCT01067716|101593465|FG000|COMPLETED|Overall Study||57||
48515168|NCT01067716|101593466|FG001|COMPLETED|Overall Study||13||
48515169|NCT01067716|101593467|FG002|COMPLETED|Overall Study||9||
48515170|NCT01067716|101593465|FG000|NOT COMPLETED|Overall Study||0||
48515171|NCT01067716|101593466|FG001|NOT COMPLETED|Overall Study||0||
48515172|NCT01067716|101593467|FG002|NOT COMPLETED|Overall Study||0||
48515173|NCT00760526|101593468|FG000|STARTED|Overall Study||74||
48515174|NCT00760526|101593469|FG001|STARTED|Overall Study||72||
48515175|NCT00760526|101593468|FG000|COMPLETED|Overall Study||69||
48515176|NCT00760526|101593469|FG001|COMPLETED|Overall Study||68||
48515177|NCT00760526|101593468|FG000|NOT COMPLETED|Overall Study||5||
48515178|NCT00760526|101593469|FG001|NOT COMPLETED|Overall Study||4||
48515179|NCT00885677|101593470|FG000|STARTED|Overall Study||462||
48515180|NCT00885677|101593471|FG001|STARTED|Overall Study||455||
48515181|NCT00885677|101593470|FG000|Intention To Treat|Overall Study||437||
48515182|NCT00885677|101593471|FG001|Intention To Treat|Overall Study||428||
48515183|NCT00885677|101593470|FG000|COMPLETED|Overall Study||279||
48515184|NCT00885677|101593471|FG001|COMPLETED|Overall Study||277||
48515185|NCT00885677|101593470|FG000|NOT COMPLETED|Overall Study||183||
48515186|NCT00885677|101593471|FG001|NOT COMPLETED|Overall Study||178||
48515187|NCT01099631|101593472|FG000|STARTED|Overall Study||6||
48515188|NCT01099631|101593473|FG001|STARTED|Overall Study||3||
48515189|NCT01099631|101593474|FG002|STARTED|Overall Study||3||
48515190|NCT01099631|101593475|FG003|STARTED|Overall Study||3||
48515191|NCT01099631|101593476|FG004|STARTED|Overall Study||3||
48515192|NCT01099631|101593477|FG005|STARTED|Overall Study||4||
48515193|NCT01099631|101593472|FG000|COMPLETED|Overall Study||6||
48515194|NCT01099631|101593473|FG001|COMPLETED|Overall Study||3||
48515195|NCT01099631|101593474|FG002|COMPLETED|Overall Study||3||
48515196|NCT01099631|101593475|FG003|COMPLETED|Overall Study||3||
48515197|NCT01099631|101593476|FG004|COMPLETED|Overall Study||3||
48515198|NCT01099631|101593477|FG005|COMPLETED|Overall Study||4||
48515199|NCT01099631|101593472|FG000|NOT COMPLETED|Overall Study||0||
48515200|NCT01099631|101593473|FG001|NOT COMPLETED|Overall Study||0||
48515201|NCT01099631|101593474|FG002|NOT COMPLETED|Overall Study||0||
48515202|NCT01099631|101593475|FG003|NOT COMPLETED|Overall Study||0||
48515203|NCT01099631|101593476|FG004|NOT COMPLETED|Overall Study||0||
48515204|NCT01099631|101593477|FG005|NOT COMPLETED|Overall Study||0||
48515205|NCT01619579|101593478|FG000|STARTED|Overall Study||5||
48515206|NCT01619579|101593479|FG001|STARTED|Overall Study||17||
48515207|NCT01619579|101593478|FG000|COMPLETED|Overall Study||5||
48515208|NCT01619579|101593479|FG001|COMPLETED|Overall Study||14||
48515209|NCT01619579|101593478|FG000|NOT COMPLETED|Overall Study||0||
48515210|NCT01619579|101593479|FG001|NOT COMPLETED|Overall Study||3||
48515211|NCT01745952|101593480|FG000|STARTED|Overall Study||4||
48515212|NCT01745952|101593481|FG001|STARTED|Overall Study||4||
48515213|NCT01745952|101593482|FG002|STARTED|Overall Study||3||
48515214|NCT01745952|101593480|FG000|COMPLETED|Overall Study||3||
48515215|NCT01745952|101593481|FG001|COMPLETED|Overall Study||3||
48515216|NCT01745952|101593482|FG002|COMPLETED|Overall Study||3||
48515217|NCT01745952|101593480|FG000|NOT COMPLETED|Overall Study||1||
48515218|NCT01745952|101593481|FG001|NOT COMPLETED|Overall Study||1||
48515219|NCT01745952|101593482|FG002|NOT COMPLETED|Overall Study||0||
48515220|NCT02284347|101593483|FG000|STARTED|Overall Study||51||
48515221|NCT02284347|101593483|FG000|COMPLETED|Overall Study||48||
48515222|NCT02284347|101593483|FG000|NOT COMPLETED|Overall Study||3||
48515223|NCT01682642|101593484|FG000|STARTED|Overall Study||61||
48515224|NCT01682642|101593485|FG001|STARTED|Overall Study||59||
48515225|NCT01682642|101593484|FG000|COMPLETED|Overall Study||61||
48515226|NCT01682642|101593485|FG001|COMPLETED|Overall Study||58||
48515227|NCT01682642|101593484|FG000|NOT COMPLETED|Overall Study||0||
48515228|NCT01682642|101593485|FG001|NOT COMPLETED|Overall Study||1||
48515229|NCT03321526|101593486|FG000|STARTED|Double-blind Treatment Phase (24 Weeks)||54||
48515230|NCT03321526|101593487|FG001|STARTED|Double-blind Treatment Phase (24 Weeks)||53||
48515231|NCT03321526|101593486|FG000|COMPLETED|Double-blind Treatment Phase (24 Weeks)||30||
48515232|NCT03321526|101593487|FG001|COMPLETED|Double-blind Treatment Phase (24 Weeks)||27||
48515233|NCT03321526|101593486|FG000|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||24||
48515234|NCT03321526|101593487|FG001|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||26||
48515235|NCT03321526|101593486|FG000|STARTED|Follow-up Phase (2 Weeks)||54||
48515236|NCT03321526|101593487|FG001|STARTED|Follow-up Phase (2 Weeks)||52||
48515237|NCT03321526|101593486|FG000|COMPLETED|Follow-up Phase (2 Weeks)||30||
48515238|NCT03321526|101593487|FG001|COMPLETED|Follow-up Phase (2 Weeks)||28||
48515239|NCT03321526|101593486|FG000|NOT COMPLETED|Follow-up Phase (2 Weeks)||24||
48515240|NCT03321526|101593487|FG001|NOT COMPLETED|Follow-up Phase (2 Weeks)||24||
48515241|NCT00114231|101593488|FG000|STARTED|Overall Study||62||
48515242|NCT00114231|101593489|FG001|STARTED|Overall Study||28||
48515243|NCT00114231|101593488|FG000|COMPLETED|Overall Study||53||
48515244|NCT00114231|101593489|FG001|COMPLETED|Overall Study||26||
48515245|NCT00114231|101593488|FG000|NOT COMPLETED|Overall Study||9||
48515246|NCT00114231|101593489|FG001|NOT COMPLETED|Overall Study||2||
48515247|NCT01553201|101593490|FG000|STARTED|Overall Study||15||
48515248|NCT01553201|101593491|FG001|STARTED|Overall Study||15||
48515249|NCT01553201|101593490|FG000|COMPLETED|Overall Study||15||
48515250|NCT01553201|101593491|FG001|COMPLETED|Overall Study||15||
48515251|NCT01553201|101593490|FG000|NOT COMPLETED|Overall Study||0||
48515252|NCT01553201|101593491|FG001|NOT COMPLETED|Overall Study||0||
48515253|NCT02788513|101593492|FG000|STARTED|Overall Study||123||
48515254|NCT02788513|101593493|FG001|STARTED|Overall Study||122||
48515255|NCT02788513|101593494|FG002|STARTED|Overall Study||122||
48515256|NCT02788513|101593495|FG003|STARTED|Overall Study||123||
48515257|NCT02788513|101593496|FG004|STARTED|Overall Study||120||
48515258|NCT02788513|101593492|FG000|COMPLETED|Overall Study||114||
48515259|NCT02788513|101593493|FG001|COMPLETED|Overall Study||114||
48515260|NCT02788513|101593494|FG002|COMPLETED|Overall Study||114||
48515261|NCT02788513|101593495|FG003|COMPLETED|Overall Study||117||
48515262|NCT02788513|101593496|FG004|COMPLETED|Overall Study||115||
48515263|NCT02788513|101593492|FG000|NOT COMPLETED|Overall Study||9||
48515264|NCT02788513|101593493|FG001|NOT COMPLETED|Overall Study||8||
48515265|NCT02788513|101593494|FG002|NOT COMPLETED|Overall Study||8||
48515266|NCT02788513|101593495|FG003|NOT COMPLETED|Overall Study||6||
48515267|NCT02788513|101593496|FG004|NOT COMPLETED|Overall Study||5||
48515268|NCT00255151|101593497|FG000|STARTED|Overall Study||140||
48515269|NCT00255151|101593498|FG001|STARTED|Overall Study||159||
48515270|NCT00255151|101593499|FG002|STARTED|Overall Study||152||
48515271|NCT00255151|101593497|FG000|COMPLETED|Overall Study||17||
48515272|NCT00255151|101593498|FG001|COMPLETED|Overall Study||110||
48515273|NCT00255151|101593499|FG002|COMPLETED|Overall Study||103||
48515274|NCT00255151|101593497|FG000|NOT COMPLETED|Overall Study||123||
48515275|NCT00255151|101593498|FG001|NOT COMPLETED|Overall Study||49||
48515276|NCT00255151|101593499|FG002|NOT COMPLETED|Overall Study||49||
48515277|NCT01225055|101593500|FG000|STARTED|Overall Study||20||
48515278|NCT01225055|101593501|FG001|STARTED|Overall Study||20||
48515279|NCT01225055|101593502|FG002|STARTED|Overall Study||21||
48515280|NCT01225055|101593500|FG000|COMPLETED|Overall Study||20||
48515281|NCT01225055|101593501|FG001|COMPLETED|Overall Study||18||
48515282|NCT01225055|101593502|FG002|COMPLETED|Overall Study||18||
48515283|NCT01225055|101593500|FG000|NOT COMPLETED|Overall Study||0||
48515284|NCT01225055|101593501|FG001|NOT COMPLETED|Overall Study||2||
48515285|NCT01225055|101593502|FG002|NOT COMPLETED|Overall Study||3||
48515286|NCT04061577|101593503|FG000|STARTED|Overall Study||1||
48515287|NCT04061577|101593504|FG001|STARTED|Overall Study||0||
48515288|NCT04061577|101593503|FG000|COMPLETED|Overall Study||0||
48515289|NCT04061577|101593504|FG001|COMPLETED|Overall Study||0||
48515290|NCT04061577|101593503|FG000|NOT COMPLETED|Overall Study||1||
48515291|NCT04061577|101593504|FG001|NOT COMPLETED|Overall Study||0||
48515292|NCT02104817|101593505|FG000|STARTED|Overall Study||6539||
48515293|NCT02104817|101593506|FG001|STARTED|Overall Study||6539||
48515294|NCT02104817|101593505|FG000|COMPLETED|Overall Study||80||
48515295|NCT02104817|101593506|FG001|COMPLETED|Overall Study||92||
48515296|NCT02104817|101593505|FG000|NOT COMPLETED|Overall Study||6459||
48515297|NCT02104817|101593506|FG001|NOT COMPLETED|Overall Study||6447||
48515298|NCT00988208|101593507|FG000|STARTED|Overall Study||526||
48515299|NCT00988208|101593508|FG001|STARTED|Overall Study||533||
48515300|NCT00988208|101593507|FG000|Treated|Overall Study||521||
48515301|NCT00988208|101593508|FG001|Treated|Overall Study||525||
48515302|NCT00988208|101593507|FG000|COMPLETED|Overall Study||95||
48515303|NCT00988208|101593508|FG001|COMPLETED|Overall Study||95||
48515304|NCT00988208|101593507|FG000|NOT COMPLETED|Overall Study||431||
48515305|NCT00988208|101593508|FG001|NOT COMPLETED|Overall Study||438||
48515306|NCT02874014|101593509|FG000|STARTED|Overall Study||56||
48515307|NCT02874014|101593509|FG000|COMPLETED|Overall Study||54||
48515308|NCT02874014|101593509|FG000|NOT COMPLETED|Overall Study||2||
48515309|NCT01220609|101593510|FG000|STARTED|Overall Study||26||
48515310|NCT01220609|101593510|FG000|COMPLETED|Overall Study||23||
48515311|NCT01220609|101593510|FG000|NOT COMPLETED|Overall Study||3||
48515312|NCT03764735|101593511|FG000|STARTED|Overall Study||151||
48515313|NCT03764735|101593512|FG001|STARTED|Overall Study||150||
48515314|NCT03764735|101593513|FG002|STARTED|Overall Study||151||
48515315|NCT03764735|101593511|FG000|COMPLETED|Overall Study||147||
48515316|NCT03764735|101593512|FG001|COMPLETED|Overall Study||144||
48515317|NCT03764735|101593513|FG002|COMPLETED|Overall Study||147||
48515318|NCT03764735|101593511|FG000|NOT COMPLETED|Overall Study||4||
48515319|NCT03764735|101593512|FG001|NOT COMPLETED|Overall Study||6||
48515320|NCT03764735|101593513|FG002|NOT COMPLETED|Overall Study||4||
48515321|NCT05181800|101593514|FG000|STARTED|Overall Study||1454||
48515322|NCT05181800|101593514|FG000|COMPLETED|Overall Study||1454||
48515323|NCT05181800|101593514|FG000|NOT COMPLETED|Overall Study||0||
48515324|NCT04184999|101593515|FG000|STARTED|Overall Study||40||40
48515325|NCT04184999|101593516|FG001|STARTED|Overall Study||40||40
48515326|NCT04184999|101593515|FG000|3 Week Tear Film Osmolarity Testing|Overall Study||40||40
48515327|NCT04184999|101593516|FG001|3 Week Tear Film Osmolarity Testing|Overall Study||40||40
48515328|NCT04184999|101593515|FG000|COMPLETED|Overall Study||40||40
48515329|NCT04184999|101593516|FG001|COMPLETED|Overall Study||40||40
48515330|NCT04184999|101593515|FG000|NOT COMPLETED|Overall Study||0||0
48515331|NCT04184999|101593516|FG001|NOT COMPLETED|Overall Study||0||0
48515332|NCT02674386|101593517|FG000|STARTED|Overall Study||20||
48515333|NCT02674386|101593518|FG001|STARTED|Overall Study||117||
48515334|NCT02674386|101593519|FG002|STARTED|Overall Study||17||
48515335|NCT02674386|101593517|FG000|Safety Analysis Set|Overall Study||20||
48515336|NCT02674386|101593518|FG001|Safety Analysis Set|Overall Study||113||
48515337|NCT02674386|101593519|FG002|Safety Analysis Set|Overall Study||17||
48515338|NCT02674386|101593517|FG000|COMPLETED|Overall Study||20||
48515339|NCT02674386|101593518|FG001|COMPLETED|Overall Study||107||
48515340|NCT02674386|101593519|FG002|COMPLETED|Overall Study||16||
48515341|NCT02674386|101593517|FG000|NOT COMPLETED|Overall Study||0||
48515342|NCT02674386|101593518|FG001|NOT COMPLETED|Overall Study||10||
48515343|NCT02674386|101593519|FG002|NOT COMPLETED|Overall Study||1||
48515344|NCT01230892|101593520|FG000|STARTED|Overall Study||15||
48515345|NCT01230892|101593521|FG001|STARTED|Overall Study||14||
48515346|NCT01230892|101593520|FG000|COMPLETED|Overall Study||12||
48515347|NCT01230892|101593521|FG001|COMPLETED|Overall Study||13||
48515348|NCT01230892|101593520|FG000|NOT COMPLETED|Overall Study||3||
48515349|NCT01230892|101593521|FG001|NOT COMPLETED|Overall Study||1||
48515350|NCT00528268|101593522|FG000|STARTED|Overall Study||6||
48515351|NCT00528268|101593523|FG001|STARTED|Overall Study||8||
48515352|NCT00528268|101593522|FG000|COMPLETED|Overall Study||5||
48515353|NCT00528268|101593523|FG001|COMPLETED|Overall Study||7||
48515354|NCT00528268|101593522|FG000|NOT COMPLETED|Overall Study||1||
48515355|NCT00528268|101593523|FG001|NOT COMPLETED|Overall Study||1||
48515356|NCT00605917|101593524|FG000|STARTED|Overall Study||987||
48515357|NCT00605917|101593524|FG000|COMPLETED|Overall Study||908||
48515358|NCT00605917|101593524|FG000|NOT COMPLETED|Overall Study||79||
48515359|NCT02990806|101593525|FG000|STARTED|Stage 1 (22 Weeks)||228||
48515360|NCT02990806|101593526|FG001|STARTED|Stage 1 (22 Weeks)||455||
48515361|NCT02990806|101593527|FG002|STARTED|Stage 1 (22 Weeks)||0||
48515362|NCT02990806|101593528|FG003|STARTED|Stage 1 (22 Weeks)||0||
48515363|NCT02990806|101593525|FG000|Safety Population|Stage 1 (22 Weeks)||227||
48515364|NCT02990806|101593526|FG001|Safety Population|Stage 1 (22 Weeks)||451||
48515365|NCT02990806|101593527|FG002|Safety Population|Stage 1 (22 Weeks)||0||
48515366|NCT02990806|101593528|FG003|Safety Population|Stage 1 (22 Weeks)||0||
48515367|NCT02990806|101593525|FG000|COMPLETED|Stage 1 (22 Weeks)||214||
48515368|NCT02990806|101593526|FG001|COMPLETED|Stage 1 (22 Weeks)||399||
48515369|NCT02990806|101593527|FG002|COMPLETED|Stage 1 (22 Weeks)||0||
48515370|NCT02990806|101593528|FG003|COMPLETED|Stage 1 (22 Weeks)||0||
48515371|NCT02990806|101593525|FG000|NOT COMPLETED|Stage 1 (22 Weeks)||14||
48515372|NCT02990806|101593526|FG001|NOT COMPLETED|Stage 1 (22 Weeks)||56||
48515373|NCT02990806|101593527|FG002|NOT COMPLETED|Stage 1 (22 Weeks)||0||
48515374|NCT02990806|101593528|FG003|NOT COMPLETED|Stage 1 (22 Weeks)||0||
48515375|NCT02990806|101593525|FG000|STARTED|Stage 2 (32 Weeks)||214||
48515376|NCT02990806|101593526|FG001|STARTED|Stage 2 (32 Weeks)||0||
48515377|NCT02990806|101593527|FG002|STARTED|Stage 2 (32 Weeks)||201||
48515378|NCT02990806|101593528|FG003|STARTED|Stage 2 (32 Weeks)||196||
48515379|NCT02990806|101593525|FG000|COMPLETED|Stage 2 (32 Weeks)||172||
48515380|NCT02990806|101593526|FG001|COMPLETED|Stage 2 (32 Weeks)||0||
48515381|NCT02990806|101593527|FG002|COMPLETED|Stage 2 (32 Weeks)||173||
48515382|NCT02990806|101593528|FG003|COMPLETED|Stage 2 (32 Weeks)||162||
48515383|NCT02990806|101593525|FG000|NOT COMPLETED|Stage 2 (32 Weeks)||42||
48515384|NCT02990806|101593526|FG001|NOT COMPLETED|Stage 2 (32 Weeks)||0||
48515385|NCT02990806|101593527|FG002|NOT COMPLETED|Stage 2 (32 Weeks)||28||
48515386|NCT02990806|101593528|FG003|NOT COMPLETED|Stage 2 (32 Weeks)||34||
48515387|NCT02990806|101593525|FG000|STARTED|Stage 3 (Safety Follow-up) (8 Weeks)||172||
48515388|NCT02990806|101593526|FG001|STARTED|Stage 3 (Safety Follow-up) (8 Weeks)||0||
48515389|NCT02990806|101593527|FG002|STARTED|Stage 3 (Safety Follow-up) (8 Weeks)||173||
48515390|NCT02990806|101593528|FG003|STARTED|Stage 3 (Safety Follow-up) (8 Weeks)||162||
48515391|NCT02990806|101593525|FG000|COMPLETED|Stage 3 (Safety Follow-up) (8 Weeks)||163||
48515392|NCT02990806|101593526|FG001|COMPLETED|Stage 3 (Safety Follow-up) (8 Weeks)||0||
48515393|NCT02990806|101593527|FG002|COMPLETED|Stage 3 (Safety Follow-up) (8 Weeks)||162||
48515394|NCT02990806|101593528|FG003|COMPLETED|Stage 3 (Safety Follow-up) (8 Weeks)||152||
48515395|NCT02990806|101593525|FG000|NOT COMPLETED|Stage 3 (Safety Follow-up) (8 Weeks)||9||
48515396|NCT02990806|101593526|FG001|NOT COMPLETED|Stage 3 (Safety Follow-up) (8 Weeks)||0||
48515397|NCT02990806|101593527|FG002|NOT COMPLETED|Stage 3 (Safety Follow-up) (8 Weeks)||11||
48515398|NCT02990806|101593528|FG003|NOT COMPLETED|Stage 3 (Safety Follow-up) (8 Weeks)||10||
48515399|NCT00353652|101593529|FG000|STARTED|First Intervention - 3 Months||15||
48515400|NCT00353652|101593530|FG001|STARTED|First Intervention - 3 Months||15||
48515401|NCT00353652|101593531|FG002|STARTED|First Intervention - 3 Months||6||
48515402|NCT00353652|101593532|FG003|STARTED|First Intervention - 3 Months||7||
48515403|NCT00353652|101593533|FG004|STARTED|First Intervention - 3 Months||3||
48515404|NCT00353652|101593534|FG005|STARTED|First Intervention - 3 Months||0||
48515405|NCT00353652|101593535|FG006|STARTED|First Intervention - 3 Months||1||
48515406|NCT00353652|101593536|FG007|STARTED|First Intervention - 3 Months||0||
48515407|NCT00353652|101593529|FG000|COMPLETED|First Intervention - 3 Months||12||
48515408|NCT00353652|101593530|FG001|COMPLETED|First Intervention - 3 Months||11||
48515409|NCT00353652|101593531|FG002|COMPLETED|First Intervention - 3 Months||6||
48515410|NCT00353652|101593532|FG003|COMPLETED|First Intervention - 3 Months||7||
48515411|NCT00353652|101593533|FG004|COMPLETED|First Intervention - 3 Months||3||
48515412|NCT00353652|101593534|FG005|COMPLETED|First Intervention - 3 Months||0||
48515413|NCT00353652|101593535|FG006|COMPLETED|First Intervention - 3 Months||1||
48515414|NCT00353652|101593536|FG007|COMPLETED|First Intervention - 3 Months||0||
48515415|NCT00353652|101593529|FG000|NOT COMPLETED|First Intervention - 3 Months||3||
48515416|NCT00353652|101593530|FG001|NOT COMPLETED|First Intervention - 3 Months||4||
48515417|NCT00353652|101593531|FG002|NOT COMPLETED|First Intervention - 3 Months||0||
48515418|NCT00353652|101593532|FG003|NOT COMPLETED|First Intervention - 3 Months||0||
48515419|NCT00353652|101593533|FG004|NOT COMPLETED|First Intervention - 3 Months||0||
48515420|NCT00353652|101593534|FG005|NOT COMPLETED|First Intervention - 3 Months||0||
48515421|NCT00353652|101593535|FG006|NOT COMPLETED|First Intervention - 3 Months||0||
48515422|NCT00353652|101593536|FG007|NOT COMPLETED|First Intervention - 3 Months||0||
48067655|NCT01539083|100485615|FG000|STARTED|Before Randomization (VCD Induction)||256||
48515423|NCT00353652|101593529|FG000|STARTED|Second Intervention - 3 Months||12||
48515424|NCT00353652|101593530|FG001|STARTED|Second Intervention - 3 Months||11||
48515425|NCT00353652|101593531|FG002|STARTED|Second Intervention - 3 Months||6||
48515426|NCT00353652|101593532|FG003|STARTED|Second Intervention - 3 Months||7||
48515427|NCT00353652|101593533|FG004|STARTED|Second Intervention - 3 Months||3||
48515428|NCT00353652|101593534|FG005|STARTED|Second Intervention - 3 Months||0||
48515429|NCT00353652|101593535|FG006|STARTED|Second Intervention - 3 Months||1||
48515430|NCT00353652|101593536|FG007|STARTED|Second Intervention - 3 Months||0||
48515431|NCT00353652|101593529|FG000|COMPLETED|Second Intervention - 3 Months||12||
48515432|NCT00353652|101593530|FG001|COMPLETED|Second Intervention - 3 Months||11||
48515433|NCT00353652|101593531|FG002|COMPLETED|Second Intervention - 3 Months||6||
48515434|NCT00353652|101593532|FG003|COMPLETED|Second Intervention - 3 Months||7||
48515435|NCT00353652|101593533|FG004|COMPLETED|Second Intervention - 3 Months||3||
48515436|NCT00353652|101593534|FG005|COMPLETED|Second Intervention - 3 Months||0||
48515437|NCT00353652|101593535|FG006|COMPLETED|Second Intervention - 3 Months||1||
48515438|NCT00353652|101593536|FG007|COMPLETED|Second Intervention - 3 Months||0||
48515439|NCT00353652|101593529|FG000|NOT COMPLETED|Second Intervention - 3 Months||0||
48515440|NCT00353652|101593530|FG001|NOT COMPLETED|Second Intervention - 3 Months||0||
48515441|NCT00353652|101593531|FG002|NOT COMPLETED|Second Intervention - 3 Months||0||
48515442|NCT00353652|101593532|FG003|NOT COMPLETED|Second Intervention - 3 Months||0||
48515443|NCT00353652|101593533|FG004|NOT COMPLETED|Second Intervention - 3 Months||0||
48515444|NCT00353652|101593534|FG005|NOT COMPLETED|Second Intervention - 3 Months||0||
48515445|NCT00353652|101593535|FG006|NOT COMPLETED|Second Intervention - 3 Months||0||
48515446|NCT00353652|101593536|FG007|NOT COMPLETED|Second Intervention - 3 Months||0||
48515447|NCT00353652|101593529|FG000|STARTED|Third Intervention - 3 Months||0||
48515448|NCT00353652|101593530|FG001|STARTED|Third Intervention - 3 Months||0||
48515449|NCT00353652|101593531|FG002|STARTED|Third Intervention - 3 Months||6||
48515450|NCT00353652|101593532|FG003|STARTED|Third Intervention - 3 Months||7||
48515451|NCT00353652|101593533|FG004|STARTED|Third Intervention - 3 Months||3||
48515452|NCT00353652|101593534|FG005|STARTED|Third Intervention - 3 Months||0||
48515453|NCT00353652|101593535|FG006|STARTED|Third Intervention - 3 Months||1||
48515454|NCT00353652|101593536|FG007|STARTED|Third Intervention - 3 Months||0||
48515455|NCT00353652|101593529|FG000|COMPLETED|Third Intervention - 3 Months||0||
48515456|NCT00353652|101593530|FG001|COMPLETED|Third Intervention - 3 Months||0||
48515457|NCT00353652|101593531|FG002|COMPLETED|Third Intervention - 3 Months||6||
48515458|NCT00353652|101593532|FG003|COMPLETED|Third Intervention - 3 Months||6||
48515459|NCT00353652|101593533|FG004|COMPLETED|Third Intervention - 3 Months||3||
48515460|NCT00353652|101593534|FG005|COMPLETED|Third Intervention - 3 Months||0||
48515461|NCT00353652|101593535|FG006|COMPLETED|Third Intervention - 3 Months||1||
48515462|NCT00353652|101593536|FG007|COMPLETED|Third Intervention - 3 Months||0||
48515463|NCT00353652|101593529|FG000|NOT COMPLETED|Third Intervention - 3 Months||0||
48515464|NCT00353652|101593530|FG001|NOT COMPLETED|Third Intervention - 3 Months||0||
48515465|NCT00353652|101593531|FG002|NOT COMPLETED|Third Intervention - 3 Months||0||
48515466|NCT00353652|101593532|FG003|NOT COMPLETED|Third Intervention - 3 Months||1||
48515467|NCT00353652|101593533|FG004|NOT COMPLETED|Third Intervention - 3 Months||0||
48515468|NCT00353652|101593534|FG005|NOT COMPLETED|Third Intervention - 3 Months||0||
48515469|NCT00353652|101593535|FG006|NOT COMPLETED|Third Intervention - 3 Months||0||
48515470|NCT00353652|101593536|FG007|NOT COMPLETED|Third Intervention - 3 Months||0||
48515471|NCT00108082|101593537|FG000|STARTED|Overall Study||91||
48515472|NCT00108082|101593538|FG001|STARTED|Overall Study||100||
48515473|NCT00108082|101593539|FG002|STARTED|Overall Study||96||
48515474|NCT00108082|101593537|FG000|COMPLETED|Overall Study||53||
48515475|NCT00108082|101593538|FG001|COMPLETED|Overall Study||68||
48515476|NCT00108082|101593539|FG002|COMPLETED|Overall Study||53||
48515477|NCT00108082|101593537|FG000|NOT COMPLETED|Overall Study||38||
48515478|NCT00108082|101593538|FG001|NOT COMPLETED|Overall Study||32||
48515479|NCT00108082|101593539|FG002|NOT COMPLETED|Overall Study||43||
48515480|NCT01832402|101593540|FG000|STARTED|Overall Study||19||
48515481|NCT01832402|101593541|FG001|STARTED|Overall Study||16||
48515482|NCT01832402|101593540|FG000|Received Allocated Medication|Overall Study||12||
48515483|NCT01832402|101593541|FG001|Received Allocated Medication|Overall Study||12||
48515484|NCT01832402|101593540|FG000|Completed Study With Correct Dose|Overall Study||10||
48515485|NCT01832402|101593541|FG001|Completed Study With Correct Dose|Overall Study||9||
48515486|NCT01832402|101593540|FG000|Completed Study With Incorrect Dose|Overall Study||2||
48515487|NCT01832402|101593541|FG001|Completed Study With Incorrect Dose|Overall Study||3||
48515488|NCT01832402|101593540|FG000|COMPLETED|Overall Study||12||
48515489|NCT01832402|101593541|FG001|COMPLETED|Overall Study||12||
48515490|NCT01832402|101593540|FG000|NOT COMPLETED|Overall Study||7||
48515491|NCT01832402|101593541|FG001|NOT COMPLETED|Overall Study||4||
48515492|NCT02956616|101593542|FG000|STARTED|Overall Study||58||
48515493|NCT02956616|101593543|FG001|STARTED|Overall Study||60||
48515494|NCT02956616|101593542|FG000|COMPLETED|Overall Study||58||
48515495|NCT02956616|101593543|FG001|COMPLETED|Overall Study||60||
48515496|NCT02956616|101593542|FG000|NOT COMPLETED|Overall Study||0||
48515497|NCT02956616|101593543|FG001|NOT COMPLETED|Overall Study||0||
48515498|NCT04241133|101593544|FG000|STARTED|Overall Study||44||
48515499|NCT04241133|101593545|FG001|STARTED|Overall Study||34||
48515500|NCT04241133|101593544|FG000|COMPLETED|Overall Study||30||
48515501|NCT04241133|101593545|FG001|COMPLETED|Overall Study||0||
48515502|NCT04241133|101593544|FG000|NOT COMPLETED|Overall Study||14||
48515503|NCT04241133|101593545|FG001|NOT COMPLETED|Overall Study||34||
48515504|NCT02994394|101593546|FG000|STARTED|Period 1 (Days 1 to 3)||14||
48515505|NCT02994394|101593547|FG001|STARTED|Period 1 (Days 1 to 3)||14||
48515506|NCT02994394|101593548|FG002|STARTED|Period 1 (Days 1 to 3)||14||
48515507|NCT02994394|101593549|FG003|STARTED|Period 1 (Days 1 to 3)||14||
48067656|NCT01539083|100485616|FG001|STARTED|Before Randomization (VCD Induction)||0||
48067657|NCT01539083|100485617|FG002|STARTED|Before Randomization (VCD Induction)||0||
48067658|NCT01539083|100485615|FG000|Treated|Before Randomization (VCD Induction)||254||
48067659|NCT01539083|100485616|FG001|Treated|Before Randomization (VCD Induction)||0||
48067660|NCT01539083|100485617|FG002|Treated|Before Randomization (VCD Induction)||0||
48067661|NCT01539083|100485615|FG000|COMPLETED|Before Randomization (VCD Induction)||203||
48067662|NCT01539083|100485616|FG001|COMPLETED|Before Randomization (VCD Induction)||0||
48067663|NCT01539083|100485617|FG002|COMPLETED|Before Randomization (VCD Induction)||0||
48067664|NCT01539083|100485615|FG000|NOT COMPLETED|Before Randomization (VCD Induction)||53||
48067665|NCT01539083|100485616|FG001|NOT COMPLETED|Before Randomization (VCD Induction)||0||
48067666|NCT01539083|100485617|FG002|NOT COMPLETED|Before Randomization (VCD Induction)||0||
48067667|NCT01539083|100485615|FG000|STARTED|After Randomization (TP and VTP)||0||
48067668|NCT01539083|100485616|FG001|STARTED|After Randomization (TP and VTP)||100||
48067669|NCT01539083|100485617|FG002|STARTED|After Randomization (TP and VTP)||103||
48067670|NCT01539083|100485615|FG000|Safety Population|After Randomization (TP and VTP)||0||
48067671|NCT01539083|100485616|FG001|Safety Population|After Randomization (TP and VTP)||99||
48067672|NCT01539083|100485617|FG002|Safety Population|After Randomization (TP and VTP)||103||
48067673|NCT01539083|100485615|FG000|COMPLETED|After Randomization (TP and VTP)||0||
48067674|NCT01539083|100485616|FG001|COMPLETED|After Randomization (TP and VTP)||79||
48067675|NCT01539083|100485617|FG002|COMPLETED|After Randomization (TP and VTP)||80||
48067676|NCT01539083|100485615|FG000|NOT COMPLETED|After Randomization (TP and VTP)||0||
48067677|NCT01539083|100485616|FG001|NOT COMPLETED|After Randomization (TP and VTP)||21||
48067678|NCT01539083|100485617|FG002|NOT COMPLETED|After Randomization (TP and VTP)||23||
48067679|NCT01784848|100485618|FG000|STARTED|Overall Study||50||
48067680|NCT01784848|100485619|FG001|STARTED|Overall Study||50||
48067681|NCT01784848|100485618|FG000|COMPLETED|Overall Study||49||
48067682|NCT01784848|100485619|FG001|COMPLETED|Overall Study||47||
48067683|NCT01784848|100485618|FG000|NOT COMPLETED|Overall Study||1||
48067684|NCT01784848|100485619|FG001|NOT COMPLETED|Overall Study||3||
48067685|NCT02436304|100485620|FG000|STARTED|Overall Study||153||
48067686|NCT02436304|100485621|FG001|STARTED|Overall Study||102||
48067687|NCT02436304|100485622|FG002|STARTED|Overall Study||101||
48067688|NCT02436304|100485620|FG000|COMPLETED|Overall Study||153||
48067689|NCT02436304|100485621|FG001|COMPLETED|Overall Study||100||
48067690|NCT02436304|100485622|FG002|COMPLETED|Overall Study||100||
48067691|NCT02436304|100485620|FG000|NOT COMPLETED|Overall Study||0||
48067692|NCT02436304|100485621|FG001|NOT COMPLETED|Overall Study||2||
48067693|NCT02436304|100485622|FG002|NOT COMPLETED|Overall Study||1||
48067694|NCT02122458|100485623|FG000|STARTED|Overall Study||12||
48067695|NCT02122458|100485624|FG001|STARTED|Overall Study||18||
48067696|NCT02122458|100485625|FG002|STARTED|Overall Study||7||
48067697|NCT02122458|100485626|FG003|STARTED|Overall Study||82||
48067698|NCT02122458|100485627|FG004|STARTED|Overall Study||45||
48067699|NCT02122458|100485628|FG005|STARTED|Overall Study||43||
48067700|NCT02122458|100485629|FG006|STARTED|Overall Study||19||
48067701|NCT02122458|100485623|FG000|COMPLETED|Overall Study||9||
48067702|NCT02122458|100485624|FG001|COMPLETED|Overall Study||13||
48067703|NCT02122458|100485625|FG002|COMPLETED|Overall Study||7||
48067704|NCT02122458|100485626|FG003|COMPLETED|Overall Study||67||
48067705|NCT02122458|100485627|FG004|COMPLETED|Overall Study||31||
48067706|NCT02122458|100485628|FG005|COMPLETED|Overall Study||23||
48067707|NCT02122458|100485629|FG006|COMPLETED|Overall Study||18||
48067708|NCT02122458|100485623|FG000|NOT COMPLETED|Overall Study||3||
48067709|NCT02122458|100485624|FG001|NOT COMPLETED|Overall Study||5||
48067710|NCT02122458|100485625|FG002|NOT COMPLETED|Overall Study||0||
48067711|NCT02122458|100485626|FG003|NOT COMPLETED|Overall Study||15||
48067712|NCT02122458|100485627|FG004|NOT COMPLETED|Overall Study||14||
48067713|NCT02122458|100485628|FG005|NOT COMPLETED|Overall Study||20||
48067714|NCT02122458|100485629|FG006|NOT COMPLETED|Overall Study||1||
48067715|NCT03096483|100485630|FG000|STARTED|Overall Study||12||
48067716|NCT03096483|100485630|FG000|COMPLETED|Overall Study||11||
48067717|NCT03096483|100485630|FG000|NOT COMPLETED|Overall Study||1||
48067718|NCT01145625|100485631|FG000|STARTED|Overall Study||161||
48067719|NCT01145625|100485632|FG001|STARTED|Overall Study||161||
48067720|NCT01145625|100485631|FG000|COMPLETED|Overall Study||137||
48067721|NCT01145625|100485632|FG001|COMPLETED|Overall Study||130||
48067722|NCT01145625|100485631|FG000|NOT COMPLETED|Overall Study||24||
48067723|NCT01145625|100485632|FG001|NOT COMPLETED|Overall Study||31||
48067724|NCT00216476|100485633|FG000|STARTED|Overall Study||329||
48067725|NCT00216476|100485634|FG001|STARTED|Overall Study||337||
48067726|NCT00216476|100485635|FG002|STARTED|Overall Study||45||
48067727|NCT00216476|100485633|FG000|COMPLETED|Overall Study||224||
48067728|NCT00216476|100485634|FG001|COMPLETED|Overall Study||230||
48067729|NCT00216476|100485635|FG002|COMPLETED|Overall Study||28||
48067730|NCT00216476|100485633|FG000|NOT COMPLETED|Overall Study||105||
48067731|NCT00216476|100485634|FG001|NOT COMPLETED|Overall Study||107||
48515508|NCT02994394|101593550|FG004|STARTED|Period 1 (Days 1 to 3)||14||
48067732|NCT00216476|100485635|FG002|NOT COMPLETED|Overall Study||17||
48067733|NCT00579878|100485636|FG000|STARTED|Overall Study||22||
48067734|NCT00579878|100485637|FG001|STARTED|Overall Study||23||
48067735|NCT00579878|100485638|FG002|STARTED|Overall Study||24||
48067736|NCT00579878|100485636|FG000|COMPLETED|Overall Study||15||
48067737|NCT00579878|100485637|FG001|COMPLETED|Overall Study||20||
48067738|NCT00579878|100485638|FG002|COMPLETED|Overall Study||14||
48067739|NCT00579878|100485636|FG000|NOT COMPLETED|Overall Study||7||
48067740|NCT00579878|100485637|FG001|NOT COMPLETED|Overall Study||3||
48067741|NCT00579878|100485638|FG002|NOT COMPLETED|Overall Study||10||
48067742|NCT00074269|100485639|FG000|STARTED|Overall Study||5||
48067743|NCT00074269|100485639|FG000|COMPLETED|Overall Study||5||
48067744|NCT00074269|100485639|FG000|NOT COMPLETED|Overall Study||0||
48067745|NCT00147212|100485640|FG000|STARTED|Overall Study||50||
48067746|NCT00147212|100485640|FG000|COMPLETED|Overall Study||50||
48067747|NCT00147212|100485640|FG000|NOT COMPLETED|Overall Study||0||
48067748|NCT00762216|100485641|FG000|STARTED|Overall Study||71||
48067749|NCT00762216|100485641|FG000|COMPLETED|Overall Study||71||
48067750|NCT00762216|100485641|FG000|NOT COMPLETED|Overall Study||0||
48067751|NCT01540266|100485642|FG000|STARTED|Overall Study||63||
48067752|NCT01540266|100485643|FG001|STARTED|Overall Study||42||
48067753|NCT01540266|100485644|FG002|STARTED|Overall Study||60||
48067754|NCT01540266|100485645|FG003|STARTED|Overall Study||38||
48067755|NCT01540266|100485646|FG004|STARTED|Overall Study||20||
48067756|NCT01540266|100485647|FG005|STARTED|Overall Study||19||
48067757|NCT01540266|100485642|FG000|COMPLETED|Overall Study||57||
48067758|NCT01540266|100485643|FG001|COMPLETED|Overall Study||41||
48067759|NCT01540266|100485644|FG002|COMPLETED|Overall Study||59||
48067760|NCT01540266|100485645|FG003|COMPLETED|Overall Study||38||
48067761|NCT01540266|100485646|FG004|COMPLETED|Overall Study||20||
48067762|NCT01540266|100485647|FG005|COMPLETED|Overall Study||19||
48067763|NCT01540266|100485642|FG000|NOT COMPLETED|Overall Study||6||
48067764|NCT01540266|100485643|FG001|NOT COMPLETED|Overall Study||1||
48067765|NCT01540266|100485644|FG002|NOT COMPLETED|Overall Study||1||
48067766|NCT01540266|100485645|FG003|NOT COMPLETED|Overall Study||0||
48067767|NCT01540266|100485646|FG004|NOT COMPLETED|Overall Study||0||
48067768|NCT01540266|100485647|FG005|NOT COMPLETED|Overall Study||0||
48067769|NCT02345226|100485648|FG000|STARTED|Double-Blind Phase||440||
48067770|NCT02345226|100485649|FG001|STARTED|Double-Blind Phase||441||
48067771|NCT02345226|100485648|FG000|COMPLETED|Double-Blind Phase||371||
48067772|NCT02345226|100485649|FG001|COMPLETED|Double-Blind Phase||370||
48067773|NCT02345226|100485648|FG000|NOT COMPLETED|Double-Blind Phase||69||
48067774|NCT02345226|100485649|FG001|NOT COMPLETED|Double-Blind Phase||71||
48067775|NCT02345226|100485648|FG000|STARTED|Open-Label Extension Phase||25||
48067776|NCT02345226|100485649|FG001|STARTED|Open-Label Extension Phase||21||
48067777|NCT02345226|100485648|FG000|COMPLETED|Open-Label Extension Phase||25||
48067778|NCT02345226|100485649|FG001|COMPLETED|Open-Label Extension Phase||20||
48067779|NCT02345226|100485648|FG000|NOT COMPLETED|Open-Label Extension Phase||0||
48067780|NCT02345226|100485649|FG001|NOT COMPLETED|Open-Label Extension Phase||1||
48067781|NCT00142935|100485650|FG000|STARTED|Overall Study||29||
48067782|NCT00142935|100485651|FG001|STARTED|Overall Study||28||
48067783|NCT00142935|100485652|FG002|STARTED|Overall Study||30||
48067784|NCT00142935|100485650|FG000|COMPLETED|Overall Study||26||
48067785|NCT00142935|100485651|FG001|COMPLETED|Overall Study||20||
48067786|NCT00142935|100485652|FG002|COMPLETED|Overall Study||23||
48067787|NCT00142935|100485650|FG000|NOT COMPLETED|Overall Study||3||
48067788|NCT00142935|100485651|FG001|NOT COMPLETED|Overall Study||8||
48067789|NCT00142935|100485652|FG002|NOT COMPLETED|Overall Study||7||
48067790|NCT03992014|100485653|FG000|STARTED|Treatment Period 1 (8 Days)||6||
48067791|NCT03992014|100485653|FG000|COMPLETED|Treatment Period 1 (8 Days)||6||
48067792|NCT03992014|100485653|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
48067793|NCT03992014|100485653|FG000|STARTED|Washout Period (7 Days)||6||
48067794|NCT03992014|100485653|FG000|COMPLETED|Washout Period (7 Days)||6||
48067795|NCT03992014|100485653|FG000|NOT COMPLETED|Washout Period (7 Days)||0||
48067796|NCT03992014|100485653|FG000|STARTED|Treatment Period 2 (8 Days)||6||
48067797|NCT03992014|100485653|FG000|COMPLETED|Treatment Period 2 (8 Days)||6||
48067798|NCT03992014|100485653|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
48067799|NCT00579137|100485654|FG000|STARTED|Overall Study||3||
48067800|NCT00579137|100485654|FG000|COMPLETED|Overall Study||3||
48067801|NCT00579137|100485654|FG000|NOT COMPLETED|Overall Study||0||
48067802|NCT04195906|100485655|FG000|STARTED|Part 1||37||
48067803|NCT04195906|100485656|FG001|STARTED|Part 1||34||
48067804|NCT04195906|100485655|FG000|COMPLETED|Part 1||34||
48067805|NCT04195906|100485656|FG001|COMPLETED|Part 1||26||
48067806|NCT04195906|100485655|FG000|NOT COMPLETED|Part 1||3||
48067807|NCT04195906|100485656|FG001|NOT COMPLETED|Part 1||8||
48067808|NCT04195906|100485655|FG000|STARTED|Part 2||34||
48067809|NCT04195906|100485656|FG001|STARTED|Part 2||26||
48067810|NCT04195906|100485655|FG000|COMPLETED|Part 2||32||
48067811|NCT04195906|100485656|FG001|COMPLETED|Part 2||19||
48067812|NCT04195906|100485655|FG000|NOT COMPLETED|Part 2||2||
48067813|NCT04195906|100485656|FG001|NOT COMPLETED|Part 2||7||
48067814|NCT00414271|100485657|FG000|STARTED|Overall Study||18||
48067815|NCT00414271|100485657|FG000|COMPLETED|Overall Study||18||
48067816|NCT00414271|100485657|FG000|NOT COMPLETED|Overall Study||0||
48067817|NCT01601860|100485658|FG000|STARTED|Overall Study||40||
48067818|NCT01601860|100485659|FG001|STARTED|Overall Study||40||
48067819|NCT01601860|100485658|FG000|COMPLETED|Overall Study||19||
48067820|NCT01601860|100485659|FG001|COMPLETED|Overall Study||31||
48067821|NCT01601860|100485658|FG000|NOT COMPLETED|Overall Study||21||
48067822|NCT01601860|100485659|FG001|NOT COMPLETED|Overall Study||9||
48067823|NCT02495831|100485660|FG000|STARTED|First Intervention||13||
48067824|NCT02495831|100485661|FG001|STARTED|First Intervention||10||
48067825|NCT02495831|100485660|FG000|COMPLETED|First Intervention||13||
48067826|NCT02495831|100485661|FG001|COMPLETED|First Intervention||10||
48067827|NCT02495831|100485660|FG000|NOT COMPLETED|First Intervention||0||
48067828|NCT02495831|100485661|FG001|NOT COMPLETED|First Intervention||0||
48067829|NCT02495831|100485660|FG000|STARTED|Second Intervention||12||
48067830|NCT02495831|100485661|FG001|STARTED|Second Intervention||10||
48067831|NCT02495831|100485660|FG000|COMPLETED|Second Intervention||12||
48067832|NCT02495831|100485661|FG001|COMPLETED|Second Intervention||10||
48067833|NCT02495831|100485660|FG000|NOT COMPLETED|Second Intervention||0||
48067834|NCT02495831|100485661|FG001|NOT COMPLETED|Second Intervention||0||
48067835|NCT02754557|100485662|FG000|STARTED|Overall Study||27||
48067836|NCT02754557|100485663|FG001|STARTED|Overall Study||38||
48067837|NCT02754557|100485662|FG000|Completed Post-treatment Assessment at Week 4|Overall Study||27||
48067838|NCT02754557|100485663|FG001|Completed Post-treatment Assessment at Week 4|Overall Study||38||
48067839|NCT02754557|100485662|FG000|Completed One-month Post-treatment Assessment at Week 8|Overall Study||19||
48067840|NCT02754557|100485663|FG001|Completed One-month Post-treatment Assessment at Week 8|Overall Study||32||
48067841|NCT02754557|100485662|FG000|COMPLETED|Overall Study||27|Completed the primary aim of the study which was the post-treatment follow up assessment at Week 4.|
48067842|NCT02754557|100485663|FG001|COMPLETED|Overall Study||38|Completed the primary aim of the study which was the post-treatment follow up assessment at Week 4.|
48067843|NCT02754557|100485662|FG000|NOT COMPLETED|Overall Study||0||
48067844|NCT02754557|100485663|FG001|NOT COMPLETED|Overall Study||0||
48067845|NCT03789396|100485664|FG000|STARTED|Overall Study||371||
48067846|NCT03789396|100485665|FG001|STARTED|Overall Study||201||
48067847|NCT03789396|100485664|FG000|COMPLETED|Overall Study||371||
48067848|NCT03789396|100485665|FG001|COMPLETED|Overall Study||201||
48067849|NCT03789396|100485664|FG000|NOT COMPLETED|Overall Study||0||
48067850|NCT03789396|100485665|FG001|NOT COMPLETED|Overall Study||0||
48067851|NCT01811680|100485666|FG000|STARTED|Overall Study||10||
48067852|NCT01811680|100485666|FG000|COMPLETED|Overall Study||10||
48067853|NCT01811680|100485666|FG000|NOT COMPLETED|Overall Study||0||
48067854|NCT02601027|100485667|FG000|STARTED|Registration to Surgery||64||
48067855|NCT02601027|100485668|FG001|STARTED|Registration to Surgery||56||
48067856|NCT02601027|100485667|FG000|COMPLETED|Registration to Surgery||44||
48067857|NCT02601027|100485668|FG001|COMPLETED|Registration to Surgery||46||
48067858|NCT02601027|100485667|FG000|NOT COMPLETED|Registration to Surgery||20||
48067859|NCT02601027|100485668|FG001|NOT COMPLETED|Registration to Surgery||10||
48067860|NCT02601027|100485667|FG000|STARTED|Surgery to Assessments||44||
48067861|NCT02601027|100485668|FG001|STARTED|Surgery to Assessments||46||
48067862|NCT02601027|100485667|FG000|COMPLETED|Surgery to Assessments||44||
48067863|NCT02601027|100485668|FG001|COMPLETED|Surgery to Assessments||46||
48067864|NCT02601027|100485667|FG000|NOT COMPLETED|Surgery to Assessments||0||
48067865|NCT02601027|100485668|FG001|NOT COMPLETED|Surgery to Assessments||0||
48067866|NCT03022435|100485669|FG000|STARTED|Overall Study||5||
48067867|NCT03022435|100485670|FG001|STARTED|Overall Study||5||
48067868|NCT03022435|100485671|FG002|STARTED|Overall Study||6||
48067869|NCT03022435|100485672|FG003|STARTED|Overall Study||3||
48067870|NCT03022435|100485673|FG004|STARTED|Overall Study||3||
48067871|NCT03022435|100485669|FG000|COMPLETED|Overall Study||5||
48067872|NCT03022435|100485670|FG001|COMPLETED|Overall Study||5||
48067873|NCT03022435|100485671|FG002|COMPLETED|Overall Study||6||
48067874|NCT03022435|100485672|FG003|COMPLETED|Overall Study||3||
48067875|NCT03022435|100485673|FG004|COMPLETED|Overall Study||3||
48067876|NCT03022435|100485669|FG000|NOT COMPLETED|Overall Study||0||
48067877|NCT03022435|100485670|FG001|NOT COMPLETED|Overall Study||0||
48067878|NCT03022435|100485671|FG002|NOT COMPLETED|Overall Study||0||
48067879|NCT03022435|100485672|FG003|NOT COMPLETED|Overall Study||0||
48515509|NCT02994394|101593551|FG005|STARTED|Period 1 (Days 1 to 3)||14||
48515510|NCT02994394|101593546|FG000|COMPLETED|Period 1 (Days 1 to 3)||14||
48515511|NCT02994394|101593547|FG001|COMPLETED|Period 1 (Days 1 to 3)||14||
48515512|NCT02994394|101593548|FG002|COMPLETED|Period 1 (Days 1 to 3)||13||
48515513|NCT02994394|101593549|FG003|COMPLETED|Period 1 (Days 1 to 3)||14||
48515514|NCT02994394|101593550|FG004|COMPLETED|Period 1 (Days 1 to 3)||14||
48515515|NCT02994394|101593551|FG005|COMPLETED|Period 1 (Days 1 to 3)||14||
48515516|NCT02994394|101593546|FG000|NOT COMPLETED|Period 1 (Days 1 to 3)||0||
48515517|NCT02994394|101593547|FG001|NOT COMPLETED|Period 1 (Days 1 to 3)||0||
48067880|NCT03022435|100485673|FG004|NOT COMPLETED|Overall Study||0||
48067881|NCT00752102|100485674|FG000|STARTED|Overall Study||22||
48067882|NCT00752102|100485675|FG001|STARTED|Overall Study||22||
48067883|NCT00752102|100485674|FG000|COMPLETED|Overall Study||19||
48515518|NCT02994394|101593548|FG002|NOT COMPLETED|Period 1 (Days 1 to 3)||1||
48515519|NCT02994394|101593549|FG003|NOT COMPLETED|Period 1 (Days 1 to 3)||0||
48067884|NCT00752102|100485675|FG001|COMPLETED|Overall Study||21||
48515520|NCT02994394|101593550|FG004|NOT COMPLETED|Period 1 (Days 1 to 3)||0||
48515521|NCT02994394|101593551|FG005|NOT COMPLETED|Period 1 (Days 1 to 3)||0||
48515522|NCT02994394|101593546|FG000|STARTED|Period 2 (Days 4 to 6)||14||
48515523|NCT02994394|101593547|FG001|STARTED|Period 2 (Days 4 to 6)||14||
48515524|NCT02994394|101593548|FG002|STARTED|Period 2 (Days 4 to 6)||13||
48515525|NCT02994394|101593549|FG003|STARTED|Period 2 (Days 4 to 6)||14||
48515526|NCT02994394|101593550|FG004|STARTED|Period 2 (Days 4 to 6)||14||
48515527|NCT02994394|101593551|FG005|STARTED|Period 2 (Days 4 to 6)||14||
48515528|NCT02994394|101593546|FG000|COMPLETED|Period 2 (Days 4 to 6)||14||
48515529|NCT02994394|101593547|FG001|COMPLETED|Period 2 (Days 4 to 6)||13||
48515530|NCT02994394|101593548|FG002|COMPLETED|Period 2 (Days 4 to 6)||13||
48515531|NCT02994394|101593549|FG003|COMPLETED|Period 2 (Days 4 to 6)||14||
48515532|NCT02994394|101593550|FG004|COMPLETED|Period 2 (Days 4 to 6)||13||
48515533|NCT02994394|101593551|FG005|COMPLETED|Period 2 (Days 4 to 6)||14||
48515534|NCT02994394|101593546|FG000|NOT COMPLETED|Period 2 (Days 4 to 6)||0||
48515535|NCT02994394|101593547|FG001|NOT COMPLETED|Period 2 (Days 4 to 6)||1||
48515536|NCT02994394|101593548|FG002|NOT COMPLETED|Period 2 (Days 4 to 6)||0||
48515537|NCT02994394|101593549|FG003|NOT COMPLETED|Period 2 (Days 4 to 6)||0||
48515538|NCT02994394|101593550|FG004|NOT COMPLETED|Period 2 (Days 4 to 6)||1||
48515539|NCT02994394|101593551|FG005|NOT COMPLETED|Period 2 (Days 4 to 6)||0||
48515540|NCT02994394|101593546|FG000|STARTED|Period 3 (Days 7 and 8)||14||
48515541|NCT02994394|101593547|FG001|STARTED|Period 3 (Days 7 and 8)||13||
48515542|NCT02994394|101593548|FG002|STARTED|Period 3 (Days 7 and 8)||13||
48515543|NCT02994394|101593549|FG003|STARTED|Period 3 (Days 7 and 8)||14||
48515544|NCT02994394|101593550|FG004|STARTED|Period 3 (Days 7 and 8)||13||
48515545|NCT02994394|101593551|FG005|STARTED|Period 3 (Days 7 and 8)||14||
48515546|NCT02994394|101593546|FG000|COMPLETED|Period 3 (Days 7 and 8)||14||
48515547|NCT02994394|101593547|FG001|COMPLETED|Period 3 (Days 7 and 8)||13||
48515548|NCT02994394|101593548|FG002|COMPLETED|Period 3 (Days 7 and 8)||13||
48515549|NCT02994394|101593549|FG003|COMPLETED|Period 3 (Days 7 and 8)||14||
48515550|NCT02994394|101593550|FG004|COMPLETED|Period 3 (Days 7 and 8)||13||
48515551|NCT02994394|101593551|FG005|COMPLETED|Period 3 (Days 7 and 8)||14||
48515552|NCT02994394|101593546|FG000|NOT COMPLETED|Period 3 (Days 7 and 8)||0||
48515553|NCT02994394|101593547|FG001|NOT COMPLETED|Period 3 (Days 7 and 8)||0||
48515554|NCT02994394|101593548|FG002|NOT COMPLETED|Period 3 (Days 7 and 8)||0||
48515555|NCT02994394|101593549|FG003|NOT COMPLETED|Period 3 (Days 7 and 8)||0||
48515556|NCT02994394|101593550|FG004|NOT COMPLETED|Period 3 (Days 7 and 8)||0||
48515557|NCT02994394|101593551|FG005|NOT COMPLETED|Period 3 (Days 7 and 8)||0||
48515558|NCT02744755|101593552|FG000|STARTED|Study Period 1||177|randomized|
48515559|NCT02744755|101593553|FG001|STARTED|Study Period 1||176|randomized|
48515560|NCT02744755|101593552|FG000|COMPLETED|Study Period 1||163|completed study period 1|
48515561|NCT02744755|101593553|FG001|COMPLETED|Study Period 1||168|completed study period 1|
48515562|NCT02744755|101593552|FG000|NOT COMPLETED|Study Period 1||14||
48515563|NCT02744755|101593553|FG001|NOT COMPLETED|Study Period 1||8||
48515564|NCT02744755|101593552|FG000|STARTED|Study Period 2||159||
48515565|NCT02744755|101593553|FG001|STARTED|Study Period 2||166||
48515566|NCT02744755|101593552|FG000|COMPLETED|Study Period 2||145||
48515567|NCT02744755|101593553|FG001|COMPLETED|Study Period 2||158||
48515568|NCT02744755|101593552|FG000|NOT COMPLETED|Study Period 2||14||
48515569|NCT02744755|101593553|FG001|NOT COMPLETED|Study Period 2||8||
48515570|NCT04744155|101593554|FG000|STARTED|Overall Study||25||
48515571|NCT04744155|101593555|FG001|STARTED|Overall Study||12||
48515572|NCT04744155|101593554|FG000|COMPLETED|Overall Study||25||
48515573|NCT04744155|101593555|FG001|COMPLETED|Overall Study||10||
48515574|NCT04744155|101593554|FG000|NOT COMPLETED|Overall Study||0||
48515575|NCT04744155|101593555|FG001|NOT COMPLETED|Overall Study||2||
48515576|NCT02010255|101593556|FG000|STARTED|Overall Study||28||
48515577|NCT02010255|101593557|FG001|STARTED|Overall Study||28||
48515578|NCT02010255|101593558|FG002|STARTED|Overall Study||25||
48515579|NCT02010255|101593559|FG003|STARTED|Overall Study||26||
48515580|NCT02010255|101593560|FG004|STARTED|Overall Study||52||
48515581|NCT02010255|101593561|FG005|STARTED|Overall Study||49||
48515582|NCT02010255|101593562|FG006|STARTED|Overall Study||34||
48515583|NCT02010255|101593563|FG007|STARTED|Overall Study||33||
48515584|NCT02010255|101593564|FG008|STARTED|Overall Study||22||
48515585|NCT02010255|101593565|FG009|STARTED|Overall Study||23||
48515586|NCT02010255|101593566|FG010|STARTED|Overall Study||3||
48515587|NCT02010255|101593567|FG011|STARTED|Overall Study||5||
48515588|NCT02010255|101593568|FG012|STARTED|Overall Study||3||
48515589|NCT02010255|101593569|FG013|STARTED|Overall Study||3||
48515590|NCT02010255|101593556|FG000|COMPLETED|Overall Study||22||
48515591|NCT02010255|101593557|FG001|COMPLETED|Overall Study||26||
48067885|NCT00752102|100485674|FG000|NOT COMPLETED|Overall Study||3||
48515592|NCT02010255|101593558|FG002|COMPLETED|Overall Study||18||
48515593|NCT02010255|101593559|FG003|COMPLETED|Overall Study||20||
48515594|NCT02010255|101593560|FG004|COMPLETED|Overall Study||48||
48515595|NCT02010255|101593561|FG005|COMPLETED|Overall Study||49||
48515596|NCT02010255|101593562|FG006|COMPLETED|Overall Study||33||
48515597|NCT02010255|101593563|FG007|COMPLETED|Overall Study||32||
48515598|NCT02010255|101593564|FG008|COMPLETED|Overall Study||21||
48515599|NCT02010255|101593565|FG009|COMPLETED|Overall Study||23||
48515600|NCT02010255|101593566|FG010|COMPLETED|Overall Study||1||
48515601|NCT02010255|101593567|FG011|COMPLETED|Overall Study||4||
48515602|NCT02010255|101593568|FG012|COMPLETED|Overall Study||3||
48515603|NCT02010255|101593569|FG013|COMPLETED|Overall Study||2||
48515604|NCT02010255|101593556|FG000|NOT COMPLETED|Overall Study||6||
48515605|NCT02010255|101593557|FG001|NOT COMPLETED|Overall Study||2||
48515606|NCT02010255|101593558|FG002|NOT COMPLETED|Overall Study||7||
48515607|NCT02010255|101593559|FG003|NOT COMPLETED|Overall Study||6||
48515608|NCT02010255|101593560|FG004|NOT COMPLETED|Overall Study||4||
48515609|NCT02010255|101593561|FG005|NOT COMPLETED|Overall Study||0||
48515610|NCT02010255|101593562|FG006|NOT COMPLETED|Overall Study||1||
48515611|NCT02010255|101593563|FG007|NOT COMPLETED|Overall Study||1||
48515612|NCT02010255|101593564|FG008|NOT COMPLETED|Overall Study||1||
48515613|NCT02010255|101593565|FG009|NOT COMPLETED|Overall Study||0||
48515614|NCT02010255|101593566|FG010|NOT COMPLETED|Overall Study||2||
48515615|NCT02010255|101593567|FG011|NOT COMPLETED|Overall Study||1||
48515616|NCT02010255|101593568|FG012|NOT COMPLETED|Overall Study||0||
48515617|NCT02010255|101593569|FG013|NOT COMPLETED|Overall Study||1||
48515618|NCT00763555|101593570|FG000|STARTED|Overall Study||44||
48515619|NCT00763555|101593571|FG001|STARTED|Overall Study||44||
48515620|NCT00763555|101593570|FG000|COMPLETED|Overall Study||40||
48515621|NCT00763555|101593571|FG001|COMPLETED|Overall Study||34||
48515622|NCT00763555|101593570|FG000|NOT COMPLETED|Overall Study||4||
48515623|NCT00763555|101593571|FG001|NOT COMPLETED|Overall Study||10||
48515624|NCT05022563|101593572|FG000|STARTED|Overall Study||11208||
48515625|NCT05022563|101593573|FG001|STARTED|Overall Study||5047||
48515626|NCT05022563|101593574|FG002|STARTED|Overall Study||2103||
48515627|NCT05022563|101593575|FG003|STARTED|Overall Study||2342||
48515628|NCT05022563|101593576|FG004|STARTED|Overall Study||26276||
48515629|NCT05022563|101593577|FG005|STARTED|Overall Study||8783||
48515630|NCT05022563|101593572|FG000|Without Active Cancer|Overall Study||10390||
48515631|NCT05022563|101593573|FG001|Without Active Cancer|Overall Study||4543||
48515632|NCT05022563|101593574|FG002|Without Active Cancer|Overall Study||1894||
48515633|NCT05022563|101593575|FG003|Without Active Cancer|Overall Study||2078||
48515634|NCT05022563|101593576|FG004|Without Active Cancer|Overall Study||23049||
48515635|NCT05022563|101593577|FG005|Without Active Cancer|Overall Study||6550||
48515636|NCT05022563|101593572|FG000|With Active Cancer (Diagnosis of Cancer Within Past 6 Months of Index Date)|Overall Study||818||
48515637|NCT05022563|101593573|FG001|With Active Cancer (Diagnosis of Cancer Within Past 6 Months of Index Date)|Overall Study||504||
48515638|NCT05022563|101593574|FG002|With Active Cancer (Diagnosis of Cancer Within Past 6 Months of Index Date)|Overall Study||209||
48515639|NCT05022563|101593575|FG003|With Active Cancer (Diagnosis of Cancer Within Past 6 Months of Index Date)|Overall Study||264||
48515640|NCT05022563|101593576|FG004|With Active Cancer (Diagnosis of Cancer Within Past 6 Months of Index Date)|Overall Study||3227||
48515641|NCT05022563|101593577|FG005|With Active Cancer (Diagnosis of Cancer Within Past 6 Months of Index Date)|Overall Study||2233||
48515642|NCT05022563|101593572|FG000|COMPLETED|Overall Study||11208||
48515643|NCT05022563|101593573|FG001|COMPLETED|Overall Study||5047||
48515644|NCT05022563|101593574|FG002|COMPLETED|Overall Study||2103||
48515645|NCT05022563|101593575|FG003|COMPLETED|Overall Study||2342||
48515646|NCT05022563|101593576|FG004|COMPLETED|Overall Study||26276||
48515647|NCT05022563|101593577|FG005|COMPLETED|Overall Study||8783||
48515648|NCT05022563|101593572|FG000|NOT COMPLETED|Overall Study||0||
48515649|NCT05022563|101593573|FG001|NOT COMPLETED|Overall Study||0||
48515650|NCT05022563|101593574|FG002|NOT COMPLETED|Overall Study||0||
48515651|NCT05022563|101593575|FG003|NOT COMPLETED|Overall Study||0||
48515652|NCT05022563|101593576|FG004|NOT COMPLETED|Overall Study||0||
48515653|NCT05022563|101593577|FG005|NOT COMPLETED|Overall Study||0||
48515654|NCT01992016|101593578|FG000|STARTED|Overall Study||4||
48515655|NCT01992016|101593579|FG001|STARTED|Overall Study||7||
48515656|NCT01992016|101593578|FG000|COMPLETED|Overall Study||4||
48515657|NCT01992016|101593579|FG001|COMPLETED|Overall Study||7||
48515658|NCT01992016|101593578|FG000|NOT COMPLETED|Overall Study||0||
48515659|NCT01992016|101593579|FG001|NOT COMPLETED|Overall Study||0||
48515660|NCT00737737|101593580|FG000|STARTED|Overall Study||2||
48515661|NCT00737737|101593581|FG001|STARTED|Overall Study||2||
48515662|NCT00737737|101593580|FG000|COMPLETED|Overall Study||2||
48515663|NCT00737737|101593581|FG001|COMPLETED|Overall Study||2||
48515664|NCT00737737|101593580|FG000|NOT COMPLETED|Overall Study||0||
48515665|NCT00737737|101593581|FG001|NOT COMPLETED|Overall Study||0||
48515666|NCT02593396|101593582|FG000|STARTED|Overall Study||40||
48515667|NCT02593396|101593583|FG001|STARTED|Overall Study||40||
48515668|NCT02593396|101593582|FG000|At Least Done One Efficacy Assessment|Overall Study||36|At least one efficacy assessment after the baseline visit.|
48515669|NCT02593396|101593583|FG001|At Least Done One Efficacy Assessment|Overall Study||36|At least one efficacy assessment after the baseline visit.|
48515670|NCT02593396|101593582|FG000|COMPLETED|Overall Study||25||
48515671|NCT02593396|101593583|FG001|COMPLETED|Overall Study||26||
48515672|NCT02593396|101593582|FG000|NOT COMPLETED|Overall Study||15||
48515673|NCT02593396|101593583|FG001|NOT COMPLETED|Overall Study||14||
48515674|NCT00493779|101593584|FG000|STARTED|Overall Study||98||
48515675|NCT00493779|101593584|FG000|COMPLETED|Overall Study||97||
48515676|NCT00493779|101593584|FG000|NOT COMPLETED|Overall Study||1||
48515677|NCT01315028|101593585|FG000|STARTED|Overall Study||10||
48515678|NCT01315028|101593586|FG001|STARTED|Overall Study||10||
48515679|NCT01315028|101593585|FG000|COMPLETED|Overall Study||9||
48515680|NCT01315028|101593586|FG001|COMPLETED|Overall Study||9||
48515681|NCT01315028|101593585|FG000|NOT COMPLETED|Overall Study||1||
48515682|NCT01315028|101593586|FG001|NOT COMPLETED|Overall Study||1||
48515683|NCT02418455|101593587|FG000|STARTED|48-Week Treatment Period||8||
48515684|NCT02418455|101593587|FG000|Emergency IND (eIND)|48-Week Treatment Period||1|Previously treated with UX003 under eIND application; did not complete the 48-Week Treatment Period.|
48515685|NCT02418455|101593587|FG000|COMPLETED|48-Week Treatment Period||7||
48515686|NCT02418455|101593587|FG000|NOT COMPLETED|48-Week Treatment Period||1||
48515687|NCT02418455|101593587|FG000|STARTED|Continuation Period||7||
48515688|NCT02418455|101593587|FG000|COMPLETED|Continuation Period||0||
48515689|NCT02418455|101593587|FG000|NOT COMPLETED|Continuation Period||7||
48515690|NCT02927834|101593588|FG000|STARTED|Overall Study||8||
48515691|NCT02927834|101593589|FG001|STARTED|Overall Study||8||
48515692|NCT02927834|101593590|FG002|STARTED|Overall Study||8||
48515693|NCT02927834|101593588|FG000|COMPLETED|Overall Study||7||
48515694|NCT02927834|101593589|FG001|COMPLETED|Overall Study||6||
48515695|NCT02927834|101593590|FG002|COMPLETED|Overall Study||6||
48515696|NCT02927834|101593588|FG000|NOT COMPLETED|Overall Study||1||
48515697|NCT02927834|101593589|FG001|NOT COMPLETED|Overall Study||2||
48515698|NCT02927834|101593590|FG002|NOT COMPLETED|Overall Study||2||
48515699|NCT04489303|101593591|FG000|STARTED|Overall Study||78||
48515700|NCT04489303|101593592|FG001|STARTED|Overall Study||78||
48515701|NCT04489303|101593591|FG000|COMPLETED|Overall Study||60||
48515702|NCT04489303|101593592|FG001|COMPLETED|Overall Study||55||
48515703|NCT04489303|101593591|FG000|NOT COMPLETED|Overall Study||18||
48515704|NCT04489303|101593592|FG001|NOT COMPLETED|Overall Study||23||
48515705|NCT05528861|101593593|FG000|STARTED|Main Study||66||
48515706|NCT05528861|101593594|FG001|STARTED|Main Study||61||
48515707|NCT05528861|101593593|FG000|COMPLETED|Main Study||60||
48515708|NCT05528861|101593594|FG001|COMPLETED|Main Study||57||
48515709|NCT05528861|101593593|FG000|NOT COMPLETED|Main Study||6||
48515710|NCT05528861|101593594|FG001|NOT COMPLETED|Main Study||4||
48515711|NCT05528861|101593593|FG000|STARTED|Open-Label Extension||60||
48515712|NCT05528861|101593594|FG001|STARTED|Open-Label Extension||57||
48515713|NCT05528861|101593593|FG000|COMPLETED|Open-Label Extension||27||
48515714|NCT05528861|101593594|FG001|COMPLETED|Open-Label Extension||30||
48515715|NCT05528861|101593593|FG000|NOT COMPLETED|Open-Label Extension||33||
48515716|NCT05528861|101593594|FG001|NOT COMPLETED|Open-Label Extension||27||
48515717|NCT03891329|101593595|FG000|STARTED|Overall Study||130||
48515718|NCT03891329|101593595|FG000|Patients With Implantation Attempt|Overall Study||128||
48515719|NCT03891329|101593595|FG000|Patients Implanted|Overall Study||127||
48515720|NCT03891329|101593595|FG000|COMPLETED|Overall Study||111||
48515721|NCT03891329|101593595|FG000|NOT COMPLETED|Overall Study||19||
48515722|NCT03136406|101593596|FG000|STARTED|Overall Study||3||
48515723|NCT03136406|101593596|FG000|COMPLETED|Overall Study||0||
48515724|NCT03136406|101593596|FG000|NOT COMPLETED|Overall Study||3||
48515725|NCT00823199|101593597|FG000|STARTED|Overall Study||10||
48515726|NCT00823199|101593597|FG000|COMPLETED|Overall Study||8||
48515727|NCT00823199|101593597|FG000|NOT COMPLETED|Overall Study||2||
48515728|NCT02792218|101593598|FG000|STARTED|Overall Study||465||
48515729|NCT02792218|101593599|FG001|STARTED|Overall Study||462||
48515730|NCT02792218|101593598|FG000|COMPLETED|Overall Study||416||
48515731|NCT02792218|101593599|FG001|COMPLETED|Overall Study||381||
48515732|NCT02792218|101593598|FG000|NOT COMPLETED|Overall Study||49||
48515733|NCT02792218|101593599|FG001|NOT COMPLETED|Overall Study||81||
48515734|NCT00612677|101593600|FG000|STARTED|Overall Study||1||
48515735|NCT00612677|101593600|FG000|COMPLETED|Overall Study||0||
48515736|NCT00612677|101593600|FG000|NOT COMPLETED|Overall Study||1||
48515737|NCT03176784|101593601|FG000|STARTED|Overall Study||314||
48515738|NCT03176784|101593602|FG001|STARTED|Overall Study||315||
48515739|NCT03176784|101593603|FG002|STARTED|Overall Study||311||
48515740|NCT03176784|101593604|FG003|STARTED|Overall Study||311||
48515741|NCT03176784|101593601|FG000|COMPLETED|Overall Study||209||
48515742|NCT03176784|101593602|FG001|COMPLETED|Overall Study||202||
48515743|NCT03176784|101593603|FG002|COMPLETED|Overall Study||198||
48515744|NCT03176784|101593604|FG003|COMPLETED|Overall Study||241||
48515745|NCT03176784|101593601|FG000|NOT COMPLETED|Overall Study||105||
48515746|NCT03176784|101593602|FG001|NOT COMPLETED|Overall Study||113||
48515747|NCT03176784|101593603|FG002|NOT COMPLETED|Overall Study||113||
48515748|NCT03176784|101593604|FG003|NOT COMPLETED|Overall Study||70||
48515749|NCT05633082|101593605|FG000|STARTED|Period 1: Lens 1, 15 Minutes||40||
48515750|NCT05633082|101593606|FG001|STARTED|Period 1: Lens 1, 15 Minutes||0||
48515751|NCT05633082|101593605|FG000|COMPLETED|Period 1: Lens 1, 15 Minutes||40||
48515752|NCT05633082|101593606|FG001|COMPLETED|Period 1: Lens 1, 15 Minutes||0||
48515753|NCT05633082|101593605|FG000|NOT COMPLETED|Period 1: Lens 1, 15 Minutes||0||
48515754|NCT05633082|101593606|FG001|NOT COMPLETED|Period 1: Lens 1, 15 Minutes||0||
48515755|NCT05633082|101593605|FG000|STARTED|Period 2: Lens 2, 15 Minutes||0||
48515756|NCT05633082|101593606|FG001|STARTED|Period 2: Lens 2, 15 Minutes||40||
48515757|NCT05633082|101593605|FG000|COMPLETED|Period 2: Lens 2, 15 Minutes||0||
48515758|NCT05633082|101593606|FG001|COMPLETED|Period 2: Lens 2, 15 Minutes||40||
48515759|NCT05633082|101593605|FG000|NOT COMPLETED|Period 2: Lens 2, 15 Minutes||0||
48515760|NCT05633082|101593606|FG001|NOT COMPLETED|Period 2: Lens 2, 15 Minutes||0||
48515761|NCT00941720|101593607|FG000|STARTED|Overall Study||71||
48515762|NCT00941720|101593607|FG000|COMPLETED|Overall Study||57||
48515763|NCT00941720|101593607|FG000|NOT COMPLETED|Overall Study||14||
48515764|NCT01610063|101593608|FG000|STARTED|Overall Study||114||
48515765|NCT01610063|101593609|FG001|STARTED|Overall Study||113||
48515766|NCT01610063|101593608|FG000|Baseline|Overall Study||114||
48515767|NCT01610063|101593609|FG001|Baseline|Overall Study||113||
48515768|NCT01610063|101593608|FG000|Completed 2-week|Overall Study||97||
48515769|NCT01610063|101593609|FG001|Completed 2-week|Overall Study||105||
48515770|NCT01610063|101593608|FG000|Completed 4-week|Overall Study||86||
48515771|NCT01610063|101593609|FG001|Completed 4-week|Overall Study||98||
48515772|NCT01610063|101593608|FG000|Completed 8-week|Overall Study||72||
48515773|NCT01610063|101593609|FG001|Completed 8-week|Overall Study||93||
48515774|NCT01610063|101593608|FG000|COMPLETED|Overall Study||72||
48515775|NCT01610063|101593609|FG001|COMPLETED|Overall Study||93||
48515776|NCT01610063|101593608|FG000|NOT COMPLETED|Overall Study||42||
48515777|NCT01610063|101593609|FG001|NOT COMPLETED|Overall Study||20||
48515778|NCT01841073|101593610|FG000|STARTED|Overall Study||22||
48515779|NCT01841073|101593611|FG001|STARTED|Overall Study||22||
48515780|NCT01841073|101593610|FG000|COMPLETED|Overall Study||20||
48515781|NCT01841073|101593611|FG001|COMPLETED|Overall Study||19||
48515782|NCT01841073|101593610|FG000|NOT COMPLETED|Overall Study||2||
48515783|NCT01841073|101593611|FG001|NOT COMPLETED|Overall Study||3||
48515784|NCT02751827|101593612|FG000|STARTED|Overall Study||41||
48515785|NCT02751827|101593613|FG001|STARTED|Overall Study||171||
48515786|NCT02751827|101593614|FG002|STARTED|Overall Study||100||
48515787|NCT02751827|101593612|FG000|COMPLETED|Overall Study||41|Eligible and assessable population : All eligible patients who have received at least one TKI administration were included in analysis.|
48515788|NCT02751827|101593613|FG001|COMPLETED|Overall Study||171|Eligible and assessable population : All eligible patients who have received at least one TKI administration were included in analysis.|
48515789|NCT02751827|101593614|FG002|COMPLETED|Overall Study||99|Eligible and assessable population : All eligible patients who have received at least one TKI administration were included in analysis.|
48515790|NCT02751827|101593612|FG000|NOT COMPLETED|Overall Study||0||
48515791|NCT02751827|101593613|FG001|NOT COMPLETED|Overall Study||0||
48515792|NCT02751827|101593614|FG002|NOT COMPLETED|Overall Study||1||
48515793|NCT01959490|101593615|FG000|STARTED|Overall Study||5||
48515794|NCT01959490|101593616|FG001|STARTED|Overall Study||6||
48515795|NCT01959490|101593617|FG002|STARTED|Overall Study||5||
48515796|NCT01959490|101593615|FG000|COMPLETED|Overall Study||5||
48515797|NCT01959490|101593616|FG001|COMPLETED|Overall Study||6||
48515798|NCT01959490|101593617|FG002|COMPLETED|Overall Study||5||
48515799|NCT01959490|101593615|FG000|NOT COMPLETED|Overall Study||0||
48515800|NCT01959490|101593616|FG001|NOT COMPLETED|Overall Study||0||
48515801|NCT01959490|101593617|FG002|NOT COMPLETED|Overall Study||0||
48515802|NCT04625062|101593618|FG000|STARTED|Overall Study||7||10
48515803|NCT04625062|101593619|FG001|STARTED|Overall Study||7||10
48515804|NCT04625062|101593618|FG000|COMPLETED|Overall Study||7||10
48515805|NCT04625062|101593619|FG001|COMPLETED|Overall Study||7||10
48515806|NCT04625062|101593618|FG000|NOT COMPLETED|Overall Study||0||0
48515807|NCT04625062|101593619|FG001|NOT COMPLETED|Overall Study||0||0
48515808|NCT00546910|101593620|FG000|STARTED|Overall Study||63||
48515809|NCT00546910|101593621|FG001|STARTED|Overall Study||62||
48515810|NCT00546910|101593620|FG000|COMPLETED|Overall Study||54||
48515811|NCT00546910|101593621|FG001|COMPLETED|Overall Study||51||
48515812|NCT00546910|101593620|FG000|NOT COMPLETED|Overall Study||9||
48515813|NCT00546910|101593621|FG001|NOT COMPLETED|Overall Study||11||
48515814|NCT02070757|101593622|FG000|STARTED|Overall Study||362||
48515815|NCT02070757|101593623|FG001|STARTED|Overall Study||364||
48515816|NCT02070757|101593622|FG000|Treated Participants|Overall Study||361||
48515817|NCT02070757|101593623|FG001|Treated Participants|Overall Study||359||
48515818|NCT02070757|101593622|FG000|COMPLETED|Overall Study||245||
48515819|NCT02070757|101593623|FG001|COMPLETED|Overall Study||250||
48515820|NCT02070757|101593622|FG000|NOT COMPLETED|Overall Study||117||
48515821|NCT02070757|101593623|FG001|NOT COMPLETED|Overall Study||114||
48515822|NCT00858013|101593624|FG000|STARTED|Overall Study||46||
48515823|NCT00858013|101593625|FG001|STARTED|Overall Study||42||
48515824|NCT00858013|101593624|FG000|COMPLETED|Overall Study||24||
48515825|NCT00858013|101593625|FG001|COMPLETED|Overall Study||23||
48515826|NCT00858013|101593624|FG000|NOT COMPLETED|Overall Study||22||
48515827|NCT00858013|101593625|FG001|NOT COMPLETED|Overall Study||19||
48515828|NCT03244475|101593626|FG000|STARTED|Overall Study||30||
48515829|NCT03244475|101593627|FG001|STARTED|Overall Study||17||
48515830|NCT03244475|101593628|FG002|STARTED|Overall Study||19||
48515831|NCT03244475|101593626|FG000|COMPLETED|Overall Study||18||
48515832|NCT03244475|101593627|FG001|COMPLETED|Overall Study||4||
48515833|NCT03244475|101593628|FG002|COMPLETED|Overall Study||19||
48515834|NCT03244475|101593626|FG000|NOT COMPLETED|Overall Study||12||
48515835|NCT03244475|101593627|FG001|NOT COMPLETED|Overall Study||13||
48515836|NCT03244475|101593628|FG002|NOT COMPLETED|Overall Study||0||
48515837|NCT01647958|101593629|FG000|STARTED|Initial Study||41||
48666796|NCT03391882|101970465|FG000|COMPLETED|Part B - Treatment Phase||0|Part B|
48515838|NCT01647958|101593630|FG001|STARTED|Initial Study||24||
48067886|NCT00752102|100485675|FG001|NOT COMPLETED|Overall Study||1||
48067887|NCT01952145|100485676|FG000|STARTED|Overall Study||278||
48067888|NCT01952145|100485677|FG001|STARTED|Overall Study||279||
48067889|NCT01952145|100485676|FG000|COMPLETED|Overall Study||250||
48067890|NCT01952145|100485677|FG001|COMPLETED|Overall Study||265||
48067891|NCT01952145|100485676|FG000|NOT COMPLETED|Overall Study||28||
48067892|NCT01952145|100485677|FG001|NOT COMPLETED|Overall Study||14||
48067893|NCT00968864|100485678|FG000|STARTED|Overall Study||53||
48067894|NCT00968864|100485678|FG000|COMPLETED|Overall Study||52||
48067895|NCT00968864|100485678|FG000|NOT COMPLETED|Overall Study||1||
48067896|NCT03277690|100485679|FG000|STARTED|Dose Titration and Maintenance||79||
48067897|NCT03277690|100485680|FG001|STARTED|Dose Titration and Maintenance||0||
48067898|NCT03277690|100485679|FG000|COMPLETED|Dose Titration and Maintenance||39||
48067899|NCT03277690|100485680|FG001|COMPLETED|Dose Titration and Maintenance||0||
48067900|NCT03277690|100485679|FG000|NOT COMPLETED|Dose Titration and Maintenance||40||
48067901|NCT03277690|100485680|FG001|NOT COMPLETED|Dose Titration and Maintenance||0||
48067902|NCT03277690|100485679|FG000|STARTED|Randomized Withdrawal||22|The number of participants starting this Period is not equal to the number who completed previous Period as 5 additional participants from the parent (SONICS) study directly entered the randomized withdrawal phase.|
48067903|NCT03277690|100485680|FG001|STARTED|Randomized Withdrawal||22|The number of participants starting this Period is not equal to the number who completed previous Period as 5 additional participants from the parent (SONICS) study directly entered the randomized withdrawal phase.|
48067904|NCT03277690|100485679|FG000|Subjects Which Were Previous Levoketoconazole Study Completers|Randomized Withdrawal||1||
48067905|NCT03277690|100485680|FG001|Subjects Which Were Previous Levoketoconazole Study Completers|Randomized Withdrawal||4||
48067906|NCT03277690|100485679|FG000|Subjects That Are Levoketoconazole Treatment naïve Subjects|Randomized Withdrawal||21||
48067907|NCT03277690|100485680|FG001|Subjects That Are Levoketoconazole Treatment naïve Subjects|Randomized Withdrawal||18||
48067908|NCT03277690|100485679|FG000|COMPLETED|Randomized Withdrawal||21||
48067909|NCT03277690|100485680|FG001|COMPLETED|Randomized Withdrawal||22||
48067910|NCT03277690|100485679|FG000|NOT COMPLETED|Randomized Withdrawal||1||
48067911|NCT03277690|100485680|FG001|NOT COMPLETED|Randomized Withdrawal||0||
48067912|NCT03277690|100485679|FG000|STARTED|Restoration||21||
48067913|NCT03277690|100485680|FG001|STARTED|Restoration||22||
48067914|NCT03277690|100485679|FG000|Subjects Which Were Previous Levoketoconazole Study Completers|Restoration||1||
48067915|NCT03277690|100485680|FG001|Subjects Which Were Previous Levoketoconazole Study Completers|Restoration||4||
48067916|NCT03277690|100485679|FG000|Subjects That Are Levoketoconazole Treatment naïve Subjects|Restoration||20||
48067917|NCT03277690|100485680|FG001|Subjects That Are Levoketoconazole Treatment naïve Subjects|Restoration||18||
48067918|NCT03277690|100485679|FG000|COMPLETED|Restoration||21||
48067919|NCT03277690|100485680|FG001|COMPLETED|Restoration||22||
48067920|NCT03277690|100485679|FG000|NOT COMPLETED|Restoration||0||
48067921|NCT03277690|100485680|FG001|NOT COMPLETED|Restoration||0||
48067922|NCT02423993|100485681|FG000|STARTED|Overall Study||19||
48067923|NCT02423993|100485682|FG001|STARTED|Overall Study||16||
48067924|NCT02423993|100485683|FG002|STARTED|Overall Study||23||
48067925|NCT02423993|100485684|FG003|STARTED|Overall Study||19||
48067926|NCT02423993|100485681|FG000|COMPLETED|Overall Study||19||
48067927|NCT02423993|100485682|FG001|COMPLETED|Overall Study||16||
48067928|NCT02423993|100485683|FG002|COMPLETED|Overall Study||23||
48067929|NCT02423993|100485684|FG003|COMPLETED|Overall Study||19||
48067930|NCT02423993|100485681|FG000|NOT COMPLETED|Overall Study||0||
48067931|NCT02423993|100485682|FG001|NOT COMPLETED|Overall Study||0||
48067932|NCT02423993|100485683|FG002|NOT COMPLETED|Overall Study||0||
48067933|NCT02423993|100485684|FG003|NOT COMPLETED|Overall Study||0||
48067934|NCT03028103|100485685|FG000|STARTED|Overall Study||16||
48067935|NCT03028103|100485686|FG001|STARTED|Overall Study||16||
48067936|NCT03028103|100485685|FG000|COMPLETED|Overall Study||16||
48067937|NCT03028103|100485686|FG001|COMPLETED|Overall Study||16||
48067938|NCT03028103|100485685|FG000|NOT COMPLETED|Overall Study||0||
48067939|NCT03028103|100485686|FG001|NOT COMPLETED|Overall Study||0||
48067940|NCT02609828|100485687|FG000|STARTED|Overall Study||74||
48067941|NCT02609828|100485688|FG001|STARTED|Overall Study||9||
48067942|NCT02609828|100485689|FG002|STARTED|Overall Study||1||
48067943|NCT02609828|100485690|FG003|STARTED|Overall Study||72||
48067944|NCT02609828|100485687|FG000|Treated|Overall Study||73||
48067945|NCT02609828|100485688|FG001|Treated|Overall Study||9||
48067946|NCT02609828|100485689|FG002|Treated|Overall Study||1||
48067947|NCT02609828|100485690|FG003|Treated|Overall Study||72||
48067948|NCT02609828|100485687|FG000|COMPLETED|Overall Study||31||
48067949|NCT02609828|100485688|FG001|COMPLETED|Overall Study||5||
48067950|NCT02609828|100485689|FG002|COMPLETED|Overall Study||0||
48067951|NCT02609828|100485690|FG003|COMPLETED|Overall Study||29||
48067952|NCT02609828|100485687|FG000|NOT COMPLETED|Overall Study||43||
48067953|NCT02609828|100485688|FG001|NOT COMPLETED|Overall Study||4||
48067954|NCT02609828|100485689|FG002|NOT COMPLETED|Overall Study||1||
48067955|NCT02609828|100485690|FG003|NOT COMPLETED|Overall Study||43||
48067956|NCT02281773|100485691|FG000|STARTED|Overall Study||87||
48067957|NCT02281773|100485692|FG001|STARTED|Overall Study||85||
48067958|NCT02281773|100485693|FG002|STARTED|Overall Study||85||
48067959|NCT02281773|100485694|FG003|STARTED|Overall Study||86||
48067960|NCT02281773|100485695|FG004|STARTED|Overall Study||173||
48067961|NCT02281773|100485691|FG000|COMPLETED|Overall Study||76||
48067962|NCT02281773|100485692|FG001|COMPLETED|Overall Study||70||
48067963|NCT02281773|100485693|FG002|COMPLETED|Overall Study||67||
48067964|NCT02281773|100485694|FG003|COMPLETED|Overall Study||65||
48067965|NCT02281773|100485695|FG004|COMPLETED|Overall Study||143||
48067966|NCT02281773|100485691|FG000|NOT COMPLETED|Overall Study||11||
48067967|NCT02281773|100485692|FG001|NOT COMPLETED|Overall Study||15||
48067968|NCT02281773|100485693|FG002|NOT COMPLETED|Overall Study||18||
48067969|NCT02281773|100485694|FG003|NOT COMPLETED|Overall Study||21||
48067970|NCT02281773|100485695|FG004|NOT COMPLETED|Overall Study||30||
48067971|NCT02713373|100485696|FG000|STARTED|Overall Study||44||
48067972|NCT02713373|100485696|FG000|COMPLETED|Overall Study||44||
48067973|NCT02713373|100485696|FG000|NOT COMPLETED|Overall Study||0||
48067974|NCT02761733|100489630|FG000|STARTED|Overall Study||60||
48067975|NCT02761733|100489631|FG001|STARTED|Overall Study||60||
48067976|NCT02761733|100489632|FG002|STARTED|Overall Study||60||
48067977|NCT02761733|100489633|FG003|STARTED|Overall Study||60||
48067978|NCT02761733|100489630|FG000|9/30/2014|Overall Study||53|Completion of the 2nd Wave of Data Collection|
48067979|NCT02761733|100489631|FG001|9/30/2014|Overall Study||56|Completion of the 2nd Wave of Data Collection|
48067980|NCT02761733|100489632|FG002|9/30/2014|Overall Study||48|Completion of the 2nd Wave of Data Collection|
48067981|NCT02761733|100489633|FG003|9/30/2014|Overall Study||55|Completion of the 2nd Wave of Data Collection|
48067982|NCT02761733|100489630|FG000|3/31/2015|Overall Study||48|Completion of the 3rd Wave of Data Collection|
48067983|NCT02761733|100489631|FG001|3/31/2015|Overall Study||47|Completion of the 3rd Wave of Data Collection|
48067984|NCT02761733|100489632|FG002|3/31/2015|Overall Study||43|Completion of the 3rd Wave of Data Collection|
48067985|NCT02761733|100489633|FG003|3/31/2015|Overall Study||50|Completion of the 3rd Wave of Data Collection|
48067986|NCT02761733|100489630|FG000|9/30/2015|Overall Study||40|Completion of the 4th Wave of Data Collection|
48067987|NCT02761733|100489631|FG001|9/30/2015|Overall Study||44|Completion of the 4th Wave of Data Collection|
48067988|NCT02761733|100489632|FG002|9/30/2015|Overall Study||33|Completion of the 4th Wave of Data Collection|
48067989|NCT02761733|100489633|FG003|9/30/2015|Overall Study||50|Completion of the 4th Wave of Data Collection|
48067990|NCT02761733|100489630|FG000|COMPLETED|Overall Study||30||
48067991|NCT02761733|100489631|FG001|COMPLETED|Overall Study||39||
48067992|NCT02761733|100489632|FG002|COMPLETED|Overall Study||33||
48067993|NCT02761733|100489633|FG003|COMPLETED|Overall Study||45||
48067994|NCT02761733|100489630|FG000|NOT COMPLETED|Overall Study||30||
48067995|NCT02761733|100489631|FG001|NOT COMPLETED|Overall Study||21||
48067996|NCT02761733|100489632|FG002|NOT COMPLETED|Overall Study||27||
48067997|NCT02761733|100489633|FG003|NOT COMPLETED|Overall Study||15||
48067998|NCT02390908|100489634|FG000|STARTED|Overall Study||40||
48067999|NCT02390908|100489635|FG001|STARTED|Overall Study||22||
48068000|NCT02390908|100489636|FG002|STARTED|Overall Study||22||
48068001|NCT02390908|100489637|FG003|STARTED|Overall Study||90||
48068002|NCT02390908|100489638|FG004|STARTED|Overall Study||120||
48068003|NCT02390908|100489634|FG000|COMPLETED|Overall Study||40||
48068004|NCT02390908|100489635|FG001|COMPLETED|Overall Study||22||
48068005|NCT02390908|100489636|FG002|COMPLETED|Overall Study||22||
48068006|NCT02390908|100489637|FG003|COMPLETED|Overall Study||90||
48068007|NCT02390908|100489638|FG004|COMPLETED|Overall Study||120||
48068008|NCT02390908|100489634|FG000|NOT COMPLETED|Overall Study||0||
48068009|NCT02390908|100489635|FG001|NOT COMPLETED|Overall Study||0||
48068010|NCT02390908|100489636|FG002|NOT COMPLETED|Overall Study||0||
48068011|NCT02390908|100489637|FG003|NOT COMPLETED|Overall Study||0||
48068012|NCT02390908|100489638|FG004|NOT COMPLETED|Overall Study||0||
48068013|NCT03943160|100489639|FG000|STARTED|Overall Study||50||
48068014|NCT03943160|100489639|FG000|COMPLETED|Overall Study||50||
48068015|NCT03943160|100489639|FG000|NOT COMPLETED|Overall Study||0||
48068016|NCT00413400|100489640|FG000|STARTED|Overall Study||24||
48068017|NCT00413400|100489641|FG001|STARTED|Overall Study||16||
48068018|NCT00413400|100489640|FG000|3 Month Visit|Overall Study||22||
48068019|NCT00413400|100489641|FG001|3 Month Visit|Overall Study||12||
48068020|NCT00413400|100489640|FG000|COMPLETED|Overall Study||22||
48068021|NCT00413400|100489641|FG001|COMPLETED|Overall Study||12||
48068022|NCT00413400|100489640|FG000|NOT COMPLETED|Overall Study||2||
48068023|NCT00413400|100489641|FG001|NOT COMPLETED|Overall Study||4||
48068024|NCT03534362|100489642|FG000|STARTED|Overall Study||0||
48068025|NCT03534362|100489643|FG001|STARTED|Overall Study||1||
48068026|NCT03534362|100489642|FG000|COMPLETED|Overall Study||0||
48068027|NCT03534362|100489643|FG001|COMPLETED|Overall Study||1||
48068028|NCT03534362|100489642|FG000|NOT COMPLETED|Overall Study||0||
48515839|NCT01647958|101593629|FG000|COMPLETED|Initial Study||39||
48068029|NCT03534362|100489643|FG001|NOT COMPLETED|Overall Study||0||
48068030|NCT02867150|100489644|FG000|STARTED|Overall Study||58||
48068031|NCT02867150|100489644|FG000|COMPLETED|Overall Study||58||
48068032|NCT02867150|100489644|FG000|NOT COMPLETED|Overall Study||0||
48515840|NCT01647958|101593630|FG001|COMPLETED|Initial Study||21||
48515841|NCT01647958|101593629|FG000|NOT COMPLETED|Initial Study||2||
48515842|NCT01647958|101593630|FG001|NOT COMPLETED|Initial Study||3||
48515843|NCT01647958|101593629|FG000|STARTED|Continuation Phase||39||
48515844|NCT01647958|101593630|FG001|STARTED|Continuation Phase||21||
48666797|NCT03391882|101970466|FG001|COMPLETED|Part B - Treatment Phase||0|Part B|
48068033|NCT02506465|100489645|FG000|STARTED|Overall Study||128||
48068034|NCT02506465|100489646|FG001|STARTED|Overall Study||57||
48068035|NCT02506465|100489645|FG000|COMPLETED|Overall Study||78||
48068036|NCT02506465|100489646|FG001|COMPLETED|Overall Study||57||
48068037|NCT02506465|100489645|FG000|NOT COMPLETED|Overall Study||50||
48068038|NCT02506465|100489646|FG001|NOT COMPLETED|Overall Study||0||
48068039|NCT02058693|100489647|FG000|STARTED|Phase 1||21||
48068040|NCT02058693|100489648|FG001|STARTED|Phase 1||20||
48068041|NCT02058693|100489647|FG000|COMPLETED|Phase 1||16||
48068042|NCT02058693|100489648|FG001|COMPLETED|Phase 1||16||
48068043|NCT02058693|100489647|FG000|NOT COMPLETED|Phase 1||5||
48068044|NCT02058693|100489648|FG001|NOT COMPLETED|Phase 1||4||
48068045|NCT02058693|100489647|FG000|STARTED|Phase 2||16||
48068046|NCT02058693|100489648|FG001|STARTED|Phase 2||16||
48068047|NCT02058693|100489647|FG000|COMPLETED|Phase 2||16||
48068048|NCT02058693|100489648|FG001|COMPLETED|Phase 2||14||
48068049|NCT02058693|100489647|FG000|NOT COMPLETED|Phase 2||0||
48068050|NCT02058693|100489648|FG001|NOT COMPLETED|Phase 2||2||
48068051|NCT02476201|100489649|FG000|STARTED|Overall Study||105||
48068052|NCT02476201|100489649|FG000|Implant Attempts|Overall Study||103||
48068053|NCT02476201|100489649|FG000|Sucessful Implants|Overall Study||102||
48068054|NCT02476201|100489649|FG000|6 Months Visit|Overall Study||82||
48068055|NCT02476201|100489649|FG000|COMPLETED|Overall Study||79||
48068056|NCT02476201|100489649|FG000|NOT COMPLETED|Overall Study||26||
48068057|NCT00370071|100489650|FG000|STARTED|Overall Study||39||
48068058|NCT00370071|100489650|FG000|COMPLETED|Overall Study||37||
48068059|NCT00370071|100489650|FG000|NOT COMPLETED|Overall Study||2||
48068060|NCT02906332|100489651|FG000|STARTED|Overall Study||12||
48068061|NCT02906332|100489651|FG000|COMPLETED|Overall Study||11||
48068062|NCT02906332|100489651|FG000|NOT COMPLETED|Overall Study||1||
48068063|NCT00734474|100489652|FG000|STARTED|Overall Study||15||
48068064|NCT00734474|100489653|FG001|STARTED|Overall Study||30||
48068065|NCT00734474|100489654|FG002|STARTED|Overall Study||304||
48068066|NCT00734474|100489655|FG003|STARTED|Overall Study||10||
48068067|NCT00734474|100489656|FG004|STARTED|Overall Study||302||
48068068|NCT00734474|100489657|FG005|STARTED|Overall Study||25||
48068069|NCT00734474|100489658|FG006|STARTED|Overall Study||24||
48068070|NCT00734474|100489659|FG007|STARTED|Overall Study||315||
48068071|NCT00734474|100489660|FG008|STARTED|Overall Study||177||
48068072|NCT00734474|100489652|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15||
48068073|NCT00734474|100489653|FG001|Received at Least 1 Dose of Study Drug|Overall Study||30||
48068074|NCT00734474|100489654|FG002|Received at Least 1 Dose of Study Drug|Overall Study||304||
48068075|NCT00734474|100489655|FG003|Received at Least 1 Dose of Study Drug|Overall Study||10||
48068076|NCT00734474|100489656|FG004|Received at Least 1 Dose of Study Drug|Overall Study||302||
48068077|NCT00734474|100489657|FG005|Received at Least 1 Dose of Study Drug|Overall Study||25||
48068078|NCT00734474|100489658|FG006|Received at Least 1 Dose of Study Drug|Overall Study||24||
48068079|NCT00734474|100489659|FG007|Received at Least 1 Dose of Study Drug|Overall Study||315||
48068080|NCT00734474|100489660|FG008|Received at Least 1 Dose of Study Drug|Overall Study||177||
48068081|NCT00734474|100489652|FG000|Entered Study Before Dose Decision Point|Overall Study||15||
48068082|NCT00734474|100489653|FG001|Entered Study Before Dose Decision Point|Overall Study||30||
48068083|NCT00734474|100489654|FG002|Entered Study Before Dose Decision Point|Overall Study||25||
48068084|NCT00734474|100489655|FG003|Entered Study Before Dose Decision Point|Overall Study||10||
48068085|NCT00734474|100489656|FG004|Entered Study Before Dose Decision Point|Overall Study||21||
48068086|NCT00734474|100489657|FG005|Entered Study Before Dose Decision Point|Overall Study||25||
48068087|NCT00734474|100489658|FG006|Entered Study Before Dose Decision Point|Overall Study||24||
48068088|NCT00734474|100489659|FG007|Entered Study Before Dose Decision Point|Overall Study||42||
48068089|NCT00734474|100489660|FG008|Entered Study Before Dose Decision Point|Overall Study||38||
48068090|NCT00734474|100489652|FG000|Completed Up to Dose Decision Point|Overall Study||8||
48068091|NCT00734474|100489653|FG001|Completed Up to Dose Decision Point|Overall Study||25||
48068092|NCT00734474|100489654|FG002|Completed Up to Dose Decision Point|Overall Study||24||
48068093|NCT00734474|100489655|FG003|Completed Up to Dose Decision Point|Overall Study||8||
48068094|NCT00734474|100489656|FG004|Completed Up to Dose Decision Point|Overall Study||21||
48068095|NCT00734474|100489657|FG005|Completed Up to Dose Decision Point|Overall Study||21||
48068096|NCT00734474|100489658|FG006|Completed Up to Dose Decision Point|Overall Study||23||
48219945|NCT05580003|100863768|FG020|COMPLETED|Part 3: Period 3 (Day 1)||0||
48068097|NCT00734474|100489659|FG007|Completed Up to Dose Decision Point|Overall Study||42||
48068098|NCT00734474|100489660|FG008|Completed Up to Dose Decision Point|Overall Study||34||
48068099|NCT00734474|100489652|FG000|Entered Study After Dose Decision Point|Overall Study||0||
48068100|NCT00734474|100489653|FG001|Entered Study After Dose Decision Point|Overall Study||0||
48219946|NCT05580003|100863769|FG021|COMPLETED|Part 3: Period 3 (Day 1)||0||
48068101|NCT00734474|100489654|FG002|Entered Study After Dose Decision Point|Overall Study||279||
48068102|NCT00734474|100489655|FG003|Entered Study After Dose Decision Point|Overall Study||0||
48068103|NCT00734474|100489656|FG004|Entered Study After Dose Decision Point|Overall Study||281||
48068104|NCT00734474|100489657|FG005|Entered Study After Dose Decision Point|Overall Study||0||
48068105|NCT00734474|100489658|FG006|Entered Study After Dose Decision Point|Overall Study||0||
48068106|NCT00734474|100489659|FG007|Entered Study After Dose Decision Point|Overall Study||273||
48515845|NCT01647958|101593629|FG000|COMPLETED|Continuation Phase||0||
48515846|NCT01647958|101593630|FG001|COMPLETED|Continuation Phase||21||
48515847|NCT01647958|101593629|FG000|NOT COMPLETED|Continuation Phase||39||
48515848|NCT01647958|101593630|FG001|NOT COMPLETED|Continuation Phase||0||
48515849|NCT01647958|101593629|FG000|STARTED|Extended Follow-up Phase||60||
48515850|NCT01647958|101593630|FG001|STARTED|Extended Follow-up Phase||0||
48515851|NCT01647958|101593629|FG000|COMPLETED|Extended Follow-up Phase||52||
48515852|NCT01647958|101593630|FG001|COMPLETED|Extended Follow-up Phase||0||
48515853|NCT01647958|101593629|FG000|NOT COMPLETED|Extended Follow-up Phase||8||
48515854|NCT01647958|101593630|FG001|NOT COMPLETED|Extended Follow-up Phase||0||
48515855|NCT04974619|101593631|FG000|STARTED|Overall Study||117||
48515856|NCT04974619|101593632|FG001|STARTED|Overall Study||21||
48515857|NCT04974619|101593633|FG002|STARTED|Overall Study||17||
48515858|NCT04974619|101593631|FG000|COMPLETED|Overall Study||117||
48515859|NCT04974619|101593632|FG001|COMPLETED|Overall Study||20||
48515860|NCT04974619|101593633|FG002|COMPLETED|Overall Study||15||
48515861|NCT04974619|101593631|FG000|NOT COMPLETED|Overall Study||0||
48515862|NCT04974619|101593632|FG001|NOT COMPLETED|Overall Study||1||
48515863|NCT04974619|101593633|FG002|NOT COMPLETED|Overall Study||2||
48515864|NCT01825837|101593634|FG000|STARTED|PART I||0||
48515865|NCT01825837|101593635|FG001|STARTED|PART I||0||
48515866|NCT01825837|101593636|FG002|STARTED|PART I||0||
48515867|NCT01825837|101593637|FG003|STARTED|PART I||104||
48515868|NCT01825837|101593634|FG000|Enrolled|PART I||0||
48515869|NCT01825837|101593635|FG001|Enrolled|PART I||0||
48515870|NCT01825837|101593636|FG002|Enrolled|PART I||0||
48515871|NCT01825837|101593637|FG003|Enrolled|PART I||104||
48515872|NCT01825837|101593634|FG000|Safety Population (Open-Label)|PART I||0||
48515873|NCT01825837|101593635|FG001|Safety Population (Open-Label)|PART I||0||
48515874|NCT01825837|101593636|FG002|Safety Population (Open-Label)|PART I||0||
48515875|NCT01825837|101593637|FG003|Safety Population (Open-Label)|PART I||104||
48515876|NCT01825837|101593634|FG000|COMPLETED|PART I||0||
48515877|NCT01825837|101593635|FG001|COMPLETED|PART I||0||
48515878|NCT01825837|101593636|FG002|COMPLETED|PART I||0||
48515879|NCT01825837|101593637|FG003|COMPLETED|PART I||87||
48515880|NCT01825837|101593634|FG000|NOT COMPLETED|PART I||0||
48515881|NCT01825837|101593635|FG001|NOT COMPLETED|PART I||0||
48515882|NCT01825837|101593636|FG002|NOT COMPLETED|PART I||0||
48515883|NCT01825837|101593637|FG003|NOT COMPLETED|PART I||17||
48515884|NCT01825837|101593634|FG000|STARTED|PART II||35||
48515885|NCT01825837|101593635|FG001|STARTED|PART II||26||
48515886|NCT01825837|101593636|FG002|STARTED|PART II||26||
48515887|NCT01825837|101593637|FG003|STARTED|PART II||0||
48515888|NCT01825837|101593634|FG000|Randomized Patients|PART II||35||
48515889|NCT01825837|101593635|FG001|Randomized Patients|PART II||26||
48515890|NCT01825837|101593636|FG002|Randomized Patients|PART II||26||
48515891|NCT01825837|101593637|FG003|Randomized Patients|PART II||0||
48515892|NCT01825837|101593634|FG000|Safety Population (Double-Blind)|PART II||35||
48515893|NCT01825837|101593635|FG001|Safety Population (Double-Blind)|PART II||26||
48515894|NCT01825837|101593636|FG002|Safety Population (Double-Blind)|PART II||26||
48515895|NCT01825837|101593637|FG003|Safety Population (Double-Blind)|PART II||0||
48515896|NCT01825837|101593634|FG000|Intent-to-Treat Population|PART II||34||
48515897|NCT01825837|101593635|FG001|Intent-to-Treat Population|PART II||25||
48515898|NCT01825837|101593636|FG002|Intent-to-Treat Population|PART II||26||
48515899|NCT01825837|101593637|FG003|Intent-to-Treat Population|PART II||0||
48515900|NCT01825837|101593634|FG000|Per-Protocol Population|PART II||32||
48515901|NCT01825837|101593635|FG001|Per-Protocol Population|PART II||23||
48515902|NCT01825837|101593636|FG002|Per-Protocol Population|PART II||24||
48515903|NCT01825837|101593637|FG003|Per-Protocol Population|PART II||0||
48515904|NCT01825837|101593634|FG000|COMPLETED|PART II||16||
48515905|NCT01825837|101593635|FG001|COMPLETED|PART II||12||
48515906|NCT01825837|101593636|FG002|COMPLETED|PART II||7||
48515907|NCT01825837|101593637|FG003|COMPLETED|PART II||0||
48515908|NCT01825837|101593634|FG000|NOT COMPLETED|PART II||19||
48515909|NCT01825837|101593635|FG001|NOT COMPLETED|PART II||14||
48515910|NCT01825837|101593636|FG002|NOT COMPLETED|PART II||19||
48515911|NCT01825837|101593637|FG003|NOT COMPLETED|PART II||0||
48515912|NCT01933919|101593638|FG000|STARTED|Double-blind Placebo-controlled Phase||19||
48515913|NCT01933919|101593639|FG001|STARTED|Double-blind Placebo-controlled Phase||19||
48515914|NCT01933919|101593638|FG000|Received Study Drug|Double-blind Placebo-controlled Phase||19||
48515915|NCT01933919|101593639|FG001|Received Study Drug|Double-blind Placebo-controlled Phase||19||
48515916|NCT01933919|101593638|FG000|COMPLETED|Double-blind Placebo-controlled Phase||19||
48515917|NCT01933919|101593639|FG001|COMPLETED|Double-blind Placebo-controlled Phase||15||
48515918|NCT01933919|101593638|FG000|NOT COMPLETED|Double-blind Placebo-controlled Phase||0||
48515919|NCT01933919|101593639|FG001|NOT COMPLETED|Double-blind Placebo-controlled Phase||4||
48515920|NCT01933919|101593638|FG000|STARTED|Open-label Long-term Phase||19||
48515921|NCT01933919|101593639|FG001|STARTED|Open-label Long-term Phase||15||
48515922|NCT01933919|101593638|FG000|COMPLETED|Open-label Long-term Phase||12||
48515923|NCT01933919|101593639|FG001|COMPLETED|Open-label Long-term Phase||9||
48515924|NCT01933919|101593638|FG000|NOT COMPLETED|Open-label Long-term Phase||7||
48515925|NCT01933919|101593639|FG001|NOT COMPLETED|Open-label Long-term Phase||6||
48515926|NCT00442546|101593640|FG000|STARTED|Overall Study||103||
48515927|NCT00442546|101593641|FG001|STARTED|Overall Study||100||
48515928|NCT00442546|101593642|FG002|STARTED|Overall Study||104||
48515929|NCT00442546|101593640|FG000|Received Treatment|Overall Study||98||
48515930|NCT00442546|101593641|FG001|Received Treatment|Overall Study||96||
48515931|NCT00442546|101593642|FG002|Received Treatment|Overall Study||98||
48515932|NCT00442546|101593640|FG000|COMPLETED|Overall Study||77||
48515933|NCT00442546|101593641|FG001|COMPLETED|Overall Study||63||
48515934|NCT00442546|101593642|FG002|COMPLETED|Overall Study||71||
48515935|NCT00442546|101593640|FG000|NOT COMPLETED|Overall Study||26||
48515936|NCT00442546|101593641|FG001|NOT COMPLETED|Overall Study||37||
48515937|NCT00442546|101593642|FG002|NOT COMPLETED|Overall Study||33||
48515938|NCT01592721|101593643|FG000|STARTED|Treatment Period||6||
48515939|NCT01592721|101593643|FG000|COMPLETED|Treatment Period||6||
48515940|NCT01592721|101593643|FG000|NOT COMPLETED|Treatment Period||0||
48515941|NCT01592721|101593643|FG000|STARTED|Long-term Follow-up||6||
48515942|NCT01592721|101593643|FG000|COMPLETED|Long-term Follow-up||5||
48515943|NCT01592721|101593643|FG000|NOT COMPLETED|Long-term Follow-up||1||
48515944|NCT01909934|101593644|FG000|STARTED|Overall Study||50||
48515945|NCT01909934|101593644|FG000|COMPLETED|Overall Study||0||
48515946|NCT01909934|101593644|FG000|NOT COMPLETED|Overall Study||50||
48515947|NCT02326363|101593645|FG000|STARTED|Overall Study||98||
48515948|NCT02326363|101593646|FG001|STARTED|Overall Study||106||
48515949|NCT02326363|101593645|FG000|COMPLETED|Overall Study||47||
48515950|NCT02326363|101593646|FG001|COMPLETED|Overall Study||50||
48515951|NCT02326363|101593645|FG000|NOT COMPLETED|Overall Study||51||
48068107|NCT00734474|100489660|FG008|Entered Study After Dose Decision Point|Overall Study||139||
48068108|NCT00734474|100489652|FG000|Completed 26-Week Visit|Overall Study||0||
48068109|NCT00734474|100489653|FG001|Completed 26-Week Visit|Overall Study||0||
48068110|NCT00734474|100489654|FG002|Completed 26-Week Visit|Overall Study||258||
48068111|NCT00734474|100489655|FG003|Completed 26-Week Visit|Overall Study||2||
48068112|NCT00734474|100489656|FG004|Completed 26-Week Visit|Overall Study||268||
48515952|NCT02326363|101593646|FG001|NOT COMPLETED|Overall Study||56||
48515953|NCT01350934|101593647|FG000|STARTED|Base Study||111||
48515954|NCT01350934|101593648|FG001|STARTED|Base Study||108||
48515955|NCT01350934|101593647|FG000|COMPLETED|Base Study||100||
48515956|NCT01350934|101593648|FG001|COMPLETED|Base Study||105||
48515957|NCT01350934|101593647|FG000|NOT COMPLETED|Base Study||11||
48515958|NCT01350934|101593648|FG001|NOT COMPLETED|Base Study||3||
48515959|NCT01350934|101593647|FG000|STARTED|Extension Study||100||
48515960|NCT01350934|101593648|FG001|STARTED|Extension Study||105||
48515961|NCT01350934|101593647|FG000|COMPLETED|Extension Study||95||
48515962|NCT01350934|101593648|FG001|COMPLETED|Extension Study||101||
48515963|NCT01350934|101593647|FG000|NOT COMPLETED|Extension Study||5||
48515964|NCT01350934|101593648|FG001|NOT COMPLETED|Extension Study||4||
48515965|NCT03490916|101593649|FG000|STARTED|Overall Study||0||
48515966|NCT03490916|101593650|FG001|STARTED|Overall Study||0||
48515967|NCT03490916|101593649|FG000|COMPLETED|Overall Study||0||
48515968|NCT03490916|101593650|FG001|COMPLETED|Overall Study||0||
48515969|NCT03490916|101593649|FG000|NOT COMPLETED|Overall Study||0||
48515970|NCT03490916|101593650|FG001|NOT COMPLETED|Overall Study||0||
48515971|NCT01559935|101593651|FG000|STARTED|Car Phase||72||
48515972|NCT01559935|101593651|FG000|COMPLETED|Car Phase||58||
48515973|NCT01559935|101593651|FG000|NOT COMPLETED|Car Phase||14||
48515974|NCT01559935|101593651|FG000|STARTED|BiRD Phase||58||
48515975|NCT01559935|101593651|FG000|COMPLETED|BiRD Phase||54||
48515976|NCT01559935|101593651|FG000|NOT COMPLETED|BiRD Phase||4||
48515977|NCT01559935|101593651|FG000|STARTED|Maintenance Phase||54||
48515978|NCT01559935|101593651|FG000|COMPLETED|Maintenance Phase||0||
48515979|NCT01559935|101593651|FG000|NOT COMPLETED|Maintenance Phase||54||
48515980|NCT00319046|101593652|FG000|STARTED|Overall Study||42||
48515981|NCT00319046|101593652|FG000|COMPLETED|Overall Study||34||
48515982|NCT00319046|101593652|FG000|NOT COMPLETED|Overall Study||8||
48515983|NCT00521989|101593653|FG000|STARTED|Overall Study||56||
48515984|NCT00521989|101593654|FG001|STARTED|Overall Study||54||
48515985|NCT00521989|101593655|FG002|STARTED|Overall Study||57||
48515986|NCT00521989|101593656|FG003|STARTED|Overall Study||54||
48666798|NCT03391882|101970467|FG002|COMPLETED|Part B - Treatment Phase||16|Part B|
48068113|NCT00734474|100489657|FG005|Completed 26-Week Visit|Overall Study||2||
48068114|NCT00734474|100489658|FG006|Completed 26-Week Visit|Overall Study||2||
48068115|NCT00734474|100489659|FG007|Completed 26-Week Visit|Overall Study||270||
48515987|NCT00521989|101593657|FG004|STARTED|Overall Study||58||
48515988|NCT00521989|101593653|FG000|COMPLETED|Overall Study||36||
48515989|NCT00521989|101593654|FG001|COMPLETED|Overall Study||37||
48515990|NCT00521989|101593655|FG002|COMPLETED|Overall Study||41||
48515991|NCT00521989|101593656|FG003|COMPLETED|Overall Study||42||
48515992|NCT00521989|101593657|FG004|COMPLETED|Overall Study||35||
48515993|NCT00521989|101593653|FG000|NOT COMPLETED|Overall Study||20||
48515994|NCT00521989|101593654|FG001|NOT COMPLETED|Overall Study||17||
48515995|NCT00521989|101593655|FG002|NOT COMPLETED|Overall Study||16||
48515996|NCT00521989|101593656|FG003|NOT COMPLETED|Overall Study||12||
48515997|NCT00521989|101593657|FG004|NOT COMPLETED|Overall Study||23||
48515998|NCT03460158|101593658|FG000|STARTED|Overall Study||101||
48515999|NCT03460158|101593658|FG000|COMPLETED|Overall Study||101||
48516000|NCT03460158|101593658|FG000|NOT COMPLETED|Overall Study||0||
48516001|NCT03648879|101593659|FG000|STARTED|Overall Study||37||
48516002|NCT03648879|101593659|FG000|COMPLETED|Overall Study||36||
48516003|NCT03648879|101593659|FG000|NOT COMPLETED|Overall Study||1||
48516004|NCT01748955|101593660|FG000|STARTED|Overall Study||6||
48516005|NCT01748955|101593661|FG001|STARTED|Overall Study||9||
48516006|NCT01748955|101593660|FG000|COMPLETED|Overall Study||3||
48516007|NCT01748955|101593661|FG001|COMPLETED|Overall Study||4||
48516008|NCT01748955|101593660|FG000|NOT COMPLETED|Overall Study||3||
48516009|NCT01748955|101593661|FG001|NOT COMPLETED|Overall Study||5||
48516010|NCT01303068|101593662|FG000|STARTED|Overall Study||6||
48516011|NCT01303068|101593663|FG001|STARTED|Overall Study||6||
48516012|NCT01303068|101593662|FG000|COMPLETED|Overall Study||6||
48516013|NCT01303068|101593663|FG001|COMPLETED|Overall Study||6||
48516014|NCT01303068|101593662|FG000|NOT COMPLETED|Overall Study||0||
48516015|NCT01303068|101593663|FG001|NOT COMPLETED|Overall Study||0||
48516016|NCT02063087|101593664|FG000|STARTED|Emergency Department Intervention||493||
48516017|NCT02063087|101593665|FG001|STARTED|Emergency Department Intervention||478||
48516018|NCT02063087|101593664|FG000|COMPLETED|Emergency Department Intervention||493||
48516019|NCT02063087|101593665|FG001|COMPLETED|Emergency Department Intervention||478||
48516020|NCT02063087|101593664|FG000|NOT COMPLETED|Emergency Department Intervention||0||
48516021|NCT02063087|101593665|FG001|NOT COMPLETED|Emergency Department Intervention||0||
48516022|NCT02063087|101593664|FG000|STARTED|7 Day Follow-up||493||
48516023|NCT02063087|101593665|FG001|STARTED|7 Day Follow-up||478||
48516024|NCT02063087|101593664|FG000|COMPLETED|7 Day Follow-up||493||
48516025|NCT02063087|101593665|FG001|COMPLETED|7 Day Follow-up||478||
48516026|NCT02063087|101593664|FG000|NOT COMPLETED|7 Day Follow-up||0||
48516027|NCT02063087|101593665|FG001|NOT COMPLETED|7 Day Follow-up||0||
48516028|NCT00271739|101593666|FG000|STARTED|Overall Study||844||
48516029|NCT00271739|101593667|FG001|STARTED|Overall Study||821||
48516030|NCT00271739|101593666|FG000|COMPLETED|Overall Study||729||
48516031|NCT00271739|101593667|FG001|COMPLETED|Overall Study||716||
48516032|NCT00271739|101593666|FG000|NOT COMPLETED|Overall Study||115||
48516033|NCT00271739|101593667|FG001|NOT COMPLETED|Overall Study||105||
48516034|NCT01359748|101593668|FG000|STARTED|Overall Study||48||
48516035|NCT01359748|101593669|FG001|STARTED|Overall Study||20||
48516036|NCT01359748|101593670|FG002|STARTED|Overall Study||10||
48516037|NCT01359748|101593671|FG003|STARTED|Overall Study||11||
48516038|NCT01359748|101593668|FG000|COMPLETED|Overall Study||48||
48516039|NCT01359748|101593669|FG001|COMPLETED|Overall Study||20||
48516040|NCT01359748|101593670|FG002|COMPLETED|Overall Study||10||
48516041|NCT01359748|101593671|FG003|COMPLETED|Overall Study||11||
48516042|NCT01359748|101593668|FG000|NOT COMPLETED|Overall Study||0||
48516043|NCT01359748|101593669|FG001|NOT COMPLETED|Overall Study||0||
48516044|NCT01359748|101593670|FG002|NOT COMPLETED|Overall Study||0||
48516045|NCT01359748|101593671|FG003|NOT COMPLETED|Overall Study||0||
48516046|NCT03135899|101593672|FG000|STARTED|Overall Study||1||
48516047|NCT03135899|101593673|FG001|STARTED|Overall Study||1||
48516048|NCT03135899|101593674|FG002|STARTED|Overall Study||1||
48516049|NCT03135899|101593675|FG003|STARTED|Overall Study||1||
48516050|NCT03135899|101593676|FG004|STARTED|Overall Study||8||
48516051|NCT03135899|101593677|FG005|STARTED|Overall Study||9||
48516052|NCT03135899|101593678|FG006|STARTED|Overall Study||8||
48516053|NCT03135899|101593679|FG007|STARTED|Overall Study||8||
48516054|NCT03135899|101593672|FG000|COMPLETED|Overall Study||1||
48516055|NCT03135899|101593673|FG001|COMPLETED|Overall Study||1||
48516056|NCT03135899|101593674|FG002|COMPLETED|Overall Study||1||
48516057|NCT03135899|101593675|FG003|COMPLETED|Overall Study||1||
48516058|NCT03135899|101593676|FG004|COMPLETED|Overall Study||8||
48516059|NCT03135899|101593677|FG005|COMPLETED|Overall Study||7||
48516060|NCT03135899|101593678|FG006|COMPLETED|Overall Study||7||
48516061|NCT03135899|101593679|FG007|COMPLETED|Overall Study||8||
48516062|NCT03135899|101593672|FG000|NOT COMPLETED|Overall Study||0||
48516063|NCT03135899|101593673|FG001|NOT COMPLETED|Overall Study||0||
48516064|NCT03135899|101593674|FG002|NOT COMPLETED|Overall Study||0||
48516065|NCT03135899|101593675|FG003|NOT COMPLETED|Overall Study||0||
48068116|NCT00734474|100489660|FG008|Completed 26-Week Visit|Overall Study||124||
48068117|NCT00734474|100489652|FG000|Completed 52-Week Visit|Overall Study||0||
48068118|NCT00734474|100489653|FG001|Completed 52-Week Visit|Overall Study||0||
48516066|NCT03135899|101593676|FG004|NOT COMPLETED|Overall Study||0||
48516067|NCT03135899|101593677|FG005|NOT COMPLETED|Overall Study||2||
48516068|NCT03135899|101593678|FG006|NOT COMPLETED|Overall Study||1||
48516069|NCT03135899|101593679|FG007|NOT COMPLETED|Overall Study||0||
48516070|NCT03808740|101593680|FG000|STARTED|Overall Study||10||
48516071|NCT03808740|101593681|FG001|STARTED|Overall Study||0||
48516072|NCT03808740|101593680|FG000|COMPLETED|Overall Study||10||
48516073|NCT03808740|101593681|FG001|COMPLETED|Overall Study||0||
48516074|NCT03808740|101593680|FG000|NOT COMPLETED|Overall Study||0||
48068119|NCT00734474|100489654|FG002|Completed 52-Week Visit|Overall Study||238||
48516075|NCT03808740|101593681|FG001|NOT COMPLETED|Overall Study||0||
48516076|NCT03401073|101593682|FG000|STARTED|Overall Study||10||
48516077|NCT03401073|101593683|FG001|STARTED|Overall Study||10||
48516078|NCT03401073|101593682|FG000|COMPLETED|Overall Study||9||
48516079|NCT03401073|101593683|FG001|COMPLETED|Overall Study||8||
48516080|NCT03401073|101593682|FG000|NOT COMPLETED|Overall Study||1||
48516081|NCT03401073|101593683|FG001|NOT COMPLETED|Overall Study||2||
48516082|NCT04287868|101593684|FG000|STARTED|Overall Study||48||
48516083|NCT04287868|101593685|FG001|STARTED|Overall Study||3||
48516084|NCT04287868|101593684|FG000|COMPLETED|Overall Study||47||
48516085|NCT04287868|101593685|FG001|COMPLETED|Overall Study||3||
48516086|NCT04287868|101593684|FG000|NOT COMPLETED|Overall Study||1||
48516087|NCT04287868|101593685|FG001|NOT COMPLETED|Overall Study||0||
48516088|NCT03547635|101593686|FG000|STARTED|Overall Study||41||
48516089|NCT03547635|101593687|FG001|STARTED|Overall Study||38||
48516090|NCT03547635|101593688|FG002|STARTED|Overall Study||37||
48516091|NCT03547635|101593686|FG000|COMPLETED|Overall Study||33||
48516092|NCT03547635|101593687|FG001|COMPLETED|Overall Study||31||
48516093|NCT03547635|101593688|FG002|COMPLETED|Overall Study||29||
48516094|NCT03547635|101593686|FG000|NOT COMPLETED|Overall Study||8||
48516095|NCT03547635|101593687|FG001|NOT COMPLETED|Overall Study||7||
48516096|NCT03547635|101593688|FG002|NOT COMPLETED|Overall Study||8||
48516097|NCT00171340|101593689|FG000|STARTED|Overall Study||532||
48516098|NCT00171340|101593690|FG001|STARTED|Overall Study||533||
48516099|NCT00171340|101593689|FG000|COMPLETED|Overall Study||408||
48516100|NCT00171340|101593690|FG001|COMPLETED|Overall Study||398||
48516101|NCT00171340|101593689|FG000|NOT COMPLETED|Overall Study||124||
48516102|NCT00171340|101593690|FG001|NOT COMPLETED|Overall Study||135||
48516103|NCT01246713|101593691|FG000|STARTED|First Acetaminophen Dosing (1 Day)||6||
48516104|NCT01246713|101593692|FG001|STARTED|First Acetaminophen Dosing (1 Day)||9||
48516105|NCT01246713|101593691|FG000|COMPLETED|First Acetaminophen Dosing (1 Day)||6||
48516106|NCT01246713|101593692|FG001|COMPLETED|First Acetaminophen Dosing (1 Day)||9||
48516107|NCT01246713|101593691|FG000|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0||
48516108|NCT01246713|101593692|FG001|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0||
48516109|NCT01246713|101593691|FG000|STARTED|Washout (at Least 14 Days)||6||
48516110|NCT01246713|101593692|FG001|STARTED|Washout (at Least 14 Days)||9||
48516111|NCT01246713|101593691|FG000|COMPLETED|Washout (at Least 14 Days)||6||
48516112|NCT01246713|101593692|FG001|COMPLETED|Washout (at Least 14 Days)||9||
48516113|NCT01246713|101593691|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0||
48516114|NCT01246713|101593692|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0||
48516115|NCT01246713|101593691|FG000|STARTED|Second Acetaminophen Dosing (1 Day)||6||
48516116|NCT01246713|101593692|FG001|STARTED|Second Acetaminophen Dosing (1 Day)||9||
48516117|NCT01246713|101593691|FG000|COMPLETED|Second Acetaminophen Dosing (1 Day)||6||
48516118|NCT01246713|101593692|FG001|COMPLETED|Second Acetaminophen Dosing (1 Day)||9||
48516119|NCT01246713|101593691|FG000|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0||
48516120|NCT01246713|101593692|FG001|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0||
48516121|NCT02808819|101593693|FG000|STARTED|Overall Study||220||
48516122|NCT02808819|101593694|FG001|STARTED|Overall Study||226||
48516123|NCT02808819|101593693|FG000|Treated|Overall Study||220||
48516124|NCT02808819|101593694|FG001|Treated|Overall Study||226||
48516125|NCT02808819|101593693|FG000|COMPLETED|Overall Study||189||
48516126|NCT02808819|101593694|FG001|COMPLETED|Overall Study||195||
48516127|NCT02808819|101593693|FG000|NOT COMPLETED|Overall Study||31||
48516128|NCT02808819|101593694|FG001|NOT COMPLETED|Overall Study||31||
48516129|NCT00384293|101593695|FG000|STARTED|MK0524A Active Run-In, Pre-randomization||937||
48516130|NCT00384293|101593696|FG001|STARTED|MK0524A Active Run-In, Pre-randomization||0||
48516131|NCT00384293|101593697|FG002|STARTED|MK0524A Active Run-In, Pre-randomization||0||
48516132|NCT00384293|101593695|FG000|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||937||
48516133|NCT00384293|101593696|FG001|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0||
48516134|NCT00384293|101593697|FG002|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0||
48516135|NCT00384293|101593695|FG000|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||813||
48516136|NCT00384293|101593696|FG001|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0||
48516137|NCT00384293|101593697|FG002|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0||
48516138|NCT00384293|101593695|FG000|COMPLETED|MK0524A Active Run-In, Pre-randomization||433||
48516139|NCT00384293|101593696|FG001|COMPLETED|MK0524A Active Run-In, Pre-randomization||0||
48516140|NCT00384293|101593697|FG002|COMPLETED|MK0524A Active Run-In, Pre-randomization||0||
48516141|NCT00384293|101593695|FG000|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||504||
48516142|NCT00384293|101593696|FG001|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0||
48516143|NCT00384293|101593697|FG002|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0||
48516144|NCT00384293|101593695|FG000|STARTED|Post-randomization Period||0||
48516145|NCT00384293|101593696|FG001|STARTED|Post-randomization Period||214||
48516146|NCT00384293|101593697|FG002|STARTED|Post-randomization Period||219||
48516147|NCT00384293|101593695|FG000|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||0||
48516148|NCT00384293|101593696|FG001|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||214||
48516149|NCT00384293|101593697|FG002|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||218||
48516150|NCT00384293|101593695|FG000|COMPLETED|Post-randomization Period||0||
48516151|NCT00384293|101593696|FG001|COMPLETED|Post-randomization Period||0||
48516152|NCT00384293|101593697|FG002|COMPLETED|Post-randomization Period||0||
48516153|NCT00384293|101593695|FG000|NOT COMPLETED|Post-randomization Period||0||
48516154|NCT00384293|101593696|FG001|NOT COMPLETED|Post-randomization Period||214||
48516155|NCT00384293|101593697|FG002|NOT COMPLETED|Post-randomization Period||219||
48516156|NCT03451006|101593698|FG000|STARTED|Overall Study||4||
48516157|NCT03451006|101593699|FG001|STARTED|Overall Study||3||
48516158|NCT03451006|101593698|FG000|COMPLETED|Overall Study||2||
48516159|NCT03451006|101593699|FG001|COMPLETED|Overall Study||1||
48516160|NCT03451006|101593698|FG000|NOT COMPLETED|Overall Study||2||
48516161|NCT03451006|101593699|FG001|NOT COMPLETED|Overall Study||2||
48516162|NCT01660022|101593700|FG000|STARTED|First Sequence (7 Days)||8||
48516163|NCT01660022|101593701|FG001|STARTED|First Sequence (7 Days)||8||
48516164|NCT01660022|101593702|FG002|STARTED|First Sequence (7 Days)||8||
48516165|NCT01660022|101593703|FG003|STARTED|First Sequence (7 Days)||8||
48516166|NCT01660022|101593704|FG004|STARTED|First Sequence (7 Days)||7||
48516167|NCT01660022|101593705|FG005|STARTED|First Sequence (7 Days)||20||
48516168|NCT01660022|101593700|FG000|COMPLETED|First Sequence (7 Days)||8||
48516169|NCT01660022|101593701|FG001|COMPLETED|First Sequence (7 Days)||7||
48516170|NCT01660022|101593702|FG002|COMPLETED|First Sequence (7 Days)||8||
48516171|NCT01660022|101593703|FG003|COMPLETED|First Sequence (7 Days)||7||
48516172|NCT01660022|101593704|FG004|COMPLETED|First Sequence (7 Days)||6||
48516173|NCT01660022|101593705|FG005|COMPLETED|First Sequence (7 Days)||16||
48516174|NCT01660022|101593700|FG000|NOT COMPLETED|First Sequence (7 Days)||0||
48516175|NCT01660022|101593701|FG001|NOT COMPLETED|First Sequence (7 Days)||1||
48516176|NCT01660022|101593702|FG002|NOT COMPLETED|First Sequence (7 Days)||0||
48516177|NCT01660022|101593703|FG003|NOT COMPLETED|First Sequence (7 Days)||1||
48516178|NCT01660022|101593704|FG004|NOT COMPLETED|First Sequence (7 Days)||1||
48516179|NCT01660022|101593705|FG005|NOT COMPLETED|First Sequence (7 Days)||4||
48516180|NCT01660022|101593700|FG000|STARTED|Second Sequence (42 Days)||8||
48516181|NCT01660022|101593701|FG001|STARTED|Second Sequence (42 Days)||7||
48516182|NCT01660022|101593702|FG002|STARTED|Second Sequence (42 Days)||8||
48516183|NCT01660022|101593703|FG003|STARTED|Second Sequence (42 Days)||7||
48516184|NCT01660022|101593704|FG004|STARTED|Second Sequence (42 Days)||6||
48516185|NCT01660022|101593705|FG005|STARTED|Second Sequence (42 Days)||16||
48516186|NCT01660022|101593700|FG000|COMPLETED|Second Sequence (42 Days)||8||
48516187|NCT01660022|101593701|FG001|COMPLETED|Second Sequence (42 Days)||7||
48516188|NCT01660022|101593702|FG002|COMPLETED|Second Sequence (42 Days)||8||
48516189|NCT01660022|101593703|FG003|COMPLETED|Second Sequence (42 Days)||7||
48516190|NCT01660022|101593704|FG004|COMPLETED|Second Sequence (42 Days)||6||
48516191|NCT01660022|101593705|FG005|COMPLETED|Second Sequence (42 Days)||16||
48516192|NCT01660022|101593700|FG000|NOT COMPLETED|Second Sequence (42 Days)||0||
48516193|NCT01660022|101593701|FG001|NOT COMPLETED|Second Sequence (42 Days)||0||
48516194|NCT01660022|101593702|FG002|NOT COMPLETED|Second Sequence (42 Days)||0||
48516195|NCT01660022|101593703|FG003|NOT COMPLETED|Second Sequence (42 Days)||0||
48516196|NCT01660022|101593704|FG004|NOT COMPLETED|Second Sequence (42 Days)||0||
48516197|NCT01660022|101593705|FG005|NOT COMPLETED|Second Sequence (42 Days)||0||
48516198|NCT03396874|101593706|FG000|STARTED|Overall Study||1181||
48516199|NCT03396874|101593707|FG001|STARTED|Overall Study||254||
48516200|NCT03396874|101593706|FG000|68Ga-PSMA Scan|Overall Study||1181||
48516201|NCT03396874|101593707|FG001|68Ga-PSMA Scan|Overall Study||0||
48516202|NCT03396874|101593706|FG000|COMPLETED|Overall Study||1181||
48516203|NCT03396874|101593707|FG001|COMPLETED|Overall Study||254||
48516204|NCT03396874|101593706|FG000|NOT COMPLETED|Overall Study||0||
48516205|NCT03396874|101593707|FG001|NOT COMPLETED|Overall Study||0||
48516206|NCT04776746|101593708|FG000|STARTED|Overall Study||77||
48516207|NCT04776746|101593708|FG000|COMPLETED|Overall Study||0||
48516208|NCT04776746|101593708|FG000|NOT COMPLETED|Overall Study||77||
48516209|NCT01606228|101593709|FG000|STARTED|Overall Study||188||
48516210|NCT01606228|101593709|FG000|COMPLETED|Overall Study||159||
48516211|NCT01606228|101593709|FG000|NOT COMPLETED|Overall Study||29||
48516212|NCT04475250|101593710|FG000|STARTED|Overall Study||100||
48516213|NCT04475250|101593710|FG000|COMPLETED|Overall Study||100||
48516214|NCT04475250|101593710|FG000|NOT COMPLETED|Overall Study||0||
48516215|NCT02449473|101593711|FG000|STARTED|Overall Study||39||
48516216|NCT02449473|101593712|FG001|STARTED|Overall Study||40||
48516217|NCT02449473|101593711|FG000|COMPLETED|Overall Study||39||
48516218|NCT02449473|101593712|FG001|COMPLETED|Overall Study||40||
48516219|NCT02449473|101593711|FG000|NOT COMPLETED|Overall Study||0||
48516220|NCT02449473|101593712|FG001|NOT COMPLETED|Overall Study||0||
48516221|NCT01223235|101593713|FG000|STARTED|Overall Study||22||
48516222|NCT01223235|101593713|FG000|COMPLETED|Overall Study||21||
48516223|NCT01223235|101593713|FG000|NOT COMPLETED|Overall Study||1||
48516224|NCT00693225|101593714|FG000|STARTED|Overall Study||43||
48516225|NCT00693225|101593715|FG001|STARTED|Overall Study||48||
48516226|NCT00693225|101593714|FG000|COMPLETED|Overall Study||41||
48516227|NCT00693225|101593715|FG001|COMPLETED|Overall Study||43||
48516228|NCT00693225|101593714|FG000|NOT COMPLETED|Overall Study||2||
48516229|NCT00693225|101593715|FG001|NOT COMPLETED|Overall Study||5||
48516230|NCT00852917|101593716|FG000|STARTED|Overall Study||106||
48516231|NCT00852917|101593717|FG001|STARTED|Overall Study||111||
48516232|NCT00852917|101593718|FG002|STARTED|Overall Study||108||
48516233|NCT00852917|101593719|FG003|STARTED|Overall Study||227||
48516234|NCT00852917|101593716|FG000|COMPLETED|Overall Study||62||
48516235|NCT00852917|101593717|FG001|COMPLETED|Overall Study||65||
48516236|NCT00852917|101593718|FG002|COMPLETED|Overall Study||50||
48516237|NCT00852917|101593719|FG003|COMPLETED|Overall Study||134||
48516238|NCT00852917|101593716|FG000|NOT COMPLETED|Overall Study||44||
48516239|NCT00852917|101593717|FG001|NOT COMPLETED|Overall Study||46||
48516240|NCT00852917|101593718|FG002|NOT COMPLETED|Overall Study||58||
48516241|NCT00852917|101593719|FG003|NOT COMPLETED|Overall Study||93||
48516242|NCT00493454|101593720|FG000|STARTED|Overall Study||6||
48516243|NCT00493454|101593720|FG000|COMPLETED|Overall Study||5||
48516244|NCT00493454|101593720|FG000|NOT COMPLETED|Overall Study||1||
48516245|NCT05158140|101593721|FG000|STARTED|Overall Study||214||
48516246|NCT05158140|101593722|FG001|STARTED|Overall Study||212||
48516247|NCT05158140|101593723|FG002|STARTED|Overall Study||214||
48516248|NCT05158140|101593724|FG003|STARTED|Overall Study||210||
48516249|NCT05158140|101593721|FG000|Received Any Vaccination|Overall Study||214||
48516250|NCT05158140|101593722|FG001|Received Any Vaccination|Overall Study||211||
48516251|NCT05158140|101593723|FG002|Received Any Vaccination|Overall Study||210||
48516252|NCT05158140|101593724|FG003|Received Any Vaccination|Overall Study||208||
48516253|NCT05158140|101593721|FG000|COMPLETED|Overall Study||208||
48516254|NCT05158140|101593722|FG001|COMPLETED|Overall Study||199||
48516255|NCT05158140|101593723|FG002|COMPLETED|Overall Study||203||
48516256|NCT05158140|101593724|FG003|COMPLETED|Overall Study||198||
48516257|NCT05158140|101593721|FG000|NOT COMPLETED|Overall Study||6||
48516258|NCT05158140|101593722|FG001|NOT COMPLETED|Overall Study||13||
48516259|NCT05158140|101593723|FG002|NOT COMPLETED|Overall Study||11||
48516260|NCT05158140|101593724|FG003|NOT COMPLETED|Overall Study||12||
48516261|NCT04553913|101593725|FG000|STARTED|Overall Study||15||
48516262|NCT04553913|101593725|FG000|COMPLETED|Overall Study||9||
48516263|NCT04553913|101593725|FG000|NOT COMPLETED|Overall Study||6||
48516264|NCT00097786|101593726|FG000|STARTED|Overall Study||2316||
48516265|NCT00097786|101593727|FG001|STARTED|Overall Study||2315||
48516266|NCT00097786|101593728|FG002|STARTED|Overall Study||2329||
48516267|NCT00097786|101593729|FG003|STARTED|Overall Study||2346||
48516268|NCT00097786|101593726|FG000|Complete FU for Progression to Diabetes|Overall Study||1709||
48516269|NCT00097786|101593727|FG001|Complete FU for Progression to Diabetes|Overall Study||1712||
48516270|NCT00097786|101593728|FG002|Complete FU for Progression to Diabetes|Overall Study||1734||
48516271|NCT00097786|101593729|FG003|Complete FU for Progression to Diabetes|Overall Study||1762||
48516272|NCT00097786|101593726|FG000|Complete Follow-up for Extended CV EPs|Overall Study||1969||
48516273|NCT00097786|101593727|FG001|Complete Follow-up for Extended CV EPs|Overall Study||1985||
48516274|NCT00097786|101593728|FG002|Complete Follow-up for Extended CV EPs|Overall Study||1987||
48516275|NCT00097786|101593729|FG003|Complete Follow-up for Extended CV EPs|Overall Study||2015||
48516276|NCT00097786|101593726|FG000|Complete Follow-up for Core CV EPs|Overall Study||1948||
48516277|NCT00097786|101593727|FG001|Complete Follow-up for Core CV EPs|Overall Study||1963||
48516278|NCT00097786|101593728|FG002|Complete Follow-up for Core CV EPs|Overall Study||1966||
48516279|NCT00097786|101593729|FG003|Complete Follow-up for Core CV EPs|Overall Study||1988||
48516280|NCT00097786|101593726|FG000|COMPLETED|Overall Study||2020||
48516281|NCT00097786|101593727|FG001|COMPLETED|Overall Study||2023||
48516282|NCT00097786|101593728|FG002|COMPLETED|Overall Study||2016||
48516283|NCT00097786|101593729|FG003|COMPLETED|Overall Study||2036||
48516284|NCT00097786|101593726|FG000|NOT COMPLETED|Overall Study||296||
48516285|NCT00097786|101593727|FG001|NOT COMPLETED|Overall Study||292||
48516286|NCT00097786|101593728|FG002|NOT COMPLETED|Overall Study||313||
48516287|NCT00097786|101593729|FG003|NOT COMPLETED|Overall Study||310||
48516288|NCT03449199|101593730|FG000|STARTED|Overall Study||42||
48516289|NCT03449199|101593731|FG001|STARTED|Overall Study||44||
48516290|NCT03449199|101593732|FG002|STARTED|Overall Study||44||
48516291|NCT03449199|101593730|FG000|COMPLETED|Overall Study||41||
48516292|NCT03449199|101593731|FG001|COMPLETED|Overall Study||43||
48516293|NCT03449199|101593732|FG002|COMPLETED|Overall Study||42||
48516294|NCT03449199|101593730|FG000|NOT COMPLETED|Overall Study||1||
48516295|NCT03449199|101593731|FG001|NOT COMPLETED|Overall Study||1||
48516296|NCT03449199|101593732|FG002|NOT COMPLETED|Overall Study||2||
48516297|NCT05353036|101593733|FG000|STARTED|Overall Study||250||
48516298|NCT05353036|101593733|FG000|COMPLETED|Overall Study||250||
48516299|NCT05353036|101593733|FG000|NOT COMPLETED|Overall Study||0||
48516300|NCT04768296|101593734|FG000|STARTED|Overall Study||3||
48516301|NCT04768296|101593735|FG001|STARTED|Overall Study||73||
48516302|NCT04768296|101593734|FG000|COMPLETED|Overall Study||2||
48516303|NCT04768296|101593735|FG001|COMPLETED|Overall Study||66||
48516304|NCT04768296|101593734|FG000|NOT COMPLETED|Overall Study||1||
48516305|NCT04768296|101593735|FG001|NOT COMPLETED|Overall Study||7||
48516306|NCT00362817|101597118|FG000|STARTED|Overall Study||17||
48516307|NCT00362817|101597118|FG000|COMPLETED|Overall Study||17||
48516308|NCT00362817|101597118|FG000|NOT COMPLETED|Overall Study||0||
48516309|NCT01567826|101597119|FG000|STARTED|Overall Study||43||
48516310|NCT01567826|101597120|FG001|STARTED|Overall Study||44||
48516311|NCT01567826|101597119|FG000|COMPLETED|Overall Study||40||
48516312|NCT01567826|101597120|FG001|COMPLETED|Overall Study||42||
48516313|NCT01567826|101597119|FG000|NOT COMPLETED|Overall Study||3||
48516314|NCT01567826|101597120|FG001|NOT COMPLETED|Overall Study||2||
48516315|NCT04157517|101597121|FG000|STARTED|Overall Study||3||
48516316|NCT04157517|101597122|FG001|STARTED|Overall Study||3||
48516317|NCT04157517|101597123|FG002|STARTED|Overall Study||3||
48516318|NCT04157517|101597124|FG003|STARTED|Overall Study||3||
48516319|NCT04157517|101597125|FG004|STARTED|Overall Study||3||
48516320|NCT04157517|101597126|FG005|STARTED|Overall Study||6||
48516321|NCT04157517|101597127|FG006|STARTED|Overall Study||3||
48516322|NCT04157517|101597128|FG007|STARTED|Overall Study||9||
48516323|NCT04157517|101597129|FG008|STARTED|Overall Study||12||
48516324|NCT04157517|101597130|FG009|STARTED|Overall Study||0||
48516325|NCT04157517|101597121|FG000|COMPLETED|Overall Study||0||
48516326|NCT04157517|101597122|FG001|COMPLETED|Overall Study||0||
48516327|NCT04157517|101597123|FG002|COMPLETED|Overall Study||0||
48516328|NCT04157517|101597124|FG003|COMPLETED|Overall Study||0||
48516329|NCT04157517|101597125|FG004|COMPLETED|Overall Study||0||
48516330|NCT04157517|101597126|FG005|COMPLETED|Overall Study||0||
48516331|NCT04157517|101597127|FG006|COMPLETED|Overall Study||0||
48516332|NCT04157517|101597128|FG007|COMPLETED|Overall Study||0||
48516333|NCT04157517|101597129|FG008|COMPLETED|Overall Study||0||
48516334|NCT04157517|101597130|FG009|COMPLETED|Overall Study||0||
48516335|NCT04157517|101597121|FG000|NOT COMPLETED|Overall Study||3||
48516336|NCT04157517|101597122|FG001|NOT COMPLETED|Overall Study||3||
48516337|NCT04157517|101597123|FG002|NOT COMPLETED|Overall Study||3||
48516338|NCT04157517|101597124|FG003|NOT COMPLETED|Overall Study||3||
48516339|NCT04157517|101597125|FG004|NOT COMPLETED|Overall Study||3||
48516340|NCT04157517|101597126|FG005|NOT COMPLETED|Overall Study||6||
48516341|NCT04157517|101597127|FG006|NOT COMPLETED|Overall Study||3||
48516342|NCT04157517|101597128|FG007|NOT COMPLETED|Overall Study||9||
48516343|NCT04157517|101597129|FG008|NOT COMPLETED|Overall Study||12||
48516344|NCT04157517|101597130|FG009|NOT COMPLETED|Overall Study||0||
48516345|NCT01523587|101597131|FG000|STARTED|Overall Study||398||
48516346|NCT01523587|101597132|FG001|STARTED|Overall Study||397||
48516347|NCT01523587|101597131|FG000|Treated|Overall Study||392||
48516348|NCT01523587|101597132|FG001|Treated|Overall Study||395||
48516349|NCT01523587|101597131|FG000|COMPLETED|Overall Study||0||
48516350|NCT01523587|101597132|FG001|COMPLETED|Overall Study||0||
48516351|NCT01523587|101597131|FG000|NOT COMPLETED|Overall Study||398||
48516352|NCT01523587|101597132|FG001|NOT COMPLETED|Overall Study||397||
48516353|NCT01253317|101597133|FG000|STARTED|Overall Study||12||
48516354|NCT01253317|101597133|FG000|COMPLETED|Overall Study||10||
48666799|NCT03391882|101970468|FG003|COMPLETED|Part B - Treatment Phase||15|Part B|
48666800|NCT03391882|101970469|FG004|COMPLETED|Part B - Treatment Phase||14|Part B|
48666801|NCT03391882|101970470|FG005|COMPLETED|Part B - Treatment Phase||15|Part B|
48666802|NCT03391882|101970465|FG000|NOT COMPLETED|Part B - Treatment Phase||0||
48666803|NCT03391882|101970466|FG001|NOT COMPLETED|Part B - Treatment Phase||0||
48666804|NCT03391882|101970467|FG002|NOT COMPLETED|Part B - Treatment Phase||3||
48666805|NCT03391882|101970468|FG003|NOT COMPLETED|Part B - Treatment Phase||3||
48666806|NCT03391882|101970469|FG004|NOT COMPLETED|Part B - Treatment Phase||4||
48666807|NCT03391882|101970470|FG005|NOT COMPLETED|Part B - Treatment Phase||4||
48666808|NCT00492544|101970471|FG000|STARTED|Overall Study||100||
48666809|NCT00492544|101970471|FG000|COMPLETED|Overall Study||100||
48666810|NCT00492544|101970471|FG000|NOT COMPLETED|Overall Study||0||
48666811|NCT04237584|101970472|FG000|STARTED|R1- Lead-in ARB Treatment (12 Weeks)||5||
48666812|NCT04237584|101970473|FG001|STARTED|R1- Lead-in ARB Treatment (12 Weeks)||5||
48666813|NCT04237584|101970474|FG002|STARTED|R1- Lead-in ARB Treatment (12 Weeks)||6||
48666814|NCT04237584|101970475|FG003|STARTED|R1- Lead-in ARB Treatment (12 Weeks)||5||
48666815|NCT04237584|101970472|FG000|COMPLETED|R1- Lead-in ARB Treatment (12 Weeks)||4||
48666816|NCT04237584|101970473|FG001|COMPLETED|R1- Lead-in ARB Treatment (12 Weeks)||4||
48666817|NCT04237584|101970474|FG002|COMPLETED|R1- Lead-in ARB Treatment (12 Weeks)||3||
48666818|NCT04237584|101970475|FG003|COMPLETED|R1- Lead-in ARB Treatment (12 Weeks)||3||
48666819|NCT04237584|101970472|FG000|NOT COMPLETED|R1- Lead-in ARB Treatment (12 Weeks)||1||
48666820|NCT04237584|101970473|FG001|NOT COMPLETED|R1- Lead-in ARB Treatment (12 Weeks)||1||
48666821|NCT04237584|101970474|FG002|NOT COMPLETED|R1- Lead-in ARB Treatment (12 Weeks)||3||
48666822|NCT04237584|101970475|FG003|NOT COMPLETED|R1- Lead-in ARB Treatment (12 Weeks)||2||
48666823|NCT04237584|101970472|FG000|STARTED|R2- ARB Treatment With Ra-223 or Placebo||4||
48666824|NCT04237584|101970473|FG001|STARTED|R2- ARB Treatment With Ra-223 or Placebo||4||
48666825|NCT04237584|101970474|FG002|STARTED|R2- ARB Treatment With Ra-223 or Placebo||3||
48666826|NCT04237584|101970475|FG003|STARTED|R2- ARB Treatment With Ra-223 or Placebo||3||
48666827|NCT04237584|101970472|FG000|COMPLETED|R2- ARB Treatment With Ra-223 or Placebo||0||
48666828|NCT04237584|101970473|FG001|COMPLETED|R2- ARB Treatment With Ra-223 or Placebo||0||
48666829|NCT04237584|101970474|FG002|COMPLETED|R2- ARB Treatment With Ra-223 or Placebo||0||
48666830|NCT04237584|101970475|FG003|COMPLETED|R2- ARB Treatment With Ra-223 or Placebo||0||
48666831|NCT04237584|101970472|FG000|NOT COMPLETED|R2- ARB Treatment With Ra-223 or Placebo||4||
48068120|NCT00734474|100489655|FG003|Completed 52-Week Visit|Overall Study||0||
48666832|NCT04237584|101970473|FG001|NOT COMPLETED|R2- ARB Treatment With Ra-223 or Placebo||4||
48666833|NCT04237584|101970474|FG002|NOT COMPLETED|R2- ARB Treatment With Ra-223 or Placebo||3||
48666834|NCT04237584|101970475|FG003|NOT COMPLETED|R2- ARB Treatment With Ra-223 or Placebo||3||
48666835|NCT05126303|101970476|FG000|STARTED|Overall Study||89||
48516355|NCT01253317|101597133|FG000|NOT COMPLETED|Overall Study||2||
48516356|NCT00743509|101597134|FG000|STARTED|Overall Study||49||
48516357|NCT00743509|101597134|FG000|COMPLETED|Overall Study||47||
48516358|NCT00743509|101597134|FG000|NOT COMPLETED|Overall Study||2||
48516359|NCT03718117|101597135|FG000|STARTED|Overall Study||51||
48516360|NCT03718117|101597136|FG001|STARTED|Overall Study||20||
48516361|NCT03718117|101597137|FG002|STARTED|Overall Study||2||
48516362|NCT03718117|101597135|FG000|Safety Population|Overall Study||51||
48516363|NCT03718117|101597136|FG001|Safety Population|Overall Study||20||
48516364|NCT03718117|101597137|FG002|Safety Population|Overall Study||2||
48516365|NCT03718117|101597135|FG000|Participants With Known Gene Arrangement; Had First Line Crizotinib|Overall Study||33||
48516366|NCT03718117|101597136|FG001|Participants With Known Gene Arrangement; Had First Line Crizotinib|Overall Study||18||
48516367|NCT03718117|101597137|FG002|Participants With Known Gene Arrangement; Had First Line Crizotinib|Overall Study||0||
48516368|NCT03718117|101597135|FG000|Participants With Known Gene Arrangement; Had Second Line Crizotinib|Overall Study||14||
48516369|NCT03718117|101597136|FG001|Participants With Known Gene Arrangement; Had Second Line Crizotinib|Overall Study||1||
48516370|NCT03718117|101597137|FG002|Participants With Known Gene Arrangement; Had Second Line Crizotinib|Overall Study||0||
48516371|NCT03718117|101597135|FG000|Participants With Known Gene Arrangement; Had Third Line Crizotinib|Overall Study||2||
48516372|NCT03718117|101597136|FG001|Participants With Known Gene Arrangement; Had Third Line Crizotinib|Overall Study||0||
48516373|NCT03718117|101597137|FG002|Participants With Known Gene Arrangement; Had Third Line Crizotinib|Overall Study||0||
48516374|NCT03718117|101597135|FG000|Participants With Known Gene Arrangement; Had Other Line Crizotinib|Overall Study||2||
48516375|NCT03718117|101597136|FG001|Participants With Known Gene Arrangement; Had Other Line Crizotinib|Overall Study||1||
48516376|NCT03718117|101597137|FG002|Participants With Known Gene Arrangement; Had Other Line Crizotinib|Overall Study||0||
48516377|NCT03718117|101597135|FG000|COMPLETED|Overall Study||37||
48516378|NCT03718117|101597136|FG001|COMPLETED|Overall Study||8||
48516379|NCT03718117|101597137|FG002|COMPLETED|Overall Study||0||
48516380|NCT03718117|101597135|FG000|NOT COMPLETED|Overall Study||14||
48516381|NCT03718117|101597136|FG001|NOT COMPLETED|Overall Study||12||
48516382|NCT03718117|101597137|FG002|NOT COMPLETED|Overall Study||2||
48516383|NCT04412057|101597138|FG000|STARTED|Overall Study||41||
48516384|NCT04412057|101597139|FG001|STARTED|Overall Study||42||
48516385|NCT04412057|101597138|FG000|Randomized Analysis Set|Overall Study||41||
48516386|NCT04412057|101597139|FG001|Randomized Analysis Set|Overall Study||42||
48516387|NCT04412057|101597138|FG000|Safety Analysis Set|Overall Study||40||
48516388|NCT04412057|101597139|FG001|Safety Analysis Set|Overall Study||42||
48516389|NCT04412057|101597138|FG000|Full Analysis Set|Overall Study||40||
48516390|NCT04412057|101597139|FG001|Full Analysis Set|Overall Study||42||
48516391|NCT04412057|101597138|FG000|Primary Analysis Set|Overall Study||31||
48516392|NCT04412057|101597139|FG001|Primary Analysis Set|Overall Study||31||
48516393|NCT04412057|101597138|FG000|COMPLETED|Overall Study||37||
48516394|NCT04412057|101597139|FG001|COMPLETED|Overall Study||35||
48516395|NCT04412057|101597138|FG000|NOT COMPLETED|Overall Study||4||
48516396|NCT04412057|101597139|FG001|NOT COMPLETED|Overall Study||7||
48516397|NCT00518622|101597140|FG000|STARTED|Overall Study||3||
48516398|NCT00518622|101597141|FG001|STARTED|Overall Study||6||
48516399|NCT00518622|101597142|FG002|STARTED|Overall Study||6||
48516400|NCT00518622|101597143|FG003|STARTED|Overall Study||5||
48516401|NCT00518622|101597144|FG004|STARTED|Overall Study||6||
48516402|NCT00518622|101597145|FG005|STARTED|Overall Study||5||
48516403|NCT00518622|101597146|FG006|STARTED|Overall Study||4||
48516404|NCT00518622|101597147|FG007|STARTED|Overall Study||5||
48516405|NCT00518622|101597140|FG000|Completed Therapy|Overall Study||3||
48516406|NCT00518622|101597141|FG001|Completed Therapy|Overall Study||5||
48516407|NCT00518622|101597142|FG002|Completed Therapy|Overall Study||6||
48516408|NCT00518622|101597143|FG003|Completed Therapy|Overall Study||5||
48516409|NCT00518622|101597144|FG004|Completed Therapy|Overall Study||6||
48516410|NCT00518622|101597145|FG005|Completed Therapy|Overall Study||5||
48516411|NCT00518622|101597146|FG006|Completed Therapy|Overall Study||4||
48516412|NCT00518622|101597147|FG007|Completed Therapy|Overall Study||5||
48516413|NCT00518622|101597140|FG000|Discontinued Therapy|Overall Study||0||
48516414|NCT00518622|101597141|FG001|Discontinued Therapy|Overall Study||1||
48516415|NCT00518622|101597142|FG002|Discontinued Therapy|Overall Study||0||
48516416|NCT00518622|101597143|FG003|Discontinued Therapy|Overall Study||0||
48516417|NCT00518622|101597144|FG004|Discontinued Therapy|Overall Study||0||
48516418|NCT00518622|101597145|FG005|Discontinued Therapy|Overall Study||0||
48516419|NCT00518622|101597146|FG006|Discontinued Therapy|Overall Study||0||
48516420|NCT00518622|101597147|FG007|Discontinued Therapy|Overall Study||0||
48516421|NCT00518622|101597140|FG000|COMPLETED|Overall Study||3||
48516422|NCT00518622|101597141|FG001|COMPLETED|Overall Study||5||
48516423|NCT00518622|101597142|FG002|COMPLETED|Overall Study||5||
48516424|NCT00518622|101597143|FG003|COMPLETED|Overall Study||5||
48516425|NCT00518622|101597144|FG004|COMPLETED|Overall Study||6||
48516426|NCT00518622|101597145|FG005|COMPLETED|Overall Study||5||
48516427|NCT00518622|101597146|FG006|COMPLETED|Overall Study||4||
48516428|NCT00518622|101597147|FG007|COMPLETED|Overall Study||5||
48516429|NCT00518622|101597140|FG000|NOT COMPLETED|Overall Study||0||
48516430|NCT00518622|101597141|FG001|NOT COMPLETED|Overall Study||1||
48516431|NCT00518622|101597142|FG002|NOT COMPLETED|Overall Study||1||
48516432|NCT00518622|101597143|FG003|NOT COMPLETED|Overall Study||0||
48516433|NCT00518622|101597144|FG004|NOT COMPLETED|Overall Study||0||
48516434|NCT00518622|101597145|FG005|NOT COMPLETED|Overall Study||0||
48516435|NCT00518622|101597146|FG006|NOT COMPLETED|Overall Study||0||
48516436|NCT00518622|101597147|FG007|NOT COMPLETED|Overall Study||0||
48516437|NCT04213209|101597148|FG000|STARTED|Overall Study||32||
48516438|NCT04213209|101597149|FG001|STARTED|Overall Study||35||
48516439|NCT04213209|101597150|FG002|STARTED|Overall Study||14||
48516440|NCT04213209|101597151|FG003|STARTED|Overall Study||6||
48516441|NCT04213209|101597152|FG004|STARTED|Overall Study||4||
48516442|NCT04213209|101597153|FG005|STARTED|Overall Study||4||
48516443|NCT04213209|101597148|FG000|COMPLETED|Overall Study||31||
48516444|NCT04213209|101597149|FG001|COMPLETED|Overall Study||35||
48516445|NCT04213209|101597150|FG002|COMPLETED|Overall Study||14||
48516446|NCT04213209|101597151|FG003|COMPLETED|Overall Study||6||
48516447|NCT04213209|101597152|FG004|COMPLETED|Overall Study||4||
48516448|NCT04213209|101597153|FG005|COMPLETED|Overall Study||4||
48516449|NCT04213209|101597148|FG000|NOT COMPLETED|Overall Study||1||
48516450|NCT04213209|101597149|FG001|NOT COMPLETED|Overall Study||0||
48516451|NCT04213209|101597150|FG002|NOT COMPLETED|Overall Study||0||
48516452|NCT04213209|101597151|FG003|NOT COMPLETED|Overall Study||0||
48516453|NCT04213209|101597152|FG004|NOT COMPLETED|Overall Study||0||
48516454|NCT04213209|101597153|FG005|NOT COMPLETED|Overall Study||0||
48516455|NCT03623620|101597154|FG000|STARTED|Overall Study||249||
48516456|NCT03623620|101597155|FG001|STARTED|Overall Study||251||
48516457|NCT03623620|101597154|FG000|COMPLETED|Overall Study||249||
48516458|NCT03623620|101597155|FG001|COMPLETED|Overall Study||251||
48516459|NCT03623620|101597154|FG000|NOT COMPLETED|Overall Study||0||
48516460|NCT03623620|101597155|FG001|NOT COMPLETED|Overall Study||0||
48516461|NCT02427984|101597156|FG000|STARTED|Overall Study||53||
48516462|NCT02427984|101597157|FG001|STARTED|Overall Study||45||
48516463|NCT02427984|101597158|FG002|STARTED|Overall Study||50||
48516464|NCT02427984|101597156|FG000|COMPLETED|Overall Study||40||
48516465|NCT02427984|101597157|FG001|COMPLETED|Overall Study||40||
48516466|NCT02427984|101597158|FG002|COMPLETED|Overall Study||32||
48516467|NCT02427984|101597156|FG000|NOT COMPLETED|Overall Study||13||
48516468|NCT02427984|101597157|FG001|NOT COMPLETED|Overall Study||5||
48516469|NCT02427984|101597158|FG002|NOT COMPLETED|Overall Study||18||
48516470|NCT02012452|101597159|FG000|STARTED|Overall Study||7||
48516471|NCT02012452|101597160|FG001|STARTED|Overall Study||2||
48516472|NCT02012452|101597159|FG000|COMPLETED|Overall Study||1||
48516473|NCT02012452|101597160|FG001|COMPLETED|Overall Study||1||
48516474|NCT02012452|101597159|FG000|NOT COMPLETED|Overall Study||6||
48516475|NCT02012452|101597160|FG001|NOT COMPLETED|Overall Study||1||
48516476|NCT00101413|101597161|FG000|STARTED|Overall Study||52||
48516477|NCT00101413|101597161|FG000|COMPLETED|Overall Study||52||
48516478|NCT00101413|101597161|FG000|NOT COMPLETED|Overall Study||0||
48516479|NCT03395639|101597162|FG000|STARTED|Main Treatment Period (0 to 4 Months)||110||
48516480|NCT03395639|101597163|FG001|STARTED|Main Treatment Period (0 to 4 Months)||58||
48516481|NCT03395639|101597164|FG002|STARTED|Main Treatment Period (0 to 4 Months)||0||
48516482|NCT03395639|101597162|FG000|Modified Intent to Treat Population|Main Treatment Period (0 to 4 Months)||109||
48516483|NCT03395639|101597163|FG001|Modified Intent to Treat Population|Main Treatment Period (0 to 4 Months)||58||
48516484|NCT03395639|101597164|FG002|Modified Intent to Treat Population|Main Treatment Period (0 to 4 Months)||0||
48516485|NCT03395639|101597162|FG000|COMPLETED|Main Treatment Period (0 to 4 Months)||107||
48516486|NCT03395639|101597163|FG001|COMPLETED|Main Treatment Period (0 to 4 Months)||55||
48516487|NCT03395639|101597164|FG002|COMPLETED|Main Treatment Period (0 to 4 Months)||0||
48516488|NCT03395639|101597162|FG000|NOT COMPLETED|Main Treatment Period (0 to 4 Months)||3||
48516489|NCT03395639|101597163|FG001|NOT COMPLETED|Main Treatment Period (0 to 4 Months)||3||
48516490|NCT03395639|101597164|FG002|NOT COMPLETED|Main Treatment Period (0 to 4 Months)||0||
48516491|NCT03395639|101597162|FG000|STARTED|Extension Period (4-13 Months)||0||
48516492|NCT03395639|101597163|FG001|STARTED|Extension Period (4-13 Months)||0||
48516493|NCT03395639|101597164|FG002|STARTED|Extension Period (4-13 Months)||147||
48516494|NCT03395639|101597162|FG000|COMPLETED|Extension Period (4-13 Months)||0||
48516495|NCT03395639|101597163|FG001|COMPLETED|Extension Period (4-13 Months)||0||
48516496|NCT03395639|101597164|FG002|COMPLETED|Extension Period (4-13 Months)||144||
48516497|NCT03395639|101597162|FG000|NOT COMPLETED|Extension Period (4-13 Months)||0||
48516498|NCT03395639|101597163|FG001|NOT COMPLETED|Extension Period (4-13 Months)||0||
48516499|NCT03395639|101597164|FG002|NOT COMPLETED|Extension Period (4-13 Months)||3||
48516500|NCT03052972|101597165|FG000|STARTED|Overall Study||18||
48516501|NCT03052972|101597166|FG001|STARTED|Overall Study||5||
48516502|NCT03052972|101597165|FG000|COMPLETED|Overall Study||18||
48516503|NCT03052972|101597166|FG001|COMPLETED|Overall Study||5||
48516504|NCT03052972|101597165|FG000|NOT COMPLETED|Overall Study||0||
48516505|NCT03052972|101597166|FG001|NOT COMPLETED|Overall Study||0||
48516506|NCT03765996|101597167|FG000|STARTED|Overall Study||18||
48516507|NCT03765996|101597168|FG001|STARTED|Overall Study||18||
48516508|NCT03765996|101597167|FG000|COMPLETED|Overall Study||14||
48516509|NCT03765996|101597168|FG001|COMPLETED|Overall Study||18||
48516510|NCT03765996|101597167|FG000|NOT COMPLETED|Overall Study||4||
48516511|NCT03765996|101597168|FG001|NOT COMPLETED|Overall Study||0||
48516512|NCT02568007|101597169|FG000|STARTED|Overall Study||2||
48516513|NCT02568007|101597170|FG001|STARTED|Overall Study||2||
48516514|NCT02568007|101597171|FG002|STARTED|Overall Study||0||
48516515|NCT02568007|101597169|FG000|COMPLETED|Overall Study||2||
48516516|NCT02568007|101597170|FG001|COMPLETED|Overall Study||2||
48516517|NCT02568007|101597171|FG002|COMPLETED|Overall Study||0||
48516518|NCT02568007|101597169|FG000|NOT COMPLETED|Overall Study||0||
48516519|NCT02568007|101597170|FG001|NOT COMPLETED|Overall Study||0||
48516520|NCT02568007|101597171|FG002|NOT COMPLETED|Overall Study||0||
48516521|NCT02014441|101597172|FG000|STARTED|Overall Study||61||
48516522|NCT02014441|101597172|FG000|Received Treatment|Overall Study||60||
48516523|NCT02014441|101597172|FG000|COMPLETED|Overall Study||49||
48516524|NCT02014441|101597172|FG000|NOT COMPLETED|Overall Study||12||
48516525|NCT01467479|101597173|FG000|STARTED|Overall Study||55||
48516526|NCT01467479|101597174|FG001|STARTED|Overall Study||69||
48516527|NCT01467479|101597175|FG002|STARTED|Overall Study||61||
48516528|NCT01467479|101597173|FG000|Treated|Overall Study||54||
48516529|NCT01467479|101597174|FG001|Treated|Overall Study||69||
48516530|NCT01467479|101597175|FG002|Treated|Overall Study||59||
48516531|NCT01467479|101597173|FG000|COMPLETED|Overall Study||46||
48516532|NCT01467479|101597174|FG001|COMPLETED|Overall Study||52||
48516533|NCT01467479|101597175|FG002|COMPLETED|Overall Study||45||
48516534|NCT01467479|101597173|FG000|NOT COMPLETED|Overall Study||9||
48516535|NCT01467479|101597174|FG001|NOT COMPLETED|Overall Study||17||
48516536|NCT01467479|101597175|FG002|NOT COMPLETED|Overall Study||16||
48516537|NCT00707434|101597176|FG000|STARTED|Overall Study||6||
48516538|NCT00707434|101597176|FG000|COMPLETED|Overall Study||5||
48516539|NCT00707434|101597176|FG000|NOT COMPLETED|Overall Study||1||
48516540|NCT02948257|101597177|FG000|STARTED|Overall Study||52||
48516541|NCT02948257|101597177|FG000|COMPLETED|Overall Study||52||
48516542|NCT02948257|101597177|FG000|NOT COMPLETED|Overall Study||0||
48516543|NCT01961882|101597178|FG000|STARTED|Overall Study||69||
48516544|NCT01961882|101597179|FG001|STARTED|Overall Study||65||
48516545|NCT01961882|101597178|FG000|COMPLETED|Overall Study||19||
48516546|NCT01961882|101597179|FG001|COMPLETED|Overall Study||23||
48516547|NCT01961882|101597178|FG000|NOT COMPLETED|Overall Study||50||
48516548|NCT01961882|101597179|FG001|NOT COMPLETED|Overall Study||42||
48516549|NCT04052698|101597180|FG000|STARTED|Overall Study||43||
48516550|NCT04052698|101597180|FG000|Safety Analysis Set (SAF)|Overall Study||43||
48516551|NCT04052698|101597180|FG000|Modified Full Analysis Set (mFAS)|Overall Study||33||
48516552|NCT04052698|101597180|FG000|COMPLETED|Overall Study||30||
48516553|NCT04052698|101597180|FG000|NOT COMPLETED|Overall Study||13||
48516554|NCT01972035|101597181|FG000|STARTED|Overall Study||66||
48516555|NCT01972035|101597182|FG001|STARTED|Overall Study||71||
48516556|NCT01972035|101597181|FG000|COMPLETED|Overall Study||27||
48516557|NCT01972035|101597182|FG001|COMPLETED|Overall Study||44||
48516558|NCT01972035|101597181|FG000|NOT COMPLETED|Overall Study||39||
48516559|NCT01972035|101597182|FG001|NOT COMPLETED|Overall Study||27||
48516560|NCT04243096|101597183|FG000|STARTED|Overall Study||62||
48516561|NCT04243096|101597183|FG000|COMPLETED|Overall Study||58||
48516562|NCT04243096|101597183|FG000|NOT COMPLETED|Overall Study||4||
48516563|NCT01286558|101597184|FG000|STARTED|Overall Study||112||
48516564|NCT01286558|101597185|FG001|STARTED|Overall Study||113||
48516565|NCT01286558|101597184|FG000|COMPLETED|Overall Study||111||
48516566|NCT01286558|101597185|FG001|COMPLETED|Overall Study||111||
48516567|NCT01286558|101597184|FG000|NOT COMPLETED|Overall Study||1||
48516568|NCT01286558|101597185|FG001|NOT COMPLETED|Overall Study||2||
48516569|NCT01552369|101597186|FG000|STARTED|Overall Study||100||
48516570|NCT01552369|101597187|FG001|STARTED|Overall Study||105||
48516571|NCT01552369|101597186|FG000|One Year|Overall Study||100|Subjects completed major endpoints; CMV disease and/or all-cause mortality|
48516572|NCT01552369|101597187|FG001|One Year|Overall Study||105|Subjects completed major endpoints; CMV disease and/or all-cause mortality|
48516573|NCT01552369|101597186|FG000|Final Follow up|Overall Study||92||
48516574|NCT01552369|101597187|FG001|Final Follow up|Overall Study||96||
48516575|NCT01552369|101597186|FG000|COMPLETED|Overall Study||92|Subjects that completed major endpoint; CMV disease and/or all-cause mortality|
48516576|NCT01552369|101597187|FG001|COMPLETED|Overall Study||96|Subjects that completed major endpoint; CMV disease and/or all-cause mortality|
48516577|NCT01552369|101597186|FG000|NOT COMPLETED|Overall Study||8||
48516578|NCT01552369|101597187|FG001|NOT COMPLETED|Overall Study||9||
48516579|NCT01885182|101597188|FG000|STARTED|Overall Study||117||
48516580|NCT01885182|101597189|FG001|STARTED|Overall Study||115||
48516581|NCT01885182|101597188|FG000|Safety Population|Overall Study||114||
48516582|NCT01885182|101597189|FG001|Safety Population|Overall Study||111||
48516583|NCT01885182|101597188|FG000|FAP Population|Overall Study||107||
48516584|NCT01885182|101597189|FG001|FAP Population|Overall Study||106||
48516585|NCT01885182|101597188|FG000|COMPLETED|Overall Study||83||
48516586|NCT01885182|101597189|FG001|COMPLETED|Overall Study||93||
48516587|NCT01885182|101597188|FG000|NOT COMPLETED|Overall Study||34||
48068121|NCT00734474|100489656|FG004|Completed 52-Week Visit|Overall Study||243||
48516588|NCT01885182|101597189|FG001|NOT COMPLETED|Overall Study||22||
48516589|NCT01684215|101597190|FG000|STARTED|Phase 1, Part 1||6||
48516590|NCT01684215|101597191|FG001|STARTED|Phase 1, Part 1||6||
48516591|NCT01684215|101597192|FG002|STARTED|Phase 1, Part 1||0||
48516592|NCT01684215|101597193|FG003|STARTED|Phase 1, Part 1||0||
48516593|NCT01684215|101597190|FG000|Treated|Phase 1, Part 1||6||
48516594|NCT01684215|101597191|FG001|Treated|Phase 1, Part 1||6||
48516595|NCT01684215|101597192|FG002|Treated|Phase 1, Part 1||0||
48516596|NCT01684215|101597193|FG003|Treated|Phase 1, Part 1||0||
48516597|NCT01684215|101597190|FG000|COMPLETED|Phase 1, Part 1||0||
48516598|NCT01684215|101597191|FG001|COMPLETED|Phase 1, Part 1||0||
48516599|NCT01684215|101597192|FG002|COMPLETED|Phase 1, Part 1||0||
48516600|NCT01684215|101597193|FG003|COMPLETED|Phase 1, Part 1||0||
48516601|NCT01684215|101597190|FG000|NOT COMPLETED|Phase 1, Part 1||6||
48516602|NCT01684215|101597191|FG001|NOT COMPLETED|Phase 1, Part 1||6||
48516603|NCT01684215|101597192|FG002|NOT COMPLETED|Phase 1, Part 1||0||
48516604|NCT01684215|101597193|FG003|NOT COMPLETED|Phase 1, Part 1||0||
48516605|NCT01684215|101597190|FG000|STARTED|Phase 1, Part 2||0||
48516606|NCT01684215|101597191|FG001|STARTED|Phase 1, Part 2||0||
48516607|NCT01684215|101597192|FG002|STARTED|Phase 1, Part 2||6||
48516608|NCT01684215|101597193|FG003|STARTED|Phase 1, Part 2||0||
48516609|NCT01684215|101597190|FG000|COMPLETED|Phase 1, Part 2||0||
48516610|NCT01684215|101597191|FG001|COMPLETED|Phase 1, Part 2||0||
48516611|NCT01684215|101597192|FG002|COMPLETED|Phase 1, Part 2||0||
48516612|NCT01684215|101597193|FG003|COMPLETED|Phase 1, Part 2||0||
48516613|NCT01684215|101597190|FG000|NOT COMPLETED|Phase 1, Part 2||0||
48516614|NCT01684215|101597191|FG001|NOT COMPLETED|Phase 1, Part 2||0||
48516615|NCT01684215|101597192|FG002|NOT COMPLETED|Phase 1, Part 2||6||
48516616|NCT01684215|101597193|FG003|NOT COMPLETED|Phase 1, Part 2||0||
48516617|NCT01684215|101597190|FG000|STARTED|Phase 2||0||
48516618|NCT01684215|101597191|FG001|STARTED|Phase 2||0||
48516619|NCT01684215|101597192|FG002|STARTED|Phase 2||0||
48516620|NCT01684215|101597193|FG003|STARTED|Phase 2||43||
48516621|NCT01684215|101597190|FG000|Treated|Phase 2||0||
48516622|NCT01684215|101597191|FG001|Treated|Phase 2||0||
48516623|NCT01684215|101597192|FG002|Treated|Phase 2||0||
48516624|NCT01684215|101597193|FG003|Treated|Phase 2||42||
48516625|NCT01684215|101597190|FG000|COMPLETED|Phase 2||0||
48516626|NCT01684215|101597191|FG001|COMPLETED|Phase 2||0||
48516627|NCT01684215|101597192|FG002|COMPLETED|Phase 2||0||
48516628|NCT01684215|101597193|FG003|COMPLETED|Phase 2||0||
48516629|NCT01684215|101597190|FG000|NOT COMPLETED|Phase 2||0||
48516630|NCT01684215|101597191|FG001|NOT COMPLETED|Phase 2||0||
48516631|NCT01684215|101597192|FG002|NOT COMPLETED|Phase 2||0||
48516632|NCT01684215|101597193|FG003|NOT COMPLETED|Phase 2||43||
48516633|NCT01132664|101597194|FG000|STARTED|Phase lb||5||
48516634|NCT01132664|101597195|FG001|STARTED|Phase lb||12||
48516635|NCT01132664|101597196|FG002|STARTED|Phase lb||0||
48516636|NCT01132664|101597197|FG003|STARTED|Phase lb||0||
48516637|NCT01132664|101597198|FG004|STARTED|Phase lb||0||
48516638|NCT01132664|101597194|FG000|COMPLETED|Phase lb||0||
48516639|NCT01132664|101597195|FG001|COMPLETED|Phase lb||0||
48516640|NCT01132664|101597196|FG002|COMPLETED|Phase lb||0||
48516641|NCT01132664|101597197|FG003|COMPLETED|Phase lb||0||
48516642|NCT01132664|101597198|FG004|COMPLETED|Phase lb||0||
48516643|NCT01132664|101597194|FG000|NOT COMPLETED|Phase lb||5||
48516644|NCT01132664|101597195|FG001|NOT COMPLETED|Phase lb||12||
48516645|NCT01132664|101597196|FG002|NOT COMPLETED|Phase lb||0||
48516646|NCT01132664|101597197|FG003|NOT COMPLETED|Phase lb||0||
48516647|NCT01132664|101597198|FG004|NOT COMPLETED|Phase lb||0||
48516648|NCT01132664|101597194|FG000|STARTED|Phase ll||0||
48516649|NCT01132664|101597195|FG001|STARTED|Phase ll||0||
48516650|NCT01132664|101597196|FG002|STARTED|Phase ll||50||
48516651|NCT01132664|101597197|FG003|STARTED|Phase ll||0||
48516652|NCT01132664|101597198|FG004|STARTED|Phase ll||0||
48516653|NCT01132664|101597194|FG000|COMPLETED|Phase ll||0||
48516654|NCT01132664|101597195|FG001|COMPLETED|Phase ll||0||
48516655|NCT01132664|101597196|FG002|COMPLETED|Phase ll||0||
48516656|NCT01132664|101597197|FG003|COMPLETED|Phase ll||0||
48516657|NCT01132664|101597198|FG004|COMPLETED|Phase ll||0||
48516658|NCT01132664|101597194|FG000|NOT COMPLETED|Phase ll||0||
48516659|NCT01132664|101597195|FG001|NOT COMPLETED|Phase ll||0||
48516660|NCT01132664|101597196|FG002|NOT COMPLETED|Phase ll||50||
48516661|NCT01132664|101597197|FG003|NOT COMPLETED|Phase ll||0||
48516662|NCT01132664|101597198|FG004|NOT COMPLETED|Phase ll||0||
48516663|NCT01132664|101597194|FG000|STARTED|BM Cohort||0||
48516664|NCT01132664|101597195|FG001|STARTED|BM Cohort||0||
48516665|NCT01132664|101597196|FG002|STARTED|BM Cohort||0||
48516666|NCT01132664|101597197|FG003|STARTED|BM Cohort||3||
48516667|NCT01132664|101597198|FG004|STARTED|BM Cohort||6||
48516668|NCT01132664|101597194|FG000|COMPLETED|BM Cohort||0||
48516669|NCT01132664|101597195|FG001|COMPLETED|BM Cohort||0||
48516670|NCT01132664|101597196|FG002|COMPLETED|BM Cohort||0||
48516671|NCT01132664|101597197|FG003|COMPLETED|BM Cohort||0||
48516672|NCT01132664|101597198|FG004|COMPLETED|BM Cohort||0||
48516673|NCT01132664|101597194|FG000|NOT COMPLETED|BM Cohort||0||
48516674|NCT01132664|101597195|FG001|NOT COMPLETED|BM Cohort||0||
48516675|NCT01132664|101597196|FG002|NOT COMPLETED|BM Cohort||0||
48516676|NCT01132664|101597197|FG003|NOT COMPLETED|BM Cohort||3||
48516677|NCT01132664|101597198|FG004|NOT COMPLETED|BM Cohort||6||
48516678|NCT02356211|101597199|FG000|STARTED|Overall Study||57||
48516679|NCT02356211|101597200|FG001|STARTED|Overall Study||52||
48516680|NCT02356211|101597199|FG000|COMPLETED|Overall Study||54||
48516681|NCT02356211|101597200|FG001|COMPLETED|Overall Study||42||
48516682|NCT02356211|101597199|FG000|NOT COMPLETED|Overall Study||3||
48516683|NCT02356211|101597200|FG001|NOT COMPLETED|Overall Study||10||
48516684|NCT01640184|101597201|FG000|STARTED|Overall Study||34||
48516685|NCT01640184|101597202|FG001|STARTED|Overall Study||23||
48516686|NCT01640184|101597203|FG002|STARTED|Overall Study||22||
48516687|NCT01640184|101597201|FG000|COMPLETED|Overall Study||26||
48516688|NCT01640184|101597202|FG001|COMPLETED|Overall Study||21||
48516689|NCT01640184|101597203|FG002|COMPLETED|Overall Study||20||
48516690|NCT01640184|101597201|FG000|NOT COMPLETED|Overall Study||8||
48516691|NCT01640184|101597202|FG001|NOT COMPLETED|Overall Study||2||
48516692|NCT01640184|101597203|FG002|NOT COMPLETED|Overall Study||2||
48516693|NCT00407745|101597204|FG000|STARTED|Overall Study||112||
48516694|NCT00407745|101597205|FG001|STARTED|Overall Study||108||
48516695|NCT00407745|101597204|FG000|Treated|Overall Study||112||
48516696|NCT00407745|101597205|FG001|Treated|Overall Study||107||
48516697|NCT00407745|101597204|FG000|COMPLETED|Overall Study||93||
48516698|NCT00407745|101597205|FG001|COMPLETED|Overall Study||91||
48516699|NCT00407745|101597204|FG000|NOT COMPLETED|Overall Study||19||
48516700|NCT00407745|101597205|FG001|NOT COMPLETED|Overall Study||17||
48516701|NCT02740179|101597206|FG000|STARTED|Overall Study||20||
48516702|NCT02740179|101597207|FG001|STARTED|Overall Study||20||
48516703|NCT02740179|101597206|FG000|COMPLETED|Overall Study||14||
48516704|NCT02740179|101597207|FG001|COMPLETED|Overall Study||19||
48516705|NCT02740179|101597206|FG000|NOT COMPLETED|Overall Study||6||
48516706|NCT02740179|101597207|FG001|NOT COMPLETED|Overall Study||1||
48516707|NCT03020719|101597208|FG000|STARTED|Overall Study||30|Treated defined as having taken at least one dose of study drug.|
48516708|NCT03020719|101597209|FG001|STARTED|Overall Study||30|Treated defined as having taken at least one dose of study drug.|
48516709|NCT03020719|101597208|FG000|COMPLETED|Overall Study||30|Completed last study visit (Week 24).|
48516710|NCT03020719|101597209|FG001|COMPLETED|Overall Study||28|Completed last study visit (Week 24).|
48516711|NCT03020719|101597208|FG000|NOT COMPLETED|Overall Study||0||
48516712|NCT03020719|101597209|FG001|NOT COMPLETED|Overall Study||2||
48516713|NCT01684878|101597210|FG000|STARTED|Part 1: Safety Run in Phase||22||
48516714|NCT01684878|101597211|FG001|STARTED|Part 1: Safety Run in Phase||28||
48516715|NCT01684878|101597212|FG002|STARTED|Part 1: Safety Run in Phase||0||
48516716|NCT01684878|101597213|FG003|STARTED|Part 1: Safety Run in Phase||0||
48516717|NCT01684878|101597210|FG000|COMPLETED|Part 1: Safety Run in Phase||6||
48516718|NCT01684878|101597211|FG001|COMPLETED|Part 1: Safety Run in Phase||5||
48516719|NCT01684878|101597212|FG002|COMPLETED|Part 1: Safety Run in Phase||0||
48516720|NCT01684878|101597213|FG003|COMPLETED|Part 1: Safety Run in Phase||0||
48516721|NCT01684878|101597210|FG000|NOT COMPLETED|Part 1: Safety Run in Phase||16||
48516722|NCT01684878|101597211|FG001|NOT COMPLETED|Part 1: Safety Run in Phase||23||
48516723|NCT01684878|101597212|FG002|NOT COMPLETED|Part 1: Safety Run in Phase||0||
48516724|NCT01684878|101597213|FG003|NOT COMPLETED|Part 1: Safety Run in Phase||0||
48516725|NCT01684878|101597210|FG000|STARTED|Part 2: Randomized Phase||0||
48516726|NCT01684878|101597211|FG001|STARTED|Part 2: Randomized Phase||0||
48516727|NCT01684878|101597212|FG002|STARTED|Part 2: Randomized Phase||78||
48516728|NCT01684878|101597213|FG003|STARTED|Part 2: Randomized Phase||78||
48516729|NCT01684878|101597210|FG000|Participants Randomized But Not Treated|Part 2: Randomized Phase||0||
48516730|NCT01684878|101597211|FG001|Participants Randomized But Not Treated|Part 2: Randomized Phase||0||
48516731|NCT01684878|101597212|FG002|Participants Randomized But Not Treated|Part 2: Randomized Phase||1||
48516732|NCT01684878|101597213|FG003|Participants Randomized But Not Treated|Part 2: Randomized Phase||2||
48516733|NCT01684878|101597210|FG000|Participants Mis-randomized|Part 2: Randomized Phase||0||
48516734|NCT01684878|101597211|FG001|Participants Mis-randomized|Part 2: Randomized Phase||0||
48516735|NCT01684878|101597212|FG002|Participants Mis-randomized|Part 2: Randomized Phase||2||
48516736|NCT01684878|101597213|FG003|Participants Mis-randomized|Part 2: Randomized Phase||0||
48516737|NCT01684878|101597210|FG000|COMPLETED|Part 2: Randomized Phase||0||
48516738|NCT01684878|101597211|FG001|COMPLETED|Part 2: Randomized Phase||0||
48516739|NCT01684878|101597212|FG002|COMPLETED|Part 2: Randomized Phase||0||
48516740|NCT01684878|101597213|FG003|COMPLETED|Part 2: Randomized Phase||0||
48516741|NCT01684878|101597210|FG000|NOT COMPLETED|Part 2: Randomized Phase||0||
48516742|NCT01684878|101597211|FG001|NOT COMPLETED|Part 2: Randomized Phase||0||
48516743|NCT01684878|101597212|FG002|NOT COMPLETED|Part 2: Randomized Phase||78||
48516744|NCT01684878|101597213|FG003|NOT COMPLETED|Part 2: Randomized Phase||78||
48516745|NCT00233987|101597214|FG000|STARTED|Overall Study||98||
48516746|NCT00233987|101597214|FG000|Eligible|Overall Study||94||
48516747|NCT00233987|101597214|FG000|Eligible and Treated|Overall Study||92||
48516748|NCT00233987|101597214|FG000|COMPLETED|Overall Study||83||
48516749|NCT00233987|101597214|FG000|NOT COMPLETED|Overall Study||15||
48516750|NCT02181296|101597215|FG000|STARTED|Overall Study||25||
48516751|NCT02181296|101597216|FG001|STARTED|Overall Study||25||
48516752|NCT02181296|101597215|FG000|COMPLETED|Overall Study||18||
48516753|NCT02181296|101597216|FG001|COMPLETED|Overall Study||19||
48516754|NCT02181296|101597215|FG000|NOT COMPLETED|Overall Study||7||
48516755|NCT02181296|101597216|FG001|NOT COMPLETED|Overall Study||6||
48516756|NCT03028896|101597217|FG000|STARTED|Overall Study||66||
48516757|NCT03028896|101597218|FG001|STARTED|Overall Study||66||
48516758|NCT03028896|101597217|FG000|COMPLETED|Overall Study||63||
48516759|NCT03028896|101597218|FG001|COMPLETED|Overall Study||66||
48516760|NCT03028896|101597217|FG000|NOT COMPLETED|Overall Study||3||
48516761|NCT03028896|101597218|FG001|NOT COMPLETED|Overall Study||0||
48516762|NCT00966381|101597219|FG000|STARTED|Overall Study||15||
48516763|NCT00966381|101597220|FG001|STARTED|Overall Study||16||
48516764|NCT00966381|101597219|FG000|COMPLETED|Overall Study||13||
48516765|NCT00966381|101597220|FG001|COMPLETED|Overall Study||14||
48516766|NCT00966381|101597219|FG000|NOT COMPLETED|Overall Study||2||
48516767|NCT00966381|101597220|FG001|NOT COMPLETED|Overall Study||2||
48516768|NCT01119807|101597221|FG000|STARTED|Overall Study||67||
48516769|NCT01119807|101597222|FG001|STARTED|Overall Study||51||
48516770|NCT01119807|101597223|FG002|STARTED|Overall Study||64||
48516771|NCT01119807|101597221|FG000|COMPLETED|Overall Study||67||
48516772|NCT01119807|101597222|FG001|COMPLETED|Overall Study||51||
48516773|NCT01119807|101597223|FG002|COMPLETED|Overall Study||64||
48516774|NCT01119807|101597221|FG000|NOT COMPLETED|Overall Study||0||
48516775|NCT01119807|101597222|FG001|NOT COMPLETED|Overall Study||0||
48516776|NCT01119807|101597223|FG002|NOT COMPLETED|Overall Study||0||
48516777|NCT03407612|101597224|FG000|STARTED|Overall Study||19||
48516778|NCT03407612|101597225|FG001|STARTED|Overall Study||23||
48516779|NCT03407612|101597224|FG000|COMPLETED|Overall Study||19||
48516780|NCT03407612|101597225|FG001|COMPLETED|Overall Study||23||
48516781|NCT03407612|101597224|FG000|NOT COMPLETED|Overall Study||0||
48516782|NCT03407612|101597225|FG001|NOT COMPLETED|Overall Study||0||
48516783|NCT01729026|101597226|FG000|STARTED|Randomization to 3-month Follow-up||9||
48516784|NCT01729026|101597227|FG001|STARTED|Randomization to 3-month Follow-up||10||
48516785|NCT01729026|101597226|FG000|COMPLETED|Randomization to 3-month Follow-up||7||
48516786|NCT01729026|101597227|FG001|COMPLETED|Randomization to 3-month Follow-up||8||
48516787|NCT01729026|101597226|FG000|NOT COMPLETED|Randomization to 3-month Follow-up||2||
48516788|NCT01729026|101597227|FG001|NOT COMPLETED|Randomization to 3-month Follow-up||2||
48516789|NCT01729026|101597226|FG000|STARTED|3-month to 6-month (Final) Follow-up||7||
48516790|NCT01729026|101597227|FG001|STARTED|3-month to 6-month (Final) Follow-up||8||
48516791|NCT01729026|101597226|FG000|COMPLETED|3-month to 6-month (Final) Follow-up||6||
48516792|NCT01729026|101597227|FG001|COMPLETED|3-month to 6-month (Final) Follow-up||6||
48516793|NCT01729026|101597226|FG000|NOT COMPLETED|3-month to 6-month (Final) Follow-up||1||
48516794|NCT01729026|101597227|FG001|NOT COMPLETED|3-month to 6-month (Final) Follow-up||2||
48516795|NCT01398059|101597228|FG000|STARTED|Overall Study||4||
48516796|NCT01398059|101597229|FG001|STARTED|Overall Study||3||
48516797|NCT01398059|101597230|FG002|STARTED|Overall Study||4||
48516798|NCT01398059|101597231|FG003|STARTED|Overall Study||2||
48516799|NCT01398059|101597232|FG004|STARTED|Overall Study||4||
48516800|NCT01398059|101597233|FG005|STARTED|Overall Study||2||
48516801|NCT01398059|101597228|FG000|COMPLETED|Overall Study||4||
48516802|NCT01398059|101597229|FG001|COMPLETED|Overall Study||3||
48516803|NCT01398059|101597230|FG002|COMPLETED|Overall Study||4||
48516804|NCT01398059|101597231|FG003|COMPLETED|Overall Study||2||
48516805|NCT01398059|101597232|FG004|COMPLETED|Overall Study||4||
48516806|NCT01398059|101597233|FG005|COMPLETED|Overall Study||2||
48516807|NCT01398059|101597228|FG000|NOT COMPLETED|Overall Study||0||
48516808|NCT01398059|101597229|FG001|NOT COMPLETED|Overall Study||0||
48516809|NCT01398059|101597230|FG002|NOT COMPLETED|Overall Study||0||
48516810|NCT01398059|101597231|FG003|NOT COMPLETED|Overall Study||0||
48516811|NCT01398059|101597232|FG004|NOT COMPLETED|Overall Study||0||
48516812|NCT01398059|101597233|FG005|NOT COMPLETED|Overall Study||0||
48516813|NCT03851588|101597234|FG000|STARTED|Overall Study||53||
48516814|NCT03851588|101597235|FG001|STARTED|Overall Study||55||
48516815|NCT03851588|101597234|FG000|COMPLETED|Overall Study||51||
48516816|NCT03851588|101597235|FG001|COMPLETED|Overall Study||52||
48516817|NCT03851588|101597234|FG000|NOT COMPLETED|Overall Study||2||
48516818|NCT03851588|101597235|FG001|NOT COMPLETED|Overall Study||3||
48516819|NCT01915940|101597236|FG000|STARTED|Pre-randomization Washout Period||169||
48516820|NCT01915940|101597237|FG001|STARTED|Pre-randomization Washout Period||0||
48516821|NCT01915940|101597238|FG002|STARTED|Pre-randomization Washout Period||0||
48516822|NCT01915940|101597236|FG000|COMPLETED|Pre-randomization Washout Period||130||
48516823|NCT01915940|101597237|FG001|COMPLETED|Pre-randomization Washout Period||0||
48516824|NCT01915940|101597238|FG002|COMPLETED|Pre-randomization Washout Period||0||
48516825|NCT01915940|101597236|FG000|NOT COMPLETED|Pre-randomization Washout Period||39||
48516826|NCT01915940|101597237|FG001|NOT COMPLETED|Pre-randomization Washout Period||0||
48516827|NCT01915940|101597238|FG002|NOT COMPLETED|Pre-randomization Washout Period||0||
48516828|NCT01915940|101597236|FG000|STARTED|Treatment Period||0||
48516829|NCT01915940|101597237|FG001|STARTED|Treatment Period||64||
48516830|NCT01915940|101597238|FG002|STARTED|Treatment Period||66||
48516831|NCT01915940|101597236|FG000|COMPLETED|Treatment Period||0||
48516832|NCT01915940|101597237|FG001|COMPLETED|Treatment Period||53||
48516833|NCT01915940|101597238|FG002|COMPLETED|Treatment Period||62||
48068122|NCT00734474|100489657|FG005|Completed 52-Week Visit|Overall Study||0||
48516834|NCT01915940|101597236|FG000|NOT COMPLETED|Treatment Period||0||
48516835|NCT01915940|101597237|FG001|NOT COMPLETED|Treatment Period||11||
48516836|NCT01915940|101597238|FG002|NOT COMPLETED|Treatment Period||4||
48516837|NCT03714555|101597239|FG000|STARTED|Overall Study||1||
48516838|NCT03714555|101597240|FG001|STARTED|Overall Study||0||
48516839|NCT03714555|101597241|FG002|STARTED|Overall Study||0||
48516840|NCT03714555|101597239|FG000|COMPLETED|Overall Study||0||
48516841|NCT03714555|101597240|FG001|COMPLETED|Overall Study||0||
48516842|NCT03714555|101597241|FG002|COMPLETED|Overall Study||0||
48516843|NCT03714555|101597239|FG000|NOT COMPLETED|Overall Study||1||
48516844|NCT03714555|101597240|FG001|NOT COMPLETED|Overall Study||0||
48516845|NCT03714555|101597241|FG002|NOT COMPLETED|Overall Study||0||
48516846|NCT02598895|101597242|FG000|STARTED|Overall Study||14||
48516847|NCT02598895|101597242|FG000|PSA50|Overall Study||14||
48516848|NCT02598895|101597242|FG000|COMPLETED|Overall Study||14||
48516849|NCT02598895|101597242|FG000|NOT COMPLETED|Overall Study||0||
48516850|NCT00194792|101597243|FG000|STARTED|Overall Study||28||
48516851|NCT00194792|101597243|FG000|COMPLETED|Overall Study||27||
48516852|NCT00194792|101597243|FG000|NOT COMPLETED|Overall Study||1||
48516853|NCT02408445|101597244|FG000|STARTED|Overall Study||10||
48516854|NCT02408445|101597245|FG001|STARTED|Overall Study||10||
48516855|NCT02408445|101597244|FG000|COMPLETED|Overall Study||10||
48516856|NCT02408445|101597245|FG001|COMPLETED|Overall Study||10||
48516857|NCT02408445|101597244|FG000|NOT COMPLETED|Overall Study||0||
48516858|NCT02408445|101597245|FG001|NOT COMPLETED|Overall Study||0||
48516859|NCT00385788|101597246|FG000|STARTED|Overall Study||12||
48516860|NCT00385788|101597247|FG001|STARTED|Overall Study||40||
48516861|NCT00385788|101597246|FG000|COMPLETED|Overall Study||12||
48516862|NCT00385788|101597247|FG001|COMPLETED|Overall Study||40||
48516863|NCT00385788|101597246|FG000|NOT COMPLETED|Overall Study||0||
48516864|NCT00385788|101597247|FG001|NOT COMPLETED|Overall Study||0||
48516865|NCT05197829|101597248|FG000|STARTED|Overall Study||16||
48516866|NCT05197829|101597249|FG001|STARTED|Overall Study||14||
48516867|NCT05197829|101597248|FG000|COMPLETED|Overall Study||16||
48516868|NCT05197829|101597249|FG001|COMPLETED|Overall Study||14||
48516869|NCT05197829|101597248|FG000|NOT COMPLETED|Overall Study||0||
48516870|NCT05197829|101597249|FG001|NOT COMPLETED|Overall Study||0||
48516871|NCT01573533|101597250|FG000|STARTED|Overall Study||9||
48516872|NCT01573533|101597250|FG000|COMPLETED|Overall Study||9||
48516873|NCT01573533|101597250|FG000|NOT COMPLETED|Overall Study||0||
48516874|NCT00945334|101597251|FG000|STARTED|Overall Study||19||
48516875|NCT00945334|101597252|FG001|STARTED|Overall Study||18||
48516876|NCT00945334|101597251|FG000|COMPLETED|Overall Study||16||
48516877|NCT00945334|101597252|FG001|COMPLETED|Overall Study||15||
48516878|NCT00945334|101597251|FG000|NOT COMPLETED|Overall Study||3||
48516879|NCT00945334|101597252|FG001|NOT COMPLETED|Overall Study||3||
48516880|NCT03326986|101597253|FG000|STARTED|Overall Study||8||
48516881|NCT03326986|101597254|FG001|STARTED|Overall Study||8||
48516882|NCT03326986|101597255|FG002|STARTED|Overall Study||8||
48516883|NCT03326986|101597253|FG000|COMPLETED|Overall Study||8||
48516884|NCT03326986|101597254|FG001|COMPLETED|Overall Study||8||
48516885|NCT03326986|101597255|FG002|COMPLETED|Overall Study||8||
48516886|NCT03326986|101597253|FG000|NOT COMPLETED|Overall Study||0||
48516887|NCT03326986|101597254|FG001|NOT COMPLETED|Overall Study||0||
48516888|NCT03326986|101597255|FG002|NOT COMPLETED|Overall Study||0||
48516889|NCT00702208|101597256|FG000|STARTED|Overall Study||198||
48516890|NCT00702208|101597256|FG000|COMPLETED|Overall Study||167||
48516891|NCT00702208|101597256|FG000|NOT COMPLETED|Overall Study||31||
48516892|NCT02674633|101597257|FG000|STARTED|Overall Study||180||
48516893|NCT02674633|101597258|FG001|STARTED|Overall Study||168||
48516894|NCT02674633|101597257|FG000|COMPLETED|Overall Study||175||
48516895|NCT02674633|101597258|FG001|COMPLETED|Overall Study||164||
48516896|NCT02674633|101597257|FG000|NOT COMPLETED|Overall Study||5||
48516897|NCT02674633|101597258|FG001|NOT COMPLETED|Overall Study||4||
48516898|NCT01688726|101597259|FG000|STARTED|Overall Study||46||
48516899|NCT01688726|101597260|FG001|STARTED|Overall Study||45||
48516900|NCT01688726|101597259|FG000|COMPLETED|Overall Study||45||
48516901|NCT01688726|101597260|FG001|COMPLETED|Overall Study||44||
48516902|NCT01688726|101597259|FG000|NOT COMPLETED|Overall Study||1||
48516903|NCT01688726|101597260|FG001|NOT COMPLETED|Overall Study||1||
48516904|NCT00987831|101597261|FG000|STARTED|Overall Study||41||
48516905|NCT00987831|101597262|FG001|STARTED|Overall Study||55||
48516906|NCT00987831|101597263|FG002|STARTED|Overall Study||62||
48516907|NCT00987831|101597261|FG000|COMPLETED|Overall Study||40||
48068123|NCT00734474|100489658|FG006|Completed 52-Week Visit|Overall Study||0||
48516908|NCT00987831|101597262|FG001|COMPLETED|Overall Study||52||
48516909|NCT00987831|101597263|FG002|COMPLETED|Overall Study||62||
48516910|NCT00987831|101597261|FG000|NOT COMPLETED|Overall Study||1||
48516911|NCT00987831|101597262|FG001|NOT COMPLETED|Overall Study||3||
48516912|NCT00987831|101597263|FG002|NOT COMPLETED|Overall Study||0||
48516913|NCT00099268|101597264|FG000|STARTED|Overall Study||374||
48516914|NCT00099268|101597265|FG001|STARTED|Overall Study||373||
48516915|NCT00099268|101597264|FG000|Intent-to-Treat|Overall Study||373||
48516916|NCT00099268|101597265|FG001|Intent-to-Treat|Overall Study||372||
48516917|NCT00099268|101597264|FG000|COMPLETED|Overall Study||282||
48516918|NCT00099268|101597265|FG001|COMPLETED|Overall Study||291||
48516919|NCT00099268|101597264|FG000|NOT COMPLETED|Overall Study||92||
48516920|NCT00099268|101597265|FG001|NOT COMPLETED|Overall Study||82||
48516921|NCT00058214|101597266|FG000|STARTED|Overall Study||25||
48516922|NCT00058214|101597266|FG000|COMPLETED|Overall Study||24||
48516923|NCT00058214|101597266|FG000|NOT COMPLETED|Overall Study||1||
48516924|NCT01083680|101597267|FG000|STARTED|Overall Study||4107||
48516925|NCT01083680|101597267|FG000|Full Analysis Set (FAS), Efficacy|Overall Study||1621||
48516926|NCT01083680|101597267|FG000|COMPLETED|Overall Study||263||
48516927|NCT01083680|101597267|FG000|NOT COMPLETED|Overall Study||3844||
48516928|NCT00880087|101597268|FG000|STARTED|Overall Study||166||
48516929|NCT00880087|101597269|FG001|STARTED|Overall Study||163||
48516930|NCT00880087|101597268|FG000|COMPLETED|Overall Study||166||
48516931|NCT00880087|101597269|FG001|COMPLETED|Overall Study||161||
48516932|NCT00880087|101597268|FG000|NOT COMPLETED|Overall Study||0||
48516933|NCT00880087|101597269|FG001|NOT COMPLETED|Overall Study||2||
48516934|NCT00794417|101597270|FG000|STARTED|Phase 1: Baseline (Day 1) up to Day 751||4||
48516935|NCT00794417|101597271|FG001|STARTED|Phase 1: Baseline (Day 1) up to Day 751||7||
48516936|NCT00794417|101597272|FG002|STARTED|Phase 1: Baseline (Day 1) up to Day 751||7||
48516937|NCT00794417|101597273|FG003|STARTED|Phase 1: Baseline (Day 1) up to Day 751||0||
48516938|NCT00794417|101597270|FG000|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||1||
48516939|NCT00794417|101597271|FG001|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||4||
48516940|NCT00794417|101597272|FG002|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||4||
48516941|NCT00794417|101597273|FG003|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||0||
48516942|NCT00794417|101597270|FG000|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3||
48516943|NCT00794417|101597271|FG001|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3||
48516944|NCT00794417|101597272|FG002|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3||
48516945|NCT00794417|101597273|FG003|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||0||
48516946|NCT00794417|101597270|FG000|STARTED|Phase 2: Baseline (Day 421) to Day 972||0||
48516947|NCT00794417|101597271|FG001|STARTED|Phase 2: Baseline (Day 421) to Day 972||0||
48516948|NCT00794417|101597272|FG002|STARTED|Phase 2: Baseline (Day 421) to Day 972||0||
48516949|NCT00794417|101597273|FG003|STARTED|Phase 2: Baseline (Day 421) to Day 972||42||
48516950|NCT00794417|101597270|FG000|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0||
48516951|NCT00794417|101597271|FG001|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0||
48516952|NCT00794417|101597272|FG002|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0||
48516953|NCT00794417|101597273|FG003|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||7||
48516954|NCT00794417|101597270|FG000|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0||
48516955|NCT00794417|101597271|FG001|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0||
48516956|NCT00794417|101597272|FG002|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0||
48516957|NCT00794417|101597273|FG003|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||35||
48516958|NCT00115934|101597274|FG000|STARTED|Overall Study||279||
48516959|NCT00115934|101597275|FG001|STARTED|Overall Study||276||
48516960|NCT00115934|101597274|FG000|COMPLETED|Overall Study||275||
48516961|NCT00115934|101597275|FG001|COMPLETED|Overall Study||274||
48516962|NCT00115934|101597274|FG000|NOT COMPLETED|Overall Study||4||
48516963|NCT00115934|101597275|FG001|NOT COMPLETED|Overall Study||2||
48516964|NCT04025684|101597276|FG000|STARTED|Overall Study||20||
48516965|NCT04025684|101597277|FG001|STARTED|Overall Study||19||
48516966|NCT04025684|101597278|FG002|STARTED|Overall Study||20||
48516967|NCT04025684|101597279|FG003|STARTED|Overall Study||21||
48516968|NCT04025684|101597276|FG000|COMPLETED|Overall Study||18||
48516969|NCT04025684|101597277|FG001|COMPLETED|Overall Study||15||
48516970|NCT04025684|101597278|FG002|COMPLETED|Overall Study||20||
48516971|NCT04025684|101597279|FG003|COMPLETED|Overall Study||20||
48516972|NCT04025684|101597276|FG000|NOT COMPLETED|Overall Study||2||
48516973|NCT04025684|101597277|FG001|NOT COMPLETED|Overall Study||4||
48516974|NCT04025684|101597278|FG002|NOT COMPLETED|Overall Study||0||
48516975|NCT04025684|101597279|FG003|NOT COMPLETED|Overall Study||1||
48516976|NCT03662308|101597280|FG000|STARTED|First Intervention||8||
48516977|NCT03662308|101597281|FG001|STARTED|First Intervention||5||
48516978|NCT03662308|101597282|FG002|STARTED|First Intervention||4||
48516979|NCT03662308|101597280|FG000|COMPLETED|First Intervention||8||
48516980|NCT03662308|101597281|FG001|COMPLETED|First Intervention||5||
48516981|NCT03662308|101597282|FG002|COMPLETED|First Intervention||4||
48516982|NCT03662308|101597280|FG000|NOT COMPLETED|First Intervention||0||
48516983|NCT03662308|101597281|FG001|NOT COMPLETED|First Intervention||0||
48516984|NCT03662308|101597282|FG002|NOT COMPLETED|First Intervention||0||
48516985|NCT03662308|101597280|FG000|STARTED|Second Intervention (Tetraplegia ONLY)||0||
48516986|NCT03662308|101597281|FG001|STARTED|Second Intervention (Tetraplegia ONLY)||5||
48516987|NCT03662308|101597282|FG002|STARTED|Second Intervention (Tetraplegia ONLY)||4||
48516988|NCT03662308|101597280|FG000|COMPLETED|Second Intervention (Tetraplegia ONLY)||0||
48516989|NCT03662308|101597281|FG001|COMPLETED|Second Intervention (Tetraplegia ONLY)||5||
48516990|NCT03662308|101597282|FG002|COMPLETED|Second Intervention (Tetraplegia ONLY)||4||
48516991|NCT03662308|101597280|FG000|NOT COMPLETED|Second Intervention (Tetraplegia ONLY)||0||
48516992|NCT03662308|101597281|FG001|NOT COMPLETED|Second Intervention (Tetraplegia ONLY)||0||
48516993|NCT03662308|101597282|FG002|NOT COMPLETED|Second Intervention (Tetraplegia ONLY)||0||
48516994|NCT04017754|101597283|FG000|STARTED|Overall Study||267||
48516995|NCT04017754|101597284|FG001|STARTED|Overall Study||185||
48516996|NCT04017754|101597283|FG000|COMPLETED|Overall Study||267||
48516997|NCT04017754|101597284|FG001|COMPLETED|Overall Study||185||
48068124|NCT00734474|100489659|FG007|Completed 52-Week Visit|Overall Study||238||
48516998|NCT04017754|101597283|FG000|NOT COMPLETED|Overall Study||0||
48516999|NCT04017754|101597284|FG001|NOT COMPLETED|Overall Study||0||
48517000|NCT00176631|101597285|FG000|STARTED|Overall Study||10||
48517001|NCT00176631|101597285|FG000|COMPLETED|Overall Study||10||
48517002|NCT00176631|101597285|FG000|NOT COMPLETED|Overall Study||0||
48517003|NCT01270620|101597286|FG000|STARTED|Overall Study||50||
48517004|NCT01270620|101597287|FG001|STARTED|Overall Study||50||
48517005|NCT01270620|101597286|FG000|COMPLETED|Overall Study||49||
48517006|NCT01270620|101597287|FG001|COMPLETED|Overall Study||47||
48517007|NCT01270620|101597286|FG000|NOT COMPLETED|Overall Study||1||
48517008|NCT01270620|101597287|FG001|NOT COMPLETED|Overall Study||3||
48517009|NCT05560555|101597288|FG000|STARTED|Overall Study||2||
48517010|NCT05560555|101597289|FG001|STARTED|Overall Study||3||
48517011|NCT05560555|101597288|FG000|COMPLETED|Overall Study||2||
48517012|NCT05560555|101597289|FG001|COMPLETED|Overall Study||3||
48517013|NCT05560555|101597288|FG000|NOT COMPLETED|Overall Study||0||
48517014|NCT05560555|101597289|FG001|NOT COMPLETED|Overall Study||0||
48517015|NCT03212794|101597290|FG000|STARTED|Overall Study||16||
48517016|NCT03212794|101597291|FG001|STARTED|Overall Study||13||
48517017|NCT03212794|101597290|FG000|COMPLETED|Overall Study||5||
48517018|NCT03212794|101597291|FG001|COMPLETED|Overall Study||5||
48517019|NCT03212794|101597290|FG000|NOT COMPLETED|Overall Study||11||
48517020|NCT03212794|101597291|FG001|NOT COMPLETED|Overall Study||8||
48517021|NCT02310789|101597292|FG000|STARTED|Overall Study||8||
48517022|NCT02310789|101597292|FG000|COMPLETED|Overall Study||7||
48517023|NCT02310789|101597292|FG000|NOT COMPLETED|Overall Study||1||
48517024|NCT00942331|101597293|FG000|STARTED|Overall Study||252||
48517025|NCT00942331|101597294|FG001|STARTED|Overall Study||254||
48517026|NCT00942331|101597293|FG000|COMPLETED|Overall Study||237|Started treatment|
48517027|NCT00942331|101597294|FG001|COMPLETED|Overall Study||232|Started treatment|
48517028|NCT00942331|101597293|FG000|NOT COMPLETED|Overall Study||15||
48517029|NCT00942331|101597294|FG001|NOT COMPLETED|Overall Study||22||
48517030|NCT00949988|101597295|FG000|STARTED|Overall Study||3||
48517031|NCT00949988|101597295|FG000|COMPLETED|Overall Study||0||
48517032|NCT00949988|101597295|FG000|NOT COMPLETED|Overall Study||3||
48517033|NCT02858726|101597296|FG000|STARTED|Overall Study||44||
48517034|NCT02858726|101597297|FG001|STARTED|Overall Study||42||
48517035|NCT02858726|101597298|FG002|STARTED|Overall Study||44||
48517036|NCT02858726|101597299|FG003|STARTED|Overall Study||45||
48517037|NCT02858726|101597296|FG000|COMPLETED|Overall Study||39||
48517038|NCT02858726|101597297|FG001|COMPLETED|Overall Study||35||
48517039|NCT02858726|101597298|FG002|COMPLETED|Overall Study||33||
48517040|NCT02858726|101597299|FG003|COMPLETED|Overall Study||42||
48517041|NCT02858726|101597296|FG000|NOT COMPLETED|Overall Study||5||
48517042|NCT02858726|101597297|FG001|NOT COMPLETED|Overall Study||7||
48517043|NCT02858726|101597298|FG002|NOT COMPLETED|Overall Study||11||
48517044|NCT02858726|101597299|FG003|NOT COMPLETED|Overall Study||3||
48517045|NCT01730040|101597300|FG000|STARTED|Overall Study||57||
48517046|NCT01730040|101597301|FG001|STARTED|Overall Study||55||
48517047|NCT01730040|101597302|FG002|STARTED|Overall Study||57||
48517048|NCT01730040|101597303|FG003|STARTED|Overall Study||47||
48517049|NCT01730040|101597304|FG004|STARTED|Overall Study||45||
48517050|NCT01730040|101597305|FG005|STARTED|Overall Study||47||
48517051|NCT01730040|101597306|FG006|STARTED|Overall Study||47||
48517052|NCT01730040|101597300|FG000|Treated|Overall Study||57||
48517053|NCT01730040|101597301|FG001|Treated|Overall Study||55||
48517054|NCT01730040|101597302|FG002|Treated|Overall Study||57||
48517055|NCT01730040|101597303|FG003|Treated|Overall Study||47||
48517056|NCT01730040|101597304|FG004|Treated|Overall Study||45||
48517057|NCT01730040|101597305|FG005|Treated|Overall Study||46||
48517058|NCT01730040|101597306|FG006|Treated|Overall Study||47||
48517059|NCT01730040|101597300|FG000|COMPLETED|Overall Study||44||
48517060|NCT01730040|101597301|FG001|COMPLETED|Overall Study||40||
48517061|NCT01730040|101597302|FG002|COMPLETED|Overall Study||46||
48517062|NCT01730040|101597303|FG003|COMPLETED|Overall Study||39||
48517063|NCT01730040|101597304|FG004|COMPLETED|Overall Study||39||
48517064|NCT01730040|101597305|FG005|COMPLETED|Overall Study||40||
48517065|NCT01730040|101597306|FG006|COMPLETED|Overall Study||38||
48517066|NCT01730040|101597300|FG000|NOT COMPLETED|Overall Study||13||
48517067|NCT01730040|101597301|FG001|NOT COMPLETED|Overall Study||15||
48517068|NCT01730040|101597302|FG002|NOT COMPLETED|Overall Study||11||
48517069|NCT01730040|101597303|FG003|NOT COMPLETED|Overall Study||8||
48517070|NCT01730040|101597304|FG004|NOT COMPLETED|Overall Study||6||
48517071|NCT01730040|101597305|FG005|NOT COMPLETED|Overall Study||7||
48517072|NCT01730040|101597306|FG006|NOT COMPLETED|Overall Study||9||
48517073|NCT03276676|101597307|FG000|STARTED|Overall Study||4||
48517074|NCT03276676|101597308|FG001|STARTED|Overall Study||6||
48517075|NCT03276676|101597307|FG000|COMPLETED|Overall Study||2||
48517076|NCT03276676|101597308|FG001|COMPLETED|Overall Study||5||
48517077|NCT03276676|101597307|FG000|NOT COMPLETED|Overall Study||2||
48517078|NCT03276676|101597308|FG001|NOT COMPLETED|Overall Study||1||
48517079|NCT02746627|101597309|FG000|STARTED|Overall Study||60||
48517080|NCT02746627|101597310|FG001|STARTED|Overall Study||30||
48517081|NCT02746627|101597311|FG002|STARTED|Overall Study||30||
48517082|NCT02746627|101597309|FG000|COMPLETED|Overall Study||59||
48517083|NCT02746627|101597310|FG001|COMPLETED|Overall Study||29||
48517084|NCT02746627|101597311|FG002|COMPLETED|Overall Study||29||
48517085|NCT02746627|101597309|FG000|NOT COMPLETED|Overall Study||1||
48517086|NCT02746627|101597310|FG001|NOT COMPLETED|Overall Study||1||
48517087|NCT02746627|101597311|FG002|NOT COMPLETED|Overall Study||1||
48517088|NCT02269631|101597312|FG000|STARTED|Overall Study||7||
48517089|NCT02269631|101597313|FG001|STARTED|Overall Study||5||
48517090|NCT02269631|101597312|FG000|COMPLETED|Overall Study||7||
48517091|NCT02269631|101597313|FG001|COMPLETED|Overall Study||5||
48517092|NCT02269631|101597312|FG000|NOT COMPLETED|Overall Study||0||
48517093|NCT02269631|101597313|FG001|NOT COMPLETED|Overall Study||0||
48517094|NCT00928226|101597314|FG000|STARTED|Overall Study||20||
48517095|NCT00928226|101597315|FG001|STARTED|Overall Study||12||
48517096|NCT00928226|101597316|FG002|STARTED|Overall Study||12||
48517097|NCT00928226|101597317|FG003|STARTED|Overall Study||12||
48517098|NCT00928226|101597314|FG000|Strata A: Small Tumor, Resected|Overall Study||6||
48517099|NCT00928226|101597315|FG001|Strata A: Small Tumor, Resected|Overall Study||6||
48517100|NCT00928226|101597316|FG002|Strata A: Small Tumor, Resected|Overall Study||6||
48517101|NCT00928226|101597317|FG003|Strata A: Small Tumor, Resected|Overall Study||6||
48517102|NCT00928226|101597314|FG000|Strata B: Small Tumor, Not Resected|Overall Study||5||
48517103|NCT00928226|101597315|FG001|Strata B: Small Tumor, Not Resected|Overall Study||0||
48517104|NCT00928226|101597316|FG002|Strata B: Small Tumor, Not Resected|Overall Study||0||
48517105|NCT00928226|101597317|FG003|Strata B: Small Tumor, Not Resected|Overall Study||0||
48517106|NCT00928226|101597314|FG000|Strata C: Large Tumor, Resected|Overall Study||8||
48517107|NCT00928226|101597315|FG001|Strata C: Large Tumor, Resected|Overall Study||6||
48517108|NCT00928226|101597316|FG002|Strata C: Large Tumor, Resected|Overall Study||6||
48517109|NCT00928226|101597317|FG003|Strata C: Large Tumor, Resected|Overall Study||6||
48517110|NCT00928226|101597314|FG000|Strata D: Large Tumor, Not Resected|Overall Study||1||
48517111|NCT00928226|101597315|FG001|Strata D: Large Tumor, Not Resected|Overall Study||0||
48517112|NCT00928226|101597316|FG002|Strata D: Large Tumor, Not Resected|Overall Study||0||
48517113|NCT00928226|101597317|FG003|Strata D: Large Tumor, Not Resected|Overall Study||0||
48517114|NCT00928226|101597314|FG000|COMPLETED|Overall Study||20||
48517115|NCT00928226|101597315|FG001|COMPLETED|Overall Study||12||
48517116|NCT00928226|101597316|FG002|COMPLETED|Overall Study||12||
48517117|NCT00928226|101597317|FG003|COMPLETED|Overall Study||12||
48517118|NCT00928226|101597314|FG000|NOT COMPLETED|Overall Study||0||
48517119|NCT00928226|101597315|FG001|NOT COMPLETED|Overall Study||0||
48517120|NCT00928226|101597316|FG002|NOT COMPLETED|Overall Study||0||
48517121|NCT00928226|101597317|FG003|NOT COMPLETED|Overall Study||0||
48517122|NCT05132569|101597318|FG000|STARTED|DB Period: 26 Weeks||3||
48517123|NCT05132569|101597319|FG001|STARTED|DB Period: 26 Weeks||3||
48517124|NCT05132569|101597318|FG000|COMPLETED|DB Period: 26 Weeks||2||
48517125|NCT05132569|101597319|FG001|COMPLETED|DB Period: 26 Weeks||1||
48517126|NCT05132569|101597318|FG000|NOT COMPLETED|DB Period: 26 Weeks||1||
48517127|NCT05132569|101597319|FG001|NOT COMPLETED|DB Period: 26 Weeks||2||
48517128|NCT05132569|101597318|FG000|STARTED|OLE: Week 27 Till Termination (Week 61)||2||
48517129|NCT05132569|101597319|FG001|STARTED|OLE: Week 27 Till Termination (Week 61)||1||
48517130|NCT05132569|101597318|FG000|COMPLETED|OLE: Week 27 Till Termination (Week 61)||0||
48517131|NCT05132569|101597319|FG001|COMPLETED|OLE: Week 27 Till Termination (Week 61)||0||
48517132|NCT05132569|101597318|FG000|NOT COMPLETED|OLE: Week 27 Till Termination (Week 61)||2||
48517133|NCT05132569|101597319|FG001|NOT COMPLETED|OLE: Week 27 Till Termination (Week 61)||1||
48517134|NCT02958319|101597320|FG000|STARTED|Overall Study||145||
48517135|NCT02958319|101597321|FG001|STARTED|Overall Study||133||
48517136|NCT02958319|101597320|FG000|COMPLETED|Overall Study||145||
48517137|NCT02958319|101597321|FG001|COMPLETED|Overall Study||133||
48517138|NCT02958319|101597320|FG000|NOT COMPLETED|Overall Study||0||
48517139|NCT02958319|101597321|FG001|NOT COMPLETED|Overall Study||0||
48517140|NCT02000531|101597322|FG000|STARTED|Overall Study||21||
48517141|NCT02000531|101597323|FG001|STARTED|Overall Study||24||
48517142|NCT02000531|101597322|FG000|Safety Population|Overall Study||21||
48517143|NCT02000531|101597323|FG001|Safety Population|Overall Study||24||
48517144|NCT02000531|101597322|FG000|COMPLETED|Overall Study||17||
48517145|NCT02000531|101597323|FG001|COMPLETED|Overall Study||16||
48517146|NCT02000531|101597322|FG000|NOT COMPLETED|Overall Study||4||
48517147|NCT02000531|101597323|FG001|NOT COMPLETED|Overall Study||8||
48517148|NCT02278718|101597324|FG000|STARTED|Overall Study||72||
48517149|NCT02278718|101597325|FG001|STARTED|Overall Study||73||
48517150|NCT02278718|101597324|FG000|Treated|Overall Study||69||
48517151|NCT02278718|101597325|FG001|Treated|Overall Study||70||
48517152|NCT02278718|101597324|FG000|Number of Patients Completed 12 Month FU|Overall Study||66||
48517153|NCT02278718|101597325|FG001|Number of Patients Completed 12 Month FU|Overall Study||63||
48517154|NCT02278718|101597324|FG000|COMPLETED|Overall Study||66||
48517155|NCT02278718|101597325|FG001|COMPLETED|Overall Study||63||
48517156|NCT02278718|101597324|FG000|NOT COMPLETED|Overall Study||6||
48517157|NCT02278718|101597325|FG001|NOT COMPLETED|Overall Study||10||
48517158|NCT01652976|101597326|FG000|STARTED|Overall Study||44||
48517159|NCT01652976|101597326|FG000|COMPLETED|Overall Study||44||
48517160|NCT01652976|101597326|FG000|NOT COMPLETED|Overall Study||0||
48517161|NCT02676284|101597327|FG000|STARTED|Overall Study||36||
48517162|NCT02676284|101597327|FG000|COMPLETED|Overall Study||35||
48517163|NCT02676284|101597327|FG000|NOT COMPLETED|Overall Study||1||
48517164|NCT01796964|101597328|FG000|STARTED|Overall Study||44||
48517165|NCT01796964|101597329|FG001|STARTED|Overall Study||45||
48517166|NCT01796964|101597328|FG000|COMPLETED|Overall Study||41||
48517167|NCT01796964|101597329|FG001|COMPLETED|Overall Study||42||
48517168|NCT01796964|101597328|FG000|NOT COMPLETED|Overall Study||3||
48517169|NCT01796964|101597329|FG001|NOT COMPLETED|Overall Study||3||
48517170|NCT02220725|101597330|FG000|STARTED|Overall Study||14||
48517171|NCT02220725|101597331|FG001|STARTED|Overall Study||27||
48517172|NCT02220725|101597332|FG002|STARTED|Overall Study||13||
48517173|NCT02220725|101597333|FG003|STARTED|Overall Study||26||
48517174|NCT02220725|101597330|FG000|COMPLETED|Overall Study||14||
48517175|NCT02220725|101597331|FG001|COMPLETED|Overall Study||27||
48517176|NCT02220725|101597332|FG002|COMPLETED|Overall Study||13||
48517177|NCT02220725|101597333|FG003|COMPLETED|Overall Study||24||
48517178|NCT02220725|101597330|FG000|NOT COMPLETED|Overall Study||0||
48517179|NCT02220725|101597331|FG001|NOT COMPLETED|Overall Study||0||
48517180|NCT02220725|101597332|FG002|NOT COMPLETED|Overall Study||0||
48517181|NCT02220725|101597333|FG003|NOT COMPLETED|Overall Study||2||
48517182|NCT02646917|101597334|FG000|STARTED|Overall Study||21||
48517183|NCT02646917|101597335|FG001|STARTED|Overall Study||20||
48517184|NCT02646917|101597334|FG000|COMPLETED|Overall Study||21||
48517185|NCT02646917|101597335|FG001|COMPLETED|Overall Study||20||
48517186|NCT02646917|101597334|FG000|NOT COMPLETED|Overall Study||0||
48517187|NCT02646917|101597335|FG001|NOT COMPLETED|Overall Study||0||
48517188|NCT00977431|101597336|FG000|STARTED|Overall Study||7||
48517189|NCT00977431|101597337|FG001|STARTED|Overall Study||6||
48517190|NCT00977431|101597338|FG002|STARTED|Overall Study||7||
48517191|NCT00977431|101597339|FG003|STARTED|Overall Study||3||
48517192|NCT00977431|101597340|FG004|STARTED|Overall Study||13||
48517193|NCT00977431|101597336|FG000|Discontinued Afatinib Before/on Day 42|Overall Study||1|Discontinued afatinib before or at the end of the concomitant treatment period (i.e. on day 42).|
48517194|NCT00977431|101597337|FG001|Discontinued Afatinib Before/on Day 42|Overall Study||0|Discontinued afatinib before or at the end of the concomitant treatment period (i.e. on day 42).|
48517195|NCT00977431|101597338|FG002|Discontinued Afatinib Before/on Day 42|Overall Study||4|Discontinued afatinib before or at the end of the concomitant treatment period (i.e. on day 42).|
48517196|NCT00977431|101597339|FG003|Discontinued Afatinib Before/on Day 42|Overall Study||0|Discontinued afatinib before or at the end of the concomitant treatment period (i.e. on day 42).|
48517197|NCT00977431|101597340|FG004|Discontinued Afatinib Before/on Day 42|Overall Study||3|Discontinued afatinib before or at the end of the concomitant treatment period (i.e. on day 42).|
48517198|NCT00977431|101597336|FG000|COMPLETED|Overall Study||0||
48517199|NCT00977431|101597337|FG001|COMPLETED|Overall Study||0||
48517200|NCT00977431|101597338|FG002|COMPLETED|Overall Study||0||
48517201|NCT00977431|101597339|FG003|COMPLETED|Overall Study||0||
48517202|NCT00977431|101597340|FG004|COMPLETED|Overall Study||0||
48517203|NCT00977431|101597336|FG000|NOT COMPLETED|Overall Study||7||
48517204|NCT00977431|101597337|FG001|NOT COMPLETED|Overall Study||6||
48517205|NCT00977431|101597338|FG002|NOT COMPLETED|Overall Study||7||
48517206|NCT00977431|101597339|FG003|NOT COMPLETED|Overall Study||3||
48517207|NCT00977431|101597340|FG004|NOT COMPLETED|Overall Study||13||
48517208|NCT01901848|101597341|FG000|STARTED|Randomized and Treated||25||
48517209|NCT01901848|101597342|FG001|STARTED|Randomized and Treated||25||
48517210|NCT01901848|101597341|FG000|COMPLETED|Randomized and Treated||22||
48517211|NCT01901848|101597342|FG001|COMPLETED|Randomized and Treated||19||
48517212|NCT01901848|101597341|FG000|NOT COMPLETED|Randomized and Treated||3||
48517213|NCT01901848|101597342|FG001|NOT COMPLETED|Randomized and Treated||6||
48517214|NCT01901848|101597341|FG000|STARTED|Removed From Analyses||22||
48517215|NCT01901848|101597342|FG001|STARTED|Removed From Analyses||19||
48517216|NCT01901848|101597341|FG000|COMPLETED|Removed From Analyses||12||
48517217|NCT01901848|101597342|FG001|COMPLETED|Removed From Analyses||19||
48517218|NCT01901848|101597341|FG000|NOT COMPLETED|Removed From Analyses||10||
48517219|NCT01901848|101597342|FG001|NOT COMPLETED|Removed From Analyses||0||
48517220|NCT01546142|101597343|FG000|STARTED|Overall Study||258||
48517221|NCT01546142|101597344|FG001|STARTED|Overall Study||258||
48517222|NCT01546142|101597343|FG000|Received Treatment|Overall Study||257||
48517223|NCT01546142|101597344|FG001|Received Treatment|Overall Study||257||
48517224|NCT01546142|101597343|FG000|COMPLETED|Overall Study||214||
48517225|NCT01546142|101597344|FG001|COMPLETED|Overall Study||224||
48517226|NCT01546142|101597343|FG000|NOT COMPLETED|Overall Study||44||
48517227|NCT01546142|101597344|FG001|NOT COMPLETED|Overall Study||34||
48517228|NCT01647711|101597345|FG000|STARTED|Overall Study||6||
48517229|NCT01647711|101597346|FG001|STARTED|Overall Study||3||
48517230|NCT01647711|101597347|FG002|STARTED|Overall Study||9||
48517231|NCT01647711|101597348|FG003|STARTED|Overall Study||11||
48517232|NCT01647711|101597349|FG004|STARTED|Overall Study||6||
48517233|NCT01647711|101597345|FG000|COMPLETED|Overall Study||0||
48517234|NCT01647711|101597346|FG001|COMPLETED|Overall Study||0||
48517235|NCT01647711|101597347|FG002|COMPLETED|Overall Study||0||
48517236|NCT01647711|101597348|FG003|COMPLETED|Overall Study||0||
48517237|NCT01647711|101597349|FG004|COMPLETED|Overall Study||0||
48517238|NCT01647711|101597345|FG000|NOT COMPLETED|Overall Study||6||
48517239|NCT01647711|101597346|FG001|NOT COMPLETED|Overall Study||3||
48517240|NCT01647711|101597347|FG002|NOT COMPLETED|Overall Study||9||
48517241|NCT01647711|101597348|FG003|NOT COMPLETED|Overall Study||11||
48517242|NCT01647711|101597349|FG004|NOT COMPLETED|Overall Study||6||
48517243|NCT00890552|101597350|FG000|STARTED|Enrollment and Pre-treatment||25||
48517244|NCT00890552|101597350|FG000|COMPLETED|Enrollment and Pre-treatment||24||
48517245|NCT00890552|101597350|FG000|NOT COMPLETED|Enrollment and Pre-treatment||1||
48517246|NCT00890552|101597350|FG000|STARTED|On-treatment||24||
48517247|NCT00890552|101597350|FG000|COMPLETED|On-treatment||14||
48517248|NCT00890552|101597350|FG000|NOT COMPLETED|On-treatment||10||
48517249|NCT00766831|101597351|FG000|STARTED|Overall Study||190||
48517250|NCT00766831|101597351|FG000|COMPLETED|Overall Study||75||
48517251|NCT00766831|101597351|FG000|NOT COMPLETED|Overall Study||115||
48517252|NCT00467987|101597352|FG000|STARTED|Overall Study||13||
48517253|NCT00467987|101597353|FG001|STARTED|Overall Study||12||
48517254|NCT00467987|101597354|FG002|STARTED|Overall Study||22||
48517255|NCT00467987|101597352|FG000|COMPLETED|Overall Study||10||
48517256|NCT00467987|101597353|FG001|COMPLETED|Overall Study||10||
48517257|NCT00467987|101597354|FG002|COMPLETED|Overall Study||22||
48517258|NCT00467987|101597352|FG000|NOT COMPLETED|Overall Study||3||
48517259|NCT00467987|101597353|FG001|NOT COMPLETED|Overall Study||2||
48517260|NCT00467987|101597354|FG002|NOT COMPLETED|Overall Study||0||
48517261|NCT00848042|101597355|FG000|STARTED|Overall Study||5||
48517262|NCT00848042|101597356|FG001|STARTED|Overall Study||5||
48517263|NCT00848042|101597357|FG002|STARTED|Overall Study||1||
48517264|NCT00848042|101597355|FG000|Day 1|Overall Study||5||
48517265|NCT00848042|101597356|FG001|Day 1|Overall Study||5||
48517266|NCT00848042|101597357|FG002|Day 1|Overall Study||1||
48517267|NCT00848042|101597355|FG000|Day 2|Overall Study||5||
48517268|NCT00848042|101597356|FG001|Day 2|Overall Study||5||
48517269|NCT00848042|101597357|FG002|Day 2|Overall Study||1||
48517270|NCT00848042|101597355|FG000|Day 3|Overall Study||5||
48517271|NCT00848042|101597356|FG001|Day 3|Overall Study||5||
48517272|NCT00848042|101597357|FG002|Day 3|Overall Study||1||
48517273|NCT00848042|101597355|FG000|Day 8|Overall Study||5||
48517274|NCT00848042|101597356|FG001|Day 8|Overall Study||5||
48517275|NCT00848042|101597357|FG002|Day 8|Overall Study||1||
48517276|NCT00848042|101597355|FG000|Day 15|Overall Study||4||
48517277|NCT00848042|101597356|FG001|Day 15|Overall Study||5||
48517278|NCT00848042|101597357|FG002|Day 15|Overall Study||1||
48517279|NCT00848042|101597355|FG000|Month 1|Overall Study||4||
48517280|NCT00848042|101597356|FG001|Month 1|Overall Study||5||
48517281|NCT00848042|101597357|FG002|Month 1|Overall Study||1||
48517282|NCT00848042|101597355|FG000|Month 2|Overall Study||1||
48517283|NCT00848042|101597356|FG001|Month 2|Overall Study||5||
48517284|NCT00848042|101597357|FG002|Month 2|Overall Study||1||
48517285|NCT00848042|101597355|FG000|Month 3|Overall Study||1||
48517286|NCT00848042|101597356|FG001|Month 3|Overall Study||4||
48517287|NCT00848042|101597357|FG002|Month 3|Overall Study||1||
48517288|NCT00848042|101597355|FG000|Month 4|Overall Study||1||
48517289|NCT00848042|101597356|FG001|Month 4|Overall Study||4||
48517290|NCT00848042|101597357|FG002|Month 4|Overall Study||1||
48517291|NCT00848042|101597355|FG000|Month 5|Overall Study||1||
48517292|NCT00848042|101597356|FG001|Month 5|Overall Study||3||
48517293|NCT00848042|101597357|FG002|Month 5|Overall Study||1||
48517294|NCT00848042|101597355|FG000|Month 6|Overall Study||1||
48517295|NCT00848042|101597356|FG001|Month 6|Overall Study||3||
48517296|NCT00848042|101597357|FG002|Month 6|Overall Study||1||
48517297|NCT00848042|101597355|FG000|COMPLETED|Overall Study||1||
48517298|NCT00848042|101597356|FG001|COMPLETED|Overall Study||3||
48517299|NCT00848042|101597357|FG002|COMPLETED|Overall Study||1||
48517300|NCT00848042|101597355|FG000|NOT COMPLETED|Overall Study||4||
48517301|NCT00848042|101597356|FG001|NOT COMPLETED|Overall Study||2||
48517302|NCT00848042|101597357|FG002|NOT COMPLETED|Overall Study||0||
48517303|NCT00418522|101597358|FG000|STARTED|Overall Study||219||
48517304|NCT00418522|101597359|FG001|STARTED|Overall Study||194||
48517305|NCT00418522|101597358|FG000|Received Treatment|Overall Study||212||
48517306|NCT00418522|101597359|FG001|Received Treatment|Overall Study||190||
48517307|NCT00418522|101597358|FG000|COMPLETED|Overall Study||136||
48517308|NCT00418522|101597359|FG001|COMPLETED|Overall Study||152||
48517309|NCT00418522|101597358|FG000|NOT COMPLETED|Overall Study||83||
48517310|NCT00418522|101597359|FG001|NOT COMPLETED|Overall Study||42||
48517311|NCT01478828|101597360|FG000|STARTED|Overall Study||2||
48517312|NCT01478828|101597360|FG000|COMPLETED|Overall Study||1||
48517313|NCT01478828|101597360|FG000|NOT COMPLETED|Overall Study||1||
48517314|NCT00708708|101597361|FG000|STARTED|Overall Study||955||
48517315|NCT00708708|101597361|FG000|COMPLETED|Overall Study||213||
48517316|NCT00708708|101597361|FG000|NOT COMPLETED|Overall Study||742||
48517317|NCT02377921|101597362|FG000|STARTED|Overall Study||45||
48517318|NCT02377921|101597363|FG001|STARTED|Overall Study||44||
48517319|NCT02377921|101597362|FG000|COMPLETED|Overall Study||44||
48517320|NCT02377921|101597363|FG001|COMPLETED|Overall Study||43||
48517321|NCT02377921|101597362|FG000|NOT COMPLETED|Overall Study||1||
48517322|NCT02377921|101597363|FG001|NOT COMPLETED|Overall Study||1||
48517323|NCT00653159|101597364|FG000|STARTED|Overall Study||11||
48517324|NCT00653159|101597365|FG001|STARTED|Overall Study||12||
48517325|NCT00653159|101597364|FG000|COMPLETED|Overall Study||6||
48517326|NCT00653159|101597365|FG001|COMPLETED|Overall Study||9||
48517327|NCT00653159|101597364|FG000|NOT COMPLETED|Overall Study||5||
48517328|NCT00653159|101597365|FG001|NOT COMPLETED|Overall Study||3||
48517329|NCT01344616|101597366|FG000|STARTED|Overall Study||244||
48517330|NCT01344616|101597367|FG001|STARTED|Overall Study||238||
48517331|NCT01344616|101597366|FG000|COMPLETED|Overall Study||209||
48517332|NCT01344616|101597367|FG001|COMPLETED|Overall Study||194||
48517333|NCT01344616|101597366|FG000|NOT COMPLETED|Overall Study||35||
48517334|NCT01344616|101597367|FG001|NOT COMPLETED|Overall Study||44||
48517335|NCT00811434|101597368|FG000|STARTED|First Intervention||7||
48517336|NCT00811434|101597369|FG001|STARTED|First Intervention||5||
48517337|NCT00811434|101597368|FG000|COMPLETED|First Intervention||4||
48517338|NCT00811434|101597369|FG001|COMPLETED|First Intervention||5||
48517339|NCT00811434|101597368|FG000|NOT COMPLETED|First Intervention||3||
48517340|NCT00811434|101597369|FG001|NOT COMPLETED|First Intervention||0||
48517341|NCT00811434|101597368|FG000|STARTED|Washout (1 Month)||4||
48517342|NCT00811434|101597369|FG001|STARTED|Washout (1 Month)||5||
48517343|NCT00811434|101597368|FG000|COMPLETED|Washout (1 Month)||4||
48517344|NCT00811434|101597369|FG001|COMPLETED|Washout (1 Month)||5||
48517345|NCT00811434|101597368|FG000|NOT COMPLETED|Washout (1 Month)||0||
48517346|NCT00811434|101597369|FG001|NOT COMPLETED|Washout (1 Month)||0||
48517347|NCT00811434|101597368|FG000|STARTED|Second Intervention||4||
48517348|NCT00811434|101597369|FG001|STARTED|Second Intervention||5||
48517349|NCT00811434|101597368|FG000|COMPLETED|Second Intervention||4||
48517350|NCT00811434|101597369|FG001|COMPLETED|Second Intervention||5||
48517351|NCT00811434|101597368|FG000|NOT COMPLETED|Second Intervention||0||
48517352|NCT00811434|101597369|FG001|NOT COMPLETED|Second Intervention||0||
48517353|NCT04276935|101597370|FG000|STARTED|Overall Study||20||
48517354|NCT04276935|101597370|FG000|Round 1|Overall Study||10||
48517355|NCT04276935|101597370|FG000|Round 2|Overall Study||7||
48517356|NCT04276935|101597370|FG000|COMPLETED|Overall Study||17||
48517357|NCT04276935|101597370|FG000|NOT COMPLETED|Overall Study||3||
48517358|NCT00373425|101597371|FG000|STARTED|Overall Study||623||
48517359|NCT00373425|101597372|FG001|STARTED|Overall Study||350||
48517360|NCT00373425|101597373|FG002|STARTED|Overall Study||134||
48517361|NCT00373425|101597374|FG003|STARTED|Overall Study||11||
48517362|NCT00373425|101597375|FG004|STARTED|Overall Study||132||
48517363|NCT00373425|101597371|FG000|Received Treatment|Overall Study||612||
48517364|NCT00373425|101597372|FG001|Received Treatment|Overall Study||342||
48517365|NCT00373425|101597373|FG002|Received Treatment|Overall Study||134||
48517366|NCT00373425|101597374|FG003|Received Treatment|Overall Study||7||
48517367|NCT00373425|101597375|FG004|Received Treatment|Overall Study||132||
48517368|NCT00373425|101597371|FG000|COMPLETED|Overall Study||253||
48517369|NCT00373425|101597372|FG001|COMPLETED|Overall Study||197||
48517370|NCT00373425|101597373|FG002|COMPLETED|Overall Study||0||
48517371|NCT00373425|101597374|FG003|COMPLETED|Overall Study||0||
48517372|NCT00373425|101597375|FG004|COMPLETED|Overall Study||60||
48517373|NCT00373425|101597371|FG000|NOT COMPLETED|Overall Study||370||
48517374|NCT00373425|101597372|FG001|NOT COMPLETED|Overall Study||153||
48517375|NCT00373425|101597373|FG002|NOT COMPLETED|Overall Study||134||
48517376|NCT00373425|101597374|FG003|NOT COMPLETED|Overall Study||11||
48517377|NCT00373425|101597375|FG004|NOT COMPLETED|Overall Study||72||
48517378|NCT02597582|101597376|FG000|STARTED|Overall Study||21||
48517379|NCT02597582|101597377|FG001|STARTED|Overall Study||20||
48517380|NCT02597582|101597376|FG000|COMPLETED|Overall Study||21||
48517381|NCT02597582|101597377|FG001|COMPLETED|Overall Study||20||
48517382|NCT02597582|101597376|FG000|NOT COMPLETED|Overall Study||0||
48517383|NCT02597582|101597377|FG001|NOT COMPLETED|Overall Study||0||
48517384|NCT02096588|101597378|FG000|STARTED|Overall Study||15||
48068125|NCT00734474|100489660|FG008|Completed 52-Week Visit|Overall Study||112||
48068126|NCT00734474|100489652|FG000|COMPLETED|Overall Study||0||
48068127|NCT00734474|100489653|FG001|COMPLETED|Overall Study||0||
48068128|NCT00734474|100489654|FG002|COMPLETED|Overall Study||192||
48517385|NCT02096588|101597379|FG001|STARTED|Overall Study||16||
48517386|NCT02096588|101597378|FG000|COMPLETED|Overall Study||13||
48517387|NCT02096588|101597379|FG001|COMPLETED|Overall Study||15||
48517388|NCT02096588|101597378|FG000|NOT COMPLETED|Overall Study||2||
48517389|NCT02096588|101597379|FG001|NOT COMPLETED|Overall Study||1||
48517390|NCT02445287|101597380|FG000|STARTED|Overall Study||35||
48517391|NCT02445287|101597381|FG001|STARTED|Overall Study||13||
48517392|NCT02445287|101597380|FG000|COMPLETED|Overall Study||35||
48517393|NCT02445287|101597381|FG001|COMPLETED|Overall Study||13||
48068129|NCT00734474|100489655|FG003|COMPLETED|Overall Study||0||
48068130|NCT00734474|100489656|FG004|COMPLETED|Overall Study||184||
48219947|NCT05580003|100863770|FG022|COMPLETED|Part 3: Period 3 (Day 1)||0||
48219948|NCT05580003|100863771|FG023|COMPLETED|Part 3: Period 3 (Day 1)||0||
48517394|NCT02445287|101597380|FG000|NOT COMPLETED|Overall Study||0||
48517395|NCT02445287|101597381|FG001|NOT COMPLETED|Overall Study||0||
48517396|NCT01803269|101597382|FG000|STARTED|Overall Study||7||
48517397|NCT01803269|101597383|FG001|STARTED|Overall Study||8||
48517398|NCT01803269|101597384|FG002|STARTED|Overall Study||14||
48517399|NCT01803269|101597382|FG000|COMPLETED|Overall Study||4||
48517400|NCT01803269|101597383|FG001|COMPLETED|Overall Study||8||
48517401|NCT01803269|101597384|FG002|COMPLETED|Overall Study||14||
48517402|NCT01803269|101597382|FG000|NOT COMPLETED|Overall Study||3||
48517403|NCT01803269|101597383|FG001|NOT COMPLETED|Overall Study||0||
48517404|NCT01803269|101597384|FG002|NOT COMPLETED|Overall Study||0||
48517405|NCT04632706|101597385|FG000|STARTED|Overall Study||6||
48517406|NCT04632706|101597386|FG001|STARTED|Overall Study||6||
48517407|NCT04632706|101597387|FG002|STARTED|Overall Study||6||
48517408|NCT04632706|101597388|FG003|STARTED|Overall Study||6||
48517409|NCT04632706|101597385|FG000|COMPLETED|Overall Study||6||
48517410|NCT04632706|101597386|FG001|COMPLETED|Overall Study||6||
48517411|NCT04632706|101597387|FG002|COMPLETED|Overall Study||5||
48517412|NCT04632706|101597388|FG003|COMPLETED|Overall Study||6||
48517413|NCT04632706|101597385|FG000|NOT COMPLETED|Overall Study||0||
48517414|NCT04632706|101597386|FG001|NOT COMPLETED|Overall Study||0||
48517415|NCT04632706|101597387|FG002|NOT COMPLETED|Overall Study||1||
48517416|NCT04632706|101597388|FG003|NOT COMPLETED|Overall Study||0||
48517417|NCT00738361|101597389|FG000|STARTED|Overall Study||4||
48517418|NCT00738361|101597389|FG000|COMPLETED|Overall Study||4||
48517419|NCT00738361|101597389|FG000|NOT COMPLETED|Overall Study||0||
48517420|NCT01191242|101597390|FG000|STARTED|Overall Study||31||
48517421|NCT01191242|101597390|FG000|COMPLETED|Overall Study||31||
48517422|NCT01191242|101597390|FG000|NOT COMPLETED|Overall Study||0||
48517423|NCT01631682|101597391|FG000|STARTED|Overall Study||55||
48517424|NCT01631682|101597392|FG001|STARTED|Overall Study||66||
48517425|NCT01631682|101597393|FG002|STARTED|Overall Study||44||
48517426|NCT01631682|101597394|FG003|STARTED|Overall Study||7||
48517427|NCT01631682|101597391|FG000|COMPLETED|Overall Study||24||
48517428|NCT01631682|101597392|FG001|COMPLETED|Overall Study||21||
48517429|NCT01631682|101597393|FG002|COMPLETED|Overall Study||13||
48517430|NCT01631682|101597394|FG003|COMPLETED|Overall Study||5||
48517431|NCT01631682|101597391|FG000|NOT COMPLETED|Overall Study||31||
48517432|NCT01631682|101597392|FG001|NOT COMPLETED|Overall Study||45||
48517433|NCT01631682|101597393|FG002|NOT COMPLETED|Overall Study||31||
48517434|NCT01631682|101597394|FG003|NOT COMPLETED|Overall Study||2||
48517435|NCT04233879|101597395|FG000|STARTED|Overall Study||298||
48517436|NCT04233879|101597396|FG001|STARTED|Overall Study||301||
48517437|NCT04233879|101597395|FG000|Treated|Overall Study||298||
48517438|NCT04233879|101597396|FG001|Treated|Overall Study||299||
48517439|NCT04233879|101597395|FG000|COMPLETED|Overall Study||1||
48517440|NCT04233879|101597396|FG001|COMPLETED|Overall Study||0||
48517441|NCT04233879|101597395|FG000|NOT COMPLETED|Overall Study||297||
48517442|NCT04233879|101597396|FG001|NOT COMPLETED|Overall Study||301||
48517443|NCT00467831|101597397|FG000|STARTED|Overall Study||3||
48517444|NCT00467831|101597397|FG000|COMPLETED|Overall Study||0||
48517445|NCT00467831|101597397|FG000|NOT COMPLETED|Overall Study||3||
48517446|NCT01602172|101597398|FG000|STARTED|Overall Study||37||
48517447|NCT01602172|101597399|FG001|STARTED|Overall Study||23||
48517448|NCT01602172|101597400|FG002|STARTED|Overall Study||22||
48517449|NCT01602172|101597398|FG000|COMPLETED|Overall Study||32||
48517450|NCT01602172|101597399|FG001|COMPLETED|Overall Study||17||
48517451|NCT01602172|101597400|FG002|COMPLETED|Overall Study||22||
48517452|NCT01602172|101597398|FG000|NOT COMPLETED|Overall Study||5||
48517453|NCT01602172|101597399|FG001|NOT COMPLETED|Overall Study||6||
48517454|NCT01602172|101597400|FG002|NOT COMPLETED|Overall Study||0||
48517455|NCT02285634|101597401|FG000|STARTED|Overall Study||15||
48517456|NCT02285634|101597402|FG001|STARTED|Overall Study||20||
48517457|NCT02285634|101597403|FG002|STARTED|Overall Study||15||
48517458|NCT02285634|101597404|FG003|STARTED|Overall Study||18||
48517459|NCT02285634|101597401|FG000|COMPLETED|Overall Study||15||
48517460|NCT02285634|101597402|FG001|COMPLETED|Overall Study||20||
48517461|NCT02285634|101597403|FG002|COMPLETED|Overall Study||11||
48517462|NCT02285634|101597404|FG003|COMPLETED|Overall Study||17||
48517463|NCT02285634|101597401|FG000|NOT COMPLETED|Overall Study||0||
48517464|NCT02285634|101597402|FG001|NOT COMPLETED|Overall Study||0||
48517465|NCT02285634|101597403|FG002|NOT COMPLETED|Overall Study||4||
48517466|NCT02285634|101597404|FG003|NOT COMPLETED|Overall Study||1||
48517467|NCT04633642|101597405|FG000|STARTED|Overall Study||27|November 2017|
48517468|NCT04633642|101597406|FG001|STARTED|Overall Study||24|November 2017|
48517469|NCT04633642|101597405|FG000|COMPLETED|Overall Study||26|December 2019|
48517470|NCT04633642|101597406|FG001|COMPLETED|Overall Study||22|December 2019|
48517471|NCT04633642|101597405|FG000|NOT COMPLETED|Overall Study||1||
48517472|NCT04633642|101597406|FG001|NOT COMPLETED|Overall Study||2||
48517473|NCT03323723|101600324|FG000|STARTED|Screening||73||
48517474|NCT03323723|101600324|FG000|COMPLETED|Screening||64||
48517475|NCT03323723|101600324|FG000|NOT COMPLETED|Screening||9||
48517476|NCT03323723|101600324|FG000|STARTED|Baseline Phase||64||
48517477|NCT03323723|101600324|FG000|COMPLETED|Baseline Phase||60||
48517478|NCT03323723|101600324|FG000|NOT COMPLETED|Baseline Phase||4||
48517479|NCT03323723|101600324|FG000|STARTED|Treatment Phase||60||
48517480|NCT03323723|101600324|FG000|COMPLETED|Treatment Phase||51||
48517481|NCT03323723|101600324|FG000|NOT COMPLETED|Treatment Phase||9||
48517482|NCT01929395|101600325|FG000|STARTED|Overall Study||19||
48517483|NCT01929395|101600326|FG001|STARTED|Overall Study||70||
48517484|NCT01929395|101600327|FG002|STARTED|Overall Study||70||
48517485|NCT01929395|101600325|FG000|COMPLETED|Overall Study||18||
48517486|NCT01929395|101600326|FG001|COMPLETED|Overall Study||69||
48517487|NCT01929395|101600327|FG002|COMPLETED|Overall Study||69||
48517488|NCT01929395|101600325|FG000|NOT COMPLETED|Overall Study||1||
48517489|NCT01929395|101600326|FG001|NOT COMPLETED|Overall Study||1||
48517490|NCT01929395|101600327|FG002|NOT COMPLETED|Overall Study||1||
48517491|NCT00337428|101600328|FG000|STARTED|Overall Study||419||
48517492|NCT00337428|101600329|FG001|STARTED|Overall Study||424||
48517493|NCT00337428|101600328|FG000|COMPLETED|Overall Study||415||
48517494|NCT00337428|101600329|FG001|COMPLETED|Overall Study||421||
48517495|NCT00337428|101600328|FG000|NOT COMPLETED|Overall Study||4||
48517496|NCT00337428|101600329|FG001|NOT COMPLETED|Overall Study||3||
48517497|NCT01355159|101600330|FG000|STARTED|Overall Study||1228||
48517498|NCT01355159|101600331|FG001|STARTED|Overall Study||1236||
48517499|NCT01355159|101600330|FG000|COMPLETED|Overall Study||1144||
48517500|NCT01355159|101600331|FG001|COMPLETED|Overall Study||1157||
48517501|NCT01355159|101600330|FG000|NOT COMPLETED|Overall Study||84||
48517502|NCT01355159|101600331|FG001|NOT COMPLETED|Overall Study||79||
48517503|NCT01553747|101600332|FG000|STARTED|Overall Study||381||
48517504|NCT01553747|101600333|FG001|STARTED|Overall Study||383||
48517505|NCT01553747|101600334|FG002|STARTED|Overall Study||382||
48517506|NCT01553747|101600332|FG000|Attended Week 12 Visit|Overall Study||296||
48517507|NCT01553747|101600333|FG001|Attended Week 12 Visit|Overall Study||301||
48517508|NCT01553747|101600334|FG002|Attended Week 12 Visit|Overall Study||312||
48517509|NCT01553747|101600332|FG000|Attended Week 26 Visit|Overall Study||259||
48517510|NCT01553747|101600333|FG001|Attended Week 26 Visit|Overall Study||271||
48517511|NCT01553747|101600334|FG002|Attended Week 26 Visit|Overall Study||278||
48517512|NCT01553747|101600332|FG000|Participated in Blinded-Placebo Period|Overall Study||246||
48517513|NCT01553747|101600333|FG001|Participated in Blinded-Placebo Period|Overall Study||253||
48517514|NCT01553747|101600334|FG002|Participated in Blinded-Placebo Period|Overall Study||272||
48517515|NCT01553747|101600332|FG000|COMPLETED|Overall Study||250||
48517516|NCT01553747|101600333|FG001|COMPLETED|Overall Study||264||
48517517|NCT01553747|101600334|FG002|COMPLETED|Overall Study||273||
48517518|NCT01553747|101600332|FG000|NOT COMPLETED|Overall Study||131||
48517519|NCT01553747|101600333|FG001|NOT COMPLETED|Overall Study||119||
48517520|NCT01553747|101600334|FG002|NOT COMPLETED|Overall Study||109||
48517521|NCT00049842|101600335|FG000|STARTED|Treatment Phase||270||
48517522|NCT00049842|101600336|FG001|STARTED|Treatment Phase||270||
48517523|NCT00049842|101600335|FG000|COMPLETED|Treatment Phase||177||
48517524|NCT00049842|101600336|FG001|COMPLETED|Treatment Phase||192||
48517525|NCT00049842|101600335|FG000|NOT COMPLETED|Treatment Phase||93||
48517526|NCT00049842|101600336|FG001|NOT COMPLETED|Treatment Phase||78||
48517527|NCT00049842|101600335|FG000|STARTED|Follow-up Phase||218||
48517528|NCT00049842|101600336|FG001|STARTED|Follow-up Phase||194||
48517529|NCT00049842|101600335|FG000|COMPLETED|Follow-up Phase||211||
48517530|NCT00049842|101600336|FG001|COMPLETED|Follow-up Phase||189||
48517531|NCT00049842|101600335|FG000|NOT COMPLETED|Follow-up Phase||7||
48517532|NCT00049842|101600336|FG001|NOT COMPLETED|Follow-up Phase||5||
48517533|NCT00479388|101600337|FG000|STARTED|Overall Study||606||
48517534|NCT00479388|101600338|FG001|STARTED|Overall Study||610||
48517535|NCT00479388|101600337|FG000|COMPLETED|Overall Study||474||
48517536|NCT00479388|101600338|FG001|COMPLETED|Overall Study||537||
48517537|NCT00479388|101600337|FG000|NOT COMPLETED|Overall Study||132||
48517538|NCT00479388|101600338|FG001|NOT COMPLETED|Overall Study||73||
48517539|NCT00321594|101600339|FG000|STARTED|Phase I, Level 1-4||3||
48517540|NCT00321594|101600340|FG001|STARTED|Phase I, Level 1-4||3||
48517541|NCT00321594|101600341|FG002|STARTED|Phase I, Level 1-4||6||
48517542|NCT00321594|101600342|FG003|STARTED|Phase I, Level 1-4||6||
48517543|NCT00321594|101600343|FG004|STARTED|Phase I, Level 1-4||0||
48517544|NCT00321594|101600339|FG000|COMPLETED|Phase I, Level 1-4||3||
48517545|NCT00321594|101600340|FG001|COMPLETED|Phase I, Level 1-4||3||
48517546|NCT00321594|101600341|FG002|COMPLETED|Phase I, Level 1-4||6||
48517547|NCT00321594|101600342|FG003|COMPLETED|Phase I, Level 1-4||6||
48517548|NCT00321594|101600343|FG004|COMPLETED|Phase I, Level 1-4||0||
48517549|NCT00321594|101600339|FG000|NOT COMPLETED|Phase I, Level 1-4||0||
48517550|NCT00321594|101600340|FG001|NOT COMPLETED|Phase I, Level 1-4||0||
48517551|NCT00321594|101600341|FG002|NOT COMPLETED|Phase I, Level 1-4||0||
48517552|NCT00321594|101600342|FG003|NOT COMPLETED|Phase I, Level 1-4||0||
48517553|NCT00321594|101600343|FG004|NOT COMPLETED|Phase I, Level 1-4||0||
48517554|NCT00321594|101600339|FG000|STARTED|Phase II, MTD Dose||0||
48517555|NCT00321594|101600340|FG001|STARTED|Phase II, MTD Dose||0||
48517556|NCT00321594|101600341|FG002|STARTED|Phase II, MTD Dose||0||
48517557|NCT00321594|101600342|FG003|STARTED|Phase II, MTD Dose||6||
48517558|NCT00321594|101600343|FG004|STARTED|Phase II, MTD Dose||36||
48517559|NCT00321594|101600339|FG000|COMPLETED|Phase II, MTD Dose||0||
48517560|NCT00321594|101600340|FG001|COMPLETED|Phase II, MTD Dose||0||
48517561|NCT00321594|101600341|FG002|COMPLETED|Phase II, MTD Dose||0||
48517562|NCT00321594|101600342|FG003|COMPLETED|Phase II, MTD Dose||6||
48517563|NCT00321594|101600343|FG004|COMPLETED|Phase II, MTD Dose||36||
48517564|NCT00321594|101600339|FG000|NOT COMPLETED|Phase II, MTD Dose||0||
48517565|NCT00321594|101600340|FG001|NOT COMPLETED|Phase II, MTD Dose||0||
48517566|NCT00321594|101600341|FG002|NOT COMPLETED|Phase II, MTD Dose||0||
48517567|NCT00321594|101600342|FG003|NOT COMPLETED|Phase II, MTD Dose||0||
48517568|NCT00321594|101600343|FG004|NOT COMPLETED|Phase II, MTD Dose||0||
48517569|NCT00824369|101600344|FG000|STARTED|Overall Study||5||
48517570|NCT00824369|101600345|FG001|STARTED|Overall Study||4||
48517571|NCT00824369|101600346|FG002|STARTED|Overall Study||3||
48517572|NCT00824369|101600347|FG003|STARTED|Overall Study||11||
48517573|NCT00824369|101600348|FG004|STARTED|Overall Study||12||
48517574|NCT00824369|101600349|FG005|STARTED|Overall Study||17||
48517575|NCT00824369|101600344|FG000|COMPLETED|Overall Study||4||
48517576|NCT00824369|101600345|FG001|COMPLETED|Overall Study||4||
48517577|NCT00824369|101600346|FG002|COMPLETED|Overall Study||2||
48517578|NCT00824369|101600347|FG003|COMPLETED|Overall Study||9||
48517579|NCT00824369|101600348|FG004|COMPLETED|Overall Study||11||
48517580|NCT00824369|101600349|FG005|COMPLETED|Overall Study||16||
48517581|NCT00824369|101600344|FG000|NOT COMPLETED|Overall Study||1||
48517582|NCT00824369|101600345|FG001|NOT COMPLETED|Overall Study||0||
48517583|NCT00824369|101600346|FG002|NOT COMPLETED|Overall Study||1||
48517584|NCT00824369|101600347|FG003|NOT COMPLETED|Overall Study||2||
48517585|NCT00824369|101600348|FG004|NOT COMPLETED|Overall Study||1||
48517586|NCT00824369|101600349|FG005|NOT COMPLETED|Overall Study||1||
48517587|NCT03122587|101600350|FG000|STARTED|Overall Study||13||
48517588|NCT03122587|101600351|FG001|STARTED|Overall Study||12||
48517589|NCT03122587|101600352|FG002|STARTED|Overall Study||13||
48517590|NCT03122587|101600350|FG000|COMPLETED|Overall Study||11||
48517591|NCT03122587|101600351|FG001|COMPLETED|Overall Study||10||
48517592|NCT03122587|101600352|FG002|COMPLETED|Overall Study||12||
48517593|NCT03122587|101600350|FG000|NOT COMPLETED|Overall Study||2||
48517594|NCT03122587|101600351|FG001|NOT COMPLETED|Overall Study||2||
48517595|NCT03122587|101600352|FG002|NOT COMPLETED|Overall Study||1||
48517596|NCT04894084|101600353|FG000|STARTED|Overall Study||25|Enrollment started April 29th 2021|
48517597|NCT04894084|101600353|FG000|COMPLETED|Overall Study||25|Study completed (Last patient out July 14th 2021)|
48517598|NCT04894084|101600353|FG000|NOT COMPLETED|Overall Study||0||
48517599|NCT04059549|101600354|FG000|STARTED|Overall Study||32||
48517600|NCT04059549|101600355|FG001|STARTED|Overall Study||36||
48517601|NCT04059549|101600354|FG000|COMPLETED|Overall Study||30||
48517602|NCT04059549|101600355|FG001|COMPLETED|Overall Study||36||
48517603|NCT04059549|101600354|FG000|NOT COMPLETED|Overall Study||2||
48517604|NCT04059549|101600355|FG001|NOT COMPLETED|Overall Study||0||
48517605|NCT00518882|101600356|FG000|STARTED|Double-Blind, Week 0-26||235||
48517606|NCT00518882|101600357|FG001|STARTED|Double-Blind, Week 0-26||232||
48517607|NCT00518882|101600356|FG000|Randomised|Double-Blind, Week 0-26||233||
48517608|NCT00518882|101600357|FG001|Randomised|Double-Blind, Week 0-26||231||
48517609|NCT00518882|101600356|FG000|COMPLETED|Double-Blind, Week 0-26||202||
48517610|NCT00518882|101600357|FG001|COMPLETED|Double-Blind, Week 0-26||187||
48517611|NCT00518882|101600356|FG000|NOT COMPLETED|Double-Blind, Week 0-26||33||
48517612|NCT00518882|101600357|FG001|NOT COMPLETED|Double-Blind, Week 0-26||45||
48517613|NCT00518882|101600356|FG000|STARTED|Open-Label Extension, Week 26-78||202||
48517614|NCT00518882|101600357|FG001|STARTED|Open-Label Extension, Week 26-78||187||
48517615|NCT00518882|101600356|FG000|COMPLETED|Open-Label Extension, Week 26-78||161||
48517616|NCT00518882|101600357|FG001|COMPLETED|Open-Label Extension, Week 26-78||138||
48517617|NCT00518882|101600356|FG000|NOT COMPLETED|Open-Label Extension, Week 26-78||41||
48517618|NCT00518882|101600357|FG001|NOT COMPLETED|Open-Label Extension, Week 26-78||49||
48517619|NCT04776954|101600358|FG000|STARTED|Overall Study||7||
48517620|NCT04776954|101600359|FG001|STARTED|Overall Study||8||
48517621|NCT04776954|101600358|FG000|COMPLETED|Overall Study||7||
48517622|NCT04776954|101600359|FG001|COMPLETED|Overall Study||8||
48517623|NCT04776954|101600358|FG000|NOT COMPLETED|Overall Study||0||
48517624|NCT04776954|101600359|FG001|NOT COMPLETED|Overall Study||0||
48517625|NCT03042468|101600360|FG000|STARTED|Overall Study||6||
48517626|NCT03042468|101600361|FG001|STARTED|Overall Study||6||
48517627|NCT03042468|101600362|FG002|STARTED|Overall Study||5||
48517628|NCT03042468|101600363|FG003|STARTED|Overall Study||6||
48517629|NCT03042468|101600364|FG004|STARTED|Overall Study||6||
48517630|NCT03042468|101600365|FG005|STARTED|Overall Study||21||
48517631|NCT03042468|101600360|FG000|COMPLETED|Overall Study||6||
48517632|NCT03042468|101600361|FG001|COMPLETED|Overall Study||5||
48517633|NCT03042468|101600362|FG002|COMPLETED|Overall Study||4||
48517634|NCT03042468|101600363|FG003|COMPLETED|Overall Study||6||
48517635|NCT03042468|101600364|FG004|COMPLETED|Overall Study||5||
48517636|NCT03042468|101600365|FG005|COMPLETED|Overall Study||19||
48517637|NCT03042468|101600360|FG000|NOT COMPLETED|Overall Study||0||
48517638|NCT03042468|101600361|FG001|NOT COMPLETED|Overall Study||1||
48517639|NCT03042468|101600362|FG002|NOT COMPLETED|Overall Study||1||
48517640|NCT03042468|101600363|FG003|NOT COMPLETED|Overall Study||0||
48517641|NCT03042468|101600364|FG004|NOT COMPLETED|Overall Study||1||
48517642|NCT03042468|101600365|FG005|NOT COMPLETED|Overall Study||2||
48517643|NCT00754442|101600366|FG000|STARTED|Overall Study||11||
48517644|NCT00754442|101600367|FG001|STARTED|Overall Study||9||
48517645|NCT00754442|101600366|FG000|COMPLETED|Overall Study||6||
48517646|NCT00754442|101600367|FG001|COMPLETED|Overall Study||6||
48517647|NCT00754442|101600366|FG000|NOT COMPLETED|Overall Study||5||
48517648|NCT00754442|101600367|FG001|NOT COMPLETED|Overall Study||3||
48517649|NCT02062801|101600368|FG000|STARTED|Overall Study||301||
48517650|NCT02062801|101600369|FG001|STARTED|Overall Study||301||
48517651|NCT02062801|101600368|FG000|COMPLETED|Overall Study||299||
48517652|NCT02062801|101600369|FG001|COMPLETED|Overall Study||297||
48517653|NCT02062801|101600368|FG000|NOT COMPLETED|Overall Study||2||
48517654|NCT02062801|101600369|FG001|NOT COMPLETED|Overall Study||4||
48517655|NCT01232491|101600370|FG000|STARTED|Overall Study||306||
48517656|NCT01232491|101600371|FG001|STARTED|Overall Study||305||
48517657|NCT01232491|101600370|FG000|Exposed (Safety Analysis Set)|Overall Study||305||
48517658|NCT01232491|101600371|FG001|Exposed (Safety Analysis Set)|Overall Study||301||
48517659|NCT01232491|101600370|FG000|COMPLETED|Overall Study||246||
48517660|NCT01232491|101600371|FG001|COMPLETED|Overall Study||242||
48517661|NCT01232491|101600370|FG000|NOT COMPLETED|Overall Study||60||
48517662|NCT01232491|101600371|FG001|NOT COMPLETED|Overall Study||63||
48517663|NCT02940730|101600372|FG000|STARTED|Intervention 1||10||
48517664|NCT02940730|101600373|FG001|STARTED|Intervention 1||0||
48517665|NCT02940730|101600372|FG000|Received Intervention|Intervention 1||10||
48517666|NCT02940730|101600373|FG001|Received Intervention|Intervention 1||0||
48517667|NCT02940730|101600372|FG000|COMPLETED|Intervention 1||10||
48517668|NCT02940730|101600373|FG001|COMPLETED|Intervention 1||0||
48517669|NCT02940730|101600372|FG000|NOT COMPLETED|Intervention 1||0||
48517670|NCT02940730|101600373|FG001|NOT COMPLETED|Intervention 1||0||
48517671|NCT02940730|101600372|FG000|STARTED|Intervention 2||10||
48517672|NCT02940730|101600373|FG001|STARTED|Intervention 2||0||
48517673|NCT02940730|101600372|FG000|Received Intervention|Intervention 2||3||
48517674|NCT02940730|101600373|FG001|Received Intervention|Intervention 2||0||
48517675|NCT02940730|101600372|FG000|COMPLETED|Intervention 2||3||
48517676|NCT02940730|101600373|FG001|COMPLETED|Intervention 2||0||
48517677|NCT02940730|101600372|FG000|NOT COMPLETED|Intervention 2||7||
48517678|NCT02940730|101600373|FG001|NOT COMPLETED|Intervention 2||0||
48517679|NCT02696031|101600374|FG000|STARTED|Up to Week 24||185||
48517680|NCT02696031|101600375|FG001|STARTED|Up to Week 24||184||
48517681|NCT02696031|101600376|FG002|STARTED|Up to Week 24||186||
48517682|NCT02696031|101600377|FG003|STARTED|Up to Week 24||0||
48517683|NCT02696031|101600378|FG004|STARTED|Up to Week 24||0||
48517684|NCT02696031|101600379|FG005|STARTED|Up to Week 24||0||
48517685|NCT02696031|101600374|FG000|COMPLETED|Up to Week 24||175|Completed week 24|
48517686|NCT02696031|101600375|FG001|COMPLETED|Up to Week 24||177|Completed week 24|
48517687|NCT02696031|101600376|FG002|COMPLETED|Up to Week 24||175|Completed week 24|
48517688|NCT02696031|101600377|FG003|COMPLETED|Up to Week 24||0|Completed week 24|
48517689|NCT02696031|101600378|FG004|COMPLETED|Up to Week 24||0|Completed week 24|
48517690|NCT02696031|101600379|FG005|COMPLETED|Up to Week 24||0|Completed week 24|
48517691|NCT02696031|101600374|FG000|NOT COMPLETED|Up to Week 24||10||
48517692|NCT02696031|101600375|FG001|NOT COMPLETED|Up to Week 24||7||
48517693|NCT02696031|101600376|FG002|NOT COMPLETED|Up to Week 24||11||
48517694|NCT02696031|101600377|FG003|NOT COMPLETED|Up to Week 24||0||
48517695|NCT02696031|101600378|FG004|NOT COMPLETED|Up to Week 24||0||
48517696|NCT02696031|101600379|FG005|NOT COMPLETED|Up to Week 24||0||
48517697|NCT02696031|101600374|FG000|STARTED|Up to Week 52||185||
48517698|NCT02696031|101600375|FG001|STARTED|Up to Week 52||184||
48517699|NCT02696031|101600376|FG002|STARTED|Up to Week 52||186||
48517700|NCT02696031|101600377|FG003|STARTED|Up to Week 52||0||
48517701|NCT02696031|101600378|FG004|STARTED|Up to Week 52||0||
48517702|NCT02696031|101600379|FG005|STARTED|Up to Week 52||0||
48517703|NCT02696031|101600374|FG000|COMPLETED|Up to Week 52||156||
48517704|NCT02696031|101600375|FG001|COMPLETED|Up to Week 52||165||
48517705|NCT02696031|101600376|FG002|COMPLETED|Up to Week 52||160||
48517706|NCT02696031|101600377|FG003|COMPLETED|Up to Week 52||0||
48517707|NCT02696031|101600378|FG004|COMPLETED|Up to Week 52||0||
48517708|NCT02696031|101600379|FG005|COMPLETED|Up to Week 52||0||
48517709|NCT02696031|101600374|FG000|NOT COMPLETED|Up to Week 52||29||
48517710|NCT02696031|101600375|FG001|NOT COMPLETED|Up to Week 52||19||
48517711|NCT02696031|101600376|FG002|NOT COMPLETED|Up to Week 52||26||
48517712|NCT02696031|101600377|FG003|NOT COMPLETED|Up to Week 52||0||
48517713|NCT02696031|101600378|FG004|NOT COMPLETED|Up to Week 52||0||
48517714|NCT02696031|101600379|FG005|NOT COMPLETED|Up to Week 52||0||
48517715|NCT02696031|101600374|FG000|STARTED|Up to Week 104||185||
48517716|NCT02696031|101600375|FG001|STARTED|Up to Week 104||184||
48517717|NCT02696031|101600376|FG002|STARTED|Up to Week 104||186||
48517718|NCT02696031|101600377|FG003|STARTED|Up to Week 104||0||
48517719|NCT02696031|101600378|FG004|STARTED|Up to Week 104||0||
48517720|NCT02696031|101600379|FG005|STARTED|Up to Week 104||0||
48068131|NCT00734474|100489657|FG005|COMPLETED|Overall Study||0||
48068132|NCT00734474|100489658|FG006|COMPLETED|Overall Study||0||
48068133|NCT00734474|100489659|FG007|COMPLETED|Overall Study||186||
48517721|NCT02696031|101600374|FG000|COMPLETED|Up to Week 104||146||
48517722|NCT02696031|101600375|FG001|COMPLETED|Up to Week 104||143||
48517723|NCT02696031|101600376|FG002|COMPLETED|Up to Week 104||149||
48517724|NCT02696031|101600377|FG003|COMPLETED|Up to Week 104||0||
48517725|NCT02696031|101600378|FG004|COMPLETED|Up to Week 104||0||
48517726|NCT02696031|101600379|FG005|COMPLETED|Up to Week 104||0||
48517727|NCT02696031|101600374|FG000|NOT COMPLETED|Up to Week 104||39||
48517728|NCT02696031|101600375|FG001|NOT COMPLETED|Up to Week 104||41||
48517729|NCT02696031|101600376|FG002|NOT COMPLETED|Up to Week 104||37||
48517730|NCT02696031|101600377|FG003|NOT COMPLETED|Up to Week 104||0||
48517731|NCT02696031|101600378|FG004|NOT COMPLETED|Up to Week 104||0||
48517732|NCT02696031|101600379|FG005|NOT COMPLETED|Up to Week 104||0||
48517733|NCT02696031|101600374|FG000|STARTED|Extension Phase From wk 104 to wk 208||0||
48517734|NCT02696031|101600375|FG001|STARTED|Extension Phase From wk 104 to wk 208||0||
48517735|NCT02696031|101600376|FG002|STARTED|Extension Phase From wk 104 to wk 208||0||
48517736|NCT02696031|101600377|FG003|STARTED|Extension Phase From wk 104 to wk 208||147||
48517737|NCT02696031|101600378|FG004|STARTED|Extension Phase From wk 104 to wk 208||147||
48517738|NCT02696031|101600379|FG005|STARTED|Extension Phase From wk 104 to wk 208||78||
48517739|NCT02696031|101600374|FG000|COMPLETED|Extension Phase From wk 104 to wk 208||0||
48517740|NCT02696031|101600375|FG001|COMPLETED|Extension Phase From wk 104 to wk 208||0||
48517741|NCT02696031|101600376|FG002|COMPLETED|Extension Phase From wk 104 to wk 208||0||
48517742|NCT02696031|101600377|FG003|COMPLETED|Extension Phase From wk 104 to wk 208||137||
48517743|NCT02696031|101600378|FG004|COMPLETED|Extension Phase From wk 104 to wk 208||132||
48517744|NCT02696031|101600379|FG005|COMPLETED|Extension Phase From wk 104 to wk 208||72||
48517745|NCT02696031|101600374|FG000|NOT COMPLETED|Extension Phase From wk 104 to wk 208||0||
48517746|NCT02696031|101600375|FG001|NOT COMPLETED|Extension Phase From wk 104 to wk 208||0||
48517747|NCT02696031|101600376|FG002|NOT COMPLETED|Extension Phase From wk 104 to wk 208||0||
48517748|NCT02696031|101600377|FG003|NOT COMPLETED|Extension Phase From wk 104 to wk 208||10||
48517749|NCT02696031|101600378|FG004|NOT COMPLETED|Extension Phase From wk 104 to wk 208||15||
48517750|NCT02696031|101600379|FG005|NOT COMPLETED|Extension Phase From wk 104 to wk 208||6||
48517751|NCT01272921|101600380|FG000|STARTED|Overall Study||71||
48517752|NCT01272921|101600381|FG001|STARTED|Overall Study||71||
48517753|NCT01272921|101600380|FG000|COMPLETED|Overall Study||69||
48517754|NCT01272921|101600381|FG001|COMPLETED|Overall Study||70||
48517755|NCT01272921|101600380|FG000|NOT COMPLETED|Overall Study||2||
48517756|NCT01272921|101600381|FG001|NOT COMPLETED|Overall Study||1||
48517757|NCT00285584|101600382|FG000|STARTED|Enrollment (Month 0)||20||
48517758|NCT00285584|101600383|FG001|STARTED|Enrollment (Month 0)||21||
48517759|NCT00285584|101600382|FG000|COMPLETED|Enrollment (Month 0)||20||
48517760|NCT00285584|101600383|FG001|COMPLETED|Enrollment (Month 0)||21||
48517761|NCT00285584|101600382|FG000|NOT COMPLETED|Enrollment (Month 0)||0||
48517762|NCT00285584|101600383|FG001|NOT COMPLETED|Enrollment (Month 0)||0||
48517763|NCT00285584|101600382|FG000|STARTED|Month 3||20||
48517764|NCT00285584|101600383|FG001|STARTED|Month 3||21||
48517765|NCT00285584|101600382|FG000|COMPLETED|Month 3||16||
48517766|NCT00285584|101600383|FG001|COMPLETED|Month 3||18||
48517767|NCT00285584|101600382|FG000|NOT COMPLETED|Month 3||4||
48517768|NCT00285584|101600383|FG001|NOT COMPLETED|Month 3||3||
48517769|NCT00285584|101600382|FG000|STARTED|Month 6||16||
48517770|NCT00285584|101600383|FG001|STARTED|Month 6||18||
48517771|NCT00285584|101600382|FG000|COMPLETED|Month 6||16||
48517772|NCT00285584|101600383|FG001|COMPLETED|Month 6||17||
48517773|NCT00285584|101600382|FG000|NOT COMPLETED|Month 6||0||
48517774|NCT00285584|101600383|FG001|NOT COMPLETED|Month 6||1||
48517775|NCT00285584|101600382|FG000|STARTED|Month 9||16||
48517776|NCT00285584|101600383|FG001|STARTED|Month 9||17||
48517777|NCT00285584|101600382|FG000|COMPLETED|Month 9||15||
48517778|NCT00285584|101600383|FG001|COMPLETED|Month 9||14||
48517779|NCT00285584|101600382|FG000|NOT COMPLETED|Month 9||1||
48517780|NCT00285584|101600383|FG001|NOT COMPLETED|Month 9||3||
48517781|NCT01563237|101600384|FG000|STARTED|Overall Study||64|69 Participants and 74 eyes were enrolled|69
48517782|NCT01563237|101600385|FG001|STARTED|Overall Study||5|69 Participants and 74 eyes were enrolled|5
48517783|NCT01563237|101600384|FG000|COMPLETED|Overall Study||54|59 participants and 64 eyes completed the study|59
48517784|NCT01563237|101600385|FG001|COMPLETED|Overall Study||5|59 participants and 64 eyes completed the study|5
48517785|NCT01563237|101600384|FG000|NOT COMPLETED|Overall Study||10||10
48517786|NCT01563237|101600385|FG001|NOT COMPLETED|Overall Study||0||0
48517787|NCT01077817|101600386|FG000|STARTED|Overall Study||684815||
48517788|NCT01077817|101600386|FG000|COMPLETED|Overall Study||684815||
48517789|NCT01077817|101600386|FG000|NOT COMPLETED|Overall Study||0||
48517790|NCT03702049|101600387|FG000|STARTED|Overall Study||50||
48517791|NCT03702049|101600387|FG000|COMPLETED|Overall Study||45||
48517792|NCT03702049|101600387|FG000|NOT COMPLETED|Overall Study||5||
48517793|NCT00904748|101600388|FG000|STARTED|Overall Study||8||
48517794|NCT00904748|101600389|FG001|STARTED|Overall Study||8||
48517795|NCT00904748|101600390|FG002|STARTED|Overall Study||8||
48517796|NCT00904748|101600391|FG003|STARTED|Overall Study||8||
48517797|NCT00904748|101600392|FG004|STARTED|Overall Study||8||
48517798|NCT00904748|101600393|FG005|STARTED|Overall Study||8||
48517799|NCT00904748|101600388|FG000|Received Treatment|Overall Study||8||
48517800|NCT00904748|101600389|FG001|Received Treatment|Overall Study||8||
48517801|NCT00904748|101600390|FG002|Received Treatment|Overall Study||8||
48517802|NCT00904748|101600391|FG003|Received Treatment|Overall Study||8||
48517803|NCT00904748|101600392|FG004|Received Treatment|Overall Study||7||
48517804|NCT00904748|101600393|FG005|Received Treatment|Overall Study||8||
48517805|NCT00904748|101600388|FG000|COMPLETED|Overall Study||7||
48517806|NCT00904748|101600389|FG001|COMPLETED|Overall Study||7||
48517807|NCT00904748|101600390|FG002|COMPLETED|Overall Study||7||
48517808|NCT00904748|101600391|FG003|COMPLETED|Overall Study||6||
48517809|NCT00904748|101600392|FG004|COMPLETED|Overall Study||7||
48517810|NCT00904748|101600393|FG005|COMPLETED|Overall Study||8||
48517811|NCT00904748|101600388|FG000|NOT COMPLETED|Overall Study||1||
48517812|NCT00904748|101600389|FG001|NOT COMPLETED|Overall Study||1||
48517813|NCT00904748|101600390|FG002|NOT COMPLETED|Overall Study||1||
48517814|NCT00904748|101600391|FG003|NOT COMPLETED|Overall Study||2||
48517815|NCT00904748|101600392|FG004|NOT COMPLETED|Overall Study||1||
48517816|NCT00904748|101600393|FG005|NOT COMPLETED|Overall Study||0||
48517817|NCT01002794|101600394|FG000|STARTED|Overall Study||70||
48517818|NCT01002794|101600395|FG001|STARTED|Overall Study||70||
48517819|NCT01002794|101600394|FG000|Three Months|Overall Study||60||
48517820|NCT01002794|101600395|FG001|Three Months|Overall Study||63||
48517821|NCT01002794|101600394|FG000|One Year|Overall Study||61||
48517822|NCT01002794|101600395|FG001|One Year|Overall Study||59||
48517823|NCT01002794|101600394|FG000|Two Years|Overall Study||64||
48517824|NCT01002794|101600395|FG001|Two Years|Overall Study||62||
48517825|NCT01002794|101600394|FG000|Five Years|Overall Study||62||
48517826|NCT01002794|101600395|FG001|Five Years|Overall Study||58||
48517827|NCT01002794|101600394|FG000|COMPLETED|Overall Study||62||
48517828|NCT01002794|101600395|FG001|COMPLETED|Overall Study||58||
48517829|NCT01002794|101600394|FG000|NOT COMPLETED|Overall Study||8||
48517830|NCT01002794|101600395|FG001|NOT COMPLETED|Overall Study||12||
48517831|NCT00882206|101600396|FG000|STARTED|Overall Study||13||
48517832|NCT00882206|101600396|FG000|COMPLETED|Overall Study||13||
48517833|NCT00882206|101600396|FG000|NOT COMPLETED|Overall Study||0||
48517834|NCT01258101|101600397|FG000|STARTED|Overall Study||151||
48517835|NCT01258101|101600398|FG001|STARTED|Overall Study||144||
48517836|NCT01258101|101600399|FG002|STARTED|Overall Study||33||
48517837|NCT01258101|101600400|FG003|STARTED|Overall Study||52||
48517838|NCT01258101|101600397|FG000|Safety Analysis Population|Overall Study||144||
48517839|NCT01258101|101600398|FG001|Safety Analysis Population|Overall Study||141||
48517840|NCT01258101|101600399|FG002|Safety Analysis Population|Overall Study||30||
48517841|NCT01258101|101600400|FG003|Safety Analysis Population|Overall Study||48||
48517842|NCT01258101|101600397|FG000|Standard Analysis Population|Overall Study||115||
48517843|NCT01258101|101600398|FG001|Standard Analysis Population|Overall Study||110||
48517844|NCT01258101|101600399|FG002|Standard Analysis Population|Overall Study||21||
48517845|NCT01258101|101600400|FG003|Standard Analysis Population|Overall Study||26||
48517846|NCT01258101|101600397|FG000|COMPLETED|Overall Study||118||
48517847|NCT01258101|101600398|FG001|COMPLETED|Overall Study||110||
48517848|NCT01258101|101600399|FG002|COMPLETED|Overall Study||22||
48517849|NCT01258101|101600400|FG003|COMPLETED|Overall Study||27||
48517850|NCT01258101|101600397|FG000|NOT COMPLETED|Overall Study||33||
48517851|NCT01258101|101600398|FG001|NOT COMPLETED|Overall Study||34||
48068134|NCT00734474|100489660|FG008|COMPLETED|Overall Study||95||
48068135|NCT00734474|100489652|FG000|NOT COMPLETED|Overall Study||15||
48068136|NCT00734474|100489653|FG001|NOT COMPLETED|Overall Study||30||
48068137|NCT00734474|100489654|FG002|NOT COMPLETED|Overall Study||112||
48068138|NCT00734474|100489655|FG003|NOT COMPLETED|Overall Study||10||
48068139|NCT00734474|100489656|FG004|NOT COMPLETED|Overall Study||118||
48068140|NCT00734474|100489657|FG005|NOT COMPLETED|Overall Study||25||
48068141|NCT00734474|100489658|FG006|NOT COMPLETED|Overall Study||24||
48068142|NCT00734474|100489659|FG007|NOT COMPLETED|Overall Study||129||
48068143|NCT00734474|100489660|FG008|NOT COMPLETED|Overall Study||82||
48068144|NCT01298531|100489661|FG000|STARTED|Overall Study||42||
48068145|NCT01298531|100489662|FG001|STARTED|Overall Study||48||
48068146|NCT01298531|100489661|FG000|COMPLETED|Overall Study||33||
48068147|NCT01298531|100489662|FG001|COMPLETED|Overall Study||41||
48068148|NCT01298531|100489661|FG000|NOT COMPLETED|Overall Study||9||
48068149|NCT01298531|100489662|FG001|NOT COMPLETED|Overall Study||7||
48068150|NCT02598960|100489663|FG000|STARTED|Treatment Period||4|= Starting Initial Treatment Period|
48068151|NCT02598960|100489664|FG001|STARTED|Treatment Period||6|= Starting Initial Treatment Period|
48068152|NCT02598960|100489665|FG002|STARTED|Treatment Period||4|= Starting Initial Treatment Period|
48068153|NCT02598960|100489666|FG003|STARTED|Treatment Period||6|= Starting Initial Treatment Period|
48068154|NCT02598960|100489667|FG004|STARTED|Treatment Period||9|= Starting Initial Treatment Period|
48068155|NCT02598960|100489668|FG005|STARTED|Treatment Period||3|= Starting Initial Treatment Period|
48068156|NCT02598960|100489669|FG006|STARTED|Treatment Period||2|= Starting Initial Treatment Period|
48068157|NCT02598960|100489670|FG007|STARTED|Treatment Period||3|= Starting Initial Treatment Period|
48517852|NCT01258101|101600399|FG002|NOT COMPLETED|Overall Study||11||
48517853|NCT01258101|101600400|FG003|NOT COMPLETED|Overall Study||25||
48517854|NCT03291041|101600401|FG000|STARTED|Overall Study||13||
48517855|NCT03291041|101600402|FG001|STARTED|Overall Study||12||
48517856|NCT03291041|101600401|FG000|COMPLETED|Overall Study||13||
48517857|NCT03291041|101600402|FG001|COMPLETED|Overall Study||12||
48517858|NCT03291041|101600401|FG000|NOT COMPLETED|Overall Study||0||
48517859|NCT03291041|101600402|FG001|NOT COMPLETED|Overall Study||0||
48517860|NCT01884688|101600403|FG000|STARTED|Overall Study||3||
48517861|NCT01884688|101600403|FG000|COMPLETED|Overall Study||1||
48517862|NCT01884688|101600403|FG000|NOT COMPLETED|Overall Study||2||
48517863|NCT03581188|101600404|FG000|STARTED|Overall Study||49||
48517864|NCT03581188|101600405|FG001|STARTED|Overall Study||51||
48517865|NCT03581188|101600404|FG000|COMPLETED|Overall Study||30||
48517866|NCT03581188|101600405|FG001|COMPLETED|Overall Study||36||
48517867|NCT03581188|101600404|FG000|NOT COMPLETED|Overall Study||19||
48517868|NCT03581188|101600405|FG001|NOT COMPLETED|Overall Study||15||
48517869|NCT02970552|101600406|FG000|STARTED|Overall Study||70||
48517870|NCT02970552|101600407|FG001|STARTED|Overall Study||70||
48517871|NCT02970552|101600406|FG000|COMPLETED|Overall Study||67||
48517872|NCT02970552|101600407|FG001|COMPLETED|Overall Study||67||
48517873|NCT02970552|101600406|FG000|NOT COMPLETED|Overall Study||3||
48517874|NCT02970552|101600407|FG001|NOT COMPLETED|Overall Study||3||
48517875|NCT00206102|101600408|FG000|STARTED|Overall Study||596||
48517876|NCT00206102|101600409|FG001|STARTED|Overall Study||502||
48517877|NCT00206102|101600408|FG000|COMPLETED|Overall Study||188||
48068158|NCT02598960|100489671|FG008|STARTED|Treatment Period||9|= Starting Initial Treatment Period|
48068159|NCT02598960|100489672|FG009|STARTED|Treatment Period||14|= Starting Initial Treatment Period|
48068160|NCT02598960|100489673|FG010|STARTED|Treatment Period||11|= Starting Initial Treatment Period|
48068161|NCT02598960|100489674|FG011|STARTED|Treatment Period||188|= Starting Initial Treatment Period|
48068162|NCT02598960|100489675|FG012|STARTED|Treatment Period||33|= Starting Initial Treatment Period|
48068163|NCT02598960|100489663|FG000|COMPLETED|Treatment Period||0|= completing initial treatment period|
48068164|NCT02598960|100489664|FG001|COMPLETED|Treatment Period||0|= completing initial treatment period|
48068165|NCT02598960|100489665|FG002|COMPLETED|Treatment Period||0|= completing initial treatment period|
48219949|NCT05580003|100863772|FG024|COMPLETED|Part 3: Period 3 (Day 1)||0||
48517878|NCT00206102|101600409|FG001|COMPLETED|Overall Study||187||
48517879|NCT00206102|101600408|FG000|NOT COMPLETED|Overall Study||408||
48517880|NCT00206102|101600409|FG001|NOT COMPLETED|Overall Study||315||
48517881|NCT04223778|101600410|FG000|STARTED|Overall Study||336||
48517882|NCT04223778|101600411|FG001|STARTED|Overall Study||336||
48517883|NCT04223778|101600410|FG000|COMPLETED|Overall Study||0||
48517884|NCT04223778|101600411|FG001|COMPLETED|Overall Study||0||
48517885|NCT04223778|101600410|FG000|NOT COMPLETED|Overall Study||336||
48517886|NCT04223778|101600411|FG001|NOT COMPLETED|Overall Study||336||
48517887|NCT03746002|101600412|FG000|STARTED|Overall Study||1||
48517888|NCT03746002|101600413|FG001|STARTED|Overall Study||2||
48517889|NCT03746002|101600412|FG000|COMPLETED|Overall Study||1||
48517890|NCT03746002|101600413|FG001|COMPLETED|Overall Study||2||
48517891|NCT03746002|101600412|FG000|NOT COMPLETED|Overall Study||0||
48517892|NCT03746002|101600413|FG001|NOT COMPLETED|Overall Study||0||
48517893|NCT00690482|101600414|FG000|STARTED|Overall Study||61||
48517894|NCT00690482|101600415|FG001|STARTED|Overall Study||57||
48517895|NCT00690482|101600414|FG000|COMPLETED|Overall Study||57||
48517896|NCT00690482|101600415|FG001|COMPLETED|Overall Study||54||
48517897|NCT00690482|101600414|FG000|NOT COMPLETED|Overall Study||4||
48517898|NCT00690482|101600415|FG001|NOT COMPLETED|Overall Study||3||
48517899|NCT01397617|101600416|FG000|STARTED|Overall Study||64||
48517900|NCT01397617|101600417|FG001|STARTED|Overall Study||53||
48517901|NCT01397617|101600418|FG002|STARTED|Overall Study||60||
48517902|NCT01397617|101600416|FG000|COMPLETED|Overall Study||33||
48517903|NCT01397617|101600417|FG001|COMPLETED|Overall Study||30||
48517904|NCT01397617|101600418|FG002|COMPLETED|Overall Study||31||
48517905|NCT01397617|101600416|FG000|NOT COMPLETED|Overall Study||31||
48517906|NCT01397617|101600417|FG001|NOT COMPLETED|Overall Study||23||
48517907|NCT01397617|101600418|FG002|NOT COMPLETED|Overall Study||29||
48517908|NCT00604201|101600419|FG000|STARTED|Overall Study||31||
48517909|NCT00604201|101600419|FG000|COMPLETED|Overall Study||21||
48517910|NCT00604201|101600419|FG000|NOT COMPLETED|Overall Study||10||
48517911|NCT02326974|101600420|FG000|STARTED|Overall Study||164||
48517912|NCT02326974|101600420|FG000|Treated|Overall Study||163||
48517913|NCT02326974|101600420|FG000|COMPLETED|Overall Study||157||
48517914|NCT02326974|101600420|FG000|NOT COMPLETED|Overall Study||7||
48517915|NCT03440424|101600421|FG000|STARTED|Overall Study||8||
48517916|NCT03440424|101600422|FG001|STARTED|Overall Study||8||
48517917|NCT03440424|101600423|FG002|STARTED|Overall Study||8||
48517918|NCT03440424|101600421|FG000|COMPLETED|Overall Study||8||
48517919|NCT03440424|101600422|FG001|COMPLETED|Overall Study||8||
48517920|NCT03440424|101600423|FG002|COMPLETED|Overall Study||8||
48517921|NCT03440424|101600421|FG000|NOT COMPLETED|Overall Study||0||
48517922|NCT03440424|101600422|FG001|NOT COMPLETED|Overall Study||0||
48517923|NCT03440424|101600423|FG002|NOT COMPLETED|Overall Study||0||
48517924|NCT01470196|101600424|FG000|STARTED|Overall Study||31||
48517925|NCT01470196|101600424|FG000|COMPLETED|Overall Study||31||
48517926|NCT01470196|101600424|FG000|NOT COMPLETED|Overall Study||0||
48517927|NCT03341000|101600425|FG000|STARTED|Overall Study||18||
48517928|NCT03341000|101600425|FG000|COMPLETED|Overall Study||17||
48517929|NCT03341000|101600425|FG000|NOT COMPLETED|Overall Study||1||
48517930|NCT02619682|101600426|FG000|STARTED|Overall Study||30||
48517931|NCT02619682|101600426|FG000|COMPLETED|Overall Study||16||
48517932|NCT02619682|101600426|FG000|NOT COMPLETED|Overall Study||14||
48517933|NCT01048502|101600427|FG000|STARTED|Overall Study||24||
48517934|NCT01048502|101600428|FG001|STARTED|Overall Study||23||
48517935|NCT01048502|101600429|FG002|STARTED|Overall Study||28||
48517936|NCT01048502|101600430|FG003|STARTED|Overall Study||25||
48517937|NCT01048502|101600427|FG000|COMPLETED|Overall Study||20||
48517938|NCT01048502|101600428|FG001|COMPLETED|Overall Study||16||
48517939|NCT01048502|101600429|FG002|COMPLETED|Overall Study||23||
48517940|NCT01048502|101600430|FG003|COMPLETED|Overall Study||21||
48068166|NCT02598960|100489666|FG003|COMPLETED|Treatment Period||0|= completing initial treatment period|
48068167|NCT02598960|100489667|FG004|COMPLETED|Treatment Period||0|= completing initial treatment period|
48517941|NCT01048502|101600427|FG000|NOT COMPLETED|Overall Study||4||
48517942|NCT01048502|101600428|FG001|NOT COMPLETED|Overall Study||7||
48517943|NCT01048502|101600429|FG002|NOT COMPLETED|Overall Study||5||
48517944|NCT01048502|101600430|FG003|NOT COMPLETED|Overall Study||4||
48517945|NCT00682617|101600431|FG000|STARTED|Overall Study||13||
48517946|NCT00682617|101600432|FG001|STARTED|Overall Study||28||
48517947|NCT00682617|101600431|FG000|COMPLETED|Overall Study||10||
48517948|NCT00682617|101600432|FG001|COMPLETED|Overall Study||21||
48517949|NCT00682617|101600431|FG000|NOT COMPLETED|Overall Study||3||
48517950|NCT00682617|101600432|FG001|NOT COMPLETED|Overall Study||7||
48517951|NCT02531594|101600433|FG000|STARTED|Overall Study||384||
48517952|NCT02531594|101600434|FG001|STARTED|Overall Study||381||
48517953|NCT02531594|101600433|FG000|COMPLETED|Overall Study||377||
48517954|NCT02531594|101600434|FG001|COMPLETED|Overall Study||373||
48517955|NCT02531594|101600433|FG000|NOT COMPLETED|Overall Study||7||
48517956|NCT02531594|101600434|FG001|NOT COMPLETED|Overall Study||8||
48517957|NCT00444821|101600435|FG000|STARTED|Overall Study||362||
48517958|NCT00444821|101600436|FG001|STARTED|Overall Study||366||
48517959|NCT00444821|101600435|FG000|Received AAA Repair|Overall Study||122||
48517960|NCT00444821|101600436|FG001|Received AAA Repair|Overall Study||326||
48517961|NCT00444821|101600435|FG000|COMPLETED|Overall Study||0||
48517962|NCT00444821|101600436|FG001|COMPLETED|Overall Study||0||
48517963|NCT00444821|101600435|FG000|NOT COMPLETED|Overall Study||362||
48517964|NCT00444821|101600436|FG001|NOT COMPLETED|Overall Study||366||
48517965|NCT03736928|101600437|FG000|STARTED|Overall Study||80||
48517966|NCT03736928|101600438|FG001|STARTED|Overall Study||80||
48517967|NCT03736928|101600439|FG002|STARTED|Overall Study||80||
48517968|NCT03736928|101600440|FG003|STARTED|Overall Study||81||
48517969|NCT03736928|101600441|FG004|STARTED|Overall Study||78||
48517970|NCT03736928|101600437|FG000|COMPLETED|Overall Study||73||
48517971|NCT03736928|101600438|FG001|COMPLETED|Overall Study||78||
48517972|NCT03736928|101600439|FG002|COMPLETED|Overall Study||75||
48517973|NCT03736928|101600440|FG003|COMPLETED|Overall Study||76||
48517974|NCT03736928|101600441|FG004|COMPLETED|Overall Study||67||
48517975|NCT03736928|101600437|FG000|NOT COMPLETED|Overall Study||7||
48517976|NCT03736928|101600438|FG001|NOT COMPLETED|Overall Study||2||
48517977|NCT03736928|101600439|FG002|NOT COMPLETED|Overall Study||5||
48517978|NCT03736928|101600440|FG003|NOT COMPLETED|Overall Study||5||
48517979|NCT03736928|101600441|FG004|NOT COMPLETED|Overall Study||11||
48517980|NCT01239472|101600442|FG000|STARTED|Overall Study||15||
48517981|NCT01239472|101600443|FG001|STARTED|Overall Study||15||
48517982|NCT01239472|101600442|FG000|COMPLETED|Overall Study||10||
48517983|NCT01239472|101600443|FG001|COMPLETED|Overall Study||12||
48517984|NCT01239472|101600442|FG000|NOT COMPLETED|Overall Study||5||
48517985|NCT01239472|101600443|FG001|NOT COMPLETED|Overall Study||3||
48517986|NCT02556307|101600444|FG000|STARTED|Overall Study||270||
48517987|NCT02556307|101600444|FG000|Treated|Overall Study||268||
48517988|NCT02556307|101600444|FG000|COMPLETED|Overall Study||217||
48517989|NCT02556307|101600444|FG000|NOT COMPLETED|Overall Study||53||
48517990|NCT00857259|101600445|FG000|STARTED|Overall Study||8||
48517991|NCT00857259|101600446|FG001|STARTED|Overall Study||1||
48517992|NCT00857259|101600447|FG002|STARTED|Overall Study||7||
48517993|NCT00857259|101600445|FG000|COMPLETED|Overall Study||7||
48517994|NCT00857259|101600446|FG001|COMPLETED|Overall Study||1||
48517995|NCT00857259|101600447|FG002|COMPLETED|Overall Study||6||
48517996|NCT00857259|101600445|FG000|NOT COMPLETED|Overall Study||1||
48517997|NCT00857259|101600446|FG001|NOT COMPLETED|Overall Study||0||
48517998|NCT00857259|101600447|FG002|NOT COMPLETED|Overall Study||1||
48517999|NCT00789113|101600448|FG000|STARTED|Overall Study||12||
48518000|NCT00789113|101600448|FG000|COMPLETED|Overall Study||12||
48518001|NCT00789113|101600448|FG000|NOT COMPLETED|Overall Study||0||
48518002|NCT03629028|101600449|FG000|STARTED|Overall Study||141|18/08/2018|
48518003|NCT03629028|101600450|FG001|STARTED|Overall Study||141|18/08/2018|
48518004|NCT03629028|101600449|FG000|COMPLETED|Overall Study||109||
48518005|NCT03629028|101600450|FG001|COMPLETED|Overall Study||116||
48518006|NCT03629028|101600449|FG000|NOT COMPLETED|Overall Study||32||
48518007|NCT03629028|101600450|FG001|NOT COMPLETED|Overall Study||25||
48518008|NCT01322971|101600451|FG000|STARTED|Overall Study||1||
48518009|NCT01322971|101600452|FG001|STARTED|Overall Study||1||
48518010|NCT01322971|101600451|FG000|COMPLETED|Overall Study||0||
48518011|NCT01322971|101600452|FG001|COMPLETED|Overall Study||0||
48518012|NCT01322971|101600451|FG000|NOT COMPLETED|Overall Study||1||
48518013|NCT01322971|101600452|FG001|NOT COMPLETED|Overall Study||1||
48518014|NCT00854373|101600453|FG000|STARTED|Overall Study||95||
48518015|NCT00854373|101600454|FG001|STARTED|Overall Study||93||
48518016|NCT00854373|101600453|FG000|COMPLETED|Overall Study||93||
48518017|NCT00854373|101600454|FG001|COMPLETED|Overall Study||89||
48518018|NCT00854373|101600453|FG000|NOT COMPLETED|Overall Study||2||
48518019|NCT00854373|101600454|FG001|NOT COMPLETED|Overall Study||4||
48518020|NCT02502734|101600455|FG000|STARTED|Double-blind Treatment Period 1||30||
48518021|NCT02502734|101600456|FG001|STARTED|Double-blind Treatment Period 1||30||
48518022|NCT02502734|101600455|FG000|COMPLETED|Double-blind Treatment Period 1||29||
48518023|NCT02502734|101600456|FG001|COMPLETED|Double-blind Treatment Period 1||30||
48518024|NCT02502734|101600455|FG000|NOT COMPLETED|Double-blind Treatment Period 1||1||
48518025|NCT02502734|101600456|FG001|NOT COMPLETED|Double-blind Treatment Period 1||0||
48518026|NCT02502734|101600455|FG000|STARTED|Washout Period||29||
48518027|NCT02502734|101600456|FG001|STARTED|Washout Period||30||
48518028|NCT02502734|101600455|FG000|COMPLETED|Washout Period||28||
48518029|NCT02502734|101600456|FG001|COMPLETED|Washout Period||30||
48666836|NCT05126303|101970477|FG001|STARTED|Overall Study||88||
48518030|NCT02502734|101600455|FG000|NOT COMPLETED|Washout Period||1||
48666837|NCT05126303|101970476|FG000|COMPLETED|Overall Study||89||
48518031|NCT02502734|101600456|FG001|NOT COMPLETED|Washout Period||0||
48518032|NCT02502734|101600455|FG000|STARTED|Double-blind Treatment Period 2||28||
48518033|NCT02502734|101600456|FG001|STARTED|Double-blind Treatment Period 2||30||
48518034|NCT02502734|101600455|FG000|COMPLETED|Double-blind Treatment Period 2||28||
48518035|NCT02502734|101600456|FG001|COMPLETED|Double-blind Treatment Period 2||30||
48518036|NCT02502734|101600455|FG000|NOT COMPLETED|Double-blind Treatment Period 2||0||
48518037|NCT02502734|101600456|FG001|NOT COMPLETED|Double-blind Treatment Period 2||0||
48518038|NCT01221090|101600457|FG000|STARTED|Overall Study||101||
48518039|NCT01221090|101600458|FG001|STARTED|Overall Study||81||
48518040|NCT01221090|101600459|FG002|STARTED|Overall Study||99||
48518041|NCT01221090|101600460|FG003|STARTED|Overall Study||95||
48518042|NCT01221090|101600457|FG000|COMPLETED|Overall Study||86||
48518043|NCT01221090|101600458|FG001|COMPLETED|Overall Study||47||
48518044|NCT01221090|101600459|FG002|COMPLETED|Overall Study||57||
48518045|NCT01221090|101600460|FG003|COMPLETED|Overall Study||73||
48518046|NCT01221090|101600457|FG000|NOT COMPLETED|Overall Study||15||
48518047|NCT01221090|101600458|FG001|NOT COMPLETED|Overall Study||34||
48518048|NCT01221090|101600459|FG002|NOT COMPLETED|Overall Study||42||
48518049|NCT01221090|101600460|FG003|NOT COMPLETED|Overall Study||22||
48518050|NCT00298740|101600461|FG000|STARTED|Overall Study||12||
48518051|NCT00298740|101600461|FG000|COMPLETED|Overall Study||3||
48518052|NCT00298740|101600461|FG000|NOT COMPLETED|Overall Study||9||
48518053|NCT02450526|101600462|FG000|STARTED|DB Period (Cycle 1)||325|Subjects randomised to each treatment group.|
48518054|NCT02450526|101600463|FG001|STARTED|DB Period (Cycle 1)||66|Subjects randomised to each treatment group.|
48518055|NCT02450526|101600464|FG002|STARTED|DB Period (Cycle 1)||107|Subjects randomised to each treatment group.|
48518056|NCT02450526|101600465|FG003|STARTED|DB Period (Cycle 1)||22|Subjects randomised to each treatment group.|
48518057|NCT02450526|101600466|FG004|STARTED|DB Period (Cycle 1)||0|Subjects randomised to each treatment group.|
48518058|NCT02450526|101600462|FG000|Safety Population|DB Period (Cycle 1)||326|1 subject was randomised to Botox placebo group but received treatment of Dysport® 50 U in Cycle 1.|
48518059|NCT02450526|101600463|FG001|Safety Population|DB Period (Cycle 1)||66|1 subject was randomised to Botox placebo group but received treatment of Dysport® 50 U in Cycle 1.|
48518060|NCT02450526|101600464|FG002|Safety Population|DB Period (Cycle 1)||107|1 subject was randomised to Botox placebo group but received treatment of Dysport® 50 U in Cycle 1.|
48518061|NCT02450526|101600465|FG003|Safety Population|DB Period (Cycle 1)||21|1 subject was randomised to Botox placebo group but received treatment of Dysport® 50 U in Cycle 1.|
48518062|NCT02450526|101600466|FG004|Safety Population|DB Period (Cycle 1)||0|1 subject was randomised to Botox placebo group but received treatment of Dysport® 50 U in Cycle 1.|
48518063|NCT02450526|101600462|FG000|COMPLETED|DB Period (Cycle 1)||294||
48518064|NCT02450526|101600463|FG001|COMPLETED|DB Period (Cycle 1)||63||
48518065|NCT02450526|101600464|FG002|COMPLETED|DB Period (Cycle 1)||97||
48518066|NCT02450526|101600465|FG003|COMPLETED|DB Period (Cycle 1)||20||
48518067|NCT02450526|101600466|FG004|COMPLETED|DB Period (Cycle 1)||0||
48518068|NCT02450526|101600462|FG000|NOT COMPLETED|DB Period (Cycle 1)||31||
48518069|NCT02450526|101600463|FG001|NOT COMPLETED|DB Period (Cycle 1)||3||
48518070|NCT02450526|101600464|FG002|NOT COMPLETED|DB Period (Cycle 1)||10||
48518071|NCT02450526|101600465|FG003|NOT COMPLETED|DB Period (Cycle 1)||2||
48518072|NCT02450526|101600466|FG004|NOT COMPLETED|DB Period (Cycle 1)||0||
48518073|NCT02450526|101600462|FG000|STARTED|OL Period (Cycles 2-5)||0||
48518074|NCT02450526|101600463|FG001|STARTED|OL Period (Cycles 2-5)||0||
48518075|NCT02450526|101600464|FG002|STARTED|OL Period (Cycles 2-5)||0||
48518076|NCT02450526|101600465|FG003|STARTED|OL Period (Cycles 2-5)||0||
48518077|NCT02450526|101600466|FG004|STARTED|OL Period (Cycles 2-5)||465||
48518078|NCT02450526|101600462|FG000|Safety Population|OL Period (Cycles 2-5)||0||
48518079|NCT02450526|101600463|FG001|Safety Population|OL Period (Cycles 2-5)||0||
48518080|NCT02450526|101600464|FG002|Safety Population|OL Period (Cycles 2-5)||0||
48518081|NCT02450526|101600465|FG003|Safety Population|OL Period (Cycles 2-5)||0||
48518082|NCT02450526|101600466|FG004|Safety Population|OL Period (Cycles 2-5)||465||
48518083|NCT02450526|101600462|FG000|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0||
48518084|NCT02450526|101600463|FG001|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0||
48518085|NCT02450526|101600464|FG002|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0||
48518086|NCT02450526|101600465|FG003|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0||
48518087|NCT02450526|101600466|FG004|Discontinued During Cycle 2|OL Period (Cycles 2-5)||28||
48518088|NCT02450526|101600462|FG000|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0||
48518089|NCT02450526|101600463|FG001|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0||
48518090|NCT02450526|101600464|FG002|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0||
48518091|NCT02450526|101600465|FG003|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0||
48518092|NCT02450526|101600466|FG004|Discontinued During Cycle 3|OL Period (Cycles 2-5)||11||
48518093|NCT02450526|101600462|FG000|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0||
48518094|NCT02450526|101600463|FG001|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0||
48518095|NCT02450526|101600464|FG002|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0||
48518096|NCT02450526|101600465|FG003|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0||
48518097|NCT02450526|101600466|FG004|Discontinued During Cycle 4|OL Period (Cycles 2-5)||2||
48219950|NCT05580003|100863773|FG025|COMPLETED|Part 3: Period 3 (Day 1)||0||
48518098|NCT02450526|101600462|FG000|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0||
48518099|NCT02450526|101600463|FG001|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0||
48518100|NCT02450526|101600464|FG002|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0||
48518101|NCT02450526|101600465|FG003|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0||
48518102|NCT02450526|101600466|FG004|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0||
48518103|NCT02450526|101600462|FG000|COMPLETED|OL Period (Cycles 2-5)||0||
48518104|NCT02450526|101600463|FG001|COMPLETED|OL Period (Cycles 2-5)||0||
48518105|NCT02450526|101600464|FG002|COMPLETED|OL Period (Cycles 2-5)||0||
48518106|NCT02450526|101600465|FG003|COMPLETED|OL Period (Cycles 2-5)||0||
48518107|NCT02450526|101600466|FG004|COMPLETED|OL Period (Cycles 2-5)||424||
48518108|NCT02450526|101600462|FG000|NOT COMPLETED|OL Period (Cycles 2-5)||0||
48518109|NCT02450526|101600463|FG001|NOT COMPLETED|OL Period (Cycles 2-5)||0||
48518110|NCT02450526|101600464|FG002|NOT COMPLETED|OL Period (Cycles 2-5)||0||
48518111|NCT02450526|101600465|FG003|NOT COMPLETED|OL Period (Cycles 2-5)||0||
48518112|NCT02450526|101600466|FG004|NOT COMPLETED|OL Period (Cycles 2-5)||41||
48518113|NCT01891812|101600467|FG000|STARTED|Overall Study||5||
48518114|NCT01891812|101600467|FG000|COMPLETED|Overall Study||0||
48518115|NCT01891812|101600467|FG000|NOT COMPLETED|Overall Study||5||
48518116|NCT00918463|101600468|FG000|STARTED|Overall Study||2||
48518117|NCT00918463|101600468|FG000|COMPLETED|Overall Study||0||
48518118|NCT00918463|101600468|FG000|NOT COMPLETED|Overall Study||2||
48518119|NCT00103402|101600469|FG000|STARTED|Overall Study||138||
48518120|NCT00103402|101600470|FG001|STARTED|Overall Study||134||
48518121|NCT00103402|101600469|FG000|COMPLETED|Overall Study||116||
48518122|NCT00103402|101600470|FG001|COMPLETED|Overall Study||117||
48518123|NCT00103402|101600469|FG000|NOT COMPLETED|Overall Study||22||
48518124|NCT00103402|101600470|FG001|NOT COMPLETED|Overall Study||17||
48518125|NCT00897949|101600471|FG000|STARTED|Overall Study||554||
48518126|NCT00897949|101600472|FG001|STARTED|Overall Study||549||
48518127|NCT00897949|101600473|FG002|STARTED|Overall Study||370||
48518128|NCT00897949|101600471|FG000|Patients Treated|Overall Study||458||
48518129|NCT00897949|101600472|FG001|Patients Treated|Overall Study||456||
48518130|NCT00897949|101600473|FG002|Patients Treated|Overall Study||304||
48518131|NCT00897949|101600471|FG000|COMPLETED|Overall Study||450||
48518132|NCT00897949|101600472|FG001|COMPLETED|Overall Study||446||
48518133|NCT00897949|101600473|FG002|COMPLETED|Overall Study||301||
48518134|NCT00897949|101600471|FG000|NOT COMPLETED|Overall Study||104||
48518135|NCT00897949|101600472|FG001|NOT COMPLETED|Overall Study||103||
48518136|NCT00897949|101600473|FG002|NOT COMPLETED|Overall Study||69||
48518137|NCT02924376|101600474|FG000|STARTED|Overall Study||108||
48518138|NCT02924376|101600475|FG001|STARTED|Overall Study||20||
48518139|NCT02924376|101600476|FG002|STARTED|Overall Study||17||
48518140|NCT02924376|101600477|FG003|STARTED|Overall Study||2||
48518141|NCT02924376|101600474|FG000|COMPLETED|Overall Study||0||
48518142|NCT02924376|101600475|FG001|COMPLETED|Overall Study||0||
48518143|NCT02924376|101600476|FG002|COMPLETED|Overall Study||0||
48518144|NCT02924376|101600477|FG003|COMPLETED|Overall Study||0||
48518145|NCT02924376|101600474|FG000|NOT COMPLETED|Overall Study||108||
48518146|NCT02924376|101600475|FG001|NOT COMPLETED|Overall Study||20||
48518147|NCT02924376|101600476|FG002|NOT COMPLETED|Overall Study||17||
48518148|NCT02924376|101600477|FG003|NOT COMPLETED|Overall Study||2||
48518149|NCT00725621|101600478|FG000|STARTED|Overall Study||516||
48518150|NCT00725621|101600478|FG000|COMPLETED|Overall Study||245||
48518151|NCT00725621|101600478|FG000|NOT COMPLETED|Overall Study||271||
48518152|NCT02575339|101600479|FG000|STARTED|Study Treatment||7||
48518153|NCT02575339|101600480|FG001|STARTED|Study Treatment||4||
48518154|NCT02575339|101600481|FG002|STARTED|Study Treatment||0||
48518155|NCT02575339|101600479|FG000|COMPLETED|Study Treatment||0||
48518156|NCT02575339|101600480|FG001|COMPLETED|Study Treatment||0||
48518157|NCT02575339|101600481|FG002|COMPLETED|Study Treatment||0||
48518158|NCT02575339|101600479|FG000|NOT COMPLETED|Study Treatment||7||
48518159|NCT02575339|101600480|FG001|NOT COMPLETED|Study Treatment||4||
48518160|NCT02575339|101600481|FG002|NOT COMPLETED|Study Treatment||0||
48518161|NCT02575339|101600479|FG000|STARTED|Follow up||7||
48518162|NCT02575339|101600480|FG001|STARTED|Follow up||4||
48518163|NCT02575339|101600481|FG002|STARTED|Follow up||0||
48518164|NCT02575339|101600479|FG000|COMPLETED|Follow up||0||
48518165|NCT02575339|101600480|FG001|COMPLETED|Follow up||0||
48518166|NCT02575339|101600481|FG002|COMPLETED|Follow up||0||
48518167|NCT02575339|101600479|FG000|NOT COMPLETED|Follow up||7||
48518168|NCT02575339|101600480|FG001|NOT COMPLETED|Follow up||4||
48219951|NCT05580003|100863774|FG026|COMPLETED|Part 3: Period 3 (Day 1)||0||
48219952|NCT05580003|100863775|FG027|COMPLETED|Part 3: Period 3 (Day 1)||0||
48219953|NCT05580003|100863748|FG000|NOT COMPLETED|Part 3: Period 3 (Day 1)||0||
48219954|NCT05580003|100863749|FG001|NOT COMPLETED|Part 3: Period 3 (Day 1)||0||
48518169|NCT02575339|101600481|FG002|NOT COMPLETED|Follow up||0||
48518170|NCT02322788|101600482|FG000|STARTED|Visit 3||15||
48518171|NCT02322788|101600483|FG001|STARTED|Visit 3||15||
48518172|NCT02322788|101600484|FG002|STARTED|Visit 3||14||
48518173|NCT02322788|101600485|FG003|STARTED|Visit 3||16||
48518174|NCT02322788|101600482|FG000|COMPLETED|Visit 3||15||
48518175|NCT02322788|101600483|FG001|COMPLETED|Visit 3||15||
48518176|NCT02322788|101600484|FG002|COMPLETED|Visit 3||14||
48518177|NCT02322788|101600485|FG003|COMPLETED|Visit 3||16||
48518178|NCT02322788|101600482|FG000|NOT COMPLETED|Visit 3||0||
48518179|NCT02322788|101600483|FG001|NOT COMPLETED|Visit 3||0||
48518180|NCT02322788|101600484|FG002|NOT COMPLETED|Visit 3||0||
48518181|NCT02322788|101600485|FG003|NOT COMPLETED|Visit 3||0||
48518182|NCT02322788|101600482|FG000|STARTED|Visit 4||15||
48518183|NCT02322788|101600483|FG001|STARTED|Visit 4||14||
48518184|NCT02322788|101600484|FG002|STARTED|Visit 4||16||
48518185|NCT02322788|101600485|FG003|STARTED|Visit 4||15||
48518186|NCT02322788|101600482|FG000|COMPLETED|Visit 4||15||
48518187|NCT02322788|101600483|FG001|COMPLETED|Visit 4||14||
48518188|NCT02322788|101600484|FG002|COMPLETED|Visit 4||16||
48518189|NCT02322788|101600485|FG003|COMPLETED|Visit 4||15||
48518190|NCT02322788|101600482|FG000|NOT COMPLETED|Visit 4||0||
48518191|NCT02322788|101600483|FG001|NOT COMPLETED|Visit 4||0||
48518192|NCT02322788|101600484|FG002|NOT COMPLETED|Visit 4||0||
48518193|NCT02322788|101600485|FG003|NOT COMPLETED|Visit 4||0||
48518194|NCT02322788|101600482|FG000|STARTED|Visit 5||16||
48518195|NCT02322788|101600483|FG001|STARTED|Visit 5||15||
48518196|NCT02322788|101600484|FG002|STARTED|Visit 5||15||
48518197|NCT02322788|101600485|FG003|STARTED|Visit 5||14||
48518198|NCT02322788|101600482|FG000|COMPLETED|Visit 5||16||
48518199|NCT02322788|101600483|FG001|COMPLETED|Visit 5||15||
48518200|NCT02322788|101600484|FG002|COMPLETED|Visit 5||15||
48518201|NCT02322788|101600485|FG003|COMPLETED|Visit 5||14||
48518202|NCT02322788|101600482|FG000|NOT COMPLETED|Visit 5||0||
48518203|NCT02322788|101600483|FG001|NOT COMPLETED|Visit 5||0||
48518204|NCT02322788|101600484|FG002|NOT COMPLETED|Visit 5||0||
48518205|NCT02322788|101600485|FG003|NOT COMPLETED|Visit 5||0||
48518206|NCT02322788|101600482|FG000|STARTED|Visit 6||14||
48518207|NCT02322788|101600483|FG001|STARTED|Visit 6||16||
48518208|NCT02322788|101600484|FG002|STARTED|Visit 6||15||
48518209|NCT02322788|101600485|FG003|STARTED|Visit 6||15||
48518210|NCT02322788|101600482|FG000|COMPLETED|Visit 6||14||
48518211|NCT02322788|101600483|FG001|COMPLETED|Visit 6||16||
48518212|NCT02322788|101600484|FG002|COMPLETED|Visit 6||15||
48518213|NCT02322788|101600485|FG003|COMPLETED|Visit 6||15||
48518214|NCT02322788|101600482|FG000|NOT COMPLETED|Visit 6||0||
48518215|NCT02322788|101600483|FG001|NOT COMPLETED|Visit 6||0||
48518216|NCT02322788|101600484|FG002|NOT COMPLETED|Visit 6||0||
48518217|NCT02322788|101600485|FG003|NOT COMPLETED|Visit 6||0||
48518218|NCT00768118|101600486|FG000|STARTED|Overall Study||11||
48518219|NCT00768118|101600486|FG000|COMPLETED|Overall Study||11||
48518220|NCT00768118|101600486|FG000|NOT COMPLETED|Overall Study||0||
48518221|NCT00810888|101600487|FG000|STARTED|Overall Study||10||
48518222|NCT00810888|101600488|FG001|STARTED|Overall Study||9||
48518223|NCT00810888|101600489|FG002|STARTED|Overall Study||73||
48518224|NCT00810888|101600487|FG000|COMPLETED|Overall Study||10||
48518225|NCT00810888|101600488|FG001|COMPLETED|Overall Study||9||
48518226|NCT00810888|101600489|FG002|COMPLETED|Overall Study||73||
48518227|NCT00810888|101600487|FG000|NOT COMPLETED|Overall Study||0||
48518228|NCT00810888|101600488|FG001|NOT COMPLETED|Overall Study||0||
48518229|NCT00810888|101600489|FG002|NOT COMPLETED|Overall Study||0||
48518230|NCT02898103|101600490|FG000|STARTED|Overall Study||4||
48518231|NCT02898103|101600491|FG001|STARTED|Overall Study||3||
48518232|NCT02898103|101600490|FG000|COMPLETED|Overall Study||4||
48518233|NCT02898103|101600491|FG001|COMPLETED|Overall Study||3||
48518234|NCT02898103|101600490|FG000|NOT COMPLETED|Overall Study||0||
48518235|NCT02898103|101600491|FG001|NOT COMPLETED|Overall Study||0||
48518236|NCT03971578|101600492|FG000|STARTED|Overall Study||25||
48518237|NCT03971578|101600493|FG001|STARTED|Overall Study||56||
48518238|NCT03971578|101600492|FG000|COMPLETED|Overall Study||14||
48518239|NCT03971578|101600493|FG001|COMPLETED|Overall Study||37||
48518240|NCT03971578|101600492|FG000|NOT COMPLETED|Overall Study||11||
48518241|NCT03971578|101600493|FG001|NOT COMPLETED|Overall Study||19||
48518242|NCT03476317|101600494|FG000|STARTED|Overall Study||0||
48518243|NCT03476317|101600495|FG001|STARTED|Overall Study||0||
48518244|NCT03476317|101600496|FG002|STARTED|Overall Study||10||
48518245|NCT03476317|101600494|FG000|COMPLETED|Overall Study||0||
48518246|NCT03476317|101600495|FG001|COMPLETED|Overall Study||0||
48518247|NCT03476317|101600496|FG002|COMPLETED|Overall Study||10||
48518248|NCT03476317|101600494|FG000|NOT COMPLETED|Overall Study||0||
48518249|NCT03476317|101600495|FG001|NOT COMPLETED|Overall Study||0||
48518250|NCT03476317|101600496|FG002|NOT COMPLETED|Overall Study||0||
48518251|NCT01345318|101600497|FG000|STARTED|Overall Study||191||
48518252|NCT01345318|101600497|FG000|COMPLETED|Overall Study||111||
48518253|NCT01345318|101600497|FG000|NOT COMPLETED|Overall Study||80||
48518254|NCT01862419|101600498|FG000|STARTED|Overall Study||1201||
48518255|NCT01862419|101600499|FG001|STARTED|Overall Study||1192||
48518256|NCT01862419|101600498|FG000|COMPLETED|Overall Study||1201||
48518257|NCT01862419|101600499|FG001|COMPLETED|Overall Study||1192||
48518258|NCT01862419|101600498|FG000|NOT COMPLETED|Overall Study||0||
48518259|NCT01862419|101600499|FG001|NOT COMPLETED|Overall Study||0||
48518260|NCT00792623|101600500|FG000|STARTED|Overall Study||29||
48518261|NCT00792623|101600500|FG000|COMPLETED|Overall Study||22||
48518262|NCT00792623|101600500|FG000|NOT COMPLETED|Overall Study||7||
48518263|NCT00094458|101600501|FG000|STARTED|Main Study: Through Week 30||170||
48518264|NCT00094458|101600502|FG001|STARTED|Main Study: Through Week 30||169||
48518265|NCT00094458|101600503|FG002|STARTED|Main Study: Through Week 30||169||
48518266|NCT00094458|101600504|FG003|STARTED|Main Study: Through Week 30||0||
48518267|NCT00094458|101600505|FG004|STARTED|Main Study: Through Week 30||0||
48518268|NCT00094458|101600506|FG005|STARTED|Main Study: Through Week 30||0||
48518269|NCT00094458|101600501|FG000|COMPLETED|Main Study: Through Week 30||86||
48518270|NCT00094458|101600502|FG001|COMPLETED|Main Study: Through Week 30||111||
48518271|NCT00094458|101600503|FG002|COMPLETED|Main Study: Through Week 30||121||
48518272|NCT00094458|101600504|FG003|COMPLETED|Main Study: Through Week 30||0||
48518273|NCT00094458|101600505|FG004|COMPLETED|Main Study: Through Week 30||0||
48518274|NCT00094458|101600506|FG005|COMPLETED|Main Study: Through Week 30||0||
48518275|NCT00094458|101600501|FG000|NOT COMPLETED|Main Study: Through Week 30||84||
48518276|NCT00094458|101600502|FG001|NOT COMPLETED|Main Study: Through Week 30||58||
48518277|NCT00094458|101600503|FG002|NOT COMPLETED|Main Study: Through Week 30||48||
48518278|NCT00094458|101600504|FG003|NOT COMPLETED|Main Study: Through Week 30||0||
48518279|NCT00094458|101600505|FG004|NOT COMPLETED|Main Study: Through Week 30||0||
48518280|NCT00094458|101600506|FG005|NOT COMPLETED|Main Study: Through Week 30||0||
48518281|NCT00094458|101600501|FG000|STARTED|Study Extension: Week 30 Through Week 50||75||
48518282|NCT00094458|101600502|FG001|STARTED|Study Extension: Week 30 Through Week 50||97||
48518283|NCT00094458|101600503|FG002|STARTED|Study Extension: Week 30 Through Week 50||108||
48518284|NCT00094458|101600504|FG003|STARTED|Study Extension: Week 30 Through Week 50||0||
48518285|NCT00094458|101600505|FG004|STARTED|Study Extension: Week 30 Through Week 50||0||
48518286|NCT00094458|101600506|FG005|STARTED|Study Extension: Week 30 Through Week 50||0||
48518287|NCT00094458|101600501|FG000|COMPLETED|Study Extension: Week 30 Through Week 50||67||
48518288|NCT00094458|101600502|FG001|COMPLETED|Study Extension: Week 30 Through Week 50||85||
48518289|NCT00094458|101600503|FG002|COMPLETED|Study Extension: Week 30 Through Week 50||90||
48518290|NCT00094458|101600504|FG003|COMPLETED|Study Extension: Week 30 Through Week 50||0||
48518291|NCT00094458|101600505|FG004|COMPLETED|Study Extension: Week 30 Through Week 50||0||
48518292|NCT00094458|101600506|FG005|COMPLETED|Study Extension: Week 30 Through Week 50||0||
48518293|NCT00094458|101600501|FG000|NOT COMPLETED|Study Extension: Week 30 Through Week 50||8||
48518294|NCT00094458|101600502|FG001|NOT COMPLETED|Study Extension: Week 30 Through Week 50||12||
48518295|NCT00094458|101600503|FG002|NOT COMPLETED|Study Extension: Week 30 Through Week 50||18||
48518296|NCT00094458|101600504|FG003|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0||
48518297|NCT00094458|101600505|FG004|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0||
48518298|NCT00094458|101600506|FG005|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0||
48518299|NCT00094458|101600501|FG000|STARTED|OLE: Open-Label Extension||0||
48518300|NCT00094458|101600502|FG001|STARTED|OLE: Open-Label Extension||0||
48518301|NCT00094458|101600503|FG002|STARTED|OLE: Open-Label Extension||0||
48518302|NCT00094458|101600504|FG003|STARTED|OLE: Open-Label Extension||8||
48518303|NCT00094458|101600505|FG004|STARTED|OLE: Open-Label Extension||18||
48518304|NCT00094458|101600506|FG005|STARTED|OLE: Open-Label Extension||17||
48518305|NCT00094458|101600501|FG000|COMPLETED|OLE: Open-Label Extension||0||
48518306|NCT00094458|101600502|FG001|COMPLETED|OLE: Open-Label Extension||0||
48518307|NCT00094458|101600503|FG002|COMPLETED|OLE: Open-Label Extension||0||
48518308|NCT00094458|101600504|FG003|COMPLETED|OLE: Open-Label Extension||7||
48518309|NCT00094458|101600505|FG004|COMPLETED|OLE: Open-Label Extension||13||
48518310|NCT00094458|101600506|FG005|COMPLETED|OLE: Open-Label Extension||13||
48518311|NCT00094458|101600501|FG000|NOT COMPLETED|OLE: Open-Label Extension||0||
48518312|NCT00094458|101600502|FG001|NOT COMPLETED|OLE: Open-Label Extension||0||
48518313|NCT00094458|101600503|FG002|NOT COMPLETED|OLE: Open-Label Extension||0||
48518314|NCT00094458|101600504|FG003|NOT COMPLETED|OLE: Open-Label Extension||1||
48518315|NCT00094458|101600505|FG004|NOT COMPLETED|OLE: Open-Label Extension||5||
48518316|NCT00094458|101600506|FG005|NOT COMPLETED|OLE: Open-Label Extension||4||
48518317|NCT00567476|101600507|FG000|STARTED|Overall Study||78||
48518318|NCT00567476|101600508|FG001|STARTED|Overall Study||38||
48518319|NCT00567476|101600507|FG000|COMPLETED|Overall Study||70||
48518320|NCT00567476|101600508|FG001|COMPLETED|Overall Study||34||
48518321|NCT00567476|101600507|FG000|NOT COMPLETED|Overall Study||8||
48518322|NCT00567476|101600508|FG001|NOT COMPLETED|Overall Study||4||
48518323|NCT03069677|101600509|FG000|STARTED|Overall Study||80||
48518324|NCT03069677|101600510|FG001|STARTED|Overall Study||80||
48518325|NCT03069677|101600509|FG000|COMPLETED|Overall Study||77||
48518326|NCT03069677|101600510|FG001|COMPLETED|Overall Study||77||
48518327|NCT03069677|101600509|FG000|NOT COMPLETED|Overall Study||3||
48518328|NCT03069677|101600510|FG001|NOT COMPLETED|Overall Study||3||
48219955|NCT05580003|100863750|FG002|NOT COMPLETED|Part 3: Period 3 (Day 1)||0||
48518329|NCT01679197|101600511|FG000|STARTED|Overall Study||23||
48518330|NCT01679197|101600511|FG000|COMPLETED|Overall Study||19||
48518331|NCT01679197|101600511|FG000|NOT COMPLETED|Overall Study||4||
48518332|NCT04628936|101600512|FG000|STARTED|Overall Study||18||
48518333|NCT04628936|101600512|FG000|COMPLETED|Overall Study||8||
48518334|NCT04628936|101600512|FG000|NOT COMPLETED|Overall Study||10||
48518335|NCT05472116|101600513|FG000|STARTED|Overall Study||193||
48518336|NCT05472116|101600513|FG000|COMPLETED|Overall Study||152||
48518337|NCT05472116|101600513|FG000|NOT COMPLETED|Overall Study||41||
48518338|NCT03870477|101600514|FG000|STARTED|Overall Study||1||
48518339|NCT03870477|101600514|FG000|COMPLETED|Overall Study||0||
48518340|NCT03870477|101600514|FG000|NOT COMPLETED|Overall Study||1||
48518341|NCT00873119|101600515|FG000|STARTED|Overall Study||44||
48518342|NCT00873119|101600516|FG001|STARTED|Overall Study||45||
48518343|NCT00873119|101600515|FG000|COMPLETED|Overall Study||0||
48518344|NCT00873119|101600516|FG001|COMPLETED|Overall Study||19||
48518345|NCT00873119|101600515|FG000|NOT COMPLETED|Overall Study||44||
48518346|NCT00873119|101600516|FG001|NOT COMPLETED|Overall Study||26||
48518347|NCT01045707|101600517|FG000|STARTED|Main: Week 0 to 26 (NN5401-3590)||266||
48518348|NCT01045707|101600518|FG001|STARTED|Main: Week 0 to 26 (NN5401-3590)||264||
48518349|NCT01045707|101600517|FG000|Exposed|Main: Week 0 to 26 (NN5401-3590)||265||
48518350|NCT01045707|101600518|FG001|Exposed|Main: Week 0 to 26 (NN5401-3590)||261||
48518351|NCT01045707|101600517|FG000|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||219||
48518352|NCT01045707|101600518|FG001|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||232||
48518353|NCT01045707|101600517|FG000|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||47||
48518354|NCT01045707|101600518|FG001|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||32||
48518355|NCT01045707|101600517|FG000|STARTED|Extension: Week 27 to 52 (NN5401-3726)||192||
48518356|NCT01045707|101600518|FG001|STARTED|Extension: Week 27 to 52 (NN5401-3726)||221||
48518357|NCT01045707|101600517|FG000|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||179||
48518358|NCT01045707|101600518|FG001|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||209||
48518359|NCT01045707|101600517|FG000|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||13||
48518360|NCT01045707|101600518|FG001|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||12||
48518361|NCT00906373|101600519|FG000|STARTED|Overall Study||6||
48518362|NCT00906373|101600520|FG001|STARTED|Overall Study||41||
48518363|NCT00906373|101600519|FG000|Received Any Amount of Study Drug|Overall Study||6||
48518364|NCT00906373|101600520|FG001|Received Any Amount of Study Drug|Overall Study||41||
48518365|NCT00906373|101600519|FG000|COMPLETED|Overall Study||6||
48518366|NCT00906373|101600520|FG001|COMPLETED|Overall Study||33||
48518367|NCT00906373|101600519|FG000|NOT COMPLETED|Overall Study||0||
48518368|NCT00906373|101600520|FG001|NOT COMPLETED|Overall Study||8||
48518369|NCT03739138|101600521|FG000|STARTED|Overall Study||0||
48518370|NCT03739138|101600522|FG001|STARTED|Overall Study||7||
48518371|NCT03739138|101600523|FG002|STARTED|Overall Study||5||
48518372|NCT03739138|101600524|FG003|STARTED|Overall Study||18||
48518373|NCT03739138|101600525|FG004|STARTED|Overall Study||0||
48518374|NCT03739138|101600521|FG000|COMPLETED|Overall Study||0||
48518375|NCT03739138|101600522|FG001|COMPLETED|Overall Study||0||
48518376|NCT03739138|101600523|FG002|COMPLETED|Overall Study||0||
48518377|NCT03739138|101600524|FG003|COMPLETED|Overall Study||0||
48518378|NCT03739138|101600525|FG004|COMPLETED|Overall Study||0||
48518379|NCT03739138|101600521|FG000|NOT COMPLETED|Overall Study||0||
48518380|NCT03739138|101600522|FG001|NOT COMPLETED|Overall Study||7||
48518381|NCT03739138|101600523|FG002|NOT COMPLETED|Overall Study||5||
48518382|NCT03739138|101600524|FG003|NOT COMPLETED|Overall Study||18||
48518383|NCT03739138|101600525|FG004|NOT COMPLETED|Overall Study||0||
48518384|NCT01507090|101600526|FG000|STARTED|Overall Study||642||
48518385|NCT01507090|101600526|FG000|COMPLETED|Overall Study||624||
48518386|NCT01507090|101600526|FG000|NOT COMPLETED|Overall Study||18||
48518387|NCT03341546|101600527|FG000|STARTED|Overall Study||20||
48518388|NCT03341546|101600527|FG000|COMPLETED|Overall Study||20||
48518389|NCT03341546|101600527|FG000|NOT COMPLETED|Overall Study||0||
48518390|NCT00256776|101600528|FG000|STARTED|Overall Study||135||
48518391|NCT00256776|101600529|FG001|STARTED|Overall Study||134||
48518392|NCT00256776|101600528|FG000|COMPLETED|Overall Study||52||
48518393|NCT00256776|101600529|FG001|COMPLETED|Overall Study||54||
48518394|NCT00256776|101600528|FG000|NOT COMPLETED|Overall Study||83||
48518395|NCT00256776|101600529|FG001|NOT COMPLETED|Overall Study||80||
48518396|NCT01014624|101600530|FG000|STARTED|Overall Study||29||
48518397|NCT01014624|101600531|FG001|STARTED|Overall Study||27||
48518398|NCT01014624|101600530|FG000|COMPLETED|Overall Study||27||
48518399|NCT01014624|101600531|FG001|COMPLETED|Overall Study||26||
48518400|NCT01014624|101600530|FG000|NOT COMPLETED|Overall Study||2||
48518401|NCT01014624|101600531|FG001|NOT COMPLETED|Overall Study||1||
48518402|NCT01298778|101600532|FG000|STARTED|Overall Study||33||
48518403|NCT01298778|101600533|FG001|STARTED|Overall Study||36||
48518404|NCT01298778|101600532|FG000|COMPLETED|Overall Study||30||
48518405|NCT01298778|101600533|FG001|COMPLETED|Overall Study||30||
48518406|NCT01298778|101600532|FG000|NOT COMPLETED|Overall Study||3||
48518407|NCT01298778|101600533|FG001|NOT COMPLETED|Overall Study||6||
48518408|NCT03844789|101600534|FG000|STARTED|Main Study||78||
48518409|NCT03844789|101600535|FG001|STARTED|Main Study||23||
48518410|NCT03844789|101600534|FG000|16 Week Main Study|Main Study||78||
48518411|NCT03844789|101600535|FG001|16 Week Main Study|Main Study||22||
48518412|NCT03844789|101600534|FG000|COMPLETED|Main Study||78||
48518413|NCT03844789|101600535|FG001|COMPLETED|Main Study||22||
48518414|NCT03844789|101600534|FG000|NOT COMPLETED|Main Study||0||
48518415|NCT03844789|101600535|FG001|NOT COMPLETED|Main Study||1||
48518416|NCT03844789|101600534|FG000|STARTED|Extension Study||78||
48518417|NCT03844789|101600535|FG001|STARTED|Extension Study||22||
48518418|NCT03844789|101600534|FG000|COMPLETED|Extension Study||78||
48518419|NCT03844789|101600535|FG001|COMPLETED|Extension Study||22||
48518420|NCT03844789|101600534|FG000|NOT COMPLETED|Extension Study||0||
48518421|NCT03844789|101600535|FG001|NOT COMPLETED|Extension Study||0||
48518422|NCT01594047|101600536|FG000|STARTED|Overall Study||29||
48518423|NCT01594047|101600537|FG001|STARTED|Overall Study||30||
48518424|NCT01594047|101600538|FG002|STARTED|Overall Study||27||
48518425|NCT01594047|101600539|FG003|STARTED|Overall Study||27||
48518426|NCT01594047|101600536|FG000|COMPLETED|Overall Study||24||
48518427|NCT01594047|101600537|FG001|COMPLETED|Overall Study||25||
48518428|NCT01594047|101600538|FG002|COMPLETED|Overall Study||23||
48518429|NCT01594047|101600539|FG003|COMPLETED|Overall Study||24||
48518430|NCT01594047|101600536|FG000|NOT COMPLETED|Overall Study||5||
48518431|NCT01594047|101600537|FG001|NOT COMPLETED|Overall Study||5||
48518432|NCT01594047|101600538|FG002|NOT COMPLETED|Overall Study||4||
48518433|NCT01594047|101600539|FG003|NOT COMPLETED|Overall Study||3||
48518434|NCT03488030|101600540|FG000|STARTED|Overall Study||101||
48518435|NCT03488030|101600541|FG001|STARTED|Overall Study||145||
48518436|NCT03488030|101600540|FG000|COMPLETED|Overall Study||101|Participants with moderate to severe IBD at Day 1.|
48518437|NCT03488030|101600541|FG001|COMPLETED|Overall Study||145|Participants with moderate to severe IBD at Day 1.|
48518438|NCT03488030|101600540|FG000|NOT COMPLETED|Overall Study||0||
48518439|NCT03488030|101600541|FG001|NOT COMPLETED|Overall Study||0||
48518440|NCT02148913|101600542|FG000|STARTED|Overall Study||3||
48518441|NCT02148913|101600543|FG001|STARTED|Overall Study||3||
48518442|NCT02148913|101600544|FG002|STARTED|Overall Study||3||
48518443|NCT02148913|101600545|FG003|STARTED|Overall Study||9||
48518444|NCT02148913|101600542|FG000|COMPLETED|Overall Study||3||
48518445|NCT02148913|101600543|FG001|COMPLETED|Overall Study||2||
48518446|NCT02148913|101600544|FG002|COMPLETED|Overall Study||3||
48518447|NCT02148913|101600545|FG003|COMPLETED|Overall Study||9||
48518448|NCT02148913|101600542|FG000|NOT COMPLETED|Overall Study||0||
48518449|NCT02148913|101600543|FG001|NOT COMPLETED|Overall Study||1||
48518450|NCT02148913|101600544|FG002|NOT COMPLETED|Overall Study||0||
48518451|NCT02148913|101600545|FG003|NOT COMPLETED|Overall Study||0||
48518452|NCT01917968|101600546|FG000|STARTED|Overall Study||225||
48518453|NCT01917968|101600547|FG001|STARTED|Overall Study||485||
48518454|NCT01917968|101600546|FG000|COMPLETED|Overall Study||171||
48518455|NCT01917968|101600547|FG001|COMPLETED|Overall Study||401||
48518456|NCT01917968|101600546|FG000|NOT COMPLETED|Overall Study||54||
48518457|NCT01917968|101600547|FG001|NOT COMPLETED|Overall Study||84||
48518458|NCT01602016|101600548|FG000|STARTED|Overall Study||0||
48518459|NCT01602016|101600548|FG000|COMPLETED|Overall Study||0||
48518460|NCT01602016|101600548|FG000|NOT COMPLETED|Overall Study||0||
48518461|NCT04086641|101600549|FG000|STARTED|Foot 1 (Two Week Utilization)||2||
48518462|NCT04086641|101600550|FG001|STARTED|Foot 1 (Two Week Utilization)||3||
48518463|NCT04086641|101600549|FG000|COMPLETED|Foot 1 (Two Week Utilization)||1||
48518464|NCT04086641|101600550|FG001|COMPLETED|Foot 1 (Two Week Utilization)||1||
48518465|NCT04086641|101600549|FG000|NOT COMPLETED|Foot 1 (Two Week Utilization)||1||
48518466|NCT04086641|101600550|FG001|NOT COMPLETED|Foot 1 (Two Week Utilization)||2||
48518467|NCT04086641|101600549|FG000|STARTED|Foot 2 (Two Week Utilization)||1||
48518468|NCT04086641|101600550|FG001|STARTED|Foot 2 (Two Week Utilization)||1||
48518469|NCT04086641|101600549|FG000|COMPLETED|Foot 2 (Two Week Utilization)||1||
48518470|NCT04086641|101600550|FG001|COMPLETED|Foot 2 (Two Week Utilization)||1||
48518471|NCT04086641|101600549|FG000|NOT COMPLETED|Foot 2 (Two Week Utilization)||0||
48518472|NCT04086641|101600550|FG001|NOT COMPLETED|Foot 2 (Two Week Utilization)||0||
48518473|NCT00303667|101600551|FG000|STARTED|Overall Study||8||
48518474|NCT00303667|101600552|FG001|STARTED|Overall Study||39||
48518475|NCT00303667|101600551|FG000|COMPLETED|Overall Study||8||
48518476|NCT00303667|101600552|FG001|COMPLETED|Overall Study||35||
48518477|NCT00303667|101600551|FG000|NOT COMPLETED|Overall Study||0||
48518478|NCT00303667|101600552|FG001|NOT COMPLETED|Overall Study||4||
48518479|NCT01841216|101600553|FG000|STARTED|Overall Study||15||
48518480|NCT01841216|101600554|FG001|STARTED|Overall Study||15||
48518481|NCT01841216|101600553|FG000|COMPLETED|Overall Study||15||
48518482|NCT01841216|101600554|FG001|COMPLETED|Overall Study||15||
48518483|NCT01841216|101600553|FG000|NOT COMPLETED|Overall Study||0||
48518484|NCT01841216|101600554|FG001|NOT COMPLETED|Overall Study||0||
48518485|NCT01534078|101600555|FG000|STARTED|Overall Study||34||
48518486|NCT01534078|101600555|FG000|COMPLETED|Overall Study||32||
48518487|NCT01534078|101600555|FG000|NOT COMPLETED|Overall Study||2||
48518488|NCT03512002|101600556|FG000|STARTED|Overall Study||3||
48518489|NCT03512002|101600557|FG001|STARTED|Overall Study||5||
48518490|NCT03512002|101600556|FG000|COMPLETED|Overall Study||3||
48518491|NCT03512002|101600557|FG001|COMPLETED|Overall Study||5||
48518492|NCT03512002|101600556|FG000|NOT COMPLETED|Overall Study||0||
48518493|NCT03512002|101600557|FG001|NOT COMPLETED|Overall Study||0||
48518494|NCT00710749|101600558|FG000|STARTED|Clinic Baseline Recording||30||
48518495|NCT00710749|101600559|FG001|STARTED|Clinic Baseline Recording||30||
48518496|NCT00710749|101600558|FG000|COMPLETED|Clinic Baseline Recording||30||
48518497|NCT00710749|101600559|FG001|COMPLETED|Clinic Baseline Recording||30||
48518498|NCT00710749|101600558|FG000|NOT COMPLETED|Clinic Baseline Recording||0||
48518499|NCT00710749|101600559|FG001|NOT COMPLETED|Clinic Baseline Recording||0||
48518500|NCT00710749|101600558|FG000|STARTED|First Intervention||30||
48518501|NCT00710749|101600559|FG001|STARTED|First Intervention||30||
48518502|NCT00710749|101600558|FG000|COMPLETED|First Intervention||29||
48518503|NCT00710749|101600559|FG001|COMPLETED|First Intervention||30||
48518504|NCT00710749|101600558|FG000|NOT COMPLETED|First Intervention||1||
48518505|NCT00710749|101600559|FG001|NOT COMPLETED|First Intervention||0||
48518506|NCT00710749|101600558|FG000|STARTED|Second Intervention||29||
48518507|NCT00710749|101600559|FG001|STARTED|Second Intervention||30||
48518508|NCT00710749|101600558|FG000|COMPLETED|Second Intervention||29||
48518509|NCT00710749|101600559|FG001|COMPLETED|Second Intervention||30||
48518510|NCT00710749|101600558|FG000|NOT COMPLETED|Second Intervention||0||
48518511|NCT00710749|101600559|FG001|NOT COMPLETED|Second Intervention||0||
48518512|NCT02994251|101600560|FG000|STARTED|Overall Study||0||
48518513|NCT02994251|101600560|FG000|COMPLETED|Overall Study||0||
48518514|NCT02994251|101600560|FG000|NOT COMPLETED|Overall Study||0||
48518515|NCT01976728|101600561|FG000|STARTED|Overall Study||10||
48518516|NCT01976728|101600562|FG001|STARTED|Overall Study||9||
48518517|NCT01976728|101600563|FG002|STARTED|Overall Study||10||
48518518|NCT01976728|101600564|FG003|STARTED|Overall Study||10||
48518519|NCT01976728|101600561|FG000|Dosed|Overall Study||10||
48518520|NCT01976728|101600562|FG001|Dosed|Overall Study||9||
48518521|NCT01976728|101600563|FG002|Dosed|Overall Study||10||
48518522|NCT01976728|101600564|FG003|Dosed|Overall Study||10||
48518523|NCT01976728|101600561|FG000|COMPLETED|Overall Study||9||
48518524|NCT01976728|101600562|FG001|COMPLETED|Overall Study||9||
48518525|NCT01976728|101600563|FG002|COMPLETED|Overall Study||10||
48518526|NCT01976728|101600564|FG003|COMPLETED|Overall Study||10||
48518527|NCT01976728|101600561|FG000|NOT COMPLETED|Overall Study||1||
48518528|NCT01976728|101600562|FG001|NOT COMPLETED|Overall Study||0||
48518529|NCT01976728|101600563|FG002|NOT COMPLETED|Overall Study||0||
48518530|NCT01976728|101600564|FG003|NOT COMPLETED|Overall Study||0||
48518531|NCT03827018|101600565|FG000|STARTED|Overall Study||42||
48518532|NCT03827018|101600566|FG001|STARTED|Overall Study||28||
48518533|NCT03827018|101600565|FG000|Completed Treatment|Overall Study||31||
48518534|NCT03827018|101600566|FG001|Completed Treatment|Overall Study||12||
48518535|NCT03827018|101600565|FG000|COMPLETED|Overall Study||39|Completed Study|
48518536|NCT03827018|101600566|FG001|COMPLETED|Overall Study||25|Completed Study|
48518537|NCT03827018|101600565|FG000|NOT COMPLETED|Overall Study||3||
48518538|NCT03827018|101600566|FG001|NOT COMPLETED|Overall Study||3||
48518539|NCT02843659|101600567|FG000|STARTED|Overall Study||5||
48518540|NCT02843659|101600568|FG001|STARTED|Overall Study||6||
48518541|NCT02843659|101600569|FG002|STARTED|Overall Study||7||
48518542|NCT02843659|101600567|FG000|COMPLETED|Overall Study||1||
48518543|NCT02843659|101600568|FG001|COMPLETED|Overall Study||0||
48518544|NCT02843659|101600569|FG002|COMPLETED|Overall Study||2||
48518545|NCT02843659|101600567|FG000|NOT COMPLETED|Overall Study||4||
48518546|NCT02843659|101600568|FG001|NOT COMPLETED|Overall Study||6||
48518547|NCT02843659|101600569|FG002|NOT COMPLETED|Overall Study||5||
48518548|NCT04142242|101600570|FG000|STARTED|Stage I||139||
48518549|NCT04142242|101600571|FG001|STARTED|Stage I||176||
48518550|NCT04142242|101600572|FG002|STARTED|Stage I||31||
48518551|NCT04142242|101600573|FG003|STARTED|Stage I||39||
48518552|NCT04142242|101600574|FG004|STARTED|Stage I||26||
48518553|NCT04142242|101600575|FG005|STARTED|Stage I||60||
48518554|NCT04142242|101600570|FG000|Vaccinated|Stage I||138||
48518555|NCT04142242|101600571|FG001|Vaccinated|Stage I||175||
48518556|NCT04142242|101600572|FG002|Vaccinated|Stage I||0||
48518557|NCT04142242|101600573|FG003|Vaccinated|Stage I||0||
48518558|NCT04142242|101600574|FG004|Vaccinated|Stage I||0||
48518559|NCT04142242|101600575|FG005|Vaccinated|Stage I||0||
48518560|NCT04142242|101600570|FG000|Stage I Full Analysis Set (FAS)|Stage I||138|Participants who had a valid serology result for at least 1 serogroup from a pre-vaccination blood sample.|
48518561|NCT04142242|101600571|FG001|Stage I Full Analysis Set (FAS)|Stage I||175|Participants who had a valid serology result for at least 1 serogroup from a pre-vaccination blood sample.|
48518562|NCT04142242|101600572|FG002|Stage I Full Analysis Set (FAS)|Stage I||31|Participants who had a valid serology result for at least 1 serogroup from a pre-vaccination blood sample.|
48518563|NCT04142242|101600573|FG003|Stage I Full Analysis Set (FAS)|Stage I||39|Participants who had a valid serology result for at least 1 serogroup from a pre-vaccination blood sample.|
48518564|NCT04142242|101600574|FG004|Stage I Full Analysis Set (FAS)|Stage I||26|Participants who had a valid serology result for at least 1 serogroup from a pre-vaccination blood sample.|
48518565|NCT04142242|101600575|FG005|Stage I Full Analysis Set (FAS)|Stage I||59|Participants who had a valid serology result for at least 1 serogroup from a pre-vaccination blood sample.|
48518566|NCT04142242|101600570|FG000|Safety Analysis Set (SafAS)|Stage I||151|Participants of Groups 1 and 2 who had received study MEQ00066 vaccine and had available safety data, were analyzed according to the actually received vaccine.|
48518567|NCT04142242|101600571|FG001|Safety Analysis Set (SafAS)|Stage I||162|Participants of Groups 1 and 2 who had received study MEQ00066 vaccine and had available safety data, were analyzed according to the actually received vaccine.|
48518568|NCT04142242|101600572|FG002|Safety Analysis Set (SafAS)|Stage I||0|Participants of Groups 1 and 2 who had received study MEQ00066 vaccine and had available safety data, were analyzed according to the actually received vaccine.|
48518569|NCT04142242|101600573|FG003|Safety Analysis Set (SafAS)|Stage I||0|Participants of Groups 1 and 2 who had received study MEQ00066 vaccine and had available safety data, were analyzed according to the actually received vaccine.|
48518570|NCT04142242|101600574|FG004|Safety Analysis Set (SafAS)|Stage I||0|Participants of Groups 1 and 2 who had received study MEQ00066 vaccine and had available safety data, were analyzed according to the actually received vaccine.|
48518571|NCT04142242|101600575|FG005|Safety Analysis Set (SafAS)|Stage I||0|Participants of Groups 1 and 2 who had received study MEQ00066 vaccine and had available safety data, were analyzed according to the actually received vaccine.|
48518572|NCT04142242|101600570|FG000|COMPLETED|Stage I||138||
48518573|NCT04142242|101600571|FG001|COMPLETED|Stage I||175||
48518574|NCT04142242|101600572|FG002|COMPLETED|Stage I||31||
48518575|NCT04142242|101600573|FG003|COMPLETED|Stage I||39||
48518576|NCT04142242|101600574|FG004|COMPLETED|Stage I||26||
48518577|NCT04142242|101600575|FG005|COMPLETED|Stage I||59||
48518578|NCT04142242|101600570|FG000|NOT COMPLETED|Stage I||1||
48518579|NCT04142242|101600571|FG001|NOT COMPLETED|Stage I||1||
48518580|NCT04142242|101600572|FG002|NOT COMPLETED|Stage I||0||
48518581|NCT04142242|101600573|FG003|NOT COMPLETED|Stage I||0||
48518582|NCT04142242|101600574|FG004|NOT COMPLETED|Stage I||0||
48518583|NCT04142242|101600575|FG005|NOT COMPLETED|Stage I||1||
48518584|NCT04142242|101600570|FG000|STARTED|Stage II||0||
48518585|NCT04142242|101600571|FG001|STARTED|Stage II||0||
48518586|NCT04142242|101600572|FG002|STARTED|Stage II||31||
48518587|NCT04142242|101600573|FG003|STARTED|Stage II||39||
48518588|NCT04142242|101600574|FG004|STARTED|Stage II||0||
48518589|NCT04142242|101600575|FG005|STARTED|Stage II||0||
48518590|NCT04142242|101600570|FG000|Vaccinated|Stage II||0||
48518591|NCT04142242|101600571|FG001|Vaccinated|Stage II||0||
48518592|NCT04142242|101600572|FG002|Vaccinated|Stage II||25||
48518593|NCT04142242|101600573|FG003|Vaccinated|Stage II||27||
48518594|NCT04142242|101600574|FG004|Vaccinated|Stage II||0||
48518595|NCT04142242|101600575|FG005|Vaccinated|Stage II||0||
48518596|NCT04142242|101600570|FG000|Stage II FAS for Persistence|Stage II||0||
48518597|NCT04142242|101600571|FG001|Stage II FAS for Persistence|Stage II||0||
48518598|NCT04142242|101600572|FG002|Stage II FAS for Persistence|Stage II||24||
48518599|NCT04142242|101600573|FG003|Stage II FAS for Persistence|Stage II||28||
48518600|NCT04142242|101600574|FG004|Stage II FAS for Persistence|Stage II||0||
48518601|NCT04142242|101600575|FG005|Stage II FAS for Persistence|Stage II||0||
48518602|NCT04142242|101600570|FG000|Safety Analysis Set|Stage II||0||
48518603|NCT04142242|101600571|FG001|Safety Analysis Set|Stage II||0||
48518604|NCT04142242|101600572|FG002|Safety Analysis Set|Stage II||27||
48518605|NCT04142242|101600573|FG003|Safety Analysis Set|Stage II||25||
48518606|NCT04142242|101600574|FG004|Safety Analysis Set|Stage II||0||
48518607|NCT04142242|101600575|FG005|Safety Analysis Set|Stage II||0||
48518608|NCT04142242|101600570|FG000|COMPLETED|Stage II||0||
48518609|NCT04142242|101600571|FG001|COMPLETED|Stage II||0||
48518610|NCT04142242|101600572|FG002|COMPLETED|Stage II||25||
48518611|NCT04142242|101600573|FG003|COMPLETED|Stage II||26||
48518612|NCT04142242|101600574|FG004|COMPLETED|Stage II||0||
48518613|NCT04142242|101600575|FG005|COMPLETED|Stage II||0||
48518614|NCT04142242|101600570|FG000|NOT COMPLETED|Stage II||0||
48518615|NCT04142242|101600571|FG001|NOT COMPLETED|Stage II||0||
48518616|NCT04142242|101600572|FG002|NOT COMPLETED|Stage II||6||
48518617|NCT04142242|101600573|FG003|NOT COMPLETED|Stage II||13||
48518618|NCT04142242|101600574|FG004|NOT COMPLETED|Stage II||0||
48518619|NCT04142242|101600575|FG005|NOT COMPLETED|Stage II||0||
48518620|NCT00502801|101600576|FG000|STARTED|Treatment Period||183||
48518621|NCT00502801|101600576|FG000|COMPLETED|Treatment Period||129||
48518622|NCT00502801|101600576|FG000|NOT COMPLETED|Treatment Period||54||
48518623|NCT00502801|101600576|FG000|STARTED|End of Therapy to Test of Cure||129||
48518624|NCT00502801|101600576|FG000|COMPLETED|End of Therapy to Test of Cure||121||
48518625|NCT00502801|101600576|FG000|NOT COMPLETED|End of Therapy to Test of Cure||8||
48518626|NCT02954159|101600577|FG000|STARTED|Overall Study||2||
48518627|NCT02954159|101600578|FG001|STARTED|Overall Study||2||
48518628|NCT02954159|101600577|FG000|COMPLETED|Overall Study||1||
48518629|NCT02954159|101600578|FG001|COMPLETED|Overall Study||1||
48518630|NCT02954159|101600577|FG000|NOT COMPLETED|Overall Study||1||
48518631|NCT02954159|101600578|FG001|NOT COMPLETED|Overall Study||1||
48518632|NCT02737592|101600579|FG000|STARTED|Overall Study||34||
48518633|NCT02737592|101600579|FG000|COMPLETED|Overall Study||33||
48518634|NCT02737592|101600579|FG000|NOT COMPLETED|Overall Study||1||
48518635|NCT02521181|101600580|FG000|STARTED|Overall Study||52||
48518636|NCT02521181|101600581|FG001|STARTED|Overall Study||90||
48518637|NCT02521181|101600582|FG002|STARTED|Overall Study||52||
48518638|NCT02521181|101600580|FG000|COMPLETED|Overall Study||52||
48518639|NCT02521181|101600581|FG001|COMPLETED|Overall Study||90||
48518640|NCT02521181|101600582|FG002|COMPLETED|Overall Study||52||
48518641|NCT02521181|101600580|FG000|NOT COMPLETED|Overall Study||0||
48518642|NCT02521181|101600581|FG001|NOT COMPLETED|Overall Study||0||
48518643|NCT02521181|101600582|FG002|NOT COMPLETED|Overall Study||0||
48518644|NCT03694808|101600583|FG000|STARTED|Overall Study||240||
48518645|NCT03694808|101600584|FG001|STARTED|Overall Study||219||
48518646|NCT03694808|101600583|FG000|COMPLETED|Overall Study||194||
48518647|NCT03694808|101600584|FG001|COMPLETED|Overall Study||193||
48518648|NCT03694808|101600583|FG000|NOT COMPLETED|Overall Study||46||
48518649|NCT03694808|101600584|FG001|NOT COMPLETED|Overall Study||26||
48518650|NCT01028911|101600585|FG000|STARTED|Overall Study||7||
48518651|NCT01028911|101600586|FG001|STARTED|Overall Study||2||
48518652|NCT01028911|101600585|FG000|COMPLETED|Overall Study||7||
48518653|NCT01028911|101600586|FG001|COMPLETED|Overall Study||2||
48518654|NCT01028911|101600585|FG000|NOT COMPLETED|Overall Study||0||
48518655|NCT01028911|101600586|FG001|NOT COMPLETED|Overall Study||0||
48518656|NCT01787279|101600587|FG000|STARTED|Overall Study||59||
48518657|NCT01787279|101600587|FG000|COMPLETED|Overall Study||56||
48518658|NCT01787279|101600587|FG000|NOT COMPLETED|Overall Study||3||
48518659|NCT02560779|101600588|FG000|STARTED|Overall Study||14||
48518660|NCT02560779|101600589|FG001|STARTED|Overall Study||13||
48518661|NCT02560779|101600588|FG000|COMPLETED|Overall Study||14||
48518662|NCT02560779|101600589|FG001|COMPLETED|Overall Study||13||
48518663|NCT02560779|101600588|FG000|NOT COMPLETED|Overall Study||0||
48518664|NCT02560779|101600589|FG001|NOT COMPLETED|Overall Study||0||
48518665|NCT01430819|101600590|FG000|STARTED|Overall Study||150||
48518666|NCT01430819|101600591|FG001|STARTED|Overall Study||150||
48518667|NCT01430819|101600590|FG000|COMPLETED|Overall Study||150||
48518668|NCT01430819|101600591|FG001|COMPLETED|Overall Study||150||
48518669|NCT01430819|101600590|FG000|NOT COMPLETED|Overall Study||0||
48518670|NCT01430819|101600591|FG001|NOT COMPLETED|Overall Study||0||
48518671|NCT01844531|101600592|FG000|STARTED|Overall Study||6||
48518672|NCT01844531|101600593|FG001|STARTED|Overall Study||6||
48518673|NCT01844531|101600594|FG002|STARTED|Overall Study||6||
48518674|NCT01844531|101600595|FG003|STARTED|Overall Study||6||
48518675|NCT01844531|101600592|FG000|COMPLETED|Overall Study||6||
48518676|NCT01844531|101600593|FG001|COMPLETED|Overall Study||5||
48518677|NCT01844531|101600594|FG002|COMPLETED|Overall Study||6||
48518678|NCT01844531|101600595|FG003|COMPLETED|Overall Study||6||
48518679|NCT01844531|101600592|FG000|NOT COMPLETED|Overall Study||0||
48518680|NCT01844531|101600593|FG001|NOT COMPLETED|Overall Study||1||
48518681|NCT01844531|101600594|FG002|NOT COMPLETED|Overall Study||0||
48518682|NCT01844531|101600595|FG003|NOT COMPLETED|Overall Study||0||
48518683|NCT02492841|101600596|FG000|STARTED|Overall Study||56||
48518684|NCT02492841|101600597|FG001|STARTED|Overall Study||53||
48518685|NCT02492841|101600598|FG002|STARTED|Overall Study||60||
48518686|NCT02492841|101600596|FG000|COMPLETED|Overall Study||22||
48518687|NCT02492841|101600597|FG001|COMPLETED|Overall Study||22||
48518688|NCT02492841|101600598|FG002|COMPLETED|Overall Study||25||
48518689|NCT02492841|101600596|FG000|NOT COMPLETED|Overall Study||34||
48518690|NCT02492841|101600597|FG001|NOT COMPLETED|Overall Study||31||
48518691|NCT02492841|101600598|FG002|NOT COMPLETED|Overall Study||35||
48518692|NCT01682148|101600599|FG000|STARTED|Overall Study||44||
48518693|NCT01682148|101600600|FG001|STARTED|Overall Study||44||
48518694|NCT01682148|101600599|FG000|COMPLETED|Overall Study||40||
48518695|NCT01682148|101600600|FG001|COMPLETED|Overall Study||41||
48518696|NCT01682148|101600599|FG000|NOT COMPLETED|Overall Study||4||
48518697|NCT01682148|101600600|FG001|NOT COMPLETED|Overall Study||3||
48518698|NCT00227266|101600601|FG000|STARTED|Overall Study||31||
48518699|NCT00227266|101600602|FG001|STARTED|Overall Study||30||
48518700|NCT00227266|101600603|FG002|STARTED|Overall Study||33||
48518701|NCT00227266|101600601|FG000|COMPLETED|Overall Study||30||
48518702|NCT00227266|101600602|FG001|COMPLETED|Overall Study||30||
48518703|NCT00227266|101600603|FG002|COMPLETED|Overall Study||29||
48518704|NCT00227266|101600601|FG000|NOT COMPLETED|Overall Study||1||
48518705|NCT00227266|101600602|FG001|NOT COMPLETED|Overall Study||0||
48518706|NCT00227266|101600603|FG002|NOT COMPLETED|Overall Study||4||
48518707|NCT00706355|101600604|FG000|STARTED|Period 1: PF-04217903 50 mg||3||
48518708|NCT00706355|101600605|FG001|STARTED|Period 1: PF-04217903 50 mg||0||
48518709|NCT00706355|101600606|FG002|STARTED|Period 1: PF-04217903 50 mg||0||
48518710|NCT00706355|101600607|FG003|STARTED|Period 1: PF-04217903 50 mg||0||
48518711|NCT00706355|101600604|FG000|COMPLETED|Period 1: PF-04217903 50 mg||0||
48518712|NCT00706355|101600605|FG001|COMPLETED|Period 1: PF-04217903 50 mg||0||
48518713|NCT00706355|101600606|FG002|COMPLETED|Period 1: PF-04217903 50 mg||0||
48518714|NCT00706355|101600607|FG003|COMPLETED|Period 1: PF-04217903 50 mg||0||
48518715|NCT00706355|101600604|FG000|NOT COMPLETED|Period 1: PF-04217903 50 mg||3||
48518716|NCT00706355|101600605|FG001|NOT COMPLETED|Period 1: PF-04217903 50 mg||0||
48518717|NCT00706355|101600606|FG002|NOT COMPLETED|Period 1: PF-04217903 50 mg||0||
48518718|NCT00706355|101600607|FG003|NOT COMPLETED|Period 1: PF-04217903 50 mg||0||
48518719|NCT00706355|101600604|FG000|STARTED|Period 2: PF-04217903 100 mg||0||
48518720|NCT00706355|101600605|FG001|STARTED|Period 2: PF-04217903 100 mg||7||
48518721|NCT00706355|101600606|FG002|STARTED|Period 2: PF-04217903 100 mg||0||
48518722|NCT00706355|101600607|FG003|STARTED|Period 2: PF-04217903 100 mg||0||
48518723|NCT00706355|101600604|FG000|COMPLETED|Period 2: PF-04217903 100 mg||0||
48518724|NCT00706355|101600605|FG001|COMPLETED|Period 2: PF-04217903 100 mg||0||
48518725|NCT00706355|101600606|FG002|COMPLETED|Period 2: PF-04217903 100 mg||0||
48518726|NCT00706355|101600607|FG003|COMPLETED|Period 2: PF-04217903 100 mg||0||
48518727|NCT00706355|101600604|FG000|NOT COMPLETED|Period 2: PF-04217903 100 mg||0||
48518728|NCT00706355|101600605|FG001|NOT COMPLETED|Period 2: PF-04217903 100 mg||7||
48518729|NCT00706355|101600606|FG002|NOT COMPLETED|Period 2: PF-04217903 100 mg||0||
48518730|NCT00706355|101600607|FG003|NOT COMPLETED|Period 2: PF-04217903 100 mg||0||
48219956|NCT05580003|100863751|FG003|NOT COMPLETED|Part 3: Period 3 (Day 1)||0||
48518731|NCT00706355|101600604|FG000|STARTED|Period 3: PF-04217903 200 mg||0||
48518732|NCT00706355|101600605|FG001|STARTED|Period 3: PF-04217903 200 mg||0||
48518733|NCT00706355|101600606|FG002|STARTED|Period 3: PF-04217903 200 mg||2||
48518734|NCT00706355|101600607|FG003|STARTED|Period 3: PF-04217903 200 mg||0||
48518735|NCT00706355|101600604|FG000|COMPLETED|Period 3: PF-04217903 200 mg||0||
48518736|NCT00706355|101600605|FG001|COMPLETED|Period 3: PF-04217903 200 mg||0||
48518737|NCT00706355|101600606|FG002|COMPLETED|Period 3: PF-04217903 200 mg||0||
48518738|NCT00706355|101600607|FG003|COMPLETED|Period 3: PF-04217903 200 mg||0||
48518739|NCT00706355|101600604|FG000|NOT COMPLETED|Period 3: PF-04217903 200 mg||0||
48518740|NCT00706355|101600605|FG001|NOT COMPLETED|Period 3: PF-04217903 200 mg||0||
48518741|NCT00706355|101600606|FG002|NOT COMPLETED|Period 3: PF-04217903 200 mg||2||
48518742|NCT00706355|101600607|FG003|NOT COMPLETED|Period 3: PF-04217903 200 mg||0||
48518743|NCT00706355|101600604|FG000|STARTED|Period 4: PF-04217903 150 mg||0||
48518744|NCT00706355|101600605|FG001|STARTED|Period 4: PF-04217903 150 mg||0||
48518745|NCT00706355|101600606|FG002|STARTED|Period 4: PF-04217903 150 mg||0||
48518746|NCT00706355|101600607|FG003|STARTED|Period 4: PF-04217903 150 mg||4||
48518747|NCT00706355|101600604|FG000|COMPLETED|Period 4: PF-04217903 150 mg||0||
48518748|NCT00706355|101600605|FG001|COMPLETED|Period 4: PF-04217903 150 mg||0||
48518749|NCT00706355|101600606|FG002|COMPLETED|Period 4: PF-04217903 150 mg||0||
48518750|NCT00706355|101600607|FG003|COMPLETED|Period 4: PF-04217903 150 mg||0||
48518751|NCT00706355|101600604|FG000|NOT COMPLETED|Period 4: PF-04217903 150 mg||0||
48518752|NCT00706355|101600605|FG001|NOT COMPLETED|Period 4: PF-04217903 150 mg||0||
48518753|NCT00706355|101600606|FG002|NOT COMPLETED|Period 4: PF-04217903 150 mg||0||
48518754|NCT00706355|101600607|FG003|NOT COMPLETED|Period 4: PF-04217903 150 mg||4||
48518755|NCT01393730|101600608|FG000|STARTED|Overall Study||40||
48518756|NCT01393730|101600608|FG000|Treated|Overall Study||38||
48518757|NCT01393730|101600608|FG000|Evaluable AR Amplification|Overall Study||21||
48518758|NCT01393730|101600608|FG000|Evaluable AR Mutation|Overall Study||14||
48518759|NCT01393730|101600608|FG000|COMPLETED|Overall Study||34||
48518760|NCT01393730|101600608|FG000|NOT COMPLETED|Overall Study||6||
48518761|NCT00251641|101600609|FG000|STARTED|Overall Study||653||
48518762|NCT00251641|101600610|FG001|STARTED|Overall Study||215||
48518763|NCT00251641|101600609|FG000|COMPLETED|Overall Study||541||
48518764|NCT00251641|101600610|FG001|COMPLETED|Overall Study||127||
48518765|NCT00251641|101600609|FG000|NOT COMPLETED|Overall Study||112||
48518766|NCT00251641|101600610|FG001|NOT COMPLETED|Overall Study||88||
48518767|NCT03005067|101600611|FG000|STARTED|Overall Study||90||
48518768|NCT03005067|101600612|FG001|STARTED|Overall Study||81||
48518769|NCT03005067|101600611|FG000|COMPLETED|Overall Study||80||
48518770|NCT03005067|101600612|FG001|COMPLETED|Overall Study||74||
48518771|NCT03005067|101600611|FG000|NOT COMPLETED|Overall Study||10||
48518772|NCT03005067|101600612|FG001|NOT COMPLETED|Overall Study||7||
48518773|NCT00706992|101603615|FG000|STARTED|Overall Study||8||
48518774|NCT00706992|101603616|FG001|STARTED|Overall Study||8||
48518775|NCT00706992|101603617|FG002|STARTED|Overall Study||9||
48518776|NCT00706992|101603618|FG003|STARTED|Overall Study||8||
48518777|NCT00706992|101603619|FG004|STARTED|Overall Study||6||
48518778|NCT00706992|101603620|FG005|STARTED|Overall Study||5||
48518779|NCT00706992|101603621|FG006|STARTED|Overall Study||6||
48518780|NCT00706992|101603615|FG000|COMPLETED|Overall Study||3||
48518781|NCT00706992|101603616|FG001|COMPLETED|Overall Study||3||
48518782|NCT00706992|101603617|FG002|COMPLETED|Overall Study||3||
48518783|NCT00706992|101603618|FG003|COMPLETED|Overall Study||6||
48518784|NCT00706992|101603619|FG004|COMPLETED|Overall Study||2||
48518785|NCT00706992|101603620|FG005|COMPLETED|Overall Study||3||
48518786|NCT00706992|101603621|FG006|COMPLETED|Overall Study||3||
48518787|NCT00706992|101603615|FG000|NOT COMPLETED|Overall Study||5||
48518788|NCT00706992|101603616|FG001|NOT COMPLETED|Overall Study||5||
48518789|NCT00706992|101603617|FG002|NOT COMPLETED|Overall Study||6||
48518790|NCT00706992|101603618|FG003|NOT COMPLETED|Overall Study||2||
48518791|NCT00706992|101603619|FG004|NOT COMPLETED|Overall Study||4||
48518792|NCT00706992|101603620|FG005|NOT COMPLETED|Overall Study||2||
48518793|NCT00706992|101603621|FG006|NOT COMPLETED|Overall Study||3||
48518794|NCT03173170|101603622|FG000|STARTED|First Intervention Period (6 Days)||10||
48518795|NCT03173170|101603622|FG000|COMPLETED|First Intervention Period (6 Days)||10||
48518796|NCT03173170|101603622|FG000|NOT COMPLETED|First Intervention Period (6 Days)||0||
48518797|NCT03173170|101603622|FG000|STARTED|Washout Period (at Least 7 Days)||10||
48518798|NCT03173170|101603622|FG000|COMPLETED|Washout Period (at Least 7 Days)||10||
48518799|NCT03173170|101603622|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
48518800|NCT03173170|101603622|FG000|STARTED|Intervention Period 2 (9 Days)||10||
48518801|NCT03173170|101603622|FG000|COMPLETED|Intervention Period 2 (9 Days)||10||
48518802|NCT03173170|101603622|FG000|NOT COMPLETED|Intervention Period 2 (9 Days)||0||
48518803|NCT01597479|101603623|FG000|STARTED|Overall Study||26||
48518804|NCT01597479|101603624|FG001|STARTED|Overall Study||26||
48518805|NCT01597479|101603623|FG000|COMPLETED|Overall Study||24||
48518806|NCT01597479|101603624|FG001|COMPLETED|Overall Study||26||
48518807|NCT01597479|101603623|FG000|NOT COMPLETED|Overall Study||2||
48518808|NCT01597479|101603624|FG001|NOT COMPLETED|Overall Study||0||
48518809|NCT02333487|101603625|FG000|STARTED|Overall Study||6||
48518810|NCT02333487|101603626|FG001|STARTED|Overall Study||8||
48518811|NCT02333487|101603627|FG002|STARTED|Overall Study||8||
48518812|NCT02333487|101603625|FG000|COMPLETED|Overall Study||6||
48518813|NCT02333487|101603626|FG001|COMPLETED|Overall Study||6||
48518814|NCT02333487|101603627|FG002|COMPLETED|Overall Study||8||
48518815|NCT02333487|101603625|FG000|NOT COMPLETED|Overall Study||0||
48518816|NCT02333487|101603626|FG001|NOT COMPLETED|Overall Study||2||
48518817|NCT02333487|101603627|FG002|NOT COMPLETED|Overall Study||0||
48518818|NCT01049412|101603628|FG000|STARTED|Period I||70||
48518819|NCT01049412|101603629|FG001|STARTED|Period I||68||
48518820|NCT01049412|101603628|FG000|Took at Least One Dose of Study Drug|Period I||69||
48518821|NCT01049412|101603629|FG001|Took at Least One Dose of Study Drug|Period I||68||
48518822|NCT01049412|101603628|FG000|COMPLETED|Period I||62||
48518823|NCT01049412|101603629|FG001|COMPLETED|Period I||55||
48518824|NCT01049412|101603628|FG000|NOT COMPLETED|Period I||8||
48518825|NCT01049412|101603629|FG001|NOT COMPLETED|Period I||13||
48518826|NCT01049412|101603628|FG000|STARTED|Period II||62||
48518827|NCT01049412|101603629|FG001|STARTED|Period II||55||
48518828|NCT01049412|101603628|FG000|COMPLETED|Period II||58||
48518829|NCT01049412|101603629|FG001|COMPLETED|Period II||52||
48518830|NCT01049412|101603628|FG000|NOT COMPLETED|Period II||4||
48518831|NCT01049412|101603629|FG001|NOT COMPLETED|Period II||3||
48518832|NCT01300624|101603630|FG000|STARTED|Overall Study||11||
48518833|NCT01300624|101603630|FG000|COMPLETED|Overall Study||11||
48518834|NCT01300624|101603630|FG000|NOT COMPLETED|Overall Study||0||
48518835|NCT01663727|101603631|FG000|STARTED|Overall Study||242||
48518836|NCT01663727|101603632|FG001|STARTED|Overall Study||239||
48518837|NCT01663727|101603631|FG000|COMPLETED|Overall Study||0||
48518838|NCT01663727|101603632|FG001|COMPLETED|Overall Study||1||
48518839|NCT01663727|101603631|FG000|NOT COMPLETED|Overall Study||242||
48518840|NCT01663727|101603632|FG001|NOT COMPLETED|Overall Study||238||
48518841|NCT02075606|101603633|FG000|STARTED|Overall Study||50||
48518842|NCT02075606|101603633|FG000|COMPLETED|Overall Study||40||
48518843|NCT02075606|101603633|FG000|NOT COMPLETED|Overall Study||10||
48518844|NCT00955552|101603634|FG000|STARTED|Overall Study||50||
48518845|NCT00955552|101603635|FG001|STARTED|Overall Study||50||
48518846|NCT00955552|101603634|FG000|COMPLETED|Overall Study||44||
48518847|NCT00955552|101603635|FG001|COMPLETED|Overall Study||45||
48518848|NCT00955552|101603634|FG000|NOT COMPLETED|Overall Study||6||
48518849|NCT00955552|101603635|FG001|NOT COMPLETED|Overall Study||5||
48518850|NCT01613378|101603636|FG000|STARTED|Overall Study||200||
48518851|NCT01613378|101603636|FG000|COMPLETED|Overall Study||161||
48518852|NCT01613378|101603636|FG000|NOT COMPLETED|Overall Study||39||
48518853|NCT00107042|101603637|FG000|STARTED|Overall Study||60||
48518854|NCT00107042|101603638|FG001|STARTED|Overall Study||63||
48518855|NCT00107042|101603637|FG000|COMPLETED|Overall Study||38||
48518856|NCT00107042|101603638|FG001|COMPLETED|Overall Study||47||
48518857|NCT00107042|101603637|FG000|NOT COMPLETED|Overall Study||22||
48518858|NCT00107042|101603638|FG001|NOT COMPLETED|Overall Study||16||
48518859|NCT01506908|101603639|FG000|STARTED|Overall Study||162||
48518860|NCT01506908|101603640|FG001|STARTED|Overall Study||161||
48518861|NCT01506908|101603639|FG000|COMPLETED|Overall Study||161||
48518862|NCT01506908|101603640|FG001|COMPLETED|Overall Study||161||
48518863|NCT01506908|101603639|FG000|NOT COMPLETED|Overall Study||1||
48518864|NCT01506908|101603640|FG001|NOT COMPLETED|Overall Study||0||
48518865|NCT00578071|101603641|FG000|STARTED|Overall Study||29||
48518866|NCT00578071|101603641|FG000|COMPLETED|Overall Study||29||
48518867|NCT00578071|101603641|FG000|NOT COMPLETED|Overall Study||0||
48518868|NCT01652729|101603642|FG000|STARTED|Overall Study||182||
48518869|NCT01652729|101603643|FG001|STARTED|Overall Study||122||
48518870|NCT01652729|101603644|FG002|STARTED|Overall Study||61||
48518871|NCT01652729|101603642|FG000|Modified Intent-to-Treat|Overall Study||181||
48518872|NCT01652729|101603643|FG001|Modified Intent-to-Treat|Overall Study||122||
48518873|NCT01652729|101603644|FG002|Modified Intent-to-Treat|Overall Study||61||
48518874|NCT01652729|101603642|FG000|Treated|Overall Study||181||
48518875|NCT01652729|101603643|FG001|Treated|Overall Study||122||
48518876|NCT01652729|101603644|FG002|Treated|Overall Study||61||
48518877|NCT01652729|101603642|FG000|Evaluable|Overall Study||143||
48518878|NCT01652729|101603643|FG001|Evaluable|Overall Study||91||
48518879|NCT01652729|101603644|FG002|Evaluable|Overall Study||43||
48518880|NCT01652729|101603642|FG000|Meal Test Subjects|Overall Study||60||
48518881|NCT01652729|101603643|FG001|Meal Test Subjects|Overall Study||41||
48518882|NCT01652729|101603644|FG002|Meal Test Subjects|Overall Study||20||
48518883|NCT01652729|101603642|FG000|Meal Test Evaluable|Overall Study||44||
48518884|NCT01652729|101603643|FG001|Meal Test Evaluable|Overall Study||31||
48518885|NCT01652729|101603644|FG002|Meal Test Evaluable|Overall Study||15||
48518886|NCT01652729|101603642|FG000|COMPLETED|Overall Study||155||
48518887|NCT01652729|101603643|FG001|COMPLETED|Overall Study||109||
48518888|NCT01652729|101603644|FG002|COMPLETED|Overall Study||47||
48518889|NCT01652729|101603642|FG000|NOT COMPLETED|Overall Study||27||
48518890|NCT01652729|101603643|FG001|NOT COMPLETED|Overall Study||13||
48518891|NCT01652729|101603644|FG002|NOT COMPLETED|Overall Study||14||
48518892|NCT02698865|101603645|FG000|STARTED|Overall Study||140||
48219957|NCT05580003|100863752|FG004|NOT COMPLETED|Part 3: Period 3 (Day 1)||0||
48219958|NCT05580003|100863753|FG005|NOT COMPLETED|Part 3: Period 3 (Day 1)||0||
48518893|NCT02698865|101603646|FG001|STARTED|Overall Study||80||
48518894|NCT02698865|101603645|FG000|Treated|Overall Study||140||
48518895|NCT02698865|101603646|FG001|Treated|Overall Study||80||
48518896|NCT02698865|101603645|FG000|COMPLETED|Overall Study||105||
48518897|NCT02698865|101603646|FG001|COMPLETED|Overall Study||47||
48518898|NCT02698865|101603645|FG000|NOT COMPLETED|Overall Study||35||
48518899|NCT02698865|101603646|FG001|NOT COMPLETED|Overall Study||33||
48518900|NCT00932282|101603647|FG000|STARTED|Pre-OIT Anti-IgE Therapy Phase||7||
48518901|NCT00932282|101603648|FG001|STARTED|Pre-OIT Anti-IgE Therapy Phase||6||
48518902|NCT00932282|101603647|FG000|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||6||
48518903|NCT00932282|101603648|FG001|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||5||
48518904|NCT00932282|101603647|FG000|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1||
48518905|NCT00932282|101603648|FG001|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1||
48518906|NCT00932282|101603647|FG000|STARTED|Modified OIT Rush Desensitization Phase||6||
48518907|NCT00932282|101603648|FG001|STARTED|Modified OIT Rush Desensitization Phase||5||
48518908|NCT00932282|101603647|FG000|COMPLETED|Modified OIT Rush Desensitization Phase||6||
48518909|NCT00932282|101603648|FG001|COMPLETED|Modified OIT Rush Desensitization Phase||5||
48518910|NCT00932282|101603647|FG000|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0||
48518911|NCT00932282|101603648|FG001|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0||
48518912|NCT00932282|101603647|FG000|STARTED|Biweekly OIT Buildup Phase||6||
48518913|NCT00932282|101603648|FG001|STARTED|Biweekly OIT Buildup Phase||5||
48518914|NCT00932282|101603647|FG000|COMPLETED|Biweekly OIT Buildup Phase||5||
48518915|NCT00932282|101603648|FG001|COMPLETED|Biweekly OIT Buildup Phase||4||
48518916|NCT00932282|101603647|FG000|NOT COMPLETED|Biweekly OIT Buildup Phase||1||
48518917|NCT00932282|101603648|FG001|NOT COMPLETED|Biweekly OIT Buildup Phase||1||
48518918|NCT00932282|101603647|FG000|STARTED|OIT Maintenance Phase||5||
48518919|NCT00932282|101603648|FG001|STARTED|OIT Maintenance Phase||4||
48518920|NCT00932282|101603647|FG000|COMPLETED|OIT Maintenance Phase||4||
48518921|NCT00932282|101603648|FG001|COMPLETED|OIT Maintenance Phase||2||
48518922|NCT00932282|101603647|FG000|NOT COMPLETED|OIT Maintenance Phase||1||
48518923|NCT00932282|101603648|FG001|NOT COMPLETED|OIT Maintenance Phase||2||
48518924|NCT00767520|101603649|FG000|STARTED|Overall Study||79||
48518925|NCT00767520|101603650|FG001|STARTED|Overall Study||78||
48518926|NCT00767520|101603649|FG000|COMPLETED|Overall Study||68||
48518927|NCT00767520|101603650|FG001|COMPLETED|Overall Study||61||
48518928|NCT00767520|101603649|FG000|NOT COMPLETED|Overall Study||11||
48518929|NCT00767520|101603650|FG001|NOT COMPLETED|Overall Study||17||
48518930|NCT03919448|101603651|FG000|STARTED|Overall Study||30||
48518931|NCT03919448|101603652|FG001|STARTED|Overall Study||30||
48518932|NCT03919448|101603653|FG002|STARTED|Overall Study||30||
48518933|NCT03919448|101603651|FG000|COMPLETED|Overall Study||29||
48518934|NCT03919448|101603652|FG001|COMPLETED|Overall Study||30||
48518935|NCT03919448|101603653|FG002|COMPLETED|Overall Study||30||
48518936|NCT03919448|101603651|FG000|NOT COMPLETED|Overall Study||1||
48518937|NCT03919448|101603652|FG001|NOT COMPLETED|Overall Study||0||
48518938|NCT03919448|101603653|FG002|NOT COMPLETED|Overall Study||0||
48518939|NCT02667821|101603654|FG000|STARTED|Overall Study||20||
48518940|NCT02667821|101603654|FG000|COMPLETED|Overall Study||20||
48518941|NCT02667821|101603654|FG000|NOT COMPLETED|Overall Study||0||
48518942|NCT01891305|101603655|FG000|STARTED|Overall Study||12||
48518943|NCT01891305|101603656|FG001|STARTED|Overall Study||12||
48518944|NCT01891305|101603657|FG002|STARTED|Overall Study||14||
48518945|NCT01891305|101603658|FG003|STARTED|Overall Study||12||
48518946|NCT01891305|101603655|FG000|COMPLETED|Overall Study||9||
48518947|NCT01891305|101603656|FG001|COMPLETED|Overall Study||11||
48518948|NCT01891305|101603657|FG002|COMPLETED|Overall Study||11||
48518949|NCT01891305|101603658|FG003|COMPLETED|Overall Study||12||
48518950|NCT01891305|101603655|FG000|NOT COMPLETED|Overall Study||3||
48518951|NCT01891305|101603656|FG001|NOT COMPLETED|Overall Study||1||
48518952|NCT01891305|101603657|FG002|NOT COMPLETED|Overall Study||3||
48518953|NCT01891305|101603658|FG003|NOT COMPLETED|Overall Study||0||
48518954|NCT01207440|101603659|FG000|STARTED|Overall Study||203||
48518955|NCT01207440|101603660|FG001|STARTED|Overall Study||64||
48518956|NCT01207440|101603661|FG002|STARTED|Overall Study||65||
48518957|NCT01207440|101603662|FG003|STARTED|Overall Study||18||
48518958|NCT01207440|101603663|FG004|STARTED|Overall Study||48||
48518959|NCT01207440|101603664|FG005|STARTED|Overall Study||46||
48518960|NCT01207440|101603665|FG006|STARTED|Overall Study||5||
48518961|NCT01207440|101603659|FG000|COMPLETED|Overall Study||0||
48518962|NCT01207440|101603660|FG001|COMPLETED|Overall Study||0||
48518963|NCT01207440|101603661|FG002|COMPLETED|Overall Study||0||
48518964|NCT01207440|101603662|FG003|COMPLETED|Overall Study||0||
48518965|NCT01207440|101603663|FG004|COMPLETED|Overall Study||0||
48518966|NCT01207440|101603664|FG005|COMPLETED|Overall Study||0||
48518967|NCT01207440|101603665|FG006|COMPLETED|Overall Study||0||
48518968|NCT01207440|101603659|FG000|NOT COMPLETED|Overall Study||203||
48518969|NCT01207440|101603660|FG001|NOT COMPLETED|Overall Study||64||
48518970|NCT01207440|101603661|FG002|NOT COMPLETED|Overall Study||65||
48518971|NCT01207440|101603662|FG003|NOT COMPLETED|Overall Study||18||
48518972|NCT01207440|101603663|FG004|NOT COMPLETED|Overall Study||48||
48518973|NCT01207440|101603664|FG005|NOT COMPLETED|Overall Study||46||
48518974|NCT01207440|101603665|FG006|NOT COMPLETED|Overall Study||5||
48518975|NCT04349631|101603666|FG000|STARTED|Overall Study||51||
48518976|NCT04349631|101603666|FG000|COMPLETED|Overall Study||41||
48518977|NCT04349631|101603666|FG000|NOT COMPLETED|Overall Study||10||
48518978|NCT01807117|101603667|FG000|STARTED|Overall Study||15||
48518979|NCT01807117|101603667|FG000|COMPLETED|Overall Study||12||
48518980|NCT01807117|101603667|FG000|NOT COMPLETED|Overall Study||3||
48518981|NCT00456495|101603668|FG000|STARTED|Overall Study||5||
48518982|NCT00456495|101603668|FG000|COMPLETED|Overall Study||3||
48518983|NCT00456495|101603668|FG000|NOT COMPLETED|Overall Study||2||
48518984|NCT00450983|101603669|FG000|STARTED|Overall Study||1||
48518985|NCT00450983|101603669|FG000|COMPLETED|Overall Study||1||
48518986|NCT00450983|101603669|FG000|NOT COMPLETED|Overall Study||0||
48518987|NCT01795079|101603670|FG000|STARTED|Overall Study||16||
48518988|NCT01795079|101603671|FG001|STARTED|Overall Study||15||
48518989|NCT01795079|101603670|FG000|COMPLETED|Overall Study||13||
48518990|NCT01795079|101603671|FG001|COMPLETED|Overall Study||12||
48518991|NCT01795079|101603670|FG000|NOT COMPLETED|Overall Study||3||
48518992|NCT01795079|101603671|FG001|NOT COMPLETED|Overall Study||3||
48518993|NCT03614494|101603672|FG000|STARTED|Overall Study||430||
48518994|NCT03614494|101603673|FG001|STARTED|Overall Study||430||
48518995|NCT03614494|101603672|FG000|COMPLETED|Overall Study||418||
48518996|NCT03614494|101603673|FG001|COMPLETED|Overall Study||418||
48518997|NCT03614494|101603672|FG000|NOT COMPLETED|Overall Study||12||
48518998|NCT03614494|101603673|FG001|NOT COMPLETED|Overall Study||12||
48518999|NCT01875471|101603674|FG000|STARTED|Overall Study||137||
48519000|NCT01875471|101603675|FG001|STARTED|Overall Study||138||
48519001|NCT01875471|101603674|FG000|Completed Per Protocol|Overall Study||127||
48519002|NCT01875471|101603675|FG001|Completed Per Protocol|Overall Study||123||
48219959|NCT05580003|100863754|FG006|NOT COMPLETED|Part 3: Period 3 (Day 1)||0||
48519003|NCT01875471|101603674|FG000|COMPLETED|Overall Study||136||
48519004|NCT01875471|101603675|FG001|COMPLETED|Overall Study||137||
48519005|NCT01875471|101603674|FG000|NOT COMPLETED|Overall Study||1||
48519006|NCT01875471|101603675|FG001|NOT COMPLETED|Overall Study||1||
48519007|NCT04798482|101603676|FG000|STARTED|Overall Study||22||
48519008|NCT04798482|101603676|FG000|COMPLETED|Overall Study||20||
48519009|NCT04798482|101603676|FG000|NOT COMPLETED|Overall Study||2||
48519010|NCT01042535|101603677|FG000|STARTED|Overall Study||44||
48519011|NCT01042535|101603677|FG000|COMPLETED|Overall Study||36||
48519012|NCT01042535|101603677|FG000|NOT COMPLETED|Overall Study||8||
48519013|NCT01922219|101603678|FG000|STARTED|Overall Study||37||
48519014|NCT01922219|101603678|FG000|COMPLETED|Overall Study||28||
48519015|NCT01922219|101603678|FG000|NOT COMPLETED|Overall Study||9||
48519016|NCT04523324|101603679|FG000|STARTED|Overall Study||211||
48519017|NCT04523324|101603680|FG001|STARTED|Overall Study||366||
48519018|NCT04523324|101603679|FG000|COMPLETED|Overall Study||203||
48519019|NCT04523324|101603680|FG001|COMPLETED|Overall Study||334||
48519020|NCT04523324|101603679|FG000|NOT COMPLETED|Overall Study||8||
48519021|NCT04523324|101603680|FG001|NOT COMPLETED|Overall Study||32||
48519022|NCT00484419|101603681|FG000|STARTED|Overall Study||57||
48519023|NCT00484419|101603682|FG001|STARTED|Overall Study||56||
48519024|NCT00484419|101603683|FG002|STARTED|Overall Study||56||
48519025|NCT00484419|101603681|FG000|COMPLETED|Overall Study||45||
48519026|NCT00484419|101603682|FG001|COMPLETED|Overall Study||51||
48519027|NCT00484419|101603683|FG002|COMPLETED|Overall Study||45||
48519028|NCT00484419|101603681|FG000|NOT COMPLETED|Overall Study||12||
48519029|NCT00484419|101603682|FG001|NOT COMPLETED|Overall Study||5||
48519030|NCT00484419|101603683|FG002|NOT COMPLETED|Overall Study||11||
48519031|NCT01202071|101603684|FG000|STARTED|Overall Study||6||
48519032|NCT01202071|101603685|FG001|STARTED|Overall Study||6||
48519033|NCT01202071|101603686|FG002|STARTED|Overall Study||6||
48519034|NCT01202071|101603687|FG003|STARTED|Overall Study||6||
48519035|NCT01202071|101603684|FG000|COMPLETED|Overall Study||6||
48519036|NCT01202071|101603685|FG001|COMPLETED|Overall Study||6||
48519037|NCT01202071|101603686|FG002|COMPLETED|Overall Study||6||
48519038|NCT01202071|101603687|FG003|COMPLETED|Overall Study||6||
48519039|NCT01202071|101603684|FG000|NOT COMPLETED|Overall Study||0||
48519040|NCT01202071|101603685|FG001|NOT COMPLETED|Overall Study||0||
48519041|NCT01202071|101603686|FG002|NOT COMPLETED|Overall Study||0||
48519042|NCT01202071|101603687|FG003|NOT COMPLETED|Overall Study||0||
48519043|NCT02938520|101603688|FG000|STARTED|Overall Study||283||
48519044|NCT02938520|101603689|FG001|STARTED|Overall Study||283||
48519045|NCT02938520|101603688|FG000|COMPLETED|Overall Study||0||
48519046|NCT02938520|101603689|FG001|COMPLETED|Overall Study||0||
48519047|NCT02938520|101603688|FG000|NOT COMPLETED|Overall Study||283||
48519048|NCT02938520|101603689|FG001|NOT COMPLETED|Overall Study||283||
48519049|NCT01201759|101603690|FG000|STARTED|Visit 1 Wash-in ( Untreated)||10||
48519050|NCT01201759|101603691|FG001|STARTED|Visit 1 Wash-in ( Untreated)||8||
48519051|NCT01201759|101603690|FG000|COMPLETED|Visit 1 Wash-in ( Untreated)||8||
48519052|NCT01201759|101603691|FG001|COMPLETED|Visit 1 Wash-in ( Untreated)||7||
48519053|NCT01201759|101603690|FG000|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||2||
48519054|NCT01201759|101603691|FG001|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||1||
48519055|NCT01201759|101603690|FG000|STARTED|Visit 2||8||
48519056|NCT01201759|101603691|FG001|STARTED|Visit 2||7||
48519057|NCT01201759|101603690|FG000|COMPLETED|Visit 2||8||
48519058|NCT01201759|101603691|FG001|COMPLETED|Visit 2||7||
48519059|NCT01201759|101603690|FG000|NOT COMPLETED|Visit 2||0||
48519060|NCT01201759|101603691|FG001|NOT COMPLETED|Visit 2||0||
48519061|NCT01201759|101603690|FG000|STARTED|Visit 3 - Washout||8||
48519062|NCT01201759|101603691|FG001|STARTED|Visit 3 - Washout||7||
48519063|NCT01201759|101603690|FG000|COMPLETED|Visit 3 - Washout||7||
48519064|NCT01201759|101603691|FG001|COMPLETED|Visit 3 - Washout||4||
48519065|NCT01201759|101603690|FG000|NOT COMPLETED|Visit 3 - Washout||1||
48519066|NCT01201759|101603691|FG001|NOT COMPLETED|Visit 3 - Washout||3||
48519067|NCT01201759|101603690|FG000|STARTED|Visit 4 Crossover||7||
48519068|NCT01201759|101603691|FG001|STARTED|Visit 4 Crossover||4||
48519069|NCT01201759|101603690|FG000|COMPLETED|Visit 4 Crossover||7||
48519070|NCT01201759|101603691|FG001|COMPLETED|Visit 4 Crossover||3||
48519071|NCT01201759|101603690|FG000|NOT COMPLETED|Visit 4 Crossover||0||
48519072|NCT01201759|101603691|FG001|NOT COMPLETED|Visit 4 Crossover||1||
48519073|NCT01201759|101603690|FG000|STARTED|Visit 5||7||
48519074|NCT01201759|101603691|FG001|STARTED|Visit 5||3||
48519075|NCT01201759|101603690|FG000|COMPLETED|Visit 5||7||
48519076|NCT01201759|101603691|FG001|COMPLETED|Visit 5||3||
48519077|NCT01201759|101603690|FG000|NOT COMPLETED|Visit 5||0||
48519078|NCT01201759|101603691|FG001|NOT COMPLETED|Visit 5||0||
48519079|NCT02504723|101603692|FG000|STARTED|Overall Study||60||
48519080|NCT02504723|101603693|FG001|STARTED|Overall Study||61||
48519081|NCT02504723|101603692|FG000|COMPLETED|Overall Study||60||
48519082|NCT02504723|101603693|FG001|COMPLETED|Overall Study||61||
48519083|NCT02504723|101603692|FG000|NOT COMPLETED|Overall Study||0||
48219960|NCT05580003|100863755|FG007|NOT COMPLETED|Part 3: Period 3 (Day 1)||0||
48519084|NCT02504723|101603693|FG001|NOT COMPLETED|Overall Study||0||
48519085|NCT03336242|101603694|FG000|STARTED|Overall Study||10||
48519086|NCT03336242|101603695|FG001|STARTED|Overall Study||10||
48519087|NCT03336242|101603694|FG000|COMPLETED|Overall Study||10||
48519088|NCT03336242|101603695|FG001|COMPLETED|Overall Study||9||
48519089|NCT03336242|101603694|FG000|NOT COMPLETED|Overall Study||0||
48519090|NCT03336242|101603695|FG001|NOT COMPLETED|Overall Study||1||
48519091|NCT01949116|101603696|FG000|STARTED|Overall Study||86||
48519092|NCT01949116|101603697|FG001|STARTED|Overall Study||90||
48519093|NCT01949116|101603696|FG000|COMPLETED|Overall Study||78||
48519094|NCT01949116|101603697|FG001|COMPLETED|Overall Study||84||
48519095|NCT01949116|101603696|FG000|NOT COMPLETED|Overall Study||8||
48519096|NCT01949116|101603697|FG001|NOT COMPLETED|Overall Study||6||
48519097|NCT02150759|101603698|FG000|STARTED|Overall Study||23||
48519098|NCT02150759|101603699|FG001|STARTED|Overall Study||23||
48519099|NCT02150759|101603698|FG000|COMPLETED|Overall Study||22||
48519100|NCT02150759|101603699|FG001|COMPLETED|Overall Study||21||
48519101|NCT02150759|101603698|FG000|NOT COMPLETED|Overall Study||1||
48519102|NCT02150759|101603699|FG001|NOT COMPLETED|Overall Study||2||
48519103|NCT02340221|101603700|FG000|STARTED|Overall Study||214||
48519104|NCT02340221|101603701|FG001|STARTED|Overall Study||417||
48519105|NCT02340221|101603700|FG000|COMPLETED|Overall Study||0||
48519106|NCT02340221|101603701|FG001|COMPLETED|Overall Study||0||
48519107|NCT02340221|101603700|FG000|NOT COMPLETED|Overall Study||214||
48519108|NCT02340221|101603701|FG001|NOT COMPLETED|Overall Study||417||
48519109|NCT03438539|101603702|FG000|STARTED|Overall Study||76||
48519110|NCT03438539|101603703|FG001|STARTED|Overall Study||72||
48519111|NCT03438539|101603704|FG002|STARTED|Overall Study||76||
48519112|NCT03438539|101603705|FG003|STARTED|Overall Study||73||
48519113|NCT03438539|101603706|FG004|STARTED|Overall Study||73||
48519114|NCT03438539|101603707|FG005|STARTED|Overall Study||74||
48519115|NCT03438539|101603702|FG000|COMPLETED|Overall Study||68||
48519116|NCT03438539|101603703|FG001|COMPLETED|Overall Study||68||
48519117|NCT03438539|101603704|FG002|COMPLETED|Overall Study||66||
48519118|NCT03438539|101603705|FG003|COMPLETED|Overall Study||64||
48519119|NCT03438539|101603706|FG004|COMPLETED|Overall Study||70||
48519120|NCT03438539|101603707|FG005|COMPLETED|Overall Study||66||
48519121|NCT03438539|101603702|FG000|NOT COMPLETED|Overall Study||8||
48519122|NCT03438539|101603703|FG001|NOT COMPLETED|Overall Study||4||
48519123|NCT03438539|101603704|FG002|NOT COMPLETED|Overall Study||10||
48519124|NCT03438539|101603705|FG003|NOT COMPLETED|Overall Study||9||
48519125|NCT03438539|101603706|FG004|NOT COMPLETED|Overall Study||3||
48519126|NCT03438539|101603707|FG005|NOT COMPLETED|Overall Study||8||
48519127|NCT02540447|101603708|FG000|STARTED|Overall Study||40||
48519128|NCT02540447|101603709|FG001|STARTED|Overall Study||40||
48519129|NCT02540447|101603708|FG000|COMPLETED|Overall Study||40||
48519130|NCT02540447|101603709|FG001|COMPLETED|Overall Study||40||
48519131|NCT02540447|101603708|FG000|NOT COMPLETED|Overall Study||0||
48519132|NCT02540447|101603709|FG001|NOT COMPLETED|Overall Study||0||
48519133|NCT02458092|101603710|FG000|STARTED|Overall Study||20||
48519134|NCT02458092|101603711|FG001|STARTED|Overall Study||10||
48519135|NCT02458092|101603710|FG000|COMPLETED|Overall Study||19||
48519136|NCT02458092|101603711|FG001|COMPLETED|Overall Study||10||
48519137|NCT02458092|101603710|FG000|NOT COMPLETED|Overall Study||1||
48519138|NCT02458092|101603711|FG001|NOT COMPLETED|Overall Study||0||
48519139|NCT02985879|101603712|FG000|STARTED|Overall Study||126||
48519140|NCT02985879|101603713|FG001|STARTED|Overall Study||127||
48519141|NCT02985879|101603714|FG002|STARTED|Overall Study||125||
48519142|NCT02985879|101603712|FG000|COMPLETED|Overall Study||50||
48519143|NCT02985879|101603713|FG001|COMPLETED|Overall Study||52||
48519144|NCT02985879|101603714|FG002|COMPLETED|Overall Study||48||
48519145|NCT02985879|101603712|FG000|NOT COMPLETED|Overall Study||76||
48519146|NCT02985879|101603713|FG001|NOT COMPLETED|Overall Study||75||
48519147|NCT02985879|101603714|FG002|NOT COMPLETED|Overall Study||77||
48519148|NCT00304707|101603715|FG000|STARTED|Overall Study||73||
48519149|NCT00304707|101603716|FG001|STARTED|Overall Study||70||
48519150|NCT00304707|101603715|FG000|COMPLETED|Overall Study||66||
48519151|NCT00304707|101603716|FG001|COMPLETED|Overall Study||64||
48219961|NCT05580003|100863756|FG008|NOT COMPLETED|Part 3: Period 3 (Day 1)||0||
48519152|NCT00304707|101603715|FG000|NOT COMPLETED|Overall Study||7||
48519153|NCT00304707|101603716|FG001|NOT COMPLETED|Overall Study||6||
48519154|NCT03330236|101603717|FG000|STARTED|Overall Study||779||
48519155|NCT03330236|101603718|FG001|STARTED|Overall Study||781||
48519156|NCT03330236|101603717|FG000|Received Surgery|Overall Study||779||
48519157|NCT03330236|101603718|FG001|Received Surgery|Overall Study||781||
48519158|NCT03330236|101603717|FG000|Modified ITT|Overall Study||773|Participants analyzed as the Modified ITT analysis population.|
48519159|NCT03330236|101603718|FG001|Modified ITT|Overall Study||774|Participants analyzed as the Modified ITT analysis population.|
48519160|NCT03330236|101603717|FG000|COMPLETED|Overall Study||679||
48519161|NCT03330236|101603718|FG001|COMPLETED|Overall Study||697||
48519162|NCT03330236|101603717|FG000|NOT COMPLETED|Overall Study||100||
48519163|NCT03330236|101603718|FG001|NOT COMPLETED|Overall Study||84||
48519164|NCT01818518|101603719|FG000|STARTED|Overall Study||310||
48519165|NCT01818518|101603720|FG001|STARTED|Overall Study||263||
48519166|NCT01818518|101603721|FG002|STARTED|Overall Study||288||
48519167|NCT01818518|101603722|FG003|STARTED|Overall Study||59||
48519168|NCT01818518|101603723|FG004|STARTED|Overall Study||38||
48519169|NCT01818518|101603724|FG005|STARTED|Overall Study||37||
48519170|NCT01818518|101603719|FG000|COMPLETED|Overall Study||310||
48519171|NCT01818518|101603720|FG001|COMPLETED|Overall Study||263||
48519172|NCT01818518|101603721|FG002|COMPLETED|Overall Study||288||
48519173|NCT01818518|101603722|FG003|COMPLETED|Overall Study||59||
48519174|NCT01818518|101603723|FG004|COMPLETED|Overall Study||38||
48519175|NCT01818518|101603724|FG005|COMPLETED|Overall Study||37||
48519176|NCT01818518|101603719|FG000|NOT COMPLETED|Overall Study||0||
48519177|NCT01818518|101603720|FG001|NOT COMPLETED|Overall Study||0||
48519178|NCT01818518|101603721|FG002|NOT COMPLETED|Overall Study||0||
48519179|NCT01818518|101603722|FG003|NOT COMPLETED|Overall Study||0||
48519180|NCT01818518|101603723|FG004|NOT COMPLETED|Overall Study||0||
48519181|NCT01818518|101603724|FG005|NOT COMPLETED|Overall Study||0||
48519182|NCT01640873|101603725|FG000|STARTED|Overall Study||22||
48519183|NCT01640873|101603726|FG001|STARTED|Overall Study||11||
48519184|NCT01640873|101603725|FG000|COMPLETED|Overall Study||20||
48519185|NCT01640873|101603726|FG001|COMPLETED|Overall Study||10||
48519186|NCT01640873|101603725|FG000|NOT COMPLETED|Overall Study||2||
48519187|NCT01640873|101603726|FG001|NOT COMPLETED|Overall Study||1||
48519188|NCT02997657|101603727|FG000|STARTED|Overall Study||140||
48519189|NCT02997657|101603728|FG001|STARTED|Overall Study||131||
48519190|NCT02997657|101603727|FG000|COMPLETED|Overall Study||109||
48219962|NCT05580003|100863757|FG009|NOT COMPLETED|Part 3: Period 3 (Day 1)||0||
48519191|NCT02997657|101603728|FG001|COMPLETED|Overall Study||97||
48519192|NCT02997657|101603727|FG000|NOT COMPLETED|Overall Study||31||
48519193|NCT02997657|101603728|FG001|NOT COMPLETED|Overall Study||34||
48519194|NCT02740920|101603729|FG000|STARTED|Overall Study||9||
48519195|NCT02740920|101603729|FG000|COMPLETED|Overall Study||9||
48519196|NCT02740920|101603729|FG000|NOT COMPLETED|Overall Study||0||
48519197|NCT04932941|101603730|FG000|STARTED|Overall Study||87||
48519198|NCT04932941|101603731|FG001|STARTED|Overall Study||45||
48519199|NCT04932941|101603730|FG000|Intention-to-Treat Set (ITT)|Overall Study||87|The ITT Set corresponded with the randomized set and included all randomized participants, irrespective of any deviation from the protocol or premature discontinuation from the study drug or withdrawal from study.|
48519200|NCT04932941|101603731|FG001|Intention-to-Treat Set (ITT)|Overall Study||45|The ITT Set corresponded with the randomized set and included all randomized participants, irrespective of any deviation from the protocol or premature discontinuation from the study drug or withdrawal from study.|
48519201|NCT04932941|101603730|FG000|Pharmacokinetic Analysis Set|Overall Study||4|The Pharmacokinetic Analysis Set included all the participants who were administered active study drug and had at least 1 post-dose evaluable plasma concentration after Day 1 dose.|
48519202|NCT04932941|101603731|FG001|Pharmacokinetic Analysis Set|Overall Study||0|The Pharmacokinetic Analysis Set included all the participants who were administered active study drug and had at least 1 post-dose evaluable plasma concentration after Day 1 dose.|
48519203|NCT04932941|101603730|FG000|Safety Set|Overall Study||86|The Safety Set included all randomized participants who received at least 1 dose of study drug.|
48519204|NCT04932941|101603731|FG001|Safety Set|Overall Study||45|The Safety Set included all randomized participants who received at least 1 dose of study drug.|
48519205|NCT04932941|101603730|FG000|COMPLETED|Overall Study||73||
48519206|NCT04932941|101603731|FG001|COMPLETED|Overall Study||38||
48519207|NCT04932941|101603730|FG000|NOT COMPLETED|Overall Study||14||
48519208|NCT04932941|101603731|FG001|NOT COMPLETED|Overall Study||7||
48519209|NCT03235479|101603732|FG000|STARTED|Overall Study||582|Randomized|
48519210|NCT03235479|101603733|FG001|STARTED|Overall Study||580|Randomized|
48519211|NCT03235479|101603732|FG000|Treated|Overall Study||546||
48519212|NCT03235479|101603733|FG001|Treated|Overall Study||549||
48666838|NCT05126303|101970477|FG001|COMPLETED|Overall Study||88||
48666839|NCT05126303|101970476|FG000|NOT COMPLETED|Overall Study||0||
48219963|NCT05580003|100863758|FG010|NOT COMPLETED|Part 3: Period 3 (Day 1)||0||
48219964|NCT05580003|100863759|FG011|NOT COMPLETED|Part 3: Period 3 (Day 1)||0||
48219965|NCT05580003|100863760|FG012|NOT COMPLETED|Part 3: Period 3 (Day 1)||0||
48219966|NCT05580003|100863761|FG013|NOT COMPLETED|Part 3: Period 3 (Day 1)||0||
48219967|NCT05580003|100863762|FG014|NOT COMPLETED|Part 3: Period 3 (Day 1)||0||
48219968|NCT05580003|100863763|FG015|NOT COMPLETED|Part 3: Period 3 (Day 1)||0||
48219969|NCT05580003|100863764|FG016|NOT COMPLETED|Part 3: Period 3 (Day 1)||0||
48219970|NCT05580003|100863765|FG017|NOT COMPLETED|Part 3: Period 3 (Day 1)||0||
48519213|NCT03235479|101603732|FG000|COMPLETED|Overall Study||541||
48519214|NCT03235479|101603733|FG001|COMPLETED|Overall Study||540||
48519215|NCT03235479|101603732|FG000|NOT COMPLETED|Overall Study||41||
48519216|NCT03235479|101603733|FG001|NOT COMPLETED|Overall Study||40||
48519217|NCT01931527|101603734|FG000|STARTED|Overall Study||16||
48519218|NCT01931527|101603735|FG001|STARTED|Overall Study||15||
48519219|NCT01931527|101603734|FG000|COMPLETED|Overall Study||16||
48519220|NCT01931527|101603735|FG001|COMPLETED|Overall Study||15||
48519221|NCT01931527|101603734|FG000|NOT COMPLETED|Overall Study||0||
48519222|NCT01931527|101603735|FG001|NOT COMPLETED|Overall Study||0||
48519223|NCT01163084|101603736|FG000|STARTED|Overall Study||4||
48219971|NCT05580003|100863766|FG018|NOT COMPLETED|Part 3: Period 3 (Day 1)||0||
48219972|NCT05580003|100863767|FG019|NOT COMPLETED|Part 3: Period 3 (Day 1)||0||
48519224|NCT01163084|101603737|FG001|STARTED|Overall Study||5||
48519225|NCT01163084|101603736|FG000|COMPLETED|Overall Study||4||
48519226|NCT01163084|101603737|FG001|COMPLETED|Overall Study||5||
48519227|NCT01163084|101603736|FG000|NOT COMPLETED|Overall Study||0||
48519228|NCT01163084|101603737|FG001|NOT COMPLETED|Overall Study||0||
48519229|NCT02234752|101603738|FG000|STARTED|Overall Study||3||
48519230|NCT02234752|101603738|FG000|COMPLETED|Overall Study||2||
48519231|NCT02234752|101603738|FG000|NOT COMPLETED|Overall Study||1||
48519232|NCT03812991|101603739|FG000|STARTED|Overall Study||11||
48519233|NCT03812991|101603740|FG001|STARTED|Overall Study||10||
48519234|NCT03812991|101603739|FG000|COMPLETED|Overall Study||8||
48519235|NCT03812991|101603740|FG001|COMPLETED|Overall Study||9||
48519236|NCT03812991|101603739|FG000|NOT COMPLETED|Overall Study||3||
48519237|NCT03812991|101603740|FG001|NOT COMPLETED|Overall Study||1||
48519238|NCT03123783|101603741|FG000|STARTED|Phase 1b||3||
48519239|NCT03123783|101603742|FG001|STARTED|Phase 1b||4||
48519240|NCT03123783|101603743|FG002|STARTED|Phase 1b||3||
48519241|NCT03123783|101603744|FG003|STARTED|Phase 1b||0||
48519242|NCT03123783|101603745|FG004|STARTED|Phase 1b||0||
48519243|NCT03123783|101603746|FG005|STARTED|Phase 1b||0||
48519244|NCT03123783|101603747|FG006|STARTED|Phase 1b||0||
48519245|NCT03123783|101603741|FG000|Participants in the Safety Population|Phase 1b||3||
48519246|NCT03123783|101603742|FG001|Participants in the Safety Population|Phase 1b||3||
48519247|NCT03123783|101603743|FG002|Participants in the Safety Population|Phase 1b||3||
48519248|NCT03123783|101603744|FG003|Participants in the Safety Population|Phase 1b||0||
48519249|NCT03123783|101603745|FG004|Participants in the Safety Population|Phase 1b||0||
48519250|NCT03123783|101603746|FG005|Participants in the Safety Population|Phase 1b||0||
48519251|NCT03123783|101603747|FG006|Participants in the Safety Population|Phase 1b||0||
48519252|NCT03123783|101603741|FG000|Participants in the Efficacy Population|Phase 1b||3||
48519253|NCT03123783|101603742|FG001|Participants in the Efficacy Population|Phase 1b||3||
48519254|NCT03123783|101603743|FG002|Participants in the Efficacy Population|Phase 1b||3||
48519255|NCT03123783|101603744|FG003|Participants in the Efficacy Population|Phase 1b||0||
48519256|NCT03123783|101603745|FG004|Participants in the Efficacy Population|Phase 1b||0||
48519257|NCT03123783|101603746|FG005|Participants in the Efficacy Population|Phase 1b||0||
48519258|NCT03123783|101603747|FG006|Participants in the Efficacy Population|Phase 1b||0||
48519259|NCT03123783|101603741|FG000|COMPLETED|Phase 1b||3|Participants completed Ph1b who did not receive RP2D did not roll over to Phase 2|
48519260|NCT03123783|101603742|FG001|COMPLETED|Phase 1b||3|Participants completed Ph1b who did not receive RP2D did not roll over to Phase 2|
48519261|NCT03123783|101603743|FG002|COMPLETED|Phase 1b||0|Participants completed Ph1b who did not receive RP2D did not roll over to Phase 2|
48519262|NCT03123783|101603744|FG003|COMPLETED|Phase 1b||0|Participants completed Ph1b who did not receive RP2D did not roll over to Phase 2|
48519263|NCT03123783|101603745|FG004|COMPLETED|Phase 1b||0|Participants completed Ph1b who did not receive RP2D did not roll over to Phase 2|
48519264|NCT03123783|101603746|FG005|COMPLETED|Phase 1b||0|Participants completed Ph1b who did not receive RP2D did not roll over to Phase 2|
48519265|NCT03123783|101603747|FG006|COMPLETED|Phase 1b||0|Participants completed Ph1b who did not receive RP2D did not roll over to Phase 2|
48519266|NCT03123783|101603741|FG000|NOT COMPLETED|Phase 1b||0||
48519267|NCT03123783|101603742|FG001|NOT COMPLETED|Phase 1b||1||
48519268|NCT03123783|101603743|FG002|NOT COMPLETED|Phase 1b||3||
48519269|NCT03123783|101603744|FG003|NOT COMPLETED|Phase 1b||0||
48519270|NCT03123783|101603745|FG004|NOT COMPLETED|Phase 1b||0||
48519271|NCT03123783|101603746|FG005|NOT COMPLETED|Phase 1b||0||
48519272|NCT03123783|101603747|FG006|NOT COMPLETED|Phase 1b||0||
48519273|NCT03123783|101603741|FG000|STARTED|Phase 2||0|Only 3 participants in Phase 1b rolled over to Phase 2 study|
48519274|NCT03123783|101603742|FG001|STARTED|Phase 2||0|Only 3 participants in Phase 1b rolled over to Phase 2 study|
48519275|NCT03123783|101603743|FG002|STARTED|Phase 2||0|Only 3 participants in Phase 1b rolled over to Phase 2 study|
48519276|NCT03123783|101603744|FG003|STARTED|Phase 2||53|Only 3 participants in Phase 1b rolled over to Phase 2 study|
48519277|NCT03123783|101603745|FG004|STARTED|Phase 2||38|Only 3 participants in Phase 1b rolled over to Phase 2 study|
48519278|NCT03123783|101603746|FG005|STARTED|Phase 2||14|Only 3 participants in Phase 1b rolled over to Phase 2 study|
48519279|NCT03123783|101603747|FG006|STARTED|Phase 2||28|Only 3 participants in Phase 1b rolled over to Phase 2 study|
48519280|NCT03123783|101603741|FG000|Phase 2 Participants in Safety Population|Phase 2||0||
48519281|NCT03123783|101603742|FG001|Phase 2 Participants in Safety Population|Phase 2||0||
48519282|NCT03123783|101603743|FG002|Phase 2 Participants in Safety Population|Phase 2||0||
48519283|NCT03123783|101603744|FG003|Phase 2 Participants in Safety Population|Phase 2||53||
48519284|NCT03123783|101603745|FG004|Phase 2 Participants in Safety Population|Phase 2||38||
48519285|NCT03123783|101603746|FG005|Phase 2 Participants in Safety Population|Phase 2||14||
48519286|NCT03123783|101603747|FG006|Phase 2 Participants in Safety Population|Phase 2||28||
48519287|NCT03123783|101603741|FG000|Phase 2 Participants in the Efficacy (EE) Population|Phase 2||0||
48519288|NCT03123783|101603742|FG001|Phase 2 Participants in the Efficacy (EE) Population|Phase 2||0||
48519289|NCT03123783|101603743|FG002|Phase 2 Participants in the Efficacy (EE) Population|Phase 2||0||
48519290|NCT03123783|101603744|FG003|Phase 2 Participants in the Efficacy (EE) Population|Phase 2||48||
48519291|NCT03123783|101603745|FG004|Phase 2 Participants in the Efficacy (EE) Population|Phase 2||33||
48519292|NCT03123783|101603746|FG005|Phase 2 Participants in the Efficacy (EE) Population|Phase 2||12||
48519293|NCT03123783|101603747|FG006|Phase 2 Participants in the Efficacy (EE) Population|Phase 2||25||
48519294|NCT03123783|101603741|FG000|COMPLETED|Phase 2||0||
48519295|NCT03123783|101603742|FG001|COMPLETED|Phase 2||0||
48519296|NCT03123783|101603743|FG002|COMPLETED|Phase 2||0||
48519297|NCT03123783|101603744|FG003|COMPLETED|Phase 2||48||
48519298|NCT03123783|101603745|FG004|COMPLETED|Phase 2||33||
48519299|NCT03123783|101603746|FG005|COMPLETED|Phase 2||12||
48519300|NCT03123783|101603747|FG006|COMPLETED|Phase 2||25||
48519301|NCT03123783|101603741|FG000|NOT COMPLETED|Phase 2||0||
48519302|NCT03123783|101603742|FG001|NOT COMPLETED|Phase 2||0||
48519303|NCT03123783|101603743|FG002|NOT COMPLETED|Phase 2||0||
48519304|NCT03123783|101603744|FG003|NOT COMPLETED|Phase 2||5||
48519305|NCT03123783|101603745|FG004|NOT COMPLETED|Phase 2||5||
48519306|NCT03123783|101603746|FG005|NOT COMPLETED|Phase 2||2||
48519307|NCT03123783|101603747|FG006|NOT COMPLETED|Phase 2||3||
48519308|NCT01522950|101603748|FG000|STARTED|Overall Study||26||
48519309|NCT01522950|101603749|FG001|STARTED|Overall Study||23||
48519310|NCT01522950|101603750|FG002|STARTED|Overall Study||27||
48519311|NCT01522950|101603748|FG000|COMPLETED|Overall Study||20||
48519312|NCT01522950|101603749|FG001|COMPLETED|Overall Study||18||
48519313|NCT01522950|101603750|FG002|COMPLETED|Overall Study||22||
48519314|NCT01522950|101603748|FG000|NOT COMPLETED|Overall Study||6||
48519315|NCT01522950|101603749|FG001|NOT COMPLETED|Overall Study||5||
48519316|NCT01522950|101603750|FG002|NOT COMPLETED|Overall Study||5||
48519317|NCT01448356|101603751|FG000|STARTED|Overall Study||10||
48519318|NCT01448356|101603751|FG000|COMPLETED|Overall Study||10||
48519319|NCT01448356|101603751|FG000|NOT COMPLETED|Overall Study||0||
48519320|NCT00836719|101603752|FG000|STARTED|Overall Study||10||
48519321|NCT00836719|101603752|FG000|COMPLETED|Overall Study||10||
48519322|NCT00836719|101603752|FG000|NOT COMPLETED|Overall Study||0||
48519323|NCT00536484|101603753|FG000|STARTED|Overall Study||445||
48519324|NCT00536484|101603754|FG001|STARTED|Overall Study||438||
48519325|NCT00536484|101603753|FG000|COMPLETED|Overall Study||385||
48519326|NCT00536484|101603754|FG001|COMPLETED|Overall Study||382||
48519327|NCT00536484|101603753|FG000|NOT COMPLETED|Overall Study||60||
48519328|NCT00536484|101603754|FG001|NOT COMPLETED|Overall Study||56||
48519329|NCT00411398|101603755|FG000|STARTED|Overall Study||15||
48519330|NCT00411398|101603755|FG000|COMPLETED|Overall Study||10||
48519331|NCT00411398|101603755|FG000|NOT COMPLETED|Overall Study||5||
48519332|NCT03351231|101603756|FG000|STARTED|Combination Therapy Period||5||
48519333|NCT03351231|101603756|FG000|COMPLETED|Combination Therapy Period||0||
48519334|NCT03351231|101603756|FG000|NOT COMPLETED|Combination Therapy Period||5||
48519335|NCT03351231|101603756|FG000|STARTED|Safety Follow-Up Period||3||
48519336|NCT03351231|101603756|FG000|COMPLETED|Safety Follow-Up Period||0||
48519337|NCT03351231|101603756|FG000|NOT COMPLETED|Safety Follow-Up Period||3||
48519338|NCT05918822|101603757|FG000|STARTED|Treatment Period 1 (Part 1 and 2: 1 Day)||3||
48519339|NCT05918822|101603758|FG001|STARTED|Treatment Period 1 (Part 1 and 2: 1 Day)||3||
48519340|NCT05918822|101603759|FG002|STARTED|Treatment Period 1 (Part 1 and 2: 1 Day)||3||
48519341|NCT05918822|101603760|FG003|STARTED|Treatment Period 1 (Part 1 and 2: 1 Day)||3||
48519342|NCT05918822|101603761|FG004|STARTED|Treatment Period 1 (Part 1 and 2: 1 Day)||3||
48519343|NCT05918822|101603762|FG005|STARTED|Treatment Period 1 (Part 1 and 2: 1 Day)||3||
48519344|NCT05918822|101603763|FG006|STARTED|Treatment Period 1 (Part 1 and 2: 1 Day)||14||
48519345|NCT05918822|101603757|FG000|COMPLETED|Treatment Period 1 (Part 1 and 2: 1 Day)||3||
48519346|NCT05918822|101603758|FG001|COMPLETED|Treatment Period 1 (Part 1 and 2: 1 Day)||3||
48519347|NCT05918822|101603759|FG002|COMPLETED|Treatment Period 1 (Part 1 and 2: 1 Day)||3||
48519348|NCT05918822|101603760|FG003|COMPLETED|Treatment Period 1 (Part 1 and 2: 1 Day)||3||
48519349|NCT05918822|101603761|FG004|COMPLETED|Treatment Period 1 (Part 1 and 2: 1 Day)||3||
48519350|NCT05918822|101603762|FG005|COMPLETED|Treatment Period 1 (Part 1 and 2: 1 Day)||3||
48519351|NCT05918822|101603763|FG006|COMPLETED|Treatment Period 1 (Part 1 and 2: 1 Day)||14||
48519352|NCT05918822|101603757|FG000|NOT COMPLETED|Treatment Period 1 (Part 1 and 2: 1 Day)||0||
48519353|NCT05918822|101603758|FG001|NOT COMPLETED|Treatment Period 1 (Part 1 and 2: 1 Day)||0||
48519354|NCT05918822|101603759|FG002|NOT COMPLETED|Treatment Period 1 (Part 1 and 2: 1 Day)||0||
48519355|NCT05918822|101603760|FG003|NOT COMPLETED|Treatment Period 1 (Part 1 and 2: 1 Day)||0||
48519356|NCT05918822|101603761|FG004|NOT COMPLETED|Treatment Period 1 (Part 1 and 2: 1 Day)||0||
48519357|NCT05918822|101603762|FG005|NOT COMPLETED|Treatment Period 1 (Part 1 and 2: 1 Day)||0||
48666840|NCT05126303|101970477|FG001|NOT COMPLETED|Overall Study||0||
48519358|NCT05918822|101603763|FG006|NOT COMPLETED|Treatment Period 1 (Part 1 and 2: 1 Day)||0||
48519359|NCT05918822|101603757|FG000|STARTED|Washout Period 1 (Part 1 and 2: 3 Days)||3||
48519360|NCT05918822|101603758|FG001|STARTED|Washout Period 1 (Part 1 and 2: 3 Days)||3||
48519361|NCT05918822|101603759|FG002|STARTED|Washout Period 1 (Part 1 and 2: 3 Days)||3||
48519362|NCT05918822|101603760|FG003|STARTED|Washout Period 1 (Part 1 and 2: 3 Days)||3||
48519363|NCT05918822|101603761|FG004|STARTED|Washout Period 1 (Part 1 and 2: 3 Days)||3||
48519364|NCT05918822|101603762|FG005|STARTED|Washout Period 1 (Part 1 and 2: 3 Days)||3||
48519365|NCT05918822|101603763|FG006|STARTED|Washout Period 1 (Part 1 and 2: 3 Days)||14||
48519366|NCT05918822|101603757|FG000|COMPLETED|Washout Period 1 (Part 1 and 2: 3 Days)||3||
48519367|NCT05918822|101603758|FG001|COMPLETED|Washout Period 1 (Part 1 and 2: 3 Days)||3||
48519368|NCT05918822|101603759|FG002|COMPLETED|Washout Period 1 (Part 1 and 2: 3 Days)||3||
48519369|NCT05918822|101603760|FG003|COMPLETED|Washout Period 1 (Part 1 and 2: 3 Days)||3||
48519370|NCT05918822|101603761|FG004|COMPLETED|Washout Period 1 (Part 1 and 2: 3 Days)||3||
48519371|NCT05918822|101603762|FG005|COMPLETED|Washout Period 1 (Part 1 and 2: 3 Days)||3||
48519372|NCT05918822|101603763|FG006|COMPLETED|Washout Period 1 (Part 1 and 2: 3 Days)||14||
48519373|NCT05918822|101603757|FG000|NOT COMPLETED|Washout Period 1 (Part 1 and 2: 3 Days)||0||
48519374|NCT05918822|101603758|FG001|NOT COMPLETED|Washout Period 1 (Part 1 and 2: 3 Days)||0||
48519375|NCT05918822|101603759|FG002|NOT COMPLETED|Washout Period 1 (Part 1 and 2: 3 Days)||0||
48519376|NCT05918822|101603760|FG003|NOT COMPLETED|Washout Period 1 (Part 1 and 2: 3 Days)||0||
48519377|NCT05918822|101603761|FG004|NOT COMPLETED|Washout Period 1 (Part 1 and 2: 3 Days)||0||
48519378|NCT05918822|101603762|FG005|NOT COMPLETED|Washout Period 1 (Part 1 and 2: 3 Days)||0||
48519379|NCT05918822|101603763|FG006|NOT COMPLETED|Washout Period 1 (Part 1 and 2: 3 Days)||0||
48519380|NCT05918822|101603757|FG000|STARTED|Treatment Period2Part1:1Day;Part2:Day1-5||3||
48519381|NCT05918822|101603758|FG001|STARTED|Treatment Period2Part1:1Day;Part2:Day1-5||3||
48519382|NCT05918822|101603759|FG002|STARTED|Treatment Period2Part1:1Day;Part2:Day1-5||3||
48519383|NCT05918822|101603760|FG003|STARTED|Treatment Period2Part1:1Day;Part2:Day1-5||3||
48519384|NCT05918822|101603761|FG004|STARTED|Treatment Period2Part1:1Day;Part2:Day1-5||3||
48519385|NCT05918822|101603762|FG005|STARTED|Treatment Period2Part1:1Day;Part2:Day1-5||3||
48519386|NCT05918822|101603763|FG006|STARTED|Treatment Period2Part1:1Day;Part2:Day1-5||14||
48519387|NCT05918822|101603757|FG000|COMPLETED|Treatment Period2Part1:1Day;Part2:Day1-5||3||
48519388|NCT05918822|101603758|FG001|COMPLETED|Treatment Period2Part1:1Day;Part2:Day1-5||3||
48519389|NCT05918822|101603759|FG002|COMPLETED|Treatment Period2Part1:1Day;Part2:Day1-5||3||
48519390|NCT05918822|101603760|FG003|COMPLETED|Treatment Period2Part1:1Day;Part2:Day1-5||3||
48519391|NCT05918822|101603761|FG004|COMPLETED|Treatment Period2Part1:1Day;Part2:Day1-5||3||
48519392|NCT05918822|101603762|FG005|COMPLETED|Treatment Period2Part1:1Day;Part2:Day1-5||3||
48519393|NCT05918822|101603763|FG006|COMPLETED|Treatment Period2Part1:1Day;Part2:Day1-5||14||
48519394|NCT05918822|101603757|FG000|NOT COMPLETED|Treatment Period2Part1:1Day;Part2:Day1-5||0||
48519395|NCT05918822|101603758|FG001|NOT COMPLETED|Treatment Period2Part1:1Day;Part2:Day1-5||0||
48519396|NCT05918822|101603759|FG002|NOT COMPLETED|Treatment Period2Part1:1Day;Part2:Day1-5||0||
48519397|NCT05918822|101603760|FG003|NOT COMPLETED|Treatment Period2Part1:1Day;Part2:Day1-5||0||
48519398|NCT05918822|101603761|FG004|NOT COMPLETED|Treatment Period2Part1:1Day;Part2:Day1-5||0||
48519399|NCT05918822|101603762|FG005|NOT COMPLETED|Treatment Period2Part1:1Day;Part2:Day1-5||0||
48519400|NCT05918822|101603763|FG006|NOT COMPLETED|Treatment Period2Part1:1Day;Part2:Day1-5||0||
48519401|NCT05918822|101603757|FG000|STARTED|Washout Period 2 (Part 1 Only: 3 Days)||3||
48519402|NCT05918822|101603758|FG001|STARTED|Washout Period 2 (Part 1 Only: 3 Days)||3||
48519403|NCT05918822|101603759|FG002|STARTED|Washout Period 2 (Part 1 Only: 3 Days)||3||
48519404|NCT05918822|101603760|FG003|STARTED|Washout Period 2 (Part 1 Only: 3 Days)||3||
48519405|NCT05918822|101603761|FG004|STARTED|Washout Period 2 (Part 1 Only: 3 Days)||3||
48519406|NCT05918822|101603762|FG005|STARTED|Washout Period 2 (Part 1 Only: 3 Days)||3||
48519407|NCT05918822|101603763|FG006|STARTED|Washout Period 2 (Part 1 Only: 3 Days)||0||
48519408|NCT05918822|101603757|FG000|COMPLETED|Washout Period 2 (Part 1 Only: 3 Days)||3||
48519409|NCT05918822|101603758|FG001|COMPLETED|Washout Period 2 (Part 1 Only: 3 Days)||3||
48519410|NCT05918822|101603759|FG002|COMPLETED|Washout Period 2 (Part 1 Only: 3 Days)||3||
48519411|NCT05918822|101603760|FG003|COMPLETED|Washout Period 2 (Part 1 Only: 3 Days)||3||
48519412|NCT05918822|101603761|FG004|COMPLETED|Washout Period 2 (Part 1 Only: 3 Days)||3||
48519413|NCT05918822|101603762|FG005|COMPLETED|Washout Period 2 (Part 1 Only: 3 Days)||3||
48519414|NCT05918822|101603763|FG006|COMPLETED|Washout Period 2 (Part 1 Only: 3 Days)||0||
48519415|NCT05918822|101603757|FG000|NOT COMPLETED|Washout Period 2 (Part 1 Only: 3 Days)||0||
48519416|NCT05918822|101603758|FG001|NOT COMPLETED|Washout Period 2 (Part 1 Only: 3 Days)||0||
48519417|NCT05918822|101603759|FG002|NOT COMPLETED|Washout Period 2 (Part 1 Only: 3 Days)||0||
48519418|NCT05918822|101603760|FG003|NOT COMPLETED|Washout Period 2 (Part 1 Only: 3 Days)||0||
48519419|NCT05918822|101603761|FG004|NOT COMPLETED|Washout Period 2 (Part 1 Only: 3 Days)||0||
48519420|NCT05918822|101603762|FG005|NOT COMPLETED|Washout Period 2 (Part 1 Only: 3 Days)||0||
48519421|NCT05918822|101603763|FG006|NOT COMPLETED|Washout Period 2 (Part 1 Only: 3 Days)||0||
48519422|NCT05918822|101603757|FG000|STARTED|Treatment Period 3 (Part 1 Only: 1 Day)||3||
48519423|NCT05918822|101603758|FG001|STARTED|Treatment Period 3 (Part 1 Only: 1 Day)||3||
48519424|NCT05918822|101603759|FG002|STARTED|Treatment Period 3 (Part 1 Only: 1 Day)||3||
48519425|NCT05918822|101603760|FG003|STARTED|Treatment Period 3 (Part 1 Only: 1 Day)||3||
48519426|NCT05918822|101603761|FG004|STARTED|Treatment Period 3 (Part 1 Only: 1 Day)||3||
48519427|NCT05918822|101603762|FG005|STARTED|Treatment Period 3 (Part 1 Only: 1 Day)||3||
48519428|NCT05918822|101603763|FG006|STARTED|Treatment Period 3 (Part 1 Only: 1 Day)||0||
48519429|NCT05918822|101603757|FG000|COMPLETED|Treatment Period 3 (Part 1 Only: 1 Day)||3||
48519430|NCT05918822|101603758|FG001|COMPLETED|Treatment Period 3 (Part 1 Only: 1 Day)||3||
48519431|NCT05918822|101603759|FG002|COMPLETED|Treatment Period 3 (Part 1 Only: 1 Day)||3||
48519432|NCT05918822|101603760|FG003|COMPLETED|Treatment Period 3 (Part 1 Only: 1 Day)||3||
48519433|NCT05918822|101603761|FG004|COMPLETED|Treatment Period 3 (Part 1 Only: 1 Day)||3||
48519434|NCT05918822|101603762|FG005|COMPLETED|Treatment Period 3 (Part 1 Only: 1 Day)||3||
48519435|NCT05918822|101603763|FG006|COMPLETED|Treatment Period 3 (Part 1 Only: 1 Day)||0||
48519436|NCT05918822|101603757|FG000|NOT COMPLETED|Treatment Period 3 (Part 1 Only: 1 Day)||0||
48519437|NCT05918822|101603758|FG001|NOT COMPLETED|Treatment Period 3 (Part 1 Only: 1 Day)||0||
48519438|NCT05918822|101603759|FG002|NOT COMPLETED|Treatment Period 3 (Part 1 Only: 1 Day)||0||
48519439|NCT05918822|101603760|FG003|NOT COMPLETED|Treatment Period 3 (Part 1 Only: 1 Day)||0||
48519440|NCT05918822|101603761|FG004|NOT COMPLETED|Treatment Period 3 (Part 1 Only: 1 Day)||0||
48519441|NCT05918822|101603762|FG005|NOT COMPLETED|Treatment Period 3 (Part 1 Only: 1 Day)||0||
48519442|NCT05918822|101603763|FG006|NOT COMPLETED|Treatment Period 3 (Part 1 Only: 1 Day)||0||
48519443|NCT03585959|101603764|FG000|STARTED|Overall Study||50||
48519444|NCT03585959|101603764|FG000|COMPLETED|Overall Study||47||
48519445|NCT03585959|101603764|FG000|NOT COMPLETED|Overall Study||3||
48519446|NCT00724373|101603765|FG000|STARTED|Overall Study||442||
48519447|NCT00724373|101603765|FG000|COMPLETED|Overall Study||271||
48519448|NCT00724373|101603765|FG000|NOT COMPLETED|Overall Study||171||
48519449|NCT01005329|101603766|FG000|STARTED|Overall Study||34||
48519450|NCT01005329|101603766|FG000|COMPLETED|Overall Study||30||
48519451|NCT01005329|101603766|FG000|NOT COMPLETED|Overall Study||4||
48519452|NCT01020799|101603767|FG000|STARTED|Overall Study||98||
48519453|NCT01020799|101603768|FG001|STARTED|Overall Study||99||
48519454|NCT01020799|101603769|FG002|STARTED|Overall Study||50||
48519455|NCT01020799|101603767|FG000|Patients Received Treatment|Overall Study||96||
48519456|NCT01020799|101603768|FG001|Patients Received Treatment|Overall Study||99||
48519457|NCT01020799|101603769|FG002|Patients Received Treatment|Overall Study||50||
48519458|NCT01020799|101603767|FG000|Full Analysis Set|Overall Study||91||
48519459|NCT01020799|101603768|FG001|Full Analysis Set|Overall Study||94||
48519460|NCT01020799|101603769|FG002|Full Analysis Set|Overall Study||49||
48519461|NCT01020799|101603767|FG000|COMPLETED|Overall Study||79||
48519462|NCT01020799|101603768|FG001|COMPLETED|Overall Study||85||
48519463|NCT01020799|101603769|FG002|COMPLETED|Overall Study||43||
48519464|NCT01020799|101603767|FG000|NOT COMPLETED|Overall Study||19||
48519465|NCT01020799|101603768|FG001|NOT COMPLETED|Overall Study||14||
48519466|NCT01020799|101603769|FG002|NOT COMPLETED|Overall Study||7||
48519467|NCT02694549|101603770|FG000|STARTED|Overall Study||12||
48519468|NCT02694549|101603770|FG000|COMPLETED|Overall Study||10||
48519469|NCT02694549|101603770|FG000|NOT COMPLETED|Overall Study||2||
48519470|NCT02747004|101603771|FG000|STARTED|Overall Study||78||
48519471|NCT02747004|101603772|FG001|STARTED|Overall Study||79||
48519472|NCT02747004|101603773|FG002|STARTED|Overall Study||77||
48519473|NCT02747004|101603771|FG000|Received at Least One Dose of Study Drug|Overall Study||78||
48519474|NCT02747004|101603772|FG001|Received at Least One Dose of Study Drug|Overall Study||79||
48519475|NCT02747004|101603773|FG002|Received at Least One Dose of Study Drug|Overall Study||77||
48519476|NCT02747004|101603771|FG000|COMPLETED|Overall Study||21||
48519477|NCT02747004|101603772|FG001|COMPLETED|Overall Study||30||
48519478|NCT02747004|101603773|FG002|COMPLETED|Overall Study||30||
48519479|NCT02747004|101603771|FG000|NOT COMPLETED|Overall Study||57||
48519480|NCT02747004|101603772|FG001|NOT COMPLETED|Overall Study||49||
48519481|NCT02747004|101603773|FG002|NOT COMPLETED|Overall Study||47||
48519482|NCT01980342|101603774|FG000|STARTED|Overall Study||1||
48519483|NCT01980342|101603774|FG000|COMPLETED|Overall Study||0||
48519484|NCT01980342|101603774|FG000|NOT COMPLETED|Overall Study||1||
48519485|NCT03710590|101603775|FG000|STARTED|Overall Study||22||
48519486|NCT03710590|101603776|FG001|STARTED|Overall Study||23||
48519487|NCT03710590|101603775|FG000|Session 1: ECIG Lab Session 15 Watts, 10 mg Nicotine|Overall Study||12||
48519488|NCT03710590|101603776|FG001|Session 1: ECIG Lab Session 15 Watts, 10 mg Nicotine|Overall Study||15||
48519489|NCT03710590|101603775|FG000|Session 2: ECIG Lab Session 15 Watts, 15 mg Nicotine|Overall Study||12||
48519490|NCT03710590|101603776|FG001|Session 2: ECIG Lab Session 15 Watts, 15 mg Nicotine|Overall Study||15||
48519491|NCT03710590|101603775|FG000|Session 3: ECIG Lab Session 15 Watts, 30 mg Nicotine|Overall Study||12||
48519492|NCT03710590|101603776|FG001|Session 3: ECIG Lab Session 15 Watts, 30 mg Nicotine|Overall Study||15||
48519493|NCT03710590|101603775|FG000|Session 4: ECIG Lab Session 30 Watts, 10 mg Nicotine|Overall Study||12||
48519494|NCT03710590|101603776|FG001|Session 4: ECIG Lab Session 30 Watts, 10 mg Nicotine|Overall Study||15||
48519495|NCT03710590|101603775|FG000|Session 5: ECIG Lab Session 30 Watts, 15 mg Nicotine|Overall Study||12||
48519496|NCT03710590|101603776|FG001|Session 5: ECIG Lab Session 30 Watts, 15 mg Nicotine|Overall Study||15||
48519497|NCT03710590|101603775|FG000|Session 6: ECIG Lab Session 30 Watts, 30 mg Nicotine|Overall Study||12||
48519498|NCT03710590|101603776|FG001|Session 6: ECIG Lab Session 30 Watts, 30 mg Nicotine|Overall Study||15||
48519499|NCT03710590|101603775|FG000|COMPLETED|Overall Study||12||
48519500|NCT03710590|101603776|FG001|COMPLETED|Overall Study||15||
48519501|NCT03710590|101603775|FG000|NOT COMPLETED|Overall Study||10||
48519502|NCT03710590|101603776|FG001|NOT COMPLETED|Overall Study||8||
48519503|NCT00606502|101603777|FG000|STARTED|Randomization||100||
48519504|NCT00606502|101603778|FG001|STARTED|Randomization||101||
48519505|NCT00606502|101603777|FG000|COMPLETED|Randomization||97||
48519506|NCT00606502|101603778|FG001|COMPLETED|Randomization||101||
48519507|NCT00606502|101603777|FG000|NOT COMPLETED|Randomization||3||
48519508|NCT00606502|101603778|FG001|NOT COMPLETED|Randomization||0||
48519509|NCT00606502|101603777|FG000|STARTED|Treatment||97||
48519510|NCT00606502|101603778|FG001|STARTED|Treatment||101||
48519511|NCT00606502|101603777|FG000|COMPLETED|Treatment||97||
48519512|NCT00606502|101603778|FG001|COMPLETED|Treatment||98||
48519513|NCT00606502|101603777|FG000|NOT COMPLETED|Treatment||0||
48519514|NCT00606502|101603778|FG001|NOT COMPLETED|Treatment||3||
48519515|NCT00986453|101603779|FG000|STARTED|Overall Study||45||
48519516|NCT00986453|101603779|FG000|COMPLETED|Overall Study||43||
48519517|NCT00986453|101603779|FG000|NOT COMPLETED|Overall Study||2||
48519518|NCT01189500|101603780|FG000|STARTED|Period 1: TAMOX Alone||30||
48519519|NCT01189500|101603780|FG000|COMPLETED|Period 1: TAMOX Alone||29||
48519520|NCT01189500|101603780|FG000|NOT COMPLETED|Period 1: TAMOX Alone||1||
48519521|NCT01189500|101603780|FG000|STARTED|Period 2: Coadministration TAMOX+DVS SR||29||
48519522|NCT01189500|101603780|FG000|COMPLETED|Period 2: Coadministration TAMOX+DVS SR||28||
48519523|NCT01189500|101603780|FG000|NOT COMPLETED|Period 2: Coadministration TAMOX+DVS SR||1||
48519524|NCT03180801|101603781|FG000|STARTED|Overall Study||50||
48519525|NCT03180801|101603782|FG001|STARTED|Overall Study||52||
48519526|NCT03180801|101603783|FG002|STARTED|Overall Study||51||
48519527|NCT03180801|101603781|FG000|Safety Population|Overall Study||50|The safety population included all vaccinated subjects|
48519528|NCT03180801|101603782|FG001|Safety Population|Overall Study||52|The safety population included all vaccinated subjects|
48519529|NCT03180801|101603783|FG002|Safety Population|Overall Study||51|The safety population included all vaccinated subjects|
48519530|NCT03180801|101603781|FG000|Intention to Treat|Overall Study||42|ITT included all vaccinated and inoculated subjects|
48519531|NCT03180801|101603782|FG001|Intention to Treat|Overall Study||40|ITT included all vaccinated and inoculated subjects|
48519532|NCT03180801|101603783|FG002|Intention to Treat|Overall Study||41|ITT included all vaccinated and inoculated subjects|
48519533|NCT03180801|101603781|FG000|COMPLETED|Overall Study||42||
48519534|NCT03180801|101603782|FG001|COMPLETED|Overall Study||40||
48519535|NCT03180801|101603783|FG002|COMPLETED|Overall Study||41||
48519536|NCT03180801|101603781|FG000|NOT COMPLETED|Overall Study||8||
48519537|NCT03180801|101603782|FG001|NOT COMPLETED|Overall Study||12||
48519538|NCT03180801|101603783|FG002|NOT COMPLETED|Overall Study||10||
48519539|NCT00619359|101603784|FG000|STARTED|Overall Study||1147||
48519540|NCT00619359|101603785|FG001|STARTED|Overall Study||1175||
48519541|NCT00619359|101603784|FG000|COMPLETED|Overall Study||1080||
48519542|NCT00619359|101603785|FG001|COMPLETED|Overall Study||1094||
48519543|NCT00619359|101603784|FG000|NOT COMPLETED|Overall Study||67||
48519544|NCT00619359|101603785|FG001|NOT COMPLETED|Overall Study||81||
48519545|NCT04740931|101603786|FG000|STARTED|Part 1 (Baseline up to Week 24)||366|Intent-to-Treat (ITT) Population|
48519546|NCT04740931|101603787|FG001|STARTED|Part 1 (Baseline up to Week 24)||363|Intent-to-Treat (ITT) Population|
48519547|NCT04740931|101603786|FG000|Received at Least One Dose of Study Drug|Part 1 (Baseline up to Week 24)||365|Safety-Evaluable Population|
48519548|NCT04740931|101603787|FG001|Received at Least One Dose of Study Drug|Part 1 (Baseline up to Week 24)||361|Safety-Evaluable Population|
48519549|NCT04740931|101603786|FG000|COMPLETED|Part 1 (Baseline up to Week 24)||360|Completed Part 1|
48519550|NCT04740931|101603787|FG001|COMPLETED|Part 1 (Baseline up to Week 24)||353|Completed Part 1|
48519551|NCT04740931|101603786|FG000|NOT COMPLETED|Part 1 (Baseline up to Week 24)||6||
48519552|NCT04740931|101603787|FG001|NOT COMPLETED|Part 1 (Baseline up to Week 24)||10||
48519553|NCT04740931|101603786|FG000|STARTED|Part 2 (Week 24 to Week 72)||360||
48519554|NCT04740931|101603787|FG001|STARTED|Part 2 (Week 24 to Week 72)||353||
48519555|NCT04740931|101603786|FG000|COMPLETED|Part 2 (Week 24 to Week 72)||333||
48519556|NCT04740931|101603787|FG001|COMPLETED|Part 2 (Week 24 to Week 72)||323||
48519557|NCT04740931|101603786|FG000|NOT COMPLETED|Part 2 (Week 24 to Week 72)||27||
48519558|NCT04740931|101603787|FG001|NOT COMPLETED|Part 2 (Week 24 to Week 72)||30||
48519559|NCT01376310|101603788|FG000|STARTED|Overall Study||126||
48519560|NCT01376310|101603789|FG001|STARTED|Overall Study||33||
48519561|NCT01376310|101603788|FG000|COMPLETED|Overall Study||90||
48519562|NCT01376310|101603789|FG001|COMPLETED|Overall Study||22||
48519563|NCT01376310|101603788|FG000|NOT COMPLETED|Overall Study||36||
48519564|NCT01376310|101603789|FG001|NOT COMPLETED|Overall Study||11||
48519565|NCT03707041|101603790|FG000|STARTED|Overall Study||6||
48519566|NCT03707041|101603791|FG001|STARTED|Overall Study||2||
48519567|NCT03707041|101603792|FG002|STARTED|Overall Study||9||
48519568|NCT03707041|101603793|FG003|STARTED|Overall Study||3||
48519569|NCT03707041|101603794|FG004|STARTED|Overall Study||9||
48519570|NCT03707041|101603795|FG005|STARTED|Overall Study||3||
48519571|NCT03707041|101603790|FG000|COMPLETED|Overall Study||6||
48519572|NCT03707041|101603791|FG001|COMPLETED|Overall Study||2||
48519573|NCT03707041|101603792|FG002|COMPLETED|Overall Study||9||
48519574|NCT03707041|101603793|FG003|COMPLETED|Overall Study||3||
48519575|NCT03707041|101603794|FG004|COMPLETED|Overall Study||9||
48519576|NCT03707041|101603795|FG005|COMPLETED|Overall Study||3||
48519577|NCT03707041|101603790|FG000|NOT COMPLETED|Overall Study||0||
48519578|NCT03707041|101603791|FG001|NOT COMPLETED|Overall Study||0||
48519579|NCT03707041|101603792|FG002|NOT COMPLETED|Overall Study||0||
48519580|NCT03707041|101603793|FG003|NOT COMPLETED|Overall Study||0||
48519581|NCT03707041|101603794|FG004|NOT COMPLETED|Overall Study||0||
48519582|NCT03707041|101603795|FG005|NOT COMPLETED|Overall Study||0||
48519583|NCT02083926|101603796|FG000|STARTED|Overall Study||9||
48519584|NCT02083926|101603797|FG001|STARTED|Overall Study||9||
48519585|NCT02083926|101603796|FG000|COMPLETED|Overall Study||8||
48519586|NCT02083926|101603797|FG001|COMPLETED|Overall Study||9||
48519587|NCT02083926|101603796|FG000|NOT COMPLETED|Overall Study||1||
48519588|NCT02083926|101603797|FG001|NOT COMPLETED|Overall Study||0||
48519589|NCT02211014|101603798|FG000|STARTED|Overall Study||13||
48519590|NCT02211014|101603799|FG001|STARTED|Overall Study||14||
48519591|NCT02211014|101603798|FG000|COMPLETED|Overall Study||11||
48519592|NCT02211014|101603799|FG001|COMPLETED|Overall Study||8||
48519593|NCT02211014|101603798|FG000|NOT COMPLETED|Overall Study||2||
48519594|NCT02211014|101603799|FG001|NOT COMPLETED|Overall Study||6||
48519595|NCT00573170|101603800|FG000|STARTED|First Treatment Period||64||
48519596|NCT00573170|101603801|FG001|STARTED|First Treatment Period||60||
48519597|NCT00573170|101603802|FG002|STARTED|First Treatment Period||60||
48519598|NCT00573170|101603803|FG003|STARTED|First Treatment Period||66||
48519599|NCT00573170|101603804|FG004|STARTED|First Treatment Period||63||
48519600|NCT00573170|101603805|FG005|STARTED|First Treatment Period||62||
48519601|NCT00573170|101603800|FG000|COMPLETED|First Treatment Period||64||
48519602|NCT00573170|101603801|FG001|COMPLETED|First Treatment Period||60||
48519603|NCT00573170|101603802|FG002|COMPLETED|First Treatment Period||60||
48519604|NCT00573170|101603803|FG003|COMPLETED|First Treatment Period||66||
48519605|NCT00573170|101603804|FG004|COMPLETED|First Treatment Period||62||
48519606|NCT00573170|101603805|FG005|COMPLETED|First Treatment Period||62||
48519607|NCT00573170|101603800|FG000|NOT COMPLETED|First Treatment Period||0||
48519608|NCT00573170|101603801|FG001|NOT COMPLETED|First Treatment Period||0||
48519609|NCT00573170|101603802|FG002|NOT COMPLETED|First Treatment Period||0||
48519610|NCT00573170|101603803|FG003|NOT COMPLETED|First Treatment Period||0||
48519611|NCT00573170|101603804|FG004|NOT COMPLETED|First Treatment Period||1||
48519612|NCT00573170|101603805|FG005|NOT COMPLETED|First Treatment Period||0||
48519613|NCT00573170|101603800|FG000|STARTED|First Washout Period||64||
48519614|NCT00573170|101603801|FG001|STARTED|First Washout Period||60||
48519615|NCT00573170|101603802|FG002|STARTED|First Washout Period||60||
48519616|NCT00573170|101603803|FG003|STARTED|First Washout Period||66||
48519617|NCT00573170|101603804|FG004|STARTED|First Washout Period||62||
48519618|NCT00573170|101603805|FG005|STARTED|First Washout Period||62||
48519619|NCT00573170|101603800|FG000|COMPLETED|First Washout Period||56||
48519620|NCT00573170|101603801|FG001|COMPLETED|First Washout Period||58||
48519621|NCT00573170|101603802|FG002|COMPLETED|First Washout Period||59||
48519622|NCT00573170|101603803|FG003|COMPLETED|First Washout Period||61||
48519623|NCT00573170|101603804|FG004|COMPLETED|First Washout Period||59||
48519624|NCT00573170|101603805|FG005|COMPLETED|First Washout Period||55||
48519625|NCT00573170|101603800|FG000|NOT COMPLETED|First Washout Period||8||
48519626|NCT00573170|101603801|FG001|NOT COMPLETED|First Washout Period||2||
48519627|NCT00573170|101603802|FG002|NOT COMPLETED|First Washout Period||1||
48519628|NCT00573170|101603803|FG003|NOT COMPLETED|First Washout Period||5||
48519629|NCT00573170|101603804|FG004|NOT COMPLETED|First Washout Period||3||
48519630|NCT00573170|101603805|FG005|NOT COMPLETED|First Washout Period||7||
48519631|NCT00573170|101603800|FG000|STARTED|Second Treatment Period||56||
48519632|NCT00573170|101603801|FG001|STARTED|Second Treatment Period||58||
48519633|NCT00573170|101603802|FG002|STARTED|Second Treatment Period||59||
48519634|NCT00573170|101603803|FG003|STARTED|Second Treatment Period||61||
48519635|NCT00573170|101603804|FG004|STARTED|Second Treatment Period||59||
48519636|NCT00573170|101603805|FG005|STARTED|Second Treatment Period||55||
48519637|NCT00573170|101603800|FG000|COMPLETED|Second Treatment Period||56||
48519638|NCT00573170|101603801|FG001|COMPLETED|Second Treatment Period||58||
48519639|NCT00573170|101603802|FG002|COMPLETED|Second Treatment Period||59||
48519640|NCT00573170|101603803|FG003|COMPLETED|Second Treatment Period||61||
48519641|NCT00573170|101603804|FG004|COMPLETED|Second Treatment Period||59||
48519642|NCT00573170|101603805|FG005|COMPLETED|Second Treatment Period||55||
48519643|NCT00573170|101603800|FG000|NOT COMPLETED|Second Treatment Period||0||
48519644|NCT00573170|101603801|FG001|NOT COMPLETED|Second Treatment Period||0||
48519645|NCT00573170|101603802|FG002|NOT COMPLETED|Second Treatment Period||0||
48519646|NCT00573170|101603803|FG003|NOT COMPLETED|Second Treatment Period||0||
48519647|NCT00573170|101603804|FG004|NOT COMPLETED|Second Treatment Period||0||
48519648|NCT00573170|101603805|FG005|NOT COMPLETED|Second Treatment Period||0||
48519649|NCT00573170|101603800|FG000|STARTED|Second Washout Period||56||
48519650|NCT00573170|101603801|FG001|STARTED|Second Washout Period||58||
48519651|NCT00573170|101603802|FG002|STARTED|Second Washout Period||59||
48519652|NCT00573170|101603803|FG003|STARTED|Second Washout Period||61||
48519653|NCT00573170|101603804|FG004|STARTED|Second Washout Period||59||
48519654|NCT00573170|101603805|FG005|STARTED|Second Washout Period||55||
48519655|NCT00573170|101603800|FG000|COMPLETED|Second Washout Period||51||
48519656|NCT00573170|101603801|FG001|COMPLETED|Second Washout Period||54||
48519657|NCT00573170|101603802|FG002|COMPLETED|Second Washout Period||55||
48519658|NCT00573170|101603803|FG003|COMPLETED|Second Washout Period||56||
48519659|NCT00573170|101603804|FG004|COMPLETED|Second Washout Period||51||
48519660|NCT00573170|101603805|FG005|COMPLETED|Second Washout Period||53||
48519661|NCT00573170|101603800|FG000|NOT COMPLETED|Second Washout Period||5||
48519662|NCT00573170|101603801|FG001|NOT COMPLETED|Second Washout Period||4||
48519663|NCT00573170|101603802|FG002|NOT COMPLETED|Second Washout Period||4||
48519664|NCT00573170|101603803|FG003|NOT COMPLETED|Second Washout Period||5||
48519665|NCT00573170|101603804|FG004|NOT COMPLETED|Second Washout Period||8||
48519666|NCT00573170|101603805|FG005|NOT COMPLETED|Second Washout Period||2||
48519667|NCT00573170|101603800|FG000|STARTED|Third Treatment Period||51||
48519668|NCT00573170|101603801|FG001|STARTED|Third Treatment Period||54||
48519669|NCT00573170|101603802|FG002|STARTED|Third Treatment Period||55||
48519670|NCT00573170|101603803|FG003|STARTED|Third Treatment Period||56||
48519671|NCT00573170|101603804|FG004|STARTED|Third Treatment Period||51||
48519672|NCT00573170|101603805|FG005|STARTED|Third Treatment Period||53||
48519673|NCT00573170|101603800|FG000|COMPLETED|Third Treatment Period||50||
48519674|NCT00573170|101603801|FG001|COMPLETED|Third Treatment Period||54||
48519675|NCT00573170|101603802|FG002|COMPLETED|Third Treatment Period||55||
48519676|NCT00573170|101603803|FG003|COMPLETED|Third Treatment Period||56||
48519677|NCT00573170|101603804|FG004|COMPLETED|Third Treatment Period||51||
48519678|NCT00573170|101603805|FG005|COMPLETED|Third Treatment Period||51||
48519679|NCT00573170|101603800|FG000|NOT COMPLETED|Third Treatment Period||1||
48519680|NCT00573170|101603801|FG001|NOT COMPLETED|Third Treatment Period||0||
48519681|NCT00573170|101603802|FG002|NOT COMPLETED|Third Treatment Period||0||
48519682|NCT00573170|101603803|FG003|NOT COMPLETED|Third Treatment Period||0||
48519683|NCT00573170|101603804|FG004|NOT COMPLETED|Third Treatment Period||0||
48519684|NCT00573170|101603805|FG005|NOT COMPLETED|Third Treatment Period||2||
48519685|NCT01546649|101603806|FG000|STARTED|Overall Study||83||
48519686|NCT01546649|101603807|FG001|STARTED|Overall Study||84||
48519687|NCT01546649|101603806|FG000|COMPLETED|Overall Study||75||
48519688|NCT01546649|101603807|FG001|COMPLETED|Overall Study||75||
48519689|NCT01546649|101603806|FG000|NOT COMPLETED|Overall Study||8||
48519690|NCT01546649|101603807|FG001|NOT COMPLETED|Overall Study||9||
48519691|NCT04764630|101603808|FG000|STARTED|Overall Study||3||
48519692|NCT04764630|101603809|FG001|STARTED|Overall Study||4||
48519693|NCT04764630|101603810|FG002|STARTED|Overall Study||3||
48519694|NCT04764630|101603811|FG003|STARTED|Overall Study||4||
48519695|NCT04764630|101603812|FG004|STARTED|Overall Study||3||
48519696|NCT04764630|101603813|FG005|STARTED|Overall Study||4||
48519697|NCT04764630|101603808|FG000|COMPLETED|Overall Study||3||
48519698|NCT04764630|101603809|FG001|COMPLETED|Overall Study||3||
48519699|NCT04764630|101603810|FG002|COMPLETED|Overall Study||3||
48519700|NCT04764630|101603811|FG003|COMPLETED|Overall Study||3||
48519701|NCT04764630|101603812|FG004|COMPLETED|Overall Study||3||
48519702|NCT04764630|101603813|FG005|COMPLETED|Overall Study||3||
48519703|NCT04764630|101603808|FG000|NOT COMPLETED|Overall Study||0||
48519704|NCT04764630|101603809|FG001|NOT COMPLETED|Overall Study||1||
48519705|NCT04764630|101603810|FG002|NOT COMPLETED|Overall Study||0||
48519706|NCT04764630|101603811|FG003|NOT COMPLETED|Overall Study||1||
48519707|NCT04764630|101603812|FG004|NOT COMPLETED|Overall Study||0||
48519708|NCT04764630|101603813|FG005|NOT COMPLETED|Overall Study||1||
48519709|NCT02384850|101603814|FG000|STARTED|Overall Study||4||
48519710|NCT02384850|101603815|FG001|STARTED|Overall Study||6||
48519711|NCT02384850|101603814|FG000|COMPLETED|Overall Study||2||
48519712|NCT02384850|101603815|FG001|COMPLETED|Overall Study||4||
48519713|NCT02384850|101603814|FG000|NOT COMPLETED|Overall Study||2||
48519714|NCT02384850|101603815|FG001|NOT COMPLETED|Overall Study||2||
48519715|NCT01280617|101603816|FG000|STARTED|Overall Study||23||
48519716|NCT01280617|101603817|FG001|STARTED|Overall Study||21||
48519717|NCT01280617|101603816|FG000|COMPLETED|Overall Study||23||
48519718|NCT01280617|101603817|FG001|COMPLETED|Overall Study||20||
48519719|NCT01280617|101603816|FG000|NOT COMPLETED|Overall Study||0||
48519720|NCT01280617|101603817|FG001|NOT COMPLETED|Overall Study||1||
48519721|NCT03463993|101603818|FG000|STARTED|Overall Study||253||
48519722|NCT03463993|101603819|FG001|STARTED|Overall Study||253||
48519723|NCT03463993|101603818|FG000|COMPLETED|Overall Study||224||
48519724|NCT03463993|101603819|FG001|COMPLETED|Overall Study||227||
48519725|NCT03463993|101603818|FG000|NOT COMPLETED|Overall Study||29||
48519726|NCT03463993|101603819|FG001|NOT COMPLETED|Overall Study||26||
48519727|NCT00685802|101603820|FG000|STARTED|First Intervention||16||
48519728|NCT00685802|101603821|FG001|STARTED|First Intervention||16||
48519729|NCT00685802|101603820|FG000|COMPLETED|First Intervention||16||
48519730|NCT00685802|101603821|FG001|COMPLETED|First Intervention||16||
48519731|NCT00685802|101603820|FG000|NOT COMPLETED|First Intervention||0||
48519732|NCT00685802|101603821|FG001|NOT COMPLETED|First Intervention||0||
48519733|NCT00685802|101603820|FG000|STARTED|Washout Period of 7 Days||16||
48519734|NCT00685802|101603821|FG001|STARTED|Washout Period of 7 Days||16||
48519735|NCT00685802|101603820|FG000|COMPLETED|Washout Period of 7 Days||14||
48519736|NCT00685802|101603821|FG001|COMPLETED|Washout Period of 7 Days||15||
48519737|NCT00685802|101603820|FG000|NOT COMPLETED|Washout Period of 7 Days||2||
48519738|NCT00685802|101603821|FG001|NOT COMPLETED|Washout Period of 7 Days||1||
48519739|NCT00685802|101603820|FG000|STARTED|Second Intervention||14||
48519740|NCT00685802|101603821|FG001|STARTED|Second Intervention||15||
48519741|NCT00685802|101603820|FG000|COMPLETED|Second Intervention||14||
48519742|NCT00685802|101603821|FG001|COMPLETED|Second Intervention||15||
48519743|NCT00685802|101603820|FG000|NOT COMPLETED|Second Intervention||0||
48519744|NCT00685802|101603821|FG001|NOT COMPLETED|Second Intervention||0||
48519745|NCT03170388|101603822|FG000|STARTED|Overall Study||147||
48519746|NCT03170388|101603823|FG001|STARTED|Overall Study||150||
48519747|NCT03170388|101603824|FG002|STARTED|Overall Study||146||
48519748|NCT03170388|101603825|FG003|STARTED|Overall Study||150||
48519749|NCT03170388|101603826|FG004|STARTED|Overall Study||148||
48519750|NCT03170388|101603822|FG000|COMPLETED|Overall Study||125||
48519751|NCT03170388|101603823|FG001|COMPLETED|Overall Study||132||
48519752|NCT03170388|101603824|FG002|COMPLETED|Overall Study||133||
48519753|NCT03170388|101603825|FG003|COMPLETED|Overall Study||132||
48519754|NCT03170388|101603826|FG004|COMPLETED|Overall Study||127||
48519755|NCT03170388|101603822|FG000|NOT COMPLETED|Overall Study||22||
48519756|NCT03170388|101603823|FG001|NOT COMPLETED|Overall Study||18||
48519757|NCT03170388|101603824|FG002|NOT COMPLETED|Overall Study||13||
48519758|NCT03170388|101603825|FG003|NOT COMPLETED|Overall Study||18||
48519759|NCT03170388|101603826|FG004|NOT COMPLETED|Overall Study||21||
48519760|NCT00977548|101603827|FG000|STARTED|Overall Study||39||
48519761|NCT00977548|101603827|FG000|COMPLETED|Overall Study||26||
48519762|NCT00977548|101603827|FG000|NOT COMPLETED|Overall Study||13||
48519763|NCT01131299|101603828|FG000|STARTED|Overall Study||42||
48519764|NCT01131299|101603829|FG001|STARTED|Overall Study||44||
48519765|NCT01131299|101603828|FG000|COMPLETED|Overall Study||38||
48519766|NCT01131299|101603829|FG001|COMPLETED|Overall Study||37||
48519767|NCT01131299|101603828|FG000|NOT COMPLETED|Overall Study||4||
48519768|NCT01131299|101603829|FG001|NOT COMPLETED|Overall Study||7||
48519769|NCT02610816|101603830|FG000|STARTED|Phase 1||38||
48519770|NCT02610816|101603831|FG001|STARTED|Phase 1||25||
48519771|NCT02610816|101603832|FG002|STARTED|Phase 1||0||
48519772|NCT02610816|101603833|FG003|STARTED|Phase 1||0||
48519773|NCT02610816|101603830|FG000|COMPLETED|Phase 1||34||
48519774|NCT02610816|101603831|FG001|COMPLETED|Phase 1||17||
48519775|NCT02610816|101603832|FG002|COMPLETED|Phase 1||0||
48519776|NCT02610816|101603833|FG003|COMPLETED|Phase 1||0||
48519777|NCT02610816|101603830|FG000|NOT COMPLETED|Phase 1||4||
48519778|NCT02610816|101603831|FG001|NOT COMPLETED|Phase 1||8||
48519779|NCT02610816|101603832|FG002|NOT COMPLETED|Phase 1||0||
48519780|NCT02610816|101603833|FG003|NOT COMPLETED|Phase 1||0||
48519781|NCT02610816|101603830|FG000|STARTED|Phase 2||0||
48519782|NCT02610816|101603831|FG001|STARTED|Phase 2||0||
48519783|NCT02610816|101603832|FG002|STARTED|Phase 2||19||
48519784|NCT02610816|101603833|FG003|STARTED|Phase 2||10||
48519785|NCT02610816|101603830|FG000|COMPLETED|Phase 2||0||
48519786|NCT02610816|101603831|FG001|COMPLETED|Phase 2||0||
48519787|NCT02610816|101603832|FG002|COMPLETED|Phase 2||8||
48519788|NCT02610816|101603833|FG003|COMPLETED|Phase 2||4||
48519789|NCT02610816|101603830|FG000|NOT COMPLETED|Phase 2||0||
48519790|NCT02610816|101603831|FG001|NOT COMPLETED|Phase 2||0||
48519791|NCT02610816|101603832|FG002|NOT COMPLETED|Phase 2||11||
48519792|NCT02610816|101603833|FG003|NOT COMPLETED|Phase 2||6||
48519793|NCT00597116|101603834|FG000|STARTED|Overall Study||14||
48519794|NCT00597116|101603835|FG001|STARTED|Overall Study||11||
48519795|NCT00597116|101603834|FG000|COMPLETED|Overall Study||0||
48519796|NCT00597116|101603835|FG001|COMPLETED|Overall Study||0||
48519797|NCT00597116|101603834|FG000|NOT COMPLETED|Overall Study||14||
48519798|NCT00597116|101603835|FG001|NOT COMPLETED|Overall Study||11||
48519799|NCT00248170|101603836|FG000|STARTED|Overall Study||2078||
48519800|NCT00248170|101603837|FG001|STARTED|Overall Study||2094||
48519801|NCT00248170|101603836|FG000|Intent-to-treat (ITT)|Overall Study||2061||
48519802|NCT00248170|101603837|FG001|Intent-to-treat (ITT)|Overall Study||2075||
48519803|NCT00248170|101603836|FG000|Safety Set|Overall Study||2049||
48519804|NCT00248170|101603837|FG001|Safety Set|Overall Study||2062||
48519805|NCT00248170|101603836|FG000|COMPLETED|Overall Study||1317||
48519806|NCT00248170|101603837|FG001|COMPLETED|Overall Study||1286||
48519807|NCT00248170|101603836|FG000|NOT COMPLETED|Overall Study||761||
48519808|NCT00248170|101603837|FG001|NOT COMPLETED|Overall Study||808||
48519809|NCT00375492|101603838|FG000|STARTED|Overall Study||96||
48519810|NCT00375492|101603839|FG001|STARTED|Overall Study||98||
48519811|NCT00375492|101603838|FG000|COMPLETED|Overall Study||70||
48519812|NCT00375492|101603839|FG001|COMPLETED|Overall Study||72||
48519813|NCT00375492|101603838|FG000|NOT COMPLETED|Overall Study||26||
48519814|NCT00375492|101603839|FG001|NOT COMPLETED|Overall Study||26||
48519815|NCT00290251|101603840|FG000|STARTED|Baseline (Month 1)||14||
48519816|NCT00290251|101603841|FG001|STARTED|Baseline (Month 1)||14||
48519817|NCT00290251|101603842|FG002|STARTED|Baseline (Month 1)||14||
48519818|NCT00290251|101603843|FG003|STARTED|Baseline (Month 1)||0||
48519819|NCT00290251|101603844|FG004|STARTED|Baseline (Month 1)||0||
48519820|NCT00290251|101603845|FG005|STARTED|Baseline (Month 1)||0||
48519821|NCT00290251|101603840|FG000|COMPLETED|Baseline (Month 1)||14||
48519822|NCT00290251|101603841|FG001|COMPLETED|Baseline (Month 1)||14||
48519823|NCT00290251|101603842|FG002|COMPLETED|Baseline (Month 1)||14||
48519824|NCT00290251|101603843|FG003|COMPLETED|Baseline (Month 1)||0||
48519825|NCT00290251|101603844|FG004|COMPLETED|Baseline (Month 1)||0||
48519826|NCT00290251|101603845|FG005|COMPLETED|Baseline (Month 1)||0||
48519827|NCT00290251|101603840|FG000|NOT COMPLETED|Baseline (Month 1)||0||
48519828|NCT00290251|101603841|FG001|NOT COMPLETED|Baseline (Month 1)||0||
48519829|NCT00290251|101603842|FG002|NOT COMPLETED|Baseline (Month 1)||0||
48519830|NCT00290251|101603843|FG003|NOT COMPLETED|Baseline (Month 1)||0||
48519831|NCT00290251|101603844|FG004|NOT COMPLETED|Baseline (Month 1)||0||
48519832|NCT00290251|101603845|FG005|NOT COMPLETED|Baseline (Month 1)||0||
48519833|NCT00290251|101603840|FG000|STARTED|Treatment 1 (Months 2-4)||0||
48519834|NCT00290251|101603841|FG001|STARTED|Treatment 1 (Months 2-4)||0||
48519835|NCT00290251|101603842|FG002|STARTED|Treatment 1 (Months 2-4)||0||
48519836|NCT00290251|101603843|FG003|STARTED|Treatment 1 (Months 2-4)||14||
48519837|NCT00290251|101603844|FG004|STARTED|Treatment 1 (Months 2-4)||14||
48519838|NCT00290251|101603845|FG005|STARTED|Treatment 1 (Months 2-4)||14||
48519839|NCT00290251|101603840|FG000|COMPLETED|Treatment 1 (Months 2-4)||0||
48519840|NCT00290251|101603841|FG001|COMPLETED|Treatment 1 (Months 2-4)||0||
48519841|NCT00290251|101603842|FG002|COMPLETED|Treatment 1 (Months 2-4)||0||
48519842|NCT00290251|101603843|FG003|COMPLETED|Treatment 1 (Months 2-4)||13||
48519843|NCT00290251|101603844|FG004|COMPLETED|Treatment 1 (Months 2-4)||13||
48519844|NCT00290251|101603845|FG005|COMPLETED|Treatment 1 (Months 2-4)||12||
48519845|NCT00290251|101603840|FG000|NOT COMPLETED|Treatment 1 (Months 2-4)||0||
48519846|NCT00290251|101603841|FG001|NOT COMPLETED|Treatment 1 (Months 2-4)||0||
48519847|NCT00290251|101603842|FG002|NOT COMPLETED|Treatment 1 (Months 2-4)||0||
48519848|NCT00290251|101603843|FG003|NOT COMPLETED|Treatment 1 (Months 2-4)||1||
48519849|NCT00290251|101603844|FG004|NOT COMPLETED|Treatment 1 (Months 2-4)||1||
48519850|NCT00290251|101603845|FG005|NOT COMPLETED|Treatment 1 (Months 2-4)||2||
48519851|NCT02459418|101603846|FG000|STARTED|Overall Study||21||
48519852|NCT02459418|101603847|FG001|STARTED|Overall Study||21||
48519853|NCT02459418|101603846|FG000|Received First Treatment|Overall Study||21||
48519854|NCT02459418|101603847|FG001|Received First Treatment|Overall Study||21||
48519855|NCT02459418|101603846|FG000|Received Second Treatment|Overall Study||13||
48519856|NCT02459418|101603847|FG001|Received Second Treatment|Overall Study||15||
48519857|NCT02459418|101603846|FG000|COMPLETED|Overall Study||13||
48519858|NCT02459418|101603847|FG001|COMPLETED|Overall Study||15||
48519859|NCT02459418|101603846|FG000|NOT COMPLETED|Overall Study||8||
48519860|NCT02459418|101603847|FG001|NOT COMPLETED|Overall Study||6||
48519861|NCT04070287|101603848|FG000|STARTED|Overall Study||114|Youth (aged 14-24 years) enrolled in the study|
48519862|NCT04070287|101603849|FG001|STARTED|Overall Study||86|Youth (aged 14-24 years) enrolled in the study|
48519863|NCT04070287|101603850|FG002|STARTED|Overall Study||81|Youth (aged 14-24 years) enrolled in the study|
48519864|NCT04070287|101603851|FG003|STARTED|Overall Study||11|Youth (aged 14-24 years) enrolled in the study|
48519865|NCT04070287|101603852|FG004|STARTED|Overall Study||96|Youth (aged 14-24 years) enrolled in the study|
48519866|NCT04070287|101603848|FG000|COMPLETED|Overall Study||103|Youth retained through a 6-month follow-up period|
48519867|NCT04070287|101603849|FG001|COMPLETED|Overall Study||44|Youth retained through a 6-month follow-up period|
48519868|NCT04070287|101603850|FG002|COMPLETED|Overall Study||75|Youth retained through a 6-month follow-up period|
48519869|NCT04070287|101603851|FG003|COMPLETED|Overall Study||7|Youth retained through a 6-month follow-up period|
48519870|NCT04070287|101603852|FG004|COMPLETED|Overall Study||95|Youth retained through a 6-month follow-up period|
48519871|NCT04070287|101603848|FG000|NOT COMPLETED|Overall Study||11||
48519872|NCT04070287|101603849|FG001|NOT COMPLETED|Overall Study||42||
48519873|NCT04070287|101603850|FG002|NOT COMPLETED|Overall Study||6||
48519874|NCT04070287|101603851|FG003|NOT COMPLETED|Overall Study||4||
48519875|NCT04070287|101603852|FG004|NOT COMPLETED|Overall Study||1||
48519876|NCT00809965|101603853|FG000|STARTED|Overall Study||5176||
48519877|NCT00809965|101603854|FG001|STARTED|Overall Study||5174||
48519878|NCT00809965|101603855|FG002|STARTED|Overall Study||5176||
48519879|NCT00809965|101603853|FG000|Treated/Safety Population|Overall Study||5125||
48519880|NCT00809965|101603854|FG001|Treated/Safety Population|Overall Study||5115||
48519881|NCT00809965|101603855|FG002|Treated/Safety Population|Overall Study||5110||
48519882|NCT00809965|101603853|FG000|Modified Intent-to-Treat Population|Overall Study||5113||
48519883|NCT00809965|101603854|FG001|Modified Intent-to-Treat Population|Overall Study||5114||
48519884|NCT00809965|101603855|FG002|Modified Intent-to-Treat Population|Overall Study||5115||
48519885|NCT00809965|101603853|FG000|COMPLETED|Overall Study||4393||
48519886|NCT00809965|101603854|FG001|COMPLETED|Overall Study||4399||
48519887|NCT00809965|101603855|FG002|COMPLETED|Overall Study||4332||
48519888|NCT00809965|101603853|FG000|NOT COMPLETED|Overall Study||783||
48519889|NCT00809965|101603854|FG001|NOT COMPLETED|Overall Study||775||
48519890|NCT00809965|101603855|FG002|NOT COMPLETED|Overall Study||844||
48519891|NCT02790034|101603856|FG000|STARTED|Overall Study||33||
48519892|NCT02790034|101603857|FG001|STARTED|Overall Study||56||
48519893|NCT02790034|101603858|FG002|STARTED|Overall Study||40||
48519894|NCT02790034|101603856|FG000|COMPLETED|Overall Study||27||
48519895|NCT02790034|101603857|FG001|COMPLETED|Overall Study||46||
48519896|NCT02790034|101603858|FG002|COMPLETED|Overall Study||36||
48519897|NCT02790034|101603856|FG000|NOT COMPLETED|Overall Study||6||
48519898|NCT02790034|101603857|FG001|NOT COMPLETED|Overall Study||10||
48519899|NCT02790034|101603858|FG002|NOT COMPLETED|Overall Study||4||
48666841|NCT02457065|101970478|FG000|STARTED|Overall Study||27||
48666842|NCT02457065|101970479|FG001|STARTED|Overall Study||27||
48519900|NCT00556491|101603859|FG000|STARTED|Overall Study||20||
48519901|NCT00556491|101603860|FG001|STARTED|Overall Study||20||
48519902|NCT00556491|101603859|FG000|COMPLETED|Overall Study||19||
48519903|NCT00556491|101603860|FG001|COMPLETED|Overall Study||19||
48519904|NCT00556491|101603859|FG000|NOT COMPLETED|Overall Study||1||
48519905|NCT00556491|101603860|FG001|NOT COMPLETED|Overall Study||1||
48519906|NCT00720226|101603861|FG000|STARTED|Overall Study||54||
48519907|NCT00720226|101603862|FG001|STARTED|Overall Study||52||
48519908|NCT00720226|101603861|FG000|COMPLETED|Overall Study||47||
48519909|NCT00720226|101603862|FG001|COMPLETED|Overall Study||48||
48519910|NCT00720226|101603861|FG000|NOT COMPLETED|Overall Study||7||
48519911|NCT00720226|101603862|FG001|NOT COMPLETED|Overall Study||4||
48519912|NCT00733369|101603863|FG000|STARTED|Overall Study||50||
48519913|NCT00733369|101603864|FG001|STARTED|Overall Study||56||
48519914|NCT00733369|101603863|FG000|COMPLETED|Overall Study||40||
48519915|NCT00733369|101603864|FG001|COMPLETED|Overall Study||47||
48519916|NCT00733369|101603863|FG000|NOT COMPLETED|Overall Study||10||
48519917|NCT00733369|101603864|FG001|NOT COMPLETED|Overall Study||9||
48519918|NCT01103479|101603865|FG000|STARTED|Overall Study||168||
48519919|NCT01103479|101603866|FG001|STARTED|Overall Study||210||
48519920|NCT01103479|101603867|FG002|STARTED|Overall Study||188||
48519921|NCT01103479|101603865|FG000|COMPLETED|Overall Study||163||
48519922|NCT01103479|101603866|FG001|COMPLETED|Overall Study||201||
48519923|NCT01103479|101603867|FG002|COMPLETED|Overall Study||174||
48519924|NCT01103479|101603865|FG000|NOT COMPLETED|Overall Study||5||
48519925|NCT01103479|101603866|FG001|NOT COMPLETED|Overall Study||9||
48519926|NCT01103479|101603867|FG002|NOT COMPLETED|Overall Study||14||
48519927|NCT03998436|101603868|FG000|STARTED|Overall Study||76||
48519928|NCT03998436|101603869|FG001|STARTED|Overall Study||76||
48519929|NCT03998436|101603870|FG002|STARTED|Overall Study||24||
48519930|NCT03998436|101603868|FG000|COMPLETED|Overall Study||68||
48519931|NCT03998436|101603869|FG001|COMPLETED|Overall Study||72||
48519932|NCT03998436|101603870|FG002|COMPLETED|Overall Study||23||
48519933|NCT03998436|101603868|FG000|NOT COMPLETED|Overall Study||8||
48519934|NCT03998436|101603869|FG001|NOT COMPLETED|Overall Study||4||
48519935|NCT03998436|101603870|FG002|NOT COMPLETED|Overall Study||1||
48519936|NCT01316419|101603871|FG000|STARTED|Overall Study||2089||
48519937|NCT01316419|101603871|FG000|COMPLETED|Overall Study||1824||
48519938|NCT01316419|101603871|FG000|NOT COMPLETED|Overall Study||265||
48519939|NCT02743728|101603872|FG000|STARTED|Overall Study||20||
48519940|NCT02743728|101603872|FG000|COMPLETED|Overall Study||20||
48519941|NCT02743728|101603872|FG000|NOT COMPLETED|Overall Study||0||
48519942|NCT03686150|101603873|FG000|STARTED|Overall Study||13||
48519943|NCT03686150|101603874|FG001|STARTED|Overall Study||12||
48519944|NCT03686150|101603875|FG002|STARTED|Overall Study||11||
48519945|NCT03686150|101603876|FG003|STARTED|Overall Study||12||
48519946|NCT03686150|101603877|FG004|STARTED|Overall Study||43||
48519947|NCT03686150|101603878|FG005|STARTED|Overall Study||21||
48519948|NCT03686150|101603873|FG000|COMPLETED|Overall Study||11||
48519949|NCT03686150|101603874|FG001|COMPLETED|Overall Study||10||
48519950|NCT03686150|101603875|FG002|COMPLETED|Overall Study||10||
48519951|NCT03686150|101603876|FG003|COMPLETED|Overall Study||12||
48519952|NCT03686150|101603877|FG004|COMPLETED|Overall Study||42||
48519953|NCT03686150|101603878|FG005|COMPLETED|Overall Study||18||
48519954|NCT03686150|101603873|FG000|NOT COMPLETED|Overall Study||2||
48519955|NCT03686150|101603874|FG001|NOT COMPLETED|Overall Study||2||
48519956|NCT03686150|101603875|FG002|NOT COMPLETED|Overall Study||1||
48519957|NCT03686150|101603876|FG003|NOT COMPLETED|Overall Study||0||
48519958|NCT03686150|101603877|FG004|NOT COMPLETED|Overall Study||1||
48519959|NCT03686150|101603878|FG005|NOT COMPLETED|Overall Study||3||
48519960|NCT01560507|101603879|FG000|STARTED|Overall Study||5||
48519961|NCT01560507|101603880|FG001|STARTED|Overall Study||2||
48519962|NCT01560507|101603881|FG002|STARTED|Overall Study||2||
48519963|NCT01560507|101603879|FG000|COMPLETED|Overall Study||1||
48519964|NCT01560507|101603880|FG001|COMPLETED|Overall Study||0||
48519965|NCT01560507|101603881|FG002|COMPLETED|Overall Study||0||
48519966|NCT01560507|101603879|FG000|NOT COMPLETED|Overall Study||4||
48519967|NCT01560507|101603880|FG001|NOT COMPLETED|Overall Study||2||
48519968|NCT01560507|101603881|FG002|NOT COMPLETED|Overall Study||2||
48519969|NCT00396331|101603882|FG000|STARTED|Overall Study||100||
48519970|NCT00396331|101603882|FG000|Number of Participants Treated|Overall Study||100||
48519971|NCT00396331|101603882|FG000|Number of Participants Transplanted|Overall Study||87||
48519972|NCT00396331|101603882|FG000|COMPLETED|Overall Study||68||
48519973|NCT00396331|101603882|FG000|NOT COMPLETED|Overall Study||32||
48519974|NCT04364737|101603883|FG000|STARTED|Overall Study||468||
48519975|NCT04364737|101603884|FG001|STARTED|Overall Study||473||
48519976|NCT04364737|101603883|FG000|COMPLETED|Overall Study||463||
48519977|NCT04364737|101603884|FG001|COMPLETED|Overall Study||463||
48519978|NCT04364737|101603883|FG000|NOT COMPLETED|Overall Study||5||
48519979|NCT04364737|101603884|FG001|NOT COMPLETED|Overall Study||10||
48519980|NCT00307931|101603885|FG000|STARTED|Overall Study||16||
48519981|NCT00307931|101603885|FG000|COMPLETED|Overall Study||15||
48519982|NCT00307931|101603885|FG000|NOT COMPLETED|Overall Study||1||
48519983|NCT00865098|101603886|FG000|STARTED|Overall Study||22||
48519984|NCT00865098|101603886|FG000|COMPLETED|Overall Study||21||
48519985|NCT00865098|101603886|FG000|NOT COMPLETED|Overall Study||1||
48519986|NCT00296491|101603887|FG000|STARTED|Overall Study||182||
48519987|NCT00296491|101603888|FG001|STARTED|Overall Study||182||
48519988|NCT00296491|101603889|FG002|STARTED|Overall Study||180||
48519989|NCT00296491|101603890|FG003|STARTED|Overall Study||181||
48519990|NCT00296491|101603887|FG000|COMPLETED|Overall Study||140||
48519991|NCT00296491|101603888|FG001|COMPLETED|Overall Study||129||
48519992|NCT00296491|101603889|FG002|COMPLETED|Overall Study||137||
48519993|NCT00296491|101603890|FG003|COMPLETED|Overall Study||138||
48519994|NCT00296491|101603887|FG000|NOT COMPLETED|Overall Study||42||
48519995|NCT00296491|101603888|FG001|NOT COMPLETED|Overall Study||53||
48519996|NCT00296491|101603889|FG002|NOT COMPLETED|Overall Study||43||
48519997|NCT00296491|101603890|FG003|NOT COMPLETED|Overall Study||43||
48519998|NCT02678442|101603891|FG000|STARTED|First Intervention||25||
48519999|NCT02678442|101603892|FG001|STARTED|First Intervention||25||
48520000|NCT02678442|101603891|FG000|COMPLETED|First Intervention||25||
48520001|NCT02678442|101603892|FG001|COMPLETED|First Intervention||25||
48520002|NCT02678442|101603891|FG000|NOT COMPLETED|First Intervention||0||
48520003|NCT02678442|101603892|FG001|NOT COMPLETED|First Intervention||0||
48520004|NCT02678442|101603891|FG000|STARTED|Second Intervention||25||
48520005|NCT02678442|101603892|FG001|STARTED|Second Intervention||25||
48520006|NCT02678442|101603891|FG000|COMPLETED|Second Intervention||23||
48520007|NCT02678442|101603892|FG001|COMPLETED|Second Intervention||23||
48520008|NCT02678442|101603891|FG000|NOT COMPLETED|Second Intervention||2||
48520009|NCT02678442|101603892|FG001|NOT COMPLETED|Second Intervention||2||
48520010|NCT02695719|101603893|FG000|STARTED|Overall Study||74||
48520011|NCT02695719|101603894|FG001|STARTED|Overall Study||82||
48520012|NCT02695719|101603893|FG000|COMPLETED|Overall Study||71||
48520013|NCT02695719|101603894|FG001|COMPLETED|Overall Study||72||
48520014|NCT02695719|101603893|FG000|NOT COMPLETED|Overall Study||3||
48520015|NCT02695719|101603894|FG001|NOT COMPLETED|Overall Study||10||
48520016|NCT03050697|101603895|FG000|STARTED|Overall Study||12||17
48520017|NCT03050697|101603895|FG000|COMPLETED|Overall Study||12||17
48520018|NCT03050697|101603895|FG000|NOT COMPLETED|Overall Study||0||0
48520019|NCT00614822|101603896|FG000|STARTED|Overall Study||50||
48520020|NCT00614822|101603896|FG000|COMPLETED|Overall Study||47||
48520021|NCT00614822|101603896|FG000|NOT COMPLETED|Overall Study||3||
48520022|NCT04039919|101603897|FG000|STARTED|Treatment Period 1||7||
48520023|NCT04039919|101603898|FG001|STARTED|Treatment Period 1||6||
48520024|NCT04039919|101603899|FG002|STARTED|Treatment Period 1||5||
48520025|NCT04039919|101603900|FG003|STARTED|Treatment Period 1||6||
48520026|NCT04039919|101603901|FG004|STARTED|Treatment Period 1||16||
48520027|NCT04039919|101603897|FG000|COMPLETED|Treatment Period 1||6||
48520028|NCT04039919|101603898|FG001|COMPLETED|Treatment Period 1||6||
48520029|NCT04039919|101603899|FG002|COMPLETED|Treatment Period 1||5||
48520030|NCT04039919|101603900|FG003|COMPLETED|Treatment Period 1||6||
48520031|NCT04039919|101603901|FG004|COMPLETED|Treatment Period 1||0||
48520032|NCT04039919|101603897|FG000|NOT COMPLETED|Treatment Period 1||1||
48520033|NCT04039919|101603898|FG001|NOT COMPLETED|Treatment Period 1||0||
48520034|NCT04039919|101603899|FG002|NOT COMPLETED|Treatment Period 1||0||
48520035|NCT04039919|101603900|FG003|NOT COMPLETED|Treatment Period 1||0||
48520036|NCT04039919|101603901|FG004|NOT COMPLETED|Treatment Period 1||16||
48520037|NCT04039919|101603897|FG000|STARTED|Treatment Period 2||6||
48520038|NCT04039919|101603898|FG001|STARTED|Treatment Period 2||6||
48520039|NCT04039919|101603899|FG002|STARTED|Treatment Period 2||5||
48520040|NCT04039919|101603900|FG003|STARTED|Treatment Period 2||6||
48520041|NCT04039919|101603901|FG004|STARTED|Treatment Period 2||0||
48520042|NCT04039919|101603897|FG000|COMPLETED|Treatment Period 2||6||
48520043|NCT04039919|101603898|FG001|COMPLETED|Treatment Period 2||6||
48520044|NCT04039919|101603899|FG002|COMPLETED|Treatment Period 2||5||
48520045|NCT04039919|101603900|FG003|COMPLETED|Treatment Period 2||6||
48520046|NCT04039919|101603901|FG004|COMPLETED|Treatment Period 2||0||
48520047|NCT04039919|101603897|FG000|NOT COMPLETED|Treatment Period 2||0||
48520048|NCT04039919|101603898|FG001|NOT COMPLETED|Treatment Period 2||0||
48520049|NCT04039919|101603899|FG002|NOT COMPLETED|Treatment Period 2||0||
48520050|NCT04039919|101603900|FG003|NOT COMPLETED|Treatment Period 2||0||
48520051|NCT04039919|101603901|FG004|NOT COMPLETED|Treatment Period 2||0||
48520052|NCT04039919|101603897|FG000|STARTED|Treatment Period 3||6||
48520053|NCT04039919|101603898|FG001|STARTED|Treatment Period 3||6||
48520054|NCT04039919|101603899|FG002|STARTED|Treatment Period 3||5||
48520055|NCT04039919|101603900|FG003|STARTED|Treatment Period 3||6||
48520056|NCT04039919|101603901|FG004|STARTED|Treatment Period 3||0||
48520057|NCT04039919|101603897|FG000|COMPLETED|Treatment Period 3||6||
48520058|NCT04039919|101603898|FG001|COMPLETED|Treatment Period 3||6||
48520059|NCT04039919|101603899|FG002|COMPLETED|Treatment Period 3||5||
48520060|NCT04039919|101603900|FG003|COMPLETED|Treatment Period 3||6||
48520061|NCT04039919|101603901|FG004|COMPLETED|Treatment Period 3||0||
48520062|NCT04039919|101603897|FG000|NOT COMPLETED|Treatment Period 3||0||
48520063|NCT04039919|101603898|FG001|NOT COMPLETED|Treatment Period 3||0||
48520064|NCT04039919|101603899|FG002|NOT COMPLETED|Treatment Period 3||0||
48520065|NCT04039919|101603900|FG003|NOT COMPLETED|Treatment Period 3||0||
48520066|NCT04039919|101603901|FG004|NOT COMPLETED|Treatment Period 3||0||
48520067|NCT04039919|101603897|FG000|STARTED|Treatment Period 4||6||
48520068|NCT04039919|101603898|FG001|STARTED|Treatment Period 4||6||
48520069|NCT04039919|101603899|FG002|STARTED|Treatment Period 4||5||
48520070|NCT04039919|101603900|FG003|STARTED|Treatment Period 4||6||
48520071|NCT04039919|101603901|FG004|STARTED|Treatment Period 4||0||
48520072|NCT04039919|101603897|FG000|COMPLETED|Treatment Period 4||6||
48520073|NCT04039919|101603898|FG001|COMPLETED|Treatment Period 4||6||
48520074|NCT04039919|101603899|FG002|COMPLETED|Treatment Period 4||5||
48520075|NCT04039919|101603900|FG003|COMPLETED|Treatment Period 4||6||
48520076|NCT04039919|101603901|FG004|COMPLETED|Treatment Period 4||0||
48520077|NCT04039919|101603897|FG000|NOT COMPLETED|Treatment Period 4||0||
48520078|NCT04039919|101603898|FG001|NOT COMPLETED|Treatment Period 4||0||
48520079|NCT04039919|101603899|FG002|NOT COMPLETED|Treatment Period 4||0||
48520080|NCT04039919|101603900|FG003|NOT COMPLETED|Treatment Period 4||0||
48520081|NCT04039919|101603901|FG004|NOT COMPLETED|Treatment Period 4||0||
48520082|NCT04039919|101603897|FG000|STARTED|Treatment Period 5||6||
48520083|NCT04039919|101603898|FG001|STARTED|Treatment Period 5||6||
48520084|NCT04039919|101603899|FG002|STARTED|Treatment Period 5||5||
48520085|NCT04039919|101603900|FG003|STARTED|Treatment Period 5||6||
48520086|NCT04039919|101603901|FG004|STARTED|Treatment Period 5||0||
48520087|NCT04039919|101603897|FG000|COMPLETED|Treatment Period 5||5||
48520088|NCT04039919|101603898|FG001|COMPLETED|Treatment Period 5||6||
48520089|NCT04039919|101603899|FG002|COMPLETED|Treatment Period 5||5||
48520090|NCT04039919|101603900|FG003|COMPLETED|Treatment Period 5||6||
48520091|NCT04039919|101603901|FG004|COMPLETED|Treatment Period 5||0||
48520092|NCT04039919|101603897|FG000|NOT COMPLETED|Treatment Period 5||1||
48520093|NCT04039919|101603898|FG001|NOT COMPLETED|Treatment Period 5||0||
48520094|NCT04039919|101603899|FG002|NOT COMPLETED|Treatment Period 5||0||
48520095|NCT04039919|101603900|FG003|NOT COMPLETED|Treatment Period 5||0||
48520096|NCT04039919|101603901|FG004|NOT COMPLETED|Treatment Period 5||0||
48520097|NCT04039919|101603897|FG000|STARTED|Treatment Period 6||5||
48520098|NCT04039919|101603898|FG001|STARTED|Treatment Period 6||6||
48520099|NCT04039919|101603899|FG002|STARTED|Treatment Period 6||5||
48520100|NCT04039919|101603900|FG003|STARTED|Treatment Period 6||6||
48520101|NCT04039919|101603901|FG004|STARTED|Treatment Period 6||0||
48520102|NCT04039919|101603897|FG000|COMPLETED|Treatment Period 6||5||
48520103|NCT04039919|101603898|FG001|COMPLETED|Treatment Period 6||6||
48520104|NCT04039919|101603899|FG002|COMPLETED|Treatment Period 6||5||
48520105|NCT04039919|101603900|FG003|COMPLETED|Treatment Period 6||6||
48520106|NCT04039919|101603901|FG004|COMPLETED|Treatment Period 6||0||
48520107|NCT04039919|101603897|FG000|NOT COMPLETED|Treatment Period 6||0||
48520108|NCT04039919|101603898|FG001|NOT COMPLETED|Treatment Period 6||0||
48520109|NCT04039919|101603899|FG002|NOT COMPLETED|Treatment Period 6||0||
48520110|NCT04039919|101603900|FG003|NOT COMPLETED|Treatment Period 6||0||
48520111|NCT04039919|101603901|FG004|NOT COMPLETED|Treatment Period 6||0||
48520112|NCT01155778|101603902|FG000|STARTED|Overall Study||4||
48520113|NCT01155778|101603903|FG001|STARTED|Overall Study||4||
48520114|NCT01155778|101603904|FG002|STARTED|Overall Study||4||
48520115|NCT01155778|101603902|FG000|COMPLETED|Overall Study||4||
48520116|NCT01155778|101603903|FG001|COMPLETED|Overall Study||4||
48520117|NCT01155778|101603904|FG002|COMPLETED|Overall Study||4||
48520118|NCT01155778|101603902|FG000|NOT COMPLETED|Overall Study||0||
48520119|NCT01155778|101603903|FG001|NOT COMPLETED|Overall Study||0||
48520120|NCT01155778|101603904|FG002|NOT COMPLETED|Overall Study||0||
48520121|NCT02631876|101603905|FG000|STARTED|Overall Study||248|ITT population: all participants randomized in the study.|
48520122|NCT02631876|101603906|FG001|STARTED|Overall Study||118|ITT population: all participants randomized in the study.|
48520123|NCT02631876|101603905|FG000|Safety Population|Overall Study||243|Enrolled participants who received at least 1 dose of mirvetuximab soravtansine or IC chemotherapy.|
48520124|NCT02631876|101603906|FG001|Safety Population|Overall Study||109|Enrolled participants who received at least 1 dose of mirvetuximab soravtansine or IC chemotherapy.|
48520125|NCT02631876|101603905|FG000|COMPLETED|Overall Study||129||
48520126|NCT02631876|101603906|FG001|COMPLETED|Overall Study||55||
48520127|NCT02631876|101603905|FG000|NOT COMPLETED|Overall Study||119||
48520128|NCT02631876|101603906|FG001|NOT COMPLETED|Overall Study||63||
48520129|NCT02668822|101603907|FG000|STARTED|Overall Study||9||
48520130|NCT02668822|101603908|FG001|STARTED|Overall Study||9||
48520131|NCT02668822|101603907|FG000|COMPLETED|Overall Study||0||
48520132|NCT02668822|101603908|FG001|COMPLETED|Overall Study||0||
48520133|NCT02668822|101603907|FG000|NOT COMPLETED|Overall Study||9||
48520134|NCT02668822|101603908|FG001|NOT COMPLETED|Overall Study||9||
48520135|NCT01602471|101603909|FG000|STARTED|Overall Study||4||
48520136|NCT01602471|101603909|FG000|COMPLETED|Overall Study||4||
48520137|NCT01602471|101603909|FG000|NOT COMPLETED|Overall Study||0||
48520138|NCT01612884|101603910|FG000|STARTED|Overall Study||19||
48520139|NCT01612884|101603911|FG001|STARTED|Overall Study||18||
48219973|NCT05580003|100863768|FG020|NOT COMPLETED|Part 3: Period 3 (Day 1)||0||
48219974|NCT05580003|100863769|FG021|NOT COMPLETED|Part 3: Period 3 (Day 1)||0||
48520140|NCT01612884|101603910|FG000|COMPLETED|Overall Study||19||
48520141|NCT01612884|101603911|FG001|COMPLETED|Overall Study||18||
48520142|NCT01612884|101603910|FG000|NOT COMPLETED|Overall Study||0||
48520143|NCT01612884|101603911|FG001|NOT COMPLETED|Overall Study||0||
48520144|NCT04109313|101603912|FG000|STARTED|Overall Study||229||
48520145|NCT04109313|101603912|FG000|Treatment-free Cohort|Overall Study||68|Participants with UAS7\<16 at Week 16 of CLOU064A2201 were followed up to 12 weeks without receiving treatment (observational period). If participants relapsed (UAS7≥16 at least once), they were transitioned to the treatment period. Otherwise, the|
48520146|NCT04109313|101603912|FG000|Treatment Cohort|Overall Study||194|Participants with a UAS7≥16 at Week 12 or Week 16 in the CLOU064A2201, as well as participants who experienced a relapse during the 12-week observational period, were administered 100 mg of LOU064 b.i.d. open-label for up to 52 weeks.|
48520147|NCT04109313|101603912|FG000|COMPLETED|Overall Study||188||
48520148|NCT04109313|101603912|FG000|NOT COMPLETED|Overall Study||41||
48520149|NCT03168321|101603913|FG000|STARTED|Overall Study||402||
48520150|NCT03168321|101603914|FG001|STARTED|Overall Study||411||
48520151|NCT03168321|101603913|FG000|COMPLETED|Overall Study||347||
48520152|NCT03168321|101603914|FG001|COMPLETED|Overall Study||356||
48520153|NCT03168321|101603913|FG000|NOT COMPLETED|Overall Study||55||
48520154|NCT03168321|101603914|FG001|NOT COMPLETED|Overall Study||55||
48666843|NCT02457065|101970478|FG000|COMPLETED|Overall Study||18||
48666844|NCT02457065|101970479|FG001|COMPLETED|Overall Study||16||
48666845|NCT02457065|101970478|FG000|NOT COMPLETED|Overall Study||9||
48666846|NCT02457065|101970479|FG001|NOT COMPLETED|Overall Study||11||
48666847|NCT02371356|101970480|FG000|STARTED|Overall Study||1320||
48666848|NCT02371356|101970481|FG001|STARTED|Overall Study||7354||
48666849|NCT02371356|101970482|FG002|STARTED|Overall Study||2804||
48666850|NCT02371356|101970483|FG003|STARTED|Overall Study||7423||
48666851|NCT02371356|101970484|FG004|STARTED|Overall Study||72183||
48666852|NCT02371356|101970480|FG000|COMPLETED|Overall Study||1320||
48666853|NCT02371356|101970481|FG001|COMPLETED|Overall Study||7354||
48666854|NCT02371356|101970482|FG002|COMPLETED|Overall Study||2804||
48666855|NCT02371356|101970483|FG003|COMPLETED|Overall Study||7423||
48666856|NCT02371356|101970484|FG004|COMPLETED|Overall Study||72183||
48666857|NCT02371356|101970480|FG000|NOT COMPLETED|Overall Study||0||
48666858|NCT02371356|101970481|FG001|NOT COMPLETED|Overall Study||0||
48666859|NCT02371356|101970482|FG002|NOT COMPLETED|Overall Study||0||
48666860|NCT02371356|101970483|FG003|NOT COMPLETED|Overall Study||0||
48666861|NCT02371356|101970484|FG004|NOT COMPLETED|Overall Study||0||
48666862|NCT02082977|101970485|FG000|STARTED|Part 1 (Up to 3.2 Years)||2||
48666863|NCT02082977|101970486|FG001|STARTED|Part 1 (Up to 3.2 Years)||1||
48666864|NCT02082977|101970487|FG002|STARTED|Part 1 (Up to 3.2 Years)||1||
48666865|NCT02082977|101970488|FG003|STARTED|Part 1 (Up to 3.2 Years)||1||
48666866|NCT02082977|101970489|FG004|STARTED|Part 1 (Up to 3.2 Years)||3||
48666867|NCT02082977|101970490|FG005|STARTED|Part 1 (Up to 3.2 Years)||4||
48666868|NCT02082977|101970491|FG006|STARTED|Part 1 (Up to 3.2 Years)||10||
48666869|NCT02082977|101970492|FG007|STARTED|Part 1 (Up to 3.2 Years)||12||
48666870|NCT02082977|101970493|FG008|STARTED|Part 1 (Up to 3.2 Years)||7||
48666871|NCT02082977|101970494|FG009|STARTED|Part 1 (Up to 3.2 Years)||0||
48666872|NCT02082977|101970485|FG000|COMPLETED|Part 1 (Up to 3.2 Years)||1||
48666873|NCT02082977|101970486|FG001|COMPLETED|Part 1 (Up to 3.2 Years)||1||
48666874|NCT02082977|101970487|FG002|COMPLETED|Part 1 (Up to 3.2 Years)||1||
48666875|NCT02082977|101970488|FG003|COMPLETED|Part 1 (Up to 3.2 Years)||1||
48666876|NCT02082977|101970489|FG004|COMPLETED|Part 1 (Up to 3.2 Years)||2||
48666877|NCT02082977|101970490|FG005|COMPLETED|Part 1 (Up to 3.2 Years)||1||
48666878|NCT02082977|101970491|FG006|COMPLETED|Part 1 (Up to 3.2 Years)||4||
48666879|NCT02082977|101970492|FG007|COMPLETED|Part 1 (Up to 3.2 Years)||7||
48666880|NCT02082977|101970493|FG008|COMPLETED|Part 1 (Up to 3.2 Years)||4||
48666881|NCT02082977|101970494|FG009|COMPLETED|Part 1 (Up to 3.2 Years)||0||
48666882|NCT02082977|101970485|FG000|NOT COMPLETED|Part 1 (Up to 3.2 Years)||1||
48666883|NCT02082977|101970486|FG001|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0||
48666884|NCT02082977|101970487|FG002|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0||
48666885|NCT02082977|101970488|FG003|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0||
48666886|NCT02082977|101970489|FG004|NOT COMPLETED|Part 1 (Up to 3.2 Years)||1||
48666887|NCT02082977|101970490|FG005|NOT COMPLETED|Part 1 (Up to 3.2 Years)||3||
48666888|NCT02082977|101970491|FG006|NOT COMPLETED|Part 1 (Up to 3.2 Years)||6||
48666889|NCT02082977|101970492|FG007|NOT COMPLETED|Part 1 (Up to 3.2 Years)||5||
48666890|NCT02082977|101970493|FG008|NOT COMPLETED|Part 1 (Up to 3.2 Years)||3||
48666891|NCT02082977|101970494|FG009|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0||
48666892|NCT02082977|101970485|FG000|STARTED|Part 2 (Up to 3.2 Years)||0||
48666893|NCT02082977|101970486|FG001|STARTED|Part 2 (Up to 3.2 Years)||0||
48666894|NCT02082977|101970487|FG002|STARTED|Part 2 (Up to 3.2 Years)||0||
48666895|NCT02082977|101970488|FG003|STARTED|Part 2 (Up to 3.2 Years)||0||
48666896|NCT02082977|101970489|FG004|STARTED|Part 2 (Up to 3.2 Years)||0||
48666897|NCT02082977|101970490|FG005|STARTED|Part 2 (Up to 3.2 Years)||0||
48666898|NCT02082977|101970491|FG006|STARTED|Part 2 (Up to 3.2 Years)||0||
48666899|NCT02082977|101970492|FG007|STARTED|Part 2 (Up to 3.2 Years)||0||
48666900|NCT02082977|101970493|FG008|STARTED|Part 2 (Up to 3.2 Years)||0||
48666901|NCT02082977|101970494|FG009|STARTED|Part 2 (Up to 3.2 Years)||0||
48666902|NCT02082977|101970485|FG000|COMPLETED|Part 2 (Up to 3.2 Years)||0||
48666903|NCT02082977|101970486|FG001|COMPLETED|Part 2 (Up to 3.2 Years)||0||
48666904|NCT02082977|101970487|FG002|COMPLETED|Part 2 (Up to 3.2 Years)||0||
48219975|NCT05580003|100863770|FG022|NOT COMPLETED|Part 3: Period 3 (Day 1)||0||
48666905|NCT02082977|101970488|FG003|COMPLETED|Part 2 (Up to 3.2 Years)||0||
48666906|NCT02082977|101970489|FG004|COMPLETED|Part 2 (Up to 3.2 Years)||0||
48666907|NCT02082977|101970490|FG005|COMPLETED|Part 2 (Up to 3.2 Years)||0||
48666908|NCT02082977|101970491|FG006|COMPLETED|Part 2 (Up to 3.2 Years)||0||
48666909|NCT02082977|101970492|FG007|COMPLETED|Part 2 (Up to 3.2 Years)||0||
48666910|NCT02082977|101970493|FG008|COMPLETED|Part 2 (Up to 3.2 Years)||0||
48666911|NCT02082977|101970494|FG009|COMPLETED|Part 2 (Up to 3.2 Years)||0||
48666912|NCT02082977|101970485|FG000|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0||
48666913|NCT02082977|101970486|FG001|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0||
48666914|NCT02082977|101970487|FG002|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0||
48666915|NCT02082977|101970488|FG003|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0||
48666916|NCT02082977|101970489|FG004|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0||
48666917|NCT02082977|101970490|FG005|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0||
48666918|NCT02082977|101970491|FG006|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0||
48666919|NCT02082977|101970492|FG007|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0||
48666920|NCT02082977|101970493|FG008|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0||
48666921|NCT02082977|101970494|FG009|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0||
48666922|NCT00867139|101970495|FG000|STARTED|Overall Study||2||
48666923|NCT00867139|101970496|FG001|STARTED|Overall Study||1||
48666924|NCT00867139|101970497|FG002|STARTED|Overall Study||4||
48666925|NCT00867139|101970495|FG000|COMPLETED|Overall Study||2||
48666926|NCT00867139|101970496|FG001|COMPLETED|Overall Study||1||
48666927|NCT00867139|101970497|FG002|COMPLETED|Overall Study||3||
48666928|NCT00867139|101970495|FG000|NOT COMPLETED|Overall Study||0||
48666929|NCT00867139|101970496|FG001|NOT COMPLETED|Overall Study||0||
48666930|NCT00867139|101970497|FG002|NOT COMPLETED|Overall Study||1||
48666931|NCT00581100|101970498|FG000|STARTED|Overall Study||38||
48666932|NCT00581100|101970499|FG001|STARTED|Overall Study||34||
48666933|NCT00581100|101970498|FG000|Modified Intent-To-Treat Population|Overall Study||36||
48666934|NCT00581100|101970499|FG001|Modified Intent-To-Treat Population|Overall Study||33||
48666935|NCT00581100|101970498|FG000|COMPLETED|Overall Study||31||
48666936|NCT00581100|101970499|FG001|COMPLETED|Overall Study||29||
48666937|NCT00581100|101970498|FG000|NOT COMPLETED|Overall Study||7||
48666938|NCT00581100|101970499|FG001|NOT COMPLETED|Overall Study||5||
48666939|NCT03204812|101970500|FG000|STARTED|Overall Study||26||
48666940|NCT03204812|101970500|FG000|COMPLETED|Overall Study||23||
48666941|NCT03204812|101970500|FG000|NOT COMPLETED|Overall Study||3||
48666942|NCT05166902|101970501|FG000|STARTED|First Intervention||34||
48666943|NCT05166902|101970502|FG001|STARTED|First Intervention||33||
48666944|NCT05166902|101970501|FG000|COMPLETED|First Intervention||34||
48666945|NCT05166902|101970502|FG001|COMPLETED|First Intervention||32||
48666946|NCT05166902|101970501|FG000|NOT COMPLETED|First Intervention||0||
48666947|NCT05166902|101970502|FG001|NOT COMPLETED|First Intervention||1||
48666948|NCT05166902|101970501|FG000|STARTED|Second Intervention||34||
48666949|NCT05166902|101970502|FG001|STARTED|Second Intervention||32||
48666950|NCT05166902|101970501|FG000|COMPLETED|Second Intervention||34||
48666951|NCT05166902|101970502|FG001|COMPLETED|Second Intervention||32||
48666952|NCT05166902|101970501|FG000|NOT COMPLETED|Second Intervention||0||
48666953|NCT05166902|101970502|FG001|NOT COMPLETED|Second Intervention||0||
48666954|NCT00509288|101970503|FG000|STARTED|Overall Study||21||
48666955|NCT00509288|101970504|FG001|STARTED|Overall Study||3||
48666956|NCT00509288|101970503|FG000|COMPLETED|Overall Study||21||
48666957|NCT00509288|101970504|FG001|COMPLETED|Overall Study||3||
48666958|NCT00509288|101970503|FG000|NOT COMPLETED|Overall Study||0||
48666959|NCT00509288|101970504|FG001|NOT COMPLETED|Overall Study||0||
48666960|NCT01441492|101970505|FG000|STARTED|Overall Study||197||
48666961|NCT01441492|101970506|FG001|STARTED|Overall Study||202||
48666962|NCT01441492|101970505|FG000|COMPLETED|Overall Study||170||
48666963|NCT01441492|101970506|FG001|COMPLETED|Overall Study||174||
48666964|NCT01441492|101970505|FG000|NOT COMPLETED|Overall Study||27||
48666965|NCT01441492|101970506|FG001|NOT COMPLETED|Overall Study||28||
48666966|NCT06034340|101970507|FG000|STARTED|Overall Study||22||22
48666967|NCT06034340|101970508|FG001|STARTED|Overall Study||22||22
48666968|NCT06034340|101970507|FG000|10 Minutes After LET Gel Application|Overall Study||11||11
48666969|NCT06034340|101970508|FG001|10 Minutes After LET Gel Application|Overall Study||11||11
48666970|NCT06034340|101970507|FG000|20 Minutes After LET Gel Application|Overall Study||11||11
48666971|NCT06034340|101970508|FG001|20 Minutes After LET Gel Application|Overall Study||11||11
48666972|NCT06034340|101970507|FG000|COMPLETED|Overall Study||22||22
48666973|NCT06034340|101970508|FG001|COMPLETED|Overall Study||22||22
48666974|NCT06034340|101970507|FG000|NOT COMPLETED|Overall Study||0||0
48666975|NCT06034340|101970508|FG001|NOT COMPLETED|Overall Study||0||0
48666976|NCT04261985|101970509|FG000|STARTED|Baseline||54||
48666977|NCT04261985|101970510|FG001|STARTED|Baseline||64||
48666978|NCT04261985|101970509|FG000|COMPLETED|Baseline||54||
48666979|NCT04261985|101970510|FG001|COMPLETED|Baseline||64||
48666980|NCT04261985|101970509|FG000|NOT COMPLETED|Baseline||0||
48666981|NCT04261985|101970510|FG001|NOT COMPLETED|Baseline||0||
48666982|NCT04261985|101970509|FG000|STARTED|6-month Follow-up||54||
48666983|NCT04261985|101970510|FG001|STARTED|6-month Follow-up||64||
48666984|NCT04261985|101970509|FG000|COMPLETED|6-month Follow-up||52||
48666985|NCT04261985|101970510|FG001|COMPLETED|6-month Follow-up||62||
48666986|NCT04261985|101970509|FG000|NOT COMPLETED|6-month Follow-up||2||
48666987|NCT04261985|101970510|FG001|NOT COMPLETED|6-month Follow-up||2||
48666988|NCT03468998|101970511|FG000|STARTED|Overall Study||7||8
48666989|NCT03468998|101970512|FG001|STARTED|Overall Study||7||7
48666990|NCT03468998|101970513|FG002|STARTED|Overall Study||1||2
48666991|NCT03468998|101970514|FG003|STARTED|Overall Study||10||10
48666992|NCT03468998|101970515|FG004|STARTED|Overall Study||10||10
48666993|NCT03468998|101970516|FG005|STARTED|Overall Study||2||4
48666994|NCT03468998|101970511|FG000|COMPLETED|Overall Study||6||7
48666995|NCT03468998|101970512|FG001|COMPLETED|Overall Study||6||6
48666996|NCT03468998|101970513|FG002|COMPLETED|Overall Study||1||2
48666997|NCT03468998|101970514|FG003|COMPLETED|Overall Study||6||6
48666998|NCT03468998|101970515|FG004|COMPLETED|Overall Study||9||9
48666999|NCT03468998|101970516|FG005|COMPLETED|Overall Study||2||4
48667000|NCT03468998|101970511|FG000|NOT COMPLETED|Overall Study||1||1
48667001|NCT03468998|101970512|FG001|NOT COMPLETED|Overall Study||1||1
48667002|NCT03468998|101970513|FG002|NOT COMPLETED|Overall Study||0||0
48667003|NCT03468998|101970514|FG003|NOT COMPLETED|Overall Study||4||4
48667004|NCT03468998|101970515|FG004|NOT COMPLETED|Overall Study||1||1
48667005|NCT03468998|101970516|FG005|NOT COMPLETED|Overall Study||0||0
48667006|NCT04053387|101970517|FG000|STARTED|Overall Study||763||
48667007|NCT04053387|101970517|FG000|COMPLETED|Overall Study||531||
48667008|NCT04053387|101970517|FG000|NOT COMPLETED|Overall Study||232||
48667009|NCT02947048|101970518|FG000|STARTED|Overall Study||5||
48667010|NCT02947048|101970519|FG001|STARTED|Overall Study||10||
48667011|NCT02947048|101970520|FG002|STARTED|Overall Study||5||
48667012|NCT02947048|101970521|FG003|STARTED|Overall Study||6||
48667013|NCT02947048|101970522|FG004|STARTED|Overall Study||11||
48667014|NCT02947048|101970523|FG005|STARTED|Overall Study||5||
48667015|NCT02947048|101970518|FG000|Safety Population|Overall Study||5|For safety analyses both placebo groups were combined.|
48667016|NCT02947048|101970519|FG001|Safety Population|Overall Study||10|For safety analyses both placebo groups were combined.|
48667017|NCT02947048|101970520|FG002|Safety Population|Overall Study||5|For safety analyses both placebo groups were combined.|
48667018|NCT02947048|101970521|FG003|Safety Population|Overall Study||6|For safety analyses both placebo groups were combined.|
48667019|NCT02947048|101970522|FG004|Safety Population|Overall Study||11|For safety analyses both placebo groups were combined.|
48667020|NCT02947048|101970523|FG005|Safety Population|Overall Study||5|For safety analyses both placebo groups were combined.|
48667021|NCT02947048|101970518|FG000|Efficacy Population|Overall Study||0|The efficacy population includes patients enrolled in the double-blind portion of the study. Two patients were omitted for the efficacy population in Cohort 1 (1 patient in placebo and 1 patient in L1-79 100 mg TID group) because there was apparent confusion in the assigned-vs.-received drug kit numbers. These patients were included in the safety population.|
48667022|NCT02947048|101970519|FG001|Efficacy Population|Overall Study||9|The efficacy population includes patients enrolled in the double-blind portion of the study. Two patients were omitted for the efficacy population in Cohort 1 (1 patient in placebo and 1 patient in L1-79 100 mg TID group) because there was apparent confusion in the assigned-vs.-received drug kit numbers. These patients were included in the safety population.|
48667023|NCT02947048|101970520|FG002|Efficacy Population|Overall Study||4|The efficacy population includes patients enrolled in the double-blind portion of the study. Two patients were omitted for the efficacy population in Cohort 1 (1 patient in placebo and 1 patient in L1-79 100 mg TID group) because there was apparent confusion in the assigned-vs.-received drug kit numbers. These patients were included in the safety population.|
48667024|NCT02947048|101970521|FG003|Efficacy Population|Overall Study||0|The efficacy population includes patients enrolled in the double-blind portion of the study. Two patients were omitted for the efficacy population in Cohort 1 (1 patient in placebo and 1 patient in L1-79 100 mg TID group) because there was apparent confusion in the assigned-vs.-received drug kit numbers. These patients were included in the safety population.|
48667025|NCT02947048|101970522|FG004|Efficacy Population|Overall Study||11|The efficacy population includes patients enrolled in the double-blind portion of the study. Two patients were omitted for the efficacy population in Cohort 1 (1 patient in placebo and 1 patient in L1-79 100 mg TID group) because there was apparent confusion in the assigned-vs.-received drug kit numbers. These patients were included in the safety population.|
48667026|NCT02947048|101970523|FG005|Efficacy Population|Overall Study||5|The efficacy population includes patients enrolled in the double-blind portion of the study. Two patients were omitted for the efficacy population in Cohort 1 (1 patient in placebo and 1 patient in L1-79 100 mg TID group) because there was apparent confusion in the assigned-vs.-received drug kit numbers. These patients were included in the safety population.|
48667027|NCT02947048|101970518|FG000|COMPLETED|Overall Study||5||
48667028|NCT02947048|101970519|FG001|COMPLETED|Overall Study||10||
48667029|NCT02947048|101970520|FG002|COMPLETED|Overall Study||5||
48667030|NCT02947048|101970521|FG003|COMPLETED|Overall Study||5||
48667031|NCT02947048|101970522|FG004|COMPLETED|Overall Study||10||
48667032|NCT02947048|101970523|FG005|COMPLETED|Overall Study||4||
48667033|NCT02947048|101970518|FG000|NOT COMPLETED|Overall Study||0||
48667034|NCT02947048|101970519|FG001|NOT COMPLETED|Overall Study||0||
48667035|NCT02947048|101970520|FG002|NOT COMPLETED|Overall Study||0||
48667036|NCT02947048|101970521|FG003|NOT COMPLETED|Overall Study||1||
48667037|NCT02947048|101970522|FG004|NOT COMPLETED|Overall Study||1||
48667038|NCT02947048|101970523|FG005|NOT COMPLETED|Overall Study||1||
48667039|NCT05270863|101970524|FG000|STARTED|Visit 2 First Intervention||31||
48667040|NCT05270863|101970525|FG001|STARTED|Visit 2 First Intervention||30||
48667041|NCT05270863|101970526|FG002|STARTED|Visit 2 First Intervention||30||
48667042|NCT05270863|101970527|FG003|STARTED|Visit 2 First Intervention||30||
48667043|NCT05270863|101970528|FG004|STARTED|Visit 2 First Intervention||31||
48667044|NCT05270863|101970529|FG005|STARTED|Visit 2 First Intervention||30||
48667045|NCT05270863|101970524|FG000|COMPLETED|Visit 2 First Intervention||31||
48667046|NCT05270863|101970525|FG001|COMPLETED|Visit 2 First Intervention||30||
48667047|NCT05270863|101970526|FG002|COMPLETED|Visit 2 First Intervention||30||
48667048|NCT05270863|101970527|FG003|COMPLETED|Visit 2 First Intervention||29||
48667049|NCT05270863|101970528|FG004|COMPLETED|Visit 2 First Intervention||31||
48667050|NCT05270863|101970529|FG005|COMPLETED|Visit 2 First Intervention||30||
48667051|NCT05270863|101970524|FG000|NOT COMPLETED|Visit 2 First Intervention||0||
48667052|NCT05270863|101970525|FG001|NOT COMPLETED|Visit 2 First Intervention||0||
48667053|NCT05270863|101970526|FG002|NOT COMPLETED|Visit 2 First Intervention||0||
48667054|NCT05270863|101970527|FG003|NOT COMPLETED|Visit 2 First Intervention||1||
48667055|NCT05270863|101970528|FG004|NOT COMPLETED|Visit 2 First Intervention||0||
48667056|NCT05270863|101970529|FG005|NOT COMPLETED|Visit 2 First Intervention||0||
48667057|NCT05270863|101970524|FG000|STARTED|First Washout||31||
48667058|NCT05270863|101970525|FG001|STARTED|First Washout||30||
48667059|NCT05270863|101970526|FG002|STARTED|First Washout||30||
48667060|NCT05270863|101970527|FG003|STARTED|First Washout||29||
48667061|NCT05270863|101970528|FG004|STARTED|First Washout||31||
48667062|NCT05270863|101970529|FG005|STARTED|First Washout||30||
48667063|NCT05270863|101970524|FG000|COMPLETED|First Washout||31||
48667064|NCT05270863|101970525|FG001|COMPLETED|First Washout||30||
48667065|NCT05270863|101970526|FG002|COMPLETED|First Washout||30||
48667066|NCT05270863|101970527|FG003|COMPLETED|First Washout||29||
48667067|NCT05270863|101970528|FG004|COMPLETED|First Washout||30||
48667068|NCT05270863|101970529|FG005|COMPLETED|First Washout||28||
48667069|NCT05270863|101970524|FG000|NOT COMPLETED|First Washout||0||
48667070|NCT05270863|101970525|FG001|NOT COMPLETED|First Washout||0||
48667071|NCT05270863|101970526|FG002|NOT COMPLETED|First Washout||0||
48667072|NCT05270863|101970527|FG003|NOT COMPLETED|First Washout||0||
48667073|NCT05270863|101970528|FG004|NOT COMPLETED|First Washout||1||
48667074|NCT05270863|101970529|FG005|NOT COMPLETED|First Washout||2||
48667075|NCT05270863|101970524|FG000|STARTED|Visit 3 Second Intervention||31||
48667076|NCT05270863|101970525|FG001|STARTED|Visit 3 Second Intervention||30||
48667077|NCT05270863|101970526|FG002|STARTED|Visit 3 Second Intervention||30||
48667078|NCT05270863|101970527|FG003|STARTED|Visit 3 Second Intervention||29||
48667079|NCT05270863|101970528|FG004|STARTED|Visit 3 Second Intervention||30||
48667080|NCT05270863|101970529|FG005|STARTED|Visit 3 Second Intervention||28||
48667081|NCT05270863|101970524|FG000|COMPLETED|Visit 3 Second Intervention||30||
48667082|NCT05270863|101970525|FG001|COMPLETED|Visit 3 Second Intervention||30||
48667083|NCT05270863|101970526|FG002|COMPLETED|Visit 3 Second Intervention||29||
48667084|NCT05270863|101970527|FG003|COMPLETED|Visit 3 Second Intervention||29||
48667085|NCT05270863|101970528|FG004|COMPLETED|Visit 3 Second Intervention||30||
48667086|NCT05270863|101970529|FG005|COMPLETED|Visit 3 Second Intervention||28||
48667087|NCT05270863|101970524|FG000|NOT COMPLETED|Visit 3 Second Intervention||1||
48667088|NCT05270863|101970525|FG001|NOT COMPLETED|Visit 3 Second Intervention||0||
48667089|NCT05270863|101970526|FG002|NOT COMPLETED|Visit 3 Second Intervention||1||
48667090|NCT05270863|101970527|FG003|NOT COMPLETED|Visit 3 Second Intervention||0||
48667091|NCT05270863|101970528|FG004|NOT COMPLETED|Visit 3 Second Intervention||0||
48667092|NCT05270863|101970529|FG005|NOT COMPLETED|Visit 3 Second Intervention||0||
48667093|NCT05270863|101970524|FG000|STARTED|Second Washout||30||
48667094|NCT05270863|101970525|FG001|STARTED|Second Washout||30||
48667095|NCT05270863|101970526|FG002|STARTED|Second Washout||29||
48667096|NCT05270863|101970527|FG003|STARTED|Second Washout||29||
48667097|NCT05270863|101970528|FG004|STARTED|Second Washout||30||
48667098|NCT05270863|101970529|FG005|STARTED|Second Washout||28||
48667099|NCT05270863|101970524|FG000|COMPLETED|Second Washout||29||
48667100|NCT05270863|101970525|FG001|COMPLETED|Second Washout||29||
48667101|NCT05270863|101970526|FG002|COMPLETED|Second Washout||29||
48667102|NCT05270863|101970527|FG003|COMPLETED|Second Washout||28||
48667103|NCT05270863|101970528|FG004|COMPLETED|Second Washout||30||
48667104|NCT05270863|101970529|FG005|COMPLETED|Second Washout||28||
48667105|NCT05270863|101970524|FG000|NOT COMPLETED|Second Washout||1||
48667106|NCT05270863|101970525|FG001|NOT COMPLETED|Second Washout||1||
48667107|NCT05270863|101970526|FG002|NOT COMPLETED|Second Washout||0||
48667108|NCT05270863|101970527|FG003|NOT COMPLETED|Second Washout||1||
48667109|NCT05270863|101970528|FG004|NOT COMPLETED|Second Washout||0||
48667110|NCT05270863|101970529|FG005|NOT COMPLETED|Second Washout||0||
48667111|NCT05270863|101970524|FG000|STARTED|Visit 4 Third Invervention||29||
48667112|NCT05270863|101970525|FG001|STARTED|Visit 4 Third Invervention||29||
48667113|NCT05270863|101970526|FG002|STARTED|Visit 4 Third Invervention||29||
48667114|NCT05270863|101970527|FG003|STARTED|Visit 4 Third Invervention||28||
48667115|NCT05270863|101970528|FG004|STARTED|Visit 4 Third Invervention||30||
48667116|NCT05270863|101970529|FG005|STARTED|Visit 4 Third Invervention||28||
48667117|NCT05270863|101970524|FG000|COMPLETED|Visit 4 Third Invervention||29||
48667118|NCT05270863|101970525|FG001|COMPLETED|Visit 4 Third Invervention||29||
48667119|NCT05270863|101970526|FG002|COMPLETED|Visit 4 Third Invervention||29||
48667120|NCT05270863|101970527|FG003|COMPLETED|Visit 4 Third Invervention||28||
48667121|NCT05270863|101970528|FG004|COMPLETED|Visit 4 Third Invervention||30||
48667122|NCT05270863|101970529|FG005|COMPLETED|Visit 4 Third Invervention||28||
48667123|NCT05270863|101970524|FG000|NOT COMPLETED|Visit 4 Third Invervention||0||
48667124|NCT05270863|101970525|FG001|NOT COMPLETED|Visit 4 Third Invervention||0||
48667125|NCT05270863|101970526|FG002|NOT COMPLETED|Visit 4 Third Invervention||0||
48667126|NCT05270863|101970527|FG003|NOT COMPLETED|Visit 4 Third Invervention||0||
48667127|NCT05270863|101970528|FG004|NOT COMPLETED|Visit 4 Third Invervention||0||
48667128|NCT05270863|101970529|FG005|NOT COMPLETED|Visit 4 Third Invervention||0||
48667129|NCT01344356|101970530|FG000|STARTED|Overall Study||1||
48667130|NCT01344356|101970531|FG001|STARTED|Overall Study||18||
48667131|NCT01344356|101970530|FG000|COMPLETED|Overall Study||1||
48667132|NCT01344356|101970531|FG001|COMPLETED|Overall Study||9||
48667133|NCT01344356|101970530|FG000|NOT COMPLETED|Overall Study||0||
48667134|NCT01344356|101970531|FG001|NOT COMPLETED|Overall Study||9||
48667135|NCT00823797|101970532|FG000|STARTED|Overall Study||29||
48667136|NCT00823797|101970533|FG001|STARTED|Overall Study||16||
48667137|NCT00823797|101970532|FG000|COMPLETED|Overall Study||29||
48667138|NCT00823797|101970533|FG001|COMPLETED|Overall Study||16||
48667139|NCT00823797|101970532|FG000|NOT COMPLETED|Overall Study||0||
48667140|NCT00823797|101970533|FG001|NOT COMPLETED|Overall Study||0||
48667141|NCT00499447|101970534|FG000|STARTED|Overall Study||13||
48667142|NCT00499447|101970534|FG000|COMPLETED|Overall Study||13||
48667143|NCT00499447|101970534|FG000|NOT COMPLETED|Overall Study||0||
48667144|NCT02096354|101970535|FG000|STARTED|Overall Study||38||
48667145|NCT02096354|101970536|FG001|STARTED|Overall Study||13||
48667146|NCT02096354|101970537|FG002|STARTED|Overall Study||11||
48667147|NCT02096354|101970535|FG000|COMPLETED|Overall Study||24||
48667148|NCT02096354|101970536|FG001|COMPLETED|Overall Study||3||
48667149|NCT02096354|101970537|FG002|COMPLETED|Overall Study||0||
48667150|NCT02096354|101970535|FG000|NOT COMPLETED|Overall Study||14||
48667151|NCT02096354|101970536|FG001|NOT COMPLETED|Overall Study||10||
48667152|NCT02096354|101970537|FG002|NOT COMPLETED|Overall Study||11||
48667153|NCT05196776|101970538|FG000|STARTED|Overall Study||54||
48667154|NCT05196776|101970539|FG001|STARTED|Overall Study||56||
48667155|NCT05196776|101970538|FG000|COMPLETED|Overall Study||53||
48667156|NCT05196776|101970539|FG001|COMPLETED|Overall Study||56||
48667157|NCT05196776|101970538|FG000|NOT COMPLETED|Overall Study||1||
48667158|NCT05196776|101970539|FG001|NOT COMPLETED|Overall Study||0||
48667159|NCT04016714|101970540|FG000|STARTED|Overall Study||595||
48667160|NCT04016714|101970541|FG001|STARTED|Overall Study||596||
48667161|NCT04016714|101970540|FG000|Vaccination 1 (V114 or Prevenar 13™)|Overall Study||595||
48667162|NCT04016714|101970541|FG001|Vaccination 1 (V114 or Prevenar 13™)|Overall Study||596||
48667163|NCT04016714|101970540|FG000|Vaccination 2 (V114 or Prevenar 13™)|Overall Study||585||
48667164|NCT04016714|101970541|FG001|Vaccination 2 (V114 or Prevenar 13™)|Overall Study||588||
48667165|NCT04016714|101970540|FG000|Vaccination 3 (V114 or Prevenar 13™)|Overall Study||573||
48667166|NCT04016714|101970541|FG001|Vaccination 3 (V114 or Prevenar 13™)|Overall Study||581||
48667167|NCT04016714|101970540|FG000|COMPLETED|Overall Study||572||
48667168|NCT04016714|101970541|FG001|COMPLETED|Overall Study||580||
48667169|NCT04016714|101970540|FG000|NOT COMPLETED|Overall Study||23||
48667170|NCT04016714|101970541|FG001|NOT COMPLETED|Overall Study||16||
48667171|NCT03309202|101970542|FG000|STARTED|Overall Study||6||
48667172|NCT03309202|101970543|FG001|STARTED|Overall Study||6||
48667173|NCT03309202|101970544|FG002|STARTED|Overall Study||6||
48667174|NCT03309202|101970545|FG003|STARTED|Overall Study||6||
48667175|NCT03309202|101970542|FG000|COMPLETED|Overall Study||5||
48667176|NCT03309202|101970543|FG001|COMPLETED|Overall Study||6||
48667177|NCT03309202|101970544|FG002|COMPLETED|Overall Study||6||
48667178|NCT03309202|101970545|FG003|COMPLETED|Overall Study||6||
48667179|NCT03309202|101970542|FG000|NOT COMPLETED|Overall Study||1||
48667180|NCT03309202|101970543|FG001|NOT COMPLETED|Overall Study||0||
48667181|NCT03309202|101970544|FG002|NOT COMPLETED|Overall Study||0||
48667182|NCT03309202|101970545|FG003|NOT COMPLETED|Overall Study||0||
48667183|NCT00737360|101970546|FG000|STARTED|Overall Study||27||
48667184|NCT00737360|101970546|FG000|COMPLETED|Overall Study||27||
48667185|NCT00737360|101970546|FG000|NOT COMPLETED|Overall Study||0||
48667186|NCT04897568|101970547|FG000|STARTED|Overall Study||64||3
48667187|NCT04897568|101970548|FG001|STARTED|Overall Study||56||3
48667188|NCT04897568|101970547|FG000|COMPLETED|Overall Study||64||3
48667189|NCT04897568|101970548|FG001|COMPLETED|Overall Study||56||3
48667190|NCT04897568|101970547|FG000|NOT COMPLETED|Overall Study||0||0
48667191|NCT04897568|101970548|FG001|NOT COMPLETED|Overall Study||0||0
48667192|NCT02927964|101970549|FG000|STARTED|Overall Study||11||
48667193|NCT02927964|101970550|FG001|STARTED|Overall Study||10||
48667194|NCT02927964|101970549|FG000|COMPLETED|Overall Study||11||
48667195|NCT02927964|101970550|FG001|COMPLETED|Overall Study||9||
48667196|NCT02927964|101970549|FG000|NOT COMPLETED|Overall Study||0||
48667197|NCT02927964|101970550|FG001|NOT COMPLETED|Overall Study||1||
48667198|NCT00689884|101970551|FG000|STARTED|Overall Study||7||
48667199|NCT00689884|101970551|FG000|COMPLETED|Overall Study||7||
48667200|NCT00689884|101970551|FG000|NOT COMPLETED|Overall Study||0||
48667201|NCT02085720|101970552|FG000|STARTED|Overall Study||819||
48667202|NCT02085720|101970552|FG000|COMPLETED|Overall Study||819||
48667203|NCT02085720|101970552|FG000|NOT COMPLETED|Overall Study||0||
48667204|NCT00734032|101970553|FG000|STARTED|Overall Study||25||
48667205|NCT00734032|101970554|FG001|STARTED|Overall Study||28||
48667206|NCT00734032|101970555|FG002|STARTED|Overall Study||28||
48667207|NCT00734032|101970556|FG003|STARTED|Overall Study||26||
48667208|NCT00734032|101970553|FG000|COMPLETED|Overall Study||25||
48667209|NCT00734032|101970554|FG001|COMPLETED|Overall Study||27||
48667210|NCT00734032|101970555|FG002|COMPLETED|Overall Study||28||
48667211|NCT00734032|101970556|FG003|COMPLETED|Overall Study||26||
48667212|NCT00734032|101970553|FG000|NOT COMPLETED|Overall Study||0||
48667213|NCT00734032|101970554|FG001|NOT COMPLETED|Overall Study||1||
48667214|NCT00734032|101970555|FG002|NOT COMPLETED|Overall Study||0||
48667215|NCT00734032|101970556|FG003|NOT COMPLETED|Overall Study||0||
48667216|NCT03931330|101970557|FG000|STARTED|Overall Study||8||
48667217|NCT03931330|101970557|FG000|4 Weeks of Neuromodulation|Overall Study||7||
48667218|NCT03931330|101970557|FG000|COMPLETED|Overall Study||7||
48667219|NCT03931330|101970557|FG000|NOT COMPLETED|Overall Study||1||
48667220|NCT02836249|101970558|FG000|STARTED|Double-Blind Treatment Phase||123||
48667221|NCT02836249|101970559|FG001|STARTED|Double-Blind Treatment Phase||58||
48667222|NCT02836249|101970560|FG002|STARTED|Double-Blind Treatment Phase||0||
48667223|NCT02836249|101970561|FG003|STARTED|Double-Blind Treatment Phase||0||
48667224|NCT02836249|101970558|FG000|COMPLETED|Double-Blind Treatment Phase||114||
48667225|NCT02836249|101970559|FG001|COMPLETED|Double-Blind Treatment Phase||52||
48667226|NCT02836249|101970560|FG002|COMPLETED|Double-Blind Treatment Phase||0||
48667227|NCT02836249|101970561|FG003|COMPLETED|Double-Blind Treatment Phase||0||
48667228|NCT02836249|101970558|FG000|NOT COMPLETED|Double-Blind Treatment Phase||9||
48667229|NCT02836249|101970559|FG001|NOT COMPLETED|Double-Blind Treatment Phase||6||
48667230|NCT02836249|101970560|FG002|NOT COMPLETED|Double-Blind Treatment Phase||0||
48667231|NCT02836249|101970561|FG003|NOT COMPLETED|Double-Blind Treatment Phase||0||
48667232|NCT02836249|101970558|FG000|STARTED|Open-Label TAF Treatment Phase||0|At the end of Double-blind Phase, participants were given the option to receive TAF in an OL TAF Extension Phase for additional 240 weeks.|
48667233|NCT02836249|101970559|FG001|STARTED|Open-Label TAF Treatment Phase||0|At the end of Double-blind Phase, participants were given the option to receive TAF in an OL TAF Extension Phase for additional 240 weeks.|
48667234|NCT02836249|101970560|FG002|STARTED|Open-Label TAF Treatment Phase||113|At the end of Double-blind Phase, participants were given the option to receive TAF in an OL TAF Extension Phase for additional 240 weeks.|
48667235|NCT02836249|101970561|FG003|STARTED|Open-Label TAF Treatment Phase||52|At the end of Double-blind Phase, participants were given the option to receive TAF in an OL TAF Extension Phase for additional 240 weeks.|
48667236|NCT02836249|101970558|FG000|COMPLETED|Open-Label TAF Treatment Phase||0||
48667237|NCT02836249|101970559|FG001|COMPLETED|Open-Label TAF Treatment Phase||0||
48667238|NCT02836249|101970560|FG002|COMPLETED|Open-Label TAF Treatment Phase||100||
48667239|NCT02836249|101970561|FG003|COMPLETED|Open-Label TAF Treatment Phase||48||
48667240|NCT02836249|101970558|FG000|NOT COMPLETED|Open-Label TAF Treatment Phase||0||
48667241|NCT02836249|101970559|FG001|NOT COMPLETED|Open-Label TAF Treatment Phase||0||
48667242|NCT02836249|101970560|FG002|NOT COMPLETED|Open-Label TAF Treatment Phase||13||
48667243|NCT02836249|101970561|FG003|NOT COMPLETED|Open-Label TAF Treatment Phase||4||
48667244|NCT05078112|101970562|FG000|STARTED|Overall Study||19||
48667245|NCT05078112|101970562|FG000|COMPLETED|Overall Study||19||
48667246|NCT05078112|101970562|FG000|NOT COMPLETED|Overall Study||0||
48667247|NCT01630109|101970563|FG000|STARTED|Overall Study||1||
48667248|NCT01630109|101970564|FG001|STARTED|Overall Study||1||
48667249|NCT01630109|101970565|FG002|STARTED|Overall Study||3||
48667250|NCT01630109|101970563|FG000|COMPLETED|Overall Study||1||
48667251|NCT01630109|101970564|FG001|COMPLETED|Overall Study||1||
48667252|NCT01630109|101970565|FG002|COMPLETED|Overall Study||3||
48667253|NCT01630109|101970563|FG000|NOT COMPLETED|Overall Study||0||
48667254|NCT01630109|101970564|FG001|NOT COMPLETED|Overall Study||0||
48667255|NCT01630109|101970565|FG002|NOT COMPLETED|Overall Study||0||
48667256|NCT01859013|101970566|FG000|STARTED|Overall Study||16||
48667257|NCT01859013|101970567|FG001|STARTED|Overall Study||14||
48667258|NCT01859013|101970566|FG000|COMPLETED|Overall Study||12||
48667259|NCT01859013|101970567|FG001|COMPLETED|Overall Study||9||
48667260|NCT01859013|101970566|FG000|NOT COMPLETED|Overall Study||4||
48667261|NCT01859013|101970567|FG001|NOT COMPLETED|Overall Study||5||
48667262|NCT00936936|101970568|FG000|STARTED|Overall Study||41||
48667263|NCT00936936|101970569|FG001|STARTED|Overall Study||23||
48667264|NCT00936936|101970568|FG000|Cycle 1|Overall Study||41||
48667265|NCT00936936|101970569|FG001|Cycle 1|Overall Study||23||
48667266|NCT00936936|101970568|FG000|Cycle 2|Overall Study||29||
48667267|NCT00936936|101970569|FG001|Cycle 2|Overall Study||23||
48667268|NCT00936936|101970568|FG000|COMPLETED|Overall Study||29||
48667269|NCT00936936|101970569|FG001|COMPLETED|Overall Study||19||
48667270|NCT00936936|101970568|FG000|NOT COMPLETED|Overall Study||12||
48667271|NCT00936936|101970569|FG001|NOT COMPLETED|Overall Study||4||
48667272|NCT02919618|101970570|FG000|STARTED|Overall Study||19||
48068168|NCT02598960|100489668|FG005|COMPLETED|Treatment Period||1|= completing initial treatment period|
48219976|NCT05580003|100863771|FG023|NOT COMPLETED|Part 3: Period 3 (Day 1)||0||
48219977|NCT05580003|100863772|FG024|NOT COMPLETED|Part 3: Period 3 (Day 1)||0||
48219978|NCT05580003|100863773|FG025|NOT COMPLETED|Part 3: Period 3 (Day 1)||0||
48219979|NCT05580003|100863774|FG026|NOT COMPLETED|Part 3: Period 3 (Day 1)||0||
48219980|NCT05580003|100863775|FG027|NOT COMPLETED|Part 3: Period 3 (Day 1)||0||
48068169|NCT02598960|100489669|FG006|COMPLETED|Treatment Period||0|= completing initial treatment period|
48068170|NCT02598960|100489670|FG007|COMPLETED|Treatment Period||0|= completing initial treatment period|
48068171|NCT02598960|100489671|FG008|COMPLETED|Treatment Period||2|= completing initial treatment period|
48068172|NCT02598960|100489672|FG009|COMPLETED|Treatment Period||3|= completing initial treatment period|
48068173|NCT02598960|100489673|FG010|COMPLETED|Treatment Period||3|= completing initial treatment period|
48068174|NCT02598960|100489674|FG011|COMPLETED|Treatment Period||23|= completing initial treatment period|
48068175|NCT02598960|100489675|FG012|COMPLETED|Treatment Period||7|= completing initial treatment period|
48068176|NCT02598960|100489663|FG000|NOT COMPLETED|Treatment Period||4||
48068177|NCT02598960|100489664|FG001|NOT COMPLETED|Treatment Period||6||
48068178|NCT02598960|100489665|FG002|NOT COMPLETED|Treatment Period||4||
48068179|NCT02598960|100489666|FG003|NOT COMPLETED|Treatment Period||6||
48068180|NCT02598960|100489667|FG004|NOT COMPLETED|Treatment Period||9||
48068181|NCT02598960|100489668|FG005|NOT COMPLETED|Treatment Period||2||
48068182|NCT02598960|100489669|FG006|NOT COMPLETED|Treatment Period||2||
48068183|NCT02598960|100489670|FG007|NOT COMPLETED|Treatment Period||3||
48068184|NCT02598960|100489671|FG008|NOT COMPLETED|Treatment Period||7||
48068185|NCT02598960|100489672|FG009|NOT COMPLETED|Treatment Period||11||
48068186|NCT02598960|100489673|FG010|NOT COMPLETED|Treatment Period||8||
48068187|NCT02598960|100489674|FG011|NOT COMPLETED|Treatment Period||165||
48068188|NCT02598960|100489675|FG012|NOT COMPLETED|Treatment Period||26||
48068189|NCT02598960|100489663|FG000|STARTED|Participants Entering Follow Up Period||4|= participants entering follow up period|
48068190|NCT02598960|100489664|FG001|STARTED|Participants Entering Follow Up Period||6|= participants entering follow up period|
48068191|NCT02598960|100489665|FG002|STARTED|Participants Entering Follow Up Period||4|= participants entering follow up period|
48068192|NCT02598960|100489666|FG003|STARTED|Participants Entering Follow Up Period||6|= participants entering follow up period|
48068193|NCT02598960|100489667|FG004|STARTED|Participants Entering Follow Up Period||9|= participants entering follow up period|
48068194|NCT02598960|100489668|FG005|STARTED|Participants Entering Follow Up Period||3|= participants entering follow up period|
48068195|NCT02598960|100489669|FG006|STARTED|Participants Entering Follow Up Period||2|= participants entering follow up period|
48068196|NCT02598960|100489670|FG007|STARTED|Participants Entering Follow Up Period||3|= participants entering follow up period|
48068197|NCT02598960|100489671|FG008|STARTED|Participants Entering Follow Up Period||9|= participants entering follow up period|
48068198|NCT02598960|100489672|FG009|STARTED|Participants Entering Follow Up Period||14|= participants entering follow up period|
48068199|NCT02598960|100489673|FG010|STARTED|Participants Entering Follow Up Period||11|= participants entering follow up period|
48068200|NCT02598960|100489674|FG011|STARTED|Participants Entering Follow Up Period||188|= participants entering follow up period|
48068201|NCT02598960|100489675|FG012|STARTED|Participants Entering Follow Up Period||33|= participants entering follow up period|
48068202|NCT02598960|100489663|FG000|COMPLETED|Participants Entering Follow Up Period||3||
48068203|NCT02598960|100489664|FG001|COMPLETED|Participants Entering Follow Up Period||6||
48068204|NCT02598960|100489665|FG002|COMPLETED|Participants Entering Follow Up Period||4||
48068205|NCT02598960|100489666|FG003|COMPLETED|Participants Entering Follow Up Period||6||
48068206|NCT02598960|100489667|FG004|COMPLETED|Participants Entering Follow Up Period||9||
48068207|NCT02598960|100489668|FG005|COMPLETED|Participants Entering Follow Up Period||3||
48068208|NCT02598960|100489669|FG006|COMPLETED|Participants Entering Follow Up Period||2||
48068209|NCT02598960|100489670|FG007|COMPLETED|Participants Entering Follow Up Period||3||
48068210|NCT02598960|100489671|FG008|COMPLETED|Participants Entering Follow Up Period||9||
48068211|NCT02598960|100489672|FG009|COMPLETED|Participants Entering Follow Up Period||13||
48068212|NCT02598960|100489673|FG010|COMPLETED|Participants Entering Follow Up Period||10||
48068213|NCT02598960|100489674|FG011|COMPLETED|Participants Entering Follow Up Period||159||
48068214|NCT02598960|100489675|FG012|COMPLETED|Participants Entering Follow Up Period||28||
48068215|NCT02598960|100489663|FG000|NOT COMPLETED|Participants Entering Follow Up Period||1||
48068216|NCT02598960|100489664|FG001|NOT COMPLETED|Participants Entering Follow Up Period||0||
48068217|NCT02598960|100489665|FG002|NOT COMPLETED|Participants Entering Follow Up Period||0||
48068218|NCT02598960|100489666|FG003|NOT COMPLETED|Participants Entering Follow Up Period||0||
48068219|NCT02598960|100489667|FG004|NOT COMPLETED|Participants Entering Follow Up Period||0||
48068220|NCT02598960|100489668|FG005|NOT COMPLETED|Participants Entering Follow Up Period||0||
48068221|NCT02598960|100489669|FG006|NOT COMPLETED|Participants Entering Follow Up Period||0||
48068222|NCT02598960|100489670|FG007|NOT COMPLETED|Participants Entering Follow Up Period||0||
48068223|NCT02598960|100489671|FG008|NOT COMPLETED|Participants Entering Follow Up Period||0||
48068224|NCT02598960|100489672|FG009|NOT COMPLETED|Participants Entering Follow Up Period||1||
48068225|NCT02598960|100489673|FG010|NOT COMPLETED|Participants Entering Follow Up Period||1||
48068226|NCT02598960|100489674|FG011|NOT COMPLETED|Participants Entering Follow Up Period||29||
48068227|NCT02598960|100489675|FG012|NOT COMPLETED|Participants Entering Follow Up Period||5||
48068228|NCT01206166|100489676|FG000|STARTED|Overall Study||73||
48068229|NCT01206166|100489677|FG001|STARTED|Overall Study||52||
48068230|NCT01206166|100489676|FG000|COMPLETED|Overall Study||71||
48068231|NCT01206166|100489677|FG001|COMPLETED|Overall Study||49||
48068232|NCT01206166|100489676|FG000|NOT COMPLETED|Overall Study||2||
48068233|NCT01206166|100489677|FG001|NOT COMPLETED|Overall Study||3||
48068234|NCT00747461|100489678|FG000|STARTED|Overall Study||5||
48068235|NCT00747461|100489678|FG000|COMPLETED|Overall Study||0||
48068236|NCT00747461|100489678|FG000|NOT COMPLETED|Overall Study||5||
48068237|NCT01868503|100489679|FG000|STARTED|Overall Study||7||
48068238|NCT01868503|100489679|FG000|COMPLETED|Overall Study||5||
48068239|NCT01868503|100489679|FG000|NOT COMPLETED|Overall Study||2||
48068240|NCT00089414|100489680|FG000|STARTED|Overall Study||2||
48068241|NCT00089414|100489681|FG001|STARTED|Overall Study||1||
48068242|NCT00089414|100489682|FG002|STARTED|Overall Study||2||
48068243|NCT00089414|100489680|FG000|COMPLETED|Overall Study||2||
48068244|NCT00089414|100489681|FG001|COMPLETED|Overall Study||1||
48068245|NCT00089414|100489682|FG002|COMPLETED|Overall Study||2||
48068246|NCT00089414|100489680|FG000|NOT COMPLETED|Overall Study||0||
48068247|NCT00089414|100489681|FG001|NOT COMPLETED|Overall Study||0||
48068248|NCT00089414|100489682|FG002|NOT COMPLETED|Overall Study||0||
48068249|NCT02358681|100489683|FG000|STARTED|Overall Study||29||
48068250|NCT02358681|100489684|FG001|STARTED|Overall Study||30||
48068251|NCT02358681|100489683|FG000|COMPLETED|Overall Study||27||
48068252|NCT02358681|100489684|FG001|COMPLETED|Overall Study||29||
48068253|NCT02358681|100489683|FG000|NOT COMPLETED|Overall Study||2||
48068254|NCT02358681|100489684|FG001|NOT COMPLETED|Overall Study||1||
48068255|NCT03473171|100489685|FG000|STARTED|Overall Study||5||
48068256|NCT03473171|100489685|FG000|COMPLETED|Overall Study||5||
48068257|NCT03473171|100489685|FG000|NOT COMPLETED|Overall Study||0||
48068258|NCT01897714|100489686|FG000|STARTED|Phase I (Dose Escalation)||4||
48068259|NCT01897714|100489687|FG001|STARTED|Phase I (Dose Escalation)||7||
48068260|NCT01897714|100489688|FG002|STARTED|Phase I (Dose Escalation)||6||
48068261|NCT01897714|100489689|FG003|STARTED|Phase I (Dose Escalation)||6||
48068262|NCT01897714|100489690|FG004|STARTED|Phase I (Dose Escalation)||0||
48068263|NCT01897714|100489691|FG005|STARTED|Phase I (Dose Escalation)||0||
48068264|NCT01897714|100489686|FG000|COMPLETED|Phase I (Dose Escalation)||1|Completed 8 cycles or more of study drug.|
48068265|NCT01897714|100489687|FG001|COMPLETED|Phase I (Dose Escalation)||0|Completed 8 cycles or more of study drug.|
48068266|NCT01897714|100489688|FG002|COMPLETED|Phase I (Dose Escalation)||1|Completed 8 cycles or more of study drug.|
48068267|NCT01897714|100489689|FG003|COMPLETED|Phase I (Dose Escalation)||0|Completed 8 cycles or more of study drug.|
48068268|NCT01897714|100489690|FG004|COMPLETED|Phase I (Dose Escalation)||0|Completed 8 cycles or more of study drug.|
48068269|NCT01897714|100489691|FG005|COMPLETED|Phase I (Dose Escalation)||0|Completed 8 cycles or more of study drug.|
48068270|NCT01897714|100489686|FG000|NOT COMPLETED|Phase I (Dose Escalation)||3||
48068271|NCT01897714|100489687|FG001|NOT COMPLETED|Phase I (Dose Escalation)||7||
48068272|NCT01897714|100489688|FG002|NOT COMPLETED|Phase I (Dose Escalation)||5||
48068273|NCT01897714|100489689|FG003|NOT COMPLETED|Phase I (Dose Escalation)||6||
48068274|NCT01897714|100489690|FG004|NOT COMPLETED|Phase I (Dose Escalation)||0||
48068275|NCT01897714|100489691|FG005|NOT COMPLETED|Phase I (Dose Escalation)||0||
48068276|NCT01897714|100489686|FG000|STARTED|Phase II (MTD)||0||
48068277|NCT01897714|100489687|FG001|STARTED|Phase II (MTD)||0||
48068278|NCT01897714|100489688|FG002|STARTED|Phase II (MTD)||0||
48068279|NCT01897714|100489689|FG003|STARTED|Phase II (MTD)||0||
48068280|NCT01897714|100489690|FG004|STARTED|Phase II (MTD)||45||
48068281|NCT01897714|100489691|FG005|STARTED|Phase II (MTD)||13||
48068282|NCT01897714|100489686|FG000|COMPLETED|Phase II (MTD)||0||
48068283|NCT01897714|100489687|FG001|COMPLETED|Phase II (MTD)||0||
48068284|NCT01897714|100489688|FG002|COMPLETED|Phase II (MTD)||0||
48068285|NCT01897714|100489689|FG003|COMPLETED|Phase II (MTD)||0||
48068286|NCT01897714|100489690|FG004|COMPLETED|Phase II (MTD)||15||
48068287|NCT01897714|100489691|FG005|COMPLETED|Phase II (MTD)||2||
48068288|NCT01897714|100489686|FG000|NOT COMPLETED|Phase II (MTD)||0||
48068289|NCT01897714|100489687|FG001|NOT COMPLETED|Phase II (MTD)||0||
48068290|NCT01897714|100489688|FG002|NOT COMPLETED|Phase II (MTD)||0||
48068291|NCT01897714|100489689|FG003|NOT COMPLETED|Phase II (MTD)||0||
48068292|NCT01897714|100489690|FG004|NOT COMPLETED|Phase II (MTD)||30||
48068293|NCT01897714|100489691|FG005|NOT COMPLETED|Phase II (MTD)||11||
48068294|NCT03822182|100489692|FG000|STARTED|Overall Study||26||
48068295|NCT03822182|100489693|FG001|STARTED|Overall Study||25||
48068296|NCT03822182|100489694|FG002|STARTED|Overall Study||27||
48068297|NCT03822182|100489692|FG000|COMPLETED|Overall Study||26||
48068298|NCT03822182|100489693|FG001|COMPLETED|Overall Study||24||
48068299|NCT03822182|100489694|FG002|COMPLETED|Overall Study||26||
48068300|NCT03822182|100489692|FG000|NOT COMPLETED|Overall Study||0||
48068301|NCT03822182|100489693|FG001|NOT COMPLETED|Overall Study||1||
48068302|NCT03822182|100489694|FG002|NOT COMPLETED|Overall Study||1||
48068303|NCT00573937|100489695|FG000|STARTED|Overall Study||0||
48068304|NCT00573937|100489696|FG001|STARTED|Overall Study||1||
48068305|NCT00573937|100489695|FG000|COMPLETED|Overall Study||0||
48068306|NCT00573937|100489696|FG001|COMPLETED|Overall Study||0||
48068307|NCT00573937|100489695|FG000|NOT COMPLETED|Overall Study||0||
48068308|NCT00573937|100489696|FG001|NOT COMPLETED|Overall Study||1||
48068309|NCT01548287|100489697|FG000|STARTED|Screening||19||
48068310|NCT01548287|100489698|FG001|STARTED|Screening||22||
48068311|NCT01548287|100489699|FG002|STARTED|Screening||20||
48068312|NCT01548287|100489700|FG003|STARTED|Screening||20||
48068313|NCT01548287|100489701|FG004|STARTED|Screening||83||
48068314|NCT01548287|100489697|FG000|COMPLETED|Screening||19||
48068315|NCT01548287|100489698|FG001|COMPLETED|Screening||22||
48068316|NCT01548287|100489699|FG002|COMPLETED|Screening||20||
48068317|NCT01548287|100489700|FG003|COMPLETED|Screening||20||
48068318|NCT01548287|100489701|FG004|COMPLETED|Screening||0||
48068319|NCT01548287|100489697|FG000|NOT COMPLETED|Screening||0||
48068320|NCT01548287|100489698|FG001|NOT COMPLETED|Screening||0||
48068321|NCT01548287|100489699|FG002|NOT COMPLETED|Screening||0||
48068322|NCT01548287|100489700|FG003|NOT COMPLETED|Screening||0||
48068323|NCT01548287|100489701|FG004|NOT COMPLETED|Screening||83||
48068324|NCT01548287|100489697|FG000|STARTED|Randomized Period||19||
48068325|NCT01548287|100489698|FG001|STARTED|Randomized Period||22||
48068326|NCT01548287|100489699|FG002|STARTED|Randomized Period||20||
48068327|NCT01548287|100489700|FG003|STARTED|Randomized Period||20||
48068328|NCT01548287|100489701|FG004|STARTED|Randomized Period||0||
48068329|NCT01548287|100489697|FG000|COMPLETED|Randomized Period||19||
48068330|NCT01548287|100489698|FG001|COMPLETED|Randomized Period||20||
48068331|NCT01548287|100489699|FG002|COMPLETED|Randomized Period||13||
48068332|NCT01548287|100489700|FG003|COMPLETED|Randomized Period||20||
48068333|NCT01548287|100489701|FG004|COMPLETED|Randomized Period||0||
48068334|NCT01548287|100489697|FG000|NOT COMPLETED|Randomized Period||0||
48068335|NCT01548287|100489698|FG001|NOT COMPLETED|Randomized Period||2||
48068336|NCT01548287|100489699|FG002|NOT COMPLETED|Randomized Period||7||
48068337|NCT01548287|100489700|FG003|NOT COMPLETED|Randomized Period||0||
48068338|NCT01548287|100489701|FG004|NOT COMPLETED|Randomized Period||0||
48068339|NCT00737243|100489702|FG000|STARTED|Overall Study||289||
48068340|NCT00737243|100489702|FG000|Successful Assay Performed|Overall Study||252||
48068341|NCT00737243|100489702|FG000|Insufficient Tissue for Assay, Withdrawn|Overall Study||37||
48068342|NCT00737243|100489702|FG000|Treated|Overall Study||223||
48068343|NCT00737243|100489702|FG000|Not Treated|Overall Study||29||
48068344|NCT00737243|100489702|FG000|Site Specific Therapy More Responsive|Overall Study||115||
48068345|NCT00737243|100489702|FG000|Site Specific Therapy Less Responsive|Overall Study||79||
48068346|NCT00737243|100489702|FG000|Empiric CUP Therapy|Overall Study||29||
48068347|NCT00737243|100489702|FG000|COMPLETED|Overall Study||194||
48068348|NCT00737243|100489702|FG000|NOT COMPLETED|Overall Study||95||
48068349|NCT00246753|100489703|FG000|STARTED|Overall Study||29||
48068350|NCT00246753|100489703|FG000|COMPLETED|Overall Study||21||
48068351|NCT00246753|100489703|FG000|NOT COMPLETED|Overall Study||8||
48068352|NCT01758523|100489704|FG000|STARTED|Overall Study||74||
48068353|NCT01758523|100489705|FG001|STARTED|Overall Study||68||
48068354|NCT01758523|100489704|FG000|Attended >/= 1 Visit Post-randomization|Overall Study||68||
48068355|NCT01758523|100489705|FG001|Attended >/= 1 Visit Post-randomization|Overall Study||67||
48068356|NCT01758523|100489704|FG000|COMPLETED|Overall Study||53||
48068357|NCT01758523|100489705|FG001|COMPLETED|Overall Study||54||
48068358|NCT01758523|100489704|FG000|NOT COMPLETED|Overall Study||21||
48068359|NCT01758523|100489705|FG001|NOT COMPLETED|Overall Study||14||
48068360|NCT03789214|100489706|FG000|STARTED|Overall Study||12||
48068361|NCT03789214|100489707|FG001|STARTED|Overall Study||14||
48068362|NCT03789214|100489708|FG002|STARTED|Overall Study||12||
48068363|NCT03789214|100489706|FG000|COMPLETED|Overall Study||8||
48068364|NCT03789214|100489707|FG001|COMPLETED|Overall Study||9||
48068365|NCT03789214|100489708|FG002|COMPLETED|Overall Study||9||
48068366|NCT03789214|100489706|FG000|NOT COMPLETED|Overall Study||4||
48068367|NCT03789214|100489707|FG001|NOT COMPLETED|Overall Study||5||
48068368|NCT03789214|100489708|FG002|NOT COMPLETED|Overall Study||3||
48068369|NCT00510497|100489709|FG000|STARTED|Overall Study||11||
48068370|NCT00510497|100489709|FG000|COMPLETED|Overall Study||8||
48068371|NCT00510497|100489709|FG000|NOT COMPLETED|Overall Study||3||
48068372|NCT00369824|100489710|FG000|STARTED|Overall Study||212||
48068373|NCT00369824|100489711|FG001|STARTED|Overall Study||214||
48068374|NCT00369824|100489712|FG002|STARTED|Overall Study||214||
48068375|NCT00369824|100489713|FG003|STARTED|Overall Study||214||
48068376|NCT00369824|100489714|FG004|STARTED|Overall Study||214||
48068377|NCT00369824|100489715|FG005|STARTED|Overall Study||215||
48068378|NCT00369824|100489710|FG000|COMPLETED|Overall Study||197||
48068379|NCT00369824|100489711|FG001|COMPLETED|Overall Study||195||
48068380|NCT00369824|100489712|FG002|COMPLETED|Overall Study||202||
48068381|NCT00369824|100489713|FG003|COMPLETED|Overall Study||199||
48068382|NCT00369824|100489714|FG004|COMPLETED|Overall Study||196||
48068383|NCT00369824|100489715|FG005|COMPLETED|Overall Study||204||
48068384|NCT00369824|100489710|FG000|NOT COMPLETED|Overall Study||15||
48068385|NCT00369824|100489711|FG001|NOT COMPLETED|Overall Study||19||
48068386|NCT00369824|100489712|FG002|NOT COMPLETED|Overall Study||12||
48068387|NCT00369824|100489713|FG003|NOT COMPLETED|Overall Study||15||
48068388|NCT00369824|100489714|FG004|NOT COMPLETED|Overall Study||18||
48068389|NCT00369824|100489715|FG005|NOT COMPLETED|Overall Study||11||
48068390|NCT00005044|100489716|FG000|STARTED|Overall Study||790||
48068391|NCT00005044|100489717|FG001|STARTED|Overall Study||789||
48068392|NCT00005044|100489716|FG000|COMPLETED|Overall Study||752||
48068393|NCT00005044|100489717|FG001|COMPLETED|Overall Study||737||
48068394|NCT00005044|100489716|FG000|NOT COMPLETED|Overall Study||38||
48068395|NCT00005044|100489717|FG001|NOT COMPLETED|Overall Study||52||
48068396|NCT02158975|100489718|FG000|STARTED|Overall Study||13||
48068397|NCT02158975|100489718|FG000|COMPLETED|Overall Study||12||
48068398|NCT02158975|100489718|FG000|NOT COMPLETED|Overall Study||1||
48068399|NCT02302807|100489719|FG000|STARTED|Overall Study||464||
48068400|NCT02302807|100489720|FG001|STARTED|Overall Study||467||
48068401|NCT02302807|100489719|FG000|Received Treatment|Overall Study||443||
48068402|NCT02302807|100489720|FG001|Received Treatment|Overall Study||459||
48068403|NCT02302807|100489719|FG000|COMPLETED|Overall Study||0||
48068404|NCT02302807|100489720|FG001|COMPLETED|Overall Study||0||
48068405|NCT02302807|100489719|FG000|NOT COMPLETED|Overall Study||464||
48068406|NCT02302807|100489720|FG001|NOT COMPLETED|Overall Study||467||
48068407|NCT01453361|100489721|FG000|STARTED|Overall Study||18||
48068408|NCT01453361|100489721|FG000|COMPLETED|Overall Study||2|"Completed means subject had successful Vigil manufacturing and had been given all the doses."|
48068409|NCT01453361|100489721|FG000|NOT COMPLETED|Overall Study||16||
48068410|NCT00660673|100489722|FG000|STARTED|Overall Study||262||
48068411|NCT00660673|100489722|FG000|COMPLETED|Overall Study||145||
48068412|NCT00660673|100489722|FG000|NOT COMPLETED|Overall Study||117||
48068413|NCT00408629|100489723|FG000|STARTED|Overall Study||258||
48068414|NCT00408629|100489724|FG001|STARTED|Overall Study||260||
48068415|NCT00408629|100489723|FG000|COMPLETED|Overall Study||161||
48068416|NCT00408629|100489724|FG001|COMPLETED|Overall Study||135||
48068417|NCT00408629|100489723|FG000|NOT COMPLETED|Overall Study||97||
48068418|NCT00408629|100489724|FG001|NOT COMPLETED|Overall Study||125||
48068419|NCT01706822|100489725|FG000|STARTED|Overall Study||8||
48068420|NCT01706822|100489725|FG000|COMPLETED|Overall Study||8||
48068421|NCT01706822|100489725|FG000|NOT COMPLETED|Overall Study||0||
48068422|NCT02315989|100489726|FG000|STARTED|Overall Study||6||
48068423|NCT02315989|100489726|FG000|COMPLETED|Overall Study||6||
48068424|NCT02315989|100489726|FG000|NOT COMPLETED|Overall Study||0||
48068425|NCT02899299|100489727|FG000|STARTED|Pre-treatment||303|Started = Randomized|
48068426|NCT02899299|100489728|FG001|STARTED|Pre-treatment||302|Started = Randomized|
48068427|NCT02899299|100489727|FG000|COMPLETED|Pre-treatment||300|Completed = Entering treatment|
48068428|NCT02899299|100489728|FG001|COMPLETED|Pre-treatment||284|Completed = Entering treatment|
48068429|NCT02899299|100489727|FG000|NOT COMPLETED|Pre-treatment||3||
48068430|NCT02899299|100489728|FG001|NOT COMPLETED|Pre-treatment||18||
48068431|NCT02899299|100489727|FG000|STARTED|Treatment||300|Started = Entering treatment|
48068432|NCT02899299|100489728|FG001|STARTED|Treatment||284|Started = Entering treatment|
48068433|NCT02899299|100489727|FG000|COMPLETED|Treatment||0|Completed|
48068434|NCT02899299|100489728|FG001|COMPLETED|Treatment||189|Completed|
48068435|NCT02899299|100489727|FG000|NOT COMPLETED|Treatment||300||
48068436|NCT02899299|100489728|FG001|NOT COMPLETED|Treatment||95||
48068437|NCT05143541|100489729|FG000|STARTED|Overall Study||80||
48068438|NCT05143541|100489729|FG000|COMPLETED|Overall Study||80||
48068439|NCT05143541|100489729|FG000|NOT COMPLETED|Overall Study||0||
48068440|NCT03998566|100489730|FG000|STARTED|Overall Study||6||
48068441|NCT03998566|100489730|FG000|COMPLETED|Overall Study||1||
48068442|NCT03998566|100489730|FG000|NOT COMPLETED|Overall Study||5||
48068443|NCT05049616|100489731|FG000|STARTED|Overall Study||34||
48068444|NCT05049616|100489732|FG001|STARTED|Overall Study||36||
48068445|NCT05049616|100489731|FG000|COMPLETED|Overall Study||31||
48068446|NCT05049616|100489732|FG001|COMPLETED|Overall Study||36||
48068447|NCT05049616|100489731|FG000|NOT COMPLETED|Overall Study||3||
48068448|NCT05049616|100489732|FG001|NOT COMPLETED|Overall Study||0||
48068449|NCT00775346|100489733|FG000|STARTED|Overall Study||92||
48068450|NCT00775346|100489733|FG000|COMPLETED|Overall Study||92||
48068451|NCT00775346|100489733|FG000|NOT COMPLETED|Overall Study||0||
48068452|NCT02022020|100489734|FG000|STARTED|Overall Study||220||
48068453|NCT02022020|100489734|FG000|COMPLETED|Overall Study||220||
48068454|NCT02022020|100489734|FG000|NOT COMPLETED|Overall Study||0||
48068455|NCT01409434|100489735|FG000|STARTED|Overall Study||44||
48068456|NCT01409434|100489735|FG000|COMPLETED|Overall Study||40||
48068457|NCT01409434|100489735|FG000|NOT COMPLETED|Overall Study||4||
48068458|NCT01426438|100489736|FG000|STARTED|Overall Study||50||
48068459|NCT01426438|100489737|FG001|STARTED|Overall Study||49||
48068460|NCT01426438|100489736|FG000|COMPLETED|Overall Study||35||
48068461|NCT01426438|100489737|FG001|COMPLETED|Overall Study||39||
48068462|NCT01426438|100489736|FG000|NOT COMPLETED|Overall Study||15||
48068463|NCT01426438|100489737|FG001|NOT COMPLETED|Overall Study||10||
48068464|NCT01961362|100489738|FG000|STARTED|Overall Study||19||
48068465|NCT01961362|100489738|FG000|COMPLETED|Overall Study||19||
48068466|NCT01961362|100489738|FG000|NOT COMPLETED|Overall Study||0||
48068467|NCT05004077|100489739|FG000|STARTED|Overall Study||2||
48068468|NCT05004077|100489740|FG001|STARTED|Overall Study||1||
48068469|NCT05004077|100489739|FG000|COMPLETED|Overall Study||2||
48068470|NCT05004077|100489740|FG001|COMPLETED|Overall Study||1||
48068471|NCT05004077|100489739|FG000|NOT COMPLETED|Overall Study||0||
48068472|NCT05004077|100489740|FG001|NOT COMPLETED|Overall Study||0||
48219981|NCT05580003|100863748|FG000|STARTED|Part 3: Washout 3 (up to 3 Days)||0||
48068473|NCT00306189|100489741|FG000|STARTED|Overall Study||57||
48068474|NCT00306189|100489742|FG001|STARTED|Overall Study||56||
48068475|NCT00306189|100489743|FG002|STARTED|Overall Study||56||
48068476|NCT00306189|100489744|FG003|STARTED|Overall Study||57||
48068477|NCT00306189|100489741|FG000|COMPLETED|Overall Study||48||
48068478|NCT00306189|100489742|FG001|COMPLETED|Overall Study||50||
48068479|NCT00306189|100489743|FG002|COMPLETED|Overall Study||45||
48068480|NCT00306189|100489744|FG003|COMPLETED|Overall Study||52||
48068481|NCT00306189|100489741|FG000|NOT COMPLETED|Overall Study||9||
48068482|NCT00306189|100489742|FG001|NOT COMPLETED|Overall Study||6||
48068483|NCT00306189|100489743|FG002|NOT COMPLETED|Overall Study||11||
48667273|NCT02919618|101970570|FG000|Primary Safety Endpoint (</=90 Days)|Overall Study||19|Phase 1 - Defined by a \</=20% rate of SAEs using CTCAE v4.0 criteria.|
48667274|NCT02919618|101970570|FG000|Primary Efficacy Endpoint (6 Months)|Overall Study||18|Phase 2 - Number of subjects with a reduction in ICD therapies 6mo before and 6mo post-SBRT.|
48667275|NCT02919618|101970570|FG000|COMPLETED|Overall Study||18||
48667276|NCT02919618|101970570|FG000|NOT COMPLETED|Overall Study||1||
48667277|NCT01585025|101970571|FG000|STARTED|Overall Study||10||
48667278|NCT01585025|101970572|FG001|STARTED|Overall Study||13||
48667279|NCT01585025|101970573|FG002|STARTED|Overall Study||12||
48667280|NCT01585025|101970571|FG000|COMPLETED|Overall Study||10||
48667281|NCT01585025|101970572|FG001|COMPLETED|Overall Study||10||
48667282|NCT01585025|101970573|FG002|COMPLETED|Overall Study||8||
48667283|NCT01585025|101970571|FG000|NOT COMPLETED|Overall Study||0||
48667284|NCT01585025|101970572|FG001|NOT COMPLETED|Overall Study||3||
48667285|NCT01585025|101970573|FG002|NOT COMPLETED|Overall Study||4||
48667286|NCT00867035|101970574|FG000|STARTED|Baseline to 1 Hour||13||
48667287|NCT00867035|101970575|FG001|STARTED|Baseline to 1 Hour||9||
48667288|NCT00867035|101970574|FG000|COMPLETED|Baseline to 1 Hour||12||
48667289|NCT00867035|101970575|FG001|COMPLETED|Baseline to 1 Hour||8||
48667290|NCT00867035|101970574|FG000|NOT COMPLETED|Baseline to 1 Hour||1||
48667291|NCT00867035|101970575|FG001|NOT COMPLETED|Baseline to 1 Hour||1||
48667292|NCT00867035|101970574|FG000|STARTED|Baseline to 2 Hours||12||
48667293|NCT00867035|101970575|FG001|STARTED|Baseline to 2 Hours||8||
48667294|NCT00867035|101970574|FG000|COMPLETED|Baseline to 2 Hours||12||
48667295|NCT00867035|101970575|FG001|COMPLETED|Baseline to 2 Hours||8||
48667296|NCT00867035|101970574|FG000|NOT COMPLETED|Baseline to 2 Hours||0||
48667297|NCT00867035|101970575|FG001|NOT COMPLETED|Baseline to 2 Hours||0||
48667298|NCT00867035|101970574|FG000|STARTED|Baseline to 4 Hours||12||
48667299|NCT00867035|101970575|FG001|STARTED|Baseline to 4 Hours||8||
48667300|NCT00867035|101970574|FG000|COMPLETED|Baseline to 4 Hours||12||
48667301|NCT00867035|101970575|FG001|COMPLETED|Baseline to 4 Hours||8||
48667302|NCT00867035|101970574|FG000|NOT COMPLETED|Baseline to 4 Hours||0||
48667303|NCT00867035|101970575|FG001|NOT COMPLETED|Baseline to 4 Hours||0||
48667304|NCT00867035|101970574|FG000|STARTED|Baseline to 1 Week||12||
48667305|NCT00867035|101970575|FG001|STARTED|Baseline to 1 Week||8||
48667306|NCT00867035|101970574|FG000|COMPLETED|Baseline to 1 Week||11||
48667307|NCT00867035|101970575|FG001|COMPLETED|Baseline to 1 Week||8||
48667308|NCT00867035|101970574|FG000|NOT COMPLETED|Baseline to 1 Week||1||
48667309|NCT00867035|101970575|FG001|NOT COMPLETED|Baseline to 1 Week||0||
48667310|NCT02439957|101970576|FG000|STARTED|Overall Study||3||
48667311|NCT02439957|101970577|FG001|STARTED|Overall Study||3||
48667312|NCT02439957|101970576|FG000|Blinded Treatment Period|Overall Study||1|Ranged from 20 to 89 days|
48667313|NCT02439957|101970577|FG001|Blinded Treatment Period|Overall Study||2|Ranged from 20 to 89 days|
48667314|NCT02439957|101970576|FG000|COMPLETED|Overall Study||0||
48667315|NCT02439957|101970577|FG001|COMPLETED|Overall Study||0||
48667316|NCT02439957|101970576|FG000|NOT COMPLETED|Overall Study||3||
48667317|NCT02439957|101970577|FG001|NOT COMPLETED|Overall Study||3||
48667318|NCT02278003|101970578|FG000|STARTED|Overall Study||49||
48667319|NCT02278003|101970579|FG001|STARTED|Overall Study||20||
48667320|NCT02278003|101970578|FG000|COMPLETED|Overall Study||30||
48667321|NCT02278003|101970579|FG001|COMPLETED|Overall Study||20||
48667322|NCT02278003|101970578|FG000|NOT COMPLETED|Overall Study||19||
48667323|NCT02278003|101970579|FG001|NOT COMPLETED|Overall Study||0||
48667324|NCT00619866|101970580|FG000|STARTED|Weeks 1 - 12||52||
48667325|NCT00619866|101970581|FG001|STARTED|Weeks 1 - 12||51||
48667326|NCT00619866|101970582|FG002|STARTED|Weeks 1 - 12||52||
48667327|NCT00619866|101970583|FG003|STARTED|Weeks 1 - 12||0||
48667328|NCT00619866|101970584|FG004|STARTED|Weeks 1 - 12||0||
48667329|NCT00619866|101970580|FG000|COMPLETED|Weeks 1 - 12||38||
48667330|NCT00619866|101970581|FG001|COMPLETED|Weeks 1 - 12||45||
48667331|NCT00619866|101970582|FG002|COMPLETED|Weeks 1 - 12||42||
48667332|NCT00619866|101970583|FG003|COMPLETED|Weeks 1 - 12||0||
48667333|NCT00619866|101970584|FG004|COMPLETED|Weeks 1 - 12||0||
48667334|NCT00619866|101970580|FG000|NOT COMPLETED|Weeks 1 - 12||14||
48667335|NCT00619866|101970581|FG001|NOT COMPLETED|Weeks 1 - 12||6||
48667336|NCT00619866|101970582|FG002|NOT COMPLETED|Weeks 1 - 12||10||
48667337|NCT00619866|101970583|FG003|NOT COMPLETED|Weeks 1 - 12||0||
48667338|NCT00619866|101970584|FG004|NOT COMPLETED|Weeks 1 - 12||0||
48667339|NCT00619866|101970580|FG000|STARTED|Weeks 13 - 24||0||
48667340|NCT00619866|101970581|FG001|STARTED|Weeks 13 - 24||45||
48667341|NCT00619866|101970582|FG002|STARTED|Weeks 13 - 24||42||
48667342|NCT00619866|101970583|FG003|STARTED|Weeks 13 - 24||18||
48667343|NCT00619866|101970584|FG004|STARTED|Weeks 13 - 24||20||
48667344|NCT00619866|101970580|FG000|COMPLETED|Weeks 13 - 24||0||
48667345|NCT00619866|101970581|FG001|COMPLETED|Weeks 13 - 24||38||
48667346|NCT00619866|101970582|FG002|COMPLETED|Weeks 13 - 24||37||
48667347|NCT00619866|101970583|FG003|COMPLETED|Weeks 13 - 24||14||
48667348|NCT00619866|101970584|FG004|COMPLETED|Weeks 13 - 24||18||
48667349|NCT00619866|101970580|FG000|NOT COMPLETED|Weeks 13 - 24||0||
48667350|NCT00619866|101970581|FG001|NOT COMPLETED|Weeks 13 - 24||7||
48667351|NCT00619866|101970582|FG002|NOT COMPLETED|Weeks 13 - 24||5||
48667352|NCT00619866|101970583|FG003|NOT COMPLETED|Weeks 13 - 24||4||
48667353|NCT00619866|101970584|FG004|NOT COMPLETED|Weeks 13 - 24||2||
48667354|NCT03199079|101970585|FG000|STARTED|Overall Study||10||
48667355|NCT03199079|101970586|FG001|STARTED|Overall Study||10||
48667356|NCT03199079|101970585|FG000|COMPLETED|Overall Study||10||
48667357|NCT03199079|101970586|FG001|COMPLETED|Overall Study||10||
48667358|NCT03199079|101970585|FG000|NOT COMPLETED|Overall Study||0||
48667359|NCT03199079|101970586|FG001|NOT COMPLETED|Overall Study||0||
48667360|NCT02445911|101970587|FG000|STARTED|Overall Study||20||
48667361|NCT02445911|101970588|FG001|STARTED|Overall Study||20||
48667362|NCT02445911|101970589|FG002|STARTED|Overall Study||21||
48667363|NCT02445911|101970590|FG003|STARTED|Overall Study||20||
48667364|NCT02445911|101970587|FG000|COMPLETED|Overall Study||20||
48667365|NCT02445911|101970588|FG001|COMPLETED|Overall Study||20||
48667366|NCT02445911|101970589|FG002|COMPLETED|Overall Study||21||
48667367|NCT02445911|101970590|FG003|COMPLETED|Overall Study||20||
48667368|NCT02445911|101970587|FG000|NOT COMPLETED|Overall Study||0||
48667369|NCT02445911|101970588|FG001|NOT COMPLETED|Overall Study||0||
48667370|NCT02445911|101970589|FG002|NOT COMPLETED|Overall Study||0||
48667371|NCT02445911|101970590|FG003|NOT COMPLETED|Overall Study||0||
48667372|NCT03033784|101970591|FG000|STARTED|Overall Study||9|Clinical visit 1|
48667373|NCT03033784|101970592|FG001|STARTED|Overall Study||2|Clinical visit 1|
48667374|NCT03033784|101970593|FG002|STARTED|Overall Study||4|Clinical visit 1|
48667375|NCT03033784|101970594|FG003|STARTED|Overall Study||4|Clinical visit 1|
48667376|NCT03033784|101970595|FG004|STARTED|Overall Study||3|Clinical visit 1|
48667377|NCT03033784|101970596|FG005|STARTED|Overall Study||2|Clinical visit 1|
48667378|NCT03033784|101970597|FG006|STARTED|Overall Study||2|Clinical visit 1|
48667379|NCT03033784|101970598|FG007|STARTED|Overall Study||2|Clinical visit 1|
48667380|NCT03033784|101970599|FG008|STARTED|Overall Study||1|Clinical visit 1|
48667381|NCT03033784|101970600|FG009|STARTED|Overall Study||1|Clinical visit 1|
48667382|NCT03033784|101970601|FG010|STARTED|Overall Study||1|Clinical visit 1|
48667383|NCT03033784|101970602|FG011|STARTED|Overall Study||1|Clinical visit 1|
48667384|NCT03033784|101970603|FG012|STARTED|Overall Study||19|Clinical visit 1|
48667385|NCT03033784|101970591|FG000|Clinical Visit 2|Overall Study||9||
48667386|NCT03033784|101970592|FG001|Clinical Visit 2|Overall Study||2||
48667387|NCT03033784|101970593|FG002|Clinical Visit 2|Overall Study||4||
48667388|NCT03033784|101970594|FG003|Clinical Visit 2|Overall Study||4||
48667389|NCT03033784|101970595|FG004|Clinical Visit 2|Overall Study||3||
48667390|NCT03033784|101970596|FG005|Clinical Visit 2|Overall Study||2||
48667391|NCT03033784|101970597|FG006|Clinical Visit 2|Overall Study||2||
48667392|NCT03033784|101970598|FG007|Clinical Visit 2|Overall Study||2||
48667393|NCT03033784|101970599|FG008|Clinical Visit 2|Overall Study||1||
48667394|NCT03033784|101970600|FG009|Clinical Visit 2|Overall Study||1||
48667395|NCT03033784|101970601|FG010|Clinical Visit 2|Overall Study||1||
48667396|NCT03033784|101970602|FG011|Clinical Visit 2|Overall Study||1||
48667397|NCT03033784|101970603|FG012|Clinical Visit 2|Overall Study||17||
48667398|NCT03033784|101970591|FG000|Clinical Visit 3|Overall Study||9||
48667399|NCT03033784|101970592|FG001|Clinical Visit 3|Overall Study||1||
48667400|NCT03033784|101970593|FG002|Clinical Visit 3|Overall Study||4||
48667401|NCT03033784|101970594|FG003|Clinical Visit 3|Overall Study||4||
48667402|NCT03033784|101970595|FG004|Clinical Visit 3|Overall Study||3||
48667403|NCT03033784|101970596|FG005|Clinical Visit 3|Overall Study||2||
48667404|NCT03033784|101970597|FG006|Clinical Visit 3|Overall Study||2||
48667405|NCT03033784|101970598|FG007|Clinical Visit 3|Overall Study||2||
48667406|NCT03033784|101970599|FG008|Clinical Visit 3|Overall Study||1||
48667407|NCT03033784|101970600|FG009|Clinical Visit 3|Overall Study||1||
48667408|NCT03033784|101970601|FG010|Clinical Visit 3|Overall Study||1||
48667409|NCT03033784|101970602|FG011|Clinical Visit 3|Overall Study||1||
48667410|NCT03033784|101970603|FG012|Clinical Visit 3|Overall Study||0||
48667411|NCT03033784|101970591|FG000|Clinical Visit 4|Overall Study||9||
48667412|NCT03033784|101970592|FG001|Clinical Visit 4|Overall Study||1||
48667413|NCT03033784|101970593|FG002|Clinical Visit 4|Overall Study||4||
48667414|NCT03033784|101970594|FG003|Clinical Visit 4|Overall Study||4||
48667415|NCT03033784|101970595|FG004|Clinical Visit 4|Overall Study||3||
48667416|NCT03033784|101970596|FG005|Clinical Visit 4|Overall Study||2||
48667417|NCT03033784|101970597|FG006|Clinical Visit 4|Overall Study||2||
48667418|NCT03033784|101970598|FG007|Clinical Visit 4|Overall Study||2||
48667419|NCT03033784|101970599|FG008|Clinical Visit 4|Overall Study||1||
48667420|NCT03033784|101970600|FG009|Clinical Visit 4|Overall Study||1||
48667421|NCT03033784|101970601|FG010|Clinical Visit 4|Overall Study||1||
48667422|NCT03033784|101970602|FG011|Clinical Visit 4|Overall Study||1||
48667423|NCT03033784|101970603|FG012|Clinical Visit 4|Overall Study||0||
48667424|NCT03033784|101970591|FG000|COMPLETED|Overall Study||9|Clinical Visit 4|
48667425|NCT03033784|101970592|FG001|COMPLETED|Overall Study||1|Clinical Visit 4|
48667426|NCT03033784|101970593|FG002|COMPLETED|Overall Study||4|Clinical Visit 4|
48667427|NCT03033784|101970594|FG003|COMPLETED|Overall Study||4|Clinical Visit 4|
48667428|NCT03033784|101970595|FG004|COMPLETED|Overall Study||3|Clinical Visit 4|
48667429|NCT03033784|101970596|FG005|COMPLETED|Overall Study||2|Clinical Visit 4|
48667430|NCT03033784|101970597|FG006|COMPLETED|Overall Study||2|Clinical Visit 4|
48667431|NCT03033784|101970598|FG007|COMPLETED|Overall Study||2|Clinical Visit 4|
48667432|NCT03033784|101970599|FG008|COMPLETED|Overall Study||1|Clinical Visit 4|
48667433|NCT03033784|101970600|FG009|COMPLETED|Overall Study||1|Clinical Visit 4|
48667434|NCT03033784|101970601|FG010|COMPLETED|Overall Study||1|Clinical Visit 4|
48667435|NCT03033784|101970602|FG011|COMPLETED|Overall Study||1|Clinical Visit 4|
48667436|NCT03033784|101970603|FG012|COMPLETED|Overall Study||17|Clinical Visit 4|
48667437|NCT03033784|101970591|FG000|NOT COMPLETED|Overall Study||0||
48667438|NCT03033784|101970592|FG001|NOT COMPLETED|Overall Study||1||
48667439|NCT03033784|101970593|FG002|NOT COMPLETED|Overall Study||0||
48667440|NCT03033784|101970594|FG003|NOT COMPLETED|Overall Study||0||
48667441|NCT03033784|101970595|FG004|NOT COMPLETED|Overall Study||0||
48667442|NCT03033784|101970596|FG005|NOT COMPLETED|Overall Study||0||
48667443|NCT03033784|101970597|FG006|NOT COMPLETED|Overall Study||0||
48667444|NCT03033784|101970598|FG007|NOT COMPLETED|Overall Study||0||
48667445|NCT03033784|101970599|FG008|NOT COMPLETED|Overall Study||0||
48667446|NCT03033784|101970600|FG009|NOT COMPLETED|Overall Study||0||
48667447|NCT03033784|101970601|FG010|NOT COMPLETED|Overall Study||0||
48667448|NCT03033784|101970602|FG011|NOT COMPLETED|Overall Study||0||
48667449|NCT03033784|101970603|FG012|NOT COMPLETED|Overall Study||2||
48667450|NCT00427037|101970604|FG000|STARTED|Overall Study||17||
48667451|NCT00427037|101970605|FG001|STARTED|Overall Study||17||
48667452|NCT00427037|101970604|FG000|COMPLETED|Overall Study||10||
48667453|NCT00427037|101970605|FG001|COMPLETED|Overall Study||10||
48667454|NCT00427037|101970604|FG000|NOT COMPLETED|Overall Study||7||
48667455|NCT00427037|101970605|FG001|NOT COMPLETED|Overall Study||7||
48667456|NCT03901430|101970606|FG000|STARTED|Overall Study||21||
48667457|NCT03901430|101970606|FG000|COMPLETED|Overall Study||21||
48667458|NCT03901430|101970606|FG000|NOT COMPLETED|Overall Study||0||
48667459|NCT03322566|101970607|FG000|STARTED|Overall Study||91||
48667460|NCT03322566|101970608|FG001|STARTED|Overall Study||87||
48667461|NCT03322566|101970609|FG002|STARTED|Overall Study||55||
48667462|NCT03322566|101970607|FG000|COMPLETED|Overall Study||46||
48667463|NCT03322566|101970608|FG001|COMPLETED|Overall Study||42||
48667464|NCT03322566|101970609|FG002|COMPLETED|Overall Study||22||
48667465|NCT03322566|101970607|FG000|NOT COMPLETED|Overall Study||45||
48667466|NCT03322566|101970608|FG001|NOT COMPLETED|Overall Study||45||
48667467|NCT03322566|101970609|FG002|NOT COMPLETED|Overall Study||33||
48667468|NCT04890509|101970610|FG000|STARTED|Overall Study||58||
48667469|NCT04890509|101970611|FG001|STARTED|Overall Study||57||
48667470|NCT04890509|101970610|FG000|COMPLETED|Overall Study||54||
48667471|NCT04890509|101970611|FG001|COMPLETED|Overall Study||53||
48667472|NCT04890509|101970610|FG000|NOT COMPLETED|Overall Study||4||
48667473|NCT04890509|101970611|FG001|NOT COMPLETED|Overall Study||4||
48667474|NCT03014089|101970612|FG000|STARTED|Overall Study||25||
48667475|NCT03014089|101970613|FG001|STARTED|Overall Study||24||
48667476|NCT03014089|101970614|FG002|STARTED|Overall Study||25||
48667477|NCT03014089|101970615|FG003|STARTED|Overall Study||16||
48667478|NCT03014089|101970612|FG000|Received Injection 1|Overall Study||25||
48667479|NCT03014089|101970613|FG001|Received Injection 1|Overall Study||24||
48667480|NCT03014089|101970614|FG002|Received Injection 1|Overall Study||25||
48667481|NCT03014089|101970615|FG003|Received Injection 1|Overall Study||16||
48667482|NCT03014089|101970612|FG000|Received Injection 2|Overall Study||25||
48667483|NCT03014089|101970613|FG001|Received Injection 2|Overall Study||24||
48667484|NCT03014089|101970614|FG002|Received Injection 2|Overall Study||24||
48667485|NCT03014089|101970615|FG003|Received Injection 2|Overall Study||16||
48667486|NCT03014089|101970612|FG000|COMPLETED|Overall Study||23||
48667487|NCT03014089|101970613|FG001|COMPLETED|Overall Study||23||
48667488|NCT03014089|101970614|FG002|COMPLETED|Overall Study||23||
48667489|NCT03014089|101970615|FG003|COMPLETED|Overall Study||15||
48667490|NCT03014089|101970612|FG000|NOT COMPLETED|Overall Study||2||
48667491|NCT03014089|101970613|FG001|NOT COMPLETED|Overall Study||1||
48667492|NCT03014089|101970614|FG002|NOT COMPLETED|Overall Study||2||
48667493|NCT03014089|101970615|FG003|NOT COMPLETED|Overall Study||1||
48667494|NCT00478257|101970616|FG000|STARTED|Overall Study||23||
48667495|NCT00478257|101970617|FG001|STARTED|Overall Study||16||
48667496|NCT00478257|101970616|FG000|COMPLETED|Overall Study||15||
48667497|NCT00478257|101970617|FG001|COMPLETED|Overall Study||13||
48667498|NCT00478257|101970616|FG000|NOT COMPLETED|Overall Study||8||
48667499|NCT00478257|101970617|FG001|NOT COMPLETED|Overall Study||3||
48667500|NCT00834574|101970618|FG000|STARTED|First Intervention||16||
48667501|NCT00834574|101970619|FG001|STARTED|First Intervention||16||
48667502|NCT00834574|101970618|FG000|COMPLETED|First Intervention||16||
48667503|NCT00834574|101970619|FG001|COMPLETED|First Intervention||16||
48667504|NCT00834574|101970618|FG000|NOT COMPLETED|First Intervention||0||
48667505|NCT00834574|101970619|FG001|NOT COMPLETED|First Intervention||0||
48667506|NCT00834574|101970618|FG000|STARTED|Washout of 7 Days||16||
48667507|NCT00834574|101970619|FG001|STARTED|Washout of 7 Days||16||
48667508|NCT00834574|101970618|FG000|COMPLETED|Washout of 7 Days||16||
48667509|NCT00834574|101970619|FG001|COMPLETED|Washout of 7 Days||16||
48667510|NCT00834574|101970618|FG000|NOT COMPLETED|Washout of 7 Days||0||
48667511|NCT00834574|101970619|FG001|NOT COMPLETED|Washout of 7 Days||0||
48667512|NCT00834574|101970618|FG000|STARTED|Second Intervention||16||
48667513|NCT00834574|101970619|FG001|STARTED|Second Intervention||16||
48667514|NCT00834574|101970618|FG000|COMPLETED|Second Intervention||16||
48667515|NCT00834574|101970619|FG001|COMPLETED|Second Intervention||16||
48667516|NCT00834574|101970618|FG000|NOT COMPLETED|Second Intervention||0||
48667517|NCT00834574|101970619|FG001|NOT COMPLETED|Second Intervention||0||
48667518|NCT04507204|101970620|FG000|STARTED|Overall Study||133||
48667519|NCT04507204|101970621|FG001|STARTED|Overall Study||134||
48667520|NCT04507204|101970620|FG000|COMPLETED|Overall Study||83||
48667521|NCT04507204|101970621|FG001|COMPLETED|Overall Study||86||
48667522|NCT04507204|101970620|FG000|NOT COMPLETED|Overall Study||50||
48667523|NCT04507204|101970621|FG001|NOT COMPLETED|Overall Study||48||
48667524|NCT00754572|101970622|FG000|STARTED|Overall Study||418||
48667525|NCT00754572|101970622|FG000|COMPLETED|Overall Study||347||
48667526|NCT00754572|101970622|FG000|NOT COMPLETED|Overall Study||71||
48667527|NCT01188967|101970623|FG000|STARTED|Overall Study||10||
48667528|NCT01188967|101970624|FG001|STARTED|Overall Study||8||
48667529|NCT01188967|101970623|FG000|COMPLETED|Overall Study||5||
48667530|NCT01188967|101970624|FG001|COMPLETED|Overall Study||4||
48667531|NCT01188967|101970623|FG000|NOT COMPLETED|Overall Study||5||
48667532|NCT01188967|101970624|FG001|NOT COMPLETED|Overall Study||4||
48667533|NCT00645658|101970625|FG000|STARTED|Overall Study||9||
48667534|NCT00645658|101970626|FG001|STARTED|Overall Study||8||
48667535|NCT00645658|101970625|FG000|COMPLETED|Overall Study||8||
48667536|NCT00645658|101970626|FG001|COMPLETED|Overall Study||6||
48667537|NCT00645658|101970625|FG000|NOT COMPLETED|Overall Study||1||
48667538|NCT00645658|101970626|FG001|NOT COMPLETED|Overall Study||2||
48667539|NCT03773484|101970627|FG000|STARTED|Pre-intervention||41||
48667540|NCT03773484|101970627|FG000|COMPLETED|Pre-intervention||41||
48667541|NCT03773484|101970627|FG000|NOT COMPLETED|Pre-intervention||0||
48667542|NCT03773484|101970627|FG000|STARTED|Post-intervention||41||
48667543|NCT03773484|101970627|FG000|COMPLETED|Post-intervention||36||
48667544|NCT03773484|101970627|FG000|NOT COMPLETED|Post-intervention||5||
48667545|NCT00244985|101970628|FG000|STARTED|Overall Study||42||
48667546|NCT00244985|101970628|FG000|COMPLETED|Overall Study||42||
48667547|NCT00244985|101970628|FG000|NOT COMPLETED|Overall Study||0||
48667548|NCT02878785|101970629|FG000|STARTED|Overall Study||3||
48667549|NCT02878785|101970630|FG001|STARTED|Overall Study||0||
48667550|NCT02878785|101970631|FG002|STARTED|Overall Study||0||
48667551|NCT02878785|101970632|FG003|STARTED|Overall Study||0||
48667552|NCT02878785|101970633|FG004|STARTED|Overall Study||0||
48667553|NCT02878785|101970634|FG005|STARTED|Overall Study||0||
48667554|NCT02878785|101970635|FG006|STARTED|Overall Study||0||
48667555|NCT02878785|101970636|FG007|STARTED|Overall Study||0||
48667556|NCT02878785|101970637|FG008|STARTED|Overall Study||3||
48667557|NCT02878785|101970638|FG009|STARTED|Overall Study||7||
48667558|NCT02878785|101970639|FG010|STARTED|Overall Study||3||
48667559|NCT02878785|101970640|FG011|STARTED|Overall Study||3||
48667560|NCT02878785|101970641|FG012|STARTED|Overall Study||3||
48667561|NCT02878785|101970642|FG013|STARTED|Overall Study||3||
48667562|NCT02878785|101970629|FG000|COMPLETED|Overall Study||3||
48667563|NCT02878785|101970630|FG001|COMPLETED|Overall Study||0||
48667564|NCT02878785|101970631|FG002|COMPLETED|Overall Study||0||
48667565|NCT02878785|101970632|FG003|COMPLETED|Overall Study||0||
48667566|NCT02878785|101970633|FG004|COMPLETED|Overall Study||0||
48667567|NCT02878785|101970634|FG005|COMPLETED|Overall Study||0||
48667568|NCT02878785|101970635|FG006|COMPLETED|Overall Study||0||
48667569|NCT02878785|101970636|FG007|COMPLETED|Overall Study||0||
48667570|NCT02878785|101970637|FG008|COMPLETED|Overall Study||3||
48667571|NCT02878785|101970638|FG009|COMPLETED|Overall Study||7||
48667572|NCT02878785|101970639|FG010|COMPLETED|Overall Study||3||
48667573|NCT02878785|101970640|FG011|COMPLETED|Overall Study||3||
48667574|NCT02878785|101970641|FG012|COMPLETED|Overall Study||3||
48667575|NCT02878785|101970642|FG013|COMPLETED|Overall Study||3||
48667576|NCT02878785|101970629|FG000|NOT COMPLETED|Overall Study||0||
48667577|NCT02878785|101970630|FG001|NOT COMPLETED|Overall Study||0||
48667578|NCT02878785|101970631|FG002|NOT COMPLETED|Overall Study||0||
48667579|NCT02878785|101970632|FG003|NOT COMPLETED|Overall Study||0||
48667580|NCT02878785|101970633|FG004|NOT COMPLETED|Overall Study||0||
48667581|NCT02878785|101970634|FG005|NOT COMPLETED|Overall Study||0||
48667582|NCT02878785|101970635|FG006|NOT COMPLETED|Overall Study||0||
48667583|NCT02878785|101970636|FG007|NOT COMPLETED|Overall Study||0||
48667584|NCT02878785|101970637|FG008|NOT COMPLETED|Overall Study||0||
48667585|NCT02878785|101970638|FG009|NOT COMPLETED|Overall Study||0||
48667586|NCT02878785|101970639|FG010|NOT COMPLETED|Overall Study||0||
48667587|NCT02878785|101970640|FG011|NOT COMPLETED|Overall Study||0||
48667588|NCT02878785|101970641|FG012|NOT COMPLETED|Overall Study||0||
48667589|NCT02878785|101970642|FG013|NOT COMPLETED|Overall Study||0||
48667590|NCT03110562|101970643|FG000|STARTED|Initial Treatment Period||195||
48667591|NCT03110562|101970644|FG001|STARTED|Initial Treatment Period||207||
48667592|NCT03110562|101970645|FG002|STARTED|Initial Treatment Period||0||
48667593|NCT03110562|101970646|FG003|STARTED|Initial Treatment Period||0||
48667594|NCT03110562|101970643|FG000|Treated|Initial Treatment Period||195||
48667595|NCT03110562|101970644|FG001|Treated|Initial Treatment Period||204||
48667596|NCT03110562|101970645|FG002|Treated|Initial Treatment Period||0||
48667597|NCT03110562|101970646|FG003|Treated|Initial Treatment Period||0||
48667598|NCT03110562|101970643|FG000|Intent-to-treat (ITT) Population|Initial Treatment Period||195|The ITT population consisted of all participants who were randomized to the study treatment, regardless of whether or not they received the study treatment.|
48667599|NCT03110562|101970644|FG001|Intent-to-treat (ITT) Population|Initial Treatment Period||207|The ITT population consisted of all participants who were randomized to the study treatment, regardless of whether or not they received the study treatment.|
48667600|NCT03110562|101970645|FG002|Intent-to-treat (ITT) Population|Initial Treatment Period||0|The ITT population consisted of all participants who were randomized to the study treatment, regardless of whether or not they received the study treatment.|
48667601|NCT03110562|101970646|FG003|Intent-to-treat (ITT) Population|Initial Treatment Period||0|The ITT population consisted of all participants who were randomized to the study treatment, regardless of whether or not they received the study treatment.|
48667602|NCT03110562|101970643|FG000|Safety Population|Initial Treatment Period||195|The safety population consisted of all participants who had received at least 1 dose of the study treatment.|
48667603|NCT03110562|101970644|FG001|Safety Population|Initial Treatment Period||204|The safety population consisted of all participants who had received at least 1 dose of the study treatment.|
48667604|NCT03110562|101970645|FG002|Safety Population|Initial Treatment Period||0|The safety population consisted of all participants who had received at least 1 dose of the study treatment.|
48667605|NCT03110562|101970646|FG003|Safety Population|Initial Treatment Period||0|The safety population consisted of all participants who had received at least 1 dose of the study treatment.|
48667606|NCT03110562|101970643|FG000|COMPLETED|Initial Treatment Period||0||
48667607|NCT03110562|101970644|FG001|COMPLETED|Initial Treatment Period||0||
48667608|NCT03110562|101970645|FG002|COMPLETED|Initial Treatment Period||0||
48667609|NCT03110562|101970646|FG003|COMPLETED|Initial Treatment Period||0||
48667610|NCT03110562|101970643|FG000|NOT COMPLETED|Initial Treatment Period||195||
48667611|NCT03110562|101970644|FG001|NOT COMPLETED|Initial Treatment Period||207||
48667612|NCT03110562|101970645|FG002|NOT COMPLETED|Initial Treatment Period||0||
48667613|NCT03110562|101970646|FG003|NOT COMPLETED|Initial Treatment Period||0||
48667614|NCT03110562|101970643|FG000|STARTED|Crossover Period||0||
48667615|NCT03110562|101970644|FG001|STARTED|Crossover Period||0||
48068484|NCT00306189|100489744|FG003|NOT COMPLETED|Overall Study||5||
48068485|NCT01786148|100489745|FG000|STARTED|Overall Study||77||
48667616|NCT03110562|101970645|FG002|STARTED|Crossover Period||66||
48667617|NCT03110562|101970646|FG003|STARTED|Crossover Period||14||
48667618|NCT03110562|101970643|FG000|COMPLETED|Crossover Period||0||
48667619|NCT03110562|101970644|FG001|COMPLETED|Crossover Period||0||
48667620|NCT03110562|101970645|FG002|COMPLETED|Crossover Period||0||
48667621|NCT03110562|101970646|FG003|COMPLETED|Crossover Period||0||
48667622|NCT03110562|101970643|FG000|NOT COMPLETED|Crossover Period||0||
48667623|NCT03110562|101970644|FG001|NOT COMPLETED|Crossover Period||0||
48667624|NCT03110562|101970645|FG002|NOT COMPLETED|Crossover Period||66||
48667625|NCT03110562|101970646|FG003|NOT COMPLETED|Crossover Period||14||
48667626|NCT00129974|101970647|FG000|STARTED|Overall Study||1||
48667627|NCT00129974|101970647|FG000|COMPLETED|Overall Study||0||
48667628|NCT00129974|101970647|FG000|NOT COMPLETED|Overall Study||1||
48667629|NCT01358734|101970648|FG000|STARTED|Overall Study||15||
48667630|NCT01358734|101970649|FG001|STARTED|Overall Study||39||
48667631|NCT01358734|101970650|FG002|STARTED|Overall Study||34||
48667632|NCT01358734|101970648|FG000|Safety Population|Overall Study||14||
48667633|NCT01358734|101970649|FG001|Safety Population|Overall Study||38||
48667634|NCT01358734|101970650|FG002|Safety Population|Overall Study||32||
48667635|NCT01358734|101970648|FG000|COMPLETED|Overall Study||0||
48667636|NCT01358734|101970649|FG001|COMPLETED|Overall Study||0||
48667637|NCT01358734|101970650|FG002|COMPLETED|Overall Study||0||
48667638|NCT01358734|101970648|FG000|NOT COMPLETED|Overall Study||15||
48667639|NCT01358734|101970649|FG001|NOT COMPLETED|Overall Study||39||
48667640|NCT01358734|101970650|FG002|NOT COMPLETED|Overall Study||34||
48667641|NCT01911260|101970651|FG000|STARTED|Supplementation Period||50||
48667642|NCT01911260|101970652|FG001|STARTED|Supplementation Period||50||
48667643|NCT01911260|101970653|FG002|STARTED|Supplementation Period||49||
48667644|NCT01911260|101970654|FG003|STARTED|Supplementation Period||50||
48667645|NCT01911260|101970651|FG000|COMPLETED|Supplementation Period||40||
48667646|NCT01911260|101970652|FG001|COMPLETED|Supplementation Period||38||
48667647|NCT01911260|101970653|FG002|COMPLETED|Supplementation Period||39||
48667648|NCT01911260|101970654|FG003|COMPLETED|Supplementation Period||42||
48667649|NCT01911260|101970651|FG000|NOT COMPLETED|Supplementation Period||10||
48667650|NCT01911260|101970652|FG001|NOT COMPLETED|Supplementation Period||12||
48667651|NCT01911260|101970653|FG002|NOT COMPLETED|Supplementation Period||10||
48667652|NCT01911260|101970654|FG003|NOT COMPLETED|Supplementation Period||8||
48667653|NCT01911260|101970651|FG000|STARTED|Follow-up Period||40||
48667654|NCT01911260|101970652|FG001|STARTED|Follow-up Period||38||
48667655|NCT01911260|101970653|FG002|STARTED|Follow-up Period||39||
48667656|NCT01911260|101970654|FG003|STARTED|Follow-up Period||42||
48667657|NCT01911260|101970651|FG000|COMPLETED|Follow-up Period||27||
48667658|NCT01911260|101970652|FG001|COMPLETED|Follow-up Period||18||
48667659|NCT01911260|101970653|FG002|COMPLETED|Follow-up Period||24||
48667660|NCT01911260|101970654|FG003|COMPLETED|Follow-up Period||30||
48667661|NCT01911260|101970651|FG000|NOT COMPLETED|Follow-up Period||13||
48667662|NCT01911260|101970652|FG001|NOT COMPLETED|Follow-up Period||20||
48667663|NCT01911260|101970653|FG002|NOT COMPLETED|Follow-up Period||15||
48667664|NCT01911260|101970654|FG003|NOT COMPLETED|Follow-up Period||12||
48667665|NCT02323048|101970655|FG000|STARTED|Overall Study||25||
48667666|NCT02323048|101970656|FG001|STARTED|Overall Study||26||
48667667|NCT02323048|101970657|FG002|STARTED|Overall Study||23||
48667668|NCT02323048|101970658|FG003|STARTED|Overall Study||7||
48667669|NCT02323048|101970659|FG004|STARTED|Overall Study||9||
48667670|NCT02323048|101970655|FG000|COMPLETED|Overall Study||24||
48667671|NCT02323048|101970656|FG001|COMPLETED|Overall Study||24||
48667672|NCT02323048|101970657|FG002|COMPLETED|Overall Study||23||
48667673|NCT02323048|101970658|FG003|COMPLETED|Overall Study||7||
48667674|NCT02323048|101970659|FG004|COMPLETED|Overall Study||9||
48667675|NCT02323048|101970655|FG000|NOT COMPLETED|Overall Study||1||
48667676|NCT02323048|101970656|FG001|NOT COMPLETED|Overall Study||2||
48667677|NCT02323048|101970657|FG002|NOT COMPLETED|Overall Study||0||
48667678|NCT02323048|101970658|FG003|NOT COMPLETED|Overall Study||0||
48667679|NCT02323048|101970659|FG004|NOT COMPLETED|Overall Study||0||
48667680|NCT01285102|101970660|FG000|STARTED|Overall Study||4||
48667681|NCT01285102|101970660|FG000|COMPLETED|Overall Study||0||
48667682|NCT01285102|101970660|FG000|NOT COMPLETED|Overall Study||4||
48667683|NCT04093453|101970661|FG000|STARTED|Fasted Study||12||
48667684|NCT04093453|101970662|FG001|STARTED|Fasted Study||13||
48667685|NCT04093453|101970663|FG002|STARTED|Fasted Study||0||
48667686|NCT04093453|101970664|FG003|STARTED|Fasted Study||0||
48667687|NCT04093453|101970665|FG004|STARTED|Fasted Study||0||
48667688|NCT04093453|101970666|FG005|STARTED|Fasted Study||0||
48667689|NCT04093453|101970661|FG000|COMPLETED|Fasted Study||10||
48667690|NCT04093453|101970662|FG001|COMPLETED|Fasted Study||9||
48667691|NCT04093453|101970663|FG002|COMPLETED|Fasted Study||0||
48667692|NCT04093453|101970664|FG003|COMPLETED|Fasted Study||0||
48667693|NCT04093453|101970665|FG004|COMPLETED|Fasted Study||0||
48667694|NCT04093453|101970666|FG005|COMPLETED|Fasted Study||0||
48667695|NCT04093453|101970661|FG000|NOT COMPLETED|Fasted Study||2||
48667696|NCT04093453|101970662|FG001|NOT COMPLETED|Fasted Study||4||
48667697|NCT04093453|101970663|FG002|NOT COMPLETED|Fasted Study||0||
48667698|NCT04093453|101970664|FG003|NOT COMPLETED|Fasted Study||0||
48667699|NCT04093453|101970665|FG004|NOT COMPLETED|Fasted Study||0||
48667700|NCT04093453|101970666|FG005|NOT COMPLETED|Fasted Study||0||
48667701|NCT04093453|101970661|FG000|STARTED|Postprandial Study||0||
48667702|NCT04093453|101970662|FG001|STARTED|Postprandial Study||0||
48667703|NCT04093453|101970663|FG002|STARTED|Postprandial Study||12||
48667704|NCT04093453|101970664|FG003|STARTED|Postprandial Study||13||
48667705|NCT04093453|101970665|FG004|STARTED|Postprandial Study||0||
48667706|NCT04093453|101970666|FG005|STARTED|Postprandial Study||0||
48667707|NCT04093453|101970661|FG000|COMPLETED|Postprandial Study||0||
48667708|NCT04093453|101970662|FG001|COMPLETED|Postprandial Study||0||
48667709|NCT04093453|101970663|FG002|COMPLETED|Postprandial Study||9||
48667710|NCT04093453|101970664|FG003|COMPLETED|Postprandial Study||11||
48667711|NCT04093453|101970665|FG004|COMPLETED|Postprandial Study||0||
48667712|NCT04093453|101970666|FG005|COMPLETED|Postprandial Study||0||
48667713|NCT04093453|101970661|FG000|NOT COMPLETED|Postprandial Study||0||
48667714|NCT04093453|101970662|FG001|NOT COMPLETED|Postprandial Study||0||
48667715|NCT04093453|101970663|FG002|NOT COMPLETED|Postprandial Study||3||
48667716|NCT04093453|101970664|FG003|NOT COMPLETED|Postprandial Study||2||
48667717|NCT04093453|101970665|FG004|NOT COMPLETED|Postprandial Study||0||
48667718|NCT04093453|101970666|FG005|NOT COMPLETED|Postprandial Study||0||
48667719|NCT04093453|101970661|FG000|STARTED|Exercise Study||0||
48667720|NCT04093453|101970662|FG001|STARTED|Exercise Study||0||
48667721|NCT04093453|101970663|FG002|STARTED|Exercise Study||0||
48667722|NCT04093453|101970664|FG003|STARTED|Exercise Study||0||
48667723|NCT04093453|101970665|FG004|STARTED|Exercise Study||13||
48667724|NCT04093453|101970666|FG005|STARTED|Exercise Study||12||
48667725|NCT04093453|101970661|FG000|COMPLETED|Exercise Study||0||
48667726|NCT04093453|101970662|FG001|COMPLETED|Exercise Study||0||
48667727|NCT04093453|101970663|FG002|COMPLETED|Exercise Study||0||
48667728|NCT04093453|101970664|FG003|COMPLETED|Exercise Study||0||
48667729|NCT04093453|101970665|FG004|COMPLETED|Exercise Study||10||
48667730|NCT04093453|101970666|FG005|COMPLETED|Exercise Study||9||
48667731|NCT04093453|101970661|FG000|NOT COMPLETED|Exercise Study||0||
48667732|NCT04093453|101970662|FG001|NOT COMPLETED|Exercise Study||0||
48667733|NCT04093453|101970663|FG002|NOT COMPLETED|Exercise Study||0||
48667734|NCT04093453|101970664|FG003|NOT COMPLETED|Exercise Study||0||
48667735|NCT04093453|101970665|FG004|NOT COMPLETED|Exercise Study||3||
48667736|NCT04093453|101970666|FG005|NOT COMPLETED|Exercise Study||3||
48667737|NCT03048682|101970667|FG000|STARTED|Overall Study||32||
48667738|NCT03048682|101970668|FG001|STARTED|Overall Study||32||
48667739|NCT03048682|101970667|FG000|COMPLETED|Overall Study||30||
48667740|NCT03048682|101970668|FG001|COMPLETED|Overall Study||30||
48667741|NCT03048682|101970667|FG000|NOT COMPLETED|Overall Study||2||
48667742|NCT03048682|101970668|FG001|NOT COMPLETED|Overall Study||2||
48667743|NCT01890031|101970669|FG000|STARTED|Overall Study||50||
48667744|NCT01890031|101970670|FG001|STARTED|Overall Study||50||
48667745|NCT01890031|101970671|FG002|STARTED|Overall Study||12||
48667746|NCT01890031|101970672|FG003|STARTED|Overall Study||11||
48667747|NCT01890031|101970673|FG004|STARTED|Overall Study||8||
48667748|NCT01890031|101970669|FG000|COMPLETED|Overall Study||50||
48667749|NCT01890031|101970670|FG001|COMPLETED|Overall Study||50||
48667750|NCT01890031|101970671|FG002|COMPLETED|Overall Study||12||
48667751|NCT01890031|101970672|FG003|COMPLETED|Overall Study||11||
48667752|NCT01890031|101970673|FG004|COMPLETED|Overall Study||8||
48667753|NCT01890031|101970669|FG000|NOT COMPLETED|Overall Study||0||
48667754|NCT01890031|101970670|FG001|NOT COMPLETED|Overall Study||0||
48068486|NCT01786148|100489746|FG001|STARTED|Overall Study||72||
48068487|NCT01786148|100489745|FG000|COMPLETED|Overall Study||55||
48068488|NCT01786148|100489746|FG001|COMPLETED|Overall Study||50||
48068489|NCT01786148|100489745|FG000|NOT COMPLETED|Overall Study||22||
48068490|NCT01786148|100489746|FG001|NOT COMPLETED|Overall Study||22||
48068491|NCT00491764|100489747|FG000|STARTED|Overall Study||37||
48068492|NCT00491764|100489748|FG001|STARTED|Overall Study||37||
48068493|NCT00491764|100489749|FG002|STARTED|Overall Study||36||
48068494|NCT00491764|100489750|FG003|STARTED|Overall Study||36||
48068495|NCT00491764|100489751|FG004|STARTED|Overall Study||36||
48068496|NCT00491764|100489752|FG005|STARTED|Overall Study||36||
48068497|NCT00491764|100489747|FG000|COMPLETED|Overall Study||32||
48068498|NCT00491764|100489748|FG001|COMPLETED|Overall Study||30||
48068499|NCT00491764|100489749|FG002|COMPLETED|Overall Study||28||
48068500|NCT00491764|100489750|FG003|COMPLETED|Overall Study||28||
48068501|NCT00491764|100489751|FG004|COMPLETED|Overall Study||33||
48068502|NCT00491764|100489752|FG005|COMPLETED|Overall Study||27||
48068503|NCT00491764|100489747|FG000|NOT COMPLETED|Overall Study||5||
48068504|NCT00491764|100489748|FG001|NOT COMPLETED|Overall Study||7||
48068505|NCT00491764|100489749|FG002|NOT COMPLETED|Overall Study||8||
48068506|NCT00491764|100489750|FG003|NOT COMPLETED|Overall Study||8||
48068507|NCT00491764|100489751|FG004|NOT COMPLETED|Overall Study||3||
48068508|NCT00491764|100489752|FG005|NOT COMPLETED|Overall Study||9||
48068509|NCT04137627|100489753|FG000|STARTED|Overall Study||25||
48068510|NCT04137627|100489754|FG001|STARTED|Overall Study||25||
48667755|NCT01890031|101970671|FG002|NOT COMPLETED|Overall Study||0||
48667756|NCT01890031|101970672|FG003|NOT COMPLETED|Overall Study||0||
48667757|NCT01890031|101970673|FG004|NOT COMPLETED|Overall Study||0||
48667758|NCT01107886|101970674|FG000|STARTED|Overall Study||8280||
48667759|NCT01107886|101970675|FG001|STARTED|Overall Study||8212||
48068511|NCT04137627|100489753|FG000|COMPLETED|Overall Study||13||
48068512|NCT04137627|100489754|FG001|COMPLETED|Overall Study||12||
48068513|NCT04137627|100489753|FG000|NOT COMPLETED|Overall Study||12||
48068514|NCT04137627|100489754|FG001|NOT COMPLETED|Overall Study||13||
48068515|NCT01986946|100489755|FG000|STARTED|Overall Study||5||
48068516|NCT01986946|100489756|FG001|STARTED|Overall Study||9||
48068517|NCT01986946|100489755|FG000|COMPLETED|Overall Study||5||
48068518|NCT01986946|100489756|FG001|COMPLETED|Overall Study||9||
48068519|NCT01986946|100489755|FG000|NOT COMPLETED|Overall Study||0||
48068520|NCT01986946|100489756|FG001|NOT COMPLETED|Overall Study||0||
48068521|NCT00400764|100489757|FG000|STARTED|Phase Ib||6||
48068522|NCT00400764|100489758|FG001|STARTED|Phase Ib||6||
48068523|NCT00400764|100489759|FG002|STARTED|Phase Ib||0||
48068524|NCT00400764|100489760|FG003|STARTED|Phase Ib||0||
48068525|NCT00400764|100489761|FG004|STARTED|Phase Ib||0||
48068526|NCT00400764|100489757|FG000|Treated|Phase Ib||6||
48068527|NCT00400764|100489758|FG001|Treated|Phase Ib||6||
48068528|NCT00400764|100489759|FG002|Treated|Phase Ib||0||
48068529|NCT00400764|100489760|FG003|Treated|Phase Ib||0||
48068530|NCT00400764|100489761|FG004|Treated|Phase Ib||0||
48068531|NCT00400764|100489757|FG000|COMPLETED|Phase Ib||0||
48068532|NCT00400764|100489758|FG001|COMPLETED|Phase Ib||2||
48068533|NCT00400764|100489759|FG002|COMPLETED|Phase Ib||0||
48068534|NCT00400764|100489760|FG003|COMPLETED|Phase Ib||0||
48068535|NCT00400764|100489761|FG004|COMPLETED|Phase Ib||0||
48068536|NCT00400764|100489757|FG000|NOT COMPLETED|Phase Ib||6||
48068537|NCT00400764|100489758|FG001|NOT COMPLETED|Phase Ib||4||
48068538|NCT00400764|100489759|FG002|NOT COMPLETED|Phase Ib||0||
48068539|NCT00400764|100489760|FG003|NOT COMPLETED|Phase Ib||0||
48068540|NCT00400764|100489761|FG004|NOT COMPLETED|Phase Ib||0||
48068541|NCT00400764|100489757|FG000|STARTED|Phase II||0||
48068542|NCT00400764|100489758|FG001|STARTED|Phase II||0||
48068543|NCT00400764|100489759|FG002|STARTED|Phase II||23||
48068544|NCT00400764|100489760|FG003|STARTED|Phase II||26||
48068545|NCT00400764|100489761|FG004|STARTED|Phase II||11||
48068546|NCT00400764|100489757|FG000|Treated|Phase II||0||
48068547|NCT00400764|100489758|FG001|Treated|Phase II||0||
48068548|NCT00400764|100489759|FG002|Treated|Phase II||22||
48068549|NCT00400764|100489760|FG003|Treated|Phase II||26||
48068550|NCT00400764|100489761|FG004|Treated|Phase II||11||
48068551|NCT00400764|100489757|FG000|COMPLETED|Phase II||0||
48068552|NCT00400764|100489758|FG001|COMPLETED|Phase II||0||
48068553|NCT00400764|100489759|FG002|COMPLETED|Phase II||0||
48068554|NCT00400764|100489760|FG003|COMPLETED|Phase II||0||
48068555|NCT00400764|100489761|FG004|COMPLETED|Phase II||0||
48068556|NCT00400764|100489757|FG000|NOT COMPLETED|Phase II||0||
48068557|NCT00400764|100489758|FG001|NOT COMPLETED|Phase II||0||
48068558|NCT00400764|100489759|FG002|NOT COMPLETED|Phase II||23||
48068559|NCT00400764|100489760|FG003|NOT COMPLETED|Phase II||26||
48068560|NCT00400764|100489761|FG004|NOT COMPLETED|Phase II||11||
48068561|NCT03175978|100489762|FG000|STARTED|Overall Study||2||
48068562|NCT03175978|100489762|FG000|COMPLETED|Overall Study||2||
48068563|NCT03175978|100489762|FG000|NOT COMPLETED|Overall Study||0||
48068564|NCT00091442|100489763|FG000|STARTED|Overall Study||373||
48068565|NCT00091442|100489764|FG001|STARTED|Overall Study||378||
48068566|NCT00091442|100489763|FG000|COMPLETED|Overall Study||4||
48068567|NCT00091442|100489764|FG001|COMPLETED|Overall Study||5||
48068568|NCT00091442|100489763|FG000|NOT COMPLETED|Overall Study||369||
48068569|NCT00091442|100489764|FG001|NOT COMPLETED|Overall Study||373||
48068570|NCT00795145|100489765|FG000|STARTED|Cohort 1||3||
48068571|NCT00795145|100489766|FG001|STARTED|Cohort 1||3||
48068572|NCT00795145|100489767|FG002|STARTED|Cohort 1||3||
48068573|NCT00795145|100489768|FG003|STARTED|Cohort 1||0||
48068574|NCT00795145|100489769|FG004|STARTED|Cohort 1||0||
48068575|NCT00795145|100489770|FG005|STARTED|Cohort 1||0||
48068576|NCT00795145|100489771|FG006|STARTED|Cohort 1||0||
48068577|NCT00795145|100489765|FG000|COMPLETED|Cohort 1||3||
48068578|NCT00795145|100489766|FG001|COMPLETED|Cohort 1||3||
48068579|NCT00795145|100489767|FG002|COMPLETED|Cohort 1||3||
48068580|NCT00795145|100489768|FG003|COMPLETED|Cohort 1||0||
48068581|NCT00795145|100489769|FG004|COMPLETED|Cohort 1||0||
48068582|NCT00795145|100489770|FG005|COMPLETED|Cohort 1||0||
48068583|NCT00795145|100489771|FG006|COMPLETED|Cohort 1||0||
48068584|NCT00795145|100489765|FG000|NOT COMPLETED|Cohort 1||0||
48068585|NCT00795145|100489766|FG001|NOT COMPLETED|Cohort 1||0||
48068586|NCT00795145|100489767|FG002|NOT COMPLETED|Cohort 1||0||
48068587|NCT00795145|100489768|FG003|NOT COMPLETED|Cohort 1||0||
48068588|NCT00795145|100489769|FG004|NOT COMPLETED|Cohort 1||0||
48068589|NCT00795145|100489770|FG005|NOT COMPLETED|Cohort 1||0||
48068590|NCT00795145|100489771|FG006|NOT COMPLETED|Cohort 1||0||
48068591|NCT00795145|100489765|FG000|STARTED|Cohort 2||0||
48068592|NCT00795145|100489766|FG001|STARTED|Cohort 2||0||
48068593|NCT00795145|100489767|FG002|STARTED|Cohort 2||0||
48068594|NCT00795145|100489768|FG003|STARTED|Cohort 2||10||
48068595|NCT00795145|100489769|FG004|STARTED|Cohort 2||10||
48068596|NCT00795145|100489770|FG005|STARTED|Cohort 2||10||
48068597|NCT00795145|100489771|FG006|STARTED|Cohort 2||10||
48068598|NCT00795145|100489765|FG000|COMPLETED|Cohort 2||0||
48068599|NCT00795145|100489766|FG001|COMPLETED|Cohort 2||0||
48068600|NCT00795145|100489767|FG002|COMPLETED|Cohort 2||0||
48068601|NCT00795145|100489768|FG003|COMPLETED|Cohort 2||10||
48068602|NCT00795145|100489769|FG004|COMPLETED|Cohort 2||10||
48068603|NCT00795145|100489770|FG005|COMPLETED|Cohort 2||10||
48068604|NCT00795145|100489771|FG006|COMPLETED|Cohort 2||10||
48068605|NCT00795145|100489765|FG000|NOT COMPLETED|Cohort 2||0||
48068606|NCT00795145|100489766|FG001|NOT COMPLETED|Cohort 2||0||
48068607|NCT00795145|100489767|FG002|NOT COMPLETED|Cohort 2||0||
48068608|NCT00795145|100489768|FG003|NOT COMPLETED|Cohort 2||0||
48068609|NCT00795145|100489769|FG004|NOT COMPLETED|Cohort 2||0||
48068610|NCT00795145|100489770|FG005|NOT COMPLETED|Cohort 2||0||
48068611|NCT00795145|100489771|FG006|NOT COMPLETED|Cohort 2||0||
48068612|NCT02008318|100489772|FG000|STARTED|Overall Study||41||
48068613|NCT02008318|100489773|FG001|STARTED|Overall Study||2||
48068614|NCT02008318|100489772|FG000|Received At Least 1 Dose of Study Drug|Overall Study||41||
48068615|NCT02008318|100489773|FG001|Received At Least 1 Dose of Study Drug|Overall Study||2||
48068616|NCT02008318|100489772|FG000|COMPLETED|Overall Study||29|Completed at least 6 cycles|
48068617|NCT02008318|100489773|FG001|COMPLETED|Overall Study||1|Completed at least 6 cycles|
48068618|NCT02008318|100489772|FG000|NOT COMPLETED|Overall Study||12||
48068619|NCT02008318|100489773|FG001|NOT COMPLETED|Overall Study||1||
48068620|NCT01950169|100489774|FG000|STARTED|Overall Study||28||
48068621|NCT01950169|100489775|FG001|STARTED|Overall Study||26||
48068622|NCT01950169|100489776|FG002|STARTED|Overall Study||25||
48068623|NCT01950169|100489774|FG000|COMPLETED|Overall Study||25||
48068624|NCT01950169|100489775|FG001|COMPLETED|Overall Study||18||
48068625|NCT01950169|100489776|FG002|COMPLETED|Overall Study||24||
48068626|NCT01950169|100489774|FG000|NOT COMPLETED|Overall Study||3||
48068627|NCT01950169|100489775|FG001|NOT COMPLETED|Overall Study||8||
48068628|NCT01950169|100489776|FG002|NOT COMPLETED|Overall Study||1||
48068629|NCT00660699|100489777|FG000|STARTED|Overall Study||50||
48068630|NCT00660699|100489777|FG000|COMPLETED|Overall Study||48||
48068631|NCT00660699|100489777|FG000|NOT COMPLETED|Overall Study||2||
48068632|NCT02498132|100489778|FG000|STARTED|Overall Study||24||
48068633|NCT02498132|100489779|FG001|STARTED|Overall Study||19||
48068634|NCT02498132|100489780|FG002|STARTED|Overall Study||9||
48068635|NCT02498132|100489778|FG000|COMPLETED|Overall Study||22||
48068636|NCT02498132|100489779|FG001|COMPLETED|Overall Study||18||
48068637|NCT02498132|100489780|FG002|COMPLETED|Overall Study||9||
48068638|NCT02498132|100489778|FG000|NOT COMPLETED|Overall Study||2||
48068639|NCT02498132|100489779|FG001|NOT COMPLETED|Overall Study||1||
48068640|NCT02498132|100489780|FG002|NOT COMPLETED|Overall Study||0||
48068641|NCT03780543|100489781|FG000|STARTED|Overall Study||26||
48068642|NCT03780543|100489782|FG001|STARTED|Overall Study||43||
48068643|NCT03780543|100489783|FG002|STARTED|Overall Study||23||
48068644|NCT03780543|100489781|FG000|COMPLETED|Overall Study||13||
48068645|NCT03780543|100489782|FG001|COMPLETED|Overall Study||28||
48068646|NCT03780543|100489783|FG002|COMPLETED|Overall Study||6||
48068647|NCT03780543|100489781|FG000|NOT COMPLETED|Overall Study||13||
48068648|NCT03780543|100489782|FG001|NOT COMPLETED|Overall Study||15||
48068649|NCT03780543|100489783|FG002|NOT COMPLETED|Overall Study||17||
48068650|NCT03428932|100489784|FG000|STARTED|Overall Study||21||
48068651|NCT03428932|100489785|FG001|STARTED|Overall Study||21||
48068652|NCT03428932|100489784|FG000|COMPLETED|Overall Study||21||
48068653|NCT03428932|100489785|FG001|COMPLETED|Overall Study||21||
48068654|NCT03428932|100489784|FG000|NOT COMPLETED|Overall Study||0||
48068655|NCT03428932|100489785|FG001|NOT COMPLETED|Overall Study||0||
48068656|NCT00404235|100489786|FG000|STARTED|Overall Study||35||
48068657|NCT00404235|100489787|FG001|STARTED|Overall Study||41||
48068658|NCT00404235|100489786|FG000|COMPLETED|Overall Study||34||
48068659|NCT00404235|100489787|FG001|COMPLETED|Overall Study||39||
48068660|NCT00404235|100489786|FG000|NOT COMPLETED|Overall Study||1||
48068661|NCT00404235|100489787|FG001|NOT COMPLETED|Overall Study||2||
48068662|NCT02110238|100489788|FG000|STARTED|12 Week Pivotal Phase||212||
48068663|NCT02110238|100489789|FG001|STARTED|12 Week Pivotal Phase||209||
48068664|NCT02110238|100489788|FG000|COMPLETED|12 Week Pivotal Phase||202||
48068665|NCT02110238|100489789|FG001|COMPLETED|12 Week Pivotal Phase||200||
48068666|NCT02110238|100489788|FG000|NOT COMPLETED|12 Week Pivotal Phase||10||
48068667|NCT02110238|100489789|FG001|NOT COMPLETED|12 Week Pivotal Phase||9||
48068668|NCT02110238|100489788|FG000|STARTED|14 Week Blinded Extension Phase||202||
48068669|NCT02110238|100489789|FG001|STARTED|14 Week Blinded Extension Phase||200||
48068670|NCT02110238|100489788|FG000|COMPLETED|14 Week Blinded Extension Phase||190||
48068671|NCT02110238|100489789|FG001|COMPLETED|14 Week Blinded Extension Phase||188||
48068672|NCT02110238|100489788|FG000|NOT COMPLETED|14 Week Blinded Extension Phase||12||
48068673|NCT02110238|100489789|FG001|NOT COMPLETED|14 Week Blinded Extension Phase||12||
48068674|NCT04696055|100489790|FG000|STARTED|Overall Study||68||
48068675|NCT04696055|100489791|FG001|STARTED|Overall Study||27||
48068676|NCT04696055|100489790|FG000|COMPLETED|Overall Study||0||
48068677|NCT04696055|100489791|FG001|COMPLETED|Overall Study||0||
48068678|NCT04696055|100489790|FG000|NOT COMPLETED|Overall Study||68||
48068679|NCT04696055|100489791|FG001|NOT COMPLETED|Overall Study||27||
48068680|NCT04057365|100489792|FG000|STARTED|Overall Study||15||
48068681|NCT04057365|100489793|FG001|STARTED|Overall Study||0||
48068682|NCT04057365|100489792|FG000|COMPLETED|Overall Study||13||
48068683|NCT04057365|100489793|FG001|COMPLETED|Overall Study||0||
48068684|NCT04057365|100489792|FG000|NOT COMPLETED|Overall Study||2||
48068685|NCT04057365|100489793|FG001|NOT COMPLETED|Overall Study||0||
48068686|NCT01202565|100489794|FG000|STARTED|Overall Study||506||
48068687|NCT01202565|100489794|FG000|Full Analysis Set|Overall Study||501||
48068688|NCT01202565|100489794|FG000|COMPLETED|Overall Study||439||
48068689|NCT01202565|100489794|FG000|NOT COMPLETED|Overall Study||67||
48068690|NCT01581710|100489795|FG000|STARTED|First Intervention (14days)||18||
48068691|NCT01581710|100489796|FG001|STARTED|First Intervention (14days)||14||
48068692|NCT01581710|100489795|FG000|COMPLETED|First Intervention (14days)||18||
48068693|NCT01581710|100489796|FG001|COMPLETED|First Intervention (14days)||14||
48068694|NCT01581710|100489795|FG000|NOT COMPLETED|First Intervention (14days)||0||
48068695|NCT01581710|100489796|FG001|NOT COMPLETED|First Intervention (14days)||0||
48068696|NCT01581710|100489795|FG000|STARTED|Washout Period (14days)||18||
48068697|NCT01581710|100489796|FG001|STARTED|Washout Period (14days)||14||
48068698|NCT01581710|100489795|FG000|COMPLETED|Washout Period (14days)||18||
48068699|NCT01581710|100489796|FG001|COMPLETED|Washout Period (14days)||14||
48068700|NCT01581710|100489795|FG000|NOT COMPLETED|Washout Period (14days)||0||
48068701|NCT01581710|100489796|FG001|NOT COMPLETED|Washout Period (14days)||0||
48068702|NCT01581710|100489795|FG000|STARTED|Second Intervention (14days)||18||
48068703|NCT01581710|100489796|FG001|STARTED|Second Intervention (14days)||14||
48068704|NCT01581710|100489795|FG000|COMPLETED|Second Intervention (14days)||18||
48068705|NCT01581710|100489796|FG001|COMPLETED|Second Intervention (14days)||12||
48068706|NCT01581710|100489795|FG000|NOT COMPLETED|Second Intervention (14days)||0||
48068707|NCT01581710|100489796|FG001|NOT COMPLETED|Second Intervention (14days)||2||
48068708|NCT04478266|100489797|FG000|STARTED|Overall Study||534||
48068709|NCT04478266|100489798|FG001|STARTED|Overall Study||534||
48068710|NCT04478266|100489797|FG000|Treated|Overall Study||533||
48068711|NCT04478266|100489798|FG001|Treated|Overall Study||533||
48068712|NCT04478266|100489797|FG000|COMPLETED|Overall Study||0||
48068713|NCT04478266|100489798|FG001|COMPLETED|Overall Study||0||
48068714|NCT04478266|100489797|FG000|NOT COMPLETED|Overall Study||534||
48068715|NCT04478266|100489798|FG001|NOT COMPLETED|Overall Study||534||
48068716|NCT01128842|100489799|FG000|STARTED|Overall Study||7||
48068717|NCT01128842|100489799|FG000|COMPLETED|Overall Study||0||
48068718|NCT01128842|100489799|FG000|NOT COMPLETED|Overall Study||7||
48068719|NCT00085709|100489800|FG000|STARTED|Overall Study||317||
48068720|NCT00085709|100489801|FG001|STARTED|Overall Study||320||
48068721|NCT00085709|100489800|FG000|Eligible|Overall Study||298||
48068722|NCT00085709|100489801|FG001|Eligible|Overall Study||301||
48068723|NCT00085709|100489800|FG000|Eligible and Did Not Withdraw Consent|Overall Study||296||
48068724|NCT00085709|100489801|FG001|Eligible and Did Not Withdraw Consent|Overall Study||300||
48068725|NCT00085709|100489800|FG000|COMPLETED|Overall Study||264||
48068726|NCT00085709|100489801|FG001|COMPLETED|Overall Study||270||
48068727|NCT00085709|100489800|FG000|NOT COMPLETED|Overall Study||53||
48068728|NCT00085709|100489801|FG001|NOT COMPLETED|Overall Study||50||
48068729|NCT01522248|100489802|FG000|STARTED|Overall Study||10||
48068730|NCT01522248|100489803|FG001|STARTED|Overall Study||10||
48068731|NCT01522248|100489802|FG000|COMPLETED|Overall Study||9||
48068732|NCT01522248|100489803|FG001|COMPLETED|Overall Study||10||
48068733|NCT01522248|100489802|FG000|NOT COMPLETED|Overall Study||1||
48068734|NCT01522248|100489803|FG001|NOT COMPLETED|Overall Study||0||
48068735|NCT01589978|100489804|FG000|STARTED|Overall Study||2681||
48068736|NCT01589978|100489804|FG000|COMPLETED|Overall Study||2681||
48068737|NCT01589978|100489804|FG000|NOT COMPLETED|Overall Study||0||
48068738|NCT02663908|100489805|FG000|STARTED|Overall Study||276||
48068739|NCT02663908|100489806|FG001|STARTED|Overall Study||269||
48068740|NCT02663908|100489805|FG000|Full Analysis Set (FAS)|Overall Study||275||
48068741|NCT02663908|100489806|FG001|Full Analysis Set (FAS)|Overall Study||269||
48068742|NCT02663908|100489805|FG000|COMPLETED|Overall Study||244||
48068743|NCT02663908|100489806|FG001|COMPLETED|Overall Study||245||
48068744|NCT02663908|100489805|FG000|NOT COMPLETED|Overall Study||32||
48068745|NCT02663908|100489806|FG001|NOT COMPLETED|Overall Study||24||
48068746|NCT01893203|100489807|FG000|STARTED|Overall Study||14||
48068747|NCT01893203|100489807|FG000|COMPLETED|Overall Study||13||
48068748|NCT01893203|100489807|FG000|NOT COMPLETED|Overall Study||1||
48068749|NCT00866788|100489808|FG000|STARTED|Overall Study||21||
48068750|NCT00866788|100489809|FG001|STARTED|Overall Study||23||
48068751|NCT00866788|100489810|FG002|STARTED|Overall Study||25||
48068752|NCT00866788|100489811|FG003|STARTED|Overall Study||21||
48068753|NCT00866788|100489808|FG000|COMPLETED|Overall Study||15||
48068754|NCT00866788|100489809|FG001|COMPLETED|Overall Study||17||
48068755|NCT00866788|100489810|FG002|COMPLETED|Overall Study||23||
48068756|NCT00866788|100489811|FG003|COMPLETED|Overall Study||16||
48068757|NCT00866788|100489808|FG000|NOT COMPLETED|Overall Study||6||
48068758|NCT00866788|100489809|FG001|NOT COMPLETED|Overall Study||6||
48068759|NCT00866788|100489810|FG002|NOT COMPLETED|Overall Study||2||
48068760|NCT00866788|100489811|FG003|NOT COMPLETED|Overall Study||5||
48068761|NCT03572244|100489812|FG000|STARTED|Overall Study||6||
48068762|NCT03572244|100489813|FG001|STARTED|Overall Study||6||
48068763|NCT03572244|100489812|FG000|COMPLETED|Overall Study||6||
48068764|NCT03572244|100489813|FG001|COMPLETED|Overall Study||6||
48068765|NCT03572244|100489812|FG000|NOT COMPLETED|Overall Study||0||
48068766|NCT03572244|100489813|FG001|NOT COMPLETED|Overall Study||0||
48068767|NCT01020981|100489814|FG000|STARTED|Overall Study||150||
48068768|NCT01020981|100489815|FG001|STARTED|Overall Study||150||
48068769|NCT01020981|100489814|FG000|COMPLETED|Overall Study||66||
48068770|NCT01020981|100489815|FG001|COMPLETED|Overall Study||60||
48068771|NCT01020981|100489814|FG000|NOT COMPLETED|Overall Study||84||
48068772|NCT01020981|100489815|FG001|NOT COMPLETED|Overall Study||90||
48068773|NCT01817530|100489816|FG000|STARTED|Overall Study||65|randomized and treated|
48068774|NCT01817530|100489817|FG001|STARTED|Overall Study||65|randomized and treated|
48068775|NCT01817530|100489818|FG002|STARTED|Overall Study||64|randomized and treated|
48068776|NCT01817530|100489819|FG003|STARTED|Overall Study||65|randomized and treated|
48068777|NCT01817530|100489820|FG004|STARTED|Overall Study||78|randomized and treated|
48068778|NCT01817530|100489821|FG005|STARTED|Overall Study||77|randomized and treated|
48068779|NCT01817530|100489822|FG006|STARTED|Overall Study||76|randomized and treated|
48068780|NCT01817530|100489823|FG007|STARTED|Overall Study||77|randomized and treated|
48068781|NCT01817530|100489816|FG000|COMPLETED|Overall Study||50||
48068782|NCT01817530|100489817|FG001|COMPLETED|Overall Study||52||
48068783|NCT01817530|100489818|FG002|COMPLETED|Overall Study||53||
48068784|NCT01817530|100489819|FG003|COMPLETED|Overall Study||52||
48068785|NCT01817530|100489820|FG004|COMPLETED|Overall Study||67||
48068786|NCT01817530|100489821|FG005|COMPLETED|Overall Study||58||
48068787|NCT01817530|100489822|FG006|COMPLETED|Overall Study||53||
48068788|NCT01817530|100489823|FG007|COMPLETED|Overall Study||53||
48068789|NCT01817530|100489816|FG000|NOT COMPLETED|Overall Study||15||
48068790|NCT01817530|100489817|FG001|NOT COMPLETED|Overall Study||13||
48068791|NCT01817530|100489818|FG002|NOT COMPLETED|Overall Study||11||
48068792|NCT01817530|100489819|FG003|NOT COMPLETED|Overall Study||13||
48068793|NCT01817530|100489820|FG004|NOT COMPLETED|Overall Study||11||
48068794|NCT01817530|100489821|FG005|NOT COMPLETED|Overall Study||19||
48068795|NCT01817530|100489822|FG006|NOT COMPLETED|Overall Study||23||
48068796|NCT01817530|100489823|FG007|NOT COMPLETED|Overall Study||24||
48068797|NCT00809354|100489824|FG000|STARTED|Overall Study||288||
48068798|NCT00809354|100489825|FG001|STARTED|Overall Study||289||
48068799|NCT00809354|100489826|FG002|STARTED|Overall Study||286||
48068800|NCT00809354|100489827|FG003|STARTED|Overall Study||288||
48068801|NCT00809354|100489828|FG004|STARTED|Overall Study||288||
48068802|NCT00809354|100489829|FG005|STARTED|Overall Study||256||
48068803|NCT00809354|100489830|FG006|STARTED|Overall Study||255||
48068804|NCT00809354|100489831|FG007|STARTED|Overall Study||257||
48068805|NCT00809354|100489832|FG008|STARTED|Overall Study||256||
48068806|NCT00809354|100489833|FG009|STARTED|Overall Study||257||
48068807|NCT00809354|100489824|FG000|Treated|Overall Study||285||
48068808|NCT00809354|100489825|FG001|Treated|Overall Study||288||
48068809|NCT00809354|100489826|FG002|Treated|Overall Study||280||
48068810|NCT00809354|100489827|FG003|Treated|Overall Study||288||
48068811|NCT00809354|100489828|FG004|Treated|Overall Study||283||
48068812|NCT00809354|100489829|FG005|Treated|Overall Study||256||
48068813|NCT00809354|100489830|FG006|Treated|Overall Study||254||
48068814|NCT00809354|100489831|FG007|Treated|Overall Study||256||
48068815|NCT00809354|100489832|FG008|Treated|Overall Study||254||
48068816|NCT00809354|100489833|FG009|Treated|Overall Study||256||
48068817|NCT00809354|100489824|FG000|COMPLETED|Overall Study||33||
48068818|NCT00809354|100489825|FG001|COMPLETED|Overall Study||31||
48068819|NCT00809354|100489826|FG002|COMPLETED|Overall Study||32||
48068820|NCT00809354|100489827|FG003|COMPLETED|Overall Study||32||
48068821|NCT00809354|100489828|FG004|COMPLETED|Overall Study||32||
48068822|NCT00809354|100489829|FG005|COMPLETED|Overall Study||31||
48068823|NCT00809354|100489830|FG006|COMPLETED|Overall Study||32||
48068824|NCT00809354|100489831|FG007|COMPLETED|Overall Study||19||
48068825|NCT00809354|100489832|FG008|COMPLETED|Overall Study||28||
48068826|NCT00809354|100489833|FG009|COMPLETED|Overall Study||31||
48068827|NCT00809354|100489824|FG000|NOT COMPLETED|Overall Study||255||
48068828|NCT00809354|100489825|FG001|NOT COMPLETED|Overall Study||258||
48068829|NCT00809354|100489826|FG002|NOT COMPLETED|Overall Study||254||
48068830|NCT00809354|100489827|FG003|NOT COMPLETED|Overall Study||256||
48068831|NCT00809354|100489828|FG004|NOT COMPLETED|Overall Study||256||
48068832|NCT00809354|100489829|FG005|NOT COMPLETED|Overall Study||225||
48068833|NCT00809354|100489830|FG006|NOT COMPLETED|Overall Study||223||
48068834|NCT00809354|100489831|FG007|NOT COMPLETED|Overall Study||238||
48068835|NCT00809354|100489832|FG008|NOT COMPLETED|Overall Study||228||
48068836|NCT00809354|100489833|FG009|NOT COMPLETED|Overall Study||226||
48068837|NCT03758443|100489834|FG000|STARTED|Induction Period||61||
48068838|NCT03758443|100489835|FG001|STARTED|Induction Period||61||
48068839|NCT03758443|100489836|FG002|STARTED|Induction Period||59||
48068840|NCT03758443|100489837|FG003|STARTED|Induction Period||58||
48068841|NCT03758443|100489834|FG000|COMPLETED|Induction Period||55||
48068842|NCT03758443|100489835|FG001|COMPLETED|Induction Period||54||
48068843|NCT03758443|100489836|FG002|COMPLETED|Induction Period||52||
48068844|NCT03758443|100489837|FG003|COMPLETED|Induction Period||50||
48068845|NCT03758443|100489834|FG000|NOT COMPLETED|Induction Period||6||
48068846|NCT03758443|100489835|FG001|NOT COMPLETED|Induction Period||7||
48068847|NCT03758443|100489836|FG002|NOT COMPLETED|Induction Period||7||
48068848|NCT03758443|100489837|FG003|NOT COMPLETED|Induction Period||8||
48068849|NCT03758443|100489834|FG000|STARTED|Extended Induction Period||42||
48068850|NCT03758443|100489835|FG001|STARTED|Extended Induction Period||32||
48068851|NCT03758443|100489836|FG002|STARTED|Extended Induction Period||32||
48068852|NCT03758443|100489837|FG003|STARTED|Extended Induction Period||29||
48068853|NCT03758443|100489834|FG000|COMPLETED|Extended Induction Period||29||
48068854|NCT03758443|100489835|FG001|COMPLETED|Extended Induction Period||29||
48068855|NCT03758443|100489836|FG002|COMPLETED|Extended Induction Period||23||
48068856|NCT03758443|100489837|FG003|COMPLETED|Extended Induction Period||22||
48068857|NCT03758443|100489834|FG000|NOT COMPLETED|Extended Induction Period||13||
48068858|NCT03758443|100489835|FG001|NOT COMPLETED|Extended Induction Period||3||
48068859|NCT03758443|100489836|FG002|NOT COMPLETED|Extended Induction Period||9||
48068860|NCT03758443|100489837|FG003|NOT COMPLETED|Extended Induction Period||7||
48068861|NCT03758443|100489834|FG000|STARTED|Maintenance Period||29||
48068862|NCT03758443|100489835|FG001|STARTED|Maintenance Period||31||
48068863|NCT03758443|100489836|FG002|STARTED|Maintenance Period||25||
48068864|NCT03758443|100489837|FG003|STARTED|Maintenance Period||22||
48068865|NCT03758443|100489834|FG000|COMPLETED|Maintenance Period||13||
48068866|NCT03758443|100489835|FG001|COMPLETED|Maintenance Period||11||
48068867|NCT03758443|100489836|FG002|COMPLETED|Maintenance Period||12||
48068868|NCT03758443|100489837|FG003|COMPLETED|Maintenance Period||9||
48068869|NCT03758443|100489834|FG000|NOT COMPLETED|Maintenance Period||16||
48068870|NCT03758443|100489835|FG001|NOT COMPLETED|Maintenance Period||20||
48068871|NCT03758443|100489836|FG002|NOT COMPLETED|Maintenance Period||13||
48068872|NCT03758443|100489837|FG003|NOT COMPLETED|Maintenance Period||13||
48068873|NCT00369707|100489838|FG000|STARTED|Induction Part A (1 Cycle -35 Days)||42||
48068874|NCT00369707|100489838|FG000|COMPLETED|Induction Part A (1 Cycle -35 Days)||42||
48068875|NCT00369707|100489838|FG000|NOT COMPLETED|Induction Part A (1 Cycle -35 Days)||0||
48068876|NCT00369707|100489838|FG000|STARTED|Induction Part B (2 Cycles)||42||
48068877|NCT00369707|100489838|FG000|COMPLETED|Induction Part B (2 Cycles)||35||
48068878|NCT00369707|100489838|FG000|NOT COMPLETED|Induction Part B (2 Cycles)||7||
48068879|NCT00369707|100489838|FG000|STARTED|Maintenance Period (up to 4 Cycles)||35||
48068880|NCT00369707|100489838|FG000|COMPLETED|Maintenance Period (up to 4 Cycles)||27||
48068881|NCT00369707|100489838|FG000|NOT COMPLETED|Maintenance Period (up to 4 Cycles)||8||
48068882|NCT00369707|100489838|FG000|STARTED|Follow up for 2 Years After Treatment||41|All patients that receive treatment go into follow up at completion of study treatment.|
48068883|NCT00369707|100489838|FG000|COMPLETED|Follow up for 2 Years After Treatment||38||
48068884|NCT00369707|100489838|FG000|NOT COMPLETED|Follow up for 2 Years After Treatment||3||
48068885|NCT01696071|100489839|FG000|STARTED|Treatment Period 1: 4 Weeks||51||
48068886|NCT01696071|100489840|FG001|STARTED|Treatment Period 1: 4 Weeks||47||
48068887|NCT01696071|100489839|FG000|COMPLETED|Treatment Period 1: 4 Weeks||51||
48068888|NCT01696071|100489840|FG001|COMPLETED|Treatment Period 1: 4 Weeks||47||
48068889|NCT01696071|100489839|FG000|NOT COMPLETED|Treatment Period 1: 4 Weeks||0||
48068890|NCT01696071|100489840|FG001|NOT COMPLETED|Treatment Period 1: 4 Weeks||0||
48068891|NCT01696071|100489839|FG000|STARTED|Treatment Period 2: 4 Weeks||51||
48068892|NCT01696071|100489840|FG001|STARTED|Treatment Period 2: 4 Weeks||47||
48068893|NCT01696071|100489839|FG000|COMPLETED|Treatment Period 2: 4 Weeks||50||
48068894|NCT01696071|100489840|FG001|COMPLETED|Treatment Period 2: 4 Weeks||47||
48068895|NCT01696071|100489839|FG000|NOT COMPLETED|Treatment Period 2: 4 Weeks||1||
48068896|NCT01696071|100489840|FG001|NOT COMPLETED|Treatment Period 2: 4 Weeks||0||
48068897|NCT03441269|100489841|FG000|STARTED|Overall Study||75||
48068898|NCT03441269|100489842|FG001|STARTED|Overall Study||75||
48068899|NCT03441269|100489843|FG002|STARTED|Overall Study||75||
48068900|NCT03441269|100489841|FG000|COMPLETED|Overall Study||75||
48068901|NCT03441269|100489842|FG001|COMPLETED|Overall Study||74||
48068902|NCT03441269|100489843|FG002|COMPLETED|Overall Study||74||
48068903|NCT03441269|100489841|FG000|NOT COMPLETED|Overall Study||0||
48068904|NCT03441269|100489842|FG001|NOT COMPLETED|Overall Study||1||
48068905|NCT03441269|100489843|FG002|NOT COMPLETED|Overall Study||1||
48068906|NCT02339285|100489844|FG000|STARTED|Overall Study||10|All randomized participants included in analysis. Intent-to-treat; last observation carried forward.|
48068907|NCT02339285|100489845|FG001|STARTED|Overall Study||11|All randomized participants included in analysis. Intent-to-treat; last observation carried forward.|
48068908|NCT02339285|100489846|FG002|STARTED|Overall Study||11|All randomized participants included in analysis. Intent-to-treat; last observation carried forward.|
48068909|NCT02339285|100489844|FG000|Completed Intervention|Overall Study||10|Number of participants that completed 5 days of stimulation.|
48068910|NCT02339285|100489845|FG001|Completed Intervention|Overall Study||10|Number of participants that completed 5 days of stimulation.|
48068911|NCT02339285|100489846|FG002|Completed Intervention|Overall Study||10|Number of participants that completed 5 days of stimulation.|
48068912|NCT02339285|100489844|FG000|2 Week Follow-up|Overall Study||9|Number of participants that attended the follow-up visit 2 weeks after completion of intervention.|
48068913|NCT02339285|100489845|FG001|2 Week Follow-up|Overall Study||10|Number of participants that attended the follow-up visit 2 weeks after completion of intervention.|
48068914|NCT02339285|100489846|FG002|2 Week Follow-up|Overall Study||10|Number of participants that attended the follow-up visit 2 weeks after completion of intervention.|
48068915|NCT02339285|100489844|FG000|4 Week Follow-up Visit|Overall Study||9|Number of participants that attended the follow-up visit 4 weeks after completion of intervention.|
48219982|NCT05580003|100863749|FG001|STARTED|Part 3: Washout 3 (up to 3 Days)||0||
48219983|NCT05580003|100863750|FG002|STARTED|Part 3: Washout 3 (up to 3 Days)||0||
48219984|NCT05580003|100863751|FG003|STARTED|Part 3: Washout 3 (up to 3 Days)||0||
48219985|NCT05580003|100863752|FG004|STARTED|Part 3: Washout 3 (up to 3 Days)||0||
48068916|NCT02339285|100489845|FG001|4 Week Follow-up Visit|Overall Study||8|Number of participants that attended the follow-up visit 4 weeks after completion of intervention.|
48068917|NCT02339285|100489846|FG002|4 Week Follow-up Visit|Overall Study||9|Number of participants that attended the follow-up visit 4 weeks after completion of intervention.|
48068918|NCT02339285|100489844|FG000|COMPLETED|Overall Study||9|Number of participants that completed all sessions.|
48068919|NCT02339285|100489845|FG001|COMPLETED|Overall Study||8|Number of participants that completed all sessions.|
48068920|NCT02339285|100489846|FG002|COMPLETED|Overall Study||9|Number of participants that completed all sessions.|
48068921|NCT02339285|100489844|FG000|NOT COMPLETED|Overall Study||1||
48068922|NCT02339285|100489845|FG001|NOT COMPLETED|Overall Study||3||
48068923|NCT02339285|100489846|FG002|NOT COMPLETED|Overall Study||2||
48068924|NCT00066729|100489847|FG000|STARTED|Overall Study||9||
48068925|NCT00066729|100489847|FG000|COMPLETED|Overall Study||7||
48068926|NCT00066729|100489847|FG000|NOT COMPLETED|Overall Study||2||
48068927|NCT00137631|100489848|FG000|STARTED|Overall Study||164||
48068928|NCT00137631|100489849|FG001|STARTED|Overall Study||174||
48068929|NCT00137631|100489848|FG000|Complete 3-month Follow-up|Overall Study||120||
48068930|NCT00137631|100489849|FG001|Complete 3-month Follow-up|Overall Study||125||
48068931|NCT00137631|100489848|FG000|Completed 6-month Follow-up|Overall Study||127||
48068932|NCT00137631|100489849|FG001|Completed 6-month Follow-up|Overall Study||133||
48068933|NCT00137631|100489848|FG000|COMPLETED|Overall Study||127||
48068934|NCT00137631|100489849|FG001|COMPLETED|Overall Study||133||
48068935|NCT00137631|100489848|FG000|NOT COMPLETED|Overall Study||37||
48068936|NCT00137631|100489849|FG001|NOT COMPLETED|Overall Study||41||
48068937|NCT01739309|100489850|FG000|STARTED|Overall Study||28||
48068938|NCT01739309|100489850|FG000|Received at Least One Dose of Study Drug|Overall Study||28||
48068939|NCT01739309|100489850|FG000|COMPLETED|Overall Study||26||
48068940|NCT01739309|100489850|FG000|NOT COMPLETED|Overall Study||2||
48068941|NCT03921073|100489851|FG000|STARTED|Overall Study||5||
48068942|NCT03921073|100489851|FG000|COMPLETED|Overall Study||5||
48068943|NCT03921073|100489851|FG000|NOT COMPLETED|Overall Study||0||
48068944|NCT00354887|100489852|FG000|STARTED|Overall Study||30||
48068945|NCT00354887|100489852|FG000|COMPLETED|Overall Study||29||
48219986|NCT05580003|100863753|FG005|STARTED|Part 3: Washout 3 (up to 3 Days)||0||
48219987|NCT05580003|100863754|FG006|STARTED|Part 3: Washout 3 (up to 3 Days)||0||
48068946|NCT00354887|100489852|FG000|NOT COMPLETED|Overall Study||1||
48068947|NCT01788228|100489853|FG000|STARTED|Overall Study||49||
48068948|NCT01788228|100489854|FG001|STARTED|Overall Study||1||
48068949|NCT01788228|100489853|FG000|COMPLETED|Overall Study||48||
48068950|NCT01788228|100489854|FG001|COMPLETED|Overall Study||1||
48068951|NCT01788228|100489853|FG000|NOT COMPLETED|Overall Study||1||
48068952|NCT01788228|100489854|FG001|NOT COMPLETED|Overall Study||0||
48068953|NCT02564796|100489855|FG000|STARTED|Overall Study||2||
48068954|NCT02564796|100489856|FG001|STARTED|Overall Study||2||
48068955|NCT02564796|100489855|FG000|COMPLETED|Overall Study||0||
48068956|NCT02564796|100489856|FG001|COMPLETED|Overall Study||0||
48068957|NCT02564796|100489855|FG000|NOT COMPLETED|Overall Study||2||
48068958|NCT02564796|100489856|FG001|NOT COMPLETED|Overall Study||2||
48068959|NCT01805440|100489857|FG000|STARTED|Overall Study||19||
48068960|NCT01805440|100489858|FG001|STARTED|Overall Study||17||
48068961|NCT01805440|100489859|FG002|STARTED|Overall Study||26||
48068962|NCT01805440|100489857|FG000|COMPLETED|Overall Study||18||
48068963|NCT01805440|100489858|FG001|COMPLETED|Overall Study||17||
48068964|NCT01805440|100489859|FG002|COMPLETED|Overall Study||26||
48068965|NCT01805440|100489857|FG000|NOT COMPLETED|Overall Study||1||
48068966|NCT01805440|100489858|FG001|NOT COMPLETED|Overall Study||0||
48068967|NCT01805440|100489859|FG002|NOT COMPLETED|Overall Study||0||
48068968|NCT00199875|100489860|FG000|STARTED|Overall Study||3||
48068969|NCT00199875|100489861|FG001|STARTED|Overall Study||3||
48068970|NCT00199875|100489862|FG002|STARTED|Overall Study||6||
48068971|NCT00199875|100489863|FG003|STARTED|Overall Study||3||
48068972|NCT00199875|100489864|FG004|STARTED|Overall Study||3||
48068973|NCT00199875|100489860|FG000|COMPLETED|Overall Study||3||
48068974|NCT00199875|100489861|FG001|COMPLETED|Overall Study||3||
48068975|NCT00199875|100489862|FG002|COMPLETED|Overall Study||6||
48068976|NCT00199875|100489863|FG003|COMPLETED|Overall Study||3||
48068977|NCT00199875|100489864|FG004|COMPLETED|Overall Study||2||
48068978|NCT00199875|100489860|FG000|NOT COMPLETED|Overall Study||0||
48068979|NCT00199875|100489861|FG001|NOT COMPLETED|Overall Study||0||
48068980|NCT00199875|100489862|FG002|NOT COMPLETED|Overall Study||0||
48068981|NCT00199875|100489863|FG003|NOT COMPLETED|Overall Study||0||
48068982|NCT00199875|100489864|FG004|NOT COMPLETED|Overall Study||1||
48068983|NCT01435603|100489865|FG000|STARTED|Overall Study||167||
48068984|NCT01435603|100489866|FG001|STARTED|Overall Study||164||
48068985|NCT01435603|100489865|FG000|COMPLETED|Overall Study||128||
48068986|NCT01435603|100489866|FG001|COMPLETED|Overall Study||129||
48068987|NCT01435603|100489865|FG000|NOT COMPLETED|Overall Study||39||
48068988|NCT01435603|100489866|FG001|NOT COMPLETED|Overall Study||35||
48068989|NCT00939640|100489867|FG000|STARTED|Overall Study||14||
48068990|NCT00939640|100489867|FG000|COMPLETED|Overall Study||13||
48068991|NCT00939640|100489867|FG000|NOT COMPLETED|Overall Study||1||
48068992|NCT01554683|100489868|FG000|STARTED|Overall Study||2||
48068993|NCT01554683|100489869|FG001|STARTED|Overall Study||1||
48068994|NCT01554683|100489870|FG002|STARTED|Overall Study||3||
48068995|NCT01554683|100489871|FG003|STARTED|Overall Study||2||
48068996|NCT01554683|100489872|FG004|STARTED|Overall Study||1||
48068997|NCT01554683|100489873|FG005|STARTED|Overall Study||0||
48068998|NCT01554683|100489868|FG000|COMPLETED|Overall Study||2||
48068999|NCT01554683|100489869|FG001|COMPLETED|Overall Study||1||
48069000|NCT01554683|100489870|FG002|COMPLETED|Overall Study||3||
48069001|NCT01554683|100489871|FG003|COMPLETED|Overall Study||2||
48069002|NCT01554683|100489872|FG004|COMPLETED|Overall Study||1||
48069003|NCT01554683|100489873|FG005|COMPLETED|Overall Study||0||
48069004|NCT01554683|100489868|FG000|NOT COMPLETED|Overall Study||0||
48069005|NCT01554683|100489869|FG001|NOT COMPLETED|Overall Study||0||
48069006|NCT01554683|100489870|FG002|NOT COMPLETED|Overall Study||0||
48069007|NCT01554683|100489871|FG003|NOT COMPLETED|Overall Study||0||
48069008|NCT01554683|100489872|FG004|NOT COMPLETED|Overall Study||0||
48069009|NCT01554683|100489873|FG005|NOT COMPLETED|Overall Study||0||
48069010|NCT00231842|100489874|FG000|STARTED|Overall Study||30||
48069011|NCT00231842|100489874|FG000|Initiated Therapy|Overall Study||27||
48069012|NCT00231842|100489874|FG000|Completed First 3 Cycles|Overall Study||27|27 participants completed the first 3 cycles of chemotherapy followed by RT|
48069013|NCT00231842|100489874|FG000|Completed Prescribed RT|Overall Study||27|26 participants had EBRT + Brachytherapy; 1 had EBRT alone|
48069014|NCT00231842|100489874|FG000|Completed Full Prescribed Therapy|Overall Study||19||
48069015|NCT00231842|100489874|FG000|COMPLETED|Overall Study||19||
48069016|NCT00231842|100489874|FG000|NOT COMPLETED|Overall Study||11||
48069017|NCT02095223|100489875|FG000|STARTED|Overall Study||2||
48069018|NCT02095223|100489876|FG001|STARTED|Overall Study||2||
48069019|NCT02095223|100489875|FG000|COMPLETED|Overall Study||1||
48069020|NCT02095223|100489876|FG001|COMPLETED|Overall Study||2||
48069021|NCT02095223|100489875|FG000|NOT COMPLETED|Overall Study||1||
48069022|NCT02095223|100489876|FG001|NOT COMPLETED|Overall Study||0||
48069023|NCT04295772|100489877|FG000|STARTED|Overall Study||39||
48069024|NCT04295772|100489878|FG001|STARTED|Overall Study||3||
48069025|NCT04295772|100489877|FG000|COMPLETED|Overall Study||22||
48069026|NCT04295772|100489878|FG001|COMPLETED|Overall Study||2||
48069027|NCT04295772|100489877|FG000|NOT COMPLETED|Overall Study||17||
48069028|NCT04295772|100489878|FG001|NOT COMPLETED|Overall Study||1||
48069029|NCT02191137|100489879|FG000|STARTED|Treatment||75||
48069030|NCT02191137|100489879|FG000|COMPLETED|Treatment||65||
48069031|NCT02191137|100489879|FG000|NOT COMPLETED|Treatment||10||
48069032|NCT02191137|100489879|FG000|STARTED|Follow-up||65||
48069033|NCT02191137|100489879|FG000|COMPLETED|Follow-up||60||
48069034|NCT02191137|100489879|FG000|NOT COMPLETED|Follow-up||5||
48069035|NCT01869439|100489880|FG000|STARTED|Overall Study||40||
48069036|NCT01869439|100489880|FG000|COMPLETED|Overall Study||40||
48069037|NCT01869439|100489880|FG000|NOT COMPLETED|Overall Study||0||
48069038|NCT00531934|100489881|FG000|STARTED|Overall Study||73||
48069039|NCT00531934|100489882|FG001|STARTED|Overall Study||74||
48069040|NCT00531934|100489881|FG000|COMPLETED|Overall Study||7||
48069041|NCT00531934|100489882|FG001|COMPLETED|Overall Study||11||
48069042|NCT00531934|100489881|FG000|NOT COMPLETED|Overall Study||66||
48069043|NCT00531934|100489882|FG001|NOT COMPLETED|Overall Study||63||
48069044|NCT00942448|100489883|FG000|STARTED|Overall Study||77||
48069045|NCT00942448|100489884|FG001|STARTED|Overall Study||76||
48069046|NCT00942448|100489885|FG002|STARTED|Overall Study||78||
48069047|NCT00942448|100489886|FG003|STARTED|Overall Study||75||
48069048|NCT00942448|100489883|FG000|COMPLETED|Overall Study||77||
48069049|NCT00942448|100489884|FG001|COMPLETED|Overall Study||76||
48069050|NCT00942448|100489885|FG002|COMPLETED|Overall Study||78||
48069051|NCT00942448|100489886|FG003|COMPLETED|Overall Study||75||
48069052|NCT00942448|100489883|FG000|NOT COMPLETED|Overall Study||0||
48069053|NCT00942448|100489884|FG001|NOT COMPLETED|Overall Study||0||
48069054|NCT00942448|100489885|FG002|NOT COMPLETED|Overall Study||0||
48069055|NCT00942448|100489886|FG003|NOT COMPLETED|Overall Study||0||
48069056|NCT00508755|100489887|FG000|STARTED|Overall Study||6||
48069057|NCT00508755|100489887|FG000|COMPLETED|Overall Study||5||
48069058|NCT00508755|100489887|FG000|NOT COMPLETED|Overall Study||1||
48069059|NCT00134030|100489888|FG000|STARTED|Overall Study||359||
48069060|NCT00134030|100489889|FG001|STARTED|Overall Study||357||
48069061|NCT00134030|100489890|FG002|STARTED|Overall Study||310||
48069062|NCT00134030|100489891|FG003|STARTED|Overall Study||308||
48069063|NCT00134030|100489888|FG000|COMPLETED|Overall Study||359||
48069064|NCT00134030|100489889|FG001|COMPLETED|Overall Study||357||
48069065|NCT00134030|100489890|FG002|COMPLETED|Overall Study||310||
48069066|NCT00134030|100489891|FG003|COMPLETED|Overall Study||308||
48069067|NCT00134030|100489888|FG000|NOT COMPLETED|Overall Study||0||
48069068|NCT00134030|100489889|FG001|NOT COMPLETED|Overall Study||0||
48069069|NCT00134030|100489890|FG002|NOT COMPLETED|Overall Study||0||
48069070|NCT00134030|100489891|FG003|NOT COMPLETED|Overall Study||0||
48069071|NCT00586625|100489892|FG000|STARTED|Overall Study||575||
48069072|NCT00586625|100489893|FG001|STARTED|Overall Study||286||
48069073|NCT00586625|100489892|FG000|COMPLETED|Overall Study||532||
48069074|NCT00586625|100489893|FG001|COMPLETED|Overall Study||269||
48069075|NCT00586625|100489892|FG000|NOT COMPLETED|Overall Study||43||
48069076|NCT00586625|100489893|FG001|NOT COMPLETED|Overall Study||17||
48069077|NCT04382391|100489894|FG000|STARTED|Overall Study||10||
48069078|NCT04382391|100489895|FG001|STARTED|Overall Study||11||
48219988|NCT05580003|100863755|FG007|STARTED|Part 3: Washout 3 (up to 3 Days)||0||
48219989|NCT05580003|100863756|FG008|STARTED|Part 3: Washout 3 (up to 3 Days)||0||
48219990|NCT05580003|100863757|FG009|STARTED|Part 3: Washout 3 (up to 3 Days)||0||
48069079|NCT04382391|100489894|FG000|COMPLETED|Overall Study||10||
48069080|NCT04382391|100489895|FG001|COMPLETED|Overall Study||11||
48069081|NCT04382391|100489894|FG000|NOT COMPLETED|Overall Study||0||
48069082|NCT04382391|100489895|FG001|NOT COMPLETED|Overall Study||0||
48069083|NCT01315665|100489896|FG000|STARTED|Overall Study||10||
48069084|NCT01315665|100489897|FG001|STARTED|Overall Study||5||
48069085|NCT01315665|100489896|FG000|COMPLETED|Overall Study||10||
48069086|NCT01315665|100489897|FG001|COMPLETED|Overall Study||5||
48069087|NCT01315665|100489896|FG000|NOT COMPLETED|Overall Study||0||
48069088|NCT01315665|100489897|FG001|NOT COMPLETED|Overall Study||0||
48069089|NCT03308786|100489898|FG000|STARTED|Overall Study||9||
48069090|NCT03308786|100489898|FG000|COMPLETED|Overall Study||0||
48069091|NCT03308786|100489898|FG000|NOT COMPLETED|Overall Study||9||
48069092|NCT02401022|100489899|FG000|STARTED|Overall Study||104||
48069093|NCT02401022|100489900|FG001|STARTED|Overall Study||110||
48069094|NCT02401022|100489899|FG000|COMPLETED|Overall Study||89||
48069095|NCT02401022|100489900|FG001|COMPLETED|Overall Study||90||
48069096|NCT02401022|100489899|FG000|NOT COMPLETED|Overall Study||15||
48069097|NCT02401022|100489900|FG001|NOT COMPLETED|Overall Study||20||
48069098|NCT00911547|100489901|FG000|STARTED|Overall Study||48||
48069099|NCT00911547|100489902|FG001|STARTED|Overall Study||201||
48069100|NCT00911547|100489903|FG002|STARTED|Overall Study||200||
48069101|NCT00911547|100489904|FG003|STARTED|Overall Study||193||
48069102|NCT00911547|100489901|FG000|COMPLETED|Overall Study||37||
48069103|NCT00911547|100489902|FG001|COMPLETED|Overall Study||159||
48069104|NCT00911547|100489903|FG002|COMPLETED|Overall Study||178||
48069105|NCT00911547|100489904|FG003|COMPLETED|Overall Study||177||
48069106|NCT00911547|100489901|FG000|NOT COMPLETED|Overall Study||11||
48069107|NCT00911547|100489902|FG001|NOT COMPLETED|Overall Study||42||
48069108|NCT00911547|100489903|FG002|NOT COMPLETED|Overall Study||22||
48069109|NCT00911547|100489904|FG003|NOT COMPLETED|Overall Study||16||
48069110|NCT04622306|100489905|FG000|STARTED|Couples Used First Assigned Condom Set||48||
48069111|NCT04622306|100489906|FG001|STARTED|Couples Used First Assigned Condom Set||50||
48069112|NCT04622306|100489907|FG002|STARTED|Couples Used First Assigned Condom Set||48||
48069113|NCT04622306|100489908|FG003|STARTED|Couples Used First Assigned Condom Set||51||
48069114|NCT04622306|100489909|FG004|STARTED|Couples Used First Assigned Condom Set||53||
48069115|NCT04622306|100489910|FG005|STARTED|Couples Used First Assigned Condom Set||50||
48069116|NCT04622306|100489905|FG000|COMPLETED|Couples Used First Assigned Condom Set||46||
48069117|NCT04622306|100489906|FG001|COMPLETED|Couples Used First Assigned Condom Set||48||
48069118|NCT04622306|100489907|FG002|COMPLETED|Couples Used First Assigned Condom Set||48||
48069119|NCT04622306|100489908|FG003|COMPLETED|Couples Used First Assigned Condom Set||51||
48069120|NCT04622306|100489909|FG004|COMPLETED|Couples Used First Assigned Condom Set||51||
48069121|NCT04622306|100489910|FG005|COMPLETED|Couples Used First Assigned Condom Set||45||
48069122|NCT04622306|100489905|FG000|NOT COMPLETED|Couples Used First Assigned Condom Set||2||
48069123|NCT04622306|100489906|FG001|NOT COMPLETED|Couples Used First Assigned Condom Set||2||
48069124|NCT04622306|100489907|FG002|NOT COMPLETED|Couples Used First Assigned Condom Set||0||
48069125|NCT04622306|100489908|FG003|NOT COMPLETED|Couples Used First Assigned Condom Set||0||
48069126|NCT04622306|100489909|FG004|NOT COMPLETED|Couples Used First Assigned Condom Set||2||
48069127|NCT04622306|100489910|FG005|NOT COMPLETED|Couples Used First Assigned Condom Set||5||
48069128|NCT04622306|100489905|FG000|STARTED|Couples Used Second Assigned Condom Set||46|Couples received their second randomly assigned set of 5 condoms along with 5 blank report forms.|
48069129|NCT04622306|100489906|FG001|STARTED|Couples Used Second Assigned Condom Set||48|Couples received their second randomly assigned set of 5 condoms along with 5 blank report forms.|
48069130|NCT04622306|100489907|FG002|STARTED|Couples Used Second Assigned Condom Set||48|Couples received their second randomly assigned set of 5 condoms along with 5 blank report forms.|
48069131|NCT04622306|100489908|FG003|STARTED|Couples Used Second Assigned Condom Set||51|Couples received their second randomly assigned set of 5 condoms along with 5 blank report forms.|
48069132|NCT04622306|100489909|FG004|STARTED|Couples Used Second Assigned Condom Set||51|Couples received their second randomly assigned set of 5 condoms along with 5 blank report forms.|
48069133|NCT04622306|100489910|FG005|STARTED|Couples Used Second Assigned Condom Set||45|Couples received their second randomly assigned set of 5 condoms along with 5 blank report forms.|
48069134|NCT04622306|100489905|FG000|COMPLETED|Couples Used Second Assigned Condom Set||46||
48069135|NCT04622306|100489906|FG001|COMPLETED|Couples Used Second Assigned Condom Set||48||
48069136|NCT04622306|100489907|FG002|COMPLETED|Couples Used Second Assigned Condom Set||48||
48069137|NCT04622306|100489908|FG003|COMPLETED|Couples Used Second Assigned Condom Set||51||
48069138|NCT04622306|100489909|FG004|COMPLETED|Couples Used Second Assigned Condom Set||51||
48069139|NCT04622306|100489910|FG005|COMPLETED|Couples Used Second Assigned Condom Set||45||
48069140|NCT04622306|100489905|FG000|NOT COMPLETED|Couples Used Second Assigned Condom Set||0||
48069141|NCT04622306|100489906|FG001|NOT COMPLETED|Couples Used Second Assigned Condom Set||0||
48069142|NCT04622306|100489907|FG002|NOT COMPLETED|Couples Used Second Assigned Condom Set||0||
48069143|NCT04622306|100489908|FG003|NOT COMPLETED|Couples Used Second Assigned Condom Set||0||
48069144|NCT04622306|100489909|FG004|NOT COMPLETED|Couples Used Second Assigned Condom Set||0||
48069145|NCT04622306|100489910|FG005|NOT COMPLETED|Couples Used Second Assigned Condom Set||0||
48069146|NCT04622306|100489905|FG000|STARTED|Couples Used Third Assigned Condom Set||46|Couples received their third set of randomly assigned set of 5 condoms and blank report forms.|
48069147|NCT04622306|100489906|FG001|STARTED|Couples Used Third Assigned Condom Set||48|Couples received their third set of randomly assigned set of 5 condoms and blank report forms.|
48069148|NCT04622306|100489907|FG002|STARTED|Couples Used Third Assigned Condom Set||48|Couples received their third set of randomly assigned set of 5 condoms and blank report forms.|
48069149|NCT04622306|100489908|FG003|STARTED|Couples Used Third Assigned Condom Set||51|Couples received their third set of randomly assigned set of 5 condoms and blank report forms.|
48069150|NCT04622306|100489909|FG004|STARTED|Couples Used Third Assigned Condom Set||51|Couples received their third set of randomly assigned set of 5 condoms and blank report forms.|
48069151|NCT04622306|100489910|FG005|STARTED|Couples Used Third Assigned Condom Set||45|Couples received their third set of randomly assigned set of 5 condoms and blank report forms.|
48069152|NCT04622306|100489905|FG000|COMPLETED|Couples Used Third Assigned Condom Set||46||
48069153|NCT04622306|100489906|FG001|COMPLETED|Couples Used Third Assigned Condom Set||48||
48069154|NCT04622306|100489907|FG002|COMPLETED|Couples Used Third Assigned Condom Set||46||
48069155|NCT04622306|100489908|FG003|COMPLETED|Couples Used Third Assigned Condom Set||48||
48069156|NCT04622306|100489909|FG004|COMPLETED|Couples Used Third Assigned Condom Set||51||
48069157|NCT04622306|100489910|FG005|COMPLETED|Couples Used Third Assigned Condom Set||45||
48069158|NCT04622306|100489905|FG000|NOT COMPLETED|Couples Used Third Assigned Condom Set||0||
48069159|NCT04622306|100489906|FG001|NOT COMPLETED|Couples Used Third Assigned Condom Set||0||
48069160|NCT04622306|100489907|FG002|NOT COMPLETED|Couples Used Third Assigned Condom Set||2||
48069161|NCT04622306|100489908|FG003|NOT COMPLETED|Couples Used Third Assigned Condom Set||3||
48069162|NCT04622306|100489909|FG004|NOT COMPLETED|Couples Used Third Assigned Condom Set||0||
48069163|NCT04622306|100489910|FG005|NOT COMPLETED|Couples Used Third Assigned Condom Set||0||
48069164|NCT03846804|100489911|FG000|STARTED|Overall Study||38||
48069165|NCT03846804|100489911|FG000|COMPLETED|Overall Study||36||
48069166|NCT03846804|100489911|FG000|NOT COMPLETED|Overall Study||2||
48069167|NCT01604408|100489912|FG000|STARTED|Treatment Period 1||102||
48069168|NCT01604408|100489913|FG001|STARTED|Treatment Period 1||99||
48069169|NCT01604408|100489912|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||102||
48069170|NCT01604408|100489913|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||99||
48069171|NCT01604408|100489912|FG000|COMPLETED|Treatment Period 1||102||
48069172|NCT01604408|100489913|FG001|COMPLETED|Treatment Period 1||98||
48069173|NCT01604408|100489912|FG000|NOT COMPLETED|Treatment Period 1||0||
48069174|NCT01604408|100489913|FG001|NOT COMPLETED|Treatment Period 1||1||
48069175|NCT01604408|100489912|FG000|STARTED|Treatment Period 2||102||
48069176|NCT01604408|100489913|FG001|STARTED|Treatment Period 2||98||
48069177|NCT01604408|100489912|FG000|COMPLETED|Treatment Period 2||100||
48069178|NCT01604408|100489913|FG001|COMPLETED|Treatment Period 2||96||
48069179|NCT01604408|100489912|FG000|NOT COMPLETED|Treatment Period 2||2||
48069180|NCT01604408|100489913|FG001|NOT COMPLETED|Treatment Period 2||2||
48069181|NCT01604408|100489912|FG000|STARTED|Treatment Period 3||100||
48069182|NCT01604408|100489913|FG001|STARTED|Treatment Period 3||96||
48069183|NCT01604408|100489912|FG000|COMPLETED|Treatment Period 3||95||
48069184|NCT01604408|100489913|FG001|COMPLETED|Treatment Period 3||91||
48069185|NCT01604408|100489912|FG000|NOT COMPLETED|Treatment Period 3||5||
48069186|NCT01604408|100489913|FG001|NOT COMPLETED|Treatment Period 3||5||
48069187|NCT01604408|100489912|FG000|STARTED|Treatment Period 4||95||
48069188|NCT01604408|100489913|FG001|STARTED|Treatment Period 4||91||
48069189|NCT01604408|100489912|FG000|COMPLETED|Treatment Period 4||92||
48069190|NCT01604408|100489913|FG001|COMPLETED|Treatment Period 4||89||
48069191|NCT01604408|100489912|FG000|NOT COMPLETED|Treatment Period 4||3||
48069192|NCT01604408|100489913|FG001|NOT COMPLETED|Treatment Period 4||2||
48069193|NCT01604408|100489912|FG000|STARTED|Treatment Period 5||92||
48069194|NCT01604408|100489913|FG001|STARTED|Treatment Period 5||89||
48069195|NCT01604408|100489912|FG000|COMPLETED|Treatment Period 5||88||
48069196|NCT01604408|100489913|FG001|COMPLETED|Treatment Period 5||89||
48069197|NCT01604408|100489912|FG000|NOT COMPLETED|Treatment Period 5||4||
48069198|NCT01604408|100489913|FG001|NOT COMPLETED|Treatment Period 5||0||
48069199|NCT01604408|100489912|FG000|STARTED|Treatment Period 6||88||
48069200|NCT01604408|100489913|FG001|STARTED|Treatment Period 6||89||
48069201|NCT01604408|100489912|FG000|COMPLETED|Treatment Period 6||86||
48069202|NCT01604408|100489913|FG001|COMPLETED|Treatment Period 6||87||
48069203|NCT01604408|100489912|FG000|NOT COMPLETED|Treatment Period 6||2||
48069204|NCT01604408|100489913|FG001|NOT COMPLETED|Treatment Period 6||2||
48069205|NCT01604408|100489912|FG000|STARTED|Observation Period||86||
48069206|NCT01604408|100489913|FG001|STARTED|Observation Period||87||
48069207|NCT01604408|100489912|FG000|COMPLETED|Observation Period||85||
48069208|NCT01604408|100489913|FG001|COMPLETED|Observation Period||84||
48069209|NCT01604408|100489912|FG000|NOT COMPLETED|Observation Period||1||
48069210|NCT01604408|100489913|FG001|NOT COMPLETED|Observation Period||3||
48069211|NCT02056639|100489914|FG000|STARTED|Overall Study||23||
48069212|NCT02056639|100489915|FG001|STARTED|Overall Study||23||
48069213|NCT02056639|100489914|FG000|COMPLETED|Overall Study||23||
48069214|NCT02056639|100489915|FG001|COMPLETED|Overall Study||23||
48069215|NCT02056639|100489914|FG000|NOT COMPLETED|Overall Study||0||
48069216|NCT02056639|100489915|FG001|NOT COMPLETED|Overall Study||0||
48069217|NCT01201785|100489916|FG000|STARTED|Overall Study||36||
48069218|NCT01201785|100489916|FG000|COMPLETED|Overall Study||20||
48069219|NCT01201785|100489916|FG000|NOT COMPLETED|Overall Study||16||
48069220|NCT04208997|100489917|FG000|STARTED|Overall Study||3||
48069221|NCT04208997|100489918|FG001|STARTED|Overall Study||2||
48069222|NCT04208997|100489917|FG000|COMPLETED|Overall Study||3||
48069223|NCT04208997|100489918|FG001|COMPLETED|Overall Study||2||
48069224|NCT04208997|100489917|FG000|NOT COMPLETED|Overall Study||0||
48069225|NCT04208997|100489918|FG001|NOT COMPLETED|Overall Study||0||
48069226|NCT01058655|100489919|FG000|STARTED|Overall Study||3||
48069227|NCT01058655|100489920|FG001|STARTED|Overall Study||3||
48069228|NCT01058655|100489921|FG002|STARTED|Overall Study||8||
48069229|NCT01058655|100489922|FG003|STARTED|Overall Study||42||
48069230|NCT01058655|100489919|FG000|Evaluable|Overall Study||3||
48069231|NCT01058655|100489920|FG001|Evaluable|Overall Study||3||
48069232|NCT01058655|100489921|FG002|Evaluable|Overall Study||6||
48069233|NCT01058655|100489922|FG003|Evaluable|Overall Study||40||
48069234|NCT01058655|100489919|FG000|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|
48069235|NCT01058655|100489920|FG001|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|
48069236|NCT01058655|100489921|FG002|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|
48069237|NCT01058655|100489922|FG003|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|
48069238|NCT01058655|100489919|FG000|NOT COMPLETED|Overall Study||3||
48069239|NCT01058655|100489920|FG001|NOT COMPLETED|Overall Study||3||
48069240|NCT01058655|100489921|FG002|NOT COMPLETED|Overall Study||8||
48069241|NCT01058655|100489922|FG003|NOT COMPLETED|Overall Study||42||
48069242|NCT02607930|100489923|FG000|STARTED|Double-Blinded Treatment Phase||316||
48069243|NCT02607930|100489924|FG001|STARTED|Double-Blinded Treatment Phase||315||
48069244|NCT02607930|100489925|FG002|STARTED|Double-Blinded Treatment Phase||0||
48069245|NCT02607930|100489926|FG003|STARTED|Double-Blinded Treatment Phase||0||
48069246|NCT02607930|100489923|FG000|COMPLETED|Double-Blinded Treatment Phase||262||
48069247|NCT02607930|100489924|FG001|COMPLETED|Double-Blinded Treatment Phase||262||
48069248|NCT02607930|100489925|FG002|COMPLETED|Double-Blinded Treatment Phase||0||
48069249|NCT02607930|100489926|FG003|COMPLETED|Double-Blinded Treatment Phase||0||
48069250|NCT02607930|100489923|FG000|NOT COMPLETED|Double-Blinded Treatment Phase||54||
48069251|NCT02607930|100489924|FG001|NOT COMPLETED|Double-Blinded Treatment Phase||53||
48069252|NCT02607930|100489925|FG002|NOT COMPLETED|Double-Blinded Treatment Phase||0||
48069253|NCT02607930|100489926|FG003|NOT COMPLETED|Double-Blinded Treatment Phase||0||
48069254|NCT02607930|100489923|FG000|STARTED|Open-Label B/F/TAF Extension Phase||0||
48069255|NCT02607930|100489924|FG001|STARTED|Open-Label B/F/TAF Extension Phase||0||
48667760|NCT01107886|101970674|FG000|COMPLETED|Overall Study||8078||
48069256|NCT02607930|100489925|FG002|STARTED|Open-Label B/F/TAF Extension Phase||252||
48069257|NCT02607930|100489926|FG003|STARTED|Open-Label B/F/TAF Extension Phase||254||
48069258|NCT02607930|100489923|FG000|COMPLETED|Open-Label B/F/TAF Extension Phase||0||
48069259|NCT02607930|100489924|FG001|COMPLETED|Open-Label B/F/TAF Extension Phase||0||
48069260|NCT02607930|100489925|FG002|COMPLETED|Open-Label B/F/TAF Extension Phase||218||
48069261|NCT02607930|100489926|FG003|COMPLETED|Open-Label B/F/TAF Extension Phase||221||
48069262|NCT02607930|100489923|FG000|NOT COMPLETED|Open-Label B/F/TAF Extension Phase||0||
48069263|NCT02607930|100489924|FG001|NOT COMPLETED|Open-Label B/F/TAF Extension Phase||0||
48069264|NCT02607930|100489925|FG002|NOT COMPLETED|Open-Label B/F/TAF Extension Phase||34||
48069265|NCT02607930|100489926|FG003|NOT COMPLETED|Open-Label B/F/TAF Extension Phase||33||
48069266|NCT01199965|100489927|FG000|STARTED|Overall Study||23||
48069267|NCT01199965|100489928|FG001|STARTED|Overall Study||24||
48069268|NCT01199965|100489927|FG000|COMPLETED|Overall Study||22||
48069269|NCT01199965|100489928|FG001|COMPLETED|Overall Study||24||
48069270|NCT01199965|100489927|FG000|NOT COMPLETED|Overall Study||1||
48069271|NCT01199965|100489928|FG001|NOT COMPLETED|Overall Study||0||
48069272|NCT04674644|100489929|FG000|STARTED|Overall Study||850|number of participants|
48069273|NCT04674644|100489929|FG000|COMPLETED|Overall Study||813|number of participants|
48069274|NCT04674644|100489929|FG000|NOT COMPLETED|Overall Study||37||
48069275|NCT01824875|100489930|FG000|STARTED|Overall Study||72||
48069276|NCT01824875|100489931|FG001|STARTED|Overall Study||72||
48069277|NCT01824875|100489930|FG000|Received Treatment and Adverse Event Data Available|Overall Study||68||
48069278|NCT01824875|100489931|FG001|Received Treatment and Adverse Event Data Available|Overall Study||71||
48069279|NCT01824875|100489930|FG000|Eligible|Overall Study||65||
48069280|NCT01824875|100489931|FG001|Eligible|Overall Study||68||
48069281|NCT01824875|100489930|FG000|Eligible Patients With MGMT by IHC Data Available|Overall Study||47||
48069282|NCT01824875|100489931|FG001|Eligible Patients With MGMT by IHC Data Available|Overall Study||50||
48069283|NCT01824875|100489930|FG000|Eligible Patients With MGMT by Promoter Methylation Data Available|Overall Study||27||
48069284|NCT01824875|100489931|FG001|Eligible Patients With MGMT by Promoter Methylation Data Available|Overall Study||30||
48069285|NCT01824875|100489930|FG000|COMPLETED|Overall Study||26||
48069286|NCT01824875|100489931|FG001|COMPLETED|Overall Study||32||
48069287|NCT01824875|100489930|FG000|NOT COMPLETED|Overall Study||46||
48069288|NCT01824875|100489931|FG001|NOT COMPLETED|Overall Study||40||
48069289|NCT02171065|100489932|FG000|STARTED|Overall Study||89||
48069290|NCT02171065|100489933|FG001|STARTED|Overall Study||93||
48069291|NCT02171065|100489934|FG002|STARTED|Overall Study||716||
48069292|NCT02171065|100489932|FG000|COMPLETED|Overall Study||88||
48069293|NCT02171065|100489933|FG001|COMPLETED|Overall Study||93||
48069294|NCT02171065|100489934|FG002|COMPLETED|Overall Study||715||
48069295|NCT02171065|100489932|FG000|NOT COMPLETED|Overall Study||1||
48069296|NCT02171065|100489933|FG001|NOT COMPLETED|Overall Study||0||
48069297|NCT02171065|100489934|FG002|NOT COMPLETED|Overall Study||1||
48069298|NCT02176343|100489935|FG000|STARTED|Overall Study||31||
48069299|NCT02176343|100489935|FG000|COMPLETED|Overall Study||31||
48069300|NCT02176343|100489935|FG000|NOT COMPLETED|Overall Study||0||
48069301|NCT01871142|100489936|FG000|STARTED|Overall Study||12||
48069302|NCT01871142|100489936|FG000|Received Placebo + Normoixa|Overall Study||11||
48069303|NCT01871142|100489936|FG000|Received Placebo + Hypoxia|Overall Study||12||
48069304|NCT01871142|100489936|FG000|Received 1000mg Aes 103+ Hypoxia|Overall Study||11||
48069305|NCT01871142|100489936|FG000|Received 3000mg Aes-103 + Hypoxia|Overall Study||12||
48069306|NCT01871142|100489936|FG000|COMPLETED|Overall Study||11||
48069307|NCT01871142|100489936|FG000|NOT COMPLETED|Overall Study||1||
48069308|NCT03476278|100489937|FG000|STARTED|Overall Study||300||
48069309|NCT03476278|100489937|FG000|COMPLETED|Overall Study||300||
48069310|NCT03476278|100489937|FG000|NOT COMPLETED|Overall Study||0||
48069311|NCT00310401|100489938|FG000|STARTED|Overall Study||260||
48069312|NCT00310401|100489939|FG001|STARTED|Overall Study||246||
48069313|NCT00310401|100489938|FG000|COMPLETED|Overall Study||260||
48069314|NCT00310401|100489939|FG001|COMPLETED|Overall Study||246||
48069315|NCT00310401|100489938|FG000|NOT COMPLETED|Overall Study||0||
48069316|NCT00310401|100489939|FG001|NOT COMPLETED|Overall Study||0||
48069317|NCT02585843|100489940|FG000|STARTED|Overall Study||10||
48069318|NCT02585843|100489941|FG001|STARTED|Overall Study||10||
48069319|NCT02585843|100489940|FG000|COMPLETED|Overall Study||9||
48069320|NCT02585843|100489941|FG001|COMPLETED|Overall Study||10||
48069321|NCT02585843|100489940|FG000|NOT COMPLETED|Overall Study||1||
48069322|NCT02585843|100489941|FG001|NOT COMPLETED|Overall Study||0||
48069323|NCT00319501|100489942|FG000|STARTED|Double-blind Period||124||
48069324|NCT00319501|100489943|FG001|STARTED|Double-blind Period||110||
48069325|NCT00319501|100489942|FG000|Received Treatment|Double-blind Period||82||
48069326|NCT00319501|100489943|FG001|Received Treatment|Double-blind Period||81||
48069327|NCT00319501|100489942|FG000|COMPLETED|Double-blind Period||81||
48069328|NCT00319501|100489943|FG001|COMPLETED|Double-blind Period||78||
48069329|NCT00319501|100489942|FG000|NOT COMPLETED|Double-blind Period||43||
48219991|NCT05580003|100863758|FG010|STARTED|Part 3: Washout 3 (up to 3 Days)||0||
48069330|NCT00319501|100489943|FG001|NOT COMPLETED|Double-blind Period||32||
48069331|NCT00319501|100489942|FG000|STARTED|Open-label Period||161||
48069332|NCT00319501|100489943|FG001|STARTED|Open-label Period||0||
48069333|NCT00319501|100489942|FG000|Received Treatment|Open-label Period||128||
48069334|NCT00319501|100489943|FG001|Received Treatment|Open-label Period||0||
48069335|NCT00319501|100489942|FG000|COMPLETED|Open-label Period||45||
48069336|NCT00319501|100489943|FG001|COMPLETED|Open-label Period||0||
48069337|NCT00319501|100489942|FG000|NOT COMPLETED|Open-label Period||116||
48069338|NCT00319501|100489943|FG001|NOT COMPLETED|Open-label Period||0||
48069339|NCT00319501|100489942|FG000|STARTED|Open-label Extension Period||51||
48069340|NCT00319501|100489943|FG001|STARTED|Open-label Extension Period||0||
48069341|NCT00319501|100489942|FG000|Received Treatment|Open-label Extension Period||33||
48069342|NCT00319501|100489943|FG001|Received Treatment|Open-label Extension Period||0||
48069343|NCT00319501|100489942|FG000|COMPLETED|Open-label Extension Period||0||
48069344|NCT00319501|100489943|FG001|COMPLETED|Open-label Extension Period||0||
48069345|NCT00319501|100489942|FG000|NOT COMPLETED|Open-label Extension Period||51||
48069346|NCT00319501|100489943|FG001|NOT COMPLETED|Open-label Extension Period||0||
48069347|NCT00371826|100489944|FG000|STARTED|Core Phase (12 Months)||49||
48069348|NCT00371826|100489945|FG001|STARTED|Core Phase (12 Months)||47||
48069349|NCT00371826|100489946|FG002|STARTED|Core Phase (12 Months)||30||
48069350|NCT00371826|100489944|FG000|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||46||
48069351|NCT00371826|100489945|FG001|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||44||
48069352|NCT00371826|100489946|FG002|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||20||
48069353|NCT00371826|100489944|FG000|Modified Intent to Treat (mITT)|Core Phase (12 Months)||27||
48069354|NCT00371826|100489945|FG001|Modified Intent to Treat (mITT)|Core Phase (12 Months)||39||
48069355|NCT00371826|100489946|FG002|Modified Intent to Treat (mITT)|Core Phase (12 Months)||6||
48069356|NCT00371826|100489944|FG000|COMPLETED|Core Phase (12 Months)||25||
48069357|NCT00371826|100489945|FG001|COMPLETED|Core Phase (12 Months)||39||
48069358|NCT00371826|100489946|FG002|COMPLETED|Core Phase (12 Months)||6||
48069359|NCT00371826|100489944|FG000|NOT COMPLETED|Core Phase (12 Months)||24||
48069360|NCT00371826|100489945|FG001|NOT COMPLETED|Core Phase (12 Months)||8||
48069361|NCT00371826|100489946|FG002|NOT COMPLETED|Core Phase (12 Months)||24||
48069362|NCT00371826|100489944|FG000|STARTED|Extension Phase (24 Months)||23||
48069363|NCT00371826|100489945|FG001|STARTED|Extension Phase (24 Months)||39||
48069364|NCT00371826|100489946|FG002|STARTED|Extension Phase (24 Months)||5||
48069365|NCT00371826|100489944|FG000|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||23||
48069366|NCT00371826|100489945|FG001|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||39||
48069367|NCT00371826|100489946|FG002|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||4||
48069368|NCT00371826|100489944|FG000|Safety Set|Extension Phase (24 Months)||22||
48069369|NCT00371826|100489945|FG001|Safety Set|Extension Phase (24 Months)||40||
48069370|NCT00371826|100489946|FG002|Safety Set|Extension Phase (24 Months)||5||
48069371|NCT00371826|100489944|FG000|COMPLETED|Extension Phase (24 Months)||18||
48069372|NCT00371826|100489945|FG001|COMPLETED|Extension Phase (24 Months)||29||
48069373|NCT00371826|100489946|FG002|COMPLETED|Extension Phase (24 Months)||3||
48069374|NCT00371826|100489944|FG000|NOT COMPLETED|Extension Phase (24 Months)||5||
48069375|NCT00371826|100489945|FG001|NOT COMPLETED|Extension Phase (24 Months)||10||
48069376|NCT00371826|100489946|FG002|NOT COMPLETED|Extension Phase (24 Months)||2||
48069377|NCT00892047|100489947|FG000|STARTED|Overall Study||91||
48069378|NCT00892047|100489948|FG001|STARTED|Overall Study||90||
48069379|NCT00892047|100489947|FG000|COMPLETED|Overall Study||87||
48069380|NCT00892047|100489948|FG001|COMPLETED|Overall Study||83||
48069381|NCT00892047|100489947|FG000|NOT COMPLETED|Overall Study||4||
48069382|NCT00892047|100489948|FG001|NOT COMPLETED|Overall Study||7||
48069383|NCT02000180|100489949|FG000|STARTED|Overall Study||18||
48069384|NCT02000180|100489950|FG001|STARTED|Overall Study||19||
48069385|NCT02000180|100489949|FG000|COMPLETED|Overall Study||18||
48069386|NCT02000180|100489950|FG001|COMPLETED|Overall Study||19||
48069387|NCT02000180|100489949|FG000|NOT COMPLETED|Overall Study||0||
48069388|NCT02000180|100489950|FG001|NOT COMPLETED|Overall Study||0||
48069389|NCT03998488|100489951|FG000|STARTED|Week 8 Colonoscopy||9||
48069390|NCT03998488|100489952|FG001|STARTED|Week 8 Colonoscopy||9||
48069391|NCT03998488|100489953|FG002|STARTED|Week 8 Colonoscopy||9||
48069392|NCT03998488|100489951|FG000|COMPLETED|Week 8 Colonoscopy||8||
48069393|NCT03998488|100489952|FG001|COMPLETED|Week 8 Colonoscopy||6||
48069394|NCT03998488|100489953|FG002|COMPLETED|Week 8 Colonoscopy||8||
48069395|NCT03998488|100489951|FG000|NOT COMPLETED|Week 8 Colonoscopy||1||
48069396|NCT03998488|100489952|FG001|NOT COMPLETED|Week 8 Colonoscopy||3||
48069397|NCT03998488|100489953|FG002|NOT COMPLETED|Week 8 Colonoscopy||1||
48069398|NCT03998488|100489951|FG000|STARTED|Follow Up||9||
48069399|NCT03998488|100489952|FG001|STARTED|Follow Up||9||
48069400|NCT03998488|100489953|FG002|STARTED|Follow Up||9||
48069401|NCT03998488|100489951|FG000|COMPLETED|Follow Up||9||
48069402|NCT03998488|100489952|FG001|COMPLETED|Follow Up||9||
48069403|NCT03998488|100489953|FG002|COMPLETED|Follow Up||9||
48069404|NCT03998488|100489951|FG000|NOT COMPLETED|Follow Up||0||
48069405|NCT03998488|100489952|FG001|NOT COMPLETED|Follow Up||0||
48069406|NCT03998488|100489953|FG002|NOT COMPLETED|Follow Up||0||
48069407|NCT01182610|100489954|FG000|STARTED|Overall Study||1||
48069408|NCT01182610|100489954|FG000|COMPLETED|Overall Study||1||
48069409|NCT01182610|100489954|FG000|NOT COMPLETED|Overall Study||0||
48069410|NCT02911857|100489955|FG000|STARTED|Overall Study||2||
48069411|NCT02911857|100489956|FG001|STARTED|Overall Study||1||
48069412|NCT02911857|100489957|FG002|STARTED|Overall Study||1||
48069413|NCT02911857|100489955|FG000|COMPLETED|Overall Study||2||
48069414|NCT02911857|100489956|FG001|COMPLETED|Overall Study||1||
48069415|NCT02911857|100489957|FG002|COMPLETED|Overall Study||1||
48069416|NCT02911857|100489955|FG000|NOT COMPLETED|Overall Study||0||
48069417|NCT02911857|100489956|FG001|NOT COMPLETED|Overall Study||0||
48069418|NCT02911857|100489957|FG002|NOT COMPLETED|Overall Study||0||
48069419|NCT04206800|100489958|FG000|STARTED|Overall Study||4||
48069420|NCT04206800|100489959|FG001|STARTED|Overall Study||1||
48069421|NCT04206800|100489958|FG000|COMPLETED|Overall Study||4||
48069422|NCT04206800|100489959|FG001|COMPLETED|Overall Study||1||
48069423|NCT04206800|100489958|FG000|NOT COMPLETED|Overall Study||0||
48069424|NCT04206800|100489959|FG001|NOT COMPLETED|Overall Study||0||
48069425|NCT02106975|100489960|FG000|STARTED|Overall Study||84||
48069426|NCT02106975|100489961|FG001|STARTED|Overall Study||83||
48069427|NCT02106975|100489960|FG000|COMPLETED|Overall Study||59||
48069428|NCT02106975|100489961|FG001|COMPLETED|Overall Study||44||
48069429|NCT02106975|100489960|FG000|NOT COMPLETED|Overall Study||25||
48069430|NCT02106975|100489961|FG001|NOT COMPLETED|Overall Study||39||
48069431|NCT00066365|100489962|FG000|STARTED|Overall Study||31||
48069432|NCT00066365|100489963|FG001|STARTED|Overall Study||18||
48069433|NCT00066365|100489962|FG000|COMPLETED|Overall Study||8||
48069434|NCT00066365|100489963|FG001|COMPLETED|Overall Study||4||
48069435|NCT00066365|100489962|FG000|NOT COMPLETED|Overall Study||23||
48069436|NCT00066365|100489963|FG001|NOT COMPLETED|Overall Study||14||
48069437|NCT03463512|100489964|FG000|STARTED|Overall Study||62||
48069438|NCT03463512|100489965|FG001|STARTED|Overall Study||62||
48069439|NCT03463512|100489964|FG000|COMPLETED|Overall Study||62||
48069440|NCT03463512|100489965|FG001|COMPLETED|Overall Study||62||
48069441|NCT03463512|100489964|FG000|NOT COMPLETED|Overall Study||0||
48069442|NCT03463512|100489965|FG001|NOT COMPLETED|Overall Study||0||
48069443|NCT00772304|100489966|FG000|STARTED|Overall Study||102||
48069444|NCT00772304|100489966|FG000|COMPLETED|Overall Study||102||
48069445|NCT00772304|100489966|FG000|NOT COMPLETED|Overall Study||0||
48069446|NCT00561457|100489967|FG000|STARTED|Overall Study||134||
48069447|NCT00561457|100489967|FG000|COMPLETED|Overall Study||110||
48069448|NCT00561457|100489967|FG000|NOT COMPLETED|Overall Study||24||
48069449|NCT04515394|100489968|FG000|STARTED|Overall Study||3||
48069450|NCT04515394|100489968|FG000|Treated|Overall Study||2||
48069451|NCT04515394|100489968|FG000|COMPLETED|Overall Study||2||
48069452|NCT04515394|100489968|FG000|NOT COMPLETED|Overall Study||1||
48069453|NCT03208127|100489969|FG000|STARTED|Overall Study||24||
48069454|NCT03208127|100489969|FG000|COMPLETED|Overall Study||23||
48069455|NCT03208127|100489969|FG000|NOT COMPLETED|Overall Study||1||
48069456|NCT00815698|100489970|FG000|STARTED|Overall Study||163||
48069457|NCT00815698|100489971|FG001|STARTED|Overall Study||171||
48069458|NCT00815698|100489970|FG000|COMPLETED|Overall Study||163||
48069459|NCT00815698|100489971|FG001|COMPLETED|Overall Study||171||
48069460|NCT00815698|100489970|FG000|NOT COMPLETED|Overall Study||0||
48069461|NCT00815698|100489971|FG001|NOT COMPLETED|Overall Study||0||
48069462|NCT00880542|100489972|FG000|STARTED|Treatment Period (Sorafenib+Ifosfamide)||7||
48069463|NCT00880542|100489972|FG000|COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||4||
48069464|NCT00880542|100489972|FG000|NOT COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||3||
48069465|NCT00880542|100489972|FG000|STARTED|Response Evaluation Period(REP): PET/CT||4||
48069466|NCT00880542|100489972|FG000|COMPLETED|Response Evaluation Period(REP): PET/CT||4||
48069467|NCT00880542|100489972|FG000|NOT COMPLETED|Response Evaluation Period(REP): PET/CT||0||
48069468|NCT00880542|100489972|FG000|STARTED|REP: Surgical Resection||4||
48069469|NCT00880542|100489972|FG000|COMPLETED|REP: Surgical Resection||3||
48069470|NCT00880542|100489972|FG000|NOT COMPLETED|REP: Surgical Resection||1||
48069471|NCT00880542|100489972|FG000|STARTED|Post Surgical Evaluation||3||
48069472|NCT00880542|100489972|FG000|COMPLETED|Post Surgical Evaluation||3||
48069473|NCT00880542|100489972|FG000|NOT COMPLETED|Post Surgical Evaluation||0||
48069474|NCT00880542|100489972|FG000|STARTED|Continued Treatment Period||0||
48069475|NCT00880542|100489972|FG000|COMPLETED|Continued Treatment Period||0||
48069476|NCT00880542|100489972|FG000|NOT COMPLETED|Continued Treatment Period||0||
48069477|NCT00880542|100489972|FG000|STARTED|Follow-up Period||7||
48069478|NCT00880542|100489972|FG000|COMPLETED|Follow-up Period||7||
48069479|NCT00880542|100489972|FG000|NOT COMPLETED|Follow-up Period||0||
48069480|NCT02925117|100489973|FG000|STARTED|Period 1 (Weeks 0 - 16)||41||
48069481|NCT02925117|100489974|FG001|STARTED|Period 1 (Weeks 0 - 16)||42||
48069482|NCT02925117|100489975|FG002|STARTED|Period 1 (Weeks 0 - 16)||42||
48069483|NCT02925117|100489976|FG003|STARTED|Period 1 (Weeks 0 - 16)||42||
48069484|NCT02925117|100489977|FG004|STARTED|Period 1 (Weeks 0 - 16)||0||
48069485|NCT02925117|100489978|FG005|STARTED|Period 1 (Weeks 0 - 16)||0||
48069486|NCT02925117|100489979|FG006|STARTED|Period 1 (Weeks 0 - 16)||0||
48069487|NCT02925117|100489980|FG007|STARTED|Period 1 (Weeks 0 - 16)||0||
48069488|NCT02925117|100489981|FG008|STARTED|Period 1 (Weeks 0 - 16)||0||
48069489|NCT02925117|100489982|FG009|STARTED|Period 1 (Weeks 0 - 16)||0||
48069490|NCT02925117|100489983|FG010|STARTED|Period 1 (Weeks 0 - 16)||0||
48069491|NCT02925117|100489984|FG011|STARTED|Period 1 (Weeks 0 - 16)||0||
48069492|NCT02925117|100489973|FG000|Received Treatment|Period 1 (Weeks 0 - 16)||40||
48069493|NCT02925117|100489974|FG001|Received Treatment|Period 1 (Weeks 0 - 16)||42||
48069494|NCT02925117|100489975|FG002|Received Treatment|Period 1 (Weeks 0 - 16)||42||
48069495|NCT02925117|100489976|FG003|Received Treatment|Period 1 (Weeks 0 - 16)||42||
48069496|NCT02925117|100489977|FG004|Received Treatment|Period 1 (Weeks 0 - 16)||0||
48069497|NCT02925117|100489978|FG005|Received Treatment|Period 1 (Weeks 0 - 16)||0||
48069498|NCT02925117|100489979|FG006|Received Treatment|Period 1 (Weeks 0 - 16)||0||
48069499|NCT02925117|100489980|FG007|Received Treatment|Period 1 (Weeks 0 - 16)||0||
48069500|NCT02925117|100489981|FG008|Received Treatment|Period 1 (Weeks 0 - 16)||0||
48069501|NCT02925117|100489982|FG009|Received Treatment|Period 1 (Weeks 0 - 16)||0||
48069502|NCT02925117|100489983|FG010|Received Treatment|Period 1 (Weeks 0 - 16)||0||
48069503|NCT02925117|100489984|FG011|Received Treatment|Period 1 (Weeks 0 - 16)||0||
48069504|NCT02925117|100489973|FG000|COMPLETED|Period 1 (Weeks 0 - 16)||23||
48069505|NCT02925117|100489974|FG001|COMPLETED|Period 1 (Weeks 0 - 16)||31||
48069506|NCT02925117|100489975|FG002|COMPLETED|Period 1 (Weeks 0 - 16)||37||
48069507|NCT02925117|100489976|FG003|COMPLETED|Period 1 (Weeks 0 - 16)||39||
48069508|NCT02925117|100489977|FG004|COMPLETED|Period 1 (Weeks 0 - 16)||0||
48069509|NCT02925117|100489978|FG005|COMPLETED|Period 1 (Weeks 0 - 16)||0||
48069510|NCT02925117|100489979|FG006|COMPLETED|Period 1 (Weeks 0 - 16)||0||
48069511|NCT02925117|100489980|FG007|COMPLETED|Period 1 (Weeks 0 - 16)||0||
48069512|NCT02925117|100489981|FG008|COMPLETED|Period 1 (Weeks 0 - 16)||0||
48069513|NCT02925117|100489982|FG009|COMPLETED|Period 1 (Weeks 0 - 16)||0||
48069514|NCT02925117|100489983|FG010|COMPLETED|Period 1 (Weeks 0 - 16)||0||
48069515|NCT02925117|100489984|FG011|COMPLETED|Period 1 (Weeks 0 - 16)||0||
48069516|NCT02925117|100489973|FG000|NOT COMPLETED|Period 1 (Weeks 0 - 16)||18||
48069517|NCT02925117|100489974|FG001|NOT COMPLETED|Period 1 (Weeks 0 - 16)||11||
48069518|NCT02925117|100489975|FG002|NOT COMPLETED|Period 1 (Weeks 0 - 16)||5||
48069519|NCT02925117|100489976|FG003|NOT COMPLETED|Period 1 (Weeks 0 - 16)||3||
48069520|NCT02925117|100489977|FG004|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0||
48069521|NCT02925117|100489978|FG005|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0||
48069522|NCT02925117|100489979|FG006|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0||
48069523|NCT02925117|100489980|FG007|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0||
48069524|NCT02925117|100489981|FG008|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0||
48069525|NCT02925117|100489982|FG009|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0||
48069526|NCT02925117|100489983|FG010|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0||
48069527|NCT02925117|100489984|FG011|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0||
48069528|NCT02925117|100489973|FG000|STARTED|Period 2 (Weeks 16 - 88)||0|Four participants completed Week 16 but were not re-randomized into Period 2.|
48069529|NCT02925117|100489974|FG001|STARTED|Period 2 (Weeks 16 - 88)||0|Four participants completed Week 16 but were not re-randomized into Period 2.|
48069530|NCT02925117|100489975|FG002|STARTED|Period 2 (Weeks 16 - 88)||0|Four participants completed Week 16 but were not re-randomized into Period 2.|
48069531|NCT02925117|100489976|FG003|STARTED|Period 2 (Weeks 16 - 88)||0|Four participants completed Week 16 but were not re-randomized into Period 2.|
48069532|NCT02925117|100489977|FG004|STARTED|Period 2 (Weeks 16 - 88)||10|Four participants completed Week 16 but were not re-randomized into Period 2.|
48069533|NCT02925117|100489978|FG005|STARTED|Period 2 (Weeks 16 - 88)||10|Four participants completed Week 16 but were not re-randomized into Period 2.|
48069534|NCT02925117|100489979|FG006|STARTED|Period 2 (Weeks 16 - 88)||15|Four participants completed Week 16 but were not re-randomized into Period 2.|
48069535|NCT02925117|100489980|FG007|STARTED|Period 2 (Weeks 16 - 88)||16|Four participants completed Week 16 but were not re-randomized into Period 2.|
48069536|NCT02925117|100489981|FG008|STARTED|Period 2 (Weeks 16 - 88)||19|Four participants completed Week 16 but were not re-randomized into Period 2.|
48069537|NCT02925117|100489982|FG009|STARTED|Period 2 (Weeks 16 - 88)||18|Four participants completed Week 16 but were not re-randomized into Period 2.|
48069538|NCT02925117|100489983|FG010|STARTED|Period 2 (Weeks 16 - 88)||19|Four participants completed Week 16 but were not re-randomized into Period 2.|
48069539|NCT02925117|100489984|FG011|STARTED|Period 2 (Weeks 16 - 88)||19|Four participants completed Week 16 but were not re-randomized into Period 2.|
48069540|NCT02925117|100489973|FG000|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0||
48069541|NCT02925117|100489974|FG001|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0||
48069542|NCT02925117|100489975|FG002|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0||
48069543|NCT02925117|100489976|FG003|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0||
48069544|NCT02925117|100489977|FG004|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||8||
48069545|NCT02925117|100489978|FG005|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||1||
48069546|NCT02925117|100489979|FG006|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||13||
48069547|NCT02925117|100489980|FG007|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||12||
48069548|NCT02925117|100489981|FG008|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||17||
48069549|NCT02925117|100489982|FG009|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||12||
48069550|NCT02925117|100489983|FG010|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||14||
48069551|NCT02925117|100489984|FG011|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||4||
48069552|NCT02925117|100489973|FG000|COMPLETED|Period 2 (Weeks 16 - 88)||0||
48069553|NCT02925117|100489974|FG001|COMPLETED|Period 2 (Weeks 16 - 88)||0||
48069554|NCT02925117|100489975|FG002|COMPLETED|Period 2 (Weeks 16 - 88)||0||
48069555|NCT02925117|100489976|FG003|COMPLETED|Period 2 (Weeks 16 - 88)||0||
48069556|NCT02925117|100489977|FG004|COMPLETED|Period 2 (Weeks 16 - 88)||8||
48069557|NCT02925117|100489978|FG005|COMPLETED|Period 2 (Weeks 16 - 88)||5||
48667761|NCT01107886|101970675|FG001|COMPLETED|Overall Study||7998||
48069558|NCT02925117|100489979|FG006|COMPLETED|Period 2 (Weeks 16 - 88)||9||
48069559|NCT02925117|100489980|FG007|COMPLETED|Period 2 (Weeks 16 - 88)||11||
48069560|NCT02925117|100489981|FG008|COMPLETED|Period 2 (Weeks 16 - 88)||13||
48069561|NCT02925117|100489982|FG009|COMPLETED|Period 2 (Weeks 16 - 88)||12||
48069562|NCT02925117|100489983|FG010|COMPLETED|Period 2 (Weeks 16 - 88)||11||
48069563|NCT02925117|100489984|FG011|COMPLETED|Period 2 (Weeks 16 - 88)||14||
48069564|NCT02925117|100489973|FG000|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0||
48069565|NCT02925117|100489974|FG001|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0||
48069566|NCT02925117|100489975|FG002|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0||
48069567|NCT02925117|100489976|FG003|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0||
48069568|NCT02925117|100489977|FG004|NOT COMPLETED|Period 2 (Weeks 16 - 88)||2||
48069569|NCT02925117|100489978|FG005|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5||
48069570|NCT02925117|100489979|FG006|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6||
48069571|NCT02925117|100489980|FG007|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5||
48069572|NCT02925117|100489981|FG008|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6||
48069573|NCT02925117|100489982|FG009|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6||
48069574|NCT02925117|100489983|FG010|NOT COMPLETED|Period 2 (Weeks 16 - 88)||8||
48069575|NCT02925117|100489984|FG011|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5||
48069576|NCT03469934|100489985|FG000|STARTED|Overall Study||12||
48069577|NCT03469934|100489986|FG001|STARTED|Overall Study||13||
48069578|NCT03469934|100489985|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||12|All participants who received etokimab or placebo and provided at least one evaluable post-dose PD measurement without any events or protocol deviation deemed to affect PD assessment.|
48069579|NCT03469934|100489986|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||13|All participants who received etokimab or placebo and provided at least one evaluable post-dose PD measurement without any events or protocol deviation deemed to affect PD assessment.|
48069580|NCT03469934|100489985|FG000|COMPLETED|Overall Study||12||
48069581|NCT03469934|100489986|FG001|COMPLETED|Overall Study||12||
48069582|NCT03469934|100489985|FG000|NOT COMPLETED|Overall Study||0||
48069583|NCT03469934|100489986|FG001|NOT COMPLETED|Overall Study||1||
48219992|NCT05580003|100863759|FG011|STARTED|Part 3: Washout 3 (up to 3 Days)||0||
48219993|NCT05580003|100863760|FG012|STARTED|Part 3: Washout 3 (up to 3 Days)||0||
48219994|NCT05580003|100863761|FG013|STARTED|Part 3: Washout 3 (up to 3 Days)||2||
48219995|NCT05580003|100863762|FG014|STARTED|Part 3: Washout 3 (up to 3 Days)||2||
48219996|NCT05580003|100863763|FG015|STARTED|Part 3: Washout 3 (up to 3 Days)||2||
48219997|NCT05580003|100863764|FG016|STARTED|Part 3: Washout 3 (up to 3 Days)||2||
48219998|NCT05580003|100863765|FG017|STARTED|Part 3: Washout 3 (up to 3 Days)||2||
48219999|NCT05580003|100863766|FG018|STARTED|Part 3: Washout 3 (up to 3 Days)||2||
48220000|NCT05580003|100863767|FG019|STARTED|Part 3: Washout 3 (up to 3 Days)||0||
48220001|NCT05580003|100863768|FG020|STARTED|Part 3: Washout 3 (up to 3 Days)||0||
48220002|NCT05580003|100863769|FG021|STARTED|Part 3: Washout 3 (up to 3 Days)||0||
48220003|NCT05580003|100863770|FG022|STARTED|Part 3: Washout 3 (up to 3 Days)||0||
48220004|NCT05580003|100863771|FG023|STARTED|Part 3: Washout 3 (up to 3 Days)||0||
48220005|NCT05580003|100863772|FG024|STARTED|Part 3: Washout 3 (up to 3 Days)||0||
48220006|NCT05580003|100863773|FG025|STARTED|Part 3: Washout 3 (up to 3 Days)||0||
48220007|NCT05580003|100863774|FG026|STARTED|Part 3: Washout 3 (up to 3 Days)||0||
48220008|NCT05580003|100863775|FG027|STARTED|Part 3: Washout 3 (up to 3 Days)||0||
48220009|NCT05580003|100863748|FG000|COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220010|NCT05580003|100863749|FG001|COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220011|NCT05580003|100863750|FG002|COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220012|NCT05580003|100863751|FG003|COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220013|NCT05580003|100863752|FG004|COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220014|NCT05580003|100863753|FG005|COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220015|NCT05580003|100863754|FG006|COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220016|NCT05580003|100863755|FG007|COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220017|NCT05580003|100863756|FG008|COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220018|NCT05580003|100863757|FG009|COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220019|NCT05580003|100863758|FG010|COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220020|NCT05580003|100863759|FG011|COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220021|NCT05580003|100863760|FG012|COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220022|NCT05580003|100863761|FG013|COMPLETED|Part 3: Washout 3 (up to 3 Days)||2||
48220023|NCT05580003|100863762|FG014|COMPLETED|Part 3: Washout 3 (up to 3 Days)||2||
48220024|NCT05580003|100863763|FG015|COMPLETED|Part 3: Washout 3 (up to 3 Days)||2||
48220025|NCT05580003|100863764|FG016|COMPLETED|Part 3: Washout 3 (up to 3 Days)||2||
48220026|NCT05580003|100863765|FG017|COMPLETED|Part 3: Washout 3 (up to 3 Days)||2||
48220027|NCT05580003|100863766|FG018|COMPLETED|Part 3: Washout 3 (up to 3 Days)||2||
48220028|NCT05580003|100863767|FG019|COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220029|NCT05580003|100863768|FG020|COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220030|NCT05580003|100863769|FG021|COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220031|NCT05580003|100863770|FG022|COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220032|NCT05580003|100863771|FG023|COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220033|NCT05580003|100863772|FG024|COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220034|NCT05580003|100863773|FG025|COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48069584|NCT01313312|100493989|FG000|STARTED|Overall Study||258||
48069585|NCT01313312|100493989|FG000|Cycle 1|Overall Study||254||
48069586|NCT01313312|100493989|FG000|Cycle 2|Overall Study||229||
48069587|NCT01313312|100493989|FG000|Cycle 3|Overall Study||175||
48069588|NCT01313312|100493989|FG000|Cycle 4|Overall Study||81||
48069589|NCT01313312|100493989|FG000|Cycle 5|Overall Study||11||
48069590|NCT01313312|100493989|FG000|COMPLETED|Overall Study||222||
48069591|NCT01313312|100493989|FG000|NOT COMPLETED|Overall Study||36||
48069592|NCT00518687|100493990|FG000|STARTED|Overall Study||4005||
48069593|NCT00518687|100493991|FG001|STARTED|Overall Study||4005||
48069594|NCT00518687|100493990|FG000|Vaccinated|Overall Study||3981||
48069595|NCT00518687|100493991|FG001|Vaccinated|Overall Study||3982||
48069596|NCT00518687|100493990|FG000|COMPLETED|Overall Study||2568||
48069597|NCT00518687|100493991|FG001|COMPLETED|Overall Study||2585||
48069598|NCT00518687|100493990|FG000|NOT COMPLETED|Overall Study||1437||
48069599|NCT00518687|100493991|FG001|NOT COMPLETED|Overall Study||1420||
48069600|NCT02693119|100493992|FG000|STARTED|Double-Blind Period||8||
48069601|NCT02693119|100493993|FG001|STARTED|Double-Blind Period||4||
48069602|NCT02693119|100493992|FG000|COMPLETED|Double-Blind Period||8||
48069603|NCT02693119|100493993|FG001|COMPLETED|Double-Blind Period||4||
48069604|NCT02693119|100493992|FG000|NOT COMPLETED|Double-Blind Period||0||
48069605|NCT02693119|100493993|FG001|NOT COMPLETED|Double-Blind Period||0||
48069606|NCT02693119|100493992|FG000|STARTED|Open-Label Period||8||
48069607|NCT02693119|100493993|FG001|STARTED|Open-Label Period||4||
48069608|NCT02693119|100493992|FG000|COMPLETED|Open-Label Period||8||
48069609|NCT02693119|100493993|FG001|COMPLETED|Open-Label Period||3||
48069610|NCT02693119|100493992|FG000|NOT COMPLETED|Open-Label Period||0||
48069611|NCT02693119|100493993|FG001|NOT COMPLETED|Open-Label Period||1||
48069612|NCT04218695|100493994|FG000|STARTED|Overall Study||17||
48069613|NCT04218695|100493995|FG001|STARTED|Overall Study||15||
48069614|NCT04218695|100493994|FG000|COMPLETED|Overall Study||16||
48069615|NCT04218695|100493995|FG001|COMPLETED|Overall Study||15||
48069616|NCT04218695|100493994|FG000|NOT COMPLETED|Overall Study||1||
48069617|NCT04218695|100493995|FG001|NOT COMPLETED|Overall Study||0||
48069618|NCT01890473|100493996|FG000|STARTED|Overall Study||111||
48069619|NCT01890473|100493997|FG001|STARTED|Overall Study||113||
48069620|NCT01890473|100493996|FG000|COMPLETED|Overall Study||109||
48069621|NCT01890473|100493997|FG001|COMPLETED|Overall Study||113||
48069622|NCT01890473|100493996|FG000|NOT COMPLETED|Overall Study||2||
48069623|NCT01890473|100493997|FG001|NOT COMPLETED|Overall Study||0||
48069624|NCT00142298|100493998|FG000|STARTED|Overall Study||667||
48069625|NCT00142298|100493999|FG001|STARTED|Overall Study||632||
48069626|NCT00142298|100494000|FG002|STARTED|Overall Study||123||
48069627|NCT00142298|100494001|FG003|STARTED|Overall Study||206||
48069628|NCT00142298|100494002|FG004|STARTED|Overall Study||56||
48069629|NCT00142298|100494003|FG005|STARTED|Overall Study||26||
48069630|NCT00142298|100494004|FG006|STARTED|Overall Study||23||
48069631|NCT00142298|100494005|FG007|STARTED|Overall Study||66||
48069632|NCT00142298|100494006|FG008|STARTED|Overall Study||57||
48069633|NCT00142298|100494007|FG009|STARTED|Overall Study||13||
48069634|NCT00142298|100493998|FG000|Safety Population|Overall Study||655||
48069635|NCT00142298|100493999|FG001|Safety Population|Overall Study||626||
48069636|NCT00142298|100494000|FG002|Safety Population|Overall Study||122||
48069637|NCT00142298|100494001|FG003|Safety Population|Overall Study||206||
48069638|NCT00142298|100494002|FG004|Safety Population|Overall Study||50||
48069639|NCT00142298|100494003|FG005|Safety Population|Overall Study||26||
48069640|NCT00142298|100494004|FG006|Safety Population|Overall Study||23||
48069641|NCT00142298|100494005|FG007|Safety Population|Overall Study||66||
48069642|NCT00142298|100494006|FG008|Safety Population|Overall Study||57||
48069643|NCT00142298|100494007|FG009|Safety Population|Overall Study||13||
48069644|NCT00142298|100493998|FG000|Per Protocol Population|Overall Study||635||
48069645|NCT00142298|100493999|FG001|Per Protocol Population|Overall Study||606||
48069646|NCT00142298|100494000|FG002|Per Protocol Population|Overall Study||120||
48069647|NCT00142298|100494001|FG003|Per Protocol Population|Overall Study||202||
48069648|NCT00142298|100494002|FG004|Per Protocol Population|Overall Study||50||
48069649|NCT00142298|100494003|FG005|Per Protocol Population|Overall Study||25||
48069650|NCT00142298|100494004|FG006|Per Protocol Population|Overall Study||19||
48069651|NCT00142298|100494005|FG007|Per Protocol Population|Overall Study||64||
48069652|NCT00142298|100494006|FG008|Per Protocol Population|Overall Study||56||
48069653|NCT00142298|100494007|FG009|Per Protocol Population|Overall Study||13||
48069654|NCT00142298|100493998|FG000|COMPLETED|Overall Study||507||
48220035|NCT05580003|100863774|FG026|COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48069655|NCT00142298|100493999|FG001|COMPLETED|Overall Study||456||
48069656|NCT00142298|100494000|FG002|COMPLETED|Overall Study||90||
48069657|NCT00142298|100494001|FG003|COMPLETED|Overall Study||121||
48069658|NCT00142298|100494002|FG004|COMPLETED|Overall Study||46||
48069659|NCT00142298|100494003|FG005|COMPLETED|Overall Study||10||
48069660|NCT00142298|100494004|FG006|COMPLETED|Overall Study||15||
48069661|NCT00142298|100494005|FG007|COMPLETED|Overall Study||58||
48069662|NCT00142298|100494006|FG008|COMPLETED|Overall Study||52||
48069663|NCT00142298|100494007|FG009|COMPLETED|Overall Study||13||
48069664|NCT00142298|100493998|FG000|NOT COMPLETED|Overall Study||160||
48069665|NCT00142298|100493999|FG001|NOT COMPLETED|Overall Study||176||
48069666|NCT00142298|100494000|FG002|NOT COMPLETED|Overall Study||33||
48069667|NCT00142298|100494001|FG003|NOT COMPLETED|Overall Study||85||
48069668|NCT00142298|100494002|FG004|NOT COMPLETED|Overall Study||10||
48069669|NCT00142298|100494003|FG005|NOT COMPLETED|Overall Study||16||
48069670|NCT00142298|100494004|FG006|NOT COMPLETED|Overall Study||8||
48069671|NCT00142298|100494005|FG007|NOT COMPLETED|Overall Study||8||
48069672|NCT00142298|100494006|FG008|NOT COMPLETED|Overall Study||5||
48069673|NCT00142298|100494007|FG009|NOT COMPLETED|Overall Study||0||
48069674|NCT02404220|100494008|FG000|STARTED|Overall Study||5||
48069675|NCT02404220|100494009|FG001|STARTED|Overall Study||8||
48069676|NCT02404220|100494010|FG002|STARTED|Overall Study||7||
48069677|NCT02404220|100494011|FG003|STARTED|Overall Study||10||
48069678|NCT02404220|100494008|FG000|COMPLETED|Overall Study||0||
48069679|NCT02404220|100494009|FG001|COMPLETED|Overall Study||0||
48069680|NCT02404220|100494010|FG002|COMPLETED|Overall Study||0||
48069681|NCT02404220|100494011|FG003|COMPLETED|Overall Study||0||
48069682|NCT02404220|100494008|FG000|NOT COMPLETED|Overall Study||5||
48069683|NCT02404220|100494009|FG001|NOT COMPLETED|Overall Study||8||
48069684|NCT02404220|100494010|FG002|NOT COMPLETED|Overall Study||7||
48069685|NCT02404220|100494011|FG003|NOT COMPLETED|Overall Study||10||
48069686|NCT02038881|100494012|FG000|STARTED|Overall Study||27||
48069687|NCT02038881|100494013|FG001|STARTED|Overall Study||29||
48069688|NCT02038881|100494014|FG002|STARTED|Overall Study||31||
48069689|NCT02038881|100494012|FG000|COMPLETED|Overall Study||24||
48069690|NCT02038881|100494013|FG001|COMPLETED|Overall Study||29||
48069691|NCT02038881|100494014|FG002|COMPLETED|Overall Study||30||
48069692|NCT02038881|100494012|FG000|NOT COMPLETED|Overall Study||3||
48069693|NCT02038881|100494013|FG001|NOT COMPLETED|Overall Study||0||
48069694|NCT02038881|100494014|FG002|NOT COMPLETED|Overall Study||1||
48069695|NCT00851630|100494015|FG000|STARTED|Overall Study||35||
48069696|NCT00851630|100494016|FG001|STARTED|Overall Study||35||
48069697|NCT00851630|100494015|FG000|COMPLETED|Overall Study||33||
48069698|NCT00851630|100494016|FG001|COMPLETED|Overall Study||33||
48069699|NCT00851630|100494015|FG000|NOT COMPLETED|Overall Study||2||
48069700|NCT00851630|100494016|FG001|NOT COMPLETED|Overall Study||2||
48069701|NCT00255125|100494017|FG000|STARTED|Overall Study||42||
48069702|NCT00255125|100494018|FG001|STARTED|Overall Study||44||
48069703|NCT00255125|100494017|FG000|COMPLETED|Overall Study||42||
48069704|NCT00255125|100494018|FG001|COMPLETED|Overall Study||44||
48069705|NCT00255125|100494017|FG000|NOT COMPLETED|Overall Study||0||
48069706|NCT00255125|100494018|FG001|NOT COMPLETED|Overall Study||0||
48069707|NCT02248701|100494019|FG000|STARTED|Overall Study||7||
48069708|NCT02248701|100494020|FG001|STARTED|Overall Study||5||
48069709|NCT02248701|100494019|FG000|COMPLETED|Overall Study||3||
48069710|NCT02248701|100494020|FG001|COMPLETED|Overall Study||3||
48069711|NCT02248701|100494019|FG000|NOT COMPLETED|Overall Study||4||
48069712|NCT02248701|100494020|FG001|NOT COMPLETED|Overall Study||2||
48069713|NCT00406354|100494021|FG000|STARTED|All Randomized Patients||60||
48069714|NCT00406354|100494022|FG001|STARTED|All Randomized Patients||61||
48069715|NCT00406354|100494023|FG002|STARTED|All Randomized Patients||60||
48069716|NCT00406354|100494021|FG000|COMPLETED|All Randomized Patients||60||
48069717|NCT00406354|100494022|FG001|COMPLETED|All Randomized Patients||61||
48069718|NCT00406354|100494023|FG002|COMPLETED|All Randomized Patients||59||
48069719|NCT00406354|100494021|FG000|NOT COMPLETED|All Randomized Patients||0||
48069720|NCT00406354|100494022|FG001|NOT COMPLETED|All Randomized Patients||0||
48069721|NCT00406354|100494023|FG002|NOT COMPLETED|All Randomized Patients||1||
48069722|NCT00406354|100494021|FG000|STARTED|All Randomized and Treated Patients||60||
48069723|NCT00406354|100494022|FG001|STARTED|All Randomized and Treated Patients||61||
48069724|NCT00406354|100494023|FG002|STARTED|All Randomized and Treated Patients||59||
48069725|NCT00406354|100494021|FG000|COMPLETED|All Randomized and Treated Patients||44||
48069726|NCT00406354|100494022|FG001|COMPLETED|All Randomized and Treated Patients||48||
48069727|NCT00406354|100494023|FG002|COMPLETED|All Randomized and Treated Patients||37||
48069728|NCT00406354|100494021|FG000|NOT COMPLETED|All Randomized and Treated Patients||16||
48069729|NCT00406354|100494022|FG001|NOT COMPLETED|All Randomized and Treated Patients||13||
48069730|NCT00406354|100494023|FG002|NOT COMPLETED|All Randomized and Treated Patients||22||
48069731|NCT02653872|100494024|FG000|STARTED|Overall Study||15||
48069732|NCT02653872|100494024|FG000|Treatment Period 1:|Overall Study||15||
48069733|NCT02653872|100494024|FG000|Treatment Period 2:|Overall Study||15||
48069734|NCT02653872|100494024|FG000|Treatment Period 3:|Overall Study||15||
48069735|NCT02653872|100494024|FG000|COMPLETED|Overall Study||15||
48069736|NCT02653872|100494024|FG000|NOT COMPLETED|Overall Study||0||
48069737|NCT03113071|100494025|FG000|STARTED|Overall Study||1||
48069738|NCT03113071|100494026|FG001|STARTED|Overall Study||0||
48069739|NCT03113071|100494025|FG000|COMPLETED|Overall Study||0||
48069740|NCT03113071|100494026|FG001|COMPLETED|Overall Study||0||
48069741|NCT03113071|100494025|FG000|NOT COMPLETED|Overall Study||1||
48069742|NCT03113071|100494026|FG001|NOT COMPLETED|Overall Study||0||
48069743|NCT01193530|100494027|FG000|STARTED|Overall Study||4||
48069744|NCT01193530|100494028|FG001|STARTED|Overall Study||8||
48069745|NCT01193530|100494027|FG000|COMPLETED|Overall Study||1||
48069746|NCT01193530|100494028|FG001|COMPLETED|Overall Study||3||
48069747|NCT01193530|100494027|FG000|NOT COMPLETED|Overall Study||3||
48069748|NCT01193530|100494028|FG001|NOT COMPLETED|Overall Study||5||
48069749|NCT03606512|100494029|FG000|STARTED|Overall Study||18||
48069750|NCT03606512|100494030|FG001|STARTED|Overall Study||20||
48069751|NCT03606512|100494029|FG000|Participants Received Placebo on Day 57|Overall Study||6||
48069752|NCT03606512|100494030|FG001|Participants Received Placebo on Day 57|Overall Study||0||
48069753|NCT03606512|100494029|FG000|Participants Received Nimenrix on Day 57|Overall Study||12||
48069754|NCT03606512|100494030|FG001|Participants Received Nimenrix on Day 57|Overall Study||0||
48069755|NCT03606512|100494029|FG000|COMPLETED|Overall Study||18||
48069756|NCT03606512|100494030|FG001|COMPLETED|Overall Study||18||
48069757|NCT03606512|100494029|FG000|NOT COMPLETED|Overall Study||0||
48069758|NCT03606512|100494030|FG001|NOT COMPLETED|Overall Study||2||
48069759|NCT00762229|100494031|FG000|STARTED|Overall Study||15||
48069760|NCT00762229|100494032|FG001|STARTED|Overall Study||24||
48069761|NCT00762229|100494031|FG000|COMPLETED|Overall Study||14||
48069762|NCT00762229|100494032|FG001|COMPLETED|Overall Study||22||
48069763|NCT00762229|100494031|FG000|NOT COMPLETED|Overall Study||1||
48069764|NCT00762229|100494032|FG001|NOT COMPLETED|Overall Study||2||
48069765|NCT01752985|100494033|FG000|STARTED|Treatment Period||29||
48069766|NCT01752985|100494034|FG001|STARTED|Treatment Period||30||
48069767|NCT01752985|100494035|FG002|STARTED|Treatment Period||29||
48069768|NCT01752985|100494033|FG000|COMPLETED|Treatment Period||25||
48069769|NCT01752985|100494034|FG001|COMPLETED|Treatment Period||27||
48069770|NCT01752985|100494035|FG002|COMPLETED|Treatment Period||24||
48069771|NCT01752985|100494033|FG000|NOT COMPLETED|Treatment Period||4||
48069772|NCT01752985|100494034|FG001|NOT COMPLETED|Treatment Period||3||
48069773|NCT01752985|100494035|FG002|NOT COMPLETED|Treatment Period||5||
48069774|NCT01752985|100494033|FG000|STARTED|Follow-up Period||28||
48069775|NCT01752985|100494034|FG001|STARTED|Follow-up Period||27||
48069776|NCT01752985|100494035|FG002|STARTED|Follow-up Period||26||
48069777|NCT01752985|100494033|FG000|COMPLETED|Follow-up Period||28||
48069778|NCT01752985|100494034|FG001|COMPLETED|Follow-up Period||27||
48069779|NCT01752985|100494035|FG002|COMPLETED|Follow-up Period||26||
48069780|NCT01752985|100494033|FG000|NOT COMPLETED|Follow-up Period||0||
48069781|NCT01752985|100494034|FG001|NOT COMPLETED|Follow-up Period||0||
48069782|NCT01752985|100494035|FG002|NOT COMPLETED|Follow-up Period||0||
48069783|NCT02467075|100494036|FG000|STARTED|Initial CT Scan||0||
48069784|NCT02467075|100494037|FG001|STARTED|Initial CT Scan||1||
48069785|NCT02467075|100494036|FG000|COMPLETED|Initial CT Scan||0||
48069786|NCT02467075|100494037|FG001|COMPLETED|Initial CT Scan||1||
48069787|NCT02467075|100494036|FG000|NOT COMPLETED|Initial CT Scan||0||
48069788|NCT02467075|100494037|FG001|NOT COMPLETED|Initial CT Scan||0||
48069789|NCT02467075|100494036|FG000|STARTED|48 Hour Follow-up||0||
48069790|NCT02467075|100494037|FG001|STARTED|48 Hour Follow-up||1||
48069791|NCT02467075|100494036|FG000|COMPLETED|48 Hour Follow-up||0||
48069792|NCT02467075|100494037|FG001|COMPLETED|48 Hour Follow-up||1||
48069793|NCT02467075|100494036|FG000|NOT COMPLETED|48 Hour Follow-up||0||
48069794|NCT02467075|100494037|FG001|NOT COMPLETED|48 Hour Follow-up||0||
48069795|NCT02467075|100494036|FG000|STARTED|72 Hour Follow-up||0||
48069796|NCT02467075|100494037|FG001|STARTED|72 Hour Follow-up||1||
48069797|NCT02467075|100494036|FG000|COMPLETED|72 Hour Follow-up||0||
48069798|NCT02467075|100494037|FG001|COMPLETED|72 Hour Follow-up||1||
48069799|NCT02467075|100494036|FG000|NOT COMPLETED|72 Hour Follow-up||0||
48069800|NCT02467075|100494037|FG001|NOT COMPLETED|72 Hour Follow-up||0||
48069801|NCT02467075|100494036|FG000|STARTED|30 Day Follow-up||0||
48069802|NCT02467075|100494037|FG001|STARTED|30 Day Follow-up||1||
48069803|NCT02467075|100494036|FG000|COMPLETED|30 Day Follow-up||0||
48069804|NCT02467075|100494037|FG001|COMPLETED|30 Day Follow-up||1||
48069805|NCT02467075|100494036|FG000|NOT COMPLETED|30 Day Follow-up||0||
48069806|NCT02467075|100494037|FG001|NOT COMPLETED|30 Day Follow-up||0||
48069807|NCT00806351|100494038|FG000|STARTED|Overall Study||15||
48069808|NCT00806351|100494039|FG001|STARTED|Overall Study||6||
48069809|NCT00806351|100494038|FG000|COMPLETED|Overall Study||10||
48069810|NCT00806351|100494039|FG001|COMPLETED|Overall Study||2||
48069811|NCT00806351|100494038|FG000|NOT COMPLETED|Overall Study||5||
48069812|NCT00806351|100494039|FG001|NOT COMPLETED|Overall Study||4||
48069813|NCT00018031|100494040|FG000|STARTED|Overall Study||36||
48069814|NCT00018031|100494040|FG000|COMPLETED|Overall Study||36||
48069815|NCT00018031|100494040|FG000|NOT COMPLETED|Overall Study||0||
48069816|NCT01480089|100494041|FG000|STARTED|Overall Study||25||
48069817|NCT01480089|100494042|FG001|STARTED|Overall Study||30||
48069818|NCT01480089|100494041|FG000|COMPLETED|Overall Study||25||
48069819|NCT01480089|100494042|FG001|COMPLETED|Overall Study||30||
48069820|NCT01480089|100494041|FG000|NOT COMPLETED|Overall Study||0||
48069821|NCT01480089|100494042|FG001|NOT COMPLETED|Overall Study||0||
48069822|NCT01030536|100494043|FG000|STARTED|Overall Study||7||
48069823|NCT01030536|100494044|FG001|STARTED|Overall Study||6||
48069824|NCT01030536|100494045|FG002|STARTED|Overall Study||6||
48069825|NCT01030536|100494046|FG003|STARTED|Overall Study||3||
48069826|NCT01030536|100494047|FG004|STARTED|Overall Study||1||
48069827|NCT01030536|100494043|FG000|COMPLETED|Overall Study||0||
48069828|NCT01030536|100494044|FG001|COMPLETED|Overall Study||0||
48069829|NCT01030536|100494045|FG002|COMPLETED|Overall Study||0||
48069830|NCT01030536|100494046|FG003|COMPLETED|Overall Study||0||
48069831|NCT01030536|100494047|FG004|COMPLETED|Overall Study||0||
48069832|NCT01030536|100494043|FG000|NOT COMPLETED|Overall Study||7||
48069833|NCT01030536|100494044|FG001|NOT COMPLETED|Overall Study||6||
48069834|NCT01030536|100494045|FG002|NOT COMPLETED|Overall Study||6||
48069835|NCT01030536|100494046|FG003|NOT COMPLETED|Overall Study||3||
48069836|NCT01030536|100494047|FG004|NOT COMPLETED|Overall Study||1||
48069837|NCT00691301|100494048|FG000|STARTED|Overall Study||55||
48069838|NCT00691301|100494048|FG000|COMPLETED|Overall Study||1||
48069839|NCT00691301|100494048|FG000|NOT COMPLETED|Overall Study||54||
48069840|NCT02004522|100494049|FG000|STARTED|Overall Study||160|Number of subjects randomized.|
48069841|NCT02004522|100494050|FG001|STARTED|Overall Study||159|Number of subjects randomized.|
48069842|NCT02004522|100494049|FG000|Number of Subjects Treated|Overall Study||158|Number of subjects exposed to treatment.|
48069843|NCT02004522|100494050|FG001|Number of Subjects Treated|Overall Study||155|Number of subjects exposed to treatment.|
48069844|NCT02004522|100494049|FG000|COMPLETED|Overall Study||34||
48069845|NCT02004522|100494050|FG001|COMPLETED|Overall Study||0||
48069846|NCT02004522|100494049|FG000|NOT COMPLETED|Overall Study||126||
48069847|NCT02004522|100494050|FG001|NOT COMPLETED|Overall Study||159||
48069848|NCT01393301|100494051|FG000|STARTED|Overall Study||26||
48069849|NCT01393301|100494052|FG001|STARTED|Overall Study||27||
48069850|NCT01393301|100494051|FG000|COMPLETED|Overall Study||17||
48069851|NCT01393301|100494052|FG001|COMPLETED|Overall Study||24||
48069852|NCT01393301|100494051|FG000|NOT COMPLETED|Overall Study||9||
48069853|NCT01393301|100494052|FG001|NOT COMPLETED|Overall Study||3||
48069854|NCT02061774|100494053|FG000|STARTED|Overall Study||10||
48069855|NCT02061774|100494054|FG001|STARTED|Overall Study||11||
48069856|NCT02061774|100494053|FG000|COMPLETED|Overall Study||10||
48069857|NCT02061774|100494054|FG001|COMPLETED|Overall Study||11||
48069858|NCT02061774|100494053|FG000|NOT COMPLETED|Overall Study||0||
48069859|NCT02061774|100494054|FG001|NOT COMPLETED|Overall Study||0||
48069860|NCT02654314|100494055|FG000|STARTED|Overall Study||136||
48069861|NCT02654314|100494056|FG001|STARTED|Overall Study||141||
48069862|NCT02654314|100494055|FG000|COMPLETED|Overall Study||136||
48069863|NCT02654314|100494056|FG001|COMPLETED|Overall Study||141||
48069864|NCT02654314|100494055|FG000|NOT COMPLETED|Overall Study||0||
48069865|NCT02654314|100494056|FG001|NOT COMPLETED|Overall Study||0||
48069866|NCT00242216|100494057|FG000|STARTED|Overall Study||39||
48069867|NCT00242216|100494058|FG001|STARTED|Overall Study||37||
48069868|NCT00242216|100494057|FG000|COMPLETED|Overall Study||21||
48069869|NCT00242216|100494058|FG001|COMPLETED|Overall Study||15||
48069870|NCT00242216|100494057|FG000|NOT COMPLETED|Overall Study||18||
48069871|NCT00242216|100494058|FG001|NOT COMPLETED|Overall Study||22||
48069872|NCT00293215|100494059|FG000|STARTED|Overall Study||6||
48069873|NCT00293215|100494060|FG001|STARTED|Overall Study||3||
48069874|NCT00293215|100494059|FG000|COMPLETED|Overall Study||1|Completed the study as planned, i.e., received all 6 cycles of CMD-193|
48069875|NCT00293215|100494060|FG001|COMPLETED|Overall Study||0|Completed the study as planned, i.e., received all 6 cycles of CMD-193|
48069876|NCT00293215|100494059|FG000|NOT COMPLETED|Overall Study||5||
48069877|NCT00293215|100494060|FG001|NOT COMPLETED|Overall Study||3||
48069878|NCT00293033|100494061|FG000|STARTED|Open-label Titration Period||151||
48069879|NCT00293033|100494061|FG000|COMPLETED|Open-label Titration Period||82||
48069880|NCT00293033|100494061|FG000|NOT COMPLETED|Open-label Titration Period||69||
48069881|NCT00293033|100494061|FG000|STARTED|Double-blind Treatment Period||82||
48069882|NCT00293033|100494061|FG000|COMPLETED|Double-blind Treatment Period||70||
48069883|NCT00293033|100494061|FG000|NOT COMPLETED|Double-blind Treatment Period||12||
48069884|NCT00724932|100494062|FG000|STARTED|Overall Study||70||
48069885|NCT00724932|100494063|FG001|STARTED|Overall Study||70||
48069886|NCT00724932|100494062|FG000|COMPLETED|Overall Study||65||
48069887|NCT00724932|100494063|FG001|COMPLETED|Overall Study||67||
48069888|NCT00724932|100494062|FG000|NOT COMPLETED|Overall Study||5||
48069889|NCT00724932|100494063|FG001|NOT COMPLETED|Overall Study||3||
48069890|NCT00570765|100494064|FG000|STARTED|DB Phase||20||
48069891|NCT00570765|100494065|FG001|STARTED|DB Phase||16||
48069892|NCT00570765|100494066|FG002|STARTED|DB Phase||24||
48069893|NCT00570765|100494067|FG003|STARTED|DB Phase||0||
48069894|NCT00570765|100494064|FG000|Received at Least 1 Dose of Study Drug|DB Phase||20||
48069895|NCT00570765|100494065|FG001|Received at Least 1 Dose of Study Drug|DB Phase||16||
48069896|NCT00570765|100494066|FG002|Received at Least 1 Dose of Study Drug|DB Phase||23||
48069897|NCT00570765|100494067|FG003|Received at Least 1 Dose of Study Drug|DB Phase||0||
48069898|NCT00570765|100494064|FG000|Safety Population|DB Phase||20||
48069899|NCT00570765|100494065|FG001|Safety Population|DB Phase||16||
48069900|NCT00570765|100494066|FG002|Safety Population|DB Phase||23||
48069901|NCT00570765|100494067|FG003|Safety Population|DB Phase||0||
48069902|NCT00570765|100494064|FG000|COMPLETED|DB Phase||16||
48069903|NCT00570765|100494065|FG001|COMPLETED|DB Phase||9||
48069904|NCT00570765|100494066|FG002|COMPLETED|DB Phase||23||
48069905|NCT00570765|100494067|FG003|COMPLETED|DB Phase||0||
48069906|NCT00570765|100494064|FG000|NOT COMPLETED|DB Phase||4||
48069907|NCT00570765|100494065|FG001|NOT COMPLETED|DB Phase||7||
48069908|NCT00570765|100494066|FG002|NOT COMPLETED|DB Phase||1||
48069909|NCT00570765|100494067|FG003|NOT COMPLETED|DB Phase||0||
48069910|NCT00570765|100494064|FG000|STARTED|LTSE Phase||0||
48069911|NCT00570765|100494065|FG001|STARTED|LTSE Phase||0||
48667762|NCT01107886|101970674|FG000|NOT COMPLETED|Overall Study||202||
48069912|NCT00570765|100494066|FG002|STARTED|LTSE Phase||0||
48069913|NCT00570765|100494067|FG003|STARTED|LTSE Phase||28||
48069914|NCT00570765|100494064|FG000|Received at Least 1 Dose of Study Drug|LTSE Phase||0||
48069915|NCT00570765|100494065|FG001|Received at Least 1 Dose of Study Drug|LTSE Phase||0||
48069916|NCT00570765|100494066|FG002|Received at Least 1 Dose of Study Drug|LTSE Phase||0||
48069917|NCT00570765|100494067|FG003|Received at Least 1 Dose of Study Drug|LTSE Phase||28||
48069918|NCT00570765|100494064|FG000|Safety Population|LTSE Phase||0||
48069919|NCT00570765|100494065|FG001|Safety Population|LTSE Phase||0||
48069920|NCT00570765|100494066|FG002|Safety Population|LTSE Phase||0||
48069921|NCT00570765|100494067|FG003|Safety Population|LTSE Phase||28||
48069922|NCT00570765|100494064|FG000|COMPLETED|LTSE Phase||0||
48069923|NCT00570765|100494065|FG001|COMPLETED|LTSE Phase||0||
48069924|NCT00570765|100494066|FG002|COMPLETED|LTSE Phase||0||
48069925|NCT00570765|100494067|FG003|COMPLETED|LTSE Phase||16||
48069926|NCT00570765|100494064|FG000|NOT COMPLETED|LTSE Phase||0||
48069927|NCT00570765|100494065|FG001|NOT COMPLETED|LTSE Phase||0||
48069928|NCT00570765|100494066|FG002|NOT COMPLETED|LTSE Phase||0||
48069929|NCT00570765|100494067|FG003|NOT COMPLETED|LTSE Phase||12||
48069930|NCT04528732|100494068|FG000|STARTED|Overall Study||29|child-caregiver dyads|
48069931|NCT04528732|100494069|FG001|STARTED|Overall Study||26|child-caregiver dyads|
48069932|NCT04528732|100494070|FG002|STARTED|Overall Study||34|child-caregiver dyads|
48069933|NCT04528732|100494068|FG000|COMPLETED|Overall Study||28|child-caregiver dyads|
48069934|NCT04528732|100494069|FG001|COMPLETED|Overall Study||25|child-caregiver dyads|
48069935|NCT04528732|100494070|FG002|COMPLETED|Overall Study||31|child-caregiver dyads|
48069936|NCT04528732|100494068|FG000|NOT COMPLETED|Overall Study||1||
48069937|NCT04528732|100494069|FG001|NOT COMPLETED|Overall Study||1||
48069938|NCT04528732|100494070|FG002|NOT COMPLETED|Overall Study||3||
48069939|NCT00434954|100494071|FG000|STARTED|Overall Study||248||
48069940|NCT00434954|100494072|FG001|STARTED|Overall Study||246||
48069941|NCT00434954|100494071|FG000|Started - Previous Treatment MET Only|Overall Study||182||
48069942|NCT00434954|100494072|FG001|Started - Previous Treatment MET Only|Overall Study||181||
48069943|NCT00434954|100494071|FG000|Started - Previous Treatment MET + SU|Overall Study||66||
48069944|NCT00434954|100494072|FG001|Started - Previous Treatment MET + SU|Overall Study||65||
48069945|NCT00434954|100494071|FG000|Full Analysis Set (FAS) Overall|Overall Study||247||
48069946|NCT00434954|100494072|FG001|Full Analysis Set (FAS) Overall|Overall Study||233||
48069947|NCT00434954|100494071|FG000|FAS - Previous Treatment MET Only|Overall Study||181||
48069948|NCT00434954|100494072|FG001|FAS - Previous Treatment MET Only|Overall Study||173||
48069949|NCT00434954|100494071|FG000|FAS - Previous Treatment MET + SU|Overall Study||66||
48069950|NCT00434954|100494072|FG001|FAS - Previous Treatment MET + SU|Overall Study||60||
48069951|NCT00434954|100494071|FG000|Completed - Previous Treatment MET Only|Overall Study||135||
48069952|NCT00434954|100494072|FG001|Completed - Previous Treatment MET Only|Overall Study||137||
48069953|NCT00434954|100494071|FG000|Completed - Previous Treatment MET + SU|Overall Study||31||
48069954|NCT00434954|100494072|FG001|Completed - Previous Treatment MET + SU|Overall Study||38||
48069955|NCT00434954|100494071|FG000|COMPLETED|Overall Study||166||
48069956|NCT00434954|100494072|FG001|COMPLETED|Overall Study||175||
48069957|NCT00434954|100494071|FG000|NOT COMPLETED|Overall Study||82||
48069958|NCT00434954|100494072|FG001|NOT COMPLETED|Overall Study||71||
48069959|NCT03485391|100494073|FG000|STARTED|Overall Study||55||
48069960|NCT03485391|100494074|FG001|STARTED|Overall Study||54||
48069961|NCT03485391|100494073|FG000|COMPLETED|Overall Study||38||
48069962|NCT03485391|100494074|FG001|COMPLETED|Overall Study||34||
48069963|NCT03485391|100494073|FG000|NOT COMPLETED|Overall Study||17||
48069964|NCT03485391|100494074|FG001|NOT COMPLETED|Overall Study||20||
48069965|NCT00313300|100494075|FG000|STARTED|Randomized in Phase A (26 Weeks)||184||
48069966|NCT00313300|100494076|FG001|STARTED|Randomized in Phase A (26 Weeks)||179||
48069967|NCT00313300|100494077|FG002|STARTED|Randomized in Phase A (26 Weeks)||184||
48069968|NCT00313300|100494078|FG003|STARTED|Randomized in Phase A (26 Weeks)||0||
48069969|NCT00313300|100494079|FG004|STARTED|Randomized in Phase A (26 Weeks)||0||
48069970|NCT00313300|100494075|FG000|COMPLETED|Randomized in Phase A (26 Weeks)||130||
48069971|NCT00313300|100494076|FG001|COMPLETED|Randomized in Phase A (26 Weeks)||140||
48069972|NCT00313300|100494077|FG002|COMPLETED|Randomized in Phase A (26 Weeks)||149||
48069973|NCT00313300|100494078|FG003|COMPLETED|Randomized in Phase A (26 Weeks)||0||
48069974|NCT00313300|100494079|FG004|COMPLETED|Randomized in Phase A (26 Weeks)||0||
48069975|NCT00313300|100494075|FG000|NOT COMPLETED|Randomized in Phase A (26 Weeks)||54||
48069976|NCT00313300|100494076|FG001|NOT COMPLETED|Randomized in Phase A (26 Weeks)||39||
48069977|NCT00313300|100494077|FG002|NOT COMPLETED|Randomized in Phase A (26 Weeks)||35||
48069978|NCT00313300|100494078|FG003|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0||
48069979|NCT00313300|100494079|FG004|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0||
48220036|NCT05580003|100863775|FG027|COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48069980|NCT00313300|100494075|FG000|STARTED|Randomized in Phase B (26 Weeks)||427||
48069981|NCT00313300|100494076|FG001|STARTED|Randomized in Phase B (26 Weeks)||138||
48069982|NCT00313300|100494077|FG002|STARTED|Randomized in Phase B (26 Weeks)||134||
48069983|NCT00313300|100494078|FG003|STARTED|Randomized in Phase B (26 Weeks)||248||
48069984|NCT00313300|100494079|FG004|STARTED|Randomized in Phase B (26 Weeks)||221||
48069985|NCT00313300|100494075|FG000|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||368||
48069986|NCT00313300|100494076|FG001|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||120||
48069987|NCT00313300|100494077|FG002|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||110||
48069988|NCT00313300|100494078|FG003|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||248||
48069989|NCT00313300|100494079|FG004|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||221||
48069990|NCT00313300|100494075|FG000|COMPLETED|Randomized in Phase B (26 Weeks)||333||
48069991|NCT00313300|100494076|FG001|COMPLETED|Randomized in Phase B (26 Weeks)||105||
48069992|NCT00313300|100494077|FG002|COMPLETED|Randomized in Phase B (26 Weeks)||94||
48069993|NCT00313300|100494078|FG003|COMPLETED|Randomized in Phase B (26 Weeks)||15||
48069994|NCT00313300|100494079|FG004|COMPLETED|Randomized in Phase B (26 Weeks)||13||
48069995|NCT00313300|100494075|FG000|NOT COMPLETED|Randomized in Phase B (26 Weeks)||94||
48069996|NCT00313300|100494076|FG001|NOT COMPLETED|Randomized in Phase B (26 Weeks)||33||
48069997|NCT00313300|100494077|FG002|NOT COMPLETED|Randomized in Phase B (26 Weeks)||40||
48069998|NCT00313300|100494078|FG003|NOT COMPLETED|Randomized in Phase B (26 Weeks)||233||
48069999|NCT00313300|100494079|FG004|NOT COMPLETED|Randomized in Phase B (26 Weeks)||208||
48070000|NCT00313300|100494075|FG000|STARTED|Follow-Up(30days)-Randomized Phase A||163||
48070001|NCT00313300|100494076|FG001|STARTED|Follow-Up(30days)-Randomized Phase A||162||
48070002|NCT00313300|100494077|FG002|STARTED|Follow-Up(30days)-Randomized Phase A||174||
48070003|NCT00313300|100494078|FG003|STARTED|Follow-Up(30days)-Randomized Phase A||0||
48070004|NCT00313300|100494079|FG004|STARTED|Follow-Up(30days)-Randomized Phase A||0||
48070005|NCT00313300|100494075|FG000|COMPLETED|Follow-Up(30days)-Randomized Phase A||158||
48070006|NCT00313300|100494076|FG001|COMPLETED|Follow-Up(30days)-Randomized Phase A||156||
48070007|NCT00313300|100494077|FG002|COMPLETED|Follow-Up(30days)-Randomized Phase A||172||
48070008|NCT00313300|100494078|FG003|COMPLETED|Follow-Up(30days)-Randomized Phase A||0||
48070009|NCT00313300|100494079|FG004|COMPLETED|Follow-Up(30days)-Randomized Phase A||0||
48070010|NCT00313300|100494075|FG000|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||5||
48070011|NCT00313300|100494076|FG001|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||6||
48070012|NCT00313300|100494077|FG002|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||2||
48070013|NCT00313300|100494078|FG003|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0||
48070014|NCT00313300|100494079|FG004|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0||
48070015|NCT00313300|100494075|FG000|STARTED|Follow-Up(30days)-Randomized Phase B||383||
48070016|NCT00313300|100494076|FG001|STARTED|Follow-Up(30days)-Randomized Phase B||123||
48070017|NCT00313300|100494077|FG002|STARTED|Follow-Up(30days)-Randomized Phase B||119||
48070018|NCT00313300|100494078|FG003|STARTED|Follow-Up(30days)-Randomized Phase B||222||
48070019|NCT00313300|100494079|FG004|STARTED|Follow-Up(30days)-Randomized Phase B||201||
48070020|NCT00313300|100494075|FG000|COMPLETED|Follow-Up(30days)-Randomized Phase B||380||
48070021|NCT00313300|100494076|FG001|COMPLETED|Follow-Up(30days)-Randomized Phase B||123||
48070022|NCT00313300|100494077|FG002|COMPLETED|Follow-Up(30days)-Randomized Phase B||117||
48070023|NCT00313300|100494078|FG003|COMPLETED|Follow-Up(30days)-Randomized Phase B||217||
48070024|NCT00313300|100494079|FG004|COMPLETED|Follow-Up(30days)-Randomized Phase B||199||
48070025|NCT00313300|100494075|FG000|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||3||
48070026|NCT00313300|100494076|FG001|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||0||
48070027|NCT00313300|100494077|FG002|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2||
48070028|NCT00313300|100494078|FG003|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||5||
48070029|NCT00313300|100494079|FG004|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2||
48070030|NCT00191269|100494080|FG000|STARTED|Overall Study||6||
48070031|NCT00191269|100494081|FG001|STARTED|Overall Study||62||
48070032|NCT00191269|100494080|FG000|COMPLETED|Overall Study||0||
48070033|NCT00191269|100494081|FG001|COMPLETED|Overall Study||4||
48070034|NCT00191269|100494080|FG000|NOT COMPLETED|Overall Study||6||
48070035|NCT00191269|100494081|FG001|NOT COMPLETED|Overall Study||58||
48070036|NCT01602120|100494082|FG000|STARTED|Overall Study||29||
48070037|NCT01602120|100494083|FG001|STARTED|Overall Study||60||
48070038|NCT01602120|100494084|FG002|STARTED|Overall Study||17||
48070039|NCT01602120|100494085|FG003|STARTED|Overall Study||53||
48070040|NCT01602120|100494082|FG000|COMPLETED|Overall Study||0||
48070041|NCT01602120|100494083|FG001|COMPLETED|Overall Study||0||
48070042|NCT01602120|100494084|FG002|COMPLETED|Overall Study||0||
48070043|NCT01602120|100494085|FG003|COMPLETED|Overall Study||0||
48070044|NCT01602120|100494082|FG000|NOT COMPLETED|Overall Study||29||
48070045|NCT01602120|100494083|FG001|NOT COMPLETED|Overall Study||60||
48070046|NCT01602120|100494084|FG002|NOT COMPLETED|Overall Study||17||
48070047|NCT01602120|100494085|FG003|NOT COMPLETED|Overall Study||53||
48070048|NCT01360593|100494086|FG000|STARTED|Overall Study||35||
48070049|NCT01360593|100494086|FG000|COMPLETED|Overall Study||35||
48070050|NCT01360593|100494086|FG000|NOT COMPLETED|Overall Study||0||
48070051|NCT02581787|100494087|FG000|STARTED|Phase 1||5||
48070052|NCT02581787|100494088|FG001|STARTED|Phase 1||0||
48070053|NCT02581787|100494089|FG002|STARTED|Phase 1||0||
48070054|NCT02581787|100494087|FG000|Received Treatment|Phase 1||5||
48070055|NCT02581787|100494088|FG001|Received Treatment|Phase 1||0||
48070056|NCT02581787|100494089|FG002|Received Treatment|Phase 1||0||
48220037|NCT05580003|100863748|FG000|NOT COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220038|NCT05580003|100863749|FG001|NOT COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220039|NCT05580003|100863750|FG002|NOT COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48070057|NCT02581787|100494087|FG000|Completed Radiation|Phase 1||4||
48070058|NCT02581787|100494088|FG001|Completed Radiation|Phase 1||0||
48070059|NCT02581787|100494089|FG002|Completed Radiation|Phase 1||0||
48070060|NCT02581787|100494087|FG000|Completed FRESO Treatments|Phase 1||4||
48070061|NCT02581787|100494088|FG001|Completed FRESO Treatments|Phase 1||0||
48070062|NCT02581787|100494089|FG002|Completed FRESO Treatments|Phase 1||0||
48070063|NCT02581787|100494087|FG000|Completed 12-month Follow-up Visit|Phase 1||5||
48070064|NCT02581787|100494088|FG001|Completed 12-month Follow-up Visit|Phase 1||0||
48070065|NCT02581787|100494089|FG002|Completed 12-month Follow-up Visit|Phase 1||0||
48070066|NCT02581787|100494087|FG000|COMPLETED|Phase 1||4||
48070067|NCT02581787|100494088|FG001|COMPLETED|Phase 1||0||
48070068|NCT02581787|100494089|FG002|COMPLETED|Phase 1||0||
48070069|NCT02581787|100494087|FG000|NOT COMPLETED|Phase 1||1||
48070070|NCT02581787|100494088|FG001|NOT COMPLETED|Phase 1||0||
48070071|NCT02581787|100494089|FG002|NOT COMPLETED|Phase 1||0||
48070072|NCT02581787|100494087|FG000|STARTED|Phase 2||0||
48070073|NCT02581787|100494088|FG001|STARTED|Phase 2||0||
48070074|NCT02581787|100494089|FG002|STARTED|Phase 2||19||
48070075|NCT02581787|100494087|FG000|Received Treatment|Phase 2||0||
48070076|NCT02581787|100494088|FG001|Received Treatment|Phase 2||0||
48070077|NCT02581787|100494089|FG002|Received Treatment|Phase 2||18||
48070078|NCT02581787|100494087|FG000|Completed Radiation|Phase 2||0||
48070079|NCT02581787|100494088|FG001|Completed Radiation|Phase 2||0||
48070080|NCT02581787|100494089|FG002|Completed Radiation|Phase 2||17||
48070081|NCT02581787|100494087|FG000|Completed FRESO Treatments|Phase 2||0||
48070082|NCT02581787|100494088|FG001|Completed FRESO Treatments|Phase 2||0||
48070083|NCT02581787|100494089|FG002|Completed FRESO Treatments|Phase 2||13||
48070084|NCT02581787|100494087|FG000|Completed 12-month Follow-up Visit|Phase 2||0||
48070085|NCT02581787|100494088|FG001|Completed 12-month Follow-up Visit|Phase 2||0||
48070086|NCT02581787|100494089|FG002|Completed 12-month Follow-up Visit|Phase 2||13||
48070087|NCT02581787|100494087|FG000|COMPLETED|Phase 2||0||
48070088|NCT02581787|100494088|FG001|COMPLETED|Phase 2||0||
48070089|NCT02581787|100494089|FG002|COMPLETED|Phase 2||12||
48070090|NCT02581787|100494087|FG000|NOT COMPLETED|Phase 2||0||
48070091|NCT02581787|100494088|FG001|NOT COMPLETED|Phase 2||0||
48070092|NCT02581787|100494089|FG002|NOT COMPLETED|Phase 2||7||
48070093|NCT01586065|100494090|FG000|STARTED|Overall Study||10||
48070094|NCT01586065|100494090|FG000|COMPLETED|Overall Study||10||
48070095|NCT01586065|100494090|FG000|NOT COMPLETED|Overall Study||0||
48070096|NCT00696800|100494091|FG000|STARTED|Overall Study||757||
48070097|NCT00696800|100494092|FG001|STARTED|Overall Study||752||
48070098|NCT00696800|100494091|FG000|Treated (ITT)|Overall Study||756||
48070099|NCT00696800|100494092|FG001|Treated (ITT)|Overall Study||750||
48070100|NCT00696800|100494091|FG000|COMPLETED|Overall Study||672||
48070101|NCT00696800|100494092|FG001|COMPLETED|Overall Study||704||
48070102|NCT00696800|100494091|FG000|NOT COMPLETED|Overall Study||85||
48070103|NCT00696800|100494092|FG001|NOT COMPLETED|Overall Study||48||
48070104|NCT03685123|100494093|FG000|STARTED|Weight Loss Phase||39||
48070105|NCT03685123|100494094|FG001|STARTED|Weight Loss Phase||0||
48070106|NCT03685123|100494095|FG002|STARTED|Weight Loss Phase||0||
48070107|NCT03685123|100494093|FG000|COMPLETED|Weight Loss Phase||33||
48070108|NCT03685123|100494094|FG001|COMPLETED|Weight Loss Phase||0||
48070109|NCT03685123|100494095|FG002|COMPLETED|Weight Loss Phase||0||
48070110|NCT03685123|100494093|FG000|NOT COMPLETED|Weight Loss Phase||6||
48070111|NCT03685123|100494094|FG001|NOT COMPLETED|Weight Loss Phase||0||
48070112|NCT03685123|100494095|FG002|NOT COMPLETED|Weight Loss Phase||0||
48070113|NCT03685123|100494093|FG000|STARTED|Weight Maintenance Phase||0|After weight loss phase, participants are randomized to the PA-REC and the WM-REC. Thus there are no additional participant in the weight loss phase of this section.|
48070114|NCT03685123|100494094|FG001|STARTED|Weight Maintenance Phase||16|After weight loss phase, participants are randomized to the PA-REC and the WM-REC. Thus there are no additional participant in the weight loss phase of this section.|
48070115|NCT03685123|100494095|FG002|STARTED|Weight Maintenance Phase||17|After weight loss phase, participants are randomized to the PA-REC and the WM-REC. Thus there are no additional participant in the weight loss phase of this section.|
48070116|NCT03685123|100494093|FG000|COMPLETED|Weight Maintenance Phase||0||
48070117|NCT03685123|100494094|FG001|COMPLETED|Weight Maintenance Phase||12||
48070118|NCT03685123|100494095|FG002|COMPLETED|Weight Maintenance Phase||9||
48070119|NCT03685123|100494093|FG000|NOT COMPLETED|Weight Maintenance Phase||0||
48070120|NCT03685123|100494094|FG001|NOT COMPLETED|Weight Maintenance Phase||4||
48070121|NCT03685123|100494095|FG002|NOT COMPLETED|Weight Maintenance Phase||8||
48070122|NCT02059408|100494096|FG000|STARTED|Overall Study||604||
48220040|NCT05580003|100863751|FG003|NOT COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48070123|NCT02059408|100494097|FG001|STARTED|Overall Study||599||
48070124|NCT02059408|100494098|FG002|STARTED|Overall Study||616||
48070125|NCT02059408|100494096|FG000|COMPLETED|Overall Study||604||
48070126|NCT02059408|100494097|FG001|COMPLETED|Overall Study||269||
48070127|NCT02059408|100494098|FG002|COMPLETED|Overall Study||258||
48070128|NCT02059408|100494096|FG000|NOT COMPLETED|Overall Study||0||
48070129|NCT02059408|100494097|FG001|NOT COMPLETED|Overall Study||330||
48070130|NCT02059408|100494098|FG002|NOT COMPLETED|Overall Study||358||
48070131|NCT02980783|100494099|FG000|STARTED|Overall Study||53||
48220041|NCT05580003|100863752|FG004|NOT COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48070132|NCT02980783|100494099|FG000|COMPLETED|Overall Study||52||
48070133|NCT02980783|100494099|FG000|NOT COMPLETED|Overall Study||1||
48070134|NCT00981370|100494100|FG000|STARTED|Overall Study||0||
48070135|NCT00981370|100494100|FG000|COMPLETED|Overall Study||0||
48070136|NCT00981370|100494100|FG000|NOT COMPLETED|Overall Study||0||
48070137|NCT00492531|100494101|FG000|STARTED|Overall Study||37||
48070138|NCT00492531|100494102|FG001|STARTED|Overall Study||37||
48070139|NCT00492531|100494101|FG000|COMPLETED|Overall Study||15||
48070140|NCT00492531|100494102|FG001|COMPLETED|Overall Study||14||
48070141|NCT00492531|100494101|FG000|NOT COMPLETED|Overall Study||22||
48070142|NCT00492531|100494102|FG001|NOT COMPLETED|Overall Study||23||
48070143|NCT04721171|100494103|FG000|STARTED|Overall Study||2||
48070144|NCT04721171|100494104|FG001|STARTED|Overall Study||2||
48070145|NCT04721171|100494103|FG000|COMPLETED|Overall Study||2||
48070146|NCT04721171|100494104|FG001|COMPLETED|Overall Study||2||
48070147|NCT04721171|100494103|FG000|NOT COMPLETED|Overall Study||0||
48070148|NCT04721171|100494104|FG001|NOT COMPLETED|Overall Study||0||
48070149|NCT02538029|100494105|FG000|STARTED|Overall Study||24||
48070150|NCT02538029|100494106|FG001|STARTED|Overall Study||10||
48070151|NCT02538029|100494107|FG002|STARTED|Overall Study||11||
48070152|NCT02538029|100494105|FG000|COMPLETED|Overall Study||23||
48070153|NCT02538029|100494106|FG001|COMPLETED|Overall Study||10||
48070154|NCT02538029|100494107|FG002|COMPLETED|Overall Study||10||
48070155|NCT02538029|100494105|FG000|NOT COMPLETED|Overall Study||1||
48070156|NCT02538029|100494106|FG001|NOT COMPLETED|Overall Study||0||
48070157|NCT02538029|100494107|FG002|NOT COMPLETED|Overall Study||1||
48070158|NCT00615108|100494108|FG000|STARTED|Overall Study||3148||
48070159|NCT00615108|100494108|FG000|COMPLETED|Overall Study||2641||
48070160|NCT00615108|100494108|FG000|NOT COMPLETED|Overall Study||507||
48070161|NCT00392860|100494109|FG000|STARTED|Overall Study||3||
48070162|NCT00392860|100494110|FG001|STARTED|Overall Study||0||
48070163|NCT00392860|100494111|FG002|STARTED|Overall Study||1||
48070164|NCT00392860|100494109|FG000|COMPLETED|Overall Study||3||
48070165|NCT00392860|100494110|FG001|COMPLETED|Overall Study||0||
48070166|NCT00392860|100494111|FG002|COMPLETED|Overall Study||1||
48070167|NCT00392860|100494109|FG000|NOT COMPLETED|Overall Study||0||
48070168|NCT00392860|100494110|FG001|NOT COMPLETED|Overall Study||0||
48070169|NCT00392860|100494111|FG002|NOT COMPLETED|Overall Study||0||
48070170|NCT05439941|100494112|FG000|STARTED|Overall Study||104||
48070171|NCT05439941|100494113|FG001|STARTED|Overall Study||102||
48070172|NCT05439941|100494114|FG002|STARTED|Overall Study||79||
48070173|NCT05439941|100494112|FG000|COMPLETED|Overall Study||0||
48070174|NCT05439941|100494113|FG001|COMPLETED|Overall Study||0||
48070175|NCT05439941|100494114|FG002|COMPLETED|Overall Study||0||
48070176|NCT05439941|100494112|FG000|NOT COMPLETED|Overall Study||104||
48070177|NCT05439941|100494113|FG001|NOT COMPLETED|Overall Study||102||
48070178|NCT05439941|100494114|FG002|NOT COMPLETED|Overall Study||79||
48070179|NCT00450255|100494115|FG000|STARTED|Overall Study||41||
48070180|NCT00450255|100494115|FG000|COMPLETED|Overall Study||40||
48070181|NCT00450255|100494115|FG000|NOT COMPLETED|Overall Study||1||
48070182|NCT00573183|100494116|FG000|STARTED|Overall Study||234||
48070183|NCT00573183|100494117|FG001|STARTED|Overall Study||237||
48070184|NCT00573183|100494116|FG000|COMPLETED|Overall Study||162||
48070185|NCT00573183|100494117|FG001|COMPLETED|Overall Study||174||
48070186|NCT00573183|100494116|FG000|NOT COMPLETED|Overall Study||72||
48070187|NCT00573183|100494117|FG001|NOT COMPLETED|Overall Study||63||
48070188|NCT03055156|100494118|FG000|STARTED|Overall Study||281||
48070189|NCT03055156|100494119|FG001|STARTED|Overall Study||273||
48070190|NCT03055156|100494118|FG000|COMPLETED|Overall Study||281||
48070191|NCT03055156|100494119|FG001|COMPLETED|Overall Study||273||
48070192|NCT03055156|100494118|FG000|NOT COMPLETED|Overall Study||0||
48070193|NCT03055156|100494119|FG001|NOT COMPLETED|Overall Study||0||
48070194|NCT03320057|100494120|FG000|STARTED|Overall Study||266||
48070195|NCT03320057|100494121|FG001|STARTED|Overall Study||60||
48070196|NCT03320057|100494120|FG000|Patient's Clinical Outcome Information Obtained|Overall Study||262||
48070197|NCT03320057|100494121|FG001|Patient's Clinical Outcome Information Obtained|Overall Study||0||
48070198|NCT03320057|100494120|FG000|Received Pharmacist Training|Overall Study||0||
48070199|NCT03320057|100494121|FG001|Received Pharmacist Training|Overall Study||56||
48070200|NCT03320057|100494120|FG000|Pharmacists Completed Baseline Survey|Overall Study||0||
48070201|NCT03320057|100494121|FG001|Pharmacists Completed Baseline Survey|Overall Study||47||
48070202|NCT03320057|100494120|FG000|COMPLETED|Overall Study||260||
48220042|NCT05580003|100863753|FG005|NOT COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48070203|NCT03320057|100494121|FG001|COMPLETED|Overall Study||43||
48220043|NCT05580003|100863754|FG006|NOT COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48070204|NCT03320057|100494120|FG000|NOT COMPLETED|Overall Study||6||
48070205|NCT03320057|100494121|FG001|NOT COMPLETED|Overall Study||17||
48070206|NCT00894166|100494122|FG000|STARTED|Overall Study||132||
48667763|NCT01107886|101970675|FG001|NOT COMPLETED|Overall Study||214||
48070207|NCT00894166|100494123|FG001|STARTED|Overall Study||109||
48070208|NCT00894166|100494124|FG002|STARTED|Overall Study||112||
48070209|NCT00894166|100494125|FG003|STARTED|Overall Study||114||
48070210|NCT00894166|100494126|FG004|STARTED|Overall Study||34||
48070211|NCT00894166|100494127|FG005|STARTED|Overall Study||36||
48070212|NCT00894166|100494128|FG006|STARTED|Overall Study||35||
48070213|NCT00894166|100494129|FG007|STARTED|Overall Study||34||
48070214|NCT00894166|100494122|FG000|COMPLETED|Overall Study||71||
48070215|NCT00894166|100494123|FG001|COMPLETED|Overall Study||46||
48070216|NCT00894166|100494124|FG002|COMPLETED|Overall Study||50||
48070217|NCT00894166|100494125|FG003|COMPLETED|Overall Study||45||
48070218|NCT00894166|100494126|FG004|COMPLETED|Overall Study||10||
48070219|NCT00894166|100494127|FG005|COMPLETED|Overall Study||20||
48070220|NCT00894166|100494128|FG006|COMPLETED|Overall Study||19||
48070221|NCT00894166|100494129|FG007|COMPLETED|Overall Study||0||
48070222|NCT00894166|100494122|FG000|NOT COMPLETED|Overall Study||61||
48070223|NCT00894166|100494123|FG001|NOT COMPLETED|Overall Study||63||
48070224|NCT00894166|100494124|FG002|NOT COMPLETED|Overall Study||62||
48070225|NCT00894166|100494125|FG003|NOT COMPLETED|Overall Study||69||
48070226|NCT00894166|100494126|FG004|NOT COMPLETED|Overall Study||24||
48070227|NCT00894166|100494127|FG005|NOT COMPLETED|Overall Study||16||
48070228|NCT00894166|100494128|FG006|NOT COMPLETED|Overall Study||16||
48070229|NCT00894166|100494129|FG007|NOT COMPLETED|Overall Study||34||
48070230|NCT05248867|100494130|FG000|STARTED|Double-blind Period||156||
48070231|NCT05248867|100494131|FG001|STARTED|Double-blind Period||482||
48070232|NCT05248867|100494132|FG002|STARTED|Double-blind Period||0||
48070233|NCT05248867|100494133|FG003|STARTED|Double-blind Period||0||
48070234|NCT05248867|100494134|FG004|STARTED|Double-blind Period||0||
48070235|NCT05248867|100494135|FG005|STARTED|Double-blind Period||0||
48070236|NCT05248867|100494130|FG000|COMPLETED|Double-blind Period||148||
48070237|NCT05248867|100494131|FG001|COMPLETED|Double-blind Period||454||
48070238|NCT05248867|100494132|FG002|COMPLETED|Double-blind Period||0||
48070239|NCT05248867|100494133|FG003|COMPLETED|Double-blind Period||0||
48070240|NCT05248867|100494134|FG004|COMPLETED|Double-blind Period||0||
48070241|NCT05248867|100494135|FG005|COMPLETED|Double-blind Period||0||
48070242|NCT05248867|100494130|FG000|NOT COMPLETED|Double-blind Period||8||
48070243|NCT05248867|100494131|FG001|NOT COMPLETED|Double-blind Period||28||
48070244|NCT05248867|100494132|FG002|NOT COMPLETED|Double-blind Period||0||
48070245|NCT05248867|100494133|FG003|NOT COMPLETED|Double-blind Period||0||
48070246|NCT05248867|100494134|FG004|NOT COMPLETED|Double-blind Period||0||
48070247|NCT05248867|100494135|FG005|NOT COMPLETED|Double-blind Period||0||
48070248|NCT05248867|100494130|FG000|STARTED|Open-label Period||0||
48070249|NCT05248867|100494131|FG001|STARTED|Open-label Period||0||
48070250|NCT05248867|100494132|FG002|STARTED|Open-label Period||3||
48070251|NCT05248867|100494133|FG003|STARTED|Open-label Period||145||
48070252|NCT05248867|100494134|FG004|STARTED|Open-label Period||17||
48070253|NCT05248867|100494135|FG005|STARTED|Open-label Period||437||
48070254|NCT05248867|100494130|FG000|COMPLETED|Open-label Period||0||
48070255|NCT05248867|100494131|FG001|COMPLETED|Open-label Period||0||
48070256|NCT05248867|100494132|FG002|COMPLETED|Open-label Period||0||
48070257|NCT05248867|100494133|FG003|COMPLETED|Open-label Period||143||
48070258|NCT05248867|100494134|FG004|COMPLETED|Open-label Period||0||
48070259|NCT05248867|100494135|FG005|COMPLETED|Open-label Period||426||
48070260|NCT05248867|100494130|FG000|NOT COMPLETED|Open-label Period||0||
48070261|NCT05248867|100494131|FG001|NOT COMPLETED|Open-label Period||0||
48070262|NCT05248867|100494132|FG002|NOT COMPLETED|Open-label Period||3||
48070263|NCT05248867|100494133|FG003|NOT COMPLETED|Open-label Period||2||
48070264|NCT05248867|100494134|FG004|NOT COMPLETED|Open-label Period||17||
48070265|NCT05248867|100494135|FG005|NOT COMPLETED|Open-label Period||11||
48070266|NCT02564497|100494136|FG000|STARTED|Overall Study||74||
48070267|NCT02564497|100494137|FG001|STARTED|Overall Study||72||
48070268|NCT02564497|100494136|FG000|COMPLETED|Overall Study||74||
48070269|NCT02564497|100494137|FG001|COMPLETED|Overall Study||72||
48070270|NCT02564497|100494136|FG000|NOT COMPLETED|Overall Study||0||
48070271|NCT02564497|100494137|FG001|NOT COMPLETED|Overall Study||0||
48070272|NCT00457301|100494138|FG000|STARTED|Overall Study||105||
48070273|NCT00457301|100494139|FG001|STARTED|Overall Study||108||
48070274|NCT00457301|100494138|FG000|COMPLETED|Overall Study||82||
48070275|NCT00457301|100494139|FG001|COMPLETED|Overall Study||84||
48070276|NCT00457301|100494138|FG000|NOT COMPLETED|Overall Study||23||
48070277|NCT00457301|100494139|FG001|NOT COMPLETED|Overall Study||24||
48070278|NCT01956435|100494140|FG000|STARTED|Overall Study||3||
48070279|NCT01956435|100494141|FG001|STARTED|Overall Study||3||
48070280|NCT01956435|100494140|FG000|COMPLETED|Overall Study||3||
48070281|NCT01956435|100494141|FG001|COMPLETED|Overall Study||3||
48070282|NCT01956435|100494140|FG000|NOT COMPLETED|Overall Study||0||
48070283|NCT01956435|100494141|FG001|NOT COMPLETED|Overall Study||0||
48070284|NCT02096679|100494142|FG000|STARTED|Overall Study||8||
48070285|NCT02096679|100494142|FG000|COMPLETED|Overall Study||8||
48070286|NCT02096679|100494142|FG000|NOT COMPLETED|Overall Study||0||
48070287|NCT01217801|100494143|FG000|STARTED|Period 1||24||
48070288|NCT01217801|100494144|FG001|STARTED|Period 1||24||
48070289|NCT01217801|100494143|FG000|COMPLETED|Period 1||23||
48070290|NCT01217801|100494144|FG001|COMPLETED|Period 1||22||
48070291|NCT01217801|100494143|FG000|NOT COMPLETED|Period 1||1||
48070292|NCT01217801|100494144|FG001|NOT COMPLETED|Period 1||2||
48070293|NCT01217801|100494143|FG000|STARTED|Period 2||23||
48070294|NCT01217801|100494144|FG001|STARTED|Period 2||22||
48070295|NCT01217801|100494143|FG000|COMPLETED|Period 2||23||
48070296|NCT01217801|100494144|FG001|COMPLETED|Period 2||22||
48070297|NCT01217801|100494143|FG000|NOT COMPLETED|Period 2||0||
48070298|NCT01217801|100494144|FG001|NOT COMPLETED|Period 2||0||
48070299|NCT02737397|100494145|FG000|STARTED|Overall Study||13||
48070300|NCT02737397|100494145|FG000|JMI-001|Overall Study||13||
48070301|NCT02737397|100494145|FG000|SJP-304|Overall Study||12||
48070302|NCT02737397|100494145|FG000|SJP-223|Overall Study||13||
48070303|NCT02737397|100494145|FG000|Placebo|Overall Study||13||
48070304|NCT02737397|100494145|FG000|COMPLETED|Overall Study||13||
48070305|NCT02737397|100494145|FG000|NOT COMPLETED|Overall Study||0||
48070306|NCT03342963|100494146|FG000|STARTED|Overall Study||27||
48070307|NCT03342963|100494147|FG001|STARTED|Overall Study||27||
48070308|NCT03342963|100494148|FG002|STARTED|Overall Study||10||
48070309|NCT03342963|100494149|FG003|STARTED|Overall Study||10||
48070310|NCT03342963|100494146|FG000|COMPLETED|Overall Study||25||
48070311|NCT03342963|100494147|FG001|COMPLETED|Overall Study||25||
48070312|NCT03342963|100494148|FG002|COMPLETED|Overall Study||10||
48070313|NCT03342963|100494149|FG003|COMPLETED|Overall Study||10||
48070314|NCT03342963|100494146|FG000|NOT COMPLETED|Overall Study||2||
48070315|NCT03342963|100494147|FG001|NOT COMPLETED|Overall Study||2||
48070316|NCT03342963|100494148|FG002|NOT COMPLETED|Overall Study||0||
48070317|NCT03342963|100494149|FG003|NOT COMPLETED|Overall Study||0||
48070318|NCT03607487|100494150|FG000|STARTED|Overall Study||9||
48070319|NCT03607487|100494151|FG001|STARTED|Overall Study||9||
48070320|NCT03607487|100494152|FG002|STARTED|Overall Study||9||
48070321|NCT03607487|100494153|FG003|STARTED|Overall Study||8||
48070322|NCT03607487|100494150|FG000|COMPLETED|Overall Study||7||
48070323|NCT03607487|100494151|FG001|COMPLETED|Overall Study||9||
48070324|NCT03607487|100494152|FG002|COMPLETED|Overall Study||9||
48070325|NCT03607487|100494153|FG003|COMPLETED|Overall Study||7||
48070326|NCT03607487|100494150|FG000|NOT COMPLETED|Overall Study||2||
48070327|NCT03607487|100494151|FG001|NOT COMPLETED|Overall Study||0||
48070328|NCT03607487|100494152|FG002|NOT COMPLETED|Overall Study||0||
48070329|NCT03607487|100494153|FG003|NOT COMPLETED|Overall Study||1||
48070330|NCT03089320|100494154|FG000|STARTED|Overall Study||60||
48070331|NCT03089320|100494155|FG001|STARTED|Overall Study||60||
48070332|NCT03089320|100494154|FG000|COMPLETED|Overall Study||57||
48070333|NCT03089320|100494155|FG001|COMPLETED|Overall Study||51||
48070334|NCT03089320|100494154|FG000|NOT COMPLETED|Overall Study||3||
48070335|NCT03089320|100494155|FG001|NOT COMPLETED|Overall Study||9||
48070336|NCT03353246|100494156|FG000|STARTED|Overall Study||500||
48070337|NCT03353246|100494156|FG000|COMPLETED|Overall Study||500||
48070338|NCT03353246|100494156|FG000|NOT COMPLETED|Overall Study||0||
48070339|NCT00545766|100494157|FG000|STARTED|Overall Study||41||
48070340|NCT00545766|100494157|FG000|COMPLETED|Overall Study||36||
48070341|NCT00545766|100494157|FG000|NOT COMPLETED|Overall Study||5||
48070342|NCT01137396|100494158|FG000|STARTED|Overall Study||30||
48070343|NCT01137396|100494159|FG001|STARTED|Overall Study||27||
48070344|NCT01137396|100494158|FG000|COMPLETED|Overall Study||22||
48070345|NCT01137396|100494159|FG001|COMPLETED|Overall Study||25||
48070346|NCT01137396|100494158|FG000|NOT COMPLETED|Overall Study||8||
48070347|NCT01137396|100494159|FG001|NOT COMPLETED|Overall Study||2||
48070348|NCT01439633|100494160|FG000|STARTED|Overall Study||22||
48070349|NCT01439633|100494160|FG000|COMPLETED|Overall Study||22||
48070350|NCT01439633|100494160|FG000|NOT COMPLETED|Overall Study||0||
48070351|NCT01696695|100494161|FG000|STARTED|Overall Study||882||
48070352|NCT01696695|100494161|FG000|COMPLETED|Overall Study||0||
48070353|NCT01696695|100494161|FG000|NOT COMPLETED|Overall Study||882||
48070354|NCT01560403|100494162|FG000|STARTED|Overall Study||5||
48070355|NCT01560403|100494163|FG001|STARTED|Overall Study||9||
48070356|NCT01560403|100494162|FG000|COMPLETED|Overall Study||5||
48070357|NCT01560403|100494163|FG001|COMPLETED|Overall Study||8||
48070358|NCT01560403|100494162|FG000|NOT COMPLETED|Overall Study||0||
48070359|NCT01560403|100494163|FG001|NOT COMPLETED|Overall Study||1||
48070360|NCT02609204|100494164|FG000|STARTED|Overall Study||51||
48070361|NCT02609204|100494164|FG000|COMPLETED|Overall Study||51||
48070362|NCT02609204|100494164|FG000|NOT COMPLETED|Overall Study||0||
48070363|NCT01846104|100494165|FG000|STARTED|Overall Study||4||
48070364|NCT01846104|100494165|FG000|COMPLETED|Overall Study||3||
48070365|NCT01846104|100494165|FG000|NOT COMPLETED|Overall Study||1||
48070366|NCT01086761|100494166|FG000|STARTED|Overall Study||9||
48070367|NCT01086761|100494167|FG001|STARTED|Overall Study||7||
48070368|NCT01086761|100494168|FG002|STARTED|Overall Study||6||
48070369|NCT01086761|100494169|FG003|STARTED|Overall Study||6||
48070370|NCT01086761|100494170|FG004|STARTED|Overall Study||4||
48070371|NCT01086761|100494171|FG005|STARTED|Overall Study||0||
48220044|NCT05580003|100863755|FG007|NOT COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48070372|NCT01086761|100494166|FG000|COMPLETED|Overall Study||9||
48070373|NCT01086761|100494167|FG001|COMPLETED|Overall Study||7||
48070374|NCT01086761|100494168|FG002|COMPLETED|Overall Study||6||
48070375|NCT01086761|100494169|FG003|COMPLETED|Overall Study||6||
48070376|NCT01086761|100494170|FG004|COMPLETED|Overall Study||4||
48070377|NCT01086761|100494171|FG005|COMPLETED|Overall Study||0||
48070378|NCT01086761|100494166|FG000|NOT COMPLETED|Overall Study||0||
48070379|NCT01086761|100494167|FG001|NOT COMPLETED|Overall Study||0||
48070380|NCT01086761|100494168|FG002|NOT COMPLETED|Overall Study||0||
48070381|NCT01086761|100494169|FG003|NOT COMPLETED|Overall Study||0||
48070382|NCT01086761|100494170|FG004|NOT COMPLETED|Overall Study||0||
48070383|NCT01086761|100494171|FG005|NOT COMPLETED|Overall Study||0||
48070384|NCT01899261|100494172|FG000|STARTED|Overall Study||20||
48070385|NCT01899261|100494172|FG000|COMPLETED|Overall Study||20||
48070386|NCT01899261|100494172|FG000|NOT COMPLETED|Overall Study||0||
48070387|NCT01787331|100494173|FG000|STARTED|Overall Study||21||
48070388|NCT01787331|100494173|FG000|COMPLETED|Overall Study||19||
48070389|NCT01787331|100494173|FG000|NOT COMPLETED|Overall Study||2||
48070390|NCT01682954|100494174|FG000|STARTED|Overall Study||40||
48070391|NCT01682954|100494175|FG001|STARTED|Overall Study||38||
48070392|NCT01682954|100494174|FG000|COMPLETED|Overall Study||35||
48070393|NCT01682954|100494175|FG001|COMPLETED|Overall Study||33||
48070394|NCT01682954|100494174|FG000|NOT COMPLETED|Overall Study||5||
48070395|NCT01682954|100494175|FG001|NOT COMPLETED|Overall Study||5||
48070396|NCT04447794|100494176|FG000|STARTED|Overall Study||64||
48070397|NCT04447794|100494177|FG001|STARTED|Overall Study||64||
48070398|NCT04447794|100494178|FG002|STARTED|Overall Study||63||
48070399|NCT04447794|100494176|FG000|COMPLETED|Overall Study||61||
48070400|NCT04447794|100494177|FG001|COMPLETED|Overall Study||60||
48070401|NCT04447794|100494178|FG002|COMPLETED|Overall Study||55||
48070402|NCT04447794|100494176|FG000|NOT COMPLETED|Overall Study||3||
48070403|NCT04447794|100494177|FG001|NOT COMPLETED|Overall Study||4||
48070404|NCT04447794|100494178|FG002|NOT COMPLETED|Overall Study||8||
48070405|NCT01431170|100494179|FG000|STARTED|Overall Study||12||
48070406|NCT01431170|100494180|FG001|STARTED|Overall Study||12||
48070407|NCT01431170|100494179|FG000|COMPLETED|Overall Study||9||
48070408|NCT01431170|100494180|FG001|COMPLETED|Overall Study||11||
48070409|NCT01431170|100494179|FG000|NOT COMPLETED|Overall Study||3||
48070410|NCT01431170|100494180|FG001|NOT COMPLETED|Overall Study||1||
48070411|NCT03000569|100494181|FG000|STARTED|Overall Study||15||
48070412|NCT03000569|100494182|FG001|STARTED|Overall Study||14||
48070413|NCT03000569|100494181|FG000|COMPLETED|Overall Study||14||
48070414|NCT03000569|100494182|FG001|COMPLETED|Overall Study||14||
48070415|NCT03000569|100494181|FG000|NOT COMPLETED|Overall Study||1||
48070416|NCT03000569|100494182|FG001|NOT COMPLETED|Overall Study||0||
48070417|NCT00546104|100494183|FG000|STARTED|Overall Study||31||
48070418|NCT00546104|100494183|FG000|COMPLETED|Overall Study||31||
48070419|NCT00546104|100494183|FG000|NOT COMPLETED|Overall Study||0||
48070420|NCT01443078|100494184|FG000|STARTED|Overall Study||42||
48070421|NCT01443078|100494184|FG000|COMPLETED|Overall Study||13||
48070422|NCT01443078|100494184|FG000|NOT COMPLETED|Overall Study||29||
48070423|NCT01706146|100494185|FG000|STARTED|Overall Study||59||
48070424|NCT01706146|100494185|FG000|COMPLETED|Overall Study||53||
48070425|NCT01706146|100494185|FG000|NOT COMPLETED|Overall Study||6||
48070426|NCT01797731|100494186|FG000|STARTED|Overall Study||50||
48070427|NCT01797731|100494187|FG001|STARTED|Overall Study||50||
48070428|NCT01797731|100494186|FG000|COMPLETED|Overall Study||47||
48070429|NCT01797731|100494187|FG001|COMPLETED|Overall Study||47||
48070430|NCT01797731|100494186|FG000|NOT COMPLETED|Overall Study||3||
48070431|NCT01797731|100494187|FG001|NOT COMPLETED|Overall Study||3||
48070432|NCT03505190|100494188|FG000|STARTED|Overall Study||9||
48070433|NCT03505190|100494189|FG001|STARTED|Overall Study||8||
48070434|NCT03505190|100494190|FG002|STARTED|Overall Study||8||
48070435|NCT03505190|100494191|FG003|STARTED|Overall Study||8||
48070436|NCT03505190|100494192|FG004|STARTED|Overall Study||8||
48070437|NCT03505190|100494188|FG000|COMPLETED|Overall Study||9||
48070438|NCT03505190|100494189|FG001|COMPLETED|Overall Study||8||
48070439|NCT03505190|100494190|FG002|COMPLETED|Overall Study||8||
48070440|NCT03505190|100494191|FG003|COMPLETED|Overall Study||8||
48070441|NCT03505190|100494192|FG004|COMPLETED|Overall Study||8||
48070442|NCT03505190|100494188|FG000|NOT COMPLETED|Overall Study||0||
48070443|NCT03505190|100494189|FG001|NOT COMPLETED|Overall Study||0||
48070444|NCT03505190|100494190|FG002|NOT COMPLETED|Overall Study||0||
48070445|NCT03505190|100494191|FG003|NOT COMPLETED|Overall Study||0||
48070446|NCT03505190|100494192|FG004|NOT COMPLETED|Overall Study||0||
48070447|NCT04066647|100494193|FG000|STARTED|Overall Study||7||
48070448|NCT04066647|100494193|FG000|COMPLETED|Overall Study||7||
48070449|NCT04066647|100494193|FG000|NOT COMPLETED|Overall Study||0||
48070450|NCT03000283|100494194|FG000|STARTED|Overall Study||7||
48070451|NCT03000283|100494194|FG000|COMPLETED|Overall Study||7||
48070452|NCT03000283|100494194|FG000|NOT COMPLETED|Overall Study||0||
48070453|NCT01773733|100494195|FG000|STARTED|Overall Study||80146||
48070454|NCT01773733|100494196|FG001|STARTED|Overall Study||13167||
48070455|NCT01773733|100494195|FG000|3 Months of Treatment|Overall Study||54841||
48070456|NCT01773733|100494196|FG001|3 Months of Treatment|Overall Study||11365||
48070457|NCT01773733|100494195|FG000|6 Months of Treatment|Overall Study||33424||
48070458|NCT01773733|100494196|FG001|6 Months of Treatment|Overall Study||8007||
48070459|NCT01773733|100494195|FG000|COMPLETED|Overall Study||21417||
48070460|NCT01773733|100494196|FG001|COMPLETED|Overall Study||4846||
48070461|NCT01773733|100494195|FG000|NOT COMPLETED|Overall Study||58729||
48070462|NCT01773733|100494196|FG001|NOT COMPLETED|Overall Study||8321||
48070463|NCT00931879|100494197|FG000|STARTED|Overall Study||22||
48070464|NCT00931879|100494198|FG001|STARTED|Overall Study||22||
48070465|NCT00931879|100494197|FG000|COMPLETED|Overall Study||19||
48070466|NCT00931879|100494198|FG001|COMPLETED|Overall Study||19||
48070467|NCT00931879|100494197|FG000|NOT COMPLETED|Overall Study||3||
48070468|NCT00931879|100494198|FG001|NOT COMPLETED|Overall Study||3||
48070469|NCT00900237|100494199|FG000|STARTED|Overall Study||7||
48070470|NCT00900237|100494200|FG001|STARTED|Overall Study||7||
48070471|NCT00900237|100494199|FG000|COMPLETED|Overall Study||7||
48070472|NCT00900237|100494200|FG001|COMPLETED|Overall Study||7||
48070473|NCT00900237|100494199|FG000|NOT COMPLETED|Overall Study||0||
48070474|NCT00900237|100494200|FG001|NOT COMPLETED|Overall Study||0||
48070475|NCT02336373|100494201|FG000|STARTED|Overall Study||32||
48070476|NCT02336373|100494201|FG000|COMPLETED|Overall Study||14||
48070477|NCT02336373|100494201|FG000|NOT COMPLETED|Overall Study||18||
48070478|NCT00108433|100494202|FG000|STARTED|Overall Study||30||
48070479|NCT00108433|100494203|FG001|STARTED|Overall Study||31||
48070480|NCT00108433|100494202|FG000|COMPLETED|Overall Study||9||
48070481|NCT00108433|100494203|FG001|COMPLETED|Overall Study||14||
48220045|NCT05580003|100863756|FG008|NOT COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220046|NCT05580003|100863757|FG009|NOT COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220047|NCT05580003|100863758|FG010|NOT COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220048|NCT05580003|100863759|FG011|NOT COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220049|NCT05580003|100863760|FG012|NOT COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220050|NCT05580003|100863761|FG013|NOT COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220051|NCT05580003|100863762|FG014|NOT COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220052|NCT05580003|100863763|FG015|NOT COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220053|NCT05580003|100863764|FG016|NOT COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220054|NCT05580003|100863765|FG017|NOT COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220055|NCT05580003|100863766|FG018|NOT COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220056|NCT05580003|100863767|FG019|NOT COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220057|NCT05580003|100863768|FG020|NOT COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220058|NCT05580003|100863769|FG021|NOT COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220059|NCT05580003|100863770|FG022|NOT COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220060|NCT05580003|100863771|FG023|NOT COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220061|NCT05580003|100863772|FG024|NOT COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220062|NCT05580003|100863773|FG025|NOT COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220063|NCT05580003|100863774|FG026|NOT COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220064|NCT05580003|100863775|FG027|NOT COMPLETED|Part 3: Washout 3 (up to 3 Days)||0||
48220065|NCT05580003|100863748|FG000|STARTED|Part 3: Period 4 (Day 1)||0||
48220066|NCT05580003|100863749|FG001|STARTED|Part 3: Period 4 (Day 1)||0||
48220067|NCT05580003|100863750|FG002|STARTED|Part 3: Period 4 (Day 1)||0||
48220068|NCT05580003|100863751|FG003|STARTED|Part 3: Period 4 (Day 1)||0||
48220069|NCT05580003|100863752|FG004|STARTED|Part 3: Period 4 (Day 1)||0||
48220070|NCT05580003|100863753|FG005|STARTED|Part 3: Period 4 (Day 1)||0||
48220071|NCT05580003|100863754|FG006|STARTED|Part 3: Period 4 (Day 1)||0||
48220072|NCT05580003|100863755|FG007|STARTED|Part 3: Period 4 (Day 1)||0||
48220073|NCT05580003|100863756|FG008|STARTED|Part 3: Period 4 (Day 1)||0||
48220074|NCT05580003|100863757|FG009|STARTED|Part 3: Period 4 (Day 1)||0||
48220075|NCT05580003|100863758|FG010|STARTED|Part 3: Period 4 (Day 1)||0||
48220076|NCT05580003|100863759|FG011|STARTED|Part 3: Period 4 (Day 1)||0||
48220077|NCT05580003|100863760|FG012|STARTED|Part 3: Period 4 (Day 1)||0||
48220078|NCT05580003|100863761|FG013|STARTED|Part 3: Period 4 (Day 1)||2||
48220079|NCT05580003|100863762|FG014|STARTED|Part 3: Period 4 (Day 1)||2||
48220080|NCT05580003|100863763|FG015|STARTED|Part 3: Period 4 (Day 1)||2||
48220081|NCT05580003|100863764|FG016|STARTED|Part 3: Period 4 (Day 1)||2||
48220082|NCT05580003|100863765|FG017|STARTED|Part 3: Period 4 (Day 1)||2||
48220083|NCT05580003|100863766|FG018|STARTED|Part 3: Period 4 (Day 1)||2||
48220084|NCT05580003|100863767|FG019|STARTED|Part 3: Period 4 (Day 1)||0||
48220085|NCT05580003|100863768|FG020|STARTED|Part 3: Period 4 (Day 1)||0||
48220086|NCT05580003|100863769|FG021|STARTED|Part 3: Period 4 (Day 1)||0||
48220087|NCT05580003|100863770|FG022|STARTED|Part 3: Period 4 (Day 1)||0||
48220088|NCT05580003|100863771|FG023|STARTED|Part 3: Period 4 (Day 1)||0||
48220089|NCT05580003|100863772|FG024|STARTED|Part 3: Period 4 (Day 1)||0||
48220090|NCT05580003|100863773|FG025|STARTED|Part 3: Period 4 (Day 1)||0||
48220091|NCT05580003|100863774|FG026|STARTED|Part 3: Period 4 (Day 1)||0||
48220092|NCT05580003|100863775|FG027|STARTED|Part 3: Period 4 (Day 1)||0||
48220093|NCT05580003|100863748|FG000|COMPLETED|Part 3: Period 4 (Day 1)||0||
48220094|NCT05580003|100863749|FG001|COMPLETED|Part 3: Period 4 (Day 1)||0||
48220095|NCT05580003|100863750|FG002|COMPLETED|Part 3: Period 4 (Day 1)||0||
48220096|NCT05580003|100863751|FG003|COMPLETED|Part 3: Period 4 (Day 1)||0||
48220097|NCT05580003|100863752|FG004|COMPLETED|Part 3: Period 4 (Day 1)||0||
48220098|NCT05580003|100863753|FG005|COMPLETED|Part 3: Period 4 (Day 1)||0||
48220099|NCT05580003|100863754|FG006|COMPLETED|Part 3: Period 4 (Day 1)||0||
48220100|NCT05580003|100863755|FG007|COMPLETED|Part 3: Period 4 (Day 1)||0||
48220101|NCT05580003|100863756|FG008|COMPLETED|Part 3: Period 4 (Day 1)||0||
48220102|NCT05580003|100863757|FG009|COMPLETED|Part 3: Period 4 (Day 1)||0||
48220103|NCT05580003|100863758|FG010|COMPLETED|Part 3: Period 4 (Day 1)||0||
48220104|NCT05580003|100863759|FG011|COMPLETED|Part 3: Period 4 (Day 1)||0||
48220105|NCT05580003|100863760|FG012|COMPLETED|Part 3: Period 4 (Day 1)||0||
48220106|NCT05580003|100863761|FG013|COMPLETED|Part 3: Period 4 (Day 1)||2||
48220107|NCT05580003|100863762|FG014|COMPLETED|Part 3: Period 4 (Day 1)||2||
48220108|NCT05580003|100863763|FG015|COMPLETED|Part 3: Period 4 (Day 1)||2||
48220109|NCT05580003|100863764|FG016|COMPLETED|Part 3: Period 4 (Day 1)||2||
48220110|NCT05580003|100863765|FG017|COMPLETED|Part 3: Period 4 (Day 1)||2||
48220111|NCT05580003|100863766|FG018|COMPLETED|Part 3: Period 4 (Day 1)||2||
48220112|NCT05580003|100863767|FG019|COMPLETED|Part 3: Period 4 (Day 1)||0||
48220113|NCT05580003|100863768|FG020|COMPLETED|Part 3: Period 4 (Day 1)||0||
48220114|NCT05580003|100863769|FG021|COMPLETED|Part 3: Period 4 (Day 1)||0||
48220115|NCT05580003|100863770|FG022|COMPLETED|Part 3: Period 4 (Day 1)||0||
48220116|NCT05580003|100863771|FG023|COMPLETED|Part 3: Period 4 (Day 1)||0||
48220117|NCT05580003|100863772|FG024|COMPLETED|Part 3: Period 4 (Day 1)||0||
48220118|NCT05580003|100863773|FG025|COMPLETED|Part 3: Period 4 (Day 1)||0||
48220119|NCT05580003|100863774|FG026|COMPLETED|Part 3: Period 4 (Day 1)||0||
48220120|NCT05580003|100863775|FG027|COMPLETED|Part 3: Period 4 (Day 1)||0||
48220121|NCT05580003|100863748|FG000|NOT COMPLETED|Part 3: Period 4 (Day 1)||0||
48220122|NCT05580003|100863749|FG001|NOT COMPLETED|Part 3: Period 4 (Day 1)||0||
48220123|NCT05580003|100863750|FG002|NOT COMPLETED|Part 3: Period 4 (Day 1)||0||
48220124|NCT05580003|100863751|FG003|NOT COMPLETED|Part 3: Period 4 (Day 1)||0||
48220125|NCT05580003|100863752|FG004|NOT COMPLETED|Part 3: Period 4 (Day 1)||0||
48220126|NCT05580003|100863753|FG005|NOT COMPLETED|Part 3: Period 4 (Day 1)||0||
48220127|NCT05580003|100863754|FG006|NOT COMPLETED|Part 3: Period 4 (Day 1)||0||
48220128|NCT05580003|100863755|FG007|NOT COMPLETED|Part 3: Period 4 (Day 1)||0||
48220129|NCT05580003|100863756|FG008|NOT COMPLETED|Part 3: Period 4 (Day 1)||0||
48220130|NCT05580003|100863757|FG009|NOT COMPLETED|Part 3: Period 4 (Day 1)||0||
48220131|NCT05580003|100863758|FG010|NOT COMPLETED|Part 3: Period 4 (Day 1)||0||
48220132|NCT05580003|100863759|FG011|NOT COMPLETED|Part 3: Period 4 (Day 1)||0||
48220133|NCT05580003|100863760|FG012|NOT COMPLETED|Part 3: Period 4 (Day 1)||0||
48220134|NCT05580003|100863761|FG013|NOT COMPLETED|Part 3: Period 4 (Day 1)||0||
48220135|NCT05580003|100863762|FG014|NOT COMPLETED|Part 3: Period 4 (Day 1)||0||
48220136|NCT05580003|100863763|FG015|NOT COMPLETED|Part 3: Period 4 (Day 1)||0||
48220137|NCT05580003|100863764|FG016|NOT COMPLETED|Part 3: Period 4 (Day 1)||0||
48220138|NCT05580003|100863765|FG017|NOT COMPLETED|Part 3: Period 4 (Day 1)||0||
48220139|NCT05580003|100863766|FG018|NOT COMPLETED|Part 3: Period 4 (Day 1)||0||
48220140|NCT05580003|100863767|FG019|NOT COMPLETED|Part 3: Period 4 (Day 1)||0||
48220141|NCT05580003|100863768|FG020|NOT COMPLETED|Part 3: Period 4 (Day 1)||0||
48220142|NCT05580003|100863769|FG021|NOT COMPLETED|Part 3: Period 4 (Day 1)||0||
48220143|NCT05580003|100863770|FG022|NOT COMPLETED|Part 3: Period 4 (Day 1)||0||
48220144|NCT05580003|100863771|FG023|NOT COMPLETED|Part 3: Period 4 (Day 1)||0||
48220145|NCT05580003|100863772|FG024|NOT COMPLETED|Part 3: Period 4 (Day 1)||0||
48220146|NCT05580003|100863773|FG025|NOT COMPLETED|Part 3: Period 4 (Day 1)||0||
48220147|NCT05580003|100863774|FG026|NOT COMPLETED|Part 3: Period 4 (Day 1)||0||
48220148|NCT05580003|100863775|FG027|NOT COMPLETED|Part 3: Period 4 (Day 1)||0||
48220149|NCT05580003|100863748|FG000|STARTED|Part 4 (Day 1 to Day 11)||0||
48220150|NCT05580003|100863749|FG001|STARTED|Part 4 (Day 1 to Day 11)||0||
48220151|NCT05580003|100863750|FG002|STARTED|Part 4 (Day 1 to Day 11)||0||
48220152|NCT05580003|100863751|FG003|STARTED|Part 4 (Day 1 to Day 11)||0||
48220153|NCT05580003|100863752|FG004|STARTED|Part 4 (Day 1 to Day 11)||0||
48220154|NCT05580003|100863753|FG005|STARTED|Part 4 (Day 1 to Day 11)||0||
48220155|NCT05580003|100863754|FG006|STARTED|Part 4 (Day 1 to Day 11)||0||
48220156|NCT05580003|100863755|FG007|STARTED|Part 4 (Day 1 to Day 11)||0||
48220157|NCT05580003|100863756|FG008|STARTED|Part 4 (Day 1 to Day 11)||0||
48220158|NCT05580003|100863757|FG009|STARTED|Part 4 (Day 1 to Day 11)||0||
48220159|NCT05580003|100863758|FG010|STARTED|Part 4 (Day 1 to Day 11)||0||
48220160|NCT05580003|100863759|FG011|STARTED|Part 4 (Day 1 to Day 11)||0||
48220161|NCT05580003|100863760|FG012|STARTED|Part 4 (Day 1 to Day 11)||0||
48220162|NCT05580003|100863761|FG013|STARTED|Part 4 (Day 1 to Day 11)||0||
48220163|NCT05580003|100863762|FG014|STARTED|Part 4 (Day 1 to Day 11)||0||
48220164|NCT05580003|100863763|FG015|STARTED|Part 4 (Day 1 to Day 11)||0||
48220165|NCT05580003|100863764|FG016|STARTED|Part 4 (Day 1 to Day 11)||0||
48220166|NCT05580003|100863765|FG017|STARTED|Part 4 (Day 1 to Day 11)||0||
48220167|NCT05580003|100863766|FG018|STARTED|Part 4 (Day 1 to Day 11)||0||
48220168|NCT05580003|100863767|FG019|STARTED|Part 4 (Day 1 to Day 11)||6||
48220169|NCT05580003|100863768|FG020|STARTED|Part 4 (Day 1 to Day 11)||0||
48220170|NCT05580003|100863769|FG021|STARTED|Part 4 (Day 1 to Day 11)||0||
48220171|NCT05580003|100863770|FG022|STARTED|Part 4 (Day 1 to Day 11)||0||
48220172|NCT05580003|100863771|FG023|STARTED|Part 4 (Day 1 to Day 11)||0||
48220173|NCT05580003|100863772|FG024|STARTED|Part 4 (Day 1 to Day 11)||0||
48220174|NCT05580003|100863773|FG025|STARTED|Part 4 (Day 1 to Day 11)||0||
48220175|NCT05580003|100863774|FG026|STARTED|Part 4 (Day 1 to Day 11)||0||
48220176|NCT05580003|100863775|FG027|STARTED|Part 4 (Day 1 to Day 11)||0||
48220177|NCT05580003|100863748|FG000|COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220178|NCT05580003|100863749|FG001|COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220179|NCT05580003|100863750|FG002|COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220180|NCT05580003|100863751|FG003|COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220181|NCT05580003|100863752|FG004|COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220182|NCT05580003|100863753|FG005|COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220183|NCT05580003|100863754|FG006|COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220184|NCT05580003|100863755|FG007|COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220185|NCT05580003|100863756|FG008|COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220186|NCT05580003|100863757|FG009|COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220187|NCT05580003|100863758|FG010|COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220188|NCT05580003|100863759|FG011|COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220189|NCT05580003|100863760|FG012|COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220190|NCT05580003|100863761|FG013|COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220191|NCT05580003|100863762|FG014|COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220192|NCT05580003|100863763|FG015|COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220193|NCT05580003|100863764|FG016|COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220194|NCT05580003|100863765|FG017|COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220195|NCT05580003|100863766|FG018|COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220196|NCT05580003|100863767|FG019|COMPLETED|Part 4 (Day 1 to Day 11)||5||
48220197|NCT05580003|100863768|FG020|COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220198|NCT05580003|100863769|FG021|COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220199|NCT05580003|100863770|FG022|COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220200|NCT05580003|100863771|FG023|COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220201|NCT05580003|100863772|FG024|COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220202|NCT05580003|100863773|FG025|COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220203|NCT05580003|100863774|FG026|COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220204|NCT05580003|100863775|FG027|COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220205|NCT05580003|100863748|FG000|NOT COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220206|NCT05580003|100863749|FG001|NOT COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220207|NCT05580003|100863750|FG002|NOT COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220208|NCT05580003|100863751|FG003|NOT COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220209|NCT05580003|100863752|FG004|NOT COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220210|NCT05580003|100863753|FG005|NOT COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220211|NCT05580003|100863754|FG006|NOT COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220212|NCT05580003|100863755|FG007|NOT COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220213|NCT05580003|100863756|FG008|NOT COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220214|NCT05580003|100863757|FG009|NOT COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220215|NCT05580003|100863758|FG010|NOT COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220216|NCT05580003|100863759|FG011|NOT COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220217|NCT05580003|100863760|FG012|NOT COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220218|NCT05580003|100863761|FG013|NOT COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220219|NCT05580003|100863762|FG014|NOT COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220220|NCT05580003|100863763|FG015|NOT COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220221|NCT05580003|100863764|FG016|NOT COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220222|NCT05580003|100863765|FG017|NOT COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220223|NCT05580003|100863766|FG018|NOT COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220224|NCT05580003|100863767|FG019|NOT COMPLETED|Part 4 (Day 1 to Day 11)||1||
48220225|NCT05580003|100863768|FG020|NOT COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220226|NCT05580003|100863769|FG021|NOT COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220227|NCT05580003|100863770|FG022|NOT COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220228|NCT05580003|100863771|FG023|NOT COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220229|NCT05580003|100863772|FG024|NOT COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220230|NCT05580003|100863773|FG025|NOT COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220231|NCT05580003|100863774|FG026|NOT COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220232|NCT05580003|100863775|FG027|NOT COMPLETED|Part 4 (Day 1 to Day 11)||0||
48220233|NCT05580003|100863748|FG000|STARTED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220234|NCT05580003|100863749|FG001|STARTED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220235|NCT05580003|100863750|FG002|STARTED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220236|NCT05580003|100863751|FG003|STARTED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220237|NCT05580003|100863752|FG004|STARTED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220238|NCT05580003|100863753|FG005|STARTED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220239|NCT05580003|100863754|FG006|STARTED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220240|NCT05580003|100863755|FG007|STARTED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220241|NCT05580003|100863756|FG008|STARTED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220242|NCT05580003|100863757|FG009|STARTED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220243|NCT05580003|100863758|FG010|STARTED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220244|NCT05580003|100863759|FG011|STARTED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220245|NCT05580003|100863760|FG012|STARTED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220246|NCT05580003|100863761|FG013|STARTED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220247|NCT05580003|100863762|FG014|STARTED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220248|NCT05580003|100863763|FG015|STARTED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220249|NCT05580003|100863764|FG016|STARTED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220250|NCT05580003|100863765|FG017|STARTED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220251|NCT05580003|100863766|FG018|STARTED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220252|NCT05580003|100863767|FG019|STARTED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220253|NCT05580003|100863768|FG020|STARTED|Part 5: Sequence AB: Period 1 (Day 1)||7||
48220254|NCT05580003|100863769|FG021|STARTED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220255|NCT05580003|100863770|FG022|STARTED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220256|NCT05580003|100863771|FG023|STARTED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220257|NCT05580003|100863772|FG024|STARTED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220258|NCT05580003|100863773|FG025|STARTED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220259|NCT05580003|100863774|FG026|STARTED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220260|NCT05580003|100863775|FG027|STARTED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220261|NCT05580003|100863748|FG000|COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220262|NCT05580003|100863749|FG001|COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220263|NCT05580003|100863750|FG002|COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220264|NCT05580003|100863751|FG003|COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220265|NCT05580003|100863752|FG004|COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220266|NCT05580003|100863753|FG005|COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220267|NCT05580003|100863754|FG006|COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220268|NCT05580003|100863755|FG007|COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220269|NCT05580003|100863756|FG008|COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220270|NCT05580003|100863757|FG009|COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220271|NCT05580003|100863758|FG010|COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220272|NCT05580003|100863759|FG011|COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220273|NCT05580003|100863760|FG012|COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220274|NCT05580003|100863761|FG013|COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220275|NCT05580003|100863762|FG014|COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220276|NCT05580003|100863763|FG015|COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220277|NCT05580003|100863764|FG016|COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220278|NCT05580003|100863765|FG017|COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220279|NCT05580003|100863766|FG018|COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220280|NCT05580003|100863767|FG019|COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220281|NCT05580003|100863768|FG020|COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||6||
48220282|NCT05580003|100863769|FG021|COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220283|NCT05580003|100863770|FG022|COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220284|NCT05580003|100863771|FG023|COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220285|NCT05580003|100863772|FG024|COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220286|NCT05580003|100863773|FG025|COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220287|NCT05580003|100863774|FG026|COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220288|NCT05580003|100863775|FG027|COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220289|NCT05580003|100863748|FG000|NOT COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220290|NCT05580003|100863749|FG001|NOT COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220291|NCT05580003|100863750|FG002|NOT COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220292|NCT05580003|100863751|FG003|NOT COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220293|NCT05580003|100863752|FG004|NOT COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220294|NCT05580003|100863753|FG005|NOT COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220295|NCT05580003|100863754|FG006|NOT COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220296|NCT05580003|100863755|FG007|NOT COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220297|NCT05580003|100863756|FG008|NOT COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220298|NCT05580003|100863757|FG009|NOT COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220299|NCT05580003|100863758|FG010|NOT COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220300|NCT05580003|100863759|FG011|NOT COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220301|NCT05580003|100863760|FG012|NOT COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220302|NCT05580003|100863761|FG013|NOT COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220303|NCT05580003|100863762|FG014|NOT COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220304|NCT05580003|100863763|FG015|NOT COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220305|NCT05580003|100863764|FG016|NOT COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220306|NCT05580003|100863765|FG017|NOT COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220307|NCT05580003|100863766|FG018|NOT COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220308|NCT05580003|100863767|FG019|NOT COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220309|NCT05580003|100863768|FG020|NOT COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||1||
48220310|NCT05580003|100863769|FG021|NOT COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220311|NCT05580003|100863770|FG022|NOT COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220312|NCT05580003|100863771|FG023|NOT COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220313|NCT05580003|100863772|FG024|NOT COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220314|NCT05580003|100863773|FG025|NOT COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220315|NCT05580003|100863774|FG026|NOT COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220316|NCT05580003|100863775|FG027|NOT COMPLETED|Part 5: Sequence AB: Period 1 (Day 1)||0||
48220317|NCT05580003|100863748|FG000|STARTED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220318|NCT05580003|100863749|FG001|STARTED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220319|NCT05580003|100863750|FG002|STARTED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220320|NCT05580003|100863751|FG003|STARTED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220321|NCT05580003|100863752|FG004|STARTED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220322|NCT05580003|100863753|FG005|STARTED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220323|NCT05580003|100863754|FG006|STARTED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220324|NCT05580003|100863755|FG007|STARTED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220325|NCT05580003|100863756|FG008|STARTED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220326|NCT05580003|100863757|FG009|STARTED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220327|NCT05580003|100863758|FG010|STARTED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220328|NCT05580003|100863759|FG011|STARTED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220329|NCT05580003|100863760|FG012|STARTED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220330|NCT05580003|100863761|FG013|STARTED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220331|NCT05580003|100863762|FG014|STARTED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220332|NCT05580003|100863763|FG015|STARTED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220333|NCT05580003|100863764|FG016|STARTED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220334|NCT05580003|100863765|FG017|STARTED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220335|NCT05580003|100863766|FG018|STARTED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220336|NCT05580003|100863767|FG019|STARTED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220337|NCT05580003|100863768|FG020|STARTED|Part 5:SequenceAB:Washout1(Upto 2 Days)||6||
48220338|NCT05580003|100863769|FG021|STARTED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220339|NCT05580003|100863770|FG022|STARTED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220340|NCT05580003|100863771|FG023|STARTED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220341|NCT05580003|100863772|FG024|STARTED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220342|NCT05580003|100863773|FG025|STARTED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220343|NCT05580003|100863774|FG026|STARTED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220344|NCT05580003|100863775|FG027|STARTED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220345|NCT05580003|100863748|FG000|COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220346|NCT05580003|100863749|FG001|COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220347|NCT05580003|100863750|FG002|COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220348|NCT05580003|100863751|FG003|COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220349|NCT05580003|100863752|FG004|COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220350|NCT05580003|100863753|FG005|COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220351|NCT05580003|100863754|FG006|COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220352|NCT05580003|100863755|FG007|COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220353|NCT05580003|100863756|FG008|COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220354|NCT05580003|100863757|FG009|COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220355|NCT05580003|100863758|FG010|COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220356|NCT05580003|100863759|FG011|COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220357|NCT05580003|100863760|FG012|COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220358|NCT05580003|100863761|FG013|COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220359|NCT05580003|100863762|FG014|COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220360|NCT05580003|100863763|FG015|COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220361|NCT05580003|100863764|FG016|COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220362|NCT05580003|100863765|FG017|COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220363|NCT05580003|100863766|FG018|COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220364|NCT05580003|100863767|FG019|COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220365|NCT05580003|100863768|FG020|COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||6||
48220366|NCT05580003|100863769|FG021|COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220367|NCT05580003|100863770|FG022|COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220368|NCT05580003|100863771|FG023|COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220369|NCT05580003|100863772|FG024|COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220370|NCT05580003|100863773|FG025|COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220371|NCT05580003|100863774|FG026|COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220372|NCT05580003|100863775|FG027|COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220373|NCT05580003|100863748|FG000|NOT COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220374|NCT05580003|100863749|FG001|NOT COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220375|NCT05580003|100863750|FG002|NOT COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220376|NCT05580003|100863751|FG003|NOT COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220377|NCT05580003|100863752|FG004|NOT COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220378|NCT05580003|100863753|FG005|NOT COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220379|NCT05580003|100863754|FG006|NOT COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220380|NCT05580003|100863755|FG007|NOT COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220381|NCT05580003|100863756|FG008|NOT COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220382|NCT05580003|100863757|FG009|NOT COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220383|NCT05580003|100863758|FG010|NOT COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220384|NCT05580003|100863759|FG011|NOT COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220385|NCT05580003|100863760|FG012|NOT COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220386|NCT05580003|100863761|FG013|NOT COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220387|NCT05580003|100863762|FG014|NOT COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220388|NCT05580003|100863763|FG015|NOT COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220389|NCT05580003|100863764|FG016|NOT COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220390|NCT05580003|100863765|FG017|NOT COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220391|NCT05580003|100863766|FG018|NOT COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220392|NCT05580003|100863767|FG019|NOT COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220393|NCT05580003|100863768|FG020|NOT COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48667764|NCT01772654|101970676|FG000|STARTED|Overall Study||2||
48220394|NCT05580003|100863769|FG021|NOT COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220395|NCT05580003|100863770|FG022|NOT COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220396|NCT05580003|100863771|FG023|NOT COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220397|NCT05580003|100863772|FG024|NOT COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220398|NCT05580003|100863773|FG025|NOT COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220399|NCT05580003|100863774|FG026|NOT COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220400|NCT05580003|100863775|FG027|NOT COMPLETED|Part 5:SequenceAB:Washout1(Upto 2 Days)||0||
48220401|NCT05580003|100863748|FG000|STARTED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220402|NCT05580003|100863749|FG001|STARTED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220403|NCT05580003|100863750|FG002|STARTED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220404|NCT05580003|100863751|FG003|STARTED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220405|NCT05580003|100863752|FG004|STARTED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220406|NCT05580003|100863753|FG005|STARTED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220407|NCT05580003|100863754|FG006|STARTED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220408|NCT05580003|100863755|FG007|STARTED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220409|NCT05580003|100863756|FG008|STARTED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220410|NCT05580003|100863757|FG009|STARTED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220411|NCT05580003|100863758|FG010|STARTED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220412|NCT05580003|100863759|FG011|STARTED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220413|NCT05580003|100863760|FG012|STARTED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220414|NCT05580003|100863761|FG013|STARTED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220415|NCT05580003|100863762|FG014|STARTED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220416|NCT05580003|100863763|FG015|STARTED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220417|NCT05580003|100863764|FG016|STARTED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220418|NCT05580003|100863765|FG017|STARTED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220419|NCT05580003|100863766|FG018|STARTED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220420|NCT05580003|100863767|FG019|STARTED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220421|NCT05580003|100863768|FG020|STARTED|Part5:SequenceAB:Period2(up to 10 Days)||6||
48220422|NCT05580003|100863769|FG021|STARTED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220423|NCT05580003|100863770|FG022|STARTED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220424|NCT05580003|100863771|FG023|STARTED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220425|NCT05580003|100863772|FG024|STARTED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220426|NCT05580003|100863773|FG025|STARTED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220427|NCT05580003|100863774|FG026|STARTED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220428|NCT05580003|100863775|FG027|STARTED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220429|NCT05580003|100863748|FG000|COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220430|NCT05580003|100863749|FG001|COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220431|NCT05580003|100863750|FG002|COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220432|NCT05580003|100863751|FG003|COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220433|NCT05580003|100863752|FG004|COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220434|NCT05580003|100863753|FG005|COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220435|NCT05580003|100863754|FG006|COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220436|NCT05580003|100863755|FG007|COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220437|NCT05580003|100863756|FG008|COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220438|NCT05580003|100863757|FG009|COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220439|NCT05580003|100863758|FG010|COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220440|NCT05580003|100863759|FG011|COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220441|NCT05580003|100863760|FG012|COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220442|NCT05580003|100863761|FG013|COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220443|NCT05580003|100863762|FG014|COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220444|NCT05580003|100863763|FG015|COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220445|NCT05580003|100863764|FG016|COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220446|NCT05580003|100863765|FG017|COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220447|NCT05580003|100863766|FG018|COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220448|NCT05580003|100863767|FG019|COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220449|NCT05580003|100863768|FG020|COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||6||
48220450|NCT05580003|100863769|FG021|COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220451|NCT05580003|100863770|FG022|COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220452|NCT05580003|100863771|FG023|COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220453|NCT05580003|100863772|FG024|COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220454|NCT05580003|100863773|FG025|COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220455|NCT05580003|100863774|FG026|COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220456|NCT05580003|100863775|FG027|COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220457|NCT05580003|100863748|FG000|NOT COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220458|NCT05580003|100863749|FG001|NOT COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220459|NCT05580003|100863750|FG002|NOT COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220460|NCT05580003|100863751|FG003|NOT COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220461|NCT05580003|100863752|FG004|NOT COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48667765|NCT01772654|101970677|FG001|STARTED|Overall Study||15||
48667766|NCT01772654|101970676|FG000|COMPLETED|Overall Study||2||
48220462|NCT05580003|100863753|FG005|NOT COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220463|NCT05580003|100863754|FG006|NOT COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220464|NCT05580003|100863755|FG007|NOT COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220465|NCT05580003|100863756|FG008|NOT COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220466|NCT05580003|100863757|FG009|NOT COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220467|NCT05580003|100863758|FG010|NOT COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220468|NCT05580003|100863759|FG011|NOT COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220469|NCT05580003|100863760|FG012|NOT COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220470|NCT05580003|100863761|FG013|NOT COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220471|NCT05580003|100863762|FG014|NOT COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220472|NCT05580003|100863763|FG015|NOT COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220473|NCT05580003|100863764|FG016|NOT COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220474|NCT05580003|100863765|FG017|NOT COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220475|NCT05580003|100863766|FG018|NOT COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220476|NCT05580003|100863767|FG019|NOT COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220477|NCT05580003|100863768|FG020|NOT COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220478|NCT05580003|100863769|FG021|NOT COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220479|NCT05580003|100863770|FG022|NOT COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220480|NCT05580003|100863771|FG023|NOT COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220481|NCT05580003|100863772|FG024|NOT COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220482|NCT05580003|100863773|FG025|NOT COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220483|NCT05580003|100863774|FG026|NOT COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220484|NCT05580003|100863775|FG027|NOT COMPLETED|Part5:SequenceAB:Period2(up to 10 Days)||0||
48220485|NCT05580003|100863748|FG000|STARTED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220486|NCT05580003|100863749|FG001|STARTED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220487|NCT05580003|100863750|FG002|STARTED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220488|NCT05580003|100863751|FG003|STARTED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220489|NCT05580003|100863752|FG004|STARTED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220490|NCT05580003|100863753|FG005|STARTED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220491|NCT05580003|100863754|FG006|STARTED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220492|NCT05580003|100863755|FG007|STARTED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220493|NCT05580003|100863756|FG008|STARTED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220494|NCT05580003|100863757|FG009|STARTED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220495|NCT05580003|100863758|FG010|STARTED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220496|NCT05580003|100863759|FG011|STARTED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220497|NCT05580003|100863760|FG012|STARTED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220498|NCT05580003|100863761|FG013|STARTED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220499|NCT05580003|100863762|FG014|STARTED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220500|NCT05580003|100863763|FG015|STARTED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220501|NCT05580003|100863764|FG016|STARTED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220502|NCT05580003|100863765|FG017|STARTED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220503|NCT05580003|100863766|FG018|STARTED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220504|NCT05580003|100863767|FG019|STARTED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220505|NCT05580003|100863768|FG020|STARTED|Part5:Sequence AB:Washout2(up to 7 Days)||6||
48220506|NCT05580003|100863769|FG021|STARTED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220507|NCT05580003|100863770|FG022|STARTED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220508|NCT05580003|100863771|FG023|STARTED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220509|NCT05580003|100863772|FG024|STARTED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220510|NCT05580003|100863773|FG025|STARTED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220511|NCT05580003|100863774|FG026|STARTED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220512|NCT05580003|100863775|FG027|STARTED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220513|NCT05580003|100863748|FG000|COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220514|NCT05580003|100863749|FG001|COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220515|NCT05580003|100863750|FG002|COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220516|NCT05580003|100863751|FG003|COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220517|NCT05580003|100863752|FG004|COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220518|NCT05580003|100863753|FG005|COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220519|NCT05580003|100863754|FG006|COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220520|NCT05580003|100863755|FG007|COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220521|NCT05580003|100863756|FG008|COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220522|NCT05580003|100863757|FG009|COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220523|NCT05580003|100863758|FG010|COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220524|NCT05580003|100863759|FG011|COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220525|NCT05580003|100863760|FG012|COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220526|NCT05580003|100863761|FG013|COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220527|NCT05580003|100863762|FG014|COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220528|NCT05580003|100863763|FG015|COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220529|NCT05580003|100863764|FG016|COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220530|NCT05580003|100863765|FG017|COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220531|NCT05580003|100863766|FG018|COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220532|NCT05580003|100863767|FG019|COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220533|NCT05580003|100863768|FG020|COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||6||
48220534|NCT05580003|100863769|FG021|COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220535|NCT05580003|100863770|FG022|COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220536|NCT05580003|100863771|FG023|COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220537|NCT05580003|100863772|FG024|COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220538|NCT05580003|100863773|FG025|COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220539|NCT05580003|100863774|FG026|COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220540|NCT05580003|100863775|FG027|COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220541|NCT05580003|100863748|FG000|NOT COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220542|NCT05580003|100863749|FG001|NOT COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220543|NCT05580003|100863750|FG002|NOT COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220544|NCT05580003|100863751|FG003|NOT COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220545|NCT05580003|100863752|FG004|NOT COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48667767|NCT01772654|101970677|FG001|COMPLETED|Overall Study||15||
48667768|NCT01772654|101970676|FG000|NOT COMPLETED|Overall Study||0||
48667769|NCT01772654|101970677|FG001|NOT COMPLETED|Overall Study||0||
48667770|NCT00601731|101970678|FG000|STARTED|Overall Study||143||
48667771|NCT00601731|101970679|FG001|STARTED|Overall Study||43||
48667772|NCT00601731|101970680|FG002|STARTED|Overall Study||166||
48667773|NCT00601731|101970681|FG003|STARTED|Overall Study||30||
48667774|NCT00601731|101970678|FG000|COMPLETED|Overall Study||120||
48667775|NCT00601731|101970679|FG001|COMPLETED|Overall Study||43||
48667776|NCT00601731|101970680|FG002|COMPLETED|Overall Study||151||
48667777|NCT00601731|101970681|FG003|COMPLETED|Overall Study||29||
48667778|NCT00601731|101970678|FG000|NOT COMPLETED|Overall Study||23||
48667779|NCT00601731|101970679|FG001|NOT COMPLETED|Overall Study||0||
48667780|NCT00601731|101970680|FG002|NOT COMPLETED|Overall Study||15||
48667781|NCT00601731|101970681|FG003|NOT COMPLETED|Overall Study||1||
48667782|NCT02935036|101970682|FG000|STARTED|Overall Study||147||
48667783|NCT02935036|101970683|FG001|STARTED|Overall Study||147||
48667784|NCT02935036|101970682|FG000|COMPLETED|Overall Study||137||
48667785|NCT02935036|101970683|FG001|COMPLETED|Overall Study||136||
48667786|NCT02935036|101970682|FG000|NOT COMPLETED|Overall Study||10||
48667787|NCT02935036|101970683|FG001|NOT COMPLETED|Overall Study||11||
48667788|NCT01561469|101970684|FG000|STARTED|Overall Study||101||
48667789|NCT01561469|101970685|FG001|STARTED|Overall Study||87||
48667790|NCT01561469|101970684|FG000|COMPLETED|Overall Study||101||
48667791|NCT01561469|101970685|FG001|COMPLETED|Overall Study||87||
48667792|NCT01561469|101970684|FG000|NOT COMPLETED|Overall Study||0||
48667793|NCT01561469|101970685|FG001|NOT COMPLETED|Overall Study||0||
48667794|NCT00659425|101970686|FG000|STARTED|Overall Study||1||
48667795|NCT00659425|101970687|FG001|STARTED|Overall Study||1||
48667796|NCT00659425|101970688|FG002|STARTED|Overall Study||1||
48667797|NCT00659425|101970689|FG003|STARTED|Overall Study||4||
48667798|NCT00659425|101970690|FG004|STARTED|Overall Study||4||
48667799|NCT00659425|101970691|FG005|STARTED|Overall Study||5||
48667800|NCT00659425|101970692|FG006|STARTED|Overall Study||8||
48667801|NCT00659425|101970693|FG007|STARTED|Overall Study||11||
48667802|NCT00659425|101970694|FG008|STARTED|Overall Study||6||
48667803|NCT00659425|101970695|FG009|STARTED|Overall Study||14||
48667804|NCT00659425|101970686|FG000|COMPLETED|Overall Study||0||
48667805|NCT00659425|101970687|FG001|COMPLETED|Overall Study||0||
48667806|NCT00659425|101970688|FG002|COMPLETED|Overall Study||0||
48667807|NCT00659425|101970689|FG003|COMPLETED|Overall Study||0||
48667808|NCT00659425|101970690|FG004|COMPLETED|Overall Study||0||
48667809|NCT00659425|101970691|FG005|COMPLETED|Overall Study||1||
48667810|NCT00659425|101970692|FG006|COMPLETED|Overall Study||0||
48667811|NCT00659425|101970693|FG007|COMPLETED|Overall Study||0||
48667812|NCT00659425|101970694|FG008|COMPLETED|Overall Study||0||
48667813|NCT00659425|101970695|FG009|COMPLETED|Overall Study||1||
48667814|NCT00659425|101970686|FG000|NOT COMPLETED|Overall Study||1||
48667815|NCT00659425|101970687|FG001|NOT COMPLETED|Overall Study||1||
48667816|NCT00659425|101970688|FG002|NOT COMPLETED|Overall Study||1||
48667817|NCT00659425|101970689|FG003|NOT COMPLETED|Overall Study||4||
48667818|NCT00659425|101970690|FG004|NOT COMPLETED|Overall Study||4||
48667819|NCT00659425|101970691|FG005|NOT COMPLETED|Overall Study||4||
48667820|NCT00659425|101970692|FG006|NOT COMPLETED|Overall Study||8||
48220546|NCT05580003|100863753|FG005|NOT COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220547|NCT05580003|100863754|FG006|NOT COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220548|NCT05580003|100863755|FG007|NOT COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48667821|NCT00659425|101970693|FG007|NOT COMPLETED|Overall Study||11||
48667822|NCT00659425|101970694|FG008|NOT COMPLETED|Overall Study||6||
48667823|NCT00659425|101970695|FG009|NOT COMPLETED|Overall Study||13||
48667824|NCT03446690|101970696|FG000|STARTED|Overall Study||33||
48667825|NCT03446690|101970697|FG001|STARTED|Overall Study||29||
48667826|NCT03446690|101970696|FG000|COMPLETED|Overall Study||26||
48667827|NCT03446690|101970697|FG001|COMPLETED|Overall Study||29||
48667828|NCT03446690|101970696|FG000|NOT COMPLETED|Overall Study||7||
48667829|NCT03446690|101970697|FG001|NOT COMPLETED|Overall Study||0||
48667830|NCT01704157|101970698|FG000|STARTED|Overall Study||33||
48667831|NCT01704157|101970698|FG000|COMPLETED|Overall Study||33||
48667832|NCT01704157|101970698|FG000|NOT COMPLETED|Overall Study||0||
48667833|NCT02593630|101970699|FG000|STARTED|Overall Study||54||
48667834|NCT02593630|101970699|FG000|COMPLETED|Overall Study||53||
48667835|NCT02593630|101970699|FG000|NOT COMPLETED|Overall Study||1||
48667836|NCT00160563|101970700|FG000|STARTED|Overall Study||59||
48667837|NCT00160563|101970701|FG001|STARTED|Overall Study||47||
48667838|NCT00160563|101970702|FG002|STARTED|Overall Study||101||
48667839|NCT00160563|101970700|FG000|COMPLETED|Overall Study||8||
48667840|NCT00160563|101970701|FG001|COMPLETED|Overall Study||2||
48667841|NCT00160563|101970702|FG002|COMPLETED|Overall Study||11||
48667842|NCT00160563|101970700|FG000|NOT COMPLETED|Overall Study||51||
48667843|NCT00160563|101970701|FG001|NOT COMPLETED|Overall Study||45||
48667844|NCT00160563|101970702|FG002|NOT COMPLETED|Overall Study||90||
48667845|NCT04023045|101970703|FG000|STARTED|Habitual Prosthesis Condition||3||
48667846|NCT04023045|101970704|FG001|STARTED|Habitual Prosthesis Condition||0||
48667847|NCT04023045|101970705|FG002|STARTED|Habitual Prosthesis Condition||0||
48667848|NCT04023045|101970703|FG000|COMPLETED|Habitual Prosthesis Condition||3||
48667849|NCT04023045|101970704|FG001|COMPLETED|Habitual Prosthesis Condition||0||
48667850|NCT04023045|101970705|FG002|COMPLETED|Habitual Prosthesis Condition||0||
48667851|NCT04023045|101970703|FG000|NOT COMPLETED|Habitual Prosthesis Condition||0||
48667852|NCT04023045|101970704|FG001|NOT COMPLETED|Habitual Prosthesis Condition||0||
48667853|NCT04023045|101970705|FG002|NOT COMPLETED|Habitual Prosthesis Condition||0||
48667854|NCT04023045|101970703|FG000|STARTED|Assist-Knee (Settings 1) Condition||0||
48667855|NCT04023045|101970704|FG001|STARTED|Assist-Knee (Settings 1) Condition||3||
48667856|NCT04023045|101970705|FG002|STARTED|Assist-Knee (Settings 1) Condition||0||
48667857|NCT04023045|101970703|FG000|COMPLETED|Assist-Knee (Settings 1) Condition||0||
48667858|NCT04023045|101970704|FG001|COMPLETED|Assist-Knee (Settings 1) Condition||3||
48667859|NCT04023045|101970705|FG002|COMPLETED|Assist-Knee (Settings 1) Condition||0||
48667860|NCT04023045|101970703|FG000|NOT COMPLETED|Assist-Knee (Settings 1) Condition||0||
48667861|NCT04023045|101970704|FG001|NOT COMPLETED|Assist-Knee (Settings 1) Condition||0||
48667862|NCT04023045|101970705|FG002|NOT COMPLETED|Assist-Knee (Settings 1) Condition||0||
48667863|NCT04023045|101970703|FG000|STARTED|Assist-Knee (Settings 2) Condition||0||
48667864|NCT04023045|101970704|FG001|STARTED|Assist-Knee (Settings 2) Condition||0||
48667865|NCT04023045|101970705|FG002|STARTED|Assist-Knee (Settings 2) Condition||3||
48667866|NCT04023045|101970703|FG000|COMPLETED|Assist-Knee (Settings 2) Condition||0||
48667867|NCT04023045|101970704|FG001|COMPLETED|Assist-Knee (Settings 2) Condition||0||
48667868|NCT04023045|101970705|FG002|COMPLETED|Assist-Knee (Settings 2) Condition||3||
48667869|NCT04023045|101970703|FG000|NOT COMPLETED|Assist-Knee (Settings 2) Condition||0||
48667870|NCT04023045|101970704|FG001|NOT COMPLETED|Assist-Knee (Settings 2) Condition||0||
48667871|NCT04023045|101970705|FG002|NOT COMPLETED|Assist-Knee (Settings 2) Condition||0||
48667872|NCT05119582|101970706|FG000|STARTED|Overall Study||20||
48667873|NCT05119582|101970706|FG000|COMPLETED|Overall Study||20||
48667874|NCT05119582|101970706|FG000|NOT COMPLETED|Overall Study||0||
48667875|NCT02106429|101970707|FG000|STARTED|Overall Study||203||
48667876|NCT02106429|101970708|FG001|STARTED|Overall Study||43||
48667877|NCT02106429|101970707|FG000|COMPLETED|Overall Study||203||
48667878|NCT02106429|101970708|FG001|COMPLETED|Overall Study||43||
48667879|NCT02106429|101970707|FG000|NOT COMPLETED|Overall Study||0||
48667880|NCT02106429|101970708|FG001|NOT COMPLETED|Overall Study||0||
48667881|NCT04033640|101970709|FG000|STARTED|Overall Study||1736||
48667882|NCT04033640|101970710|FG001|STARTED|Overall Study||18||
48667883|NCT04033640|101970709|FG000|COMPLETED|Overall Study||1736||
48667884|NCT04033640|101970710|FG001|COMPLETED|Overall Study||18||
48667885|NCT04033640|101970709|FG000|NOT COMPLETED|Overall Study||0||
48667886|NCT04033640|101970710|FG001|NOT COMPLETED|Overall Study||0||
48667887|NCT00822094|101970711|FG000|STARTED|Overall Study||81||
48667888|NCT00822094|101970712|FG001|STARTED|Overall Study||45||
48667889|NCT00822094|101970711|FG000|COMPLETED|Overall Study||37||
48667890|NCT00822094|101970712|FG001|COMPLETED|Overall Study||20||
48667891|NCT00822094|101970711|FG000|NOT COMPLETED|Overall Study||44||
48667892|NCT00822094|101970712|FG001|NOT COMPLETED|Overall Study||25||
48667893|NCT00425555|101970713|FG000|STARTED|Overall Study||79||
48667894|NCT00425555|101970714|FG001|STARTED|Overall Study||60||
48667895|NCT00425555|101970713|FG000|COMPLETED|Overall Study||0||
48667896|NCT00425555|101970714|FG001|COMPLETED|Overall Study||0||
48667897|NCT00425555|101970713|FG000|NOT COMPLETED|Overall Study||79||
48667898|NCT00425555|101970714|FG001|NOT COMPLETED|Overall Study||60||
48667899|NCT01690273|101970715|FG000|STARTED|Overall Study||18||
48667900|NCT01690273|101970716|FG001|STARTED|Overall Study||17||
48667901|NCT01690273|101970717|FG002|STARTED|Overall Study||20||
48667902|NCT01690273|101970715|FG000|COMPLETED|Overall Study||18||
48667903|NCT01690273|101970716|FG001|COMPLETED|Overall Study||17||
48667904|NCT01690273|101970717|FG002|COMPLETED|Overall Study||20||
48667905|NCT01690273|101970715|FG000|NOT COMPLETED|Overall Study||0||
48667906|NCT01690273|101970716|FG001|NOT COMPLETED|Overall Study||0||
48220549|NCT05580003|100863756|FG008|NOT COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220550|NCT05580003|100863757|FG009|NOT COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220551|NCT05580003|100863758|FG010|NOT COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220552|NCT05580003|100863759|FG011|NOT COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220553|NCT05580003|100863760|FG012|NOT COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220554|NCT05580003|100863761|FG013|NOT COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220555|NCT05580003|100863762|FG014|NOT COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220556|NCT05580003|100863763|FG015|NOT COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220557|NCT05580003|100863764|FG016|NOT COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220558|NCT05580003|100863765|FG017|NOT COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220559|NCT05580003|100863766|FG018|NOT COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220560|NCT05580003|100863767|FG019|NOT COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220561|NCT05580003|100863768|FG020|NOT COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220562|NCT05580003|100863769|FG021|NOT COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220563|NCT05580003|100863770|FG022|NOT COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220564|NCT05580003|100863771|FG023|NOT COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220565|NCT05580003|100863772|FG024|NOT COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220566|NCT05580003|100863773|FG025|NOT COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220567|NCT05580003|100863774|FG026|NOT COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220568|NCT05580003|100863775|FG027|NOT COMPLETED|Part5:Sequence AB:Washout2(up to 7 Days)||0||
48220569|NCT05580003|100863748|FG000|STARTED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220570|NCT05580003|100863749|FG001|STARTED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220571|NCT05580003|100863750|FG002|STARTED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220572|NCT05580003|100863751|FG003|STARTED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220573|NCT05580003|100863752|FG004|STARTED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220574|NCT05580003|100863753|FG005|STARTED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220575|NCT05580003|100863754|FG006|STARTED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220576|NCT05580003|100863755|FG007|STARTED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220577|NCT05580003|100863756|FG008|STARTED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220578|NCT05580003|100863757|FG009|STARTED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220579|NCT05580003|100863758|FG010|STARTED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220580|NCT05580003|100863759|FG011|STARTED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220581|NCT05580003|100863760|FG012|STARTED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220582|NCT05580003|100863761|FG013|STARTED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220583|NCT05580003|100863762|FG014|STARTED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220584|NCT05580003|100863763|FG015|STARTED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220585|NCT05580003|100863764|FG016|STARTED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220586|NCT05580003|100863765|FG017|STARTED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220587|NCT05580003|100863766|FG018|STARTED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220588|NCT05580003|100863767|FG019|STARTED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220589|NCT05580003|100863768|FG020|STARTED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220590|NCT05580003|100863769|FG021|STARTED|Part5:Sequence BA:Period1(up to 10 Days)||7||
48220591|NCT05580003|100863770|FG022|STARTED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220592|NCT05580003|100863771|FG023|STARTED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220593|NCT05580003|100863772|FG024|STARTED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220594|NCT05580003|100863773|FG025|STARTED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220595|NCT05580003|100863774|FG026|STARTED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220596|NCT05580003|100863775|FG027|STARTED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220597|NCT05580003|100863748|FG000|COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220598|NCT05580003|100863749|FG001|COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220599|NCT05580003|100863750|FG002|COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220600|NCT05580003|100863751|FG003|COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220601|NCT05580003|100863752|FG004|COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220602|NCT05580003|100863753|FG005|COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220603|NCT05580003|100863754|FG006|COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220604|NCT05580003|100863755|FG007|COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220605|NCT05580003|100863756|FG008|COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220606|NCT05580003|100863757|FG009|COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220607|NCT05580003|100863758|FG010|COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220608|NCT05580003|100863759|FG011|COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220609|NCT05580003|100863760|FG012|COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220610|NCT05580003|100863761|FG013|COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220611|NCT05580003|100863762|FG014|COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220612|NCT05580003|100863763|FG015|COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220613|NCT05580003|100863764|FG016|COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220614|NCT05580003|100863765|FG017|COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220615|NCT05580003|100863766|FG018|COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220616|NCT05580003|100863767|FG019|COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220617|NCT05580003|100863768|FG020|COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220618|NCT05580003|100863769|FG021|COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||6||
48220619|NCT05580003|100863770|FG022|COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220620|NCT05580003|100863771|FG023|COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220621|NCT05580003|100863772|FG024|COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220622|NCT05580003|100863773|FG025|COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220623|NCT05580003|100863774|FG026|COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220624|NCT05580003|100863775|FG027|COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220625|NCT05580003|100863748|FG000|NOT COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220626|NCT05580003|100863749|FG001|NOT COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220627|NCT05580003|100863750|FG002|NOT COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220628|NCT05580003|100863751|FG003|NOT COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220629|NCT05580003|100863752|FG004|NOT COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220630|NCT05580003|100863753|FG005|NOT COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220631|NCT05580003|100863754|FG006|NOT COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220632|NCT05580003|100863755|FG007|NOT COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220633|NCT05580003|100863756|FG008|NOT COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220634|NCT05580003|100863757|FG009|NOT COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220635|NCT05580003|100863758|FG010|NOT COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220636|NCT05580003|100863759|FG011|NOT COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220637|NCT05580003|100863760|FG012|NOT COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220638|NCT05580003|100863761|FG013|NOT COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220639|NCT05580003|100863762|FG014|NOT COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220640|NCT05580003|100863763|FG015|NOT COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220641|NCT05580003|100863764|FG016|NOT COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220642|NCT05580003|100863765|FG017|NOT COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220643|NCT05580003|100863766|FG018|NOT COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220644|NCT05580003|100863767|FG019|NOT COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220645|NCT05580003|100863768|FG020|NOT COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220646|NCT05580003|100863769|FG021|NOT COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||1||
48220647|NCT05580003|100863770|FG022|NOT COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220648|NCT05580003|100863771|FG023|NOT COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220649|NCT05580003|100863772|FG024|NOT COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220650|NCT05580003|100863773|FG025|NOT COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220651|NCT05580003|100863774|FG026|NOT COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220652|NCT05580003|100863775|FG027|NOT COMPLETED|Part5:Sequence BA:Period1(up to 10 Days)||0||
48220653|NCT05580003|100863748|FG000|STARTED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220654|NCT05580003|100863749|FG001|STARTED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220655|NCT05580003|100863750|FG002|STARTED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220656|NCT05580003|100863751|FG003|STARTED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220657|NCT05580003|100863752|FG004|STARTED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220658|NCT05580003|100863753|FG005|STARTED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220659|NCT05580003|100863754|FG006|STARTED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220660|NCT05580003|100863755|FG007|STARTED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220661|NCT05580003|100863756|FG008|STARTED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220662|NCT05580003|100863757|FG009|STARTED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220663|NCT05580003|100863758|FG010|STARTED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220664|NCT05580003|100863759|FG011|STARTED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220665|NCT05580003|100863760|FG012|STARTED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220666|NCT05580003|100863761|FG013|STARTED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220667|NCT05580003|100863762|FG014|STARTED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220668|NCT05580003|100863763|FG015|STARTED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220669|NCT05580003|100863764|FG016|STARTED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220670|NCT05580003|100863765|FG017|STARTED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220671|NCT05580003|100863766|FG018|STARTED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220672|NCT05580003|100863767|FG019|STARTED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220673|NCT05580003|100863768|FG020|STARTED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220674|NCT05580003|100863769|FG021|STARTED|Part5:Sequence BA:Washout1(up to 7 Days)||6||
48220675|NCT05580003|100863770|FG022|STARTED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220676|NCT05580003|100863771|FG023|STARTED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220677|NCT05580003|100863772|FG024|STARTED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220678|NCT05580003|100863773|FG025|STARTED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220679|NCT05580003|100863774|FG026|STARTED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220680|NCT05580003|100863775|FG027|STARTED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220681|NCT05580003|100863748|FG000|COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48667907|NCT01690273|101970717|FG002|NOT COMPLETED|Overall Study||0||
48667908|NCT02014376|101970718|FG000|STARTED|Overall Study||15||
48220682|NCT05580003|100863749|FG001|COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220683|NCT05580003|100863750|FG002|COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220684|NCT05580003|100863751|FG003|COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220685|NCT05580003|100863752|FG004|COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220686|NCT05580003|100863753|FG005|COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220687|NCT05580003|100863754|FG006|COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220688|NCT05580003|100863755|FG007|COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220689|NCT05580003|100863756|FG008|COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220690|NCT05580003|100863757|FG009|COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220691|NCT05580003|100863758|FG010|COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220692|NCT05580003|100863759|FG011|COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220693|NCT05580003|100863760|FG012|COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220694|NCT05580003|100863761|FG013|COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220695|NCT05580003|100863762|FG014|COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220696|NCT05580003|100863763|FG015|COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220697|NCT05580003|100863764|FG016|COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220698|NCT05580003|100863765|FG017|COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220699|NCT05580003|100863766|FG018|COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220700|NCT05580003|100863767|FG019|COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220701|NCT05580003|100863768|FG020|COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220702|NCT05580003|100863769|FG021|COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||6||
48220703|NCT05580003|100863770|FG022|COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220704|NCT05580003|100863771|FG023|COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220705|NCT05580003|100863772|FG024|COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220706|NCT05580003|100863773|FG025|COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220707|NCT05580003|100863774|FG026|COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220708|NCT05580003|100863775|FG027|COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220709|NCT05580003|100863748|FG000|NOT COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220710|NCT05580003|100863749|FG001|NOT COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220711|NCT05580003|100863750|FG002|NOT COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220712|NCT05580003|100863751|FG003|NOT COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220713|NCT05580003|100863752|FG004|NOT COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220714|NCT05580003|100863753|FG005|NOT COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220715|NCT05580003|100863754|FG006|NOT COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220716|NCT05580003|100863755|FG007|NOT COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220717|NCT05580003|100863756|FG008|NOT COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220718|NCT05580003|100863757|FG009|NOT COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220719|NCT05580003|100863758|FG010|NOT COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220720|NCT05580003|100863759|FG011|NOT COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220721|NCT05580003|100863760|FG012|NOT COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220722|NCT05580003|100863761|FG013|NOT COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220723|NCT05580003|100863762|FG014|NOT COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220724|NCT05580003|100863763|FG015|NOT COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220725|NCT05580003|100863764|FG016|NOT COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220726|NCT05580003|100863765|FG017|NOT COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220727|NCT05580003|100863766|FG018|NOT COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220728|NCT05580003|100863767|FG019|NOT COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220729|NCT05580003|100863768|FG020|NOT COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220730|NCT05580003|100863769|FG021|NOT COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220731|NCT05580003|100863770|FG022|NOT COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220732|NCT05580003|100863771|FG023|NOT COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220733|NCT05580003|100863772|FG024|NOT COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220734|NCT05580003|100863773|FG025|NOT COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220735|NCT05580003|100863774|FG026|NOT COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220736|NCT05580003|100863775|FG027|NOT COMPLETED|Part5:Sequence BA:Washout1(up to 7 Days)||0||
48220737|NCT05580003|100863748|FG000|STARTED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220738|NCT05580003|100863749|FG001|STARTED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220739|NCT05580003|100863750|FG002|STARTED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220740|NCT05580003|100863751|FG003|STARTED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220741|NCT05580003|100863752|FG004|STARTED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220742|NCT05580003|100863753|FG005|STARTED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220743|NCT05580003|100863754|FG006|STARTED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220744|NCT05580003|100863755|FG007|STARTED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220745|NCT05580003|100863756|FG008|STARTED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220746|NCT05580003|100863757|FG009|STARTED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48667909|NCT02014376|101970719|FG001|STARTED|Overall Study||16||
48667910|NCT02014376|101970720|FG002|STARTED|Overall Study||17||
48220747|NCT05580003|100863758|FG010|STARTED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220748|NCT05580003|100863759|FG011|STARTED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220749|NCT05580003|100863760|FG012|STARTED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220750|NCT05580003|100863761|FG013|STARTED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220751|NCT05580003|100863762|FG014|STARTED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220752|NCT05580003|100863763|FG015|STARTED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220753|NCT05580003|100863764|FG016|STARTED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220754|NCT05580003|100863765|FG017|STARTED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220755|NCT05580003|100863766|FG018|STARTED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220756|NCT05580003|100863767|FG019|STARTED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220757|NCT05580003|100863768|FG020|STARTED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220758|NCT05580003|100863769|FG021|STARTED|Part 5: Sequence BA: Period 2 (Day 1)||6||
48220759|NCT05580003|100863770|FG022|STARTED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220760|NCT05580003|100863771|FG023|STARTED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220761|NCT05580003|100863772|FG024|STARTED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220762|NCT05580003|100863773|FG025|STARTED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220763|NCT05580003|100863774|FG026|STARTED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220764|NCT05580003|100863775|FG027|STARTED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220765|NCT05580003|100863748|FG000|COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220766|NCT05580003|100863749|FG001|COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220767|NCT05580003|100863750|FG002|COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220768|NCT05580003|100863751|FG003|COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220769|NCT05580003|100863752|FG004|COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220770|NCT05580003|100863753|FG005|COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220771|NCT05580003|100863754|FG006|COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220772|NCT05580003|100863755|FG007|COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220773|NCT05580003|100863756|FG008|COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220774|NCT05580003|100863757|FG009|COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220775|NCT05580003|100863758|FG010|COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220776|NCT05580003|100863759|FG011|COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220777|NCT05580003|100863760|FG012|COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220778|NCT05580003|100863761|FG013|COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220779|NCT05580003|100863762|FG014|COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220780|NCT05580003|100863763|FG015|COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220781|NCT05580003|100863764|FG016|COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220782|NCT05580003|100863765|FG017|COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220783|NCT05580003|100863766|FG018|COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220784|NCT05580003|100863767|FG019|COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220785|NCT05580003|100863768|FG020|COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220786|NCT05580003|100863769|FG021|COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||6||
48220787|NCT05580003|100863770|FG022|COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220788|NCT05580003|100863771|FG023|COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220789|NCT05580003|100863772|FG024|COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220790|NCT05580003|100863773|FG025|COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220791|NCT05580003|100863774|FG026|COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220792|NCT05580003|100863775|FG027|COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220793|NCT05580003|100863748|FG000|NOT COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220794|NCT05580003|100863749|FG001|NOT COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220795|NCT05580003|100863750|FG002|NOT COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220796|NCT05580003|100863751|FG003|NOT COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220797|NCT05580003|100863752|FG004|NOT COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220798|NCT05580003|100863753|FG005|NOT COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220799|NCT05580003|100863754|FG006|NOT COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220800|NCT05580003|100863755|FG007|NOT COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220801|NCT05580003|100863756|FG008|NOT COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220802|NCT05580003|100863757|FG009|NOT COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220803|NCT05580003|100863758|FG010|NOT COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220804|NCT05580003|100863759|FG011|NOT COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220805|NCT05580003|100863760|FG012|NOT COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220806|NCT05580003|100863761|FG013|NOT COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220807|NCT05580003|100863762|FG014|NOT COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220808|NCT05580003|100863763|FG015|NOT COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220809|NCT05580003|100863764|FG016|NOT COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220810|NCT05580003|100863765|FG017|NOT COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220811|NCT05580003|100863766|FG018|NOT COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220812|NCT05580003|100863767|FG019|NOT COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220813|NCT05580003|100863768|FG020|NOT COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220814|NCT05580003|100863769|FG021|NOT COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220815|NCT05580003|100863770|FG022|NOT COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220816|NCT05580003|100863771|FG023|NOT COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220817|NCT05580003|100863772|FG024|NOT COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220818|NCT05580003|100863773|FG025|NOT COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220819|NCT05580003|100863774|FG026|NOT COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220820|NCT05580003|100863775|FG027|NOT COMPLETED|Part 5: Sequence BA: Period 2 (Day 1)||0||
48220821|NCT05580003|100863748|FG000|STARTED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220822|NCT05580003|100863749|FG001|STARTED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220823|NCT05580003|100863750|FG002|STARTED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220824|NCT05580003|100863751|FG003|STARTED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220825|NCT05580003|100863752|FG004|STARTED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220826|NCT05580003|100863753|FG005|STARTED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220827|NCT05580003|100863754|FG006|STARTED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220828|NCT05580003|100863755|FG007|STARTED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220829|NCT05580003|100863756|FG008|STARTED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220830|NCT05580003|100863757|FG009|STARTED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220831|NCT05580003|100863758|FG010|STARTED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220832|NCT05580003|100863759|FG011|STARTED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220833|NCT05580003|100863760|FG012|STARTED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220834|NCT05580003|100863761|FG013|STARTED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220835|NCT05580003|100863762|FG014|STARTED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220836|NCT05580003|100863763|FG015|STARTED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220837|NCT05580003|100863764|FG016|STARTED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220838|NCT05580003|100863765|FG017|STARTED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220839|NCT05580003|100863766|FG018|STARTED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220840|NCT05580003|100863767|FG019|STARTED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220841|NCT05580003|100863768|FG020|STARTED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220842|NCT05580003|100863769|FG021|STARTED|Part5:Sequence BA:Washout2(up to 2 Days)||6||
48220843|NCT05580003|100863770|FG022|STARTED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220844|NCT05580003|100863771|FG023|STARTED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220845|NCT05580003|100863772|FG024|STARTED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220846|NCT05580003|100863773|FG025|STARTED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220847|NCT05580003|100863774|FG026|STARTED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220848|NCT05580003|100863775|FG027|STARTED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220849|NCT05580003|100863748|FG000|COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220850|NCT05580003|100863749|FG001|COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220851|NCT05580003|100863750|FG002|COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220852|NCT05580003|100863751|FG003|COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220853|NCT05580003|100863752|FG004|COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220854|NCT05580003|100863753|FG005|COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220855|NCT05580003|100863754|FG006|COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220856|NCT05580003|100863755|FG007|COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220857|NCT05580003|100863756|FG008|COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220858|NCT05580003|100863757|FG009|COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220859|NCT05580003|100863758|FG010|COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220860|NCT05580003|100863759|FG011|COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220861|NCT05580003|100863760|FG012|COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220862|NCT05580003|100863761|FG013|COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220863|NCT05580003|100863762|FG014|COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220864|NCT05580003|100863763|FG015|COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220865|NCT05580003|100863764|FG016|COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220866|NCT05580003|100863765|FG017|COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220867|NCT05580003|100863766|FG018|COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220868|NCT05580003|100863767|FG019|COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220869|NCT05580003|100863768|FG020|COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220870|NCT05580003|100863769|FG021|COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||6||
48220871|NCT05580003|100863770|FG022|COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220872|NCT05580003|100863771|FG023|COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220873|NCT05580003|100863772|FG024|COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220874|NCT05580003|100863773|FG025|COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220875|NCT05580003|100863774|FG026|COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220876|NCT05580003|100863775|FG027|COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220877|NCT05580003|100863748|FG000|NOT COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220878|NCT05580003|100863749|FG001|NOT COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220879|NCT05580003|100863750|FG002|NOT COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220880|NCT05580003|100863751|FG003|NOT COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220881|NCT05580003|100863752|FG004|NOT COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220882|NCT05580003|100863753|FG005|NOT COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220883|NCT05580003|100863754|FG006|NOT COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220884|NCT05580003|100863755|FG007|NOT COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220885|NCT05580003|100863756|FG008|NOT COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220886|NCT05580003|100863757|FG009|NOT COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220887|NCT05580003|100863758|FG010|NOT COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220888|NCT05580003|100863759|FG011|NOT COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220889|NCT05580003|100863760|FG012|NOT COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220890|NCT05580003|100863761|FG013|NOT COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220891|NCT05580003|100863762|FG014|NOT COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220892|NCT05580003|100863763|FG015|NOT COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220893|NCT05580003|100863764|FG016|NOT COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220894|NCT05580003|100863765|FG017|NOT COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220895|NCT05580003|100863766|FG018|NOT COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220896|NCT05580003|100863767|FG019|NOT COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220897|NCT05580003|100863768|FG020|NOT COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220898|NCT05580003|100863769|FG021|NOT COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220899|NCT05580003|100863770|FG022|NOT COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220900|NCT05580003|100863771|FG023|NOT COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220901|NCT05580003|100863772|FG024|NOT COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220902|NCT05580003|100863773|FG025|NOT COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220903|NCT05580003|100863774|FG026|NOT COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220904|NCT05580003|100863775|FG027|NOT COMPLETED|Part5:Sequence BA:Washout2(up to 2 Days)||0||
48220905|NCT05580003|100863748|FG000|STARTED|Part 6 Period 1 (Day 1)||0||
48220906|NCT05580003|100863749|FG001|STARTED|Part 6 Period 1 (Day 1)||0||
48220907|NCT05580003|100863750|FG002|STARTED|Part 6 Period 1 (Day 1)||0||
48220908|NCT05580003|100863751|FG003|STARTED|Part 6 Period 1 (Day 1)||0||
48220909|NCT05580003|100863752|FG004|STARTED|Part 6 Period 1 (Day 1)||0||
48220910|NCT05580003|100863753|FG005|STARTED|Part 6 Period 1 (Day 1)||0||
48220911|NCT05580003|100863754|FG006|STARTED|Part 6 Period 1 (Day 1)||0||
48220912|NCT05580003|100863755|FG007|STARTED|Part 6 Period 1 (Day 1)||0||
48220913|NCT05580003|100863756|FG008|STARTED|Part 6 Period 1 (Day 1)||0||
48220914|NCT05580003|100863757|FG009|STARTED|Part 6 Period 1 (Day 1)||0||
48220915|NCT05580003|100863758|FG010|STARTED|Part 6 Period 1 (Day 1)||0||
48220916|NCT05580003|100863759|FG011|STARTED|Part 6 Period 1 (Day 1)||0||
48220917|NCT05580003|100863760|FG012|STARTED|Part 6 Period 1 (Day 1)||0||
48220918|NCT05580003|100863761|FG013|STARTED|Part 6 Period 1 (Day 1)||0||
48220919|NCT05580003|100863762|FG014|STARTED|Part 6 Period 1 (Day 1)||0||
48220920|NCT05580003|100863763|FG015|STARTED|Part 6 Period 1 (Day 1)||0||
48220921|NCT05580003|100863764|FG016|STARTED|Part 6 Period 1 (Day 1)||0||
48220922|NCT05580003|100863765|FG017|STARTED|Part 6 Period 1 (Day 1)||0||
48220923|NCT05580003|100863766|FG018|STARTED|Part 6 Period 1 (Day 1)||0||
48220924|NCT05580003|100863767|FG019|STARTED|Part 6 Period 1 (Day 1)||0||
48220925|NCT05580003|100863768|FG020|STARTED|Part 6 Period 1 (Day 1)||0||
48220926|NCT05580003|100863769|FG021|STARTED|Part 6 Period 1 (Day 1)||0||
48220927|NCT05580003|100863770|FG022|STARTED|Part 6 Period 1 (Day 1)||4||
48220928|NCT05580003|100863771|FG023|STARTED|Part 6 Period 1 (Day 1)||4||
48220929|NCT05580003|100863772|FG024|STARTED|Part 6 Period 1 (Day 1)||4||
48220930|NCT05580003|100863773|FG025|STARTED|Part 6 Period 1 (Day 1)||4||
48220931|NCT05580003|100863774|FG026|STARTED|Part 6 Period 1 (Day 1)||4||
48220932|NCT05580003|100863775|FG027|STARTED|Part 6 Period 1 (Day 1)||4||
48220933|NCT05580003|100863748|FG000|COMPLETED|Part 6 Period 1 (Day 1)||0||
48220934|NCT05580003|100863749|FG001|COMPLETED|Part 6 Period 1 (Day 1)||0||
48220935|NCT05580003|100863750|FG002|COMPLETED|Part 6 Period 1 (Day 1)||0||
48220936|NCT05580003|100863751|FG003|COMPLETED|Part 6 Period 1 (Day 1)||0||
48220937|NCT05580003|100863752|FG004|COMPLETED|Part 6 Period 1 (Day 1)||0||
48220938|NCT05580003|100863753|FG005|COMPLETED|Part 6 Period 1 (Day 1)||0||
48220939|NCT05580003|100863754|FG006|COMPLETED|Part 6 Period 1 (Day 1)||0||
48220940|NCT05580003|100863755|FG007|COMPLETED|Part 6 Period 1 (Day 1)||0||
48220941|NCT05580003|100863756|FG008|COMPLETED|Part 6 Period 1 (Day 1)||0||
48220942|NCT05580003|100863757|FG009|COMPLETED|Part 6 Period 1 (Day 1)||0||
48220943|NCT05580003|100863758|FG010|COMPLETED|Part 6 Period 1 (Day 1)||0||
48220944|NCT05580003|100863759|FG011|COMPLETED|Part 6 Period 1 (Day 1)||0||
48220945|NCT05580003|100863760|FG012|COMPLETED|Part 6 Period 1 (Day 1)||0||
48220946|NCT05580003|100863761|FG013|COMPLETED|Part 6 Period 1 (Day 1)||0||
48220947|NCT05580003|100863762|FG014|COMPLETED|Part 6 Period 1 (Day 1)||0||
48220948|NCT05580003|100863763|FG015|COMPLETED|Part 6 Period 1 (Day 1)||0||
48220949|NCT05580003|100863764|FG016|COMPLETED|Part 6 Period 1 (Day 1)||0||
48220950|NCT05580003|100863765|FG017|COMPLETED|Part 6 Period 1 (Day 1)||0||
48220951|NCT05580003|100863766|FG018|COMPLETED|Part 6 Period 1 (Day 1)||0||
48220952|NCT05580003|100863767|FG019|COMPLETED|Part 6 Period 1 (Day 1)||0||
48220953|NCT05580003|100863768|FG020|COMPLETED|Part 6 Period 1 (Day 1)||0||
48220954|NCT05580003|100863769|FG021|COMPLETED|Part 6 Period 1 (Day 1)||0||
48220955|NCT05580003|100863770|FG022|COMPLETED|Part 6 Period 1 (Day 1)||4||
48220956|NCT05580003|100863771|FG023|COMPLETED|Part 6 Period 1 (Day 1)||4||
48220957|NCT05580003|100863772|FG024|COMPLETED|Part 6 Period 1 (Day 1)||4||
48220958|NCT05580003|100863773|FG025|COMPLETED|Part 6 Period 1 (Day 1)||4||
48220959|NCT05580003|100863774|FG026|COMPLETED|Part 6 Period 1 (Day 1)||4||
48220960|NCT05580003|100863775|FG027|COMPLETED|Part 6 Period 1 (Day 1)||4||
48220961|NCT05580003|100863748|FG000|NOT COMPLETED|Part 6 Period 1 (Day 1)||0||
48220962|NCT05580003|100863749|FG001|NOT COMPLETED|Part 6 Period 1 (Day 1)||0||
48220963|NCT05580003|100863750|FG002|NOT COMPLETED|Part 6 Period 1 (Day 1)||0||
48220964|NCT05580003|100863751|FG003|NOT COMPLETED|Part 6 Period 1 (Day 1)||0||
48220965|NCT05580003|100863752|FG004|NOT COMPLETED|Part 6 Period 1 (Day 1)||0||
48220966|NCT05580003|100863753|FG005|NOT COMPLETED|Part 6 Period 1 (Day 1)||0||
48220967|NCT05580003|100863754|FG006|NOT COMPLETED|Part 6 Period 1 (Day 1)||0||
48220968|NCT05580003|100863755|FG007|NOT COMPLETED|Part 6 Period 1 (Day 1)||0||
48220969|NCT05580003|100863756|FG008|NOT COMPLETED|Part 6 Period 1 (Day 1)||0||
48220970|NCT05580003|100863757|FG009|NOT COMPLETED|Part 6 Period 1 (Day 1)||0||
48220971|NCT05580003|100863758|FG010|NOT COMPLETED|Part 6 Period 1 (Day 1)||0||
48220972|NCT05580003|100863759|FG011|NOT COMPLETED|Part 6 Period 1 (Day 1)||0||
48220973|NCT05580003|100863760|FG012|NOT COMPLETED|Part 6 Period 1 (Day 1)||0||
48220974|NCT05580003|100863761|FG013|NOT COMPLETED|Part 6 Period 1 (Day 1)||0||
48220975|NCT05580003|100863762|FG014|NOT COMPLETED|Part 6 Period 1 (Day 1)||0||
48220976|NCT05580003|100863763|FG015|NOT COMPLETED|Part 6 Period 1 (Day 1)||0||
48220977|NCT05580003|100863764|FG016|NOT COMPLETED|Part 6 Period 1 (Day 1)||0||
48220978|NCT05580003|100863765|FG017|NOT COMPLETED|Part 6 Period 1 (Day 1)||0||
48220979|NCT05580003|100863766|FG018|NOT COMPLETED|Part 6 Period 1 (Day 1)||0||
48220980|NCT05580003|100863767|FG019|NOT COMPLETED|Part 6 Period 1 (Day 1)||0||
48220981|NCT05580003|100863768|FG020|NOT COMPLETED|Part 6 Period 1 (Day 1)||0||
48220982|NCT05580003|100863769|FG021|NOT COMPLETED|Part 6 Period 1 (Day 1)||0||
48220983|NCT05580003|100863770|FG022|NOT COMPLETED|Part 6 Period 1 (Day 1)||0||
48220984|NCT05580003|100863771|FG023|NOT COMPLETED|Part 6 Period 1 (Day 1)||0||
48220985|NCT05580003|100863772|FG024|NOT COMPLETED|Part 6 Period 1 (Day 1)||0||
48220986|NCT05580003|100863773|FG025|NOT COMPLETED|Part 6 Period 1 (Day 1)||0||
48220987|NCT05580003|100863774|FG026|NOT COMPLETED|Part 6 Period 1 (Day 1)||0||
48220988|NCT05580003|100863775|FG027|NOT COMPLETED|Part 6 Period 1 (Day 1)||0||
48220989|NCT05580003|100863748|FG000|STARTED|Part 6: Washout 1 (up to 7 Days)||0||
48220990|NCT05580003|100863749|FG001|STARTED|Part 6: Washout 1 (up to 7 Days)||0||
48220991|NCT05580003|100863750|FG002|STARTED|Part 6: Washout 1 (up to 7 Days)||0||
48220992|NCT05580003|100863751|FG003|STARTED|Part 6: Washout 1 (up to 7 Days)||0||
48220993|NCT05580003|100863752|FG004|STARTED|Part 6: Washout 1 (up to 7 Days)||0||
48220994|NCT05580003|100863753|FG005|STARTED|Part 6: Washout 1 (up to 7 Days)||0||
48220995|NCT05580003|100863754|FG006|STARTED|Part 6: Washout 1 (up to 7 Days)||0||
48220996|NCT05580003|100863755|FG007|STARTED|Part 6: Washout 1 (up to 7 Days)||0||
48220997|NCT05580003|100863756|FG008|STARTED|Part 6: Washout 1 (up to 7 Days)||0||
48220998|NCT05580003|100863757|FG009|STARTED|Part 6: Washout 1 (up to 7 Days)||0||
48220999|NCT05580003|100863758|FG010|STARTED|Part 6: Washout 1 (up to 7 Days)||0||
48221000|NCT05580003|100863759|FG011|STARTED|Part 6: Washout 1 (up to 7 Days)||0||
48221001|NCT05580003|100863760|FG012|STARTED|Part 6: Washout 1 (up to 7 Days)||0||
48221002|NCT05580003|100863761|FG013|STARTED|Part 6: Washout 1 (up to 7 Days)||0||
48221003|NCT05580003|100863762|FG014|STARTED|Part 6: Washout 1 (up to 7 Days)||0||
48221004|NCT05580003|100863763|FG015|STARTED|Part 6: Washout 1 (up to 7 Days)||0||
48221005|NCT05580003|100863764|FG016|STARTED|Part 6: Washout 1 (up to 7 Days)||0||
48221006|NCT05580003|100863765|FG017|STARTED|Part 6: Washout 1 (up to 7 Days)||0||
48221007|NCT05580003|100863766|FG018|STARTED|Part 6: Washout 1 (up to 7 Days)||0||
48221008|NCT05580003|100863767|FG019|STARTED|Part 6: Washout 1 (up to 7 Days)||0||
48221009|NCT05580003|100863768|FG020|STARTED|Part 6: Washout 1 (up to 7 Days)||0||
48221010|NCT05580003|100863769|FG021|STARTED|Part 6: Washout 1 (up to 7 Days)||0||
48221011|NCT05580003|100863770|FG022|STARTED|Part 6: Washout 1 (up to 7 Days)||4||
48221012|NCT05580003|100863771|FG023|STARTED|Part 6: Washout 1 (up to 7 Days)||4||
48221013|NCT05580003|100863772|FG024|STARTED|Part 6: Washout 1 (up to 7 Days)||4||
48221014|NCT05580003|100863773|FG025|STARTED|Part 6: Washout 1 (up to 7 Days)||4||
48221015|NCT05580003|100863774|FG026|STARTED|Part 6: Washout 1 (up to 7 Days)||4||
48221016|NCT05580003|100863775|FG027|STARTED|Part 6: Washout 1 (up to 7 Days)||4||
48221017|NCT05580003|100863748|FG000|COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221018|NCT05580003|100863749|FG001|COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221019|NCT05580003|100863750|FG002|COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221020|NCT05580003|100863751|FG003|COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221021|NCT05580003|100863752|FG004|COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221022|NCT05580003|100863753|FG005|COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221023|NCT05580003|100863754|FG006|COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221024|NCT05580003|100863755|FG007|COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221025|NCT05580003|100863756|FG008|COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221026|NCT05580003|100863757|FG009|COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221027|NCT05580003|100863758|FG010|COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221028|NCT05580003|100863759|FG011|COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221029|NCT05580003|100863760|FG012|COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221030|NCT05580003|100863761|FG013|COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221031|NCT05580003|100863762|FG014|COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221032|NCT05580003|100863763|FG015|COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221033|NCT05580003|100863764|FG016|COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221034|NCT05580003|100863765|FG017|COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221035|NCT05580003|100863766|FG018|COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221036|NCT05580003|100863767|FG019|COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221037|NCT05580003|100863768|FG020|COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221038|NCT05580003|100863769|FG021|COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221039|NCT05580003|100863770|FG022|COMPLETED|Part 6: Washout 1 (up to 7 Days)||4||
48221040|NCT05580003|100863771|FG023|COMPLETED|Part 6: Washout 1 (up to 7 Days)||4||
48221041|NCT05580003|100863772|FG024|COMPLETED|Part 6: Washout 1 (up to 7 Days)||4||
48221042|NCT05580003|100863773|FG025|COMPLETED|Part 6: Washout 1 (up to 7 Days)||4||
48221043|NCT05580003|100863774|FG026|COMPLETED|Part 6: Washout 1 (up to 7 Days)||4||
48221044|NCT05580003|100863775|FG027|COMPLETED|Part 6: Washout 1 (up to 7 Days)||4||
48221045|NCT05580003|100863748|FG000|NOT COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221046|NCT05580003|100863749|FG001|NOT COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221047|NCT05580003|100863750|FG002|NOT COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221048|NCT05580003|100863751|FG003|NOT COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221049|NCT05580003|100863752|FG004|NOT COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221050|NCT05580003|100863753|FG005|NOT COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221051|NCT05580003|100863754|FG006|NOT COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221052|NCT05580003|100863755|FG007|NOT COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221053|NCT05580003|100863756|FG008|NOT COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221054|NCT05580003|100863757|FG009|NOT COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221055|NCT05580003|100863758|FG010|NOT COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221056|NCT05580003|100863759|FG011|NOT COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221057|NCT05580003|100863760|FG012|NOT COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221058|NCT05580003|100863761|FG013|NOT COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221059|NCT05580003|100863762|FG014|NOT COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221060|NCT05580003|100863763|FG015|NOT COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221061|NCT05580003|100863764|FG016|NOT COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221062|NCT05580003|100863765|FG017|NOT COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221063|NCT05580003|100863766|FG018|NOT COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221064|NCT05580003|100863767|FG019|NOT COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221065|NCT05580003|100863768|FG020|NOT COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221066|NCT05580003|100863769|FG021|NOT COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221067|NCT05580003|100863770|FG022|NOT COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221068|NCT05580003|100863771|FG023|NOT COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221069|NCT05580003|100863772|FG024|NOT COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221070|NCT05580003|100863773|FG025|NOT COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221071|NCT05580003|100863774|FG026|NOT COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221072|NCT05580003|100863775|FG027|NOT COMPLETED|Part 6: Washout 1 (up to 7 Days)||0||
48221073|NCT05580003|100863748|FG000|STARTED|Part 6 Period 2 (Day 1)||0||
48221074|NCT05580003|100863749|FG001|STARTED|Part 6 Period 2 (Day 1)||0||
48221075|NCT05580003|100863750|FG002|STARTED|Part 6 Period 2 (Day 1)||0||
48221076|NCT05580003|100863751|FG003|STARTED|Part 6 Period 2 (Day 1)||0||
48221077|NCT05580003|100863752|FG004|STARTED|Part 6 Period 2 (Day 1)||0||
48221078|NCT05580003|100863753|FG005|STARTED|Part 6 Period 2 (Day 1)||0||
48221079|NCT05580003|100863754|FG006|STARTED|Part 6 Period 2 (Day 1)||0||
48221080|NCT05580003|100863755|FG007|STARTED|Part 6 Period 2 (Day 1)||0||
48221081|NCT05580003|100863756|FG008|STARTED|Part 6 Period 2 (Day 1)||0||
48221082|NCT05580003|100863757|FG009|STARTED|Part 6 Period 2 (Day 1)||0||
48221083|NCT05580003|100863758|FG010|STARTED|Part 6 Period 2 (Day 1)||0||
48221084|NCT05580003|100863759|FG011|STARTED|Part 6 Period 2 (Day 1)||0||
48221085|NCT05580003|100863760|FG012|STARTED|Part 6 Period 2 (Day 1)||0||
48221086|NCT05580003|100863761|FG013|STARTED|Part 6 Period 2 (Day 1)||0||
48221087|NCT05580003|100863762|FG014|STARTED|Part 6 Period 2 (Day 1)||0||
48221088|NCT05580003|100863763|FG015|STARTED|Part 6 Period 2 (Day 1)||0||
48221089|NCT05580003|100863764|FG016|STARTED|Part 6 Period 2 (Day 1)||0||
48221090|NCT05580003|100863765|FG017|STARTED|Part 6 Period 2 (Day 1)||0||
48221091|NCT05580003|100863766|FG018|STARTED|Part 6 Period 2 (Day 1)||0||
48221092|NCT05580003|100863767|FG019|STARTED|Part 6 Period 2 (Day 1)||0||
48221093|NCT05580003|100863768|FG020|STARTED|Part 6 Period 2 (Day 1)||0||
48221094|NCT05580003|100863769|FG021|STARTED|Part 6 Period 2 (Day 1)||0||
48221095|NCT05580003|100863770|FG022|STARTED|Part 6 Period 2 (Day 1)||4||
48221096|NCT05580003|100863771|FG023|STARTED|Part 6 Period 2 (Day 1)||4||
48221097|NCT05580003|100863772|FG024|STARTED|Part 6 Period 2 (Day 1)||4||
48221098|NCT05580003|100863773|FG025|STARTED|Part 6 Period 2 (Day 1)||4||
48221099|NCT05580003|100863774|FG026|STARTED|Part 6 Period 2 (Day 1)||4||
48221100|NCT05580003|100863775|FG027|STARTED|Part 6 Period 2 (Day 1)||4||
48221101|NCT05580003|100863748|FG000|COMPLETED|Part 6 Period 2 (Day 1)||0||
48221102|NCT05580003|100863749|FG001|COMPLETED|Part 6 Period 2 (Day 1)||0||
48221103|NCT05580003|100863750|FG002|COMPLETED|Part 6 Period 2 (Day 1)||0||
48221104|NCT05580003|100863751|FG003|COMPLETED|Part 6 Period 2 (Day 1)||0||
48221105|NCT05580003|100863752|FG004|COMPLETED|Part 6 Period 2 (Day 1)||0||
48221106|NCT05580003|100863753|FG005|COMPLETED|Part 6 Period 2 (Day 1)||0||
48221107|NCT05580003|100863754|FG006|COMPLETED|Part 6 Period 2 (Day 1)||0||
48221108|NCT05580003|100863755|FG007|COMPLETED|Part 6 Period 2 (Day 1)||0||
48221109|NCT05580003|100863756|FG008|COMPLETED|Part 6 Period 2 (Day 1)||0||
48221110|NCT05580003|100863757|FG009|COMPLETED|Part 6 Period 2 (Day 1)||0||
48221111|NCT05580003|100863758|FG010|COMPLETED|Part 6 Period 2 (Day 1)||0||
48221112|NCT05580003|100863759|FG011|COMPLETED|Part 6 Period 2 (Day 1)||0||
48221113|NCT05580003|100863760|FG012|COMPLETED|Part 6 Period 2 (Day 1)||0||
48221114|NCT05580003|100863761|FG013|COMPLETED|Part 6 Period 2 (Day 1)||0||
48221115|NCT05580003|100863762|FG014|COMPLETED|Part 6 Period 2 (Day 1)||0||
48221116|NCT05580003|100863763|FG015|COMPLETED|Part 6 Period 2 (Day 1)||0||
48221117|NCT05580003|100863764|FG016|COMPLETED|Part 6 Period 2 (Day 1)||0||
48221118|NCT05580003|100863765|FG017|COMPLETED|Part 6 Period 2 (Day 1)||0||
48667911|NCT02014376|101970718|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15|Intent-to-treat (ITT) Population|
48667912|NCT02014376|101970719|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16|Intent-to-treat (ITT) Population|
48667913|NCT02014376|101970720|FG002|Received at Least 1 Dose of Study Drug|Overall Study||17|Intent-to-treat (ITT) Population|
48667914|NCT02014376|101970718|FG000|COMPLETED|Overall Study||12||
48667915|NCT02014376|101970719|FG001|COMPLETED|Overall Study||15||
48667916|NCT02014376|101970720|FG002|COMPLETED|Overall Study||17||
48667917|NCT02014376|101970718|FG000|NOT COMPLETED|Overall Study||3||
48667918|NCT02014376|101970719|FG001|NOT COMPLETED|Overall Study||1||
48667919|NCT02014376|101970720|FG002|NOT COMPLETED|Overall Study||0||
48667920|NCT02191618|101970721|FG000|STARTED|Overall Study||150||
48667921|NCT02191618|101970721|FG000|COMPLETED|Overall Study||143||
48667922|NCT02191618|101970721|FG000|NOT COMPLETED|Overall Study||7||
48667923|NCT00654355|101970722|FG000|STARTED|Overall Study||15||
48667924|NCT00654355|101970723|FG001|STARTED|Overall Study||15||
48667925|NCT00654355|101970722|FG000|COMPLETED|Overall Study||13||
48667926|NCT00654355|101970723|FG001|COMPLETED|Overall Study||13||
48667927|NCT00654355|101970722|FG000|NOT COMPLETED|Overall Study||2||
48667928|NCT00654355|101970723|FG001|NOT COMPLETED|Overall Study||2||
48667929|NCT03802916|101970724|FG000|STARTED|Overall Study||15||
48667930|NCT03802916|101970725|FG001|STARTED|Overall Study||15||
48667931|NCT03802916|101970724|FG000|COMPLETED|Overall Study||15||
48667932|NCT03802916|101970725|FG001|COMPLETED|Overall Study||13||
48667933|NCT03802916|101970724|FG000|NOT COMPLETED|Overall Study||0||
48667934|NCT03802916|101970725|FG001|NOT COMPLETED|Overall Study||2||
48667935|NCT03814044|101970726|FG000|STARTED|Overall Study||149||150
48667936|NCT03814044|101970726|FG000|BIORAPTOR™ Knotless Suture Anchor|Overall Study||58||58
48667937|NCT03814044|101970726|FG000|SpeedLock Hip Suture Anchor|Overall Study||93||94
48667938|NCT03814044|101970726|FG000|COMPLETED|Overall Study||148||149
48667939|NCT03814044|101970726|FG000|NOT COMPLETED|Overall Study||1||1
48667940|NCT00542178|101970727|FG000|STARTED|Overall Study||390||
48667941|NCT00542178|101970728|FG001|STARTED|Overall Study||412||
48667942|NCT00542178|101970729|FG002|STARTED|Overall Study||382||
48667943|NCT00542178|101970730|FG003|STARTED|Overall Study||370||
48667944|NCT00542178|101970731|FG004|STARTED|Overall Study||464||
48667945|NCT00542178|101970732|FG005|STARTED|Overall Study||495||
48667946|NCT00542178|101970733|FG006|STARTED|Overall Study||493||
48667947|NCT00542178|101970734|FG007|STARTED|Overall Study||466||
48667948|NCT00542178|101970727|FG000|COMPLETED|Overall Study||315||
48667949|NCT00542178|101970728|FG001|COMPLETED|Overall Study||332||
48667950|NCT00542178|101970729|FG002|COMPLETED|Overall Study||308||
48667951|NCT00542178|101970730|FG003|COMPLETED|Overall Study||308||
48667952|NCT00542178|101970731|FG004|COMPLETED|Overall Study||400||
48667953|NCT00542178|101970732|FG005|COMPLETED|Overall Study||406||
48667954|NCT00542178|101970733|FG006|COMPLETED|Overall Study||406||
48667955|NCT00542178|101970734|FG007|COMPLETED|Overall Study||381||
48667956|NCT00542178|101970727|FG000|NOT COMPLETED|Overall Study||75||
48667957|NCT00542178|101970728|FG001|NOT COMPLETED|Overall Study||80||
48667958|NCT00542178|101970729|FG002|NOT COMPLETED|Overall Study||74||
48667959|NCT00542178|101970730|FG003|NOT COMPLETED|Overall Study||62||
48667960|NCT00542178|101970731|FG004|NOT COMPLETED|Overall Study||64||
48667961|NCT00542178|101970732|FG005|NOT COMPLETED|Overall Study||89||
48667962|NCT00542178|101970733|FG006|NOT COMPLETED|Overall Study||87||
48667963|NCT00542178|101970734|FG007|NOT COMPLETED|Overall Study||85||
48667964|NCT00867334|101970735|FG000|STARTED|Overall Study||6||
48667965|NCT00867334|101970736|FG001|STARTED|Overall Study||1||
48667966|NCT00867334|101970735|FG000|COMPLETED|Overall Study||4||
48667967|NCT00867334|101970736|FG001|COMPLETED|Overall Study||0||
48667968|NCT00867334|101970735|FG000|NOT COMPLETED|Overall Study||2||
48667969|NCT00867334|101970736|FG001|NOT COMPLETED|Overall Study||1||
48667970|NCT03112902|101970737|FG000|STARTED|Overall Study||2||
48667971|NCT03112902|101970738|FG001|STARTED|Overall Study||2||
48667972|NCT03112902|101970739|FG002|STARTED|Overall Study||3||
48667973|NCT03112902|101970740|FG003|STARTED|Overall Study||1||
48667974|NCT03112902|101970741|FG004|STARTED|Overall Study||1||
48667975|NCT03112902|101970742|FG005|STARTED|Overall Study||3||
48667976|NCT03112902|101970743|FG006|STARTED|Overall Study||9||
48667977|NCT03112902|101970744|FG007|STARTED|Overall Study||3||
48667978|NCT03112902|101970745|FG008|STARTED|Overall Study||0||
48667979|NCT03112902|101970746|FG009|STARTED|Overall Study||0||
48667980|NCT03112902|101970737|FG000|COMPLETED|Overall Study||0||
48667981|NCT03112902|101970738|FG001|COMPLETED|Overall Study||2||
48667982|NCT03112902|101970739|FG002|COMPLETED|Overall Study||2||
48667983|NCT03112902|101970740|FG003|COMPLETED|Overall Study||0||
48667984|NCT03112902|101970741|FG004|COMPLETED|Overall Study||1||
48667985|NCT03112902|101970742|FG005|COMPLETED|Overall Study||0||
48667986|NCT03112902|101970743|FG006|COMPLETED|Overall Study||1||
48667987|NCT03112902|101970744|FG007|COMPLETED|Overall Study||1||
48667988|NCT03112902|101970745|FG008|COMPLETED|Overall Study||0||
48667989|NCT03112902|101970746|FG009|COMPLETED|Overall Study||0||
48667990|NCT03112902|101970737|FG000|NOT COMPLETED|Overall Study||2||
48667991|NCT03112902|101970738|FG001|NOT COMPLETED|Overall Study||0||
48667992|NCT03112902|101970739|FG002|NOT COMPLETED|Overall Study||1||
48667993|NCT03112902|101970740|FG003|NOT COMPLETED|Overall Study||1||
48667994|NCT03112902|101970741|FG004|NOT COMPLETED|Overall Study||0||
48667995|NCT03112902|101970742|FG005|NOT COMPLETED|Overall Study||3||
48667996|NCT03112902|101970743|FG006|NOT COMPLETED|Overall Study||8||
48667997|NCT03112902|101970744|FG007|NOT COMPLETED|Overall Study||2||
48667998|NCT03112902|101970745|FG008|NOT COMPLETED|Overall Study||0||
48667999|NCT03112902|101970746|FG009|NOT COMPLETED|Overall Study||0||
48668000|NCT04992273|101970747|FG000|STARTED|Overall Study||2||
48668001|NCT04992273|101970748|FG001|STARTED|Overall Study||5||
48668002|NCT04992273|101970747|FG000|COMPLETED|Overall Study||2||
48668003|NCT04992273|101970748|FG001|COMPLETED|Overall Study||4||
48668004|NCT04992273|101970747|FG000|NOT COMPLETED|Overall Study||0||
48668005|NCT04992273|101970748|FG001|NOT COMPLETED|Overall Study||1||
48668006|NCT02157610|101970749|FG000|STARTED|Overall Study||100||
48668007|NCT02157610|101970750|FG001|STARTED|Overall Study||102||
48668008|NCT02157610|101970749|FG000|COMPLETED|Overall Study||96||
48668009|NCT02157610|101970750|FG001|COMPLETED|Overall Study||98||
48668010|NCT02157610|101970749|FG000|NOT COMPLETED|Overall Study||4||
48668011|NCT02157610|101970750|FG001|NOT COMPLETED|Overall Study||4||
48668012|NCT01082939|101970751|FG000|STARTED|Overall Study||80||
48668013|NCT01082939|101970751|FG000|COMPLETED|Overall Study||80||
48668014|NCT01082939|101970751|FG000|NOT COMPLETED|Overall Study||0||
48668015|NCT05293717|101970752|FG000|STARTED|Overall Study||16||
48668016|NCT05293717|101970752|FG000|COMPLETED|Overall Study||15||
48668017|NCT05293717|101970752|FG000|NOT COMPLETED|Overall Study||1||
48668018|NCT04540367|101970753|FG000|STARTED|Overall Study||16||
48668019|NCT04540367|101970754|FG001|STARTED|Overall Study||16||
48668020|NCT04540367|101970755|FG002|STARTED|Overall Study||18||
48668021|NCT04540367|101970756|FG003|STARTED|Overall Study||19||
48668022|NCT04540367|101970753|FG000|COMPLETED|Overall Study||16||
48668023|NCT04540367|101970754|FG001|COMPLETED|Overall Study||16||
48668024|NCT04540367|101970755|FG002|COMPLETED|Overall Study||13||
48668025|NCT04540367|101970756|FG003|COMPLETED|Overall Study||15||
48668026|NCT04540367|101970753|FG000|NOT COMPLETED|Overall Study||0||
48668027|NCT04540367|101970754|FG001|NOT COMPLETED|Overall Study||0||
48668028|NCT04540367|101970755|FG002|NOT COMPLETED|Overall Study||5||
48668029|NCT04540367|101970756|FG003|NOT COMPLETED|Overall Study||4||
48668030|NCT04881058|101970757|FG000|STARTED|Overall Study||10||
48668031|NCT04881058|101970757|FG000|COMPLETED|Overall Study||10||
48668032|NCT04881058|101970757|FG000|NOT COMPLETED|Overall Study||0||
48668033|NCT02371889|101970758|FG000|STARTED|Overall Study||85||
48668034|NCT02371889|101970759|FG001|STARTED|Overall Study||85||
48668035|NCT02371889|101970758|FG000|COMPLETED|Overall Study||66||
48668036|NCT02371889|101970759|FG001|COMPLETED|Overall Study||71||
48668037|NCT02371889|101970758|FG000|NOT COMPLETED|Overall Study||19||
48668038|NCT02371889|101970759|FG001|NOT COMPLETED|Overall Study||14||
48668039|NCT00967499|101970760|FG000|STARTED|Overall Study||111||
48668040|NCT00967499|101970761|FG001|STARTED|Overall Study||109||
48668041|NCT00967499|101970760|FG000|Treated (Full Analysis Set)|Overall Study||48||
48668042|NCT00967499|101970761|FG001|Treated (Full Analysis Set)|Overall Study||50||
48668043|NCT00967499|101970760|FG000|COMPLETED|Overall Study||46||
48668044|NCT00967499|101970761|FG001|COMPLETED|Overall Study||49||
48668045|NCT00967499|101970760|FG000|NOT COMPLETED|Overall Study||65||
48668046|NCT00967499|101970761|FG001|NOT COMPLETED|Overall Study||60||
48668047|NCT00889005|101970762|FG000|STARTED|Overall Study||65||
48668048|NCT00889005|101970763|FG001|STARTED|Overall Study||74||
48668049|NCT00889005|101970762|FG000|COMPLETED|Overall Study||57||
48668050|NCT00889005|101970763|FG001|COMPLETED|Overall Study||72||
48668051|NCT00889005|101970762|FG000|NOT COMPLETED|Overall Study||8||
48668052|NCT00889005|101970763|FG001|NOT COMPLETED|Overall Study||2||
48668053|NCT00654732|101970764|FG000|STARTED|Overall Study||26||
48668054|NCT00654732|101970765|FG001|STARTED|Overall Study||32||
48668055|NCT00654732|101970764|FG000|COMPLETED|Overall Study||22||
48668056|NCT00654732|101970765|FG001|COMPLETED|Overall Study||26||
48668057|NCT00654732|101970764|FG000|NOT COMPLETED|Overall Study||4||
48668058|NCT00654732|101970765|FG001|NOT COMPLETED|Overall Study||6||
48668059|NCT03032484|101970766|FG000|STARTED|Overall Study Cycle 1 (C1)||13|After C1, all subjects were treated with a combination of TVB-2640 with Bevacizumab|
48668060|NCT03032484|101970767|FG001|STARTED|Overall Study Cycle 1 (C1)||12|After C1, all subjects were treated with a combination of TVB-2640 with Bevacizumab|
48668061|NCT03032484|101970766|FG000|COMPLETED|Overall Study Cycle 1 (C1)||12||
48668062|NCT03032484|101970767|FG001|COMPLETED|Overall Study Cycle 1 (C1)||12||
48668063|NCT03032484|101970766|FG000|NOT COMPLETED|Overall Study Cycle 1 (C1)||1||
48668064|NCT03032484|101970767|FG001|NOT COMPLETED|Overall Study Cycle 1 (C1)||0||
48668065|NCT03032484|101970766|FG000|STARTED|Start of Second Cycle (C2)||24|All subjects were aggregated from Arms 1 and 2 into a single treatment group from cycle 2 onwards, and efficacy and safety data were assessed for the aggregated group.|
48668066|NCT03032484|101970767|FG001|STARTED|Start of Second Cycle (C2)||0|All subjects were aggregated from Arms 1 and 2 into a single treatment group from cycle 2 onwards, and efficacy and safety data were assessed for the aggregated group.|
48668067|NCT03032484|101970766|FG000|COMPLETED|Start of Second Cycle (C2)||23||
48668068|NCT03032484|101970767|FG001|COMPLETED|Start of Second Cycle (C2)||0||
48668069|NCT03032484|101970766|FG000|NOT COMPLETED|Start of Second Cycle (C2)||1||
48668070|NCT03032484|101970767|FG001|NOT COMPLETED|Start of Second Cycle (C2)||0||
48668071|NCT03341936|101970768|FG000|STARTED|Overall Study||29||
48668072|NCT03341936|101970768|FG000|Treated|Overall Study||28||
48668073|NCT03341936|101970768|FG000|COMPLETED|Overall Study||18||
48668074|NCT03341936|101970768|FG000|NOT COMPLETED|Overall Study||11||
48668075|NCT03038087|101970769|FG000|STARTED|Overall Study||10||
48668076|NCT03038087|101970769|FG000|COMPLETED|Overall Study||9||
48668077|NCT03038087|101970769|FG000|NOT COMPLETED|Overall Study||1||
48668078|NCT03637348|101970770|FG000|STARTED|Overall Study||45||
48668079|NCT03637348|101970770|FG000|COMPLETED|Overall Study||45||
48668080|NCT03637348|101970770|FG000|NOT COMPLETED|Overall Study||0||
48668081|NCT00982280|101970771|FG000|STARTED|Observation Period||82||
48668082|NCT00982280|101970771|FG000|COMPLETED|Observation Period||63||
48668083|NCT00982280|101970771|FG000|NOT COMPLETED|Observation Period||19||
48668084|NCT00982280|101970771|FG000|STARTED|Titration and Optimal Dose Period||63||
48668085|NCT00982280|101970771|FG000|COMPLETED|Titration and Optimal Dose Period||55||
48668086|NCT00982280|101970771|FG000|NOT COMPLETED|Titration and Optimal Dose Period||8||
48668087|NCT00982280|101970771|FG000|STARTED|Maintenance Period||55||
48668088|NCT00982280|101970771|FG000|COMPLETED|Maintenance Period||54||
48668089|NCT00982280|101970771|FG000|NOT COMPLETED|Maintenance Period||1||
48668090|NCT03134209|101970772|FG000|STARTED|Overall Study||53||
48668091|NCT03134209|101970773|FG001|STARTED|Overall Study||54||
48668092|NCT03134209|101970774|FG002|STARTED|Overall Study||53||
48668093|NCT03134209|101970772|FG000|COMPLETED|Overall Study||53||
48668094|NCT03134209|101970773|FG001|COMPLETED|Overall Study||54||
48668095|NCT03134209|101970774|FG002|COMPLETED|Overall Study||53||
48668096|NCT03134209|101970772|FG000|NOT COMPLETED|Overall Study||0||
48668097|NCT03134209|101970773|FG001|NOT COMPLETED|Overall Study||0||
48668098|NCT03134209|101970774|FG002|NOT COMPLETED|Overall Study||0||
48668099|NCT00103844|101970775|FG000|STARTED|Overall Study||101||
48668100|NCT00103844|101970776|FG001|STARTED|Overall Study||49||
48668101|NCT00103844|101970775|FG000|Crossed Over|Overall Study||22||
48668102|NCT00103844|101970776|FG001|Crossed Over|Overall Study||40||
48668103|NCT00103844|101970775|FG000|COMPLETED|Overall Study||101||
48668104|NCT00103844|101970776|FG001|COMPLETED|Overall Study||49||
48668105|NCT00103844|101970775|FG000|NOT COMPLETED|Overall Study||0||
48668106|NCT00103844|101970776|FG001|NOT COMPLETED|Overall Study||0||
48668107|NCT04339062|101970777|FG000|STARTED|Overall Study||0||
48668108|NCT04339062|101970778|FG001|STARTED|Overall Study||12||
48668109|NCT04339062|101970777|FG000|COMPLETED|Overall Study||0||
48668110|NCT04339062|101970778|FG001|COMPLETED|Overall Study||11||
48668111|NCT04339062|101970777|FG000|NOT COMPLETED|Overall Study||0||
48668112|NCT04339062|101970778|FG001|NOT COMPLETED|Overall Study||1||
48668113|NCT03132467|101970779|FG000|STARTED|Overall Study||8||
48668114|NCT03132467|101970779|FG000|COMPLETED|Overall Study||4||
48668115|NCT03132467|101970779|FG000|NOT COMPLETED|Overall Study||4||
48668116|NCT01992757|101970780|FG000|STARTED|Overall Study||51||
48668117|NCT01992757|101970780|FG000|COMPLETED|Overall Study||49||
48668118|NCT01992757|101970780|FG000|NOT COMPLETED|Overall Study||2||
48668119|NCT00573768|101972993|FG000|STARTED|Overall Study||89||
48668120|NCT00573768|101972994|FG001|STARTED|Overall Study||91||
48668121|NCT00573768|101972995|FG002|STARTED|Overall Study||91||
48668122|NCT00573768|101972993|FG000|COMPLETED|Overall Study||87||
48668123|NCT00573768|101972994|FG001|COMPLETED|Overall Study||89||
48668124|NCT00573768|101972995|FG002|COMPLETED|Overall Study||87||
48668125|NCT00573768|101972993|FG000|NOT COMPLETED|Overall Study||2||
48668126|NCT00573768|101972994|FG001|NOT COMPLETED|Overall Study||2||
48668127|NCT00573768|101972995|FG002|NOT COMPLETED|Overall Study||4||
48668128|NCT01538199|101972996|FG000|STARTED|Overall Study||10||
48668129|NCT01538199|101972997|FG001|STARTED|Overall Study||11||
48668130|NCT01538199|101972998|FG002|STARTED|Overall Study||4||
48668131|NCT01538199|101972999|FG003|STARTED|Overall Study||3||
48668132|NCT01538199|101972996|FG000|COMPLETED|Overall Study||8|"1 active participant excluded as completer in analyses because last visit was out of window."|
48668133|NCT01538199|101972997|FG001|COMPLETED|Overall Study||8|"1 active participant excluded as completer in analyses because last visit was out of window."|
48668134|NCT01538199|101972998|FG002|COMPLETED|Overall Study||3|"1 active participant excluded as completer in analyses because last visit was out of window."|
48668135|NCT01538199|101972999|FG003|COMPLETED|Overall Study||1|"1 active participant excluded as completer in analyses because last visit was out of window."|
48668136|NCT01538199|101972996|FG000|NOT COMPLETED|Overall Study||2||
48668137|NCT01538199|101972997|FG001|NOT COMPLETED|Overall Study||3||
48668138|NCT01538199|101972998|FG002|NOT COMPLETED|Overall Study||1||
48221119|NCT05580003|100863766|FG018|COMPLETED|Part 6 Period 2 (Day 1)||0||
48221120|NCT05580003|100863767|FG019|COMPLETED|Part 6 Period 2 (Day 1)||0||
48668139|NCT01538199|101972999|FG003|NOT COMPLETED|Overall Study||2||
48668140|NCT01483560|101973000|FG000|STARTED|Overall Study||219||
48668141|NCT01483560|101973001|FG001|STARTED|Overall Study||209||
48668142|NCT01483560|101973000|FG000|COMPLETED|Overall Study||193||
48668143|NCT01483560|101973001|FG001|COMPLETED|Overall Study||194||
48668144|NCT01483560|101973000|FG000|NOT COMPLETED|Overall Study||26||
48668145|NCT01483560|101973001|FG001|NOT COMPLETED|Overall Study||15||
48668146|NCT03514134|101973002|FG000|STARTED|Overall Study||23||
48668147|NCT03514134|101973003|FG001|STARTED|Overall Study||48||
48668148|NCT03514134|101973002|FG000|COMPLETED|Overall Study||23||
48668149|NCT03514134|101973003|FG001|COMPLETED|Overall Study||47||
48668150|NCT03514134|101973002|FG000|NOT COMPLETED|Overall Study||0||
48668151|NCT03514134|101973003|FG001|NOT COMPLETED|Overall Study||1||
48668152|NCT05077969|101973004|FG000|STARTED|Overall Study||2||
48668153|NCT05077969|101973005|FG001|STARTED|Overall Study||2||
48668154|NCT05077969|101973004|FG000|COMPLETED|Overall Study||1||
48668155|NCT05077969|101973005|FG001|COMPLETED|Overall Study||2||
48668156|NCT05077969|101973004|FG000|NOT COMPLETED|Overall Study||1||
48668157|NCT05077969|101973005|FG001|NOT COMPLETED|Overall Study||0||
48668158|NCT04023487|101973006|FG000|STARTED|Overall Study||104||
48668159|NCT04023487|101973007|FG001|STARTED|Overall Study||105||
48221121|NCT05580003|100863768|FG020|COMPLETED|Part 6 Period 2 (Day 1)||0||
48221122|NCT05580003|100863769|FG021|COMPLETED|Part 6 Period 2 (Day 1)||0||
48668160|NCT04023487|101973006|FG000|COMPLETED|Overall Study||86||
48668161|NCT04023487|101973007|FG001|COMPLETED|Overall Study||90||
48668162|NCT04023487|101973006|FG000|NOT COMPLETED|Overall Study||18||
48668163|NCT04023487|101973007|FG001|NOT COMPLETED|Overall Study||15||
48668164|NCT03360344|101973008|FG000|STARTED|Overall Study||15|Analysis was completed on 68 wrists (units of study)|25
48668165|NCT03360344|101973009|FG001|STARTED|Overall Study||16|Analysis was completed on 68 wrists (units of study)|20
48668166|NCT03360344|101973010|FG002|STARTED|Overall Study||13|Analysis was completed on 68 wrists (units of study)|23
48668167|NCT03360344|101973008|FG000|COMPLETED|Overall Study||15|Analysis was completed on 68 wrists (units of study)|25
48668168|NCT03360344|101973009|FG001|COMPLETED|Overall Study||15|Analysis was completed on 68 wrists (units of study)|19
48668169|NCT03360344|101973010|FG002|COMPLETED|Overall Study||12|Analysis was completed on 68 wrists (units of study)|22
48668170|NCT03360344|101973008|FG000|NOT COMPLETED|Overall Study||0||0
48668171|NCT03360344|101973009|FG001|NOT COMPLETED|Overall Study||1||1
48668172|NCT03360344|101973010|FG002|NOT COMPLETED|Overall Study||1||1
48668173|NCT01257750|101973011|FG000|STARTED|Overall Study||20||
48668174|NCT01257750|101973011|FG000|COMPLETED|Overall Study||20||
48668175|NCT01257750|101973011|FG000|NOT COMPLETED|Overall Study||0||
48668176|NCT00189137|101973012|FG000|STARTED|Overall Study||37||
48668177|NCT00189137|101973013|FG001|STARTED|Overall Study||43||
48668178|NCT00189137|101973012|FG000|COMPLETED|Overall Study||37||
48668179|NCT00189137|101973013|FG001|COMPLETED|Overall Study||43||
48668180|NCT00189137|101973012|FG000|NOT COMPLETED|Overall Study||0||
48668181|NCT00189137|101973013|FG001|NOT COMPLETED|Overall Study||0||
48668182|NCT00183248|101973014|FG000|STARTED|Overall Study||4||
48668183|NCT00183248|101973015|FG001|STARTED|Overall Study||5||
48668184|NCT00183248|101973014|FG000|COMPLETED|Overall Study||3||
48668185|NCT00183248|101973015|FG001|COMPLETED|Overall Study||4||
48668186|NCT00183248|101973014|FG000|NOT COMPLETED|Overall Study||1||
48668187|NCT00183248|101973015|FG001|NOT COMPLETED|Overall Study||1||
48668188|NCT00347269|101973016|FG000|STARTED|Overall Study||503||
48668189|NCT00347269|101973017|FG001|STARTED|Overall Study||501||
48668190|NCT00347269|101973016|FG000|COMPLETED|Overall Study||409||
48668191|NCT00347269|101973017|FG001|COMPLETED|Overall Study||395||
48668192|NCT00347269|101973016|FG000|NOT COMPLETED|Overall Study||94||
48221123|NCT05580003|100863770|FG022|COMPLETED|Part 6 Period 2 (Day 1)||4||
48221124|NCT05580003|100863771|FG023|COMPLETED|Part 6 Period 2 (Day 1)||4||
48221125|NCT05580003|100863772|FG024|COMPLETED|Part 6 Period 2 (Day 1)||3||
48221126|NCT05580003|100863773|FG025|COMPLETED|Part 6 Period 2 (Day 1)||4||
48221127|NCT05580003|100863774|FG026|COMPLETED|Part 6 Period 2 (Day 1)||4||
48221128|NCT05580003|100863775|FG027|COMPLETED|Part 6 Period 2 (Day 1)||3||
48221129|NCT05580003|100863748|FG000|NOT COMPLETED|Part 6 Period 2 (Day 1)||0||
48221130|NCT05580003|100863749|FG001|NOT COMPLETED|Part 6 Period 2 (Day 1)||0||
48221131|NCT05580003|100863750|FG002|NOT COMPLETED|Part 6 Period 2 (Day 1)||0||
48221132|NCT05580003|100863751|FG003|NOT COMPLETED|Part 6 Period 2 (Day 1)||0||
48221133|NCT05580003|100863752|FG004|NOT COMPLETED|Part 6 Period 2 (Day 1)||0||
48221134|NCT05580003|100863753|FG005|NOT COMPLETED|Part 6 Period 2 (Day 1)||0||
48221135|NCT05580003|100863754|FG006|NOT COMPLETED|Part 6 Period 2 (Day 1)||0||
48221136|NCT05580003|100863755|FG007|NOT COMPLETED|Part 6 Period 2 (Day 1)||0||
48221137|NCT05580003|100863756|FG008|NOT COMPLETED|Part 6 Period 2 (Day 1)||0||
48221138|NCT05580003|100863757|FG009|NOT COMPLETED|Part 6 Period 2 (Day 1)||0||
48221139|NCT05580003|100863758|FG010|NOT COMPLETED|Part 6 Period 2 (Day 1)||0||
48221140|NCT05580003|100863759|FG011|NOT COMPLETED|Part 6 Period 2 (Day 1)||0||
48221141|NCT05580003|100863760|FG012|NOT COMPLETED|Part 6 Period 2 (Day 1)||0||
48221142|NCT05580003|100863761|FG013|NOT COMPLETED|Part 6 Period 2 (Day 1)||0||
48221143|NCT05580003|100863762|FG014|NOT COMPLETED|Part 6 Period 2 (Day 1)||0||
48221144|NCT05580003|100863763|FG015|NOT COMPLETED|Part 6 Period 2 (Day 1)||0||
48221145|NCT05580003|100863764|FG016|NOT COMPLETED|Part 6 Period 2 (Day 1)||0||
48221146|NCT05580003|100863765|FG017|NOT COMPLETED|Part 6 Period 2 (Day 1)||0||
48221147|NCT05580003|100863766|FG018|NOT COMPLETED|Part 6 Period 2 (Day 1)||0||
48221148|NCT05580003|100863767|FG019|NOT COMPLETED|Part 6 Period 2 (Day 1)||0||
48221149|NCT05580003|100863768|FG020|NOT COMPLETED|Part 6 Period 2 (Day 1)||0||
48221150|NCT05580003|100863769|FG021|NOT COMPLETED|Part 6 Period 2 (Day 1)||0||
48221151|NCT05580003|100863770|FG022|NOT COMPLETED|Part 6 Period 2 (Day 1)||0||
48221152|NCT05580003|100863771|FG023|NOT COMPLETED|Part 6 Period 2 (Day 1)||0||
48221153|NCT05580003|100863772|FG024|NOT COMPLETED|Part 6 Period 2 (Day 1)||1||
48221154|NCT05580003|100863773|FG025|NOT COMPLETED|Part 6 Period 2 (Day 1)||0||
48221155|NCT05580003|100863774|FG026|NOT COMPLETED|Part 6 Period 2 (Day 1)||0||
48221156|NCT05580003|100863775|FG027|NOT COMPLETED|Part 6 Period 2 (Day 1)||1||
48221157|NCT05580003|100863748|FG000|STARTED|Part 6: Washout 2 (up to 7 Days)||0||
48221158|NCT05580003|100863749|FG001|STARTED|Part 6: Washout 2 (up to 7 Days)||0||
48221159|NCT05580003|100863750|FG002|STARTED|Part 6: Washout 2 (up to 7 Days)||0||
48221160|NCT05580003|100863751|FG003|STARTED|Part 6: Washout 2 (up to 7 Days)||0||
48221161|NCT05580003|100863752|FG004|STARTED|Part 6: Washout 2 (up to 7 Days)||0||
48221162|NCT05580003|100863753|FG005|STARTED|Part 6: Washout 2 (up to 7 Days)||0||
48221163|NCT05580003|100863754|FG006|STARTED|Part 6: Washout 2 (up to 7 Days)||0||
48221164|NCT05580003|100863755|FG007|STARTED|Part 6: Washout 2 (up to 7 Days)||0||
48221165|NCT05580003|100863756|FG008|STARTED|Part 6: Washout 2 (up to 7 Days)||0||
48221166|NCT05580003|100863757|FG009|STARTED|Part 6: Washout 2 (up to 7 Days)||0||
48221167|NCT05580003|100863758|FG010|STARTED|Part 6: Washout 2 (up to 7 Days)||0||
48221168|NCT05580003|100863759|FG011|STARTED|Part 6: Washout 2 (up to 7 Days)||0||
48221169|NCT05580003|100863760|FG012|STARTED|Part 6: Washout 2 (up to 7 Days)||0||
48221170|NCT05580003|100863761|FG013|STARTED|Part 6: Washout 2 (up to 7 Days)||0||
48221171|NCT05580003|100863762|FG014|STARTED|Part 6: Washout 2 (up to 7 Days)||0||
48221172|NCT05580003|100863763|FG015|STARTED|Part 6: Washout 2 (up to 7 Days)||0||
48221173|NCT05580003|100863764|FG016|STARTED|Part 6: Washout 2 (up to 7 Days)||0||
48221174|NCT05580003|100863765|FG017|STARTED|Part 6: Washout 2 (up to 7 Days)||0||
48221175|NCT05580003|100863766|FG018|STARTED|Part 6: Washout 2 (up to 7 Days)||0||
48221176|NCT05580003|100863767|FG019|STARTED|Part 6: Washout 2 (up to 7 Days)||0||
48221177|NCT05580003|100863768|FG020|STARTED|Part 6: Washout 2 (up to 7 Days)||0||
48221178|NCT05580003|100863769|FG021|STARTED|Part 6: Washout 2 (up to 7 Days)||0||
48221179|NCT05580003|100863770|FG022|STARTED|Part 6: Washout 2 (up to 7 Days)||4||
48221180|NCT05580003|100863771|FG023|STARTED|Part 6: Washout 2 (up to 7 Days)||4||
48221181|NCT05580003|100863772|FG024|STARTED|Part 6: Washout 2 (up to 7 Days)||3||
48221182|NCT05580003|100863773|FG025|STARTED|Part 6: Washout 2 (up to 7 Days)||4||
48221183|NCT05580003|100863774|FG026|STARTED|Part 6: Washout 2 (up to 7 Days)||4||
48221184|NCT05580003|100863775|FG027|STARTED|Part 6: Washout 2 (up to 7 Days)||3||
48221185|NCT05580003|100863748|FG000|COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221186|NCT05580003|100863749|FG001|COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221187|NCT05580003|100863750|FG002|COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221188|NCT05580003|100863751|FG003|COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221189|NCT05580003|100863752|FG004|COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221190|NCT05580003|100863753|FG005|COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221191|NCT05580003|100863754|FG006|COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221192|NCT05580003|100863755|FG007|COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221193|NCT05580003|100863756|FG008|COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221194|NCT05580003|100863757|FG009|COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221195|NCT05580003|100863758|FG010|COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221196|NCT05580003|100863759|FG011|COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221197|NCT05580003|100863760|FG012|COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221198|NCT05580003|100863761|FG013|COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221199|NCT05580003|100863762|FG014|COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221200|NCT05580003|100863763|FG015|COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221201|NCT05580003|100863764|FG016|COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221202|NCT05580003|100863765|FG017|COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221203|NCT05580003|100863766|FG018|COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221204|NCT05580003|100863767|FG019|COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221205|NCT05580003|100863768|FG020|COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221206|NCT05580003|100863769|FG021|COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221207|NCT05580003|100863770|FG022|COMPLETED|Part 6: Washout 2 (up to 7 Days)||4||
48221208|NCT05580003|100863771|FG023|COMPLETED|Part 6: Washout 2 (up to 7 Days)||4||
48221209|NCT05580003|100863772|FG024|COMPLETED|Part 6: Washout 2 (up to 7 Days)||3||
48221210|NCT05580003|100863773|FG025|COMPLETED|Part 6: Washout 2 (up to 7 Days)||4||
48221211|NCT05580003|100863774|FG026|COMPLETED|Part 6: Washout 2 (up to 7 Days)||4||
48221212|NCT05580003|100863775|FG027|COMPLETED|Part 6: Washout 2 (up to 7 Days)||3||
48221213|NCT05580003|100863748|FG000|NOT COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221214|NCT05580003|100863749|FG001|NOT COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221215|NCT05580003|100863750|FG002|NOT COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221216|NCT05580003|100863751|FG003|NOT COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221217|NCT05580003|100863752|FG004|NOT COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221218|NCT05580003|100863753|FG005|NOT COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221219|NCT05580003|100863754|FG006|NOT COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221220|NCT05580003|100863755|FG007|NOT COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221221|NCT05580003|100863756|FG008|NOT COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221222|NCT05580003|100863757|FG009|NOT COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221223|NCT05580003|100863758|FG010|NOT COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221224|NCT05580003|100863759|FG011|NOT COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221225|NCT05580003|100863760|FG012|NOT COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221226|NCT05580003|100863761|FG013|NOT COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221227|NCT05580003|100863762|FG014|NOT COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221228|NCT05580003|100863763|FG015|NOT COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221229|NCT05580003|100863764|FG016|NOT COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221230|NCT05580003|100863765|FG017|NOT COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221231|NCT05580003|100863766|FG018|NOT COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221232|NCT05580003|100863767|FG019|NOT COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221233|NCT05580003|100863768|FG020|NOT COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221234|NCT05580003|100863769|FG021|NOT COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221235|NCT05580003|100863770|FG022|NOT COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221236|NCT05580003|100863771|FG023|NOT COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221237|NCT05580003|100863772|FG024|NOT COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221238|NCT05580003|100863773|FG025|NOT COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221239|NCT05580003|100863774|FG026|NOT COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221240|NCT05580003|100863775|FG027|NOT COMPLETED|Part 6: Washout 2 (up to 7 Days)||0||
48221241|NCT05580003|100863748|FG000|STARTED|Part 6 Period 3 (Day 1)||0||
48221242|NCT05580003|100863749|FG001|STARTED|Part 6 Period 3 (Day 1)||0||
48221243|NCT05580003|100863750|FG002|STARTED|Part 6 Period 3 (Day 1)||0||
48221244|NCT05580003|100863751|FG003|STARTED|Part 6 Period 3 (Day 1)||0||
48221245|NCT05580003|100863752|FG004|STARTED|Part 6 Period 3 (Day 1)||0||
48221246|NCT05580003|100863753|FG005|STARTED|Part 6 Period 3 (Day 1)||0||
48221247|NCT05580003|100863754|FG006|STARTED|Part 6 Period 3 (Day 1)||0||
48221248|NCT05580003|100863755|FG007|STARTED|Part 6 Period 3 (Day 1)||0||
48221249|NCT05580003|100863756|FG008|STARTED|Part 6 Period 3 (Day 1)||0||
48221250|NCT05580003|100863757|FG009|STARTED|Part 6 Period 3 (Day 1)||0||
48221251|NCT05580003|100863758|FG010|STARTED|Part 6 Period 3 (Day 1)||0||
48221252|NCT05580003|100863759|FG011|STARTED|Part 6 Period 3 (Day 1)||0||
48221253|NCT05580003|100863760|FG012|STARTED|Part 6 Period 3 (Day 1)||0||
48221254|NCT05580003|100863761|FG013|STARTED|Part 6 Period 3 (Day 1)||0||
48221255|NCT05580003|100863762|FG014|STARTED|Part 6 Period 3 (Day 1)||0||
48221256|NCT05580003|100863763|FG015|STARTED|Part 6 Period 3 (Day 1)||0||
48221257|NCT05580003|100863764|FG016|STARTED|Part 6 Period 3 (Day 1)||0||
48221258|NCT05580003|100863765|FG017|STARTED|Part 6 Period 3 (Day 1)||0||
48221259|NCT05580003|100863766|FG018|STARTED|Part 6 Period 3 (Day 1)||0||
48221260|NCT05580003|100863767|FG019|STARTED|Part 6 Period 3 (Day 1)||0||
48221261|NCT05580003|100863768|FG020|STARTED|Part 6 Period 3 (Day 1)||0||
48221262|NCT05580003|100863769|FG021|STARTED|Part 6 Period 3 (Day 1)||0||
48221263|NCT05580003|100863770|FG022|STARTED|Part 6 Period 3 (Day 1)||4||
48221264|NCT05580003|100863771|FG023|STARTED|Part 6 Period 3 (Day 1)||4||
48221265|NCT05580003|100863772|FG024|STARTED|Part 6 Period 3 (Day 1)||3||
48221266|NCT05580003|100863773|FG025|STARTED|Part 6 Period 3 (Day 1)||4||
48221267|NCT05580003|100863774|FG026|STARTED|Part 6 Period 3 (Day 1)||4||
48221268|NCT05580003|100863775|FG027|STARTED|Part 6 Period 3 (Day 1)||3||
48221269|NCT05580003|100863748|FG000|COMPLETED|Part 6 Period 3 (Day 1)||0||
48221270|NCT05580003|100863749|FG001|COMPLETED|Part 6 Period 3 (Day 1)||0||
48221271|NCT05580003|100863750|FG002|COMPLETED|Part 6 Period 3 (Day 1)||0||
48221272|NCT05580003|100863751|FG003|COMPLETED|Part 6 Period 3 (Day 1)||0||
48221273|NCT05580003|100863752|FG004|COMPLETED|Part 6 Period 3 (Day 1)||0||
48221274|NCT05580003|100863753|FG005|COMPLETED|Part 6 Period 3 (Day 1)||0||
48221275|NCT05580003|100863754|FG006|COMPLETED|Part 6 Period 3 (Day 1)||0||
48221276|NCT05580003|100863755|FG007|COMPLETED|Part 6 Period 3 (Day 1)||0||
48221277|NCT05580003|100863756|FG008|COMPLETED|Part 6 Period 3 (Day 1)||0||
48221278|NCT05580003|100863757|FG009|COMPLETED|Part 6 Period 3 (Day 1)||0||
48221279|NCT05580003|100863758|FG010|COMPLETED|Part 6 Period 3 (Day 1)||0||
48221280|NCT05580003|100863759|FG011|COMPLETED|Part 6 Period 3 (Day 1)||0||
48221281|NCT05580003|100863760|FG012|COMPLETED|Part 6 Period 3 (Day 1)||0||
48221282|NCT05580003|100863761|FG013|COMPLETED|Part 6 Period 3 (Day 1)||0||
48221283|NCT05580003|100863762|FG014|COMPLETED|Part 6 Period 3 (Day 1)||0||
48221284|NCT05580003|100863763|FG015|COMPLETED|Part 6 Period 3 (Day 1)||0||
48221285|NCT05580003|100863764|FG016|COMPLETED|Part 6 Period 3 (Day 1)||0||
48221286|NCT05580003|100863765|FG017|COMPLETED|Part 6 Period 3 (Day 1)||0||
48221287|NCT05580003|100863766|FG018|COMPLETED|Part 6 Period 3 (Day 1)||0||
48221288|NCT05580003|100863767|FG019|COMPLETED|Part 6 Period 3 (Day 1)||0||
48221289|NCT05580003|100863768|FG020|COMPLETED|Part 6 Period 3 (Day 1)||0||
48221290|NCT05580003|100863769|FG021|COMPLETED|Part 6 Period 3 (Day 1)||0||
48221291|NCT05580003|100863770|FG022|COMPLETED|Part 6 Period 3 (Day 1)||4||
48221292|NCT05580003|100863771|FG023|COMPLETED|Part 6 Period 3 (Day 1)||4||
48221293|NCT05580003|100863772|FG024|COMPLETED|Part 6 Period 3 (Day 1)||3||
48221294|NCT05580003|100863773|FG025|COMPLETED|Part 6 Period 3 (Day 1)||4||
48221295|NCT05580003|100863774|FG026|COMPLETED|Part 6 Period 3 (Day 1)||4||
48221296|NCT05580003|100863775|FG027|COMPLETED|Part 6 Period 3 (Day 1)||3||
48221297|NCT05580003|100863748|FG000|NOT COMPLETED|Part 6 Period 3 (Day 1)||0||
48221298|NCT05580003|100863749|FG001|NOT COMPLETED|Part 6 Period 3 (Day 1)||0||
48221299|NCT05580003|100863750|FG002|NOT COMPLETED|Part 6 Period 3 (Day 1)||0||
48221300|NCT05580003|100863751|FG003|NOT COMPLETED|Part 6 Period 3 (Day 1)||0||
48221301|NCT05580003|100863752|FG004|NOT COMPLETED|Part 6 Period 3 (Day 1)||0||
48221302|NCT05580003|100863753|FG005|NOT COMPLETED|Part 6 Period 3 (Day 1)||0||
48221303|NCT05580003|100863754|FG006|NOT COMPLETED|Part 6 Period 3 (Day 1)||0||
48221304|NCT05580003|100863755|FG007|NOT COMPLETED|Part 6 Period 3 (Day 1)||0||
48221305|NCT05580003|100863756|FG008|NOT COMPLETED|Part 6 Period 3 (Day 1)||0||
48221306|NCT05580003|100863757|FG009|NOT COMPLETED|Part 6 Period 3 (Day 1)||0||
48221307|NCT05580003|100863758|FG010|NOT COMPLETED|Part 6 Period 3 (Day 1)||0||
48221308|NCT05580003|100863759|FG011|NOT COMPLETED|Part 6 Period 3 (Day 1)||0||
48221309|NCT05580003|100863760|FG012|NOT COMPLETED|Part 6 Period 3 (Day 1)||0||
48221310|NCT05580003|100863761|FG013|NOT COMPLETED|Part 6 Period 3 (Day 1)||0||
48221311|NCT05580003|100863762|FG014|NOT COMPLETED|Part 6 Period 3 (Day 1)||0||
48221312|NCT05580003|100863763|FG015|NOT COMPLETED|Part 6 Period 3 (Day 1)||0||
48221313|NCT05580003|100863764|FG016|NOT COMPLETED|Part 6 Period 3 (Day 1)||0||
48221314|NCT05580003|100863765|FG017|NOT COMPLETED|Part 6 Period 3 (Day 1)||0||
48221315|NCT05580003|100863766|FG018|NOT COMPLETED|Part 6 Period 3 (Day 1)||0||
48221316|NCT05580003|100863767|FG019|NOT COMPLETED|Part 6 Period 3 (Day 1)||0||
48221317|NCT05580003|100863768|FG020|NOT COMPLETED|Part 6 Period 3 (Day 1)||0||
48221318|NCT05580003|100863769|FG021|NOT COMPLETED|Part 6 Period 3 (Day 1)||0||
48221319|NCT05580003|100863770|FG022|NOT COMPLETED|Part 6 Period 3 (Day 1)||0||
48221320|NCT05580003|100863771|FG023|NOT COMPLETED|Part 6 Period 3 (Day 1)||0||
48221321|NCT05580003|100863772|FG024|NOT COMPLETED|Part 6 Period 3 (Day 1)||0||
48221322|NCT05580003|100863773|FG025|NOT COMPLETED|Part 6 Period 3 (Day 1)||0||
48221323|NCT05580003|100863774|FG026|NOT COMPLETED|Part 6 Period 3 (Day 1)||0||
48221324|NCT05580003|100863775|FG027|NOT COMPLETED|Part 6 Period 3 (Day 1)||0||
48221325|NCT01595282|100863776|FG000|STARTED|Overall Study||47||
48221326|NCT01595282|100863777|FG001|STARTED|Overall Study||47||
48221327|NCT01595282|100863776|FG000|COMPLETED|Overall Study||47||
48221328|NCT01595282|100863777|FG001|COMPLETED|Overall Study||47||
48221329|NCT01595282|100863776|FG000|NOT COMPLETED|Overall Study||0||
48221330|NCT01595282|100863777|FG001|NOT COMPLETED|Overall Study||0||
48221331|NCT02417376|100863778|FG000|STARTED|Overall Study||35||
48221332|NCT02417376|100863779|FG001|STARTED|Overall Study||35||
48221333|NCT02417376|100863778|FG000|COMPLETED|Overall Study||30||
48221334|NCT02417376|100863779|FG001|COMPLETED|Overall Study||25||
48221335|NCT02417376|100863778|FG000|NOT COMPLETED|Overall Study||5||
48221336|NCT02417376|100863779|FG001|NOT COMPLETED|Overall Study||10||
48221337|NCT02633215|100863780|FG000|STARTED|Overall Study||18||
48221338|NCT02633215|100863781|FG001|STARTED|Overall Study||18||
48221339|NCT02633215|100863780|FG000|COMPLETED|Overall Study||16||
48221340|NCT02633215|100863781|FG001|COMPLETED|Overall Study||15||
48221341|NCT02633215|100863780|FG000|NOT COMPLETED|Overall Study||2||
48221342|NCT02633215|100863781|FG001|NOT COMPLETED|Overall Study||3||
48221343|NCT02866942|100863782|FG000|STARTED|Overall Study||479||
48221344|NCT02866942|100863782|FG000|COMPLETED|Overall Study||478||
48221345|NCT02866942|100863782|FG000|NOT COMPLETED|Overall Study||1||
48221346|NCT00795184|100863783|FG000|STARTED|Overall Study||65||
48221347|NCT00795184|100863784|FG001|STARTED|Overall Study||57||
48221348|NCT00795184|100863783|FG000|COMPLETED|Overall Study||57||
48221349|NCT00795184|100863784|FG001|COMPLETED|Overall Study||44||
48221350|NCT00795184|100863783|FG000|NOT COMPLETED|Overall Study||8||
48221351|NCT00795184|100863784|FG001|NOT COMPLETED|Overall Study||13||
48221352|NCT02823028|100863785|FG000|STARTED|Overall Study||240||
48221353|NCT02823028|100863786|FG001|STARTED|Overall Study||480||
48221354|NCT02823028|100863787|FG002|STARTED|Overall Study||240||
48221355|NCT02823028|100863788|FG003|STARTED|Overall Study||20||
48221356|NCT02823028|100863785|FG000|COMPLETED|Overall Study||235||
48221357|NCT02823028|100863786|FG001|COMPLETED|Overall Study||457||
48221358|NCT02823028|100863787|FG002|COMPLETED|Overall Study||230||
48221359|NCT02823028|100863788|FG003|COMPLETED|Overall Study||20||
48221360|NCT02823028|100863785|FG000|NOT COMPLETED|Overall Study||5||
48221361|NCT02823028|100863786|FG001|NOT COMPLETED|Overall Study||23||
48221362|NCT02823028|100863787|FG002|NOT COMPLETED|Overall Study||10||
48221363|NCT02823028|100863788|FG003|NOT COMPLETED|Overall Study||0||
48221364|NCT01367236|100863789|FG000|STARTED|Overall Study||30||
48221365|NCT01367236|100863790|FG001|STARTED|Overall Study||30||
48221366|NCT01367236|100863789|FG000|COMPLETED|Overall Study||27||
48221367|NCT01367236|100863790|FG001|COMPLETED|Overall Study||29||
48221368|NCT01367236|100863789|FG000|NOT COMPLETED|Overall Study||3||
48221369|NCT01367236|100863790|FG001|NOT COMPLETED|Overall Study||1||
48221370|NCT05171777|100863791|FG000|STARTED|Treatment Crossover Period||89||
48221371|NCT05171777|100863792|FG001|STARTED|Treatment Crossover Period||90||
48221372|NCT05171777|100863793|FG002|STARTED|Treatment Crossover Period||0||
48221373|NCT05171777|100863794|FG003|STARTED|Treatment Crossover Period||0||
48221374|NCT05171777|100863791|FG000|COMPLETED|Treatment Crossover Period||53||
48221375|NCT05171777|100863792|FG001|COMPLETED|Treatment Crossover Period||54||
48221376|NCT05171777|100863793|FG002|COMPLETED|Treatment Crossover Period||0||
48221377|NCT05171777|100863794|FG003|COMPLETED|Treatment Crossover Period||0||
48221378|NCT05171777|100863791|FG000|NOT COMPLETED|Treatment Crossover Period||36||
48221379|NCT05171777|100863792|FG001|NOT COMPLETED|Treatment Crossover Period||36||
48221380|NCT05171777|100863793|FG002|NOT COMPLETED|Treatment Crossover Period||0||
48221381|NCT05171777|100863794|FG003|NOT COMPLETED|Treatment Crossover Period||0||
48221382|NCT05171777|100863791|FG000|STARTED|Treatment Continuation Period||0||
48221383|NCT05171777|100863792|FG001|STARTED|Treatment Continuation Period||0||
48221384|NCT05171777|100863793|FG002|STARTED|Treatment Continuation Period||22||
48221385|NCT05171777|100863794|FG003|STARTED|Treatment Continuation Period||85||
48221386|NCT05171777|100863791|FG000|COMPLETED|Treatment Continuation Period||0||
48221387|NCT05171777|100863792|FG001|COMPLETED|Treatment Continuation Period||0||
48221388|NCT05171777|100863793|FG002|COMPLETED|Treatment Continuation Period||0||
48221389|NCT05171777|100863794|FG003|COMPLETED|Treatment Continuation Period||0||
48221390|NCT05171777|100863791|FG000|NOT COMPLETED|Treatment Continuation Period||0||
48221391|NCT05171777|100863792|FG001|NOT COMPLETED|Treatment Continuation Period||0||
48221392|NCT05171777|100863793|FG002|NOT COMPLETED|Treatment Continuation Period||22||
48221393|NCT05171777|100863794|FG003|NOT COMPLETED|Treatment Continuation Period||85||
48221394|NCT03878979|100863795|FG000|STARTED|Overall Study||20||
48221395|NCT03878979|100863796|FG001|STARTED|Overall Study||6||
48221396|NCT03878979|100863795|FG000|COMPLETED|Overall Study||20||
48221397|NCT03878979|100863796|FG001|COMPLETED|Overall Study||6||
48221398|NCT03878979|100863795|FG000|NOT COMPLETED|Overall Study||0||
48221399|NCT03878979|100863796|FG001|NOT COMPLETED|Overall Study||0||
48221400|NCT01900249|100863797|FG000|STARTED|Overall Study||67||
48221401|NCT01900249|100863798|FG001|STARTED|Overall Study||68||
48221402|NCT01900249|100863799|FG002|STARTED|Overall Study||69||
48221403|NCT01900249|100863797|FG000|COMPLETED|Overall Study||64||
48221404|NCT01900249|100863798|FG001|COMPLETED|Overall Study||63||
48221405|NCT01900249|100863799|FG002|COMPLETED|Overall Study||65||
48221406|NCT01900249|100863797|FG000|NOT COMPLETED|Overall Study||3||
48221407|NCT01900249|100863798|FG001|NOT COMPLETED|Overall Study||5||
48221408|NCT01900249|100863799|FG002|NOT COMPLETED|Overall Study||4||
48221409|NCT02755805|100863800|FG000|STARTED|Overall Study||15||
48221410|NCT02755805|100863801|FG001|STARTED|Overall Study||15||
48221411|NCT02755805|100863800|FG000|COMPLETED|Overall Study||13||
48221412|NCT02755805|100863801|FG001|COMPLETED|Overall Study||11||
48221413|NCT02755805|100863800|FG000|NOT COMPLETED|Overall Study||2||
48221414|NCT02755805|100863801|FG001|NOT COMPLETED|Overall Study||4||
48221415|NCT03624972|100863802|FG000|STARTED|Overall Study||71||
48221416|NCT03624972|100863803|FG001|STARTED|Overall Study||73||
48221417|NCT03624972|100863804|FG002|STARTED|Overall Study||9||
48221418|NCT03624972|100863802|FG000|COMPLETED|Overall Study||69||
48221419|NCT03624972|100863803|FG001|COMPLETED|Overall Study||71||
48221420|NCT03624972|100863804|FG002|COMPLETED|Overall Study||9||
48221421|NCT03624972|100863802|FG000|NOT COMPLETED|Overall Study||2||
48221422|NCT03624972|100863803|FG001|NOT COMPLETED|Overall Study||2||
48221423|NCT03624972|100863804|FG002|NOT COMPLETED|Overall Study||0||
48221424|NCT00570700|100863805|FG000|STARTED|Overall Study||38||
48221425|NCT00570700|100863805|FG000|COMPLETED|Overall Study||27||
48221426|NCT00570700|100863805|FG000|NOT COMPLETED|Overall Study||11||
48221427|NCT02161146|100863806|FG000|STARTED|Overall Study||47||
48221428|NCT02161146|100863807|FG001|STARTED|Overall Study||47||
48221429|NCT02161146|100863808|FG002|STARTED|Overall Study||49||
48221430|NCT02161146|100863809|FG003|STARTED|Overall Study||48||
48221431|NCT02161146|100863810|FG004|STARTED|Overall Study||49||
48221432|NCT02161146|100863806|FG000|COMPLETED|Overall Study||46||
48221433|NCT02161146|100863807|FG001|COMPLETED|Overall Study||43||
48221434|NCT02161146|100863808|FG002|COMPLETED|Overall Study||49||
48221435|NCT02161146|100863809|FG003|COMPLETED|Overall Study||45||
48221436|NCT02161146|100863810|FG004|COMPLETED|Overall Study||48||
48221437|NCT02161146|100863806|FG000|NOT COMPLETED|Overall Study||1||
48221438|NCT02161146|100863807|FG001|NOT COMPLETED|Overall Study||4||
48221439|NCT02161146|100863808|FG002|NOT COMPLETED|Overall Study||0||
48221440|NCT02161146|100863809|FG003|NOT COMPLETED|Overall Study||3||
48221441|NCT02161146|100863810|FG004|NOT COMPLETED|Overall Study||1||
48221442|NCT00754065|100863811|FG000|STARTED|Overall Study||203||
48221443|NCT00754065|100863812|FG001|STARTED|Overall Study||206||
48221444|NCT00754065|100863811|FG000|Participants Received Treatment|Overall Study||191||
48221445|NCT00754065|100863812|FG001|Participants Received Treatment|Overall Study||204||
48221446|NCT00754065|100863811|FG000|Cycle 6|Overall Study||141||
48221447|NCT00754065|100863812|FG001|Cycle 6|Overall Study||153||
48221448|NCT00754065|100863811|FG000|COMPLETED|Overall Study||122||
48221449|NCT00754065|100863812|FG001|COMPLETED|Overall Study||126||
48221450|NCT00754065|100863811|FG000|NOT COMPLETED|Overall Study||81||
48221451|NCT00754065|100863812|FG001|NOT COMPLETED|Overall Study||80||
48221452|NCT00989196|100863813|FG000|STARTED|PK Crossover Period||10||
48221453|NCT00989196|100863814|FG001|STARTED|PK Crossover Period||12||
48221454|NCT00989196|100863813|FG000|COMPLETED|PK Crossover Period||10||
48221455|NCT00989196|100863814|FG001|COMPLETED|PK Crossover Period||12||
48221456|NCT00989196|100863813|FG000|NOT COMPLETED|PK Crossover Period||0||
48221457|NCT00989196|100863814|FG001|NOT COMPLETED|PK Crossover Period||0||
48221458|NCT00989196|100863813|FG000|STARTED|Treatment Period||10||
48221459|NCT00989196|100863814|FG001|STARTED|Treatment Period||12||
48221460|NCT00989196|100863813|FG000|COMPLETED|Treatment Period||9||
48221461|NCT00989196|100863814|FG001|COMPLETED|Treatment Period||12||
48221462|NCT00989196|100863813|FG000|NOT COMPLETED|Treatment Period||1||
48221463|NCT00989196|100863814|FG001|NOT COMPLETED|Treatment Period||0||
48221464|NCT00003222|100863815|FG000|STARTED|Overall Study||13||
48221465|NCT00003222|100863816|FG001|STARTED|Overall Study||28||
48221466|NCT00003222|100863815|FG000|COMPLETED|Overall Study||13||
48221467|NCT00003222|100863816|FG001|COMPLETED|Overall Study||27||
48221468|NCT00003222|100863815|FG000|NOT COMPLETED|Overall Study||0||
48221469|NCT00003222|100863816|FG001|NOT COMPLETED|Overall Study||1||
48221470|NCT02128113|100863817|FG000|STARTED|Overall Study||103||
48221471|NCT02128113|100863818|FG001|STARTED|Overall Study||102||
48221472|NCT02128113|100863819|FG002|STARTED|Overall Study||102||
48221473|NCT02128113|100863817|FG000|COMPLETED|Overall Study||100||
48221474|NCT02128113|100863818|FG001|COMPLETED|Overall Study||99||
48221475|NCT02128113|100863819|FG002|COMPLETED|Overall Study||101||
48221476|NCT02128113|100863817|FG000|NOT COMPLETED|Overall Study||3||
48221477|NCT02128113|100863818|FG001|NOT COMPLETED|Overall Study||3||
48221478|NCT02128113|100863819|FG002|NOT COMPLETED|Overall Study||1||
48221479|NCT03488719|100863820|FG000|STARTED|Overall Study||9||
48221480|NCT03488719|100863821|FG001|STARTED|Overall Study||16||
48221481|NCT03488719|100863822|FG002|STARTED|Overall Study||12||
48221482|NCT03488719|100863820|FG000|Metoprolol 25 mg|Overall Study||9||
48221483|NCT03488719|100863821|FG001|Metoprolol 25 mg|Overall Study||13||
48221484|NCT03488719|100863822|FG002|Metoprolol 25 mg|Overall Study||5||
48221485|NCT03488719|100863820|FG000|Metoprolol 50 mg|Overall Study||9||
48221486|NCT03488719|100863821|FG001|Metoprolol 50 mg|Overall Study||13||
48221487|NCT03488719|100863822|FG002|Metoprolol 50 mg|Overall Study||6||
48221488|NCT03488719|100863820|FG000|Metoprolol 100 mg|Overall Study||9||
48221489|NCT03488719|100863821|FG001|Metoprolol 100 mg|Overall Study||13||
48221490|NCT03488719|100863822|FG002|Metoprolol 100 mg|Overall Study||5||
48221491|NCT03488719|100863820|FG000|COMPLETED|Overall Study||9||
48221492|NCT03488719|100863821|FG001|COMPLETED|Overall Study||12||
48221493|NCT03488719|100863822|FG002|COMPLETED|Overall Study||5||
48221494|NCT03488719|100863820|FG000|NOT COMPLETED|Overall Study||0||
48221495|NCT03488719|100863821|FG001|NOT COMPLETED|Overall Study||4||
48221496|NCT03488719|100863822|FG002|NOT COMPLETED|Overall Study||7||
48221497|NCT04337931|100863823|FG000|STARTED|Overall Study||12||
48221498|NCT04337931|100863824|FG001|STARTED|Overall Study||14||
48221499|NCT04337931|100863825|FG002|STARTED|Overall Study||19||
48221500|NCT04337931|100863823|FG000|Safety Population|Overall Study||12||
48221501|NCT04337931|100863824|FG001|Safety Population|Overall Study||13||
48221502|NCT04337931|100863825|FG002|Safety Population|Overall Study||19||
48221503|NCT04337931|100863823|FG000|Efficacy Population|Overall Study||11||
48221504|NCT04337931|100863824|FG001|Efficacy Population|Overall Study||13||
48221505|NCT04337931|100863825|FG002|Efficacy Population|Overall Study||19||
48221506|NCT04337931|100863823|FG000|COMPLETED|Overall Study||0||
48221507|NCT04337931|100863824|FG001|COMPLETED|Overall Study||0||
48221508|NCT04337931|100863825|FG002|COMPLETED|Overall Study||0||
48221509|NCT04337931|100863823|FG000|NOT COMPLETED|Overall Study||12||
48221510|NCT04337931|100863824|FG001|NOT COMPLETED|Overall Study||14||
48221511|NCT04337931|100863825|FG002|NOT COMPLETED|Overall Study||19||
48221512|NCT02790281|100863826|FG000|STARTED|Overall Study||33||
48221513|NCT02790281|100863826|FG000|COMPLETED|Overall Study||33||
48221514|NCT02790281|100863826|FG000|NOT COMPLETED|Overall Study||0||
48221515|NCT02132949|100863827|FG000|STARTED|Overall Study||199|ITT Population|
48221516|NCT02132949|100863828|FG001|STARTED|Overall Study||201|ITT Population|
48221517|NCT02132949|100863827|FG000|Received Any Cohort A Study Treatment|Overall Study||198|Safety Population for Cohort A|
48221518|NCT02132949|100863828|FG001|Received Any Cohort A Study Treatment|Overall Study||1|Safety Population for Cohort A|
48221519|NCT02132949|100863827|FG000|Received Any Cohort B Study Treatment|Overall Study||0|Safety Population for Cohort B|
48221520|NCT02132949|100863828|FG001|Received Any Cohort B Study Treatment|Overall Study||198|Safety Population for Cohort B|
48221521|NCT02132949|100863827|FG000|Underwent Surgery|Overall Study||187||
48221522|NCT02132949|100863828|FG001|Underwent Surgery|Overall Study||194||
48221523|NCT02132949|100863827|FG000|Completed Neoadjuvant Treatment (25 Weeks)|Overall Study||182||
48221524|NCT02132949|100863828|FG001|Completed Neoadjuvant Treatment (25 Weeks)|Overall Study||189||
48221525|NCT02132949|100863827|FG000|Started Adjuvant Treatment|Overall Study||181||
48221526|NCT02132949|100863828|FG001|Started Adjuvant Treatment|Overall Study||190||
48221527|NCT02132949|100863827|FG000|Completed Adjuvant Treatment (Up to 39 Weeks)|Overall Study||163||
48221528|NCT02132949|100863828|FG001|Completed Adjuvant Treatment (Up to 39 Weeks)|Overall Study||176||
48221529|NCT02132949|100863827|FG000|Started Treatment-Free Follow-Up (Up to 5 Years)|Overall Study||195|Includes participants who completed or discontinued neoadjuvant/adjuvant treatment.|
48221530|NCT02132949|100863828|FG001|Started Treatment-Free Follow-Up (Up to 5 Years)|Overall Study||195|Includes participants who completed or discontinued neoadjuvant/adjuvant treatment.|
48221531|NCT02132949|100863827|FG000|COMPLETED|Overall Study||158||
48221532|NCT02132949|100863828|FG001|COMPLETED|Overall Study||173||
48221533|NCT02132949|100863827|FG000|NOT COMPLETED|Overall Study||41||
48221534|NCT02132949|100863828|FG001|NOT COMPLETED|Overall Study||28||
48221535|NCT00274261|100863829|FG000|STARTED|Overall Study||932||
48221536|NCT00274261|100863830|FG001|STARTED|Overall Study||633||
48221537|NCT00274261|100863829|FG000|COMPLETED|Overall Study||443||
48221538|NCT00274261|100863830|FG001|COMPLETED|Overall Study||296||
48221539|NCT00274261|100863829|FG000|NOT COMPLETED|Overall Study||489||
48221540|NCT00274261|100863830|FG001|NOT COMPLETED|Overall Study||337||
48221541|NCT04111510|100863831|FG000|STARTED|Overall Study||6||
48221542|NCT04111510|100863831|FG000|COMPLETED|Overall Study||6||
48221543|NCT04111510|100863831|FG000|NOT COMPLETED|Overall Study||0||
48221544|NCT04124432|100863832|FG000|STARTED|Overall Study||26||
48221545|NCT04124432|100863832|FG000|THC + No Nicotine/Tobacco|Overall Study||23||
48221546|NCT04124432|100863832|FG000|THC + Ad-libitum Use of Preferred Brand Cigarettes|Overall Study||20||
48221547|NCT04124432|100863832|FG000|THC + Ad-libitum Use of Low Nicotine Content E-Cig (3% Nicotine JUUL)|Overall Study||24||
48221548|NCT04124432|100863832|FG000|THC + Ad-libitum Use of High Nicotine Content E-Cig (5% Nicotine JUUL)|Overall Study||22||
48221549|NCT04124432|100863832|FG000|Placebo Cannabis + Ad-libitum Use of Preferred Brand Cigarettes|Overall Study||21||
48221550|NCT04124432|100863832|FG000|Placebo Cannabis + Ad-libitum Use of Low Nicotine Content E-Cig (3% Nicotine JUUL)|Overall Study||22||
48221551|NCT04124432|100863832|FG000|Placebo Cannabis + Ad-libitum Use of High Nicotine Content E-Cig (5% Nicotine JUUL)|Overall Study||21||
48221552|NCT04124432|100863832|FG000|COMPLETED|Overall Study||20||
48221553|NCT04124432|100863832|FG000|NOT COMPLETED|Overall Study||6||
48221554|NCT01808534|100863833|FG000|STARTED|Overall Study||5||
48221555|NCT01808534|100863833|FG000|COMPLETED|Overall Study||1||
48221556|NCT01808534|100863833|FG000|NOT COMPLETED|Overall Study||4||
48221557|NCT01359150|100863834|FG000|STARTED|Overall Study||112||
48221558|NCT01359150|100863835|FG001|STARTED|Overall Study||111||
48221559|NCT01359150|100863834|FG000|COMPLETED|Overall Study||105||
48221560|NCT01359150|100863835|FG001|COMPLETED|Overall Study||106||
48221561|NCT01359150|100863834|FG000|NOT COMPLETED|Overall Study||7||
48221562|NCT01359150|100863835|FG001|NOT COMPLETED|Overall Study||5||
48221563|NCT00112359|100863836|FG000|STARTED|Overall Study||84||
48221564|NCT00112359|100863837|FG001|STARTED|Overall Study||80||
48221565|NCT00112359|100863836|FG000|COMPLETED|Overall Study||57||
48221566|NCT00112359|100863837|FG001|COMPLETED|Overall Study||67||
48221567|NCT00112359|100863836|FG000|NOT COMPLETED|Overall Study||27||
48221568|NCT00112359|100863837|FG001|NOT COMPLETED|Overall Study||13||
48221569|NCT00914966|100863838|FG000|STARTED|Step 1: 1500 Units||20||
48221570|NCT00914966|100863838|FG000|COMPLETED|Step 1: 1500 Units||18||
48221571|NCT00914966|100863838|FG000|NOT COMPLETED|Step 1: 1500 Units||2||
48221572|NCT00914966|100863838|FG000|STARTED|Step 2: 2000 Units||13||
48221573|NCT00914966|100863838|FG000|COMPLETED|Step 2: 2000 Units||12||
48221574|NCT00914966|100863838|FG000|NOT COMPLETED|Step 2: 2000 Units||1||
48221575|NCT00914966|100863838|FG000|STARTED|Step 3: 2500 Units||12||
48221576|NCT00914966|100863838|FG000|COMPLETED|Step 3: 2500 Units||12||
48221577|NCT00914966|100863838|FG000|NOT COMPLETED|Step 3: 2500 Units||0||
48221578|NCT04448561|100863839|FG000|STARTED|Overall Study||16||
48221579|NCT04448561|100863840|FG001|STARTED|Overall Study||8||
48221580|NCT04448561|100863839|FG000|COMPLETED|Overall Study||15||
48221581|NCT04448561|100863840|FG001|COMPLETED|Overall Study||8||
48221582|NCT04448561|100863839|FG000|NOT COMPLETED|Overall Study||1||
48221583|NCT04448561|100863840|FG001|NOT COMPLETED|Overall Study||0||
48221584|NCT01378416|100863841|FG000|STARTED|Overall Study||16||
48221585|NCT01378416|100863841|FG000|COMPLETED|Overall Study||16||
48221586|NCT01378416|100863841|FG000|NOT COMPLETED|Overall Study||0||
48221587|NCT00588406|100863842|FG000|STARTED|Overall Study||46||
48221588|NCT00588406|100863843|FG001|STARTED|Overall Study||49||
48221589|NCT00588406|100863842|FG000|COMPLETED|Overall Study||46||
48221590|NCT00588406|100863843|FG001|COMPLETED|Overall Study||49||
48221591|NCT00588406|100863842|FG000|NOT COMPLETED|Overall Study||0||
48221592|NCT00588406|100863843|FG001|NOT COMPLETED|Overall Study||0||
48221593|NCT01108003|100863844|FG000|STARTED|Overall Study||4||
48221594|NCT01108003|100863845|FG001|STARTED|Overall Study||3||
48221595|NCT01108003|100863844|FG000|COMPLETED|Overall Study||4||
48221596|NCT01108003|100863845|FG001|COMPLETED|Overall Study||3||
48221597|NCT01108003|100863844|FG000|NOT COMPLETED|Overall Study||0||
48221598|NCT01108003|100863845|FG001|NOT COMPLETED|Overall Study||0||
48221599|NCT03160521|100863846|FG000|STARTED|Overall Study||144||
48221600|NCT03160521|100863847|FG001|STARTED|Overall Study||146||
48221601|NCT03160521|100863848|FG002|STARTED|Overall Study||147||
48221602|NCT03160521|100863846|FG000|COMPLETED|Overall Study||107||
48221603|NCT03160521|100863847|FG001|COMPLETED|Overall Study||95||
48221604|NCT03160521|100863848|FG002|COMPLETED|Overall Study||88||
48221605|NCT03160521|100863846|FG000|NOT COMPLETED|Overall Study||37||
48221606|NCT03160521|100863847|FG001|NOT COMPLETED|Overall Study||51||
48221607|NCT03160521|100863848|FG002|NOT COMPLETED|Overall Study||59||
48221608|NCT03660618|100863849|FG000|STARTED|Overall Study||1||
48221609|NCT03660618|100863849|FG000|COMPLETED|Overall Study||1||
48221610|NCT03660618|100863849|FG000|NOT COMPLETED|Overall Study||0||
48221611|NCT03351075|100863850|FG000|STARTED|Intensive Treatment Phase (4 mo FU)||92||
48221612|NCT03351075|100863851|FG001|STARTED|Intensive Treatment Phase (4 mo FU)||92||
48221613|NCT03351075|100863850|FG000|COMPLETED|Intensive Treatment Phase (4 mo FU)||86||
48221614|NCT03351075|100863851|FG001|COMPLETED|Intensive Treatment Phase (4 mo FU)||87||
48221615|NCT03351075|100863850|FG000|NOT COMPLETED|Intensive Treatment Phase (4 mo FU)||6||
48221616|NCT03351075|100863851|FG001|NOT COMPLETED|Intensive Treatment Phase (4 mo FU)||5||
48221617|NCT03351075|100863850|FG000|STARTED|Maintenance Treatment Phase (12 mo FU)||86||
48221618|NCT03351075|100863851|FG001|STARTED|Maintenance Treatment Phase (12 mo FU)||87||
48221619|NCT03351075|100863850|FG000|COMPLETED|Maintenance Treatment Phase (12 mo FU)||85||
48221620|NCT03351075|100863851|FG001|COMPLETED|Maintenance Treatment Phase (12 mo FU)||87||
48221621|NCT03351075|100863850|FG000|NOT COMPLETED|Maintenance Treatment Phase (12 mo FU)||1||
48221622|NCT03351075|100863851|FG001|NOT COMPLETED|Maintenance Treatment Phase (12 mo FU)||0||
48221623|NCT03351075|100863850|FG000|STARTED|End of Trial (18 mo FU)||85||
48221624|NCT03351075|100863851|FG001|STARTED|End of Trial (18 mo FU)||87||
48221625|NCT03351075|100863850|FG000|COMPLETED|End of Trial (18 mo FU)||84||
48221626|NCT03351075|100863851|FG001|COMPLETED|End of Trial (18 mo FU)||86||
48221627|NCT03351075|100863850|FG000|NOT COMPLETED|End of Trial (18 mo FU)||1||
48221628|NCT03351075|100863851|FG001|NOT COMPLETED|End of Trial (18 mo FU)||1||
48221629|NCT00100698|100863852|FG000|STARTED|Overall Study||27||
48221630|NCT00100698|100863853|FG001|STARTED|Overall Study||29||
48221631|NCT00100698|100863852|FG000|COMPLETED|Overall Study||21||
48221632|NCT00100698|100863853|FG001|COMPLETED|Overall Study||27||
48221633|NCT00100698|100863852|FG000|NOT COMPLETED|Overall Study||6||
48221634|NCT00100698|100863853|FG001|NOT COMPLETED|Overall Study||2||
48221635|NCT01220869|100863854|FG000|STARTED|Overall Study||110||
48221636|NCT01220869|100863854|FG000|COMPLETED|Overall Study||104||
48221637|NCT01220869|100863854|FG000|NOT COMPLETED|Overall Study||6||
48221638|NCT02392234|100863855|FG000|STARTED|Treatment Period 1 (8 Weeks)||41||
48221639|NCT02392234|100863856|FG001|STARTED|Treatment Period 1 (8 Weeks)||43||
48221640|NCT02392234|100863857|FG002|STARTED|Treatment Period 1 (8 Weeks)||40||
48221641|NCT02392234|100863858|FG003|STARTED|Treatment Period 1 (8 Weeks)||42||
48221642|NCT02392234|100863859|FG004|STARTED|Treatment Period 1 (8 Weeks)||41||
48221643|NCT02392234|100863860|FG005|STARTED|Treatment Period 1 (8 Weeks)||41||
48221644|NCT02392234|100863855|FG000|Treated|Treatment Period 1 (8 Weeks)||41||
48221645|NCT02392234|100863856|FG001|Treated|Treatment Period 1 (8 Weeks)||43||
48221646|NCT02392234|100863857|FG002|Treated|Treatment Period 1 (8 Weeks)||39||
48221647|NCT02392234|100863858|FG003|Treated|Treatment Period 1 (8 Weeks)||42||
48221648|NCT02392234|100863859|FG004|Treated|Treatment Period 1 (8 Weeks)||40||
48221649|NCT02392234|100863860|FG005|Treated|Treatment Period 1 (8 Weeks)||41||
48221650|NCT02392234|100863855|FG000|COMPLETED|Treatment Period 1 (8 Weeks)||38||
48221651|NCT02392234|100863856|FG001|COMPLETED|Treatment Period 1 (8 Weeks)||43||
48221652|NCT02392234|100863857|FG002|COMPLETED|Treatment Period 1 (8 Weeks)||38||
48221653|NCT02392234|100863858|FG003|COMPLETED|Treatment Period 1 (8 Weeks)||41||
48221654|NCT02392234|100863859|FG004|COMPLETED|Treatment Period 1 (8 Weeks)||37||
48221655|NCT02392234|100863860|FG005|COMPLETED|Treatment Period 1 (8 Weeks)||38||
48221656|NCT02392234|100863855|FG000|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3||
48221657|NCT02392234|100863856|FG001|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0||
48221658|NCT02392234|100863857|FG002|NOT COMPLETED|Treatment Period 1 (8 Weeks)||2||
48221659|NCT02392234|100863858|FG003|NOT COMPLETED|Treatment Period 1 (8 Weeks)||1||
48221660|NCT02392234|100863859|FG004|NOT COMPLETED|Treatment Period 1 (8 Weeks)||4||
48221661|NCT02392234|100863860|FG005|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3||
48221662|NCT02392234|100863855|FG000|STARTED|Treatment Period 2 (8 Weeks)||38||
48221663|NCT02392234|100863856|FG001|STARTED|Treatment Period 2 (8 Weeks)||43||
48221664|NCT02392234|100863857|FG002|STARTED|Treatment Period 2 (8 Weeks)||38||
48221665|NCT02392234|100863858|FG003|STARTED|Treatment Period 2 (8 Weeks)||41||
48221666|NCT02392234|100863859|FG004|STARTED|Treatment Period 2 (8 Weeks)||37||
48221667|NCT02392234|100863860|FG005|STARTED|Treatment Period 2 (8 Weeks)||38||
48668193|NCT00347269|101973017|FG001|NOT COMPLETED|Overall Study||106||
48221668|NCT02392234|100863855|FG000|COMPLETED|Treatment Period 2 (8 Weeks)||37||
48221669|NCT02392234|100863856|FG001|COMPLETED|Treatment Period 2 (8 Weeks)||43||
48221670|NCT02392234|100863857|FG002|COMPLETED|Treatment Period 2 (8 Weeks)||38||
48221671|NCT02392234|100863858|FG003|COMPLETED|Treatment Period 2 (8 Weeks)||41||
48221672|NCT02392234|100863859|FG004|COMPLETED|Treatment Period 2 (8 Weeks)||37||
48221673|NCT02392234|100863860|FG005|COMPLETED|Treatment Period 2 (8 Weeks)||38||
48221674|NCT02392234|100863855|FG000|NOT COMPLETED|Treatment Period 2 (8 Weeks)||1||
48221675|NCT02392234|100863856|FG001|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0||
48221676|NCT02392234|100863857|FG002|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0||
48221677|NCT02392234|100863858|FG003|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0||
48221678|NCT02392234|100863859|FG004|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0||
48221679|NCT02392234|100863860|FG005|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0||
48221680|NCT00829036|100863861|FG000|STARTED|Overall Study||24||
48221681|NCT00829036|100863861|FG000|COMPLETED|Overall Study||24||
48221682|NCT00829036|100863861|FG000|NOT COMPLETED|Overall Study||0||
48221683|NCT03760913|100863862|FG000|STARTED|Overall Study||17||
48221684|NCT03760913|100863863|FG001|STARTED|Overall Study||3||
48221685|NCT03760913|100863864|FG002|STARTED|Overall Study||6||
48221686|NCT03760913|100863865|FG003|STARTED|Overall Study||3||
48221687|NCT03760913|100863866|FG004|STARTED|Overall Study||6||
48221688|NCT03760913|100863867|FG005|STARTED|Overall Study||3||
48221689|NCT03760913|100863868|FG006|STARTED|Overall Study||6||
48221690|NCT03760913|100863869|FG007|STARTED|Overall Study||3||
48221691|NCT03760913|100863870|FG008|STARTED|Overall Study||3||
48221692|NCT03760913|100863871|FG009|STARTED|Overall Study||6||
48221693|NCT03760913|100863872|FG010|STARTED|Overall Study||6||
48221694|NCT03760913|100863873|FG011|STARTED|Overall Study||6||
48221695|NCT03760913|100863874|FG012|STARTED|Overall Study||12||
48221696|NCT03760913|100863875|FG013|STARTED|Overall Study||6||
48221697|NCT03760913|100863876|FG014|STARTED|Overall Study||6||
48221698|NCT03760913|100863877|FG015|STARTED|Overall Study||6||
48221699|NCT03760913|100863878|FG016|STARTED|Overall Study||6||
48221700|NCT03760913|100863879|FG017|STARTED|Overall Study||6||
48221701|NCT03760913|100863880|FG018|STARTED|Overall Study||6||
48221702|NCT03760913|100863862|FG000|COMPLETED|Overall Study||17||
48221703|NCT03760913|100863863|FG001|COMPLETED|Overall Study||3||
48221704|NCT03760913|100863864|FG002|COMPLETED|Overall Study||6||
48221705|NCT03760913|100863865|FG003|COMPLETED|Overall Study||3||
48221706|NCT03760913|100863866|FG004|COMPLETED|Overall Study||6||
48221707|NCT03760913|100863867|FG005|COMPLETED|Overall Study||3||
48221708|NCT03760913|100863868|FG006|COMPLETED|Overall Study||6||
48221709|NCT03760913|100863869|FG007|COMPLETED|Overall Study||3||
48221710|NCT03760913|100863870|FG008|COMPLETED|Overall Study||3||
48221711|NCT03760913|100863871|FG009|COMPLETED|Overall Study||6||
48221712|NCT03760913|100863872|FG010|COMPLETED|Overall Study||6||
48221713|NCT03760913|100863873|FG011|COMPLETED|Overall Study||6||
48221714|NCT03760913|100863874|FG012|COMPLETED|Overall Study||12||
48221715|NCT03760913|100863875|FG013|COMPLETED|Overall Study||6||
48221716|NCT03760913|100863876|FG014|COMPLETED|Overall Study||6||
48221717|NCT03760913|100863877|FG015|COMPLETED|Overall Study||6||
48221718|NCT03760913|100863878|FG016|COMPLETED|Overall Study||6||
48221719|NCT03760913|100863879|FG017|COMPLETED|Overall Study||6||
48221720|NCT03760913|100863880|FG018|COMPLETED|Overall Study||6||
48221721|NCT03760913|100863862|FG000|NOT COMPLETED|Overall Study||0||
48221722|NCT03760913|100863863|FG001|NOT COMPLETED|Overall Study||0||
48221723|NCT03760913|100863864|FG002|NOT COMPLETED|Overall Study||0||
48221724|NCT03760913|100863865|FG003|NOT COMPLETED|Overall Study||0||
48221725|NCT03760913|100863866|FG004|NOT COMPLETED|Overall Study||0||
48221726|NCT03760913|100863867|FG005|NOT COMPLETED|Overall Study||0||
48221727|NCT03760913|100863868|FG006|NOT COMPLETED|Overall Study||0||
48221728|NCT03760913|100863869|FG007|NOT COMPLETED|Overall Study||0||
48221729|NCT03760913|100863870|FG008|NOT COMPLETED|Overall Study||0||
48221730|NCT03760913|100863871|FG009|NOT COMPLETED|Overall Study||0||
48221731|NCT03760913|100863872|FG010|NOT COMPLETED|Overall Study||0||
48221732|NCT03760913|100863873|FG011|NOT COMPLETED|Overall Study||0||
48221733|NCT03760913|100863874|FG012|NOT COMPLETED|Overall Study||0||
48221734|NCT03760913|100863875|FG013|NOT COMPLETED|Overall Study||0||
48221735|NCT03760913|100863876|FG014|NOT COMPLETED|Overall Study||0||
48221736|NCT03760913|100863877|FG015|NOT COMPLETED|Overall Study||0||
48221737|NCT03760913|100863878|FG016|NOT COMPLETED|Overall Study||0||
48221738|NCT03760913|100863879|FG017|NOT COMPLETED|Overall Study||0||
48221739|NCT03760913|100863880|FG018|NOT COMPLETED|Overall Study||0||
48221740|NCT04075396|100863881|FG000|STARTED|Overall Study||15||
48221741|NCT04075396|100863882|FG001|STARTED|Overall Study||14||
48221742|NCT04075396|100863881|FG000|Treated (Safety Analysis Population)|Overall Study||15||
48221743|NCT04075396|100863882|FG001|Treated (Safety Analysis Population)|Overall Study||13||
48221744|NCT04075396|100863881|FG000|COMPLETED|Overall Study||0||
48221745|NCT04075396|100863882|FG001|COMPLETED|Overall Study||0||
48221746|NCT04075396|100863881|FG000|NOT COMPLETED|Overall Study||15||
48221747|NCT04075396|100863882|FG001|NOT COMPLETED|Overall Study||14||
48221748|NCT00229658|100863883|FG000|STARTED|Overall Study||766||
48221749|NCT00229658|100863884|FG001|STARTED|Overall Study||531||
48221750|NCT00229658|100863883|FG000|COMPLETED|Overall Study||541||
48221751|NCT00229658|100863884|FG001|COMPLETED|Overall Study||364||
48221752|NCT00229658|100863883|FG000|NOT COMPLETED|Overall Study||225||
48221753|NCT00229658|100863884|FG001|NOT COMPLETED|Overall Study||167||
48221754|NCT02593149|100863885|FG000|STARTED|Run-In||340||20
48221755|NCT02593149|100863886|FG001|STARTED|Run-In||361||20
48221756|NCT02593149|100863885|FG000|COMPLETED|Run-In||304||20
48221757|NCT02593149|100863886|FG001|COMPLETED|Run-In||323||20
48221758|NCT02593149|100863885|FG000|NOT COMPLETED|Run-In||36||0
48221759|NCT02593149|100863886|FG001|NOT COMPLETED|Run-In||38||0
48221760|NCT02593149|100863885|FG000|STARTED|Intervention||942||20
48221761|NCT02593149|100863886|FG001|STARTED|Intervention||960||20
48221762|NCT02593149|100863885|FG000|COMPLETED|Intervention||826||20
48221763|NCT02593149|100863886|FG001|COMPLETED|Intervention||845||20
48221764|NCT02593149|100863885|FG000|NOT COMPLETED|Intervention||116||0
48221765|NCT02593149|100863886|FG001|NOT COMPLETED|Intervention||115||0
48221766|NCT01700205|100863887|FG000|STARTED|Overall Study||59||
48221767|NCT01700205|100863888|FG001|STARTED|Overall Study||54||
48221768|NCT01700205|100863887|FG000|COMPLETED|Overall Study||44||
48221769|NCT01700205|100863888|FG001|COMPLETED|Overall Study||39||
48221770|NCT01700205|100863887|FG000|NOT COMPLETED|Overall Study||15||
48221771|NCT01700205|100863888|FG001|NOT COMPLETED|Overall Study||15||
48221772|NCT00790699|100863889|FG000|STARTED|Overall Study||17||
48221773|NCT00790699|100863890|FG001|STARTED|Overall Study||14||
48221774|NCT00790699|100863889|FG000|COMPLETED|Overall Study||16||
48221775|NCT00790699|100863890|FG001|COMPLETED|Overall Study||14||
48221776|NCT00790699|100863889|FG000|NOT COMPLETED|Overall Study||1||
48221777|NCT00790699|100863890|FG001|NOT COMPLETED|Overall Study||0||
48221778|NCT02369484|100863891|FG000|STARTED|Overall Study||13||
48221779|NCT02369484|100863891|FG000|COMPLETED|Overall Study||13||
48221780|NCT02369484|100863891|FG000|NOT COMPLETED|Overall Study||0||
48221781|NCT00999336|100863892|FG000|STARTED|Overall Study||8||
48221782|NCT00999336|100863893|FG001|STARTED|Overall Study||8||
48221783|NCT00999336|100863894|FG002|STARTED|Overall Study||8||
48221784|NCT00999336|100863895|FG003|STARTED|Overall Study||8||
48221785|NCT00999336|100863892|FG000|COMPLETED|Overall Study||8||
48221786|NCT00999336|100863893|FG001|COMPLETED|Overall Study||8||
48221787|NCT00999336|100863894|FG002|COMPLETED|Overall Study||8||
48221788|NCT00999336|100863895|FG003|COMPLETED|Overall Study||8||
48221789|NCT00999336|100863892|FG000|NOT COMPLETED|Overall Study||0||
48221790|NCT00999336|100863893|FG001|NOT COMPLETED|Overall Study||0||
48221791|NCT00999336|100863894|FG002|NOT COMPLETED|Overall Study||0||
48221792|NCT00999336|100863895|FG003|NOT COMPLETED|Overall Study||0||
48221793|NCT01211184|100863896|FG000|STARTED|Overall Study||20||
48221794|NCT01211184|100863897|FG001|STARTED|Overall Study||20||
48221795|NCT01211184|100863898|FG002|STARTED|Overall Study||20||
48221796|NCT01211184|100863896|FG000|COMPLETED|Overall Study||20||
48221797|NCT01211184|100863897|FG001|COMPLETED|Overall Study||18||
48221798|NCT01211184|100863898|FG002|COMPLETED|Overall Study||19||
48221799|NCT01211184|100863896|FG000|NOT COMPLETED|Overall Study||0||
48221800|NCT01211184|100863897|FG001|NOT COMPLETED|Overall Study||2||
48221801|NCT01211184|100863898|FG002|NOT COMPLETED|Overall Study||1||
48221802|NCT02672033|100863899|FG000|STARTED|Overall Study||2||
48221803|NCT02672033|100863899|FG000|COMPLETED|Overall Study||2||
48221804|NCT02672033|100863899|FG000|NOT COMPLETED|Overall Study||0||
48221805|NCT00145470|100863900|FG000|STARTED|Overall Study||167||
48221806|NCT00145470|100863901|FG001|STARTED|Overall Study||159||
48221807|NCT00145470|100863900|FG000|Treated|Overall Study||166||
48221808|NCT00145470|100863901|FG001|Treated|Overall Study||158||
48221809|NCT00145470|100863900|FG000|COMPLETED|Overall Study||55||
48221810|NCT00145470|100863901|FG001|COMPLETED|Overall Study||61||
48221811|NCT00145470|100863900|FG000|NOT COMPLETED|Overall Study||112||
48221812|NCT00145470|100863901|FG001|NOT COMPLETED|Overall Study||98||
48221813|NCT03234374|100863902|FG000|STARTED|Overall Study||35||
48221814|NCT03234374|100863903|FG001|STARTED|Overall Study||17||
48221815|NCT03234374|100863902|FG000|COMPLETED|Overall Study||34||
48221816|NCT03234374|100863903|FG001|COMPLETED|Overall Study||16||
48221817|NCT03234374|100863902|FG000|NOT COMPLETED|Overall Study||1||
48221818|NCT03234374|100863903|FG001|NOT COMPLETED|Overall Study||1||
48221819|NCT00968149|100863904|FG000|STARTED|Overall Study||280||
48221820|NCT00968149|100863905|FG001|STARTED|Overall Study||133||
48221821|NCT00968149|100863904|FG000|COMPLETED|Overall Study||269||
48221822|NCT00968149|100863905|FG001|COMPLETED|Overall Study||127||
48221823|NCT00968149|100863904|FG000|NOT COMPLETED|Overall Study||11||
48221824|NCT00968149|100863905|FG001|NOT COMPLETED|Overall Study||6||
48221825|NCT01638000|100863906|FG000|STARTED|Overall Study||943||
48221826|NCT01638000|100863907|FG001|STARTED|Overall Study||944||
48221827|NCT01638000|100863906|FG000|Received at Least 1 Double-Blind Dose|Overall Study||936||
48221828|NCT01638000|100863907|FG001|Received at Least 1 Double-Blind Dose|Overall Study||934||
48221829|NCT01638000|100863906|FG000|COMPLETED|Overall Study||883||
48221830|NCT01638000|100863907|FG001|COMPLETED|Overall Study||873||
48221831|NCT01638000|100863906|FG000|NOT COMPLETED|Overall Study||60||
48221832|NCT01638000|100863907|FG001|NOT COMPLETED|Overall Study||71||
48221833|NCT01400958|100863908|FG000|STARTED|Overall Study||3||
48221834|NCT01400958|100863909|FG001|STARTED|Overall Study||3||
48221835|NCT01400958|100863908|FG000|COMPLETED|Overall Study||2||
48221836|NCT01400958|100863909|FG001|COMPLETED|Overall Study||1||
48221837|NCT01400958|100863908|FG000|NOT COMPLETED|Overall Study||1||
48221838|NCT01400958|100863909|FG001|NOT COMPLETED|Overall Study||2||
48221839|NCT00575016|100863910|FG000|STARTED|Treatment Cycle 1||17||
48221840|NCT00575016|100863911|FG001|STARTED|Treatment Cycle 1||21||
48221841|NCT00575016|100863912|FG002|STARTED|Treatment Cycle 1||19||
48221842|NCT00575016|100863913|FG003|STARTED|Treatment Cycle 1||17||
48221843|NCT00575016|100863910|FG000|COMPLETED|Treatment Cycle 1||8||
48221844|NCT00575016|100863911|FG001|COMPLETED|Treatment Cycle 1||16||
48221845|NCT00575016|100863912|FG002|COMPLETED|Treatment Cycle 1||15||
48221846|NCT00575016|100863913|FG003|COMPLETED|Treatment Cycle 1||12||
48221847|NCT00575016|100863910|FG000|NOT COMPLETED|Treatment Cycle 1||9||
48221848|NCT00575016|100863911|FG001|NOT COMPLETED|Treatment Cycle 1||5||
48221849|NCT00575016|100863912|FG002|NOT COMPLETED|Treatment Cycle 1||4||
48221850|NCT00575016|100863913|FG003|NOT COMPLETED|Treatment Cycle 1||5||
48221851|NCT00575016|100863910|FG000|STARTED|Treatment Cycle 2||31||
48221852|NCT00575016|100863911|FG001|STARTED|Treatment Cycle 2||0||
48221853|NCT00575016|100863912|FG002|STARTED|Treatment Cycle 2||0||
48221854|NCT00575016|100863913|FG003|STARTED|Treatment Cycle 2||0||
48221855|NCT00575016|100863910|FG000|COMPLETED|Treatment Cycle 2||30||
48221856|NCT00575016|100863911|FG001|COMPLETED|Treatment Cycle 2||0||
48221857|NCT00575016|100863912|FG002|COMPLETED|Treatment Cycle 2||0||
48221858|NCT00575016|100863913|FG003|COMPLETED|Treatment Cycle 2||0||
48221859|NCT00575016|100863910|FG000|NOT COMPLETED|Treatment Cycle 2||1||
48221860|NCT00575016|100863911|FG001|NOT COMPLETED|Treatment Cycle 2||0||
48221861|NCT00575016|100863912|FG002|NOT COMPLETED|Treatment Cycle 2||0||
48221862|NCT00575016|100863913|FG003|NOT COMPLETED|Treatment Cycle 2||0||
48221863|NCT03613740|100863914|FG000|STARTED|Overall Study||14||
48221864|NCT03613740|100863915|FG001|STARTED|Overall Study||14||
48221865|NCT03613740|100863914|FG000|COMPLETED|Overall Study||13||
48221866|NCT03613740|100863915|FG001|COMPLETED|Overall Study||13||
48221867|NCT03613740|100863914|FG000|NOT COMPLETED|Overall Study||1||
48221868|NCT03613740|100863915|FG001|NOT COMPLETED|Overall Study||1||
48221869|NCT01288443|100863916|FG000|STARTED|Overall Study||31||
48221870|NCT01288443|100863917|FG001|STARTED|Overall Study||30||
48221871|NCT01288443|100863918|FG002|STARTED|Overall Study||31||
48221872|NCT01288443|100863919|FG003|STARTED|Overall Study||31||
48221873|NCT01288443|100863920|FG004|STARTED|Overall Study||30||
48221874|NCT01288443|100863921|FG005|STARTED|Overall Study||30||
48221875|NCT01288443|100863916|FG000|Treated|Overall Study||31||
48221876|NCT01288443|100863917|FG001|Treated|Overall Study||30||
48221877|NCT01288443|100863918|FG002|Treated|Overall Study||31||
48221878|NCT01288443|100863919|FG003|Treated|Overall Study||31||
48221879|NCT01288443|100863920|FG004|Treated|Overall Study||29||
48221880|NCT01288443|100863921|FG005|Treated|Overall Study||30||
48221881|NCT01288443|100863916|FG000|COMPLETED|Overall Study||31||
48221882|NCT01288443|100863917|FG001|COMPLETED|Overall Study||29||
48221883|NCT01288443|100863918|FG002|COMPLETED|Overall Study||30||
48221884|NCT01288443|100863919|FG003|COMPLETED|Overall Study||27||
48221885|NCT01288443|100863920|FG004|COMPLETED|Overall Study||23||
48221886|NCT01288443|100863921|FG005|COMPLETED|Overall Study||25||
48221887|NCT01288443|100863916|FG000|NOT COMPLETED|Overall Study||0||
48221888|NCT01288443|100863917|FG001|NOT COMPLETED|Overall Study||1||
48221889|NCT01288443|100863918|FG002|NOT COMPLETED|Overall Study||1||
48221890|NCT01288443|100863919|FG003|NOT COMPLETED|Overall Study||4||
48221891|NCT01288443|100863920|FG004|NOT COMPLETED|Overall Study||7||
48221892|NCT01288443|100863921|FG005|NOT COMPLETED|Overall Study||5||
48221893|NCT03092726|100863922|FG000|STARTED|Overall Study||88||
48221894|NCT03092726|100863923|FG001|STARTED|Overall Study||95||
48221895|NCT03092726|100863922|FG000|Treated|Overall Study||88||
48221896|NCT03092726|100863923|FG001|Treated|Overall Study||95||
48221897|NCT03092726|100863922|FG000|COMPLETED|Overall Study||79|Completed the treatment period.|
48221898|NCT03092726|100863923|FG001|COMPLETED|Overall Study||81|Completed the treatment period.|
48221899|NCT03092726|100863922|FG000|NOT COMPLETED|Overall Study||9||
48221900|NCT03092726|100863923|FG001|NOT COMPLETED|Overall Study||14||
48221901|NCT00580866|100863924|FG000|STARTED|Overall Study||10||
48221902|NCT00580866|100863925|FG001|STARTED|Overall Study||7||
48221903|NCT00580866|100863924|FG000|COMPLETED|Overall Study||8||
48221904|NCT00580866|100863925|FG001|COMPLETED|Overall Study||5||
48221905|NCT00580866|100863924|FG000|NOT COMPLETED|Overall Study||2||
48221906|NCT00580866|100863925|FG001|NOT COMPLETED|Overall Study||2||
48221907|NCT02313675|100863926|FG000|STARTED|Overall Study||11||
48221908|NCT02313675|100863927|FG001|STARTED|Overall Study||11||
48221909|NCT02313675|100863928|FG002|STARTED|Overall Study||11||
48221910|NCT02313675|100863929|FG003|STARTED|Overall Study||11||
48221911|NCT02313675|100863926|FG000|COMPLETED|Overall Study||11||
48221912|NCT02313675|100863927|FG001|COMPLETED|Overall Study||11||
48221913|NCT02313675|100863928|FG002|COMPLETED|Overall Study||11||
48221914|NCT02313675|100863929|FG003|COMPLETED|Overall Study||11||
48221915|NCT02313675|100863926|FG000|NOT COMPLETED|Overall Study||0||
48221916|NCT02313675|100863927|FG001|NOT COMPLETED|Overall Study||0||
48221917|NCT02313675|100863928|FG002|NOT COMPLETED|Overall Study||0||
48221918|NCT02313675|100863929|FG003|NOT COMPLETED|Overall Study||0||
48221919|NCT01880736|100863930|FG000|STARTED|Overall Study||114||
48221920|NCT01880736|100863931|FG001|STARTED|Overall Study||115||
48221921|NCT01880736|100863932|FG002|STARTED|Overall Study||115||
48221922|NCT01880736|100863933|FG003|STARTED|Overall Study||114||
48221923|NCT01880736|100863930|FG000|COMPLETED|Overall Study||113||
48221924|NCT01880736|100863931|FG001|COMPLETED|Overall Study||113||
48221925|NCT01880736|100863932|FG002|COMPLETED|Overall Study||114||
48221926|NCT01880736|100863933|FG003|COMPLETED|Overall Study||108||
48221927|NCT01880736|100863930|FG000|NOT COMPLETED|Overall Study||1||
48221928|NCT01880736|100863931|FG001|NOT COMPLETED|Overall Study||2||
48221929|NCT01880736|100863932|FG002|NOT COMPLETED|Overall Study||1||
48221930|NCT01880736|100863933|FG003|NOT COMPLETED|Overall Study||6||
48221931|NCT03781375|100863934|FG000|STARTED|Double-blind Phase||12||
48221932|NCT03781375|100863935|FG001|STARTED|Double-blind Phase||13||
48221933|NCT03781375|100863934|FG000|Received Study Drug|Double-blind Phase||12||
48221934|NCT03781375|100863935|FG001|Received Study Drug|Double-blind Phase||13||
48221935|NCT03781375|100863934|FG000|COMPLETED|Double-blind Phase||5||
48221936|NCT03781375|100863935|FG001|COMPLETED|Double-blind Phase||7||
48221937|NCT03781375|100863934|FG000|NOT COMPLETED|Double-blind Phase||7||
48221938|NCT03781375|100863935|FG001|NOT COMPLETED|Double-blind Phase||6||
48221939|NCT03781375|100863934|FG000|STARTED|Open-label Phase||11|Participants who completed blinded treatment or who withdrew early due to flare or lack of response|
48221940|NCT03781375|100863935|FG001|STARTED|Open-label Phase||9|Participants who completed blinded treatment or who withdrew early due to flare or lack of response|
48221941|NCT03781375|100863934|FG000|Received Study Drug|Open-label Phase||10||
48221942|NCT03781375|100863935|FG001|Received Study Drug|Open-label Phase||9||
48221943|NCT03781375|100863934|FG000|COMPLETED|Open-label Phase||8||
48221944|NCT03781375|100863935|FG001|COMPLETED|Open-label Phase||6||
48221945|NCT03781375|100863934|FG000|NOT COMPLETED|Open-label Phase||3||
48221946|NCT03781375|100863935|FG001|NOT COMPLETED|Open-label Phase||3||
48221947|NCT03027128|100863936|FG000|STARTED|Overall Study||6||
48221948|NCT03027128|100863936|FG000|COMPLETED|Overall Study||6|Completed defined as receiving at least one dose of study drug.|
48221949|NCT03027128|100863936|FG000|NOT COMPLETED|Overall Study||0||
48221950|NCT04612244|100863937|FG000|STARTED|Overall Study||305||305
48221951|NCT04612244|100863938|FG001|STARTED|Overall Study||302||302
48221952|NCT04612244|100863937|FG000|COMPLETED|Overall Study||293||293
48221953|NCT04612244|100863938|FG001|COMPLETED|Overall Study||290||290
48221954|NCT04612244|100863937|FG000|NOT COMPLETED|Overall Study||12||12
48221955|NCT04612244|100863938|FG001|NOT COMPLETED|Overall Study||12||12
48221956|NCT00727909|100863939|FG000|STARTED|Overall Study||65||
48221957|NCT00727909|100863940|FG001|STARTED|Overall Study||72||
48221958|NCT00727909|100863941|FG002|STARTED|Overall Study||67||
48221959|NCT00727909|100863942|FG003|STARTED|Overall Study||75||
48221960|NCT00727909|100863939|FG000|COMPLETED|Overall Study||60||
48221961|NCT00727909|100863940|FG001|COMPLETED|Overall Study||61||
48221962|NCT00727909|100863941|FG002|COMPLETED|Overall Study||58||
48221963|NCT00727909|100863942|FG003|COMPLETED|Overall Study||70||
48221964|NCT00727909|100863939|FG000|NOT COMPLETED|Overall Study||5||
48221965|NCT00727909|100863940|FG001|NOT COMPLETED|Overall Study||11||
48221966|NCT00727909|100863941|FG002|NOT COMPLETED|Overall Study||9||
48221967|NCT00727909|100863942|FG003|NOT COMPLETED|Overall Study||5||
48221968|NCT01571557|100863943|FG000|STARTED|Overall Study||573||
48221969|NCT01571557|100863943|FG000|COMPLETED|Overall Study||573||
48221970|NCT01571557|100863943|FG000|NOT COMPLETED|Overall Study||0||
48221971|NCT01953224|100863944|FG000|STARTED|Overall Study||20||
48221972|NCT01953224|100863945|FG001|STARTED|Overall Study||20||
48221973|NCT01953224|100863944|FG000|COMPLETED|Overall Study||18||
48221974|NCT01953224|100863945|FG001|COMPLETED|Overall Study||17||
48221975|NCT01953224|100863944|FG000|NOT COMPLETED|Overall Study||2||
48221976|NCT01953224|100863945|FG001|NOT COMPLETED|Overall Study||3||
48221977|NCT02431273|100863946|FG000|STARTED|TDF (Single IVR)||6||
48221978|NCT02431273|100863946|FG000|COMPLETED|TDF (Single IVR)||6|All 6 participants that completed Period 1 (TDF IVR) screened for Period 2 (TDF-FTC IVR)|
48221979|NCT02431273|100863946|FG000|NOT COMPLETED|TDF (Single IVR)||0||
48221980|NCT02431273|100863946|FG000|STARTED|TDF-FTC (Dual IVR)||6||
48221981|NCT02431273|100863946|FG000|COMPLETED|TDF-FTC (Dual IVR)||6|2 of 6 participants that completed Period 2 (TDF-FTC IVR) screened for Period 3 (TDF-FTC-MVC IVR)|
48221982|NCT02431273|100863946|FG000|NOT COMPLETED|TDF-FTC (Dual IVR)||0||
48221983|NCT02431273|100863946|FG000|STARTED|TDF-FTC-MVC (Triple IVR)||6||
48221984|NCT02431273|100863946|FG000|COMPLETED|TDF-FTC-MVC (Triple IVR)||6|2 participants that completed Periods 1 and 2, along with 4 new subjects participated in Period 3|
48221985|NCT02431273|100863946|FG000|NOT COMPLETED|TDF-FTC-MVC (Triple IVR)||0||
48221986|NCT04919499|100863947|FG000|STARTED|Overall Study||3||
48221987|NCT04919499|100863948|FG001|STARTED|Overall Study||3||
48221988|NCT04919499|100863949|FG002|STARTED|Overall Study||6||
48221989|NCT04919499|100863950|FG003|STARTED|Overall Study||11||
48221990|NCT04919499|100863951|FG004|STARTED|Overall Study||23||
48221991|NCT04919499|100863947|FG000|Treated|Overall Study||3||
48221992|NCT04919499|100863948|FG001|Treated|Overall Study||3||
48221993|NCT04919499|100863949|FG002|Treated|Overall Study||6||
48221994|NCT04919499|100863950|FG003|Treated|Overall Study||10||
48221995|NCT04919499|100863951|FG004|Treated|Overall Study||23||
48221996|NCT04919499|100863947|FG000|COMPLETED|Overall Study||3||
48221997|NCT04919499|100863948|FG001|COMPLETED|Overall Study||3||
48221998|NCT04919499|100863949|FG002|COMPLETED|Overall Study||6||
48221999|NCT04919499|100863950|FG003|COMPLETED|Overall Study||10||
48222000|NCT04919499|100863951|FG004|COMPLETED|Overall Study||21||
48222001|NCT04919499|100863947|FG000|NOT COMPLETED|Overall Study||0||
48222002|NCT04919499|100863948|FG001|NOT COMPLETED|Overall Study||0||
48222003|NCT04919499|100863949|FG002|NOT COMPLETED|Overall Study||0||
48222004|NCT04919499|100863950|FG003|NOT COMPLETED|Overall Study||1||
48222005|NCT04919499|100863951|FG004|NOT COMPLETED|Overall Study||2||
48222006|NCT06571695|100863952|FG000|STARTED|Overall Study||80||
48222007|NCT06571695|100863953|FG001|STARTED|Overall Study||87||
48222008|NCT06571695|100863952|FG000|COMPLETED|Overall Study||79||
48222009|NCT06571695|100863953|FG001|COMPLETED|Overall Study||81||
48222010|NCT06571695|100863952|FG000|NOT COMPLETED|Overall Study||1||
48222011|NCT06571695|100863953|FG001|NOT COMPLETED|Overall Study||6||
48222012|NCT01268306|100863954|FG000|STARTED|Overall Study||8||
48222013|NCT01268306|100863954|FG000|COMPLETED|Overall Study||7||
48222014|NCT01268306|100863954|FG000|NOT COMPLETED|Overall Study||1||
48222015|NCT02988193|100863955|FG000|STARTED|Overall Study||12||
48222016|NCT02988193|100863956|FG001|STARTED|Overall Study||16||
48222017|NCT02988193|100863955|FG000|COMPLETED|Overall Study||12||
48222018|NCT02988193|100863956|FG001|COMPLETED|Overall Study||16||
48222019|NCT02988193|100863955|FG000|NOT COMPLETED|Overall Study||0||
48222020|NCT02988193|100863956|FG001|NOT COMPLETED|Overall Study||0||
48222021|NCT02357966|100863957|FG000|STARTED|Overall Study||3||
48222022|NCT02357966|100863958|FG001|STARTED|Overall Study||3||
48222023|NCT02357966|100863959|FG002|STARTED|Overall Study||6||
48222024|NCT02357966|100863960|FG003|STARTED|Overall Study||4||
48222025|NCT02357966|100863961|FG004|STARTED|Overall Study||24||
48222026|NCT02357966|100863962|FG005|STARTED|Overall Study||12||
48222027|NCT02357966|100863957|FG000|COMPLETED|Overall Study||2||
48222028|NCT02357966|100863958|FG001|COMPLETED|Overall Study||3||
48222029|NCT02357966|100863959|FG002|COMPLETED|Overall Study||5||
48222030|NCT02357966|100863960|FG003|COMPLETED|Overall Study||4||
48222031|NCT02357966|100863961|FG004|COMPLETED|Overall Study||21||
48222032|NCT02357966|100863962|FG005|COMPLETED|Overall Study||12||
48222033|NCT02357966|100863957|FG000|NOT COMPLETED|Overall Study||1||
48222034|NCT02357966|100863958|FG001|NOT COMPLETED|Overall Study||0||
48222035|NCT02357966|100863959|FG002|NOT COMPLETED|Overall Study||1||
48222036|NCT02357966|100863960|FG003|NOT COMPLETED|Overall Study||0||
48222037|NCT02357966|100863961|FG004|NOT COMPLETED|Overall Study||3||
48222038|NCT02357966|100863962|FG005|NOT COMPLETED|Overall Study||0||
48222039|NCT04941703|100863963|FG000|STARTED|Overall Study||8||
48222040|NCT04941703|100863964|FG001|STARTED|Overall Study||10||
48222041|NCT04941703|100863963|FG000|COMPLETED|Overall Study||8||
48222042|NCT04941703|100863964|FG001|COMPLETED|Overall Study||10||
48222043|NCT04941703|100863963|FG000|NOT COMPLETED|Overall Study||0||
48222044|NCT04941703|100863964|FG001|NOT COMPLETED|Overall Study||0||
48222045|NCT03246724|100863965|FG000|STARTED|Overall Study||99||
48222046|NCT03246724|100863966|FG001|STARTED|Overall Study||91||
48222047|NCT03246724|100863967|FG002|STARTED|Overall Study||85||
48222048|NCT03246724|100863968|FG003|STARTED|Overall Study||52||
48222049|NCT03246724|100863965|FG000|COMPLETED|Overall Study||85||
48222050|NCT03246724|100863966|FG001|COMPLETED|Overall Study||84||
48222051|NCT03246724|100863967|FG002|COMPLETED|Overall Study||70||
48222052|NCT03246724|100863968|FG003|COMPLETED|Overall Study||44||
48222053|NCT03246724|100863965|FG000|NOT COMPLETED|Overall Study||14||
48222054|NCT03246724|100863966|FG001|NOT COMPLETED|Overall Study||7||
48222055|NCT03246724|100863967|FG002|NOT COMPLETED|Overall Study||15||
48222056|NCT03246724|100863968|FG003|NOT COMPLETED|Overall Study||8||
48222057|NCT00116649|100863969|FG000|STARTED|Overall Study||551||
48222058|NCT00116649|100863969|FG000|COMPLETED|Overall Study||396||
48222059|NCT00116649|100863969|FG000|NOT COMPLETED|Overall Study||155||
48222060|NCT00503906|100863970|FG000|STARTED|Overall Study||30||
48222061|NCT00503906|100863970|FG000|COMPLETED|Overall Study||29||
48222062|NCT00503906|100863970|FG000|NOT COMPLETED|Overall Study||1||
48222063|NCT03637296|100863971|FG000|STARTED|Overall Study||10||
48222064|NCT03637296|100863972|FG001|STARTED|Overall Study||5||
48222065|NCT03637296|100863971|FG000|COMPLETED|Overall Study||10||
48222066|NCT03637296|100863972|FG001|COMPLETED|Overall Study||5||
48222067|NCT03637296|100863971|FG000|NOT COMPLETED|Overall Study||0||
48222068|NCT03637296|100863972|FG001|NOT COMPLETED|Overall Study||0||
48222069|NCT05957198|100863973|FG000|STARTED|Overall Study||114921||
48222070|NCT05957198|100863973|FG000|COMPLETED|Overall Study||114921||
48222071|NCT05957198|100863973|FG000|NOT COMPLETED|Overall Study||0||
48668194|NCT00829244|101973018|FG000|STARTED|Overall Study||96||
48668195|NCT00829244|101973019|FG001|STARTED|Overall Study||104||
48668196|NCT00829244|101973018|FG000|COMPLETED|Overall Study||82||
48668197|NCT00829244|101973019|FG001|COMPLETED|Overall Study||83||
48668198|NCT00829244|101973018|FG000|NOT COMPLETED|Overall Study||14||
48668199|NCT00829244|101973019|FG001|NOT COMPLETED|Overall Study||21||
48668200|NCT05093621|101973020|FG000|STARTED|Overall Study||23||
48668201|NCT05093621|101973021|FG001|STARTED|Overall Study||24||
48668202|NCT05093621|101973020|FG000|Yale Site Participants|Overall Study||18||
48668203|NCT05093621|101973021|FG001|Yale Site Participants|Overall Study||18||
48668204|NCT05093621|101973020|FG000|COMPLETED|Overall Study||23||
48668205|NCT05093621|101973021|FG001|COMPLETED|Overall Study||24||
48668206|NCT05093621|101973020|FG000|NOT COMPLETED|Overall Study||0||
48668207|NCT05093621|101973021|FG001|NOT COMPLETED|Overall Study||0||
48668208|NCT01432444|101973022|FG000|STARTED|Tolerability/Cross-titration Phase||325||
48668209|NCT01432444|101973023|FG001|STARTED|Tolerability/Cross-titration Phase||0||
48668210|NCT01432444|101973024|FG002|STARTED|Tolerability/Cross-titration Phase||0||
48668211|NCT01432444|101973022|FG000|COMPLETED|Tolerability/Cross-titration Phase||265||
48668212|NCT01432444|101973023|FG001|COMPLETED|Tolerability/Cross-titration Phase||0||
48668213|NCT01432444|101973024|FG002|COMPLETED|Tolerability/Cross-titration Phase||0||
48668214|NCT01432444|101973022|FG000|NOT COMPLETED|Tolerability/Cross-titration Phase||60||
48668215|NCT01432444|101973023|FG001|NOT COMPLETED|Tolerability/Cross-titration Phase||0||
48668216|NCT01432444|101973024|FG002|NOT COMPLETED|Tolerability/Cross-titration Phase||0||
48668217|NCT01432444|101973022|FG000|STARTED|Treatment Phase||0||
48668218|NCT01432444|101973023|FG001|STARTED|Treatment Phase||433||
48668219|NCT01432444|101973024|FG002|STARTED|Treatment Phase||0||
48668220|NCT01432444|101973022|FG000|COMPLETED|Treatment Phase||0||
48668221|NCT01432444|101973023|FG001|COMPLETED|Treatment Phase||293||
48668222|NCT01432444|101973024|FG002|COMPLETED|Treatment Phase||0||
48668223|NCT01432444|101973022|FG000|NOT COMPLETED|Treatment Phase||0||
48668224|NCT01432444|101973023|FG001|NOT COMPLETED|Treatment Phase||140||
48668225|NCT01432444|101973024|FG002|NOT COMPLETED|Treatment Phase||0||
48668226|NCT01432444|101973022|FG000|STARTED|Extension Phase||0||
48668227|NCT01432444|101973023|FG001|STARTED|Extension Phase||0||
48668228|NCT01432444|101973024|FG002|STARTED|Extension Phase||192||
48668229|NCT01432444|101973022|FG000|COMPLETED|Extension Phase||0||
48668230|NCT01432444|101973023|FG001|COMPLETED|Extension Phase||0||
48668231|NCT01432444|101973024|FG002|COMPLETED|Extension Phase||0||
48668232|NCT01432444|101973022|FG000|NOT COMPLETED|Extension Phase||0||
48668233|NCT01432444|101973023|FG001|NOT COMPLETED|Extension Phase||0||
48668234|NCT01432444|101973024|FG002|NOT COMPLETED|Extension Phase||192||
48668235|NCT02296099|101973025|FG000|STARTED|Overall Study||57||
48668236|NCT02296099|101973026|FG001|STARTED|Overall Study||57||
48668237|NCT02296099|101973025|FG000|COMPLETED|Overall Study||54||
48668238|NCT02296099|101973026|FG001|COMPLETED|Overall Study||55||
48668239|NCT02296099|101973025|FG000|NOT COMPLETED|Overall Study||3||
48668240|NCT02296099|101973026|FG001|NOT COMPLETED|Overall Study||2||
48668241|NCT02360085|101973027|FG000|STARTED|Overall Study||65||
48668242|NCT02360085|101973027|FG000|COMPLETED|Overall Study||49||
48668243|NCT02360085|101973027|FG000|NOT COMPLETED|Overall Study||16||
48668244|NCT00759395|101973028|FG000|STARTED|Overall Study||13||
48668245|NCT00759395|101973029|FG001|STARTED|Overall Study||9||
48668246|NCT00759395|101973028|FG000|COMPLETED|Overall Study||11||
48668247|NCT00759395|101973029|FG001|COMPLETED|Overall Study||7||
48668248|NCT00759395|101973028|FG000|NOT COMPLETED|Overall Study||2||
48668249|NCT00759395|101973029|FG001|NOT COMPLETED|Overall Study||2||
48668250|NCT02399228|101973030|FG000|STARTED|Overall Study||13||
48668251|NCT02399228|101973030|FG000|COMPLETED|Overall Study||7||
48668252|NCT02399228|101973030|FG000|NOT COMPLETED|Overall Study||6||
48668253|NCT02880319|101973031|FG000|STARTED|Overall Study||98||
48668254|NCT02880319|101973032|FG001|STARTED|Overall Study||44||
48668255|NCT02880319|101973031|FG000|COMPLETED|Overall Study||98||
48668256|NCT02880319|101973032|FG001|COMPLETED|Overall Study||44||
48668257|NCT02880319|101973031|FG000|NOT COMPLETED|Overall Study||0||
48668258|NCT02880319|101973032|FG001|NOT COMPLETED|Overall Study||0||
48668259|NCT01514357|101973033|FG000|STARTED|Overall Study||12||
48668260|NCT01514357|101973034|FG001|STARTED|Overall Study||0||
48668261|NCT01514357|101973033|FG000|COMPLETED|Overall Study||8||
48668262|NCT01514357|101973034|FG001|COMPLETED|Overall Study||0||
48668263|NCT01514357|101973033|FG000|NOT COMPLETED|Overall Study||4||
48668264|NCT01514357|101973034|FG001|NOT COMPLETED|Overall Study||0||
48668265|NCT00829868|101973035|FG000|STARTED|First Intervention||21||
48668266|NCT00829868|101973036|FG001|STARTED|First Intervention||21||
48668267|NCT00829868|101973035|FG000|COMPLETED|First Intervention||21||
48668268|NCT00829868|101973036|FG001|COMPLETED|First Intervention||21||
48668269|NCT00829868|101973035|FG000|NOT COMPLETED|First Intervention||0||
48668270|NCT00829868|101973036|FG001|NOT COMPLETED|First Intervention||0||
48668271|NCT00829868|101973035|FG000|STARTED|Washout||21||
48668272|NCT00829868|101973036|FG001|STARTED|Washout||21||
48668273|NCT00829868|101973035|FG000|COMPLETED|Washout||20||
48668274|NCT00829868|101973036|FG001|COMPLETED|Washout||21||
48668275|NCT00829868|101973035|FG000|NOT COMPLETED|Washout||1||
48668276|NCT00829868|101973036|FG001|NOT COMPLETED|Washout||0||
48668277|NCT00829868|101973035|FG000|STARTED|Second Intervention||20||
48668278|NCT00829868|101973036|FG001|STARTED|Second Intervention||21||
48668279|NCT00829868|101973035|FG000|COMPLETED|Second Intervention||20||
48668280|NCT00829868|101973036|FG001|COMPLETED|Second Intervention||21||
48668281|NCT00829868|101973035|FG000|NOT COMPLETED|Second Intervention||0||
48668282|NCT00829868|101973036|FG001|NOT COMPLETED|Second Intervention||0||
48668283|NCT01362790|101973037|FG000|STARTED|Pilot Phase & Phase 2||11||
48668284|NCT01362790|101973038|FG001|STARTED|Pilot Phase & Phase 2||8||
48668285|NCT01362790|101973039|FG002|STARTED|Pilot Phase & Phase 2||7||
48668286|NCT01362790|101973040|FG003|STARTED|Pilot Phase & Phase 2||15||
48668287|NCT01362790|101973041|FG004|STARTED|Pilot Phase & Phase 2||0||
48668288|NCT01362790|101973042|FG005|STARTED|Pilot Phase & Phase 2||4||
48668289|NCT01362790|101973043|FG006|STARTED|Pilot Phase & Phase 2||0||
48668290|NCT01362790|101973037|FG000|COMPLETED|Pilot Phase & Phase 2||1||
48668291|NCT01362790|101973038|FG001|COMPLETED|Pilot Phase & Phase 2||0||
48668292|NCT01362790|101973039|FG002|COMPLETED|Pilot Phase & Phase 2||2||
48668293|NCT01362790|101973040|FG003|COMPLETED|Pilot Phase & Phase 2||1||
48668294|NCT01362790|101973041|FG004|COMPLETED|Pilot Phase & Phase 2||0||
48668295|NCT01362790|101973042|FG005|COMPLETED|Pilot Phase & Phase 2||0||
48668296|NCT01362790|101973043|FG006|COMPLETED|Pilot Phase & Phase 2||0||
48668297|NCT01362790|101973037|FG000|NOT COMPLETED|Pilot Phase & Phase 2||10||
48668298|NCT01362790|101973038|FG001|NOT COMPLETED|Pilot Phase & Phase 2||8||
48668299|NCT01362790|101973039|FG002|NOT COMPLETED|Pilot Phase & Phase 2||5||
48668300|NCT01362790|101973040|FG003|NOT COMPLETED|Pilot Phase & Phase 2||14||
48668301|NCT01362790|101973041|FG004|NOT COMPLETED|Pilot Phase & Phase 2||0||
48668302|NCT01362790|101973042|FG005|NOT COMPLETED|Pilot Phase & Phase 2||4||
48668303|NCT01362790|101973043|FG006|NOT COMPLETED|Pilot Phase & Phase 2||0||
48668304|NCT01362790|101973037|FG000|STARTED|Dose De-escalation of Regimen A||0||
48668305|NCT01362790|101973038|FG001|STARTED|Dose De-escalation of Regimen A||0||
48668306|NCT01362790|101973039|FG002|STARTED|Dose De-escalation of Regimen A||0||
48668307|NCT01362790|101973040|FG003|STARTED|Dose De-escalation of Regimen A||0||
48668308|NCT01362790|101973041|FG004|STARTED|Dose De-escalation of Regimen A||8||
48668309|NCT01362790|101973042|FG005|STARTED|Dose De-escalation of Regimen A||0||
48668310|NCT01362790|101973043|FG006|STARTED|Dose De-escalation of Regimen A||0||
48668311|NCT01362790|101973037|FG000|COMPLETED|Dose De-escalation of Regimen A||0||
48668312|NCT01362790|101973038|FG001|COMPLETED|Dose De-escalation of Regimen A||0||
48668313|NCT01362790|101973039|FG002|COMPLETED|Dose De-escalation of Regimen A||0||
48668314|NCT01362790|101973040|FG003|COMPLETED|Dose De-escalation of Regimen A||0||
48668315|NCT01362790|101973041|FG004|COMPLETED|Dose De-escalation of Regimen A||2||
48668316|NCT01362790|101973042|FG005|COMPLETED|Dose De-escalation of Regimen A||0||
48668317|NCT01362790|101973043|FG006|COMPLETED|Dose De-escalation of Regimen A||0||
48668318|NCT01362790|101973037|FG000|NOT COMPLETED|Dose De-escalation of Regimen A||0||
48668319|NCT01362790|101973038|FG001|NOT COMPLETED|Dose De-escalation of Regimen A||0||
48668320|NCT01362790|101973039|FG002|NOT COMPLETED|Dose De-escalation of Regimen A||0||
48668321|NCT01362790|101973040|FG003|NOT COMPLETED|Dose De-escalation of Regimen A||0||
48668322|NCT01362790|101973041|FG004|NOT COMPLETED|Dose De-escalation of Regimen A||6||
48668323|NCT01362790|101973042|FG005|NOT COMPLETED|Dose De-escalation of Regimen A||0||
48668324|NCT01362790|101973043|FG006|NOT COMPLETED|Dose De-escalation of Regimen A||0||
48668325|NCT03226691|101973044|FG000|STARTED|Overall Study||15||
48668326|NCT03226691|101973044|FG000|COMPLETED|Overall Study||15||
48668327|NCT03226691|101973044|FG000|NOT COMPLETED|Overall Study||0||
48668328|NCT01948427|101973045|FG000|STARTED|Overall Study||49||
48668329|NCT01948427|101973046|FG001|STARTED|Overall Study||89||
48668330|NCT01948427|101973047|FG002|STARTED|Overall Study||4||
48668331|NCT01948427|101973048|FG003|STARTED|Overall Study||1||
48668332|NCT01948427|101973049|FG004|STARTED|Overall Study||60||
48668333|NCT01948427|101973045|FG000|COMPLETED|Overall Study||42||
48668334|NCT01948427|101973046|FG001|COMPLETED|Overall Study||72||
48668335|NCT01948427|101973047|FG002|COMPLETED|Overall Study||4||
48668336|NCT01948427|101973048|FG003|COMPLETED|Overall Study||1||
48668337|NCT01948427|101973049|FG004|COMPLETED|Overall Study||46||
48668338|NCT01948427|101973045|FG000|NOT COMPLETED|Overall Study||7||
48668339|NCT01948427|101973046|FG001|NOT COMPLETED|Overall Study||17||
48668340|NCT01948427|101973047|FG002|NOT COMPLETED|Overall Study||0||
48668341|NCT01948427|101973048|FG003|NOT COMPLETED|Overall Study||0||
48668342|NCT01948427|101973049|FG004|NOT COMPLETED|Overall Study||14||
48668343|NCT00123630|101973050|FG000|STARTED|Overall Study||15||
48668344|NCT00123630|101973051|FG001|STARTED|Overall Study||15||
48668345|NCT00123630|101973050|FG000|COMPLETED|Overall Study||15||
48668346|NCT00123630|101973051|FG001|COMPLETED|Overall Study||15||
48668347|NCT00123630|101973050|FG000|NOT COMPLETED|Overall Study||0||
48668348|NCT00123630|101973051|FG001|NOT COMPLETED|Overall Study||0||
48668349|NCT00337168|101973052|FG000|STARTED|Overall Study||37||
48668350|NCT00337168|101973052|FG000|Eligible|Overall Study||37||
48668351|NCT00337168|101973052|FG000|Eligible and Treated|Overall Study||36||
48668352|NCT00337168|101973052|FG000|COMPLETED|Overall Study||29||
48668353|NCT00337168|101973052|FG000|NOT COMPLETED|Overall Study||8||
48668354|NCT00189475|101973053|FG000|STARTED|Overall Study||42||
48668355|NCT00189475|101973054|FG001|STARTED|Overall Study||42||
48668356|NCT00189475|101973053|FG000|COMPLETED|Overall Study||42||
48668357|NCT00189475|101973054|FG001|COMPLETED|Overall Study||42||
48668358|NCT00189475|101973053|FG000|NOT COMPLETED|Overall Study||0||
48668359|NCT00189475|101973054|FG001|NOT COMPLETED|Overall Study||0||
48668360|NCT01139515|101973055|FG000|STARTED|First Intervention Period||4||
48668361|NCT01139515|101973056|FG001|STARTED|First Intervention Period||4||
48668362|NCT01139515|101973057|FG002|STARTED|First Intervention Period||4||
48668363|NCT01139515|101973058|FG003|STARTED|First Intervention Period||4||
48668364|NCT01139515|101973055|FG000|COMPLETED|First Intervention Period||4||
48668365|NCT01139515|101973056|FG001|COMPLETED|First Intervention Period||4||
48668366|NCT01139515|101973057|FG002|COMPLETED|First Intervention Period||4||
48668367|NCT01139515|101973058|FG003|COMPLETED|First Intervention Period||4||
48668368|NCT01139515|101973055|FG000|NOT COMPLETED|First Intervention Period||0||
48668369|NCT01139515|101973056|FG001|NOT COMPLETED|First Intervention Period||0||
48668370|NCT01139515|101973057|FG002|NOT COMPLETED|First Intervention Period||0||
48668371|NCT01139515|101973058|FG003|NOT COMPLETED|First Intervention Period||0||
48668372|NCT01139515|101973055|FG000|STARTED|Washout Period I (46hrs)||4||
48668373|NCT01139515|101973056|FG001|STARTED|Washout Period I (46hrs)||4||
48668374|NCT01139515|101973057|FG002|STARTED|Washout Period I (46hrs)||4||
48668375|NCT01139515|101973058|FG003|STARTED|Washout Period I (46hrs)||4||
48668376|NCT01139515|101973055|FG000|COMPLETED|Washout Period I (46hrs)||4||
48668377|NCT01139515|101973056|FG001|COMPLETED|Washout Period I (46hrs)||4||
48668378|NCT01139515|101973057|FG002|COMPLETED|Washout Period I (46hrs)||4||
48668379|NCT01139515|101973058|FG003|COMPLETED|Washout Period I (46hrs)||4||
48668380|NCT01139515|101973055|FG000|NOT COMPLETED|Washout Period I (46hrs)||0||
48668381|NCT01139515|101973056|FG001|NOT COMPLETED|Washout Period I (46hrs)||0||
48668382|NCT01139515|101973057|FG002|NOT COMPLETED|Washout Period I (46hrs)||0||
48668383|NCT01139515|101973058|FG003|NOT COMPLETED|Washout Period I (46hrs)||0||
48668384|NCT01139515|101973055|FG000|STARTED|Second Intervention Period||4||
48668385|NCT01139515|101973056|FG001|STARTED|Second Intervention Period||4||
48668386|NCT01139515|101973057|FG002|STARTED|Second Intervention Period||4||
48668387|NCT01139515|101973058|FG003|STARTED|Second Intervention Period||4||
48668388|NCT01139515|101973055|FG000|COMPLETED|Second Intervention Period||4||
48668389|NCT01139515|101973056|FG001|COMPLETED|Second Intervention Period||4||
48668390|NCT01139515|101973057|FG002|COMPLETED|Second Intervention Period||4||
48668391|NCT01139515|101973058|FG003|COMPLETED|Second Intervention Period||4||
48668392|NCT01139515|101973055|FG000|NOT COMPLETED|Second Intervention Period||0||
48668393|NCT01139515|101973056|FG001|NOT COMPLETED|Second Intervention Period||0||
48668394|NCT01139515|101973057|FG002|NOT COMPLETED|Second Intervention Period||0||
48668395|NCT01139515|101973058|FG003|NOT COMPLETED|Second Intervention Period||0||
48668396|NCT01139515|101973055|FG000|STARTED|Washout Period 2 (46 Hrs)||4||
48668397|NCT01139515|101973056|FG001|STARTED|Washout Period 2 (46 Hrs)||4||
48668398|NCT01139515|101973057|FG002|STARTED|Washout Period 2 (46 Hrs)||4||
48668399|NCT01139515|101973058|FG003|STARTED|Washout Period 2 (46 Hrs)||4||
48668400|NCT01139515|101973055|FG000|COMPLETED|Washout Period 2 (46 Hrs)||4||
48668401|NCT01139515|101973056|FG001|COMPLETED|Washout Period 2 (46 Hrs)||4||
48668402|NCT01139515|101973057|FG002|COMPLETED|Washout Period 2 (46 Hrs)||4||
48668403|NCT01139515|101973058|FG003|COMPLETED|Washout Period 2 (46 Hrs)||4||
48668404|NCT01139515|101973055|FG000|NOT COMPLETED|Washout Period 2 (46 Hrs)||0||
48668405|NCT01139515|101973056|FG001|NOT COMPLETED|Washout Period 2 (46 Hrs)||0||
48668406|NCT01139515|101973057|FG002|NOT COMPLETED|Washout Period 2 (46 Hrs)||0||
48668407|NCT01139515|101973058|FG003|NOT COMPLETED|Washout Period 2 (46 Hrs)||0||
48668408|NCT01139515|101973055|FG000|STARTED|Third Intervention Period||4||
48668409|NCT01139515|101973056|FG001|STARTED|Third Intervention Period||4||
48668410|NCT01139515|101973057|FG002|STARTED|Third Intervention Period||4||
48668411|NCT01139515|101973058|FG003|STARTED|Third Intervention Period||4||
48668412|NCT01139515|101973055|FG000|COMPLETED|Third Intervention Period||4||
48668413|NCT01139515|101973056|FG001|COMPLETED|Third Intervention Period||4||
48668414|NCT01139515|101973057|FG002|COMPLETED|Third Intervention Period||4||
48668415|NCT01139515|101973058|FG003|COMPLETED|Third Intervention Period||4||
48668416|NCT01139515|101973055|FG000|NOT COMPLETED|Third Intervention Period||0||
48668417|NCT01139515|101973056|FG001|NOT COMPLETED|Third Intervention Period||0||
48668418|NCT01139515|101973057|FG002|NOT COMPLETED|Third Intervention Period||0||
48668419|NCT01139515|101973058|FG003|NOT COMPLETED|Third Intervention Period||0||
48668420|NCT01139515|101973055|FG000|STARTED|Washout Period 3 (46 Hrs)||4||
48668421|NCT01139515|101973056|FG001|STARTED|Washout Period 3 (46 Hrs)||4||
48668422|NCT01139515|101973057|FG002|STARTED|Washout Period 3 (46 Hrs)||4||
48668423|NCT01139515|101973058|FG003|STARTED|Washout Period 3 (46 Hrs)||4||
48668424|NCT01139515|101973055|FG000|COMPLETED|Washout Period 3 (46 Hrs)||4||
48668425|NCT01139515|101973056|FG001|COMPLETED|Washout Period 3 (46 Hrs)||4||
48668426|NCT01139515|101973057|FG002|COMPLETED|Washout Period 3 (46 Hrs)||4||
48668427|NCT01139515|101973058|FG003|COMPLETED|Washout Period 3 (46 Hrs)||4||
48668428|NCT01139515|101973055|FG000|NOT COMPLETED|Washout Period 3 (46 Hrs)||0||
48668429|NCT01139515|101973056|FG001|NOT COMPLETED|Washout Period 3 (46 Hrs)||0||
48668430|NCT01139515|101973057|FG002|NOT COMPLETED|Washout Period 3 (46 Hrs)||0||
48668431|NCT01139515|101973058|FG003|NOT COMPLETED|Washout Period 3 (46 Hrs)||0||
48668432|NCT01139515|101973055|FG000|STARTED|Fourth Intervention Period||4||
48668433|NCT01139515|101973056|FG001|STARTED|Fourth Intervention Period||4||
48668434|NCT01139515|101973057|FG002|STARTED|Fourth Intervention Period||4||
48668435|NCT01139515|101973058|FG003|STARTED|Fourth Intervention Period||4||
48668436|NCT01139515|101973055|FG000|COMPLETED|Fourth Intervention Period||4||
48668437|NCT01139515|101973056|FG001|COMPLETED|Fourth Intervention Period||4||
48668438|NCT01139515|101973057|FG002|COMPLETED|Fourth Intervention Period||4||
48668439|NCT01139515|101973058|FG003|COMPLETED|Fourth Intervention Period||4||
48668440|NCT01139515|101973055|FG000|NOT COMPLETED|Fourth Intervention Period||0||
48668441|NCT01139515|101973056|FG001|NOT COMPLETED|Fourth Intervention Period||0||
48668442|NCT01139515|101973057|FG002|NOT COMPLETED|Fourth Intervention Period||0||
48668443|NCT01139515|101973058|FG003|NOT COMPLETED|Fourth Intervention Period||0||
48668444|NCT00779909|101973059|FG000|STARTED|Overall Study||10||
48668445|NCT00779909|101973060|FG001|STARTED|Overall Study||9||
48668446|NCT00779909|101973061|FG002|STARTED|Overall Study||8||
48668447|NCT00779909|101973062|FG003|STARTED|Overall Study||8||
48668448|NCT00779909|101973059|FG000|COMPLETED|Overall Study||9||
48668449|NCT00779909|101973060|FG001|COMPLETED|Overall Study||8||
48668450|NCT00779909|101973061|FG002|COMPLETED|Overall Study||8||
48668451|NCT00779909|101973062|FG003|COMPLETED|Overall Study||7||
48668452|NCT00779909|101973059|FG000|NOT COMPLETED|Overall Study||1||
48668453|NCT00779909|101973060|FG001|NOT COMPLETED|Overall Study||1||
48668454|NCT00779909|101973061|FG002|NOT COMPLETED|Overall Study||0||
48668455|NCT00779909|101973062|FG003|NOT COMPLETED|Overall Study||1||
48668456|NCT02796651|101973063|FG000|STARTED|Overall Study||132||
48668457|NCT02796651|101973063|FG000|Formoterol Fumarate (FF) 6 μg|Overall Study||107|Participants had 1 puff each from 2 identical Pressair DPI (FF 6μg \& placebo) in morning \& evening|
48668458|NCT02796651|101973063|FG000|Formoterol Fumarate (FF) 12 μg|Overall Study||121|Participants had 1 puff each from 2 identical Pressair DPI (FF 12μg \& placebo) in morning \& evening|
48668459|NCT02796651|101973063|FG000|Formoterol Fumarate (FF) 24 μg|Overall Study||105|Participants had 1 puff each from 2 identical Pressair DPI (FF 24μg \& placebo) in morning \& evening|
48668460|NCT02796651|101973063|FG000|Perforomist 20 μg|Overall Study||118|Participants took 1 vial of Perforomist 20μg oral nebulization solution in morning \& evening|
48668461|NCT02796651|101973063|FG000|Perforomist 40 μg|Overall Study||108|Participants took 1 dose of 2 vials of Perforomist 20μg oral nebulization solution on Day 1 morning|
48668462|NCT02796651|101973063|FG000|Placebo (Lactose Monohydrate)|Overall Study||38|Participants had 1 puff from Pressair DPI (FF 6/12/24 μg matching placebo) in morning \& evening|
48668463|NCT02796651|101973063|FG000|COMPLETED|Overall Study||106||
48668464|NCT02796651|101973063|FG000|NOT COMPLETED|Overall Study||26||
48668465|NCT00829998|101973064|FG000|STARTED|First Intervention||21||
48668466|NCT00829998|101973065|FG001|STARTED|First Intervention||20||
48668467|NCT00829998|101973064|FG000|COMPLETED|First Intervention||21||
48668468|NCT00829998|101973065|FG001|COMPLETED|First Intervention||20||
48668469|NCT00829998|101973064|FG000|NOT COMPLETED|First Intervention||0||
48668470|NCT00829998|101973065|FG001|NOT COMPLETED|First Intervention||0||
48668471|NCT00829998|101973064|FG000|STARTED|Washout||21||
48668472|NCT00829998|101973065|FG001|STARTED|Washout||20||
48668473|NCT00829998|101973064|FG000|COMPLETED|Washout||21||
48668474|NCT00829998|101973065|FG001|COMPLETED|Washout||19||
48668475|NCT00829998|101973064|FG000|NOT COMPLETED|Washout||0||
48668476|NCT00829998|101973065|FG001|NOT COMPLETED|Washout||1||
48668477|NCT00829998|101973064|FG000|STARTED|Second Intervention||21||
48668478|NCT00829998|101973065|FG001|STARTED|Second Intervention||19||
48668479|NCT00829998|101973064|FG000|COMPLETED|Second Intervention||21||
48668480|NCT00829998|101973065|FG001|COMPLETED|Second Intervention||19||
48668481|NCT00829998|101973064|FG000|NOT COMPLETED|Second Intervention||0||
48668482|NCT00829998|101973065|FG001|NOT COMPLETED|Second Intervention||0||
48668483|NCT03038620|101973066|FG000|STARTED|Overall Study||92||
48668484|NCT03038620|101973067|FG001|STARTED|Overall Study||93||
48668485|NCT03038620|101973066|FG000|COMPLETED|Overall Study||73||
48668486|NCT03038620|101973067|FG001|COMPLETED|Overall Study||55||
48668487|NCT03038620|101973066|FG000|NOT COMPLETED|Overall Study||19||
48668488|NCT03038620|101973067|FG001|NOT COMPLETED|Overall Study||38||
48668489|NCT04282148|101973068|FG000|STARTED|Overall Study||105||
48668490|NCT04282148|101973068|FG000|COMPLETED|Overall Study||102||
48668491|NCT04282148|101973068|FG000|NOT COMPLETED|Overall Study||3||
48668492|NCT05012579|101973069|FG000|STARTED|Overall Study||40||
48668493|NCT05012579|101973069|FG000|COMPLETED|Overall Study||37||
48668494|NCT05012579|101973069|FG000|NOT COMPLETED|Overall Study||3||
48668495|NCT05599100|101973070|FG000|STARTED|Overall Study||16||
48668496|NCT05599100|101973070|FG000|COMPLETED|Overall Study||15||
48668497|NCT05599100|101973070|FG000|NOT COMPLETED|Overall Study||1||
48668498|NCT01217892|101973071|FG000|STARTED|Overall Study||100||
48668499|NCT01217892|101973072|FG001|STARTED|Overall Study||100||
48668500|NCT01217892|101973073|FG002|STARTED|Overall Study||99||
48668501|NCT01217892|101973074|FG003|STARTED|Overall Study||101||
48668502|NCT01217892|101973071|FG000|COMPLETED|Overall Study||93||
48668503|NCT01217892|101973072|FG001|COMPLETED|Overall Study||94||
48668504|NCT01217892|101973073|FG002|COMPLETED|Overall Study||90||
48668505|NCT01217892|101973074|FG003|COMPLETED|Overall Study||93||
48668506|NCT01217892|101973071|FG000|NOT COMPLETED|Overall Study||7||
48668507|NCT01217892|101973072|FG001|NOT COMPLETED|Overall Study||6||
48668508|NCT01217892|101973073|FG002|NOT COMPLETED|Overall Study||9||
48668509|NCT01217892|101973074|FG003|NOT COMPLETED|Overall Study||8||
48668510|NCT00643279|101973075|FG000|STARTED|Overall Study||134||
48668511|NCT00643279|101973076|FG001|STARTED|Overall Study||140||
48668512|NCT00643279|101973075|FG000|COMPLETED|Overall Study||118||
48668513|NCT00643279|101973076|FG001|COMPLETED|Overall Study||127||
48668514|NCT00643279|101973075|FG000|NOT COMPLETED|Overall Study||16||
48668515|NCT00643279|101973076|FG001|NOT COMPLETED|Overall Study||13||
48668516|NCT03781479|101973077|FG000|STARTED|Overall Study||6||
48668517|NCT03781479|101973078|FG001|STARTED|Overall Study||6||
48668518|NCT03781479|101973079|FG002|STARTED|Overall Study||1||
48668519|NCT03781479|101973077|FG000|COMPLETED|Overall Study||6||
48668520|NCT03781479|101973078|FG001|COMPLETED|Overall Study||6||
48668521|NCT03781479|101973079|FG002|COMPLETED|Overall Study||0||
48668522|NCT03781479|101973077|FG000|NOT COMPLETED|Overall Study||0||
48668523|NCT03781479|101973078|FG001|NOT COMPLETED|Overall Study||0||
48668524|NCT03781479|101973079|FG002|NOT COMPLETED|Overall Study||1||
48668525|NCT00565747|101973080|FG000|STARTED|Overall Study||654||
48668526|NCT00565747|101973081|FG001|STARTED|Overall Study||678||
48668527|NCT00565747|101973080|FG000|COMPLETED|Overall Study||587||
48668528|NCT00565747|101973081|FG001|COMPLETED|Overall Study||605||
48668529|NCT00565747|101973080|FG000|NOT COMPLETED|Overall Study||67||
48668530|NCT00565747|101973081|FG001|NOT COMPLETED|Overall Study||73||
48668531|NCT01202162|101973082|FG000|STARTED|Overall Study||43||
48668532|NCT01202162|101973083|FG001|STARTED|Overall Study||42||
48668533|NCT01202162|101973082|FG000|COMPLETED|Overall Study||40||
48668534|NCT01202162|101973083|FG001|COMPLETED|Overall Study||40||
48668535|NCT01202162|101973082|FG000|NOT COMPLETED|Overall Study||3||
48668536|NCT01202162|101973083|FG001|NOT COMPLETED|Overall Study||2||
48668537|NCT03787615|101973084|FG000|STARTED|Overall Study||31||
48668538|NCT03787615|101973084|FG000|COMPLETED|Overall Study||27||
48668539|NCT03787615|101973084|FG000|NOT COMPLETED|Overall Study||4||
48668540|NCT05305651|101973085|FG000|STARTED|Overall Study||217||
48668541|NCT05305651|101973085|FG000|COMPLETED|Overall Study||208||
48668542|NCT05305651|101973085|FG000|NOT COMPLETED|Overall Study||9||
48668543|NCT02852330|101973086|FG000|STARTED|Overall Study||20||
48668544|NCT02852330|101973086|FG000|COMPLETED|Overall Study||20||
48668545|NCT02852330|101973086|FG000|NOT COMPLETED|Overall Study||0||
48668546|NCT00397540|101973087|FG000|STARTED|Overall Study||60||
48668547|NCT00397540|101973088|FG001|STARTED|Overall Study||85||
48668548|NCT00397540|101973087|FG000|COMPLETED|Overall Study||59||
48668549|NCT00397540|101973088|FG001|COMPLETED|Overall Study||85||
48668550|NCT00397540|101973087|FG000|NOT COMPLETED|Overall Study||1||
48668551|NCT00397540|101973088|FG001|NOT COMPLETED|Overall Study||0||
48668552|NCT01156844|101973089|FG000|STARTED|Overall Study||48||
48668553|NCT01156844|101973090|FG001|STARTED|Overall Study||48||
48668554|NCT01156844|101973091|FG002|STARTED|Overall Study||48||
48668555|NCT01156844|101973092|FG003|STARTED|Overall Study||47||
48668556|NCT01156844|101973089|FG000|PD & Safety Sets: Received Study Drug|Overall Study||48||
48668557|NCT01156844|101973090|FG001|PD & Safety Sets: Received Study Drug|Overall Study||47||
48668558|NCT01156844|101973091|FG002|PD & Safety Sets: Received Study Drug|Overall Study||48||
48668559|NCT01156844|101973092|FG003|PD & Safety Sets: Received Study Drug|Overall Study||46||
48668560|NCT01156844|101973089|FG000|COMPLETED|Overall Study||46||
48668561|NCT01156844|101973090|FG001|COMPLETED|Overall Study||46||
48668562|NCT01156844|101973091|FG002|COMPLETED|Overall Study||42||
48668563|NCT01156844|101973092|FG003|COMPLETED|Overall Study||41||
48668564|NCT01156844|101973089|FG000|NOT COMPLETED|Overall Study||2||
48668565|NCT01156844|101973090|FG001|NOT COMPLETED|Overall Study||2||
48668566|NCT01156844|101973091|FG002|NOT COMPLETED|Overall Study||6||
48668567|NCT01156844|101973092|FG003|NOT COMPLETED|Overall Study||6||
48668568|NCT01174563|101973093|FG000|STARTED|Overall Study||60||
48668569|NCT01174563|101973093|FG000|Efficacy Set|Overall Study||59|Efficacy set included all participants who received at least one dose of study medication.|
48668570|NCT01174563|101973093|FG000|Safety Set|Overall Study||59|Safety set included all participants who received at least one dose of study medication.|
48668571|NCT01174563|101973093|FG000|COMPLETED|Overall Study||0||
48668572|NCT01174563|101973093|FG000|NOT COMPLETED|Overall Study||60||
48668573|NCT01085903|101973094|FG000|STARTED|Overall Study||21||
48668574|NCT01085903|101973095|FG001|STARTED|Overall Study||4||
48668575|NCT01085903|101973096|FG002|STARTED|Overall Study||3||
48668576|NCT01085903|101973094|FG000|COMPLETED|Overall Study||21||
48668577|NCT01085903|101973095|FG001|COMPLETED|Overall Study||4||
48668578|NCT01085903|101973096|FG002|COMPLETED|Overall Study||3||
48668579|NCT01085903|101973094|FG000|NOT COMPLETED|Overall Study||0||
48668580|NCT01085903|101973095|FG001|NOT COMPLETED|Overall Study||0||
48668581|NCT01085903|101973096|FG002|NOT COMPLETED|Overall Study||0||
48668582|NCT01644331|101973097|FG000|STARTED|Overall Study||129||
48668583|NCT01644331|101973098|FG001|STARTED|Overall Study||128||
48668584|NCT01644331|101973097|FG000|COMPLETED|Overall Study||118||
48668585|NCT01644331|101973098|FG001|COMPLETED|Overall Study||118||
48668586|NCT01644331|101973097|FG000|NOT COMPLETED|Overall Study||11||
48668587|NCT01644331|101973098|FG001|NOT COMPLETED|Overall Study||10||
48668588|NCT00601367|101973099|FG000|STARTED|Overall Study||480||
48668589|NCT00601367|101973099|FG000|COMPLETED|Overall Study||293||
48668590|NCT00601367|101973099|FG000|NOT COMPLETED|Overall Study||187||
48668591|NCT00775658|101973100|FG000|STARTED|First Intervention||10||
48668592|NCT00775658|101973101|FG001|STARTED|First Intervention||11||
48668593|NCT00775658|101973100|FG000|COMPLETED|First Intervention||10||
48668594|NCT00775658|101973101|FG001|COMPLETED|First Intervention||11||
48668595|NCT00775658|101973100|FG000|NOT COMPLETED|First Intervention||0||
48668596|NCT00775658|101973101|FG001|NOT COMPLETED|First Intervention||0||
48668597|NCT00775658|101973100|FG000|STARTED|Second Intervention||10||
48668598|NCT00775658|101973101|FG001|STARTED|Second Intervention||11||
48668599|NCT00775658|101973100|FG000|COMPLETED|Second Intervention||10||
48668600|NCT00775658|101973101|FG001|COMPLETED|Second Intervention||11||
48668601|NCT00775658|101973100|FG000|NOT COMPLETED|Second Intervention||0||
48668602|NCT00775658|101973101|FG001|NOT COMPLETED|Second Intervention||0||
48668603|NCT04118764|101973102|FG000|STARTED|Overall Study||6||
48668604|NCT04118764|101973102|FG000|COMPLETED|Overall Study||6||
48668605|NCT04118764|101973102|FG000|NOT COMPLETED|Overall Study||0||
48668606|NCT03290027|101973103|FG000|STARTED|Overall Study||277||
48668607|NCT03290027|101973104|FG001|STARTED|Overall Study||273||
48668608|NCT03290027|101973103|FG000|COMPLETED|Overall Study||219||
48668609|NCT03290027|101973104|FG001|COMPLETED|Overall Study||228||
48668610|NCT03290027|101973103|FG000|NOT COMPLETED|Overall Study||58||
48668611|NCT03290027|101973104|FG001|NOT COMPLETED|Overall Study||45||
48668612|NCT02997085|101973105|FG000|STARTED|Overall Study||34||
48668613|NCT02997085|101973106|FG001|STARTED|Overall Study||35||
48668614|NCT02997085|101973107|FG002|STARTED|Overall Study||34||
48668615|NCT02997085|101973105|FG000|COMPLETED|Overall Study||34||
48668616|NCT02997085|101973106|FG001|COMPLETED|Overall Study||35||
48668617|NCT02997085|101973107|FG002|COMPLETED|Overall Study||34||
48668618|NCT02997085|101973105|FG000|NOT COMPLETED|Overall Study||0||
48668619|NCT02997085|101973106|FG001|NOT COMPLETED|Overall Study||0||
48668620|NCT02997085|101973107|FG002|NOT COMPLETED|Overall Study||0||
48668621|NCT01951391|101973108|FG000|STARTED|Overall Study||5||
48668622|NCT01951391|101973109|FG001|STARTED|Overall Study||5||
48668623|NCT01951391|101973108|FG000|COMPLETED|Overall Study||5||
48668624|NCT01951391|101973109|FG001|COMPLETED|Overall Study||5||
48668625|NCT01951391|101973108|FG000|NOT COMPLETED|Overall Study||0||
48668626|NCT01951391|101973109|FG001|NOT COMPLETED|Overall Study||0||
48668627|NCT02090764|101973110|FG000|STARTED|Overall Study||206||
48668628|NCT02090764|101973111|FG001|STARTED|Overall Study||206||
48668629|NCT02090764|101973110|FG000|COMPLETED|Overall Study||200||
48668630|NCT02090764|101973111|FG001|COMPLETED|Overall Study||186||
48668631|NCT02090764|101973110|FG000|NOT COMPLETED|Overall Study||6||
48668632|NCT02090764|101973111|FG001|NOT COMPLETED|Overall Study||20||
48668633|NCT01943227|101973112|FG000|STARTED|Overall Study||10||
48668634|NCT01943227|101973113|FG001|STARTED|Overall Study||10||
48668635|NCT01943227|101973112|FG000|COMPLETED|Overall Study||10||
48668636|NCT01943227|101973113|FG001|COMPLETED|Overall Study||10||
48668637|NCT01943227|101973112|FG000|NOT COMPLETED|Overall Study||0||
48668638|NCT01943227|101973113|FG001|NOT COMPLETED|Overall Study||0||
48668639|NCT00758563|101973114|FG000|STARTED|Overall Study||7||
48668640|NCT00758563|101973115|FG001|STARTED|Overall Study||8||
48668641|NCT00758563|101973114|FG000|COMPLETED|Overall Study||7||
48668642|NCT00758563|101973115|FG001|COMPLETED|Overall Study||8||
48668643|NCT00758563|101973114|FG000|NOT COMPLETED|Overall Study||0||
48668644|NCT00758563|101973115|FG001|NOT COMPLETED|Overall Study||0||
48668645|NCT02014467|101973116|FG000|STARTED|Overall Study||365||
48668646|NCT02014467|101973117|FG001|STARTED|Overall Study||119||
48668647|NCT02014467|101973116|FG000|COMPLETED|Overall Study||340||
48668648|NCT02014467|101973117|FG001|COMPLETED|Overall Study||112||
48668649|NCT02014467|101973116|FG000|NOT COMPLETED|Overall Study||25||
48668650|NCT02014467|101973117|FG001|NOT COMPLETED|Overall Study||7||
48668651|NCT03682367|101973118|FG000|STARTED|Overall Study||4||
48668652|NCT03682367|101973119|FG001|STARTED|Overall Study||4||
48668653|NCT03682367|101973118|FG000|COMPLETED|Overall Study||2||
48668654|NCT03682367|101973119|FG001|COMPLETED|Overall Study||0||
48668655|NCT03682367|101973118|FG000|NOT COMPLETED|Overall Study||2||
48668656|NCT03682367|101973119|FG001|NOT COMPLETED|Overall Study||4||
48668657|NCT01853280|101973120|FG000|STARTED|Overall Study||22||
48668658|NCT01853280|101973121|FG001|STARTED|Overall Study||22||
48668659|NCT01853280|101973120|FG000|COMPLETED|Overall Study||20||
48668660|NCT01853280|101973121|FG001|COMPLETED|Overall Study||16||
48668661|NCT01853280|101973120|FG000|NOT COMPLETED|Overall Study||2||
48668662|NCT01853280|101973121|FG001|NOT COMPLETED|Overall Study||6||
48668663|NCT01220687|101973122|FG000|STARTED|Overall Study||16||
48668664|NCT01220687|101973123|FG001|STARTED|Overall Study||15||
48668665|NCT01220687|101973122|FG000|COMPLETED|Overall Study||14||
48668666|NCT01220687|101973123|FG001|COMPLETED|Overall Study||14||
48668667|NCT01220687|101973122|FG000|NOT COMPLETED|Overall Study||2||
48668668|NCT01220687|101973123|FG001|NOT COMPLETED|Overall Study||1||
48668669|NCT04486716|101973124|FG000|STARTED|Overall Study||111|Enrolled participants (completed Screening period)|
48668670|NCT04486716|101973124|FG000|Full Analysis Set / Safety Analysis Set|Overall Study||102|All participants who received at least 1 dose of the study drug|
48668671|NCT04486716|101973124|FG000|COMPLETED|Overall Study||89|Completed study treatment in the Core phase|
48668672|NCT04486716|101973124|FG000|NOT COMPLETED|Overall Study||22||
48668673|NCT03271151|101973125|FG000|STARTED|Overall Study||80||
48668674|NCT03271151|101973126|FG001|STARTED|Overall Study||80||
48668675|NCT03271151|101973125|FG000|COMPLETED|Overall Study||78||
48668676|NCT03271151|101973126|FG001|COMPLETED|Overall Study||77||
48668677|NCT03271151|101973125|FG000|NOT COMPLETED|Overall Study||2||
48668678|NCT03271151|101973126|FG001|NOT COMPLETED|Overall Study||3||
48668679|NCT04439253|101973127|FG000|STARTED|Overall Study||4|All 4 patients enrolled were eligible and treated in the arm.|
48668680|NCT04439253|101973127|FG000|COMPLETED|Overall Study||0|Treatment continued until disease progression or intolerability.|
48668681|NCT04439253|101973127|FG000|NOT COMPLETED|Overall Study||4||
48668682|NCT02167867|101973128|FG000|STARTED|Overall Study||22||
48668683|NCT02167867|101973129|FG001|STARTED|Overall Study||22||
48668684|NCT02167867|101973128|FG000|COMPLETED|Overall Study||22||
48668685|NCT02167867|101973129|FG001|COMPLETED|Overall Study||22||
48668686|NCT02167867|101973128|FG000|NOT COMPLETED|Overall Study||0||
48668687|NCT02167867|101973129|FG001|NOT COMPLETED|Overall Study||0||
48668688|NCT03094663|101973130|FG000|STARTED|Overall Study||43||
48668689|NCT03094663|101973131|FG001|STARTED|Overall Study||43||
48668690|NCT03094663|101973130|FG000|COMPLETED|Overall Study||43||
48668691|NCT03094663|101973131|FG001|COMPLETED|Overall Study||43||
48668692|NCT03094663|101973130|FG000|NOT COMPLETED|Overall Study||0||
48668693|NCT03094663|101973131|FG001|NOT COMPLETED|Overall Study||0||
48668694|NCT00114101|101973132|FG000|STARTED|Overall Study||231||
48668695|NCT00114101|101973133|FG001|STARTED|Overall Study||229||
48668696|NCT00114101|101973132|FG000|COMPLETED|Overall Study||231||
48668697|NCT00114101|101973133|FG001|COMPLETED|Overall Study||229||
48668698|NCT00114101|101973132|FG000|NOT COMPLETED|Overall Study||0||
48668699|NCT00114101|101973133|FG001|NOT COMPLETED|Overall Study||0||
48668700|NCT03433339|101973134|FG000|STARTED|Overall Study||10||
48668701|NCT03433339|101973135|FG001|STARTED|Overall Study||10||
48668702|NCT03433339|101973134|FG000|COMPLETED|Overall Study||8||
48668703|NCT03433339|101973135|FG001|COMPLETED|Overall Study||6||
48668704|NCT03433339|101973134|FG000|NOT COMPLETED|Overall Study||2||
48668705|NCT03433339|101973135|FG001|NOT COMPLETED|Overall Study||4||
48668706|NCT03370276|101973136|FG000|STARTED|Overall Study||3||
48668707|NCT03370276|101973137|FG001|STARTED|Overall Study||44||
48668708|NCT03370276|101973138|FG002|STARTED|Overall Study||48||
48668709|NCT03370276|101973136|FG000|COMPLETED|Overall Study||3||
48668710|NCT03370276|101973137|FG001|COMPLETED|Overall Study||42||
48668711|NCT03370276|101973138|FG002|COMPLETED|Overall Study||43||
48668712|NCT03370276|101973136|FG000|NOT COMPLETED|Overall Study||0||
48668713|NCT03370276|101973137|FG001|NOT COMPLETED|Overall Study||2||
48668714|NCT03370276|101973138|FG002|NOT COMPLETED|Overall Study||5||
48668715|NCT01563341|101973139|FG000|STARTED|Overall Study||5||
48668716|NCT01563341|101973139|FG000|COMPLETED|Overall Study||0||
48668717|NCT01563341|101973139|FG000|NOT COMPLETED|Overall Study||5||
48668718|NCT03189524|101973140|FG000|STARTED|Overall Study||11||
48668719|NCT03189524|101973141|FG001|STARTED|Overall Study||10||
48668720|NCT03189524|101973142|FG002|STARTED|Overall Study||23||
48668721|NCT03189524|101973140|FG000|Received at Least 1 Dose of Study Drug|Overall Study||11||
48668722|NCT03189524|101973141|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10||
48668723|NCT03189524|101973142|FG002|Received at Least 1 Dose of Study Drug|Overall Study||23||
48668724|NCT03189524|101973140|FG000|COMPLETED|Overall Study||0||
48668725|NCT03189524|101973141|FG001|COMPLETED|Overall Study||0||
48668726|NCT03189524|101973142|FG002|COMPLETED|Overall Study||0||
48668727|NCT03189524|101973140|FG000|NOT COMPLETED|Overall Study||11||
48668728|NCT03189524|101973141|FG001|NOT COMPLETED|Overall Study||10||
48668729|NCT03189524|101973142|FG002|NOT COMPLETED|Overall Study||23||
48668730|NCT05833789|101973143|FG000|STARTED|Overall Study||5||
48668731|NCT05833789|101973143|FG000|COMPLETED|Overall Study||5||
48668732|NCT05833789|101973143|FG000|NOT COMPLETED|Overall Study||0||
48668733|NCT02143414|101973144|FG000|STARTED|Induction||29||
48668734|NCT02143414|101973145|FG001|STARTED|Induction||24||
48668735|NCT02143414|101973144|FG000|Completed Induction|Induction||24||
48668736|NCT02143414|101973145|FG001|Completed Induction|Induction||19||
48668737|NCT02143414|101973144|FG000|COMPLETED|Induction||19||
48668738|NCT02143414|101973145|FG001|COMPLETED|Induction||18||
48668739|NCT02143414|101973144|FG000|NOT COMPLETED|Induction||10||
48668740|NCT02143414|101973145|FG001|NOT COMPLETED|Induction||6||
48668741|NCT02143414|101973144|FG000|STARTED|Post-remission||19||
48668742|NCT02143414|101973145|FG001|STARTED|Post-remission||18||
48668743|NCT02143414|101973144|FG000|COMPLETED|Post-remission||14||
48668744|NCT02143414|101973145|FG001|COMPLETED|Post-remission||16||
48668745|NCT02143414|101973144|FG000|NOT COMPLETED|Post-remission||5||
48668746|NCT02143414|101973145|FG001|NOT COMPLETED|Post-remission||2||
48668747|NCT02143414|101973144|FG000|STARTED|Maintenance||14||
48668748|NCT02143414|101973145|FG001|STARTED|Maintenance||16||
48668749|NCT02143414|101973144|FG000|COMPLETED|Maintenance||4||
48668750|NCT02143414|101973145|FG001|COMPLETED|Maintenance||0||
48668751|NCT02143414|101973144|FG000|NOT COMPLETED|Maintenance||10||
48668752|NCT02143414|101973145|FG001|NOT COMPLETED|Maintenance||16||
48668753|NCT02839161|101973146|FG000|STARTED|Overall Study||8||
48668754|NCT02839161|101973147|FG001|STARTED|Overall Study||8||
48668755|NCT02839161|101973148|FG002|STARTED|Overall Study||8||
48668756|NCT02839161|101973149|FG003|STARTED|Overall Study||8||
48668757|NCT02839161|101973150|FG004|STARTED|Overall Study||8||
48668758|NCT02839161|101973151|FG005|STARTED|Overall Study||8||
48668759|NCT02839161|101973152|FG006|STARTED|Overall Study||6||
48668760|NCT02839161|101973153|FG007|STARTED|Overall Study||6||
48668761|NCT02839161|101973146|FG000|COMPLETED|Overall Study||8||
48668762|NCT02839161|101973147|FG001|COMPLETED|Overall Study||8||
48668763|NCT02839161|101973148|FG002|COMPLETED|Overall Study||8||
48668764|NCT02839161|101973149|FG003|COMPLETED|Overall Study||8||
48668765|NCT02839161|101973150|FG004|COMPLETED|Overall Study||8||
48668766|NCT02839161|101973151|FG005|COMPLETED|Overall Study||8||
48668767|NCT02839161|101973152|FG006|COMPLETED|Overall Study||6||
48668768|NCT02839161|101973153|FG007|COMPLETED|Overall Study||6||
48668769|NCT02839161|101973146|FG000|NOT COMPLETED|Overall Study||0||
48668770|NCT02839161|101973147|FG001|NOT COMPLETED|Overall Study||0||
48668771|NCT02839161|101973148|FG002|NOT COMPLETED|Overall Study||0||
48668772|NCT02839161|101973149|FG003|NOT COMPLETED|Overall Study||0||
48668773|NCT02839161|101973150|FG004|NOT COMPLETED|Overall Study||0||
48668774|NCT02839161|101973151|FG005|NOT COMPLETED|Overall Study||0||
48668775|NCT02839161|101973152|FG006|NOT COMPLETED|Overall Study||0||
48668776|NCT02839161|101973153|FG007|NOT COMPLETED|Overall Study||0||
48668777|NCT04743973|101973154|FG000|STARTED|Overall Study||40||
48668778|NCT04743973|101973154|FG000|COMPLETED|Overall Study||35||
48668779|NCT04743973|101973154|FG000|NOT COMPLETED|Overall Study||5||
48668780|NCT02790931|101973155|FG000|STARTED|Overall Study||39||
48668781|NCT02790931|101973156|FG001|STARTED|Overall Study||39||
48668782|NCT02790931|101973155|FG000|COMPLETED|Overall Study||15||
48668783|NCT02790931|101973156|FG001|COMPLETED|Overall Study||19||
48668784|NCT02790931|101973155|FG000|NOT COMPLETED|Overall Study||24||
48668785|NCT02790931|101973156|FG001|NOT COMPLETED|Overall Study||20||
48668786|NCT05034952|101973157|FG000|STARTED|Overall Study||77||
48668787|NCT05034952|101973158|FG001|STARTED|Overall Study||76||
48668788|NCT05034952|101973159|FG002|STARTED|Overall Study||74||
48668789|NCT05034952|101973160|FG003|STARTED|Overall Study||76||
48668790|NCT05034952|101973157|FG000|COMPLETED|Overall Study||75||
48668791|NCT05034952|101973158|FG001|COMPLETED|Overall Study||70||
48668792|NCT05034952|101973159|FG002|COMPLETED|Overall Study||70||
48668793|NCT05034952|101973160|FG003|COMPLETED|Overall Study||72||
48668794|NCT05034952|101973157|FG000|NOT COMPLETED|Overall Study||2||
48668795|NCT05034952|101973158|FG001|NOT COMPLETED|Overall Study||6||
48668796|NCT05034952|101973159|FG002|NOT COMPLETED|Overall Study||4||
48668797|NCT05034952|101973160|FG003|NOT COMPLETED|Overall Study||4||
48668798|NCT03896503|101973161|FG000|STARTED|Initial Subgroup and Arm Enrollment||10||
48668799|NCT03896503|101973162|FG001|STARTED|Initial Subgroup and Arm Enrollment||20||
48668800|NCT03896503|101973163|FG002|STARTED|Initial Subgroup and Arm Enrollment||10||
48668801|NCT03896503|101973164|FG003|STARTED|Initial Subgroup and Arm Enrollment||11||
48668802|NCT03896503|101973165|FG004|STARTED|Initial Subgroup and Arm Enrollment||23||
48668803|NCT03896503|101973166|FG005|STARTED|Initial Subgroup and Arm Enrollment||9||
48668804|NCT03896503|101973167|FG006|STARTED|Initial Subgroup and Arm Enrollment||18||
48668805|NCT03896503|101973168|FG007|STARTED|Initial Subgroup and Arm Enrollment||3||
48668806|NCT03896503|101973161|FG000|Not Treated|Initial Subgroup and Arm Enrollment||1||
48668807|NCT03896503|101973162|FG001|Not Treated|Initial Subgroup and Arm Enrollment||0||
48668808|NCT03896503|101973163|FG002|Not Treated|Initial Subgroup and Arm Enrollment||10||
48668809|NCT03896503|101973164|FG003|Not Treated|Initial Subgroup and Arm Enrollment||1||
48668810|NCT03896503|101973165|FG004|Not Treated|Initial Subgroup and Arm Enrollment||2||
48668811|NCT03896503|101973166|FG005|Not Treated|Initial Subgroup and Arm Enrollment||9||
48668812|NCT03896503|101973167|FG006|Not Treated|Initial Subgroup and Arm Enrollment||2||
48668813|NCT03896503|101973168|FG007|Not Treated|Initial Subgroup and Arm Enrollment||3||
48668814|NCT03896503|101973161|FG000|Off Treatment|Initial Subgroup and Arm Enrollment||7||
48668815|NCT03896503|101973162|FG001|Off Treatment|Initial Subgroup and Arm Enrollment||17||
48668816|NCT03896503|101973163|FG002|Off Treatment|Initial Subgroup and Arm Enrollment||0||
48668817|NCT03896503|101973164|FG003|Off Treatment|Initial Subgroup and Arm Enrollment||10||
48668818|NCT03896503|101973165|FG004|Off Treatment|Initial Subgroup and Arm Enrollment||0||
48668819|NCT03896503|101973166|FG005|Off Treatment|Initial Subgroup and Arm Enrollment||0||
48668820|NCT03896503|101973167|FG006|Off Treatment|Initial Subgroup and Arm Enrollment||16||
48668821|NCT03896503|101973168|FG007|Off Treatment|Initial Subgroup and Arm Enrollment||0||
48668822|NCT03896503|101973161|FG000|COMPLETED|Initial Subgroup and Arm Enrollment||7||
48668823|NCT03896503|101973162|FG001|COMPLETED|Initial Subgroup and Arm Enrollment||18||
48668824|NCT03896503|101973163|FG002|COMPLETED|Initial Subgroup and Arm Enrollment||0||
48668825|NCT03896503|101973164|FG003|COMPLETED|Initial Subgroup and Arm Enrollment||10||
48668826|NCT03896503|101973165|FG004|COMPLETED|Initial Subgroup and Arm Enrollment||20||
48668827|NCT03896503|101973166|FG005|COMPLETED|Initial Subgroup and Arm Enrollment||0||
48668828|NCT03896503|101973167|FG006|COMPLETED|Initial Subgroup and Arm Enrollment||16||
48668829|NCT03896503|101973168|FG007|COMPLETED|Initial Subgroup and Arm Enrollment||0||
48668830|NCT03896503|101973161|FG000|NOT COMPLETED|Initial Subgroup and Arm Enrollment||3||
48668831|NCT03896503|101973162|FG001|NOT COMPLETED|Initial Subgroup and Arm Enrollment||2||
48668832|NCT03896503|101973163|FG002|NOT COMPLETED|Initial Subgroup and Arm Enrollment||10||
48668833|NCT03896503|101973164|FG003|NOT COMPLETED|Initial Subgroup and Arm Enrollment||1||
48668834|NCT03896503|101973165|FG004|NOT COMPLETED|Initial Subgroup and Arm Enrollment||3||
48668835|NCT03896503|101973166|FG005|NOT COMPLETED|Initial Subgroup and Arm Enrollment||9||
48668836|NCT03896503|101973167|FG006|NOT COMPLETED|Initial Subgroup and Arm Enrollment||2||
48668837|NCT03896503|101973168|FG007|NOT COMPLETED|Initial Subgroup and Arm Enrollment||3||
48668838|NCT03896503|101973161|FG000|STARTED|Crossover Participants||0||
48668839|NCT03896503|101973162|FG001|STARTED|Crossover Participants||5||
48668840|NCT03896503|101973163|FG002|STARTED|Crossover Participants||0||
48668841|NCT03896503|101973164|FG003|STARTED|Crossover Participants||0||
48668842|NCT03896503|101973165|FG004|STARTED|Crossover Participants||6||
48668843|NCT03896503|101973166|FG005|STARTED|Crossover Participants||0||
48668844|NCT03896503|101973167|FG006|STARTED|Crossover Participants||0||
48668845|NCT03896503|101973168|FG007|STARTED|Crossover Participants||0||
48668846|NCT03896503|101973161|FG000|Not Treated|Crossover Participants||0||
48668847|NCT03896503|101973162|FG001|Not Treated|Crossover Participants||0||
48668848|NCT03896503|101973163|FG002|Not Treated|Crossover Participants||0||
48668849|NCT03896503|101973164|FG003|Not Treated|Crossover Participants||0||
48668850|NCT03896503|101973165|FG004|Not Treated|Crossover Participants||0||
48668851|NCT03896503|101973166|FG005|Not Treated|Crossover Participants||0||
48668852|NCT03896503|101973167|FG006|Not Treated|Crossover Participants||0||
48668853|NCT03896503|101973168|FG007|Not Treated|Crossover Participants||0||
48668854|NCT03896503|101973161|FG000|Off Treatment|Crossover Participants||0||
48668855|NCT03896503|101973162|FG001|Off Treatment|Crossover Participants||0||
48668856|NCT03896503|101973163|FG002|Off Treatment|Crossover Participants||0||
48668857|NCT03896503|101973164|FG003|Off Treatment|Crossover Participants||0||
48668858|NCT03896503|101973165|FG004|Off Treatment|Crossover Participants||0||
48668859|NCT03896503|101973166|FG005|Off Treatment|Crossover Participants||0||
48668860|NCT03896503|101973167|FG006|Off Treatment|Crossover Participants||0||
48668861|NCT03896503|101973168|FG007|Off Treatment|Crossover Participants||0||
48668862|NCT03896503|101973161|FG000|COMPLETED|Crossover Participants||0||
48668863|NCT03896503|101973162|FG001|COMPLETED|Crossover Participants||5||
48668864|NCT03896503|101973163|FG002|COMPLETED|Crossover Participants||0||
48668865|NCT03896503|101973164|FG003|COMPLETED|Crossover Participants||0||
48668866|NCT03896503|101973165|FG004|COMPLETED|Crossover Participants||6||
48668867|NCT03896503|101973166|FG005|COMPLETED|Crossover Participants||0||
48668868|NCT03896503|101973167|FG006|COMPLETED|Crossover Participants||0||
48668869|NCT03896503|101973168|FG007|COMPLETED|Crossover Participants||0||
48668870|NCT03896503|101973161|FG000|NOT COMPLETED|Crossover Participants||0||
48668871|NCT03896503|101973162|FG001|NOT COMPLETED|Crossover Participants||0||
48668872|NCT03896503|101973163|FG002|NOT COMPLETED|Crossover Participants||0||
48668873|NCT03896503|101973164|FG003|NOT COMPLETED|Crossover Participants||0||
48668874|NCT03896503|101973165|FG004|NOT COMPLETED|Crossover Participants||0||
48668875|NCT03896503|101973166|FG005|NOT COMPLETED|Crossover Participants||0||
48668876|NCT03896503|101973167|FG006|NOT COMPLETED|Crossover Participants||0||
48668877|NCT03896503|101973168|FG007|NOT COMPLETED|Crossover Participants||0||
48668878|NCT02723955|101973169|FG000|STARTED|Escalation Phase||1||
48668879|NCT02723955|101973170|FG001|STARTED|Escalation Phase||1||
48668880|NCT02723955|101973171|FG002|STARTED|Escalation Phase||2||
48668881|NCT02723955|101973172|FG003|STARTED|Escalation Phase||7||
48668882|NCT02723955|101973173|FG004|STARTED|Escalation Phase||24||
48668883|NCT02723955|101973174|FG005|STARTED|Escalation Phase||25||
48668884|NCT02723955|101973175|FG006|STARTED|Escalation Phase||15||
48668885|NCT02723955|101973176|FG007|STARTED|Escalation Phase||27||
48668886|NCT02723955|101973177|FG008|STARTED|Escalation Phase||7||
48668887|NCT02723955|101973178|FG009|STARTED|Escalation Phase||0||
48668888|NCT02723955|101973179|FG010|STARTED|Escalation Phase||0||
48668889|NCT02723955|101973180|FG011|STARTED|Escalation Phase||0||
48668890|NCT02723955|101973181|FG012|STARTED|Escalation Phase||5||
48668891|NCT02723955|101973182|FG013|STARTED|Escalation Phase||5||
48668892|NCT02723955|101973183|FG014|STARTED|Escalation Phase||5||
48668893|NCT02723955|101973184|FG015|STARTED|Escalation Phase||8||
48668894|NCT02723955|101973185|FG016|STARTED|Escalation Phase||11||
48668895|NCT02723955|101973186|FG017|STARTED|Escalation Phase||11||
48668896|NCT02723955|101973187|FG018|STARTED|Escalation Phase||1||
48668897|NCT02723955|101973188|FG019|STARTED|Escalation Phase||4||
48668898|NCT02723955|101973189|FG020|STARTED|Escalation Phase||16||
48668899|NCT02723955|101973190|FG021|STARTED|Escalation Phase||4||
48668900|NCT02723955|101973191|FG022|STARTED|Escalation Phase||3||
48668901|NCT02723955|101973192|FG023|STARTED|Escalation Phase||6||
48668902|NCT02723955|101973193|FG024|STARTED|Escalation Phase||36||
48668903|NCT02723955|101973194|FG025|STARTED|Escalation Phase||13||
48668904|NCT02723955|101973195|FG026|STARTED|Escalation Phase||22||
48668905|NCT02723955|101973196|FG027|STARTED|Escalation Phase||1||
48668906|NCT02723955|101973197|FG028|STARTED|Escalation Phase||4||
48668907|NCT02723955|101973198|FG029|STARTED|Escalation Phase||0||
48668908|NCT02723955|101973199|FG030|STARTED|Escalation Phase||0||
48668909|NCT02723955|101973200|FG031|STARTED|Escalation Phase||0||
48668910|NCT02723955|101973201|FG032|STARTED|Escalation Phase||0||
48668911|NCT02723955|101973202|FG033|STARTED|Escalation Phase||0||
48668912|NCT02723955|101973203|FG034|STARTED|Escalation Phase||0||
48668913|NCT02723955|101973204|FG035|STARTED|Escalation Phase||0||
48668914|NCT02723955|101973205|FG036|STARTED|Escalation Phase||0||
48668915|NCT02723955|101973206|FG037|STARTED|Escalation Phase||0||
48668916|NCT02723955|101973207|FG038|STARTED|Escalation Phase||0||
48668917|NCT02723955|101973208|FG039|STARTED|Escalation Phase||0||
48668918|NCT02723955|101973209|FG040|STARTED|Escalation Phase||0||
48668919|NCT02723955|101973210|FG041|STARTED|Escalation Phase||0||
48668920|NCT02723955|101973211|FG042|STARTED|Escalation Phase||0||
48668921|NCT02723955|101973169|FG000|COMPLETED|Escalation Phase||0||
48668922|NCT02723955|101973170|FG001|COMPLETED|Escalation Phase||0||
48668923|NCT02723955|101973171|FG002|COMPLETED|Escalation Phase||0||
48668924|NCT02723955|101973172|FG003|COMPLETED|Escalation Phase||0||
48668925|NCT02723955|101973173|FG004|COMPLETED|Escalation Phase||0||
48668926|NCT02723955|101973174|FG005|COMPLETED|Escalation Phase||1||
48668927|NCT02723955|101973175|FG006|COMPLETED|Escalation Phase||0||
48668928|NCT02723955|101973176|FG007|COMPLETED|Escalation Phase||0||
48668929|NCT02723955|101973177|FG008|COMPLETED|Escalation Phase||0||
48668930|NCT02723955|101973178|FG009|COMPLETED|Escalation Phase||0||
48668931|NCT02723955|101973179|FG010|COMPLETED|Escalation Phase||0||
48668932|NCT02723955|101973180|FG011|COMPLETED|Escalation Phase||0||
48668933|NCT02723955|101973181|FG012|COMPLETED|Escalation Phase||1||
48668934|NCT02723955|101973182|FG013|COMPLETED|Escalation Phase||1||
48668935|NCT02723955|101973183|FG014|COMPLETED|Escalation Phase||0||
48668936|NCT02723955|101973184|FG015|COMPLETED|Escalation Phase||1||
48668937|NCT02723955|101973185|FG016|COMPLETED|Escalation Phase||3||
48668938|NCT02723955|101973186|FG017|COMPLETED|Escalation Phase||0||
48668939|NCT02723955|101973187|FG018|COMPLETED|Escalation Phase||0||
48668940|NCT02723955|101973188|FG019|COMPLETED|Escalation Phase||0||
48668941|NCT02723955|101973189|FG020|COMPLETED|Escalation Phase||0||
48668942|NCT02723955|101973190|FG021|COMPLETED|Escalation Phase||0||
48668943|NCT02723955|101973191|FG022|COMPLETED|Escalation Phase||1||
48668944|NCT02723955|101973192|FG023|COMPLETED|Escalation Phase||0||
48668945|NCT02723955|101973193|FG024|COMPLETED|Escalation Phase||1||
48668946|NCT02723955|101973194|FG025|COMPLETED|Escalation Phase||3||
48668947|NCT02723955|101973195|FG026|COMPLETED|Escalation Phase||1||
48668948|NCT02723955|101973196|FG027|COMPLETED|Escalation Phase||0||
48668949|NCT02723955|101973197|FG028|COMPLETED|Escalation Phase||0||
48668950|NCT02723955|101973198|FG029|COMPLETED|Escalation Phase||0||
48668951|NCT02723955|101973199|FG030|COMPLETED|Escalation Phase||0||
48668952|NCT02723955|101973200|FG031|COMPLETED|Escalation Phase||0||
48668953|NCT02723955|101973201|FG032|COMPLETED|Escalation Phase||0||
48668954|NCT02723955|101973202|FG033|COMPLETED|Escalation Phase||0||
48668955|NCT02723955|101973203|FG034|COMPLETED|Escalation Phase||0||
48668956|NCT02723955|101973204|FG035|COMPLETED|Escalation Phase||0||
48668957|NCT02723955|101973205|FG036|COMPLETED|Escalation Phase||0||
48668958|NCT02723955|101973206|FG037|COMPLETED|Escalation Phase||0||
48668959|NCT02723955|101973207|FG038|COMPLETED|Escalation Phase||0||
48668960|NCT02723955|101973208|FG039|COMPLETED|Escalation Phase||0||
48668961|NCT02723955|101973209|FG040|COMPLETED|Escalation Phase||0||
48668962|NCT02723955|101973210|FG041|COMPLETED|Escalation Phase||0||
48668963|NCT02723955|101973211|FG042|COMPLETED|Escalation Phase||0||
48668964|NCT02723955|101973169|FG000|NOT COMPLETED|Escalation Phase||1||
48668965|NCT02723955|101973170|FG001|NOT COMPLETED|Escalation Phase||1||
48668966|NCT02723955|101973171|FG002|NOT COMPLETED|Escalation Phase||2||
48668967|NCT02723955|101973172|FG003|NOT COMPLETED|Escalation Phase||7||
48668968|NCT02723955|101973173|FG004|NOT COMPLETED|Escalation Phase||24||
48668969|NCT02723955|101973174|FG005|NOT COMPLETED|Escalation Phase||24||
48668970|NCT02723955|101973175|FG006|NOT COMPLETED|Escalation Phase||15||
48668971|NCT02723955|101973176|FG007|NOT COMPLETED|Escalation Phase||27||
48668972|NCT02723955|101973177|FG008|NOT COMPLETED|Escalation Phase||7||
48668973|NCT02723955|101973178|FG009|NOT COMPLETED|Escalation Phase||0||
48668974|NCT02723955|101973179|FG010|NOT COMPLETED|Escalation Phase||0||
48668975|NCT02723955|101973180|FG011|NOT COMPLETED|Escalation Phase||0||
48668976|NCT02723955|101973181|FG012|NOT COMPLETED|Escalation Phase||4||
48668977|NCT02723955|101973182|FG013|NOT COMPLETED|Escalation Phase||4||
48668978|NCT02723955|101973183|FG014|NOT COMPLETED|Escalation Phase||5||
48668979|NCT02723955|101973184|FG015|NOT COMPLETED|Escalation Phase||7||
48668980|NCT02723955|101973185|FG016|NOT COMPLETED|Escalation Phase||8||
48668981|NCT02723955|101973186|FG017|NOT COMPLETED|Escalation Phase||11||
48668982|NCT02723955|101973187|FG018|NOT COMPLETED|Escalation Phase||1||
48668983|NCT02723955|101973188|FG019|NOT COMPLETED|Escalation Phase||4||
48668984|NCT02723955|101973189|FG020|NOT COMPLETED|Escalation Phase||16||
48668985|NCT02723955|101973190|FG021|NOT COMPLETED|Escalation Phase||4||
48668986|NCT02723955|101973191|FG022|NOT COMPLETED|Escalation Phase||2||
48668987|NCT02723955|101973192|FG023|NOT COMPLETED|Escalation Phase||6||
48668988|NCT02723955|101973193|FG024|NOT COMPLETED|Escalation Phase||35||
48668989|NCT02723955|101973194|FG025|NOT COMPLETED|Escalation Phase||10||
48668990|NCT02723955|101973195|FG026|NOT COMPLETED|Escalation Phase||21||
48668991|NCT02723955|101973196|FG027|NOT COMPLETED|Escalation Phase||1||
48668992|NCT02723955|101973197|FG028|NOT COMPLETED|Escalation Phase||4||
48668993|NCT02723955|101973198|FG029|NOT COMPLETED|Escalation Phase||0||
48668994|NCT02723955|101973199|FG030|NOT COMPLETED|Escalation Phase||0||
48668995|NCT02723955|101973200|FG031|NOT COMPLETED|Escalation Phase||0||
48668996|NCT02723955|101973201|FG032|NOT COMPLETED|Escalation Phase||0||
48668997|NCT02723955|101973202|FG033|NOT COMPLETED|Escalation Phase||0||
48668998|NCT02723955|101973203|FG034|NOT COMPLETED|Escalation Phase||0||
48668999|NCT02723955|101973204|FG035|NOT COMPLETED|Escalation Phase||0||
48669000|NCT02723955|101973205|FG036|NOT COMPLETED|Escalation Phase||0||
48669001|NCT02723955|101973206|FG037|NOT COMPLETED|Escalation Phase||0||
48669002|NCT02723955|101973207|FG038|NOT COMPLETED|Escalation Phase||0||
48669003|NCT02723955|101973208|FG039|NOT COMPLETED|Escalation Phase||0||
48669004|NCT02723955|101973209|FG040|NOT COMPLETED|Escalation Phase||0||
48669005|NCT02723955|101973210|FG041|NOT COMPLETED|Escalation Phase||0||
48669006|NCT02723955|101973211|FG042|NOT COMPLETED|Escalation Phase||0||
48669007|NCT02723955|101973169|FG000|STARTED|Expansion Phase||0||
48669008|NCT02723955|101973170|FG001|STARTED|Expansion Phase||0||
48669009|NCT02723955|101973171|FG002|STARTED|Expansion Phase||0||
48669010|NCT02723955|101973172|FG003|STARTED|Expansion Phase||0||
48669011|NCT02723955|101973173|FG004|STARTED|Expansion Phase||0||
48669012|NCT02723955|101973174|FG005|STARTED|Expansion Phase||0||
48669013|NCT02723955|101973175|FG006|STARTED|Expansion Phase||0||
48669014|NCT02723955|101973176|FG007|STARTED|Expansion Phase||0||
48669015|NCT02723955|101973177|FG008|STARTED|Expansion Phase||0||
48669016|NCT02723955|101973178|FG009|STARTED|Expansion Phase||39||
48669017|NCT02723955|101973179|FG010|STARTED|Expansion Phase||115||
48669018|NCT02723955|101973180|FG011|STARTED|Expansion Phase||59||
48669019|NCT02723955|101973181|FG012|STARTED|Expansion Phase||0||
48669020|NCT02723955|101973182|FG013|STARTED|Expansion Phase||0||
48669021|NCT02723955|101973183|FG014|STARTED|Expansion Phase||0||
48669022|NCT02723955|101973184|FG015|STARTED|Expansion Phase||0||
48669023|NCT02723955|101973185|FG016|STARTED|Expansion Phase||0||
48669024|NCT02723955|101973186|FG017|STARTED|Expansion Phase||0||
48669025|NCT02723955|101973187|FG018|STARTED|Expansion Phase||0||
48669026|NCT02723955|101973188|FG019|STARTED|Expansion Phase||0||
48669027|NCT02723955|101973189|FG020|STARTED|Expansion Phase||0||
48669028|NCT02723955|101973190|FG021|STARTED|Expansion Phase||0||
48669029|NCT02723955|101973191|FG022|STARTED|Expansion Phase||0||
48669030|NCT02723955|101973192|FG023|STARTED|Expansion Phase||0||
48669031|NCT02723955|101973193|FG024|STARTED|Expansion Phase||0||
48669032|NCT02723955|101973194|FG025|STARTED|Expansion Phase||0||
48669033|NCT02723955|101973195|FG026|STARTED|Expansion Phase||0||
48669034|NCT02723955|101973196|FG027|STARTED|Expansion Phase||0||
48669035|NCT02723955|101973197|FG028|STARTED|Expansion Phase||0||
48669036|NCT02723955|101973198|FG029|STARTED|Expansion Phase||14||
48669037|NCT02723955|101973199|FG030|STARTED|Expansion Phase||255||
48669038|NCT02723955|101973200|FG031|STARTED|Expansion Phase||44||
48669039|NCT02723955|101973201|FG032|STARTED|Expansion Phase||23||
48669040|NCT02723955|101973202|FG033|STARTED|Expansion Phase||4||
48669041|NCT02723955|101973203|FG034|STARTED|Expansion Phase||6||
48669042|NCT02723955|101973204|FG035|STARTED|Expansion Phase||5||
48669043|NCT02723955|101973205|FG036|STARTED|Expansion Phase||1||
48669044|NCT02723955|101973206|FG037|STARTED|Expansion Phase||0||
48669045|NCT02723955|101973207|FG038|STARTED|Expansion Phase||0||
48669046|NCT02723955|101973208|FG039|STARTED|Expansion Phase||0||
48669047|NCT02723955|101973209|FG040|STARTED|Expansion Phase||0||
48669048|NCT02723955|101973210|FG041|STARTED|Expansion Phase||0||
48669049|NCT02723955|101973211|FG042|STARTED|Expansion Phase||0||
48669050|NCT02723955|101973169|FG000|COMPLETED|Expansion Phase||0||
48669051|NCT02723955|101973170|FG001|COMPLETED|Expansion Phase||0||
48669052|NCT02723955|101973171|FG002|COMPLETED|Expansion Phase||0||
48669053|NCT02723955|101973172|FG003|COMPLETED|Expansion Phase||0||
48669054|NCT02723955|101973173|FG004|COMPLETED|Expansion Phase||0||
48669055|NCT02723955|101973174|FG005|COMPLETED|Expansion Phase||0||
48669056|NCT02723955|101973175|FG006|COMPLETED|Expansion Phase||0||
48669057|NCT02723955|101973176|FG007|COMPLETED|Expansion Phase||0||
48669058|NCT02723955|101973177|FG008|COMPLETED|Expansion Phase||0||
48669059|NCT02723955|101973178|FG009|COMPLETED|Expansion Phase||1||
48669060|NCT02723955|101973179|FG010|COMPLETED|Expansion Phase||3||
48669061|NCT02723955|101973180|FG011|COMPLETED|Expansion Phase||3||
48669062|NCT02723955|101973181|FG012|COMPLETED|Expansion Phase||0||
48669063|NCT02723955|101973182|FG013|COMPLETED|Expansion Phase||0||
48669064|NCT02723955|101973183|FG014|COMPLETED|Expansion Phase||0||
48669065|NCT02723955|101973184|FG015|COMPLETED|Expansion Phase||0||
48669066|NCT02723955|101973185|FG016|COMPLETED|Expansion Phase||0||
48669067|NCT02723955|101973186|FG017|COMPLETED|Expansion Phase||0||
48669068|NCT02723955|101973187|FG018|COMPLETED|Expansion Phase||0||
48669069|NCT02723955|101973188|FG019|COMPLETED|Expansion Phase||0||
48669070|NCT02723955|101973189|FG020|COMPLETED|Expansion Phase||0||
48669071|NCT02723955|101973190|FG021|COMPLETED|Expansion Phase||0||
48669072|NCT02723955|101973191|FG022|COMPLETED|Expansion Phase||0||
48669073|NCT02723955|101973192|FG023|COMPLETED|Expansion Phase||0||
48669074|NCT02723955|101973193|FG024|COMPLETED|Expansion Phase||0||
48669075|NCT02723955|101973194|FG025|COMPLETED|Expansion Phase||0||
48669076|NCT02723955|101973195|FG026|COMPLETED|Expansion Phase||0||
48669077|NCT02723955|101973196|FG027|COMPLETED|Expansion Phase||0||
48669078|NCT02723955|101973197|FG028|COMPLETED|Expansion Phase||0||
48669079|NCT02723955|101973198|FG029|COMPLETED|Expansion Phase||1||
48669080|NCT02723955|101973199|FG030|COMPLETED|Expansion Phase||14||
48669081|NCT02723955|101973200|FG031|COMPLETED|Expansion Phase||2||
48669082|NCT02723955|101973201|FG032|COMPLETED|Expansion Phase||3||
48669083|NCT02723955|101973202|FG033|COMPLETED|Expansion Phase||0||
48669084|NCT02723955|101973203|FG034|COMPLETED|Expansion Phase||3||
48669085|NCT02723955|101973204|FG035|COMPLETED|Expansion Phase||1||
48669086|NCT02723955|101973205|FG036|COMPLETED|Expansion Phase||0||
48669087|NCT02723955|101973206|FG037|COMPLETED|Expansion Phase||0||
48669088|NCT02723955|101973207|FG038|COMPLETED|Expansion Phase||0||
48669089|NCT02723955|101973208|FG039|COMPLETED|Expansion Phase||0||
48669090|NCT02723955|101973209|FG040|COMPLETED|Expansion Phase||0||
48669091|NCT02723955|101973210|FG041|COMPLETED|Expansion Phase||0||
48669092|NCT02723955|101973211|FG042|COMPLETED|Expansion Phase||0||
48669093|NCT02723955|101973169|FG000|NOT COMPLETED|Expansion Phase||0||
48669094|NCT02723955|101973170|FG001|NOT COMPLETED|Expansion Phase||0||
48669095|NCT02723955|101973171|FG002|NOT COMPLETED|Expansion Phase||0||
48669096|NCT02723955|101973172|FG003|NOT COMPLETED|Expansion Phase||0||
48669097|NCT02723955|101973173|FG004|NOT COMPLETED|Expansion Phase||0||
48669098|NCT02723955|101973174|FG005|NOT COMPLETED|Expansion Phase||0||
48669099|NCT02723955|101973175|FG006|NOT COMPLETED|Expansion Phase||0||
48669100|NCT02723955|101973176|FG007|NOT COMPLETED|Expansion Phase||0||
48669101|NCT02723955|101973177|FG008|NOT COMPLETED|Expansion Phase||0||
48669102|NCT02723955|101973178|FG009|NOT COMPLETED|Expansion Phase||38||
48669103|NCT02723955|101973179|FG010|NOT COMPLETED|Expansion Phase||112||
48669104|NCT02723955|101973180|FG011|NOT COMPLETED|Expansion Phase||56||
48669105|NCT02723955|101973181|FG012|NOT COMPLETED|Expansion Phase||0||
48669106|NCT02723955|101973182|FG013|NOT COMPLETED|Expansion Phase||0||
48669107|NCT02723955|101973183|FG014|NOT COMPLETED|Expansion Phase||0||
48669108|NCT02723955|101973184|FG015|NOT COMPLETED|Expansion Phase||0||
48669109|NCT02723955|101973185|FG016|NOT COMPLETED|Expansion Phase||0||
48669110|NCT02723955|101973186|FG017|NOT COMPLETED|Expansion Phase||0||
48669111|NCT02723955|101973187|FG018|NOT COMPLETED|Expansion Phase||0||
48669112|NCT02723955|101973188|FG019|NOT COMPLETED|Expansion Phase||0||
48669113|NCT02723955|101973189|FG020|NOT COMPLETED|Expansion Phase||0||
48669114|NCT02723955|101973190|FG021|NOT COMPLETED|Expansion Phase||0||
48669115|NCT02723955|101973191|FG022|NOT COMPLETED|Expansion Phase||0||
48669116|NCT02723955|101973192|FG023|NOT COMPLETED|Expansion Phase||0||
48669117|NCT02723955|101973193|FG024|NOT COMPLETED|Expansion Phase||0||
48669118|NCT02723955|101973194|FG025|NOT COMPLETED|Expansion Phase||0||
48669119|NCT02723955|101973195|FG026|NOT COMPLETED|Expansion Phase||0||
48669120|NCT02723955|101973196|FG027|NOT COMPLETED|Expansion Phase||0||
48669121|NCT02723955|101973197|FG028|NOT COMPLETED|Expansion Phase||0||
48669122|NCT02723955|101973198|FG029|NOT COMPLETED|Expansion Phase||13||
48669123|NCT02723955|101973199|FG030|NOT COMPLETED|Expansion Phase||241||
48669124|NCT02723955|101973200|FG031|NOT COMPLETED|Expansion Phase||42||
48669125|NCT02723955|101973201|FG032|NOT COMPLETED|Expansion Phase||20||
48669126|NCT02723955|101973202|FG033|NOT COMPLETED|Expansion Phase||4||
48669127|NCT02723955|101973203|FG034|NOT COMPLETED|Expansion Phase||3||
48669128|NCT02723955|101973204|FG035|NOT COMPLETED|Expansion Phase||4||
48669129|NCT02723955|101973205|FG036|NOT COMPLETED|Expansion Phase||1||
48669130|NCT02723955|101973206|FG037|NOT COMPLETED|Expansion Phase||0||
48669131|NCT02723955|101973207|FG038|NOT COMPLETED|Expansion Phase||0||
48669132|NCT02723955|101973208|FG039|NOT COMPLETED|Expansion Phase||0||
48669133|NCT02723955|101973209|FG040|NOT COMPLETED|Expansion Phase||0||
48669134|NCT02723955|101973210|FG041|NOT COMPLETED|Expansion Phase||0||
48669135|NCT02723955|101973211|FG042|NOT COMPLETED|Expansion Phase||0||
48669136|NCT02723955|101973169|FG000|STARTED|Crossover/ Re-treatment Phase||0||
48669137|NCT02723955|101973170|FG001|STARTED|Crossover/ Re-treatment Phase||0||
48669138|NCT02723955|101973171|FG002|STARTED|Crossover/ Re-treatment Phase||0||
48669139|NCT02723955|101973172|FG003|STARTED|Crossover/ Re-treatment Phase||0||
48669140|NCT02723955|101973173|FG004|STARTED|Crossover/ Re-treatment Phase||0||
48669141|NCT02723955|101973174|FG005|STARTED|Crossover/ Re-treatment Phase||0||
48669142|NCT02723955|101973175|FG006|STARTED|Crossover/ Re-treatment Phase||0||
48669143|NCT02723955|101973176|FG007|STARTED|Crossover/ Re-treatment Phase||0||
48669144|NCT02723955|101973177|FG008|STARTED|Crossover/ Re-treatment Phase||0||
48669145|NCT02723955|101973178|FG009|STARTED|Crossover/ Re-treatment Phase||0||
48669146|NCT02723955|101973179|FG010|STARTED|Crossover/ Re-treatment Phase||0||
48669147|NCT02723955|101973180|FG011|STARTED|Crossover/ Re-treatment Phase||0||
48669148|NCT02723955|101973181|FG012|STARTED|Crossover/ Re-treatment Phase||0||
48669149|NCT02723955|101973182|FG013|STARTED|Crossover/ Re-treatment Phase||0||
48669150|NCT02723955|101973183|FG014|STARTED|Crossover/ Re-treatment Phase||0||
48669151|NCT02723955|101973184|FG015|STARTED|Crossover/ Re-treatment Phase||0||
48669152|NCT02723955|101973185|FG016|STARTED|Crossover/ Re-treatment Phase||0||
48669153|NCT02723955|101973186|FG017|STARTED|Crossover/ Re-treatment Phase||0||
48669154|NCT02723955|101973187|FG018|STARTED|Crossover/ Re-treatment Phase||0||
48669155|NCT02723955|101973188|FG019|STARTED|Crossover/ Re-treatment Phase||0||
48669156|NCT02723955|101973189|FG020|STARTED|Crossover/ Re-treatment Phase||0||
48669157|NCT02723955|101973190|FG021|STARTED|Crossover/ Re-treatment Phase||0||
48669158|NCT02723955|101973191|FG022|STARTED|Crossover/ Re-treatment Phase||0||
48669159|NCT02723955|101973192|FG023|STARTED|Crossover/ Re-treatment Phase||0||
48669160|NCT02723955|101973193|FG024|STARTED|Crossover/ Re-treatment Phase||0||
48669161|NCT02723955|101973194|FG025|STARTED|Crossover/ Re-treatment Phase||0||
48669162|NCT02723955|101973195|FG026|STARTED|Crossover/ Re-treatment Phase||0||
48669163|NCT02723955|101973196|FG027|STARTED|Crossover/ Re-treatment Phase||0||
48669164|NCT02723955|101973197|FG028|STARTED|Crossover/ Re-treatment Phase||0||
48669165|NCT02723955|101973198|FG029|STARTED|Crossover/ Re-treatment Phase||0||
48669166|NCT02723955|101973199|FG030|STARTED|Crossover/ Re-treatment Phase||0||
48669167|NCT02723955|101973200|FG031|STARTED|Crossover/ Re-treatment Phase||0||
48669168|NCT02723955|101973201|FG032|STARTED|Crossover/ Re-treatment Phase||0||
48669169|NCT02723955|101973202|FG033|STARTED|Crossover/ Re-treatment Phase||0||
48669170|NCT02723955|101973203|FG034|STARTED|Crossover/ Re-treatment Phase||0||
48669171|NCT02723955|101973204|FG035|STARTED|Crossover/ Re-treatment Phase||0||
48669172|NCT02723955|101973205|FG036|STARTED|Crossover/ Re-treatment Phase||0||
48669173|NCT02723955|101973206|FG037|STARTED|Crossover/ Re-treatment Phase||1||
48669174|NCT02723955|101973207|FG038|STARTED|Crossover/ Re-treatment Phase||19||
48669175|NCT02723955|101973208|FG039|STARTED|Crossover/ Re-treatment Phase||42||
48669176|NCT02723955|101973209|FG040|STARTED|Crossover/ Re-treatment Phase||2||
48669177|NCT02723955|101973210|FG041|STARTED|Crossover/ Re-treatment Phase||1||
48669178|NCT02723955|101973211|FG042|STARTED|Crossover/ Re-treatment Phase||1||
48669179|NCT02723955|101973169|FG000|COMPLETED|Crossover/ Re-treatment Phase||0||
48669180|NCT02723955|101973170|FG001|COMPLETED|Crossover/ Re-treatment Phase||0||
48669181|NCT02723955|101973171|FG002|COMPLETED|Crossover/ Re-treatment Phase||0||
48669182|NCT02723955|101973172|FG003|COMPLETED|Crossover/ Re-treatment Phase||0||
48669183|NCT02723955|101973173|FG004|COMPLETED|Crossover/ Re-treatment Phase||0||
48669184|NCT02723955|101973174|FG005|COMPLETED|Crossover/ Re-treatment Phase||0||
48669185|NCT02723955|101973175|FG006|COMPLETED|Crossover/ Re-treatment Phase||0||
48669186|NCT02723955|101973176|FG007|COMPLETED|Crossover/ Re-treatment Phase||0||
48669187|NCT02723955|101973177|FG008|COMPLETED|Crossover/ Re-treatment Phase||0||
48669188|NCT02723955|101973178|FG009|COMPLETED|Crossover/ Re-treatment Phase||0||
48669189|NCT02723955|101973179|FG010|COMPLETED|Crossover/ Re-treatment Phase||0||
48669190|NCT02723955|101973180|FG011|COMPLETED|Crossover/ Re-treatment Phase||0||
48669191|NCT02723955|101973181|FG012|COMPLETED|Crossover/ Re-treatment Phase||0||
48669192|NCT02723955|101973182|FG013|COMPLETED|Crossover/ Re-treatment Phase||0||
48669193|NCT02723955|101973183|FG014|COMPLETED|Crossover/ Re-treatment Phase||0||
48669194|NCT02723955|101973184|FG015|COMPLETED|Crossover/ Re-treatment Phase||0||
48669195|NCT02723955|101973185|FG016|COMPLETED|Crossover/ Re-treatment Phase||0||
48669196|NCT02723955|101973186|FG017|COMPLETED|Crossover/ Re-treatment Phase||0||
48669197|NCT02723955|101973187|FG018|COMPLETED|Crossover/ Re-treatment Phase||0||
48669198|NCT02723955|101973188|FG019|COMPLETED|Crossover/ Re-treatment Phase||0||
48669199|NCT02723955|101973189|FG020|COMPLETED|Crossover/ Re-treatment Phase||0||
48669200|NCT02723955|101973190|FG021|COMPLETED|Crossover/ Re-treatment Phase||0||
48669201|NCT02723955|101973191|FG022|COMPLETED|Crossover/ Re-treatment Phase||0||
48669202|NCT02723955|101973192|FG023|COMPLETED|Crossover/ Re-treatment Phase||0||
48669203|NCT02723955|101973193|FG024|COMPLETED|Crossover/ Re-treatment Phase||0||
48669204|NCT02723955|101973194|FG025|COMPLETED|Crossover/ Re-treatment Phase||0||
48669205|NCT02723955|101973195|FG026|COMPLETED|Crossover/ Re-treatment Phase||0||
48669206|NCT02723955|101973196|FG027|COMPLETED|Crossover/ Re-treatment Phase||0||
48669207|NCT02723955|101973197|FG028|COMPLETED|Crossover/ Re-treatment Phase||0||
48669208|NCT02723955|101973198|FG029|COMPLETED|Crossover/ Re-treatment Phase||0||
48669209|NCT02723955|101973199|FG030|COMPLETED|Crossover/ Re-treatment Phase||0||
48669210|NCT02723955|101973200|FG031|COMPLETED|Crossover/ Re-treatment Phase||0||
48669211|NCT02723955|101973201|FG032|COMPLETED|Crossover/ Re-treatment Phase||0||
48669212|NCT02723955|101973202|FG033|COMPLETED|Crossover/ Re-treatment Phase||0||
48669213|NCT02723955|101973203|FG034|COMPLETED|Crossover/ Re-treatment Phase||0||
48669214|NCT02723955|101973204|FG035|COMPLETED|Crossover/ Re-treatment Phase||0||
48669215|NCT02723955|101973205|FG036|COMPLETED|Crossover/ Re-treatment Phase||0||
48669216|NCT02723955|101973206|FG037|COMPLETED|Crossover/ Re-treatment Phase||0||
48669217|NCT02723955|101973207|FG038|COMPLETED|Crossover/ Re-treatment Phase||0||
48669218|NCT02723955|101973208|FG039|COMPLETED|Crossover/ Re-treatment Phase||3||
48669219|NCT02723955|101973209|FG040|COMPLETED|Crossover/ Re-treatment Phase||0||
48669220|NCT02723955|101973210|FG041|COMPLETED|Crossover/ Re-treatment Phase||0||
48669221|NCT02723955|101973211|FG042|COMPLETED|Crossover/ Re-treatment Phase||0||
48669222|NCT02723955|101973169|FG000|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669223|NCT02723955|101973170|FG001|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669224|NCT02723955|101973171|FG002|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669225|NCT02723955|101973172|FG003|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669226|NCT02723955|101973173|FG004|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669227|NCT02723955|101973174|FG005|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669228|NCT02723955|101973175|FG006|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669229|NCT02723955|101973176|FG007|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669230|NCT02723955|101973177|FG008|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669231|NCT02723955|101973178|FG009|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669232|NCT02723955|101973179|FG010|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669233|NCT02723955|101973180|FG011|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669234|NCT02723955|101973181|FG012|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669235|NCT02723955|101973182|FG013|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669236|NCT02723955|101973183|FG014|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669237|NCT02723955|101973184|FG015|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669238|NCT02723955|101973185|FG016|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669239|NCT02723955|101973186|FG017|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669240|NCT02723955|101973187|FG018|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669241|NCT02723955|101973188|FG019|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669242|NCT02723955|101973189|FG020|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669243|NCT02723955|101973190|FG021|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669244|NCT02723955|101973191|FG022|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669245|NCT02723955|101973192|FG023|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669246|NCT02723955|101973193|FG024|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669247|NCT02723955|101973194|FG025|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669248|NCT02723955|101973195|FG026|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669249|NCT02723955|101973196|FG027|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669250|NCT02723955|101973197|FG028|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669251|NCT02723955|101973198|FG029|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669252|NCT02723955|101973199|FG030|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669253|NCT02723955|101973200|FG031|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669254|NCT02723955|101973201|FG032|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669255|NCT02723955|101973202|FG033|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669256|NCT02723955|101973203|FG034|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669257|NCT02723955|101973204|FG035|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669258|NCT02723955|101973205|FG036|NOT COMPLETED|Crossover/ Re-treatment Phase||0||
48669259|NCT02723955|101973206|FG037|NOT COMPLETED|Crossover/ Re-treatment Phase||1||
48669260|NCT02723955|101973207|FG038|NOT COMPLETED|Crossover/ Re-treatment Phase||19||
48669261|NCT02723955|101973208|FG039|NOT COMPLETED|Crossover/ Re-treatment Phase||39||
48669262|NCT02723955|101973209|FG040|NOT COMPLETED|Crossover/ Re-treatment Phase||2||
48669263|NCT02723955|101973210|FG041|NOT COMPLETED|Crossover/ Re-treatment Phase||1||
48669264|NCT02723955|101973211|FG042|NOT COMPLETED|Crossover/ Re-treatment Phase||1||
48669265|NCT04038957|101973212|FG000|STARTED|Overall Study||22||
48669266|NCT04038957|101973212|FG000|COMPLETED|Overall Study||20||
48669267|NCT04038957|101973212|FG000|NOT COMPLETED|Overall Study||2||
48669268|NCT00837369|101973213|FG000|STARTED|Overall Study||100||
48669269|NCT00837369|101973213|FG000|COMPLETED|Overall Study||100||
48669270|NCT00837369|101973213|FG000|NOT COMPLETED|Overall Study||0||
48669271|NCT01744782|101974773|FG000|STARTED|Overall Study||17||
48669272|NCT01744782|101974773|FG000|COMPLETED|Overall Study||16||
48669273|NCT01744782|101974773|FG000|NOT COMPLETED|Overall Study||1||
48669274|NCT01333969|101974774|FG000|STARTED|Overall Study||30||
48669275|NCT01333969|101974775|FG001|STARTED|Overall Study||30||
48669276|NCT01333969|101974774|FG000|COMPLETED|Overall Study||30||
48669277|NCT01333969|101974775|FG001|COMPLETED|Overall Study||30||
48669278|NCT01333969|101974774|FG000|NOT COMPLETED|Overall Study||0||
48669279|NCT01333969|101974775|FG001|NOT COMPLETED|Overall Study||0||
48669280|NCT05391893|101974776|FG000|STARTED|Overall Study||177||
48669281|NCT05391893|101974777|FG001|STARTED|Overall Study||267||
48669282|NCT05391893|101974776|FG000|COMPLETED|Overall Study||172||
48669283|NCT05391893|101974777|FG001|COMPLETED|Overall Study||249||
48669284|NCT05391893|101974776|FG000|NOT COMPLETED|Overall Study||5||
48669285|NCT05391893|101974777|FG001|NOT COMPLETED|Overall Study||18||
48669286|NCT01841736|101974778|FG000|STARTED|Overall Study||97||
48669287|NCT01841736|101974779|FG001|STARTED|Overall Study||74||
48669288|NCT01841736|101974778|FG000|Crossover|Overall Study||0|Crossed over for pazopanib following disease progression on placebo|
48669289|NCT01841736|101974779|FG001|Crossover|Overall Study||49|Crossed over for pazopanib following disease progression on placebo|
48669290|NCT01841736|101974778|FG000|COMPLETED|Overall Study||97|Included in efficacy analysis|
48669291|NCT01841736|101974779|FG001|COMPLETED|Overall Study||74|Included in efficacy analysis|
48669292|NCT01841736|101974778|FG000|NOT COMPLETED|Overall Study||0||
48669293|NCT01841736|101974779|FG001|NOT COMPLETED|Overall Study||0||
48669294|NCT00601900|101974780|FG000|STARTED|Overall Study||195||
48669295|NCT00601900|101974781|FG001|STARTED|Overall Study||199||
48669296|NCT00601900|101974780|FG000|COMPLETED|Overall Study||195||
48669297|NCT00601900|101974781|FG001|COMPLETED|Overall Study||196||
48669298|NCT00601900|101974780|FG000|NOT COMPLETED|Overall Study||0||
48669299|NCT00601900|101974781|FG001|NOT COMPLETED|Overall Study||3||
48669300|NCT03056040|101974782|FG000|STARTED|Primary Evaluation Period||98||
48669301|NCT03056040|101974783|FG001|STARTED|Primary Evaluation Period||99||
48669302|NCT03056040|101974782|FG000|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||97|Participants included in the Safety Set|
48669303|NCT03056040|101974783|FG001|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||98|Participants included in the Safety Set|
48669304|NCT03056040|101974782|FG000|Participants in the Full Analysis Set (FAS)|Primary Evaluation Period||97||
48669305|NCT03056040|101974783|FG001|Participants in the Full Analysis Set (FAS)|Primary Evaluation Period||98||
48669306|NCT03056040|101974782|FG000|COMPLETED|Primary Evaluation Period||96||
48669307|NCT03056040|101974783|FG001|COMPLETED|Primary Evaluation Period||95||
48669308|NCT03056040|101974782|FG000|NOT COMPLETED|Primary Evaluation Period||2||
48669309|NCT03056040|101974783|FG001|NOT COMPLETED|Primary Evaluation Period||4||
48669310|NCT03056040|101974782|FG000|STARTED|Extension Period||96||
48669311|NCT03056040|101974783|FG001|STARTED|Extension Period||95||
48669312|NCT03056040|101974782|FG000|COMPLETED|Extension Period||92||
48669313|NCT03056040|101974783|FG001|COMPLETED|Extension Period||88||
48669314|NCT03056040|101974782|FG000|NOT COMPLETED|Extension Period||4||
48669315|NCT03056040|101974783|FG001|NOT COMPLETED|Extension Period||7||
48669316|NCT00334815|101974784|FG000|STARTED|Overall Study||16||
48669317|NCT00334815|101974785|FG001|STARTED|Overall Study||13||
48669318|NCT00334815|101974784|FG000|COMPLETED|Overall Study||9||
48669319|NCT00334815|101974785|FG001|COMPLETED|Overall Study||3||
48669320|NCT00334815|101974784|FG000|NOT COMPLETED|Overall Study||7||
48669321|NCT00334815|101974785|FG001|NOT COMPLETED|Overall Study||10||
48669322|NCT04256941|101974786|FG000|STARTED|Overall Study||1||
48669323|NCT04256941|101974787|FG001|STARTED|Overall Study||3||
48669324|NCT04256941|101974786|FG000|COMPLETED|Overall Study||0||
48669325|NCT04256941|101974787|FG001|COMPLETED|Overall Study||0||
48669326|NCT04256941|101974786|FG000|NOT COMPLETED|Overall Study||1||
48669327|NCT04256941|101974787|FG001|NOT COMPLETED|Overall Study||3||
48669328|NCT04418466|101974788|FG000|STARTED|Overall Study||17|Started Oral Phase|
48669329|NCT04418466|101974789|FG001|STARTED|Overall Study||17|Started Oral Phase|
48669330|NCT04418466|101974788|FG000|Started Implant Phase|Overall Study||14||
48669331|NCT04418466|101974789|FG001|Started Implant Phase|Overall Study||14||
48669332|NCT04418466|101974788|FG000|COMPLETED|Overall Study||12|Completed Implant Phase|
48669333|NCT04418466|101974789|FG001|COMPLETED|Overall Study||11|Completed Implant Phase|
48669334|NCT04418466|101974788|FG000|NOT COMPLETED|Overall Study||5||
48669335|NCT04418466|101974789|FG001|NOT COMPLETED|Overall Study||6||
48669336|NCT02325154|101974790|FG000|STARTED|Overall Study||100||
48669337|NCT02325154|101974790|FG000|COMPLETED|Overall Study||99||
48669338|NCT02325154|101974790|FG000|NOT COMPLETED|Overall Study||1||
48669339|NCT04083235|101974791|FG000|STARTED|Overall Study||383||
48669340|NCT04083235|101974792|FG001|STARTED|Overall Study||387||
48669341|NCT04083235|101974791|FG000|Received Treatment|Overall Study||370||
48669342|NCT04083235|101974792|FG001|Received Treatment|Overall Study||379||
48669343|NCT04083235|101974791|FG000|COMPLETED|Overall Study||59||
48669344|NCT04083235|101974792|FG001|COMPLETED|Overall Study||77||
48669345|NCT04083235|101974791|FG000|NOT COMPLETED|Overall Study||324||
48669346|NCT04083235|101974792|FG001|NOT COMPLETED|Overall Study||310||
48669347|NCT02023866|101974793|FG000|STARTED|Overall Study||36||
48669348|NCT02023866|101974793|FG000|COMPLETED|Overall Study||30||
48669349|NCT02023866|101974793|FG000|NOT COMPLETED|Overall Study||6||
48669350|NCT04802967|101974794|FG000|STARTED|Part A||6||
48669351|NCT04802967|101974795|FG001|STARTED|Part A||6||
48669352|NCT04802967|101974796|FG002|STARTED|Part A||0||
48669353|NCT04802967|101974797|FG003|STARTED|Part A||0||
48669354|NCT04802967|101974798|FG004|STARTED|Part A||0||
48669355|NCT04802967|101974799|FG005|STARTED|Part A||0||
48669356|NCT04802967|101974800|FG006|STARTED|Part A||0||
48669357|NCT04802967|101974801|FG007|STARTED|Part A||0||
48669358|NCT04802967|101974802|FG008|STARTED|Part A||0||
48669359|NCT04802967|101974803|FG009|STARTED|Part A||0||
48669360|NCT04802967|101974794|FG000|Enrolled, Randomized and Dosed|Part A||6|Enrolled is any subject who signed an informed consent form.|
48669361|NCT04802967|101974795|FG001|Enrolled, Randomized and Dosed|Part A||6|Enrolled is any subject who signed an informed consent form.|
48669362|NCT04802967|101974796|FG002|Enrolled, Randomized and Dosed|Part A||0|Enrolled is any subject who signed an informed consent form.|
48669363|NCT04802967|101974797|FG003|Enrolled, Randomized and Dosed|Part A||0|Enrolled is any subject who signed an informed consent form.|
48669364|NCT04802967|101974798|FG004|Enrolled, Randomized and Dosed|Part A||0|Enrolled is any subject who signed an informed consent form.|
48669365|NCT04802967|101974799|FG005|Enrolled, Randomized and Dosed|Part A||0|Enrolled is any subject who signed an informed consent form.|
48669366|NCT04802967|101974800|FG006|Enrolled, Randomized and Dosed|Part A||0|Enrolled is any subject who signed an informed consent form.|
48669367|NCT04802967|101974801|FG007|Enrolled, Randomized and Dosed|Part A||0|Enrolled is any subject who signed an informed consent form.|
48669368|NCT04802967|101974802|FG008|Enrolled, Randomized and Dosed|Part A||0|Enrolled is any subject who signed an informed consent form.|
48669369|NCT04802967|101974803|FG009|Enrolled, Randomized and Dosed|Part A||0|Enrolled is any subject who signed an informed consent form.|
48669370|NCT04802967|101974794|FG000|COMPLETED|Part A||6||
48669371|NCT04802967|101974795|FG001|COMPLETED|Part A||6||
48669372|NCT04802967|101974796|FG002|COMPLETED|Part A||0||
48669373|NCT04802967|101974797|FG003|COMPLETED|Part A||0||
48669374|NCT04802967|101974798|FG004|COMPLETED|Part A||0||
48669375|NCT04802967|101974799|FG005|COMPLETED|Part A||0||
48669376|NCT04802967|101974800|FG006|COMPLETED|Part A||0||
48669377|NCT04802967|101974801|FG007|COMPLETED|Part A||0||
48669378|NCT04802967|101974802|FG008|COMPLETED|Part A||0||
48669379|NCT04802967|101974803|FG009|COMPLETED|Part A||0||
48669380|NCT04802967|101974794|FG000|NOT COMPLETED|Part A||0||
48669381|NCT04802967|101974795|FG001|NOT COMPLETED|Part A||0||
48669382|NCT04802967|101974796|FG002|NOT COMPLETED|Part A||0||
48669383|NCT04802967|101974797|FG003|NOT COMPLETED|Part A||0||
48669384|NCT04802967|101974798|FG004|NOT COMPLETED|Part A||0||
48669385|NCT04802967|101974799|FG005|NOT COMPLETED|Part A||0||
48669386|NCT04802967|101974800|FG006|NOT COMPLETED|Part A||0||
48669387|NCT04802967|101974801|FG007|NOT COMPLETED|Part A||0||
48669388|NCT04802967|101974802|FG008|NOT COMPLETED|Part A||0||
48669389|NCT04802967|101974803|FG009|NOT COMPLETED|Part A||0||
48669390|NCT04802967|101974794|FG000|STARTED|Part B||0||
48669391|NCT04802967|101974795|FG001|STARTED|Part B||0||
48669392|NCT04802967|101974796|FG002|STARTED|Part B||16||
48669393|NCT04802967|101974797|FG003|STARTED|Part B||16||
48669394|NCT04802967|101974798|FG004|STARTED|Part B||16||
48669395|NCT04802967|101974799|FG005|STARTED|Part B||17||
48669396|NCT04802967|101974800|FG006|STARTED|Part B||16||
48669397|NCT04802967|101974801|FG007|STARTED|Part B||16||
48669398|NCT04802967|101974802|FG008|STARTED|Part B||16||
48669399|NCT04802967|101974803|FG009|STARTED|Part B||16||
48669400|NCT04802967|101974794|FG000|Enrolled, Randomized and Dosed|Part B||0|Overall, in part B, 129 subjects were enrolled and 128 were dosed during Part B of the study, because 1 pt withdrawn prior to dosing due to a code break issue. All the 128 subjects dosed were randomised evenly across treatment groups and completed Part B of the study.|
48669401|NCT04802967|101974795|FG001|Enrolled, Randomized and Dosed|Part B||0|Overall, in part B, 129 subjects were enrolled and 128 were dosed during Part B of the study, because 1 pt withdrawn prior to dosing due to a code break issue. All the 128 subjects dosed were randomised evenly across treatment groups and completed Part B of the study.|
48669402|NCT04802967|101974796|FG002|Enrolled, Randomized and Dosed|Part B||16|Overall, in part B, 129 subjects were enrolled and 128 were dosed during Part B of the study, because 1 pt withdrawn prior to dosing due to a code break issue. All the 128 subjects dosed were randomised evenly across treatment groups and completed Part B of the study.|
48669403|NCT04802967|101974797|FG003|Enrolled, Randomized and Dosed|Part B||16|Overall, in part B, 129 subjects were enrolled and 128 were dosed during Part B of the study, because 1 pt withdrawn prior to dosing due to a code break issue. All the 128 subjects dosed were randomised evenly across treatment groups and completed Part B of the study.|
48669404|NCT04802967|101974798|FG004|Enrolled, Randomized and Dosed|Part B||16|Overall, in part B, 129 subjects were enrolled and 128 were dosed during Part B of the study, because 1 pt withdrawn prior to dosing due to a code break issue. All the 128 subjects dosed were randomised evenly across treatment groups and completed Part B of the study.|
48669405|NCT04802967|101974799|FG005|Enrolled, Randomized and Dosed|Part B||16|Overall, in part B, 129 subjects were enrolled and 128 were dosed during Part B of the study, because 1 pt withdrawn prior to dosing due to a code break issue. All the 128 subjects dosed were randomised evenly across treatment groups and completed Part B of the study.|
48669406|NCT04802967|101974800|FG006|Enrolled, Randomized and Dosed|Part B||16|Overall, in part B, 129 subjects were enrolled and 128 were dosed during Part B of the study, because 1 pt withdrawn prior to dosing due to a code break issue. All the 128 subjects dosed were randomised evenly across treatment groups and completed Part B of the study.|
48669407|NCT04802967|101974801|FG007|Enrolled, Randomized and Dosed|Part B||16|Overall, in part B, 129 subjects were enrolled and 128 were dosed during Part B of the study, because 1 pt withdrawn prior to dosing due to a code break issue. All the 128 subjects dosed were randomised evenly across treatment groups and completed Part B of the study.|
48669408|NCT04802967|101974802|FG008|Enrolled, Randomized and Dosed|Part B||16|Overall, in part B, 129 subjects were enrolled and 128 were dosed during Part B of the study, because 1 pt withdrawn prior to dosing due to a code break issue. All the 128 subjects dosed were randomised evenly across treatment groups and completed Part B of the study.|
48669409|NCT04802967|101974803|FG009|Enrolled, Randomized and Dosed|Part B||16|Overall, in part B, 129 subjects were enrolled and 128 were dosed during Part B of the study, because 1 pt withdrawn prior to dosing due to a code break issue. All the 128 subjects dosed were randomised evenly across treatment groups and completed Part B of the study.|
48669410|NCT04802967|101974794|FG000|COMPLETED|Part B||0||
48669411|NCT04802967|101974795|FG001|COMPLETED|Part B||0||
48669412|NCT04802967|101974796|FG002|COMPLETED|Part B||16||
48669413|NCT04802967|101974797|FG003|COMPLETED|Part B||16||
48669414|NCT04802967|101974798|FG004|COMPLETED|Part B||16||
48669415|NCT04802967|101974799|FG005|COMPLETED|Part B||16||
48669416|NCT04802967|101974800|FG006|COMPLETED|Part B||16||
48669417|NCT04802967|101974801|FG007|COMPLETED|Part B||16||
48669418|NCT04802967|101974802|FG008|COMPLETED|Part B||16||
48669419|NCT04802967|101974803|FG009|COMPLETED|Part B||16||
48669420|NCT04802967|101974794|FG000|NOT COMPLETED|Part B||0||
48669421|NCT04802967|101974795|FG001|NOT COMPLETED|Part B||0||
48669422|NCT04802967|101974796|FG002|NOT COMPLETED|Part B||0||
48669423|NCT04802967|101974797|FG003|NOT COMPLETED|Part B||0||
48669424|NCT04802967|101974798|FG004|NOT COMPLETED|Part B||0||
48669425|NCT04802967|101974799|FG005|NOT COMPLETED|Part B||1||
48669426|NCT04802967|101974800|FG006|NOT COMPLETED|Part B||0||
48669427|NCT04802967|101974801|FG007|NOT COMPLETED|Part B||0||
48669428|NCT04802967|101974802|FG008|NOT COMPLETED|Part B||0||
48669429|NCT04802967|101974803|FG009|NOT COMPLETED|Part B||0||
48669430|NCT04150718|101974804|FG000|STARTED|Overall Study||24||
48669431|NCT04150718|101974805|FG001|STARTED|Overall Study||42||
48669432|NCT04150718|101974806|FG002|STARTED|Overall Study||11||
48669433|NCT04150718|101974804|FG000|COMPLETED|Overall Study||20||
48669434|NCT04150718|101974805|FG001|COMPLETED|Overall Study||33||
48669435|NCT04150718|101974806|FG002|COMPLETED|Overall Study||0||
48669436|NCT04150718|101974804|FG000|NOT COMPLETED|Overall Study||4||
48669437|NCT04150718|101974805|FG001|NOT COMPLETED|Overall Study||9||
48669438|NCT04150718|101974806|FG002|NOT COMPLETED|Overall Study||11||
48669439|NCT01784068|101974807|FG000|STARTED|NTCS Phase||215||
48669440|NCT01784068|101974808|FG001|STARTED|NTCS Phase||0||
48669441|NCT01784068|101974807|FG000|NTRI Phase|NTCS Phase||86||
48669442|NCT01784068|101974808|FG001|NTRI Phase|NTCS Phase||0||
48669443|NCT01784068|101974807|FG000|NTCT Phase|NTCS Phase||13||
48669444|NCT01784068|101974808|FG001|NTCT Phase|NTCS Phase||0||
48669445|NCT01784068|101974807|FG000|TFR-2 Phase|NTCS Phase||8||
48669446|NCT01784068|101974808|FG001|TFR-2 Phase|NTCS Phase||0||
48669447|NCT01784068|101974807|FG000|NTCT-P Phase|NTCS Phase||2||
48669448|NCT01784068|101974808|FG001|NTCT-P Phase|NTCS Phase||0||
48669449|NCT01784068|101974807|FG000|NTRI-2|NTCS Phase||0||
48669450|NCT01784068|101974808|FG001|NTRI-2|NTCS Phase||0||
48669451|NCT01784068|101974807|FG000|COMPLETED|NTCS Phase||0|Completed = Still on Study Phase which means a patient has no end of study phase completion CRF page as of data Cut-off date: 30-NOV-2015|
48669452|NCT01784068|101974808|FG001|COMPLETED|NTCS Phase||0|Completed = Still on Study Phase which means a patient has no end of study phase completion CRF page as of data Cut-off date: 30-NOV-2015|
48669453|NCT01784068|101974807|FG000|NOT COMPLETED|NTCS Phase||215||
48669454|NCT01784068|101974808|FG001|NOT COMPLETED|NTCS Phase||0||
48669455|NCT01784068|101974807|FG000|STARTED|TFR Phase||0||
48669456|NCT01784068|101974808|FG001|STARTED|TFR Phase||190||
48669457|NCT01784068|101974807|FG000|COMPLETED|TFR Phase||0||
48669458|NCT01784068|101974808|FG001|COMPLETED|TFR Phase||97||
48669459|NCT01784068|101974807|FG000|NOT COMPLETED|TFR Phase||0||
48669460|NCT01784068|101974808|FG001|NOT COMPLETED|TFR Phase||93||
48669461|NCT02965716|101974809|FG000|STARTED|Overall Study||11||
48669462|NCT02965716|101974810|FG001|STARTED|Overall Study||27||
48669463|NCT02965716|101974809|FG000|COMPLETED|Overall Study||0||
48669464|NCT02965716|101974810|FG001|COMPLETED|Overall Study||3||
48669465|NCT02965716|101974809|FG000|NOT COMPLETED|Overall Study||11||
48669466|NCT02965716|101974810|FG001|NOT COMPLETED|Overall Study||24||
48669467|NCT03973320|101974811|FG000|STARTED|Overall Study||11292||
48669468|NCT03973320|101974811|FG000|COMPLETED|Overall Study||11292||
48669469|NCT03973320|101974811|FG000|NOT COMPLETED|Overall Study||0||
48669470|NCT03090152|101974812|FG000|STARTED|Overall Study||60||
48669471|NCT03090152|101974813|FG001|STARTED|Overall Study||60||
48669472|NCT03090152|101974814|FG002|STARTED|Overall Study||60||
48669473|NCT03090152|101974812|FG000|COMPLETED|Overall Study||59||
48669474|NCT03090152|101974813|FG001|COMPLETED|Overall Study||56||
48669475|NCT03090152|101974814|FG002|COMPLETED|Overall Study||59||
48669476|NCT03090152|101974812|FG000|NOT COMPLETED|Overall Study||1||
48669477|NCT03090152|101974813|FG001|NOT COMPLETED|Overall Study||4||
48669478|NCT03090152|101974814|FG002|NOT COMPLETED|Overall Study||1||
48669479|NCT03606642|101974815|FG000|STARTED|Overall Study||50||
48669480|NCT03606642|101974815|FG000|COMPLETED|Overall Study||45||
48669481|NCT03606642|101974815|FG000|NOT COMPLETED|Overall Study||5||
48669482|NCT00408005|101974816|FG000|STARTED|Induction||1596||
48669483|NCT00408005|101974817|FG001|STARTED|Induction||299||
48669484|NCT00408005|101974818|FG002|STARTED|Induction||0||
48669485|NCT00408005|101974819|FG003|STARTED|Induction||0||
48669486|NCT00408005|101974820|FG004|STARTED|Induction||0||
48669487|NCT00408005|101974821|FG005|STARTED|Induction||0||
48669488|NCT00408005|101974822|FG006|STARTED|Induction||0||
48669489|NCT00408005|101974823|FG007|STARTED|Induction||0||
48669490|NCT00408005|101974816|FG000|COMPLETED|Induction||1189||
48669491|NCT00408005|101974817|FG001|COMPLETED|Induction||205||
48669492|NCT00408005|101974818|FG002|COMPLETED|Induction||0||
48669493|NCT00408005|101974819|FG003|COMPLETED|Induction||0||
48669494|NCT00408005|101974820|FG004|COMPLETED|Induction||0||
48669495|NCT00408005|101974821|FG005|COMPLETED|Induction||0||
48669496|NCT00408005|101974822|FG006|COMPLETED|Induction||0||
48669497|NCT00408005|101974823|FG007|COMPLETED|Induction||0||
48669498|NCT00408005|101974816|FG000|NOT COMPLETED|Induction||407||
48669499|NCT00408005|101974817|FG001|NOT COMPLETED|Induction||94||
48669500|NCT00408005|101974818|FG002|NOT COMPLETED|Induction||0||
48669501|NCT00408005|101974819|FG003|NOT COMPLETED|Induction||0||
48669502|NCT00408005|101974820|FG004|NOT COMPLETED|Induction||0||
48669503|NCT00408005|101974821|FG005|NOT COMPLETED|Induction||0||
48669504|NCT00408005|101974822|FG006|NOT COMPLETED|Induction||0||
48669505|NCT00408005|101974823|FG007|NOT COMPLETED|Induction||0||
48669506|NCT00408005|101974816|FG000|STARTED|Post Induction Therapy by Tx Assignment||0||
48669507|NCT00408005|101974817|FG001|STARTED|Post Induction Therapy by Tx Assignment||0||
48669508|NCT00408005|101974818|FG002|STARTED|Post Induction Therapy by Tx Assignment||372||
48669509|NCT00408005|101974819|FG003|STARTED|Post Induction Therapy by Tx Assignment||147||
48669510|NCT00408005|101974820|FG004|STARTED|Post Induction Therapy by Tx Assignment||451||
48669511|NCT00408005|101974821|FG005|STARTED|Post Induction Therapy by Tx Assignment||219||
48669512|NCT00408005|101974822|FG006|STARTED|Post Induction Therapy by Tx Assignment||143||
48669513|NCT00408005|101974823|FG007|STARTED|Post Induction Therapy by Tx Assignment||62||
48669514|NCT00408005|101974816|FG000|Low Risk|Post Induction Therapy by Tx Assignment||0||
48669515|NCT00408005|101974817|FG001|Low Risk|Post Induction Therapy by Tx Assignment||0||
48669516|NCT00408005|101974818|FG002|Low Risk|Post Induction Therapy by Tx Assignment||217||
48669517|NCT00408005|101974819|FG003|Low Risk|Post Induction Therapy by Tx Assignment||0||
48669518|NCT00408005|101974820|FG004|Low Risk|Post Induction Therapy by Tx Assignment||55||
48669519|NCT00408005|101974821|FG005|Low Risk|Post Induction Therapy by Tx Assignment||0||
48669520|NCT00408005|101974822|FG006|Low Risk|Post Induction Therapy by Tx Assignment||0||
48669521|NCT00408005|101974823|FG007|Low Risk|Post Induction Therapy by Tx Assignment||0||
48669522|NCT00408005|101974816|FG000|Intermediate Risk|Post Induction Therapy by Tx Assignment||0||
48669523|NCT00408005|101974817|FG001|Intermediate Risk|Post Induction Therapy by Tx Assignment||0||
48669524|NCT00408005|101974818|FG002|Intermediate Risk|Post Induction Therapy by Tx Assignment||99||
48669525|NCT00408005|101974819|FG003|Intermediate Risk|Post Induction Therapy by Tx Assignment||95||
48669526|NCT00408005|101974820|FG004|Intermediate Risk|Post Induction Therapy by Tx Assignment||257||
48669527|NCT00408005|101974821|FG005|Intermediate Risk|Post Induction Therapy by Tx Assignment||93||
48669528|NCT00408005|101974822|FG006|Intermediate Risk|Post Induction Therapy by Tx Assignment||0||
48669529|NCT00408005|101974823|FG007|Intermediate Risk|Post Induction Therapy by Tx Assignment||0||
48669530|NCT00408005|101974816|FG000|High Risk|Post Induction Therapy by Tx Assignment||0||
48669531|NCT00408005|101974817|FG001|High Risk|Post Induction Therapy by Tx Assignment||0||
48669532|NCT00408005|101974818|FG002|High Risk|Post Induction Therapy by Tx Assignment||56||
48669533|NCT00408005|101974819|FG003|High Risk|Post Induction Therapy by Tx Assignment||52||
48669534|NCT00408005|101974820|FG004|High Risk|Post Induction Therapy by Tx Assignment||55||
48669535|NCT00408005|101974821|FG005|High Risk|Post Induction Therapy by Tx Assignment||52||
48669536|NCT00408005|101974822|FG006|High Risk|Post Induction Therapy by Tx Assignment||0||
48669537|NCT00408005|101974823|FG007|High Risk|Post Induction Therapy by Tx Assignment||0||
48669538|NCT00408005|101974816|FG000|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0||
48669539|NCT00408005|101974817|FG001|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0||
48669540|NCT00408005|101974818|FG002|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0||
48669541|NCT00408005|101974819|FG003|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0||
48669542|NCT00408005|101974820|FG004|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||84||
48669543|NCT00408005|101974821|FG005|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||31||
48669544|NCT00408005|101974822|FG006|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0||
48669545|NCT00408005|101974823|FG007|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0||
48669546|NCT00408005|101974816|FG000|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0||
48669547|NCT00408005|101974817|FG001|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0||
48669548|NCT00408005|101974818|FG002|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0||
48669549|NCT00408005|101974819|FG003|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0||
48669550|NCT00408005|101974820|FG004|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0||
48669551|NCT00408005|101974821|FG005|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||43||
48669552|NCT00408005|101974822|FG006|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0||
48669553|NCT00408005|101974823|FG007|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0||
48669554|NCT00408005|101974816|FG000|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0||
48669555|NCT00408005|101974817|FG001|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0||
48669556|NCT00408005|101974818|FG002|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0||
48669557|NCT00408005|101974819|FG003|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0||
48669558|NCT00408005|101974820|FG004|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0||
48669559|NCT00408005|101974821|FG005|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0||
48669560|NCT00408005|101974822|FG006|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||82||
48669561|NCT00408005|101974823|FG007|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0||
48669562|NCT00408005|101974816|FG000|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0||
48669563|NCT00408005|101974817|FG001|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0||
48669564|NCT00408005|101974818|FG002|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0||
48669565|NCT00408005|101974819|FG003|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0||
48669566|NCT00408005|101974820|FG004|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0||
48669567|NCT00408005|101974821|FG005|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0||
48669568|NCT00408005|101974822|FG006|T-LLy High Risk|Post Induction Therapy by Tx Assignment||61||
48669569|NCT00408005|101974823|FG007|T-LLy High Risk|Post Induction Therapy by Tx Assignment||60||
48669570|NCT00408005|101974816|FG000|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0||
48669571|NCT00408005|101974817|FG001|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0||
48669572|NCT00408005|101974818|FG002|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0||
48669573|NCT00408005|101974819|FG003|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0||
48669574|NCT00408005|101974820|FG004|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0||
48669575|NCT00408005|101974821|FG005|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0||
48669576|NCT00408005|101974822|FG006|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0||
48669577|NCT00408005|101974823|FG007|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||2||
48669578|NCT00408005|101974816|FG000|COMPLETED|Post Induction Therapy by Tx Assignment||0||
48669579|NCT00408005|101974817|FG001|COMPLETED|Post Induction Therapy by Tx Assignment||0||
48669580|NCT00408005|101974818|FG002|COMPLETED|Post Induction Therapy by Tx Assignment||287||
48669581|NCT00408005|101974819|FG003|COMPLETED|Post Induction Therapy by Tx Assignment||103||
48669582|NCT00408005|101974820|FG004|COMPLETED|Post Induction Therapy by Tx Assignment||319||
48669583|NCT00408005|101974821|FG005|COMPLETED|Post Induction Therapy by Tx Assignment||118||
48669584|NCT00408005|101974822|FG006|COMPLETED|Post Induction Therapy by Tx Assignment||115||
48669585|NCT00408005|101974823|FG007|COMPLETED|Post Induction Therapy by Tx Assignment||48||
48669586|NCT00408005|101974816|FG000|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0||
48669587|NCT00408005|101974817|FG001|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0||
48669588|NCT00408005|101974818|FG002|NOT COMPLETED|Post Induction Therapy by Tx Assignment||85||
48669589|NCT00408005|101974819|FG003|NOT COMPLETED|Post Induction Therapy by Tx Assignment||44||
48669590|NCT00408005|101974820|FG004|NOT COMPLETED|Post Induction Therapy by Tx Assignment||132||
48669591|NCT00408005|101974821|FG005|NOT COMPLETED|Post Induction Therapy by Tx Assignment||101||
48669592|NCT00408005|101974822|FG006|NOT COMPLETED|Post Induction Therapy by Tx Assignment||28||
48669593|NCT00408005|101974823|FG007|NOT COMPLETED|Post Induction Therapy by Tx Assignment||14||
48669594|NCT06136897|101974824|FG000|STARTED|Overall Study||35||
48669595|NCT06136897|101974824|FG000|Started Protocol Therapy|Overall Study||35||
48669596|NCT06136897|101974824|FG000|Eligible and Treated|Overall Study||32||
48669597|NCT06136897|101974824|FG000|Eligible, Treated and Mutation Status Confirmed|Overall Study||25|Primary efficacy analysis set|
48669598|NCT06136897|101974824|FG000|COMPLETED|Overall Study||0||
48669599|NCT06136897|101974824|FG000|NOT COMPLETED|Overall Study||35||
48669600|NCT00977574|101974825|FG000|STARTED|Overall Study||116||
48669601|NCT00977574|101974826|FG001|STARTED|Overall Study||115||
48669602|NCT00977574|101974827|FG002|STARTED|Overall Study||118||
48669603|NCT00977574|101974825|FG000|COMPLETED|Overall Study||112||
48669604|NCT00977574|101974826|FG001|COMPLETED|Overall Study||113||
48669605|NCT00977574|101974827|FG002|COMPLETED|Overall Study||114||
48669606|NCT00977574|101974825|FG000|NOT COMPLETED|Overall Study||4||
48669607|NCT00977574|101974826|FG001|NOT COMPLETED|Overall Study||2||
48669608|NCT00977574|101974827|FG002|NOT COMPLETED|Overall Study||4||
48669609|NCT03575897|101974828|FG000|STARTED|Overall Study||25||
48669610|NCT03575897|101974829|FG001|STARTED|Overall Study||25||
48669611|NCT03575897|101974828|FG000|COMPLETED|Overall Study||13||
48669612|NCT03575897|101974829|FG001|COMPLETED|Overall Study||12||
48669613|NCT03575897|101974828|FG000|NOT COMPLETED|Overall Study||12||
48669614|NCT03575897|101974829|FG001|NOT COMPLETED|Overall Study||13||
48669615|NCT04749615|101974830|FG000|STARTED|Overall Study||47||
48669616|NCT04749615|101974831|FG001|STARTED|Overall Study||47||
48669617|NCT04749615|101974830|FG000|COMPLETED|Overall Study||41||
48669618|NCT04749615|101974831|FG001|COMPLETED|Overall Study||37||
48669619|NCT04749615|101974830|FG000|NOT COMPLETED|Overall Study||6||
48669620|NCT04749615|101974831|FG001|NOT COMPLETED|Overall Study||10||
48669621|NCT02936752|101974832|FG000|STARTED|Overall Study||22||
48669622|NCT02936752|101974833|FG001|STARTED|Overall Study||6||
48669623|NCT02936752|101974832|FG000|COMPLETED|Overall Study||16||
48669624|NCT02936752|101974833|FG001|COMPLETED|Overall Study||3||
48669625|NCT02936752|101974832|FG000|NOT COMPLETED|Overall Study||6||
48669626|NCT02936752|101974833|FG001|NOT COMPLETED|Overall Study||3||
48669627|NCT05308004|101974834|FG000|STARTED|Overall Study||4||
48669628|NCT05308004|101974835|FG001|STARTED|Overall Study||3||
48669629|NCT05308004|101974834|FG000|COMPLETED|Overall Study||4||
48669630|NCT05308004|101974835|FG001|COMPLETED|Overall Study||2||
48669631|NCT05308004|101974834|FG000|NOT COMPLETED|Overall Study||0||
48669632|NCT05308004|101974835|FG001|NOT COMPLETED|Overall Study||1||
48669633|NCT03557697|101974836|FG000|STARTED|Overall Study||30||
48669634|NCT03557697|101974837|FG001|STARTED|Overall Study||30||
48669635|NCT03557697|101974836|FG000|COMPLETED|Overall Study||28||
48669636|NCT03557697|101974837|FG001|COMPLETED|Overall Study||26||
48669637|NCT03557697|101974836|FG000|NOT COMPLETED|Overall Study||2||
48669638|NCT03557697|101974837|FG001|NOT COMPLETED|Overall Study||4||
48669639|NCT05104476|101974838|FG000|STARTED|Overall Study||22||
48669640|NCT05104476|101974839|FG001|STARTED|Overall Study||42||
48669641|NCT05104476|101974838|FG000|Received at Least 1 Dose of Study Drug|Overall Study||21||
48669642|NCT05104476|101974839|FG001|Received at Least 1 Dose of Study Drug|Overall Study||40||
48669643|NCT05104476|101974838|FG000|COMPLETED|Overall Study||16||
48669644|NCT05104476|101974839|FG001|COMPLETED|Overall Study||32||
48669645|NCT05104476|101974838|FG000|NOT COMPLETED|Overall Study||6||
48669646|NCT05104476|101974839|FG001|NOT COMPLETED|Overall Study||10||
48669647|NCT03106779|101974840|FG000|STARTED|Overall Study||157||
48669648|NCT03106779|101974841|FG001|STARTED|Overall Study||76||
48669649|NCT03106779|101974840|FG000|Treated|Overall Study||156||
48669650|NCT03106779|101974841|FG001|Treated|Overall Study||0||
48669651|NCT03106779|101974840|FG000|Not Treated|Overall Study||1|One patient randomized to asciminib was discontinued due to cytopenia as per Investigator's decision and never took medication.|
48669652|NCT03106779|101974841|FG001|Not Treated|Overall Study||0|One patient randomized to asciminib was discontinued due to cytopenia as per Investigator's decision and never took medication.|
48669653|NCT03106779|101974840|FG000|COMPLETED|Overall Study||97|Completed = Patients ongoing at the time of the primary analysis cut-off|
48669654|NCT03106779|101974841|FG001|COMPLETED|Overall Study||22|Completed = Patients ongoing at the time of the primary analysis cut-off|
48669655|NCT03106779|101974840|FG000|NOT COMPLETED|Overall Study||60||
48669656|NCT03106779|101974841|FG001|NOT COMPLETED|Overall Study||54||
48669657|NCT04033445|101974842|FG000|STARTED|IS-1 and IS-2 Period 1 (Week 0 to 12)||109||
48669658|NCT04033445|101974843|FG001|STARTED|IS-1 and IS-2 Period 1 (Week 0 to 12)||108||
48669659|NCT04033445|101974844|FG002|STARTED|IS-1 and IS-2 Period 1 (Week 0 to 12)||111||
48669660|NCT04033445|101974845|FG003|STARTED|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669661|NCT04033445|101974846|FG004|STARTED|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669662|NCT04033445|101974847|FG005|STARTED|IS-1 and IS-2 Period 1 (Week 0 to 12)||296||
48669663|NCT04033445|101974848|FG006|STARTED|IS-1 and IS-2 Period 1 (Week 0 to 12)||440||
48669664|NCT04033445|101974849|FG007|STARTED|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669665|NCT04033445|101974850|FG008|STARTED|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669666|NCT04033445|101974851|FG009|STARTED|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669667|NCT04033445|101974852|FG010|STARTED|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669668|NCT04033445|101974853|FG011|STARTED|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669669|NCT04033445|101974854|FG012|STARTED|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669670|NCT04033445|101974855|FG013|STARTED|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669671|NCT04033445|101974842|FG000|Treated|IS-1 and IS-2 Period 1 (Week 0 to 12)||108||
48669672|NCT04033445|101974843|FG001|Treated|IS-1 and IS-2 Period 1 (Week 0 to 12)||108||
48669673|NCT04033445|101974844|FG002|Treated|IS-1 and IS-2 Period 1 (Week 0 to 12)||111||
48669674|NCT04033445|101974845|FG003|Treated|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669675|NCT04033445|101974846|FG004|Treated|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669676|NCT04033445|101974847|FG005|Treated|IS-1 and IS-2 Period 1 (Week 0 to 12)||295||
48669677|NCT04033445|101974848|FG006|Treated|IS-1 and IS-2 Period 1 (Week 0 to 12)||440||
48669678|NCT04033445|101974849|FG007|Treated|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669679|NCT04033445|101974850|FG008|Treated|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669680|NCT04033445|101974851|FG009|Treated|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669681|NCT04033445|101974852|FG010|Treated|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669682|NCT04033445|101974853|FG011|Treated|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669683|NCT04033445|101974854|FG012|Treated|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669684|NCT04033445|101974855|FG013|Treated|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669685|NCT04033445|101974842|FG000|Full Analysis Set (FAS)|IS-1 and IS-2 Period 1 (Week 0 to 12)||105|All randomized participants (in IS-1 and IS-2) with a modified Mayo score (MMS) of 5 to 9 who received at least 1 (partial or complete) dose of study intervention.|
48669686|NCT04033445|101974843|FG001|Full Analysis Set (FAS)|IS-1 and IS-2 Period 1 (Week 0 to 12)||101|All randomized participants (in IS-1 and IS-2) with a modified Mayo score (MMS) of 5 to 9 who received at least 1 (partial or complete) dose of study intervention.|
48669687|NCT04033445|101974844|FG002|Full Analysis Set (FAS)|IS-1 and IS-2 Period 1 (Week 0 to 12)||107|All randomized participants (in IS-1 and IS-2) with a modified Mayo score (MMS) of 5 to 9 who received at least 1 (partial or complete) dose of study intervention.|
48669688|NCT04033445|101974845|FG003|Full Analysis Set (FAS)|IS-1 and IS-2 Period 1 (Week 0 to 12)||0|All randomized participants (in IS-1 and IS-2) with a modified Mayo score (MMS) of 5 to 9 who received at least 1 (partial or complete) dose of study intervention.|
48669689|NCT04033445|101974846|FG004|Full Analysis Set (FAS)|IS-1 and IS-2 Period 1 (Week 0 to 12)||0|All randomized participants (in IS-1 and IS-2) with a modified Mayo score (MMS) of 5 to 9 who received at least 1 (partial or complete) dose of study intervention.|
48669690|NCT04033445|101974847|FG005|Full Analysis Set (FAS)|IS-1 and IS-2 Period 1 (Week 0 to 12)||280|All randomized participants (in IS-1 and IS-2) with a modified Mayo score (MMS) of 5 to 9 who received at least 1 (partial or complete) dose of study intervention.|
48669691|NCT04033445|101974848|FG006|Full Analysis Set (FAS)|IS-1 and IS-2 Period 1 (Week 0 to 12)||421|All randomized participants (in IS-1 and IS-2) with a modified Mayo score (MMS) of 5 to 9 who received at least 1 (partial or complete) dose of study intervention.|
48669692|NCT04033445|101974849|FG007|Full Analysis Set (FAS)|IS-1 and IS-2 Period 1 (Week 0 to 12)||0|All randomized participants (in IS-1 and IS-2) with a modified Mayo score (MMS) of 5 to 9 who received at least 1 (partial or complete) dose of study intervention.|
48669693|NCT04033445|101974850|FG008|Full Analysis Set (FAS)|IS-1 and IS-2 Period 1 (Week 0 to 12)||0|All randomized participants (in IS-1 and IS-2) with a modified Mayo score (MMS) of 5 to 9 who received at least 1 (partial or complete) dose of study intervention.|
48669694|NCT04033445|101974851|FG009|Full Analysis Set (FAS)|IS-1 and IS-2 Period 1 (Week 0 to 12)||0|All randomized participants (in IS-1 and IS-2) with a modified Mayo score (MMS) of 5 to 9 who received at least 1 (partial or complete) dose of study intervention.|
48669695|NCT04033445|101974852|FG010|Full Analysis Set (FAS)|IS-1 and IS-2 Period 1 (Week 0 to 12)||0|All randomized participants (in IS-1 and IS-2) with a modified Mayo score (MMS) of 5 to 9 who received at least 1 (partial or complete) dose of study intervention.|
48669696|NCT04033445|101974853|FG011|Full Analysis Set (FAS)|IS-1 and IS-2 Period 1 (Week 0 to 12)||0|All randomized participants (in IS-1 and IS-2) with a modified Mayo score (MMS) of 5 to 9 who received at least 1 (partial or complete) dose of study intervention.|
48669697|NCT04033445|101974854|FG012|Full Analysis Set (FAS)|IS-1 and IS-2 Period 1 (Week 0 to 12)||0|All randomized participants (in IS-1 and IS-2) with a modified Mayo score (MMS) of 5 to 9 who received at least 1 (partial or complete) dose of study intervention.|
48669698|NCT04033445|101974855|FG013|Full Analysis Set (FAS)|IS-1 and IS-2 Period 1 (Week 0 to 12)||0|All randomized participants (in IS-1 and IS-2) with a modified Mayo score (MMS) of 5 to 9 who received at least 1 (partial or complete) dose of study intervention.|
48669699|NCT04033445|101974842|FG000|FAS Participants Who Enrolled Into MS|IS-1 and IS-2 Period 1 (Week 0 to 12)||32|FAS participants with clinical response status at Week I-12 as determined by the interactive web response system based on the local endoscopy subscore, as prespecified in the protocol.|
48669700|NCT04033445|101974843|FG001|FAS Participants Who Enrolled Into MS|IS-1 and IS-2 Period 1 (Week 0 to 12)||60|FAS participants with clinical response status at Week I-12 as determined by the interactive web response system based on the local endoscopy subscore, as prespecified in the protocol.|
48669701|NCT04033445|101974844|FG002|FAS Participants Who Enrolled Into MS|IS-1 and IS-2 Period 1 (Week 0 to 12)||65|FAS participants with clinical response status at Week I-12 as determined by the interactive web response system based on the local endoscopy subscore, as prespecified in the protocol.|
48669702|NCT04033445|101974845|FG003|FAS Participants Who Enrolled Into MS|IS-1 and IS-2 Period 1 (Week 0 to 12)||0|FAS participants with clinical response status at Week I-12 as determined by the interactive web response system based on the local endoscopy subscore, as prespecified in the protocol.|
48669703|NCT04033445|101974846|FG004|FAS Participants Who Enrolled Into MS|IS-1 and IS-2 Period 1 (Week 0 to 12)||0|FAS participants with clinical response status at Week I-12 as determined by the interactive web response system based on the local endoscopy subscore, as prespecified in the protocol.|
48669704|NCT04033445|101974847|FG005|FAS Participants Who Enrolled Into MS|IS-1 and IS-2 Period 1 (Week 0 to 12)||82|FAS participants with clinical response status at Week I-12 as determined by the interactive web response system based on the local endoscopy subscore, as prespecified in the protocol.|
48669705|NCT04033445|101974848|FG006|FAS Participants Who Enrolled Into MS|IS-1 and IS-2 Period 1 (Week 0 to 12)||274|FAS participants with clinical response status at Week I-12 as determined by the interactive web response system based on the local endoscopy subscore, as prespecified in the protocol.|
48670265|NCT01928394|101974921|FG000|Transition|Treatment Period||3|Participants who will transition after completing MT due to disease progression (DP)|
48669706|NCT04033445|101974849|FG007|FAS Participants Who Enrolled Into MS|IS-1 and IS-2 Period 1 (Week 0 to 12)||0|FAS participants with clinical response status at Week I-12 as determined by the interactive web response system based on the local endoscopy subscore, as prespecified in the protocol.|
48669707|NCT04033445|101974850|FG008|FAS Participants Who Enrolled Into MS|IS-1 and IS-2 Period 1 (Week 0 to 12)||0|FAS participants with clinical response status at Week I-12 as determined by the interactive web response system based on the local endoscopy subscore, as prespecified in the protocol.|
48669708|NCT04033445|101974851|FG009|FAS Participants Who Enrolled Into MS|IS-1 and IS-2 Period 1 (Week 0 to 12)||0|FAS participants with clinical response status at Week I-12 as determined by the interactive web response system based on the local endoscopy subscore, as prespecified in the protocol.|
48669709|NCT04033445|101974852|FG010|FAS Participants Who Enrolled Into MS|IS-1 and IS-2 Period 1 (Week 0 to 12)||0|FAS participants with clinical response status at Week I-12 as determined by the interactive web response system based on the local endoscopy subscore, as prespecified in the protocol.|
48669710|NCT04033445|101974853|FG011|FAS Participants Who Enrolled Into MS|IS-1 and IS-2 Period 1 (Week 0 to 12)||0|FAS participants with clinical response status at Week I-12 as determined by the interactive web response system based on the local endoscopy subscore, as prespecified in the protocol.|
48669711|NCT04033445|101974854|FG012|FAS Participants Who Enrolled Into MS|IS-1 and IS-2 Period 1 (Week 0 to 12)||0|FAS participants with clinical response status at Week I-12 as determined by the interactive web response system based on the local endoscopy subscore, as prespecified in the protocol.|
48669712|NCT04033445|101974855|FG013|FAS Participants Who Enrolled Into MS|IS-1 and IS-2 Period 1 (Week 0 to 12)||0|FAS participants with clinical response status at Week I-12 as determined by the interactive web response system based on the local endoscopy subscore, as prespecified in the protocol.|
48669713|NCT04033445|101974842|FG000|COMPLETED|IS-1 and IS-2 Period 1 (Week 0 to 12)||103||
48669714|NCT04033445|101974843|FG001|COMPLETED|IS-1 and IS-2 Period 1 (Week 0 to 12)||105||
48669715|NCT04033445|101974844|FG002|COMPLETED|IS-1 and IS-2 Period 1 (Week 0 to 12)||110||
48669716|NCT04033445|101974845|FG003|COMPLETED|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669717|NCT04033445|101974846|FG004|COMPLETED|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669718|NCT04033445|101974847|FG005|COMPLETED|IS-1 and IS-2 Period 1 (Week 0 to 12)||270||
48669719|NCT04033445|101974848|FG006|COMPLETED|IS-1 and IS-2 Period 1 (Week 0 to 12)||422||
48669720|NCT04033445|101974849|FG007|COMPLETED|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669721|NCT04033445|101974850|FG008|COMPLETED|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669722|NCT04033445|101974851|FG009|COMPLETED|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669723|NCT04033445|101974852|FG010|COMPLETED|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669724|NCT04033445|101974853|FG011|COMPLETED|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669725|NCT04033445|101974854|FG012|COMPLETED|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669726|NCT04033445|101974855|FG013|COMPLETED|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669727|NCT04033445|101974842|FG000|NOT COMPLETED|IS-1 and IS-2 Period 1 (Week 0 to 12)||6||
48669728|NCT04033445|101974843|FG001|NOT COMPLETED|IS-1 and IS-2 Period 1 (Week 0 to 12)||3||
48669729|NCT04033445|101974844|FG002|NOT COMPLETED|IS-1 and IS-2 Period 1 (Week 0 to 12)||1||
48669730|NCT04033445|101974845|FG003|NOT COMPLETED|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669731|NCT04033445|101974846|FG004|NOT COMPLETED|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669732|NCT04033445|101974847|FG005|NOT COMPLETED|IS-1 and IS-2 Period 1 (Week 0 to 12)||26||
48669733|NCT04033445|101974848|FG006|NOT COMPLETED|IS-1 and IS-2 Period 1 (Week 0 to 12)||18||
48669734|NCT04033445|101974849|FG007|NOT COMPLETED|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669735|NCT04033445|101974850|FG008|NOT COMPLETED|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669736|NCT04033445|101974851|FG009|NOT COMPLETED|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669737|NCT04033445|101974852|FG010|NOT COMPLETED|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669738|NCT04033445|101974853|FG011|NOT COMPLETED|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669739|NCT04033445|101974854|FG012|NOT COMPLETED|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669740|NCT04033445|101974855|FG013|NOT COMPLETED|IS-1 and IS-2 Period 1 (Week 0 to 12)||0||
48669741|NCT04033445|101974842|FG000|STARTED|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669742|NCT04033445|101974843|FG001|STARTED|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669743|NCT04033445|101974844|FG002|STARTED|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669744|NCT04033445|101974845|FG003|STARTED|IS-1 and IS-2 Period 2 (Week 12 to 24)||67||
48669745|NCT04033445|101974846|FG004|STARTED|IS-1 and IS-2 Period 2 (Week 12 to 24)||79||
48669746|NCT04033445|101974847|FG005|STARTED|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669747|NCT04033445|101974848|FG006|STARTED|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669748|NCT04033445|101974849|FG007|STARTED|IS-1 and IS-2 Period 2 (Week 12 to 24)||172||
48669749|NCT04033445|101974850|FG008|STARTED|IS-1 and IS-2 Period 2 (Week 12 to 24)||129||
48669750|NCT04033445|101974851|FG009|STARTED|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669751|NCT04033445|101974852|FG010|STARTED|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669752|NCT04033445|101974853|FG011|STARTED|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669753|NCT04033445|101974854|FG012|STARTED|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669754|NCT04033445|101974855|FG013|STARTED|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669755|NCT04033445|101974842|FG000|IS-1: Period 1 Guselkumab 200 mg IV Non Responders|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669756|NCT04033445|101974843|FG001|IS-1: Period 1 Guselkumab 200 mg IV Non Responders|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669757|NCT04033445|101974844|FG002|IS-1: Period 1 Guselkumab 200 mg IV Non Responders|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669758|NCT04033445|101974845|FG003|IS-1: Period 1 Guselkumab 200 mg IV Non Responders|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669759|NCT04033445|101974846|FG004|IS-1: Period 1 Guselkumab 200 mg IV Non Responders|IS-1 and IS-2 Period 2 (Week 12 to 24)||38||
48669760|NCT04033445|101974847|FG005|IS-1: Period 1 Guselkumab 200 mg IV Non Responders|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669761|NCT04033445|101974848|FG006|IS-1: Period 1 Guselkumab 200 mg IV Non Responders|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669762|NCT04033445|101974849|FG007|IS-1: Period 1 Guselkumab 200 mg IV Non Responders|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669763|NCT04033445|101974850|FG008|IS-1: Period 1 Guselkumab 200 mg IV Non Responders|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669764|NCT04033445|101974851|FG009|IS-1: Period 1 Guselkumab 200 mg IV Non Responders|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669765|NCT04033445|101974852|FG010|IS-1: Period 1 Guselkumab 200 mg IV Non Responders|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669766|NCT04033445|101974853|FG011|IS-1: Period 1 Guselkumab 200 mg IV Non Responders|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669767|NCT04033445|101974854|FG012|IS-1: Period 1 Guselkumab 200 mg IV Non Responders|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669768|NCT04033445|101974855|FG013|IS-1: Period 1 Guselkumab 200 mg IV Non Responders|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669769|NCT04033445|101974842|FG000|IS-1: Period 1 Guselkumab 400 mg IV Non Responders|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669770|NCT04033445|101974843|FG001|IS-1: Period 1 Guselkumab 400 mg IV Non Responders|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669771|NCT04033445|101974844|FG002|IS-1: Period 1 Guselkumab 400 mg IV Non Responders|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669772|NCT04033445|101974845|FG003|IS-1: Period 1 Guselkumab 400 mg IV Non Responders|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669773|NCT04033445|101974846|FG004|IS-1: Period 1 Guselkumab 400 mg IV Non Responders|IS-1 and IS-2 Period 2 (Week 12 to 24)||41||
48669774|NCT04033445|101974847|FG005|IS-1: Period 1 Guselkumab 400 mg IV Non Responders|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669775|NCT04033445|101974848|FG006|IS-1: Period 1 Guselkumab 400 mg IV Non Responders|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669776|NCT04033445|101974849|FG007|IS-1: Period 1 Guselkumab 400 mg IV Non Responders|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669777|NCT04033445|101974850|FG008|IS-1: Period 1 Guselkumab 400 mg IV Non Responders|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669778|NCT04033445|101974851|FG009|IS-1: Period 1 Guselkumab 400 mg IV Non Responders|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669779|NCT04033445|101974852|FG010|IS-1: Period 1 Guselkumab 400 mg IV Non Responders|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669780|NCT04033445|101974853|FG011|IS-1: Period 1 Guselkumab 400 mg IV Non Responders|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669781|NCT04033445|101974854|FG012|IS-1: Period 1 Guselkumab 400 mg IV Non Responders|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669782|NCT04033445|101974855|FG013|IS-1: Period 1 Guselkumab 400 mg IV Non Responders|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669783|NCT04033445|101974842|FG000|Treated|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669784|NCT04033445|101974843|FG001|Treated|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669785|NCT04033445|101974844|FG002|Treated|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669786|NCT04033445|101974845|FG003|Treated|IS-1 and IS-2 Period 2 (Week 12 to 24)||67||
48669787|NCT04033445|101974846|FG004|Treated|IS-1 and IS-2 Period 2 (Week 12 to 24)||79||
48669788|NCT04033445|101974847|FG005|Treated|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669789|NCT04033445|101974848|FG006|Treated|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669790|NCT04033445|101974849|FG007|Treated|IS-1 and IS-2 Period 2 (Week 12 to 24)||171||
48669791|NCT04033445|101974850|FG008|Treated|IS-1 and IS-2 Period 2 (Week 12 to 24)||129||
48669792|NCT04033445|101974851|FG009|Treated|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669793|NCT04033445|101974852|FG010|Treated|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669794|NCT04033445|101974853|FG011|Treated|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669795|NCT04033445|101974854|FG012|Treated|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669796|NCT04033445|101974855|FG013|Treated|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669797|NCT04033445|101974842|FG000|FAS Participants Who Enrolled Into MS|IS-1 and IS-2 Period 2 (Week 12 to 24)||0|FAS participants with clinical response status at Week I-24 as determined by the interactive web response system based on the local endoscopy subscore, as prespecified in the protocol.|
48669798|NCT04033445|101974843|FG001|FAS Participants Who Enrolled Into MS|IS-1 and IS-2 Period 2 (Week 12 to 24)||0|FAS participants with clinical response status at Week I-24 as determined by the interactive web response system based on the local endoscopy subscore, as prespecified in the protocol.|
48669799|NCT04033445|101974844|FG002|FAS Participants Who Enrolled Into MS|IS-1 and IS-2 Period 2 (Week 12 to 24)||0|FAS participants with clinical response status at Week I-24 as determined by the interactive web response system based on the local endoscopy subscore, as prespecified in the protocol.|
48669800|NCT04033445|101974845|FG003|FAS Participants Who Enrolled Into MS|IS-1 and IS-2 Period 2 (Week 12 to 24)||49|FAS participants with clinical response status at Week I-24 as determined by the interactive web response system based on the local endoscopy subscore, as prespecified in the protocol.|
48669801|NCT04033445|101974846|FG004|FAS Participants Who Enrolled Into MS|IS-1 and IS-2 Period 2 (Week 12 to 24)||49|FAS participants with clinical response status at Week I-24 as determined by the interactive web response system based on the local endoscopy subscore, as prespecified in the protocol.|
48669802|NCT04033445|101974847|FG005|FAS Participants Who Enrolled Into MS|IS-1 and IS-2 Period 2 (Week 12 to 24)||0|FAS participants with clinical response status at Week I-24 as determined by the interactive web response system based on the local endoscopy subscore, as prespecified in the protocol.|
48669803|NCT04033445|101974848|FG006|FAS Participants Who Enrolled Into MS|IS-1 and IS-2 Period 2 (Week 12 to 24)||0|FAS participants with clinical response status at Week I-24 as determined by the interactive web response system based on the local endoscopy subscore, as prespecified in the protocol.|
48669804|NCT04033445|101974849|FG007|FAS Participants Who Enrolled Into MS|IS-1 and IS-2 Period 2 (Week 12 to 24)||120|FAS participants with clinical response status at Week I-24 as determined by the interactive web response system based on the local endoscopy subscore, as prespecified in the protocol.|
48670068|NCT02626533|101974882|FG000|"Stratified to Stiff Group"|Overall Study||32|"After completing all study activities/follow up, patients were stratified to the Stiff group if they reported a certain score across all questionnaires."|
48669805|NCT04033445|101974850|FG008|FAS Participants Who Enrolled Into MS|IS-1 and IS-2 Period 2 (Week 12 to 24)||74|FAS participants with clinical response status at Week I-24 as determined by the interactive web response system based on the local endoscopy subscore, as prespecified in the protocol.|
48669806|NCT04033445|101974851|FG009|FAS Participants Who Enrolled Into MS|IS-1 and IS-2 Period 2 (Week 12 to 24)||0|FAS participants with clinical response status at Week I-24 as determined by the interactive web response system based on the local endoscopy subscore, as prespecified in the protocol.|
48669807|NCT04033445|101974852|FG010|FAS Participants Who Enrolled Into MS|IS-1 and IS-2 Period 2 (Week 12 to 24)||0|FAS participants with clinical response status at Week I-24 as determined by the interactive web response system based on the local endoscopy subscore, as prespecified in the protocol.|
48669808|NCT04033445|101974853|FG011|FAS Participants Who Enrolled Into MS|IS-1 and IS-2 Period 2 (Week 12 to 24)||0|FAS participants with clinical response status at Week I-24 as determined by the interactive web response system based on the local endoscopy subscore, as prespecified in the protocol.|
48669809|NCT04033445|101974854|FG012|FAS Participants Who Enrolled Into MS|IS-1 and IS-2 Period 2 (Week 12 to 24)||0|FAS participants with clinical response status at Week I-24 as determined by the interactive web response system based on the local endoscopy subscore, as prespecified in the protocol.|
48669810|NCT04033445|101974855|FG013|FAS Participants Who Enrolled Into MS|IS-1 and IS-2 Period 2 (Week 12 to 24)||0|FAS participants with clinical response status at Week I-24 as determined by the interactive web response system based on the local endoscopy subscore, as prespecified in the protocol.|
48669811|NCT04033445|101974842|FG000|COMPLETED|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669812|NCT04033445|101974843|FG001|COMPLETED|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669813|NCT04033445|101974844|FG002|COMPLETED|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669814|NCT04033445|101974845|FG003|COMPLETED|IS-1 and IS-2 Period 2 (Week 12 to 24)||64||
48669815|NCT04033445|101974846|FG004|COMPLETED|IS-1 and IS-2 Period 2 (Week 12 to 24)||77||
48669816|NCT04033445|101974847|FG005|COMPLETED|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669817|NCT04033445|101974848|FG006|COMPLETED|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669818|NCT04033445|101974849|FG007|COMPLETED|IS-1 and IS-2 Period 2 (Week 12 to 24)||162||
48669819|NCT04033445|101974850|FG008|COMPLETED|IS-1 and IS-2 Period 2 (Week 12 to 24)||117||
48669820|NCT04033445|101974851|FG009|COMPLETED|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669821|NCT04033445|101974852|FG010|COMPLETED|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669822|NCT04033445|101974853|FG011|COMPLETED|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669823|NCT04033445|101974854|FG012|COMPLETED|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669824|NCT04033445|101974855|FG013|COMPLETED|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669825|NCT04033445|101974842|FG000|NOT COMPLETED|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669826|NCT04033445|101974843|FG001|NOT COMPLETED|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669827|NCT04033445|101974844|FG002|NOT COMPLETED|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669828|NCT04033445|101974845|FG003|NOT COMPLETED|IS-1 and IS-2 Period 2 (Week 12 to 24)||3||
48669829|NCT04033445|101974846|FG004|NOT COMPLETED|IS-1 and IS-2 Period 2 (Week 12 to 24)||2||
48669830|NCT04033445|101974847|FG005|NOT COMPLETED|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669831|NCT04033445|101974848|FG006|NOT COMPLETED|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669832|NCT04033445|101974849|FG007|NOT COMPLETED|IS-1 and IS-2 Period 2 (Week 12 to 24)||10||
48669833|NCT04033445|101974850|FG008|NOT COMPLETED|IS-1 and IS-2 Period 2 (Week 12 to 24)||12||
48669834|NCT04033445|101974851|FG009|NOT COMPLETED|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669835|NCT04033445|101974852|FG010|NOT COMPLETED|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669836|NCT04033445|101974853|FG011|NOT COMPLETED|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669837|NCT04033445|101974854|FG012|NOT COMPLETED|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669838|NCT04033445|101974855|FG013|NOT COMPLETED|IS-1 and IS-2 Period 2 (Week 12 to 24)||0||
48669839|NCT04033445|101974842|FG000|STARTED|Maintenance Study (Week 0 to Week 44)||0||
48669840|NCT04033445|101974843|FG001|STARTED|Maintenance Study (Week 0 to Week 44)||0||
48669841|NCT04033445|101974844|FG002|STARTED|Maintenance Study (Week 0 to Week 44)||0||
48669842|NCT04033445|101974845|FG003|STARTED|Maintenance Study (Week 0 to Week 44)||0||
48669843|NCT04033445|101974846|FG004|STARTED|Maintenance Study (Week 0 to Week 44)||0||
48669844|NCT04033445|101974847|FG005|STARTED|Maintenance Study (Week 0 to Week 44)||0||
48669845|NCT04033445|101974848|FG006|STARTED|Maintenance Study (Week 0 to Week 44)||0||
48669846|NCT04033445|101974849|FG007|STARTED|Maintenance Study (Week 0 to Week 44)||0||
48669847|NCT04033445|101974850|FG008|STARTED|Maintenance Study (Week 0 to Week 44)||0||
48669848|NCT04033445|101974851|FG009|STARTED|Maintenance Study (Week 0 to Week 44)||201||
48669849|NCT04033445|101974852|FG010|STARTED|Maintenance Study (Week 0 to Week 44)||199||
48669850|NCT04033445|101974853|FG011|STARTED|Maintenance Study (Week 0 to Week 44)||199||
48669851|NCT04033445|101974854|FG012|STARTED|Maintenance Study (Week 0 to Week 44)||122||
48669852|NCT04033445|101974855|FG013|STARTED|Maintenance Study (Week 0 to Week 44)||125||
48669853|NCT04033445|101974842|FG000|Treated|Maintenance Study (Week 0 to Week 44)||0||
48669854|NCT04033445|101974843|FG001|Treated|Maintenance Study (Week 0 to Week 44)||0||
48669855|NCT04033445|101974844|FG002|Treated|Maintenance Study (Week 0 to Week 44)||0||
48669856|NCT04033445|101974845|FG003|Treated|Maintenance Study (Week 0 to Week 44)||0||
48669857|NCT04033445|101974846|FG004|Treated|Maintenance Study (Week 0 to Week 44)||0||
48669858|NCT04033445|101974847|FG005|Treated|Maintenance Study (Week 0 to Week 44)||0||
48669859|NCT04033445|101974848|FG006|Treated|Maintenance Study (Week 0 to Week 44)||0||
48669860|NCT04033445|101974849|FG007|Treated|Maintenance Study (Week 0 to Week 44)||0||
48669861|NCT04033445|101974850|FG008|Treated|Maintenance Study (Week 0 to Week 44)||0||
48669862|NCT04033445|101974851|FG009|Treated|Maintenance Study (Week 0 to Week 44)||201||
48669863|NCT04033445|101974852|FG010|Treated|Maintenance Study (Week 0 to Week 44)||199||
48669864|NCT04033445|101974853|FG011|Treated|Maintenance Study (Week 0 to Week 44)||199||
48669865|NCT04033445|101974854|FG012|Treated|Maintenance Study (Week 0 to Week 44)||122||
48669866|NCT04033445|101974855|FG013|Treated|Maintenance Study (Week 0 to Week 44)||125||
48669867|NCT04033445|101974842|FG000|Full Analysis Set|Maintenance Study (Week 0 to Week 44)||0|All participants with a MMS of 5 to 9 who received at least 1 dose (partial or complete) of study intervention in MS, including both randomized and nonrandomized.|
48669868|NCT04033445|101974843|FG001|Full Analysis Set|Maintenance Study (Week 0 to Week 44)||0|All participants with a MMS of 5 to 9 who received at least 1 dose (partial or complete) of study intervention in MS, including both randomized and nonrandomized.|
48669869|NCT04033445|101974844|FG002|Full Analysis Set|Maintenance Study (Week 0 to Week 44)||0|All participants with a MMS of 5 to 9 who received at least 1 dose (partial or complete) of study intervention in MS, including both randomized and nonrandomized.|
48669870|NCT04033445|101974845|FG003|Full Analysis Set|Maintenance Study (Week 0 to Week 44)||0|All participants with a MMS of 5 to 9 who received at least 1 dose (partial or complete) of study intervention in MS, including both randomized and nonrandomized.|
48669871|NCT04033445|101974846|FG004|Full Analysis Set|Maintenance Study (Week 0 to Week 44)||0|All participants with a MMS of 5 to 9 who received at least 1 dose (partial or complete) of study intervention in MS, including both randomized and nonrandomized.|
48669872|NCT04033445|101974847|FG005|Full Analysis Set|Maintenance Study (Week 0 to Week 44)||0|All participants with a MMS of 5 to 9 who received at least 1 dose (partial or complete) of study intervention in MS, including both randomized and nonrandomized.|
48669873|NCT04033445|101974848|FG006|Full Analysis Set|Maintenance Study (Week 0 to Week 44)||0|All participants with a MMS of 5 to 9 who received at least 1 dose (partial or complete) of study intervention in MS, including both randomized and nonrandomized.|
48669874|NCT04033445|101974849|FG007|Full Analysis Set|Maintenance Study (Week 0 to Week 44)||0|All participants with a MMS of 5 to 9 who received at least 1 dose (partial or complete) of study intervention in MS, including both randomized and nonrandomized.|
48669875|NCT04033445|101974850|FG008|Full Analysis Set|Maintenance Study (Week 0 to Week 44)||0|All participants with a MMS of 5 to 9 who received at least 1 dose (partial or complete) of study intervention in MS, including both randomized and nonrandomized.|
48669876|NCT04033445|101974851|FG009|Full Analysis Set|Maintenance Study (Week 0 to Week 44)||190|All participants with a MMS of 5 to 9 who received at least 1 dose (partial or complete) of study intervention in MS, including both randomized and nonrandomized.|
48669877|NCT04033445|101974852|FG010|Full Analysis Set|Maintenance Study (Week 0 to Week 44)||188|All participants with a MMS of 5 to 9 who received at least 1 dose (partial or complete) of study intervention in MS, including both randomized and nonrandomized.|
48669878|NCT04033445|101974853|FG011|Full Analysis Set|Maintenance Study (Week 0 to Week 44)||190|All participants with a MMS of 5 to 9 who received at least 1 dose (partial or complete) of study intervention in MS, including both randomized and nonrandomized.|
48669879|NCT04033445|101974854|FG012|Full Analysis Set|Maintenance Study (Week 0 to Week 44)||114|All participants with a MMS of 5 to 9 who received at least 1 dose (partial or complete) of study intervention in MS, including both randomized and nonrandomized.|
48669880|NCT04033445|101974855|FG013|Full Analysis Set|Maintenance Study (Week 0 to Week 44)||123|All participants with a MMS of 5 to 9 who received at least 1 dose (partial or complete) of study intervention in MS, including both randomized and nonrandomized.|
48669881|NCT04033445|101974842|FG000|Safety All Randomized and Treated Analysis Set|Maintenance Study (Week 0 to Week 44)||0|All participants (regardless of MMS) who were randomized in MS and received at least 1 dose of study intervention in MS.|
48669882|NCT04033445|101974843|FG001|Safety All Randomized and Treated Analysis Set|Maintenance Study (Week 0 to Week 44)||0|All participants (regardless of MMS) who were randomized in MS and received at least 1 dose of study intervention in MS.|
48669883|NCT04033445|101974844|FG002|Safety All Randomized and Treated Analysis Set|Maintenance Study (Week 0 to Week 44)||0|All participants (regardless of MMS) who were randomized in MS and received at least 1 dose of study intervention in MS.|
48669884|NCT04033445|101974845|FG003|Safety All Randomized and Treated Analysis Set|Maintenance Study (Week 0 to Week 44)||0|All participants (regardless of MMS) who were randomized in MS and received at least 1 dose of study intervention in MS.|
48669885|NCT04033445|101974846|FG004|Safety All Randomized and Treated Analysis Set|Maintenance Study (Week 0 to Week 44)||0|All participants (regardless of MMS) who were randomized in MS and received at least 1 dose of study intervention in MS.|
48669886|NCT04033445|101974847|FG005|Safety All Randomized and Treated Analysis Set|Maintenance Study (Week 0 to Week 44)||0|All participants (regardless of MMS) who were randomized in MS and received at least 1 dose of study intervention in MS.|
48669887|NCT04033445|101974848|FG006|Safety All Randomized and Treated Analysis Set|Maintenance Study (Week 0 to Week 44)||0|All participants (regardless of MMS) who were randomized in MS and received at least 1 dose of study intervention in MS.|
48669888|NCT04033445|101974849|FG007|Safety All Randomized and Treated Analysis Set|Maintenance Study (Week 0 to Week 44)||0|All participants (regardless of MMS) who were randomized in MS and received at least 1 dose of study intervention in MS.|
48669889|NCT04033445|101974850|FG008|Safety All Randomized and Treated Analysis Set|Maintenance Study (Week 0 to Week 44)||0|All participants (regardless of MMS) who were randomized in MS and received at least 1 dose of study intervention in MS.|
48669890|NCT04033445|101974851|FG009|Safety All Randomized and Treated Analysis Set|Maintenance Study (Week 0 to Week 44)||203|All participants (regardless of MMS) who were randomized in MS and received at least 1 dose of study intervention in MS.|
48669891|NCT04033445|101974852|FG010|Safety All Randomized and Treated Analysis Set|Maintenance Study (Week 0 to Week 44)||197|All participants (regardless of MMS) who were randomized in MS and received at least 1 dose of study intervention in MS.|
48669892|NCT04033445|101974853|FG011|Safety All Randomized and Treated Analysis Set|Maintenance Study (Week 0 to Week 44)||199|All participants (regardless of MMS) who were randomized in MS and received at least 1 dose of study intervention in MS.|
48669893|NCT04033445|101974854|FG012|Safety All Randomized and Treated Analysis Set|Maintenance Study (Week 0 to Week 44)||0|All participants (regardless of MMS) who were randomized in MS and received at least 1 dose of study intervention in MS.|
48669894|NCT04033445|101974855|FG013|Safety All Randomized and Treated Analysis Set|Maintenance Study (Week 0 to Week 44)||0|All participants (regardless of MMS) who were randomized in MS and received at least 1 dose of study intervention in MS.|
48669895|NCT04033445|101974842|FG000|Dose Adjustment|Maintenance Study (Week 0 to Week 44)||0||
48669896|NCT04033445|101974843|FG001|Dose Adjustment|Maintenance Study (Week 0 to Week 44)||0||
48669897|NCT04033445|101974844|FG002|Dose Adjustment|Maintenance Study (Week 0 to Week 44)||0||
48669898|NCT04033445|101974845|FG003|Dose Adjustment|Maintenance Study (Week 0 to Week 44)||0||
48669899|NCT04033445|101974846|FG004|Dose Adjustment|Maintenance Study (Week 0 to Week 44)||0||
48669900|NCT04033445|101974847|FG005|Dose Adjustment|Maintenance Study (Week 0 to Week 44)||0||
48669901|NCT04033445|101974848|FG006|Dose Adjustment|Maintenance Study (Week 0 to Week 44)||0||
48669902|NCT04033445|101974849|FG007|Dose Adjustment|Maintenance Study (Week 0 to Week 44)||0||
48669903|NCT04033445|101974850|FG008|Dose Adjustment|Maintenance Study (Week 0 to Week 44)||0||
48669904|NCT04033445|101974851|FG009|Dose Adjustment|Maintenance Study (Week 0 to Week 44)||75||
48669905|NCT04033445|101974852|FG010|Dose Adjustment|Maintenance Study (Week 0 to Week 44)||23||
48669906|NCT04033445|101974853|FG011|Dose Adjustment|Maintenance Study (Week 0 to Week 44)||31||
48669907|NCT04033445|101974854|FG012|Dose Adjustment|Maintenance Study (Week 0 to Week 44)||0||
48669908|NCT04033445|101974855|FG013|Dose Adjustment|Maintenance Study (Week 0 to Week 44)||0||
48669909|NCT04033445|101974842|FG000|Safety All Nonrandomized and Treated Analysis Set|Maintenance Study (Week 0 to Week 44)||0|All participants (regardless of MMS) who entered in MS but were not randomized and received at least 1 dose of study intervention in MS.|
48669910|NCT04033445|101974843|FG001|Safety All Nonrandomized and Treated Analysis Set|Maintenance Study (Week 0 to Week 44)||0|All participants (regardless of MMS) who entered in MS but were not randomized and received at least 1 dose of study intervention in MS.|
48669911|NCT04033445|101974844|FG002|Safety All Nonrandomized and Treated Analysis Set|Maintenance Study (Week 0 to Week 44)||0|All participants (regardless of MMS) who entered in MS but were not randomized and received at least 1 dose of study intervention in MS.|
48669912|NCT04033445|101974845|FG003|Safety All Nonrandomized and Treated Analysis Set|Maintenance Study (Week 0 to Week 44)||0|All participants (regardless of MMS) who entered in MS but were not randomized and received at least 1 dose of study intervention in MS.|
48669913|NCT04033445|101974846|FG004|Safety All Nonrandomized and Treated Analysis Set|Maintenance Study (Week 0 to Week 44)||0|All participants (regardless of MMS) who entered in MS but were not randomized and received at least 1 dose of study intervention in MS.|
48669914|NCT04033445|101974847|FG005|Safety All Nonrandomized and Treated Analysis Set|Maintenance Study (Week 0 to Week 44)||0|All participants (regardless of MMS) who entered in MS but were not randomized and received at least 1 dose of study intervention in MS.|
48669915|NCT04033445|101974848|FG006|Safety All Nonrandomized and Treated Analysis Set|Maintenance Study (Week 0 to Week 44)||0|All participants (regardless of MMS) who entered in MS but were not randomized and received at least 1 dose of study intervention in MS.|
48669916|NCT04033445|101974849|FG007|Safety All Nonrandomized and Treated Analysis Set|Maintenance Study (Week 0 to Week 44)||0|All participants (regardless of MMS) who entered in MS but were not randomized and received at least 1 dose of study intervention in MS.|
48669917|NCT04033445|101974850|FG008|Safety All Nonrandomized and Treated Analysis Set|Maintenance Study (Week 0 to Week 44)||0|All participants (regardless of MMS) who entered in MS but were not randomized and received at least 1 dose of study intervention in MS.|
48669918|NCT04033445|101974851|FG009|Safety All Nonrandomized and Treated Analysis Set|Maintenance Study (Week 0 to Week 44)||0|All participants (regardless of MMS) who entered in MS but were not randomized and received at least 1 dose of study intervention in MS.|
48669919|NCT04033445|101974852|FG010|Safety All Nonrandomized and Treated Analysis Set|Maintenance Study (Week 0 to Week 44)||0|All participants (regardless of MMS) who entered in MS but were not randomized and received at least 1 dose of study intervention in MS.|
48669920|NCT04033445|101974853|FG011|Safety All Nonrandomized and Treated Analysis Set|Maintenance Study (Week 0 to Week 44)||0|All participants (regardless of MMS) who entered in MS but were not randomized and received at least 1 dose of study intervention in MS.|
48669921|NCT04033445|101974854|FG012|Safety All Nonrandomized and Treated Analysis Set|Maintenance Study (Week 0 to Week 44)||122|All participants (regardless of MMS) who entered in MS but were not randomized and received at least 1 dose of study intervention in MS.|
48669922|NCT04033445|101974855|FG013|Safety All Nonrandomized and Treated Analysis Set|Maintenance Study (Week 0 to Week 44)||125|All participants (regardless of MMS) who entered in MS but were not randomized and received at least 1 dose of study intervention in MS.|
48669923|NCT04033445|101974842|FG000|COMPLETED|Maintenance Study (Week 0 to Week 44)||0||
48669924|NCT04033445|101974843|FG001|COMPLETED|Maintenance Study (Week 0 to Week 44)||0||
48669925|NCT04033445|101974844|FG002|COMPLETED|Maintenance Study (Week 0 to Week 44)||0||
48669926|NCT04033445|101974845|FG003|COMPLETED|Maintenance Study (Week 0 to Week 44)||0||
48669927|NCT04033445|101974846|FG004|COMPLETED|Maintenance Study (Week 0 to Week 44)||0||
48669928|NCT04033445|101974847|FG005|COMPLETED|Maintenance Study (Week 0 to Week 44)||0||
48669929|NCT04033445|101974848|FG006|COMPLETED|Maintenance Study (Week 0 to Week 44)||0||
48669930|NCT04033445|101974849|FG007|COMPLETED|Maintenance Study (Week 0 to Week 44)||0||
48669931|NCT04033445|101974850|FG008|COMPLETED|Maintenance Study (Week 0 to Week 44)||0||
48669932|NCT04033445|101974851|FG009|COMPLETED|Maintenance Study (Week 0 to Week 44)||173||
48669933|NCT04033445|101974852|FG010|COMPLETED|Maintenance Study (Week 0 to Week 44)||177||
48669934|NCT04033445|101974853|FG011|COMPLETED|Maintenance Study (Week 0 to Week 44)||176||
48669935|NCT04033445|101974854|FG012|COMPLETED|Maintenance Study (Week 0 to Week 44)||95||
48669936|NCT04033445|101974855|FG013|COMPLETED|Maintenance Study (Week 0 to Week 44)||107||
48669937|NCT04033445|101974842|FG000|NOT COMPLETED|Maintenance Study (Week 0 to Week 44)||0||
48669938|NCT04033445|101974843|FG001|NOT COMPLETED|Maintenance Study (Week 0 to Week 44)||0||
48669939|NCT04033445|101974844|FG002|NOT COMPLETED|Maintenance Study (Week 0 to Week 44)||0||
48669940|NCT04033445|101974845|FG003|NOT COMPLETED|Maintenance Study (Week 0 to Week 44)||0||
48669941|NCT04033445|101974846|FG004|NOT COMPLETED|Maintenance Study (Week 0 to Week 44)||0||
48669942|NCT04033445|101974847|FG005|NOT COMPLETED|Maintenance Study (Week 0 to Week 44)||0||
48669943|NCT04033445|101974848|FG006|NOT COMPLETED|Maintenance Study (Week 0 to Week 44)||0||
48669944|NCT04033445|101974849|FG007|NOT COMPLETED|Maintenance Study (Week 0 to Week 44)||0||
48669945|NCT04033445|101974850|FG008|NOT COMPLETED|Maintenance Study (Week 0 to Week 44)||0||
48669946|NCT04033445|101974851|FG009|NOT COMPLETED|Maintenance Study (Week 0 to Week 44)||28||
48669947|NCT04033445|101974852|FG010|NOT COMPLETED|Maintenance Study (Week 0 to Week 44)||22||
48669948|NCT04033445|101974853|FG011|NOT COMPLETED|Maintenance Study (Week 0 to Week 44)||23||
48669949|NCT04033445|101974854|FG012|NOT COMPLETED|Maintenance Study (Week 0 to Week 44)||27||
48669950|NCT04033445|101974855|FG013|NOT COMPLETED|Maintenance Study (Week 0 to Week 44)||18||
48669951|NCT03038672|101974856|FG000|STARTED|Initial Treatment||27||
48669952|NCT03038672|101974857|FG001|STARTED|Initial Treatment||27||
48669953|NCT03038672|101974856|FG000|COMPLETED|Initial Treatment||25||
48669954|NCT03038672|101974857|FG001|COMPLETED|Initial Treatment||26||
48669955|NCT03038672|101974856|FG000|NOT COMPLETED|Initial Treatment||2||
48669956|NCT03038672|101974857|FG001|NOT COMPLETED|Initial Treatment||1||
48669957|NCT03038672|101974856|FG000|STARTED|Cross Over From Group I to Group II||7||
48669958|NCT03038672|101974857|FG001|STARTED|Cross Over From Group I to Group II||26||
48669959|NCT03038672|101974856|FG000|COMPLETED|Cross Over From Group I to Group II||7||
48669960|NCT03038672|101974857|FG001|COMPLETED|Cross Over From Group I to Group II||26||
48669961|NCT03038672|101974856|FG000|NOT COMPLETED|Cross Over From Group I to Group II||0||
48669962|NCT03038672|101974857|FG001|NOT COMPLETED|Cross Over From Group I to Group II||0||
48669963|NCT04439266|101974858|FG000|STARTED|Overall Study||5||
48669964|NCT04439266|101974858|FG000|Eligible|Overall Study||4|1 patient is ineligible. This is the primary analysis population.|
48669965|NCT04439266|101974858|FG000|COMPLETED|Overall Study||0|Treatment continued until disease progression or intolerability.|
48669966|NCT04439266|101974858|FG000|NOT COMPLETED|Overall Study||5||
48669967|NCT05730335|101974859|FG000|STARTED|Overall Study||59||
48669968|NCT05730335|101974859|FG000|Received at Least 1 Study Treatment|Overall Study||59||
48669969|NCT05730335|101974859|FG000|Completed 12-Week Post-Final Treatment Visit|Overall Study||51||
48669970|NCT05730335|101974859|FG000|COMPLETED|Overall Study||0||
48669971|NCT05730335|101974859|FG000|NOT COMPLETED|Overall Study||59||
48669972|NCT05870865|101974860|FG000|STARTED|Randomized||36||
48669973|NCT05870865|101974861|FG001|STARTED|Randomized||36||
48669974|NCT05870865|101974862|FG002|STARTED|Randomized||36||
48669975|NCT05870865|101974863|FG003|STARTED|Randomized||36||
48669976|NCT05870865|101974860|FG000|COMPLETED|Randomized||34||
48669977|NCT05870865|101974861|FG001|COMPLETED|Randomized||32||
48669978|NCT05870865|101974862|FG002|COMPLETED|Randomized||32||
48669979|NCT05870865|101974863|FG003|COMPLETED|Randomized||33||
48669980|NCT05870865|101974860|FG000|NOT COMPLETED|Randomized||2||
48669981|NCT05870865|101974861|FG001|NOT COMPLETED|Randomized||4||
48669982|NCT05870865|101974862|FG002|NOT COMPLETED|Randomized||4||
48669983|NCT05870865|101974863|FG003|NOT COMPLETED|Randomized||3||
48669984|NCT05870865|101974860|FG000|STARTED|Treatment Period||34||
48669985|NCT05870865|101974861|FG001|STARTED|Treatment Period||32||
48669986|NCT05870865|101974862|FG002|STARTED|Treatment Period||32||
48669987|NCT05870865|101974863|FG003|STARTED|Treatment Period||33||
48669988|NCT05870865|101974860|FG000|COMPLETED|Treatment Period||33||
48669989|NCT05870865|101974861|FG001|COMPLETED|Treatment Period||29||
48669990|NCT05870865|101974862|FG002|COMPLETED|Treatment Period||28||
48669991|NCT05870865|101974863|FG003|COMPLETED|Treatment Period||30||
48669992|NCT05870865|101974860|FG000|NOT COMPLETED|Treatment Period||1||
48669993|NCT05870865|101974861|FG001|NOT COMPLETED|Treatment Period||3||
48669994|NCT05870865|101974862|FG002|NOT COMPLETED|Treatment Period||4||
48669995|NCT05870865|101974863|FG003|NOT COMPLETED|Treatment Period||3||
48669996|NCT02506673|101974864|FG000|STARTED|Overall Study||13||
48669997|NCT02506673|101974865|FG001|STARTED|Overall Study||13||
48669998|NCT02506673|101974864|FG000|COMPLETED|Overall Study||13||
48669999|NCT02506673|101974865|FG001|COMPLETED|Overall Study||13||
48670000|NCT02506673|101974864|FG000|NOT COMPLETED|Overall Study||0||
48670001|NCT02506673|101974865|FG001|NOT COMPLETED|Overall Study||0||
48670002|NCT03601897|101974866|FG000|STARTED|Overall Study||24||
48670003|NCT03601897|101974867|FG001|STARTED|Overall Study||19||
48670004|NCT03601897|101974868|FG002|STARTED|Overall Study||12||
48670005|NCT03601897|101974869|FG003|STARTED|Overall Study||6||
48670006|NCT03601897|101974870|FG004|STARTED|Overall Study||15||
48070482|NCT00108433|100494202|FG000|NOT COMPLETED|Overall Study||21||
48070483|NCT00108433|100494203|FG001|NOT COMPLETED|Overall Study||17||
48070484|NCT00150709|100494204|FG000|STARTED|Overall Study||79||
48070485|NCT00150709|100494205|FG001|STARTED|Overall Study||89||
48070486|NCT00150709|100494206|FG002|STARTED|Overall Study||41||
48070487|NCT00150709|100494207|FG003|STARTED|Overall Study||14||
48070488|NCT00150709|100494204|FG000|COMPLETED|Overall Study||24||
48070489|NCT00150709|100494205|FG001|COMPLETED|Overall Study||27||
48070490|NCT00150709|100494206|FG002|COMPLETED|Overall Study||17||
48070491|NCT00150709|100494207|FG003|COMPLETED|Overall Study||6||
48070492|NCT00150709|100494204|FG000|NOT COMPLETED|Overall Study||55||
48070493|NCT00150709|100494205|FG001|NOT COMPLETED|Overall Study||62||
48070494|NCT00150709|100494206|FG002|NOT COMPLETED|Overall Study||24||
48070495|NCT00150709|100494207|FG003|NOT COMPLETED|Overall Study||8||
48070496|NCT01065597|100494208|FG000|STARTED|Overall Study||13||
48070497|NCT01065597|100494208|FG000|COMPLETED|Overall Study||12||
48070498|NCT01065597|100494208|FG000|NOT COMPLETED|Overall Study||1||
48070499|NCT01387789|100494209|FG000|STARTED|Overall Study||71||
48070500|NCT01387789|100494209|FG000|COMPLETED|Overall Study||63||
48070501|NCT01387789|100494209|FG000|NOT COMPLETED|Overall Study||8||
48070502|NCT00850070|100494210|FG000|STARTED|Overall Study||23||
48070503|NCT00850070|100494211|FG001|STARTED|Overall Study||23||
48070504|NCT00850070|100494210|FG000|COMPLETED|Overall Study||20||
48070505|NCT00850070|100494211|FG001|COMPLETED|Overall Study||22||
48070506|NCT00850070|100494210|FG000|NOT COMPLETED|Overall Study||3||
48070507|NCT00850070|100494211|FG001|NOT COMPLETED|Overall Study||1||
48070508|NCT00412542|100494212|FG000|STARTED|Overall Study||33||
48070509|NCT00412542|100494213|FG001|STARTED|Overall Study||45||
48070510|NCT00412542|100494212|FG000|COMPLETED|Overall Study||33||
48070511|NCT00412542|100494213|FG001|COMPLETED|Overall Study||42||
48070512|NCT00412542|100494212|FG000|NOT COMPLETED|Overall Study||0||
48070513|NCT00412542|100494213|FG001|NOT COMPLETED|Overall Study||3||
48070514|NCT02187744|100494214|FG000|STARTED|Study||113||
48070515|NCT02187744|100494215|FG001|STARTED|Study||112||
48070516|NCT02187744|100494214|FG000|COMPLETED|Study||109||
48070517|NCT02187744|100494215|FG001|COMPLETED|Study||106||
48070518|NCT02187744|100494214|FG000|NOT COMPLETED|Study||4||
48070519|NCT02187744|100494215|FG001|NOT COMPLETED|Study||6||
48070520|NCT02187744|100494214|FG000|STARTED|Treatment||113||
48070521|NCT02187744|100494215|FG001|STARTED|Treatment||112||
48070522|NCT02187744|100494214|FG000|COMPLETED|Treatment||109||
48070523|NCT02187744|100494215|FG001|COMPLETED|Treatment||107||
48070524|NCT02187744|100494214|FG000|NOT COMPLETED|Treatment||4||
48070525|NCT02187744|100494215|FG001|NOT COMPLETED|Treatment||5||
48070526|NCT03423082|100494216|FG000|STARTED|Overall Study||1||
48070527|NCT03423082|100494216|FG000|COMPLETED|Overall Study||1||
48070528|NCT03423082|100494216|FG000|NOT COMPLETED|Overall Study||0||
48070529|NCT03689530|100494217|FG000|STARTED|Overall Study||272||
48070530|NCT03689530|100494218|FG001|STARTED|Overall Study||178||
48070531|NCT03689530|100494217|FG000|6-month Follow-up|Overall Study||223||
48070532|NCT03689530|100494218|FG001|6-month Follow-up|Overall Study||169||
48070533|NCT03689530|100494217|FG000|12-month Follow-up|Overall Study||212||
48070534|NCT03689530|100494218|FG001|12-month Follow-up|Overall Study||162||
48070535|NCT03689530|100494217|FG000|COMPLETED|Overall Study||219||
48070536|NCT03689530|100494218|FG001|COMPLETED|Overall Study||162||
48070537|NCT03689530|100494217|FG000|NOT COMPLETED|Overall Study||53||
48070538|NCT03689530|100494218|FG001|NOT COMPLETED|Overall Study||16||
48070539|NCT01622231|100494219|FG000|STARTED|Overall Study||61||
48070540|NCT01622231|100494219|FG000|COMPLETED|Overall Study||59||
48070541|NCT01622231|100494219|FG000|NOT COMPLETED|Overall Study||2||
48070542|NCT00114530|100494220|FG000|STARTED|Overall Study||36||
48070543|NCT00114530|100494221|FG001|STARTED|Overall Study||39||
48070544|NCT00114530|100494220|FG000|COMPLETED|Overall Study||27||
48070545|NCT00114530|100494221|FG001|COMPLETED|Overall Study||19||
48070546|NCT00114530|100494220|FG000|NOT COMPLETED|Overall Study||9||
48070547|NCT00114530|100494221|FG001|NOT COMPLETED|Overall Study||20||
48070548|NCT02168361|100494222|FG000|STARTED|Overall Study||62||
48070549|NCT02168361|100494223|FG001|STARTED|Overall Study||31||
48070550|NCT02168361|100494222|FG000|COMPLETED|Overall Study||57||
48070551|NCT02168361|100494223|FG001|COMPLETED|Overall Study||21||
48070552|NCT02168361|100494222|FG000|NOT COMPLETED|Overall Study||5||
48070553|NCT02168361|100494223|FG001|NOT COMPLETED|Overall Study||10||
48070554|NCT03557853|100494224|FG000|STARTED|12 Months of Follow-up: Interim Analysis||39||
48070555|NCT03557853|100494224|FG000|COMPLETED|12 Months of Follow-up: Interim Analysis||22|22 patients completed 12 months of follow-up and entered into the preliminary statistical analysis.|
48070556|NCT03557853|100494224|FG000|NOT COMPLETED|12 Months of Follow-up: Interim Analysis||17||
48070557|NCT03557853|100494224|FG000|STARTED|24 Weeks of Follow-up: Final Analysis||39||
48070558|NCT03557853|100494224|FG000|COMPLETED|24 Weeks of Follow-up: Final Analysis||30||
48070559|NCT03557853|100494224|FG000|NOT COMPLETED|24 Weeks of Follow-up: Final Analysis||9||
48070560|NCT03763175|100494225|FG000|STARTED|Overall Study||20||
48070561|NCT03763175|100494226|FG001|STARTED|Overall Study||19||
48070562|NCT03763175|100494227|FG002|STARTED|Overall Study||20||
48070563|NCT03763175|100494225|FG000|COMPLETED|Overall Study||19||
48070564|NCT03763175|100494226|FG001|COMPLETED|Overall Study||17||
48070565|NCT03763175|100494227|FG002|COMPLETED|Overall Study||19||
48070566|NCT03763175|100494225|FG000|NOT COMPLETED|Overall Study||1||
48070567|NCT03763175|100494226|FG001|NOT COMPLETED|Overall Study||2||
48070568|NCT03763175|100494227|FG002|NOT COMPLETED|Overall Study||1||
48070569|NCT00843856|100494228|FG000|STARTED|Overall Study||20||
48070570|NCT00843856|100494229|FG001|STARTED|Overall Study||20||
48070571|NCT00843856|100494228|FG000|COMPLETED|Overall Study||19||
48070572|NCT00843856|100494229|FG001|COMPLETED|Overall Study||18||
48070573|NCT00843856|100494228|FG000|NOT COMPLETED|Overall Study||1||
48070574|NCT00843856|100494229|FG001|NOT COMPLETED|Overall Study||2||
48070575|NCT00478231|100494230|FG000|STARTED|Overall Study||209||
48070576|NCT00478231|100494230|FG000|Treated|Overall Study||206||
48070577|NCT00478231|100494230|FG000|COMPLETED|Overall Study||125||
48070578|NCT00478231|100494230|FG000|NOT COMPLETED|Overall Study||84||
48070579|NCT03698409|100494231|FG000|STARTED|Overall Study||39||
48070580|NCT03698409|100494232|FG001|STARTED|Overall Study||29||
48070581|NCT03698409|100494231|FG000|COMPLETED|Overall Study||39||
48070582|NCT03698409|100494232|FG001|COMPLETED|Overall Study||29||
48070583|NCT03698409|100494231|FG000|NOT COMPLETED|Overall Study||0||
48070584|NCT03698409|100494232|FG001|NOT COMPLETED|Overall Study||0||
48070585|NCT00539656|100494233|FG000|STARTED|Overall Study||3||
48070586|NCT00539656|100494233|FG000|COMPLETED|Overall Study||3||
48070587|NCT00539656|100494233|FG000|NOT COMPLETED|Overall Study||0||
48070588|NCT00850343|100494234|FG000|STARTED|Overall Study||110||
48070589|NCT00850343|100494235|FG001|STARTED|Overall Study||12||
48070590|NCT00850343|100494236|FG002|STARTED|Overall Study||43||
48070591|NCT00850343|100494237|FG003|STARTED|Overall Study||43||
48070592|NCT00850343|100494234|FG000|Completed Week 24|Overall Study||94||
48070593|NCT00850343|100494235|FG001|Completed Week 24|Overall Study||12||
48070594|NCT00850343|100494236|FG002|Completed Week 24|Overall Study||39||
48070595|NCT00850343|100494237|FG003|Completed Week 24|Overall Study||39||
48070596|NCT00850343|100494234|FG000|Completed Week 52|Overall Study||88||
48070597|NCT00850343|100494235|FG001|Completed Week 52|Overall Study||11||
48070598|NCT00850343|100494236|FG002|Completed Week 52|Overall Study||37||
48070599|NCT00850343|100494237|FG003|Completed Week 52|Overall Study||37||
48070600|NCT00850343|100494234|FG000|COMPLETED|Overall Study||64||
48070601|NCT00850343|100494235|FG001|COMPLETED|Overall Study||9||
48070602|NCT00850343|100494236|FG002|COMPLETED|Overall Study||29||
48070603|NCT00850343|100494237|FG003|COMPLETED|Overall Study||30||
48070604|NCT00850343|100494234|FG000|NOT COMPLETED|Overall Study||46||
48070605|NCT00850343|100494235|FG001|NOT COMPLETED|Overall Study||3||
48070606|NCT00850343|100494236|FG002|NOT COMPLETED|Overall Study||14||
48070607|NCT00850343|100494237|FG003|NOT COMPLETED|Overall Study||13||
48070608|NCT03137537|100494238|FG000|STARTED|Overall Study||12||
48070609|NCT03137537|100494239|FG001|STARTED|Overall Study||11||
48070610|NCT03137537|100494238|FG000|COMPLETED|Overall Study||12||
48070611|NCT03137537|100494239|FG001|COMPLETED|Overall Study||10||
48070612|NCT03137537|100494238|FG000|NOT COMPLETED|Overall Study||0||
48070613|NCT03137537|100494239|FG001|NOT COMPLETED|Overall Study||1||
48070614|NCT02422303|100494240|FG000|STARTED|Overall Study||6||
48070615|NCT02422303|100494241|FG001|STARTED|Overall Study||6||
48070616|NCT02422303|100494240|FG000|COMPLETED|Overall Study||5||
48070617|NCT02422303|100494241|FG001|COMPLETED|Overall Study||5||
48070618|NCT02422303|100494240|FG000|NOT COMPLETED|Overall Study||1||
48070619|NCT02422303|100494241|FG001|NOT COMPLETED|Overall Study||1||
48070620|NCT01816074|100494242|FG000|STARTED|Phase 1||11||
48070621|NCT01816074|100494243|FG001|STARTED|Phase 1||9||
48070622|NCT01816074|100494244|FG002|STARTED|Phase 1||11||
48070623|NCT01816074|100494245|FG003|STARTED|Phase 1||10||
48070624|NCT01816074|100494242|FG000|COMPLETED|Phase 1||11||
48070625|NCT01816074|100494243|FG001|COMPLETED|Phase 1||9||
48070626|NCT01816074|100494244|FG002|COMPLETED|Phase 1||10||
48070627|NCT01816074|100494245|FG003|COMPLETED|Phase 1||10||
48070628|NCT01816074|100494242|FG000|NOT COMPLETED|Phase 1||0||
48070629|NCT01816074|100494243|FG001|NOT COMPLETED|Phase 1||0||
48070630|NCT01816074|100494244|FG002|NOT COMPLETED|Phase 1||1||
48070631|NCT01816074|100494245|FG003|NOT COMPLETED|Phase 1||0||
48070632|NCT01816074|100494242|FG000|STARTED|Phase 2||11||
48070633|NCT01816074|100494243|FG001|STARTED|Phase 2||9||
48070634|NCT01816074|100494244|FG002|STARTED|Phase 2||10||
48070635|NCT01816074|100494245|FG003|STARTED|Phase 2||10||
48070636|NCT01816074|100494242|FG000|COMPLETED|Phase 2||9||
48070637|NCT01816074|100494243|FG001|COMPLETED|Phase 2||7||
48070638|NCT01816074|100494244|FG002|COMPLETED|Phase 2||10||
48070639|NCT01816074|100494245|FG003|COMPLETED|Phase 2||9||
48070640|NCT01816074|100494242|FG000|NOT COMPLETED|Phase 2||2||
48070641|NCT01816074|100494243|FG001|NOT COMPLETED|Phase 2||2||
48070642|NCT01816074|100494244|FG002|NOT COMPLETED|Phase 2||0||
48070643|NCT01816074|100494245|FG003|NOT COMPLETED|Phase 2||1||
48070644|NCT00929383|100494246|FG000|STARTED|Overall Study||82||
48070645|NCT00929383|100494246|FG000|COMPLETED|Overall Study||67||
48070646|NCT00929383|100494246|FG000|NOT COMPLETED|Overall Study||15||
48070647|NCT00178633|100494247|FG000|STARTED|Overall Study||43||
48070648|NCT00178633|100494247|FG000|COMPLETED|Overall Study||37||
48070649|NCT00178633|100494247|FG000|NOT COMPLETED|Overall Study||6||
48070650|NCT02877134|100494248|FG000|STARTED|Main Study (Parts I,II): Up to Week 38||72||
48070651|NCT02877134|100494249|FG001|STARTED|Main Study (Parts I,II): Up to Week 38||73||
48070652|NCT02877134|100494250|FG002|STARTED|Main Study (Parts I,II): Up to Week 38||48||
48070653|NCT02877134|100494251|FG003|STARTED|Main Study (Parts I,II): Up to Week 38||50||
48070654|NCT02877134|100494252|FG004|STARTED|Main Study (Parts I,II): Up to Week 38||49||
48070655|NCT02877134|100494253|FG005|STARTED|Main Study (Parts I,II): Up to Week 38||49||
48070656|NCT02877134|100494254|FG006|STARTED|Main Study (Parts I,II): Up to Week 38||47||
48070657|NCT02877134|100494255|FG007|STARTED|Main Study (Parts I,II): Up to Week 38||0||
48070658|NCT02877134|100494256|FG008|STARTED|Main Study (Parts I,II): Up to Week 38||0||
48070659|NCT02877134|100494257|FG009|STARTED|Main Study (Parts I,II): Up to Week 38||0||
48070660|NCT02877134|100494258|FG010|STARTED|Main Study (Parts I,II): Up to Week 38||0||
48070661|NCT02877134|100494259|FG011|STARTED|Main Study (Parts I,II): Up to Week 38||0||
48070662|NCT02877134|100494248|FG000|Placebo Non Responders at Week 12|Main Study (Parts I,II): Up to Week 38||44||
48070663|NCT02877134|100494249|FG001|Placebo Non Responders at Week 12|Main Study (Parts I,II): Up to Week 38||0||
48070664|NCT02877134|100494250|FG002|Placebo Non Responders at Week 12|Main Study (Parts I,II): Up to Week 38||31||
48070665|NCT02877134|100494251|FG003|Placebo Non Responders at Week 12|Main Study (Parts I,II): Up to Week 38||0||
48070666|NCT02877134|100494252|FG004|Placebo Non Responders at Week 12|Main Study (Parts I,II): Up to Week 38||0||
48070667|NCT02877134|100494253|FG005|Placebo Non Responders at Week 12|Main Study (Parts I,II): Up to Week 38||0||
48070668|NCT02877134|100494254|FG006|Placebo Non Responders at Week 12|Main Study (Parts I,II): Up to Week 38||0||
48070669|NCT02877134|100494255|FG007|Placebo Non Responders at Week 12|Main Study (Parts I,II): Up to Week 38||0||
48070670|NCT02877134|100494256|FG008|Placebo Non Responders at Week 12|Main Study (Parts I,II): Up to Week 38||0||
48070671|NCT02877134|100494257|FG009|Placebo Non Responders at Week 12|Main Study (Parts I,II): Up to Week 38||0||
48070672|NCT02877134|100494258|FG010|Placebo Non Responders at Week 12|Main Study (Parts I,II): Up to Week 38||0||
48070673|NCT02877134|100494259|FG011|Placebo Non Responders at Week 12|Main Study (Parts I,II): Up to Week 38||0||
48070674|NCT02877134|100494248|FG000|COMPLETED|Main Study (Parts I,II): Up to Week 38||58||
48070675|NCT02877134|100494249|FG001|COMPLETED|Main Study (Parts I,II): Up to Week 38||48||
48070676|NCT02877134|100494250|FG002|COMPLETED|Main Study (Parts I,II): Up to Week 38||40||
48070677|NCT02877134|100494251|FG003|COMPLETED|Main Study (Parts I,II): Up to Week 38||35||
48070678|NCT02877134|100494252|FG004|COMPLETED|Main Study (Parts I,II): Up to Week 38||42||
48070679|NCT02877134|100494253|FG005|COMPLETED|Main Study (Parts I,II): Up to Week 38||39||
48070680|NCT02877134|100494254|FG006|COMPLETED|Main Study (Parts I,II): Up to Week 38||42||
48070681|NCT02877134|100494255|FG007|COMPLETED|Main Study (Parts I,II): Up to Week 38||0||
48070682|NCT02877134|100494256|FG008|COMPLETED|Main Study (Parts I,II): Up to Week 38||0||
48070683|NCT02877134|100494257|FG009|COMPLETED|Main Study (Parts I,II): Up to Week 38||0||
48070684|NCT02877134|100494258|FG010|COMPLETED|Main Study (Parts I,II): Up to Week 38||0||
48070685|NCT02877134|100494259|FG011|COMPLETED|Main Study (Parts I,II): Up to Week 38||0||
48070686|NCT02877134|100494248|FG000|NOT COMPLETED|Main Study (Parts I,II): Up to Week 38||14||
48070687|NCT02877134|100494249|FG001|NOT COMPLETED|Main Study (Parts I,II): Up to Week 38||25||
48070688|NCT02877134|100494250|FG002|NOT COMPLETED|Main Study (Parts I,II): Up to Week 38||8||
48070689|NCT02877134|100494251|FG003|NOT COMPLETED|Main Study (Parts I,II): Up to Week 38||15||
48070690|NCT02877134|100494252|FG004|NOT COMPLETED|Main Study (Parts I,II): Up to Week 38||7||
48070691|NCT02877134|100494253|FG005|NOT COMPLETED|Main Study (Parts I,II): Up to Week 38||10||
48070692|NCT02877134|100494254|FG006|NOT COMPLETED|Main Study (Parts I,II): Up to Week 38||5||
48070693|NCT02877134|100494255|FG007|NOT COMPLETED|Main Study (Parts I,II): Up to Week 38||0||
48070694|NCT02877134|100494256|FG008|NOT COMPLETED|Main Study (Parts I,II): Up to Week 38||0||
48070695|NCT02877134|100494257|FG009|NOT COMPLETED|Main Study (Parts I,II): Up to Week 38||0||
48070696|NCT02877134|100494258|FG010|NOT COMPLETED|Main Study (Parts I,II): Up to Week 38||0||
48070697|NCT02877134|100494259|FG011|NOT COMPLETED|Main Study (Parts I,II): Up to Week 38||0||
48070698|NCT02877134|100494248|FG000|STARTED|Part II LTE Phase: From Week 24-88||0||
48070699|NCT02877134|100494249|FG001|STARTED|Part II LTE Phase: From Week 24-88||0||
48070700|NCT02877134|100494250|FG002|STARTED|Part II LTE Phase: From Week 24-88||0||
48070701|NCT02877134|100494251|FG003|STARTED|Part II LTE Phase: From Week 24-88||0||
48070702|NCT02877134|100494252|FG004|STARTED|Part II LTE Phase: From Week 24-88||0||
48070703|NCT02877134|100494253|FG005|STARTED|Part II LTE Phase: From Week 24-88||0||
48070704|NCT02877134|100494254|FG006|STARTED|Part II LTE Phase: From Week 24-88||0||
48070705|NCT02877134|100494255|FG007|STARTED|Part II LTE Phase: From Week 24-88||22||
48070706|NCT02877134|100494256|FG008|STARTED|Part II LTE Phase: From Week 24-88||21||
48070707|NCT02877134|100494257|FG009|STARTED|Part II LTE Phase: From Week 24-88||27||
48070708|NCT02877134|100494258|FG010|STARTED|Part II LTE Phase: From Week 24-88||24||
48070709|NCT02877134|100494259|FG011|STARTED|Part II LTE Phase: From Week 24-88||28||
48070710|NCT02877134|100494248|FG000|COMPLETED|Part II LTE Phase: From Week 24-88||0||
48070711|NCT02877134|100494249|FG001|COMPLETED|Part II LTE Phase: From Week 24-88||0||
48070712|NCT02877134|100494250|FG002|COMPLETED|Part II LTE Phase: From Week 24-88||0||
48070713|NCT02877134|100494251|FG003|COMPLETED|Part II LTE Phase: From Week 24-88||0||
48070714|NCT02877134|100494252|FG004|COMPLETED|Part II LTE Phase: From Week 24-88||0||
48070715|NCT02877134|100494253|FG005|COMPLETED|Part II LTE Phase: From Week 24-88||0||
48070716|NCT02877134|100494254|FG006|COMPLETED|Part II LTE Phase: From Week 24-88||0||
48070717|NCT02877134|100494255|FG007|COMPLETED|Part II LTE Phase: From Week 24-88||20||
48070718|NCT02877134|100494256|FG008|COMPLETED|Part II LTE Phase: From Week 24-88||17||
48070719|NCT02877134|100494257|FG009|COMPLETED|Part II LTE Phase: From Week 24-88||20||
48070720|NCT02877134|100494258|FG010|COMPLETED|Part II LTE Phase: From Week 24-88||14||
48070721|NCT02877134|100494259|FG011|COMPLETED|Part II LTE Phase: From Week 24-88||24||
48070722|NCT02877134|100494248|FG000|NOT COMPLETED|Part II LTE Phase: From Week 24-88||0||
48070723|NCT02877134|100494249|FG001|NOT COMPLETED|Part II LTE Phase: From Week 24-88||0||
48070724|NCT02877134|100494250|FG002|NOT COMPLETED|Part II LTE Phase: From Week 24-88||0||
48070725|NCT02877134|100494251|FG003|NOT COMPLETED|Part II LTE Phase: From Week 24-88||0||
48070726|NCT02877134|100494252|FG004|NOT COMPLETED|Part II LTE Phase: From Week 24-88||0||
48070727|NCT02877134|100494253|FG005|NOT COMPLETED|Part II LTE Phase: From Week 24-88||0||
48070728|NCT02877134|100494254|FG006|NOT COMPLETED|Part II LTE Phase: From Week 24-88||0||
48070729|NCT02877134|100494255|FG007|NOT COMPLETED|Part II LTE Phase: From Week 24-88||2||
48070730|NCT02877134|100494256|FG008|NOT COMPLETED|Part II LTE Phase: From Week 24-88||4||
48070731|NCT02877134|100494257|FG009|NOT COMPLETED|Part II LTE Phase: From Week 24-88||7||
48070732|NCT02877134|100494258|FG010|NOT COMPLETED|Part II LTE Phase: From Week 24-88||10||
48070733|NCT02877134|100494259|FG011|NOT COMPLETED|Part II LTE Phase: From Week 24-88||4||
48070734|NCT03719586|100494260|FG000|STARTED|Overall Study||177||
48070735|NCT03719586|100494261|FG001|STARTED|Overall Study||176||
48070736|NCT03719586|100494262|FG002|STARTED|Overall Study||158||
48070737|NCT03719586|100494263|FG003|STARTED|Overall Study||169||
48070738|NCT03719586|100494260|FG000|COMPLETED|Overall Study||169||
48070739|NCT03719586|100494261|FG001|COMPLETED|Overall Study||169||
48070740|NCT03719586|100494262|FG002|COMPLETED|Overall Study||154||
48070741|NCT03719586|100494263|FG003|COMPLETED|Overall Study||169||
48070742|NCT03719586|100494260|FG000|NOT COMPLETED|Overall Study||8||
48070743|NCT03719586|100494261|FG001|NOT COMPLETED|Overall Study||7||
48070744|NCT03719586|100494262|FG002|NOT COMPLETED|Overall Study||4||
48070745|NCT03719586|100494263|FG003|NOT COMPLETED|Overall Study||0||
48070746|NCT03095885|100494264|FG000|STARTED|Overall Study||22||
48070747|NCT03095885|100494264|FG000|COMPLETED|Overall Study||22||
48070748|NCT03095885|100494264|FG000|NOT COMPLETED|Overall Study||0||
48070749|NCT00428792|100494265|FG000|STARTED|Overall Study||80||
48070750|NCT00428792|100494266|FG001|STARTED|Overall Study||70||
48070751|NCT00428792|100494265|FG000|COMPLETED|Overall Study||79||
48070752|NCT00428792|100494266|FG001|COMPLETED|Overall Study||66||
48070753|NCT00428792|100494265|FG000|NOT COMPLETED|Overall Study||1||
48070754|NCT00428792|100494266|FG001|NOT COMPLETED|Overall Study||4||
48070755|NCT00437983|100494267|FG000|STARTED|Overall Study||79||
48070756|NCT00437983|100494268|FG001|STARTED|Overall Study||78||
48070757|NCT00437983|100494267|FG000|COMPLETED|Overall Study||66||
48070758|NCT00437983|100494268|FG001|COMPLETED|Overall Study||65||
48070759|NCT00437983|100494267|FG000|NOT COMPLETED|Overall Study||13||
48070760|NCT00437983|100494268|FG001|NOT COMPLETED|Overall Study||13||
48070761|NCT03583697|100494269|FG000|STARTED|Overall Study||11||
48070762|NCT03583697|100494270|FG001|STARTED|Overall Study||32||
48070763|NCT03583697|100494271|FG002|STARTED|Overall Study||32||
48070764|NCT03583697|100494269|FG000|Cohort 1: Age >= 24 to < 60 Months|Overall Study||4||
48070765|NCT03583697|100494270|FG001|Cohort 1: Age >= 24 to < 60 Months|Overall Study||15||
48070766|NCT03583697|100494271|FG002|Cohort 1: Age >= 24 to < 60 Months|Overall Study||16||
48070767|NCT03583697|100494269|FG000|Cohort 2: Age >= 6 to < 24 Months|Overall Study||4||
48070768|NCT03583697|100494270|FG001|Cohort 2: Age >= 6 to < 24 Months|Overall Study||8||
48070769|NCT03583697|100494271|FG002|Cohort 2: Age >= 6 to < 24 Months|Overall Study||8||
48070770|NCT03583697|100494269|FG000|Cohort 3: Age 0 to < 6 Months|Overall Study||3||
48070771|NCT03583697|100494270|FG001|Cohort 3: Age 0 to < 6 Months|Overall Study||9||
48070772|NCT03583697|100494271|FG002|Cohort 3: Age 0 to < 6 Months|Overall Study||8||
48070773|NCT03583697|100494269|FG000|COMPLETED|Overall Study||11||
48070774|NCT03583697|100494270|FG001|COMPLETED|Overall Study||31||
48070775|NCT03583697|100494271|FG002|COMPLETED|Overall Study||31||
48070776|NCT03583697|100494269|FG000|NOT COMPLETED|Overall Study||0||
48070777|NCT03583697|100494270|FG001|NOT COMPLETED|Overall Study||1||
48070778|NCT03583697|100494271|FG002|NOT COMPLETED|Overall Study||1||
48070779|NCT00193258|100494272|FG000|STARTED|Overall Study||94||
48070780|NCT00193258|100494272|FG000|COMPLETED|Overall Study||94||
48070781|NCT00193258|100494272|FG000|NOT COMPLETED|Overall Study||0||
48070782|NCT01447433|100494273|FG000|STARTED|Overall Study||26||
48070783|NCT01447433|100494274|FG001|STARTED|Overall Study||27||
48070784|NCT01447433|100494273|FG000|COMPLETED|Overall Study||22||
48070785|NCT01447433|100494274|FG001|COMPLETED|Overall Study||21||
48070786|NCT01447433|100494273|FG000|NOT COMPLETED|Overall Study||4||
48070787|NCT01447433|100494274|FG001|NOT COMPLETED|Overall Study||6||
48070788|NCT02465515|100494275|FG000|STARTED|Overall Study||4732||
48070789|NCT02465515|100494276|FG001|STARTED|Overall Study||4731||
48070790|NCT02465515|100494275|FG000|COMPLETED|Overall Study||4578||
48070791|NCT02465515|100494276|FG001|COMPLETED|Overall Study||4620||
48070792|NCT02465515|100494275|FG000|NOT COMPLETED|Overall Study||154||
48070793|NCT02465515|100494276|FG001|NOT COMPLETED|Overall Study||111||
48070794|NCT00722423|100494277|FG000|STARTED|Overall Study||182||
48070795|NCT00722423|100494278|FG001|STARTED|Overall Study||182||
48070796|NCT00722423|100494277|FG000|COMPLETED|Overall Study||182||
48070797|NCT00722423|100494278|FG001|COMPLETED|Overall Study||181||
48070798|NCT00722423|100494277|FG000|NOT COMPLETED|Overall Study||0||
48070799|NCT00722423|100494278|FG001|NOT COMPLETED|Overall Study||1||
48070800|NCT00509041|100494279|FG000|STARTED|Overall Study||43||
48070801|NCT00509041|100494279|FG000|COMPLETED|Overall Study||43||
48070802|NCT00509041|100494279|FG000|NOT COMPLETED|Overall Study||0||
48070803|NCT00726375|100494280|FG000|STARTED|Overall Study||34||
48070804|NCT00726375|100494280|FG000|COMPLETED|Overall Study||34||
48070805|NCT00726375|100494280|FG000|NOT COMPLETED|Overall Study||0||
48070806|NCT01543958|100494281|FG000|STARTED|Overall Study||40||
48070807|NCT01543958|100494281|FG000|COMPLETED|Overall Study||36||
48070808|NCT01543958|100494281|FG000|NOT COMPLETED|Overall Study||4||
48070809|NCT03641339|100494282|FG000|STARTED|Overall Study||16||
48070810|NCT03641339|100494283|FG001|STARTED|Overall Study||17||
48070811|NCT03641339|100494284|FG002|STARTED|Overall Study||15||
48070812|NCT03641339|100494285|FG003|STARTED|Overall Study||16||
48070813|NCT03641339|100494286|FG004|STARTED|Overall Study||15||
48070814|NCT03641339|100494287|FG005|STARTED|Overall Study||16||
48070815|NCT03641339|100494282|FG000|COMPLETED|Overall Study||15||
48070816|NCT03641339|100494283|FG001|COMPLETED|Overall Study||15||
48070817|NCT03641339|100494284|FG002|COMPLETED|Overall Study||15||
48070818|NCT03641339|100494285|FG003|COMPLETED|Overall Study||14||
48070819|NCT03641339|100494286|FG004|COMPLETED|Overall Study||15||
48070820|NCT03641339|100494287|FG005|COMPLETED|Overall Study||15||
48070821|NCT03641339|100494282|FG000|NOT COMPLETED|Overall Study||1||
48070822|NCT03641339|100494283|FG001|NOT COMPLETED|Overall Study||2||
48070823|NCT03641339|100494284|FG002|NOT COMPLETED|Overall Study||0||
48070824|NCT03641339|100494285|FG003|NOT COMPLETED|Overall Study||2||
48070825|NCT03641339|100494286|FG004|NOT COMPLETED|Overall Study||0||
48070826|NCT03641339|100494287|FG005|NOT COMPLETED|Overall Study||1||
48070827|NCT00944671|100494288|FG000|STARTED|Period I||4||
48070828|NCT00944671|100494289|FG001|STARTED|Period I||4||
48070829|NCT00944671|100494290|FG002|STARTED|Period I||4||
48070830|NCT00944671|100494291|FG003|STARTED|Period I||4||
48070831|NCT00944671|100494292|FG004|STARTED|Period I||4||
48070832|NCT00944671|100494293|FG005|STARTED|Period I||4||
48070833|NCT00944671|100494288|FG000|COMPLETED|Period I||4||
48070834|NCT00944671|100494289|FG001|COMPLETED|Period I||4||
48070835|NCT00944671|100494290|FG002|COMPLETED|Period I||4||
48070836|NCT00944671|100494291|FG003|COMPLETED|Period I||4||
48070837|NCT00944671|100494292|FG004|COMPLETED|Period I||4||
48070838|NCT00944671|100494293|FG005|COMPLETED|Period I||4||
48070839|NCT00944671|100494288|FG000|NOT COMPLETED|Period I||0||
48070840|NCT00944671|100494289|FG001|NOT COMPLETED|Period I||0||
48070841|NCT00944671|100494290|FG002|NOT COMPLETED|Period I||0||
48070842|NCT00944671|100494291|FG003|NOT COMPLETED|Period I||0||
48070843|NCT00944671|100494292|FG004|NOT COMPLETED|Period I||0||
48070844|NCT00944671|100494293|FG005|NOT COMPLETED|Period I||0||
48070845|NCT00944671|100494288|FG000|STARTED|Period II||4||
48070846|NCT00944671|100494289|FG001|STARTED|Period II||4||
48070847|NCT00944671|100494290|FG002|STARTED|Period II||4||
48070848|NCT00944671|100494291|FG003|STARTED|Period II||4||
48070849|NCT00944671|100494292|FG004|STARTED|Period II||4||
48070850|NCT00944671|100494293|FG005|STARTED|Period II||4||
48070851|NCT00944671|100494288|FG000|COMPLETED|Period II||4||
48070852|NCT00944671|100494289|FG001|COMPLETED|Period II||4||
48070853|NCT00944671|100494290|FG002|COMPLETED|Period II||4||
48070854|NCT00944671|100494291|FG003|COMPLETED|Period II||4||
48070855|NCT00944671|100494292|FG004|COMPLETED|Period II||4||
48070856|NCT00944671|100494293|FG005|COMPLETED|Period II||4||
48070857|NCT00944671|100494288|FG000|NOT COMPLETED|Period II||0||
48070858|NCT00944671|100494289|FG001|NOT COMPLETED|Period II||0||
48070859|NCT00944671|100494290|FG002|NOT COMPLETED|Period II||0||
48070860|NCT00944671|100494291|FG003|NOT COMPLETED|Period II||0||
48070861|NCT00944671|100494292|FG004|NOT COMPLETED|Period II||0||
48070862|NCT00944671|100494293|FG005|NOT COMPLETED|Period II||0||
48070863|NCT00944671|100494288|FG000|STARTED|Period III||4||
48070864|NCT00944671|100494289|FG001|STARTED|Period III||4||
48070865|NCT00944671|100494290|FG002|STARTED|Period III||4||
48070866|NCT00944671|100494291|FG003|STARTED|Period III||4||
48070867|NCT00944671|100494292|FG004|STARTED|Period III||4||
48070868|NCT00944671|100494293|FG005|STARTED|Period III||4||
48070869|NCT00944671|100494288|FG000|COMPLETED|Period III||4||
48070870|NCT00944671|100494289|FG001|COMPLETED|Period III||4||
48070871|NCT00944671|100494290|FG002|COMPLETED|Period III||4||
48070872|NCT00944671|100494291|FG003|COMPLETED|Period III||4||
48070873|NCT00944671|100494292|FG004|COMPLETED|Period III||4||
48070874|NCT00944671|100494293|FG005|COMPLETED|Period III||4||
48070875|NCT00944671|100494288|FG000|NOT COMPLETED|Period III||0||
48070876|NCT00944671|100494289|FG001|NOT COMPLETED|Period III||0||
48070877|NCT00944671|100494290|FG002|NOT COMPLETED|Period III||0||
48070878|NCT00944671|100494291|FG003|NOT COMPLETED|Period III||0||
48070879|NCT00944671|100494292|FG004|NOT COMPLETED|Period III||0||
48070880|NCT00944671|100494293|FG005|NOT COMPLETED|Period III||0||
48070881|NCT01390649|100494294|FG000|STARTED|Overall Study||57||
48070882|NCT01390649|100494294|FG000|COMPLETED|Overall Study||56||
48070883|NCT01390649|100494294|FG000|NOT COMPLETED|Overall Study||1||
48070884|NCT03095612|100494295|FG000|STARTED|Dose Escalation:Selinexor 60mg+Docetaxel||3||
48070885|NCT03095612|100494296|FG001|STARTED|Dose Escalation:Selinexor 60mg+Docetaxel||0||
48070886|NCT03095612|100494297|FG002|STARTED|Dose Escalation:Selinexor 60mg+Docetaxel||0||
48070887|NCT03095612|100494298|FG003|STARTED|Dose Escalation:Selinexor 60mg+Docetaxel||0||
48070888|NCT03095612|100494299|FG004|STARTED|Dose Escalation:Selinexor 60mg+Docetaxel||0||
48070889|NCT03095612|100494300|FG005|STARTED|Dose Escalation:Selinexor 60mg+Docetaxel||0||
48070890|NCT03095612|100494301|FG006|STARTED|Dose Escalation:Selinexor 60mg+Docetaxel||0||
48070891|NCT03095612|100494295|FG000|COMPLETED|Dose Escalation:Selinexor 60mg+Docetaxel||3||
48070892|NCT03095612|100494296|FG001|COMPLETED|Dose Escalation:Selinexor 60mg+Docetaxel||0||
48070893|NCT03095612|100494297|FG002|COMPLETED|Dose Escalation:Selinexor 60mg+Docetaxel||0||
48070894|NCT03095612|100494298|FG003|COMPLETED|Dose Escalation:Selinexor 60mg+Docetaxel||0||
48070895|NCT03095612|100494299|FG004|COMPLETED|Dose Escalation:Selinexor 60mg+Docetaxel||0||
48070896|NCT03095612|100494300|FG005|COMPLETED|Dose Escalation:Selinexor 60mg+Docetaxel||0||
48070897|NCT03095612|100494301|FG006|COMPLETED|Dose Escalation:Selinexor 60mg+Docetaxel||0||
48070898|NCT03095612|100494295|FG000|NOT COMPLETED|Dose Escalation:Selinexor 60mg+Docetaxel||0||
48070899|NCT03095612|100494296|FG001|NOT COMPLETED|Dose Escalation:Selinexor 60mg+Docetaxel||0||
48070900|NCT03095612|100494297|FG002|NOT COMPLETED|Dose Escalation:Selinexor 60mg+Docetaxel||0||
48070901|NCT03095612|100494298|FG003|NOT COMPLETED|Dose Escalation:Selinexor 60mg+Docetaxel||0||
48070902|NCT03095612|100494299|FG004|NOT COMPLETED|Dose Escalation:Selinexor 60mg+Docetaxel||0||
48070903|NCT03095612|100494300|FG005|NOT COMPLETED|Dose Escalation:Selinexor 60mg+Docetaxel||0||
48070904|NCT03095612|100494301|FG006|NOT COMPLETED|Dose Escalation:Selinexor 60mg+Docetaxel||0||
48070905|NCT03095612|100494295|FG000|STARTED|Dose Escalation:Selinexor 80mg+Docetaxel||0||
48070906|NCT03095612|100494296|FG001|STARTED|Dose Escalation:Selinexor 80mg+Docetaxel||4||
48070907|NCT03095612|100494297|FG002|STARTED|Dose Escalation:Selinexor 80mg+Docetaxel||0||
48070908|NCT03095612|100494298|FG003|STARTED|Dose Escalation:Selinexor 80mg+Docetaxel||0||
48070909|NCT03095612|100494299|FG004|STARTED|Dose Escalation:Selinexor 80mg+Docetaxel||0||
48070910|NCT03095612|100494300|FG005|STARTED|Dose Escalation:Selinexor 80mg+Docetaxel||0||
48070911|NCT03095612|100494301|FG006|STARTED|Dose Escalation:Selinexor 80mg+Docetaxel||0||
48070912|NCT03095612|100494295|FG000|COMPLETED|Dose Escalation:Selinexor 80mg+Docetaxel||0||
48070913|NCT03095612|100494296|FG001|COMPLETED|Dose Escalation:Selinexor 80mg+Docetaxel||0||
48070914|NCT03095612|100494297|FG002|COMPLETED|Dose Escalation:Selinexor 80mg+Docetaxel||0||
48070915|NCT03095612|100494298|FG003|COMPLETED|Dose Escalation:Selinexor 80mg+Docetaxel||0||
48070916|NCT03095612|100494299|FG004|COMPLETED|Dose Escalation:Selinexor 80mg+Docetaxel||0||
48070917|NCT03095612|100494300|FG005|COMPLETED|Dose Escalation:Selinexor 80mg+Docetaxel||0||
48070918|NCT03095612|100494301|FG006|COMPLETED|Dose Escalation:Selinexor 80mg+Docetaxel||0||
48070919|NCT03095612|100494295|FG000|NOT COMPLETED|Dose Escalation:Selinexor 80mg+Docetaxel||0||
48070920|NCT03095612|100494296|FG001|NOT COMPLETED|Dose Escalation:Selinexor 80mg+Docetaxel||4||
48070921|NCT03095612|100494297|FG002|NOT COMPLETED|Dose Escalation:Selinexor 80mg+Docetaxel||0||
48070922|NCT03095612|100494298|FG003|NOT COMPLETED|Dose Escalation:Selinexor 80mg+Docetaxel||0||
48070923|NCT03095612|100494299|FG004|NOT COMPLETED|Dose Escalation:Selinexor 80mg+Docetaxel||0||
48070924|NCT03095612|100494300|FG005|NOT COMPLETED|Dose Escalation:Selinexor 80mg+Docetaxel||0||
48070925|NCT03095612|100494301|FG006|NOT COMPLETED|Dose Escalation:Selinexor 80mg+Docetaxel||0||
48070926|NCT03095612|100494295|FG000|STARTED|Dose Escalation:Selinexor100mg+Docetaxel||0||
48070927|NCT03095612|100494296|FG001|STARTED|Dose Escalation:Selinexor100mg+Docetaxel||0||
48070928|NCT03095612|100494297|FG002|STARTED|Dose Escalation:Selinexor100mg+Docetaxel||0||
48070929|NCT03095612|100494298|FG003|STARTED|Dose Escalation:Selinexor100mg+Docetaxel||0||
48070930|NCT03095612|100494299|FG004|STARTED|Dose Escalation:Selinexor100mg+Docetaxel||0||
48070931|NCT03095612|100494300|FG005|STARTED|Dose Escalation:Selinexor100mg+Docetaxel||0||
48070932|NCT03095612|100494301|FG006|STARTED|Dose Escalation:Selinexor100mg+Docetaxel||0||
48070933|NCT03095612|100494295|FG000|COMPLETED|Dose Escalation:Selinexor100mg+Docetaxel||0||
48070934|NCT03095612|100494296|FG001|COMPLETED|Dose Escalation:Selinexor100mg+Docetaxel||0||
48070935|NCT03095612|100494297|FG002|COMPLETED|Dose Escalation:Selinexor100mg+Docetaxel||0||
48070936|NCT03095612|100494298|FG003|COMPLETED|Dose Escalation:Selinexor100mg+Docetaxel||0||
48070937|NCT03095612|100494299|FG004|COMPLETED|Dose Escalation:Selinexor100mg+Docetaxel||0||
48070938|NCT03095612|100494300|FG005|COMPLETED|Dose Escalation:Selinexor100mg+Docetaxel||0||
48070939|NCT03095612|100494301|FG006|COMPLETED|Dose Escalation:Selinexor100mg+Docetaxel||0||
48070940|NCT03095612|100494295|FG000|NOT COMPLETED|Dose Escalation:Selinexor100mg+Docetaxel||0||
48070941|NCT03095612|100494296|FG001|NOT COMPLETED|Dose Escalation:Selinexor100mg+Docetaxel||0||
48070942|NCT03095612|100494297|FG002|NOT COMPLETED|Dose Escalation:Selinexor100mg+Docetaxel||0||
48070943|NCT03095612|100494298|FG003|NOT COMPLETED|Dose Escalation:Selinexor100mg+Docetaxel||0||
48070944|NCT03095612|100494299|FG004|NOT COMPLETED|Dose Escalation:Selinexor100mg+Docetaxel||0||
48070945|NCT03095612|100494300|FG005|NOT COMPLETED|Dose Escalation:Selinexor100mg+Docetaxel||0||
48070946|NCT03095612|100494301|FG006|NOT COMPLETED|Dose Escalation:Selinexor100mg+Docetaxel||0||
48070947|NCT03095612|100494295|FG000|STARTED|Dose Expansion:Selinexor 60 mg+Docetaxel||0||
48070948|NCT03095612|100494296|FG001|STARTED|Dose Expansion:Selinexor 60 mg+Docetaxel||0||
48070949|NCT03095612|100494297|FG002|STARTED|Dose Expansion:Selinexor 60 mg+Docetaxel||0||
48070950|NCT03095612|100494298|FG003|STARTED|Dose Expansion:Selinexor 60 mg+Docetaxel||33||
48070951|NCT03095612|100494299|FG004|STARTED|Dose Expansion:Selinexor 60 mg+Docetaxel||0||
48070952|NCT03095612|100494300|FG005|STARTED|Dose Expansion:Selinexor 60 mg+Docetaxel||0||
48070953|NCT03095612|100494301|FG006|STARTED|Dose Expansion:Selinexor 60 mg+Docetaxel||0||
48070954|NCT03095612|100494295|FG000|COMPLETED|Dose Expansion:Selinexor 60 mg+Docetaxel||0||
48070955|NCT03095612|100494296|FG001|COMPLETED|Dose Expansion:Selinexor 60 mg+Docetaxel||0||
48070956|NCT03095612|100494297|FG002|COMPLETED|Dose Expansion:Selinexor 60 mg+Docetaxel||0||
48070957|NCT03095612|100494298|FG003|COMPLETED|Dose Expansion:Selinexor 60 mg+Docetaxel||33||
48070958|NCT03095612|100494299|FG004|COMPLETED|Dose Expansion:Selinexor 60 mg+Docetaxel||0||
48070959|NCT03095612|100494300|FG005|COMPLETED|Dose Expansion:Selinexor 60 mg+Docetaxel||0||
48070960|NCT03095612|100494301|FG006|COMPLETED|Dose Expansion:Selinexor 60 mg+Docetaxel||0||
48070961|NCT03095612|100494295|FG000|NOT COMPLETED|Dose Expansion:Selinexor 60 mg+Docetaxel||0||
48070962|NCT03095612|100494296|FG001|NOT COMPLETED|Dose Expansion:Selinexor 60 mg+Docetaxel||0||
48070963|NCT03095612|100494297|FG002|NOT COMPLETED|Dose Expansion:Selinexor 60 mg+Docetaxel||0||
48070964|NCT03095612|100494298|FG003|NOT COMPLETED|Dose Expansion:Selinexor 60 mg+Docetaxel||0||
48070965|NCT03095612|100494299|FG004|NOT COMPLETED|Dose Expansion:Selinexor 60 mg+Docetaxel||0||
48070966|NCT03095612|100494300|FG005|NOT COMPLETED|Dose Expansion:Selinexor 60 mg+Docetaxel||0||
48070967|NCT03095612|100494301|FG006|NOT COMPLETED|Dose Expansion:Selinexor 60 mg+Docetaxel||0||
48070968|NCT03095612|100494295|FG000|STARTED|Selinexor 40 mg Monotherapy||0||
48070969|NCT03095612|100494296|FG001|STARTED|Selinexor 40 mg Monotherapy||0||
48070970|NCT03095612|100494297|FG002|STARTED|Selinexor 40 mg Monotherapy||0||
48070971|NCT03095612|100494298|FG003|STARTED|Selinexor 40 mg Monotherapy||0||
48070972|NCT03095612|100494299|FG004|STARTED|Selinexor 40 mg Monotherapy||0||
48070973|NCT03095612|100494300|FG005|STARTED|Selinexor 40 mg Monotherapy||0||
48070974|NCT03095612|100494301|FG006|STARTED|Selinexor 40 mg Monotherapy||0||
48070975|NCT03095612|100494295|FG000|COMPLETED|Selinexor 40 mg Monotherapy||0||
48070976|NCT03095612|100494296|FG001|COMPLETED|Selinexor 40 mg Monotherapy||0||
48070977|NCT03095612|100494297|FG002|COMPLETED|Selinexor 40 mg Monotherapy||0||
48070978|NCT03095612|100494298|FG003|COMPLETED|Selinexor 40 mg Monotherapy||0||
48070979|NCT03095612|100494299|FG004|COMPLETED|Selinexor 40 mg Monotherapy||0||
48070980|NCT03095612|100494300|FG005|COMPLETED|Selinexor 40 mg Monotherapy||0||
48070981|NCT03095612|100494301|FG006|COMPLETED|Selinexor 40 mg Monotherapy||0||
48070982|NCT03095612|100494295|FG000|NOT COMPLETED|Selinexor 40 mg Monotherapy||0||
48070983|NCT03095612|100494296|FG001|NOT COMPLETED|Selinexor 40 mg Monotherapy||0||
48070984|NCT03095612|100494297|FG002|NOT COMPLETED|Selinexor 40 mg Monotherapy||0||
48070985|NCT03095612|100494298|FG003|NOT COMPLETED|Selinexor 40 mg Monotherapy||0||
48070986|NCT03095612|100494299|FG004|NOT COMPLETED|Selinexor 40 mg Monotherapy||0||
48070987|NCT03095612|100494300|FG005|NOT COMPLETED|Selinexor 40 mg Monotherapy||0||
48070988|NCT03095612|100494301|FG006|NOT COMPLETED|Selinexor 40 mg Monotherapy||0||
48070989|NCT03095612|100494295|FG000|STARTED|Selinexor 60 mg Monotherapy||0||
48070990|NCT03095612|100494296|FG001|STARTED|Selinexor 60 mg Monotherapy||0||
48070991|NCT03095612|100494297|FG002|STARTED|Selinexor 60 mg Monotherapy||0||
48070992|NCT03095612|100494298|FG003|STARTED|Selinexor 60 mg Monotherapy||0||
48070993|NCT03095612|100494299|FG004|STARTED|Selinexor 60 mg Monotherapy||0||
48070994|NCT03095612|100494300|FG005|STARTED|Selinexor 60 mg Monotherapy||0||
48070995|NCT03095612|100494301|FG006|STARTED|Selinexor 60 mg Monotherapy||0||
48070996|NCT03095612|100494295|FG000|COMPLETED|Selinexor 60 mg Monotherapy||0||
48070997|NCT03095612|100494296|FG001|COMPLETED|Selinexor 60 mg Monotherapy||0||
48070998|NCT03095612|100494297|FG002|COMPLETED|Selinexor 60 mg Monotherapy||0||
48070999|NCT03095612|100494298|FG003|COMPLETED|Selinexor 60 mg Monotherapy||0||
48071000|NCT03095612|100494299|FG004|COMPLETED|Selinexor 60 mg Monotherapy||0||
48071001|NCT03095612|100494300|FG005|COMPLETED|Selinexor 60 mg Monotherapy||0||
48071002|NCT03095612|100494301|FG006|COMPLETED|Selinexor 60 mg Monotherapy||0||
48071003|NCT03095612|100494295|FG000|NOT COMPLETED|Selinexor 60 mg Monotherapy||0||
48071004|NCT03095612|100494296|FG001|NOT COMPLETED|Selinexor 60 mg Monotherapy||0||
48071005|NCT03095612|100494297|FG002|NOT COMPLETED|Selinexor 60 mg Monotherapy||0||
48071006|NCT03095612|100494298|FG003|NOT COMPLETED|Selinexor 60 mg Monotherapy||0||
48071007|NCT03095612|100494299|FG004|NOT COMPLETED|Selinexor 60 mg Monotherapy||0||
48071008|NCT03095612|100494300|FG005|NOT COMPLETED|Selinexor 60 mg Monotherapy||0||
48071009|NCT03095612|100494301|FG006|NOT COMPLETED|Selinexor 60 mg Monotherapy||0||
48071010|NCT03095612|100494295|FG000|STARTED|Selinexor 80 mg Monotherapy||0||
48071011|NCT03095612|100494296|FG001|STARTED|Selinexor 80 mg Monotherapy||0||
48071012|NCT03095612|100494297|FG002|STARTED|Selinexor 80 mg Monotherapy||0||
48071013|NCT03095612|100494298|FG003|STARTED|Selinexor 80 mg Monotherapy||0||
48071014|NCT03095612|100494299|FG004|STARTED|Selinexor 80 mg Monotherapy||0||
48071015|NCT03095612|100494300|FG005|STARTED|Selinexor 80 mg Monotherapy||0||
48071016|NCT03095612|100494301|FG006|STARTED|Selinexor 80 mg Monotherapy||0||
48071017|NCT03095612|100494295|FG000|COMPLETED|Selinexor 80 mg Monotherapy||0||
48071018|NCT03095612|100494296|FG001|COMPLETED|Selinexor 80 mg Monotherapy||0||
48071019|NCT03095612|100494297|FG002|COMPLETED|Selinexor 80 mg Monotherapy||0||
48071020|NCT03095612|100494298|FG003|COMPLETED|Selinexor 80 mg Monotherapy||0||
48071021|NCT03095612|100494299|FG004|COMPLETED|Selinexor 80 mg Monotherapy||0||
48071022|NCT03095612|100494300|FG005|COMPLETED|Selinexor 80 mg Monotherapy||0||
48071023|NCT03095612|100494301|FG006|COMPLETED|Selinexor 80 mg Monotherapy||0||
48071024|NCT03095612|100494295|FG000|NOT COMPLETED|Selinexor 80 mg Monotherapy||0||
48071025|NCT03095612|100494296|FG001|NOT COMPLETED|Selinexor 80 mg Monotherapy||0||
48071026|NCT03095612|100494297|FG002|NOT COMPLETED|Selinexor 80 mg Monotherapy||0||
48071027|NCT03095612|100494298|FG003|NOT COMPLETED|Selinexor 80 mg Monotherapy||0||
48071028|NCT03095612|100494299|FG004|NOT COMPLETED|Selinexor 80 mg Monotherapy||0||
48071029|NCT03095612|100494300|FG005|NOT COMPLETED|Selinexor 80 mg Monotherapy||0||
48071030|NCT03095612|100494301|FG006|NOT COMPLETED|Selinexor 80 mg Monotherapy||0||
48071031|NCT00001880|100494302|FG000|STARTED|Overall Study||42||
48071032|NCT00001880|100494302|FG000|COMPLETED|Overall Study||28||
48071033|NCT00001880|100494302|FG000|NOT COMPLETED|Overall Study||14||
48071034|NCT01686828|100494303|FG000|STARTED|Overall Study||13||
48071035|NCT01686828|100494304|FG001|STARTED|Overall Study||14||
48071036|NCT01686828|100494305|FG002|STARTED|Overall Study||13||
48071037|NCT01686828|100494306|FG003|STARTED|Overall Study||13||
48071038|NCT01686828|100494303|FG000|COMPLETED|Overall Study||12||
48071039|NCT01686828|100494304|FG001|COMPLETED|Overall Study||13||
48071040|NCT01686828|100494305|FG002|COMPLETED|Overall Study||12||
48071041|NCT01686828|100494306|FG003|COMPLETED|Overall Study||13||
48071042|NCT01686828|100494303|FG000|NOT COMPLETED|Overall Study||1||
48071043|NCT01686828|100494304|FG001|NOT COMPLETED|Overall Study||1||
48071044|NCT01686828|100494305|FG002|NOT COMPLETED|Overall Study||1||
48071045|NCT01686828|100494306|FG003|NOT COMPLETED|Overall Study||0||
48071046|NCT02774954|100494307|FG000|STARTED|Baseline||482||
48071047|NCT02774954|100494308|FG001|STARTED|Baseline||497||
48071048|NCT02774954|100494307|FG000|Completed Baseline Interview and Intervention|Baseline||482||
48071049|NCT02774954|100494308|FG001|Completed Baseline Interview and Intervention|Baseline||497||
48071050|NCT02774954|100494307|FG000|COMPLETED|Baseline||482||
48071051|NCT02774954|100494308|FG001|COMPLETED|Baseline||497||
48071052|NCT02774954|100494307|FG000|NOT COMPLETED|Baseline||0||
48071053|NCT02774954|100494308|FG001|NOT COMPLETED|Baseline||0||
48071054|NCT02774954|100494307|FG000|STARTED|6 Month Follow-up||482||
48071055|NCT02774954|100494308|FG001|STARTED|6 Month Follow-up||497||
48071056|NCT02774954|100494307|FG000|COMPLETED|6 Month Follow-up||286||
48071057|NCT02774954|100494308|FG001|COMPLETED|6 Month Follow-up||313||
48071058|NCT02774954|100494307|FG000|NOT COMPLETED|6 Month Follow-up||196||
48071059|NCT02774954|100494308|FG001|NOT COMPLETED|6 Month Follow-up||184||
48071060|NCT02774954|100494307|FG000|STARTED|12 Month Follow-up||286||
48071061|NCT02774954|100494308|FG001|STARTED|12 Month Follow-up||313||
48071062|NCT02774954|100494307|FG000|COMPLETED|12 Month Follow-up||253||
48071063|NCT02774954|100494308|FG001|COMPLETED|12 Month Follow-up||279||
48071064|NCT02774954|100494307|FG000|NOT COMPLETED|12 Month Follow-up||33||
48071065|NCT02774954|100494308|FG001|NOT COMPLETED|12 Month Follow-up||34||
48071066|NCT00354744|100494309|FG000|STARTED|Overall Study||109||
48071067|NCT00354744|100494309|FG000|COMPLETED|Overall Study||67||
48071068|NCT00354744|100494309|FG000|NOT COMPLETED|Overall Study||42||
48071069|NCT00398918|100494310|FG000|STARTED|Overall Study||10||
48071070|NCT00398918|100494310|FG000|COMPLETED|Overall Study||10||
48071071|NCT00398918|100494310|FG000|NOT COMPLETED|Overall Study||0||
48071072|NCT01237821|100494311|FG000|STARTED|Overall Study||32||
48071073|NCT01237821|100494312|FG001|STARTED|Overall Study||34||
48071074|NCT01237821|100494311|FG000|COMPLETED|Overall Study||26||
48071075|NCT01237821|100494312|FG001|COMPLETED|Overall Study||34||
48071076|NCT01237821|100494311|FG000|NOT COMPLETED|Overall Study||6||
48071077|NCT01237821|100494312|FG001|NOT COMPLETED|Overall Study||0||
48071078|NCT02369016|100494313|FG000|STARTED|Overall Study||17||
48071079|NCT02369016|100494314|FG001|STARTED|Overall Study||8||
48071080|NCT02369016|100494313|FG000|Switched to Copanlisib After Study Unblinding|Overall Study||0||
48071081|NCT02369016|100494314|FG001|Switched to Copanlisib After Study Unblinding|Overall Study||7||
48071082|NCT02369016|100494313|FG000|COMPLETED|Overall Study||0||
48071083|NCT02369016|100494314|FG001|COMPLETED|Overall Study||0||
48071084|NCT02369016|100494313|FG000|NOT COMPLETED|Overall Study||17||
48071085|NCT02369016|100494314|FG001|NOT COMPLETED|Overall Study||8||
48071086|NCT01313858|100494315|FG000|STARTED|Overall Study||524||
48071087|NCT01313858|100494316|FG001|STARTED|Overall Study||546||
48071088|NCT01313858|100494317|FG002|STARTED|Overall Study||543||
48071089|NCT01313858|100494315|FG000|COMPLETED|Overall Study||238||
48071090|NCT01313858|100494316|FG001|COMPLETED|Overall Study||276||
48071091|NCT01313858|100494317|FG002|COMPLETED|Overall Study||305||
48071092|NCT01313858|100494315|FG000|NOT COMPLETED|Overall Study||286||
48071093|NCT01313858|100494316|FG001|NOT COMPLETED|Overall Study||270||
48071094|NCT01313858|100494317|FG002|NOT COMPLETED|Overall Study||238||
48071095|NCT02002091|100494318|FG000|STARTED|Screening||122||
48071096|NCT02002091|100494319|FG001|STARTED|Screening||205||
48071097|NCT02002091|100494318|FG000|COMPLETED|Screening||109||
48071098|NCT02002091|100494319|FG001|COMPLETED|Screening||191||
48071099|NCT02002091|100494318|FG000|NOT COMPLETED|Screening||13||
48071100|NCT02002091|100494319|FG001|NOT COMPLETED|Screening||14||
48071101|NCT02002091|100494318|FG000|STARTED|One Year Follow up||109||
48071102|NCT02002091|100494319|FG001|STARTED|One Year Follow up||191||
48071103|NCT02002091|100494318|FG000|COMPLETED|One Year Follow up||109||
48071104|NCT02002091|100494319|FG001|COMPLETED|One Year Follow up||191||
48071105|NCT02002091|100494318|FG000|NOT COMPLETED|One Year Follow up||0||
48071106|NCT02002091|100494319|FG001|NOT COMPLETED|One Year Follow up||0||
48071107|NCT01705730|100494320|FG000|STARTED|Overall Study||68||
48071108|NCT01705730|100494320|FG000|COMPLETED|Overall Study||59||
48071109|NCT01705730|100494320|FG000|NOT COMPLETED|Overall Study||9||
48071110|NCT02657538|100494321|FG000|STARTED|Overall Study||35||
48071111|NCT02657538|100494321|FG000|Received Near Infrared Transillumination|Overall Study||35||
48071112|NCT02657538|100494321|FG000|Received Visual Caries Detection + Bite|Overall Study||35||
48071113|NCT02657538|100494321|FG000|COMPLETED|Overall Study||31||
48071114|NCT02657538|100494321|FG000|NOT COMPLETED|Overall Study||4||
48670007|NCT03601897|101974871|FG005|STARTED|Overall Study||5||
48670008|NCT03601897|101974872|FG006|STARTED|Overall Study||28||
48670009|NCT03601897|101974873|FG007|STARTED|Overall Study||10||
48670010|NCT03601897|101974874|FG008|STARTED|Overall Study||22||
48670011|NCT03601897|101974875|FG009|STARTED|Overall Study||16||
48670012|NCT03601897|101974876|FG010|STARTED|Overall Study||20||
48670013|NCT03601897|101974866|FG000|mITT Population|Overall Study||18|Modified Intent-to-Treat (mITT) Population includes all participants who had at least one dose of the combined study drugs, had measurable disease at baseline, and had at least one post-baseline assessment. Participants without a post-baseline assessment who discontinued study treatment due to clinical progression, death, or a rebastinib-related AE will also be included in the mITT population.|
48670014|NCT03601897|101974867|FG001|mITT Population|Overall Study||14|Modified Intent-to-Treat (mITT) Population includes all participants who had at least one dose of the combined study drugs, had measurable disease at baseline, and had at least one post-baseline assessment. Participants without a post-baseline assessment who discontinued study treatment due to clinical progression, death, or a rebastinib-related AE will also be included in the mITT population.|
48670015|NCT03601897|101974868|FG002|mITT Population|Overall Study||10|Modified Intent-to-Treat (mITT) Population includes all participants who had at least one dose of the combined study drugs, had measurable disease at baseline, and had at least one post-baseline assessment. Participants without a post-baseline assessment who discontinued study treatment due to clinical progression, death, or a rebastinib-related AE will also be included in the mITT population.|
48670016|NCT03601897|101974869|FG003|mITT Population|Overall Study||6|Modified Intent-to-Treat (mITT) Population includes all participants who had at least one dose of the combined study drugs, had measurable disease at baseline, and had at least one post-baseline assessment. Participants without a post-baseline assessment who discontinued study treatment due to clinical progression, death, or a rebastinib-related AE will also be included in the mITT population.|
48670017|NCT03601897|101974870|FG004|mITT Population|Overall Study||13|Modified Intent-to-Treat (mITT) Population includes all participants who had at least one dose of the combined study drugs, had measurable disease at baseline, and had at least one post-baseline assessment. Participants without a post-baseline assessment who discontinued study treatment due to clinical progression, death, or a rebastinib-related AE will also be included in the mITT population.|
48670018|NCT03601897|101974871|FG005|mITT Population|Overall Study||4|Modified Intent-to-Treat (mITT) Population includes all participants who had at least one dose of the combined study drugs, had measurable disease at baseline, and had at least one post-baseline assessment. Participants without a post-baseline assessment who discontinued study treatment due to clinical progression, death, or a rebastinib-related AE will also be included in the mITT population.|
48670142|NCT02115282|101974894|FG001|Treated|Overall Study||293||
48670431|NCT02460458|101974944|FG000|NOT COMPLETED|Confirmatory Phase||55||
48670214|NCT05844137|101974912|FG000|COMPLETED|Overall Study||10||
48670215|NCT05844137|101974912|FG000|NOT COMPLETED|Overall Study||0||
48670019|NCT03601897|101974872|FG006|mITT Population|Overall Study||26|Modified Intent-to-Treat (mITT) Population includes all participants who had at least one dose of the combined study drugs, had measurable disease at baseline, and had at least one post-baseline assessment. Participants without a post-baseline assessment who discontinued study treatment due to clinical progression, death, or a rebastinib-related AE will also be included in the mITT population.|
48670020|NCT03601897|101974873|FG007|mITT Population|Overall Study||9|Modified Intent-to-Treat (mITT) Population includes all participants who had at least one dose of the combined study drugs, had measurable disease at baseline, and had at least one post-baseline assessment. Participants without a post-baseline assessment who discontinued study treatment due to clinical progression, death, or a rebastinib-related AE will also be included in the mITT population.|
48670021|NCT03601897|101974874|FG008|mITT Population|Overall Study||20|Modified Intent-to-Treat (mITT) Population includes all participants who had at least one dose of the combined study drugs, had measurable disease at baseline, and had at least one post-baseline assessment. Participants without a post-baseline assessment who discontinued study treatment due to clinical progression, death, or a rebastinib-related AE will also be included in the mITT population.|
48670022|NCT03601897|101974875|FG009|mITT Population|Overall Study||14|Modified Intent-to-Treat (mITT) Population includes all participants who had at least one dose of the combined study drugs, had measurable disease at baseline, and had at least one post-baseline assessment. Participants without a post-baseline assessment who discontinued study treatment due to clinical progression, death, or a rebastinib-related AE will also be included in the mITT population.|
48670023|NCT03601897|101974876|FG010|mITT Population|Overall Study||19|Modified Intent-to-Treat (mITT) Population includes all participants who had at least one dose of the combined study drugs, had measurable disease at baseline, and had at least one post-baseline assessment. Participants without a post-baseline assessment who discontinued study treatment due to clinical progression, death, or a rebastinib-related AE will also be included in the mITT population.|
48670024|NCT03601897|101974866|FG000|COMPLETED|Overall Study||1||
48670025|NCT03601897|101974867|FG001|COMPLETED|Overall Study||6||
48670026|NCT03601897|101974868|FG002|COMPLETED|Overall Study||5||
48670027|NCT03601897|101974869|FG003|COMPLETED|Overall Study||4||
48670028|NCT03601897|101974870|FG004|COMPLETED|Overall Study||9||
48670029|NCT03601897|101974871|FG005|COMPLETED|Overall Study||2||
48670030|NCT03601897|101974872|FG006|COMPLETED|Overall Study||12||
48670031|NCT03601897|101974873|FG007|COMPLETED|Overall Study||5||
48670032|NCT03601897|101974874|FG008|COMPLETED|Overall Study||9||
48670033|NCT03601897|101974875|FG009|COMPLETED|Overall Study||5||
48670034|NCT03601897|101974876|FG010|COMPLETED|Overall Study||7||
48670035|NCT03601897|101974866|FG000|NOT COMPLETED|Overall Study||23||
48670036|NCT03601897|101974867|FG001|NOT COMPLETED|Overall Study||13||
48670069|NCT02626533|101974882|FG000|"Stratified to Non-stiff Group"|Overall Study||130|"After completing all study activities/follow up, patients were stratified to the Non-stiff group if they reported a certain score across all questionnaires."|
48670070|NCT02626533|101974882|FG000|COMPLETED|Overall Study||162||
48670071|NCT02626533|101974882|FG000|NOT COMPLETED|Overall Study||17||
48670072|NCT03680092|101974883|FG000|STARTED|Overall Study||28||
48670073|NCT03680092|101974884|FG001|STARTED|Overall Study||15||
48670074|NCT03680092|101974883|FG000|COMPLETED|Overall Study||25||
48670075|NCT03680092|101974884|FG001|COMPLETED|Overall Study||15||
48670076|NCT03680092|101974883|FG000|NOT COMPLETED|Overall Study||3||
48670077|NCT03680092|101974884|FG001|NOT COMPLETED|Overall Study||0||
48670078|NCT04117347|101974885|FG000|STARTED|Overall Study||15||
48670079|NCT04117347|101974886|FG001|STARTED|Overall Study||15||
48670080|NCT04117347|101974887|FG002|STARTED|Overall Study||16||
48670081|NCT04117347|101974885|FG000|COMPLETED|Overall Study||14||
48670082|NCT04117347|101974886|FG001|COMPLETED|Overall Study||13||
48670083|NCT04117347|101974887|FG002|COMPLETED|Overall Study||15||
48670084|NCT04117347|101974885|FG000|NOT COMPLETED|Overall Study||1||
48670085|NCT04117347|101974886|FG001|NOT COMPLETED|Overall Study||2||
48670086|NCT04117347|101974887|FG002|NOT COMPLETED|Overall Study||1||
48670087|NCT00843882|101974888|FG000|STARTED|Step 1||38||
48670088|NCT00843882|101974889|FG001|STARTED|Step 1||103||
48670089|NCT00843882|101974890|FG002|STARTED|Step 1||106||
48670090|NCT00843882|101974888|FG000|Treated Patients|Step 1||36||
48670091|NCT00843882|101974889|FG001|Treated Patients|Step 1||103||
48670092|NCT00843882|101974890|FG002|Treated Patients|Step 1||106||
48670093|NCT00843882|101974888|FG000|Evaluable Patients Included in Primary Analysis|Step 1||0||
48670094|NCT00843882|101974889|FG001|Evaluable Patients Included in Primary Analysis|Step 1||96||
48670095|NCT00843882|101974890|FG002|Evaluable Patients Included in Primary Analysis|Step 1||99||
48670096|NCT00843882|101974888|FG000|Patients With Cytogenetic Response Data Available|Step 1||0||
48670097|NCT00843882|101974889|FG001|Patients With Cytogenetic Response Data Available|Step 1||55||
48670098|NCT00843882|101974890|FG002|Patients With Cytogenetic Response Data Available|Step 1||51||
48670099|NCT00843882|101974888|FG000|COMPLETED|Step 1||6||
48670100|NCT00843882|101974889|FG001|COMPLETED|Step 1||48||
48670101|NCT00843882|101974890|FG002|COMPLETED|Step 1||41||
48670102|NCT00843882|101974888|FG000|NOT COMPLETED|Step 1||32||
48670103|NCT00843882|101974889|FG001|NOT COMPLETED|Step 1||55||
48670104|NCT00843882|101974890|FG002|NOT COMPLETED|Step 1||65||
48670105|NCT00843882|101974888|FG000|STARTED|Step 2 (Cross-over to Arm B)||7||
48670106|NCT00843882|101974889|FG001|STARTED|Step 2 (Cross-over to Arm B)||46||
48670107|NCT00843882|101974890|FG002|STARTED|Step 2 (Cross-over to Arm B)||0||
48670108|NCT00843882|101974888|FG000|Evaluable Patients Included in Primary Analysis|Step 2 (Cross-over to Arm B)||7||
48670109|NCT00843882|101974889|FG001|Evaluable Patients Included in Primary Analysis|Step 2 (Cross-over to Arm B)||37||
48670110|NCT00843882|101974890|FG002|Evaluable Patients Included in Primary Analysis|Step 2 (Cross-over to Arm B)||0||
48670111|NCT00843882|101974888|FG000|COMPLETED|Step 2 (Cross-over to Arm B)||3||
48670112|NCT00843882|101974889|FG001|COMPLETED|Step 2 (Cross-over to Arm B)||20||
48670113|NCT00843882|101974890|FG002|COMPLETED|Step 2 (Cross-over to Arm B)||0||
48670114|NCT00843882|101974888|FG000|NOT COMPLETED|Step 2 (Cross-over to Arm B)||4||
48670115|NCT00843882|101974889|FG001|NOT COMPLETED|Step 2 (Cross-over to Arm B)||26||
48670116|NCT00843882|101974890|FG002|NOT COMPLETED|Step 2 (Cross-over to Arm B)||0||
48670117|NCT00644228|101974891|FG000|STARTED|Randomization & Eligibility||261||
48670118|NCT00644228|101974892|FG001|STARTED|Randomization & Eligibility||264||
48670119|NCT00644228|101974891|FG000|Eligible and Analyzable|Randomization & Eligibility||229|"All patients who were consented and did not withdraw consent prior to treatment are Analyzable."|
48670120|NCT00644228|101974892|FG001|Eligible and Analyzable|Randomization & Eligibility||242|"All patients who were consented and did not withdraw consent prior to treatment are Analyzable."|
48670121|NCT00644228|101974891|FG000|COMPLETED|Randomization & Eligibility||229|"Completed does not apply to this study period."|
48670122|NCT00644228|101974892|FG001|COMPLETED|Randomization & Eligibility||242|"Completed does not apply to this study period."|
48670123|NCT00644228|101974891|FG000|NOT COMPLETED|Randomization & Eligibility||32||
48670124|NCT00644228|101974892|FG001|NOT COMPLETED|Randomization & Eligibility||22||
48670125|NCT00644228|101974891|FG000|STARTED|Induction Therapy||229||
48670126|NCT00644228|101974892|FG001|STARTED|Induction Therapy||242||
48670127|NCT00644228|101974891|FG000|COMPLETED|Induction Therapy||146||
48670128|NCT00644228|101974892|FG001|COMPLETED|Induction Therapy||137||
48670129|NCT00644228|101974891|FG000|NOT COMPLETED|Induction Therapy||83||
48670130|NCT00644228|101974892|FG001|NOT COMPLETED|Induction Therapy||105||
48670131|NCT00644228|101974891|FG000|STARTED|Maintenance||143||
48670132|NCT00644228|101974892|FG001|STARTED|Maintenance||135||
48670133|NCT00644228|101974891|FG000|COMPLETED|Maintenance||0|"Patients were treated until progression or removal/refusal. Completed does not apply."|
48670134|NCT00644228|101974892|FG001|COMPLETED|Maintenance||0|"Patients were treated until progression or removal/refusal. Completed does not apply."|
48670135|NCT00644228|101974891|FG000|NOT COMPLETED|Maintenance||143||
48670136|NCT00644228|101974892|FG001|NOT COMPLETED|Maintenance||135||
48670137|NCT02115282|101974893|FG000|STARTED|Overall Study||305||
48670138|NCT02115282|101974894|FG001|STARTED|Overall Study||303||
48670139|NCT02115282|101974893|FG000|Eligible|Overall Study||265||
48670140|NCT02115282|101974894|FG001|Eligible|Overall Study||257||
48670141|NCT02115282|101974893|FG000|Treated|Overall Study||296||
48670143|NCT02115282|101974893|FG000|COMPLETED|Overall Study||0|"There was no prespecified maximum cycles in the study. Patients were treated until disease progression or intolerability.~At the time the primary results were reported, 6 patients were still receiving treatment and they stopped treatment afterwards."|
48670144|NCT02115282|101974894|FG001|COMPLETED|Overall Study||0|"There was no prespecified maximum cycles in the study. Patients were treated until disease progression or intolerability.~At the time the primary results were reported, 6 patients were still receiving treatment and they stopped treatment afterwards."|
48670145|NCT02115282|101974893|FG000|NOT COMPLETED|Overall Study||305||
48670146|NCT02115282|101974894|FG001|NOT COMPLETED|Overall Study||303||
48670147|NCT04971109|101974895|FG000|STARTED|Overall Study||372||
48670148|NCT04971109|101974896|FG001|STARTED|Overall Study||95||
48670149|NCT04971109|101974895|FG000|COMPLETED|Overall Study||329||
48670150|NCT04971109|101974896|FG001|COMPLETED|Overall Study||86||
48670151|NCT04971109|101974895|FG000|NOT COMPLETED|Overall Study||43||
48670152|NCT04971109|101974896|FG001|NOT COMPLETED|Overall Study||9||
48670153|NCT05268276|101974897|FG000|STARTED|Overall Study||50||
48670154|NCT05268276|101974898|FG001|STARTED|Overall Study||50||
48670155|NCT05268276|101974897|FG000|COMPLETED|Overall Study||47||
48670156|NCT05268276|101974898|FG001|COMPLETED|Overall Study||45||
48670157|NCT05268276|101974897|FG000|NOT COMPLETED|Overall Study||3||
48670158|NCT05268276|101974898|FG001|NOT COMPLETED|Overall Study||5||
48670159|NCT02286089|101974899|FG000|STARTED|Overall Study||3||
48670160|NCT02286089|101974900|FG001|STARTED|Overall Study||3||
48670161|NCT02286089|101974901|FG002|STARTED|Overall Study||6||
48670162|NCT02286089|101974902|FG003|STARTED|Overall Study||12||
48670163|NCT02286089|101974899|FG000|COMPLETED|Overall Study||2||
48670164|NCT02286089|101974900|FG001|COMPLETED|Overall Study||2||
48670165|NCT02286089|101974901|FG002|COMPLETED|Overall Study||0||
48670166|NCT02286089|101974902|FG003|COMPLETED|Overall Study||0||
48670167|NCT02286089|101974899|FG000|NOT COMPLETED|Overall Study||1||
48670168|NCT02286089|101974900|FG001|NOT COMPLETED|Overall Study||1||
48670169|NCT02286089|101974901|FG002|NOT COMPLETED|Overall Study||6||
48670170|NCT02286089|101974902|FG003|NOT COMPLETED|Overall Study||12||
48670171|NCT02473445|101974903|FG000|STARTED|Overall Study||22||
48670172|NCT02473445|101974903|FG000|COMPLETED|Overall Study||0||
48670173|NCT02473445|101974903|FG000|NOT COMPLETED|Overall Study||22||
48670174|NCT03717753|101974904|FG000|STARTED|Overall Study||70||
48670175|NCT03717753|101974905|FG001|STARTED|Overall Study||70||
48670176|NCT03717753|101974904|FG000|COMPLETED|Overall Study||70||
48670177|NCT03717753|101974905|FG001|COMPLETED|Overall Study||70||
48670178|NCT03717753|101974904|FG000|NOT COMPLETED|Overall Study||0||
48670179|NCT03717753|101974905|FG001|NOT COMPLETED|Overall Study||0||
48670180|NCT03988621|101974906|FG000|STARTED|Overall Study||167|Caregivers|
48670181|NCT03988621|101974907|FG001|STARTED|Overall Study||176|Caregivers|
48670182|NCT03988621|101974906|FG000|Started (Caregivers)|Overall Study||125||
48670183|NCT03988621|101974907|FG001|Started (Caregivers)|Overall Study||125||
48670184|NCT03988621|101974906|FG000|3-Month Survey(Caregivers)|Overall Study||93||
48670185|NCT03988621|101974907|FG001|3-Month Survey(Caregivers)|Overall Study||103||
48670186|NCT03988621|101974906|FG000|6-Month Survey(Caregivers)|Overall Study||93|Primary study endpoint at 6 months.|
48670187|NCT03988621|101974907|FG001|6-Month Survey(Caregivers)|Overall Study||101|Primary study endpoint at 6 months.|
48670188|NCT03988621|101974906|FG000|9-Month Survey(Caregivers)|Overall Study||103|Some participants who did not complete data at 6 months were available again at 9- and 12-months. But, the primary analysis was done with 6-month data.|
48670189|NCT03988621|101974907|FG001|9-Month Survey(Caregivers)|Overall Study||104|Some participants who did not complete data at 6 months were available again at 9- and 12-months. But, the primary analysis was done with 6-month data.|
48670190|NCT03988621|101974906|FG000|12-Month Survey(Caregivers)|Overall Study||95||
48670191|NCT03988621|101974907|FG001|12-Month Survey(Caregivers)|Overall Study||101||
48670192|NCT03988621|101974906|FG000|Started (Patients)|Overall Study||42||
48670193|NCT03988621|101974907|FG001|Started (Patients)|Overall Study||51||
48670194|NCT03988621|101974906|FG000|12 Month Survey/Completed(Patients)|Overall Study||26|Patient primary study endpoint at 12 months.|
48670195|NCT03988621|101974907|FG001|12 Month Survey/Completed(Patients)|Overall Study||31|Patient primary study endpoint at 12 months.|
48670196|NCT03988621|101974906|FG000|COMPLETED|Overall Study||121|Caregivers and Patients: 12 Month Timepoint Complete|
48670197|NCT03988621|101974907|FG001|COMPLETED|Overall Study||132|Caregivers and Patients: 12 Month Timepoint Complete|
48670198|NCT03988621|101974906|FG000|NOT COMPLETED|Overall Study||46||
48670199|NCT03988621|101974907|FG001|NOT COMPLETED|Overall Study||44||
48670200|NCT03484819|101974908|FG000|STARTED|Overall Study||12||
48670201|NCT03484819|101974908|FG000|COMPLETED|Overall Study||0||
48670202|NCT03484819|101974908|FG000|NOT COMPLETED|Overall Study||12||
48670203|NCT04526665|101974909|FG000|STARTED|Overall Study||108||
48670204|NCT04526665|101974910|FG001|STARTED|Overall Study||53||
48670205|NCT04526665|101974909|FG000|COMPLETED|Overall Study||94|Completed DB period|
48670206|NCT04526665|101974910|FG001|COMPLETED|Overall Study||46|Completed DB period|
48670207|NCT04526665|101974909|FG000|NOT COMPLETED|Overall Study||14||
48670208|NCT04526665|101974910|FG001|NOT COMPLETED|Overall Study||7||
48670209|NCT05347485|101974911|FG000|STARTED|Overall Study||86||
48670210|NCT05347485|101974911|FG000|Treated|Overall Study||82||
48670211|NCT05347485|101974911|FG000|COMPLETED|Overall Study||0||
48670212|NCT05347485|101974911|FG000|NOT COMPLETED|Overall Study||86||
48670213|NCT05844137|101974912|FG000|STARTED|Overall Study||10||
48670266|NCT01928394|101974922|FG001|Transition|Treatment Period||0|Participants who will transition after completing MT due to disease progression (DP)|
48670267|NCT01928394|101974923|FG002|Transition|Treatment Period||0|Participants who will transition after completing MT due to disease progression (DP)|
48670268|NCT01928394|101974924|FG003|Transition|Treatment Period||9|Participants who will transition after completing MT due to disease progression (DP)|
48670269|NCT01928394|101974925|FG004|Transition|Treatment Period||0|Participants who will transition after completing MT due to disease progression (DP)|
48670270|NCT01928394|101974926|FG005|Transition|Treatment Period||0|Participants who will transition after completing MT due to disease progression (DP)|
48670271|NCT01928394|101974927|FG006|Transition|Treatment Period||0|Participants who will transition after completing MT due to disease progression (DP)|
48670272|NCT01928394|101974928|FG007|Transition|Treatment Period||2|Participants who will transition after completing MT due to disease progression (DP)|
48670273|NCT01928394|101974929|FG008|Transition|Treatment Period||0|Participants who will transition after completing MT due to disease progression (DP)|
48670274|NCT01928394|101974930|FG009|Transition|Treatment Period||0|Participants who will transition after completing MT due to disease progression (DP)|
48670275|NCT01928394|101974931|FG010|Transition|Treatment Period||0|Participants who will transition after completing MT due to disease progression (DP)|
48670276|NCT01928394|101974932|FG011|Transition|Treatment Period||17|Participants who will transition after completing MT due to disease progression (DP)|
48670277|NCT01928394|101974933|FG012|Transition|Treatment Period||0|Participants who will transition after completing MT due to disease progression (DP)|
48670278|NCT01928394|101974934|FG013|Transition|Treatment Period||2|Participants who will transition after completing MT due to disease progression (DP)|
48670279|NCT01928394|101974935|FG014|Transition|Treatment Period||0|Participants who will transition after completing MT due to disease progression (DP)|
48670280|NCT01928394|101974936|FG015|Transition|Treatment Period||0|Participants who will transition after completing MT due to disease progression (DP)|
48670281|NCT01928394|101974937|FG016|Transition|Treatment Period||0|Participants who will transition after completing MT due to disease progression (DP)|
48670282|NCT01928394|101974938|FG017|Transition|Treatment Period||20|Participants who will transition after completing MT due to disease progression (DP)|
48670283|NCT01928394|101974939|FG018|Transition|Treatment Period||0|Participants who will transition after completing MT due to disease progression (DP)|
48670284|NCT01928394|101974940|FG019|Transition|Treatment Period||0|Participants who will transition after completing MT due to disease progression (DP)|
48670285|NCT01928394|101974941|FG020|Transition|Treatment Period||0|Participants who will transition after completing MT due to disease progression (DP)|
48670286|NCT01928394|101974942|FG021|Transition|Treatment Period||0|Participants who will transition after completing MT due to disease progression (DP)|
48670287|NCT01928394|101974943|FG022|Transition|Treatment Period||0|Participants who will transition after completing MT due to disease progression (DP)|
48670288|NCT01928394|101974921|FG000|Transition- Continued|Treatment Period||0|Participants who were transitioned to another treatment after disease progression (DP).|
48670289|NCT01928394|101974922|FG001|Transition- Continued|Treatment Period||0|Participants who were transitioned to another treatment after disease progression (DP).|
48670290|NCT01928394|101974923|FG002|Transition- Continued|Treatment Period||3|Participants who were transitioned to another treatment after disease progression (DP).|
48670291|NCT01928394|101974924|FG003|Transition- Continued|Treatment Period||0|Participants who were transitioned to another treatment after disease progression (DP).|
48670292|NCT01928394|101974925|FG004|Transition- Continued|Treatment Period||0|Participants who were transitioned to another treatment after disease progression (DP).|
48670293|NCT01928394|101974926|FG005|Transition- Continued|Treatment Period||3|Participants who were transitioned to another treatment after disease progression (DP).|
48670294|NCT01928394|101974927|FG006|Transition- Continued|Treatment Period||6|Participants who were transitioned to another treatment after disease progression (DP).|
48670295|NCT01928394|101974928|FG007|Transition- Continued|Treatment Period||0|Participants who were transitioned to another treatment after disease progression (DP).|
48670296|NCT01928394|101974929|FG008|Transition- Continued|Treatment Period||1|Participants who were transitioned to another treatment after disease progression (DP).|
48670297|NCT01928394|101974930|FG009|Transition- Continued|Treatment Period||1|Participants who were transitioned to another treatment after disease progression (DP).|
48670298|NCT01928394|101974931|FG010|Transition- Continued|Treatment Period||0|Participants who were transitioned to another treatment after disease progression (DP).|
48670299|NCT01928394|101974932|FG011|Transition- Continued|Treatment Period||0|Participants who were transitioned to another treatment after disease progression (DP).|
48670300|NCT01928394|101974933|FG012|Transition- Continued|Treatment Period||17|Participants who were transitioned to another treatment after disease progression (DP).|
48670301|NCT01928394|101974934|FG013|Transition- Continued|Treatment Period||0|Participants who were transitioned to another treatment after disease progression (DP).|
48670302|NCT01928394|101974935|FG014|Transition- Continued|Treatment Period||2|Participants who were transitioned to another treatment after disease progression (DP).|
48670303|NCT01928394|101974936|FG015|Transition- Continued|Treatment Period||0|Participants who were transitioned to another treatment after disease progression (DP).|
48670304|NCT01928394|101974937|FG016|Transition- Continued|Treatment Period||0|Participants who were transitioned to another treatment after disease progression (DP).|
48670305|NCT01928394|101974938|FG017|Transition- Continued|Treatment Period||0|Participants who were transitioned to another treatment after disease progression (DP).|
48670306|NCT01928394|101974939|FG018|Transition- Continued|Treatment Period||1|Participants who were transitioned to another treatment after disease progression (DP).|
48670307|NCT01928394|101974940|FG019|Transition- Continued|Treatment Period||19|Participants who were transitioned to another treatment after disease progression (DP).|
48670432|NCT02460458|101974944|FG000|STARTED|First Prospective Phase||210||
48670308|NCT01928394|101974941|FG020|Transition- Continued|Treatment Period||0|Participants who were transitioned to another treatment after disease progression (DP).|
48670309|NCT01928394|101974942|FG021|Transition- Continued|Treatment Period||0|Participants who were transitioned to another treatment after disease progression (DP).|
48670310|NCT01928394|101974943|FG022|Transition- Continued|Treatment Period||0|Participants who were transitioned to another treatment after disease progression (DP).|
48670311|NCT01928394|101974921|FG000|COMPLETED|Treatment Period||0|Completed = continuing treatment period|
48670312|NCT01928394|101974922|FG001|COMPLETED|Treatment Period||0|Completed = continuing treatment period|
48670313|NCT01928394|101974923|FG002|COMPLETED|Treatment Period||0|Completed = continuing treatment period|
48670314|NCT01928394|101974924|FG003|COMPLETED|Treatment Period||3|Completed = continuing treatment period|
48670315|NCT01928394|101974925|FG004|COMPLETED|Treatment Period||0|Completed = continuing treatment period|
48670316|NCT01928394|101974926|FG005|COMPLETED|Treatment Period||6|Completed = continuing treatment period|
48670317|NCT01928394|101974927|FG006|COMPLETED|Treatment Period||3|Completed = continuing treatment period|
48670318|NCT01928394|101974928|FG007|COMPLETED|Treatment Period||0|Completed = continuing treatment period|
48670319|NCT01928394|101974929|FG008|COMPLETED|Treatment Period||0|Completed = continuing treatment period|
48670320|NCT01928394|101974930|FG009|COMPLETED|Treatment Period||0|Completed = continuing treatment period|
48670321|NCT01928394|101974931|FG010|COMPLETED|Treatment Period||0|Completed = continuing treatment period|
48670322|NCT01928394|101974932|FG011|COMPLETED|Treatment Period||5|Completed = continuing treatment period|
48670323|NCT01928394|101974933|FG012|COMPLETED|Treatment Period||6|Completed = continuing treatment period|
48670324|NCT01928394|101974934|FG013|COMPLETED|Treatment Period||8|Completed = continuing treatment period|
48670325|NCT01928394|101974935|FG014|COMPLETED|Treatment Period||8|Completed = continuing treatment period|
48670326|NCT01928394|101974936|FG015|COMPLETED|Treatment Period||1|Completed = continuing treatment period|
48670327|NCT01928394|101974937|FG016|COMPLETED|Treatment Period||5|Completed = continuing treatment period|
48670328|NCT01928394|101974938|FG017|COMPLETED|Treatment Period||7|Completed = continuing treatment period|
48670329|NCT01928394|101974939|FG018|COMPLETED|Treatment Period||22|Completed = continuing treatment period|
48670330|NCT01928394|101974940|FG019|COMPLETED|Treatment Period||8|Completed = continuing treatment period|
48670331|NCT01928394|101974941|FG020|COMPLETED|Treatment Period||1|Completed = continuing treatment period|
48670332|NCT01928394|101974942|FG021|COMPLETED|Treatment Period||1|Completed = continuing treatment period|
48670333|NCT01928394|101974943|FG022|COMPLETED|Treatment Period||3|Completed = continuing treatment period|
48670334|NCT01928394|101974921|FG000|NOT COMPLETED|Treatment Period||18||
48670335|NCT01928394|101974922|FG001|NOT COMPLETED|Treatment Period||3||
48670336|NCT01928394|101974923|FG002|NOT COMPLETED|Treatment Period||18||
48670337|NCT01928394|101974924|FG003|NOT COMPLETED|Treatment Period||56||
48670338|NCT01928394|101974925|FG004|NOT COMPLETED|Treatment Period||3||
48670339|NCT01928394|101974926|FG005|NOT COMPLETED|Treatment Period||43||
48670340|NCT01928394|101974927|FG006|NOT COMPLETED|Treatment Period||49||
48670341|NCT01928394|101974928|FG007|NOT COMPLETED|Treatment Period||18||
48670342|NCT01928394|101974929|FG008|NOT COMPLETED|Treatment Period||3||
48670343|NCT01928394|101974930|FG009|NOT COMPLETED|Treatment Period||18||
48670344|NCT01928394|101974931|FG010|NOT COMPLETED|Treatment Period||30||
48670345|NCT01928394|101974932|FG011|NOT COMPLETED|Treatment Period||93||
48670346|NCT01928394|101974933|FG012|NOT COMPLETED|Treatment Period||55||
48670347|NCT01928394|101974934|FG013|NOT COMPLETED|Treatment Period||139||
48670348|NCT01928394|101974935|FG014|NOT COMPLETED|Treatment Period||88||
48670349|NCT01928394|101974936|FG015|NOT COMPLETED|Treatment Period||2||
48670350|NCT01928394|101974937|FG016|NOT COMPLETED|Treatment Period||50||
48670351|NCT01928394|101974938|FG017|NOT COMPLETED|Treatment Period||71||
48670352|NCT01928394|101974939|FG018|NOT COMPLETED|Treatment Period||70||
48670353|NCT01928394|101974940|FG019|NOT COMPLETED|Treatment Period||96||
48670354|NCT01928394|101974941|FG020|NOT COMPLETED|Treatment Period||40||
48670355|NCT01928394|101974942|FG021|NOT COMPLETED|Treatment Period||42||
48670356|NCT01928394|101974943|FG022|NOT COMPLETED|Treatment Period||39||
48670357|NCT01928394|101974921|FG000|STARTED|Follow-up Period||15|started = number of Participants regardless of continuing treatment or not.|
48670358|NCT01928394|101974922|FG001|STARTED|Follow-up Period||3|started = number of Participants regardless of continuing treatment or not.|
48670359|NCT01928394|101974923|FG002|STARTED|Follow-up Period||18|started = number of Participants regardless of continuing treatment or not.|
48670360|NCT01928394|101974924|FG003|STARTED|Follow-up Period||50|started = number of Participants regardless of continuing treatment or not.|
48670361|NCT01928394|101974925|FG004|STARTED|Follow-up Period||3|started = number of Participants regardless of continuing treatment or not.|
48670362|NCT01928394|101974926|FG005|STARTED|Follow-up Period||49|started = number of Participants regardless of continuing treatment or not.|
48670363|NCT01928394|101974927|FG006|STARTED|Follow-up Period||52|started = number of Participants regardless of continuing treatment or not.|
48670364|NCT01928394|101974928|FG007|STARTED|Follow-up Period||16|started = number of Participants regardless of continuing treatment or not.|
48670365|NCT01928394|101974929|FG008|STARTED|Follow-up Period||3|started = number of Participants regardless of continuing treatment or not.|
48670366|NCT01928394|101974930|FG009|STARTED|Follow-up Period||18|started = number of Participants regardless of continuing treatment or not.|
48670367|NCT01928394|101974931|FG010|STARTED|Follow-up Period||30|started = number of Participants regardless of continuing treatment or not.|
48670433|NCT02460458|101974944|FG000|COMPLETED|First Prospective Phase||126||
48670368|NCT01928394|101974932|FG011|STARTED|Follow-up Period||81|started = number of Participants regardless of continuing treatment or not.|
48670369|NCT01928394|101974933|FG012|STARTED|Follow-up Period||61|started = number of Participants regardless of continuing treatment or not.|
48670370|NCT01928394|101974934|FG013|STARTED|Follow-up Period||145|started = number of Participants regardless of continuing treatment or not.|
48670371|NCT01928394|101974935|FG014|STARTED|Follow-up Period||96|started = number of Participants regardless of continuing treatment or not.|
48670372|NCT01928394|101974936|FG015|STARTED|Follow-up Period||3|started = number of Participants regardless of continuing treatment or not.|
48670373|NCT01928394|101974937|FG016|STARTED|Follow-up Period||55|started = number of Participants regardless of continuing treatment or not.|
48670374|NCT01928394|101974938|FG017|STARTED|Follow-up Period||58|started = number of Participants regardless of continuing treatment or not.|
48670375|NCT01928394|101974939|FG018|STARTED|Follow-up Period||92|started = number of Participants regardless of continuing treatment or not.|
48670376|NCT01928394|101974940|FG019|STARTED|Follow-up Period||104|started = number of Participants regardless of continuing treatment or not.|
48670377|NCT01928394|101974941|FG020|STARTED|Follow-up Period||41|started = number of Participants regardless of continuing treatment or not.|
48670378|NCT01928394|101974942|FG021|STARTED|Follow-up Period||43|started = number of Participants regardless of continuing treatment or not.|
48670379|NCT01928394|101974943|FG022|STARTED|Follow-up Period||42|started = number of Participants regardless of continuing treatment or not.|
48670380|NCT01928394|101974921|FG000|COMPLETED|Follow-up Period||12|completed = continuing to be followed|
48670381|NCT01928394|101974922|FG001|COMPLETED|Follow-up Period||3|completed = continuing to be followed|
48670382|NCT01928394|101974923|FG002|COMPLETED|Follow-up Period||15|completed = continuing to be followed|
48670383|NCT01928394|101974924|FG003|COMPLETED|Follow-up Period||40|completed = continuing to be followed|
48670384|NCT01928394|101974925|FG004|COMPLETED|Follow-up Period||3|completed = continuing to be followed|
48670385|NCT01928394|101974926|FG005|COMPLETED|Follow-up Period||41|completed = continuing to be followed|
48670386|NCT01928394|101974927|FG006|COMPLETED|Follow-up Period||40|completed = continuing to be followed|
48670387|NCT01928394|101974928|FG007|COMPLETED|Follow-up Period||10|completed = continuing to be followed|
48670388|NCT01928394|101974929|FG008|COMPLETED|Follow-up Period||2|completed = continuing to be followed|
48670389|NCT01928394|101974930|FG009|COMPLETED|Follow-up Period||16|completed = continuing to be followed|
48670390|NCT01928394|101974931|FG010|COMPLETED|Follow-up Period||19|completed = continuing to be followed|
48670391|NCT01928394|101974932|FG011|COMPLETED|Follow-up Period||59|completed = continuing to be followed|
48670392|NCT01928394|101974933|FG012|COMPLETED|Follow-up Period||47|completed = continuing to be followed|
48670393|NCT01928394|101974934|FG013|COMPLETED|Follow-up Period||107|completed = continuing to be followed|
48670394|NCT01928394|101974935|FG014|COMPLETED|Follow-up Period||66|completed = continuing to be followed|
48670395|NCT01928394|101974936|FG015|COMPLETED|Follow-up Period||3|completed = continuing to be followed|
48670396|NCT01928394|101974937|FG016|COMPLETED|Follow-up Period||41|completed = continuing to be followed|
48670397|NCT01928394|101974938|FG017|COMPLETED|Follow-up Period||50|completed = continuing to be followed|
48670398|NCT01928394|101974939|FG018|COMPLETED|Follow-up Period||76|completed = continuing to be followed|
48670399|NCT01928394|101974940|FG019|COMPLETED|Follow-up Period||83|completed = continuing to be followed|
48670400|NCT01928394|101974941|FG020|COMPLETED|Follow-up Period||32|completed = continuing to be followed|
48670401|NCT01928394|101974942|FG021|COMPLETED|Follow-up Period||34|completed = continuing to be followed|
48670402|NCT01928394|101974943|FG022|COMPLETED|Follow-up Period||36|completed = continuing to be followed|
48670403|NCT01928394|101974921|FG000|NOT COMPLETED|Follow-up Period||3||
48670404|NCT01928394|101974922|FG001|NOT COMPLETED|Follow-up Period||0||
48670405|NCT01928394|101974923|FG002|NOT COMPLETED|Follow-up Period||3||
48670406|NCT01928394|101974924|FG003|NOT COMPLETED|Follow-up Period||10||
48670407|NCT01928394|101974925|FG004|NOT COMPLETED|Follow-up Period||0||
48670408|NCT01928394|101974926|FG005|NOT COMPLETED|Follow-up Period||8||
48670409|NCT01928394|101974927|FG006|NOT COMPLETED|Follow-up Period||12||
48670410|NCT01928394|101974928|FG007|NOT COMPLETED|Follow-up Period||6||
48670411|NCT01928394|101974929|FG008|NOT COMPLETED|Follow-up Period||1||
48670412|NCT01928394|101974930|FG009|NOT COMPLETED|Follow-up Period||2||
48670413|NCT01928394|101974931|FG010|NOT COMPLETED|Follow-up Period||11||
48670414|NCT01928394|101974932|FG011|NOT COMPLETED|Follow-up Period||22||
48670415|NCT01928394|101974933|FG012|NOT COMPLETED|Follow-up Period||14||
48670416|NCT01928394|101974934|FG013|NOT COMPLETED|Follow-up Period||38||
48670417|NCT01928394|101974935|FG014|NOT COMPLETED|Follow-up Period||30||
48670418|NCT01928394|101974936|FG015|NOT COMPLETED|Follow-up Period||0||
48670419|NCT01928394|101974937|FG016|NOT COMPLETED|Follow-up Period||14||
48670420|NCT01928394|101974938|FG017|NOT COMPLETED|Follow-up Period||8||
48670421|NCT01928394|101974939|FG018|NOT COMPLETED|Follow-up Period||16||
48670422|NCT01928394|101974940|FG019|NOT COMPLETED|Follow-up Period||21||
48670423|NCT01928394|101974941|FG020|NOT COMPLETED|Follow-up Period||9||
48670424|NCT01928394|101974942|FG021|NOT COMPLETED|Follow-up Period||9||
48670425|NCT01928394|101974943|FG022|NOT COMPLETED|Follow-up Period||6||
48670426|NCT02460458|101974944|FG000|STARTED|Retrospective Phase||265||
48670427|NCT02460458|101974944|FG000|COMPLETED|Retrospective Phase||265||
48670428|NCT02460458|101974944|FG000|NOT COMPLETED|Retrospective Phase||0||
48670429|NCT02460458|101974944|FG000|STARTED|Confirmatory Phase||265||
48670430|NCT02460458|101974944|FG000|COMPLETED|Confirmatory Phase||210||
